id|nct_id|mesh_term|downcase_mesh_term|mesh_type
6524559|NCT00759070|Ritonavir|ritonavir|mesh-list
6524560|NCT00759070|Lopinavir|lopinavir|mesh-list
6524561|NCT00759070|Tenofovir|tenofovir|mesh-list
6791284|NCT02238704|Calcium, Dietary|calcium, dietary|mesh-list
6791285|NCT02238704|Iron|iron|mesh-list
6791286|NCT02238704|Folic Acid|folic acid|mesh-list
6791287|NCT02238704|Vitamin B Complex|vitamin b complex|mesh-list
6791288|NCT02238704|Calcium|calcium|mesh-list
6791289|NCT02238704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6791290|NCT02238704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791291|NCT02238704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6791292|NCT02238704|Trace Elements|trace elements|mesh-ancestor
6791293|NCT02238704|Micronutrients|micronutrients|mesh-ancestor
6791294|NCT02238704|Hematinics|hematinics|mesh-ancestor
6791295|NCT02238704|Vitamins|vitamins|mesh-ancestor
6791296|NCT02238717|Pregabalin|pregabalin|mesh-list
6791297|NCT02238717|PF-06372865|pf-06372865|mesh-list
6791298|NCT02238717|Analgesics|analgesics|mesh-ancestor
6791299|NCT02238717|Sensory System Agents|sensory system agents|mesh-ancestor
6791300|NCT02238717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6791301|NCT02238717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791302|NCT02238717|Anticonvulsants|anticonvulsants|mesh-ancestor
6791303|NCT02238717|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6791304|NCT02238717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6791305|NCT02238717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791306|NCT02238717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6791307|NCT02238717|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6791308|NCT02238717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6791309|NCT02238717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6791310|NCT02238717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6791311|NCT02238717|GABA Modulators|gaba modulators|mesh-ancestor
6791312|NCT02238717|GABA Agents|gaba agents|mesh-ancestor
6791313|NCT02238717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6791314|NCT02238808|Estradiol|estradiol|mesh-list
6791315|NCT02238808|Estrogens|estrogens|mesh-list
6791316|NCT02238808|Hormones|hormones|mesh-ancestor
6791317|NCT02238808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6791318|NCT02238808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791319|NCT02238860|Tenofovir|tenofovir|mesh-list
6791320|NCT02238860|Antiviral Agents|antiviral agents|mesh-ancestor
6791321|NCT02238860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6791322|NCT02238860|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6791323|NCT02238860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6791324|NCT02238860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6791325|NCT02238860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791326|NCT02238860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6791327|NCT02238860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6791328|NCT02239107|Acetylcysteine|acetylcysteine|mesh-list
6791329|NCT02239107|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6791330|NCT02239107|Antiviral Agents|antiviral agents|mesh-ancestor
6791331|NCT02239107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6791332|NCT02239107|Expectorants|expectorants|mesh-ancestor
6791333|NCT02239107|Respiratory System Agents|respiratory system agents|mesh-ancestor
6791334|NCT02239107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6791335|NCT02239107|Antioxidants|antioxidants|mesh-ancestor
6791336|NCT02239107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791337|NCT02239107|Protective Agents|protective agents|mesh-ancestor
6791338|NCT02239107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791339|NCT02239107|Antidotes|antidotes|mesh-ancestor
6791340|NCT02239276|Stiripentol|stiripentol|mesh-list
6791341|NCT02239276|Anticonvulsants|anticonvulsants|mesh-ancestor
6791342|NCT02239445|Dexmedetomidine|dexmedetomidine|mesh-list
6791343|NCT02239445|Chloral Hydrate|chloral hydrate|mesh-list
6791344|NCT02239445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6791345|NCT02239445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6791346|NCT02239445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791347|NCT02239445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6791348|NCT02239445|Analgesics|analgesics|mesh-ancestor
6791349|NCT02239445|Sensory System Agents|sensory system agents|mesh-ancestor
6791350|NCT02239445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6791351|NCT02239445|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6791352|NCT02239445|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6791353|NCT02239445|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6791354|NCT02239445|Adrenergic Agents|adrenergic agents|mesh-ancestor
6524562|NCT00759070|Emtricitabine|emtricitabine|mesh-list
6524563|NCT00759070|Efavirenz|efavirenz|mesh-list
6791355|NCT02239445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6791356|NCT02239445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791357|NCT02239458|Saxagliptin|saxagliptin|mesh-list
6524564|NCT00759070|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6524565|NCT00759070|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6524566|NCT00759070|Protease Inhibitors|protease inhibitors|mesh-ancestor
6524567|NCT00759070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6524568|NCT00759070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524569|NCT00759070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6524570|NCT00759070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6524571|NCT00759070|Antiviral Agents|antiviral agents|mesh-ancestor
6524572|NCT00759070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6524573|NCT00759070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6524574|NCT00759070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6524575|NCT00759070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6524576|NCT00759070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6524577|NCT00759070|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6524578|NCT00759070|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6524579|NCT00759070|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6524580|NCT00759070|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6524581|NCT00759070|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6524582|NCT00759083|Bivalirudin|bivalirudin|mesh-list
6524583|NCT00759083|Antithrombins|antithrombins|mesh-ancestor
6524584|NCT00759083|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6524585|NCT00759083|Protease Inhibitors|protease inhibitors|mesh-ancestor
6524586|NCT00759083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6524587|NCT00759083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524588|NCT00759083|Anticoagulants|anticoagulants|mesh-ancestor
6524589|NCT00759122|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6524590|NCT00759122|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6524591|NCT00759122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6524592|NCT00759122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6524593|NCT00759122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524594|NCT00759122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6524595|NCT00759122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524596|NCT00759122|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6524597|NCT00759122|Antidepressive Agents|antidepressive agents|mesh-ancestor
6524598|NCT00759122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6524599|NCT00759200|Interferons|interferons|mesh-list
6524600|NCT00759200|Interferon-alpha|interferon-alpha|mesh-list
6524601|NCT00759200|Interferon alpha-2|interferon alpha-2|mesh-list
6524602|NCT00759200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6524603|NCT00759200|Antiviral Agents|antiviral agents|mesh-ancestor
6524604|NCT00759200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6524605|NCT00759200|Immunologic Factors|immunologic factors|mesh-ancestor
6524606|NCT00759200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524607|NCT00759226|Leucovorin|leucovorin|mesh-list
6524608|NCT00759226|Folic Acid|folic acid|mesh-list
6524609|NCT00759226|Gemcitabine|gemcitabine|mesh-list
6524610|NCT00759226|Cisplatin|cisplatin|mesh-list
6524611|NCT00759226|Levoleucovorin|levoleucovorin|mesh-list
6524612|NCT00759226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6524613|NCT00759226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6524614|NCT00759226|Antimetabolites|antimetabolites|mesh-ancestor
6791358|NCT02239458|Incretins|incretins|mesh-ancestor
6791359|NCT02239458|Hormones|hormones|mesh-ancestor
6791360|NCT02239458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6791361|NCT02239458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791362|NCT02239458|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6791363|NCT02239458|Protease Inhibitors|protease inhibitors|mesh-ancestor
6791364|NCT02239458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6791365|NCT02239458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791366|NCT02239458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6791367|NCT02239484|Tadalafil|tadalafil|mesh-list
6791368|NCT02239484|Tamsulosin|tamsulosin|mesh-list
6791369|NCT02239484|Vasodilator Agents|vasodilator agents|mesh-ancestor
6791370|NCT02239484|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6791371|NCT02239484|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6791372|NCT02239484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6791373|NCT02239484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791374|NCT02239484|Urological Agents|urological agents|mesh-ancestor
6791375|NCT02239484|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6791376|NCT02239484|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6791377|NCT02239484|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6791378|NCT02239484|Adrenergic Agents|adrenergic agents|mesh-ancestor
6791379|NCT02239484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6524615|NCT00759226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524616|NCT00759226|Antiviral Agents|antiviral agents|mesh-ancestor
6524617|NCT00759226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6524618|NCT00759226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6524619|NCT00759226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6524620|NCT00759226|Immunologic Factors|immunologic factors|mesh-ancestor
6524621|NCT00759226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524622|NCT00759226|Antidotes|antidotes|mesh-ancestor
6524623|NCT00759226|Protective Agents|protective agents|mesh-ancestor
6524624|NCT00759226|Vitamin B Complex|vitamin b complex|mesh-ancestor
6524625|NCT00759226|Vitamins|vitamins|mesh-ancestor
6524626|NCT00759226|Micronutrients|micronutrients|mesh-ancestor
6524627|NCT00759226|Hematinics|hematinics|mesh-ancestor
6524628|NCT00759239|Timolol|timolol|mesh-list
6524629|NCT00759239|Travoprost|travoprost|mesh-list
6524630|NCT00759239|Maleic acid|maleic acid|mesh-list
6524631|NCT00759239|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6524632|NCT00759239|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6524633|NCT00759239|Adrenergic Agents|adrenergic agents|mesh-ancestor
6524634|NCT00759239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6524635|NCT00759239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524636|NCT00759239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524637|NCT00759239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6524638|NCT00759239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6524639|NCT00759239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6524640|NCT00759291|Acipimox|acipimox|mesh-list
6524641|NCT00759291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6524642|NCT00759291|Antimetabolites|antimetabolites|mesh-ancestor
6524643|NCT00759291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524644|NCT00759291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6524645|NCT00759317|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6524646|NCT00759317|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6524647|NCT00759317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6524648|NCT00759317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6524649|NCT00759317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524650|NCT00759317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6524651|NCT00759317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524652|NCT00759317|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6524653|NCT00759317|Antidepressive Agents|antidepressive agents|mesh-ancestor
6524654|NCT00759317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6524655|NCT00759421|Olanzapine|olanzapine|mesh-list
6524656|NCT00759421|Sertindole|sertindole|mesh-list
6524657|NCT00759421|Antiemetics|antiemetics|mesh-ancestor
6524658|NCT00759421|Autonomic Agents|autonomic agents|mesh-ancestor
6524659|NCT00759421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6524660|NCT00759421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524661|NCT00759421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6524662|NCT00759421|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6524663|NCT00759421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6524664|NCT00759421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6524665|NCT00759421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6524666|NCT00759421|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6524667|NCT00759421|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6524668|NCT00759421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6524669|NCT00759421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524670|NCT00759421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6524671|NCT00759421|Serotonin Agents|serotonin agents|mesh-ancestor
6791380|NCT02239484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791381|NCT02239523|Denosumab|denosumab|mesh-list
6791382|NCT02239523|Teriparatide|teriparatide|mesh-list
6791383|NCT02239523|Diphosphonates|diphosphonates|mesh-list
6791384|NCT02239523|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6791385|NCT02239523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791386|NCT02239523|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6791387|NCT02239614|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6791388|NCT02239614|Aluminum sulfate|aluminum sulfate|mesh-list
6791389|NCT02239614|Immunologic Factors|immunologic factors|mesh-ancestor
6791390|NCT02239614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791391|NCT02239614|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6791392|NCT02239614|Antacids|antacids|mesh-ancestor
6791393|NCT02239614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791394|NCT02239614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6791395|NCT02239731|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6791396|NCT02239731|Doxycycline|doxycycline|mesh-list
6524672|NCT00759460|Olanzapine|olanzapine|mesh-list
6524673|NCT00759460|Sertindole|sertindole|mesh-list
6524674|NCT00759460|Antiemetics|antiemetics|mesh-ancestor
6524675|NCT00759460|Autonomic Agents|autonomic agents|mesh-ancestor
6524676|NCT00759460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6524677|NCT00759460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524678|NCT00759460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6524679|NCT00759460|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6524680|NCT00759460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6524681|NCT00759460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6524682|NCT00759460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6524683|NCT00759460|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6524684|NCT00759460|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6524685|NCT00759460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6524686|NCT00759460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524687|NCT00759460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6524688|NCT00759460|Serotonin Agents|serotonin agents|mesh-ancestor
6524689|NCT00759551|Olmesartan|olmesartan|mesh-list
6524690|NCT00759551|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
6524691|NCT00759551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6524692|NCT00759551|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6791397|NCT02239731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6791398|NCT02239731|Antimalarials|antimalarials|mesh-ancestor
6791399|NCT02239731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6791400|NCT02239731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6791401|NCT02239835|Ritonavir|ritonavir|mesh-list
6791402|NCT02239835|Saquinavir|saquinavir|mesh-list
6791403|NCT02239835|Tipranavir|tipranavir|mesh-list
6791404|NCT02239835|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6791405|NCT02239835|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6791406|NCT02239835|Protease Inhibitors|protease inhibitors|mesh-ancestor
6791407|NCT02239835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6791408|NCT02239835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791409|NCT02239835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6791410|NCT02239835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6791411|NCT02239835|Antiviral Agents|antiviral agents|mesh-ancestor
6791412|NCT02239835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6791413|NCT02239835|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6791414|NCT02239835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6791415|NCT02239874|Vitamin D|vitamin d|mesh-list
6791416|NCT02239874|Ergocalciferols|ergocalciferols|mesh-list
6791417|NCT02239874|Vitamins|vitamins|mesh-list
6791418|NCT02239874|Micronutrients|micronutrients|mesh-ancestor
6791419|NCT02239874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791420|NCT02239874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6791421|NCT02239874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6791422|NCT02239900|Ipilimumab|ipilimumab|mesh-list
6791423|NCT02239900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6791424|NCT02239900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6791425|NCT02239900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6791426|NCT02239900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791427|NCT02239913|Topiramate|topiramate|mesh-list
6791428|NCT02239913|Phentermine|phentermine|mesh-list
6791429|NCT02239913|Cocaine|cocaine|mesh-list
6791430|NCT02239913|Anticonvulsants|anticonvulsants|mesh-ancestor
6791431|NCT02239913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6791432|NCT02239913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791433|NCT02239913|Anesthetics, Local|anesthetics, local|mesh-ancestor
6791434|NCT02239913|Anesthetics|anesthetics|mesh-ancestor
6791435|NCT02239913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6791436|NCT02239913|Sensory System Agents|sensory system agents|mesh-ancestor
6791437|NCT02239913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6791438|NCT02239913|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6791439|NCT02239913|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6791440|NCT02239913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6791441|NCT02239913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6791442|NCT02239913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791443|NCT02239913|Dopamine Agents|dopamine agents|mesh-ancestor
6791444|NCT02239913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6791445|NCT02239913|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6791446|NCT02239913|Appetite Depressants|appetite depressants|mesh-ancestor
6791447|NCT02239913|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6791448|NCT02239913|Sympathomimetics|sympathomimetics|mesh-ancestor
6791449|NCT02239913|Autonomic Agents|autonomic agents|mesh-ancestor
6791450|NCT02239913|Adrenergic Agents|adrenergic agents|mesh-ancestor
6791451|NCT02239952|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6791452|NCT02239952|Sunitinib|sunitinib|mesh-list
6524693|NCT00759551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6524694|NCT00759551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524695|NCT00759720|Glyburide|glyburide|mesh-list
6524696|NCT00759720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6524697|NCT00759720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524698|NCT00759733|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6524699|NCT00759733|Natriuretic Agents|natriuretic agents|mesh-ancestor
6524700|NCT00759733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524701|NCT00759824|Cyclophosphamide|cyclophosphamide|mesh-list
6524702|NCT00759824|Doxorubicin|doxorubicin|mesh-list
6524703|NCT00759824|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6524704|NCT00759824|Vindesine|vindesine|mesh-list
6524705|NCT00759824|Valproic Acid|valproic acid|mesh-list
6524706|NCT00759824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6524707|NCT00759824|Immunologic Factors|immunologic factors|mesh-ancestor
6524708|NCT00759824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524709|NCT00759824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6524710|NCT00759824|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6524711|NCT00759824|Alkylating Agents|alkylating agents|mesh-ancestor
6524712|NCT00759824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524713|NCT00759824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6524714|NCT00759824|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6524715|NCT00759824|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6524716|NCT00759824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6524717|NCT00759824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6524718|NCT00759824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6524719|NCT00759824|Anticonvulsants|anticonvulsants|mesh-ancestor
6524720|NCT00759824|GABA Agents|gaba agents|mesh-ancestor
6524721|NCT00759824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6524722|NCT00759824|Antimanic Agents|antimanic agents|mesh-ancestor
6524723|NCT00759824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6524724|NCT00759824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6524725|NCT00759824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6524726|NCT00759824|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6524727|NCT00759824|Tubulin Modulators|tubulin modulators|mesh-ancestor
6791453|NCT02239952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6791454|NCT02239952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6791455|NCT02239952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6791456|NCT02239952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791457|NCT02239952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6791458|NCT02239952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6791459|NCT02239952|Growth Substances|growth substances|mesh-ancestor
6791460|NCT02239952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791461|NCT02239952|Growth Inhibitors|growth inhibitors|mesh-ancestor
6791462|NCT02240017|Gemcitabine|gemcitabine|mesh-list
6791463|NCT02240017|Carboplatin|carboplatin|mesh-list
6791464|NCT02240017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6791465|NCT02240017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6791466|NCT02240017|Antimetabolites|antimetabolites|mesh-ancestor
6791467|NCT02240017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791468|NCT02240017|Antiviral Agents|antiviral agents|mesh-ancestor
6791469|NCT02240017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6791470|NCT02240017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6791471|NCT02240017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6791472|NCT02240017|Immunologic Factors|immunologic factors|mesh-ancestor
6791473|NCT02240017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791474|NCT02240043|Hormones|hormones|mesh-list
6791475|NCT02240043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6791476|NCT02240043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524728|NCT00759824|Antimitotic Agents|antimitotic agents|mesh-ancestor
6524729|NCT00759824|Mitosis Modulators|mitosis modulators|mesh-ancestor
6524730|NCT00759928|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6524731|NCT00759928|Sorafenib|sorafenib|mesh-list
6524732|NCT00759928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6524733|NCT00759928|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6524734|NCT00759928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6524735|NCT00759928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524736|NCT00759993|Chromium|chromium|mesh-list
6524737|NCT00759993|Trace Elements|trace elements|mesh-ancestor
6524738|NCT00759993|Micronutrients|micronutrients|mesh-ancestor
6524739|NCT00759993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524740|NCT00760032|Ciprofloxacin|ciprofloxacin|mesh-list
6524741|NCT00760032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6524742|NCT00760032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6524743|NCT00760032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6524744|NCT00760032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6524745|NCT00760032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6524746|NCT00760032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524747|NCT00760032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6791477|NCT02240160|Nabiximols|nabiximols|mesh-list
6791478|NCT02240160|Analgesics|analgesics|mesh-ancestor
6791479|NCT02240160|Sensory System Agents|sensory system agents|mesh-ancestor
6791480|NCT02240160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6791481|NCT02240160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791482|NCT02240173|Haloperidol|haloperidol|mesh-list
6791483|NCT02240173|Haloperidol decanoate|haloperidol decanoate|mesh-list
6791484|NCT02240173|Antiemetics|antiemetics|mesh-ancestor
6791485|NCT02240173|Autonomic Agents|autonomic agents|mesh-ancestor
6791486|NCT02240173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6791487|NCT02240173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791488|NCT02240173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6791489|NCT02240173|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6791490|NCT02240173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6791491|NCT02240173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6791492|NCT02240173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6791493|NCT02240173|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6791494|NCT02240173|Dopamine Agents|dopamine agents|mesh-ancestor
6791495|NCT02240173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6791496|NCT02240173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791497|NCT02240173|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6791498|NCT02240199|Lidocaine|lidocaine|mesh-list
6791499|NCT02240199|Pregabalin|pregabalin|mesh-list
6791500|NCT02240199|Anesthetics, Local|anesthetics, local|mesh-ancestor
6791501|NCT02240199|Anesthetics|anesthetics|mesh-ancestor
6791502|NCT02240199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6791503|NCT02240199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791504|NCT02240199|Sensory System Agents|sensory system agents|mesh-ancestor
6791505|NCT02240199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6791506|NCT02240199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6791507|NCT02240199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6791508|NCT02240199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6791509|NCT02240199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6791510|NCT02240199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791511|NCT02240199|Analgesics|analgesics|mesh-ancestor
6791512|NCT02240199|Anticonvulsants|anticonvulsants|mesh-ancestor
6791513|NCT02240199|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6791514|NCT02240199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6791515|NCT02240199|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6791516|NCT02240199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6791517|NCT02240199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6791518|NCT02240212|Paclitaxel|paclitaxel|mesh-list
6791519|NCT02240212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6791520|NCT02240212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6791521|NCT02240212|Tubulin Modulators|tubulin modulators|mesh-ancestor
6791522|NCT02240212|Antimitotic Agents|antimitotic agents|mesh-ancestor
6791523|NCT02240212|Mitosis Modulators|mitosis modulators|mesh-ancestor
6791524|NCT02240212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791525|NCT02240238|Gemcitabine|gemcitabine|mesh-list
6791526|NCT02240238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6791527|NCT02240238|Antimetabolites|antimetabolites|mesh-ancestor
6791528|NCT02240238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791529|NCT02240238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6791530|NCT02240238|Antiviral Agents|antiviral agents|mesh-ancestor
6791531|NCT02240238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6524748|NCT00760032|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6524749|NCT00760032|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6524750|NCT00760045|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6524751|NCT00760045|Hyaluronic Acid|hyaluronic acid|mesh-list
6524752|NCT00760045|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6524753|NCT00760045|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6524754|NCT00760045|Immunologic Factors|immunologic factors|mesh-ancestor
6524755|NCT00760045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524756|NCT00760045|Viscosupplements|viscosupplements|mesh-ancestor
6524757|NCT00760045|Protective Agents|protective agents|mesh-ancestor
6524758|NCT00760149|Rifampin|rifampin|mesh-list
6524759|NCT00760149|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6524760|NCT00760149|Antitubercular Agents|antitubercular agents|mesh-ancestor
6524761|NCT00760149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6524762|NCT00760149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6524763|NCT00760149|Leprostatic Agents|leprostatic agents|mesh-ancestor
6524764|NCT00760149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6524765|NCT00760149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6524766|NCT00760149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524767|NCT00760149|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6524768|NCT00760149|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6524769|NCT00760149|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6524770|NCT00760149|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6524771|NCT00760149|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6524772|NCT00760149|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6524773|NCT00760175|Vaccines|vaccines|mesh-list
6524774|NCT00760175|Immunologic Factors|immunologic factors|mesh-ancestor
6524775|NCT00760175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524776|NCT00760279|Azithromycin|azithromycin|mesh-list
6524777|NCT00760279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6524778|NCT00760279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6524779|NCT00760318|Levetiracetam|levetiracetam|mesh-list
6524780|NCT00760318|Anticonvulsants|anticonvulsants|mesh-ancestor
6524781|NCT00760318|Nootropic Agents|nootropic agents|mesh-ancestor
6524782|NCT00760370|Zoledronic Acid|zoledronic acid|mesh-list
6524783|NCT00760370|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6524784|NCT00760370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524785|NCT00760448|Insulin|insulin|mesh-list
6524786|NCT00760448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6524787|NCT00760448|Insulin Detemir|insulin detemir|mesh-list
6524788|NCT00760448|Isophane Insulin, Human|isophane insulin, human|mesh-list
6524789|NCT00760448|Insulin, Isophane|insulin, isophane|mesh-list
6524790|NCT00760448|Isophane insulin, beef|isophane insulin, beef|mesh-list
6524791|NCT00760448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6524792|NCT00760448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524793|NCT00760695|Dronabinol|dronabinol|mesh-list
6524794|NCT00760695|Hallucinogens|hallucinogens|mesh-ancestor
6524795|NCT00760695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524796|NCT00760695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6524797|NCT00760695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6524798|NCT00760695|Analgesics|analgesics|mesh-ancestor
6524799|NCT00760695|Sensory System Agents|sensory system agents|mesh-ancestor
6524800|NCT00760695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6524801|NCT00760695|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6524802|NCT00760695|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6524803|NCT00760695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6524804|NCT00760695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524805|NCT00760695|Hormones|hormones|mesh-ancestor
6524806|NCT00760695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6524807|NCT00760864|Methotrexate|methotrexate|mesh-list
6524808|NCT00760864|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6524809|NCT00760864|Abortifacient Agents|abortifacient agents|mesh-ancestor
6524810|NCT00760864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6524811|NCT00760864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524812|NCT00760864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6524813|NCT00760864|Antimetabolites|antimetabolites|mesh-ancestor
6524814|NCT00760864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524815|NCT00760864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6524816|NCT00760864|Dermatologic Agents|dermatologic agents|mesh-ancestor
6524817|NCT00760864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6524818|NCT00760864|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6791532|NCT02240238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6791533|NCT02240238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6791534|NCT02240238|Immunologic Factors|immunologic factors|mesh-ancestor
6524819|NCT00760864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6524820|NCT00760864|Immunologic Factors|immunologic factors|mesh-ancestor
6524821|NCT00760864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6524822|NCT00760864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6524823|NCT00760916|Treprostinil|treprostinil|mesh-list
6524824|NCT00760916|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6524825|NCT00760968|Methotrexate|methotrexate|mesh-list
6524826|NCT00760968|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6524827|NCT00760968|Abortifacient Agents|abortifacient agents|mesh-ancestor
6524828|NCT00760968|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6524829|NCT00760968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524830|NCT00760968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6524831|NCT00760968|Antimetabolites|antimetabolites|mesh-ancestor
6524832|NCT00760968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524833|NCT00760968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6524834|NCT00760968|Dermatologic Agents|dermatologic agents|mesh-ancestor
6524835|NCT00760968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6524836|NCT00760968|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6524837|NCT00760968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6524838|NCT00760968|Immunologic Factors|immunologic factors|mesh-ancestor
6524839|NCT00760968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6524840|NCT00760968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6524841|NCT00760981|Imatinib Mesylate|imatinib mesylate|mesh-list
6524842|NCT00760981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6524843|NCT00760981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6524844|NCT00760981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6524845|NCT00760981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524846|NCT00761020|Mefloquine|mefloquine|mesh-list
6524847|NCT00761020|Antimalarials|antimalarials|mesh-ancestor
6524848|NCT00761020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6524849|NCT00761020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6524850|NCT00761020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6537259|NCT00821496|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6537260|NCT00821496|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6537261|NCT00821535|Maraviroc|maraviroc|mesh-list
6537262|NCT00821535|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6537263|NCT00821535|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6537264|NCT00821535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537265|NCT00821535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6537266|NCT00821535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6537267|NCT00821535|Antiviral Agents|antiviral agents|mesh-ancestor
6537268|NCT00821535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6537269|NCT00821535|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6537270|NCT00821574|Valsartan|valsartan|mesh-list
6537271|NCT00821574|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6537272|NCT00821574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6537273|NCT00821574|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6537274|NCT00821574|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6537275|NCT00821574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537276|NCT00821574|Diuretics|diuretics|mesh-ancestor
6537277|NCT00821574|Natriuretic Agents|natriuretic agents|mesh-ancestor
6537278|NCT00821574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537279|NCT00821574|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6537280|NCT00821574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6537281|NCT00821600|Risperidone|risperidone|mesh-list
6537282|NCT00821600|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6537283|NCT00821600|Serotonin Agents|serotonin agents|mesh-ancestor
6537284|NCT00821600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6791535|NCT02240238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791536|NCT02240407|Acetaminophen|acetaminophen|mesh-list
6791537|NCT02240407|Diphenhydramine|diphenhydramine|mesh-list
6791538|NCT02240407|Promethazine|promethazine|mesh-list
6791539|NCT02240407|Sirolimus|sirolimus|mesh-list
6791540|NCT02240407|Rituximab|rituximab|mesh-list
6791541|NCT02240407|Lidocaine|lidocaine|mesh-list
6791542|NCT02240407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6791543|NCT02240407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6791544|NCT02240407|Immunologic Factors|immunologic factors|mesh-ancestor
6791545|NCT02240407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791546|NCT02240407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6791547|NCT02240407|Anesthetics, Local|anesthetics, local|mesh-ancestor
6791548|NCT02240407|Anesthetics|anesthetics|mesh-ancestor
6791549|NCT02240407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6791550|NCT02240407|Sensory System Agents|sensory system agents|mesh-ancestor
6791551|NCT02240407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6524851|NCT00761228|Apomorphine|apomorphine|mesh-list
6524852|NCT00761228|Emetics|emetics|mesh-ancestor
6524853|NCT00761228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524854|NCT00761228|Autonomic Agents|autonomic agents|mesh-ancestor
6524855|NCT00761228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6524856|NCT00761228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6524857|NCT00761228|Dopamine Agonists|dopamine agonists|mesh-ancestor
6524858|NCT00761228|Dopamine Agents|dopamine agents|mesh-ancestor
6524859|NCT00761228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6524860|NCT00761228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524861|NCT00761241|Gemcitabine|gemcitabine|mesh-list
6524862|NCT00761241|Interferons|interferons|mesh-list
6524863|NCT00761241|Interferon-alpha|interferon-alpha|mesh-list
6524864|NCT00761241|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
6524865|NCT00761241|Docetaxel|docetaxel|mesh-list
6524866|NCT00761241|Oxaliplatin|oxaliplatin|mesh-list
6524867|NCT00761241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6524868|NCT00761241|Antimetabolites|antimetabolites|mesh-ancestor
6524869|NCT00761241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524870|NCT00761241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6524871|NCT00761241|Antiviral Agents|antiviral agents|mesh-ancestor
6524872|NCT00761241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6524873|NCT00761241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6524874|NCT00761241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6524875|NCT00761241|Immunologic Factors|immunologic factors|mesh-ancestor
6524876|NCT00761241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524877|NCT00761241|Tubulin Modulators|tubulin modulators|mesh-ancestor
6524878|NCT00761241|Antimitotic Agents|antimitotic agents|mesh-ancestor
6524879|NCT00761241|Mitosis Modulators|mitosis modulators|mesh-ancestor
6524880|NCT00761254|Domperidone|domperidone|mesh-list
6524881|NCT00761254|Antiemetics|antiemetics|mesh-ancestor
6524882|NCT00761254|Autonomic Agents|autonomic agents|mesh-ancestor
6524883|NCT00761254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6524884|NCT00761254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524885|NCT00761254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6524886|NCT00761254|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6524887|NCT00761254|Dopamine Agents|dopamine agents|mesh-ancestor
6524888|NCT00761254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6524889|NCT00761254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524890|NCT00761332|Teriparatide|teriparatide|mesh-list
6524891|NCT00761332|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
6524892|NCT00761332|Diphosphonates|diphosphonates|mesh-list
6524893|NCT00761332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6524894|NCT00761332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524895|NCT00761332|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6524896|NCT00761332|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6524897|NCT00761332|Hormone Antagonists|hormone antagonists|mesh-ancestor
6524898|NCT00761332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6524899|NCT00761332|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6524900|NCT00761332|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6524901|NCT00761358|Z 338|z 338|mesh-list
6524902|NCT00761358|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6524903|NCT00761358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6524904|NCT00761358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524905|NCT00761358|Cholinergic Agents|cholinergic agents|mesh-ancestor
6524906|NCT00761358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6524907|NCT00761358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524908|NCT00761358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6524909|NCT00761449|Lenalidomide|lenalidomide|mesh-list
6524910|NCT00761449|Immunologic Factors|immunologic factors|mesh-ancestor
6524911|NCT00761449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524912|NCT00761449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6524913|NCT00761449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6524914|NCT00761449|Growth Substances|growth substances|mesh-ancestor
6524915|NCT00761449|Growth Inhibitors|growth inhibitors|mesh-ancestor
6791552|NCT02240407|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6791553|NCT02240407|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6791554|NCT02240407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6791555|NCT02240407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6791556|NCT02240407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791557|NCT02240407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6791558|NCT02240407|Analgesics|analgesics|mesh-ancestor
6791559|NCT02240407|Antipyretics|antipyretics|mesh-ancestor
6791560|NCT02240407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6791561|NCT02240407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6524916|NCT00761449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6524917|NCT00761501|Naproxen|naproxen|mesh-list
6524918|NCT00761501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6524919|NCT00761501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6524920|NCT00761501|Analgesics|analgesics|mesh-ancestor
6524921|NCT00761501|Sensory System Agents|sensory system agents|mesh-ancestor
6524922|NCT00761501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6524923|NCT00761501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524924|NCT00761501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6524925|NCT00761501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6524926|NCT00761501|Gout Suppressants|gout suppressants|mesh-ancestor
6524927|NCT00761501|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6524928|NCT00761501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6524929|NCT00761501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524930|NCT00761540|Liraglutide|liraglutide|mesh-list
6524931|NCT00761540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6524932|NCT00761540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524933|NCT00761540|Incretins|incretins|mesh-ancestor
6524934|NCT00761540|Hormones|hormones|mesh-ancestor
6524935|NCT00761540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6524936|NCT00761644|Sirolimus|sirolimus|mesh-list
6524937|NCT00761644|Bevacizumab|bevacizumab|mesh-list
6524938|NCT00761644|Doxorubicin|doxorubicin|mesh-list
6524939|NCT00761644|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6524940|NCT00761644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6524941|NCT00761644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6524942|NCT00761644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6524943|NCT00761644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6524944|NCT00761644|Growth Substances|growth substances|mesh-ancestor
6524945|NCT00761644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524946|NCT00761644|Growth Inhibitors|growth inhibitors|mesh-ancestor
6524947|NCT00761644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6524948|NCT00761644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6524949|NCT00761644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6524950|NCT00761644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6524951|NCT00761644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524952|NCT00761644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6524953|NCT00761644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6524954|NCT00761644|Antifungal Agents|antifungal agents|mesh-ancestor
6524955|NCT00761644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6524956|NCT00761644|Immunologic Factors|immunologic factors|mesh-ancestor
6524957|NCT00761670|Risperidone|risperidone|mesh-list
6524958|NCT00761670|Amisulpride|amisulpride|mesh-list
6524959|NCT00761670|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6524960|NCT00761670|Serotonin Agents|serotonin agents|mesh-ancestor
6524961|NCT00761670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6524962|NCT00761670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524963|NCT00761670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524964|NCT00761670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6524965|NCT00761670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6524966|NCT00761670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6524967|NCT00761670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6524968|NCT00761670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6524969|NCT00761670|Dopamine Agents|dopamine agents|mesh-ancestor
6791562|NCT02240407|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6791563|NCT02240407|Antifungal Agents|antifungal agents|mesh-ancestor
6791564|NCT02240407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6791565|NCT02240407|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6791566|NCT02240407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6791567|NCT02240407|Antiemetics|antiemetics|mesh-ancestor
6791568|NCT02240407|Autonomic Agents|autonomic agents|mesh-ancestor
6791569|NCT02240407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6791570|NCT02240407|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6791571|NCT02240407|Histamine Antagonists|histamine antagonists|mesh-ancestor
6791572|NCT02240407|Histamine Agents|histamine agents|mesh-ancestor
6791573|NCT02240407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6791574|NCT02240407|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6791575|NCT02240407|Antipruritics|antipruritics|mesh-ancestor
6791576|NCT02240407|Dermatologic Agents|dermatologic agents|mesh-ancestor
6791577|NCT02240433|Sorafenib|sorafenib|mesh-list
6791578|NCT02240433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6791579|NCT02240433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6791580|NCT02240433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6791581|NCT02240433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791582|NCT02240459|Fesoterodine|fesoterodine|mesh-list
6791583|NCT02240459|Oxybutynin|oxybutynin|mesh-list
6524970|NCT00761670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6524971|NCT00761670|Antidepressive Agents|antidepressive agents|mesh-ancestor
6524972|NCT00761722|Azacitidine|azacitidine|mesh-list
6524973|NCT00761722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6524974|NCT00761722|Antimetabolites|antimetabolites|mesh-ancestor
6524975|NCT00761722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524976|NCT00761722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6524977|NCT00761722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6524978|NCT00761852|Ruboxistaurin|ruboxistaurin|mesh-list
6524979|NCT00761852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6524980|NCT00761852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524981|NCT00761904|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6524982|NCT00761904|Simvastatin|simvastatin|mesh-list
6524983|NCT00761904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6524984|NCT00761904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6524985|NCT00761904|Antimetabolites|antimetabolites|mesh-ancestor
6524986|NCT00761904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524987|NCT00761904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6524988|NCT00761904|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6524989|NCT00761904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6524990|NCT00761904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6524991|NCT00761904|Diuretics|diuretics|mesh-ancestor
6524992|NCT00761904|Natriuretic Agents|natriuretic agents|mesh-ancestor
6524993|NCT00761904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524994|NCT00761904|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6524995|NCT00761904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6524996|NCT00762060|Anesthetics|anesthetics|mesh-list
6524997|NCT00762060|Anesthetics, Local|anesthetics, local|mesh-list
6524998|NCT00762060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6524999|NCT00762060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525000|NCT00762060|Sensory System Agents|sensory system agents|mesh-ancestor
6525001|NCT00762060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6791584|NCT02240459|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6791585|NCT02240459|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6791586|NCT02240459|Cholinergic Agents|cholinergic agents|mesh-ancestor
6791587|NCT02240459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6791588|NCT02240459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791589|NCT02240459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791590|NCT02240459|Urological Agents|urological agents|mesh-ancestor
6791591|NCT02240459|Parasympatholytics|parasympatholytics|mesh-ancestor
6791592|NCT02240459|Autonomic Agents|autonomic agents|mesh-ancestor
6791593|NCT02240459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6791594|NCT02240498|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6791595|NCT02240498|Methylene Blue|methylene blue|mesh-list
6791596|NCT02240498|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6791597|NCT02240498|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6791598|NCT02240498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6791599|NCT02240498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6791600|NCT02240498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791601|NCT02240537|Sargramostim|sargramostim|mesh-list
6791602|NCT02240537|Immunologic Factors|immunologic factors|mesh-ancestor
6791603|NCT02240537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791604|NCT02240602|Oxycodone|oxycodone|mesh-list
6791605|NCT02240602|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6791606|NCT02240602|Narcotics|narcotics|mesh-ancestor
6791607|NCT02240602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6791608|NCT02240602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791609|NCT02240602|Analgesics|analgesics|mesh-ancestor
6791610|NCT02240602|Sensory System Agents|sensory system agents|mesh-ancestor
6791611|NCT02240602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6791612|NCT02240641|Antihypertensive Agents|antihypertensive agents|mesh-list
6791613|NCT02240641|Lacidipine|lacidipine|mesh-list
6791614|NCT02240641|Diuretics|diuretics|mesh-list
6791615|NCT02240641|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
6791616|NCT02240641|Enzyme Inhibitors|enzyme inhibitors|mesh-list
6791617|NCT02240641|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6791618|NCT02240641|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
6791619|NCT02240641|Natriuretic Agents|natriuretic agents|mesh-ancestor
6791620|NCT02240641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791621|NCT02240641|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6791622|NCT02240641|Adrenergic Agents|adrenergic agents|mesh-ancestor
6791623|NCT02240641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5992823|NCT00117845|Denileukin diftitox|denileukin diftitox|mesh-list
6525002|NCT00762099|Pregabalin|pregabalin|mesh-list
6525003|NCT00762099|Analgesics|analgesics|mesh-ancestor
6525004|NCT00762099|Sensory System Agents|sensory system agents|mesh-ancestor
6525005|NCT00762099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6525006|NCT00762099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525007|NCT00762099|Anticonvulsants|anticonvulsants|mesh-ancestor
6525008|NCT00762099|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6525009|NCT00762099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6525010|NCT00762099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525011|NCT00762099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6525012|NCT00762099|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6525013|NCT00762099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6525014|NCT00762099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6525015|NCT00762099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6525016|NCT00762151|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6525017|NCT00762151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6525018|NCT00762190|Insulin|insulin|mesh-list
6525019|NCT00762190|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6525020|NCT00762190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6525021|NCT00762190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525022|NCT00762255|Bevacizumab|bevacizumab|mesh-list
6791624|NCT02240641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791625|NCT02240641|Protease Inhibitors|protease inhibitors|mesh-ancestor
6791626|NCT02240641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6791627|NCT02240641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6791628|NCT02240641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6791629|NCT02240719|Everolimus|everolimus|mesh-list
6791630|NCT02240719|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6791631|NCT02240719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6791632|NCT02240719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6791633|NCT02240719|Immunologic Factors|immunologic factors|mesh-ancestor
6791634|NCT02240719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791635|NCT02240719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6791636|NCT02240719|Alkylating Agents|alkylating agents|mesh-ancestor
6791637|NCT02240719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791638|NCT02240888|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6791639|NCT02240888|Immunologic Factors|immunologic factors|mesh-ancestor
6791640|NCT02240888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791641|NCT02240927|Enoxaparin|enoxaparin|mesh-list
6791642|NCT02240927|Warfarin|warfarin|mesh-list
6791643|NCT02240927|Enoxaparin sodium|enoxaparin sodium|mesh-list
6791644|NCT02240927|Anticoagulants|anticoagulants|mesh-ancestor
6791645|NCT02240927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6791646|NCT02240927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6791647|NCT02240927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791648|NCT02240953|Warfarin|warfarin|mesh-list
6791649|NCT02240953|Anticoagulants|anticoagulants|mesh-ancestor
6791650|NCT02241005|Allantoin|allantoin|mesh-list
6791651|NCT02241005|Dermatologic Agents|dermatologic agents|mesh-ancestor
6791652|NCT02241018|Antibodies|antibodies|mesh-list
6791653|NCT02241018|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6791654|NCT02241018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
6791655|NCT02241018|Immunologic Factors|immunologic factors|mesh-ancestor
6791656|NCT02241018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791657|NCT02241018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6791658|NCT02241018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791659|NCT02241031|Oprelvekin|oprelvekin|mesh-list
6791660|NCT02241031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6791661|NCT02241083|Dopamine|dopamine|mesh-list
6791662|NCT02241083|Norepinephrine|norepinephrine|mesh-list
6791663|NCT02241083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6791664|NCT02241083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6791665|NCT02241083|Adrenergic Agents|adrenergic agents|mesh-ancestor
6791666|NCT02241083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6791667|NCT02241083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791668|NCT02241083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791669|NCT02241083|Sympathomimetics|sympathomimetics|mesh-ancestor
6791670|NCT02241083|Autonomic Agents|autonomic agents|mesh-ancestor
6791671|NCT02241083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6791672|NCT02241083|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6791673|NCT02241083|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6791674|NCT02241083|Dopamine Agents|dopamine agents|mesh-ancestor
6791675|NCT02241083|Protective Agents|protective agents|mesh-ancestor
6791676|NCT02241096|Lidocaine|lidocaine|mesh-list
6791677|NCT02241096|Anesthetics, Local|anesthetics, local|mesh-ancestor
6791678|NCT02241096|Anesthetics|anesthetics|mesh-ancestor
6791679|NCT02241096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6525023|NCT00762255|Irinotecan|irinotecan|mesh-list
6525024|NCT00762255|Vorinostat|vorinostat|mesh-list
6525025|NCT00762255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6525026|NCT00762255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6525027|NCT00762255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6525028|NCT00762255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6525029|NCT00762255|Growth Substances|growth substances|mesh-ancestor
6525030|NCT00762255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525031|NCT00762255|Growth Inhibitors|growth inhibitors|mesh-ancestor
6525032|NCT00762255|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6525033|NCT00762255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6525034|NCT00762255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6525035|NCT00762255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525036|NCT00762255|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6525037|NCT00762346|Zoledronic Acid|zoledronic acid|mesh-list
6525038|NCT00762346|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6525039|NCT00762346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525040|NCT00762554|Fentanyl|fentanyl|mesh-list
6525041|NCT00762554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6525042|NCT00762554|Narcotics|narcotics|mesh-ancestor
6525043|NCT00762554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6525044|NCT00762554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525045|NCT00762554|Analgesics|analgesics|mesh-ancestor
6525046|NCT00762554|Sensory System Agents|sensory system agents|mesh-ancestor
6525047|NCT00762554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6525048|NCT00762554|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6525049|NCT00762554|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6525050|NCT00762554|Anesthetics, General|anesthetics, general|mesh-ancestor
6525051|NCT00762554|Anesthetics|anesthetics|mesh-ancestor
6525052|NCT00762567|Phenylephrine|phenylephrine|mesh-list
6525053|NCT00762567|Oxymetazoline|oxymetazoline|mesh-list
6525054|NCT00762567|Nasal Decongestants|nasal decongestants|mesh-list
6525055|NCT00762567|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6525056|NCT00762567|Mydriatics|mydriatics|mesh-ancestor
6525057|NCT00762567|Autonomic Agents|autonomic agents|mesh-ancestor
6525058|NCT00762567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6525059|NCT00762567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525060|NCT00762567|Sympathomimetics|sympathomimetics|mesh-ancestor
6525061|NCT00762567|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6525062|NCT00762567|Respiratory System Agents|respiratory system agents|mesh-ancestor
6525063|NCT00762567|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6525064|NCT00762567|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6525065|NCT00762567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6525066|NCT00762567|Adrenergic Agents|adrenergic agents|mesh-ancestor
6525067|NCT00762567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6525068|NCT00762567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525069|NCT00762567|Protective Agents|protective agents|mesh-ancestor
6525070|NCT00762632|Everolimus|everolimus|mesh-list
6525071|NCT00762632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6525072|NCT00762632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6258221|NCT03080493|Acetaminophen|acetaminophen|mesh-list
6258222|NCT03080493|Ibuprofen|ibuprofen|mesh-list
6258223|NCT03080493|Gabapentin|gabapentin|mesh-list
6258224|NCT03080493|Codeine|codeine|mesh-list
6258225|NCT03080493|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6258226|NCT03080493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6258227|NCT03080493|Analgesics|analgesics|mesh-ancestor
6258228|NCT03080493|Sensory System Agents|sensory system agents|mesh-ancestor
6258229|NCT03080493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6258230|NCT03080493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525073|NCT00762632|Immunologic Factors|immunologic factors|mesh-ancestor
6525074|NCT00762632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525075|NCT00762658|Betamethasone|betamethasone|mesh-list
6525076|NCT00762658|Tacrolimus|tacrolimus|mesh-list
6525077|NCT00762658|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
6525078|NCT00762658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6525079|NCT00762658|Immunologic Factors|immunologic factors|mesh-ancestor
6525080|NCT00762658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525081|NCT00762658|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6525082|NCT00762658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6525083|NCT00762658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525084|NCT00762658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6525085|NCT00762658|Glucocorticoids|glucocorticoids|mesh-ancestor
6525086|NCT00762658|Hormones|hormones|mesh-ancestor
6525087|NCT00762658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6525088|NCT00762658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6525089|NCT00762658|Respiratory System Agents|respiratory system agents|mesh-ancestor
6525090|NCT00762671|Ebselen|ebselen|mesh-list
6791680|NCT02241096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791681|NCT02241096|Sensory System Agents|sensory system agents|mesh-ancestor
6791682|NCT02241096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6791683|NCT02241096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6791684|NCT02241096|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6791685|NCT02241096|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6791686|NCT02241096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6791687|NCT02241096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791688|NCT02241148|Acetaminophen|acetaminophen|mesh-list
6791689|NCT02241148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6791690|NCT02241148|Analgesics|analgesics|mesh-ancestor
6791691|NCT02241148|Sensory System Agents|sensory system agents|mesh-ancestor
6791692|NCT02241148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6791693|NCT02241148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791694|NCT02241148|Antipyretics|antipyretics|mesh-ancestor
6791695|NCT02241161|Bacteriocins|bacteriocins|mesh-list
6791696|NCT02241161|Antioxidants|antioxidants|mesh-list
6791697|NCT02241161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791698|NCT02241161|Protective Agents|protective agents|mesh-ancestor
6791699|NCT02241161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791700|NCT02241161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6791701|NCT02241161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6791702|NCT02241174|Sodium Hypochlorite|sodium hypochlorite|mesh-list
6791703|NCT02241174|Eusol|eusol|mesh-list
6791704|NCT02241174|Disinfectants|disinfectants|mesh-ancestor
6791705|NCT02241174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6791706|NCT02241200|Darbepoetin alfa|darbepoetin alfa|mesh-list
6791707|NCT02241200|Hematinics|hematinics|mesh-ancestor
6791708|NCT02241278|Ketamine|ketamine|mesh-list
6791709|NCT02241278|Analgesics|analgesics|mesh-ancestor
6791710|NCT02241278|Sensory System Agents|sensory system agents|mesh-ancestor
6791711|NCT02241278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6791712|NCT02241278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791713|NCT02241278|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6791714|NCT02241278|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6791715|NCT02241278|Anesthetics, General|anesthetics, general|mesh-ancestor
6791716|NCT02241278|Anesthetics|anesthetics|mesh-ancestor
6791717|NCT02241278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6791718|NCT02241278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6791719|NCT02241278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6791720|NCT02241278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6791721|NCT02241278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791722|NCT02241356|Methamphetamine|methamphetamine|mesh-list
6791723|NCT02241356|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6791724|NCT02241356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791725|NCT02241356|Sympathomimetics|sympathomimetics|mesh-ancestor
6791726|NCT02241356|Autonomic Agents|autonomic agents|mesh-ancestor
6791727|NCT02241356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6791728|NCT02241356|Dopamine Agents|dopamine agents|mesh-ancestor
6791729|NCT02241356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6791730|NCT02241356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791731|NCT02241356|Adrenergic Agents|adrenergic agents|mesh-ancestor
6791732|NCT02241356|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6791733|NCT02241356|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6791734|NCT02241356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6791735|NCT02241356|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6791736|NCT02241421|Amoxicillin|amoxicillin|mesh-list
6791737|NCT02241421|Vancomycin|vancomycin|mesh-list
6791738|NCT02241421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6791739|NCT02241421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6791740|NCT02241460|Lidocaine|lidocaine|mesh-list
6791741|NCT02241460|Anesthetics, Local|anesthetics, local|mesh-ancestor
6791742|NCT02241460|Anesthetics|anesthetics|mesh-ancestor
6791743|NCT02241460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6791744|NCT02241460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791745|NCT02241460|Sensory System Agents|sensory system agents|mesh-ancestor
6791746|NCT02241460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6791747|NCT02241460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6791748|NCT02241460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6791749|NCT02241460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6791750|NCT02241460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6791751|NCT02241460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525091|NCT00762671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6525092|NCT00762671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6525093|NCT00762671|Analgesics|analgesics|mesh-ancestor
6525094|NCT00762671|Sensory System Agents|sensory system agents|mesh-ancestor
6525095|NCT00762671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6525096|NCT00762671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525097|NCT00762671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6525098|NCT00762671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6525099|NCT00762671|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6525100|NCT00762671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6525101|NCT00762671|Antioxidants|antioxidants|mesh-ancestor
6525102|NCT00762671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525103|NCT00762671|Protective Agents|protective agents|mesh-ancestor
6525104|NCT00762671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6525105|NCT00762671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6791752|NCT02241499|Fluorouracil|fluorouracil|mesh-list
6791753|NCT02241499|Oxaliplatin|oxaliplatin|mesh-list
6791754|NCT02241499|Antimetabolites|antimetabolites|mesh-ancestor
6791755|NCT02241499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791756|NCT02241499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6791757|NCT02241499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6791758|NCT02241499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6791759|NCT02241499|Immunologic Factors|immunologic factors|mesh-ancestor
6791760|NCT02241499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791761|NCT02241564|Sirolimus|sirolimus|mesh-list
6791762|NCT02241564|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
6791763|NCT02241564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6791764|NCT02241564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791765|NCT02241564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6791766|NCT02241564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6791767|NCT02241564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6791768|NCT02241564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6791769|NCT02241564|Antifungal Agents|antifungal agents|mesh-ancestor
6791770|NCT02241564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6791771|NCT02241564|Immunologic Factors|immunologic factors|mesh-ancestor
6791772|NCT02241564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791773|NCT02241590|Entecavir|entecavir|mesh-list
6791774|NCT02241590|Antiviral Agents|antiviral agents|mesh-ancestor
6791775|NCT02241590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6791776|NCT02241616|Entecavir|entecavir|mesh-list
6791777|NCT02241616|Antiviral Agents|antiviral agents|mesh-ancestor
6791778|NCT02241616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6258231|NCT03080493|Antipyretics|antipyretics|mesh-ancestor
6258232|NCT03080493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6258233|NCT03080493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6258234|NCT03080493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6258235|NCT03080493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6258236|NCT03080493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6258237|NCT03080493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258238|NCT03080493|Anticonvulsants|anticonvulsants|mesh-ancestor
6258239|NCT03080493|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6258240|NCT03080493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6525106|NCT00762671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6525107|NCT00762736|Pioglitazone|pioglitazone|mesh-list
6525108|NCT00762736|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
6525109|NCT00762736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6791779|NCT02241759|Moxifloxacin|moxifloxacin|mesh-list
6791780|NCT02241759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6791781|NCT02241759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6791782|NCT02241759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6791783|NCT02241759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6791784|NCT02241759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6791785|NCT02241759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791786|NCT02241759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6791787|NCT02241876|Acetylcysteine|acetylcysteine|mesh-list
6791788|NCT02241876|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6791789|NCT02241876|Antiviral Agents|antiviral agents|mesh-ancestor
6791790|NCT02241876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6791791|NCT02241876|Expectorants|expectorants|mesh-ancestor
6791792|NCT02241876|Respiratory System Agents|respiratory system agents|mesh-ancestor
6791793|NCT02241876|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6791794|NCT02241876|Antioxidants|antioxidants|mesh-ancestor
6791795|NCT02241876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791796|NCT02241876|Protective Agents|protective agents|mesh-ancestor
6791797|NCT02241876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791798|NCT02241876|Antidotes|antidotes|mesh-ancestor
6791799|NCT02241941|Daptomycin|daptomycin|mesh-list
6791800|NCT02241941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6791801|NCT02241941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6791802|NCT02242032|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6791803|NCT02242032|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6791804|NCT02242084|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6791805|NCT02242084|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6791806|NCT02242084|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6791807|NCT02242084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791808|NCT02242149|Diacetylrhein|diacetylrhein|mesh-list
6791809|NCT02242149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6791810|NCT02242214|Misoprostol|misoprostol|mesh-list
6791811|NCT02242214|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6791812|NCT02242214|Abortifacient Agents|abortifacient agents|mesh-ancestor
6791813|NCT02242214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6791814|NCT02242214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791815|NCT02242214|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6791816|NCT02242214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6791817|NCT02242214|Oxytocics|oxytocics|mesh-ancestor
6791818|NCT02242227|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6791819|NCT02242227|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6791820|NCT02242227|Autonomic Agents|autonomic agents|mesh-ancestor
6791821|NCT02242227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6791822|NCT02242227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791823|NCT02242227|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6791824|NCT02242227|Respiratory System Agents|respiratory system agents|mesh-ancestor
6791825|NCT02242227|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6791826|NCT02242227|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6791827|NCT02242227|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6791828|NCT02242227|Adrenergic Agents|adrenergic agents|mesh-ancestor
6791829|NCT02242227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6791830|NCT02242227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791831|NCT02242240|Formoterol Fumarate|formoterol fumarate|mesh-list
6791832|NCT02242240|Tiotropium Bromide|tiotropium bromide|mesh-list
6791833|NCT02242240|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6791834|NCT02242240|Autonomic Agents|autonomic agents|mesh-ancestor
6791835|NCT02242240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6791836|NCT02242240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791837|NCT02242240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6791838|NCT02242240|Respiratory System Agents|respiratory system agents|mesh-ancestor
6791839|NCT02242240|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6791840|NCT02242240|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6791841|NCT02242240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6791842|NCT02242240|Adrenergic Agents|adrenergic agents|mesh-ancestor
6791843|NCT02242240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6791844|NCT02242240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791845|NCT02242240|Parasympatholytics|parasympatholytics|mesh-ancestor
6791846|NCT02242240|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6791847|NCT02242240|Cholinergic Agents|cholinergic agents|mesh-ancestor
6791848|NCT02242253|Tiotropium Bromide|tiotropium bromide|mesh-list
6791849|NCT02242253|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6525110|NCT00762736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525111|NCT00762736|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6525112|NCT00762736|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6525113|NCT00762736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525114|NCT00762749|Diphenhydramine|diphenhydramine|mesh-list
6525115|NCT00762749|Promethazine|promethazine|mesh-list
6525116|NCT00762749|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6525117|NCT00762749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6525118|NCT00762749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6525119|NCT00762749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525120|NCT00762749|Anesthetics, Local|anesthetics, local|mesh-ancestor
6525121|NCT00762749|Anesthetics|anesthetics|mesh-ancestor
6525122|NCT00762749|Sensory System Agents|sensory system agents|mesh-ancestor
6525123|NCT00762749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6525124|NCT00762749|Antiemetics|antiemetics|mesh-ancestor
6525125|NCT00762749|Autonomic Agents|autonomic agents|mesh-ancestor
6525126|NCT00762749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6525127|NCT00762749|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6525128|NCT00762749|Histamine Antagonists|histamine antagonists|mesh-ancestor
6525129|NCT00762749|Histamine Agents|histamine agents|mesh-ancestor
6525130|NCT00762749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6525131|NCT00762749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525132|NCT00762749|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6525133|NCT00762749|Antipruritics|antipruritics|mesh-ancestor
6525134|NCT00762749|Dermatologic Agents|dermatologic agents|mesh-ancestor
6525135|NCT00762775|Vitamin D|vitamin d|mesh-list
6525136|NCT00762775|Calcium|calcium|mesh-list
6525137|NCT00762775|Vitamins|vitamins|mesh-ancestor
6525138|NCT00762775|Micronutrients|micronutrients|mesh-ancestor
6525139|NCT00762775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525140|NCT00762775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6525141|NCT00762775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6525142|NCT00762918|Vitamin D|vitamin d|mesh-list
6525143|NCT00762918|Cholecalciferol|cholecalciferol|mesh-list
6525144|NCT00762918|Vitamins|vitamins|mesh-ancestor
6525145|NCT00762918|Micronutrients|micronutrients|mesh-ancestor
6525146|NCT00762918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525147|NCT00762918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6525148|NCT00762918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6525149|NCT00762944|Cimetidine|cimetidine|mesh-list
5992824|NCT00117845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992825|NCT00117962|Carboplatin|carboplatin|mesh-list
5992826|NCT00117962|Pemetrexed|pemetrexed|mesh-list
5992827|NCT00117962|Cetuximab|cetuximab|mesh-list
5992828|NCT00117962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992829|NCT00117962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5992830|NCT00117962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992831|NCT00117962|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5992832|NCT00117962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5992833|NCT00117962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5992834|NCT00118040|Genistein|genistein|mesh-list
5992835|NCT00118040|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6525150|NCT00762944|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6525151|NCT00762944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6525152|NCT00762944|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6525153|NCT00762944|Histamine Antagonists|histamine antagonists|mesh-ancestor
6525154|NCT00762944|Histamine Agents|histamine agents|mesh-ancestor
6525155|NCT00762944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6525156|NCT00762944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525157|NCT00762944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525158|NCT00762944|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6525159|NCT00762944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6525160|NCT00762944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6525161|NCT00762957|Metformin|metformin|mesh-list
6525162|NCT00762957|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6525163|NCT00762957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525164|NCT00762983|Loratadine|loratadine|mesh-list
6525165|NCT00762983|Antipruritics|antipruritics|mesh-ancestor
6525166|NCT00762983|Dermatologic Agents|dermatologic agents|mesh-ancestor
6525167|NCT00762983|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6525168|NCT00762983|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6791850|NCT02242253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6791851|NCT02242253|Autonomic Agents|autonomic agents|mesh-ancestor
5992836|NCT00118040|Protective Agents|protective agents|mesh-ancestor
6525169|NCT00762983|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6525170|NCT00762983|Histamine Antagonists|histamine antagonists|mesh-ancestor
6525171|NCT00762983|Histamine Agents|histamine agents|mesh-ancestor
6525172|NCT00762983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6525173|NCT00762983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525174|NCT00762983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525175|NCT00763165|Triclosan|triclosan|mesh-list
6525176|NCT00763165|Fluorides|fluorides|mesh-list
6525177|NCT00763165|Cariostatic Agents|cariostatic agents|mesh-ancestor
6525178|NCT00763165|Protective Agents|protective agents|mesh-ancestor
6525179|NCT00763165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525180|NCT00763165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6525181|NCT00763165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6525182|NCT00763165|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6525183|NCT00763165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6525184|NCT00763165|Antimetabolites|antimetabolites|mesh-ancestor
6525185|NCT00763165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525186|NCT00763165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6525187|NCT00763178|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6525188|NCT00763178|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6525189|NCT00763178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6525190|NCT00763178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6525191|NCT00763178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525192|NCT00763178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6525193|NCT00763178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525194|NCT00763178|Analgesics|analgesics|mesh-ancestor
6525195|NCT00763178|Sensory System Agents|sensory system agents|mesh-ancestor
6525196|NCT00763178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6525197|NCT00763178|Antidepressive Agents|antidepressive agents|mesh-ancestor
6525198|NCT00763178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6525199|NCT00763178|Dopamine Agents|dopamine agents|mesh-ancestor
6525200|NCT00763204|Betamethasone|betamethasone|mesh-list
6525201|NCT00763204|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
6525202|NCT00763204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6525203|NCT00763204|Glucocorticoids|glucocorticoids|mesh-ancestor
6525204|NCT00763204|Hormones|hormones|mesh-ancestor
6525205|NCT00763204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6525206|NCT00763204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525207|NCT00763204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6525208|NCT00763204|Respiratory System Agents|respiratory system agents|mesh-ancestor
6525209|NCT00763347|Alogliptin|alogliptin|mesh-list
6525210|NCT00763347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6525211|NCT00763347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525212|NCT00763347|Incretins|incretins|mesh-ancestor
6525213|NCT00763347|Hormones|hormones|mesh-ancestor
6525214|NCT00763347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6525215|NCT00763347|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6525216|NCT00763347|Protease Inhibitors|protease inhibitors|mesh-ancestor
6525217|NCT00763347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6525218|NCT00763347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525219|NCT00763373|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6525220|NCT00763373|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6525221|NCT00763373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6525222|NCT00763373|Antitubercular Agents|antitubercular agents|mesh-ancestor
6525223|NCT00763438|Sertindole|sertindole|mesh-list
6525224|NCT00763438|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6525225|NCT00763438|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6525226|NCT00763438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6525227|NCT00763438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791852|NCT02242253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6791853|NCT02242253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791854|NCT02242253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6791855|NCT02242253|Respiratory System Agents|respiratory system agents|mesh-ancestor
6791856|NCT02242253|Parasympatholytics|parasympatholytics|mesh-ancestor
6791857|NCT02242253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6791858|NCT02242253|Cholinergic Agents|cholinergic agents|mesh-ancestor
6791859|NCT02242253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6791860|NCT02242253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791861|NCT02242253|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6791862|NCT02242253|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6525228|NCT00763438|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6525229|NCT00763568|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6525230|NCT00763568|Nitazoxanide|nitazoxanide|mesh-list
6525231|NCT00763568|Antiviral Agents|antiviral agents|mesh-ancestor
6525232|NCT00763568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6525233|NCT00763568|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6537285|NCT00821600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537286|NCT00821600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537287|NCT00821600|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6537288|NCT00821600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6537289|NCT00821600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6537290|NCT00821600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6537291|NCT00821600|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6537292|NCT00821600|Dopamine Agents|dopamine agents|mesh-ancestor
6537293|NCT00821652|Freund's Adjuvant|freund's adjuvant|mesh-list
6537294|NCT00821652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6537295|NCT00821652|Immunologic Factors|immunologic factors|mesh-ancestor
6537296|NCT00821652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537297|NCT00821782|Azithromycin|azithromycin|mesh-list
6537298|NCT00821782|Levofloxacin|levofloxacin|mesh-list
6537299|NCT00821782|Ofloxacin|ofloxacin|mesh-list
6537300|NCT00821782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6537301|NCT00821782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6537302|NCT00821782|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6537303|NCT00821782|Renal Agents|renal agents|mesh-ancestor
6537304|NCT00821782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6537305|NCT00821782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6537306|NCT00821782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6537307|NCT00821782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537308|NCT00821782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6537309|NCT00821782|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6537310|NCT00821782|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6537311|NCT00821834|Ticlopidine|ticlopidine|mesh-list
6537312|NCT00821834|Clopidogrel|clopidogrel|mesh-list
6537313|NCT00821834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6537314|NCT00821834|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6537315|NCT00821834|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6537316|NCT00821834|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6537317|NCT00821834|Purinergic Agents|purinergic agents|mesh-ancestor
6537318|NCT00821834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6537319|NCT00821834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537320|NCT00821834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537321|NCT00821834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6537322|NCT00821834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6537323|NCT00821834|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6537324|NCT00821834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6537325|NCT00821834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6537326|NCT00821912|Docetaxel|docetaxel|mesh-list
6537327|NCT00821912|Capecitabine|capecitabine|mesh-list
6537328|NCT00821912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6537329|NCT00821912|Tubulin Modulators|tubulin modulators|mesh-ancestor
6537330|NCT00821912|Antimitotic Agents|antimitotic agents|mesh-ancestor
6537331|NCT00821912|Mitosis Modulators|mitosis modulators|mesh-ancestor
6537332|NCT00821912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537333|NCT00821912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6537334|NCT00821912|Antimetabolites|antimetabolites|mesh-ancestor
6537335|NCT00822029|Alendronate|alendronate|mesh-list
6791863|NCT02242253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6791864|NCT02242253|Adrenergic Agents|adrenergic agents|mesh-ancestor
6791865|NCT02242266|Tiotropium Bromide|tiotropium bromide|mesh-list
6791866|NCT02242266|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6791867|NCT02242266|Autonomic Agents|autonomic agents|mesh-ancestor
6791868|NCT02242266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6791869|NCT02242266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791870|NCT02242266|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6791871|NCT02242266|Respiratory System Agents|respiratory system agents|mesh-ancestor
6791872|NCT02242266|Parasympatholytics|parasympatholytics|mesh-ancestor
6791873|NCT02242266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6791874|NCT02242266|Cholinergic Agents|cholinergic agents|mesh-ancestor
6791875|NCT02242266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6791876|NCT02242266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791877|NCT02242279|Tiotropium Bromide|tiotropium bromide|mesh-list
6791878|NCT02242279|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6791879|NCT02242279|Autonomic Agents|autonomic agents|mesh-ancestor
6791880|NCT02242279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6525234|NCT00763633|Vitamins|vitamins|mesh-list
6525235|NCT00763633|Vitamin B 6|vitamin b 6|mesh-list
6525236|NCT00763633|Pyridoxal|pyridoxal|mesh-list
6525237|NCT00763633|Pyridoxine|pyridoxine|mesh-list
6525238|NCT00763633|Vitamin B Complex|vitamin b complex|mesh-list
6525239|NCT00763633|Micronutrients|micronutrients|mesh-ancestor
6525240|NCT00763633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525241|NCT00763646|Docetaxel|docetaxel|mesh-list
6525242|NCT00763646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6525243|NCT00763646|Tubulin Modulators|tubulin modulators|mesh-ancestor
6525244|NCT00763646|Antimitotic Agents|antimitotic agents|mesh-ancestor
6525245|NCT00763646|Mitosis Modulators|mitosis modulators|mesh-ancestor
6525246|NCT00763646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525247|NCT00763685|Etoricoxib|etoricoxib|mesh-list
6525248|NCT00763685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6525249|NCT00763685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6525250|NCT00763685|Analgesics|analgesics|mesh-ancestor
6525251|NCT00763685|Sensory System Agents|sensory system agents|mesh-ancestor
6525252|NCT00763685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6525253|NCT00763685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525254|NCT00763685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6525255|NCT00763685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6525256|NCT00763685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6525257|NCT00763685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6525258|NCT00763685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6525259|NCT00763685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525260|NCT00763763|Interferons|interferons|mesh-list
6525261|NCT00763763|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6525262|NCT00763763|Interferon-alpha|interferon-alpha|mesh-list
6525263|NCT00763763|Dexamethasone|dexamethasone|mesh-list
6525264|NCT00763763|Vincristine|vincristine|mesh-list
6525265|NCT00763763|Imatinib Mesylate|imatinib mesylate|mesh-list
6525266|NCT00763763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6525267|NCT00763763|Antiemetics|antiemetics|mesh-ancestor
6525268|NCT00763763|Autonomic Agents|autonomic agents|mesh-ancestor
6525269|NCT00763763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6525270|NCT00763763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525271|NCT00763763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6525272|NCT00763763|Glucocorticoids|glucocorticoids|mesh-ancestor
6525273|NCT00763763|Hormones|hormones|mesh-ancestor
6525274|NCT00763763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6525275|NCT00763763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6525276|NCT00763763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6525277|NCT00763763|Antiviral Agents|antiviral agents|mesh-ancestor
6525278|NCT00763763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6525279|NCT00763763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6525280|NCT00763763|Tubulin Modulators|tubulin modulators|mesh-ancestor
6525281|NCT00763763|Antimitotic Agents|antimitotic agents|mesh-ancestor
6525282|NCT00763763|Mitosis Modulators|mitosis modulators|mesh-ancestor
6525283|NCT00763763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525284|NCT00763763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6525285|NCT00763763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6525286|NCT00763763|Immunologic Factors|immunologic factors|mesh-ancestor
6525287|NCT00763789|Remifentanil|remifentanil|mesh-list
6525288|NCT00763789|Anesthetics|anesthetics|mesh-list
6525289|NCT00763789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6525290|NCT00763789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525291|NCT00763789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6525292|NCT00763789|Narcotics|narcotics|mesh-ancestor
6525293|NCT00763789|Analgesics|analgesics|mesh-ancestor
6525294|NCT00763789|Sensory System Agents|sensory system agents|mesh-ancestor
6525295|NCT00763789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6525296|NCT00763880|Lidocaine|lidocaine|mesh-list
6525297|NCT00763880|Anesthetics, Local|anesthetics, local|mesh-ancestor
6525298|NCT00763880|Anesthetics|anesthetics|mesh-ancestor
6525299|NCT00763880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6525300|NCT00763880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525301|NCT00763880|Sensory System Agents|sensory system agents|mesh-ancestor
6525302|NCT00763880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6525303|NCT00763880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6525304|NCT00763880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6525305|NCT00763880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6525306|NCT00763880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6525307|NCT00763880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525308|NCT00763893|Losartan|losartan|mesh-list
6525309|NCT00763893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6525310|NCT00763893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6525311|NCT00763893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6525312|NCT00763893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6525313|NCT00763893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525314|NCT00763906|Norepinephrine|norepinephrine|mesh-list
6525315|NCT00763906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6525316|NCT00763906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6525317|NCT00763906|Adrenergic Agents|adrenergic agents|mesh-ancestor
6525318|NCT00763906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6525319|NCT00763906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525320|NCT00763906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525321|NCT00763906|Sympathomimetics|sympathomimetics|mesh-ancestor
6525322|NCT00763906|Autonomic Agents|autonomic agents|mesh-ancestor
6525323|NCT00763906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6525324|NCT00763906|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6525325|NCT00763997|Acetaminophen|acetaminophen|mesh-list
6525326|NCT00763997|Dipyrone|dipyrone|mesh-list
6525327|NCT00763997|Ibuprofen|ibuprofen|mesh-list
6525328|NCT00763997|Parecoxib|parecoxib|mesh-list
6525329|NCT00763997|Valdecoxib|valdecoxib|mesh-list
6525330|NCT00763997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6525331|NCT00763997|Analgesics|analgesics|mesh-ancestor
6525332|NCT00763997|Sensory System Agents|sensory system agents|mesh-ancestor
6525333|NCT00763997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6525334|NCT00763997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525335|NCT00763997|Antipyretics|antipyretics|mesh-ancestor
6525336|NCT00763997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6525337|NCT00763997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6525338|NCT00763997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6525339|NCT00763997|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6525340|NCT00763997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6525341|NCT00763997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525342|NCT00763997|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6525343|NCT00764036|Artesunate|artesunate|mesh-list
6525344|NCT00764036|Antimalarials|antimalarials|mesh-ancestor
6525345|NCT00764036|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6525346|NCT00764036|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6525347|NCT00764036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6525348|NCT00764036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6525349|NCT00764036|Antiviral Agents|antiviral agents|mesh-ancestor
6525350|NCT00764036|Schistosomicides|schistosomicides|mesh-ancestor
6525351|NCT00764036|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6525352|NCT00764036|Anthelmintics|anthelmintics|mesh-ancestor
6525353|NCT00764062|Amoxicillin|amoxicillin|mesh-list
6525354|NCT00764062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6525355|NCT00764062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6525356|NCT00764114|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6525357|NCT00764114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6525358|NCT00764140|Mitogens|mitogens|mesh-list
6525359|NCT00764140|Mitosis Modulators|mitosis modulators|mesh-ancestor
6525360|NCT00764140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525361|NCT00764166|Docetaxel|docetaxel|mesh-list
6525362|NCT00764166|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
6525363|NCT00764166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6525364|NCT00764166|Tubulin Modulators|tubulin modulators|mesh-ancestor
6791881|NCT02242279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791882|NCT02242279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6791883|NCT02242279|Respiratory System Agents|respiratory system agents|mesh-ancestor
6791884|NCT02242279|Parasympatholytics|parasympatholytics|mesh-ancestor
6791885|NCT02242279|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6791886|NCT02242279|Cholinergic Agents|cholinergic agents|mesh-ancestor
6791887|NCT02242279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6791888|NCT02242279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791889|NCT02242292|Scopolamine|scopolamine|mesh-list
6791890|NCT02242292|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
6791891|NCT02242292|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6791892|NCT02242292|Antiemetics|antiemetics|mesh-ancestor
6791893|NCT02242292|Autonomic Agents|autonomic agents|mesh-ancestor
6791894|NCT02242292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6791895|NCT02242292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791896|NCT02242292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6791897|NCT02242292|Mydriatics|mydriatics|mesh-ancestor
6791898|NCT02242292|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6791899|NCT02242292|Cholinergic Agents|cholinergic agents|mesh-ancestor
6791900|NCT02242292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6791901|NCT02242292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525365|NCT00764166|Antimitotic Agents|antimitotic agents|mesh-ancestor
6525366|NCT00764166|Mitosis Modulators|mitosis modulators|mesh-ancestor
6525367|NCT00764166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525368|NCT00764166|Hormones|hormones|mesh-ancestor
6525369|NCT00764166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6525370|NCT00764166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525371|NCT00764244|Triamcinolone|triamcinolone|mesh-list
6525372|NCT00764244|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6525373|NCT00764244|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6525374|NCT00764244|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6525375|NCT00764244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6525376|NCT00764244|Glucocorticoids|glucocorticoids|mesh-ancestor
6525377|NCT00764244|Hormones|hormones|mesh-ancestor
6525378|NCT00764244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6525379|NCT00764244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525380|NCT00764244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6525381|NCT00764244|Immunologic Factors|immunologic factors|mesh-ancestor
6525382|NCT00764244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6525383|NCT00764244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258241|NCT03080493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6258242|NCT03080493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6258243|NCT03080493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6525384|NCT00764270|Thioctic Acid|thioctic acid|mesh-list
6525385|NCT00764270|Antioxidants|antioxidants|mesh-ancestor
6525386|NCT00764270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525387|NCT00764270|Protective Agents|protective agents|mesh-ancestor
6525388|NCT00764270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525389|NCT00764270|Vitamin B Complex|vitamin b complex|mesh-ancestor
6525390|NCT00764270|Vitamins|vitamins|mesh-ancestor
6525391|NCT00764270|Micronutrients|micronutrients|mesh-ancestor
6525392|NCT00764374|Z 338|z 338|mesh-list
6525393|NCT00764374|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6525394|NCT00764374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6525395|NCT00764374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525396|NCT00764374|Cholinergic Agents|cholinergic agents|mesh-ancestor
6525397|NCT00764374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6525398|NCT00764374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525399|NCT00764374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6525400|NCT00764413|Methylprednisolone|methylprednisolone|mesh-list
6525401|NCT00764413|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6525402|NCT00764413|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6525403|NCT00764413|Prednisolone|prednisolone|mesh-list
6525404|NCT00764413|Prednisolone acetate|prednisolone acetate|mesh-list
6525405|NCT00764413|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6525406|NCT00764413|Prednisolone phosphate|prednisolone phosphate|mesh-list
6525407|NCT00764413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6525408|NCT00764413|Antiemetics|antiemetics|mesh-ancestor
6525409|NCT00764413|Autonomic Agents|autonomic agents|mesh-ancestor
6525410|NCT00764413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6525411|NCT00764413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525412|NCT00764413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6525413|NCT00764413|Glucocorticoids|glucocorticoids|mesh-ancestor
6525414|NCT00764413|Hormones|hormones|mesh-ancestor
6525415|NCT00764413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6525416|NCT00764413|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6525417|NCT00764413|Protective Agents|protective agents|mesh-ancestor
6525418|NCT00764413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6525419|NCT00764413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6525420|NCT00764426|Ethanol|ethanol|mesh-list
6525421|NCT00764426|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6525422|NCT00764426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6525423|NCT00764426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6525424|NCT00764426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525425|NCT00764439|Nicotine|nicotine|mesh-list
6791902|NCT02242292|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6791903|NCT02242292|Parasympatholytics|parasympatholytics|mesh-ancestor
6791904|NCT02242318|Valsartan|valsartan|mesh-list
6791905|NCT02242318|Telmisartan|telmisartan|mesh-list
6791906|NCT02242318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6791907|NCT02242318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6791908|NCT02242318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6791909|NCT02242318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791910|NCT02242331|Telmisartan|telmisartan|mesh-list
6525426|NCT00764439|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6525427|NCT00764439|Autonomic Agents|autonomic agents|mesh-ancestor
6525428|NCT00764439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6525429|NCT00764439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525430|NCT00764439|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6525431|NCT00764439|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6525432|NCT00764439|Cholinergic Agents|cholinergic agents|mesh-ancestor
6525433|NCT00764439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6525434|NCT00764439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525435|NCT00764556|Insulin|insulin|mesh-list
6525436|NCT00764556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6525437|NCT00764556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525438|NCT00764582|Moxifloxacin|moxifloxacin|mesh-list
6525439|NCT00764582|Levofloxacin|levofloxacin|mesh-list
6525440|NCT00764582|Ofloxacin|ofloxacin|mesh-list
6525441|NCT00764582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6525442|NCT00764582|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6525443|NCT00764582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6525444|NCT00764582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6525445|NCT00764582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6525446|NCT00764582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6525447|NCT00764582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6525448|NCT00764582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525449|NCT00764582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6525450|NCT00764582|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6525451|NCT00764582|Renal Agents|renal agents|mesh-ancestor
6525452|NCT00764582|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6525453|NCT00764582|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6525454|NCT00764595|Imatinib Mesylate|imatinib mesylate|mesh-list
6525455|NCT00764595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6525456|NCT00764595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6525457|NCT00764595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6525458|NCT00764595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525459|NCT00764712|Insulin|insulin|mesh-list
6791911|NCT02242331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6791912|NCT02242331|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6791913|NCT02242331|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6791914|NCT02242331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791915|NCT02242344|Telmisartan|telmisartan|mesh-list
6791916|NCT02242344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6791917|NCT02242344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6791918|NCT02242344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6791919|NCT02242344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791920|NCT02242357|Telmisartan|telmisartan|mesh-list
6791921|NCT02242357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6791922|NCT02242357|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6791923|NCT02242357|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6791924|NCT02242357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791925|NCT02242370|Telmisartan|telmisartan|mesh-list
6791926|NCT02242370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6791927|NCT02242370|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6791928|NCT02242370|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6791929|NCT02242370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791930|NCT02242383|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6791931|NCT02242383|Telmisartan|telmisartan|mesh-list
6791932|NCT02242383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6791933|NCT02242383|Diuretics|diuretics|mesh-ancestor
6791934|NCT02242383|Natriuretic Agents|natriuretic agents|mesh-ancestor
6791935|NCT02242383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791936|NCT02242383|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6791937|NCT02242383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6791938|NCT02242383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791939|NCT02242383|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6791940|NCT02242383|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6791941|NCT02242396|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6791942|NCT02242396|Telmisartan|telmisartan|mesh-list
6791943|NCT02242396|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
6791944|NCT02242396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6791945|NCT02242396|Diuretics|diuretics|mesh-ancestor
6791946|NCT02242396|Natriuretic Agents|natriuretic agents|mesh-ancestor
6791947|NCT02242396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791948|NCT02242396|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6525460|NCT00764712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6525461|NCT00764712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525462|NCT00764725|Sulfasalazine|sulfasalazine|mesh-list
6525463|NCT00764725|Methotrexate|methotrexate|mesh-list
6525464|NCT00764725|Infliximab|infliximab|mesh-list
6525465|NCT00764725|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6525466|NCT00764725|Abortifacient Agents|abortifacient agents|mesh-ancestor
6525467|NCT00764725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6525468|NCT00764725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525469|NCT00764725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6525470|NCT00764725|Antimetabolites|antimetabolites|mesh-ancestor
6525471|NCT00764725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525472|NCT00764725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6525473|NCT00764725|Dermatologic Agents|dermatologic agents|mesh-ancestor
6525474|NCT00764725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6525475|NCT00764725|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6525476|NCT00764725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6525477|NCT00764725|Immunologic Factors|immunologic factors|mesh-ancestor
6525478|NCT00764725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6525479|NCT00764725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6525480|NCT00764725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6525481|NCT00764725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6525482|NCT00764725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6525483|NCT00764725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6525484|NCT00764725|Analgesics|analgesics|mesh-ancestor
6525485|NCT00764725|Sensory System Agents|sensory system agents|mesh-ancestor
6525486|NCT00764725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6525487|NCT00764725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6525488|NCT00764816|Caseins|caseins|mesh-list
6525489|NCT00764816|Chelating Agents|chelating agents|mesh-ancestor
6525490|NCT00764816|Sequestering Agents|sequestering agents|mesh-ancestor
6525491|NCT00764816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525492|NCT00764855|Propofol|propofol|mesh-list
6525493|NCT00764855|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6525494|NCT00764855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6525495|NCT00764855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525496|NCT00764855|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6525497|NCT00764855|Anesthetics, General|anesthetics, general|mesh-ancestor
6525498|NCT00764855|Anesthetics|anesthetics|mesh-ancestor
6525499|NCT00764907|Leucovorin|leucovorin|mesh-list
6525500|NCT00764907|Cytarabine|cytarabine|mesh-list
6525501|NCT00764907|Dexamethasone|dexamethasone|mesh-list
6525502|NCT00764907|Prednisone|prednisone|mesh-list
6525503|NCT00764907|Cyclophosphamide|cyclophosphamide|mesh-list
6525504|NCT00764907|Ifosfamide|ifosfamide|mesh-list
6525505|NCT00764907|Doxorubicin|doxorubicin|mesh-list
6525506|NCT00764907|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6525507|NCT00764907|Methotrexate|methotrexate|mesh-list
6525508|NCT00764907|Etoposide|etoposide|mesh-list
6525509|NCT00764907|Vincristine|vincristine|mesh-list
6525510|NCT00764907|Daunorubicin|daunorubicin|mesh-list
6525511|NCT00764907|Asparaginase|asparaginase|mesh-list
6525512|NCT00764907|Mercaptopurine|mercaptopurine|mesh-list
6525513|NCT00764907|Thioguanine|thioguanine|mesh-list
6525514|NCT00764907|Vindesine|vindesine|mesh-list
6525515|NCT00764907|Levoleucovorin|levoleucovorin|mesh-list
6258244|NCT03080493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6258245|NCT03080493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6258246|NCT03080493|Antimanic Agents|antimanic agents|mesh-ancestor
6258247|NCT03080493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6258248|NCT03080493|Narcotics|narcotics|mesh-ancestor
6258249|NCT03080493|Antitussive Agents|antitussive agents|mesh-ancestor
6258250|NCT03080493|Respiratory System Agents|respiratory system agents|mesh-ancestor
6525516|NCT00764907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6525517|NCT00764907|Immunologic Factors|immunologic factors|mesh-ancestor
6525518|NCT00764907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525519|NCT00764907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6525520|NCT00764907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6525521|NCT00764907|Alkylating Agents|alkylating agents|mesh-ancestor
6525522|NCT00764907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525523|NCT00764907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6525524|NCT00764907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6525525|NCT00764907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6525526|NCT00764907|Antiemetics|antiemetics|mesh-ancestor
6525527|NCT00764907|Autonomic Agents|autonomic agents|mesh-ancestor
6525528|NCT00764907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6258251|NCT03080493|Laxatives|laxatives|mesh-ancestor
6525529|NCT00764907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6525530|NCT00764907|Glucocorticoids|glucocorticoids|mesh-ancestor
6525531|NCT00764907|Hormones|hormones|mesh-ancestor
6525532|NCT00764907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6525533|NCT00764907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6525534|NCT00764907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6525535|NCT00764907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6525536|NCT00764907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6525537|NCT00764907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6525538|NCT00764907|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6525539|NCT00764907|Abortifacient Agents|abortifacient agents|mesh-ancestor
6525540|NCT00764907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6525541|NCT00764907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6525542|NCT00764907|Antimetabolites|antimetabolites|mesh-ancestor
6525543|NCT00764907|Dermatologic Agents|dermatologic agents|mesh-ancestor
6525544|NCT00764907|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6525545|NCT00764907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6525546|NCT00764907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6525547|NCT00764907|Antiviral Agents|antiviral agents|mesh-ancestor
6525548|NCT00764907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6525549|NCT00764907|Antidotes|antidotes|mesh-ancestor
6525550|NCT00764907|Protective Agents|protective agents|mesh-ancestor
6525551|NCT00764907|Vitamin B Complex|vitamin b complex|mesh-ancestor
6525552|NCT00764907|Vitamins|vitamins|mesh-ancestor
6525553|NCT00764907|Micronutrients|micronutrients|mesh-ancestor
6525554|NCT00764907|Tubulin Modulators|tubulin modulators|mesh-ancestor
6525555|NCT00764907|Antimitotic Agents|antimitotic agents|mesh-ancestor
6525556|NCT00764907|Mitosis Modulators|mitosis modulators|mesh-ancestor
6525557|NCT00764972|Sorafenib|sorafenib|mesh-list
6525558|NCT00764972|Vinorelbine|vinorelbine|mesh-list
6525559|NCT00764972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6525560|NCT00764972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6525561|NCT00764972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6525562|NCT00764972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525563|NCT00764972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6525564|NCT00764972|Tubulin Modulators|tubulin modulators|mesh-ancestor
6525565|NCT00764972|Antimitotic Agents|antimitotic agents|mesh-ancestor
6525566|NCT00764972|Mitosis Modulators|mitosis modulators|mesh-ancestor
6525567|NCT00765011|Cetuximab|cetuximab|mesh-list
6525568|NCT00765011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6525569|NCT00765011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6525570|NCT00765024|Ivermectin|ivermectin|mesh-list
6525571|NCT00765024|Albendazole|albendazole|mesh-list
6525572|NCT00765024|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6525573|NCT00765024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6525574|NCT00765024|Anthelmintics|anthelmintics|mesh-ancestor
6525575|NCT00765024|Anticestodal Agents|anticestodal agents|mesh-ancestor
6525576|NCT00765024|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6525577|NCT00765024|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6525578|NCT00765024|Tubulin Modulators|tubulin modulators|mesh-ancestor
6525579|NCT00765024|Antimitotic Agents|antimitotic agents|mesh-ancestor
6525580|NCT00765024|Mitosis Modulators|mitosis modulators|mesh-ancestor
6525581|NCT00765024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525582|NCT00765024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6525583|NCT00765154|Ritonavir|ritonavir|mesh-list
6525584|NCT00765154|Darunavir|darunavir|mesh-list
6525585|NCT00765154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6525586|NCT00765154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6791949|NCT02242396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6791950|NCT02242396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791951|NCT02242396|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6791952|NCT02242396|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6791953|NCT02242409|Gemcitabine|gemcitabine|mesh-list
6791954|NCT02242409|Paclitaxel|paclitaxel|mesh-list
6791955|NCT02242409|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6791956|NCT02242409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6791957|NCT02242409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6791958|NCT02242409|Tubulin Modulators|tubulin modulators|mesh-ancestor
6791959|NCT02242409|Antimitotic Agents|antimitotic agents|mesh-ancestor
6791960|NCT02242409|Mitosis Modulators|mitosis modulators|mesh-ancestor
6791961|NCT02242409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791962|NCT02242409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6791963|NCT02242409|Antimetabolites|antimetabolites|mesh-ancestor
6791964|NCT02242409|Antiviral Agents|antiviral agents|mesh-ancestor
6791965|NCT02242409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6791966|NCT02242409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6791967|NCT02242409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6525587|NCT00765154|Protease Inhibitors|protease inhibitors|mesh-ancestor
6525588|NCT00765154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6525589|NCT00765154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525590|NCT00765154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6525591|NCT00765154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6525592|NCT00765154|Antiviral Agents|antiviral agents|mesh-ancestor
6525593|NCT00765154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6525594|NCT00765154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6525595|NCT00765154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6525596|NCT00765167|Chlorhexidine|chlorhexidine|mesh-list
6525597|NCT00765167|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6525598|NCT00765167|Triclosan|triclosan|mesh-list
6525599|NCT00765167|Fluorides|fluorides|mesh-list
6525600|NCT00765167|Cariostatic Agents|cariostatic agents|mesh-ancestor
6525601|NCT00765167|Protective Agents|protective agents|mesh-ancestor
6525602|NCT00765167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525603|NCT00765167|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6525604|NCT00765167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6525605|NCT00765167|Disinfectants|disinfectants|mesh-ancestor
6525606|NCT00765167|Dermatologic Agents|dermatologic agents|mesh-ancestor
6525607|NCT00765167|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6525608|NCT00765167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6525609|NCT00765167|Antimetabolites|antimetabolites|mesh-ancestor
6525610|NCT00765167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525611|NCT00765167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6525612|NCT00765271|Ritonavir|ritonavir|mesh-list
6525613|NCT00765271|Darunavir|darunavir|mesh-list
6525614|NCT00765271|Raltegravir Potassium|raltegravir potassium|mesh-list
6525615|NCT00765271|Abacavir|abacavir|mesh-list
6525616|NCT00765271|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6525617|NCT00765271|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6258252|NCT03080493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6258253|NCT03081117|Insulin|insulin|mesh-list
6258254|NCT03081117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6258255|NCT03081117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258256|NCT03082196|Fluorides|fluorides|mesh-list
6525618|NCT00765271|Protease Inhibitors|protease inhibitors|mesh-ancestor
6525619|NCT00765271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6525620|NCT00765271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525621|NCT00765271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6525622|NCT00765271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6525623|NCT00765271|Antiviral Agents|antiviral agents|mesh-ancestor
6525624|NCT00765271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6525625|NCT00765271|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6525626|NCT00765271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6525627|NCT00765271|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6525628|NCT00765271|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6525629|NCT00765271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6525630|NCT00765271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6525631|NCT00765310|Thioctic Acid|thioctic acid|mesh-list
6525632|NCT00765310|Antioxidants|antioxidants|mesh-ancestor
6525633|NCT00765310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525634|NCT00765310|Protective Agents|protective agents|mesh-ancestor
6525635|NCT00765310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525636|NCT00765310|Vitamin B Complex|vitamin b complex|mesh-ancestor
6525637|NCT00765310|Vitamins|vitamins|mesh-ancestor
6525638|NCT00765310|Micronutrients|micronutrients|mesh-ancestor
6525639|NCT00765427|Retinol acetate|retinol acetate|mesh-list
6525640|NCT00765427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6525641|NCT00765427|Immunologic Factors|immunologic factors|mesh-ancestor
6525642|NCT00765427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525643|NCT00765427|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6525644|NCT00765427|Protective Agents|protective agents|mesh-ancestor
6525645|NCT00765427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6537336|NCT00822029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6537337|NCT00822029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537338|NCT00822055|Timolol|timolol|mesh-list
6537339|NCT00822055|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6537340|NCT00822055|Dorzolamide|dorzolamide|mesh-list
6537341|NCT00822055|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
6537342|NCT00822055|Maleic acid|maleic acid|mesh-list
6537343|NCT00822055|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6537344|NCT00822055|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6537345|NCT00822055|Adrenergic Agents|adrenergic agents|mesh-ancestor
6537346|NCT00822055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6537347|NCT00822055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537348|NCT00822055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258257|NCT03082196|Sodium Fluoride|sodium fluoride|mesh-list
6525646|NCT00765557|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
6525647|NCT00765557|Laxatives|laxatives|mesh-ancestor
6525648|NCT00765557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6525649|NCT00765921|Ranibizumab|ranibizumab|mesh-list
6525650|NCT00765921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6525651|NCT00765921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6525652|NCT00765921|Growth Substances|growth substances|mesh-ancestor
6525653|NCT00765921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525654|NCT00765921|Growth Inhibitors|growth inhibitors|mesh-ancestor
6525655|NCT00765921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6525656|NCT00765934|Lidocaine|lidocaine|mesh-list
6525657|NCT00765934|Tetracaine|tetracaine|mesh-list
6525658|NCT00765934|Anesthetics, Local|anesthetics, local|mesh-ancestor
6525659|NCT00765934|Anesthetics|anesthetics|mesh-ancestor
6525660|NCT00765934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5992837|NCT00118040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992838|NCT00118040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992839|NCT00118040|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5992840|NCT00118040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6018502|NCT00381303|Darunavir|darunavir|mesh-list
6525661|NCT00765934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525662|NCT00765934|Sensory System Agents|sensory system agents|mesh-ancestor
6525663|NCT00765934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6525664|NCT00765934|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6525665|NCT00765934|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6525666|NCT00765934|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6525667|NCT00765934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6525668|NCT00765934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525669|NCT00765973|Topotecan|topotecan|mesh-list
6525670|NCT00765973|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6525671|NCT00765973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6525672|NCT00765973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6525673|NCT00765973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525674|NCT00765973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6525675|NCT00765986|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6525676|NCT00765986|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
6525677|NCT00765986|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6525678|NCT00765986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525679|NCT00766025|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6525680|NCT00766025|Calcium|calcium|mesh-list
6525681|NCT00766025|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6525682|NCT00766025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525683|NCT00766025|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6525684|NCT00766025|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6525685|NCT00766025|Antimetabolites|antimetabolites|mesh-ancestor
6525686|NCT00766025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525687|NCT00766025|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6525688|NCT00766025|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6525689|NCT00766025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6525690|NCT00766064|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6525691|NCT00766064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6525692|NCT00766064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6525693|NCT00766064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6525694|NCT00766064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525695|NCT00766064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6525696|NCT00766064|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6525697|NCT00766064|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6525698|NCT00766064|Serotonin Agents|serotonin agents|mesh-ancestor
6525699|NCT00766064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6525700|NCT00766064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525701|NCT00766064|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6525702|NCT00766064|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6525703|NCT00766064|Dopamine Agents|dopamine agents|mesh-ancestor
6525704|NCT00766155|Capecitabine|capecitabine|mesh-list
6525705|NCT00766155|Oxaliplatin|oxaliplatin|mesh-list
6525706|NCT00766155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6525707|NCT00766155|Antimetabolites|antimetabolites|mesh-ancestor
6525708|NCT00766155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525709|NCT00766155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6525710|NCT00766181|Lidocaine|lidocaine|mesh-list
6525711|NCT00766181|Anesthetics, Local|anesthetics, local|mesh-ancestor
6525712|NCT00766181|Anesthetics|anesthetics|mesh-ancestor
6525713|NCT00766181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6525714|NCT00766181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525715|NCT00766181|Sensory System Agents|sensory system agents|mesh-ancestor
6525716|NCT00766181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6525717|NCT00766181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6525718|NCT00766181|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6525719|NCT00766181|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6525720|NCT00766181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6525721|NCT00766181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525722|NCT00766220|Irinotecan|irinotecan|mesh-list
6525723|NCT00766220|Cetuximab|cetuximab|mesh-list
6525724|NCT00766220|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6525725|NCT00766220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6525726|NCT00766220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6525727|NCT00766220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525728|NCT00766220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6525729|NCT00766220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6525730|NCT00766246|Bevacizumab|bevacizumab|mesh-list
6525731|NCT00766246|Carboplatin|carboplatin|mesh-list
6525732|NCT00766246|Docetaxel|docetaxel|mesh-list
6525733|NCT00766246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6525734|NCT00766246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6525735|NCT00766246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6525736|NCT00766246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6525737|NCT00766246|Growth Substances|growth substances|mesh-ancestor
6525738|NCT00766246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525739|NCT00766246|Growth Inhibitors|growth inhibitors|mesh-ancestor
6525740|NCT00766246|Tubulin Modulators|tubulin modulators|mesh-ancestor
6525741|NCT00766246|Antimitotic Agents|antimitotic agents|mesh-ancestor
6525742|NCT00766246|Mitosis Modulators|mitosis modulators|mesh-ancestor
6525743|NCT00766246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525744|NCT00766285|Vaccines|vaccines|mesh-list
6525745|NCT00766285|Immunologic Factors|immunologic factors|mesh-ancestor
6525746|NCT00766285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525747|NCT00766337|Sirolimus|sirolimus|mesh-list
6525748|NCT00766337|Ranibizumab|ranibizumab|mesh-list
6525749|NCT00766337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6525750|NCT00766337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6525751|NCT00766337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6525752|NCT00766337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6525753|NCT00766337|Antifungal Agents|antifungal agents|mesh-ancestor
6525754|NCT00766337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6525755|NCT00766337|Immunologic Factors|immunologic factors|mesh-ancestor
6525756|NCT00766337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525757|NCT00766337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6525758|NCT00766337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6791968|NCT02242409|Immunologic Factors|immunologic factors|mesh-ancestor
6791969|NCT02242409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791970|NCT02242474|Adalimumab|adalimumab|mesh-list
6791971|NCT02242474|Etanercept|etanercept|mesh-list
6791972|NCT02242474|Golimumab|golimumab|mesh-list
6791973|NCT02242474|Infliximab|infliximab|mesh-list
6791974|NCT02242474|Certolizumab Pegol|certolizumab pegol|mesh-list
6791975|NCT02242474|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6791976|NCT02242474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6791977|NCT02242474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6791978|NCT02242474|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6791979|NCT02242474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6791980|NCT02242474|Analgesics|analgesics|mesh-ancestor
6791981|NCT02242474|Sensory System Agents|sensory system agents|mesh-ancestor
6791982|NCT02242474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6791983|NCT02242474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791984|NCT02242474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6791985|NCT02242474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6791986|NCT02242474|Immunologic Factors|immunologic factors|mesh-ancestor
6791987|NCT02242474|Dermatologic Agents|dermatologic agents|mesh-ancestor
6791988|NCT02242474|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6791989|NCT02242513|Lidocaine|lidocaine|mesh-list
6791990|NCT02242513|Anesthetics, Local|anesthetics, local|mesh-ancestor
6791991|NCT02242513|Anesthetics|anesthetics|mesh-ancestor
6791992|NCT02242513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6791993|NCT02242513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791994|NCT02242513|Sensory System Agents|sensory system agents|mesh-ancestor
6791995|NCT02242513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6791996|NCT02242513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6791997|NCT02242513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6791998|NCT02242513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6525759|NCT00766337|Growth Substances|growth substances|mesh-ancestor
6525760|NCT00766337|Growth Inhibitors|growth inhibitors|mesh-ancestor
6525761|NCT00766350|Amitriptyline|amitriptyline|mesh-list
6525762|NCT00766350|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6525763|NCT00766350|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6525764|NCT00766350|Antidepressive Agents|antidepressive agents|mesh-ancestor
6525765|NCT00766350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6525766|NCT00766350|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6525767|NCT00766350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6525768|NCT00766350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6525769|NCT00766350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525770|NCT00766350|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6525771|NCT00766350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6525772|NCT00766350|Analgesics|analgesics|mesh-ancestor
6525773|NCT00766350|Sensory System Agents|sensory system agents|mesh-ancestor
6525774|NCT00766350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6525775|NCT00766350|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6525776|NCT00766350|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6525777|NCT00766350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6525778|NCT00766350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525779|NCT00766350|Adrenergic Agents|adrenergic agents|mesh-ancestor
6525780|NCT00766350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6525781|NCT00766402|Acetaminophen|acetaminophen|mesh-list
6525782|NCT00766402|Diclofenac|diclofenac|mesh-list
6525783|NCT00766402|Tramadol|tramadol|mesh-list
6525784|NCT00766402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6525785|NCT00766402|Analgesics|analgesics|mesh-ancestor
6525786|NCT00766402|Sensory System Agents|sensory system agents|mesh-ancestor
6525787|NCT00766402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6525788|NCT00766402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525789|NCT00766402|Antipyretics|antipyretics|mesh-ancestor
6525790|NCT00766402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6525791|NCT00766402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6525792|NCT00766402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6525793|NCT00766402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6525794|NCT00766402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6791999|NCT02242513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6792000|NCT02242513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792001|NCT02242591|Ropivacaine|ropivacaine|mesh-list
6792002|NCT02242591|Anesthetics, Local|anesthetics, local|mesh-ancestor
6792003|NCT02242591|Anesthetics|anesthetics|mesh-ancestor
6792004|NCT02242591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6792005|NCT02242591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792006|NCT02242591|Sensory System Agents|sensory system agents|mesh-ancestor
6792007|NCT02242591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6792008|NCT02242656|Opium|opium|mesh-list
6792009|NCT02242656|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6792010|NCT02242656|Narcotics|narcotics|mesh-ancestor
6792011|NCT02242656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6792012|NCT02242656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792013|NCT02242656|Analgesics|analgesics|mesh-ancestor
6792014|NCT02242656|Sensory System Agents|sensory system agents|mesh-ancestor
6792015|NCT02242656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6792016|NCT02242656|Antidiarrheals|antidiarrheals|mesh-ancestor
6792017|NCT02242656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6792018|NCT02242656|Antitussive Agents|antitussive agents|mesh-ancestor
6792019|NCT02242656|Respiratory System Agents|respiratory system agents|mesh-ancestor
6792020|NCT02242695|Clotrimazole|clotrimazole|mesh-list
6792021|NCT02242695|Dequalinium|dequalinium|mesh-list
6792022|NCT02242695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6792023|NCT02242695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6792024|NCT02242695|Antifungal Agents|antifungal agents|mesh-ancestor
6792025|NCT02242695|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6792026|NCT02242695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6792027|NCT02242695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6792028|NCT02242695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792029|NCT02242695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6792030|NCT02242695|Hormone Antagonists|hormone antagonists|mesh-ancestor
6792031|NCT02242695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6792032|NCT02242695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792033|NCT02242734|Hydrocodone|hydrocodone|mesh-list
6792034|NCT02242734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6792035|NCT02242734|Narcotics|narcotics|mesh-ancestor
5724136|NCT03189043|Anti-Infective Agents|anti-infective agents|mesh-list
6525795|NCT00766402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525796|NCT00766402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6525797|NCT00766402|Narcotics|narcotics|mesh-ancestor
6525798|NCT00766402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6525799|NCT00766441|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6525800|NCT00766441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6525801|NCT00766441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525802|NCT00766441|Incretins|incretins|mesh-ancestor
6525803|NCT00766441|Hormones|hormones|mesh-ancestor
6525804|NCT00766441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6525805|NCT00766441|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6525806|NCT00766441|Protease Inhibitors|protease inhibitors|mesh-ancestor
6525807|NCT00766441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6525808|NCT00766441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525809|NCT00766480|Fluorouracil|fluorouracil|mesh-list
6525810|NCT00766480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6525811|NCT00766480|Antimetabolites|antimetabolites|mesh-ancestor
6525812|NCT00766480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525813|NCT00766480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6525814|NCT00766480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6525815|NCT00766480|Immunologic Factors|immunologic factors|mesh-ancestor
6525816|NCT00766480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525817|NCT00766545|Cilostazol|cilostazol|mesh-list
6525818|NCT00766545|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6525819|NCT00766545|Autonomic Agents|autonomic agents|mesh-ancestor
6525820|NCT00766545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6525821|NCT00766545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525822|NCT00766545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6525823|NCT00766545|Respiratory System Agents|respiratory system agents|mesh-ancestor
6525824|NCT00766545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6525825|NCT00766545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6525826|NCT00766545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525827|NCT00766545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6525828|NCT00766545|Vasodilator Agents|vasodilator agents|mesh-ancestor
6525829|NCT00766545|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6792036|NCT02242734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6792037|NCT02242734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792038|NCT02242734|Analgesics|analgesics|mesh-ancestor
6792039|NCT02242734|Sensory System Agents|sensory system agents|mesh-ancestor
6792040|NCT02242734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6792041|NCT02242734|Antitussive Agents|antitussive agents|mesh-ancestor
6792042|NCT02242734|Respiratory System Agents|respiratory system agents|mesh-ancestor
6792043|NCT02242799|Artesunate|artesunate|mesh-list
6792044|NCT02242799|Lumefantrine|lumefantrine|mesh-list
6792045|NCT02242799|Artemether|artemether|mesh-list
6792046|NCT02242799|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6792047|NCT02242799|Amodiaquine|amodiaquine|mesh-list
6792048|NCT02242799|Dolutegravir|dolutegravir|mesh-list
6792049|NCT02242799|Antimalarials|antimalarials|mesh-ancestor
6792050|NCT02242799|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6792051|NCT02242799|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6792052|NCT02242799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6792053|NCT02242799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6792054|NCT02242799|Antiviral Agents|antiviral agents|mesh-ancestor
6792055|NCT02242799|Schistosomicides|schistosomicides|mesh-ancestor
6792056|NCT02242799|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6792057|NCT02242799|Anthelmintics|anthelmintics|mesh-ancestor
6792058|NCT02242799|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6792059|NCT02242799|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6792060|NCT02242799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6792061|NCT02242799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792062|NCT02242799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6792063|NCT02242799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6792064|NCT02242812|Metoprolol|metoprolol|mesh-list
6792065|NCT02242812|Telmisartan|telmisartan|mesh-list
6792066|NCT02242812|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6792067|NCT02242812|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6792068|NCT02242812|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6792069|NCT02242812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792070|NCT02242812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6792071|NCT02242812|Sympatholytics|sympatholytics|mesh-ancestor
6792072|NCT02242812|Autonomic Agents|autonomic agents|mesh-ancestor
6792073|NCT02242812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5724137|NCT03189043|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6525830|NCT00766545|Protective Agents|protective agents|mesh-ancestor
6525831|NCT00766545|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6525832|NCT00766545|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6525833|NCT00766545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6525834|NCT00766662|Pyrimethamine|pyrimethamine|mesh-list
6525835|NCT00766662|Sulfadoxine|sulfadoxine|mesh-list
6525836|NCT00766662|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6525837|NCT00766662|Antimalarials|antimalarials|mesh-ancestor
6525838|NCT00766662|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6525839|NCT00766662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6525840|NCT00766662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6525841|NCT00766662|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6525842|NCT00766662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6525843|NCT00766662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525844|NCT00766662|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6525845|NCT00766662|Renal Agents|renal agents|mesh-ancestor
6525846|NCT00766805|Propranolol|propranolol|mesh-list
6525847|NCT00766805|Isosorbide|isosorbide|mesh-list
6525848|NCT00766805|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
6525849|NCT00766805|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
6525850|NCT00766805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6525851|NCT00766805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6525852|NCT00766805|Adrenergic Agents|adrenergic agents|mesh-ancestor
6525853|NCT00766805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6525854|NCT00766805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525855|NCT00766805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525856|NCT00766805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6525857|NCT00766805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6525858|NCT00766805|Vasodilator Agents|vasodilator agents|mesh-ancestor
6525859|NCT00766805|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6525860|NCT00766805|Diuretics|diuretics|mesh-ancestor
6525861|NCT00766805|Natriuretic Agents|natriuretic agents|mesh-ancestor
6525862|NCT00766805|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6525863|NCT00766818|Lopinavir|lopinavir|mesh-list
6525864|NCT00766818|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6525865|NCT00766818|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6525866|NCT00766818|Protease Inhibitors|protease inhibitors|mesh-ancestor
6525867|NCT00766818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6525868|NCT00766818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525869|NCT00766818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6525870|NCT00766818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6525871|NCT00766818|Antiviral Agents|antiviral agents|mesh-ancestor
6525872|NCT00766818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6525873|NCT00766818|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6525874|NCT00766818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6525875|NCT00766857|Insulin|insulin|mesh-list
6525876|NCT00766857|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6525877|NCT00766857|Insulin Glargine|insulin glargine|mesh-list
6525878|NCT00766857|Exenatide|exenatide|mesh-list
6525879|NCT00766857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6525880|NCT00766857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525881|NCT00766857|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6525882|NCT00766857|Incretins|incretins|mesh-ancestor
6525883|NCT00766857|Hormones|hormones|mesh-ancestor
6525884|NCT00766857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6525885|NCT00766870|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6525886|NCT00766870|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6525887|NCT00766870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6525888|NCT00766870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6525889|NCT00766870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525890|NCT00766870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6525891|NCT00766870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525892|NCT00766870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6525893|NCT00766870|Antidepressive Agents|antidepressive agents|mesh-ancestor
6525894|NCT00766870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6525895|NCT00766896|Aspirin|aspirin|mesh-list
6525896|NCT00766896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6525897|NCT00766896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6525898|NCT00766896|Analgesics|analgesics|mesh-ancestor
6525899|NCT00766896|Sensory System Agents|sensory system agents|mesh-ancestor
6525900|NCT00766896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6525901|NCT00766896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792074|NCT02242812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525902|NCT00766896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6525903|NCT00766896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6525904|NCT00766896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6525905|NCT00766896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6525906|NCT00766896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525907|NCT00766896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6525908|NCT00766896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6525909|NCT00766896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6525910|NCT00766896|Antipyretics|antipyretics|mesh-ancestor
6525911|NCT00766909|Cyclosporine|cyclosporine|mesh-list
6525912|NCT00766909|Tacrolimus|tacrolimus|mesh-list
6525913|NCT00766909|Cyclosporins|cyclosporins|mesh-list
6525914|NCT00766909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6525915|NCT00766909|Immunologic Factors|immunologic factors|mesh-ancestor
6525916|NCT00766909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525917|NCT00766909|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6525918|NCT00766909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6525919|NCT00766909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525920|NCT00766909|Antifungal Agents|antifungal agents|mesh-ancestor
6525921|NCT00766909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6525922|NCT00766909|Dermatologic Agents|dermatologic agents|mesh-ancestor
6525923|NCT00766909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6525924|NCT00767091|Rivastigmine|rivastigmine|mesh-list
6525925|NCT00767091|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
6525926|NCT00767091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6525927|NCT00767091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525928|NCT00767091|Cholinergic Agents|cholinergic agents|mesh-ancestor
6525929|NCT00767091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6525930|NCT00767091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525931|NCT00767091|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6525932|NCT00767091|Protective Agents|protective agents|mesh-ancestor
6525933|NCT00767117|Ritonavir|ritonavir|mesh-list
6525934|NCT00767117|Lopinavir|lopinavir|mesh-list
6525935|NCT00767117|Etravirine|etravirine|mesh-list
6525936|NCT00767117|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6525937|NCT00767117|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6525938|NCT00767117|Protease Inhibitors|protease inhibitors|mesh-ancestor
6525939|NCT00767117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6525940|NCT00767117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525941|NCT00767117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6525942|NCT00767117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6525943|NCT00767117|Antiviral Agents|antiviral agents|mesh-ancestor
6525944|NCT00767117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6792075|NCT02242812|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6792076|NCT02242812|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6792077|NCT02242812|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6792078|NCT02242812|Adrenergic Agents|adrenergic agents|mesh-ancestor
6792079|NCT02242812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6792080|NCT02242825|Telmisartan|telmisartan|mesh-list
6792081|NCT02242825|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
6792082|NCT02242825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6792083|NCT02242825|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6792084|NCT02242825|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6792085|NCT02242825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792086|NCT02242825|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6792087|NCT02242825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6792088|NCT02242825|Diuretics|diuretics|mesh-ancestor
6792089|NCT02242825|Natriuretic Agents|natriuretic agents|mesh-ancestor
6792090|NCT02242825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792091|NCT02242838|Telmisartan|telmisartan|mesh-list
6792092|NCT02242838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6792093|NCT02242838|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6792094|NCT02242838|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6792095|NCT02242838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792096|NCT02242851|Telmisartan|telmisartan|mesh-list
6792097|NCT02242851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6792098|NCT02242851|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6792099|NCT02242851|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6792100|NCT02242851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792101|NCT02242864|Telmisartan|telmisartan|mesh-list
6525945|NCT00767117|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6525946|NCT00767117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6525947|NCT00767117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6525948|NCT00767117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6525949|NCT00767169|Ibandronic Acid|ibandronic acid|mesh-list
6525950|NCT00767169|Pamidronate|pamidronate|mesh-list
6525951|NCT00767169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6525952|NCT00767169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525953|NCT00767221|Budesonide|budesonide|mesh-list
6525954|NCT00767221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
6525955|NCT00767221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6525956|NCT00767221|Autonomic Agents|autonomic agents|mesh-ancestor
6525957|NCT00767221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6525958|NCT00767221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525959|NCT00767221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6525960|NCT00767221|Respiratory System Agents|respiratory system agents|mesh-ancestor
6525961|NCT00767221|Glucocorticoids|glucocorticoids|mesh-ancestor
6525962|NCT00767221|Hormones|hormones|mesh-ancestor
6525963|NCT00767221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6525964|NCT00767260|Insulin|insulin|mesh-list
6525965|NCT00767260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6525966|NCT00767260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525967|NCT00767286|Cobalt|cobalt|mesh-list
6525968|NCT00767286|Goserelin|goserelin|mesh-list
6525969|NCT00767286|Flutamide|flutamide|mesh-list
6792102|NCT02242864|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
6792103|NCT02242864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6792104|NCT02242864|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6792105|NCT02242864|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6792106|NCT02242864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792107|NCT02242864|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6792108|NCT02242864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6792109|NCT02242864|Diuretics|diuretics|mesh-ancestor
6792110|NCT02242864|Natriuretic Agents|natriuretic agents|mesh-ancestor
6792111|NCT02242864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792112|NCT02242877|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6792113|NCT02242877|Telmisartan|telmisartan|mesh-list
6792114|NCT02242877|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6792115|NCT02242877|Diuretics|diuretics|mesh-ancestor
6792116|NCT02242877|Natriuretic Agents|natriuretic agents|mesh-ancestor
6792117|NCT02242877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792118|NCT02242877|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6792119|NCT02242877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6792120|NCT02242877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792121|NCT02242877|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6792122|NCT02242877|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6792123|NCT02242929|Imiquimod|imiquimod|mesh-list
6792124|NCT02242929|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6792125|NCT02242929|Immunologic Factors|immunologic factors|mesh-ancestor
6792126|NCT02242929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792127|NCT02242929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6792128|NCT02242929|Interferon Inducers|interferon inducers|mesh-ancestor
6792129|NCT02242955|Diazepam|diazepam|mesh-list
6792130|NCT02242955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6792131|NCT02242955|Anticonvulsants|anticonvulsants|mesh-ancestor
6792132|NCT02242955|Antiemetics|antiemetics|mesh-ancestor
6792133|NCT02242955|Autonomic Agents|autonomic agents|mesh-ancestor
6792134|NCT02242955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6792135|NCT02242955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792136|NCT02242955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6792137|NCT02242955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6792138|NCT02242955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6792139|NCT02242955|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6792140|NCT02242955|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6792141|NCT02242955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6792142|NCT02242955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6792143|NCT02242955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6792144|NCT02242955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6792145|NCT02242955|Anesthetics, General|anesthetics, general|mesh-ancestor
6792146|NCT02242955|Anesthetics|anesthetics|mesh-ancestor
6792147|NCT02242955|GABA Modulators|gaba modulators|mesh-ancestor
6792148|NCT02242955|GABA Agents|gaba agents|mesh-ancestor
6792149|NCT02242955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6792150|NCT02242955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792151|NCT02243098|Digoxin|digoxin|mesh-list
6525970|NCT00767286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6525971|NCT00767286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6792152|NCT02243098|Atorvastatin|atorvastatin|mesh-list
6525972|NCT00767286|Trace Elements|trace elements|mesh-ancestor
6525973|NCT00767286|Micronutrients|micronutrients|mesh-ancestor
6525974|NCT00767286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525975|NCT00767286|Androgen Antagonists|androgen antagonists|mesh-ancestor
6525976|NCT00767286|Hormone Antagonists|hormone antagonists|mesh-ancestor
6525977|NCT00767286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6537349|NCT00822055|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6537350|NCT00822055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6537351|NCT00822055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6537352|NCT00822055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6537353|NCT00822055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6537354|NCT00822055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6537355|NCT00822055|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6537356|NCT00822081|Timolol|timolol|mesh-list
6537357|NCT00822081|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6537358|NCT00822081|Dorzolamide|dorzolamide|mesh-list
6537359|NCT00822081|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
6537360|NCT00822081|Maleic acid|maleic acid|mesh-list
6537361|NCT00822081|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6792153|NCT02243098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6792154|NCT02243098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6792155|NCT02243098|Antimetabolites|antimetabolites|mesh-ancestor
6792156|NCT02243098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792157|NCT02243098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6792158|NCT02243098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6792159|NCT02243098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6792160|NCT02243098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6792161|NCT02243098|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6792162|NCT02243098|Protective Agents|protective agents|mesh-ancestor
6792163|NCT02243098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792164|NCT02243124|Dexamethasone|dexamethasone|mesh-list
6792165|NCT02243124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6792166|NCT02243124|Antiemetics|antiemetics|mesh-ancestor
6792167|NCT02243124|Autonomic Agents|autonomic agents|mesh-ancestor
6792168|NCT02243124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6792169|NCT02243124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792170|NCT02243124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6792171|NCT02243124|Glucocorticoids|glucocorticoids|mesh-ancestor
6792172|NCT02243124|Hormones|hormones|mesh-ancestor
6792173|NCT02243124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6792174|NCT02243124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6792175|NCT02243124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6792176|NCT02243137|Aspirin|aspirin|mesh-list
6792177|NCT02243137|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
6792178|NCT02243137|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6792179|NCT02243137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6792180|NCT02243137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6792181|NCT02243137|Analgesics|analgesics|mesh-ancestor
6792182|NCT02243137|Sensory System Agents|sensory system agents|mesh-ancestor
6792183|NCT02243137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6792184|NCT02243137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792185|NCT02243137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6792186|NCT02243137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6792187|NCT02243137|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6792188|NCT02243137|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6792189|NCT02243137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792190|NCT02243137|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6792191|NCT02243137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6792192|NCT02243137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6792193|NCT02243137|Antipyretics|antipyretics|mesh-ancestor
6792194|NCT02243241|Moxifloxacin|moxifloxacin|mesh-list
6792195|NCT02243241|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6792196|NCT02243241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6792197|NCT02243241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6792198|NCT02243241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6792199|NCT02243241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6792200|NCT02243241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6792201|NCT02243241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792202|NCT02243241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6792203|NCT02243241|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6792204|NCT02243241|Contraceptive Agents|contraceptive agents|mesh-ancestor
6792205|NCT02243241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6792206|NCT02243241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6525978|NCT00767468|Sorafenib|sorafenib|mesh-list
6525979|NCT00767468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6525980|NCT00767468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6525981|NCT00767468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6525982|NCT00767468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525983|NCT00767481|Travoprost|travoprost|mesh-list
6525984|NCT00767481|Brinzolamide|brinzolamide|mesh-list
6525985|NCT00767481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6525986|NCT00767481|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6525987|NCT00767481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6525988|NCT00767481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525989|NCT00767494|Travoprost|travoprost|mesh-list
6525990|NCT00767494|Brinzolamide|brinzolamide|mesh-list
6525991|NCT00767494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6525992|NCT00767494|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6525993|NCT00767494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6525994|NCT00767494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525995|NCT00767546|Botulinum Toxins|botulinum toxins|mesh-list
6525996|NCT00767546|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6525997|NCT00767546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6525998|NCT00767546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6525999|NCT00767546|Cholinergic Agents|cholinergic agents|mesh-ancestor
6526000|NCT00767546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6526001|NCT00767546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526002|NCT00767559|PENTA|penta|mesh-list
6526003|NCT00767559|Warfarin|warfarin|mesh-list
6526004|NCT00767559|Fondaparinux|fondaparinux|mesh-list
6526005|NCT00767559|Anticoagulants|anticoagulants|mesh-ancestor
6526006|NCT00767559|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6526007|NCT00767559|Antithrombins|antithrombins|mesh-ancestor
6526008|NCT00767559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6526009|NCT00767559|Protease Inhibitors|protease inhibitors|mesh-ancestor
6526010|NCT00767559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6526011|NCT00767559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526012|NCT00767559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6526013|NCT00767559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6526014|NCT00767598|Sildenafil Citrate|sildenafil citrate|mesh-list
6526015|NCT00767598|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6526016|NCT00767598|Udenafil|udenafil|mesh-list
6526017|NCT00767598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
6526018|NCT00767598|Vasodilator Agents|vasodilator agents|mesh-ancestor
6526019|NCT00767598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6526020|NCT00767598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6526021|NCT00767598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526022|NCT00767598|Urological Agents|urological agents|mesh-ancestor
6526023|NCT00767663|Dipyridamole|dipyridamole|mesh-list
6526024|NCT00767663|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6526025|NCT00767663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6526026|NCT00767663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526027|NCT00767663|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6526028|NCT00767663|Vasodilator Agents|vasodilator agents|mesh-ancestor
6526029|NCT00767689|Vitamin B 6|vitamin b 6|mesh-list
6526030|NCT00767689|Pyridoxal|pyridoxal|mesh-list
6526031|NCT00767689|Pyridoxine|pyridoxine|mesh-list
6526032|NCT00767689|Vitamins|vitamins|mesh-ancestor
6526033|NCT00767689|Micronutrients|micronutrients|mesh-ancestor
6526034|NCT00767689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526035|NCT00767689|Vitamin B Complex|vitamin b complex|mesh-ancestor
6526036|NCT00767715|Haloperidol|haloperidol|mesh-list
6526037|NCT00767715|Olanzapine|olanzapine|mesh-list
6526038|NCT00767715|Haloperidol decanoate|haloperidol decanoate|mesh-list
6526039|NCT00767715|Antiemetics|antiemetics|mesh-ancestor
6792207|NCT02243241|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6792208|NCT02243241|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6792209|NCT02243241|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6792210|NCT02243254|Ibuprofen|ibuprofen|mesh-list
6792211|NCT02243254|Remifentanil|remifentanil|mesh-list
6792212|NCT02243254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6792213|NCT02243254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6792214|NCT02243254|Analgesics|analgesics|mesh-ancestor
6792215|NCT02243254|Sensory System Agents|sensory system agents|mesh-ancestor
6792216|NCT02243254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6792217|NCT02243254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792218|NCT02243254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6792219|NCT02243254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6526040|NCT00767715|Autonomic Agents|autonomic agents|mesh-ancestor
6526041|NCT00767715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6526042|NCT00767715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526043|NCT00767715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6526044|NCT00767715|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6526045|NCT00767715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6526046|NCT00767715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6526047|NCT00767715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6526048|NCT00767715|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6526049|NCT00767715|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6526050|NCT00767715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6526051|NCT00767715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526052|NCT00767715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6526053|NCT00767715|Serotonin Agents|serotonin agents|mesh-ancestor
6526054|NCT00767715|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6526055|NCT00767715|Dopamine Agents|dopamine agents|mesh-ancestor
6526056|NCT00767715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6526057|NCT00767728|Mesalamine|mesalamine|mesh-list
6526058|NCT00767728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6526059|NCT00767728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6526060|NCT00767728|Analgesics|analgesics|mesh-ancestor
6526061|NCT00767728|Sensory System Agents|sensory system agents|mesh-ancestor
6526062|NCT00767728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6526063|NCT00767728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526064|NCT00767728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6526065|NCT00767728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6526066|NCT00767754|Paroxetine|paroxetine|mesh-list
6526067|NCT00767754|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6526068|NCT00767754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6526069|NCT00767754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6526070|NCT00767754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526071|NCT00767754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6526072|NCT00767754|Serotonin Agents|serotonin agents|mesh-ancestor
6526073|NCT00767754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526074|NCT00767754|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6526075|NCT00767754|Antidepressive Agents|antidepressive agents|mesh-ancestor
6526076|NCT00767754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6526077|NCT00767754|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6526078|NCT00767754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6526079|NCT00767754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6526080|NCT00767871|Citalopram|citalopram|mesh-list
6526081|NCT00767871|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6526082|NCT00767871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6526083|NCT00767871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6526084|NCT00767871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526085|NCT00767871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6526086|NCT00767871|Serotonin Agents|serotonin agents|mesh-ancestor
6526087|NCT00767871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526088|NCT00767871|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6526089|NCT00767871|Antidepressive Agents|antidepressive agents|mesh-ancestor
6526090|NCT00767871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6526091|NCT00767975|Rifampin|rifampin|mesh-list
6526092|NCT00767975|Isoniazid|isoniazid|mesh-list
6526093|NCT00767975|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6792220|NCT02243254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6792221|NCT02243254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6792222|NCT02243254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792223|NCT02243254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6792224|NCT02243254|Narcotics|narcotics|mesh-ancestor
6792225|NCT02243254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6526094|NCT00767975|Antitubercular Agents|antitubercular agents|mesh-ancestor
6526095|NCT00767975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6526096|NCT00767975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6526097|NCT00767975|Leprostatic Agents|leprostatic agents|mesh-ancestor
6526098|NCT00767975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6526099|NCT00767975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6526100|NCT00767975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526101|NCT00767975|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6526102|NCT00767975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6526103|NCT00767975|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6526104|NCT00767975|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6526105|NCT00767975|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6526106|NCT00767975|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6526107|NCT00767975|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6526108|NCT00767975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6526109|NCT00767975|Antimetabolites|antimetabolites|mesh-ancestor
6526110|NCT00767975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6526111|NCT00768131|Paclitaxel|paclitaxel|mesh-list
6526112|NCT00768131|Carboplatin|carboplatin|mesh-list
6526113|NCT00768131|Cetuximab|cetuximab|mesh-list
6526114|NCT00768131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6526115|NCT00768131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6526116|NCT00768131|Tubulin Modulators|tubulin modulators|mesh-ancestor
6526117|NCT00768131|Antimitotic Agents|antimitotic agents|mesh-ancestor
6526118|NCT00768131|Mitosis Modulators|mitosis modulators|mesh-ancestor
6526119|NCT00768131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526120|NCT00768131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6526121|NCT00768157|Lamivudine|lamivudine|mesh-list
6526122|NCT00768157|Entecavir|entecavir|mesh-list
6526123|NCT00768157|Antiviral Agents|antiviral agents|mesh-list
6526124|NCT00768157|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6526125|NCT00768157|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6526126|NCT00768157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6526127|NCT00768157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526128|NCT00768157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6526129|NCT00768157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6526130|NCT00768157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6526131|NCT00768183|Ethanol|ethanol|mesh-list
6526132|NCT00768183|Morphine|morphine|mesh-list
6526133|NCT00768183|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6526134|NCT00768183|Narcotics|narcotics|mesh-ancestor
6526135|NCT00768183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6526136|NCT00768183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526137|NCT00768183|Analgesics|analgesics|mesh-ancestor
6526138|NCT00768183|Sensory System Agents|sensory system agents|mesh-ancestor
6526139|NCT00768183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6526140|NCT00768183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6526141|NCT00768183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6526142|NCT00768209|Topiramate|topiramate|mesh-list
6526143|NCT00768209|Phentermine|phentermine|mesh-list
6526144|NCT00768209|Anticonvulsants|anticonvulsants|mesh-ancestor
6526145|NCT00768209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6526146|NCT00768209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526147|NCT00768209|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6526148|NCT00768209|Appetite Depressants|appetite depressants|mesh-ancestor
6526149|NCT00768209|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6526150|NCT00768209|Sympathomimetics|sympathomimetics|mesh-ancestor
6526151|NCT00768209|Autonomic Agents|autonomic agents|mesh-ancestor
6792226|NCT02243358|Gemcitabine|gemcitabine|mesh-list
6792227|NCT02243358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6792228|NCT02243358|Antimetabolites|antimetabolites|mesh-ancestor
6792229|NCT02243358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792230|NCT02243358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6792231|NCT02243358|Antiviral Agents|antiviral agents|mesh-ancestor
6792232|NCT02243358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6792233|NCT02243358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6792234|NCT02243358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6792235|NCT02243358|Immunologic Factors|immunologic factors|mesh-ancestor
6792236|NCT02243358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792237|NCT02243436|Cytarabine|cytarabine|mesh-list
6792238|NCT02243436|Methylprednisolone|methylprednisolone|mesh-list
6792239|NCT02243436|Etoposide|etoposide|mesh-list
6792240|NCT02243436|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6526152|NCT00768209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6792241|NCT02243436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6792242|NCT02243436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6526153|NCT00768209|Adrenergic Agents|adrenergic agents|mesh-ancestor
6526154|NCT00768209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6526155|NCT00768209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526156|NCT00768391|Olaratumab|olaratumab|mesh-list
6526157|NCT00768391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6526158|NCT00768404|Phentermine|phentermine|mesh-list
6526159|NCT00768404|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6526160|NCT00768404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526161|NCT00768404|Appetite Depressants|appetite depressants|mesh-ancestor
6526162|NCT00768404|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6526163|NCT00768404|Sympathomimetics|sympathomimetics|mesh-ancestor
6526164|NCT00768404|Autonomic Agents|autonomic agents|mesh-ancestor
6526165|NCT00768404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6526166|NCT00768404|Adrenergic Agents|adrenergic agents|mesh-ancestor
6526167|NCT00768404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6526168|NCT00768404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526169|NCT00768456|Ropivacaine|ropivacaine|mesh-list
6526170|NCT00768456|Anesthetics, Local|anesthetics, local|mesh-ancestor
6526171|NCT00768456|Anesthetics|anesthetics|mesh-ancestor
6526172|NCT00768456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6526173|NCT00768456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526174|NCT00768456|Sensory System Agents|sensory system agents|mesh-ancestor
6526175|NCT00768456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6526176|NCT00768508|Naltrexone|naltrexone|mesh-list
6526177|NCT00768508|Ondansetron|ondansetron|mesh-list
6526178|NCT00768508|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6526179|NCT00768508|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6526180|NCT00768508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526181|NCT00768508|Sensory System Agents|sensory system agents|mesh-ancestor
6526182|NCT00768508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6526183|NCT00768508|Antiemetics|antiemetics|mesh-ancestor
6526184|NCT00768508|Autonomic Agents|autonomic agents|mesh-ancestor
6526185|NCT00768508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6526186|NCT00768508|Antipruritics|antipruritics|mesh-ancestor
6526187|NCT00768508|Dermatologic Agents|dermatologic agents|mesh-ancestor
6526188|NCT00768508|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6792243|NCT02243436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6792244|NCT02243436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6792245|NCT02243436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6792246|NCT02243436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792247|NCT02243436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6792248|NCT02243436|Antimetabolites|antimetabolites|mesh-ancestor
6792249|NCT02243436|Antiviral Agents|antiviral agents|mesh-ancestor
6792250|NCT02243436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6792251|NCT02243436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6792252|NCT02243436|Immunologic Factors|immunologic factors|mesh-ancestor
6792253|NCT02243436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792254|NCT02243436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6792255|NCT02243436|Antiemetics|antiemetics|mesh-ancestor
6792256|NCT02243436|Autonomic Agents|autonomic agents|mesh-ancestor
6792257|NCT02243436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6792258|NCT02243436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6792259|NCT02243436|Glucocorticoids|glucocorticoids|mesh-ancestor
6792260|NCT02243436|Hormones|hormones|mesh-ancestor
6792261|NCT02243436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6792262|NCT02243436|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6792263|NCT02243436|Protective Agents|protective agents|mesh-ancestor
6792264|NCT02243436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6792265|NCT02243553|Vitamin K|vitamin k|mesh-list
6792266|NCT02243553|Ritonavir|ritonavir|mesh-list
6792267|NCT02243553|Tipranavir|tipranavir|mesh-list
6792268|NCT02243553|Digoxin|digoxin|mesh-list
6792269|NCT02243553|Midazolam|midazolam|mesh-list
6792270|NCT02243553|Dextromethorphan|dextromethorphan|mesh-list
6792271|NCT02243553|Caffeine|caffeine|mesh-list
6792272|NCT02243553|Omeprazole|omeprazole|mesh-list
6792273|NCT02243553|Warfarin|warfarin|mesh-list
6792274|NCT02243553|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6792275|NCT02243553|Vitamins|vitamins|mesh-ancestor
6792276|NCT02243553|Micronutrients|micronutrients|mesh-ancestor
6792277|NCT02243553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792278|NCT02243553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6792279|NCT02243553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6792280|NCT02243553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6526189|NCT00768508|Serotonin Agents|serotonin agents|mesh-ancestor
6792281|NCT02243553|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6792282|NCT02243553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6792283|NCT02243553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6526190|NCT00768508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6526191|NCT00768508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526192|NCT00768508|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6526193|NCT00768508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6526194|NCT00768508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6526195|NCT00768508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6526196|NCT00768508|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6526197|NCT00768573|Sildenafil Citrate|sildenafil citrate|mesh-list
6526198|NCT00768573|Vasodilator Agents|vasodilator agents|mesh-ancestor
6526199|NCT00768573|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6526200|NCT00768573|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6526201|NCT00768573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6526202|NCT00768573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526203|NCT00768573|Urological Agents|urological agents|mesh-ancestor
6526204|NCT00768612|Risperidone|risperidone|mesh-list
6526205|NCT00768612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6526206|NCT00768612|Serotonin Agents|serotonin agents|mesh-ancestor
6526207|NCT00768612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6526208|NCT00768612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526209|NCT00768612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526210|NCT00768612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6526211|NCT00768612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6526212|NCT00768612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6526213|NCT00768612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6526214|NCT00768612|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6526215|NCT00768612|Dopamine Agents|dopamine agents|mesh-ancestor
6526216|NCT00768638|Atorvastatin|atorvastatin|mesh-list
6526217|NCT00768638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6526218|NCT00768638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6526219|NCT00768638|Antimetabolites|antimetabolites|mesh-ancestor
6526220|NCT00768638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526221|NCT00768638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6526222|NCT00768638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6526223|NCT00768638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6526224|NCT00768677|Topiramate|topiramate|mesh-list
6526225|NCT00768677|Anticonvulsants|anticonvulsants|mesh-ancestor
6526226|NCT00768677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6526227|NCT00768677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526228|NCT00768690|Ketoconazole|ketoconazole|mesh-list
6526229|NCT00768690|Antifungal Agents|antifungal agents|mesh-ancestor
6526230|NCT00768690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6526231|NCT00768690|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6526232|NCT00768690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6526233|NCT00768690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6526234|NCT00768690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526235|NCT00768690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6792284|NCT02243553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6792285|NCT02243553|Anesthetics, General|anesthetics, general|mesh-ancestor
6792286|NCT02243553|Anesthetics|anesthetics|mesh-ancestor
6792287|NCT02243553|GABA Modulators|gaba modulators|mesh-ancestor
6792288|NCT02243553|GABA Agents|gaba agents|mesh-ancestor
6792289|NCT02243553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6792290|NCT02243553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792291|NCT02243553|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6792292|NCT02243553|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6792293|NCT02243553|Protease Inhibitors|protease inhibitors|mesh-ancestor
6792294|NCT02243553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6792295|NCT02243553|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6792296|NCT02243553|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6792297|NCT02243553|Antiviral Agents|antiviral agents|mesh-ancestor
6792298|NCT02243553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6792299|NCT02243553|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6792300|NCT02243553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6792301|NCT02243553|Anticoagulants|anticoagulants|mesh-ancestor
6792302|NCT02243553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6792303|NCT02243553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6792304|NCT02243553|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6792305|NCT02243553|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6792306|NCT02243553|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6792307|NCT02243553|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6792308|NCT02243553|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6792309|NCT02243553|Purinergic Agents|purinergic agents|mesh-ancestor
6792310|NCT02243553|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6792311|NCT02243553|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6526236|NCT00768690|Hormone Antagonists|hormone antagonists|mesh-ancestor
6526237|NCT00768690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6526238|NCT00768690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526239|NCT00768690|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6526240|NCT00768729|Sirolimus|sirolimus|mesh-list
6526241|NCT00768729|Azathioprine|azathioprine|mesh-list
6526242|NCT00768729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6526243|NCT00768729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6526244|NCT00768729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6526245|NCT00768729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6526246|NCT00768729|Antifungal Agents|antifungal agents|mesh-ancestor
6526247|NCT00768729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6526248|NCT00768729|Immunologic Factors|immunologic factors|mesh-ancestor
6792312|NCT02243553|Protective Agents|protective agents|mesh-ancestor
6792313|NCT02243553|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6792314|NCT02243553|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6792315|NCT02243553|Hemostatics|hemostatics|mesh-ancestor
6792316|NCT02243553|Coagulants|coagulants|mesh-ancestor
6792317|NCT02243553|Antitussive Agents|antitussive agents|mesh-ancestor
6792318|NCT02243553|Respiratory System Agents|respiratory system agents|mesh-ancestor
6792319|NCT02243553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6792320|NCT02243553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6792321|NCT02243566|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6792322|NCT02243566|Telmisartan|telmisartan|mesh-list
6792323|NCT02243566|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
6792324|NCT02243566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6792325|NCT02243566|Diuretics|diuretics|mesh-ancestor
6792326|NCT02243566|Natriuretic Agents|natriuretic agents|mesh-ancestor
6792327|NCT02243566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792328|NCT02243566|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6792329|NCT02243566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6792330|NCT02243566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792331|NCT02243566|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6792332|NCT02243566|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6792333|NCT02243618|Rebamipide|rebamipide|mesh-list
6792334|NCT02243618|Polaprezinc|polaprezinc|mesh-list
6792335|NCT02243618|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6792336|NCT02243618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6792337|NCT02243618|Antioxidants|antioxidants|mesh-ancestor
6792338|NCT02243618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792339|NCT02243618|Protective Agents|protective agents|mesh-ancestor
6792340|NCT02243618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792341|NCT02243618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6792342|NCT02243631|Probenecid|probenecid|mesh-list
6792343|NCT02243631|Uricosuric Agents|uricosuric agents|mesh-ancestor
6792344|NCT02243631|Gout Suppressants|gout suppressants|mesh-ancestor
6792345|NCT02243631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6792346|NCT02243631|Renal Agents|renal agents|mesh-ancestor
6792347|NCT02243644|Albendazole|albendazole|mesh-list
6792348|NCT02243644|Anthelmintics|anthelmintics|mesh-ancestor
6792349|NCT02243644|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6792350|NCT02243644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6792351|NCT02243644|Anticestodal Agents|anticestodal agents|mesh-ancestor
6792352|NCT02243644|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6792353|NCT02243644|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6792354|NCT02243644|Tubulin Modulators|tubulin modulators|mesh-ancestor
6792355|NCT02243644|Antimitotic Agents|antimitotic agents|mesh-ancestor
6792356|NCT02243644|Mitosis Modulators|mitosis modulators|mesh-ancestor
6792357|NCT02243644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792358|NCT02243644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6792359|NCT02243735|Ferrous fumarate|ferrous fumarate|mesh-list
6792360|NCT02243735|Trace Elements|trace elements|mesh-ancestor
6792361|NCT02243735|Micronutrients|micronutrients|mesh-ancestor
6792362|NCT02243735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792363|NCT02243800|Cholecalciferol|cholecalciferol|mesh-list
6792364|NCT02243800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6792365|NCT02243800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792366|NCT02243800|Vitamins|vitamins|mesh-ancestor
6792367|NCT02243800|Micronutrients|micronutrients|mesh-ancestor
6792368|NCT02243800|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6792369|NCT02243813|Psilocybin|psilocybin|mesh-list
6792370|NCT02243813|Hallucinogens|hallucinogens|mesh-ancestor
6792371|NCT02243813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792372|NCT02243813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6792373|NCT02243826|Nitrous Oxide|nitrous oxide|mesh-list
6792374|NCT02243826|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6526249|NCT00768729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526250|NCT00768729|Antimetabolites|antimetabolites|mesh-ancestor
6526251|NCT00768729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526252|NCT00768729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6526253|NCT00768729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6526254|NCT00768768|Terbinafine|terbinafine|mesh-list
6526255|NCT00768768|Antifungal Agents|antifungal agents|mesh-ancestor
6526256|NCT00768768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6526257|NCT00768768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6792375|NCT02243826|Anesthetics, General|anesthetics, general|mesh-ancestor
6792376|NCT02243826|Anesthetics|anesthetics|mesh-ancestor
6792377|NCT02243826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6792378|NCT02243826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792379|NCT02243826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6792380|NCT02243826|Analgesics|analgesics|mesh-ancestor
6792381|NCT02243826|Sensory System Agents|sensory system agents|mesh-ancestor
6792382|NCT02243826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6792383|NCT02243839|Fibrinolytic Agents|fibrinolytic agents|mesh-list
6792384|NCT02243839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6792385|NCT02243839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792386|NCT02243852|Hormones|hormones|mesh-list
6792387|NCT02243852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6792388|NCT02243852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792389|NCT02243878|Ranibizumab|ranibizumab|mesh-list
6792390|NCT02243878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6792391|NCT02243878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6792392|NCT02243878|Growth Substances|growth substances|mesh-ancestor
6792393|NCT02243878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792394|NCT02243878|Growth Inhibitors|growth inhibitors|mesh-ancestor
6792395|NCT02243878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6792396|NCT02244021|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6792397|NCT02244021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6792398|NCT02244021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6792399|NCT02244073|Insulin|insulin|mesh-list
6792400|NCT02244073|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6792401|NCT02244073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6792402|NCT02244073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792403|NCT02244086|Bupivacaine|bupivacaine|mesh-list
6792404|NCT02244086|Anesthetics, Local|anesthetics, local|mesh-ancestor
6792405|NCT02244086|Anesthetics|anesthetics|mesh-ancestor
6792406|NCT02244086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6792407|NCT02244086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792408|NCT02244086|Sensory System Agents|sensory system agents|mesh-ancestor
6792409|NCT02244086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6792410|NCT02244112|Midazolam|midazolam|mesh-list
6792411|NCT02244112|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6792412|NCT02244112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6792413|NCT02244112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6792414|NCT02244112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792415|NCT02244112|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6792416|NCT02244112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6792417|NCT02244112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6792418|NCT02244112|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6792419|NCT02244112|Anesthetics, General|anesthetics, general|mesh-ancestor
6792420|NCT02244112|Anesthetics|anesthetics|mesh-ancestor
6792421|NCT02244112|GABA Modulators|gaba modulators|mesh-ancestor
6792422|NCT02244112|GABA Agents|gaba agents|mesh-ancestor
6792423|NCT02244112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6792424|NCT02244112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792425|NCT02244125|Dexamethasone|dexamethasone|mesh-list
6792426|NCT02244125|Cyclophosphamide|cyclophosphamide|mesh-list
6792427|NCT02244125|Pomalidomide|pomalidomide|mesh-list
6792428|NCT02244125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6792429|NCT02244125|Immunologic Factors|immunologic factors|mesh-ancestor
6792430|NCT02244125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792431|NCT02244125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6792432|NCT02244125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6792433|NCT02244125|Alkylating Agents|alkylating agents|mesh-ancestor
6792434|NCT02244125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792435|NCT02244125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6792436|NCT02244125|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6792437|NCT02244125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6792438|NCT02244125|Antiemetics|antiemetics|mesh-ancestor
6792439|NCT02244125|Autonomic Agents|autonomic agents|mesh-ancestor
6526258|NCT00768768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526259|NCT00768820|Risperidone|risperidone|mesh-list
6526260|NCT00768820|Methylphenidate|methylphenidate|mesh-list
6526261|NCT00768820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6526262|NCT00768820|Serotonin Agents|serotonin agents|mesh-ancestor
6526263|NCT00768820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6526264|NCT00768820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526265|NCT00768820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526266|NCT00768820|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6526267|NCT00768820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6526268|NCT00768820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6526269|NCT00768820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6526270|NCT00768820|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6526271|NCT00768820|Dopamine Agents|dopamine agents|mesh-ancestor
6526272|NCT00768820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6526273|NCT00768820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6526274|NCT00768820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6526275|NCT00768820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6526276|NCT00768859|Paclitaxel|paclitaxel|mesh-list
6526277|NCT00768859|Carboplatin|carboplatin|mesh-list
6526278|NCT00768859|Trastuzumab|trastuzumab|mesh-list
6526279|NCT00768859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6526280|NCT00768859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6526281|NCT00768859|Tubulin Modulators|tubulin modulators|mesh-ancestor
6526282|NCT00768859|Antimitotic Agents|antimitotic agents|mesh-ancestor
6526283|NCT00768859|Mitosis Modulators|mitosis modulators|mesh-ancestor
6526284|NCT00768859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526285|NCT00768859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6526286|NCT00768911|Temozolomide|temozolomide|mesh-list
6526287|NCT00768911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6526288|NCT00768911|Alkylating Agents|alkylating agents|mesh-ancestor
6526289|NCT00768911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526290|NCT00768911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6526291|NCT00768937|Sorafenib|sorafenib|mesh-list
6526292|NCT00768937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6526293|NCT00768937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6526294|NCT00768937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6526295|NCT00768937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526296|NCT00768963|Ranibizumab|ranibizumab|mesh-list
6792440|NCT02244125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6792441|NCT02244125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6792442|NCT02244125|Glucocorticoids|glucocorticoids|mesh-ancestor
6792443|NCT02244125|Hormones|hormones|mesh-ancestor
6792444|NCT02244125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6792445|NCT02244125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6792446|NCT02244125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6792447|NCT02244125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6792448|NCT02244125|Growth Substances|growth substances|mesh-ancestor
6792449|NCT02244125|Growth Inhibitors|growth inhibitors|mesh-ancestor
6792450|NCT02244151|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6792451|NCT02244151|Luteolytic Agents|luteolytic agents|mesh-ancestor
6792452|NCT02244151|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6792453|NCT02244151|Contraceptive Agents|contraceptive agents|mesh-ancestor
6792454|NCT02244151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6792455|NCT02244151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792456|NCT02244151|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6792457|NCT02244151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6792458|NCT02244151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6792459|NCT02244164|Liraglutide|liraglutide|mesh-list
6792460|NCT02244164|Exenatide|exenatide|mesh-list
6792461|NCT02244164|Lixisenatide|lixisenatide|mesh-list
6792462|NCT02244164|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
6792463|NCT02244164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6792464|NCT02244164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792465|NCT02244164|Incretins|incretins|mesh-ancestor
6792466|NCT02244164|Hormones|hormones|mesh-ancestor
6792467|NCT02244164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6792468|NCT02244164|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6792469|NCT02244164|Protease Inhibitors|protease inhibitors|mesh-ancestor
6792470|NCT02244164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6792471|NCT02244164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792472|NCT02244190|Ritonavir|ritonavir|mesh-list
6792473|NCT02244190|Tipranavir|tipranavir|mesh-list
6792474|NCT02244190|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6526297|NCT00768963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6526298|NCT00768963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6526299|NCT00768963|Growth Substances|growth substances|mesh-ancestor
6526300|NCT00768963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526301|NCT00768963|Growth Inhibitors|growth inhibitors|mesh-ancestor
6526302|NCT00768963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6526303|NCT00769041|Moxifloxacin|moxifloxacin|mesh-list
6526304|NCT00769041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6526305|NCT00769041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6526306|NCT00769041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6526307|NCT00769041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6526308|NCT00769041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6526309|NCT00769041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526310|NCT00769041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6526311|NCT00769054|Ropivacaine|ropivacaine|mesh-list
6526312|NCT00769054|Anesthetics, Local|anesthetics, local|mesh-ancestor
6526313|NCT00769054|Anesthetics|anesthetics|mesh-ancestor
6526314|NCT00769054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6526315|NCT00769054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526316|NCT00769054|Sensory System Agents|sensory system agents|mesh-ancestor
6526317|NCT00769054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6526318|NCT00769093|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
6526319|NCT00769093|Hematinics|hematinics|mesh-ancestor
6526320|NCT00769093|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6526321|NCT00769093|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6526322|NCT00769145|Ranibizumab|ranibizumab|mesh-list
6526323|NCT00769145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6526324|NCT00769145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6526325|NCT00769145|Growth Substances|growth substances|mesh-ancestor
6526326|NCT00769145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792475|NCT02244190|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6792476|NCT02244190|Protease Inhibitors|protease inhibitors|mesh-ancestor
6792477|NCT02244190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6792478|NCT02244190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792479|NCT02244190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6792480|NCT02244190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6792481|NCT02244190|Antiviral Agents|antiviral agents|mesh-ancestor
6792482|NCT02244190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6792483|NCT02244190|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6792484|NCT02244190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6792485|NCT02244216|Fenoterol|fenoterol|mesh-list
6792486|NCT02244216|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6792487|NCT02244216|Autonomic Agents|autonomic agents|mesh-ancestor
6792488|NCT02244216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6792489|NCT02244216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792490|NCT02244216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6792491|NCT02244216|Respiratory System Agents|respiratory system agents|mesh-ancestor
6792492|NCT02244216|Sympathomimetics|sympathomimetics|mesh-ancestor
6792493|NCT02244216|Tocolytic Agents|tocolytic agents|mesh-ancestor
6792494|NCT02244216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6792495|NCT02244216|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6792496|NCT02244216|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6792497|NCT02244216|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6792498|NCT02244216|Adrenergic Agents|adrenergic agents|mesh-ancestor
6792499|NCT02244216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6792500|NCT02244216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792501|NCT02244229|Tamsulosin|tamsulosin|mesh-list
6792502|NCT02244229|Finasteride|finasteride|mesh-list
6792503|NCT02244229|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6792504|NCT02244229|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6792505|NCT02244229|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6792506|NCT02244229|Adrenergic Agents|adrenergic agents|mesh-ancestor
6792507|NCT02244229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6792508|NCT02244229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792509|NCT02244229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792510|NCT02244229|Urological Agents|urological agents|mesh-ancestor
6792511|NCT02244229|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6792512|NCT02244229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6258258|NCT03082196|Fluorides, Topical|fluorides, topical|mesh-list
6258259|NCT03082196|Cariostatic Agents|cariostatic agents|mesh-ancestor
6258260|NCT03082196|Protective Agents|protective agents|mesh-ancestor
6258261|NCT03082196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258262|NCT03083132|Modafinil|modafinil|mesh-list
6258263|NCT03083132|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6526327|NCT00769145|Growth Inhibitors|growth inhibitors|mesh-ancestor
6526328|NCT00769145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6526329|NCT00769158|Topiramate|topiramate|mesh-list
6526330|NCT00769158|Naltrexone|naltrexone|mesh-list
6526331|NCT00769158|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6526332|NCT00769158|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6526333|NCT00769158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526334|NCT00769158|Sensory System Agents|sensory system agents|mesh-ancestor
6526335|NCT00769158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6526336|NCT00769158|Anticonvulsants|anticonvulsants|mesh-ancestor
6526337|NCT00769158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6526338|NCT00769171|Moxifloxacin|moxifloxacin|mesh-list
6526339|NCT00769171|Metronidazole|metronidazole|mesh-list
6526340|NCT00769171|Ceftriaxone|ceftriaxone|mesh-list
6526341|NCT00769171|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6526342|NCT00769171|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6526343|NCT00769171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6526344|NCT00769171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6526345|NCT00769171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6526346|NCT00769171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6526347|NCT00769171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526348|NCT00769171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6526349|NCT00769171|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6526350|NCT00769171|Contraceptive Agents|contraceptive agents|mesh-ancestor
6526351|NCT00769171|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6526352|NCT00769171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526353|NCT00769171|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6526354|NCT00769171|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6526355|NCT00769171|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6526356|NCT00769171|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6526357|NCT00769171|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6526358|NCT00769210|Simvastatin|simvastatin|mesh-list
6526359|NCT00769210|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6526360|NCT00769210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6526361|NCT00769210|Antimetabolites|antimetabolites|mesh-ancestor
6526362|NCT00769210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526363|NCT00769210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6526364|NCT00769210|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6526365|NCT00769210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6537362|NCT00822081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6537363|NCT00822081|Adrenergic Agents|adrenergic agents|mesh-ancestor
6537364|NCT00822081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6537365|NCT00822081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537366|NCT00822081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537367|NCT00822081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6537368|NCT00822081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6537369|NCT00822081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6537370|NCT00822081|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6537371|NCT00822081|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6537372|NCT00822081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6537373|NCT00822081|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6537374|NCT00822133|Lidocaine|lidocaine|mesh-list
6537375|NCT00822133|Ketamine|ketamine|mesh-list
6537376|NCT00822133|Anesthetics, Local|anesthetics, local|mesh-ancestor
6537377|NCT00822133|Anesthetics|anesthetics|mesh-ancestor
6537378|NCT00822133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6537379|NCT00822133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537380|NCT00822133|Sensory System Agents|sensory system agents|mesh-ancestor
6537381|NCT00822133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6537382|NCT00822133|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6537383|NCT00822133|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6537384|NCT00822133|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6537385|NCT00822133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6537386|NCT00822133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537387|NCT00822133|Analgesics|analgesics|mesh-ancestor
6537388|NCT00822133|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6537389|NCT00822133|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6537390|NCT00822133|Anesthetics, General|anesthetics, general|mesh-ancestor
6537391|NCT00822133|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6537392|NCT00822133|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6537393|NCT00822133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6537394|NCT00822211|Vildagliptin|vildagliptin|mesh-list
6537395|NCT00822211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6537396|NCT00822211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526366|NCT00769288|2'-fluoro-5-ethylarabinosyluracil|2'-fluoro-5-ethylarabinosyluracil|mesh-list
6526367|NCT00769288|Deoxyuridine|deoxyuridine|mesh-list
6526368|NCT00769288|Antimetabolites|antimetabolites|mesh-ancestor
6526369|NCT00769288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526370|NCT00769288|Antiviral Agents|antiviral agents|mesh-ancestor
6526371|NCT00769288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6526372|NCT00769288|Growth Inhibitors|growth inhibitors|mesh-ancestor
6526373|NCT00769288|Growth Substances|growth substances|mesh-ancestor
6526374|NCT00769288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526375|NCT00769405|Leucovorin|leucovorin|mesh-list
6526376|NCT00769405|Fluorouracil|fluorouracil|mesh-list
6526377|NCT00769405|Oxaliplatin|oxaliplatin|mesh-list
6526378|NCT00769405|Calcium|calcium|mesh-list
6526379|NCT00769405|Levoleucovorin|levoleucovorin|mesh-list
6526380|NCT00769405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6526381|NCT00769405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526382|NCT00769405|Antimetabolites|antimetabolites|mesh-ancestor
6526383|NCT00769405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526384|NCT00769405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6526385|NCT00769405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6526386|NCT00769405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6526387|NCT00769405|Immunologic Factors|immunologic factors|mesh-ancestor
6526388|NCT00769405|Antidotes|antidotes|mesh-ancestor
6526389|NCT00769405|Protective Agents|protective agents|mesh-ancestor
6526390|NCT00769405|Vitamin B Complex|vitamin b complex|mesh-ancestor
6526391|NCT00769405|Vitamins|vitamins|mesh-ancestor
6526392|NCT00769405|Micronutrients|micronutrients|mesh-ancestor
6526393|NCT00769470|Carboplatin|carboplatin|mesh-list
6526394|NCT00769470|Docetaxel|docetaxel|mesh-list
6526395|NCT00769470|Trastuzumab|trastuzumab|mesh-list
6526396|NCT00769470|Lapatinib|lapatinib|mesh-list
6526397|NCT00769470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6792513|NCT02244229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6792514|NCT02244229|Hormone Antagonists|hormone antagonists|mesh-ancestor
6792515|NCT02244229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6792516|NCT02244242|Tamsulosin|tamsulosin|mesh-list
6792517|NCT02244242|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6792518|NCT02244242|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6792519|NCT02244242|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6792520|NCT02244242|Adrenergic Agents|adrenergic agents|mesh-ancestor
6792521|NCT02244242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6792522|NCT02244242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792523|NCT02244242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792524|NCT02244242|Urological Agents|urological agents|mesh-ancestor
6792525|NCT02244255|Tamsulosin|tamsulosin|mesh-list
6792526|NCT02244255|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6792527|NCT02244255|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6792528|NCT02244255|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6792529|NCT02244255|Adrenergic Agents|adrenergic agents|mesh-ancestor
6792530|NCT02244255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6792531|NCT02244255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792532|NCT02244255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792533|NCT02244255|Urological Agents|urological agents|mesh-ancestor
6792534|NCT02244268|Tamsulosin|tamsulosin|mesh-list
6792535|NCT02244268|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6792536|NCT02244268|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6792537|NCT02244268|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6792538|NCT02244268|Adrenergic Agents|adrenergic agents|mesh-ancestor
6792539|NCT02244268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6792540|NCT02244268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792541|NCT02244268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792542|NCT02244268|Urological Agents|urological agents|mesh-ancestor
6792543|NCT02244281|Tamsulosin|tamsulosin|mesh-list
6792544|NCT02244281|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6792545|NCT02244281|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6792546|NCT02244281|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6792547|NCT02244281|Adrenergic Agents|adrenergic agents|mesh-ancestor
6792548|NCT02244281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6792549|NCT02244281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792550|NCT02244281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792551|NCT02244281|Urological Agents|urological agents|mesh-ancestor
6792552|NCT02244294|Tamsulosin|tamsulosin|mesh-list
6526398|NCT00769470|Tubulin Modulators|tubulin modulators|mesh-ancestor
6526399|NCT00769470|Antimitotic Agents|antimitotic agents|mesh-ancestor
6526400|NCT00769470|Mitosis Modulators|mitosis modulators|mesh-ancestor
6526401|NCT00769470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526402|NCT00769470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6526403|NCT00769470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6526404|NCT00769470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6526405|NCT00769522|Cyclophosphamide|cyclophosphamide|mesh-list
6526406|NCT00769522|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6526407|NCT00769522|Rituximab|rituximab|mesh-list
6526408|NCT00769522|Fludarabine|fludarabine|mesh-list
6526409|NCT00769522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6526410|NCT00769522|Immunologic Factors|immunologic factors|mesh-ancestor
6526411|NCT00769522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526412|NCT00769522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6526413|NCT00769522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6526414|NCT00769522|Alkylating Agents|alkylating agents|mesh-ancestor
6526415|NCT00769522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526416|NCT00769522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6526417|NCT00769522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6526418|NCT00769522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6526419|NCT00769548|Goserelin|goserelin|mesh-list
6526420|NCT00769548|Flutamide|flutamide|mesh-list
6526421|NCT00769548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6526422|NCT00769548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6526423|NCT00769548|Androgen Antagonists|androgen antagonists|mesh-ancestor
6526424|NCT00769548|Hormone Antagonists|hormone antagonists|mesh-ancestor
6526425|NCT00769548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6526426|NCT00769548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526427|NCT00769587|Thalidomide|thalidomide|mesh-list
6526428|NCT00769587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6526429|NCT00769587|Immunologic Factors|immunologic factors|mesh-ancestor
6526430|NCT00769587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526431|NCT00769587|Leprostatic Agents|leprostatic agents|mesh-ancestor
6526432|NCT00769587|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6526433|NCT00769587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6526434|NCT00769587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6792553|NCT02244294|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6792554|NCT02244294|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6792555|NCT02244294|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6792556|NCT02244294|Adrenergic Agents|adrenergic agents|mesh-ancestor
6792557|NCT02244294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6258264|NCT03083132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258265|NCT03083132|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6792558|NCT02244294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792559|NCT02244294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792560|NCT02244294|Urological Agents|urological agents|mesh-ancestor
6792561|NCT02244307|Adrenergic Agents|adrenergic agents|mesh-list
6792562|NCT02244307|Adrenergic Antagonists|adrenergic antagonists|mesh-list
6792563|NCT02244307|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
6792564|NCT02244307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6792565|NCT02244307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792566|NCT02244307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792567|NCT02244320|Tamsulosin|tamsulosin|mesh-list
6792568|NCT02244320|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6792569|NCT02244320|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6792570|NCT02244320|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6792571|NCT02244320|Adrenergic Agents|adrenergic agents|mesh-ancestor
6792572|NCT02244320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6792573|NCT02244320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792574|NCT02244320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792575|NCT02244320|Urological Agents|urological agents|mesh-ancestor
6792576|NCT02244437|Acetaminophen|acetaminophen|mesh-list
6792577|NCT02244437|Ibuprofen|ibuprofen|mesh-list
6792578|NCT02244437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6792579|NCT02244437|Analgesics|analgesics|mesh-ancestor
6792580|NCT02244437|Sensory System Agents|sensory system agents|mesh-ancestor
6792581|NCT02244437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6792582|NCT02244437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792583|NCT02244437|Antipyretics|antipyretics|mesh-ancestor
6792584|NCT02244437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6792585|NCT02244437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6792586|NCT02244437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6792587|NCT02244437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6792588|NCT02244437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6526435|NCT00769587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6526436|NCT00769587|Growth Substances|growth substances|mesh-ancestor
6526437|NCT00769587|Growth Inhibitors|growth inhibitors|mesh-ancestor
6526438|NCT00769587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6526439|NCT00769873|Heparin|heparin|mesh-list
6526440|NCT00769873|Enoxaparin|enoxaparin|mesh-list
6526441|NCT00769873|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6526442|NCT00769873|Tinzaparin|tinzaparin|mesh-list
6526443|NCT00769873|Dalteparin|dalteparin|mesh-list
6526444|NCT00769873|Anticoagulants|anticoagulants|mesh-ancestor
6526445|NCT00769873|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6526446|NCT00769873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6526447|NCT00769873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526448|NCT00769990|Genistein|genistein|mesh-list
6526449|NCT00769990|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6526450|NCT00769990|Protective Agents|protective agents|mesh-ancestor
6526451|NCT00769990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526452|NCT00769990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6526453|NCT00769990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6526454|NCT00769990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6526455|NCT00769990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526456|NCT00769990|Phytoestrogens|phytoestrogens|mesh-ancestor
6526457|NCT00769990|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6526458|NCT00769990|Estrogens|estrogens|mesh-ancestor
6526459|NCT00769990|Hormones|hormones|mesh-ancestor
6526460|NCT00769990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6526461|NCT00770042|Ritonavir|ritonavir|mesh-list
6526462|NCT00770042|Ketoconazole|ketoconazole|mesh-list
6526463|NCT00770042|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6526464|NCT00770042|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6526465|NCT00770042|Protease Inhibitors|protease inhibitors|mesh-ancestor
6526466|NCT00770042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6526467|NCT00770042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526468|NCT00770042|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6526469|NCT00770042|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6526470|NCT00770042|Antiviral Agents|antiviral agents|mesh-ancestor
6526471|NCT00770042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6526472|NCT00770042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6526473|NCT00770042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6526474|NCT00770042|Antifungal Agents|antifungal agents|mesh-ancestor
6526475|NCT00770042|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6526476|NCT00770042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6526477|NCT00770042|Hormone Antagonists|hormone antagonists|mesh-ancestor
5992841|NCT00118040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992842|NCT00118040|Phytoestrogens|phytoestrogens|mesh-ancestor
5992843|NCT00118040|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
5992844|NCT00118040|Estrogens|estrogens|mesh-ancestor
5992845|NCT00118040|Hormones|hormones|mesh-ancestor
5992846|NCT00118040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5992847|NCT00118131|Docetaxel|docetaxel|mesh-list
5992848|NCT00118131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992849|NCT00118131|Tubulin Modulators|tubulin modulators|mesh-ancestor
6526478|NCT00770042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6526479|NCT00770042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526480|NCT00770107|Thiamine|thiamine|mesh-list
6526481|NCT00770107|Vitamin B Complex|vitamin b complex|mesh-ancestor
6526482|NCT00770107|Vitamins|vitamins|mesh-ancestor
6526483|NCT00770107|Micronutrients|micronutrients|mesh-ancestor
6526484|NCT00770107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526485|NCT00770172|Lenograstim|lenograstim|mesh-list
6526486|NCT00770172|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6526487|NCT00770172|Immunologic Factors|immunologic factors|mesh-ancestor
6526488|NCT00770172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526489|NCT00770263|Sirolimus|sirolimus|mesh-list
6526490|NCT00770263|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6526491|NCT00770263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6526492|NCT00770263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6526493|NCT00770263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6526494|NCT00770263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526495|NCT00770263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6526496|NCT00770263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6526497|NCT00770263|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6526498|NCT00770263|Antifungal Agents|antifungal agents|mesh-ancestor
6526499|NCT00770263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6526500|NCT00770263|Immunologic Factors|immunologic factors|mesh-ancestor
6526501|NCT00770263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526502|NCT00770302|Saxagliptin|saxagliptin|mesh-list
6526503|NCT00770302|Incretins|incretins|mesh-ancestor
6526504|NCT00770302|Hormones|hormones|mesh-ancestor
6526505|NCT00770302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6526506|NCT00770302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526507|NCT00770302|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6526508|NCT00770302|Protease Inhibitors|protease inhibitors|mesh-ancestor
6526509|NCT00770302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6526510|NCT00770302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526511|NCT00770302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6526512|NCT00770354|Letrozole|letrozole|mesh-list
6526513|NCT00770354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6526514|NCT00770354|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6526515|NCT00770354|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6526516|NCT00770354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6526517|NCT00770354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526518|NCT00770354|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6526519|NCT00770354|Hormone Antagonists|hormone antagonists|mesh-ancestor
6526520|NCT00770354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6526521|NCT00770354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526522|NCT00770406|Botulinum Toxins|botulinum toxins|mesh-list
6526523|NCT00770406|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6526524|NCT00770406|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6526525|NCT00770406|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6526526|NCT00770406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6526527|NCT00770406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526528|NCT00770406|Cholinergic Agents|cholinergic agents|mesh-ancestor
6526529|NCT00770406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6526530|NCT00770406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526531|NCT00770406|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6526532|NCT00770406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6526533|NCT00770445|Insulin|insulin|mesh-list
6526534|NCT00770445|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6526535|NCT00770445|Metformin|metformin|mesh-list
6526536|NCT00770445|Pioglitazone|pioglitazone|mesh-list
6526537|NCT00770445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6526538|NCT00770445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526539|NCT00770471|Temozolomide|temozolomide|mesh-list
6526540|NCT00770471|Veliparib|veliparib|mesh-list
6526541|NCT00770471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6526542|NCT00770471|Alkylating Agents|alkylating agents|mesh-ancestor
6526543|NCT00770471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526544|NCT00770471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6526545|NCT00770471|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6792589|NCT02244437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792590|NCT02244489|Capecitabine|capecitabine|mesh-list
6792591|NCT02244489|Oxaliplatin|oxaliplatin|mesh-list
6792592|NCT02244489|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
6792593|NCT02244489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6792594|NCT02244489|Antimetabolites|antimetabolites|mesh-ancestor
6792595|NCT02244489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792596|NCT02244489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6792597|NCT02244489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6792598|NCT02244489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6792599|NCT02244502|Paclitaxel|paclitaxel|mesh-list
6792600|NCT02244502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6792601|NCT02244502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6792602|NCT02244502|Tubulin Modulators|tubulin modulators|mesh-ancestor
6792603|NCT02244502|Antimitotic Agents|antimitotic agents|mesh-ancestor
6792604|NCT02244502|Mitosis Modulators|mitosis modulators|mesh-ancestor
6792605|NCT02244502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792606|NCT02244515|Dexmedetomidine|dexmedetomidine|mesh-list
6792607|NCT02244515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6258266|NCT03083132|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6258267|NCT03083132|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6258268|NCT03083132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258269|NCT03083470|Paclitaxel|paclitaxel|mesh-list
6258270|NCT03083470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6258271|NCT03083470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6258272|NCT03083470|Tubulin Modulators|tubulin modulators|mesh-ancestor
6258273|NCT03083470|Antimitotic Agents|antimitotic agents|mesh-ancestor
6526546|NCT00770471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6526547|NCT00770497|Pioglitazone|pioglitazone|mesh-list
6526548|NCT00770497|Ramipril|ramipril|mesh-list
6526549|NCT00770497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6526550|NCT00770497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526551|NCT00770497|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6526552|NCT00770497|Protease Inhibitors|protease inhibitors|mesh-ancestor
6526553|NCT00770497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6526554|NCT00770497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526555|NCT00770497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6526556|NCT00770536|Doxorubicin|doxorubicin|mesh-list
6526557|NCT00770536|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6526558|NCT00770536|Topotecan|topotecan|mesh-list
6526559|NCT00770536|Trebananib|trebananib|mesh-list
6526560|NCT00770536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6526561|NCT00770536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6526562|NCT00770536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6526563|NCT00770536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6526564|NCT00770536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6526565|NCT00770536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526566|NCT00770536|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6526567|NCT00770536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6526568|NCT00770536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6526569|NCT00770536|Growth Substances|growth substances|mesh-ancestor
6526570|NCT00770536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526571|NCT00770536|Growth Inhibitors|growth inhibitors|mesh-ancestor
6526572|NCT00770575|Pioglitazone|pioglitazone|mesh-list
6526573|NCT00770575|Atorvastatin|atorvastatin|mesh-list
6526574|NCT00770575|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6526575|NCT00770575|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6526576|NCT00770575|Antimetabolites|antimetabolites|mesh-ancestor
6526577|NCT00770575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526578|NCT00770575|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6526579|NCT00770575|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6526580|NCT00770575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6526581|NCT00770575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6526582|NCT00770575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526583|NCT00770640|Insulin|insulin|mesh-list
6526584|NCT00770640|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6526585|NCT00770640|Pioglitazone|pioglitazone|mesh-list
6526586|NCT00770640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6526587|NCT00770640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526588|NCT00770666|Bupropion|bupropion|mesh-list
6526589|NCT00770666|Nicotine|nicotine|mesh-list
6526590|NCT00770666|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6526591|NCT00770666|Autonomic Agents|autonomic agents|mesh-ancestor
6526592|NCT00770666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6526593|NCT00770666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526594|NCT00770666|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6526595|NCT00770666|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6526596|NCT00770666|Cholinergic Agents|cholinergic agents|mesh-ancestor
6526597|NCT00770666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6526598|NCT00770666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526599|NCT00770666|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6526600|NCT00770666|Antidepressive Agents|antidepressive agents|mesh-ancestor
6526601|NCT00770666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6526602|NCT00770666|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6526603|NCT00770666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6526604|NCT00770666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6526605|NCT00770666|Dopamine Agents|dopamine agents|mesh-ancestor
6526606|NCT00770666|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6526607|NCT00770666|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6526608|NCT00770666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6526609|NCT00770705|Phenoxybenzamine|phenoxybenzamine|mesh-list
6526610|NCT00770705|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6526611|NCT00770705|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6526612|NCT00770705|Adrenergic Agents|adrenergic agents|mesh-ancestor
6526613|NCT00770705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6526614|NCT00770705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526615|NCT00770705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526616|NCT00770705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6526617|NCT00770705|Vasodilator Agents|vasodilator agents|mesh-ancestor
6526618|NCT00770718|Thrombin|thrombin|mesh-list
6526619|NCT00770718|Hemostatics|hemostatics|mesh-ancestor
6792608|NCT02244515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6526620|NCT00770718|Coagulants|coagulants|mesh-ancestor
6526621|NCT00770731|Sirolimus|sirolimus|mesh-list
6526622|NCT00770731|Bortezomib|bortezomib|mesh-list
6526623|NCT00770731|Topotecan|topotecan|mesh-list
6526624|NCT00770731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6526625|NCT00770731|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6526626|NCT00770731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6526627|NCT00770731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6526628|NCT00770731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526629|NCT00770731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6526630|NCT00770731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6526631|NCT00770731|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6526632|NCT00770731|Antifungal Agents|antifungal agents|mesh-ancestor
6526633|NCT00770731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6526634|NCT00770731|Immunologic Factors|immunologic factors|mesh-ancestor
6526635|NCT00770731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526636|NCT00770744|Olanzapine|olanzapine|mesh-list
6526637|NCT00770744|Antiemetics|antiemetics|mesh-ancestor
6526638|NCT00770744|Autonomic Agents|autonomic agents|mesh-ancestor
6526639|NCT00770744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6526640|NCT00770744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526641|NCT00770744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6526642|NCT00770744|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6526643|NCT00770744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6526644|NCT00770744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6526645|NCT00770744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6526646|NCT00770744|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6526647|NCT00770744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6526648|NCT00770744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6526649|NCT00770744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526650|NCT00770744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6526651|NCT00770744|Serotonin Agents|serotonin agents|mesh-ancestor
6526652|NCT00770796|Atorvastatin|atorvastatin|mesh-list
6526653|NCT00770796|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6526654|NCT00770796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6526655|NCT00770796|Antimetabolites|antimetabolites|mesh-ancestor
6526656|NCT00770796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526657|NCT00770796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6526658|NCT00770796|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6526659|NCT00770796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6526660|NCT00770835|Metformin|metformin|mesh-list
6526661|NCT00770835|Pioglitazone|pioglitazone|mesh-list
6526662|NCT00770835|Glyburide|glyburide|mesh-list
6526663|NCT00770835|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6526664|NCT00770835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526665|NCT00770900|Montelukast|montelukast|mesh-list
6526666|NCT00770900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6526667|NCT00770900|Respiratory System Agents|respiratory system agents|mesh-ancestor
6526668|NCT00770900|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6526669|NCT00770900|Hormone Antagonists|hormone antagonists|mesh-ancestor
6526670|NCT00770900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6526671|NCT00770900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526672|NCT00770900|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6526673|NCT00770900|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6526674|NCT00770900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526675|NCT00770952|Pioglitazone|pioglitazone|mesh-list
6526676|NCT00770952|Glimepiride|glimepiride|mesh-list
6526677|NCT00770952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6526678|NCT00770952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526679|NCT00770952|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6526680|NCT00770952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6526681|NCT00770952|Immunologic Factors|immunologic factors|mesh-ancestor
6526682|NCT00770978|Ceftobiprole|ceftobiprole|mesh-list
6526683|NCT00770978|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
6526684|NCT00770978|Cephalosporins|cephalosporins|mesh-list
6526685|NCT00770978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6526686|NCT00770978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6526687|NCT00771004|Pioglitazone|pioglitazone|mesh-list
6526688|NCT00771004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6526689|NCT00771004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526690|NCT00771017|Leuprolide|leuprolide|mesh-list
6792609|NCT02244515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792610|NCT02244515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6792611|NCT02244515|Analgesics|analgesics|mesh-ancestor
6526691|NCT00771017|Goserelin|goserelin|mesh-list
6526692|NCT00771017|Bicalutamide|bicalutamide|mesh-list
6526693|NCT00771017|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6526694|NCT00771017|Fertility Agents|fertility agents|mesh-ancestor
6526695|NCT00771017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6526696|NCT00771017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526697|NCT00771017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6526698|NCT00771017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6526699|NCT00771017|Androgen Antagonists|androgen antagonists|mesh-ancestor
6526700|NCT00771017|Hormone Antagonists|hormone antagonists|mesh-ancestor
6526701|NCT00771017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6526702|NCT00771043|Natalizumab|natalizumab|mesh-list
6526703|NCT00771043|Immunologic Factors|immunologic factors|mesh-ancestor
6526704|NCT00771043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526705|NCT00771147|Sorafenib|sorafenib|mesh-list
6526706|NCT00771147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6526707|NCT00771147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6526708|NCT00771147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6526709|NCT00771147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526710|NCT00771199|Fentanyl|fentanyl|mesh-list
6526711|NCT00771199|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6526712|NCT00771199|Narcotics|narcotics|mesh-ancestor
6526713|NCT00771199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6526714|NCT00771199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526715|NCT00771199|Analgesics|analgesics|mesh-ancestor
6526716|NCT00771199|Sensory System Agents|sensory system agents|mesh-ancestor
6526717|NCT00771199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6526718|NCT00771199|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6526719|NCT00771199|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6526720|NCT00771199|Anesthetics, General|anesthetics, general|mesh-ancestor
6526721|NCT00771199|Anesthetics|anesthetics|mesh-ancestor
6526722|NCT00771251|Golimumab|golimumab|mesh-list
6526723|NCT00771251|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6526724|NCT00771251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6526725|NCT00771251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6526726|NCT00771251|Immunologic Factors|immunologic factors|mesh-ancestor
6526727|NCT00771251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537397|NCT00822211|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6537398|NCT00822211|Protease Inhibitors|protease inhibitors|mesh-ancestor
6537399|NCT00822211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6537400|NCT00822211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537401|NCT00822263|Acetylcysteine|acetylcysteine|mesh-list
6537402|NCT00822263|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6537403|NCT00822263|Antiviral Agents|antiviral agents|mesh-ancestor
6537404|NCT00822263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6537405|NCT00822263|Expectorants|expectorants|mesh-ancestor
6537406|NCT00822263|Respiratory System Agents|respiratory system agents|mesh-ancestor
6537407|NCT00822263|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6537408|NCT00822263|Antioxidants|antioxidants|mesh-ancestor
6537409|NCT00822263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537410|NCT00822263|Protective Agents|protective agents|mesh-ancestor
6537411|NCT00822263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537412|NCT00822263|Antidotes|antidotes|mesh-ancestor
6537413|NCT00822315|Efavirenz|efavirenz|mesh-list
6537414|NCT00822315|Raltegravir Potassium|raltegravir potassium|mesh-list
6537415|NCT00822315|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6537416|NCT00822315|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6537417|NCT00822315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6537418|NCT00822315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537419|NCT00822315|Antiviral Agents|antiviral agents|mesh-ancestor
6537420|NCT00822315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6537421|NCT00822315|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6537422|NCT00822315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6537423|NCT00822315|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6537424|NCT00822315|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6537425|NCT00822315|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6537426|NCT00822315|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6537427|NCT00822315|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6537428|NCT00822315|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6537429|NCT00822315|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6537430|NCT00822315|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6538078|NCT00825617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6538079|NCT00825617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538080|NCT00825643|Insulin Detemir|insulin detemir|mesh-list
6538081|NCT00825643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6526728|NCT00771303|Fibrin fragment D|fibrin fragment d|mesh-list
6526729|NCT00771303|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6526730|NCT00771303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6526731|NCT00771303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526732|NCT00771303|Hemostatics|hemostatics|mesh-ancestor
6526733|NCT00771303|Coagulants|coagulants|mesh-ancestor
6526734|NCT00771342|Nitric Oxide|nitric oxide|mesh-list
6526735|NCT00771342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6526736|NCT00771342|Autonomic Agents|autonomic agents|mesh-ancestor
6526737|NCT00771342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6526738|NCT00771342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526739|NCT00771342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6526740|NCT00771342|Respiratory System Agents|respiratory system agents|mesh-ancestor
6526741|NCT00771342|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6526742|NCT00771342|Antioxidants|antioxidants|mesh-ancestor
6526743|NCT00771342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526744|NCT00771342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6526745|NCT00771342|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6526746|NCT00771342|Vasodilator Agents|vasodilator agents|mesh-ancestor
6526747|NCT00771342|Gasotransmitters|gasotransmitters|mesh-ancestor
6526748|NCT00771342|Protective Agents|protective agents|mesh-ancestor
6526749|NCT00771368|Nitric Oxide|nitric oxide|mesh-list
6526750|NCT00771368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6526751|NCT00771368|Autonomic Agents|autonomic agents|mesh-ancestor
6526752|NCT00771368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6526753|NCT00771368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526754|NCT00771368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6526755|NCT00771368|Respiratory System Agents|respiratory system agents|mesh-ancestor
6526756|NCT00771368|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6526757|NCT00771368|Antioxidants|antioxidants|mesh-ancestor
6526758|NCT00771368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526759|NCT00771368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6526760|NCT00771368|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6526761|NCT00771368|Vasodilator Agents|vasodilator agents|mesh-ancestor
6526762|NCT00771368|Gasotransmitters|gasotransmitters|mesh-ancestor
6526763|NCT00771368|Protective Agents|protective agents|mesh-ancestor
6526764|NCT00771381|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
6526765|NCT00771381|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6526766|NCT00771381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526767|NCT00771394|Tamsulosin|tamsulosin|mesh-list
6526768|NCT00771394|Solifenacin Succinate|solifenacin succinate|mesh-list
6526769|NCT00771394|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6526770|NCT00771394|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6526771|NCT00771394|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6526772|NCT00771394|Adrenergic Agents|adrenergic agents|mesh-ancestor
6526773|NCT00771394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6526774|NCT00771394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526775|NCT00771394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526776|NCT00771394|Urological Agents|urological agents|mesh-ancestor
6526777|NCT00771394|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6526778|NCT00771394|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6526779|NCT00771394|Cholinergic Agents|cholinergic agents|mesh-ancestor
6526780|NCT00771420|Mavrilimumab|mavrilimumab|mesh-list
6526781|NCT00771420|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6526782|NCT00771420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6526783|NCT00771420|Immunologic Factors|immunologic factors|mesh-ancestor
6526784|NCT00771420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526785|NCT00771433|Lenograstim|lenograstim|mesh-list
6526786|NCT00771433|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6526787|NCT00771433|Immunologic Factors|immunologic factors|mesh-ancestor
6792612|NCT02244515|Sensory System Agents|sensory system agents|mesh-ancestor
6792613|NCT02244515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6792614|NCT02244515|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6792615|NCT02244515|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6792616|NCT02244515|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6792617|NCT02244515|Adrenergic Agents|adrenergic agents|mesh-ancestor
6792618|NCT02244515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6792619|NCT02244515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792620|NCT02244528|Sildenafil Citrate|sildenafil citrate|mesh-list
6792621|NCT02244528|Vasodilator Agents|vasodilator agents|mesh-ancestor
6792622|NCT02244528|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6792623|NCT02244528|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6526788|NCT00771433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526789|NCT00771459|Ropivacaine|ropivacaine|mesh-list
6526790|NCT00771459|Anesthetics, Local|anesthetics, local|mesh-ancestor
6526791|NCT00771459|Anesthetics|anesthetics|mesh-ancestor
6526792|NCT00771459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6526793|NCT00771459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526794|NCT00771459|Sensory System Agents|sensory system agents|mesh-ancestor
6526795|NCT00771459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6526796|NCT00771498|Lopinavir|lopinavir|mesh-list
6526797|NCT00771498|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6526798|NCT00771498|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6526799|NCT00771498|Protease Inhibitors|protease inhibitors|mesh-ancestor
6526800|NCT00771498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6526801|NCT00771498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526802|NCT00771498|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6526803|NCT00771498|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6526804|NCT00771498|Antiviral Agents|antiviral agents|mesh-ancestor
6526805|NCT00771498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6526806|NCT00771498|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6526807|NCT00771498|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6526808|NCT00771511|Capsaicin|capsaicin|mesh-list
6526809|NCT00771511|Antipruritics|antipruritics|mesh-ancestor
6526810|NCT00771511|Dermatologic Agents|dermatologic agents|mesh-ancestor
6526811|NCT00771511|Sensory System Agents|sensory system agents|mesh-ancestor
6526812|NCT00771511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6526813|NCT00771511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526814|NCT00771524|Ceftobiprole|ceftobiprole|mesh-list
6526815|NCT00771524|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
6526816|NCT00771524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6526817|NCT00771524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6526818|NCT00771563|Cisplatin|cisplatin|mesh-list
6526819|NCT00771563|Docetaxel|docetaxel|mesh-list
6526820|NCT00771563|Enoxaparin|enoxaparin|mesh-list
6526821|NCT00771563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6526822|NCT00771563|Tubulin Modulators|tubulin modulators|mesh-ancestor
6526823|NCT00771563|Antimitotic Agents|antimitotic agents|mesh-ancestor
6526824|NCT00771563|Mitosis Modulators|mitosis modulators|mesh-ancestor
6526825|NCT00771563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526826|NCT00771563|Anticoagulants|anticoagulants|mesh-ancestor
6526827|NCT00771563|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6526828|NCT00771563|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6526829|NCT00771641|Cobalt|cobalt|mesh-list
6526830|NCT00771641|Trace Elements|trace elements|mesh-ancestor
6526831|NCT00771641|Micronutrients|micronutrients|mesh-ancestor
6526832|NCT00771641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526833|NCT00771654|Phentermine|phentermine|mesh-list
6526834|NCT00771654|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6526835|NCT00771654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526836|NCT00771654|Appetite Depressants|appetite depressants|mesh-ancestor
6526837|NCT00771654|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6526838|NCT00771654|Sympathomimetics|sympathomimetics|mesh-ancestor
6526839|NCT00771654|Autonomic Agents|autonomic agents|mesh-ancestor
6526840|NCT00771654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6526841|NCT00771654|Adrenergic Agents|adrenergic agents|mesh-ancestor
6526842|NCT00771654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6526843|NCT00771654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526844|NCT00771680|Insulin|insulin|mesh-list
6526845|NCT00771680|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6526846|NCT00771680|Insulin Aspart|insulin aspart|mesh-list
6526847|NCT00771680|Insulin, Long-Acting|insulin, long-acting|mesh-list
6526848|NCT00771680|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6526849|NCT00771680|Insulin Detemir|insulin detemir|mesh-list
6526850|NCT00771680|Biphasic Insulins|biphasic insulins|mesh-list
6526851|NCT00771680|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6526852|NCT00771680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6526853|NCT00771680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526854|NCT00771693|Insulin Aspart|insulin aspart|mesh-list
6526855|NCT00771693|Insulin, Long-Acting|insulin, long-acting|mesh-list
6526856|NCT00771693|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6526857|NCT00771693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6526858|NCT00771693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526859|NCT00771706|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
6526860|NCT00771706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6526861|NCT00771706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526862|NCT00771719|Ceftobiprole|ceftobiprole|mesh-list
6526863|NCT00771719|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
6526864|NCT00771719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6526865|NCT00771719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6526866|NCT00771823|Maraviroc|maraviroc|mesh-list
6526867|NCT00771823|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6526868|NCT00771823|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6526869|NCT00771823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526870|NCT00771823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6526871|NCT00771823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6526872|NCT00771823|Antiviral Agents|antiviral agents|mesh-ancestor
6526873|NCT00771823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6526874|NCT00771823|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6526875|NCT00771888|Lanreotide|lanreotide|mesh-list
6526876|NCT00771888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6526877|NCT00771979|Saracatinib|saracatinib|mesh-list
6526878|NCT00771979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6526879|NCT00771979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6526880|NCT00771979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526881|NCT00772057|Propranolol|propranolol|mesh-list
6526882|NCT00772057|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6526883|NCT00772057|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6526884|NCT00772057|Adrenergic Agents|adrenergic agents|mesh-ancestor
6526885|NCT00772057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6526886|NCT00772057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526887|NCT00772057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526888|NCT00772057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6526889|NCT00772057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6526890|NCT00772057|Vasodilator Agents|vasodilator agents|mesh-ancestor
6526891|NCT00772122|Lenograstim|lenograstim|mesh-list
6526892|NCT00772122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6526893|NCT00772122|Immunologic Factors|immunologic factors|mesh-ancestor
6526894|NCT00772122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526895|NCT00772135|Sildenafil Citrate|sildenafil citrate|mesh-list
6526896|NCT00772135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526897|NCT00772135|Vasodilator Agents|vasodilator agents|mesh-ancestor
6526898|NCT00772135|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6526899|NCT00772135|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6526900|NCT00772135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6526901|NCT00772135|Urological Agents|urological agents|mesh-ancestor
6526902|NCT00772161|Methylphenidate|methylphenidate|mesh-list
6526903|NCT00772161|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6526904|NCT00772161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526905|NCT00772161|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6526906|NCT00772161|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6526907|NCT00772161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6526908|NCT00772161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526909|NCT00772161|Dopamine Agents|dopamine agents|mesh-ancestor
6526910|NCT00772161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6526911|NCT00772174|Metformin|metformin|mesh-list
6526912|NCT00772174|Pioglitazone|pioglitazone|mesh-list
6526913|NCT00772174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6526914|NCT00772174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526915|NCT00772187|Fentanyl|fentanyl|mesh-list
6526916|NCT00772187|Morphine|morphine|mesh-list
6526917|NCT00772187|Anesthetics|anesthetics|mesh-ancestor
6792624|NCT02244528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6792625|NCT02244528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792626|NCT02244528|Urological Agents|urological agents|mesh-ancestor
6792627|NCT02244567|Metformin|metformin|mesh-list
6792628|NCT02244567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792629|NCT02244567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6792630|NCT02244632|Bevacizumab|bevacizumab|mesh-list
6792631|NCT02244632|Fluorouracil|fluorouracil|mesh-list
6792632|NCT02244632|Oxaliplatin|oxaliplatin|mesh-list
6792633|NCT02244632|Irinotecan|irinotecan|mesh-list
6792634|NCT02244632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6792635|NCT02244632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6792636|NCT02244632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6792637|NCT02244632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6792638|NCT02244632|Growth Substances|growth substances|mesh-ancestor
6792639|NCT02244632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792640|NCT02244632|Growth Inhibitors|growth inhibitors|mesh-ancestor
6792641|NCT02244632|Antimetabolites|antimetabolites|mesh-ancestor
6792642|NCT02244632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792643|NCT02244632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6792644|NCT02244632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6792645|NCT02244632|Immunologic Factors|immunologic factors|mesh-ancestor
6526918|NCT00772187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6526919|NCT00772187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526920|NCT00772187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6526921|NCT00772187|Narcotics|narcotics|mesh-ancestor
6526922|NCT00772187|Analgesics|analgesics|mesh-ancestor
6526923|NCT00772187|Sensory System Agents|sensory system agents|mesh-ancestor
6526924|NCT00772187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6526925|NCT00772187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6526926|NCT00772187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6526927|NCT00772187|Anesthetics, General|anesthetics, general|mesh-ancestor
6526928|NCT00772265|Insulin|insulin|mesh-list
6526929|NCT00772265|Isophane Insulin, Human|isophane insulin, human|mesh-list
6526930|NCT00772265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6526931|NCT00772265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526932|NCT00772291|Pregabalin|pregabalin|mesh-list
6526933|NCT00772291|Analgesics|analgesics|mesh-ancestor
6526934|NCT00772291|Sensory System Agents|sensory system agents|mesh-ancestor
6526935|NCT00772291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6526936|NCT00772291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526937|NCT00772291|Anticonvulsants|anticonvulsants|mesh-ancestor
6526938|NCT00772291|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6526939|NCT00772291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6526940|NCT00772291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526941|NCT00772291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6526942|NCT00772291|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6526943|NCT00772291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6526944|NCT00772291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6526945|NCT00772291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6526946|NCT00772356|Insulin|insulin|mesh-list
6526947|NCT00772356|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6526948|NCT00772356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6526949|NCT00772356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526950|NCT00772395|Risedronic Acid|risedronic acid|mesh-list
6526951|NCT00772395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6526952|NCT00772395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6526953|NCT00772395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526954|NCT00772395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6526955|NCT00772395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526956|NCT00772395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6526957|NCT00772473|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-list
6526958|NCT00772473|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6526959|NCT00772473|Serotonin Agents|serotonin agents|mesh-ancestor
6526960|NCT00772473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6526961|NCT00772473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526962|NCT00772473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526963|NCT00772499|Atenolol|atenolol|mesh-list
6526964|NCT00772499|Amlodipine|amlodipine|mesh-list
6526965|NCT00772499|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6526966|NCT00772499|Olmesartan|olmesartan|mesh-list
6526967|NCT00772499|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6526968|NCT00772499|Hydralazine|hydralazine|mesh-list
6526969|NCT00772499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6526970|NCT00772499|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6526971|NCT00772499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6526972|NCT00772499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526973|NCT00772499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6526974|NCT00772499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6526975|NCT00772499|Vasodilator Agents|vasodilator agents|mesh-ancestor
6526976|NCT00772499|Diuretics|diuretics|mesh-ancestor
6526977|NCT00772499|Natriuretic Agents|natriuretic agents|mesh-ancestor
6526978|NCT00772499|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6526979|NCT00772499|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6526980|NCT00772499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6526981|NCT00772499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6526982|NCT00772499|Sympatholytics|sympatholytics|mesh-ancestor
6526983|NCT00772499|Autonomic Agents|autonomic agents|mesh-ancestor
6258274|NCT03083470|Mitosis Modulators|mitosis modulators|mesh-ancestor
6526984|NCT00772499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6526985|NCT00772499|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6526986|NCT00772499|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6526987|NCT00772499|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6526988|NCT00772499|Adrenergic Agents|adrenergic agents|mesh-ancestor
6526989|NCT00772499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6537431|NCT00822380|Iron|iron|mesh-list
6526990|NCT00772551|Raltegravir Potassium|raltegravir potassium|mesh-list
6526991|NCT00772551|Ezetimibe|ezetimibe|mesh-list
6526992|NCT00772551|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6526993|NCT00772551|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6526994|NCT00772551|Antimetabolites|antimetabolites|mesh-ancestor
6526995|NCT00772551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6526996|NCT00772551|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6526997|NCT00772551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6526998|NCT00772551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6526999|NCT00772551|Antiviral Agents|antiviral agents|mesh-ancestor
6527000|NCT00772551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6527001|NCT00772551|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6527002|NCT00772551|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6527003|NCT00772551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6527004|NCT00772564|Atorvastatin|atorvastatin|mesh-list
6527005|NCT00772564|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6527006|NCT00772564|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6527007|NCT00772564|Antimetabolites|antimetabolites|mesh-ancestor
6527008|NCT00772564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527009|NCT00772564|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6527010|NCT00772564|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6527011|NCT00772564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6527012|NCT00772616|Sufentanil|sufentanil|mesh-list
6527013|NCT00772616|Remifentanil|remifentanil|mesh-list
6527014|NCT00772616|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6527015|NCT00772616|Narcotics|narcotics|mesh-ancestor
6527016|NCT00772616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6527017|NCT00772616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527018|NCT00772616|Analgesics|analgesics|mesh-ancestor
6527019|NCT00772616|Sensory System Agents|sensory system agents|mesh-ancestor
6527020|NCT00772616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6527021|NCT00772616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6527022|NCT00772616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6527023|NCT00772616|Anesthetics, General|anesthetics, general|mesh-ancestor
6527024|NCT00772616|Anesthetics|anesthetics|mesh-ancestor
6527025|NCT00772655|Rituximab|rituximab|mesh-list
6792646|NCT02244632|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6792647|NCT02244632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6792648|NCT02244632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6792649|NCT02244671|Botulinum Toxins|botulinum toxins|mesh-list
6792650|NCT02244671|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6792651|NCT02244671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6792652|NCT02244671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792653|NCT02244671|Cholinergic Agents|cholinergic agents|mesh-ancestor
6792654|NCT02244671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6792655|NCT02244671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792656|NCT02244710|Clopidogrel|clopidogrel|mesh-list
6792657|NCT02244710|Ticagrelor|ticagrelor|mesh-list
6792658|NCT02244710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6792659|NCT02244710|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6792660|NCT02244710|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6792661|NCT02244710|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6792662|NCT02244710|Purinergic Agents|purinergic agents|mesh-ancestor
6792663|NCT02244710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6792664|NCT02244710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792665|NCT02244710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792666|NCT02244762|Hydrocodone|hydrocodone|mesh-list
5992850|NCT00118131|Antimitotic Agents|antimitotic agents|mesh-ancestor
5992851|NCT00118131|Mitosis Modulators|mitosis modulators|mesh-ancestor
5992852|NCT00118131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992853|NCT00118144|Bortezomib|bortezomib|mesh-list
5992854|NCT00118144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992855|NCT00118157|Tamoxifen|tamoxifen|mesh-list
5992856|NCT00118157|Lapatinib|lapatinib|mesh-list
5992857|NCT00118157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992858|NCT00118157|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5992859|NCT00118157|Hormone Antagonists|hormone antagonists|mesh-ancestor
5992860|NCT00118157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5992861|NCT00118157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992862|NCT00118157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5992863|NCT00118157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992864|NCT00118157|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5992865|NCT00118157|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6527026|NCT00772655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6527027|NCT00772655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6527028|NCT00772655|Immunologic Factors|immunologic factors|mesh-ancestor
6527029|NCT00772655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527030|NCT00772655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6527031|NCT00772681|Docetaxel|docetaxel|mesh-list
6527032|NCT00772681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6527033|NCT00772681|Tubulin Modulators|tubulin modulators|mesh-ancestor
6527034|NCT00772681|Antimitotic Agents|antimitotic agents|mesh-ancestor
6527035|NCT00772681|Mitosis Modulators|mitosis modulators|mesh-ancestor
6527036|NCT00772681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527037|NCT00772694|Sorafenib|sorafenib|mesh-list
6527038|NCT00772694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6527039|NCT00772694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6527040|NCT00772694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6527041|NCT00772694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527042|NCT00772720|Raltegravir Potassium|raltegravir potassium|mesh-list
6527043|NCT00772720|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6527044|NCT00772720|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6527045|NCT00772720|Antiviral Agents|antiviral agents|mesh-ancestor
6527046|NCT00772720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6527047|NCT00772720|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6527048|NCT00772720|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6527049|NCT00772720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6527050|NCT00772720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527051|NCT00772759|AZD-3199|azd-3199|mesh-list
6527052|NCT00772759|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6527053|NCT00772759|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6527054|NCT00772759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6527055|NCT00772759|Adrenergic Agents|adrenergic agents|mesh-ancestor
6527056|NCT00772759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6527057|NCT00772759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527058|NCT00772759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527059|NCT00772798|Paclitaxel|paclitaxel|mesh-list
6527060|NCT00772798|Carboplatin|carboplatin|mesh-list
6527061|NCT00772798|Vorinostat|vorinostat|mesh-list
6527062|NCT00772798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6527063|NCT00772798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6792667|NCT02244762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6792668|NCT02244762|Narcotics|narcotics|mesh-ancestor
6792669|NCT02244762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6792670|NCT02244762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792671|NCT02244762|Analgesics|analgesics|mesh-ancestor
6792672|NCT02244762|Sensory System Agents|sensory system agents|mesh-ancestor
6792673|NCT02244762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6792674|NCT02244762|Antitussive Agents|antitussive agents|mesh-ancestor
6792675|NCT02244762|Respiratory System Agents|respiratory system agents|mesh-ancestor
6527064|NCT00772798|Tubulin Modulators|tubulin modulators|mesh-ancestor
6527065|NCT00772798|Antimitotic Agents|antimitotic agents|mesh-ancestor
6527066|NCT00772798|Mitosis Modulators|mitosis modulators|mesh-ancestor
6527067|NCT00772798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527068|NCT00772798|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6527069|NCT00772798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6527070|NCT00772837|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6527071|NCT00772837|Amoxicillin|amoxicillin|mesh-list
6527072|NCT00772837|Clarithromycin|clarithromycin|mesh-list
6527073|NCT00772837|Omeprazole|omeprazole|mesh-list
6527074|NCT00772837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6527075|NCT00772837|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6527076|NCT00772837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6527077|NCT00772837|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6527078|NCT00772837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6527079|NCT00772837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527080|NCT00772837|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6527081|NCT00772837|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6527082|NCT00772837|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6527083|NCT00772863|Docetaxel|docetaxel|mesh-list
6527084|NCT00772863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6527085|NCT00772863|Tubulin Modulators|tubulin modulators|mesh-ancestor
6527086|NCT00772863|Antimitotic Agents|antimitotic agents|mesh-ancestor
6527087|NCT00772863|Mitosis Modulators|mitosis modulators|mesh-ancestor
6527088|NCT00772863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527089|NCT00772902|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6527090|NCT00772902|Lopinavir|lopinavir|mesh-list
6527091|NCT00772902|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6527092|NCT00772902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6527093|NCT00772902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6527094|NCT00772902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527095|NCT00772902|Antiviral Agents|antiviral agents|mesh-ancestor
6527096|NCT00772902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6527097|NCT00772902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6527098|NCT00772902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6527099|NCT00772902|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6527100|NCT00772902|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6527101|NCT00772902|Protease Inhibitors|protease inhibitors|mesh-ancestor
6527102|NCT00772902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6527103|NCT00772902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6527104|NCT00773058|Hydrocortisone|hydrocortisone|mesh-list
6527105|NCT00773058|Glucocorticoids|glucocorticoids|mesh-list
6527106|NCT00773058|Hormones|hormones|mesh-ancestor
6527107|NCT00773058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6527108|NCT00773058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792676|NCT02244827|Levonadifloxacin|levonadifloxacin|mesh-list
6792677|NCT02244827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6792678|NCT02244827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6792679|NCT02244866|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6792680|NCT02244866|Hormones|hormones|mesh-ancestor
6792681|NCT02244866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6792682|NCT02244866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792683|NCT02244879|Resveratrol|resveratrol|mesh-list
6792684|NCT02244879|Antioxidants|antioxidants|mesh-ancestor
6792685|NCT02244879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792686|NCT02244879|Protective Agents|protective agents|mesh-ancestor
6792687|NCT02244879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792688|NCT02244879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6792689|NCT02244879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6792690|NCT02245022|Tenofovir|tenofovir|mesh-list
6792691|NCT02245022|Lamivudine|lamivudine|mesh-list
6792692|NCT02245022|Efavirenz|efavirenz|mesh-list
6792693|NCT02245022|Dolutegravir|dolutegravir|mesh-list
6792694|NCT02245022|Antiviral Agents|antiviral agents|mesh-ancestor
6792695|NCT02245022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6792696|NCT02245022|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6792697|NCT02245022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6792698|NCT02245022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6792699|NCT02245022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792700|NCT02245022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6792701|NCT02245022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6792702|NCT02245022|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6792703|NCT02245022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6792704|NCT02245022|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6527109|NCT00773058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6527110|NCT00773084|Lisinopril|lisinopril|mesh-list
6527111|NCT00773084|Spironolactone|spironolactone|mesh-list
6527112|NCT00773084|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6527113|NCT00773084|Hormone Antagonists|hormone antagonists|mesh-ancestor
6527114|NCT00773084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6527115|NCT00773084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527116|NCT00773084|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6527117|NCT00773084|Diuretics|diuretics|mesh-ancestor
6527118|NCT00773084|Natriuretic Agents|natriuretic agents|mesh-ancestor
6527119|NCT00773084|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6527120|NCT00773084|Protease Inhibitors|protease inhibitors|mesh-ancestor
6527121|NCT00773084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6527122|NCT00773084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527123|NCT00773084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6527124|NCT00773084|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6527125|NCT00773084|Protective Agents|protective agents|mesh-ancestor
6527126|NCT00773149|Alemtuzumab|alemtuzumab|mesh-list
6527127|NCT00773149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6527128|NCT00773149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6527129|NCT00773162|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6527130|NCT00773162|Antidepressive Agents|antidepressive agents|mesh-ancestor
6527131|NCT00773162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6527132|NCT00773162|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6527133|NCT00773162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6527134|NCT00773162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6527135|NCT00773162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527136|NCT00773188|Bevacizumab|bevacizumab|mesh-list
6527137|NCT00773188|Vinorelbine|vinorelbine|mesh-list
6527138|NCT00773188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6527139|NCT00773188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6527140|NCT00773188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6527141|NCT00773188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6527142|NCT00773188|Growth Substances|growth substances|mesh-ancestor
6527143|NCT00773188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527144|NCT00773188|Growth Inhibitors|growth inhibitors|mesh-ancestor
6527145|NCT00773188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6527146|NCT00773188|Tubulin Modulators|tubulin modulators|mesh-ancestor
6527147|NCT00773188|Antimitotic Agents|antimitotic agents|mesh-ancestor
6527148|NCT00773188|Mitosis Modulators|mitosis modulators|mesh-ancestor
6527149|NCT00773188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527150|NCT00773201|Sotalol|sotalol|mesh-list
6527151|NCT00773201|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6527152|NCT00773201|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6527153|NCT00773201|Adrenergic Agents|adrenergic agents|mesh-ancestor
6527154|NCT00773201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6527155|NCT00773201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527156|NCT00773201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527157|NCT00773201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6527158|NCT00773201|Sympatholytics|sympatholytics|mesh-ancestor
6527159|NCT00773201|Autonomic Agents|autonomic agents|mesh-ancestor
6527160|NCT00773201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6537432|NCT00822380|Trace Elements|trace elements|mesh-list
6537433|NCT00822380|Folic Acid|folic acid|mesh-list
6537434|NCT00822380|Ascorbic Acid|ascorbic acid|mesh-list
6537435|NCT00822380|Micronutrients|micronutrients|mesh-list
6537436|NCT00822380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537437|NCT00822380|Hematinics|hematinics|mesh-ancestor
6537438|NCT00822380|Vitamin B Complex|vitamin b complex|mesh-ancestor
6537439|NCT00822380|Vitamins|vitamins|mesh-ancestor
6792705|NCT02245022|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6792706|NCT02245022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6792707|NCT02245022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6792708|NCT02245022|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6792709|NCT02245022|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6792710|NCT02245087|Atorvastatin|atorvastatin|mesh-list
6792711|NCT02245087|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6792712|NCT02245087|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6792713|NCT02245087|Antimetabolites|antimetabolites|mesh-ancestor
6792714|NCT02245087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792715|NCT02245087|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6792716|NCT02245087|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6792717|NCT02245087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6792718|NCT02245126|Lidocaine|lidocaine|mesh-list
5992866|NCT00118157|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6258275|NCT03083470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258276|NCT03083639|Esomeprazole|esomeprazole|mesh-list
6258277|NCT03083639|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6258278|NCT03083639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6258279|NCT03083639|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6258280|NCT03083639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6258281|NCT03083639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258282|NCT03083847|Chloroquine|chloroquine|mesh-list
6258283|NCT03083847|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
6258284|NCT03083847|Pyrimethamine|pyrimethamine|mesh-list
6258285|NCT03083847|Amebicides|amebicides|mesh-ancestor
6258286|NCT03083847|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6258287|NCT03083847|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6258288|NCT03083847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6527161|NCT00773331|Epoetin Alfa|epoetin alfa|mesh-list
6527162|NCT00773331|Hematinics|hematinics|mesh-ancestor
6527163|NCT00773552|Solifenacin Succinate|solifenacin succinate|mesh-list
6527164|NCT00773552|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6527165|NCT00773552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6527166|NCT00773552|Cholinergic Agents|cholinergic agents|mesh-ancestor
6527167|NCT00773552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6527168|NCT00773552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527169|NCT00773552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527170|NCT00773552|Urological Agents|urological agents|mesh-ancestor
6527171|NCT00773578|Nitric Oxide|nitric oxide|mesh-list
6527172|NCT00773578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6527173|NCT00773578|Autonomic Agents|autonomic agents|mesh-ancestor
6527174|NCT00773578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6527175|NCT00773578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527176|NCT00773578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6527177|NCT00773578|Respiratory System Agents|respiratory system agents|mesh-ancestor
6527178|NCT00773578|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6527179|NCT00773578|Antioxidants|antioxidants|mesh-ancestor
6527180|NCT00773578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527181|NCT00773578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6527182|NCT00773578|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6527183|NCT00773578|Vasodilator Agents|vasodilator agents|mesh-ancestor
6527184|NCT00773578|Gasotransmitters|gasotransmitters|mesh-ancestor
6527185|NCT00773578|Protective Agents|protective agents|mesh-ancestor
6527186|NCT00773591|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6527187|NCT00773591|Botulinum Toxins|botulinum toxins|mesh-list
6527188|NCT00773591|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6527189|NCT00773591|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6527190|NCT00773591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6527191|NCT00773591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527192|NCT00773591|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6527193|NCT00773591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6527194|NCT00773591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527195|NCT00773591|Cholinergic Agents|cholinergic agents|mesh-ancestor
6527196|NCT00773591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6527197|NCT00773630|Cilostazol|cilostazol|mesh-list
6527198|NCT00773630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6527199|NCT00773630|Autonomic Agents|autonomic agents|mesh-ancestor
6527200|NCT00773630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6527201|NCT00773630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527202|NCT00773630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6527203|NCT00773630|Respiratory System Agents|respiratory system agents|mesh-ancestor
6527204|NCT00773630|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6527205|NCT00773630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6527206|NCT00773630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527207|NCT00773630|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6527208|NCT00773630|Vasodilator Agents|vasodilator agents|mesh-ancestor
6527209|NCT00773630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6527210|NCT00773630|Protective Agents|protective agents|mesh-ancestor
6527211|NCT00773630|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6527212|NCT00773630|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6527213|NCT00773630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6527214|NCT00773708|Raltegravir Potassium|raltegravir potassium|mesh-list
6527215|NCT00773708|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6527216|NCT00773708|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6527217|NCT00773708|Antiviral Agents|antiviral agents|mesh-ancestor
6527218|NCT00773708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6527219|NCT00773708|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6258289|NCT03083847|Antimalarials|antimalarials|mesh-ancestor
6527220|NCT00773708|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6527221|NCT00773708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6527222|NCT00773708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527223|NCT00773812|Mecamylamine|mecamylamine|mesh-list
6527224|NCT00773812|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6527225|NCT00773812|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
6527226|NCT00773812|Autonomic Agents|autonomic agents|mesh-ancestor
6527227|NCT00773812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6527228|NCT00773812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527229|NCT00773812|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
6527230|NCT00773812|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6527231|NCT00773812|Cholinergic Agents|cholinergic agents|mesh-ancestor
6527232|NCT00773812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6527233|NCT00773812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527234|NCT00773916|Methylphenidate|methylphenidate|mesh-list
6527235|NCT00773916|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6527236|NCT00773916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527237|NCT00773916|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6527238|NCT00773916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6527239|NCT00773916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6527240|NCT00773916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527241|NCT00773916|Dopamine Agents|dopamine agents|mesh-ancestor
6527242|NCT00773916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6527243|NCT00774007|Mesalamine|mesalamine|mesh-list
6527244|NCT00774007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6527245|NCT00774007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6527246|NCT00774007|Analgesics|analgesics|mesh-ancestor
6527247|NCT00774007|Sensory System Agents|sensory system agents|mesh-ancestor
6527248|NCT00774007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6527249|NCT00774007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527250|NCT00774007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6527251|NCT00774007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6527252|NCT00774020|Zoledronic Acid|zoledronic acid|mesh-list
6527253|NCT00774020|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6527254|NCT00774020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527255|NCT00774072|Tobramycin|tobramycin|mesh-list
6527256|NCT00774072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6527257|NCT00774072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6527258|NCT00774111|Dolutegravir|dolutegravir|mesh-list
6792719|NCT02245126|Bupivacaine|bupivacaine|mesh-list
6792720|NCT02245126|Anesthetics, Local|anesthetics, local|mesh-ancestor
6792721|NCT02245126|Anesthetics|anesthetics|mesh-ancestor
6792722|NCT02245126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6792723|NCT02245126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792724|NCT02245126|Sensory System Agents|sensory system agents|mesh-ancestor
6792725|NCT02245126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6792726|NCT02245126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6792727|NCT02245126|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6792728|NCT02245126|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6792729|NCT02245126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6792730|NCT02245126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792731|NCT02245165|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
6792732|NCT02245165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6792733|NCT02245165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792734|NCT02245191|Phenylephrine|phenylephrine|mesh-list
6792735|NCT02245191|Oxymetazoline|oxymetazoline|mesh-list
6792736|NCT02245191|Ephedrine|ephedrine|mesh-list
6792737|NCT02245191|Metaraminol|metaraminol|mesh-list
6792738|NCT02245191|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6792739|NCT02245191|Mydriatics|mydriatics|mesh-ancestor
6792740|NCT02245191|Autonomic Agents|autonomic agents|mesh-ancestor
6792741|NCT02245191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6792742|NCT02245191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792743|NCT02245191|Sympathomimetics|sympathomimetics|mesh-ancestor
6792744|NCT02245191|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6792745|NCT02245191|Nasal Decongestants|nasal decongestants|mesh-ancestor
6792746|NCT02245191|Respiratory System Agents|respiratory system agents|mesh-ancestor
6792747|NCT02245191|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6792748|NCT02245191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6792749|NCT02245191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6792750|NCT02245191|Adrenergic Agents|adrenergic agents|mesh-ancestor
6792751|NCT02245191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6792752|NCT02245191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527259|NCT00774111|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6527260|NCT00774111|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6527261|NCT00774111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6527262|NCT00774111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527263|NCT00774111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6527264|NCT00774111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6527265|NCT00774111|Antiviral Agents|antiviral agents|mesh-ancestor
6527266|NCT00774111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6527267|NCT00774189|Clarithromycin|clarithromycin|mesh-list
6527268|NCT00774189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6527269|NCT00774189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6527270|NCT00774189|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6527271|NCT00774189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6527272|NCT00774189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527273|NCT00774189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6527274|NCT00774189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6527275|NCT00774241|Bevacizumab|bevacizumab|mesh-list
6527276|NCT00774241|Docetaxel|docetaxel|mesh-list
6527277|NCT00774241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6527278|NCT00774241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6527279|NCT00774241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6527280|NCT00774241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6527281|NCT00774241|Growth Substances|growth substances|mesh-ancestor
6527282|NCT00774241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527283|NCT00774241|Growth Inhibitors|growth inhibitors|mesh-ancestor
6527284|NCT00774241|Tubulin Modulators|tubulin modulators|mesh-ancestor
6527285|NCT00774241|Antimitotic Agents|antimitotic agents|mesh-ancestor
6527286|NCT00774241|Mitosis Modulators|mitosis modulators|mesh-ancestor
6527287|NCT00774241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527288|NCT00774280|Cyclophosphamide|cyclophosphamide|mesh-list
6527289|NCT00774280|Busulfan|busulfan|mesh-list
6527290|NCT00774280|Fludarabine|fludarabine|mesh-list
6527291|NCT00774280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6527292|NCT00774280|Immunologic Factors|immunologic factors|mesh-ancestor
6527293|NCT00774280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527294|NCT00774280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6527295|NCT00774280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6527296|NCT00774280|Alkylating Agents|alkylating agents|mesh-ancestor
6527297|NCT00774280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527298|NCT00774280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6527299|NCT00774280|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6527300|NCT00774319|Cisplatin|cisplatin|mesh-list
6527301|NCT00774319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6527302|NCT00774358|Aldesleukin|aldesleukin|mesh-list
6527303|NCT00774358|Interleukin-2|interleukin-2|mesh-list
6527304|NCT00774358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6792753|NCT02245191|Protective Agents|protective agents|mesh-ancestor
6792754|NCT02245191|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6792755|NCT02245256|Dexmedetomidine|dexmedetomidine|mesh-list
6792756|NCT02245256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6792757|NCT02245256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6792758|NCT02245256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792759|NCT02245256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6792760|NCT02245256|Analgesics|analgesics|mesh-ancestor
6792761|NCT02245256|Sensory System Agents|sensory system agents|mesh-ancestor
6792762|NCT02245256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6792763|NCT02245256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6792764|NCT02245256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6792765|NCT02245256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6792766|NCT02245256|Adrenergic Agents|adrenergic agents|mesh-ancestor
6792767|NCT02245256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6792768|NCT02245256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792769|NCT02245269|Ritonavir|ritonavir|mesh-list
6792770|NCT02245269|Tipranavir|tipranavir|mesh-list
5992867|NCT00118157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5992868|NCT00118157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5992869|NCT00118209|Prednisone|prednisone|mesh-list
5992870|NCT00118209|Cyclophosphamide|cyclophosphamide|mesh-list
5992871|NCT00118209|Rituximab|rituximab|mesh-list
6527305|NCT00774358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6527306|NCT00774358|Analgesics|analgesics|mesh-ancestor
6527307|NCT00774358|Sensory System Agents|sensory system agents|mesh-ancestor
6527308|NCT00774358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6527309|NCT00774358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527310|NCT00774358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6792771|NCT02245269|Atorvastatin|atorvastatin|mesh-list
6527311|NCT00774358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6527312|NCT00774358|Antiviral Agents|antiviral agents|mesh-ancestor
6527313|NCT00774358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6527314|NCT00774423|Riluzole|riluzole|mesh-list
6527315|NCT00774423|Anticonvulsants|anticonvulsants|mesh-ancestor
6527316|NCT00774423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6527317|NCT00774423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6527318|NCT00774423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6527319|NCT00774423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527320|NCT00774423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527321|NCT00774423|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6527322|NCT00774423|Protective Agents|protective agents|mesh-ancestor
6527323|NCT00774462|Rituximab|rituximab|mesh-list
6527324|NCT00774462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6527325|NCT00774462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6527326|NCT00774462|Immunologic Factors|immunologic factors|mesh-ancestor
6527327|NCT00774462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527328|NCT00774462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6527329|NCT00774475|Clopidogrel|clopidogrel|mesh-list
6527330|NCT00774475|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6527331|NCT00774475|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6527332|NCT00774475|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6527333|NCT00774475|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6527334|NCT00774475|Purinergic Agents|purinergic agents|mesh-ancestor
6527335|NCT00774475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6527336|NCT00774475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527337|NCT00774475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527338|NCT00774488|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
6527339|NCT00774488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6527340|NCT00774488|Incretins|incretins|mesh-ancestor
6527341|NCT00774488|Hormones|hormones|mesh-ancestor
6527342|NCT00774488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6527343|NCT00774488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527344|NCT00774501|Anesthetics|anesthetics|mesh-list
6527345|NCT00774501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6527346|NCT00774501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527347|NCT00774527|Cyclophosphamide|cyclophosphamide|mesh-list
6527348|NCT00774527|Fludarabine|fludarabine|mesh-list
6527349|NCT00774527|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6527350|NCT00774527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6527351|NCT00774527|Immunologic Factors|immunologic factors|mesh-ancestor
6527352|NCT00774527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527353|NCT00774527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6527354|NCT00774527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6527355|NCT00774527|Alkylating Agents|alkylating agents|mesh-ancestor
6527356|NCT00774527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527357|NCT00774527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6527358|NCT00774527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6527359|NCT00774540|Ketorolac|ketorolac|mesh-list
6527360|NCT00774540|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6527361|NCT00774540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6527362|NCT00774540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6527363|NCT00774540|Analgesics|analgesics|mesh-ancestor
6527364|NCT00774540|Sensory System Agents|sensory system agents|mesh-ancestor
6527365|NCT00774540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6527366|NCT00774540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527367|NCT00774540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6527368|NCT00774540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6527369|NCT00774540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6527370|NCT00774540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6527371|NCT00774540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527372|NCT00774605|Varenicline|varenicline|mesh-list
6527373|NCT00774605|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6527374|NCT00774605|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6527375|NCT00774605|Cholinergic Agents|cholinergic agents|mesh-ancestor
6527376|NCT00774605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6527377|NCT00774605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527378|NCT00774605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527379|NCT00774644|Clarithromycin|clarithromycin|mesh-list
6527380|NCT00774644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6527381|NCT00774644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6527382|NCT00774644|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6527383|NCT00774644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6527384|NCT00774644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527385|NCT00774644|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6527386|NCT00774644|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6527387|NCT00774683|Raltegravir Potassium|raltegravir potassium|mesh-list
6527388|NCT00774683|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6527389|NCT00774683|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6527390|NCT00774683|Antiviral Agents|antiviral agents|mesh-ancestor
6527391|NCT00774683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6527392|NCT00774683|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6527393|NCT00774683|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6527394|NCT00774683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6527395|NCT00774683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527396|NCT00774696|Clarithromycin|clarithromycin|mesh-list
6527397|NCT00774696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6527398|NCT00774696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6527399|NCT00774696|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6527400|NCT00774696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6527401|NCT00774696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527402|NCT00774696|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6527403|NCT00774696|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6527404|NCT00774722|Metronidazole|metronidazole|mesh-list
6527405|NCT00774722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6527406|NCT00774722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6527407|NCT00774722|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6527408|NCT00774722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6527409|NCT00774735|Dolutegravir|dolutegravir|mesh-list
6527410|NCT00774735|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6527411|NCT00774735|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6527412|NCT00774735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6527413|NCT00774735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527414|NCT00774735|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6527415|NCT00774735|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6527416|NCT00774735|Antiviral Agents|antiviral agents|mesh-ancestor
6527417|NCT00774735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6527418|NCT00774813|Citalopram|citalopram|mesh-list
6527419|NCT00774813|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6527420|NCT00774813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6527421|NCT00774813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6527422|NCT00774813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527423|NCT00774813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6527424|NCT00774813|Serotonin Agents|serotonin agents|mesh-ancestor
6527425|NCT00774813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527426|NCT00774813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6527427|NCT00774813|Antidepressive Agents|antidepressive agents|mesh-ancestor
6527428|NCT00774813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6527429|NCT00774878|Fulvestrant|fulvestrant|mesh-list
6527430|NCT00774878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6527431|NCT00774878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6527432|NCT00774878|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6792772|NCT02245269|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6792773|NCT02245269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6792774|NCT02245269|Antimetabolites|antimetabolites|mesh-ancestor
6792775|NCT02245269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792776|NCT02245269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6792777|NCT02245269|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6792778|NCT02245269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6792779|NCT02245269|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6792780|NCT02245269|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6792781|NCT02245269|Protease Inhibitors|protease inhibitors|mesh-ancestor
6792782|NCT02245269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6792783|NCT02245269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6792784|NCT02245269|Antiviral Agents|antiviral agents|mesh-ancestor
6792785|NCT02245269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6792786|NCT02245269|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6792787|NCT02245269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6792788|NCT02245295|Anesthetics|anesthetics|mesh-list
6792789|NCT02245295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6792790|NCT02245295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792791|NCT02245321|Ferrous gluconate|ferrous gluconate|mesh-list
6792792|NCT02245321|Hematinics|hematinics|mesh-ancestor
6792793|NCT02245334|Povidone-Iodine|povidone-iodine|mesh-list
6792794|NCT02245334|Povidone|povidone|mesh-list
6792795|NCT02245334|Plasma Substitutes|plasma substitutes|mesh-ancestor
6527433|NCT00774878|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6527434|NCT00774878|Hormone Antagonists|hormone antagonists|mesh-ancestor
6527435|NCT00774878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6527436|NCT00774878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527437|NCT00774904|Losartan|losartan|mesh-list
6527438|NCT00774904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6527439|NCT00774904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6527440|NCT00774904|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6527441|NCT00774904|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6527442|NCT00774904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527443|NCT00774969|Metronidazole|metronidazole|mesh-list
6527444|NCT00774969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6527445|NCT00774969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6527446|NCT00774969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6527447|NCT00774969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6527448|NCT00774982|Mercaptopurine|mercaptopurine|mesh-list
6527449|NCT00774982|Antimetabolites|antimetabolites|mesh-ancestor
6527450|NCT00774982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527451|NCT00774982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6527452|NCT00774982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6527453|NCT00774982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6527454|NCT00774982|Immunologic Factors|immunologic factors|mesh-ancestor
6527455|NCT00774982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527456|NCT00774982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6527457|NCT00774982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6527458|NCT00775034|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6527459|NCT00775034|Hemostatics|hemostatics|mesh-ancestor
6527460|NCT00775034|Coagulants|coagulants|mesh-ancestor
6527461|NCT00775047|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6527462|NCT00775047|Medroxyprogesterone|medroxyprogesterone|mesh-list
6527463|NCT00775047|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6527464|NCT00775047|Contraceptive Agents|contraceptive agents|mesh-ancestor
6527465|NCT00775047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6527466|NCT00775047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527467|NCT00775047|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6527468|NCT00775047|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6527469|NCT00775047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6527470|NCT00775047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6527471|NCT00775047|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6527472|NCT00775047|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6527473|NCT00775047|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6537440|NCT00822380|Antioxidants|antioxidants|mesh-ancestor
6537441|NCT00822380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537442|NCT00822380|Protective Agents|protective agents|mesh-ancestor
6537443|NCT00822393|Busulfan|busulfan|mesh-list
6537444|NCT00822393|Treosulfan|treosulfan|mesh-list
6537445|NCT00822393|Alkylating Agents|alkylating agents|mesh-ancestor
6537446|NCT00822393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537447|NCT00822393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6537448|NCT00822393|Immunologic Factors|immunologic factors|mesh-ancestor
6537449|NCT00822393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537450|NCT00822393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6537451|NCT00822393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6537452|NCT00822393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6537453|NCT00822419|Lidocaine|lidocaine|mesh-list
6537454|NCT00822419|Ketamine|ketamine|mesh-list
6537455|NCT00822419|Anesthetics, Local|anesthetics, local|mesh-ancestor
6537456|NCT00822419|Anesthetics|anesthetics|mesh-ancestor
6537457|NCT00822419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6537458|NCT00822419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537459|NCT00822419|Sensory System Agents|sensory system agents|mesh-ancestor
6537460|NCT00822419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6537461|NCT00822419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6537462|NCT00822419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6537463|NCT00822419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6537464|NCT00822419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6537465|NCT00822419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537466|NCT00822419|Analgesics|analgesics|mesh-ancestor
6537467|NCT00822419|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6537468|NCT00822419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6537469|NCT00822419|Anesthetics, General|anesthetics, general|mesh-ancestor
6537470|NCT00822419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6537471|NCT00822419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6527474|NCT00775073|Bevacizumab|bevacizumab|mesh-list
6527475|NCT00775073|Everolimus|everolimus|mesh-list
6527476|NCT00775073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6527477|NCT00775073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6527478|NCT00775073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6527479|NCT00775073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6792796|NCT02245334|Blood Substitutes|blood substitutes|mesh-ancestor
6792797|NCT02245334|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6792798|NCT02245334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6792799|NCT02245373|Antidepressive Agents|antidepressive agents|mesh-list
6792800|NCT02245373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6792801|NCT02245438|Ritonavir|ritonavir|mesh-list
6792802|NCT02245438|Tipranavir|tipranavir|mesh-list
6792803|NCT02245438|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6792804|NCT02245438|Norethindrone|norethindrone|mesh-list
6792805|NCT02245438|Norethindrone Acetate|norethindrone acetate|mesh-list
6792806|NCT02245438|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
6792807|NCT02245438|Norinyl|norinyl|mesh-list
6792808|NCT02245438|Estradiol|estradiol|mesh-list
6792809|NCT02245438|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6792810|NCT02245438|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6792811|NCT02245438|Protease Inhibitors|protease inhibitors|mesh-ancestor
6792812|NCT02245438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6792813|NCT02245438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792814|NCT02245438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6792815|NCT02245438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6792816|NCT02245438|Antiviral Agents|antiviral agents|mesh-ancestor
6792817|NCT02245438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6792818|NCT02245438|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6792819|NCT02245438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6792820|NCT02245438|Estrogens|estrogens|mesh-ancestor
6792821|NCT02245438|Hormones|hormones|mesh-ancestor
6792822|NCT02245438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6792823|NCT02245438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792824|NCT02245438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6792825|NCT02245438|Contraceptive Agents|contraceptive agents|mesh-ancestor
6792826|NCT02245438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6792827|NCT02245438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6792828|NCT02245438|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6792829|NCT02245438|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6792830|NCT02245438|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6792831|NCT02245438|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6792832|NCT02245438|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
6792833|NCT02245451|Ritonavir|ritonavir|mesh-list
6792834|NCT02245451|Tipranavir|tipranavir|mesh-list
6792835|NCT02245451|Methadone|methadone|mesh-list
6792836|NCT02245451|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6792837|NCT02245451|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6792838|NCT02245451|Protease Inhibitors|protease inhibitors|mesh-ancestor
6792839|NCT02245451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6792840|NCT02245451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792841|NCT02245451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6792842|NCT02245451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6792843|NCT02245451|Antiviral Agents|antiviral agents|mesh-ancestor
6792844|NCT02245451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6792845|NCT02245451|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6792846|NCT02245451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6792847|NCT02245451|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6792848|NCT02245451|Narcotics|narcotics|mesh-ancestor
6792849|NCT02245451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6792850|NCT02245451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792851|NCT02245451|Analgesics|analgesics|mesh-ancestor
6792852|NCT02245451|Sensory System Agents|sensory system agents|mesh-ancestor
6792853|NCT02245451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6792854|NCT02245451|Antitussive Agents|antitussive agents|mesh-ancestor
6792855|NCT02245451|Respiratory System Agents|respiratory system agents|mesh-ancestor
6792856|NCT02245464|Telmisartan|telmisartan|mesh-list
6792857|NCT02245464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6792858|NCT02245464|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6792859|NCT02245464|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6792860|NCT02245464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792861|NCT02245477|Mitogens|mitogens|mesh-list
6792862|NCT02245477|Endothelial Growth Factors|endothelial growth factors|mesh-list
6792863|NCT02245477|Mitosis Modulators|mitosis modulators|mesh-ancestor
6527480|NCT00775073|Growth Substances|growth substances|mesh-ancestor
6527481|NCT00775073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527482|NCT00775073|Growth Inhibitors|growth inhibitors|mesh-ancestor
6527483|NCT00775073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6527484|NCT00775073|Immunologic Factors|immunologic factors|mesh-ancestor
6527485|NCT00775086|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6527486|NCT00775086|Norelgestromin|norelgestromin|mesh-list
6527487|NCT00775086|Contraceptive Agents|contraceptive agents|mesh-list
6527488|NCT00775086|Estradiol|estradiol|mesh-list
6527489|NCT00775086|Estrogens|estrogens|mesh-ancestor
6527490|NCT00775086|Hormones|hormones|mesh-ancestor
6527491|NCT00775086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6527492|NCT00775086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527493|NCT00775086|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6527494|NCT00775086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6527495|NCT00775086|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6527496|NCT00775086|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6527497|NCT00775086|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6527498|NCT00775125|Ritonavir|ritonavir|mesh-list
6527499|NCT00775125|Darunavir|darunavir|mesh-list
6527500|NCT00775125|Fosamprenavir|fosamprenavir|mesh-list
6527501|NCT00775125|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6527502|NCT00775125|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6527503|NCT00775125|Protease Inhibitors|protease inhibitors|mesh-ancestor
6527504|NCT00775125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6527505|NCT00775125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527506|NCT00775125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6527507|NCT00775125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6527508|NCT00775125|Antiviral Agents|antiviral agents|mesh-ancestor
6792864|NCT02245477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792865|NCT02245477|Growth Substances|growth substances|mesh-ancestor
6792866|NCT02245477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792867|NCT02245490|Tamsulosin|tamsulosin|mesh-list
6792868|NCT02245490|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6792869|NCT02245490|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6792870|NCT02245490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6792871|NCT02245490|Adrenergic Agents|adrenergic agents|mesh-ancestor
6792872|NCT02245490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6792873|NCT02245490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792874|NCT02245490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792875|NCT02245490|Urological Agents|urological agents|mesh-ancestor
6792876|NCT02245503|Tamsulosin|tamsulosin|mesh-list
6792877|NCT02245503|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6792878|NCT02245503|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6792879|NCT02245503|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6792880|NCT02245503|Adrenergic Agents|adrenergic agents|mesh-ancestor
6792881|NCT02245503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6792882|NCT02245503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792883|NCT02245503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792884|NCT02245503|Urological Agents|urological agents|mesh-ancestor
6792885|NCT02245529|Tamsulosin|tamsulosin|mesh-list
6792886|NCT02245529|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6792887|NCT02245529|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6792888|NCT02245529|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6792889|NCT02245529|Adrenergic Agents|adrenergic agents|mesh-ancestor
6792890|NCT02245529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6792891|NCT02245529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792892|NCT02245529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792893|NCT02245529|Urological Agents|urological agents|mesh-ancestor
6792894|NCT02245555|Tamsulosin|tamsulosin|mesh-list
5992872|NCT00118209|Doxorubicin|doxorubicin|mesh-list
5992873|NCT00118209|Etoposide|etoposide|mesh-list
5992874|NCT00118209|Vincristine|vincristine|mesh-list
5992875|NCT00118209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5992876|NCT00118209|Immunologic Factors|immunologic factors|mesh-ancestor
5992877|NCT00118209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992878|NCT00118209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5992879|NCT00118209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5992880|NCT00118209|Alkylating Agents|alkylating agents|mesh-ancestor
5992881|NCT00118209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992882|NCT00118209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992883|NCT00118209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6527509|NCT00775125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6527510|NCT00775125|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6527511|NCT00775125|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6527512|NCT00775151|Amlodipine|amlodipine|mesh-list
6527513|NCT00775151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6527514|NCT00775151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6527515|NCT00775151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6527516|NCT00775151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527517|NCT00775151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6527518|NCT00775151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527519|NCT00775151|Vasodilator Agents|vasodilator agents|mesh-ancestor
6527520|NCT00775164|Metformin|metformin|mesh-list
6527521|NCT00775164|Pioglitazone|pioglitazone|mesh-list
6527522|NCT00775164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6527523|NCT00775164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527524|NCT00775177|Doxycycline|doxycycline|mesh-list
6527525|NCT00775177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6527526|NCT00775177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6527527|NCT00775177|Antimalarials|antimalarials|mesh-ancestor
6527528|NCT00775177|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6527529|NCT00775177|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6527530|NCT00775242|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6527531|NCT00775242|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6527532|NCT00775242|Estradiol|estradiol|mesh-list
6527533|NCT00775242|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6792895|NCT02245555|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6792896|NCT02245555|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6792897|NCT02245555|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6792898|NCT02245555|Adrenergic Agents|adrenergic agents|mesh-ancestor
6792899|NCT02245555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6792900|NCT02245555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792901|NCT02245555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792902|NCT02245555|Urological Agents|urological agents|mesh-ancestor
6792903|NCT02245789|Remifentanil|remifentanil|mesh-list
6792904|NCT02245789|Propofol|propofol|mesh-list
6792905|NCT02245789|Anesthetics|anesthetics|mesh-ancestor
6792906|NCT02245789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6792907|NCT02245789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792908|NCT02245789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6792909|NCT02245789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6792910|NCT02245789|Anesthetics, General|anesthetics, general|mesh-ancestor
6792911|NCT02245789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6792912|NCT02245789|Narcotics|narcotics|mesh-ancestor
6792913|NCT02245789|Analgesics|analgesics|mesh-ancestor
6792914|NCT02245789|Sensory System Agents|sensory system agents|mesh-ancestor
6792915|NCT02245789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6792916|NCT02245841|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6792917|NCT02245841|Hormones|hormones|mesh-ancestor
6792918|NCT02245841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6792919|NCT02245841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792920|NCT02245867|Antibodies|antibodies|mesh-list
6792921|NCT02245867|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6792922|NCT02245867|Immunologic Factors|immunologic factors|mesh-ancestor
6792923|NCT02245867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792924|NCT02245932|Resveratrol|resveratrol|mesh-list
6792925|NCT02245932|Antioxidants|antioxidants|mesh-ancestor
6792926|NCT02245932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792927|NCT02245932|Protective Agents|protective agents|mesh-ancestor
6792928|NCT02245932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792929|NCT02245932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6792930|NCT02245932|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6792931|NCT02246023|Propofol|propofol|mesh-list
6792932|NCT02246023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6792933|NCT02246023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6792934|NCT02246023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792935|NCT02246023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6792936|NCT02246023|Anesthetics, General|anesthetics, general|mesh-ancestor
6792937|NCT02246023|Anesthetics|anesthetics|mesh-ancestor
6792938|NCT02246049|Leucovorin|leucovorin|mesh-list
6792939|NCT02246049|Bevacizumab|bevacizumab|mesh-list
6792940|NCT02246049|Fluorouracil|fluorouracil|mesh-list
6792941|NCT02246049|Oxaliplatin|oxaliplatin|mesh-list
6792942|NCT02246049|Irinotecan|irinotecan|mesh-list
6792943|NCT02246049|Calcium|calcium|mesh-list
6527534|NCT00775242|Estrogens|estrogens|mesh-list
6527535|NCT00775242|Progesterone|progesterone|mesh-list
6527536|NCT00775242|Progestins|progestins|mesh-list
6527537|NCT00775242|Hormones|hormones|mesh-ancestor
6792944|NCT02246049|Levoleucovorin|levoleucovorin|mesh-list
6792945|NCT02246049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6527538|NCT00775242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6527539|NCT00775242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527540|NCT00775242|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6527541|NCT00775242|Contraceptive Agents|contraceptive agents|mesh-ancestor
6527542|NCT00775242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6527543|NCT00775242|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6527544|NCT00775255|Clarithromycin|clarithromycin|mesh-list
6527545|NCT00775255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6527546|NCT00775255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6527547|NCT00775255|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6527548|NCT00775255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6527549|NCT00775255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527550|NCT00775255|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6527551|NCT00775255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6527552|NCT00775294|Maraviroc|maraviroc|mesh-list
6527553|NCT00775294|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6527554|NCT00775294|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6527555|NCT00775294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527556|NCT00775294|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6527557|NCT00775294|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6527558|NCT00775294|Antiviral Agents|antiviral agents|mesh-ancestor
6527559|NCT00775294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6258290|NCT03083847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6258291|NCT03083847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6258292|NCT03083847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6258293|NCT03083847|Analgesics|analgesics|mesh-ancestor
6258294|NCT03083847|Sensory System Agents|sensory system agents|mesh-ancestor
6258295|NCT03083847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6527560|NCT00775294|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6527561|NCT00775359|Fenofibrate|fenofibrate|mesh-list
6527562|NCT00775359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6527563|NCT00775359|Antimetabolites|antimetabolites|mesh-ancestor
6527564|NCT00775359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527565|NCT00775359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6527566|NCT00775372|Clarithromycin|clarithromycin|mesh-list
6527567|NCT00775372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6527568|NCT00775372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6527569|NCT00775372|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6527570|NCT00775372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6527571|NCT00775372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527572|NCT00775372|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6527573|NCT00775372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6527574|NCT00775476|Acetylcysteine|acetylcysteine|mesh-list
6527575|NCT00775476|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6527576|NCT00775476|Antiviral Agents|antiviral agents|mesh-ancestor
6527577|NCT00775476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6527578|NCT00775476|Expectorants|expectorants|mesh-ancestor
6527579|NCT00775476|Respiratory System Agents|respiratory system agents|mesh-ancestor
6527580|NCT00775476|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6527581|NCT00775476|Antioxidants|antioxidants|mesh-ancestor
6527582|NCT00775476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527583|NCT00775476|Protective Agents|protective agents|mesh-ancestor
6527584|NCT00775476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527585|NCT00775476|Antidotes|antidotes|mesh-ancestor
6792946|NCT02246049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6792947|NCT02246049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6792948|NCT02246049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6792949|NCT02246049|Growth Substances|growth substances|mesh-ancestor
6792950|NCT02246049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258296|NCT03083847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258297|NCT03083847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6258298|NCT03083847|Filaricides|filaricides|mesh-ancestor
6258299|NCT03083847|Antinematodal Agents|antinematodal agents|mesh-ancestor
6258300|NCT03083847|Anthelmintics|anthelmintics|mesh-ancestor
6258301|NCT03083847|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6258302|NCT03083847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6258303|NCT03083847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258304|NCT03083990|Bevacizumab|bevacizumab|mesh-list
6258305|NCT03083990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6258306|NCT03083990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6258307|NCT03083990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6258308|NCT03083990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6258309|NCT03083990|Growth Substances|growth substances|mesh-ancestor
6527586|NCT00775489|Beclomethasone|beclomethasone|mesh-list
6527587|NCT00775489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6527588|NCT00775489|Glucocorticoids|glucocorticoids|mesh-ancestor
6527589|NCT00775489|Hormones|hormones|mesh-ancestor
6527590|NCT00775489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6527591|NCT00775489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527592|NCT00775489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6527593|NCT00775489|Respiratory System Agents|respiratory system agents|mesh-ancestor
6527594|NCT00775541|Ascorbic Acid|ascorbic acid|mesh-list
6527595|NCT00775541|Vitamins|vitamins|mesh-ancestor
6527596|NCT00775541|Micronutrients|micronutrients|mesh-ancestor
6527597|NCT00775541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527598|NCT00775541|Antioxidants|antioxidants|mesh-ancestor
6527599|NCT00775541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527600|NCT00775541|Protective Agents|protective agents|mesh-ancestor
6527601|NCT00775580|Atenolol|atenolol|mesh-list
6527602|NCT00775580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6527603|NCT00775580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6527604|NCT00775580|Sympatholytics|sympatholytics|mesh-ancestor
6527605|NCT00775580|Autonomic Agents|autonomic agents|mesh-ancestor
6527606|NCT00775580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6527607|NCT00775580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527608|NCT00775580|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6527609|NCT00775580|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6527610|NCT00775580|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6527611|NCT00775580|Adrenergic Agents|adrenergic agents|mesh-ancestor
6527612|NCT00775580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6527613|NCT00775580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527614|NCT00775619|Carvedilol|carvedilol|mesh-list
6527615|NCT00775619|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6527616|NCT00775619|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6527617|NCT00775619|Adrenergic Agents|adrenergic agents|mesh-ancestor
6527618|NCT00775619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6527619|NCT00775619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527620|NCT00775619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527621|NCT00775619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6527622|NCT00775619|Antioxidants|antioxidants|mesh-ancestor
6527623|NCT00775619|Protective Agents|protective agents|mesh-ancestor
6527624|NCT00775619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6527625|NCT00775619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6527626|NCT00775619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6527627|NCT00775619|Vasodilator Agents|vasodilator agents|mesh-ancestor
6527628|NCT00775619|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6527629|NCT00775619|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6527630|NCT00775632|Cyclosporine|cyclosporine|mesh-list
6527631|NCT00775632|Methotrexate|methotrexate|mesh-list
6527632|NCT00775632|Alemtuzumab|alemtuzumab|mesh-list
6527633|NCT00775632|Cyclosporins|cyclosporins|mesh-list
6527634|NCT00775632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6527635|NCT00775632|Abortifacient Agents|abortifacient agents|mesh-ancestor
6527636|NCT00775632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6527637|NCT00775632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527638|NCT00775632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6527639|NCT00775632|Antimetabolites|antimetabolites|mesh-ancestor
6527640|NCT00775632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527641|NCT00775632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6527642|NCT00775632|Dermatologic Agents|dermatologic agents|mesh-ancestor
6527643|NCT00775632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6527644|NCT00775632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6527645|NCT00775632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6527646|NCT00775632|Immunologic Factors|immunologic factors|mesh-ancestor
6527647|NCT00775632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6527648|NCT00775632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6527649|NCT00775632|Antifungal Agents|antifungal agents|mesh-ancestor
6527650|NCT00775632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6527651|NCT00775632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6527652|NCT00775632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6527653|NCT00775697|Montelukast|montelukast|mesh-list
6527654|NCT00775697|Leukotriene Antagonists|leukotriene antagonists|mesh-list
6527655|NCT00775697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6527656|NCT00775697|Respiratory System Agents|respiratory system agents|mesh-ancestor
6527657|NCT00775697|Hormone Antagonists|hormone antagonists|mesh-ancestor
6527658|NCT00775697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6527659|NCT00775697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527660|NCT00775697|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6527661|NCT00775697|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6527662|NCT00775697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527663|NCT00775736|Insulin|insulin|mesh-list
6527664|NCT00775736|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6527665|NCT00775736|Insulin Aspart|insulin aspart|mesh-list
6527666|NCT00775736|Insulin, Long-Acting|insulin, long-acting|mesh-list
6527667|NCT00775736|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6527668|NCT00775736|Biphasic Insulins|biphasic insulins|mesh-list
6527669|NCT00775736|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6527670|NCT00775736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6527671|NCT00775736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527672|NCT00775749|Nicotine|nicotine|mesh-list
6527673|NCT00775749|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6527674|NCT00775749|Autonomic Agents|autonomic agents|mesh-ancestor
6527675|NCT00775749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6527676|NCT00775749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527677|NCT00775749|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6527678|NCT00775749|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6527679|NCT00775749|Cholinergic Agents|cholinergic agents|mesh-ancestor
6527680|NCT00775749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6527681|NCT00775749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527682|NCT00775762|Aspirin|aspirin|mesh-list
6527683|NCT00775762|Clopidogrel|clopidogrel|mesh-list
6527684|NCT00775762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6527685|NCT00775762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6527686|NCT00775762|Analgesics|analgesics|mesh-ancestor
6527687|NCT00775762|Sensory System Agents|sensory system agents|mesh-ancestor
6527688|NCT00775762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6527689|NCT00775762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527690|NCT00775762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6527691|NCT00775762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6527692|NCT00775762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6527693|NCT00775762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6527694|NCT00775762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527695|NCT00775762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6527696|NCT00775762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6527697|NCT00775762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6527698|NCT00775762|Antipyretics|antipyretics|mesh-ancestor
6527699|NCT00775762|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6527700|NCT00775762|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6527701|NCT00775762|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6527702|NCT00775762|Purinergic Agents|purinergic agents|mesh-ancestor
6527703|NCT00775762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6527704|NCT00775814|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6527705|NCT00775814|Candesartan|candesartan|mesh-list
6527706|NCT00775814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6527707|NCT00775814|Diuretics|diuretics|mesh-ancestor
6527708|NCT00775814|Natriuretic Agents|natriuretic agents|mesh-ancestor
6527709|NCT00775814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527710|NCT00775814|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6527711|NCT00775814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6527712|NCT00775814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527713|NCT00775814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6527714|NCT00775814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6527715|NCT00775827|Fenofibrate|fenofibrate|mesh-list
6527716|NCT00775827|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6527717|NCT00775827|Antimetabolites|antimetabolites|mesh-ancestor
6527718|NCT00775827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527719|NCT00775827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6527720|NCT00775840|Candesartan|candesartan|mesh-list
6527721|NCT00775840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6527722|NCT00775840|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6527723|NCT00775840|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6527724|NCT00775840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527725|NCT00775879|Sevoflurane|sevoflurane|mesh-list
6527726|NCT00775879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6527727|NCT00775879|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6527728|NCT00775879|Anesthetics, General|anesthetics, general|mesh-ancestor
6527729|NCT00775879|Anesthetics|anesthetics|mesh-ancestor
6527730|NCT00775879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6527731|NCT00775879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527732|NCT00775905|Amlodipine|amlodipine|mesh-list
6527733|NCT00775905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6527734|NCT00775905|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6527735|NCT00775905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6527736|NCT00775905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527737|NCT00775905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6527738|NCT00775905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527739|NCT00775905|Vasodilator Agents|vasodilator agents|mesh-ancestor
6527740|NCT00775918|Doxycycline|doxycycline|mesh-list
6527741|NCT00775918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6527742|NCT00775918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6527743|NCT00775918|Antimalarials|antimalarials|mesh-ancestor
6527744|NCT00775918|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6527745|NCT00775918|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6527746|NCT00775996|Clorazepate Dipotassium|clorazepate dipotassium|mesh-list
6527747|NCT00775996|Anticonvulsants|anticonvulsants|mesh-ancestor
6527748|NCT00775996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6527749|NCT00775996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6527750|NCT00775996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6527751|NCT00775996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527752|NCT00775996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6527753|NCT00775996|GABA Modulators|gaba modulators|mesh-ancestor
6527754|NCT00775996|GABA Agents|gaba agents|mesh-ancestor
6527755|NCT00775996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6527756|NCT00775996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527757|NCT00776022|Cetirizine|cetirizine|mesh-list
6527758|NCT00776022|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6527759|NCT00776022|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6527760|NCT00776022|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6527761|NCT00776022|Histamine Antagonists|histamine antagonists|mesh-ancestor
6527762|NCT00776022|Histamine Agents|histamine agents|mesh-ancestor
6527763|NCT00776022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6527764|NCT00776022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527765|NCT00776022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527766|NCT00776074|Leuprolide|leuprolide|mesh-list
6527767|NCT00776074|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6527768|NCT00776074|Fertility Agents|fertility agents|mesh-ancestor
6527769|NCT00776074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6527770|NCT00776074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527771|NCT00776074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6527772|NCT00776074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6527773|NCT00776113|Carvedilol|carvedilol|mesh-list
6527774|NCT00776113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6527775|NCT00776113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6527776|NCT00776113|Adrenergic Agents|adrenergic agents|mesh-ancestor
6527777|NCT00776113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6527778|NCT00776113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527779|NCT00776113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527780|NCT00776113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6527781|NCT00776113|Antioxidants|antioxidants|mesh-ancestor
6527782|NCT00776113|Protective Agents|protective agents|mesh-ancestor
6527783|NCT00776113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6527784|NCT00776113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6527785|NCT00776113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6527786|NCT00776113|Vasodilator Agents|vasodilator agents|mesh-ancestor
6527787|NCT00776113|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6527788|NCT00776113|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6527789|NCT00776139|Cetirizine|cetirizine|mesh-list
6527790|NCT00776139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6527791|NCT00776139|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6527792|NCT00776139|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6527793|NCT00776139|Histamine Antagonists|histamine antagonists|mesh-ancestor
6527794|NCT00776139|Histamine Agents|histamine agents|mesh-ancestor
6527795|NCT00776139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6527796|NCT00776139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527797|NCT00776139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527798|NCT00776217|Loratadine|loratadine|mesh-list
6527799|NCT00776217|Antipruritics|antipruritics|mesh-ancestor
6527800|NCT00776217|Dermatologic Agents|dermatologic agents|mesh-ancestor
6792951|NCT02246049|Growth Inhibitors|growth inhibitors|mesh-ancestor
6792952|NCT02246049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6792953|NCT02246049|Antimetabolites|antimetabolites|mesh-ancestor
6792954|NCT02246049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527801|NCT00776217|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6527802|NCT00776217|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6527803|NCT00776217|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6527804|NCT00776217|Histamine Antagonists|histamine antagonists|mesh-ancestor
6527805|NCT00776217|Histamine Agents|histamine agents|mesh-ancestor
6527806|NCT00776217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6527807|NCT00776217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527808|NCT00776217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527809|NCT00776282|Loratadine|loratadine|mesh-list
6527810|NCT00776282|Antipruritics|antipruritics|mesh-ancestor
6527811|NCT00776282|Dermatologic Agents|dermatologic agents|mesh-ancestor
6527812|NCT00776282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6527813|NCT00776282|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6527814|NCT00776282|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6527815|NCT00776282|Histamine Antagonists|histamine antagonists|mesh-ancestor
6527816|NCT00776282|Histamine Agents|histamine agents|mesh-ancestor
6527817|NCT00776282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6527818|NCT00776282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527819|NCT00776282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527820|NCT00776334|Fosinopril|fosinopril|mesh-list
6527821|NCT00776334|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6527822|NCT00776334|Protease Inhibitors|protease inhibitors|mesh-ancestor
6527823|NCT00776334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6527824|NCT00776334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527825|NCT00776334|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6527826|NCT00776347|Donepezil|donepezil|mesh-list
6527827|NCT00776347|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6527828|NCT00776347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6527829|NCT00776347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527830|NCT00776347|Cholinergic Agents|cholinergic agents|mesh-ancestor
6527831|NCT00776347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6527832|NCT00776347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527833|NCT00776347|Nootropic Agents|nootropic agents|mesh-ancestor
6527834|NCT00776360|Oxytocin|oxytocin|mesh-list
6527835|NCT00776360|Oxytocics|oxytocics|mesh-ancestor
6527836|NCT00776360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6527837|NCT00776360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527838|NCT00776425|Epoetin Alfa|epoetin alfa|mesh-list
6527839|NCT00776425|Hematinics|hematinics|mesh-ancestor
6527840|NCT00776438|Vaccines|vaccines|mesh-list
6527841|NCT00776438|Immunologic Factors|immunologic factors|mesh-ancestor
6527842|NCT00776438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527843|NCT00776477|Aspirin|aspirin|mesh-list
6527844|NCT00776477|Clopidogrel|clopidogrel|mesh-list
6527845|NCT00776477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6527846|NCT00776477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6527847|NCT00776477|Analgesics|analgesics|mesh-ancestor
6527848|NCT00776477|Sensory System Agents|sensory system agents|mesh-ancestor
6527849|NCT00776477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6527850|NCT00776477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527851|NCT00776477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6527852|NCT00776477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6527853|NCT00776477|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6527854|NCT00776477|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6527855|NCT00776477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527856|NCT00776477|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6527857|NCT00776477|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6527858|NCT00776477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6527859|NCT00776477|Antipyretics|antipyretics|mesh-ancestor
6527860|NCT00776477|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6527861|NCT00776477|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6527862|NCT00776477|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6527863|NCT00776477|Purinergic Agents|purinergic agents|mesh-ancestor
6527864|NCT00776477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6527865|NCT00776490|Glimepiride|glimepiride|mesh-list
6527866|NCT00776490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6527867|NCT00776490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6527868|NCT00776490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527869|NCT00776490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6527870|NCT00776490|Immunologic Factors|immunologic factors|mesh-ancestor
6527871|NCT00776503|Vorinostat|vorinostat|mesh-list
6527872|NCT00776503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6527873|NCT00776503|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6792955|NCT02246049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6792956|NCT02246049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6527874|NCT00776503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6527875|NCT00776503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527876|NCT00776516|Rifampin|rifampin|mesh-list
6527877|NCT00776516|Mirabegron|mirabegron|mesh-list
6527878|NCT00776516|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6527879|NCT00776516|Antitubercular Agents|antitubercular agents|mesh-ancestor
6527880|NCT00776516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6527881|NCT00776516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6527882|NCT00776516|Leprostatic Agents|leprostatic agents|mesh-ancestor
6527883|NCT00776516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6527884|NCT00776516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6527885|NCT00776516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527886|NCT00776516|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6527887|NCT00776516|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6527888|NCT00776516|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6527889|NCT00776516|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6527890|NCT00776516|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6527891|NCT00776516|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6527892|NCT00776516|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6527893|NCT00776516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6527894|NCT00776516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6527895|NCT00776516|Adrenergic Agents|adrenergic agents|mesh-ancestor
6527896|NCT00776516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6527897|NCT00776516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527898|NCT00776516|Urological Agents|urological agents|mesh-ancestor
6527899|NCT00776542|Minocycline|minocycline|mesh-list
6527900|NCT00776542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6527901|NCT00776542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6527902|NCT00776568|Antihypertensive Agents|antihypertensive agents|mesh-list
6527903|NCT00776607|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6527904|NCT00776607|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6527905|NCT00776607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527906|NCT00776620|Glimepiride|glimepiride|mesh-list
6527907|NCT00776620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6527908|NCT00776620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6527909|NCT00776620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527910|NCT00776620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6527911|NCT00776620|Immunologic Factors|immunologic factors|mesh-ancestor
6527912|NCT00776633|Aspirin|aspirin|mesh-list
6527913|NCT00776633|Clopidogrel|clopidogrel|mesh-list
6527914|NCT00776633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6527915|NCT00776633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6527916|NCT00776633|Analgesics|analgesics|mesh-ancestor
6527917|NCT00776633|Sensory System Agents|sensory system agents|mesh-ancestor
6527918|NCT00776633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6527919|NCT00776633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527920|NCT00776633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6527921|NCT00776633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6527922|NCT00776633|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6527923|NCT00776633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6527924|NCT00776633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527925|NCT00776633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6527926|NCT00776633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6527927|NCT00776633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6527928|NCT00776633|Antipyretics|antipyretics|mesh-ancestor
6527929|NCT00776633|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6527930|NCT00776633|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6527931|NCT00776633|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6527932|NCT00776633|Purinergic Agents|purinergic agents|mesh-ancestor
6527933|NCT00776633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6527934|NCT00776646|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6527935|NCT00776646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6527936|NCT00776646|Diuretics|diuretics|mesh-ancestor
6527937|NCT00776646|Natriuretic Agents|natriuretic agents|mesh-ancestor
6527938|NCT00776646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527939|NCT00776646|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6527940|NCT00776646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6527941|NCT00776646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527942|NCT00776672|Fosinopril|fosinopril|mesh-list
6527943|NCT00776672|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6527944|NCT00776672|Protease Inhibitors|protease inhibitors|mesh-ancestor
6527945|NCT00776672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6527946|NCT00776672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527947|NCT00776672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6527948|NCT00776698|Bevacizumab|bevacizumab|mesh-list
6527949|NCT00776698|Etoposide|etoposide|mesh-list
6527950|NCT00776698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6527951|NCT00776698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6527952|NCT00776698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6527953|NCT00776698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6527954|NCT00776698|Growth Substances|growth substances|mesh-ancestor
6527955|NCT00776698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527956|NCT00776698|Growth Inhibitors|growth inhibitors|mesh-ancestor
6527957|NCT00776698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6527958|NCT00776698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6527959|NCT00776698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6527960|NCT00776698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6527961|NCT00776698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527962|NCT00776724|Docetaxel|docetaxel|mesh-list
6527963|NCT00776724|Epirubicin|epirubicin|mesh-list
6527964|NCT00776724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6527965|NCT00776724|Tubulin Modulators|tubulin modulators|mesh-ancestor
6527966|NCT00776724|Antimitotic Agents|antimitotic agents|mesh-ancestor
6527967|NCT00776724|Mitosis Modulators|mitosis modulators|mesh-ancestor
6527968|NCT00776724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527969|NCT00776724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6527970|NCT00776724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6527971|NCT00776724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6527972|NCT00776724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6537472|NCT00822419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6537473|NCT00822536|Aspirin|aspirin|mesh-list
6537474|NCT00822536|Clopidogrel|clopidogrel|mesh-list
6537475|NCT00822536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6537476|NCT00822536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6537477|NCT00822536|Analgesics|analgesics|mesh-ancestor
6537478|NCT00822536|Sensory System Agents|sensory system agents|mesh-ancestor
6537479|NCT00822536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6537480|NCT00822536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537481|NCT00822536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6537482|NCT00822536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6537483|NCT00822536|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6537484|NCT00822536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6537485|NCT00822536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537486|NCT00822536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6537487|NCT00822536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6537488|NCT00822536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6537489|NCT00822536|Antipyretics|antipyretics|mesh-ancestor
6537490|NCT00822536|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6792957|NCT02246049|Immunologic Factors|immunologic factors|mesh-ancestor
6792958|NCT02246049|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6792959|NCT02246049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6792960|NCT02246049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6792961|NCT02246049|Antidotes|antidotes|mesh-ancestor
6792962|NCT02246049|Protective Agents|protective agents|mesh-ancestor
6792963|NCT02246049|Vitamin B Complex|vitamin b complex|mesh-ancestor
6792964|NCT02246049|Vitamins|vitamins|mesh-ancestor
6792965|NCT02246049|Micronutrients|micronutrients|mesh-ancestor
6792966|NCT02246127|Everolimus|everolimus|mesh-list
6792967|NCT02246127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6792968|NCT02246127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6792969|NCT02246127|Immunologic Factors|immunologic factors|mesh-ancestor
6792970|NCT02246127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792971|NCT02246179|Lidocaine|lidocaine|mesh-list
6792972|NCT02246179|Epinephrine|epinephrine|mesh-list
6792973|NCT02246179|Prilocaine|prilocaine|mesh-list
6792974|NCT02246179|Carticaine|carticaine|mesh-list
6792975|NCT02246179|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
6792976|NCT02246179|Anesthetics, Local|anesthetics, local|mesh-ancestor
6792977|NCT02246179|Anesthetics|anesthetics|mesh-ancestor
6792978|NCT02246179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6792979|NCT02246179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6792980|NCT02246179|Sensory System Agents|sensory system agents|mesh-ancestor
6792981|NCT02246179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6792982|NCT02246179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6792983|NCT02246179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6792984|NCT02246179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6792985|NCT02246179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6527973|NCT00776763|Bevacizumab|bevacizumab|mesh-list
6527974|NCT00776763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6527975|NCT00776763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6527976|NCT00776763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6527977|NCT00776763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6527978|NCT00776763|Growth Substances|growth substances|mesh-ancestor
6527979|NCT00776763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527980|NCT00776763|Growth Inhibitors|growth inhibitors|mesh-ancestor
6527981|NCT00776802|Dexamethasone|dexamethasone|mesh-list
6527982|NCT00776802|Etoposide|etoposide|mesh-list
6527983|NCT00776802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6527984|NCT00776802|Antiemetics|antiemetics|mesh-ancestor
6527985|NCT00776802|Autonomic Agents|autonomic agents|mesh-ancestor
6527986|NCT00776802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6527987|NCT00776802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6527988|NCT00776802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6527989|NCT00776802|Glucocorticoids|glucocorticoids|mesh-ancestor
6527990|NCT00776802|Hormones|hormones|mesh-ancestor
6527991|NCT00776802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6527992|NCT00776802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6527993|NCT00776802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6527994|NCT00776802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6527995|NCT00776802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6527996|NCT00776802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6527997|NCT00776802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6527998|NCT00776802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6527999|NCT00776828|Cilostazol|cilostazol|mesh-list
6528000|NCT00776828|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6528001|NCT00776828|Autonomic Agents|autonomic agents|mesh-ancestor
6528002|NCT00776828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6528003|NCT00776828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528004|NCT00776828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6528005|NCT00776828|Respiratory System Agents|respiratory system agents|mesh-ancestor
6528006|NCT00776828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6528007|NCT00776828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6528008|NCT00776828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528009|NCT00776828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6528010|NCT00776828|Vasodilator Agents|vasodilator agents|mesh-ancestor
6528011|NCT00776828|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6528012|NCT00776828|Protective Agents|protective agents|mesh-ancestor
6528013|NCT00776828|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6528014|NCT00776828|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6528015|NCT00776828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6528016|NCT00776841|Cholic Acids|cholic acids|mesh-list
6528017|NCT00776841|Bile Acids and Salts|bile acids and salts|mesh-list
6528018|NCT00776841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6528019|NCT00777114|Bortezomib|bortezomib|mesh-list
6528020|NCT00777114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6528021|NCT00777140|Deferoxamine|deferoxamine|mesh-list
6528022|NCT00777140|Siderophores|siderophores|mesh-ancestor
6528023|NCT00777140|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6528024|NCT00777140|Chelating Agents|chelating agents|mesh-ancestor
6528025|NCT00777140|Sequestering Agents|sequestering agents|mesh-ancestor
6528026|NCT00777140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528027|NCT00777166|Oxytocin|oxytocin|mesh-list
6528028|NCT00777166|Oxytocics|oxytocics|mesh-ancestor
6528029|NCT00777166|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6528030|NCT00777166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528031|NCT00777218|Topiramate|topiramate|mesh-list
6528032|NCT00777218|Propranolol|propranolol|mesh-list
6528033|NCT00777218|Zonisamide|zonisamide|mesh-list
6528034|NCT00777218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6528035|NCT00777218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6528036|NCT00777218|Adrenergic Agents|adrenergic agents|mesh-ancestor
6528037|NCT00777218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6528038|NCT00777218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528039|NCT00777218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528040|NCT00777218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6528041|NCT00777218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6528042|NCT00777218|Vasodilator Agents|vasodilator agents|mesh-ancestor
6528043|NCT00777218|Anticonvulsants|anticonvulsants|mesh-ancestor
6528044|NCT00777218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6528045|NCT00777218|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6528046|NCT00777218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6528047|NCT00777218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6528048|NCT00777244|Mitotane|mitotane|mesh-list
6528049|NCT00777244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6528050|NCT00777244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6528051|NCT00777322|Riboflavin|riboflavin|mesh-list
6528052|NCT00777322|Dextrans|dextrans|mesh-list
6528053|NCT00777322|Vitamin B Complex|vitamin b complex|mesh-ancestor
6528054|NCT00777322|Vitamins|vitamins|mesh-ancestor
6528055|NCT00777322|Micronutrients|micronutrients|mesh-ancestor
6528056|NCT00777322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528057|NCT00777322|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6528058|NCT00777322|Dermatologic Agents|dermatologic agents|mesh-ancestor
6528059|NCT00777322|Anticoagulants|anticoagulants|mesh-ancestor
6528060|NCT00777322|Plasma Substitutes|plasma substitutes|mesh-ancestor
6528061|NCT00777322|Blood Substitutes|blood substitutes|mesh-ancestor
6528062|NCT00777413|Minocycline|minocycline|mesh-list
6528063|NCT00777413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6528064|NCT00777413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6528065|NCT00777439|Domperidone|domperidone|mesh-list
6528066|NCT00777439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528067|NCT00777439|Antiemetics|antiemetics|mesh-ancestor
6528068|NCT00777439|Autonomic Agents|autonomic agents|mesh-ancestor
6528069|NCT00777439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6528070|NCT00777439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528071|NCT00777439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6528072|NCT00777439|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6528073|NCT00777439|Dopamine Agents|dopamine agents|mesh-ancestor
6528074|NCT00777439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6528075|NCT00777478|Sunitinib|sunitinib|mesh-list
6528076|NCT00777478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6528077|NCT00777478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6528078|NCT00777478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6528079|NCT00777478|Growth Substances|growth substances|mesh-ancestor
6528080|NCT00777478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528081|NCT00777478|Growth Inhibitors|growth inhibitors|mesh-ancestor
6528082|NCT00777478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6528083|NCT00777478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6528084|NCT00777478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528085|NCT00777504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
6528086|NCT00777504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6528087|NCT00777504|Growth Substances|growth substances|mesh-ancestor
6528088|NCT00777504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528089|NCT00777504|Growth Inhibitors|growth inhibitors|mesh-ancestor
6528090|NCT00777504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6528091|NCT00777517|Atorvastatin|atorvastatin|mesh-list
6528092|NCT00777517|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6528093|NCT00777517|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6528094|NCT00777517|Antimetabolites|antimetabolites|mesh-ancestor
6528095|NCT00777517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528096|NCT00777517|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6528097|NCT00777517|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6528098|NCT00777517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6528099|NCT00777543|Ferulic acid|ferulic acid|mesh-list
6528100|NCT00777543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6528101|NCT00777543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6528102|NCT00777543|Analgesics|analgesics|mesh-ancestor
6528103|NCT00777543|Sensory System Agents|sensory system agents|mesh-ancestor
6528104|NCT00777543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6528105|NCT00777543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528106|NCT00777543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6528107|NCT00777543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6528108|NCT00777543|Anticoagulants|anticoagulants|mesh-ancestor
6528109|NCT00777543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6528110|NCT00777543|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6528111|NCT00777543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6792986|NCT02246179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6792987|NCT02246179|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6792988|NCT02246179|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6792989|NCT02246179|Adrenergic Agents|adrenergic agents|mesh-ancestor
6792990|NCT02246179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6792991|NCT02246179|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6792992|NCT02246179|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6792993|NCT02246179|Autonomic Agents|autonomic agents|mesh-ancestor
6792994|NCT02246179|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6528112|NCT00777543|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6528113|NCT00777543|Antioxidants|antioxidants|mesh-ancestor
6528114|NCT00777543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528115|NCT00777543|Protective Agents|protective agents|mesh-ancestor
6528116|NCT00777569|Nicotine|nicotine|mesh-list
6528117|NCT00777569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6528118|NCT00777569|Autonomic Agents|autonomic agents|mesh-ancestor
6528119|NCT00777569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6528120|NCT00777569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528121|NCT00777569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6528122|NCT00777569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6528123|NCT00777569|Cholinergic Agents|cholinergic agents|mesh-ancestor
6528124|NCT00777569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6528125|NCT00777569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528126|NCT00777595|Moxifloxacin|moxifloxacin|mesh-list
6528127|NCT00777595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6528128|NCT00777595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6528129|NCT00777595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6528130|NCT00777595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6528131|NCT00777595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6528132|NCT00777595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528133|NCT00777595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6528134|NCT00777673|Paclitaxel|paclitaxel|mesh-list
6528135|NCT00777673|Cyclophosphamide|cyclophosphamide|mesh-list
6528136|NCT00777673|Bevacizumab|bevacizumab|mesh-list
6258310|NCT03083990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258311|NCT03083990|Growth Inhibitors|growth inhibitors|mesh-ancestor
6258312|NCT03084315|Nicotine|nicotine|mesh-list
6258313|NCT03084315|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6258314|NCT03084315|Autonomic Agents|autonomic agents|mesh-ancestor
6258315|NCT03084315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6258316|NCT03084315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258317|NCT03084315|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6258318|NCT03084315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6258319|NCT03084315|Cholinergic Agents|cholinergic agents|mesh-ancestor
6528137|NCT00777673|Carboplatin|carboplatin|mesh-list
6528138|NCT00777673|Doxorubicin|doxorubicin|mesh-list
6528139|NCT00777673|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6528140|NCT00777673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6528141|NCT00777673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6528142|NCT00777673|Tubulin Modulators|tubulin modulators|mesh-ancestor
6528143|NCT00777673|Antimitotic Agents|antimitotic agents|mesh-ancestor
6528144|NCT00777673|Mitosis Modulators|mitosis modulators|mesh-ancestor
6528145|NCT00777673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528146|NCT00777673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6528147|NCT00777673|Immunologic Factors|immunologic factors|mesh-ancestor
6528148|NCT00777673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528149|NCT00777673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6528150|NCT00777673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6528151|NCT00777673|Alkylating Agents|alkylating agents|mesh-ancestor
6528152|NCT00777673|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6528153|NCT00777673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6792995|NCT02246179|Respiratory System Agents|respiratory system agents|mesh-ancestor
6792996|NCT02246179|Mydriatics|mydriatics|mesh-ancestor
6792997|NCT02246179|Sympathomimetics|sympathomimetics|mesh-ancestor
6792998|NCT02246179|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6792999|NCT02246179|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
6793000|NCT02246244|Citalopram|citalopram|mesh-list
6793001|NCT02246244|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6793002|NCT02246244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6793003|NCT02246244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6793004|NCT02246244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793005|NCT02246244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6793006|NCT02246244|Serotonin Agents|serotonin agents|mesh-ancestor
6793007|NCT02246244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793008|NCT02246244|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6793009|NCT02246244|Antidepressive Agents|antidepressive agents|mesh-ancestor
6793010|NCT02246244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6793011|NCT02246257|Metformin|metformin|mesh-list
6793012|NCT02246257|Losartan|losartan|mesh-list
6793013|NCT02246257|Simvastatin|simvastatin|mesh-list
6793014|NCT02246257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6793015|NCT02246257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793016|NCT02246257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6793017|NCT02246257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6793018|NCT02246257|Antimetabolites|antimetabolites|mesh-ancestor
6528154|NCT00777673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6528155|NCT00777673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6528156|NCT00777673|Growth Substances|growth substances|mesh-ancestor
6528157|NCT00777673|Growth Inhibitors|growth inhibitors|mesh-ancestor
6528158|NCT00777673|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6528159|NCT00777673|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6528160|NCT00777673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6528161|NCT00777673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6528162|NCT00777699|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6528163|NCT00777699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6528164|NCT00777699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6528165|NCT00777699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6528166|NCT00777699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528167|NCT00777738|Bortezomib|bortezomib|mesh-list
6528168|NCT00777738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6528169|NCT00777933|Cyclosporine|cyclosporine|mesh-list
6528170|NCT00777933|Tacrolimus|tacrolimus|mesh-list
6528171|NCT00777933|Cyclosporins|cyclosporins|mesh-list
6528172|NCT00777933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6528173|NCT00777933|Immunologic Factors|immunologic factors|mesh-ancestor
6528174|NCT00777933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528175|NCT00777933|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6528176|NCT00777933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6528177|NCT00777933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528178|NCT00777933|Antifungal Agents|antifungal agents|mesh-ancestor
6528179|NCT00777933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6528180|NCT00777933|Dermatologic Agents|dermatologic agents|mesh-ancestor
6528181|NCT00777933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6528182|NCT00777959|Sirolimus|sirolimus|mesh-list
6528183|NCT00777959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6528184|NCT00777959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6528185|NCT00777959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6528186|NCT00777959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6528187|NCT00777959|Antifungal Agents|antifungal agents|mesh-ancestor
6528188|NCT00777959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6528189|NCT00777959|Immunologic Factors|immunologic factors|mesh-ancestor
6528190|NCT00777959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528191|NCT00777972|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6528192|NCT00777972|Fosinopril|fosinopril|mesh-list
6528193|NCT00777972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6528194|NCT00777972|Diuretics|diuretics|mesh-ancestor
6528195|NCT00777972|Natriuretic Agents|natriuretic agents|mesh-ancestor
6793019|NCT02246257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793020|NCT02246257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6793021|NCT02246257|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6793022|NCT02246257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6793023|NCT02246257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6793024|NCT02246257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6793025|NCT02246257|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6793026|NCT02246257|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6793027|NCT02246270|Heparin|heparin|mesh-list
6793028|NCT02246270|Calcium heparin|calcium heparin|mesh-list
6793029|NCT02246270|Anticoagulants|anticoagulants|mesh-ancestor
6793030|NCT02246270|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6793031|NCT02246270|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6793032|NCT02246270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528196|NCT00777972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528197|NCT00777972|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6528198|NCT00777972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6528199|NCT00777972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528200|NCT00777972|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6528201|NCT00777972|Protease Inhibitors|protease inhibitors|mesh-ancestor
6528202|NCT00777972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6528203|NCT00777985|Bosentan|bosentan|mesh-list
6528204|NCT00777985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6528205|NCT00777985|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6528206|NCT00777985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528207|NCT00777998|Ferrous fumarate|ferrous fumarate|mesh-list
6528208|NCT00777998|Thalidomide|thalidomide|mesh-list
6528209|NCT00777998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6528210|NCT00777998|Immunologic Factors|immunologic factors|mesh-ancestor
6528211|NCT00777998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528212|NCT00777998|Leprostatic Agents|leprostatic agents|mesh-ancestor
6528213|NCT00777998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6528214|NCT00777998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6528215|NCT00777998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6528216|NCT00777998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6528217|NCT00777998|Growth Substances|growth substances|mesh-ancestor
6528218|NCT00777998|Growth Inhibitors|growth inhibitors|mesh-ancestor
6528219|NCT00777998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6528220|NCT00777998|Trace Elements|trace elements|mesh-ancestor
6528221|NCT00777998|Micronutrients|micronutrients|mesh-ancestor
6528222|NCT00778011|Ondansetron|ondansetron|mesh-list
6528223|NCT00778011|Metoclopramide|metoclopramide|mesh-list
6528224|NCT00778011|Antiemetics|antiemetics|mesh-ancestor
6528225|NCT00778011|Autonomic Agents|autonomic agents|mesh-ancestor
6528226|NCT00778011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6528227|NCT00778011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528228|NCT00778011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6528229|NCT00778011|Antipruritics|antipruritics|mesh-ancestor
6528230|NCT00778011|Dermatologic Agents|dermatologic agents|mesh-ancestor
6528231|NCT00778011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6528232|NCT00778011|Serotonin Agents|serotonin agents|mesh-ancestor
6793033|NCT02246595|Vilobelimab|vilobelimab|mesh-list
6793034|NCT02246595|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6793035|NCT02246595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6793036|NCT02246595|Immunologic Factors|immunologic factors|mesh-ancestor
6793037|NCT02246595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793038|NCT02246621|Letrozole|letrozole|mesh-list
6793039|NCT02246621|Anastrozole|anastrozole|mesh-list
6793040|NCT02246621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6793041|NCT02246621|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6793042|NCT02246621|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6793043|NCT02246621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6793044|NCT02246621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793045|NCT02246621|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6793046|NCT02246621|Hormone Antagonists|hormone antagonists|mesh-ancestor
6793047|NCT02246621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6793048|NCT02246621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793049|NCT02246621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6793050|NCT02246712|Tramadol|tramadol|mesh-list
6793051|NCT02246712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6793052|NCT02246712|Narcotics|narcotics|mesh-ancestor
6793053|NCT02246712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6793054|NCT02246712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793055|NCT02246712|Analgesics|analgesics|mesh-ancestor
6793056|NCT02246712|Sensory System Agents|sensory system agents|mesh-ancestor
6793057|NCT02246712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6793058|NCT02246816|Opium|opium|mesh-list
6793059|NCT02246816|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6793060|NCT02246816|Narcotics|narcotics|mesh-ancestor
6793061|NCT02246816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6793062|NCT02246816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793063|NCT02246816|Analgesics|analgesics|mesh-ancestor
6793064|NCT02246816|Sensory System Agents|sensory system agents|mesh-ancestor
6793065|NCT02246816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6793066|NCT02246816|Antidiarrheals|antidiarrheals|mesh-ancestor
6793067|NCT02246816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6793068|NCT02246816|Antitussive Agents|antitussive agents|mesh-ancestor
6793069|NCT02246816|Respiratory System Agents|respiratory system agents|mesh-ancestor
6793070|NCT02246842|Immunoglobulins|immunoglobulins|mesh-list
6528233|NCT00778011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6793071|NCT02246842|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6528234|NCT00778011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528235|NCT00778011|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6528236|NCT00778011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6528237|NCT00778011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6528238|NCT00778011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6528239|NCT00778011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6528240|NCT00778011|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6528241|NCT00778011|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6528242|NCT00778011|Dopamine Agents|dopamine agents|mesh-ancestor
6528243|NCT00778024|Fluoxetine|fluoxetine|mesh-list
6528244|NCT00778024|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6528245|NCT00778024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6528246|NCT00778024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6528247|NCT00778024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528248|NCT00778024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6528249|NCT00778024|Serotonin Agents|serotonin agents|mesh-ancestor
6528250|NCT00778024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793072|NCT02246842|Antibodies|antibodies|mesh-list
6793073|NCT02246842|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6793074|NCT02246842|gamma-Globulins|gamma-globulins|mesh-list
6793075|NCT02246842|Immunologic Factors|immunologic factors|mesh-ancestor
6793076|NCT02246842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793077|NCT02246855|Immunoglobulins|immunoglobulins|mesh-list
6793078|NCT02246855|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6793079|NCT02246855|Antibodies|antibodies|mesh-list
6793080|NCT02246855|Immunologic Factors|immunologic factors|mesh-ancestor
6793081|NCT02246855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793082|NCT02246868|Factor VIII|factor viii|mesh-list
6793083|NCT02246868|Coagulants|coagulants|mesh-ancestor
6793084|NCT02246881|Factor VIII|factor viii|mesh-list
6793085|NCT02246881|Coagulants|coagulants|mesh-ancestor
6793086|NCT02246894|Factor VIII|factor viii|mesh-list
6793087|NCT02246894|Coagulants|coagulants|mesh-ancestor
6793088|NCT02246920|Fluticasone|fluticasone|mesh-list
6793089|NCT02246920|Xhance|xhance|mesh-list
6793090|NCT02246920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6793091|NCT02246920|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6793092|NCT02246920|Autonomic Agents|autonomic agents|mesh-ancestor
6793093|NCT02246920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6793094|NCT02246920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793095|NCT02246920|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6793096|NCT02246920|Respiratory System Agents|respiratory system agents|mesh-ancestor
6793097|NCT02246920|Dermatologic Agents|dermatologic agents|mesh-ancestor
6793098|NCT02246920|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6793099|NCT02247128|Aspirin|aspirin|mesh-list
6793100|NCT02247128|Clopidogrel|clopidogrel|mesh-list
6793101|NCT02247128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6793102|NCT02247128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6793103|NCT02247128|Analgesics|analgesics|mesh-ancestor
6793104|NCT02247128|Sensory System Agents|sensory system agents|mesh-ancestor
6793105|NCT02247128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6793106|NCT02247128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793107|NCT02247128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6793108|NCT02247128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6793109|NCT02247128|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6793110|NCT02247128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6793111|NCT02247128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793112|NCT02247128|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6793113|NCT02247128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6793114|NCT02247128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6793115|NCT02247128|Antipyretics|antipyretics|mesh-ancestor
6793116|NCT02247128|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6793117|NCT02247128|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6793118|NCT02247128|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6793119|NCT02247128|Purinergic Agents|purinergic agents|mesh-ancestor
6793120|NCT02247128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6793121|NCT02247141|Immunoglobulins|immunoglobulins|mesh-list
6793122|NCT02247141|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6793123|NCT02247141|Antibodies|antibodies|mesh-list
6793124|NCT02247141|Immunologic Factors|immunologic factors|mesh-ancestor
6793125|NCT02247141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793126|NCT02247154|Immunoglobulins|immunoglobulins|mesh-list
6793127|NCT02247154|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6793128|NCT02247154|Antibodies|antibodies|mesh-list
6793129|NCT02247154|Immunologic Factors|immunologic factors|mesh-ancestor
6793130|NCT02247154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793131|NCT02247258|Azathioprine|azathioprine|mesh-list
6528251|NCT00778024|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6528252|NCT00778024|Antidepressive Agents|antidepressive agents|mesh-ancestor
6528253|NCT00778024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6528254|NCT00778024|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6528255|NCT00778024|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6528256|NCT00778024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6528257|NCT00778037|Cyclobenzaprine|cyclobenzaprine|mesh-list
6528258|NCT00778037|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6528259|NCT00778037|Antidepressive Agents|antidepressive agents|mesh-ancestor
6528260|NCT00778037|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6528261|NCT00778037|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6528262|NCT00778037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528263|NCT00778037|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6528264|NCT00778037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6528265|NCT00778037|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6528266|NCT00778037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6528267|NCT00778050|Amoxicillin|amoxicillin|mesh-list
6528268|NCT00778050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6528269|NCT00778050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6528270|NCT00778063|Dexmedetomidine|dexmedetomidine|mesh-list
6528271|NCT00778063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6528272|NCT00778063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6528273|NCT00778063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528274|NCT00778063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6528275|NCT00778063|Analgesics|analgesics|mesh-ancestor
6528276|NCT00778063|Sensory System Agents|sensory system agents|mesh-ancestor
6528277|NCT00778063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6528278|NCT00778063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6793132|NCT02247258|Antimetabolites|antimetabolites|mesh-ancestor
6793133|NCT02247258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793134|NCT02247258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6793135|NCT02247258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6793136|NCT02247258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6793137|NCT02247258|Immunologic Factors|immunologic factors|mesh-ancestor
6793138|NCT02247258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793139|NCT02247258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6793140|NCT02247310|Interferons|interferons|mesh-list
6793141|NCT02247310|Interferon-beta|interferon-beta|mesh-list
6793142|NCT02247310|Interferon beta-1b|interferon beta-1b|mesh-list
6793143|NCT02247310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6793144|NCT02247310|Antiviral Agents|antiviral agents|mesh-ancestor
6793145|NCT02247310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6793146|NCT02247310|Immunologic Factors|immunologic factors|mesh-ancestor
6793147|NCT02247310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793148|NCT02247310|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6793149|NCT02247362|Vaccines|vaccines|mesh-list
6793150|NCT02247362|Hemagglutinins|hemagglutinins|mesh-list
6793151|NCT02247362|Immunologic Factors|immunologic factors|mesh-ancestor
6793152|NCT02247362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793153|NCT02247362|Agglutinins|agglutinins|mesh-ancestor
6793154|NCT02247414|Aspirin|aspirin|mesh-list
6793155|NCT02247414|Heparin|heparin|mesh-list
6793156|NCT02247414|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6793157|NCT02247414|Tinzaparin|tinzaparin|mesh-list
6793158|NCT02247414|Dalteparin|dalteparin|mesh-list
6793159|NCT02247414|Dipyridamole|dipyridamole|mesh-list
6793160|NCT02247414|Warfarin|warfarin|mesh-list
6793161|NCT02247414|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6793162|NCT02247414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6793163|NCT02247414|Analgesics|analgesics|mesh-ancestor
6793164|NCT02247414|Sensory System Agents|sensory system agents|mesh-ancestor
6793165|NCT02247414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6793166|NCT02247414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793167|NCT02247414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6793168|NCT02247414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6793169|NCT02247414|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6793170|NCT02247414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6793171|NCT02247414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793172|NCT02247414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6793173|NCT02247414|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6793174|NCT02247414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6793175|NCT02247414|Antipyretics|antipyretics|mesh-ancestor
6793176|NCT02247414|Anticoagulants|anticoagulants|mesh-ancestor
6793177|NCT02247414|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6793178|NCT02247414|Vasodilator Agents|vasodilator agents|mesh-ancestor
6793179|NCT02247505|Tadalafil|tadalafil|mesh-list
6793180|NCT02247505|Tamsulosin|tamsulosin|mesh-list
6528279|NCT00778063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6528280|NCT00778063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6528281|NCT00778063|Adrenergic Agents|adrenergic agents|mesh-ancestor
6528282|NCT00778063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6528283|NCT00778063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528284|NCT00778076|Hyaluronic Acid|hyaluronic acid|mesh-list
6528285|NCT00778076|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6528286|NCT00778076|Immunologic Factors|immunologic factors|mesh-ancestor
6528287|NCT00778076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528288|NCT00778076|Viscosupplements|viscosupplements|mesh-ancestor
6528289|NCT00778076|Protective Agents|protective agents|mesh-ancestor
6528290|NCT00778089|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
6528291|NCT00778089|Vasodilator Agents|vasodilator agents|mesh-ancestor
6528292|NCT00778089|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
6528293|NCT00778089|Protective Agents|protective agents|mesh-ancestor
6528294|NCT00778089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528295|NCT00778115|Simethicone|simethicone|mesh-list
6793181|NCT02247505|Vasodilator Agents|vasodilator agents|mesh-ancestor
6793182|NCT02247505|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6793183|NCT02247505|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6793184|NCT02247505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6793185|NCT02247505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793186|NCT02247505|Urological Agents|urological agents|mesh-ancestor
6793187|NCT02247505|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6793188|NCT02247505|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6793189|NCT02247505|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6793190|NCT02247505|Adrenergic Agents|adrenergic agents|mesh-ancestor
6793191|NCT02247505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6793192|NCT02247505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793193|NCT02247518|Tadalafil|tadalafil|mesh-list
6793194|NCT02247518|Tamsulosin|tamsulosin|mesh-list
6793195|NCT02247518|Vasodilator Agents|vasodilator agents|mesh-ancestor
6793196|NCT02247518|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6793197|NCT02247518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6793198|NCT02247518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6793199|NCT02247518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793200|NCT02247518|Urological Agents|urological agents|mesh-ancestor
6793201|NCT02247518|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6793202|NCT02247518|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6793203|NCT02247518|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6793204|NCT02247518|Adrenergic Agents|adrenergic agents|mesh-ancestor
6793205|NCT02247518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6793206|NCT02247518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793207|NCT02247544|Trabectedin|trabectedin|mesh-list
6793208|NCT02247544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6793209|NCT02247544|Alkylating Agents|alkylating agents|mesh-ancestor
6793210|NCT02247544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793211|NCT02247544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6793212|NCT02247557|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6793213|NCT02247557|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6793214|NCT02247557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6793215|NCT02247557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6793216|NCT02247557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793217|NCT02247557|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6793218|NCT02247557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6793219|NCT02247557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793220|NCT02247557|Cholinergic Agents|cholinergic agents|mesh-ancestor
6793221|NCT02247557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6793222|NCT02247596|Resveratrol|resveratrol|mesh-list
6793223|NCT02247596|Antioxidants|antioxidants|mesh-ancestor
6793224|NCT02247596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793225|NCT02247596|Protective Agents|protective agents|mesh-ancestor
6793226|NCT02247596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793227|NCT02247596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6793228|NCT02247596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6793229|NCT02247648|Tramadol|tramadol|mesh-list
6793230|NCT02247648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6793231|NCT02247648|Narcotics|narcotics|mesh-ancestor
6793232|NCT02247648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6793233|NCT02247648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793234|NCT02247648|Analgesics|analgesics|mesh-ancestor
6793235|NCT02247648|Sensory System Agents|sensory system agents|mesh-ancestor
6528296|NCT00778115|Loperamide|loperamide|mesh-list
6528297|NCT00778115|Antidiarrheals|antidiarrheals|mesh-list
6528298|NCT00778115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6528299|NCT00778115|Antifoaming Agents|antifoaming agents|mesh-ancestor
6528300|NCT00778115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528301|NCT00778115|Emollients|emollients|mesh-ancestor
6528302|NCT00778115|Dermatologic Agents|dermatologic agents|mesh-ancestor
6528303|NCT00778128|Gemcitabine|gemcitabine|mesh-list
6528304|NCT00778128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6528305|NCT00778128|Antimetabolites|antimetabolites|mesh-ancestor
6528306|NCT00778128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528307|NCT00778128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6528308|NCT00778128|Antiviral Agents|antiviral agents|mesh-ancestor
6793236|NCT02247648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6793237|NCT02247687|Raltegravir Potassium|raltegravir potassium|mesh-list
6793238|NCT02247687|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
6793239|NCT02247687|Protease Inhibitors|protease inhibitors|mesh-list
6793240|NCT02247687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6793241|NCT02247687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6793242|NCT02247687|Antiviral Agents|antiviral agents|mesh-ancestor
6793243|NCT02247687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6793244|NCT02247687|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6793245|NCT02247687|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6793246|NCT02247687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6793247|NCT02247687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793248|NCT02247687|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6793249|NCT02247986|Methylphenidate|methylphenidate|mesh-list
6793250|NCT02247986|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6793251|NCT02247986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793252|NCT02247986|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6793253|NCT02247986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6793254|NCT02247986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6793255|NCT02247986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793256|NCT02247986|Dopamine Agents|dopamine agents|mesh-ancestor
6793257|NCT02247986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6793258|NCT02248012|Everolimus|everolimus|mesh-list
6793259|NCT02248012|Temozolomide|temozolomide|mesh-list
6793260|NCT02248012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6793261|NCT02248012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6793262|NCT02248012|Immunologic Factors|immunologic factors|mesh-ancestor
6793263|NCT02248012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793264|NCT02248012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6793265|NCT02248012|Alkylating Agents|alkylating agents|mesh-ancestor
6793266|NCT02248012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793267|NCT02248051|CXA-10|cxa-10|mesh-list
6793268|NCT02248051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6258320|NCT03084315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6258321|NCT03084315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258322|NCT03084796|Bromides|bromides|mesh-list
6258323|NCT03084796|Tiotropium Bromide|tiotropium bromide|mesh-list
6258324|NCT03084796|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6258325|NCT03084796|Autonomic Agents|autonomic agents|mesh-ancestor
6528309|NCT00778128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6528310|NCT00778128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6528311|NCT00778128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6528312|NCT00778128|Immunologic Factors|immunologic factors|mesh-ancestor
6528313|NCT00778128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528314|NCT00778141|Metformin|metformin|mesh-list
6528315|NCT00778141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6528316|NCT00778141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528317|NCT00778180|Furosemide|furosemide|mesh-list
6528318|NCT00778180|Diuretics|diuretics|mesh-ancestor
6528319|NCT00778180|Natriuretic Agents|natriuretic agents|mesh-ancestor
6528320|NCT00778180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528321|NCT00778180|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6528322|NCT00778180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6528323|NCT00778180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528324|NCT00778193|Aspirin|aspirin|mesh-list
6528325|NCT00778193|Celecoxib|celecoxib|mesh-list
6528326|NCT00778193|Naproxen|naproxen|mesh-list
6528327|NCT00778193|Clopidogrel|clopidogrel|mesh-list
6528328|NCT00778193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6528329|NCT00778193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6528330|NCT00778193|Analgesics|analgesics|mesh-ancestor
6528331|NCT00778193|Sensory System Agents|sensory system agents|mesh-ancestor
6528332|NCT00778193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6528333|NCT00778193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528334|NCT00778193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6528335|NCT00778193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6528336|NCT00778193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6528337|NCT00778193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6528338|NCT00778193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528339|NCT00778193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6528340|NCT00778193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6528341|NCT00778193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6528342|NCT00778193|Antipyretics|antipyretics|mesh-ancestor
6528343|NCT00778193|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6793269|NCT02248129|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6793270|NCT02248129|Telmisartan|telmisartan|mesh-list
6793271|NCT02248129|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6793272|NCT02248129|Diuretics|diuretics|mesh-ancestor
6793273|NCT02248129|Natriuretic Agents|natriuretic agents|mesh-ancestor
6793274|NCT02248129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793275|NCT02248129|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6793276|NCT02248129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6793277|NCT02248129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793278|NCT02248129|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6793279|NCT02248129|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6793280|NCT02248142|Pramipexole|pramipexole|mesh-list
6793281|NCT02248142|Antioxidants|antioxidants|mesh-ancestor
6793282|NCT02248142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793283|NCT02248142|Protective Agents|protective agents|mesh-ancestor
6793284|NCT02248142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793285|NCT02248142|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6793286|NCT02248142|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6793287|NCT02248142|Dopamine Agonists|dopamine agonists|mesh-ancestor
6793288|NCT02248142|Dopamine Agents|dopamine agents|mesh-ancestor
6793289|NCT02248142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6793290|NCT02248155|Pramipexole|pramipexole|mesh-list
6793291|NCT02248155|Antioxidants|antioxidants|mesh-ancestor
6793292|NCT02248155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793293|NCT02248155|Protective Agents|protective agents|mesh-ancestor
6793294|NCT02248155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793295|NCT02248155|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6793296|NCT02248155|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6793297|NCT02248155|Dopamine Agonists|dopamine agonists|mesh-ancestor
6793298|NCT02248155|Dopamine Agents|dopamine agents|mesh-ancestor
6793299|NCT02248155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6793300|NCT02248168|Pramipexole|pramipexole|mesh-list
6793301|NCT02248168|Antioxidants|antioxidants|mesh-ancestor
6793302|NCT02248168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793303|NCT02248168|Protective Agents|protective agents|mesh-ancestor
6793304|NCT02248168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793305|NCT02248168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6793306|NCT02248168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6793307|NCT02248168|Dopamine Agonists|dopamine agonists|mesh-ancestor
6793308|NCT02248168|Dopamine Agents|dopamine agents|mesh-ancestor
6793309|NCT02248168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6528344|NCT00778193|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6528345|NCT00778193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6528346|NCT00778193|Purinergic Agents|purinergic agents|mesh-ancestor
6528347|NCT00778193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6528348|NCT00778193|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6528349|NCT00778193|Gout Suppressants|gout suppressants|mesh-ancestor
6528350|NCT00778232|Gabapentin|gabapentin|mesh-list
6528351|NCT00778232|Analgesics|analgesics|mesh-ancestor
6528352|NCT00778232|Sensory System Agents|sensory system agents|mesh-ancestor
6528353|NCT00778232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6528354|NCT00778232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528355|NCT00778232|Anticonvulsants|anticonvulsants|mesh-ancestor
6528356|NCT00778232|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6528357|NCT00778232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6528358|NCT00778232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6528359|NCT00778232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6528360|NCT00778232|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6528361|NCT00778232|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6528362|NCT00778232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6528363|NCT00778232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528364|NCT00778232|Antimanic Agents|antimanic agents|mesh-ancestor
6528365|NCT00778245|Cefprozil|cefprozil|mesh-list
6528366|NCT00778245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6528367|NCT00778245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6528368|NCT00778271|Gabapentin|gabapentin|mesh-list
6528369|NCT00778271|Analgesics|analgesics|mesh-ancestor
6528370|NCT00778271|Sensory System Agents|sensory system agents|mesh-ancestor
6528371|NCT00778271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6528372|NCT00778271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528373|NCT00778271|Anticonvulsants|anticonvulsants|mesh-ancestor
6528374|NCT00778271|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6528375|NCT00778271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6528376|NCT00778271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6528377|NCT00778271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6528378|NCT00778271|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6528379|NCT00778271|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6528380|NCT00778271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6528381|NCT00778271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528382|NCT00778271|Antimanic Agents|antimanic agents|mesh-ancestor
6793310|NCT02248181|Pramipexole|pramipexole|mesh-list
6793311|NCT02248181|Antioxidants|antioxidants|mesh-ancestor
6793312|NCT02248181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793313|NCT02248181|Protective Agents|protective agents|mesh-ancestor
6793314|NCT02248181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793315|NCT02248181|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6793316|NCT02248181|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6793317|NCT02248181|Dopamine Agonists|dopamine agonists|mesh-ancestor
6793318|NCT02248181|Dopamine Agents|dopamine agents|mesh-ancestor
6793319|NCT02248181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6793320|NCT02248207|Pramipexole|pramipexole|mesh-list
6793321|NCT02248207|Antioxidants|antioxidants|mesh-ancestor
6793322|NCT02248207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793323|NCT02248207|Protective Agents|protective agents|mesh-ancestor
6793324|NCT02248207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793325|NCT02248207|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6793326|NCT02248207|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6793327|NCT02248207|Dopamine Agonists|dopamine agonists|mesh-ancestor
6793328|NCT02248207|Dopamine Agents|dopamine agents|mesh-ancestor
6793329|NCT02248207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6793330|NCT02248220|Pramipexole|pramipexole|mesh-list
6793331|NCT02248220|Antioxidants|antioxidants|mesh-ancestor
6793332|NCT02248220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793333|NCT02248220|Protective Agents|protective agents|mesh-ancestor
6793334|NCT02248220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793335|NCT02248220|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6793336|NCT02248220|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6793337|NCT02248220|Dopamine Agonists|dopamine agonists|mesh-ancestor
6793338|NCT02248220|Dopamine Agents|dopamine agents|mesh-ancestor
6793339|NCT02248220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6793340|NCT02248233|Nimodipine|nimodipine|mesh-list
6793341|NCT02248233|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
6793342|NCT02248233|Nootropic Agents|nootropic agents|mesh-ancestor
6793343|NCT02248233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6793344|NCT02248233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6793345|NCT02248233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6528383|NCT00778284|Amoxicillin|amoxicillin|mesh-list
6528384|NCT00778284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6528385|NCT00778284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6528386|NCT00778297|Vaccines|vaccines|mesh-list
6528387|NCT00778297|Immunologic Factors|immunologic factors|mesh-ancestor
6528388|NCT00778297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528389|NCT00778349|Metformin|metformin|mesh-list
6528390|NCT00778349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6528391|NCT00778349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528392|NCT00778401|Gabapentin|gabapentin|mesh-list
6528393|NCT00778401|Analgesics|analgesics|mesh-ancestor
6528394|NCT00778401|Sensory System Agents|sensory system agents|mesh-ancestor
6528395|NCT00778401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6528396|NCT00778401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528397|NCT00778401|Anticonvulsants|anticonvulsants|mesh-ancestor
6528398|NCT00778401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6528399|NCT00778401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6528400|NCT00778401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6528401|NCT00778401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6528402|NCT00778401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6528403|NCT00778401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6528404|NCT00778401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6528405|NCT00778401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528406|NCT00778401|Antimanic Agents|antimanic agents|mesh-ancestor
6528407|NCT00778414|Amoxicillin|amoxicillin|mesh-list
6528408|NCT00778414|Clavulanic Acids|clavulanic acids|mesh-list
6528409|NCT00778414|Clavulanic Acid|clavulanic acid|mesh-list
6528410|NCT00778414|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6528411|NCT00778414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6528412|NCT00778414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6528413|NCT00778414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6528414|NCT00778414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528415|NCT00778414|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6528416|NCT00778427|Metformin|metformin|mesh-list
6528417|NCT00778427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6528418|NCT00778427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528419|NCT00778466|Metformin|metformin|mesh-list
6528420|NCT00778466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5992884|NCT00118209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5992885|NCT00118209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5992886|NCT00118209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6528421|NCT00778466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528422|NCT00778505|Remifentanil|remifentanil|mesh-list
6528423|NCT00778505|Propofol|propofol|mesh-list
6528424|NCT00778505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6528425|NCT00778505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6528426|NCT00778505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528427|NCT00778505|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6528428|NCT00778505|Anesthetics, General|anesthetics, general|mesh-ancestor
6528429|NCT00778505|Anesthetics|anesthetics|mesh-ancestor
6528430|NCT00778505|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6528431|NCT00778505|Narcotics|narcotics|mesh-ancestor
6528432|NCT00778505|Analgesics|analgesics|mesh-ancestor
6528433|NCT00778505|Sensory System Agents|sensory system agents|mesh-ancestor
6528434|NCT00778505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6528435|NCT00778544|Amoxicillin|amoxicillin|mesh-list
6528436|NCT00778544|Clavulanic Acids|clavulanic acids|mesh-list
6528437|NCT00778544|Clavulanic Acid|clavulanic acid|mesh-list
6528438|NCT00778544|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6528439|NCT00778544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6528440|NCT00778544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6528441|NCT00778544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6528442|NCT00778544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528443|NCT00778544|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6528444|NCT00778557|Cefprozil|cefprozil|mesh-list
6528445|NCT00778557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6528446|NCT00778557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6528447|NCT00778583|Nitrofurantoin|nitrofurantoin|mesh-list
6793346|NCT02248233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793347|NCT02248233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6793348|NCT02248233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793349|NCT02248233|Vasodilator Agents|vasodilator agents|mesh-ancestor
6793350|NCT02248259|Itraconazole|itraconazole|mesh-list
6793351|NCT02248259|BI 409306|bi 409306|mesh-list
6793352|NCT02248259|Antifungal Agents|antifungal agents|mesh-ancestor
6793353|NCT02248259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6528448|NCT00778583|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6528449|NCT00778583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6528450|NCT00778583|Renal Agents|renal agents|mesh-ancestor
6528451|NCT00778583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6528452|NCT00778596|Prednisolone|prednisolone|mesh-list
6528453|NCT00778596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6528454|NCT00778596|Glucocorticoids|glucocorticoids|mesh-ancestor
6528455|NCT00778596|Hormones|hormones|mesh-ancestor
6528456|NCT00778596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6528457|NCT00778596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528458|NCT00778596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6528459|NCT00778596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6528460|NCT00778609|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
6528461|NCT00778609|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
6528462|NCT00778609|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6528463|NCT00778609|Contraceptive Agents|contraceptive agents|mesh-ancestor
6528464|NCT00778609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6528465|NCT00778609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528466|NCT00778609|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6528467|NCT00778609|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6528468|NCT00778609|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6528469|NCT00778609|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6528470|NCT00778609|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6528471|NCT00778609|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
6528472|NCT00778609|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6528473|NCT00778609|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6537491|NCT00822536|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6537492|NCT00822536|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6537493|NCT00822536|Purinergic Agents|purinergic agents|mesh-ancestor
6537494|NCT00822536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6537495|NCT00822549|Morphine|morphine|mesh-list
6537496|NCT00822549|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6537497|NCT00822549|Narcotics|narcotics|mesh-ancestor
6537498|NCT00822549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6537499|NCT00822549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537500|NCT00822549|Analgesics|analgesics|mesh-ancestor
6537501|NCT00822549|Sensory System Agents|sensory system agents|mesh-ancestor
6537502|NCT00822549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6537503|NCT00822614|Fentanyl|fentanyl|mesh-list
6537504|NCT00822614|Morphine|morphine|mesh-list
6537505|NCT00822614|Oxycodone|oxycodone|mesh-list
6537506|NCT00822614|Hydromorphone|hydromorphone|mesh-list
6537507|NCT00822614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6537508|NCT00822614|Narcotics|narcotics|mesh-ancestor
6537509|NCT00822614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6537510|NCT00822614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537511|NCT00822614|Analgesics|analgesics|mesh-ancestor
6793354|NCT02248259|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6793355|NCT02248259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6793356|NCT02248259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6793357|NCT02248259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793358|NCT02248259|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6793359|NCT02248259|Hormone Antagonists|hormone antagonists|mesh-ancestor
6793360|NCT02248259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6793361|NCT02248259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793362|NCT02248259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6793363|NCT02248259|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6793364|NCT02248415|Anesthetics|anesthetics|mesh-list
6793365|NCT02248415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6793366|NCT02248415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793367|NCT02248428|Thalidomide|thalidomide|mesh-list
6793368|NCT02248428|Clarithromycin|clarithromycin|mesh-list
6793369|NCT02248428|Dexamethasone|dexamethasone|mesh-list
6793370|NCT02248428|Cyclophosphamide|cyclophosphamide|mesh-list
6793371|NCT02248428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6793372|NCT02248428|Immunologic Factors|immunologic factors|mesh-ancestor
6793373|NCT02248428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793374|NCT02248428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6793375|NCT02248428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6793376|NCT02248428|Alkylating Agents|alkylating agents|mesh-ancestor
6793377|NCT02248428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793378|NCT02248428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6528474|NCT00778661|Amoxicillin|amoxicillin|mesh-list
6528475|NCT00778661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6528476|NCT00778661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6528477|NCT00778674|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6528478|NCT00778674|Benazepril|benazepril|mesh-list
6528479|NCT00778674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6528480|NCT00778674|Diuretics|diuretics|mesh-ancestor
6528481|NCT00778674|Natriuretic Agents|natriuretic agents|mesh-ancestor
6528482|NCT00778674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528483|NCT00778674|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6528484|NCT00778674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6528485|NCT00778674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528486|NCT00778674|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6528487|NCT00778674|Protease Inhibitors|protease inhibitors|mesh-ancestor
6528488|NCT00778674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6528489|NCT00778713|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6528490|NCT00778713|Fosinopril|fosinopril|mesh-list
6528491|NCT00778713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6528492|NCT00778713|Diuretics|diuretics|mesh-ancestor
6528493|NCT00778713|Natriuretic Agents|natriuretic agents|mesh-ancestor
6528494|NCT00778713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528495|NCT00778713|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6528496|NCT00778713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6528497|NCT00778713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528498|NCT00778713|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6528499|NCT00778713|Protease Inhibitors|protease inhibitors|mesh-ancestor
6528500|NCT00778713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6528501|NCT00778726|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6528502|NCT00778726|Benazepril|benazepril|mesh-list
6528503|NCT00778726|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6528504|NCT00778726|Diuretics|diuretics|mesh-ancestor
6528505|NCT00778726|Natriuretic Agents|natriuretic agents|mesh-ancestor
6528506|NCT00778726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528507|NCT00778726|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6528508|NCT00778726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6528509|NCT00778726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793379|NCT02248428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6793380|NCT02248428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6793381|NCT02248428|Antiemetics|antiemetics|mesh-ancestor
6793382|NCT02248428|Autonomic Agents|autonomic agents|mesh-ancestor
6793383|NCT02248428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6793384|NCT02248428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6793385|NCT02248428|Glucocorticoids|glucocorticoids|mesh-ancestor
6793386|NCT02248428|Hormones|hormones|mesh-ancestor
6793387|NCT02248428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6793388|NCT02248428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6793389|NCT02248428|Leprostatic Agents|leprostatic agents|mesh-ancestor
6793390|NCT02248428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6793391|NCT02248428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6793392|NCT02248428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6793393|NCT02248428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6793394|NCT02248428|Growth Substances|growth substances|mesh-ancestor
6793395|NCT02248428|Growth Inhibitors|growth inhibitors|mesh-ancestor
6793396|NCT02248428|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6793397|NCT02248428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6793398|NCT02248428|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6793399|NCT02248428|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6793400|NCT02248454|Insulin Lispro|insulin lispro|mesh-list
6793401|NCT02248454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6793402|NCT02248454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793403|NCT02248493|Acetaminophen|acetaminophen|mesh-list
6793404|NCT02248493|Ketoprofen|ketoprofen|mesh-list
6793405|NCT02248493|Morphine|morphine|mesh-list
6793406|NCT02248493|Tramadol|tramadol|mesh-list
6793407|NCT02248493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6793408|NCT02248493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6793409|NCT02248493|Narcotics|narcotics|mesh-ancestor
6793410|NCT02248493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6793411|NCT02248493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793412|NCT02248493|Analgesics|analgesics|mesh-ancestor
6793413|NCT02248493|Sensory System Agents|sensory system agents|mesh-ancestor
6793414|NCT02248493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6793415|NCT02248493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6793416|NCT02248493|Antipyretics|antipyretics|mesh-ancestor
6793417|NCT02248493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6528510|NCT00778726|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6528511|NCT00778726|Protease Inhibitors|protease inhibitors|mesh-ancestor
6528512|NCT00778726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6528513|NCT00778739|Cefprozil|cefprozil|mesh-list
6528514|NCT00778739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6528515|NCT00778739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6528516|NCT00778752|Lenalidomide|lenalidomide|mesh-list
6528517|NCT00778752|Immunologic Factors|immunologic factors|mesh-ancestor
6528518|NCT00778752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528519|NCT00778752|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6528520|NCT00778752|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6528521|NCT00778752|Growth Substances|growth substances|mesh-ancestor
6528522|NCT00778752|Growth Inhibitors|growth inhibitors|mesh-ancestor
6528523|NCT00778752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6528524|NCT00778765|Gabapentin|gabapentin|mesh-list
6528525|NCT00778765|Analgesics|analgesics|mesh-ancestor
6528526|NCT00778765|Sensory System Agents|sensory system agents|mesh-ancestor
6528527|NCT00778765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6528528|NCT00778765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528529|NCT00778765|Anticonvulsants|anticonvulsants|mesh-ancestor
6528530|NCT00778765|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6528531|NCT00778765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6528532|NCT00778765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6528533|NCT00778765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6528534|NCT00778765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6793418|NCT02248493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6793419|NCT02248493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6793420|NCT02248493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6793421|NCT02248493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6793422|NCT02248493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793423|NCT02248506|Clotrimazole|clotrimazole|mesh-list
6793424|NCT02248506|Miconazole|miconazole|mesh-list
6793425|NCT02248506|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6793426|NCT02248506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6793427|NCT02248506|Antifungal Agents|antifungal agents|mesh-ancestor
6793428|NCT02248506|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6793429|NCT02248506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6793430|NCT02248506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6793431|NCT02248506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793432|NCT02248506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6793433|NCT02248506|Hormone Antagonists|hormone antagonists|mesh-ancestor
6793434|NCT02248506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6793435|NCT02248506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793436|NCT02248506|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6793437|NCT02248506|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6793438|NCT02248571|Bevacizumab|bevacizumab|mesh-list
6793439|NCT02248571|Capecitabine|capecitabine|mesh-list
6793440|NCT02248571|Everolimus|everolimus|mesh-list
6793441|NCT02248571|Exemestane|exemestane|mesh-list
6793442|NCT02248571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6793443|NCT02248571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6793444|NCT02248571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6793445|NCT02248571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6793446|NCT02248571|Growth Substances|growth substances|mesh-ancestor
6793447|NCT02248571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793448|NCT02248571|Growth Inhibitors|growth inhibitors|mesh-ancestor
6793449|NCT02248571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6793450|NCT02248571|Antimetabolites|antimetabolites|mesh-ancestor
6793451|NCT02248571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793452|NCT02248571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6793453|NCT02248571|Immunologic Factors|immunologic factors|mesh-ancestor
6793454|NCT02248571|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6793455|NCT02248571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6793456|NCT02248571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6793457|NCT02248571|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6793458|NCT02248571|Hormone Antagonists|hormone antagonists|mesh-ancestor
6793459|NCT02248571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6793460|NCT02248584|Ascorbic Acid|ascorbic acid|mesh-list
6793461|NCT02248584|Vitamins|vitamins|mesh-ancestor
6793462|NCT02248584|Micronutrients|micronutrients|mesh-ancestor
6793463|NCT02248584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793464|NCT02248584|Antioxidants|antioxidants|mesh-ancestor
6793465|NCT02248584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528535|NCT00778765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6528536|NCT00778765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6528537|NCT00778765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528538|NCT00778765|Antimanic Agents|antimanic agents|mesh-ancestor
6528539|NCT00778778|Cefprozil|cefprozil|mesh-list
6528540|NCT00778778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6528541|NCT00778778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6528542|NCT00778791|Metformin|metformin|mesh-list
6528543|NCT00778791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6528544|NCT00778791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528545|NCT00778908|Cisplatin|cisplatin|mesh-list
6528546|NCT00778908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6528547|NCT00778973|Sertraline|sertraline|mesh-list
6528548|NCT00778973|Antidepressive Agents|antidepressive agents|mesh-ancestor
6528549|NCT00778973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6528550|NCT00778973|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6528551|NCT00778973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6528552|NCT00778973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6528553|NCT00778973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528554|NCT00778973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6528555|NCT00778973|Serotonin Agents|serotonin agents|mesh-ancestor
6793466|NCT02248584|Protective Agents|protective agents|mesh-ancestor
6793467|NCT02248597|Mycophenolic Acid|mycophenolic acid|mesh-list
6793468|NCT02248597|Cyclophosphamide|cyclophosphamide|mesh-list
6793469|NCT02248597|Busulfan|busulfan|mesh-list
6793470|NCT02248597|Fludarabine|fludarabine|mesh-list
6793471|NCT02248597|Fludarabine phosphate|fludarabine phosphate|mesh-list
6793472|NCT02248597|Tacrolimus|tacrolimus|mesh-list
6793473|NCT02248597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6793474|NCT02248597|Immunologic Factors|immunologic factors|mesh-ancestor
6793475|NCT02248597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793476|NCT02248597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6793477|NCT02248597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6793478|NCT02248597|Alkylating Agents|alkylating agents|mesh-ancestor
6793479|NCT02248597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793480|NCT02248597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6793481|NCT02248597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6793482|NCT02248597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6793483|NCT02248597|Antimetabolites|antimetabolites|mesh-ancestor
6793484|NCT02248597|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6793485|NCT02248597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6793486|NCT02248597|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6793487|NCT02248597|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6793488|NCT02248597|Antitubercular Agents|antitubercular agents|mesh-ancestor
6793489|NCT02248597|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6793490|NCT02248597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6793491|NCT02248753|Metoprolol|metoprolol|mesh-list
6793492|NCT02248753|Digoxin|digoxin|mesh-list
6793493|NCT02248753|Amiodarone|amiodarone|mesh-list
6793494|NCT02248753|Verapamil|verapamil|mesh-list
6793495|NCT02248753|Flecainide|flecainide|mesh-list
6793496|NCT02248753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6793497|NCT02248753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6793498|NCT02248753|Sympatholytics|sympatholytics|mesh-ancestor
6793499|NCT02248753|Autonomic Agents|autonomic agents|mesh-ancestor
6793500|NCT02248753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6793501|NCT02248753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793502|NCT02248753|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6793503|NCT02248753|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6793504|NCT02248753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6793505|NCT02248753|Adrenergic Agents|adrenergic agents|mesh-ancestor
6793506|NCT02248753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6793507|NCT02248753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793508|NCT02248753|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6793509|NCT02248753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6793510|NCT02248753|Protective Agents|protective agents|mesh-ancestor
6793511|NCT02248753|Vasodilator Agents|vasodilator agents|mesh-ancestor
6793512|NCT02248753|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6793513|NCT02248753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6793514|NCT02248753|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6793515|NCT02248753|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6793516|NCT02248753|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6793517|NCT02248753|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6793518|NCT02248753|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6793519|NCT02248753|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6793520|NCT02248753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6528556|NCT00778973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528557|NCT00779012|Infliximab|infliximab|mesh-list
6528558|NCT00779012|Dermatologic Agents|dermatologic agents|mesh-ancestor
6528559|NCT00779012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6528560|NCT00779012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6528561|NCT00779051|Zolpidem|zolpidem|mesh-list
6528562|NCT00779051|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6528563|NCT00779051|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6528564|NCT00779051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6528565|NCT00779051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528566|NCT00779051|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6528567|NCT00779051|GABA Agonists|gaba agonists|mesh-ancestor
6528568|NCT00779051|GABA Agents|gaba agents|mesh-ancestor
6528569|NCT00779051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6528570|NCT00779051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528571|NCT00779064|Rivaroxaban|rivaroxaban|mesh-list
6528572|NCT00779064|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6528573|NCT00779064|Antithrombins|antithrombins|mesh-ancestor
6528574|NCT00779064|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6528575|NCT00779064|Protease Inhibitors|protease inhibitors|mesh-ancestor
6528576|NCT00779064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6528577|NCT00779064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528578|NCT00779064|Anticoagulants|anticoagulants|mesh-ancestor
6528579|NCT00779129|Cyclophosphamide|cyclophosphamide|mesh-list
6528580|NCT00779129|Doxorubicin|doxorubicin|mesh-list
6528581|NCT00779129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6528582|NCT00779129|Immunologic Factors|immunologic factors|mesh-ancestor
6528583|NCT00779129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528584|NCT00779129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6528585|NCT00779129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6528586|NCT00779129|Alkylating Agents|alkylating agents|mesh-ancestor
6528587|NCT00779129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528588|NCT00779129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6528589|NCT00779129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6528590|NCT00779129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6528591|NCT00779129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6528592|NCT00779129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6528593|NCT00779129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6528594|NCT00779194|Sirolimus|sirolimus|mesh-list
6528595|NCT00779194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6528596|NCT00779194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6528597|NCT00779194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6528598|NCT00779194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6528599|NCT00779194|Antifungal Agents|antifungal agents|mesh-ancestor
6528600|NCT00779194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6528601|NCT00779194|Immunologic Factors|immunologic factors|mesh-ancestor
6528602|NCT00779194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528603|NCT00779220|Methotrexate|methotrexate|mesh-list
6793521|NCT02248753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6793522|NCT02248753|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6793523|NCT02248792|Methotrexate|methotrexate|mesh-list
6793524|NCT02248792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6793525|NCT02248792|Abortifacient Agents|abortifacient agents|mesh-ancestor
6793526|NCT02248792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6793527|NCT02248792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793528|NCT02248792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6793529|NCT02248792|Antimetabolites|antimetabolites|mesh-ancestor
6793530|NCT02248792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793531|NCT02248792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6793532|NCT02248792|Dermatologic Agents|dermatologic agents|mesh-ancestor
6793533|NCT02248792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6793534|NCT02248792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6793535|NCT02248792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6793536|NCT02248792|Immunologic Factors|immunologic factors|mesh-ancestor
6793537|NCT02248792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6793538|NCT02248792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6793539|NCT02248844|Botulinum Toxins|botulinum toxins|mesh-list
6793540|NCT02248844|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6793541|NCT02248844|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6793542|NCT02248844|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6793543|NCT02248844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6793544|NCT02248844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793545|NCT02248844|Cholinergic Agents|cholinergic agents|mesh-ancestor
6528604|NCT00779220|Ocrelizumab|ocrelizumab|mesh-list
6528605|NCT00779220|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6528606|NCT00779220|Abortifacient Agents|abortifacient agents|mesh-ancestor
6528607|NCT00779220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6528608|NCT00779220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528609|NCT00779220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6528610|NCT00779220|Antimetabolites|antimetabolites|mesh-ancestor
6528611|NCT00779220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528612|NCT00779220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6528613|NCT00779220|Dermatologic Agents|dermatologic agents|mesh-ancestor
6528614|NCT00779220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6528615|NCT00779220|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6528616|NCT00779220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6528617|NCT00779220|Immunologic Factors|immunologic factors|mesh-ancestor
6528618|NCT00779220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6528619|NCT00779220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6528620|NCT00779233|Zidovudine|zidovudine|mesh-list
6528621|NCT00779233|Antimetabolites|antimetabolites|mesh-ancestor
6528622|NCT00779233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528623|NCT00779233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6528624|NCT00779233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6528625|NCT00779233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6528626|NCT00779233|Antiviral Agents|antiviral agents|mesh-ancestor
6528627|NCT00779233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6528628|NCT00779233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6528629|NCT00779233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6528630|NCT00779350|Sertraline|sertraline|mesh-list
6528631|NCT00779350|Antidepressive Agents|antidepressive agents|mesh-ancestor
6528632|NCT00779350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6528633|NCT00779350|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6528634|NCT00779350|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6528635|NCT00779350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6528636|NCT00779350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528637|NCT00779350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6528638|NCT00779350|Serotonin Agents|serotonin agents|mesh-ancestor
6528639|NCT00779350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528640|NCT00779376|Zidovudine|zidovudine|mesh-list
6528641|NCT00779376|Antimetabolites|antimetabolites|mesh-ancestor
6528642|NCT00779376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528643|NCT00779376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6528644|NCT00779376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6528645|NCT00779376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6528646|NCT00779376|Antiviral Agents|antiviral agents|mesh-ancestor
6528647|NCT00779376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6528648|NCT00779376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6528649|NCT00779376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6528650|NCT00779389|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6528651|NCT00779389|Dasatinib|dasatinib|mesh-list
6528652|NCT00779389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6528653|NCT00779389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6528654|NCT00779389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6528655|NCT00779389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528656|NCT00779441|Zolpidem|zolpidem|mesh-list
6528657|NCT00779441|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6528658|NCT00779441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6528659|NCT00779441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6528660|NCT00779441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528661|NCT00779441|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6528662|NCT00779441|GABA Agonists|gaba agonists|mesh-ancestor
6528663|NCT00779441|GABA Agents|gaba agents|mesh-ancestor
6528664|NCT00779441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6528665|NCT00779441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528666|NCT00779454|Gemcitabine|gemcitabine|mesh-list
6528667|NCT00779454|Capecitabine|capecitabine|mesh-list
6528668|NCT00779454|Oxaliplatin|oxaliplatin|mesh-list
6528669|NCT00779454|Panitumumab|panitumumab|mesh-list
6528670|NCT00779454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6528671|NCT00779454|Antimetabolites|antimetabolites|mesh-ancestor
6528672|NCT00779454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528673|NCT00779454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6528674|NCT00779454|Antiviral Agents|antiviral agents|mesh-ancestor
6528675|NCT00779454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6528676|NCT00779454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6528677|NCT00779454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6793546|NCT02248844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6528678|NCT00779454|Immunologic Factors|immunologic factors|mesh-ancestor
6528679|NCT00779454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528680|NCT00779454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6528681|NCT00779493|Curcumin|curcumin|mesh-list
6528682|NCT00779493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528683|NCT00779493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6528684|NCT00779493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6528685|NCT00779493|Analgesics|analgesics|mesh-ancestor
6528686|NCT00779493|Sensory System Agents|sensory system agents|mesh-ancestor
6528687|NCT00779493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6528688|NCT00779493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6528689|NCT00779493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6793547|NCT02248844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793548|NCT02248844|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6793549|NCT02248844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6793550|NCT02248870|Dexamethasone|dexamethasone|mesh-list
6793551|NCT02248870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6793552|NCT02248870|Antiemetics|antiemetics|mesh-ancestor
6793553|NCT02248870|Autonomic Agents|autonomic agents|mesh-ancestor
6793554|NCT02248870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6793555|NCT02248870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793556|NCT02248870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6793557|NCT02248870|Glucocorticoids|glucocorticoids|mesh-ancestor
6793558|NCT02248870|Hormones|hormones|mesh-ancestor
6793559|NCT02248870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6793560|NCT02248870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6793561|NCT02248870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6793562|NCT02248883|Moxifloxacin|moxifloxacin|mesh-list
6793563|NCT02248883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6793564|NCT02248883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6793565|NCT02248883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6793566|NCT02248883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6793567|NCT02248883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6793568|NCT02248883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793569|NCT02248883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6793570|NCT02248896|Telmisartan|telmisartan|mesh-list
6793571|NCT02248896|Antihypertensive Agents|antihypertensive agents|mesh-list
6793572|NCT02248896|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
6793573|NCT02248896|Enzyme Inhibitors|enzyme inhibitors|mesh-list
6793574|NCT02248896|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6793575|NCT02248896|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6793576|NCT02248896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793577|NCT02248896|Protease Inhibitors|protease inhibitors|mesh-ancestor
6793578|NCT02248987|Antipsychotic Agents|antipsychotic agents|mesh-list
6793579|NCT02248987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6793580|NCT02248987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6793581|NCT02248987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793582|NCT02248987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6793583|NCT02249013|Paclitaxel|paclitaxel|mesh-list
6793584|NCT02249013|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6793585|NCT02249013|Carboplatin|carboplatin|mesh-list
6793586|NCT02249013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6793587|NCT02249013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6793588|NCT02249013|Tubulin Modulators|tubulin modulators|mesh-ancestor
6793589|NCT02249013|Antimitotic Agents|antimitotic agents|mesh-ancestor
6793590|NCT02249013|Mitosis Modulators|mitosis modulators|mesh-ancestor
6793591|NCT02249013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793592|NCT02249026|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6793593|NCT02249026|Buprenorphine|buprenorphine|mesh-list
6793594|NCT02249026|Opiate Alkaloids|opiate alkaloids|mesh-list
6793595|NCT02249026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6793596|NCT02249026|Narcotics|narcotics|mesh-ancestor
6793597|NCT02249026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6793598|NCT02249026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793599|NCT02249026|Analgesics|analgesics|mesh-ancestor
6793600|NCT02249026|Sensory System Agents|sensory system agents|mesh-ancestor
6793601|NCT02249026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6793602|NCT02249026|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6793603|NCT02249039|Clonidine|clonidine|mesh-list
6793604|NCT02249039|Analgesics|analgesics|mesh-ancestor
6793605|NCT02249039|Sensory System Agents|sensory system agents|mesh-ancestor
6793606|NCT02249039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6793607|NCT02249039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793608|NCT02249039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6528690|NCT00779493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6528691|NCT00779493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6528692|NCT00779493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528693|NCT00779649|Bisacodyl|bisacodyl|mesh-list
6528694|NCT00779649|Cathartics|cathartics|mesh-ancestor
6528695|NCT00779649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6528696|NCT00779649|Laxatives|laxatives|mesh-ancestor
6528697|NCT00779714|Cytarabine|cytarabine|mesh-list
6528698|NCT00779714|Paclitaxel|paclitaxel|mesh-list
6528699|NCT00779714|Cisplatin|cisplatin|mesh-list
6528700|NCT00779714|Dacarbazine|dacarbazine|mesh-list
6528701|NCT00779714|Treosulfan|treosulfan|mesh-list
6528702|NCT00779714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6528703|NCT00779714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6528704|NCT00779714|Tubulin Modulators|tubulin modulators|mesh-ancestor
6528705|NCT00779714|Antimitotic Agents|antimitotic agents|mesh-ancestor
6528706|NCT00779714|Mitosis Modulators|mitosis modulators|mesh-ancestor
6528707|NCT00779714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528708|NCT00779714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6528709|NCT00779714|Antimetabolites|antimetabolites|mesh-ancestor
6528710|NCT00779714|Antiviral Agents|antiviral agents|mesh-ancestor
6528711|NCT00779714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6528712|NCT00779714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6528713|NCT00779714|Immunologic Factors|immunologic factors|mesh-ancestor
6528714|NCT00779714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528715|NCT00779714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6528716|NCT00779714|Alkylating Agents|alkylating agents|mesh-ancestor
6528717|NCT00779753|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
6528718|NCT00779753|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6528719|NCT00779753|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6528720|NCT00779792|Triamcinolone|triamcinolone|mesh-list
6528721|NCT00779792|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6528722|NCT00779792|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6528723|NCT00779792|Clobetasol|clobetasol|mesh-list
6528724|NCT00779792|Mineral Oil|mineral oil|mesh-list
6528725|NCT00779792|Tacrolimus|tacrolimus|mesh-list
6528726|NCT00779792|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6528727|NCT00779792|Glycerol|glycerol|mesh-list
6793609|NCT02249039|Sympatholytics|sympatholytics|mesh-ancestor
6793610|NCT02249039|Autonomic Agents|autonomic agents|mesh-ancestor
6793611|NCT02249039|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6793612|NCT02249039|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6793613|NCT02249039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6793614|NCT02249039|Adrenergic Agents|adrenergic agents|mesh-ancestor
6793615|NCT02249039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6793616|NCT02249039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793617|NCT02249078|Quetmolimab|quetmolimab|mesh-list
6793618|NCT02249078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6793619|NCT02249130|Ritonavir|ritonavir|mesh-list
6793620|NCT02249130|Lamivudine|lamivudine|mesh-list
6793621|NCT02249130|Zidovudine|zidovudine|mesh-list
6793622|NCT02249130|Stavudine|stavudine|mesh-list
6793623|NCT02249130|Tipranavir|tipranavir|mesh-list
6793624|NCT02249130|Delavirdine|delavirdine|mesh-list
6793625|NCT02249130|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6793626|NCT02249130|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6793627|NCT02249130|Protease Inhibitors|protease inhibitors|mesh-ancestor
6793628|NCT02249130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6793629|NCT02249130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793630|NCT02249130|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6793631|NCT02249130|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6793632|NCT02249130|Antiviral Agents|antiviral agents|mesh-ancestor
6793633|NCT02249130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6793634|NCT02249130|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6793635|NCT02249130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6793636|NCT02249130|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6793637|NCT02249130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6793638|NCT02249130|Antimetabolites|antimetabolites|mesh-ancestor
6793639|NCT02249234|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6793640|NCT02249234|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6793641|NCT02249234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6793642|NCT02249234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528728|NCT00779792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6528729|NCT00779792|Immunologic Factors|immunologic factors|mesh-ancestor
6528730|NCT00779792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793643|NCT02249234|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6793644|NCT02249234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6528731|NCT00779792|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6528732|NCT00779792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6528733|NCT00779792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528734|NCT00779792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6528735|NCT00779792|Glucocorticoids|glucocorticoids|mesh-ancestor
6528736|NCT00779792|Hormones|hormones|mesh-ancestor
6528737|NCT00779792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6528738|NCT00779792|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6528739|NCT00779792|Protective Agents|protective agents|mesh-ancestor
6528740|NCT00779792|Emollients|emollients|mesh-ancestor
6528741|NCT00779792|Dermatologic Agents|dermatologic agents|mesh-ancestor
6528742|NCT00779805|Pseudoephedrine|pseudoephedrine|mesh-list
6528743|NCT00779805|Ephedrine|ephedrine|mesh-list
6528744|NCT00779805|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6528745|NCT00779805|Autonomic Agents|autonomic agents|mesh-ancestor
6528746|NCT00779805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6528747|NCT00779805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528748|NCT00779805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6528749|NCT00779805|Respiratory System Agents|respiratory system agents|mesh-ancestor
6528750|NCT00779805|Nasal Decongestants|nasal decongestants|mesh-ancestor
6528751|NCT00779805|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6528752|NCT00779805|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6528753|NCT00779805|Sympathomimetics|sympathomimetics|mesh-ancestor
6528754|NCT00779805|Adrenergic Agents|adrenergic agents|mesh-ancestor
6528755|NCT00779805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6528756|NCT00779805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528757|NCT00779831|Pseudoephedrine|pseudoephedrine|mesh-list
6528758|NCT00779831|Ephedrine|ephedrine|mesh-list
6528759|NCT00779831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6528760|NCT00779831|Autonomic Agents|autonomic agents|mesh-ancestor
6528761|NCT00779831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6528762|NCT00779831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528763|NCT00779831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6528764|NCT00779831|Respiratory System Agents|respiratory system agents|mesh-ancestor
6793645|NCT02249234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793646|NCT02249234|Cholinergic Agents|cholinergic agents|mesh-ancestor
6793647|NCT02249234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6793648|NCT02249299|Nabiximols|nabiximols|mesh-list
6793649|NCT02249299|Analgesics|analgesics|mesh-ancestor
6793650|NCT02249299|Sensory System Agents|sensory system agents|mesh-ancestor
6793651|NCT02249299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6793652|NCT02249299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793653|NCT02249364|Propofol|propofol|mesh-list
6793654|NCT02249364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6793655|NCT02249364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6793656|NCT02249364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793657|NCT02249364|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6793658|NCT02249364|Anesthetics, General|anesthetics, general|mesh-ancestor
6793659|NCT02249364|Anesthetics|anesthetics|mesh-ancestor
6793660|NCT02249416|Ritonavir|ritonavir|mesh-list
6793661|NCT02249416|Zidovudine|zidovudine|mesh-list
6793662|NCT02249416|Tipranavir|tipranavir|mesh-list
6793663|NCT02249416|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6793664|NCT02249416|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6793665|NCT02249416|Protease Inhibitors|protease inhibitors|mesh-ancestor
6793666|NCT02249416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6793667|NCT02249416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793668|NCT02249416|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6793669|NCT02249416|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6793670|NCT02249416|Antiviral Agents|antiviral agents|mesh-ancestor
6793671|NCT02249416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6793672|NCT02249416|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6793673|NCT02249416|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6793674|NCT02249416|Antimetabolites|antimetabolites|mesh-ancestor
6793675|NCT02249416|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6793676|NCT02249416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6793677|NCT02249442|Ritonavir|ritonavir|mesh-list
6793678|NCT02249442|Tipranavir|tipranavir|mesh-list
6793679|NCT02249442|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6793680|NCT02249442|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6793681|NCT02249442|Protease Inhibitors|protease inhibitors|mesh-ancestor
6793682|NCT02249442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6793683|NCT02249442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793684|NCT02249442|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6793685|NCT02249442|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6528765|NCT00779831|Nasal Decongestants|nasal decongestants|mesh-ancestor
6528766|NCT00779831|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6528767|NCT00779831|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6528768|NCT00779831|Sympathomimetics|sympathomimetics|mesh-ancestor
6528769|NCT00779831|Adrenergic Agents|adrenergic agents|mesh-ancestor
6528770|NCT00779831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6528771|NCT00779831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528772|NCT00779896|Tazarotene|tazarotene|mesh-list
6528773|NCT00779896|Dermatologic Agents|dermatologic agents|mesh-ancestor
6528774|NCT00779896|Keratolytic Agents|keratolytic agents|mesh-ancestor
6528775|NCT00779922|Lenalidomide|lenalidomide|mesh-list
6528776|NCT00779922|Immunologic Factors|immunologic factors|mesh-ancestor
6528777|NCT00779922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528778|NCT00779922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6528779|NCT00779922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6528780|NCT00779922|Growth Substances|growth substances|mesh-ancestor
6528781|NCT00779922|Growth Inhibitors|growth inhibitors|mesh-ancestor
6528782|NCT00779922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6528783|NCT00779935|Infliximab|infliximab|mesh-list
6528784|NCT00779935|Dermatologic Agents|dermatologic agents|mesh-ancestor
6528785|NCT00779935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6528786|NCT00779935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6528787|NCT00780013|Metformin|metformin|mesh-list
6528788|NCT00780013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6528789|NCT00780013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528790|NCT00780039|Carboplatin|carboplatin|mesh-list
6528791|NCT00780039|Doxorubicin|doxorubicin|mesh-list
6528792|NCT00780039|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6793686|NCT02249442|Antiviral Agents|antiviral agents|mesh-ancestor
6793687|NCT02249442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6793688|NCT02249442|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6793689|NCT02249442|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6793690|NCT02249481|Bupivacaine|bupivacaine|mesh-list
6793691|NCT02249481|Anesthetics, Local|anesthetics, local|mesh-ancestor
6793692|NCT02249481|Anesthetics|anesthetics|mesh-ancestor
6793693|NCT02249481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6793694|NCT02249481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793695|NCT02249481|Sensory System Agents|sensory system agents|mesh-ancestor
6793696|NCT02249481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6793697|NCT02249546|Amoxicillin|amoxicillin|mesh-list
6793698|NCT02249546|Clarithromycin|clarithromycin|mesh-list
6793699|NCT02249546|Acetylcysteine|acetylcysteine|mesh-list
6793700|NCT02249546|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6793701|NCT02249546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6793702|NCT02249546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6793703|NCT02249546|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6793704|NCT02249546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6793705|NCT02249546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793706|NCT02249546|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6793707|NCT02249546|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6793708|NCT02249546|Antiviral Agents|antiviral agents|mesh-ancestor
6793709|NCT02249546|Expectorants|expectorants|mesh-ancestor
6793710|NCT02249546|Respiratory System Agents|respiratory system agents|mesh-ancestor
6793711|NCT02249546|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6793712|NCT02249546|Antioxidants|antioxidants|mesh-ancestor
6793713|NCT02249546|Protective Agents|protective agents|mesh-ancestor
6793714|NCT02249546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793715|NCT02249546|Antidotes|antidotes|mesh-ancestor
6793716|NCT02249663|Fluticasone|fluticasone|mesh-list
6793717|NCT02249663|Xhance|xhance|mesh-list
6793718|NCT02249663|Azelastine|azelastine|mesh-list
6793719|NCT02249663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6793720|NCT02249663|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6793721|NCT02249663|Autonomic Agents|autonomic agents|mesh-ancestor
6793722|NCT02249663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6793723|NCT02249663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793724|NCT02249663|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6793725|NCT02249663|Respiratory System Agents|respiratory system agents|mesh-ancestor
6793726|NCT02249663|Dermatologic Agents|dermatologic agents|mesh-ancestor
6793727|NCT02249663|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6793728|NCT02249663|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6793729|NCT02249663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6793730|NCT02249663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793731|NCT02249663|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6793732|NCT02249663|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6793733|NCT02249663|Histamine Antagonists|histamine antagonists|mesh-ancestor
6528793|NCT00780039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6528794|NCT00780039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6528795|NCT00780039|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6528796|NCT00780039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6528797|NCT00780039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6528798|NCT00780039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528799|NCT00780104|Cytarabine|cytarabine|mesh-list
6528800|NCT00780104|Sirolimus|sirolimus|mesh-list
6528801|NCT00780104|Etoposide|etoposide|mesh-list
6528802|NCT00780104|Mitoxantrone|mitoxantrone|mesh-list
6528803|NCT00780104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6528804|NCT00780104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6793734|NCT02249663|Histamine Agents|histamine agents|mesh-ancestor
6793735|NCT02249663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6793736|NCT02249702|Gemcitabine|gemcitabine|mesh-list
6793737|NCT02249702|Docetaxel|docetaxel|mesh-list
6793738|NCT02249702|Trabectedin|trabectedin|mesh-list
6793739|NCT02249702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6793740|NCT02249702|Antimetabolites|antimetabolites|mesh-ancestor
6793741|NCT02249702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793742|NCT02249702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6793743|NCT02249702|Antiviral Agents|antiviral agents|mesh-ancestor
6793744|NCT02249702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6793745|NCT02249702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6793746|NCT02249702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6793747|NCT02249702|Immunologic Factors|immunologic factors|mesh-ancestor
6793748|NCT02249702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793749|NCT02249702|Tubulin Modulators|tubulin modulators|mesh-ancestor
6793750|NCT02249702|Antimitotic Agents|antimitotic agents|mesh-ancestor
6793751|NCT02249702|Mitosis Modulators|mitosis modulators|mesh-ancestor
6793752|NCT02249702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6793753|NCT02249702|Alkylating Agents|alkylating agents|mesh-ancestor
6793754|NCT02249741|Ibandronic Acid|ibandronic acid|mesh-list
6793755|NCT02249741|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6793756|NCT02249741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793757|NCT02249780|Parathyroid Hormone|parathyroid hormone|mesh-list
6793758|NCT02249780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6793759|NCT02249780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528805|NCT00780104|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6528806|NCT00780104|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6528807|NCT00780104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6528808|NCT00780104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528809|NCT00780104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6528810|NCT00780104|Antimetabolites|antimetabolites|mesh-ancestor
6528811|NCT00780104|Antiviral Agents|antiviral agents|mesh-ancestor
6528812|NCT00780104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6528813|NCT00780104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6528814|NCT00780104|Immunologic Factors|immunologic factors|mesh-ancestor
6528815|NCT00780104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528816|NCT00780104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6528817|NCT00780104|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6528818|NCT00780104|Antifungal Agents|antifungal agents|mesh-ancestor
6528819|NCT00780104|Analgesics|analgesics|mesh-ancestor
6528820|NCT00780104|Sensory System Agents|sensory system agents|mesh-ancestor
6528821|NCT00780104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6528822|NCT00780169|Sorafenib|sorafenib|mesh-list
6528823|NCT00780169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6528824|NCT00780169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6528825|NCT00780169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6528826|NCT00780169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528827|NCT00780182|Brincidofovir|brincidofovir|mesh-list
6528828|NCT00780182|Antiviral Agents|antiviral agents|mesh-ancestor
6528829|NCT00780182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6528830|NCT00780325|Celecoxib|celecoxib|mesh-list
6528831|NCT00780325|Naproxen|naproxen|mesh-list
6528832|NCT00780325|Acetazolamide|acetazolamide|mesh-list
6528833|NCT00780325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6528834|NCT00780325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6528835|NCT00780325|Analgesics|analgesics|mesh-ancestor
6528836|NCT00780325|Sensory System Agents|sensory system agents|mesh-ancestor
6528837|NCT00780325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6528838|NCT00780325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528839|NCT00780325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6528840|NCT00780325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6793760|NCT02249871|Omeprazole|omeprazole|mesh-list
6793761|NCT02249871|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6793762|NCT02249871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6793763|NCT02249871|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6793764|NCT02249871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6793765|NCT02249871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793766|NCT02249884|Carbamide Peroxide|carbamide peroxide|mesh-list
6793767|NCT02249884|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6793768|NCT02249884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6793769|NCT02249897|Cholestyramine Resin|cholestyramine resin|mesh-list
6793770|NCT02249897|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6793771|NCT02249897|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6793772|NCT02249897|Antimetabolites|antimetabolites|mesh-ancestor
6793773|NCT02249897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793774|NCT02249897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6793775|NCT02249910|Metformin|metformin|mesh-list
6793776|NCT02249910|Digoxin|digoxin|mesh-list
6793777|NCT02249910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6793778|NCT02249910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793779|NCT02249910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6793780|NCT02249910|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6793781|NCT02249910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6793782|NCT02249910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793783|NCT02249910|Protective Agents|protective agents|mesh-ancestor
6793784|NCT02249936|Omeprazole|omeprazole|mesh-list
6793785|NCT02249936|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6793786|NCT02249936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6793787|NCT02249936|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6793788|NCT02249936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6793789|NCT02249936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793790|NCT02250118|Bevacizumab|bevacizumab|mesh-list
6793791|NCT02250118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6793792|NCT02250118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6793793|NCT02250118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6793794|NCT02250118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6793795|NCT02250118|Growth Substances|growth substances|mesh-ancestor
6793796|NCT02250118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793797|NCT02250118|Growth Inhibitors|growth inhibitors|mesh-ancestor
6793798|NCT02250209|Capecitabine|capecitabine|mesh-list
6793799|NCT02250209|Oxaliplatin|oxaliplatin|mesh-list
6528841|NCT00780325|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6528842|NCT00780325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6528843|NCT00780325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6528844|NCT00780325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528845|NCT00780325|Gout Suppressants|gout suppressants|mesh-ancestor
6528846|NCT00780325|Anticonvulsants|anticonvulsants|mesh-ancestor
6528847|NCT00780325|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6528848|NCT00780325|Diuretics|diuretics|mesh-ancestor
6528849|NCT00780325|Natriuretic Agents|natriuretic agents|mesh-ancestor
6528850|NCT00780377|Bradykinin|bradykinin|mesh-list
6528851|NCT00780377|Kininogens|kininogens|mesh-list
6528852|NCT00780377|Vasodilator Agents|vasodilator agents|mesh-ancestor
6528853|NCT00780377|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
6528854|NCT00780377|Protease Inhibitors|protease inhibitors|mesh-ancestor
6528855|NCT00780377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6528856|NCT00780377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528857|NCT00780598|Tosedostat|tosedostat|mesh-list
6528858|NCT00780598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6528859|NCT00780598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537512|NCT00822614|Sensory System Agents|sensory system agents|mesh-ancestor
6537513|NCT00822614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6537514|NCT00822614|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6537515|NCT00822614|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6537516|NCT00822614|Anesthetics, General|anesthetics, general|mesh-ancestor
6537517|NCT00822614|Anesthetics|anesthetics|mesh-ancestor
6537518|NCT00822627|Vaccines|vaccines|mesh-list
6537519|NCT00822627|Immunologic Factors|immunologic factors|mesh-ancestor
6537520|NCT00822627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537521|NCT00822666|Clopidogrel|clopidogrel|mesh-list
6537522|NCT00822666|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6537523|NCT00822666|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6537524|NCT00822666|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6537525|NCT00822666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6537526|NCT00822666|Purinergic Agents|purinergic agents|mesh-ancestor
6537527|NCT00822666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6537528|NCT00822666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537529|NCT00822666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537530|NCT00822744|Citalopram|citalopram|mesh-list
6537531|NCT00822744|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6537532|NCT00822744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6537533|NCT00822744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6537534|NCT00822744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537535|NCT00822744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6537536|NCT00822744|Serotonin Agents|serotonin agents|mesh-ancestor
6537537|NCT00822744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537538|NCT00822744|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6537539|NCT00822744|Antidepressive Agents|antidepressive agents|mesh-ancestor
6537540|NCT00822744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6537541|NCT00822783|Omalizumab|omalizumab|mesh-list
6537542|NCT00822783|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6793800|NCT02250209|Trastuzumab|trastuzumab|mesh-list
6793801|NCT02250209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6793802|NCT02250209|Antimetabolites|antimetabolites|mesh-ancestor
6793803|NCT02250209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793804|NCT02250209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6793805|NCT02250209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6793806|NCT02250300|Ixazomib|ixazomib|mesh-list
6793807|NCT02250300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6793808|NCT02250300|Protease Inhibitors|protease inhibitors|mesh-ancestor
6793809|NCT02250300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6793810|NCT02250300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793811|NCT02250482|Factor VIII|factor viii|mesh-list
6793812|NCT02250482|Coagulants|coagulants|mesh-ancestor
6793813|NCT02250508|Factor VIII|factor viii|mesh-list
6793814|NCT02250508|Coagulants|coagulants|mesh-ancestor
6793815|NCT02250534|Nicotine|nicotine|mesh-list
6793816|NCT02250534|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6793817|NCT02250534|Autonomic Agents|autonomic agents|mesh-ancestor
6793818|NCT02250534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6793819|NCT02250534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793820|NCT02250534|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6793821|NCT02250534|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6793822|NCT02250534|Cholinergic Agents|cholinergic agents|mesh-ancestor
6793823|NCT02250534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6793824|NCT02250534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793825|NCT02250599|Paclitaxel|paclitaxel|mesh-list
6528860|NCT00780637|Bradykinin|bradykinin|mesh-list
6528861|NCT00780637|Kininogens|kininogens|mesh-list
6528862|NCT00780637|Vasodilator Agents|vasodilator agents|mesh-ancestor
6793826|NCT02250599|Bevacizumab|bevacizumab|mesh-list
6793827|NCT02250599|Carboplatin|carboplatin|mesh-list
6793828|NCT02250599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6793829|NCT02250599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6793830|NCT02250599|Tubulin Modulators|tubulin modulators|mesh-ancestor
6793831|NCT02250599|Antimitotic Agents|antimitotic agents|mesh-ancestor
6793832|NCT02250599|Mitosis Modulators|mitosis modulators|mesh-ancestor
6793833|NCT02250599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793834|NCT02250599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6793835|NCT02250599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6793836|NCT02250599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6793837|NCT02250599|Growth Substances|growth substances|mesh-ancestor
6793838|NCT02250599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793839|NCT02250599|Growth Inhibitors|growth inhibitors|mesh-ancestor
6793840|NCT02250664|Nicotine|nicotine|mesh-list
6793841|NCT02250664|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6793842|NCT02250664|Autonomic Agents|autonomic agents|mesh-ancestor
6793843|NCT02250664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6793844|NCT02250664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793845|NCT02250664|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6793846|NCT02250664|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6793847|NCT02250664|Cholinergic Agents|cholinergic agents|mesh-ancestor
6793848|NCT02250664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6793849|NCT02250664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793850|NCT02250729|Pholcodine|pholcodine|mesh-list
6793851|NCT02250729|Analgesics|analgesics|mesh-ancestor
6793852|NCT02250729|Sensory System Agents|sensory system agents|mesh-ancestor
6793853|NCT02250729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6793854|NCT02250729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793855|NCT02250729|Antitussive Agents|antitussive agents|mesh-ancestor
6793856|NCT02250729|Respiratory System Agents|respiratory system agents|mesh-ancestor
6793857|NCT02250781|TIC10 compound|tic10 compound|mesh-list
6793858|NCT02250781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6793859|NCT02250794|Insulin|insulin|mesh-list
6793860|NCT02250794|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6793861|NCT02250794|Metformin|metformin|mesh-list
6793862|NCT02250794|Insulin Glargine|insulin glargine|mesh-list
6793863|NCT02250794|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6793864|NCT02250794|Insulin Lispro|insulin lispro|mesh-list
6793865|NCT02250794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6793866|NCT02250794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793867|NCT02250794|Incretins|incretins|mesh-ancestor
6793868|NCT02250794|Hormones|hormones|mesh-ancestor
6793869|NCT02250794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6793870|NCT02250794|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6793871|NCT02250794|Protease Inhibitors|protease inhibitors|mesh-ancestor
6793872|NCT02250794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6793873|NCT02250794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793874|NCT02250820|Pentobarbital|pentobarbital|mesh-list
6793875|NCT02250820|Dexmedetomidine|dexmedetomidine|mesh-list
6793876|NCT02250820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6793877|NCT02250820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6793878|NCT02250820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793879|NCT02250820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6793880|NCT02250820|Analgesics|analgesics|mesh-ancestor
6793881|NCT02250820|Sensory System Agents|sensory system agents|mesh-ancestor
6793882|NCT02250820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6793883|NCT02250820|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6793884|NCT02250820|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6793885|NCT02250820|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6793886|NCT02250820|Adrenergic Agents|adrenergic agents|mesh-ancestor
6793887|NCT02250820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6793888|NCT02250820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793889|NCT02250820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6793890|NCT02250820|GABA Modulators|gaba modulators|mesh-ancestor
6793891|NCT02250820|GABA Agents|gaba agents|mesh-ancestor
6793892|NCT02250833|Amlodipine|amlodipine|mesh-list
6793893|NCT02250833|Telmisartan|telmisartan|mesh-list
6793894|NCT02250833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6793895|NCT02250833|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6793896|NCT02250833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6528863|NCT00780637|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
6793897|NCT02250833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528864|NCT00780637|Protease Inhibitors|protease inhibitors|mesh-ancestor
6528865|NCT00780637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6528866|NCT00780637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528867|NCT00780650|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6528868|NCT00780650|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6528869|NCT00780650|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6528870|NCT00780650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6528871|NCT00780650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528872|NCT00780650|Adrenergic Agents|adrenergic agents|mesh-ancestor
6528873|NCT00780650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6528874|NCT00780650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528875|NCT00780728|Sildenafil Citrate|sildenafil citrate|mesh-list
6528876|NCT00780728|Vasodilator Agents|vasodilator agents|mesh-ancestor
6528877|NCT00780728|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6528878|NCT00780728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6528879|NCT00780728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6528880|NCT00780728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528881|NCT00780728|Urological Agents|urological agents|mesh-ancestor
6528882|NCT00780754|Dutasteride|dutasteride|mesh-list
6528883|NCT00780754|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6528884|NCT00780754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6528885|NCT00780754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6528886|NCT00780754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528887|NCT00780754|Hormone Antagonists|hormone antagonists|mesh-ancestor
6528888|NCT00780754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6528889|NCT00780754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528890|NCT00780780|Triamcinolone|triamcinolone|mesh-list
6528891|NCT00780780|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6528892|NCT00780780|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6528893|NCT00780780|Nepafenac|nepafenac|mesh-list
6528894|NCT00780780|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6528895|NCT00780780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6528896|NCT00780780|Glucocorticoids|glucocorticoids|mesh-ancestor
6528897|NCT00780780|Hormones|hormones|mesh-ancestor
6528898|NCT00780780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6528899|NCT00780780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528900|NCT00780780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6528901|NCT00780780|Immunologic Factors|immunologic factors|mesh-ancestor
6528902|NCT00780780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6528903|NCT00780780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528904|NCT00780780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6528905|NCT00780780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6528906|NCT00780780|Analgesics|analgesics|mesh-ancestor
6528907|NCT00780780|Sensory System Agents|sensory system agents|mesh-ancestor
6528908|NCT00780780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6528909|NCT00780780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6528910|NCT00780793|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
6528911|NCT00780793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6528912|NCT00780832|Caffeine|caffeine|mesh-list
6528913|NCT00780832|Cholinergic Antagonists|cholinergic antagonists|mesh-list
6528914|NCT00780832|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6528915|NCT00780832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528916|NCT00780832|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6528917|NCT00780832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6528918|NCT00780832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528919|NCT00780832|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6528920|NCT00780832|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6528921|NCT00780832|Purinergic Agents|purinergic agents|mesh-ancestor
6528922|NCT00780832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6528923|NCT00780832|Cholinergic Agents|cholinergic agents|mesh-ancestor
6528924|NCT00780858|Ganirelix|ganirelix|mesh-list
6528925|NCT00780858|Hormone Antagonists|hormone antagonists|mesh-ancestor
6528926|NCT00780858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6528927|NCT00780858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528928|NCT00781105|Telbivudine|telbivudine|mesh-list
6528929|NCT00781105|Antiviral Agents|antiviral agents|mesh-ancestor
6528930|NCT00781105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6528931|NCT00781105|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6528932|NCT00781105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6528933|NCT00781105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528934|NCT00781131|Pregabalin|pregabalin|mesh-list
6528935|NCT00781131|Analgesics|analgesics|mesh-ancestor
6528936|NCT00781131|Sensory System Agents|sensory system agents|mesh-ancestor
6528937|NCT00781131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6528938|NCT00781131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528939|NCT00781131|Anticonvulsants|anticonvulsants|mesh-ancestor
6528940|NCT00781131|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6528941|NCT00781131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6528942|NCT00781131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528943|NCT00781131|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6528944|NCT00781131|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6528945|NCT00781131|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6528946|NCT00781131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6528947|NCT00781131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6528948|NCT00781157|Phenylephrine|phenylephrine|mesh-list
6528949|NCT00781157|Oxymetazoline|oxymetazoline|mesh-list
6528950|NCT00781157|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6528951|NCT00781157|Mydriatics|mydriatics|mesh-ancestor
6528952|NCT00781157|Autonomic Agents|autonomic agents|mesh-ancestor
6528953|NCT00781157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6528954|NCT00781157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528955|NCT00781157|Sympathomimetics|sympathomimetics|mesh-ancestor
6528956|NCT00781157|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6528957|NCT00781157|Nasal Decongestants|nasal decongestants|mesh-ancestor
6528958|NCT00781157|Respiratory System Agents|respiratory system agents|mesh-ancestor
6528959|NCT00781157|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6528960|NCT00781157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6528961|NCT00781157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6528962|NCT00781157|Adrenergic Agents|adrenergic agents|mesh-ancestor
6528963|NCT00781157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6528964|NCT00781157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528965|NCT00781157|Protective Agents|protective agents|mesh-ancestor
6528966|NCT00781196|Folic Acid|folic acid|mesh-list
6528967|NCT00781196|Hematinics|hematinics|mesh-ancestor
6528968|NCT00781196|Vitamin B Complex|vitamin b complex|mesh-ancestor
6528969|NCT00781196|Vitamins|vitamins|mesh-ancestor
6528970|NCT00781196|Micronutrients|micronutrients|mesh-ancestor
6528971|NCT00781196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793898|NCT02250833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6793899|NCT02250833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793900|NCT02250833|Vasodilator Agents|vasodilator agents|mesh-ancestor
6793901|NCT02250833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6793902|NCT02250833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6793903|NCT02250859|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6793904|NCT02250859|Minocycline|minocycline|mesh-list
6793905|NCT02250859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6793906|NCT02250872|Cisplatin|cisplatin|mesh-list
6793907|NCT02250872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6793908|NCT02250924|Caffeine|caffeine|mesh-list
6793909|NCT02250924|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6793910|NCT02250924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793911|NCT02250924|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6793912|NCT02250924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6793913|NCT02250924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793914|NCT02250924|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6793915|NCT02250924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6793916|NCT02250924|Purinergic Agents|purinergic agents|mesh-ancestor
6793917|NCT02250924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6793918|NCT02251015|Salicylic Acid|salicylic acid|mesh-list
6793919|NCT02251015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6793920|NCT02251015|Antifungal Agents|antifungal agents|mesh-ancestor
6793921|NCT02251015|Keratolytic Agents|keratolytic agents|mesh-ancestor
6793922|NCT02251015|Dermatologic Agents|dermatologic agents|mesh-ancestor
6793923|NCT02251041|Tocopherols|tocopherols|mesh-list
6793924|NCT02251041|Vitamin E|vitamin e|mesh-list
6793925|NCT02251041|alpha-Tocopherol|alpha-tocopherol|mesh-list
6793926|NCT02251041|Infliximab|infliximab|mesh-list
6793927|NCT02251041|Epoprostenol|epoprostenol|mesh-list
6793928|NCT02251041|Tezosentan|tezosentan|mesh-list
6793929|NCT02251041|Melatonin|melatonin|mesh-list
6793930|NCT02251041|Antithrombins|antithrombins|mesh-list
6793931|NCT02251041|Antithrombin III|antithrombin iii|mesh-list
6793932|NCT02251041|Epoetin Alfa|epoetin alfa|mesh-list
6528972|NCT00781261|Zoledronic Acid|zoledronic acid|mesh-list
6793933|NCT02251041|Dermatologic Agents|dermatologic agents|mesh-ancestor
6793934|NCT02251041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6793935|NCT02251041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6793936|NCT02251041|Antioxidants|antioxidants|mesh-ancestor
6528973|NCT00781261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6528974|NCT00781261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528975|NCT00781287|Raltegravir Potassium|raltegravir potassium|mesh-list
6528976|NCT00781287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6528977|NCT00781287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6528978|NCT00781287|Antiviral Agents|antiviral agents|mesh-ancestor
6528979|NCT00781287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6528980|NCT00781287|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6528981|NCT00781287|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6528982|NCT00781287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6528983|NCT00781287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6528984|NCT00781300|Loteprednol Etabonate|loteprednol etabonate|mesh-list
6528985|NCT00781300|Dexamethasone|dexamethasone|mesh-list
6528986|NCT00781300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6528987|NCT00781300|Antiemetics|antiemetics|mesh-ancestor
6528988|NCT00781300|Autonomic Agents|autonomic agents|mesh-ancestor
6528989|NCT00781300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6528990|NCT00781300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6528991|NCT00781300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6528992|NCT00781300|Glucocorticoids|glucocorticoids|mesh-ancestor
6528993|NCT00781300|Hormones|hormones|mesh-ancestor
6528994|NCT00781300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6528995|NCT00781300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6528996|NCT00781300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6528997|NCT00781300|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6528998|NCT00781352|Nitrous Oxide|nitrous oxide|mesh-list
6528999|NCT00781352|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6529000|NCT00781352|Anesthetics, General|anesthetics, general|mesh-ancestor
6529001|NCT00781352|Anesthetics|anesthetics|mesh-ancestor
6529002|NCT00781352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6529003|NCT00781352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529004|NCT00781352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6529005|NCT00781352|Analgesics|analgesics|mesh-ancestor
6529006|NCT00781352|Sensory System Agents|sensory system agents|mesh-ancestor
6529007|NCT00781352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6529008|NCT00781378|Plasminogen|plasminogen|mesh-list
6529009|NCT00781378|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6529010|NCT00781378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6529011|NCT00781378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6529012|NCT00781378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529013|NCT00781404|Adenosine|adenosine|mesh-list
6529014|NCT00781404|Analgesics|analgesics|mesh-ancestor
6529015|NCT00781404|Sensory System Agents|sensory system agents|mesh-ancestor
6529016|NCT00781404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6529017|NCT00781404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529018|NCT00781404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6529019|NCT00781404|Vasodilator Agents|vasodilator agents|mesh-ancestor
6529020|NCT00781404|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6529021|NCT00781404|Purinergic Agonists|purinergic agonists|mesh-ancestor
6529022|NCT00781404|Purinergic Agents|purinergic agents|mesh-ancestor
6529023|NCT00781404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6529024|NCT00781404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529025|NCT00781417|Vitamin D|vitamin d|mesh-list
6529026|NCT00781417|Ergocalciferols|ergocalciferols|mesh-list
6529027|NCT00781417|Cholecalciferol|cholecalciferol|mesh-list
6529028|NCT00781417|Vitamins|vitamins|mesh-list
6529029|NCT00781417|Micronutrients|micronutrients|mesh-ancestor
6529030|NCT00781417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529031|NCT00781417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6529032|NCT00781417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6529033|NCT00781482|Zolpidem|zolpidem|mesh-list
6793937|NCT02251041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793938|NCT02251041|Protective Agents|protective agents|mesh-ancestor
6793939|NCT02251041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793940|NCT02251041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6793941|NCT02251041|Hematinics|hematinics|mesh-ancestor
6793942|NCT02251041|Vitamins|vitamins|mesh-ancestor
6793943|NCT02251041|Micronutrients|micronutrients|mesh-ancestor
6793944|NCT02251041|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6793945|NCT02251041|Protease Inhibitors|protease inhibitors|mesh-ancestor
6793946|NCT02251041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6793947|NCT02251041|Anticoagulants|anticoagulants|mesh-ancestor
6793948|NCT02251041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6793949|NCT02251041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6529034|NCT00781482|Eszopiclone|eszopiclone|mesh-list
6793950|NCT02251041|Vasodilator Agents|vasodilator agents|mesh-ancestor
6529035|NCT00781482|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6529036|NCT00781482|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6529037|NCT00781482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6529038|NCT00781482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529039|NCT00781482|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6529040|NCT00781482|GABA Agonists|gaba agonists|mesh-ancestor
6529041|NCT00781482|GABA Agents|gaba agents|mesh-ancestor
6529042|NCT00781482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6529043|NCT00781482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529044|NCT00781521|Ofloxacin|ofloxacin|mesh-list
6529045|NCT00781521|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6529046|NCT00781521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6529047|NCT00781521|Renal Agents|renal agents|mesh-ancestor
6529048|NCT00781521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6529049|NCT00781521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6529050|NCT00781521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6529051|NCT00781521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6529052|NCT00781521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529053|NCT00781521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6529054|NCT00781521|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6529055|NCT00781521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6529056|NCT00781547|Hormones|hormones|mesh-list
6529057|NCT00781547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6529058|NCT00781547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529059|NCT00781573|Clopidogrel|clopidogrel|mesh-list
6529060|NCT00781573|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6529061|NCT00781573|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6529062|NCT00781573|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6529063|NCT00781573|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6529064|NCT00781573|Purinergic Agents|purinergic agents|mesh-ancestor
6529065|NCT00781573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6529066|NCT00781573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529067|NCT00781573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529068|NCT00781586|Caffeine|caffeine|mesh-list
6529069|NCT00781586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529070|NCT00781586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6529071|NCT00781586|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6529072|NCT00781586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6529073|NCT00781586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529074|NCT00781586|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6529075|NCT00781586|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6529076|NCT00781586|Purinergic Agents|purinergic agents|mesh-ancestor
6529077|NCT00781586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6529078|NCT00781625|Methenamine hippurate|methenamine hippurate|mesh-list
6529079|NCT00781625|Methenamine|methenamine|mesh-list
6529080|NCT00781625|Methenamine mandelate|methenamine mandelate|mesh-list
6529081|NCT00781625|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6529082|NCT00781625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6529083|NCT00781625|Renal Agents|renal agents|mesh-ancestor
6529084|NCT00781625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6529085|NCT00781755|Varenicline|varenicline|mesh-list
6529086|NCT00781755|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6529087|NCT00781755|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6529088|NCT00781755|Cholinergic Agents|cholinergic agents|mesh-ancestor
6529089|NCT00781755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6529090|NCT00781755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529091|NCT00781755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529092|NCT00781781|Alemtuzumab|alemtuzumab|mesh-list
6793951|NCT02251119|Ritonavir|ritonavir|mesh-list
6793952|NCT02251119|Tipranavir|tipranavir|mesh-list
6793953|NCT02251119|Loperamide|loperamide|mesh-list
6793954|NCT02251119|Antidiarrheals|antidiarrheals|mesh-list
6793955|NCT02251119|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6793956|NCT02251119|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6793957|NCT02251119|Protease Inhibitors|protease inhibitors|mesh-ancestor
6793958|NCT02251119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6793959|NCT02251119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793960|NCT02251119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6793961|NCT02251119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6793962|NCT02251119|Antiviral Agents|antiviral agents|mesh-ancestor
6793963|NCT02251119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6793964|NCT02251119|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6793965|NCT02251119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6529093|NCT00781781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6529094|NCT00781781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6529095|NCT00781820|Bifonazole|bifonazole|mesh-list
6529096|NCT00781820|Antifungal Agents|antifungal agents|mesh-ancestor
6529097|NCT00781820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6529098|NCT00781846|Sirolimus|sirolimus|mesh-list
6529099|NCT00781846|Bevacizumab|bevacizumab|mesh-list
6529100|NCT00781846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6529101|NCT00781846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6529102|NCT00781846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6529103|NCT00781846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6529104|NCT00781846|Growth Substances|growth substances|mesh-ancestor
6529105|NCT00781846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529106|NCT00781846|Growth Inhibitors|growth inhibitors|mesh-ancestor
6529107|NCT00781846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6529108|NCT00781846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6529109|NCT00781846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6529110|NCT00781846|Antifungal Agents|antifungal agents|mesh-ancestor
6529111|NCT00781846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6529112|NCT00781846|Immunologic Factors|immunologic factors|mesh-ancestor
6529113|NCT00782041|Leucovorin|leucovorin|mesh-list
6529114|NCT00782041|Folic Acid|folic acid|mesh-list
6529115|NCT00782041|Fluorouracil|fluorouracil|mesh-list
6529116|NCT00782041|Oxaliplatin|oxaliplatin|mesh-list
6529117|NCT00782041|Levoleucovorin|levoleucovorin|mesh-list
6529118|NCT00782041|Antimetabolites|antimetabolites|mesh-ancestor
6529119|NCT00782041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529120|NCT00782041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6529121|NCT00782041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6529122|NCT00782041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6529123|NCT00782041|Immunologic Factors|immunologic factors|mesh-ancestor
6529124|NCT00782041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529125|NCT00782041|Antidotes|antidotes|mesh-ancestor
6529126|NCT00782041|Protective Agents|protective agents|mesh-ancestor
6529127|NCT00782041|Vitamin B Complex|vitamin b complex|mesh-ancestor
6529128|NCT00782041|Vitamins|vitamins|mesh-ancestor
6529129|NCT00782041|Micronutrients|micronutrients|mesh-ancestor
6529130|NCT00782041|Hematinics|hematinics|mesh-ancestor
6529131|NCT00782093|Volociximab|volociximab|mesh-list
6529132|NCT00782093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6529133|NCT00782093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6529134|NCT00782093|Growth Substances|growth substances|mesh-ancestor
6529135|NCT00782093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529136|NCT00782093|Growth Inhibitors|growth inhibitors|mesh-ancestor
6529137|NCT00782093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6529138|NCT00782106|Immunoglobulins|immunoglobulins|mesh-list
6529139|NCT00782106|Antibodies|antibodies|mesh-list
6529140|NCT00782106|gamma-Globulins|gamma-globulins|mesh-list
6529141|NCT00782106|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6529142|NCT00782106|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6529143|NCT00782106|Immunoglobulin G|immunoglobulin g|mesh-list
6529144|NCT00782106|Immunologic Factors|immunologic factors|mesh-ancestor
6529145|NCT00782106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529146|NCT00782197|Hyaluronic Acid|hyaluronic acid|mesh-list
6529147|NCT00782197|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6529148|NCT00782197|Immunologic Factors|immunologic factors|mesh-ancestor
6529149|NCT00782197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529150|NCT00782197|Viscosupplements|viscosupplements|mesh-ancestor
6529151|NCT00782197|Protective Agents|protective agents|mesh-ancestor
6529152|NCT00782301|Maraviroc|maraviroc|mesh-list
6529153|NCT00782301|Etravirine|etravirine|mesh-list
6529154|NCT00782301|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6529155|NCT00782301|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6529156|NCT00782301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529157|NCT00782301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6529158|NCT00782301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6529159|NCT00782301|Antiviral Agents|antiviral agents|mesh-ancestor
6529160|NCT00782301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6529161|NCT00782301|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6529162|NCT00782301|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6529163|NCT00782301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6529164|NCT00782301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6529165|NCT00782327|Losartan|losartan|mesh-list
6529166|NCT00782327|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6529167|NCT00782327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6529168|NCT00782327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6529169|NCT00782327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6529170|NCT00782327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529171|NCT00782405|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6529172|NCT00782405|Mirtazapine|mirtazapine|mesh-list
6529173|NCT00782405|Antidepressive Agents|antidepressive agents|mesh-ancestor
6529174|NCT00782405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6529175|NCT00782405|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6529176|NCT00782405|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6529177|NCT00782405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6529178|NCT00782405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529179|NCT00782405|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6529180|NCT00782405|Histamine Antagonists|histamine antagonists|mesh-ancestor
6529181|NCT00782405|Histamine Agents|histamine agents|mesh-ancestor
6529182|NCT00782405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6529183|NCT00782405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529184|NCT00782405|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6529185|NCT00782405|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6529186|NCT00782405|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6529187|NCT00782405|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6529188|NCT00782405|Adrenergic Agents|adrenergic agents|mesh-ancestor
6529189|NCT00782405|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6529190|NCT00782405|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6529191|NCT00782405|Serotonin Agents|serotonin agents|mesh-ancestor
6529192|NCT00782405|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6537543|NCT00822783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6537544|NCT00822783|Respiratory System Agents|respiratory system agents|mesh-ancestor
6537545|NCT00822809|Prednisolone|prednisolone|mesh-list
6793966|NCT02251119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6793967|NCT02251132|Ritonavir|ritonavir|mesh-list
6793968|NCT02251132|Erythromycin|erythromycin|mesh-list
6793969|NCT02251132|Erythromycin Estolate|erythromycin estolate|mesh-list
6793970|NCT02251132|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
6793971|NCT02251132|Erythromycin stearate|erythromycin stearate|mesh-list
6793972|NCT02251132|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6793973|NCT02251132|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6793974|NCT02251132|Protease Inhibitors|protease inhibitors|mesh-ancestor
6793975|NCT02251132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6793976|NCT02251132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793977|NCT02251132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6793978|NCT02251132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6793979|NCT02251132|Antiviral Agents|antiviral agents|mesh-ancestor
6793980|NCT02251132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6793981|NCT02251132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6793982|NCT02251132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6793983|NCT02251132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6537546|NCT00822809|Catumaxomab|catumaxomab|mesh-list
6537547|NCT00822809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6537548|NCT00822809|Glucocorticoids|glucocorticoids|mesh-ancestor
6537549|NCT00822809|Hormones|hormones|mesh-ancestor
6537550|NCT00822809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6537551|NCT00822809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537552|NCT00822809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6537553|NCT00822809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6537554|NCT00822809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6537555|NCT00822848|Sorafenib|sorafenib|mesh-list
6537556|NCT00822848|Epirubicin|epirubicin|mesh-list
6537557|NCT00822848|Ifosfamide|ifosfamide|mesh-list
6537558|NCT00822848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6537559|NCT00822848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6537560|NCT00822848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6537561|NCT00822848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537562|NCT00822848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6537563|NCT00822848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6537564|NCT00822848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6537565|NCT00822848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6537566|NCT00822848|Alkylating Agents|alkylating agents|mesh-ancestor
6537567|NCT00822913|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6537568|NCT00822913|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6537569|NCT00822913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6537570|NCT00822913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6537571|NCT00822913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537572|NCT00822913|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6537573|NCT00822913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6537574|NCT00822913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537575|NCT00822913|Cholinergic Agents|cholinergic agents|mesh-ancestor
6529193|NCT00782470|Factor VIII|factor viii|mesh-list
6529194|NCT00782470|Coagulants|coagulants|mesh-ancestor
6529195|NCT00782548|Morphine|morphine|mesh-list
6529196|NCT00782548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6529197|NCT00782548|Narcotics|narcotics|mesh-ancestor
6529198|NCT00782548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6529199|NCT00782548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529200|NCT00782548|Analgesics|analgesics|mesh-ancestor
6529201|NCT00782548|Sensory System Agents|sensory system agents|mesh-ancestor
6529202|NCT00782548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6529203|NCT00782652|Nitric Oxide|nitric oxide|mesh-list
6529204|NCT00782652|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6529205|NCT00782652|Autonomic Agents|autonomic agents|mesh-ancestor
6529206|NCT00782652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6529207|NCT00782652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529208|NCT00782652|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6529209|NCT00782652|Respiratory System Agents|respiratory system agents|mesh-ancestor
6529210|NCT00782652|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6529211|NCT00782652|Antioxidants|antioxidants|mesh-ancestor
6529212|NCT00782652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529213|NCT00782652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6529214|NCT00782652|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6529215|NCT00782652|Vasodilator Agents|vasodilator agents|mesh-ancestor
6529216|NCT00782652|Gasotransmitters|gasotransmitters|mesh-ancestor
6529217|NCT00782652|Protective Agents|protective agents|mesh-ancestor
6529218|NCT00782847|Cyproterone Acetate|cyproterone acetate|mesh-list
6529219|NCT00782847|Cyproterone|cyproterone|mesh-list
6529220|NCT00782847|Androgen Antagonists|androgen antagonists|mesh-ancestor
6529221|NCT00782847|Hormone Antagonists|hormone antagonists|mesh-ancestor
6529222|NCT00782847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6529223|NCT00782847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529224|NCT00782847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6529225|NCT00782847|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6529226|NCT00782847|Contraceptive Agents|contraceptive agents|mesh-ancestor
6529227|NCT00782847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6529228|NCT00782951|Morphine|morphine|mesh-list
6529229|NCT00782951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6529230|NCT00782951|Narcotics|narcotics|mesh-ancestor
6529231|NCT00782951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6529232|NCT00782951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529233|NCT00782951|Analgesics|analgesics|mesh-ancestor
6529234|NCT00782951|Sensory System Agents|sensory system agents|mesh-ancestor
6529235|NCT00782951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6529236|NCT00783016|Morphine|morphine|mesh-list
6529237|NCT00783016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6529238|NCT00783016|Narcotics|narcotics|mesh-ancestor
6529239|NCT00783016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6529240|NCT00783016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529241|NCT00783016|Analgesics|analgesics|mesh-ancestor
6529242|NCT00783016|Sensory System Agents|sensory system agents|mesh-ancestor
6529243|NCT00783016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6529244|NCT00783042|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6529245|NCT00783042|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6529246|NCT00783042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6529247|NCT00783042|Antimetabolites|antimetabolites|mesh-ancestor
6529248|NCT00783042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529249|NCT00783042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6529250|NCT00783042|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6529251|NCT00783042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6529252|NCT00783068|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
6529253|NCT00783068|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6529254|NCT00783068|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6529255|NCT00783068|Cholinergic Agents|cholinergic agents|mesh-ancestor
6529256|NCT00783068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6529257|NCT00783068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529258|NCT00783068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529259|NCT00783081|Cilostazol|cilostazol|mesh-list
6529260|NCT00783081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6529261|NCT00783081|Autonomic Agents|autonomic agents|mesh-ancestor
6529262|NCT00783081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6793984|NCT02251132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6793985|NCT02251132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6793986|NCT02251145|Ritonavir|ritonavir|mesh-list
6793987|NCT02251145|Tenofovir|tenofovir|mesh-list
6529263|NCT00783081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6793988|NCT02251145|Tipranavir|tipranavir|mesh-list
6529264|NCT00783081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6529265|NCT00783081|Respiratory System Agents|respiratory system agents|mesh-ancestor
6529266|NCT00783081|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6529267|NCT00783081|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6529268|NCT00783081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529269|NCT00783081|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6529270|NCT00783081|Vasodilator Agents|vasodilator agents|mesh-ancestor
6529271|NCT00783081|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6529272|NCT00783081|Protective Agents|protective agents|mesh-ancestor
6529273|NCT00783081|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6529274|NCT00783081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6529275|NCT00783081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6529276|NCT00783107|Cyclosporine|cyclosporine|mesh-list
6529277|NCT00783107|Cyclosporins|cyclosporins|mesh-list
6529278|NCT00783107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6529279|NCT00783107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529280|NCT00783107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6529281|NCT00783107|Immunologic Factors|immunologic factors|mesh-ancestor
6529282|NCT00783107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529283|NCT00783107|Antifungal Agents|antifungal agents|mesh-ancestor
6529284|NCT00783107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6529285|NCT00783107|Dermatologic Agents|dermatologic agents|mesh-ancestor
6529286|NCT00783107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6529287|NCT00783107|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5992887|NCT00118209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5992888|NCT00118209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5992889|NCT00118209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5992890|NCT00118209|Glucocorticoids|glucocorticoids|mesh-ancestor
5992891|NCT00118209|Hormones|hormones|mesh-ancestor
5992892|NCT00118209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5992893|NCT00118209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5992894|NCT00118209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5992895|NCT00118209|Tubulin Modulators|tubulin modulators|mesh-ancestor
5992896|NCT00118209|Antimitotic Agents|antimitotic agents|mesh-ancestor
5992897|NCT00118209|Mitosis Modulators|mitosis modulators|mesh-ancestor
5992898|NCT00118274|Cyclophosphamide|cyclophosphamide|mesh-list
6258326|NCT03084796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6258327|NCT03084796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258328|NCT03084796|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6258329|NCT03084796|Respiratory System Agents|respiratory system agents|mesh-ancestor
6258330|NCT03084796|Parasympatholytics|parasympatholytics|mesh-ancestor
6258331|NCT03084796|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6258332|NCT03084796|Cholinergic Agents|cholinergic agents|mesh-ancestor
6258333|NCT03084796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6258334|NCT03084796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258335|NCT03084796|Anticonvulsants|anticonvulsants|mesh-ancestor
6258336|NCT03085797|Mometasone Furoate|mometasone furoate|mesh-list
6258337|NCT03085797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6529288|NCT00783172|Gemcitabine|gemcitabine|mesh-list
6529289|NCT00783172|Mitogens|mitogens|mesh-list
6529290|NCT00783172|Enkephalin, Methionine|enkephalin, methionine|mesh-list
6529291|NCT00783172|Enkephalins|enkephalins|mesh-list
6529292|NCT00783172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6529293|NCT00783172|Antimetabolites|antimetabolites|mesh-ancestor
6529294|NCT00783172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529295|NCT00783172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6529296|NCT00783172|Antiviral Agents|antiviral agents|mesh-ancestor
6529297|NCT00783172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6529298|NCT00783172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6529299|NCT00783172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6529300|NCT00783172|Immunologic Factors|immunologic factors|mesh-ancestor
6529301|NCT00783172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529302|NCT00783172|Mitosis Modulators|mitosis modulators|mesh-ancestor
6529303|NCT00783172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6529304|NCT00783250|Albuterol|albuterol|mesh-list
6529305|NCT00783250|Tiotropium Bromide|tiotropium bromide|mesh-list
6529306|NCT00783250|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6529307|NCT00783250|Autonomic Agents|autonomic agents|mesh-ancestor
6529308|NCT00783250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6529309|NCT00783250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529310|NCT00783250|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6529311|NCT00783250|Respiratory System Agents|respiratory system agents|mesh-ancestor
6529312|NCT00783250|Parasympatholytics|parasympatholytics|mesh-ancestor
6529313|NCT00783250|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6529314|NCT00783250|Cholinergic Agents|cholinergic agents|mesh-ancestor
6529315|NCT00783250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6529316|NCT00783250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529317|NCT00783250|Tocolytic Agents|tocolytic agents|mesh-ancestor
6529318|NCT00783250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6529319|NCT00783250|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6529320|NCT00783250|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6529321|NCT00783250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6529322|NCT00783250|Adrenergic Agents|adrenergic agents|mesh-ancestor
6529323|NCT00783380|Vaccines|vaccines|mesh-list
6529324|NCT00783380|Immunologic Factors|immunologic factors|mesh-ancestor
6529325|NCT00783380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529326|NCT00783393|Temozolomide|temozolomide|mesh-list
6529327|NCT00783393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6529328|NCT00783393|Alkylating Agents|alkylating agents|mesh-ancestor
6529329|NCT00783393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529330|NCT00783393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6529331|NCT00783471|Docetaxel|docetaxel|mesh-list
6529332|NCT00783471|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6529333|NCT00783471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6529334|NCT00783471|Tubulin Modulators|tubulin modulators|mesh-ancestor
6529335|NCT00783471|Antimitotic Agents|antimitotic agents|mesh-ancestor
6529336|NCT00783471|Mitosis Modulators|mitosis modulators|mesh-ancestor
6529337|NCT00783471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529338|NCT00783471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6529339|NCT00783471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6529340|NCT00783484|Maraviroc|maraviroc|mesh-list
6529341|NCT00783484|Darunavir|darunavir|mesh-list
6529342|NCT00783484|Midazolam|midazolam|mesh-list
6529343|NCT00783484|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6529344|NCT00783484|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6529345|NCT00783484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6529346|NCT00783484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529347|NCT00783484|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6529348|NCT00783484|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6529349|NCT00783484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6529350|NCT00783484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6529351|NCT00783484|Anesthetics, General|anesthetics, general|mesh-ancestor
6529352|NCT00783484|Anesthetics|anesthetics|mesh-ancestor
6529353|NCT00783484|GABA Modulators|gaba modulators|mesh-ancestor
6529354|NCT00783484|GABA Agents|gaba agents|mesh-ancestor
6529355|NCT00783484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6529356|NCT00783484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529357|NCT00783484|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6529358|NCT00783484|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6793989|NCT02251145|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6793990|NCT02251145|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6793991|NCT02251145|Protease Inhibitors|protease inhibitors|mesh-ancestor
6793992|NCT02251145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6793993|NCT02251145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6793994|NCT02251145|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6793995|NCT02251145|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6793996|NCT02251145|Antiviral Agents|antiviral agents|mesh-ancestor
6793997|NCT02251145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6793998|NCT02251145|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6793999|NCT02251145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6794000|NCT02251145|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6794001|NCT02251145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6794002|NCT02251158|Ritonavir|ritonavir|mesh-list
6794003|NCT02251158|Tipranavir|tipranavir|mesh-list
6794004|NCT02251158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6794005|NCT02251158|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6794006|NCT02251158|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6794007|NCT02251158|Protease Inhibitors|protease inhibitors|mesh-ancestor
6794008|NCT02251158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6794009|NCT02251158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794010|NCT02251158|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6794011|NCT02251158|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6794012|NCT02251158|Antiviral Agents|antiviral agents|mesh-ancestor
6794013|NCT02251158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6794014|NCT02251158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6794015|NCT02251158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6794016|NCT02251171|Ritonavir|ritonavir|mesh-list
6794017|NCT02251171|Tipranavir|tipranavir|mesh-list
6794018|NCT02251171|Rifabutin|rifabutin|mesh-list
6794019|NCT02251171|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6529359|NCT00783484|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6529360|NCT00783484|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6529361|NCT00783484|Antiviral Agents|antiviral agents|mesh-ancestor
6529362|NCT00783484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6529363|NCT00783484|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6529364|NCT00783484|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6529365|NCT00783484|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6529366|NCT00783484|Protease Inhibitors|protease inhibitors|mesh-ancestor
6529367|NCT00783484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6529368|NCT00783510|Adalimumab|adalimumab|mesh-list
6529369|NCT00783510|Methotrexate|methotrexate|mesh-list
6529370|NCT00783510|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6529371|NCT00783510|Abortifacient Agents|abortifacient agents|mesh-ancestor
6529372|NCT00783510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6529373|NCT00783510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529374|NCT00783510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6529375|NCT00783510|Antimetabolites|antimetabolites|mesh-ancestor
6529376|NCT00783510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529377|NCT00783510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6529378|NCT00783510|Dermatologic Agents|dermatologic agents|mesh-ancestor
6529379|NCT00783510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6529380|NCT00783510|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6529381|NCT00783510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6529382|NCT00783510|Immunologic Factors|immunologic factors|mesh-ancestor
6529383|NCT00783510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6529384|NCT00783510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6529385|NCT00783510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6529386|NCT00783523|Doxycycline|doxycycline|mesh-list
6529387|NCT00783523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6529388|NCT00783523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6529389|NCT00783523|Antimalarials|antimalarials|mesh-ancestor
6529390|NCT00783523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6529391|NCT00783523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6529392|NCT00783536|Etanercept|etanercept|mesh-list
6529393|NCT00783536|Methotrexate|methotrexate|mesh-list
6529394|NCT00783536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6529395|NCT00783536|Abortifacient Agents|abortifacient agents|mesh-ancestor
6529396|NCT00783536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6529397|NCT00783536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529398|NCT00783536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6529399|NCT00783536|Antimetabolites|antimetabolites|mesh-ancestor
6529400|NCT00783536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529401|NCT00783536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6529402|NCT00783536|Dermatologic Agents|dermatologic agents|mesh-ancestor
6529403|NCT00783536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6529404|NCT00783536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6529405|NCT00783536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6529406|NCT00783536|Immunologic Factors|immunologic factors|mesh-ancestor
6529407|NCT00783536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6529408|NCT00783536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6529409|NCT00783536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6529410|NCT00783536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6529411|NCT00783536|Analgesics|analgesics|mesh-ancestor
6529412|NCT00783536|Sensory System Agents|sensory system agents|mesh-ancestor
6529413|NCT00783536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6529414|NCT00783536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6529415|NCT00783536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6529416|NCT00783601|Montelukast|montelukast|mesh-list
6529417|NCT00783601|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6529418|NCT00783601|Respiratory System Agents|respiratory system agents|mesh-ancestor
6529419|NCT00783601|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6529420|NCT00783601|Hormone Antagonists|hormone antagonists|mesh-ancestor
6529421|NCT00783601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6529422|NCT00783601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529423|NCT00783601|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6529424|NCT00783601|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6529425|NCT00783601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529426|NCT00783653|Sunitinib|sunitinib|mesh-list
6529427|NCT00783653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6529428|NCT00783653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6529429|NCT00783653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6529430|NCT00783653|Growth Substances|growth substances|mesh-ancestor
6529431|NCT00783653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529432|NCT00783653|Growth Inhibitors|growth inhibitors|mesh-ancestor
6258338|NCT03085797|Dermatologic Agents|dermatologic agents|mesh-ancestor
6258339|NCT03085797|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6258340|NCT03085914|Leucovorin|leucovorin|mesh-list
6258341|NCT03085914|Gemcitabine|gemcitabine|mesh-list
6258342|NCT03085914|Paclitaxel|paclitaxel|mesh-list
6258343|NCT03085914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6258344|NCT03085914|Cyclophosphamide|cyclophosphamide|mesh-list
6258345|NCT03085914|Carboplatin|carboplatin|mesh-list
6258346|NCT03085914|Fluorouracil|fluorouracil|mesh-list
6258347|NCT03085914|Pembrolizumab|pembrolizumab|mesh-list
6529433|NCT00783653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6529434|NCT00783653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6529435|NCT00783653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529436|NCT00783731|Midazolam|midazolam|mesh-list
6529437|NCT00783731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6529438|NCT00783731|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6529439|NCT00783731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6529440|NCT00783731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529441|NCT00783731|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6529442|NCT00783731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6529443|NCT00783731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6529444|NCT00783731|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6529445|NCT00783731|Anesthetics, General|anesthetics, general|mesh-ancestor
6529446|NCT00783731|Anesthetics|anesthetics|mesh-ancestor
6529447|NCT00783731|GABA Modulators|gaba modulators|mesh-ancestor
6529448|NCT00783731|GABA Agents|gaba agents|mesh-ancestor
6529449|NCT00783731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6529450|NCT00783731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529451|NCT00783744|Insulin|insulin|mesh-list
6529452|NCT00783744|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6529453|NCT00783744|Metformin|metformin|mesh-list
6529454|NCT00783744|Insulin Glargine|insulin glargine|mesh-list
6529455|NCT00783744|Glimepiride|glimepiride|mesh-list
6529456|NCT00783744|Isophane Insulin, Human|isophane insulin, human|mesh-list
6529457|NCT00783744|Insulin, Isophane|insulin, isophane|mesh-list
6529458|NCT00783744|Isophane insulin, beef|isophane insulin, beef|mesh-list
6529459|NCT00783744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6529460|NCT00783744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529461|NCT00783744|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6529462|NCT00783744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6529463|NCT00783744|Immunologic Factors|immunologic factors|mesh-ancestor
6529464|NCT00783900|Metoprolol|metoprolol|mesh-list
6529465|NCT00783900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6529466|NCT00783900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6529467|NCT00783900|Sympatholytics|sympatholytics|mesh-ancestor
6529468|NCT00783900|Autonomic Agents|autonomic agents|mesh-ancestor
6529469|NCT00783900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6529470|NCT00783900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529471|NCT00783900|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6529472|NCT00783900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6529473|NCT00783900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6529474|NCT00783900|Adrenergic Agents|adrenergic agents|mesh-ancestor
6529475|NCT00783900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6529476|NCT00783900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529477|NCT00783926|Vaccines|vaccines|mesh-list
6529478|NCT00783926|Hemagglutinins|hemagglutinins|mesh-list
6529479|NCT00783926|Immunologic Factors|immunologic factors|mesh-ancestor
6529480|NCT00783926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529481|NCT00783926|Agglutinins|agglutinins|mesh-ancestor
6529482|NCT00784017|Asparaginase|asparaginase|mesh-list
6529483|NCT00784017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6529484|NCT00784082|Hydroxyurea|hydroxyurea|mesh-list
6529485|NCT00784082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6529486|NCT00784082|Antisickling Agents|antisickling agents|mesh-ancestor
6529487|NCT00784082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6529488|NCT00784082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529489|NCT00784082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6529490|NCT00784186|Misoprostol|misoprostol|mesh-list
6529491|NCT00784186|Mifepristone|mifepristone|mesh-list
6529492|NCT00784186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6258348|NCT03085914|Oxaliplatin|oxaliplatin|mesh-list
6258349|NCT03085914|Pemetrexed|pemetrexed|mesh-list
6529493|NCT00784186|Abortifacient Agents|abortifacient agents|mesh-ancestor
6529494|NCT00784186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6529495|NCT00784186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258350|NCT03085914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6258351|NCT03085914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6529496|NCT00784186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6529497|NCT00784186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6529498|NCT00784186|Oxytocics|oxytocics|mesh-ancestor
6529499|NCT00784186|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6529500|NCT00784186|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6529501|NCT00784186|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6529502|NCT00784186|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6529503|NCT00784186|Contraceptive Agents|contraceptive agents|mesh-ancestor
6529504|NCT00784186|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6529505|NCT00784186|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6529506|NCT00784186|Hormone Antagonists|hormone antagonists|mesh-ancestor
6529507|NCT00784186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6529508|NCT00784186|Luteolytic Agents|luteolytic agents|mesh-ancestor
6529509|NCT00784186|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6529510|NCT00784186|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6529511|NCT00784290|Orantinib|orantinib|mesh-list
6529512|NCT00784290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6529513|NCT00784290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6529514|NCT00784290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529515|NCT00784316|Metoprolol|metoprolol|mesh-list
6529516|NCT00784316|Amiodarone|amiodarone|mesh-list
6529517|NCT00784316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6529518|NCT00784316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6529519|NCT00784316|Sympatholytics|sympatholytics|mesh-ancestor
6529520|NCT00784316|Autonomic Agents|autonomic agents|mesh-ancestor
6529521|NCT00784316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6529522|NCT00784316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529523|NCT00784316|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6529524|NCT00784316|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6529525|NCT00784316|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6529526|NCT00784316|Adrenergic Agents|adrenergic agents|mesh-ancestor
6529527|NCT00784316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6529528|NCT00784316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529529|NCT00784316|Vasodilator Agents|vasodilator agents|mesh-ancestor
6529530|NCT00784316|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6529531|NCT00784316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6529532|NCT00784316|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6529533|NCT00784316|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6529534|NCT00784316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6529535|NCT00784316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6529536|NCT00784316|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6529537|NCT00784316|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6529538|NCT00784316|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6537576|NCT00822913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6537577|NCT00823004|Letrozole|letrozole|mesh-list
6537578|NCT00823004|Contraceptive Agents|contraceptive agents|mesh-list
6537579|NCT00823004|Contraceptives, Oral|contraceptives, oral|mesh-list
6537580|NCT00823004|Buserelin|buserelin|mesh-list
6537581|NCT00823004|Ganirelix|ganirelix|mesh-list
6537582|NCT00823004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6537583|NCT00823004|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6537584|NCT00823004|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6537585|NCT00823004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6537586|NCT00823004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537587|NCT00823004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6537588|NCT00823004|Hormone Antagonists|hormone antagonists|mesh-ancestor
6537589|NCT00823004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6537590|NCT00823004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537591|NCT00823004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6537592|NCT00823004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6537593|NCT00823004|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6537594|NCT00823004|Fertility Agents|fertility agents|mesh-ancestor
6537595|NCT00823030|Lidocaine|lidocaine|mesh-list
6537596|NCT00823030|Anesthetics, Local|anesthetics, local|mesh-ancestor
6537597|NCT00823030|Anesthetics|anesthetics|mesh-ancestor
6537598|NCT00823030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6537599|NCT00823030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537600|NCT00823030|Sensory System Agents|sensory system agents|mesh-ancestor
6537601|NCT00823030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6537602|NCT00823030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6537603|NCT00823030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6537604|NCT00823030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5724138|NCT03189186|Pembrolizumab|pembrolizumab|mesh-list
6529539|NCT00784394|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
6529540|NCT00784394|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6529541|NCT00784394|Protective Agents|protective agents|mesh-ancestor
6529542|NCT00784394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529543|NCT00784394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6529544|NCT00784420|Raltegravir Potassium|raltegravir potassium|mesh-list
6529545|NCT00784420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6529546|NCT00784420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6529547|NCT00784420|Antiviral Agents|antiviral agents|mesh-ancestor
6529548|NCT00784420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6529549|NCT00784420|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6529550|NCT00784420|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6529551|NCT00784420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6529552|NCT00784420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529553|NCT00784446|Bevacizumab|bevacizumab|mesh-list
6529554|NCT00784446|Capecitabine|capecitabine|mesh-list
6529555|NCT00784446|Oxaliplatin|oxaliplatin|mesh-list
6529556|NCT00784446|Imatinib Mesylate|imatinib mesylate|mesh-list
6529557|NCT00784446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6529558|NCT00784446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6529559|NCT00784446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6529560|NCT00784446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6529561|NCT00784446|Growth Substances|growth substances|mesh-ancestor
6529562|NCT00784446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529563|NCT00784446|Growth Inhibitors|growth inhibitors|mesh-ancestor
6529564|NCT00784446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6529565|NCT00784446|Antimetabolites|antimetabolites|mesh-ancestor
6529566|NCT00784446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529567|NCT00784446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6529568|NCT00784446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6529569|NCT00784472|Morphine|morphine|mesh-list
6529570|NCT00784472|Oxycodone|oxycodone|mesh-list
6529571|NCT00784472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6529572|NCT00784472|Narcotics|narcotics|mesh-ancestor
6529573|NCT00784472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6529574|NCT00784472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529575|NCT00784472|Analgesics|analgesics|mesh-ancestor
6529576|NCT00784472|Sensory System Agents|sensory system agents|mesh-ancestor
6794020|NCT02251171|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6794021|NCT02251171|Protease Inhibitors|protease inhibitors|mesh-ancestor
6794022|NCT02251171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6794023|NCT02251171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794024|NCT02251171|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6794025|NCT02251171|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6794026|NCT02251171|Antiviral Agents|antiviral agents|mesh-ancestor
6794027|NCT02251171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6794028|NCT02251171|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6794029|NCT02251171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6794030|NCT02251171|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6794031|NCT02251171|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6794032|NCT02251171|Antitubercular Agents|antitubercular agents|mesh-ancestor
6794033|NCT02251184|Aspirin|aspirin|mesh-list
6794034|NCT02251184|Dipyridamole|dipyridamole|mesh-list
6794035|NCT02251184|Lansoprazole|lansoprazole|mesh-list
6794036|NCT02251184|Dexlansoprazole|dexlansoprazole|mesh-list
6794037|NCT02251184|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
6794038|NCT02251184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6794039|NCT02251184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6794040|NCT02251184|Analgesics|analgesics|mesh-ancestor
6794041|NCT02251184|Sensory System Agents|sensory system agents|mesh-ancestor
6794042|NCT02251184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6794043|NCT02251184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6794044|NCT02251184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6794045|NCT02251184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6794046|NCT02251184|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6794047|NCT02251184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6794048|NCT02251184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794049|NCT02251184|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6794050|NCT02251184|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6794051|NCT02251184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6794052|NCT02251184|Antipyretics|antipyretics|mesh-ancestor
6794053|NCT02251184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5992899|NCT00118274|Vaccines|vaccines|mesh-list
6529577|NCT00784472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6794054|NCT02251184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6794055|NCT02251184|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6529578|NCT00784485|Omalizumab|omalizumab|mesh-list
6529579|NCT00784485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6529580|NCT00784485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6529581|NCT00784485|Respiratory System Agents|respiratory system agents|mesh-ancestor
6529582|NCT00784498|Midazolam|midazolam|mesh-list
6529583|NCT00784498|Ketamine|ketamine|mesh-list
6529584|NCT00784498|Propofol|propofol|mesh-list
6529585|NCT00784498|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6529586|NCT00784498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6529587|NCT00784498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529588|NCT00784498|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6529589|NCT00784498|Anesthetics, General|anesthetics, general|mesh-ancestor
6529590|NCT00784498|Anesthetics|anesthetics|mesh-ancestor
6529591|NCT00784498|Analgesics|analgesics|mesh-ancestor
6529592|NCT00784498|Sensory System Agents|sensory system agents|mesh-ancestor
6529593|NCT00784498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6529594|NCT00784498|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6529595|NCT00784498|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6529596|NCT00784498|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6529597|NCT00784498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6529598|NCT00784498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529599|NCT00784498|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6529600|NCT00784498|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6529601|NCT00784498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6529602|NCT00784498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6529603|NCT00784498|GABA Modulators|gaba modulators|mesh-ancestor
6529604|NCT00784498|GABA Agents|gaba agents|mesh-ancestor
6529605|NCT00784511|Vitamin D|vitamin d|mesh-list
6529606|NCT00784511|Ergocalciferols|ergocalciferols|mesh-list
6529607|NCT00784511|Cholecalciferol|cholecalciferol|mesh-list
6529608|NCT00784511|Vitamins|vitamins|mesh-list
6529609|NCT00784511|Micronutrients|micronutrients|mesh-ancestor
6529610|NCT00784511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529611|NCT00784511|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6529612|NCT00784511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6529613|NCT00784589|Rituximab|rituximab|mesh-list
6529614|NCT00784589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6529615|NCT00784589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6529616|NCT00784589|Immunologic Factors|immunologic factors|mesh-ancestor
6529617|NCT00784589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529618|NCT00784589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6529619|NCT00784667|Cetuximab|cetuximab|mesh-list
6529620|NCT00784667|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6529621|NCT00784667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6529622|NCT00784667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6529623|NCT00784667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6529624|NCT00784667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6529625|NCT00784667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529626|NCT00784680|Tamoxifen|tamoxifen|mesh-list
6529627|NCT00784680|Anastrozole|anastrozole|mesh-list
6529628|NCT00784680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6794056|NCT02251184|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6794057|NCT02251184|Vasodilator Agents|vasodilator agents|mesh-ancestor
6794058|NCT02251223|Ritonavir|ritonavir|mesh-list
6794059|NCT02251223|Tipranavir|tipranavir|mesh-list
6794060|NCT02251223|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6794061|NCT02251223|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6794062|NCT02251223|Protease Inhibitors|protease inhibitors|mesh-ancestor
6794063|NCT02251223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6794064|NCT02251223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794065|NCT02251223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6794066|NCT02251223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6794067|NCT02251223|Antiviral Agents|antiviral agents|mesh-ancestor
6794068|NCT02251223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6794069|NCT02251223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6794070|NCT02251223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6794071|NCT02251249|Acetaminophen|acetaminophen|mesh-list
6794072|NCT02251249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6794073|NCT02251249|Analgesics|analgesics|mesh-ancestor
6794074|NCT02251249|Sensory System Agents|sensory system agents|mesh-ancestor
6794075|NCT02251249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6794076|NCT02251249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6794077|NCT02251249|Antipyretics|antipyretics|mesh-ancestor
6794078|NCT02251288|Vaccines|vaccines|mesh-list
6258352|NCT03085914|Tubulin Modulators|tubulin modulators|mesh-ancestor
6529629|NCT00784680|Hormone Antagonists|hormone antagonists|mesh-ancestor
6529630|NCT00784680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6529631|NCT00784680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529632|NCT00784680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6529633|NCT00784680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6529634|NCT00784680|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6529635|NCT00784680|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6529636|NCT00784680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6529637|NCT00784680|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6529638|NCT00784680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6529639|NCT00784680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6529640|NCT00784680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258353|NCT03085914|Antimitotic Agents|antimitotic agents|mesh-ancestor
6258354|NCT03085914|Mitosis Modulators|mitosis modulators|mesh-ancestor
6258355|NCT03085914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258356|NCT03085914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6258357|NCT03085914|Immunologic Factors|immunologic factors|mesh-ancestor
6258358|NCT03085914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258359|NCT03085914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6258360|NCT03085914|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6258361|NCT03085914|Alkylating Agents|alkylating agents|mesh-ancestor
6529641|NCT00784732|Mometasone Furoate|mometasone furoate|mesh-list
6529642|NCT00784732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6529643|NCT00784732|Dermatologic Agents|dermatologic agents|mesh-ancestor
6529644|NCT00784732|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6529645|NCT00784745|Dexamethasone|dexamethasone|mesh-list
6529646|NCT00784745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6529647|NCT00784745|Antiemetics|antiemetics|mesh-ancestor
6529648|NCT00784745|Autonomic Agents|autonomic agents|mesh-ancestor
6529649|NCT00784745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6529650|NCT00784745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529651|NCT00784745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6529652|NCT00784745|Glucocorticoids|glucocorticoids|mesh-ancestor
6529653|NCT00784745|Hormones|hormones|mesh-ancestor
6529654|NCT00784745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6529655|NCT00784745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6529656|NCT00784745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6529657|NCT00784797|Oxytocin|oxytocin|mesh-list
6529658|NCT00784797|Mifepristone|mifepristone|mesh-list
6529659|NCT00784797|Oxytocics|oxytocics|mesh-ancestor
6529660|NCT00784797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6529661|NCT00784797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529662|NCT00784797|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6529663|NCT00784797|Abortifacient Agents|abortifacient agents|mesh-ancestor
6529664|NCT00784797|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6529665|NCT00784797|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6529666|NCT00784797|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6529667|NCT00784797|Contraceptive Agents|contraceptive agents|mesh-ancestor
6529668|NCT00784797|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6529669|NCT00784797|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6529670|NCT00784797|Hormone Antagonists|hormone antagonists|mesh-ancestor
6529671|NCT00784797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6794079|NCT02251288|Immunologic Factors|immunologic factors|mesh-ancestor
6794080|NCT02251288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258362|NCT03085914|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6529672|NCT00784797|Luteolytic Agents|luteolytic agents|mesh-ancestor
6529673|NCT00784797|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6529674|NCT00784797|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6529675|NCT00784823|Bortezomib|bortezomib|mesh-list
6529676|NCT00784823|Melphalan|melphalan|mesh-list
6529677|NCT00784823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6529678|NCT00784823|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6529679|NCT00784823|Alkylating Agents|alkylating agents|mesh-ancestor
6529680|NCT00784823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529681|NCT00784823|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6529682|NCT00784823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6529683|NCT00784823|Immunologic Factors|immunologic factors|mesh-ancestor
6529684|NCT00784823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529685|NCT00784862|Tamoxifen|tamoxifen|mesh-list
6529686|NCT00784862|Anastrozole|anastrozole|mesh-list
6529687|NCT00784862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6529688|NCT00784862|Hormone Antagonists|hormone antagonists|mesh-ancestor
6529689|NCT00784862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6529690|NCT00784862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529691|NCT00784862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6529692|NCT00784862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6529693|NCT00784862|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6529694|NCT00784862|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6529695|NCT00784862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6529696|NCT00784862|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6529697|NCT00784862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6529698|NCT00784862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6529699|NCT00784862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529700|NCT00784888|Aromatase Inhibitors|aromatase inhibitors|mesh-list
6529701|NCT00784888|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6529702|NCT00784888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6529703|NCT00784888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529704|NCT00784888|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6529705|NCT00784888|Hormone Antagonists|hormone antagonists|mesh-ancestor
6529706|NCT00784888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6529707|NCT00784888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529708|NCT00784914|Sirolimus|sirolimus|mesh-list
6529709|NCT00784914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6529710|NCT00784914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6529711|NCT00784914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6529712|NCT00784914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6529713|NCT00784914|Antifungal Agents|antifungal agents|mesh-ancestor
6529714|NCT00784914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6529715|NCT00784914|Immunologic Factors|immunologic factors|mesh-ancestor
6529716|NCT00784914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529717|NCT00784940|Tamoxifen|tamoxifen|mesh-list
6529718|NCT00784940|Anastrozole|anastrozole|mesh-list
6529719|NCT00784940|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6529720|NCT00784940|Hormone Antagonists|hormone antagonists|mesh-ancestor
6529721|NCT00784940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6529722|NCT00784940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529723|NCT00784940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6529724|NCT00784940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6529725|NCT00784940|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6529726|NCT00784940|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6529727|NCT00784940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6529728|NCT00784940|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6529729|NCT00784940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6529730|NCT00784940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6529731|NCT00784940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529732|NCT00784966|Etanercept|etanercept|mesh-list
6529733|NCT00784966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6529734|NCT00784966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6529735|NCT00784966|Analgesics|analgesics|mesh-ancestor
6529736|NCT00784966|Sensory System Agents|sensory system agents|mesh-ancestor
6529737|NCT00784966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6529738|NCT00784966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529739|NCT00784966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6529740|NCT00784966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6529741|NCT00784966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6529742|NCT00784966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6529743|NCT00784966|Immunologic Factors|immunologic factors|mesh-ancestor
6529744|NCT00785018|Complement C1s|complement c1s|mesh-list
6529745|NCT00785018|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
6529746|NCT00785018|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
6529747|NCT00785018|Immunologic Factors|immunologic factors|mesh-ancestor
6529748|NCT00785018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529749|NCT00785018|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6529750|NCT00785018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6529751|NCT00785083|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6529752|NCT00785083|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6529753|NCT00785083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529754|NCT00785083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6529755|NCT00785083|Immunologic Factors|immunologic factors|mesh-ancestor
6529756|NCT00785083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529757|NCT00785109|Vitamin K|vitamin k|mesh-list
6529758|NCT00785109|Vitamins|vitamins|mesh-ancestor
6529759|NCT00785109|Micronutrients|micronutrients|mesh-ancestor
6529760|NCT00785109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529761|NCT00785109|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6529762|NCT00785109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6529763|NCT00785109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529764|NCT00785109|Hemostatics|hemostatics|mesh-ancestor
6529765|NCT00785109|Coagulants|coagulants|mesh-ancestor
6794081|NCT02251431|Exenatide|exenatide|mesh-list
6794082|NCT02251431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6794083|NCT02251431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6794084|NCT02251431|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6794085|NCT02251431|Incretins|incretins|mesh-ancestor
6794086|NCT02251431|Hormones|hormones|mesh-ancestor
6794087|NCT02251431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6794088|NCT02251457|Ranolazine|ranolazine|mesh-list
6794089|NCT02251457|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6794090|NCT02251457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6794091|NCT02251457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794092|NCT02251483|Immunoglobulins|immunoglobulins|mesh-list
6794093|NCT02251483|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6794094|NCT02251483|Antibodies|antibodies|mesh-list
6794095|NCT02251483|Immunologic Factors|immunologic factors|mesh-ancestor
6794096|NCT02251483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6794097|NCT02251509|Metoprolol|metoprolol|mesh-list
6794098|NCT02251509|Carvedilol|carvedilol|mesh-list
6794099|NCT02251509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6794100|NCT02251509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6794101|NCT02251509|Sympatholytics|sympatholytics|mesh-ancestor
6794102|NCT02251509|Autonomic Agents|autonomic agents|mesh-ancestor
6794103|NCT02251509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6794104|NCT02251509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6794105|NCT02251509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6794106|NCT02251509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6794107|NCT02251509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6794108|NCT02251509|Adrenergic Agents|adrenergic agents|mesh-ancestor
6794109|NCT02251509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6794110|NCT02251509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794111|NCT02251509|Antioxidants|antioxidants|mesh-ancestor
6794112|NCT02251509|Protective Agents|protective agents|mesh-ancestor
6794113|NCT02251509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6794114|NCT02251509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6794115|NCT02251509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6794116|NCT02251509|Vasodilator Agents|vasodilator agents|mesh-ancestor
6794117|NCT02251509|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6794118|NCT02251509|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6794119|NCT02251600|Deflazacort|deflazacort|mesh-list
6794120|NCT02251600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6794121|NCT02251600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6794122|NCT02251600|Immunologic Factors|immunologic factors|mesh-ancestor
6794123|NCT02251600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6794124|NCT02251626|Ubiquinone|ubiquinone|mesh-list
6794125|NCT02251626|Coenzyme Q10|coenzyme q10|mesh-list
6794126|NCT02251626|Micronutrients|micronutrients|mesh-ancestor
6794127|NCT02251626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6794128|NCT02251626|Vitamins|vitamins|mesh-ancestor
6794129|NCT02251691|Tacrolimus|tacrolimus|mesh-list
6794130|NCT02251691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6794131|NCT02251691|Immunologic Factors|immunologic factors|mesh-ancestor
6794132|NCT02251691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529766|NCT00785122|Cyclophosphamide|cyclophosphamide|mesh-list
6529767|NCT00785122|Molgramostim|molgramostim|mesh-list
6529768|NCT00785122|Imiquimod|imiquimod|mesh-list
6529769|NCT00785122|Sargramostim|sargramostim|mesh-list
6529770|NCT00785122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6529771|NCT00785122|Immunologic Factors|immunologic factors|mesh-ancestor
6529772|NCT00785122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529773|NCT00785122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6529774|NCT00785122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6529775|NCT00785122|Alkylating Agents|alkylating agents|mesh-ancestor
6529776|NCT00785122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529777|NCT00785122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6529778|NCT00785122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6529779|NCT00785122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6529780|NCT00785122|Interferon Inducers|interferon inducers|mesh-ancestor
6529781|NCT00785200|Chlorhexidine|chlorhexidine|mesh-list
6529782|NCT00785200|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6529783|NCT00785200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6529784|NCT00785200|Disinfectants|disinfectants|mesh-ancestor
6529785|NCT00785330|Rituximab|rituximab|mesh-list
6529786|NCT00785330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6529787|NCT00785330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6529788|NCT00785330|Immunologic Factors|immunologic factors|mesh-ancestor
6529789|NCT00785330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529790|NCT00785330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6529791|NCT00785382|Pregabalin|pregabalin|mesh-list
6529792|NCT00785382|Analgesics|analgesics|mesh-ancestor
6529793|NCT00785382|Sensory System Agents|sensory system agents|mesh-ancestor
6529794|NCT00785382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6529795|NCT00785382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529796|NCT00785382|Anticonvulsants|anticonvulsants|mesh-ancestor
6529797|NCT00785382|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6529798|NCT00785382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6529799|NCT00785382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529800|NCT00785382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6529801|NCT00785382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6529802|NCT00785382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6529803|NCT00785382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6529804|NCT00785382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6529805|NCT00785395|Oxytocin|oxytocin|mesh-list
6529806|NCT00785395|Oxytocics|oxytocics|mesh-ancestor
6529807|NCT00785395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6529808|NCT00785395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529809|NCT00785421|Leucovorin|leucovorin|mesh-list
6529810|NCT00785421|Folic Acid|folic acid|mesh-list
6529811|NCT00785421|Gemcitabine|gemcitabine|mesh-list
6529812|NCT00785421|Cisplatin|cisplatin|mesh-list
6529813|NCT00785421|Enoxaparin|enoxaparin|mesh-list
6529814|NCT00785421|Enoxaparin sodium|enoxaparin sodium|mesh-list
6529815|NCT00785421|Levoleucovorin|levoleucovorin|mesh-list
6529816|NCT00785421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6529817|NCT00785421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6529818|NCT00785421|Antimetabolites|antimetabolites|mesh-ancestor
6529819|NCT00785421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529820|NCT00785421|Antiviral Agents|antiviral agents|mesh-ancestor
6529821|NCT00785421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6529822|NCT00785421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6529823|NCT00785421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6529824|NCT00785421|Immunologic Factors|immunologic factors|mesh-ancestor
6529825|NCT00785421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529826|NCT00785421|Antidotes|antidotes|mesh-ancestor
6529827|NCT00785421|Protective Agents|protective agents|mesh-ancestor
6529828|NCT00785421|Vitamin B Complex|vitamin b complex|mesh-ancestor
6529829|NCT00785421|Vitamins|vitamins|mesh-ancestor
6529830|NCT00785421|Micronutrients|micronutrients|mesh-ancestor
6794133|NCT02251691|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6794134|NCT02251691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6794135|NCT02251691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794136|NCT02251769|Ritonavir|ritonavir|mesh-list
6794137|NCT02251769|Tipranavir|tipranavir|mesh-list
6794138|NCT02251769|Clarithromycin|clarithromycin|mesh-list
6794139|NCT02251769|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6794140|NCT02251769|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6794141|NCT02251769|Protease Inhibitors|protease inhibitors|mesh-ancestor
6794142|NCT02251769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6258363|NCT03085914|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6529831|NCT00785421|Hematinics|hematinics|mesh-ancestor
6529832|NCT00785421|Anticoagulants|anticoagulants|mesh-ancestor
6529833|NCT00785421|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6529834|NCT00785421|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6529835|NCT00785434|Citalopram|citalopram|mesh-list
6529836|NCT00785434|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6529837|NCT00785434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6529838|NCT00785434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6529839|NCT00785434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529840|NCT00785434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6529841|NCT00785434|Serotonin Agents|serotonin agents|mesh-ancestor
6529842|NCT00785434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529843|NCT00785434|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6529844|NCT00785434|Antidepressive Agents|antidepressive agents|mesh-ancestor
6529845|NCT00785434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6529846|NCT00785460|Benphothiamine|benphothiamine|mesh-list
6529847|NCT00785460|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6529848|NCT00785460|Immunologic Factors|immunologic factors|mesh-ancestor
6529849|NCT00785460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529850|NCT00785460|Chelating Agents|chelating agents|mesh-ancestor
6529851|NCT00785460|Sequestering Agents|sequestering agents|mesh-ancestor
6529852|NCT00785460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529853|NCT00785473|Cholecalciferol|cholecalciferol|mesh-list
6529854|NCT00785473|Calcium Carbonate|calcium carbonate|mesh-list
6529855|NCT00785473|Calcium|calcium|mesh-list
6529856|NCT00785473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6529857|NCT00785473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529858|NCT00785473|Vitamins|vitamins|mesh-ancestor
6529859|NCT00785473|Micronutrients|micronutrients|mesh-ancestor
6529860|NCT00785473|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6529861|NCT00785473|Antacids|antacids|mesh-ancestor
6529862|NCT00785473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529863|NCT00785473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6529864|NCT00785525|Lenograstim|lenograstim|mesh-list
6529865|NCT00785525|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6529866|NCT00785525|Immunologic Factors|immunologic factors|mesh-ancestor
6529867|NCT00785525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992900|NCT00118274|Freund's Adjuvant|freund's adjuvant|mesh-list
5992901|NCT00118274|Immunologic Factors|immunologic factors|mesh-ancestor
5992902|NCT00118274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992903|NCT00118274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5992904|NCT00118274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5992905|NCT00118274|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5992906|NCT00118274|Alkylating Agents|alkylating agents|mesh-ancestor
5992907|NCT00118274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992908|NCT00118274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992909|NCT00118274|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5992910|NCT00118274|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5992911|NCT00118287|Etanercept|etanercept|mesh-list
5992912|NCT00118287|Azacitidine|azacitidine|mesh-list
5992913|NCT00118287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5992914|NCT00118287|Antimetabolites|antimetabolites|mesh-ancestor
5992915|NCT00118287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992916|NCT00118287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992917|NCT00118287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5992918|NCT00118287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5992919|NCT00118287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5992920|NCT00118287|Analgesics|analgesics|mesh-ancestor
6529868|NCT00785551|Quinine|quinine|mesh-list
6529869|NCT00785551|Antimalarials|antimalarials|mesh-ancestor
6529870|NCT00785551|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6529871|NCT00785551|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6529872|NCT00785551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6529873|NCT00785551|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6529874|NCT00785551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529875|NCT00785551|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6529876|NCT00785551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6529877|NCT00785551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6529878|NCT00785551|Analgesics|analgesics|mesh-ancestor
6529879|NCT00785551|Sensory System Agents|sensory system agents|mesh-ancestor
6529880|NCT00785603|Tramadol|tramadol|mesh-list
6529881|NCT00785603|Paroxetine|paroxetine|mesh-list
6529882|NCT00785603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6529883|NCT00785603|Narcotics|narcotics|mesh-ancestor
6794143|NCT02251769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794144|NCT02251769|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6529884|NCT00785603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5992921|NCT00118287|Sensory System Agents|sensory system agents|mesh-ancestor
6529885|NCT00785603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529886|NCT00785603|Analgesics|analgesics|mesh-ancestor
6529887|NCT00785603|Sensory System Agents|sensory system agents|mesh-ancestor
6529888|NCT00785603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6529889|NCT00785603|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6529890|NCT00785603|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6529891|NCT00785603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6529892|NCT00785603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529893|NCT00785603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6529894|NCT00785603|Serotonin Agents|serotonin agents|mesh-ancestor
6529895|NCT00785603|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6529896|NCT00785603|Antidepressive Agents|antidepressive agents|mesh-ancestor
6529897|NCT00785603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6529898|NCT00785603|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6529899|NCT00785603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6529900|NCT00785603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6529901|NCT00785811|N-Methylaspartate|n-methylaspartate|mesh-list
6529902|NCT00785811|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
6529903|NCT00785811|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6529904|NCT00785811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6529905|NCT00785811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529906|NCT00785811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529907|NCT00785863|Ketorolac|ketorolac|mesh-list
6529908|NCT00785863|Parecoxib|parecoxib|mesh-list
6529909|NCT00785863|Remifentanil|remifentanil|mesh-list
6529910|NCT00785863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6529911|NCT00785863|Narcotics|narcotics|mesh-ancestor
6529912|NCT00785863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6529913|NCT00785863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529914|NCT00785863|Analgesics|analgesics|mesh-ancestor
6529915|NCT00785863|Sensory System Agents|sensory system agents|mesh-ancestor
6529916|NCT00785863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6529917|NCT00785863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6529918|NCT00785863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6529919|NCT00785863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6529920|NCT00785863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6529921|NCT00785863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6529922|NCT00785863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6529923|NCT00785863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529924|NCT00785863|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6529925|NCT00785941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6529926|NCT00785941|Immunologic Factors|immunologic factors|mesh-ancestor
6529927|NCT00785941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529928|NCT00785967|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6529929|NCT00785967|Immunologic Factors|immunologic factors|mesh-ancestor
6529930|NCT00785967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529931|NCT00786058|Fluorouracil|fluorouracil|mesh-list
6529932|NCT00786058|Antimetabolites|antimetabolites|mesh-ancestor
6529933|NCT00786058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529934|NCT00786058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6529935|NCT00786058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6529936|NCT00786058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6529937|NCT00786058|Immunologic Factors|immunologic factors|mesh-ancestor
6529938|NCT00786058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529939|NCT00786110|Paclitaxel|paclitaxel|mesh-list
6529940|NCT00786110|Sorafenib|sorafenib|mesh-list
6529941|NCT00786110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6529942|NCT00786110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6529943|NCT00786110|Tubulin Modulators|tubulin modulators|mesh-ancestor
6529944|NCT00786110|Antimitotic Agents|antimitotic agents|mesh-ancestor
6529945|NCT00786110|Mitosis Modulators|mitosis modulators|mesh-ancestor
6529946|NCT00786110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529947|NCT00786110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6529948|NCT00786110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6529949|NCT00786136|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6529950|NCT00786136|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6529951|NCT00786136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6529952|NCT00786136|Antimetabolites|antimetabolites|mesh-ancestor
6529953|NCT00786136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529954|NCT00786136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6529955|NCT00786136|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6529956|NCT00786136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6529957|NCT00786149|Varenicline|varenicline|mesh-list
6529958|NCT00786149|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6529959|NCT00786149|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6529960|NCT00786149|Cholinergic Agents|cholinergic agents|mesh-ancestor
6529961|NCT00786149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6529962|NCT00786149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529963|NCT00786149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529964|NCT00786240|Fesoterodine|fesoterodine|mesh-list
6529965|NCT00786240|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6529966|NCT00786240|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6529967|NCT00786240|Cholinergic Agents|cholinergic agents|mesh-ancestor
6529968|NCT00786240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6529969|NCT00786240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529970|NCT00786240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529971|NCT00786240|Urological Agents|urological agents|mesh-ancestor
6529972|NCT00786253|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6529973|NCT00786253|Vasodilator Agents|vasodilator agents|mesh-ancestor
6529974|NCT00786253|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6529975|NCT00786253|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6529976|NCT00786253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6529977|NCT00786253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529978|NCT00786253|Urological Agents|urological agents|mesh-ancestor
6529979|NCT00786279|Ethanol|ethanol|mesh-list
6529980|NCT00786279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6529981|NCT00786279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6529982|NCT00786279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6529983|NCT00786279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529984|NCT00786305|Amikacin|amikacin|mesh-list
6529985|NCT00786305|Ceftazidime|ceftazidime|mesh-list
6529986|NCT00786305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6529987|NCT00786305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6529988|NCT00786318|Ziprasidone|ziprasidone|mesh-list
6529989|NCT00786318|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6529990|NCT00786318|Serotonin Agents|serotonin agents|mesh-ancestor
6529991|NCT00786318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6529992|NCT00786318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6529993|NCT00786318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6529994|NCT00786318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6529995|NCT00786318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6529996|NCT00786318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6529997|NCT00786318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6529998|NCT00786318|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6529999|NCT00786318|Dopamine Agents|dopamine agents|mesh-ancestor
6530000|NCT00786331|Carboplatin|carboplatin|mesh-list
6530001|NCT00786331|Pemetrexed|pemetrexed|mesh-list
6530002|NCT00786331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6530003|NCT00786331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6530004|NCT00786331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530005|NCT00786331|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6530006|NCT00786331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6530007|NCT00786370|Dexmedetomidine|dexmedetomidine|mesh-list
6530008|NCT00786370|Propofol|propofol|mesh-list
6530009|NCT00786370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6530010|NCT00786370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6530011|NCT00786370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530012|NCT00786370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6530013|NCT00786370|Anesthetics, General|anesthetics, general|mesh-ancestor
6530014|NCT00786370|Anesthetics|anesthetics|mesh-ancestor
6530015|NCT00786370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6530016|NCT00786370|Analgesics|analgesics|mesh-ancestor
6530017|NCT00786370|Sensory System Agents|sensory system agents|mesh-ancestor
6530018|NCT00786370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6530019|NCT00786370|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6530020|NCT00786370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6530021|NCT00786370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6530022|NCT00786370|Adrenergic Agents|adrenergic agents|mesh-ancestor
6530023|NCT00786370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6530024|NCT00786370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530025|NCT00786383|Ramucirumab|ramucirumab|mesh-list
6530026|NCT00786383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6530027|NCT00786396|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6530028|NCT00786396|Antiviral Agents|antiviral agents|mesh-ancestor
6530029|NCT00786396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6530030|NCT00786448|Darifenacin|darifenacin|mesh-list
6530031|NCT00786448|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6530032|NCT00786448|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6530033|NCT00786448|Cholinergic Agents|cholinergic agents|mesh-ancestor
6530034|NCT00786448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6530035|NCT00786448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530036|NCT00786448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530037|NCT00786448|Urological Agents|urological agents|mesh-ancestor
6530038|NCT00786461|Silver Nitrate|silver nitrate|mesh-list
6530039|NCT00786461|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6530040|NCT00786461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6530041|NCT00786513|Anti-Infective Agents|anti-infective agents|mesh-list
6530042|NCT00786513|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6530043|NCT00786552|Paclitaxel|paclitaxel|mesh-list
6530044|NCT00786552|Pemetrexed|pemetrexed|mesh-list
6530045|NCT00786552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6530046|NCT00786552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6530047|NCT00786552|Tubulin Modulators|tubulin modulators|mesh-ancestor
6530048|NCT00786552|Antimitotic Agents|antimitotic agents|mesh-ancestor
6530049|NCT00786552|Mitosis Modulators|mitosis modulators|mesh-ancestor
6530050|NCT00786552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530051|NCT00786552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6530052|NCT00786552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6530053|NCT00786552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6530054|NCT00786669|Cefixime|cefixime|mesh-list
6530055|NCT00786669|Cefpodoxime|cefpodoxime|mesh-list
6530056|NCT00786669|Bevacizumab|bevacizumab|mesh-list
6530057|NCT00786669|Irinotecan|irinotecan|mesh-list
6530058|NCT00786669|Vincristine|vincristine|mesh-list
6530059|NCT00786669|Temozolomide|temozolomide|mesh-list
6530060|NCT00786669|Camptothecin|camptothecin|mesh-list
6530061|NCT00786669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6530062|NCT00786669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6530063|NCT00786669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6530064|NCT00786669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6530065|NCT00786669|Growth Substances|growth substances|mesh-ancestor
6530066|NCT00786669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530067|NCT00786669|Growth Inhibitors|growth inhibitors|mesh-ancestor
6530068|NCT00786669|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6530069|NCT00786669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6530070|NCT00786669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6530071|NCT00786669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530072|NCT00786669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6530073|NCT00786669|Tubulin Modulators|tubulin modulators|mesh-ancestor
6530074|NCT00786669|Antimitotic Agents|antimitotic agents|mesh-ancestor
6530075|NCT00786669|Mitosis Modulators|mitosis modulators|mesh-ancestor
6530076|NCT00786669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6530077|NCT00786669|Alkylating Agents|alkylating agents|mesh-ancestor
6530078|NCT00786669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6530079|NCT00786669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6530080|NCT00786695|Esomeprazole|esomeprazole|mesh-list
6530081|NCT00786695|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6530082|NCT00786695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6530083|NCT00786695|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6530084|NCT00786695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6530085|NCT00786695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530086|NCT00786734|Pitavastatin|pitavastatin|mesh-list
6530087|NCT00786734|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6530088|NCT00786734|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6794145|NCT02251769|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6794146|NCT02251769|Antiviral Agents|antiviral agents|mesh-ancestor
6794147|NCT02251769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6794148|NCT02251769|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6794149|NCT02251769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6794150|NCT02251769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6794151|NCT02251769|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6794152|NCT02251795|Aspirin|aspirin|mesh-list
6794153|NCT02251795|Ritonavir|ritonavir|mesh-list
6794154|NCT02251795|Darunavir|darunavir|mesh-list
6794155|NCT02251795|Tipranavir|tipranavir|mesh-list
6794156|NCT02251795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6794157|NCT02251795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6794158|NCT02251795|Analgesics|analgesics|mesh-ancestor
6794159|NCT02251795|Sensory System Agents|sensory system agents|mesh-ancestor
6794160|NCT02251795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6258364|NCT03085914|Antimetabolites|antimetabolites|mesh-ancestor
6530089|NCT00786734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6794161|NCT02251795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530090|NCT00786734|Antimetabolites|antimetabolites|mesh-ancestor
6530091|NCT00786734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530092|NCT00786734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6530093|NCT00786734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6530094|NCT00786851|Lenalidomide|lenalidomide|mesh-list
6530095|NCT00786851|Immunologic Factors|immunologic factors|mesh-ancestor
6530096|NCT00786851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530097|NCT00786851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6530098|NCT00786851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6530099|NCT00786851|Growth Substances|growth substances|mesh-ancestor
6530100|NCT00786851|Growth Inhibitors|growth inhibitors|mesh-ancestor
6530101|NCT00786851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6530102|NCT00787007|Equol|equol|mesh-list
6530103|NCT00787007|Phytoestrogens|phytoestrogens|mesh-ancestor
6530104|NCT00787007|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6530105|NCT00787007|Estrogens|estrogens|mesh-ancestor
6530106|NCT00787007|Hormones|hormones|mesh-ancestor
6530107|NCT00787007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6530108|NCT00787007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530109|NCT00787111|Fluoxetine|fluoxetine|mesh-list
6530110|NCT00787111|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6530111|NCT00787111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6530112|NCT00787111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6530113|NCT00787111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530114|NCT00787111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6530115|NCT00787111|Serotonin Agents|serotonin agents|mesh-ancestor
6530116|NCT00787111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530117|NCT00787111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6530118|NCT00787111|Antidepressive Agents|antidepressive agents|mesh-ancestor
6530119|NCT00787111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6530120|NCT00787111|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6530121|NCT00787111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6530122|NCT00787111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6530123|NCT00787371|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6530124|NCT00787371|Interferon-alpha|interferon-alpha|mesh-list
6530125|NCT00787371|Antiviral Agents|antiviral agents|mesh-ancestor
6530126|NCT00787371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6530127|NCT00787371|Immunologic Factors|immunologic factors|mesh-ancestor
6530128|NCT00787371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530129|NCT00787384|Imatinib Mesylate|imatinib mesylate|mesh-list
6530130|NCT00787384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6530131|NCT00787384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6530132|NCT00787384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6530133|NCT00787384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530134|NCT00787410|Gefitinib|gefitinib|mesh-list
6530135|NCT00787410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6530136|NCT00787410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6530137|NCT00787410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6530138|NCT00787410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530139|NCT00787436|Thalidomide|thalidomide|mesh-list
6530140|NCT00787436|Timolol|timolol|mesh-list
6530141|NCT00787436|Propranolol|propranolol|mesh-list
6530142|NCT00787436|Nadolol|nadolol|mesh-list
6530143|NCT00787436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6530144|NCT00787436|Immunologic Factors|immunologic factors|mesh-ancestor
6530145|NCT00787436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530146|NCT00787436|Leprostatic Agents|leprostatic agents|mesh-ancestor
6530147|NCT00787436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6530148|NCT00787436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6530149|NCT00787436|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6530150|NCT00787436|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6530151|NCT00787436|Growth Substances|growth substances|mesh-ancestor
6530152|NCT00787436|Growth Inhibitors|growth inhibitors|mesh-ancestor
6530153|NCT00787436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6530154|NCT00787436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6530155|NCT00787436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6530156|NCT00787436|Adrenergic Agents|adrenergic agents|mesh-ancestor
6530157|NCT00787436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6530158|NCT00787436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530159|NCT00787436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6530160|NCT00787436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6530161|NCT00787436|Vasodilator Agents|vasodilator agents|mesh-ancestor
6530162|NCT00787436|Sympatholytics|sympatholytics|mesh-ancestor
6530163|NCT00787436|Autonomic Agents|autonomic agents|mesh-ancestor
6258365|NCT03085914|Antiviral Agents|antiviral agents|mesh-ancestor
6530164|NCT00787436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6530165|NCT00787462|Pregabalin|pregabalin|mesh-list
6530166|NCT00787462|Analgesics|analgesics|mesh-ancestor
6530167|NCT00787462|Sensory System Agents|sensory system agents|mesh-ancestor
6530168|NCT00787462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6530169|NCT00787462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530170|NCT00787462|Anticonvulsants|anticonvulsants|mesh-ancestor
6530171|NCT00787462|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6530172|NCT00787462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6530173|NCT00787462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530174|NCT00787462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6530175|NCT00787462|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6530176|NCT00787462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6530177|NCT00787462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6530178|NCT00787462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6530179|NCT00787501|Citalopram|citalopram|mesh-list
6530180|NCT00787501|Fluoxetine|fluoxetine|mesh-list
6530181|NCT00787501|Sertraline|sertraline|mesh-list
6530182|NCT00787501|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6530183|NCT00787501|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6530184|NCT00787501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6530185|NCT00787501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530186|NCT00787501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6530187|NCT00787501|Serotonin Agents|serotonin agents|mesh-ancestor
6530188|NCT00787501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530189|NCT00787501|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6530190|NCT00787501|Antidepressive Agents|antidepressive agents|mesh-ancestor
6530191|NCT00787501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6530192|NCT00787501|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6530193|NCT00787501|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6794162|NCT02251795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6794163|NCT02251795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6794164|NCT02251795|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6794165|NCT02251795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6794166|NCT02251795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794167|NCT02251795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6794168|NCT02251795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6794169|NCT02251795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6794170|NCT02251795|Antipyretics|antipyretics|mesh-ancestor
6794171|NCT02251795|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6794172|NCT02251795|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6794173|NCT02251795|Protease Inhibitors|protease inhibitors|mesh-ancestor
6794174|NCT02251795|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6794175|NCT02251795|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6794176|NCT02251795|Antiviral Agents|antiviral agents|mesh-ancestor
6794177|NCT02251795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6794178|NCT02251795|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6794179|NCT02251795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6794180|NCT02251847|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6794181|NCT02251847|Ezetimibe|ezetimibe|mesh-list
6794182|NCT02251847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6794183|NCT02251847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6794184|NCT02251847|Antimetabolites|antimetabolites|mesh-ancestor
6794185|NCT02251847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794186|NCT02251847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6794187|NCT02251847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6794188|NCT02251847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6794189|NCT02251925|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6794190|NCT02251925|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6794191|NCT02251925|Estradiol|estradiol|mesh-list
6794192|NCT02251925|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6794193|NCT02251925|Estrogens|estrogens|mesh-ancestor
6794194|NCT02251925|Hormones|hormones|mesh-ancestor
6794195|NCT02251925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6794196|NCT02251925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6794197|NCT02251925|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6794198|NCT02251925|Contraceptive Agents|contraceptive agents|mesh-ancestor
6794199|NCT02251925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6794200|NCT02251925|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6794201|NCT02251951|Paclitaxel|paclitaxel|mesh-list
6794202|NCT02251951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6794203|NCT02251951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6794204|NCT02251951|Tubulin Modulators|tubulin modulators|mesh-ancestor
6530194|NCT00787501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6530195|NCT00787553|Cefazolin|cefazolin|mesh-list
6530196|NCT00787553|Tinidazole|tinidazole|mesh-list
6530197|NCT00787553|Imidazole|imidazole|mesh-list
6530198|NCT00787553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6530199|NCT00787553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6530200|NCT00787553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6530201|NCT00787553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530202|NCT00787553|Alkylating Agents|alkylating agents|mesh-ancestor
6530203|NCT00787553|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
6530204|NCT00787553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6530205|NCT00787553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6530206|NCT00787657|Interferons|interferons|mesh-list
6530207|NCT00787657|Interferon-beta|interferon-beta|mesh-list
6530208|NCT00787657|Interferon beta-1b|interferon beta-1b|mesh-list
6530209|NCT00787657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6530210|NCT00787657|Antiviral Agents|antiviral agents|mesh-ancestor
6530211|NCT00787657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6530212|NCT00787657|Immunologic Factors|immunologic factors|mesh-ancestor
6530213|NCT00787657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530214|NCT00787657|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6530215|NCT00787774|Raltegravir Potassium|raltegravir potassium|mesh-list
6530216|NCT00787774|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6530217|NCT00787774|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6530218|NCT00787774|Antiviral Agents|antiviral agents|mesh-ancestor
6794205|NCT02251951|Antimitotic Agents|antimitotic agents|mesh-ancestor
6794206|NCT02251951|Mitosis Modulators|mitosis modulators|mesh-ancestor
6794207|NCT02251951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794208|NCT02251964|Rituximab|rituximab|mesh-list
6794209|NCT02251964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6258366|NCT03085914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6258367|NCT03085914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6258368|NCT03085914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6258369|NCT03085914|Antidotes|antidotes|mesh-ancestor
6258370|NCT03085914|Protective Agents|protective agents|mesh-ancestor
6258371|NCT03085914|Vitamin B Complex|vitamin b complex|mesh-ancestor
6258372|NCT03085914|Vitamins|vitamins|mesh-ancestor
6258373|NCT03085914|Micronutrients|micronutrients|mesh-ancestor
6258374|NCT03085914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6258375|NCT03085914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6258376|NCT03086213|Lidocaine|lidocaine|mesh-list
6258377|NCT03086213|Sufentanil|sufentanil|mesh-list
6258378|NCT03086213|Dexmedetomidine|dexmedetomidine|mesh-list
6794210|NCT02251964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6794211|NCT02251964|Immunologic Factors|immunologic factors|mesh-ancestor
6794212|NCT02251964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6794213|NCT02251964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6794214|NCT02251977|Leucovorin|leucovorin|mesh-list
6794215|NCT02251977|Fluorouracil|fluorouracil|mesh-list
6794216|NCT02251977|Capecitabine|capecitabine|mesh-list
6794217|NCT02251977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6794218|NCT02251977|Antimetabolites|antimetabolites|mesh-ancestor
6794219|NCT02251977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794220|NCT02251977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6794221|NCT02251977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6794222|NCT02251977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6794223|NCT02251977|Immunologic Factors|immunologic factors|mesh-ancestor
6794224|NCT02251977|Antidotes|antidotes|mesh-ancestor
6794225|NCT02251977|Protective Agents|protective agents|mesh-ancestor
6794226|NCT02251977|Vitamin B Complex|vitamin b complex|mesh-ancestor
6794227|NCT02251977|Vitamins|vitamins|mesh-ancestor
6794228|NCT02251977|Micronutrients|micronutrients|mesh-ancestor
6794229|NCT02252107|Decitabine|decitabine|mesh-list
6794230|NCT02252107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6794231|NCT02252107|Antimetabolites|antimetabolites|mesh-ancestor
6794232|NCT02252107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794233|NCT02252107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6794234|NCT02252107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6794235|NCT02252263|Elotuzumab|elotuzumab|mesh-list
6794236|NCT02252263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6794237|NCT02252302|Albuterol|albuterol|mesh-list
6794238|NCT02252302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6794239|NCT02252302|Autonomic Agents|autonomic agents|mesh-ancestor
6794240|NCT02252302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6258379|NCT03086213|Dsuvia|dsuvia|mesh-list
6258380|NCT03086213|Ropivacaine|ropivacaine|mesh-list
6258381|NCT03086213|Propofol|propofol|mesh-list
6530219|NCT00787774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6530220|NCT00787774|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6530221|NCT00787774|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6530222|NCT00787774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6530223|NCT00787774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530224|NCT00787813|Acetylcysteine|acetylcysteine|mesh-list
6530225|NCT00787813|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6530226|NCT00787813|Antiviral Agents|antiviral agents|mesh-ancestor
6530227|NCT00787813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6530228|NCT00787813|Expectorants|expectorants|mesh-ancestor
6530229|NCT00787813|Respiratory System Agents|respiratory system agents|mesh-ancestor
6530230|NCT00787813|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6530231|NCT00787813|Antioxidants|antioxidants|mesh-ancestor
6530232|NCT00787813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530233|NCT00787813|Protective Agents|protective agents|mesh-ancestor
6530234|NCT00787813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530235|NCT00787813|Antidotes|antidotes|mesh-ancestor
6530236|NCT00787826|Vaccines|vaccines|mesh-list
6530237|NCT00787826|Immunologic Factors|immunologic factors|mesh-ancestor
6530238|NCT00787826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530239|NCT00787969|Sirolimus|sirolimus|mesh-list
6794241|NCT02252302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6794242|NCT02252302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6794243|NCT02252302|Respiratory System Agents|respiratory system agents|mesh-ancestor
6794244|NCT02252302|Tocolytic Agents|tocolytic agents|mesh-ancestor
6794245|NCT02252302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6794246|NCT02252302|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6794247|NCT02252302|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6794248|NCT02252302|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6794249|NCT02252302|Adrenergic Agents|adrenergic agents|mesh-ancestor
6794250|NCT02252302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6794251|NCT02252302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794252|NCT02252328|Simvastatin|simvastatin|mesh-list
6794253|NCT02252328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6794254|NCT02252328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6794255|NCT02252328|Antimetabolites|antimetabolites|mesh-ancestor
6794256|NCT02252328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794257|NCT02252328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6794258|NCT02252328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6794259|NCT02252328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6794260|NCT02252341|Acetylcysteine|acetylcysteine|mesh-list
6794261|NCT02252341|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6794262|NCT02252341|Antiviral Agents|antiviral agents|mesh-ancestor
6794263|NCT02252341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6794264|NCT02252341|Expectorants|expectorants|mesh-ancestor
6794265|NCT02252341|Respiratory System Agents|respiratory system agents|mesh-ancestor
6794266|NCT02252341|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6794267|NCT02252341|Antioxidants|antioxidants|mesh-ancestor
6794268|NCT02252341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794269|NCT02252341|Protective Agents|protective agents|mesh-ancestor
6794270|NCT02252341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6794271|NCT02252341|Antidotes|antidotes|mesh-ancestor
6794272|NCT02252367|Tadalafil|tadalafil|mesh-list
6794273|NCT02252367|Vasodilator Agents|vasodilator agents|mesh-ancestor
6794274|NCT02252367|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6794275|NCT02252367|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6794276|NCT02252367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6794277|NCT02252367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794278|NCT02252367|Urological Agents|urological agents|mesh-ancestor
6794279|NCT02252419|Acetaminophen|acetaminophen|mesh-list
6794280|NCT02252419|Dexamethasone|dexamethasone|mesh-list
6794281|NCT02252419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6794282|NCT02252419|Antiemetics|antiemetics|mesh-ancestor
6794283|NCT02252419|Autonomic Agents|autonomic agents|mesh-ancestor
6794284|NCT02252419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6794285|NCT02252419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6794286|NCT02252419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6794287|NCT02252419|Glucocorticoids|glucocorticoids|mesh-ancestor
6794288|NCT02252419|Hormones|hormones|mesh-ancestor
6794289|NCT02252419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6794290|NCT02252419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6794291|NCT02252419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6794292|NCT02252419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6794293|NCT02252419|Analgesics|analgesics|mesh-ancestor
6794294|NCT02252419|Sensory System Agents|sensory system agents|mesh-ancestor
6794295|NCT02252419|Antipyretics|antipyretics|mesh-ancestor
6794296|NCT02252458|Fentanyl|fentanyl|mesh-list
6794297|NCT02252458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6530240|NCT00787969|Rituximab|rituximab|mesh-list
6530241|NCT00787969|Cladribine|cladribine|mesh-list
6530242|NCT00787969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6530243|NCT00787969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6530244|NCT00787969|Immunologic Factors|immunologic factors|mesh-ancestor
6530245|NCT00787969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530246|NCT00787969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6530247|NCT00787969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6530248|NCT00787969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6530249|NCT00787969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6530250|NCT00787969|Antifungal Agents|antifungal agents|mesh-ancestor
6530251|NCT00787969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6530252|NCT00788034|Vortioxetine|vortioxetine|mesh-list
6530253|NCT00788034|Antidepressive Agents|antidepressive agents|mesh-ancestor
6530254|NCT00788034|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6530255|NCT00788034|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6530256|NCT00788034|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6530257|NCT00788034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6530258|NCT00788034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530259|NCT00788034|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6530260|NCT00788034|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6530261|NCT00788034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6530262|NCT00788034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530263|NCT00788034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6530264|NCT00788034|Serotonin Agents|serotonin agents|mesh-ancestor
6530265|NCT00788034|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6530266|NCT00788034|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6794298|NCT02252458|Narcotics|narcotics|mesh-ancestor
6794299|NCT02252458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6794300|NCT02252458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6794301|NCT02252458|Analgesics|analgesics|mesh-ancestor
6794302|NCT02252458|Sensory System Agents|sensory system agents|mesh-ancestor
6794303|NCT02252458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6794304|NCT02252458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6794305|NCT02252458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6794306|NCT02252458|Anesthetics, General|anesthetics, general|mesh-ancestor
6794307|NCT02252458|Anesthetics|anesthetics|mesh-ancestor
6794308|NCT02252497|Tranexamic Acid|tranexamic acid|mesh-list
6794309|NCT02252497|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6794310|NCT02252497|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6794311|NCT02252497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794312|NCT02252497|Hemostatics|hemostatics|mesh-ancestor
6794313|NCT02252497|Coagulants|coagulants|mesh-ancestor
6794314|NCT02252523|Dexmedetomidine|dexmedetomidine|mesh-list
6794315|NCT02252523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6794316|NCT02252523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6794317|NCT02252523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6794318|NCT02252523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6794319|NCT02252523|Analgesics|analgesics|mesh-ancestor
6794320|NCT02252523|Sensory System Agents|sensory system agents|mesh-ancestor
6794321|NCT02252523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6794322|NCT02252523|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6794323|NCT02252523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6794324|NCT02252523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6794325|NCT02252523|Adrenergic Agents|adrenergic agents|mesh-ancestor
6794326|NCT02252523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6794327|NCT02252523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794328|NCT02252614|Acetaminophen|acetaminophen|mesh-list
6794329|NCT02252614|Naproxen|naproxen|mesh-list
6794330|NCT02252614|Codeine|codeine|mesh-list
6794331|NCT02252614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6794332|NCT02252614|Analgesics|analgesics|mesh-ancestor
6794333|NCT02252614|Sensory System Agents|sensory system agents|mesh-ancestor
6794334|NCT02252614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6794335|NCT02252614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6794336|NCT02252614|Antipyretics|antipyretics|mesh-ancestor
6794337|NCT02252614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6794338|NCT02252614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6794339|NCT02252614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6794340|NCT02252614|Gout Suppressants|gout suppressants|mesh-ancestor
6794341|NCT02252614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6794342|NCT02252614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6794343|NCT02252614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794344|NCT02252614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6794345|NCT02252614|Narcotics|narcotics|mesh-ancestor
6794346|NCT02252614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6530267|NCT00788034|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6530268|NCT00788034|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6530269|NCT00788047|Dextromethorphan|dextromethorphan|mesh-list
6530270|NCT00788047|Antitussive Agents|antitussive agents|mesh-ancestor
6530271|NCT00788047|Respiratory System Agents|respiratory system agents|mesh-ancestor
6530272|NCT00788047|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6530273|NCT00788047|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6530274|NCT00788047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6530275|NCT00788047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530276|NCT00788047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530277|NCT00788060|Everolimus|everolimus|mesh-list
6530278|NCT00788060|Sunitinib|sunitinib|mesh-list
6530279|NCT00788060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6530280|NCT00788060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6530281|NCT00788060|Immunologic Factors|immunologic factors|mesh-ancestor
6530282|NCT00788060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530283|NCT00788060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6530284|NCT00788060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6530285|NCT00788060|Growth Substances|growth substances|mesh-ancestor
6530286|NCT00788060|Growth Inhibitors|growth inhibitors|mesh-ancestor
6530287|NCT00788060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6530288|NCT00788060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6530289|NCT00788060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530290|NCT00788099|Gemcitabine|gemcitabine|mesh-list
6530291|NCT00788099|Sorafenib|sorafenib|mesh-list
6530292|NCT00788099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6530293|NCT00788099|Antimetabolites|antimetabolites|mesh-ancestor
6530294|NCT00788099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530295|NCT00788099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6530296|NCT00788099|Antiviral Agents|antiviral agents|mesh-ancestor
6530297|NCT00788099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6530298|NCT00788099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6530299|NCT00788099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6530300|NCT00788099|Immunologic Factors|immunologic factors|mesh-ancestor
6530301|NCT00788099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530302|NCT00788099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6530303|NCT00788112|Vorinostat|vorinostat|mesh-list
6530304|NCT00788112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6530305|NCT00788112|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6530306|NCT00788112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6530307|NCT00788112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537605|NCT00823030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6537606|NCT00823030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537607|NCT00823121|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6537608|NCT00823121|Buserelin|buserelin|mesh-list
6537609|NCT00823121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6537610|NCT00823121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537611|NCT00823121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6537612|NCT00823121|Fertility Agents|fertility agents|mesh-ancestor
6537613|NCT00823186|Paclitaxel|paclitaxel|mesh-list
6537614|NCT00823186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6537615|NCT00823186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6537616|NCT00823186|Tubulin Modulators|tubulin modulators|mesh-ancestor
6537617|NCT00823186|Antimitotic Agents|antimitotic agents|mesh-ancestor
6537618|NCT00823186|Mitosis Modulators|mitosis modulators|mesh-ancestor
6537619|NCT00823186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537620|NCT00823238|Tobramycin|tobramycin|mesh-list
6537621|NCT00823238|Ceftazidime|ceftazidime|mesh-list
6537622|NCT00823238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6537623|NCT00823238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6537624|NCT00823290|Sorafenib|sorafenib|mesh-list
6537625|NCT00823290|Panobinostat|panobinostat|mesh-list
6537626|NCT00823290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6537627|NCT00823290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6537628|NCT00823290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6537629|NCT00823290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537630|NCT00823290|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6537631|NCT00823342|Tenofovir|tenofovir|mesh-list
6537632|NCT00823342|Clevudine|clevudine|mesh-list
6537633|NCT00823342|Antiviral Agents|antiviral agents|mesh-ancestor
6537634|NCT00823342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6537635|NCT00823342|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6537636|NCT00823342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6537637|NCT00823342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6794347|NCT02252614|Antitussive Agents|antitussive agents|mesh-ancestor
6530308|NCT00788125|Carboplatin|carboplatin|mesh-list
6530309|NCT00788125|Etoposide|etoposide|mesh-list
6530310|NCT00788125|Ifosfamide|ifosfamide|mesh-list
6530311|NCT00788125|Dasatinib|dasatinib|mesh-list
6530312|NCT00788125|Etoposide phosphate|etoposide phosphate|mesh-list
6530313|NCT00788125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6530314|NCT00788125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6530315|NCT00788125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6794348|NCT02252614|Respiratory System Agents|respiratory system agents|mesh-ancestor
6794349|NCT02252627|Phenylephrine|phenylephrine|mesh-list
6794350|NCT02252627|Oxymetazoline|oxymetazoline|mesh-list
6794351|NCT02252627|Ephedrine|ephedrine|mesh-list
6794352|NCT02252627|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6794353|NCT02252627|Mydriatics|mydriatics|mesh-ancestor
6794354|NCT02252627|Autonomic Agents|autonomic agents|mesh-ancestor
6794355|NCT02252627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6794356|NCT02252627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6794357|NCT02252627|Sympathomimetics|sympathomimetics|mesh-ancestor
6794358|NCT02252627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6794359|NCT02252627|Nasal Decongestants|nasal decongestants|mesh-ancestor
6794360|NCT02252627|Respiratory System Agents|respiratory system agents|mesh-ancestor
6794361|NCT02252627|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6794362|NCT02252627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6794363|NCT02252627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6794364|NCT02252627|Adrenergic Agents|adrenergic agents|mesh-ancestor
6794365|NCT02252627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6794366|NCT02252627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794367|NCT02252627|Protective Agents|protective agents|mesh-ancestor
6794368|NCT02252627|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6794369|NCT02252692|Enalapril|enalapril|mesh-list
6794370|NCT02252692|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6794371|NCT02252692|Protease Inhibitors|protease inhibitors|mesh-ancestor
6794372|NCT02252692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6794373|NCT02252692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794374|NCT02252692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6794375|NCT02252731|Warfarin|warfarin|mesh-list
6794376|NCT02252731|Anticoagulants|anticoagulants|mesh-ancestor
6794377|NCT02252770|Nitric Oxide|nitric oxide|mesh-list
6794378|NCT02252770|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6794379|NCT02252770|Autonomic Agents|autonomic agents|mesh-ancestor
6794380|NCT02252770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6794381|NCT02252770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6794382|NCT02252770|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6794383|NCT02252770|Respiratory System Agents|respiratory system agents|mesh-ancestor
6794384|NCT02252770|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6794385|NCT02252770|Antioxidants|antioxidants|mesh-ancestor
6794386|NCT02252770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794387|NCT02252770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6794388|NCT02252770|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6794389|NCT02252770|Vasodilator Agents|vasodilator agents|mesh-ancestor
6794390|NCT02252770|Gasotransmitters|gasotransmitters|mesh-ancestor
6794391|NCT02252770|Protective Agents|protective agents|mesh-ancestor
6794392|NCT02252796|Paclitaxel|paclitaxel|mesh-list
6794393|NCT02252796|Carboplatin|carboplatin|mesh-list
6794394|NCT02252796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6794395|NCT02252796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6794396|NCT02252796|Tubulin Modulators|tubulin modulators|mesh-ancestor
6794397|NCT02252796|Antimitotic Agents|antimitotic agents|mesh-ancestor
6794398|NCT02252796|Mitosis Modulators|mitosis modulators|mesh-ancestor
6794399|NCT02252796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794400|NCT02252809|Methylprednisolone|methylprednisolone|mesh-list
6794401|NCT02252809|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6794402|NCT02252809|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6794403|NCT02252809|Prednisolone|prednisolone|mesh-list
6794404|NCT02252809|Prednisolone acetate|prednisolone acetate|mesh-list
6794405|NCT02252809|Adalimumab|adalimumab|mesh-list
6794406|NCT02252809|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6794407|NCT02252809|Prednisolone phosphate|prednisolone phosphate|mesh-list
6794408|NCT02252809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6794409|NCT02252809|Antiemetics|antiemetics|mesh-ancestor
6794410|NCT02252809|Autonomic Agents|autonomic agents|mesh-ancestor
6794411|NCT02252809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6794412|NCT02252809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6794413|NCT02252809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6794414|NCT02252809|Glucocorticoids|glucocorticoids|mesh-ancestor
6794415|NCT02252809|Hormones|hormones|mesh-ancestor
6530316|NCT00788125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6530317|NCT00788125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6530318|NCT00788125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530319|NCT00788125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6530320|NCT00788125|Alkylating Agents|alkylating agents|mesh-ancestor
6530321|NCT00788125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6530322|NCT00788138|Vitamin D|vitamin d|mesh-list
6794416|NCT02252809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6794417|NCT02252809|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6794418|NCT02252809|Protective Agents|protective agents|mesh-ancestor
6794419|NCT02252809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6794420|NCT02252809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6794421|NCT02252809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6794422|NCT02252887|Gemcitabine|gemcitabine|mesh-list
6794423|NCT02252887|Trastuzumab|trastuzumab|mesh-list
6794424|NCT02252887|Pertuzumab|pertuzumab|mesh-list
6794425|NCT02252887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6794426|NCT02252887|Antimetabolites|antimetabolites|mesh-ancestor
6794427|NCT02252887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794428|NCT02252887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6794429|NCT02252887|Antiviral Agents|antiviral agents|mesh-ancestor
6794430|NCT02252887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6794431|NCT02252887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6794432|NCT02252887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6794433|NCT02252887|Immunologic Factors|immunologic factors|mesh-ancestor
6794434|NCT02252887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6794435|NCT02252887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6794436|NCT02252913|Docetaxel|docetaxel|mesh-list
6794437|NCT02252913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6794438|NCT02252913|Tubulin Modulators|tubulin modulators|mesh-ancestor
6794439|NCT02252913|Antimitotic Agents|antimitotic agents|mesh-ancestor
6794440|NCT02252913|Mitosis Modulators|mitosis modulators|mesh-ancestor
6794441|NCT02252913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794442|NCT02252926|Acetaminophen|acetaminophen|mesh-list
6794443|NCT02252926|Lidocaine|lidocaine|mesh-list
6794444|NCT02252926|Morphine|morphine|mesh-list
6794445|NCT02252926|Gabapentin|gabapentin|mesh-list
6794446|NCT02252926|Bupivacaine|bupivacaine|mesh-list
6794447|NCT02252926|Anesthetics, Local|anesthetics, local|mesh-ancestor
6794448|NCT02252926|Anesthetics|anesthetics|mesh-ancestor
6794449|NCT02252926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6794450|NCT02252926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6794451|NCT02252926|Sensory System Agents|sensory system agents|mesh-ancestor
6794452|NCT02252926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6794453|NCT02252926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6794454|NCT02252926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6794455|NCT02252926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6794456|NCT02252926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6794457|NCT02252926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794458|NCT02252926|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6794459|NCT02252926|Narcotics|narcotics|mesh-ancestor
6794460|NCT02252926|Analgesics|analgesics|mesh-ancestor
6794461|NCT02252926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6794462|NCT02252926|Antipyretics|antipyretics|mesh-ancestor
6794463|NCT02252926|Anticonvulsants|anticonvulsants|mesh-ancestor
6794464|NCT02252926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6794465|NCT02252926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6794466|NCT02252926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6794467|NCT02252926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6794468|NCT02252926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6794469|NCT02252926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6794470|NCT02252926|Antimanic Agents|antimanic agents|mesh-ancestor
6794471|NCT02252978|Ciprofloxacin|ciprofloxacin|mesh-list
6794472|NCT02252978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6794473|NCT02252978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6794474|NCT02252978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6794475|NCT02252978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6794476|NCT02252978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6794477|NCT02252978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794478|NCT02252978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6794479|NCT02252978|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6794480|NCT02252978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6794481|NCT02253004|Cilostazol|cilostazol|mesh-list
6794482|NCT02253004|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6794483|NCT02253004|Autonomic Agents|autonomic agents|mesh-ancestor
6794484|NCT02253004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6530323|NCT00788138|Cholecalciferol|cholecalciferol|mesh-list
6530324|NCT00788138|Vitamins|vitamins|mesh-ancestor
6530325|NCT00788138|Micronutrients|micronutrients|mesh-ancestor
6530326|NCT00788138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530327|NCT00788138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6530328|NCT00788138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6530329|NCT00788164|Imiquimod|imiquimod|mesh-list
6530330|NCT00788164|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6530331|NCT00788164|Immunologic Factors|immunologic factors|mesh-ancestor
6530332|NCT00788164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530333|NCT00788164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6530334|NCT00788164|Interferon Inducers|interferon inducers|mesh-ancestor
6530335|NCT00788242|Insulin|insulin|mesh-list
6530336|NCT00788242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6530337|NCT00788242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530338|NCT00788294|Tanezumab|tanezumab|mesh-list
6530339|NCT00788294|Analgesics|analgesics|mesh-ancestor
6530340|NCT00788294|Sensory System Agents|sensory system agents|mesh-ancestor
6530341|NCT00788294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6530342|NCT00788294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530343|NCT00788320|Vitamin D|vitamin d|mesh-list
6530344|NCT00788320|Cholecalciferol|cholecalciferol|mesh-list
6530345|NCT00788320|Vitamins|vitamins|mesh-ancestor
6530346|NCT00788320|Micronutrients|micronutrients|mesh-ancestor
6530347|NCT00788320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530348|NCT00788320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6530349|NCT00788320|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6530350|NCT00788333|Trastuzumab|trastuzumab|mesh-list
6530351|NCT00788333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6530352|NCT00788333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6530353|NCT00788398|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6530354|NCT00788424|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
6530355|NCT00788424|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6530356|NCT00788424|Immunologic Factors|immunologic factors|mesh-ancestor
6530357|NCT00788424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530358|NCT00788424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6530359|NCT00788424|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6530360|NCT00788424|Protective Agents|protective agents|mesh-ancestor
6530361|NCT00788424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6530362|NCT00788424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6794485|NCT02253004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6794486|NCT02253004|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6794487|NCT02253004|Respiratory System Agents|respiratory system agents|mesh-ancestor
6794488|NCT02253004|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6794489|NCT02253004|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6794490|NCT02253004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794491|NCT02253004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6794492|NCT02253004|Vasodilator Agents|vasodilator agents|mesh-ancestor
6794493|NCT02253004|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6794494|NCT02253004|Protective Agents|protective agents|mesh-ancestor
6794495|NCT02253004|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6794496|NCT02253004|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6794497|NCT02253004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6794498|NCT02253069|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
6794499|NCT02253069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6794500|NCT02253095|Micronutrients|micronutrients|mesh-list
6794501|NCT02253095|Trace Elements|trace elements|mesh-list
6794502|NCT02253095|Albendazole|albendazole|mesh-list
6794503|NCT02253095|Anthelmintics|anthelmintics|mesh-ancestor
6794504|NCT02253095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6794505|NCT02253095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6794506|NCT02253095|Anticestodal Agents|anticestodal agents|mesh-ancestor
6794507|NCT02253095|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6794508|NCT02253095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6794509|NCT02253095|Tubulin Modulators|tubulin modulators|mesh-ancestor
6794510|NCT02253095|Antimitotic Agents|antimitotic agents|mesh-ancestor
6794511|NCT02253095|Mitosis Modulators|mitosis modulators|mesh-ancestor
6794512|NCT02253095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794513|NCT02253095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6794514|NCT02253095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6794515|NCT02253108|Everolimus|everolimus|mesh-list
6794516|NCT02253108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6794517|NCT02253108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6258382|NCT03086213|Anesthetics, Local|anesthetics, local|mesh-ancestor
6530363|NCT00788424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6794518|NCT02253108|Immunologic Factors|immunologic factors|mesh-ancestor
6530364|NCT00788424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530365|NCT00788424|Antiviral Agents|antiviral agents|mesh-ancestor
6530366|NCT00788424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6530367|NCT00788463|Beclomethasone|beclomethasone|mesh-list
6530368|NCT00788463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6530369|NCT00788463|Glucocorticoids|glucocorticoids|mesh-ancestor
6530370|NCT00788463|Hormones|hormones|mesh-ancestor
6530371|NCT00788463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6530372|NCT00788463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530373|NCT00788463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6530374|NCT00788463|Respiratory System Agents|respiratory system agents|mesh-ancestor
6530375|NCT00788515|Lormetazepam|lormetazepam|mesh-list
6530376|NCT00788515|Volinanserin|volinanserin|mesh-list
6530377|NCT00788515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6530378|NCT00788515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6530379|NCT00788515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530380|NCT00788515|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6530381|NCT00788515|Serotonin Agents|serotonin agents|mesh-ancestor
6530382|NCT00788515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6530383|NCT00788515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530384|NCT00788567|Mycophenolic Acid|mycophenolic acid|mesh-list
6530385|NCT00788567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6530386|NCT00788567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6530387|NCT00788567|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6530388|NCT00788567|Antitubercular Agents|antitubercular agents|mesh-ancestor
6530389|NCT00788567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6530390|NCT00788567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6530391|NCT00788567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6530392|NCT00788567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794519|NCT02253108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6794520|NCT02253121|Insulin|insulin|mesh-list
6794521|NCT02253121|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6794522|NCT02253121|Dapagliflozin|dapagliflozin|mesh-list
6794523|NCT02253121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6794524|NCT02253121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6794525|NCT02253121|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6794526|NCT02253121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530393|NCT00788580|Sirolimus|sirolimus|mesh-list
6530394|NCT00788580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6530395|NCT00788580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6530396|NCT00788580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6530397|NCT00788580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6530398|NCT00788580|Antifungal Agents|antifungal agents|mesh-ancestor
6530399|NCT00788580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6530400|NCT00788580|Immunologic Factors|immunologic factors|mesh-ancestor
6530401|NCT00788580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530402|NCT00788606|Bevacizumab|bevacizumab|mesh-list
6530403|NCT00788606|Rituximab|rituximab|mesh-list
6530404|NCT00788606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6530405|NCT00788606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6530406|NCT00788606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6530407|NCT00788606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6530408|NCT00788606|Growth Substances|growth substances|mesh-ancestor
6530409|NCT00788606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530410|NCT00788606|Growth Inhibitors|growth inhibitors|mesh-ancestor
6530411|NCT00788606|Immunologic Factors|immunologic factors|mesh-ancestor
6530412|NCT00788606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6530413|NCT00788671|Levonorgestrel|levonorgestrel|mesh-list
6530414|NCT00788671|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6530415|NCT00788671|Contraceptive Agents|contraceptive agents|mesh-ancestor
6530416|NCT00788671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6530417|NCT00788671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530418|NCT00788671|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6530419|NCT00788671|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6530420|NCT00788671|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6530421|NCT00788684|Rituximab|rituximab|mesh-list
6530422|NCT00788684|Navitoclax|navitoclax|mesh-list
6530423|NCT00788684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6794527|NCT02253199|Dexmedetomidine|dexmedetomidine|mesh-list
6794528|NCT02253199|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6794529|NCT02253199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6794530|NCT02253199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6794531|NCT02253199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6794532|NCT02253199|Analgesics|analgesics|mesh-ancestor
6794533|NCT02253199|Sensory System Agents|sensory system agents|mesh-ancestor
6794534|NCT02253199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6794535|NCT02253199|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6794536|NCT02253199|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6794537|NCT02253199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6794538|NCT02253199|Adrenergic Agents|adrenergic agents|mesh-ancestor
6794539|NCT02253199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6794540|NCT02253199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794541|NCT02253212|Carboplatin|carboplatin|mesh-list
6794542|NCT02253212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6794543|NCT02253264|Rituximab|rituximab|mesh-list
6794544|NCT02253264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6794545|NCT02253264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6794546|NCT02253264|Immunologic Factors|immunologic factors|mesh-ancestor
6794547|NCT02253264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6794548|NCT02253264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6794549|NCT02253420|Itraconazole|itraconazole|mesh-list
6794550|NCT02253420|Rifampin|rifampin|mesh-list
6794551|NCT02253420|Antifungal Agents|antifungal agents|mesh-ancestor
6794552|NCT02253420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6794553|NCT02253420|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6794554|NCT02253420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6794555|NCT02253420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6794556|NCT02253420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794557|NCT02253420|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6794558|NCT02253420|Hormone Antagonists|hormone antagonists|mesh-ancestor
6794559|NCT02253420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6794560|NCT02253420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6794561|NCT02253420|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6794562|NCT02253420|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6794563|NCT02253420|Antitubercular Agents|antitubercular agents|mesh-ancestor
6794564|NCT02253420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6794565|NCT02253420|Leprostatic Agents|leprostatic agents|mesh-ancestor
6794566|NCT02253420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6794567|NCT02253420|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6794568|NCT02253420|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6530424|NCT00788684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6530425|NCT00788684|Immunologic Factors|immunologic factors|mesh-ancestor
6530426|NCT00788684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530427|NCT00788684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6530428|NCT00788749|Fluticasone|fluticasone|mesh-list
6530429|NCT00788749|Xhance|xhance|mesh-list
6530430|NCT00788749|Prednisolone|prednisolone|mesh-list
6530431|NCT00788749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6530432|NCT00788749|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6530433|NCT00788749|Autonomic Agents|autonomic agents|mesh-ancestor
6530434|NCT00788749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6530435|NCT00788749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530436|NCT00788749|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6530437|NCT00788749|Respiratory System Agents|respiratory system agents|mesh-ancestor
6530438|NCT00788749|Dermatologic Agents|dermatologic agents|mesh-ancestor
6530439|NCT00788749|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6530440|NCT00788749|Glucocorticoids|glucocorticoids|mesh-ancestor
6530441|NCT00788749|Hormones|hormones|mesh-ancestor
6530442|NCT00788749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6530443|NCT00788749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6530444|NCT00788749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6530445|NCT00788840|Isophane Insulin, Human|isophane insulin, human|mesh-list
6530446|NCT00788840|Insulin, Isophane|insulin, isophane|mesh-list
6530447|NCT00788840|Isophane insulin, beef|isophane insulin, beef|mesh-list
6530448|NCT00788840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6530449|NCT00788840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530450|NCT00788918|Interferons|interferons|mesh-list
6530451|NCT00788918|Ribavirin|ribavirin|mesh-list
6530452|NCT00788918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6530453|NCT00788918|Antiviral Agents|antiviral agents|mesh-ancestor
6530454|NCT00788918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6530455|NCT00788918|Antimetabolites|antimetabolites|mesh-ancestor
6530456|NCT00788918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530457|NCT00788931|Paclitaxel|paclitaxel|mesh-list
6794569|NCT02253420|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6794570|NCT02253420|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6794571|NCT02253420|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6794572|NCT02253420|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6794573|NCT02253446|Diclofenac|diclofenac|mesh-list
6794574|NCT02253446|Piroxicam|piroxicam|mesh-list
6794575|NCT02253446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6794576|NCT02253446|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6794577|NCT02253446|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6794578|NCT02253446|Analgesics|analgesics|mesh-ancestor
6794579|NCT02253446|Sensory System Agents|sensory system agents|mesh-ancestor
6794580|NCT02253446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6794581|NCT02253446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6794582|NCT02253446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6794583|NCT02253446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6794584|NCT02253446|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6794585|NCT02253446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6794586|NCT02253446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794587|NCT02253459|Capecitabine|capecitabine|mesh-list
6794588|NCT02253459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6794589|NCT02253459|Antimetabolites|antimetabolites|mesh-ancestor
6794590|NCT02253459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794591|NCT02253459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6794592|NCT02253485|Telbivudine|telbivudine|mesh-list
6794593|NCT02253485|Antiviral Agents|antiviral agents|mesh-ancestor
6794594|NCT02253485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6794595|NCT02253485|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6794596|NCT02253485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6794597|NCT02253485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794598|NCT02253524|Metoclopramide|metoclopramide|mesh-list
6794599|NCT02253524|Dimenhydrinate|dimenhydrinate|mesh-list
6794600|NCT02253524|Antiemetics|antiemetics|mesh-ancestor
6794601|NCT02253524|Autonomic Agents|autonomic agents|mesh-ancestor
6794602|NCT02253524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6794603|NCT02253524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6794604|NCT02253524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6794605|NCT02253524|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6794606|NCT02253524|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6258383|NCT03086213|Anesthetics|anesthetics|mesh-ancestor
6530458|NCT00788931|Trastuzumab|trastuzumab|mesh-list
6530459|NCT00788931|Panobinostat|panobinostat|mesh-list
6794607|NCT02253524|Dopamine Agents|dopamine agents|mesh-ancestor
6794608|NCT02253524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6530460|NCT00788931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6530461|NCT00788931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6530462|NCT00788931|Tubulin Modulators|tubulin modulators|mesh-ancestor
6530463|NCT00788931|Antimitotic Agents|antimitotic agents|mesh-ancestor
6530464|NCT00788931|Mitosis Modulators|mitosis modulators|mesh-ancestor
6530465|NCT00788931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530466|NCT00788931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6530467|NCT00788931|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6530468|NCT00788931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6530469|NCT00789061|Lansoprazole|lansoprazole|mesh-list
6530470|NCT00789061|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
6530471|NCT00789061|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6530472|NCT00789061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6530473|NCT00789061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6530474|NCT00789061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530475|NCT00789165|Quinidine|quinidine|mesh-list
6530476|NCT00789165|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6530477|NCT00789165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6530478|NCT00789165|Adrenergic Agents|adrenergic agents|mesh-ancestor
6530479|NCT00789165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5992922|NCT00118287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5992923|NCT00118287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992924|NCT00118287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5992925|NCT00118287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5992926|NCT00118287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5992927|NCT00118287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5992928|NCT00118287|Immunologic Factors|immunologic factors|mesh-ancestor
5992929|NCT00118352|Cyclosporine|cyclosporine|mesh-list
5992930|NCT00118352|Mycophenolic Acid|mycophenolic acid|mesh-list
5992931|NCT00118352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5992932|NCT00118352|Alemtuzumab|alemtuzumab|mesh-list
5992933|NCT00118352|Fludarabine|fludarabine|mesh-list
5992934|NCT00118352|Fludarabine phosphate|fludarabine phosphate|mesh-list
5992935|NCT00118352|Antibodies|antibodies|mesh-list
5992936|NCT00118352|Immunoglobulins|immunoglobulins|mesh-list
5992937|NCT00118352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5992938|NCT00118352|Cyclosporins|cyclosporins|mesh-list
5992939|NCT00118352|Immunologic Factors|immunologic factors|mesh-ancestor
5992940|NCT00118352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992941|NCT00118352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992942|NCT00118352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5992943|NCT00118352|Antimetabolites|antimetabolites|mesh-ancestor
5992944|NCT00118352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992945|NCT00118352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5992946|NCT00118352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5992947|NCT00118352|Antifungal Agents|antifungal agents|mesh-ancestor
5992948|NCT00118352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5992949|NCT00118352|Dermatologic Agents|dermatologic agents|mesh-ancestor
5992950|NCT00118352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5992951|NCT00118352|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5992952|NCT00118352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5992953|NCT00118352|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5992954|NCT00118352|Antitubercular Agents|antitubercular agents|mesh-ancestor
5992955|NCT00118352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5992956|NCT00118365|Eflornithine|eflornithine|mesh-list
5992957|NCT00118365|Sulindac|sulindac|mesh-list
5992958|NCT00118365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992959|NCT00118365|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5992960|NCT00118365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5992961|NCT00118365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5992962|NCT00118365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5992963|NCT00118365|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
5992964|NCT00118365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5992965|NCT00118365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992966|NCT00118365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5992967|NCT00118365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5992968|NCT00118365|Analgesics|analgesics|mesh-ancestor
5992969|NCT00118365|Sensory System Agents|sensory system agents|mesh-ancestor
5992970|NCT00118365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5992971|NCT00118365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992972|NCT00118365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5992973|NCT00118365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5992974|NCT00118365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5992975|NCT00118378|Modafinil|modafinil|mesh-list
5992976|NCT00118378|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5992977|NCT00118378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992978|NCT00118378|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
5992979|NCT00118378|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5992980|NCT00118378|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5992981|NCT00118378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992982|NCT00118404|Fluoxetine|fluoxetine|mesh-list
5992983|NCT00118404|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5992984|NCT00118404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5992985|NCT00118404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5992986|NCT00118404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992987|NCT00118404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5992988|NCT00118404|Serotonin Agents|serotonin agents|mesh-ancestor
5992989|NCT00118404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992990|NCT00118404|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5992991|NCT00118404|Antidepressive Agents|antidepressive agents|mesh-ancestor
5992992|NCT00118404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5992993|NCT00118404|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5992994|NCT00118404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5992995|NCT00118404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5992996|NCT00118417|Clonazepam|clonazepam|mesh-list
6530480|NCT00789165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530481|NCT00789165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530482|NCT00789165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6530483|NCT00789165|Antimalarials|antimalarials|mesh-ancestor
6530484|NCT00789165|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6530485|NCT00789165|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6530486|NCT00789165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6530487|NCT00789165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6530488|NCT00789165|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6530489|NCT00789165|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6530490|NCT00789165|Cholinergic Agents|cholinergic agents|mesh-ancestor
6530491|NCT00789165|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6530492|NCT00789165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6530493|NCT00789165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6794609|NCT02253524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794610|NCT02253524|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6794611|NCT02253524|Histamine Antagonists|histamine antagonists|mesh-ancestor
6794612|NCT02253524|Histamine Agents|histamine agents|mesh-ancestor
6794613|NCT02253550|Sofosbuvir|sofosbuvir|mesh-list
6794614|NCT02253550|Simeprevir|simeprevir|mesh-list
6794615|NCT02253550|Antiviral Agents|antiviral agents|mesh-ancestor
6794616|NCT02253550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6794617|NCT02253550|Protease Inhibitors|protease inhibitors|mesh-ancestor
6794618|NCT02253550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6794619|NCT02253550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794620|NCT02253602|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
6794621|NCT02253602|Hematinics|hematinics|mesh-ancestor
6794622|NCT02253602|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6794623|NCT02253602|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6794624|NCT02253758|Propofol|propofol|mesh-list
6794625|NCT02253758|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6794626|NCT02253758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6794627|NCT02253758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6794628|NCT02253758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6794629|NCT02253758|Anesthetics, General|anesthetics, general|mesh-ancestor
6794630|NCT02253758|Anesthetics|anesthetics|mesh-ancestor
6794631|NCT02253784|Dexamethasone|dexamethasone|mesh-list
6794632|NCT02253784|Bupivacaine|bupivacaine|mesh-list
6794633|NCT02253784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6794634|NCT02253784|Antiemetics|antiemetics|mesh-ancestor
6794635|NCT02253784|Autonomic Agents|autonomic agents|mesh-ancestor
6794636|NCT02253784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6794637|NCT02253784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6794638|NCT02253784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6794639|NCT02253784|Glucocorticoids|glucocorticoids|mesh-ancestor
6794640|NCT02253784|Hormones|hormones|mesh-ancestor
6794641|NCT02253784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6794642|NCT02253784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6794643|NCT02253784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6794644|NCT02253784|Anesthetics, Local|anesthetics, local|mesh-ancestor
6794645|NCT02253784|Anesthetics|anesthetics|mesh-ancestor
6794646|NCT02253784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6794647|NCT02253784|Sensory System Agents|sensory system agents|mesh-ancestor
6794648|NCT02253797|Ritonavir|ritonavir|mesh-list
6530494|NCT00789165|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6530495|NCT00789165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6530496|NCT00789308|Cyclosporine|cyclosporine|mesh-list
6530497|NCT00789308|Sirolimus|sirolimus|mesh-list
6530498|NCT00789308|Mycophenolic Acid|mycophenolic acid|mesh-list
6530499|NCT00789308|Etanercept|etanercept|mesh-list
6530500|NCT00789308|Heparin|heparin|mesh-list
6530501|NCT00789308|Dextrans|dextrans|mesh-list
6530502|NCT00789308|Tacrolimus|tacrolimus|mesh-list
6530503|NCT00789308|Cyclosporins|cyclosporins|mesh-list
6530504|NCT00789308|Thymoglobulin|thymoglobulin|mesh-list
6530505|NCT00789308|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6530506|NCT00789308|Basiliximab|basiliximab|mesh-list
6530507|NCT00789308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6530508|NCT00789308|Immunologic Factors|immunologic factors|mesh-ancestor
6530509|NCT00789308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530510|NCT00789308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6530511|NCT00789308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6530512|NCT00789308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530513|NCT00789308|Antifungal Agents|antifungal agents|mesh-ancestor
6530514|NCT00789308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6530515|NCT00789308|Dermatologic Agents|dermatologic agents|mesh-ancestor
6530516|NCT00789308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6530517|NCT00789308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6530518|NCT00789308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6530519|NCT00789308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6530520|NCT00789308|Antitubercular Agents|antitubercular agents|mesh-ancestor
6530521|NCT00789308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6530522|NCT00789308|Anticoagulants|anticoagulants|mesh-ancestor
6530523|NCT00789308|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6530524|NCT00789308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6530525|NCT00789308|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6530526|NCT00789308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6530527|NCT00789308|Analgesics|analgesics|mesh-ancestor
6530528|NCT00789308|Sensory System Agents|sensory system agents|mesh-ancestor
6530529|NCT00789308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6530530|NCT00789308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6530531|NCT00789308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6530532|NCT00789308|Plasma Substitutes|plasma substitutes|mesh-ancestor
6530533|NCT00789308|Blood Substitutes|blood substitutes|mesh-ancestor
6530534|NCT00789386|Midazolam|midazolam|mesh-list
6530535|NCT00789386|Remifentanil|remifentanil|mesh-list
6530536|NCT00789386|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6530537|NCT00789386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6530538|NCT00789386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6530539|NCT00789386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530540|NCT00789386|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6530541|NCT00789386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6530542|NCT00789386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6530543|NCT00789386|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6530544|NCT00789386|Anesthetics, General|anesthetics, general|mesh-ancestor
6530545|NCT00789386|Anesthetics|anesthetics|mesh-ancestor
6530546|NCT00789386|GABA Modulators|gaba modulators|mesh-ancestor
6530547|NCT00789386|GABA Agents|gaba agents|mesh-ancestor
6530548|NCT00789386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6530549|NCT00789386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530550|NCT00789386|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6530551|NCT00789386|Narcotics|narcotics|mesh-ancestor
6794649|NCT02253797|Tipranavir|tipranavir|mesh-list
6794650|NCT02253797|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6794651|NCT02253797|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6794652|NCT02253797|Protease Inhibitors|protease inhibitors|mesh-ancestor
6794653|NCT02253797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6794654|NCT02253797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794655|NCT02253797|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6794656|NCT02253797|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6794657|NCT02253797|Antiviral Agents|antiviral agents|mesh-ancestor
6794658|NCT02253797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6794659|NCT02253797|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6794660|NCT02253797|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6794661|NCT02253810|Tranexamic Acid|tranexamic acid|mesh-list
6794662|NCT02253810|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6794663|NCT02253810|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6794664|NCT02253810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794665|NCT02253810|Hemostatics|hemostatics|mesh-ancestor
6794666|NCT02253810|Coagulants|coagulants|mesh-ancestor
6530552|NCT00789386|Analgesics|analgesics|mesh-ancestor
6530553|NCT00789386|Sensory System Agents|sensory system agents|mesh-ancestor
6530554|NCT00789386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6530555|NCT00789399|PENTA|penta|mesh-list
6530556|NCT00789399|Fondaparinux|fondaparinux|mesh-list
6530557|NCT00789399|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6530558|NCT00789399|Antithrombins|antithrombins|mesh-ancestor
6530559|NCT00789399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6530560|NCT00789399|Protease Inhibitors|protease inhibitors|mesh-ancestor
6530561|NCT00789399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6530562|NCT00789399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530563|NCT00789399|Anticoagulants|anticoagulants|mesh-ancestor
6530564|NCT00789399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6530565|NCT00789399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6530566|NCT00789464|Trimethoprim|trimethoprim|mesh-list
6530567|NCT00789464|Sulfamethoxazole|sulfamethoxazole|mesh-list
6530568|NCT00789464|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6530569|NCT00789464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6530570|NCT00789464|Renal Agents|renal agents|mesh-ancestor
6530571|NCT00789464|Antimalarials|antimalarials|mesh-ancestor
6530572|NCT00789464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6530573|NCT00789464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6530574|NCT00789464|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6530575|NCT00789464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6530576|NCT00789464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530577|NCT00789464|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6530578|NCT00789464|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6530579|NCT00789464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6530580|NCT00789503|Vitamin D|vitamin d|mesh-list
6530581|NCT00789503|Cholecalciferol|cholecalciferol|mesh-list
6530582|NCT00789503|Calcium|calcium|mesh-list
6530583|NCT00789503|Vitamins|vitamins|mesh-ancestor
6530584|NCT00789503|Micronutrients|micronutrients|mesh-ancestor
6530585|NCT00789503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530586|NCT00789503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6530587|NCT00789503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6530588|NCT00789568|Moxifloxacin|moxifloxacin|mesh-list
6530589|NCT00789568|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6530590|NCT00789568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6530591|NCT00789568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6530592|NCT00789568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6530593|NCT00789568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6530594|NCT00789568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6530595|NCT00789568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530596|NCT00789568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6530597|NCT00789568|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6530598|NCT00789568|Contraceptive Agents|contraceptive agents|mesh-ancestor
6530599|NCT00789568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6530600|NCT00789568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530601|NCT00789568|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6530602|NCT00789568|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6530603|NCT00789568|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6530604|NCT00789620|Lidocaine|lidocaine|mesh-list
6530605|NCT00789620|Anesthetics, Local|anesthetics, local|mesh-ancestor
6530606|NCT00789620|Anesthetics|anesthetics|mesh-ancestor
6530607|NCT00789620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6530608|NCT00789620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530609|NCT00789620|Sensory System Agents|sensory system agents|mesh-ancestor
6530610|NCT00789620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6530611|NCT00789620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6530612|NCT00789620|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6530613|NCT00789620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6530614|NCT00789620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6530615|NCT00789620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530616|NCT00789646|Lidocaine|lidocaine|mesh-list
6530617|NCT00789646|Anesthetics, Local|anesthetics, local|mesh-ancestor
6530618|NCT00789646|Anesthetics|anesthetics|mesh-ancestor
6530619|NCT00789646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6530620|NCT00789646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530621|NCT00789646|Sensory System Agents|sensory system agents|mesh-ancestor
6530622|NCT00789646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6794667|NCT02253836|Ritonavir|ritonavir|mesh-list
6794668|NCT02253836|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6794669|NCT02253836|Tipranavir|tipranavir|mesh-list
6794670|NCT02253836|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6794671|NCT02253836|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6794672|NCT02253836|Protease Inhibitors|protease inhibitors|mesh-ancestor
6530623|NCT00789646|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6530624|NCT00789646|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6530625|NCT00789646|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6530626|NCT00789646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6530627|NCT00789646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530628|NCT00789711|Insulin|insulin|mesh-list
6530629|NCT00789711|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6530630|NCT00789711|Insulin Aspart|insulin aspart|mesh-list
6530631|NCT00789711|Insulin Detemir|insulin detemir|mesh-list
6530632|NCT00789711|Biphasic Insulins|biphasic insulins|mesh-list
6530633|NCT00789711|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6530634|NCT00789711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6530635|NCT00789711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530636|NCT00789763|Gemcitabine|gemcitabine|mesh-list
6530637|NCT00789763|Sorafenib|sorafenib|mesh-list
6530638|NCT00789763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6530639|NCT00789763|Antimetabolites|antimetabolites|mesh-ancestor
6530640|NCT00789763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530641|NCT00789763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6530642|NCT00789763|Antiviral Agents|antiviral agents|mesh-ancestor
6530643|NCT00789763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6530644|NCT00789763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6530645|NCT00789763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6530646|NCT00789763|Immunologic Factors|immunologic factors|mesh-ancestor
6530647|NCT00789763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530648|NCT00789763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6530649|NCT00789945|Insulin|insulin|mesh-list
6530650|NCT00789945|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6530651|NCT00789945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6530652|NCT00789945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530653|NCT00789971|Triamcinolone|triamcinolone|mesh-list
6530654|NCT00789971|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6530655|NCT00789971|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6530656|NCT00789971|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6530657|NCT00789971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6530658|NCT00789971|Glucocorticoids|glucocorticoids|mesh-ancestor
6530659|NCT00789971|Hormones|hormones|mesh-ancestor
6530660|NCT00789971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6530661|NCT00789971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530662|NCT00789971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6530663|NCT00789971|Immunologic Factors|immunologic factors|mesh-ancestor
6530664|NCT00789971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6530665|NCT00789971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537638|NCT00823342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537639|NCT00823342|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6537640|NCT00823342|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6537641|NCT00823381|Resveratrol|resveratrol|mesh-list
6537642|NCT00823381|Antioxidants|antioxidants|mesh-ancestor
6537643|NCT00823381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537644|NCT00823381|Protective Agents|protective agents|mesh-ancestor
6537645|NCT00823381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537646|NCT00823381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6537647|NCT00823381|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6537648|NCT00823433|Penicillins|penicillins|mesh-list
6537649|NCT00823433|Penicillin V|penicillin v|mesh-list
6537650|NCT00823433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6537651|NCT00823433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6537652|NCT00823550|Lamivudine|lamivudine|mesh-list
6537653|NCT00823550|Entecavir|entecavir|mesh-list
6537654|NCT00823550|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6537655|NCT00823550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6537656|NCT00823550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6537657|NCT00823550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537658|NCT00823550|Antiviral Agents|antiviral agents|mesh-ancestor
6537659|NCT00823550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6537660|NCT00823550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6537661|NCT00823550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6537662|NCT00823563|Adenosine|adenosine|mesh-list
6537663|NCT00823563|Nitroglycerin|nitroglycerin|mesh-list
6537664|NCT00823563|Vasodilator Agents|vasodilator agents|mesh-ancestor
6537665|NCT00823563|Analgesics|analgesics|mesh-ancestor
6537666|NCT00823563|Sensory System Agents|sensory system agents|mesh-ancestor
6537667|NCT00823563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6794673|NCT02253836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6794674|NCT02253836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530666|NCT00790075|Risperidone|risperidone|mesh-list
6530667|NCT00790075|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6530668|NCT00790075|Serotonin Agents|serotonin agents|mesh-ancestor
6530669|NCT00790075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6530670|NCT00790075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530671|NCT00790075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530672|NCT00790075|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6530673|NCT00790075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6530674|NCT00790075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6530675|NCT00790075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6530676|NCT00790075|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6530677|NCT00790075|Dopamine Agents|dopamine agents|mesh-ancestor
6530678|NCT00790101|Risedronic Acid|risedronic acid|mesh-list
6530679|NCT00790101|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
6530680|NCT00790101|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6530681|NCT00790101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6530682|NCT00790101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530683|NCT00790101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6530684|NCT00790101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530685|NCT00790101|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6530686|NCT00790101|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6530687|NCT00790101|Hormone Antagonists|hormone antagonists|mesh-ancestor
6530688|NCT00790101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6794675|NCT02253836|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6794676|NCT02253836|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6794677|NCT02253836|Antiviral Agents|antiviral agents|mesh-ancestor
6794678|NCT02253836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6794679|NCT02253836|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6794680|NCT02253836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6794681|NCT02253849|Ritonavir|ritonavir|mesh-list
6794682|NCT02253849|Tipranavir|tipranavir|mesh-list
6794683|NCT02253849|Carbamazepine|carbamazepine|mesh-list
6794684|NCT02253849|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6794685|NCT02253849|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6794686|NCT02253849|Protease Inhibitors|protease inhibitors|mesh-ancestor
6794687|NCT02253849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6794688|NCT02253849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794689|NCT02253849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6794690|NCT02253849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6794691|NCT02253849|Antiviral Agents|antiviral agents|mesh-ancestor
6794692|NCT02253849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6794693|NCT02253849|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6794694|NCT02253849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6794695|NCT02253849|Anticonvulsants|anticonvulsants|mesh-ancestor
6794696|NCT02253849|Antimanic Agents|antimanic agents|mesh-ancestor
6794697|NCT02253849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6794698|NCT02253849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6794699|NCT02253849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6794700|NCT02253849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6794701|NCT02253849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6794702|NCT02253849|Analgesics|analgesics|mesh-ancestor
6794703|NCT02253849|Sensory System Agents|sensory system agents|mesh-ancestor
6794704|NCT02253849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6794705|NCT02253849|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6794706|NCT02253849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6794707|NCT02253849|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6794708|NCT02253849|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6794709|NCT02253862|Ritonavir|ritonavir|mesh-list
6794710|NCT02253862|Tipranavir|tipranavir|mesh-list
6794711|NCT02253862|Tadalafil|tadalafil|mesh-list
6794712|NCT02253862|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6794713|NCT02253862|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6794714|NCT02253862|Protease Inhibitors|protease inhibitors|mesh-ancestor
6794715|NCT02253862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6794716|NCT02253862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794717|NCT02253862|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6794718|NCT02253862|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6794719|NCT02253862|Antiviral Agents|antiviral agents|mesh-ancestor
6794720|NCT02253862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6794721|NCT02253862|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6794722|NCT02253862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6794723|NCT02253862|Vasodilator Agents|vasodilator agents|mesh-ancestor
6794724|NCT02253862|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6794725|NCT02253862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6530689|NCT00790101|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6530690|NCT00790101|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6530691|NCT00790114|Midazolam|midazolam|mesh-list
6530692|NCT00790114|Caffeine|caffeine|mesh-list
6530693|NCT00790114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6530694|NCT00790114|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6530695|NCT00790114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6530696|NCT00790114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530697|NCT00790114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6530698|NCT00790114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6530699|NCT00790114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6530700|NCT00790114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6530701|NCT00790114|Anesthetics, General|anesthetics, general|mesh-ancestor
6530702|NCT00790114|Anesthetics|anesthetics|mesh-ancestor
6530703|NCT00790114|GABA Modulators|gaba modulators|mesh-ancestor
6530704|NCT00790114|GABA Agents|gaba agents|mesh-ancestor
6530705|NCT00790114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6530706|NCT00790114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530707|NCT00790114|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6530708|NCT00790114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6530709|NCT00790114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6530710|NCT00790114|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6530711|NCT00790114|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6530712|NCT00790114|Purinergic Agents|purinergic agents|mesh-ancestor
6530713|NCT00790153|Insulin|insulin|mesh-list
6530714|NCT00790153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6530715|NCT00790153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530716|NCT00790179|Ropivacaine|ropivacaine|mesh-list
6530717|NCT00790179|Anesthetics, Local|anesthetics, local|mesh-ancestor
6530718|NCT00790179|Anesthetics|anesthetics|mesh-ancestor
6530719|NCT00790179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6530720|NCT00790179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530721|NCT00790179|Sensory System Agents|sensory system agents|mesh-ancestor
6530722|NCT00790179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6530723|NCT00790244|Doxorubicin|doxorubicin|mesh-list
6530724|NCT00790244|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6530725|NCT00790244|Ifosfamide|ifosfamide|mesh-list
6530726|NCT00790244|Isophosphamide mustard|isophosphamide mustard|mesh-list
6794726|NCT02253862|Urological Agents|urological agents|mesh-ancestor
6794727|NCT02253875|Ritonavir|ritonavir|mesh-list
6794728|NCT02253875|Tipranavir|tipranavir|mesh-list
6794729|NCT02253875|Omeprazole|omeprazole|mesh-list
6794730|NCT02253875|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6794731|NCT02253875|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6794732|NCT02253875|Protease Inhibitors|protease inhibitors|mesh-ancestor
6794733|NCT02253875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6794734|NCT02253875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794735|NCT02253875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6794736|NCT02253875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6794737|NCT02253875|Antiviral Agents|antiviral agents|mesh-ancestor
6794738|NCT02253875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6794739|NCT02253875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6794740|NCT02253875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6794741|NCT02253875|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6794742|NCT02253875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6794743|NCT02253875|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6794744|NCT02253888|Ritonavir|ritonavir|mesh-list
6794745|NCT02253888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6794746|NCT02253888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6794747|NCT02253888|Protease Inhibitors|protease inhibitors|mesh-ancestor
6794748|NCT02253888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6794749|NCT02253888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794750|NCT02253888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6794751|NCT02253888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6794752|NCT02253888|Antiviral Agents|antiviral agents|mesh-ancestor
6794753|NCT02253888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6794754|NCT02253888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6794755|NCT02253888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6794756|NCT02253901|Ritonavir|ritonavir|mesh-list
6794757|NCT02253901|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6794758|NCT02253901|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6794759|NCT02253901|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6794760|NCT02253901|Protease Inhibitors|protease inhibitors|mesh-ancestor
6794761|NCT02253901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6530727|NCT00790244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6530728|NCT00790244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6530729|NCT00790244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6530730|NCT00790244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6530731|NCT00790244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6530732|NCT00790244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530733|NCT00790244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6530734|NCT00790244|Alkylating Agents|alkylating agents|mesh-ancestor
6530735|NCT00790387|Heparin|heparin|mesh-list
6530736|NCT00790387|Enoxaparin|enoxaparin|mesh-list
6530737|NCT00790387|Calcium heparin|calcium heparin|mesh-list
6530738|NCT00790387|Tirofiban|tirofiban|mesh-list
6530739|NCT00790387|Anticoagulants|anticoagulants|mesh-ancestor
6530740|NCT00790387|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6530741|NCT00790387|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6530742|NCT00790387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530743|NCT00790387|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6530744|NCT00790413|Rituximab|rituximab|mesh-list
6530745|NCT00790413|Fludarabine|fludarabine|mesh-list
6530746|NCT00790413|Thiotepa|thiotepa|mesh-list
6530747|NCT00790413|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
6530748|NCT00790413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6530749|NCT00790413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6530750|NCT00790413|Immunologic Factors|immunologic factors|mesh-ancestor
6530751|NCT00790413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530752|NCT00790413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6530753|NCT00790413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530754|NCT00790413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6530755|NCT00790413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6530756|NCT00790413|Alkylating Agents|alkylating agents|mesh-ancestor
6530757|NCT00790413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6530758|NCT00790413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6530759|NCT00790413|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6530760|NCT00790439|Cyclosporine|cyclosporine|mesh-list
6530761|NCT00790439|Sirolimus|sirolimus|mesh-list
6530762|NCT00790439|Mycophenolic Acid|mycophenolic acid|mesh-list
6530763|NCT00790439|Heparin|heparin|mesh-list
6530764|NCT00790439|Calcium heparin|calcium heparin|mesh-list
6530765|NCT00790439|Dextrans|dextrans|mesh-list
6530766|NCT00790439|Tacrolimus|tacrolimus|mesh-list
6530767|NCT00790439|Cyclosporins|cyclosporins|mesh-list
6530768|NCT00790439|Basiliximab|basiliximab|mesh-list
6530769|NCT00790439|Daclizumab|daclizumab|mesh-list
6530770|NCT00790439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6530771|NCT00790439|Immunologic Factors|immunologic factors|mesh-ancestor
6530772|NCT00790439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530773|NCT00790439|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6530774|NCT00790439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6530775|NCT00790439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530776|NCT00790439|Antifungal Agents|antifungal agents|mesh-ancestor
6530777|NCT00790439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6530778|NCT00790439|Dermatologic Agents|dermatologic agents|mesh-ancestor
6530779|NCT00790439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6530780|NCT00790439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6530781|NCT00790439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6530782|NCT00790439|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6530783|NCT00790439|Antitubercular Agents|antitubercular agents|mesh-ancestor
6530784|NCT00790439|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6530785|NCT00790439|Anticoagulants|anticoagulants|mesh-ancestor
6530786|NCT00790439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6530787|NCT00790439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6530788|NCT00790439|Plasma Substitutes|plasma substitutes|mesh-ancestor
6530789|NCT00790439|Blood Substitutes|blood substitutes|mesh-ancestor
6530790|NCT00790595|Sunitinib|sunitinib|mesh-list
6530791|NCT00790595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6530792|NCT00790595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6530793|NCT00790595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6530794|NCT00790595|Growth Substances|growth substances|mesh-ancestor
6530795|NCT00790595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530796|NCT00790595|Growth Inhibitors|growth inhibitors|mesh-ancestor
6530797|NCT00790595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6530798|NCT00790595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6530799|NCT00790595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530800|NCT00790608|Nitric Oxide|nitric oxide|mesh-list
6530801|NCT00790608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6530802|NCT00790608|Autonomic Agents|autonomic agents|mesh-ancestor
6530803|NCT00790608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6530804|NCT00790608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530805|NCT00790608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6530806|NCT00790608|Respiratory System Agents|respiratory system agents|mesh-ancestor
6530807|NCT00790608|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6530808|NCT00790608|Antioxidants|antioxidants|mesh-ancestor
6530809|NCT00790608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530810|NCT00790608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6530811|NCT00790608|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6530812|NCT00790608|Vasodilator Agents|vasodilator agents|mesh-ancestor
6530813|NCT00790608|Gasotransmitters|gasotransmitters|mesh-ancestor
6530814|NCT00790608|Protective Agents|protective agents|mesh-ancestor
6530815|NCT00790777|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6530816|NCT00790777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6530817|NCT00790777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6530818|NCT00790777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6794762|NCT02253901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794763|NCT02253901|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6794764|NCT02253901|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6794765|NCT02253901|Antiviral Agents|antiviral agents|mesh-ancestor
6794766|NCT02253901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6794767|NCT02253901|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6794768|NCT02253901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6794769|NCT02253901|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6794770|NCT02253901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6794771|NCT02253914|Ritonavir|ritonavir|mesh-list
6794772|NCT02253914|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6794773|NCT02253914|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6794774|NCT02253914|Protease Inhibitors|protease inhibitors|mesh-ancestor
6794775|NCT02253914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6794776|NCT02253914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794777|NCT02253914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6794778|NCT02253914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6794779|NCT02253914|Antiviral Agents|antiviral agents|mesh-ancestor
6794780|NCT02253914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6794781|NCT02253914|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6794782|NCT02253914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6794783|NCT02253927|Ritonavir|ritonavir|mesh-list
6794784|NCT02253927|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6794785|NCT02253927|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6794786|NCT02253927|Protease Inhibitors|protease inhibitors|mesh-ancestor
6794787|NCT02253927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6794788|NCT02253927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794789|NCT02253927|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6794790|NCT02253927|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6794791|NCT02253927|Antiviral Agents|antiviral agents|mesh-ancestor
6794792|NCT02253927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6794793|NCT02253927|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6794794|NCT02253927|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6794795|NCT02253940|Ritonavir|ritonavir|mesh-list
6794796|NCT02253940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6794797|NCT02253940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6794798|NCT02253940|Protease Inhibitors|protease inhibitors|mesh-ancestor
6794799|NCT02253940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6794800|NCT02253940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794801|NCT02253940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6794802|NCT02253940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6794803|NCT02253940|Antiviral Agents|antiviral agents|mesh-ancestor
6794804|NCT02253940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6794805|NCT02253940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6794806|NCT02253940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6794807|NCT02253953|Ritonavir|ritonavir|mesh-list
6794808|NCT02253953|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6794809|NCT02253953|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6794810|NCT02253953|Protease Inhibitors|protease inhibitors|mesh-ancestor
6794811|NCT02253953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6794812|NCT02253953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794813|NCT02253953|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6794814|NCT02253953|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6794815|NCT02253953|Antiviral Agents|antiviral agents|mesh-ancestor
6794816|NCT02253953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6794817|NCT02253953|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6794818|NCT02253953|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6794819|NCT02253966|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6794820|NCT02253966|Methylprednisolone|methylprednisolone|mesh-list
6794821|NCT02253966|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6530819|NCT00790777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530820|NCT00790777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6530821|NCT00790777|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6530822|NCT00790777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6530823|NCT00790777|Serotonin Agents|serotonin agents|mesh-ancestor
6530824|NCT00790777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6530825|NCT00790777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530826|NCT00790777|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6530827|NCT00790777|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6530828|NCT00790777|Dopamine Agents|dopamine agents|mesh-ancestor
6530829|NCT00790816|Lapatinib|lapatinib|mesh-list
6530830|NCT00790816|Antineoplastic Agents|antineoplastic agents|mesh-list
6530831|NCT00790816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6530832|NCT00790816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6530833|NCT00790816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530834|NCT00790881|Lumefantrine|lumefantrine|mesh-list
6530835|NCT00790881|Artemether|artemether|mesh-list
6530836|NCT00790881|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6530837|NCT00790881|Antimalarials|antimalarials|mesh-ancestor
6530838|NCT00790881|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6530839|NCT00790881|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6530840|NCT00790881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6530841|NCT00790894|Epothilones|epothilones|mesh-list
6530842|NCT00790894|Tubulin Modulators|tubulin modulators|mesh-ancestor
6794822|NCT02253966|Prednisolone|prednisolone|mesh-list
6794823|NCT02253966|Prednisolone acetate|prednisolone acetate|mesh-list
6794824|NCT02253966|Lidocaine|lidocaine|mesh-list
6794825|NCT02253966|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6794826|NCT02253966|Prednisolone phosphate|prednisolone phosphate|mesh-list
6794827|NCT02253966|Anesthetics, Local|anesthetics, local|mesh-ancestor
6794828|NCT02253966|Anesthetics|anesthetics|mesh-ancestor
6794829|NCT02253966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6794830|NCT02253966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6794831|NCT02253966|Sensory System Agents|sensory system agents|mesh-ancestor
6794832|NCT02253966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6794833|NCT02253966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6794834|NCT02253966|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6794835|NCT02253966|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6794836|NCT02253966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6794837|NCT02253966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794838|NCT02253966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6794839|NCT02253966|Antiemetics|antiemetics|mesh-ancestor
6794840|NCT02253966|Autonomic Agents|autonomic agents|mesh-ancestor
6794841|NCT02253966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6794842|NCT02253966|Glucocorticoids|glucocorticoids|mesh-ancestor
6794843|NCT02253966|Hormones|hormones|mesh-ancestor
6794844|NCT02253966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6794845|NCT02253966|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6794846|NCT02253966|Protective Agents|protective agents|mesh-ancestor
6794847|NCT02253966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6794848|NCT02253966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6794849|NCT02254005|Maytansine|maytansine|mesh-list
6794850|NCT02254005|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
6794851|NCT02254005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6794852|NCT02254005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6794853|NCT02254005|Tubulin Modulators|tubulin modulators|mesh-ancestor
6794854|NCT02254005|Antimitotic Agents|antimitotic agents|mesh-ancestor
6794855|NCT02254005|Mitosis Modulators|mitosis modulators|mesh-ancestor
6794856|NCT02254005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794857|NCT02254005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6794858|NCT02254018|Maytansine|maytansine|mesh-list
6794859|NCT02254018|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
6794860|NCT02254018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6794861|NCT02254018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6794862|NCT02254018|Tubulin Modulators|tubulin modulators|mesh-ancestor
6794863|NCT02254018|Antimitotic Agents|antimitotic agents|mesh-ancestor
6794864|NCT02254018|Mitosis Modulators|mitosis modulators|mesh-ancestor
6794865|NCT02254018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794866|NCT02254018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6794867|NCT02254031|Maytansine|maytansine|mesh-list
6794868|NCT02254031|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
6794869|NCT02254031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6794870|NCT02254031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6794871|NCT02254031|Tubulin Modulators|tubulin modulators|mesh-ancestor
6794872|NCT02254031|Antimitotic Agents|antimitotic agents|mesh-ancestor
6530843|NCT00790894|Antimitotic Agents|antimitotic agents|mesh-ancestor
6530844|NCT00790894|Mitosis Modulators|mitosis modulators|mesh-ancestor
6530845|NCT00790894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530846|NCT00790894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6530847|NCT00790920|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
6530848|NCT00790920|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6530849|NCT00790920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6530850|NCT00790920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530851|NCT00790946|Valsartan|valsartan|mesh-list
6530852|NCT00790946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6794873|NCT02254031|Mitosis Modulators|mitosis modulators|mesh-ancestor
6794874|NCT02254031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794875|NCT02254031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6794876|NCT02254044|Maytansine|maytansine|mesh-list
6794877|NCT02254044|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
6794878|NCT02254044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6794879|NCT02254044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6794880|NCT02254044|Tubulin Modulators|tubulin modulators|mesh-ancestor
6794881|NCT02254044|Antimitotic Agents|antimitotic agents|mesh-ancestor
6794882|NCT02254044|Mitosis Modulators|mitosis modulators|mesh-ancestor
6794883|NCT02254044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794884|NCT02254044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6794885|NCT02254148|Metoprolol|metoprolol|mesh-list
6794886|NCT02254148|Digoxin|digoxin|mesh-list
6794887|NCT02254148|Midazolam|midazolam|mesh-list
6794888|NCT02254148|Caffeine|caffeine|mesh-list
6794889|NCT02254148|Omeprazole|omeprazole|mesh-list
6794890|NCT02254148|Warfarin|warfarin|mesh-list
6794891|NCT02254148|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6794892|NCT02254148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6794893|NCT02254148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6794894|NCT02254148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6794895|NCT02254148|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6794896|NCT02254148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6794897|NCT02254148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6794898|NCT02254148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6794899|NCT02254148|Anesthetics, General|anesthetics, general|mesh-ancestor
6794900|NCT02254148|Anesthetics|anesthetics|mesh-ancestor
6794901|NCT02254148|GABA Modulators|gaba modulators|mesh-ancestor
6794902|NCT02254148|GABA Agents|gaba agents|mesh-ancestor
6794903|NCT02254148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6794904|NCT02254148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794905|NCT02254148|Anticoagulants|anticoagulants|mesh-ancestor
6794906|NCT02254148|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6794907|NCT02254148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6794908|NCT02254148|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6794909|NCT02254148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6794910|NCT02254148|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6794911|NCT02254148|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6794912|NCT02254148|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6794913|NCT02254148|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6794914|NCT02254148|Purinergic Agents|purinergic agents|mesh-ancestor
6794915|NCT02254148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6794916|NCT02254148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6794917|NCT02254148|Sympatholytics|sympatholytics|mesh-ancestor
6794918|NCT02254148|Autonomic Agents|autonomic agents|mesh-ancestor
6794919|NCT02254148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6794920|NCT02254148|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6794921|NCT02254148|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6794922|NCT02254148|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6794923|NCT02254148|Adrenergic Agents|adrenergic agents|mesh-ancestor
6794924|NCT02254148|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6794925|NCT02254148|Protective Agents|protective agents|mesh-ancestor
6794926|NCT02254174|Tiotropium Bromide|tiotropium bromide|mesh-list
6794927|NCT02254174|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6794928|NCT02254174|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6794929|NCT02254174|Autonomic Agents|autonomic agents|mesh-ancestor
6794930|NCT02254174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6794931|NCT02254174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6794932|NCT02254174|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6794933|NCT02254174|Respiratory System Agents|respiratory system agents|mesh-ancestor
6794934|NCT02254174|Parasympatholytics|parasympatholytics|mesh-ancestor
6794935|NCT02254174|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6794936|NCT02254174|Cholinergic Agents|cholinergic agents|mesh-ancestor
6794937|NCT02254174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6530853|NCT00790946|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6530854|NCT00790946|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6530855|NCT00790946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530856|NCT00790985|Naproxen|naproxen|mesh-list
6530857|NCT00790985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6530858|NCT00790985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6530859|NCT00790985|Analgesics|analgesics|mesh-ancestor
6530860|NCT00790985|Sensory System Agents|sensory system agents|mesh-ancestor
6530861|NCT00790985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6530862|NCT00790985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530863|NCT00790985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6530864|NCT00790985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6530865|NCT00790985|Gout Suppressants|gout suppressants|mesh-ancestor
6530866|NCT00790985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6530867|NCT00790985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6530868|NCT00790985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530869|NCT00790998|Ivermectin|ivermectin|mesh-list
6530870|NCT00790998|Moxidectin|moxidectin|mesh-list
6530871|NCT00790998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6530872|NCT00790998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6530873|NCT00790998|Anthelmintics|anthelmintics|mesh-ancestor
6530874|NCT00790998|Antinematodal Agents|antinematodal agents|mesh-ancestor
6530875|NCT00791011|Bortezomib|bortezomib|mesh-list
6530876|NCT00791011|Vorinostat|vorinostat|mesh-list
6530877|NCT00791011|Conatumumab|conatumumab|mesh-list
6530878|NCT00791011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6530879|NCT00791011|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6530880|NCT00791011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6530881|NCT00791011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530882|NCT00791011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6530883|NCT00791024|Lidocaine|lidocaine|mesh-list
6530884|NCT00791024|Anesthetics, Local|anesthetics, local|mesh-ancestor
6530885|NCT00791024|Anesthetics|anesthetics|mesh-ancestor
6530886|NCT00791024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6530887|NCT00791024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530888|NCT00791024|Sensory System Agents|sensory system agents|mesh-ancestor
6530889|NCT00791024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6530890|NCT00791024|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6530891|NCT00791024|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6530892|NCT00791024|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6530893|NCT00791024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6530894|NCT00791024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530895|NCT00791141|Cetuximab|cetuximab|mesh-list
6530896|NCT00791141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6530897|NCT00791141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6794938|NCT02254174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794939|NCT02254174|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6794940|NCT02254174|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6794941|NCT02254174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6794942|NCT02254174|Adrenergic Agents|adrenergic agents|mesh-ancestor
6794943|NCT02254187|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6794944|NCT02254187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6794945|NCT02254187|Autonomic Agents|autonomic agents|mesh-ancestor
6794946|NCT02254187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6794947|NCT02254187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6794948|NCT02254187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6794949|NCT02254187|Respiratory System Agents|respiratory system agents|mesh-ancestor
6794950|NCT02254187|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6794951|NCT02254187|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6794952|NCT02254187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6794953|NCT02254187|Adrenergic Agents|adrenergic agents|mesh-ancestor
6794954|NCT02254187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6794955|NCT02254187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794956|NCT02254226|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6794957|NCT02254226|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6794958|NCT02254226|Autonomic Agents|autonomic agents|mesh-ancestor
6794959|NCT02254226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6794960|NCT02254226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6794961|NCT02254226|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6794962|NCT02254226|Respiratory System Agents|respiratory system agents|mesh-ancestor
6794963|NCT02254226|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6794964|NCT02254226|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6530898|NCT00791167|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6530899|NCT00791167|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6530900|NCT00791167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6530901|NCT00791167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6530902|NCT00791167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530903|NCT00791167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6530904|NCT00791167|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6530905|NCT00791167|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6530906|NCT00791167|Serotonin Agents|serotonin agents|mesh-ancestor
6530907|NCT00791167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6530908|NCT00791167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530909|NCT00791167|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6530910|NCT00791167|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6530911|NCT00791167|Dopamine Agents|dopamine agents|mesh-ancestor
6530912|NCT00791193|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6530913|NCT00791193|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6530914|NCT00791193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6530915|NCT00791193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6530916|NCT00791193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530917|NCT00791193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6530918|NCT00791193|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6530919|NCT00791193|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6530920|NCT00791193|Serotonin Agents|serotonin agents|mesh-ancestor
6530921|NCT00791193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6530922|NCT00791193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530923|NCT00791193|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6530924|NCT00791193|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6530925|NCT00791193|Dopamine Agents|dopamine agents|mesh-ancestor
6530926|NCT00791232|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6530927|NCT00791232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6530928|NCT00791232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6530929|NCT00791232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6530930|NCT00791232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530931|NCT00791232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6530932|NCT00791232|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6530933|NCT00791232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6530934|NCT00791232|Serotonin Agents|serotonin agents|mesh-ancestor
6530935|NCT00791232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6530936|NCT00791232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530937|NCT00791232|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6530938|NCT00791232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6530939|NCT00791232|Dopamine Agents|dopamine agents|mesh-ancestor
6530940|NCT00791271|Interferons|interferons|mesh-list
6530941|NCT00791271|Interferon-alpha|interferon-alpha|mesh-list
6530942|NCT00791271|Interferon alpha-2|interferon alpha-2|mesh-list
6530943|NCT00791271|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6530944|NCT00791271|Decitabine|decitabine|mesh-list
6530945|NCT00791271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6530946|NCT00791271|Antiviral Agents|antiviral agents|mesh-ancestor
6530947|NCT00791271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6530948|NCT00791271|Immunologic Factors|immunologic factors|mesh-ancestor
6530949|NCT00791271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530950|NCT00791271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6530951|NCT00791271|Antimetabolites|antimetabolites|mesh-ancestor
6530952|NCT00791271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530953|NCT00791271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6530954|NCT00791284|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6530955|NCT00791284|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6530956|NCT00791284|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6794965|NCT02254226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6794966|NCT02254226|Adrenergic Agents|adrenergic agents|mesh-ancestor
6794967|NCT02254226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6794968|NCT02254226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794969|NCT02254239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6794970|NCT02254239|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6794971|NCT02254239|Everolimus|everolimus|mesh-list
6794972|NCT02254239|Antibodies|antibodies|mesh-list
6794973|NCT02254239|Immunoglobulins|immunoglobulins|mesh-list
6794974|NCT02254239|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6794975|NCT02254239|Immunoconjugates|immunoconjugates|mesh-list
6794976|NCT02254239|Immunologic Factors|immunologic factors|mesh-ancestor
6794977|NCT02254239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530957|NCT00791284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6530958|NCT00791284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530959|NCT00791284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6530960|NCT00791284|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6530961|NCT00791284|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6530962|NCT00791284|Serotonin Agents|serotonin agents|mesh-ancestor
6530963|NCT00791284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6530964|NCT00791284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530965|NCT00791284|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6530966|NCT00791284|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6530967|NCT00791284|Dopamine Agents|dopamine agents|mesh-ancestor
6530968|NCT00791297|Ulipristal acetate|ulipristal acetate|mesh-list
6530969|NCT00791297|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6530970|NCT00791297|Contraceptive Agents|contraceptive agents|mesh-ancestor
6530971|NCT00791297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6530972|NCT00791297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530973|NCT00791297|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6530974|NCT00791349|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6530975|NCT00791349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6530976|NCT00791349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6530977|NCT00791349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6530978|NCT00791349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530979|NCT00791349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6530980|NCT00791349|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6530981|NCT00791349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6530982|NCT00791349|Serotonin Agents|serotonin agents|mesh-ancestor
6530983|NCT00791349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6530984|NCT00791349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530985|NCT00791349|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6530986|NCT00791349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6530987|NCT00791349|Dopamine Agents|dopamine agents|mesh-ancestor
6530988|NCT00791401|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6530989|NCT00791401|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6530990|NCT00791401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6530991|NCT00791401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6530992|NCT00791401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6530993|NCT00791401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6530994|NCT00791401|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6530995|NCT00791401|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6530996|NCT00791401|Serotonin Agents|serotonin agents|mesh-ancestor
6530997|NCT00791401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6530998|NCT00791401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6530999|NCT00791401|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6531000|NCT00791401|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6531001|NCT00791401|Dopamine Agents|dopamine agents|mesh-ancestor
6531002|NCT00791427|Ranibizumab|ranibizumab|mesh-list
6531003|NCT00791427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6531004|NCT00791427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6531005|NCT00791427|Growth Substances|growth substances|mesh-ancestor
6531006|NCT00791427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531007|NCT00791427|Growth Inhibitors|growth inhibitors|mesh-ancestor
6531008|NCT00791427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6531009|NCT00791505|Ciprofloxacin|ciprofloxacin|mesh-list
6531010|NCT00791505|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6531011|NCT00791505|Fluoroquinolones|fluoroquinolones|mesh-list
6531012|NCT00791505|Trimethoprim|trimethoprim|mesh-list
6531013|NCT00791505|Sulfamethoxazole|sulfamethoxazole|mesh-list
6531014|NCT00791505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6531015|NCT00791505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6531016|NCT00791505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6531017|NCT00791505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6531018|NCT00791505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6531019|NCT00791505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531020|NCT00791505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6531021|NCT00791505|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6531022|NCT00791505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6531023|NCT00791505|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6531024|NCT00791505|Renal Agents|renal agents|mesh-ancestor
6531025|NCT00791505|Antimalarials|antimalarials|mesh-ancestor
6531026|NCT00791505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6531027|NCT00791505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6531028|NCT00791505|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6531029|NCT00791505|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6531030|NCT00791505|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6531031|NCT00791505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6531032|NCT00791531|Methotrexate|methotrexate|mesh-list
6531033|NCT00791531|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6531034|NCT00791531|Abortifacient Agents|abortifacient agents|mesh-ancestor
6531035|NCT00791531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6531036|NCT00791531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531037|NCT00791531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6531038|NCT00791531|Antimetabolites|antimetabolites|mesh-ancestor
6531039|NCT00791531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531040|NCT00791531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6531041|NCT00791531|Dermatologic Agents|dermatologic agents|mesh-ancestor
6531042|NCT00791531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6531043|NCT00791531|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6531044|NCT00791531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6531045|NCT00791531|Immunologic Factors|immunologic factors|mesh-ancestor
6531046|NCT00791531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6531047|NCT00791531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6794978|NCT02254239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6794979|NCT02254239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6794980|NCT02254447|Candesartan|candesartan|mesh-list
6794981|NCT02254447|Candesartan cilexetil|candesartan cilexetil|mesh-list
6794982|NCT02254447|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6794983|NCT02254447|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6794984|NCT02254447|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6794985|NCT02254447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794986|NCT02254525|Ibuprofen|ibuprofen|mesh-list
6794987|NCT02254525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6794988|NCT02254525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6794989|NCT02254525|Analgesics|analgesics|mesh-ancestor
6794990|NCT02254525|Sensory System Agents|sensory system agents|mesh-ancestor
6794991|NCT02254525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6794992|NCT02254525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6794993|NCT02254525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6794994|NCT02254525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6794995|NCT02254525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6794996|NCT02254525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6794997|NCT02254525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6794998|NCT02254577|Progesterone|progesterone|mesh-list
6794999|NCT02254577|Progestins|progestins|mesh-ancestor
6795000|NCT02254577|Hormones|hormones|mesh-ancestor
6795001|NCT02254577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6795002|NCT02254577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795003|NCT02254629|Laxatives|laxatives|mesh-list
6795004|NCT02254629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6795005|NCT02254655|Antirheumatic Agents|antirheumatic agents|mesh-list
6795006|NCT02254655|Puerarin|puerarin|mesh-list
6795007|NCT02254655|Vasodilator Agents|vasodilator agents|mesh-ancestor
6795008|NCT02254668|Mycophenolic Acid|mycophenolic acid|mesh-list
6795009|NCT02254668|Everolimus|everolimus|mesh-list
6795010|NCT02254668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6795011|NCT02254668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6795012|NCT02254668|Immunologic Factors|immunologic factors|mesh-ancestor
6795013|NCT02254668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795014|NCT02254668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6795015|NCT02254668|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6795016|NCT02254668|Antitubercular Agents|antitubercular agents|mesh-ancestor
6795017|NCT02254668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6795018|NCT02254668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6795019|NCT02254668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6795020|NCT02254668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795021|NCT02254720|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6531048|NCT00791544|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6531049|NCT00791544|Sorafenib|sorafenib|mesh-list
6531050|NCT00791544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6531051|NCT00791544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6531052|NCT00791544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6531053|NCT00791544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531054|NCT00791622|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6531055|NCT00791622|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6531056|NCT00791622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6531057|NCT00791622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6531058|NCT00791622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531059|NCT00791622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6531060|NCT00791622|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6531061|NCT00791622|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6531062|NCT00791622|Serotonin Agents|serotonin agents|mesh-ancestor
6531063|NCT00791622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6531064|NCT00791622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531065|NCT00791622|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6531066|NCT00791622|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6531067|NCT00791622|Dopamine Agents|dopamine agents|mesh-ancestor
6531068|NCT00791713|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6531069|NCT00791713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6531070|NCT00791713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6531071|NCT00791713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6531072|NCT00791713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531073|NCT00791713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6531074|NCT00791713|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6531075|NCT00791713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6531076|NCT00791713|Serotonin Agents|serotonin agents|mesh-ancestor
6531077|NCT00791713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6531078|NCT00791713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531079|NCT00791713|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6531080|NCT00791713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6795022|NCT02254759|Midazolam|midazolam|mesh-list
6795023|NCT02254759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6795024|NCT02254759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6795025|NCT02254759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6795026|NCT02254759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795027|NCT02254759|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6795028|NCT02254759|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6795029|NCT02254759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6795030|NCT02254759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6795031|NCT02254759|Anesthetics, General|anesthetics, general|mesh-ancestor
6795032|NCT02254759|Anesthetics|anesthetics|mesh-ancestor
6795033|NCT02254759|GABA Modulators|gaba modulators|mesh-ancestor
6795034|NCT02254759|GABA Agents|gaba agents|mesh-ancestor
6795035|NCT02254759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6795036|NCT02254759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795037|NCT02254824|Atorvastatin|atorvastatin|mesh-list
6795038|NCT02254824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6795039|NCT02254824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6795040|NCT02254824|Antimetabolites|antimetabolites|mesh-ancestor
6795041|NCT02254824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795042|NCT02254824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6795043|NCT02254824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6795044|NCT02254824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6795045|NCT02254889|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
6795046|NCT02254889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6795047|NCT02254889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795048|NCT02254915|BCG Vaccine|bcg vaccine|mesh-list
6795049|NCT02254915|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6795050|NCT02254915|Immunologic Factors|immunologic factors|mesh-ancestor
6795051|NCT02254915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795052|NCT02254941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6795053|NCT02254941|Antibodies|antibodies|mesh-list
6795054|NCT02254941|Immunoglobulins|immunoglobulins|mesh-list
6795055|NCT02254941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6795056|NCT02254941|Immunologic Factors|immunologic factors|mesh-ancestor
6795057|NCT02254941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795058|NCT02254941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6795059|NCT02254954|Temozolomide|temozolomide|mesh-list
6795060|NCT02254954|Macitentan|macitentan|mesh-list
6795061|NCT02254954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6795062|NCT02254954|Alkylating Agents|alkylating agents|mesh-ancestor
6531081|NCT00791713|Dopamine Agents|dopamine agents|mesh-ancestor
6531082|NCT00791739|Pregabalin|pregabalin|mesh-list
6531083|NCT00791739|Trazodone|trazodone|mesh-list
6531084|NCT00791739|Analgesics|analgesics|mesh-ancestor
6531085|NCT00791739|Sensory System Agents|sensory system agents|mesh-ancestor
6531086|NCT00791739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6531087|NCT00791739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531088|NCT00791739|Anticonvulsants|anticonvulsants|mesh-ancestor
6531089|NCT00791739|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6531090|NCT00791739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6531091|NCT00791739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531092|NCT00791739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6531093|NCT00791739|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6531094|NCT00791739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6531095|NCT00791739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6531096|NCT00791739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6531097|NCT00791739|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6531098|NCT00791739|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6531099|NCT00791739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6531100|NCT00791739|Serotonin Agents|serotonin agents|mesh-ancestor
6531101|NCT00791739|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6531102|NCT00791739|Antidepressive Agents|antidepressive agents|mesh-ancestor
6531103|NCT00791804|Fentanyl|fentanyl|mesh-list
6531104|NCT00791804|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6531105|NCT00791804|Narcotics|narcotics|mesh-ancestor
6531106|NCT00791804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6531107|NCT00791804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531108|NCT00791804|Analgesics|analgesics|mesh-ancestor
6531109|NCT00791804|Sensory System Agents|sensory system agents|mesh-ancestor
6531110|NCT00791804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6531111|NCT00791804|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6531112|NCT00791804|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6531113|NCT00791804|Anesthetics, General|anesthetics, general|mesh-ancestor
6531114|NCT00791804|Anesthetics|anesthetics|mesh-ancestor
6531115|NCT00791830|Irbesartan|irbesartan|mesh-list
6531116|NCT00791830|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6531117|NCT00791830|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6531118|NCT00791830|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6531119|NCT00791830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531120|NCT00791856|Methyltestosterone|methyltestosterone|mesh-list
6531121|NCT00791856|Testosterone|testosterone|mesh-list
6531122|NCT00791856|Testosterone undecanoate|testosterone undecanoate|mesh-list
6531123|NCT00791856|Testosterone enanthate|testosterone enanthate|mesh-list
6531124|NCT00791856|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6531125|NCT00791856|Androgens|androgens|mesh-ancestor
6531126|NCT00791856|Hormones|hormones|mesh-ancestor
6531127|NCT00791856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6531128|NCT00791856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531129|NCT00791856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6531130|NCT00791856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6531131|NCT00791856|Anabolic Agents|anabolic agents|mesh-ancestor
6531132|NCT00791895|Insulin Aspart|insulin aspart|mesh-list
6531133|NCT00791895|Biphasic Insulins|biphasic insulins|mesh-list
6531134|NCT00791895|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6531135|NCT00791895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6531136|NCT00791895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531137|NCT00791960|Dimenhydrinate|dimenhydrinate|mesh-list
6531138|NCT00791960|Antiemetics|antiemetics|mesh-ancestor
6531139|NCT00791960|Autonomic Agents|autonomic agents|mesh-ancestor
6531140|NCT00791960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6531141|NCT00791960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531142|NCT00791960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6531143|NCT00791960|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6531144|NCT00791960|Histamine Antagonists|histamine antagonists|mesh-ancestor
6531145|NCT00791960|Histamine Agents|histamine agents|mesh-ancestor
6531146|NCT00791960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6531147|NCT00791960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531148|NCT00792012|Temozolomide|temozolomide|mesh-list
6531149|NCT00792012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6531150|NCT00792012|Alkylating Agents|alkylating agents|mesh-ancestor
6531151|NCT00792012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531152|NCT00792012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6531153|NCT00792025|Sunitinib|sunitinib|mesh-list
6531154|NCT00792025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6531155|NCT00792025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6531156|NCT00792025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6531157|NCT00792025|Growth Substances|growth substances|mesh-ancestor
6531158|NCT00792025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531159|NCT00792025|Growth Inhibitors|growth inhibitors|mesh-ancestor
6531160|NCT00792025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6531161|NCT00792025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6531162|NCT00792025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537668|NCT00823563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537669|NCT00823563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6537670|NCT00823563|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6537671|NCT00823563|Purinergic Agonists|purinergic agonists|mesh-ancestor
6537672|NCT00823563|Purinergic Agents|purinergic agents|mesh-ancestor
6537673|NCT00823563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6537674|NCT00823563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537675|NCT00823576|Ropivacaine|ropivacaine|mesh-list
6537676|NCT00823576|Anesthetics, Local|anesthetics, local|mesh-ancestor
6795063|NCT02254954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795064|NCT02254954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6795065|NCT02254954|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
6795066|NCT02254954|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6795067|NCT02254954|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
6795068|NCT02254967|Vancomycin|vancomycin|mesh-list
6795069|NCT02254967|Fidaxomicin|fidaxomicin|mesh-list
6795070|NCT02254967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6795071|NCT02254967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6795072|NCT02254980|Vitamin E|vitamin e|mesh-list
6795073|NCT02254980|Vitamins|vitamins|mesh-ancestor
6795074|NCT02254980|Micronutrients|micronutrients|mesh-ancestor
6795075|NCT02254980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795076|NCT02254980|Antioxidants|antioxidants|mesh-ancestor
6795077|NCT02254980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795078|NCT02254980|Protective Agents|protective agents|mesh-ancestor
6795079|NCT02255006|Glyburide|glyburide|mesh-list
6795080|NCT02255006|Celecoxib|celecoxib|mesh-list
6795081|NCT02255006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6795082|NCT02255006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6795083|NCT02255006|Analgesics|analgesics|mesh-ancestor
6795084|NCT02255006|Sensory System Agents|sensory system agents|mesh-ancestor
6795085|NCT02255006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6795086|NCT02255006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795087|NCT02255006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6795088|NCT02255006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6795089|NCT02255006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6795090|NCT02255006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6795091|NCT02255006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6795092|NCT02255006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795093|NCT02255006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6795094|NCT02255045|Diclofenac|diclofenac|mesh-list
6795095|NCT02255045|Meloxicam|meloxicam|mesh-list
6795096|NCT02255045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6795097|NCT02255045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6795098|NCT02255045|Analgesics|analgesics|mesh-ancestor
6795099|NCT02255045|Sensory System Agents|sensory system agents|mesh-ancestor
6795100|NCT02255045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6795101|NCT02255045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795102|NCT02255045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6795103|NCT02255045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6795104|NCT02255045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6795105|NCT02255045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6795106|NCT02255045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795107|NCT02255045|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6795108|NCT02255084|Menthol|menthol|mesh-list
6795109|NCT02255084|Antipruritics|antipruritics|mesh-ancestor
6795110|NCT02255084|Dermatologic Agents|dermatologic agents|mesh-ancestor
6795111|NCT02255162|Cytarabine|cytarabine|mesh-list
6795112|NCT02255162|Lenalidomide|lenalidomide|mesh-list
6795113|NCT02255162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6795114|NCT02255162|Antimetabolites|antimetabolites|mesh-ancestor
6795115|NCT02255162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795116|NCT02255162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6795117|NCT02255162|Antiviral Agents|antiviral agents|mesh-ancestor
6795118|NCT02255162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6795119|NCT02255162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6531163|NCT00792168|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6531164|NCT00792168|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6531165|NCT00792168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6531166|NCT00792168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6531167|NCT00792168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531168|NCT00792168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6531169|NCT00792168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531170|NCT00792168|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6531171|NCT00792168|Antidepressive Agents|antidepressive agents|mesh-ancestor
6531172|NCT00792168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6795120|NCT02255162|Immunologic Factors|immunologic factors|mesh-ancestor
6795121|NCT02255162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795122|NCT02255162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6795123|NCT02255162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6795124|NCT02255162|Growth Substances|growth substances|mesh-ancestor
6795125|NCT02255162|Growth Inhibitors|growth inhibitors|mesh-ancestor
6795126|NCT02255227|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6795127|NCT02255227|Immunologic Factors|immunologic factors|mesh-ancestor
6795128|NCT02255227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795129|NCT02255253|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6795130|NCT02255253|Telmisartan|telmisartan|mesh-list
6795131|NCT02255253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6795132|NCT02255253|Diuretics|diuretics|mesh-ancestor
6795133|NCT02255253|Natriuretic Agents|natriuretic agents|mesh-ancestor
6795134|NCT02255253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795135|NCT02255253|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6795136|NCT02255253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6795137|NCT02255253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795138|NCT02255253|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6795139|NCT02255253|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6795140|NCT02255266|Liraglutide|liraglutide|mesh-list
6795141|NCT02255266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6795142|NCT02255266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795143|NCT02255266|Incretins|incretins|mesh-ancestor
6795144|NCT02255266|Hormones|hormones|mesh-ancestor
6795145|NCT02255266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6795146|NCT02255292|Cannabidiol|cannabidiol|mesh-list
6795147|NCT02255292|Anticonvulsants|anticonvulsants|mesh-ancestor
6795148|NCT02255305|Anti-Infective Agents|anti-infective agents|mesh-list
6795149|NCT02255305|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6795150|NCT02255370|Curcumin|curcumin|mesh-list
6795151|NCT02255370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6795152|NCT02255370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6795153|NCT02255370|Analgesics|analgesics|mesh-ancestor
6795154|NCT02255370|Sensory System Agents|sensory system agents|mesh-ancestor
6795155|NCT02255370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6795156|NCT02255370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795157|NCT02255370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6795158|NCT02255370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6795159|NCT02255370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6795160|NCT02255370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6795161|NCT02255370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795162|NCT02255396|Estradiol|estradiol|mesh-list
6795163|NCT02255396|Estrogens|estrogens|mesh-ancestor
6795164|NCT02255396|Hormones|hormones|mesh-ancestor
6795165|NCT02255396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6795166|NCT02255396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795167|NCT02255578|Clomiphene|clomiphene|mesh-list
6795168|NCT02255578|Enclomiphene|enclomiphene|mesh-list
6795169|NCT02255578|Zuclomiphene|zuclomiphene|mesh-list
6795170|NCT02255578|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6795171|NCT02255578|Hormone Antagonists|hormone antagonists|mesh-ancestor
6795172|NCT02255578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6795173|NCT02255578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795174|NCT02255578|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6795175|NCT02255578|Fertility Agents|fertility agents|mesh-ancestor
6795176|NCT02255578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6795177|NCT02255578|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6795178|NCT02255578|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6795179|NCT02255591|Lidocaine|lidocaine|mesh-list
6795180|NCT02255591|Epinephrine|epinephrine|mesh-list
6795181|NCT02255591|Racepinephrine|racepinephrine|mesh-list
6795182|NCT02255591|Epinephryl borate|epinephryl borate|mesh-list
6531173|NCT00792181|Midazolam|midazolam|mesh-list
6531174|NCT00792181|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6531175|NCT00792181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6531176|NCT00792181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6531177|NCT00792181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531178|NCT00792181|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6531179|NCT00792181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6531180|NCT00792181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6531181|NCT00792181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6531182|NCT00792181|Anesthetics, General|anesthetics, general|mesh-ancestor
6531183|NCT00792181|Anesthetics|anesthetics|mesh-ancestor
6531184|NCT00792181|GABA Modulators|gaba modulators|mesh-ancestor
6531185|NCT00792181|GABA Agents|gaba agents|mesh-ancestor
6531186|NCT00792181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6531187|NCT00792181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531188|NCT00792246|Voriconazole|voriconazole|mesh-list
6531189|NCT00792246|Antifungal Agents|antifungal agents|mesh-ancestor
6531190|NCT00792246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6531191|NCT00792246|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6531192|NCT00792246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6531193|NCT00792246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6531194|NCT00792246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531195|NCT00792246|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6531196|NCT00792246|Hormone Antagonists|hormone antagonists|mesh-ancestor
6531197|NCT00792246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6531198|NCT00792246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531199|NCT00792246|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6531200|NCT00792324|Efavirenz|efavirenz|mesh-list
6531201|NCT00792324|Etravirine|etravirine|mesh-list
6531202|NCT00792324|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6531203|NCT00792324|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6531204|NCT00792324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6531205|NCT00792324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531206|NCT00792324|Antiviral Agents|antiviral agents|mesh-ancestor
6531207|NCT00792324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6531208|NCT00792324|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6531209|NCT00792324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6531210|NCT00792324|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6531211|NCT00792324|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6531212|NCT00792324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6531213|NCT00792324|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6531214|NCT00792337|Simvastatin|simvastatin|mesh-list
6531215|NCT00792337|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6531216|NCT00792337|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6531217|NCT00792337|Antimetabolites|antimetabolites|mesh-ancestor
6531218|NCT00792337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531219|NCT00792337|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6531220|NCT00792337|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6531221|NCT00792337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6531222|NCT00792350|Sorafenib|sorafenib|mesh-list
6531223|NCT00792350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6531224|NCT00792350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6531225|NCT00792350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6531226|NCT00792350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531227|NCT00792363|Irinotecan|irinotecan|mesh-list
6531228|NCT00792363|Panitumumab|panitumumab|mesh-list
6531229|NCT00792363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6531230|NCT00792363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6531231|NCT00792363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6531232|NCT00792363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531233|NCT00792363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6531234|NCT00792363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6531235|NCT00792376|Diclofenac|diclofenac|mesh-list
6531236|NCT00792376|Etoricoxib|etoricoxib|mesh-list
6531237|NCT00792376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6531238|NCT00792376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6531239|NCT00792376|Analgesics|analgesics|mesh-ancestor
6795183|NCT02255591|Anesthetics, Local|anesthetics, local|mesh-ancestor
6795184|NCT02255591|Anesthetics|anesthetics|mesh-ancestor
6795185|NCT02255591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6795186|NCT02255591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795187|NCT02255591|Sensory System Agents|sensory system agents|mesh-ancestor
6531240|NCT00792376|Sensory System Agents|sensory system agents|mesh-ancestor
6531241|NCT00792376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6531242|NCT00792376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531243|NCT00792376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6531244|NCT00792376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6531245|NCT00792376|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6531246|NCT00792376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6531247|NCT00792376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531248|NCT00792376|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6531249|NCT00792584|Efavirenz|efavirenz|mesh-list
6531250|NCT00792584|Etravirine|etravirine|mesh-list
6531251|NCT00792584|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6531252|NCT00792584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6531253|NCT00792584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6531254|NCT00792584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531255|NCT00792584|Antiviral Agents|antiviral agents|mesh-ancestor
6531256|NCT00792584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6531257|NCT00792584|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6531258|NCT00792584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6795188|NCT02255591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6795189|NCT02255591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6795190|NCT02255591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6795191|NCT02255591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6795192|NCT02255591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6795193|NCT02255591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795194|NCT02255591|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6795195|NCT02255591|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6795196|NCT02255591|Adrenergic Agents|adrenergic agents|mesh-ancestor
6795197|NCT02255591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6795198|NCT02255591|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6795199|NCT02255591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6795200|NCT02255591|Autonomic Agents|autonomic agents|mesh-ancestor
6795201|NCT02255591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6795202|NCT02255591|Respiratory System Agents|respiratory system agents|mesh-ancestor
6795203|NCT02255591|Mydriatics|mydriatics|mesh-ancestor
6795204|NCT02255591|Sympathomimetics|sympathomimetics|mesh-ancestor
6795205|NCT02255591|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6795206|NCT02255682|Simvastatin|simvastatin|mesh-list
6795207|NCT02255682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6795208|NCT02255682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6795209|NCT02255682|Antimetabolites|antimetabolites|mesh-ancestor
6795210|NCT02255682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795211|NCT02255682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6795212|NCT02255682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6795213|NCT02255682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6795214|NCT02255734|Acyclovir|acyclovir|mesh-list
6795215|NCT02255734|Antiviral Agents|antiviral agents|mesh-ancestor
6795216|NCT02255734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6795217|NCT02255747|Lactulose|lactulose|mesh-list
6795218|NCT02255747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6795219|NCT02255799|Donepezil|donepezil|mesh-list
6795220|NCT02255799|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6795221|NCT02255799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6795222|NCT02255799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795223|NCT02255799|Cholinergic Agents|cholinergic agents|mesh-ancestor
6795224|NCT02255799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6795225|NCT02255799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795226|NCT02255799|Nootropic Agents|nootropic agents|mesh-ancestor
6795227|NCT02255812|Quinine|quinine|mesh-list
6795228|NCT02255812|Citric Acid|citric acid|mesh-list
6795229|NCT02255812|Sodium Citrate|sodium citrate|mesh-list
6795230|NCT02255812|Antimalarials|antimalarials|mesh-ancestor
6795231|NCT02255812|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6795232|NCT02255812|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6795233|NCT02255812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6795234|NCT02255812|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6795235|NCT02255812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795236|NCT02255812|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6795237|NCT02255812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6795238|NCT02255812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6795239|NCT02255812|Analgesics|analgesics|mesh-ancestor
6795240|NCT02255812|Sensory System Agents|sensory system agents|mesh-ancestor
6795241|NCT02255812|Anticoagulants|anticoagulants|mesh-ancestor
6795242|NCT02255812|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6795243|NCT02255812|Chelating Agents|chelating agents|mesh-ancestor
6531259|NCT00792584|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6531260|NCT00792584|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6531261|NCT00792584|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6531262|NCT00792584|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6531263|NCT00792662|Methylphenidate|methylphenidate|mesh-list
6531264|NCT00792662|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6531265|NCT00792662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531266|NCT00792662|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6531267|NCT00792662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6531268|NCT00792662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6531269|NCT00792662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531270|NCT00792662|Dopamine Agents|dopamine agents|mesh-ancestor
6531271|NCT00792662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6531272|NCT00792714|Mannitol|mannitol|mesh-list
6531273|NCT00792714|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6531274|NCT00792714|Diuretics|diuretics|mesh-ancestor
6531275|NCT00792714|Natriuretic Agents|natriuretic agents|mesh-ancestor
6531276|NCT00792714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531277|NCT00792740|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
6531278|NCT00792740|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6531279|NCT00792740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6531280|NCT00792740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531281|NCT00792766|Everolimus|everolimus|mesh-list
6531282|NCT00792766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6531283|NCT00792766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6531284|NCT00792766|Immunologic Factors|immunologic factors|mesh-ancestor
6531285|NCT00792766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531286|NCT00792779|Propofol|propofol|mesh-list
6531287|NCT00792779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6531288|NCT00792779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5992997|NCT00118417|Sertraline|sertraline|mesh-list
5992998|NCT00118417|Antidepressive Agents|antidepressive agents|mesh-ancestor
5992999|NCT00118417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5993000|NCT00118417|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5993001|NCT00118417|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5993002|NCT00118417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5993003|NCT00118417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531289|NCT00792779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531290|NCT00792779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6531291|NCT00792779|Anesthetics, General|anesthetics, general|mesh-ancestor
6531292|NCT00792779|Anesthetics|anesthetics|mesh-ancestor
6531293|NCT00792818|Ibuprofen|ibuprofen|mesh-list
6531294|NCT00792818|Curcumin|curcumin|mesh-list
6531295|NCT00792818|Turmeric extract|turmeric extract|mesh-list
6531296|NCT00792818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6531297|NCT00792818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6531298|NCT00792818|Analgesics|analgesics|mesh-ancestor
6531299|NCT00792818|Sensory System Agents|sensory system agents|mesh-ancestor
6531300|NCT00792818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6531301|NCT00792818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531302|NCT00792818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6531303|NCT00792818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6531304|NCT00792818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6531305|NCT00792818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6531306|NCT00792818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531307|NCT00792818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6531308|NCT00792818|Antioxidants|antioxidants|mesh-ancestor
6531309|NCT00792818|Protective Agents|protective agents|mesh-ancestor
6531310|NCT00792857|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
6531311|NCT00792857|Vitamins|vitamins|mesh-ancestor
6531312|NCT00792857|Micronutrients|micronutrients|mesh-ancestor
6531313|NCT00792857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531314|NCT00792857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6531315|NCT00793052|Dexamethasone|dexamethasone|mesh-list
6531316|NCT00793052|Etoricoxib|etoricoxib|mesh-list
6795244|NCT02255812|Sequestering Agents|sequestering agents|mesh-ancestor
6795245|NCT02255812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795246|NCT02255942|Zinc|zinc|mesh-list
6795247|NCT02255942|Iron|iron|mesh-list
6795248|NCT02255942|Zinc Sulfate|zinc sulfate|mesh-list
6795249|NCT02255942|Zinc Oxide|zinc oxide|mesh-list
6795250|NCT02255942|Trace Elements|trace elements|mesh-ancestor
6795251|NCT02255942|Micronutrients|micronutrients|mesh-ancestor
6531317|NCT00793052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6531318|NCT00793052|Antiemetics|antiemetics|mesh-ancestor
6531319|NCT00793052|Autonomic Agents|autonomic agents|mesh-ancestor
6531320|NCT00793052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6531321|NCT00793052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531322|NCT00793052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6531323|NCT00793052|Glucocorticoids|glucocorticoids|mesh-ancestor
6531324|NCT00793052|Hormones|hormones|mesh-ancestor
6531325|NCT00793052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6531326|NCT00793052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6531327|NCT00793052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6531328|NCT00793052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6531329|NCT00793052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6531330|NCT00793052|Analgesics|analgesics|mesh-ancestor
6531331|NCT00793052|Sensory System Agents|sensory system agents|mesh-ancestor
6531332|NCT00793052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6531333|NCT00793052|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6531334|NCT00793052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6531335|NCT00793052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6531336|NCT00793052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531337|NCT00793091|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6531338|NCT00793091|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6531339|NCT00793195|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6531340|NCT00793195|SMOFlipid|smoflipid|mesh-list
6531341|NCT00793195|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6531342|NCT00793195|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6531343|NCT00793195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6531344|NCT00793221|Sirolimus|sirolimus|mesh-list
6531345|NCT00793221|Everolimus|everolimus|mesh-list
6531346|NCT00793221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6531347|NCT00793221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6531348|NCT00793221|Immunologic Factors|immunologic factors|mesh-ancestor
6531349|NCT00793221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531350|NCT00793221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6531351|NCT00793221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6531352|NCT00793221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6531353|NCT00793221|Antifungal Agents|antifungal agents|mesh-ancestor
6531354|NCT00793234|Enoxaparin|enoxaparin|mesh-list
6531355|NCT00793234|Anticoagulants|anticoagulants|mesh-ancestor
6531356|NCT00793234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6531357|NCT00793234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6531358|NCT00793234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531359|NCT00793273|Insulin Detemir|insulin detemir|mesh-list
6531360|NCT00793273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6531361|NCT00793273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531362|NCT00793338|Sildenafil Citrate|sildenafil citrate|mesh-list
6531363|NCT00793338|Vasodilator Agents|vasodilator agents|mesh-ancestor
6531364|NCT00793338|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6531365|NCT00793338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6531366|NCT00793338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6531367|NCT00793338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531368|NCT00793338|Urological Agents|urological agents|mesh-ancestor
6531369|NCT00793377|Tamoxifen|tamoxifen|mesh-list
6531370|NCT00793377|Cyclophosphamide|cyclophosphamide|mesh-list
6531371|NCT00793377|Docetaxel|docetaxel|mesh-list
6531372|NCT00793377|Doxorubicin|doxorubicin|mesh-list
6531373|NCT00793377|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6531374|NCT00793377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6531375|NCT00793377|Immunologic Factors|immunologic factors|mesh-ancestor
6531376|NCT00793377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531377|NCT00793377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6531378|NCT00793377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6531379|NCT00793377|Alkylating Agents|alkylating agents|mesh-ancestor
6531380|NCT00793377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795252|NCT02255942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795253|NCT02255942|Astringents|astringents|mesh-ancestor
6795254|NCT02255942|Dermatologic Agents|dermatologic agents|mesh-ancestor
6795255|NCT02255942|Sunscreening Agents|sunscreening agents|mesh-ancestor
6795256|NCT02255942|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6795257|NCT02255942|Protective Agents|protective agents|mesh-ancestor
6795258|NCT02255955|Acetaminophen|acetaminophen|mesh-list
6795259|NCT02255955|Naproxen|naproxen|mesh-list
6795260|NCT02255955|Codeine|codeine|mesh-list
6795261|NCT02255955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6795262|NCT02255955|Analgesics|analgesics|mesh-ancestor
6795263|NCT02255955|Sensory System Agents|sensory system agents|mesh-ancestor
6795264|NCT02255955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6795265|NCT02255955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531381|NCT00793377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6531382|NCT00793377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6531383|NCT00793377|Tubulin Modulators|tubulin modulators|mesh-ancestor
6531384|NCT00793377|Antimitotic Agents|antimitotic agents|mesh-ancestor
6531385|NCT00793377|Mitosis Modulators|mitosis modulators|mesh-ancestor
6531386|NCT00793377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6531387|NCT00793377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6531388|NCT00793377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6531389|NCT00793377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6531390|NCT00793377|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6531391|NCT00793377|Hormone Antagonists|hormone antagonists|mesh-ancestor
6531392|NCT00793377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6531393|NCT00793377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6531394|NCT00793377|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6531395|NCT00793377|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6531396|NCT00793377|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6531397|NCT00793429|Prucalopride|prucalopride|mesh-list
6531398|NCT00793429|Laxatives|laxatives|mesh-ancestor
6531399|NCT00793429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6531400|NCT00793429|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
6531401|NCT00793429|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6531402|NCT00793429|Serotonin Agents|serotonin agents|mesh-ancestor
6531403|NCT00793429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6531404|NCT00793429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531405|NCT00793429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531406|NCT00793468|Nicotine|nicotine|mesh-list
6531407|NCT00793468|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6531408|NCT00793468|Autonomic Agents|autonomic agents|mesh-ancestor
6531409|NCT00793468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6531410|NCT00793468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531411|NCT00793468|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6531412|NCT00793468|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6531413|NCT00793468|Cholinergic Agents|cholinergic agents|mesh-ancestor
6531414|NCT00793468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6531415|NCT00793468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531416|NCT00793559|Terlipressin|terlipressin|mesh-list
6531417|NCT00793559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6531418|NCT00793559|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6531419|NCT00793663|Dexamethasone|dexamethasone|mesh-list
6531420|NCT00793663|Dexamethasone acetate|dexamethasone acetate|mesh-list
6531421|NCT00793663|Ondansetron|ondansetron|mesh-list
6531422|NCT00793663|Sevoflurane|sevoflurane|mesh-list
6531423|NCT00793663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6531424|NCT00793663|Antiemetics|antiemetics|mesh-ancestor
6531425|NCT00793663|Autonomic Agents|autonomic agents|mesh-ancestor
6531426|NCT00793663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6795266|NCT02255955|Antipyretics|antipyretics|mesh-ancestor
6795267|NCT02255955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6795268|NCT02255955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6795269|NCT02255955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6795270|NCT02255955|Gout Suppressants|gout suppressants|mesh-ancestor
6795271|NCT02255955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6795272|NCT02255955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6795273|NCT02255955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795274|NCT02255955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6795275|NCT02255955|Narcotics|narcotics|mesh-ancestor
6795276|NCT02255955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6795277|NCT02255955|Antitussive Agents|antitussive agents|mesh-ancestor
6795278|NCT02255955|Respiratory System Agents|respiratory system agents|mesh-ancestor
6795279|NCT02256033|Istradefylline|istradefylline|mesh-list
6795280|NCT02256033|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
6795281|NCT02256033|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6795282|NCT02256033|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6795283|NCT02256033|Purinergic Agents|purinergic agents|mesh-ancestor
6795284|NCT02256033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6795285|NCT02256033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795286|NCT02256033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795287|NCT02256124|Lamotrigine|lamotrigine|mesh-list
6795288|NCT02256124|Anticonvulsants|anticonvulsants|mesh-ancestor
5993004|NCT00118417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5993005|NCT00118417|Serotonin Agents|serotonin agents|mesh-ancestor
5993006|NCT00118417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993007|NCT00118417|Anticonvulsants|anticonvulsants|mesh-ancestor
5993008|NCT00118417|GABA Modulators|gaba modulators|mesh-ancestor
5993009|NCT00118417|GABA Agents|gaba agents|mesh-ancestor
5993010|NCT00118430|Antidepressive Agents|antidepressive agents|mesh-list
5993011|NCT00118430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5993012|NCT00118482|Fludrocortisone|fludrocortisone|mesh-list
5993013|NCT00118482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5993014|NCT00118716|Fluticasone|fluticasone|mesh-list
5993015|NCT00118716|Xhance|xhance|mesh-list
5993016|NCT00118716|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5993017|NCT00118716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5993018|NCT00118716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6531427|NCT00793663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531428|NCT00793663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6531429|NCT00793663|Glucocorticoids|glucocorticoids|mesh-ancestor
6531430|NCT00793663|Hormones|hormones|mesh-ancestor
6531431|NCT00793663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6531432|NCT00793663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6531433|NCT00793663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6531434|NCT00793663|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6531435|NCT00793663|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6531436|NCT00793663|Anesthetics, General|anesthetics, general|mesh-ancestor
6531437|NCT00793663|Anesthetics|anesthetics|mesh-ancestor
6531438|NCT00793663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6531439|NCT00793663|Antipruritics|antipruritics|mesh-ancestor
6531440|NCT00793663|Dermatologic Agents|dermatologic agents|mesh-ancestor
6531441|NCT00793663|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6531442|NCT00793663|Serotonin Agents|serotonin agents|mesh-ancestor
6531443|NCT00793663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6531444|NCT00793663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531445|NCT00793663|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6531446|NCT00793663|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6531447|NCT00793663|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6531448|NCT00793663|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6531449|NCT00793741|Somatostatin|somatostatin|mesh-list
6531450|NCT00793741|Hormones|hormones|mesh-ancestor
6531451|NCT00793741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6531452|NCT00793741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531453|NCT00793754|Aspirin|aspirin|mesh-list
6531454|NCT00793754|Atorvastatin|atorvastatin|mesh-list
6531455|NCT00793754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6531456|NCT00793754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6531457|NCT00793754|Analgesics|analgesics|mesh-ancestor
6531458|NCT00793754|Sensory System Agents|sensory system agents|mesh-ancestor
6531459|NCT00793754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6531460|NCT00793754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531461|NCT00793754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6531462|NCT00793754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6531463|NCT00793754|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6531464|NCT00793754|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6531465|NCT00793754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531466|NCT00793754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6531467|NCT00793754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6531468|NCT00793754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6531469|NCT00793754|Antipyretics|antipyretics|mesh-ancestor
6531470|NCT00793754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6531471|NCT00793754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6531472|NCT00793754|Antimetabolites|antimetabolites|mesh-ancestor
6531473|NCT00793754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6531474|NCT00793754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6531475|NCT00793767|Epoetin Alfa|epoetin alfa|mesh-list
6531476|NCT00793767|Hematinics|hematinics|mesh-ancestor
6531477|NCT00793845|Cyclophosphamide|cyclophosphamide|mesh-list
6531478|NCT00793845|Melphalan|melphalan|mesh-list
6531479|NCT00793845|Thiotepa|thiotepa|mesh-list
6531480|NCT00793845|Carboplatin|carboplatin|mesh-list
6531481|NCT00793845|Etoposide|etoposide|mesh-list
6531482|NCT00793845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6531483|NCT00793845|Immunologic Factors|immunologic factors|mesh-ancestor
6531484|NCT00793845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531485|NCT00793845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6531486|NCT00793845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6531487|NCT00793845|Alkylating Agents|alkylating agents|mesh-ancestor
6531488|NCT00793845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531489|NCT00793845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6531490|NCT00793845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6531491|NCT00793845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5993019|NCT00118716|Autonomic Agents|autonomic agents|mesh-ancestor
5993020|NCT00118716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6531492|NCT00793845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6531493|NCT00793845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6531494|NCT00793845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6531495|NCT00793858|Ciclesonide|ciclesonide|mesh-list
6531496|NCT00793858|Glucocorticoids|glucocorticoids|mesh-ancestor
6531497|NCT00793858|Hormones|hormones|mesh-ancestor
6531498|NCT00793858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6531499|NCT00793858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531500|NCT00793858|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6531501|NCT00793897|Paclitaxel|paclitaxel|mesh-list
6531502|NCT00793897|Carboplatin|carboplatin|mesh-list
6531503|NCT00793897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6531504|NCT00793897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6531505|NCT00793897|Tubulin Modulators|tubulin modulators|mesh-ancestor
6531506|NCT00793897|Antimitotic Agents|antimitotic agents|mesh-ancestor
6531507|NCT00793897|Mitosis Modulators|mitosis modulators|mesh-ancestor
6531508|NCT00793897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531509|NCT00793923|Dexamethasone|dexamethasone|mesh-list
6531510|NCT00793923|Ranibizumab|ranibizumab|mesh-list
6531511|NCT00793923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6531512|NCT00793923|Antiemetics|antiemetics|mesh-ancestor
6531513|NCT00793923|Autonomic Agents|autonomic agents|mesh-ancestor
6531514|NCT00793923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6531515|NCT00793923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531516|NCT00793923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6531517|NCT00793923|Glucocorticoids|glucocorticoids|mesh-ancestor
6531518|NCT00793923|Hormones|hormones|mesh-ancestor
6531519|NCT00793923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6531520|NCT00793923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6531521|NCT00793923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6531522|NCT00793923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6531523|NCT00793923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6531524|NCT00793923|Growth Substances|growth substances|mesh-ancestor
6531525|NCT00793923|Growth Inhibitors|growth inhibitors|mesh-ancestor
6531526|NCT00793975|Ramucirumab|ramucirumab|mesh-list
6531527|NCT00793975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6531528|NCT00793988|Anesthetics|anesthetics|mesh-list
6531529|NCT00793988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6531530|NCT00793988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537677|NCT00823576|Anesthetics|anesthetics|mesh-ancestor
6537678|NCT00823576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6795289|NCT02256124|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6795290|NCT02256124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6795291|NCT02256124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795292|NCT02256124|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6795293|NCT02256124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795294|NCT02256124|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6258384|NCT03086213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6258385|NCT03086213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258386|NCT03086213|Sensory System Agents|sensory system agents|mesh-ancestor
6258387|NCT03086213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6258388|NCT03086213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6258389|NCT03086213|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6537679|NCT00823576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795295|NCT02256124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6795296|NCT02256124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6795297|NCT02256124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6795298|NCT02256124|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6795299|NCT02256150|Mizoribine|mizoribine|mesh-list
6795300|NCT02256150|Cyclophosphamide|cyclophosphamide|mesh-list
6795301|NCT02256150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6795302|NCT02256150|Immunologic Factors|immunologic factors|mesh-ancestor
6795303|NCT02256150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795304|NCT02256150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6795305|NCT02256150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6795306|NCT02256150|Alkylating Agents|alkylating agents|mesh-ancestor
6795307|NCT02256150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795308|NCT02256150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6795309|NCT02256150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6795310|NCT02256150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6795311|NCT02256150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6795312|NCT02256150|Analgesics|analgesics|mesh-ancestor
6795313|NCT02256150|Sensory System Agents|sensory system agents|mesh-ancestor
6531531|NCT00794209|Fentanyl|fentanyl|mesh-list
6531532|NCT00794209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6531533|NCT00794209|Narcotics|narcotics|mesh-ancestor
6531534|NCT00794209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6531535|NCT00794209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531536|NCT00794209|Analgesics|analgesics|mesh-ancestor
6531537|NCT00794209|Sensory System Agents|sensory system agents|mesh-ancestor
6531538|NCT00794209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6531539|NCT00794209|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6531540|NCT00794209|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6531541|NCT00794209|Anesthetics, General|anesthetics, general|mesh-ancestor
6531542|NCT00794209|Anesthetics|anesthetics|mesh-ancestor
6531543|NCT00794235|Sorafenib|sorafenib|mesh-list
6795314|NCT02256150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6795315|NCT02256150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6795316|NCT02256150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6795317|NCT02256150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6795318|NCT02256150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6795319|NCT02256150|Antimalarials|antimalarials|mesh-ancestor
6795320|NCT02256150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6795321|NCT02256150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6795322|NCT02256150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6795323|NCT02256215|Vitamin D|vitamin d|mesh-list
6795324|NCT02256215|Vitamins|vitamins|mesh-ancestor
6795325|NCT02256215|Micronutrients|micronutrients|mesh-ancestor
6795326|NCT02256215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795327|NCT02256215|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6795328|NCT02256228|Ropivacaine|ropivacaine|mesh-list
6795329|NCT02256228|Anesthetics, Local|anesthetics, local|mesh-ancestor
6795330|NCT02256228|Anesthetics|anesthetics|mesh-ancestor
6795331|NCT02256228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6795332|NCT02256228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795333|NCT02256228|Sensory System Agents|sensory system agents|mesh-ancestor
6795334|NCT02256228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6795335|NCT02256254|Simvastatin|simvastatin|mesh-list
6795336|NCT02256254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6795337|NCT02256254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6795338|NCT02256254|Antimetabolites|antimetabolites|mesh-ancestor
6795339|NCT02256254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795340|NCT02256254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6795341|NCT02256254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6795342|NCT02256254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6795343|NCT02256280|Neostigmine|neostigmine|mesh-list
6795344|NCT02256280|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6795345|NCT02256280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6795346|NCT02256280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795347|NCT02256280|Cholinergic Agents|cholinergic agents|mesh-ancestor
6795348|NCT02256280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6795349|NCT02256280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795350|NCT02256280|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6795351|NCT02256280|Autonomic Agents|autonomic agents|mesh-ancestor
6795352|NCT02256280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6795353|NCT02256319|Dexmedetomidine|dexmedetomidine|mesh-list
6795354|NCT02256319|Propofol|propofol|mesh-list
6795355|NCT02256319|Imidazole|imidazole|mesh-list
6795356|NCT02256319|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6795357|NCT02256319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6795358|NCT02256319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795359|NCT02256319|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6795360|NCT02256319|Anesthetics, General|anesthetics, general|mesh-ancestor
6795361|NCT02256319|Anesthetics|anesthetics|mesh-ancestor
6795362|NCT02256319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6795363|NCT02256319|Analgesics|analgesics|mesh-ancestor
6795364|NCT02256319|Sensory System Agents|sensory system agents|mesh-ancestor
6795365|NCT02256319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6795366|NCT02256319|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6795367|NCT02256319|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6795368|NCT02256319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6795369|NCT02256319|Adrenergic Agents|adrenergic agents|mesh-ancestor
6795370|NCT02256319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6258390|NCT03086213|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6531544|NCT00794235|Dacarbazine|dacarbazine|mesh-list
6795371|NCT02256319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795372|NCT02256319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6531545|NCT00794235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6795373|NCT02256423|Ibuprofen|ibuprofen|mesh-list
6531546|NCT00794235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6531547|NCT00794235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6531548|NCT00794235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531549|NCT00794235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6531550|NCT00794235|Alkylating Agents|alkylating agents|mesh-ancestor
6531551|NCT00794261|Lenograstim|lenograstim|mesh-list
6531552|NCT00794261|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6531553|NCT00794261|Immunologic Factors|immunologic factors|mesh-ancestor
6531554|NCT00794261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531555|NCT00794326|Dialysis Solutions|dialysis solutions|mesh-list
6531556|NCT00794326|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6531557|NCT00794443|Diphosphonates|diphosphonates|mesh-list
6531558|NCT00794443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6531559|NCT00794443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531560|NCT00794625|Valproic Acid|valproic acid|mesh-list
6531561|NCT00794625|Risperidone|risperidone|mesh-list
6531562|NCT00794625|Dextroamphetamine|dextroamphetamine|mesh-list
6531563|NCT00794625|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6531564|NCT00794625|Serotonin Agents|serotonin agents|mesh-ancestor
6531565|NCT00794625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6531566|NCT00794625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531567|NCT00794625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531568|NCT00794625|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6531569|NCT00794625|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6531570|NCT00794625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6531571|NCT00794625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6531572|NCT00794625|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6531573|NCT00794625|Dopamine Agents|dopamine agents|mesh-ancestor
6531574|NCT00794625|Anticonvulsants|anticonvulsants|mesh-ancestor
6531575|NCT00794625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6531576|NCT00794625|GABA Agents|gaba agents|mesh-ancestor
6531577|NCT00794625|Antimanic Agents|antimanic agents|mesh-ancestor
6531578|NCT00794625|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6531579|NCT00794625|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6531580|NCT00794625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6531581|NCT00794625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6531582|NCT00794638|Rituximab|rituximab|mesh-list
6795374|NCT02256423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6795375|NCT02256423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6795376|NCT02256423|Analgesics|analgesics|mesh-ancestor
6795377|NCT02256423|Sensory System Agents|sensory system agents|mesh-ancestor
6795378|NCT02256423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6795379|NCT02256423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795380|NCT02256423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6795381|NCT02256423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6795382|NCT02256423|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6795383|NCT02256423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6795384|NCT02256423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795385|NCT02256462|Adalimumab|adalimumab|mesh-list
6795386|NCT02256462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6795387|NCT02256462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6531583|NCT00794638|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6531584|NCT00794638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6531585|NCT00794638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6531586|NCT00794638|Immunologic Factors|immunologic factors|mesh-ancestor
6531587|NCT00794638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531588|NCT00794638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6531589|NCT00794638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6531590|NCT00794638|Alkylating Agents|alkylating agents|mesh-ancestor
6531591|NCT00794638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531592|NCT00794703|Itraconazole|itraconazole|mesh-list
6531593|NCT00794703|Micafungin|micafungin|mesh-list
6531594|NCT00794703|Antifungal Agents|antifungal agents|mesh-ancestor
6531595|NCT00794703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6531596|NCT00794703|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6531597|NCT00794703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6531598|NCT00794703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6531599|NCT00794703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531600|NCT00794703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6531601|NCT00794703|Hormone Antagonists|hormone antagonists|mesh-ancestor
6531602|NCT00794703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6531603|NCT00794703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531604|NCT00794703|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6531605|NCT00794755|Vitamin K|vitamin k|mesh-list
6531606|NCT00794755|Vitamin K 1|vitamin k 1|mesh-list
6531607|NCT00794755|Vitamins|vitamins|mesh-ancestor
6531608|NCT00794755|Micronutrients|micronutrients|mesh-ancestor
6531609|NCT00794755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531610|NCT00794755|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6531611|NCT00794755|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6531612|NCT00794755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531613|NCT00794755|Hemostatics|hemostatics|mesh-ancestor
6531614|NCT00794755|Coagulants|coagulants|mesh-ancestor
6531615|NCT00794807|Alefacept|alefacept|mesh-list
6531616|NCT00794807|Dermatologic Agents|dermatologic agents|mesh-ancestor
6531617|NCT00794807|Immunologic Factors|immunologic factors|mesh-ancestor
6531618|NCT00794807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531619|NCT00794859|Sorafenib|sorafenib|mesh-list
6531620|NCT00794859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6531621|NCT00794859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6531622|NCT00794859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6531623|NCT00794859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531624|NCT00794885|Folic Acid|folic acid|mesh-list
6531625|NCT00794885|Vitamin B Complex|vitamin b complex|mesh-list
6531626|NCT00794885|Enalapril|enalapril|mesh-list
6795388|NCT02256605|Vitamin D|vitamin d|mesh-list
6795389|NCT02256605|Cholecalciferol|cholecalciferol|mesh-list
6795390|NCT02256605|Vitamins|vitamins|mesh-ancestor
6795391|NCT02256605|Micronutrients|micronutrients|mesh-ancestor
6795392|NCT02256605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795393|NCT02256605|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6795394|NCT02256605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6795395|NCT02256683|Dabigatran|dabigatran|mesh-list
6795396|NCT02256683|Phenprocoumon|phenprocoumon|mesh-list
6795397|NCT02256683|Antithrombins|antithrombins|mesh-ancestor
6795398|NCT02256683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6795399|NCT02256683|Protease Inhibitors|protease inhibitors|mesh-ancestor
6795400|NCT02256683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6795401|NCT02256683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795402|NCT02256683|Anticoagulants|anticoagulants|mesh-ancestor
6795403|NCT02256709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6795404|NCT02256722|Propranolol|propranolol|mesh-list
6795405|NCT02256722|Bisoprolol|bisoprolol|mesh-list
6795406|NCT02256722|Acipimox|acipimox|mesh-list
6795407|NCT02256722|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6795408|NCT02256722|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6795409|NCT02256722|Autonomic Agents|autonomic agents|mesh-ancestor
6795410|NCT02256722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6795411|NCT02256722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795412|NCT02256722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6795413|NCT02256722|Respiratory System Agents|respiratory system agents|mesh-ancestor
6795414|NCT02256722|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6795415|NCT02256722|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6795416|NCT02256722|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6795417|NCT02256722|Adrenergic Agents|adrenergic agents|mesh-ancestor
6795418|NCT02256722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6795419|NCT02256722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531627|NCT00794885|Enalaprilat|enalaprilat|mesh-list
6531628|NCT00794885|Maleic acid|maleic acid|mesh-list
6531629|NCT00794885|Hematinics|hematinics|mesh-ancestor
6531630|NCT00794885|Vitamins|vitamins|mesh-ancestor
6531631|NCT00794885|Micronutrients|micronutrients|mesh-ancestor
6531632|NCT00794885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531633|NCT00794885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6531634|NCT00794885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531635|NCT00794885|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6531636|NCT00794885|Protease Inhibitors|protease inhibitors|mesh-ancestor
6531637|NCT00794885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6531638|NCT00794898|Infliximab|infliximab|mesh-list
6531639|NCT00794898|Dermatologic Agents|dermatologic agents|mesh-ancestor
6531640|NCT00794898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6531641|NCT00794898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6531642|NCT00794976|Dexamethasone|dexamethasone|mesh-list
6531643|NCT00794976|Dexamethasone acetate|dexamethasone acetate|mesh-list
6531644|NCT00794976|BB 1101|bb 1101|mesh-list
6531645|NCT00794976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6531646|NCT00794976|Antiemetics|antiemetics|mesh-ancestor
6531647|NCT00794976|Autonomic Agents|autonomic agents|mesh-ancestor
6531648|NCT00794976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6531649|NCT00794976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531650|NCT00794976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6531651|NCT00794976|Glucocorticoids|glucocorticoids|mesh-ancestor
6531652|NCT00794976|Hormones|hormones|mesh-ancestor
6531653|NCT00794976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6531654|NCT00794976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6531655|NCT00794976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6531656|NCT00794976|Protease Inhibitors|protease inhibitors|mesh-ancestor
6531657|NCT00794976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6531658|NCT00794976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531659|NCT00795015|Insulin|insulin|mesh-list
6531660|NCT00795015|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6531661|NCT00795015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6531662|NCT00795015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531663|NCT00795106|Capsaicin|capsaicin|mesh-list
6531664|NCT00795106|Antipruritics|antipruritics|mesh-ancestor
6531665|NCT00795106|Dermatologic Agents|dermatologic agents|mesh-ancestor
6531666|NCT00795106|Sensory System Agents|sensory system agents|mesh-ancestor
6531667|NCT00795106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6531668|NCT00795106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531669|NCT00795171|Docetaxel|docetaxel|mesh-list
6531670|NCT00795171|Sunitinib|sunitinib|mesh-list
6531671|NCT00795171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6531672|NCT00795171|Tubulin Modulators|tubulin modulators|mesh-ancestor
6531673|NCT00795171|Antimitotic Agents|antimitotic agents|mesh-ancestor
6531674|NCT00795171|Mitosis Modulators|mitosis modulators|mesh-ancestor
6531675|NCT00795171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531676|NCT00795171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6531677|NCT00795171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6531678|NCT00795171|Growth Substances|growth substances|mesh-ancestor
6531679|NCT00795171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531680|NCT00795171|Growth Inhibitors|growth inhibitors|mesh-ancestor
6531681|NCT00795171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6531682|NCT00795171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6531683|NCT00795223|Morphine|morphine|mesh-list
6531684|NCT00795223|Bupivacaine|bupivacaine|mesh-list
6531685|NCT00795223|Anesthetics, Local|anesthetics, local|mesh-ancestor
6531686|NCT00795223|Anesthetics|anesthetics|mesh-ancestor
6531687|NCT00795223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6531688|NCT00795223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531689|NCT00795223|Sensory System Agents|sensory system agents|mesh-ancestor
6531690|NCT00795223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6795420|NCT02256722|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6795421|NCT02256722|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6795422|NCT02256722|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6795423|NCT02256722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6795424|NCT02256722|Vasodilator Agents|vasodilator agents|mesh-ancestor
6795425|NCT02256722|Sympatholytics|sympatholytics|mesh-ancestor
6795426|NCT02256722|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6795427|NCT02256722|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6795428|NCT02256722|Antimetabolites|antimetabolites|mesh-ancestor
6795429|NCT02256722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6531691|NCT00795223|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6531692|NCT00795223|Narcotics|narcotics|mesh-ancestor
6531693|NCT00795223|Analgesics|analgesics|mesh-ancestor
6531694|NCT00795262|Thioctic Acid|thioctic acid|mesh-list
6531695|NCT00795262|Quinapril|quinapril|mesh-list
6531696|NCT00795262|Antioxidants|antioxidants|mesh-ancestor
6531697|NCT00795262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531698|NCT00795262|Protective Agents|protective agents|mesh-ancestor
6531699|NCT00795262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531700|NCT00795262|Vitamin B Complex|vitamin b complex|mesh-ancestor
6531701|NCT00795262|Vitamins|vitamins|mesh-ancestor
6531702|NCT00795262|Micronutrients|micronutrients|mesh-ancestor
6531703|NCT00795262|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6531704|NCT00795262|Protease Inhibitors|protease inhibitors|mesh-ancestor
6531705|NCT00795262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6531706|NCT00795262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6531707|NCT00795301|Capecitabine|capecitabine|mesh-list
6531708|NCT00795301|Oxaliplatin|oxaliplatin|mesh-list
6531709|NCT00795301|Cetuximab|cetuximab|mesh-list
6531710|NCT00795301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6531711|NCT00795301|Antimetabolites|antimetabolites|mesh-ancestor
6531712|NCT00795301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531713|NCT00795301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6531714|NCT00795301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6531715|NCT00795314|Fentanyl|fentanyl|mesh-list
6531716|NCT00795314|Butorphanol|butorphanol|mesh-list
6531717|NCT00795314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6531718|NCT00795314|Narcotics|narcotics|mesh-ancestor
6531719|NCT00795314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6531720|NCT00795314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531721|NCT00795314|Analgesics|analgesics|mesh-ancestor
6531722|NCT00795314|Sensory System Agents|sensory system agents|mesh-ancestor
6531723|NCT00795314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6531724|NCT00795314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6531725|NCT00795314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6531726|NCT00795314|Anesthetics, General|anesthetics, general|mesh-ancestor
6531727|NCT00795314|Anesthetics|anesthetics|mesh-ancestor
6531728|NCT00795314|Antitussive Agents|antitussive agents|mesh-ancestor
6531729|NCT00795314|Respiratory System Agents|respiratory system agents|mesh-ancestor
6531730|NCT00795314|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6531731|NCT00795353|Alefacept|alefacept|mesh-list
6531732|NCT00795353|Dermatologic Agents|dermatologic agents|mesh-ancestor
6531733|NCT00795353|Immunologic Factors|immunologic factors|mesh-ancestor
6531734|NCT00795353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531735|NCT00795444|Maraviroc|maraviroc|mesh-list
6531736|NCT00795444|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6531737|NCT00795444|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6531738|NCT00795444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531739|NCT00795444|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6531740|NCT00795444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6531741|NCT00795444|Antiviral Agents|antiviral agents|mesh-ancestor
6531742|NCT00795444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6531743|NCT00795444|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6531744|NCT00795457|Poly I-C|poly i-c|mesh-list
6531745|NCT00795457|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6531746|NCT00795457|Vaccines|vaccines|mesh-list
6531747|NCT00795457|Poly ICLC|poly iclc|mesh-list
6531748|NCT00795457|Immunologic Factors|immunologic factors|mesh-ancestor
6531749|NCT00795457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531750|NCT00795457|Interferon Inducers|interferon inducers|mesh-ancestor
6531751|NCT00795457|Laxatives|laxatives|mesh-ancestor
6531752|NCT00795457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6531753|NCT00795457|Antiviral Agents|antiviral agents|mesh-ancestor
6531754|NCT00795457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6531755|NCT00795470|Anti-Infective Agents|anti-infective agents|mesh-list
6531756|NCT00795470|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6531757|NCT00795483|Zoledronic Acid|zoledronic acid|mesh-list
6531758|NCT00795483|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6531759|NCT00795483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531760|NCT00795496|Histamine|histamine|mesh-list
6531761|NCT00795496|Histamine Agonists|histamine agonists|mesh-ancestor
6531762|NCT00795496|Histamine Agents|histamine agents|mesh-ancestor
6531763|NCT00795496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6531764|NCT00795496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531765|NCT00795496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531766|NCT00795548|Azacitidine|azacitidine|mesh-list
6531767|NCT00795548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6795430|NCT02256735|Moxifloxacin|moxifloxacin|mesh-list
6531768|NCT00795548|Antimetabolites|antimetabolites|mesh-ancestor
6531769|NCT00795548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531770|NCT00795548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6795431|NCT02256735|p-Hydroxyamphetamine|p-hydroxyamphetamine|mesh-list
6531771|NCT00795548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6531772|NCT00795574|Infliximab|infliximab|mesh-list
6531773|NCT00795574|Dermatologic Agents|dermatologic agents|mesh-ancestor
6531774|NCT00795574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6531775|NCT00795574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6531776|NCT00795587|Mannitol|mannitol|mesh-list
6531777|NCT00795587|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6531778|NCT00795587|Diuretics|diuretics|mesh-ancestor
6531779|NCT00795587|Natriuretic Agents|natriuretic agents|mesh-ancestor
6531780|NCT00795587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531781|NCT00795613|Doxorubicin|doxorubicin|mesh-list
6531782|NCT00795613|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6531783|NCT00795613|Vincristine|vincristine|mesh-list
6531784|NCT00795613|Procarbazine|procarbazine|mesh-list
6531785|NCT00795613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6531786|NCT00795613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6531787|NCT00795613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6531788|NCT00795613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6531789|NCT00795613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6531790|NCT00795613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531791|NCT00795613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6531792|NCT00795613|Tubulin Modulators|tubulin modulators|mesh-ancestor
6531793|NCT00795613|Antimitotic Agents|antimitotic agents|mesh-ancestor
6531794|NCT00795613|Mitosis Modulators|mitosis modulators|mesh-ancestor
6531795|NCT00795678|Gemcitabine|gemcitabine|mesh-list
6531796|NCT00795678|Paclitaxel|paclitaxel|mesh-list
6531797|NCT00795678|Vinorelbine|vinorelbine|mesh-list
6531798|NCT00795678|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6531799|NCT00795678|Cyclophosphamide|cyclophosphamide|mesh-list
6531800|NCT00795678|Doxorubicin|doxorubicin|mesh-list
6531801|NCT00795678|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6531802|NCT00795678|Capecitabine|capecitabine|mesh-list
6531803|NCT00795678|Trastuzumab|trastuzumab|mesh-list
6531804|NCT00795678|Lapatinib|lapatinib|mesh-list
6531805|NCT00795678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6531806|NCT00795678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6531807|NCT00795678|Tubulin Modulators|tubulin modulators|mesh-ancestor
6531808|NCT00795678|Antimitotic Agents|antimitotic agents|mesh-ancestor
6531809|NCT00795678|Mitosis Modulators|mitosis modulators|mesh-ancestor
6531810|NCT00795678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531811|NCT00795678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6531812|NCT00795678|Immunologic Factors|immunologic factors|mesh-ancestor
6531813|NCT00795678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531814|NCT00795678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6531815|NCT00795678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6531816|NCT00795678|Alkylating Agents|alkylating agents|mesh-ancestor
6531817|NCT00795678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6531818|NCT00795678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6531819|NCT00795678|Antimetabolites|antimetabolites|mesh-ancestor
6531820|NCT00795678|Antiviral Agents|antiviral agents|mesh-ancestor
6531821|NCT00795678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6531822|NCT00795678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6531823|NCT00795678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6531824|NCT00795678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6531825|NCT00795678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6531826|NCT00795678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6531827|NCT00795678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6531828|NCT00795756|Cytarabine|cytarabine|mesh-list
6531829|NCT00795756|Methotrexate|methotrexate|mesh-list
6531830|NCT00795756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6531831|NCT00795756|Abortifacient Agents|abortifacient agents|mesh-ancestor
6531832|NCT00795756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6531833|NCT00795756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531834|NCT00795756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6531835|NCT00795756|Antimetabolites|antimetabolites|mesh-ancestor
6795432|NCT02256735|Ritobegron|ritobegron|mesh-list
6795433|NCT02256735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6795434|NCT02256735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6795435|NCT02256735|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6795436|NCT02256735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6795437|NCT02256735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6795438|NCT02256735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795439|NCT02256735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6531836|NCT00795756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531837|NCT00795756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6531838|NCT00795756|Dermatologic Agents|dermatologic agents|mesh-ancestor
6531839|NCT00795756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6531840|NCT00795756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6531841|NCT00795756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6531842|NCT00795756|Immunologic Factors|immunologic factors|mesh-ancestor
6531843|NCT00795756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6531844|NCT00795756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6531845|NCT00795756|Antiviral Agents|antiviral agents|mesh-ancestor
6531846|NCT00795756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6531847|NCT00795808|Metformin|metformin|mesh-list
6531848|NCT00795808|Clomiphene|clomiphene|mesh-list
6531849|NCT00795808|Enclomiphene|enclomiphene|mesh-list
6531850|NCT00795808|Zuclomiphene|zuclomiphene|mesh-list
6531851|NCT00795808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6531852|NCT00795808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531853|NCT00795808|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6531854|NCT00795808|Hormone Antagonists|hormone antagonists|mesh-ancestor
6531855|NCT00795808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6531856|NCT00795808|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6531857|NCT00795808|Fertility Agents|fertility agents|mesh-ancestor
6531858|NCT00795808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6531859|NCT00795808|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6531860|NCT00795808|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6531861|NCT00795847|Losartan|losartan|mesh-list
6531862|NCT00795847|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6531863|NCT00795847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6531864|NCT00795847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6531865|NCT00795847|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6531866|NCT00795847|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6531867|NCT00795847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531868|NCT00795847|Diuretics|diuretics|mesh-ancestor
6531869|NCT00795847|Natriuretic Agents|natriuretic agents|mesh-ancestor
6531870|NCT00795847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531871|NCT00795847|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6531872|NCT00795847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6531873|NCT00795899|Paclitaxel|paclitaxel|mesh-list
6531874|NCT00795899|Cyclophosphamide|cyclophosphamide|mesh-list
6531875|NCT00795899|Trastuzumab|trastuzumab|mesh-list
6531876|NCT00795899|Epirubicin|epirubicin|mesh-list
6531877|NCT00795899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6531878|NCT00795899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6531879|NCT00795899|Tubulin Modulators|tubulin modulators|mesh-ancestor
6531880|NCT00795899|Antimitotic Agents|antimitotic agents|mesh-ancestor
6531881|NCT00795899|Mitosis Modulators|mitosis modulators|mesh-ancestor
6531882|NCT00795899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531883|NCT00795899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6531884|NCT00795899|Immunologic Factors|immunologic factors|mesh-ancestor
6531885|NCT00795899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531886|NCT00795899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6531887|NCT00795899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6531888|NCT00795899|Alkylating Agents|alkylating agents|mesh-ancestor
6531889|NCT00795899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6531890|NCT00795899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6531891|NCT00795899|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6531892|NCT00795899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6531893|NCT00795899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6531894|NCT00795899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6531895|NCT00795912|Atorvastatin|atorvastatin|mesh-list
6531896|NCT00795912|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6531897|NCT00795912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6531898|NCT00795912|Antimetabolites|antimetabolites|mesh-ancestor
6531899|NCT00795912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531900|NCT00795912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6531901|NCT00795912|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6531902|NCT00795912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6531903|NCT00795925|Propiverine|propiverine|mesh-list
6531904|NCT00795925|Parasympatholytics|parasympatholytics|mesh-ancestor
6531905|NCT00795925|Autonomic Agents|autonomic agents|mesh-ancestor
6531906|NCT00795925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6531907|NCT00795925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531908|NCT00795925|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6531909|NCT00795925|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6531910|NCT00795925|Cholinergic Agents|cholinergic agents|mesh-ancestor
6531911|NCT00795925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6531912|NCT00795925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531913|NCT00795925|Urological Agents|urological agents|mesh-ancestor
6531914|NCT00795938|Sildenafil Citrate|sildenafil citrate|mesh-list
6531915|NCT00795938|Vasodilator Agents|vasodilator agents|mesh-ancestor
6531916|NCT00795938|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6531917|NCT00795938|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6531918|NCT00795938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6531919|NCT00795938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531920|NCT00795938|Urological Agents|urological agents|mesh-ancestor
6531921|NCT00795977|Picibanil|picibanil|mesh-list
6531922|NCT00795977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6531923|NCT00796029|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6531924|NCT00796029|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6531925|NCT00796029|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6531926|NCT00796029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6531927|NCT00796029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531928|NCT00796029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6531929|NCT00796029|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6531930|NCT00796029|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6531931|NCT00796029|Serotonin Agents|serotonin agents|mesh-ancestor
6531932|NCT00796029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6531933|NCT00796029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531934|NCT00796029|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6531935|NCT00796029|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6531936|NCT00796029|Dopamine Agents|dopamine agents|mesh-ancestor
6531937|NCT00796081|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6531938|NCT00796081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6531939|NCT00796081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6531940|NCT00796081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6531941|NCT00796081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531942|NCT00796081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6531943|NCT00796081|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6531944|NCT00796081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6531945|NCT00796081|Serotonin Agents|serotonin agents|mesh-ancestor
6531946|NCT00796081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6531947|NCT00796081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531948|NCT00796081|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6795440|NCT02256735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795441|NCT02256735|Mydriatics|mydriatics|mesh-ancestor
6795442|NCT02256735|Autonomic Agents|autonomic agents|mesh-ancestor
6795443|NCT02256735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6795444|NCT02256735|Sympathomimetics|sympathomimetics|mesh-ancestor
6795445|NCT02256735|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6795446|NCT02256735|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6795447|NCT02256735|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6795448|NCT02256735|Adrenergic Agents|adrenergic agents|mesh-ancestor
6795449|NCT02256735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6795450|NCT02256748|Midazolam|midazolam|mesh-list
6795451|NCT02256748|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6795452|NCT02256748|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6795453|NCT02256748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6795454|NCT02256748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795455|NCT02256748|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6795456|NCT02256748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6795457|NCT02256748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6795458|NCT02256748|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6795459|NCT02256748|Anesthetics, General|anesthetics, general|mesh-ancestor
6795460|NCT02256748|Anesthetics|anesthetics|mesh-ancestor
6795461|NCT02256748|GABA Modulators|gaba modulators|mesh-ancestor
6795462|NCT02256748|GABA Agents|gaba agents|mesh-ancestor
6795463|NCT02256748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6795464|NCT02256748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795465|NCT02256774|Ritonavir|ritonavir|mesh-list
6795466|NCT02256774|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6795467|NCT02256774|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6795468|NCT02256774|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6795469|NCT02256774|Protease Inhibitors|protease inhibitors|mesh-ancestor
6795470|NCT02256774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6795471|NCT02256774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795472|NCT02256774|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6795473|NCT02256774|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6795474|NCT02256774|Antiviral Agents|antiviral agents|mesh-ancestor
6795475|NCT02256774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6795476|NCT02256774|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6795477|NCT02256774|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6795478|NCT02256774|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6531949|NCT00796081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6531950|NCT00796081|Dopamine Agents|dopamine agents|mesh-ancestor
6537680|NCT00823576|Sensory System Agents|sensory system agents|mesh-ancestor
6537681|NCT00823576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6537682|NCT00823602|Buserelin|buserelin|mesh-list
6537683|NCT00823602|Ganirelix|ganirelix|mesh-list
6537684|NCT00823602|Hormone Antagonists|hormone antagonists|mesh-ancestor
6537685|NCT00823602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6537686|NCT00823602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537687|NCT00823602|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6537688|NCT00823602|Fertility Agents|fertility agents|mesh-ancestor
6537689|NCT00823602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6537690|NCT00823641|Infliximab|infliximab|mesh-list
6537691|NCT00823641|Dermatologic Agents|dermatologic agents|mesh-ancestor
6537692|NCT00823641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6537693|NCT00823641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6537694|NCT00823849|Cilostazol|cilostazol|mesh-list
6537695|NCT00823849|Probucol|probucol|mesh-list
6537696|NCT00823849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6537697|NCT00823849|Autonomic Agents|autonomic agents|mesh-ancestor
6537698|NCT00823849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6537699|NCT00823849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537700|NCT00823849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6537701|NCT00823849|Respiratory System Agents|respiratory system agents|mesh-ancestor
6537702|NCT00823849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6537703|NCT00823849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6537704|NCT00823849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537705|NCT00823849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6537706|NCT00823849|Vasodilator Agents|vasodilator agents|mesh-ancestor
6537707|NCT00823849|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6537708|NCT00823849|Protective Agents|protective agents|mesh-ancestor
6537709|NCT00823849|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6537710|NCT00823849|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6537711|NCT00823849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6537712|NCT00823849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6537713|NCT00823849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6537714|NCT00823849|Antimetabolites|antimetabolites|mesh-ancestor
6537715|NCT00823849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6537716|NCT00823849|Antioxidants|antioxidants|mesh-ancestor
6537717|NCT00823862|Ribavirin|ribavirin|mesh-list
6537718|NCT00823862|Antimetabolites|antimetabolites|mesh-ancestor
6537719|NCT00823862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537720|NCT00823862|Antiviral Agents|antiviral agents|mesh-ancestor
6537721|NCT00823862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6537722|NCT00823875|Cilostazol|cilostazol|mesh-list
6537723|NCT00823875|Probucol|probucol|mesh-list
6537724|NCT00823875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6537725|NCT00823875|Autonomic Agents|autonomic agents|mesh-ancestor
6537726|NCT00823875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6537727|NCT00823875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537728|NCT00823875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6537729|NCT00823875|Respiratory System Agents|respiratory system agents|mesh-ancestor
6537730|NCT00823875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6795479|NCT02256774|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6795480|NCT02256813|Vitamin K|vitamin k|mesh-list
6795481|NCT02256813|Vitamin K 1|vitamin k 1|mesh-list
6795482|NCT02256813|Midazolam|midazolam|mesh-list
6795483|NCT02256813|Dextromethorphan|dextromethorphan|mesh-list
6795484|NCT02256813|Caffeine|caffeine|mesh-list
6795485|NCT02256813|Omeprazole|omeprazole|mesh-list
6795486|NCT02256813|Warfarin|warfarin|mesh-list
6795487|NCT02256813|Vitamins|vitamins|mesh-ancestor
6795488|NCT02256813|Micronutrients|micronutrients|mesh-ancestor
6795489|NCT02256813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795490|NCT02256813|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6795491|NCT02256813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6795492|NCT02256813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6795493|NCT02256813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6795494|NCT02256813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6537731|NCT00823875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6538082|NCT00825643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795495|NCT02256813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6795496|NCT02256813|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6531951|NCT00796159|Olmesartan|olmesartan|mesh-list
6531952|NCT00796159|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6531953|NCT00796159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6531954|NCT00796159|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6531955|NCT00796159|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6531956|NCT00796159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531957|NCT00796185|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6531958|NCT00796185|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6531959|NCT00796185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6795497|NCT02256813|Anesthetics, General|anesthetics, general|mesh-ancestor
6795498|NCT02256813|Anesthetics|anesthetics|mesh-ancestor
6795499|NCT02256813|GABA Modulators|gaba modulators|mesh-ancestor
6795500|NCT02256813|GABA Agents|gaba agents|mesh-ancestor
6795501|NCT02256813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6795502|NCT02256813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795503|NCT02256813|Anticoagulants|anticoagulants|mesh-ancestor
6795504|NCT02256813|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6795505|NCT02256813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6795506|NCT02256813|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6795507|NCT02256813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6795508|NCT02256813|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6795509|NCT02256813|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6795510|NCT02256813|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6795511|NCT02256813|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6795512|NCT02256813|Purinergic Agents|purinergic agents|mesh-ancestor
6795513|NCT02256813|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6795514|NCT02256813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6795515|NCT02256813|Hemostatics|hemostatics|mesh-ancestor
6795516|NCT02256813|Coagulants|coagulants|mesh-ancestor
6795517|NCT02256813|Antitussive Agents|antitussive agents|mesh-ancestor
6795518|NCT02256813|Respiratory System Agents|respiratory system agents|mesh-ancestor
6795519|NCT02256813|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6795520|NCT02256813|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6795521|NCT02256826|Ritonavir|ritonavir|mesh-list
6795522|NCT02256826|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6795523|NCT02256826|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6795524|NCT02256826|Protease Inhibitors|protease inhibitors|mesh-ancestor
6795525|NCT02256826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6795526|NCT02256826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795527|NCT02256826|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6795528|NCT02256826|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6795529|NCT02256826|Antiviral Agents|antiviral agents|mesh-ancestor
6795530|NCT02256826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6795531|NCT02256826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6795532|NCT02256826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6795533|NCT02256865|Ketoconazole|ketoconazole|mesh-list
6795534|NCT02256865|Hydrocortisone|hydrocortisone|mesh-list
6795535|NCT02256865|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6795536|NCT02256865|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6795537|NCT02256865|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6795538|NCT02256865|Methyltestosterone|methyltestosterone|mesh-list
6795539|NCT02256865|Testosterone|testosterone|mesh-list
6795540|NCT02256865|Testosterone undecanoate|testosterone undecanoate|mesh-list
6795541|NCT02256865|Testosterone enanthate|testosterone enanthate|mesh-list
6795542|NCT02256865|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6795543|NCT02256865|Androgens|androgens|mesh-ancestor
6795544|NCT02256865|Hormones|hormones|mesh-ancestor
6795545|NCT02256865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6795546|NCT02256865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795547|NCT02256865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6795548|NCT02256865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6795549|NCT02256865|Anabolic Agents|anabolic agents|mesh-ancestor
6795550|NCT02256865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6795551|NCT02256865|Antifungal Agents|antifungal agents|mesh-ancestor
6795552|NCT02256865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6795553|NCT02256865|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6795554|NCT02256865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6795555|NCT02256865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6795556|NCT02256865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795557|NCT02256865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6795558|NCT02256865|Hormone Antagonists|hormone antagonists|mesh-ancestor
6795559|NCT02256865|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6795560|NCT02256878|Amitriptyline|amitriptyline|mesh-list
6795561|NCT02256878|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6531960|NCT00796185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6531961|NCT00796185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531962|NCT00796185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6531963|NCT00796185|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6531964|NCT00796185|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6531965|NCT00796185|Serotonin Agents|serotonin agents|mesh-ancestor
6531966|NCT00796185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6531967|NCT00796185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531968|NCT00796185|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6531969|NCT00796185|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6531970|NCT00796185|Dopamine Agents|dopamine agents|mesh-ancestor
6531971|NCT00796198|Latanoprost|latanoprost|mesh-list
6531972|NCT00796198|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6531973|NCT00796198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6531974|NCT00796211|Nortriptyline|nortriptyline|mesh-list
6531975|NCT00796211|Calcipotriene|calcipotriene|mesh-list
6531976|NCT00796211|Dermatologic Agents|dermatologic agents|mesh-ancestor
6531977|NCT00796211|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6531978|NCT00796211|Antidepressive Agents|antidepressive agents|mesh-ancestor
6531979|NCT00796211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6531980|NCT00796211|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6531981|NCT00796211|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6531982|NCT00796211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6531983|NCT00796211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6531984|NCT00796211|Adrenergic Agents|adrenergic agents|mesh-ancestor
6531985|NCT00796211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6531986|NCT00796211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6531987|NCT00796250|Prednisolone|prednisolone|mesh-list
6531988|NCT00796250|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6531989|NCT00796250|Methylprednisolone|methylprednisolone|mesh-list
6531990|NCT00796250|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6531991|NCT00796250|Prednisolone acetate|prednisolone acetate|mesh-list
6531992|NCT00796250|Azathioprine|azathioprine|mesh-list
6531993|NCT00796250|Infliximab|infliximab|mesh-list
6531994|NCT00796250|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6531995|NCT00796250|Prednisolone phosphate|prednisolone phosphate|mesh-list
6531996|NCT00796250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6531997|NCT00796250|Glucocorticoids|glucocorticoids|mesh-ancestor
6795562|NCT02256878|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6795563|NCT02256878|Antidepressive Agents|antidepressive agents|mesh-ancestor
6795564|NCT02256878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6795565|NCT02256878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6795566|NCT02256878|Analgesics|analgesics|mesh-ancestor
6795567|NCT02256878|Sensory System Agents|sensory system agents|mesh-ancestor
6795568|NCT02256878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6795569|NCT02256878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795570|NCT02256878|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6795571|NCT02256878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6795572|NCT02256878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6795573|NCT02256878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795574|NCT02256878|Adrenergic Agents|adrenergic agents|mesh-ancestor
6795575|NCT02256878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6795576|NCT02256878|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6795577|NCT02256878|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6795578|NCT02256878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6795579|NCT02256943|Amitriptyline|amitriptyline|mesh-list
6795580|NCT02256943|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6795581|NCT02256943|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6795582|NCT02256943|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6795583|NCT02256943|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6795584|NCT02256943|Cholinergic Agents|cholinergic agents|mesh-ancestor
6795585|NCT02256943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6795586|NCT02256943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795587|NCT02256943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795588|NCT02256943|Urological Agents|urological agents|mesh-ancestor
6795589|NCT02256943|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6795590|NCT02256943|Antidepressive Agents|antidepressive agents|mesh-ancestor
6795591|NCT02256943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6795592|NCT02256943|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6795593|NCT02256943|Analgesics|analgesics|mesh-ancestor
6795594|NCT02256943|Sensory System Agents|sensory system agents|mesh-ancestor
6795595|NCT02256943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6795596|NCT02256943|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6531998|NCT00796250|Hormones|hormones|mesh-ancestor
6531999|NCT00796250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6532000|NCT00796250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532001|NCT00796250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6532002|NCT00796250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6532003|NCT00796250|Antiemetics|antiemetics|mesh-ancestor
6532004|NCT00796250|Autonomic Agents|autonomic agents|mesh-ancestor
6532005|NCT00796250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6532006|NCT00796250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6532007|NCT00796250|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6532008|NCT00796250|Protective Agents|protective agents|mesh-ancestor
6532009|NCT00796250|Dermatologic Agents|dermatologic agents|mesh-ancestor
6532010|NCT00796250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6532011|NCT00796250|Antimetabolites|antimetabolites|mesh-ancestor
6532012|NCT00796250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532013|NCT00796250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6532014|NCT00796250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6532015|NCT00796250|Immunologic Factors|immunologic factors|mesh-ancestor
6532016|NCT00796263|Dolutegravir|dolutegravir|mesh-list
6532017|NCT00796263|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6532018|NCT00796263|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6532019|NCT00796263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6532020|NCT00796263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532021|NCT00796263|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6532022|NCT00796263|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6532023|NCT00796263|Antiviral Agents|antiviral agents|mesh-ancestor
6532024|NCT00796263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6532025|NCT00796276|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6795597|NCT02256943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6795598|NCT02256943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6795599|NCT02256943|Adrenergic Agents|adrenergic agents|mesh-ancestor
6795600|NCT02256943|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6795601|NCT02256943|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6795602|NCT02256943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6795603|NCT02256956|Amitriptyline|amitriptyline|mesh-list
6795604|NCT02256956|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6795605|NCT02256956|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6795606|NCT02256956|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6795607|NCT02256956|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6795608|NCT02256956|Cholinergic Agents|cholinergic agents|mesh-ancestor
6795609|NCT02256956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6795610|NCT02256956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795611|NCT02256956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795612|NCT02256956|Urological Agents|urological agents|mesh-ancestor
6795613|NCT02256956|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6795614|NCT02256956|Antidepressive Agents|antidepressive agents|mesh-ancestor
6795615|NCT02256956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6795616|NCT02256956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6795617|NCT02256956|Analgesics|analgesics|mesh-ancestor
6795618|NCT02256956|Sensory System Agents|sensory system agents|mesh-ancestor
6795619|NCT02256956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6795620|NCT02256956|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6795621|NCT02256956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6795622|NCT02256956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6795623|NCT02256956|Adrenergic Agents|adrenergic agents|mesh-ancestor
6795624|NCT02256956|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6795625|NCT02256956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6795626|NCT02256956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6795627|NCT02257008|Ritonavir|ritonavir|mesh-list
6795628|NCT02257008|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6795629|NCT02257008|Nelfinavir|nelfinavir|mesh-list
6795630|NCT02257008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6795631|NCT02257008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6795632|NCT02257008|Protease Inhibitors|protease inhibitors|mesh-ancestor
6795633|NCT02257008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6795634|NCT02257008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795635|NCT02257008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6795636|NCT02257008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6795637|NCT02257008|Antiviral Agents|antiviral agents|mesh-ancestor
6795638|NCT02257008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6795639|NCT02257008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6795640|NCT02257008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6795641|NCT02257021|Ritonavir|ritonavir|mesh-list
6795642|NCT02257021|Tipranavir|tipranavir|mesh-list
6795643|NCT02257021|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6532026|NCT00796276|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6532027|NCT00796276|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6532028|NCT00796276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6532029|NCT00796276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532030|NCT00796276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6532031|NCT00796276|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6532032|NCT00796276|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6532033|NCT00796276|Serotonin Agents|serotonin agents|mesh-ancestor
6532034|NCT00796276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6532035|NCT00796276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532036|NCT00796276|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6532037|NCT00796276|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6532038|NCT00796276|Dopamine Agents|dopamine agents|mesh-ancestor
6532039|NCT00796432|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6795644|NCT02257021|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6795645|NCT02257021|Protease Inhibitors|protease inhibitors|mesh-ancestor
6795646|NCT02257021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6795647|NCT02257021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795648|NCT02257021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6795649|NCT02257021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6795650|NCT02257021|Antiviral Agents|antiviral agents|mesh-ancestor
6795651|NCT02257021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6795652|NCT02257021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6795653|NCT02257021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6795654|NCT02257138|Decitabine|decitabine|mesh-list
6795655|NCT02257138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6795656|NCT02257138|Antimetabolites|antimetabolites|mesh-ancestor
6795657|NCT02257138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795658|NCT02257138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6795659|NCT02257138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6795660|NCT02257242|Rituximab|rituximab|mesh-list
6795661|NCT02257242|Vincristine|vincristine|mesh-list
6795662|NCT02257242|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6795663|NCT02257242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6795664|NCT02257242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6795665|NCT02257242|Immunologic Factors|immunologic factors|mesh-ancestor
6795666|NCT02257242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795667|NCT02257242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6795668|NCT02257242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6795669|NCT02257242|Tubulin Modulators|tubulin modulators|mesh-ancestor
6795670|NCT02257242|Antimitotic Agents|antimitotic agents|mesh-ancestor
6795671|NCT02257242|Mitosis Modulators|mitosis modulators|mesh-ancestor
6795672|NCT02257242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795673|NCT02257242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6795674|NCT02257242|Alkylating Agents|alkylating agents|mesh-ancestor
6795675|NCT02257294|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6795676|NCT02257294|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6795677|NCT02257294|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6795678|NCT02257294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795679|NCT02257346|Lidocaine|lidocaine|mesh-list
6795680|NCT02257346|Anesthetics, Local|anesthetics, local|mesh-ancestor
6795681|NCT02257346|Anesthetics|anesthetics|mesh-ancestor
6795682|NCT02257346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6795683|NCT02257346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795684|NCT02257346|Sensory System Agents|sensory system agents|mesh-ancestor
6795685|NCT02257346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6795686|NCT02257346|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6795687|NCT02257346|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6795688|NCT02257346|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6795689|NCT02257346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6795690|NCT02257346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795691|NCT02257398|Moxifloxacin|moxifloxacin|mesh-list
6795692|NCT02257398|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6795693|NCT02257398|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6795694|NCT02257398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6795695|NCT02257398|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6795696|NCT02257398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6795697|NCT02257398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6795698|NCT02257398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795699|NCT02257398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6795700|NCT02257398|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6532040|NCT00796432|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6532041|NCT00796432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6532042|NCT00796432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6532043|NCT00796432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532044|NCT00796432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6532045|NCT00796432|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6532046|NCT00796432|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6532047|NCT00796432|Serotonin Agents|serotonin agents|mesh-ancestor
6532048|NCT00796432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6532049|NCT00796432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532050|NCT00796432|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6532051|NCT00796432|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6532052|NCT00796432|Dopamine Agents|dopamine agents|mesh-ancestor
6532053|NCT00796458|Docetaxel|docetaxel|mesh-list
6532054|NCT00796458|Hormones|hormones|mesh-list
6532055|NCT00796458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6532056|NCT00796458|Tubulin Modulators|tubulin modulators|mesh-ancestor
6532057|NCT00796458|Antimitotic Agents|antimitotic agents|mesh-ancestor
6532058|NCT00796458|Mitosis Modulators|mitosis modulators|mesh-ancestor
6532059|NCT00796458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532060|NCT00796458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6532061|NCT00796458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532062|NCT00796471|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6532063|NCT00796471|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6532064|NCT00796471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6532065|NCT00796471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6532066|NCT00796471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532067|NCT00796471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6532068|NCT00796471|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6532069|NCT00796471|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6532070|NCT00796471|Serotonin Agents|serotonin agents|mesh-ancestor
6532071|NCT00796471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6532072|NCT00796471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532073|NCT00796471|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6532074|NCT00796471|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6532075|NCT00796471|Dopamine Agents|dopamine agents|mesh-ancestor
6532076|NCT00796497|Ondansetron|ondansetron|mesh-list
6532077|NCT00796497|Antiemetics|antiemetics|mesh-ancestor
6532078|NCT00796497|Autonomic Agents|autonomic agents|mesh-ancestor
6532079|NCT00796497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6532080|NCT00796497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532081|NCT00796497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6532082|NCT00796497|Antipruritics|antipruritics|mesh-ancestor
6532083|NCT00796497|Dermatologic Agents|dermatologic agents|mesh-ancestor
6532084|NCT00796497|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6532085|NCT00796497|Serotonin Agents|serotonin agents|mesh-ancestor
6532086|NCT00796497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6532087|NCT00796497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532088|NCT00796497|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6532089|NCT00796497|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6532090|NCT00796497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6532091|NCT00796497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6795701|NCT02257398|Contraceptive Agents|contraceptive agents|mesh-ancestor
6795702|NCT02257398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6795703|NCT02257398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795704|NCT02257398|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6795705|NCT02257398|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6795706|NCT02257398|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6795707|NCT02257463|Theophylline|theophylline|mesh-list
6795708|NCT02257463|Bronchodilator Agents|bronchodilator agents|mesh-list
6795709|NCT02257463|Autonomic Agents|autonomic agents|mesh-ancestor
6795710|NCT02257463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6795711|NCT02257463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795712|NCT02257463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6795713|NCT02257463|Respiratory System Agents|respiratory system agents|mesh-ancestor
6795714|NCT02257463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6795715|NCT02257463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795716|NCT02257463|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6795717|NCT02257463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6795718|NCT02257463|Vasodilator Agents|vasodilator agents|mesh-ancestor
6795719|NCT02257463|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6795720|NCT02257463|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6795721|NCT02257463|Purinergic Agents|purinergic agents|mesh-ancestor
6532092|NCT00796497|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6532093|NCT00796640|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6532094|NCT00796640|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6532095|NCT00796640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6532096|NCT00796640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6532097|NCT00796640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532098|NCT00796640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6532099|NCT00796640|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6532100|NCT00796640|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6532101|NCT00796640|Serotonin Agents|serotonin agents|mesh-ancestor
6532102|NCT00796640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6532103|NCT00796640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532104|NCT00796640|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6532105|NCT00796640|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6532106|NCT00796640|Dopamine Agents|dopamine agents|mesh-ancestor
6532107|NCT00796692|Heparin|heparin|mesh-list
6532108|NCT00796692|Calcium heparin|calcium heparin|mesh-list
6795722|NCT02257476|Dexamethasone|dexamethasone|mesh-list
6795723|NCT02257476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6795724|NCT02257476|Antiemetics|antiemetics|mesh-ancestor
6795725|NCT02257476|Autonomic Agents|autonomic agents|mesh-ancestor
6795726|NCT02257476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6795727|NCT02257476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795728|NCT02257476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6795729|NCT02257476|Glucocorticoids|glucocorticoids|mesh-ancestor
6795730|NCT02257476|Hormones|hormones|mesh-ancestor
6795731|NCT02257476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6795732|NCT02257476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6795733|NCT02257476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6795734|NCT02257502|Aflibercept|aflibercept|mesh-list
6795735|NCT02257502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6795736|NCT02257502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6795737|NCT02257502|Growth Substances|growth substances|mesh-ancestor
6795738|NCT02257502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795739|NCT02257502|Growth Inhibitors|growth inhibitors|mesh-ancestor
6795740|NCT02257502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6795741|NCT02257580|Aminocaproic Acid|aminocaproic acid|mesh-list
6795742|NCT02257580|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6795743|NCT02257580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6795744|NCT02257580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795745|NCT02257580|Hemostatics|hemostatics|mesh-ancestor
6795746|NCT02257580|Coagulants|coagulants|mesh-ancestor
6795747|NCT02257671|Contraceptive Agents|contraceptive agents|mesh-list
6795748|NCT02257671|Levonorgestrel|levonorgestrel|mesh-list
6795749|NCT02257671|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6795750|NCT02257671|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
6795751|NCT02257671|Contraceptives, Oral|contraceptives, oral|mesh-list
6795752|NCT02257671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6795753|NCT02257671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795754|NCT02257671|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6795755|NCT02257671|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6795756|NCT02257671|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6795757|NCT02257671|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6795758|NCT02257671|Estrogens|estrogens|mesh-ancestor
6795759|NCT02257671|Hormones|hormones|mesh-ancestor
6795760|NCT02257671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6795761|NCT02257671|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6795762|NCT02257697|Mizoribine|mizoribine|mesh-list
6795763|NCT02257697|Cyclophosphamide|cyclophosphamide|mesh-list
6795764|NCT02257697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6795765|NCT02257697|Immunologic Factors|immunologic factors|mesh-ancestor
6795766|NCT02257697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795767|NCT02257697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6795768|NCT02257697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6795769|NCT02257697|Alkylating Agents|alkylating agents|mesh-ancestor
6795770|NCT02257697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795771|NCT02257697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6795772|NCT02257697|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6795773|NCT02257697|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6795774|NCT02257697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6795775|NCT02257697|Analgesics|analgesics|mesh-ancestor
6795776|NCT02257697|Sensory System Agents|sensory system agents|mesh-ancestor
6795777|NCT02257697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6532109|NCT00796692|Nadroparin|nadroparin|mesh-list
6532110|NCT00796692|Anticoagulants|anticoagulants|mesh-ancestor
6532111|NCT00796692|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6532112|NCT00796692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6532113|NCT00796692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532114|NCT00796796|Sirolimus|sirolimus|mesh-list
6532115|NCT00796796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6532116|NCT00796796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6532117|NCT00796796|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6532118|NCT00796796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6532119|NCT00796796|Antifungal Agents|antifungal agents|mesh-ancestor
6532120|NCT00796796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6532121|NCT00796796|Immunologic Factors|immunologic factors|mesh-ancestor
6532122|NCT00796796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532123|NCT00796835|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6532124|NCT00796835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6532125|NCT00796835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6532126|NCT00796835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6532127|NCT00796835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532128|NCT00796835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6532129|NCT00796835|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6532130|NCT00796835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6532131|NCT00796835|Serotonin Agents|serotonin agents|mesh-ancestor
6532132|NCT00796835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6532133|NCT00796835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532134|NCT00796835|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6532135|NCT00796835|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6532136|NCT00796835|Dopamine Agents|dopamine agents|mesh-ancestor
6532137|NCT00796887|Niacin|niacin|mesh-list
6532138|NCT00796887|Niacinamide|niacinamide|mesh-list
6532139|NCT00796887|Nicotinic Acids|nicotinic acids|mesh-list
6532140|NCT00796887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6532141|NCT00796887|Antimetabolites|antimetabolites|mesh-ancestor
6532142|NCT00796887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532143|NCT00796887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6532144|NCT00796887|Vasodilator Agents|vasodilator agents|mesh-ancestor
6532145|NCT00796887|Vitamin B Complex|vitamin b complex|mesh-ancestor
6532146|NCT00796887|Vitamins|vitamins|mesh-ancestor
6532147|NCT00796887|Micronutrients|micronutrients|mesh-ancestor
6532148|NCT00796887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532149|NCT00796900|Dantrolene|dantrolene|mesh-list
6532150|NCT00796900|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6532151|NCT00796900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532152|NCT00796900|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6532153|NCT00796900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6532154|NCT00797017|Fentanyl|fentanyl|mesh-list
6532155|NCT00797017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6532156|NCT00797017|Narcotics|narcotics|mesh-ancestor
6532157|NCT00797017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6532158|NCT00797017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532159|NCT00797017|Analgesics|analgesics|mesh-ancestor
6532160|NCT00797017|Sensory System Agents|sensory system agents|mesh-ancestor
6532161|NCT00797017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6532162|NCT00797017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6532163|NCT00797017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6532164|NCT00797017|Anesthetics, General|anesthetics, general|mesh-ancestor
6532165|NCT00797017|Anesthetics|anesthetics|mesh-ancestor
6532166|NCT00797030|Cyclosporine|cyclosporine|mesh-list
6532167|NCT00797030|Cyclosporins|cyclosporins|mesh-list
6532168|NCT00797030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6532169|NCT00797030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532170|NCT00797030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6532171|NCT00797030|Immunologic Factors|immunologic factors|mesh-ancestor
6532172|NCT00797030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532173|NCT00797030|Antifungal Agents|antifungal agents|mesh-ancestor
6532174|NCT00797030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6532175|NCT00797030|Dermatologic Agents|dermatologic agents|mesh-ancestor
6532176|NCT00797030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6532177|NCT00797030|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6532178|NCT00797056|Aspirin|aspirin|mesh-list
6532179|NCT00797056|Clopidogrel|clopidogrel|mesh-list
6532180|NCT00797056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6532181|NCT00797056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6532182|NCT00797056|Analgesics|analgesics|mesh-ancestor
6532183|NCT00797056|Sensory System Agents|sensory system agents|mesh-ancestor
6532184|NCT00797056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6795778|NCT02257697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6532185|NCT00797056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532186|NCT00797056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6532187|NCT00797056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6532188|NCT00797056|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6532189|NCT00797056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6532190|NCT00797056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532191|NCT00797056|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6532192|NCT00797056|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6532193|NCT00797056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6532194|NCT00797056|Antipyretics|antipyretics|mesh-ancestor
6532195|NCT00797056|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6532196|NCT00797056|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6532197|NCT00797056|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6532198|NCT00797056|Purinergic Agents|purinergic agents|mesh-ancestor
6532199|NCT00797056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6532200|NCT00797160|Propofol|propofol|mesh-list
6532201|NCT00797160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6532202|NCT00797160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6532203|NCT00797160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532204|NCT00797160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6532205|NCT00797160|Anesthetics, General|anesthetics, general|mesh-ancestor
6532206|NCT00797160|Anesthetics|anesthetics|mesh-ancestor
6532207|NCT00797264|Morphine|morphine|mesh-list
6532208|NCT00797264|Ketamine|ketamine|mesh-list
6532209|NCT00797264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6532210|NCT00797264|Narcotics|narcotics|mesh-ancestor
6532211|NCT00797264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6532212|NCT00797264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532213|NCT00797264|Analgesics|analgesics|mesh-ancestor
6532214|NCT00797264|Sensory System Agents|sensory system agents|mesh-ancestor
6532215|NCT00797264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6532216|NCT00797264|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6532217|NCT00797264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6532218|NCT00797264|Anesthetics, General|anesthetics, general|mesh-ancestor
6532219|NCT00797264|Anesthetics|anesthetics|mesh-ancestor
6532220|NCT00797264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6532221|NCT00797264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6532222|NCT00797264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6532223|NCT00797264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532224|NCT00797303|Bevacizumab|bevacizumab|mesh-list
6795779|NCT02257697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6795780|NCT02257697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6795781|NCT02257697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6795782|NCT02257697|Antimalarials|antimalarials|mesh-ancestor
6795783|NCT02257697|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6795784|NCT02257697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6795785|NCT02257697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6795786|NCT02257788|Leronlimab|leronlimab|mesh-list
6795787|NCT02257788|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6795788|NCT02257788|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6795789|NCT02257788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795790|NCT02257788|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6795791|NCT02257788|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6795792|NCT02257788|Antiviral Agents|antiviral agents|mesh-ancestor
6795793|NCT02257788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6795794|NCT02257918|Ceftriaxone|ceftriaxone|mesh-list
6795795|NCT02257918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6795796|NCT02257918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6795797|NCT02258009|Ranibizumab|ranibizumab|mesh-list
6795798|NCT02258009|Aflibercept|aflibercept|mesh-list
6795799|NCT02258009|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6795800|NCT02258009|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6795801|NCT02258009|Growth Substances|growth substances|mesh-ancestor
6795802|NCT02258009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795803|NCT02258009|Growth Inhibitors|growth inhibitors|mesh-ancestor
6795804|NCT02258009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6795805|NCT02258204|Ketamine|ketamine|mesh-list
6795806|NCT02258204|Analgesics|analgesics|mesh-ancestor
6795807|NCT02258204|Sensory System Agents|sensory system agents|mesh-ancestor
6795808|NCT02258204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6795809|NCT02258204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795810|NCT02258204|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6795811|NCT02258204|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6795812|NCT02258204|Anesthetics, General|anesthetics, general|mesh-ancestor
6795813|NCT02258204|Anesthetics|anesthetics|mesh-ancestor
6532225|NCT00797303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6532226|NCT00797303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6532227|NCT00797303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6532228|NCT00797303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6532229|NCT00797303|Growth Substances|growth substances|mesh-ancestor
6532230|NCT00797303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532231|NCT00797303|Growth Inhibitors|growth inhibitors|mesh-ancestor
6532232|NCT00797394|Saw palmetto extract|saw palmetto extract|mesh-list
6532233|NCT00797394|Urological Agents|urological agents|mesh-ancestor
6532234|NCT00797420|Fluconazole|fluconazole|mesh-list
6532235|NCT00797420|Antifungal Agents|antifungal agents|mesh-ancestor
6532236|NCT00797420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6532237|NCT00797420|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6795814|NCT02258204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6795815|NCT02258204|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6795816|NCT02258204|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6795817|NCT02258204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6795818|NCT02258204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795819|NCT02258282|Etanercept|etanercept|mesh-list
6795820|NCT02258282|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6795821|NCT02258282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6795822|NCT02258282|Analgesics|analgesics|mesh-ancestor
6795823|NCT02258282|Sensory System Agents|sensory system agents|mesh-ancestor
6795824|NCT02258282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6795825|NCT02258282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795826|NCT02258282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6795827|NCT02258282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6795828|NCT02258282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6795829|NCT02258282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6795830|NCT02258282|Immunologic Factors|immunologic factors|mesh-ancestor
6532238|NCT00797420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6532239|NCT00797420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6532240|NCT00797420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532241|NCT00797420|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6532242|NCT00797420|Hormone Antagonists|hormone antagonists|mesh-ancestor
6532243|NCT00797420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6532244|NCT00797420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532245|NCT00797420|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6532246|NCT00797420|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6532247|NCT00797472|Bleomycin|bleomycin|mesh-list
6532248|NCT00797472|Dacarbazine|dacarbazine|mesh-list
6532249|NCT00797472|Vinblastine|vinblastine|mesh-list
6532250|NCT00797472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6532251|NCT00797472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6532252|NCT00797472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532253|NCT00797472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6532254|NCT00797472|Alkylating Agents|alkylating agents|mesh-ancestor
6532255|NCT00797472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6532256|NCT00797472|Tubulin Modulators|tubulin modulators|mesh-ancestor
6532257|NCT00797472|Antimitotic Agents|antimitotic agents|mesh-ancestor
6532258|NCT00797472|Mitosis Modulators|mitosis modulators|mesh-ancestor
6532259|NCT00797485|Leucovorin|leucovorin|mesh-list
6532260|NCT00797485|Bevacizumab|bevacizumab|mesh-list
6532261|NCT00797485|Fluorouracil|fluorouracil|mesh-list
6532262|NCT00797485|Capecitabine|capecitabine|mesh-list
6532263|NCT00797485|Irinotecan|irinotecan|mesh-list
6532264|NCT00797485|Calcium|calcium|mesh-list
6532265|NCT00797485|Levoleucovorin|levoleucovorin|mesh-list
6532266|NCT00797485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6532267|NCT00797485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6532268|NCT00797485|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6532269|NCT00797485|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6532270|NCT00797485|Growth Substances|growth substances|mesh-ancestor
6532271|NCT00797485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532272|NCT00797485|Growth Inhibitors|growth inhibitors|mesh-ancestor
6532273|NCT00797485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6532274|NCT00797485|Antimetabolites|antimetabolites|mesh-ancestor
6532275|NCT00797485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532276|NCT00797485|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6532277|NCT00797485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6532278|NCT00797485|Immunologic Factors|immunologic factors|mesh-ancestor
6532279|NCT00797485|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6532280|NCT00797485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6532281|NCT00797485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6532282|NCT00797485|Antidotes|antidotes|mesh-ancestor
6532283|NCT00797485|Protective Agents|protective agents|mesh-ancestor
6532284|NCT00797485|Vitamin B Complex|vitamin b complex|mesh-ancestor
6532285|NCT00797485|Vitamins|vitamins|mesh-ancestor
6532286|NCT00797485|Micronutrients|micronutrients|mesh-ancestor
6532287|NCT00797693|Misoprostol|misoprostol|mesh-list
6532288|NCT00797693|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6532289|NCT00797693|Abortifacient Agents|abortifacient agents|mesh-ancestor
6532290|NCT00797693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6532291|NCT00797693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532292|NCT00797693|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6532293|NCT00797693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6532294|NCT00797693|Oxytocics|oxytocics|mesh-ancestor
6532295|NCT00797745|Ritonavir|ritonavir|mesh-list
6532296|NCT00797745|Ribavirin|ribavirin|mesh-list
6532297|NCT00797745|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6532298|NCT00797745|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6532299|NCT00797745|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6532300|NCT00797745|Protease Inhibitors|protease inhibitors|mesh-ancestor
6795831|NCT02258542|Benralizumab|benralizumab|mesh-list
6795832|NCT02258542|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6795833|NCT02258542|Respiratory System Agents|respiratory system agents|mesh-ancestor
6795834|NCT02258581|Tenofovir|tenofovir|mesh-list
6795835|NCT02258581|Vesatolimod|vesatolimod|mesh-list
6795836|NCT02258581|Antiviral Agents|antiviral agents|mesh-ancestor
6795837|NCT02258581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6795838|NCT02258581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6795839|NCT02258581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6795840|NCT02258581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6795841|NCT02258581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795842|NCT02258581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6532301|NCT00797745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6532302|NCT00797745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532303|NCT00797745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6532304|NCT00797745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6532305|NCT00797745|Antiviral Agents|antiviral agents|mesh-ancestor
6532306|NCT00797745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6532307|NCT00797745|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6532308|NCT00797745|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6532309|NCT00797745|Antimetabolites|antimetabolites|mesh-ancestor
6532310|NCT00797771|Insulin|insulin|mesh-list
6532311|NCT00797771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6532312|NCT00797771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532313|NCT00797784|Etanercept|etanercept|mesh-list
6532314|NCT00797784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6532315|NCT00797784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6532316|NCT00797784|Analgesics|analgesics|mesh-ancestor
6532317|NCT00797784|Sensory System Agents|sensory system agents|mesh-ancestor
6532318|NCT00797784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6532319|NCT00797784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532320|NCT00797784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6532321|NCT00797784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6532322|NCT00797784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6532323|NCT00797784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6532324|NCT00797784|Immunologic Factors|immunologic factors|mesh-ancestor
6532325|NCT00797810|Cytarabine|cytarabine|mesh-list
6532326|NCT00797810|Dexamethasone|dexamethasone|mesh-list
6532327|NCT00797810|Prednisone|prednisone|mesh-list
6532328|NCT00797810|Cyclophosphamide|cyclophosphamide|mesh-list
6532329|NCT00797810|Ifosfamide|ifosfamide|mesh-list
6532330|NCT00797810|Rituximab|rituximab|mesh-list
6532331|NCT00797810|Vincristine|vincristine|mesh-list
6532332|NCT00797810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6532333|NCT00797810|Immunologic Factors|immunologic factors|mesh-ancestor
6532334|NCT00797810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532335|NCT00797810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6532336|NCT00797810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6532337|NCT00797810|Alkylating Agents|alkylating agents|mesh-ancestor
6532338|NCT00797810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532339|NCT00797810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6532340|NCT00797810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6532341|NCT00797810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6532342|NCT00797810|Antiemetics|antiemetics|mesh-ancestor
6532343|NCT00797810|Autonomic Agents|autonomic agents|mesh-ancestor
6532344|NCT00797810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6532345|NCT00797810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6532346|NCT00797810|Glucocorticoids|glucocorticoids|mesh-ancestor
6532347|NCT00797810|Hormones|hormones|mesh-ancestor
6532348|NCT00797810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6532349|NCT00797810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6532350|NCT00797810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6532351|NCT00797810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6532352|NCT00797810|Antimetabolites|antimetabolites|mesh-ancestor
6532353|NCT00797810|Antiviral Agents|antiviral agents|mesh-ancestor
6532354|NCT00797810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6532355|NCT00797810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6532356|NCT00797810|Tubulin Modulators|tubulin modulators|mesh-ancestor
6532357|NCT00797810|Antimitotic Agents|antimitotic agents|mesh-ancestor
6532358|NCT00797810|Mitosis Modulators|mitosis modulators|mesh-ancestor
6532359|NCT00797836|Interferons|interferons|mesh-list
6532360|NCT00797836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6532361|NCT00797836|Antiviral Agents|antiviral agents|mesh-ancestor
6532362|NCT00797836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6532363|NCT00797927|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6795843|NCT02258581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6795844|NCT02258607|Trametinib|trametinib|mesh-list
6795845|NCT02258607|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
6795846|NCT02258607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6795847|NCT02258607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6795848|NCT02258607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6795849|NCT02258607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795850|NCT02258620|Isosorbide|isosorbide|mesh-list
6795851|NCT02258620|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
6795852|NCT02258620|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
6532364|NCT00797927|Antipsychotic Agents|antipsychotic agents|mesh-list
6532365|NCT00797927|Antidepressive Agents|antidepressive agents|mesh-ancestor
6532366|NCT00797927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6532367|NCT00797927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6532368|NCT00797927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6532369|NCT00797927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532370|NCT00797953|Cardiotonic Agents|cardiotonic agents|mesh-list
6537732|NCT00823875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537733|NCT00823875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6537734|NCT00823875|Vasodilator Agents|vasodilator agents|mesh-ancestor
6537735|NCT00823875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6537736|NCT00823875|Protective Agents|protective agents|mesh-ancestor
6537737|NCT00823875|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6537738|NCT00823875|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6537739|NCT00823875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6537740|NCT00823875|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6537741|NCT00823875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6537742|NCT00823875|Antimetabolites|antimetabolites|mesh-ancestor
6537743|NCT00823875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6537744|NCT00823875|Antioxidants|antioxidants|mesh-ancestor
6537745|NCT00823940|Glucagon|glucagon|mesh-list
6537746|NCT00823940|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6537747|NCT00823940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6537748|NCT00823940|Hormones|hormones|mesh-ancestor
6537749|NCT00823940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6537750|NCT00823940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537751|NCT00823940|Incretins|incretins|mesh-ancestor
6537752|NCT00824057|Midazolam|midazolam|mesh-list
6537753|NCT00824057|Caffeine|caffeine|mesh-list
6537754|NCT00824057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6537755|NCT00824057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6537756|NCT00824057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6537757|NCT00824057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537758|NCT00824057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6537759|NCT00824057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6537760|NCT00824057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6537761|NCT00824057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6537762|NCT00824057|Anesthetics, General|anesthetics, general|mesh-ancestor
6537763|NCT00824057|Anesthetics|anesthetics|mesh-ancestor
6537764|NCT00824057|GABA Modulators|gaba modulators|mesh-ancestor
6537765|NCT00824057|GABA Agents|gaba agents|mesh-ancestor
6537766|NCT00824057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6537767|NCT00824057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537768|NCT00824057|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6537769|NCT00824057|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6537770|NCT00824057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6537771|NCT00824057|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6537772|NCT00824057|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6537773|NCT00824057|Purinergic Agents|purinergic agents|mesh-ancestor
6537774|NCT00824109|Anti-Infective Agents|anti-infective agents|mesh-list
6537775|NCT00824109|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6538083|NCT00825656|Capsaicin|capsaicin|mesh-list
6538084|NCT00825656|Antipruritics|antipruritics|mesh-ancestor
6538085|NCT00825656|Dermatologic Agents|dermatologic agents|mesh-ancestor
6538086|NCT00825656|Sensory System Agents|sensory system agents|mesh-ancestor
6538087|NCT00825656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6538088|NCT00825656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538089|NCT00825721|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6538090|NCT00825721|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6538091|NCT00825851|Nicotine|nicotine|mesh-list
6538092|NCT00825851|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6538093|NCT00825851|Autonomic Agents|autonomic agents|mesh-ancestor
6538094|NCT00825851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6538095|NCT00825851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538096|NCT00825851|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6795853|NCT02258620|Nitroglycerin|nitroglycerin|mesh-list
6795854|NCT02258620|Vasodilator Agents|vasodilator agents|mesh-ancestor
6795855|NCT02258620|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6795856|NCT02258620|Diuretics|diuretics|mesh-ancestor
6795857|NCT02258620|Natriuretic Agents|natriuretic agents|mesh-ancestor
6795858|NCT02258620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795859|NCT02258620|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6795860|NCT02258620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795861|NCT02258763|Amoxicillin|amoxicillin|mesh-list
6795862|NCT02258763|Clavulanic Acid|clavulanic acid|mesh-list
6795863|NCT02258763|Clavulanic Acids|clavulanic acids|mesh-list
6795864|NCT02258763|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6795865|NCT02258763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6795866|NCT02258763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6795867|NCT02258763|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6532371|NCT00798070|Cyclophosphamide|cyclophosphamide|mesh-list
6532372|NCT00798070|Fluorouracil|fluorouracil|mesh-list
6532373|NCT00798070|Docetaxel|docetaxel|mesh-list
6532374|NCT00798070|Epirubicin|epirubicin|mesh-list
6532375|NCT00798070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6532376|NCT00798070|Immunologic Factors|immunologic factors|mesh-ancestor
6532377|NCT00798070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532378|NCT00798070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6532379|NCT00798070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6532380|NCT00798070|Alkylating Agents|alkylating agents|mesh-ancestor
6532381|NCT00798070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532382|NCT00798070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6532383|NCT00798070|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6532384|NCT00798070|Antimetabolites|antimetabolites|mesh-ancestor
6532385|NCT00798070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6532386|NCT00798070|Tubulin Modulators|tubulin modulators|mesh-ancestor
6532387|NCT00798070|Antimitotic Agents|antimitotic agents|mesh-ancestor
6532388|NCT00798070|Mitosis Modulators|mitosis modulators|mesh-ancestor
6532389|NCT00798070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6532390|NCT00798070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6532391|NCT00798070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6532392|NCT00798070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6532393|NCT00798083|Lidocaine|lidocaine|mesh-list
6532394|NCT00798083|Ketamine|ketamine|mesh-list
6532395|NCT00798083|Amitriptyline|amitriptyline|mesh-list
6532396|NCT00798083|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6532397|NCT00798083|Anesthetics, Local|anesthetics, local|mesh-ancestor
6532398|NCT00798083|Anesthetics|anesthetics|mesh-ancestor
6532399|NCT00798083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6532400|NCT00798083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532401|NCT00798083|Sensory System Agents|sensory system agents|mesh-ancestor
6532402|NCT00798083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6532403|NCT00798083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6532404|NCT00798083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6532405|NCT00798083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6532406|NCT00798083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6532407|NCT00798083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532408|NCT00798083|Analgesics|analgesics|mesh-ancestor
6532409|NCT00798083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6532410|NCT00798083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6532411|NCT00798083|Anesthetics, General|anesthetics, general|mesh-ancestor
6532412|NCT00798083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6532413|NCT00798083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6532414|NCT00798083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6532415|NCT00798083|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6532416|NCT00798083|Antidepressive Agents|antidepressive agents|mesh-ancestor
6532417|NCT00798083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6532418|NCT00798083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6532419|NCT00798083|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6532420|NCT00798083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6532421|NCT00798083|Adrenergic Agents|adrenergic agents|mesh-ancestor
6532422|NCT00798083|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6532423|NCT00798083|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6532424|NCT00798148|Carboplatin|carboplatin|mesh-list
6532425|NCT00798148|Etoposide|etoposide|mesh-list
6532426|NCT00798148|Melphalan|melphalan|mesh-list
6532427|NCT00798148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6532428|NCT00798148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6532429|NCT00798148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6532430|NCT00798148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6795868|NCT02258763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6795869|NCT02258763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795870|NCT02258815|Dinutuximab|dinutuximab|mesh-list
6795871|NCT02258815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6795872|NCT02258828|Memantine|memantine|mesh-list
6795873|NCT02258828|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6795874|NCT02258828|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6795875|NCT02258828|Dopamine Agents|dopamine agents|mesh-ancestor
6795876|NCT02258828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6795877|NCT02258828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795878|NCT02258828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795879|NCT02258828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6795880|NCT02258828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6795881|NCT02258906|Urinastatin|urinastatin|mesh-list
6532431|NCT00798148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6532432|NCT00798148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532433|NCT00798148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6532434|NCT00798148|Alkylating Agents|alkylating agents|mesh-ancestor
6532435|NCT00798148|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6532436|NCT00798148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6532437|NCT00798148|Immunologic Factors|immunologic factors|mesh-ancestor
6532438|NCT00798148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532439|NCT00798213|Gemtuzumab|gemtuzumab|mesh-list
6532440|NCT00798213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6532441|NCT00798213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6532442|NCT00798252|Paclitaxel|paclitaxel|mesh-list
6532443|NCT00798252|Docetaxel|docetaxel|mesh-list
6532444|NCT00798252|Doxorubicin|doxorubicin|mesh-list
6532445|NCT00798252|Capecitabine|capecitabine|mesh-list
6532446|NCT00798252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6532447|NCT00798252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6532448|NCT00798252|Tubulin Modulators|tubulin modulators|mesh-ancestor
6532449|NCT00798252|Antimitotic Agents|antimitotic agents|mesh-ancestor
6532450|NCT00798252|Mitosis Modulators|mitosis modulators|mesh-ancestor
6532451|NCT00798252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532452|NCT00798252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6532453|NCT00798252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6532454|NCT00798252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6532455|NCT00798252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6532456|NCT00798252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6532457|NCT00798252|Antimetabolites|antimetabolites|mesh-ancestor
6532458|NCT00798343|Vaccines|vaccines|mesh-list
6532459|NCT00798343|Immunologic Factors|immunologic factors|mesh-ancestor
6532460|NCT00798343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532461|NCT00798395|Zopiclone|zopiclone|mesh-list
6532462|NCT00798395|Mirtazapine|mirtazapine|mesh-list
6532463|NCT00798395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6532464|NCT00798395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6532465|NCT00798395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532466|NCT00798395|Antidepressive Agents|antidepressive agents|mesh-ancestor
6532467|NCT00798395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6532468|NCT00798395|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6532469|NCT00798395|Histamine Antagonists|histamine antagonists|mesh-ancestor
6532470|NCT00798395|Histamine Agents|histamine agents|mesh-ancestor
6532471|NCT00798395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6532472|NCT00798395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532473|NCT00798395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6532474|NCT00798395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6532475|NCT00798395|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6532476|NCT00798395|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6532477|NCT00798395|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6532478|NCT00798395|Adrenergic Agents|adrenergic agents|mesh-ancestor
6532479|NCT00798395|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6532480|NCT00798395|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6532481|NCT00798395|Serotonin Agents|serotonin agents|mesh-ancestor
6532482|NCT00798395|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6532483|NCT00798460|Lamivudine|lamivudine|mesh-list
6532484|NCT00798460|Adefovir|adefovir|mesh-list
6532485|NCT00798460|Clevudine|clevudine|mesh-list
6532486|NCT00798460|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6532487|NCT00798460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6532488|NCT00798460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6532489|NCT00798460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532490|NCT00798460|Antiviral Agents|antiviral agents|mesh-ancestor
6532491|NCT00798460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6532492|NCT00798460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6532493|NCT00798460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6532494|NCT00798473|Zoledronic Acid|zoledronic acid|mesh-list
6532495|NCT00798473|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6532496|NCT00798473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532497|NCT00798525|Lepirudin|lepirudin|mesh-list
6532498|NCT00798525|Argatroban|argatroban|mesh-list
6532499|NCT00798525|Antithrombins|antithrombins|mesh-ancestor
6532500|NCT00798525|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6532501|NCT00798525|Protease Inhibitors|protease inhibitors|mesh-ancestor
6532502|NCT00798525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6532503|NCT00798525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795882|NCT02258906|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6532504|NCT00798525|Anticoagulants|anticoagulants|mesh-ancestor
6532505|NCT00798525|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6532506|NCT00798525|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6532507|NCT00798525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6532508|NCT00798616|Methylprednisolone|methylprednisolone|mesh-list
6532509|NCT00798616|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6532510|NCT00798616|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6532511|NCT00798616|Prednisolone|prednisolone|mesh-list
6532512|NCT00798616|Prednisolone acetate|prednisolone acetate|mesh-list
6795883|NCT02258906|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6795884|NCT02258906|Protease Inhibitors|protease inhibitors|mesh-ancestor
6795885|NCT02258906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6795886|NCT02258906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795887|NCT02259075|Botulinum Toxins|botulinum toxins|mesh-list
6795888|NCT02259075|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6795889|NCT02259075|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6795890|NCT02259075|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6795891|NCT02259075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6795892|NCT02259075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795893|NCT02259075|Cholinergic Agents|cholinergic agents|mesh-ancestor
6795894|NCT02259075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6795895|NCT02259075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795896|NCT02259075|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6795897|NCT02259075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6795898|NCT02259179|Naltrexone|naltrexone|mesh-list
6795899|NCT02259179|Bupropion|bupropion|mesh-list
6795900|NCT02259179|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6795901|NCT02259179|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6795902|NCT02259179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795903|NCT02259179|Sensory System Agents|sensory system agents|mesh-ancestor
6795904|NCT02259179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6795905|NCT02259179|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6795906|NCT02259179|Antidepressive Agents|antidepressive agents|mesh-ancestor
6795907|NCT02259179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6795908|NCT02259179|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6795909|NCT02259179|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6795910|NCT02259179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6795911|NCT02259179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795912|NCT02259179|Dopamine Agents|dopamine agents|mesh-ancestor
6795913|NCT02259179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6795914|NCT02259179|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6795915|NCT02259179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6795916|NCT02259179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6795917|NCT02259309|Misoprostol|misoprostol|mesh-list
6795918|NCT02259309|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6795919|NCT02259309|Abortifacient Agents|abortifacient agents|mesh-ancestor
6795920|NCT02259309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6795921|NCT02259309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795922|NCT02259309|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6795923|NCT02259309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6795924|NCT02259309|Oxytocics|oxytocics|mesh-ancestor
6795925|NCT02259361|4-Aminopyridine|4-aminopyridine|mesh-list
6795926|NCT02259361|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6795927|NCT02259361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6795928|NCT02259361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795929|NCT02259374|Ropivacaine|ropivacaine|mesh-list
6795930|NCT02259374|Anesthetics, Local|anesthetics, local|mesh-ancestor
6795931|NCT02259374|Anesthetics|anesthetics|mesh-ancestor
6795932|NCT02259374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6795933|NCT02259374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795934|NCT02259374|Sensory System Agents|sensory system agents|mesh-ancestor
6795935|NCT02259374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6795936|NCT02259426|Piperaquine|piperaquine|mesh-list
6795937|NCT02259426|Primaquine|primaquine|mesh-list
6795938|NCT02259426|Artenimol|artenimol|mesh-list
6795939|NCT02259426|Antimalarials|antimalarials|mesh-ancestor
6795940|NCT02259426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6795941|NCT02259426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6795942|NCT02259426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6795943|NCT02259491|Calcium|calcium|mesh-list
6795944|NCT02259491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6795945|NCT02259491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795946|NCT02259530|Psychotropic Drugs|psychotropic drugs|mesh-list
6795947|NCT02259543|Tetracycline|tetracycline|mesh-list
6795948|NCT02259543|Citric Acid|citric acid|mesh-list
6532513|NCT00798616|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6795949|NCT02259543|Sodium Citrate|sodium citrate|mesh-list
6532514|NCT00798616|Prednisolone phosphate|prednisolone phosphate|mesh-list
6532515|NCT00798616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6532516|NCT00798616|Antiemetics|antiemetics|mesh-ancestor
6532517|NCT00798616|Autonomic Agents|autonomic agents|mesh-ancestor
6532518|NCT00798616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6532519|NCT00798616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532520|NCT00798616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6532521|NCT00798616|Glucocorticoids|glucocorticoids|mesh-ancestor
6532522|NCT00798616|Hormones|hormones|mesh-ancestor
6532523|NCT00798616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6532524|NCT00798616|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6532525|NCT00798616|Protective Agents|protective agents|mesh-ancestor
6532526|NCT00798616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6258391|NCT03086213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6258392|NCT03086213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258393|NCT03086213|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6258394|NCT03086213|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6258395|NCT03086213|Anesthetics, General|anesthetics, general|mesh-ancestor
6258396|NCT03086213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6258397|NCT03086213|Analgesics|analgesics|mesh-ancestor
6258398|NCT03086213|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6258399|NCT03086213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6258400|NCT03086213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6258401|NCT03086213|Adrenergic Agents|adrenergic agents|mesh-ancestor
6258402|NCT03086213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6258403|NCT03086213|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6258404|NCT03086213|Narcotics|narcotics|mesh-ancestor
6258405|NCT03086213|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6258406|NCT03086343|Abatacept|abatacept|mesh-list
6258407|NCT03086343|Upadacitinib|upadacitinib|mesh-list
6258408|NCT03086343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6389824|NCT00189397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532527|NCT00798616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6532528|NCT00798772|Micronutrients|micronutrients|mesh-list
6532529|NCT00798772|Trace Elements|trace elements|mesh-list
6532530|NCT00798772|Antioxidants|antioxidants|mesh-list
6532531|NCT00798772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532532|NCT00798772|Protective Agents|protective agents|mesh-ancestor
6532533|NCT00798772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532534|NCT00798785|Rituximab|rituximab|mesh-list
6532535|NCT00798785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6532536|NCT00798785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6532537|NCT00798785|Immunologic Factors|immunologic factors|mesh-ancestor
6532538|NCT00798785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532539|NCT00798785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6532540|NCT00798876|Vitamin E|vitamin e|mesh-list
6532541|NCT00798876|Vitamins|vitamins|mesh-ancestor
6532542|NCT00798876|Micronutrients|micronutrients|mesh-ancestor
6532543|NCT00798876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532544|NCT00798876|Antioxidants|antioxidants|mesh-ancestor
6532545|NCT00798876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532546|NCT00798876|Protective Agents|protective agents|mesh-ancestor
6532547|NCT00798915|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
6532548|NCT00798915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6532549|NCT00798915|Incretins|incretins|mesh-ancestor
6532550|NCT00798915|Hormones|hormones|mesh-ancestor
6795950|NCT02259543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6795951|NCT02259543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6795952|NCT02259543|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6795953|NCT02259543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6795954|NCT02259543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795955|NCT02259543|Anticoagulants|anticoagulants|mesh-ancestor
6795956|NCT02259543|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6795957|NCT02259543|Chelating Agents|chelating agents|mesh-ancestor
6795958|NCT02259543|Sequestering Agents|sequestering agents|mesh-ancestor
6795959|NCT02259595|Acetylcysteine|acetylcysteine|mesh-list
6795960|NCT02259595|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6795961|NCT02259595|Disufenton sodium|disufenton sodium|mesh-list
6389825|NCT00189397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6389826|NCT00189410|Carboplatin|carboplatin|mesh-list
6389827|NCT00189410|Doxorubicin|doxorubicin|mesh-list
6389828|NCT00189410|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6389829|NCT00189410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6389830|NCT00189410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6389831|NCT00189410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6389832|NCT00189410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6389833|NCT00189410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6532551|NCT00798915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6532552|NCT00798915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532553|NCT00798954|Sirolimus|sirolimus|mesh-list
6532554|NCT00798954|Paclitaxel|paclitaxel|mesh-list
6532555|NCT00798954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6532556|NCT00798954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6532557|NCT00798954|Tubulin Modulators|tubulin modulators|mesh-ancestor
6532558|NCT00798954|Antimitotic Agents|antimitotic agents|mesh-ancestor
6532559|NCT00798954|Mitosis Modulators|mitosis modulators|mesh-ancestor
6532560|NCT00798954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532561|NCT00798954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6532562|NCT00798954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6532563|NCT00798954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6532564|NCT00798954|Antifungal Agents|antifungal agents|mesh-ancestor
6532565|NCT00798954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6532566|NCT00798954|Immunologic Factors|immunologic factors|mesh-ancestor
6532567|NCT00798954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795962|NCT02259595|Antiviral Agents|antiviral agents|mesh-ancestor
6795963|NCT02259595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6795964|NCT02259595|Expectorants|expectorants|mesh-ancestor
6795965|NCT02259595|Respiratory System Agents|respiratory system agents|mesh-ancestor
6795966|NCT02259595|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6795967|NCT02259595|Antioxidants|antioxidants|mesh-ancestor
6795968|NCT02259595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795969|NCT02259595|Protective Agents|protective agents|mesh-ancestor
6795970|NCT02259595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795971|NCT02259595|Antidotes|antidotes|mesh-ancestor
6795972|NCT02259621|Paclitaxel|paclitaxel|mesh-list
6795973|NCT02259621|Carboplatin|carboplatin|mesh-list
6795974|NCT02259621|Nivolumab|nivolumab|mesh-list
6795975|NCT02259621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6795976|NCT02259621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6795977|NCT02259621|Tubulin Modulators|tubulin modulators|mesh-ancestor
6795978|NCT02259621|Antimitotic Agents|antimitotic agents|mesh-ancestor
6795979|NCT02259621|Mitosis Modulators|mitosis modulators|mesh-ancestor
6795980|NCT02259621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795981|NCT02259621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6795982|NCT02259621|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6795983|NCT02259647|Sorafenib|sorafenib|mesh-list
6795984|NCT02259647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6795985|NCT02259647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6795986|NCT02259647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6795987|NCT02259647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6795988|NCT02259738|Kallikreins|kallikreins|mesh-list
6795989|NCT02259738|Coagulants|coagulants|mesh-ancestor
6795990|NCT02259738|Fertility Agents, Male|fertility agents, male|mesh-ancestor
6795991|NCT02259738|Fertility Agents|fertility agents|mesh-ancestor
6795992|NCT02259738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6795993|NCT02259738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6795994|NCT02259777|Amlodipine|amlodipine|mesh-list
6795995|NCT02259777|Telmisartan|telmisartan|mesh-list
6795996|NCT02259777|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
6795997|NCT02259777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6795998|NCT02259777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6795999|NCT02259777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6796000|NCT02259777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796001|NCT02259777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6796002|NCT02259777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796003|NCT02259777|Vasodilator Agents|vasodilator agents|mesh-ancestor
6796004|NCT02259777|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6796005|NCT02259777|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6796006|NCT02259790|Amlodipine|amlodipine|mesh-list
6796007|NCT02259790|Telmisartan|telmisartan|mesh-list
6796008|NCT02259790|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
6796009|NCT02259790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6796010|NCT02259790|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6796011|NCT02259790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6796012|NCT02259790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796013|NCT02259790|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6796014|NCT02259790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796015|NCT02259790|Vasodilator Agents|vasodilator agents|mesh-ancestor
6796016|NCT02259790|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6796017|NCT02259790|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6532568|NCT00798980|Levonorgestrel|levonorgestrel|mesh-list
6532569|NCT00798980|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6532570|NCT00798980|Contraceptive Agents|contraceptive agents|mesh-ancestor
6532571|NCT00798980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6532572|NCT00798980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532573|NCT00798980|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6532574|NCT00798980|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6532575|NCT00798980|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6532576|NCT00798993|Cholecalciferol|cholecalciferol|mesh-list
6532577|NCT00798993|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
6532578|NCT00798993|Calcifediol|calcifediol|mesh-list
6258409|NCT03086343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258410|NCT03086343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6258411|NCT03086343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6258412|NCT03086343|Immunologic Factors|immunologic factors|mesh-ancestor
6258413|NCT03086343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258414|NCT03086343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6258415|NCT03086343|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
6258416|NCT03086343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6258417|NCT03086343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6258418|NCT03086356|Dabigatran|dabigatran|mesh-list
6258419|NCT03086356|Antithrombins|antithrombins|mesh-ancestor
6258420|NCT03086356|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6258421|NCT03086356|Protease Inhibitors|protease inhibitors|mesh-ancestor
6532579|NCT00798993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6532580|NCT00798993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532581|NCT00798993|Vitamins|vitamins|mesh-ancestor
6532582|NCT00798993|Micronutrients|micronutrients|mesh-ancestor
6532583|NCT00798993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6532584|NCT00799045|Clopidogrel|clopidogrel|mesh-list
6532585|NCT00799045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6532586|NCT00799045|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6532587|NCT00799045|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6532588|NCT00799045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6532589|NCT00799045|Purinergic Agents|purinergic agents|mesh-ancestor
6532590|NCT00799045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6532591|NCT00799045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532592|NCT00799045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532593|NCT00799071|Posaconazole|posaconazole|mesh-list
6532594|NCT00799071|Antifungal Agents|antifungal agents|mesh-ancestor
6532595|NCT00799071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6532596|NCT00799071|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6532597|NCT00799071|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6532598|NCT00799071|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6532599|NCT00799071|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6532600|NCT00799071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6532601|NCT00799071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6532602|NCT00799071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796018|NCT02259803|Amlodipine|amlodipine|mesh-list
6796019|NCT02259803|Telmisartan|telmisartan|mesh-list
6796020|NCT02259803|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
6796021|NCT02259803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6796022|NCT02259803|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6796023|NCT02259803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6796024|NCT02259803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796025|NCT02259803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6796026|NCT02259803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796027|NCT02259803|Vasodilator Agents|vasodilator agents|mesh-ancestor
6796028|NCT02259803|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6796029|NCT02259803|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6796030|NCT02259816|Amlodipine|amlodipine|mesh-list
6796031|NCT02259816|Telmisartan|telmisartan|mesh-list
6796032|NCT02259816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6796033|NCT02259816|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6796034|NCT02259816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6796035|NCT02259816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5993021|NCT00118716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993022|NCT00118716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5993023|NCT00118716|Respiratory System Agents|respiratory system agents|mesh-ancestor
5993024|NCT00118716|Dermatologic Agents|dermatologic agents|mesh-ancestor
5993025|NCT00118716|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5993026|NCT00118716|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5993027|NCT00118716|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5993028|NCT00118716|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5993029|NCT00118716|Adrenergic Agents|adrenergic agents|mesh-ancestor
5993030|NCT00118716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5993031|NCT00118716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5993032|NCT00118742|Cyclosporine|cyclosporine|mesh-list
5993033|NCT00118742|Sirolimus|sirolimus|mesh-list
5993034|NCT00118742|Mycophenolic Acid|mycophenolic acid|mesh-list
5993035|NCT00118742|Tacrolimus|tacrolimus|mesh-list
5993036|NCT00118742|Cyclosporins|cyclosporins|mesh-list
5993037|NCT00118742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5993038|NCT00118742|Immunologic Factors|immunologic factors|mesh-ancestor
5993039|NCT00118742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993040|NCT00118742|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5993041|NCT00118742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5993042|NCT00118742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5993043|NCT00118742|Antifungal Agents|antifungal agents|mesh-ancestor
5993044|NCT00118742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5993045|NCT00118742|Dermatologic Agents|dermatologic agents|mesh-ancestor
5993046|NCT00118742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5993047|NCT00118742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5993048|NCT00118742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6532603|NCT00799071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6532604|NCT00799071|Hormone Antagonists|hormone antagonists|mesh-ancestor
6532605|NCT00799071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6532606|NCT00799071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532607|NCT00799136|Prednisone|prednisone|mesh-list
6532608|NCT00799136|Vincristine|vincristine|mesh-list
6532609|NCT00799136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6532610|NCT00799136|Glucocorticoids|glucocorticoids|mesh-ancestor
6532611|NCT00799136|Hormones|hormones|mesh-ancestor
6532612|NCT00799136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6532613|NCT00799136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532614|NCT00799136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6532615|NCT00799136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6532616|NCT00799136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6532617|NCT00799136|Tubulin Modulators|tubulin modulators|mesh-ancestor
6532618|NCT00799136|Antimitotic Agents|antimitotic agents|mesh-ancestor
6532619|NCT00799136|Mitosis Modulators|mitosis modulators|mesh-ancestor
6537776|NCT00824135|Mycophenolic Acid|mycophenolic acid|mesh-list
6796036|NCT02259816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6796037|NCT02259816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796038|NCT02259816|Vasodilator Agents|vasodilator agents|mesh-ancestor
6796039|NCT02259816|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6796040|NCT02259816|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6796041|NCT02259829|Amlodipine|amlodipine|mesh-list
6796042|NCT02259829|Telmisartan|telmisartan|mesh-list
6796043|NCT02259829|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
6796044|NCT02259829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6796045|NCT02259829|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6796046|NCT02259829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6796047|NCT02259829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796048|NCT02259829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6796049|NCT02259829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796050|NCT02259829|Vasodilator Agents|vasodilator agents|mesh-ancestor
6796051|NCT02259829|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6796052|NCT02259829|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5993049|NCT00118742|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6532620|NCT00799136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532621|NCT00799149|Etoricoxib|etoricoxib|mesh-list
6532622|NCT00799149|Gabapentin|gabapentin|mesh-list
6532623|NCT00799149|Analgesics|analgesics|mesh-ancestor
6532624|NCT00799149|Sensory System Agents|sensory system agents|mesh-ancestor
6532625|NCT00799149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6532626|NCT00799149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532627|NCT00799149|Anticonvulsants|anticonvulsants|mesh-ancestor
6532628|NCT00799149|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6532629|NCT00799149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6532630|NCT00799149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6532631|NCT00799149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6532632|NCT00799149|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6532633|NCT00799149|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6532634|NCT00799149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6532635|NCT00799149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532636|NCT00799149|Antimanic Agents|antimanic agents|mesh-ancestor
6532637|NCT00799149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6532638|NCT00799149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6532639|NCT00799149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6532640|NCT00799149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6532641|NCT00799149|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6532642|NCT00799149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6532643|NCT00799149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6532644|NCT00799175|Ketorolac|ketorolac|mesh-list
6532645|NCT00799175|Epinephrine|epinephrine|mesh-list
6532646|NCT00799175|Ropivacaine|ropivacaine|mesh-list
6532647|NCT00799175|Anesthetics, Local|anesthetics, local|mesh-ancestor
6532648|NCT00799175|Anesthetics|anesthetics|mesh-ancestor
6532649|NCT00799175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6532650|NCT00799175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532651|NCT00799175|Sensory System Agents|sensory system agents|mesh-ancestor
6532652|NCT00799175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6532653|NCT00799175|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6532654|NCT00799175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6532655|NCT00799175|Adrenergic Agents|adrenergic agents|mesh-ancestor
6532656|NCT00799175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6532657|NCT00799175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532658|NCT00799175|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6532659|NCT00799175|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6532660|NCT00799175|Autonomic Agents|autonomic agents|mesh-ancestor
6532661|NCT00799175|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6532662|NCT00799175|Respiratory System Agents|respiratory system agents|mesh-ancestor
6532663|NCT00799175|Mydriatics|mydriatics|mesh-ancestor
6532664|NCT00799175|Sympathomimetics|sympathomimetics|mesh-ancestor
6532665|NCT00799175|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6532666|NCT00799175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6532667|NCT00799175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6796053|NCT02259855|Interferons|interferons|mesh-list
6796054|NCT02259855|Ritonavir|ritonavir|mesh-list
6796055|NCT02259855|Ribavirin|ribavirin|mesh-list
6796056|NCT02259855|Tipranavir|tipranavir|mesh-list
6796057|NCT02259855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6796058|NCT02259855|Antiviral Agents|antiviral agents|mesh-ancestor
6796059|NCT02259855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6796060|NCT02259855|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6796061|NCT02259855|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6796062|NCT02259855|Protease Inhibitors|protease inhibitors|mesh-ancestor
6796063|NCT02259855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6796064|NCT02259855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796065|NCT02259855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6796066|NCT02259855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6796067|NCT02259855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6796068|NCT02259855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6796069|NCT02259855|Antimetabolites|antimetabolites|mesh-ancestor
6796070|NCT02259868|Ritonavir|ritonavir|mesh-list
6796071|NCT02259868|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6796072|NCT02259868|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6796073|NCT02259868|Protease Inhibitors|protease inhibitors|mesh-ancestor
6796074|NCT02259868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6796075|NCT02259868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796076|NCT02259868|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6532668|NCT00799175|Analgesics|analgesics|mesh-ancestor
6796077|NCT02259868|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6796078|NCT02259868|Antiviral Agents|antiviral agents|mesh-ancestor
6532669|NCT00799175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6532670|NCT00799175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6532671|NCT00799175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6532672|NCT00799175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6532673|NCT00799188|Everolimus|everolimus|mesh-list
6532674|NCT00799188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6532675|NCT00799188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6532676|NCT00799188|Immunologic Factors|immunologic factors|mesh-ancestor
6532677|NCT00799188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532678|NCT00799201|Naloxone|naloxone|mesh-list
6532679|NCT00799201|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6532680|NCT00799201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532681|NCT00799201|Sensory System Agents|sensory system agents|mesh-ancestor
6532682|NCT00799201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6532683|NCT00799214|Metronidazole|metronidazole|mesh-list
6532684|NCT00799214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6532685|NCT00799214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6532686|NCT00799214|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6532687|NCT00799214|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6532688|NCT00799240|Cisplatin|cisplatin|mesh-list
6796079|NCT02259868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6796080|NCT02259868|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6796081|NCT02259868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6796082|NCT02259920|p-Hydroxyamphetamine|p-hydroxyamphetamine|mesh-list
6796083|NCT02259920|Mydriatics|mydriatics|mesh-ancestor
6796084|NCT02259920|Autonomic Agents|autonomic agents|mesh-ancestor
6796085|NCT02259920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6796086|NCT02259920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796087|NCT02259920|Sympathomimetics|sympathomimetics|mesh-ancestor
6796088|NCT02259946|Bromides|bromides|mesh-list
6796089|NCT02259946|Tiotropium Bromide|tiotropium bromide|mesh-list
6796090|NCT02259946|Olodaterol|olodaterol|mesh-list
6796091|NCT02259946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6796092|NCT02259946|Autonomic Agents|autonomic agents|mesh-ancestor
6796093|NCT02259946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6796094|NCT02259946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796095|NCT02259946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6796096|NCT02259946|Respiratory System Agents|respiratory system agents|mesh-ancestor
6796097|NCT02259946|Parasympatholytics|parasympatholytics|mesh-ancestor
6796098|NCT02259946|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6796099|NCT02259946|Cholinergic Agents|cholinergic agents|mesh-ancestor
6796100|NCT02259946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6796101|NCT02259946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796102|NCT02259946|Anticonvulsants|anticonvulsants|mesh-ancestor
6796103|NCT02259959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6796104|NCT02259959|Tiotropium Bromide|tiotropium bromide|mesh-list
6796105|NCT02259959|Olodaterol|olodaterol|mesh-list
6796106|NCT02259959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6796107|NCT02259959|Autonomic Agents|autonomic agents|mesh-ancestor
6796108|NCT02259959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6796109|NCT02259959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796110|NCT02259959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6796111|NCT02259959|Respiratory System Agents|respiratory system agents|mesh-ancestor
6796112|NCT02259959|Parasympatholytics|parasympatholytics|mesh-ancestor
6796113|NCT02259959|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6796114|NCT02259959|Cholinergic Agents|cholinergic agents|mesh-ancestor
6796115|NCT02259959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6796116|NCT02259959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796117|NCT02259985|Itasetron|itasetron|mesh-list
6796118|NCT02259985|Antiemetics|antiemetics|mesh-ancestor
6796119|NCT02259985|Autonomic Agents|autonomic agents|mesh-ancestor
6796120|NCT02259985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6796121|NCT02259985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796122|NCT02259985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6796123|NCT02259985|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6796124|NCT02259985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6796125|NCT02259985|Serotonin Agents|serotonin agents|mesh-ancestor
6796126|NCT02259985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6796127|NCT02259985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796128|NCT02259998|Dipyridamole|dipyridamole|mesh-list
6796129|NCT02259998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6796130|NCT02259998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6796131|NCT02259998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796132|NCT02259998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6532689|NCT00799240|Pemetrexed|pemetrexed|mesh-list
6796133|NCT02259998|Vasodilator Agents|vasodilator agents|mesh-ancestor
6532690|NCT00799240|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6532691|NCT00799240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6532692|NCT00799240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6532693|NCT00799240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532694|NCT00799240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6532695|NCT00799240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6532696|NCT00799240|Immunologic Factors|immunologic factors|mesh-ancestor
6532697|NCT00799240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532698|NCT00799266|Zoledronic Acid|zoledronic acid|mesh-list
6532699|NCT00799266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6532700|NCT00799266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532701|NCT00799448|Insulin|insulin|mesh-list
6532702|NCT00799448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6532703|NCT00799448|Repaglinide|repaglinide|mesh-list
6532704|NCT00799448|Isophane Insulin, Human|isophane insulin, human|mesh-list
6532705|NCT00799448|Insulin, Isophane|insulin, isophane|mesh-list
6532706|NCT00799448|Isophane insulin, beef|isophane insulin, beef|mesh-list
6532707|NCT00799448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6532708|NCT00799448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532709|NCT00799513|Lenalidomide|lenalidomide|mesh-list
6532710|NCT00799513|Immunologic Factors|immunologic factors|mesh-ancestor
6532711|NCT00799513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532712|NCT00799513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6532713|NCT00799513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6532714|NCT00799513|Growth Substances|growth substances|mesh-ancestor
6532715|NCT00799513|Growth Inhibitors|growth inhibitors|mesh-ancestor
6532716|NCT00799513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6532717|NCT00799539|Prednisone|prednisone|mesh-list
6532718|NCT00799539|Bortezomib|bortezomib|mesh-list
6532719|NCT00799539|Melphalan|melphalan|mesh-list
6532720|NCT00799539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6532721|NCT00799539|Glucocorticoids|glucocorticoids|mesh-ancestor
6532722|NCT00799539|Hormones|hormones|mesh-ancestor
6532723|NCT00799539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6532724|NCT00799539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532725|NCT00799539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6532726|NCT00799539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6532727|NCT00799539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6532728|NCT00799539|Alkylating Agents|alkylating agents|mesh-ancestor
6532729|NCT00799539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532730|NCT00799539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6532731|NCT00799539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6532732|NCT00799539|Immunologic Factors|immunologic factors|mesh-ancestor
6532733|NCT00799656|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide|mesh-list
6532734|NCT00799656|Enzyme Activators|enzyme activators|mesh-ancestor
6532735|NCT00799656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532736|NCT00799682|Travoprost|travoprost|mesh-list
6796134|NCT02260011|Bromides|bromides|mesh-list
6796135|NCT02260011|Norflurane|norflurane|mesh-list
6796136|NCT02260011|Ipratropium|ipratropium|mesh-list
6796137|NCT02260011|Anticonvulsants|anticonvulsants|mesh-ancestor
6796138|NCT02260011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6796139|NCT02260011|Autonomic Agents|autonomic agents|mesh-ancestor
6796140|NCT02260011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6796141|NCT02260011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796142|NCT02260011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6796143|NCT02260011|Respiratory System Agents|respiratory system agents|mesh-ancestor
6796144|NCT02260011|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6796145|NCT02260011|Cholinergic Agents|cholinergic agents|mesh-ancestor
6796146|NCT02260011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6796147|NCT02260011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796148|NCT02260011|Anesthetics|anesthetics|mesh-ancestor
6796149|NCT02260011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6796150|NCT02260024|Pramipexole|pramipexole|mesh-list
6796151|NCT02260024|Antioxidants|antioxidants|mesh-ancestor
6796152|NCT02260024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796153|NCT02260024|Protective Agents|protective agents|mesh-ancestor
6796154|NCT02260024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796155|NCT02260024|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6796156|NCT02260024|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6796157|NCT02260024|Dopamine Agonists|dopamine agonists|mesh-ancestor
6796158|NCT02260024|Dopamine Agents|dopamine agents|mesh-ancestor
6796159|NCT02260024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6796160|NCT02260037|Epinastine|epinastine|mesh-list
6796161|NCT02260037|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6532737|NCT00799682|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6532738|NCT00799682|Latanoprost|latanoprost|mesh-list
6532739|NCT00799682|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6532740|NCT00799682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6532741|NCT00799760|Oseltamivir|oseltamivir|mesh-list
6532742|NCT00799760|Zanamivir|zanamivir|mesh-list
6532743|NCT00799760|Antiviral Agents|antiviral agents|mesh-ancestor
6532744|NCT00799760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6532745|NCT00799760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6532746|NCT00799760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532747|NCT00799838|Amoxicillin|amoxicillin|mesh-list
6532748|NCT00799838|Ketoprofen|ketoprofen|mesh-list
6532749|NCT00799838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6532750|NCT00799838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6532751|NCT00799838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6532752|NCT00799838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6532753|NCT00799838|Analgesics|analgesics|mesh-ancestor
6532754|NCT00799838|Sensory System Agents|sensory system agents|mesh-ancestor
6532755|NCT00799838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6532756|NCT00799838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532757|NCT00799838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6532758|NCT00799838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6532759|NCT00799838|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6532760|NCT00799838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6532761|NCT00799838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532762|NCT00799864|Tenofovir|tenofovir|mesh-list
6532763|NCT00799864|Lamivudine|lamivudine|mesh-list
6532764|NCT00799864|Zidovudine|zidovudine|mesh-list
6532765|NCT00799864|Emtricitabine|emtricitabine|mesh-list
6532766|NCT00799864|Abacavir|abacavir|mesh-list
6532767|NCT00799864|Rilpivirine|rilpivirine|mesh-list
6532768|NCT00799864|Antiviral Agents|antiviral agents|mesh-ancestor
6532769|NCT00799864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6532770|NCT00799864|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6796162|NCT02260037|Histamine Antagonists|histamine antagonists|mesh-ancestor
6796163|NCT02260037|Histamine Agents|histamine agents|mesh-ancestor
6796164|NCT02260037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6796165|NCT02260037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796166|NCT02260037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796167|NCT02260050|Epinastine|epinastine|mesh-list
6796168|NCT02260050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6796169|NCT02260050|Histamine Antagonists|histamine antagonists|mesh-ancestor
6796170|NCT02260050|Histamine Agents|histamine agents|mesh-ancestor
6796171|NCT02260050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6796172|NCT02260050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796173|NCT02260050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796174|NCT02260063|Epinastine|epinastine|mesh-list
6796175|NCT02260063|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6796176|NCT02260063|Histamine Antagonists|histamine antagonists|mesh-ancestor
6796177|NCT02260063|Histamine Agents|histamine agents|mesh-ancestor
6796178|NCT02260063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6796179|NCT02260063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796180|NCT02260063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796181|NCT02260089|Telmisartan|telmisartan|mesh-list
6796182|NCT02260089|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6796183|NCT02260089|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6796184|NCT02260089|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6796185|NCT02260089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796186|NCT02260102|Temocillin|temocillin|mesh-list
6796187|NCT02260102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6796188|NCT02260102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6796189|NCT02260206|Colchicine|colchicine|mesh-list
6796190|NCT02260206|Gout Suppressants|gout suppressants|mesh-ancestor
6796191|NCT02260206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6796192|NCT02260206|Tubulin Modulators|tubulin modulators|mesh-ancestor
6796193|NCT02260206|Antimitotic Agents|antimitotic agents|mesh-ancestor
6796194|NCT02260206|Mitosis Modulators|mitosis modulators|mesh-ancestor
6796195|NCT02260206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796196|NCT02260206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6796197|NCT02260323|Antirheumatic Agents|antirheumatic agents|mesh-list
6796198|NCT02260336|Celecoxib|celecoxib|mesh-list
6796199|NCT02260336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6796200|NCT02260336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6796201|NCT02260336|Analgesics|analgesics|mesh-ancestor
6532771|NCT00799864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6532772|NCT00799864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6532773|NCT00799864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532774|NCT00799864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6532775|NCT00799864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6532776|NCT00799864|Antimetabolites|antimetabolites|mesh-ancestor
6532777|NCT00799890|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
6532778|NCT00799890|Antioxidants|antioxidants|mesh-ancestor
6532779|NCT00799890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532780|NCT00799890|Protective Agents|protective agents|mesh-ancestor
6532781|NCT00799890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532782|NCT00799890|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
6532783|NCT00799890|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6532784|NCT00799890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6532785|NCT00799890|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6537777|NCT00824135|Rituximab|rituximab|mesh-list
6537778|NCT00824135|Melphalan|melphalan|mesh-list
6537779|NCT00824135|Thiotepa|thiotepa|mesh-list
6537780|NCT00824135|Clofarabine|clofarabine|mesh-list
6537781|NCT00824135|Muromonab-CD3|muromonab-cd3|mesh-list
6537782|NCT00824135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6537783|NCT00824135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6537784|NCT00824135|Immunologic Factors|immunologic factors|mesh-ancestor
6537785|NCT00824135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537786|NCT00824135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6537787|NCT00824135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6537788|NCT00824135|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6537789|NCT00824135|Antitubercular Agents|antitubercular agents|mesh-ancestor
6537790|NCT00824135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6537791|NCT00824135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6537792|NCT00824135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6537793|NCT00824135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537794|NCT00824135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6537795|NCT00824135|Alkylating Agents|alkylating agents|mesh-ancestor
6537796|NCT00824135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6537797|NCT00824135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6538097|NCT00825851|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6796202|NCT02260336|Sensory System Agents|sensory system agents|mesh-ancestor
6796203|NCT02260336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6796204|NCT02260336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796205|NCT02260336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6796206|NCT02260336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6796207|NCT02260336|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6796208|NCT02260336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6796209|NCT02260336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6796210|NCT02260336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796211|NCT02260414|Tinzaparin|tinzaparin|mesh-list
6796212|NCT02260414|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6796213|NCT02260414|Dalteparin|dalteparin|mesh-list
6796214|NCT02260414|Anticoagulants|anticoagulants|mesh-ancestor
6796215|NCT02260414|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6796216|NCT02260414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6796217|NCT02260414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796218|NCT02260505|Imatinib Mesylate|imatinib mesylate|mesh-list
6796219|NCT02260505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6796220|NCT02260505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6796221|NCT02260505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6796222|NCT02260505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796223|NCT02260544|Doxorubicin|doxorubicin|mesh-list
6796224|NCT02260544|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6796225|NCT02260544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6796226|NCT02260544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6796227|NCT02260544|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6796228|NCT02260544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6796229|NCT02260544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6796230|NCT02260544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796231|NCT02260557|Selexipag|selexipag|mesh-list
6796232|NCT02260557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6796233|NCT02260570|Tolcapone|tolcapone|mesh-list
6796234|NCT02260570|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6796235|NCT02260570|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6796236|NCT02260570|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6796237|NCT02260570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6796238|NCT02260570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796239|NCT02260661|Fulvestrant|fulvestrant|mesh-list
6796240|NCT02260661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6532786|NCT00799968|Fibrinolytic Agents|fibrinolytic agents|mesh-list
6532787|NCT00799968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6532788|NCT00799968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532789|NCT00800137|Heparin|heparin|mesh-list
6532790|NCT00800137|Calcium heparin|calcium heparin|mesh-list
6532791|NCT00800137|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6532792|NCT00800137|Tinzaparin|tinzaparin|mesh-list
6532793|NCT00800137|Dalteparin|dalteparin|mesh-list
6532794|NCT00800137|Warfarin|warfarin|mesh-list
6532795|NCT00800137|Anticoagulants|anticoagulants|mesh-ancestor
6532796|NCT00800137|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6532797|NCT00800137|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6532798|NCT00800137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532799|NCT00800150|Fludarabine|fludarabine|mesh-list
6532800|NCT00800150|Fludarabine phosphate|fludarabine phosphate|mesh-list
6532801|NCT00800150|Melphalan|melphalan|mesh-list
6532802|NCT00800150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6532803|NCT00800150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6532804|NCT00800150|Antimetabolites|antimetabolites|mesh-ancestor
6532805|NCT00800150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532806|NCT00800150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6532807|NCT00800150|Immunologic Factors|immunologic factors|mesh-ancestor
6532808|NCT00800150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532809|NCT00800150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6532810|NCT00800150|Alkylating Agents|alkylating agents|mesh-ancestor
6532811|NCT00800150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6532812|NCT00800215|Lacosamide|lacosamide|mesh-list
6532813|NCT00800215|Anticonvulsants|anticonvulsants|mesh-ancestor
6532814|NCT00800215|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6532815|NCT00800215|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6532816|NCT00800215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6532817|NCT00800215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796241|NCT02260661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6796242|NCT02260661|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6796243|NCT02260661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6796244|NCT02260661|Hormone Antagonists|hormone antagonists|mesh-ancestor
6796245|NCT02260661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6796246|NCT02260661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796247|NCT02260687|Aflibercept|aflibercept|mesh-list
6796248|NCT02260687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6796249|NCT02260687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6796250|NCT02260687|Growth Substances|growth substances|mesh-ancestor
6796251|NCT02260687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796252|NCT02260687|Growth Inhibitors|growth inhibitors|mesh-ancestor
6796253|NCT02260687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6796254|NCT02260908|Enoxaparin|enoxaparin|mesh-list
6796255|NCT02260908|Anticoagulants|anticoagulants|mesh-ancestor
6796256|NCT02260908|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6796257|NCT02260908|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6796258|NCT02260908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796259|NCT02260947|Ibuprofen|ibuprofen|mesh-list
6796260|NCT02260947|Pregabalin|pregabalin|mesh-list
6796261|NCT02260947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6796262|NCT02260947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6796263|NCT02260947|Analgesics|analgesics|mesh-ancestor
6796264|NCT02260947|Sensory System Agents|sensory system agents|mesh-ancestor
6796265|NCT02260947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6796266|NCT02260947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796267|NCT02260947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6796268|NCT02260947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6796269|NCT02260947|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6796270|NCT02260947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6796271|NCT02260947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796272|NCT02260947|Anticonvulsants|anticonvulsants|mesh-ancestor
6796273|NCT02260947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6796274|NCT02260947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6796275|NCT02260947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6796276|NCT02260947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6796277|NCT02260947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6796278|NCT02260947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6796279|NCT02260947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6796280|NCT02261025|Aspirin|aspirin|mesh-list
6796281|NCT02261025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6532818|NCT00800267|Timolol|timolol|mesh-list
6796282|NCT02261025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6532819|NCT00800267|Latanoprost|latanoprost|mesh-list
6532820|NCT00800267|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6532821|NCT00800267|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6532822|NCT00800267|Adrenergic Agents|adrenergic agents|mesh-ancestor
6532823|NCT00800267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6532824|NCT00800267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532825|NCT00800267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532826|NCT00800267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6532827|NCT00800267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6532828|NCT00800267|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6532829|NCT00800267|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6532830|NCT00800280|Cimetidine|cimetidine|mesh-list
6532831|NCT00800280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6532832|NCT00800280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6532833|NCT00800280|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6532834|NCT00800280|Histamine Antagonists|histamine antagonists|mesh-ancestor
6532835|NCT00800280|Histamine Agents|histamine agents|mesh-ancestor
6532836|NCT00800280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6532837|NCT00800280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532838|NCT00800280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532839|NCT00800280|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6532840|NCT00800280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6532841|NCT00800280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6532842|NCT00800293|Betamethasone|betamethasone|mesh-list
6532843|NCT00800293|Betamethasone Valerate|betamethasone valerate|mesh-list
6532844|NCT00800293|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
6532845|NCT00800293|Betamethasone benzoate|betamethasone benzoate|mesh-list
6532846|NCT00800293|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
6532847|NCT00800293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6532848|NCT00800293|Glucocorticoids|glucocorticoids|mesh-ancestor
6532849|NCT00800293|Hormones|hormones|mesh-ancestor
6532850|NCT00800293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6796283|NCT02261025|Analgesics|analgesics|mesh-ancestor
6796284|NCT02261025|Sensory System Agents|sensory system agents|mesh-ancestor
6796285|NCT02261025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6796286|NCT02261025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796287|NCT02261025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6796288|NCT02261025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6796289|NCT02261025|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6796290|NCT02261025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6796291|NCT02261025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796292|NCT02261025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6796293|NCT02261025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6796294|NCT02261025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6796295|NCT02261025|Antipyretics|antipyretics|mesh-ancestor
6796296|NCT02261064|Amlodipine|amlodipine|mesh-list
6796297|NCT02261064|Telmisartan|telmisartan|mesh-list
6796298|NCT02261064|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
6796299|NCT02261064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6796300|NCT02261064|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6796301|NCT02261064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6796302|NCT02261064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796303|NCT02261064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6796304|NCT02261064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796305|NCT02261064|Vasodilator Agents|vasodilator agents|mesh-ancestor
6796306|NCT02261064|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6796307|NCT02261064|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6796308|NCT02261077|Scopolamine|scopolamine|mesh-list
6796309|NCT02261077|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
6796310|NCT02261077|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6796311|NCT02261077|Antiemetics|antiemetics|mesh-ancestor
6796312|NCT02261077|Autonomic Agents|autonomic agents|mesh-ancestor
6796313|NCT02261077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6796314|NCT02261077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796315|NCT02261077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6796316|NCT02261077|Mydriatics|mydriatics|mesh-ancestor
6796317|NCT02261077|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6796318|NCT02261077|Cholinergic Agents|cholinergic agents|mesh-ancestor
6796319|NCT02261077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6796320|NCT02261077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796321|NCT02261077|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6796322|NCT02261077|Parasympatholytics|parasympatholytics|mesh-ancestor
6796323|NCT02261090|Pramipexole|pramipexole|mesh-list
6796324|NCT02261090|Antioxidants|antioxidants|mesh-ancestor
6532851|NCT00800293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532852|NCT00800293|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6532853|NCT00800293|Respiratory System Agents|respiratory system agents|mesh-ancestor
6532854|NCT00800306|Simendan|simendan|mesh-list
6532855|NCT00800306|Dobutamine|dobutamine|mesh-list
6532856|NCT00800306|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6532857|NCT00800306|Vasodilator Agents|vasodilator agents|mesh-ancestor
6532858|NCT00800306|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6532859|NCT00800306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6532860|NCT00800306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6532861|NCT00800306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532862|NCT00800306|Protective Agents|protective agents|mesh-ancestor
6532863|NCT00800306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532864|NCT00800306|Sympathomimetics|sympathomimetics|mesh-ancestor
6532865|NCT00800306|Autonomic Agents|autonomic agents|mesh-ancestor
6532866|NCT00800306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6532867|NCT00800306|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6532868|NCT00800306|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6532869|NCT00800306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6532870|NCT00800306|Adrenergic Agents|adrenergic agents|mesh-ancestor
6532871|NCT00800306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6532872|NCT00800319|ALKS-33|alks-33|mesh-list
6532873|NCT00800319|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6532874|NCT00800319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532875|NCT00800319|Sensory System Agents|sensory system agents|mesh-ancestor
6532876|NCT00800319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6532877|NCT00800358|Calcitriol|calcitriol|mesh-list
6532878|NCT00800358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6796325|NCT02261090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796326|NCT02261090|Protective Agents|protective agents|mesh-ancestor
6796327|NCT02261090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796328|NCT02261090|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6796329|NCT02261090|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6796330|NCT02261090|Dopamine Agonists|dopamine agonists|mesh-ancestor
6796331|NCT02261090|Dopamine Agents|dopamine agents|mesh-ancestor
6796332|NCT02261090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6796333|NCT02261103|Pramipexole|pramipexole|mesh-list
6796334|NCT02261103|Antioxidants|antioxidants|mesh-ancestor
6796335|NCT02261103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796336|NCT02261103|Protective Agents|protective agents|mesh-ancestor
6796337|NCT02261103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796338|NCT02261103|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6796339|NCT02261103|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6796340|NCT02261103|Dopamine Agonists|dopamine agonists|mesh-ancestor
6796341|NCT02261103|Dopamine Agents|dopamine agents|mesh-ancestor
6796342|NCT02261103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6796343|NCT02261116|Telmisartan|telmisartan|mesh-list
6796344|NCT02261116|Candesartan|candesartan|mesh-list
6796345|NCT02261116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6796346|NCT02261116|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6796347|NCT02261116|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6796348|NCT02261116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796349|NCT02261129|Telmisartan|telmisartan|mesh-list
6796350|NCT02261129|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6796351|NCT02261129|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6796352|NCT02261129|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6796353|NCT02261129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796354|NCT02261155|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
6796355|NCT02261155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6796356|NCT02261155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796357|NCT02261207|Axitinib|axitinib|mesh-list
6796358|NCT02261207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6796359|NCT02261207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6796360|NCT02261207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6796361|NCT02261207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796362|NCT02261220|Durvalumab|durvalumab|mesh-list
6796363|NCT02261220|Tremelimumab|tremelimumab|mesh-list
6796364|NCT02261220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6796365|NCT02261220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6796366|NCT02261298|Nivolumab|nivolumab|mesh-list
6796367|NCT02261298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6796368|NCT02261298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6532879|NCT00800358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532880|NCT00800358|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6532881|NCT00800358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6532882|NCT00800358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532883|NCT00800358|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6532884|NCT00800358|Vitamins|vitamins|mesh-ancestor
6532885|NCT00800358|Micronutrients|micronutrients|mesh-ancestor
6532886|NCT00800358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6532887|NCT00800423|Timolol|timolol|mesh-list
6532888|NCT00800423|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6532889|NCT00800423|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6532890|NCT00800423|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6532891|NCT00800423|Adrenergic Agents|adrenergic agents|mesh-ancestor
6532892|NCT00800423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6532893|NCT00800423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532894|NCT00800423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532895|NCT00800423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6532896|NCT00800423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6532897|NCT00800423|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6532898|NCT00800423|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6532899|NCT00800423|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6532900|NCT00800462|Bromides|bromides|mesh-list
6532901|NCT00800462|Oxybutynin|oxybutynin|mesh-list
6532902|NCT00800462|Darifenacin|darifenacin|mesh-list
6532903|NCT00800462|Anticonvulsants|anticonvulsants|mesh-ancestor
6532904|NCT00800462|Parasympatholytics|parasympatholytics|mesh-ancestor
6532905|NCT00800462|Autonomic Agents|autonomic agents|mesh-ancestor
6532906|NCT00800462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6532907|NCT00800462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532908|NCT00800462|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6532909|NCT00800462|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6532910|NCT00800462|Cholinergic Agents|cholinergic agents|mesh-ancestor
6532911|NCT00800462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6532912|NCT00800462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532913|NCT00800462|Urological Agents|urological agents|mesh-ancestor
6532914|NCT00800475|Gemfibrozil|gemfibrozil|mesh-list
6532915|NCT00800475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6532916|NCT00800475|Antimetabolites|antimetabolites|mesh-ancestor
6532917|NCT00800475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532918|NCT00800475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6796369|NCT02261298|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6796370|NCT02261298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532919|NCT00800475|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6532920|NCT00800475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6532921|NCT00800475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6532922|NCT00800514|Amantadine|amantadine|mesh-list
6532923|NCT00800514|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6532924|NCT00800514|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6532925|NCT00800514|Antiviral Agents|antiviral agents|mesh-ancestor
6532926|NCT00800514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6532927|NCT00800514|Dopamine Agents|dopamine agents|mesh-ancestor
6532928|NCT00800514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6532929|NCT00800514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532930|NCT00800514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532931|NCT00800514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6532932|NCT00800514|Analgesics|analgesics|mesh-ancestor
6532933|NCT00800514|Sensory System Agents|sensory system agents|mesh-ancestor
6532934|NCT00800514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6532935|NCT00800527|Diclofenac|diclofenac|mesh-list
6532936|NCT00800527|Gabapentin|gabapentin|mesh-list
6532937|NCT00800527|Analgesics|analgesics|mesh-ancestor
6532938|NCT00800527|Sensory System Agents|sensory system agents|mesh-ancestor
6532939|NCT00800527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6532940|NCT00800527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532941|NCT00800527|Anticonvulsants|anticonvulsants|mesh-ancestor
6532942|NCT00800527|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6532943|NCT00800527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6532944|NCT00800527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6532945|NCT00800527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6532946|NCT00800527|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6532947|NCT00800527|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6532948|NCT00800527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6532949|NCT00800527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532950|NCT00800527|Antimanic Agents|antimanic agents|mesh-ancestor
6532951|NCT00800527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6532952|NCT00800527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6532953|NCT00800527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6532954|NCT00800527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6532955|NCT00800527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6532956|NCT00800527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6532957|NCT00800553|Donepezil|donepezil|mesh-list
6532958|NCT00800553|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6532959|NCT00800553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6532960|NCT00800553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532961|NCT00800553|Cholinergic Agents|cholinergic agents|mesh-ancestor
6532962|NCT00800553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6532963|NCT00800553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532964|NCT00800553|Nootropic Agents|nootropic agents|mesh-ancestor
6532965|NCT00800566|Clofarabine|clofarabine|mesh-list
6532966|NCT00800566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6532967|NCT00800566|Antimetabolites|antimetabolites|mesh-ancestor
6532968|NCT00800566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532969|NCT00800566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6532970|NCT00800592|Sildenafil Citrate|sildenafil citrate|mesh-list
6532971|NCT00800592|Vasodilator Agents|vasodilator agents|mesh-ancestor
6538098|NCT00825851|Cholinergic Agents|cholinergic agents|mesh-ancestor
6796371|NCT02261506|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6796372|NCT02261506|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6796373|NCT02261506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6796374|NCT02261506|Antitubercular Agents|antitubercular agents|mesh-ancestor
6796375|NCT02261636|Mesalamine|mesalamine|mesh-list
6796376|NCT02261636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6796377|NCT02261636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6796378|NCT02261636|Analgesics|analgesics|mesh-ancestor
6796379|NCT02261636|Sensory System Agents|sensory system agents|mesh-ancestor
6796380|NCT02261636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6796381|NCT02261636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796382|NCT02261636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6796383|NCT02261636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6796384|NCT02261662|Ribavirin|ribavirin|mesh-list
6796385|NCT02261662|Betamethasone|betamethasone|mesh-list
6796386|NCT02261662|Antimetabolites|antimetabolites|mesh-ancestor
6796387|NCT02261662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796388|NCT02261662|Antiviral Agents|antiviral agents|mesh-ancestor
6796389|NCT02261662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6796390|NCT02261662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6796391|NCT02261662|Glucocorticoids|glucocorticoids|mesh-ancestor
6796392|NCT02261662|Hormones|hormones|mesh-ancestor
6532972|NCT00800592|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6532973|NCT00800592|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6532974|NCT00800592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6532975|NCT00800592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532976|NCT00800592|Urological Agents|urological agents|mesh-ancestor
6532977|NCT00800709|Memantine|memantine|mesh-list
6532978|NCT00800709|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6532979|NCT00800709|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6532980|NCT00800709|Dopamine Agents|dopamine agents|mesh-ancestor
6532981|NCT00800709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6532982|NCT00800709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532983|NCT00800709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532984|NCT00800709|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6532985|NCT00800709|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6532986|NCT00800722|Sirolimus|sirolimus|mesh-list
6532987|NCT00800722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6796393|NCT02261662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6796394|NCT02261662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796395|NCT02261662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6796396|NCT02261662|Respiratory System Agents|respiratory system agents|mesh-ancestor
6796397|NCT02261675|Dexmedetomidine|dexmedetomidine|mesh-list
6796398|NCT02261675|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6796399|NCT02261675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6796400|NCT02261675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796401|NCT02261675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6796402|NCT02261675|Analgesics|analgesics|mesh-ancestor
6796403|NCT02261675|Sensory System Agents|sensory system agents|mesh-ancestor
6796404|NCT02261675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6796405|NCT02261675|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6796406|NCT02261675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6796407|NCT02261675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6796408|NCT02261675|Adrenergic Agents|adrenergic agents|mesh-ancestor
6796409|NCT02261675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6796410|NCT02261675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796411|NCT02261779|Tretinoin|tretinoin|mesh-list
6796412|NCT02261779|Tranylcypromine|tranylcypromine|mesh-list
6796413|NCT02261779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6796414|NCT02261779|Keratolytic Agents|keratolytic agents|mesh-ancestor
6796415|NCT02261779|Dermatologic Agents|dermatologic agents|mesh-ancestor
6796416|NCT02261779|Antidepressive Agents|antidepressive agents|mesh-ancestor
6796417|NCT02261779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6796418|NCT02261779|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6796419|NCT02261779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6796420|NCT02261779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796421|NCT02261779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6796422|NCT02261779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6796423|NCT02261779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6796424|NCT02261779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796425|NCT02261844|Resveratrol|resveratrol|mesh-list
6796426|NCT02261844|Antioxidants|antioxidants|mesh-ancestor
6796427|NCT02261844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796428|NCT02261844|Protective Agents|protective agents|mesh-ancestor
6796429|NCT02261844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796430|NCT02261844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6796431|NCT02261844|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6796432|NCT02261883|Treprostinil|treprostinil|mesh-list
6796433|NCT02261883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6796434|NCT02261896|Ciprofloxacin|ciprofloxacin|mesh-list
6796435|NCT02261896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6796436|NCT02261896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6796437|NCT02261896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6796438|NCT02261896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6796439|NCT02261896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6796440|NCT02261896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796441|NCT02261896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6796442|NCT02261896|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6796443|NCT02261896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6796444|NCT02261922|Ticagrelor|ticagrelor|mesh-list
6796445|NCT02261922|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6796446|NCT02261922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6796447|NCT02261922|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6532988|NCT00800722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6532989|NCT00800722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6532990|NCT00800722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6532991|NCT00800722|Antifungal Agents|antifungal agents|mesh-ancestor
6532992|NCT00800722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6532993|NCT00800722|Immunologic Factors|immunologic factors|mesh-ancestor
6532994|NCT00800722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6532995|NCT00800748|Ribavirin|ribavirin|mesh-list
6532996|NCT00800748|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6532997|NCT00800748|Antimetabolites|antimetabolites|mesh-ancestor
6532998|NCT00800748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6532999|NCT00800748|Antiviral Agents|antiviral agents|mesh-ancestor
6533000|NCT00800748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6533001|NCT00800761|Deferiprone|deferiprone|mesh-list
6533002|NCT00800761|Deferoxamine|deferoxamine|mesh-list
6533003|NCT00800761|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6533004|NCT00800761|Chelating Agents|chelating agents|mesh-ancestor
6533005|NCT00800761|Sequestering Agents|sequestering agents|mesh-ancestor
6533006|NCT00800761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6533007|NCT00800761|Siderophores|siderophores|mesh-ancestor
6533008|NCT00800787|Immunoglobulins|immunoglobulins|mesh-list
6533009|NCT00800787|Immunologic Factors|immunologic factors|mesh-ancestor
6533010|NCT00800787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533011|NCT00800800|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6533012|NCT00800800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6533013|NCT00800800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6533014|NCT00800800|Antimetabolites|antimetabolites|mesh-ancestor
6533015|NCT00800800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6533016|NCT00800800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6533017|NCT00800800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6533018|NCT00800800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6533019|NCT00800826|Dexmedetomidine|dexmedetomidine|mesh-list
6533020|NCT00800826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6533021|NCT00800826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6533022|NCT00800826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533023|NCT00800826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6533024|NCT00800826|Analgesics|analgesics|mesh-ancestor
6533025|NCT00800826|Sensory System Agents|sensory system agents|mesh-ancestor
6533026|NCT00800826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6533027|NCT00800826|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6533028|NCT00800826|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6533029|NCT00800826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6533030|NCT00800826|Adrenergic Agents|adrenergic agents|mesh-ancestor
6533031|NCT00800826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6533032|NCT00800826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6533033|NCT00800917|Sirolimus|sirolimus|mesh-list
6533034|NCT00800917|Bevacizumab|bevacizumab|mesh-list
6533035|NCT00800917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6533036|NCT00800917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6796448|NCT02261922|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6796449|NCT02261922|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6796450|NCT02261922|Purinergic Agents|purinergic agents|mesh-ancestor
6796451|NCT02261922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6796452|NCT02261922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796453|NCT02261922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796454|NCT02262143|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6796455|NCT02262143|Fenofibrate|fenofibrate|mesh-list
6796456|NCT02262143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6796457|NCT02262143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6796458|NCT02262143|Antimetabolites|antimetabolites|mesh-ancestor
6796459|NCT02262143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796460|NCT02262143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6796461|NCT02262143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6796462|NCT02262143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6796463|NCT02262156|Antidepressive Agents|antidepressive agents|mesh-list
6796464|NCT02262156|Serotonin|serotonin|mesh-list
6796465|NCT02262156|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
6796466|NCT02262156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6796467|NCT02262156|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6796468|NCT02262156|Serotonin Agents|serotonin agents|mesh-ancestor
6796469|NCT02262156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6796470|NCT02262156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796471|NCT02262156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796472|NCT02262156|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6533037|NCT00800917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6533038|NCT00800917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6533039|NCT00800917|Growth Substances|growth substances|mesh-ancestor
6533040|NCT00800917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533041|NCT00800917|Growth Inhibitors|growth inhibitors|mesh-ancestor
6533042|NCT00800917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6533043|NCT00800917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6533044|NCT00800917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6533045|NCT00800917|Antifungal Agents|antifungal agents|mesh-ancestor
6533046|NCT00800917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6533047|NCT00800917|Immunologic Factors|immunologic factors|mesh-ancestor
6533048|NCT00800930|Butyric Acid|butyric acid|mesh-list
6533049|NCT00800930|Histamine Antagonists|histamine antagonists|mesh-ancestor
6533050|NCT00800930|Histamine Agents|histamine agents|mesh-ancestor
6796473|NCT02262156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6796474|NCT02262169|Omeprazole|omeprazole|mesh-list
6796475|NCT02262169|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6796476|NCT02262169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6796477|NCT02262169|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6796478|NCT02262169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6796479|NCT02262169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796480|NCT02262299|Pirfenidone|pirfenidone|mesh-list
6796481|NCT02262299|Analgesics|analgesics|mesh-ancestor
6796482|NCT02262299|Sensory System Agents|sensory system agents|mesh-ancestor
6796483|NCT02262299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6796484|NCT02262299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796485|NCT02262299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6796486|NCT02262299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6796487|NCT02262299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6796488|NCT02262299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6796489|NCT02262299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6796490|NCT02262325|Etoposide|etoposide|mesh-list
6796491|NCT02262325|Etoposide phosphate|etoposide phosphate|mesh-list
6796492|NCT02262325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6796493|NCT02262325|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6796494|NCT02262325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6796495|NCT02262325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6796496|NCT02262325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6796497|NCT02262325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796498|NCT02262416|Leuprolide|leuprolide|mesh-list
6796499|NCT02262416|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6796500|NCT02262416|Fertility Agents|fertility agents|mesh-ancestor
6796501|NCT02262416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6796502|NCT02262416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796503|NCT02262416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6796504|NCT02262416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6796505|NCT02262455|Doxorubicin|doxorubicin|mesh-list
6796506|NCT02262455|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6796507|NCT02262455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6796508|NCT02262455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6796509|NCT02262455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6796510|NCT02262455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6796511|NCT02262455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6796512|NCT02262455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796513|NCT02262481|Dydrogesterone|dydrogesterone|mesh-list
6796514|NCT02262481|Progestins|progestins|mesh-ancestor
6796515|NCT02262481|Hormones|hormones|mesh-ancestor
6796516|NCT02262481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6796517|NCT02262481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796518|NCT02262520|Digoxin|digoxin|mesh-list
6796519|NCT02262520|Apixaban|apixaban|mesh-list
6796520|NCT02262520|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6796521|NCT02262520|Antithrombins|antithrombins|mesh-ancestor
6796522|NCT02262520|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6796523|NCT02262520|Protease Inhibitors|protease inhibitors|mesh-ancestor
6796524|NCT02262520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6796525|NCT02262520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796526|NCT02262520|Anticoagulants|anticoagulants|mesh-ancestor
6796527|NCT02262520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6796528|NCT02262520|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6796529|NCT02262520|Protective Agents|protective agents|mesh-ancestor
6796530|NCT02262520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796531|NCT02262533|Atenolol|atenolol|mesh-list
6796532|NCT02262533|Apixaban|apixaban|mesh-list
6796533|NCT02262533|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6796534|NCT02262533|Antithrombins|antithrombins|mesh-ancestor
6533051|NCT00800930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6533052|NCT00800930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6533053|NCT00800930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533054|NCT00800943|Alemtuzumab|alemtuzumab|mesh-list
6533055|NCT00800943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6533056|NCT00800943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6533057|NCT00801034|Calcium|calcium|mesh-list
6533058|NCT00801034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6533059|NCT00801034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533060|NCT00801047|Remifentanil|remifentanil|mesh-list
6533061|NCT00801047|Bupivacaine|bupivacaine|mesh-list
6533062|NCT00801047|Anesthetics, Local|anesthetics, local|mesh-ancestor
6533063|NCT00801047|Anesthetics|anesthetics|mesh-ancestor
6533064|NCT00801047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6533065|NCT00801047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533066|NCT00801047|Sensory System Agents|sensory system agents|mesh-ancestor
6533067|NCT00801047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6533068|NCT00801047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6533069|NCT00801047|Narcotics|narcotics|mesh-ancestor
6533070|NCT00801047|Analgesics|analgesics|mesh-ancestor
6533071|NCT00801086|Ethanol|ethanol|mesh-list
6533072|NCT00801086|Tempol|tempol|mesh-list
6533073|NCT00801086|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6533074|NCT00801086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6533075|NCT00801086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6533076|NCT00801086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533077|NCT00801086|Antioxidants|antioxidants|mesh-ancestor
6533078|NCT00801086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6533079|NCT00801086|Protective Agents|protective agents|mesh-ancestor
6533080|NCT00801086|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6533081|NCT00801086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6533082|NCT00801086|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6533083|NCT00801086|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6533084|NCT00801125|Natalizumab|natalizumab|mesh-list
6533085|NCT00801125|Immunologic Factors|immunologic factors|mesh-ancestor
6533086|NCT00801125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533087|NCT00801151|Vinorelbine|vinorelbine|mesh-list
6533088|NCT00801151|Vorinostat|vorinostat|mesh-list
6533089|NCT00801151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6533090|NCT00801151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6533091|NCT00801151|Tubulin Modulators|tubulin modulators|mesh-ancestor
6533092|NCT00801151|Antimitotic Agents|antimitotic agents|mesh-ancestor
6533093|NCT00801151|Mitosis Modulators|mitosis modulators|mesh-ancestor
6533094|NCT00801151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6533095|NCT00801151|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6533096|NCT00801151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6533097|NCT00801177|Necitumumab|necitumumab|mesh-list
6533098|NCT00801177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6533099|NCT00801177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6533100|NCT00801177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6533101|NCT00801177|Immunologic Factors|immunologic factors|mesh-ancestor
6533102|NCT00801177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533103|NCT00801255|Lactams|lactams|mesh-list
6533104|NCT00801255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6533105|NCT00801255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6533106|NCT00801268|Emodin|emodin|mesh-list
6533107|NCT00801268|Cathartics|cathartics|mesh-ancestor
6533108|NCT00801268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6533109|NCT00801268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6533110|NCT00801268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6533111|NCT00801268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6533112|NCT00801281|Prednisone|prednisone|mesh-list
6533113|NCT00801281|Cyclophosphamide|cyclophosphamide|mesh-list
6533114|NCT00801281|Rituximab|rituximab|mesh-list
6533115|NCT00801281|Doxorubicin|doxorubicin|mesh-list
6533116|NCT00801281|Vincristine|vincristine|mesh-list
6533117|NCT00801281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6533118|NCT00801281|Immunologic Factors|immunologic factors|mesh-ancestor
6533119|NCT00801281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533120|NCT00801281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6533121|NCT00801281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6533122|NCT00801281|Alkylating Agents|alkylating agents|mesh-ancestor
6533123|NCT00801281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6533124|NCT00801281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6796535|NCT02262533|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6258422|NCT03086356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6533125|NCT00801281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6533126|NCT00801281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6533127|NCT00801281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6533128|NCT00801281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6533129|NCT00801281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6533130|NCT00801281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6533131|NCT00801281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6796536|NCT02262533|Protease Inhibitors|protease inhibitors|mesh-ancestor
6796537|NCT02262533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6796538|NCT02262533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796539|NCT02262533|Anticoagulants|anticoagulants|mesh-ancestor
6796540|NCT02262533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6796541|NCT02262533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6796542|NCT02262533|Sympatholytics|sympatholytics|mesh-ancestor
6796543|NCT02262533|Autonomic Agents|autonomic agents|mesh-ancestor
6796544|NCT02262533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6796545|NCT02262533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796546|NCT02262533|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6796547|NCT02262533|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6796548|NCT02262533|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6796549|NCT02262533|Adrenergic Agents|adrenergic agents|mesh-ancestor
6796550|NCT02262533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6796551|NCT02262546|Moxifloxacin|moxifloxacin|mesh-list
6796552|NCT02262546|Pramipexole|pramipexole|mesh-list
6796553|NCT02262546|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6796554|NCT02262546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6796555|NCT02262546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6796556|NCT02262546|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6796557|NCT02262546|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6796558|NCT02262546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6796559|NCT02262546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796560|NCT02262546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6796561|NCT02262546|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6796562|NCT02262546|Contraceptive Agents|contraceptive agents|mesh-ancestor
6796563|NCT02262546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6796564|NCT02262546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796565|NCT02262546|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6796566|NCT02262546|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6796567|NCT02262546|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6796568|NCT02262546|Antioxidants|antioxidants|mesh-ancestor
6796569|NCT02262546|Protective Agents|protective agents|mesh-ancestor
6796570|NCT02262546|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6796571|NCT02262546|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6796572|NCT02262546|Dopamine Agonists|dopamine agonists|mesh-ancestor
6796573|NCT02262546|Dopamine Agents|dopamine agents|mesh-ancestor
6796574|NCT02262546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6796575|NCT02262559|Telmisartan|telmisartan|mesh-list
6796576|NCT02262559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6796577|NCT02262559|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6796578|NCT02262559|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6796579|NCT02262559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796580|NCT02262572|Telmisartan|telmisartan|mesh-list
6796581|NCT02262572|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6796582|NCT02262572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6796583|NCT02262572|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6796584|NCT02262572|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6796585|NCT02262572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796586|NCT02262572|Diuretics|diuretics|mesh-ancestor
6796587|NCT02262572|Natriuretic Agents|natriuretic agents|mesh-ancestor
6796588|NCT02262572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796589|NCT02262572|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6796590|NCT02262572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6796591|NCT02262585|Telmisartan|telmisartan|mesh-list
6796592|NCT02262585|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6796593|NCT02262585|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6796594|NCT02262585|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6796595|NCT02262585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796596|NCT02262598|Telmisartan|telmisartan|mesh-list
6796597|NCT02262598|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6796598|NCT02262598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5993050|NCT00118742|Antitubercular Agents|antitubercular agents|mesh-ancestor
6533132|NCT00801281|Glucocorticoids|glucocorticoids|mesh-ancestor
6533133|NCT00801281|Hormones|hormones|mesh-ancestor
6533134|NCT00801281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6533135|NCT00801281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6533136|NCT00801281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6533137|NCT00801281|Tubulin Modulators|tubulin modulators|mesh-ancestor
6533138|NCT00801281|Antimitotic Agents|antimitotic agents|mesh-ancestor
6533139|NCT00801281|Mitosis Modulators|mitosis modulators|mesh-ancestor
6533140|NCT00801294|Nintedanib|nintedanib|mesh-list
6533141|NCT00801294|Afatinib|afatinib|mesh-list
6533142|NCT00801294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6533143|NCT00801294|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6533144|NCT00801294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6533145|NCT00801294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6533146|NCT00801359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6533147|NCT00801385|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6533148|NCT00801385|Sorafenib|sorafenib|mesh-list
6533149|NCT00801385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6533150|NCT00801385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6533151|NCT00801385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6533152|NCT00801385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6533153|NCT00801411|Cyclophosphamide|cyclophosphamide|mesh-list
6533154|NCT00801411|Docetaxel|docetaxel|mesh-list
6533155|NCT00801411|Doxorubicin|doxorubicin|mesh-list
6533156|NCT00801411|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6533157|NCT00801411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6533158|NCT00801411|Immunologic Factors|immunologic factors|mesh-ancestor
6533159|NCT00801411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533160|NCT00801411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6533161|NCT00801411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6533162|NCT00801411|Alkylating Agents|alkylating agents|mesh-ancestor
6533163|NCT00801411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6533164|NCT00801411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6533165|NCT00801411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6533166|NCT00801411|Tubulin Modulators|tubulin modulators|mesh-ancestor
6533167|NCT00801411|Antimitotic Agents|antimitotic agents|mesh-ancestor
6533168|NCT00801411|Mitosis Modulators|mitosis modulators|mesh-ancestor
6533169|NCT00801411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6533170|NCT00801411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6533171|NCT00801411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6533172|NCT00801411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6533173|NCT00801450|Triamcinolone|triamcinolone|mesh-list
6533174|NCT00801450|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6533175|NCT00801450|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6533176|NCT00801450|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6796599|NCT02262598|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6796600|NCT02262598|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6796601|NCT02262598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796602|NCT02262598|Diuretics|diuretics|mesh-ancestor
6796603|NCT02262598|Natriuretic Agents|natriuretic agents|mesh-ancestor
6796604|NCT02262598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796605|NCT02262598|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6796606|NCT02262598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6796607|NCT02262611|Telmisartan|telmisartan|mesh-list
6796608|NCT02262611|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
6796609|NCT02262611|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6796610|NCT02262611|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6796611|NCT02262611|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6796612|NCT02262611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796613|NCT02262611|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6796614|NCT02262611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6796615|NCT02262611|Diuretics|diuretics|mesh-ancestor
6796616|NCT02262611|Natriuretic Agents|natriuretic agents|mesh-ancestor
6796617|NCT02262611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796618|NCT02262624|Telmisartan|telmisartan|mesh-list
6796619|NCT02262624|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6796620|NCT02262624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6796621|NCT02262624|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6796622|NCT02262624|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6796623|NCT02262624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796624|NCT02262624|Diuretics|diuretics|mesh-ancestor
6796625|NCT02262624|Natriuretic Agents|natriuretic agents|mesh-ancestor
6796626|NCT02262624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533177|NCT00801450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6533178|NCT00801450|Glucocorticoids|glucocorticoids|mesh-ancestor
6533179|NCT00801450|Hormones|hormones|mesh-ancestor
6533180|NCT00801450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6533181|NCT00801450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533182|NCT00801450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6533183|NCT00801450|Immunologic Factors|immunologic factors|mesh-ancestor
6533184|NCT00801450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6533185|NCT00801450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6533186|NCT00801489|Cytarabine|cytarabine|mesh-list
6533187|NCT00801489|Fludarabine|fludarabine|mesh-list
6533188|NCT00801489|Fludarabine phosphate|fludarabine phosphate|mesh-list
6533189|NCT00801489|Decitabine|decitabine|mesh-list
6533190|NCT00801489|Idarubicin|idarubicin|mesh-list
6533191|NCT00801489|Gemtuzumab|gemtuzumab|mesh-list
6533192|NCT00801489|Calicheamicins|calicheamicins|mesh-list
6533193|NCT00801489|Lenograstim|lenograstim|mesh-list
6533194|NCT00801489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6796627|NCT02262624|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6796628|NCT02262624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6796629|NCT02262637|Telmisartan|telmisartan|mesh-list
6796630|NCT02262637|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
6796631|NCT02262637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6796632|NCT02262637|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6796633|NCT02262637|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6796634|NCT02262637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796635|NCT02262637|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6796636|NCT02262637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6796637|NCT02262637|Diuretics|diuretics|mesh-ancestor
6796638|NCT02262637|Natriuretic Agents|natriuretic agents|mesh-ancestor
6796639|NCT02262637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796640|NCT02262650|Telmisartan|telmisartan|mesh-list
6796641|NCT02262650|Clopidogrel|clopidogrel|mesh-list
6796642|NCT02262650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6796643|NCT02262650|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6796644|NCT02262650|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6796645|NCT02262650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6796646|NCT02262650|Purinergic Agents|purinergic agents|mesh-ancestor
6796647|NCT02262650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6796648|NCT02262650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796649|NCT02262650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796650|NCT02262650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6796651|NCT02262650|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6796652|NCT02262650|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6796653|NCT02262676|Rivaroxaban|rivaroxaban|mesh-list
6796654|NCT02262676|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6796655|NCT02262676|Antithrombins|antithrombins|mesh-ancestor
6796656|NCT02262676|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6796657|NCT02262676|Protease Inhibitors|protease inhibitors|mesh-ancestor
6796658|NCT02262676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6796659|NCT02262676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796660|NCT02262676|Anticoagulants|anticoagulants|mesh-ancestor
6796661|NCT02262702|Acetaminophen|acetaminophen|mesh-list
6796662|NCT02262702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6796663|NCT02262702|Analgesics|analgesics|mesh-ancestor
6796664|NCT02262702|Sensory System Agents|sensory system agents|mesh-ancestor
6796665|NCT02262702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6796666|NCT02262702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796667|NCT02262702|Antipyretics|antipyretics|mesh-ancestor
6796668|NCT02262715|Oseltamivir|oseltamivir|mesh-list
6796669|NCT02262715|Antiviral Agents|antiviral agents|mesh-ancestor
6796670|NCT02262715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6796671|NCT02262715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6796672|NCT02262715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796673|NCT02262741|Durvalumab|durvalumab|mesh-list
6796674|NCT02262741|Tremelimumab|tremelimumab|mesh-list
6796675|NCT02262741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6796676|NCT02262741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6796677|NCT02262767|Trimethobenzamide|trimethobenzamide|mesh-list
6796678|NCT02262767|Antiemetics|antiemetics|mesh-ancestor
6796679|NCT02262767|Autonomic Agents|autonomic agents|mesh-ancestor
6796680|NCT02262767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6796681|NCT02262767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796682|NCT02262767|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6796683|NCT02262780|Telmisartan|telmisartan|mesh-list
6533195|NCT00801489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6533196|NCT00801489|Antimetabolites|antimetabolites|mesh-ancestor
6533197|NCT00801489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6533198|NCT00801489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6533199|NCT00801489|Immunologic Factors|immunologic factors|mesh-ancestor
6533200|NCT00801489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533201|NCT00801489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6533202|NCT00801489|Antiviral Agents|antiviral agents|mesh-ancestor
6533203|NCT00801489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6533204|NCT00801489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6533205|NCT00801489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6533206|NCT00801489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6533207|NCT00801489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6533208|NCT00801489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6537798|NCT00824135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6537799|NCT00824135|Antimetabolites|antimetabolites|mesh-ancestor
6537800|NCT00824200|Tamsulosin|tamsulosin|mesh-list
6537801|NCT00824200|Adrenergic Agents|adrenergic agents|mesh-list
6537802|NCT00824200|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
6537803|NCT00824200|Adrenergic Antagonists|adrenergic antagonists|mesh-list
6537804|NCT00824200|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6537805|NCT00824200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6537806|NCT00824200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537807|NCT00824200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537808|NCT00824200|Urological Agents|urological agents|mesh-ancestor
6537809|NCT00824239|Fentanyl|fentanyl|mesh-list
6537810|NCT00824239|Midazolam|midazolam|mesh-list
6537811|NCT00824239|Propofol|propofol|mesh-list
6537812|NCT00824239|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6537813|NCT00824239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6537814|NCT00824239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537815|NCT00824239|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6537816|NCT00824239|Anesthetics, General|anesthetics, general|mesh-ancestor
6537817|NCT00824239|Anesthetics|anesthetics|mesh-ancestor
6537818|NCT00824239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6537819|NCT00824239|Narcotics|narcotics|mesh-ancestor
6537820|NCT00824239|Analgesics|analgesics|mesh-ancestor
6537821|NCT00824239|Sensory System Agents|sensory system agents|mesh-ancestor
6537822|NCT00824239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6537823|NCT00824239|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6537824|NCT00824239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6537825|NCT00824239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6537826|NCT00824239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6537827|NCT00824239|GABA Modulators|gaba modulators|mesh-ancestor
6537828|NCT00824239|GABA Agents|gaba agents|mesh-ancestor
6537829|NCT00824239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6537830|NCT00824239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537831|NCT00824317|Methylphenidate|methylphenidate|mesh-list
6537832|NCT00824317|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6537833|NCT00824317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537834|NCT00824317|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6537835|NCT00824317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6537836|NCT00824317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6537837|NCT00824317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537838|NCT00824317|Dopamine Agents|dopamine agents|mesh-ancestor
6537839|NCT00824317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6537840|NCT00824668|Insulin|insulin|mesh-list
6537841|NCT00824668|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6537842|NCT00824668|Insulin Glargine|insulin glargine|mesh-list
6537843|NCT00824668|Insulin Aspart|insulin aspart|mesh-list
6537844|NCT00824668|Biphasic Insulins|biphasic insulins|mesh-list
6538099|NCT00825851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6796684|NCT02262780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6796685|NCT02262780|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6796686|NCT02262780|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6796687|NCT02262780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796688|NCT02262793|Telmisartan|telmisartan|mesh-list
6796689|NCT02262793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6796690|NCT02262793|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6796691|NCT02262793|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6796692|NCT02262793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796693|NCT02262858|Telmisartan|telmisartan|mesh-list
6796694|NCT02262858|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6796695|NCT02262858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6533209|NCT00801515|Maraviroc|maraviroc|mesh-list
6533210|NCT00801515|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6533211|NCT00801515|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6533212|NCT00801515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6533213|NCT00801515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6533214|NCT00801515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6533215|NCT00801515|Antiviral Agents|antiviral agents|mesh-ancestor
6533216|NCT00801515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6533217|NCT00801515|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6533218|NCT00801528|Diclofenac|diclofenac|mesh-list
6533219|NCT00801528|Ropivacaine|ropivacaine|mesh-list
6533220|NCT00801528|Anesthetics, Local|anesthetics, local|mesh-ancestor
6533221|NCT00801528|Anesthetics|anesthetics|mesh-ancestor
6533222|NCT00801528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6533223|NCT00801528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533224|NCT00801528|Sensory System Agents|sensory system agents|mesh-ancestor
6533225|NCT00801528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6533226|NCT00801528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6533227|NCT00801528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6533228|NCT00801528|Analgesics|analgesics|mesh-ancestor
6533229|NCT00801528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6533230|NCT00801528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6533231|NCT00801528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6533232|NCT00801528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6533233|NCT00801528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6533234|NCT00801580|Doxorubicin|doxorubicin|mesh-list
6533235|NCT00801580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6533236|NCT00801580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6533237|NCT00801580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6533238|NCT00801580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6533239|NCT00801580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6533240|NCT00801580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6533241|NCT00801580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6533242|NCT00801606|Zinc|zinc|mesh-list
6533243|NCT00801606|Trace Elements|trace elements|mesh-list
6533244|NCT00801606|Micronutrients|micronutrients|mesh-list
6533245|NCT00801606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533246|NCT00801697|Vaccines|vaccines|mesh-list
6533247|NCT00801697|Immunologic Factors|immunologic factors|mesh-ancestor
6533248|NCT00801697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533249|NCT00801736|Paclitaxel|paclitaxel|mesh-list
6533250|NCT00801736|Cisplatin|cisplatin|mesh-list
6533251|NCT00801736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6533252|NCT00801736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6533253|NCT00801736|Tubulin Modulators|tubulin modulators|mesh-ancestor
6533254|NCT00801736|Antimitotic Agents|antimitotic agents|mesh-ancestor
6533255|NCT00801736|Mitosis Modulators|mitosis modulators|mesh-ancestor
6796696|NCT02262858|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6796697|NCT02262858|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6796698|NCT02262858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796699|NCT02262858|Diuretics|diuretics|mesh-ancestor
6796700|NCT02262858|Natriuretic Agents|natriuretic agents|mesh-ancestor
6796701|NCT02262858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796702|NCT02262858|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6796703|NCT02262858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6796704|NCT02262897|Paclitaxel|paclitaxel|mesh-list
6796705|NCT02262897|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6796706|NCT02262897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6796707|NCT02262897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6796708|NCT02262897|Tubulin Modulators|tubulin modulators|mesh-ancestor
6796709|NCT02262897|Antimitotic Agents|antimitotic agents|mesh-ancestor
6796710|NCT02262897|Mitosis Modulators|mitosis modulators|mesh-ancestor
6796711|NCT02262897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796712|NCT02262923|Metoclopramide|metoclopramide|mesh-list
6796713|NCT02262923|Antiemetics|antiemetics|mesh-ancestor
6796714|NCT02262923|Autonomic Agents|autonomic agents|mesh-ancestor
6796715|NCT02262923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6796716|NCT02262923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796717|NCT02262923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6796718|NCT02262923|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6533256|NCT00801736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6533257|NCT00801788|Oxycodone|oxycodone|mesh-list
6533258|NCT00801788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6533259|NCT00801788|Narcotics|narcotics|mesh-ancestor
6533260|NCT00801788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6533261|NCT00801788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533262|NCT00801788|Analgesics|analgesics|mesh-ancestor
6533263|NCT00801788|Sensory System Agents|sensory system agents|mesh-ancestor
6533264|NCT00801788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6533265|NCT00801853|Interleukin-4|interleukin-4|mesh-list
6533266|NCT00801853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6533267|NCT00801853|Immunologic Factors|immunologic factors|mesh-ancestor
6533268|NCT00801853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533269|NCT00801853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6533270|NCT00801853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6533271|NCT00801866|Bevacizumab|bevacizumab|mesh-list
6796719|NCT02262923|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6796720|NCT02262923|Dopamine Agents|dopamine agents|mesh-ancestor
6796721|NCT02262923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6796722|NCT02262923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796723|NCT02262936|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
6796724|NCT02262936|Fesoterodine|fesoterodine|mesh-list
6796725|NCT02262936|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6796726|NCT02262936|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6796727|NCT02262936|Cholinergic Agents|cholinergic agents|mesh-ancestor
6796728|NCT02262936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6796729|NCT02262936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796730|NCT02262936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796731|NCT02262936|Urological Agents|urological agents|mesh-ancestor
6796732|NCT02262936|Hemostatics|hemostatics|mesh-ancestor
6796733|NCT02262936|Coagulants|coagulants|mesh-ancestor
6796734|NCT02262936|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6796735|NCT02262936|Natriuretic Agents|natriuretic agents|mesh-ancestor
6796736|NCT02263027|Vaccines|vaccines|mesh-list
6796737|NCT02263027|Immunologic Factors|immunologic factors|mesh-ancestor
6796738|NCT02263027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796739|NCT02263066|Factor VIII|factor viii|mesh-list
6796740|NCT02263066|Coagulants|coagulants|mesh-ancestor
6533272|NCT00801866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6533273|NCT00801866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6533274|NCT00801866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6533275|NCT00801866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6533276|NCT00801866|Growth Substances|growth substances|mesh-ancestor
6533277|NCT00801866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533278|NCT00801866|Growth Inhibitors|growth inhibitors|mesh-ancestor
6533279|NCT00801879|Mupirocin|mupirocin|mesh-list
6533280|NCT00801879|Calcium|calcium|mesh-list
6533281|NCT00801879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6796741|NCT02263105|Temozolomide|temozolomide|mesh-list
6796742|NCT02263105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6796743|NCT02263105|Alkylating Agents|alkylating agents|mesh-ancestor
6796744|NCT02263105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796745|NCT02263105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6796746|NCT02263170|Phenobarbital|phenobarbital|mesh-list
6796747|NCT02263170|Anticonvulsants|anticonvulsants|mesh-ancestor
6796748|NCT02263170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6796749|NCT02263170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6796750|NCT02263170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796751|NCT02263170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6796752|NCT02263170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6796753|NCT02263170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6796754|NCT02263170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796755|NCT02263170|GABA Modulators|gaba modulators|mesh-ancestor
6796756|NCT02263170|GABA Agents|gaba agents|mesh-ancestor
6796757|NCT02263170|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6796758|NCT02263170|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6796759|NCT02263170|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6796760|NCT02263196|Ethanol|ethanol|mesh-list
6796761|NCT02263196|Povidone-Iodine|povidone-iodine|mesh-list
6796762|NCT02263196|Povidone|povidone|mesh-list
6796763|NCT02263196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6796764|NCT02263196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6796765|NCT02263196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6796766|NCT02263196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796767|NCT02263196|Plasma Substitutes|plasma substitutes|mesh-ancestor
6796768|NCT02263196|Blood Substitutes|blood substitutes|mesh-ancestor
6796769|NCT02263248|Buprenorphine|buprenorphine|mesh-list
6796770|NCT02263248|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6796771|NCT02263248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6796772|NCT02263248|Narcotics|narcotics|mesh-ancestor
6796773|NCT02263248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6796774|NCT02263248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796775|NCT02263248|Analgesics|analgesics|mesh-ancestor
6796776|NCT02263248|Sensory System Agents|sensory system agents|mesh-ancestor
6796777|NCT02263248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6796778|NCT02263248|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6796779|NCT02263248|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6796780|NCT02263248|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6796781|NCT02263248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6796782|NCT02263248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796783|NCT02263248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6796784|NCT02263248|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6796785|NCT02263248|Antidepressive Agents|antidepressive agents|mesh-ancestor
6796786|NCT02263248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6796787|NCT02263352|Carotenoids|carotenoids|mesh-list
6796788|NCT02263352|Antioxidants|antioxidants|mesh-ancestor
6796789|NCT02263352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796790|NCT02263352|Protective Agents|protective agents|mesh-ancestor
6796791|NCT02263352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796792|NCT02263495|Gemcitabine|gemcitabine|mesh-list
6796793|NCT02263495|Paclitaxel|paclitaxel|mesh-list
6796794|NCT02263495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6796795|NCT02263495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6796796|NCT02263495|Tubulin Modulators|tubulin modulators|mesh-ancestor
6796797|NCT02263495|Antimitotic Agents|antimitotic agents|mesh-ancestor
6796798|NCT02263495|Mitosis Modulators|mitosis modulators|mesh-ancestor
6796799|NCT02263495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796800|NCT02263495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6796801|NCT02263495|Antimetabolites|antimetabolites|mesh-ancestor
6796802|NCT02263495|Antiviral Agents|antiviral agents|mesh-ancestor
6533282|NCT00801879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533283|NCT00801879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6533284|NCT00801879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6533285|NCT00801879|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6533286|NCT00801879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6533287|NCT00801879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6533288|NCT00801905|Nepafenac|nepafenac|mesh-list
6533289|NCT00801905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6533290|NCT00801905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6533291|NCT00801905|Analgesics|analgesics|mesh-ancestor
6533292|NCT00801905|Sensory System Agents|sensory system agents|mesh-ancestor
6533293|NCT00801905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6533294|NCT00801905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533295|NCT00801905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6533296|NCT00801905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6533297|NCT00801918|Cyclophosphamide|cyclophosphamide|mesh-list
6533298|NCT00801918|Ifosfamide|ifosfamide|mesh-list
6533299|NCT00801918|Etoposide|etoposide|mesh-list
6533300|NCT00801918|Denileukin diftitox|denileukin diftitox|mesh-list
6533301|NCT00801918|Interleukin-2|interleukin-2|mesh-list
6533302|NCT00801918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6533303|NCT00801918|Immunologic Factors|immunologic factors|mesh-ancestor
6533304|NCT00801918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533305|NCT00801918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6533306|NCT00801918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6533307|NCT00801918|Alkylating Agents|alkylating agents|mesh-ancestor
6533308|NCT00801918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6533309|NCT00801918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6533310|NCT00801918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6533311|NCT00801918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6533312|NCT00801918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6533313|NCT00801918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6533314|NCT00801918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6533315|NCT00801918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6533316|NCT00801918|Analgesics|analgesics|mesh-ancestor
6533317|NCT00801918|Sensory System Agents|sensory system agents|mesh-ancestor
6533318|NCT00801918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6533319|NCT00801944|Solifenacin Succinate|solifenacin succinate|mesh-list
6533320|NCT00801944|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6533321|NCT00801944|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6533322|NCT00801944|Cholinergic Agents|cholinergic agents|mesh-ancestor
6533323|NCT00801944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6533324|NCT00801944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6533325|NCT00801944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533326|NCT00801944|Urological Agents|urological agents|mesh-ancestor
6533327|NCT00801957|Hydrocortisone|hydrocortisone|mesh-list
6533328|NCT00801957|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6533329|NCT00801957|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6533330|NCT00801957|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6533331|NCT00801957|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
6533332|NCT00801957|Tacrolimus|tacrolimus|mesh-list
6533333|NCT00801957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6533334|NCT00801957|Immunologic Factors|immunologic factors|mesh-ancestor
6533335|NCT00801957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533336|NCT00801957|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6796803|NCT02263495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6796804|NCT02263495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6796805|NCT02263495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6796806|NCT02263495|Immunologic Factors|immunologic factors|mesh-ancestor
6796807|NCT02263495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796808|NCT02263638|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6796809|NCT02263638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6796810|NCT02263677|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6796811|NCT02263677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6796812|NCT02263677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796813|NCT02263677|Incretins|incretins|mesh-ancestor
6796814|NCT02263677|Hormones|hormones|mesh-ancestor
6796815|NCT02263677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6796816|NCT02263677|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6796817|NCT02263677|Protease Inhibitors|protease inhibitors|mesh-ancestor
6796818|NCT02263677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6796819|NCT02263677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796820|NCT02263690|Lidocaine|lidocaine|mesh-list
6796821|NCT02263690|Anesthetics, Local|anesthetics, local|mesh-ancestor
6796822|NCT02263690|Anesthetics|anesthetics|mesh-ancestor
6533337|NCT00801957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6533338|NCT00801957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6533339|NCT00801957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6533340|NCT00801957|Dermatologic Agents|dermatologic agents|mesh-ancestor
6533341|NCT00802009|Dexamethasone|dexamethasone|mesh-list
6533342|NCT00802009|Mepivacaine|mepivacaine|mesh-list
6533343|NCT00802009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6533344|NCT00802009|Antiemetics|antiemetics|mesh-ancestor
6533345|NCT00802009|Autonomic Agents|autonomic agents|mesh-ancestor
6533346|NCT00802009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6533347|NCT00802009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533348|NCT00802009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6533349|NCT00802009|Glucocorticoids|glucocorticoids|mesh-ancestor
6533350|NCT00802009|Hormones|hormones|mesh-ancestor
6533351|NCT00802009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6533352|NCT00802009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6533353|NCT00802009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6533354|NCT00802009|Anesthetics, Local|anesthetics, local|mesh-ancestor
6533355|NCT00802009|Anesthetics|anesthetics|mesh-ancestor
6533356|NCT00802009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6533357|NCT00802009|Sensory System Agents|sensory system agents|mesh-ancestor
6533358|NCT00802035|Baclofen|baclofen|mesh-list
6533359|NCT00802035|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6533360|NCT00802035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533361|NCT00802035|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6533362|NCT00802035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6533363|NCT00802035|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6533364|NCT00802035|GABA Agonists|gaba agonists|mesh-ancestor
6533365|NCT00802035|GABA Agents|gaba agents|mesh-ancestor
6533366|NCT00802035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6533367|NCT00802035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6533368|NCT00802048|Ropivacaine|ropivacaine|mesh-list
6533369|NCT00802048|Anesthetics, Local|anesthetics, local|mesh-list
6533370|NCT00802048|Anesthetics|anesthetics|mesh-list
6533371|NCT00802048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6533372|NCT00802048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533373|NCT00802048|Sensory System Agents|sensory system agents|mesh-ancestor
6533374|NCT00802048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6533375|NCT00802087|Acetaminophen|acetaminophen|mesh-list
6533376|NCT00802087|Hydrocodone|hydrocodone|mesh-list
6533377|NCT00802087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6533378|NCT00802087|Analgesics|analgesics|mesh-ancestor
6533379|NCT00802087|Sensory System Agents|sensory system agents|mesh-ancestor
6533380|NCT00802087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6533381|NCT00802087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533382|NCT00802087|Antipyretics|antipyretics|mesh-ancestor
6533383|NCT00802087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6533384|NCT00802087|Narcotics|narcotics|mesh-ancestor
6533385|NCT00802087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6533386|NCT00802087|Antitussive Agents|antitussive agents|mesh-ancestor
6533387|NCT00802087|Respiratory System Agents|respiratory system agents|mesh-ancestor
6533388|NCT00802139|Iron|iron|mesh-list
6533389|NCT00802139|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6533390|NCT00802139|Trace Elements|trace elements|mesh-ancestor
6533391|NCT00802139|Micronutrients|micronutrients|mesh-ancestor
6533392|NCT00802139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533393|NCT00802139|Hematinics|hematinics|mesh-ancestor
6533394|NCT00802217|Capsaicin|capsaicin|mesh-list
6533395|NCT00802217|Antipruritics|antipruritics|mesh-ancestor
6533396|NCT00802217|Dermatologic Agents|dermatologic agents|mesh-ancestor
6533397|NCT00802217|Sensory System Agents|sensory system agents|mesh-ancestor
6533398|NCT00802217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6533399|NCT00802217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533400|NCT00802230|Terbutaline|terbutaline|mesh-list
6533401|NCT00802230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6533402|NCT00802230|Autonomic Agents|autonomic agents|mesh-ancestor
6533403|NCT00802230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6796823|NCT02263690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6796824|NCT02263690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796825|NCT02263690|Sensory System Agents|sensory system agents|mesh-ancestor
6796826|NCT02263690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6796827|NCT02263690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6796828|NCT02263690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6796829|NCT02263690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6796830|NCT02263690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6796831|NCT02263690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6533404|NCT00802230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533405|NCT00802230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6533406|NCT00802230|Respiratory System Agents|respiratory system agents|mesh-ancestor
6533407|NCT00802230|Sympathomimetics|sympathomimetics|mesh-ancestor
6533408|NCT00802230|Tocolytic Agents|tocolytic agents|mesh-ancestor
6533409|NCT00802230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6533410|NCT00802230|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6533411|NCT00802230|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6533412|NCT00802230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6533413|NCT00802230|Adrenergic Agents|adrenergic agents|mesh-ancestor
6533414|NCT00802230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6533415|NCT00802230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6533416|NCT00802243|Leflunomide|leflunomide|mesh-list
6533417|NCT00802243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6533418|NCT00802243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6533419|NCT00802243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6533420|NCT00802243|Immunologic Factors|immunologic factors|mesh-ancestor
6533421|NCT00802243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533422|NCT00802282|Psilocybin|psilocybin|mesh-list
6533423|NCT00802282|Hallucinogens|hallucinogens|mesh-ancestor
6533424|NCT00802282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533425|NCT00802282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6533426|NCT00802308|Morphine|morphine|mesh-list
6533427|NCT00802308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6533428|NCT00802308|Narcotics|narcotics|mesh-ancestor
6533429|NCT00802308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6533430|NCT00802308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533431|NCT00802308|Analgesics|analgesics|mesh-ancestor
6533432|NCT00802308|Sensory System Agents|sensory system agents|mesh-ancestor
6533433|NCT00802308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6533434|NCT00802321|Dutasteride|dutasteride|mesh-list
6533435|NCT00802321|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6533436|NCT00802321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6533437|NCT00802321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6533438|NCT00802321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6533439|NCT00802321|Hormone Antagonists|hormone antagonists|mesh-ancestor
6533440|NCT00802321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6533441|NCT00802321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533442|NCT00802334|Ritonavir|ritonavir|mesh-list
6533443|NCT00802334|Lopinavir|lopinavir|mesh-list
6533444|NCT00802334|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6533445|NCT00802334|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6533446|NCT00802334|Protease Inhibitors|protease inhibitors|mesh-ancestor
6533447|NCT00802334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6533448|NCT00802334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6533449|NCT00802334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6796832|NCT02263872|Minocycline|minocycline|mesh-list
6796833|NCT02263872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6796834|NCT02263872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6796835|NCT02263924|Tocotrienols|tocotrienols|mesh-list
6796836|NCT02263924|Vitamin E|vitamin e|mesh-list
6796837|NCT02263924|Tocopherols|tocopherols|mesh-list
6796838|NCT02263924|Antioxidants|antioxidants|mesh-ancestor
6796839|NCT02263924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796840|NCT02263924|Protective Agents|protective agents|mesh-ancestor
6796841|NCT02263924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796842|NCT02263924|Vitamins|vitamins|mesh-ancestor
6796843|NCT02263924|Micronutrients|micronutrients|mesh-ancestor
6796844|NCT02263950|Artemether|artemether|mesh-list
6796845|NCT02263950|Antimalarials|antimalarials|mesh-ancestor
6796846|NCT02263950|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6796847|NCT02263950|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6796848|NCT02263950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6796849|NCT02263976|Bromides|bromides|mesh-list
6796850|NCT02263976|Tiotropium Bromide|tiotropium bromide|mesh-list
6796851|NCT02263976|Methacholine Chloride|methacholine chloride|mesh-list
6796852|NCT02263976|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6796853|NCT02263976|Autonomic Agents|autonomic agents|mesh-ancestor
6796854|NCT02263976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6796855|NCT02263976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796856|NCT02263976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6796857|NCT02263976|Respiratory System Agents|respiratory system agents|mesh-ancestor
6796858|NCT02263976|Parasympatholytics|parasympatholytics|mesh-ancestor
6796859|NCT02263976|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6796860|NCT02263976|Cholinergic Agents|cholinergic agents|mesh-ancestor
6796861|NCT02263976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6533450|NCT00802334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6533451|NCT00802334|Antiviral Agents|antiviral agents|mesh-ancestor
6533452|NCT00802334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6533453|NCT00802334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6533454|NCT00802334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6533455|NCT00802373|Solifenacin Succinate|solifenacin succinate|mesh-list
6533456|NCT00802373|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6533457|NCT00802373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6533458|NCT00802373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6533459|NCT00802373|Cholinergic Agents|cholinergic agents|mesh-ancestor
6533460|NCT00802373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6533461|NCT00802373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6533462|NCT00802373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533463|NCT00802373|Urological Agents|urological agents|mesh-ancestor
6533464|NCT00802451|Mesalamine|mesalamine|mesh-list
6533465|NCT00802451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6533466|NCT00802451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6533467|NCT00802451|Analgesics|analgesics|mesh-ancestor
6533468|NCT00802451|Sensory System Agents|sensory system agents|mesh-ancestor
6533469|NCT00802451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6533470|NCT00802451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533471|NCT00802451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6533472|NCT00802451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6533473|NCT00802568|Fludarabine|fludarabine|mesh-list
6533474|NCT00802568|Fludarabine phosphate|fludarabine phosphate|mesh-list
6533475|NCT00802568|Busulfan|busulfan|mesh-list
6533476|NCT00802568|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6533477|NCT00802568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6533478|NCT00802568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6533479|NCT00802568|Antimetabolites|antimetabolites|mesh-ancestor
6796862|NCT02263976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796863|NCT02263976|Anticonvulsants|anticonvulsants|mesh-ancestor
6796864|NCT02263976|Miotics|miotics|mesh-ancestor
6796865|NCT02263976|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6796866|NCT02263976|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
6796867|NCT02263976|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6796868|NCT02263976|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6796869|NCT02263989|Telmisartan|telmisartan|mesh-list
6796870|NCT02263989|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6796871|NCT02263989|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6796872|NCT02263989|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6796873|NCT02263989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796874|NCT02264002|Metoprolol|metoprolol|mesh-list
6796875|NCT02264002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6796876|NCT02264002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6796877|NCT02264002|Sympatholytics|sympatholytics|mesh-ancestor
6796878|NCT02264002|Autonomic Agents|autonomic agents|mesh-ancestor
6796879|NCT02264002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6796880|NCT02264002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796881|NCT02264002|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6796882|NCT02264002|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6796883|NCT02264002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6796884|NCT02264002|Adrenergic Agents|adrenergic agents|mesh-ancestor
6796885|NCT02264002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6796886|NCT02264002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796887|NCT02264015|Moxifloxacin|moxifloxacin|mesh-list
6796888|NCT02264015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6796889|NCT02264015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6796890|NCT02264015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6796891|NCT02264015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6796892|NCT02264015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6796893|NCT02264015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796894|NCT02264015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6796895|NCT02264028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6796896|NCT02264041|Itraconazole|itraconazole|mesh-list
6796897|NCT02264041|Antifungal Agents|antifungal agents|mesh-ancestor
6796898|NCT02264041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6796899|NCT02264041|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6796900|NCT02264041|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6796901|NCT02264041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6796902|NCT02264041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796903|NCT02264041|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6796904|NCT02264041|Hormone Antagonists|hormone antagonists|mesh-ancestor
6533480|NCT00802568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6533481|NCT00802568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6533482|NCT00802568|Immunologic Factors|immunologic factors|mesh-ancestor
6533483|NCT00802568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533484|NCT00802568|Alkylating Agents|alkylating agents|mesh-ancestor
6533485|NCT00802568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6533486|NCT00802568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6533487|NCT00802581|Anesthetics|anesthetics|mesh-list
6533488|NCT00802581|Anesthetics, Local|anesthetics, local|mesh-list
6533489|NCT00802581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6533490|NCT00802581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533491|NCT00802581|Sensory System Agents|sensory system agents|mesh-ancestor
6533492|NCT00802581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6533493|NCT00802594|Pafuramidine|pafuramidine|mesh-list
6533494|NCT00802594|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6533495|NCT00802594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6533496|NCT00802594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6533497|NCT00802594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6533498|NCT00802646|Epinephrine|epinephrine|mesh-list
6533499|NCT00802646|Fentanyl|fentanyl|mesh-list
6533500|NCT00802646|Bupivacaine|bupivacaine|mesh-list
6533501|NCT00802646|Anesthetics, Local|anesthetics, local|mesh-ancestor
6533502|NCT00802646|Anesthetics|anesthetics|mesh-ancestor
6533503|NCT00802646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6533504|NCT00802646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533505|NCT00802646|Sensory System Agents|sensory system agents|mesh-ancestor
6533506|NCT00802646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6533507|NCT00802646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6533508|NCT00802646|Narcotics|narcotics|mesh-ancestor
6533509|NCT00802646|Analgesics|analgesics|mesh-ancestor
6533510|NCT00802646|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6533511|NCT00802646|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6533512|NCT00802646|Anesthetics, General|anesthetics, general|mesh-ancestor
6533513|NCT00802646|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6533514|NCT00802646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6533515|NCT00802646|Adrenergic Agents|adrenergic agents|mesh-ancestor
6533516|NCT00802646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6533517|NCT00802646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6533518|NCT00802646|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6533519|NCT00802646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6533520|NCT00802646|Autonomic Agents|autonomic agents|mesh-ancestor
6533521|NCT00802646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6796905|NCT02264041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6796906|NCT02264041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796907|NCT02264041|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6796908|NCT02264093|Propranolol|propranolol|mesh-list
6796909|NCT02264093|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6796910|NCT02264093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6796911|NCT02264093|Adrenergic Agents|adrenergic agents|mesh-ancestor
6796912|NCT02264093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6796913|NCT02264093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796914|NCT02264093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796915|NCT02264093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6796916|NCT02264093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6796917|NCT02264093|Vasodilator Agents|vasodilator agents|mesh-ancestor
6796918|NCT02264106|Pantoprazole|pantoprazole|mesh-list
6796919|NCT02264106|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6796920|NCT02264106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6796921|NCT02264106|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6796922|NCT02264106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6796923|NCT02264106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796924|NCT02264119|Pantoprazole|pantoprazole|mesh-list
6796925|NCT02264119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6796926|NCT02264119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6796927|NCT02264119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6796928|NCT02264119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6796929|NCT02264119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796930|NCT02264132|Pramipexole|pramipexole|mesh-list
6796931|NCT02264132|Antioxidants|antioxidants|mesh-ancestor
6796932|NCT02264132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796933|NCT02264132|Protective Agents|protective agents|mesh-ancestor
6796934|NCT02264132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796935|NCT02264132|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6796936|NCT02264132|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6533522|NCT00802646|Respiratory System Agents|respiratory system agents|mesh-ancestor
6533523|NCT00802646|Mydriatics|mydriatics|mesh-ancestor
6533524|NCT00802646|Sympathomimetics|sympathomimetics|mesh-ancestor
6796937|NCT02264132|Dopamine Agonists|dopamine agonists|mesh-ancestor
6796938|NCT02264132|Dopamine Agents|dopamine agents|mesh-ancestor
6796939|NCT02264132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6796940|NCT02264145|Norflurane|norflurane|mesh-list
6796941|NCT02264145|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6796942|NCT02264145|Anesthetics|anesthetics|mesh-ancestor
6796943|NCT02264145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6796944|NCT02264145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796945|NCT02264158|Telmisartan|telmisartan|mesh-list
6796946|NCT02264158|Lacidipine|lacidipine|mesh-list
6796947|NCT02264158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6796948|NCT02264158|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6796949|NCT02264158|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6796950|NCT02264158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796951|NCT02264158|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6796952|NCT02264158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6796953|NCT02264158|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6796954|NCT02264158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796955|NCT02264171|Ketoconazole|ketoconazole|mesh-list
6796956|NCT02264171|Tamsulosin|tamsulosin|mesh-list
6796957|NCT02264171|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6796958|NCT02264171|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6796959|NCT02264171|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6796960|NCT02264171|Adrenergic Agents|adrenergic agents|mesh-ancestor
6796961|NCT02264171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6796962|NCT02264171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796963|NCT02264171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796964|NCT02264171|Urological Agents|urological agents|mesh-ancestor
6796965|NCT02264171|Antifungal Agents|antifungal agents|mesh-ancestor
6796966|NCT02264171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6796967|NCT02264171|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6796968|NCT02264171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6796969|NCT02264171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6796970|NCT02264171|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6796971|NCT02264171|Hormone Antagonists|hormone antagonists|mesh-ancestor
6796972|NCT02264171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6796973|NCT02264171|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6796974|NCT02264184|Paroxetine|paroxetine|mesh-list
6796975|NCT02264184|Tamsulosin|tamsulosin|mesh-list
6796976|NCT02264184|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6796977|NCT02264184|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6796978|NCT02264184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6796979|NCT02264184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6796980|NCT02264184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6796981|NCT02264184|Serotonin Agents|serotonin agents|mesh-ancestor
6796982|NCT02264184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796983|NCT02264184|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6796984|NCT02264184|Antidepressive Agents|antidepressive agents|mesh-ancestor
6796985|NCT02264184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6796986|NCT02264184|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6796987|NCT02264184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6796988|NCT02264184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6796989|NCT02264184|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6796990|NCT02264184|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6796991|NCT02264184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6796992|NCT02264184|Adrenergic Agents|adrenergic agents|mesh-ancestor
6796993|NCT02264184|Urological Agents|urological agents|mesh-ancestor
6796994|NCT02264236|Vaccines|vaccines|mesh-list
6796995|NCT02264236|Immunologic Factors|immunologic factors|mesh-ancestor
6796996|NCT02264236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6796997|NCT02264301|Puerarin|puerarin|mesh-list
6796998|NCT02264301|Vasodilator Agents|vasodilator agents|mesh-ancestor
6796999|NCT02264522|Dialysis Solutions|dialysis solutions|mesh-list
6797000|NCT02264522|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6797001|NCT02264561|Caffeine|caffeine|mesh-list
6797002|NCT02264561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6797003|NCT02264561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797004|NCT02264561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6797005|NCT02264561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6533525|NCT00802646|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6533526|NCT00802802|Efavirenz|efavirenz|mesh-list
6533527|NCT00802802|Rifampin|rifampin|mesh-list
6533528|NCT00802802|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6533529|NCT00802802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6533530|NCT00802802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6533531|NCT00802802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6533532|NCT00802802|Antiviral Agents|antiviral agents|mesh-ancestor
6533533|NCT00802802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6533534|NCT00802802|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6533535|NCT00802802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6533536|NCT00802802|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6533537|NCT00802802|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6533538|NCT00802802|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6533539|NCT00802802|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6533540|NCT00802802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6533541|NCT00802802|Antitubercular Agents|antitubercular agents|mesh-ancestor
6533542|NCT00802802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6533543|NCT00802802|Leprostatic Agents|leprostatic agents|mesh-ancestor
6533544|NCT00802802|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6797006|NCT02264561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797007|NCT02264561|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6797008|NCT02264561|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6797009|NCT02264561|Purinergic Agents|purinergic agents|mesh-ancestor
6797010|NCT02264561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6797011|NCT02264587|Domperidone|domperidone|mesh-list
6797012|NCT02264587|Mosapride|mosapride|mesh-list
6797013|NCT02264587|Antiemetics|antiemetics|mesh-ancestor
6797014|NCT02264587|Autonomic Agents|autonomic agents|mesh-ancestor
6797015|NCT02264587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6797016|NCT02264587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797017|NCT02264587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6797018|NCT02264587|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6797019|NCT02264587|Dopamine Agents|dopamine agents|mesh-ancestor
6797020|NCT02264587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6797021|NCT02264587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797022|NCT02264587|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6797023|NCT02264587|Serotonin Agents|serotonin agents|mesh-ancestor
6533545|NCT00802802|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6533546|NCT00802802|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6533547|NCT00802815|Etanercept|etanercept|mesh-list
6533548|NCT00802815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6533549|NCT00802815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6533550|NCT00802815|Analgesics|analgesics|mesh-ancestor
6533551|NCT00802815|Sensory System Agents|sensory system agents|mesh-ancestor
6533552|NCT00802815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6533553|NCT00802815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533554|NCT00802815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6533555|NCT00802815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6533556|NCT00802815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6533557|NCT00802815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6533558|NCT00802815|Immunologic Factors|immunologic factors|mesh-ancestor
6533559|NCT00802828|Famotidine|famotidine|mesh-list
6533560|NCT00802828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6533561|NCT00802828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6533562|NCT00802828|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6533563|NCT00802828|Histamine Antagonists|histamine antagonists|mesh-ancestor
6533564|NCT00802828|Histamine Agents|histamine agents|mesh-ancestor
6533565|NCT00802828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6533566|NCT00802828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6533567|NCT00802828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533568|NCT00802906|Bevacizumab|bevacizumab|mesh-list
6533569|NCT00802906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6533570|NCT00802906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6797024|NCT02264626|Remifentanil|remifentanil|mesh-list
6797025|NCT02264626|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6797026|NCT02264626|Narcotics|narcotics|mesh-ancestor
6797027|NCT02264626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6797028|NCT02264626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797029|NCT02264626|Analgesics|analgesics|mesh-ancestor
6797030|NCT02264626|Sensory System Agents|sensory system agents|mesh-ancestor
6797031|NCT02264626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6797032|NCT02264665|Everolimus|everolimus|mesh-list
6797033|NCT02264665|Sunitinib|sunitinib|mesh-list
6797034|NCT02264665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6797035|NCT02264665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6797036|NCT02264665|Immunologic Factors|immunologic factors|mesh-ancestor
6797037|NCT02264665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797038|NCT02264665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6797039|NCT02264665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6797040|NCT02264665|Growth Substances|growth substances|mesh-ancestor
6797041|NCT02264665|Growth Inhibitors|growth inhibitors|mesh-ancestor
6797042|NCT02264665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6797043|NCT02264665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6797044|NCT02264665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797045|NCT02264743|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6797046|NCT02264743|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6797047|NCT02264743|Estradiol|estradiol|mesh-list
6797048|NCT02264743|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6797049|NCT02264743|Estrogens|estrogens|mesh-ancestor
6797050|NCT02264743|Hormones|hormones|mesh-ancestor
6797051|NCT02264743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6797052|NCT02264743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797053|NCT02264743|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6797054|NCT02264743|Contraceptive Agents|contraceptive agents|mesh-ancestor
6797055|NCT02264743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6797056|NCT02264743|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6797057|NCT02264769|Carbetocin|carbetocin|mesh-list
6797058|NCT02264769|Oxytocics|oxytocics|mesh-ancestor
6797059|NCT02264769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6797060|NCT02264769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797061|NCT02264795|Lidocaine|lidocaine|mesh-list
6797062|NCT02264795|Anesthetics, Local|anesthetics, local|mesh-ancestor
6797063|NCT02264795|Anesthetics|anesthetics|mesh-ancestor
6797064|NCT02264795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6797065|NCT02264795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797066|NCT02264795|Sensory System Agents|sensory system agents|mesh-ancestor
6797067|NCT02264795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6797068|NCT02264795|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6797069|NCT02264795|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6797070|NCT02264795|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6797071|NCT02264795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6533571|NCT00802906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6533572|NCT00802906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6533573|NCT00802906|Growth Substances|growth substances|mesh-ancestor
6533574|NCT00802906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533575|NCT00802906|Growth Inhibitors|growth inhibitors|mesh-ancestor
6533576|NCT00802958|Clobetasol|clobetasol|mesh-list
6533577|NCT00802958|Halobetasol|halobetasol|mesh-list
6533578|NCT00802958|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6533579|NCT00802958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6533580|NCT00802958|Glucocorticoids|glucocorticoids|mesh-ancestor
6533581|NCT00802958|Hormones|hormones|mesh-ancestor
6533582|NCT00802958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6533583|NCT00802958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533584|NCT00803166|Clobetasol|clobetasol|mesh-list
6533585|NCT00803166|Halobetasol|halobetasol|mesh-list
6533586|NCT00803166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6533587|NCT00803166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6533588|NCT00803166|Glucocorticoids|glucocorticoids|mesh-ancestor
6533589|NCT00803166|Hormones|hormones|mesh-ancestor
6533590|NCT00803166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6533591|NCT00803166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533592|NCT00803192|Famotidine|famotidine|mesh-list
6533593|NCT00803192|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6533594|NCT00803192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6533595|NCT00803192|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6533596|NCT00803192|Histamine Antagonists|histamine antagonists|mesh-ancestor
6533597|NCT00803192|Histamine Agents|histamine agents|mesh-ancestor
6533598|NCT00803192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6533599|NCT00803192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6533600|NCT00803192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533601|NCT00803218|Fluticasone|fluticasone|mesh-list
6533602|NCT00803218|Xhance|xhance|mesh-list
6533603|NCT00803218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6533604|NCT00803218|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6533605|NCT00803218|Autonomic Agents|autonomic agents|mesh-ancestor
6533606|NCT00803218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6533607|NCT00803218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533608|NCT00803218|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6533609|NCT00803218|Respiratory System Agents|respiratory system agents|mesh-ancestor
6533610|NCT00803218|Dermatologic Agents|dermatologic agents|mesh-ancestor
6533611|NCT00803218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6533612|NCT00803309|Interferons|interferons|mesh-list
6533613|NCT00803309|Ribavirin|ribavirin|mesh-list
6533614|NCT00803309|Interferon-alpha|interferon-alpha|mesh-list
6533615|NCT00803309|Interferon alpha-2|interferon alpha-2|mesh-list
6533616|NCT00803309|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6533617|NCT00803309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6533618|NCT00803309|Antiviral Agents|antiviral agents|mesh-ancestor
6533619|NCT00803309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6533620|NCT00803309|Antimetabolites|antimetabolites|mesh-ancestor
6533621|NCT00803309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6533622|NCT00803309|Immunologic Factors|immunologic factors|mesh-ancestor
6797072|NCT02264795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797073|NCT02264834|Sufentanil|sufentanil|mesh-list
6797074|NCT02264834|Dsuvia|dsuvia|mesh-list
6797075|NCT02264834|Levobupivacaine|levobupivacaine|mesh-list
6797076|NCT02264834|Anesthetics, Local|anesthetics, local|mesh-ancestor
6797077|NCT02264834|Anesthetics|anesthetics|mesh-ancestor
6797078|NCT02264834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6797079|NCT02264834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797080|NCT02264834|Sensory System Agents|sensory system agents|mesh-ancestor
6797081|NCT02264834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6797082|NCT02264834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6797083|NCT02264834|Narcotics|narcotics|mesh-ancestor
6797084|NCT02264834|Analgesics|analgesics|mesh-ancestor
6797085|NCT02264834|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6797086|NCT02264834|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6797087|NCT02264834|Anesthetics, General|anesthetics, general|mesh-ancestor
6797088|NCT02264847|Clomiphene|clomiphene|mesh-list
6797089|NCT02264847|Enclomiphene|enclomiphene|mesh-list
6797090|NCT02264847|Zuclomiphene|zuclomiphene|mesh-list
6797091|NCT02264847|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6797092|NCT02264847|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6797093|NCT02264847|Hormone Antagonists|hormone antagonists|mesh-ancestor
6533623|NCT00803309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533624|NCT00803335|Estrogens|estrogens|mesh-list
6533625|NCT00803335|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6533626|NCT00803335|Hormones|hormones|mesh-ancestor
6533627|NCT00803335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6533628|NCT00803335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533629|NCT00803374|Ipilimumab|ipilimumab|mesh-list
6533630|NCT00803374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6533631|NCT00803374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6533632|NCT00803374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6533633|NCT00803374|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6533634|NCT00803374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6533635|NCT00803374|Immunologic Factors|immunologic factors|mesh-ancestor
6533636|NCT00803374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533637|NCT00803387|Travoprost|travoprost|mesh-list
6533638|NCT00803387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6533639|NCT00803439|Clobetasol|clobetasol|mesh-list
6533640|NCT00803439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6533641|NCT00803439|Glucocorticoids|glucocorticoids|mesh-ancestor
6533642|NCT00803439|Hormones|hormones|mesh-ancestor
6533643|NCT00803439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6533644|NCT00803439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533645|NCT00803465|Fluticasone|fluticasone|mesh-list
6533646|NCT00803465|Xhance|xhance|mesh-list
6533647|NCT00803465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6533648|NCT00803465|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6533649|NCT00803465|Autonomic Agents|autonomic agents|mesh-ancestor
6533650|NCT00803465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6533651|NCT00803465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533652|NCT00803465|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6533653|NCT00803465|Respiratory System Agents|respiratory system agents|mesh-ancestor
6533654|NCT00803465|Dermatologic Agents|dermatologic agents|mesh-ancestor
6533655|NCT00803465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6537845|NCT00824668|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6537846|NCT00824668|Insulin glulisine|insulin glulisine|mesh-list
6537847|NCT00824668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6537848|NCT00824668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537849|NCT00824707|Entecavir|entecavir|mesh-list
6537850|NCT00824707|Antiviral Agents|antiviral agents|mesh-ancestor
6537851|NCT00824707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6537852|NCT00824785|Capecitabine|capecitabine|mesh-list
6537853|NCT00824785|Oxaliplatin|oxaliplatin|mesh-list
6537854|NCT00824785|Epirubicin|epirubicin|mesh-list
6797094|NCT02264847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6797095|NCT02264847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797096|NCT02264847|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6797097|NCT02264847|Fertility Agents|fertility agents|mesh-ancestor
6797098|NCT02264847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6797099|NCT02264847|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6797100|NCT02264847|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6797101|NCT02264873|Decitabine|decitabine|mesh-list
6797102|NCT02264873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6797103|NCT02264873|Antimetabolites|antimetabolites|mesh-ancestor
6797104|NCT02264873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797105|NCT02264873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6797106|NCT02264873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6797107|NCT02264912|Clopidogrel|clopidogrel|mesh-list
6797108|NCT02264912|Ticagrelor|ticagrelor|mesh-list
6797109|NCT02264912|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6797110|NCT02264912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
6797111|NCT02264912|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6797112|NCT02264912|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6797113|NCT02264912|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6797114|NCT02264912|Purinergic Agents|purinergic agents|mesh-ancestor
6797115|NCT02264912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6797116|NCT02264912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797117|NCT02264912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797118|NCT02264938|Antioxidants|antioxidants|mesh-list
6797119|NCT02264938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797120|NCT02264938|Protective Agents|protective agents|mesh-ancestor
6797121|NCT02264938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797122|NCT02265068|Ticagrelor|ticagrelor|mesh-list
6797123|NCT02265068|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6797124|NCT02265068|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6797125|NCT02265068|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6797126|NCT02265068|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6537855|NCT00824785|Panitumumab|panitumumab|mesh-list
6533656|NCT00803530|Ascorbic Acid|ascorbic acid|mesh-list
6533657|NCT00803530|Antioxidants|antioxidants|mesh-ancestor
6533658|NCT00803530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6533659|NCT00803530|Protective Agents|protective agents|mesh-ancestor
6533660|NCT00803530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533661|NCT00803530|Vitamins|vitamins|mesh-ancestor
6533662|NCT00803530|Micronutrients|micronutrients|mesh-ancestor
6533663|NCT00803556|Paclitaxel|paclitaxel|mesh-list
6533664|NCT00803556|Trastuzumab|trastuzumab|mesh-list
6533665|NCT00803556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6533666|NCT00803556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6533667|NCT00803556|Tubulin Modulators|tubulin modulators|mesh-ancestor
6533668|NCT00803556|Antimitotic Agents|antimitotic agents|mesh-ancestor
6533669|NCT00803556|Mitosis Modulators|mitosis modulators|mesh-ancestor
6533670|NCT00803556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6533671|NCT00803556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6533672|NCT00803699|Selenium|selenium|mesh-list
6533673|NCT00803699|Antioxidants|antioxidants|mesh-ancestor
6533674|NCT00803699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6533675|NCT00803699|Protective Agents|protective agents|mesh-ancestor
6533676|NCT00803699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533677|NCT00803699|Trace Elements|trace elements|mesh-ancestor
6533678|NCT00803699|Micronutrients|micronutrients|mesh-ancestor
6533679|NCT00803725|Fentanyl|fentanyl|mesh-list
6533680|NCT00803725|Mepivacaine|mepivacaine|mesh-list
6533681|NCT00803725|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6533682|NCT00803725|Narcotics|narcotics|mesh-ancestor
6533683|NCT00803725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6533684|NCT00803725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533685|NCT00803725|Analgesics|analgesics|mesh-ancestor
6533686|NCT00803725|Sensory System Agents|sensory system agents|mesh-ancestor
6533687|NCT00803725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6533688|NCT00803725|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6533689|NCT00803725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6533690|NCT00803725|Anesthetics, General|anesthetics, general|mesh-ancestor
6533691|NCT00803725|Anesthetics|anesthetics|mesh-ancestor
6533692|NCT00803725|Anesthetics, Local|anesthetics, local|mesh-ancestor
6533693|NCT00803764|Naproxen|naproxen|mesh-list
6533694|NCT00803764|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6533695|NCT00803764|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6533696|NCT00803764|Analgesics|analgesics|mesh-ancestor
6533697|NCT00803764|Sensory System Agents|sensory system agents|mesh-ancestor
6533698|NCT00803764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6533699|NCT00803764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533700|NCT00803764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6533701|NCT00803764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6797127|NCT02265068|Purinergic Agents|purinergic agents|mesh-ancestor
6797128|NCT02265068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6797129|NCT02265068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797130|NCT02265068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797131|NCT02265276|Pioglitazone|pioglitazone|mesh-list
6797132|NCT02265276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6797133|NCT02265276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797134|NCT02265289|Clopidogrel|clopidogrel|mesh-list
6797135|NCT02265289|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6797136|NCT02265289|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6797137|NCT02265289|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6797138|NCT02265289|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6797139|NCT02265289|Purinergic Agents|purinergic agents|mesh-ancestor
6797140|NCT02265289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6797141|NCT02265289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797142|NCT02265289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797143|NCT02265328|Prednisolone|prednisolone|mesh-list
6797144|NCT02265328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6797145|NCT02265328|Glucocorticoids|glucocorticoids|mesh-ancestor
6797146|NCT02265328|Hormones|hormones|mesh-ancestor
6797147|NCT02265328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6797148|NCT02265328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797149|NCT02265328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6797150|NCT02265328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6797151|NCT02265367|Milnacipran|milnacipran|mesh-list
6797152|NCT02265367|Levomilnacipran|levomilnacipran|mesh-list
6797153|NCT02265367|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6797154|NCT02265367|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6533702|NCT00803764|Gout Suppressants|gout suppressants|mesh-ancestor
6533703|NCT00803764|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6533704|NCT00803764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6533705|NCT00803764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6533706|NCT00803803|Pilocarpine|pilocarpine|mesh-list
6533707|NCT00803803|Miotics|miotics|mesh-ancestor
6533708|NCT00803803|Autonomic Agents|autonomic agents|mesh-ancestor
6533709|NCT00803803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6533710|NCT00803803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533711|NCT00803803|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6533712|NCT00803803|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6533713|NCT00803803|Cholinergic Agents|cholinergic agents|mesh-ancestor
6533714|NCT00803803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6533715|NCT00803803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6533716|NCT00803816|Everolimus|everolimus|mesh-list
6533717|NCT00803816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6533718|NCT00803816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6797155|NCT02265367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6797156|NCT02265367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797157|NCT02265367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6797158|NCT02265367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797159|NCT02265367|Antidepressive Agents|antidepressive agents|mesh-ancestor
6797160|NCT02265367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6797161|NCT02265367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6797162|NCT02265367|Analgesics|analgesics|mesh-ancestor
6797163|NCT02265367|Sensory System Agents|sensory system agents|mesh-ancestor
6797164|NCT02265367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6797165|NCT02265406|Anti-Infective Agents|anti-infective agents|mesh-list
6797166|NCT02265445|beta-Lactams|beta-lactams|mesh-list
6797167|NCT02265445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6797168|NCT02265445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6797169|NCT02265484|Rifaximin|rifaximin|mesh-list
6797170|NCT02265484|Bromocriptine|bromocriptine|mesh-list
6797171|NCT02265484|Lactulose|lactulose|mesh-list
6797172|NCT02265484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6797173|NCT02265484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6797174|NCT02265484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6797175|NCT02265484|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6797176|NCT02265484|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6797177|NCT02265484|Hormone Antagonists|hormone antagonists|mesh-ancestor
6797178|NCT02265484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6797179|NCT02265484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797180|NCT02265484|Dopamine Agonists|dopamine agonists|mesh-ancestor
6797181|NCT02265484|Dopamine Agents|dopamine agents|mesh-ancestor
6797182|NCT02265484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6797183|NCT02265484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797184|NCT02265562|Alprostadil|alprostadil|mesh-list
6797185|NCT02265562|Misoprostol|misoprostol|mesh-list
6797186|NCT02265562|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6797187|NCT02265562|Abortifacient Agents|abortifacient agents|mesh-ancestor
6797188|NCT02265562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6797189|NCT02265562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797190|NCT02265562|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6797191|NCT02265562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6797192|NCT02265562|Oxytocics|oxytocics|mesh-ancestor
6797193|NCT02265562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6797194|NCT02265562|Vasodilator Agents|vasodilator agents|mesh-ancestor
6797195|NCT02265562|Urological Agents|urological agents|mesh-ancestor
6797196|NCT02265575|Hyaluronic Acid|hyaluronic acid|mesh-list
6797197|NCT02265575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6797198|NCT02265575|Immunologic Factors|immunologic factors|mesh-ancestor
6797199|NCT02265575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797200|NCT02265575|Viscosupplements|viscosupplements|mesh-ancestor
6797201|NCT02265575|Protective Agents|protective agents|mesh-ancestor
6797202|NCT02265718|Methylphenidate|methylphenidate|mesh-list
6797203|NCT02265718|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6797204|NCT02265718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797205|NCT02265718|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6797206|NCT02265718|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6797207|NCT02265718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6797208|NCT02265718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797209|NCT02265718|Dopamine Agents|dopamine agents|mesh-ancestor
6797210|NCT02265718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6797211|NCT02265731|Rituximab|rituximab|mesh-list
6797212|NCT02265731|Venetoclax|venetoclax|mesh-list
6797213|NCT02265731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6533719|NCT00803816|Immunologic Factors|immunologic factors|mesh-ancestor
6533720|NCT00803816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533721|NCT00803829|Sulfalene|sulfalene|mesh-list
6533722|NCT00803829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6533723|NCT00803829|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6533724|NCT00803829|Renal Agents|renal agents|mesh-ancestor
6533725|NCT00803829|Antimalarials|antimalarials|mesh-ancestor
6533726|NCT00803829|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6533727|NCT00803829|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6533728|NCT00803842|Doxycycline|doxycycline|mesh-list
6797214|NCT02265731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6797215|NCT02265731|Immunologic Factors|immunologic factors|mesh-ancestor
6797216|NCT02265731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797217|NCT02265731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6797218|NCT02265770|Cyclophosphamide|cyclophosphamide|mesh-list
6797219|NCT02265770|Cisplatin|cisplatin|mesh-list
6797220|NCT02265770|Carboplatin|carboplatin|mesh-list
6797221|NCT02265770|Methotrexate|methotrexate|mesh-list
6797222|NCT02265770|Etoposide|etoposide|mesh-list
6797223|NCT02265770|Etoposide phosphate|etoposide phosphate|mesh-list
6797224|NCT02265770|Vincristine|vincristine|mesh-list
6797225|NCT02265770|Valproic Acid|valproic acid|mesh-list
6797226|NCT02265770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6797227|NCT02265770|Immunologic Factors|immunologic factors|mesh-ancestor
6797228|NCT02265770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797229|NCT02265770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6797230|NCT02265770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6797231|NCT02265770|Alkylating Agents|alkylating agents|mesh-ancestor
6797232|NCT02265770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797233|NCT02265770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6797234|NCT02265770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6797235|NCT02265770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6797236|NCT02265770|Abortifacient Agents|abortifacient agents|mesh-ancestor
6797237|NCT02265770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6797238|NCT02265770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6797239|NCT02265770|Antimetabolites|antimetabolites|mesh-ancestor
6797240|NCT02265770|Dermatologic Agents|dermatologic agents|mesh-ancestor
6797241|NCT02265770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6797242|NCT02265770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6797243|NCT02265770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6797244|NCT02265770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6797245|NCT02265770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6797246|NCT02265770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6797247|NCT02265770|Tubulin Modulators|tubulin modulators|mesh-ancestor
6797248|NCT02265770|Antimitotic Agents|antimitotic agents|mesh-ancestor
6797249|NCT02265770|Mitosis Modulators|mitosis modulators|mesh-ancestor
6797250|NCT02265770|Anticonvulsants|anticonvulsants|mesh-ancestor
6797251|NCT02265770|GABA Agents|gaba agents|mesh-ancestor
6797252|NCT02265770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6797253|NCT02265770|Antimanic Agents|antimanic agents|mesh-ancestor
6797254|NCT02265770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6797255|NCT02265770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6797256|NCT02265770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6797257|NCT02265809|Aldesleukin|aldesleukin|mesh-list
6797258|NCT02265809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6797259|NCT02265809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6797260|NCT02265809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6797261|NCT02265809|Antiviral Agents|antiviral agents|mesh-ancestor
6797262|NCT02265809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6797263|NCT02265822|Midazolam|midazolam|mesh-list
6797264|NCT02265822|Melatonin|melatonin|mesh-list
6797265|NCT02265822|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6797266|NCT02265822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6797267|NCT02265822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6797268|NCT02265822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797269|NCT02265822|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6797270|NCT02265822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6797271|NCT02265822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6797272|NCT02265822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6797273|NCT02265822|Anesthetics, General|anesthetics, general|mesh-ancestor
6797274|NCT02265822|Anesthetics|anesthetics|mesh-ancestor
6797275|NCT02265822|GABA Modulators|gaba modulators|mesh-ancestor
6797276|NCT02265822|GABA Agents|gaba agents|mesh-ancestor
6797277|NCT02265822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6797278|NCT02265822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797279|NCT02265822|Antioxidants|antioxidants|mesh-ancestor
6797280|NCT02265822|Protective Agents|protective agents|mesh-ancestor
6797281|NCT02265874|Nicotine|nicotine|mesh-list
6797282|NCT02265874|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6533729|NCT00803842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6533730|NCT00803842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6533731|NCT00803842|Antimalarials|antimalarials|mesh-ancestor
6533732|NCT00803842|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6533733|NCT00803842|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6533734|NCT00803868|Varenicline|varenicline|mesh-list
6533735|NCT00803868|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6533736|NCT00803868|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6533737|NCT00803868|Cholinergic Agents|cholinergic agents|mesh-ancestor
6533738|NCT00803868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6533739|NCT00803868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6533740|NCT00803868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533741|NCT00803907|Imiquimod|imiquimod|mesh-list
6533742|NCT00803907|Immunologic Factors|immunologic factors|mesh-list
6533743|NCT00803907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6533744|NCT00803907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533745|NCT00803907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6533746|NCT00803907|Interferon Inducers|interferon inducers|mesh-ancestor
6533747|NCT00803933|Pentamidine|pentamidine|mesh-list
6533748|NCT00803933|Pafuramidine|pafuramidine|mesh-list
6533749|NCT00803933|Antifungal Agents|antifungal agents|mesh-ancestor
6533750|NCT00803933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6533751|NCT00803933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6533752|NCT00803933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6533753|NCT00803933|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6533754|NCT00803946|Ibuprofen|ibuprofen|mesh-list
6533755|NCT00803946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6533756|NCT00803946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6533757|NCT00803946|Analgesics|analgesics|mesh-ancestor
6533758|NCT00803946|Sensory System Agents|sensory system agents|mesh-ancestor
6533759|NCT00803946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6533760|NCT00803946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533761|NCT00803946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6533762|NCT00803946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6533763|NCT00803946|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6533764|NCT00803946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6533765|NCT00803946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797283|NCT02265874|Autonomic Agents|autonomic agents|mesh-ancestor
6797284|NCT02265874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6797285|NCT02265874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797286|NCT02265874|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6797287|NCT02265874|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6797288|NCT02265874|Cholinergic Agents|cholinergic agents|mesh-ancestor
6797289|NCT02265874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6797290|NCT02265874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797291|NCT02266030|Aspirin|aspirin|mesh-list
6797292|NCT02266030|Cilostazol|cilostazol|mesh-list
6797293|NCT02266030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6797294|NCT02266030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6797295|NCT02266030|Analgesics|analgesics|mesh-ancestor
6797296|NCT02266030|Sensory System Agents|sensory system agents|mesh-ancestor
6797297|NCT02266030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6797298|NCT02266030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797299|NCT02266030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6797300|NCT02266030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6797301|NCT02266030|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6797302|NCT02266030|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6797303|NCT02266030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797304|NCT02266030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6797305|NCT02266030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6797306|NCT02266030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6797307|NCT02266030|Antipyretics|antipyretics|mesh-ancestor
6797308|NCT02266030|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6797309|NCT02266030|Autonomic Agents|autonomic agents|mesh-ancestor
6797310|NCT02266030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6797311|NCT02266030|Respiratory System Agents|respiratory system agents|mesh-ancestor
6797312|NCT02266030|Vasodilator Agents|vasodilator agents|mesh-ancestor
6797313|NCT02266030|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6797314|NCT02266030|Protective Agents|protective agents|mesh-ancestor
6797315|NCT02266030|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6797316|NCT02266030|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6797317|NCT02266056|Rocuronium|rocuronium|mesh-list
6797318|NCT02266056|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6797319|NCT02266056|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6797320|NCT02266056|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6533766|NCT00803972|Insulin|insulin|mesh-list
6533767|NCT00803972|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6533768|NCT00803972|Insulin Lispro|insulin lispro|mesh-list
6533769|NCT00803972|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6533770|NCT00803972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533771|NCT00804050|Vitamins|vitamins|mesh-list
6533772|NCT00804050|Micronutrients|micronutrients|mesh-ancestor
6533773|NCT00804050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533774|NCT00804115|Timolol|timolol|mesh-list
6533775|NCT00804115|Latanoprost|latanoprost|mesh-list
6533776|NCT00804115|Pilocarpine|pilocarpine|mesh-list
6533777|NCT00804115|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6533778|NCT00804115|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6533779|NCT00804115|Adrenergic Agents|adrenergic agents|mesh-ancestor
6533780|NCT00804115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5993051|NCT00118742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5993052|NCT00118755|Bevacizumab|bevacizumab|mesh-list
5993053|NCT00118755|Capecitabine|capecitabine|mesh-list
5993054|NCT00118755|Oxaliplatin|oxaliplatin|mesh-list
5993055|NCT00118755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5993056|NCT00118755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5993057|NCT00118755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5993058|NCT00118755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5993059|NCT00118755|Growth Substances|growth substances|mesh-ancestor
5993060|NCT00118755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993061|NCT00118755|Growth Inhibitors|growth inhibitors|mesh-ancestor
5993062|NCT00118755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5993063|NCT00118755|Antimetabolites|antimetabolites|mesh-ancestor
5993064|NCT00118755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5993065|NCT00118898|Ritonavir|ritonavir|mesh-list
5993066|NCT00118898|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6533781|NCT00804115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797321|NCT02266056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6797322|NCT02266056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797323|NCT02266160|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
6797324|NCT02266160|Anesthetics, Local|anesthetics, local|mesh-ancestor
6797325|NCT02266160|Anesthetics|anesthetics|mesh-ancestor
6797326|NCT02266160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6797327|NCT02266160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797328|NCT02266160|Sensory System Agents|sensory system agents|mesh-ancestor
6797329|NCT02266160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6797330|NCT02266160|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
6797331|NCT02266173|Pertuzumab|pertuzumab|mesh-list
6797332|NCT02266173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6797333|NCT02266173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6797334|NCT02266264|Hydrocortisone|hydrocortisone|mesh-list
6797335|NCT02266264|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6797336|NCT02266264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5993067|NCT00118898|Tenofovir|tenofovir|mesh-list
5993068|NCT00118898|Lamivudine|lamivudine|mesh-list
6533782|NCT00804115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533783|NCT00804115|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6533784|NCT00804115|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6533785|NCT00804115|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6533786|NCT00804115|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6533787|NCT00804115|Miotics|miotics|mesh-ancestor
6533788|NCT00804115|Autonomic Agents|autonomic agents|mesh-ancestor
6533789|NCT00804115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6533790|NCT00804115|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6533791|NCT00804115|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6533792|NCT00804115|Cholinergic Agents|cholinergic agents|mesh-ancestor
6533793|NCT00804206|Bevacizumab|bevacizumab|mesh-list
6533794|NCT00804206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6533795|NCT00804206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6533796|NCT00804206|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6533797|NCT00804206|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6533798|NCT00804206|Growth Substances|growth substances|mesh-ancestor
6533799|NCT00804206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533800|NCT00804206|Growth Inhibitors|growth inhibitors|mesh-ancestor
6533801|NCT00804219|Vaccines|vaccines|mesh-list
6797337|NCT02266303|Insulin|insulin|mesh-list
6797338|NCT02266303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6797339|NCT02266303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797340|NCT02266329|Prazosin|prazosin|mesh-list
6797341|NCT02266329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6797342|NCT02266329|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6797343|NCT02266329|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6797344|NCT02266329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6797345|NCT02266329|Adrenergic Agents|adrenergic agents|mesh-ancestor
6797346|NCT02266329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6797347|NCT02266329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797348|NCT02266329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797349|NCT02266355|Omalizumab|omalizumab|mesh-list
6797350|NCT02266355|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6797351|NCT02266355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6797352|NCT02266355|Respiratory System Agents|respiratory system agents|mesh-ancestor
6797353|NCT02266485|Pravastatin|pravastatin|mesh-list
6797354|NCT02266485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6797355|NCT02266485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6797356|NCT02266485|Antimetabolites|antimetabolites|mesh-ancestor
6797357|NCT02266485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797358|NCT02266485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6797359|NCT02266485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6797360|NCT02266485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6797361|NCT02266511|Tamsulosin|tamsulosin|mesh-list
6797362|NCT02266511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6797363|NCT02266511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6797364|NCT02266511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6797365|NCT02266511|Adrenergic Agents|adrenergic agents|mesh-ancestor
6797366|NCT02266511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6797367|NCT02266511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797368|NCT02266511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797369|NCT02266511|Urological Agents|urological agents|mesh-ancestor
6797370|NCT02266524|Tamsulosin|tamsulosin|mesh-list
6797371|NCT02266524|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6797372|NCT02266524|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6797373|NCT02266524|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6797374|NCT02266524|Adrenergic Agents|adrenergic agents|mesh-ancestor
6797375|NCT02266524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6797376|NCT02266524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797377|NCT02266524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797378|NCT02266524|Urological Agents|urological agents|mesh-ancestor
6797379|NCT02266537|Doxazosin|doxazosin|mesh-list
6797380|NCT02266537|Tamsulosin|tamsulosin|mesh-list
6797381|NCT02266537|Alfuzosin|alfuzosin|mesh-list
6797382|NCT02266537|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6797383|NCT02266537|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6797384|NCT02266537|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6797385|NCT02266537|Adrenergic Agents|adrenergic agents|mesh-ancestor
6797386|NCT02266537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6797387|NCT02266537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797388|NCT02266537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797389|NCT02266537|Urological Agents|urological agents|mesh-ancestor
5993069|NCT00118898|Emtricitabine|emtricitabine|mesh-list
6533802|NCT00804219|Immunologic Factors|immunologic factors|mesh-ancestor
6533803|NCT00804219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533804|NCT00804245|Choline|choline|mesh-list
6533805|NCT00804245|Lipotropic Agents|lipotropic agents|mesh-ancestor
6533806|NCT00804245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6533807|NCT00804245|Antimetabolites|antimetabolites|mesh-ancestor
6533808|NCT00804245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6533809|NCT00804245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6533810|NCT00804245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6533811|NCT00804245|Nootropic Agents|nootropic agents|mesh-ancestor
6533812|NCT00804271|Memantine|memantine|mesh-list
6533813|NCT00804271|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6533814|NCT00804271|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6533815|NCT00804271|Dopamine Agents|dopamine agents|mesh-ancestor
6533816|NCT00804271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6533817|NCT00804271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6533818|NCT00804271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533819|NCT00804271|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6533820|NCT00804271|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6533821|NCT00804297|Octreotide|octreotide|mesh-list
6533822|NCT00804297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6533823|NCT00804297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6533824|NCT00804297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6533825|NCT00804310|Lapatinib|lapatinib|mesh-list
6533826|NCT00804310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6533827|NCT00804310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6533828|NCT00804310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6533829|NCT00804310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6533830|NCT00804336|Everolimus|everolimus|mesh-list
6533831|NCT00804336|Pasireotide|pasireotide|mesh-list
6533832|NCT00804336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6533833|NCT00804336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6533834|NCT00804336|Immunologic Factors|immunologic factors|mesh-ancestor
6533835|NCT00804336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533836|NCT00804336|Hormones|hormones|mesh-ancestor
6533837|NCT00804336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6533838|NCT00804388|Vitamin E|vitamin e|mesh-list
6533839|NCT00804388|Vitamins|vitamins|mesh-ancestor
6533840|NCT00804388|Micronutrients|micronutrients|mesh-ancestor
6533841|NCT00804388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533842|NCT00804388|Antioxidants|antioxidants|mesh-ancestor
6533843|NCT00804388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6533844|NCT00804388|Protective Agents|protective agents|mesh-ancestor
6533845|NCT00804401|Naproxen|naproxen|mesh-list
6258423|NCT03086356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258424|NCT03086356|Anticoagulants|anticoagulants|mesh-ancestor
6258425|NCT03086460|Formoterol Fumarate|formoterol fumarate|mesh-list
6258426|NCT03086460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6258427|NCT03086460|Autonomic Agents|autonomic agents|mesh-ancestor
6258428|NCT03086460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6258429|NCT03086460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258430|NCT03086460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6258431|NCT03086460|Respiratory System Agents|respiratory system agents|mesh-ancestor
6258432|NCT03086460|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6258433|NCT03086460|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6258434|NCT03086460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6258435|NCT03086460|Adrenergic Agents|adrenergic agents|mesh-ancestor
6258436|NCT03086460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6258437|NCT03086460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258438|NCT03087019|Pembrolizumab|pembrolizumab|mesh-list
6258439|NCT03087019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6258440|NCT03087019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6258441|NCT03087604|Lidocaine|lidocaine|mesh-list
6258442|NCT03087604|Epinephrine|epinephrine|mesh-list
6533846|NCT00804401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6533847|NCT00804401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6533848|NCT00804401|Analgesics|analgesics|mesh-ancestor
6533849|NCT00804401|Sensory System Agents|sensory system agents|mesh-ancestor
6533850|NCT00804401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6533851|NCT00804401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533852|NCT00804401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6533853|NCT00804401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6533854|NCT00804401|Gout Suppressants|gout suppressants|mesh-ancestor
6533855|NCT00804401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6533856|NCT00804401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6533857|NCT00804401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6533858|NCT00804440|Ibuprofen|ibuprofen|mesh-list
6533859|NCT00804440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6533860|NCT00804440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6533861|NCT00804440|Analgesics|analgesics|mesh-ancestor
6533862|NCT00804440|Sensory System Agents|sensory system agents|mesh-ancestor
6533863|NCT00804440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6533864|NCT00804440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533865|NCT00804440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6533866|NCT00804440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6533867|NCT00804440|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6533868|NCT00804440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6533869|NCT00804440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6533870|NCT00804531|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6797390|NCT02266537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6797391|NCT02266589|Hydrocortisone|hydrocortisone|mesh-list
6797392|NCT02266589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6797393|NCT02266784|Nicotine|nicotine|mesh-list
6797394|NCT02266784|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6797395|NCT02266784|Autonomic Agents|autonomic agents|mesh-ancestor
6797396|NCT02266784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6797397|NCT02266784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797398|NCT02266784|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6797399|NCT02266784|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6797400|NCT02266784|Cholinergic Agents|cholinergic agents|mesh-ancestor
6797401|NCT02266784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6797402|NCT02266784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797403|NCT02266849|Loperamide|loperamide|mesh-list
6797404|NCT02266849|Antidiarrheals|antidiarrheals|mesh-list
6797405|NCT02266849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6797406|NCT02266927|Fluticasone|fluticasone|mesh-list
6797407|NCT02266927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6797408|NCT02266927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6797409|NCT02266927|Autonomic Agents|autonomic agents|mesh-ancestor
6797410|NCT02266927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6797411|NCT02266927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797412|NCT02266927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6797413|NCT02266927|Respiratory System Agents|respiratory system agents|mesh-ancestor
6797414|NCT02266927|Dermatologic Agents|dermatologic agents|mesh-ancestor
6797415|NCT02266927|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6797416|NCT02267044|Ropivacaine|ropivacaine|mesh-list
6797417|NCT02267044|Anesthetics, Local|anesthetics, local|mesh-ancestor
6797418|NCT02267044|Anesthetics|anesthetics|mesh-ancestor
6797419|NCT02267044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6797420|NCT02267044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797421|NCT02267044|Sensory System Agents|sensory system agents|mesh-ancestor
6797422|NCT02267044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6797423|NCT02267057|Acetaminophen|acetaminophen|mesh-list
6797424|NCT02267057|Buprenorphine|buprenorphine|mesh-list
6797425|NCT02267057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6797426|NCT02267057|Analgesics|analgesics|mesh-ancestor
6797427|NCT02267057|Sensory System Agents|sensory system agents|mesh-ancestor
6797428|NCT02267057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6797429|NCT02267057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797430|NCT02267057|Antipyretics|antipyretics|mesh-ancestor
6797431|NCT02267057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6797432|NCT02267057|Narcotics|narcotics|mesh-ancestor
6797433|NCT02267057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6797434|NCT02267057|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6797435|NCT02267122|Mupirocin|mupirocin|mesh-list
6797436|NCT02267122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6797437|NCT02267122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6797438|NCT02267122|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6797439|NCT02267122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6797440|NCT02267122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797441|NCT02267239|Chlorhexidine|chlorhexidine|mesh-list
6797442|NCT02267239|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6797443|NCT02267239|Listerine|listerine|mesh-list
6797444|NCT02267239|Hexetidine|hexetidine|mesh-list
6797445|NCT02267239|Menthol|menthol|mesh-list
6797446|NCT02267239|Sodium Fluoride|sodium fluoride|mesh-list
6797447|NCT02267239|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6797448|NCT02267239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6797449|NCT02267239|Disinfectants|disinfectants|mesh-ancestor
6797450|NCT02267239|Dermatologic Agents|dermatologic agents|mesh-ancestor
6797451|NCT02267239|Cariostatic Agents|cariostatic agents|mesh-ancestor
6797452|NCT02267239|Protective Agents|protective agents|mesh-ancestor
6533871|NCT00804531|Methylprednisolone|methylprednisolone|mesh-list
6533872|NCT00804531|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6533873|NCT00804531|Prednisolone|prednisolone|mesh-list
6533874|NCT00804531|Prednisolone acetate|prednisolone acetate|mesh-list
6533875|NCT00804531|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6533876|NCT00804531|Prednisolone phosphate|prednisolone phosphate|mesh-list
6533877|NCT00804531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6533878|NCT00804531|Antiemetics|antiemetics|mesh-ancestor
6533879|NCT00804531|Autonomic Agents|autonomic agents|mesh-ancestor
6533880|NCT00804531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6533881|NCT00804531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533882|NCT00804531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6533883|NCT00804531|Glucocorticoids|glucocorticoids|mesh-ancestor
6533884|NCT00804531|Hormones|hormones|mesh-ancestor
6533885|NCT00804531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6533886|NCT00804531|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6533887|NCT00804531|Protective Agents|protective agents|mesh-ancestor
6533888|NCT00804531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6533889|NCT00804531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6533890|NCT00804622|Tenofovir|tenofovir|mesh-list
6533891|NCT00804622|Telbivudine|telbivudine|mesh-list
6533892|NCT00804622|Antiviral Agents|antiviral agents|mesh-ancestor
6533893|NCT00804622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6797453|NCT02267239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797454|NCT02267239|Antipruritics|antipruritics|mesh-ancestor
6797455|NCT02267239|Antifungal Agents|antifungal agents|mesh-ancestor
6797456|NCT02267252|Antibodies|antibodies|mesh-list
6797457|NCT02267252|Immunologic Factors|immunologic factors|mesh-ancestor
6797458|NCT02267252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797459|NCT02267304|Morphine|morphine|mesh-list
6797460|NCT02267304|Naloxone|naloxone|mesh-list
6797461|NCT02267304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6797462|NCT02267304|Narcotics|narcotics|mesh-ancestor
6797463|NCT02267304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6797464|NCT02267304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797465|NCT02267304|Analgesics|analgesics|mesh-ancestor
6797466|NCT02267304|Sensory System Agents|sensory system agents|mesh-ancestor
6797467|NCT02267304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6797468|NCT02267304|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6797469|NCT02267408|Warfarin|warfarin|mesh-list
6797470|NCT02267408|Anticoagulants|anticoagulants|mesh-ancestor
6797471|NCT02267616|Etonogestrel|etonogestrel|mesh-list
6797472|NCT02267616|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6797473|NCT02267616|Contraceptive Agents|contraceptive agents|mesh-ancestor
6797474|NCT02267616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6797475|NCT02267616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797476|NCT02267616|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6797477|NCT02267655|Nitric Oxide|nitric oxide|mesh-list
6797478|NCT02267655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6797479|NCT02267655|Autonomic Agents|autonomic agents|mesh-ancestor
6797480|NCT02267655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6797481|NCT02267655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797482|NCT02267655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6797483|NCT02267655|Respiratory System Agents|respiratory system agents|mesh-ancestor
6797484|NCT02267655|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6797485|NCT02267655|Antioxidants|antioxidants|mesh-ancestor
6797486|NCT02267655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797487|NCT02267655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6797488|NCT02267655|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6797489|NCT02267655|Vasodilator Agents|vasodilator agents|mesh-ancestor
6797490|NCT02267655|Gasotransmitters|gasotransmitters|mesh-ancestor
6797491|NCT02267655|Protective Agents|protective agents|mesh-ancestor
6797492|NCT02267681|Fentanyl|fentanyl|mesh-list
6797493|NCT02267681|Alfentanil|alfentanil|mesh-list
6797494|NCT02267681|Propofol|propofol|mesh-list
6797495|NCT02267681|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6797496|NCT02267681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6797497|NCT02267681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797498|NCT02267681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6797499|NCT02267681|Anesthetics, General|anesthetics, general|mesh-ancestor
6797500|NCT02267681|Anesthetics|anesthetics|mesh-ancestor
6797501|NCT02267681|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6797502|NCT02267681|Narcotics|narcotics|mesh-ancestor
6797503|NCT02267681|Analgesics|analgesics|mesh-ancestor
6797504|NCT02267681|Sensory System Agents|sensory system agents|mesh-ancestor
6797505|NCT02267681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6533894|NCT00804622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6533895|NCT00804622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6533896|NCT00804622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6533897|NCT00804622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6533898|NCT00804622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6533899|NCT00804622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6533900|NCT00804674|Bupivacaine|bupivacaine|mesh-list
6533901|NCT00804674|Anesthetics, Local|anesthetics, local|mesh-ancestor
6533902|NCT00804674|Anesthetics|anesthetics|mesh-ancestor
6533903|NCT00804674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6533904|NCT00804674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533905|NCT00804674|Sensory System Agents|sensory system agents|mesh-ancestor
6533906|NCT00804674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6533907|NCT00804752|Vitamin D|vitamin d|mesh-list
6533908|NCT00804752|Ergocalciferols|ergocalciferols|mesh-list
6533909|NCT00804752|Vitamins|vitamins|mesh-list
6533910|NCT00804752|Micronutrients|micronutrients|mesh-ancestor
6533911|NCT00804752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533912|NCT00804752|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6533913|NCT00804752|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6533914|NCT00804791|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6533915|NCT00804791|Lubricant Eye Drops|lubricant eye drops|mesh-list
6533916|NCT00804791|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6533917|NCT00804830|Bevacizumab|bevacizumab|mesh-list
6533918|NCT00804830|Doxorubicin|doxorubicin|mesh-list
6533919|NCT00804830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6533920|NCT00804830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6533921|NCT00804830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6533922|NCT00804830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6533923|NCT00804830|Growth Substances|growth substances|mesh-ancestor
6533924|NCT00804830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533925|NCT00804830|Growth Inhibitors|growth inhibitors|mesh-ancestor
6533926|NCT00804830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6533927|NCT00804830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6533928|NCT00804830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6533929|NCT00804830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6533930|NCT00804830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797506|NCT02267681|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6797507|NCT02267707|Gemcitabine|gemcitabine|mesh-list
6797508|NCT02267707|Paclitaxel|paclitaxel|mesh-list
6797509|NCT02267707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6797510|NCT02267707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6797511|NCT02267707|Tubulin Modulators|tubulin modulators|mesh-ancestor
6797512|NCT02267707|Antimitotic Agents|antimitotic agents|mesh-ancestor
6797513|NCT02267707|Mitosis Modulators|mitosis modulators|mesh-ancestor
6797514|NCT02267707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797515|NCT02267707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6797516|NCT02267707|Antimetabolites|antimetabolites|mesh-ancestor
6797517|NCT02267707|Antiviral Agents|antiviral agents|mesh-ancestor
6797518|NCT02267707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6797519|NCT02267707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6797520|NCT02267707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6797521|NCT02267707|Immunologic Factors|immunologic factors|mesh-ancestor
6797522|NCT02267707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797523|NCT02267720|Salicylic Acid|salicylic acid|mesh-list
6797524|NCT02267720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6797525|NCT02267720|Antifungal Agents|antifungal agents|mesh-ancestor
6797526|NCT02267720|Keratolytic Agents|keratolytic agents|mesh-ancestor
6797527|NCT02267720|Dermatologic Agents|dermatologic agents|mesh-ancestor
6797528|NCT02267915|Rituximab|rituximab|mesh-list
6797529|NCT02267915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6797530|NCT02267915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6797531|NCT02267915|Immunologic Factors|immunologic factors|mesh-ancestor
6797532|NCT02267915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797533|NCT02267915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6797534|NCT02267980|Ketamine|ketamine|mesh-list
6797535|NCT02267980|Sevoflurane|sevoflurane|mesh-list
6797536|NCT02267980|Analgesics|analgesics|mesh-ancestor
6797537|NCT02267980|Sensory System Agents|sensory system agents|mesh-ancestor
6797538|NCT02267980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6797539|NCT02267980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797540|NCT02267980|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6797541|NCT02267980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6797542|NCT02267980|Anesthetics, General|anesthetics, general|mesh-ancestor
6797543|NCT02267980|Anesthetics|anesthetics|mesh-ancestor
6797544|NCT02267980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6533931|NCT00804856|Cytarabine|cytarabine|mesh-list
6797545|NCT02267980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6533932|NCT00804856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6533933|NCT00804856|Antimetabolites|antimetabolites|mesh-ancestor
6533934|NCT00804856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6533935|NCT00804856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6533936|NCT00804856|Antiviral Agents|antiviral agents|mesh-ancestor
6533937|NCT00804856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6533938|NCT00804856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6533939|NCT00804856|Immunologic Factors|immunologic factors|mesh-ancestor
6533940|NCT00804856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533941|NCT00804895|Cortivazol|cortivazol|mesh-list
6533942|NCT00804895|Verapamil|verapamil|mesh-list
6533943|NCT00804895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6533944|NCT00804895|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6533945|NCT00804895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6533946|NCT00804895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6533947|NCT00804895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6533948|NCT00804895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533949|NCT00804895|Vasodilator Agents|vasodilator agents|mesh-ancestor
6533950|NCT00804895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6533951|NCT00804921|Bevacizumab|bevacizumab|mesh-list
6533952|NCT00804921|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6533953|NCT00804921|Acetazolamide|acetazolamide|mesh-list
6533954|NCT00804921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6533955|NCT00804921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6533956|NCT00804921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6533957|NCT00804921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6533958|NCT00804921|Growth Substances|growth substances|mesh-ancestor
6533959|NCT00804921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533960|NCT00804921|Growth Inhibitors|growth inhibitors|mesh-ancestor
6797546|NCT02267980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6797547|NCT02267980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6797548|NCT02267980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797549|NCT02267980|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6797550|NCT02267980|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6797551|NCT02268006|Capecitabine|capecitabine|mesh-list
6797552|NCT02268006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6797553|NCT02268006|Antimetabolites|antimetabolites|mesh-ancestor
6797554|NCT02268006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797555|NCT02268006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6797556|NCT02268019|Epinephrine|epinephrine|mesh-list
6797557|NCT02268019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6797558|NCT02268019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6797559|NCT02268019|Adrenergic Agents|adrenergic agents|mesh-ancestor
6797560|NCT02268019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6797561|NCT02268019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797562|NCT02268019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797563|NCT02268019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6797564|NCT02268019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6797565|NCT02268019|Autonomic Agents|autonomic agents|mesh-ancestor
6797566|NCT02268019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6797567|NCT02268019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6797568|NCT02268019|Respiratory System Agents|respiratory system agents|mesh-ancestor
6797569|NCT02268019|Mydriatics|mydriatics|mesh-ancestor
6797570|NCT02268019|Sympathomimetics|sympathomimetics|mesh-ancestor
6797571|NCT02268019|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6797572|NCT02268032|Androgens|androgens|mesh-list
6797573|NCT02268032|Hormones|hormones|mesh-ancestor
6797574|NCT02268032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6797575|NCT02268032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797576|NCT02268071|Antihypertensive Agents|antihypertensive agents|mesh-list
6533961|NCT00804921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6533962|NCT00804921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6533963|NCT00804921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6533964|NCT00804921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6533965|NCT00804921|Adrenergic Agents|adrenergic agents|mesh-ancestor
6533966|NCT00804921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6533967|NCT00804921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6533968|NCT00804921|Anticonvulsants|anticonvulsants|mesh-ancestor
6533969|NCT00804921|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6533970|NCT00804921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6533971|NCT00804921|Diuretics|diuretics|mesh-ancestor
6533972|NCT00804921|Natriuretic Agents|natriuretic agents|mesh-ancestor
6533973|NCT00804934|Ranibizumab|ranibizumab|mesh-list
6533974|NCT00804934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6533975|NCT00804934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6533976|NCT00804934|Growth Substances|growth substances|mesh-ancestor
6533977|NCT00804934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533978|NCT00804934|Growth Inhibitors|growth inhibitors|mesh-ancestor
6533979|NCT00804934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6533980|NCT00804947|Melphalan|melphalan|mesh-list
6533981|NCT00804947|Busulfan|busulfan|mesh-list
6533982|NCT00804947|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6533983|NCT00804947|Alkylating Agents|alkylating agents|mesh-ancestor
6533984|NCT00804947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6533985|NCT00804947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6533986|NCT00804947|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6533987|NCT00804947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6533988|NCT00804947|Immunologic Factors|immunologic factors|mesh-ancestor
6533989|NCT00804947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6533990|NCT00804960|Letrozole|letrozole|mesh-list
6533991|NCT00804960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6533992|NCT00804960|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6533993|NCT00804960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6533994|NCT00804960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6533995|NCT00804960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6533996|NCT00804960|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6533997|NCT00804960|Hormone Antagonists|hormone antagonists|mesh-ancestor
6533998|NCT00804960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6533999|NCT00804960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534000|NCT00805012|Docetaxel|docetaxel|mesh-list
6534001|NCT00805012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6534002|NCT00805012|Tubulin Modulators|tubulin modulators|mesh-ancestor
6534003|NCT00805012|Antimitotic Agents|antimitotic agents|mesh-ancestor
6797577|NCT02268149|Prednisone|prednisone|mesh-list
6797578|NCT02268149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6797579|NCT02268149|Glucocorticoids|glucocorticoids|mesh-ancestor
6797580|NCT02268149|Hormones|hormones|mesh-ancestor
6797581|NCT02268149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6797582|NCT02268149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797583|NCT02268149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6797584|NCT02268149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6797585|NCT02268201|Tacrolimus|tacrolimus|mesh-list
6797586|NCT02268201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6797587|NCT02268201|Immunologic Factors|immunologic factors|mesh-ancestor
6797588|NCT02268201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797589|NCT02268201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6797590|NCT02268201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6797591|NCT02268201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797592|NCT02268279|Solithromycin|solithromycin|mesh-list
6797593|NCT02268279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6797594|NCT02268279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6797595|NCT02268305|Dimethyl sulfone|dimethyl sulfone|mesh-list
6797596|NCT02268305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6797597|NCT02268357|Propranolol|propranolol|mesh-list
6797598|NCT02268357|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6797599|NCT02268357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6797600|NCT02268357|Adrenergic Agents|adrenergic agents|mesh-ancestor
6797601|NCT02268357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6797602|NCT02268357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797603|NCT02268357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797604|NCT02268357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6797605|NCT02268357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6797606|NCT02268357|Vasodilator Agents|vasodilator agents|mesh-ancestor
6797607|NCT02268370|Dasatinib|dasatinib|mesh-list
6797608|NCT02268370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6534004|NCT00805012|Mitosis Modulators|mitosis modulators|mesh-ancestor
6534005|NCT00805012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534006|NCT00805064|Triamcinolone|triamcinolone|mesh-list
6534007|NCT00805064|Bevacizumab|bevacizumab|mesh-list
6534008|NCT00805064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6534009|NCT00805064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6534010|NCT00805064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6534011|NCT00805064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6534012|NCT00805064|Growth Substances|growth substances|mesh-ancestor
6534013|NCT00805064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534014|NCT00805064|Growth Inhibitors|growth inhibitors|mesh-ancestor
6534015|NCT00805064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6534016|NCT00805064|Glucocorticoids|glucocorticoids|mesh-ancestor
6534017|NCT00805064|Hormones|hormones|mesh-ancestor
6534018|NCT00805064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6534019|NCT00805090|Itraconazole|itraconazole|mesh-list
6534020|NCT00805090|Diclofenac|diclofenac|mesh-list
6534021|NCT00805090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6534022|NCT00805090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6534023|NCT00805090|Analgesics|analgesics|mesh-ancestor
6534024|NCT00805090|Sensory System Agents|sensory system agents|mesh-ancestor
6534025|NCT00805090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6534026|NCT00805090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534027|NCT00805090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6534028|NCT00805090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6534029|NCT00805090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6534030|NCT00805090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6534031|NCT00805090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534032|NCT00805090|Antifungal Agents|antifungal agents|mesh-ancestor
6534033|NCT00805090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6534034|NCT00805090|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6534035|NCT00805090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6534036|NCT00805090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6534037|NCT00805090|Hormone Antagonists|hormone antagonists|mesh-ancestor
6797609|NCT02268370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6797610|NCT02268370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6797611|NCT02268370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797612|NCT02268383|Luspatercept|luspatercept|mesh-list
6797613|NCT02268383|Hematinics|hematinics|mesh-ancestor
6797614|NCT02268409|Luspatercept|luspatercept|mesh-list
6797615|NCT02268409|Hematinics|hematinics|mesh-ancestor
6797616|NCT02268422|Buprenorphine|buprenorphine|mesh-list
6797617|NCT02268422|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6797618|NCT02268422|Narcotics|narcotics|mesh-ancestor
6797619|NCT02268422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6797620|NCT02268422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797621|NCT02268422|Analgesics|analgesics|mesh-ancestor
6797622|NCT02268422|Sensory System Agents|sensory system agents|mesh-ancestor
6797623|NCT02268422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6797624|NCT02268422|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6797625|NCT02268435|Imatinib Mesylate|imatinib mesylate|mesh-list
6797626|NCT02268435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6797627|NCT02268435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6797628|NCT02268435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6797629|NCT02268435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797630|NCT02268448|Clonidine|clonidine|mesh-list
6797631|NCT02268448|Naltrexone|naltrexone|mesh-list
6797632|NCT02268448|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6797633|NCT02268448|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6797634|NCT02268448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797635|NCT02268448|Sensory System Agents|sensory system agents|mesh-ancestor
6797636|NCT02268448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6797637|NCT02268448|Analgesics|analgesics|mesh-ancestor
6797638|NCT02268448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6797639|NCT02268448|Sympatholytics|sympatholytics|mesh-ancestor
6797640|NCT02268448|Autonomic Agents|autonomic agents|mesh-ancestor
6797641|NCT02268448|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6797642|NCT02268448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6797643|NCT02268448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6797644|NCT02268448|Adrenergic Agents|adrenergic agents|mesh-ancestor
6797645|NCT02268448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6797646|NCT02268448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797647|NCT02268487|Sertraline|sertraline|mesh-list
6797648|NCT02268487|Antidepressive Agents|antidepressive agents|mesh-ancestor
6797649|NCT02268487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6534038|NCT00805090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6534039|NCT00805090|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6534040|NCT00805116|Cod Liver Oil|cod liver oil|mesh-list
6534041|NCT00805116|Vitamins|vitamins|mesh-ancestor
6534042|NCT00805116|Micronutrients|micronutrients|mesh-ancestor
6534043|NCT00805116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534044|NCT00805155|Mometasone Furoate|mometasone furoate|mesh-list
6534045|NCT00805155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6534046|NCT00805155|Dermatologic Agents|dermatologic agents|mesh-ancestor
6534047|NCT00805155|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6534048|NCT00805233|Bromfenac|bromfenac|mesh-list
6534049|NCT00805233|Ranibizumab|ranibizumab|mesh-list
6534050|NCT00805233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6534051|NCT00805233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5993070|NCT00118898|Abacavir|abacavir|mesh-list
5993071|NCT00118898|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5993072|NCT00118898|Efavirenz|efavirenz|mesh-list
5993073|NCT00118898|Dideoxynucleosides|dideoxynucleosides|mesh-list
5993074|NCT00118898|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5993075|NCT00118898|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5993076|NCT00118898|Protease Inhibitors|protease inhibitors|mesh-ancestor
5993077|NCT00118898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5993078|NCT00118898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534052|NCT00805233|Growth Substances|growth substances|mesh-ancestor
6534053|NCT00805233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534054|NCT00805233|Growth Inhibitors|growth inhibitors|mesh-ancestor
6534055|NCT00805233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6534056|NCT00805233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6534057|NCT00805233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6534058|NCT00805233|Analgesics|analgesics|mesh-ancestor
6534059|NCT00805233|Sensory System Agents|sensory system agents|mesh-ancestor
6534060|NCT00805233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6534061|NCT00805233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6534062|NCT00805233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6537856|NCT00824785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6537857|NCT00824785|Antimetabolites|antimetabolites|mesh-ancestor
6537858|NCT00824785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537859|NCT00824785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6537860|NCT00824785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6537861|NCT00824785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6537862|NCT00824785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6537863|NCT00824785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6537864|NCT00824785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6537865|NCT00824811|Fluorometholone|fluorometholone|mesh-list
6537866|NCT00824811|Cyclosporine|cyclosporine|mesh-list
6537867|NCT00824811|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6537868|NCT00824811|Lubricant Eye Drops|lubricant eye drops|mesh-list
6537869|NCT00824811|Cyclosporins|cyclosporins|mesh-list
6537870|NCT00824811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6537871|NCT00824811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537872|NCT00824811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6537873|NCT00824811|Immunologic Factors|immunologic factors|mesh-ancestor
6537874|NCT00824811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537875|NCT00824811|Antifungal Agents|antifungal agents|mesh-ancestor
6537876|NCT00824811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6537877|NCT00824811|Dermatologic Agents|dermatologic agents|mesh-ancestor
6537878|NCT00824811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6537879|NCT00824811|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6537880|NCT00824811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6537881|NCT00824811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6537882|NCT00824811|Glucocorticoids|glucocorticoids|mesh-ancestor
6537883|NCT00824811|Hormones|hormones|mesh-ancestor
6537884|NCT00824811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6537885|NCT00824811|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6537886|NCT00824863|Ketoconazole|ketoconazole|mesh-list
6537887|NCT00824863|Antifungal Agents|antifungal agents|mesh-ancestor
6537888|NCT00824863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6537889|NCT00824863|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6537890|NCT00824863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6537891|NCT00824863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6537892|NCT00824863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797650|NCT02268487|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6797651|NCT02268487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6537893|NCT00824863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6534063|NCT00805298|Methylprednisolone|methylprednisolone|mesh-list
6534064|NCT00805298|Epinephrine|epinephrine|mesh-list
6534065|NCT00805298|Racepinephrine|racepinephrine|mesh-list
6534066|NCT00805298|Epinephryl borate|epinephryl borate|mesh-list
6534067|NCT00805298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6534068|NCT00805298|Antiemetics|antiemetics|mesh-ancestor
6534069|NCT00805298|Autonomic Agents|autonomic agents|mesh-ancestor
6534070|NCT00805298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6534071|NCT00805298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534072|NCT00805298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6534073|NCT00805298|Glucocorticoids|glucocorticoids|mesh-ancestor
6534074|NCT00805298|Hormones|hormones|mesh-ancestor
6534075|NCT00805298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6534076|NCT00805298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6534077|NCT00805298|Protective Agents|protective agents|mesh-ancestor
6534078|NCT00805298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6534079|NCT00805298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6534080|NCT00805298|Adrenergic Agents|adrenergic agents|mesh-ancestor
6534081|NCT00805298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6534082|NCT00805298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797652|NCT02268487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6797653|NCT02268487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797654|NCT02268487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6797655|NCT02268487|Serotonin Agents|serotonin agents|mesh-ancestor
6797656|NCT02268487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797657|NCT02268565|Aspirin|aspirin|mesh-list
6797658|NCT02268565|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
6797659|NCT02268565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
6797660|NCT02268565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6797661|NCT02268565|Analgesics|analgesics|mesh-ancestor
6797662|NCT02268565|Sensory System Agents|sensory system agents|mesh-ancestor
6797663|NCT02268565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6797664|NCT02268565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797665|NCT02268565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6797666|NCT02268565|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6797667|NCT02268565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6797668|NCT02268565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797669|NCT02268565|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6797670|NCT02268565|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6797671|NCT02268565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6797672|NCT02268565|Antipyretics|antipyretics|mesh-ancestor
6797673|NCT02268656|Propofol|propofol|mesh-list
6797674|NCT02268656|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6797675|NCT02268656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6797676|NCT02268656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797677|NCT02268656|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6797678|NCT02268656|Anesthetics, General|anesthetics, general|mesh-ancestor
6797679|NCT02268656|Anesthetics|anesthetics|mesh-ancestor
6797680|NCT02268695|Docetaxel|docetaxel|mesh-list
6797681|NCT02268695|Cetuximab|cetuximab|mesh-list
6797682|NCT02268695|Sargramostim|sargramostim|mesh-list
6797683|NCT02268695|Lenograstim|lenograstim|mesh-list
6797684|NCT02268695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6797685|NCT02268695|Tubulin Modulators|tubulin modulators|mesh-ancestor
6797686|NCT02268695|Antimitotic Agents|antimitotic agents|mesh-ancestor
6797687|NCT02268695|Mitosis Modulators|mitosis modulators|mesh-ancestor
6797688|NCT02268695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797689|NCT02268695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6797690|NCT02268695|Immunologic Factors|immunologic factors|mesh-ancestor
6797691|NCT02268695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797692|NCT02268695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6797693|NCT02268773|Aspirin|aspirin|mesh-list
6797694|NCT02268773|Dipyridamole|dipyridamole|mesh-list
6797695|NCT02268773|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
6797696|NCT02268773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6797697|NCT02268773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6797698|NCT02268773|Analgesics|analgesics|mesh-ancestor
6797699|NCT02268773|Sensory System Agents|sensory system agents|mesh-ancestor
6797700|NCT02268773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6797701|NCT02268773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797702|NCT02268773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6797703|NCT02268773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6534083|NCT00805298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6534084|NCT00805298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6534085|NCT00805298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6534086|NCT00805298|Respiratory System Agents|respiratory system agents|mesh-ancestor
6534087|NCT00805298|Mydriatics|mydriatics|mesh-ancestor
6534088|NCT00805298|Sympathomimetics|sympathomimetics|mesh-ancestor
6534089|NCT00805298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6534090|NCT00805311|Aspirin|aspirin|mesh-list
6534091|NCT00805311|Losartan|losartan|mesh-list
6534092|NCT00805311|Amlodipine|amlodipine|mesh-list
6534093|NCT00805311|Atorvastatin|atorvastatin|mesh-list
6534094|NCT00805311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6534095|NCT00805311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6534096|NCT00805311|Analgesics|analgesics|mesh-ancestor
6534097|NCT00805311|Sensory System Agents|sensory system agents|mesh-ancestor
6534098|NCT00805311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6534099|NCT00805311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534100|NCT00805311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6534101|NCT00805311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6534102|NCT00805311|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6534103|NCT00805311|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6534104|NCT00805311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534105|NCT00805311|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6534106|NCT00805311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6534107|NCT00805311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6534108|NCT00805311|Antipyretics|antipyretics|mesh-ancestor
6534109|NCT00805311|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6534110|NCT00805311|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6534111|NCT00805311|Antimetabolites|antimetabolites|mesh-ancestor
6534112|NCT00805311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6797704|NCT02268773|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6797705|NCT02268773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6797706|NCT02268773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797707|NCT02268773|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6797708|NCT02268773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6797709|NCT02268773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6797710|NCT02268773|Antipyretics|antipyretics|mesh-ancestor
6797711|NCT02268773|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6797712|NCT02268773|Vasodilator Agents|vasodilator agents|mesh-ancestor
6797713|NCT02268825|Pembrolizumab|pembrolizumab|mesh-list
6797714|NCT02268825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6797715|NCT02268825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6797716|NCT02268890|Bortezomib|bortezomib|mesh-list
6797717|NCT02268890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6797718|NCT02268903|Furosemide|furosemide|mesh-list
6797719|NCT02268903|Diuretics|diuretics|mesh-list
6797720|NCT02268903|Natriuretic Agents|natriuretic agents|mesh-ancestor
6797721|NCT02268903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797722|NCT02268903|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6797723|NCT02268903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6797724|NCT02268903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797725|NCT02268968|Lidocaine|lidocaine|mesh-list
6797726|NCT02268968|Anesthetics, Local|anesthetics, local|mesh-ancestor
6797727|NCT02268968|Anesthetics|anesthetics|mesh-ancestor
6797728|NCT02268968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6797729|NCT02268968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797730|NCT02268968|Sensory System Agents|sensory system agents|mesh-ancestor
6797731|NCT02268968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6797732|NCT02268968|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6797733|NCT02268968|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6797734|NCT02268968|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6797735|NCT02268968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6797736|NCT02268968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797737|NCT02269046|Simvastatin|simvastatin|mesh-list
6797738|NCT02269046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6797739|NCT02269046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6797740|NCT02269046|Antimetabolites|antimetabolites|mesh-ancestor
6797741|NCT02269046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797742|NCT02269046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6797743|NCT02269046|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6797744|NCT02269046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6797745|NCT02269072|Anastrozole|anastrozole|mesh-list
6797746|NCT02269072|Leuprolide|leuprolide|mesh-list
6534113|NCT00805311|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6534114|NCT00805311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6534115|NCT00805311|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6534116|NCT00805311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6534117|NCT00805311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6534118|NCT00805311|Vasodilator Agents|vasodilator agents|mesh-ancestor
6534119|NCT00805311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6534120|NCT00805311|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6534121|NCT00805311|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6534122|NCT00805519|Chloroquine|chloroquine|mesh-list
6534123|NCT00805519|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
6534124|NCT00805519|Prednisolone|prednisolone|mesh-list
6534125|NCT00805519|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6534126|NCT00805519|Methylprednisolone|methylprednisolone|mesh-list
6534127|NCT00805519|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6534128|NCT00805519|Prednisolone acetate|prednisolone acetate|mesh-list
6534129|NCT00805519|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6534130|NCT00805519|Prednisolone phosphate|prednisolone phosphate|mesh-list
6534131|NCT00805519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6534132|NCT00805519|Glucocorticoids|glucocorticoids|mesh-ancestor
6534133|NCT00805519|Hormones|hormones|mesh-ancestor
6534134|NCT00805519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6534135|NCT00805519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534136|NCT00805519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6534137|NCT00805519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6534138|NCT00805519|Antiemetics|antiemetics|mesh-ancestor
6534139|NCT00805519|Autonomic Agents|autonomic agents|mesh-ancestor
6534140|NCT00805519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6534141|NCT00805519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6534142|NCT00805519|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6534143|NCT00805519|Protective Agents|protective agents|mesh-ancestor
6534144|NCT00805519|Amebicides|amebicides|mesh-ancestor
6534145|NCT00805519|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6534146|NCT00805519|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6534147|NCT00805519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6534148|NCT00805519|Antimalarials|antimalarials|mesh-ancestor
6534149|NCT00805519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6534150|NCT00805519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6534151|NCT00805519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6534152|NCT00805519|Analgesics|analgesics|mesh-ancestor
6534153|NCT00805519|Sensory System Agents|sensory system agents|mesh-ancestor
6534154|NCT00805519|Filaricides|filaricides|mesh-ancestor
6534155|NCT00805519|Antinematodal Agents|antinematodal agents|mesh-ancestor
6534156|NCT00805519|Anthelmintics|anthelmintics|mesh-ancestor
6534157|NCT00805558|Moxifloxacin|moxifloxacin|mesh-list
6534158|NCT00805558|Metronidazole|metronidazole|mesh-list
6534159|NCT00805558|Ciprofloxacin|ciprofloxacin|mesh-list
6534160|NCT00805558|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6534161|NCT00805558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6534162|NCT00805558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6534163|NCT00805558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6534164|NCT00805558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6534165|NCT00805558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6534166|NCT00805558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534167|NCT00805558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6534168|NCT00805558|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6534169|NCT00805558|Contraceptive Agents|contraceptive agents|mesh-ancestor
6534170|NCT00805558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6534171|NCT00805558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534172|NCT00805558|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6534173|NCT00805558|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6534174|NCT00805558|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6797747|NCT02269072|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6797748|NCT02269072|Testosterone|testosterone|mesh-list
6797749|NCT02269072|Androgens|androgens|mesh-ancestor
6797750|NCT02269072|Hormones|hormones|mesh-ancestor
6797751|NCT02269072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6797752|NCT02269072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797753|NCT02269072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6797754|NCT02269072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6797755|NCT02269072|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6797756|NCT02269072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6797757|NCT02269072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6797758|NCT02269072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534175|NCT00805558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6797759|NCT02269072|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6534176|NCT00805558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6534177|NCT00805558|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6534178|NCT00805558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6534179|NCT00805649|Dexamethasone|dexamethasone|mesh-list
6534180|NCT00805649|Bevacizumab|bevacizumab|mesh-list
6534181|NCT00805649|Temazepam|temazepam|mesh-list
6534182|NCT00805649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6534183|NCT00805649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6534184|NCT00805649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6534185|NCT00805649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6534186|NCT00805649|Growth Substances|growth substances|mesh-ancestor
6534187|NCT00805649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534188|NCT00805649|Growth Inhibitors|growth inhibitors|mesh-ancestor
6534189|NCT00805649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6534190|NCT00805649|Antiemetics|antiemetics|mesh-ancestor
6534191|NCT00805649|Autonomic Agents|autonomic agents|mesh-ancestor
6534192|NCT00805649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6534193|NCT00805649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6534194|NCT00805649|Glucocorticoids|glucocorticoids|mesh-ancestor
6534195|NCT00805649|Hormones|hormones|mesh-ancestor
6534196|NCT00805649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6534197|NCT00805649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6534198|NCT00805649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6534199|NCT00805649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6534200|NCT00805649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6534201|NCT00805649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6534202|NCT00805649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6534203|NCT00805649|GABA Modulators|gaba modulators|mesh-ancestor
6534204|NCT00805649|GABA Agents|gaba agents|mesh-ancestor
6534205|NCT00805649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6534206|NCT00805649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534207|NCT00805662|Oxytocin|oxytocin|mesh-list
6534208|NCT00805662|Oxytocics|oxytocics|mesh-ancestor
6534209|NCT00805662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6534210|NCT00805662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534211|NCT00805701|Dutasteride|dutasteride|mesh-list
6534212|NCT00805701|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6534213|NCT00805701|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6797760|NCT02269072|Hormone Antagonists|hormone antagonists|mesh-ancestor
6797761|NCT02269072|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6797762|NCT02269072|Fertility Agents|fertility agents|mesh-ancestor
6797763|NCT02269072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6797764|NCT02269072|Natriuretic Agents|natriuretic agents|mesh-ancestor
6797765|NCT02269176|Losartan|losartan|mesh-list
6797766|NCT02269176|Telmisartan|telmisartan|mesh-list
6797767|NCT02269176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6797768|NCT02269176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6797769|NCT02269176|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6797770|NCT02269176|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6797771|NCT02269176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797772|NCT02269202|Midazolam|midazolam|mesh-list
6797773|NCT02269202|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6797774|NCT02269202|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6797775|NCT02269202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6797776|NCT02269202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797777|NCT02269202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6797778|NCT02269202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6797779|NCT02269202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6797780|NCT02269202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6797781|NCT02269202|Anesthetics, General|anesthetics, general|mesh-ancestor
6797782|NCT02269202|Anesthetics|anesthetics|mesh-ancestor
6797783|NCT02269202|GABA Modulators|gaba modulators|mesh-ancestor
6797784|NCT02269202|GABA Agents|gaba agents|mesh-ancestor
6797785|NCT02269202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6797786|NCT02269202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797787|NCT02269228|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
6797788|NCT02269228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6797789|NCT02269280|Azacitidine|azacitidine|mesh-list
6797790|NCT02269280|Decitabine|decitabine|mesh-list
6797791|NCT02269280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6797792|NCT02269280|Antimetabolites|antimetabolites|mesh-ancestor
6534214|NCT00805701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6534215|NCT00805701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534216|NCT00805701|Hormone Antagonists|hormone antagonists|mesh-ancestor
6537894|NCT00824863|Hormone Antagonists|hormone antagonists|mesh-ancestor
6534217|NCT00805701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6534218|NCT00805701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534219|NCT00805857|Tipranavir|tipranavir|mesh-list
6534220|NCT00805857|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6534221|NCT00805857|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6534222|NCT00805857|Antiviral Agents|antiviral agents|mesh-ancestor
6534223|NCT00805857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6534224|NCT00806169|Triamcinolone|triamcinolone|mesh-list
6534225|NCT00806169|Bevacizumab|bevacizumab|mesh-list
6534226|NCT00806169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6534227|NCT00806169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6534228|NCT00806169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6534229|NCT00806169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6534230|NCT00806169|Growth Substances|growth substances|mesh-ancestor
6534231|NCT00806169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534232|NCT00806169|Growth Inhibitors|growth inhibitors|mesh-ancestor
6534233|NCT00806169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6534234|NCT00806169|Glucocorticoids|glucocorticoids|mesh-ancestor
6534235|NCT00806169|Hormones|hormones|mesh-ancestor
6534236|NCT00806169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6534237|NCT00806247|Tapentadol|tapentadol|mesh-list
6534238|NCT00806247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6534239|NCT00806247|Narcotics|narcotics|mesh-ancestor
6534240|NCT00806247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6534241|NCT00806247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534242|NCT00806247|Analgesics|analgesics|mesh-ancestor
6534243|NCT00806247|Sensory System Agents|sensory system agents|mesh-ancestor
6534244|NCT00806247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6534245|NCT00806247|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6534246|NCT00806247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6534247|NCT00806247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6534248|NCT00806247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534249|NCT00806247|Adrenergic Agents|adrenergic agents|mesh-ancestor
6534250|NCT00806247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6534251|NCT00806299|Loperamide|loperamide|mesh-list
6534252|NCT00806299|Antidiarrheals|antidiarrheals|mesh-list
6534253|NCT00806299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6534254|NCT00806468|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
6534255|NCT00806468|Hemostatics|hemostatics|mesh-ancestor
6797793|NCT02269280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797794|NCT02269280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6797795|NCT02269280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6797796|NCT02269293|Paclitaxel|paclitaxel|mesh-list
6797797|NCT02269293|Carboplatin|carboplatin|mesh-list
6797798|NCT02269293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6797799|NCT02269293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6797800|NCT02269293|Tubulin Modulators|tubulin modulators|mesh-ancestor
6797801|NCT02269293|Antimitotic Agents|antimitotic agents|mesh-ancestor
6797802|NCT02269293|Mitosis Modulators|mitosis modulators|mesh-ancestor
6797803|NCT02269293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797804|NCT02269319|Linezolid|linezolid|mesh-list
6797805|NCT02269319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6797806|NCT02269319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6797807|NCT02269319|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6797808|NCT02269319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6797809|NCT02269319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797810|NCT02269358|Methotrexate|methotrexate|mesh-list
6797811|NCT02269358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6797812|NCT02269358|Abortifacient Agents|abortifacient agents|mesh-ancestor
6797813|NCT02269358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6797814|NCT02269358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797815|NCT02269358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6797816|NCT02269358|Antimetabolites|antimetabolites|mesh-ancestor
6797817|NCT02269358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797818|NCT02269358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6797819|NCT02269358|Dermatologic Agents|dermatologic agents|mesh-ancestor
6797820|NCT02269358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6797821|NCT02269358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6797822|NCT02269358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6797823|NCT02269358|Immunologic Factors|immunologic factors|mesh-ancestor
6797824|NCT02269358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6797825|NCT02269358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6797826|NCT02269449|Hemostatics|hemostatics|mesh-list
6797827|NCT02269449|Coagulants|coagulants|mesh-ancestor
6797828|NCT02269462|Efavirenz|efavirenz|mesh-list
6534256|NCT00806468|Coagulants|coagulants|mesh-ancestor
6534257|NCT00806468|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6534258|NCT00806468|Natriuretic Agents|natriuretic agents|mesh-ancestor
6534259|NCT00806468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534260|NCT00806481|Sevelamer|sevelamer|mesh-list
6534261|NCT00806481|Chelating Agents|chelating agents|mesh-ancestor
6534262|NCT00806481|Sequestering Agents|sequestering agents|mesh-ancestor
6534263|NCT00806481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534264|NCT00806611|Ethanol|ethanol|mesh-list
6534265|NCT00806611|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6534266|NCT00806611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6534267|NCT00806611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6534268|NCT00806611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534269|NCT00806663|Sunitinib|sunitinib|mesh-list
6534270|NCT00806663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6534271|NCT00806663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6534272|NCT00806663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6534273|NCT00806663|Growth Substances|growth substances|mesh-ancestor
6534274|NCT00806663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534275|NCT00806663|Growth Inhibitors|growth inhibitors|mesh-ancestor
6534276|NCT00806663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6534277|NCT00806663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6534278|NCT00806663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534279|NCT00806741|Phenylephrine|phenylephrine|mesh-list
6534280|NCT00806741|Oxymetazoline|oxymetazoline|mesh-list
6534281|NCT00806741|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
6534282|NCT00806741|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6534283|NCT00806741|Mydriatics|mydriatics|mesh-ancestor
6534284|NCT00806741|Autonomic Agents|autonomic agents|mesh-ancestor
6534285|NCT00806741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6534286|NCT00806741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534287|NCT00806741|Sympathomimetics|sympathomimetics|mesh-ancestor
6534288|NCT00806741|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6534289|NCT00806741|Nasal Decongestants|nasal decongestants|mesh-ancestor
6534290|NCT00806741|Respiratory System Agents|respiratory system agents|mesh-ancestor
6534291|NCT00806741|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6534292|NCT00806741|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6534293|NCT00806741|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6534294|NCT00806741|Adrenergic Agents|adrenergic agents|mesh-ancestor
6534295|NCT00806741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6534296|NCT00806741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534297|NCT00806741|Protective Agents|protective agents|mesh-ancestor
6534298|NCT00806741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6534299|NCT00806754|Ciclesonide|ciclesonide|mesh-list
6534300|NCT00806754|Azelastine|azelastine|mesh-list
6534301|NCT00806754|Glucocorticoids|glucocorticoids|mesh-ancestor
6534302|NCT00806754|Hormones|hormones|mesh-ancestor
6534303|NCT00806754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6534304|NCT00806754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534305|NCT00806754|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6534306|NCT00806754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6534307|NCT00806754|Autonomic Agents|autonomic agents|mesh-ancestor
6534308|NCT00806754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6534309|NCT00806754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6534310|NCT00806754|Respiratory System Agents|respiratory system agents|mesh-ancestor
6534311|NCT00806754|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6534312|NCT00806754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6534313|NCT00806754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534314|NCT00806754|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6534315|NCT00806754|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6534316|NCT00806754|Histamine Antagonists|histamine antagonists|mesh-ancestor
6534317|NCT00806754|Histamine Agents|histamine agents|mesh-ancestor
6534318|NCT00806754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6534319|NCT00806767|Fludarabine|fludarabine|mesh-list
6534320|NCT00806767|Fludarabine phosphate|fludarabine phosphate|mesh-list
6534321|NCT00806767|Busulfan|busulfan|mesh-list
6797829|NCT02269462|Nevirapine|nevirapine|mesh-list
6797830|NCT02269462|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6797831|NCT02269462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6797832|NCT02269462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6797833|NCT02269462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797834|NCT02269462|Antiviral Agents|antiviral agents|mesh-ancestor
6797835|NCT02269462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6534322|NCT00806767|Immunoglobulins|immunoglobulins|mesh-list
6534323|NCT00806767|Antibodies|antibodies|mesh-list
6534324|NCT00806767|gamma-Globulins|gamma-globulins|mesh-list
6534325|NCT00806767|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6534326|NCT00806767|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6534327|NCT00806767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6534328|NCT00806767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6534329|NCT00806767|Antimetabolites|antimetabolites|mesh-ancestor
6534330|NCT00806767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534331|NCT00806767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6534332|NCT00806767|Immunologic Factors|immunologic factors|mesh-ancestor
6534333|NCT00806767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534334|NCT00806767|Alkylating Agents|alkylating agents|mesh-ancestor
6534335|NCT00806767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6534336|NCT00806767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6534337|NCT00806871|Methylprednisolone|methylprednisolone|mesh-list
6534338|NCT00806871|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6534339|NCT00806871|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6534340|NCT00806871|Prednisolone|prednisolone|mesh-list
6534341|NCT00806871|Prednisolone acetate|prednisolone acetate|mesh-list
6534342|NCT00806871|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6534343|NCT00806871|Prednisolone phosphate|prednisolone phosphate|mesh-list
6534344|NCT00806871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6534345|NCT00806871|Antiemetics|antiemetics|mesh-ancestor
6534346|NCT00806871|Autonomic Agents|autonomic agents|mesh-ancestor
6534347|NCT00806871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6534348|NCT00806871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534349|NCT00806871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6534350|NCT00806871|Glucocorticoids|glucocorticoids|mesh-ancestor
6534351|NCT00806871|Hormones|hormones|mesh-ancestor
6534352|NCT00806871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6534353|NCT00806871|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6534354|NCT00806871|Protective Agents|protective agents|mesh-ancestor
6534355|NCT00806871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6534356|NCT00806871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6534357|NCT00806897|Insulin Detemir|insulin detemir|mesh-list
6534358|NCT00806897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6534359|NCT00806897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534360|NCT00806910|Conivaptan|conivaptan|mesh-list
6534361|NCT00806910|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6534362|NCT00806910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534363|NCT00806910|Natriuretic Agents|natriuretic agents|mesh-ancestor
6534364|NCT00806910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534365|NCT00806923|Gemcitabine|gemcitabine|mesh-list
6534366|NCT00806923|Bevacizumab|bevacizumab|mesh-list
6534367|NCT00806923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6534368|NCT00806923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6534369|NCT00806923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6534370|NCT00806923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6534371|NCT00806923|Growth Substances|growth substances|mesh-ancestor
6534372|NCT00806923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534373|NCT00806923|Growth Inhibitors|growth inhibitors|mesh-ancestor
6797836|NCT02269462|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6797837|NCT02269462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6797838|NCT02269462|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6797839|NCT02269462|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6797840|NCT02269462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6797841|NCT02269462|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6797842|NCT02269462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6797843|NCT02269462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6797844|NCT02269514|Nicotine|nicotine|mesh-list
6797845|NCT02269514|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6797846|NCT02269514|Autonomic Agents|autonomic agents|mesh-ancestor
6797847|NCT02269514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6797848|NCT02269514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797849|NCT02269514|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6797850|NCT02269514|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6797851|NCT02269514|Cholinergic Agents|cholinergic agents|mesh-ancestor
6797852|NCT02269514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6797853|NCT02269514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797854|NCT02269540|Acetylcysteine|acetylcysteine|mesh-list
6797855|NCT02269540|Sertraline|sertraline|mesh-list
6797856|NCT02269540|Citalopram|citalopram|mesh-list
6797857|NCT02269540|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6797858|NCT02269540|Antiviral Agents|antiviral agents|mesh-ancestor
6797859|NCT02269540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6534374|NCT00806923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6534375|NCT00806923|Antimetabolites|antimetabolites|mesh-ancestor
6534376|NCT00806923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534377|NCT00806923|Antiviral Agents|antiviral agents|mesh-ancestor
6534378|NCT00806923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6534379|NCT00806923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6534380|NCT00806923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6534381|NCT00806923|Immunologic Factors|immunologic factors|mesh-ancestor
6534382|NCT00806936|Insulin|insulin|mesh-list
6534383|NCT00806936|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6534384|NCT00806936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6534385|NCT00806936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534386|NCT00806962|Vaccines|vaccines|mesh-list
6797860|NCT02269540|Expectorants|expectorants|mesh-ancestor
6797861|NCT02269540|Respiratory System Agents|respiratory system agents|mesh-ancestor
6797862|NCT02269540|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6797863|NCT02269540|Antioxidants|antioxidants|mesh-ancestor
6797864|NCT02269540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797865|NCT02269540|Protective Agents|protective agents|mesh-ancestor
6797866|NCT02269540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797867|NCT02269540|Antidotes|antidotes|mesh-ancestor
6797868|NCT02269540|Antidepressive Agents|antidepressive agents|mesh-ancestor
6797869|NCT02269540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6797870|NCT02269540|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6797871|NCT02269540|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6797872|NCT02269540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6797873|NCT02269540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6797874|NCT02269540|Serotonin Agents|serotonin agents|mesh-ancestor
6797875|NCT02269540|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6797876|NCT02269605|Bryostatin 1|bryostatin 1|mesh-list
6797877|NCT02269605|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6797878|NCT02269605|Immunologic Factors|immunologic factors|mesh-ancestor
6797879|NCT02269605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797880|NCT02269605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6797881|NCT02269644|Azithromycin|azithromycin|mesh-list
6797882|NCT02269644|Linezolid|linezolid|mesh-list
6797883|NCT02269644|Dalbavancin|dalbavancin|mesh-list
6797884|NCT02269644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6797885|NCT02269644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6797886|NCT02269644|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6797887|NCT02269644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6797888|NCT02269644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797889|NCT02269696|Metoprolol|metoprolol|mesh-list
6797890|NCT02269696|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6797891|NCT02269696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6797892|NCT02269696|Sympatholytics|sympatholytics|mesh-ancestor
6797893|NCT02269696|Autonomic Agents|autonomic agents|mesh-ancestor
6797894|NCT02269696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6797895|NCT02269696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797896|NCT02269696|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6797897|NCT02269696|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6797898|NCT02269696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6797899|NCT02269696|Adrenergic Agents|adrenergic agents|mesh-ancestor
6797900|NCT02269696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6797901|NCT02269696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5993079|NCT00118898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6534387|NCT00806962|Immunologic Factors|immunologic factors|mesh-ancestor
6534388|NCT00806962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534389|NCT00807053|Ciclesonide|ciclesonide|mesh-list
6534390|NCT00807053|Glucocorticoids|glucocorticoids|mesh-ancestor
6534391|NCT00807053|Hormones|hormones|mesh-ancestor
6534392|NCT00807053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6534393|NCT00807053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534394|NCT00807053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6534395|NCT00807066|Gefitinib|gefitinib|mesh-list
6534396|NCT00807066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6534397|NCT00807066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6534398|NCT00807066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6534399|NCT00807066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534400|NCT00807079|Carboplatin|carboplatin|mesh-list
6534401|NCT00807079|Topotecan|topotecan|mesh-list
6534402|NCT00807079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6534403|NCT00807079|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6534404|NCT00807079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6534405|NCT00807079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6797902|NCT02269735|Insulin|insulin|mesh-list
6797903|NCT02269735|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6797904|NCT02269735|Insulin Aspart|insulin aspart|mesh-list
6797905|NCT02269735|MK-2640|mk-2640|mesh-list
6797906|NCT02269735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6797907|NCT02269735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797908|NCT02269748|Analgesics|analgesics|mesh-list
6797909|NCT02269748|Sensory System Agents|sensory system agents|mesh-ancestor
6797910|NCT02269748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6797911|NCT02269748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797912|NCT02269800|Benzalkonium Compounds|benzalkonium compounds|mesh-list
6797913|NCT02269800|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6797914|NCT02269800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6797915|NCT02269904|Fluorouracil|fluorouracil|mesh-list
6797916|NCT02269904|Antimetabolites|antimetabolites|mesh-ancestor
6797917|NCT02269904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797918|NCT02269904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6797919|NCT02269904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6797920|NCT02269904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6797921|NCT02269904|Immunologic Factors|immunologic factors|mesh-ancestor
6797922|NCT02269904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797923|NCT02269969|Tobramycin|tobramycin|mesh-list
6797924|NCT02269969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6797925|NCT02269969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6797926|NCT02270034|Crizotinib|crizotinib|mesh-list
6797927|NCT02270034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6797928|NCT02270034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6797929|NCT02270034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6797930|NCT02270034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797931|NCT02270281|Dexmedetomidine|dexmedetomidine|mesh-list
6797932|NCT02270281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6797933|NCT02270281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6797934|NCT02270281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797935|NCT02270281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6797936|NCT02270281|Analgesics|analgesics|mesh-ancestor
6797937|NCT02270281|Sensory System Agents|sensory system agents|mesh-ancestor
6797938|NCT02270281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6797939|NCT02270281|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6797940|NCT02270281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6797941|NCT02270281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6797942|NCT02270281|Adrenergic Agents|adrenergic agents|mesh-ancestor
6797943|NCT02270281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6797944|NCT02270281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797945|NCT02270307|Cyclophosphamide|cyclophosphamide|mesh-list
6797946|NCT02270307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6797947|NCT02270307|Immunologic Factors|immunologic factors|mesh-ancestor
6797948|NCT02270307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797949|NCT02270307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6797950|NCT02270307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6797951|NCT02270307|Alkylating Agents|alkylating agents|mesh-ancestor
6797952|NCT02270307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797953|NCT02270307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6797954|NCT02270307|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6797955|NCT02270424|Fluticasone|fluticasone|mesh-list
6797956|NCT02270424|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6534406|NCT00807079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534407|NCT00807118|Fesoterodine|fesoterodine|mesh-list
6534408|NCT00807118|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6534409|NCT00807118|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6534410|NCT00807118|Cholinergic Agents|cholinergic agents|mesh-ancestor
6534411|NCT00807118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6534412|NCT00807118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534413|NCT00807118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534414|NCT00807118|Urological Agents|urological agents|mesh-ancestor
6534415|NCT00807196|Cyclophosphamide|cyclophosphamide|mesh-list
6534416|NCT00807196|Rituximab|rituximab|mesh-list
6534417|NCT00807196|Fludarabine|fludarabine|mesh-list
6534418|NCT00807196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6534419|NCT00807196|Immunologic Factors|immunologic factors|mesh-ancestor
6534420|NCT00807196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534421|NCT00807196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6534422|NCT00807196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6534423|NCT00807196|Alkylating Agents|alkylating agents|mesh-ancestor
6534424|NCT00807196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534425|NCT00807196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6534426|NCT00807196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6534427|NCT00807196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6534428|NCT00807222|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6534429|NCT00807222|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6534430|NCT00807222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797957|NCT02270424|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6797958|NCT02270424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6797959|NCT02270424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6797960|NCT02270424|Autonomic Agents|autonomic agents|mesh-ancestor
6797961|NCT02270424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6797962|NCT02270424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797963|NCT02270424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6797964|NCT02270424|Respiratory System Agents|respiratory system agents|mesh-ancestor
6797965|NCT02270424|Dermatologic Agents|dermatologic agents|mesh-ancestor
6797966|NCT02270424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6797967|NCT02270424|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6797968|NCT02270424|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6797969|NCT02270424|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6797970|NCT02270424|Adrenergic Agents|adrenergic agents|mesh-ancestor
6797971|NCT02270424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6797972|NCT02270424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797973|NCT02270424|Glucocorticoids|glucocorticoids|mesh-ancestor
6797974|NCT02270424|Hormones|hormones|mesh-ancestor
6797975|NCT02270424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6797976|NCT02270424|Sympathomimetics|sympathomimetics|mesh-ancestor
6797977|NCT02270437|Epinephrine|epinephrine|mesh-list
6797978|NCT02270437|Racepinephrine|racepinephrine|mesh-list
6797979|NCT02270437|Fentanyl|fentanyl|mesh-list
6797980|NCT02270437|Ropivacaine|ropivacaine|mesh-list
6797981|NCT02270437|Epinephryl borate|epinephryl borate|mesh-list
6797982|NCT02270437|Anesthetics, Local|anesthetics, local|mesh-ancestor
6797983|NCT02270437|Anesthetics|anesthetics|mesh-ancestor
6797984|NCT02270437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6797985|NCT02270437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6797986|NCT02270437|Sensory System Agents|sensory system agents|mesh-ancestor
6797987|NCT02270437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6797988|NCT02270437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6797989|NCT02270437|Narcotics|narcotics|mesh-ancestor
6797990|NCT02270437|Analgesics|analgesics|mesh-ancestor
6797991|NCT02270437|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6797992|NCT02270437|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6797993|NCT02270437|Anesthetics, General|anesthetics, general|mesh-ancestor
6797994|NCT02270437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6797995|NCT02270437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6797996|NCT02270437|Adrenergic Agents|adrenergic agents|mesh-ancestor
6797997|NCT02270437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6797998|NCT02270437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6797999|NCT02270437|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6798000|NCT02270437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6798001|NCT02270437|Autonomic Agents|autonomic agents|mesh-ancestor
6798002|NCT02270437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6798003|NCT02270437|Respiratory System Agents|respiratory system agents|mesh-ancestor
6798004|NCT02270437|Mydriatics|mydriatics|mesh-ancestor
6798005|NCT02270437|Sympathomimetics|sympathomimetics|mesh-ancestor
6798006|NCT02270437|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6798007|NCT02270606|Calcium, Dietary|calcium, dietary|mesh-list
6798008|NCT02270606|Leucovorin|leucovorin|mesh-list
6534431|NCT00807222|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6534432|NCT00807222|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6534433|NCT00807222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6534434|NCT00807222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534435|NCT00807222|Dopamine Agents|dopamine agents|mesh-ancestor
6534436|NCT00807222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6534437|NCT00807261|Gemcitabine|gemcitabine|mesh-list
6534438|NCT00807261|Docetaxel|docetaxel|mesh-list
6534439|NCT00807261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6534440|NCT00807261|Antimetabolites|antimetabolites|mesh-ancestor
6534441|NCT00807261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534442|NCT00807261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6534443|NCT00807261|Antiviral Agents|antiviral agents|mesh-ancestor
6534444|NCT00807261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6534445|NCT00807261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6534446|NCT00807261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6534447|NCT00807261|Immunologic Factors|immunologic factors|mesh-ancestor
6534448|NCT00807261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534449|NCT00807261|Tubulin Modulators|tubulin modulators|mesh-ancestor
6534450|NCT00807261|Antimitotic Agents|antimitotic agents|mesh-ancestor
6534451|NCT00807261|Mitosis Modulators|mitosis modulators|mesh-ancestor
6537895|NCT00824863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6537896|NCT00824863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537897|NCT00824863|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6537898|NCT00825019|Paroxetine|paroxetine|mesh-list
6537899|NCT00825019|Amibegron|amibegron|mesh-list
6537900|NCT00825019|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6537901|NCT00825019|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6537902|NCT00825019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6537903|NCT00825019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537904|NCT00825019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6537905|NCT00825019|Serotonin Agents|serotonin agents|mesh-ancestor
6537906|NCT00825019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798009|NCT02270606|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
6798010|NCT02270606|Tetrahydrofolates|tetrahydrofolates|mesh-list
6798011|NCT02270606|Fluorouracil|fluorouracil|mesh-list
6798012|NCT02270606|Oxaliplatin|oxaliplatin|mesh-list
6798013|NCT02270606|Calcium|calcium|mesh-list
6798014|NCT02270606|Levoleucovorin|levoleucovorin|mesh-list
6798015|NCT02270606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6798016|NCT02270606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798017|NCT02270606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6798018|NCT02270606|Antimetabolites|antimetabolites|mesh-ancestor
6798019|NCT02270606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6798020|NCT02270606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6798021|NCT02270606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6798022|NCT02270606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6798023|NCT02270606|Immunologic Factors|immunologic factors|mesh-ancestor
6798024|NCT02270606|Antidotes|antidotes|mesh-ancestor
6798025|NCT02270606|Protective Agents|protective agents|mesh-ancestor
6798026|NCT02270606|Vitamin B Complex|vitamin b complex|mesh-ancestor
6798027|NCT02270606|Vitamins|vitamins|mesh-ancestor
6798028|NCT02270606|Micronutrients|micronutrients|mesh-ancestor
6798029|NCT02270632|Methotrexate|methotrexate|mesh-list
6798030|NCT02270632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6798031|NCT02270632|Abortifacient Agents|abortifacient agents|mesh-ancestor
6798032|NCT02270632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6798033|NCT02270632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798034|NCT02270632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6798035|NCT02270632|Antimetabolites|antimetabolites|mesh-ancestor
6798036|NCT02270632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6798037|NCT02270632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6798038|NCT02270632|Dermatologic Agents|dermatologic agents|mesh-ancestor
6798039|NCT02270632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6798040|NCT02270632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6798041|NCT02270632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6798042|NCT02270632|Immunologic Factors|immunologic factors|mesh-ancestor
6798043|NCT02270632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6798044|NCT02270632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6798045|NCT02270749|Vitamin B 12|vitamin b 12|mesh-list
6798046|NCT02270749|Hydroxocobalamin|hydroxocobalamin|mesh-list
6798047|NCT02270749|Vitamins|vitamins|mesh-ancestor
6798048|NCT02270749|Micronutrients|micronutrients|mesh-ancestor
6798049|NCT02270749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798050|NCT02270749|Vitamin B Complex|vitamin b complex|mesh-ancestor
6534452|NCT00807326|Simethicone|simethicone|mesh-list
6534453|NCT00807326|Loperamide|loperamide|mesh-list
6534454|NCT00807326|Antidiarrheals|antidiarrheals|mesh-list
6534455|NCT00807326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6534456|NCT00807326|Antifoaming Agents|antifoaming agents|mesh-ancestor
6534457|NCT00807326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534458|NCT00807326|Emollients|emollients|mesh-ancestor
6534459|NCT00807326|Dermatologic Agents|dermatologic agents|mesh-ancestor
6534460|NCT00807443|Raltegravir Potassium|raltegravir potassium|mesh-list
6534461|NCT00807443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6534462|NCT00807443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6534463|NCT00807443|Antiviral Agents|antiviral agents|mesh-ancestor
6534464|NCT00807443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6534465|NCT00807443|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6534466|NCT00807443|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6534467|NCT00807443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6534468|NCT00807443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534469|NCT00807521|Dexamethasone|dexamethasone|mesh-list
6534470|NCT00807521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6534471|NCT00807521|Antiemetics|antiemetics|mesh-ancestor
6534472|NCT00807521|Autonomic Agents|autonomic agents|mesh-ancestor
6534473|NCT00807521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6534474|NCT00807521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798051|NCT02270749|Hematinics|hematinics|mesh-ancestor
6798052|NCT02270788|Leucovorin|leucovorin|mesh-list
6798053|NCT02270788|Cytarabine|cytarabine|mesh-list
6798054|NCT02270788|Hydrocortisone|hydrocortisone|mesh-list
6798055|NCT02270788|Methotrexate|methotrexate|mesh-list
6798056|NCT02270788|Sorafenib|sorafenib|mesh-list
6798057|NCT02270788|Crenolanib|crenolanib|mesh-list
6798058|NCT02270788|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6798059|NCT02270788|Abortifacient Agents|abortifacient agents|mesh-ancestor
6798060|NCT02270788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6798061|NCT02270788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798062|NCT02270788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6798063|NCT02270788|Antimetabolites|antimetabolites|mesh-ancestor
6798064|NCT02270788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6798065|NCT02270788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6798066|NCT02270788|Dermatologic Agents|dermatologic agents|mesh-ancestor
6798067|NCT02270788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6798068|NCT02270788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6798069|NCT02270788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6798070|NCT02270788|Immunologic Factors|immunologic factors|mesh-ancestor
6798071|NCT02270788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6798072|NCT02270788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6798073|NCT02270788|Antiviral Agents|antiviral agents|mesh-ancestor
6798074|NCT02270788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6798075|NCT02270788|Antidotes|antidotes|mesh-ancestor
6798076|NCT02270788|Protective Agents|protective agents|mesh-ancestor
6798077|NCT02270788|Vitamin B Complex|vitamin b complex|mesh-ancestor
6798078|NCT02270788|Vitamins|vitamins|mesh-ancestor
6798079|NCT02270788|Micronutrients|micronutrients|mesh-ancestor
6798080|NCT02270788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6798081|NCT02270788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6798082|NCT02270827|Hydrocortisone|hydrocortisone|mesh-list
6798083|NCT02270827|Aminophylline|aminophylline|mesh-list
6798084|NCT02270827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6798085|NCT02270827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6798086|NCT02270827|Autonomic Agents|autonomic agents|mesh-ancestor
6798087|NCT02270827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6798088|NCT02270827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798089|NCT02270827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6798090|NCT02270827|Respiratory System Agents|respiratory system agents|mesh-ancestor
6798091|NCT02270827|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6798092|NCT02270827|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6798093|NCT02270827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6798094|NCT02270827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6798095|NCT02270827|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6798096|NCT02270827|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6798097|NCT02270827|Purinergic Agents|purinergic agents|mesh-ancestor
6798098|NCT02270827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6798099|NCT02270827|Protective Agents|protective agents|mesh-ancestor
6798100|NCT02270918|Apixaban|apixaban|mesh-list
6798101|NCT02270918|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6798102|NCT02270918|Antithrombins|antithrombins|mesh-ancestor
6534475|NCT00807521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6798103|NCT02270918|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6798104|NCT02270918|Protease Inhibitors|protease inhibitors|mesh-ancestor
6798105|NCT02270918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6534476|NCT00807521|Glucocorticoids|glucocorticoids|mesh-ancestor
6534477|NCT00807521|Hormones|hormones|mesh-ancestor
6534478|NCT00807521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6534479|NCT00807521|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6534480|NCT00807521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6534481|NCT00807534|Bromides|bromides|mesh-list
6534482|NCT00807534|Ipratropium|ipratropium|mesh-list
6534483|NCT00807534|Anticonvulsants|anticonvulsants|mesh-ancestor
6534484|NCT00807534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6534485|NCT00807534|Autonomic Agents|autonomic agents|mesh-ancestor
6534486|NCT00807534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6534487|NCT00807534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534488|NCT00807534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6534489|NCT00807534|Respiratory System Agents|respiratory system agents|mesh-ancestor
6534490|NCT00807534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6534491|NCT00807534|Cholinergic Agents|cholinergic agents|mesh-ancestor
6534492|NCT00807534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6534493|NCT00807534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534494|NCT00807547|Vaccines|vaccines|mesh-list
6534495|NCT00807547|Immunologic Factors|immunologic factors|mesh-ancestor
6534496|NCT00807547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534497|NCT00807625|Copper|copper|mesh-list
6534498|NCT00807625|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6534499|NCT00807625|Medroxyprogesterone|medroxyprogesterone|mesh-list
6534500|NCT00807625|Trace Elements|trace elements|mesh-ancestor
6534501|NCT00807625|Micronutrients|micronutrients|mesh-ancestor
6534502|NCT00807625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534503|NCT00807625|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6534504|NCT00807625|Contraceptive Agents|contraceptive agents|mesh-ancestor
6534505|NCT00807625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6534506|NCT00807625|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6534507|NCT00807625|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6534508|NCT00807625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6534509|NCT00807625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6534510|NCT00807625|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6534511|NCT00807625|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6534512|NCT00807625|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6534513|NCT00807690|Tacrolimus|tacrolimus|mesh-list
6534514|NCT00807690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6534515|NCT00807690|Immunologic Factors|immunologic factors|mesh-ancestor
6534516|NCT00807690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534517|NCT00807690|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6534518|NCT00807690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6534519|NCT00807690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534520|NCT00807755|Carboplatin|carboplatin|mesh-list
6534521|NCT00807755|Etoposide|etoposide|mesh-list
6534522|NCT00807755|Everolimus|everolimus|mesh-list
6534523|NCT00807755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6534524|NCT00807755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6534525|NCT00807755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6534526|NCT00807755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6534527|NCT00807755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6534528|NCT00807755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534529|NCT00807755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6534530|NCT00807755|Immunologic Factors|immunologic factors|mesh-ancestor
6534531|NCT00807755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534532|NCT00807807|Folic Acid|folic acid|mesh-list
6534533|NCT00807807|Vitamin B Complex|vitamin b complex|mesh-list
6534534|NCT00807807|Hematinics|hematinics|mesh-ancestor
6534535|NCT00807807|Vitamins|vitamins|mesh-ancestor
6534536|NCT00807807|Micronutrients|micronutrients|mesh-ancestor
6534537|NCT00807807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798106|NCT02270918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6798107|NCT02270918|Anticoagulants|anticoagulants|mesh-ancestor
6798108|NCT02270970|Belimumab|belimumab|mesh-list
6798109|NCT02270970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6798110|NCT02270970|Immunologic Factors|immunologic factors|mesh-ancestor
6798111|NCT02270970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798112|NCT02270996|Anti-Infective Agents|anti-infective agents|mesh-list
6798113|NCT02270996|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6798114|NCT02271035|Hyaluronic Acid|hyaluronic acid|mesh-list
6798115|NCT02271035|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6798116|NCT02271035|Immunologic Factors|immunologic factors|mesh-ancestor
6798117|NCT02271035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534538|NCT00807859|Paclitaxel|paclitaxel|mesh-list
6798118|NCT02271035|Viscosupplements|viscosupplements|mesh-ancestor
6798119|NCT02271035|Protective Agents|protective agents|mesh-ancestor
6534539|NCT00807859|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6534540|NCT00807859|Capecitabine|capecitabine|mesh-list
6534541|NCT00807859|Trastuzumab|trastuzumab|mesh-list
6534542|NCT00807859|Lapatinib|lapatinib|mesh-list
6534543|NCT00807859|Trebananib|trebananib|mesh-list
6534544|NCT00807859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6534545|NCT00807859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6534546|NCT00807859|Tubulin Modulators|tubulin modulators|mesh-ancestor
6534547|NCT00807859|Antimitotic Agents|antimitotic agents|mesh-ancestor
6534548|NCT00807859|Mitosis Modulators|mitosis modulators|mesh-ancestor
6534549|NCT00807859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534550|NCT00807859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6534551|NCT00807859|Antimetabolites|antimetabolites|mesh-ancestor
6534552|NCT00807859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6534553|NCT00807859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6534554|NCT00807859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6534555|NCT00807859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6534556|NCT00807859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6534557|NCT00807859|Growth Substances|growth substances|mesh-ancestor
6534558|NCT00807859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534559|NCT00807859|Growth Inhibitors|growth inhibitors|mesh-ancestor
6534560|NCT00807872|Antibodies|antibodies|mesh-list
6534561|NCT00807872|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6534562|NCT00807872|Immunologic Factors|immunologic factors|mesh-ancestor
6534563|NCT00807872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534564|NCT00807950|Simvastatin|simvastatin|mesh-list
6534565|NCT00807950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6534566|NCT00807950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6534567|NCT00807950|Antimetabolites|antimetabolites|mesh-ancestor
6534568|NCT00807950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534569|NCT00807950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6534570|NCT00807950|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6534571|NCT00807950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6534572|NCT00807963|Zoledronic Acid|zoledronic acid|mesh-list
6534573|NCT00807963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6534574|NCT00807963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534575|NCT00808002|Tenofovir|tenofovir|mesh-list
6534576|NCT00808002|Emtricitabine|emtricitabine|mesh-list
6534577|NCT00808002|Raltegravir Potassium|raltegravir potassium|mesh-list
6534578|NCT00808002|Maraviroc|maraviroc|mesh-list
6534579|NCT00808002|Antiviral Agents|antiviral agents|mesh-ancestor
6534580|NCT00808002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6534581|NCT00808002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6534582|NCT00808002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6534583|NCT00808002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6534584|NCT00808002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534585|NCT00808002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6534586|NCT00808002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6534587|NCT00808002|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6534588|NCT00808002|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6534589|NCT00808002|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6534590|NCT00808002|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6534591|NCT00808002|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6534592|NCT00808054|Lidocaine|lidocaine|mesh-list
6534593|NCT00808054|Prilocaine|prilocaine|mesh-list
6534594|NCT00808054|Anesthetics, Local|anesthetics, local|mesh-ancestor
6534595|NCT00808054|Anesthetics|anesthetics|mesh-ancestor
6534596|NCT00808054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6534597|NCT00808054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534598|NCT00808054|Sensory System Agents|sensory system agents|mesh-ancestor
6534599|NCT00808054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6534600|NCT00808054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6534601|NCT00808054|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6534602|NCT00808054|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6534603|NCT00808054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6534604|NCT00808054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534605|NCT00808145|Gemcitabine|gemcitabine|mesh-list
6534606|NCT00808145|Cisplatin|cisplatin|mesh-list
6534607|NCT00808145|Sorafenib|sorafenib|mesh-list
6534608|NCT00808145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6534609|NCT00808145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6534610|NCT00808145|Antimetabolites|antimetabolites|mesh-ancestor
6534611|NCT00808145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534612|NCT00808145|Antiviral Agents|antiviral agents|mesh-ancestor
6534613|NCT00808145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6534614|NCT00808145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6534615|NCT00808145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6534616|NCT00808145|Immunologic Factors|immunologic factors|mesh-ancestor
6534617|NCT00808145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534618|NCT00808145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6534619|NCT00808171|Lidocaine|lidocaine|mesh-list
6534620|NCT00808171|Nitrous Oxide|nitrous oxide|mesh-list
6534621|NCT00808171|Anesthetics, Local|anesthetics, local|mesh-list
6534622|NCT00808171|Prilocaine|prilocaine|mesh-list
6534623|NCT00808171|Anesthetics|anesthetics|mesh-list
6534624|NCT00808171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6534625|NCT00808171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534626|NCT00808171|Sensory System Agents|sensory system agents|mesh-ancestor
6534627|NCT00808171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6534628|NCT00808171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6534629|NCT00808171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6534630|NCT00808171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6534631|NCT00808171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6534632|NCT00808171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534633|NCT00808171|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6798120|NCT02271113|Enoxaparin|enoxaparin|mesh-list
6798121|NCT02271113|Enoxaparin sodium|enoxaparin sodium|mesh-list
6798122|NCT02271113|Anticoagulants|anticoagulants|mesh-ancestor
6798123|NCT02271113|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6798124|NCT02271113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6798125|NCT02271113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6798126|NCT02271126|Heparin|heparin|mesh-list
6798127|NCT02271126|Thromboplastin|thromboplastin|mesh-list
6798128|NCT02271126|Anticoagulants|anticoagulants|mesh-ancestor
6798129|NCT02271126|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6798130|NCT02271126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6798131|NCT02271126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6798132|NCT02271126|Hemostatics|hemostatics|mesh-ancestor
6798133|NCT02271126|Coagulants|coagulants|mesh-ancestor
6798134|NCT02271165|Immunoglobulins|immunoglobulins|mesh-list
6798135|NCT02271165|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6798136|NCT02271165|Antibodies|antibodies|mesh-list
6798137|NCT02271165|Immunologic Factors|immunologic factors|mesh-ancestor
6798138|NCT02271165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798139|NCT02271191|Nicardipine|nicardipine|mesh-list
6798140|NCT02271191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6798141|NCT02271191|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6798142|NCT02271191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6798143|NCT02271191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6798144|NCT02271191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6798145|NCT02271191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798146|NCT02271191|Vasodilator Agents|vasodilator agents|mesh-ancestor
6798147|NCT02271204|Ibandronic Acid|ibandronic acid|mesh-list
6798148|NCT02271204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6798149|NCT02271204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798150|NCT02271230|Vitamin D|vitamin d|mesh-list
6798151|NCT02271230|Ergocalciferols|ergocalciferols|mesh-list
6798152|NCT02271230|Vitamins|vitamins|mesh-list
6798153|NCT02271230|Micronutrients|micronutrients|mesh-ancestor
6798154|NCT02271230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798155|NCT02271230|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6798156|NCT02271230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6798157|NCT02271282|Toremifene|toremifene|mesh-list
6798158|NCT02271282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6798159|NCT02271282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6798160|NCT02271282|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6798161|NCT02271282|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6798162|NCT02271282|Hormone Antagonists|hormone antagonists|mesh-ancestor
6798163|NCT02271282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6798164|NCT02271282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798165|NCT02271282|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6798166|NCT02271295|Enoxaparin|enoxaparin|mesh-list
6798167|NCT02271295|Anticoagulants|anticoagulants|mesh-ancestor
6798168|NCT02271295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6798169|NCT02271295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6798170|NCT02271295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724139|NCT03189186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6534634|NCT00808171|Anesthetics, General|anesthetics, general|mesh-ancestor
6534635|NCT00808171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6534636|NCT00808171|Analgesics|analgesics|mesh-ancestor
6534637|NCT00808184|Raltegravir Potassium|raltegravir potassium|mesh-list
6534638|NCT00808184|Midazolam|midazolam|mesh-list
6534639|NCT00808184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6534640|NCT00808184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6534641|NCT00808184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6534642|NCT00808184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534643|NCT00808184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6534644|NCT00808184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6534645|NCT00808184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6534646|NCT00808184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6534647|NCT00808184|Anesthetics, General|anesthetics, general|mesh-ancestor
6534648|NCT00808184|Anesthetics|anesthetics|mesh-ancestor
6534649|NCT00808184|GABA Modulators|gaba modulators|mesh-ancestor
6534650|NCT00808184|GABA Agents|gaba agents|mesh-ancestor
6534651|NCT00808184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6534652|NCT00808184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534653|NCT00808184|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6534654|NCT00808184|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6534655|NCT00808184|Antiviral Agents|antiviral agents|mesh-ancestor
6534656|NCT00808184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6534657|NCT00808184|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6534658|NCT00808184|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6534659|NCT00808184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6534660|NCT00808223|Alefacept|alefacept|mesh-list
6534661|NCT00808223|Dermatologic Agents|dermatologic agents|mesh-ancestor
6534662|NCT00808223|Immunologic Factors|immunologic factors|mesh-ancestor
6534663|NCT00808223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534664|NCT00808275|Calcium, Dietary|calcium, dietary|mesh-list
6534665|NCT00808275|Calcium|calcium|mesh-list
6534666|NCT00808275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6534667|NCT00808275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534668|NCT00808275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6534669|NCT00808314|Dipyridamole|dipyridamole|mesh-list
6534670|NCT00808314|Regadenoson|regadenoson|mesh-list
6534671|NCT00808314|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6534672|NCT00808314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6534673|NCT00808314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534674|NCT00808314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6534675|NCT00808314|Vasodilator Agents|vasodilator agents|mesh-ancestor
6534676|NCT00808314|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
6534677|NCT00808314|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6534678|NCT00808314|Purinergic Agonists|purinergic agonists|mesh-ancestor
6534679|NCT00808314|Purinergic Agents|purinergic agents|mesh-ancestor
6534680|NCT00808314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6534681|NCT00808314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534682|NCT00808327|Fentanyl|fentanyl|mesh-list
6534683|NCT00808327|Bupivacaine|bupivacaine|mesh-list
6534684|NCT00808327|Anesthetics, Local|anesthetics, local|mesh-ancestor
6534685|NCT00808327|Anesthetics|anesthetics|mesh-ancestor
6534686|NCT00808327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6534687|NCT00808327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534688|NCT00808327|Sensory System Agents|sensory system agents|mesh-ancestor
6534689|NCT00808327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6534690|NCT00808327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6534691|NCT00808327|Narcotics|narcotics|mesh-ancestor
6534692|NCT00808327|Analgesics|analgesics|mesh-ancestor
6534693|NCT00808327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6534694|NCT00808327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6534695|NCT00808327|Anesthetics, General|anesthetics, general|mesh-ancestor
6534696|NCT00808366|Antifungal Agents|antifungal agents|mesh-list
6534697|NCT00808366|Clotrimazole|clotrimazole|mesh-list
6534698|NCT00808366|Miconazole|miconazole|mesh-list
6534699|NCT00808366|Keratolytic Agents|keratolytic agents|mesh-list
6534700|NCT00808366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6534701|NCT00808366|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6534702|NCT00808366|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6534703|NCT00808366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6534704|NCT00808366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6534705|NCT00808366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534706|NCT00808366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6534707|NCT00808366|Hormone Antagonists|hormone antagonists|mesh-ancestor
6534708|NCT00808366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6534709|NCT00808366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534710|NCT00808366|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6534711|NCT00808366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6534712|NCT00808366|Dermatologic Agents|dermatologic agents|mesh-ancestor
6534713|NCT00808392|Vaccines|vaccines|mesh-list
6534714|NCT00808392|Immunologic Factors|immunologic factors|mesh-ancestor
6534715|NCT00808392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534716|NCT00808418|Docetaxel|docetaxel|mesh-list
6534717|NCT00808418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6534718|NCT00808418|Tubulin Modulators|tubulin modulators|mesh-ancestor
6534719|NCT00808418|Antimitotic Agents|antimitotic agents|mesh-ancestor
6534720|NCT00808418|Mitosis Modulators|mitosis modulators|mesh-ancestor
6534721|NCT00808418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534722|NCT00808678|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6534723|NCT00808678|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6534724|NCT00808678|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6534725|NCT00808678|Antimetabolites|antimetabolites|mesh-ancestor
6534726|NCT00808678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534727|NCT00808678|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6534728|NCT00808678|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6534729|NCT00808678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6534730|NCT00808704|Epoetin Alfa|epoetin alfa|mesh-list
6534731|NCT00808704|Hematinics|hematinics|mesh-ancestor
6534732|NCT00808717|Atorvastatin|atorvastatin|mesh-list
6534733|NCT00808717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6534734|NCT00808717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6534735|NCT00808717|Antimetabolites|antimetabolites|mesh-ancestor
6534736|NCT00808717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534737|NCT00808717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6534738|NCT00808717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6534739|NCT00808717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6534740|NCT00808743|Celecoxib|celecoxib|mesh-list
6534741|NCT00808743|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
6534742|NCT00808743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6534743|NCT00808743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6534744|NCT00808743|Analgesics|analgesics|mesh-ancestor
6534745|NCT00808743|Sensory System Agents|sensory system agents|mesh-ancestor
6534746|NCT00808743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6534747|NCT00808743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534748|NCT00808743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6534749|NCT00808743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6534750|NCT00808743|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6534751|NCT00808743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6534752|NCT00808743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6534753|NCT00808743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534754|NCT00808743|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6534755|NCT00808743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6534756|NCT00808795|Acetylcysteine|acetylcysteine|mesh-list
6798171|NCT02271347|Brincidofovir|brincidofovir|mesh-list
6798172|NCT02271347|Antiviral Agents|antiviral agents|mesh-ancestor
6798173|NCT02271347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6798174|NCT02271360|Cabergoline|cabergoline|mesh-list
6798175|NCT02271360|Calcium Dobesilate|calcium dobesilate|mesh-list
6798176|NCT02271360|Calcium|calcium|mesh-list
6798177|NCT02271360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6798178|NCT02271360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798179|NCT02271360|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6798180|NCT02271360|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6798181|NCT02271360|Dopamine Agonists|dopamine agonists|mesh-ancestor
6798182|NCT02271360|Dopamine Agents|dopamine agents|mesh-ancestor
6798183|NCT02271360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6798184|NCT02271360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6798185|NCT02271360|Hemostatics|hemostatics|mesh-ancestor
6798186|NCT02271360|Coagulants|coagulants|mesh-ancestor
6798187|NCT02271399|Aspirin|aspirin|mesh-list
6798188|NCT02271399|Rivaroxaban|rivaroxaban|mesh-list
6798189|NCT02271399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6798190|NCT02271399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6798191|NCT02271399|Analgesics|analgesics|mesh-ancestor
6798192|NCT02271399|Sensory System Agents|sensory system agents|mesh-ancestor
6798193|NCT02271399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6798194|NCT02271399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798195|NCT02271399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6798196|NCT02271399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6798197|NCT02271399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6798198|NCT02271399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6534757|NCT00808795|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6534758|NCT00808795|Antiviral Agents|antiviral agents|mesh-ancestor
6534759|NCT00808795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6534760|NCT00808795|Expectorants|expectorants|mesh-ancestor
6534761|NCT00808795|Respiratory System Agents|respiratory system agents|mesh-ancestor
6534762|NCT00808795|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6534763|NCT00808795|Antioxidants|antioxidants|mesh-ancestor
6534764|NCT00808795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534765|NCT00808795|Protective Agents|protective agents|mesh-ancestor
6534766|NCT00808795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534767|NCT00808795|Antidotes|antidotes|mesh-ancestor
6534768|NCT00808912|Sildenafil Citrate|sildenafil citrate|mesh-list
6534769|NCT00808912|Vasodilator Agents|vasodilator agents|mesh-ancestor
6534770|NCT00808912|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6534771|NCT00808912|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6534772|NCT00808912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6534773|NCT00808912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534774|NCT00808912|Urological Agents|urological agents|mesh-ancestor
6534775|NCT00808951|Artesunate|artesunate|mesh-list
6534776|NCT00808951|Lumefantrine|lumefantrine|mesh-list
6534777|NCT00808951|Artemether|artemether|mesh-list
6534778|NCT00808951|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6534779|NCT00808951|Amodiaquine|amodiaquine|mesh-list
6534780|NCT00808951|Antimalarials|antimalarials|mesh-ancestor
6534781|NCT00808951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6534782|NCT00808951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6534783|NCT00808951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6534784|NCT00808951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6534785|NCT00808951|Antiviral Agents|antiviral agents|mesh-ancestor
6534786|NCT00808951|Schistosomicides|schistosomicides|mesh-ancestor
6534787|NCT00808951|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6798199|NCT02271399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6798200|NCT02271399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6798201|NCT02271399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6798202|NCT02271399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6798203|NCT02271399|Antipyretics|antipyretics|mesh-ancestor
6798204|NCT02271399|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6798205|NCT02271399|Antithrombins|antithrombins|mesh-ancestor
6798206|NCT02271399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6798207|NCT02271399|Protease Inhibitors|protease inhibitors|mesh-ancestor
6798208|NCT02271399|Anticoagulants|anticoagulants|mesh-ancestor
6798209|NCT02271412|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6798210|NCT02271412|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6798211|NCT02271412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6798212|NCT02271412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6798213|NCT02271412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6798214|NCT02271412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6798215|NCT02271412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798216|NCT02271412|Antidepressive Agents|antidepressive agents|mesh-ancestor
6798217|NCT02271412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6798218|NCT02271438|Moxifloxacin|moxifloxacin|mesh-list
6798219|NCT02271438|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6798220|NCT02271438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6798221|NCT02271438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6798222|NCT02271438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6798223|NCT02271438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6798224|NCT02271438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6798225|NCT02271438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6798226|NCT02271438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6798227|NCT02271438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6798228|NCT02271438|Contraceptive Agents|contraceptive agents|mesh-ancestor
6798229|NCT02271438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6798230|NCT02271438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798231|NCT02271438|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6798232|NCT02271438|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6798233|NCT02271438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6798234|NCT02271464|Cyclophosphamide|cyclophosphamide|mesh-list
6798235|NCT02271464|Bevacizumab|bevacizumab|mesh-list
6798236|NCT02271464|Capecitabine|capecitabine|mesh-list
6798237|NCT02271464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6798238|NCT02271464|Immunologic Factors|immunologic factors|mesh-ancestor
6798239|NCT02271464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798240|NCT02271464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6534788|NCT00808951|Anthelmintics|anthelmintics|mesh-ancestor
6534789|NCT00808977|Mesalamine|mesalamine|mesh-list
6534790|NCT00808977|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6534791|NCT00808977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6534792|NCT00808977|Analgesics|analgesics|mesh-ancestor
6534793|NCT00808977|Sensory System Agents|sensory system agents|mesh-ancestor
6534794|NCT00808977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6534795|NCT00808977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534796|NCT00808977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6534797|NCT00808977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6534798|NCT00809016|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6534799|NCT00809016|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6534800|NCT00809016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534801|NCT00809029|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
6534802|NCT00809029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6534803|NCT00809029|Incretins|incretins|mesh-ancestor
6534804|NCT00809029|Hormones|hormones|mesh-ancestor
6534805|NCT00809029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6534806|NCT00809029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534807|NCT00809042|Hydroxyurea|hydroxyurea|mesh-list
6534808|NCT00809042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6534809|NCT00809042|Antisickling Agents|antisickling agents|mesh-ancestor
6534810|NCT00809042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6534811|NCT00809042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534812|NCT00809042|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6534813|NCT00809068|Tibolone|tibolone|mesh-list
6534814|NCT00809068|Fenofibrate|fenofibrate|mesh-list
6534815|NCT00809068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6534816|NCT00809068|Antimetabolites|antimetabolites|mesh-ancestor
6534817|NCT00809068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534818|NCT00809068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6534819|NCT00809068|Androgen Antagonists|androgen antagonists|mesh-ancestor
6534820|NCT00809068|Hormone Antagonists|hormone antagonists|mesh-ancestor
6534821|NCT00809068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6534822|NCT00809068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534823|NCT00809068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6534824|NCT00809068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6534825|NCT00809068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6534826|NCT00809068|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6534827|NCT00809068|Anabolic Agents|anabolic agents|mesh-ancestor
6534828|NCT00809068|Hormones|hormones|mesh-ancestor
6534829|NCT00809107|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6534830|NCT00809107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6534831|NCT00809107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534832|NCT00809172|Cyclosporine|cyclosporine|mesh-list
6534833|NCT00809172|Methotrexate|methotrexate|mesh-list
6534834|NCT00809172|Cyclosporins|cyclosporins|mesh-list
6534835|NCT00809172|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6534836|NCT00809172|Abortifacient Agents|abortifacient agents|mesh-ancestor
6534837|NCT00809172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6534838|NCT00809172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534839|NCT00809172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6534840|NCT00809172|Antimetabolites|antimetabolites|mesh-ancestor
6534841|NCT00809172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534842|NCT00809172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6534843|NCT00809172|Dermatologic Agents|dermatologic agents|mesh-ancestor
6534844|NCT00809172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6534845|NCT00809172|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6534846|NCT00809172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6534847|NCT00809172|Immunologic Factors|immunologic factors|mesh-ancestor
6798241|NCT02271464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6798242|NCT02271464|Alkylating Agents|alkylating agents|mesh-ancestor
6798243|NCT02271464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6798244|NCT02271464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6798245|NCT02271464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6798246|NCT02271464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6798247|NCT02271464|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6798248|NCT02271464|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6798249|NCT02271464|Growth Substances|growth substances|mesh-ancestor
6798250|NCT02271464|Growth Inhibitors|growth inhibitors|mesh-ancestor
6798251|NCT02271464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6798252|NCT02271464|Antimetabolites|antimetabolites|mesh-ancestor
6798253|NCT02271542|Propofol|propofol|mesh-list
6798254|NCT02271542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6534848|NCT00809172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6534849|NCT00809172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6534850|NCT00809172|Antifungal Agents|antifungal agents|mesh-ancestor
6534851|NCT00809172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6534852|NCT00809172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6537907|NCT00825019|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6537908|NCT00825019|Antidepressive Agents|antidepressive agents|mesh-ancestor
6537909|NCT00825019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6537910|NCT00825019|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6537911|NCT00825019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6537912|NCT00825019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6537913|NCT00825019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6537914|NCT00825019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6537915|NCT00825019|Adrenergic Agents|adrenergic agents|mesh-ancestor
6537916|NCT00825045|Risperidone|risperidone|mesh-list
6537917|NCT00825045|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6537918|NCT00825045|Serotonin Agents|serotonin agents|mesh-ancestor
6537919|NCT00825045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6537920|NCT00825045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537921|NCT00825045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537922|NCT00825045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6537923|NCT00825045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6798255|NCT02271542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6798256|NCT02271542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798257|NCT02271542|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6798258|NCT02271542|Anesthetics, General|anesthetics, general|mesh-ancestor
6798259|NCT02271542|Anesthetics|anesthetics|mesh-ancestor
6798260|NCT02271555|Remifentanil|remifentanil|mesh-list
6798261|NCT02271555|Sevoflurane|sevoflurane|mesh-list
6798262|NCT02271555|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6798263|NCT02271555|Narcotics|narcotics|mesh-ancestor
6798264|NCT02271555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6798265|NCT02271555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798266|NCT02271555|Analgesics|analgesics|mesh-ancestor
6798267|NCT02271555|Sensory System Agents|sensory system agents|mesh-ancestor
6798268|NCT02271555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6798269|NCT02271555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6798270|NCT02271555|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6798271|NCT02271555|Anesthetics, General|anesthetics, general|mesh-ancestor
6798272|NCT02271555|Anesthetics|anesthetics|mesh-ancestor
6798273|NCT02271646|Bupivacaine|bupivacaine|mesh-list
6798274|NCT02271646|Anesthetics, Local|anesthetics, local|mesh-ancestor
6798275|NCT02271646|Anesthetics|anesthetics|mesh-ancestor
6798276|NCT02271646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6798277|NCT02271646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798278|NCT02271646|Sensory System Agents|sensory system agents|mesh-ancestor
6798279|NCT02271646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6798280|NCT02271802|Butyric Acid|butyric acid|mesh-list
6798281|NCT02271802|Histamine Antagonists|histamine antagonists|mesh-ancestor
6798282|NCT02271802|Histamine Agents|histamine agents|mesh-ancestor
6798283|NCT02271802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6798284|NCT02271802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6798285|NCT02271802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798286|NCT02271893|Dextromethorphan|dextromethorphan|mesh-list
6798287|NCT02271893|Antitussive Agents|antitussive agents|mesh-ancestor
6798288|NCT02271893|Respiratory System Agents|respiratory system agents|mesh-ancestor
6798289|NCT02271893|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6798290|NCT02271893|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6798291|NCT02271893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6798292|NCT02271893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6798293|NCT02271893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798294|NCT02271958|Mifepristone|mifepristone|mesh-list
6798295|NCT02271958|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6798296|NCT02271958|Abortifacient Agents|abortifacient agents|mesh-ancestor
6798297|NCT02271958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6798298|NCT02271958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798299|NCT02271958|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6798300|NCT02271958|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6798301|NCT02271958|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6798302|NCT02271958|Contraceptive Agents|contraceptive agents|mesh-ancestor
6798303|NCT02271958|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6798304|NCT02271958|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6798305|NCT02271958|Hormone Antagonists|hormone antagonists|mesh-ancestor
6798306|NCT02271958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6534853|NCT00809198|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6534854|NCT00809198|Hyaluronic Acid|hyaluronic acid|mesh-list
6534855|NCT00809198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6534856|NCT00809198|Immunologic Factors|immunologic factors|mesh-ancestor
6534857|NCT00809198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534858|NCT00809198|Viscosupplements|viscosupplements|mesh-ancestor
6534859|NCT00809198|Protective Agents|protective agents|mesh-ancestor
6534860|NCT00809198|Laxatives|laxatives|mesh-ancestor
6534861|NCT00809198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6534862|NCT00809237|Hydroxychloroquine|hydroxychloroquine|mesh-list
6534863|NCT00809237|Gefitinib|gefitinib|mesh-list
6534864|NCT00809237|Antimalarials|antimalarials|mesh-ancestor
6534865|NCT00809237|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6534866|NCT00809237|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6534867|NCT00809237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6534868|NCT00809237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6534869|NCT00809237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534870|NCT00809237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6534871|NCT00809237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6534872|NCT00809237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6534873|NCT00809289|Moxifloxacin|moxifloxacin|mesh-list
6534874|NCT00809289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6534875|NCT00809289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6534876|NCT00809289|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6534877|NCT00809289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6534878|NCT00809289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6534879|NCT00809289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534880|NCT00809289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6534881|NCT00809393|Tranexamic Acid|tranexamic acid|mesh-list
6534882|NCT00809393|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6534883|NCT00809393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6534884|NCT00809393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534885|NCT00809393|Hemostatics|hemostatics|mesh-ancestor
6534886|NCT00809393|Coagulants|coagulants|mesh-ancestor
6534887|NCT00809536|Metformin|metformin|mesh-list
6534888|NCT00809536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6534889|NCT00809536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534890|NCT00809549|Lenograstim|lenograstim|mesh-list
6534891|NCT00809549|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6534892|NCT00809549|Immunologic Factors|immunologic factors|mesh-ancestor
6534893|NCT00809549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534894|NCT00809627|Caffeine|caffeine|mesh-list
6534895|NCT00809627|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6534896|NCT00809627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534897|NCT00809627|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6534898|NCT00809627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6534899|NCT00809627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534900|NCT00809627|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6534901|NCT00809627|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6534902|NCT00809627|Purinergic Agents|purinergic agents|mesh-ancestor
6534903|NCT00809627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6534904|NCT00809692|Histamine|histamine|mesh-list
6534905|NCT00809692|Histamine phosphate|histamine phosphate|mesh-list
6798307|NCT02271958|Luteolytic Agents|luteolytic agents|mesh-ancestor
6798308|NCT02271958|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6798309|NCT02271958|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6798310|NCT02271971|Vitamin D|vitamin d|mesh-list
6798311|NCT02271971|Cholecalciferol|cholecalciferol|mesh-list
6798312|NCT02271971|Vitamins|vitamins|mesh-ancestor
6798313|NCT02271971|Micronutrients|micronutrients|mesh-ancestor
6798314|NCT02271971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798315|NCT02271971|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6798316|NCT02271971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6798317|NCT02271997|Ferrous fumarate|ferrous fumarate|mesh-list
6798318|NCT02271997|Ferrous gluconate|ferrous gluconate|mesh-list
6798319|NCT02271997|Trace Elements|trace elements|mesh-ancestor
6798320|NCT02271997|Micronutrients|micronutrients|mesh-ancestor
6798321|NCT02271997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798322|NCT02271997|Hematinics|hematinics|mesh-ancestor
6798323|NCT02272049|Xenon|xenon|mesh-list
6798324|NCT02272049|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6798325|NCT02272049|Anesthetics, General|anesthetics, general|mesh-ancestor
6798326|NCT02272049|Anesthetics|anesthetics|mesh-ancestor
6798327|NCT02272049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6534906|NCT00809692|Histamine Agonists|histamine agonists|mesh-ancestor
6534907|NCT00809692|Histamine Agents|histamine agents|mesh-ancestor
6534908|NCT00809692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6534909|NCT00809692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534910|NCT00809692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534911|NCT00809705|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6534912|NCT00809705|Incretins|incretins|mesh-ancestor
6534913|NCT00809705|Hormones|hormones|mesh-ancestor
6534914|NCT00809705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6534915|NCT00809705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534916|NCT00809718|Raltegravir Potassium|raltegravir potassium|mesh-list
6534917|NCT00809718|Rifapentine|rifapentine|mesh-list
6534918|NCT00809718|Rifampin|rifampin|mesh-list
6534919|NCT00809718|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6534920|NCT00809718|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6534921|NCT00809718|Antiviral Agents|antiviral agents|mesh-ancestor
6534922|NCT00809718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6534923|NCT00809718|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6534924|NCT00809718|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6534925|NCT00809718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6534926|NCT00809718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534927|NCT00809718|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6534928|NCT00809718|Antitubercular Agents|antitubercular agents|mesh-ancestor
6534929|NCT00809718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6534930|NCT00809718|Leprostatic Agents|leprostatic agents|mesh-ancestor
6534931|NCT00809718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6534932|NCT00809718|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6534933|NCT00809718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6534934|NCT00809718|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6534935|NCT00809718|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6534936|NCT00809718|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6534937|NCT00809718|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6534938|NCT00809744|Cholecalciferol|cholecalciferol|mesh-list
6534939|NCT00809744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6534940|NCT00809744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534941|NCT00809744|Vitamins|vitamins|mesh-ancestor
6534942|NCT00809744|Micronutrients|micronutrients|mesh-ancestor
6534943|NCT00809744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6534944|NCT00809796|Pentamidine|pentamidine|mesh-list
6534945|NCT00809796|Antifungal Agents|antifungal agents|mesh-ancestor
6534946|NCT00809796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6534947|NCT00809796|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6534948|NCT00809796|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6534949|NCT00809796|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6534950|NCT00809874|Caseins|caseins|mesh-list
6534951|NCT00809874|Chelating Agents|chelating agents|mesh-ancestor
6534952|NCT00809874|Sequestering Agents|sequestering agents|mesh-ancestor
6534953|NCT00809874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534954|NCT00809887|Micafungin|micafungin|mesh-list
6534955|NCT00809887|Antifungal Agents|antifungal agents|mesh-ancestor
6534956|NCT00809887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6534957|NCT00809913|Ciprofloxacin|ciprofloxacin|mesh-list
6534958|NCT00809913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6534959|NCT00809913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6534960|NCT00809913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6534961|NCT00809913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6534962|NCT00809913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6534963|NCT00809913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534964|NCT00809913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6534965|NCT00809913|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6534966|NCT00809913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6534967|NCT00809939|Progesterone|progesterone|mesh-list
6534968|NCT00809939|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
6798328|NCT02272049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798329|NCT02272101|Vitamin D|vitamin d|mesh-list
6798330|NCT02272101|Vitamins|vitamins|mesh-ancestor
6798331|NCT02272101|Micronutrients|micronutrients|mesh-ancestor
6798332|NCT02272101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798333|NCT02272101|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6798334|NCT02272166|Propofol|propofol|mesh-list
6798335|NCT02272166|Sevoflurane|sevoflurane|mesh-list
6798336|NCT02272166|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6798337|NCT02272166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6798338|NCT02272166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798339|NCT02272166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6534969|NCT00809939|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
6798340|NCT02272166|Anesthetics, General|anesthetics, general|mesh-ancestor
6798341|NCT02272166|Anesthetics|anesthetics|mesh-ancestor
6534970|NCT00809939|Progestins|progestins|mesh-ancestor
6534971|NCT00809939|Hormones|hormones|mesh-ancestor
6534972|NCT00809939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6534973|NCT00809939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534974|NCT00809939|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6534975|NCT00809939|Hormone Antagonists|hormone antagonists|mesh-ancestor
6534976|NCT00810017|Trastuzumab|trastuzumab|mesh-list
6534977|NCT00810017|Etoposide|etoposide|mesh-list
6534978|NCT00810017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6534979|NCT00810017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6534980|NCT00810017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6534981|NCT00810017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6534982|NCT00810017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6534983|NCT00810017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6534984|NCT00810017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534985|NCT00810030|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6534986|NCT00810030|Hematinics|hematinics|mesh-ancestor
6534987|NCT00810121|Ketoprofen|ketoprofen|mesh-list
6534988|NCT00810121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6534989|NCT00810121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6534990|NCT00810121|Analgesics|analgesics|mesh-ancestor
6534991|NCT00810121|Sensory System Agents|sensory system agents|mesh-ancestor
6534992|NCT00810121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6534993|NCT00810121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6534994|NCT00810121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6534995|NCT00810121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6534996|NCT00810121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6534997|NCT00810121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6534998|NCT00810121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6534999|NCT00810316|Clonazepam|clonazepam|mesh-list
6535000|NCT00810316|Alprazolam|alprazolam|mesh-list
6535001|NCT00810316|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6535002|NCT00810316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6535003|NCT00810316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535004|NCT00810316|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6535005|NCT00810316|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6535006|NCT00810316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6535007|NCT00810316|GABA Modulators|gaba modulators|mesh-ancestor
6535008|NCT00810316|GABA Agents|gaba agents|mesh-ancestor
6535009|NCT00810316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6535010|NCT00810316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535011|NCT00810316|Anticonvulsants|anticonvulsants|mesh-ancestor
6535012|NCT00810381|Nitroprusside|nitroprusside|mesh-list
6535013|NCT00810381|Isosorbide|isosorbide|mesh-list
6535014|NCT00810381|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
6535015|NCT00810381|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
6535016|NCT00810381|Nitroglycerin|nitroglycerin|mesh-list
6535017|NCT00810381|Vasodilator Agents|vasodilator agents|mesh-ancestor
6535018|NCT00810381|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6535019|NCT00810381|Diuretics|diuretics|mesh-ancestor
6535020|NCT00810381|Natriuretic Agents|natriuretic agents|mesh-ancestor
6535021|NCT00810381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535022|NCT00810381|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6535023|NCT00810381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535024|NCT00810381|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6535025|NCT00810446|Rifabutin|rifabutin|mesh-list
6535026|NCT00810446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6535027|NCT00810446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6535028|NCT00810446|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6535029|NCT00810446|Antitubercular Agents|antitubercular agents|mesh-ancestor
6535030|NCT00810524|Lamivudine|lamivudine|mesh-list
6535031|NCT00810524|Adefovir|adefovir|mesh-list
6535032|NCT00810524|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6535033|NCT00810524|Telbivudine|telbivudine|mesh-list
6535034|NCT00810524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6535035|NCT00810524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6535036|NCT00810524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6535037|NCT00810524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535038|NCT00810524|Antiviral Agents|antiviral agents|mesh-ancestor
6798342|NCT02272166|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6798343|NCT02272166|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6798344|NCT02272270|Minocycline|minocycline|mesh-list
6798345|NCT02272270|Temozolomide|temozolomide|mesh-list
6798346|NCT02272270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6798347|NCT02272270|Alkylating Agents|alkylating agents|mesh-ancestor
6535039|NCT00810524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6535040|NCT00810524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6535041|NCT00810524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6535042|NCT00810563|Bupivacaine|bupivacaine|mesh-list
6535043|NCT00810563|Anesthetics, Local|anesthetics, local|mesh-ancestor
6535044|NCT00810563|Anesthetics|anesthetics|mesh-ancestor
6535045|NCT00810563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6535046|NCT00810563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535047|NCT00810563|Sensory System Agents|sensory system agents|mesh-ancestor
6535048|NCT00810563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6535049|NCT00810589|Insulin|insulin|mesh-list
6535050|NCT00810589|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6535051|NCT00810589|Insulin Lispro|insulin lispro|mesh-list
6535052|NCT00810589|Insulin Detemir|insulin detemir|mesh-list
6535053|NCT00810589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6535054|NCT00810589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535055|NCT00810680|Valproic Acid|valproic acid|mesh-list
6535056|NCT00810680|Anticonvulsants|anticonvulsants|mesh-ancestor
6535057|NCT00810680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6535058|NCT00810680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535059|NCT00810680|GABA Agents|gaba agents|mesh-ancestor
6535060|NCT00810680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6535061|NCT00810680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535062|NCT00810680|Antimanic Agents|antimanic agents|mesh-ancestor
6535063|NCT00810680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6535064|NCT00810680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6535065|NCT00810680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6535066|NCT00810706|Exemestane|exemestane|mesh-list
6535067|NCT00810706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6535068|NCT00810706|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6535069|NCT00810706|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6535070|NCT00810706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6535071|NCT00810706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535072|NCT00810706|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6798348|NCT02272270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6798349|NCT02272270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6798350|NCT02272270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6798351|NCT02272270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6798352|NCT02272387|Vitamin D|vitamin d|mesh-list
6798353|NCT02272387|Cholecalciferol|cholecalciferol|mesh-list
6798354|NCT02272387|Vitamins|vitamins|mesh-ancestor
6798355|NCT02272387|Micronutrients|micronutrients|mesh-ancestor
6798356|NCT02272387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798357|NCT02272387|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6798358|NCT02272387|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6798359|NCT02272478|Decitabine|decitabine|mesh-list
6798360|NCT02272478|Gemtuzumab|gemtuzumab|mesh-list
6798361|NCT02272478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6798362|NCT02272478|Antimetabolites|antimetabolites|mesh-ancestor
6798363|NCT02272478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6798364|NCT02272478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6798365|NCT02272478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6798366|NCT02272478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6798367|NCT02272517|Vortioxetine|vortioxetine|mesh-list
6798368|NCT02272517|Citalopram|citalopram|mesh-list
6798369|NCT02272517|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6798370|NCT02272517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6798371|NCT02272517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6798372|NCT02272517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6798373|NCT02272517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6798374|NCT02272517|Serotonin Agents|serotonin agents|mesh-ancestor
6798375|NCT02272517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798376|NCT02272517|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6798377|NCT02272517|Antidepressive Agents|antidepressive agents|mesh-ancestor
6798378|NCT02272517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6798379|NCT02272517|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6798380|NCT02272517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6798381|NCT02272517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6798382|NCT02272517|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6798383|NCT02272517|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6798384|NCT02272517|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6798385|NCT02272517|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6798386|NCT02272582|Heparin|heparin|mesh-list
6798387|NCT02272582|Anticoagulants|anticoagulants|mesh-ancestor
6535073|NCT00810706|Hormone Antagonists|hormone antagonists|mesh-ancestor
6537924|NCT00825045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6798388|NCT02272582|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6535074|NCT00810706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6535075|NCT00810706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535076|NCT00810836|Dimethyl Fumarate|dimethyl fumarate|mesh-list
6535077|NCT00810836|Dermatologic Agents|dermatologic agents|mesh-ancestor
6535078|NCT00810836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6535079|NCT00810836|Immunologic Factors|immunologic factors|mesh-ancestor
6535080|NCT00810836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535081|NCT00810849|Prednisolone|prednisolone|mesh-list
6535082|NCT00810849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6535083|NCT00810849|Glucocorticoids|glucocorticoids|mesh-ancestor
6535084|NCT00810849|Hormones|hormones|mesh-ancestor
6535085|NCT00810849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6535086|NCT00810849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535087|NCT00810849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6535088|NCT00810849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6535089|NCT00810862|Pimecrolimus|pimecrolimus|mesh-list
6535090|NCT00810862|Lactitol|lactitol|mesh-list
6535091|NCT00810862|Cathartics|cathartics|mesh-ancestor
6535092|NCT00810862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6535093|NCT00810862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6535094|NCT00810862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6535095|NCT00810862|Analgesics|analgesics|mesh-ancestor
6535096|NCT00810862|Sensory System Agents|sensory system agents|mesh-ancestor
6535097|NCT00810862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6535098|NCT00810862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535099|NCT00810862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6535100|NCT00810862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6535101|NCT00810862|Dermatologic Agents|dermatologic agents|mesh-ancestor
6535102|NCT00810862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6535103|NCT00810862|Immunologic Factors|immunologic factors|mesh-ancestor
6535104|NCT00810862|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6535105|NCT00810862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6535106|NCT00810862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535107|NCT00810914|Bupivacaine|bupivacaine|mesh-list
6535108|NCT00810914|Anesthetics, Local|anesthetics, local|mesh-ancestor
6798389|NCT02272582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6798390|NCT02272582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6798391|NCT02272647|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6798392|NCT02272647|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6798393|NCT02272647|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6798394|NCT02272647|Medroxyprogesterone|medroxyprogesterone|mesh-list
6798395|NCT02272647|Estradiol|estradiol|mesh-list
6798396|NCT02272647|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6798397|NCT02272647|Progesterone|progesterone|mesh-list
6798398|NCT02272647|Estrogens|estrogens|mesh-ancestor
6798399|NCT02272647|Hormones|hormones|mesh-ancestor
6798400|NCT02272647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6798401|NCT02272647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798402|NCT02272647|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6798403|NCT02272647|Contraceptive Agents|contraceptive agents|mesh-ancestor
6798404|NCT02272647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6798405|NCT02272647|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6798406|NCT02272647|Progestins|progestins|mesh-ancestor
6798407|NCT02272647|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6798408|NCT02272647|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6798409|NCT02272647|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6798410|NCT02272647|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6798411|NCT02272647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6798412|NCT02272647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6798413|NCT02272660|Parecoxib|parecoxib|mesh-list
6798414|NCT02272660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6798415|NCT02272660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6798416|NCT02272660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6798417|NCT02272660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6798418|NCT02272660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6798419|NCT02272660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6798420|NCT02272660|Analgesics|analgesics|mesh-ancestor
6798421|NCT02272660|Sensory System Agents|sensory system agents|mesh-ancestor
6798422|NCT02272660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6798423|NCT02272660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798424|NCT02272660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6798425|NCT02272660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6798426|NCT02272699|Paclitaxel|paclitaxel|mesh-list
6535109|NCT00810914|Anesthetics|anesthetics|mesh-ancestor
6535110|NCT00810914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6535111|NCT00810914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535112|NCT00810914|Sensory System Agents|sensory system agents|mesh-ancestor
6535113|NCT00810914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6535114|NCT00810940|Mannitol|mannitol|mesh-list
6535115|NCT00810940|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6535116|NCT00810940|Diuretics|diuretics|mesh-ancestor
6535117|NCT00810940|Natriuretic Agents|natriuretic agents|mesh-ancestor
6535118|NCT00810940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535119|NCT00810953|Pentamidine|pentamidine|mesh-list
6535120|NCT00810953|Antifungal Agents|antifungal agents|mesh-ancestor
6535121|NCT00810953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6535122|NCT00810953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6535123|NCT00810953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6535124|NCT00810953|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6535125|NCT00811005|5-Methoxypsoralen|5-methoxypsoralen|mesh-list
6535126|NCT00811005|Methoxsalen|methoxsalen|mesh-list
6535127|NCT00811005|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6535128|NCT00811005|Dermatologic Agents|dermatologic agents|mesh-ancestor
6535129|NCT00811005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6535130|NCT00811031|Prednisone|prednisone|mesh-list
6535131|NCT00811031|Docetaxel|docetaxel|mesh-list
6535132|NCT00811031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6535133|NCT00811031|Tubulin Modulators|tubulin modulators|mesh-ancestor
6535134|NCT00811031|Antimitotic Agents|antimitotic agents|mesh-ancestor
6535135|NCT00811031|Mitosis Modulators|mitosis modulators|mesh-ancestor
6535136|NCT00811031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535137|NCT00811031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6535138|NCT00811031|Glucocorticoids|glucocorticoids|mesh-ancestor
6535139|NCT00811031|Hormones|hormones|mesh-ancestor
6535140|NCT00811031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6535141|NCT00811031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535142|NCT00811031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6535143|NCT00811083|Succimer|succimer|mesh-list
6535144|NCT00811083|Antidotes|antidotes|mesh-ancestor
6535145|NCT00811083|Protective Agents|protective agents|mesh-ancestor
6535146|NCT00811083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535147|NCT00811083|Chelating Agents|chelating agents|mesh-ancestor
6535148|NCT00811083|Sequestering Agents|sequestering agents|mesh-ancestor
6535149|NCT00811083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535150|NCT00811096|Chloroquine|chloroquine|mesh-list
6535151|NCT00811096|Tinidazole|tinidazole|mesh-list
6535152|NCT00811096|Amebicides|amebicides|mesh-ancestor
6535153|NCT00811096|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6535154|NCT00811096|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6535155|NCT00811096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6535156|NCT00811096|Antimalarials|antimalarials|mesh-ancestor
6535157|NCT00811096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6535158|NCT00811096|Alkylating Agents|alkylating agents|mesh-ancestor
6535159|NCT00811096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535160|NCT00811096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6535161|NCT00811096|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
6535162|NCT00811122|Corticosterone|corticosterone|mesh-list
6535163|NCT00811122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6535164|NCT00811200|Triamcinolone|triamcinolone|mesh-list
6535165|NCT00811200|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6535166|NCT00811200|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6535167|NCT00811200|Ranibizumab|ranibizumab|mesh-list
6535168|NCT00811200|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6535169|NCT00811200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6535170|NCT00811200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6535171|NCT00811200|Growth Substances|growth substances|mesh-ancestor
6535172|NCT00811200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535173|NCT00811200|Growth Inhibitors|growth inhibitors|mesh-ancestor
6535174|NCT00811200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6535175|NCT00811200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6535176|NCT00811200|Glucocorticoids|glucocorticoids|mesh-ancestor
6535177|NCT00811200|Hormones|hormones|mesh-ancestor
6535178|NCT00811200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6535179|NCT00811200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6535180|NCT00811200|Immunologic Factors|immunologic factors|mesh-ancestor
6535181|NCT00811200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6535182|NCT00811200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535183|NCT00811226|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6798427|NCT02272699|Nimotuzumab|nimotuzumab|mesh-list
6535184|NCT00811226|Olmesartan|olmesartan|mesh-list
6535185|NCT00811226|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6535186|NCT00811226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6535187|NCT00811226|Diuretics|diuretics|mesh-ancestor
6535188|NCT00811226|Natriuretic Agents|natriuretic agents|mesh-ancestor
6535189|NCT00811226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535190|NCT00811226|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6535191|NCT00811226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6535192|NCT00811226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535193|NCT00811226|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6535194|NCT00811226|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6535195|NCT00811239|Antivenins|antivenins|mesh-list
6535196|NCT00811239|Immunologic Factors|immunologic factors|mesh-ancestor
6535197|NCT00811239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537925|NCT00825045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6537926|NCT00825045|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6537927|NCT00825045|Dopamine Agents|dopamine agents|mesh-ancestor
6537928|NCT00825058|Paroxetine|paroxetine|mesh-list
6537929|NCT00825058|Amibegron|amibegron|mesh-list
6537930|NCT00825058|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6537931|NCT00825058|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6537932|NCT00825058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6537933|NCT00825058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537934|NCT00825058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6537935|NCT00825058|Serotonin Agents|serotonin agents|mesh-ancestor
6537936|NCT00825058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537937|NCT00825058|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6537938|NCT00825058|Antidepressive Agents|antidepressive agents|mesh-ancestor
6537939|NCT00825058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6537940|NCT00825058|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6537941|NCT00825058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6537942|NCT00825058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6537943|NCT00825058|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6537944|NCT00825058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6537945|NCT00825058|Adrenergic Agents|adrenergic agents|mesh-ancestor
6537946|NCT00825071|Dexamethasone|dexamethasone|mesh-list
6537947|NCT00825071|Ondansetron|ondansetron|mesh-list
6537948|NCT00825071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6537949|NCT00825071|Antiemetics|antiemetics|mesh-ancestor
6537950|NCT00825071|Autonomic Agents|autonomic agents|mesh-ancestor
6537951|NCT00825071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6537952|NCT00825071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537953|NCT00825071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6537954|NCT00825071|Glucocorticoids|glucocorticoids|mesh-ancestor
6537955|NCT00825071|Hormones|hormones|mesh-ancestor
6537956|NCT00825071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6537957|NCT00825071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6537958|NCT00825071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6537959|NCT00825071|Antipruritics|antipruritics|mesh-ancestor
6537960|NCT00825071|Dermatologic Agents|dermatologic agents|mesh-ancestor
6537961|NCT00825071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6537962|NCT00825071|Serotonin Agents|serotonin agents|mesh-ancestor
6537963|NCT00825071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6537964|NCT00825071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537965|NCT00825071|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6537966|NCT00825071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6537967|NCT00825071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6537968|NCT00825071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6537969|NCT00825071|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6537970|NCT00825097|Botulinum Toxins|botulinum toxins|mesh-list
6537971|NCT00825097|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6537972|NCT00825097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6537973|NCT00825097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537974|NCT00825097|Cholinergic Agents|cholinergic agents|mesh-ancestor
6537975|NCT00825097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6537976|NCT00825097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537977|NCT00825123|Metoprolol|metoprolol|mesh-list
6537978|NCT00825123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6537979|NCT00825123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6537980|NCT00825123|Sympatholytics|sympatholytics|mesh-ancestor
6537981|NCT00825123|Autonomic Agents|autonomic agents|mesh-ancestor
6537982|NCT00825123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6537983|NCT00825123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537984|NCT00825123|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6537985|NCT00825123|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6537986|NCT00825123|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6535198|NCT00811291|Calcium, Dietary|calcium, dietary|mesh-list
6535199|NCT00811291|Folic Acid|folic acid|mesh-list
6535200|NCT00811291|Calcium|calcium|mesh-list
6535201|NCT00811291|Vitamins|vitamins|mesh-ancestor
6535202|NCT00811291|Micronutrients|micronutrients|mesh-ancestor
6535203|NCT00811291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535204|NCT00811291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6535205|NCT00811291|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6535206|NCT00811291|Hematinics|hematinics|mesh-ancestor
6535207|NCT00811291|Vitamin B Complex|vitamin b complex|mesh-ancestor
6535208|NCT00811330|Atorvastatin|atorvastatin|mesh-list
6535209|NCT00811330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6535210|NCT00811330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6535211|NCT00811330|Antimetabolites|antimetabolites|mesh-ancestor
6535212|NCT00811330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535213|NCT00811330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6535214|NCT00811330|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6535215|NCT00811330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6535216|NCT00811356|Rosiglitazone|rosiglitazone|mesh-list
6535217|NCT00811356|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6535218|NCT00811356|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6535219|NCT00811356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6535220|NCT00811356|Antimetabolites|antimetabolites|mesh-ancestor
6535221|NCT00811356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535222|NCT00811356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6535223|NCT00811356|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6535224|NCT00811356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6535225|NCT00811356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6535226|NCT00811356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535227|NCT00811369|Fulvestrant|fulvestrant|mesh-list
6535228|NCT00811369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6535229|NCT00811369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6535230|NCT00811369|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6535231|NCT00811369|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6535232|NCT00811369|Hormone Antagonists|hormone antagonists|mesh-ancestor
6535233|NCT00811369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6535234|NCT00811369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535235|NCT00811408|Cidofovir|cidofovir|mesh-list
6535236|NCT00811408|Carboplatin|carboplatin|mesh-list
6535237|NCT00811408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6535238|NCT00811408|Antiviral Agents|antiviral agents|mesh-ancestor
6535239|NCT00811408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6535240|NCT00811408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6535241|NCT00811408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535242|NCT00811421|Pyrimethamine|pyrimethamine|mesh-list
6535243|NCT00811421|Sulfadoxine|sulfadoxine|mesh-list
6535244|NCT00811421|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6535245|NCT00811421|Mefloquine|mefloquine|mesh-list
6535246|NCT00811421|Antimalarials|antimalarials|mesh-ancestor
6535247|NCT00811421|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6535248|NCT00811421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6535249|NCT00811421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6535250|NCT00811421|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6535251|NCT00811421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6535252|NCT00811421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535253|NCT00811421|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6535254|NCT00811421|Renal Agents|renal agents|mesh-ancestor
6535255|NCT00811447|Docetaxel|docetaxel|mesh-list
6535256|NCT00811447|Fluorouracil|fluorouracil|mesh-list
6535257|NCT00811447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6535258|NCT00811447|Tubulin Modulators|tubulin modulators|mesh-ancestor
6535259|NCT00811447|Antimitotic Agents|antimitotic agents|mesh-ancestor
6535260|NCT00811447|Mitosis Modulators|mitosis modulators|mesh-ancestor
6535261|NCT00811447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535262|NCT00811447|Antimetabolites|antimetabolites|mesh-ancestor
6535263|NCT00811447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6535264|NCT00811447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6535265|NCT00811447|Immunologic Factors|immunologic factors|mesh-ancestor
6535266|NCT00811447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535267|NCT00811460|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6535268|NCT00811460|Incretins|incretins|mesh-ancestor
6535269|NCT00811460|Hormones|hormones|mesh-ancestor
6535270|NCT00811460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6798428|NCT02272699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6798429|NCT02272699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6535271|NCT00811460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535272|NCT00811486|Spironolactone|spironolactone|mesh-list
6535273|NCT00811486|Conivaptan|conivaptan|mesh-list
6535274|NCT00811486|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6535275|NCT00811486|Hormone Antagonists|hormone antagonists|mesh-ancestor
6535276|NCT00811486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6535277|NCT00811486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535278|NCT00811486|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6535279|NCT00811486|Diuretics|diuretics|mesh-ancestor
6535280|NCT00811486|Natriuretic Agents|natriuretic agents|mesh-ancestor
6535281|NCT00811486|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6535282|NCT00811486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535283|NCT00811603|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6535284|NCT00811603|Cefazolin|cefazolin|mesh-list
6535285|NCT00811603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6535286|NCT00811681|Pioglitazone|pioglitazone|mesh-list
6535287|NCT00811681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6535288|NCT00811681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535289|NCT00811746|Eszopiclone|eszopiclone|mesh-list
6535290|NCT00811746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6535291|NCT00811746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6535292|NCT00811746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535293|NCT00811759|Temozolomide|temozolomide|mesh-list
6535294|NCT00811759|Sorafenib|sorafenib|mesh-list
6535295|NCT00811759|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6535296|NCT00811759|Alkylating Agents|alkylating agents|mesh-ancestor
6535297|NCT00811759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535298|NCT00811759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6535299|NCT00811759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6535300|NCT00811759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6535301|NCT00811785|Copper|copper|mesh-list
6535302|NCT00811785|Trace Elements|trace elements|mesh-ancestor
6535303|NCT00811785|Micronutrients|micronutrients|mesh-ancestor
6535304|NCT00811785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535305|NCT00811837|Midazolam|midazolam|mesh-list
6535306|NCT00811837|Remifentanil|remifentanil|mesh-list
6535307|NCT00811837|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6535308|NCT00811837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6535309|NCT00811837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6798430|NCT02272699|Tubulin Modulators|tubulin modulators|mesh-ancestor
6798431|NCT02272699|Antimitotic Agents|antimitotic agents|mesh-ancestor
6798432|NCT02272699|Mitosis Modulators|mitosis modulators|mesh-ancestor
6798433|NCT02272699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6798434|NCT02272699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6798435|NCT02272738|Gemcitabine|gemcitabine|mesh-list
6798436|NCT02272738|Paclitaxel|paclitaxel|mesh-list
6798437|NCT02272738|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6798438|NCT02272738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6798439|NCT02272738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6798440|NCT02272738|Tubulin Modulators|tubulin modulators|mesh-ancestor
6798441|NCT02272738|Antimitotic Agents|antimitotic agents|mesh-ancestor
6798442|NCT02272738|Mitosis Modulators|mitosis modulators|mesh-ancestor
6798443|NCT02272738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6798444|NCT02272738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6798445|NCT02272738|Antimetabolites|antimetabolites|mesh-ancestor
6798446|NCT02272738|Antiviral Agents|antiviral agents|mesh-ancestor
6798447|NCT02272738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6798448|NCT02272738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6798449|NCT02272738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6798450|NCT02272738|Immunologic Factors|immunologic factors|mesh-ancestor
6798451|NCT02272738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798452|NCT02272764|Itraconazole|itraconazole|mesh-list
6798453|NCT02272764|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
6798454|NCT02272764|Antifungal Agents|antifungal agents|mesh-ancestor
6798455|NCT02272764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6798456|NCT02272764|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6798457|NCT02272764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6798458|NCT02272764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6798459|NCT02272764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6798460|NCT02272764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6798461|NCT02272764|Hormone Antagonists|hormone antagonists|mesh-ancestor
6798462|NCT02272764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6798463|NCT02272764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258443|NCT03087604|Anesthetics, Local|anesthetics, local|mesh-ancestor
6535310|NCT00811837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535311|NCT00811837|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6535312|NCT00811837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6535313|NCT00811837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6535314|NCT00811837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6535315|NCT00811837|Anesthetics, General|anesthetics, general|mesh-ancestor
6535316|NCT00811837|Anesthetics|anesthetics|mesh-ancestor
6535317|NCT00811837|GABA Modulators|gaba modulators|mesh-ancestor
6535318|NCT00811837|GABA Agents|gaba agents|mesh-ancestor
6535319|NCT00811837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6535320|NCT00811837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535321|NCT00811837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6535322|NCT00811837|Narcotics|narcotics|mesh-ancestor
6535323|NCT00811837|Analgesics|analgesics|mesh-ancestor
6535324|NCT00811837|Sensory System Agents|sensory system agents|mesh-ancestor
6535325|NCT00811837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6535326|NCT00811876|Leuprolide|leuprolide|mesh-list
6535327|NCT00811876|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6535328|NCT00811876|Fertility Agents|fertility agents|mesh-ancestor
6535329|NCT00811876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6535330|NCT00811876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535331|NCT00811876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6535332|NCT00811876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6535333|NCT00811915|Sirolimus|sirolimus|mesh-list
6535334|NCT00811915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6535335|NCT00811915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6535336|NCT00811915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6535337|NCT00811915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6535338|NCT00811915|Antifungal Agents|antifungal agents|mesh-ancestor
6535339|NCT00811915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6535340|NCT00811915|Immunologic Factors|immunologic factors|mesh-ancestor
6798464|NCT02272764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6798465|NCT02272829|Analgesics, Opioid|analgesics, opioid|mesh-list
6798466|NCT02272829|Narcotics|narcotics|mesh-ancestor
6798467|NCT02272829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6798468|NCT02272829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798469|NCT02272829|Analgesics|analgesics|mesh-ancestor
6798470|NCT02272829|Sensory System Agents|sensory system agents|mesh-ancestor
6798471|NCT02272829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6798472|NCT02272855|Ipilimumab|ipilimumab|mesh-list
6798473|NCT02272855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6798474|NCT02272855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6798475|NCT02272855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6798476|NCT02272855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6798477|NCT02272868|Rifaximin|rifaximin|mesh-list
6798478|NCT02272868|Omeprazole|omeprazole|mesh-list
6798479|NCT02272868|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
6798480|NCT02272868|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6798481|NCT02272868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6798482|NCT02272868|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6798483|NCT02272868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6798484|NCT02272868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6798485|NCT02272868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6798486|NCT02272868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6798487|NCT02272868|Laxatives|laxatives|mesh-ancestor
6535341|NCT00811915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535342|NCT00811967|Ribavirin|ribavirin|mesh-list
6535343|NCT00811967|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6535344|NCT00811967|Interferon-alpha|interferon-alpha|mesh-list
6535345|NCT00811967|Antimetabolites|antimetabolites|mesh-ancestor
6535346|NCT00811967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535347|NCT00811967|Antiviral Agents|antiviral agents|mesh-ancestor
6535348|NCT00811967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6535349|NCT00811967|Immunologic Factors|immunologic factors|mesh-ancestor
6535350|NCT00811967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535351|NCT00811980|Vancomycin|vancomycin|mesh-list
6535352|NCT00811980|Linezolid|linezolid|mesh-list
6535353|NCT00811980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6535354|NCT00811980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6535355|NCT00811980|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5993080|NCT00118898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5993081|NCT00118898|Antiviral Agents|antiviral agents|mesh-ancestor
5993082|NCT00118898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5993083|NCT00118898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5993084|NCT00118898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5993085|NCT00118898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5993086|NCT00118898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5993087|NCT00118898|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5993088|NCT00118898|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5993089|NCT00118898|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5993090|NCT00118898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5993091|NCT00118898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5993092|NCT00118898|Antimetabolites|antimetabolites|mesh-ancestor
5993093|NCT00119015|Fluticasone|fluticasone|mesh-list
5993094|NCT00119015|Xhance|xhance|mesh-list
5993095|NCT00119015|Montelukast|montelukast|mesh-list
5993096|NCT00119015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5993097|NCT00119015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5993098|NCT00119015|Autonomic Agents|autonomic agents|mesh-ancestor
5993099|NCT00119015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5993100|NCT00119015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993101|NCT00119015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5993102|NCT00119015|Respiratory System Agents|respiratory system agents|mesh-ancestor
5993103|NCT00119015|Dermatologic Agents|dermatologic agents|mesh-ancestor
5993104|NCT00119015|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5993105|NCT00119015|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5993106|NCT00119015|Hormone Antagonists|hormone antagonists|mesh-ancestor
5993107|NCT00119015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5993108|NCT00119015|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5993109|NCT00119015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5993110|NCT00119015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535356|NCT00811980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6535357|NCT00811980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535358|NCT00811993|Gemcitabine|gemcitabine|mesh-list
6535359|NCT00811993|Etoposide|etoposide|mesh-list
6535360|NCT00811993|Docetaxel|docetaxel|mesh-list
6535361|NCT00811993|Bevacizumab|bevacizumab|mesh-list
6535362|NCT00811993|Carboplatin|carboplatin|mesh-list
6535363|NCT00811993|Capecitabine|capecitabine|mesh-list
6535364|NCT00811993|Trastuzumab|trastuzumab|mesh-list
6535365|NCT00811993|Irinotecan|irinotecan|mesh-list
6535366|NCT00811993|Cetuximab|cetuximab|mesh-list
6535367|NCT00811993|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6535368|NCT00811993|Temozolomide|temozolomide|mesh-list
6535369|NCT00811993|Sorafenib|sorafenib|mesh-list
6535370|NCT00811993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6535371|NCT00811993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6535372|NCT00811993|Tubulin Modulators|tubulin modulators|mesh-ancestor
6535373|NCT00811993|Antimitotic Agents|antimitotic agents|mesh-ancestor
6535374|NCT00811993|Mitosis Modulators|mitosis modulators|mesh-ancestor
6535375|NCT00811993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535376|NCT00811993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6535377|NCT00811993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6535378|NCT00811993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6535379|NCT00811993|Growth Substances|growth substances|mesh-ancestor
6535380|NCT00811993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535381|NCT00811993|Growth Inhibitors|growth inhibitors|mesh-ancestor
6535382|NCT00811993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5993111|NCT00119106|Tenofovir|tenofovir|mesh-list
6535383|NCT00811993|Antimetabolites|antimetabolites|mesh-ancestor
6535384|NCT00811993|Antiviral Agents|antiviral agents|mesh-ancestor
6535385|NCT00811993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6535386|NCT00811993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6535387|NCT00811993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6535388|NCT00811993|Immunologic Factors|immunologic factors|mesh-ancestor
6535389|NCT00811993|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6535390|NCT00811993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6535391|NCT00811993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6535392|NCT00811993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6535393|NCT00811993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6535394|NCT00811993|Alkylating Agents|alkylating agents|mesh-ancestor
6535395|NCT00812019|Vaccines|vaccines|mesh-list
6535396|NCT00812019|MF59 oil emulsion|mf59 oil emulsion|mesh-list
6535397|NCT00812019|Immunologic Factors|immunologic factors|mesh-ancestor
6535398|NCT00812019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535399|NCT00812019|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6535400|NCT00812032|Aspirin|aspirin|mesh-list
6535401|NCT00812032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6535402|NCT00812032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6535403|NCT00812032|Analgesics|analgesics|mesh-ancestor
6535404|NCT00812032|Sensory System Agents|sensory system agents|mesh-ancestor
6535405|NCT00812032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6535406|NCT00812032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535407|NCT00812032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6535408|NCT00812032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6535409|NCT00812032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6535410|NCT00812032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6535411|NCT00812032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535412|NCT00812032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6535413|NCT00812032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6535414|NCT00812032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6535415|NCT00812032|Antipyretics|antipyretics|mesh-ancestor
6535416|NCT00812123|Cyclosporine|cyclosporine|mesh-list
6535417|NCT00812123|Sirolimus|sirolimus|mesh-list
6535418|NCT00812123|Mycophenolic Acid|mycophenolic acid|mesh-list
6535419|NCT00812123|Prednisone|prednisone|mesh-list
6535420|NCT00812123|Cyclosporins|cyclosporins|mesh-list
6535421|NCT00812123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6535422|NCT00812123|Glucocorticoids|glucocorticoids|mesh-ancestor
6535423|NCT00812123|Hormones|hormones|mesh-ancestor
6535424|NCT00812123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6535425|NCT00812123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535426|NCT00812123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6535427|NCT00812123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6535428|NCT00812123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6535429|NCT00812123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535430|NCT00812123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6535431|NCT00812123|Immunologic Factors|immunologic factors|mesh-ancestor
6535432|NCT00812123|Antifungal Agents|antifungal agents|mesh-ancestor
6535433|NCT00812123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6535434|NCT00812123|Dermatologic Agents|dermatologic agents|mesh-ancestor
6535435|NCT00812123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6535436|NCT00812123|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6535437|NCT00812123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6535438|NCT00812123|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6535439|NCT00812123|Antitubercular Agents|antitubercular agents|mesh-ancestor
6535440|NCT00812123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6535441|NCT00812175|Sorafenib|sorafenib|mesh-list
6535442|NCT00812175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6535443|NCT00812175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6535444|NCT00812175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6535445|NCT00812175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535446|NCT00812214|Eszopiclone|eszopiclone|mesh-list
6535447|NCT00812214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6535448|NCT00812214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6535449|NCT00812214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535450|NCT00812266|Carboplatin|carboplatin|mesh-list
6535451|NCT00812266|Etoposide|etoposide|mesh-list
6535452|NCT00812266|Topotecan|topotecan|mesh-list
6535453|NCT00812266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6535454|NCT00812266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6535455|NCT00812266|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6535456|NCT00812266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5993112|NCT00119106|Antiviral Agents|antiviral agents|mesh-ancestor
6535457|NCT00812266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6535458|NCT00812266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537987|NCT00825123|Adrenergic Agents|adrenergic agents|mesh-ancestor
6535459|NCT00812266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6535460|NCT00812292|Rilpivirine|rilpivirine|mesh-list
6535461|NCT00812292|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6535462|NCT00812292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6535463|NCT00812292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6535464|NCT00812292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535465|NCT00812292|Antiviral Agents|antiviral agents|mesh-ancestor
6535466|NCT00812292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6535467|NCT00812292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6535468|NCT00812292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6535469|NCT00812318|Cabotegravir|cabotegravir|mesh-list
6535470|NCT00812318|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6535471|NCT00812318|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6535472|NCT00812318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6535473|NCT00812318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535474|NCT00812318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6535475|NCT00812318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6535476|NCT00812318|Antiviral Agents|antiviral agents|mesh-ancestor
6535477|NCT00812318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6535478|NCT00812344|Ketoconazole|ketoconazole|mesh-list
6535479|NCT00812344|Antifungal Agents|antifungal agents|mesh-ancestor
6535480|NCT00812344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6535481|NCT00812344|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6535482|NCT00812344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6535483|NCT00812344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6535484|NCT00812344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535485|NCT00812344|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6535486|NCT00812344|Hormone Antagonists|hormone antagonists|mesh-ancestor
6798488|NCT02272998|Ponatinib|ponatinib|mesh-list
6798489|NCT02272998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6798490|NCT02272998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6798491|NCT02272998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6798492|NCT02272998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6798493|NCT02273102|Tretinoin|tretinoin|mesh-list
6798494|NCT02273102|Tranylcypromine|tranylcypromine|mesh-list
6798495|NCT02273102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6798496|NCT02273102|Keratolytic Agents|keratolytic agents|mesh-ancestor
6798497|NCT02273102|Dermatologic Agents|dermatologic agents|mesh-ancestor
6798498|NCT02273102|Antidepressive Agents|antidepressive agents|mesh-ancestor
6798499|NCT02273102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6798500|NCT02273102|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6798501|NCT02273102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6798502|NCT02273102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6798503|NCT02273102|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6798504|NCT02273102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6798505|NCT02273102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6798506|NCT02273102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798507|NCT02273128|Calcitonin|calcitonin|mesh-list
6798508|NCT02273128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6798509|NCT02273128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798510|NCT02273128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6798511|NCT02273154|Buspirone|buspirone|mesh-list
6798512|NCT02273154|Paroxetine|paroxetine|mesh-list
6798513|NCT02273154|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6798514|NCT02273154|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6798515|NCT02273154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6798516|NCT02273154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6798517|NCT02273154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6798518|NCT02273154|Serotonin Agents|serotonin agents|mesh-ancestor
6798519|NCT02273154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798520|NCT02273154|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6798521|NCT02273154|Antidepressive Agents|antidepressive agents|mesh-ancestor
6798522|NCT02273154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6798523|NCT02273154|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6798524|NCT02273154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6798525|NCT02273154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6798526|NCT02273154|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6798527|NCT02273154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6798528|NCT02273154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6798529|NCT02273154|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6798530|NCT02273258|Insulin|insulin|mesh-list
6798531|NCT02273258|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6798532|NCT02273258|Insulin Lispro|insulin lispro|mesh-list
6798533|NCT02273258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6535487|NCT00812344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6535488|NCT00812344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535489|NCT00812344|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6535490|NCT00812370|Bivalirudin|bivalirudin|mesh-list
6535491|NCT00812370|Antithrombins|antithrombins|mesh-ancestor
6535492|NCT00812370|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6535493|NCT00812370|Protease Inhibitors|protease inhibitors|mesh-ancestor
6535494|NCT00812370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6535495|NCT00812370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535496|NCT00812370|Anticoagulants|anticoagulants|mesh-ancestor
6535497|NCT00812396|Methyltestosterone|methyltestosterone|mesh-list
6535498|NCT00812396|Testosterone|testosterone|mesh-list
6535499|NCT00812396|Testosterone undecanoate|testosterone undecanoate|mesh-list
6535500|NCT00812396|Testosterone enanthate|testosterone enanthate|mesh-list
6535501|NCT00812396|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6535502|NCT00812396|Androgens|androgens|mesh-ancestor
6535503|NCT00812396|Hormones|hormones|mesh-ancestor
6535504|NCT00812396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6535505|NCT00812396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535506|NCT00812396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6535507|NCT00812396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6535508|NCT00812396|Anabolic Agents|anabolic agents|mesh-ancestor
6535509|NCT00812422|Ibuprofen|ibuprofen|mesh-list
6535510|NCT00812422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6535511|NCT00812422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6535512|NCT00812422|Analgesics|analgesics|mesh-ancestor
6535513|NCT00812422|Sensory System Agents|sensory system agents|mesh-ancestor
6535514|NCT00812422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6535515|NCT00812422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535516|NCT00812422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6535517|NCT00812422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6535518|NCT00812422|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6535519|NCT00812422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6535520|NCT00812422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535521|NCT00812435|Eptifibatide|eptifibatide|mesh-list
6535522|NCT00812435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6535523|NCT00812448|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
6535524|NCT00812448|Antioxidants|antioxidants|mesh-ancestor
6535525|NCT00812448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535526|NCT00812448|Protective Agents|protective agents|mesh-ancestor
6535527|NCT00812448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535528|NCT00812448|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
6535529|NCT00812448|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6535530|NCT00812448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6535531|NCT00812448|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6535532|NCT00812513|Becaplermin|becaplermin|mesh-list
6535533|NCT00812513|Anticoagulants|anticoagulants|mesh-ancestor
6798534|NCT02273258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798535|NCT02273271|Alovudine|alovudine|mesh-list
6798536|NCT02273271|Antiviral Agents|antiviral agents|mesh-ancestor
6798537|NCT02273271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6798538|NCT02273375|Durvalumab|durvalumab|mesh-list
6798539|NCT02273375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6798540|NCT02273375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6798541|NCT02273440|Theophylline|theophylline|mesh-list
6798542|NCT02273440|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6798543|NCT02273440|Autonomic Agents|autonomic agents|mesh-ancestor
6798544|NCT02273440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6798545|NCT02273440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798546|NCT02273440|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6798547|NCT02273440|Respiratory System Agents|respiratory system agents|mesh-ancestor
6798548|NCT02273440|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6798549|NCT02273440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6798550|NCT02273440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6798551|NCT02273440|Vasodilator Agents|vasodilator agents|mesh-ancestor
6798552|NCT02273440|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6798553|NCT02273440|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6798554|NCT02273440|Purinergic Agents|purinergic agents|mesh-ancestor
6798555|NCT02273440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6798556|NCT02273453|Oxazepam|oxazepam|mesh-list
6798557|NCT02273453|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6798558|NCT02273453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6798559|NCT02273453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798560|NCT02273453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6535534|NCT00812513|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
6535535|NCT00812513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6535536|NCT00812513|Growth Substances|growth substances|mesh-ancestor
6535537|NCT00812513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535538|NCT00812578|Cholecalciferol|cholecalciferol|mesh-list
6535539|NCT00812578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6535540|NCT00812578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535541|NCT00812578|Vitamins|vitamins|mesh-ancestor
6535542|NCT00812578|Micronutrients|micronutrients|mesh-ancestor
6535543|NCT00812578|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6535544|NCT00812669|Cyclophosphamide|cyclophosphamide|mesh-list
6535545|NCT00812669|Rituximab|rituximab|mesh-list
6535546|NCT00812669|Fludarabine|fludarabine|mesh-list
6535547|NCT00812669|Fludarabine phosphate|fludarabine phosphate|mesh-list
6535548|NCT00812669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6535549|NCT00812669|Immunologic Factors|immunologic factors|mesh-ancestor
6535550|NCT00812669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535551|NCT00812669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6535552|NCT00812669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6535553|NCT00812669|Alkylating Agents|alkylating agents|mesh-ancestor
6535554|NCT00812669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535555|NCT00812669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6535556|NCT00812669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6535557|NCT00812669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6535558|NCT00812669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6535559|NCT00812669|Antimetabolites|antimetabolites|mesh-ancestor
6535560|NCT00812682|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6535561|NCT00812682|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6535562|NCT00812682|Respiratory System Agents|respiratory system agents|mesh-ancestor
6535563|NCT00812760|Levodopa|levodopa|mesh-list
6535564|NCT00812760|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6535565|NCT00812760|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6535566|NCT00812760|Dopamine Agents|dopamine agents|mesh-ancestor
6535567|NCT00812760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6535568|NCT00812760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535569|NCT00812760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535570|NCT00812786|Cyclosporine|cyclosporine|mesh-list
6535571|NCT00812786|Mycophenolic Acid|mycophenolic acid|mesh-list
6535572|NCT00812786|Everolimus|everolimus|mesh-list
6535573|NCT00812786|Tacrolimus|tacrolimus|mesh-list
6535574|NCT00812786|Cyclosporins|cyclosporins|mesh-list
6535575|NCT00812786|Immunosuppressive Agents|immunosuppressive agents|mesh-list
6535576|NCT00812786|Immunologic Factors|immunologic factors|mesh-ancestor
6535577|NCT00812786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535578|NCT00812786|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6535579|NCT00812786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6535580|NCT00812786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535581|NCT00812786|Antifungal Agents|antifungal agents|mesh-ancestor
6798561|NCT02273453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6798562|NCT02273453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6798563|NCT02273453|GABA Modulators|gaba modulators|mesh-ancestor
6798564|NCT02273453|GABA Agents|gaba agents|mesh-ancestor
6798565|NCT02273453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6798566|NCT02273453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6798567|NCT02273466|Desipramine|desipramine|mesh-list
6798568|NCT02273466|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6798569|NCT02273466|Antidepressive Agents|antidepressive agents|mesh-ancestor
6798570|NCT02273466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6798571|NCT02273466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6798572|NCT02273466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6798573|NCT02273466|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6798574|NCT02273466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6798575|NCT02273466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6798576|NCT02273466|Adrenergic Agents|adrenergic agents|mesh-ancestor
6798577|NCT02273466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6798578|NCT02273466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798579|NCT02273479|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
6798580|NCT02273479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6798581|NCT02273492|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
6798582|NCT02273492|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6798583|NCT02273505|Aspirin|aspirin|mesh-list
6798584|NCT02273505|Salicylic Acid|salicylic acid|mesh-list
6798585|NCT02273505|Salicylates|salicylates|mesh-list
6535582|NCT00812786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6535583|NCT00812786|Dermatologic Agents|dermatologic agents|mesh-ancestor
6535584|NCT00812786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6535585|NCT00812786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6535586|NCT00812786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6535587|NCT00812786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6535588|NCT00812786|Antitubercular Agents|antitubercular agents|mesh-ancestor
6535589|NCT00812786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6535590|NCT00812825|Prednisolone|prednisolone|mesh-list
6535591|NCT00812825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6535592|NCT00812825|Glucocorticoids|glucocorticoids|mesh-ancestor
6535593|NCT00812825|Hormones|hormones|mesh-ancestor
6535594|NCT00812825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6535595|NCT00812825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535596|NCT00812825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6535597|NCT00812825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6535598|NCT00812851|Dronabinol|dronabinol|mesh-list
6535599|NCT00812851|Hallucinogens|hallucinogens|mesh-ancestor
6535600|NCT00812851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535601|NCT00812851|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6535602|NCT00812851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6535603|NCT00812851|Analgesics|analgesics|mesh-ancestor
6535604|NCT00812851|Sensory System Agents|sensory system agents|mesh-ancestor
6535605|NCT00812851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6535606|NCT00812851|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6535607|NCT00812851|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6535608|NCT00812851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6535609|NCT00812851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535610|NCT00812851|Hormones|hormones|mesh-ancestor
6535611|NCT00812851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6535612|NCT00812864|Capecitabine|capecitabine|mesh-list
6535613|NCT00812864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6535614|NCT00812864|Antimetabolites|antimetabolites|mesh-ancestor
6535615|NCT00812864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535616|NCT00812864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6535617|NCT00812994|Citalopram|citalopram|mesh-list
6535618|NCT00812994|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6535619|NCT00812994|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6535620|NCT00812994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6535621|NCT00812994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535622|NCT00812994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6535623|NCT00812994|Serotonin Agents|serotonin agents|mesh-ancestor
6535624|NCT00812994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535625|NCT00812994|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6535626|NCT00812994|Antidepressive Agents|antidepressive agents|mesh-ancestor
6535627|NCT00812994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6535628|NCT00813059|Bevacizumab|bevacizumab|mesh-list
6535629|NCT00813059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6535630|NCT00813059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6535631|NCT00813059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6535632|NCT00813059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6535633|NCT00813059|Growth Substances|growth substances|mesh-ancestor
6535634|NCT00813059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535635|NCT00813059|Growth Inhibitors|growth inhibitors|mesh-ancestor
6535636|NCT00813072|Docetaxel|docetaxel|mesh-list
6535637|NCT00813072|Irinotecan|irinotecan|mesh-list
6535638|NCT00813072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6535639|NCT00813072|Tubulin Modulators|tubulin modulators|mesh-ancestor
6535640|NCT00813072|Antimitotic Agents|antimitotic agents|mesh-ancestor
6535641|NCT00813072|Mitosis Modulators|mitosis modulators|mesh-ancestor
6535642|NCT00813072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535643|NCT00813072|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6535644|NCT00813072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6535645|NCT00813072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6535646|NCT00813137|Endostar protein|endostar protein|mesh-list
6535647|NCT00813137|Endostatins|endostatins|mesh-list
6535648|NCT00813137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6535649|NCT00813137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6535650|NCT00813137|Growth Substances|growth substances|mesh-ancestor
6535651|NCT00813137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535652|NCT00813137|Growth Inhibitors|growth inhibitors|mesh-ancestor
6535653|NCT00813137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6537988|NCT00825123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6537989|NCT00825123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537990|NCT00825149|Prednisone|prednisone|mesh-list
6537991|NCT00825149|Cyclophosphamide|cyclophosphamide|mesh-list
6537992|NCT00825149|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6537993|NCT00825149|Doxorubicin|doxorubicin|mesh-list
6537994|NCT00825149|Fludarabine|fludarabine|mesh-list
6537995|NCT00825149|Vincristine|vincristine|mesh-list
6798586|NCT02273505|Dipyridamole|dipyridamole|mesh-list
6798587|NCT02273505|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
6798588|NCT02273505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6798589|NCT02273505|Antifungal Agents|antifungal agents|mesh-ancestor
6798590|NCT02273505|Keratolytic Agents|keratolytic agents|mesh-ancestor
6798591|NCT02273505|Dermatologic Agents|dermatologic agents|mesh-ancestor
6798592|NCT02273505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6798593|NCT02273505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6798594|NCT02273505|Analgesics|analgesics|mesh-ancestor
6798595|NCT02273505|Sensory System Agents|sensory system agents|mesh-ancestor
6798596|NCT02273505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6798597|NCT02273505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798598|NCT02273505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6798599|NCT02273505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6798600|NCT02273505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6798601|NCT02273505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6798602|NCT02273505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6798603|NCT02273505|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6798604|NCT02273505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6798605|NCT02273505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6798606|NCT02273505|Antipyretics|antipyretics|mesh-ancestor
6798607|NCT02273505|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6798608|NCT02273505|Vasodilator Agents|vasodilator agents|mesh-ancestor
6798609|NCT02273518|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
6798610|NCT02273518|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6798611|NCT02273531|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
6798612|NCT02273531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6798613|NCT02273544|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
6798614|NCT02273544|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6798615|NCT02273557|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
6798616|NCT02273557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6798617|NCT02273570|Vitamin D|vitamin d|mesh-list
6798618|NCT02273570|Calcium|calcium|mesh-list
6798619|NCT02273570|Vitamins|vitamins|mesh-ancestor
6798620|NCT02273570|Micronutrients|micronutrients|mesh-ancestor
6798621|NCT02273570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798622|NCT02273570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6798623|NCT02273570|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6798624|NCT02273583|Cyclophosphamide|cyclophosphamide|mesh-list
6798625|NCT02273583|Methotrexate|methotrexate|mesh-list
6798626|NCT02273583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6798627|NCT02273583|Immunologic Factors|immunologic factors|mesh-ancestor
6798628|NCT02273583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798629|NCT02273583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6798630|NCT02273583|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6798631|NCT02273583|Alkylating Agents|alkylating agents|mesh-ancestor
6798632|NCT02273583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6798633|NCT02273583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6798634|NCT02273583|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6798635|NCT02273583|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6798636|NCT02273583|Abortifacient Agents|abortifacient agents|mesh-ancestor
6798637|NCT02273583|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6798638|NCT02273583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6798639|NCT02273583|Antimetabolites|antimetabolites|mesh-ancestor
6798640|NCT02273583|Dermatologic Agents|dermatologic agents|mesh-ancestor
6798641|NCT02273583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6798642|NCT02273583|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5993113|NCT00119106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6537996|NCT00825149|Obinutuzumab|obinutuzumab|mesh-list
6537997|NCT00825149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6535654|NCT00813202|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6535655|NCT00813202|Natriuretic Agents|natriuretic agents|mesh-ancestor
6535656|NCT00813202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535657|NCT00813228|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6535658|NCT00813228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6535659|NCT00813228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535660|NCT00813228|Incretins|incretins|mesh-ancestor
6535661|NCT00813228|Hormones|hormones|mesh-ancestor
6535662|NCT00813228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6535663|NCT00813228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6535664|NCT00813228|Protease Inhibitors|protease inhibitors|mesh-ancestor
6535665|NCT00813228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6535666|NCT00813228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535667|NCT00813241|Celecoxib|celecoxib|mesh-list
6535668|NCT00813241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6535669|NCT00813241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6535670|NCT00813241|Analgesics|analgesics|mesh-ancestor
6535671|NCT00813241|Sensory System Agents|sensory system agents|mesh-ancestor
6535672|NCT00813241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6535673|NCT00813241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535674|NCT00813241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6535675|NCT00813241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6535676|NCT00813241|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6535677|NCT00813241|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6535678|NCT00813241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6535679|NCT00813241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535680|NCT00813332|Docetaxel|docetaxel|mesh-list
6535681|NCT00813332|Endostar protein|endostar protein|mesh-list
6535682|NCT00813332|Endostatins|endostatins|mesh-list
6535683|NCT00813332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6535684|NCT00813332|Tubulin Modulators|tubulin modulators|mesh-ancestor
6535685|NCT00813332|Antimitotic Agents|antimitotic agents|mesh-ancestor
6535686|NCT00813332|Mitosis Modulators|mitosis modulators|mesh-ancestor
6535687|NCT00813332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535688|NCT00813332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6535689|NCT00813332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6535690|NCT00813332|Growth Substances|growth substances|mesh-ancestor
6535691|NCT00813332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535692|NCT00813332|Growth Inhibitors|growth inhibitors|mesh-ancestor
6535693|NCT00813410|Insulin|insulin|mesh-list
6535694|NCT00813410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6535695|NCT00813410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535696|NCT00813423|Hydroxychloroquine|hydroxychloroquine|mesh-list
6535697|NCT00813423|Sunitinib|sunitinib|mesh-list
6535698|NCT00813423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6535699|NCT00813423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6535700|NCT00813423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6535701|NCT00813423|Growth Substances|growth substances|mesh-ancestor
6535702|NCT00813423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535703|NCT00813423|Growth Inhibitors|growth inhibitors|mesh-ancestor
6535704|NCT00813423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6535705|NCT00813423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6535706|NCT00813423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535707|NCT00813423|Antimalarials|antimalarials|mesh-ancestor
6535708|NCT00813423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6535709|NCT00813423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6535710|NCT00813423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6535711|NCT00813423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6535712|NCT00813436|Oxytocin|oxytocin|mesh-list
6535713|NCT00813436|Oxytocics|oxytocics|mesh-ancestor
6535714|NCT00813436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6535715|NCT00813436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535716|NCT00813449|Dacarbazine|dacarbazine|mesh-list
6535717|NCT00813449|Endostar protein|endostar protein|mesh-list
6798643|NCT02273583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6798644|NCT02273609|Vitamin K|vitamin k|mesh-list
6798645|NCT02273609|Warfarin|warfarin|mesh-list
6798646|NCT02273609|Acenocoumarol|acenocoumarol|mesh-list
6798647|NCT02273609|Vitamins|vitamins|mesh-ancestor
6798648|NCT02273609|Micronutrients|micronutrients|mesh-ancestor
6798649|NCT02273609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798650|NCT02273609|Anticoagulants|anticoagulants|mesh-ancestor
6798651|NCT02273609|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6798652|NCT02273609|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6798653|NCT02273609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537998|NCT00825149|Immunologic Factors|immunologic factors|mesh-ancestor
6535718|NCT00813449|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6535719|NCT00813449|Alkylating Agents|alkylating agents|mesh-ancestor
6535720|NCT00813449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535721|NCT00813449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6535722|NCT00813449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6535723|NCT00813449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6535724|NCT00813449|Growth Substances|growth substances|mesh-ancestor
6535725|NCT00813449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535726|NCT00813449|Growth Inhibitors|growth inhibitors|mesh-ancestor
6535727|NCT00813475|Insulin|insulin|mesh-list
6535728|NCT00813475|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6535729|NCT00813475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6535730|NCT00813475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535731|NCT00813501|Immunosuppressive Agents|immunosuppressive agents|mesh-list
6535732|NCT00813501|Immunologic Factors|immunologic factors|mesh-ancestor
6535733|NCT00813501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535734|NCT00813527|Fenofibrate|fenofibrate|mesh-list
6535735|NCT00813527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6535736|NCT00813527|Antimetabolites|antimetabolites|mesh-ancestor
6535737|NCT00813527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535738|NCT00813527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6535739|NCT00813566|Alovudine|alovudine|mesh-list
6535740|NCT00813566|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6535741|NCT00813566|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6535742|NCT00813566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535743|NCT00813566|Antiviral Agents|antiviral agents|mesh-ancestor
6535744|NCT00813566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6535745|NCT00813631|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6535746|NCT00813631|Laxatives|laxatives|mesh-ancestor
6535747|NCT00813631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6535748|NCT00813696|Gemcitabine|gemcitabine|mesh-list
6535749|NCT00813696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6535750|NCT00813696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6535751|NCT00813696|Antimetabolites|antimetabolites|mesh-ancestor
6535752|NCT00813696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535753|NCT00813696|Antiviral Agents|antiviral agents|mesh-ancestor
6535754|NCT00813696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6535755|NCT00813696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6535756|NCT00813696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6535757|NCT00813696|Immunologic Factors|immunologic factors|mesh-ancestor
6535758|NCT00813696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535759|NCT00813722|Losartan|losartan|mesh-list
6535760|NCT00813722|Atenolol|atenolol|mesh-list
6535761|NCT00813722|Amlodipine|amlodipine|mesh-list
6535762|NCT00813722|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6535763|NCT00813722|Calcium|calcium|mesh-list
6535764|NCT00813722|Diuretics|diuretics|mesh-list
6535765|NCT00813722|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
6535766|NCT00813722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6798654|NCT02273609|Hemostatics|hemostatics|mesh-ancestor
6798655|NCT02273609|Coagulants|coagulants|mesh-ancestor
6798656|NCT02273622|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
6798657|NCT02273622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6798658|NCT02273622|Antioxidants|antioxidants|mesh-ancestor
6798659|NCT02273622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6798660|NCT02273622|Protective Agents|protective agents|mesh-ancestor
6798661|NCT02273622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798662|NCT02273622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6798663|NCT02273635|Andrographolide|andrographolide|mesh-list
6798664|NCT02273635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6798665|NCT02273635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6798666|NCT02273635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6798667|NCT02273635|Analgesics|analgesics|mesh-ancestor
6798668|NCT02273635|Sensory System Agents|sensory system agents|mesh-ancestor
6798669|NCT02273635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6798670|NCT02273635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798671|NCT02273635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6798672|NCT02273635|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6798673|NCT02273635|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6798674|NCT02273635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6798675|NCT02273635|Antiviral Agents|antiviral agents|mesh-ancestor
6798676|NCT02273635|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6798677|NCT02273661|Amphotericin B|amphotericin b|mesh-list
6798678|NCT02273661|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6535767|NCT00813722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535768|NCT00813722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6535769|NCT00813722|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6535770|NCT00813722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6535771|NCT00813722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535772|NCT00813722|Vasodilator Agents|vasodilator agents|mesh-ancestor
6535773|NCT00813722|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6535774|NCT00813722|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6535775|NCT00813722|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6535776|NCT00813722|Natriuretic Agents|natriuretic agents|mesh-ancestor
6535777|NCT00813722|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6535778|NCT00813722|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6535779|NCT00813722|Adrenergic Agents|adrenergic agents|mesh-ancestor
6535780|NCT00813722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6535781|NCT00813722|Sympatholytics|sympatholytics|mesh-ancestor
6535782|NCT00813722|Autonomic Agents|autonomic agents|mesh-ancestor
6535783|NCT00813722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6535784|NCT00813722|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6535785|NCT00813735|Dexetimide|dexetimide|mesh-list
6535786|NCT00813735|Eszopiclone|eszopiclone|mesh-list
6535787|NCT00813735|Citalopram|citalopram|mesh-list
6535788|NCT00813735|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6535789|NCT00813735|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6535790|NCT00813735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6535791|NCT00813735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535792|NCT00813735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6535793|NCT00813735|Serotonin Agents|serotonin agents|mesh-ancestor
6798679|NCT02273661|Amebicides|amebicides|mesh-ancestor
6798680|NCT02273661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6798681|NCT02273661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6798682|NCT02273661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6798683|NCT02273661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6798684|NCT02273661|Antifungal Agents|antifungal agents|mesh-ancestor
6798685|NCT02273700|Rivaroxaban|rivaroxaban|mesh-list
6798686|NCT02273700|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6798687|NCT02273700|Antithrombins|antithrombins|mesh-ancestor
6798688|NCT02273700|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6798689|NCT02273700|Protease Inhibitors|protease inhibitors|mesh-ancestor
6798690|NCT02273700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6798691|NCT02273700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6798692|NCT02273700|Anticoagulants|anticoagulants|mesh-ancestor
6798693|NCT02273713|Paclitaxel|paclitaxel|mesh-list
6798694|NCT02273713|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6798695|NCT02273713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6798696|NCT02273713|Tubulin Modulators|tubulin modulators|mesh-ancestor
6798697|NCT02273713|Antimitotic Agents|antimitotic agents|mesh-ancestor
6798698|NCT02273713|Mitosis Modulators|mitosis modulators|mesh-ancestor
6798699|NCT02273713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6798700|NCT02273765|Tenofovir|tenofovir|mesh-list
6798701|NCT02273765|Lamivudine|lamivudine|mesh-list
6798702|NCT02273765|Efavirenz|efavirenz|mesh-list
6798703|NCT02273765|Raltegravir Potassium|raltegravir potassium|mesh-list
6798704|NCT02273765|Antiviral Agents|antiviral agents|mesh-ancestor
6798705|NCT02273765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6798706|NCT02273765|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6798707|NCT02273765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6798708|NCT02273765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6798709|NCT02273765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6798710|NCT02273765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6798711|NCT02273765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6798712|NCT02273765|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6798713|NCT02273765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6798714|NCT02273765|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6798715|NCT02273765|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6798716|NCT02273765|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6798717|NCT02273765|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6798718|NCT02273765|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6798719|NCT02273765|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6798720|NCT02273791|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6798721|NCT02273791|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6798722|NCT02273791|Clomiphene|clomiphene|mesh-list
6798723|NCT02273791|Enclomiphene|enclomiphene|mesh-list
6798724|NCT02273791|Zuclomiphene|zuclomiphene|mesh-list
6798725|NCT02273791|Estradiol|estradiol|mesh-list
6798726|NCT02273791|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6798727|NCT02273791|Estrogens|estrogens|mesh-ancestor
6798728|NCT02273791|Hormones|hormones|mesh-ancestor
6535794|NCT00813735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535795|NCT00813735|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6535796|NCT00813735|Antidepressive Agents|antidepressive agents|mesh-ancestor
6535797|NCT00813735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6535798|NCT00813735|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6535799|NCT00813735|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6535800|NCT00813735|Parasympatholytics|parasympatholytics|mesh-ancestor
6535801|NCT00813735|Autonomic Agents|autonomic agents|mesh-ancestor
6535802|NCT00813735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6535803|NCT00813735|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6535804|NCT00813735|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6535805|NCT00813735|Cholinergic Agents|cholinergic agents|mesh-ancestor
6535806|NCT00813735|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6535807|NCT00813735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6535808|NCT00813774|Certolizumab Pegol|certolizumab pegol|mesh-list
6535809|NCT00813774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6535810|NCT00813774|Immunologic Factors|immunologic factors|mesh-ancestor
6535811|NCT00813774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535812|NCT00813774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6535813|NCT00813891|Ranibizumab|ranibizumab|mesh-list
6535814|NCT00813891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6535815|NCT00813891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6535816|NCT00813891|Growth Substances|growth substances|mesh-ancestor
6535817|NCT00813891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535818|NCT00813891|Growth Inhibitors|growth inhibitors|mesh-ancestor
6535819|NCT00813891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6535820|NCT00814008|Insulin|insulin|mesh-list
6535821|NCT00814008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6535822|NCT00814008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535823|NCT00814021|Sunitinib|sunitinib|mesh-list
6535824|NCT00814021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6535825|NCT00814021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6535826|NCT00814021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6535827|NCT00814021|Growth Substances|growth substances|mesh-ancestor
6535828|NCT00814021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535829|NCT00814021|Growth Inhibitors|growth inhibitors|mesh-ancestor
6798729|NCT02273791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6798730|NCT02273791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798731|NCT02273791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6798732|NCT02273791|Contraceptive Agents|contraceptive agents|mesh-ancestor
6798733|NCT02273791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6798734|NCT02273791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6798735|NCT02273791|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6798736|NCT02273791|Hormone Antagonists|hormone antagonists|mesh-ancestor
6798737|NCT02273791|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6798738|NCT02273791|Fertility Agents|fertility agents|mesh-ancestor
6798739|NCT02273791|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6798740|NCT02273791|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6798741|NCT02273804|Topiramate|topiramate|mesh-list
6798742|NCT02273804|Anticonvulsants|anticonvulsants|mesh-ancestor
6798743|NCT02273804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6798744|NCT02273804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798745|NCT02273817|Ciclesonide|ciclesonide|mesh-list
6798746|NCT02273817|Glucocorticoids|glucocorticoids|mesh-ancestor
6798747|NCT02273817|Hormones|hormones|mesh-ancestor
6798748|NCT02273817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6798749|NCT02273817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798750|NCT02273817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6798751|NCT02273843|Vitamin D|vitamin d|mesh-list
6798752|NCT02273843|Ergocalciferols|ergocalciferols|mesh-list
6798753|NCT02273843|Cholecalciferol|cholecalciferol|mesh-list
6798754|NCT02273843|Vitamins|vitamins|mesh-list
6798755|NCT02273843|Micronutrients|micronutrients|mesh-ancestor
6798756|NCT02273843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798757|NCT02273843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6798758|NCT02273843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6798759|NCT02273895|Scopolamine|scopolamine|mesh-list
6798760|NCT02273895|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
6798761|NCT02273895|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6798762|NCT02273895|Antiemetics|antiemetics|mesh-ancestor
6798763|NCT02273895|Autonomic Agents|autonomic agents|mesh-ancestor
6798764|NCT02273895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6798765|NCT02273895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798766|NCT02273895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6535830|NCT00814021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6535831|NCT00814021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6535832|NCT00814021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535833|NCT00814047|Yohimbine|yohimbine|mesh-list
6535834|NCT00814047|Mydriatics|mydriatics|mesh-ancestor
6535835|NCT00814047|Autonomic Agents|autonomic agents|mesh-ancestor
6535836|NCT00814047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6535837|NCT00814047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535838|NCT00814047|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6535839|NCT00814047|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6535840|NCT00814047|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6535841|NCT00814047|Adrenergic Agents|adrenergic agents|mesh-ancestor
6535842|NCT00814047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6535843|NCT00814047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535844|NCT00814047|Urological Agents|urological agents|mesh-ancestor
6535845|NCT00814086|Paclitaxel|paclitaxel|mesh-list
6535846|NCT00814086|Cisplatin|cisplatin|mesh-list
6535847|NCT00814086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6535848|NCT00814086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6535849|NCT00814086|Tubulin Modulators|tubulin modulators|mesh-ancestor
6535850|NCT00814086|Antimitotic Agents|antimitotic agents|mesh-ancestor
6535851|NCT00814086|Mitosis Modulators|mitosis modulators|mesh-ancestor
6535852|NCT00814086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535853|NCT00814125|Tamoxifen|tamoxifen|mesh-list
6535854|NCT00814125|Anastrozole|anastrozole|mesh-list
6535855|NCT00814125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6535856|NCT00814125|Hormone Antagonists|hormone antagonists|mesh-ancestor
6798767|NCT02273895|Mydriatics|mydriatics|mesh-ancestor
6798768|NCT02273895|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6798769|NCT02273895|Cholinergic Agents|cholinergic agents|mesh-ancestor
6798770|NCT02273895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6798771|NCT02273895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6798772|NCT02273895|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6798773|NCT02273895|Parasympatholytics|parasympatholytics|mesh-ancestor
6798774|NCT02273947|BMS-955176|bms-955176|mesh-list
6798775|NCT02273947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6798776|NCT02273947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6798777|NCT02273947|Antiviral Agents|antiviral agents|mesh-ancestor
6798778|NCT02273947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6798779|NCT02273986|Digoxin|digoxin|mesh-list
6798780|NCT02273986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6798781|NCT02273986|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6798782|NCT02273986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6798783|NCT02273986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6798784|NCT02273986|Protective Agents|protective agents|mesh-ancestor
6798785|NCT02273986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798786|NCT02274012|Paclitaxel|paclitaxel|mesh-list
6798787|NCT02274012|Afatinib|afatinib|mesh-list
6798788|NCT02274012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6798789|NCT02274012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6798790|NCT02274012|Tubulin Modulators|tubulin modulators|mesh-ancestor
6798791|NCT02274012|Antimitotic Agents|antimitotic agents|mesh-ancestor
6798792|NCT02274012|Mitosis Modulators|mitosis modulators|mesh-ancestor
6798793|NCT02274012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6798794|NCT02274012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6798795|NCT02274012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6798796|NCT02274051|Kinetin|kinetin|mesh-list
6798797|NCT02274051|Plant Growth Regulators|plant growth regulators|mesh-ancestor
6798798|NCT02274051|Growth Substances|growth substances|mesh-ancestor
6798799|NCT02274051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798800|NCT02274077|Bupivacaine|bupivacaine|mesh-list
6798801|NCT02274077|Anesthetics, Local|anesthetics, local|mesh-ancestor
6798802|NCT02274077|Anesthetics|anesthetics|mesh-ancestor
6798803|NCT02274077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6798804|NCT02274077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798805|NCT02274077|Sensory System Agents|sensory system agents|mesh-ancestor
6798806|NCT02274077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6798807|NCT02274090|Metformin|metformin|mesh-list
6798808|NCT02274090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6798809|NCT02274090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798810|NCT02274142|Methamphetamine|methamphetamine|mesh-list
6798811|NCT02274142|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6798812|NCT02274142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798813|NCT02274142|Sympathomimetics|sympathomimetics|mesh-ancestor
6798814|NCT02274142|Autonomic Agents|autonomic agents|mesh-ancestor
6798815|NCT02274142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6798816|NCT02274142|Dopamine Agents|dopamine agents|mesh-ancestor
6535857|NCT00814125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6535858|NCT00814125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535859|NCT00814125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6535860|NCT00814125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6535861|NCT00814125|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6535862|NCT00814125|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6535863|NCT00814125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6535864|NCT00814125|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6535865|NCT00814125|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6535866|NCT00814125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6535867|NCT00814125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6798817|NCT02274142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6798818|NCT02274142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6798819|NCT02274142|Adrenergic Agents|adrenergic agents|mesh-ancestor
6798820|NCT02274142|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6798821|NCT02274142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6798822|NCT02274142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6798823|NCT02274142|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6798824|NCT02274155|Antibodies|antibodies|mesh-list
6798825|NCT02274155|Immunologic Factors|immunologic factors|mesh-ancestor
6798826|NCT02274155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798827|NCT02274181|Enclomiphene|enclomiphene|mesh-list
6798828|NCT02274181|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6798829|NCT02274181|Hormone Antagonists|hormone antagonists|mesh-ancestor
6798830|NCT02274181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6798831|NCT02274181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798832|NCT02274181|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6798833|NCT02274181|Fertility Agents|fertility agents|mesh-ancestor
6798834|NCT02274181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6798835|NCT02274181|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6798836|NCT02274181|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6798837|NCT02274259|Ranibizumab|ranibizumab|mesh-list
6798838|NCT02274259|Aflibercept|aflibercept|mesh-list
6798839|NCT02274259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6798840|NCT02274259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6798841|NCT02274259|Growth Substances|growth substances|mesh-ancestor
6798842|NCT02274259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798843|NCT02274259|Growth Inhibitors|growth inhibitors|mesh-ancestor
6798844|NCT02274259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6798845|NCT02274285|Vaccines|vaccines|mesh-list
6798846|NCT02274285|Immunologic Factors|immunologic factors|mesh-ancestor
6798847|NCT02274285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798848|NCT02274337|Abivertinib|abivertinib|mesh-list
6798849|NCT02274337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6798850|NCT02274337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6798851|NCT02274337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6798852|NCT02274415|Vaccines|vaccines|mesh-list
6798853|NCT02274415|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6798854|NCT02274415|Immunologic Factors|immunologic factors|mesh-ancestor
6798855|NCT02274415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798856|NCT02274454|Oxytocin|oxytocin|mesh-list
6798857|NCT02274454|Calcium|calcium|mesh-list
6798858|NCT02274454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6798859|NCT02274454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798860|NCT02274454|Oxytocics|oxytocics|mesh-ancestor
6798861|NCT02274454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6798862|NCT02274506|Vidarabine|vidarabine|mesh-list
6798863|NCT02274506|Cyclophosphamide|cyclophosphamide|mesh-list
6798864|NCT02274506|Fludarabine|fludarabine|mesh-list
6798865|NCT02274506|Fludarabine phosphate|fludarabine phosphate|mesh-list
6798866|NCT02274506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6798867|NCT02274506|Immunologic Factors|immunologic factors|mesh-ancestor
6798868|NCT02274506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798869|NCT02274506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6798870|NCT02274506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6798871|NCT02274506|Alkylating Agents|alkylating agents|mesh-ancestor
6798872|NCT02274506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6798873|NCT02274506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6798874|NCT02274506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6798875|NCT02274506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6798876|NCT02274506|Antimetabolites|antimetabolites|mesh-ancestor
6798877|NCT02274506|Antiviral Agents|antiviral agents|mesh-ancestor
6798878|NCT02274506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6535868|NCT00814216|Fluticasone|fluticasone|mesh-list
6535869|NCT00814216|Xhance|xhance|mesh-list
6535870|NCT00814216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6535871|NCT00814216|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6535872|NCT00814216|Autonomic Agents|autonomic agents|mesh-ancestor
6535873|NCT00814216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6535874|NCT00814216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535875|NCT00814216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6535876|NCT00814216|Respiratory System Agents|respiratory system agents|mesh-ancestor
6535877|NCT00814216|Dermatologic Agents|dermatologic agents|mesh-ancestor
6535878|NCT00814216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6535879|NCT00814229|Vaccines|vaccines|mesh-list
6535880|NCT00814229|Aluminum sulfate|aluminum sulfate|mesh-list
6535881|NCT00814229|Immunologic Factors|immunologic factors|mesh-ancestor
5993114|NCT00119106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5993115|NCT00119106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5993116|NCT00119106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5993117|NCT00119106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5993118|NCT00119106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5993119|NCT00119106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5993120|NCT00119158|Fluticasone|fluticasone|mesh-list
5993121|NCT00119158|Xhance|xhance|mesh-list
5993122|NCT00119158|Pimecrolimus|pimecrolimus|mesh-list
5993123|NCT00119158|Tacrolimus|tacrolimus|mesh-list
5993124|NCT00119158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5993125|NCT00119158|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5993126|NCT00119158|Autonomic Agents|autonomic agents|mesh-ancestor
5993127|NCT00119158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5993128|NCT00119158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993129|NCT00119158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5993130|NCT00119158|Respiratory System Agents|respiratory system agents|mesh-ancestor
5993131|NCT00119158|Dermatologic Agents|dermatologic agents|mesh-ancestor
5993132|NCT00119158|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5993133|NCT00119158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5993134|NCT00119158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5993135|NCT00119158|Analgesics|analgesics|mesh-ancestor
5993136|NCT00119158|Sensory System Agents|sensory system agents|mesh-ancestor
5993137|NCT00119158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5993138|NCT00119158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5993139|NCT00119158|Immunologic Factors|immunologic factors|mesh-ancestor
5993140|NCT00119158|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5993141|NCT00119158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5993142|NCT00119158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5993143|NCT00119262|Tamoxifen|tamoxifen|mesh-list
5993144|NCT00119262|Cyclophosphamide|cyclophosphamide|mesh-list
6258444|NCT03087604|Anesthetics|anesthetics|mesh-ancestor
6258445|NCT03087604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6258446|NCT03087604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258447|NCT03087604|Sensory System Agents|sensory system agents|mesh-ancestor
6535882|NCT00814229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535883|NCT00814229|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6535884|NCT00814268|Aspirin|aspirin|mesh-list
6535885|NCT00814268|Clopidogrel|clopidogrel|mesh-list
6535886|NCT00814268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6798879|NCT02274545|Vaccines|vaccines|mesh-list
6798880|NCT02274545|Immunologic Factors|immunologic factors|mesh-ancestor
6798881|NCT02274545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993145|NCT00119262|Bevacizumab|bevacizumab|mesh-list
5993146|NCT00119262|Doxorubicin|doxorubicin|mesh-list
6535887|NCT00814268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6535888|NCT00814268|Analgesics|analgesics|mesh-ancestor
6535889|NCT00814268|Sensory System Agents|sensory system agents|mesh-ancestor
6535890|NCT00814268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6535891|NCT00814268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535892|NCT00814268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6535893|NCT00814268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6535894|NCT00814268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6535895|NCT00814268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6535896|NCT00814268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535897|NCT00814268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6535898|NCT00814268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6535899|NCT00814268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6535900|NCT00814268|Antipyretics|antipyretics|mesh-ancestor
6535901|NCT00814268|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6535902|NCT00814268|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6535903|NCT00814268|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6535904|NCT00814268|Purinergic Agents|purinergic agents|mesh-ancestor
6535905|NCT00814268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6535906|NCT00814281|Montelukast|montelukast|mesh-list
6535907|NCT00814281|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6535908|NCT00814281|Respiratory System Agents|respiratory system agents|mesh-ancestor
6535909|NCT00814281|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6535910|NCT00814281|Hormone Antagonists|hormone antagonists|mesh-ancestor
6535911|NCT00814281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6535912|NCT00814281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535913|NCT00814281|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6535914|NCT00814281|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6535915|NCT00814281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535916|NCT00814359|Benzydamine|benzydamine|mesh-list
6535917|NCT00814359|Sucralfate|sucralfate|mesh-list
6535918|NCT00814359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6535919|NCT00814359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6535920|NCT00814359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6798882|NCT02274610|Docetaxel|docetaxel|mesh-list
6798883|NCT02274610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6798884|NCT02274610|Tubulin Modulators|tubulin modulators|mesh-ancestor
6798885|NCT02274610|Antimitotic Agents|antimitotic agents|mesh-ancestor
6798886|NCT02274610|Mitosis Modulators|mitosis modulators|mesh-ancestor
6798887|NCT02274610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6798888|NCT02274623|Calcifediol|calcifediol|mesh-list
6798889|NCT02274623|Vitamins|vitamins|mesh-ancestor
6798890|NCT02274623|Micronutrients|micronutrients|mesh-ancestor
6798891|NCT02274623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798892|NCT02274623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6798893|NCT02274662|Cyclosporine|cyclosporine|mesh-list
6798894|NCT02274662|Tacrolimus|tacrolimus|mesh-list
6798895|NCT02274662|Cyclosporins|cyclosporins|mesh-list
6798896|NCT02274662|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6798897|NCT02274662|Thymoglobulin|thymoglobulin|mesh-list
6798898|NCT02274662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6798899|NCT02274662|Immunologic Factors|immunologic factors|mesh-ancestor
6798900|NCT02274662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798901|NCT02274662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6798902|NCT02274662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6798903|NCT02274662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6798904|NCT02274662|Antifungal Agents|antifungal agents|mesh-ancestor
6798905|NCT02274662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6798906|NCT02274662|Dermatologic Agents|dermatologic agents|mesh-ancestor
6798907|NCT02274662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6798908|NCT02274740|Metformin|metformin|mesh-list
6798909|NCT02274740|Lixisenatide|lixisenatide|mesh-list
6798910|NCT02274740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6798911|NCT02274740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798912|NCT02274779|Leuprolide|leuprolide|mesh-list
6798913|NCT02274779|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6798914|NCT02274779|Fertility Agents|fertility agents|mesh-ancestor
6798915|NCT02274779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6798916|NCT02274779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798917|NCT02274779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6798918|NCT02274779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6798919|NCT02274961|Pantoprazole|pantoprazole|mesh-list
6798920|NCT02274961|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6798921|NCT02274961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6798922|NCT02274961|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6798923|NCT02274961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6798924|NCT02274961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535921|NCT00814515|Cyclosporine|cyclosporine|mesh-list
6535922|NCT00814515|Cyclosporins|cyclosporins|mesh-list
6535923|NCT00814515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6535924|NCT00814515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535925|NCT00814515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6535926|NCT00814515|Immunologic Factors|immunologic factors|mesh-ancestor
6535927|NCT00814515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535928|NCT00814515|Antifungal Agents|antifungal agents|mesh-ancestor
6535929|NCT00814515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6535930|NCT00814515|Dermatologic Agents|dermatologic agents|mesh-ancestor
6535931|NCT00814515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6535932|NCT00814515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6535933|NCT00814528|Imiquimod|imiquimod|mesh-list
6535934|NCT00814528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6535935|NCT00814528|Immunologic Factors|immunologic factors|mesh-ancestor
6535936|NCT00814528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535937|NCT00814528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6535938|NCT00814528|Interferon Inducers|interferon inducers|mesh-ancestor
6535939|NCT00814541|Dexamethasone|dexamethasone|mesh-list
6535940|NCT00814541|Doxorubicin|doxorubicin|mesh-list
6535941|NCT00814541|Bortezomib|bortezomib|mesh-list
6535942|NCT00814541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6535943|NCT00814541|Antiemetics|antiemetics|mesh-ancestor
6535944|NCT00814541|Autonomic Agents|autonomic agents|mesh-ancestor
6535945|NCT00814541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6535946|NCT00814541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535947|NCT00814541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6535948|NCT00814541|Glucocorticoids|glucocorticoids|mesh-ancestor
6535949|NCT00814541|Hormones|hormones|mesh-ancestor
6535950|NCT00814541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6535951|NCT00814541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6535952|NCT00814541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6535953|NCT00814541|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6535954|NCT00814541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6535955|NCT00814541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6535956|NCT00814541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6535957|NCT00814541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535958|NCT00814593|Carmustine|carmustine|mesh-list
6535959|NCT00814593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6535960|NCT00814593|Alkylating Agents|alkylating agents|mesh-ancestor
6535961|NCT00814593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535962|NCT00814593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6535963|NCT00814606|Ribavirin|ribavirin|mesh-list
6535964|NCT00814606|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6535965|NCT00814606|Antimetabolites|antimetabolites|mesh-ancestor
6535966|NCT00814606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535967|NCT00814606|Antiviral Agents|antiviral agents|mesh-ancestor
6798925|NCT02274974|Lidocaine|lidocaine|mesh-list
6798926|NCT02274974|Epinephrine|epinephrine|mesh-list
6798927|NCT02274974|Anesthetics, Local|anesthetics, local|mesh-list
6798928|NCT02274974|Anesthetics|anesthetics|mesh-list
6798929|NCT02274974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6798930|NCT02274974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798931|NCT02274974|Sensory System Agents|sensory system agents|mesh-ancestor
6798932|NCT02274974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6798933|NCT02274974|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6798934|NCT02274974|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6798935|NCT02274974|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6798936|NCT02274974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6798937|NCT02274974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6798938|NCT02274974|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6798939|NCT02274974|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6798940|NCT02274974|Adrenergic Agents|adrenergic agents|mesh-ancestor
6798941|NCT02274974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6798942|NCT02274974|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6798943|NCT02274974|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6798944|NCT02274974|Autonomic Agents|autonomic agents|mesh-ancestor
6798945|NCT02274974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6798946|NCT02274974|Respiratory System Agents|respiratory system agents|mesh-ancestor
6798947|NCT02274974|Mydriatics|mydriatics|mesh-ancestor
6798948|NCT02274974|Sympathomimetics|sympathomimetics|mesh-ancestor
6798949|NCT02274974|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6798950|NCT02275013|Simendan|simendan|mesh-list
6798951|NCT02275013|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6798952|NCT02275013|Vasodilator Agents|vasodilator agents|mesh-ancestor
6798953|NCT02275013|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6535968|NCT00814606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6535969|NCT00814619|Capecitabine|capecitabine|mesh-list
6535970|NCT00814619|Panitumumab|panitumumab|mesh-list
6535971|NCT00814619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6535972|NCT00814619|Antimetabolites|antimetabolites|mesh-ancestor
6535973|NCT00814619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535974|NCT00814619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6535975|NCT00814619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6535976|NCT00814645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6535977|NCT00814723|Ezetimibe|ezetimibe|mesh-list
6535978|NCT00814723|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6535979|NCT00814723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6535980|NCT00814723|Antimetabolites|antimetabolites|mesh-ancestor
6535981|NCT00814723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535982|NCT00814723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6535983|NCT00814736|Sildenafil Citrate|sildenafil citrate|mesh-list
6535984|NCT00814736|Vasodilator Agents|vasodilator agents|mesh-ancestor
6535985|NCT00814736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6535986|NCT00814736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6535987|NCT00814736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6535988|NCT00814736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6535989|NCT00814736|Urological Agents|urological agents|mesh-ancestor
6535990|NCT00814762|Vaccines|vaccines|mesh-list
6535991|NCT00814762|Immunologic Factors|immunologic factors|mesh-ancestor
6535992|NCT00814762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6535993|NCT00814866|Adalimumab|adalimumab|mesh-list
6535994|NCT00814866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6535995|NCT00814866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6535996|NCT00814905|Clindamycin|clindamycin|mesh-list
6798954|NCT02275013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6798955|NCT02275013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6798956|NCT02275013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6798957|NCT02275013|Protective Agents|protective agents|mesh-ancestor
6798958|NCT02275013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798959|NCT02275039|Gemcitabine|gemcitabine|mesh-list
6798960|NCT02275039|Vaccines|vaccines|mesh-list
6798961|NCT02275039|Immunologic Factors|immunologic factors|mesh-ancestor
6798962|NCT02275039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798963|NCT02275039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6798964|NCT02275039|Antimetabolites|antimetabolites|mesh-ancestor
6798965|NCT02275039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6798966|NCT02275039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6798967|NCT02275039|Antiviral Agents|antiviral agents|mesh-ancestor
6798968|NCT02275039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6798969|NCT02275039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6798970|NCT02275039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6798971|NCT02275130|Calcium, Dietary|calcium, dietary|mesh-list
6798972|NCT02275130|Calcium|calcium|mesh-list
6798973|NCT02275130|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6798974|NCT02275130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798975|NCT02275130|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6798976|NCT02275182|Dexmedetomidine|dexmedetomidine|mesh-list
6798977|NCT02275182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6798978|NCT02275182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6798979|NCT02275182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798980|NCT02275182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6798981|NCT02275182|Analgesics|analgesics|mesh-ancestor
6798982|NCT02275182|Sensory System Agents|sensory system agents|mesh-ancestor
6798983|NCT02275182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6798984|NCT02275182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6798985|NCT02275182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6798986|NCT02275182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6798987|NCT02275182|Adrenergic Agents|adrenergic agents|mesh-ancestor
6798988|NCT02275182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6798989|NCT02275182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6798990|NCT02275247|Ropivacaine|ropivacaine|mesh-list
6798991|NCT02275247|Anesthetics|anesthetics|mesh-ancestor
6798992|NCT02275247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6798993|NCT02275247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6798994|NCT02275247|Anesthetics, Local|anesthetics, local|mesh-ancestor
6798995|NCT02275247|Sensory System Agents|sensory system agents|mesh-ancestor
6798996|NCT02275247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6798997|NCT02275286|Trabectedin|trabectedin|mesh-list
6798998|NCT02275286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6535997|NCT00814905|Clindamycin palmitate|clindamycin palmitate|mesh-list
6535998|NCT00814905|Clindamycin phosphate|clindamycin phosphate|mesh-list
6535999|NCT00814905|Gentamicins|gentamicins|mesh-list
6536000|NCT00814905|Ampicillin|ampicillin|mesh-list
6536001|NCT00814905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6536002|NCT00814905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6536003|NCT00814905|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6536004|NCT00814905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6536005|NCT00814905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536006|NCT00814918|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6536007|NCT00814918|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6536008|NCT00814918|Dermatologic Agents|dermatologic agents|mesh-ancestor
6536009|NCT00814944|Sirolimus|sirolimus|mesh-list
6536010|NCT00814944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6536011|NCT00814944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6536012|NCT00814944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6536013|NCT00814944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6536014|NCT00814944|Antifungal Agents|antifungal agents|mesh-ancestor
6536015|NCT00814944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6536016|NCT00814944|Immunologic Factors|immunologic factors|mesh-ancestor
6536017|NCT00814944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536018|NCT00815022|Fentanyl|fentanyl|mesh-list
6536019|NCT00815022|Morphine|morphine|mesh-list
6536020|NCT00815022|Bupivacaine|bupivacaine|mesh-list
6536021|NCT00815022|Anesthetics, Local|anesthetics, local|mesh-ancestor
6536022|NCT00815022|Anesthetics|anesthetics|mesh-ancestor
6536023|NCT00815022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6536024|NCT00815022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536025|NCT00815022|Sensory System Agents|sensory system agents|mesh-ancestor
6536026|NCT00815022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6536027|NCT00815022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6536028|NCT00815022|Narcotics|narcotics|mesh-ancestor
6536029|NCT00815022|Analgesics|analgesics|mesh-ancestor
6536030|NCT00815022|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6536031|NCT00815022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6536032|NCT00815022|Anesthetics, General|anesthetics, general|mesh-ancestor
6536033|NCT00815048|Atropine|atropine|mesh-list
6536034|NCT00815048|Fentanyl|fentanyl|mesh-list
6536035|NCT00815048|Remifentanil|remifentanil|mesh-list
6536036|NCT00815048|Succinylcholine|succinylcholine|mesh-list
6536037|NCT00815048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6536038|NCT00815048|Narcotics|narcotics|mesh-ancestor
6536039|NCT00815048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6536040|NCT00815048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536041|NCT00815048|Analgesics|analgesics|mesh-ancestor
6536042|NCT00815048|Sensory System Agents|sensory system agents|mesh-ancestor
6536043|NCT00815048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6536044|NCT00815048|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6536045|NCT00815048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6536046|NCT00815048|Anesthetics, General|anesthetics, general|mesh-ancestor
6536047|NCT00815048|Anesthetics|anesthetics|mesh-ancestor
6536048|NCT00815048|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6536049|NCT00815048|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6536050|NCT00815048|Autonomic Agents|autonomic agents|mesh-ancestor
6536051|NCT00815048|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6536052|NCT00815048|Respiratory System Agents|respiratory system agents|mesh-ancestor
6536053|NCT00815048|Mydriatics|mydriatics|mesh-ancestor
6536054|NCT00815048|Parasympatholytics|parasympatholytics|mesh-ancestor
6536055|NCT00815048|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6536056|NCT00815048|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6536057|NCT00815048|Cholinergic Agents|cholinergic agents|mesh-ancestor
6536058|NCT00815048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6536059|NCT00815048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536060|NCT00815048|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
6536061|NCT00815048|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6536062|NCT00815048|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6537999|NCT00825149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538000|NCT00825149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6538001|NCT00825149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6538002|NCT00825149|Alkylating Agents|alkylating agents|mesh-ancestor
6538003|NCT00825149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538004|NCT00825149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6538005|NCT00825149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6538006|NCT00825149|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6538007|NCT00825149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6538008|NCT00825149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6538009|NCT00825149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6536063|NCT00815204|Dexamethasone|dexamethasone|mesh-list
6536064|NCT00815204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6536065|NCT00815204|Antiemetics|antiemetics|mesh-ancestor
6536066|NCT00815204|Autonomic Agents|autonomic agents|mesh-ancestor
6536067|NCT00815204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6536068|NCT00815204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536069|NCT00815204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6536070|NCT00815204|Glucocorticoids|glucocorticoids|mesh-ancestor
6536071|NCT00815204|Hormones|hormones|mesh-ancestor
6536072|NCT00815204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6536073|NCT00815204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6536074|NCT00815204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6536075|NCT00815256|Riboflavin|riboflavin|mesh-list
6536076|NCT00815256|Vitamin B Complex|vitamin b complex|mesh-ancestor
6536077|NCT00815256|Vitamins|vitamins|mesh-ancestor
6536078|NCT00815256|Micronutrients|micronutrients|mesh-ancestor
6798999|NCT02275286|Alkylating Agents|alkylating agents|mesh-ancestor
6799000|NCT02275286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799001|NCT02275286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6799002|NCT02275299|Methotrexate|methotrexate|mesh-list
6799003|NCT02275299|Leflunomide|leflunomide|mesh-list
6799004|NCT02275299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6799005|NCT02275299|Abortifacient Agents|abortifacient agents|mesh-ancestor
6799006|NCT02275299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6799007|NCT02275299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799008|NCT02275299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6799009|NCT02275299|Antimetabolites|antimetabolites|mesh-ancestor
6799010|NCT02275299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799011|NCT02275299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6799012|NCT02275299|Dermatologic Agents|dermatologic agents|mesh-ancestor
6799013|NCT02275299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6799014|NCT02275299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6799015|NCT02275299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6799016|NCT02275299|Immunologic Factors|immunologic factors|mesh-ancestor
6799017|NCT02275299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6799018|NCT02275299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6799019|NCT02275416|Ipilimumab|ipilimumab|mesh-list
6799020|NCT02275416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6799021|NCT02275416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6799022|NCT02275416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6799023|NCT02275416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799024|NCT02275533|Nivolumab|nivolumab|mesh-list
6799025|NCT02275533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6799026|NCT02275533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6799027|NCT02275533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6799028|NCT02275533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799029|NCT02275598|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6799030|NCT02275598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6799031|NCT02275598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6799032|NCT02275663|Cytarabine|cytarabine|mesh-list
6799033|NCT02275663|Fludarabine|fludarabine|mesh-list
6799034|NCT02275663|Azacitidine|azacitidine|mesh-list
6799035|NCT02275663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6799036|NCT02275663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6799037|NCT02275663|Antimetabolites|antimetabolites|mesh-ancestor
6799038|NCT02275663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799039|NCT02275663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6799040|NCT02275663|Immunologic Factors|immunologic factors|mesh-ancestor
6799041|NCT02275663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799042|NCT02275663|Antiviral Agents|antiviral agents|mesh-ancestor
6799043|NCT02275663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6799044|NCT02275663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6799045|NCT02275702|Dexamethasone|dexamethasone|mesh-list
6799046|NCT02275702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6799047|NCT02275702|Antiemetics|antiemetics|mesh-ancestor
6799048|NCT02275702|Autonomic Agents|autonomic agents|mesh-ancestor
6799049|NCT02275702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6799050|NCT02275702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799051|NCT02275702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6799052|NCT02275702|Glucocorticoids|glucocorticoids|mesh-ancestor
6799053|NCT02275702|Hormones|hormones|mesh-ancestor
6799054|NCT02275702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6536079|NCT00815256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536080|NCT00815256|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6536081|NCT00815256|Dermatologic Agents|dermatologic agents|mesh-ancestor
6536082|NCT00815269|Sevoflurane|sevoflurane|mesh-list
6536083|NCT00815269|Desflurane|desflurane|mesh-list
6536084|NCT00815269|Isoflurane|isoflurane|mesh-list
6536085|NCT00815269|Halothane|halothane|mesh-list
6536086|NCT00815269|Enflurane|enflurane|mesh-list
6536087|NCT00815269|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6536088|NCT00815269|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6536089|NCT00815269|Anesthetics, General|anesthetics, general|mesh-ancestor
6536090|NCT00815269|Anesthetics|anesthetics|mesh-ancestor
6536091|NCT00815269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6536092|NCT00815269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536093|NCT00815282|Vaccines|vaccines|mesh-list
6536094|NCT00815282|Immunologic Factors|immunologic factors|mesh-ancestor
6536095|NCT00815282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536096|NCT00815373|Timolol|timolol|mesh-list
6536097|NCT00815373|Dorzolamide|dorzolamide|mesh-list
6536098|NCT00815373|Latanoprost|latanoprost|mesh-list
6536099|NCT00815373|Maleic acid|maleic acid|mesh-list
6536100|NCT00815373|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6536101|NCT00815373|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6536102|NCT00815373|Adrenergic Agents|adrenergic agents|mesh-ancestor
6536103|NCT00815373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6536104|NCT00815373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536105|NCT00815373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536106|NCT00815373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6536107|NCT00815373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6536108|NCT00815373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6536109|NCT00815373|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6536110|NCT00815373|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6536111|NCT00815373|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6536112|NCT00815399|Metformin|metformin|mesh-list
6536113|NCT00815399|Pioglitazone|pioglitazone|mesh-list
6536114|NCT00815399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6536115|NCT00815399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536116|NCT00815464|Antiviral Agents|antiviral agents|mesh-list
6536117|NCT00815464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6536118|NCT00815503|Ropivacaine|ropivacaine|mesh-list
6536119|NCT00815503|Anesthetics, Local|anesthetics, local|mesh-ancestor
6536120|NCT00815503|Anesthetics|anesthetics|mesh-ancestor
6536121|NCT00815503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6536122|NCT00815503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536123|NCT00815503|Sensory System Agents|sensory system agents|mesh-ancestor
6536124|NCT00815503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6536125|NCT00815542|Dinoprostone|dinoprostone|mesh-list
6536126|NCT00815542|Oxytocics|oxytocics|mesh-ancestor
6536127|NCT00815542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6536128|NCT00815542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536129|NCT00815568|Vidarabine|vidarabine|mesh-list
6536130|NCT00815568|Fludarabine|fludarabine|mesh-list
6536131|NCT00815568|Fludarabine phosphate|fludarabine phosphate|mesh-list
6536132|NCT00815568|Busulfan|busulfan|mesh-list
6536133|NCT00815568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6536134|NCT00815568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6536135|NCT00815568|Antimetabolites|antimetabolites|mesh-ancestor
6799055|NCT02275702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6799056|NCT02275702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6799057|NCT02275806|Irinotecan|irinotecan|mesh-list
6799058|NCT02275806|Camptothecin|camptothecin|mesh-list
6799059|NCT02275806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6799060|NCT02275806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6799061|NCT02275806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6799062|NCT02275806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6799063|NCT02275806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799064|NCT02275806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6799065|NCT02275832|Minoxidil|minoxidil|mesh-list
6799066|NCT02275832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6799067|NCT02275832|Vasodilator Agents|vasodilator agents|mesh-ancestor
6799068|NCT02275845|Metformin|metformin|mesh-list
6799069|NCT02275845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6799070|NCT02275845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799071|NCT02275897|Methamphetamine|methamphetamine|mesh-list
6799072|NCT02275897|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6799073|NCT02275897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536136|NCT00815568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536137|NCT00815568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6536138|NCT00815568|Immunologic Factors|immunologic factors|mesh-ancestor
6799074|NCT02275897|Sympathomimetics|sympathomimetics|mesh-ancestor
6799075|NCT02275897|Autonomic Agents|autonomic agents|mesh-ancestor
6536139|NCT00815568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536140|NCT00815568|Antiviral Agents|antiviral agents|mesh-ancestor
6536141|NCT00815568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6536142|NCT00815568|Alkylating Agents|alkylating agents|mesh-ancestor
6536143|NCT00815568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6536144|NCT00815568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6536145|NCT00815594|Bevacizumab|bevacizumab|mesh-list
6536146|NCT00815594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6536147|NCT00815594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6536148|NCT00815594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6536149|NCT00815594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6536150|NCT00815594|Growth Substances|growth substances|mesh-ancestor
6536151|NCT00815594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536152|NCT00815594|Growth Inhibitors|growth inhibitors|mesh-ancestor
6536153|NCT00815646|Sildenafil Citrate|sildenafil citrate|mesh-list
6536154|NCT00815646|Vasodilator Agents|vasodilator agents|mesh-ancestor
6536155|NCT00815646|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6536156|NCT00815646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6536157|NCT00815646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6536158|NCT00815646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536159|NCT00815646|Urological Agents|urological agents|mesh-ancestor
6536160|NCT00815841|Methylphenidate|methylphenidate|mesh-list
6536161|NCT00815841|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6536162|NCT00815841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536163|NCT00815841|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6536164|NCT00815841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6536165|NCT00815841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6536166|NCT00815841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536167|NCT00815841|Dopamine Agents|dopamine agents|mesh-ancestor
6799076|NCT02275897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6799077|NCT02275897|Dopamine Agents|dopamine agents|mesh-ancestor
6799078|NCT02275897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6799079|NCT02275897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799080|NCT02275897|Adrenergic Agents|adrenergic agents|mesh-ancestor
6799081|NCT02275897|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6799082|NCT02275897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6799083|NCT02275897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6799084|NCT02275897|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6799085|NCT02275962|Rifampin|rifampin|mesh-list
6799086|NCT02275962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6799087|NCT02275962|Antitubercular Agents|antitubercular agents|mesh-ancestor
6799088|NCT02275962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6799089|NCT02275962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6799090|NCT02275962|Leprostatic Agents|leprostatic agents|mesh-ancestor
6799091|NCT02275962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6799092|NCT02275962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6799093|NCT02275962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799094|NCT02275962|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6799095|NCT02275962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6799096|NCT02275962|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6799097|NCT02275962|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6799098|NCT02275962|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6799099|NCT02275962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6799100|NCT02275975|Fluconazole|fluconazole|mesh-list
6799101|NCT02275975|Antifungal Agents|antifungal agents|mesh-ancestor
6799102|NCT02275975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6799103|NCT02275975|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6799104|NCT02275975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6799105|NCT02275975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6799106|NCT02275975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799107|NCT02275975|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6799108|NCT02275975|Hormone Antagonists|hormone antagonists|mesh-ancestor
6799109|NCT02275975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6799110|NCT02275975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799111|NCT02275975|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6799112|NCT02275975|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6799113|NCT02275988|Clarithromycin|clarithromycin|mesh-list
6799114|NCT02275988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6799115|NCT02275988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6799116|NCT02275988|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6536168|NCT00815841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6536169|NCT00815854|Folic Acid|folic acid|mesh-list
6536170|NCT00815854|Hematinics|hematinics|mesh-ancestor
6536171|NCT00815854|Vitamin B Complex|vitamin b complex|mesh-ancestor
6536172|NCT00815854|Vitamins|vitamins|mesh-ancestor
6536173|NCT00815854|Micronutrients|micronutrients|mesh-ancestor
6536174|NCT00815854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536175|NCT00815867|Epoetin Alfa|epoetin alfa|mesh-list
6536176|NCT00815867|Hematinics|hematinics|mesh-ancestor
6536177|NCT00815893|Dexmedetomidine|dexmedetomidine|mesh-list
6536178|NCT00815893|Propofol|propofol|mesh-list
6536179|NCT00815893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6536180|NCT00815893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6799117|NCT02275988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6799118|NCT02275988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799119|NCT02275988|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6799120|NCT02275988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6799121|NCT02276001|Cyclosporine|cyclosporine|mesh-list
6799122|NCT02276001|Cyclosporins|cyclosporins|mesh-list
6799123|NCT02276001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6799124|NCT02276001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799125|NCT02276001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6799126|NCT02276001|Immunologic Factors|immunologic factors|mesh-ancestor
6799127|NCT02276001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799128|NCT02276001|Antifungal Agents|antifungal agents|mesh-ancestor
6799129|NCT02276001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6799130|NCT02276001|Dermatologic Agents|dermatologic agents|mesh-ancestor
6799131|NCT02276001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6799132|NCT02276001|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6799133|NCT02276014|Beta Carotene|beta carotene|mesh-list
6799134|NCT02276014|Carotenoids|carotenoids|mesh-list
6799135|NCT02276014|Antioxidants|antioxidants|mesh-ancestor
6799136|NCT02276014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799137|NCT02276014|Protective Agents|protective agents|mesh-ancestor
6799138|NCT02276014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799139|NCT02276014|Provitamins|provitamins|mesh-ancestor
6799140|NCT02276014|Vitamins|vitamins|mesh-ancestor
6799141|NCT02276014|Micronutrients|micronutrients|mesh-ancestor
6799142|NCT02276092|Anti-Infective Agents|anti-infective agents|mesh-list
6799143|NCT02276092|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6799144|NCT02276196|Insulin glulisine|insulin glulisine|mesh-list
6799145|NCT02276196|Lixisenatide|lixisenatide|mesh-list
6799146|NCT02276196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6799147|NCT02276196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799148|NCT02276300|Cyclophosphamide|cyclophosphamide|mesh-list
6799149|NCT02276300|Imiquimod|imiquimod|mesh-list
6799150|NCT02276300|Sargramostim|sargramostim|mesh-list
6799151|NCT02276300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6799152|NCT02276300|Immunologic Factors|immunologic factors|mesh-ancestor
6799153|NCT02276300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799154|NCT02276300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6799155|NCT02276300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6799156|NCT02276300|Alkylating Agents|alkylating agents|mesh-ancestor
6799157|NCT02276300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799158|NCT02276300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6799159|NCT02276300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6799160|NCT02276300|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6799161|NCT02276300|Interferon Inducers|interferon inducers|mesh-ancestor
6536181|NCT00815893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536182|NCT00815893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6536183|NCT00815893|Anesthetics, General|anesthetics, general|mesh-ancestor
6536184|NCT00815893|Anesthetics|anesthetics|mesh-ancestor
6536185|NCT00815893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6536186|NCT00815893|Analgesics|analgesics|mesh-ancestor
6536187|NCT00815893|Sensory System Agents|sensory system agents|mesh-ancestor
6536188|NCT00815893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6536189|NCT00815893|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6536190|NCT00815893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6536191|NCT00815893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6536192|NCT00815893|Adrenergic Agents|adrenergic agents|mesh-ancestor
6536193|NCT00815893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6536194|NCT00815893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536195|NCT00815945|Carboplatin|carboplatin|mesh-list
6536196|NCT00815945|Doxorubicin|doxorubicin|mesh-list
6536197|NCT00815945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6536198|NCT00815945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6536199|NCT00815945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6536200|NCT00815945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6536201|NCT00815945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6536202|NCT00815945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536203|NCT00816049|Mercaptopurine|mercaptopurine|mesh-list
6536204|NCT00816049|Antimetabolites|antimetabolites|mesh-ancestor
6536205|NCT00816049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536206|NCT00816049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6536207|NCT00816049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6536208|NCT00816049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6536209|NCT00816049|Immunologic Factors|immunologic factors|mesh-ancestor
6536210|NCT00816049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536211|NCT00816049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6536212|NCT00816049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6536213|NCT00816127|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
6536214|NCT00816127|Hemostatics|hemostatics|mesh-ancestor
6536215|NCT00816127|Coagulants|coagulants|mesh-ancestor
6536216|NCT00816127|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6536217|NCT00816127|Natriuretic Agents|natriuretic agents|mesh-ancestor
6536218|NCT00816127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536219|NCT00816140|Clarithromycin|clarithromycin|mesh-list
6536220|NCT00816140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6536221|NCT00816140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6536222|NCT00816140|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6536223|NCT00816140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6536224|NCT00816140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536225|NCT00816140|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6536226|NCT00816140|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6536227|NCT00816205|Nifedipine|nifedipine|mesh-list
6536228|NCT00816205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6799162|NCT02276365|Pioglitazone|pioglitazone|mesh-list
6799163|NCT02276365|Empagliflozin|empagliflozin|mesh-list
6799164|NCT02276365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6799165|NCT02276365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799166|NCT02276365|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6799167|NCT02276365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799168|NCT02276378|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6799169|NCT02276378|Telmisartan|telmisartan|mesh-list
6799170|NCT02276378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6799171|NCT02276378|Diuretics|diuretics|mesh-ancestor
6799172|NCT02276378|Natriuretic Agents|natriuretic agents|mesh-ancestor
6536229|NCT00816205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6536230|NCT00816205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536231|NCT00816205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6536232|NCT00816205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536233|NCT00816205|Vasodilator Agents|vasodilator agents|mesh-ancestor
6536234|NCT00816205|Tocolytic Agents|tocolytic agents|mesh-ancestor
6536235|NCT00816205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6536236|NCT00816218|Pioglitazone|pioglitazone|mesh-list
6536237|NCT00816218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6536238|NCT00816218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536239|NCT00816244|Atorvastatin|atorvastatin|mesh-list
6536240|NCT00816244|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6536241|NCT00816244|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6536242|NCT00816244|Antimetabolites|antimetabolites|mesh-ancestor
6536243|NCT00816244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536244|NCT00816244|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6536245|NCT00816244|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6536246|NCT00816244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6536247|NCT00816283|Dasatinib|dasatinib|mesh-list
6536248|NCT00816283|Vorinostat|vorinostat|mesh-list
6536249|NCT00816283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6536250|NCT00816283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6536251|NCT00816283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6536252|NCT00816283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536253|NCT00816283|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6536254|NCT00816335|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6536255|NCT00816335|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6536256|NCT00816335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536257|NCT00816413|Cyclosporine|cyclosporine|mesh-list
6536258|NCT00816413|Mycophenolic Acid|mycophenolic acid|mesh-list
6536259|NCT00816413|Pentostatin|pentostatin|mesh-list
6536260|NCT00816413|Cyclosporins|cyclosporins|mesh-list
6536261|NCT00816413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6536262|NCT00816413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536263|NCT00816413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6536264|NCT00816413|Immunologic Factors|immunologic factors|mesh-ancestor
6536265|NCT00816413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536266|NCT00816413|Antifungal Agents|antifungal agents|mesh-ancestor
6536267|NCT00816413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6536268|NCT00816413|Dermatologic Agents|dermatologic agents|mesh-ancestor
6536269|NCT00816413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6536270|NCT00816413|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6536271|NCT00816413|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6536272|NCT00816413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6536273|NCT00816413|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6536274|NCT00816413|Antitubercular Agents|antitubercular agents|mesh-ancestor
6536275|NCT00816413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6536276|NCT00816413|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
6536277|NCT00816426|Moxifloxacin|moxifloxacin|mesh-list
6536278|NCT00816426|Rifampin|rifampin|mesh-list
6536279|NCT00816426|Isoniazid|isoniazid|mesh-list
6536280|NCT00816426|Pyrazinamide|pyrazinamide|mesh-list
6536281|NCT00816426|Kanamycin|kanamycin|mesh-list
6536282|NCT00816426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6536283|NCT00816426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6536284|NCT00816426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6536285|NCT00816426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6536286|NCT00816426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6536287|NCT00816426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536288|NCT00816426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6536289|NCT00816426|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6799173|NCT02276378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799174|NCT02276378|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6799175|NCT02276378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6799176|NCT02276378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799177|NCT02276378|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6799178|NCT02276378|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6799179|NCT02276391|Telmisartan|telmisartan|mesh-list
6799180|NCT02276391|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6799181|NCT02276391|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6799182|NCT02276391|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6799183|NCT02276391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799184|NCT02276495|Ketorolac|ketorolac|mesh-list
6799185|NCT02276495|Clonidine|clonidine|mesh-list
6799186|NCT02276495|Epinephrine|epinephrine|mesh-list
6536290|NCT00816426|Antitubercular Agents|antitubercular agents|mesh-ancestor
6536291|NCT00816426|Leprostatic Agents|leprostatic agents|mesh-ancestor
6536292|NCT00816426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6536293|NCT00816426|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6536294|NCT00816426|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6536295|NCT00816426|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6536296|NCT00816426|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6536297|NCT00816426|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6536298|NCT00816426|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6536299|NCT00816426|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6536300|NCT00816426|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6536301|NCT00816426|Antimetabolites|antimetabolites|mesh-ancestor
6536302|NCT00816426|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6536303|NCT00816426|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6536304|NCT00816517|Botulinum Toxins|botulinum toxins|mesh-list
6536305|NCT00816517|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6536306|NCT00816517|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6536307|NCT00816517|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6536308|NCT00816517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6536309|NCT00816517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536310|NCT00816517|Cholinergic Agents|cholinergic agents|mesh-ancestor
6536311|NCT00816517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6536312|NCT00816517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536313|NCT00816517|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6536314|NCT00816517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6536315|NCT00816543|Docetaxel|docetaxel|mesh-list
6536316|NCT00816543|Oxaliplatin|oxaliplatin|mesh-list
6536317|NCT00816543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6536318|NCT00816543|Tubulin Modulators|tubulin modulators|mesh-ancestor
6536319|NCT00816543|Antimitotic Agents|antimitotic agents|mesh-ancestor
6536320|NCT00816543|Mitosis Modulators|mitosis modulators|mesh-ancestor
6536321|NCT00816543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536322|NCT00816634|Paclitaxel|paclitaxel|mesh-list
6536323|NCT00816634|Capecitabine|capecitabine|mesh-list
6799187|NCT02276495|Ropivacaine|ropivacaine|mesh-list
6799188|NCT02276495|Anesthetics, Local|anesthetics, local|mesh-ancestor
6799189|NCT02276495|Anesthetics|anesthetics|mesh-ancestor
6799190|NCT02276495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6799191|NCT02276495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799192|NCT02276495|Sensory System Agents|sensory system agents|mesh-ancestor
6799193|NCT02276495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6799194|NCT02276495|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6799195|NCT02276495|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6799196|NCT02276495|Adrenergic Agents|adrenergic agents|mesh-ancestor
6799197|NCT02276495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6799198|NCT02276495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799199|NCT02276495|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6799200|NCT02276495|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6799201|NCT02276495|Autonomic Agents|autonomic agents|mesh-ancestor
6799202|NCT02276495|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6799203|NCT02276495|Respiratory System Agents|respiratory system agents|mesh-ancestor
6799204|NCT02276495|Mydriatics|mydriatics|mesh-ancestor
6799205|NCT02276495|Sympathomimetics|sympathomimetics|mesh-ancestor
6799206|NCT02276495|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6799207|NCT02276495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6799208|NCT02276495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6799209|NCT02276495|Analgesics|analgesics|mesh-ancestor
6799210|NCT02276495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6799211|NCT02276495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6799212|NCT02276495|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6799213|NCT02276495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6799214|NCT02276495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6799215|NCT02276495|Sympatholytics|sympatholytics|mesh-ancestor
6799216|NCT02276495|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6799217|NCT02276677|Oxytocin|oxytocin|mesh-list
6799218|NCT02276677|Oxytocics|oxytocics|mesh-ancestor
6799219|NCT02276677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6799220|NCT02276677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799221|NCT02276690|Hepcidins|hepcidins|mesh-list
6799222|NCT02276690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6799223|NCT02276755|Vitamin D|vitamin d|mesh-list
6799224|NCT02276755|Cholecalciferol|cholecalciferol|mesh-list
6799225|NCT02276755|Vitamins|vitamins|mesh-ancestor
6799226|NCT02276755|Micronutrients|micronutrients|mesh-ancestor
6799227|NCT02276755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799228|NCT02276755|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6799229|NCT02276755|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6799230|NCT02276768|Trimebutine|trimebutine|mesh-list
6799231|NCT02276768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6799232|NCT02276768|Parasympatholytics|parasympatholytics|mesh-ancestor
6799233|NCT02276768|Autonomic Agents|autonomic agents|mesh-ancestor
6799234|NCT02276768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6799235|NCT02276768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799236|NCT02276846|Paclitaxel|paclitaxel|mesh-list
6799237|NCT02276846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6799238|NCT02276846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6799239|NCT02276846|Tubulin Modulators|tubulin modulators|mesh-ancestor
6799240|NCT02276846|Antimitotic Agents|antimitotic agents|mesh-ancestor
6799241|NCT02276846|Mitosis Modulators|mitosis modulators|mesh-ancestor
6799242|NCT02276846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799243|NCT02276859|Insulin|insulin|mesh-list
6799244|NCT02276859|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6799245|NCT02276859|Insulin Aspart|insulin aspart|mesh-list
6799246|NCT02276859|Insulin Lispro|insulin lispro|mesh-list
6799247|NCT02276859|Insulin glulisine|insulin glulisine|mesh-list
6799248|NCT02276859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6799249|NCT02276859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799250|NCT02276911|Ibuprofen|ibuprofen|mesh-list
6799251|NCT02276911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6799252|NCT02276911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6799253|NCT02276911|Analgesics|analgesics|mesh-ancestor
6799254|NCT02276911|Sensory System Agents|sensory system agents|mesh-ancestor
6799255|NCT02276911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6799256|NCT02276911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799257|NCT02276911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6799258|NCT02276911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6799259|NCT02276911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6799260|NCT02276911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6799261|NCT02276911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799262|NCT02276989|Riboflavin|riboflavin|mesh-list
6799263|NCT02276989|Quinine|quinine|mesh-list
6799264|NCT02276989|Acetazolamide|acetazolamide|mesh-list
6799265|NCT02276989|Vitamins|vitamins|mesh-ancestor
6799266|NCT02276989|Micronutrients|micronutrients|mesh-ancestor
6799267|NCT02276989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799268|NCT02276989|Vitamin B Complex|vitamin b complex|mesh-ancestor
6799269|NCT02276989|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6799270|NCT02276989|Dermatologic Agents|dermatologic agents|mesh-ancestor
6799271|NCT02276989|Anticonvulsants|anticonvulsants|mesh-ancestor
6799272|NCT02276989|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6799273|NCT02276989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6799274|NCT02276989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799275|NCT02276989|Diuretics|diuretics|mesh-ancestor
6799276|NCT02276989|Natriuretic Agents|natriuretic agents|mesh-ancestor
6799277|NCT02276989|Antimalarials|antimalarials|mesh-ancestor
6799278|NCT02276989|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6799279|NCT02276989|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6799280|NCT02276989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6799281|NCT02276989|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6799282|NCT02276989|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6799283|NCT02276989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6799284|NCT02276989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6799285|NCT02276989|Analgesics|analgesics|mesh-ancestor
6799286|NCT02276989|Sensory System Agents|sensory system agents|mesh-ancestor
6799287|NCT02277041|Misoprostol|misoprostol|mesh-list
6799288|NCT02277041|Carbetocin|carbetocin|mesh-list
6799289|NCT02277041|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6799290|NCT02277041|Abortifacient Agents|abortifacient agents|mesh-ancestor
6799291|NCT02277041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6799292|NCT02277041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799293|NCT02277041|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6799294|NCT02277041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6799295|NCT02277041|Oxytocics|oxytocics|mesh-ancestor
6799296|NCT02277067|Misoprostol|misoprostol|mesh-list
6799297|NCT02277067|Carbetocin|carbetocin|mesh-list
6799298|NCT02277067|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6799299|NCT02277067|Abortifacient Agents|abortifacient agents|mesh-ancestor
6799300|NCT02277067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6799301|NCT02277067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799302|NCT02277067|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6799303|NCT02277067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6799304|NCT02277067|Oxytocics|oxytocics|mesh-ancestor
6799305|NCT02277132|Sildenafil Citrate|sildenafil citrate|mesh-list
6799306|NCT02277132|Vasodilator Agents|vasodilator agents|mesh-ancestor
6799307|NCT02277132|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6799308|NCT02277132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6799309|NCT02277132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6799310|NCT02277132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799311|NCT02277132|Urological Agents|urological agents|mesh-ancestor
6799312|NCT02277171|Nitric Oxide|nitric oxide|mesh-list
6799313|NCT02277171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6799314|NCT02277171|Autonomic Agents|autonomic agents|mesh-ancestor
6799315|NCT02277171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6799316|NCT02277171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799317|NCT02277171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6799318|NCT02277171|Respiratory System Agents|respiratory system agents|mesh-ancestor
6799319|NCT02277171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6799320|NCT02277171|Antioxidants|antioxidants|mesh-ancestor
6799321|NCT02277171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799322|NCT02277171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6799323|NCT02277171|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6799324|NCT02277171|Vasodilator Agents|vasodilator agents|mesh-ancestor
6799325|NCT02277171|Gasotransmitters|gasotransmitters|mesh-ancestor
6799326|NCT02277171|Protective Agents|protective agents|mesh-ancestor
6799327|NCT02277184|Cisplatin|cisplatin|mesh-list
6799328|NCT02277184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6799329|NCT02277197|Cetuximab|cetuximab|mesh-list
6799330|NCT02277197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6799331|NCT02277197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6799332|NCT02277223|Curcumin|curcumin|mesh-list
6799333|NCT02277223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6799334|NCT02277223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6799335|NCT02277223|Analgesics|analgesics|mesh-ancestor
6799336|NCT02277223|Sensory System Agents|sensory system agents|mesh-ancestor
6799337|NCT02277223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6799338|NCT02277223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799339|NCT02277223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6799340|NCT02277223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6799341|NCT02277223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6799342|NCT02277223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6799343|NCT02277223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799344|NCT02277457|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6799345|NCT02277457|Crizotinib|crizotinib|mesh-list
6799346|NCT02277457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6799347|NCT02277457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6799348|NCT02277457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6799349|NCT02277457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799350|NCT02277587|Hydrocortisone|hydrocortisone|mesh-list
6799351|NCT02277587|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6799352|NCT02277587|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6799353|NCT02277587|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6799354|NCT02277587|Cortisone|cortisone|mesh-list
6799355|NCT02277587|Glucocorticoids|glucocorticoids|mesh-list
6799356|NCT02277587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6799357|NCT02277587|Hormones|hormones|mesh-ancestor
6799358|NCT02277587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6799359|NCT02277587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799360|NCT02277600|Darunavir|darunavir|mesh-list
6799361|NCT02277600|Cobicistat|cobicistat|mesh-list
6799362|NCT02277600|Fostemsavir|fostemsavir|mesh-list
6799363|NCT02277600|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6799364|NCT02277600|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6799365|NCT02277600|Protease Inhibitors|protease inhibitors|mesh-ancestor
6799366|NCT02277600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6799367|NCT02277600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799368|NCT02277600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6799369|NCT02277600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6799370|NCT02277600|Antiviral Agents|antiviral agents|mesh-ancestor
6799371|NCT02277600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6799372|NCT02277600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6799373|NCT02277600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6799374|NCT02277600|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6799375|NCT02277600|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6799376|NCT02277678|Morphine|morphine|mesh-list
6799377|NCT02277678|Oxycodone|oxycodone|mesh-list
6799378|NCT02277678|Analgesics, Opioid|analgesics, opioid|mesh-list
6799379|NCT02277678|Narcotics|narcotics|mesh-ancestor
5993147|NCT00119262|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6799380|NCT02277678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6799381|NCT02277678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799382|NCT02277678|Analgesics|analgesics|mesh-ancestor
6799383|NCT02277678|Sensory System Agents|sensory system agents|mesh-ancestor
6799384|NCT02277678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6799385|NCT02277717|Trastuzumab|trastuzumab|mesh-list
6799386|NCT02277717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6799387|NCT02277717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6799388|NCT02277730|Phenylephrine|phenylephrine|mesh-list
6799389|NCT02277730|Oxymetazoline|oxymetazoline|mesh-list
6799390|NCT02277730|Ephedrine|ephedrine|mesh-list
6799391|NCT02277730|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
6799392|NCT02277730|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6799393|NCT02277730|Mydriatics|mydriatics|mesh-ancestor
6799394|NCT02277730|Autonomic Agents|autonomic agents|mesh-ancestor
6799395|NCT02277730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6799396|NCT02277730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799397|NCT02277730|Sympathomimetics|sympathomimetics|mesh-ancestor
6799398|NCT02277730|Nasal Decongestants|nasal decongestants|mesh-ancestor
6799399|NCT02277730|Respiratory System Agents|respiratory system agents|mesh-ancestor
6799400|NCT02277730|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6799401|NCT02277730|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6799402|NCT02277730|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6799403|NCT02277730|Adrenergic Agents|adrenergic agents|mesh-ancestor
6799404|NCT02277730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6799405|NCT02277730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799406|NCT02277730|Protective Agents|protective agents|mesh-ancestor
6799407|NCT02277730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6799408|NCT02277782|Fentanyl|fentanyl|mesh-list
6799409|NCT02277782|Hydromorphone|hydromorphone|mesh-list
6799410|NCT02277782|Bupivacaine|bupivacaine|mesh-list
6799411|NCT02277782|Anesthetics, Local|anesthetics, local|mesh-ancestor
6799412|NCT02277782|Anesthetics|anesthetics|mesh-ancestor
6799413|NCT02277782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6799414|NCT02277782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799415|NCT02277782|Sensory System Agents|sensory system agents|mesh-ancestor
6799416|NCT02277782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6799417|NCT02277782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6799418|NCT02277782|Narcotics|narcotics|mesh-ancestor
6799419|NCT02277782|Analgesics|analgesics|mesh-ancestor
6799420|NCT02277782|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6799421|NCT02277782|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6799422|NCT02277782|Anesthetics, General|anesthetics, general|mesh-ancestor
6799423|NCT02277808|Amikacin|amikacin|mesh-list
6799424|NCT02277808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6799425|NCT02277808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6799426|NCT02277847|Cytarabine|cytarabine|mesh-list
6799427|NCT02277847|Idarubicin|idarubicin|mesh-list
6799428|NCT02277847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6799429|NCT02277847|Antimetabolites|antimetabolites|mesh-ancestor
6799430|NCT02277847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799431|NCT02277847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6799432|NCT02277847|Antiviral Agents|antiviral agents|mesh-ancestor
6799433|NCT02277847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6799434|NCT02277847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6799435|NCT02277847|Immunologic Factors|immunologic factors|mesh-ancestor
6799436|NCT02277847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799437|NCT02277847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6799438|NCT02277847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6799439|NCT02277847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6799440|NCT02277847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6799441|NCT02277886|Esomeprazole|esomeprazole|mesh-list
6799442|NCT02277886|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6799443|NCT02277886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6799444|NCT02277886|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6799445|NCT02277886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6799446|NCT02277886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799447|NCT02277938|Amantadine|amantadine|mesh-list
6799448|NCT02277938|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6799449|NCT02277938|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6799450|NCT02277938|Antiviral Agents|antiviral agents|mesh-ancestor
6799451|NCT02277938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6799452|NCT02277938|Dopamine Agents|dopamine agents|mesh-ancestor
6799453|NCT02277938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6799454|NCT02277938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799455|NCT02277938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799456|NCT02277938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6799457|NCT02277938|Analgesics|analgesics|mesh-ancestor
6799458|NCT02277938|Sensory System Agents|sensory system agents|mesh-ancestor
6799459|NCT02277938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6799460|NCT02278081|Lansoprazole|lansoprazole|mesh-list
6799461|NCT02278081|Dexlansoprazole|dexlansoprazole|mesh-list
6799462|NCT02278081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6799463|NCT02278081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6799464|NCT02278081|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6799465|NCT02278081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6799466|NCT02278081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799467|NCT02278172|Vitamin D|vitamin d|mesh-list
6799468|NCT02278172|Ergocalciferols|ergocalciferols|mesh-list
6799469|NCT02278172|Cholecalciferol|cholecalciferol|mesh-list
6799470|NCT02278172|Vitamins|vitamins|mesh-list
6799471|NCT02278172|Micronutrients|micronutrients|mesh-ancestor
6799472|NCT02278172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799473|NCT02278172|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6799474|NCT02278172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6799475|NCT02278185|Leuprolide|leuprolide|mesh-list
6799476|NCT02278185|Goserelin|goserelin|mesh-list
6799477|NCT02278185|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6799478|NCT02278185|Tryptophan|tryptophan|mesh-list
6799479|NCT02278185|Androgens|androgens|mesh-list
6799480|NCT02278185|Hormones|hormones|mesh-ancestor
6799481|NCT02278185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6799482|NCT02278185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799483|NCT02278185|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6799484|NCT02278185|Fertility Agents|fertility agents|mesh-ancestor
6799485|NCT02278185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6799486|NCT02278185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6799487|NCT02278185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6799488|NCT02278185|Luteolytic Agents|luteolytic agents|mesh-ancestor
6799489|NCT02278185|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6799490|NCT02278185|Contraceptive Agents|contraceptive agents|mesh-ancestor
6799491|NCT02278185|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6799492|NCT02278185|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6799493|NCT02278185|Antidepressive Agents|antidepressive agents|mesh-ancestor
6799494|NCT02278185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6799495|NCT02278250|Carboplatin|carboplatin|mesh-list
6799496|NCT02278250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6799497|NCT02278302|Ethanol|ethanol|mesh-list
6799498|NCT02278302|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
6799499|NCT02278302|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6799500|NCT02278302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6799501|NCT02278302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6799502|NCT02278302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799503|NCT02278302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6799504|NCT02278315|Dexamethasone|dexamethasone|mesh-list
6799505|NCT02278315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6799506|NCT02278315|Antiemetics|antiemetics|mesh-ancestor
6799507|NCT02278315|Autonomic Agents|autonomic agents|mesh-ancestor
6799508|NCT02278315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6799509|NCT02278315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799510|NCT02278315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6799511|NCT02278315|Glucocorticoids|glucocorticoids|mesh-ancestor
6799512|NCT02278315|Hormones|hormones|mesh-ancestor
6799513|NCT02278315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6799514|NCT02278315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6799515|NCT02278315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6799516|NCT02278419|Sofosbuvir|sofosbuvir|mesh-list
6799517|NCT02278419|Simeprevir|simeprevir|mesh-list
6799518|NCT02278419|Antiviral Agents|antiviral agents|mesh-ancestor
6799519|NCT02278419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6799520|NCT02278419|Protease Inhibitors|protease inhibitors|mesh-ancestor
6799521|NCT02278419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6799522|NCT02278419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799523|NCT02278458|Gemcitabine|gemcitabine|mesh-list
6799524|NCT02278458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6799525|NCT02278458|Antimetabolites|antimetabolites|mesh-ancestor
6799526|NCT02278458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799527|NCT02278458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6799528|NCT02278458|Antiviral Agents|antiviral agents|mesh-ancestor
6799529|NCT02278458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6799530|NCT02278458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6799531|NCT02278458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6799532|NCT02278458|Immunologic Factors|immunologic factors|mesh-ancestor
6799533|NCT02278458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799534|NCT02278510|Topotecan|topotecan|mesh-list
6799535|NCT02278510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6799536|NCT02278510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6799537|NCT02278510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6799538|NCT02278510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799539|NCT02278510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6799540|NCT02278575|Antithrombins|antithrombins|mesh-list
6799541|NCT02278575|Antithrombin III|antithrombin iii|mesh-list
6799542|NCT02278575|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6799543|NCT02278575|Protease Inhibitors|protease inhibitors|mesh-ancestor
6799544|NCT02278575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6799545|NCT02278575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799546|NCT02278575|Anticoagulants|anticoagulants|mesh-ancestor
6799547|NCT02278588|Rasagiline|rasagiline|mesh-list
6799548|NCT02278588|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6799549|NCT02278588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6799550|NCT02278588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799551|NCT02278588|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6799552|NCT02278588|Protective Agents|protective agents|mesh-ancestor
6799553|NCT02278588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799554|NCT02278601|Fentanyl|fentanyl|mesh-list
6799555|NCT02278601|Ropivacaine|ropivacaine|mesh-list
6799556|NCT02278601|Anesthetics, Local|anesthetics, local|mesh-list
6799557|NCT02278601|Anesthetics|anesthetics|mesh-list
6799558|NCT02278601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6799559|NCT02278601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799560|NCT02278601|Sensory System Agents|sensory system agents|mesh-ancestor
6799561|NCT02278601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6799562|NCT02278601|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6799563|NCT02278601|Narcotics|narcotics|mesh-ancestor
6799564|NCT02278601|Analgesics|analgesics|mesh-ancestor
6799565|NCT02278601|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6799566|NCT02278601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6799567|NCT02278601|Anesthetics, General|anesthetics, general|mesh-ancestor
6799568|NCT02278692|Vitamin K|vitamin k|mesh-list
6799569|NCT02278692|Vitamins|vitamins|mesh-ancestor
6799570|NCT02278692|Micronutrients|micronutrients|mesh-ancestor
6799571|NCT02278692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799572|NCT02278692|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6799573|NCT02278692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6799574|NCT02278692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799575|NCT02278692|Hemostatics|hemostatics|mesh-ancestor
6799576|NCT02278692|Coagulants|coagulants|mesh-ancestor
6799577|NCT02278861|Tretinoin|tretinoin|mesh-list
6799578|NCT02278861|Isotretinoin|isotretinoin|mesh-list
6799579|NCT02278861|Sunscreening Agents|sunscreening agents|mesh-list
6799580|NCT02278861|Dermatologic Agents|dermatologic agents|mesh-ancestor
6799581|NCT02278861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6799582|NCT02278861|Keratolytic Agents|keratolytic agents|mesh-ancestor
6799583|NCT02278861|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6799584|NCT02278861|Protective Agents|protective agents|mesh-ancestor
6799585|NCT02278861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799586|NCT02278887|Cyclophosphamide|cyclophosphamide|mesh-list
6799587|NCT02278887|Fludarabine|fludarabine|mesh-list
6799588|NCT02278887|Ipilimumab|ipilimumab|mesh-list
6799589|NCT02278887|Interleukin-2|interleukin-2|mesh-list
6799590|NCT02278887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6799591|NCT02278887|Immunologic Factors|immunologic factors|mesh-ancestor
6799592|NCT02278887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799593|NCT02278887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6799594|NCT02278887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6799595|NCT02278887|Alkylating Agents|alkylating agents|mesh-ancestor
6799596|NCT02278887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799597|NCT02278887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6799598|NCT02278887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6799599|NCT02278887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6799600|NCT02278887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6799601|NCT02278887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6799602|NCT02278887|Analgesics|analgesics|mesh-ancestor
6799603|NCT02278887|Sensory System Agents|sensory system agents|mesh-ancestor
6799604|NCT02278887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6799605|NCT02278913|Insulin|insulin|mesh-list
6799606|NCT02278913|Insulin Glargine|insulin glargine|mesh-list
6799607|NCT02278913|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6799608|NCT02278913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6799609|NCT02278913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799610|NCT02278926|Insulin|insulin|mesh-list
6799611|NCT02278926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6799612|NCT02278926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799613|NCT02278965|Metformin|metformin|mesh-list
6799614|NCT02278965|Biguanides|biguanides|mesh-list
6799615|NCT02278965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6799616|NCT02278965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799617|NCT02278978|Nintedanib|nintedanib|mesh-list
6799618|NCT02278978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6799619|NCT02278978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6799620|NCT02278978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6799621|NCT02278978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799622|NCT02279121|Taurolidine|taurolidine|mesh-list
6799623|NCT02279121|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6799624|NCT02279121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6799625|NCT02279121|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6799626|NCT02279121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6799627|NCT02279134|Paclitaxel|paclitaxel|mesh-list
6799628|NCT02279134|Nedaplatin|nedaplatin|mesh-list
6799629|NCT02279134|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6799630|NCT02279134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6799631|NCT02279134|Tubulin Modulators|tubulin modulators|mesh-ancestor
6799632|NCT02279134|Antimitotic Agents|antimitotic agents|mesh-ancestor
6799633|NCT02279134|Mitosis Modulators|mitosis modulators|mesh-ancestor
6799634|NCT02279134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799635|NCT02279147|Neostigmine|neostigmine|mesh-list
6799636|NCT02279147|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6799637|NCT02279147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6799638|NCT02279147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799639|NCT02279147|Cholinergic Agents|cholinergic agents|mesh-ancestor
6799640|NCT02279147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6799641|NCT02279147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799642|NCT02279147|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6799643|NCT02279147|Autonomic Agents|autonomic agents|mesh-ancestor
6799644|NCT02279147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6799645|NCT02279186|Tranexamic Acid|tranexamic acid|mesh-list
6799646|NCT02279186|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6799647|NCT02279186|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6799648|NCT02279186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799649|NCT02279186|Hemostatics|hemostatics|mesh-ancestor
6799650|NCT02279186|Coagulants|coagulants|mesh-ancestor
6799651|NCT02279316|Vitamin D|vitamin d|mesh-list
6799652|NCT02279316|Cholecalciferol|cholecalciferol|mesh-list
6799653|NCT02279316|Vitamins|vitamins|mesh-ancestor
6799654|NCT02279316|Micronutrients|micronutrients|mesh-ancestor
6799655|NCT02279316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799656|NCT02279316|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6799657|NCT02279316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6799658|NCT02279342|Febuxostat|febuxostat|mesh-list
6799659|NCT02279342|Gout Suppressants|gout suppressants|mesh-ancestor
6799660|NCT02279342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6799661|NCT02279381|Chlorhexidine|chlorhexidine|mesh-list
6799662|NCT02279381|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6799663|NCT02279381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6799664|NCT02279381|Disinfectants|disinfectants|mesh-ancestor
6799665|NCT02279394|Dexamethasone|dexamethasone|mesh-list
6799666|NCT02279394|Lenalidomide|lenalidomide|mesh-list
6799667|NCT02279394|Elotuzumab|elotuzumab|mesh-list
6799668|NCT02279394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6799669|NCT02279394|Antiemetics|antiemetics|mesh-ancestor
6799670|NCT02279394|Autonomic Agents|autonomic agents|mesh-ancestor
6799671|NCT02279394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6799672|NCT02279394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799673|NCT02279394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6799674|NCT02279394|Glucocorticoids|glucocorticoids|mesh-ancestor
6799675|NCT02279394|Hormones|hormones|mesh-ancestor
6799676|NCT02279394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6799677|NCT02279394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6799678|NCT02279394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6799679|NCT02279394|Immunologic Factors|immunologic factors|mesh-ancestor
6799680|NCT02279394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6799681|NCT02279394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6799682|NCT02279394|Growth Substances|growth substances|mesh-ancestor
6799683|NCT02279394|Growth Inhibitors|growth inhibitors|mesh-ancestor
6799684|NCT02279511|Adenosine|adenosine|mesh-list
6799685|NCT02279511|Analgesics|analgesics|mesh-ancestor
6799686|NCT02279511|Sensory System Agents|sensory system agents|mesh-ancestor
6799687|NCT02279511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6799688|NCT02279511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799689|NCT02279511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6799690|NCT02279511|Vasodilator Agents|vasodilator agents|mesh-ancestor
6799691|NCT02279511|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6799692|NCT02279511|Purinergic Agonists|purinergic agonists|mesh-ancestor
6799693|NCT02279511|Purinergic Agents|purinergic agents|mesh-ancestor
6799694|NCT02279511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6799695|NCT02279511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799696|NCT02279537|Aflibercept|aflibercept|mesh-list
6799697|NCT02279537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6799698|NCT02279537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6799699|NCT02279537|Growth Substances|growth substances|mesh-ancestor
6799700|NCT02279537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799701|NCT02279537|Growth Inhibitors|growth inhibitors|mesh-ancestor
6799702|NCT02279537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6799703|NCT02279563|Fluticasone|fluticasone|mesh-list
6799704|NCT02279563|Xhance|xhance|mesh-list
6799705|NCT02279563|Azelastine|azelastine|mesh-list
6799706|NCT02279563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6799707|NCT02279563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6799708|NCT02279563|Autonomic Agents|autonomic agents|mesh-ancestor
6799709|NCT02279563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6799710|NCT02279563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799711|NCT02279563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6799712|NCT02279563|Respiratory System Agents|respiratory system agents|mesh-ancestor
6799713|NCT02279563|Dermatologic Agents|dermatologic agents|mesh-ancestor
6799714|NCT02279563|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6799715|NCT02279563|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6799716|NCT02279563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6799717|NCT02279563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799718|NCT02279563|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6799719|NCT02279563|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6799720|NCT02279563|Histamine Antagonists|histamine antagonists|mesh-ancestor
6799721|NCT02279563|Histamine Agents|histamine agents|mesh-ancestor
6799722|NCT02279563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6799723|NCT02279576|Paclitaxel|paclitaxel|mesh-list
6799724|NCT02279576|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6799725|NCT02279576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6799726|NCT02279576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6799727|NCT02279576|Tubulin Modulators|tubulin modulators|mesh-ancestor
6799728|NCT02279576|Antimitotic Agents|antimitotic agents|mesh-ancestor
6799729|NCT02279576|Mitosis Modulators|mitosis modulators|mesh-ancestor
6799730|NCT02279576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799731|NCT02279589|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6799732|NCT02279589|Immunologic Factors|immunologic factors|mesh-ancestor
6799733|NCT02279589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799734|NCT02279615|Tamsulosin|tamsulosin|mesh-list
6799735|NCT02279615|Mirabegron|mirabegron|mesh-list
6799736|NCT02279615|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6799737|NCT02279615|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6799738|NCT02279615|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6799739|NCT02279615|Adrenergic Agents|adrenergic agents|mesh-ancestor
6799740|NCT02279615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6799741|NCT02279615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799742|NCT02279615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799743|NCT02279615|Urological Agents|urological agents|mesh-ancestor
6799744|NCT02279615|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6799745|NCT02279615|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6799746|NCT02279615|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6799747|NCT02279628|Morphine|morphine|mesh-list
6799748|NCT02279628|Ropivacaine|ropivacaine|mesh-list
6799749|NCT02279628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6799750|NCT02279628|Narcotics|narcotics|mesh-ancestor
6799751|NCT02279628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6799752|NCT02279628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799753|NCT02279628|Analgesics|analgesics|mesh-ancestor
6799754|NCT02279628|Sensory System Agents|sensory system agents|mesh-ancestor
6799755|NCT02279628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6799756|NCT02279628|Anesthetics, Local|anesthetics, local|mesh-ancestor
6799757|NCT02279628|Anesthetics|anesthetics|mesh-ancestor
6799758|NCT02279654|Lenalidomide|lenalidomide|mesh-list
6799759|NCT02279654|Immunologic Factors|immunologic factors|mesh-ancestor
6799760|NCT02279654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799761|NCT02279654|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6799762|NCT02279654|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6799763|NCT02279654|Growth Substances|growth substances|mesh-ancestor
6799764|NCT02279654|Growth Inhibitors|growth inhibitors|mesh-ancestor
6799765|NCT02279654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6799766|NCT02279758|Metformin|metformin|mesh-list
6799767|NCT02279758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6799768|NCT02279758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799769|NCT02279875|Rifampin|rifampin|mesh-list
6799770|NCT02279875|Isoniazid|isoniazid|mesh-list
6799771|NCT02279875|Linezolid|linezolid|mesh-list
6799772|NCT02279875|Pyrazinamide|pyrazinamide|mesh-list
6799773|NCT02279875|Ethambutol|ethambutol|mesh-list
6799774|NCT02279875|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6799775|NCT02279875|Antitubercular Agents|antitubercular agents|mesh-ancestor
6799776|NCT02279875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6799777|NCT02279875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6799778|NCT02279875|Leprostatic Agents|leprostatic agents|mesh-ancestor
6799779|NCT02279875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6799780|NCT02279875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6799781|NCT02279875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799782|NCT02279875|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6799783|NCT02279875|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6799784|NCT02279875|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6799785|NCT02279875|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6799786|NCT02279875|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6799787|NCT02279875|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6799788|NCT02279875|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6799789|NCT02279875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6799790|NCT02279875|Antimetabolites|antimetabolites|mesh-ancestor
6799791|NCT02279875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6799792|NCT02279875|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6799793|NCT02279914|Misoprostol|misoprostol|mesh-list
6799794|NCT02279914|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6799795|NCT02279914|Abortifacient Agents|abortifacient agents|mesh-ancestor
6799796|NCT02279914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6799797|NCT02279914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799798|NCT02279914|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6799799|NCT02279914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6799800|NCT02279914|Oxytocics|oxytocics|mesh-ancestor
6799801|NCT02279953|Vortioxetine|vortioxetine|mesh-list
6799802|NCT02279953|Antidepressive Agents|antidepressive agents|mesh-ancestor
6799803|NCT02279953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6799804|NCT02279953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6799805|NCT02279953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6799806|NCT02279953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6799807|NCT02279953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799808|NCT02279953|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6799809|NCT02279953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6799810|NCT02279953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6799811|NCT02279953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799812|NCT02279953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6799813|NCT02279953|Serotonin Agents|serotonin agents|mesh-ancestor
6799814|NCT02279953|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6799815|NCT02279953|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6799816|NCT02279953|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6799817|NCT02279953|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6799818|NCT02279966|Vortioxetine|vortioxetine|mesh-list
6799819|NCT02279966|Paroxetine|paroxetine|mesh-list
6799820|NCT02279966|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6799821|NCT02279966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6799822|NCT02279966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6799823|NCT02279966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799824|NCT02279966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6799825|NCT02279966|Serotonin Agents|serotonin agents|mesh-ancestor
6799826|NCT02279966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799827|NCT02279966|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6799828|NCT02279966|Antidepressive Agents|antidepressive agents|mesh-ancestor
6799829|NCT02279966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6799830|NCT02279966|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6799831|NCT02279966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6799832|NCT02279966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6799833|NCT02279966|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6799834|NCT02279966|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6799835|NCT02279966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6799836|NCT02279966|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6799837|NCT02279966|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6799838|NCT02279966|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6799839|NCT02279966|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6799840|NCT02279992|Carboplatin|carboplatin|mesh-list
6799841|NCT02279992|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6799842|NCT02279992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6799843|NCT02279992|Vasodilator Agents|vasodilator agents|mesh-ancestor
6799844|NCT02279992|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6799845|NCT02279992|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6799846|NCT02279992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6799847|NCT02279992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799848|NCT02279992|Urological Agents|urological agents|mesh-ancestor
6799849|NCT02280031|Aspirin|aspirin|mesh-list
6799850|NCT02280031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6799851|NCT02280031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6799852|NCT02280031|Analgesics|analgesics|mesh-ancestor
6799853|NCT02280031|Sensory System Agents|sensory system agents|mesh-ancestor
6799854|NCT02280031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6799855|NCT02280031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799856|NCT02280031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6799857|NCT02280031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6799858|NCT02280031|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6799859|NCT02280031|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6799860|NCT02280031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799861|NCT02280031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6799862|NCT02280031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6799863|NCT02280031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6799864|NCT02280031|Antipyretics|antipyretics|mesh-ancestor
6799865|NCT02280057|Metformin|metformin|mesh-list
6799866|NCT02280057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6799867|NCT02280057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799868|NCT02280070|Leucovorin|leucovorin|mesh-list
6799869|NCT02280070|Fluorouracil|fluorouracil|mesh-list
6799870|NCT02280070|Tegafur|tegafur|mesh-list
6799871|NCT02280070|Oxaliplatin|oxaliplatin|mesh-list
6799872|NCT02280070|Antibodies|antibodies|mesh-list
6799873|NCT02280070|Immunoglobulins|immunoglobulins|mesh-list
6799874|NCT02280070|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
6799875|NCT02280070|Immunologic Factors|immunologic factors|mesh-ancestor
6799876|NCT02280070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799877|NCT02280070|Antimetabolites|antimetabolites|mesh-ancestor
6799878|NCT02280070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799879|NCT02280070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6799880|NCT02280070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6799881|NCT02280070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6799882|NCT02280070|Antidotes|antidotes|mesh-ancestor
6799883|NCT02280070|Protective Agents|protective agents|mesh-ancestor
6799884|NCT02280070|Vitamin B Complex|vitamin b complex|mesh-ancestor
6799885|NCT02280070|Vitamins|vitamins|mesh-ancestor
6799886|NCT02280070|Micronutrients|micronutrients|mesh-ancestor
6799887|NCT02280083|Botulinum Toxins|botulinum toxins|mesh-list
6799888|NCT02280083|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6799889|NCT02280083|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6799890|NCT02280083|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6799891|NCT02280083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6799892|NCT02280083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799893|NCT02280083|Cholinergic Agents|cholinergic agents|mesh-ancestor
6799894|NCT02280083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6799895|NCT02280083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799896|NCT02280083|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6799897|NCT02280083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6799898|NCT02280109|Tenofovir|tenofovir|mesh-list
6799899|NCT02280109|Antiviral Agents|antiviral agents|mesh-ancestor
6799900|NCT02280109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6799901|NCT02280109|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6799902|NCT02280109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6799903|NCT02280109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6799904|NCT02280109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799905|NCT02280109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6799906|NCT02280109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6799907|NCT02280148|Propofol|propofol|mesh-list
6799908|NCT02280148|Anesthetics|anesthetics|mesh-ancestor
6799909|NCT02280148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6799910|NCT02280148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799911|NCT02280148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6799912|NCT02280148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6799913|NCT02280148|Anesthetics, General|anesthetics, general|mesh-ancestor
6799914|NCT02280174|Linagliptin|linagliptin|mesh-list
6799915|NCT02280174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6799916|NCT02280174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799917|NCT02280174|Incretins|incretins|mesh-ancestor
6799918|NCT02280174|Hormones|hormones|mesh-ancestor
6799919|NCT02280174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6799920|NCT02280174|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6799921|NCT02280174|Protease Inhibitors|protease inhibitors|mesh-ancestor
6799922|NCT02280174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6799923|NCT02280174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799924|NCT02280239|Acetaminophen|acetaminophen|mesh-list
6799925|NCT02280239|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6799926|NCT02280239|Analgesics|analgesics|mesh-ancestor
6799927|NCT02280239|Sensory System Agents|sensory system agents|mesh-ancestor
6799928|NCT02280239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6799929|NCT02280239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799930|NCT02280239|Antipyretics|antipyretics|mesh-ancestor
6799931|NCT02280265|Factor VIII|factor viii|mesh-list
6799932|NCT02280265|Coagulants|coagulants|mesh-ancestor
6799933|NCT02280447|Vaccines|vaccines|mesh-list
6799934|NCT02280447|Immunologic Factors|immunologic factors|mesh-ancestor
6799935|NCT02280447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799936|NCT02280486|Glimepiride|glimepiride|mesh-list
6799937|NCT02280486|Saxagliptin|saxagliptin|mesh-list
6799938|NCT02280486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6799939|NCT02280486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6799940|NCT02280486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799941|NCT02280486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6799942|NCT02280486|Immunologic Factors|immunologic factors|mesh-ancestor
6799943|NCT02280486|Incretins|incretins|mesh-ancestor
6799944|NCT02280486|Hormones|hormones|mesh-ancestor
6799945|NCT02280486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6799946|NCT02280486|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6799947|NCT02280486|Protease Inhibitors|protease inhibitors|mesh-ancestor
6799948|NCT02280486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6799949|NCT02280486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799950|NCT02280525|Vidarabine|vidarabine|mesh-list
6799951|NCT02280525|Cytarabine|cytarabine|mesh-list
6799952|NCT02280525|Cyclophosphamide|cyclophosphamide|mesh-list
6799953|NCT02280525|Rituximab|rituximab|mesh-list
6799954|NCT02280525|Fludarabine|fludarabine|mesh-list
6799955|NCT02280525|Fludarabine phosphate|fludarabine phosphate|mesh-list
6799956|NCT02280525|Lenalidomide|lenalidomide|mesh-list
6799957|NCT02280525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6799958|NCT02280525|Immunologic Factors|immunologic factors|mesh-ancestor
6799959|NCT02280525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799960|NCT02280525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6799961|NCT02280525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6799962|NCT02280525|Alkylating Agents|alkylating agents|mesh-ancestor
6799963|NCT02280525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799964|NCT02280525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6799965|NCT02280525|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6799966|NCT02280525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6799967|NCT02280525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6799968|NCT02280525|Antimetabolites|antimetabolites|mesh-ancestor
6799969|NCT02280525|Antiviral Agents|antiviral agents|mesh-ancestor
6799970|NCT02280525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6799971|NCT02280525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6799972|NCT02280525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6799973|NCT02280525|Growth Substances|growth substances|mesh-ancestor
6799974|NCT02280525|Growth Inhibitors|growth inhibitors|mesh-ancestor
6799975|NCT02280538|Hyaluronic Acid|hyaluronic acid|mesh-list
6799976|NCT02280538|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6799977|NCT02280538|Immunologic Factors|immunologic factors|mesh-ancestor
6799978|NCT02280538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799979|NCT02280538|Viscosupplements|viscosupplements|mesh-ancestor
6799980|NCT02280538|Protective Agents|protective agents|mesh-ancestor
6799981|NCT02280590|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6799982|NCT02280590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6799983|NCT02280590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6799984|NCT02280590|Antimetabolites|antimetabolites|mesh-ancestor
6799985|NCT02280590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6799986|NCT02280590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6799987|NCT02280590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6799988|NCT02280590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6799989|NCT02280603|Minoxidil|minoxidil|mesh-list
6799990|NCT02280603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6799991|NCT02280603|Vasodilator Agents|vasodilator agents|mesh-ancestor
6799992|NCT02280616|Budesonide|budesonide|mesh-list
6799993|NCT02280616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6799994|NCT02280616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6799995|NCT02280616|Autonomic Agents|autonomic agents|mesh-ancestor
6799996|NCT02280616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6799997|NCT02280616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6799998|NCT02280616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6799999|NCT02280616|Respiratory System Agents|respiratory system agents|mesh-ancestor
6800000|NCT02280616|Glucocorticoids|glucocorticoids|mesh-ancestor
6800001|NCT02280616|Hormones|hormones|mesh-ancestor
6800002|NCT02280616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6800003|NCT02280629|Mesalamine|mesalamine|mesh-list
6800004|NCT02280629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6800005|NCT02280629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6800006|NCT02280629|Analgesics|analgesics|mesh-ancestor
6800007|NCT02280629|Sensory System Agents|sensory system agents|mesh-ancestor
6800008|NCT02280629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6800009|NCT02280629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800010|NCT02280629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6800011|NCT02280629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6800012|NCT02280694|Celecoxib|celecoxib|mesh-list
6800013|NCT02280694|Cyclophosphamide|cyclophosphamide|mesh-list
6800014|NCT02280694|Capecitabine|capecitabine|mesh-list
6800015|NCT02280694|Methotrexate|methotrexate|mesh-list
6800016|NCT02280694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6800017|NCT02280694|Immunologic Factors|immunologic factors|mesh-ancestor
6800018|NCT02280694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800019|NCT02280694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6800020|NCT02280694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6800021|NCT02280694|Alkylating Agents|alkylating agents|mesh-ancestor
6800022|NCT02280694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800023|NCT02280694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6800024|NCT02280694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6800025|NCT02280694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6800026|NCT02280694|Antimetabolites|antimetabolites|mesh-ancestor
6800027|NCT02280694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6800028|NCT02280694|Abortifacient Agents|abortifacient agents|mesh-ancestor
6800029|NCT02280694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6800030|NCT02280694|Dermatologic Agents|dermatologic agents|mesh-ancestor
6800031|NCT02280694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6800032|NCT02280694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6800033|NCT02280694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6800034|NCT02280694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6800035|NCT02280694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6800036|NCT02280694|Analgesics|analgesics|mesh-ancestor
6800037|NCT02280694|Sensory System Agents|sensory system agents|mesh-ancestor
6800038|NCT02280694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6800039|NCT02280694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6800040|NCT02280694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6800041|NCT02280694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6800042|NCT02280720|Tryptophan|tryptophan|mesh-list
6800043|NCT02280720|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6800044|NCT02280720|Antidepressive Agents|antidepressive agents|mesh-ancestor
6800045|NCT02280720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6800046|NCT02280772|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
6800047|NCT02280772|Cathartics|cathartics|mesh-ancestor
6800048|NCT02280772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6800049|NCT02280785|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6800050|NCT02280785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6800051|NCT02280785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6800052|NCT02280850|Nitroglycerin|nitroglycerin|mesh-list
6800053|NCT02280850|Vasodilator Agents|vasodilator agents|mesh-ancestor
6800054|NCT02280876|Andrographolide|andrographolide|mesh-list
6800055|NCT02280876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6800056|NCT02280876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6800057|NCT02280876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6800058|NCT02280876|Analgesics|analgesics|mesh-ancestor
6800059|NCT02280876|Sensory System Agents|sensory system agents|mesh-ancestor
6800060|NCT02280876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6800061|NCT02280876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800062|NCT02280876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6800063|NCT02280876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6800064|NCT02280876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6800065|NCT02280876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6800066|NCT02280876|Antiviral Agents|antiviral agents|mesh-ancestor
6800067|NCT02280876|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6800068|NCT02280993|Dexamethasone|dexamethasone|mesh-list
6800069|NCT02280993|Cisplatin|cisplatin|mesh-list
6800070|NCT02280993|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6258448|NCT03087604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5993148|NCT00119262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5993149|NCT00119262|Antibodies|antibodies|mesh-list
5993150|NCT00119262|Immunoglobulins|immunoglobulins|mesh-list
5993151|NCT00119262|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5993152|NCT00119262|Lenograstim|lenograstim|mesh-list
5993153|NCT00119262|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5993154|NCT00119262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6800071|NCT02280993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6800072|NCT02280993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6800073|NCT02280993|Antiemetics|antiemetics|mesh-ancestor
6800074|NCT02280993|Autonomic Agents|autonomic agents|mesh-ancestor
6800075|NCT02280993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6800076|NCT02280993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800077|NCT02280993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6800078|NCT02280993|Glucocorticoids|glucocorticoids|mesh-ancestor
6800079|NCT02280993|Hormones|hormones|mesh-ancestor
6800080|NCT02280993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6800081|NCT02280993|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6800082|NCT02280993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6800083|NCT02281006|Sodium thiosulfate|sodium thiosulfate|mesh-list
6800084|NCT02281006|Antidotes|antidotes|mesh-ancestor
6800085|NCT02281006|Protective Agents|protective agents|mesh-ancestor
6800086|NCT02281006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800087|NCT02281006|Antioxidants|antioxidants|mesh-ancestor
6800088|NCT02281006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800089|NCT02281006|Antitubercular Agents|antitubercular agents|mesh-ancestor
6800090|NCT02281006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6800091|NCT02281006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6800092|NCT02281006|Chelating Agents|chelating agents|mesh-ancestor
6800093|NCT02281006|Sequestering Agents|sequestering agents|mesh-ancestor
6800094|NCT02281045|Citric Acid|citric acid|mesh-list
6800095|NCT02281045|Sodium Citrate|sodium citrate|mesh-list
6800096|NCT02281045|Anticoagulants|anticoagulants|mesh-ancestor
6800097|NCT02281045|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6800098|NCT02281045|Chelating Agents|chelating agents|mesh-ancestor
6800099|NCT02281045|Sequestering Agents|sequestering agents|mesh-ancestor
6800100|NCT02281045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800101|NCT02281058|Abatacept|abatacept|mesh-list
6800102|NCT02281058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6800103|NCT02281058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800104|NCT02281058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6800105|NCT02281058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6800106|NCT02281058|Immunologic Factors|immunologic factors|mesh-ancestor
6800107|NCT02281058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800108|NCT02281058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6800109|NCT02281201|Thrombin|thrombin|mesh-list
6800110|NCT02281201|Hemostatics|hemostatics|mesh-ancestor
6800111|NCT02281201|Coagulants|coagulants|mesh-ancestor
6800112|NCT02281240|Oprelvekin|oprelvekin|mesh-list
6800113|NCT02281240|Heparin|heparin|mesh-list
6800114|NCT02281240|Anticoagulants|anticoagulants|mesh-ancestor
6800115|NCT02281240|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6800116|NCT02281240|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6800117|NCT02281240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800118|NCT02281240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6800119|NCT02281266|Entecavir|entecavir|mesh-list
6800120|NCT02281266|Thymalfasin|thymalfasin|mesh-list
6800121|NCT02281266|Antiviral Agents|antiviral agents|mesh-ancestor
6800122|NCT02281266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6800123|NCT02281266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6800124|NCT02281266|Immunologic Factors|immunologic factors|mesh-ancestor
6800125|NCT02281266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800126|NCT02281279|Rituximab|rituximab|mesh-list
6800127|NCT02281279|Lenalidomide|lenalidomide|mesh-list
6800128|NCT02281279|Romidepsin|romidepsin|mesh-list
6800129|NCT02281279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6800130|NCT02281279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6800131|NCT02281279|Immunologic Factors|immunologic factors|mesh-ancestor
6800132|NCT02281279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993155|NCT00119262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800133|NCT02281279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6800134|NCT02281279|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6800135|NCT02281279|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6800136|NCT02281279|Growth Substances|growth substances|mesh-ancestor
6800137|NCT02281279|Growth Inhibitors|growth inhibitors|mesh-ancestor
6800138|NCT02281279|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6800139|NCT02281292|Ranibizumab|ranibizumab|mesh-list
6800140|NCT02281292|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6800141|NCT02281292|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6800142|NCT02281292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6800143|NCT02281292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6800144|NCT02281292|Growth Substances|growth substances|mesh-ancestor
6800145|NCT02281292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800146|NCT02281292|Growth Inhibitors|growth inhibitors|mesh-ancestor
6800147|NCT02281292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6800148|NCT02281305|Colchicine|colchicine|mesh-list
6800149|NCT02281305|Gout Suppressants|gout suppressants|mesh-ancestor
6800150|NCT02281305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6800151|NCT02281305|Tubulin Modulators|tubulin modulators|mesh-ancestor
6800152|NCT02281305|Antimitotic Agents|antimitotic agents|mesh-ancestor
6800153|NCT02281305|Mitosis Modulators|mitosis modulators|mesh-ancestor
6800154|NCT02281305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800155|NCT02281305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6800156|NCT02281370|Cyclosporine|cyclosporine|mesh-list
6800157|NCT02281370|Cyclosporins|cyclosporins|mesh-list
6800158|NCT02281370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6800159|NCT02281370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800160|NCT02281370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6800161|NCT02281370|Immunologic Factors|immunologic factors|mesh-ancestor
6800162|NCT02281370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800163|NCT02281370|Antifungal Agents|antifungal agents|mesh-ancestor
6800164|NCT02281370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6800165|NCT02281370|Dermatologic Agents|dermatologic agents|mesh-ancestor
6800166|NCT02281370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6800167|NCT02281370|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6800168|NCT02281383|BCG Vaccine|bcg vaccine|mesh-list
6800169|NCT02281383|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6800170|NCT02281383|Immunologic Factors|immunologic factors|mesh-ancestor
6800171|NCT02281383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800172|NCT02281396|Vaccines|vaccines|mesh-list
6800173|NCT02281396|Immunologic Factors|immunologic factors|mesh-ancestor
6800174|NCT02281396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800175|NCT02281643|Doxycycline|doxycycline|mesh-list
6800176|NCT02281643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6800177|NCT02281643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6800178|NCT02281643|Antimalarials|antimalarials|mesh-ancestor
6800179|NCT02281643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6800180|NCT02281643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6800181|NCT02281669|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
6800182|NCT02281669|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6800183|NCT02281669|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6800184|NCT02281669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6800185|NCT02281669|Schistosomicides|schistosomicides|mesh-ancestor
6800186|NCT02281669|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6800187|NCT02281669|Anthelmintics|anthelmintics|mesh-ancestor
6800188|NCT02281682|Fluorouracil|fluorouracil|mesh-list
6800189|NCT02281682|Imiquimod|imiquimod|mesh-list
6800190|NCT02281682|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
6800191|NCT02281682|Antimetabolites|antimetabolites|mesh-ancestor
6800192|NCT02281682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800193|NCT02281682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6800194|NCT02281682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6800195|NCT02281682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6800196|NCT02281682|Immunologic Factors|immunologic factors|mesh-ancestor
6800197|NCT02281682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800198|NCT02281682|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6800199|NCT02281682|Interferon Inducers|interferon inducers|mesh-ancestor
6800200|NCT02281682|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6800201|NCT02281682|Dermatologic Agents|dermatologic agents|mesh-ancestor
6800202|NCT02281708|Cisplatin|cisplatin|mesh-list
6800203|NCT02281708|Vinorelbine|vinorelbine|mesh-list
6800204|NCT02281708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6800205|NCT02281708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6800206|NCT02281708|Tubulin Modulators|tubulin modulators|mesh-ancestor
6800207|NCT02281708|Antimitotic Agents|antimitotic agents|mesh-ancestor
6800208|NCT02281708|Mitosis Modulators|mitosis modulators|mesh-ancestor
6800209|NCT02281708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800210|NCT02281721|Calcium Carbonate|calcium carbonate|mesh-list
6800211|NCT02281721|Antacids|antacids|mesh-ancestor
6800212|NCT02281721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800213|NCT02281721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6800214|NCT02281799|Mercaptopurine|mercaptopurine|mesh-list
6800215|NCT02281799|Azathioprine|azathioprine|mesh-list
6800216|NCT02281799|Antimetabolites|antimetabolites|mesh-ancestor
6800217|NCT02281799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800218|NCT02281799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6800219|NCT02281799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6800220|NCT02281799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6800221|NCT02281799|Immunologic Factors|immunologic factors|mesh-ancestor
6800222|NCT02281799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800223|NCT02281799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6800224|NCT02281799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6800225|NCT02281799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6800226|NCT02281838|Enalapril|enalapril|mesh-list
6800227|NCT02281838|Hydralazine|hydralazine|mesh-list
6800228|NCT02281838|Labetalol|labetalol|mesh-list
6800229|NCT02281838|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6800230|NCT02281838|Protease Inhibitors|protease inhibitors|mesh-ancestor
6800231|NCT02281838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6800232|NCT02281838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800233|NCT02281838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6800234|NCT02281838|Vasodilator Agents|vasodilator agents|mesh-ancestor
6800235|NCT02281838|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6800236|NCT02281838|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6800237|NCT02281838|Adrenergic Agents|adrenergic agents|mesh-ancestor
6800238|NCT02281838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6800239|NCT02281838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800240|NCT02281838|Sympathomimetics|sympathomimetics|mesh-ancestor
6800241|NCT02281838|Autonomic Agents|autonomic agents|mesh-ancestor
6800242|NCT02281838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6800243|NCT02281838|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6800244|NCT02281838|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6800245|NCT02281929|Amoxicillin|amoxicillin|mesh-list
6800246|NCT02281929|Clavulanic Acids|clavulanic acids|mesh-list
6800247|NCT02281929|Clavulanic Acid|clavulanic acid|mesh-list
6800248|NCT02281929|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6800249|NCT02281929|Prednisolone|prednisolone|mesh-list
6800250|NCT02281929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6800251|NCT02281929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6800252|NCT02281929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6800253|NCT02281929|Glucocorticoids|glucocorticoids|mesh-ancestor
6800254|NCT02281929|Hormones|hormones|mesh-ancestor
6800255|NCT02281929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6800256|NCT02281929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800257|NCT02281929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6800258|NCT02281929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6800259|NCT02281929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6800260|NCT02281929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800261|NCT02281929|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6800262|NCT02281968|Naproxen|naproxen|mesh-list
6800263|NCT02281968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6800264|NCT02281968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6800265|NCT02281968|Analgesics|analgesics|mesh-ancestor
6800266|NCT02281968|Sensory System Agents|sensory system agents|mesh-ancestor
6800267|NCT02281968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6800268|NCT02281968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800269|NCT02281968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6800270|NCT02281968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6800271|NCT02281968|Gout Suppressants|gout suppressants|mesh-ancestor
6800272|NCT02281968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6800273|NCT02281968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6800274|NCT02281968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800275|NCT02281981|Curcumin|curcumin|mesh-list
6800276|NCT02281981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6800277|NCT02281981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6800278|NCT02281981|Analgesics|analgesics|mesh-ancestor
6800279|NCT02281981|Sensory System Agents|sensory system agents|mesh-ancestor
6800280|NCT02281981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6800281|NCT02281981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800282|NCT02281981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6800283|NCT02281981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6800284|NCT02281981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6800285|NCT02281981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6800286|NCT02281981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800287|NCT02282059|Sunitinib|sunitinib|mesh-list
6800288|NCT02282059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6800289|NCT02282059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6800290|NCT02282059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6800291|NCT02282059|Growth Substances|growth substances|mesh-ancestor
6800292|NCT02282059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800293|NCT02282059|Growth Inhibitors|growth inhibitors|mesh-ancestor
6800294|NCT02282059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6800295|NCT02282059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6800296|NCT02282059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800297|NCT02282085|Olanzapine|olanzapine|mesh-list
6800298|NCT02282085|Risperidone|risperidone|mesh-list
6800299|NCT02282085|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6800300|NCT02282085|Aripiprazole|aripiprazole|mesh-list
6800301|NCT02282085|Ziprasidone|ziprasidone|mesh-list
6800302|NCT02282085|Antipsychotic Agents|antipsychotic agents|mesh-list
6800303|NCT02282085|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
6800304|NCT02282085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6800305|NCT02282085|Serotonin Agents|serotonin agents|mesh-ancestor
6800306|NCT02282085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6800307|NCT02282085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800308|NCT02282085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800309|NCT02282085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6800310|NCT02282085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6800311|NCT02282085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6800312|NCT02282085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6800313|NCT02282085|Dopamine Agents|dopamine agents|mesh-ancestor
6800314|NCT02282085|Antiemetics|antiemetics|mesh-ancestor
6800315|NCT02282085|Autonomic Agents|autonomic agents|mesh-ancestor
6800316|NCT02282085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6800317|NCT02282085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6800318|NCT02282085|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6800319|NCT02282085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6800320|NCT02282085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6800321|NCT02282085|Antidepressive Agents|antidepressive agents|mesh-ancestor
6800322|NCT02282085|Dopamine Agonists|dopamine agonists|mesh-ancestor
6800323|NCT02282085|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6800324|NCT02282085|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6800325|NCT02282085|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6800326|NCT02282085|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6800327|NCT02282085|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6800328|NCT02282085|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6800329|NCT02282085|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6800330|NCT02282085|Adrenergic Agents|adrenergic agents|mesh-ancestor
6800331|NCT02282098|Colchicine|colchicine|mesh-list
6800332|NCT02282098|Gout Suppressants|gout suppressants|mesh-ancestor
6800333|NCT02282098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6800334|NCT02282098|Tubulin Modulators|tubulin modulators|mesh-ancestor
6800335|NCT02282098|Antimitotic Agents|antimitotic agents|mesh-ancestor
6800336|NCT02282098|Mitosis Modulators|mitosis modulators|mesh-ancestor
6800337|NCT02282098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800338|NCT02282098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6800339|NCT02282137|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
6800340|NCT02282137|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6800341|NCT02282137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800342|NCT02282150|Hydrocortisone|hydrocortisone|mesh-list
6800343|NCT02282150|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6800344|NCT02282150|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6800345|NCT02282150|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6800346|NCT02282150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6800347|NCT02282176|Azithromycin|azithromycin|mesh-list
6800348|NCT02282176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5993156|NCT00119262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5993157|NCT00119262|Immunologic Factors|immunologic factors|mesh-ancestor
5993158|NCT00119262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993159|NCT00119262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5993160|NCT00119262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5993161|NCT00119262|Alkylating Agents|alkylating agents|mesh-ancestor
5993162|NCT00119262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5993163|NCT00119262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5993164|NCT00119262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5993165|NCT00119262|Growth Substances|growth substances|mesh-ancestor
5993166|NCT00119262|Growth Inhibitors|growth inhibitors|mesh-ancestor
5993167|NCT00119262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5993168|NCT00119262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5993169|NCT00119262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6258449|NCT03087604|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6800349|NCT02282176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6800350|NCT02282241|Melatonin|melatonin|mesh-list
6800351|NCT02282241|Antioxidants|antioxidants|mesh-ancestor
6800352|NCT02282241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800353|NCT02282241|Protective Agents|protective agents|mesh-ancestor
6800354|NCT02282241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800355|NCT02282241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6800356|NCT02282267|Gefitinib|gefitinib|mesh-list
6800357|NCT02282267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6800358|NCT02282267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6800359|NCT02282267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6800360|NCT02282267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800361|NCT02282280|Prilocaine|prilocaine|mesh-list
6800362|NCT02282280|Anesthetics, Local|anesthetics, local|mesh-ancestor
6800363|NCT02282280|Anesthetics|anesthetics|mesh-ancestor
6800364|NCT02282280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6800365|NCT02282280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800366|NCT02282280|Sensory System Agents|sensory system agents|mesh-ancestor
6800367|NCT02282280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6800368|NCT02282319|Dexmedetomidine|dexmedetomidine|mesh-list
6800369|NCT02282319|Chloroprocaine|chloroprocaine|mesh-list
6800370|NCT02282319|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6800371|NCT02282319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6800372|NCT02282319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800373|NCT02282319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6800374|NCT02282319|Analgesics|analgesics|mesh-ancestor
6800375|NCT02282319|Sensory System Agents|sensory system agents|mesh-ancestor
6800376|NCT02282319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6800377|NCT02282319|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6800378|NCT02282319|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6800379|NCT02282319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6800380|NCT02282319|Adrenergic Agents|adrenergic agents|mesh-ancestor
6800381|NCT02282319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6800382|NCT02282319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800383|NCT02282319|Anesthetics, Local|anesthetics, local|mesh-ancestor
6800384|NCT02282319|Anesthetics|anesthetics|mesh-ancestor
6800385|NCT02282358|Mocetinostat|mocetinostat|mesh-list
6800386|NCT02282358|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6800387|NCT02282358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6800388|NCT02282358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800389|NCT02282371|Cetuximab|cetuximab|mesh-list
6800390|NCT02282371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6800391|NCT02282371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6800392|NCT02282384|Oseltamivir|oseltamivir|mesh-list
6800393|NCT02282384|Calcium Carbonate|calcium carbonate|mesh-list
6800394|NCT02282384|Antiviral Agents|antiviral agents|mesh-ancestor
6800395|NCT02282384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6800396|NCT02282384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6800397|NCT02282384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800398|NCT02282384|Antacids|antacids|mesh-ancestor
6800399|NCT02282384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6800400|NCT02282410|Factor VIII|factor viii|mesh-list
6800401|NCT02282410|Coagulants|coagulants|mesh-ancestor
6800402|NCT02282657|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
6800403|NCT02282657|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6800404|NCT02282657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6800405|NCT02282657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800406|NCT02282683|Prednisone|prednisone|mesh-list
6800407|NCT02282683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6800408|NCT02282683|Glucocorticoids|glucocorticoids|mesh-ancestor
6800409|NCT02282683|Hormones|hormones|mesh-ancestor
6800410|NCT02282683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6800411|NCT02282683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800412|NCT02282683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6800413|NCT02282683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6800414|NCT02282709|Asunaprevir|asunaprevir|mesh-list
6800415|NCT02282709|Protease Inhibitors|protease inhibitors|mesh-ancestor
6800416|NCT02282709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6800417|NCT02282709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800418|NCT02282774|Lidocaine|lidocaine|mesh-list
6800419|NCT02282774|Bupivacaine|bupivacaine|mesh-list
6800420|NCT02282774|Anesthetics, Local|anesthetics, local|mesh-ancestor
6800421|NCT02282774|Anesthetics|anesthetics|mesh-ancestor
6800422|NCT02282774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6800423|NCT02282774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800424|NCT02282774|Sensory System Agents|sensory system agents|mesh-ancestor
6800425|NCT02282774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6800426|NCT02282774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6800427|NCT02282774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6800428|NCT02282774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6800429|NCT02282774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6800430|NCT02282774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800431|NCT02282787|Dexmedetomidine|dexmedetomidine|mesh-list
6800432|NCT02282787|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6800433|NCT02282787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6800434|NCT02282787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800435|NCT02282787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6800436|NCT02282787|Analgesics|analgesics|mesh-ancestor
6800437|NCT02282787|Sensory System Agents|sensory system agents|mesh-ancestor
6800438|NCT02282787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6800439|NCT02282787|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6800440|NCT02282787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6800441|NCT02282787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6800442|NCT02282787|Adrenergic Agents|adrenergic agents|mesh-ancestor
6800443|NCT02282787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6800444|NCT02282787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800445|NCT02282800|Vitamin D|vitamin d|mesh-list
6800446|NCT02282800|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
6800447|NCT02282800|Vitamins|vitamins|mesh-ancestor
6800448|NCT02282800|Micronutrients|micronutrients|mesh-ancestor
6800449|NCT02282800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800450|NCT02282800|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6800451|NCT02282826|Acyclovir|acyclovir|mesh-list
6800452|NCT02282826|Antiviral Agents|antiviral agents|mesh-ancestor
6800453|NCT02282826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6800454|NCT02282891|Ketamine|ketamine|mesh-list
6800455|NCT02282891|Propofol|propofol|mesh-list
6800456|NCT02282891|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6800457|NCT02282891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6800458|NCT02282891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800459|NCT02282891|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6800460|NCT02282891|Anesthetics, General|anesthetics, general|mesh-ancestor
6800461|NCT02282891|Anesthetics|anesthetics|mesh-ancestor
6800462|NCT02282891|Analgesics|analgesics|mesh-ancestor
6800463|NCT02282891|Sensory System Agents|sensory system agents|mesh-ancestor
6800464|NCT02282891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6800465|NCT02282891|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6800466|NCT02282891|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6800467|NCT02282891|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6800468|NCT02282891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6800469|NCT02282891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800470|NCT02282956|Droperidol|droperidol|mesh-list
6800471|NCT02282956|Morphine|morphine|mesh-list
6800472|NCT02282956|Ropivacaine|ropivacaine|mesh-list
6800473|NCT02282956|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6800474|NCT02282956|Narcotics|narcotics|mesh-ancestor
6800475|NCT02282956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6800476|NCT02282956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800477|NCT02282956|Analgesics|analgesics|mesh-ancestor
6800478|NCT02282956|Sensory System Agents|sensory system agents|mesh-ancestor
6800479|NCT02282956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6800480|NCT02282956|Anesthetics, Local|anesthetics, local|mesh-ancestor
6800481|NCT02282956|Anesthetics|anesthetics|mesh-ancestor
6800482|NCT02282956|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6800483|NCT02282956|Antiemetics|antiemetics|mesh-ancestor
6800484|NCT02282956|Autonomic Agents|autonomic agents|mesh-ancestor
6800485|NCT02282956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6800486|NCT02282956|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6800487|NCT02282956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6800488|NCT02282956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6800489|NCT02282956|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6800490|NCT02282956|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6800491|NCT02282956|Dopamine Agents|dopamine agents|mesh-ancestor
6800492|NCT02282956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6800493|NCT02282956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800494|NCT02283060|Tenofovir|tenofovir|mesh-list
6800495|NCT02283060|Emtricitabine|emtricitabine|mesh-list
6800496|NCT02283060|Efavirenz|efavirenz|mesh-list
6800497|NCT02283060|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6800498|NCT02283060|Cobicistat|cobicistat|mesh-list
6800499|NCT02283060|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6800500|NCT02283060|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6800501|NCT02283060|Elvitegravir|elvitegravir|mesh-list
6800502|NCT02283060|Antiviral Agents|antiviral agents|mesh-ancestor
6800503|NCT02283060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6800504|NCT02283060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6800505|NCT02283060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6800506|NCT02283060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6800507|NCT02283060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800508|NCT02283060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6800509|NCT02283060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6800510|NCT02283060|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6800511|NCT02283060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6800512|NCT02283060|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6800513|NCT02283060|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6800514|NCT02283060|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6800515|NCT02283060|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6800516|NCT02283060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6800517|NCT02283060|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6800518|NCT02283112|Anti-Infective Agents|anti-infective agents|mesh-list
6800519|NCT02283112|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6800520|NCT02283112|Antiviral Agents|antiviral agents|mesh-list
6800521|NCT02283112|Contraceptive Agents|contraceptive agents|mesh-list
6800522|NCT02283112|Contraceptives, Oral|contraceptives, oral|mesh-list
6800523|NCT02283112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6800524|NCT02283112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800525|NCT02283112|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6800526|NCT02283177|Cytarabine|cytarabine|mesh-list
6800527|NCT02283177|Daunorubicin|daunorubicin|mesh-list
6800528|NCT02283177|Idarubicin|idarubicin|mesh-list
6800529|NCT02283177|Crenolanib|crenolanib|mesh-list
6800530|NCT02283177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6800531|NCT02283177|Antimetabolites|antimetabolites|mesh-ancestor
6800532|NCT02283177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800533|NCT02283177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6800534|NCT02283177|Antiviral Agents|antiviral agents|mesh-ancestor
6800535|NCT02283177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6800536|NCT02283177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6800537|NCT02283177|Immunologic Factors|immunologic factors|mesh-ancestor
6800538|NCT02283177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800539|NCT02283177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6800540|NCT02283177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6800541|NCT02283177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6800542|NCT02283177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6800543|NCT02283190|Asparaginase|asparaginase|mesh-list
6800544|NCT02283190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6800545|NCT02283203|Acetaminophen|acetaminophen|mesh-list
6800546|NCT02283203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6800547|NCT02283203|Analgesics|analgesics|mesh-ancestor
6800548|NCT02283203|Sensory System Agents|sensory system agents|mesh-ancestor
6800549|NCT02283203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6800550|NCT02283203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800551|NCT02283203|Antipyretics|antipyretics|mesh-ancestor
6800552|NCT02283242|Galantamine|galantamine|mesh-list
6800553|NCT02283242|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6800554|NCT02283242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6800555|NCT02283242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800556|NCT02283242|Cholinergic Agents|cholinergic agents|mesh-ancestor
6800557|NCT02283242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6800558|NCT02283242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800559|NCT02283242|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6800560|NCT02283242|Autonomic Agents|autonomic agents|mesh-ancestor
6800561|NCT02283242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6800562|NCT02283242|Nootropic Agents|nootropic agents|mesh-ancestor
6800563|NCT02283281|Dronabinol|dronabinol|mesh-list
6800564|NCT02283281|Hallucinogens|hallucinogens|mesh-ancestor
6800565|NCT02283281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800566|NCT02283281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6800567|NCT02283281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6800568|NCT02283281|Analgesics|analgesics|mesh-ancestor
6800569|NCT02283281|Sensory System Agents|sensory system agents|mesh-ancestor
6800570|NCT02283281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6800571|NCT02283281|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6800572|NCT02283281|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6800573|NCT02283281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6800574|NCT02283281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800575|NCT02283281|Hormones|hormones|mesh-ancestor
6800576|NCT02283281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6800577|NCT02283320|Docetaxel|docetaxel|mesh-list
5993170|NCT00119262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5993171|NCT00119262|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5993172|NCT00119262|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5993173|NCT00119262|Hormone Antagonists|hormone antagonists|mesh-ancestor
5993174|NCT00119262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5993175|NCT00119262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5993176|NCT00119262|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5993177|NCT00119262|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5993178|NCT00119262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5993179|NCT00119262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5993180|NCT00119379|Tenofovir|tenofovir|mesh-list
5993181|NCT00119379|Antiviral Agents|antiviral agents|mesh-ancestor
6800578|NCT02283320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6800579|NCT02283320|Tubulin Modulators|tubulin modulators|mesh-ancestor
6800580|NCT02283320|Antimitotic Agents|antimitotic agents|mesh-ancestor
6800581|NCT02283320|Mitosis Modulators|mitosis modulators|mesh-ancestor
6800582|NCT02283320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800583|NCT02283359|Irinotecan|irinotecan|mesh-list
6800584|NCT02283359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6800585|NCT02283359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6800586|NCT02283359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6800587|NCT02283359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800588|NCT02283359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6800589|NCT02283372|Gemcitabine|gemcitabine|mesh-list
6800590|NCT02283372|Paclitaxel|paclitaxel|mesh-list
6800591|NCT02283372|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6800592|NCT02283372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6800593|NCT02283372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6800594|NCT02283372|Tubulin Modulators|tubulin modulators|mesh-ancestor
6800595|NCT02283372|Antimitotic Agents|antimitotic agents|mesh-ancestor
6800596|NCT02283372|Mitosis Modulators|mitosis modulators|mesh-ancestor
6800597|NCT02283372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800598|NCT02283372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6800599|NCT02283372|Antimetabolites|antimetabolites|mesh-ancestor
6800600|NCT02283372|Antiviral Agents|antiviral agents|mesh-ancestor
6800601|NCT02283372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6800602|NCT02283372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6800603|NCT02283372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6800604|NCT02283372|Immunologic Factors|immunologic factors|mesh-ancestor
6800605|NCT02283372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800606|NCT02283424|Carboplatin|carboplatin|mesh-list
6800607|NCT02283424|Docetaxel|docetaxel|mesh-list
6800608|NCT02283424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6800609|NCT02283424|Tubulin Modulators|tubulin modulators|mesh-ancestor
6800610|NCT02283424|Antimitotic Agents|antimitotic agents|mesh-ancestor
6800611|NCT02283424|Mitosis Modulators|mitosis modulators|mesh-ancestor
6800612|NCT02283424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800613|NCT02283476|Gemcitabine|gemcitabine|mesh-list
6800614|NCT02283476|Endostar protein|endostar protein|mesh-list
6800615|NCT02283476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6800616|NCT02283476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6800617|NCT02283476|Antimetabolites|antimetabolites|mesh-ancestor
6800618|NCT02283476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800619|NCT02283476|Antiviral Agents|antiviral agents|mesh-ancestor
6800620|NCT02283476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6800621|NCT02283476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6800622|NCT02283476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6800623|NCT02283476|Immunologic Factors|immunologic factors|mesh-ancestor
6800624|NCT02283476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800625|NCT02283476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6800626|NCT02283476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6800627|NCT02283476|Growth Substances|growth substances|mesh-ancestor
6800628|NCT02283476|Growth Inhibitors|growth inhibitors|mesh-ancestor
6800629|NCT02283489|Paclitaxel|paclitaxel|mesh-list
6800630|NCT02283489|Endostatins|endostatins|mesh-list
6800631|NCT02283489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6800632|NCT02283489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6800633|NCT02283489|Tubulin Modulators|tubulin modulators|mesh-ancestor
6800634|NCT02283489|Antimitotic Agents|antimitotic agents|mesh-ancestor
6800635|NCT02283489|Mitosis Modulators|mitosis modulators|mesh-ancestor
6800636|NCT02283489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800637|NCT02283489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6800638|NCT02283489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6800639|NCT02283489|Growth Substances|growth substances|mesh-ancestor
6800640|NCT02283489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800641|NCT02283489|Growth Inhibitors|growth inhibitors|mesh-ancestor
6800642|NCT02283515|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6800643|NCT02283515|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6800644|NCT02283515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6800645|NCT02283515|Antimetabolites|antimetabolites|mesh-ancestor
6800646|NCT02283515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5993182|NCT00119379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5993183|NCT00119379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5993184|NCT00119379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5993185|NCT00119379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5993186|NCT00119379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5993187|NCT00119379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5993188|NCT00119379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5993189|NCT00119392|Cyclosporine|cyclosporine|mesh-list
6800647|NCT02283515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6800648|NCT02283515|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6800649|NCT02283515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6800650|NCT02283554|Metformin|metformin|mesh-list
6800651|NCT02283554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6800652|NCT02283554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800653|NCT02283645|Minoxidil|minoxidil|mesh-list
6800654|NCT02283645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6800655|NCT02283645|Vasodilator Agents|vasodilator agents|mesh-ancestor
6800656|NCT02283710|Pentoxifylline|pentoxifylline|mesh-list
6800657|NCT02283710|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6800658|NCT02283710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6800659|NCT02283710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800660|NCT02283710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6800661|NCT02283710|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6800662|NCT02283710|Protective Agents|protective agents|mesh-ancestor
6800663|NCT02283710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800664|NCT02283710|Vasodilator Agents|vasodilator agents|mesh-ancestor
6800665|NCT02283710|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6800666|NCT02283710|Antioxidants|antioxidants|mesh-ancestor
6800667|NCT02283775|Dexamethasone|dexamethasone|mesh-list
6800668|NCT02283775|Pomalidomide|pomalidomide|mesh-list
6800669|NCT02283775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6800670|NCT02283775|Antiemetics|antiemetics|mesh-ancestor
6800671|NCT02283775|Autonomic Agents|autonomic agents|mesh-ancestor
6800672|NCT02283775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6800673|NCT02283775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800674|NCT02283775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6800675|NCT02283775|Glucocorticoids|glucocorticoids|mesh-ancestor
6800676|NCT02283775|Hormones|hormones|mesh-ancestor
6800677|NCT02283775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6800678|NCT02283775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6800679|NCT02283775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6800680|NCT02283775|Immunologic Factors|immunologic factors|mesh-ancestor
6800681|NCT02283775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6800682|NCT02283775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6800683|NCT02283775|Growth Substances|growth substances|mesh-ancestor
6800684|NCT02283775|Growth Inhibitors|growth inhibitors|mesh-ancestor
6800685|NCT02283801|Lamotrigine|lamotrigine|mesh-list
6800686|NCT02283801|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
6800687|NCT02283801|Anticonvulsants|anticonvulsants|mesh-ancestor
5993190|NCT00119392|Mycophenolic Acid|mycophenolic acid|mesh-list
5993191|NCT00119392|Rituximab|rituximab|mesh-list
6800688|NCT02283801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6800689|NCT02283801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6800690|NCT02283801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800691|NCT02283801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6800692|NCT02283801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800693|NCT02283801|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6800694|NCT02283801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6800695|NCT02283801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6800696|NCT02283801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6800697|NCT02283801|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6800698|NCT02283801|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6800699|NCT02283866|Desflurane|desflurane|mesh-list
6800700|NCT02283866|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6800701|NCT02283866|Anesthetics, General|anesthetics, general|mesh-ancestor
6800702|NCT02283866|Anesthetics|anesthetics|mesh-ancestor
6800703|NCT02283866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6800704|NCT02283866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800705|NCT02283905|Voriconazole|voriconazole|mesh-list
6800706|NCT02283905|Amphotericin B|amphotericin b|mesh-list
6800707|NCT02283905|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6800708|NCT02283905|Antifungal Agents|antifungal agents|mesh-ancestor
6800709|NCT02283905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6800710|NCT02283905|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6800711|NCT02283905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6800712|NCT02283905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6800713|NCT02283905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800714|NCT02283905|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6800715|NCT02283905|Hormone Antagonists|hormone antagonists|mesh-ancestor
6800716|NCT02283905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6800717|NCT02283905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800718|NCT02283905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5993192|NCT00119392|Fludarabine|fludarabine|mesh-list
6800719|NCT02283905|Amebicides|amebicides|mesh-ancestor
6800720|NCT02283905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6800721|NCT02283905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6800722|NCT02283905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6800723|NCT02283996|Methylprednisolone|methylprednisolone|mesh-list
6800724|NCT02283996|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6800725|NCT02283996|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6800726|NCT02283996|Prednisolone|prednisolone|mesh-list
6800727|NCT02283996|Prednisolone acetate|prednisolone acetate|mesh-list
6800728|NCT02283996|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6800729|NCT02283996|Prednisolone phosphate|prednisolone phosphate|mesh-list
6800730|NCT02283996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6800731|NCT02283996|Antiemetics|antiemetics|mesh-ancestor
6800732|NCT02283996|Autonomic Agents|autonomic agents|mesh-ancestor
6800733|NCT02283996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6800734|NCT02283996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800735|NCT02283996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6800736|NCT02283996|Glucocorticoids|glucocorticoids|mesh-ancestor
6800737|NCT02283996|Hormones|hormones|mesh-ancestor
6800738|NCT02283996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6800739|NCT02283996|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6800740|NCT02283996|Protective Agents|protective agents|mesh-ancestor
6800741|NCT02283996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6800742|NCT02283996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6800743|NCT02284035|Raltegravir Potassium|raltegravir potassium|mesh-list
6800744|NCT02284035|Lamivudine|lamivudine|mesh-list
6800745|NCT02284035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6800746|NCT02284035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6800747|NCT02284035|Antiviral Agents|antiviral agents|mesh-ancestor
6800748|NCT02284035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6800749|NCT02284035|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6800750|NCT02284035|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6800751|NCT02284035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6800752|NCT02284035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800753|NCT02284035|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6800754|NCT02284035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6800755|NCT02284048|Ticagrelor|ticagrelor|mesh-list
6800756|NCT02284048|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6800757|NCT02284048|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6800758|NCT02284048|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6800759|NCT02284048|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6800760|NCT02284048|Purinergic Agents|purinergic agents|mesh-ancestor
6800761|NCT02284048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6800762|NCT02284048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800763|NCT02284048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800764|NCT02284204|Midazolam|midazolam|mesh-list
6800765|NCT02284204|Ketamine|ketamine|mesh-list
6800766|NCT02284204|Sevoflurane|sevoflurane|mesh-list
6800767|NCT02284204|Analgesics|analgesics|mesh-ancestor
6800768|NCT02284204|Sensory System Agents|sensory system agents|mesh-ancestor
6800769|NCT02284204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6800770|NCT02284204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800771|NCT02284204|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6800772|NCT02284204|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6800773|NCT02284204|Anesthetics, General|anesthetics, general|mesh-ancestor
6800774|NCT02284204|Anesthetics|anesthetics|mesh-ancestor
6800775|NCT02284204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6800776|NCT02284204|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6800777|NCT02284204|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6800778|NCT02284204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6800779|NCT02284204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800780|NCT02284204|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6800781|NCT02284204|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6800782|NCT02284204|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6800783|NCT02284204|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6800784|NCT02284204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6800785|NCT02284204|GABA Modulators|gaba modulators|mesh-ancestor
6800786|NCT02284204|GABA Agents|gaba agents|mesh-ancestor
6800787|NCT02284204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6800788|NCT02284204|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6800789|NCT02284230|Liraglutide|liraglutide|mesh-list
6800790|NCT02284230|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6800791|NCT02284230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800792|NCT02284230|Incretins|incretins|mesh-ancestor
6800793|NCT02284230|Hormones|hormones|mesh-ancestor
6800794|NCT02284230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6800795|NCT02284269|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
6800796|NCT02284269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800797|NCT02284269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6800798|NCT02284269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800799|NCT02284282|Lidocaine|lidocaine|mesh-list
6800800|NCT02284282|Morphine|morphine|mesh-list
6800801|NCT02284282|Bupivacaine|bupivacaine|mesh-list
6800802|NCT02284282|Anesthetics, Local|anesthetics, local|mesh-ancestor
6800803|NCT02284282|Anesthetics|anesthetics|mesh-ancestor
6800804|NCT02284282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6800805|NCT02284282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800806|NCT02284282|Sensory System Agents|sensory system agents|mesh-ancestor
6800807|NCT02284282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6800808|NCT02284282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6800809|NCT02284282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6800810|NCT02284282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6800811|NCT02284282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6800812|NCT02284282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800813|NCT02284282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6800814|NCT02284282|Narcotics|narcotics|mesh-ancestor
6800815|NCT02284282|Analgesics|analgesics|mesh-ancestor
6800816|NCT02284412|Neostigmine|neostigmine|mesh-list
6800817|NCT02284412|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6800818|NCT02284412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6800819|NCT02284412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800820|NCT02284412|Cholinergic Agents|cholinergic agents|mesh-ancestor
6800821|NCT02284412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6800822|NCT02284412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800823|NCT02284412|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6800824|NCT02284412|Autonomic Agents|autonomic agents|mesh-ancestor
6800825|NCT02284412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6800826|NCT02284490|Pemetrexed|pemetrexed|mesh-list
6800827|NCT02284490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6800828|NCT02284490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6800829|NCT02284490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800830|NCT02284490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6800831|NCT02284490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6800832|NCT02284503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6800833|NCT02284503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6800834|NCT02284503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6800835|NCT02284503|Antimetabolites|antimetabolites|mesh-ancestor
6800836|NCT02284503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800837|NCT02284503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6800838|NCT02284503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6800839|NCT02284503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6800840|NCT02284529|Leucovorin|leucovorin|mesh-list
6800841|NCT02284529|Fluorouracil|fluorouracil|mesh-list
6800842|NCT02284529|Antimetabolites|antimetabolites|mesh-ancestor
6800843|NCT02284529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800844|NCT02284529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6800845|NCT02284529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6800846|NCT02284529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6800847|NCT02284529|Immunologic Factors|immunologic factors|mesh-ancestor
6800848|NCT02284529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800849|NCT02284529|Antidotes|antidotes|mesh-ancestor
6800850|NCT02284529|Protective Agents|protective agents|mesh-ancestor
6800851|NCT02284529|Vitamin B Complex|vitamin b complex|mesh-ancestor
6800852|NCT02284529|Vitamins|vitamins|mesh-ancestor
6800853|NCT02284529|Micronutrients|micronutrients|mesh-ancestor
6800854|NCT02284672|Dexmedetomidine|dexmedetomidine|mesh-list
6800855|NCT02284672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6800856|NCT02284672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6800857|NCT02284672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800858|NCT02284672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6800859|NCT02284672|Analgesics|analgesics|mesh-ancestor
6800860|NCT02284672|Sensory System Agents|sensory system agents|mesh-ancestor
6800861|NCT02284672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6800862|NCT02284672|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6800863|NCT02284672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6800864|NCT02284672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6800865|NCT02284672|Adrenergic Agents|adrenergic agents|mesh-ancestor
6800866|NCT02284672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6800867|NCT02284672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800868|NCT02284737|Sildenafil Citrate|sildenafil citrate|mesh-list
6800869|NCT02284737|Vasodilator Agents|vasodilator agents|mesh-ancestor
6800870|NCT02284737|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6800871|NCT02284737|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6800872|NCT02284737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6800873|NCT02284737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800874|NCT02284737|Urological Agents|urological agents|mesh-ancestor
5993193|NCT00119392|Fludarabine phosphate|fludarabine phosphate|mesh-list
5993194|NCT00119392|Cyclosporins|cyclosporins|mesh-list
5993195|NCT00119392|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5993196|NCT00119392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5993197|NCT00119392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5993198|NCT00119392|Immunologic Factors|immunologic factors|mesh-ancestor
5993199|NCT00119392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993200|NCT00119392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5993201|NCT00119392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5993202|NCT00119392|Antimetabolites|antimetabolites|mesh-ancestor
5993203|NCT00119392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800875|NCT02284984|Rituximab|rituximab|mesh-list
6800876|NCT02284984|Belimumab|belimumab|mesh-list
6800877|NCT02284984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6800878|NCT02284984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6800879|NCT02284984|Immunologic Factors|immunologic factors|mesh-ancestor
6800880|NCT02284984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800881|NCT02284984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6800882|NCT02284984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6800883|NCT02285036|Vaccines|vaccines|mesh-list
6800884|NCT02285036|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6800885|NCT02285036|Immunologic Factors|immunologic factors|mesh-ancestor
6800886|NCT02285036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800887|NCT02285075|Temocillin|temocillin|mesh-list
6800888|NCT02285075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6800889|NCT02285075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6800890|NCT02285101|BCT-100|bct-100|mesh-list
6800891|NCT02285101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6800892|NCT02285140|Vancomycin|vancomycin|mesh-list
6800893|NCT02285140|Cefazolin|cefazolin|mesh-list
6800894|NCT02285140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6800895|NCT02285140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6800896|NCT02285179|Tamoxifen|tamoxifen|mesh-list
6800897|NCT02285179|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6800898|NCT02285179|Hormone Antagonists|hormone antagonists|mesh-ancestor
6800899|NCT02285179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6800900|NCT02285179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800901|NCT02285179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6800902|NCT02285179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6800903|NCT02285179|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6800904|NCT02285179|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6800905|NCT02285179|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6800906|NCT02285309|Enoximone|enoximone|mesh-list
6800907|NCT02285309|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6800908|NCT02285309|Vasodilator Agents|vasodilator agents|mesh-ancestor
6800909|NCT02285309|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6800910|NCT02285309|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6800911|NCT02285309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6800912|NCT02285309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800913|NCT02285309|Protective Agents|protective agents|mesh-ancestor
6800914|NCT02285309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800915|NCT02285374|Tenofovir|tenofovir|mesh-list
6800916|NCT02285374|Emtricitabine|emtricitabine|mesh-list
6800917|NCT02285374|Efavirenz|efavirenz|mesh-list
6800918|NCT02285374|Dolutegravir|dolutegravir|mesh-list
6800919|NCT02285374|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6800920|NCT02285374|Antiviral Agents|antiviral agents|mesh-ancestor
6800921|NCT02285374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6800922|NCT02285374|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6800923|NCT02285374|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6800924|NCT02285374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6800925|NCT02285374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800926|NCT02285374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6800927|NCT02285374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6800928|NCT02285374|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6800929|NCT02285374|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6800930|NCT02285374|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6800931|NCT02285374|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6800932|NCT02285374|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6800933|NCT02285374|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6800934|NCT02285374|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6800935|NCT02285374|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6800936|NCT02285413|Cisplatin|cisplatin|mesh-list
6800937|NCT02285413|Vaccines|vaccines|mesh-list
6800938|NCT02285413|Immunologic Factors|immunologic factors|mesh-ancestor
6800939|NCT02285413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800940|NCT02285413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6800941|NCT02285491|Bupivacaine|bupivacaine|mesh-list
6800942|NCT02285491|Anesthetics, Local|anesthetics, local|mesh-ancestor
6800943|NCT02285491|Anesthetics|anesthetics|mesh-ancestor
6800944|NCT02285491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6800945|NCT02285491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800946|NCT02285491|Sensory System Agents|sensory system agents|mesh-ancestor
6258450|NCT03087604|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6258451|NCT03087604|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6800947|NCT02285491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6800948|NCT02285647|Rolapitant|rolapitant|mesh-list
6800949|NCT02285647|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6800950|NCT02285647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6800951|NCT02285647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800952|NCT02285647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800953|NCT02285699|Fluvoxamine|fluvoxamine|mesh-list
6800954|NCT02285699|Citalopram|citalopram|mesh-list
6800955|NCT02285699|Fluoxetine|fluoxetine|mesh-list
6800956|NCT02285699|Paroxetine|paroxetine|mesh-list
6800957|NCT02285699|Sertraline|sertraline|mesh-list
6800958|NCT02285699|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6800959|NCT02285699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6800960|NCT02285699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6800961|NCT02285699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800962|NCT02285699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6800963|NCT02285699|Serotonin Agents|serotonin agents|mesh-ancestor
6800964|NCT02285699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800965|NCT02285699|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6800966|NCT02285699|Antidepressive Agents|antidepressive agents|mesh-ancestor
6800967|NCT02285699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6800968|NCT02285699|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6800969|NCT02285699|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6800970|NCT02285699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6800971|NCT02285699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6800972|NCT02285699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6800973|NCT02285699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6800974|NCT02285699|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6800975|NCT02285699|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6800976|NCT02285738|Aspirin|aspirin|mesh-list
6800977|NCT02285738|Simvastatin|simvastatin|mesh-list
6800978|NCT02285738|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6800979|NCT02285738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6800980|NCT02285738|Analgesics|analgesics|mesh-ancestor
6800981|NCT02285738|Sensory System Agents|sensory system agents|mesh-ancestor
6800982|NCT02285738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6800983|NCT02285738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6800984|NCT02285738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6800985|NCT02285738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6800986|NCT02285738|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6800987|NCT02285738|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6800988|NCT02285738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6800989|NCT02285738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6800990|NCT02285738|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6800991|NCT02285738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6800992|NCT02285738|Antipyretics|antipyretics|mesh-ancestor
6800993|NCT02285738|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6800994|NCT02285738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6800995|NCT02285738|Antimetabolites|antimetabolites|mesh-ancestor
6800996|NCT02285738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6800997|NCT02285738|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6800998|NCT02285751|Aspirin|aspirin|mesh-list
6800999|NCT02285751|Clopidogrel|clopidogrel|mesh-list
6801000|NCT02285751|Ticagrelor|ticagrelor|mesh-list
6801001|NCT02285751|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6801002|NCT02285751|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6801003|NCT02285751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6801004|NCT02285751|Analgesics|analgesics|mesh-ancestor
6801005|NCT02285751|Sensory System Agents|sensory system agents|mesh-ancestor
6801006|NCT02285751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6801007|NCT02285751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801008|NCT02285751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6801009|NCT02285751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6801010|NCT02285751|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6801011|NCT02285751|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6801012|NCT02285751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801013|NCT02285751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6801014|NCT02285751|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6801015|NCT02285751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6801016|NCT02285751|Antipyretics|antipyretics|mesh-ancestor
6801017|NCT02285751|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6801018|NCT02285751|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6801019|NCT02285751|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6801020|NCT02285751|Purinergic Agents|purinergic agents|mesh-ancestor
6801021|NCT02285751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6801022|NCT02285829|Bromides|bromides|mesh-list
6801023|NCT02285829|Rocuronium|rocuronium|mesh-list
6801024|NCT02285829|Cisatracurium|cisatracurium|mesh-list
6801025|NCT02285829|Anticonvulsants|anticonvulsants|mesh-ancestor
6801026|NCT02285829|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6801027|NCT02285829|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6801028|NCT02285829|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6801029|NCT02285829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6801030|NCT02285829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801031|NCT02285959|Bevacizumab|bevacizumab|mesh-list
6801032|NCT02285959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6801033|NCT02285959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6801034|NCT02285959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6801035|NCT02285959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6801036|NCT02285959|Growth Substances|growth substances|mesh-ancestor
6801037|NCT02285959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801038|NCT02285959|Growth Inhibitors|growth inhibitors|mesh-ancestor
6801039|NCT02285972|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
6801040|NCT02285972|Tenoxicam|tenoxicam|mesh-list
6801041|NCT02285972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6801042|NCT02285972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6801043|NCT02285972|Analgesics|analgesics|mesh-ancestor
6801044|NCT02285972|Sensory System Agents|sensory system agents|mesh-ancestor
6801045|NCT02285972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6801046|NCT02285972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801047|NCT02285972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6801048|NCT02285972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6801049|NCT02285972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6801050|NCT02285972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6801051|NCT02285972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801052|NCT02285985|Saxagliptin|saxagliptin|mesh-list
6801053|NCT02285985|Incretins|incretins|mesh-ancestor
6801054|NCT02285985|Hormones|hormones|mesh-ancestor
6801055|NCT02285985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6801056|NCT02285985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801057|NCT02285985|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6801058|NCT02285985|Protease Inhibitors|protease inhibitors|mesh-ancestor
6801059|NCT02285985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6801060|NCT02285985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801061|NCT02285985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6801062|NCT02286206|Clozapine|clozapine|mesh-list
6801063|NCT02286206|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6801064|NCT02286206|Serotonin Agents|serotonin agents|mesh-ancestor
6801065|NCT02286206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6801066|NCT02286206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801067|NCT02286206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801068|NCT02286206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6801069|NCT02286206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6801070|NCT02286206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6801071|NCT02286206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6801072|NCT02286206|GABA Antagonists|gaba antagonists|mesh-ancestor
6801073|NCT02286206|GABA Agents|gaba agents|mesh-ancestor
6801074|NCT02286219|Immunoglobulins|immunoglobulins|mesh-list
6801075|NCT02286219|Immunoglobulin G|immunoglobulin g|mesh-list
6801076|NCT02286219|Immunologic Factors|immunologic factors|mesh-ancestor
6801077|NCT02286219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801078|NCT02286258|Calcium, Dietary|calcium, dietary|mesh-list
6801079|NCT02286258|Edetic Acid|edetic acid|mesh-list
6801080|NCT02286258|Calcium|calcium|mesh-list
6801081|NCT02286258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6801082|NCT02286258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801083|NCT02286258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6801084|NCT02286258|Chelating Agents|chelating agents|mesh-ancestor
5993204|NCT00119392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5993205|NCT00119392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5993206|NCT00119392|Antifungal Agents|antifungal agents|mesh-ancestor
5993207|NCT00119392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5993208|NCT00119392|Dermatologic Agents|dermatologic agents|mesh-ancestor
5993209|NCT00119392|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5993210|NCT00119392|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6258452|NCT03087604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6801085|NCT02286258|Sequestering Agents|sequestering agents|mesh-ancestor
6801086|NCT02286258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801087|NCT02286258|Anticoagulants|anticoagulants|mesh-ancestor
6801088|NCT02286258|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6801089|NCT02286388|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6801090|NCT02286388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6801091|NCT02286414|Vitamins|vitamins|mesh-list
6801092|NCT02286414|Vitamin K|vitamin k|mesh-list
6801093|NCT02286414|Warfarin|warfarin|mesh-list
6801094|NCT02286414|Rivaroxaban|rivaroxaban|mesh-list
6801095|NCT02286414|Dabigatran|dabigatran|mesh-list
6801096|NCT02286414|Apixaban|apixaban|mesh-list
6801097|NCT02286414|Acenocoumarol|acenocoumarol|mesh-list
6801098|NCT02286414|Fluindione|fluindione|mesh-list
6801099|NCT02286414|Micronutrients|micronutrients|mesh-ancestor
6801100|NCT02286414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801101|NCT02286414|Anticoagulants|anticoagulants|mesh-ancestor
6801102|NCT02286414|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6801103|NCT02286414|Antithrombins|antithrombins|mesh-ancestor
6801104|NCT02286414|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6801105|NCT02286414|Protease Inhibitors|protease inhibitors|mesh-ancestor
6801106|NCT02286414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6801107|NCT02286414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801108|NCT02286414|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6801109|NCT02286414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6801110|NCT02286414|Hemostatics|hemostatics|mesh-ancestor
6801111|NCT02286414|Coagulants|coagulants|mesh-ancestor
6801112|NCT02286453|Diclofenac|diclofenac|mesh-list
6801113|NCT02286453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6801114|NCT02286453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6801115|NCT02286453|Analgesics|analgesics|mesh-ancestor
6801116|NCT02286453|Sensory System Agents|sensory system agents|mesh-ancestor
6801117|NCT02286453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6801118|NCT02286453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801119|NCT02286453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6801120|NCT02286453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6801121|NCT02286453|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6801122|NCT02286453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6801123|NCT02286453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801124|NCT02286544|Atorvastatin|atorvastatin|mesh-list
6801125|NCT02286544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6801126|NCT02286544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6801127|NCT02286544|Antimetabolites|antimetabolites|mesh-ancestor
6801128|NCT02286544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801129|NCT02286544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6801130|NCT02286544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6801131|NCT02286544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6801132|NCT02286596|Heparin|heparin|mesh-list
6801133|NCT02286596|Dextrans|dextrans|mesh-list
6801134|NCT02286596|Anticoagulants|anticoagulants|mesh-ancestor
6801135|NCT02286596|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6801136|NCT02286596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6801137|NCT02286596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258453|NCT03087604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258454|NCT03087604|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6258455|NCT03087604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6258456|NCT03087604|Adrenergic Agents|adrenergic agents|mesh-ancestor
6258457|NCT03087604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6258458|NCT03087604|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6258459|NCT03087604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6258460|NCT03087604|Autonomic Agents|autonomic agents|mesh-ancestor
6258461|NCT03087604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6801138|NCT02286596|Plasma Substitutes|plasma substitutes|mesh-ancestor
6801139|NCT02286596|Blood Substitutes|blood substitutes|mesh-ancestor
6801140|NCT02286609|Deflazacort|deflazacort|mesh-list
6801141|NCT02286609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6801142|NCT02286609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6801143|NCT02286609|Immunologic Factors|immunologic factors|mesh-ancestor
6801144|NCT02286609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801145|NCT02286622|Deflazacort|deflazacort|mesh-list
6801146|NCT02286622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6801147|NCT02286622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6801148|NCT02286622|Immunologic Factors|immunologic factors|mesh-ancestor
6801149|NCT02286622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801150|NCT02286635|Clarithromycin|clarithromycin|mesh-list
6801151|NCT02286635|Rifampin|rifampin|mesh-list
6801152|NCT02286635|Deflazacort|deflazacort|mesh-list
6801153|NCT02286635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6801154|NCT02286635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6801155|NCT02286635|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6801156|NCT02286635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6801157|NCT02286635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801158|NCT02286635|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6801159|NCT02286635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6801160|NCT02286635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6801161|NCT02286635|Antitubercular Agents|antitubercular agents|mesh-ancestor
6801162|NCT02286635|Leprostatic Agents|leprostatic agents|mesh-ancestor
6801163|NCT02286635|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6801164|NCT02286635|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6801165|NCT02286635|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6801166|NCT02286635|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6801167|NCT02286635|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6801168|NCT02286635|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6801169|NCT02286635|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6801170|NCT02286635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6801171|NCT02286635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6801172|NCT02286635|Immunologic Factors|immunologic factors|mesh-ancestor
6801173|NCT02286635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801174|NCT02286687|Talazoparib|talazoparib|mesh-list
6258462|NCT03087604|Respiratory System Agents|respiratory system agents|mesh-ancestor
6801175|NCT02286687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6801176|NCT02286687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6801177|NCT02286687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801178|NCT02286687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6801179|NCT02286700|Desonide|desonide|mesh-list
6801180|NCT02286700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6801181|NCT02286752|Neostigmine|neostigmine|mesh-list
6801182|NCT02286752|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6801183|NCT02286752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6801184|NCT02286752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801185|NCT02286752|Cholinergic Agents|cholinergic agents|mesh-ancestor
6801186|NCT02286752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6801187|NCT02286752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801188|NCT02286752|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6801189|NCT02286752|Autonomic Agents|autonomic agents|mesh-ancestor
6801190|NCT02286752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6801191|NCT02286830|Zoledronic Acid|zoledronic acid|mesh-list
6801192|NCT02286830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6801193|NCT02286830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801194|NCT02286934|Carvedilol|carvedilol|mesh-list
6801195|NCT02286934|Isoproterenol|isoproterenol|mesh-list
6801196|NCT02286934|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6801197|NCT02286934|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6801198|NCT02286934|Adrenergic Agents|adrenergic agents|mesh-ancestor
6801199|NCT02286934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6801200|NCT02286934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801201|NCT02286934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801202|NCT02286934|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6801203|NCT02286934|Antioxidants|antioxidants|mesh-ancestor
6801204|NCT02286934|Protective Agents|protective agents|mesh-ancestor
6801205|NCT02286934|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6801206|NCT02286934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6801207|NCT02286934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6801208|NCT02286934|Vasodilator Agents|vasodilator agents|mesh-ancestor
6801209|NCT02286934|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6801210|NCT02286934|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6801211|NCT02286934|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6801212|NCT02286934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6801213|NCT02286934|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6801214|NCT02286934|Autonomic Agents|autonomic agents|mesh-ancestor
6801215|NCT02286934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6801216|NCT02286934|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6801217|NCT02286934|Respiratory System Agents|respiratory system agents|mesh-ancestor
6801218|NCT02286934|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6801219|NCT02286934|Sympathomimetics|sympathomimetics|mesh-ancestor
6801220|NCT02286973|Tranexamic Acid|tranexamic acid|mesh-list
6801221|NCT02286973|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6801222|NCT02286973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6801223|NCT02286973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801224|NCT02286973|Hemostatics|hemostatics|mesh-ancestor
6801225|NCT02286973|Coagulants|coagulants|mesh-ancestor
6801226|NCT02286986|Cannabidiol|cannabidiol|mesh-list
6801227|NCT02286986|Anticonvulsants|anticonvulsants|mesh-ancestor
6801228|NCT02287064|Immunoglobulins|immunoglobulins|mesh-list
6801229|NCT02287064|Antibodies|antibodies|mesh-list
6801230|NCT02287064|gamma-Globulins|gamma-globulins|mesh-list
6801231|NCT02287064|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6801232|NCT02287064|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6801233|NCT02287064|Immunologic Factors|immunologic factors|mesh-ancestor
6801234|NCT02287064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801235|NCT02287129|Paclitaxel|paclitaxel|mesh-list
6801236|NCT02287129|Carboplatin|carboplatin|mesh-list
6801237|NCT02287129|Capecitabine|capecitabine|mesh-list
6801238|NCT02287129|Oxaliplatin|oxaliplatin|mesh-list
6801239|NCT02287129|Epirubicin|epirubicin|mesh-list
6801240|NCT02287129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6801241|NCT02287129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6801242|NCT02287129|Tubulin Modulators|tubulin modulators|mesh-ancestor
6801243|NCT02287129|Antimitotic Agents|antimitotic agents|mesh-ancestor
6801244|NCT02287129|Mitosis Modulators|mitosis modulators|mesh-ancestor
6801245|NCT02287129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801246|NCT02287129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6801247|NCT02287129|Antimetabolites|antimetabolites|mesh-ancestor
6801248|NCT02287129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6801249|NCT02287129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6801250|NCT02287129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6801251|NCT02287129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6801252|NCT02287181|Remifentanil|remifentanil|mesh-list
6801253|NCT02287181|Propofol|propofol|mesh-list
6801254|NCT02287181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6801255|NCT02287181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6801256|NCT02287181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801257|NCT02287181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6801258|NCT02287181|Anesthetics, General|anesthetics, general|mesh-ancestor
6801259|NCT02287181|Anesthetics|anesthetics|mesh-ancestor
6801260|NCT02287181|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6801261|NCT02287181|Narcotics|narcotics|mesh-ancestor
6801262|NCT02287181|Analgesics|analgesics|mesh-ancestor
6801263|NCT02287181|Sensory System Agents|sensory system agents|mesh-ancestor
6801264|NCT02287181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6801265|NCT02287233|Cytarabine|cytarabine|mesh-list
6801266|NCT02287233|Venetoclax|venetoclax|mesh-list
6801267|NCT02287233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6801268|NCT02287233|Antimetabolites|antimetabolites|mesh-ancestor
6801269|NCT02287233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801270|NCT02287233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6801271|NCT02287233|Antiviral Agents|antiviral agents|mesh-ancestor
6801272|NCT02287233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6801273|NCT02287233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6801274|NCT02287233|Immunologic Factors|immunologic factors|mesh-ancestor
6801275|NCT02287233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801276|NCT02287246|Bupivacaine|bupivacaine|mesh-list
6801277|NCT02287246|Anesthetics, Local|anesthetics, local|mesh-ancestor
6801278|NCT02287246|Anesthetics|anesthetics|mesh-ancestor
6801279|NCT02287246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6801280|NCT02287246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801281|NCT02287246|Sensory System Agents|sensory system agents|mesh-ancestor
6801282|NCT02287246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6801283|NCT02287259|Olanzapine|olanzapine|mesh-list
6801284|NCT02287259|Antiemetics|antiemetics|mesh-ancestor
6801285|NCT02287259|Autonomic Agents|autonomic agents|mesh-ancestor
6801286|NCT02287259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6801287|NCT02287259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801288|NCT02287259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6801289|NCT02287259|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6801290|NCT02287259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6801291|NCT02287259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6801292|NCT02287259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6801293|NCT02287259|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6801294|NCT02287259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6801295|NCT02287259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6801296|NCT02287259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801297|NCT02287259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6801298|NCT02287259|Serotonin Agents|serotonin agents|mesh-ancestor
6801299|NCT02287272|Cimetidine|cimetidine|mesh-list
6801300|NCT02287272|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6801301|NCT02287272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6801302|NCT02287272|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6801303|NCT02287272|Histamine Antagonists|histamine antagonists|mesh-ancestor
6801304|NCT02287272|Histamine Agents|histamine agents|mesh-ancestor
6801305|NCT02287272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6801306|NCT02287272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801307|NCT02287272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801308|NCT02287272|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6801309|NCT02287272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6801310|NCT02287272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6801311|NCT02287389|Mitomycins|mitomycins|mesh-list
6801312|NCT02287389|Mitomycin|mitomycin|mesh-list
6801313|NCT02287389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6801314|NCT02287389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6801315|NCT02287389|Alkylating Agents|alkylating agents|mesh-ancestor
6801316|NCT02287389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801317|NCT02287389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6801318|NCT02287389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6801319|NCT02287428|Pembrolizumab|pembrolizumab|mesh-list
6801320|NCT02287428|Temozolomide|temozolomide|mesh-list
6801321|NCT02287428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6801322|NCT02287428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6801323|NCT02287428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6801324|NCT02287428|Alkylating Agents|alkylating agents|mesh-ancestor
6801325|NCT02287428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801326|NCT02287558|Pomalidomide|pomalidomide|mesh-list
6801327|NCT02287558|Immunologic Factors|immunologic factors|mesh-ancestor
6801328|NCT02287558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801329|NCT02287558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6801330|NCT02287558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6801331|NCT02287558|Growth Substances|growth substances|mesh-ancestor
6801332|NCT02287558|Growth Inhibitors|growth inhibitors|mesh-ancestor
6801333|NCT02287558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6801334|NCT02287792|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6801335|NCT02287792|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6801336|NCT02287792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801337|NCT02287857|Tenofovir|tenofovir|mesh-list
6801338|NCT02287857|Antiviral Agents|antiviral agents|mesh-ancestor
6801339|NCT02287857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6801340|NCT02287857|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6801341|NCT02287857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6801342|NCT02287857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6801343|NCT02287857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801344|NCT02287857|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6801345|NCT02287857|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6801346|NCT02287870|Lidocaine|lidocaine|mesh-list
6801347|NCT02287870|Chloroprocaine|chloroprocaine|mesh-list
6801348|NCT02287870|Procaine|procaine|mesh-list
6801349|NCT02287870|Anesthetics, Local|anesthetics, local|mesh-ancestor
6801350|NCT02287870|Anesthetics|anesthetics|mesh-ancestor
6801351|NCT02287870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6801352|NCT02287870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801353|NCT02287870|Sensory System Agents|sensory system agents|mesh-ancestor
6801354|NCT02287870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6801355|NCT02287870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6801356|NCT02287870|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6801357|NCT02287870|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6801358|NCT02287870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6801359|NCT02287870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801360|NCT02288000|Memantine|memantine|mesh-list
6801361|NCT02288000|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6801362|NCT02288000|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6801363|NCT02288000|Dopamine Agents|dopamine agents|mesh-ancestor
6801364|NCT02288000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6801365|NCT02288000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801366|NCT02288000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801367|NCT02288000|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6801368|NCT02288000|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6801369|NCT02288078|Dexamethasone|dexamethasone|mesh-list
6801370|NCT02288078|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
6801371|NCT02288078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6801372|NCT02288078|Antiemetics|antiemetics|mesh-ancestor
6801373|NCT02288078|Autonomic Agents|autonomic agents|mesh-ancestor
6801374|NCT02288078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6801375|NCT02288078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801376|NCT02288078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6801377|NCT02288078|Glucocorticoids|glucocorticoids|mesh-ancestor
6801378|NCT02288078|Hormones|hormones|mesh-ancestor
6801379|NCT02288078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6801380|NCT02288078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6801381|NCT02288078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6801382|NCT02288078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6801383|NCT02288078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801384|NCT02288130|Ulipristal acetate|ulipristal acetate|mesh-list
6801385|NCT02288130|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6801386|NCT02288130|Contraceptive Agents|contraceptive agents|mesh-ancestor
6801387|NCT02288130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6801388|NCT02288130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801389|NCT02288130|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6801390|NCT02288195|Capecitabine|capecitabine|mesh-list
6801391|NCT02288195|Oxaliplatin|oxaliplatin|mesh-list
6801392|NCT02288195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6801393|NCT02288195|Antimetabolites|antimetabolites|mesh-ancestor
6801394|NCT02288195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801395|NCT02288195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6801396|NCT02288208|Tenofovir|tenofovir|mesh-list
6801397|NCT02288208|Entecavir|entecavir|mesh-list
6801398|NCT02288208|Antiviral Agents|antiviral agents|mesh-list
6801399|NCT02288208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6801400|NCT02288208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6801401|NCT02288208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6801402|NCT02288208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6801403|NCT02288208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801404|NCT02288208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6801405|NCT02288208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6801406|NCT02288234|Telavancin|telavancin|mesh-list
6801407|NCT02288234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6801408|NCT02288234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6801409|NCT02288286|Vaccines|vaccines|mesh-list
6801410|NCT02288286|Immunologic Factors|immunologic factors|mesh-ancestor
6801411|NCT02288286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801412|NCT02288338|Atorvastatin|atorvastatin|mesh-list
6801413|NCT02288338|Ezetimibe|ezetimibe|mesh-list
6801414|NCT02288338|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6801415|NCT02288338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6801416|NCT02288338|Antimetabolites|antimetabolites|mesh-ancestor
6801417|NCT02288338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801418|NCT02288338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6801419|NCT02288338|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6801420|NCT02288338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6801421|NCT02288429|Colistin|colistin|mesh-list
6801422|NCT02288429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6801423|NCT02288429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6801424|NCT02288507|Sorafenib|sorafenib|mesh-list
6801425|NCT02288507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6801426|NCT02288507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6801427|NCT02288507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6801428|NCT02288507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801429|NCT02288741|Dexamethasone|dexamethasone|mesh-list
6801430|NCT02288741|Dexamethasone acetate|dexamethasone acetate|mesh-list
6801431|NCT02288741|Melphalan|melphalan|mesh-list
6801432|NCT02288741|BB 1101|bb 1101|mesh-list
6801433|NCT02288741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6801434|NCT02288741|Antiemetics|antiemetics|mesh-ancestor
6801435|NCT02288741|Autonomic Agents|autonomic agents|mesh-ancestor
6801436|NCT02288741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6801437|NCT02288741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801438|NCT02288741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6801439|NCT02288741|Glucocorticoids|glucocorticoids|mesh-ancestor
6801440|NCT02288741|Hormones|hormones|mesh-ancestor
6801441|NCT02288741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6801442|NCT02288741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6801443|NCT02288741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6801444|NCT02288741|Protease Inhibitors|protease inhibitors|mesh-ancestor
6801445|NCT02288741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6801446|NCT02288741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801447|NCT02288741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6801448|NCT02288741|Alkylating Agents|alkylating agents|mesh-ancestor
6801449|NCT02288741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6801450|NCT02288741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6801451|NCT02288741|Immunologic Factors|immunologic factors|mesh-ancestor
6801452|NCT02288832|Azithromycin|azithromycin|mesh-list
6801453|NCT02288832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6801454|NCT02288832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6801455|NCT02288923|Acetaminophen|acetaminophen|mesh-list
6801456|NCT02288923|Ibuprofen|ibuprofen|mesh-list
6801457|NCT02288923|Morphine|morphine|mesh-list
6801458|NCT02288923|Antiemetics|antiemetics|mesh-list
6801459|NCT02288923|Anesthetics|anesthetics|mesh-list
6801460|NCT02288923|Emetics|emetics|mesh-list
6801461|NCT02288923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6801462|NCT02288923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801463|NCT02288923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6801464|NCT02288923|Narcotics|narcotics|mesh-ancestor
6801465|NCT02288923|Analgesics|analgesics|mesh-ancestor
6801466|NCT02288923|Sensory System Agents|sensory system agents|mesh-ancestor
6801467|NCT02288923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6801468|NCT02288923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6801469|NCT02288923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6801470|NCT02288923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6801471|NCT02288923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6801472|NCT02288923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6801473|NCT02288923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6801474|NCT02288923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801475|NCT02288923|Antipyretics|antipyretics|mesh-ancestor
6801476|NCT02288923|Autonomic Agents|autonomic agents|mesh-ancestor
6801477|NCT02288923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6801478|NCT02288962|Cabergoline|cabergoline|mesh-list
6801479|NCT02288962|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6801480|NCT02288962|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6801481|NCT02288962|Dopamine Agonists|dopamine agonists|mesh-ancestor
6801482|NCT02288962|Dopamine Agents|dopamine agents|mesh-ancestor
6801483|NCT02288962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6801484|NCT02288962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801485|NCT02288962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801486|NCT02289027|Vaccines|vaccines|mesh-list
6801487|NCT02289027|Immunologic Factors|immunologic factors|mesh-ancestor
6801488|NCT02289027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801489|NCT02289144|Ceritinib|ceritinib|mesh-list
6801490|NCT02289144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6801491|NCT02289144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6801492|NCT02289144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5993211|NCT00119392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5993212|NCT00119392|Antitubercular Agents|antitubercular agents|mesh-ancestor
5993213|NCT00119392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5993214|NCT00119678|Prednisone|prednisone|mesh-list
5993215|NCT00119678|Abatacept|abatacept|mesh-list
5993216|NCT00119678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5993217|NCT00119678|Glucocorticoids|glucocorticoids|mesh-ancestor
5993218|NCT00119678|Hormones|hormones|mesh-ancestor
5993219|NCT00119678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6801493|NCT02289144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801494|NCT02289209|Pembrolizumab|pembrolizumab|mesh-list
6801495|NCT02289209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6801496|NCT02289209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6801497|NCT02289248|Ketamine|ketamine|mesh-list
6801498|NCT02289248|Analgesics|analgesics|mesh-ancestor
6801499|NCT02289248|Sensory System Agents|sensory system agents|mesh-ancestor
6801500|NCT02289248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6801501|NCT02289248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801502|NCT02289248|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6801503|NCT02289248|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6801504|NCT02289248|Anesthetics, General|anesthetics, general|mesh-ancestor
6801505|NCT02289248|Anesthetics|anesthetics|mesh-ancestor
5993220|NCT00119678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993221|NCT00119678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5993222|NCT00119678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5993223|NCT00119678|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5993224|NCT00119678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5993225|NCT00119678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6801506|NCT02289248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6801507|NCT02289248|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6801508|NCT02289248|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6801509|NCT02289248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6801510|NCT02289248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801511|NCT02289261|Dexmedetomidine|dexmedetomidine|mesh-list
6801512|NCT02289261|Morphine|morphine|mesh-list
6801513|NCT02289261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6801514|NCT02289261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6801515|NCT02289261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801516|NCT02289261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6801517|NCT02289261|Analgesics|analgesics|mesh-ancestor
6801518|NCT02289261|Sensory System Agents|sensory system agents|mesh-ancestor
6801519|NCT02289261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6801520|NCT02289261|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6801521|NCT02289261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6801522|NCT02289261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6801523|NCT02289261|Adrenergic Agents|adrenergic agents|mesh-ancestor
6801524|NCT02289261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5993226|NCT00119678|Immunologic Factors|immunologic factors|mesh-ancestor
6801525|NCT02289261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801526|NCT02289261|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6801527|NCT02289261|Narcotics|narcotics|mesh-ancestor
6801528|NCT02289274|Aceclofenac|aceclofenac|mesh-list
5993227|NCT00119678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5993228|NCT00120250|Eszopiclone|eszopiclone|mesh-list
5993229|NCT00120250|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5993230|NCT00120250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5993231|NCT00120250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993232|NCT00120289|Niacin|niacin|mesh-list
5993233|NCT00120289|Simvastatin|simvastatin|mesh-list
5993234|NCT00120289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5993235|NCT00120289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6801529|NCT02289274|Eperisone|eperisone|mesh-list
6801530|NCT02289274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6801531|NCT02289274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6801532|NCT02289274|Analgesics|analgesics|mesh-ancestor
6801533|NCT02289274|Sensory System Agents|sensory system agents|mesh-ancestor
6801534|NCT02289274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6801535|NCT02289274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801536|NCT02289274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6801537|NCT02289274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6801538|NCT02289274|Anticonvulsants|anticonvulsants|mesh-ancestor
6801539|NCT02289274|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5993236|NCT00120289|Antimetabolites|antimetabolites|mesh-ancestor
5993237|NCT00120289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5993238|NCT00120289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5993239|NCT00120289|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5993240|NCT00120289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5993241|NCT00120289|Vasodilator Agents|vasodilator agents|mesh-ancestor
6801540|NCT02289274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6801541|NCT02289274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801542|NCT02289274|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6801543|NCT02289274|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6801544|NCT02289274|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6801545|NCT02289274|Parasympatholytics|parasympatholytics|mesh-ancestor
6801546|NCT02289274|Autonomic Agents|autonomic agents|mesh-ancestor
6801547|NCT02289274|Vasodilator Agents|vasodilator agents|mesh-ancestor
6801548|NCT02289378|Docetaxel|docetaxel|mesh-list
6801549|NCT02289378|Oxaliplatin|oxaliplatin|mesh-list
6801550|NCT02289378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6801551|NCT02289378|Tubulin Modulators|tubulin modulators|mesh-ancestor
6801552|NCT02289378|Antimitotic Agents|antimitotic agents|mesh-ancestor
6801553|NCT02289378|Mitosis Modulators|mitosis modulators|mesh-ancestor
6801554|NCT02289378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801555|NCT02289391|Anesthetics|anesthetics|mesh-list
6801556|NCT02289391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6801557|NCT02289391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801558|NCT02289430|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6801559|NCT02289430|Ezetimibe|ezetimibe|mesh-list
6801560|NCT02289430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6801561|NCT02289430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6801562|NCT02289430|Antimetabolites|antimetabolites|mesh-ancestor
6801563|NCT02289430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801564|NCT02289430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6801565|NCT02289430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6801566|NCT02289430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6801567|NCT02289482|Ritonavir|ritonavir|mesh-list
6801568|NCT02289482|GSK-2838232|gsk-2838232|mesh-list
6801569|NCT02289482|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6801570|NCT02289482|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6801571|NCT02289482|Protease Inhibitors|protease inhibitors|mesh-ancestor
6801572|NCT02289482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6801573|NCT02289482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801574|NCT02289482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6801575|NCT02289482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6801576|NCT02289482|Antiviral Agents|antiviral agents|mesh-ancestor
6801577|NCT02289482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6801578|NCT02289482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6801579|NCT02289482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6801580|NCT02289495|Ritonavir|ritonavir|mesh-list
6801581|NCT02289495|GSK-2838232|gsk-2838232|mesh-list
6801582|NCT02289495|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5993242|NCT00120289|Vitamin B Complex|vitamin b complex|mesh-ancestor
6801583|NCT02289495|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6801584|NCT02289495|Protease Inhibitors|protease inhibitors|mesh-ancestor
6801585|NCT02289495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6801586|NCT02289495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801587|NCT02289495|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6801588|NCT02289495|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6801589|NCT02289495|Antiviral Agents|antiviral agents|mesh-ancestor
6801590|NCT02289495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6801591|NCT02289495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6801592|NCT02289495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6801593|NCT02289547|Capecitabine|capecitabine|mesh-list
6801594|NCT02289547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6801595|NCT02289547|Antimetabolites|antimetabolites|mesh-ancestor
6801596|NCT02289547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801597|NCT02289547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6801598|NCT02289586|Fentanyl|fentanyl|mesh-list
6801599|NCT02289586|Midazolam|midazolam|mesh-list
6801600|NCT02289586|Remifentanil|remifentanil|mesh-list
6801601|NCT02289586|Dezocine|dezocine|mesh-list
6801602|NCT02289586|Propofol|propofol|mesh-list
6801603|NCT02289586|Rocuronium|rocuronium|mesh-list
6801604|NCT02289586|Anesthetics|anesthetics|mesh-ancestor
6801605|NCT02289586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6801606|NCT02289586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801607|NCT02289586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6801608|NCT02289586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6801609|NCT02289586|Anesthetics, General|anesthetics, general|mesh-ancestor
6801610|NCT02289586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6801611|NCT02289586|Narcotics|narcotics|mesh-ancestor
6801612|NCT02289586|Analgesics|analgesics|mesh-ancestor
6801613|NCT02289586|Sensory System Agents|sensory system agents|mesh-ancestor
6801614|NCT02289586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6801615|NCT02289586|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6801616|NCT02289586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6801617|NCT02289586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6801618|NCT02289586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6801619|NCT02289586|GABA Modulators|gaba modulators|mesh-ancestor
6801620|NCT02289586|GABA Agents|gaba agents|mesh-ancestor
6801621|NCT02289586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6801622|NCT02289586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801623|NCT02289586|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6801624|NCT02289586|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6801625|NCT02289586|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6801626|NCT02289703|Rivaroxaban|rivaroxaban|mesh-list
6801627|NCT02289703|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6801628|NCT02289703|Antithrombins|antithrombins|mesh-ancestor
6801629|NCT02289703|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6801630|NCT02289703|Protease Inhibitors|protease inhibitors|mesh-ancestor
6801631|NCT02289703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6801632|NCT02289703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801633|NCT02289703|Anticoagulants|anticoagulants|mesh-ancestor
6801634|NCT02289768|Salicylic Acid|salicylic acid|mesh-list
6801635|NCT02289768|Salicylates|salicylates|mesh-list
6801636|NCT02289768|Fluorouracil|fluorouracil|mesh-list
6801637|NCT02289768|Antimetabolites|antimetabolites|mesh-ancestor
6801638|NCT02289768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801639|NCT02289768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6801640|NCT02289768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6801641|NCT02289768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6801642|NCT02289768|Immunologic Factors|immunologic factors|mesh-ancestor
6801643|NCT02289768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801644|NCT02289768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6801645|NCT02289768|Antifungal Agents|antifungal agents|mesh-ancestor
6801646|NCT02289768|Keratolytic Agents|keratolytic agents|mesh-ancestor
6801647|NCT02289768|Dermatologic Agents|dermatologic agents|mesh-ancestor
6801648|NCT02289768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6801649|NCT02289768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6801650|NCT02289768|Analgesics|analgesics|mesh-ancestor
6801651|NCT02289768|Sensory System Agents|sensory system agents|mesh-ancestor
6801652|NCT02289768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6801653|NCT02289768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6801654|NCT02289768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6801655|NCT02289768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6801656|NCT02289768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6801657|NCT02289807|Cisplatin|cisplatin|mesh-list
6801658|NCT02289807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6801659|NCT02289924|Aflibercept|aflibercept|mesh-list
6801660|NCT02289924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6801661|NCT02289924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6801662|NCT02289924|Growth Substances|growth substances|mesh-ancestor
6801663|NCT02289924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801664|NCT02289924|Growth Inhibitors|growth inhibitors|mesh-ancestor
6801665|NCT02289924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6801666|NCT02289937|Ropivacaine|ropivacaine|mesh-list
6801667|NCT02289937|Anesthetics, Local|anesthetics, local|mesh-ancestor
6801668|NCT02289937|Anesthetics|anesthetics|mesh-ancestor
6801669|NCT02289937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6801670|NCT02289937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801671|NCT02289937|Sensory System Agents|sensory system agents|mesh-ancestor
6801672|NCT02289937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6801673|NCT02290002|Calcium Dobesilate|calcium dobesilate|mesh-list
6801674|NCT02290002|Calcium|calcium|mesh-list
6801675|NCT02290002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6801676|NCT02290002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801677|NCT02290002|Hemostatics|hemostatics|mesh-ancestor
6801678|NCT02290002|Coagulants|coagulants|mesh-ancestor
6801679|NCT02290054|Anesthetics|anesthetics|mesh-list
6801680|NCT02290054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6801681|NCT02290054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801682|NCT02290132|Thymoglobulin|thymoglobulin|mesh-list
6801683|NCT02290132|Immunologic Factors|immunologic factors|mesh-ancestor
6801684|NCT02290132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801685|NCT02290132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6801686|NCT02290327|Pantoprazole|pantoprazole|mesh-list
6801687|NCT02290327|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6801688|NCT02290327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6801689|NCT02290327|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6801690|NCT02290327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6801691|NCT02290327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801692|NCT02290431|Dexamethasone|dexamethasone|mesh-list
6801693|NCT02290431|Bortezomib|bortezomib|mesh-list
6801694|NCT02290431|Panobinostat|panobinostat|mesh-list
6801695|NCT02290431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6801696|NCT02290431|Antiemetics|antiemetics|mesh-ancestor
6801697|NCT02290431|Autonomic Agents|autonomic agents|mesh-ancestor
6801698|NCT02290431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6801699|NCT02290431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801700|NCT02290431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6801701|NCT02290431|Glucocorticoids|glucocorticoids|mesh-ancestor
6801702|NCT02290431|Hormones|hormones|mesh-ancestor
6801703|NCT02290431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6801704|NCT02290431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6801705|NCT02290431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6801706|NCT02290431|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6801707|NCT02290431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6801708|NCT02290431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801709|NCT02290470|Dexamethasone|dexamethasone|mesh-list
6801710|NCT02290470|Dexamethasone acetate|dexamethasone acetate|mesh-list
6801711|NCT02290470|Paclitaxel|paclitaxel|mesh-list
6801712|NCT02290470|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6801713|NCT02290470|Carboplatin|carboplatin|mesh-list
6801714|NCT02290470|Olanzapine|olanzapine|mesh-list
6801715|NCT02290470|Palonosetron|palonosetron|mesh-list
6801716|NCT02290470|BB 1101|bb 1101|mesh-list
6801717|NCT02290470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6801718|NCT02290470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6801719|NCT02290470|Tubulin Modulators|tubulin modulators|mesh-ancestor
6801720|NCT02290470|Antimitotic Agents|antimitotic agents|mesh-ancestor
6801721|NCT02290470|Mitosis Modulators|mitosis modulators|mesh-ancestor
6801722|NCT02290470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801723|NCT02290470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6801724|NCT02290470|Antiemetics|antiemetics|mesh-ancestor
6801725|NCT02290470|Autonomic Agents|autonomic agents|mesh-ancestor
6801726|NCT02290470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6801727|NCT02290470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801728|NCT02290470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6801729|NCT02290470|Glucocorticoids|glucocorticoids|mesh-ancestor
6801730|NCT02290470|Hormones|hormones|mesh-ancestor
6801731|NCT02290470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6801732|NCT02290470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6801733|NCT02290470|Protease Inhibitors|protease inhibitors|mesh-ancestor
6801734|NCT02290470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6801735|NCT02290470|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6801736|NCT02290470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6801737|NCT02290470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6801738|NCT02290470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6801739|NCT02290470|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6801740|NCT02290470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6801741|NCT02290470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6801742|NCT02290470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6801743|NCT02290470|Serotonin Agents|serotonin agents|mesh-ancestor
6801744|NCT02290470|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6801745|NCT02290470|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6801746|NCT02290717|Fluticasone|fluticasone|mesh-list
6801747|NCT02290717|Xhance|xhance|mesh-list
6801748|NCT02290717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6801749|NCT02290717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6801750|NCT02290717|Autonomic Agents|autonomic agents|mesh-ancestor
6801751|NCT02290717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6801752|NCT02290717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801753|NCT02290717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6801754|NCT02290717|Respiratory System Agents|respiratory system agents|mesh-ancestor
6801755|NCT02290717|Dermatologic Agents|dermatologic agents|mesh-ancestor
6801756|NCT02290717|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6801757|NCT02291055|Durvalumab|durvalumab|mesh-list
6801758|NCT02291055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6801759|NCT02291055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6801760|NCT02291094|Lidocaine|lidocaine|mesh-list
6801761|NCT02291094|Remifentanil|remifentanil|mesh-list
6801762|NCT02291094|Anesthetics, Local|anesthetics, local|mesh-ancestor
6801763|NCT02291094|Anesthetics|anesthetics|mesh-ancestor
6801764|NCT02291094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6801765|NCT02291094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801766|NCT02291094|Sensory System Agents|sensory system agents|mesh-ancestor
6801767|NCT02291094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6801768|NCT02291094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6801769|NCT02291094|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6801770|NCT02291094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6801771|NCT02291094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6801772|NCT02291094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801773|NCT02291094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6801774|NCT02291094|Narcotics|narcotics|mesh-ancestor
6801775|NCT02291094|Analgesics|analgesics|mesh-ancestor
6801776|NCT02291211|Cisplatin|cisplatin|mesh-list
6801777|NCT02291211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6801778|NCT02291341|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6801779|NCT02291341|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6801780|NCT02291341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6801781|NCT02291341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6801782|NCT02291341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801783|NCT02291341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6801784|NCT02291341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801785|NCT02291341|Analgesics|analgesics|mesh-ancestor
6801786|NCT02291341|Sensory System Agents|sensory system agents|mesh-ancestor
6801787|NCT02291341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6801788|NCT02291341|Antidepressive Agents|antidepressive agents|mesh-ancestor
6801789|NCT02291341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6801790|NCT02291341|Dopamine Agents|dopamine agents|mesh-ancestor
6801791|NCT02291367|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6801792|NCT02291367|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6801793|NCT02291367|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6801794|NCT02291367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6801795|NCT02291367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801796|NCT02291367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6801797|NCT02291367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801798|NCT02291367|Analgesics|analgesics|mesh-ancestor
6801799|NCT02291367|Sensory System Agents|sensory system agents|mesh-ancestor
6801800|NCT02291367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6801801|NCT02291367|Antidepressive Agents|antidepressive agents|mesh-ancestor
6801802|NCT02291367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6801803|NCT02291367|Dopamine Agents|dopamine agents|mesh-ancestor
6801804|NCT02291380|Botulinum Toxins|botulinum toxins|mesh-list
6801805|NCT02291380|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6801806|NCT02291380|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6801807|NCT02291380|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6801808|NCT02291380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6801809|NCT02291380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801810|NCT02291380|Cholinergic Agents|cholinergic agents|mesh-ancestor
6801811|NCT02291380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6801812|NCT02291380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801813|NCT02291380|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6801814|NCT02291380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6801815|NCT02291471|T0001|t0001|mesh-list
6801816|NCT02291471|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
6801817|NCT02291471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6801818|NCT02291471|Immunologic Factors|immunologic factors|mesh-ancestor
6801819|NCT02291471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801820|NCT02291536|Dronabinol|dronabinol|mesh-list
6801821|NCT02291536|Cannabidiol|cannabidiol|mesh-list
6801822|NCT02291536|Anticonvulsants|anticonvulsants|mesh-ancestor
6801823|NCT02291536|Hallucinogens|hallucinogens|mesh-ancestor
6801824|NCT02291536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801825|NCT02291536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6801826|NCT02291536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6801827|NCT02291536|Analgesics|analgesics|mesh-ancestor
6801828|NCT02291536|Sensory System Agents|sensory system agents|mesh-ancestor
6801829|NCT02291536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6801830|NCT02291536|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6801831|NCT02291536|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6801832|NCT02291536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6801833|NCT02291536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801834|NCT02291536|Hormones|hormones|mesh-ancestor
6801835|NCT02291536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6801836|NCT02291562|Dronabinol|dronabinol|mesh-list
6801837|NCT02291562|Cannabidiol|cannabidiol|mesh-list
6801838|NCT02291562|Anticonvulsants|anticonvulsants|mesh-ancestor
6801839|NCT02291562|Hallucinogens|hallucinogens|mesh-ancestor
6801840|NCT02291562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801841|NCT02291562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6801842|NCT02291562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6801843|NCT02291562|Analgesics|analgesics|mesh-ancestor
6801844|NCT02291562|Sensory System Agents|sensory system agents|mesh-ancestor
6801845|NCT02291562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6801846|NCT02291562|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6801847|NCT02291562|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6801848|NCT02291562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6801849|NCT02291562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801850|NCT02291562|Hormones|hormones|mesh-ancestor
6801851|NCT02291562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6801852|NCT02291666|Tolbutamide|tolbutamide|mesh-list
6801853|NCT02291666|Midazolam|midazolam|mesh-list
6801854|NCT02291666|Dextromethorphan|dextromethorphan|mesh-list
6801855|NCT02291666|Caffeine|caffeine|mesh-list
6801856|NCT02291666|Chlorzoxazone|chlorzoxazone|mesh-list
6801857|NCT02291666|Bupropion|bupropion|mesh-list
6801858|NCT02291666|Omeprazole|omeprazole|mesh-list
6801859|NCT02291666|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6801860|NCT02291666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6801861|NCT02291666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6801862|NCT02291666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801863|NCT02291666|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6801864|NCT02291666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6801865|NCT02291666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6801866|NCT02291666|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6801867|NCT02291666|Anesthetics, General|anesthetics, general|mesh-ancestor
6801868|NCT02291666|Anesthetics|anesthetics|mesh-ancestor
6801869|NCT02291666|GABA Modulators|gaba modulators|mesh-ancestor
6801870|NCT02291666|GABA Agents|gaba agents|mesh-ancestor
6801871|NCT02291666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6801872|NCT02291666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801873|NCT02291666|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6801874|NCT02291666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6801875|NCT02291666|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6801876|NCT02291666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6801877|NCT02291666|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6801878|NCT02291666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6801879|NCT02291666|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6801880|NCT02291666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6801881|NCT02291666|Purinergic Agents|purinergic agents|mesh-ancestor
6801882|NCT02291666|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6801883|NCT02291666|Antidepressive Agents|antidepressive agents|mesh-ancestor
6801884|NCT02291666|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6801885|NCT02291666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6801886|NCT02291666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6801887|NCT02291666|Dopamine Agents|dopamine agents|mesh-ancestor
6801888|NCT02291666|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6801889|NCT02291666|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6801890|NCT02291666|Antitussive Agents|antitussive agents|mesh-ancestor
6801891|NCT02291666|Respiratory System Agents|respiratory system agents|mesh-ancestor
6801892|NCT02291666|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6801893|NCT02291666|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6801894|NCT02291666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6801895|NCT02291666|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6801896|NCT02291666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6801897|NCT02291666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6801898|NCT02291705|Tramadol|tramadol|mesh-list
6801899|NCT02291705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6801900|NCT02291705|Narcotics|narcotics|mesh-ancestor
6801901|NCT02291705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6801902|NCT02291705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801903|NCT02291705|Analgesics|analgesics|mesh-ancestor
6801904|NCT02291705|Sensory System Agents|sensory system agents|mesh-ancestor
6801905|NCT02291705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6801906|NCT02291731|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6801907|NCT02291731|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6801908|NCT02291796|Bezafibrate|bezafibrate|mesh-list
6801909|NCT02291796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6801910|NCT02291796|Antimetabolites|antimetabolites|mesh-ancestor
6801911|NCT02291796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801912|NCT02291796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6801913|NCT02291874|Ipragliflozin|ipragliflozin|mesh-list
6801914|NCT02291874|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6801915|NCT02291874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801916|NCT02291874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6801917|NCT02291874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801918|NCT02291887|Ranibizumab|ranibizumab|mesh-list
6801919|NCT02291887|Aflibercept|aflibercept|mesh-list
6801920|NCT02291887|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6801921|NCT02291887|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6801922|NCT02291887|Growth Substances|growth substances|mesh-ancestor
6801923|NCT02291887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801924|NCT02291887|Growth Inhibitors|growth inhibitors|mesh-ancestor
6801925|NCT02291887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6801926|NCT02292069|Amlodipine|amlodipine|mesh-list
6801927|NCT02292069|Atorvastatin|atorvastatin|mesh-list
6801928|NCT02292069|Calcium|calcium|mesh-list
6801929|NCT02292069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6801930|NCT02292069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801931|NCT02292069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6801932|NCT02292069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6801933|NCT02292069|Antimetabolites|antimetabolites|mesh-ancestor
6801934|NCT02292069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801935|NCT02292069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6801936|NCT02292069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6801937|NCT02292069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6801938|NCT02292069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6801939|NCT02292069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6801940|NCT02292069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6801941|NCT02292069|Vasodilator Agents|vasodilator agents|mesh-ancestor
6801942|NCT02292121|Mannitol|mannitol|mesh-list
6801943|NCT02292121|Lactitol|lactitol|mesh-list
6801944|NCT02292121|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6801945|NCT02292121|Diuretics|diuretics|mesh-ancestor
6801946|NCT02292121|Natriuretic Agents|natriuretic agents|mesh-ancestor
6801947|NCT02292121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801948|NCT02292121|Cathartics|cathartics|mesh-ancestor
6801949|NCT02292121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6801950|NCT02292173|Sorafenib|sorafenib|mesh-list
6801951|NCT02292173|Trametinib|trametinib|mesh-list
6801952|NCT02292173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6801953|NCT02292173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6801954|NCT02292173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6801955|NCT02292173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801956|NCT02292225|Obinutuzumab|obinutuzumab|mesh-list
6801957|NCT02292225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6801958|NCT02292225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6801959|NCT02292238|Benphothiamine|benphothiamine|mesh-list
6801960|NCT02292238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6801961|NCT02292238|Immunologic Factors|immunologic factors|mesh-ancestor
6801962|NCT02292238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801963|NCT02292238|Chelating Agents|chelating agents|mesh-ancestor
6801964|NCT02292238|Sequestering Agents|sequestering agents|mesh-ancestor
6801965|NCT02292238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801966|NCT02292277|Ticagrelor|ticagrelor|mesh-list
6801967|NCT02292277|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6801968|NCT02292277|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6801969|NCT02292277|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6801970|NCT02292277|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6801971|NCT02292277|Purinergic Agents|purinergic agents|mesh-ancestor
6801972|NCT02292277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6801973|NCT02292277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6801974|NCT02292277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801975|NCT02292290|Pioglitazone|pioglitazone|mesh-list
6801976|NCT02292290|Liraglutide|liraglutide|mesh-list
6801977|NCT02292290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6801978|NCT02292290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801979|NCT02292290|Incretins|incretins|mesh-ancestor
6801980|NCT02292290|Hormones|hormones|mesh-ancestor
6801981|NCT02292290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6801982|NCT02292303|Zinc|zinc|mesh-list
6801983|NCT02292303|Zinc Oxide|zinc oxide|mesh-list
6801984|NCT02292303|Trace Elements|trace elements|mesh-ancestor
6801985|NCT02292303|Micronutrients|micronutrients|mesh-ancestor
6801986|NCT02292303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6801987|NCT02292303|Dermatologic Agents|dermatologic agents|mesh-ancestor
6801988|NCT02292303|Sunscreening Agents|sunscreening agents|mesh-ancestor
6801989|NCT02292303|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6801990|NCT02292303|Protective Agents|protective agents|mesh-ancestor
6801991|NCT02292459|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
6801992|NCT02292459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6801993|NCT02292459|Laxatives|laxatives|mesh-ancestor
6801994|NCT02292459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6801995|NCT02292472|Botulinum Toxins|botulinum toxins|mesh-list
6801996|NCT02292472|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6801997|NCT02292472|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6801998|NCT02292472|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6801999|NCT02292472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6802000|NCT02292472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6802001|NCT02292472|Cholinergic Agents|cholinergic agents|mesh-ancestor
6802002|NCT02292472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6802003|NCT02292472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802004|NCT02292472|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6802005|NCT02292472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6802006|NCT02292550|Ceritinib|ceritinib|mesh-list
6802007|NCT02292550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6802008|NCT02292550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6802009|NCT02292550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6802010|NCT02292550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6802011|NCT02292667|Acetaminophen|acetaminophen|mesh-list
6802012|NCT02292667|Morphine|morphine|mesh-list
6802013|NCT02292667|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6802014|NCT02292667|Narcotics|narcotics|mesh-ancestor
6802015|NCT02292667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6802016|NCT02292667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802017|NCT02292667|Analgesics|analgesics|mesh-ancestor
6802018|NCT02292667|Sensory System Agents|sensory system agents|mesh-ancestor
6802019|NCT02292667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6802020|NCT02292667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6802021|NCT02292667|Antipyretics|antipyretics|mesh-ancestor
6802022|NCT02292732|Trametinib|trametinib|mesh-list
6802023|NCT02292732|Norinyl|norinyl|mesh-list
6802024|NCT02292732|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
6802025|NCT02292732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6802026|NCT02292732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6802027|NCT02292732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6802028|NCT02292732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6802029|NCT02292732|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6802030|NCT02292732|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6802031|NCT02292732|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6802032|NCT02292732|Contraceptive Agents|contraceptive agents|mesh-ancestor
6802033|NCT02292732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6802034|NCT02292732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802035|NCT02292732|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6802036|NCT02292732|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6802037|NCT02292732|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
6802038|NCT02292732|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6802039|NCT02292966|Asunaprevir|asunaprevir|mesh-list
6802040|NCT02292966|Protease Inhibitors|protease inhibitors|mesh-ancestor
6802041|NCT02292966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6802042|NCT02292966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6802043|NCT02292979|Doxorubicin|doxorubicin|mesh-list
6802044|NCT02292979|Bleomycin|bleomycin|mesh-list
6802045|NCT02292979|Dacarbazine|dacarbazine|mesh-list
6802046|NCT02292979|Vinblastine|vinblastine|mesh-list
6802047|NCT02292979|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6802048|NCT02292979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6802049|NCT02292979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6802050|NCT02292979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6802051|NCT02292979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6802052|NCT02292979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6802053|NCT02292979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6802054|NCT02292979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6802055|NCT02292979|Alkylating Agents|alkylating agents|mesh-ancestor
6802056|NCT02292979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6802057|NCT02292979|Tubulin Modulators|tubulin modulators|mesh-ancestor
6802058|NCT02292979|Antimitotic Agents|antimitotic agents|mesh-ancestor
6802059|NCT02292979|Mitosis Modulators|mitosis modulators|mesh-ancestor
6802060|NCT02292979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6802061|NCT02293109|Leucovorin|leucovorin|mesh-list
6802062|NCT02293109|Cytarabine|cytarabine|mesh-list
6802063|NCT02293109|Dexamethasone|dexamethasone|mesh-list
6802064|NCT02293109|Methylprednisolone|methylprednisolone|mesh-list
6802065|NCT02293109|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6802066|NCT02293109|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6802067|NCT02293109|Prednisolone|prednisolone|mesh-list
6802068|NCT02293109|Prednisolone acetate|prednisolone acetate|mesh-list
6802069|NCT02293109|Cyclophosphamide|cyclophosphamide|mesh-list
6802070|NCT02293109|Rituximab|rituximab|mesh-list
6802071|NCT02293109|Doxorubicin|doxorubicin|mesh-list
6802072|NCT02293109|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6802073|NCT02293109|Methotrexate|methotrexate|mesh-list
6802074|NCT02293109|Vincristine|vincristine|mesh-list
6802075|NCT02293109|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6802076|NCT02293109|Prednisolone phosphate|prednisolone phosphate|mesh-list
6802077|NCT02293109|Levoleucovorin|levoleucovorin|mesh-list
6802078|NCT02293109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6802079|NCT02293109|Immunologic Factors|immunologic factors|mesh-ancestor
6802080|NCT02293109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802081|NCT02293109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6802082|NCT02293109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6802083|NCT02293109|Alkylating Agents|alkylating agents|mesh-ancestor
6802084|NCT02293109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6802085|NCT02293109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6802086|NCT02293109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6802087|NCT02293109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6802088|NCT02293109|Antiemetics|antiemetics|mesh-ancestor
6802089|NCT02293109|Autonomic Agents|autonomic agents|mesh-ancestor
6802090|NCT02293109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6802091|NCT02293109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6802092|NCT02293109|Glucocorticoids|glucocorticoids|mesh-ancestor
6802093|NCT02293109|Hormones|hormones|mesh-ancestor
6802094|NCT02293109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6802095|NCT02293109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6802096|NCT02293109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6802097|NCT02293109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6802098|NCT02293109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6802099|NCT02293109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6802100|NCT02293109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6802101|NCT02293109|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6802102|NCT02293109|Abortifacient Agents|abortifacient agents|mesh-ancestor
6802103|NCT02293109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6802104|NCT02293109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6802105|NCT02293109|Antimetabolites|antimetabolites|mesh-ancestor
6802106|NCT02293109|Dermatologic Agents|dermatologic agents|mesh-ancestor
6802107|NCT02293109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5993243|NCT00120289|Vitamins|vitamins|mesh-ancestor
5993244|NCT00120289|Micronutrients|micronutrients|mesh-ancestor
5993245|NCT00120289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993246|NCT00120523|Pimecrolimus|pimecrolimus|mesh-list
5993247|NCT00120523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5993248|NCT00120523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5993249|NCT00120523|Analgesics|analgesics|mesh-ancestor
5993250|NCT00120523|Sensory System Agents|sensory system agents|mesh-ancestor
5993251|NCT00120523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5993252|NCT00120523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993253|NCT00120523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5993254|NCT00120523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5993255|NCT00120523|Dermatologic Agents|dermatologic agents|mesh-ancestor
5993256|NCT00120523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5993257|NCT00120523|Immunologic Factors|immunologic factors|mesh-ancestor
5993258|NCT00120523|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5993259|NCT00120523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6802108|NCT02293109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6802109|NCT02293109|Antiviral Agents|antiviral agents|mesh-ancestor
6802110|NCT02293109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6802111|NCT02293109|Antidotes|antidotes|mesh-ancestor
6802112|NCT02293109|Protective Agents|protective agents|mesh-ancestor
6802113|NCT02293109|Vitamin B Complex|vitamin b complex|mesh-ancestor
6802114|NCT02293109|Vitamins|vitamins|mesh-ancestor
6802115|NCT02293109|Micronutrients|micronutrients|mesh-ancestor
6802116|NCT02293109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6802117|NCT02293109|Tubulin Modulators|tubulin modulators|mesh-ancestor
6802118|NCT02293109|Antimitotic Agents|antimitotic agents|mesh-ancestor
6802119|NCT02293109|Mitosis Modulators|mitosis modulators|mesh-ancestor
6802120|NCT02293109|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6802121|NCT02293148|Moxifloxacin|moxifloxacin|mesh-list
6802122|NCT02293148|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6802123|NCT02293148|Glycine|glycine|mesh-list
6802124|NCT02293148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6802125|NCT02293148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6802126|NCT02293148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6802127|NCT02293148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6802128|NCT02293148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6802129|NCT02293148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6802130|NCT02293148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6802131|NCT02293148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6802132|NCT02293148|Contraceptive Agents|contraceptive agents|mesh-ancestor
6802133|NCT02293148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6802134|NCT02293148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017670|NCT00374556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6258463|NCT03087604|Mydriatics|mydriatics|mesh-ancestor
6802135|NCT02293148|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6802136|NCT02293148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6802137|NCT02293148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6802138|NCT02293148|Glycine Agents|glycine agents|mesh-ancestor
6802139|NCT02293148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6802140|NCT02293187|Vitamin D|vitamin d|mesh-list
6802141|NCT02293187|Cholecalciferol|cholecalciferol|mesh-list
6802142|NCT02293187|Vitamins|vitamins|mesh-ancestor
6802143|NCT02293187|Micronutrients|micronutrients|mesh-ancestor
6802144|NCT02293187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802145|NCT02293187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6802146|NCT02293187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6802147|NCT02293291|Lithium Carbonate|lithium carbonate|mesh-list
6802148|NCT02293291|Antidepressive Agents|antidepressive agents|mesh-ancestor
6802149|NCT02293291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6802150|NCT02293291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6802151|NCT02293291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6802152|NCT02293291|Antimanic Agents|antimanic agents|mesh-ancestor
6802153|NCT02293291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6802154|NCT02293291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6802155|NCT02293291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802156|NCT02293330|Levobupivacaine|levobupivacaine|mesh-list
6802157|NCT02293330|Anesthetics, Local|anesthetics, local|mesh-ancestor
6802158|NCT02293330|Anesthetics|anesthetics|mesh-ancestor
6802159|NCT02293330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6802160|NCT02293330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802161|NCT02293330|Sensory System Agents|sensory system agents|mesh-ancestor
6802162|NCT02293330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6802163|NCT02293356|Nimotuzumab|nimotuzumab|mesh-list
6802164|NCT02293356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6802165|NCT02293356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6802166|NCT02293447|Lidocaine|lidocaine|mesh-list
6802167|NCT02293447|Anesthetics, Local|anesthetics, local|mesh-list
6802168|NCT02293447|Anesthetics|anesthetics|mesh-list
6802169|NCT02293447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6802170|NCT02293447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993260|NCT00120523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5993261|NCT00120874|Memantine|memantine|mesh-list
5993262|NCT00120874|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5993263|NCT00120874|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5993264|NCT00120874|Dopamine Agents|dopamine agents|mesh-ancestor
5993265|NCT00120874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5993266|NCT00120874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5993267|NCT00120874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993268|NCT00120874|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5993269|NCT00120874|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6802171|NCT02293447|Sensory System Agents|sensory system agents|mesh-ancestor
6802172|NCT02293447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6802173|NCT02293447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6802174|NCT02293447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6802175|NCT02293447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6802176|NCT02293447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6802177|NCT02293447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6802178|NCT02293525|Morphine|morphine|mesh-list
6802179|NCT02293525|Oxycodone|oxycodone|mesh-list
6802180|NCT02293525|Ropivacaine|ropivacaine|mesh-list
6802181|NCT02293525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6802182|NCT02293525|Narcotics|narcotics|mesh-ancestor
6802183|NCT02293525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6802184|NCT02293525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802185|NCT02293525|Analgesics|analgesics|mesh-ancestor
6802186|NCT02293525|Sensory System Agents|sensory system agents|mesh-ancestor
6802187|NCT02293525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6802188|NCT02293525|Anesthetics, Local|anesthetics, local|mesh-ancestor
6802189|NCT02293525|Anesthetics|anesthetics|mesh-ancestor
6802190|NCT02293551|Insulin Lispro|insulin lispro|mesh-list
6802191|NCT02293551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6802192|NCT02293551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802193|NCT02293590|Sulfasalazine|sulfasalazine|mesh-list
6802194|NCT02293590|Certolizumab Pegol|certolizumab pegol|mesh-list
6802195|NCT02293590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6802196|NCT02293590|Immunologic Factors|immunologic factors|mesh-ancestor
6802197|NCT02293590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802198|NCT02293590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6802199|NCT02293590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6802200|NCT02293590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6802201|NCT02293590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6802202|NCT02293590|Analgesics|analgesics|mesh-ancestor
6802203|NCT02293590|Sensory System Agents|sensory system agents|mesh-ancestor
6802204|NCT02293590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6802205|NCT02293590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6802206|NCT02293590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6802207|NCT02293668|Letrozole|letrozole|mesh-list
6802208|NCT02293668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6802209|NCT02293668|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6802210|NCT02293668|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6802211|NCT02293668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6802212|NCT02293668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6802213|NCT02293668|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6802214|NCT02293668|Hormone Antagonists|hormone antagonists|mesh-ancestor
6802215|NCT02293668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6802216|NCT02293668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802217|NCT02293681|Infliximab|infliximab|mesh-list
6802218|NCT02293681|Dermatologic Agents|dermatologic agents|mesh-ancestor
6802219|NCT02293681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6802220|NCT02293681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6802221|NCT02293694|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6802222|NCT02293694|Medroxyprogesterone|medroxyprogesterone|mesh-list
6802223|NCT02293694|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6802224|NCT02293694|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6802225|NCT02293694|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6802226|NCT02293694|Contraceptive Agents|contraceptive agents|mesh-ancestor
6802227|NCT02293694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6802228|NCT02293694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802229|NCT02293694|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6802230|NCT02293694|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6802231|NCT02293694|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6802232|NCT02293694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6802233|NCT02293694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6802234|NCT02293785|Oxycodone|oxycodone|mesh-list
6802235|NCT02293785|Naloxone|naloxone|mesh-list
6802236|NCT02293785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6802237|NCT02293785|Narcotics|narcotics|mesh-ancestor
6802238|NCT02293785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6802239|NCT02293785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802240|NCT02293785|Analgesics|analgesics|mesh-ancestor
6802241|NCT02293785|Sensory System Agents|sensory system agents|mesh-ancestor
6802242|NCT02293785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6802243|NCT02293785|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6802244|NCT02293824|Caffeine|caffeine|mesh-list
6802245|NCT02293824|Caffeine citrate|caffeine citrate|mesh-list
6802246|NCT02293824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6802247|NCT02293824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6802248|NCT02293824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802249|NCT02293824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6802250|NCT02293824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6802251|NCT02293824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6802252|NCT02293824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6802253|NCT02293824|Purinergic Agents|purinergic agents|mesh-ancestor
6802254|NCT02293824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6802255|NCT02293876|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6802256|NCT02293876|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6802257|NCT02293889|Vitamin D|vitamin d|mesh-list
6802258|NCT02293889|Ergocalciferols|ergocalciferols|mesh-list
6802259|NCT02293889|Cholecalciferol|cholecalciferol|mesh-list
6802260|NCT02293889|Vitamins|vitamins|mesh-list
6802261|NCT02293889|Micronutrients|micronutrients|mesh-ancestor
6802262|NCT02293889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802263|NCT02293889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6802264|NCT02293889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6802265|NCT02293954|Antibodies|antibodies|mesh-list
6802266|NCT02293954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6802267|NCT02293954|Immunologic Factors|immunologic factors|mesh-ancestor
6802268|NCT02293954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802269|NCT02293980|Nivolumab|nivolumab|mesh-list
6802270|NCT02293980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6802271|NCT02293980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6802272|NCT02293980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6802273|NCT02293980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6802274|NCT02294006|Metformin|metformin|mesh-list
6802275|NCT02294006|Everolimus|everolimus|mesh-list
6802276|NCT02294006|Octreotide|octreotide|mesh-list
6802277|NCT02294006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6802278|NCT02294006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802279|NCT02294006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6802280|NCT02294006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6802281|NCT02294006|Immunologic Factors|immunologic factors|mesh-ancestor
6802282|NCT02294006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6802283|NCT02294006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6802284|NCT02294032|Immunosuppressive Agents|immunosuppressive agents|mesh-list
6802285|NCT02294032|Immunologic Factors|immunologic factors|mesh-ancestor
6802286|NCT02294032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802287|NCT02294071|Acetaminophen|acetaminophen|mesh-list
6802288|NCT02294071|Ibuprofen|ibuprofen|mesh-list
6802289|NCT02294071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6802290|NCT02294071|Analgesics|analgesics|mesh-ancestor
6802291|NCT02294071|Sensory System Agents|sensory system agents|mesh-ancestor
6802292|NCT02294071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6802293|NCT02294071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802294|NCT02294071|Antipyretics|antipyretics|mesh-ancestor
6802295|NCT02294071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6802296|NCT02294071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6802297|NCT02294071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6802298|NCT02294071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6802299|NCT02294071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6802300|NCT02294071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6802301|NCT02294084|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6802302|NCT02294084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6802303|NCT02294084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802304|NCT02294084|Incretins|incretins|mesh-ancestor
6802305|NCT02294084|Hormones|hormones|mesh-ancestor
6802306|NCT02294084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6802307|NCT02294084|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6802308|NCT02294084|Protease Inhibitors|protease inhibitors|mesh-ancestor
6802309|NCT02294084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6802310|NCT02294084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6802311|NCT02294110|Anesthetics|anesthetics|mesh-list
6802312|NCT02294110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6802313|NCT02294110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802314|NCT02294162|Ketamine|ketamine|mesh-list
6802315|NCT02294162|Analgesics|analgesics|mesh-ancestor
6802316|NCT02294162|Sensory System Agents|sensory system agents|mesh-ancestor
6802317|NCT02294162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6802318|NCT02294162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802319|NCT02294162|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6802320|NCT02294162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6802321|NCT02294162|Anesthetics, General|anesthetics, general|mesh-ancestor
6802322|NCT02294162|Anesthetics|anesthetics|mesh-ancestor
6802323|NCT02294162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6802324|NCT02294162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6802325|NCT02294162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6802326|NCT02294162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6802327|NCT02294162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6802328|NCT02294240|Folic Acid|folic acid|mesh-list
6802329|NCT02294240|Hematinics|hematinics|mesh-ancestor
6802330|NCT02294240|Vitamin B Complex|vitamin b complex|mesh-ancestor
6802331|NCT02294240|Vitamins|vitamins|mesh-ancestor
6802332|NCT02294240|Micronutrients|micronutrients|mesh-ancestor
6802333|NCT02294240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802334|NCT02294266|Ethanol|ethanol|mesh-list
6802335|NCT02294266|Methamphetamine|methamphetamine|mesh-list
6802336|NCT02294266|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6802337|NCT02294266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6802338|NCT02294266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6802339|NCT02294266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802340|NCT02294266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6802341|NCT02294266|Sympathomimetics|sympathomimetics|mesh-ancestor
6802342|NCT02294266|Autonomic Agents|autonomic agents|mesh-ancestor
6802343|NCT02294266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6802344|NCT02294266|Dopamine Agents|dopamine agents|mesh-ancestor
6802345|NCT02294266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6802346|NCT02294266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6802347|NCT02294266|Adrenergic Agents|adrenergic agents|mesh-ancestor
6802348|NCT02294266|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6802349|NCT02294266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6802350|NCT02294266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6802351|NCT02294266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6802352|NCT02294279|Beclomethasone|beclomethasone|mesh-list
6802353|NCT02294279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6802354|NCT02294279|Glucocorticoids|glucocorticoids|mesh-ancestor
6802355|NCT02294279|Hormones|hormones|mesh-ancestor
6802356|NCT02294279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6802357|NCT02294279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802358|NCT02294279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6802359|NCT02294279|Respiratory System Agents|respiratory system agents|mesh-ancestor
5993270|NCT00121134|Cyclophosphamide|cyclophosphamide|mesh-list
6802360|NCT02294292|Carvedilol|carvedilol|mesh-list
6802361|NCT02294292|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6802362|NCT02294292|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6802363|NCT02294292|Adrenergic Agents|adrenergic agents|mesh-ancestor
6802364|NCT02294292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6802365|NCT02294292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6802366|NCT02294292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802367|NCT02294292|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6802368|NCT02294292|Antioxidants|antioxidants|mesh-ancestor
6802369|NCT02294292|Protective Agents|protective agents|mesh-ancestor
6802370|NCT02294292|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6802371|NCT02294292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6802372|NCT02294292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6802373|NCT02294292|Vasodilator Agents|vasodilator agents|mesh-ancestor
6802374|NCT02294292|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6802375|NCT02294292|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6802376|NCT02294305|Vortioxetine|vortioxetine|mesh-list
6802377|NCT02294305|Antidepressive Agents|antidepressive agents|mesh-ancestor
6802378|NCT02294305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6802379|NCT02294305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6802380|NCT02294305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6802381|NCT02294305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6802382|NCT02294305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802383|NCT02294305|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6802384|NCT02294305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6802385|NCT02294305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6802386|NCT02294305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6802387|NCT02294305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6802388|NCT02294305|Serotonin Agents|serotonin agents|mesh-ancestor
6802389|NCT02294305|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6802390|NCT02294305|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6802391|NCT02294305|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6802392|NCT02294305|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6802393|NCT02294344|Cyclophosphamide|cyclophosphamide|mesh-list
6802394|NCT02294344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6802395|NCT02294344|Immunologic Factors|immunologic factors|mesh-ancestor
6802396|NCT02294344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802397|NCT02294344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6802398|NCT02294344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6802399|NCT02294344|Alkylating Agents|alkylating agents|mesh-ancestor
6802400|NCT02294344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6802401|NCT02294344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6802402|NCT02294344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6802403|NCT02294357|Dexamethasone|dexamethasone|mesh-list
6802404|NCT02294357|Dexamethasone acetate|dexamethasone acetate|mesh-list
6802405|NCT02294357|Prednisone|prednisone|mesh-list
6802406|NCT02294357|Methylprednisolone|methylprednisolone|mesh-list
6802407|NCT02294357|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6802408|NCT02294357|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6802409|NCT02294357|Prednisolone|prednisolone|mesh-list
6802410|NCT02294357|Prednisolone acetate|prednisolone acetate|mesh-list
6802411|NCT02294357|Lenalidomide|lenalidomide|mesh-list
6802412|NCT02294357|Pomalidomide|pomalidomide|mesh-list
6802413|NCT02294357|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6802414|NCT02294357|Prednisolone phosphate|prednisolone phosphate|mesh-list
6802415|NCT02294357|BB 1101|bb 1101|mesh-list
6802416|NCT02294357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6802417|NCT02294357|Antiemetics|antiemetics|mesh-ancestor
6802418|NCT02294357|Autonomic Agents|autonomic agents|mesh-ancestor
6802419|NCT02294357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6802420|NCT02294357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802421|NCT02294357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6802422|NCT02294357|Glucocorticoids|glucocorticoids|mesh-ancestor
6802423|NCT02294357|Hormones|hormones|mesh-ancestor
6802424|NCT02294357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6802425|NCT02294357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6802426|NCT02294357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6802427|NCT02294357|Protease Inhibitors|protease inhibitors|mesh-ancestor
6802428|NCT02294357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6802429|NCT02294357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6802430|NCT02294357|Immunologic Factors|immunologic factors|mesh-ancestor
6802431|NCT02294357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6802432|NCT02294357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6802433|NCT02294357|Growth Substances|growth substances|mesh-ancestor
6802434|NCT02294357|Growth Inhibitors|growth inhibitors|mesh-ancestor
6802435|NCT02294357|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6802436|NCT02294357|Protective Agents|protective agents|mesh-ancestor
6802437|NCT02294539|Losartan|losartan|mesh-list
6802438|NCT02294539|Amlodipine|amlodipine|mesh-list
6802439|NCT02294539|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6802440|NCT02294539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6802441|NCT02294539|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6802442|NCT02294539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6802443|NCT02294539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6802444|NCT02294539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6802445|NCT02294539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802446|NCT02294539|Vasodilator Agents|vasodilator agents|mesh-ancestor
6802447|NCT02294539|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6802448|NCT02294539|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6802449|NCT02294539|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6802450|NCT02294539|Diuretics|diuretics|mesh-ancestor
6802451|NCT02294539|Natriuretic Agents|natriuretic agents|mesh-ancestor
6802452|NCT02294539|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6802453|NCT02294552|Mycophenolic Acid|mycophenolic acid|mesh-list
6802454|NCT02294552|Cyclophosphamide|cyclophosphamide|mesh-list
6802455|NCT02294552|Busulfan|busulfan|mesh-list
6802456|NCT02294552|Fludarabine|fludarabine|mesh-list
6802457|NCT02294552|Fludarabine phosphate|fludarabine phosphate|mesh-list
6802458|NCT02294552|Tacrolimus|tacrolimus|mesh-list
6802459|NCT02294552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6802460|NCT02294552|Immunologic Factors|immunologic factors|mesh-ancestor
6802461|NCT02294552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802462|NCT02294552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6802463|NCT02294552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6802464|NCT02294552|Alkylating Agents|alkylating agents|mesh-ancestor
6802465|NCT02294552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6802466|NCT02294552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6802467|NCT02294552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6802468|NCT02294552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6802469|NCT02294552|Antimetabolites|antimetabolites|mesh-ancestor
6802470|NCT02294552|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6802471|NCT02294552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6802472|NCT02294552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6802473|NCT02294552|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6802474|NCT02294552|Antitubercular Agents|antitubercular agents|mesh-ancestor
6802475|NCT02294552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6802476|NCT02294552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5993271|NCT00121134|Bevacizumab|bevacizumab|mesh-list
5993272|NCT00121134|Capecitabine|capecitabine|mesh-list
5993273|NCT00121134|Methotrexate|methotrexate|mesh-list
5993274|NCT00121134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5993275|NCT00121134|Immunologic Factors|immunologic factors|mesh-ancestor
5993276|NCT00121134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993277|NCT00121134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5993278|NCT00121134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5993279|NCT00121134|Alkylating Agents|alkylating agents|mesh-ancestor
5993280|NCT00121134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5993281|NCT00121134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5993282|NCT00121134|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5993283|NCT00121134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5993284|NCT00121134|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5993285|NCT00121134|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5993286|NCT00121134|Growth Substances|growth substances|mesh-ancestor
5993287|NCT00121134|Growth Inhibitors|growth inhibitors|mesh-ancestor
5993288|NCT00121134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5993289|NCT00121134|Antimetabolites|antimetabolites|mesh-ancestor
5993290|NCT00121134|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5993291|NCT00121134|Abortifacient Agents|abortifacient agents|mesh-ancestor
5993292|NCT00121134|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5993293|NCT00121134|Dermatologic Agents|dermatologic agents|mesh-ancestor
5993294|NCT00121134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5993295|NCT00121134|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5993296|NCT00121134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5993297|NCT00121186|Methotrexate|methotrexate|mesh-list
5993298|NCT00121186|Fludarabine phosphate|fludarabine phosphate|mesh-list
5993299|NCT00121186|Fludarabine|fludarabine|mesh-list
5993300|NCT00121186|Melphalan|melphalan|mesh-list
5993301|NCT00121186|Tacrolimus|tacrolimus|mesh-list
6802477|NCT02294591|Acetylcysteine|acetylcysteine|mesh-list
6802478|NCT02294591|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6802479|NCT02294591|Antiviral Agents|antiviral agents|mesh-ancestor
6802480|NCT02294591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6258464|NCT03087604|Sympathomimetics|sympathomimetics|mesh-ancestor
6258465|NCT03087604|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6258466|NCT03087786|Nicotine|nicotine|mesh-list
6258467|NCT03087786|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6258468|NCT03087786|Autonomic Agents|autonomic agents|mesh-ancestor
6258469|NCT03087786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6258470|NCT03087786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258471|NCT03087786|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6258472|NCT03087786|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6802481|NCT02294591|Expectorants|expectorants|mesh-ancestor
6802482|NCT02294591|Respiratory System Agents|respiratory system agents|mesh-ancestor
6802483|NCT02294591|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6802484|NCT02294591|Antioxidants|antioxidants|mesh-ancestor
6802485|NCT02294591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6802486|NCT02294591|Protective Agents|protective agents|mesh-ancestor
6802487|NCT02294591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802488|NCT02294591|Antidotes|antidotes|mesh-ancestor
6802489|NCT02294617|Nicotine|nicotine|mesh-list
6802490|NCT02294617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6802491|NCT02294617|Autonomic Agents|autonomic agents|mesh-ancestor
6802492|NCT02294617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6802493|NCT02294617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802494|NCT02294617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6802495|NCT02294617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6802496|NCT02294617|Cholinergic Agents|cholinergic agents|mesh-ancestor
6802497|NCT02294617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6802498|NCT02294617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6802499|NCT02294643|Aspirin|aspirin|mesh-list
6802500|NCT02294643|Sarpogrelate|sarpogrelate|mesh-list
6802501|NCT02294643|Clopidogrel|clopidogrel|mesh-list
6802502|NCT02294643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6802503|NCT02294643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6802504|NCT02294643|Analgesics|analgesics|mesh-ancestor
6802505|NCT02294643|Sensory System Agents|sensory system agents|mesh-ancestor
6802506|NCT02294643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6802507|NCT02294643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802508|NCT02294643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6802509|NCT02294643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6802510|NCT02294643|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6802511|NCT02294643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6802512|NCT02294643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6802513|NCT02294643|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6802514|NCT02294643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6802515|NCT02294643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6802516|NCT02294643|Antipyretics|antipyretics|mesh-ancestor
6802517|NCT02294643|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6802518|NCT02294643|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6802519|NCT02294643|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6802520|NCT02294643|Purinergic Agents|purinergic agents|mesh-ancestor
6802521|NCT02294643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6802522|NCT02294643|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6802523|NCT02294643|Serotonin Agents|serotonin agents|mesh-ancestor
6802524|NCT02294656|Triamcinolone|triamcinolone|mesh-list
6802525|NCT02294656|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5993302|NCT00121186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5993303|NCT00121186|Abortifacient Agents|abortifacient agents|mesh-ancestor
5993304|NCT00121186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5993305|NCT00121186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993306|NCT00121186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5993307|NCT00121186|Antimetabolites|antimetabolites|mesh-ancestor
5993308|NCT00121186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5993309|NCT00121186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5993310|NCT00121186|Dermatologic Agents|dermatologic agents|mesh-ancestor
5993311|NCT00121186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5993312|NCT00121186|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5993313|NCT00121186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5993314|NCT00121186|Immunologic Factors|immunologic factors|mesh-ancestor
5993315|NCT00121186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5993316|NCT00121186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5993317|NCT00121186|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6258473|NCT03087786|Cholinergic Agents|cholinergic agents|mesh-ancestor
6258474|NCT03087786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6802526|NCT02294656|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6802527|NCT02294656|Ranibizumab|ranibizumab|mesh-list
6802528|NCT02294656|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6802529|NCT02294656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6802530|NCT02294656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6802531|NCT02294656|Growth Substances|growth substances|mesh-ancestor
6802532|NCT02294656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802533|NCT02294656|Growth Inhibitors|growth inhibitors|mesh-ancestor
6802534|NCT02294656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6802535|NCT02294656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6802536|NCT02294656|Glucocorticoids|glucocorticoids|mesh-ancestor
6802537|NCT02294656|Hormones|hormones|mesh-ancestor
6802538|NCT02294656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6802539|NCT02294656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6802540|NCT02294656|Immunologic Factors|immunologic factors|mesh-ancestor
6802541|NCT02294656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6802542|NCT02294656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6802543|NCT02294838|Citric Acid|citric acid|mesh-list
6802544|NCT02294838|Sodium Citrate|sodium citrate|mesh-list
6802545|NCT02294838|Anticoagulants|anticoagulants|mesh-ancestor
6802546|NCT02294838|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6802547|NCT02294838|Chelating Agents|chelating agents|mesh-ancestor
6802548|NCT02294838|Sequestering Agents|sequestering agents|mesh-ancestor
6802549|NCT02294838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5993318|NCT00121186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5993319|NCT00121186|Alkylating Agents|alkylating agents|mesh-ancestor
5993320|NCT00121186|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5993321|NCT00121199|Prednisone|prednisone|mesh-list
5993322|NCT00121199|Cyclophosphamide|cyclophosphamide|mesh-list
5993323|NCT00121199|Bevacizumab|bevacizumab|mesh-list
5993324|NCT00121199|Rituximab|rituximab|mesh-list
6802550|NCT02294955|Amiodarone|amiodarone|mesh-list
6802551|NCT02294955|Sotalol|sotalol|mesh-list
6802552|NCT02294955|Flecainide|flecainide|mesh-list
6802553|NCT02294955|Dronedarone|dronedarone|mesh-list
6802554|NCT02294955|Propafenone|propafenone|mesh-list
6802555|NCT02294955|Disopyramide|disopyramide|mesh-list
6802556|NCT02294955|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6802557|NCT02294955|Vasodilator Agents|vasodilator agents|mesh-ancestor
6802558|NCT02294955|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6802559|NCT02294955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6802560|NCT02294955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6802561|NCT02294955|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6802562|NCT02294955|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6802563|NCT02294955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6802564|NCT02294955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6802565|NCT02294955|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6802566|NCT02294955|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6802567|NCT02294955|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6802568|NCT02294955|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6802569|NCT02294955|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6802570|NCT02294955|Adrenergic Agents|adrenergic agents|mesh-ancestor
6802571|NCT02294955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6802572|NCT02294955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802573|NCT02294955|Sympatholytics|sympatholytics|mesh-ancestor
6802574|NCT02294955|Autonomic Agents|autonomic agents|mesh-ancestor
6802575|NCT02294955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6802576|NCT02294955|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6802577|NCT02294994|Tirofiban|tirofiban|mesh-list
6802578|NCT02294994|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6802579|NCT02294994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6802580|NCT02294994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6802581|NCT02294994|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6802582|NCT02295046|Amlodipine|amlodipine|mesh-list
6802583|NCT02295046|Atorvastatin|atorvastatin|mesh-list
6802584|NCT02295046|Calcium|calcium|mesh-list
6802585|NCT02295046|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6802586|NCT02295046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802587|NCT02295046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5993325|NCT00121199|Doxorubicin|doxorubicin|mesh-list
5993326|NCT00121199|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5993327|NCT00121199|Vincristine|vincristine|mesh-list
5993328|NCT00121199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5993329|NCT00121199|Antibodies|antibodies|mesh-list
5993330|NCT00121199|Immunoglobulins|immunoglobulins|mesh-list
5993331|NCT00121199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5993332|NCT00121199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5993333|NCT00121199|Immunologic Factors|immunologic factors|mesh-ancestor
5993334|NCT00121199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993335|NCT00121199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5993336|NCT00121199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5993337|NCT00121199|Alkylating Agents|alkylating agents|mesh-ancestor
5993338|NCT00121199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5993339|NCT00121199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5993340|NCT00121199|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5993341|NCT00121199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5993342|NCT00121199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5993343|NCT00121199|Growth Substances|growth substances|mesh-ancestor
5993344|NCT00121199|Growth Inhibitors|growth inhibitors|mesh-ancestor
5993345|NCT00121199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5993346|NCT00121199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5993347|NCT00121199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5993348|NCT00121199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5993349|NCT00121199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5993350|NCT00121199|Glucocorticoids|glucocorticoids|mesh-ancestor
5993351|NCT00121199|Hormones|hormones|mesh-ancestor
5993352|NCT00121199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5993353|NCT00121199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6258475|NCT03087786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258476|NCT03087851|Zoledronic Acid|zoledronic acid|mesh-list
6258477|NCT03087851|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6258478|NCT03087851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258479|NCT03088137|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6258480|NCT03088137|Hormones|hormones|mesh-ancestor
6802588|NCT02295046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6802589|NCT02295046|Antimetabolites|antimetabolites|mesh-ancestor
6802590|NCT02295046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6802591|NCT02295046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6802592|NCT02295046|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6802593|NCT02295046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6802594|NCT02295046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6802595|NCT02295046|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6802596|NCT02295046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6802597|NCT02295046|Vasodilator Agents|vasodilator agents|mesh-ancestor
6802598|NCT02295124|Oxycodone|oxycodone|mesh-list
6802599|NCT02295124|Hydromorphone|hydromorphone|mesh-list
6802600|NCT02295124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6802601|NCT02295124|Narcotics|narcotics|mesh-ancestor
6802602|NCT02295124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6802603|NCT02295124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802604|NCT02295124|Analgesics|analgesics|mesh-ancestor
6802605|NCT02295124|Sensory System Agents|sensory system agents|mesh-ancestor
6802606|NCT02295124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6802607|NCT02295150|Nadroparin|nadroparin|mesh-list
6802608|NCT02295150|Anticoagulants|anticoagulants|mesh-ancestor
6802609|NCT02295150|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6802610|NCT02295150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6802611|NCT02295150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6802612|NCT02295189|Triamcinolone|triamcinolone|mesh-list
6258481|NCT03088137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6258482|NCT03088137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258483|NCT03088267|Amphetamine|amphetamine|mesh-list
6258484|NCT03088267|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6258485|NCT03088267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258486|NCT03088267|Sympathomimetics|sympathomimetics|mesh-ancestor
6258487|NCT03088267|Autonomic Agents|autonomic agents|mesh-ancestor
6258488|NCT03088267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6536324|NCT00816634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6536325|NCT00816634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6536326|NCT00816634|Tubulin Modulators|tubulin modulators|mesh-ancestor
6536327|NCT00816634|Antimitotic Agents|antimitotic agents|mesh-ancestor
6536328|NCT00816634|Mitosis Modulators|mitosis modulators|mesh-ancestor
6536329|NCT00816634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536330|NCT00816634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6536331|NCT00816634|Antimetabolites|antimetabolites|mesh-ancestor
6536332|NCT00816660|Factor VIII|factor viii|mesh-list
6258489|NCT03088267|Dopamine Agents|dopamine agents|mesh-ancestor
6258490|NCT03088267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6258491|NCT03088267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258492|NCT03088267|Adrenergic Agents|adrenergic agents|mesh-ancestor
6258493|NCT03088267|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6258494|NCT03088267|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6258495|NCT03088267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6258496|NCT03088267|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6258497|NCT03088345|Vasopressins|vasopressins|mesh-list
6258498|NCT03088345|Arginine Vasopressin|arginine vasopressin|mesh-list
6258499|NCT03088345|Hemostatics|hemostatics|mesh-ancestor
6258500|NCT03088345|Coagulants|coagulants|mesh-ancestor
6258501|NCT03088345|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6258502|NCT03088345|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6258503|NCT03088345|Natriuretic Agents|natriuretic agents|mesh-ancestor
6258504|NCT03088345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258505|NCT03088800|Ibuprofen|ibuprofen|mesh-list
6258506|NCT03088800|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6258507|NCT03088800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6258508|NCT03088800|Analgesics|analgesics|mesh-ancestor
6258509|NCT03088800|Sensory System Agents|sensory system agents|mesh-ancestor
6258510|NCT03088800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6258511|NCT03088800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258512|NCT03088800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6258513|NCT03088800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6258514|NCT03088800|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6258515|NCT03088800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6258516|NCT03088800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258517|NCT03089216|Calcium Carbonate|calcium carbonate|mesh-list
6258518|NCT03089216|Calcium|calcium|mesh-list
6258519|NCT03089216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6258520|NCT03089216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258521|NCT03089216|Antacids|antacids|mesh-ancestor
6536333|NCT00816660|Coagulants|coagulants|mesh-ancestor
6802613|NCT02295189|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6802614|NCT02295189|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6802615|NCT02295189|Ketorolac|ketorolac|mesh-list
6258522|NCT03089216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258523|NCT03089216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6258524|NCT03090620|Lorazepam|lorazepam|mesh-list
6258525|NCT03090620|Physostigmine|physostigmine|mesh-list
6258526|NCT03090620|Anticonvulsants|anticonvulsants|mesh-ancestor
6258527|NCT03090620|Antiemetics|antiemetics|mesh-ancestor
6258528|NCT03090620|Autonomic Agents|autonomic agents|mesh-ancestor
6258529|NCT03090620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6258530|NCT03090620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258531|NCT03090620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6258532|NCT03090620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6258533|NCT03090620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6258534|NCT03090620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6258535|NCT03090620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6258536|NCT03090620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6258537|NCT03090620|GABA Modulators|gaba modulators|mesh-ancestor
6258538|NCT03090620|GABA Agents|gaba agents|mesh-ancestor
6258539|NCT03090620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6258540|NCT03090620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258541|NCT03090620|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6258542|NCT03090620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6258543|NCT03090620|Cholinergic Agents|cholinergic agents|mesh-ancestor
6258544|NCT03090620|Miotics|miotics|mesh-ancestor
6258545|NCT03091348|Methyltestosterone|methyltestosterone|mesh-list
6258546|NCT03091348|Testosterone|testosterone|mesh-list
6258547|NCT03091348|Testosterone undecanoate|testosterone undecanoate|mesh-list
6258548|NCT03091348|Testosterone enanthate|testosterone enanthate|mesh-list
6258549|NCT03091348|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6258550|NCT03091348|Androgens|androgens|mesh-ancestor
6258551|NCT03091348|Hormones|hormones|mesh-ancestor
6258552|NCT03091348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6258553|NCT03091348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258554|NCT03091348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6258555|NCT03091348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6258556|NCT03091348|Anabolic Agents|anabolic agents|mesh-ancestor
6258557|NCT03091400|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6258558|NCT03091400|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6258559|NCT03091400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6258560|NCT03091400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6258561|NCT03091400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258562|NCT03091400|Adrenergic Agents|adrenergic agents|mesh-ancestor
6258563|NCT03091400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6258564|NCT03091400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536334|NCT00816673|Melatonin|melatonin|mesh-list
6802616|NCT02295189|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6802617|NCT02295189|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6802618|NCT02295189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6802619|NCT02295189|Glucocorticoids|glucocorticoids|mesh-ancestor
6802620|NCT02295189|Hormones|hormones|mesh-ancestor
6802621|NCT02295189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6802622|NCT02295189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802623|NCT02295189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6802624|NCT02295189|Immunologic Factors|immunologic factors|mesh-ancestor
6802625|NCT02295189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6802626|NCT02295189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6802627|NCT02295189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6802628|NCT02295189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6802629|NCT02295189|Analgesics|analgesics|mesh-ancestor
6802630|NCT02295189|Sensory System Agents|sensory system agents|mesh-ancestor
6802631|NCT02295189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6802632|NCT02295189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6802633|NCT02295189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6802634|NCT02295475|Warfarin|warfarin|mesh-list
6802635|NCT02295475|Apixaban|apixaban|mesh-list
5993354|NCT00121199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5993355|NCT00121199|Tubulin Modulators|tubulin modulators|mesh-ancestor
5993356|NCT00121199|Antimitotic Agents|antimitotic agents|mesh-ancestor
5993357|NCT00121199|Mitosis Modulators|mitosis modulators|mesh-ancestor
5993358|NCT00121225|Vorinostat|vorinostat|mesh-list
6802636|NCT02295475|Anticoagulants|anticoagulants|mesh-ancestor
6258565|NCT03091439|Dalbavancin|dalbavancin|mesh-list
6258566|NCT03091439|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6802637|NCT02295475|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5993359|NCT00121225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5993360|NCT00121225|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5993361|NCT00121225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5993362|NCT00121225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5993363|NCT00121251|Gemcitabine|gemcitabine|mesh-list
5993364|NCT00121251|Capecitabine|capecitabine|mesh-list
5993365|NCT00121251|Sorafenib|sorafenib|mesh-list
5993366|NCT00121251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6802638|NCT02295475|Antithrombins|antithrombins|mesh-ancestor
6802639|NCT02295475|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6802640|NCT02295475|Protease Inhibitors|protease inhibitors|mesh-ancestor
6802641|NCT02295475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6802642|NCT02295475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6802643|NCT02295566|Nitric Oxide|nitric oxide|mesh-list
6802644|NCT02295566|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6802645|NCT02295566|Autonomic Agents|autonomic agents|mesh-ancestor
6802646|NCT02295566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6802647|NCT02295566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802648|NCT02295566|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6802649|NCT02295566|Respiratory System Agents|respiratory system agents|mesh-ancestor
6802650|NCT02295566|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6802651|NCT02295566|Antioxidants|antioxidants|mesh-ancestor
6802652|NCT02295566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6802653|NCT02295566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6802654|NCT02295566|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6802655|NCT02295566|Vasodilator Agents|vasodilator agents|mesh-ancestor
6802656|NCT02295566|Gasotransmitters|gasotransmitters|mesh-ancestor
6802657|NCT02295566|Protective Agents|protective agents|mesh-ancestor
6802658|NCT02295709|Dexamethasone|dexamethasone|mesh-list
6802659|NCT02295709|Dexamethasone acetate|dexamethasone acetate|mesh-list
5993367|NCT00121251|Antimetabolites|antimetabolites|mesh-ancestor
5993368|NCT00121251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258567|NCT03091439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6258568|NCT03091478|Pembrolizumab|pembrolizumab|mesh-list
6258569|NCT03091478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6258570|NCT03091478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6258571|NCT03091673|Glucagon|glucagon|mesh-list
6258572|NCT03091673|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6258573|NCT03091673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6258574|NCT03091673|Hormones|hormones|mesh-ancestor
6258575|NCT03091673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6258576|NCT03091673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258577|NCT03091673|Incretins|incretins|mesh-ancestor
6258578|NCT03091777|Metronidazole|metronidazole|mesh-list
6536335|NCT00816673|Antioxidants|antioxidants|mesh-ancestor
6536336|NCT00816673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536337|NCT00816673|Protective Agents|protective agents|mesh-ancestor
6536338|NCT00816673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536339|NCT00816673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6536340|NCT00816699|Anesthetics|anesthetics|mesh-list
6536341|NCT00816699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6536342|NCT00816699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536343|NCT00816712|Methyltestosterone|methyltestosterone|mesh-list
6536344|NCT00816712|Testosterone|testosterone|mesh-list
6536345|NCT00816712|Testosterone undecanoate|testosterone undecanoate|mesh-list
6536346|NCT00816712|Testosterone enanthate|testosterone enanthate|mesh-list
6536347|NCT00816712|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6536348|NCT00816712|Androgens|androgens|mesh-ancestor
6536349|NCT00816712|Hormones|hormones|mesh-ancestor
6536350|NCT00816712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6536351|NCT00816712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536352|NCT00816712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6536353|NCT00816712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6536354|NCT00816712|Anabolic Agents|anabolic agents|mesh-ancestor
6536355|NCT00816790|Tazobactam|tazobactam|mesh-list
6536356|NCT00816790|Piperacillin|piperacillin|mesh-list
6536357|NCT00816790|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
6536358|NCT00816790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6536359|NCT00816790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6536360|NCT00816790|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6536361|NCT00816790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6536362|NCT00816790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536363|NCT00816816|Docetaxel|docetaxel|mesh-list
6802660|NCT02295709|BB 1101|bb 1101|mesh-list
6802661|NCT02295709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6802662|NCT02295709|Antiemetics|antiemetics|mesh-ancestor
6802663|NCT02295709|Autonomic Agents|autonomic agents|mesh-ancestor
6802664|NCT02295709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6802665|NCT02295709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802666|NCT02295709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6802667|NCT02295709|Glucocorticoids|glucocorticoids|mesh-ancestor
6802668|NCT02295709|Hormones|hormones|mesh-ancestor
6802669|NCT02295709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6802670|NCT02295709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6802671|NCT02295709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6802672|NCT02295709|Protease Inhibitors|protease inhibitors|mesh-ancestor
6802673|NCT02295709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6802674|NCT02295709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6802675|NCT02295722|Gemcitabine|gemcitabine|mesh-list
6802676|NCT02295722|Melphalan|melphalan|mesh-list
6802677|NCT02295722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6802678|NCT02295722|Antimetabolites|antimetabolites|mesh-ancestor
6802679|NCT02295722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6802680|NCT02295722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6802681|NCT02295722|Antiviral Agents|antiviral agents|mesh-ancestor
6802682|NCT02295722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6802683|NCT02295722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6802684|NCT02295722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6802685|NCT02295722|Immunologic Factors|immunologic factors|mesh-ancestor
6802686|NCT02295722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802687|NCT02295722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6802688|NCT02295722|Alkylating Agents|alkylating agents|mesh-ancestor
6802689|NCT02295722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6802690|NCT02295748|Deflazacort|deflazacort|mesh-list
6802691|NCT02295748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6802692|NCT02295748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6802693|NCT02295748|Immunologic Factors|immunologic factors|mesh-ancestor
6802694|NCT02295748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802695|NCT02295787|Ketamine|ketamine|mesh-list
6802696|NCT02295787|Analgesics|analgesics|mesh-ancestor
6802697|NCT02295787|Sensory System Agents|sensory system agents|mesh-ancestor
6802698|NCT02295787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6802699|NCT02295787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802700|NCT02295787|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6802701|NCT02295787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6802702|NCT02295787|Anesthetics, General|anesthetics, general|mesh-ancestor
6802703|NCT02295787|Anesthetics|anesthetics|mesh-ancestor
6802704|NCT02295787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6802705|NCT02295787|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6802706|NCT02295787|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6802707|NCT02295787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6802708|NCT02295787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6802709|NCT02295826|Aspirin|aspirin|mesh-list
6802710|NCT02295826|Dabigatran|dabigatran|mesh-list
6802711|NCT02295826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6802712|NCT02295826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6802713|NCT02295826|Analgesics|analgesics|mesh-ancestor
6802714|NCT02295826|Sensory System Agents|sensory system agents|mesh-ancestor
6802715|NCT02295826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6802716|NCT02295826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802717|NCT02295826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6802718|NCT02295826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6802719|NCT02295826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6802720|NCT02295826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6802721|NCT02295826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6802722|NCT02295826|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6802723|NCT02295826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6802724|NCT02295826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6802725|NCT02295826|Antipyretics|antipyretics|mesh-ancestor
6802726|NCT02295826|Antithrombins|antithrombins|mesh-ancestor
6802727|NCT02295826|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6802728|NCT02295826|Protease Inhibitors|protease inhibitors|mesh-ancestor
6802729|NCT02295826|Anticoagulants|anticoagulants|mesh-ancestor
6802730|NCT02295852|Calcium|calcium|mesh-list
6802731|NCT02295852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6802732|NCT02295852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802733|NCT02295930|Bevacizumab|bevacizumab|mesh-list
6802734|NCT02295930|Cetuximab|cetuximab|mesh-list
6802735|NCT02295930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6802736|NCT02295930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6802737|NCT02295930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6802738|NCT02295930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6802739|NCT02295930|Growth Substances|growth substances|mesh-ancestor
6802740|NCT02295930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802741|NCT02295930|Growth Inhibitors|growth inhibitors|mesh-ancestor
6802742|NCT02296021|Amoxicillin|amoxicillin|mesh-list
6802743|NCT02296021|Clarithromycin|clarithromycin|mesh-list
6802744|NCT02296021|Esomeprazole|esomeprazole|mesh-list
6802745|NCT02296021|Bismuth|bismuth|mesh-list
6802746|NCT02296021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6802747|NCT02296021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6802748|NCT02296021|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6802749|NCT02296021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6802750|NCT02296021|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6802751|NCT02296021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6802752|NCT02296021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6802753|NCT02296021|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6802754|NCT02296021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6802755|NCT02296021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6802756|NCT02296021|Antacids|antacids|mesh-ancestor
6802757|NCT02296047|Bromides|bromides|mesh-list
6802758|NCT02296047|Albuterol|albuterol|mesh-list
6802759|NCT02296047|Ipratropium|ipratropium|mesh-list
6802760|NCT02296047|Anticonvulsants|anticonvulsants|mesh-ancestor
6802761|NCT02296047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6802762|NCT02296047|Autonomic Agents|autonomic agents|mesh-ancestor
6802763|NCT02296047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6802764|NCT02296047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802765|NCT02296047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6802766|NCT02296047|Respiratory System Agents|respiratory system agents|mesh-ancestor
6802767|NCT02296047|Tocolytic Agents|tocolytic agents|mesh-ancestor
6802768|NCT02296047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6802769|NCT02296047|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6802770|NCT02296047|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6802771|NCT02296047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6802772|NCT02296047|Adrenergic Agents|adrenergic agents|mesh-ancestor
6802773|NCT02296047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6802774|NCT02296047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6802775|NCT02296047|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6802776|NCT02296047|Cholinergic Agents|cholinergic agents|mesh-ancestor
6802777|NCT02296073|Fentanyl|fentanyl|mesh-list
6802778|NCT02296073|Midazolam|midazolam|mesh-list
6802779|NCT02296073|Dexmedetomidine|dexmedetomidine|mesh-list
6802780|NCT02296073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6802781|NCT02296073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6802782|NCT02296073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802783|NCT02296073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6802784|NCT02296073|Analgesics|analgesics|mesh-ancestor
6802785|NCT02296073|Sensory System Agents|sensory system agents|mesh-ancestor
6802786|NCT02296073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5993369|NCT00121251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5993370|NCT00121251|Antiviral Agents|antiviral agents|mesh-ancestor
5993371|NCT00121251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5993372|NCT00121251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5993373|NCT00121251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5993374|NCT00121251|Immunologic Factors|immunologic factors|mesh-ancestor
5993375|NCT00121251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993376|NCT00121251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5993377|NCT00121641|Metformin|metformin|mesh-list
5993378|NCT00121641|Saxagliptin|saxagliptin|mesh-list
6802787|NCT02296073|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6802788|NCT02296073|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6802789|NCT02296073|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6802790|NCT02296073|Adrenergic Agents|adrenergic agents|mesh-ancestor
6802791|NCT02296073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6536364|NCT00816816|Fluorouracil|fluorouracil|mesh-list
6536365|NCT00816816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6536366|NCT00816816|Tubulin Modulators|tubulin modulators|mesh-ancestor
6536367|NCT00816816|Antimitotic Agents|antimitotic agents|mesh-ancestor
6536368|NCT00816816|Mitosis Modulators|mitosis modulators|mesh-ancestor
6536369|NCT00816816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536370|NCT00816816|Antimetabolites|antimetabolites|mesh-ancestor
6536371|NCT00816816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6536372|NCT00816816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6536373|NCT00816816|Immunologic Factors|immunologic factors|mesh-ancestor
6802792|NCT02296073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6802793|NCT02296073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6802794|NCT02296073|Narcotics|narcotics|mesh-ancestor
6802795|NCT02296073|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6802796|NCT02296073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6802797|NCT02296073|Anesthetics, General|anesthetics, general|mesh-ancestor
6802798|NCT02296073|Anesthetics|anesthetics|mesh-ancestor
6802799|NCT02296073|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6802800|NCT02296073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6802801|NCT02296073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6802802|NCT02296073|GABA Modulators|gaba modulators|mesh-ancestor
6802803|NCT02296073|GABA Agents|gaba agents|mesh-ancestor
6802804|NCT02296203|Irinotecan|irinotecan|mesh-list
6802805|NCT02296203|Cetuximab|cetuximab|mesh-list
6802806|NCT02296203|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6802807|NCT02296203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6802808|NCT02296203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6802809|NCT02296203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6802810|NCT02296203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6802811|NCT02296203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6802812|NCT02296229|Androgens|androgens|mesh-list
6802813|NCT02296229|Hormones|hormones|mesh-ancestor
6802814|NCT02296229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6802815|NCT02296229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802816|NCT02296281|Pirfenidone|pirfenidone|mesh-list
6802817|NCT02296281|Analgesics|analgesics|mesh-ancestor
6802818|NCT02296281|Sensory System Agents|sensory system agents|mesh-ancestor
6802819|NCT02296281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6802820|NCT02296281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802821|NCT02296281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6802822|NCT02296281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6802823|NCT02296281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6802824|NCT02296281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6802825|NCT02296281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6802826|NCT02296333|Ondansetron|ondansetron|mesh-list
6802827|NCT02296333|Antiemetics|antiemetics|mesh-ancestor
6802828|NCT02296333|Autonomic Agents|autonomic agents|mesh-ancestor
6802829|NCT02296333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6802830|NCT02296333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802831|NCT02296333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6802832|NCT02296333|Antipruritics|antipruritics|mesh-ancestor
6802833|NCT02296333|Dermatologic Agents|dermatologic agents|mesh-ancestor
6802834|NCT02296333|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6802835|NCT02296333|Serotonin Agents|serotonin agents|mesh-ancestor
6802836|NCT02296333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6802837|NCT02296333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6802838|NCT02296333|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6802839|NCT02296333|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6802840|NCT02296333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6802841|NCT02296333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6802842|NCT02296333|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6802843|NCT02296359|Vaccines|vaccines|mesh-list
6802844|NCT02296359|Immunologic Factors|immunologic factors|mesh-ancestor
6802845|NCT02296359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802846|NCT02296398|Romidepsin|romidepsin|mesh-list
6802847|NCT02296398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6802848|NCT02296398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6802849|NCT02296411|Glycopyrrolate|glycopyrrolate|mesh-list
6802850|NCT02296411|Bromides|bromides|mesh-list
6802851|NCT02296411|Anticonvulsants|anticonvulsants|mesh-ancestor
6802852|NCT02296411|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6802853|NCT02296411|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6802854|NCT02296411|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6802855|NCT02296411|Cholinergic Agents|cholinergic agents|mesh-ancestor
6802856|NCT02296411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6802857|NCT02296411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6802858|NCT02296411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802859|NCT02296463|Vaccines|vaccines|mesh-list
6802860|NCT02296463|Immunologic Factors|immunologic factors|mesh-ancestor
6802861|NCT02296463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802862|NCT02296567|Bevacizumab|bevacizumab|mesh-list
6802863|NCT02296567|Ranibizumab|ranibizumab|mesh-list
6802864|NCT02296567|Aflibercept|aflibercept|mesh-list
6802865|NCT02296567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6802866|NCT02296567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6802867|NCT02296567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6802868|NCT02296567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6802869|NCT02296567|Growth Substances|growth substances|mesh-ancestor
6802870|NCT02296567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802871|NCT02296567|Growth Inhibitors|growth inhibitors|mesh-ancestor
6802872|NCT02296671|Leucovorin|leucovorin|mesh-list
6802873|NCT02296671|Fluorouracil|fluorouracil|mesh-list
6802874|NCT02296671|Oxaliplatin|oxaliplatin|mesh-list
6802875|NCT02296671|Pemetrexed|pemetrexed|mesh-list
6802876|NCT02296671|Antimetabolites|antimetabolites|mesh-ancestor
6802877|NCT02296671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6802878|NCT02296671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6802879|NCT02296671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6802880|NCT02296671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5993379|NCT00121641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6536374|NCT00816816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538010|NCT00825149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6538011|NCT00825149|Glucocorticoids|glucocorticoids|mesh-ancestor
6538012|NCT00825149|Hormones|hormones|mesh-ancestor
6538013|NCT00825149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6538014|NCT00825149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6538015|NCT00825149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6538016|NCT00825149|Tubulin Modulators|tubulin modulators|mesh-ancestor
6538017|NCT00825149|Antimitotic Agents|antimitotic agents|mesh-ancestor
6538018|NCT00825149|Mitosis Modulators|mitosis modulators|mesh-ancestor
6538019|NCT00825149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6538020|NCT00825188|Amlodipine|amlodipine|mesh-list
6538021|NCT00825188|Eplerenone|eplerenone|mesh-list
6538022|NCT00825188|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6538023|NCT00825188|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6538024|NCT00825188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6538025|NCT00825188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538026|NCT00825188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6538027|NCT00825188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538028|NCT00825188|Vasodilator Agents|vasodilator agents|mesh-ancestor
6538029|NCT00825188|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6538030|NCT00825188|Hormone Antagonists|hormone antagonists|mesh-ancestor
6538031|NCT00825188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6538032|NCT00825188|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6538033|NCT00825188|Diuretics|diuretics|mesh-ancestor
6538034|NCT00825188|Natriuretic Agents|natriuretic agents|mesh-ancestor
6538035|NCT00825201|Paclitaxel|paclitaxel|mesh-list
6538036|NCT00825201|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6538037|NCT00825201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6538038|NCT00825201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6538039|NCT00825201|Tubulin Modulators|tubulin modulators|mesh-ancestor
6538040|NCT00825201|Antimitotic Agents|antimitotic agents|mesh-ancestor
6538041|NCT00825201|Mitosis Modulators|mitosis modulators|mesh-ancestor
6538042|NCT00825201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538043|NCT00825253|Insulin|insulin|mesh-list
6538044|NCT00825253|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6538045|NCT00825253|Insulin Aspart|insulin aspart|mesh-list
6538046|NCT00825253|Biphasic Insulins|biphasic insulins|mesh-list
6538047|NCT00825253|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6538048|NCT00825253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6538049|NCT00825253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538050|NCT00825396|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6538051|NCT00825396|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6538052|NCT00825422|Ropivacaine|ropivacaine|mesh-list
6538053|NCT00825422|Anesthetics, Local|anesthetics, local|mesh-ancestor
6538054|NCT00825422|Anesthetics|anesthetics|mesh-ancestor
6538055|NCT00825422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6538056|NCT00825422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538057|NCT00825422|Sensory System Agents|sensory system agents|mesh-ancestor
6538058|NCT00825422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6802881|NCT02296671|Immunologic Factors|immunologic factors|mesh-ancestor
6802882|NCT02296671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802883|NCT02296671|Antidotes|antidotes|mesh-ancestor
6802884|NCT02296671|Protective Agents|protective agents|mesh-ancestor
6802885|NCT02296671|Vitamin B Complex|vitamin b complex|mesh-ancestor
6802886|NCT02296671|Vitamins|vitamins|mesh-ancestor
6802887|NCT02296671|Micronutrients|micronutrients|mesh-ancestor
6802888|NCT02296671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6802889|NCT02296671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6802890|NCT02296671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6802891|NCT02296684|Cisplatin|cisplatin|mesh-list
6802892|NCT02296684|Pembrolizumab|pembrolizumab|mesh-list
6802893|NCT02296684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6802894|NCT02296684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6802895|NCT02296723|Valganciclovir|valganciclovir|mesh-list
6802896|NCT02296723|Antiviral Agents|antiviral agents|mesh-ancestor
6802897|NCT02296723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6802898|NCT02296749|Sirolimus|sirolimus|mesh-list
6802899|NCT02296749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6802900|NCT02296749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6802901|NCT02296749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6802902|NCT02296749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6802903|NCT02296749|Antifungal Agents|antifungal agents|mesh-ancestor
6802904|NCT02296749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6802905|NCT02296749|Immunologic Factors|immunologic factors|mesh-ancestor
6802906|NCT02296749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802907|NCT02296762|Sirolimus|sirolimus|mesh-list
6802908|NCT02296762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6802909|NCT02296762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6802910|NCT02296762|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6802911|NCT02296762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6802912|NCT02296762|Antifungal Agents|antifungal agents|mesh-ancestor
6802913|NCT02296762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6802914|NCT02296762|Immunologic Factors|immunologic factors|mesh-ancestor
6802915|NCT02296762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802916|NCT02296996|Trametinib|trametinib|mesh-list
6802917|NCT02296996|Dabrafenib|dabrafenib|mesh-list
6802918|NCT02296996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6802919|NCT02296996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6802920|NCT02296996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6802921|NCT02296996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6802922|NCT02297204|Aflibercept|aflibercept|mesh-list
6802923|NCT02297204|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6802924|NCT02297204|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6802925|NCT02297204|Growth Substances|growth substances|mesh-ancestor
6802926|NCT02297204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802927|NCT02297204|Growth Inhibitors|growth inhibitors|mesh-ancestor
6802928|NCT02297204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6802929|NCT02297217|Paclitaxel|paclitaxel|mesh-list
6802930|NCT02297217|Carboplatin|carboplatin|mesh-list
6802931|NCT02297217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6802932|NCT02297217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6802933|NCT02297217|Tubulin Modulators|tubulin modulators|mesh-ancestor
6802934|NCT02297217|Antimitotic Agents|antimitotic agents|mesh-ancestor
6802935|NCT02297217|Mitosis Modulators|mitosis modulators|mesh-ancestor
6802936|NCT02297217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6802937|NCT02297386|Testosterone|testosterone|mesh-list
6802938|NCT02297386|Dihydrotestosterone|dihydrotestosterone|mesh-list
6802939|NCT02297386|Androgens|androgens|mesh-ancestor
6802940|NCT02297386|Hormones|hormones|mesh-ancestor
6802941|NCT02297386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6802942|NCT02297386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802943|NCT02297477|Artesunate|artesunate|mesh-list
6802944|NCT02297477|Atovaquone|atovaquone|mesh-list
6802945|NCT02297477|Proguanil|proguanil|mesh-list
6802946|NCT02297477|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
6802947|NCT02297477|Antimalarials|antimalarials|mesh-ancestor
6802948|NCT02297477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6802949|NCT02297477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6802950|NCT02297477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6802951|NCT02297477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6802952|NCT02297477|Antiviral Agents|antiviral agents|mesh-ancestor
6802953|NCT02297477|Schistosomicides|schistosomicides|mesh-ancestor
6802954|NCT02297477|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6802955|NCT02297477|Anthelmintics|anthelmintics|mesh-ancestor
6802956|NCT02297477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6802957|NCT02297477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6802958|NCT02297477|Antimetabolites|antimetabolites|mesh-ancestor
6802959|NCT02297529|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
6802960|NCT02297529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6802961|NCT02297529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6802962|NCT02297568|Vitamin D|vitamin d|mesh-list
6802963|NCT02297568|Ergocalciferols|ergocalciferols|mesh-list
6802964|NCT02297568|Vitamins|vitamins|mesh-ancestor
6802965|NCT02297568|Micronutrients|micronutrients|mesh-ancestor
6802966|NCT02297568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802967|NCT02297568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6802968|NCT02297568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6802969|NCT02297594|Ziresovir|ziresovir|mesh-list
6802970|NCT02297594|Antiviral Agents|antiviral agents|mesh-ancestor
6802971|NCT02297594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6802972|NCT02297620|Ipragliflozin|ipragliflozin|mesh-list
6802973|NCT02297620|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6802974|NCT02297620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6802975|NCT02297620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6802976|NCT02297620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802977|NCT02297763|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6802978|NCT02297763|Antidepressive Agents|antidepressive agents|mesh-ancestor
6802979|NCT02297763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6802980|NCT02297763|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6802981|NCT02297763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6802982|NCT02297763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6802983|NCT02297763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802984|NCT02297854|Valganciclovir|valganciclovir|mesh-list
6802985|NCT02297854|Antiviral Agents|antiviral agents|mesh-ancestor
6802986|NCT02297854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6802987|NCT02297906|Ketorolac|ketorolac|mesh-list
6802988|NCT02297906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6802989|NCT02297906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6802990|NCT02297906|Analgesics|analgesics|mesh-ancestor
6802991|NCT02297906|Sensory System Agents|sensory system agents|mesh-ancestor
6802992|NCT02297906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6802993|NCT02297906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6802994|NCT02297906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6802995|NCT02297906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6802996|NCT02297906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6802997|NCT02297906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6802998|NCT02297906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6802999|NCT02297945|Metyrapone|metyrapone|mesh-list
6803000|NCT02297945|Antimetabolites|antimetabolites|mesh-ancestor
6803001|NCT02297945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6803002|NCT02297945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6803003|NCT02297997|Cetylpyridinium|cetylpyridinium|mesh-list
6803004|NCT02297997|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6803005|NCT02297997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6803006|NCT02298010|Capecitabine|capecitabine|mesh-list
6803007|NCT02298010|Oxaliplatin|oxaliplatin|mesh-list
6803008|NCT02298010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6803009|NCT02298010|Antimetabolites|antimetabolites|mesh-ancestor
6803010|NCT02298010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6803011|NCT02298010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6803012|NCT02298062|Infliximab|infliximab|mesh-list
6803013|NCT02298062|Dermatologic Agents|dermatologic agents|mesh-ancestor
6803014|NCT02298062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6803015|NCT02298062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6803016|NCT02298088|Clopidogrel|clopidogrel|mesh-list
6803017|NCT02298088|Ticagrelor|ticagrelor|mesh-list
6803018|NCT02298088|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6803019|NCT02298088|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6803020|NCT02298088|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6803021|NCT02298088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6803022|NCT02298088|Purinergic Agents|purinergic agents|mesh-ancestor
6803023|NCT02298088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6803024|NCT02298088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6803025|NCT02298088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803026|NCT02298101|Edetic Acid|edetic acid|mesh-list
6803027|NCT02298101|Pentetic Acid|pentetic acid|mesh-list
6803028|NCT02298101|Antidotes|antidotes|mesh-ancestor
6803029|NCT02298101|Protective Agents|protective agents|mesh-ancestor
6803030|NCT02298101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803031|NCT02298101|Chelating Agents|chelating agents|mesh-ancestor
6803032|NCT02298101|Sequestering Agents|sequestering agents|mesh-ancestor
6803033|NCT02298101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6803034|NCT02298101|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6803035|NCT02298101|Anticoagulants|anticoagulants|mesh-ancestor
6803036|NCT02298101|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6803037|NCT02298153|Atezolizumab|atezolizumab|mesh-list
6803038|NCT02298153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6803039|NCT02298166|Cytarabine|cytarabine|mesh-list
6803040|NCT02298166|Mitoxantrone|mitoxantrone|mesh-list
6803041|NCT02298166|Crenolanib|crenolanib|mesh-list
6803042|NCT02298166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6803043|NCT02298166|Antimetabolites|antimetabolites|mesh-ancestor
6803044|NCT02298166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6803045|NCT02298166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6803046|NCT02298166|Antiviral Agents|antiviral agents|mesh-ancestor
6803047|NCT02298166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6803048|NCT02298166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6803049|NCT02298166|Immunologic Factors|immunologic factors|mesh-ancestor
6803050|NCT02298166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803051|NCT02298166|Analgesics|analgesics|mesh-ancestor
6803052|NCT02298166|Sensory System Agents|sensory system agents|mesh-ancestor
6803053|NCT02298166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6803054|NCT02298166|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6803055|NCT02298166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6803056|NCT02298166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6803057|NCT02298205|Beclomethasone|beclomethasone|mesh-list
6803058|NCT02298205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6803059|NCT02298205|Glucocorticoids|glucocorticoids|mesh-ancestor
6803060|NCT02298205|Hormones|hormones|mesh-ancestor
6803061|NCT02298205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6803062|NCT02298205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803063|NCT02298205|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6803064|NCT02298205|Respiratory System Agents|respiratory system agents|mesh-ancestor
6803065|NCT02298218|Meloxicam|meloxicam|mesh-list
6803066|NCT02298218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6803067|NCT02298218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6803068|NCT02298218|Analgesics|analgesics|mesh-ancestor
6803069|NCT02298218|Sensory System Agents|sensory system agents|mesh-ancestor
6803070|NCT02298218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6803071|NCT02298218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803072|NCT02298218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6803073|NCT02298218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6803074|NCT02298218|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6803075|NCT02298218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6803076|NCT02298218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6803077|NCT02298218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6803078|NCT02298283|Prednisone|prednisone|mesh-list
6803079|NCT02298283|Cyclophosphamide|cyclophosphamide|mesh-list
6803080|NCT02298283|Doxorubicin|doxorubicin|mesh-list
6803081|NCT02298283|Etoposide|etoposide|mesh-list
6803082|NCT02298283|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6803083|NCT02298283|Vincristine|vincristine|mesh-list
6803084|NCT02298283|Bleomycin|bleomycin|mesh-list
6803085|NCT02298283|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6803086|NCT02298283|Procarbazine|procarbazine|mesh-list
6803087|NCT02298283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6803088|NCT02298283|Immunologic Factors|immunologic factors|mesh-ancestor
6803089|NCT02298283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803090|NCT02298283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6803091|NCT02298283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6803092|NCT02298283|Alkylating Agents|alkylating agents|mesh-ancestor
6803093|NCT02298283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6803094|NCT02298283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6803095|NCT02298283|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6803096|NCT02298283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6803097|NCT02298283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6803098|NCT02298283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6803099|NCT02298283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6803100|NCT02298283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6803101|NCT02298283|Glucocorticoids|glucocorticoids|mesh-ancestor
6803102|NCT02298283|Hormones|hormones|mesh-ancestor
6803103|NCT02298283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6803104|NCT02298283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6803105|NCT02298283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6803106|NCT02298283|Tubulin Modulators|tubulin modulators|mesh-ancestor
6803107|NCT02298283|Antimitotic Agents|antimitotic agents|mesh-ancestor
6803108|NCT02298283|Mitosis Modulators|mitosis modulators|mesh-ancestor
6803109|NCT02298283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6803110|NCT02298335|Prednisone|prednisone|mesh-list
6803111|NCT02298335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6803112|NCT02298335|Glucocorticoids|glucocorticoids|mesh-ancestor
6803113|NCT02298335|Hormones|hormones|mesh-ancestor
6803114|NCT02298335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6803115|NCT02298335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803116|NCT02298335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6803117|NCT02298335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6803118|NCT02298348|Cyclophosphamide|cyclophosphamide|mesh-list
6803119|NCT02298348|Sorafenib|sorafenib|mesh-list
6803120|NCT02298348|Topotecan|topotecan|mesh-list
6803121|NCT02298348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6803122|NCT02298348|Immunologic Factors|immunologic factors|mesh-ancestor
6803123|NCT02298348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803124|NCT02298348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6803125|NCT02298348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6803126|NCT02298348|Alkylating Agents|alkylating agents|mesh-ancestor
6803127|NCT02298348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6803128|NCT02298348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6803129|NCT02298348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6803130|NCT02298348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6803131|NCT02298348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6803132|NCT02298348|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6803133|NCT02298348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6803134|NCT02298387|Antibodies, Bispecific|antibodies, bispecific|mesh-list
6803135|NCT02298387|Immunologic Factors|immunologic factors|mesh-ancestor
6803136|NCT02298387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803137|NCT02298530|Caffeine|caffeine|mesh-list
6803138|NCT02298530|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6803139|NCT02298530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803140|NCT02298530|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6803141|NCT02298530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6803142|NCT02298530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6803143|NCT02298530|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6803144|NCT02298530|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6803145|NCT02298530|Purinergic Agents|purinergic agents|mesh-ancestor
6803146|NCT02298530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6803147|NCT02298582|Fentanyl|fentanyl|mesh-list
6803148|NCT02298582|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6803149|NCT02298582|Narcotics|narcotics|mesh-ancestor
6803150|NCT02298582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6803151|NCT02298582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803152|NCT02298582|Analgesics|analgesics|mesh-ancestor
6803153|NCT02298582|Sensory System Agents|sensory system agents|mesh-ancestor
6803154|NCT02298582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6803155|NCT02298582|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6803156|NCT02298582|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6803157|NCT02298582|Anesthetics, General|anesthetics, general|mesh-ancestor
6803158|NCT02298582|Anesthetics|anesthetics|mesh-ancestor
6803159|NCT02298595|Cetuximab|cetuximab|mesh-list
6803160|NCT02298595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6803161|NCT02298595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6803162|NCT02298660|Botulinum Toxins|botulinum toxins|mesh-list
6803163|NCT02298660|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6803164|NCT02298660|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6803165|NCT02298660|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6803166|NCT02298660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6803167|NCT02298660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6803168|NCT02298660|Cholinergic Agents|cholinergic agents|mesh-ancestor
6803169|NCT02298660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6803170|NCT02298660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803171|NCT02298660|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6803172|NCT02298660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6803173|NCT02298764|Psychotropic Drugs|psychotropic drugs|mesh-list
6803174|NCT02298985|Curcumin|curcumin|mesh-list
6803175|NCT02298985|Antipsychotic Agents|antipsychotic agents|mesh-list
6803176|NCT02298985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6803177|NCT02298985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6803178|NCT02298985|Analgesics|analgesics|mesh-ancestor
6803179|NCT02298985|Sensory System Agents|sensory system agents|mesh-ancestor
6803180|NCT02298985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6803181|NCT02298985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803182|NCT02298985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6803183|NCT02298985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6803184|NCT02298985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6803185|NCT02298985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6803186|NCT02298985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6803187|NCT02298985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6803188|NCT02298985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6803189|NCT02298985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6803190|NCT02299024|Analgesics, Opioid|analgesics, opioid|mesh-list
6803191|NCT02299024|Narcotics|narcotics|mesh-ancestor
6803192|NCT02299024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6803193|NCT02299024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803194|NCT02299024|Analgesics|analgesics|mesh-ancestor
6803195|NCT02299024|Sensory System Agents|sensory system agents|mesh-ancestor
6803196|NCT02299024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6803197|NCT02299063|Dexmedetomidine|dexmedetomidine|mesh-list
6803198|NCT02299063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6803199|NCT02299063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6803200|NCT02299063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803201|NCT02299063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6803202|NCT02299063|Analgesics|analgesics|mesh-ancestor
6803203|NCT02299063|Sensory System Agents|sensory system agents|mesh-ancestor
6803204|NCT02299063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6803205|NCT02299063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6803206|NCT02299063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6803207|NCT02299063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6803208|NCT02299063|Adrenergic Agents|adrenergic agents|mesh-ancestor
6803209|NCT02299063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6803210|NCT02299063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6803211|NCT02299115|Prednisolone|prednisolone|mesh-list
6803212|NCT02299115|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6803213|NCT02299115|Methylprednisolone|methylprednisolone|mesh-list
6803214|NCT02299115|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6803215|NCT02299115|Prednisolone acetate|prednisolone acetate|mesh-list
6803216|NCT02299115|Vigabatrin|vigabatrin|mesh-list
6803217|NCT02299115|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6803218|NCT02299115|Prednisolone phosphate|prednisolone phosphate|mesh-list
6803219|NCT02299115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6803220|NCT02299115|Glucocorticoids|glucocorticoids|mesh-ancestor
6803221|NCT02299115|Hormones|hormones|mesh-ancestor
6803222|NCT02299115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6803223|NCT02299115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803224|NCT02299115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6803225|NCT02299115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6803226|NCT02299115|Antiemetics|antiemetics|mesh-ancestor
6803227|NCT02299115|Autonomic Agents|autonomic agents|mesh-ancestor
6803228|NCT02299115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6803229|NCT02299115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6803230|NCT02299115|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6803231|NCT02299115|Protective Agents|protective agents|mesh-ancestor
6803232|NCT02299115|Anticonvulsants|anticonvulsants|mesh-ancestor
6803233|NCT02299115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6803234|NCT02299115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6803235|NCT02299115|GABA Agents|gaba agents|mesh-ancestor
6803236|NCT02299115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6803237|NCT02299232|Dexmedetomidine|dexmedetomidine|mesh-list
6803238|NCT02299232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6803239|NCT02299232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6803240|NCT02299232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803241|NCT02299232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6803242|NCT02299232|Analgesics|analgesics|mesh-ancestor
6803243|NCT02299232|Sensory System Agents|sensory system agents|mesh-ancestor
6803244|NCT02299232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6803245|NCT02299232|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6803246|NCT02299232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6803247|NCT02299232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6803248|NCT02299232|Adrenergic Agents|adrenergic agents|mesh-ancestor
6803249|NCT02299232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6803250|NCT02299232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6803251|NCT02299245|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6803252|NCT02299245|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6803253|NCT02299245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6803254|NCT02299245|Antimetabolites|antimetabolites|mesh-ancestor
6803255|NCT02299245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6803256|NCT02299245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6803257|NCT02299245|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6803258|NCT02299245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6803259|NCT02299271|Ropivacaine|ropivacaine|mesh-list
6803260|NCT02299271|Anesthetics, Local|anesthetics, local|mesh-ancestor
6803261|NCT02299271|Anesthetics|anesthetics|mesh-ancestor
6803262|NCT02299271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6803263|NCT02299271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803264|NCT02299271|Sensory System Agents|sensory system agents|mesh-ancestor
6803265|NCT02299271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6803266|NCT02299310|Valsartan|valsartan|mesh-list
6803267|NCT02299310|Perindopril|perindopril|mesh-list
6803268|NCT02299310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6803269|NCT02299310|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6803270|NCT02299310|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6803271|NCT02299310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6803272|NCT02299310|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6803273|NCT02299310|Protease Inhibitors|protease inhibitors|mesh-ancestor
6803274|NCT02299310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6803275|NCT02299401|Misoprostol|misoprostol|mesh-list
6803276|NCT02299401|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6803277|NCT02299401|Abortifacient Agents|abortifacient agents|mesh-ancestor
6803278|NCT02299401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6803279|NCT02299401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803280|NCT02299401|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6803281|NCT02299401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6803282|NCT02299401|Oxytocics|oxytocics|mesh-ancestor
6803283|NCT02299440|Ketamine|ketamine|mesh-list
6803284|NCT02299440|Analgesics|analgesics|mesh-ancestor
6803285|NCT02299440|Sensory System Agents|sensory system agents|mesh-ancestor
6803286|NCT02299440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6803287|NCT02299440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803288|NCT02299440|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6803289|NCT02299440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6803290|NCT02299440|Anesthetics, General|anesthetics, general|mesh-ancestor
6803291|NCT02299440|Anesthetics|anesthetics|mesh-ancestor
6803292|NCT02299440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6803293|NCT02299440|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6803294|NCT02299440|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6803295|NCT02299440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6803296|NCT02299440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6803297|NCT02299518|Cytarabine|cytarabine|mesh-list
6803298|NCT02299518|Etoposide|etoposide|mesh-list
6803299|NCT02299518|Mitoxantrone|mitoxantrone|mesh-list
6803300|NCT02299518|Etoposide phosphate|etoposide phosphate|mesh-list
6803301|NCT02299518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6803302|NCT02299518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6803303|NCT02299518|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6803304|NCT02299518|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6803305|NCT02299518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6803306|NCT02299518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6803307|NCT02299518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6803308|NCT02299518|Antimetabolites|antimetabolites|mesh-ancestor
6803309|NCT02299518|Antiviral Agents|antiviral agents|mesh-ancestor
6803310|NCT02299518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6803311|NCT02299518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6803312|NCT02299518|Immunologic Factors|immunologic factors|mesh-ancestor
6803313|NCT02299518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803314|NCT02299518|Analgesics|analgesics|mesh-ancestor
6803315|NCT02299518|Sensory System Agents|sensory system agents|mesh-ancestor
6803316|NCT02299518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6803317|NCT02299557|Phenylephrine|phenylephrine|mesh-list
6803318|NCT02299557|Oxymetazoline|oxymetazoline|mesh-list
6803319|NCT02299557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6803320|NCT02299557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6803321|NCT02299557|Adrenergic Agents|adrenergic agents|mesh-ancestor
6803322|NCT02299557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6803323|NCT02299557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6803324|NCT02299557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803325|NCT02299557|Sympathomimetics|sympathomimetics|mesh-ancestor
6803326|NCT02299557|Autonomic Agents|autonomic agents|mesh-ancestor
6803327|NCT02299557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6803328|NCT02299557|Nasal Decongestants|nasal decongestants|mesh-ancestor
6803329|NCT02299557|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6803330|NCT02299557|Respiratory System Agents|respiratory system agents|mesh-ancestor
6803331|NCT02299557|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6803332|NCT02299557|Mydriatics|mydriatics|mesh-ancestor
6803333|NCT02299557|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6803334|NCT02299557|Protective Agents|protective agents|mesh-ancestor
6803335|NCT02299687|Omeprazole|omeprazole|mesh-list
6803336|NCT02299687|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6803337|NCT02299687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6803338|NCT02299687|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6803339|NCT02299687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6803340|NCT02299687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6803341|NCT02299726|Spironolactone|spironolactone|mesh-list
6803342|NCT02299726|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6803343|NCT02299726|Hormone Antagonists|hormone antagonists|mesh-ancestor
6803344|NCT02299726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6803345|NCT02299726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803346|NCT02299726|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6803347|NCT02299726|Diuretics|diuretics|mesh-ancestor
6803348|NCT02299726|Natriuretic Agents|natriuretic agents|mesh-ancestor
6803349|NCT02299765|Gemcitabine|gemcitabine|mesh-list
6803350|NCT02299765|Carboplatin|carboplatin|mesh-list
6803351|NCT02299765|Gefitinib|gefitinib|mesh-list
6803352|NCT02299765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6803353|NCT02299765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6803354|NCT02299765|Antimetabolites|antimetabolites|mesh-ancestor
6803355|NCT02299765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6803356|NCT02299765|Antiviral Agents|antiviral agents|mesh-ancestor
6803357|NCT02299765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6803358|NCT02299765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6803359|NCT02299765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6803360|NCT02299765|Immunologic Factors|immunologic factors|mesh-ancestor
6803361|NCT02299765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803362|NCT02299765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6803363|NCT02299817|Denosumab|denosumab|mesh-list
6803364|NCT02299817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6803365|NCT02299817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803366|NCT02299882|Vancomycin|vancomycin|mesh-list
6803367|NCT02299882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6803368|NCT02299882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6803369|NCT02299908|Bupivacaine|bupivacaine|mesh-list
6803370|NCT02299908|Anesthetics, Local|anesthetics, local|mesh-list
6803371|NCT02299908|Anesthetics|anesthetics|mesh-list
6803372|NCT02299908|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6803373|NCT02299908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6803374|NCT02299908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803375|NCT02299908|Sensory System Agents|sensory system agents|mesh-ancestor
6803376|NCT02299908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6803377|NCT02299999|Gemcitabine|gemcitabine|mesh-list
6803378|NCT02299999|Paclitaxel|paclitaxel|mesh-list
6803379|NCT02299999|Vincristine|vincristine|mesh-list
6803380|NCT02299999|Vinorelbine|vinorelbine|mesh-list
6803381|NCT02299999|Vinblastine|vinblastine|mesh-list
6803382|NCT02299999|Docetaxel|docetaxel|mesh-list
6803383|NCT02299999|Vinca Alkaloids|vinca alkaloids|mesh-list
6803384|NCT02299999|Cyclophosphamide|cyclophosphamide|mesh-list
6803385|NCT02299999|Bevacizumab|bevacizumab|mesh-list
6803386|NCT02299999|Cisplatin|cisplatin|mesh-list
6803387|NCT02299999|Carboplatin|carboplatin|mesh-list
6803388|NCT02299999|Doxorubicin|doxorubicin|mesh-list
6803389|NCT02299999|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6803390|NCT02299999|Capecitabine|capecitabine|mesh-list
6803391|NCT02299999|Methotrexate|methotrexate|mesh-list
6803392|NCT02299999|Durvalumab|durvalumab|mesh-list
6803393|NCT02299999|Epirubicin|epirubicin|mesh-list
6803394|NCT02299999|Olaparib|olaparib|mesh-list
6803395|NCT02299999|Mitomycins|mitomycins|mesh-list
6803396|NCT02299999|Mitomycin|mitomycin|mesh-list
6803397|NCT02299999|Bicalutamide|bicalutamide|mesh-list
6803398|NCT02299999|Taxane|taxane|mesh-list
6803399|NCT02299999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6803400|NCT02299999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6803401|NCT02299999|Tubulin Modulators|tubulin modulators|mesh-ancestor
6803402|NCT02299999|Antimitotic Agents|antimitotic agents|mesh-ancestor
6803403|NCT02299999|Mitosis Modulators|mitosis modulators|mesh-ancestor
6803404|NCT02299999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6803405|NCT02299999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6803406|NCT02299999|Immunologic Factors|immunologic factors|mesh-ancestor
6803407|NCT02299999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803408|NCT02299999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6803409|NCT02299999|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6803410|NCT02299999|Alkylating Agents|alkylating agents|mesh-ancestor
6803411|NCT02299999|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6803412|NCT02299999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6803413|NCT02299999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6803414|NCT02299999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6803415|NCT02299999|Growth Substances|growth substances|mesh-ancestor
6803416|NCT02299999|Growth Inhibitors|growth inhibitors|mesh-ancestor
6803417|NCT02299999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6803418|NCT02299999|Antimetabolites|antimetabolites|mesh-ancestor
6803419|NCT02299999|Antiviral Agents|antiviral agents|mesh-ancestor
6803420|NCT02299999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6803421|NCT02299999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6803422|NCT02299999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6803423|NCT02299999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6803424|NCT02299999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6803425|NCT02299999|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6803426|NCT02299999|Abortifacient Agents|abortifacient agents|mesh-ancestor
6803427|NCT02299999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6803428|NCT02299999|Dermatologic Agents|dermatologic agents|mesh-ancestor
6803429|NCT02299999|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6803430|NCT02299999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6803431|NCT02299999|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6803432|NCT02299999|Androgen Antagonists|androgen antagonists|mesh-ancestor
6803433|NCT02299999|Hormone Antagonists|hormone antagonists|mesh-ancestor
6803434|NCT02299999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6803435|NCT02300038|Lidocaine|lidocaine|mesh-list
6803436|NCT02300038|Anesthetics, Local|anesthetics, local|mesh-ancestor
6803437|NCT02300038|Anesthetics|anesthetics|mesh-ancestor
6803438|NCT02300038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6803439|NCT02300038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803440|NCT02300038|Sensory System Agents|sensory system agents|mesh-ancestor
6803441|NCT02300038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6803442|NCT02300038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6803443|NCT02300038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6803444|NCT02300038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6803445|NCT02300038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6803446|NCT02300038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6803447|NCT02300064|Antioxidants|antioxidants|mesh-list
6803448|NCT02300064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6803449|NCT02300064|Protective Agents|protective agents|mesh-ancestor
6803450|NCT02300064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803451|NCT02300194|Morphine|morphine|mesh-list
6803452|NCT02300194|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6803453|NCT02300194|Narcotics|narcotics|mesh-ancestor
6803454|NCT02300194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6803455|NCT02300194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803456|NCT02300194|Analgesics|analgesics|mesh-ancestor
6803457|NCT02300194|Sensory System Agents|sensory system agents|mesh-ancestor
6803458|NCT02300194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6803459|NCT02300350|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
6803460|NCT02300350|Digoxin|digoxin|mesh-list
6803461|NCT02300350|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6803462|NCT02300350|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6803463|NCT02300350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6803464|NCT02300350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6803465|NCT02300350|Protective Agents|protective agents|mesh-ancestor
6803466|NCT02300350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803467|NCT02300350|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6803468|NCT02300350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6803469|NCT02300363|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
6803470|NCT02300363|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6803471|NCT02300363|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6803472|NCT02300363|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6803473|NCT02300363|Antimetabolites|antimetabolites|mesh-ancestor
6803474|NCT02300363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6803475|NCT02300363|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6803476|NCT02300363|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6803477|NCT02300363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6803478|NCT02300363|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6803479|NCT02300363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6803480|NCT02300363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803481|NCT02300376|Edetic Acid|edetic acid|mesh-list
6803482|NCT02300376|Calcium|calcium|mesh-list
6803483|NCT02300376|Pentetic Acid|pentetic acid|mesh-list
6803484|NCT02300376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6803485|NCT02300376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803486|NCT02300376|Anticoagulants|anticoagulants|mesh-ancestor
6803487|NCT02300376|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6803488|NCT02300376|Chelating Agents|chelating agents|mesh-ancestor
6803489|NCT02300376|Sequestering Agents|sequestering agents|mesh-ancestor
6803490|NCT02300376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6803491|NCT02300376|Antidotes|antidotes|mesh-ancestor
6803492|NCT02300376|Protective Agents|protective agents|mesh-ancestor
6803493|NCT02300376|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6803494|NCT02300428|Ferrous fumarate|ferrous fumarate|mesh-list
6803495|NCT02300428|Ferrous gluconate|ferrous gluconate|mesh-list
6803496|NCT02300428|Trace Elements|trace elements|mesh-ancestor
6803497|NCT02300428|Micronutrients|micronutrients|mesh-ancestor
6803498|NCT02300428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803499|NCT02300428|Hematinics|hematinics|mesh-ancestor
6803500|NCT02300623|Lamivudine|lamivudine|mesh-list
6803501|NCT02300623|Stavudine|stavudine|mesh-list
6803502|NCT02300623|Indinavir|indinavir|mesh-list
6803503|NCT02300623|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6803504|NCT02300623|Interleukin-2|interleukin-2|mesh-list
6803505|NCT02300623|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6803506|NCT02300623|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6803507|NCT02300623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6803508|NCT02300623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6803509|NCT02300623|Antiviral Agents|antiviral agents|mesh-ancestor
6803510|NCT02300623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6803511|NCT02300623|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6803512|NCT02300623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6803513|NCT02300623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6803514|NCT02300623|Analgesics|analgesics|mesh-ancestor
6803515|NCT02300623|Sensory System Agents|sensory system agents|mesh-ancestor
6803516|NCT02300623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6803517|NCT02300623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803518|NCT02300623|Antimetabolites|antimetabolites|mesh-ancestor
6803519|NCT02300623|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6803520|NCT02300623|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6803521|NCT02300623|Protease Inhibitors|protease inhibitors|mesh-ancestor
6803522|NCT02300649|Dexmedetomidine|dexmedetomidine|mesh-list
6803523|NCT02300649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6803524|NCT02300649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6803525|NCT02300649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803526|NCT02300649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6803527|NCT02300649|Analgesics|analgesics|mesh-ancestor
6803528|NCT02300649|Sensory System Agents|sensory system agents|mesh-ancestor
6803529|NCT02300649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6803530|NCT02300649|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6536375|NCT00816855|Docetaxel|docetaxel|mesh-list
6803531|NCT02300649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6803532|NCT02300649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6803533|NCT02300649|Adrenergic Agents|adrenergic agents|mesh-ancestor
6803534|NCT02300649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6803535|NCT02300649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6803536|NCT02300688|Maleic acid|maleic acid|mesh-list
6803537|NCT02300688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6803538|NCT02300688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6803539|NCT02300701|Omalizumab|omalizumab|mesh-list
6803540|NCT02300701|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6803541|NCT02300701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6803542|NCT02300701|Respiratory System Agents|respiratory system agents|mesh-ancestor
6803543|NCT02300740|Niacinamide|niacinamide|mesh-list
6803544|NCT02300740|Niacin|niacin|mesh-list
6803545|NCT02300740|Nicotinic Acids|nicotinic acids|mesh-list
6803546|NCT02300740|Vitamin B Complex|vitamin b complex|mesh-ancestor
6803547|NCT02300740|Vitamins|vitamins|mesh-ancestor
6803548|NCT02300740|Micronutrients|micronutrients|mesh-ancestor
6803549|NCT02300740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803550|NCT02300740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6803551|NCT02300740|Antimetabolites|antimetabolites|mesh-ancestor
6803552|NCT02300740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6803553|NCT02300740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6803554|NCT02300740|Vasodilator Agents|vasodilator agents|mesh-ancestor
6803555|NCT02300818|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6803556|NCT02300818|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6803557|NCT02300922|Antibodies|antibodies|mesh-list
6803558|NCT02300922|Immunologic Factors|immunologic factors|mesh-ancestor
6803559|NCT02300922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803560|NCT02300935|Paclitaxel|paclitaxel|mesh-list
6803561|NCT02300935|Trametinib|trametinib|mesh-list
6803562|NCT02300935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6803563|NCT02300935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6803564|NCT02300935|Tubulin Modulators|tubulin modulators|mesh-ancestor
6803565|NCT02300935|Antimitotic Agents|antimitotic agents|mesh-ancestor
6803566|NCT02300935|Mitosis Modulators|mitosis modulators|mesh-ancestor
6803567|NCT02300935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6803568|NCT02300935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6803569|NCT02300935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6803570|NCT02300948|Folic Acid|folic acid|mesh-list
6803571|NCT02300948|Vitamin B Complex|vitamin b complex|mesh-list
6803572|NCT02300948|Hematinics|hematinics|mesh-ancestor
6803573|NCT02300948|Vitamins|vitamins|mesh-ancestor
6803574|NCT02300948|Micronutrients|micronutrients|mesh-ancestor
6803575|NCT02300948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803576|NCT02301000|Metronidazole|metronidazole|mesh-list
6803577|NCT02301000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6803578|NCT02301000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6803579|NCT02301000|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6803580|NCT02301000|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6803581|NCT02301026|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
6803582|NCT02301026|Hematinics|hematinics|mesh-ancestor
6803583|NCT02301091|Mitomycins|mitomycins|mesh-list
6803584|NCT02301091|Mitomycin|mitomycin|mesh-list
6803585|NCT02301091|Pirarubicin|pirarubicin|mesh-list
6803586|NCT02301091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6803587|NCT02301091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6803588|NCT02301091|Alkylating Agents|alkylating agents|mesh-ancestor
6803589|NCT02301091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6803590|NCT02301091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6803591|NCT02301091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6803592|NCT02301130|Durvalumab|durvalumab|mesh-list
6803593|NCT02301130|Tremelimumab|tremelimumab|mesh-list
6803594|NCT02301130|Mogamulizumab|mogamulizumab|mesh-list
6803595|NCT02301130|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6803596|NCT02301130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6803597|NCT02301130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6803598|NCT02301130|Immunologic Factors|immunologic factors|mesh-ancestor
6803599|NCT02301130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803600|NCT02301208|Nedaplatin|nedaplatin|mesh-list
6803601|NCT02301208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6803602|NCT02301221|Vancomycin|vancomycin|mesh-list
6803603|NCT02301221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6803604|NCT02301221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6803605|NCT02301286|Aspirin|aspirin|mesh-list
6803606|NCT02301286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6803607|NCT02301286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6803608|NCT02301286|Analgesics|analgesics|mesh-ancestor
6803609|NCT02301286|Sensory System Agents|sensory system agents|mesh-ancestor
6803610|NCT02301286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6803611|NCT02301286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803612|NCT02301286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6803613|NCT02301286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6803614|NCT02301286|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6803615|NCT02301286|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6803616|NCT02301286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6803617|NCT02301286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6803618|NCT02301286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6803619|NCT02301286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6803620|NCT02301286|Antipyretics|antipyretics|mesh-ancestor
6803621|NCT02301481|Oxaliplatin|oxaliplatin|mesh-list
6803622|NCT02301481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6803623|NCT02301494|Fluocinonide|fluocinonide|mesh-list
6803624|NCT02301494|Imiquimod|imiquimod|mesh-list
6803625|NCT02301494|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6803626|NCT02301494|Immunologic Factors|immunologic factors|mesh-ancestor
6803627|NCT02301494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803628|NCT02301494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6803629|NCT02301494|Interferon Inducers|interferon inducers|mesh-ancestor
6803630|NCT02301494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6803631|NCT02301494|Glucocorticoids|glucocorticoids|mesh-ancestor
6803632|NCT02301494|Hormones|hormones|mesh-ancestor
6803633|NCT02301494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6803634|NCT02301494|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6803635|NCT02301650|Tenofovir|tenofovir|mesh-list
6803636|NCT02301650|Lamivudine|lamivudine|mesh-list
6803637|NCT02301650|Telbivudine|telbivudine|mesh-list
6803638|NCT02301650|Antiviral Agents|antiviral agents|mesh-ancestor
6803639|NCT02301650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6258579|NCT03091777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6258580|NCT03091777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6258581|NCT03091777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6258582|NCT03091777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6258583|NCT03091920|Praliciguat|praliciguat|mesh-list
6258584|NCT03091920|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
6258585|NCT03091920|Enzyme Activators|enzyme activators|mesh-ancestor
6258586|NCT03091920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258587|NCT03091920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6258588|NCT03092375|Ribavirin|ribavirin|mesh-list
6536376|NCT00816855|Fluorouracil|fluorouracil|mesh-list
6803640|NCT02301650|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6803641|NCT02301650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6803642|NCT02301650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6803643|NCT02301650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6803644|NCT02301650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6803645|NCT02301650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6803646|NCT02301676|Dexmedetomidine|dexmedetomidine|mesh-list
6803647|NCT02301676|Propofol|propofol|mesh-list
6803648|NCT02301676|Sevoflurane|sevoflurane|mesh-list
6803649|NCT02301676|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6803650|NCT02301676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6803651|NCT02301676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803652|NCT02301676|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6803653|NCT02301676|Anesthetics, General|anesthetics, general|mesh-ancestor
6803654|NCT02301676|Anesthetics|anesthetics|mesh-ancestor
6803655|NCT02301676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6803656|NCT02301676|Analgesics|analgesics|mesh-ancestor
6803657|NCT02301676|Sensory System Agents|sensory system agents|mesh-ancestor
6803658|NCT02301676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6803659|NCT02301676|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6803660|NCT02301676|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6803661|NCT02301676|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6803662|NCT02301676|Adrenergic Agents|adrenergic agents|mesh-ancestor
6803663|NCT02301676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6803664|NCT02301676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6803665|NCT02301676|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6803666|NCT02301676|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6803667|NCT02301715|Oxytocin|oxytocin|mesh-list
6803668|NCT02301715|Oxytocics|oxytocics|mesh-ancestor
6803669|NCT02301715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6803670|NCT02301715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803671|NCT02301780|Aspirin|aspirin|mesh-list
6803672|NCT02301780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6803673|NCT02301780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6803674|NCT02301780|Analgesics|analgesics|mesh-ancestor
5993380|NCT00121641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993381|NCT00121641|Incretins|incretins|mesh-ancestor
5993382|NCT00121641|Hormones|hormones|mesh-ancestor
5993383|NCT00121641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5993384|NCT00121641|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5993385|NCT00121641|Protease Inhibitors|protease inhibitors|mesh-ancestor
5993386|NCT00121641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5993387|NCT00121641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536377|NCT00816855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5993388|NCT00121667|Metformin|metformin|mesh-list
5993389|NCT00121667|Pioglitazone|pioglitazone|mesh-list
5993390|NCT00121667|Saxagliptin|saxagliptin|mesh-list
5993391|NCT00121667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5993392|NCT00121667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993393|NCT00121667|Incretins|incretins|mesh-ancestor
5993394|NCT00121667|Hormones|hormones|mesh-ancestor
6536378|NCT00816855|Tubulin Modulators|tubulin modulators|mesh-ancestor
6536379|NCT00816855|Antimitotic Agents|antimitotic agents|mesh-ancestor
6536380|NCT00816855|Mitosis Modulators|mitosis modulators|mesh-ancestor
6536381|NCT00816855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536382|NCT00816855|Antimetabolites|antimetabolites|mesh-ancestor
6536383|NCT00816855|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6536384|NCT00816855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6536385|NCT00816855|Immunologic Factors|immunologic factors|mesh-ancestor
6536386|NCT00816855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993395|NCT00121667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5993396|NCT00121667|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5993397|NCT00121667|Protease Inhibitors|protease inhibitors|mesh-ancestor
5993398|NCT00121667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6258589|NCT03092375|Antimetabolites|antimetabolites|mesh-ancestor
6258590|NCT03092375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258591|NCT03092375|Antiviral Agents|antiviral agents|mesh-ancestor
6258592|NCT03092375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6803675|NCT02301780|Sensory System Agents|sensory system agents|mesh-ancestor
6803676|NCT02301780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6803677|NCT02301780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803678|NCT02301780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6803679|NCT02301780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6803680|NCT02301780|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6803681|NCT02301780|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6803682|NCT02301780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6803683|NCT02301780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6803684|NCT02301780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6803685|NCT02301780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6803686|NCT02301780|Antipyretics|antipyretics|mesh-ancestor
6803687|NCT02301806|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6803688|NCT02301806|Glimepiride|glimepiride|mesh-list
6803689|NCT02301806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6803690|NCT02301806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803691|NCT02301806|Incretins|incretins|mesh-ancestor
6803692|NCT02301806|Hormones|hormones|mesh-ancestor
6803693|NCT02301806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6803694|NCT02301806|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6803695|NCT02301806|Protease Inhibitors|protease inhibitors|mesh-ancestor
6803696|NCT02301806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6803697|NCT02301806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6803698|NCT02301806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6803699|NCT02301806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6803700|NCT02301806|Immunologic Factors|immunologic factors|mesh-ancestor
6803701|NCT02301910|Tenecteplase|tenecteplase|mesh-list
6803702|NCT02301910|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6803703|NCT02301910|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6803704|NCT02301910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6803705|NCT02301949|Thalidomide|thalidomide|mesh-list
6803706|NCT02301949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6803707|NCT02301949|Immunologic Factors|immunologic factors|mesh-ancestor
6803708|NCT02301949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803709|NCT02301949|Leprostatic Agents|leprostatic agents|mesh-ancestor
6803710|NCT02301949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6803711|NCT02301949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6803712|NCT02301949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6803713|NCT02301949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6803714|NCT02301949|Growth Substances|growth substances|mesh-ancestor
6803715|NCT02301949|Growth Inhibitors|growth inhibitors|mesh-ancestor
6803716|NCT02301949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6803717|NCT02301962|Panitumumab|panitumumab|mesh-list
6803718|NCT02301962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6803719|NCT02301962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6803720|NCT02302170|Vaccines|vaccines|mesh-list
6803721|NCT02302170|Immunologic Factors|immunologic factors|mesh-ancestor
6803722|NCT02302170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803723|NCT02302209|Oxytocin|oxytocin|mesh-list
6803724|NCT02302209|Oxytocics|oxytocics|mesh-ancestor
6803725|NCT02302209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6803726|NCT02302209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803727|NCT02302274|Flecainide|flecainide|mesh-list
6803728|NCT02302274|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6803729|NCT02302274|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6803730|NCT02302274|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6803731|NCT02302274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6803732|NCT02302274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6803733|NCT02302326|Folic Acid|folic acid|mesh-list
6803734|NCT02302326|Inositol|inositol|mesh-list
6803735|NCT02302326|Metformin|metformin|mesh-list
6803736|NCT02302326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6803737|NCT02302326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803738|NCT02302326|Hematinics|hematinics|mesh-ancestor
6803739|NCT02302326|Vitamin B Complex|vitamin b complex|mesh-ancestor
6803740|NCT02302326|Vitamins|vitamins|mesh-ancestor
6803741|NCT02302326|Micronutrients|micronutrients|mesh-ancestor
6803742|NCT02302378|Bupivacaine|bupivacaine|mesh-list
6803743|NCT02302378|Anesthetics, Local|anesthetics, local|mesh-ancestor
6803744|NCT02302378|Anesthetics|anesthetics|mesh-ancestor
6803745|NCT02302378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6803746|NCT02302378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803747|NCT02302378|Sensory System Agents|sensory system agents|mesh-ancestor
6803748|NCT02302378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6803749|NCT02302404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6803750|NCT02302430|Oxytocin|oxytocin|mesh-list
6803751|NCT02302430|Oxytocics|oxytocics|mesh-ancestor
6803752|NCT02302430|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6803753|NCT02302430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803754|NCT02302456|Tranexamic Acid|tranexamic acid|mesh-list
6803755|NCT02302456|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6803756|NCT02302456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6803757|NCT02302456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6803758|NCT02302456|Hemostatics|hemostatics|mesh-ancestor
6803759|NCT02302456|Coagulants|coagulants|mesh-ancestor
6803760|NCT02302469|Lenalidomide|lenalidomide|mesh-list
6803761|NCT02302469|Immunologic Factors|immunologic factors|mesh-ancestor
6803762|NCT02302469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803763|NCT02302469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6803764|NCT02302469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6803765|NCT02302469|Growth Substances|growth substances|mesh-ancestor
6803766|NCT02302469|Growth Inhibitors|growth inhibitors|mesh-ancestor
6803767|NCT02302469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6803768|NCT02302495|Prednisone|prednisone|mesh-list
6803769|NCT02302495|Melphalan|melphalan|mesh-list
6803770|NCT02302495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6803771|NCT02302495|Glucocorticoids|glucocorticoids|mesh-ancestor
6803772|NCT02302495|Hormones|hormones|mesh-ancestor
6803773|NCT02302495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6803774|NCT02302495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803775|NCT02302495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6803776|NCT02302495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6803777|NCT02302495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6803778|NCT02302495|Alkylating Agents|alkylating agents|mesh-ancestor
6803779|NCT02302495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6803780|NCT02302495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6803781|NCT02302495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6803782|NCT02302495|Immunologic Factors|immunologic factors|mesh-ancestor
6803783|NCT02302508|Clopidogrel|clopidogrel|mesh-list
6803784|NCT02302508|Ticagrelor|ticagrelor|mesh-list
6803785|NCT02302508|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6803786|NCT02302508|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6803787|NCT02302508|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6803788|NCT02302508|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6803789|NCT02302508|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6803790|NCT02302508|Purinergic Agents|purinergic agents|mesh-ancestor
6803791|NCT02302508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6803792|NCT02302508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6803793|NCT02302508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258593|NCT03092752|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6258594|NCT03092752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389834|NCT00189410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389835|NCT00189501|Cinacalcet|cinacalcet|mesh-list
6389836|NCT00189501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6389837|NCT00189501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389838|NCT00189501|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6389839|NCT00189501|Hormone Antagonists|hormone antagonists|mesh-ancestor
6803794|NCT02302547|Ritonavir|ritonavir|mesh-list
6803795|NCT02302547|Lopinavir|lopinavir|mesh-list
6803796|NCT02302547|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6803797|NCT02302547|Darunavir|darunavir|mesh-list
6803798|NCT02302547|Indinavir|indinavir|mesh-list
6803799|NCT02302547|Saquinavir|saquinavir|mesh-list
6803800|NCT02302547|Fosamprenavir|fosamprenavir|mesh-list
6803801|NCT02302547|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
6803802|NCT02302547|Tenofovir|tenofovir|mesh-list
6803803|NCT02302547|Emtricitabine|emtricitabine|mesh-list
6803804|NCT02302547|Raltegravir Potassium|raltegravir potassium|mesh-list
6803805|NCT02302547|Nevirapine|nevirapine|mesh-list
6803806|NCT02302547|Maraviroc|maraviroc|mesh-list
6803807|NCT02302547|Dolutegravir|dolutegravir|mesh-list
6803808|NCT02302547|Cobicistat|cobicistat|mesh-list
6803809|NCT02302547|Rilpivirine|rilpivirine|mesh-list
6803810|NCT02302547|Tipranavir|tipranavir|mesh-list
6803811|NCT02302547|Enfuvirtide|enfuvirtide|mesh-list
6803812|NCT02302547|Elvitegravir|elvitegravir|mesh-list
6803813|NCT02302547|Efavirenz|efavirenz|mesh-list
6803814|NCT02302547|Etravirine|etravirine|mesh-list
6803815|NCT02302547|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
6803816|NCT02302547|Protease Inhibitors|protease inhibitors|mesh-list
6803817|NCT02302547|Integrase Inhibitors|integrase inhibitors|mesh-list
6803818|NCT02302547|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6803819|NCT02302547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6803820|NCT02302547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6803821|NCT02302547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6803822|NCT02302547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6803823|NCT02302547|Antiviral Agents|antiviral agents|mesh-ancestor
6803824|NCT02302547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6803825|NCT02302547|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6803826|NCT02302547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6803827|NCT02302547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6803828|NCT02302547|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6803829|NCT02302547|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6803830|NCT02302547|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6803831|NCT02302547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6803832|NCT02302547|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6803833|NCT02302547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6803834|NCT02302547|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6803835|NCT02302547|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6803836|NCT02302547|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6803837|NCT02302586|Morphine|morphine|mesh-list
6803838|NCT02302586|Bupivacaine|bupivacaine|mesh-list
6803839|NCT02302586|Anesthetics, Local|anesthetics, local|mesh-ancestor
6803840|NCT02302586|Anesthetics|anesthetics|mesh-ancestor
6803841|NCT02302586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6803842|NCT02302586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803843|NCT02302586|Sensory System Agents|sensory system agents|mesh-ancestor
6803844|NCT02302586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6803845|NCT02302586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6803846|NCT02302586|Narcotics|narcotics|mesh-ancestor
6803847|NCT02302586|Analgesics|analgesics|mesh-ancestor
6803848|NCT02302729|Micronutrients|micronutrients|mesh-list
6803849|NCT02302729|Trace Elements|trace elements|mesh-list
6803850|NCT02302729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803851|NCT02302768|Selenium|selenium|mesh-list
6803852|NCT02302768|Antioxidants|antioxidants|mesh-ancestor
6803853|NCT02302768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6803854|NCT02302768|Protective Agents|protective agents|mesh-ancestor
6803855|NCT02302768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803856|NCT02302768|Trace Elements|trace elements|mesh-ancestor
6803857|NCT02302768|Micronutrients|micronutrients|mesh-ancestor
6803858|NCT02302950|Raltegravir Potassium|raltegravir potassium|mesh-list
6803859|NCT02302950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6803860|NCT02302950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6803861|NCT02302950|Antiviral Agents|antiviral agents|mesh-ancestor
6803862|NCT02302950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6803863|NCT02302950|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6803864|NCT02302950|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6803865|NCT02302950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6803866|NCT02302950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6803867|NCT02302976|Exenatide|exenatide|mesh-list
6803868|NCT02302976|Cocaine|cocaine|mesh-list
6803869|NCT02302976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6803870|NCT02302976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803871|NCT02302976|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6803872|NCT02302976|Incretins|incretins|mesh-ancestor
6803873|NCT02302976|Hormones|hormones|mesh-ancestor
6803874|NCT02302976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6803875|NCT02302976|Anesthetics, Local|anesthetics, local|mesh-ancestor
6803876|NCT02302976|Anesthetics|anesthetics|mesh-ancestor
6803877|NCT02302976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6803878|NCT02302976|Sensory System Agents|sensory system agents|mesh-ancestor
6803879|NCT02302976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6803880|NCT02302976|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6803881|NCT02302976|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6803882|NCT02302976|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6803883|NCT02302976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6803884|NCT02302976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6803885|NCT02302976|Dopamine Agents|dopamine agents|mesh-ancestor
6803886|NCT02302976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6803887|NCT02302989|Ranibizumab|ranibizumab|mesh-list
6803888|NCT02302989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6803889|NCT02302989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6803890|NCT02302989|Growth Substances|growth substances|mesh-ancestor
6803891|NCT02302989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803892|NCT02302989|Growth Inhibitors|growth inhibitors|mesh-ancestor
6803893|NCT02302989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6803894|NCT02303002|Botulinum Toxins|botulinum toxins|mesh-list
6803895|NCT02303002|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6803896|NCT02303002|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6803897|NCT02303002|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6803898|NCT02303002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6803899|NCT02303002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6803900|NCT02303002|Cholinergic Agents|cholinergic agents|mesh-ancestor
6803901|NCT02303002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6803902|NCT02303002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803903|NCT02303002|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6803904|NCT02303002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6803905|NCT02303028|Topotecan|topotecan|mesh-list
6803906|NCT02303028|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6803907|NCT02303028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6803908|NCT02303028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6803909|NCT02303028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6803910|NCT02303028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6803911|NCT02303106|Lamotrigine|lamotrigine|mesh-list
6803912|NCT02303106|Anticonvulsants|anticonvulsants|mesh-ancestor
6803913|NCT02303106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6803914|NCT02303106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6803915|NCT02303106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6803916|NCT02303106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6803917|NCT02303106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803918|NCT02303106|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6803919|NCT02303106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6803920|NCT02303106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6803921|NCT02303106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6803922|NCT02303106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6803923|NCT02303119|Rituximab|rituximab|mesh-list
6803924|NCT02303119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6803925|NCT02303119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6803926|NCT02303119|Immunologic Factors|immunologic factors|mesh-ancestor
6803927|NCT02303119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803928|NCT02303119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6803929|NCT02303171|Enoxaparin|enoxaparin|mesh-list
6803930|NCT02303171|Warfarin|warfarin|mesh-list
6803931|NCT02303171|Anticoagulants|anticoagulants|mesh-ancestor
6803932|NCT02303171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6803933|NCT02303171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6803934|NCT02303171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6803935|NCT02303223|Propofol|propofol|mesh-list
6803936|NCT02303223|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6803937|NCT02303223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6803938|NCT02303223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803939|NCT02303223|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6803940|NCT02303223|Anesthetics, General|anesthetics, general|mesh-ancestor
6803941|NCT02303223|Anesthetics|anesthetics|mesh-ancestor
6803942|NCT02303327|Androgens|androgens|mesh-list
6803943|NCT02303327|Hormones|hormones|mesh-ancestor
6803944|NCT02303327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6803945|NCT02303327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803946|NCT02303366|Pembrolizumab|pembrolizumab|mesh-list
6803947|NCT02303366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6803948|NCT02303366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6803949|NCT02303405|Pioglitazone|pioglitazone|mesh-list
6803950|NCT02303405|Hydroxychloroquine|hydroxychloroquine|mesh-list
6803951|NCT02303405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6803952|NCT02303405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803953|NCT02303405|Antimalarials|antimalarials|mesh-ancestor
6803954|NCT02303405|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6803955|NCT02303405|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6803956|NCT02303405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6803957|NCT02303405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6803958|NCT02303405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6803959|NCT02303405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6803960|NCT02303418|Oxytocin|oxytocin|mesh-list
6803961|NCT02303418|Carbetocin|carbetocin|mesh-list
6803962|NCT02303418|Oxytocics|oxytocics|mesh-ancestor
6803963|NCT02303418|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6803964|NCT02303418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803965|NCT02303444|Sorafenib|sorafenib|mesh-list
6803966|NCT02303444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6803967|NCT02303444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6803968|NCT02303444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6803969|NCT02303444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6803970|NCT02303483|Niacinamide|niacinamide|mesh-list
6803971|NCT02303483|Niacin|niacin|mesh-list
6803972|NCT02303483|Nicotinic Acids|nicotinic acids|mesh-list
6803973|NCT02303483|Vitamin B Complex|vitamin b complex|mesh-ancestor
6803974|NCT02303483|Vitamins|vitamins|mesh-ancestor
6803975|NCT02303483|Micronutrients|micronutrients|mesh-ancestor
6803976|NCT02303483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803977|NCT02303483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6803978|NCT02303483|Antimetabolites|antimetabolites|mesh-ancestor
6803979|NCT02303483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6803980|NCT02303483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6803981|NCT02303483|Vasodilator Agents|vasodilator agents|mesh-ancestor
6803982|NCT02303587|Methylprednisolone|methylprednisolone|mesh-list
6803983|NCT02303587|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6803984|NCT02303587|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6803985|NCT02303587|Prednisolone|prednisolone|mesh-list
6803986|NCT02303587|Prednisolone acetate|prednisolone acetate|mesh-list
6803987|NCT02303587|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6803988|NCT02303587|Prednisolone phosphate|prednisolone phosphate|mesh-list
6803989|NCT02303587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6803990|NCT02303587|Antiemetics|antiemetics|mesh-ancestor
6803991|NCT02303587|Autonomic Agents|autonomic agents|mesh-ancestor
6803992|NCT02303587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6803993|NCT02303587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6803994|NCT02303587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6803995|NCT02303587|Glucocorticoids|glucocorticoids|mesh-ancestor
6803996|NCT02303587|Hormones|hormones|mesh-ancestor
6803997|NCT02303587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6803998|NCT02303587|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6803999|NCT02303587|Protective Agents|protective agents|mesh-ancestor
6804000|NCT02303587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6804001|NCT02303587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6804002|NCT02303600|Montelukast|montelukast|mesh-list
6804003|NCT02303600|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6804004|NCT02303600|Respiratory System Agents|respiratory system agents|mesh-ancestor
6804005|NCT02303600|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6804006|NCT02303600|Hormone Antagonists|hormone antagonists|mesh-ancestor
6804007|NCT02303600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6804008|NCT02303600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804009|NCT02303600|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6804010|NCT02303600|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6804011|NCT02303600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804012|NCT02303639|Amiodarone|amiodarone|mesh-list
6804013|NCT02303639|Sotalol|sotalol|mesh-list
6804014|NCT02303639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
6804015|NCT02303639|Vasodilator Agents|vasodilator agents|mesh-ancestor
6804016|NCT02303639|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6804017|NCT02303639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6804018|NCT02303639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804019|NCT02303639|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6804020|NCT02303639|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6804021|NCT02303639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6804022|NCT02303639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6804023|NCT02303639|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6804024|NCT02303639|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6804025|NCT02303639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6804026|NCT02303639|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6804027|NCT02303639|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6804028|NCT02303639|Adrenergic Agents|adrenergic agents|mesh-ancestor
6804029|NCT02303639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6804030|NCT02303639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804031|NCT02303639|Sympatholytics|sympatholytics|mesh-ancestor
6804032|NCT02303639|Autonomic Agents|autonomic agents|mesh-ancestor
6804033|NCT02303639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6804034|NCT02303730|Insulin Glargine|insulin glargine|mesh-list
6804035|NCT02303730|Exenatide|exenatide|mesh-list
6804036|NCT02303730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6804037|NCT02303730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804038|NCT02303730|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6804039|NCT02303730|Incretins|incretins|mesh-ancestor
6804040|NCT02303730|Hormones|hormones|mesh-ancestor
6804041|NCT02303730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6804042|NCT02303769|Tamsulosin|tamsulosin|mesh-list
6804043|NCT02303769|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6804044|NCT02303769|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6804045|NCT02303769|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6804046|NCT02303769|Adrenergic Agents|adrenergic agents|mesh-ancestor
6804047|NCT02303769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6804048|NCT02303769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804049|NCT02303769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804050|NCT02303769|Urological Agents|urological agents|mesh-ancestor
6804051|NCT02303782|Azacitidine|azacitidine|mesh-list
6804052|NCT02303782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6804053|NCT02303782|Antimetabolites|antimetabolites|mesh-ancestor
6804054|NCT02303782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804055|NCT02303782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6804056|NCT02303782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6804057|NCT02303795|Warfarin|warfarin|mesh-list
6804058|NCT02303795|Rivaroxaban|rivaroxaban|mesh-list
6804059|NCT02303795|Anticoagulants|anticoagulants|mesh-ancestor
6804060|NCT02303795|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6804061|NCT02303795|Antithrombins|antithrombins|mesh-ancestor
6804062|NCT02303795|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6804063|NCT02303795|Protease Inhibitors|protease inhibitors|mesh-ancestor
6804064|NCT02303795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6804065|NCT02303795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804066|NCT02303847|Ketamine|ketamine|mesh-list
6804067|NCT02303847|Analgesics|analgesics|mesh-ancestor
6804068|NCT02303847|Sensory System Agents|sensory system agents|mesh-ancestor
6804069|NCT02303847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6804070|NCT02303847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804071|NCT02303847|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6804072|NCT02303847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6804073|NCT02303847|Anesthetics, General|anesthetics, general|mesh-ancestor
6804074|NCT02303847|Anesthetics|anesthetics|mesh-ancestor
6804075|NCT02303847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6804076|NCT02303847|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6804077|NCT02303847|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6804078|NCT02303847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6804079|NCT02303847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804080|NCT02303873|Alendronate|alendronate|mesh-list
6804081|NCT02303873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6804082|NCT02303873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804083|NCT02303886|Methylene Blue|methylene blue|mesh-list
6804084|NCT02303886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6804085|NCT02303886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804086|NCT02303899|Gemcitabine|gemcitabine|mesh-list
6804087|NCT02303899|Imatinib Mesylate|imatinib mesylate|mesh-list
6804088|NCT02303899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6804089|NCT02303899|Antimetabolites|antimetabolites|mesh-ancestor
6804090|NCT02303899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804091|NCT02303899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6804092|NCT02303899|Antiviral Agents|antiviral agents|mesh-ancestor
6804093|NCT02303899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6804094|NCT02303899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6804095|NCT02303899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6804096|NCT02303899|Immunologic Factors|immunologic factors|mesh-ancestor
6804097|NCT02303899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804098|NCT02303899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6804099|NCT02303912|Carboplatin|carboplatin|mesh-list
6804100|NCT02303912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6804101|NCT02303951|Atezolizumab|atezolizumab|mesh-list
6804102|NCT02303951|Vemurafenib|vemurafenib|mesh-list
6804103|NCT02303951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6804104|NCT02303951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6804105|NCT02303951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6804106|NCT02303951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804107|NCT02304042|Oxytocin|oxytocin|mesh-list
6804108|NCT02304042|Carbetocin|carbetocin|mesh-list
6804109|NCT02304042|Oxytocics|oxytocics|mesh-ancestor
6804110|NCT02304042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6804111|NCT02304042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804112|NCT02304055|Oxytocin|oxytocin|mesh-list
6804113|NCT02304055|Carbetocin|carbetocin|mesh-list
6804114|NCT02304055|Oxytocics|oxytocics|mesh-ancestor
6804115|NCT02304055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6804116|NCT02304055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804117|NCT02304081|Saxagliptin|saxagliptin|mesh-list
6804118|NCT02304081|Incretins|incretins|mesh-ancestor
6804119|NCT02304081|Hormones|hormones|mesh-ancestor
6804120|NCT02304081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6804121|NCT02304081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804122|NCT02304081|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6804123|NCT02304081|Protease Inhibitors|protease inhibitors|mesh-ancestor
6804124|NCT02304081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6804125|NCT02304081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804126|NCT02304081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6804127|NCT02304094|Methylprednisolone|methylprednisolone|mesh-list
6804128|NCT02304094|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6804129|NCT02304094|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6804130|NCT02304094|Prednisolone|prednisolone|mesh-list
6804131|NCT02304094|Prednisolone acetate|prednisolone acetate|mesh-list
6804132|NCT02304094|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6804133|NCT02304094|Prednisolone phosphate|prednisolone phosphate|mesh-list
6804134|NCT02304094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6804135|NCT02304094|Antiemetics|antiemetics|mesh-ancestor
6804136|NCT02304094|Autonomic Agents|autonomic agents|mesh-ancestor
6804137|NCT02304094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6804138|NCT02304094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804139|NCT02304094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6804140|NCT02304094|Glucocorticoids|glucocorticoids|mesh-ancestor
6804141|NCT02304094|Hormones|hormones|mesh-ancestor
6804142|NCT02304094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6804143|NCT02304094|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6804144|NCT02304094|Protective Agents|protective agents|mesh-ancestor
6804145|NCT02304094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6804146|NCT02304094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6804147|NCT02304107|Letrozole|letrozole|mesh-list
6804148|NCT02304107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6804149|NCT02304107|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6804150|NCT02304107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6804151|NCT02304107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6804152|NCT02304107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804153|NCT02304107|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6804154|NCT02304107|Hormone Antagonists|hormone antagonists|mesh-ancestor
6804155|NCT02304107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6804156|NCT02304107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804157|NCT02304198|Udenafil|udenafil|mesh-list
6804158|NCT02304198|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6804159|NCT02304198|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6804160|NCT02304198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6804161|NCT02304198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804162|NCT02304211|Insulin|insulin|mesh-list
6804163|NCT02304211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6804164|NCT02304211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804165|NCT02304237|Progesterone|progesterone|mesh-list
6804166|NCT02304237|Progestins|progestins|mesh-ancestor
6804167|NCT02304237|Hormones|hormones|mesh-ancestor
6804168|NCT02304237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6804169|NCT02304237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804170|NCT02304250|Dexamethasone|dexamethasone|mesh-list
6804171|NCT02304250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6804172|NCT02304250|Antiemetics|antiemetics|mesh-ancestor
6804173|NCT02304250|Autonomic Agents|autonomic agents|mesh-ancestor
6804174|NCT02304250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6804175|NCT02304250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804176|NCT02304250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6804177|NCT02304250|Glucocorticoids|glucocorticoids|mesh-ancestor
6804178|NCT02304250|Hormones|hormones|mesh-ancestor
6804179|NCT02304250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6804180|NCT02304250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6804181|NCT02304250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6804182|NCT02304276|Calcium|calcium|mesh-list
6804183|NCT02304276|Fluorides|fluorides|mesh-list
6804184|NCT02304276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6804185|NCT02304276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804186|NCT02304276|Cariostatic Agents|cariostatic agents|mesh-ancestor
6804187|NCT02304276|Protective Agents|protective agents|mesh-ancestor
6804188|NCT02304289|Artesunate|artesunate|mesh-list
6804189|NCT02304289|Antimalarials|antimalarials|mesh-ancestor
6804190|NCT02304289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6804191|NCT02304289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6804192|NCT02304289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6804193|NCT02304289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6804194|NCT02304289|Antiviral Agents|antiviral agents|mesh-ancestor
6804195|NCT02304289|Schistosomicides|schistosomicides|mesh-ancestor
6804196|NCT02304289|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6804197|NCT02304289|Anthelmintics|anthelmintics|mesh-ancestor
6804198|NCT02304302|Memantine|memantine|mesh-list
6804199|NCT02304302|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6804200|NCT02304302|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6804201|NCT02304302|Dopamine Agents|dopamine agents|mesh-ancestor
6804202|NCT02304302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6804203|NCT02304302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804204|NCT02304302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804205|NCT02304302|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6804206|NCT02304302|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6804207|NCT02304354|Rituximab|rituximab|mesh-list
6804208|NCT02304354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6804209|NCT02304354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6804210|NCT02304354|Immunologic Factors|immunologic factors|mesh-ancestor
6804211|NCT02304354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804212|NCT02304354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6804213|NCT02304393|Atezolizumab|atezolizumab|mesh-list
6804214|NCT02304393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6804215|NCT02304445|Chlorotrianisene|chlorotrianisene|mesh-list
6804216|NCT02304445|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6804217|NCT02304445|Estrogens|estrogens|mesh-ancestor
6804218|NCT02304445|Hormones|hormones|mesh-ancestor
6804219|NCT02304445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6804220|NCT02304445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804221|NCT02304445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6804222|NCT02304445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6804223|NCT02304458|Nivolumab|nivolumab|mesh-list
6804224|NCT02304458|Ipilimumab|ipilimumab|mesh-list
6804225|NCT02304458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6804226|NCT02304458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6804227|NCT02304458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6804228|NCT02304458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804229|NCT02304627|Insulin|insulin|mesh-list
6804230|NCT02304627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6804231|NCT02304627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804232|NCT02304783|Acetaminophen|acetaminophen|mesh-list
6804233|NCT02304783|Piroxicam|piroxicam|mesh-list
6804234|NCT02304783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6804235|NCT02304783|Analgesics|analgesics|mesh-ancestor
6804236|NCT02304783|Sensory System Agents|sensory system agents|mesh-ancestor
6804237|NCT02304783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6804238|NCT02304783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804239|NCT02304783|Antipyretics|antipyretics|mesh-ancestor
6804240|NCT02304783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6804241|NCT02304783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6804242|NCT02304783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6804243|NCT02304783|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6804244|NCT02304783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6804245|NCT02304783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804246|NCT02304809|Vemurafenib|vemurafenib|mesh-list
6804247|NCT02304809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6804248|NCT02304809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6804249|NCT02304809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6804250|NCT02304809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804251|NCT02304822|Ciprofloxacin|ciprofloxacin|mesh-list
6804252|NCT02304822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6804253|NCT02304822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6804254|NCT02304822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6804255|NCT02304822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6804256|NCT02304822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6804257|NCT02304822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804258|NCT02304822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6804259|NCT02304822|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6804260|NCT02304822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6804261|NCT02304887|Denosumab|denosumab|mesh-list
6804262|NCT02304887|Teriparatide|teriparatide|mesh-list
6804263|NCT02304887|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6804264|NCT02304887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804265|NCT02304887|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6804266|NCT02305030|Opicapone|opicapone|mesh-list
6804267|NCT02305030|Warfarin|warfarin|mesh-list
6804268|NCT02305030|Anticoagulants|anticoagulants|mesh-ancestor
6804269|NCT02305030|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6804270|NCT02305030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6804271|NCT02305030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804272|NCT02305030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6804273|NCT02305030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6804274|NCT02305069|Pioglitazone|pioglitazone|mesh-list
6804275|NCT02305069|Octreotide|octreotide|mesh-list
6804276|NCT02305069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6804277|NCT02305069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804278|NCT02305069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6804279|NCT02305069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6804280|NCT02305069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6804281|NCT02305160|Poractant alfa|poractant alfa|mesh-list
6804282|NCT02305160|Beractant|beractant|mesh-list
6804283|NCT02305160|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
6804284|NCT02305160|Respiratory System Agents|respiratory system agents|mesh-ancestor
6804285|NCT02305173|Dexamethasone|dexamethasone|mesh-list
6804286|NCT02305173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6804287|NCT02305173|Antiemetics|antiemetics|mesh-ancestor
6804288|NCT02305173|Autonomic Agents|autonomic agents|mesh-ancestor
6804289|NCT02305173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6804290|NCT02305173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804291|NCT02305173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6804292|NCT02305173|Glucocorticoids|glucocorticoids|mesh-ancestor
6804293|NCT02305173|Hormones|hormones|mesh-ancestor
6804294|NCT02305173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6804295|NCT02305173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6804296|NCT02305173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6804297|NCT02305186|Pembrolizumab|pembrolizumab|mesh-list
6804298|NCT02305186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6804299|NCT02305186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6804300|NCT02305199|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6804301|NCT02305264|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6804302|NCT02305264|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6804303|NCT02305264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804304|NCT02305355|Atorvastatin|atorvastatin|mesh-list
6804305|NCT02305355|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6804306|NCT02305355|Simvastatin|simvastatin|mesh-list
6804307|NCT02305355|Pravastatin|pravastatin|mesh-list
6804308|NCT02305355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6804309|NCT02305355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6804310|NCT02305355|Antimetabolites|antimetabolites|mesh-ancestor
6804311|NCT02305355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804312|NCT02305355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6804313|NCT02305355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6804314|NCT02305355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6804315|NCT02305394|Ketamine|ketamine|mesh-list
6804316|NCT02305394|Propofol|propofol|mesh-list
6804317|NCT02305394|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6804318|NCT02305394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6804319|NCT02305394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804320|NCT02305394|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6804321|NCT02305394|Anesthetics, General|anesthetics, general|mesh-ancestor
6804322|NCT02305394|Anesthetics|anesthetics|mesh-ancestor
6804323|NCT02305394|Analgesics|analgesics|mesh-ancestor
6804324|NCT02305394|Sensory System Agents|sensory system agents|mesh-ancestor
6804325|NCT02305394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6804326|NCT02305394|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6804327|NCT02305394|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6804328|NCT02305394|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6804329|NCT02305394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6804330|NCT02305394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804331|NCT02305485|Everolimus|everolimus|mesh-list
6804332|NCT02305485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6804333|NCT02305485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6804334|NCT02305485|Immunologic Factors|immunologic factors|mesh-ancestor
6804335|NCT02305485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804336|NCT02305550|Nitric Oxide|nitric oxide|mesh-list
6804337|NCT02305550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6804338|NCT02305550|Autonomic Agents|autonomic agents|mesh-ancestor
6804339|NCT02305550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6804340|NCT02305550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804341|NCT02305550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6804342|NCT02305550|Respiratory System Agents|respiratory system agents|mesh-ancestor
6804343|NCT02305550|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6804344|NCT02305550|Antioxidants|antioxidants|mesh-ancestor
6804345|NCT02305550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804346|NCT02305550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6804347|NCT02305550|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6804348|NCT02305550|Vasodilator Agents|vasodilator agents|mesh-ancestor
6804349|NCT02305550|Gasotransmitters|gasotransmitters|mesh-ancestor
6804350|NCT02305550|Protective Agents|protective agents|mesh-ancestor
6804351|NCT02305615|Bevacizumab|bevacizumab|mesh-list
6804352|NCT02305615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6804353|NCT02305615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6804354|NCT02305615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6804355|NCT02305615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6804356|NCT02305615|Growth Substances|growth substances|mesh-ancestor
6804357|NCT02305615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804358|NCT02305615|Growth Inhibitors|growth inhibitors|mesh-ancestor
6804359|NCT02305654|Paclitaxel|paclitaxel|mesh-list
6804360|NCT02305654|Ifosfamide|ifosfamide|mesh-list
6804361|NCT02305654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6804362|NCT02305654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6804363|NCT02305654|Tubulin Modulators|tubulin modulators|mesh-ancestor
6804364|NCT02305654|Antimitotic Agents|antimitotic agents|mesh-ancestor
6804365|NCT02305654|Mitosis Modulators|mitosis modulators|mesh-ancestor
6804366|NCT02305654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804367|NCT02305654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6804368|NCT02305654|Alkylating Agents|alkylating agents|mesh-ancestor
6804369|NCT02305693|Letrozole|letrozole|mesh-list
6804370|NCT02305693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6804371|NCT02305693|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6804372|NCT02305693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6804373|NCT02305693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6804374|NCT02305693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804375|NCT02305693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5993399|NCT00121667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5993400|NCT00121719|Lenvatinib|lenvatinib|mesh-list
6804376|NCT02305693|Hormone Antagonists|hormone antagonists|mesh-ancestor
6804377|NCT02305693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5993401|NCT00121719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5993402|NCT00121719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5993403|NCT00121719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6804378|NCT02305693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804379|NCT02305810|Everolimus|everolimus|mesh-list
6804380|NCT02305810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6804381|NCT02305810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6804382|NCT02305810|Immunologic Factors|immunologic factors|mesh-ancestor
6804383|NCT02305810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804384|NCT02305823|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6804385|NCT02305823|Aripiprazole|aripiprazole|mesh-list
6804386|NCT02305823|Ziprasidone|ziprasidone|mesh-list
6804387|NCT02305823|Antidepressive Agents|antidepressive agents|mesh-ancestor
6804388|NCT02305823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6804389|NCT02305823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6804390|NCT02305823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6804391|NCT02305823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6804392|NCT02305823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804393|NCT02305823|Dopamine Agonists|dopamine agonists|mesh-ancestor
6804394|NCT02305823|Dopamine Agents|dopamine agents|mesh-ancestor
6804395|NCT02305823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6804396|NCT02305823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804397|NCT02305823|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6804398|NCT02305823|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6804399|NCT02305823|Serotonin Agents|serotonin agents|mesh-ancestor
6804400|NCT02305823|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6804401|NCT02305823|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6804402|NCT02305823|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6804403|NCT02305823|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6804404|NCT02305836|Donepezil|donepezil|mesh-list
6804405|NCT02305836|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6804406|NCT02305836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6804407|NCT02305836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804408|NCT02305836|Cholinergic Agents|cholinergic agents|mesh-ancestor
6804409|NCT02305836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6804410|NCT02305836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804411|NCT02305836|Nootropic Agents|nootropic agents|mesh-ancestor
6804412|NCT02305862|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6804413|NCT02305862|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6804414|NCT02305862|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6804415|NCT02305862|Antimetabolites|antimetabolites|mesh-ancestor
6804416|NCT02305862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804417|NCT02305862|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6804418|NCT02305862|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6804419|NCT02305862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6804420|NCT02305901|Repaglinide|repaglinide|mesh-list
6804421|NCT02305901|Bupropion|bupropion|mesh-list
6804422|NCT02305901|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6804423|NCT02305901|Antidepressive Agents|antidepressive agents|mesh-ancestor
6804424|NCT02305901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6804425|NCT02305901|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6804426|NCT02305901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6804427|NCT02305901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6804428|NCT02305901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804429|NCT02305901|Dopamine Agents|dopamine agents|mesh-ancestor
6804430|NCT02305901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6804431|NCT02305901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804432|NCT02305901|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6804433|NCT02305901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6804434|NCT02305901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6804435|NCT02305901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6804436|NCT02305927|Vitamin D|vitamin d|mesh-list
6804437|NCT02305927|Cholecalciferol|cholecalciferol|mesh-list
6804438|NCT02305927|Vitamins|vitamins|mesh-ancestor
6804439|NCT02305927|Micronutrients|micronutrients|mesh-ancestor
6804440|NCT02305927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804441|NCT02305927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6804442|NCT02305927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6804443|NCT02305940|Doxycycline|doxycycline|mesh-list
6804444|NCT02305940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6804445|NCT02305940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6804446|NCT02305940|Antimalarials|antimalarials|mesh-ancestor
6804447|NCT02305940|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6804448|NCT02305940|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6804449|NCT02305979|Loratadine|loratadine|mesh-list
6804450|NCT02305979|Antipruritics|antipruritics|mesh-ancestor
6804451|NCT02305979|Dermatologic Agents|dermatologic agents|mesh-ancestor
6804452|NCT02305979|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6804453|NCT02305979|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6804454|NCT02305979|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6804455|NCT02305979|Histamine Antagonists|histamine antagonists|mesh-ancestor
6804456|NCT02305979|Histamine Agents|histamine agents|mesh-ancestor
6804457|NCT02305979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6804458|NCT02305979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804459|NCT02305979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804460|NCT02305992|Bupivacaine|bupivacaine|mesh-list
6804461|NCT02305992|Anesthetics, Local|anesthetics, local|mesh-list
6804462|NCT02305992|Anesthetics|anesthetics|mesh-list
6804463|NCT02305992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6804464|NCT02305992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804465|NCT02305992|Sensory System Agents|sensory system agents|mesh-ancestor
6804466|NCT02305992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6804467|NCT02306031|Diclofenac|diclofenac|mesh-list
6804468|NCT02306031|Lubricant Eye Drops|lubricant eye drops|mesh-list
6804469|NCT02306031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6804470|NCT02306031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6804471|NCT02306031|Analgesics|analgesics|mesh-ancestor
6804472|NCT02306031|Sensory System Agents|sensory system agents|mesh-ancestor
6804473|NCT02306031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6804474|NCT02306031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804475|NCT02306031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6804476|NCT02306031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6804477|NCT02306031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6804478|NCT02306031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6804479|NCT02306031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804480|NCT02306031|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6804481|NCT02306031|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6804482|NCT02306070|Metformin|metformin|mesh-list
6804483|NCT02306070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6804484|NCT02306070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804485|NCT02306187|Eldecalcitol|eldecalcitol|mesh-list
6804486|NCT02306187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6804487|NCT02306187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804488|NCT02306239|Terlipressin|terlipressin|mesh-list
6804489|NCT02306239|Norepinephrine|norepinephrine|mesh-list
6804490|NCT02306239|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6804491|NCT02306239|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6804492|NCT02306239|Adrenergic Agents|adrenergic agents|mesh-ancestor
6804493|NCT02306239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6804494|NCT02306239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804495|NCT02306239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804496|NCT02306239|Sympathomimetics|sympathomimetics|mesh-ancestor
6804497|NCT02306239|Autonomic Agents|autonomic agents|mesh-ancestor
6804498|NCT02306239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6804499|NCT02306239|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6804500|NCT02306239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6804501|NCT02306278|Gabapentin|gabapentin|mesh-list
6804502|NCT02306278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804503|NCT02306278|Analgesics|analgesics|mesh-ancestor
6804504|NCT02306278|Sensory System Agents|sensory system agents|mesh-ancestor
6804505|NCT02306278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6804506|NCT02306278|Anticonvulsants|anticonvulsants|mesh-ancestor
6804507|NCT02306278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6804508|NCT02306278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6804509|NCT02306278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6804510|NCT02306278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6804511|NCT02306278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6804512|NCT02306278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6804513|NCT02306278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6804514|NCT02306278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804515|NCT02306278|Antimanic Agents|antimanic agents|mesh-ancestor
6804516|NCT02306473|Mannitol|mannitol|mesh-list
6804517|NCT02306473|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6804518|NCT02306473|Diuretics|diuretics|mesh-ancestor
6804519|NCT02306473|Natriuretic Agents|natriuretic agents|mesh-ancestor
6804520|NCT02306473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804521|NCT02306564|Cabergoline|cabergoline|mesh-list
6804522|NCT02306564|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6804523|NCT02306564|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6804524|NCT02306564|Dopamine Agonists|dopamine agonists|mesh-ancestor
6804525|NCT02306564|Dopamine Agents|dopamine agents|mesh-ancestor
6804526|NCT02306564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6804527|NCT02306564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804528|NCT02306564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804529|NCT02306577|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6804530|NCT02306577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6804531|NCT02306577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6804532|NCT02306577|Antiviral Agents|antiviral agents|mesh-ancestor
6804533|NCT02306577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6804534|NCT02306629|Epratuzumab|epratuzumab|mesh-list
6804535|NCT02306629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6804536|NCT02306629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6804537|NCT02306733|Oxytocin|oxytocin|mesh-list
6804538|NCT02306733|Ergonovine|ergonovine|mesh-list
6804539|NCT02306733|Oxytocics|oxytocics|mesh-ancestor
6804540|NCT02306733|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6804541|NCT02306733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804542|NCT02306772|Mesalamine|mesalamine|mesh-list
6804543|NCT02306772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6804544|NCT02306772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6804545|NCT02306772|Analgesics|analgesics|mesh-ancestor
6804546|NCT02306772|Sensory System Agents|sensory system agents|mesh-ancestor
6804547|NCT02306772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6804548|NCT02306772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804549|NCT02306772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6804550|NCT02306772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6804551|NCT02306785|Mesalamine|mesalamine|mesh-list
6804552|NCT02306785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6804553|NCT02306785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6804554|NCT02306785|Analgesics|analgesics|mesh-ancestor
6804555|NCT02306785|Sensory System Agents|sensory system agents|mesh-ancestor
6804556|NCT02306785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6804557|NCT02306785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804558|NCT02306785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6804559|NCT02306785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6804560|NCT02306798|Mesalamine|mesalamine|mesh-list
6804561|NCT02306798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6804562|NCT02306798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6804563|NCT02306798|Analgesics|analgesics|mesh-ancestor
6804564|NCT02306798|Sensory System Agents|sensory system agents|mesh-ancestor
6804565|NCT02306798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6804566|NCT02306798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804567|NCT02306798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6804568|NCT02306798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6804569|NCT02306889|Fenofibrate|fenofibrate|mesh-list
6804570|NCT02306889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6804571|NCT02306889|Antimetabolites|antimetabolites|mesh-ancestor
6804572|NCT02306889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804573|NCT02306889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6804574|NCT02306902|Fenofibrate|fenofibrate|mesh-list
6804575|NCT02306902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6804576|NCT02306902|Antimetabolites|antimetabolites|mesh-ancestor
6804577|NCT02306902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804578|NCT02306902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6804579|NCT02306954|Aldesleukin|aldesleukin|mesh-list
6804580|NCT02306954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6804581|NCT02306954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6804582|NCT02306954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6804583|NCT02306954|Antiviral Agents|antiviral agents|mesh-ancestor
6804584|NCT02306954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6804585|NCT02307006|Vancomycin|vancomycin|mesh-list
6804586|NCT02307006|Cefazolin|cefazolin|mesh-list
6804587|NCT02307006|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
6804588|NCT02307006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6804589|NCT02307006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6804590|NCT02307045|Nicotine|nicotine|mesh-list
6804591|NCT02307045|Varenicline|varenicline|mesh-list
6804592|NCT02307045|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6804593|NCT02307045|Autonomic Agents|autonomic agents|mesh-ancestor
6804594|NCT02307045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6804595|NCT02307045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804596|NCT02307045|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6804597|NCT02307045|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6804598|NCT02307045|Cholinergic Agents|cholinergic agents|mesh-ancestor
6804599|NCT02307045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6804600|NCT02307045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804601|NCT02307149|Ipilimumab|ipilimumab|mesh-list
6804602|NCT02307149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6804603|NCT02307149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6804604|NCT02307149|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6804605|NCT02307149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804606|NCT02307201|Magnesium Sulfate|magnesium sulfate|mesh-list
6804607|NCT02307201|Analgesics|analgesics|mesh-ancestor
6804608|NCT02307201|Sensory System Agents|sensory system agents|mesh-ancestor
6804609|NCT02307201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6804610|NCT02307201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804611|NCT02307201|Anesthetics|anesthetics|mesh-ancestor
6804612|NCT02307201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6804613|NCT02307201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6804614|NCT02307201|Anticonvulsants|anticonvulsants|mesh-ancestor
6804615|NCT02307201|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6804616|NCT02307201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6804617|NCT02307201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804618|NCT02307201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6804619|NCT02307201|Tocolytic Agents|tocolytic agents|mesh-ancestor
6804620|NCT02307201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6804621|NCT02307227|Paclitaxel|paclitaxel|mesh-list
6804622|NCT02307227|Docetaxel|docetaxel|mesh-list
6804623|NCT02307227|Trastuzumab|trastuzumab|mesh-list
6804624|NCT02307227|Epirubicin|epirubicin|mesh-list
6804625|NCT02307227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6804626|NCT02307227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6804627|NCT02307227|Tubulin Modulators|tubulin modulators|mesh-ancestor
6804628|NCT02307227|Antimitotic Agents|antimitotic agents|mesh-ancestor
6804629|NCT02307227|Mitosis Modulators|mitosis modulators|mesh-ancestor
6804630|NCT02307227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804631|NCT02307227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6804632|NCT02307227|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6804633|NCT02307227|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6804634|NCT02307227|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6804635|NCT02307227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6804636|NCT02307305|Acetaminophen|acetaminophen|mesh-list
6804637|NCT02307305|Celecoxib|celecoxib|mesh-list
6804638|NCT02307305|Naproxen|naproxen|mesh-list
6804639|NCT02307305|Oxycodone|oxycodone|mesh-list
6804640|NCT02307305|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6804641|NCT02307305|Tramadol|tramadol|mesh-list
6804642|NCT02307305|Naloxone|naloxone|mesh-list
6804643|NCT02307305|Esomeprazole|esomeprazole|mesh-list
6804644|NCT02307305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6804645|NCT02307305|Analgesics|analgesics|mesh-ancestor
6804646|NCT02307305|Sensory System Agents|sensory system agents|mesh-ancestor
6804647|NCT02307305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6804648|NCT02307305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804649|NCT02307305|Antipyretics|antipyretics|mesh-ancestor
6804650|NCT02307305|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6804651|NCT02307305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6804652|NCT02307305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6804653|NCT02307305|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6804654|NCT02307305|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6804655|NCT02307305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6804656|NCT02307305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804657|NCT02307305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6804658|NCT02307305|Narcotics|narcotics|mesh-ancestor
6804659|NCT02307305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6804660|NCT02307305|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6804661|NCT02307305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6804662|NCT02307305|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6804663|NCT02307305|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6804664|NCT02307305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6804665|NCT02307305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6804666|NCT02307305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6804667|NCT02307305|Antidepressive Agents|antidepressive agents|mesh-ancestor
6804668|NCT02307305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6804669|NCT02307305|Dopamine Agents|dopamine agents|mesh-ancestor
6804670|NCT02307305|Gout Suppressants|gout suppressants|mesh-ancestor
6804671|NCT02307305|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6804672|NCT02307383|Lactitol|lactitol|mesh-list
6258595|NCT03093207|Aspirin|aspirin|mesh-list
6258596|NCT03093207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6258597|NCT03093207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6258598|NCT03093207|Analgesics|analgesics|mesh-ancestor
6258599|NCT03093207|Sensory System Agents|sensory system agents|mesh-ancestor
6258600|NCT03093207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6258601|NCT03093207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258602|NCT03093207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6258603|NCT03093207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6258604|NCT03093207|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6258605|NCT03093207|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6258606|NCT03093207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258607|NCT03093207|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6804673|NCT02307383|Cathartics|cathartics|mesh-ancestor
6804674|NCT02307383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6804675|NCT02307396|Haloperidol|haloperidol|mesh-list
6804676|NCT02307396|Pimozide|pimozide|mesh-list
6804677|NCT02307396|Olanzapine|olanzapine|mesh-list
6804678|NCT02307396|Risperidone|risperidone|mesh-list
6804679|NCT02307396|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6804680|NCT02307396|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6804681|NCT02307396|Ziprasidone|ziprasidone|mesh-list
6804682|NCT02307396|Amisulpride|amisulpride|mesh-list
6804683|NCT02307396|Perphenazine|perphenazine|mesh-list
6804684|NCT02307396|Sertindole|sertindole|mesh-list
6804685|NCT02307396|Fluphenazine|fluphenazine|mesh-list
6804686|NCT02307396|Fluphenazine depot|fluphenazine depot|mesh-list
6804687|NCT02307396|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
6804688|NCT02307396|Sulpiride|sulpiride|mesh-list
6804689|NCT02307396|Thioridazine|thioridazine|mesh-list
6804690|NCT02307396|Clopenthixol|clopenthixol|mesh-list
6804691|NCT02307396|Fluspirilene|fluspirilene|mesh-list
6804692|NCT02307396|Perazine|perazine|mesh-list
6804693|NCT02307396|Bromperidol|bromperidol|mesh-list
6804694|NCT02307396|Benperidol|benperidol|mesh-list
6804695|NCT02307396|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6804696|NCT02307396|Serotonin Agents|serotonin agents|mesh-ancestor
6804697|NCT02307396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6804698|NCT02307396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804699|NCT02307396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804700|NCT02307396|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6804701|NCT02307396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6804702|NCT02307396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6804703|NCT02307396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6804704|NCT02307396|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6804705|NCT02307396|Dopamine Agents|dopamine agents|mesh-ancestor
6804706|NCT02307396|Antiemetics|antiemetics|mesh-ancestor
6804707|NCT02307396|Autonomic Agents|autonomic agents|mesh-ancestor
6804708|NCT02307396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6804709|NCT02307396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6804710|NCT02307396|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6804711|NCT02307396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6804712|NCT02307396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6804713|NCT02307396|Antidepressive Agents|antidepressive agents|mesh-ancestor
6804714|NCT02307396|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6804715|NCT02307396|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6804716|NCT02307396|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6804717|NCT02307396|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6804718|NCT02307487|Mitomycins|mitomycins|mesh-list
6804719|NCT02307487|Mitomycin|mitomycin|mesh-list
6804720|NCT02307487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6804721|NCT02307487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6804722|NCT02307487|Alkylating Agents|alkylating agents|mesh-ancestor
6804723|NCT02307487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804724|NCT02307487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6804725|NCT02307487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6804726|NCT02307565|Midodrine|midodrine|mesh-list
6804727|NCT02307565|Sympathomimetics|sympathomimetics|mesh-ancestor
6804728|NCT02307565|Autonomic Agents|autonomic agents|mesh-ancestor
6804729|NCT02307565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6804730|NCT02307565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804731|NCT02307565|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6804732|NCT02307565|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6804733|NCT02307565|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6804734|NCT02307565|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6804735|NCT02307565|Adrenergic Agents|adrenergic agents|mesh-ancestor
6804736|NCT02307565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6804737|NCT02307565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804738|NCT02307591|Amiodarone|amiodarone|mesh-list
6804739|NCT02307591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6804740|NCT02307591|Vasodilator Agents|vasodilator agents|mesh-ancestor
6804741|NCT02307591|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6804742|NCT02307591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6804743|NCT02307591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804744|NCT02307591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6804745|NCT02307591|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6804746|NCT02307591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6804747|NCT02307591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6804748|NCT02307591|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6804749|NCT02307591|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6804750|NCT02307591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6804751|NCT02307695|Saxagliptin|saxagliptin|mesh-list
6804752|NCT02307695|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
6804753|NCT02307695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6804754|NCT02307695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804755|NCT02307695|Incretins|incretins|mesh-ancestor
6804756|NCT02307695|Hormones|hormones|mesh-ancestor
6804757|NCT02307695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6804758|NCT02307695|Protease Inhibitors|protease inhibitors|mesh-ancestor
6804759|NCT02307695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6804760|NCT02307695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804761|NCT02307721|Remifentanil|remifentanil|mesh-list
6804762|NCT02307721|Naloxone|naloxone|mesh-list
6804763|NCT02307721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6804764|NCT02307721|Narcotics|narcotics|mesh-ancestor
6804765|NCT02307721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6804766|NCT02307721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804767|NCT02307721|Analgesics|analgesics|mesh-ancestor
6804768|NCT02307721|Sensory System Agents|sensory system agents|mesh-ancestor
6804769|NCT02307721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6804770|NCT02307721|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6804771|NCT02307825|Azithromycin|azithromycin|mesh-list
6804772|NCT02307825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6804773|NCT02307825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6804774|NCT02307864|Moxifloxacin|moxifloxacin|mesh-list
6804775|NCT02307864|Tramadol|tramadol|mesh-list
6804776|NCT02307864|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6804777|NCT02307864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6804778|NCT02307864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6804779|NCT02307864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6804780|NCT02307864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6804781|NCT02307864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6804782|NCT02307864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804783|NCT02307864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6804784|NCT02307864|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6804785|NCT02307864|Contraceptive Agents|contraceptive agents|mesh-ancestor
6804786|NCT02307864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6804787|NCT02307864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804788|NCT02307864|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6804789|NCT02307864|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6804790|NCT02307864|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6804791|NCT02307864|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6804792|NCT02307864|Narcotics|narcotics|mesh-ancestor
6804793|NCT02307864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6804794|NCT02307864|Analgesics|analgesics|mesh-ancestor
6804795|NCT02307864|Sensory System Agents|sensory system agents|mesh-ancestor
6804796|NCT02307864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6804797|NCT02307955|Fluorophosphate|fluorophosphate|mesh-list
6804798|NCT02307955|Cariostatic Agents|cariostatic agents|mesh-ancestor
6804799|NCT02307955|Protective Agents|protective agents|mesh-ancestor
6804800|NCT02307955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804801|NCT02307968|Insulin|insulin|mesh-list
6804802|NCT02307968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6804803|NCT02307968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804804|NCT02308072|Olaparib|olaparib|mesh-list
6804805|NCT02308072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6804806|NCT02308072|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6804807|NCT02308072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6804808|NCT02308072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804809|NCT02308098|Budesonide|budesonide|mesh-list
6804810|NCT02308098|Formoterol Fumarate|formoterol fumarate|mesh-list
6804811|NCT02308098|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6804812|NCT02308098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6804813|NCT02308098|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6804814|NCT02308098|Autonomic Agents|autonomic agents|mesh-ancestor
6804815|NCT02308098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6804816|NCT02308098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804817|NCT02308098|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6804818|NCT02308098|Respiratory System Agents|respiratory system agents|mesh-ancestor
6804819|NCT02308098|Glucocorticoids|glucocorticoids|mesh-ancestor
6804820|NCT02308098|Hormones|hormones|mesh-ancestor
6804821|NCT02308098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6804822|NCT02308098|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6804823|NCT02308098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6804824|NCT02308098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6804825|NCT02308098|Adrenergic Agents|adrenergic agents|mesh-ancestor
6804826|NCT02308098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6804827|NCT02308098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804828|NCT02308137|Domperidone|domperidone|mesh-list
6804829|NCT02308137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804830|NCT02308137|Antiemetics|antiemetics|mesh-ancestor
6804831|NCT02308137|Autonomic Agents|autonomic agents|mesh-ancestor
6804832|NCT02308137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6804833|NCT02308137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804834|NCT02308137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6804835|NCT02308137|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6804836|NCT02308137|Dopamine Agents|dopamine agents|mesh-ancestor
6804837|NCT02308137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6804838|NCT02308202|Perindopril|perindopril|mesh-list
6804839|NCT02308202|Doxazosin|doxazosin|mesh-list
6804840|NCT02308202|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6804841|NCT02308202|Protease Inhibitors|protease inhibitors|mesh-ancestor
6804842|NCT02308202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6804843|NCT02308202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804844|NCT02308202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6804845|NCT02308202|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6804846|NCT02308202|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6804847|NCT02308202|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6804848|NCT02308202|Adrenergic Agents|adrenergic agents|mesh-ancestor
6804849|NCT02308202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6804850|NCT02308202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804851|NCT02308241|Ribavirin|ribavirin|mesh-list
6804852|NCT02308241|Antimetabolites|antimetabolites|mesh-ancestor
6804853|NCT02308241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804854|NCT02308241|Antiviral Agents|antiviral agents|mesh-ancestor
6804855|NCT02308241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6804856|NCT02308254|Lixisenatide|lixisenatide|mesh-list
6804857|NCT02308254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6804858|NCT02308254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804859|NCT02308280|Bortezomib|bortezomib|mesh-list
6804860|NCT02308280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6804861|NCT02308319|Tenofovir|tenofovir|mesh-list
6804862|NCT02308319|Antiviral Agents|antiviral agents|mesh-ancestor
6804863|NCT02308319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6804864|NCT02308319|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6804865|NCT02308319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6804866|NCT02308319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6804867|NCT02308319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804868|NCT02308319|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6804869|NCT02308319|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6804870|NCT02308332|Tenofovir|tenofovir|mesh-list
6804871|NCT02308332|Emtricitabine|emtricitabine|mesh-list
6804872|NCT02308332|Rilpivirine|rilpivirine|mesh-list
6804873|NCT02308332|Antiviral Agents|antiviral agents|mesh-ancestor
6804874|NCT02308332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6804875|NCT02308332|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6804876|NCT02308332|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6804877|NCT02308332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6804878|NCT02308332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804879|NCT02308332|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6804880|NCT02308332|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6804881|NCT02308553|Paclitaxel|paclitaxel|mesh-list
6804882|NCT02308553|Nintedanib|nintedanib|mesh-list
6804883|NCT02308553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6804884|NCT02308553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6804885|NCT02308553|Tubulin Modulators|tubulin modulators|mesh-ancestor
6804886|NCT02308553|Antimitotic Agents|antimitotic agents|mesh-ancestor
6804887|NCT02308553|Mitosis Modulators|mitosis modulators|mesh-ancestor
6804888|NCT02308553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804889|NCT02308553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6804890|NCT02308553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6804891|NCT02308644|Bevacizumab|bevacizumab|mesh-list
6804892|NCT02308644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6804893|NCT02308644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6804894|NCT02308644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6804895|NCT02308644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6804896|NCT02308644|Growth Substances|growth substances|mesh-ancestor
6804897|NCT02308644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804898|NCT02308644|Growth Inhibitors|growth inhibitors|mesh-ancestor
6804899|NCT02308891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6804900|NCT02308930|Vitamin D|vitamin d|mesh-list
6804901|NCT02308930|Vitamins|vitamins|mesh-list
6804902|NCT02308930|Vitamin A|vitamin a|mesh-list
6804903|NCT02308930|Retinol palmitate|retinol palmitate|mesh-list
6804904|NCT02308930|Micronutrients|micronutrients|mesh-ancestor
6804905|NCT02308930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804906|NCT02308930|Antioxidants|antioxidants|mesh-ancestor
6804907|NCT02308930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804908|NCT02308930|Protective Agents|protective agents|mesh-ancestor
6804909|NCT02308930|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6804910|NCT02308930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6804911|NCT02308930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6804912|NCT02308969|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
6804913|NCT02308969|Hallucinogens|hallucinogens|mesh-ancestor
6804914|NCT02308969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804915|NCT02308969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6804916|NCT02308969|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6804917|NCT02308969|Serotonin Agents|serotonin agents|mesh-ancestor
6804918|NCT02308969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6804919|NCT02308969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804920|NCT02308969|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6804921|NCT02308982|Immunoglobulins|immunoglobulins|mesh-list
6804922|NCT02308982|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6804923|NCT02308982|Antibodies|antibodies|mesh-list
6804924|NCT02308982|gamma-Globulins|gamma-globulins|mesh-list
6804925|NCT02308982|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6804926|NCT02308982|Immunologic Factors|immunologic factors|mesh-ancestor
6804927|NCT02308982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804928|NCT02309177|Gemcitabine|gemcitabine|mesh-list
6804929|NCT02309177|Paclitaxel|paclitaxel|mesh-list
6804930|NCT02309177|Carboplatin|carboplatin|mesh-list
6804931|NCT02309177|Nivolumab|nivolumab|mesh-list
6804932|NCT02309177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6804933|NCT02309177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6804934|NCT02309177|Tubulin Modulators|tubulin modulators|mesh-ancestor
6804935|NCT02309177|Antimitotic Agents|antimitotic agents|mesh-ancestor
6804936|NCT02309177|Mitosis Modulators|mitosis modulators|mesh-ancestor
6804937|NCT02309177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804938|NCT02309177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6804939|NCT02309177|Antimetabolites|antimetabolites|mesh-ancestor
6804940|NCT02309177|Antiviral Agents|antiviral agents|mesh-ancestor
6804941|NCT02309177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6804942|NCT02309177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6804943|NCT02309177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6804944|NCT02309177|Immunologic Factors|immunologic factors|mesh-ancestor
6804945|NCT02309177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804946|NCT02309177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6804947|NCT02309177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6804948|NCT02309281|Aflibercept|aflibercept|mesh-list
6804949|NCT02309281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6804950|NCT02309281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6804951|NCT02309281|Growth Substances|growth substances|mesh-ancestor
6804952|NCT02309281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804953|NCT02309281|Growth Inhibitors|growth inhibitors|mesh-ancestor
6804954|NCT02309281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6804955|NCT02309320|Gontivimab|gontivimab|mesh-list
6804956|NCT02309320|Antiviral Agents|antiviral agents|mesh-ancestor
6804957|NCT02309320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6804958|NCT02309346|Clindamycin|clindamycin|mesh-list
6804959|NCT02309346|Clindamycin palmitate|clindamycin palmitate|mesh-list
6804960|NCT02309346|Clindamycin phosphate|clindamycin phosphate|mesh-list
6804961|NCT02309346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6804962|NCT02309346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6804963|NCT02309346|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6804964|NCT02309346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6804965|NCT02309346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804966|NCT02309385|Dexamethasone|dexamethasone|mesh-list
6804967|NCT02309385|Dexamethasone acetate|dexamethasone acetate|mesh-list
6804968|NCT02309385|Prednisolone|prednisolone|mesh-list
6804969|NCT02309385|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6804970|NCT02309385|Methylprednisolone|methylprednisolone|mesh-list
6804971|NCT02309385|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6804972|NCT02309385|Prednisolone acetate|prednisolone acetate|mesh-list
6804973|NCT02309385|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6804974|NCT02309385|Prednisolone phosphate|prednisolone phosphate|mesh-list
6804975|NCT02309385|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
6804976|NCT02309385|BB 1101|bb 1101|mesh-list
6804977|NCT02309385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6804978|NCT02309385|Antiemetics|antiemetics|mesh-ancestor
6804979|NCT02309385|Autonomic Agents|autonomic agents|mesh-ancestor
6804980|NCT02309385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6804981|NCT02309385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6804982|NCT02309385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6804983|NCT02309385|Glucocorticoids|glucocorticoids|mesh-ancestor
6804984|NCT02309385|Hormones|hormones|mesh-ancestor
6804985|NCT02309385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6804986|NCT02309385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6804987|NCT02309385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6804988|NCT02309385|Protease Inhibitors|protease inhibitors|mesh-ancestor
6804989|NCT02309385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6804990|NCT02309385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6804991|NCT02309385|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6804992|NCT02309385|Protective Agents|protective agents|mesh-ancestor
6804993|NCT02309424|Acetic Acid|acetic acid|mesh-list
6804994|NCT02309424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6804995|NCT02309424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6804996|NCT02309437|Oxycodone|oxycodone|mesh-list
6804997|NCT02309437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6804998|NCT02309437|Narcotics|narcotics|mesh-ancestor
6804999|NCT02309437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6805000|NCT02309437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805001|NCT02309437|Analgesics|analgesics|mesh-ancestor
6805002|NCT02309437|Sensory System Agents|sensory system agents|mesh-ancestor
6805003|NCT02309437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6805004|NCT02309450|Asunaprevir|asunaprevir|mesh-list
6805005|NCT02309450|Protease Inhibitors|protease inhibitors|mesh-ancestor
6805006|NCT02309450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6805007|NCT02309450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805008|NCT02309463|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-list
6805009|NCT02309463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805010|NCT02309554|Nonoxynol|nonoxynol|mesh-list
6805011|NCT02309554|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
6805012|NCT02309554|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
6805013|NCT02309554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805014|NCT02309554|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6805015|NCT02309554|Contraceptive Agents|contraceptive agents|mesh-ancestor
6805016|NCT02309554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6805017|NCT02309554|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6805018|NCT02309645|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6805019|NCT02309645|Hemostatics|hemostatics|mesh-ancestor
6805020|NCT02309645|Coagulants|coagulants|mesh-ancestor
6805021|NCT02309658|Gemcitabine|gemcitabine|mesh-list
6805022|NCT02309658|Cisplatin|cisplatin|mesh-list
6805023|NCT02309658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6805024|NCT02309658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6805025|NCT02309658|Antimetabolites|antimetabolites|mesh-ancestor
6805026|NCT02309658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805027|NCT02309658|Antiviral Agents|antiviral agents|mesh-ancestor
6805028|NCT02309658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6805029|NCT02309658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6805030|NCT02309658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6805031|NCT02309658|Immunologic Factors|immunologic factors|mesh-ancestor
6805032|NCT02309658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805033|NCT02309801|Daidzin|daidzin|mesh-list
6805034|NCT02309801|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6805035|NCT02309801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6805036|NCT02309801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805037|NCT02309879|Lidocaine|lidocaine|mesh-list
6805038|NCT02309879|Magnesium Sulfate|magnesium sulfate|mesh-list
6805039|NCT02309879|Remifentanil|remifentanil|mesh-list
6805040|NCT02309879|Anesthetics, Local|anesthetics, local|mesh-ancestor
6805041|NCT02309879|Anesthetics|anesthetics|mesh-ancestor
6805042|NCT02309879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6805043|NCT02309879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805044|NCT02309879|Sensory System Agents|sensory system agents|mesh-ancestor
6805045|NCT02309879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6805046|NCT02309879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6805047|NCT02309879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6805048|NCT02309879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6805049|NCT02309879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6805050|NCT02309879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805051|NCT02309879|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6805052|NCT02309879|Narcotics|narcotics|mesh-ancestor
6805053|NCT02309879|Analgesics|analgesics|mesh-ancestor
6805054|NCT02309879|Anticonvulsants|anticonvulsants|mesh-ancestor
6805055|NCT02309879|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6805056|NCT02309879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6805057|NCT02309879|Tocolytic Agents|tocolytic agents|mesh-ancestor
6805058|NCT02309879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6805059|NCT02309931|Antidiarrheals|antidiarrheals|mesh-list
6805060|NCT02309931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6805061|NCT02309970|Aspirin|aspirin|mesh-list
6805062|NCT02309970|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6805063|NCT02309970|Warfarin|warfarin|mesh-list
6805064|NCT02309970|Rivaroxaban|rivaroxaban|mesh-list
6805065|NCT02309970|Dabigatran|dabigatran|mesh-list
6805066|NCT02309970|Apixaban|apixaban|mesh-list
6805067|NCT02309970|Clopidogrel|clopidogrel|mesh-list
6805068|NCT02309970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6805069|NCT02309970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6805070|NCT02309970|Analgesics|analgesics|mesh-ancestor
6805071|NCT02309970|Sensory System Agents|sensory system agents|mesh-ancestor
6805072|NCT02309970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6805073|NCT02309970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805074|NCT02309970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6805075|NCT02309970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6805076|NCT02309970|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6805077|NCT02309970|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6805078|NCT02309970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805079|NCT02309970|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6805080|NCT02309970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6805081|NCT02309970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6805082|NCT02309970|Antipyretics|antipyretics|mesh-ancestor
6805083|NCT02309970|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6805084|NCT02309970|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6805085|NCT02309970|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6805086|NCT02309970|Purinergic Agents|purinergic agents|mesh-ancestor
6805087|NCT02309970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6805088|NCT02309970|Anticoagulants|anticoagulants|mesh-ancestor
6805089|NCT02309970|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6805090|NCT02309970|Antithrombins|antithrombins|mesh-ancestor
6805091|NCT02309970|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6805092|NCT02309970|Protease Inhibitors|protease inhibitors|mesh-ancestor
6805093|NCT02310009|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6805094|NCT02310009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6805095|NCT02310074|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6805096|NCT02310074|Hormones|hormones|mesh-list
6805097|NCT02310074|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6805098|NCT02310074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6805099|NCT02310074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805100|NCT02310074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6805101|NCT02310087|Vitamin E|vitamin e|mesh-list
6805102|NCT02310087|Vitamins|vitamins|mesh-ancestor
6805103|NCT02310087|Micronutrients|micronutrients|mesh-ancestor
6805104|NCT02310087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805105|NCT02310087|Antioxidants|antioxidants|mesh-ancestor
6805106|NCT02310087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805107|NCT02310087|Protective Agents|protective agents|mesh-ancestor
6805108|NCT02310243|Palbociclib|palbociclib|mesh-list
6805109|NCT02310243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6805110|NCT02310243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6805111|NCT02310243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6805112|NCT02310243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805113|NCT02310269|Pasireotide|pasireotide|mesh-list
6805114|NCT02310269|Hormones|hormones|mesh-ancestor
6805115|NCT02310269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6805116|NCT02310269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805117|NCT02310295|Triamcinolone|triamcinolone|mesh-list
6805118|NCT02310295|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6805119|NCT02310295|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6805120|NCT02310295|Bevacizumab|bevacizumab|mesh-list
6805121|NCT02310295|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6805122|NCT02310295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6805123|NCT02310295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6805124|NCT02310295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6805125|NCT02310295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6805126|NCT02310295|Growth Substances|growth substances|mesh-ancestor
6805127|NCT02310295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805128|NCT02310295|Growth Inhibitors|growth inhibitors|mesh-ancestor
6805129|NCT02310295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6805130|NCT02310295|Glucocorticoids|glucocorticoids|mesh-ancestor
6805131|NCT02310295|Hormones|hormones|mesh-ancestor
6805132|NCT02310295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6805133|NCT02310295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6805134|NCT02310295|Immunologic Factors|immunologic factors|mesh-ancestor
6805135|NCT02310295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6805136|NCT02310295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805137|NCT02310347|Dronabinol|dronabinol|mesh-list
6805138|NCT02310347|Hallucinogens|hallucinogens|mesh-ancestor
6805139|NCT02310347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805140|NCT02310347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6805141|NCT02310347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6805142|NCT02310347|Analgesics|analgesics|mesh-ancestor
6805143|NCT02310347|Sensory System Agents|sensory system agents|mesh-ancestor
6805144|NCT02310347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6805145|NCT02310347|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6805146|NCT02310347|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6805147|NCT02310347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6805148|NCT02310347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805149|NCT02310347|Hormones|hormones|mesh-ancestor
6805150|NCT02310347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6805151|NCT02310360|Fallypride|fallypride|mesh-list
6805152|NCT02310360|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6805153|NCT02310360|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6805154|NCT02310360|Dopamine Agents|dopamine agents|mesh-ancestor
6805155|NCT02310360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6805156|NCT02310360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805157|NCT02310360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805158|NCT02310373|Nicotine|nicotine|mesh-list
6805159|NCT02310373|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6805160|NCT02310373|Autonomic Agents|autonomic agents|mesh-ancestor
6805161|NCT02310373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6805162|NCT02310373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805163|NCT02310373|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6805164|NCT02310373|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6805165|NCT02310373|Cholinergic Agents|cholinergic agents|mesh-ancestor
6805166|NCT02310373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6805167|NCT02310373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805168|NCT02310490|Mannitol|mannitol|mesh-list
6805169|NCT02310490|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6805170|NCT02310490|Diuretics|diuretics|mesh-ancestor
6805171|NCT02310490|Natriuretic Agents|natriuretic agents|mesh-ancestor
6805172|NCT02310490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805173|NCT02310997|Cyclophosphamide|cyclophosphamide|mesh-list
6805174|NCT02310997|Melphalan|melphalan|mesh-list
6805175|NCT02310997|Busulfan|busulfan|mesh-list
6805176|NCT02310997|Fludarabine|fludarabine|mesh-list
6805177|NCT02310997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6805178|NCT02310997|Immunologic Factors|immunologic factors|mesh-ancestor
6805179|NCT02310997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805180|NCT02310997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6805181|NCT02310997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6805182|NCT02310997|Alkylating Agents|alkylating agents|mesh-ancestor
6805183|NCT02310997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805184|NCT02310997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6805185|NCT02310997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6805186|NCT02311010|Tacrolimus|tacrolimus|mesh-list
6805187|NCT02311010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6805188|NCT02311010|Immunologic Factors|immunologic factors|mesh-ancestor
6805189|NCT02311010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805190|NCT02311010|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6805191|NCT02311010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6805192|NCT02311010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805193|NCT02311088|Caffeine|caffeine|mesh-list
6805194|NCT02311088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6805195|NCT02311088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805196|NCT02311088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6805197|NCT02311088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6805198|NCT02311088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805199|NCT02311088|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6805200|NCT02311088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6805201|NCT02311088|Purinergic Agents|purinergic agents|mesh-ancestor
6805202|NCT02311088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6805203|NCT02311101|Mitomycins|mitomycins|mesh-list
6805204|NCT02311101|Mitomycin|mitomycin|mesh-list
6805205|NCT02311101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6805206|NCT02311101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6805207|NCT02311101|Alkylating Agents|alkylating agents|mesh-ancestor
6805208|NCT02311101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805209|NCT02311101|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6805210|NCT02311101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6805211|NCT02311179|Cimetidine|cimetidine|mesh-list
6805212|NCT02311179|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6805213|NCT02311179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6805214|NCT02311179|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6805215|NCT02311179|Histamine Antagonists|histamine antagonists|mesh-ancestor
6805216|NCT02311179|Histamine Agents|histamine agents|mesh-ancestor
6805217|NCT02311179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6805218|NCT02311179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805219|NCT02311179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805220|NCT02311179|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6805221|NCT02311179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6805222|NCT02311179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6805223|NCT02311205|Sorafenib|sorafenib|mesh-list
6805224|NCT02311205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6805225|NCT02311205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6805226|NCT02311205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6805227|NCT02311205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805228|NCT02311231|Heparin|heparin|mesh-list
6805229|NCT02311231|Calcium heparin|calcium heparin|mesh-list
6805230|NCT02311231|Bivalirudin|bivalirudin|mesh-list
6805231|NCT02311231|Anticoagulants|anticoagulants|mesh-ancestor
6805232|NCT02311231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6805233|NCT02311231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6805234|NCT02311231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805235|NCT02311231|Antithrombins|antithrombins|mesh-ancestor
6805236|NCT02311231|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6805237|NCT02311231|Protease Inhibitors|protease inhibitors|mesh-ancestor
6805238|NCT02311231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6805239|NCT02311439|Folfirinox|folfirinox|mesh-list
6805240|NCT02311439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6805241|NCT02311517|Ropivacaine|ropivacaine|mesh-list
6805242|NCT02311517|Anesthetics, Local|anesthetics, local|mesh-ancestor
6805243|NCT02311517|Anesthetics|anesthetics|mesh-ancestor
6805244|NCT02311517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6805245|NCT02311517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805246|NCT02311517|Sensory System Agents|sensory system agents|mesh-ancestor
6805247|NCT02311517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6805248|NCT02311530|Felodipine|felodipine|mesh-list
6805249|NCT02311530|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6805250|NCT02311530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6805251|NCT02311530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6805252|NCT02311530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6805253|NCT02311530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805254|NCT02311530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6805255|NCT02311530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805256|NCT02311530|Vasodilator Agents|vasodilator agents|mesh-ancestor
6805257|NCT02311569|Mirabegron|mirabegron|mesh-list
6805258|NCT02311569|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6805259|NCT02311569|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6805260|NCT02311569|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6805261|NCT02311569|Adrenergic Agents|adrenergic agents|mesh-ancestor
6805262|NCT02311569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6805263|NCT02311569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805264|NCT02311569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805265|NCT02311569|Urological Agents|urological agents|mesh-ancestor
6805266|NCT02311582|Pembrolizumab|pembrolizumab|mesh-list
6805267|NCT02311582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6805268|NCT02311582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6805269|NCT02311608|Octreotide|octreotide|mesh-list
6805270|NCT02311608|Terlipressin|terlipressin|mesh-list
6805271|NCT02311608|Somatostatin|somatostatin|mesh-list
6805272|NCT02311608|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6805273|NCT02311608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6805274|NCT02311608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6805275|NCT02311608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6805276|NCT02311608|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6805277|NCT02311608|Hormones|hormones|mesh-ancestor
6805278|NCT02311608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6805279|NCT02311608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805280|NCT02311686|Ethanol|ethanol|mesh-list
6805281|NCT02311686|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6805282|NCT02311686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6805283|NCT02311686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6805284|NCT02311686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805285|NCT02311764|Carboplatin|carboplatin|mesh-list
6805286|NCT02311764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6805287|NCT02311777|Pregabalin|pregabalin|mesh-list
6805288|NCT02311777|Ketamine|ketamine|mesh-list
6805289|NCT02311777|Analgesics|analgesics|mesh-ancestor
6805290|NCT02311777|Sensory System Agents|sensory system agents|mesh-ancestor
6805291|NCT02311777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6805292|NCT02311777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805293|NCT02311777|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6805294|NCT02311777|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6805295|NCT02311777|Anesthetics, General|anesthetics, general|mesh-ancestor
6805296|NCT02311777|Anesthetics|anesthetics|mesh-ancestor
6805297|NCT02311777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6805298|NCT02311777|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6805299|NCT02311777|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6805300|NCT02311777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6805301|NCT02311777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805302|NCT02311777|Anticonvulsants|anticonvulsants|mesh-ancestor
6805303|NCT02311777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6805304|NCT02311777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6805305|NCT02311777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6805306|NCT02311777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6805307|NCT02311777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6805308|NCT02311777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6805309|NCT02311946|Palbociclib|palbociclib|mesh-list
6805310|NCT02311946|Rabeprazole|rabeprazole|mesh-list
6805311|NCT02311946|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
6805312|NCT02311946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6805313|NCT02311946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6805314|NCT02311946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6805315|NCT02311946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805316|NCT02311946|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6805317|NCT02311946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6805318|NCT02311998|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
6805319|NCT02311998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6805320|NCT02311998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6805321|NCT02311998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6805322|NCT02312037|Gemtuzumab|gemtuzumab|mesh-list
6805323|NCT02312037|Antibodies|antibodies|mesh-list
6805324|NCT02312037|Immunoconjugates|immunoconjugates|mesh-list
6805325|NCT02312037|Immunologic Factors|immunologic factors|mesh-ancestor
6805326|NCT02312037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805327|NCT02312037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6805328|NCT02312037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6805329|NCT02312076|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6805330|NCT02312076|Luteolytic Agents|luteolytic agents|mesh-ancestor
6805331|NCT02312076|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6805332|NCT02312076|Contraceptive Agents|contraceptive agents|mesh-ancestor
6805333|NCT02312076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6805334|NCT02312076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805335|NCT02312076|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6805336|NCT02312076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6805337|NCT02312076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6805338|NCT02312089|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6805339|NCT02312089|Luteolytic Agents|luteolytic agents|mesh-ancestor
6805340|NCT02312089|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6805341|NCT02312089|Contraceptive Agents|contraceptive agents|mesh-ancestor
6805342|NCT02312089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6805343|NCT02312089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805344|NCT02312089|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6805345|NCT02312089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6805346|NCT02312089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6805347|NCT02312102|Lenalidomide|lenalidomide|mesh-list
6805348|NCT02312102|Bortezomib|bortezomib|mesh-list
6805349|NCT02312102|Immunologic Factors|immunologic factors|mesh-ancestor
6805350|NCT02312102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805351|NCT02312102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6805352|NCT02312102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6805353|NCT02312102|Growth Substances|growth substances|mesh-ancestor
6805354|NCT02312102|Growth Inhibitors|growth inhibitors|mesh-ancestor
6805355|NCT02312102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6805356|NCT02312115|Furosemide|furosemide|mesh-list
6805357|NCT02312115|Diuretics|diuretics|mesh-ancestor
6805358|NCT02312115|Natriuretic Agents|natriuretic agents|mesh-ancestor
6805359|NCT02312115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805360|NCT02312115|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6805361|NCT02312115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6805362|NCT02312115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805363|NCT02312180|Plasminogen|plasminogen|mesh-list
6805364|NCT02312180|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6805365|NCT02312180|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6805366|NCT02312180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805367|NCT02312232|Levodopa|levodopa|mesh-list
6805368|NCT02312232|Carbidopa|carbidopa|mesh-list
6805369|NCT02312232|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6805370|NCT02312232|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6805371|NCT02312232|Dopamine Agents|dopamine agents|mesh-ancestor
6805372|NCT02312232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6805373|NCT02312232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805374|NCT02312232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805375|NCT02312232|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6805376|NCT02312232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6805377|NCT02312245|Gemcitabine|gemcitabine|mesh-list
6805378|NCT02312245|Paclitaxel|paclitaxel|mesh-list
6805379|NCT02312245|Bevacizumab|bevacizumab|mesh-list
6805380|NCT02312245|Doxorubicin|doxorubicin|mesh-list
6805381|NCT02312245|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6805382|NCT02312245|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6805383|NCT02312245|Topotecan|topotecan|mesh-list
6805384|NCT02312245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6805385|NCT02312245|Endothelial Growth Factors|endothelial growth factors|mesh-list
6805386|NCT02312245|Antibodies|antibodies|mesh-list
6805387|NCT02312245|Immunoglobulins|immunoglobulins|mesh-list
6805388|NCT02312245|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6805389|NCT02312245|Immunoglobulin G|immunoglobulin g|mesh-list
6805390|NCT02312245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6805391|NCT02312245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6805392|NCT02312245|Tubulin Modulators|tubulin modulators|mesh-ancestor
6805393|NCT02312245|Antimitotic Agents|antimitotic agents|mesh-ancestor
6805394|NCT02312245|Mitosis Modulators|mitosis modulators|mesh-ancestor
6805395|NCT02312245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805396|NCT02312245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6805397|NCT02312245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6805398|NCT02312245|Growth Substances|growth substances|mesh-ancestor
6805399|NCT02312245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805400|NCT02312245|Growth Inhibitors|growth inhibitors|mesh-ancestor
6805401|NCT02312245|Immunologic Factors|immunologic factors|mesh-ancestor
6805402|NCT02312245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6805403|NCT02312245|Antimetabolites|antimetabolites|mesh-ancestor
6805404|NCT02312245|Antiviral Agents|antiviral agents|mesh-ancestor
6805405|NCT02312245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6805406|NCT02312245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6805407|NCT02312245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6805408|NCT02312245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6805409|NCT02312245|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6805410|NCT02312245|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6805411|NCT02312245|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6805412|NCT02312297|Minocycline|minocycline|mesh-list
6805413|NCT02312297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6805414|NCT02312297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6805415|NCT02312375|Amlodipine|amlodipine|mesh-list
6805416|NCT02312375|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6805417|NCT02312375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6805418|NCT02312375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6805419|NCT02312375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805420|NCT02312375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6805421|NCT02312375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805422|NCT02312375|Vasodilator Agents|vasodilator agents|mesh-ancestor
6805423|NCT02312427|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
6805424|NCT02312427|Protease Inhibitors|protease inhibitors|mesh-ancestor
6805425|NCT02312427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6805426|NCT02312427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805427|NCT02312427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6805428|NCT02312427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805429|NCT02312440|Tranexamic Acid|tranexamic acid|mesh-list
6805430|NCT02312440|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6805431|NCT02312440|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6805432|NCT02312440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805433|NCT02312440|Hemostatics|hemostatics|mesh-ancestor
6805434|NCT02312440|Coagulants|coagulants|mesh-ancestor
6805435|NCT02312492|Palmitic Acid|palmitic acid|mesh-list
6805436|NCT02312492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6805437|NCT02312492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805438|NCT02312531|Immunoglobulins|immunoglobulins|mesh-list
6805439|NCT02312531|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6805440|NCT02312531|Antibodies|antibodies|mesh-list
6805441|NCT02312531|Immunologic Factors|immunologic factors|mesh-ancestor
6805442|NCT02312531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805443|NCT02312544|Timolol|timolol|mesh-list
6805444|NCT02312544|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6805445|NCT02312544|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6805446|NCT02312544|Adrenergic Agents|adrenergic agents|mesh-ancestor
6805447|NCT02312544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6805448|NCT02312544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805449|NCT02312544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805450|NCT02312544|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6805451|NCT02312544|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6805452|NCT02312609|Minocycline|minocycline|mesh-list
6805453|NCT02312609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6805454|NCT02312609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6805455|NCT02312635|Cycloserine|cycloserine|mesh-list
6805456|NCT02312635|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6805457|NCT02312635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6805458|NCT02312635|Renal Agents|renal agents|mesh-ancestor
6805459|NCT02312635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6805460|NCT02312635|Antitubercular Agents|antitubercular agents|mesh-ancestor
6805461|NCT02312635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6805462|NCT02312635|Antimetabolites|antimetabolites|mesh-ancestor
6805463|NCT02312635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805464|NCT02312661|Metformin|metformin|mesh-list
6805465|NCT02312661|Paclitaxel|paclitaxel|mesh-list
6805466|NCT02312661|Carboplatin|carboplatin|mesh-list
6805467|NCT02312661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6805468|NCT02312661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6805469|NCT02312661|Tubulin Modulators|tubulin modulators|mesh-ancestor
6805470|NCT02312661|Antimitotic Agents|antimitotic agents|mesh-ancestor
6805471|NCT02312661|Mitosis Modulators|mitosis modulators|mesh-ancestor
6805472|NCT02312661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805473|NCT02312661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6805474|NCT02312661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805475|NCT02312804|Paclitaxel|paclitaxel|mesh-list
6805476|NCT02312804|Carboplatin|carboplatin|mesh-list
6805477|NCT02312804|Infigratinib|infigratinib|mesh-list
6805478|NCT02312804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6805479|NCT02312804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6805480|NCT02312804|Tubulin Modulators|tubulin modulators|mesh-ancestor
6805481|NCT02312804|Antimitotic Agents|antimitotic agents|mesh-ancestor
6805482|NCT02312804|Mitosis Modulators|mitosis modulators|mesh-ancestor
6805483|NCT02312804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805484|NCT02312908|Clonazepam|clonazepam|mesh-list
6805485|NCT02312908|Anticonvulsants|anticonvulsants|mesh-ancestor
6805486|NCT02312908|GABA Modulators|gaba modulators|mesh-ancestor
6805487|NCT02312908|GABA Agents|gaba agents|mesh-ancestor
6805488|NCT02312908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6805489|NCT02312908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805490|NCT02312908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805491|NCT02312999|Plasma-lyte 148|plasma-lyte 148|mesh-list
6805492|NCT02312999|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6805493|NCT02312999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6805494|NCT02313051|Everolimus|everolimus|mesh-list
6805495|NCT02313051|Letrozole|letrozole|mesh-list
6805496|NCT02313051|Goserelin|goserelin|mesh-list
6805497|NCT02313051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6805498|NCT02313051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6805499|NCT02313051|Immunologic Factors|immunologic factors|mesh-ancestor
6805500|NCT02313051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805501|NCT02313051|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6805502|NCT02313051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6805503|NCT02313051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6805504|NCT02313051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805505|NCT02313051|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6805506|NCT02313051|Hormone Antagonists|hormone antagonists|mesh-ancestor
6805507|NCT02313051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6805508|NCT02313051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6805509|NCT02313064|CXA-10|cxa-10|mesh-list
6805510|NCT02313064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6805511|NCT02313103|Lofexidine|lofexidine|mesh-list
6805512|NCT02313103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6805513|NCT02313103|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6805514|NCT02313103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805515|NCT02313103|Sensory System Agents|sensory system agents|mesh-ancestor
6805516|NCT02313103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6805517|NCT02313103|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6805518|NCT02313103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6805519|NCT02313103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6805520|NCT02313103|Adrenergic Agents|adrenergic agents|mesh-ancestor
6805521|NCT02313103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6805522|NCT02313103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805523|NCT02313220|Dapagliflozin|dapagliflozin|mesh-list
6805524|NCT02313220|Exenatide|exenatide|mesh-list
6805525|NCT02313220|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6805526|NCT02313220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805527|NCT02313220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6805528|NCT02313220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805529|NCT02313220|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6805530|NCT02313220|Incretins|incretins|mesh-ancestor
6805531|NCT02313220|Hormones|hormones|mesh-ancestor
6805532|NCT02313220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6805533|NCT02313272|Bevacizumab|bevacizumab|mesh-list
6805534|NCT02313272|Pembrolizumab|pembrolizumab|mesh-list
6805535|NCT02313272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6805536|NCT02313272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6805537|NCT02313272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6805538|NCT02313272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6805539|NCT02313272|Growth Substances|growth substances|mesh-ancestor
6805540|NCT02313272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805541|NCT02313272|Growth Inhibitors|growth inhibitors|mesh-ancestor
6805542|NCT02313337|Fentanyl|fentanyl|mesh-list
6805543|NCT02313337|Midazolam|midazolam|mesh-list
6805544|NCT02313337|Anesthetics|anesthetics|mesh-list
6805545|NCT02313337|Propofol|propofol|mesh-list
6805546|NCT02313337|Atracurium|atracurium|mesh-list
6805547|NCT02313337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6805548|NCT02313337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805549|NCT02313337|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6805550|NCT02313337|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6805551|NCT02313337|Anesthetics, General|anesthetics, general|mesh-ancestor
6805552|NCT02313337|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6805553|NCT02313337|Narcotics|narcotics|mesh-ancestor
6805554|NCT02313337|Analgesics|analgesics|mesh-ancestor
6805555|NCT02313337|Sensory System Agents|sensory system agents|mesh-ancestor
6805556|NCT02313337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6805557|NCT02313337|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6805558|NCT02313337|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6805559|NCT02313337|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6805560|NCT02313337|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6805561|NCT02313337|GABA Modulators|gaba modulators|mesh-ancestor
6805562|NCT02313337|GABA Agents|gaba agents|mesh-ancestor
6805563|NCT02313337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6805564|NCT02313337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805565|NCT02313337|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6805566|NCT02313337|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6805567|NCT02313337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6805568|NCT02313337|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
6805569|NCT02313337|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6805570|NCT02313337|Cholinergic Agents|cholinergic agents|mesh-ancestor
6805571|NCT02313389|Rituximab|rituximab|mesh-list
6805572|NCT02313389|Methotrexate|methotrexate|mesh-list
6805573|NCT02313389|Temozolomide|temozolomide|mesh-list
6805574|NCT02313389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6805575|NCT02313389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6805576|NCT02313389|Immunologic Factors|immunologic factors|mesh-ancestor
6805577|NCT02313389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805578|NCT02313389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6805579|NCT02313389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6805580|NCT02313389|Abortifacient Agents|abortifacient agents|mesh-ancestor
6805581|NCT02313389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6805582|NCT02313389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6805583|NCT02313389|Antimetabolites|antimetabolites|mesh-ancestor
6805584|NCT02313389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805585|NCT02313389|Dermatologic Agents|dermatologic agents|mesh-ancestor
6805586|NCT02313389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6805587|NCT02313389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6805588|NCT02313389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6805589|NCT02313389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6805590|NCT02313389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6805591|NCT02313389|Alkylating Agents|alkylating agents|mesh-ancestor
6805592|NCT02313584|Dabigatran|dabigatran|mesh-list
6805593|NCT02313584|Antithrombins|antithrombins|mesh-ancestor
6805594|NCT02313584|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6805595|NCT02313584|Protease Inhibitors|protease inhibitors|mesh-ancestor
6805596|NCT02313584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6805597|NCT02313584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805598|NCT02313584|Anticoagulants|anticoagulants|mesh-ancestor
6805599|NCT02313727|Pamidronate|pamidronate|mesh-list
6805600|NCT02313727|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6805601|NCT02313727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805602|NCT02313805|Insulin|insulin|mesh-list
6805603|NCT02313805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6805604|NCT02313805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805605|NCT02313883|Taurolidine|taurolidine|mesh-list
6805606|NCT02313883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6805607|NCT02313883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6805608|NCT02313883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6805609|NCT02313922|Etanercept|etanercept|mesh-list
6805610|NCT02313922|Methotrexate|methotrexate|mesh-list
6805611|NCT02313922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6805612|NCT02313922|Abortifacient Agents|abortifacient agents|mesh-ancestor
6805613|NCT02313922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6805614|NCT02313922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805615|NCT02313922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6805616|NCT02313922|Antimetabolites|antimetabolites|mesh-ancestor
6805617|NCT02313922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805618|NCT02313922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6805619|NCT02313922|Dermatologic Agents|dermatologic agents|mesh-ancestor
6805620|NCT02313922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6805621|NCT02313922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6805622|NCT02313922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6805623|NCT02313922|Immunologic Factors|immunologic factors|mesh-ancestor
6805624|NCT02313922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6805625|NCT02313922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6805626|NCT02313922|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6805627|NCT02313922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6805628|NCT02313922|Analgesics|analgesics|mesh-ancestor
6805629|NCT02313922|Sensory System Agents|sensory system agents|mesh-ancestor
6805630|NCT02313922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6805631|NCT02313922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6805632|NCT02313922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6805633|NCT02314013|Metronidazole|metronidazole|mesh-list
6805634|NCT02314013|Cephalosporins|cephalosporins|mesh-list
6805635|NCT02314013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6805636|NCT02314013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6805637|NCT02314013|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6805638|NCT02314013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6805639|NCT02314182|Bevacizumab|bevacizumab|mesh-list
6805640|NCT02314182|Capecitabine|capecitabine|mesh-list
6805641|NCT02314182|Oxaliplatin|oxaliplatin|mesh-list
6805642|NCT02314182|Irinotecan|irinotecan|mesh-list
6805643|NCT02314182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6805644|NCT02314182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6805645|NCT02314182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6805646|NCT02314182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6805647|NCT02314182|Growth Substances|growth substances|mesh-ancestor
6805648|NCT02314182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805649|NCT02314182|Growth Inhibitors|growth inhibitors|mesh-ancestor
6805650|NCT02314182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6805651|NCT02314182|Antimetabolites|antimetabolites|mesh-ancestor
6805652|NCT02314182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805653|NCT02314182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6805654|NCT02314182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6805655|NCT02314182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6805656|NCT02314195|Serotonin|serotonin|mesh-list
6805657|NCT02314195|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
6805658|NCT02314195|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6805659|NCT02314195|Serotonin Agents|serotonin agents|mesh-ancestor
6805660|NCT02314195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6805661|NCT02314195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805662|NCT02314195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805663|NCT02314195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6805664|NCT02314195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6805665|NCT02314208|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
6805666|NCT02314208|Resveratrol|resveratrol|mesh-list
6805667|NCT02314208|Atorvastatin|atorvastatin|mesh-list
6805668|NCT02314208|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6805669|NCT02314208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6805670|NCT02314208|Antimetabolites|antimetabolites|mesh-ancestor
6805671|NCT02314208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805672|NCT02314208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6805673|NCT02314208|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6805674|NCT02314208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6805675|NCT02314208|Antioxidants|antioxidants|mesh-ancestor
6805676|NCT02314208|Protective Agents|protective agents|mesh-ancestor
6805677|NCT02314208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805678|NCT02314208|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6805679|NCT02314208|Cathartics|cathartics|mesh-ancestor
6805680|NCT02314208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6805681|NCT02314273|Oprelvekin|oprelvekin|mesh-list
6805682|NCT02314273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6805683|NCT02314286|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6805684|NCT02314286|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6805685|NCT02314286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6805686|NCT02314286|Antimetabolites|antimetabolites|mesh-ancestor
6805687|NCT02314286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805688|NCT02314286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6805689|NCT02314286|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6805690|NCT02314286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6805691|NCT02314312|Cyclosporine|cyclosporine|mesh-list
6805692|NCT02314312|Prednisolone|prednisolone|mesh-list
6805693|NCT02314312|Everolimus|everolimus|mesh-list
6805694|NCT02314312|Cyclosporins|cyclosporins|mesh-list
6805695|NCT02314312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6805696|NCT02314312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805697|NCT02314312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6805698|NCT02314312|Immunologic Factors|immunologic factors|mesh-ancestor
6805699|NCT02314312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805700|NCT02314312|Antifungal Agents|antifungal agents|mesh-ancestor
6805701|NCT02314312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6805702|NCT02314312|Dermatologic Agents|dermatologic agents|mesh-ancestor
6805703|NCT02314312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6805704|NCT02314312|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6805705|NCT02314312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6805706|NCT02314312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6805707|NCT02314312|Glucocorticoids|glucocorticoids|mesh-ancestor
6805708|NCT02314312|Hormones|hormones|mesh-ancestor
6805709|NCT02314312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6805710|NCT02314312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6805711|NCT02314325|Factor VIII|factor viii|mesh-list
6805712|NCT02314325|Coagulants|coagulants|mesh-ancestor
6805713|NCT02314351|Fentanyl|fentanyl|mesh-list
6805714|NCT02314351|Metoclopramide|metoclopramide|mesh-list
6805715|NCT02314351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6805716|NCT02314351|Narcotics|narcotics|mesh-ancestor
6805717|NCT02314351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6805718|NCT02314351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805719|NCT02314351|Analgesics|analgesics|mesh-ancestor
6805720|NCT02314351|Sensory System Agents|sensory system agents|mesh-ancestor
6805721|NCT02314351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6805722|NCT02314351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6805723|NCT02314351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6805724|NCT02314351|Anesthetics, General|anesthetics, general|mesh-ancestor
6805725|NCT02314351|Anesthetics|anesthetics|mesh-ancestor
6805726|NCT02314351|Antiemetics|antiemetics|mesh-ancestor
6805727|NCT02314351|Autonomic Agents|autonomic agents|mesh-ancestor
6805728|NCT02314351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6805729|NCT02314351|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6805730|NCT02314351|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6805731|NCT02314351|Dopamine Agents|dopamine agents|mesh-ancestor
6805732|NCT02314351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6805733|NCT02314351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805734|NCT02314377|Bevacizumab|bevacizumab|mesh-list
6805735|NCT02314377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6805736|NCT02314377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6805737|NCT02314377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6805738|NCT02314377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6805739|NCT02314377|Growth Substances|growth substances|mesh-ancestor
6805740|NCT02314377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805741|NCT02314377|Growth Inhibitors|growth inhibitors|mesh-ancestor
6805742|NCT02314468|Glycerol|glycerol|mesh-list
6805743|NCT02314468|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6805744|NCT02314468|Protective Agents|protective agents|mesh-ancestor
6805745|NCT02314468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805746|NCT02314481|Trastuzumab|trastuzumab|mesh-list
6805747|NCT02314481|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
6805748|NCT02314481|Atezolizumab|atezolizumab|mesh-list
6805749|NCT02314481|Vemurafenib|vemurafenib|mesh-list
6805750|NCT02314481|Maytansine|maytansine|mesh-list
6805751|NCT02314481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6805752|NCT02314481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6805753|NCT02314481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6805754|NCT02314481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6805755|NCT02314481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805756|NCT02314481|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6805757|NCT02314481|Tubulin Modulators|tubulin modulators|mesh-ancestor
6805758|NCT02314481|Antimitotic Agents|antimitotic agents|mesh-ancestor
6805759|NCT02314481|Mitosis Modulators|mitosis modulators|mesh-ancestor
6805760|NCT02314533|Fenofibrate|fenofibrate|mesh-list
6805761|NCT02314533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6805762|NCT02314533|Antimetabolites|antimetabolites|mesh-ancestor
6805763|NCT02314533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805764|NCT02314533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6805765|NCT02314559|Propofol|propofol|mesh-list
6805766|NCT02314559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6805767|NCT02314559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6805768|NCT02314559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805769|NCT02314559|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6805770|NCT02314559|Anesthetics, General|anesthetics, general|mesh-ancestor
6805771|NCT02314559|Anesthetics|anesthetics|mesh-ancestor
6805772|NCT02314754|Misoprostol|misoprostol|mesh-list
6805773|NCT02314754|Mifepristone|mifepristone|mesh-list
6805774|NCT02314754|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6805775|NCT02314754|Abortifacient Agents|abortifacient agents|mesh-ancestor
6805776|NCT02314754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6805777|NCT02314754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805778|NCT02314754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6805779|NCT02314754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6805780|NCT02314754|Oxytocics|oxytocics|mesh-ancestor
6805781|NCT02314754|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6805782|NCT02314754|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6805783|NCT02314754|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6805784|NCT02314754|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6805785|NCT02314754|Contraceptive Agents|contraceptive agents|mesh-ancestor
6805786|NCT02314754|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6805787|NCT02314754|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6805788|NCT02314754|Hormone Antagonists|hormone antagonists|mesh-ancestor
6805789|NCT02314754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6805790|NCT02314754|Luteolytic Agents|luteolytic agents|mesh-ancestor
6805791|NCT02314754|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6805792|NCT02314754|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6805793|NCT02314806|Clindamycin|clindamycin|mesh-list
6805794|NCT02314806|Clindamycin palmitate|clindamycin palmitate|mesh-list
6805795|NCT02314806|Clindamycin phosphate|clindamycin phosphate|mesh-list
6805796|NCT02314806|Gentamicins|gentamicins|mesh-list
6805797|NCT02314806|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6805798|NCT02314806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6805799|NCT02314806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6805800|NCT02314806|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6805801|NCT02314806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6805802|NCT02314806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805803|NCT02314871|Morphine|morphine|mesh-list
6805804|NCT02314871|Pirinitramide|pirinitramide|mesh-list
6805805|NCT02314871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6805806|NCT02314871|Narcotics|narcotics|mesh-ancestor
6805807|NCT02314871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6805808|NCT02314871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805809|NCT02314871|Analgesics|analgesics|mesh-ancestor
6805810|NCT02314871|Sensory System Agents|sensory system agents|mesh-ancestor
6805811|NCT02314871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6805812|NCT02314988|Tranexamic Acid|tranexamic acid|mesh-list
6805813|NCT02314988|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6805814|NCT02314988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6805815|NCT02314988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805816|NCT02314988|Hemostatics|hemostatics|mesh-ancestor
6805817|NCT02314988|Coagulants|coagulants|mesh-ancestor
6805818|NCT02315001|Liraglutide|liraglutide|mesh-list
6805819|NCT02315001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6805820|NCT02315001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805821|NCT02315001|Incretins|incretins|mesh-ancestor
6805822|NCT02315001|Hormones|hormones|mesh-ancestor
6805823|NCT02315001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6805824|NCT02315066|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6805825|NCT02315066|Immunoglobulin G|immunoglobulin g|mesh-list
6805826|NCT02315066|Immunologic Factors|immunologic factors|mesh-ancestor
6805827|NCT02315066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805828|NCT02315118|Rituximab|rituximab|mesh-list
6805829|NCT02315118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6805830|NCT02315118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6805831|NCT02315118|Immunologic Factors|immunologic factors|mesh-ancestor
6805832|NCT02315118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805833|NCT02315118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6805834|NCT02315157|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6805835|NCT02315157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5993404|NCT00121719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5993405|NCT00121810|Mycophenolic Acid|mycophenolic acid|mesh-list
5993406|NCT00121810|Sirolimus|sirolimus|mesh-list
5993407|NCT00121810|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
5993408|NCT00121810|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5993409|NCT00121810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5993410|NCT00121810|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5993411|NCT00121810|Antitubercular Agents|antitubercular agents|mesh-ancestor
5993412|NCT00121810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6536387|NCT00816868|Capecitabine|capecitabine|mesh-list
6805836|NCT02315157|Alkylating Agents|alkylating agents|mesh-ancestor
5993413|NCT00121810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5993414|NCT00121810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6805837|NCT02315157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805838|NCT02315157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6805839|NCT02315196|Paclitaxel|paclitaxel|mesh-list
6805840|NCT02315196|Carboplatin|carboplatin|mesh-list
6805841|NCT02315196|Doxorubicin|doxorubicin|mesh-list
6805842|NCT02315196|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6805843|NCT02315196|Epirubicin|epirubicin|mesh-list
6805844|NCT02315196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6805845|NCT02315196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6805846|NCT02315196|Tubulin Modulators|tubulin modulators|mesh-ancestor
6805847|NCT02315196|Antimitotic Agents|antimitotic agents|mesh-ancestor
6805848|NCT02315196|Mitosis Modulators|mitosis modulators|mesh-ancestor
6805849|NCT02315196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805850|NCT02315196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5993415|NCT00121810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5993416|NCT00121810|Antifungal Agents|antifungal agents|mesh-ancestor
5993417|NCT00121810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5993418|NCT00121810|Immunologic Factors|immunologic factors|mesh-ancestor
5993419|NCT00121810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993420|NCT00121836|Bevacizumab|bevacizumab|mesh-list
5993421|NCT00121836|Capecitabine|capecitabine|mesh-list
5993422|NCT00121836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5993423|NCT00121836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5993424|NCT00121836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5993425|NCT00121836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5993426|NCT00121836|Growth Substances|growth substances|mesh-ancestor
5993427|NCT00121836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993428|NCT00121836|Growth Inhibitors|growth inhibitors|mesh-ancestor
5993429|NCT00121836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5993430|NCT00121836|Antimetabolites|antimetabolites|mesh-ancestor
5993431|NCT00121836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5993432|NCT00121992|Cyclophosphamide|cyclophosphamide|mesh-list
6805851|NCT02315196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6805852|NCT02315196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6805853|NCT02315196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6805854|NCT02315287|Pioglitazone|pioglitazone|mesh-list
6805855|NCT02315287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6805856|NCT02315287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805857|NCT02315326|Rituximab|rituximab|mesh-list
6805858|NCT02315326|Methotrexate|methotrexate|mesh-list
6805859|NCT02315326|Procarbazine|procarbazine|mesh-list
6805860|NCT02315326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6805861|NCT02315326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5993433|NCT00121992|Docetaxel|docetaxel|mesh-list
5993434|NCT00121992|Doxorubicin|doxorubicin|mesh-list
5993435|NCT00121992|Fluorouracil|fluorouracil|mesh-list
5993436|NCT00121992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5993437|NCT00121992|Immunologic Factors|immunologic factors|mesh-ancestor
5993438|NCT00121992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993439|NCT00121992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5993440|NCT00121992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5993441|NCT00121992|Alkylating Agents|alkylating agents|mesh-ancestor
5993442|NCT00121992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805862|NCT02315326|Immunologic Factors|immunologic factors|mesh-ancestor
6805863|NCT02315326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805864|NCT02315326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6805865|NCT02315326|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6805866|NCT02315326|Abortifacient Agents|abortifacient agents|mesh-ancestor
6805867|NCT02315326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6805868|NCT02315326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6805869|NCT02315326|Antimetabolites|antimetabolites|mesh-ancestor
6805870|NCT02315326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805871|NCT02315326|Dermatologic Agents|dermatologic agents|mesh-ancestor
6805872|NCT02315326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6805873|NCT02315326|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6805874|NCT02315326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6805875|NCT02315326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6805876|NCT02315391|Glycine|glycine|mesh-list
6805877|NCT02315391|Glycine Agents|glycine agents|mesh-ancestor
6805878|NCT02315391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5993443|NCT00121992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6258608|NCT03093207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6805879|NCT02315391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805880|NCT02315391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805881|NCT02315495|Saxagliptin|saxagliptin|mesh-list
6805882|NCT02315495|Acarbose|acarbose|mesh-list
6805883|NCT02315495|Incretins|incretins|mesh-ancestor
6805884|NCT02315495|Hormones|hormones|mesh-ancestor
6805885|NCT02315495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6805886|NCT02315495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805887|NCT02315495|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6805888|NCT02315495|Protease Inhibitors|protease inhibitors|mesh-ancestor
6805889|NCT02315495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6805890|NCT02315495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805891|NCT02315495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6805892|NCT02315495|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6805893|NCT02315547|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6805894|NCT02315547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6805895|NCT02315573|Lidocaine|lidocaine|mesh-list
6805896|NCT02315573|Epinephrine|epinephrine|mesh-list
6805897|NCT02315573|Racepinephrine|racepinephrine|mesh-list
6805898|NCT02315573|Bupivacaine|bupivacaine|mesh-list
6805899|NCT02315573|Epinephryl borate|epinephryl borate|mesh-list
6805900|NCT02315573|Anesthetics, Local|anesthetics, local|mesh-ancestor
6805901|NCT02315573|Anesthetics|anesthetics|mesh-ancestor
6805902|NCT02315573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6805903|NCT02315573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805904|NCT02315573|Sensory System Agents|sensory system agents|mesh-ancestor
6805905|NCT02315573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6805906|NCT02315573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6805907|NCT02315573|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6805908|NCT02315573|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6805909|NCT02315573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6805910|NCT02315573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258609|NCT03093207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6258610|NCT03093207|Antipyretics|antipyretics|mesh-ancestor
6258611|NCT03093272|Prednisone|prednisone|mesh-list
6258612|NCT03093272|Docetaxel|docetaxel|mesh-list
6258613|NCT03093272|Leuprolide|leuprolide|mesh-list
6258614|NCT03093272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6258615|NCT03093272|Tubulin Modulators|tubulin modulators|mesh-ancestor
6258616|NCT03093272|Antimitotic Agents|antimitotic agents|mesh-ancestor
6258617|NCT03093272|Mitosis Modulators|mitosis modulators|mesh-ancestor
6258618|NCT03093272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258619|NCT03093272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6258620|NCT03093272|Glucocorticoids|glucocorticoids|mesh-ancestor
6258621|NCT03093272|Hormones|hormones|mesh-ancestor
6258622|NCT03093272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6258623|NCT03093272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805911|NCT02315573|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6805912|NCT02315573|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6805913|NCT02315573|Adrenergic Agents|adrenergic agents|mesh-ancestor
6805914|NCT02315573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6805915|NCT02315573|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6805916|NCT02315573|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6805917|NCT02315573|Autonomic Agents|autonomic agents|mesh-ancestor
6805918|NCT02315573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6805919|NCT02315573|Respiratory System Agents|respiratory system agents|mesh-ancestor
6805920|NCT02315573|Mydriatics|mydriatics|mesh-ancestor
6805921|NCT02315573|Sympathomimetics|sympathomimetics|mesh-ancestor
6805922|NCT02315573|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6805923|NCT02315651|Ubiquinone|ubiquinone|mesh-list
6805924|NCT02315651|Coenzyme Q10|coenzyme q10|mesh-list
6805925|NCT02315651|Micronutrients|micronutrients|mesh-ancestor
6805926|NCT02315651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805927|NCT02315651|Vitamins|vitamins|mesh-ancestor
6805928|NCT02315690|Piperaquine|piperaquine|mesh-list
6805929|NCT02315690|Artenimol|artenimol|mesh-list
6805930|NCT02315690|Antimalarials|antimalarials|mesh-ancestor
6805931|NCT02315690|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6805932|NCT02315690|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6805933|NCT02315690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6805934|NCT02315768|Obinutuzumab|obinutuzumab|mesh-list
6805935|NCT02315768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6805936|NCT02315768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6258624|NCT03093272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6805937|NCT02315898|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6805938|NCT02315898|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6805939|NCT02315898|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6805940|NCT02315898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805941|NCT02315950|Botulinum Toxins|botulinum toxins|mesh-list
6805942|NCT02315950|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6805943|NCT02315950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6805944|NCT02315950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805945|NCT02315950|Cholinergic Agents|cholinergic agents|mesh-ancestor
6805946|NCT02315950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6805947|NCT02315950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805948|NCT02316028|Decitabine|decitabine|mesh-list
6805949|NCT02316028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6805950|NCT02316028|Antimetabolites|antimetabolites|mesh-ancestor
6805951|NCT02316028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805952|NCT02316028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6805953|NCT02316028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6805954|NCT02316197|Peposertib|peposertib|mesh-list
6805955|NCT02316197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6805956|NCT02316197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6805957|NCT02316197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805958|NCT02316236|Dexmedetomidine|dexmedetomidine|mesh-list
6805959|NCT02316236|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6805960|NCT02316236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6805961|NCT02316236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805962|NCT02316236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6805963|NCT02316236|Analgesics|analgesics|mesh-ancestor
6805964|NCT02316236|Sensory System Agents|sensory system agents|mesh-ancestor
6805965|NCT02316236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6805966|NCT02316236|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6805967|NCT02316236|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6805968|NCT02316236|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6805969|NCT02316236|Adrenergic Agents|adrenergic agents|mesh-ancestor
6805970|NCT02316236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6805971|NCT02316236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805972|NCT02316249|Estradiol|estradiol|mesh-list
6805973|NCT02316249|Hormones|hormones|mesh-ancestor
6805974|NCT02316249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6805975|NCT02316249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805976|NCT02316249|Estrogens|estrogens|mesh-ancestor
6805977|NCT02316301|Misoprostol|misoprostol|mesh-list
6805978|NCT02316301|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6805979|NCT02316301|Abortifacient Agents|abortifacient agents|mesh-ancestor
6805980|NCT02316301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6805981|NCT02316301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805982|NCT02316301|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6805983|NCT02316301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6805984|NCT02316301|Oxytocics|oxytocics|mesh-ancestor
6805985|NCT02316327|Gemcitabine|gemcitabine|mesh-list
6805986|NCT02316327|Bevacizumab|bevacizumab|mesh-list
6805987|NCT02316327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6805988|NCT02316327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6805989|NCT02316327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6805990|NCT02316327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6805991|NCT02316327|Growth Substances|growth substances|mesh-ancestor
6805992|NCT02316327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6805993|NCT02316327|Growth Inhibitors|growth inhibitors|mesh-ancestor
6805994|NCT02316327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6805995|NCT02316327|Antimetabolites|antimetabolites|mesh-ancestor
6805996|NCT02316327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6805997|NCT02316327|Antiviral Agents|antiviral agents|mesh-ancestor
6805998|NCT02316327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6805999|NCT02316327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6806000|NCT02316327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6806001|NCT02316327|Immunologic Factors|immunologic factors|mesh-ancestor
6806002|NCT02316340|Hydroxychloroquine|hydroxychloroquine|mesh-list
6806003|NCT02316340|Vorinostat|vorinostat|mesh-list
6806004|NCT02316340|Antimalarials|antimalarials|mesh-ancestor
6806005|NCT02316340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6806006|NCT02316340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6806007|NCT02316340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6806008|NCT02316340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6806009|NCT02316340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6806010|NCT02316340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6806011|NCT02316340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6806012|NCT02316340|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6806013|NCT02316379|Xenon|xenon|mesh-list
6806014|NCT02316379|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6806015|NCT02316379|Anesthetics, General|anesthetics, general|mesh-ancestor
6806016|NCT02316379|Anesthetics|anesthetics|mesh-ancestor
6806017|NCT02316379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6806018|NCT02316379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806019|NCT02316496|Irinotecan|irinotecan|mesh-list
6806020|NCT02316496|Cetuximab|cetuximab|mesh-list
6806021|NCT02316496|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6806022|NCT02316496|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6806023|NCT02316496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6806024|NCT02316496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6806025|NCT02316496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6806026|NCT02316496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6806027|NCT02316535|Capecitabine|capecitabine|mesh-list
6806028|NCT02316535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6258625|NCT03093272|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6258626|NCT03093272|Fertility Agents|fertility agents|mesh-ancestor
6258627|NCT03093272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6258628|NCT03093324|Dimethyl Fumarate|dimethyl fumarate|mesh-list
6258629|NCT03093324|Dermatologic Agents|dermatologic agents|mesh-ancestor
6258630|NCT03093324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6258631|NCT03093324|Immunologic Factors|immunologic factors|mesh-ancestor
6258632|NCT03093324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258633|NCT03093415|Grazoprevir|grazoprevir|mesh-list
6258634|NCT03093415|Antiviral Agents|antiviral agents|mesh-ancestor
6258635|NCT03093415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6258636|NCT03093480|Factor VIII|factor viii|mesh-list
6806029|NCT02316535|Antimetabolites|antimetabolites|mesh-ancestor
6806030|NCT02316535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6806031|NCT02316535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6806032|NCT02316626|Progesterone|progesterone|mesh-list
6806033|NCT02316626|Progestins|progestins|mesh-ancestor
6806034|NCT02316626|Hormones|hormones|mesh-ancestor
6806035|NCT02316626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6806036|NCT02316626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806037|NCT02316704|Tacrine|tacrine|mesh-list
6806038|NCT02316704|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6806039|NCT02316704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6806040|NCT02316704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6806041|NCT02316704|Cholinergic Agents|cholinergic agents|mesh-ancestor
6806042|NCT02316704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6806043|NCT02316704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258637|NCT03093480|Coagulants|coagulants|mesh-ancestor
6258638|NCT03093870|Capecitabine|capecitabine|mesh-list
6806044|NCT02316704|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6806045|NCT02316704|Autonomic Agents|autonomic agents|mesh-ancestor
6806046|NCT02316704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6806047|NCT02316704|Nootropic Agents|nootropic agents|mesh-ancestor
6806048|NCT02316899|Linaclotide|linaclotide|mesh-list
6806049|NCT02316899|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
6806050|NCT02316899|Enzyme Activators|enzyme activators|mesh-ancestor
6806051|NCT02316899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6806052|NCT02316899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6806053|NCT02316964|Aldesleukin|aldesleukin|mesh-list
6806054|NCT02316964|Decitabine|decitabine|mesh-list
6806055|NCT02316964|Azacitidine|azacitidine|mesh-list
6806056|NCT02316964|Interleukin-2|interleukin-2|mesh-list
6806057|NCT02316964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6806058|NCT02316964|Antimetabolites|antimetabolites|mesh-ancestor
6806059|NCT02316964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6806060|NCT02316964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6806061|NCT02316964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6806062|NCT02316964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6806063|NCT02316964|Analgesics|analgesics|mesh-ancestor
6806064|NCT02316964|Sensory System Agents|sensory system agents|mesh-ancestor
6806065|NCT02316964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6806066|NCT02316964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806067|NCT02316964|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6806068|NCT02316964|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6806069|NCT02316964|Antiviral Agents|antiviral agents|mesh-ancestor
6806070|NCT02316964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6806071|NCT02317146|Magnesium Sulfate|magnesium sulfate|mesh-list
6806072|NCT02317146|Analgesics|analgesics|mesh-ancestor
6806073|NCT02317146|Sensory System Agents|sensory system agents|mesh-ancestor
6806074|NCT02317146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6806075|NCT02317146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806076|NCT02317146|Anesthetics|anesthetics|mesh-ancestor
6806077|NCT02317146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6806078|NCT02317146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6806079|NCT02317146|Anticonvulsants|anticonvulsants|mesh-ancestor
6806080|NCT02317146|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6806081|NCT02317146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6806082|NCT02317146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6806083|NCT02317146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6806084|NCT02317146|Tocolytic Agents|tocolytic agents|mesh-ancestor
6806085|NCT02317146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6806086|NCT02317159|Imatinib Mesylate|imatinib mesylate|mesh-list
6806087|NCT02317159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6806088|NCT02317159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6806089|NCT02317159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6806090|NCT02317159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6806091|NCT02317198|Clopidogrel|clopidogrel|mesh-list
6806092|NCT02317198|Ticagrelor|ticagrelor|mesh-list
6806093|NCT02317198|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6806094|NCT02317198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6806095|NCT02317198|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6806096|NCT02317198|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6806097|NCT02317198|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6806098|NCT02317198|Purinergic Agents|purinergic agents|mesh-ancestor
6806099|NCT02317198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6806100|NCT02317198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6806101|NCT02317198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806102|NCT02317237|Anesthetics|anesthetics|mesh-list
6806103|NCT02317237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6806104|NCT02317237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806105|NCT02317263|Testosterone|testosterone|mesh-list
6806106|NCT02317263|Androgens|androgens|mesh-ancestor
6806107|NCT02317263|Hormones|hormones|mesh-ancestor
6806108|NCT02317263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6806109|NCT02317263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806110|NCT02317341|Midazolam|midazolam|mesh-list
6806111|NCT02317341|Ketamine|ketamine|mesh-list
6806112|NCT02317341|Analgesics|analgesics|mesh-ancestor
6806113|NCT02317341|Sensory System Agents|sensory system agents|mesh-ancestor
6806114|NCT02317341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6806115|NCT02317341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806116|NCT02317341|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6806117|NCT02317341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6806118|NCT02317341|Anesthetics, General|anesthetics, general|mesh-ancestor
6806119|NCT02317341|Anesthetics|anesthetics|mesh-ancestor
6806120|NCT02317341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6806121|NCT02317341|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6806122|NCT02317341|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6806123|NCT02317341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6806124|NCT02317341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6806125|NCT02317341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6806126|NCT02317341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6806127|NCT02317341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6806128|NCT02317341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6806129|NCT02317341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6806130|NCT02317341|GABA Modulators|gaba modulators|mesh-ancestor
6806131|NCT02317341|GABA Agents|gaba agents|mesh-ancestor
6806132|NCT02317419|Gemcitabine|gemcitabine|mesh-list
6806133|NCT02317419|Paclitaxel|paclitaxel|mesh-list
6806134|NCT02317419|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6806135|NCT02317419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6806136|NCT02317419|Tubulin Modulators|tubulin modulators|mesh-ancestor
6806137|NCT02317419|Antimitotic Agents|antimitotic agents|mesh-ancestor
6806138|NCT02317419|Mitosis Modulators|mitosis modulators|mesh-ancestor
6806139|NCT02317419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6806140|NCT02317419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6806141|NCT02317419|Antimetabolites|antimetabolites|mesh-ancestor
6806142|NCT02317419|Antiviral Agents|antiviral agents|mesh-ancestor
6806143|NCT02317419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6806144|NCT02317419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6806145|NCT02317419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6806146|NCT02317419|Immunologic Factors|immunologic factors|mesh-ancestor
6806147|NCT02317419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806148|NCT02317471|Oxaliplatin|oxaliplatin|mesh-list
6806149|NCT02317471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6258639|NCT03093870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6258640|NCT03093870|Antimetabolites|antimetabolites|mesh-ancestor
6258641|NCT03093870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258642|NCT03093870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6258643|NCT03094611|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
6538059|NCT00825552|Risperidone|risperidone|mesh-list
6806150|NCT02317484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
6806151|NCT02317484|Ipragliflozin|ipragliflozin|mesh-list
6806152|NCT02317484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6806153|NCT02317484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6806154|NCT02317484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806155|NCT02317497|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
6806156|NCT02317601|Methylprednisolone|methylprednisolone|mesh-list
6806157|NCT02317601|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6806158|NCT02317601|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6806159|NCT02317601|Prednisolone|prednisolone|mesh-list
6806160|NCT02317601|Prednisolone acetate|prednisolone acetate|mesh-list
6806161|NCT02317601|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6806162|NCT02317601|Prednisolone phosphate|prednisolone phosphate|mesh-list
6806163|NCT02317601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6806164|NCT02317601|Antiemetics|antiemetics|mesh-ancestor
6806165|NCT02317601|Autonomic Agents|autonomic agents|mesh-ancestor
6806166|NCT02317601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6806167|NCT02317601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806168|NCT02317601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6806169|NCT02317601|Glucocorticoids|glucocorticoids|mesh-ancestor
6806170|NCT02317601|Hormones|hormones|mesh-ancestor
6806171|NCT02317601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6806172|NCT02317601|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6806173|NCT02317601|Protective Agents|protective agents|mesh-ancestor
6806174|NCT02317601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6806175|NCT02317601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6806176|NCT02317640|Testosterone|testosterone|mesh-list
6806177|NCT02317640|Androgens|androgens|mesh-ancestor
6806178|NCT02317640|Hormones|hormones|mesh-ancestor
6806179|NCT02317640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6806180|NCT02317640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806181|NCT02317679|Bosentan|bosentan|mesh-list
6806182|NCT02317679|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6806183|NCT02317679|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6806184|NCT02317679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6806185|NCT02317770|Lidocaine|lidocaine|mesh-list
6806186|NCT02317770|Anesthetics, Local|anesthetics, local|mesh-ancestor
6806187|NCT02317770|Anesthetics|anesthetics|mesh-ancestor
6806188|NCT02317770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6806189|NCT02317770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806190|NCT02317770|Sensory System Agents|sensory system agents|mesh-ancestor
6806191|NCT02317770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6806192|NCT02317770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6806193|NCT02317770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6806194|NCT02317770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6806195|NCT02317770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6806196|NCT02317770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6806197|NCT02317861|Febuxostat|febuxostat|mesh-list
6806198|NCT02317861|Verinurad|verinurad|mesh-list
6806199|NCT02317861|Benzbromarone|benzbromarone|mesh-list
6806200|NCT02317861|Gout Suppressants|gout suppressants|mesh-ancestor
6806201|NCT02317861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6806202|NCT02317861|Uricosuric Agents|uricosuric agents|mesh-ancestor
6806203|NCT02317861|Renal Agents|renal agents|mesh-ancestor
6806204|NCT02317991|Paclitaxel|paclitaxel|mesh-list
6806205|NCT02317991|Ramucirumab|ramucirumab|mesh-list
6806206|NCT02317991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6806207|NCT02317991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6806208|NCT02317991|Tubulin Modulators|tubulin modulators|mesh-ancestor
6806209|NCT02317991|Antimitotic Agents|antimitotic agents|mesh-ancestor
6806210|NCT02317991|Mitosis Modulators|mitosis modulators|mesh-ancestor
6806211|NCT02317991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6806212|NCT02318017|Methylphenidate|methylphenidate|mesh-list
6806213|NCT02318017|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6806214|NCT02318017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806215|NCT02318017|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6806216|NCT02318017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6806217|NCT02318017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6806218|NCT02318017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6806219|NCT02318017|Dopamine Agents|dopamine agents|mesh-ancestor
6806220|NCT02318017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6806221|NCT02318043|Fluticasone|fluticasone|mesh-list
6806222|NCT02318043|Budesonide|budesonide|mesh-list
6806223|NCT02318043|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6806224|NCT02318043|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6806225|NCT02318043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6806226|NCT02318043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6806227|NCT02318043|Autonomic Agents|autonomic agents|mesh-ancestor
6806228|NCT02318043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6806229|NCT02318043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806230|NCT02318043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6806231|NCT02318043|Respiratory System Agents|respiratory system agents|mesh-ancestor
6806232|NCT02318043|Dermatologic Agents|dermatologic agents|mesh-ancestor
6806233|NCT02318043|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6806234|NCT02318043|Glucocorticoids|glucocorticoids|mesh-ancestor
6806235|NCT02318043|Hormones|hormones|mesh-ancestor
6806236|NCT02318043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6806237|NCT02318043|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6806238|NCT02318043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6806239|NCT02318043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6806240|NCT02318043|Adrenergic Agents|adrenergic agents|mesh-ancestor
6806241|NCT02318043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6806242|NCT02318043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6806243|NCT02318043|Sympathomimetics|sympathomimetics|mesh-ancestor
6806244|NCT02318056|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6806245|NCT02318056|Bacitracin|bacitracin|mesh-list
6806246|NCT02318056|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6806247|NCT02318056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6806248|NCT02318056|Laxatives|laxatives|mesh-ancestor
6806249|NCT02318056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6806250|NCT02318056|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6806251|NCT02318082|Aldesleukin|aldesleukin|mesh-list
6806252|NCT02318082|Interleukin-2|interleukin-2|mesh-list
6806253|NCT02318082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6806254|NCT02318082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6806255|NCT02318082|Analgesics|analgesics|mesh-ancestor
6806256|NCT02318082|Sensory System Agents|sensory system agents|mesh-ancestor
6806257|NCT02318082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6806258|NCT02318082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806259|NCT02318082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6806260|NCT02318082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6806261|NCT02318082|Antiviral Agents|antiviral agents|mesh-ancestor
6806262|NCT02318082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6806263|NCT02318121|Oxytocin|oxytocin|mesh-list
6806264|NCT02318121|Oxytocics|oxytocics|mesh-ancestor
6806265|NCT02318121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6806266|NCT02318121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806267|NCT02318199|Anesthetics|anesthetics|mesh-list
6806268|NCT02318199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6806269|NCT02318199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806270|NCT02318225|Misoprostol|misoprostol|mesh-list
6806271|NCT02318225|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6806272|NCT02318225|Abortifacient Agents|abortifacient agents|mesh-ancestor
6806273|NCT02318225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6806274|NCT02318225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806275|NCT02318225|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6806276|NCT02318225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6806277|NCT02318225|Oxytocics|oxytocics|mesh-ancestor
6806278|NCT02318290|Analgesics|analgesics|mesh-list
6806279|NCT02318290|Narcotics|narcotics|mesh-list
6806280|NCT02318290|Sensory System Agents|sensory system agents|mesh-ancestor
6806281|NCT02318290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6806282|NCT02318290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806283|NCT02318290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6806284|NCT02318433|Dexamethasone|dexamethasone|mesh-list
6806285|NCT02318433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6806286|NCT02318433|Antiemetics|antiemetics|mesh-ancestor
6806287|NCT02318433|Autonomic Agents|autonomic agents|mesh-ancestor
6806288|NCT02318433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6806289|NCT02318433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806290|NCT02318433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6806291|NCT02318433|Glucocorticoids|glucocorticoids|mesh-ancestor
6806292|NCT02318433|Hormones|hormones|mesh-ancestor
6806293|NCT02318433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6806294|NCT02318433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6806295|NCT02318433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6806296|NCT02318446|Folic Acid|folic acid|mesh-list
6806297|NCT02318446|Hematinics|hematinics|mesh-ancestor
6806298|NCT02318446|Vitamin B Complex|vitamin b complex|mesh-ancestor
6806299|NCT02318446|Vitamins|vitamins|mesh-ancestor
6806300|NCT02318446|Micronutrients|micronutrients|mesh-ancestor
6806301|NCT02318446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806302|NCT02318511|Hyaluronic Acid|hyaluronic acid|mesh-list
6806303|NCT02318511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6806304|NCT02318511|Immunologic Factors|immunologic factors|mesh-ancestor
6806305|NCT02318511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806306|NCT02318511|Viscosupplements|viscosupplements|mesh-ancestor
6806307|NCT02318511|Protective Agents|protective agents|mesh-ancestor
6806308|NCT02318537|Cannabidiol|cannabidiol|mesh-list
6806309|NCT02318537|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6806310|NCT02318537|Anticonvulsants|anticonvulsants|mesh-ancestor
6806311|NCT02318563|Cannabidiol|cannabidiol|mesh-list
6806312|NCT02318563|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6806313|NCT02318563|Anticonvulsants|anticonvulsants|mesh-ancestor
6806314|NCT02318758|Ethanol|ethanol|mesh-list
6806315|NCT02318758|Treprostinil|treprostinil|mesh-list
6806316|NCT02318758|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6806317|NCT02318758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6806318|NCT02318758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6806319|NCT02318758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806320|NCT02318758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6806321|NCT02318771|Pembrolizumab|pembrolizumab|mesh-list
6806322|NCT02318771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6806323|NCT02318771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6806324|NCT02318810|Rocuronium|rocuronium|mesh-list
6806325|NCT02318810|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6806326|NCT02318810|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6806327|NCT02318810|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6806328|NCT02318810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6806329|NCT02318810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806330|NCT02318836|Lofexidine|lofexidine|mesh-list
6806331|NCT02318836|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6806332|NCT02318836|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6806333|NCT02318836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806334|NCT02318836|Sensory System Agents|sensory system agents|mesh-ancestor
6806335|NCT02318836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6806336|NCT02318836|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6806337|NCT02318836|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6806338|NCT02318836|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6806339|NCT02318836|Adrenergic Agents|adrenergic agents|mesh-ancestor
6806340|NCT02318836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6806341|NCT02318836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6806342|NCT02318888|Icodextrin|icodextrin|mesh-list
6806343|NCT02318888|Dialysis Solutions|dialysis solutions|mesh-ancestor
6806344|NCT02318888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6806345|NCT02319018|Calcium, Dietary|calcium, dietary|mesh-list
6806346|NCT02319018|Leucovorin|leucovorin|mesh-list
6806347|NCT02319018|Folic Acid|folic acid|mesh-list
6806348|NCT02319018|Fluorouracil|fluorouracil|mesh-list
6806349|NCT02319018|Oxaliplatin|oxaliplatin|mesh-list
6806350|NCT02319018|Calcium|calcium|mesh-list
6806351|NCT02319018|Levoleucovorin|levoleucovorin|mesh-list
6806352|NCT02319018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6806353|NCT02319018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806354|NCT02319018|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6806355|NCT02319018|Antimetabolites|antimetabolites|mesh-ancestor
6806356|NCT02319018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6806357|NCT02319018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6806358|NCT02319018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6806359|NCT02319018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6806360|NCT02319018|Immunologic Factors|immunologic factors|mesh-ancestor
6806361|NCT02319018|Antidotes|antidotes|mesh-ancestor
6806362|NCT02319018|Protective Agents|protective agents|mesh-ancestor
6806363|NCT02319018|Vitamin B Complex|vitamin b complex|mesh-ancestor
6806364|NCT02319018|Vitamins|vitamins|mesh-ancestor
6806365|NCT02319018|Micronutrients|micronutrients|mesh-ancestor
6806366|NCT02319018|Hematinics|hematinics|mesh-ancestor
6806367|NCT02319135|Cytarabine|cytarabine|mesh-list
6806368|NCT02319135|Fludarabine|fludarabine|mesh-list
6806369|NCT02319135|Lenograstim|lenograstim|mesh-list
6806370|NCT02319135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6806371|NCT02319135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6806372|NCT02319135|Antimetabolites|antimetabolites|mesh-ancestor
6806373|NCT02319135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6806374|NCT02319135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6806375|NCT02319135|Immunologic Factors|immunologic factors|mesh-ancestor
6806376|NCT02319135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806377|NCT02319135|Antiviral Agents|antiviral agents|mesh-ancestor
6806378|NCT02319135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6806379|NCT02319135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6806380|NCT02319161|Calcium Channel Blockers|calcium channel blockers|mesh-list
6806381|NCT02319161|Calcium|calcium|mesh-list
6806382|NCT02319161|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
6806383|NCT02319161|Esmolol|esmolol|mesh-list
6806384|NCT02319161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6806385|NCT02319161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806386|NCT02319161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6806387|NCT02319161|Adrenergic Agents|adrenergic agents|mesh-ancestor
6806388|NCT02319161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6806389|NCT02319161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6806390|NCT02319161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6806391|NCT02319161|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6806392|NCT02319187|Irinotecan|irinotecan|mesh-list
6806393|NCT02319187|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6806394|NCT02319187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6806395|NCT02319187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6806396|NCT02319187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6806397|NCT02319187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6806398|NCT02319200|Metformin|metformin|mesh-list
6806399|NCT02319200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6806400|NCT02319200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806401|NCT02319265|Melatonin|melatonin|mesh-list
6806402|NCT02319265|Antioxidants|antioxidants|mesh-ancestor
6806403|NCT02319265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6806404|NCT02319265|Protective Agents|protective agents|mesh-ancestor
6806405|NCT02319265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806406|NCT02319265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6806407|NCT02319278|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
6806408|NCT02319278|Hematinics|hematinics|mesh-ancestor
6806409|NCT02319278|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6806410|NCT02319278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6806411|NCT02319343|Methylprednisolone|methylprednisolone|mesh-list
6806412|NCT02319343|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6806413|NCT02319343|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6806414|NCT02319343|Prednisolone|prednisolone|mesh-list
6806415|NCT02319343|Prednisolone acetate|prednisolone acetate|mesh-list
6806416|NCT02319343|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6806417|NCT02319343|Prednisolone phosphate|prednisolone phosphate|mesh-list
6806418|NCT02319343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6806419|NCT02319343|Antiemetics|antiemetics|mesh-ancestor
6806420|NCT02319343|Autonomic Agents|autonomic agents|mesh-ancestor
6806421|NCT02319343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6806422|NCT02319343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806423|NCT02319343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6806424|NCT02319343|Glucocorticoids|glucocorticoids|mesh-ancestor
6806425|NCT02319343|Hormones|hormones|mesh-ancestor
6806426|NCT02319343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6806427|NCT02319343|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6806428|NCT02319343|Protective Agents|protective agents|mesh-ancestor
6806429|NCT02319343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6806430|NCT02319343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6806431|NCT02319460|Thrombin|thrombin|mesh-list
6806432|NCT02319460|Hemostatics|hemostatics|mesh-ancestor
6806433|NCT02319460|Coagulants|coagulants|mesh-ancestor
6806434|NCT02319499|Vitamin A|vitamin a|mesh-list
6806435|NCT02319499|Iron|iron|mesh-list
6806436|NCT02319499|Zinc|zinc|mesh-list
6806437|NCT02319499|Vitamins|vitamins|mesh-ancestor
6806438|NCT02319499|Micronutrients|micronutrients|mesh-ancestor
6806439|NCT02319499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806440|NCT02319499|Trace Elements|trace elements|mesh-ancestor
6806441|NCT02319564|Beclomethasone|beclomethasone|mesh-list
6806442|NCT02319564|Albuterol|albuterol|mesh-list
6806443|NCT02319564|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6806444|NCT02319564|Autonomic Agents|autonomic agents|mesh-ancestor
6806445|NCT02319564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6806446|NCT02319564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806447|NCT02319564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6806448|NCT02319564|Respiratory System Agents|respiratory system agents|mesh-ancestor
6806449|NCT02319564|Tocolytic Agents|tocolytic agents|mesh-ancestor
6806450|NCT02319564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6806451|NCT02319564|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6806452|NCT02319564|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6806453|NCT02319564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6806454|NCT02319564|Adrenergic Agents|adrenergic agents|mesh-ancestor
6806455|NCT02319564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6806456|NCT02319564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6806457|NCT02319564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6806458|NCT02319564|Glucocorticoids|glucocorticoids|mesh-ancestor
6806459|NCT02319564|Hormones|hormones|mesh-ancestor
6806460|NCT02319564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6806461|NCT02319577|Vinorelbine|vinorelbine|mesh-list
6806462|NCT02319577|Gefitinib|gefitinib|mesh-list
6806463|NCT02319577|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6806464|NCT02319577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6806465|NCT02319577|Tubulin Modulators|tubulin modulators|mesh-ancestor
6806466|NCT02319577|Antimitotic Agents|antimitotic agents|mesh-ancestor
6806467|NCT02319577|Mitosis Modulators|mitosis modulators|mesh-ancestor
6806468|NCT02319577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6806469|NCT02319577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6806470|NCT02319577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6806471|NCT02319616|Clobetasol|clobetasol|mesh-list
6806472|NCT02319616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6806473|NCT02319616|Glucocorticoids|glucocorticoids|mesh-ancestor
6806474|NCT02319616|Hormones|hormones|mesh-ancestor
6806475|NCT02319616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6806476|NCT02319616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806477|NCT02319629|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
6806478|NCT02319629|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6806479|NCT02319629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6806480|NCT02319707|Oxytocin|oxytocin|mesh-list
6806481|NCT02319707|Oxytocics|oxytocics|mesh-ancestor
6806482|NCT02319707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6806483|NCT02319707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806484|NCT02319772|Galidesivir|galidesivir|mesh-list
6806485|NCT02319772|Antiviral Agents|antiviral agents|mesh-ancestor
6806486|NCT02319772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6806487|NCT02319889|Paclitaxel|paclitaxel|mesh-list
6806488|NCT02319889|Carboplatin|carboplatin|mesh-list
6806489|NCT02319889|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6806490|NCT02319889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6806491|NCT02319889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6806492|NCT02319889|Tubulin Modulators|tubulin modulators|mesh-ancestor
6806493|NCT02319889|Antimitotic Agents|antimitotic agents|mesh-ancestor
6806494|NCT02319889|Mitosis Modulators|mitosis modulators|mesh-ancestor
6806495|NCT02319889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6806496|NCT02319915|Tranexamic Acid|tranexamic acid|mesh-list
6806497|NCT02319915|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6806498|NCT02319915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6806499|NCT02319915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6806500|NCT02319915|Hemostatics|hemostatics|mesh-ancestor
6806501|NCT02319915|Coagulants|coagulants|mesh-ancestor
6806502|NCT02319941|Clopidogrel|clopidogrel|mesh-list
6806503|NCT02319941|Ticagrelor|ticagrelor|mesh-list
6806504|NCT02319941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6806505|NCT02319941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6806506|NCT02319941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6806507|NCT02319941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6806508|NCT02319941|Purinergic Agents|purinergic agents|mesh-ancestor
6806509|NCT02319941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6806510|NCT02319941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6806511|NCT02319941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806512|NCT02320032|Aripiprazole|aripiprazole|mesh-list
6806513|NCT02320032|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
6806514|NCT02320032|Antidepressive Agents|antidepressive agents|mesh-ancestor
6806515|NCT02320032|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6806516|NCT02320032|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6806517|NCT02320032|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6806518|NCT02320032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6806519|NCT02320032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806520|NCT02320032|Dopamine Agonists|dopamine agonists|mesh-ancestor
6806521|NCT02320032|Dopamine Agents|dopamine agents|mesh-ancestor
6806522|NCT02320032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6806523|NCT02320032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6806524|NCT02320032|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6806525|NCT02320032|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6806526|NCT02320032|Serotonin Agents|serotonin agents|mesh-ancestor
6806527|NCT02320032|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6806528|NCT02320032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6806529|NCT02320032|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6806530|NCT02320032|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6806531|NCT02320045|Exenatide|exenatide|mesh-list
6806532|NCT02320045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6806533|NCT02320045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806534|NCT02320045|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6806535|NCT02320045|Incretins|incretins|mesh-ancestor
6806536|NCT02320045|Hormones|hormones|mesh-ancestor
6806537|NCT02320045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6806538|NCT02320084|Nitisinone|nitisinone|mesh-list
6806539|NCT02320084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6806540|NCT02320084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6806541|NCT02320240|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6806542|NCT02320240|Fluvoxamine|fluvoxamine|mesh-list
6806543|NCT02320240|Citalopram|citalopram|mesh-list
6806544|NCT02320240|Fluoxetine|fluoxetine|mesh-list
6806545|NCT02320240|Paroxetine|paroxetine|mesh-list
6806546|NCT02320240|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6806547|NCT02320240|Sertraline|sertraline|mesh-list
6806548|NCT02320240|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6806549|NCT02320240|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6806550|NCT02320240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6806551|NCT02320240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6806552|NCT02320240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6806553|NCT02320240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6806554|NCT02320240|Serotonin Agents|serotonin agents|mesh-ancestor
6806555|NCT02320240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806556|NCT02320240|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6806557|NCT02320240|Antidepressive Agents|antidepressive agents|mesh-ancestor
6806558|NCT02320240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6806559|NCT02320240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6806560|NCT02320240|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6806561|NCT02320240|Analgesics|analgesics|mesh-ancestor
6806562|NCT02320240|Sensory System Agents|sensory system agents|mesh-ancestor
6806563|NCT02320240|Dopamine Agents|dopamine agents|mesh-ancestor
6806564|NCT02320240|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6806565|NCT02320240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6806566|NCT02320240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6806567|NCT02320240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6806568|NCT02320240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6806569|NCT02320240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6806570|NCT02320240|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6806571|NCT02320240|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6806572|NCT02320357|Clopidogrel|clopidogrel|mesh-list
6806573|NCT02320357|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6806574|NCT02320357|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6806575|NCT02320357|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6806576|NCT02320357|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6806577|NCT02320357|Purinergic Agents|purinergic agents|mesh-ancestor
6806578|NCT02320357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6806579|NCT02320357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6806580|NCT02320357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806581|NCT02320383|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6806582|NCT02320383|Obinutuzumab|obinutuzumab|mesh-list
6806583|NCT02320383|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6806584|NCT02320383|Alkylating Agents|alkylating agents|mesh-ancestor
6806585|NCT02320383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6806586|NCT02320383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6806587|NCT02320383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6806588|NCT02320448|Cisplatin|cisplatin|mesh-list
6806589|NCT02320448|Doxorubicin|doxorubicin|mesh-list
6806590|NCT02320448|Oxaliplatin|oxaliplatin|mesh-list
6806591|NCT02320448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6806592|NCT02320448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6806593|NCT02320448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6806594|NCT02320448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6806595|NCT02320448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6806596|NCT02320448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6806597|NCT02320474|Aflibercept|aflibercept|mesh-list
6806598|NCT02320474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6806599|NCT02320474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6806600|NCT02320474|Growth Substances|growth substances|mesh-ancestor
6806601|NCT02320474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806602|NCT02320474|Growth Inhibitors|growth inhibitors|mesh-ancestor
6806603|NCT02320474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6806604|NCT02320604|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6806605|NCT02320604|Antifungal Agents|antifungal agents|mesh-ancestor
6806606|NCT02320604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6806607|NCT02320604|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6806608|NCT02320604|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6806609|NCT02320734|Rocuronium|rocuronium|mesh-list
6806610|NCT02320734|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6806611|NCT02320734|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6806612|NCT02320734|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6806613|NCT02320734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6806614|NCT02320734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806615|NCT02320773|Mirabegron|mirabegron|mesh-list
6806616|NCT02320773|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6806617|NCT02320773|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6806618|NCT02320773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6806619|NCT02320773|Adrenergic Agents|adrenergic agents|mesh-ancestor
6806620|NCT02320773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6806621|NCT02320773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6806622|NCT02320773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806623|NCT02320773|Urological Agents|urological agents|mesh-ancestor
6806624|NCT02320877|Methaqualone|methaqualone|mesh-list
6806625|NCT02320877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6806626|NCT02320877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6806627|NCT02320877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806628|NCT02321176|Resveratrol|resveratrol|mesh-list
6806629|NCT02321176|Antioxidants|antioxidants|mesh-ancestor
6806630|NCT02321176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6806631|NCT02321176|Protective Agents|protective agents|mesh-ancestor
6806632|NCT02321176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806633|NCT02321176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6806634|NCT02321176|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6806635|NCT02321241|Aflibercept|aflibercept|mesh-list
6806636|NCT02321241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6806637|NCT02321241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6806638|NCT02321241|Growth Substances|growth substances|mesh-ancestor
6806639|NCT02321241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806640|NCT02321241|Growth Inhibitors|growth inhibitors|mesh-ancestor
6806641|NCT02321241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6806642|NCT02321267|Ranibizumab|ranibizumab|mesh-list
6806643|NCT02321267|Aflibercept|aflibercept|mesh-list
6806644|NCT02321267|Verteporfin|verteporfin|mesh-list
6806645|NCT02321267|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6806646|NCT02321267|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6806647|NCT02321267|Growth Substances|growth substances|mesh-ancestor
6806648|NCT02321267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806649|NCT02321267|Growth Inhibitors|growth inhibitors|mesh-ancestor
6806650|NCT02321267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6806651|NCT02321267|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6806652|NCT02321267|Dermatologic Agents|dermatologic agents|mesh-ancestor
6806653|NCT02321280|Denosumab|denosumab|mesh-list
6806654|NCT02321280|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6806655|NCT02321280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806656|NCT02321293|Curcumin|curcumin|mesh-list
6806657|NCT02321293|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6806658|NCT02321293|Gefitinib|gefitinib|mesh-list
6806659|NCT02321293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6806660|NCT02321293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6806661|NCT02321293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6806662|NCT02321293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6806663|NCT02321293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6806664|NCT02321293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6806665|NCT02321293|Analgesics|analgesics|mesh-ancestor
6806666|NCT02321293|Sensory System Agents|sensory system agents|mesh-ancestor
6806667|NCT02321293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6806668|NCT02321293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806669|NCT02321293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6806670|NCT02321293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6806671|NCT02321371|Rifaximin|rifaximin|mesh-list
6806672|NCT02321371|Lactulose|lactulose|mesh-list
6806673|NCT02321371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6806674|NCT02321371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6806675|NCT02321371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6806676|NCT02321384|Ritonavir|ritonavir|mesh-list
6806677|NCT02321384|Midazolam|midazolam|mesh-list
6806678|NCT02321384|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6806679|NCT02321384|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6806680|NCT02321384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6806681|NCT02321384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806682|NCT02321384|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6806683|NCT02321384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6806684|NCT02321384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6806685|NCT02321384|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6806686|NCT02321384|Anesthetics, General|anesthetics, general|mesh-ancestor
6806687|NCT02321384|Anesthetics|anesthetics|mesh-ancestor
6806688|NCT02321384|GABA Modulators|gaba modulators|mesh-ancestor
6806689|NCT02321384|GABA Agents|gaba agents|mesh-ancestor
6806690|NCT02321384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6806691|NCT02321384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6806692|NCT02321384|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6806693|NCT02321384|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6806694|NCT02321384|Protease Inhibitors|protease inhibitors|mesh-ancestor
6806695|NCT02321384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6806696|NCT02321384|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6806697|NCT02321384|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6806698|NCT02321384|Antiviral Agents|antiviral agents|mesh-ancestor
6806699|NCT02321384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6806700|NCT02321384|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6806701|NCT02321384|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6806702|NCT02321397|Oxycodone|oxycodone|mesh-list
6806703|NCT02321397|Naloxone|naloxone|mesh-list
6806704|NCT02321397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6806705|NCT02321397|Narcotics|narcotics|mesh-ancestor
6806706|NCT02321397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6806707|NCT02321397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806708|NCT02321397|Analgesics|analgesics|mesh-ancestor
6806709|NCT02321397|Sensory System Agents|sensory system agents|mesh-ancestor
6806710|NCT02321397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6806711|NCT02321397|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6806712|NCT02321501|Everolimus|everolimus|mesh-list
6806713|NCT02321501|Ceritinib|ceritinib|mesh-list
6806714|NCT02321501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6806715|NCT02321501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6806716|NCT02321501|Immunologic Factors|immunologic factors|mesh-ancestor
6806717|NCT02321501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806718|NCT02321501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6806719|NCT02321501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6806720|NCT02321501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6806721|NCT02321579|Vitamin B 6|vitamin b 6|mesh-list
6806722|NCT02321579|Pyridoxal|pyridoxal|mesh-list
6806723|NCT02321579|Pyridoxine|pyridoxine|mesh-list
6806724|NCT02321579|Vitamins|vitamins|mesh-ancestor
6806725|NCT02321579|Micronutrients|micronutrients|mesh-ancestor
6806726|NCT02321579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806727|NCT02321579|Vitamin B Complex|vitamin b complex|mesh-ancestor
6806728|NCT02321761|Amantadine|amantadine|mesh-list
6806729|NCT02321761|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6806730|NCT02321761|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6806731|NCT02321761|Antiviral Agents|antiviral agents|mesh-ancestor
6806732|NCT02321761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6806733|NCT02321761|Dopamine Agents|dopamine agents|mesh-ancestor
6806734|NCT02321761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6806735|NCT02321761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6806736|NCT02321761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806737|NCT02321761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6806738|NCT02321761|Analgesics|analgesics|mesh-ancestor
6806739|NCT02321761|Sensory System Agents|sensory system agents|mesh-ancestor
6806740|NCT02321761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6806741|NCT02321839|Ranibizumab|ranibizumab|mesh-list
6806742|NCT02321839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6806743|NCT02321839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6806744|NCT02321839|Growth Substances|growth substances|mesh-ancestor
6806745|NCT02321839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806746|NCT02321839|Growth Inhibitors|growth inhibitors|mesh-ancestor
6806747|NCT02321839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6806748|NCT02321852|Mannitol|mannitol|mesh-list
6806749|NCT02321852|Triflusal|triflusal|mesh-list
6806750|NCT02321852|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6806751|NCT02321852|Diuretics|diuretics|mesh-ancestor
6806752|NCT02321852|Natriuretic Agents|natriuretic agents|mesh-ancestor
6806753|NCT02321852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806754|NCT02321852|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6806755|NCT02321878|Liraglutide|liraglutide|mesh-list
6806756|NCT02321878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6806757|NCT02321878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806758|NCT02321878|Incretins|incretins|mesh-ancestor
6806759|NCT02321878|Hormones|hormones|mesh-ancestor
6806760|NCT02321878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6806761|NCT02322008|Adalimumab|adalimumab|mesh-list
6806762|NCT02322008|Infliximab|infliximab|mesh-list
6806763|NCT02322008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6806764|NCT02322008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6806765|NCT02322008|Dermatologic Agents|dermatologic agents|mesh-ancestor
6806766|NCT02322008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6806767|NCT02322099|Alendronate|alendronate|mesh-list
6806768|NCT02322099|Cholecalciferol|cholecalciferol|mesh-list
6806769|NCT02322099|Tenofovir|tenofovir|mesh-list
6806770|NCT02322099|Calcium Carbonate|calcium carbonate|mesh-list
6806771|NCT02322099|Calcium|calcium|mesh-list
6806772|NCT02322099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6806773|NCT02322099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806774|NCT02322099|Antiviral Agents|antiviral agents|mesh-ancestor
6806775|NCT02322099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6806776|NCT02322099|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6806777|NCT02322099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6806778|NCT02322099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6806779|NCT02322099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6806780|NCT02322099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6806781|NCT02322099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6806782|NCT02322099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6806783|NCT02322099|Antacids|antacids|mesh-ancestor
6806784|NCT02322099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6806785|NCT02322099|Vitamins|vitamins|mesh-ancestor
6806786|NCT02322099|Micronutrients|micronutrients|mesh-ancestor
6806787|NCT02322203|Niacin|niacin|mesh-list
6806788|NCT02322203|Niacinamide|niacinamide|mesh-list
6806789|NCT02322203|Nicotinic Acids|nicotinic acids|mesh-list
6806790|NCT02322203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6806791|NCT02322203|Antimetabolites|antimetabolites|mesh-ancestor
6806792|NCT02322203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6806793|NCT02322203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6806794|NCT02322203|Vasodilator Agents|vasodilator agents|mesh-ancestor
6806795|NCT02322203|Vitamin B Complex|vitamin b complex|mesh-ancestor
6806796|NCT02322203|Vitamins|vitamins|mesh-ancestor
6806797|NCT02322203|Micronutrients|micronutrients|mesh-ancestor
6806798|NCT02322203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806799|NCT02322346|Levobupivacaine|levobupivacaine|mesh-list
6806800|NCT02322346|Anesthetics, Local|anesthetics, local|mesh-ancestor
6806801|NCT02322346|Anesthetics|anesthetics|mesh-ancestor
6806802|NCT02322346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6806803|NCT02322346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806804|NCT02322346|Sensory System Agents|sensory system agents|mesh-ancestor
6806805|NCT02322346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6806806|NCT02322372|Bupivacaine|bupivacaine|mesh-list
6806807|NCT02322372|Anesthetics|anesthetics|mesh-ancestor
6806808|NCT02322372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6806809|NCT02322372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806810|NCT02322372|Anesthetics, Local|anesthetics, local|mesh-ancestor
6806811|NCT02322372|Sensory System Agents|sensory system agents|mesh-ancestor
6806812|NCT02322372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6806813|NCT02322502|Propofol|propofol|mesh-list
6806814|NCT02322502|Sevoflurane|sevoflurane|mesh-list
6806815|NCT02322502|Desflurane|desflurane|mesh-list
6806816|NCT02322502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6806817|NCT02322502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6806818|NCT02322502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806819|NCT02322502|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6806820|NCT02322502|Anesthetics, General|anesthetics, general|mesh-ancestor
6806821|NCT02322502|Anesthetics|anesthetics|mesh-ancestor
6806822|NCT02322502|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6806823|NCT02322502|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6806824|NCT02322580|Etanercept|etanercept|mesh-list
6806825|NCT02322580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6806826|NCT02322580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6806827|NCT02322580|Analgesics|analgesics|mesh-ancestor
6806828|NCT02322580|Sensory System Agents|sensory system agents|mesh-ancestor
6806829|NCT02322580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6806830|NCT02322580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806831|NCT02322580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6806832|NCT02322580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6806833|NCT02322580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6806834|NCT02322580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6806835|NCT02322580|Immunologic Factors|immunologic factors|mesh-ancestor
6806836|NCT02322619|Moxifloxacin|moxifloxacin|mesh-list
6806837|NCT02322619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6806838|NCT02322619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6806839|NCT02322619|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6806840|NCT02322619|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6806841|NCT02322619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6806842|NCT02322619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6806843|NCT02322619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6806844|NCT02322645|Eszopiclone|eszopiclone|mesh-list
6806845|NCT02322645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6806846|NCT02322645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6806847|NCT02322645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806848|NCT02322658|Eszopiclone|eszopiclone|mesh-list
6806849|NCT02322658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6806850|NCT02322658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6806851|NCT02322658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806852|NCT02322671|Montelukast|montelukast|mesh-list
6806853|NCT02322671|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6806854|NCT02322671|Respiratory System Agents|respiratory system agents|mesh-ancestor
6806855|NCT02322671|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6806856|NCT02322671|Hormone Antagonists|hormone antagonists|mesh-ancestor
6806857|NCT02322671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6806858|NCT02322671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806859|NCT02322671|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6806860|NCT02322671|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6806861|NCT02322671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6806862|NCT02322853|Tamoxifen|tamoxifen|mesh-list
6806863|NCT02322853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6806864|NCT02322853|Hormone Antagonists|hormone antagonists|mesh-ancestor
6806865|NCT02322853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6806866|NCT02322853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806867|NCT02322853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6806868|NCT02322853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6806869|NCT02322853|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6806870|NCT02322853|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6806871|NCT02322853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6806872|NCT02323100|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
6806873|NCT02323100|Glycerol|glycerol|mesh-list
6806874|NCT02323100|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6258644|NCT03094611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6258645|NCT03094611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6258646|NCT03094611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6258647|NCT03094637|Pembrolizumab|pembrolizumab|mesh-list
6258648|NCT03094637|Azacitidine|azacitidine|mesh-list
6258649|NCT03094637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6258650|NCT03094637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6258651|NCT03094637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6258652|NCT03094637|Antimetabolites|antimetabolites|mesh-ancestor
6258653|NCT03094637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258654|NCT03094637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6258655|NCT03095118|Daratumumab|daratumumab|mesh-list
6806875|NCT02323100|Protective Agents|protective agents|mesh-ancestor
6806876|NCT02323100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806877|NCT02323100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6806878|NCT02323139|Azacitidine|azacitidine|mesh-list
6806879|NCT02323139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5993444|NCT00121992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6806880|NCT02323139|Antimetabolites|antimetabolites|mesh-ancestor
6806881|NCT02323139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6806882|NCT02323139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6806883|NCT02323139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6806884|NCT02323191|Atezolizumab|atezolizumab|mesh-list
6806885|NCT02323191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6806886|NCT02323230|Cyclophosphamide|cyclophosphamide|mesh-list
6806887|NCT02323230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6806888|NCT02323230|Immunologic Factors|immunologic factors|mesh-ancestor
6806889|NCT02323230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806890|NCT02323230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6806891|NCT02323230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6806892|NCT02323230|Alkylating Agents|alkylating agents|mesh-ancestor
6806893|NCT02323230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6806894|NCT02323230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6806895|NCT02323230|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6806896|NCT02323269|Dimethyl Fumarate|dimethyl fumarate|mesh-list
6806897|NCT02323269|Dermatologic Agents|dermatologic agents|mesh-ancestor
6806898|NCT02323269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6806899|NCT02323269|Immunologic Factors|immunologic factors|mesh-ancestor
6806900|NCT02323269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806901|NCT02323282|Ropivacaine|ropivacaine|mesh-list
6806902|NCT02323282|Anesthetics, Local|anesthetics, local|mesh-ancestor
6806903|NCT02323282|Anesthetics|anesthetics|mesh-ancestor
6806904|NCT02323282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6806905|NCT02323282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806906|NCT02323282|Sensory System Agents|sensory system agents|mesh-ancestor
6806907|NCT02323282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6806908|NCT02323347|Progesterone|progesterone|mesh-list
6806909|NCT02323347|Progestins|progestins|mesh-ancestor
6806910|NCT02323347|Hormones|hormones|mesh-ancestor
6806911|NCT02323347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6806912|NCT02323347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806913|NCT02323373|Tranexamic Acid|tranexamic acid|mesh-list
6806914|NCT02323373|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6806915|NCT02323373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6806916|NCT02323373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6806917|NCT02323373|Hemostatics|hemostatics|mesh-ancestor
6806918|NCT02323373|Coagulants|coagulants|mesh-ancestor
6806919|NCT02323399|Phenylephrine|phenylephrine|mesh-list
6806920|NCT02323399|Oxymetazoline|oxymetazoline|mesh-list
6806921|NCT02323399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6806922|NCT02323399|Mydriatics|mydriatics|mesh-ancestor
6806923|NCT02323399|Autonomic Agents|autonomic agents|mesh-ancestor
6806924|NCT02323399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6806925|NCT02323399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806926|NCT02323399|Sympathomimetics|sympathomimetics|mesh-ancestor
6806927|NCT02323399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6806928|NCT02323399|Nasal Decongestants|nasal decongestants|mesh-ancestor
6806929|NCT02323399|Respiratory System Agents|respiratory system agents|mesh-ancestor
6806930|NCT02323399|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6806931|NCT02323399|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6806932|NCT02323399|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6806933|NCT02323399|Adrenergic Agents|adrenergic agents|mesh-ancestor
6806934|NCT02323399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6806935|NCT02323399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6806936|NCT02323399|Protective Agents|protective agents|mesh-ancestor
6806937|NCT02323412|Amoxicillin|amoxicillin|mesh-list
6806938|NCT02323412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6806939|NCT02323412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6806940|NCT02323438|Menthol|menthol|mesh-list
6806941|NCT02323438|Nicotine|nicotine|mesh-list
6806942|NCT02323438|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6806943|NCT02323438|Autonomic Agents|autonomic agents|mesh-ancestor
6806944|NCT02323438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6806945|NCT02323438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806946|NCT02323438|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6806947|NCT02323438|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6806948|NCT02323438|Cholinergic Agents|cholinergic agents|mesh-ancestor
6806949|NCT02323438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6806950|NCT02323438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6806951|NCT02323438|Antipruritics|antipruritics|mesh-ancestor
6806952|NCT02323438|Dermatologic Agents|dermatologic agents|mesh-ancestor
6806953|NCT02323451|Chitosan|chitosan|mesh-list
6806954|NCT02323451|Hyaluronic Acid|hyaluronic acid|mesh-list
6806955|NCT02323451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6806956|NCT02323451|Immunologic Factors|immunologic factors|mesh-ancestor
6806957|NCT02323451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806958|NCT02323451|Viscosupplements|viscosupplements|mesh-ancestor
6806959|NCT02323451|Protective Agents|protective agents|mesh-ancestor
6806960|NCT02323451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6806961|NCT02323451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6806962|NCT02323451|Antimetabolites|antimetabolites|mesh-ancestor
6806963|NCT02323451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6806964|NCT02323451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6806965|NCT02323451|Chelating Agents|chelating agents|mesh-ancestor
6806966|NCT02323451|Sequestering Agents|sequestering agents|mesh-ancestor
6806967|NCT02323451|Hemostatics|hemostatics|mesh-ancestor
6806968|NCT02323451|Coagulants|coagulants|mesh-ancestor
6806969|NCT02323516|Aspirin|aspirin|mesh-list
6806970|NCT02323516|Loperamide|loperamide|mesh-list
6806971|NCT02323516|Antidiarrheals|antidiarrheals|mesh-list
6806972|NCT02323516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6806973|NCT02323516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6806974|NCT02323516|Analgesics|analgesics|mesh-ancestor
6806975|NCT02323516|Sensory System Agents|sensory system agents|mesh-ancestor
6806976|NCT02323516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6806977|NCT02323516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6806978|NCT02323516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6806979|NCT02323516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6806980|NCT02323516|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6806981|NCT02323516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6806982|NCT02323516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6806983|NCT02323516|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6806984|NCT02323516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6806985|NCT02323516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6806986|NCT02323516|Antipyretics|antipyretics|mesh-ancestor
6806987|NCT02323516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6806988|NCT02323529|Nitisinone|nitisinone|mesh-list
6806989|NCT02323529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6806990|NCT02323529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6806991|NCT02323594|Asunaprevir|asunaprevir|mesh-list
6806992|NCT02323594|Protease Inhibitors|protease inhibitors|mesh-ancestor
6806993|NCT02323594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6806994|NCT02323594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6806995|NCT02323607|Cytarabine|cytarabine|mesh-list
6806996|NCT02323607|Decitabine|decitabine|mesh-list
6806997|NCT02323607|Daunorubicin|daunorubicin|mesh-list
6806998|NCT02323607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6806999|NCT02323607|Antimetabolites|antimetabolites|mesh-ancestor
6807000|NCT02323607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807001|NCT02323607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6807002|NCT02323607|Antiviral Agents|antiviral agents|mesh-ancestor
6807003|NCT02323607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6807004|NCT02323607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6807005|NCT02323607|Immunologic Factors|immunologic factors|mesh-ancestor
6807006|NCT02323607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807007|NCT02323607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6807008|NCT02323607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6807009|NCT02323607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6807010|NCT02323607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6807011|NCT02323737|Cisplatin|cisplatin|mesh-list
6807012|NCT02323737|Irinotecan|irinotecan|mesh-list
6807013|NCT02323737|Etoposide|etoposide|mesh-list
6807014|NCT02323737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6807015|NCT02323737|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6807016|NCT02323737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6807017|NCT02323737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6807018|NCT02323737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807019|NCT02323737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6807020|NCT02323737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6807021|NCT02323906|Sorafenib|sorafenib|mesh-list
6807022|NCT02323906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6807023|NCT02323906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6807024|NCT02323906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6807025|NCT02323906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807026|NCT02323971|Ticagrelor|ticagrelor|mesh-list
6807027|NCT02323971|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6807028|NCT02323971|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6807029|NCT02323971|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6807030|NCT02323971|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6807031|NCT02323971|Purinergic Agents|purinergic agents|mesh-ancestor
6807032|NCT02323971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6807033|NCT02323971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807034|NCT02323971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807035|NCT02324010|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6807036|NCT02324010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6807037|NCT02324010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807038|NCT02324010|Incretins|incretins|mesh-ancestor
6807039|NCT02324010|Hormones|hormones|mesh-ancestor
6807040|NCT02324010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6807041|NCT02324010|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6807042|NCT02324010|Protease Inhibitors|protease inhibitors|mesh-ancestor
6807043|NCT02324010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6807044|NCT02324010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807045|NCT02324088|Cyclophosphamide|cyclophosphamide|mesh-list
6807046|NCT02324088|Docetaxel|docetaxel|mesh-list
6807047|NCT02324088|Epirubicin|epirubicin|mesh-list
6807048|NCT02324088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6807049|NCT02324088|Immunologic Factors|immunologic factors|mesh-ancestor
6807050|NCT02324088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807051|NCT02324088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6807052|NCT02324088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6807053|NCT02324088|Alkylating Agents|alkylating agents|mesh-ancestor
6807054|NCT02324088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807055|NCT02324088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6807056|NCT02324088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6807057|NCT02324088|Tubulin Modulators|tubulin modulators|mesh-ancestor
6807058|NCT02324088|Antimitotic Agents|antimitotic agents|mesh-ancestor
6807059|NCT02324088|Mitosis Modulators|mitosis modulators|mesh-ancestor
6807060|NCT02324088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6807061|NCT02324088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6807062|NCT02324088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6807063|NCT02324088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6807064|NCT02324166|Cefazolin|cefazolin|mesh-list
6807065|NCT02324166|Lidocaine|lidocaine|mesh-list
6807066|NCT02324166|Anesthetics, Local|anesthetics, local|mesh-ancestor
6807067|NCT02324166|Anesthetics|anesthetics|mesh-ancestor
6807068|NCT02324166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6807069|NCT02324166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807070|NCT02324166|Sensory System Agents|sensory system agents|mesh-ancestor
6807071|NCT02324166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6807072|NCT02324166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6807073|NCT02324166|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6807074|NCT02324166|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6807075|NCT02324166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6807076|NCT02324166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807077|NCT02324166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6807078|NCT02324166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6807079|NCT02324257|Obinutuzumab|obinutuzumab|mesh-list
6807080|NCT02324257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6807081|NCT02324257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6807082|NCT02324283|Propofol|propofol|mesh-list
6807083|NCT02324283|Desflurane|desflurane|mesh-list
6807084|NCT02324283|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6807085|NCT02324283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6807086|NCT02324283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807087|NCT02324283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6807088|NCT02324283|Anesthetics, General|anesthetics, general|mesh-ancestor
6807089|NCT02324283|Anesthetics|anesthetics|mesh-ancestor
6807090|NCT02324283|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6807091|NCT02324296|Cisplatin|cisplatin|mesh-list
6807092|NCT02324296|Etoposide|etoposide|mesh-list
6807093|NCT02324296|Ifosfamide|ifosfamide|mesh-list
6807094|NCT02324296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6807095|NCT02324296|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6807096|NCT02324296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6807097|NCT02324296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6807098|NCT02324296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6807099|NCT02324296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807100|NCT02324296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6807101|NCT02324296|Alkylating Agents|alkylating agents|mesh-ancestor
6807102|NCT02324387|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
6807103|NCT02324387|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6807104|NCT02324387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807105|NCT02324413|Clonidine|clonidine|mesh-list
6807106|NCT02324413|Analgesics|analgesics|mesh-ancestor
6807107|NCT02324413|Sensory System Agents|sensory system agents|mesh-ancestor
6807108|NCT02324413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6807109|NCT02324413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807110|NCT02324413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6807111|NCT02324413|Sympatholytics|sympatholytics|mesh-ancestor
6807112|NCT02324413|Autonomic Agents|autonomic agents|mesh-ancestor
6807113|NCT02324413|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6807114|NCT02324413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6807115|NCT02324413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6807116|NCT02324413|Adrenergic Agents|adrenergic agents|mesh-ancestor
6807117|NCT02324413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6807118|NCT02324413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807119|NCT02324452|Fluorouracil|fluorouracil|mesh-list
6807120|NCT02324452|Capecitabine|capecitabine|mesh-list
6807121|NCT02324452|Antimetabolites|antimetabolites|mesh-ancestor
6807122|NCT02324452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807123|NCT02324452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6807124|NCT02324452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6807125|NCT02324452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6807126|NCT02324452|Immunologic Factors|immunologic factors|mesh-ancestor
6807127|NCT02324452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807128|NCT02324491|CKD732|ckd732|mesh-list
6807129|NCT02324491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6807130|NCT02324491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6807131|NCT02324491|Growth Substances|growth substances|mesh-ancestor
6807132|NCT02324491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807133|NCT02324491|Growth Inhibitors|growth inhibitors|mesh-ancestor
6807134|NCT02324491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6807135|NCT02324582|Pembrolizumab|pembrolizumab|mesh-list
6807136|NCT02324582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6807137|NCT02324582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6807138|NCT02324608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6807139|NCT02324608|Cetuximab|cetuximab|mesh-list
6807140|NCT02324608|Antibodies|antibodies|mesh-list
6807141|NCT02324608|Immunoglobulins|immunoglobulins|mesh-list
6807142|NCT02324608|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6807143|NCT02324608|Immunologic Factors|immunologic factors|mesh-ancestor
6807144|NCT02324608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807145|NCT02324608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6807146|NCT02324621|TIC10 compound|tic10 compound|mesh-list
6807147|NCT02324621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6807148|NCT02324686|Vitamin K|vitamin k|mesh-list
6807149|NCT02324686|Vitamin K 1|vitamin k 1|mesh-list
6807150|NCT02324686|Vitamins|vitamins|mesh-ancestor
6807151|NCT02324686|Micronutrients|micronutrients|mesh-ancestor
6807152|NCT02324686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807153|NCT02324686|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6807154|NCT02324686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6807155|NCT02324686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807156|NCT02324686|Hemostatics|hemostatics|mesh-ancestor
6807157|NCT02324686|Coagulants|coagulants|mesh-ancestor
6807158|NCT02324725|Naltrexone|naltrexone|mesh-list
6807159|NCT02324725|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6807160|NCT02324725|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6807161|NCT02324725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807162|NCT02324725|Sensory System Agents|sensory system agents|mesh-ancestor
6807163|NCT02324725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6807164|NCT02324738|Piperaquine|piperaquine|mesh-list
6807165|NCT02324738|Artenimol|artenimol|mesh-list
6807166|NCT02324738|Mefloquine|mefloquine|mesh-list
6807167|NCT02324738|Antimalarials|antimalarials|mesh-ancestor
6807168|NCT02324738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6807169|NCT02324738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6807170|NCT02324738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6807171|NCT02324933|Fentanyl|fentanyl|mesh-list
6807172|NCT02324933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6807173|NCT02324933|Narcotics|narcotics|mesh-ancestor
6807174|NCT02324933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6807175|NCT02324933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807176|NCT02324933|Analgesics|analgesics|mesh-ancestor
6807177|NCT02324933|Sensory System Agents|sensory system agents|mesh-ancestor
6807178|NCT02324933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6807179|NCT02324933|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6807180|NCT02324933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6807181|NCT02324933|Anesthetics, General|anesthetics, general|mesh-ancestor
6807182|NCT02324933|Anesthetics|anesthetics|mesh-ancestor
6807183|NCT02324998|Olaparib|olaparib|mesh-list
6807184|NCT02324998|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6807185|NCT02324998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6807186|NCT02324998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807187|NCT02324998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6807188|NCT02325011|Fluconazole|fluconazole|mesh-list
6807189|NCT02325011|Nabiximols|nabiximols|mesh-list
6807190|NCT02325011|Dronabinol|dronabinol|mesh-list
6807191|NCT02325011|Cannabidiol|cannabidiol|mesh-list
6807192|NCT02325011|Antifungal Agents|antifungal agents|mesh-ancestor
6807193|NCT02325011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6807194|NCT02325011|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6807195|NCT02325011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6807196|NCT02325011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6807197|NCT02325011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807198|NCT02325011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6807199|NCT02325011|Hormone Antagonists|hormone antagonists|mesh-ancestor
6807200|NCT02325011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6807201|NCT02325011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807202|NCT02325011|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6807203|NCT02325011|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6807204|NCT02325011|Analgesics|analgesics|mesh-ancestor
6807205|NCT02325011|Sensory System Agents|sensory system agents|mesh-ancestor
6807206|NCT02325011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6807207|NCT02325011|Anticonvulsants|anticonvulsants|mesh-ancestor
6807208|NCT02325011|Hallucinogens|hallucinogens|mesh-ancestor
6807209|NCT02325011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6807210|NCT02325011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6807211|NCT02325011|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6807212|NCT02325011|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6807213|NCT02325011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6807214|NCT02325011|Hormones|hormones|mesh-ancestor
6807215|NCT02325024|Nabiximols|nabiximols|mesh-list
6807216|NCT02325024|Analgesics|analgesics|mesh-ancestor
6807217|NCT02325024|Sensory System Agents|sensory system agents|mesh-ancestor
6807218|NCT02325024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6807219|NCT02325024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807220|NCT02325063|Botulinum Toxins|botulinum toxins|mesh-list
6807221|NCT02325063|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6807222|NCT02325063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6807223|NCT02325063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807224|NCT02325063|Cholinergic Agents|cholinergic agents|mesh-ancestor
6807225|NCT02325063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6807226|NCT02325063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807227|NCT02325180|Lumefantrine|lumefantrine|mesh-list
6807228|NCT02325180|Artemether|artemether|mesh-list
6807229|NCT02325180|Piperaquine|piperaquine|mesh-list
6807230|NCT02325180|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6807231|NCT02325180|Artenimol|artenimol|mesh-list
6807232|NCT02325180|Antimalarials|antimalarials|mesh-ancestor
6807233|NCT02325180|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6807234|NCT02325180|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6807235|NCT02325180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6807236|NCT02325206|Dapagliflozin|dapagliflozin|mesh-list
6807237|NCT02325206|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6807238|NCT02325206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807239|NCT02325206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6807240|NCT02325206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807241|NCT02325245|Metformin|metformin|mesh-list
6807242|NCT02325245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6807243|NCT02325245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807244|NCT02325349|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
6807245|NCT02325349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807246|NCT02325362|Miglustat|miglustat|mesh-list
6807247|NCT02325362|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
6807248|NCT02325362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6807249|NCT02325362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807250|NCT02325362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6807251|NCT02325362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6807252|NCT02325362|Antiviral Agents|antiviral agents|mesh-ancestor
6807253|NCT02325362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6807254|NCT02325362|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6807255|NCT02325362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6807256|NCT02325362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807257|NCT02325440|Natalizumab|natalizumab|mesh-list
6807258|NCT02325440|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6807259|NCT02325440|Immunologic Factors|immunologic factors|mesh-ancestor
6807260|NCT02325440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807261|NCT02325440|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6807262|NCT02325440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807263|NCT02325440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6807264|NCT02325466|Aspirin|aspirin|mesh-list
6807265|NCT02325466|Ticagrelor|ticagrelor|mesh-list
6807266|NCT02325466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6807267|NCT02325466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6807268|NCT02325466|Analgesics|analgesics|mesh-ancestor
6807269|NCT02325466|Sensory System Agents|sensory system agents|mesh-ancestor
6807270|NCT02325466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6807271|NCT02325466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807272|NCT02325466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6807273|NCT02325466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6807274|NCT02325466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6807275|NCT02325466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6807276|NCT02325466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807277|NCT02325466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6807278|NCT02325466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6807279|NCT02325466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6807280|NCT02325466|Antipyretics|antipyretics|mesh-ancestor
6807281|NCT02325466|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6807282|NCT02325466|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6807283|NCT02325466|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6807284|NCT02325466|Purinergic Agents|purinergic agents|mesh-ancestor
6807285|NCT02325466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6807286|NCT02325479|Enoxaparin|enoxaparin|mesh-list
6807287|NCT02325479|Anticoagulants|anticoagulants|mesh-ancestor
6807288|NCT02325479|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6807289|NCT02325479|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6807290|NCT02325479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807291|NCT02325557|Pembrolizumab|pembrolizumab|mesh-list
6807292|NCT02325557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6807293|NCT02325557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6807294|NCT02325583|Midazolam|midazolam|mesh-list
6807295|NCT02325583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6807296|NCT02325583|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6807297|NCT02325583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6807298|NCT02325583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807299|NCT02325583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6807300|NCT02325583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6807301|NCT02325583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6807302|NCT02325583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6807303|NCT02325583|Anesthetics, General|anesthetics, general|mesh-ancestor
6807304|NCT02325583|Anesthetics|anesthetics|mesh-ancestor
6807305|NCT02325583|GABA Modulators|gaba modulators|mesh-ancestor
6807306|NCT02325583|GABA Agents|gaba agents|mesh-ancestor
6807307|NCT02325583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6807308|NCT02325583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807309|NCT02325882|Fentanyl|fentanyl|mesh-list
6807310|NCT02325882|Dexmedetomidine|dexmedetomidine|mesh-list
6807311|NCT02325882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6807312|NCT02325882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6807313|NCT02325882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807314|NCT02325882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6807315|NCT02325882|Analgesics|analgesics|mesh-ancestor
6807316|NCT02325882|Sensory System Agents|sensory system agents|mesh-ancestor
6807317|NCT02325882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6807318|NCT02325882|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6807319|NCT02325882|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6807320|NCT02325882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6807321|NCT02325882|Adrenergic Agents|adrenergic agents|mesh-ancestor
6807322|NCT02325882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6807323|NCT02325882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807324|NCT02325882|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6807325|NCT02325882|Narcotics|narcotics|mesh-ancestor
6807326|NCT02325882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6807327|NCT02325882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6807328|NCT02325882|Anesthetics, General|anesthetics, general|mesh-ancestor
6807329|NCT02325882|Anesthetics|anesthetics|mesh-ancestor
6807330|NCT02325934|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6807331|NCT02325934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6807332|NCT02325934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6807333|NCT02325934|Antiviral Agents|antiviral agents|mesh-ancestor
6807334|NCT02325934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6807335|NCT05144854|Capecitabine|capecitabine|mesh-list
6807336|NCT05144854|Tegafur|tegafur|mesh-list
6807337|NCT05144854|Oxaliplatin|oxaliplatin|mesh-list
6807338|NCT05144854|Nivolumab|nivolumab|mesh-list
6807339|NCT05144854|Ipilimumab|ipilimumab|mesh-list
6807340|NCT05144854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6807341|NCT05144854|Antimetabolites|antimetabolites|mesh-ancestor
6807342|NCT05144854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807343|NCT05144854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6807344|NCT05144854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6807345|NCT05144854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6807346|NCT05144529|Nivolumab|nivolumab|mesh-list
6807347|NCT05144529|Ipilimumab|ipilimumab|mesh-list
6807348|NCT05144529|Evolocumab|evolocumab|mesh-list
6807349|NCT05144529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6807350|NCT05144529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6807351|NCT05144529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6807352|NCT05144529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807353|NCT05144529|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6807354|NCT05144529|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6807355|NCT05144529|Antimetabolites|antimetabolites|mesh-ancestor
6807356|NCT05144529|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6807357|NCT05144399|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6807358|NCT05144399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6807359|NCT05144282|Bevacizumab|bevacizumab|mesh-list
6807360|NCT05144282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6807361|NCT05144282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6807362|NCT05144282|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6807363|NCT05144282|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6807364|NCT05144282|Growth Substances|growth substances|mesh-ancestor
6807365|NCT05144282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807366|NCT05144282|Growth Inhibitors|growth inhibitors|mesh-ancestor
6807367|NCT05144100|Cisplatin|cisplatin|mesh-list
6807368|NCT05144100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6807369|NCT05144009|Prednisone|prednisone|mesh-list
6807370|NCT05144009|Cyclophosphamide|cyclophosphamide|mesh-list
6807371|NCT05144009|Rituximab|rituximab|mesh-list
6807372|NCT05144009|Doxorubicin|doxorubicin|mesh-list
6807373|NCT05144009|Vincristine|vincristine|mesh-list
6807374|NCT05144009|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
6807375|NCT05144009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6807376|NCT05144009|Immunologic Factors|immunologic factors|mesh-ancestor
6807377|NCT05144009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807378|NCT05144009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6807379|NCT05144009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6807380|NCT05144009|Alkylating Agents|alkylating agents|mesh-ancestor
6807381|NCT05144009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807382|NCT05144009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6807383|NCT05144009|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6807384|NCT05144009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6807385|NCT05144009|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6807386|NCT05144009|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6807387|NCT05144009|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6807388|NCT05144009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6807389|NCT05144009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6807390|NCT05144009|Glucocorticoids|glucocorticoids|mesh-ancestor
6807391|NCT05144009|Hormones|hormones|mesh-ancestor
6807392|NCT05144009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6807393|NCT05144009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6807394|NCT05144009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6807395|NCT05144009|Tubulin Modulators|tubulin modulators|mesh-ancestor
6807396|NCT05144009|Antimitotic Agents|antimitotic agents|mesh-ancestor
6807397|NCT05144009|Mitosis Modulators|mitosis modulators|mesh-ancestor
6807398|NCT05143762|Acetaminophen|acetaminophen|mesh-list
6807399|NCT05143762|Dexamethasone|dexamethasone|mesh-list
6807400|NCT05143762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6807401|NCT05143762|Antiemetics|antiemetics|mesh-ancestor
6807402|NCT05143762|Autonomic Agents|autonomic agents|mesh-ancestor
6807403|NCT05143762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6807404|NCT05143762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807405|NCT05143762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6807406|NCT05143762|Glucocorticoids|glucocorticoids|mesh-ancestor
6807407|NCT05143762|Hormones|hormones|mesh-ancestor
6807408|NCT05143762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6807409|NCT05143762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6807410|NCT05143762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6807411|NCT05143762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6807412|NCT05143762|Analgesics|analgesics|mesh-ancestor
6807413|NCT05143762|Sensory System Agents|sensory system agents|mesh-ancestor
6807414|NCT05143762|Antipyretics|antipyretics|mesh-ancestor
6807415|NCT05143723|Hormones|hormones|mesh-list
6807416|NCT05143723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6807417|NCT05143723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807418|NCT05143502|Fluticasone|fluticasone|mesh-list
6807419|NCT05143502|Xhance|xhance|mesh-list
6807420|NCT05143502|Prednisolone|prednisolone|mesh-list
6807421|NCT05143502|Montelukast|montelukast|mesh-list
6807422|NCT05143502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6807423|NCT05143502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6807424|NCT05143502|Autonomic Agents|autonomic agents|mesh-ancestor
6807425|NCT05143502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6807426|NCT05143502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807427|NCT05143502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6807428|NCT05143502|Respiratory System Agents|respiratory system agents|mesh-ancestor
6807429|NCT05143502|Dermatologic Agents|dermatologic agents|mesh-ancestor
5993445|NCT00121992|Tubulin Modulators|tubulin modulators|mesh-ancestor
6807430|NCT05143502|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6807431|NCT05143502|Glucocorticoids|glucocorticoids|mesh-ancestor
6807432|NCT05143502|Hormones|hormones|mesh-ancestor
6807433|NCT05143502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6807434|NCT05143502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6807435|NCT05143502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6807436|NCT05143502|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6807437|NCT05143502|Hormone Antagonists|hormone antagonists|mesh-ancestor
6807438|NCT05143502|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6807439|NCT05143502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6807440|NCT05143502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807441|NCT05143281|Dexamethasone|dexamethasone|mesh-list
6807442|NCT05143281|Dexamethasone acetate|dexamethasone acetate|mesh-list
6807443|NCT05143281|BB 1101|bb 1101|mesh-list
6807444|NCT05143281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6807445|NCT05143281|Antiemetics|antiemetics|mesh-ancestor
6807446|NCT05143281|Autonomic Agents|autonomic agents|mesh-ancestor
6807447|NCT05143281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6807448|NCT05143281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807449|NCT05143281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6807450|NCT05143281|Glucocorticoids|glucocorticoids|mesh-ancestor
6807451|NCT05143281|Hormones|hormones|mesh-ancestor
6807452|NCT05143281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6807453|NCT05143281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6807454|NCT05143281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6807455|NCT05143281|Protease Inhibitors|protease inhibitors|mesh-ancestor
6807456|NCT05143281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6807457|NCT05143281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807458|NCT05143164|Gentamicins|gentamicins|mesh-list
6807459|NCT05143164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6807460|NCT05143164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6807461|NCT05143164|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6807462|NCT05143164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6807463|NCT05143164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807464|NCT05143125|Decitabine|decitabine|mesh-list
6807465|NCT05143125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6807466|NCT05143125|Antimetabolites|antimetabolites|mesh-ancestor
6807467|NCT05143125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807468|NCT05143125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6807469|NCT05143125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6807470|NCT05142904|Iodine|iodine|mesh-list
6807471|NCT05142904|Cadexomer iodine|cadexomer iodine|mesh-list
6807472|NCT05142904|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6807473|NCT05142904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6807474|NCT05142904|Trace Elements|trace elements|mesh-ancestor
6807475|NCT05142904|Micronutrients|micronutrients|mesh-ancestor
6807476|NCT05142904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807477|NCT05142865|Carboplatin|carboplatin|mesh-list
6807478|NCT05142865|Etoposide|etoposide|mesh-list
6807479|NCT05142865|Apatinib|apatinib|mesh-list
6807480|NCT05142865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6807481|NCT05142865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6807482|NCT05142865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6807483|NCT05142865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6807484|NCT05142865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6807485|NCT05142865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807486|NCT05142865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6807487|NCT05142709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
6807488|NCT05142709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807489|NCT05142709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6807490|NCT05118737|Colchicine|colchicine|mesh-list
6807491|NCT05118737|Gout Suppressants|gout suppressants|mesh-ancestor
6807492|NCT05118737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6807493|NCT05118737|Tubulin Modulators|tubulin modulators|mesh-ancestor
6807494|NCT05118737|Antimitotic Agents|antimitotic agents|mesh-ancestor
6807495|NCT05118737|Mitosis Modulators|mitosis modulators|mesh-ancestor
6807496|NCT05118737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807497|NCT05118737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6807498|NCT05118685|Estrogens|estrogens|mesh-list
6807499|NCT05118685|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6807500|NCT05118685|Hormones|hormones|mesh-ancestor
6807501|NCT05118685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6807502|NCT05118685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807503|NCT05109364|Terazosin|terazosin|mesh-list
6807504|NCT05109364|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6807505|NCT05109364|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5993446|NCT00121992|Antimitotic Agents|antimitotic agents|mesh-ancestor
5993447|NCT00121992|Mitosis Modulators|mitosis modulators|mesh-ancestor
5993448|NCT00121992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5993449|NCT00121992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5993450|NCT00121992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5993451|NCT00121992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5993452|NCT00121992|Antimetabolites|antimetabolites|mesh-ancestor
5993453|NCT00121992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5993454|NCT00122278|Dexamethasone|dexamethasone|mesh-list
5993455|NCT00122278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5993456|NCT00122278|Antiemetics|antiemetics|mesh-ancestor
5993457|NCT00122278|Autonomic Agents|autonomic agents|mesh-ancestor
5993458|NCT00122278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5993459|NCT00122278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993460|NCT00122278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5993461|NCT00122278|Glucocorticoids|glucocorticoids|mesh-ancestor
5993462|NCT00122278|Hormones|hormones|mesh-ancestor
5993463|NCT00122278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5993464|NCT00122278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6807506|NCT05109364|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6807507|NCT05109364|Adrenergic Agents|adrenergic agents|mesh-ancestor
6807508|NCT05109364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6807509|NCT05109364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807510|NCT05109364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807511|NCT05109364|Urological Agents|urological agents|mesh-ancestor
6807512|NCT05055024|Mazindol|mazindol|mesh-list
6807513|NCT05055024|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6807514|NCT05055024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807515|NCT05055024|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6807516|NCT05055024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6807517|NCT05055024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6807518|NCT05055024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807519|NCT05055024|Adrenergic Agents|adrenergic agents|mesh-ancestor
6807520|NCT05055024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6807521|NCT05055024|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6807522|NCT05055024|Dopamine Agents|dopamine agents|mesh-ancestor
6807523|NCT05045313|Probenecid|probenecid|mesh-list
6807524|NCT05045313|Digoxin|digoxin|mesh-list
6807525|NCT05045313|Warfarin|warfarin|mesh-list
6807526|NCT05045313|Anticoagulants|anticoagulants|mesh-ancestor
6807527|NCT05045313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6807528|NCT05045313|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6807529|NCT05045313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6807530|NCT05045313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807531|NCT05045313|Protective Agents|protective agents|mesh-ancestor
6807532|NCT05045313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807533|NCT05045313|Uricosuric Agents|uricosuric agents|mesh-ancestor
6807534|NCT05045313|Gout Suppressants|gout suppressants|mesh-ancestor
6807535|NCT05045313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6807536|NCT05045313|Renal Agents|renal agents|mesh-ancestor
6807537|NCT05042466|Psilocybin|psilocybin|mesh-list
6807538|NCT05042466|Hallucinogens|hallucinogens|mesh-ancestor
6807539|NCT05042466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807540|NCT05042466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6807541|NCT05037552|Hemostatics|hemostatics|mesh-list
6807542|NCT05037552|Coagulants|coagulants|mesh-ancestor
6807543|NCT05036980|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
6807544|NCT05036980|Antioxidants|antioxidants|mesh-ancestor
6807545|NCT05036980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807546|NCT05036980|Protective Agents|protective agents|mesh-ancestor
6807547|NCT05036980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807548|NCT05036980|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6807549|NCT05036980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6807550|NCT05021926|Lidocaine|lidocaine|mesh-list
6807551|NCT05021926|Hyaluronic Acid|hyaluronic acid|mesh-list
6807552|NCT05021926|Anesthetics, Local|anesthetics, local|mesh-ancestor
6807553|NCT05021926|Anesthetics|anesthetics|mesh-ancestor
6807554|NCT05021926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6807555|NCT05021926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807556|NCT05021926|Sensory System Agents|sensory system agents|mesh-ancestor
6258656|NCT03095118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6258657|NCT03095508|Menthol|menthol|mesh-list
6807557|NCT05021926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6807558|NCT05021926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6807559|NCT05021926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6807560|NCT05021926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6807561|NCT05021926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6807562|NCT05021926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807563|NCT05021926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6807564|NCT05021926|Immunologic Factors|immunologic factors|mesh-ancestor
6807565|NCT05021926|Viscosupplements|viscosupplements|mesh-ancestor
6807566|NCT05021926|Protective Agents|protective agents|mesh-ancestor
6807567|NCT05021913|Lidocaine|lidocaine|mesh-list
6807568|NCT05021913|Hyaluronic Acid|hyaluronic acid|mesh-list
6807569|NCT05021913|Anesthetics, Local|anesthetics, local|mesh-ancestor
6807570|NCT05021913|Anesthetics|anesthetics|mesh-ancestor
6807571|NCT05021913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6807572|NCT05021913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807573|NCT05021913|Sensory System Agents|sensory system agents|mesh-ancestor
6807574|NCT05021913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6807575|NCT05021913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6807576|NCT05021913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6807577|NCT05021913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6807578|NCT05021913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6807579|NCT05021913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807580|NCT05021913|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6807581|NCT05021913|Immunologic Factors|immunologic factors|mesh-ancestor
6807582|NCT05021913|Viscosupplements|viscosupplements|mesh-ancestor
6807583|NCT05021913|Protective Agents|protective agents|mesh-ancestor
6807584|NCT04987931|Talazoparib|talazoparib|mesh-list
6807585|NCT04987931|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6807586|NCT04987931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6807587|NCT04987931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807588|NCT04987931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6807589|NCT04967092|Anti-Allergic Agents|anti-allergic agents|mesh-list
6807590|NCT04961190|Paroxetine|paroxetine|mesh-list
6807591|NCT04961190|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6807592|NCT04961190|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6807593|NCT04961190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6807594|NCT04961190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6807595|NCT04961190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807596|NCT04961190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6807597|NCT04961190|Serotonin Agents|serotonin agents|mesh-ancestor
6807598|NCT04961190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807599|NCT04961190|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6807600|NCT04961190|Antidepressive Agents|antidepressive agents|mesh-ancestor
6807601|NCT04961190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6807602|NCT04961190|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6807603|NCT04961190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6807604|NCT04961190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6807605|NCT04961190|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6807606|NCT04958811|Bevacizumab|bevacizumab|mesh-list
6807607|NCT04958811|Atezolizumab|atezolizumab|mesh-list
6807608|NCT04958811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6807609|NCT04958811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6807610|NCT04958811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6807611|NCT04958811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6807612|NCT04958811|Growth Substances|growth substances|mesh-ancestor
6807613|NCT04958811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807614|NCT04958811|Growth Inhibitors|growth inhibitors|mesh-ancestor
6807615|NCT04956627|Itraconazole|itraconazole|mesh-list
6807616|NCT04956627|Phenytoin|phenytoin|mesh-list
6807617|NCT04956627|Gemfibrozil|gemfibrozil|mesh-list
6807618|NCT04956627|Antifungal Agents|antifungal agents|mesh-ancestor
6807619|NCT04956627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6807620|NCT04956627|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6807621|NCT04956627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6807622|NCT04956627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6807623|NCT04956627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807624|NCT04956627|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6807625|NCT04956627|Hormone Antagonists|hormone antagonists|mesh-ancestor
6807626|NCT04956627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6807627|NCT04956627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807628|NCT04956627|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6807629|NCT04956627|Anticonvulsants|anticonvulsants|mesh-ancestor
6807630|NCT04956627|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6807631|NCT04956627|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6807632|NCT04956627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6807633|NCT04956627|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6807634|NCT04956627|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6807635|NCT04956627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6807636|NCT04956627|Antimetabolites|antimetabolites|mesh-ancestor
6807637|NCT04956627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6807638|NCT04956627|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6807639|NCT04929847|Emollients|emollients|mesh-list
6807640|NCT04929847|Dermatologic Agents|dermatologic agents|mesh-ancestor
6807641|NCT04929834|Emollients|emollients|mesh-list
6807642|NCT04929834|Dermatologic Agents|dermatologic agents|mesh-ancestor
6807643|NCT04881955|Ecopipam|ecopipam|mesh-list
6807644|NCT04881955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6807645|NCT04881955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6807646|NCT04881955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6807647|NCT04881955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807648|NCT04881955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6807649|NCT04881955|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6807650|NCT04881955|Dopamine Agents|dopamine agents|mesh-ancestor
6807651|NCT04881955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6807652|NCT04881955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807653|NCT04850222|Fluoxetine|fluoxetine|mesh-list
6807654|NCT04850222|Calcium|calcium|mesh-list
6807655|NCT04850222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6807656|NCT04850222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807657|NCT04850222|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6807658|NCT04850222|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6807659|NCT04850222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6807660|NCT04850222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807661|NCT04850222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6807662|NCT04850222|Serotonin Agents|serotonin agents|mesh-ancestor
6807663|NCT04850222|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6807664|NCT04850222|Antidepressive Agents|antidepressive agents|mesh-ancestor
6807665|NCT04850222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6807666|NCT04850222|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6807667|NCT04850222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6807668|NCT04850222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6807669|NCT04747054|Pembrolizumab|pembrolizumab|mesh-list
6807670|NCT04747054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6807671|NCT04747054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6807672|NCT04724967|Dimenhydrinate|dimenhydrinate|mesh-list
6807673|NCT04724967|Antiemetics|antiemetics|mesh-ancestor
6807674|NCT04724967|Autonomic Agents|autonomic agents|mesh-ancestor
6807675|NCT04724967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6807676|NCT04724967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807677|NCT04724967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6807678|NCT04724967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6807679|NCT04724967|Histamine Antagonists|histamine antagonists|mesh-ancestor
6807680|NCT04724967|Histamine Agents|histamine agents|mesh-ancestor
6807681|NCT04724967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6807682|NCT04724967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807683|NCT04722952|Cytarabine|cytarabine|mesh-list
6807684|NCT04722952|Azacitidine|azacitidine|mesh-list
6807685|NCT04722952|Homoharringtonine|homoharringtonine|mesh-list
6807686|NCT04722952|Visilizumab|visilizumab|mesh-list
6807687|NCT04722952|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6807688|NCT04722952|Antimetabolites|antimetabolites|mesh-ancestor
6807689|NCT04722952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807690|NCT04722952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6807691|NCT04722952|Antiviral Agents|antiviral agents|mesh-ancestor
6807692|NCT04722952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6807693|NCT04722952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6807694|NCT04722952|Immunologic Factors|immunologic factors|mesh-ancestor
6807695|NCT04722952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807696|NCT04722952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6807697|NCT04722952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6807698|NCT04722952|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6807699|NCT04716933|Carboplatin|carboplatin|mesh-list
6807700|NCT04716933|Pembrolizumab|pembrolizumab|mesh-list
6807701|NCT04716933|Pemetrexed|pemetrexed|mesh-list
6807702|NCT04716933|Lenvatinib|lenvatinib|mesh-list
6807703|NCT04716933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6807704|NCT04716933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6807705|NCT04716933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6807706|NCT04716933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807707|NCT04716933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6807708|NCT04716933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6807709|NCT04716933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6807710|NCT04715191|Cyclophosphamide|cyclophosphamide|mesh-list
6807711|NCT04715191|Fludarabine|fludarabine|mesh-list
6807712|NCT04715191|Fludarabine phosphate|fludarabine phosphate|mesh-list
6807713|NCT04715191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6807714|NCT04715191|Immunologic Factors|immunologic factors|mesh-ancestor
6807715|NCT04715191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807716|NCT04715191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6807717|NCT04715191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6807718|NCT04715191|Alkylating Agents|alkylating agents|mesh-ancestor
6807719|NCT04715191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807720|NCT04715191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6807721|NCT04715191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6807722|NCT04715191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6807723|NCT04715191|Antimetabolites|antimetabolites|mesh-ancestor
6807724|NCT04711902|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6807725|NCT04711902|Immunologic Factors|immunologic factors|mesh-ancestor
6807726|NCT04711902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807727|NCT04707664|Sargramostim|sargramostim|mesh-list
6807728|NCT04707664|Immunologic Factors|immunologic factors|mesh-ancestor
6807729|NCT04707664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807730|NCT04703361|Niacin|niacin|mesh-list
6807731|NCT04703361|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6807732|NCT04703361|Antimetabolites|antimetabolites|mesh-ancestor
6807733|NCT04703361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807734|NCT04703361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6807735|NCT04703361|Vasodilator Agents|vasodilator agents|mesh-ancestor
6807736|NCT04703361|Vitamin B Complex|vitamin b complex|mesh-ancestor
6807737|NCT04703361|Vitamins|vitamins|mesh-ancestor
6807738|NCT04703361|Micronutrients|micronutrients|mesh-ancestor
6807739|NCT04703361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807740|NCT04674241|Dexmedetomidine|dexmedetomidine|mesh-list
6807741|NCT04674241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6807742|NCT04674241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6807743|NCT04674241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807744|NCT04674241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6807745|NCT04674241|Analgesics|analgesics|mesh-ancestor
6807746|NCT04674241|Sensory System Agents|sensory system agents|mesh-ancestor
6807747|NCT04674241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6807748|NCT04674241|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6807749|NCT04674241|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6807750|NCT04674241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6807751|NCT04674241|Adrenergic Agents|adrenergic agents|mesh-ancestor
6807752|NCT04674241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6807753|NCT04674241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807754|NCT04670068|Cyclophosphamide|cyclophosphamide|mesh-list
6807755|NCT04670068|Fludarabine|fludarabine|mesh-list
6807756|NCT04670068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6807757|NCT04670068|Immunologic Factors|immunologic factors|mesh-ancestor
6807758|NCT04670068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807759|NCT04670068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6807760|NCT04670068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6807761|NCT04670068|Alkylating Agents|alkylating agents|mesh-ancestor
6807762|NCT04670068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807763|NCT04670068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6807764|NCT04670068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6807765|NCT04650204|Anticonvulsants|anticonvulsants|mesh-list
6807766|NCT04641728|Pembrolizumab|pembrolizumab|mesh-list
6807767|NCT04641728|Olaparib|olaparib|mesh-list
6807768|NCT04641728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6807769|NCT04641728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6807770|NCT04641728|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6807771|NCT04641728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6807772|NCT04641728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807773|NCT04600895|Favipiravir|favipiravir|mesh-list
6807774|NCT04600895|Antiviral Agents|antiviral agents|mesh-ancestor
6807775|NCT04600895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6807776|NCT04586660|Denosumab|denosumab|mesh-list
6807777|NCT04586660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6807778|NCT04586660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807779|NCT04558359|Angiotensin II|angiotensin ii|mesh-list
6807780|NCT04558359|Giapreza|giapreza|mesh-list
6807781|NCT04558359|Angiotensinogen|angiotensinogen|mesh-list
6807782|NCT04558359|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6807783|NCT04558359|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6807784|NCT04558359|Protease Inhibitors|protease inhibitors|mesh-ancestor
6807785|NCT04558359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6807786|NCT04558359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807787|NCT04551144|Methyltestosterone|methyltestosterone|mesh-list
6807788|NCT04551144|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6807789|NCT04551144|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6807790|NCT04551144|Estradiol|estradiol|mesh-list
6807791|NCT04551144|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6807792|NCT04551144|Testosterone|testosterone|mesh-list
6807793|NCT04551144|Testosterone undecanoate|testosterone undecanoate|mesh-list
6807794|NCT04551144|Testosterone enanthate|testosterone enanthate|mesh-list
6807795|NCT04551144|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6807796|NCT04551144|Estrogens|estrogens|mesh-ancestor
6807797|NCT04551144|Hormones|hormones|mesh-ancestor
6807798|NCT04551144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6807799|NCT04551144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807800|NCT04551144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6807801|NCT04551144|Contraceptive Agents|contraceptive agents|mesh-ancestor
6807802|NCT04551144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6807803|NCT04551144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6807804|NCT04551144|Androgens|androgens|mesh-ancestor
6807805|NCT04551144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6807806|NCT04551144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6807807|NCT04551144|Anabolic Agents|anabolic agents|mesh-ancestor
6807808|NCT04541589|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6807809|NCT04541589|Immunologic Factors|immunologic factors|mesh-ancestor
6807810|NCT04541589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807811|NCT04534881|Progesterone|progesterone|mesh-list
6807812|NCT04534881|Progestins|progestins|mesh-ancestor
6807813|NCT04534881|Hormones|hormones|mesh-ancestor
6807814|NCT04534881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6807815|NCT04534881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807816|NCT04532502|Anesthetics|anesthetics|mesh-list
6807817|NCT04532502|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
6807818|NCT04532502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6807819|NCT04532502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807820|NCT04532502|Anesthetics, General|anesthetics, general|mesh-ancestor
6807821|NCT04532463|Fluconazole|fluconazole|mesh-list
6807822|NCT04532463|Amphotericin B|amphotericin b|mesh-list
6807823|NCT04532463|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6807824|NCT04532463|Flucytosine|flucytosine|mesh-list
6807825|NCT04532463|Antifungal Agents|antifungal agents|mesh-ancestor
6807826|NCT04532463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6807827|NCT04532463|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6807828|NCT04532463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6807829|NCT04532463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6807830|NCT04532463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807831|NCT04532463|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6807832|NCT04532463|Hormone Antagonists|hormone antagonists|mesh-ancestor
6807833|NCT04532463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6807834|NCT04532463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807835|NCT04532463|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6807836|NCT04532463|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6807837|NCT04532463|Amebicides|amebicides|mesh-ancestor
6807838|NCT04532463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6807839|NCT04532463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6807840|NCT04532463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6807841|NCT04532463|Antimetabolites|antimetabolites|mesh-ancestor
6807842|NCT04496908|Misoprostol|misoprostol|mesh-list
6807843|NCT04496908|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6807844|NCT04496908|Abortifacient Agents|abortifacient agents|mesh-ancestor
6807845|NCT04496908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6807846|NCT04496908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807847|NCT04496908|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6807848|NCT04496908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6807849|NCT04496908|Oxytocics|oxytocics|mesh-ancestor
6807850|NCT04452747|Dinoprostone|dinoprostone|mesh-list
6807851|NCT04452747|Oxytocics|oxytocics|mesh-ancestor
6807852|NCT04452747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6807853|NCT04452747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807854|NCT04384107|Vaccines|vaccines|mesh-list
6807855|NCT04384107|Immunologic Factors|immunologic factors|mesh-ancestor
6807856|NCT04384107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807857|NCT04382924|Ifenprodil|ifenprodil|mesh-list
6807858|NCT04382924|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6807859|NCT04382924|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6807860|NCT04382924|Adrenergic Agents|adrenergic agents|mesh-ancestor
6807861|NCT04382924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6807862|NCT04382924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807863|NCT04382924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807864|NCT04382924|Vasodilator Agents|vasodilator agents|mesh-ancestor
6807865|NCT04382924|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6807866|NCT04382924|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6807867|NCT04377932|Cyclophosphamide|cyclophosphamide|mesh-list
6807868|NCT04377932|Fludarabine|fludarabine|mesh-list
6807869|NCT04377932|Fludarabine phosphate|fludarabine phosphate|mesh-list
6807870|NCT04377932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6807871|NCT04377932|Immunologic Factors|immunologic factors|mesh-ancestor
6807872|NCT04377932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807873|NCT04377932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6807874|NCT04377932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5993465|NCT00122278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5993466|NCT00122317|Eculizumab|eculizumab|mesh-list
5993467|NCT00122317|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5993468|NCT00122317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5993469|NCT00122317|Immunologic Factors|immunologic factors|mesh-ancestor
5993470|NCT00122317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993471|NCT00122369|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
5993472|NCT00122369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5993473|NCT00122369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993474|NCT00122382|Methotrexate|methotrexate|mesh-list
5993475|NCT00122382|Abatacept|abatacept|mesh-list
5993476|NCT00122382|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5993477|NCT00122382|Abortifacient Agents|abortifacient agents|mesh-ancestor
5993478|NCT00122382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5993479|NCT00122382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993480|NCT00122382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5993481|NCT00122382|Antimetabolites|antimetabolites|mesh-ancestor
5993482|NCT00122382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5993483|NCT00122382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6807875|NCT04377932|Alkylating Agents|alkylating agents|mesh-ancestor
6807876|NCT04377932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807877|NCT04377932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6807878|NCT04377932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6807879|NCT04377932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6807880|NCT04377932|Antimetabolites|antimetabolites|mesh-ancestor
6807881|NCT04371640|Sirolimus|sirolimus|mesh-list
6807882|NCT04371640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6807883|NCT04371640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6807884|NCT04371640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6807885|NCT04371640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6807886|NCT04371640|Antifungal Agents|antifungal agents|mesh-ancestor
6807887|NCT04371640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6807888|NCT04371640|Immunologic Factors|immunologic factors|mesh-ancestor
6807889|NCT04371640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258658|NCT03095508|Antipruritics|antipruritics|mesh-ancestor
6258659|NCT03095508|Dermatologic Agents|dermatologic agents|mesh-ancestor
6258660|NCT03095521|Menthol|menthol|mesh-list
6258661|NCT03095521|Antipruritics|antipruritics|mesh-ancestor
6258662|NCT03095521|Dermatologic Agents|dermatologic agents|mesh-ancestor
6258663|NCT03095638|Dolutegravir|dolutegravir|mesh-list
6807890|NCT04364997|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6258664|NCT03095638|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6258665|NCT03095638|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6258666|NCT03095638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6258667|NCT03095638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258668|NCT03095638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6258669|NCT03095638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6258670|NCT03095638|Antiviral Agents|antiviral agents|mesh-ancestor
6258671|NCT03095638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6258672|NCT03095651|Insulin Glargine|insulin glargine|mesh-list
6258673|NCT03095651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6258674|NCT03095651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258675|NCT03096314|Vitamin D|vitamin d|mesh-list
6258676|NCT03096314|Cholecalciferol|cholecalciferol|mesh-list
6807891|NCT04364997|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6807892|NCT04364997|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6807893|NCT04364997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6807894|NCT04364997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6807895|NCT04364997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807896|NCT04364997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6807897|NCT04364997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807898|NCT04364997|Analgesics|analgesics|mesh-ancestor
6807899|NCT04364997|Sensory System Agents|sensory system agents|mesh-ancestor
6807900|NCT04364997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6807901|NCT04364997|Antidepressive Agents|antidepressive agents|mesh-ancestor
6807902|NCT04364997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6807903|NCT04364997|Dopamine Agents|dopamine agents|mesh-ancestor
6807904|NCT04356196|Verapamil|verapamil|mesh-list
6807905|NCT04356196|Bisoprolol|bisoprolol|mesh-list
6807906|NCT04356196|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6807907|NCT04356196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6807908|NCT04356196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6807909|NCT04356196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807910|NCT04356196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6807911|NCT04356196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807912|NCT04356196|Vasodilator Agents|vasodilator agents|mesh-ancestor
6807913|NCT04356196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6807914|NCT04356196|Sympatholytics|sympatholytics|mesh-ancestor
6807915|NCT04356196|Autonomic Agents|autonomic agents|mesh-ancestor
6807916|NCT04356196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6807917|NCT04356196|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6807918|NCT04356196|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6807919|NCT04356196|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6807920|NCT04356196|Adrenergic Agents|adrenergic agents|mesh-ancestor
6807921|NCT04356196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6807922|NCT04306315|Brodalumab|brodalumab|mesh-list
6807923|NCT04306315|Dermatologic Agents|dermatologic agents|mesh-ancestor
6807924|NCT04258410|Quercetin|quercetin|mesh-list
6807925|NCT04258410|Antioxidants|antioxidants|mesh-ancestor
6807926|NCT04258410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807927|NCT04258410|Protective Agents|protective agents|mesh-ancestor
6807928|NCT04258410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807929|NCT04224688|Rozanolixizumab|rozanolixizumab|mesh-list
6807930|NCT04224688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6807931|NCT04224688|Immunologic Factors|immunologic factors|mesh-ancestor
6807932|NCT04224688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807933|NCT04218123|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6807934|NCT04218123|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6807935|NCT04218123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6807936|NCT04218123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6807937|NCT04218123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807938|NCT04218123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6807939|NCT04218123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807940|NCT04218123|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6807941|NCT04218123|Antidepressive Agents|antidepressive agents|mesh-ancestor
6807942|NCT04218123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6807943|NCT04202679|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
6807944|NCT04202679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6807945|NCT04202679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807946|NCT04199728|Liraglutide|liraglutide|mesh-list
6807947|NCT04199728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6807948|NCT04199728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258677|NCT03096314|Vitamins|vitamins|mesh-ancestor
6258678|NCT03096314|Micronutrients|micronutrients|mesh-ancestor
6807949|NCT04199728|Incretins|incretins|mesh-ancestor
6807950|NCT04199728|Hormones|hormones|mesh-ancestor
6807951|NCT04199728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6807952|NCT04191616|Dexamethasone|dexamethasone|mesh-list
6807953|NCT04191616|Pomalidomide|pomalidomide|mesh-list
6807954|NCT04191616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6807955|NCT04191616|Antiemetics|antiemetics|mesh-ancestor
6807956|NCT04191616|Autonomic Agents|autonomic agents|mesh-ancestor
6807957|NCT04191616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6807958|NCT04191616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807959|NCT04191616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6807960|NCT04191616|Glucocorticoids|glucocorticoids|mesh-ancestor
6807961|NCT04191616|Hormones|hormones|mesh-ancestor
6807962|NCT04191616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6807963|NCT04191616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6807964|NCT04191616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6807965|NCT04191616|Immunologic Factors|immunologic factors|mesh-ancestor
6807966|NCT04191616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6807967|NCT04191616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6807968|NCT04191616|Growth Substances|growth substances|mesh-ancestor
6807969|NCT04191616|Growth Inhibitors|growth inhibitors|mesh-ancestor
6807970|NCT04184622|Tirzepatide|tirzepatide|mesh-list
6807971|NCT04184622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6807972|NCT04184622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807973|NCT04184622|Incretins|incretins|mesh-ancestor
6807974|NCT04184622|Hormones|hormones|mesh-ancestor
6807975|NCT04184622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6807976|NCT04170543|Dapagliflozin|dapagliflozin|mesh-list
6807977|NCT04170543|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6807978|NCT04170543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6807979|NCT04170543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6807980|NCT04170543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807981|NCT04120454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6807982|NCT04120454|Pembrolizumab|pembrolizumab|mesh-list
6807983|NCT04120454|Ramucirumab|ramucirumab|mesh-list
6807984|NCT04120454|Antibodies|antibodies|mesh-list
6807985|NCT04120454|Immunoglobulins|immunoglobulins|mesh-list
6807986|NCT04120454|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6807987|NCT04120454|Lexatumumab|lexatumumab|mesh-list
6807988|NCT04120454|Immunologic Factors|immunologic factors|mesh-ancestor
6807989|NCT04120454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6807990|NCT04120454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6807991|NCT04107168|Bevacizumab|bevacizumab|mesh-list
6807992|NCT04107168|Pembrolizumab|pembrolizumab|mesh-list
6807993|NCT04107168|Nivolumab|nivolumab|mesh-list
6807994|NCT04107168|Ipilimumab|ipilimumab|mesh-list
6807995|NCT04107168|Durvalumab|durvalumab|mesh-list
6807996|NCT04107168|Atezolizumab|atezolizumab|mesh-list
6807997|NCT04107168|Tremelimumab|tremelimumab|mesh-list
6807998|NCT04107168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6807999|NCT04107168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6808000|NCT04107168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6808001|NCT04107168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6808002|NCT04107168|Growth Substances|growth substances|mesh-ancestor
6808003|NCT04107168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808004|NCT04107168|Growth Inhibitors|growth inhibitors|mesh-ancestor
6808005|NCT04107168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6808006|NCT04107168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808007|NCT04098237|Pancrelipase|pancrelipase|mesh-list
6808008|NCT04098237|Pancreatin|pancreatin|mesh-list
6808009|NCT04098237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6808010|NCT04097730|Riboflavin|riboflavin|mesh-list
6808011|NCT04097730|Moxifloxacin|moxifloxacin|mesh-list
6808012|NCT04097730|Difluprednate|difluprednate|mesh-list
6808013|NCT04097730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6808014|NCT04097730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6808015|NCT04097730|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6808016|NCT04097730|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6808017|NCT04097730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6808018|NCT04097730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808019|NCT04097730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6808020|NCT04097730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808021|NCT04097730|Vitamin B Complex|vitamin b complex|mesh-ancestor
6808022|NCT04097730|Vitamins|vitamins|mesh-ancestor
6808023|NCT04097730|Micronutrients|micronutrients|mesh-ancestor
6808024|NCT04097730|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6808025|NCT04097730|Dermatologic Agents|dermatologic agents|mesh-ancestor
6808026|NCT04097730|Glucocorticoids|glucocorticoids|mesh-ancestor
6808027|NCT04097730|Hormones|hormones|mesh-ancestor
6808028|NCT04097730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6808029|NCT04050540|Doxycycline|doxycycline|mesh-list
6808030|NCT04050540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6808031|NCT04050540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6808032|NCT04050540|Antimalarials|antimalarials|mesh-ancestor
6808033|NCT04050540|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6808034|NCT04050540|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6808035|NCT04034459|Leucovorin|leucovorin|mesh-list
6808036|NCT04034459|Folic Acid|folic acid|mesh-list
6808037|NCT04034459|Bevacizumab|bevacizumab|mesh-list
6808038|NCT04034459|Cetuximab|cetuximab|mesh-list
6808039|NCT04034459|Oxaliplatin|oxaliplatin|mesh-list
6808040|NCT04034459|Irinotecan|irinotecan|mesh-list
6808041|NCT04034459|Levoleucovorin|levoleucovorin|mesh-list
6808042|NCT04034459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6808043|NCT04034459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6808044|NCT04034459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6808045|NCT04034459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6808046|NCT04034459|Growth Substances|growth substances|mesh-ancestor
6808047|NCT04034459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808048|NCT04034459|Growth Inhibitors|growth inhibitors|mesh-ancestor
6808049|NCT04034459|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6808050|NCT04034459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6808051|NCT04034459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6808052|NCT04034459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808053|NCT04034459|Antidotes|antidotes|mesh-ancestor
6808054|NCT04034459|Protective Agents|protective agents|mesh-ancestor
6808055|NCT04034459|Vitamin B Complex|vitamin b complex|mesh-ancestor
6808056|NCT04034459|Vitamins|vitamins|mesh-ancestor
6808057|NCT04034459|Micronutrients|micronutrients|mesh-ancestor
6808058|NCT04034459|Hematinics|hematinics|mesh-ancestor
6808059|NCT04030052|Factor VIII|factor viii|mesh-list
6808060|NCT04030052|Coagulants|coagulants|mesh-ancestor
6808061|NCT04008706|Acalabrutinib|acalabrutinib|mesh-list
6808062|NCT04008706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6808063|NCT04005729|Cangrelor|cangrelor|mesh-list
6808064|NCT04005729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6808065|NCT04005729|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6808066|NCT04005729|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6808067|NCT04005729|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6808068|NCT04005729|Purinergic Agents|purinergic agents|mesh-ancestor
6808069|NCT04005729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6808070|NCT04005729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808071|NCT04005729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808072|NCT04000737|Sorafenib|sorafenib|mesh-list
6808073|NCT04000737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6808074|NCT04000737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6808075|NCT04000737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6808076|NCT04000737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808077|NCT03950076|Edoxaban|edoxaban|mesh-list
6808078|NCT03950076|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6808079|NCT03950076|Antithrombins|antithrombins|mesh-ancestor
6808080|NCT03950076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6808081|NCT03950076|Protease Inhibitors|protease inhibitors|mesh-ancestor
6808082|NCT03950076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6808083|NCT03950076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808084|NCT03950076|Anticoagulants|anticoagulants|mesh-ancestor
6808085|NCT03914885|Fludarabine|fludarabine|mesh-list
6808086|NCT03914885|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6808087|NCT03914885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6808088|NCT03914885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808089|NCT03914885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6808090|NCT03914885|Alkylating Agents|alkylating agents|mesh-ancestor
6808091|NCT03913741|Tisotumab vedotin|tisotumab vedotin|mesh-list
6808092|NCT03913741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6808093|NCT03913741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6808094|NCT03885089|Infliximab|infliximab|mesh-list
6808095|NCT03885089|Dermatologic Agents|dermatologic agents|mesh-ancestor
6808096|NCT03885089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6808097|NCT03885089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6808098|NCT03866239|Atezolizumab|atezolizumab|mesh-list
6808099|NCT03866239|Obinutuzumab|obinutuzumab|mesh-list
6808100|NCT03866239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6808101|NCT03866239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6808102|NCT03842436|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6808103|NCT03842436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6808104|NCT03842436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6808105|NCT03842436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6808106|NCT03842436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808107|NCT03842436|Antiviral Agents|antiviral agents|mesh-ancestor
6808108|NCT03842436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6808109|NCT03842436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6808110|NCT03842436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6808111|NCT03823534|Acetaminophen|acetaminophen|mesh-list
6808112|NCT03823534|Ketorolac|ketorolac|mesh-list
6808113|NCT03823534|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
6808114|NCT03823534|Morphine|morphine|mesh-list
6808115|NCT03823534|Oxycodone|oxycodone|mesh-list
6808116|NCT03823534|Hydrocodone|hydrocodone|mesh-list
6808117|NCT03823534|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6808118|NCT03823534|Narcotics|narcotics|mesh-ancestor
6808119|NCT03823534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6808120|NCT03823534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808121|NCT03823534|Analgesics|analgesics|mesh-ancestor
6808122|NCT03823534|Sensory System Agents|sensory system agents|mesh-ancestor
6808123|NCT03823534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6808124|NCT03823534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6808125|NCT03823534|Antipyretics|antipyretics|mesh-ancestor
6808126|NCT03823534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6808127|NCT03823534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6808128|NCT03823534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6808129|NCT03823534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6808130|NCT03823534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6808131|NCT03823534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808132|NCT03823534|Antitussive Agents|antitussive agents|mesh-ancestor
6808133|NCT03823534|Respiratory System Agents|respiratory system agents|mesh-ancestor
6808134|NCT03812991|Calcitonin|calcitonin|mesh-list
6808135|NCT03812991|Salmon calcitonin|salmon calcitonin|mesh-list
6808136|NCT03812991|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
6808137|NCT03812991|Katacalcin|katacalcin|mesh-list
6808138|NCT03812991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6808139|NCT03812991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808140|NCT03812991|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6808141|NCT03812991|Vasodilator Agents|vasodilator agents|mesh-ancestor
6808142|NCT03793478|Cytarabine|cytarabine|mesh-list
6808143|NCT03793478|Fludarabine|fludarabine|mesh-list
6808144|NCT03793478|Etoposide|etoposide|mesh-list
6808145|NCT03793478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6808146|NCT03793478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6808147|NCT03793478|Antimetabolites|antimetabolites|mesh-ancestor
6808148|NCT03793478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808149|NCT03793478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6808150|NCT03793478|Immunologic Factors|immunologic factors|mesh-ancestor
6808151|NCT03793478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808152|NCT03793478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6808153|NCT03793478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6808154|NCT03793478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6808155|NCT03793478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6808156|NCT03793478|Antiviral Agents|antiviral agents|mesh-ancestor
6808157|NCT03793478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6808158|NCT03779243|Melatonin|melatonin|mesh-list
6808159|NCT03779243|Antioxidants|antioxidants|mesh-ancestor
6808160|NCT03779243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808161|NCT03779243|Protective Agents|protective agents|mesh-ancestor
6808162|NCT03779243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808163|NCT03779243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6808164|NCT03757013|Apremilast|apremilast|mesh-list
6808165|NCT03757013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6808166|NCT03757013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6808167|NCT03757013|Analgesics|analgesics|mesh-ancestor
6808168|NCT03757013|Sensory System Agents|sensory system agents|mesh-ancestor
6808169|NCT03757013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6808170|NCT03757013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808171|NCT03757013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6808172|NCT03757013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6808173|NCT03757013|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6808174|NCT03757013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6808175|NCT03757013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6808176|NCT03757013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808177|NCT03738228|Cisplatin|cisplatin|mesh-list
6808178|NCT03738228|Atezolizumab|atezolizumab|mesh-list
6808179|NCT03738228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6808180|NCT03738228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6808181|NCT03738228|Immunologic Factors|immunologic factors|mesh-ancestor
6808182|NCT03738228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808183|NCT03729271|Rifaximin|rifaximin|mesh-list
6808184|NCT03729271|Lactulose|lactulose|mesh-list
6808185|NCT03729271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6808186|NCT03729271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6808187|NCT03729271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6808188|NCT03721068|Cyclophosphamide|cyclophosphamide|mesh-list
6808189|NCT03721068|Fludarabine|fludarabine|mesh-list
6808190|NCT03721068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6808191|NCT03721068|Immunologic Factors|immunologic factors|mesh-ancestor
6808192|NCT03721068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808193|NCT03721068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6808194|NCT03721068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6808195|NCT03721068|Alkylating Agents|alkylating agents|mesh-ancestor
6808196|NCT03721068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808197|NCT03721068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6808198|NCT03721068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6808199|NCT03696784|Cyclophosphamide|cyclophosphamide|mesh-list
6808200|NCT03696784|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6808201|NCT03696784|Fludarabine|fludarabine|mesh-list
6808202|NCT03696784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6808203|NCT03696784|Immunologic Factors|immunologic factors|mesh-ancestor
6808204|NCT03696784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808205|NCT03696784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6808206|NCT03696784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6808207|NCT03696784|Alkylating Agents|alkylating agents|mesh-ancestor
6808208|NCT03696784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808209|NCT03696784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6808210|NCT03696784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6808211|NCT03693846|Nivolumab|nivolumab|mesh-list
6808212|NCT03693846|Ipilimumab|ipilimumab|mesh-list
6808213|NCT03693846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6808214|NCT03693846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6808215|NCT03693846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6808216|NCT03693846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808217|NCT03646162|Zuclomiphene|zuclomiphene|mesh-list
6808218|NCT03646162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6808219|NCT03646162|Hormone Antagonists|hormone antagonists|mesh-ancestor
6808220|NCT03646162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6808221|NCT03646162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808222|NCT03646162|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6808223|NCT03646162|Fertility Agents|fertility agents|mesh-ancestor
6808224|NCT03646162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6808225|NCT03646162|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6808226|NCT03646162|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6808227|NCT03635788|Rilpivirine|rilpivirine|mesh-list
6808228|NCT03635788|Cabotegravir|cabotegravir|mesh-list
6808229|NCT03635788|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6808230|NCT03635788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6808231|NCT03635788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6808232|NCT03635788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808233|NCT03635788|Antiviral Agents|antiviral agents|mesh-ancestor
6808234|NCT03635788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6808235|NCT03635788|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6808236|NCT03635788|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6808237|NCT03635788|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6808238|NCT03635788|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6808239|NCT03619213|Dapagliflozin|dapagliflozin|mesh-list
6808240|NCT03619213|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6808241|NCT03619213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808242|NCT03619213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6808243|NCT03619213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808244|NCT03602157|Fludarabine|fludarabine|mesh-list
6808245|NCT03602157|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6808246|NCT03602157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6808247|NCT03602157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808248|NCT03602157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6808249|NCT03602157|Alkylating Agents|alkylating agents|mesh-ancestor
6808250|NCT03601455|Durvalumab|durvalumab|mesh-list
6808251|NCT03601455|Ipilimumab|ipilimumab|mesh-list
6808252|NCT03601455|Tremelimumab|tremelimumab|mesh-list
6808253|NCT03601455|Immunoglobulins|immunoglobulins|mesh-list
6808254|NCT03601455|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6808255|NCT03601455|Immunoglobulin G|immunoglobulin g|mesh-list
6808256|NCT03601455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6808257|NCT03601455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6808258|NCT03601455|Immunologic Factors|immunologic factors|mesh-ancestor
6808259|NCT03601455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808260|NCT03601455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6808261|NCT03601455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808262|NCT03594162|Cyclophosphamide|cyclophosphamide|mesh-list
6808263|NCT03594162|Fludarabine|fludarabine|mesh-list
6808264|NCT03594162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6808265|NCT03594162|Immunologic Factors|immunologic factors|mesh-ancestor
6808266|NCT03594162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808267|NCT03594162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6808268|NCT03594162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6808269|NCT03594162|Alkylating Agents|alkylating agents|mesh-ancestor
6808270|NCT03594162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808271|NCT03594162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6808272|NCT03594162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6808273|NCT03519997|Pembrolizumab|pembrolizumab|mesh-list
6808274|NCT03519997|Bavituximab|bavituximab|mesh-list
6808275|NCT03519997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6808276|NCT03519997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6808277|NCT03437330|Insulin Glargine|insulin glargine|mesh-list
6808278|NCT03437330|Empagliflozin|empagliflozin|mesh-list
6808279|NCT03437330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6808280|NCT03437330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808281|NCT03437330|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6808282|NCT03437330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808283|NCT03424122|Rituximab|rituximab|mesh-list
6808284|NCT03424122|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6808285|NCT03424122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6808286|NCT03424122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6808287|NCT03424122|Immunologic Factors|immunologic factors|mesh-ancestor
6808288|NCT03424122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808289|NCT03424122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6808290|NCT03424122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6808291|NCT03424122|Alkylating Agents|alkylating agents|mesh-ancestor
6808292|NCT03424122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808293|NCT03405714|Brivaracetam|brivaracetam|mesh-list
6808294|NCT03405714|Anticonvulsants|anticonvulsants|mesh-ancestor
6808295|NCT03317392|Olaparib|olaparib|mesh-list
6808296|NCT03317392|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
6808297|NCT03317392|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
6808298|NCT03317392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6808299|NCT03317392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808300|NCT03317392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6808301|NCT03261830|Clindamycin|clindamycin|mesh-list
6808302|NCT03261830|Clindamycin palmitate|clindamycin palmitate|mesh-list
6808303|NCT03261830|Clindamycin phosphate|clindamycin phosphate|mesh-list
6808304|NCT03261830|Cefazolin|cefazolin|mesh-list
6808305|NCT03261830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6808306|NCT03261830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6808307|NCT03261830|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6808308|NCT03261830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6808309|NCT03261830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808310|NCT03219528|Rifaximin|rifaximin|mesh-list
6808311|NCT03219528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6808312|NCT03219528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6808313|NCT03219528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6808314|NCT03121534|Dexamethasone|dexamethasone|mesh-list
6808315|NCT03121534|Blinatumomab|blinatumomab|mesh-list
6808316|NCT03121534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6808317|NCT03121534|Antiemetics|antiemetics|mesh-ancestor
6808318|NCT03121534|Autonomic Agents|autonomic agents|mesh-ancestor
6808319|NCT03121534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6808320|NCT03121534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808321|NCT03121534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6808322|NCT03121534|Glucocorticoids|glucocorticoids|mesh-ancestor
6808323|NCT03121534|Hormones|hormones|mesh-ancestor
6808324|NCT03121534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6808325|NCT03121534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6808326|NCT03121534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6808327|NCT03111732|Pembrolizumab|pembrolizumab|mesh-list
6808328|NCT03111732|Capecitabine|capecitabine|mesh-list
6808329|NCT03111732|Oxaliplatin|oxaliplatin|mesh-list
6808330|NCT03111732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6808331|NCT03111732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6808332|NCT03111732|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6808333|NCT03111732|Antimetabolites|antimetabolites|mesh-ancestor
6808334|NCT03111732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808335|NCT03088059|Durvalumab|durvalumab|mesh-list
6808336|NCT03088059|Palbociclib|palbociclib|mesh-list
6808337|NCT03088059|Niraparib|niraparib|mesh-list
6808338|NCT03088059|Afatinib|afatinib|mesh-list
6808339|NCT03088059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6808340|NCT03088059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6808341|NCT03088059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6808342|NCT03088059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6808343|NCT03088059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808344|NCT03088059|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6808345|NCT03065244|Infliximab|infliximab|mesh-list
6808346|NCT03065244|Immunoglobulins|immunoglobulins|mesh-list
6808347|NCT03065244|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6808348|NCT03065244|gamma-Globulins|gamma-globulins|mesh-list
6808349|NCT03065244|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6808350|NCT03065244|Immunologic Factors|immunologic factors|mesh-ancestor
6808351|NCT03065244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808352|NCT03065244|Dermatologic Agents|dermatologic agents|mesh-ancestor
6808353|NCT03065244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6808354|NCT03065244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6808355|NCT03007732|Ascorbic Acid|ascorbic acid|mesh-list
6808356|NCT03007732|Prednisone|prednisone|mesh-list
6808357|NCT03007732|Leuprolide|leuprolide|mesh-list
6808358|NCT03007732|Methyltestosterone|methyltestosterone|mesh-list
6808359|NCT03007732|Pembrolizumab|pembrolizumab|mesh-list
6808360|NCT03007732|Abiraterone Acetate|abiraterone acetate|mesh-list
6808361|NCT03007732|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6808362|NCT03007732|Androgens|androgens|mesh-list
6808363|NCT03007732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6808364|NCT03007732|Glucocorticoids|glucocorticoids|mesh-ancestor
6808365|NCT03007732|Hormones|hormones|mesh-ancestor
6808366|NCT03007732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6808367|NCT03007732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808368|NCT03007732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6808369|NCT03007732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6808370|NCT03007732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6808371|NCT03007732|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6808372|NCT03007732|Fertility Agents|fertility agents|mesh-ancestor
6808373|NCT03007732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6808374|NCT03007732|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6808375|NCT03007732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6808376|NCT03007732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808377|NCT03007732|Hormone Antagonists|hormone antagonists|mesh-ancestor
6808378|NCT03007732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6808379|NCT03007732|Antioxidants|antioxidants|mesh-ancestor
6808380|NCT03007732|Protective Agents|protective agents|mesh-ancestor
6808381|NCT03007732|Vitamins|vitamins|mesh-ancestor
6808382|NCT03007732|Micronutrients|micronutrients|mesh-ancestor
6808383|NCT03007732|Estrogens|estrogens|mesh-ancestor
6808384|NCT03007732|Anabolic Agents|anabolic agents|mesh-ancestor
6808385|NCT02965716|Pembrolizumab|pembrolizumab|mesh-list
6808386|NCT02965716|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
6808387|NCT02965716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6808388|NCT02965716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6808389|NCT02952924|Midazolam|midazolam|mesh-list
6808390|NCT02952924|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6808391|NCT02952924|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6808392|NCT02952924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6808393|NCT02952924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808394|NCT02952924|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6808395|NCT02952924|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6808396|NCT02952924|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6808397|NCT02952924|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6808398|NCT02952924|Anesthetics, General|anesthetics, general|mesh-ancestor
6808399|NCT02952924|Anesthetics|anesthetics|mesh-ancestor
6808400|NCT02952924|GABA Modulators|gaba modulators|mesh-ancestor
6808401|NCT02952924|GABA Agents|gaba agents|mesh-ancestor
6808402|NCT02952924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6808403|NCT02952924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808404|NCT02946996|Metformin|metformin|mesh-list
6808405|NCT02946996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6808406|NCT02946996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808407|NCT02934529|Leucovorin|leucovorin|mesh-list
6808408|NCT02934529|Folic Acid|folic acid|mesh-list
6808409|NCT02934529|Bevacizumab|bevacizumab|mesh-list
6808410|NCT02934529|Cetuximab|cetuximab|mesh-list
6808411|NCT02934529|Fluorouracil|fluorouracil|mesh-list
6808412|NCT02934529|Capecitabine|capecitabine|mesh-list
5993484|NCT00122382|Dermatologic Agents|dermatologic agents|mesh-ancestor
5993485|NCT00122382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5993486|NCT00122382|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5993487|NCT00122382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5993488|NCT00122382|Immunologic Factors|immunologic factors|mesh-ancestor
5993489|NCT00122382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5993490|NCT00122382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5993491|NCT00122382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5993492|NCT00122447|Aspirin|aspirin|mesh-list
5993493|NCT00122447|Thioctic Acid|thioctic acid|mesh-list
5993494|NCT00122447|Olmesartan|olmesartan|mesh-list
5993495|NCT00122447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5993496|NCT00122447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5993497|NCT00122447|Analgesics|analgesics|mesh-ancestor
5993498|NCT00122447|Sensory System Agents|sensory system agents|mesh-ancestor
5993499|NCT00122447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5993500|NCT00122447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993501|NCT00122447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5993502|NCT00122447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5993503|NCT00122447|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6808413|NCT02934529|Irinotecan|irinotecan|mesh-list
6808414|NCT02934529|Levoleucovorin|levoleucovorin|mesh-list
6808415|NCT02934529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6808416|NCT02934529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6808417|NCT02934529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6808418|NCT02934529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6808419|NCT02934529|Growth Substances|growth substances|mesh-ancestor
6808420|NCT02934529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808421|NCT02934529|Growth Inhibitors|growth inhibitors|mesh-ancestor
6808422|NCT02934529|Antimetabolites|antimetabolites|mesh-ancestor
6808423|NCT02934529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808424|NCT02934529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6808425|NCT02934529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6808426|NCT02934529|Immunologic Factors|immunologic factors|mesh-ancestor
6808427|NCT02934529|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6808428|NCT02934529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6808429|NCT02934529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6808430|NCT02934529|Antidotes|antidotes|mesh-ancestor
6808431|NCT02934529|Protective Agents|protective agents|mesh-ancestor
6808432|NCT02934529|Vitamin B Complex|vitamin b complex|mesh-ancestor
6808433|NCT02934529|Vitamins|vitamins|mesh-ancestor
6808434|NCT02934529|Micronutrients|micronutrients|mesh-ancestor
6808435|NCT02934529|Hematinics|hematinics|mesh-ancestor
6808436|NCT02816736|Valsartan|valsartan|mesh-list
6808437|NCT02816736|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
6808438|NCT02816736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5993504|NCT00122447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5993505|NCT00122447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5993506|NCT00122447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6808439|NCT02816736|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6808440|NCT02816736|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6808441|NCT02816736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808442|NCT02774421|Trastuzumab|trastuzumab|mesh-list
6808443|NCT02774421|Molgramostim|molgramostim|mesh-list
6808444|NCT02774421|Sargramostim|sargramostim|mesh-list
6808445|NCT02774421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6808446|NCT02774421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6808447|NCT02774421|Immunologic Factors|immunologic factors|mesh-ancestor
6808448|NCT02774421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808449|NCT02713373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6808450|NCT02713373|Pembrolizumab|pembrolizumab|mesh-list
6808451|NCT02713373|Cetuximab|cetuximab|mesh-list
6808452|NCT02713373|Antibodies|antibodies|mesh-list
6808453|NCT02713373|Immunoglobulins|immunoglobulins|mesh-list
6808454|NCT02713373|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6808455|NCT02713373|Immunologic Factors|immunologic factors|mesh-ancestor
6808456|NCT02713373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808457|NCT02713373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6808458|NCT02681302|Nivolumab|nivolumab|mesh-list
6808459|NCT02681302|Ipilimumab|ipilimumab|mesh-list
6808460|NCT02681302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6808461|NCT02681302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6808462|NCT02681302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6808463|NCT02681302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808464|NCT02632409|Nivolumab|nivolumab|mesh-list
6808465|NCT02632409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6808466|NCT02632409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6808467|NCT02632409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6808468|NCT02632409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808469|NCT02627443|Gemcitabine|gemcitabine|mesh-list
6808470|NCT02627443|Carboplatin|carboplatin|mesh-list
6808471|NCT02627443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6808472|NCT02627443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6808473|NCT02627443|Antimetabolites|antimetabolites|mesh-ancestor
6808474|NCT02627443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808475|NCT02627443|Antiviral Agents|antiviral agents|mesh-ancestor
6808476|NCT02627443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6808477|NCT02627443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6808478|NCT02627443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6808479|NCT02627443|Immunologic Factors|immunologic factors|mesh-ancestor
6808480|NCT02627443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808481|NCT02590094|Bevacizumab|bevacizumab|mesh-list
6808482|NCT02590094|Aflibercept|aflibercept|mesh-list
6808483|NCT02590094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6808484|NCT02590094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6808485|NCT02590094|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6808486|NCT02590094|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6808487|NCT02590094|Growth Substances|growth substances|mesh-ancestor
6808488|NCT02590094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808489|NCT02590094|Growth Inhibitors|growth inhibitors|mesh-ancestor
6808490|NCT02516241|Gemcitabine|gemcitabine|mesh-list
6808491|NCT02516241|Carboplatin|carboplatin|mesh-list
6808492|NCT02516241|Durvalumab|durvalumab|mesh-list
6808493|NCT02516241|Tremelimumab|tremelimumab|mesh-list
6808494|NCT02516241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6808495|NCT02516241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6808496|NCT02516241|Antimetabolites|antimetabolites|mesh-ancestor
6808497|NCT02516241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808498|NCT02516241|Antiviral Agents|antiviral agents|mesh-ancestor
6808499|NCT02516241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6808500|NCT02516241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6808501|NCT02516241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6808502|NCT02516241|Immunologic Factors|immunologic factors|mesh-ancestor
6808503|NCT02516241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808504|NCT02516241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6808505|NCT02431702|Haloperidol|haloperidol|mesh-list
6808506|NCT02431702|Olanzapine|olanzapine|mesh-list
6808507|NCT02431702|Risperidone|risperidone|mesh-list
6808508|NCT02431702|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6808509|NCT02431702|Aripiprazole|aripiprazole|mesh-list
6808510|NCT02431702|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6808511|NCT02431702|Haloperidol decanoate|haloperidol decanoate|mesh-list
6808512|NCT02431702|Perphenazine|perphenazine|mesh-list
6808513|NCT02431702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6808514|NCT02431702|Serotonin Agents|serotonin agents|mesh-ancestor
6808515|NCT02431702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6808516|NCT02431702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808517|NCT02431702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808518|NCT02431702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6808519|NCT02431702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6808520|NCT02431702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6808521|NCT02431702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6808522|NCT02431702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6808523|NCT02431702|Dopamine Agents|dopamine agents|mesh-ancestor
6808524|NCT02431702|Antiemetics|antiemetics|mesh-ancestor
6808525|NCT02431702|Autonomic Agents|autonomic agents|mesh-ancestor
6808526|NCT02431702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6808527|NCT02431702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6808528|NCT02431702|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6808529|NCT02431702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6808530|NCT02431702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6808531|NCT02431702|Antidepressive Agents|antidepressive agents|mesh-ancestor
6808532|NCT02431702|Dopamine Agonists|dopamine agonists|mesh-ancestor
6808533|NCT02431702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6808534|NCT02431702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6808535|NCT02431702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6808536|NCT02431702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6808537|NCT02431702|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6808538|NCT02420912|Nivolumab|nivolumab|mesh-list
6808539|NCT02420912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6808540|NCT02420912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6808541|NCT02420912|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6808542|NCT02420912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808543|NCT02136069|Infliximab|infliximab|mesh-list
6808544|NCT02136069|Etrolizumab|etrolizumab|mesh-list
6808545|NCT02136069|Dermatologic Agents|dermatologic agents|mesh-ancestor
6808546|NCT02136069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6808547|NCT02136069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6808548|NCT02136069|Immunologic Factors|immunologic factors|mesh-ancestor
6808549|NCT02136069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808550|NCT02096874|Bevacizumab|bevacizumab|mesh-list
6808551|NCT02096874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6808552|NCT02096874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6808553|NCT02096874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6808554|NCT02096874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6808555|NCT02096874|Growth Substances|growth substances|mesh-ancestor
6808556|NCT02096874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808557|NCT02096874|Growth Inhibitors|growth inhibitors|mesh-ancestor
6808558|NCT02086552|Lenalidomide|lenalidomide|mesh-list
6808559|NCT02086552|Immunologic Factors|immunologic factors|mesh-ancestor
6808560|NCT02086552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808561|NCT02086552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6808562|NCT02086552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6808563|NCT02086552|Growth Substances|growth substances|mesh-ancestor
6808564|NCT02086552|Growth Inhibitors|growth inhibitors|mesh-ancestor
6808565|NCT02086552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6808566|NCT01024608|Beclomethasone|beclomethasone|mesh-list
6808567|NCT01024608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6808568|NCT01024608|Glucocorticoids|glucocorticoids|mesh-ancestor
6808569|NCT01024608|Hormones|hormones|mesh-ancestor
6808570|NCT01024608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6808571|NCT01024608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808572|NCT01024608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6808573|NCT01024608|Respiratory System Agents|respiratory system agents|mesh-ancestor
6808574|NCT00988247|Beclomethasone|beclomethasone|mesh-list
6808575|NCT00988247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6808576|NCT00988247|Glucocorticoids|glucocorticoids|mesh-ancestor
6808577|NCT00988247|Hormones|hormones|mesh-ancestor
6808578|NCT00988247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6808579|NCT00988247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808580|NCT00988247|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6808581|NCT00988247|Respiratory System Agents|respiratory system agents|mesh-ancestor
6808582|NCT00838981|Methadone|methadone|mesh-list
6808583|NCT00838981|Modafinil|modafinil|mesh-list
6808584|NCT00838981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6808585|NCT00838981|Narcotics|narcotics|mesh-ancestor
6808586|NCT00838981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6808587|NCT00838981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808588|NCT00838981|Analgesics|analgesics|mesh-ancestor
6808589|NCT00838981|Sensory System Agents|sensory system agents|mesh-ancestor
6808590|NCT00838981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6808591|NCT00838981|Antitussive Agents|antitussive agents|mesh-ancestor
6808592|NCT00838981|Respiratory System Agents|respiratory system agents|mesh-ancestor
6808593|NCT00838981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6808594|NCT00838981|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6808595|NCT00838981|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6808596|NCT00838981|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6808597|NCT00838981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808598|NCT00730639|Nivolumab|nivolumab|mesh-list
6808599|NCT00730639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6808600|NCT00730639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6808601|NCT00730639|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6808602|NCT00730639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808603|NCT00363038|Vitamins|vitamins|mesh-list
6808604|NCT00363038|Vitamin K|vitamin k|mesh-list
6808605|NCT00363038|Vitamin A|vitamin a|mesh-list
6808606|NCT00363038|Petrolatum|petrolatum|mesh-list
6808607|NCT00363038|Micronutrients|micronutrients|mesh-ancestor
6808608|NCT00363038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808609|NCT00363038|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6808610|NCT00363038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6808611|NCT00363038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808612|NCT00363038|Hemostatics|hemostatics|mesh-ancestor
6808613|NCT00363038|Coagulants|coagulants|mesh-ancestor
6808614|NCT00363038|Emollients|emollients|mesh-ancestor
6808615|NCT00363038|Dermatologic Agents|dermatologic agents|mesh-ancestor
6808616|NCT05146453|Anesthetics|anesthetics|mesh-list
6808617|NCT05146453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6808618|NCT05146453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808619|NCT05146271|Anesthetics|anesthetics|mesh-list
6808620|NCT05146271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6808621|NCT05146271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808622|NCT05146245|Risperidone|risperidone|mesh-list
6808623|NCT05146245|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6808624|NCT05146245|Serotonin Agents|serotonin agents|mesh-ancestor
6808625|NCT05146245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6808626|NCT05146245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808627|NCT05146245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808628|NCT05146245|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6808629|NCT05146245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6808630|NCT05146245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6808631|NCT05146245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6808632|NCT05146245|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6808633|NCT05146245|Dopamine Agents|dopamine agents|mesh-ancestor
6808634|NCT05146089|Bosentan|bosentan|mesh-list
6808635|NCT05146089|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6808636|NCT05146089|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6808637|NCT05146089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808638|NCT05145660|Cisplatin|cisplatin|mesh-list
6808639|NCT05145660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6808640|NCT05145634|Anticoagulants|anticoagulants|mesh-list
6808641|NCT05145543|Dexamethasone|dexamethasone|mesh-list
6808642|NCT05145543|Fentanyl|fentanyl|mesh-list
6808643|NCT05145543|Levobupivacaine|levobupivacaine|mesh-list
6808644|NCT05145543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6808645|NCT05145543|Antiemetics|antiemetics|mesh-ancestor
6808646|NCT05145543|Autonomic Agents|autonomic agents|mesh-ancestor
6808647|NCT05145543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6808648|NCT05145543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808649|NCT05145543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6808650|NCT05145543|Glucocorticoids|glucocorticoids|mesh-ancestor
6808651|NCT05145543|Hormones|hormones|mesh-ancestor
6808652|NCT05145543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6808653|NCT05145543|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6808654|NCT05145543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6808655|NCT05145543|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6808656|NCT05145543|Narcotics|narcotics|mesh-ancestor
6808657|NCT05145543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6808658|NCT05145543|Analgesics|analgesics|mesh-ancestor
6808659|NCT05145543|Sensory System Agents|sensory system agents|mesh-ancestor
6808660|NCT05145543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6808661|NCT05145543|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6808662|NCT05145543|Anesthetics, General|anesthetics, general|mesh-ancestor
6808663|NCT05145543|Anesthetics|anesthetics|mesh-ancestor
6808664|NCT05145543|Anesthetics, Local|anesthetics, local|mesh-ancestor
6808665|NCT05145296|Daratumumab|daratumumab|mesh-list
6808666|NCT05145296|Abatacept|abatacept|mesh-list
6808667|NCT05145296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6808668|NCT05145296|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6808669|NCT05145296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808670|NCT05145296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6808671|NCT05145296|Immunologic Factors|immunologic factors|mesh-ancestor
6808672|NCT05145296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808673|NCT05145296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6808674|NCT05145283|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
6808675|NCT05145283|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6808676|NCT05145283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6808677|NCT05145283|Immunologic Factors|immunologic factors|mesh-ancestor
6808678|NCT05145283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808679|NCT05145270|Sulforaphane|sulforaphane|mesh-list
6808680|NCT05145270|Dexetimide|dexetimide|mesh-list
6808681|NCT05145270|Citalopram|citalopram|mesh-list
6808682|NCT05145270|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6808683|NCT05145270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6808684|NCT05145270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6808685|NCT05145270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808686|NCT05145270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6808687|NCT05145270|Serotonin Agents|serotonin agents|mesh-ancestor
6808688|NCT05145270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808689|NCT05145270|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6808690|NCT05145270|Antidepressive Agents|antidepressive agents|mesh-ancestor
6808691|NCT05145270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6808692|NCT05145270|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6808693|NCT05145270|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6808694|NCT05145270|Parasympatholytics|parasympatholytics|mesh-ancestor
6808695|NCT05145270|Autonomic Agents|autonomic agents|mesh-ancestor
6808696|NCT05145270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6808697|NCT05145270|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6808698|NCT05145270|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6808699|NCT05145270|Cholinergic Agents|cholinergic agents|mesh-ancestor
6808700|NCT05145270|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6808701|NCT05145270|Protective Agents|protective agents|mesh-ancestor
6808702|NCT05145270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6808703|NCT05131386|Trabectedin|trabectedin|mesh-list
6808704|NCT05131386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6808705|NCT05131386|Alkylating Agents|alkylating agents|mesh-ancestor
6808706|NCT05131386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808707|NCT05131386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6808708|NCT05128617|Paclitaxel|paclitaxel|mesh-list
6808709|NCT05128617|Cyclophosphamide|cyclophosphamide|mesh-list
6808710|NCT05128617|Epirubicin|epirubicin|mesh-list
6808711|NCT05128617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6808712|NCT05128617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6808713|NCT05128617|Tubulin Modulators|tubulin modulators|mesh-ancestor
6808714|NCT05128617|Antimitotic Agents|antimitotic agents|mesh-ancestor
6808715|NCT05128617|Mitosis Modulators|mitosis modulators|mesh-ancestor
6808716|NCT05128617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808717|NCT05128617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6808718|NCT05128617|Immunologic Factors|immunologic factors|mesh-ancestor
6808719|NCT05128617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808720|NCT05128617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6808721|NCT05128617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6808722|NCT05128617|Alkylating Agents|alkylating agents|mesh-ancestor
6808723|NCT05128617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6808724|NCT05128617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6808725|NCT05128617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6808726|NCT05128617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6808727|NCT05128617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6808728|NCT05100134|Ceritinib|ceritinib|mesh-list
6808729|NCT05100134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6808730|NCT05100134|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6808731|NCT05100134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6808732|NCT05100134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808733|NCT05079620|Amoxicillin|amoxicillin|mesh-list
6808734|NCT05079620|Vancomycin|vancomycin|mesh-list
6808735|NCT05079620|Levofloxacin|levofloxacin|mesh-list
6808736|NCT05079620|Ofloxacin|ofloxacin|mesh-list
6808737|NCT05079620|Ceftriaxone|ceftriaxone|mesh-list
6808738|NCT05079620|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6808739|NCT05079620|Clavulanic Acids|clavulanic acids|mesh-list
6808740|NCT05079620|Clavulanic Acid|clavulanic acid|mesh-list
6808741|NCT05079620|Cefepime|cefepime|mesh-list
6808742|NCT05079620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6808743|NCT05079620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6808744|NCT05079620|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6808745|NCT05079620|Renal Agents|renal agents|mesh-ancestor
6808746|NCT05079620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6808747|NCT05079620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6808748|NCT05079620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6808749|NCT05079620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808750|NCT05079620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6808751|NCT05079620|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6808752|NCT05079620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6808753|NCT05079620|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6808754|NCT05043805|Dextromethorphan|dextromethorphan|mesh-list
6808755|NCT05043805|Antitussive Agents|antitussive agents|mesh-ancestor
6808756|NCT05043805|Respiratory System Agents|respiratory system agents|mesh-ancestor
6808757|NCT05043805|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6808758|NCT05043805|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6808759|NCT05043805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6808760|NCT05043805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808761|NCT05043805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808762|NCT05021978|Pramoxine|pramoxine|mesh-list
6808763|NCT05021978|Anesthetics, Local|anesthetics, local|mesh-ancestor
6808764|NCT05021978|Anesthetics|anesthetics|mesh-ancestor
6808765|NCT05021978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6808766|NCT05021978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808767|NCT05021978|Sensory System Agents|sensory system agents|mesh-ancestor
6808768|NCT05021978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6808769|NCT05019430|Cocaine|cocaine|mesh-list
6808770|NCT05019430|Zolmitriptan|zolmitriptan|mesh-list
6808771|NCT05019430|Anesthetics, Local|anesthetics, local|mesh-ancestor
6808772|NCT05019430|Anesthetics|anesthetics|mesh-ancestor
6808773|NCT05019430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6808774|NCT05019430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808775|NCT05019430|Sensory System Agents|sensory system agents|mesh-ancestor
6808776|NCT05019430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6808777|NCT05019430|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6808778|NCT05019430|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6808779|NCT05019430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6808780|NCT05019430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6808781|NCT05019430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808782|NCT05019430|Dopamine Agents|dopamine agents|mesh-ancestor
6808783|NCT05019430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6808784|NCT05019430|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6808785|NCT05019430|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6808786|NCT05019430|Serotonin Agents|serotonin agents|mesh-ancestor
6808787|NCT05017012|Paclitaxel|paclitaxel|mesh-list
6808788|NCT05017012|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6808789|NCT05017012|Carboplatin|carboplatin|mesh-list
6808790|NCT05017012|Pembrolizumab|pembrolizumab|mesh-list
6808791|NCT05017012|Pemetrexed|pemetrexed|mesh-list
6808792|NCT05017012|Axitinib|axitinib|mesh-list
6808793|NCT05017012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6808794|NCT05017012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6808795|NCT05017012|Tubulin Modulators|tubulin modulators|mesh-ancestor
6808796|NCT05017012|Antimitotic Agents|antimitotic agents|mesh-ancestor
6808797|NCT05017012|Mitosis Modulators|mitosis modulators|mesh-ancestor
6808798|NCT05017012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808799|NCT05017012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6808800|NCT05017012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6808801|NCT05017012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6808802|NCT05017012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6808803|NCT05017012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6808804|NCT04991480|Talazoparib|talazoparib|mesh-list
6808805|NCT04991480|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6808806|NCT04991480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6808807|NCT04991480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808808|NCT04991480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6808809|NCT04987294|Rasburicase|rasburicase|mesh-list
6808810|NCT04987294|Gout Suppressants|gout suppressants|mesh-ancestor
6808811|NCT04987294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6808812|NCT04961541|Vaccines|vaccines|mesh-list
6808813|NCT04961541|Immunologic Factors|immunologic factors|mesh-ancestor
6808814|NCT04961541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808815|NCT04956302|Dexamethasone|dexamethasone|mesh-list
6808816|NCT04956302|Dexamethasone acetate|dexamethasone acetate|mesh-list
6808817|NCT04956302|Bortezomib|bortezomib|mesh-list
6808818|NCT04956302|Daratumumab|daratumumab|mesh-list
6808819|NCT04956302|Panobinostat|panobinostat|mesh-list
6808820|NCT04956302|Ichthammol|ichthammol|mesh-list
6808821|NCT04956302|BB 1101|bb 1101|mesh-list
6808822|NCT04956302|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6808823|NCT04956302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6808824|NCT04956302|Antiemetics|antiemetics|mesh-ancestor
6808825|NCT04956302|Autonomic Agents|autonomic agents|mesh-ancestor
6808826|NCT04956302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6808827|NCT04956302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808828|NCT04956302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6808829|NCT04956302|Glucocorticoids|glucocorticoids|mesh-ancestor
6808830|NCT04956302|Hormones|hormones|mesh-ancestor
6808831|NCT04956302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6808832|NCT04956302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6808833|NCT04956302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6808834|NCT04956302|Protease Inhibitors|protease inhibitors|mesh-ancestor
6808835|NCT04956302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6808836|NCT04956302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808837|NCT04956302|Immunologic Factors|immunologic factors|mesh-ancestor
6808838|NCT04956302|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6808839|NCT04956302|Dermatologic Agents|dermatologic agents|mesh-ancestor
6808840|NCT04944654|Emtricitabine|emtricitabine|mesh-list
6808841|NCT04944654|Antiviral Agents|antiviral agents|mesh-ancestor
6808842|NCT04944654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6808843|NCT04944654|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6808844|NCT04944654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6808845|NCT04944654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6808846|NCT04944654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808847|NCT04944654|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6808848|NCT04944654|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6808849|NCT04907032|Mirabegron|mirabegron|mesh-list
6808850|NCT04907032|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6808851|NCT04907032|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6808852|NCT04907032|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6808853|NCT04907032|Adrenergic Agents|adrenergic agents|mesh-ancestor
6808854|NCT04907032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6808855|NCT04907032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808856|NCT04907032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808857|NCT04907032|Urological Agents|urological agents|mesh-ancestor
6808858|NCT04834362|Insulin|insulin|mesh-list
6808859|NCT04834362|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6808860|NCT04834362|Insulin Glargine|insulin glargine|mesh-list
6808861|NCT04834362|Insulin Aspart|insulin aspart|mesh-list
6808862|NCT04834362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6808863|NCT04834362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808864|NCT04826354|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6808865|NCT04826354|Ezetimibe|ezetimibe|mesh-list
6808866|NCT04826354|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6808867|NCT04826354|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5993507|NCT00122447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5993508|NCT00122447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5993509|NCT00122447|Antipyretics|antipyretics|mesh-ancestor
5993510|NCT00122447|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5993511|NCT00122447|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5993512|NCT00122447|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5993513|NCT00122447|Antioxidants|antioxidants|mesh-ancestor
5993514|NCT00122447|Protective Agents|protective agents|mesh-ancestor
5993515|NCT00122447|Vitamin B Complex|vitamin b complex|mesh-ancestor
5993516|NCT00122447|Vitamins|vitamins|mesh-ancestor
5993517|NCT00122447|Micronutrients|micronutrients|mesh-ancestor
5993518|NCT00122460|Cisplatin|cisplatin|mesh-list
5993519|NCT00122460|Carboplatin|carboplatin|mesh-list
5993520|NCT00122460|Fluorouracil|fluorouracil|mesh-list
5993521|NCT00122460|Cetuximab|cetuximab|mesh-list
5993522|NCT00122460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5993523|NCT00122460|Antimetabolites|antimetabolites|mesh-ancestor
5993524|NCT00122460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5993525|NCT00122460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6808868|NCT04826354|Antimetabolites|antimetabolites|mesh-ancestor
6808869|NCT04826354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808870|NCT04826354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6808871|NCT04826354|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6808872|NCT04826354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6808873|NCT04802356|Dexamethasone|dexamethasone|mesh-list
6808874|NCT04802356|Lenalidomide|lenalidomide|mesh-list
6808875|NCT04802356|Bortezomib|bortezomib|mesh-list
6808876|NCT04802356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6808877|NCT04802356|Antiemetics|antiemetics|mesh-ancestor
6808878|NCT04802356|Autonomic Agents|autonomic agents|mesh-ancestor
6808879|NCT04802356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6808880|NCT04802356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808881|NCT04802356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6808882|NCT04802356|Glucocorticoids|glucocorticoids|mesh-ancestor
6808883|NCT04802356|Hormones|hormones|mesh-ancestor
6808884|NCT04802356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6808885|NCT04802356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6808886|NCT04802356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6808887|NCT04802356|Immunologic Factors|immunologic factors|mesh-ancestor
6808888|NCT04802356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6808889|NCT04802356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6808890|NCT04802356|Growth Substances|growth substances|mesh-ancestor
6808891|NCT04802356|Growth Inhibitors|growth inhibitors|mesh-ancestor
6808892|NCT04785261|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6808893|NCT04785261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6808894|NCT04777006|Amitriptyline|amitriptyline|mesh-list
6808895|NCT04777006|Fluoxetine|fluoxetine|mesh-list
6808896|NCT04777006|Antidepressive Agents|antidepressive agents|mesh-list
6808897|NCT04777006|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6808898|NCT04777006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6808899|NCT04777006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6808900|NCT04777006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808901|NCT04777006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6808902|NCT04777006|Serotonin Agents|serotonin agents|mesh-ancestor
6808903|NCT04777006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808904|NCT04777006|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6808905|NCT04777006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6808906|NCT04777006|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6808907|NCT04777006|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6808908|NCT04777006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6808909|NCT04777006|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5993526|NCT00122460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5993527|NCT00122460|Immunologic Factors|immunologic factors|mesh-ancestor
6808910|NCT04777006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6808911|NCT04777006|Analgesics|analgesics|mesh-ancestor
6808912|NCT04777006|Sensory System Agents|sensory system agents|mesh-ancestor
6808913|NCT04777006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6808914|NCT04777006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6808915|NCT04777006|Adrenergic Agents|adrenergic agents|mesh-ancestor
6808916|NCT04743570|Methylnaltrexone|methylnaltrexone|mesh-list
6808917|NCT04743570|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6808918|NCT04743570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808919|NCT04743570|Sensory System Agents|sensory system agents|mesh-ancestor
6808920|NCT04743570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6808921|NCT04708613|Corticosterone|corticosterone|mesh-list
6808922|NCT04708613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6808923|NCT04681482|Apixaban|apixaban|mesh-list
6808924|NCT04681482|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6808925|NCT04681482|Antithrombins|antithrombins|mesh-ancestor
6808926|NCT04681482|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6808927|NCT04681482|Protease Inhibitors|protease inhibitors|mesh-ancestor
6808928|NCT04681482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6808929|NCT04681482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808930|NCT04681482|Anticoagulants|anticoagulants|mesh-ancestor
6808931|NCT04635943|Ivermectin|ivermectin|mesh-list
6808932|NCT04635943|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6808933|NCT04635943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6808934|NCT04633239|Olaparib|olaparib|mesh-list
6808935|NCT04633239|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
6808936|NCT04633239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6808937|NCT04633239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808938|NCT04633239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6808939|NCT04629729|Cyclophosphamide|cyclophosphamide|mesh-list
6808940|NCT04629729|Fludarabine|fludarabine|mesh-list
6808941|NCT04629729|Interleukin-2|interleukin-2|mesh-list
6808942|NCT04629729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6808943|NCT04629729|Immunologic Factors|immunologic factors|mesh-ancestor
6808944|NCT04629729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808945|NCT04629729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6808946|NCT04629729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6808947|NCT04629729|Alkylating Agents|alkylating agents|mesh-ancestor
6808948|NCT04629729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808949|NCT04629729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6808950|NCT04629729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6808951|NCT04629729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6808952|NCT04629729|Analgesics|analgesics|mesh-ancestor
6808953|NCT04629729|Sensory System Agents|sensory system agents|mesh-ancestor
6808954|NCT04629729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6808955|NCT04546633|Lumefantrine|lumefantrine|mesh-list
6808956|NCT04546633|Antimalarials|antimalarials|mesh-ancestor
6808957|NCT04546633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6808958|NCT04546633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6808959|NCT04546633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6808960|NCT04512534|Antibodies|antibodies|mesh-list
6808961|NCT04512534|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
6808962|NCT04512534|Immunologic Factors|immunologic factors|mesh-ancestor
6808963|NCT04512534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808964|NCT04512534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6808965|NCT04512534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808966|NCT04510506|Pancrelipase|pancrelipase|mesh-list
6808967|NCT04510506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6808968|NCT04495179|Durvalumab|durvalumab|mesh-list
6808969|NCT04495179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6808970|NCT04495179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6808971|NCT04478695|Pembrolizumab|pembrolizumab|mesh-list
6808972|NCT04478695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6808973|NCT04478695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6808974|NCT04477486|Venetoclax|venetoclax|mesh-list
6808975|NCT04477486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6808976|NCT04425447|Anesthetics|anesthetics|mesh-list
6808977|NCT04425447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6808978|NCT04425447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6808979|NCT04368988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6808980|NCT04355728|Heparin|heparin|mesh-list
6808981|NCT04355728|Calcium heparin|calcium heparin|mesh-list
6808982|NCT04355728|Anticoagulants|anticoagulants|mesh-ancestor
6808983|NCT04355728|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6808984|NCT04355728|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6808985|NCT04355728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808986|NCT04328714|Interferons|interferons|mesh-list
6808987|NCT04328714|Interferon-gamma|interferon-gamma|mesh-list
6808988|NCT04328714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6808989|NCT04328714|Antiviral Agents|antiviral agents|mesh-ancestor
6808990|NCT04328714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6808991|NCT04303780|Docetaxel|docetaxel|mesh-list
6808992|NCT04303780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6808993|NCT04303780|Tubulin Modulators|tubulin modulators|mesh-ancestor
6808994|NCT04303780|Antimitotic Agents|antimitotic agents|mesh-ancestor
6808995|NCT04303780|Mitosis Modulators|mitosis modulators|mesh-ancestor
6808996|NCT04303780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6808997|NCT04233164|Methylprednisolone|methylprednisolone|mesh-list
6808998|NCT04233164|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6808999|NCT04233164|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6809000|NCT04233164|Prednisolone|prednisolone|mesh-list
6809001|NCT04233164|Prednisolone acetate|prednisolone acetate|mesh-list
6809002|NCT04233164|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6809003|NCT04233164|Prednisolone phosphate|prednisolone phosphate|mesh-list
6809004|NCT04233164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6809005|NCT04233164|Antiemetics|antiemetics|mesh-ancestor
6809006|NCT04233164|Autonomic Agents|autonomic agents|mesh-ancestor
6809007|NCT04233164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6809008|NCT04233164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809009|NCT04233164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6809010|NCT04233164|Glucocorticoids|glucocorticoids|mesh-ancestor
6809011|NCT04233164|Hormones|hormones|mesh-ancestor
6809012|NCT04233164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6809013|NCT04233164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6809014|NCT04233164|Protective Agents|protective agents|mesh-ancestor
6809015|NCT04233164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6809016|NCT04233164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6809017|NCT04227288|Betamethasone|betamethasone|mesh-list
6809018|NCT04227288|Betamethasone Valerate|betamethasone valerate|mesh-list
6809019|NCT04227288|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
6809020|NCT04227288|Betamethasone benzoate|betamethasone benzoate|mesh-list
6809021|NCT04227288|Calcipotriene|calcipotriene|mesh-list
6809022|NCT04227288|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
6809023|NCT04227288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6809024|NCT04227288|Glucocorticoids|glucocorticoids|mesh-ancestor
6809025|NCT04227288|Hormones|hormones|mesh-ancestor
6809026|NCT04227288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6809027|NCT04227288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809028|NCT04227288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6809029|NCT04227288|Respiratory System Agents|respiratory system agents|mesh-ancestor
6809030|NCT04227288|Dermatologic Agents|dermatologic agents|mesh-ancestor
6809031|NCT04223024|Nimotuzumab|nimotuzumab|mesh-list
6809032|NCT04223024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6809033|NCT04223024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6809034|NCT04194554|Leuprolide|leuprolide|mesh-list
6809035|NCT04194554|Abiraterone Acetate|abiraterone acetate|mesh-list
6809036|NCT04194554|Niraparib|niraparib|mesh-list
6809037|NCT04194554|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6809038|NCT04194554|Fertility Agents|fertility agents|mesh-ancestor
6809039|NCT04194554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6809040|NCT04194554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809041|NCT04194554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6809042|NCT04194554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6809043|NCT04194554|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6809044|NCT04194554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6809045|NCT04194554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809046|NCT04194554|Hormone Antagonists|hormone antagonists|mesh-ancestor
6809047|NCT04194554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6809048|NCT04194554|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6809049|NCT04194554|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6809050|NCT04182997|Dexamethasone|dexamethasone|mesh-list
6809051|NCT04182997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6809052|NCT04182997|Antiemetics|antiemetics|mesh-ancestor
6809053|NCT04182997|Autonomic Agents|autonomic agents|mesh-ancestor
6809054|NCT04182997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6809055|NCT04182997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809056|NCT04182997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6809057|NCT04182997|Glucocorticoids|glucocorticoids|mesh-ancestor
6809058|NCT04182997|Hormones|hormones|mesh-ancestor
5993528|NCT00122460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993529|NCT00122460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5993530|NCT00122681|Vaccines|vaccines|mesh-list
5993531|NCT00122681|Immunologic Factors|immunologic factors|mesh-ancestor
5993532|NCT00122681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993533|NCT00122980|Hydroxyurea|hydroxyurea|mesh-list
5993534|NCT00122980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5993535|NCT00122980|Antisickling Agents|antisickling agents|mesh-ancestor
5993536|NCT00122980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5993537|NCT00122980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5993538|NCT00122980|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5993539|NCT00123110|Metformin|metformin|mesh-list
5993540|NCT00123110|Leuprolide|leuprolide|mesh-list
5993541|NCT00123110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5993542|NCT00123110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993543|NCT00123110|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5993544|NCT00123110|Fertility Agents|fertility agents|mesh-ancestor
6809059|NCT04182997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6809060|NCT04182997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6809061|NCT04182997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6809062|NCT04137354|Vitamins|vitamins|mesh-list
6809063|NCT04137354|Vitamin A|vitamin a|mesh-list
6809064|NCT04137354|Iron|iron|mesh-list
6809065|NCT04137354|Retinol palmitate|retinol palmitate|mesh-list
6809066|NCT04137354|Micronutrients|micronutrients|mesh-ancestor
6809067|NCT04137354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809068|NCT04137354|Trace Elements|trace elements|mesh-ancestor
6809069|NCT04137354|Antioxidants|antioxidants|mesh-ancestor
6809070|NCT04137354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809071|NCT04137354|Protective Agents|protective agents|mesh-ancestor
6809072|NCT04137354|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6809073|NCT04137354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6809074|NCT04068181|Pembrolizumab|pembrolizumab|mesh-list
6809075|NCT04068181|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
6809076|NCT04068181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6809077|NCT04068181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6809078|NCT04033068|Vaccines|vaccines|mesh-list
6809079|NCT04033068|Immunologic Factors|immunologic factors|mesh-ancestor
6809080|NCT04033068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809081|NCT04023227|Valsartan|valsartan|mesh-list
6809082|NCT04023227|Enalapril|enalapril|mesh-list
6809083|NCT04023227|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6809084|NCT04023227|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6809085|NCT04023227|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6809086|NCT04023227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809087|NCT04023227|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6809088|NCT04023227|Protease Inhibitors|protease inhibitors|mesh-ancestor
6809089|NCT04023227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6809090|NCT04002037|Dexamethasone|dexamethasone|mesh-list
6809091|NCT04002037|Triamcinolone|triamcinolone|mesh-list
6809092|NCT04002037|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6809093|NCT04002037|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6809094|NCT04002037|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6809095|NCT04002037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6809096|NCT04002037|Antiemetics|antiemetics|mesh-ancestor
6809097|NCT04002037|Autonomic Agents|autonomic agents|mesh-ancestor
6809098|NCT04002037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6809099|NCT04002037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809100|NCT04002037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6809101|NCT04002037|Glucocorticoids|glucocorticoids|mesh-ancestor
6809102|NCT04002037|Hormones|hormones|mesh-ancestor
6809103|NCT04002037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6809104|NCT04002037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6809105|NCT04002037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6809106|NCT04002037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6809107|NCT04002037|Immunologic Factors|immunologic factors|mesh-ancestor
6809108|NCT04002037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6809109|NCT04002037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809110|NCT03988634|Valsartan|valsartan|mesh-list
6809111|NCT03988634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6809112|NCT03988634|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6809113|NCT03988634|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6809114|NCT03988634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809115|NCT03961516|Pancrelipase|pancrelipase|mesh-list
6809116|NCT03961516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6809117|NCT03954938|Cocaine|cocaine|mesh-list
6809118|NCT03954938|Anesthetics, Local|anesthetics, local|mesh-ancestor
6809119|NCT03954938|Anesthetics|anesthetics|mesh-ancestor
6809120|NCT03954938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6809121|NCT03954938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809122|NCT03954938|Sensory System Agents|sensory system agents|mesh-ancestor
6809123|NCT03954938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6809124|NCT03954938|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6809125|NCT03954938|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6809126|NCT03954938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6809127|NCT03954938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6809128|NCT03954938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809129|NCT03954938|Dopamine Agents|dopamine agents|mesh-ancestor
6809130|NCT03954938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6809131|NCT03940352|Venetoclax|venetoclax|mesh-list
6809132|NCT03940352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6809133|NCT03937986|Cocaine|cocaine|mesh-list
6809134|NCT03937986|Suvorexant|suvorexant|mesh-list
6809135|NCT03937986|Anesthetics, Local|anesthetics, local|mesh-ancestor
6809136|NCT03937986|Anesthetics|anesthetics|mesh-ancestor
6809137|NCT03937986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6809138|NCT03937986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809139|NCT03937986|Sensory System Agents|sensory system agents|mesh-ancestor
6809140|NCT03937986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6809141|NCT03937986|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6809142|NCT03937986|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6809143|NCT03937986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6809144|NCT03937986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6809145|NCT03937986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809146|NCT03937986|Dopamine Agents|dopamine agents|mesh-ancestor
6809147|NCT03937986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6809148|NCT03937986|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6809149|NCT03937986|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6809150|NCT03937986|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
6809151|NCT03844750|Pembrolizumab|pembrolizumab|mesh-list
6809152|NCT03844750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6809153|NCT03844750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6809154|NCT03822897|Cisplatin|cisplatin|mesh-list
6809155|NCT03822897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6809156|NCT03749616|Acetaminophen|acetaminophen|mesh-list
6809157|NCT03749616|Ibuprofen|ibuprofen|mesh-list
6809158|NCT03749616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6809159|NCT03749616|Analgesics|analgesics|mesh-ancestor
6809160|NCT03749616|Sensory System Agents|sensory system agents|mesh-ancestor
6809161|NCT03749616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6809162|NCT03749616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809163|NCT03749616|Antipyretics|antipyretics|mesh-ancestor
6809164|NCT03749616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6809165|NCT03749616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6809166|NCT03749616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6809167|NCT03749616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6809168|NCT03749616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6809169|NCT03749616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809170|NCT03734016|Zanubrutinib|zanubrutinib|mesh-list
6809171|NCT03734016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6809172|NCT03734016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6809173|NCT03734016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6809174|NCT03734016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809175|NCT03612466|Plerixafor|plerixafor|mesh-list
6809176|NCT03612466|Calcium Carbonate|calcium carbonate|mesh-list
6809177|NCT03612466|Calcium|calcium|mesh-list
6809178|NCT03612466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6809179|NCT03612466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809180|NCT03612466|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6809181|NCT03612466|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6809182|NCT03612466|Antiviral Agents|antiviral agents|mesh-ancestor
6809183|NCT03612466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6809184|NCT03612466|Antacids|antacids|mesh-ancestor
6809185|NCT03612466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809186|NCT03612466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6809187|NCT03599635|Bupivacaine|bupivacaine|mesh-list
6809188|NCT03599635|Anesthetics, Local|anesthetics, local|mesh-ancestor
6809189|NCT03599635|Anesthetics|anesthetics|mesh-ancestor
6809190|NCT03599635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6809191|NCT03599635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809192|NCT03599635|Sensory System Agents|sensory system agents|mesh-ancestor
6809193|NCT03599635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6809194|NCT03570632|Metformin|metformin|mesh-list
6809195|NCT03570632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6809196|NCT03570632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809197|NCT03565835|Prednisone|prednisone|mesh-list
6809198|NCT03565835|Abiraterone Acetate|abiraterone acetate|mesh-list
6809199|NCT03565835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6809200|NCT03565835|Glucocorticoids|glucocorticoids|mesh-ancestor
6809201|NCT03565835|Hormones|hormones|mesh-ancestor
6809202|NCT03565835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6809203|NCT03565835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809204|NCT03565835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6809205|NCT03565835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6809206|NCT03565835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6809207|NCT03565835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6809208|NCT03565835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809209|NCT03565835|Hormone Antagonists|hormone antagonists|mesh-ancestor
6809210|NCT03565835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6809211|NCT03546829|Vancomycin|vancomycin|mesh-list
6809212|NCT03546829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6809213|NCT03546829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6809214|NCT03543839|Belimumab|belimumab|mesh-list
6809215|NCT03543839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6809216|NCT03543839|Immunologic Factors|immunologic factors|mesh-ancestor
6809217|NCT03543839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809218|NCT03499119|Erenumab|erenumab|mesh-list
6809219|NCT03499119|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
6809220|NCT03499119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809221|NCT03499119|Analgesics|analgesics|mesh-ancestor
6809222|NCT03499119|Sensory System Agents|sensory system agents|mesh-ancestor
6809223|NCT03499119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6809224|NCT03499119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809225|NCT03490058|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6809226|NCT03490058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6809227|NCT03490058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6809228|NCT03490058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6809229|NCT03490058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809230|NCT03490058|Antiviral Agents|antiviral agents|mesh-ancestor
6809231|NCT03490058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6809232|NCT03490058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6809233|NCT03490058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6809234|NCT03451825|Avelumab|avelumab|mesh-list
6809235|NCT03451825|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6809236|NCT03451825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6809237|NCT03451825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6809238|NCT03451825|Immunologic Factors|immunologic factors|mesh-ancestor
6809239|NCT03451825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809240|NCT03439046|Letrozole|letrozole|mesh-list
6809241|NCT03439046|Fulvestrant|fulvestrant|mesh-list
6809242|NCT03439046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6809243|NCT03439046|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6809244|NCT03439046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6809245|NCT03439046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6809246|NCT03439046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809247|NCT03439046|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6809248|NCT03439046|Hormone Antagonists|hormone antagonists|mesh-ancestor
6809249|NCT03439046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6809250|NCT03439046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809251|NCT03439046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6809252|NCT03439046|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6809253|NCT03406897|Vitamin D|vitamin d|mesh-list
6809254|NCT03406897|Cholecalciferol|cholecalciferol|mesh-list
6809255|NCT03406897|Vitamins|vitamins|mesh-ancestor
6809256|NCT03406897|Micronutrients|micronutrients|mesh-ancestor
6809257|NCT03406897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809258|NCT03406897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6809259|NCT03406897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6809260|NCT03369041|Irinotecan|irinotecan|mesh-list
6809261|NCT03369041|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6809262|NCT03369041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6809263|NCT03369041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6809264|NCT03369041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809265|NCT03369041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6809266|NCT03350984|Insulin|insulin|mesh-list
6809267|NCT03350984|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6809268|NCT03350984|Insulin Glargine|insulin glargine|mesh-list
6809269|NCT03350984|Insulin Lispro|insulin lispro|mesh-list
6809270|NCT03350984|Insulin, Isophane|insulin, isophane|mesh-list
6809271|NCT03350984|Isophane Insulin, Human|isophane insulin, human|mesh-list
6809272|NCT03350984|Isophane insulin, beef|isophane insulin, beef|mesh-list
6809273|NCT03350984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6809274|NCT03350984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809275|NCT03331341|Doxorubicin|doxorubicin|mesh-list
6809276|NCT03331341|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6809277|NCT03331341|Pembrolizumab|pembrolizumab|mesh-list
6809278|NCT03331341|Dacarbazine|dacarbazine|mesh-list
6809279|NCT03331341|Vinblastine|vinblastine|mesh-list
6809280|NCT03331341|Imidazole|imidazole|mesh-list
6809281|NCT03331341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6809282|NCT03331341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6809283|NCT03331341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6809284|NCT03331341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6809285|NCT03331341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6809286|NCT03331341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809287|NCT03331341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6809288|NCT03331341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6809289|NCT03331341|Alkylating Agents|alkylating agents|mesh-ancestor
6809290|NCT03331341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6809291|NCT03331341|Tubulin Modulators|tubulin modulators|mesh-ancestor
6809292|NCT03331341|Antimitotic Agents|antimitotic agents|mesh-ancestor
6809293|NCT03331341|Mitosis Modulators|mitosis modulators|mesh-ancestor
6809294|NCT03328845|Insulin|insulin|mesh-list
6809295|NCT03328845|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6809296|NCT03328845|Insulin Lispro|insulin lispro|mesh-list
6809297|NCT03328845|Insulin Aspart|insulin aspart|mesh-list
6809298|NCT03328845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6809299|NCT03328845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809300|NCT03305341|Molgramostim|molgramostim|mesh-list
6809301|NCT03305341|Sargramostim|sargramostim|mesh-list
6809302|NCT03305341|Immunologic Factors|immunologic factors|mesh-ancestor
6809303|NCT03305341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809304|NCT03305341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6809305|NCT03300427|Valsartan|valsartan|mesh-list
6809306|NCT03300427|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
6809307|NCT03300427|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6809308|NCT03300427|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6809309|NCT03300427|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6809310|NCT03300427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809311|NCT03288324|Tofacitinib|tofacitinib|mesh-list
6809312|NCT03288324|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6809313|NCT03288324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6809314|NCT03288324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809315|NCT03284047|Botulinum Toxins|botulinum toxins|mesh-list
6809316|NCT03284047|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6809317|NCT03284047|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6809318|NCT03284047|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6809319|NCT03284047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6809320|NCT03284047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809321|NCT03284047|Cholinergic Agents|cholinergic agents|mesh-ancestor
6809322|NCT03284047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6809323|NCT03284047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809324|NCT03284047|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6809325|NCT03284047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6809326|NCT03277261|Teriflunomide|teriflunomide|mesh-list
6809327|NCT03277261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6809328|NCT03277261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6809329|NCT03277261|Analgesics|analgesics|mesh-ancestor
6809330|NCT03277261|Sensory System Agents|sensory system agents|mesh-ancestor
6809331|NCT03277261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6809332|NCT03277261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809333|NCT03277261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6809334|NCT03277261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6809335|NCT03277261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6809336|NCT03277261|Immunologic Factors|immunologic factors|mesh-ancestor
6809337|NCT03277248|Teriflunomide|teriflunomide|mesh-list
6809338|NCT03277248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6809339|NCT03277248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6809340|NCT03277248|Analgesics|analgesics|mesh-ancestor
6809341|NCT03277248|Sensory System Agents|sensory system agents|mesh-ancestor
6809342|NCT03277248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6809343|NCT03277248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809344|NCT03277248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6809345|NCT03277248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6809346|NCT03277248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6809347|NCT03277248|Immunologic Factors|immunologic factors|mesh-ancestor
6809348|NCT03229499|Anastrozole|anastrozole|mesh-list
6809349|NCT03229499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6809350|NCT03229499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6809351|NCT03229499|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6809352|NCT03229499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6809353|NCT03229499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6809354|NCT03229499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809355|NCT03229499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6809356|NCT03229499|Hormone Antagonists|hormone antagonists|mesh-ancestor
6809357|NCT03229499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6809358|NCT03229499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809359|NCT03203850|Deferasirox|deferasirox|mesh-list
6809360|NCT03203850|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6809361|NCT03203850|Chelating Agents|chelating agents|mesh-ancestor
6809362|NCT03203850|Sequestering Agents|sequestering agents|mesh-ancestor
6809363|NCT03203850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809364|NCT03190174|Sirolimus|sirolimus|mesh-list
6809365|NCT03190174|Nivolumab|nivolumab|mesh-list
6809366|NCT03190174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6809367|NCT03190174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6809368|NCT03190174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6809369|NCT03190174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809370|NCT03190174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6809371|NCT03190174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6809372|NCT03190174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6809373|NCT03190174|Antifungal Agents|antifungal agents|mesh-ancestor
6809374|NCT03190174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6809375|NCT03190174|Immunologic Factors|immunologic factors|mesh-ancestor
6809376|NCT03190174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809377|NCT03187353|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6809378|NCT03187353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6809379|NCT03187353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809380|NCT03187353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6809381|NCT03187353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6809382|NCT03187353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6809383|NCT03187353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809384|NCT03187353|Dopamine Agents|dopamine agents|mesh-ancestor
6809385|NCT03187353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6809386|NCT03173976|Zoledronic Acid|zoledronic acid|mesh-list
6809387|NCT03173976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6809388|NCT03173976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809389|NCT03148899|Oxytocin|oxytocin|mesh-list
6809390|NCT03148899|Oxytocics|oxytocics|mesh-ancestor
6809391|NCT03148899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6809392|NCT03148899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809393|NCT03136627|Nivolumab|nivolumab|mesh-list
6809394|NCT03136627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6809395|NCT03136627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6809396|NCT03136627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6809397|NCT03136627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809398|NCT03114319|Nazartinib|nazartinib|mesh-list
6809399|NCT03114319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6809400|NCT03084549|Ropivacaine|ropivacaine|mesh-list
6809401|NCT03084549|Anesthetics, Local|anesthetics, local|mesh-ancestor
6809402|NCT03084549|Anesthetics|anesthetics|mesh-ancestor
6809403|NCT03084549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6809404|NCT03084549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809405|NCT03084549|Sensory System Agents|sensory system agents|mesh-ancestor
6809406|NCT03084549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6809407|NCT03064763|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
6809408|NCT03064763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6809409|NCT03064763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6809410|NCT03026348|Aluminum phosphate|aluminum phosphate|mesh-list
6809411|NCT03026348|Vaccines|vaccines|mesh-list
6809412|NCT03026348|Immunologic Factors|immunologic factors|mesh-ancestor
6809413|NCT03026348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809414|NCT03026348|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6809415|NCT03026348|Antacids|antacids|mesh-ancestor
6809416|NCT03026348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809417|NCT03026348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6809418|NCT02966548|Nivolumab|nivolumab|mesh-list
6809419|NCT02966548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6809420|NCT02966548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6809421|NCT02966548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6809422|NCT02966548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809423|NCT02959164|Gemcitabine|gemcitabine|mesh-list
6809424|NCT02959164|Decitabine|decitabine|mesh-list
6809425|NCT02959164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6809426|NCT02959164|Antimetabolites|antimetabolites|mesh-ancestor
6809427|NCT02959164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809428|NCT02959164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6809429|NCT02959164|Antiviral Agents|antiviral agents|mesh-ancestor
6809430|NCT02959164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6809431|NCT02959164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6809432|NCT02959164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6809433|NCT02959164|Immunologic Factors|immunologic factors|mesh-ancestor
6809434|NCT02959164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809435|NCT02928224|Leucovorin|leucovorin|mesh-list
6809436|NCT02928224|Folic Acid|folic acid|mesh-list
6809437|NCT02928224|Fluorouracil|fluorouracil|mesh-list
6809438|NCT02928224|Irinotecan|irinotecan|mesh-list
6809439|NCT02928224|Cetuximab|cetuximab|mesh-list
6809440|NCT02928224|Levoleucovorin|levoleucovorin|mesh-list
6809441|NCT02928224|Antimetabolites|antimetabolites|mesh-ancestor
6809442|NCT02928224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809443|NCT02928224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6809444|NCT02928224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6809445|NCT02928224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6809446|NCT02928224|Immunologic Factors|immunologic factors|mesh-ancestor
6809447|NCT02928224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809448|NCT02928224|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6809449|NCT02928224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6809450|NCT02928224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6809451|NCT02928224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6809452|NCT02928224|Antidotes|antidotes|mesh-ancestor
6809453|NCT02928224|Protective Agents|protective agents|mesh-ancestor
6809454|NCT02928224|Vitamin B Complex|vitamin b complex|mesh-ancestor
6809455|NCT02928224|Vitamins|vitamins|mesh-ancestor
6809456|NCT02928224|Micronutrients|micronutrients|mesh-ancestor
6809457|NCT02928224|Hematinics|hematinics|mesh-ancestor
6809458|NCT02922985|Acetaminophen|acetaminophen|mesh-list
6809459|NCT02922985|Ketorolac|ketorolac|mesh-list
6809460|NCT02922985|Bupivacaine|bupivacaine|mesh-list
6809461|NCT02922985|Anesthetics, Local|anesthetics, local|mesh-ancestor
6809462|NCT02922985|Anesthetics|anesthetics|mesh-ancestor
6809463|NCT02922985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6809464|NCT02922985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809465|NCT02922985|Sensory System Agents|sensory system agents|mesh-ancestor
6809466|NCT02922985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6809467|NCT02922985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6809468|NCT02922985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6809469|NCT02922985|Analgesics|analgesics|mesh-ancestor
6809470|NCT02922985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6809471|NCT02922985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6809472|NCT02922985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6809473|NCT02922985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6809474|NCT02922985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809475|NCT02922985|Antipyretics|antipyretics|mesh-ancestor
6809476|NCT02837783|Linaclotide|linaclotide|mesh-list
6809477|NCT02837783|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
6809478|NCT02837783|Enzyme Activators|enzyme activators|mesh-ancestor
6809479|NCT02837783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809480|NCT02837783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6809481|NCT02827201|Gemcitabine|gemcitabine|mesh-list
6809482|NCT02827201|Paclitaxel|paclitaxel|mesh-list
6809483|NCT02827201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6809484|NCT02827201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6809485|NCT02827201|Tubulin Modulators|tubulin modulators|mesh-ancestor
6809486|NCT02827201|Antimitotic Agents|antimitotic agents|mesh-ancestor
6809487|NCT02827201|Mitosis Modulators|mitosis modulators|mesh-ancestor
6809488|NCT02827201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809489|NCT02827201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6809490|NCT02827201|Antimetabolites|antimetabolites|mesh-ancestor
6809491|NCT02827201|Antiviral Agents|antiviral agents|mesh-ancestor
6809492|NCT02827201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6809493|NCT02827201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6809494|NCT02827201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6809495|NCT02827201|Immunologic Factors|immunologic factors|mesh-ancestor
6809496|NCT02827201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809497|NCT02786537|Ritonavir|ritonavir|mesh-list
6809498|NCT02786537|Ribavirin|ribavirin|mesh-list
6809499|NCT02786537|Sofosbuvir|sofosbuvir|mesh-list
6809500|NCT02786537|Grazoprevir|grazoprevir|mesh-list
6809501|NCT02786537|Ledipasvir|ledipasvir|mesh-list
6809502|NCT02786537|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6809503|NCT02786537|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6809504|NCT02786537|Protease Inhibitors|protease inhibitors|mesh-ancestor
6809505|NCT02786537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6809506|NCT02786537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809507|NCT02786537|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6809508|NCT02786537|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6809509|NCT02786537|Antiviral Agents|antiviral agents|mesh-ancestor
6809510|NCT02786537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6809511|NCT02786537|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6809512|NCT02786537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6809513|NCT02786537|Antimetabolites|antimetabolites|mesh-ancestor
6809514|NCT02710084|Oxytocin|oxytocin|mesh-list
6809515|NCT02710084|Oxytocics|oxytocics|mesh-ancestor
6809516|NCT02710084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6809517|NCT02710084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809518|NCT02678312|Enalapril|enalapril|mesh-list
6809519|NCT02678312|Enalaprilat|enalaprilat|mesh-list
6809520|NCT02678312|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
6809521|NCT02678312|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6809522|NCT02678312|Protease Inhibitors|protease inhibitors|mesh-ancestor
6809523|NCT02678312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6809524|NCT02678312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809525|NCT02678312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6809526|NCT02678312|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6809527|NCT02645474|Ropivacaine|ropivacaine|mesh-list
6809528|NCT02645474|Anesthetics, Local|anesthetics, local|mesh-ancestor
6809529|NCT02645474|Anesthetics|anesthetics|mesh-ancestor
6809530|NCT02645474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6809531|NCT02645474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809532|NCT02645474|Sensory System Agents|sensory system agents|mesh-ancestor
6809533|NCT02645474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6809534|NCT02617277|Durvalumab|durvalumab|mesh-list
6809535|NCT02617277|Adavosertib|adavosertib|mesh-list
6809536|NCT02617277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6809537|NCT02617277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6809538|NCT02617277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6809539|NCT02617277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809540|NCT02530034|Antibodies|antibodies|mesh-list
6809541|NCT02530034|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6809542|NCT02530034|Immunologic Factors|immunologic factors|mesh-ancestor
6809543|NCT02530034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809544|NCT02519348|Bevacizumab|bevacizumab|mesh-list
6809545|NCT02519348|Durvalumab|durvalumab|mesh-list
6809546|NCT02519348|Tremelimumab|tremelimumab|mesh-list
6809547|NCT02519348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6809548|NCT02519348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6809549|NCT02519348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6809550|NCT02519348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6809551|NCT02519348|Growth Substances|growth substances|mesh-ancestor
6809552|NCT02519348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809553|NCT02519348|Growth Inhibitors|growth inhibitors|mesh-ancestor
6809554|NCT02512172|Pembrolizumab|pembrolizumab|mesh-list
6809555|NCT02512172|Azacitidine|azacitidine|mesh-list
6809556|NCT02512172|Romidepsin|romidepsin|mesh-list
6809557|NCT02512172|Cc-486|cc-486|mesh-list
6809558|NCT02512172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6809559|NCT02512172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6809560|NCT02512172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6809561|NCT02512172|Antimetabolites|antimetabolites|mesh-ancestor
6809562|NCT02512172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809563|NCT02512172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6809564|NCT02512172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6809565|NCT02494258|Azacitidine|azacitidine|mesh-list
6809566|NCT02494258|Cc-486|cc-486|mesh-list
6809567|NCT02494258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6809568|NCT02494258|Antimetabolites|antimetabolites|mesh-ancestor
6809569|NCT02494258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809570|NCT02494258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6809571|NCT02494258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6809572|NCT02352337|Gemcitabine|gemcitabine|mesh-list
6809573|NCT02352337|Folfirinox|folfirinox|mesh-list
6809574|NCT02352337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6809575|NCT02352337|Antimetabolites|antimetabolites|mesh-ancestor
6809576|NCT02352337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809577|NCT02352337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6809578|NCT02352337|Antiviral Agents|antiviral agents|mesh-ancestor
6809579|NCT02352337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6809580|NCT02352337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6809581|NCT02352337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6809582|NCT02352337|Immunologic Factors|immunologic factors|mesh-ancestor
6809583|NCT02352337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809584|NCT02338609|Everolimus|everolimus|mesh-list
6809585|NCT02338609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6809586|NCT02338609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6809587|NCT02338609|Immunologic Factors|immunologic factors|mesh-ancestor
6809588|NCT02338609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809589|NCT02229149|Paclitaxel|paclitaxel|mesh-list
6809590|NCT02229149|Vinorelbine|vinorelbine|mesh-list
6809591|NCT02229149|Docetaxel|docetaxel|mesh-list
6809592|NCT02229149|Capecitabine|capecitabine|mesh-list
6809593|NCT02229149|Trastuzumab|trastuzumab|mesh-list
6809594|NCT02229149|Pertuzumab|pertuzumab|mesh-list
6809595|NCT02229149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6809596|NCT02229149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6809597|NCT02229149|Tubulin Modulators|tubulin modulators|mesh-ancestor
6809598|NCT02229149|Antimitotic Agents|antimitotic agents|mesh-ancestor
6809599|NCT02229149|Mitosis Modulators|mitosis modulators|mesh-ancestor
6809600|NCT02229149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809601|NCT02229149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6809602|NCT02229149|Antimetabolites|antimetabolites|mesh-ancestor
6809603|NCT02229149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6809604|NCT02187991|Paclitaxel|paclitaxel|mesh-list
6809605|NCT02187991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6809606|NCT02187991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6809607|NCT02187991|Tubulin Modulators|tubulin modulators|mesh-ancestor
6809608|NCT02187991|Antimitotic Agents|antimitotic agents|mesh-ancestor
6809609|NCT02187991|Mitosis Modulators|mitosis modulators|mesh-ancestor
6809610|NCT02187991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809611|NCT02184416|Everolimus|everolimus|mesh-list
6809612|NCT02184416|Sorafenib|sorafenib|mesh-list
6809613|NCT02184416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6809614|NCT02184416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6809615|NCT02184416|Immunologic Factors|immunologic factors|mesh-ancestor
6809616|NCT02184416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809617|NCT02184416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6809618|NCT02184416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6809619|NCT02184416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809620|NCT02182687|Doxorubicin|doxorubicin|mesh-list
6809621|NCT02182687|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6809622|NCT02182687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6809623|NCT02182687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6809624|NCT02182687|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6809625|NCT02182687|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6809626|NCT02182687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6809627|NCT02182687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258679|NCT03096314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258680|NCT03096314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6258681|NCT03096314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6258682|NCT03096353|Naloxone|naloxone|mesh-list
6258683|NCT03096353|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6258684|NCT03096353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258685|NCT03096353|Sensory System Agents|sensory system agents|mesh-ancestor
6258686|NCT03096353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6258687|NCT03096444|Lidocaine|lidocaine|mesh-list
6258688|NCT03096444|Ketamine|ketamine|mesh-list
6258689|NCT03096444|Amitriptyline|amitriptyline|mesh-list
6258690|NCT03096444|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6258691|NCT03096444|Anesthetics, Local|anesthetics, local|mesh-ancestor
6258692|NCT03096444|Anesthetics|anesthetics|mesh-ancestor
6258693|NCT03096444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6258694|NCT03096444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258695|NCT03096444|Sensory System Agents|sensory system agents|mesh-ancestor
6258696|NCT03096444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6258697|NCT03096444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6809628|NCT01976273|Glycolic acid|glycolic acid|mesh-list
6809629|NCT01976273|Keratolytic Agents|keratolytic agents|mesh-ancestor
6809630|NCT01976273|Dermatologic Agents|dermatologic agents|mesh-ancestor
6809631|NCT01802086|Lidocaine|lidocaine|mesh-list
6809632|NCT01802086|Prilocaine|prilocaine|mesh-list
6809633|NCT01802086|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
6809634|NCT01802086|Anesthetics, Local|anesthetics, local|mesh-ancestor
6809635|NCT01802086|Anesthetics|anesthetics|mesh-ancestor
6809636|NCT01802086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6809637|NCT01802086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809638|NCT01802086|Sensory System Agents|sensory system agents|mesh-ancestor
6809639|NCT01802086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6809640|NCT01802086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6809641|NCT01802086|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6809642|NCT01802086|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6809643|NCT01802086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6809644|NCT01802086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809645|NCT01802086|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
6809646|NCT01525316|Lactoferrin|lactoferrin|mesh-list
6809647|NCT01525316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6809648|NCT01388491|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6809649|NCT01388491|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6809650|NCT01388491|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6809651|NCT01388491|Desogestrel|desogestrel|mesh-list
6809652|NCT01388491|Estradiol|estradiol|mesh-list
6809653|NCT01388491|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6809654|NCT01388491|Estrogens|estrogens|mesh-ancestor
6809655|NCT01388491|Hormones|hormones|mesh-ancestor
6809656|NCT01388491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6809657|NCT01388491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809658|NCT01388491|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6809659|NCT01388491|Contraceptive Agents|contraceptive agents|mesh-ancestor
6809660|NCT01388491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6809661|NCT01388491|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6809662|NCT01388491|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6809663|NCT01388491|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6809664|NCT01388491|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6809665|NCT01388491|Progestins|progestins|mesh-ancestor
6809666|NCT01373151|Adalimumab|adalimumab|mesh-list
6809667|NCT01373151|Methotrexate|methotrexate|mesh-list
6809668|NCT01373151|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6809669|NCT01373151|Abortifacient Agents|abortifacient agents|mesh-ancestor
6809670|NCT01373151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6809671|NCT01373151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809672|NCT01373151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6809673|NCT01373151|Antimetabolites|antimetabolites|mesh-ancestor
6809674|NCT01373151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809675|NCT01373151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6809676|NCT01373151|Dermatologic Agents|dermatologic agents|mesh-ancestor
6809677|NCT01373151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6809678|NCT01373151|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6809679|NCT01373151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6809680|NCT01373151|Immunologic Factors|immunologic factors|mesh-ancestor
6809681|NCT01373151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6809682|NCT01373151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6809683|NCT01373151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6809684|NCT01351103|Spartalizumab|spartalizumab|mesh-list
6809685|NCT01351103|LGK974|lgk974|mesh-list
6809686|NCT01351103|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6809687|NCT01351103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809688|NCT01351103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6809689|NCT01351103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6809690|NCT01274611|Botulinum Toxins|botulinum toxins|mesh-list
6809691|NCT01274611|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6809692|NCT01274611|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6809693|NCT01274611|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6809694|NCT01274611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6809695|NCT01274611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809696|NCT01274611|Cholinergic Agents|cholinergic agents|mesh-ancestor
6809697|NCT01274611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6809698|NCT01274611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809699|NCT01274611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6809700|NCT01274611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6809701|NCT00960297|Paclitaxel|paclitaxel|mesh-list
6809702|NCT00960297|Bevacizumab|bevacizumab|mesh-list
6809703|NCT00960297|Carboplatin|carboplatin|mesh-list
6809704|NCT00960297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6809705|NCT00960297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6809706|NCT00960297|Tubulin Modulators|tubulin modulators|mesh-ancestor
6809707|NCT00960297|Antimitotic Agents|antimitotic agents|mesh-ancestor
6809708|NCT00960297|Mitosis Modulators|mitosis modulators|mesh-ancestor
6809709|NCT00960297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809710|NCT00960297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6809711|NCT00960297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6809712|NCT00960297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6809713|NCT00960297|Growth Substances|growth substances|mesh-ancestor
6809714|NCT00960297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809715|NCT00960297|Growth Inhibitors|growth inhibitors|mesh-ancestor
6809716|NCT00910650|Aldesleukin|aldesleukin|mesh-list
6809717|NCT00910650|Interleukin-2|interleukin-2|mesh-list
6809718|NCT00910650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6809719|NCT00910650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6809720|NCT00910650|Analgesics|analgesics|mesh-ancestor
6809721|NCT00910650|Sensory System Agents|sensory system agents|mesh-ancestor
6809722|NCT00910650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6809723|NCT00910650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809724|NCT00910650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6809725|NCT00910650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6809726|NCT00910650|Antiviral Agents|antiviral agents|mesh-ancestor
6809727|NCT00910650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6809728|NCT00756288|Photosensitizing Agents|photosensitizing agents|mesh-list
6809729|NCT00756288|Dermatologic Agents|dermatologic agents|mesh-ancestor
6809730|NCT00703326|Docetaxel|docetaxel|mesh-list
6809731|NCT00703326|Ramucirumab|ramucirumab|mesh-list
6809732|NCT00703326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6809733|NCT00703326|Tubulin Modulators|tubulin modulators|mesh-ancestor
6809734|NCT00703326|Antimitotic Agents|antimitotic agents|mesh-ancestor
6809735|NCT00703326|Mitosis Modulators|mitosis modulators|mesh-ancestor
6809736|NCT00703326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809737|NCT00602667|Cyclophosphamide|cyclophosphamide|mesh-list
6809738|NCT00602667|Cisplatin|cisplatin|mesh-list
6809739|NCT00602667|Carboplatin|carboplatin|mesh-list
6809740|NCT00602667|Methotrexate|methotrexate|mesh-list
6809741|NCT00602667|Etoposide|etoposide|mesh-list
6809742|NCT00602667|Etoposide phosphate|etoposide phosphate|mesh-list
6809743|NCT00602667|Vincristine|vincristine|mesh-list
6809744|NCT00602667|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6809745|NCT00602667|Topotecan|topotecan|mesh-list
6809746|NCT00602667|Vinblastine|vinblastine|mesh-list
6809747|NCT00602667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6809748|NCT00602667|Immunologic Factors|immunologic factors|mesh-ancestor
6809749|NCT00602667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809750|NCT00602667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6809751|NCT00602667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6809752|NCT00602667|Alkylating Agents|alkylating agents|mesh-ancestor
6809753|NCT00602667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809754|NCT00602667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6809755|NCT00602667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6809756|NCT00602667|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6809757|NCT00602667|Abortifacient Agents|abortifacient agents|mesh-ancestor
6809758|NCT00602667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6809759|NCT00602667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6809760|NCT00602667|Antimetabolites|antimetabolites|mesh-ancestor
6809761|NCT00602667|Dermatologic Agents|dermatologic agents|mesh-ancestor
6809762|NCT00602667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6809763|NCT00602667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6809764|NCT00602667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6809765|NCT00602667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6809766|NCT00602667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6809767|NCT00602667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6809768|NCT00602667|Tubulin Modulators|tubulin modulators|mesh-ancestor
6809769|NCT00602667|Antimitotic Agents|antimitotic agents|mesh-ancestor
6809770|NCT00602667|Mitosis Modulators|mitosis modulators|mesh-ancestor
6809771|NCT00602667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6809772|NCT00602667|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6809773|NCT00472186|Lansoprazole|lansoprazole|mesh-list
6809774|NCT00472186|Dexlansoprazole|dexlansoprazole|mesh-list
6809775|NCT00472186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6809776|NCT00472186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6809777|NCT00472186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6809778|NCT00472186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6809779|NCT00472186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809780|NCT05148000|Botulinum Toxins|botulinum toxins|mesh-list
6809781|NCT05148000|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6809782|NCT05148000|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6809783|NCT05148000|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6809784|NCT05148000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6809785|NCT05148000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809786|NCT05148000|Cholinergic Agents|cholinergic agents|mesh-ancestor
6809787|NCT05148000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6809788|NCT05148000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809789|NCT05148000|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6809790|NCT05148000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6809791|NCT05147857|Misoprostol|misoprostol|mesh-list
6809792|NCT05147857|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6809793|NCT05147857|Abortifacient Agents|abortifacient agents|mesh-ancestor
6809794|NCT05147857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6809795|NCT05147857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809796|NCT05147857|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6809797|NCT05147857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6809798|NCT05147857|Oxytocics|oxytocics|mesh-ancestor
6809799|NCT05147805|Treprostinil|treprostinil|mesh-list
6809800|NCT05147805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6809801|NCT05147753|Moxonidine|moxonidine|mesh-list
6809802|NCT05147753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6809803|NCT05147727|Fluconazole|fluconazole|mesh-list
6809804|NCT05147727|Antifungal Agents|antifungal agents|mesh-ancestor
6809805|NCT05147727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6809806|NCT05147727|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6809807|NCT05147727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6809808|NCT05147727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6809809|NCT05147727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809810|NCT05147727|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6809811|NCT05147727|Hormone Antagonists|hormone antagonists|mesh-ancestor
6809812|NCT05147727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6809813|NCT05147727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809814|NCT05147727|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6809815|NCT05147727|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6809816|NCT05147493|Dexamethasone|dexamethasone|mesh-list
6809817|NCT05147493|Cyclophosphamide|cyclophosphamide|mesh-list
6809818|NCT05147493|Lenalidomide|lenalidomide|mesh-list
6809819|NCT05147493|Bortezomib|bortezomib|mesh-list
6809820|NCT05147493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6809821|NCT05147493|Immunologic Factors|immunologic factors|mesh-ancestor
6809822|NCT05147493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809823|NCT05147493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6809824|NCT05147493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6809825|NCT05147493|Alkylating Agents|alkylating agents|mesh-ancestor
6809826|NCT05147493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809827|NCT05147493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6809828|NCT05147493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6809829|NCT05147493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6809830|NCT05147493|Antiemetics|antiemetics|mesh-ancestor
6809831|NCT05147493|Autonomic Agents|autonomic agents|mesh-ancestor
6809832|NCT05147493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6809833|NCT05147493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6809834|NCT05147493|Glucocorticoids|glucocorticoids|mesh-ancestor
6809835|NCT05147493|Hormones|hormones|mesh-ancestor
6809836|NCT05147493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6809837|NCT05147493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6809838|NCT05147493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6809839|NCT05147493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6809840|NCT05147493|Growth Substances|growth substances|mesh-ancestor
6809841|NCT05147493|Growth Inhibitors|growth inhibitors|mesh-ancestor
6809842|NCT05147233|Dexamethasone|dexamethasone|mesh-list
6809843|NCT05147233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6809844|NCT05147233|Antiemetics|antiemetics|mesh-ancestor
6809845|NCT05147233|Autonomic Agents|autonomic agents|mesh-ancestor
6809846|NCT05147233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6809847|NCT05147233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809848|NCT05147233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6809849|NCT05147233|Glucocorticoids|glucocorticoids|mesh-ancestor
6809850|NCT05147233|Hormones|hormones|mesh-ancestor
6809851|NCT05147233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6809852|NCT05147233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6809853|NCT05147233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6809854|NCT05147194|Trimetazidine|trimetazidine|mesh-list
6809855|NCT05147194|Vasodilator Agents|vasodilator agents|mesh-ancestor
6809856|NCT05147090|Empagliflozin|empagliflozin|mesh-list
6809857|NCT05147090|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6809858|NCT05147090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809859|NCT05147090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6809860|NCT05147090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809861|NCT05146895|Imiquimod|imiquimod|mesh-list
6809862|NCT05146895|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6809863|NCT05146895|Immunologic Factors|immunologic factors|mesh-ancestor
6809864|NCT05146895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809865|NCT05146895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6809866|NCT05146895|Interferon Inducers|interferon inducers|mesh-ancestor
6809867|NCT05146804|Sulforaphane|sulforaphane|mesh-list
6809868|NCT05146804|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6809869|NCT05146804|Protective Agents|protective agents|mesh-ancestor
6809870|NCT05146804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809871|NCT05146804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6809872|NCT05146778|Lidocaine|lidocaine|mesh-list
6809873|NCT05146778|Fentanyl|fentanyl|mesh-list
6809874|NCT05146778|Dexmedetomidine|dexmedetomidine|mesh-list
6809875|NCT05146778|Analgesics, Opioid|analgesics, opioid|mesh-list
6809876|NCT05146778|Anesthetics|anesthetics|mesh-list
6809877|NCT05146778|Anesthetics, Local|anesthetics, local|mesh-ancestor
6809878|NCT05146778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6809879|NCT05146778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809880|NCT05146778|Sensory System Agents|sensory system agents|mesh-ancestor
6809881|NCT05146778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6809882|NCT05146778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6809883|NCT05146778|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6809884|NCT05146778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6809885|NCT05146778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6809886|NCT05146778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809887|NCT05146778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6809888|NCT05146778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6809889|NCT05146778|Analgesics|analgesics|mesh-ancestor
6809890|NCT05146778|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6809891|NCT05146778|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6809892|NCT05146778|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6809893|NCT05146778|Adrenergic Agents|adrenergic agents|mesh-ancestor
6809894|NCT05146778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6809895|NCT05146778|Narcotics|narcotics|mesh-ancestor
6809896|NCT05146778|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6809897|NCT05146778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6809898|NCT05146778|Anesthetics, General|anesthetics, general|mesh-ancestor
6809899|NCT05146739|Vidarabine|vidarabine|mesh-list
6809900|NCT05146739|Cytarabine|cytarabine|mesh-list
6809901|NCT05146739|Fludarabine|fludarabine|mesh-list
6809902|NCT05146739|Fludarabine phosphate|fludarabine phosphate|mesh-list
6809903|NCT05146739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6809904|NCT05146739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6809905|NCT05146739|Antimetabolites|antimetabolites|mesh-ancestor
6809906|NCT05146739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809907|NCT05146739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6809908|NCT05146739|Immunologic Factors|immunologic factors|mesh-ancestor
6809909|NCT05146739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809910|NCT05146739|Antiviral Agents|antiviral agents|mesh-ancestor
6809911|NCT05146739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6809912|NCT05146713|Propolis|propolis|mesh-list
6809913|NCT05146713|Sodium Hypochlorite|sodium hypochlorite|mesh-list
6809914|NCT05146713|Eusol|eusol|mesh-list
5993545|NCT00123110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5993546|NCT00123110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5993547|NCT00123110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5993548|NCT00123123|Chlorhexidine|chlorhexidine|mesh-list
5993549|NCT00123123|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5993550|NCT00123123|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5993551|NCT00123123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5993552|NCT00123123|Disinfectants|disinfectants|mesh-ancestor
6809915|NCT05146713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6809916|NCT05146713|Disinfectants|disinfectants|mesh-ancestor
6809917|NCT05145608|Lamotrigine|lamotrigine|mesh-list
6809918|NCT05145608|Anticonvulsants|anticonvulsants|mesh-list
6809919|NCT05145608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6809920|NCT05145608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6809921|NCT05145608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809922|NCT05145608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6809923|NCT05145608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809924|NCT05145608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6809925|NCT05145608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6809926|NCT05145608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6809927|NCT05145608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6809928|NCT05145608|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6809929|NCT05134987|Insulin Detemir|insulin detemir|mesh-list
6809930|NCT05134987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6809931|NCT05134987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809932|NCT05122182|Proxigermanium|proxigermanium|mesh-list
6809933|NCT05122182|Candesartan|candesartan|mesh-list
6809934|NCT05122182|Candesartan cilexetil|candesartan cilexetil|mesh-list
6809935|NCT05122182|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6809936|NCT05122182|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6809937|NCT05122182|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6809938|NCT05122182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809939|NCT05122182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6809940|NCT05122182|Interferon Inducers|interferon inducers|mesh-ancestor
6809941|NCT05122182|Immunologic Factors|immunologic factors|mesh-ancestor
6809942|NCT05122182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809943|NCT05118308|Liver Extracts|liver extracts|mesh-list
6809944|NCT05118308|Hematinics|hematinics|mesh-ancestor
6809945|NCT05116800|Gemcitabine|gemcitabine|mesh-list
6809946|NCT05116800|Docetaxel|docetaxel|mesh-list
6809947|NCT05116800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6809948|NCT05116800|Antimetabolites|antimetabolites|mesh-ancestor
6809949|NCT05116800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6809950|NCT05116800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6809951|NCT05116800|Antiviral Agents|antiviral agents|mesh-ancestor
6809952|NCT05116800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6809953|NCT05116800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6809954|NCT05116800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6809955|NCT05116800|Immunologic Factors|immunologic factors|mesh-ancestor
6809956|NCT05116800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809957|NCT05116800|Tubulin Modulators|tubulin modulators|mesh-ancestor
6809958|NCT05116800|Antimitotic Agents|antimitotic agents|mesh-ancestor
6809959|NCT05116800|Mitosis Modulators|mitosis modulators|mesh-ancestor
6809960|NCT05112861|Bevacizumab|bevacizumab|mesh-list
6809961|NCT05112861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6809962|NCT05112861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6809963|NCT05112861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6809964|NCT05112861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6809965|NCT05112861|Growth Substances|growth substances|mesh-ancestor
6809966|NCT05112861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809967|NCT05112861|Growth Inhibitors|growth inhibitors|mesh-ancestor
6809968|NCT05089565|Interferons|interferons|mesh-list
6809969|NCT05089565|Interferon-gamma|interferon-gamma|mesh-list
6809970|NCT05089565|Antibodies|antibodies|mesh-list
6809971|NCT05089565|Immunoglobulin G|immunoglobulin g|mesh-list
6809972|NCT05089565|Immunologic Factors|immunologic factors|mesh-ancestor
6809973|NCT05089565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809974|NCT05089565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6809975|NCT05089565|Antiviral Agents|antiviral agents|mesh-ancestor
6809976|NCT05089565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6809977|NCT05085327|Sunscreening Agents|sunscreening agents|mesh-list
6809978|NCT05085327|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6809979|NCT05085327|Protective Agents|protective agents|mesh-ancestor
6809980|NCT05085327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809981|NCT05085327|Dermatologic Agents|dermatologic agents|mesh-ancestor
6809982|NCT05083975|Anesthetics|anesthetics|mesh-list
6809983|NCT05083975|Anesthetics, Local|anesthetics, local|mesh-list
6809984|NCT05083975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6809985|NCT05083975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809986|NCT05083975|Sensory System Agents|sensory system agents|mesh-ancestor
6809987|NCT05083975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6809988|NCT05078463|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
6809989|NCT05078463|Terephthalic acid|terephthalic acid|mesh-list
6809990|NCT05078463|Anesthetics, Local|anesthetics, local|mesh-ancestor
6809991|NCT05078463|Anesthetics|anesthetics|mesh-ancestor
6809992|NCT05078463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6809993|NCT05078463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6809994|NCT05078463|Sensory System Agents|sensory system agents|mesh-ancestor
6809995|NCT05078463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6809996|NCT05078463|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
6809997|NCT05078463|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6809998|NCT05078463|Antioxidants|antioxidants|mesh-ancestor
6809999|NCT05078463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810000|NCT05078463|Protective Agents|protective agents|mesh-ancestor
6810001|NCT05042440|Factor VIII|factor viii|mesh-list
6810002|NCT05042440|BAX 855|bax 855|mesh-list
6810003|NCT05042440|Coagulants|coagulants|mesh-ancestor
6810004|NCT04984889|Protein C|protein c|mesh-list
6810005|NCT04984889|Anticoagulants|anticoagulants|mesh-ancestor
6810006|NCT04984889|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6810007|NCT04984889|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6810008|NCT04984889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810009|NCT04984837|Gemcitabine|gemcitabine|mesh-list
6810010|NCT04984837|Oxaliplatin|oxaliplatin|mesh-list
6810011|NCT04984837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6810012|NCT04984837|Antimetabolites|antimetabolites|mesh-ancestor
6810013|NCT04984837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810014|NCT04984837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6810015|NCT04984837|Antiviral Agents|antiviral agents|mesh-ancestor
6810016|NCT04984837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6810017|NCT04984837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6810018|NCT04984837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6810019|NCT04984837|Immunologic Factors|immunologic factors|mesh-ancestor
6810020|NCT04984837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810021|NCT04974216|Rituximab|rituximab|mesh-list
6810022|NCT04974216|Lenalidomide|lenalidomide|mesh-list
6810023|NCT04974216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6810024|NCT04974216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6810025|NCT04974216|Immunologic Factors|immunologic factors|mesh-ancestor
6810026|NCT04974216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810027|NCT04974216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6810028|NCT04974216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6810029|NCT04974216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6810030|NCT04974216|Growth Substances|growth substances|mesh-ancestor
6810031|NCT04974216|Growth Inhibitors|growth inhibitors|mesh-ancestor
6810032|NCT04969510|Pramoxine|pramoxine|mesh-list
6810033|NCT04969510|Anesthetics, Local|anesthetics, local|mesh-ancestor
6810034|NCT04969510|Anesthetics|anesthetics|mesh-ancestor
6810035|NCT04969510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6810036|NCT04969510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810037|NCT04969510|Sensory System Agents|sensory system agents|mesh-ancestor
6810038|NCT04969510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6810039|NCT04968106|Doxorubicin|doxorubicin|mesh-list
6810040|NCT04968106|Ifosfamide|ifosfamide|mesh-list
6810041|NCT04968106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6810042|NCT04968106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6810043|NCT04968106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6810044|NCT04968106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6810045|NCT04968106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6810046|NCT04968106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810047|NCT04968106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6810048|NCT04968106|Alkylating Agents|alkylating agents|mesh-ancestor
6810049|NCT04952753|Leucovorin|leucovorin|mesh-list
6810050|NCT04952753|Bevacizumab|bevacizumab|mesh-list
6810051|NCT04952753|Oxaliplatin|oxaliplatin|mesh-list
6810052|NCT04952753|Irinotecan|irinotecan|mesh-list
6810053|NCT04952753|Levoleucovorin|levoleucovorin|mesh-list
6810054|NCT04952753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6810055|NCT04952753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6810056|NCT04952753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6810057|NCT04952753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6810058|NCT04952753|Growth Substances|growth substances|mesh-ancestor
6810059|NCT04952753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810060|NCT04952753|Growth Inhibitors|growth inhibitors|mesh-ancestor
6810061|NCT04952753|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6810062|NCT04952753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6810063|NCT04952753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6810064|NCT04952753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810065|NCT04952753|Antidotes|antidotes|mesh-ancestor
6810066|NCT04952753|Protective Agents|protective agents|mesh-ancestor
6810067|NCT04952753|Vitamin B Complex|vitamin b complex|mesh-ancestor
6810068|NCT04952753|Vitamins|vitamins|mesh-ancestor
6810069|NCT04952753|Micronutrients|micronutrients|mesh-ancestor
6810070|NCT04948463|Vancomycin|vancomycin|mesh-list
6810071|NCT04948463|Ciprofloxacin|ciprofloxacin|mesh-list
6810072|NCT04948463|Tazobactam|tazobactam|mesh-list
6810073|NCT04948463|Piperacillin|piperacillin|mesh-list
6810074|NCT04948463|Amikacin|amikacin|mesh-list
6810075|NCT04948463|Ceftazidime|ceftazidime|mesh-list
6810076|NCT04948463|Cefepime|cefepime|mesh-list
6810077|NCT04948463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6810078|NCT04948463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6810079|NCT04948463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6810080|NCT04948463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6810081|NCT04948463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6810082|NCT04948463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810083|NCT04948463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6810084|NCT04948463|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6810085|NCT04948463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6810086|NCT04948463|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6810087|NCT04941261|Vaccines|vaccines|mesh-list
6810088|NCT04941261|Immunologic Factors|immunologic factors|mesh-ancestor
6810089|NCT04941261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810090|NCT04939363|Venetoclax|venetoclax|mesh-list
6810091|NCT04939363|Obinutuzumab|obinutuzumab|mesh-list
6810092|NCT04939363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6810093|NCT04939363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6810094|NCT04899349|Metformin|metformin|mesh-list
6810095|NCT04899349|Dapagliflozin|dapagliflozin|mesh-list
6810096|NCT04899349|Fulvestrant|fulvestrant|mesh-list
6810097|NCT04899349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6810098|NCT04899349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810099|NCT04899349|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6810100|NCT04899349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810101|NCT04899349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6810102|NCT04899349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6810103|NCT04899349|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6810104|NCT04899349|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6810105|NCT04899349|Hormone Antagonists|hormone antagonists|mesh-ancestor
6810106|NCT04899349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6810107|NCT04894721|Ivermectin|ivermectin|mesh-list
6810108|NCT04894721|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6810109|NCT04894721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6810110|NCT04874311|Doxorubicin|doxorubicin|mesh-list
6810111|NCT04874311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6810112|NCT04874311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6810113|NCT04874311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6810114|NCT04874311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6810115|NCT04874311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6810116|NCT04874311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810117|NCT04833140|Estradiol|estradiol|mesh-list
6810118|NCT04833140|Estrogens|estrogens|mesh-ancestor
6810119|NCT04833140|Hormones|hormones|mesh-ancestor
6810120|NCT04833140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6810121|NCT04833140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810122|NCT04825197|Poractant alfa|poractant alfa|mesh-list
6810123|NCT04825197|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
6810124|NCT04825197|Respiratory System Agents|respiratory system agents|mesh-ancestor
5993553|NCT00123123|Dermatologic Agents|dermatologic agents|mesh-ancestor
5993554|NCT00123162|Sildenafil Citrate|sildenafil citrate|mesh-list
5993555|NCT00123162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5993556|NCT00123162|Vasodilator Agents|vasodilator agents|mesh-ancestor
5993557|NCT00123162|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5993558|NCT00123162|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5993559|NCT00123162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6810125|NCT04817956|Trastuzumab|trastuzumab|mesh-list
6810126|NCT04817956|Pertuzumab|pertuzumab|mesh-list
6810127|NCT04817956|Atezolizumab|atezolizumab|mesh-list
6810128|NCT04817956|Vemurafenib|vemurafenib|mesh-list
6810129|NCT04817956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6810130|NCT04817956|Entrectinib|entrectinib|mesh-list
6810131|NCT04817956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6810132|NCT04817956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6810133|NCT04817956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810134|NCT04817956|Immunologic Factors|immunologic factors|mesh-ancestor
6810135|NCT04817956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5993560|NCT00123162|Urological Agents|urological agents|mesh-ancestor
6810136|NCT04817956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6810137|NCT04817956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810138|NCT04802590|Venetoclax|venetoclax|mesh-list
6810139|NCT04802590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6810140|NCT04793659|Fasudil|fasudil|mesh-list
6810141|NCT04793659|1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine|1-(5-isoquinolinesulfonyl)-2-methylpiperazine|mesh-list
6810142|NCT04793659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6810143|NCT04793659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6810144|NCT04793659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810145|NCT04793659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6810146|NCT04793659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810147|NCT04793659|Vasodilator Agents|vasodilator agents|mesh-ancestor
6810148|NCT04793659|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6810149|NCT04793659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6810150|NCT04789148|Oxytocin|oxytocin|mesh-list
6810151|NCT04789148|Oxytocics|oxytocics|mesh-ancestor
6810152|NCT04789148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6810153|NCT04789148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810154|NCT04783675|Rituximab|rituximab|mesh-list
6810155|NCT04783675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6810156|NCT04783675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6810157|NCT04783675|Immunologic Factors|immunologic factors|mesh-ancestor
6810158|NCT04783675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810159|NCT04783675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6810160|NCT04776148|Trifluridine|trifluridine|mesh-list
6810161|NCT04776148|Pembrolizumab|pembrolizumab|mesh-list
6810162|NCT04776148|Lenvatinib|lenvatinib|mesh-list
6810163|NCT04776148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6810164|NCT04776148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6810165|NCT04776148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6810166|NCT04776148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6810167|NCT04776148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810168|NCT04776148|Antimetabolites|antimetabolites|mesh-ancestor
6810169|NCT04776148|Antiviral Agents|antiviral agents|mesh-ancestor
6810170|NCT04776148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6810171|NCT04752696|Leucovorin|leucovorin|mesh-list
6810172|NCT04752696|Fluorouracil|fluorouracil|mesh-list
6810173|NCT04752696|Irinotecan|irinotecan|mesh-list
6810174|NCT04752696|Onvansertib|onvansertib|mesh-list
6810175|NCT04752696|Antimetabolites|antimetabolites|mesh-ancestor
6810176|NCT04752696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810177|NCT04752696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6810178|NCT04752696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6810179|NCT04752696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6810180|NCT04752696|Immunologic Factors|immunologic factors|mesh-ancestor
6810181|NCT04752696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810182|NCT04752696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6810183|NCT04752696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6810184|NCT04752696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6810185|NCT04752696|Antidotes|antidotes|mesh-ancestor
6810186|NCT04752696|Protective Agents|protective agents|mesh-ancestor
6810187|NCT04752696|Vitamin B Complex|vitamin b complex|mesh-ancestor
6810188|NCT04752696|Vitamins|vitamins|mesh-ancestor
6810189|NCT04752696|Micronutrients|micronutrients|mesh-ancestor
6810190|NCT04752696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6810191|NCT04742140|Magnesium Sulfate|magnesium sulfate|mesh-list
6810192|NCT04742140|Analgesics|analgesics|mesh-ancestor
6810193|NCT04742140|Sensory System Agents|sensory system agents|mesh-ancestor
6810194|NCT04742140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6810195|NCT04742140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810196|NCT04742140|Anesthetics|anesthetics|mesh-ancestor
6810197|NCT04742140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6810198|NCT04742140|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6810199|NCT04742140|Anticonvulsants|anticonvulsants|mesh-ancestor
6810200|NCT04742140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6810201|NCT04742140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6810202|NCT04742140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810203|NCT04742140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6810204|NCT04742140|Tocolytic Agents|tocolytic agents|mesh-ancestor
6810205|NCT04742140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5993561|NCT00123474|Dasatinib|dasatinib|mesh-list
6810206|NCT04715230|Lorazepam|lorazepam|mesh-list
6810207|NCT04715230|Haloperidol|haloperidol|mesh-list
6810208|NCT04715230|Haloperidol decanoate|haloperidol decanoate|mesh-list
6810209|NCT04715230|Antiemetics|antiemetics|mesh-ancestor
6810210|NCT04715230|Autonomic Agents|autonomic agents|mesh-ancestor
6810211|NCT04715230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6810212|NCT04715230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810213|NCT04715230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6810214|NCT04715230|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6810215|NCT04715230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6810216|NCT04715230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6810217|NCT04715230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6810218|NCT04715230|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6810219|NCT04715230|Dopamine Agents|dopamine agents|mesh-ancestor
6810220|NCT04715230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6810221|NCT04715230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810222|NCT04715230|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6810223|NCT04715230|Anticonvulsants|anticonvulsants|mesh-ancestor
6810224|NCT04715230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6810225|NCT04715230|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6810226|NCT04715230|GABA Modulators|gaba modulators|mesh-ancestor
6810227|NCT04715230|GABA Agents|gaba agents|mesh-ancestor
6810228|NCT04677387|Naloxone|naloxone|mesh-list
6810229|NCT04677387|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6810230|NCT04677387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810231|NCT04677387|Sensory System Agents|sensory system agents|mesh-ancestor
6810232|NCT04677387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6810233|NCT04665037|Posaconazole|posaconazole|mesh-list
6810234|NCT04665037|Antifungal Agents|antifungal agents|mesh-ancestor
6810235|NCT04665037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6810236|NCT04665037|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6810237|NCT04665037|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6810238|NCT04665037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6810239|NCT04665037|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6810240|NCT04665037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6810241|NCT04665037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6810242|NCT04665037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810243|NCT04665037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6810244|NCT04665037|Hormone Antagonists|hormone antagonists|mesh-ancestor
6810245|NCT04665037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6810246|NCT04665037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810247|NCT04643379|Carboplatin|carboplatin|mesh-list
6810248|NCT04643379|Pembrolizumab|pembrolizumab|mesh-list
6810249|NCT04643379|Olaparib|olaparib|mesh-list
6810250|NCT04643379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6810251|NCT04643379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6810252|NCT04643379|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6810253|NCT04643379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6810254|NCT04643379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810255|NCT04604067|Acalabrutinib|acalabrutinib|mesh-list
6810256|NCT04604067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6810257|NCT04590274|Azithromycin|azithromycin|mesh-list
6810258|NCT04590274|Hydroxychloroquine|hydroxychloroquine|mesh-list
6810259|NCT04590274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6810260|NCT04590274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6810261|NCT04590274|Antimalarials|antimalarials|mesh-ancestor
6810262|NCT04590274|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6810263|NCT04590274|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6810264|NCT04590274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6810265|NCT04590274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810266|NCT04590274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6810267|NCT04567784|Cannabidiol|cannabidiol|mesh-list
6810268|NCT04567784|Anticonvulsants|anticonvulsants|mesh-ancestor
6810269|NCT04526899|Cemiplimab|cemiplimab|mesh-list
6810270|NCT04526899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6810271|NCT04526899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6810272|NCT04515147|Vaccines|vaccines|mesh-list
6810273|NCT04515147|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6810274|NCT04515147|Immunologic Factors|immunologic factors|mesh-ancestor
6810275|NCT04515147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810276|NCT04512235|Dexamethasone|dexamethasone|mesh-list
6810277|NCT04512235|Cyclophosphamide|cyclophosphamide|mesh-list
6810278|NCT04512235|Bortezomib|bortezomib|mesh-list
6810279|NCT04512235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6810280|NCT04512235|Immunologic Factors|immunologic factors|mesh-ancestor
6810281|NCT04512235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810282|NCT04512235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6810283|NCT04512235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6810284|NCT04512235|Alkylating Agents|alkylating agents|mesh-ancestor
6810285|NCT04512235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810286|NCT04512235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6810287|NCT04512235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6810288|NCT04512235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6810289|NCT04512235|Antiemetics|antiemetics|mesh-ancestor
6810290|NCT04512235|Autonomic Agents|autonomic agents|mesh-ancestor
6810291|NCT04512235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6810292|NCT04512235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6810293|NCT04512235|Glucocorticoids|glucocorticoids|mesh-ancestor
6810294|NCT04512235|Hormones|hormones|mesh-ancestor
6810295|NCT04512235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6810296|NCT04512235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6810297|NCT04504825|Dexamethasone|dexamethasone|mesh-list
6810298|NCT04504825|Cyclophosphamide|cyclophosphamide|mesh-list
6810299|NCT04504825|Bortezomib|bortezomib|mesh-list
6810300|NCT04504825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6810301|NCT04504825|Immunologic Factors|immunologic factors|mesh-ancestor
6810302|NCT04504825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810303|NCT04504825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6810304|NCT04504825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6810305|NCT04504825|Alkylating Agents|alkylating agents|mesh-ancestor
6810306|NCT04504825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810307|NCT04504825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6810308|NCT04504825|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6810309|NCT04504825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6810310|NCT04504825|Antiemetics|antiemetics|mesh-ancestor
6810311|NCT04504825|Autonomic Agents|autonomic agents|mesh-ancestor
6810312|NCT04504825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6810313|NCT04504825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6810314|NCT04504825|Glucocorticoids|glucocorticoids|mesh-ancestor
6810315|NCT04504825|Hormones|hormones|mesh-ancestor
6810316|NCT04504825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6810317|NCT04504825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6810318|NCT04497116|Gemcitabine|gemcitabine|mesh-list
6810319|NCT04497116|Talazoparib|talazoparib|mesh-list
6810320|NCT04497116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6810321|NCT04497116|Antimetabolites|antimetabolites|mesh-ancestor
6810322|NCT04497116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810323|NCT04497116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6810324|NCT04497116|Antiviral Agents|antiviral agents|mesh-ancestor
6810325|NCT04497116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6810326|NCT04497116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6810327|NCT04497116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6810328|NCT04497116|Immunologic Factors|immunologic factors|mesh-ancestor
6810329|NCT04497116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810330|NCT04497116|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6810331|NCT04474470|Cetuximab|cetuximab|mesh-list
6810332|NCT04474470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6810333|NCT04474470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6810334|NCT04440358|Carboplatin|carboplatin|mesh-list
6810335|NCT04440358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6810336|NCT04381832|Docetaxel|docetaxel|mesh-list
6810337|NCT04381832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6810338|NCT04381832|Tubulin Modulators|tubulin modulators|mesh-ancestor
6810339|NCT04381832|Antimitotic Agents|antimitotic agents|mesh-ancestor
6810340|NCT04381832|Mitosis Modulators|mitosis modulators|mesh-ancestor
6810341|NCT04381832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810342|NCT04339140|Zafirlukast|zafirlukast|mesh-list
6810343|NCT04339140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6810344|NCT04339140|Respiratory System Agents|respiratory system agents|mesh-ancestor
6810345|NCT04339140|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6810346|NCT04339140|Hormone Antagonists|hormone antagonists|mesh-ancestor
6810347|NCT04339140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6810348|NCT04339140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810349|NCT04317534|Pembrolizumab|pembrolizumab|mesh-list
6810350|NCT04317534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6810351|NCT04317534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6810352|NCT04294810|Atezolizumab|atezolizumab|mesh-list
6810353|NCT04294810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6810354|NCT04283617|Insulin|insulin|mesh-list
6810355|NCT04283617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6810356|NCT04283617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810357|NCT04246372|Tofacitinib|tofacitinib|mesh-list
6810358|NCT04246372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6810359|NCT04246372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6810360|NCT04246372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810361|NCT04192994|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6810362|NCT04192994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6810363|NCT04182321|Metformin|metformin|mesh-list
6810364|NCT04182321|Entecavir|entecavir|mesh-list
6810365|NCT04182321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6810366|NCT04182321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810367|NCT04182321|Antiviral Agents|antiviral agents|mesh-ancestor
6810368|NCT04182321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6810369|NCT04146142|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6810370|NCT04146142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6810371|NCT04143282|Metformin|metformin|mesh-list
6810372|NCT04143282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6810373|NCT04143282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810374|NCT04124588|Hemostatics|hemostatics|mesh-list
6810375|NCT04124588|Coagulants|coagulants|mesh-ancestor
6810376|NCT04104672|Gemcitabine|gemcitabine|mesh-list
6810377|NCT04104672|Paclitaxel|paclitaxel|mesh-list
6810378|NCT04104672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6810379|NCT04104672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6810380|NCT04104672|Tubulin Modulators|tubulin modulators|mesh-ancestor
6810381|NCT04104672|Antimitotic Agents|antimitotic agents|mesh-ancestor
6810382|NCT04104672|Mitosis Modulators|mitosis modulators|mesh-ancestor
6810383|NCT04104672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810384|NCT04104672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6810385|NCT04104672|Antimetabolites|antimetabolites|mesh-ancestor
6810386|NCT04104672|Antiviral Agents|antiviral agents|mesh-ancestor
6810387|NCT04104672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6810388|NCT04104672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6810389|NCT04104672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6810390|NCT04104672|Immunologic Factors|immunologic factors|mesh-ancestor
6810391|NCT04104672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810392|NCT04062279|Autoantibodies|autoantibodies|mesh-list
6810393|NCT04062279|Immunologic Factors|immunologic factors|mesh-ancestor
6810394|NCT04062279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810395|NCT04035278|Vaccines|vaccines|mesh-list
6810396|NCT04035278|Immunologic Factors|immunologic factors|mesh-ancestor
6810397|NCT04035278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810398|NCT03989414|Dexamethasone|dexamethasone|mesh-list
6810399|NCT03989414|Bortezomib|bortezomib|mesh-list
6810400|NCT03989414|Daratumumab|daratumumab|mesh-list
6810401|NCT03989414|Elotuzumab|elotuzumab|mesh-list
6810402|NCT03989414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6810403|NCT03989414|Antiemetics|antiemetics|mesh-ancestor
6810404|NCT03989414|Autonomic Agents|autonomic agents|mesh-ancestor
6810405|NCT03989414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6810406|NCT03989414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810407|NCT03989414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6810408|NCT03989414|Glucocorticoids|glucocorticoids|mesh-ancestor
6810409|NCT03989414|Hormones|hormones|mesh-ancestor
6810410|NCT03989414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6810411|NCT03989414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6810412|NCT03989414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6810413|NCT03964207|Tiotropium Bromide|tiotropium bromide|mesh-list
6810414|NCT03964207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6810415|NCT03964207|Autonomic Agents|autonomic agents|mesh-ancestor
6810416|NCT03964207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6810417|NCT03964207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810418|NCT03964207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6810419|NCT03964207|Respiratory System Agents|respiratory system agents|mesh-ancestor
6810420|NCT03964207|Parasympatholytics|parasympatholytics|mesh-ancestor
6810421|NCT03964207|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6810422|NCT03964207|Cholinergic Agents|cholinergic agents|mesh-ancestor
6810423|NCT03964207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6810424|NCT03964207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810425|NCT03937830|Bevacizumab|bevacizumab|mesh-list
6810426|NCT03937830|Durvalumab|durvalumab|mesh-list
6810427|NCT03937830|Doxorubicin|doxorubicin|mesh-list
6810428|NCT03937830|Tremelimumab|tremelimumab|mesh-list
6810429|NCT03937830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6810430|NCT03937830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6810431|NCT03937830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6810432|NCT03937830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6810433|NCT03937830|Growth Substances|growth substances|mesh-ancestor
6810434|NCT03937830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810435|NCT03937830|Growth Inhibitors|growth inhibitors|mesh-ancestor
6810436|NCT03937830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6810437|NCT03937830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6810438|NCT03937830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6810439|NCT03937830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6810440|NCT03937830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810441|NCT03916341|Nicotine|nicotine|mesh-list
6810442|NCT03916341|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6810443|NCT03916341|Autonomic Agents|autonomic agents|mesh-ancestor
6810444|NCT03916341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6810445|NCT03916341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810446|NCT03916341|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6810447|NCT03916341|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6810448|NCT03916341|Cholinergic Agents|cholinergic agents|mesh-ancestor
6810449|NCT03916341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6810450|NCT03916341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810451|NCT03891446|Bimatoprost|bimatoprost|mesh-list
6810452|NCT03891446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6810453|NCT03881020|Fluorides|fluorides|mesh-list
6810454|NCT03881020|Cariostatic Agents|cariostatic agents|mesh-ancestor
6810455|NCT03881020|Protective Agents|protective agents|mesh-ancestor
6810456|NCT03881020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810457|NCT03872401|Evolocumab|evolocumab|mesh-list
6810458|NCT03872401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6810459|NCT03872401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6810460|NCT03872401|Antimetabolites|antimetabolites|mesh-ancestor
6810461|NCT03872401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810462|NCT03872401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6810463|NCT03797261|Venetoclax|venetoclax|mesh-list
6810464|NCT03797261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6810465|NCT03773666|Durvalumab|durvalumab|mesh-list
6810466|NCT03773666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6810467|NCT03773666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6810468|NCT03719924|Paclitaxel|paclitaxel|mesh-list
6810469|NCT03719924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6810470|NCT03719924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6396829|NCT00209742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6810471|NCT03719924|Tubulin Modulators|tubulin modulators|mesh-ancestor
6810472|NCT03719924|Antimitotic Agents|antimitotic agents|mesh-ancestor
6810473|NCT03719924|Mitosis Modulators|mitosis modulators|mesh-ancestor
6810474|NCT03719924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810475|NCT03686306|Sildenafil Citrate|sildenafil citrate|mesh-list
6810476|NCT03686306|Vasodilator Agents|vasodilator agents|mesh-ancestor
6810477|NCT03686306|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6810478|NCT03686306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6810479|NCT03686306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6810480|NCT03686306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810481|NCT03686306|Urological Agents|urological agents|mesh-ancestor
6810482|NCT03661138|Upadacitinib|upadacitinib|mesh-list
6810483|NCT03661138|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
6810484|NCT03661138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6810485|NCT03661138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6810486|NCT03661138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810487|NCT03661138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6810488|NCT03631199|Paclitaxel|paclitaxel|mesh-list
6810489|NCT03631199|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6810490|NCT03631199|Carboplatin|carboplatin|mesh-list
6810491|NCT03631199|Pembrolizumab|pembrolizumab|mesh-list
6810492|NCT03631199|Pemetrexed|pemetrexed|mesh-list
6810493|NCT03631199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6810494|NCT03631199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6810495|NCT03631199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6810496|NCT03631199|Tubulin Modulators|tubulin modulators|mesh-ancestor
6810497|NCT03631199|Antimitotic Agents|antimitotic agents|mesh-ancestor
6810498|NCT03631199|Mitosis Modulators|mitosis modulators|mesh-ancestor
6810499|NCT03631199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810500|NCT03631199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6810501|NCT03631199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6810502|NCT03631199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6810503|NCT03631199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6810504|NCT03631199|Immunologic Factors|immunologic factors|mesh-ancestor
6810505|NCT03631199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810506|NCT03620903|Rituximab|rituximab|mesh-list
6810507|NCT03620903|Bortezomib|bortezomib|mesh-list
6810508|NCT03620903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6810509|NCT03620903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6810510|NCT03620903|Immunologic Factors|immunologic factors|mesh-ancestor
6810511|NCT03620903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810512|NCT03620903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6810513|NCT03589976|Sirolimus|sirolimus|mesh-list
6810514|NCT03589976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6810515|NCT03589976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6810516|NCT03589976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6810517|NCT03589976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6810518|NCT03589976|Antifungal Agents|antifungal agents|mesh-ancestor
6810519|NCT03589976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6810520|NCT03589976|Immunologic Factors|immunologic factors|mesh-ancestor
6810521|NCT03589976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810522|NCT03579615|Insulin|insulin|mesh-list
6810523|NCT03579615|Insulin Aspart|insulin aspart|mesh-list
6810524|NCT03579615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6810525|NCT03579615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810526|NCT03532139|Enoxaparin|enoxaparin|mesh-list
6810527|NCT03532139|Enoxaparin sodium|enoxaparin sodium|mesh-list
6810528|NCT03532139|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6810529|NCT03532139|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6810530|NCT03532139|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6810531|NCT03532139|Antimetabolites|antimetabolites|mesh-ancestor
6810532|NCT03532139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810533|NCT03532139|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6810534|NCT03532139|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6810535|NCT03532139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6810536|NCT03532139|Anticoagulants|anticoagulants|mesh-ancestor
6810537|NCT03532139|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6810538|NCT03532139|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6810539|NCT03517449|Paclitaxel|paclitaxel|mesh-list
6810540|NCT03517449|Doxorubicin|doxorubicin|mesh-list
6810541|NCT03517449|Pembrolizumab|pembrolizumab|mesh-list
6810542|NCT03517449|Lenvatinib|lenvatinib|mesh-list
6810543|NCT03517449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6810544|NCT03517449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6810545|NCT03517449|Tubulin Modulators|tubulin modulators|mesh-ancestor
6810546|NCT03517449|Antimitotic Agents|antimitotic agents|mesh-ancestor
6810547|NCT03517449|Mitosis Modulators|mitosis modulators|mesh-ancestor
6396830|NCT00209742|Antiviral Agents|antiviral agents|mesh-ancestor
6810548|NCT03517449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810549|NCT03517449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6810550|NCT03517449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6810551|NCT03517449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6810552|NCT03517449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6810553|NCT03517449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6810554|NCT03517449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6810555|NCT03475953|Avelumab|avelumab|mesh-list
6810556|NCT03475953|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6810557|NCT03475953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6810558|NCT03475953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6810559|NCT03475953|Immunologic Factors|immunologic factors|mesh-ancestor
6810560|NCT03475953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810561|NCT03447574|Ethanol|ethanol|mesh-list
6810562|NCT03447574|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6810563|NCT03447574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6810564|NCT03447574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6810565|NCT03447574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810566|NCT03421353|Gemcitabine|gemcitabine|mesh-list
6810567|NCT03421353|Paclitaxel|paclitaxel|mesh-list
6810568|NCT03421353|Carboplatin|carboplatin|mesh-list
6810569|NCT03421353|Durvalumab|durvalumab|mesh-list
6810570|NCT03421353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6810571|NCT03421353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6810572|NCT03421353|Tubulin Modulators|tubulin modulators|mesh-ancestor
6810573|NCT03421353|Antimitotic Agents|antimitotic agents|mesh-ancestor
6810574|NCT03421353|Mitosis Modulators|mitosis modulators|mesh-ancestor
6810575|NCT03421353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810576|NCT03421353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6810577|NCT03421353|Antimetabolites|antimetabolites|mesh-ancestor
6810578|NCT03421353|Antiviral Agents|antiviral agents|mesh-ancestor
6810579|NCT03421353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6810580|NCT03421353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6810581|NCT03421353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6810582|NCT03421353|Immunologic Factors|immunologic factors|mesh-ancestor
6810583|NCT03421353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810584|NCT03421353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6810585|NCT03368729|Trastuzumab|trastuzumab|mesh-list
6810586|NCT03368729|Niraparib|niraparib|mesh-list
6810587|NCT03368729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6810588|NCT03368729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6810589|NCT03368729|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6810590|NCT03368729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6810591|NCT03368729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810592|NCT03344341|Dapagliflozin|dapagliflozin|mesh-list
6810593|NCT03344341|Acarbose|acarbose|mesh-list
6810594|NCT03344341|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6810595|NCT03344341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810596|NCT03344341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6810597|NCT03344341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810598|NCT03344341|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6810599|NCT03344341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6810600|NCT03336216|Leucovorin|leucovorin|mesh-list
6810601|NCT03336216|Gemcitabine|gemcitabine|mesh-list
6810602|NCT03336216|Paclitaxel|paclitaxel|mesh-list
6810603|NCT03336216|Fluorouracil|fluorouracil|mesh-list
6810604|NCT03336216|Oxaliplatin|oxaliplatin|mesh-list
6810605|NCT03336216|Nivolumab|nivolumab|mesh-list
6810606|NCT03336216|Irinotecan|irinotecan|mesh-list
6810607|NCT03336216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6810608|NCT03336216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6810609|NCT03336216|Tubulin Modulators|tubulin modulators|mesh-ancestor
6810610|NCT03336216|Antimitotic Agents|antimitotic agents|mesh-ancestor
6810611|NCT03336216|Mitosis Modulators|mitosis modulators|mesh-ancestor
6810612|NCT03336216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810613|NCT03336216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6810614|NCT03336216|Antimetabolites|antimetabolites|mesh-ancestor
6810615|NCT03336216|Antiviral Agents|antiviral agents|mesh-ancestor
6810616|NCT03336216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6810617|NCT03336216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6810618|NCT03336216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6810619|NCT03336216|Immunologic Factors|immunologic factors|mesh-ancestor
6810620|NCT03336216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810621|NCT03336216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6810622|NCT03336216|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6810623|NCT03336216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6810624|NCT03336216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6810625|NCT03336216|Antidotes|antidotes|mesh-ancestor
6810626|NCT03336216|Protective Agents|protective agents|mesh-ancestor
6810627|NCT03336216|Vitamin B Complex|vitamin b complex|mesh-ancestor
6810628|NCT03336216|Vitamins|vitamins|mesh-ancestor
6810629|NCT03336216|Micronutrients|micronutrients|mesh-ancestor
6810630|NCT03331731|Pembrolizumab|pembrolizumab|mesh-list
6810631|NCT03331731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6810632|NCT03331731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6810633|NCT03276468|Atezolizumab|atezolizumab|mesh-list
6810634|NCT03276468|Venetoclax|venetoclax|mesh-list
6810635|NCT03276468|Obinutuzumab|obinutuzumab|mesh-list
6810636|NCT03276468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6810637|NCT03276468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6810638|NCT03260881|Liraglutide|liraglutide|mesh-list
6810639|NCT03260881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6810640|NCT03260881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810641|NCT03260881|Incretins|incretins|mesh-ancestor
6810642|NCT03260881|Hormones|hormones|mesh-ancestor
6810643|NCT03260881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6810644|NCT03238495|Metformin|metformin|mesh-list
6810645|NCT03238495|Carboplatin|carboplatin|mesh-list
6810646|NCT03238495|Docetaxel|docetaxel|mesh-list
6810647|NCT03238495|Trastuzumab|trastuzumab|mesh-list
6810648|NCT03238495|Pertuzumab|pertuzumab|mesh-list
6810649|NCT03238495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6810650|NCT03238495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6810651|NCT03238495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810652|NCT03238495|Tubulin Modulators|tubulin modulators|mesh-ancestor
6810653|NCT03238495|Antimitotic Agents|antimitotic agents|mesh-ancestor
6810654|NCT03238495|Mitosis Modulators|mitosis modulators|mesh-ancestor
6810655|NCT03238495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810656|NCT03238495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6810657|NCT03232138|Sulforaphane|sulforaphane|mesh-list
6810658|NCT03232138|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6810659|NCT03232138|Protective Agents|protective agents|mesh-ancestor
6810660|NCT03232138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810661|NCT03232138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6810662|NCT03212963|Clobetasol|clobetasol|mesh-list
6810663|NCT03212963|Halobetasol|halobetasol|mesh-list
6810664|NCT03212963|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6810665|NCT03212963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6810666|NCT03212963|Glucocorticoids|glucocorticoids|mesh-ancestor
6810667|NCT03212963|Hormones|hormones|mesh-ancestor
6810668|NCT03212963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6810669|NCT03212963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810670|NCT03135262|Rituximab|rituximab|mesh-list
6810671|NCT03135262|Obinutuzumab|obinutuzumab|mesh-list
6810672|NCT03135262|Venetoclax|venetoclax|mesh-list
6810673|NCT03135262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6810674|NCT03135262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6810675|NCT03135262|Immunologic Factors|immunologic factors|mesh-ancestor
6810676|NCT03135262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810677|NCT03135262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6810678|NCT03104075|Vaccines|vaccines|mesh-list
6810679|NCT03104075|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6810680|NCT03104075|Immunologic Factors|immunologic factors|mesh-ancestor
6810681|NCT03104075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810682|NCT03103750|Calcitriol|calcitriol|mesh-list
6810683|NCT03103750|Amphetamine|amphetamine|mesh-list
6810684|NCT03103750|Dextroamphetamine|dextroamphetamine|mesh-list
6810685|NCT03103750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6810686|NCT03103750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810687|NCT03103750|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6810688|NCT03103750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6810689|NCT03103750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810690|NCT03103750|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6810691|NCT03103750|Vitamins|vitamins|mesh-ancestor
6810692|NCT03103750|Micronutrients|micronutrients|mesh-ancestor
6810693|NCT03103750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6810694|NCT03103750|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6810695|NCT03103750|Sympathomimetics|sympathomimetics|mesh-ancestor
6810696|NCT03103750|Autonomic Agents|autonomic agents|mesh-ancestor
6810697|NCT03103750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6810698|NCT03103750|Dopamine Agents|dopamine agents|mesh-ancestor
6810699|NCT03103750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6810700|NCT03103750|Adrenergic Agents|adrenergic agents|mesh-ancestor
6810701|NCT03103750|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6810702|NCT03103750|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6810703|NCT03103750|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6810704|NCT03080935|Evolocumab|evolocumab|mesh-list
6810705|NCT03080935|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6810706|NCT03080935|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6810707|NCT03080935|Antimetabolites|antimetabolites|mesh-ancestor
6810708|NCT03080935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810709|NCT03080935|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6810710|NCT03077620|Suvorexant|suvorexant|mesh-list
6810711|NCT03077620|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6810712|NCT03077620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6810713|NCT03077620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6810714|NCT03077620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810715|NCT03077620|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
6810716|NCT03077620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6810717|NCT03077620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810718|NCT03072628|Nicotine|nicotine|mesh-list
6810719|NCT03072628|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6810720|NCT03072628|Autonomic Agents|autonomic agents|mesh-ancestor
6810721|NCT03072628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6810722|NCT03072628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810723|NCT03072628|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6810724|NCT03072628|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6810725|NCT03072628|Cholinergic Agents|cholinergic agents|mesh-ancestor
6810726|NCT03072628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6810727|NCT03072628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810728|NCT02998645|Cyclosporine|cyclosporine|mesh-list
6810729|NCT02998645|Cyclosporins|cyclosporins|mesh-list
6810730|NCT02998645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6810731|NCT02998645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810732|NCT02998645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6810733|NCT02998645|Immunologic Factors|immunologic factors|mesh-ancestor
6810734|NCT02998645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810735|NCT02998645|Antifungal Agents|antifungal agents|mesh-ancestor
6810736|NCT02998645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6810737|NCT02998645|Dermatologic Agents|dermatologic agents|mesh-ancestor
6810738|NCT02998645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6810739|NCT02998645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6810740|NCT02981472|Vitamin K|vitamin k|mesh-list
6810741|NCT02981472|Heparin|heparin|mesh-list
6810742|NCT02981472|Enoxaparin|enoxaparin|mesh-list
6810743|NCT02981472|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6810744|NCT02981472|Tinzaparin|tinzaparin|mesh-list
6810745|NCT02981472|Dalteparin|dalteparin|mesh-list
6810746|NCT02981472|Warfarin|warfarin|mesh-list
6810747|NCT02981472|Apixaban|apixaban|mesh-list
6810748|NCT02981472|Vitamins|vitamins|mesh-ancestor
6810749|NCT02981472|Micronutrients|micronutrients|mesh-ancestor
6810750|NCT02981472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810751|NCT02981472|Anticoagulants|anticoagulants|mesh-ancestor
6810752|NCT02981472|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6810753|NCT02981472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6810754|NCT02981472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810755|NCT02981472|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6810756|NCT02981472|Antithrombins|antithrombins|mesh-ancestor
6810757|NCT02981472|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6810758|NCT02981472|Protease Inhibitors|protease inhibitors|mesh-ancestor
6810759|NCT02981472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6810760|NCT02981472|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5993562|NCT00123474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5993563|NCT00123474|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5993564|NCT00123474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5993565|NCT00123474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5993566|NCT00123487|Dasatinib|dasatinib|mesh-list
5993567|NCT00123487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5993568|NCT00123487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5993569|NCT00123487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6810761|NCT02981472|Hemostatics|hemostatics|mesh-ancestor
6810762|NCT02981472|Coagulants|coagulants|mesh-ancestor
6810763|NCT02955966|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6810764|NCT02955966|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6810765|NCT02955966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810766|NCT02907983|Bupivacaine|bupivacaine|mesh-list
6810767|NCT02907983|Anesthetics, Local|anesthetics, local|mesh-ancestor
6810768|NCT02907983|Anesthetics|anesthetics|mesh-ancestor
6810769|NCT02907983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6810770|NCT02907983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810771|NCT02907983|Sensory System Agents|sensory system agents|mesh-ancestor
6810772|NCT02907983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6810773|NCT02880540|Fentanyl|fentanyl|mesh-list
6810774|NCT02880540|Dexmedetomidine|dexmedetomidine|mesh-list
6810775|NCT02880540|Morphine|morphine|mesh-list
6810776|NCT02880540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6810777|NCT02880540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6810778|NCT02880540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810779|NCT02880540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6810780|NCT02880540|Analgesics|analgesics|mesh-ancestor
6810781|NCT02880540|Sensory System Agents|sensory system agents|mesh-ancestor
6810782|NCT02880540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6810783|NCT02880540|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6810784|NCT02880540|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6810785|NCT02880540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6810786|NCT02880540|Adrenergic Agents|adrenergic agents|mesh-ancestor
6810787|NCT02880540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6810788|NCT02880540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810789|NCT02880540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6810790|NCT02880540|Narcotics|narcotics|mesh-ancestor
6810791|NCT02880540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6810792|NCT02880540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6810793|NCT02880540|Anesthetics, General|anesthetics, general|mesh-ancestor
6810794|NCT02880540|Anesthetics|anesthetics|mesh-ancestor
6810795|NCT02859415|Plicamycin|plicamycin|mesh-list
6810796|NCT02859415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6810797|NCT02859415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810798|NCT02859415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6810799|NCT02859415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6810800|NCT02859415|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6810801|NCT02859415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6810802|NCT02859415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810803|NCT02859415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6810804|NCT02841215|Ivermectin|ivermectin|mesh-list
6810805|NCT02841215|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6810806|NCT02841215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6810807|NCT02802566|Vitamins|vitamins|mesh-list
6810808|NCT02802566|Micronutrients|micronutrients|mesh-ancestor
6810809|NCT02802566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810810|NCT02799641|Lidocaine|lidocaine|mesh-list
6810811|NCT02799641|Diazepam|diazepam|mesh-list
6810812|NCT02799641|Anesthetics, Local|anesthetics, local|mesh-ancestor
6810813|NCT02799641|Anesthetics|anesthetics|mesh-ancestor
6810814|NCT02799641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6810815|NCT02799641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810816|NCT02799641|Sensory System Agents|sensory system agents|mesh-ancestor
6810817|NCT02799641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6810818|NCT02799641|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6810819|NCT02799641|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6810820|NCT02799641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6810821|NCT02799641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6810822|NCT02799641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810823|NCT02799641|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6810824|NCT02799641|Anticonvulsants|anticonvulsants|mesh-ancestor
6810825|NCT02799641|Antiemetics|antiemetics|mesh-ancestor
6810826|NCT02799641|Autonomic Agents|autonomic agents|mesh-ancestor
6810827|NCT02799641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6810828|NCT02799641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6810829|NCT02799641|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6810830|NCT02799641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6810831|NCT02799641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6810832|NCT02799641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6810833|NCT02799641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6810834|NCT02799641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6810835|NCT02799641|Anesthetics, General|anesthetics, general|mesh-ancestor
6810836|NCT02799641|GABA Modulators|gaba modulators|mesh-ancestor
6810837|NCT02799641|GABA Agents|gaba agents|mesh-ancestor
6810838|NCT02799641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6810839|NCT02782663|Upadacitinib|upadacitinib|mesh-list
6810840|NCT02782663|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
6810841|NCT02782663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6810842|NCT02782663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6810843|NCT02782663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810844|NCT02782663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6810845|NCT02755844|Metformin|metformin|mesh-list
6810846|NCT02755844|Cyclophosphamide|cyclophosphamide|mesh-list
6810847|NCT02755844|Olaparib|olaparib|mesh-list
6810848|NCT02755844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6810849|NCT02755844|Immunologic Factors|immunologic factors|mesh-ancestor
6810850|NCT02755844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810851|NCT02755844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6810852|NCT02755844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6810853|NCT02755844|Alkylating Agents|alkylating agents|mesh-ancestor
6810854|NCT02755844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810855|NCT02755844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6810856|NCT02755844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6810857|NCT02755844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6810858|NCT02755844|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6810859|NCT02755844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6810860|NCT02741388|Gemcitabine|gemcitabine|mesh-list
6810861|NCT02741388|Cytarabine|cytarabine|mesh-list
6810862|NCT02741388|Dexamethasone|dexamethasone|mesh-list
6810863|NCT02741388|Rituximab|rituximab|mesh-list
6810864|NCT02741388|Oxaliplatin|oxaliplatin|mesh-list
6810865|NCT02741388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6810866|NCT02741388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6810867|NCT02741388|Antiemetics|antiemetics|mesh-ancestor
6810868|NCT02741388|Autonomic Agents|autonomic agents|mesh-ancestor
6810869|NCT02741388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6810870|NCT02741388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810871|NCT02741388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6810872|NCT02741388|Glucocorticoids|glucocorticoids|mesh-ancestor
6810873|NCT02741388|Hormones|hormones|mesh-ancestor
6810874|NCT02741388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6810875|NCT02741388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6810876|NCT02741388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6810877|NCT02741388|Immunologic Factors|immunologic factors|mesh-ancestor
6810878|NCT02741388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6810879|NCT02741388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6810880|NCT02741388|Antimetabolites|antimetabolites|mesh-ancestor
6810881|NCT02741388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810882|NCT02741388|Antiviral Agents|antiviral agents|mesh-ancestor
6810883|NCT02741388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6810884|NCT02741388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6810885|NCT02741388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6810886|NCT02686346|Etoposide|etoposide|mesh-list
6810887|NCT02686346|Ifosfamide|ifosfamide|mesh-list
6810888|NCT02686346|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6810889|NCT02686346|Carboplatin|carboplatin|mesh-list
6810890|NCT02686346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6810891|NCT02686346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6810892|NCT02686346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6810893|NCT02686346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6810894|NCT02686346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6810895|NCT02686346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810896|NCT02686346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6810897|NCT02686346|Alkylating Agents|alkylating agents|mesh-ancestor
6810898|NCT02686346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6810899|NCT02662985|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6810900|NCT02662985|Immunologic Factors|immunologic factors|mesh-ancestor
6810901|NCT02662985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810902|NCT02536339|Trastuzumab|trastuzumab|mesh-list
6810903|NCT02536339|Pertuzumab|pertuzumab|mesh-list
6810904|NCT02536339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6810905|NCT02536339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6810906|NCT02523469|Nivolumab|nivolumab|mesh-list
6810907|NCT02523469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6810908|NCT02523469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6810909|NCT02523469|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6810910|NCT02523469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810911|NCT02514083|Fludarabine|fludarabine|mesh-list
6810912|NCT02514083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6810913|NCT02333370|Tamoxifen|tamoxifen|mesh-list
6810914|NCT02333370|Letrozole|letrozole|mesh-list
6810915|NCT02333370|Fulvestrant|fulvestrant|mesh-list
6810916|NCT02333370|Goserelin|goserelin|mesh-list
6810917|NCT02333370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6810918|NCT02333370|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6810919|NCT02333370|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6810920|NCT02333370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6810921|NCT02333370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810922|NCT02333370|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6810923|NCT02333370|Hormone Antagonists|hormone antagonists|mesh-ancestor
6810924|NCT02333370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6810925|NCT02333370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810926|NCT02333370|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6810927|NCT02333370|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6810928|NCT02333370|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6810929|NCT02333370|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6810930|NCT02333370|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6810931|NCT02298257|Doxorubicin|doxorubicin|mesh-list
6810932|NCT02298257|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6810933|NCT02298257|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6810934|NCT02298257|Dacarbazine|dacarbazine|mesh-list
6810935|NCT02298257|Vinblastine|vinblastine|mesh-list
6810936|NCT02298257|Antibodies|antibodies|mesh-list
6810937|NCT02298257|Immunoglobulins|immunoglobulins|mesh-list
6810938|NCT02298257|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6810939|NCT02298257|Immunoconjugates|immunoconjugates|mesh-list
6810940|NCT02298257|Immunologic Factors|immunologic factors|mesh-ancestor
6810941|NCT02298257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810942|NCT02298257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6810943|NCT02298257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6810944|NCT02298257|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6810945|NCT02298257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6810946|NCT02298257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6810947|NCT02298257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810948|NCT02298257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6810949|NCT02298257|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6810950|NCT02298257|Alkylating Agents|alkylating agents|mesh-ancestor
6810951|NCT02298257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6810952|NCT02298257|Tubulin Modulators|tubulin modulators|mesh-ancestor
6810953|NCT02298257|Antimitotic Agents|antimitotic agents|mesh-ancestor
6810954|NCT02298257|Mitosis Modulators|mitosis modulators|mesh-ancestor
6810955|NCT02229136|Prednisolone|prednisolone|mesh-list
6810956|NCT02229136|Hydrocortisone|hydrocortisone|mesh-list
6810957|NCT02229136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6810958|NCT02229136|Glucocorticoids|glucocorticoids|mesh-ancestor
6810959|NCT02229136|Hormones|hormones|mesh-ancestor
6810960|NCT02229136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6810961|NCT02229136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810962|NCT02229136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6810963|NCT02229136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6810964|NCT02189798|Imidacloprid|imidacloprid|mesh-list
6810965|NCT02189798|Cholinergic Agents|cholinergic agents|mesh-ancestor
6810966|NCT02189798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6810967|NCT02189798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810968|NCT02189798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810969|NCT02180724|Acalabrutinib|acalabrutinib|mesh-list
6810970|NCT02180724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6810971|NCT02108964|Nazartinib|nazartinib|mesh-list
6810972|NCT02108964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6810973|NCT02050308|Nicotine|nicotine|mesh-list
6810974|NCT02050308|Varenicline|varenicline|mesh-list
6810975|NCT02050308|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6810976|NCT02050308|Autonomic Agents|autonomic agents|mesh-ancestor
6810977|NCT02050308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6810978|NCT02050308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810979|NCT02050308|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6810980|NCT02050308|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6810981|NCT02050308|Cholinergic Agents|cholinergic agents|mesh-ancestor
6810982|NCT02050308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6810983|NCT02050308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810984|NCT01958021|Letrozole|letrozole|mesh-list
6810985|NCT01958021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6810986|NCT01958021|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6810987|NCT01958021|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6810988|NCT01958021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6810989|NCT01958021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6810990|NCT01958021|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6810991|NCT01958021|Hormone Antagonists|hormone antagonists|mesh-ancestor
6810992|NCT01958021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6810993|NCT01958021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6810994|NCT01869361|Indomethacin|indomethacin|mesh-list
6810995|NCT01869361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6810996|NCT01869361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6810997|NCT01869361|Analgesics|analgesics|mesh-ancestor
6810998|NCT01869361|Sensory System Agents|sensory system agents|mesh-ancestor
6810999|NCT01869361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6811000|NCT01869361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811001|NCT01869361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6811002|NCT01869361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6811003|NCT01869361|Gout Suppressants|gout suppressants|mesh-ancestor
6811004|NCT01869361|Tocolytic Agents|tocolytic agents|mesh-ancestor
6811005|NCT01869361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6811006|NCT01869361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6811007|NCT01869361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6811008|NCT01869361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811009|NCT01828099|Carboplatin|carboplatin|mesh-list
6811010|NCT01828099|Pemetrexed|pemetrexed|mesh-list
6811011|NCT01828099|Ceritinib|ceritinib|mesh-list
6811012|NCT01828099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6811013|NCT01828099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6811014|NCT01828099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811015|NCT01828099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6811016|NCT01828099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6811017|NCT01828099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6811018|NCT01593254|Imatinib Mesylate|imatinib mesylate|mesh-list
6811019|NCT01593254|Dasatinib|dasatinib|mesh-list
6811020|NCT01593254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6811021|NCT01593254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6811022|NCT01593254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6811023|NCT01593254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811024|NCT01578967|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6811025|NCT01578967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6811026|NCT01578967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6811027|NCT01186003|Insulin Detemir|insulin detemir|mesh-list
6811028|NCT01186003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6811029|NCT01186003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811030|NCT00943618|Bupropion|bupropion|mesh-list
6811031|NCT00943618|Varenicline|varenicline|mesh-list
6811032|NCT00943618|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6811033|NCT00943618|Antidepressive Agents|antidepressive agents|mesh-ancestor
6811034|NCT00943618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6811035|NCT00943618|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6811036|NCT00943618|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6811037|NCT00943618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6811038|NCT00943618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811039|NCT00943618|Dopamine Agents|dopamine agents|mesh-ancestor
6811040|NCT00943618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6811041|NCT00943618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811042|NCT00943618|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6811043|NCT00943618|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6811044|NCT00943618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6811045|NCT00943618|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6811046|NCT00943618|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6811047|NCT00943618|Cholinergic Agents|cholinergic agents|mesh-ancestor
6811048|NCT00914823|Hormones|hormones|mesh-list
6811049|NCT00914823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6811050|NCT00914823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811051|NCT00529763|Dasatinib|dasatinib|mesh-list
6811052|NCT00529763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6811053|NCT00529763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6811054|NCT00529763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6811055|NCT00529763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811056|NCT05150015|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6811057|NCT05150015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6811058|NCT05149898|Cannabidiol|cannabidiol|mesh-list
6811059|NCT05149898|Anticonvulsants|anticonvulsants|mesh-ancestor
6811060|NCT05149768|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6811061|NCT05149768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6811062|NCT05149768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6811063|NCT05149378|Azacitidine|azacitidine|mesh-list
6811064|NCT05149378|Venetoclax|venetoclax|mesh-list
6811065|NCT05149378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6811066|NCT05149378|Antimetabolites|antimetabolites|mesh-ancestor
6811067|NCT05149378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811068|NCT05149378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6811069|NCT05149378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6811070|NCT05149339|Cholecalciferol|cholecalciferol|mesh-list
6811071|NCT05149339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6811072|NCT05149339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811073|NCT05149339|Vitamins|vitamins|mesh-ancestor
6811074|NCT05149339|Micronutrients|micronutrients|mesh-ancestor
6811075|NCT05149339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6811076|NCT05149248|Vaccines|vaccines|mesh-list
6811077|NCT05149248|Immunologic Factors|immunologic factors|mesh-ancestor
6811078|NCT05149248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811079|NCT05149170|Antibodies|antibodies|mesh-list
6811080|NCT05149170|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6811081|NCT05149170|Immunologic Factors|immunologic factors|mesh-ancestor
6811082|NCT05149170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811083|NCT05149092|Caseins|caseins|mesh-list
6811084|NCT05149092|Chelating Agents|chelating agents|mesh-ancestor
6811085|NCT05149092|Sequestering Agents|sequestering agents|mesh-ancestor
6811086|NCT05149092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811087|NCT05148910|Copper|copper|mesh-list
6811088|NCT05148910|Trace Elements|trace elements|mesh-ancestor
6811089|NCT05148910|Micronutrients|micronutrients|mesh-ancestor
6811090|NCT05148910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811091|NCT05148884|Befiradol|befiradol|mesh-list
6811092|NCT05148884|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6811093|NCT05148884|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6811094|NCT05148884|Serotonin Agents|serotonin agents|mesh-ancestor
6811095|NCT05148884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6811096|NCT05148884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811097|NCT05148884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811098|NCT05148767|Irinotecan|irinotecan|mesh-list
6811099|NCT05148767|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6811100|NCT05148767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6811101|NCT05148767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6811102|NCT05148767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811103|NCT05148767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6811104|NCT05148715|Tacrolimus|tacrolimus|mesh-list
6811105|NCT05148715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6811106|NCT05148715|Immunologic Factors|immunologic factors|mesh-ancestor
6811107|NCT05148715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811108|NCT05148715|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6811109|NCT05148715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6811110|NCT05148715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811111|NCT05148702|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6811112|NCT05148702|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6811113|NCT05148702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6811114|NCT05148702|Antitubercular Agents|antitubercular agents|mesh-ancestor
6811115|NCT05148689|Phenylephrine|phenylephrine|mesh-list
6811116|NCT05148689|Oxymetazoline|oxymetazoline|mesh-list
6811117|NCT05148689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6811118|NCT05148689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6811119|NCT05148689|Adrenergic Agents|adrenergic agents|mesh-ancestor
6811120|NCT05148689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6811121|NCT05148689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811122|NCT05148689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811123|NCT05148689|Sympathomimetics|sympathomimetics|mesh-ancestor
6811124|NCT05148689|Autonomic Agents|autonomic agents|mesh-ancestor
6811125|NCT05148689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6811126|NCT05148689|Nasal Decongestants|nasal decongestants|mesh-ancestor
6811127|NCT05148689|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6811128|NCT05148689|Respiratory System Agents|respiratory system agents|mesh-ancestor
6811129|NCT05148689|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6811130|NCT05148689|Mydriatics|mydriatics|mesh-ancestor
6811131|NCT05148689|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6811132|NCT05148689|Protective Agents|protective agents|mesh-ancestor
6811133|NCT05148442|Azacitidine|azacitidine|mesh-list
6811134|NCT05148442|Decitabine|decitabine|mesh-list
6811135|NCT05148442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6811136|NCT05148442|Antimetabolites|antimetabolites|mesh-ancestor
6811137|NCT05148442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811138|NCT05148442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6811139|NCT05148442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6811140|NCT05148403|Glyburide|glyburide|mesh-list
6811141|NCT05148403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6811142|NCT05148403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811143|NCT05148208|Dialysis Solutions|dialysis solutions|mesh-list
6811144|NCT05148208|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6811145|NCT05148195|Leucovorin|leucovorin|mesh-list
6811146|NCT05148195|Docetaxel|docetaxel|mesh-list
6811147|NCT05148195|Irinotecan|irinotecan|mesh-list
6811148|NCT05148195|Calcium|calcium|mesh-list
6811149|NCT05148195|Levoleucovorin|levoleucovorin|mesh-list
6811150|NCT05148195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6811151|NCT05148195|Tubulin Modulators|tubulin modulators|mesh-ancestor
6811152|NCT05148195|Antimitotic Agents|antimitotic agents|mesh-ancestor
6811153|NCT05148195|Mitosis Modulators|mitosis modulators|mesh-ancestor
6811154|NCT05148195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811155|NCT05148195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6811156|NCT05148195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811157|NCT05148195|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6811158|NCT05148195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6811159|NCT05148195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6811160|NCT05148195|Antidotes|antidotes|mesh-ancestor
6811161|NCT05148195|Protective Agents|protective agents|mesh-ancestor
6811162|NCT05148195|Vitamin B Complex|vitamin b complex|mesh-ancestor
6811163|NCT05148195|Vitamins|vitamins|mesh-ancestor
6811164|NCT05148195|Micronutrients|micronutrients|mesh-ancestor
6811165|NCT05148169|Sulforaphane|sulforaphane|mesh-list
6811166|NCT05148169|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6811167|NCT05148169|Protective Agents|protective agents|mesh-ancestor
6811168|NCT05148169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811169|NCT05148169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6811170|NCT05148143|Raltitrexed|raltitrexed|mesh-list
6811171|NCT05148143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6811172|NCT05148143|Antimetabolites|antimetabolites|mesh-ancestor
6811173|NCT05148143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811174|NCT05148143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6811175|NCT05148143|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6811176|NCT05148143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6811177|NCT05148026|Heparin|heparin|mesh-list
6811178|NCT05148026|Calcium heparin|calcium heparin|mesh-list
6811179|NCT05148026|Dialysis Solutions|dialysis solutions|mesh-list
6811180|NCT05148026|Anticoagulants|anticoagulants|mesh-ancestor
6811181|NCT05148026|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6811182|NCT05148026|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6811183|NCT05148026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811184|NCT05148026|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6811185|NCT05145218|Paclitaxel|paclitaxel|mesh-list
6811186|NCT05145218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6811187|NCT05145218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6811188|NCT05145218|Tubulin Modulators|tubulin modulators|mesh-ancestor
6811189|NCT05145218|Antimitotic Agents|antimitotic agents|mesh-ancestor
6811190|NCT05145218|Mitosis Modulators|mitosis modulators|mesh-ancestor
6811191|NCT05145218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811192|NCT05138029|Dexamethasone|dexamethasone|mesh-list
6811193|NCT05138029|Dexamethasone acetate|dexamethasone acetate|mesh-list
6811194|NCT05138029|Ranibizumab|ranibizumab|mesh-list
6811195|NCT05138029|BB 1101|bb 1101|mesh-list
6811196|NCT05138029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6811197|NCT05138029|Antiemetics|antiemetics|mesh-ancestor
6811198|NCT05138029|Autonomic Agents|autonomic agents|mesh-ancestor
6811199|NCT05138029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6811200|NCT05138029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811201|NCT05138029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6811202|NCT05138029|Glucocorticoids|glucocorticoids|mesh-ancestor
6811203|NCT05138029|Hormones|hormones|mesh-ancestor
6811204|NCT05138029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6811205|NCT05138029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6811206|NCT05138029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6811207|NCT05138029|Protease Inhibitors|protease inhibitors|mesh-ancestor
6811208|NCT05138029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6811209|NCT05138029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811210|NCT05138029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6811211|NCT05138029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6811212|NCT05138029|Growth Substances|growth substances|mesh-ancestor
6811213|NCT05138029|Growth Inhibitors|growth inhibitors|mesh-ancestor
6811214|NCT05136040|Bupivacaine|bupivacaine|mesh-list
6811215|NCT05136040|Anesthetics, Local|anesthetics, local|mesh-ancestor
6811216|NCT05136040|Anesthetics|anesthetics|mesh-ancestor
6811217|NCT05136040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6811218|NCT05136040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811219|NCT05136040|Sensory System Agents|sensory system agents|mesh-ancestor
6811220|NCT05136040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6811221|NCT05132179|Sodium Hypochlorite|sodium hypochlorite|mesh-list
6811222|NCT05132179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6811223|NCT05132179|Disinfectants|disinfectants|mesh-ancestor
6811224|NCT05132179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6811225|NCT05131061|Fludrocortisone|fludrocortisone|mesh-list
6811226|NCT05131061|Captopril|captopril|mesh-list
6811227|NCT05131061|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6811228|NCT05131061|Protease Inhibitors|protease inhibitors|mesh-ancestor
6811229|NCT05131061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6811230|NCT05131061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811231|NCT05131061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6811232|NCT05131061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5993570|NCT00123487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811233|NCT05121298|Upadacitinib|upadacitinib|mesh-list
6811234|NCT05121298|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
6811235|NCT05121298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6811236|NCT05121298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6811237|NCT05121298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811238|NCT05121298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6811239|NCT05103644|Atorvastatin|atorvastatin|mesh-list
6811240|NCT05103644|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6811241|NCT05103644|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6811242|NCT05103644|Antimetabolites|antimetabolites|mesh-ancestor
6811243|NCT05103644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811244|NCT05103644|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6811245|NCT05103644|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6811246|NCT05103644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6811247|NCT05100264|Acetic Acid|acetic acid|mesh-list
6811248|NCT05100264|Retinol acetate|retinol acetate|mesh-list
6811249|NCT05100264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6811250|NCT05100264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6811251|NCT05100264|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6811252|NCT05100264|Immunologic Factors|immunologic factors|mesh-ancestor
6811253|NCT05100264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811254|NCT05100264|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6811255|NCT05100264|Protective Agents|protective agents|mesh-ancestor
6811256|NCT05100264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6811257|NCT05098210|Poly I-C|poly i-c|mesh-list
6811258|NCT05098210|Nivolumab|nivolumab|mesh-list
6811259|NCT05098210|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6811260|NCT05098210|Poly ICLC|poly iclc|mesh-list
6811261|NCT05098210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6811262|NCT05098210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6811263|NCT05098210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6811264|NCT05098210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811265|NCT05098210|Interferon Inducers|interferon inducers|mesh-ancestor
6811266|NCT05098210|Immunologic Factors|immunologic factors|mesh-ancestor
6811267|NCT05098210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811268|NCT05098210|Laxatives|laxatives|mesh-ancestor
6811269|NCT05098210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6811270|NCT05098210|Antiviral Agents|antiviral agents|mesh-ancestor
6811271|NCT05098210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6811272|NCT05084521|Famotidine|famotidine|mesh-list
6811273|NCT05084521|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6811274|NCT05084521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6811275|NCT05084521|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6811276|NCT05084521|Histamine Antagonists|histamine antagonists|mesh-ancestor
6811277|NCT05084521|Histamine Agents|histamine agents|mesh-ancestor
6811278|NCT05084521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6811279|NCT05084521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811280|NCT05084521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811281|NCT05078931|Pembrolizumab|pembrolizumab|mesh-list
6811282|NCT05078931|Lenvatinib|lenvatinib|mesh-list
6811283|NCT05078931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6811284|NCT05078931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6811285|NCT05078931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6811286|NCT05078931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6811287|NCT05078931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811288|NCT05029856|Vaccines|vaccines|mesh-list
6811289|NCT05029856|Immunologic Factors|immunologic factors|mesh-ancestor
6811290|NCT05029856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811291|NCT05012631|Losartan|losartan|mesh-list
6811292|NCT05012631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6811293|NCT05012631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6811294|NCT05012631|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6811295|NCT05012631|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6811296|NCT05012631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811297|NCT04992260|Vaccines|vaccines|mesh-list
6811298|NCT04992260|Immunologic Factors|immunologic factors|mesh-ancestor
6811299|NCT04992260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811300|NCT04989491|Rituximab|rituximab|mesh-list
6811301|NCT04989491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6811302|NCT04989491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6811303|NCT04989491|Immunologic Factors|immunologic factors|mesh-ancestor
6811304|NCT04989491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993571|NCT00123604|Metoprolol|metoprolol|mesh-list
6811305|NCT04989491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6811306|NCT04989322|Carboplatin|carboplatin|mesh-list
6811307|NCT04989322|Pembrolizumab|pembrolizumab|mesh-list
6811308|NCT04989322|Pemetrexed|pemetrexed|mesh-list
6811309|NCT04989322|Lenvatinib|lenvatinib|mesh-list
6811310|NCT04989322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6811311|NCT04989322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6811312|NCT04989322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6811313|NCT04989322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811314|NCT04989322|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6811315|NCT04989322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6811316|NCT04989322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6811317|NCT04965038|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6811318|NCT04965038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6811319|NCT04965038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6811320|NCT04965038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811321|NCT04935112|Pantoprazole|pantoprazole|mesh-list
6811322|NCT04935112|Famotidine|famotidine|mesh-list
6811323|NCT04935112|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6811324|NCT04935112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6811325|NCT04935112|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6811326|NCT04935112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6811327|NCT04935112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811328|NCT04935112|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6811329|NCT04935112|Histamine Antagonists|histamine antagonists|mesh-ancestor
6811330|NCT04935112|Histamine Agents|histamine agents|mesh-ancestor
6811331|NCT04935112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6811332|NCT04935112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811333|NCT04931511|Betamethasone|betamethasone|mesh-list
6811334|NCT04931511|Betamethasone Valerate|betamethasone valerate|mesh-list
6811335|NCT04931511|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
6811336|NCT04931511|Betamethasone benzoate|betamethasone benzoate|mesh-list
6811337|NCT04931511|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
6811338|NCT04931511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6811339|NCT04931511|Glucocorticoids|glucocorticoids|mesh-ancestor
6811340|NCT04931511|Hormones|hormones|mesh-ancestor
6811341|NCT04931511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6811342|NCT04931511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811343|NCT04931511|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6811344|NCT04931511|Respiratory System Agents|respiratory system agents|mesh-ancestor
6811345|NCT04929028|Fluorouracil|fluorouracil|mesh-list
6811346|NCT04929028|Capecitabine|capecitabine|mesh-list
6811347|NCT04929028|Nivolumab|nivolumab|mesh-list
6811348|NCT04929028|Mitomycins|mitomycins|mesh-list
6811349|NCT04929028|Mitomycin|mitomycin|mesh-list
6811350|NCT04929028|Antimetabolites|antimetabolites|mesh-ancestor
6811351|NCT04929028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811352|NCT04929028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6811353|NCT04929028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6811354|NCT04929028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6811355|NCT04929028|Immunologic Factors|immunologic factors|mesh-ancestor
6811356|NCT04929028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811357|NCT04929028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6811358|NCT04929028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6811359|NCT04929028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6811360|NCT04929028|Alkylating Agents|alkylating agents|mesh-ancestor
6811361|NCT04929028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6811362|NCT04929028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6811363|NCT04920942|Ivermectin|ivermectin|mesh-list
6811364|NCT04920942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6811365|NCT04920942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6811366|NCT04905121|Psilocybin|psilocybin|mesh-list
6811367|NCT04905121|Hallucinogens|hallucinogens|mesh-ancestor
6811368|NCT04905121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811369|NCT04905121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6811370|NCT04901754|Apatinib|apatinib|mesh-list
6811371|NCT04901754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6811372|NCT04901754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6811373|NCT04901754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6811374|NCT04901754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811375|NCT04883437|Obinutuzumab|obinutuzumab|mesh-list
6811376|NCT04883437|Acalabrutinib|acalabrutinib|mesh-list
6811377|NCT04883437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6811378|NCT04883437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6811379|NCT04848753|Paclitaxel|paclitaxel|mesh-list
6811380|NCT04848753|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6811381|NCT04848753|Cisplatin|cisplatin|mesh-list
6811382|NCT04848753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6811383|NCT04848753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6811384|NCT04848753|Tubulin Modulators|tubulin modulators|mesh-ancestor
6811385|NCT04848753|Antimitotic Agents|antimitotic agents|mesh-ancestor
6811386|NCT04848753|Mitosis Modulators|mitosis modulators|mesh-ancestor
6811387|NCT04848753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811388|NCT04804709|Panobinostat|panobinostat|mesh-list
6811389|NCT04804709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6811390|NCT04804709|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6811391|NCT04804709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6811392|NCT04804709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811393|NCT04731103|Lamivudine|lamivudine|mesh-list
6811394|NCT04731103|Zidovudine|zidovudine|mesh-list
6811395|NCT04731103|Abacavir|abacavir|mesh-list
6811396|NCT04731103|Dideoxynucleosides|dideoxynucleosides|mesh-list
6811397|NCT04731103|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6811398|NCT04731103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6811399|NCT04731103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6811400|NCT04731103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811401|NCT04731103|Antiviral Agents|antiviral agents|mesh-ancestor
6811402|NCT04731103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6811403|NCT04731103|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6811404|NCT04731103|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6811405|NCT04731103|Antimetabolites|antimetabolites|mesh-ancestor
6811406|NCT04694781|Pembrolizumab|pembrolizumab|mesh-list
6811407|NCT04694781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6811408|NCT04694781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6811409|NCT04690673|Acetaminophen|acetaminophen|mesh-list
6811410|NCT04690673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6811411|NCT04690673|Analgesics|analgesics|mesh-ancestor
6811412|NCT04690673|Sensory System Agents|sensory system agents|mesh-ancestor
6811413|NCT04690673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6811414|NCT04690673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811415|NCT04690673|Antipyretics|antipyretics|mesh-ancestor
6811416|NCT04682288|Levofloxacin|levofloxacin|mesh-list
6811417|NCT04682288|Ofloxacin|ofloxacin|mesh-list
6811418|NCT04682288|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6811419|NCT04682288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6811420|NCT04682288|Renal Agents|renal agents|mesh-ancestor
6811421|NCT04682288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6811422|NCT04682288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6811423|NCT04682288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6811424|NCT04682288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6811425|NCT04682288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811426|NCT04682288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6811427|NCT04682288|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6811428|NCT04682288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6811429|NCT04675866|Paclitaxel|paclitaxel|mesh-list
6811430|NCT04675866|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6811431|NCT04675866|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6811432|NCT04675866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6811433|NCT04675866|Tubulin Modulators|tubulin modulators|mesh-ancestor
6811434|NCT04675866|Antimitotic Agents|antimitotic agents|mesh-ancestor
6811435|NCT04675866|Mitosis Modulators|mitosis modulators|mesh-ancestor
6811436|NCT04675866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811437|NCT04652375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6811438|NCT04618744|Insulin|insulin|mesh-list
6811439|NCT04618744|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6811440|NCT04618744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6811441|NCT04618744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811442|NCT04608409|Paclitaxel|paclitaxel|mesh-list
6811443|NCT04608409|Lapatinib|lapatinib|mesh-list
6811444|NCT04608409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6811445|NCT04608409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6811446|NCT04608409|Tubulin Modulators|tubulin modulators|mesh-ancestor
6811447|NCT04608409|Antimitotic Agents|antimitotic agents|mesh-ancestor
6811448|NCT04608409|Mitosis Modulators|mitosis modulators|mesh-ancestor
6811449|NCT04608409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811450|NCT04608409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6811451|NCT04608409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6811452|NCT04606797|Nicotine|nicotine|mesh-list
6811453|NCT04606797|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6811454|NCT04606797|Autonomic Agents|autonomic agents|mesh-ancestor
6811455|NCT04606797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6811456|NCT04606797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811457|NCT04606797|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6811458|NCT04606797|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6811459|NCT04606797|Cholinergic Agents|cholinergic agents|mesh-ancestor
6811460|NCT04606797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6811461|NCT04606797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811462|NCT04606576|Insulin|insulin|mesh-list
6811463|NCT04606576|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6811464|NCT04606576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6811465|NCT04606576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811466|NCT04583787|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
6811467|NCT04583787|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6811468|NCT04583787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811469|NCT04580992|Ajmaline|ajmaline|mesh-list
6811470|NCT04580992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6811471|NCT04580992|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6811472|NCT04580992|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6811473|NCT04580992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6811474|NCT04580992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811475|NCT04572451|Nivolumab|nivolumab|mesh-list
6811476|NCT04572451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6811477|NCT04572451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6811478|NCT04572451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6811479|NCT04572451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811480|NCT04559217|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
6811481|NCT04559217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811482|NCT04554732|Mitogens|mitogens|mesh-list
6811483|NCT04554732|Mitosis Modulators|mitosis modulators|mesh-ancestor
6811484|NCT04554732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811485|NCT04544111|Trametinib|trametinib|mesh-list
6811486|NCT04544111|Dabrafenib|dabrafenib|mesh-list
6811487|NCT04544111|Spartalizumab|spartalizumab|mesh-list
6811488|NCT04544111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6811489|NCT04544111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6811490|NCT04544111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6811491|NCT04544111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811492|NCT04544111|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6811493|NCT04536467|Goserelin|goserelin|mesh-list
6811494|NCT04536467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6811495|NCT04536467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6811496|NCT04530981|Repaglinide|repaglinide|mesh-list
6811497|NCT04530981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6811498|NCT04530981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811499|NCT04523480|Methyltestosterone|methyltestosterone|mesh-list
6811500|NCT04523480|Testosterone|testosterone|mesh-list
6811501|NCT04523480|Testosterone undecanoate|testosterone undecanoate|mesh-list
6811502|NCT04523480|Testosterone enanthate|testosterone enanthate|mesh-list
6811503|NCT04523480|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6811504|NCT04523480|Androgens|androgens|mesh-ancestor
6811505|NCT04523480|Hormones|hormones|mesh-ancestor
6811506|NCT04523480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6811507|NCT04523480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811508|NCT04523480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6811509|NCT04523480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6811510|NCT04523480|Anabolic Agents|anabolic agents|mesh-ancestor
6811511|NCT04469634|Antibodies|antibodies|mesh-list
6811512|NCT04469634|Immunologic Factors|immunologic factors|mesh-ancestor
6811513|NCT04469634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811514|NCT04455178|Indapamide|indapamide|mesh-list
6811515|NCT04455178|Spironolactone|spironolactone|mesh-list
6811516|NCT04455178|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6811517|NCT04455178|Hormone Antagonists|hormone antagonists|mesh-ancestor
6811518|NCT04455178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6811519|NCT04455178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811520|NCT04455178|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6811521|NCT04455178|Diuretics|diuretics|mesh-ancestor
6811522|NCT04455178|Natriuretic Agents|natriuretic agents|mesh-ancestor
6811523|NCT04455178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6811524|NCT04455178|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6811525|NCT04455178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6811526|NCT04455178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811527|NCT04400110|Amoxicillin|amoxicillin|mesh-list
6811528|NCT04400110|Clavulanic Acids|clavulanic acids|mesh-list
6811529|NCT04400110|Clavulanic Acid|clavulanic acid|mesh-list
6811530|NCT04400110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6811531|NCT04400110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6811532|NCT04400110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6811533|NCT04400110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811534|NCT04400110|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6811535|NCT04388501|Atorvastatin|atorvastatin|mesh-list
6811536|NCT04388501|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6811537|NCT04388501|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6811538|NCT04388501|Antimetabolites|antimetabolites|mesh-ancestor
6811539|NCT04388501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811540|NCT04388501|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6811541|NCT04388501|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6811542|NCT04388501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6811543|NCT04356339|Interferons|interferons|mesh-list
6811544|NCT04356339|Interferon-beta|interferon-beta|mesh-list
6811545|NCT04356339|Interferon beta-1b|interferon beta-1b|mesh-list
6811546|NCT04356339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6811547|NCT04356339|Antiviral Agents|antiviral agents|mesh-ancestor
6811548|NCT04356339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6811549|NCT04356339|Immunologic Factors|immunologic factors|mesh-ancestor
6811550|NCT04356339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811551|NCT04356339|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6811552|NCT04308837|Diphenhydramine|diphenhydramine|mesh-list
6811553|NCT04308837|Promethazine|promethazine|mesh-list
6811554|NCT04308837|Dexamethasone|dexamethasone|mesh-list
6811555|NCT04308837|Paclitaxel|paclitaxel|mesh-list
6811556|NCT04308837|Carboplatin|carboplatin|mesh-list
6811557|NCT04308837|Palonosetron|palonosetron|mesh-list
6811558|NCT04308837|Famotidine|famotidine|mesh-list
6811559|NCT04308837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6811560|NCT04308837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6811561|NCT04308837|Tubulin Modulators|tubulin modulators|mesh-ancestor
6811562|NCT04308837|Antimitotic Agents|antimitotic agents|mesh-ancestor
6811563|NCT04308837|Mitosis Modulators|mitosis modulators|mesh-ancestor
6811564|NCT04308837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811565|NCT04308837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6811566|NCT04308837|Antiemetics|antiemetics|mesh-ancestor
6811567|NCT04308837|Autonomic Agents|autonomic agents|mesh-ancestor
6811568|NCT04308837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6811569|NCT04308837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811570|NCT04308837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6811571|NCT04308837|Glucocorticoids|glucocorticoids|mesh-ancestor
6811572|NCT04308837|Hormones|hormones|mesh-ancestor
6811573|NCT04308837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6811574|NCT04308837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6811575|NCT04308837|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6811576|NCT04308837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6811577|NCT04308837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6811578|NCT04308837|Anesthetics, Local|anesthetics, local|mesh-ancestor
6811579|NCT04308837|Anesthetics|anesthetics|mesh-ancestor
6811580|NCT04308837|Sensory System Agents|sensory system agents|mesh-ancestor
6811581|NCT04308837|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6811582|NCT04308837|Histamine Antagonists|histamine antagonists|mesh-ancestor
6811583|NCT04308837|Histamine Agents|histamine agents|mesh-ancestor
6811584|NCT04308837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6811585|NCT04308837|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6811586|NCT04308837|Antipruritics|antipruritics|mesh-ancestor
6811587|NCT04308837|Dermatologic Agents|dermatologic agents|mesh-ancestor
6811588|NCT04308837|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6811589|NCT04308837|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6811590|NCT04308837|Serotonin Agents|serotonin agents|mesh-ancestor
6811591|NCT04308837|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6811592|NCT04308837|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6811593|NCT04303702|Oxytocin|oxytocin|mesh-list
6811594|NCT04303702|Oxytocics|oxytocics|mesh-ancestor
6811595|NCT04303702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6811596|NCT04303702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811597|NCT04303000|Analgesics, Opioid|analgesics, opioid|mesh-list
6811598|NCT04303000|Naloxone|naloxone|mesh-list
6811599|NCT04303000|Narcotics|narcotics|mesh-ancestor
6811600|NCT04303000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6811601|NCT04303000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811602|NCT04303000|Analgesics|analgesics|mesh-ancestor
6811603|NCT04303000|Sensory System Agents|sensory system agents|mesh-ancestor
6811604|NCT04303000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6811605|NCT04303000|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6811606|NCT04298034|Labetalol|labetalol|mesh-list
6811607|NCT04298034|Nifedipine|nifedipine|mesh-list
6811608|NCT04298034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6811609|NCT04298034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6811610|NCT04298034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811611|NCT04298034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6811612|NCT04298034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811613|NCT04298034|Vasodilator Agents|vasodilator agents|mesh-ancestor
6811614|NCT04298034|Tocolytic Agents|tocolytic agents|mesh-ancestor
6811615|NCT04298034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6811616|NCT04298034|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6811617|NCT04298034|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6811618|NCT04298034|Adrenergic Agents|adrenergic agents|mesh-ancestor
6811619|NCT04298034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6811620|NCT04298034|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6811621|NCT04298034|Sympathomimetics|sympathomimetics|mesh-ancestor
6811622|NCT04298034|Autonomic Agents|autonomic agents|mesh-ancestor
6811623|NCT04298034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6811624|NCT04298034|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6811625|NCT04298034|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6811626|NCT04254549|Rifaximin|rifaximin|mesh-list
6811627|NCT04254549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6811628|NCT04254549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6811629|NCT04254549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6811630|NCT04252287|Canagliflozin|canagliflozin|mesh-list
6811631|NCT04252287|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6811632|NCT04252287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811633|NCT04252287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6811634|NCT04252287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811635|NCT04231318|Triamcinolone|triamcinolone|mesh-list
6811636|NCT04231318|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6811637|NCT04231318|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6811638|NCT04231318|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6811639|NCT04231318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6811640|NCT04231318|Glucocorticoids|glucocorticoids|mesh-ancestor
6811641|NCT04231318|Hormones|hormones|mesh-ancestor
6811642|NCT04231318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6811643|NCT04231318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811644|NCT04231318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6811645|NCT04231318|Immunologic Factors|immunologic factors|mesh-ancestor
6811646|NCT04231318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6811647|NCT04231318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811648|NCT04225078|Moxifloxacin|moxifloxacin|mesh-list
6811649|NCT04225078|Loperamide|loperamide|mesh-list
6811650|NCT04225078|Antidiarrheals|antidiarrheals|mesh-list
6811651|NCT04225078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6811652|NCT04225078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6811653|NCT04225078|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6811654|NCT04225078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6811655|NCT04225078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6811656|NCT04225078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811657|NCT04225078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6811658|NCT04225078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6811659|NCT04198649|Azithromycin|azithromycin|mesh-list
6811660|NCT04198649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6811661|NCT04198649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6811662|NCT04177654|Albendazole|albendazole|mesh-list
6811663|NCT04177654|Mebendazole|mebendazole|mesh-list
6811664|NCT04177654|Benzimidazole|benzimidazole|mesh-list
6811665|NCT04177654|Anthelmintics|anthelmintics|mesh-ancestor
6811666|NCT04177654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6811667|NCT04177654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6811668|NCT04177654|Anticestodal Agents|anticestodal agents|mesh-ancestor
6811669|NCT04177654|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6811670|NCT04177654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6811671|NCT04177654|Tubulin Modulators|tubulin modulators|mesh-ancestor
6811672|NCT04177654|Antimitotic Agents|antimitotic agents|mesh-ancestor
6811673|NCT04177654|Mitosis Modulators|mitosis modulators|mesh-ancestor
6811674|NCT04177654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811675|NCT04177654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6811676|NCT04177654|Antinematodal Agents|antinematodal agents|mesh-ancestor
6811677|NCT04172402|Gemcitabine|gemcitabine|mesh-list
6811678|NCT04172402|Nivolumab|nivolumab|mesh-list
6811679|NCT04172402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6811680|NCT04172402|Antimetabolites|antimetabolites|mesh-ancestor
6811681|NCT04172402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811682|NCT04172402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6811683|NCT04172402|Antiviral Agents|antiviral agents|mesh-ancestor
6811684|NCT04172402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6811685|NCT04172402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6811686|NCT04172402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6811687|NCT04172402|Immunologic Factors|immunologic factors|mesh-ancestor
6811688|NCT04172402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811689|NCT04172402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6811690|NCT04172402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6811691|NCT04111419|Amlodipine|amlodipine|mesh-list
6811692|NCT04111419|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
6811693|NCT04111419|Atorvastatin|atorvastatin|mesh-list
6811694|NCT04111419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6811695|NCT04111419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6811696|NCT04111419|Antimetabolites|antimetabolites|mesh-ancestor
6811697|NCT04111419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811698|NCT04111419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6811699|NCT04111419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6811700|NCT04111419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6811701|NCT04111419|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6811702|NCT04111419|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6811703|NCT04111419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6811704|NCT04111419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6811705|NCT04111419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811706|NCT04111419|Vasodilator Agents|vasodilator agents|mesh-ancestor
6811707|NCT04071613|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6811708|NCT04071613|Plasminogen|plasminogen|mesh-list
6811709|NCT04071613|Tenecteplase|tenecteplase|mesh-list
6811710|NCT04071613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6811711|NCT04071613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6811712|NCT04071613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811713|NCT04062708|Durvalumab|durvalumab|mesh-list
6811714|NCT04062708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6811715|NCT04062708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6811716|NCT04040231|Nivolumab|nivolumab|mesh-list
6811717|NCT04040231|Sargramostim|sargramostim|mesh-list
6811718|NCT04040231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6811719|NCT04040231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6811720|NCT04040231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6811721|NCT04040231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811722|NCT04040231|Immunologic Factors|immunologic factors|mesh-ancestor
6811723|NCT04040231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811724|NCT04030026|Nalbuphine|nalbuphine|mesh-list
6811725|NCT04030026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6811726|NCT04030026|Narcotics|narcotics|mesh-ancestor
6811727|NCT04030026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6811728|NCT04030026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811729|NCT04030026|Analgesics|analgesics|mesh-ancestor
6811730|NCT04030026|Sensory System Agents|sensory system agents|mesh-ancestor
6811731|NCT04030026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6811732|NCT04026191|Hyaluronic Acid|hyaluronic acid|mesh-list
6811733|NCT04026191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6811734|NCT04026191|Immunologic Factors|immunologic factors|mesh-ancestor
6811735|NCT04026191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811736|NCT04026191|Viscosupplements|viscosupplements|mesh-ancestor
6811737|NCT04026191|Protective Agents|protective agents|mesh-ancestor
6811738|NCT04006769|Imatinib Mesylate|imatinib mesylate|mesh-list
6811739|NCT04006769|Entacapone|entacapone|mesh-list
6811740|NCT04006769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6811741|NCT04006769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6811742|NCT04006769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6811743|NCT04006769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811744|NCT04006769|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6811745|NCT04006769|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6811746|NCT04006769|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6811747|NCT03970746|Pembrolizumab|pembrolizumab|mesh-list
6811748|NCT03970746|Pemetrexed|pemetrexed|mesh-list
6811749|NCT03970746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6811750|NCT03970746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6811751|NCT03970746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6811752|NCT03970746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811753|NCT03970746|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6811754|NCT03970746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6811755|NCT03969420|Cytarabine|cytarabine|mesh-list
6811756|NCT03969420|Alvocidib|alvocidib|mesh-list
6811757|NCT03969420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6811758|NCT03969420|Antimetabolites|antimetabolites|mesh-ancestor
6811759|NCT03969420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811760|NCT03969420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6811761|NCT03969420|Antiviral Agents|antiviral agents|mesh-ancestor
6811762|NCT03969420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6811763|NCT03969420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6811764|NCT03969420|Immunologic Factors|immunologic factors|mesh-ancestor
6811765|NCT03969420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811766|NCT03969420|Growth Inhibitors|growth inhibitors|mesh-ancestor
6811767|NCT03969420|Growth Substances|growth substances|mesh-ancestor
6811768|NCT03969420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6811769|NCT03969420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6811770|NCT03962894|Prednisolone|prednisolone|mesh-list
6811771|NCT03962894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6811772|NCT03962894|Glucocorticoids|glucocorticoids|mesh-ancestor
6811773|NCT03962894|Hormones|hormones|mesh-ancestor
6811774|NCT03962894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6811775|NCT03962894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811776|NCT03962894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6811777|NCT03962894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6811778|NCT03917472|Aflibercept|aflibercept|mesh-list
6811779|NCT03917472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6811780|NCT03917472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6811781|NCT03917472|Growth Substances|growth substances|mesh-ancestor
6811782|NCT03917472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811783|NCT03917472|Growth Inhibitors|growth inhibitors|mesh-ancestor
6811784|NCT03917472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6811785|NCT03916627|Cemiplimab|cemiplimab|mesh-list
6811786|NCT03916627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6811787|NCT03916627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6811788|NCT03893318|Lidocaine|lidocaine|mesh-list
6811789|NCT03893318|Anesthetics, Local|anesthetics, local|mesh-ancestor
6811790|NCT03893318|Anesthetics|anesthetics|mesh-ancestor
6811791|NCT03893318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6811792|NCT03893318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811793|NCT03893318|Sensory System Agents|sensory system agents|mesh-ancestor
6811794|NCT03893318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6811795|NCT03893318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6811796|NCT03893318|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6811797|NCT03893318|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6811798|NCT03893318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6811799|NCT03893318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811800|NCT03832010|Triamcinolone|triamcinolone|mesh-list
6811801|NCT03832010|Hydrocortisone|hydrocortisone|mesh-list
6811802|NCT03832010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6811803|NCT03832010|Glucocorticoids|glucocorticoids|mesh-ancestor
6811804|NCT03832010|Hormones|hormones|mesh-ancestor
6811805|NCT03832010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6811806|NCT03832010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811807|NCT03817125|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6811808|NCT03817125|Vancomycin|vancomycin|mesh-list
6811809|NCT03817125|Nivolumab|nivolumab|mesh-list
6811810|NCT03817125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6811811|NCT03817125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6811812|NCT03817125|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6811813|NCT03817125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811814|NCT03817125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6811815|NCT03783026|Apremilast|apremilast|mesh-list
6811816|NCT03783026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6811817|NCT03783026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6811818|NCT03783026|Analgesics|analgesics|mesh-ancestor
6811819|NCT03783026|Sensory System Agents|sensory system agents|mesh-ancestor
6811820|NCT03783026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6811821|NCT03783026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811822|NCT03783026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6811823|NCT03783026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6811824|NCT03783026|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6811825|NCT03783026|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6811826|NCT03783026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6811827|NCT03783026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811828|NCT03733132|Metformin|metformin|mesh-list
6811829|NCT03733132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6811830|NCT03733132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811831|NCT03625466|Ivacaftor|ivacaftor|mesh-list
6811832|NCT03625466|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6811833|NCT03625466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6811834|NCT03625466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811835|NCT03605719|Dexamethasone|dexamethasone|mesh-list
6811836|NCT03605719|Nivolumab|nivolumab|mesh-list
6811837|NCT03605719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6811838|NCT03605719|Antiemetics|antiemetics|mesh-ancestor
6811839|NCT03605719|Autonomic Agents|autonomic agents|mesh-ancestor
6811840|NCT03605719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6811841|NCT03605719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811842|NCT03605719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6811843|NCT03605719|Glucocorticoids|glucocorticoids|mesh-ancestor
6811844|NCT03605719|Hormones|hormones|mesh-ancestor
6811845|NCT03605719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6811846|NCT03605719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6811847|NCT03605719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6811848|NCT03605719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6811849|NCT03605719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6811850|NCT03605719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811851|NCT03529890|Nivolumab|nivolumab|mesh-list
6811852|NCT03529890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6811853|NCT03529890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6811854|NCT03529890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6811855|NCT03529890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811856|NCT03476239|Blinatumomab|blinatumomab|mesh-list
6811857|NCT03476239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6811858|NCT03451799|Temozolomide|temozolomide|mesh-list
6811859|NCT03451799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6811860|NCT03451799|Alkylating Agents|alkylating agents|mesh-ancestor
6811861|NCT03451799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811862|NCT03451799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6811863|NCT03428945|Hydroxychloroquine|hydroxychloroquine|mesh-list
6811864|NCT03428945|Antimalarials|antimalarials|mesh-ancestor
6811865|NCT03428945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6811866|NCT03428945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6811867|NCT03428945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6811868|NCT03428945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6811869|NCT03428945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811870|NCT03428945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6811871|NCT03423121|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
6811872|NCT03423121|Antiviral Agents|antiviral agents|mesh-ancestor
6811873|NCT03423121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6811874|NCT03423121|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6811875|NCT03423121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6811876|NCT03417479|Gabapentin|gabapentin|mesh-list
6811877|NCT03417479|Analgesics|analgesics|mesh-ancestor
6811878|NCT03417479|Sensory System Agents|sensory system agents|mesh-ancestor
6811879|NCT03417479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6811880|NCT03417479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811881|NCT03417479|Anticonvulsants|anticonvulsants|mesh-ancestor
6811882|NCT03417479|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6811883|NCT03417479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6811884|NCT03417479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6811885|NCT03417479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6811886|NCT03417479|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6811887|NCT03417479|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6811888|NCT03417479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6811889|NCT03417479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811890|NCT03417479|Antimanic Agents|antimanic agents|mesh-ancestor
6811891|NCT03400306|Paclitaxel|paclitaxel|mesh-list
6811892|NCT03400306|Carboplatin|carboplatin|mesh-list
6811893|NCT03400306|Veliparib|veliparib|mesh-list
6811894|NCT03400306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6811895|NCT03400306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6811896|NCT03400306|Tubulin Modulators|tubulin modulators|mesh-ancestor
6811897|NCT03400306|Antimitotic Agents|antimitotic agents|mesh-ancestor
6811898|NCT03400306|Mitosis Modulators|mitosis modulators|mesh-ancestor
6811899|NCT03400306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811900|NCT03400306|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6811901|NCT03400306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6811902|NCT03317795|Tranexamic Acid|tranexamic acid|mesh-list
6811903|NCT03317795|Levonorgestrel|levonorgestrel|mesh-list
6811904|NCT03317795|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6811905|NCT03317795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6811906|NCT03317795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811907|NCT03317795|Hemostatics|hemostatics|mesh-ancestor
6811908|NCT03317795|Coagulants|coagulants|mesh-ancestor
6811909|NCT03317795|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6811910|NCT03317795|Contraceptive Agents|contraceptive agents|mesh-ancestor
6811911|NCT03317795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6811912|NCT03317795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811913|NCT03317795|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6811914|NCT03317795|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6811915|NCT03317795|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6811916|NCT03284723|Letrozole|letrozole|mesh-list
6811917|NCT03284723|Palbociclib|palbociclib|mesh-list
6811918|NCT03284723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6811919|NCT03284723|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6811920|NCT03284723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6811921|NCT03284723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6811922|NCT03284723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811923|NCT03284723|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6811924|NCT03284723|Hormone Antagonists|hormone antagonists|mesh-ancestor
6811925|NCT03284723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6811926|NCT03284723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811927|NCT03284723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6811928|NCT03223610|Prednisone|prednisone|mesh-list
6811929|NCT03223610|Lenalidomide|lenalidomide|mesh-list
6811930|NCT03223610|Venetoclax|venetoclax|mesh-list
6811931|NCT03223610|Obinutuzumab|obinutuzumab|mesh-list
6811932|NCT03223610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6811933|NCT03223610|Glucocorticoids|glucocorticoids|mesh-ancestor
6811934|NCT03223610|Hormones|hormones|mesh-ancestor
6811935|NCT03223610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6811936|NCT03223610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811937|NCT03223610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6811938|NCT03223610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6811939|NCT03223610|Immunologic Factors|immunologic factors|mesh-ancestor
6811940|NCT03223610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6811941|NCT03223610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6811942|NCT03223610|Growth Substances|growth substances|mesh-ancestor
6811943|NCT03223610|Growth Inhibitors|growth inhibitors|mesh-ancestor
6811944|NCT03223610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6811945|NCT03214250|Gemcitabine|gemcitabine|mesh-list
6811946|NCT03214250|Paclitaxel|paclitaxel|mesh-list
6811947|NCT03214250|Nivolumab|nivolumab|mesh-list
6811948|NCT03214250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6811949|NCT03214250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6811950|NCT03214250|Tubulin Modulators|tubulin modulators|mesh-ancestor
6811951|NCT03214250|Antimitotic Agents|antimitotic agents|mesh-ancestor
6811952|NCT03214250|Mitosis Modulators|mitosis modulators|mesh-ancestor
6811953|NCT03214250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811954|NCT03214250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6811955|NCT03214250|Antimetabolites|antimetabolites|mesh-ancestor
6811956|NCT03214250|Antiviral Agents|antiviral agents|mesh-ancestor
6811957|NCT03214250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6811958|NCT03214250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6811959|NCT03214250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6811960|NCT03214250|Immunologic Factors|immunologic factors|mesh-ancestor
6811961|NCT03214250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811962|NCT03214250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6811963|NCT03214250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6811964|NCT03174275|Paclitaxel|paclitaxel|mesh-list
6811965|NCT03174275|Carboplatin|carboplatin|mesh-list
6811966|NCT03174275|Durvalumab|durvalumab|mesh-list
6811967|NCT03174275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6811968|NCT03174275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6811969|NCT03174275|Tubulin Modulators|tubulin modulators|mesh-ancestor
6811970|NCT03174275|Antimitotic Agents|antimitotic agents|mesh-ancestor
6811971|NCT03174275|Mitosis Modulators|mitosis modulators|mesh-ancestor
6811972|NCT03174275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811973|NCT03174275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6811974|NCT03115294|Theophylline|theophylline|mesh-list
6811975|NCT03115294|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6811976|NCT03115294|Autonomic Agents|autonomic agents|mesh-ancestor
6811977|NCT03115294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6811978|NCT03115294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6811979|NCT03115294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6811980|NCT03115294|Respiratory System Agents|respiratory system agents|mesh-ancestor
6811981|NCT03115294|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6811982|NCT03115294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6811983|NCT03115294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6811984|NCT03115294|Vasodilator Agents|vasodilator agents|mesh-ancestor
6811985|NCT03115294|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6811986|NCT03115294|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6811987|NCT03115294|Purinergic Agents|purinergic agents|mesh-ancestor
6811988|NCT03115294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6811989|NCT03087656|Levofloxacin|levofloxacin|mesh-list
6811990|NCT03087656|Ofloxacin|ofloxacin|mesh-list
6811991|NCT03087656|Ceftriaxone|ceftriaxone|mesh-list
6811992|NCT03087656|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6811993|NCT03087656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6811994|NCT03087656|Renal Agents|renal agents|mesh-ancestor
6811995|NCT03087656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6811996|NCT03087656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6811997|NCT03087656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6811998|NCT03087656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6811999|NCT03087656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812000|NCT03087656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6812001|NCT03087656|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6812002|NCT03087656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6812003|NCT03085004|Gemcitabine|gemcitabine|mesh-list
6812004|NCT03085004|Ethanol|ethanol|mesh-list
6812005|NCT03085004|Paclitaxel|paclitaxel|mesh-list
6812006|NCT03085004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6812007|NCT03085004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6812008|NCT03085004|Tubulin Modulators|tubulin modulators|mesh-ancestor
6812009|NCT03085004|Antimitotic Agents|antimitotic agents|mesh-ancestor
6812010|NCT03085004|Mitosis Modulators|mitosis modulators|mesh-ancestor
6812011|NCT03085004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812012|NCT03085004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6812013|NCT03085004|Antimetabolites|antimetabolites|mesh-ancestor
6812014|NCT03085004|Antiviral Agents|antiviral agents|mesh-ancestor
6812015|NCT03085004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6812016|NCT03085004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6812017|NCT03085004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6812018|NCT03085004|Immunologic Factors|immunologic factors|mesh-ancestor
6812019|NCT03085004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993572|NCT00123604|Carvedilol|carvedilol|mesh-list
6812020|NCT03085004|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6812021|NCT03085004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6812022|NCT03084640|Pembrolizumab|pembrolizumab|mesh-list
6812023|NCT03084640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6812024|NCT03084640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6812025|NCT03033069|Sertraline|sertraline|mesh-list
6812026|NCT03033069|Brexpiprazole|brexpiprazole|mesh-list
6812027|NCT03033069|Antidepressive Agents|antidepressive agents|mesh-ancestor
6812028|NCT03033069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6812029|NCT03033069|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6812030|NCT03033069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6812031|NCT03033069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6812032|NCT03033069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812033|NCT03033069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6812034|NCT03033069|Serotonin Agents|serotonin agents|mesh-ancestor
6812035|NCT03033069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812036|NCT03033069|Dopamine Agonists|dopamine agonists|mesh-ancestor
6812037|NCT03033069|Dopamine Agents|dopamine agents|mesh-ancestor
6812038|NCT02976753|Factor VIII|factor viii|mesh-list
6812039|NCT02976753|Coagulants|coagulants|mesh-ancestor
6812040|NCT02946424|Simvastatin|simvastatin|mesh-list
6812041|NCT02946424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6812042|NCT02946424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6812043|NCT02946424|Antimetabolites|antimetabolites|mesh-ancestor
6812044|NCT02946424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812045|NCT02946424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6812046|NCT02946424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6812047|NCT02946424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6812048|NCT02891954|Canagliflozin|canagliflozin|mesh-list
6812049|NCT02891954|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6812050|NCT02891954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812051|NCT02891954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6812052|NCT02891954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812053|NCT02863770|Pancrelipase|pancrelipase|mesh-list
6812054|NCT02863770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6812055|NCT02663622|Methotrexate|methotrexate|mesh-list
6812056|NCT02663622|Tacrolimus|tacrolimus|mesh-list
6812057|NCT02663622|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6812058|NCT02663622|Abortifacient Agents|abortifacient agents|mesh-ancestor
6812059|NCT02663622|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6812060|NCT02663622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812061|NCT02663622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6812062|NCT02663622|Antimetabolites|antimetabolites|mesh-ancestor
6812063|NCT02663622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812064|NCT02663622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6812065|NCT02663622|Dermatologic Agents|dermatologic agents|mesh-ancestor
6812066|NCT02663622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6812067|NCT02663622|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6812068|NCT02663622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6812069|NCT02663622|Immunologic Factors|immunologic factors|mesh-ancestor
6812070|NCT02663622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6812071|NCT02663622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6812072|NCT02663622|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6812073|NCT02609503|Pembrolizumab|pembrolizumab|mesh-list
6812074|NCT02609503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6812075|NCT02609503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6812076|NCT02587598|Cytarabine|cytarabine|mesh-list
6812077|NCT02587598|Azacitidine|azacitidine|mesh-list
6812078|NCT02587598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6812079|NCT02587598|Antimetabolites|antimetabolites|mesh-ancestor
6812080|NCT02587598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812081|NCT02587598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6812082|NCT02587598|Antiviral Agents|antiviral agents|mesh-ancestor
6812083|NCT02587598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6812084|NCT02587598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6812085|NCT02587598|Immunologic Factors|immunologic factors|mesh-ancestor
6812086|NCT02587598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812087|NCT02587598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6812088|NCT02485574|Calcium|calcium|mesh-list
6812089|NCT02485574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6812090|NCT02485574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812091|NCT02462421|Canagliflozin|canagliflozin|mesh-list
6812092|NCT02462421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6812093|NCT02462421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812094|NCT02462421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6812095|NCT02462421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812096|NCT02350764|Nivolumab|nivolumab|mesh-list
6812097|NCT02350764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6812098|NCT02350764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6812099|NCT02350764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6812100|NCT02350764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812101|NCT02091934|Dipivefrin|dipivefrin|mesh-list
6812102|NCT02091934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6812103|NCT02091934|Adrenergic Agents|adrenergic agents|mesh-ancestor
6812104|NCT02091934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6812105|NCT02091934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812106|NCT02091934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812107|NCT02032823|Olaparib|olaparib|mesh-list
6812108|NCT02032823|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6812109|NCT02032823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6812110|NCT02032823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812111|NCT02032823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6812112|NCT02023996|Trastuzumab|trastuzumab|mesh-list
6812113|NCT02023996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6812114|NCT02023996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6812115|NCT01639690|Busulfan|busulfan|mesh-list
6812116|NCT01639690|Immunologic Factors|immunologic factors|mesh-ancestor
6812117|NCT01639690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812118|NCT01639690|Alkylating Agents|alkylating agents|mesh-ancestor
6812119|NCT01639690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812120|NCT01639690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6812121|NCT01639690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6812122|NCT01639690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6812123|NCT01639690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6812124|NCT01612351|Paclitaxel|paclitaxel|mesh-list
6812125|NCT01612351|Cisplatin|cisplatin|mesh-list
6812126|NCT01612351|Carboplatin|carboplatin|mesh-list
6812127|NCT01612351|Lapatinib|lapatinib|mesh-list
6812128|NCT01612351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6812129|NCT01612351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6812130|NCT01612351|Tubulin Modulators|tubulin modulators|mesh-ancestor
6812131|NCT01612351|Antimitotic Agents|antimitotic agents|mesh-ancestor
6812132|NCT01612351|Mitosis Modulators|mitosis modulators|mesh-ancestor
6812133|NCT01612351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812134|NCT01612351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6812135|NCT01612351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6812136|NCT01460160|Dasatinib|dasatinib|mesh-list
6812137|NCT01460160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6258698|NCT03096444|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6258699|NCT03096444|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6258700|NCT03096444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6396831|NCT00209742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6812138|NCT01460160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6812139|NCT01460160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6812140|NCT01460160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812141|NCT01291004|Drospirenone|drospirenone|mesh-list
6812142|NCT01291004|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6812143|NCT01291004|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6812144|NCT01291004|Levonorgestrel|levonorgestrel|mesh-list
6812145|NCT01291004|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6812146|NCT01291004|Desogestrel|desogestrel|mesh-list
6812147|NCT01291004|Contraceptive Agents|contraceptive agents|mesh-list
6812148|NCT01291004|Contraceptives, Oral|contraceptives, oral|mesh-list
6812149|NCT01291004|Estradiol|estradiol|mesh-list
6812150|NCT01291004|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6812151|NCT01291004|Estrogens|estrogens|mesh-ancestor
6812152|NCT01291004|Hormones|hormones|mesh-ancestor
6812153|NCT01291004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6812154|NCT01291004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812155|NCT01291004|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6812156|NCT01291004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6812157|NCT01291004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6812158|NCT01291004|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6812159|NCT01291004|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6812160|NCT01291004|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6812161|NCT01291004|Hormone Antagonists|hormone antagonists|mesh-ancestor
6812162|NCT01291004|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6812163|NCT01291004|Diuretics|diuretics|mesh-ancestor
6812164|NCT01291004|Natriuretic Agents|natriuretic agents|mesh-ancestor
6812165|NCT01291004|Progestins|progestins|mesh-ancestor
6812166|NCT01170702|Ropivacaine|ropivacaine|mesh-list
6812167|NCT01170702|Anesthetics, Local|anesthetics, local|mesh-ancestor
6812168|NCT01170702|Anesthetics|anesthetics|mesh-ancestor
6812169|NCT01170702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6812170|NCT01170702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812171|NCT01170702|Sensory System Agents|sensory system agents|mesh-ancestor
6812172|NCT01170702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6812173|NCT01018563|Farletuzumab|farletuzumab|mesh-list
6812174|NCT01018563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6812175|NCT00805961|Bevacizumab|bevacizumab|mesh-list
6812176|NCT00805961|Everolimus|everolimus|mesh-list
6812177|NCT00805961|Temozolomide|temozolomide|mesh-list
6812178|NCT00805961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6812179|NCT00805961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6812180|NCT00805961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6812181|NCT00805961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6812182|NCT00805961|Growth Substances|growth substances|mesh-ancestor
6812183|NCT00805961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812184|NCT00805961|Growth Inhibitors|growth inhibitors|mesh-ancestor
6812185|NCT00805961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6812186|NCT00805961|Immunologic Factors|immunologic factors|mesh-ancestor
6812187|NCT00805961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6812188|NCT00805961|Alkylating Agents|alkylating agents|mesh-ancestor
6812189|NCT00805961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812190|NCT00750841|Cediranib|cediranib|mesh-list
6812191|NCT00750841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6812192|NCT00750841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6812193|NCT00750841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6812194|NCT00750841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812195|NCT00600496|Sirolimus|sirolimus|mesh-list
6812196|NCT00600496|Docetaxel|docetaxel|mesh-list
6812197|NCT00600496|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6812198|NCT00600496|Dacarbazine|dacarbazine|mesh-list
6812199|NCT00600496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6812200|NCT00600496|Tubulin Modulators|tubulin modulators|mesh-ancestor
6812201|NCT00600496|Antimitotic Agents|antimitotic agents|mesh-ancestor
6812202|NCT00600496|Mitosis Modulators|mitosis modulators|mesh-ancestor
6812203|NCT00600496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812204|NCT00600496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6812205|NCT00600496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6812206|NCT00600496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6812207|NCT00600496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6812208|NCT00600496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6812209|NCT00600496|Antifungal Agents|antifungal agents|mesh-ancestor
6812210|NCT00600496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6812211|NCT00600496|Immunologic Factors|immunologic factors|mesh-ancestor
6812212|NCT00600496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812213|NCT00600496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6812214|NCT00600496|Alkylating Agents|alkylating agents|mesh-ancestor
6812215|NCT00374660|Oxaliplatin|oxaliplatin|mesh-list
6812216|NCT00374660|Irofulven|irofulven|mesh-list
6812217|NCT00374660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6812218|NCT00374660|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6812219|NCT00374660|Alkylating Agents|alkylating agents|mesh-ancestor
6812220|NCT00374660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812221|NCT00112411|Bronchodilator Agents|bronchodilator agents|mesh-list
6812222|NCT00112411|Autonomic Agents|autonomic agents|mesh-ancestor
6812223|NCT00112411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6812224|NCT00112411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812225|NCT00112411|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6812226|NCT00112411|Respiratory System Agents|respiratory system agents|mesh-ancestor
6812227|NCT00109668|Beclomethasone|beclomethasone|mesh-list
6812228|NCT00109668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6812229|NCT00109668|Glucocorticoids|glucocorticoids|mesh-ancestor
6812230|NCT00109668|Hormones|hormones|mesh-ancestor
6812231|NCT00109668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6812232|NCT00109668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812233|NCT00109668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6812234|NCT00109668|Respiratory System Agents|respiratory system agents|mesh-ancestor
6812235|NCT05152472|Atezolizumab|atezolizumab|mesh-list
6812236|NCT05152472|Imatinib Mesylate|imatinib mesylate|mesh-list
6812237|NCT05152472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6812238|NCT05152472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6812239|NCT05152472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6812240|NCT05152472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812241|NCT05152420|Rivaroxaban|rivaroxaban|mesh-list
6812242|NCT05152420|Apixaban|apixaban|mesh-list
6812243|NCT05152420|Edoxaban|edoxaban|mesh-list
6812244|NCT05152420|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6812245|NCT05152420|Antithrombins|antithrombins|mesh-ancestor
6812246|NCT05152420|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6812247|NCT05152420|Protease Inhibitors|protease inhibitors|mesh-ancestor
6812248|NCT05152420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6812249|NCT05152420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812250|NCT05152420|Anticoagulants|anticoagulants|mesh-ancestor
6812251|NCT05152355|Budesonide|budesonide|mesh-list
6812252|NCT05152355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6812253|NCT05152355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6812254|NCT05152355|Autonomic Agents|autonomic agents|mesh-ancestor
6812255|NCT05152355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6812256|NCT05152355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812257|NCT05152355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6812258|NCT05152355|Respiratory System Agents|respiratory system agents|mesh-ancestor
6812259|NCT05152355|Glucocorticoids|glucocorticoids|mesh-ancestor
6812260|NCT05152355|Hormones|hormones|mesh-ancestor
6812261|NCT05152355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6812262|NCT05152303|Propofol|propofol|mesh-list
6812263|NCT05152303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6812264|NCT05152303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6812265|NCT05152303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812266|NCT05152303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6812267|NCT05152303|Anesthetics, General|anesthetics, general|mesh-ancestor
6812268|NCT05152303|Anesthetics|anesthetics|mesh-ancestor
6812269|NCT05152264|Analgesics|analgesics|mesh-list
6812270|NCT05152264|Sensory System Agents|sensory system agents|mesh-ancestor
6812271|NCT05152264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6812272|NCT05152264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812273|NCT05152186|Disinfectants|disinfectants|mesh-list
6812274|NCT05152186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6812275|NCT05151874|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6812276|NCT05151874|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6812277|NCT05151874|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6812278|NCT05151874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6812279|NCT05151874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812280|NCT05151874|Cholinergic Agents|cholinergic agents|mesh-ancestor
6812281|NCT05151874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6812282|NCT05151874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812283|NCT05151874|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6812284|NCT05151874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6812285|NCT05151796|Aspirin|aspirin|mesh-list
6812286|NCT05151796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6812287|NCT05151796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6812288|NCT05151796|Analgesics|analgesics|mesh-ancestor
6812289|NCT05151796|Sensory System Agents|sensory system agents|mesh-ancestor
6812290|NCT05151796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6812291|NCT05151796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812292|NCT05151796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6812293|NCT05151796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6812294|NCT05151796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6812295|NCT05151796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6812296|NCT05151796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812297|NCT05151796|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6812298|NCT05151796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6812299|NCT05151796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6812300|NCT05151796|Antipyretics|antipyretics|mesh-ancestor
6812301|NCT05151679|Iron|iron|mesh-list
6812302|NCT05151679|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6812303|NCT05151679|Iron Chelating Agents|iron chelating agents|mesh-list
6812304|NCT05151679|Trace Elements|trace elements|mesh-ancestor
6812305|NCT05151679|Micronutrients|micronutrients|mesh-ancestor
6812306|NCT05151679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812307|NCT05151679|Hematinics|hematinics|mesh-ancestor
6812308|NCT05151679|Chelating Agents|chelating agents|mesh-ancestor
6812309|NCT05151679|Sequestering Agents|sequestering agents|mesh-ancestor
6812310|NCT05151679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812311|NCT05151614|Colchicine|colchicine|mesh-list
6812312|NCT05151614|Gout Suppressants|gout suppressants|mesh-ancestor
6812313|NCT05151614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6812314|NCT05151614|Tubulin Modulators|tubulin modulators|mesh-ancestor
6812315|NCT05151614|Antimitotic Agents|antimitotic agents|mesh-ancestor
6812316|NCT05151614|Mitosis Modulators|mitosis modulators|mesh-ancestor
6812317|NCT05151614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812318|NCT05151614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6812319|NCT05151549|Carboplatin|carboplatin|mesh-list
6812320|NCT05151549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6812321|NCT05151510|Lidocaine|lidocaine|mesh-list
6812322|NCT05151510|Anesthetics, Local|anesthetics, local|mesh-ancestor
6812323|NCT05151510|Anesthetics|anesthetics|mesh-ancestor
6812324|NCT05151510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6812325|NCT05151510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812326|NCT05151510|Sensory System Agents|sensory system agents|mesh-ancestor
6812327|NCT05151510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6812328|NCT05151510|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6812329|NCT05151510|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6812330|NCT05151510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6812331|NCT05151510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6812332|NCT05151510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812333|NCT05151393|Vitamin D|vitamin d|mesh-list
6812334|NCT05151393|Cholecalciferol|cholecalciferol|mesh-list
6812335|NCT05151393|Vitamins|vitamins|mesh-ancestor
6812336|NCT05151393|Micronutrients|micronutrients|mesh-ancestor
6812337|NCT05151393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812338|NCT05151393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6812339|NCT05151393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6812340|NCT05151328|Plecanatide|plecanatide|mesh-list
6812341|NCT05151328|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
6812342|NCT05151328|Enzyme Activators|enzyme activators|mesh-ancestor
6812343|NCT05151328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812344|NCT05151328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6812345|NCT05151042|Salicylic Acid|salicylic acid|mesh-list
6812346|NCT05151042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6812347|NCT05151042|Antifungal Agents|antifungal agents|mesh-ancestor
6812348|NCT05151042|Keratolytic Agents|keratolytic agents|mesh-ancestor
6812349|NCT05151042|Dermatologic Agents|dermatologic agents|mesh-ancestor
6812350|NCT05151016|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6812351|NCT05151016|Mifepristone|mifepristone|mesh-list
6812352|NCT05151016|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6812353|NCT05151016|Abortifacient Agents|abortifacient agents|mesh-ancestor
6812354|NCT05151016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6812355|NCT05151016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812356|NCT05151016|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6812357|NCT05151016|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6812358|NCT05151016|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6812359|NCT05151016|Contraceptive Agents|contraceptive agents|mesh-ancestor
6812360|NCT05151016|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6812361|NCT05151016|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6812362|NCT05151016|Hormone Antagonists|hormone antagonists|mesh-ancestor
6812363|NCT05151016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6812364|NCT05151016|Luteolytic Agents|luteolytic agents|mesh-ancestor
6812365|NCT05151016|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6812366|NCT05151016|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6812367|NCT05151016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6812368|NCT05151016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6812369|NCT05150899|Fexofenadine|fexofenadine|mesh-list
6812370|NCT05150899|Tamsulosin|tamsulosin|mesh-list
6812371|NCT05150899|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6812372|NCT05150899|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6812373|NCT05150899|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6812374|NCT05150899|Adrenergic Agents|adrenergic agents|mesh-ancestor
6812375|NCT05150899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6812376|NCT05150899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812377|NCT05150899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812378|NCT05150899|Urological Agents|urological agents|mesh-ancestor
6812379|NCT05150899|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6812380|NCT05150899|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6812381|NCT05150899|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6812382|NCT05150899|Histamine Antagonists|histamine antagonists|mesh-ancestor
6812383|NCT05150899|Histamine Agents|histamine agents|mesh-ancestor
6812384|NCT05150795|Pregabalin|pregabalin|mesh-list
6812385|NCT05150795|Fentanyl|fentanyl|mesh-list
6812386|NCT05150795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6812387|NCT05150795|Narcotics|narcotics|mesh-ancestor
6812388|NCT05150795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6812389|NCT05150795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812390|NCT05150795|Analgesics|analgesics|mesh-ancestor
6812391|NCT05150795|Sensory System Agents|sensory system agents|mesh-ancestor
6812392|NCT05150795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6812393|NCT05150795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6812394|NCT05150795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6812395|NCT05150795|Anesthetics, General|anesthetics, general|mesh-ancestor
6812396|NCT05150795|Anesthetics|anesthetics|mesh-ancestor
6812397|NCT05150795|Anticonvulsants|anticonvulsants|mesh-ancestor
6812398|NCT05150795|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6812399|NCT05150795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6812400|NCT05150795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812401|NCT05150795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6812402|NCT05150795|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6812403|NCT05150795|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6812404|NCT05150795|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6812405|NCT05150756|Lidocaine|lidocaine|mesh-list
6812406|NCT05150756|Morphine|morphine|mesh-list
6812407|NCT05150756|Anesthetics, Local|anesthetics, local|mesh-ancestor
6812408|NCT05150756|Anesthetics|anesthetics|mesh-ancestor
6812409|NCT05150756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6812410|NCT05150756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812411|NCT05150756|Sensory System Agents|sensory system agents|mesh-ancestor
6812412|NCT05150756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6812413|NCT05150756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6812414|NCT05150756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6812415|NCT05150756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6812416|NCT05150756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6812417|NCT05150756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812418|NCT05150756|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6812419|NCT05150756|Narcotics|narcotics|mesh-ancestor
6812420|NCT05150756|Analgesics|analgesics|mesh-ancestor
6812421|NCT05148754|Elsulfavirine|elsulfavirine|mesh-list
6812422|NCT05148754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6812423|NCT05148754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6812424|NCT05148754|Antiviral Agents|antiviral agents|mesh-ancestor
6812425|NCT05148754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6812426|NCT05133817|Norepinephrine|norepinephrine|mesh-list
6812427|NCT05133817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
6812428|NCT05133817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6812429|NCT05133817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6812430|NCT05133817|Adrenergic Agents|adrenergic agents|mesh-ancestor
6812431|NCT05133817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6812432|NCT05133817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812433|NCT05133817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812434|NCT05133817|Sympathomimetics|sympathomimetics|mesh-ancestor
6812435|NCT05133817|Autonomic Agents|autonomic agents|mesh-ancestor
6812436|NCT05133817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6812437|NCT05130268|Dronedarone|dronedarone|mesh-list
6812438|NCT05130268|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6812439|NCT05111353|Poly ICLC|poly iclc|mesh-list
6812440|NCT05111353|Interferon Inducers|interferon inducers|mesh-ancestor
6812441|NCT05111353|Immunologic Factors|immunologic factors|mesh-ancestor
6812442|NCT05111353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812443|NCT05108740|Everolimus|everolimus|mesh-list
6812444|NCT05108740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6812445|NCT05108740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6812446|NCT05108740|Immunologic Factors|immunologic factors|mesh-ancestor
6812447|NCT05108740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812448|NCT05076513|Niraparib|niraparib|mesh-list
6812449|NCT05076513|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6812450|NCT05076513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6812451|NCT05076513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812452|NCT05076513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6812453|NCT05051891|Prednisone|prednisone|mesh-list
6812454|NCT05051891|Cyclophosphamide|cyclophosphamide|mesh-list
6812455|NCT05051891|Vincristine|vincristine|mesh-list
6812456|NCT05051891|Rituximab|rituximab|mesh-list
6812457|NCT05051891|Doxorubicin|doxorubicin|mesh-list
6812458|NCT05051891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6812459|NCT05051891|Immunologic Factors|immunologic factors|mesh-ancestor
6812460|NCT05051891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812461|NCT05051891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6812462|NCT05051891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6812463|NCT05051891|Alkylating Agents|alkylating agents|mesh-ancestor
6812464|NCT05051891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812465|NCT05051891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6812466|NCT05051891|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6812467|NCT05051891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6812468|NCT05051891|Glucocorticoids|glucocorticoids|mesh-ancestor
6812469|NCT05051891|Hormones|hormones|mesh-ancestor
6812470|NCT05051891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6812471|NCT05051891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6812472|NCT05051891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6812473|NCT05051891|Tubulin Modulators|tubulin modulators|mesh-ancestor
6812474|NCT05051891|Antimitotic Agents|antimitotic agents|mesh-ancestor
6812475|NCT05051891|Mitosis Modulators|mitosis modulators|mesh-ancestor
6812476|NCT05051891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6812477|NCT05051891|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6812478|NCT05051891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6812479|NCT05051891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6812480|NCT05051891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6258701|NCT03096444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258702|NCT03096444|Analgesics|analgesics|mesh-ancestor
6258703|NCT03096444|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6258704|NCT03096444|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6812481|NCT05011123|Vaccines|vaccines|mesh-list
6812482|NCT05011123|Immunologic Factors|immunologic factors|mesh-ancestor
6812483|NCT05011123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812484|NCT04998981|Fenofibrate|fenofibrate|mesh-list
6812485|NCT04998981|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6812486|NCT04998981|Antimetabolites|antimetabolites|mesh-ancestor
6812487|NCT04998981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812488|NCT04998981|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6812489|NCT04991350|Bevacizumab|bevacizumab|mesh-list
6812490|NCT04991350|Ranibizumab|ranibizumab|mesh-list
6812491|NCT04991350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6812492|NCT04991350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6812493|NCT04991350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6812494|NCT04991350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6812495|NCT04991350|Growth Substances|growth substances|mesh-ancestor
6812496|NCT04991350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812497|NCT04991350|Growth Inhibitors|growth inhibitors|mesh-ancestor
6812498|NCT04971031|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6812499|NCT04971031|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6812500|NCT04940572|Valproic Acid|valproic acid|mesh-list
6812501|NCT04940572|Anticonvulsants|anticonvulsants|mesh-ancestor
6812502|NCT04940572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6812503|NCT04940572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812504|NCT04940572|GABA Agents|gaba agents|mesh-ancestor
6812505|NCT04940572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6812506|NCT04940572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812507|NCT04940572|Antimanic Agents|antimanic agents|mesh-ancestor
6812508|NCT04940572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6812509|NCT04940572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6812510|NCT04940572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6812511|NCT04936685|Vaccines|vaccines|mesh-list
6812512|NCT04936685|Immunologic Factors|immunologic factors|mesh-ancestor
6812513|NCT04936685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812514|NCT04933058|Acetaminophen|acetaminophen|mesh-list
6812515|NCT04933058|Fentanyl|fentanyl|mesh-list
6812516|NCT04933058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6812517|NCT04933058|Narcotics|narcotics|mesh-ancestor
6812518|NCT04933058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6812519|NCT04933058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812520|NCT04933058|Analgesics|analgesics|mesh-ancestor
6812521|NCT04933058|Sensory System Agents|sensory system agents|mesh-ancestor
6812522|NCT04933058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6812523|NCT04933058|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6812524|NCT04933058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6812525|NCT04933058|Anesthetics, General|anesthetics, general|mesh-ancestor
6812526|NCT04933058|Anesthetics|anesthetics|mesh-ancestor
6812527|NCT04933058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6812528|NCT04933058|Antipyretics|antipyretics|mesh-ancestor
6812529|NCT04924062|Gemcitabine|gemcitabine|mesh-list
6812530|NCT04924062|Cisplatin|cisplatin|mesh-list
6812531|NCT04924062|Pembrolizumab|pembrolizumab|mesh-list
6812532|NCT04924062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6812533|NCT04924062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6812534|NCT04924062|Antimetabolites|antimetabolites|mesh-ancestor
6812535|NCT04924062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812536|NCT04924062|Antiviral Agents|antiviral agents|mesh-ancestor
6812537|NCT04924062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6812538|NCT04924062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6812539|NCT04924062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6812540|NCT04924062|Immunologic Factors|immunologic factors|mesh-ancestor
6812541|NCT04924062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812542|NCT04924062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6812543|NCT04899583|Sirolimus|sirolimus|mesh-list
6812544|NCT04899583|Paclitaxel|paclitaxel|mesh-list
6812545|NCT04899583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6812546|NCT04899583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6812547|NCT04899583|Tubulin Modulators|tubulin modulators|mesh-ancestor
6812548|NCT04899583|Antimitotic Agents|antimitotic agents|mesh-ancestor
6812549|NCT04899583|Mitosis Modulators|mitosis modulators|mesh-ancestor
6812550|NCT04899583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812551|NCT04899583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6812552|NCT04899583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6812553|NCT04899583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6812554|NCT04899583|Antifungal Agents|antifungal agents|mesh-ancestor
6812555|NCT04899583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6812556|NCT04899583|Immunologic Factors|immunologic factors|mesh-ancestor
6812557|NCT04899583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812558|NCT04891991|Infliximab|infliximab|mesh-list
6812559|NCT04891991|Dermatologic Agents|dermatologic agents|mesh-ancestor
6812560|NCT04891991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6812561|NCT04891991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6812562|NCT04830592|Pembrolizumab|pembrolizumab|mesh-list
6812563|NCT04830592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6812564|NCT04830592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6812565|NCT04777851|Nivolumab|nivolumab|mesh-list
6812566|NCT04777851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6812567|NCT04777851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6812568|NCT04777851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6812569|NCT04777851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812570|NCT04761887|Ropivacaine|ropivacaine|mesh-list
6812571|NCT04761887|Anesthetics, Local|anesthetics, local|mesh-ancestor
6812572|NCT04761887|Anesthetics|anesthetics|mesh-ancestor
6812573|NCT04761887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6812574|NCT04761887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812575|NCT04761887|Sensory System Agents|sensory system agents|mesh-ancestor
6812576|NCT04761887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6812577|NCT04753879|Gemcitabine|gemcitabine|mesh-list
6812578|NCT04753879|Paclitaxel|paclitaxel|mesh-list
6812579|NCT04753879|Pembrolizumab|pembrolizumab|mesh-list
6812580|NCT04753879|Capecitabine|capecitabine|mesh-list
6812581|NCT04753879|Irinotecan|irinotecan|mesh-list
6812582|NCT04753879|Olaparib|olaparib|mesh-list
6812583|NCT04753879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6812584|NCT04753879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6812585|NCT04753879|Tubulin Modulators|tubulin modulators|mesh-ancestor
6812586|NCT04753879|Antimitotic Agents|antimitotic agents|mesh-ancestor
6812587|NCT04753879|Mitosis Modulators|mitosis modulators|mesh-ancestor
6812588|NCT04753879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812589|NCT04753879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6812590|NCT04753879|Antimetabolites|antimetabolites|mesh-ancestor
6812591|NCT04753879|Antiviral Agents|antiviral agents|mesh-ancestor
6812592|NCT04753879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6812593|NCT04753879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6812594|NCT04753879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6812595|NCT04753879|Immunologic Factors|immunologic factors|mesh-ancestor
6812596|NCT04753879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812597|NCT04753879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6812598|NCT04753879|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6812599|NCT04753879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6812600|NCT04753879|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6812601|NCT04750759|Niclosamide|niclosamide|mesh-list
6812602|NCT04750759|Camostat|camostat|mesh-list
6812603|NCT04750759|Protease Inhibitors|protease inhibitors|mesh-ancestor
6812604|NCT04750759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6812605|NCT04750759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812606|NCT04750759|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6812607|NCT04750759|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6812608|NCT04750759|Anticestodal Agents|anticestodal agents|mesh-ancestor
6812609|NCT04750759|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6812610|NCT04750759|Anthelmintics|anthelmintics|mesh-ancestor
6812611|NCT04750759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6812612|NCT04750759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6812613|NCT04750759|Antinematodal Agents|antinematodal agents|mesh-ancestor
6812614|NCT04721977|Capecitabine|capecitabine|mesh-list
6812615|NCT04721977|Trastuzumab|trastuzumab|mesh-list
6812616|NCT04721977|Tucatinib|tucatinib|mesh-list
6812617|NCT04721977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6812618|NCT04721977|Antimetabolites|antimetabolites|mesh-ancestor
6812619|NCT04721977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812620|NCT04721977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6812621|NCT04721977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6812622|NCT04721977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6812623|NCT04721977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6812624|NCT04720716|Sorafenib|sorafenib|mesh-list
6812625|NCT04720716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6812626|NCT04720716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6812627|NCT04720716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6812628|NCT04720716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812629|NCT04622839|Acetaminophen|acetaminophen|mesh-list
6812630|NCT04622839|Ibuprofen|ibuprofen|mesh-list
6812631|NCT04622839|Diclofenac|diclofenac|mesh-list
6812632|NCT04622839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6812633|NCT04622839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6812634|NCT04622839|Analgesics|analgesics|mesh-ancestor
6812635|NCT04622839|Sensory System Agents|sensory system agents|mesh-ancestor
6812636|NCT04622839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6812637|NCT04622839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812638|NCT04622839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6812639|NCT04622839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6812640|NCT04622839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6812641|NCT04622839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6812642|NCT04622839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812643|NCT04622839|Antipyretics|antipyretics|mesh-ancestor
6812644|NCT04614909|Temozolomide|temozolomide|mesh-list
6812645|NCT04614909|Olaparib|olaparib|mesh-list
6812646|NCT04614909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6812647|NCT04614909|Alkylating Agents|alkylating agents|mesh-ancestor
6812648|NCT04614909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812649|NCT04614909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6812650|NCT04614909|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6812651|NCT04614909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6812652|NCT04609423|Vitamin D|vitamin d|mesh-list
6812653|NCT04609423|Cod Liver Oil|cod liver oil|mesh-list
6812654|NCT04609423|Vitamins|vitamins|mesh-ancestor
6812655|NCT04609423|Micronutrients|micronutrients|mesh-ancestor
6812656|NCT04609423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812657|NCT04609423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6812658|NCT04602975|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6812659|NCT04602975|Vaccines|vaccines|mesh-list
6812660|NCT04602975|Immunologic Factors|immunologic factors|mesh-ancestor
6812661|NCT04602975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812662|NCT04602975|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6812663|NCT04602975|Antacids|antacids|mesh-ancestor
6812664|NCT04602975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812665|NCT04602975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6812666|NCT04597372|Tamsulosin|tamsulosin|mesh-list
6812667|NCT04597372|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6812668|NCT04597372|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6812669|NCT04597372|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6812670|NCT04597372|Adrenergic Agents|adrenergic agents|mesh-ancestor
6812671|NCT04597372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6812672|NCT04597372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812673|NCT04597372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812674|NCT04597372|Urological Agents|urological agents|mesh-ancestor
6812675|NCT04591626|Insulin Glargine|insulin glargine|mesh-list
6812676|NCT04591626|Dulaglutide|dulaglutide|mesh-list
6812677|NCT04591626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6812678|NCT04591626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812679|NCT04584684|Ethanol|ethanol|mesh-list
6812680|NCT04584684|Hydrogen Peroxide|hydrogen peroxide|mesh-list
6812681|NCT04584684|Cetylpyridinium|cetylpyridinium|mesh-list
6812682|NCT04584684|Povidone|povidone|mesh-list
6812683|NCT04584684|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6812684|NCT04584684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6812685|NCT04584684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6812686|NCT04584684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812687|NCT04584684|Plasma Substitutes|plasma substitutes|mesh-ancestor
6812688|NCT04584684|Blood Substitutes|blood substitutes|mesh-ancestor
6812689|NCT04574154|Anesthetics|anesthetics|mesh-list
6812690|NCT04574154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6812691|NCT04574154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812692|NCT04558866|Methyltestosterone|methyltestosterone|mesh-list
6812693|NCT04558866|Testosterone|testosterone|mesh-list
6812694|NCT04558866|Testosterone undecanoate|testosterone undecanoate|mesh-list
6812695|NCT04558866|Testosterone enanthate|testosterone enanthate|mesh-list
6812696|NCT04558866|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6812697|NCT04558866|Androgens|androgens|mesh-ancestor
6812698|NCT04558866|Hormones|hormones|mesh-ancestor
6812699|NCT04558866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6812700|NCT04558866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812701|NCT04558866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6812702|NCT04558866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6812703|NCT04558866|Anabolic Agents|anabolic agents|mesh-ancestor
6812704|NCT04556370|Norepinephrine|norepinephrine|mesh-list
6812705|NCT04556370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6812706|NCT04556370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6812707|NCT04556370|Adrenergic Agents|adrenergic agents|mesh-ancestor
6812708|NCT04556370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6812709|NCT04556370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812710|NCT04556370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812711|NCT04556370|Sympathomimetics|sympathomimetics|mesh-ancestor
6812712|NCT04556370|Autonomic Agents|autonomic agents|mesh-ancestor
6812713|NCT04556370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6812714|NCT04556370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6812715|NCT04526821|Lactoferrin|lactoferrin|mesh-list
6812716|NCT04526821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6812717|NCT04492241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6812718|NCT04445389|Vaccines|vaccines|mesh-list
6812719|NCT04445389|Immunologic Factors|immunologic factors|mesh-ancestor
6812720|NCT04445389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812721|NCT04416386|Ascorbic Acid|ascorbic acid|mesh-list
6812722|NCT04416386|Vitamins|vitamins|mesh-ancestor
6812723|NCT04416386|Micronutrients|micronutrients|mesh-ancestor
6812724|NCT04416386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812725|NCT04416386|Antioxidants|antioxidants|mesh-ancestor
6812726|NCT04416386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812727|NCT04416386|Protective Agents|protective agents|mesh-ancestor
6812728|NCT04365257|Prazosin|prazosin|mesh-list
6812729|NCT04365257|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-list
6812730|NCT04365257|Adrenergic Antagonists|adrenergic antagonists|mesh-list
6812731|NCT04365257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6812732|NCT04365257|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6812733|NCT04365257|Adrenergic Agents|adrenergic agents|mesh-ancestor
6812734|NCT04365257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6812735|NCT04365257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812736|NCT04365257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812737|NCT04365088|Deflazacort|deflazacort|mesh-list
6812738|NCT04365088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6812739|NCT04365088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6812740|NCT04365088|Immunologic Factors|immunologic factors|mesh-ancestor
6812741|NCT04365088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812742|NCT04349579|Rifamycins|rifamycins|mesh-list
6812743|NCT04349579|Rifamycin SV|rifamycin sv|mesh-list
6812744|NCT04349579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6812745|NCT04349579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6812746|NCT04349579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6812747|NCT04234529|Caffeine|caffeine|mesh-list
6812748|NCT04234529|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6812749|NCT04234529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812750|NCT04234529|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6812751|NCT04234529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6812752|NCT04234529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812753|NCT04234529|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6812754|NCT04234529|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6812755|NCT04234529|Purinergic Agents|purinergic agents|mesh-ancestor
6812756|NCT04234529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6812757|NCT04217954|Bevacizumab|bevacizumab|mesh-list
6812758|NCT04217954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6812759|NCT04217954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6812760|NCT04217954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6812761|NCT04217954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6812762|NCT04217954|Growth Substances|growth substances|mesh-ancestor
6812763|NCT04217954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812764|NCT04217954|Growth Inhibitors|growth inhibitors|mesh-ancestor
6258705|NCT03096444|Anesthetics, General|anesthetics, general|mesh-ancestor
6258706|NCT03096444|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6258707|NCT03096444|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6258708|NCT03096444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6258709|NCT03096444|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6258710|NCT03096444|Antidepressive Agents|antidepressive agents|mesh-ancestor
6812765|NCT04197713|Olaparib|olaparib|mesh-list
6812766|NCT04197713|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
6812767|NCT04197713|Adavosertib|adavosertib|mesh-list
6812768|NCT04197713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6812769|NCT04197713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812770|NCT04197713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6812771|NCT04195776|Tenofovir|tenofovir|mesh-list
6812772|NCT04195776|Antiviral Agents|antiviral agents|mesh-ancestor
6812773|NCT04195776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6812774|NCT04195776|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6812775|NCT04195776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6812776|NCT04195776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6812777|NCT04195776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812778|NCT04195776|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6812779|NCT04195776|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5993573|NCT00123604|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5993574|NCT00123604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6812780|NCT04192110|Diuretics|diuretics|mesh-list
6812781|NCT04192110|Natriuretic Agents|natriuretic agents|mesh-ancestor
6812782|NCT04192110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812783|NCT04182100|Aspirin|aspirin|mesh-list
6812784|NCT04182100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6812785|NCT04182100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6812786|NCT04182100|Analgesics|analgesics|mesh-ancestor
6812787|NCT04182100|Sensory System Agents|sensory system agents|mesh-ancestor
6812788|NCT04182100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6812789|NCT04182100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812790|NCT04182100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6812791|NCT04182100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6812792|NCT04182100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6812793|NCT04182100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6812794|NCT04182100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812795|NCT04182100|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6812796|NCT04182100|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6812797|NCT04182100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6812798|NCT04182100|Antipyretics|antipyretics|mesh-ancestor
6812799|NCT04179019|Amlodipine|amlodipine|mesh-list
6812800|NCT04179019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6812801|NCT04179019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6812802|NCT04179019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6812803|NCT04179019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812804|NCT04179019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6812805|NCT04179019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812806|NCT04179019|Vasodilator Agents|vasodilator agents|mesh-ancestor
6812807|NCT04127578|Sirolimus|sirolimus|mesh-list
6812808|NCT04127578|Prednisone|prednisone|mesh-list
6812809|NCT04127578|Methylprednisolone|methylprednisolone|mesh-list
6812810|NCT04127578|Rituximab|rituximab|mesh-list
6812811|NCT04127578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6812812|NCT04127578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6812813|NCT04127578|Immunologic Factors|immunologic factors|mesh-ancestor
6812814|NCT04127578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812815|NCT04127578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6812816|NCT04127578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6812817|NCT04127578|Glucocorticoids|glucocorticoids|mesh-ancestor
6812818|NCT04127578|Hormones|hormones|mesh-ancestor
6812819|NCT04127578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6812820|NCT04127578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6812821|NCT04127578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6812822|NCT04127578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6812823|NCT04127578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6812824|NCT04127578|Antifungal Agents|antifungal agents|mesh-ancestor
6812825|NCT04127578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6812826|NCT04127578|Antiemetics|antiemetics|mesh-ancestor
6812827|NCT04127578|Autonomic Agents|autonomic agents|mesh-ancestor
6812828|NCT04127578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6812829|NCT04127578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6812830|NCT04127578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6812831|NCT04127578|Protective Agents|protective agents|mesh-ancestor
6812832|NCT04126317|Aflibercept|aflibercept|mesh-list
6812833|NCT04126317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6812834|NCT04126317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6812835|NCT04126317|Growth Substances|growth substances|mesh-ancestor
6812836|NCT04126317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812837|NCT04126317|Growth Inhibitors|growth inhibitors|mesh-ancestor
6812838|NCT04126317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6812839|NCT04084717|Crizotinib|crizotinib|mesh-list
6812840|NCT04084717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6812841|NCT04084717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6812842|NCT04084717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6812843|NCT04084717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812844|NCT04056182|Lofexidine|lofexidine|mesh-list
6812845|NCT04056182|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6812846|NCT04056182|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6812847|NCT04056182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812848|NCT04056182|Sensory System Agents|sensory system agents|mesh-ancestor
6812849|NCT04056182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6812850|NCT04056182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6812851|NCT04056182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6812852|NCT04056182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6812853|NCT04056182|Adrenergic Agents|adrenergic agents|mesh-ancestor
6812854|NCT04056182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5993575|NCT00123604|Sympatholytics|sympatholytics|mesh-ancestor
6812855|NCT04056182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812856|NCT04049851|Ivermectin|ivermectin|mesh-list
6812857|NCT04049851|Moxidectin|moxidectin|mesh-list
6812858|NCT04049851|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6812859|NCT04049851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6812860|NCT04049851|Anthelmintics|anthelmintics|mesh-ancestor
6812861|NCT04049851|Antinematodal Agents|antinematodal agents|mesh-ancestor
6812862|NCT04025554|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6812863|NCT04025554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6812864|NCT03966625|Autoantibodies|autoantibodies|mesh-list
6812865|NCT03966625|Immunologic Factors|immunologic factors|mesh-ancestor
6812866|NCT03966625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812867|NCT03961568|Cenobamate|cenobamate|mesh-list
6812868|NCT03961568|Anticonvulsants|anticonvulsants|mesh-ancestor
6812869|NCT03959358|Lenalidomide|lenalidomide|mesh-list
6812870|NCT03959358|Pomalidomide|pomalidomide|mesh-list
6812871|NCT03959358|Immunologic Factors|immunologic factors|mesh-ancestor
6812872|NCT03959358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812873|NCT03959358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6812874|NCT03959358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6812875|NCT03959358|Growth Substances|growth substances|mesh-ancestor
6812876|NCT03959358|Growth Inhibitors|growth inhibitors|mesh-ancestor
6812877|NCT03959358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6812878|NCT03954106|Defibrotide|defibrotide|mesh-list
6812879|NCT03954106|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6812880|NCT03954106|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6812881|NCT03954106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812882|NCT03954106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6812883|NCT03948867|Hydroxyurea|hydroxyurea|mesh-list
6812884|NCT03948867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6812885|NCT03948867|Antisickling Agents|antisickling agents|mesh-ancestor
6812886|NCT03948867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6812887|NCT03948867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812888|NCT03948867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6812889|NCT03944356|Trametinib|trametinib|mesh-list
6812890|NCT03944356|Dabrafenib|dabrafenib|mesh-list
6812891|NCT03944356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6812892|NCT03944356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6812893|NCT03944356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6812894|NCT03944356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812895|NCT03930498|Antibodies|antibodies|mesh-list
6812896|NCT03930498|Antibodies, Blocking|antibodies, blocking|mesh-list
6812897|NCT03930498|Immunologic Factors|immunologic factors|mesh-ancestor
6812898|NCT03930498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812899|NCT03921424|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6812900|NCT03921424|Immunologic Factors|immunologic factors|mesh-ancestor
6812901|NCT03921424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812902|NCT03898934|Vitamin D|vitamin d|mesh-list
6812903|NCT03898934|Vitamins|vitamins|mesh-ancestor
6812904|NCT03898934|Micronutrients|micronutrients|mesh-ancestor
6812905|NCT03898934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812906|NCT03898934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6812907|NCT03893617|Propranolol|propranolol|mesh-list
6812908|NCT03893617|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6812909|NCT03893617|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6812910|NCT03893617|Adrenergic Agents|adrenergic agents|mesh-ancestor
6812911|NCT03893617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6812912|NCT03893617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812913|NCT03893617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812914|NCT03893617|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6812915|NCT03893617|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6812916|NCT03893617|Vasodilator Agents|vasodilator agents|mesh-ancestor
6812917|NCT03831932|Osimertinib|osimertinib|mesh-list
6812918|NCT03831932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6812919|NCT03831932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6812920|NCT03831932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6812921|NCT03831932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812922|NCT03817554|Dopamine|dopamine|mesh-list
6812923|NCT03817554|Pramipexole|pramipexole|mesh-list
6812924|NCT03817554|Dopamine Agonists|dopamine agonists|mesh-list
6812925|NCT03817554|Antioxidants|antioxidants|mesh-ancestor
6812926|NCT03817554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812927|NCT03817554|Protective Agents|protective agents|mesh-ancestor
6812928|NCT03817554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812929|NCT03817554|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6812930|NCT03817554|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6812931|NCT03817554|Dopamine Agents|dopamine agents|mesh-ancestor
6812932|NCT03817554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6812933|NCT03817554|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6812934|NCT03817554|Sympathomimetics|sympathomimetics|mesh-ancestor
6812935|NCT03817554|Autonomic Agents|autonomic agents|mesh-ancestor
6812936|NCT03817554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6812937|NCT03789591|Hydroxyurea|hydroxyurea|mesh-list
6812938|NCT03789591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6812939|NCT03789591|Antisickling Agents|antisickling agents|mesh-ancestor
6812940|NCT03789591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6812941|NCT03789591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812942|NCT03789591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6812943|NCT03782259|Dapagliflozin|dapagliflozin|mesh-list
6812944|NCT03782259|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6812945|NCT03782259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812946|NCT03782259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6812947|NCT03782259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812948|NCT03778294|Temozolomide|temozolomide|mesh-list
6812949|NCT03778294|Levodopa|levodopa|mesh-list
6812950|NCT03778294|Fluorides|fluorides|mesh-list
6812951|NCT03778294|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
6812952|NCT03778294|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6812953|NCT03778294|Alkylating Agents|alkylating agents|mesh-ancestor
6812954|NCT03778294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812955|NCT03778294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6812956|NCT03778294|Cariostatic Agents|cariostatic agents|mesh-ancestor
6812957|NCT03778294|Protective Agents|protective agents|mesh-ancestor
6812958|NCT03778294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812959|NCT03778294|Dopamine Agents|dopamine agents|mesh-ancestor
6812960|NCT03778294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6812961|NCT03778294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6812962|NCT03778294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6812963|NCT03736538|Nitrous Oxide|nitrous oxide|mesh-list
6812964|NCT03736538|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6812965|NCT03736538|Anesthetics, General|anesthetics, general|mesh-ancestor
6812966|NCT03736538|Anesthetics|anesthetics|mesh-ancestor
6812967|NCT03736538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6812968|NCT03736538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812969|NCT03736538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6812970|NCT03736538|Analgesics|analgesics|mesh-ancestor
6812971|NCT03736538|Sensory System Agents|sensory system agents|mesh-ancestor
6812972|NCT03736538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6812973|NCT03717896|Thiamine|thiamine|mesh-list
6812974|NCT03717896|Vitamins|vitamins|mesh-ancestor
6812975|NCT03717896|Micronutrients|micronutrients|mesh-ancestor
6812976|NCT03717896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812977|NCT03717896|Vitamin B Complex|vitamin b complex|mesh-ancestor
6812978|NCT03678753|Cenobamate|cenobamate|mesh-list
6812979|NCT03678753|Anticonvulsants|anticonvulsants|mesh-ancestor
6812980|NCT03598777|Botulinum Toxins|botulinum toxins|mesh-list
6812981|NCT03598777|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6812982|NCT03598777|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6812983|NCT03598777|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6812984|NCT03598777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6812985|NCT03598777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6812986|NCT03598777|Cholinergic Agents|cholinergic agents|mesh-ancestor
6812987|NCT03598777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6812988|NCT03598777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6812989|NCT03598777|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6812990|NCT03598777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6812991|NCT03593252|Metronidazole|metronidazole|mesh-list
6812992|NCT03593252|Cefazolin|cefazolin|mesh-list
6812993|NCT03593252|Neomycin|neomycin|mesh-list
6812994|NCT03593252|Picosulfate sodium|picosulfate sodium|mesh-list
6812995|NCT03593252|Magnesium Oxide|magnesium oxide|mesh-list
6812996|NCT03593252|Citric Acid|citric acid|mesh-list
6812997|NCT03593252|Sodium Citrate|sodium citrate|mesh-list
6812998|NCT03593252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6812999|NCT03593252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6813000|NCT03593252|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6813001|NCT03593252|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6813002|NCT03593252|Cathartics|cathartics|mesh-ancestor
6813003|NCT03593252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6813004|NCT03593252|Anticoagulants|anticoagulants|mesh-ancestor
6813005|NCT03593252|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6813006|NCT03593252|Chelating Agents|chelating agents|mesh-ancestor
6813007|NCT03593252|Sequestering Agents|sequestering agents|mesh-ancestor
6813008|NCT03593252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6813009|NCT03593252|Antacids|antacids|mesh-ancestor
6813010|NCT03593252|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6813011|NCT03593252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6813012|NCT03582488|Corticosterone|corticosterone|mesh-list
6813013|NCT03582488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6813014|NCT03574792|Oxycodone|oxycodone|mesh-list
6813015|NCT03574792|Methadone|methadone|mesh-list
6813016|NCT03574792|Gabapentin|gabapentin|mesh-list
6813017|NCT03574792|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6813018|NCT03574792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6813019|NCT03574792|Narcotics|narcotics|mesh-ancestor
6813020|NCT03574792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6813021|NCT03574792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813022|NCT03574792|Analgesics|analgesics|mesh-ancestor
6813023|NCT03574792|Sensory System Agents|sensory system agents|mesh-ancestor
6813024|NCT03574792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6813025|NCT03574792|Anticonvulsants|anticonvulsants|mesh-ancestor
6813026|NCT03574792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6813027|NCT03574792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6813028|NCT03574792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6813029|NCT03574792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6813030|NCT03574792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6813031|NCT03574792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6813032|NCT03574792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6813033|NCT03574792|Antimanic Agents|antimanic agents|mesh-ancestor
6813034|NCT03574792|Antitussive Agents|antitussive agents|mesh-ancestor
6813035|NCT03574792|Respiratory System Agents|respiratory system agents|mesh-ancestor
6813036|NCT03574792|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6813037|NCT03574792|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6813038|NCT03574792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6813039|NCT03574792|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6813040|NCT03574792|Antidepressive Agents|antidepressive agents|mesh-ancestor
6813041|NCT03450707|Thiamine|thiamine|mesh-list
6813042|NCT03450707|Vitamins|vitamins|mesh-ancestor
6813043|NCT03450707|Micronutrients|micronutrients|mesh-ancestor
6813044|NCT03450707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813045|NCT03450707|Vitamin B Complex|vitamin b complex|mesh-ancestor
6813046|NCT03440450|Gemcitabine|gemcitabine|mesh-list
6813047|NCT03440450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6813048|NCT03440450|Antimetabolites|antimetabolites|mesh-ancestor
6813049|NCT03440450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6813050|NCT03440450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6813051|NCT03440450|Antiviral Agents|antiviral agents|mesh-ancestor
6813052|NCT03440450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6813053|NCT03440450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6813054|NCT03440450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6813055|NCT03440450|Immunologic Factors|immunologic factors|mesh-ancestor
6813056|NCT03440450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813057|NCT03391479|Avelumab|avelumab|mesh-list
6813058|NCT03391479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6813059|NCT03391479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6813060|NCT03368066|Cosyntropin|cosyntropin|mesh-list
6813061|NCT03368066|Hormones|hormones|mesh-ancestor
6813062|NCT03368066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6813063|NCT03368066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813064|NCT03365622|Acetaminophen|acetaminophen|mesh-list
6813065|NCT03365622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6813066|NCT03365622|Analgesics|analgesics|mesh-ancestor
6813067|NCT03365622|Sensory System Agents|sensory system agents|mesh-ancestor
6813068|NCT03365622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6813069|NCT03365622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813070|NCT03365622|Antipyretics|antipyretics|mesh-ancestor
6813071|NCT03361436|Halichondrin B|halichondrin b|mesh-list
6813072|NCT03361436|Tubulin Modulators|tubulin modulators|mesh-ancestor
6813073|NCT03361436|Antimitotic Agents|antimitotic agents|mesh-ancestor
6813074|NCT03361436|Mitosis Modulators|mitosis modulators|mesh-ancestor
6813075|NCT03361436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6813076|NCT03361436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6813077|NCT03356483|Niacin|niacin|mesh-list
6813078|NCT03356483|Nicotinic Acids|nicotinic acids|mesh-list
6813079|NCT03356483|Psilocybin|psilocybin|mesh-list
6813080|NCT03356483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6813081|NCT03356483|Antimetabolites|antimetabolites|mesh-ancestor
6813082|NCT03356483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6813083|NCT03356483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6813084|NCT03356483|Vasodilator Agents|vasodilator agents|mesh-ancestor
6813085|NCT03356483|Vitamin B Complex|vitamin b complex|mesh-ancestor
6813086|NCT03356483|Vitamins|vitamins|mesh-ancestor
6813087|NCT03356483|Micronutrients|micronutrients|mesh-ancestor
6813088|NCT03356483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813089|NCT03356483|Hallucinogens|hallucinogens|mesh-ancestor
6813090|NCT03356483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6813091|NCT03289650|Tacrolimus|tacrolimus|mesh-list
6813092|NCT03289650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6813093|NCT03289650|Immunologic Factors|immunologic factors|mesh-ancestor
6813094|NCT03289650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813095|NCT03289650|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6813096|NCT03289650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6813097|NCT03289650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6813098|NCT03276052|Bromides|bromides|mesh-list
6813099|NCT03276052|Anticonvulsants|anticonvulsants|mesh-ancestor
6813100|NCT03275857|Cisplatin|cisplatin|mesh-list
6813101|NCT03275857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6813102|NCT03265145|Cholinergic Agents|cholinergic agents|mesh-list
6813103|NCT03265145|Muscarinic Antagonists|muscarinic antagonists|mesh-list
6813104|NCT03265145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6813105|NCT03265145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6813106|NCT03265145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813107|NCT03265145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6813108|NCT03219437|Methotrexate|methotrexate|mesh-list
6813109|NCT03219437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6813110|NCT03219437|Abortifacient Agents|abortifacient agents|mesh-ancestor
6813111|NCT03219437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6813112|NCT03219437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813113|NCT03219437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6813114|NCT03219437|Antimetabolites|antimetabolites|mesh-ancestor
6813115|NCT03219437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6813116|NCT03219437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6813117|NCT03219437|Dermatologic Agents|dermatologic agents|mesh-ancestor
6813118|NCT03219437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6813119|NCT03219437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6813120|NCT03219437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6813121|NCT03219437|Immunologic Factors|immunologic factors|mesh-ancestor
6813122|NCT03219437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6813123|NCT03219437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6813124|NCT03202537|Dexlansoprazole|dexlansoprazole|mesh-list
6813125|NCT03202537|Lansoprazole|lansoprazole|mesh-list
6813126|NCT03202537|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6813127|NCT03202537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6813128|NCT03202537|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6813129|NCT03202537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6813130|NCT03202537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6813131|NCT03197935|Paclitaxel|paclitaxel|mesh-list
6813132|NCT03197935|Cyclophosphamide|cyclophosphamide|mesh-list
6813133|NCT03197935|Doxorubicin|doxorubicin|mesh-list
6813134|NCT03197935|Atezolizumab|atezolizumab|mesh-list
6813135|NCT03197935|Antibodies|antibodies|mesh-list
6813136|NCT03197935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6813137|NCT03197935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6813138|NCT03197935|Tubulin Modulators|tubulin modulators|mesh-ancestor
6813139|NCT03197935|Antimitotic Agents|antimitotic agents|mesh-ancestor
6813140|NCT03197935|Mitosis Modulators|mitosis modulators|mesh-ancestor
6813141|NCT03197935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6813142|NCT03197935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6813143|NCT03197935|Immunologic Factors|immunologic factors|mesh-ancestor
6813144|NCT03197935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813145|NCT03197935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6813146|NCT03197935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6813147|NCT03197935|Alkylating Agents|alkylating agents|mesh-ancestor
6813148|NCT03197935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6813149|NCT03197935|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6813150|NCT03197935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6813151|NCT03197935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6813152|NCT03197935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6813153|NCT03150511|Tesamorelin|tesamorelin|mesh-list
6813154|NCT03150511|Growth Substances|growth substances|mesh-ancestor
6813155|NCT03150511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813156|NCT03042819|Doxorubicin|doxorubicin|mesh-list
6813157|NCT03042819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6813158|NCT03042819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6813159|NCT03042819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6813160|NCT03042819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6813161|NCT03042819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6813162|NCT03042819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6813163|NCT03030222|Empagliflozin|empagliflozin|mesh-list
6813164|NCT03030222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6813165|NCT03030222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6813166|NCT03030222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6813167|NCT03030222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813168|NCT02892604|Insulin|insulin|mesh-list
6813169|NCT02892604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6813170|NCT02892604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813171|NCT02832687|Acetaminophen|acetaminophen|mesh-list
6813172|NCT02832687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6813173|NCT02832687|Analgesics|analgesics|mesh-ancestor
6813174|NCT02832687|Sensory System Agents|sensory system agents|mesh-ancestor
6813175|NCT02832687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6813176|NCT02832687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813177|NCT02832687|Antipyretics|antipyretics|mesh-ancestor
6813178|NCT02830477|Factor VIII|factor viii|mesh-list
6813179|NCT02830477|Coagulants|coagulants|mesh-ancestor
6813180|NCT02789345|Osimertinib|osimertinib|mesh-list
6813181|NCT02789345|Ramucirumab|ramucirumab|mesh-list
6813182|NCT02789345|Necitumumab|necitumumab|mesh-list
6813183|NCT02789345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6813184|NCT02789345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6813185|NCT02789345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6813186|NCT02789345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6813187|NCT02789345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6813188|NCT02703220|Acetazolamide|acetazolamide|mesh-list
6813189|NCT02703220|Finasteride|finasteride|mesh-list
6813190|NCT02703220|Anticonvulsants|anticonvulsants|mesh-ancestor
6813191|NCT02703220|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6813192|NCT02703220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6813193|NCT02703220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6813194|NCT02703220|Diuretics|diuretics|mesh-ancestor
6813195|NCT02703220|Natriuretic Agents|natriuretic agents|mesh-ancestor
6813196|NCT02703220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813197|NCT02703220|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6813198|NCT02703220|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6813199|NCT02703220|Hormone Antagonists|hormone antagonists|mesh-ancestor
6813200|NCT02703220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6813201|NCT02703220|Urological Agents|urological agents|mesh-ancestor
6813202|NCT02650986|Cyclophosphamide|cyclophosphamide|mesh-list
6813203|NCT02650986|Decitabine|decitabine|mesh-list
6813204|NCT02650986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6813205|NCT02650986|Immunologic Factors|immunologic factors|mesh-ancestor
6813206|NCT02650986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813207|NCT02650986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6813208|NCT02650986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6813209|NCT02650986|Alkylating Agents|alkylating agents|mesh-ancestor
6813210|NCT02650986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6813211|NCT02650986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6813212|NCT02650986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6813213|NCT02650986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6813214|NCT02650986|Antimetabolites|antimetabolites|mesh-ancestor
6813215|NCT02650986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6813216|NCT02568449|Nintedanib|nintedanib|mesh-list
6813217|NCT02568449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6813218|NCT02568449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6813219|NCT02568449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6813220|NCT02568449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6813221|NCT02546622|Factor VIII|factor viii|mesh-list
6813222|NCT02546622|Coagulants|coagulants|mesh-ancestor
6813223|NCT02542696|Apomorphine|apomorphine|mesh-list
6813224|NCT02542696|Emetics|emetics|mesh-ancestor
6813225|NCT02542696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813226|NCT02542696|Autonomic Agents|autonomic agents|mesh-ancestor
6813227|NCT02542696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6813228|NCT02542696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6813229|NCT02542696|Dopamine Agonists|dopamine agonists|mesh-ancestor
6813230|NCT02542696|Dopamine Agents|dopamine agents|mesh-ancestor
6813231|NCT02542696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6813232|NCT02542696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6813233|NCT02499900|Glatiramer Acetate|glatiramer acetate|mesh-list
6813234|NCT02499900|(T,G)-A-L|(t,g)-a-l|mesh-list
6813235|NCT02499900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6813236|NCT02499900|Immunologic Factors|immunologic factors|mesh-ancestor
6813237|NCT02499900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813238|NCT02499900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6813239|NCT02499900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6813240|NCT02286154|Hydroxyurea|hydroxyurea|mesh-list
6813241|NCT02286154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6813242|NCT02286154|Antisickling Agents|antisickling agents|mesh-ancestor
6813243|NCT02286154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6813244|NCT02286154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6813245|NCT02286154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6813246|NCT02269917|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
6813247|NCT02269917|Protease Inhibitors|protease inhibitors|mesh-list
6813248|NCT02269917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6813249|NCT02269917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6813250|NCT02269917|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6813251|NCT02269917|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6813252|NCT02269917|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6813253|NCT02269917|Antiviral Agents|antiviral agents|mesh-ancestor
6813254|NCT02269917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6813255|NCT02143388|Cisplatin|cisplatin|mesh-list
6813256|NCT02143388|Capecitabine|capecitabine|mesh-list
6813257|NCT02143388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6813258|NCT02143388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6813259|NCT02143388|Antimetabolites|antimetabolites|mesh-ancestor
6813260|NCT02143388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6813261|NCT02021773|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6813262|NCT02021773|Immunologic Factors|immunologic factors|mesh-ancestor
6813263|NCT02021773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813264|NCT01530997|Cisplatin|cisplatin|mesh-list
6813265|NCT01530997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6813266|NCT01331616|Bevacizumab|bevacizumab|mesh-list
6813267|NCT01331616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6813268|NCT01331616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6813269|NCT01331616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6813270|NCT01331616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6813271|NCT01331616|Growth Substances|growth substances|mesh-ancestor
6813272|NCT01331616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813273|NCT01331616|Growth Inhibitors|growth inhibitors|mesh-ancestor
6813274|NCT01109004|Dexamethasone|dexamethasone|mesh-list
6813275|NCT01109004|Lenalidomide|lenalidomide|mesh-list
6813276|NCT01109004|Bortezomib|bortezomib|mesh-list
6813277|NCT01109004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6813278|NCT01109004|Antiemetics|antiemetics|mesh-ancestor
6813279|NCT01109004|Autonomic Agents|autonomic agents|mesh-ancestor
6813280|NCT01109004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6813281|NCT01109004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813282|NCT01109004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6813283|NCT01109004|Glucocorticoids|glucocorticoids|mesh-ancestor
6813284|NCT01109004|Hormones|hormones|mesh-ancestor
6813285|NCT01109004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6813286|NCT01109004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6813287|NCT01109004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6813288|NCT01109004|Immunologic Factors|immunologic factors|mesh-ancestor
6813289|NCT01109004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6813290|NCT01109004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6813291|NCT01109004|Growth Substances|growth substances|mesh-ancestor
6813292|NCT01109004|Growth Inhibitors|growth inhibitors|mesh-ancestor
6813293|NCT01067521|Glatiramer Acetate|glatiramer acetate|mesh-list
6813294|NCT01067521|(T,G)-A-L|(t,g)-a-l|mesh-list
6813295|NCT01067521|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6813296|NCT01067521|Immunologic Factors|immunologic factors|mesh-ancestor
6813297|NCT01067521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813298|NCT01067521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6813299|NCT01067521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6813300|NCT00861705|Paclitaxel|paclitaxel|mesh-list
6813301|NCT00861705|Cyclophosphamide|cyclophosphamide|mesh-list
6813302|NCT00861705|Bevacizumab|bevacizumab|mesh-list
6813303|NCT00861705|Carboplatin|carboplatin|mesh-list
6813304|NCT00861705|Doxorubicin|doxorubicin|mesh-list
6813305|NCT00861705|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6813306|NCT00861705|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6813307|NCT00861705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6813308|NCT00861705|Antibodies|antibodies|mesh-list
6813309|NCT00861705|Immunoglobulins|immunoglobulins|mesh-list
6813310|NCT00861705|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6813311|NCT00861705|Immunoglobulin G|immunoglobulin g|mesh-list
6813312|NCT00861705|Endothelial Growth Factors|endothelial growth factors|mesh-list
6813313|NCT00861705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6813314|NCT00861705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6813315|NCT00861705|Tubulin Modulators|tubulin modulators|mesh-ancestor
6813316|NCT00861705|Antimitotic Agents|antimitotic agents|mesh-ancestor
6813317|NCT00861705|Mitosis Modulators|mitosis modulators|mesh-ancestor
6813318|NCT00861705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6813319|NCT00861705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6813320|NCT00861705|Immunologic Factors|immunologic factors|mesh-ancestor
6813321|NCT00861705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813322|NCT00861705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6813323|NCT00861705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6813324|NCT00861705|Alkylating Agents|alkylating agents|mesh-ancestor
6813325|NCT00861705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6813326|NCT00861705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6813327|NCT00861705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6813328|NCT00861705|Growth Substances|growth substances|mesh-ancestor
6813329|NCT00861705|Growth Inhibitors|growth inhibitors|mesh-ancestor
6813330|NCT00861705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6813331|NCT00861705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6813332|NCT00861705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6813333|NCT00861705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6813334|NCT00593905|Bosentan|bosentan|mesh-list
6813335|NCT00593905|Ambrisentan|ambrisentan|mesh-list
6813336|NCT00593905|Sitaxsentan|sitaxsentan|mesh-list
6813337|NCT00593905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6813338|NCT00593905|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6813339|NCT00593905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6813340|NCT00548912|Spironolactone|spironolactone|mesh-list
6813341|NCT00548912|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6813342|NCT00548912|Hormone Antagonists|hormone antagonists|mesh-ancestor
6813343|NCT00548912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6813344|NCT00548912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813345|NCT00548912|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6813346|NCT00548912|Diuretics|diuretics|mesh-ancestor
6813347|NCT00548912|Natriuretic Agents|natriuretic agents|mesh-ancestor
6813348|NCT00501826|Cytarabine|cytarabine|mesh-list
6813349|NCT00501826|6-methoxypurine arabinoside|6-methoxypurine arabinoside|mesh-list
6813350|NCT00501826|Dexamethasone|dexamethasone|mesh-list
6813351|NCT00501826|Dexamethasone acetate|dexamethasone acetate|mesh-list
6813352|NCT00501826|Prednisone|prednisone|mesh-list
6813353|NCT00501826|Cortisone|cortisone|mesh-list
6813354|NCT00501826|Cyclophosphamide|cyclophosphamide|mesh-list
6813355|NCT00501826|Doxorubicin|doxorubicin|mesh-list
6813356|NCT00501826|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6813357|NCT00501826|Methotrexate|methotrexate|mesh-list
6813358|NCT00501826|Vincristine|vincristine|mesh-list
6813359|NCT00501826|Asparaginase|asparaginase|mesh-list
6813360|NCT00501826|Venetoclax|venetoclax|mesh-list
6813361|NCT00501826|Mercaptopurine|mercaptopurine|mesh-list
6813362|NCT00501826|Pegaspargase|pegaspargase|mesh-list
6813363|NCT00501826|BB 1101|bb 1101|mesh-list
6813364|NCT00501826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6813365|NCT00501826|Immunologic Factors|immunologic factors|mesh-ancestor
6813366|NCT00501826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813367|NCT00501826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6813368|NCT00501826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6813369|NCT00501826|Alkylating Agents|alkylating agents|mesh-ancestor
6813370|NCT00501826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6813371|NCT00501826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6813372|NCT00501826|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6813373|NCT00501826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6813374|NCT00501826|Antiemetics|antiemetics|mesh-ancestor
6813375|NCT00501826|Autonomic Agents|autonomic agents|mesh-ancestor
6813376|NCT00501826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6813377|NCT00501826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6813378|NCT00501826|Glucocorticoids|glucocorticoids|mesh-ancestor
6813379|NCT00501826|Hormones|hormones|mesh-ancestor
6813380|NCT00501826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6813381|NCT00501826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6813382|NCT00501826|Protease Inhibitors|protease inhibitors|mesh-ancestor
6813383|NCT00501826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6813384|NCT00501826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6813385|NCT00501826|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6813386|NCT00501826|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6813387|NCT00501826|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6813388|NCT00501826|Abortifacient Agents|abortifacient agents|mesh-ancestor
6813389|NCT00501826|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6813390|NCT00501826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6813391|NCT00501826|Antimetabolites|antimetabolites|mesh-ancestor
6813392|NCT00501826|Dermatologic Agents|dermatologic agents|mesh-ancestor
6813393|NCT00501826|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6813394|NCT00501826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6813395|NCT00501826|Antiviral Agents|antiviral agents|mesh-ancestor
6813396|NCT00501826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6813397|NCT00501826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6813398|NCT00501826|Tubulin Modulators|tubulin modulators|mesh-ancestor
6813399|NCT00501826|Antimitotic Agents|antimitotic agents|mesh-ancestor
6813400|NCT00501826|Mitosis Modulators|mitosis modulators|mesh-ancestor
6813401|NCT05154136|Itraconazole|itraconazole|mesh-list
6813402|NCT05154136|Antifungal Agents|antifungal agents|mesh-ancestor
6813403|NCT05154136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6813404|NCT05154136|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6813405|NCT05154136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6813406|NCT05154136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6813407|NCT05154136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6813408|NCT05154136|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6813409|NCT05154136|Hormone Antagonists|hormone antagonists|mesh-ancestor
6813410|NCT05154136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6813411|NCT05154136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813412|NCT05154136|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6813413|NCT05153928|Norethindrone|norethindrone|mesh-list
6813414|NCT05153928|Norethindrone Acetate|norethindrone acetate|mesh-list
6813415|NCT05153928|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6813416|NCT05153928|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6813417|NCT05153928|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6813418|NCT05153928|Contraceptive Agents|contraceptive agents|mesh-ancestor
6813419|NCT05153928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6813420|NCT05153928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813421|NCT05153928|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6813422|NCT05153928|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6813423|NCT05153785|Lidocaine|lidocaine|mesh-list
6813424|NCT05153785|Anesthetics, Local|anesthetics, local|mesh-ancestor
6813425|NCT05153785|Anesthetics|anesthetics|mesh-ancestor
6813426|NCT05153785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6813427|NCT05153785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813428|NCT05153785|Sensory System Agents|sensory system agents|mesh-ancestor
6813429|NCT05153785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6813430|NCT05153785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6813431|NCT05153785|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6813432|NCT05153785|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6813433|NCT05153785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6813434|NCT05153785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6813435|NCT05153668|Everolimus|everolimus|mesh-list
6813436|NCT05153668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6813437|NCT05153668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6813438|NCT05153668|Immunologic Factors|immunologic factors|mesh-ancestor
6813439|NCT05153668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813440|NCT05153603|Olaparib|olaparib|mesh-list
6813441|NCT05153603|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6813442|NCT05153603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6813443|NCT05153603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6813444|NCT05153603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6813445|NCT05153486|Ethanol|ethanol|mesh-list
6813446|NCT05153486|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6813447|NCT05153486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6813448|NCT05153486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6813449|NCT05153486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813450|NCT05153304|Nivolumab|nivolumab|mesh-list
6813451|NCT05153304|Ipilimumab|ipilimumab|mesh-list
6813452|NCT05153304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6813453|NCT05153304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6813454|NCT05153304|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6813455|NCT05153304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6813456|NCT05153200|Adalimumab|adalimumab|mesh-list
6813457|NCT05153200|Upadacitinib|upadacitinib|mesh-list
6813458|NCT05153200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6813459|NCT05153200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6813460|NCT05153200|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
6813461|NCT05153200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6813462|NCT05153200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6813463|NCT05153200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6813464|NCT05153070|Cyclosporine|cyclosporine|mesh-list
6813465|NCT05153070|Cyclosporins|cyclosporins|mesh-list
6813466|NCT05153070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6813467|NCT05153070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6813468|NCT05153070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6813469|NCT05153070|Immunologic Factors|immunologic factors|mesh-ancestor
6813470|NCT05153070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813471|NCT05153070|Antifungal Agents|antifungal agents|mesh-ancestor
6813472|NCT05153070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6813473|NCT05153070|Dermatologic Agents|dermatologic agents|mesh-ancestor
5993576|NCT00123604|Autonomic Agents|autonomic agents|mesh-ancestor
5993577|NCT00123604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5993578|NCT00123604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993579|NCT00123604|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5993580|NCT00123604|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5993581|NCT00123604|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5993582|NCT00123604|Adrenergic Agents|adrenergic agents|mesh-ancestor
5993583|NCT00123604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5993584|NCT00123604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5993585|NCT00123604|Antioxidants|antioxidants|mesh-ancestor
5993586|NCT00123604|Protective Agents|protective agents|mesh-ancestor
5993587|NCT00123604|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5993588|NCT00123604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6813474|NCT05153070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6813475|NCT05153070|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6813476|NCT05152940|Ertugliflozin|ertugliflozin|mesh-list
6813477|NCT05152940|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6813478|NCT05152940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6813479|NCT05152940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6813480|NCT05152940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813481|NCT05152901|Epinephrine|epinephrine|mesh-list
6813482|NCT05152901|Racepinephrine|racepinephrine|mesh-list
6813483|NCT05152901|Epinephryl borate|epinephryl borate|mesh-list
6813484|NCT05152901|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6813485|NCT05152901|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6813486|NCT05152901|Adrenergic Agents|adrenergic agents|mesh-ancestor
6813487|NCT05152901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6813488|NCT05152901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6813489|NCT05152901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813490|NCT05152901|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6813491|NCT05152901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6813492|NCT05152901|Autonomic Agents|autonomic agents|mesh-ancestor
6813493|NCT05152901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6813494|NCT05152901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6813495|NCT05152901|Respiratory System Agents|respiratory system agents|mesh-ancestor
6813496|NCT05152901|Mydriatics|mydriatics|mesh-ancestor
6813497|NCT05152901|Sympathomimetics|sympathomimetics|mesh-ancestor
6813498|NCT05152901|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6813499|NCT05152667|Dienogest|dienogest|mesh-list
6813500|NCT05152667|Levonorgestrel|levonorgestrel|mesh-list
6813501|NCT05152667|Progestins|progestins|mesh-list
6813502|NCT05152667|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6813503|NCT05152667|Contraceptive Agents|contraceptive agents|mesh-ancestor
6813504|NCT05152667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6813505|NCT05152667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813506|NCT05152667|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6813507|NCT05152667|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6813508|NCT05152667|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6813509|NCT05152667|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6813510|NCT05152667|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6813511|NCT05152667|Hormone Antagonists|hormone antagonists|mesh-ancestor
6813512|NCT05152667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6813513|NCT05152667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6813514|NCT05152667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6813515|NCT05152667|Hormones|hormones|mesh-ancestor
6813516|NCT05152511|Pentoxifylline|pentoxifylline|mesh-list
6813517|NCT05152511|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6813518|NCT05152511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6813519|NCT05152511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6813520|NCT05152511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6813521|NCT05152511|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6813522|NCT05152511|Protective Agents|protective agents|mesh-ancestor
6813523|NCT05152511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813524|NCT05152511|Vasodilator Agents|vasodilator agents|mesh-ancestor
6813525|NCT05152511|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6813526|NCT05152511|Antioxidants|antioxidants|mesh-ancestor
6813527|NCT05132985|Carboplatin|carboplatin|mesh-list
6813528|NCT05132985|Pemetrexed|pemetrexed|mesh-list
6813529|NCT05132985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6813530|NCT05132985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6813531|NCT05132985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6813532|NCT05132985|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6813533|NCT05132985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6813534|NCT05118399|Bupivacaine|bupivacaine|mesh-list
6813535|NCT05118399|Anesthetics, Local|anesthetics, local|mesh-ancestor
6813536|NCT05118399|Anesthetics|anesthetics|mesh-ancestor
6813537|NCT05118399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6813538|NCT05118399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813539|NCT05118399|Sensory System Agents|sensory system agents|mesh-ancestor
6813540|NCT05118399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6813541|NCT05111821|Deferiprone|deferiprone|mesh-list
6813542|NCT05111821|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6813543|NCT05111821|Chelating Agents|chelating agents|mesh-ancestor
6813544|NCT05111821|Sequestering Agents|sequestering agents|mesh-ancestor
6813545|NCT05111821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258711|NCT03096444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6813546|NCT05096468|Pregabalin|pregabalin|mesh-list
6813547|NCT05096468|Ketamine|ketamine|mesh-list
6813548|NCT05096468|Esketamine|esketamine|mesh-list
6813549|NCT05096468|Analgesics|analgesics|mesh-ancestor
6813550|NCT05096468|Sensory System Agents|sensory system agents|mesh-ancestor
6813551|NCT05096468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6813552|NCT05096468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813553|NCT05096468|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6813554|NCT05096468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6813555|NCT05096468|Anesthetics, General|anesthetics, general|mesh-ancestor
6813556|NCT05096468|Anesthetics|anesthetics|mesh-ancestor
6813557|NCT05096468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6813558|NCT05096468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6813559|NCT05096468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6813560|NCT05096468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6813561|NCT05096468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6813562|NCT05096468|Anticonvulsants|anticonvulsants|mesh-ancestor
6813563|NCT05096468|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6813564|NCT05096468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6813565|NCT05096468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6813566|NCT05096468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6813567|NCT05096468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6813568|NCT05096468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6813569|NCT05096468|Antidepressive Agents|antidepressive agents|mesh-ancestor
6813570|NCT05095922|Valsartan|valsartan|mesh-list
6813571|NCT05095922|Calcium Dobesilate|calcium dobesilate|mesh-list
6813572|NCT05095922|Calcium|calcium|mesh-list
6813573|NCT05095922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6813574|NCT05095922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813575|NCT05095922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6813576|NCT05095922|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6813577|NCT05095922|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6813578|NCT05095922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6813579|NCT05095922|Hemostatics|hemostatics|mesh-ancestor
6813580|NCT05095922|Coagulants|coagulants|mesh-ancestor
6813581|NCT05092698|Vitamin D|vitamin d|mesh-list
6813582|NCT05092698|Cholecalciferol|cholecalciferol|mesh-list
6813583|NCT05092698|Vitamins|vitamins|mesh-ancestor
6813584|NCT05092698|Micronutrients|micronutrients|mesh-ancestor
6813585|NCT05092698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813586|NCT05092698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6813587|NCT05092698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6813588|NCT05090033|Ofatumumab|ofatumumab|mesh-list
6813589|NCT05090033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6813590|NCT05054348|Pembrolizumab|pembrolizumab|mesh-list
6813591|NCT05054348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6813592|NCT05054348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6813593|NCT05010304|Amoxicillin|amoxicillin|mesh-list
6813594|NCT05010304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6813595|NCT05010304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6813596|NCT04947631|Tadalafil|tadalafil|mesh-list
6813597|NCT04947631|Dutasteride|dutasteride|mesh-list
6813598|NCT04947631|Vasodilator Agents|vasodilator agents|mesh-ancestor
6813599|NCT04947631|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6813600|NCT04947631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6813601|NCT04947631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6813602|NCT04947631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6813603|NCT04947631|Urological Agents|urological agents|mesh-ancestor
6813604|NCT04947631|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6813605|NCT04947631|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6813606|NCT04947631|Hormone Antagonists|hormone antagonists|mesh-ancestor
6813607|NCT04947631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6813608|NCT04947631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813609|NCT04916938|Psychotropic Drugs|psychotropic drugs|mesh-list
6813610|NCT04905316|Durvalumab|durvalumab|mesh-list
6813611|NCT04905316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6813612|NCT04905316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6813613|NCT04897022|Pembrolizumab|pembrolizumab|mesh-list
6813614|NCT04897022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6813615|NCT04897022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6813616|NCT04884893|Nitrous Oxide|nitrous oxide|mesh-list
6813617|NCT04884893|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6813618|NCT04884893|Anesthetics, General|anesthetics, general|mesh-ancestor
6813619|NCT04884893|Anesthetics|anesthetics|mesh-ancestor
6813620|NCT04884893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6813621|NCT04884893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813622|NCT04884893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6813623|NCT04884893|Analgesics|analgesics|mesh-ancestor
6813624|NCT04884893|Sensory System Agents|sensory system agents|mesh-ancestor
6813625|NCT04884893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6813626|NCT04883242|Dexamethasone|dexamethasone|mesh-list
6813627|NCT04883242|Dexamethasone acetate|dexamethasone acetate|mesh-list
6813628|NCT04883242|Pomalidomide|pomalidomide|mesh-list
6813629|NCT04883242|Ichthammol|ichthammol|mesh-list
6813630|NCT04883242|BB 1101|bb 1101|mesh-list
6813631|NCT04883242|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6813632|NCT04883242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6813633|NCT04883242|Antiemetics|antiemetics|mesh-ancestor
6813634|NCT04883242|Autonomic Agents|autonomic agents|mesh-ancestor
6813635|NCT04883242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6813636|NCT04883242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813637|NCT04883242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6813638|NCT04883242|Glucocorticoids|glucocorticoids|mesh-ancestor
6813639|NCT04883242|Hormones|hormones|mesh-ancestor
6813640|NCT04883242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6813641|NCT04883242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6813642|NCT04883242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6813643|NCT04883242|Protease Inhibitors|protease inhibitors|mesh-ancestor
6813644|NCT04883242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6813645|NCT04883242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6813646|NCT04883242|Immunologic Factors|immunologic factors|mesh-ancestor
6813647|NCT04883242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6813648|NCT04883242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6813649|NCT04883242|Growth Substances|growth substances|mesh-ancestor
6813650|NCT04883242|Growth Inhibitors|growth inhibitors|mesh-ancestor
6813651|NCT04883242|Dermatologic Agents|dermatologic agents|mesh-ancestor
6813652|NCT04877379|Ceftibuten|ceftibuten|mesh-list
6813653|NCT04877379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6813654|NCT04877379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6813655|NCT04852679|Lanreotide|lanreotide|mesh-list
6813656|NCT04852679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6813657|NCT04814446|Vaccines|vaccines|mesh-list
6813658|NCT04814446|Immunologic Factors|immunologic factors|mesh-ancestor
6813659|NCT04814446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813660|NCT04778267|Dexamethasone|dexamethasone|mesh-list
6813661|NCT04778267|Bupivacaine|bupivacaine|mesh-list
6813662|NCT04778267|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
6813663|NCT04778267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6813664|NCT04778267|Antiemetics|antiemetics|mesh-ancestor
6813665|NCT04778267|Autonomic Agents|autonomic agents|mesh-ancestor
6813666|NCT04778267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6813667|NCT04778267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813668|NCT04778267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6813669|NCT04778267|Glucocorticoids|glucocorticoids|mesh-ancestor
6813670|NCT04778267|Hormones|hormones|mesh-ancestor
6813671|NCT04778267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6813672|NCT04778267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6813673|NCT04778267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6813674|NCT04778267|Anesthetics, Local|anesthetics, local|mesh-ancestor
6813675|NCT04778267|Anesthetics|anesthetics|mesh-ancestor
6813676|NCT04778267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6813677|NCT04778267|Sensory System Agents|sensory system agents|mesh-ancestor
6813678|NCT04760717|Spironolactone|spironolactone|mesh-list
6813679|NCT04760717|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6813680|NCT04760717|Hormone Antagonists|hormone antagonists|mesh-ancestor
6813681|NCT04760717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6813682|NCT04760717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813683|NCT04760717|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6813684|NCT04760717|Diuretics|diuretics|mesh-ancestor
6813685|NCT04760717|Natriuretic Agents|natriuretic agents|mesh-ancestor
6813686|NCT04732182|Donepezil|donepezil|mesh-list
6813687|NCT04732182|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6813688|NCT04732182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6813689|NCT04732182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6813690|NCT04732182|Cholinergic Agents|cholinergic agents|mesh-ancestor
6813691|NCT04732182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6813692|NCT04732182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813693|NCT04732182|Nootropic Agents|nootropic agents|mesh-ancestor
6813694|NCT04702256|Mycophenolic Acid|mycophenolic acid|mesh-list
6813695|NCT04702256|Prednisone|prednisone|mesh-list
6813696|NCT04702256|Methylprednisolone|methylprednisolone|mesh-list
6813697|NCT04702256|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6813698|NCT04702256|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6813699|NCT04702256|Prednisolone|prednisolone|mesh-list
6813700|NCT04702256|Prednisolone acetate|prednisolone acetate|mesh-list
6813701|NCT04702256|Obinutuzumab|obinutuzumab|mesh-list
6813702|NCT04702256|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6813703|NCT04702256|Prednisolone phosphate|prednisolone phosphate|mesh-list
6813704|NCT04702256|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
6813705|NCT04702256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6813706|NCT04702256|Glucocorticoids|glucocorticoids|mesh-ancestor
6813707|NCT04702256|Hormones|hormones|mesh-ancestor
6813708|NCT04702256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6813709|NCT04702256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813710|NCT04702256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6813711|NCT04702256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6813712|NCT04702256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6813713|NCT04702256|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6813714|NCT04702256|Antitubercular Agents|antitubercular agents|mesh-ancestor
6813715|NCT04702256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6813716|NCT04702256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6813717|NCT04702256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6813718|NCT04702256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6813719|NCT04702256|Antiemetics|antiemetics|mesh-ancestor
6813720|NCT04702256|Autonomic Agents|autonomic agents|mesh-ancestor
6813721|NCT04702256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6813722|NCT04702256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6813723|NCT04702256|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6813724|NCT04702256|Protective Agents|protective agents|mesh-ancestor
6813725|NCT04702256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6813726|NCT04702256|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6813727|NCT04702256|Histamine Antagonists|histamine antagonists|mesh-ancestor
6813728|NCT04702256|Histamine Agents|histamine agents|mesh-ancestor
6813729|NCT04702256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6813730|NCT04688814|Morphine|morphine|mesh-list
6813731|NCT04688814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6813732|NCT04688814|Narcotics|narcotics|mesh-ancestor
6813733|NCT04688814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6813734|NCT04688814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813735|NCT04688814|Analgesics|analgesics|mesh-ancestor
6813736|NCT04688814|Sensory System Agents|sensory system agents|mesh-ancestor
6813737|NCT04688814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6813738|NCT04638634|Immunoglobulins|immunoglobulins|mesh-list
6813739|NCT04638634|Immunologic Factors|immunologic factors|mesh-ancestor
6813740|NCT04638634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813741|NCT04624854|Aspirin|aspirin|mesh-list
6813742|NCT04624854|Clopidogrel|clopidogrel|mesh-list
6813743|NCT04624854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6813744|NCT04624854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6813745|NCT04624854|Analgesics|analgesics|mesh-ancestor
6813746|NCT04624854|Sensory System Agents|sensory system agents|mesh-ancestor
6813747|NCT04624854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6813748|NCT04624854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813749|NCT04624854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6813750|NCT04624854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6813751|NCT04624854|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6813752|NCT04624854|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6813753|NCT04624854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6813754|NCT04624854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6813755|NCT04624854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6813756|NCT04624854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6813757|NCT04624854|Antipyretics|antipyretics|mesh-ancestor
6813758|NCT04624854|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6813759|NCT04624854|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6813760|NCT04624854|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6813761|NCT04624854|Purinergic Agents|purinergic agents|mesh-ancestor
6813762|NCT04624854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6813763|NCT05259722|Alitretinoin|alitretinoin|mesh-list
6813764|NCT05259722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6813765|NCT05259722|Dermatologic Agents|dermatologic agents|mesh-ancestor
6813766|NCT05259709|Cemiplimab|cemiplimab|mesh-list
6813767|NCT05259709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6813768|NCT05259709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6813769|NCT05259696|Pembrolizumab|pembrolizumab|mesh-list
6813770|NCT05259696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6813771|NCT05259696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6813772|NCT05259631|Propofol|propofol|mesh-list
6813773|NCT05259631|Sevoflurane|sevoflurane|mesh-list
6813774|NCT05259631|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6813775|NCT05259631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6813776|NCT05259631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813777|NCT05259631|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6813778|NCT05259631|Anesthetics, General|anesthetics, general|mesh-ancestor
6813779|NCT05259631|Anesthetics|anesthetics|mesh-ancestor
6813780|NCT05259631|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6813781|NCT05259631|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6813782|NCT05259566|Menthol|menthol|mesh-list
6813783|NCT05259566|Antipruritics|antipruritics|mesh-ancestor
6813784|NCT05259566|Dermatologic Agents|dermatologic agents|mesh-ancestor
6813785|NCT05259527|Vitamin D|vitamin d|mesh-list
6813786|NCT05259527|Ergocalciferols|ergocalciferols|mesh-list
6813787|NCT05259527|Cholecalciferol|cholecalciferol|mesh-list
6813788|NCT05259527|Vitamins|vitamins|mesh-list
6813789|NCT05259527|Micronutrients|micronutrients|mesh-ancestor
6813790|NCT05259527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813791|NCT05259527|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6813792|NCT05259527|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6813793|NCT05259319|Atezolizumab|atezolizumab|mesh-list
6813794|NCT05259319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6813795|NCT05259241|Thrombin|thrombin|mesh-list
6813796|NCT05259241|Hemostatics|hemostatics|mesh-ancestor
6813797|NCT05259241|Coagulants|coagulants|mesh-ancestor
6813798|NCT05259137|Enalapril|enalapril|mesh-list
6813799|NCT05259137|Enalaprilat|enalaprilat|mesh-list
6813800|NCT05259137|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6813801|NCT05259137|Protease Inhibitors|protease inhibitors|mesh-ancestor
6813802|NCT05259137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6813803|NCT05259137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6813804|NCT05259137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6813805|NCT05259098|Sufentanil|sufentanil|mesh-list
6813806|NCT05259098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6813807|NCT05259098|Narcotics|narcotics|mesh-ancestor
6813808|NCT05259098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6813809|NCT05259098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813810|NCT05259098|Analgesics|analgesics|mesh-ancestor
6813811|NCT05259098|Sensory System Agents|sensory system agents|mesh-ancestor
6813812|NCT05259098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6813813|NCT05259098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6813814|NCT05259098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6813815|NCT05259098|Anesthetics, General|anesthetics, general|mesh-ancestor
6813816|NCT05259098|Anesthetics|anesthetics|mesh-ancestor
6813817|NCT05259046|Vitamin K 2|vitamin k 2|mesh-list
6813818|NCT05259046|Vitamin K|vitamin k|mesh-list
6813819|NCT05259046|Vitamin MK 7|vitamin mk 7|mesh-list
6813820|NCT05259046|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6813821|NCT05259046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6813822|NCT05259046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6813823|NCT05259046|Hemostatics|hemostatics|mesh-ancestor
6813824|NCT05259046|Coagulants|coagulants|mesh-ancestor
6813825|NCT05259046|Vitamins|vitamins|mesh-ancestor
6813826|NCT05259046|Micronutrients|micronutrients|mesh-ancestor
6813827|NCT05259046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813828|NCT05259007|Amoxicillin|amoxicillin|mesh-list
6813829|NCT05259007|Clarithromycin|clarithromycin|mesh-list
6813830|NCT05259007|Propolis|propolis|mesh-list
6813831|NCT05259007|Lansoprazole|lansoprazole|mesh-list
6813832|NCT05259007|Dexlansoprazole|dexlansoprazole|mesh-list
6813833|NCT05259007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6813834|NCT05259007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6813835|NCT05259007|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6813836|NCT05259007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6813837|NCT05259007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6813838|NCT05259007|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6813839|NCT05259007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6813840|NCT05259007|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6813841|NCT05259007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6813842|NCT05259007|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6813843|NCT05258955|Chlorhexidine|chlorhexidine|mesh-list
6813844|NCT05258955|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6813845|NCT05258955|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6813846|NCT05258955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6813847|NCT05258955|Disinfectants|disinfectants|mesh-ancestor
6813848|NCT05258955|Dermatologic Agents|dermatologic agents|mesh-ancestor
6813849|NCT05258851|Ceftazidime|ceftazidime|mesh-list
6813850|NCT05258851|Colistin|colistin|mesh-list
6813851|NCT05258851|Avibactam|avibactam|mesh-list
6813852|NCT05258851|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
6813853|NCT05258851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6813854|NCT05258851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6813855|NCT05258851|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6813856|NCT05258851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6813857|NCT05258851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6813858|NCT05258799|Cytarabine|cytarabine|mesh-list
6813859|NCT05258799|Decitabine|decitabine|mesh-list
6813860|NCT05258799|Aclarubicin|aclarubicin|mesh-list
6813861|NCT05258799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6813862|NCT05258799|Antimetabolites|antimetabolites|mesh-ancestor
6813863|NCT05258799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6813864|NCT05258799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6813865|NCT05258799|Antiviral Agents|antiviral agents|mesh-ancestor
6813866|NCT05258799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6813867|NCT05258799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6813868|NCT05258799|Immunologic Factors|immunologic factors|mesh-ancestor
6813869|NCT05258799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813870|NCT05258799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6813871|NCT05258799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6813872|NCT05258799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6813873|NCT05258799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6813874|NCT05258773|Azasetron|azasetron|mesh-list
6813875|NCT05258773|Antiemetics|antiemetics|mesh-ancestor
6813876|NCT05258773|Autonomic Agents|autonomic agents|mesh-ancestor
6813877|NCT05258773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6813878|NCT05258773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813879|NCT05258773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6813880|NCT05258773|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6813881|NCT05258773|Serotonin Agents|serotonin agents|mesh-ancestor
6813882|NCT05258773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6813883|NCT05258773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6813884|NCT05258747|Olaparib|olaparib|mesh-list
6813885|NCT05258747|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6813886|NCT05258747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6813887|NCT05258747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6813888|NCT05258747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6813889|NCT05258721|Fluorides|fluorides|mesh-list
6813890|NCT05258721|Cariostatic Agents|cariostatic agents|mesh-ancestor
6813891|NCT05258721|Protective Agents|protective agents|mesh-ancestor
6813892|NCT05258721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813893|NCT05258682|Acetylcysteine|acetylcysteine|mesh-list
6813894|NCT05258682|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6813895|NCT05258682|Antiviral Agents|antiviral agents|mesh-ancestor
6813896|NCT05258682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6813897|NCT05258682|Expectorants|expectorants|mesh-ancestor
6813898|NCT05258682|Respiratory System Agents|respiratory system agents|mesh-ancestor
6813899|NCT05258682|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6813900|NCT05258682|Antioxidants|antioxidants|mesh-ancestor
6813901|NCT05258682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6813902|NCT05258682|Protective Agents|protective agents|mesh-ancestor
5993589|NCT00123604|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5993590|NCT00123604|Vasodilator Agents|vasodilator agents|mesh-ancestor
5993591|NCT00123604|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5993592|NCT00123604|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5993593|NCT00123630|Omalizumab|omalizumab|mesh-list
5993594|NCT00123630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5993595|NCT00123630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5993596|NCT00123630|Respiratory System Agents|respiratory system agents|mesh-ancestor
5993597|NCT00123643|Rosiglitazone|rosiglitazone|mesh-list
6813903|NCT05258682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813904|NCT05258682|Antidotes|antidotes|mesh-ancestor
6813905|NCT05258565|Plasminogen|plasminogen|mesh-list
6813906|NCT05258565|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6813907|NCT05258565|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5993598|NCT00123643|Glyburide|glyburide|mesh-list
6813908|NCT05258565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6813909|NCT05258565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6813910|NCT05258474|Niacinamide|niacinamide|mesh-list
6813911|NCT05258474|Niacin|niacin|mesh-list
6813912|NCT05258474|Nicotinic Acids|nicotinic acids|mesh-list
6813913|NCT05258474|Vitamin B Complex|vitamin b complex|mesh-ancestor
6813914|NCT05258474|Vitamins|vitamins|mesh-ancestor
6813915|NCT05258474|Micronutrients|micronutrients|mesh-ancestor
6813916|NCT05258474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813917|NCT05258474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6813918|NCT05258474|Antimetabolites|antimetabolites|mesh-ancestor
6813919|NCT05258474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6813920|NCT05258474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6813921|NCT05258474|Vasodilator Agents|vasodilator agents|mesh-ancestor
6813922|NCT05258292|Insulin|insulin|mesh-list
6813923|NCT05258292|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6813924|NCT05258292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813925|NCT05258279|Carboplatin|carboplatin|mesh-list
6813926|NCT05258279|Pembrolizumab|pembrolizumab|mesh-list
6813927|NCT05258279|Pemetrexed|pemetrexed|mesh-list
6813928|NCT05258279|Lenvatinib|lenvatinib|mesh-list
6813929|NCT05258279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6813930|NCT05258279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6813931|NCT05258279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6813932|NCT05258279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6813933|NCT05258279|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6813934|NCT05258279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6813935|NCT05258279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6813936|NCT05258136|Antibodies|antibodies|mesh-list
6813937|NCT05258136|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6813938|NCT05258136|Immunologic Factors|immunologic factors|mesh-ancestor
6813939|NCT05258136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813940|NCT05258110|Midazolam|midazolam|mesh-list
6813941|NCT05258110|BI 425809|bi 425809|mesh-list
6813942|NCT05258110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6813943|NCT05258110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6813944|NCT05258110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6813945|NCT05258110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813946|NCT05258110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6813947|NCT05258110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6813948|NCT05258110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6813949|NCT05258110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6813950|NCT05258110|Anesthetics, General|anesthetics, general|mesh-ancestor
6813951|NCT05258110|Anesthetics|anesthetics|mesh-ancestor
6813952|NCT05258110|GABA Modulators|gaba modulators|mesh-ancestor
6813953|NCT05258110|GABA Agents|gaba agents|mesh-ancestor
6813954|NCT05258110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6813955|NCT05258110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6813956|NCT05258110|Nootropic Agents|nootropic agents|mesh-ancestor
6813957|NCT05258045|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6813958|NCT05258045|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6813959|NCT05258045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6813960|NCT05257447|Baclofen|baclofen|mesh-list
6813961|NCT05257447|Chlorzoxazone|chlorzoxazone|mesh-list
6813962|NCT05257447|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6813963|NCT05257447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813964|NCT05257447|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6813965|NCT05257447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6813966|NCT05257447|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6813967|NCT05257447|GABA Agonists|gaba agonists|mesh-ancestor
6813968|NCT05257447|GABA Agents|gaba agents|mesh-ancestor
6813969|NCT05257447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6813970|NCT05257447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6813971|NCT05257148|Nebivolol|nebivolol|mesh-list
6813972|NCT05257148|Zofenopril|zofenopril|mesh-list
6813973|NCT05257148|Captopril|captopril|mesh-list
6813974|NCT05257148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6813975|NCT05257148|Vasodilator Agents|vasodilator agents|mesh-ancestor
6813976|NCT05257148|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6813977|NCT05257148|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6813978|NCT05257148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6813979|NCT05257148|Adrenergic Agents|adrenergic agents|mesh-ancestor
6813980|NCT05257148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6813981|NCT05257148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6813982|NCT05257148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813983|NCT05257148|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6813984|NCT05257148|Protease Inhibitors|protease inhibitors|mesh-ancestor
6813985|NCT05257148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6813986|NCT05256056|Bupivacaine|bupivacaine|mesh-list
6813987|NCT05256056|Anesthetics, Local|anesthetics, local|mesh-ancestor
6813988|NCT05256056|Anesthetics|anesthetics|mesh-ancestor
6813989|NCT05256056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6813990|NCT05256056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6813991|NCT05256056|Sensory System Agents|sensory system agents|mesh-ancestor
6813992|NCT05256056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6813993|NCT05250141|Levodopa|levodopa|mesh-list
6813994|NCT05250141|Carbidopa|carbidopa|mesh-list
6813995|NCT05250141|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6813996|NCT05250141|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6813997|NCT05250141|Dopamine Agents|dopamine agents|mesh-ancestor
6813998|NCT05250141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6813999|NCT05250141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814000|NCT05250141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6814001|NCT05250141|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6814002|NCT05250141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6814003|NCT05242029|Psilocybin|psilocybin|mesh-list
6814004|NCT05242029|Hallucinogens|hallucinogens|mesh-ancestor
6814005|NCT05242029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6814006|NCT05242029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6814007|NCT05233696|Paclitaxel|paclitaxel|mesh-list
6814008|NCT05233696|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6814009|NCT05233696|Pembrolizumab|pembrolizumab|mesh-list
6814010|NCT05233696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6814011|NCT05233696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814012|NCT05233696|Tubulin Modulators|tubulin modulators|mesh-ancestor
6814013|NCT05233696|Antimitotic Agents|antimitotic agents|mesh-ancestor
6814014|NCT05233696|Mitosis Modulators|mitosis modulators|mesh-ancestor
6814015|NCT05233696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814016|NCT05233696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6814017|NCT05232357|Sodium thiosulfate|sodium thiosulfate|mesh-list
6814018|NCT05232357|Methylene Blue|methylene blue|mesh-list
6814019|NCT05232357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6814020|NCT05232357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814021|NCT05232357|Antidotes|antidotes|mesh-ancestor
6814022|NCT05232357|Protective Agents|protective agents|mesh-ancestor
6814023|NCT05232357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6814024|NCT05232357|Antioxidants|antioxidants|mesh-ancestor
6814025|NCT05232357|Antitubercular Agents|antitubercular agents|mesh-ancestor
6814026|NCT05232357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6814027|NCT05232357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6814028|NCT05232357|Chelating Agents|chelating agents|mesh-ancestor
6814029|NCT05232357|Sequestering Agents|sequestering agents|mesh-ancestor
6814030|NCT05231980|Thioctic Acid|thioctic acid|mesh-list
6814031|NCT05231980|Pentoxifylline|pentoxifylline|mesh-list
6814032|NCT05231980|Clomiphene|clomiphene|mesh-list
6814033|NCT05231980|Enclomiphene|enclomiphene|mesh-list
6536388|NCT00816868|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6536389|NCT00816868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6536390|NCT00816868|Antimetabolites|antimetabolites|mesh-ancestor
6536391|NCT00816868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536392|NCT00816868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6536393|NCT00816868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6536394|NCT00816868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6536395|NCT00816894|Olanzapine|olanzapine|mesh-list
6536396|NCT00816894|Antiemetics|antiemetics|mesh-ancestor
6536397|NCT00816894|Autonomic Agents|autonomic agents|mesh-ancestor
6536398|NCT00816894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6536399|NCT00816894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536400|NCT00816894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6536401|NCT00816894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6536402|NCT00816894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6536403|NCT00816894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6536404|NCT00816894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6536405|NCT00816894|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6536406|NCT00816894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6536407|NCT00816894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6536408|NCT00816894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536409|NCT00816894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6536410|NCT00816894|Serotonin Agents|serotonin agents|mesh-ancestor
6536411|NCT00816959|Bleomycin|bleomycin|mesh-list
6814034|NCT05231980|Zuclomiphene|zuclomiphene|mesh-list
6814035|NCT05231980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814036|NCT05231980|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6814037|NCT05231980|Hormone Antagonists|hormone antagonists|mesh-ancestor
6814038|NCT05231980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6814039|NCT05231980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6814040|NCT05231980|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6814041|NCT05231980|Fertility Agents|fertility agents|mesh-ancestor
6814042|NCT05231980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6814043|NCT05231980|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6814044|NCT05231980|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6814045|NCT05231980|Antioxidants|antioxidants|mesh-ancestor
6814046|NCT05231980|Protective Agents|protective agents|mesh-ancestor
6814047|NCT05231980|Vitamin B Complex|vitamin b complex|mesh-ancestor
6814048|NCT05231980|Vitamins|vitamins|mesh-ancestor
6814049|NCT05231980|Micronutrients|micronutrients|mesh-ancestor
6814050|NCT05231980|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6814051|NCT05231980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6814052|NCT05231980|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6814053|NCT05231980|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6814054|NCT05231980|Vasodilator Agents|vasodilator agents|mesh-ancestor
6814055|NCT05231980|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6814056|NCT05231629|Dexamethasone|dexamethasone|mesh-list
6814057|NCT05231629|Dexamethasone acetate|dexamethasone acetate|mesh-list
6814058|NCT05231629|Melphalan|melphalan|mesh-list
6814059|NCT05231629|Lenalidomide|lenalidomide|mesh-list
6814060|NCT05231629|Bortezomib|bortezomib|mesh-list
6814061|NCT05231629|Daratumumab|daratumumab|mesh-list
6814062|NCT05231629|BB 1101|bb 1101|mesh-list
6814063|NCT05231629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6814064|NCT05231629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6814065|NCT05231629|Antiemetics|antiemetics|mesh-ancestor
6814066|NCT05231629|Autonomic Agents|autonomic agents|mesh-ancestor
6814067|NCT05231629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6814068|NCT05231629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6814069|NCT05231629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6814070|NCT05231629|Glucocorticoids|glucocorticoids|mesh-ancestor
6814071|NCT05231629|Hormones|hormones|mesh-ancestor
6814072|NCT05231629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6814073|NCT05231629|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6814074|NCT05231629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814075|NCT05231629|Protease Inhibitors|protease inhibitors|mesh-ancestor
6814076|NCT05231629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6814077|NCT05231629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814078|NCT05231629|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6814079|NCT05231629|Alkylating Agents|alkylating agents|mesh-ancestor
6814080|NCT05231629|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6814081|NCT05231629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6814082|NCT05231629|Immunologic Factors|immunologic factors|mesh-ancestor
6814083|NCT05231629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6814084|NCT05231629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6814085|NCT05231629|Growth Substances|growth substances|mesh-ancestor
6814086|NCT05231629|Growth Inhibitors|growth inhibitors|mesh-ancestor
6814087|NCT05222139|Vaccines|vaccines|mesh-list
6814088|NCT05222139|Immunologic Factors|immunologic factors|mesh-ancestor
6814089|NCT05222139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6814090|NCT05218668|Fasudil|fasudil|mesh-list
6814091|NCT05218668|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6814092|NCT05218668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6814093|NCT05218668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814094|NCT05218668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6814095|NCT05218668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6814096|NCT05218668|Vasodilator Agents|vasodilator agents|mesh-ancestor
6814097|NCT05218668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6814098|NCT05218668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6814099|NCT05212389|Contraceptive Agents|contraceptive agents|mesh-list
6814100|NCT05212389|Contraceptives, Oral|contraceptives, oral|mesh-list
6814101|NCT05212389|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
6814102|NCT05212389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6814103|NCT05212389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6814104|NCT05212389|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6814105|NCT05211609|Methyldopa|methyldopa|mesh-list
6814106|NCT05211609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6814107|NCT05211609|Sympatholytics|sympatholytics|mesh-ancestor
6814108|NCT05211609|Autonomic Agents|autonomic agents|mesh-ancestor
6814109|NCT05211609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6814110|NCT05211609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6814111|NCT05211609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6814112|NCT05211609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6814113|NCT05211609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6814114|NCT05211609|Adrenergic Agents|adrenergic agents|mesh-ancestor
6814115|NCT05211609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6814116|NCT05211609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814117|NCT05211336|Prednisone|prednisone|mesh-list
6814118|NCT05211336|Nivolumab|nivolumab|mesh-list
6814119|NCT05211336|Lenalidomide|lenalidomide|mesh-list
6814120|NCT05211336|Venetoclax|venetoclax|mesh-list
6814121|NCT05211336|Obinutuzumab|obinutuzumab|mesh-list
6814122|NCT05211336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6814123|NCT05211336|Glucocorticoids|glucocorticoids|mesh-ancestor
6814124|NCT05211336|Hormones|hormones|mesh-ancestor
6814125|NCT05211336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6814126|NCT05211336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6814127|NCT05211336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6814128|NCT05211336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814129|NCT05211336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6814130|NCT05211336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6814131|NCT05211336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814132|NCT05211336|Immunologic Factors|immunologic factors|mesh-ancestor
6814133|NCT05211336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6814134|NCT05211336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6814135|NCT05211336|Growth Substances|growth substances|mesh-ancestor
6814136|NCT05211336|Growth Inhibitors|growth inhibitors|mesh-ancestor
6814137|NCT05195450|Tenofovir|tenofovir|mesh-list
6814138|NCT05195450|Antiviral Agents|antiviral agents|mesh-ancestor
6814139|NCT05195450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6814140|NCT05195450|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6814141|NCT05195450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6814142|NCT05195450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6814143|NCT05195450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814144|NCT05195450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6814145|NCT05195450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6814146|NCT05193071|Aspirin|aspirin|mesh-list
6814147|NCT05193071|Clopidogrel|clopidogrel|mesh-list
6814148|NCT05193071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6814149|NCT05193071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6814150|NCT05193071|Analgesics|analgesics|mesh-ancestor
6814151|NCT05193071|Sensory System Agents|sensory system agents|mesh-ancestor
6814152|NCT05193071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6814153|NCT05193071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6814154|NCT05193071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6814155|NCT05193071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6814156|NCT05193071|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6814157|NCT05193071|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6814158|NCT05193071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814159|NCT05193071|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6814160|NCT05193071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6814161|NCT05193071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6814162|NCT05193071|Antipyretics|antipyretics|mesh-ancestor
6814163|NCT05193071|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6814164|NCT05193071|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6814165|NCT05193071|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6814166|NCT05193071|Purinergic Agents|purinergic agents|mesh-ancestor
6814167|NCT05193071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6814168|NCT05189197|Zanubrutinib|zanubrutinib|mesh-list
6814169|NCT05189197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814170|NCT05189197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6814171|NCT05189197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6814172|NCT05189197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814173|NCT05185947|Paclitaxel|paclitaxel|mesh-list
6814174|NCT05185947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6814175|NCT05185947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814176|NCT05185947|Tubulin Modulators|tubulin modulators|mesh-ancestor
6814177|NCT05185947|Antimitotic Agents|antimitotic agents|mesh-ancestor
6814178|NCT05185947|Mitosis Modulators|mitosis modulators|mesh-ancestor
6814179|NCT05185947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814180|NCT05179603|Pembrolizumab|pembrolizumab|mesh-list
6814181|NCT05179603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6814182|NCT05179603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814183|NCT05176509|Pembrolizumab|pembrolizumab|mesh-list
6814184|NCT05176509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5993599|NCT00123643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5993600|NCT00123643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6814185|NCT05176509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814186|NCT05171647|Gemcitabine|gemcitabine|mesh-list
6814187|NCT05171647|Rituximab|rituximab|mesh-list
6814188|NCT05171647|Oxaliplatin|oxaliplatin|mesh-list
6814189|NCT05171647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6814190|NCT05171647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814191|NCT05171647|Immunologic Factors|immunologic factors|mesh-ancestor
6814192|NCT05171647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6814193|NCT05171647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6814194|NCT05171647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6814195|NCT05171647|Antimetabolites|antimetabolites|mesh-ancestor
6814196|NCT05171647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814197|NCT05171647|Antiviral Agents|antiviral agents|mesh-ancestor
6814198|NCT05171647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6814199|NCT05171647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6814200|NCT05171647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6814201|NCT05170399|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6814202|NCT05170399|Immunologic Factors|immunologic factors|mesh-ancestor
6814203|NCT05170399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6814204|NCT05170204|Durvalumab|durvalumab|mesh-list
6814205|NCT05170204|Pralsetinib|pralsetinib|mesh-list
6814206|NCT05170204|Entrectinib|entrectinib|mesh-list
6814207|NCT05170204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6814208|NCT05170204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814209|NCT05170204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6814210|NCT05170204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6814211|NCT05170204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814212|NCT05169684|Docetaxel|docetaxel|mesh-list
6814213|NCT05169684|Nivolumab|nivolumab|mesh-list
6814214|NCT05169684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814215|NCT05169684|Tubulin Modulators|tubulin modulators|mesh-ancestor
6814216|NCT05169684|Antimitotic Agents|antimitotic agents|mesh-ancestor
6814217|NCT05169684|Mitosis Modulators|mitosis modulators|mesh-ancestor
6814218|NCT05169684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814219|NCT05169684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6814220|NCT05169684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6814221|NCT05169658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6814222|NCT05169658|Obinutuzumab|obinutuzumab|mesh-list
6814223|NCT05169658|Antibodies|antibodies|mesh-list
6814224|NCT05169658|Immunoglobulins|immunoglobulins|mesh-list
6814225|NCT05169658|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6814226|NCT05169658|Immunoconjugates|immunoconjugates|mesh-list
6814227|NCT05169658|Antibodies, Bispecific|antibodies, bispecific|mesh-list
6814228|NCT05169658|Immunologic Factors|immunologic factors|mesh-ancestor
6814229|NCT05169658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6814230|NCT05169658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814231|NCT05158140|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6814232|NCT05158140|Immunologic Factors|immunologic factors|mesh-ancestor
6814233|NCT05158140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6814234|NCT05155033|Aldesleukin|aldesleukin|mesh-list
6814235|NCT05155033|Pembrolizumab|pembrolizumab|mesh-list
6814236|NCT05155033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6814237|NCT05155033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814238|NCT05155033|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6814239|NCT05155033|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6814240|NCT05155033|Antiviral Agents|antiviral agents|mesh-ancestor
6814241|NCT05155033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6814242|NCT05148234|Decitabine|decitabine|mesh-list
6814243|NCT05148234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6814244|NCT05148234|Antimetabolites|antimetabolites|mesh-ancestor
6814245|NCT05148234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814246|NCT05148234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814247|NCT05148234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6814248|NCT05142228|Erenumab|erenumab|mesh-list
6814249|NCT05142228|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
6536412|NCT00816959|Dacarbazine|dacarbazine|mesh-list
6536413|NCT00816959|Vinblastine|vinblastine|mesh-list
6536414|NCT00816959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6814250|NCT05142228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814251|NCT05142228|Analgesics|analgesics|mesh-ancestor
6814252|NCT05142228|Sensory System Agents|sensory system agents|mesh-ancestor
6814253|NCT05142228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6536415|NCT00816959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6536416|NCT00816959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814254|NCT05142228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6814255|NCT05137626|Digoxin|digoxin|mesh-list
6814256|NCT05137626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6814257|NCT05137626|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6814258|NCT05137626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6814259|NCT05137626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814260|NCT05137626|Protective Agents|protective agents|mesh-ancestor
6814261|NCT05137626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6814262|NCT05132699|Cannabidiol|cannabidiol|mesh-list
6814263|NCT05132699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6814264|NCT05132699|Anticonvulsants|anticonvulsants|mesh-ancestor
6814265|NCT05127044|Bilirubin|bilirubin|mesh-list
6814266|NCT05127044|Antioxidants|antioxidants|mesh-ancestor
6814267|NCT05127044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814268|NCT05127044|Protective Agents|protective agents|mesh-ancestor
6814269|NCT05127044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6814270|NCT05116189|Paclitaxel|paclitaxel|mesh-list
6814271|NCT05116189|Docetaxel|docetaxel|mesh-list
6814272|NCT05116189|Bevacizumab|bevacizumab|mesh-list
6814273|NCT05116189|Pembrolizumab|pembrolizumab|mesh-list
6814274|NCT05116189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6814275|NCT05116189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814276|NCT05116189|Tubulin Modulators|tubulin modulators|mesh-ancestor
6814277|NCT05116189|Antimitotic Agents|antimitotic agents|mesh-ancestor
6814278|NCT05116189|Mitosis Modulators|mitosis modulators|mesh-ancestor
6814279|NCT05116189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814280|NCT05116189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6814281|NCT05116189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6814282|NCT05116189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6814283|NCT05116189|Growth Substances|growth substances|mesh-ancestor
6814284|NCT05116189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6814285|NCT05116189|Growth Inhibitors|growth inhibitors|mesh-ancestor
6814286|NCT05111145|Ivacaftor|ivacaftor|mesh-list
6814287|NCT05111145|Elexacaftor|elexacaftor|mesh-list
6814288|NCT05111145|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6814289|NCT05111145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6814290|NCT05111145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814291|NCT05104723|Tofacitinib|tofacitinib|mesh-list
6814292|NCT05104723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6814293|NCT05104723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6814294|NCT05104723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814295|NCT05102721|Avelumab|avelumab|mesh-list
6814296|NCT05102721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6814297|NCT05102721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814298|NCT05089734|Docetaxel|docetaxel|mesh-list
6814299|NCT05089734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814300|NCT05089734|Tubulin Modulators|tubulin modulators|mesh-ancestor
6814301|NCT05089734|Antimitotic Agents|antimitotic agents|mesh-ancestor
6814302|NCT05089734|Mitosis Modulators|mitosis modulators|mesh-ancestor
6814303|NCT05089734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814304|NCT05084599|Metaraminol|metaraminol|mesh-list
6814305|NCT05084599|Sympathomimetics|sympathomimetics|mesh-ancestor
6814306|NCT05084599|Autonomic Agents|autonomic agents|mesh-ancestor
6814307|NCT05084599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6814308|NCT05084599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6814309|NCT05084599|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6814310|NCT05084599|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6814311|NCT05084599|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6814312|NCT05084599|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6814313|NCT05084599|Adrenergic Agents|adrenergic agents|mesh-ancestor
6814314|NCT05084599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6814315|NCT05084599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814316|NCT05069597|Pancrelipase|pancrelipase|mesh-list
6814317|NCT05069597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6814318|NCT05067283|Pembrolizumab|pembrolizumab|mesh-list
6814319|NCT05067283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6814320|NCT05067283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814321|NCT05064059|Pembrolizumab|pembrolizumab|mesh-list
6814322|NCT05064059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6814323|NCT05064059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814324|NCT05063162|Rozanolixizumab|rozanolixizumab|mesh-list
6814325|NCT05063162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6814326|NCT05063162|Immunologic Factors|immunologic factors|mesh-ancestor
6814327|NCT05063162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6814328|NCT05059977|Immunoglobulins|immunoglobulins|mesh-list
6814329|NCT05059977|gamma-Globulins|gamma-globulins|mesh-list
5993601|NCT00123955|Spironolactone|spironolactone|mesh-list
6814330|NCT05059977|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6814331|NCT05059977|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6814332|NCT05059977|Immunologic Factors|immunologic factors|mesh-ancestor
6814333|NCT05059977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6814334|NCT05050916|Vitamin D|vitamin d|mesh-list
6814335|NCT05050916|Vitamins|vitamins|mesh-ancestor
6814336|NCT05050916|Micronutrients|micronutrients|mesh-ancestor
6814337|NCT05050916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6814338|NCT05050916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6814339|NCT05035407|Aldesleukin|aldesleukin|mesh-list
6814340|NCT05035407|Cyclophosphamide|cyclophosphamide|mesh-list
6814341|NCT05035407|Fludarabine|fludarabine|mesh-list
6814342|NCT05035407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6814343|NCT05035407|Immunologic Factors|immunologic factors|mesh-ancestor
6814344|NCT05035407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6814345|NCT05035407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6814346|NCT05035407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6814347|NCT05035407|Alkylating Agents|alkylating agents|mesh-ancestor
6814348|NCT05035407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814349|NCT05035407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814350|NCT05035407|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6814351|NCT05035407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6814352|NCT05035407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6814353|NCT05035407|Antiviral Agents|antiviral agents|mesh-ancestor
6814354|NCT05035407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6814355|NCT05033808|Epirubicin|epirubicin|mesh-list
6814356|NCT05033808|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6814357|NCT05033808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814358|NCT05033808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6814359|NCT05033808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6814360|NCT05033808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6814361|NCT05033808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814362|NCT05027945|Mycophenolic Acid|mycophenolic acid|mesh-list
6814363|NCT05027945|Sirolimus|sirolimus|mesh-list
6814364|NCT05027945|Cyclophosphamide|cyclophosphamide|mesh-list
6814365|NCT05027945|Busulfan|busulfan|mesh-list
6814366|NCT05027945|Fludarabine|fludarabine|mesh-list
6814367|NCT05027945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6814368|NCT05027945|Immunologic Factors|immunologic factors|mesh-ancestor
6814369|NCT05027945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6814370|NCT05027945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6814371|NCT05027945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6814372|NCT05027945|Alkylating Agents|alkylating agents|mesh-ancestor
6814373|NCT05027945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814374|NCT05027945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814375|NCT05027945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6814376|NCT05027945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6814377|NCT05027945|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6814378|NCT05027945|Antitubercular Agents|antitubercular agents|mesh-ancestor
6814379|NCT05027945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6814380|NCT05027945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6814381|NCT05027945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6814382|NCT05027945|Antifungal Agents|antifungal agents|mesh-ancestor
6814383|NCT05012644|Palbociclib|palbociclib|mesh-list
6814384|NCT05012644|Aromatase Inhibitors|aromatase inhibitors|mesh-list
6814385|NCT05012644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814386|NCT05012644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6814387|NCT05012644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6814388|NCT05012644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814389|NCT05012644|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6814390|NCT05012644|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6814391|NCT05012644|Hormone Antagonists|hormone antagonists|mesh-ancestor
6814392|NCT05012644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6814393|NCT05012644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6814394|NCT05009992|Panobinostat|panobinostat|mesh-list
6814395|NCT05009992|TIC10 compound|tic10 compound|mesh-list
6814396|NCT05009992|Dopamine|dopamine|mesh-list
6814397|NCT05009992|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
6814398|NCT05009992|GDC-0084|gdc-0084|mesh-list
6814399|NCT05009992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814400|NCT05009992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6814401|NCT05009992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814402|NCT05009992|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6814403|NCT05009992|Sympathomimetics|sympathomimetics|mesh-ancestor
6814404|NCT05009992|Autonomic Agents|autonomic agents|mesh-ancestor
6814405|NCT05009992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6814406|NCT05009992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6814407|NCT05009992|Dopamine Agents|dopamine agents|mesh-ancestor
6814408|NCT05009992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6814409|NCT05009992|Protective Agents|protective agents|mesh-ancestor
6814410|NCT05009979|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6814411|NCT05009979|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6814412|NCT05009979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814413|NCT05008913|Adavosertib|adavosertib|mesh-list
6814414|NCT05008913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6814415|NCT05008913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814416|NCT05008003|Vitamin D|vitamin d|mesh-list
6814417|NCT05008003|Cholecalciferol|cholecalciferol|mesh-list
6814418|NCT05008003|Curcumin|curcumin|mesh-list
6814419|NCT05008003|Quercetin|quercetin|mesh-list
6814420|NCT05008003|Vitamins|vitamins|mesh-ancestor
6814421|NCT05008003|Micronutrients|micronutrients|mesh-ancestor
6814422|NCT05008003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6814423|NCT05008003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6814424|NCT05008003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6814425|NCT05008003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6814426|NCT05008003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6814427|NCT05008003|Analgesics|analgesics|mesh-ancestor
6814428|NCT05008003|Sensory System Agents|sensory system agents|mesh-ancestor
6814429|NCT05008003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6814430|NCT05008003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6814431|NCT05008003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6814432|NCT05008003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814433|NCT05008003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6814434|NCT05008003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814435|NCT05008003|Antioxidants|antioxidants|mesh-ancestor
6814436|NCT05008003|Protective Agents|protective agents|mesh-ancestor
6814437|NCT05007106|Paclitaxel|paclitaxel|mesh-list
6814438|NCT05007106|Fluorouracil|fluorouracil|mesh-list
6814439|NCT05007106|Pembrolizumab|pembrolizumab|mesh-list
6814440|NCT05007106|Lenvatinib|lenvatinib|mesh-list
6814441|NCT05007106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6814442|NCT05007106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814443|NCT05007106|Tubulin Modulators|tubulin modulators|mesh-ancestor
6814444|NCT05007106|Antimitotic Agents|antimitotic agents|mesh-ancestor
6814445|NCT05007106|Mitosis Modulators|mitosis modulators|mesh-ancestor
6814446|NCT05007106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814447|NCT05007106|Antimetabolites|antimetabolites|mesh-ancestor
6814448|NCT05007106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6814449|NCT05007106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6814450|NCT05007106|Immunologic Factors|immunologic factors|mesh-ancestor
6814451|NCT05007106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6814452|NCT05007106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6814453|NCT05007106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6814454|NCT05007106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6814455|NCT05002569|Nivolumab|nivolumab|mesh-list
6814456|NCT05002569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6814457|NCT05002569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814458|NCT05002569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6814459|NCT05002569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814460|NCT05001373|Vaccines|vaccines|mesh-list
6814461|NCT05001373|Immunologic Factors|immunologic factors|mesh-ancestor
6814462|NCT05001373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6814463|NCT04990804|Analgesics, Opioid|analgesics, opioid|mesh-list
6814464|NCT04990804|Analgesics|analgesics|mesh-list
6814465|NCT04990804|Narcotics|narcotics|mesh-ancestor
6814466|NCT04990804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6814467|NCT04990804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6814468|NCT04990804|Sensory System Agents|sensory system agents|mesh-ancestor
6814469|NCT04990804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6814470|NCT04989283|Paclitaxel|paclitaxel|mesh-list
6814471|NCT04989283|Etoposide|etoposide|mesh-list
6814472|NCT04989283|Podophyllotoxin|podophyllotoxin|mesh-list
6814473|NCT04989283|Cisplatin|cisplatin|mesh-list
6814474|NCT04989283|Carboplatin|carboplatin|mesh-list
6814475|NCT04989283|Pemetrexed|pemetrexed|mesh-list
6814476|NCT04989283|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6814477|NCT04989283|Etoposide phosphate|etoposide phosphate|mesh-list
6814478|NCT04989283|Atezolizumab|atezolizumab|mesh-list
6814479|NCT04989283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6814480|NCT04989283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6814481|NCT04989283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814482|NCT04989283|Tubulin Modulators|tubulin modulators|mesh-ancestor
6814483|NCT04989283|Antimitotic Agents|antimitotic agents|mesh-ancestor
6814484|NCT04989283|Mitosis Modulators|mitosis modulators|mesh-ancestor
6814485|NCT04989283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814486|NCT04989283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6814487|NCT04989283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6814488|NCT04989283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6814489|NCT04989283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6814490|NCT04989283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6814491|NCT04989283|Immunologic Factors|immunologic factors|mesh-ancestor
6814492|NCT04989283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6814493|NCT04989283|Keratolytic Agents|keratolytic agents|mesh-ancestor
6814494|NCT04989283|Dermatologic Agents|dermatologic agents|mesh-ancestor
6814495|NCT04988035|Remdesivir|remdesivir|mesh-list
6814496|NCT04988035|Antimetabolites|antimetabolites|mesh-ancestor
6814497|NCT04988035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814498|NCT04988035|Antiviral Agents|antiviral agents|mesh-ancestor
6814499|NCT04988035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6814500|NCT04980495|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6814501|NCT04963296|Acetaminophen|acetaminophen|mesh-list
6814502|NCT04963296|Diphenhydramine|diphenhydramine|mesh-list
6814503|NCT04963296|Promethazine|promethazine|mesh-list
6814504|NCT04963296|Methylprednisolone|methylprednisolone|mesh-list
6814505|NCT04963296|Obinutuzumab|obinutuzumab|mesh-list
6814506|NCT04963296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6814507|NCT04963296|Analgesics|analgesics|mesh-ancestor
6814508|NCT04963296|Sensory System Agents|sensory system agents|mesh-ancestor
6814509|NCT04963296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6814510|NCT04963296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6814511|NCT04963296|Antipyretics|antipyretics|mesh-ancestor
6814512|NCT04963296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6814513|NCT04963296|Antiemetics|antiemetics|mesh-ancestor
6814514|NCT04963296|Autonomic Agents|autonomic agents|mesh-ancestor
6814515|NCT04963296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6814516|NCT04963296|Glucocorticoids|glucocorticoids|mesh-ancestor
6814517|NCT04963296|Hormones|hormones|mesh-ancestor
6814518|NCT04963296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6814519|NCT04963296|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6814520|NCT04963296|Protective Agents|protective agents|mesh-ancestor
6814521|NCT04963296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814522|NCT04963296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6814523|NCT04963296|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6814524|NCT04963296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6814525|NCT04963296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6814526|NCT04963296|Anesthetics, Local|anesthetics, local|mesh-ancestor
6814527|NCT04963296|Anesthetics|anesthetics|mesh-ancestor
6814528|NCT04963296|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6814529|NCT04963296|Histamine Antagonists|histamine antagonists|mesh-ancestor
6814530|NCT04963296|Histamine Agents|histamine agents|mesh-ancestor
6814531|NCT04963296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6814532|NCT04963296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814533|NCT04963296|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6814534|NCT04963296|Antipruritics|antipruritics|mesh-ancestor
6814535|NCT04963296|Dermatologic Agents|dermatologic agents|mesh-ancestor
6814536|NCT04956692|Paclitaxel|paclitaxel|mesh-list
6814537|NCT04956692|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6814538|NCT04956692|Carboplatin|carboplatin|mesh-list
6814539|NCT04956692|Pembrolizumab|pembrolizumab|mesh-list
6814540|NCT04956692|Pemetrexed|pemetrexed|mesh-list
6814541|NCT04956692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6814542|NCT04956692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814543|NCT04956692|Tubulin Modulators|tubulin modulators|mesh-ancestor
6814544|NCT04956692|Antimitotic Agents|antimitotic agents|mesh-ancestor
6814545|NCT04956692|Mitosis Modulators|mitosis modulators|mesh-ancestor
6814546|NCT04956692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814547|NCT04956692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6814548|NCT04956692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6814549|NCT04956692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6814550|NCT04956692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6814551|NCT04950465|Fluorides|fluorides|mesh-list
6814552|NCT04950465|Cariostatic Agents|cariostatic agents|mesh-ancestor
6814553|NCT04950465|Protective Agents|protective agents|mesh-ancestor
6814554|NCT04950465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6814555|NCT04940065|Ofatumumab|ofatumumab|mesh-list
6814556|NCT04940065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814557|NCT04938830|Palivizumab|palivizumab|mesh-list
6814558|NCT04938830|Antiviral Agents|antiviral agents|mesh-ancestor
6814559|NCT04938830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6814560|NCT04933617|Prednisone|prednisone|mesh-list
6814561|NCT04933617|Cyclophosphamide|cyclophosphamide|mesh-list
6814562|NCT04933617|Rituximab|rituximab|mesh-list
6814563|NCT04933617|Doxorubicin|doxorubicin|mesh-list
6814564|NCT04933617|Etoposide|etoposide|mesh-list
6814565|NCT04933617|Vincristine|vincristine|mesh-list
6814566|NCT04933617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6814567|NCT04933617|Immunologic Factors|immunologic factors|mesh-ancestor
6814568|NCT04933617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6814569|NCT04933617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6814570|NCT04933617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6814571|NCT04933617|Alkylating Agents|alkylating agents|mesh-ancestor
6814572|NCT04933617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814573|NCT04933617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814574|NCT04933617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6814575|NCT04933617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6814576|NCT04933617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6814577|NCT04933617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6814578|NCT04933617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6814579|NCT04933617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6814580|NCT04933617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6814581|NCT04933617|Glucocorticoids|glucocorticoids|mesh-ancestor
6814582|NCT04933617|Hormones|hormones|mesh-ancestor
6814583|NCT04933617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6814584|NCT04933617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6814585|NCT04933617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6814586|NCT04933617|Tubulin Modulators|tubulin modulators|mesh-ancestor
6814587|NCT04933617|Antimitotic Agents|antimitotic agents|mesh-ancestor
6814588|NCT04933617|Mitosis Modulators|mitosis modulators|mesh-ancestor
6814589|NCT04933539|Dexamethasone|dexamethasone|mesh-list
6814590|NCT04933539|Daratumumab|daratumumab|mesh-list
6814591|NCT04933539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6814592|NCT04933539|Antiemetics|antiemetics|mesh-ancestor
6814593|NCT04933539|Autonomic Agents|autonomic agents|mesh-ancestor
6814594|NCT04933539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6814595|NCT04933539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6814596|NCT04933539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6814597|NCT04933539|Glucocorticoids|glucocorticoids|mesh-ancestor
6814598|NCT04933539|Hormones|hormones|mesh-ancestor
6814599|NCT04933539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6814600|NCT04933539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6814601|NCT04933539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814602|NCT04923139|Rivaroxaban|rivaroxaban|mesh-list
6814603|NCT04923139|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6814604|NCT04923139|Antithrombins|antithrombins|mesh-ancestor
6814605|NCT04923139|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6814606|NCT04923139|Protease Inhibitors|protease inhibitors|mesh-ancestor
6814607|NCT04923139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6814608|NCT04923139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814609|NCT04923139|Anticoagulants|anticoagulants|mesh-ancestor
6814610|NCT04915183|Atorvastatin|atorvastatin|mesh-list
6814611|NCT04915183|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6814612|NCT04915183|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6814613|NCT04915183|Antimetabolites|antimetabolites|mesh-ancestor
6814614|NCT04915183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814615|NCT04915183|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6814616|NCT04915183|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6814617|NCT04915183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6814618|NCT04914897|Paclitaxel|paclitaxel|mesh-list
6814619|NCT04914897|Carboplatin|carboplatin|mesh-list
6814620|NCT04914897|Pembrolizumab|pembrolizumab|mesh-list
6814621|NCT04914897|Pemetrexed|pemetrexed|mesh-list
6814622|NCT04914897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6814623|NCT04914897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814624|NCT04914897|Tubulin Modulators|tubulin modulators|mesh-ancestor
6814625|NCT04914897|Antimitotic Agents|antimitotic agents|mesh-ancestor
6814626|NCT04914897|Mitosis Modulators|mitosis modulators|mesh-ancestor
6814627|NCT04914897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814628|NCT04914897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6814629|NCT04914897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6814630|NCT04914897|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6814631|NCT04914897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6814632|NCT04913220|Cemiplimab|cemiplimab|mesh-list
6814633|NCT04913220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6814634|NCT04913220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814635|NCT04907851|Denosumab|denosumab|mesh-list
6814636|NCT04907851|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6814637|NCT04907851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6814638|NCT04906278|Oxytocin|oxytocin|mesh-list
6814639|NCT04906278|Oxytocics|oxytocics|mesh-ancestor
6814640|NCT04906278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6814641|NCT04906278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6814642|NCT04904588|Mycophenolic Acid|mycophenolic acid|mesh-list
6814643|NCT04904588|Cyclophosphamide|cyclophosphamide|mesh-list
6814644|NCT04904588|Melphalan|melphalan|mesh-list
6814645|NCT04904588|Busulfan|busulfan|mesh-list
6814646|NCT04904588|Fludarabine|fludarabine|mesh-list
6814647|NCT04904588|Tacrolimus|tacrolimus|mesh-list
6814648|NCT04904588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6814649|NCT04904588|Immunologic Factors|immunologic factors|mesh-ancestor
6814650|NCT04904588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6814651|NCT04904588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6814652|NCT04904588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6814653|NCT04904588|Alkylating Agents|alkylating agents|mesh-ancestor
6814654|NCT04904588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814655|NCT04904588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814656|NCT04904588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6814657|NCT04904588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6814658|NCT04904588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6814659|NCT04904588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6814660|NCT04904588|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6814661|NCT04904588|Antitubercular Agents|antitubercular agents|mesh-ancestor
6814662|NCT04904588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6814663|NCT04904588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6814664|NCT04896073|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
6814665|NCT04896073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6814666|NCT04896073|Alkylating Agents|alkylating agents|mesh-ancestor
6814667|NCT04896073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814668|NCT04896073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814669|NCT04895722|Pembrolizumab|pembrolizumab|mesh-list
6814670|NCT04895722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6814671|NCT04895722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814672|NCT04895358|Paclitaxel|paclitaxel|mesh-list
6814673|NCT04895358|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6814674|NCT04895358|Doxorubicin|doxorubicin|mesh-list
6814675|NCT04895358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6814676|NCT04895358|Pembrolizumab|pembrolizumab|mesh-list
6814677|NCT04895358|Capecitabine|capecitabine|mesh-list
6814678|NCT04895358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6814679|NCT04895358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814680|NCT04895358|Tubulin Modulators|tubulin modulators|mesh-ancestor
6814681|NCT04895358|Antimitotic Agents|antimitotic agents|mesh-ancestor
6814682|NCT04895358|Mitosis Modulators|mitosis modulators|mesh-ancestor
6814683|NCT04895358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814684|NCT04895358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6814685|NCT04895358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6814686|NCT04895358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6814687|NCT04895358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6814688|NCT04895358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6814689|NCT04895358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6814690|NCT04895358|Antimetabolites|antimetabolites|mesh-ancestor
6814691|NCT04890093|Vincristine|vincristine|mesh-list
6814692|NCT04890093|Temozolomide|temozolomide|mesh-list
6814693|NCT04890093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6814694|NCT04890093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814695|NCT04890093|Tubulin Modulators|tubulin modulators|mesh-ancestor
6814696|NCT04890093|Antimitotic Agents|antimitotic agents|mesh-ancestor
6814697|NCT04890093|Mitosis Modulators|mitosis modulators|mesh-ancestor
6814698|NCT04890093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814699|NCT04890093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6814700|NCT04890093|Alkylating Agents|alkylating agents|mesh-ancestor
6814701|NCT04862221|Diphenhydramine|diphenhydramine|mesh-list
6814702|NCT04862221|Promethazine|promethazine|mesh-list
6814703|NCT04862221|Methylprednisolone|methylprednisolone|mesh-list
6814704|NCT04862221|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6814705|NCT04862221|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6814706|NCT04862221|Prednisolone|prednisolone|mesh-list
6814707|NCT04862221|Prednisolone acetate|prednisolone acetate|mesh-list
6814708|NCT04862221|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6814709|NCT04862221|Prednisolone phosphate|prednisolone phosphate|mesh-list
6814710|NCT04862221|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6814711|NCT04862221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6814712|NCT04862221|Antiemetics|antiemetics|mesh-ancestor
6814713|NCT04862221|Autonomic Agents|autonomic agents|mesh-ancestor
6814714|NCT04862221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6814715|NCT04862221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6814716|NCT04862221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6814717|NCT04862221|Glucocorticoids|glucocorticoids|mesh-ancestor
6814718|NCT04862221|Hormones|hormones|mesh-ancestor
6814719|NCT04862221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6814720|NCT04862221|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6814721|NCT04862221|Protective Agents|protective agents|mesh-ancestor
6814722|NCT04862221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6814723|NCT04862221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814724|NCT04862221|Immunologic Factors|immunologic factors|mesh-ancestor
6814725|NCT04862221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6814726|NCT04862221|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6814727|NCT04862221|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6814728|NCT04862221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6814729|NCT04862221|Anesthetics, Local|anesthetics, local|mesh-ancestor
6814730|NCT04862221|Anesthetics|anesthetics|mesh-ancestor
6814731|NCT04862221|Sensory System Agents|sensory system agents|mesh-ancestor
6814732|NCT04862221|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6814733|NCT04862221|Histamine Antagonists|histamine antagonists|mesh-ancestor
6814734|NCT04862221|Histamine Agents|histamine agents|mesh-ancestor
6814735|NCT04862221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6814736|NCT04862221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814737|NCT04862221|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6814738|NCT04862221|Antipruritics|antipruritics|mesh-ancestor
6814739|NCT04862221|Dermatologic Agents|dermatologic agents|mesh-ancestor
6814740|NCT04859608|Eculizumab|eculizumab|mesh-list
6814741|NCT04859608|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6814742|NCT04859608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6814743|NCT04859608|Immunologic Factors|immunologic factors|mesh-ancestor
6814744|NCT04859608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6814745|NCT04858334|Olaparib|olaparib|mesh-list
6814746|NCT04858334|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
6814747|NCT04858334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5993602|NCT00123955|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5993603|NCT00123955|Hormone Antagonists|hormone antagonists|mesh-ancestor
5993604|NCT00123955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5993605|NCT00123955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993606|NCT00123955|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5993607|NCT00123955|Diuretics|diuretics|mesh-ancestor
5993608|NCT00123955|Natriuretic Agents|natriuretic agents|mesh-ancestor
6814748|NCT04858334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814749|NCT04858334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814750|NCT04847453|Dexamethasone|dexamethasone|mesh-list
6814751|NCT04847453|Dexamethasone acetate|dexamethasone acetate|mesh-list
6814752|NCT04847453|Venetoclax|venetoclax|mesh-list
6814753|NCT04847453|Ixazomib|ixazomib|mesh-list
6814754|NCT04847453|Ichthammol|ichthammol|mesh-list
6814755|NCT04847453|BB 1101|bb 1101|mesh-list
6814756|NCT04847453|Glycine|glycine|mesh-list
6814757|NCT04847453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6814758|NCT04847453|Antiemetics|antiemetics|mesh-ancestor
6814759|NCT04847453|Autonomic Agents|autonomic agents|mesh-ancestor
6814760|NCT04847453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6814761|NCT04847453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6814762|NCT04847453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6814763|NCT04847453|Glucocorticoids|glucocorticoids|mesh-ancestor
6814764|NCT04847453|Hormones|hormones|mesh-ancestor
6814765|NCT04847453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6814766|NCT04847453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6814767|NCT04847453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814768|NCT04847453|Protease Inhibitors|protease inhibitors|mesh-ancestor
6814769|NCT04847453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6814770|NCT04847453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814771|NCT04847453|Dermatologic Agents|dermatologic agents|mesh-ancestor
6814772|NCT04847453|Glycine Agents|glycine agents|mesh-ancestor
6814773|NCT04847453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6814774|NCT04827953|Gemcitabine|gemcitabine|mesh-list
6814775|NCT04827953|Paclitaxel|paclitaxel|mesh-list
6814776|NCT04827953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6814777|NCT04827953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814778|NCT04827953|Tubulin Modulators|tubulin modulators|mesh-ancestor
6814779|NCT04827953|Antimitotic Agents|antimitotic agents|mesh-ancestor
6814780|NCT04827953|Mitosis Modulators|mitosis modulators|mesh-ancestor
6814781|NCT04827953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814782|NCT04827953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6814783|NCT04827953|Antimetabolites|antimetabolites|mesh-ancestor
6814784|NCT04827953|Antiviral Agents|antiviral agents|mesh-ancestor
6814785|NCT04827953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6814786|NCT04827953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6814787|NCT04827953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6814788|NCT04827953|Immunologic Factors|immunologic factors|mesh-ancestor
6814789|NCT04827953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6814790|NCT04820452|Aflibercept|aflibercept|mesh-list
6814791|NCT04820452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6814792|NCT04820452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6814793|NCT04820452|Growth Substances|growth substances|mesh-ancestor
6814794|NCT04820452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6814795|NCT04820452|Growth Inhibitors|growth inhibitors|mesh-ancestor
6814796|NCT04820452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814797|NCT04818177|Immunoglobulins|immunoglobulins|mesh-list
6814798|NCT04818177|Antibodies|antibodies|mesh-list
6814799|NCT04818177|gamma-Globulins|gamma-globulins|mesh-list
6814800|NCT04818177|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6814801|NCT04818177|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6814802|NCT04818177|Immunologic Factors|immunologic factors|mesh-ancestor
6814803|NCT04818177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6814804|NCT04815720|Pembrolizumab|pembrolizumab|mesh-list
6814805|NCT04815720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6814806|NCT04815720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814807|NCT04799249|Gemcitabine|gemcitabine|mesh-list
6814808|NCT04799249|Carboplatin|carboplatin|mesh-list
6814809|NCT04799249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814810|NCT04799249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6814811|NCT04799249|Antimetabolites|antimetabolites|mesh-ancestor
6814812|NCT04799249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814813|NCT04799249|Antiviral Agents|antiviral agents|mesh-ancestor
6814814|NCT04799249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6814815|NCT04799249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6814816|NCT04799249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6814817|NCT04799249|Immunologic Factors|immunologic factors|mesh-ancestor
6814818|NCT04799249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6814819|NCT04791514|Treprostinil|treprostinil|mesh-list
6814820|NCT04791514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6814821|NCT04781881|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
6814822|NCT04781881|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6814823|NCT04781881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814824|NCT04780061|Vitamin D|vitamin d|mesh-list
6814825|NCT04780061|Cholecalciferol|cholecalciferol|mesh-list
6814826|NCT04780061|Vitamins|vitamins|mesh-list
6814827|NCT04780061|Vitamin K|vitamin k|mesh-list
6814828|NCT04780061|Vitamin K 2|vitamin k 2|mesh-list
6814829|NCT04780061|Micronutrients|micronutrients|mesh-ancestor
6814830|NCT04780061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6814831|NCT04780061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6814832|NCT04780061|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6814833|NCT04780061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814834|NCT04780061|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6814835|NCT04780061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6814836|NCT04780061|Hemostatics|hemostatics|mesh-ancestor
6814837|NCT04780061|Coagulants|coagulants|mesh-ancestor
6814838|NCT04754386|Antibodies|antibodies|mesh-list
6814839|NCT04754386|Immunologic Factors|immunologic factors|mesh-ancestor
6814840|NCT04754386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6814841|NCT04751370|Nivolumab|nivolumab|mesh-list
6814842|NCT04751370|Ipilimumab|ipilimumab|mesh-list
6814843|NCT04751370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6814844|NCT04751370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814845|NCT04751370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6814846|NCT04751370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814847|NCT04745351|Remdesivir|remdesivir|mesh-list
6814848|NCT04745351|Antimetabolites|antimetabolites|mesh-ancestor
6814849|NCT04745351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814850|NCT04745351|Antiviral Agents|antiviral agents|mesh-ancestor
6814851|NCT04745351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6814852|NCT04740307|Pembrolizumab|pembrolizumab|mesh-list
6814853|NCT04740307|Lenvatinib|lenvatinib|mesh-list
6814854|NCT04740307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6814855|NCT04740307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814856|NCT04740307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6814857|NCT04740307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6814858|NCT04740307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814859|NCT04739800|Paclitaxel|paclitaxel|mesh-list
6814860|NCT04739800|Doxorubicin|doxorubicin|mesh-list
6814861|NCT04739800|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6814862|NCT04739800|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6814863|NCT04739800|Durvalumab|durvalumab|mesh-list
6814864|NCT04739800|Topotecan|topotecan|mesh-list
6814865|NCT04739800|Olaparib|olaparib|mesh-list
6814866|NCT04739800|Cediranib|cediranib|mesh-list
6814867|NCT04739800|Maleic acid|maleic acid|mesh-list
6814868|NCT04739800|Immunoglobulins|immunoglobulins|mesh-list
6814869|NCT04739800|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6814870|NCT04739800|Immunoglobulin G|immunoglobulin g|mesh-list
6814871|NCT04739800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6814872|NCT04739800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814873|NCT04739800|Tubulin Modulators|tubulin modulators|mesh-ancestor
6814874|NCT04739800|Antimitotic Agents|antimitotic agents|mesh-ancestor
6814875|NCT04739800|Mitosis Modulators|mitosis modulators|mesh-ancestor
6814876|NCT04739800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814877|NCT04739800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6814878|NCT04739800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6814879|NCT04739800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6814880|NCT04739800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6814881|NCT04739800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6814882|NCT04739800|Immunologic Factors|immunologic factors|mesh-ancestor
6814883|NCT04739800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6814884|NCT04739800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6814885|NCT04739800|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6814886|NCT04739800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6814887|NCT04739761|Trastuzumab|trastuzumab|mesh-list
6814888|NCT04739761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6814889|NCT04739761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814890|NCT04738487|Pembrolizumab|pembrolizumab|mesh-list
6814891|NCT04738487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6814892|NCT04738487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814893|NCT04738149|Bimatoprost|bimatoprost|mesh-list
6814894|NCT04738149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6814895|NCT04725188|Docetaxel|docetaxel|mesh-list
6814896|NCT04725188|Pembrolizumab|pembrolizumab|mesh-list
6814897|NCT04725188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814898|NCT04725188|Tubulin Modulators|tubulin modulators|mesh-ancestor
6814899|NCT04725188|Antimitotic Agents|antimitotic agents|mesh-ancestor
6814900|NCT04725188|Mitosis Modulators|mitosis modulators|mesh-ancestor
6814901|NCT04725188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814902|NCT04725188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6814903|NCT04721015|Docetaxel|docetaxel|mesh-list
6814904|NCT04721015|Osimertinib|osimertinib|mesh-list
6814905|NCT04721015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814906|NCT04721015|Tubulin Modulators|tubulin modulators|mesh-ancestor
6814907|NCT04721015|Antimitotic Agents|antimitotic agents|mesh-ancestor
6814908|NCT04721015|Mitosis Modulators|mitosis modulators|mesh-ancestor
6814909|NCT04721015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5993609|NCT00124020|Vancomycin|vancomycin|mesh-list
5993610|NCT00124020|Telavancin|telavancin|mesh-list
5993611|NCT00124020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5993612|NCT00124020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5993613|NCT00124072|Folic Acid|folic acid|mesh-list
5993614|NCT00124072|Vitamin B 12|vitamin b 12|mesh-list
5993615|NCT00124072|Hydroxocobalamin|hydroxocobalamin|mesh-list
5993616|NCT00124072|Simvastatin|simvastatin|mesh-list
5993617|NCT00124072|Vitamins|vitamins|mesh-ancestor
5993618|NCT00124072|Micronutrients|micronutrients|mesh-ancestor
5993619|NCT00124072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993620|NCT00124072|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5993621|NCT00124072|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5993622|NCT00124072|Antimetabolites|antimetabolites|mesh-ancestor
5993623|NCT00124072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5993624|NCT00124072|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5993625|NCT00124072|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5993626|NCT00124072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5993627|NCT00124072|Hematinics|hematinics|mesh-ancestor
5993628|NCT00124072|Vitamin B Complex|vitamin b complex|mesh-ancestor
6814910|NCT04721015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5993629|NCT00124176|Albuterol|albuterol|mesh-list
5993630|NCT00124176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6814911|NCT04721015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6814912|NCT04711356|Vaccines|vaccines|mesh-list
6814913|NCT04711356|Immunologic Factors|immunologic factors|mesh-ancestor
5993631|NCT00124176|Autonomic Agents|autonomic agents|mesh-ancestor
5993632|NCT00124176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5993633|NCT00124176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993634|NCT00124176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5993635|NCT00124176|Respiratory System Agents|respiratory system agents|mesh-ancestor
5993636|NCT00124176|Tocolytic Agents|tocolytic agents|mesh-ancestor
5993637|NCT00124176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5993638|NCT00124176|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5993639|NCT00124176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6814914|NCT04711356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6814915|NCT04704661|Trastuzumab|trastuzumab|mesh-list
6814916|NCT04704661|Camptothecin|camptothecin|mesh-list
6814917|NCT04704661|Immunoconjugates|immunoconjugates|mesh-list
6814918|NCT04704661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6814919|NCT04704661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814920|NCT04704661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6814921|NCT04704661|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6814922|NCT04704661|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6814923|NCT04704661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6814924|NCT04704661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814925|NCT04704661|Immunologic Factors|immunologic factors|mesh-ancestor
6814926|NCT04704661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6814927|NCT04700124|Gemcitabine|gemcitabine|mesh-list
6814928|NCT04700124|Cisplatin|cisplatin|mesh-list
6814929|NCT04700124|Pembrolizumab|pembrolizumab|mesh-list
6814930|NCT04700124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814931|NCT04700124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6814932|NCT04700124|Antimetabolites|antimetabolites|mesh-ancestor
6814933|NCT04700124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814934|NCT04700124|Antiviral Agents|antiviral agents|mesh-ancestor
6814935|NCT04700124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6814936|NCT04700124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6814937|NCT04700124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6814938|NCT04700124|Immunologic Factors|immunologic factors|mesh-ancestor
6814939|NCT04700124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6814940|NCT04700124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6814941|NCT04681144|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
6814942|NCT04681144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814943|NCT04660747|Anticoagulants|anticoagulants|mesh-list
6814944|NCT04659629|Pembrolizumab|pembrolizumab|mesh-list
6814945|NCT04659629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6814946|NCT04659629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814947|NCT04639843|Doxorubicin|doxorubicin|mesh-list
6814948|NCT04639843|Romidepsin|romidepsin|mesh-list
6814949|NCT04639843|Azacitidine|azacitidine|mesh-list
6814950|NCT04639843|Cc-486|cc-486|mesh-list
6814951|NCT04639843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6814952|NCT04639843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814953|NCT04639843|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6814954|NCT04639843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6814955|NCT04639843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6814956|NCT04639843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814957|NCT04639843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6814958|NCT04639843|Antimetabolites|antimetabolites|mesh-ancestor
6814959|NCT04634877|Paclitaxel|paclitaxel|mesh-list
6814960|NCT04634877|Docetaxel|docetaxel|mesh-list
6814961|NCT04634877|Cisplatin|cisplatin|mesh-list
6814962|NCT04634877|Carboplatin|carboplatin|mesh-list
6814963|NCT04634877|Pembrolizumab|pembrolizumab|mesh-list
6814964|NCT04634877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6814965|NCT04634877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814966|NCT04634877|Tubulin Modulators|tubulin modulators|mesh-ancestor
6814967|NCT04634877|Antimitotic Agents|antimitotic agents|mesh-ancestor
6814968|NCT04634877|Mitosis Modulators|mitosis modulators|mesh-ancestor
6814969|NCT04634877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814970|NCT04634877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6814971|NCT04626518|Pembrolizumab|pembrolizumab|mesh-list
6814972|NCT04626518|Lenvatinib|lenvatinib|mesh-list
6814973|NCT04626518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6814974|NCT04626518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814975|NCT04626518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6814976|NCT04626518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5993640|NCT00124176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6814977|NCT04626518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814978|NCT04626479|Pembrolizumab|pembrolizumab|mesh-list
6814979|NCT04626479|Lenvatinib|lenvatinib|mesh-list
6814980|NCT04626479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6814981|NCT04626479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814982|NCT04626479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6814983|NCT04626479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6814984|NCT04626479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814985|NCT04613596|Pembrolizumab|pembrolizumab|mesh-list
6814986|NCT04613596|Adagrasib|adagrasib|mesh-list
6814987|NCT04613596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6814988|NCT04613596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6814989|NCT04594733|Minocycline|minocycline|mesh-list
6814990|NCT04594733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6814991|NCT04594733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6814992|NCT04593927|Siponimod|siponimod|mesh-list
6814993|NCT04593927|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6814994|NCT04593927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6814995|NCT04593927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6814996|NCT04593927|Immunologic Factors|immunologic factors|mesh-ancestor
6814997|NCT04593927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6814998|NCT04583969|Remdesivir|remdesivir|mesh-list
6814999|NCT04583969|Antimetabolites|antimetabolites|mesh-ancestor
6815000|NCT04583969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815001|NCT04583969|Antiviral Agents|antiviral agents|mesh-ancestor
6815002|NCT04583969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6815003|NCT04583956|Remdesivir|remdesivir|mesh-list
6815004|NCT04583956|Antimetabolites|antimetabolites|mesh-ancestor
6815005|NCT04583956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815006|NCT04583956|Antiviral Agents|antiviral agents|mesh-ancestor
6815007|NCT04583956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6815008|NCT04579224|Gemcitabine|gemcitabine|mesh-list
6815009|NCT04579224|Paclitaxel|paclitaxel|mesh-list
6815010|NCT04579224|Docetaxel|docetaxel|mesh-list
6815011|NCT04579224|Halichondrin B|halichondrin b|mesh-list
6815012|NCT04579224|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6815013|NCT04579224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6815014|NCT04579224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815015|NCT04579224|Tubulin Modulators|tubulin modulators|mesh-ancestor
6815016|NCT04579224|Antimitotic Agents|antimitotic agents|mesh-ancestor
6815017|NCT04579224|Mitosis Modulators|mitosis modulators|mesh-ancestor
6815018|NCT04579224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815019|NCT04579224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6815020|NCT04579224|Antimetabolites|antimetabolites|mesh-ancestor
6815021|NCT04579224|Antiviral Agents|antiviral agents|mesh-ancestor
6815022|NCT04579224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6815023|NCT04579224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6815024|NCT04579224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6815025|NCT04579224|Immunologic Factors|immunologic factors|mesh-ancestor
6815026|NCT04579224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815027|NCT04576117|Vinblastine|vinblastine|mesh-list
6815028|NCT04576117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6815029|NCT04576117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815030|NCT04576117|Tubulin Modulators|tubulin modulators|mesh-ancestor
6815031|NCT04576117|Antimitotic Agents|antimitotic agents|mesh-ancestor
6815032|NCT04576117|Mitosis Modulators|mitosis modulators|mesh-ancestor
6815033|NCT04576117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815034|NCT04564742|Dapagliflozin|dapagliflozin|mesh-list
6815035|NCT04564742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6815036|NCT04564742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815037|NCT04564742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6815038|NCT04564742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815039|NCT04562090|Mirabegron|mirabegron|mesh-list
6815040|NCT04562090|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6815041|NCT04562090|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6815042|NCT04562090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6815043|NCT04562090|Adrenergic Agents|adrenergic agents|mesh-ancestor
6815044|NCT04562090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6815045|NCT04562090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815046|NCT04562090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815047|NCT04562090|Urological Agents|urological agents|mesh-ancestor
6815048|NCT04548752|Pembrolizumab|pembrolizumab|mesh-list
6815049|NCT04548752|Olaparib|olaparib|mesh-list
6815050|NCT04548752|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
6815051|NCT04548752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6815052|NCT04548752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815053|NCT04548752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6815054|NCT04548752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815055|NCT04526574|Vaccines|vaccines|mesh-list
6815056|NCT04526574|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6815057|NCT04526574|Immunologic Factors|immunologic factors|mesh-ancestor
6815058|NCT04526574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815059|NCT04524455|Dexamethasone|dexamethasone|mesh-list
6815060|NCT04524455|Blinatumomab|blinatumomab|mesh-list
6815061|NCT04524455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6815062|NCT04524455|Antiemetics|antiemetics|mesh-ancestor
6815063|NCT04524455|Autonomic Agents|autonomic agents|mesh-ancestor
6815064|NCT04524455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6815065|NCT04524455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815066|NCT04524455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6815067|NCT04524455|Glucocorticoids|glucocorticoids|mesh-ancestor
6815068|NCT04524455|Hormones|hormones|mesh-ancestor
6815069|NCT04524455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6815070|NCT04524455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6815071|NCT04524455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815072|NCT04521621|Pembrolizumab|pembrolizumab|mesh-list
6815073|NCT04521621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6815074|NCT04521621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815075|NCT04513522|Nivolumab|nivolumab|mesh-list
6815076|NCT04513522|Ipilimumab|ipilimumab|mesh-list
6815077|NCT04513522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6815078|NCT04513522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815079|NCT04513522|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6815080|NCT04513522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815081|NCT04500548|Nivolumab|nivolumab|mesh-list
6815082|NCT04500548|Ipilimumab|ipilimumab|mesh-list
6815083|NCT04500548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6815084|NCT04500548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815085|NCT04500548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6815086|NCT04500548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815087|NCT04482673|Vitamin D|vitamin d|mesh-list
6815088|NCT04482673|Ergocalciferols|ergocalciferols|mesh-list
6815089|NCT04482673|Cholecalciferol|cholecalciferol|mesh-list
6815090|NCT04482673|Vitamins|vitamins|mesh-list
6815091|NCT04482673|Micronutrients|micronutrients|mesh-ancestor
6815092|NCT04482673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815093|NCT04482673|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6815094|NCT04482673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6815095|NCT04472299|Ropivacaine|ropivacaine|mesh-list
6815096|NCT04472299|Anesthetics, Local|anesthetics, local|mesh-ancestor
6815097|NCT04472299|Anesthetics|anesthetics|mesh-ancestor
6815098|NCT04472299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6815099|NCT04472299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815100|NCT04472299|Sensory System Agents|sensory system agents|mesh-ancestor
6815101|NCT04472299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6815102|NCT04468087|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6815103|NCT04468087|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6815104|NCT04468087|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6815105|NCT04468087|Protease Inhibitors|protease inhibitors|mesh-ancestor
6815106|NCT04468087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6815107|NCT04468087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815108|NCT04468087|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6815109|NCT04468087|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6815110|NCT04468087|Antiviral Agents|antiviral agents|mesh-ancestor
6815111|NCT04468087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6815112|NCT04434092|Eculizumab|eculizumab|mesh-list
6815113|NCT04434092|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6815114|NCT04434092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6815115|NCT04434092|Immunologic Factors|immunologic factors|mesh-ancestor
6815116|NCT04434092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815117|NCT04431258|Folfirinox|folfirinox|mesh-list
6815118|NCT04431258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815119|NCT04417257|Fenretinide|fenretinide|mesh-list
6815120|NCT04417257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815121|NCT04417257|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6815122|NCT04417257|Protective Agents|protective agents|mesh-ancestor
6815123|NCT04417257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815124|NCT04401761|Aspirin|aspirin|mesh-list
6815125|NCT04401761|Rivaroxaban|rivaroxaban|mesh-list
6815126|NCT04401761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6815127|NCT04401761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6815128|NCT04401761|Analgesics|analgesics|mesh-ancestor
6815129|NCT04401761|Sensory System Agents|sensory system agents|mesh-ancestor
6815130|NCT04401761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6815131|NCT04401761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815132|NCT04401761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6815133|NCT04401761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6815134|NCT04401761|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6815135|NCT04401761|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6815136|NCT04401761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815137|NCT04401761|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6815138|NCT04401761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6815139|NCT04401761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6815140|NCT04401761|Antipyretics|antipyretics|mesh-ancestor
6815141|NCT04401761|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6815142|NCT04401761|Antithrombins|antithrombins|mesh-ancestor
6815143|NCT04401761|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6815144|NCT04401761|Protease Inhibitors|protease inhibitors|mesh-ancestor
6815145|NCT04401761|Anticoagulants|anticoagulants|mesh-ancestor
6815146|NCT04401553|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6815147|NCT04401553|Vancomycin|vancomycin|mesh-list
6815148|NCT04401553|Cephalosporins|cephalosporins|mesh-list
6815149|NCT04401553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6815150|NCT04396860|Nivolumab|nivolumab|mesh-list
6815151|NCT04396860|Ipilimumab|ipilimumab|mesh-list
6815152|NCT04396860|Temozolomide|temozolomide|mesh-list
6815153|NCT04396860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6815154|NCT04396860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815155|NCT04396860|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6815156|NCT04396860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815157|NCT04396860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6815158|NCT04396860|Alkylating Agents|alkylating agents|mesh-ancestor
6815159|NCT04390646|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
6815160|NCT04390646|Hormones|hormones|mesh-ancestor
6815161|NCT04390646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6815162|NCT04390646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815163|NCT04379011|Brivaracetam|brivaracetam|mesh-list
6815164|NCT04379011|Anticonvulsants|anticonvulsants|mesh-ancestor
6815165|NCT04370795|Sirolimus|sirolimus|mesh-list
6815166|NCT04370795|Busulfan|busulfan|mesh-list
6815167|NCT04370795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6815168|NCT04370795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6815169|NCT04370795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6815170|NCT04370795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815171|NCT04370795|Antifungal Agents|antifungal agents|mesh-ancestor
6815172|NCT04370795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6815173|NCT04370795|Immunologic Factors|immunologic factors|mesh-ancestor
6815174|NCT04370795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815175|NCT04370795|Alkylating Agents|alkylating agents|mesh-ancestor
6815176|NCT04370795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815177|NCT04370795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6815178|NCT04370795|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6815179|NCT04370418|Fluorouracil|fluorouracil|mesh-list
6815180|NCT04370418|Antimetabolites|antimetabolites|mesh-ancestor
6815181|NCT04370418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815182|NCT04370418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6815183|NCT04370418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815184|NCT04370418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6815185|NCT04370418|Immunologic Factors|immunologic factors|mesh-ancestor
6815186|NCT04370418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815187|NCT04364230|Poly ICLC|poly iclc|mesh-list
6815188|NCT04364230|Immunologic Factors|immunologic factors|mesh-ancestor
6815189|NCT04364230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815190|NCT04364230|Interferon Inducers|interferon inducers|mesh-ancestor
6815191|NCT04340843|Decitabine|decitabine|mesh-list
6815192|NCT04340843|Azacitidine|azacitidine|mesh-list
6815193|NCT04340843|Belinostat|belinostat|mesh-list
6815194|NCT04340843|Guadecitabine|guadecitabine|mesh-list
6815195|NCT04340843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6815196|NCT04340843|Antimetabolites|antimetabolites|mesh-ancestor
6815197|NCT04340843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815198|NCT04340843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815199|NCT04340843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6815200|NCT04340843|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6815201|NCT04339751|Vorinostat|vorinostat|mesh-list
6815202|NCT04339751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815203|NCT04339751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6815204|NCT04339751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6815205|NCT04339751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815206|NCT04337580|Omeprazole|omeprazole|mesh-list
6815207|NCT04337580|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6815208|NCT04337580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6815209|NCT04337580|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6815210|NCT04337580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6815211|NCT04337580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815212|NCT04310020|Atezolizumab|atezolizumab|mesh-list
6815213|NCT04310020|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6815214|NCT04310020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815215|NCT04310020|Immunologic Factors|immunologic factors|mesh-ancestor
6815216|NCT04310020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815217|NCT04310007|Gemcitabine|gemcitabine|mesh-list
6815218|NCT04310007|Paclitaxel|paclitaxel|mesh-list
6815219|NCT04310007|Docetaxel|docetaxel|mesh-list
6815220|NCT04310007|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6815221|NCT04310007|Nivolumab|nivolumab|mesh-list
6815222|NCT04310007|Ramucirumab|ramucirumab|mesh-list
6815223|NCT04310007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6815224|NCT04310007|Antibodies|antibodies|mesh-list
6815225|NCT04310007|Immunoglobulins|immunoglobulins|mesh-list
6815226|NCT04310007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6815227|NCT04310007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6815228|NCT04310007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815229|NCT04310007|Tubulin Modulators|tubulin modulators|mesh-ancestor
6815230|NCT04310007|Antimitotic Agents|antimitotic agents|mesh-ancestor
6815231|NCT04310007|Mitosis Modulators|mitosis modulators|mesh-ancestor
6815232|NCT04310007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815233|NCT04310007|Immunologic Factors|immunologic factors|mesh-ancestor
6815234|NCT04310007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815235|NCT04310007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6815236|NCT04310007|Antimetabolites|antimetabolites|mesh-ancestor
6815237|NCT04310007|Antiviral Agents|antiviral agents|mesh-ancestor
6815238|NCT04310007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6815239|NCT04310007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6815240|NCT04310007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6815241|NCT04310007|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6815242|NCT04298567|Aspirin|aspirin|mesh-list
6815243|NCT04298567|Rivaroxaban|rivaroxaban|mesh-list
6815244|NCT04298567|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6815245|NCT04298567|Antithrombins|antithrombins|mesh-ancestor
6815246|NCT04298567|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6815247|NCT04298567|Protease Inhibitors|protease inhibitors|mesh-ancestor
6815248|NCT04298567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6815249|NCT04298567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815250|NCT04298567|Anticoagulants|anticoagulants|mesh-ancestor
6815251|NCT04298567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6815252|NCT04298567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6815253|NCT04298567|Analgesics|analgesics|mesh-ancestor
6815254|NCT04298567|Sensory System Agents|sensory system agents|mesh-ancestor
6815255|NCT04298567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6815256|NCT04298567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815257|NCT04298567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6815258|NCT04298567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6815259|NCT04298567|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6815260|NCT04298567|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6815261|NCT04298567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6815262|NCT04298567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6815263|NCT04298567|Antipyretics|antipyretics|mesh-ancestor
6815264|NCT04294550|Naloxegol|naloxegol|mesh-list
6815265|NCT04294550|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6815266|NCT04294550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815267|NCT04294550|Sensory System Agents|sensory system agents|mesh-ancestor
6815268|NCT04294550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6815269|NCT04284787|Pembrolizumab|pembrolizumab|mesh-list
6815270|NCT04284787|Azacitidine|azacitidine|mesh-list
6815271|NCT04284787|Venetoclax|venetoclax|mesh-list
6815272|NCT04284787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6815273|NCT04284787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815274|NCT04284787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6815275|NCT04284787|Antimetabolites|antimetabolites|mesh-ancestor
6815276|NCT04284787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815277|NCT04284787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6815278|NCT04282187|Azacitidine|azacitidine|mesh-list
6815279|NCT04282187|Decitabine|decitabine|mesh-list
6815280|NCT04282187|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
6815281|NCT04282187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6815282|NCT04282187|Antimetabolites|antimetabolites|mesh-ancestor
6815283|NCT04282187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815284|NCT04282187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815285|NCT04282187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6815286|NCT04282187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6815287|NCT04269902|Venetoclax|venetoclax|mesh-list
6815288|NCT04269902|Obinutuzumab|obinutuzumab|mesh-list
6815289|NCT04269902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815290|NCT04269902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6815291|NCT04223856|Gemcitabine|gemcitabine|mesh-list
6815292|NCT04223856|Carboplatin|carboplatin|mesh-list
6815293|NCT04223856|Pembrolizumab|pembrolizumab|mesh-list
6815294|NCT04223856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815295|NCT04223856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6815296|NCT04223856|Antimetabolites|antimetabolites|mesh-ancestor
6815297|NCT04223856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815298|NCT04223856|Antiviral Agents|antiviral agents|mesh-ancestor
6815299|NCT04223856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6815300|NCT04223856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6815301|NCT04223856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6815302|NCT04223856|Immunologic Factors|immunologic factors|mesh-ancestor
6815303|NCT04223856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815304|NCT04223856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6815305|NCT04218851|Posaconazole|posaconazole|mesh-list
6815306|NCT04218851|Antifungal Agents|antifungal agents|mesh-ancestor
6815307|NCT04218851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6815308|NCT04218851|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6815309|NCT04218851|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6815310|NCT04218851|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6815311|NCT04218851|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6815312|NCT04218851|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6815313|NCT04218851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6815314|NCT04218851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815315|NCT04218851|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6815316|NCT04218851|Hormone Antagonists|hormone antagonists|mesh-ancestor
6815317|NCT04218851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6815318|NCT04218851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815319|NCT04216290|Gemcitabine|gemcitabine|mesh-list
6815320|NCT04216290|Cisplatin|cisplatin|mesh-list
6815321|NCT04216290|Carboplatin|carboplatin|mesh-list
6815322|NCT04216290|Doxorubicin|doxorubicin|mesh-list
6815323|NCT04216290|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6815324|NCT04216290|Fluorouracil|fluorouracil|mesh-list
6815325|NCT04216290|Methotrexate|methotrexate|mesh-list
6815326|NCT04216290|Durvalumab|durvalumab|mesh-list
6815327|NCT04216290|Mitomycins|mitomycins|mesh-list
6258712|NCT03096444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6258713|NCT03096444|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6396832|NCT00209742|Interferon Inducers|interferon inducers|mesh-ancestor
6815328|NCT04216290|Mitomycin|mitomycin|mesh-list
6815329|NCT04216290|Vinblastine|vinblastine|mesh-list
6815330|NCT04216290|Immunoglobulins|immunoglobulins|mesh-list
6815331|NCT04216290|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6815332|NCT04216290|Immunoglobulin G|immunoglobulin g|mesh-list
6815333|NCT04216290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815334|NCT04216290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6815335|NCT04216290|Antimetabolites|antimetabolites|mesh-ancestor
6815336|NCT04216290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815337|NCT04216290|Antiviral Agents|antiviral agents|mesh-ancestor
6815338|NCT04216290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6815339|NCT04216290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6815340|NCT04216290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6815341|NCT04216290|Immunologic Factors|immunologic factors|mesh-ancestor
6815342|NCT04216290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815343|NCT04216290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6815344|NCT04216290|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6815345|NCT04216290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6815346|NCT04216290|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6815347|NCT04216290|Abortifacient Agents|abortifacient agents|mesh-ancestor
6815348|NCT04216290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6815349|NCT04216290|Dermatologic Agents|dermatologic agents|mesh-ancestor
6815350|NCT04216290|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6815351|NCT04216290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6815352|NCT04216290|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6815353|NCT04216290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6815354|NCT04216290|Alkylating Agents|alkylating agents|mesh-ancestor
6815355|NCT04216290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6815356|NCT04216290|Tubulin Modulators|tubulin modulators|mesh-ancestor
6815357|NCT04216290|Antimitotic Agents|antimitotic agents|mesh-ancestor
6815358|NCT04216290|Mitosis Modulators|mitosis modulators|mesh-ancestor
6815359|NCT04214262|Atezolizumab|atezolizumab|mesh-list
6815360|NCT04214262|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6815361|NCT04214262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815362|NCT04214262|Immunologic Factors|immunologic factors|mesh-ancestor
6815363|NCT04214262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815364|NCT04210115|Calcium, Dietary|calcium, dietary|mesh-list
6815365|NCT04210115|Leucovorin|leucovorin|mesh-list
6815366|NCT04210115|Pembrolizumab|pembrolizumab|mesh-list
6815367|NCT04210115|Oxaliplatin|oxaliplatin|mesh-list
6815368|NCT04210115|Calcium|calcium|mesh-list
6815369|NCT04210115|Levoleucovorin|levoleucovorin|mesh-list
6815370|NCT04210115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815371|NCT04210115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6815372|NCT04210115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815373|NCT04210115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6815374|NCT04210115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6815375|NCT04210115|Antidotes|antidotes|mesh-ancestor
6815376|NCT04210115|Protective Agents|protective agents|mesh-ancestor
6815377|NCT04210115|Vitamin B Complex|vitamin b complex|mesh-ancestor
6815378|NCT04210115|Vitamins|vitamins|mesh-ancestor
6815379|NCT04210115|Micronutrients|micronutrients|mesh-ancestor
6815380|NCT04207190|Gemtuzumab|gemtuzumab|mesh-list
6815381|NCT04207190|Talazoparib|talazoparib|mesh-list
6815382|NCT04207190|Calicheamicins|calicheamicins|mesh-list
6815383|NCT04207190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6815384|NCT04207190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815385|NCT04207190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6815386|NCT04207190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6815387|NCT04207190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815388|NCT04207190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6815389|NCT04197986|Infigratinib|infigratinib|mesh-list
6815390|NCT04197986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815391|NCT04181060|Bevacizumab|bevacizumab|mesh-list
6815392|NCT04181060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6815393|NCT04181060|Osimertinib|osimertinib|mesh-list
6815394|NCT04181060|Endothelial Growth Factors|endothelial growth factors|mesh-list
6815395|NCT04181060|Antibodies|antibodies|mesh-list
6815396|NCT04181060|Immunoglobulins|immunoglobulins|mesh-list
6815397|NCT04181060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6815398|NCT04181060|Immunoglobulin G|immunoglobulin g|mesh-list
6815399|NCT04181060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815400|NCT04181060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6815401|NCT04181060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6815402|NCT04181060|Growth Substances|growth substances|mesh-ancestor
6815403|NCT04181060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815404|NCT04181060|Growth Inhibitors|growth inhibitors|mesh-ancestor
6815405|NCT04181060|Immunologic Factors|immunologic factors|mesh-ancestor
6815406|NCT04181060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815407|NCT04181060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6815408|NCT04181060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6815409|NCT04175431|Prednisone|prednisone|mesh-list
6815410|NCT04175431|Abiraterone Acetate|abiraterone acetate|mesh-list
6815411|NCT04175431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6815412|NCT04175431|Glucocorticoids|glucocorticoids|mesh-ancestor
6815413|NCT04175431|Hormones|hormones|mesh-ancestor
6815414|NCT04175431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6815415|NCT04175431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815416|NCT04175431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6815417|NCT04175431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815418|NCT04175431|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6815419|NCT04175431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6815420|NCT04175431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815421|NCT04175431|Hormone Antagonists|hormone antagonists|mesh-ancestor
6815422|NCT04175431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6815423|NCT04164082|Gemcitabine|gemcitabine|mesh-list
6815424|NCT04164082|Pembrolizumab|pembrolizumab|mesh-list
6815425|NCT04164082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6815426|NCT04164082|Antimetabolites|antimetabolites|mesh-ancestor
6815427|NCT04164082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815428|NCT04164082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815429|NCT04164082|Antiviral Agents|antiviral agents|mesh-ancestor
6815430|NCT04164082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6815431|NCT04164082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6815432|NCT04164082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6815433|NCT04164082|Immunologic Factors|immunologic factors|mesh-ancestor
6815434|NCT04164082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815435|NCT04164082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6815436|NCT04145700|Gemcitabine|gemcitabine|mesh-list
6815437|NCT04145700|Docetaxel|docetaxel|mesh-list
6815438|NCT04145700|Ramucirumab|ramucirumab|mesh-list
6815439|NCT04145700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6815440|NCT04145700|Antimetabolites|antimetabolites|mesh-ancestor
6815441|NCT04145700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815442|NCT04145700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815443|NCT04145700|Antiviral Agents|antiviral agents|mesh-ancestor
6815444|NCT04145700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6815445|NCT04145700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6815446|NCT04145700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6815447|NCT04145700|Immunologic Factors|immunologic factors|mesh-ancestor
6815448|NCT04145700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815449|NCT04145700|Tubulin Modulators|tubulin modulators|mesh-ancestor
6815450|NCT04145700|Antimitotic Agents|antimitotic agents|mesh-ancestor
6815451|NCT04145700|Mitosis Modulators|mitosis modulators|mesh-ancestor
6815452|NCT04142658|Warfarin|warfarin|mesh-list
6815453|NCT04142658|Apixaban|apixaban|mesh-list
6815454|NCT04142658|Anticoagulants|anticoagulants|mesh-ancestor
6815455|NCT04142658|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6815456|NCT04142658|Antithrombins|antithrombins|mesh-ancestor
6815457|NCT04142658|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6815458|NCT04142658|Protease Inhibitors|protease inhibitors|mesh-ancestor
6815459|NCT04142658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6815460|NCT04142658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815461|NCT04127682|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6815462|NCT04127682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6815463|NCT04125836|Octreotide|octreotide|mesh-list
6815464|NCT04125836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6815465|NCT04125836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6815466|NCT04125836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815467|NCT04108858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6815468|NCT04108858|Trastuzumab|trastuzumab|mesh-list
6815469|NCT04108858|Pertuzumab|pertuzumab|mesh-list
6815470|NCT04108858|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
6815471|NCT04108858|Antibodies|antibodies|mesh-list
6815472|NCT04108858|Immunoglobulins|immunoglobulins|mesh-list
6815473|NCT04108858|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6815474|NCT04108858|Immunologic Factors|immunologic factors|mesh-ancestor
6815475|NCT04108858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815476|NCT04108858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815477|NCT04107038|Anesthetics|anesthetics|mesh-list
6815478|NCT04107038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6815479|NCT04107038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815480|NCT04095273|Pembrolizumab|pembrolizumab|mesh-list
6815481|NCT04095273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6815482|NCT04095273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815483|NCT04090398|Paclitaxel|paclitaxel|mesh-list
6815484|NCT04090398|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6815485|NCT04090398|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
6815486|NCT04090398|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6815487|NCT04090398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815488|NCT04090398|Tubulin Modulators|tubulin modulators|mesh-ancestor
6815489|NCT04090398|Antimitotic Agents|antimitotic agents|mesh-ancestor
6815490|NCT04090398|Mitosis Modulators|mitosis modulators|mesh-ancestor
6815491|NCT04090398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815492|NCT04086485|Olaparib|olaparib|mesh-list
6815493|NCT04086485|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6815494|NCT04086485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6815495|NCT04086485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815496|NCT04086485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815497|NCT04076462|Octreotide|octreotide|mesh-list
6815498|NCT04076462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6815499|NCT04076462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6815500|NCT04076462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815501|NCT04071236|Avelumab|avelumab|mesh-list
6815502|NCT04071236|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
6815503|NCT04071236|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6815504|NCT04071236|Peposertib|peposertib|mesh-list
6815505|NCT04071236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6815506|NCT04071236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815507|NCT04071236|Immunologic Factors|immunologic factors|mesh-ancestor
6815508|NCT04071236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815509|NCT04071236|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6815510|NCT04071236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6815511|NCT04071236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815512|NCT04071223|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
6815513|NCT04071223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815514|NCT04058067|Aflibercept|aflibercept|mesh-list
6815515|NCT04058067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6815516|NCT04058067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6815517|NCT04058067|Growth Substances|growth substances|mesh-ancestor
6815518|NCT04058067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815519|NCT04058067|Growth Inhibitors|growth inhibitors|mesh-ancestor
6815520|NCT04058067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815521|NCT04054752|Vaccines|vaccines|mesh-list
6815522|NCT04054752|Immunologic Factors|immunologic factors|mesh-ancestor
6815523|NCT04054752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815524|NCT04046939|Pramipexole|pramipexole|mesh-list
6815525|NCT04046939|Antioxidants|antioxidants|mesh-ancestor
6815526|NCT04046939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815527|NCT04046939|Protective Agents|protective agents|mesh-ancestor
6815528|NCT04046939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815529|NCT04046939|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6815530|NCT04046939|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6815531|NCT04046939|Dopamine Agonists|dopamine agonists|mesh-ancestor
6815532|NCT04046939|Dopamine Agents|dopamine agents|mesh-ancestor
6815533|NCT04046939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6815534|NCT04045795|Dexamethasone|dexamethasone|mesh-list
6815535|NCT04045795|Pomalidomide|pomalidomide|mesh-list
6815536|NCT04045795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6815537|NCT04045795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6815538|NCT04045795|Antiemetics|antiemetics|mesh-ancestor
6815539|NCT04045795|Autonomic Agents|autonomic agents|mesh-ancestor
6815540|NCT04045795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6815541|NCT04045795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815542|NCT04045795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6815543|NCT04045795|Glucocorticoids|glucocorticoids|mesh-ancestor
6815544|NCT04045795|Hormones|hormones|mesh-ancestor
6815545|NCT04045795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6815546|NCT04045795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6815547|NCT04045795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815548|NCT04045795|Immunologic Factors|immunologic factors|mesh-ancestor
6815549|NCT04045795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6815550|NCT04045795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6815551|NCT04045795|Growth Substances|growth substances|mesh-ancestor
6815552|NCT04045795|Growth Inhibitors|growth inhibitors|mesh-ancestor
6815553|NCT04029480|Metformin|metformin|mesh-list
6815554|NCT04029480|Ertugliflozin|ertugliflozin|mesh-list
6815555|NCT04029480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6815556|NCT04029480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815557|NCT04029480|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6815558|NCT04029480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815559|NCT03999515|Abiraterone Acetate|abiraterone acetate|mesh-list
6815560|NCT03999515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815561|NCT03999515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6815562|NCT03999515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6815563|NCT03999515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815564|NCT03999515|Hormone Antagonists|hormone antagonists|mesh-ancestor
6815565|NCT03999515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6815566|NCT03999515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815567|NCT03999515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6815568|NCT03993717|Vaccines|vaccines|mesh-list
6815569|NCT03993717|Immunologic Factors|immunologic factors|mesh-ancestor
6815570|NCT03993717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815571|NCT03993262|Bortezomib|bortezomib|mesh-list
6815572|NCT03993262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815573|NCT03970447|Temozolomide|temozolomide|mesh-list
6815574|NCT03970447|Lomustine|lomustine|mesh-list
6815575|NCT03970447|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
6815576|NCT03970447|GDC-0084|gdc-0084|mesh-list
6815577|NCT03970447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6815578|NCT03970447|Alkylating Agents|alkylating agents|mesh-ancestor
6815579|NCT03970447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815580|NCT03970447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815581|NCT03970447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6815582|NCT03954899|Melatonin|melatonin|mesh-list
6815583|NCT03954899|Antioxidants|antioxidants|mesh-ancestor
6815584|NCT03954899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815585|NCT03954899|Protective Agents|protective agents|mesh-ancestor
6815586|NCT03954899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815587|NCT03954899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6815588|NCT03954067|Pembrolizumab|pembrolizumab|mesh-list
6815589|NCT03954067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6815590|NCT03954067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815591|NCT03951025|Melatonin|melatonin|mesh-list
6815592|NCT03951025|Antioxidants|antioxidants|mesh-ancestor
6815593|NCT03951025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815594|NCT03951025|Protective Agents|protective agents|mesh-ancestor
6815595|NCT03951025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815596|NCT03951025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6815597|NCT03948074|Dronabinol|dronabinol|mesh-list
6815598|NCT03948074|Cannabidiol|cannabidiol|mesh-list
6815599|NCT03948074|Anticonvulsants|anticonvulsants|mesh-ancestor
6815600|NCT03948074|Hallucinogens|hallucinogens|mesh-ancestor
6815601|NCT03948074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815602|NCT03948074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6815603|NCT03948074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6815604|NCT03948074|Analgesics|analgesics|mesh-ancestor
6815605|NCT03948074|Sensory System Agents|sensory system agents|mesh-ancestor
6815606|NCT03948074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6815607|NCT03948074|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6815608|NCT03948074|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6815609|NCT03948074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6815610|NCT03948074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815611|NCT03948074|Hormones|hormones|mesh-ancestor
6815612|NCT03948074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6815613|NCT03924856|Gemcitabine|gemcitabine|mesh-list
6815614|NCT03924856|Pembrolizumab|pembrolizumab|mesh-list
6815615|NCT03924856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815616|NCT03924856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6815617|NCT03924856|Antimetabolites|antimetabolites|mesh-ancestor
6815618|NCT03924856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815619|NCT03924856|Antiviral Agents|antiviral agents|mesh-ancestor
6815620|NCT03924856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6815621|NCT03924856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6815622|NCT03924856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6815623|NCT03924856|Immunologic Factors|immunologic factors|mesh-ancestor
6815624|NCT03924856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815625|NCT03924856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6815626|NCT03914612|Paclitaxel|paclitaxel|mesh-list
6815627|NCT03914612|Carboplatin|carboplatin|mesh-list
6815628|NCT03914612|Pembrolizumab|pembrolizumab|mesh-list
6815629|NCT03914612|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6815630|NCT03914612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6815631|NCT03914612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815632|NCT03914612|Tubulin Modulators|tubulin modulators|mesh-ancestor
6815633|NCT03914612|Antimitotic Agents|antimitotic agents|mesh-ancestor
6815634|NCT03914612|Mitosis Modulators|mitosis modulators|mesh-ancestor
6815635|NCT03914612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815636|NCT03914612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6815637|NCT03908307|Dexamethasone|dexamethasone|mesh-list
6815638|NCT03908307|Dexamethasone acetate|dexamethasone acetate|mesh-list
6815639|NCT03908307|BB 1101|bb 1101|mesh-list
6815640|NCT03908307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6815641|NCT03908307|Antiemetics|antiemetics|mesh-ancestor
6815642|NCT03908307|Autonomic Agents|autonomic agents|mesh-ancestor
6815643|NCT03908307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6815644|NCT03908307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815645|NCT03908307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6815646|NCT03908307|Glucocorticoids|glucocorticoids|mesh-ancestor
6815647|NCT03908307|Hormones|hormones|mesh-ancestor
6815648|NCT03908307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6815649|NCT03908307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6815650|NCT03908307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815651|NCT03908307|Protease Inhibitors|protease inhibitors|mesh-ancestor
6815652|NCT03908307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6815653|NCT03908307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815654|NCT03907488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6815655|NCT03907488|Nivolumab|nivolumab|mesh-list
6815656|NCT03907488|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6815657|NCT03907488|Doxorubicin|doxorubicin|mesh-list
6815658|NCT03907488|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6815659|NCT03907488|Dacarbazine|dacarbazine|mesh-list
6815660|NCT03907488|Vinblastine|vinblastine|mesh-list
6815661|NCT03907488|Antibodies|antibodies|mesh-list
6815662|NCT03907488|Immunoglobulins|immunoglobulins|mesh-list
6815663|NCT03907488|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6815664|NCT03907488|Lenograstim|lenograstim|mesh-list
6815665|NCT03907488|Immunoconjugates|immunoconjugates|mesh-list
6815666|NCT03907488|Imidazole|imidazole|mesh-list
6815667|NCT03907488|Immunologic Factors|immunologic factors|mesh-ancestor
6815668|NCT03907488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815669|NCT03907488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815670|NCT03907488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6815671|NCT03907488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6815672|NCT03907488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6815673|NCT03907488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6815674|NCT03907488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815675|NCT03907488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6815676|NCT03907488|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6815677|NCT03907488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6815678|NCT03907488|Alkylating Agents|alkylating agents|mesh-ancestor
6815679|NCT03907488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6815680|NCT03907488|Tubulin Modulators|tubulin modulators|mesh-ancestor
6815681|NCT03907488|Antimitotic Agents|antimitotic agents|mesh-ancestor
6815682|NCT03907488|Mitosis Modulators|mitosis modulators|mesh-ancestor
6815683|NCT03878979|Nivolumab|nivolumab|mesh-list
6815684|NCT03878979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6815685|NCT03878979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815686|NCT03878979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6815687|NCT03878979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815688|NCT03872947|Leucovorin|leucovorin|mesh-list
6815689|NCT03872947|Gemcitabine|gemcitabine|mesh-list
6815690|NCT03872947|Bevacizumab|bevacizumab|mesh-list
6815691|NCT03872947|Carboplatin|carboplatin|mesh-list
6815692|NCT03872947|Pembrolizumab|pembrolizumab|mesh-list
6815693|NCT03872947|Nivolumab|nivolumab|mesh-list
6815694|NCT03872947|Irinotecan|irinotecan|mesh-list
6815695|NCT03872947|Topotecan|topotecan|mesh-list
6815696|NCT03872947|Imiquimod|imiquimod|mesh-list
6815697|NCT03872947|Ramucirumab|ramucirumab|mesh-list
6815698|NCT03872947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815699|NCT03872947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815700|NCT03872947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6815701|NCT03872947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6815702|NCT03872947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6815703|NCT03872947|Growth Substances|growth substances|mesh-ancestor
6815704|NCT03872947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815705|NCT03872947|Growth Inhibitors|growth inhibitors|mesh-ancestor
6815706|NCT03872947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6815707|NCT03872947|Antimetabolites|antimetabolites|mesh-ancestor
6815708|NCT03872947|Antiviral Agents|antiviral agents|mesh-ancestor
6815709|NCT03872947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6815710|NCT03872947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6815711|NCT03872947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6815712|NCT03872947|Immunologic Factors|immunologic factors|mesh-ancestor
6815713|NCT03872947|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6815714|NCT03872947|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6815715|NCT03872947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6815716|NCT03872947|Antidotes|antidotes|mesh-ancestor
6815717|NCT03872947|Protective Agents|protective agents|mesh-ancestor
6815718|NCT03872947|Vitamin B Complex|vitamin b complex|mesh-ancestor
6815719|NCT03872947|Vitamins|vitamins|mesh-ancestor
6815720|NCT03872947|Micronutrients|micronutrients|mesh-ancestor
6815721|NCT03872947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6815722|NCT03872947|Interferon Inducers|interferon inducers|mesh-ancestor
6815723|NCT03871257|Carboplatin|carboplatin|mesh-list
6815724|NCT03871257|Vincristine|vincristine|mesh-list
6815725|NCT03871257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815726|NCT03871257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6815727|NCT03871257|Tubulin Modulators|tubulin modulators|mesh-ancestor
6815728|NCT03871257|Antimitotic Agents|antimitotic agents|mesh-ancestor
6815729|NCT03871257|Mitosis Modulators|mitosis modulators|mesh-ancestor
6815730|NCT03871257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815731|NCT03866382|Nivolumab|nivolumab|mesh-list
6815732|NCT03866382|Ipilimumab|ipilimumab|mesh-list
6815733|NCT03866382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6815734|NCT03866382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815735|NCT03866382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6815736|NCT03866382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815737|NCT03865940|Lidocaine|lidocaine|mesh-list
6815738|NCT03865940|Guanfacine|guanfacine|mesh-list
6815739|NCT03865940|Anesthetics, Local|anesthetics, local|mesh-ancestor
6815740|NCT03865940|Anesthetics|anesthetics|mesh-ancestor
6815741|NCT03865940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6815742|NCT03865940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815743|NCT03865940|Sensory System Agents|sensory system agents|mesh-ancestor
6815744|NCT03865940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6815745|NCT03865940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6815746|NCT03865940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6815747|NCT03865940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6815748|NCT03865940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6815749|NCT03865940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815750|NCT03865940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6815751|NCT03865940|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6815752|NCT03865940|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6815753|NCT03865940|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6815754|NCT03865940|Adrenergic Agents|adrenergic agents|mesh-ancestor
6815755|NCT03865940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6815756|NCT03834493|Pembrolizumab|pembrolizumab|mesh-list
6815757|NCT03834493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6815758|NCT03834493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815759|NCT03828201|Levofloxacin|levofloxacin|mesh-list
6815760|NCT03828201|Ofloxacin|ofloxacin|mesh-list
6815761|NCT03828201|Linezolid|linezolid|mesh-list
6815762|NCT03828201|Bedaquiline|bedaquiline|mesh-list
6815763|NCT03828201|Clofazimine|clofazimine|mesh-list
6815764|NCT03828201|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6815765|NCT03828201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6815766|NCT03828201|Renal Agents|renal agents|mesh-ancestor
6815767|NCT03828201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6815768|NCT03828201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6815769|NCT03828201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6815770|NCT03828201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6815771|NCT03828201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815772|NCT03828201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815773|NCT03828201|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6815774|NCT03828201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6815775|NCT03828201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6815776|NCT03828201|Antitubercular Agents|antitubercular agents|mesh-ancestor
6815777|NCT03828201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6815778|NCT03828201|Leprostatic Agents|leprostatic agents|mesh-ancestor
6815779|NCT03811002|Cisplatin|cisplatin|mesh-list
6815780|NCT03811002|Carboplatin|carboplatin|mesh-list
6815781|NCT03811002|Etoposide|etoposide|mesh-list
6815782|NCT03811002|Etoposide phosphate|etoposide phosphate|mesh-list
6815783|NCT03811002|Atezolizumab|atezolizumab|mesh-list
6815784|NCT03811002|Podophyllotoxin|podophyllotoxin|mesh-list
6815785|NCT03811002|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6815786|NCT03811002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815787|NCT03811002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6815788|NCT03811002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6815789|NCT03811002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6815790|NCT03811002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6815791|NCT03811002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815792|NCT03811002|Immunologic Factors|immunologic factors|mesh-ancestor
6815793|NCT03811002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815794|NCT03811002|Keratolytic Agents|keratolytic agents|mesh-ancestor
6815795|NCT03811002|Dermatologic Agents|dermatologic agents|mesh-ancestor
6815796|NCT03811002|Tubulin Modulators|tubulin modulators|mesh-ancestor
6815797|NCT03811002|Antimitotic Agents|antimitotic agents|mesh-ancestor
6815798|NCT03811002|Mitosis Modulators|mitosis modulators|mesh-ancestor
6815799|NCT03793166|Nivolumab|nivolumab|mesh-list
6815800|NCT03793166|Ipilimumab|ipilimumab|mesh-list
6815801|NCT03793166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6815802|NCT03793166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815803|NCT03793166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6815804|NCT03793166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815805|NCT03792750|Nivolumab|nivolumab|mesh-list
6815806|NCT03792750|Linrodostat|linrodostat|mesh-list
6815807|NCT03792750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6815808|NCT03792750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815809|NCT03792750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6815810|NCT03792750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815811|NCT03792750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6815812|NCT03783403|Rituximab|rituximab|mesh-list
6815813|NCT03783403|Cetuximab|cetuximab|mesh-list
6815814|NCT03783403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6815815|NCT03783403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815816|NCT03783403|Immunologic Factors|immunologic factors|mesh-ancestor
6815817|NCT03783403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815818|NCT03783403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6815819|NCT03779854|Vidarabine|vidarabine|mesh-list
6815820|NCT03779854|Cyclophosphamide|cyclophosphamide|mesh-list
6815821|NCT03779854|Busulfan|busulfan|mesh-list
6815822|NCT03779854|Thiotepa|thiotepa|mesh-list
6815823|NCT03779854|Methotrexate|methotrexate|mesh-list
6815824|NCT03779854|Fludarabine|fludarabine|mesh-list
6815825|NCT03779854|Fludarabine phosphate|fludarabine phosphate|mesh-list
6815826|NCT03779854|Tacrolimus|tacrolimus|mesh-list
6815827|NCT03779854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6815828|NCT03779854|Immunologic Factors|immunologic factors|mesh-ancestor
6815829|NCT03779854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815830|NCT03779854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6815831|NCT03779854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6815832|NCT03779854|Alkylating Agents|alkylating agents|mesh-ancestor
6815833|NCT03779854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815834|NCT03779854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815835|NCT03779854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6815836|NCT03779854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6815837|NCT03779854|Abortifacient Agents|abortifacient agents|mesh-ancestor
6815838|NCT03779854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6815839|NCT03779854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6815840|NCT03779854|Antimetabolites|antimetabolites|mesh-ancestor
6815841|NCT03779854|Dermatologic Agents|dermatologic agents|mesh-ancestor
6815842|NCT03779854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6815843|NCT03779854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6815844|NCT03779854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6815845|NCT03779854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6815846|NCT03779854|Antiviral Agents|antiviral agents|mesh-ancestor
6815847|NCT03779854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6815848|NCT03776864|Pembrolizumab|pembrolizumab|mesh-list
6815849|NCT03776864|Immunoglobulins|immunoglobulins|mesh-list
6815850|NCT03776864|Immunoglobulin G|immunoglobulin g|mesh-list
6815851|NCT03776864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6815852|NCT03776864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815853|NCT03776864|Immunologic Factors|immunologic factors|mesh-ancestor
6815854|NCT03776864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815855|NCT03773107|Dexamethasone|dexamethasone|mesh-list
6815856|NCT03773107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6815857|NCT03773107|Antiemetics|antiemetics|mesh-ancestor
6815858|NCT03773107|Autonomic Agents|autonomic agents|mesh-ancestor
6815859|NCT03773107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6815860|NCT03773107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815861|NCT03773107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6815862|NCT03773107|Glucocorticoids|glucocorticoids|mesh-ancestor
6815863|NCT03773107|Hormones|hormones|mesh-ancestor
6815864|NCT03773107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6815865|NCT03773107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6815866|NCT03773107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815867|NCT03765619|Aspirin|aspirin|mesh-list
6815868|NCT03765619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6815869|NCT03765619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6815870|NCT03765619|Analgesics|analgesics|mesh-ancestor
6815871|NCT03765619|Sensory System Agents|sensory system agents|mesh-ancestor
6815872|NCT03765619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6815873|NCT03765619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815874|NCT03765619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6815875|NCT03765619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6815876|NCT03765619|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6815877|NCT03765619|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6815878|NCT03765619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815879|NCT03765619|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6815880|NCT03765619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6815881|NCT03765619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6815882|NCT03765619|Antipyretics|antipyretics|mesh-ancestor
6815883|NCT03761056|Cyclophosphamide|cyclophosphamide|mesh-list
6815884|NCT03761056|Fludarabine|fludarabine|mesh-list
6815885|NCT03761056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6815886|NCT03761056|Immunologic Factors|immunologic factors|mesh-ancestor
6815887|NCT03761056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815888|NCT03761056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6815889|NCT03761056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6815890|NCT03761056|Alkylating Agents|alkylating agents|mesh-ancestor
6815891|NCT03761056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815892|NCT03761056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815893|NCT03761056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6815894|NCT03739593|Dexamethasone|dexamethasone|mesh-list
6815895|NCT03739593|Dexamethasone acetate|dexamethasone acetate|mesh-list
6815896|NCT03739593|BB 1101|bb 1101|mesh-list
6815897|NCT03739593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6815898|NCT03739593|Antiemetics|antiemetics|mesh-ancestor
6815899|NCT03739593|Autonomic Agents|autonomic agents|mesh-ancestor
6815900|NCT03739593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6815901|NCT03739593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815902|NCT03739593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6815903|NCT03739593|Glucocorticoids|glucocorticoids|mesh-ancestor
6815904|NCT03739593|Hormones|hormones|mesh-ancestor
6815905|NCT03739593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6815906|NCT03739593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6815907|NCT03739593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815908|NCT03739593|Protease Inhibitors|protease inhibitors|mesh-ancestor
6815909|NCT03739593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6815910|NCT03739593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815911|NCT03739138|Pembrolizumab|pembrolizumab|mesh-list
6815912|NCT03739138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6815913|NCT03739138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815914|NCT03737994|Cisplatin|cisplatin|mesh-list
6815915|NCT03737994|Carboplatin|carboplatin|mesh-list
6815916|NCT03737994|Pemetrexed|pemetrexed|mesh-list
6815917|NCT03737994|Crizotinib|crizotinib|mesh-list
6815918|NCT03737994|Ceritinib|ceritinib|mesh-list
6815919|NCT03737994|Ensartinib|ensartinib|mesh-list
6815920|NCT03737994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815921|NCT03737994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6815922|NCT03737994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815923|NCT03737994|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6815924|NCT03737994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6815925|NCT03737994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6815926|NCT03737981|Venetoclax|venetoclax|mesh-list
6815927|NCT03737981|Obinutuzumab|obinutuzumab|mesh-list
6815928|NCT03737981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815929|NCT03737981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6815930|NCT03735628|Nivolumab|nivolumab|mesh-list
6815931|NCT03735628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6815932|NCT03735628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815933|NCT03735628|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6815934|NCT03735628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815935|NCT03733067|Abatacept|abatacept|mesh-list
6815936|NCT03733067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6815937|NCT03733067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815938|NCT03733067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815939|NCT03733067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6815940|NCT03733067|Immunologic Factors|immunologic factors|mesh-ancestor
6815941|NCT03733067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815942|NCT03733067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6815943|NCT03725059|Paclitaxel|paclitaxel|mesh-list
6815944|NCT03725059|Cyclophosphamide|cyclophosphamide|mesh-list
6815945|NCT03725059|Doxorubicin|doxorubicin|mesh-list
6815946|NCT03725059|Pembrolizumab|pembrolizumab|mesh-list
6815947|NCT03725059|Epirubicin|epirubicin|mesh-list
6815948|NCT03725059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6815949|NCT03725059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815950|NCT03725059|Tubulin Modulators|tubulin modulators|mesh-ancestor
6815951|NCT03725059|Antimitotic Agents|antimitotic agents|mesh-ancestor
6815952|NCT03725059|Mitosis Modulators|mitosis modulators|mesh-ancestor
6815953|NCT03725059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815954|NCT03725059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6815955|NCT03725059|Immunologic Factors|immunologic factors|mesh-ancestor
6815956|NCT03725059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815957|NCT03725059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6815958|NCT03725059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6815959|NCT03725059|Alkylating Agents|alkylating agents|mesh-ancestor
6815960|NCT03725059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6815961|NCT03725059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6815962|NCT03725059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6815963|NCT03725059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6815964|NCT03725059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6815965|NCT03725059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6815966|NCT03724019|Ketamine|ketamine|mesh-list
6815967|NCT03724019|Analgesics|analgesics|mesh-ancestor
6815968|NCT03724019|Sensory System Agents|sensory system agents|mesh-ancestor
6815969|NCT03724019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6815970|NCT03724019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815971|NCT03724019|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6815972|NCT03724019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6815973|NCT03724019|Anesthetics, General|anesthetics, general|mesh-ancestor
6815974|NCT03724019|Anesthetics|anesthetics|mesh-ancestor
6815975|NCT03724019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6815976|NCT03724019|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6815977|NCT03724019|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6815978|NCT03724019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6815979|NCT03724019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815980|NCT03711032|Pembrolizumab|pembrolizumab|mesh-list
6815981|NCT03711032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6815982|NCT03711032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815983|NCT03682068|Gemcitabine|gemcitabine|mesh-list
6815984|NCT03682068|Carboplatin|carboplatin|mesh-list
6815985|NCT03682068|Durvalumab|durvalumab|mesh-list
6815986|NCT03682068|Tremelimumab|tremelimumab|mesh-list
6815987|NCT03682068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6815988|NCT03682068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6815989|NCT03682068|Antimetabolites|antimetabolites|mesh-ancestor
6815990|NCT03682068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6815991|NCT03682068|Antiviral Agents|antiviral agents|mesh-ancestor
6815992|NCT03682068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6815993|NCT03682068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6815994|NCT03682068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6815995|NCT03682068|Immunologic Factors|immunologic factors|mesh-ancestor
6815996|NCT03682068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6815997|NCT03682068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6815998|NCT03660930|Sirolimus|sirolimus|mesh-list
6815999|NCT03660930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6816000|NCT03660930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6816001|NCT03660930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6816002|NCT03660930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816003|NCT03660930|Antifungal Agents|antifungal agents|mesh-ancestor
6816004|NCT03660930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6816005|NCT03660930|Immunologic Factors|immunologic factors|mesh-ancestor
6816006|NCT03660930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6816007|NCT03655197|Doxycycline|doxycycline|mesh-list
6816008|NCT03655197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6816009|NCT03655197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6816010|NCT03655197|Antimalarials|antimalarials|mesh-ancestor
6816011|NCT03655197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6816012|NCT03655197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6816013|NCT03654833|Bevacizumab|bevacizumab|mesh-list
6816014|NCT03654833|Pembrolizumab|pembrolizumab|mesh-list
6816015|NCT03654833|Atezolizumab|atezolizumab|mesh-list
6816016|NCT03654833|Niraparib|niraparib|mesh-list
6816017|NCT03654833|Rucaparib|rucaparib|mesh-list
6816018|NCT03654833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6816019|NCT03654833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816020|NCT03654833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6816021|NCT03654833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6816022|NCT03654833|Growth Substances|growth substances|mesh-ancestor
6816023|NCT03654833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6816024|NCT03654833|Growth Inhibitors|growth inhibitors|mesh-ancestor
6816025|NCT03654833|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6816026|NCT03654833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6816027|NCT03654833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816028|NCT03617718|Glycine|glycine|mesh-list
6816029|NCT03617718|Glycine Agents|glycine agents|mesh-ancestor
6816030|NCT03617718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6816031|NCT03617718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816032|NCT03617718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6816033|NCT03614728|Azacitidine|azacitidine|mesh-list
6816034|NCT03614728|GSK-3326595|gsk-3326595|mesh-list
6816035|NCT03614728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6816036|NCT03614728|Antimetabolites|antimetabolites|mesh-ancestor
6816037|NCT03614728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816038|NCT03614728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816039|NCT03614728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6816040|NCT03604978|Nivolumab|nivolumab|mesh-list
6816041|NCT03604978|Ipilimumab|ipilimumab|mesh-list
6816042|NCT03604978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6816043|NCT03604978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816044|NCT03604978|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6816045|NCT03604978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816046|NCT03576989|Mineral Oil|mineral oil|mesh-list
6816047|NCT03576989|Emollients|emollients|mesh-ancestor
6816048|NCT03576989|Dermatologic Agents|dermatologic agents|mesh-ancestor
6816049|NCT03565445|Pembrolizumab|pembrolizumab|mesh-list
6816050|NCT03565445|Nivolumab|nivolumab|mesh-list
6816051|NCT03565445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6816052|NCT03565445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816053|NCT03565445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6816054|NCT03565445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816055|NCT03560466|Prednisone|prednisone|mesh-list
6816056|NCT03560466|Prednisolone|prednisolone|mesh-list
6816057|NCT03560466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6816058|NCT03560466|Glucocorticoids|glucocorticoids|mesh-ancestor
6816059|NCT03560466|Hormones|hormones|mesh-ancestor
6816060|NCT03560466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6816061|NCT03560466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6816062|NCT03560466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6816063|NCT03560466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816064|NCT03535272|Bismuth|bismuth|mesh-list
6816065|NCT03535272|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
6816066|NCT03535272|Antacids|antacids|mesh-ancestor
6816067|NCT03535272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816068|NCT03535272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6816069|NCT03535272|Antidiarrheals|antidiarrheals|mesh-ancestor
6816070|NCT03520842|Methotrexate|methotrexate|mesh-list
6816071|NCT03520842|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6816072|NCT03520842|Abortifacient Agents|abortifacient agents|mesh-ancestor
6816073|NCT03520842|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6816074|NCT03520842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6816075|NCT03520842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6816076|NCT03520842|Antimetabolites|antimetabolites|mesh-ancestor
6816077|NCT03520842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816078|NCT03520842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816079|NCT03520842|Dermatologic Agents|dermatologic agents|mesh-ancestor
6816080|NCT03520842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6816081|NCT03520842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6816082|NCT03520842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6816083|NCT03520842|Immunologic Factors|immunologic factors|mesh-ancestor
6816084|NCT03520842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6816085|NCT03520842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6816086|NCT03520660|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
6816087|NCT03520660|Antiviral Agents|antiviral agents|mesh-ancestor
6816088|NCT03520660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6816089|NCT03518086|Mirikizumab|mirikizumab|mesh-list
6816090|NCT03518086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6816091|NCT03518086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6816092|NCT03518086|Analgesics|analgesics|mesh-ancestor
6816093|NCT03518086|Sensory System Agents|sensory system agents|mesh-ancestor
6816094|NCT03518086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6816095|NCT03518086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6816096|NCT03518086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6816097|NCT03518086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6816098|NCT03518086|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6816099|NCT03518086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6816100|NCT03516981|Pembrolizumab|pembrolizumab|mesh-list
6816101|NCT03516981|Lenvatinib|lenvatinib|mesh-list
6816102|NCT03516981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6816103|NCT03516981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816104|NCT03516981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6816105|NCT03516981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6816106|NCT03516981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816107|NCT03486873|Pembrolizumab|pembrolizumab|mesh-list
6816108|NCT03486873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6816109|NCT03486873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816110|NCT03478865|Vitamin A|vitamin a|mesh-list
6816111|NCT03478865|Retinol palmitate|retinol palmitate|mesh-list
6816112|NCT03478865|Vitamins|vitamins|mesh-ancestor
6816113|NCT03478865|Micronutrients|micronutrients|mesh-ancestor
6816114|NCT03478865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6816115|NCT03478865|Antioxidants|antioxidants|mesh-ancestor
6816116|NCT03478865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816117|NCT03478865|Protective Agents|protective agents|mesh-ancestor
6816118|NCT03478865|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6816119|NCT03478865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816120|NCT03473730|Daratumumab|daratumumab|mesh-list
6816121|NCT03473730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816122|NCT03450122|Aldesleukin|aldesleukin|mesh-list
6816123|NCT03450122|Cyclophosphamide|cyclophosphamide|mesh-list
6816124|NCT03450122|Interleukin-2|interleukin-2|mesh-list
6816125|NCT03450122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6816126|NCT03450122|Immunologic Factors|immunologic factors|mesh-ancestor
6816127|NCT03450122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6816128|NCT03450122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6816129|NCT03450122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6816130|NCT03450122|Alkylating Agents|alkylating agents|mesh-ancestor
6816131|NCT03450122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816132|NCT03450122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816133|NCT03450122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6816134|NCT03450122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6816135|NCT03450122|Analgesics|analgesics|mesh-ancestor
6816136|NCT03450122|Sensory System Agents|sensory system agents|mesh-ancestor
6816137|NCT03450122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6816138|NCT03450122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6816139|NCT03450122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6816140|NCT03450122|Antiviral Agents|antiviral agents|mesh-ancestor
6816141|NCT03450122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6816142|NCT03447808|Daratumumab|daratumumab|mesh-list
6816143|NCT03447808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816144|NCT03429244|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
6816145|NCT03429244|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6816146|NCT03429244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816147|NCT03389477|Cisplatin|cisplatin|mesh-list
6816148|NCT03389477|Cetuximab|cetuximab|mesh-list
6816149|NCT03389477|Palbociclib|palbociclib|mesh-list
6816150|NCT03389477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816151|NCT03389477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6816152|NCT03389477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6816153|NCT03389477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6816154|NCT03389477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816155|NCT03369301|Immunoglobulins|immunoglobulins|mesh-list
6816156|NCT03369301|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6816157|NCT03369301|Antibodies|antibodies|mesh-list
6816158|NCT03369301|Immunologic Factors|immunologic factors|mesh-ancestor
6816159|NCT03369301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6816160|NCT03347123|Nivolumab|nivolumab|mesh-list
6816161|NCT03347123|Ipilimumab|ipilimumab|mesh-list
6816162|NCT03347123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6816163|NCT03347123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816164|NCT03347123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6816165|NCT03347123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816166|NCT03330028|Diphenhydramine|diphenhydramine|mesh-list
6816167|NCT03330028|Promethazine|promethazine|mesh-list
6816168|NCT03330028|Dexamethasone|dexamethasone|mesh-list
6816169|NCT03330028|Paclitaxel|paclitaxel|mesh-list
6816170|NCT03330028|Cisplatin|cisplatin|mesh-list
6816171|NCT03330028|Mitomycins|mitomycins|mesh-list
6816172|NCT03330028|Mitomycin|mitomycin|mesh-list
6816173|NCT03330028|Famotidine|famotidine|mesh-list
6816174|NCT03330028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6816175|NCT03330028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816176|NCT03330028|Tubulin Modulators|tubulin modulators|mesh-ancestor
6816177|NCT03330028|Antimitotic Agents|antimitotic agents|mesh-ancestor
6816178|NCT03330028|Mitosis Modulators|mitosis modulators|mesh-ancestor
6816179|NCT03330028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816180|NCT03330028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6816181|NCT03330028|Antiemetics|antiemetics|mesh-ancestor
6816182|NCT03330028|Autonomic Agents|autonomic agents|mesh-ancestor
6816183|NCT03330028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6816184|NCT03330028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6816185|NCT03330028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6816186|NCT03330028|Glucocorticoids|glucocorticoids|mesh-ancestor
6816187|NCT03330028|Hormones|hormones|mesh-ancestor
6816188|NCT03330028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6816189|NCT03330028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6816190|NCT03330028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6816191|NCT03330028|Alkylating Agents|alkylating agents|mesh-ancestor
6816192|NCT03330028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6816193|NCT03330028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6816194|NCT03330028|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6816195|NCT03330028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6816196|NCT03330028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6816197|NCT03330028|Anesthetics, Local|anesthetics, local|mesh-ancestor
6816198|NCT03330028|Anesthetics|anesthetics|mesh-ancestor
6816199|NCT03330028|Sensory System Agents|sensory system agents|mesh-ancestor
6816200|NCT03330028|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6816201|NCT03330028|Histamine Antagonists|histamine antagonists|mesh-ancestor
6816202|NCT03330028|Histamine Agents|histamine agents|mesh-ancestor
6816203|NCT03330028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6816204|NCT03330028|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6816205|NCT03330028|Antipruritics|antipruritics|mesh-ancestor
6816206|NCT03330028|Dermatologic Agents|dermatologic agents|mesh-ancestor
6816207|NCT03330028|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6816208|NCT03330028|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6816209|NCT03309007|Metformin|metformin|mesh-list
6816210|NCT03309007|Calcium Carbonate|calcium carbonate|mesh-list
6816211|NCT03309007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6816212|NCT03309007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6816213|NCT03309007|Antacids|antacids|mesh-ancestor
6816214|NCT03309007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816215|NCT03309007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6816216|NCT03307616|Nivolumab|nivolumab|mesh-list
6816217|NCT03307616|Ipilimumab|ipilimumab|mesh-list
6816218|NCT03307616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6816219|NCT03307616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816220|NCT03307616|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6816221|NCT03307616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816222|NCT03306979|Acetylcysteine|acetylcysteine|mesh-list
6816223|NCT03306979|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6816224|NCT03306979|Antiviral Agents|antiviral agents|mesh-ancestor
6816225|NCT03306979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6816226|NCT03306979|Expectorants|expectorants|mesh-ancestor
6816227|NCT03306979|Respiratory System Agents|respiratory system agents|mesh-ancestor
6816228|NCT03306979|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6816229|NCT03306979|Antioxidants|antioxidants|mesh-ancestor
6816230|NCT03306979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816231|NCT03306979|Protective Agents|protective agents|mesh-ancestor
6816232|NCT03306979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6816233|NCT03306979|Antidotes|antidotes|mesh-ancestor
6816234|NCT03290937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6816235|NCT03290937|Cetuximab|cetuximab|mesh-list
6816236|NCT03290937|Irinotecan|irinotecan|mesh-list
6816237|NCT03290937|Camptothecin|camptothecin|mesh-list
6816238|NCT03290937|Antibodies|antibodies|mesh-list
6816239|NCT03290937|Immunoglobulins|immunoglobulins|mesh-list
6816240|NCT03290937|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6816241|NCT03290937|Immunoglobulin G|immunoglobulin g|mesh-list
6816242|NCT03290937|Immunologic Factors|immunologic factors|mesh-ancestor
6816243|NCT03290937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6816244|NCT03290937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816245|NCT03290937|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6816246|NCT03290937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6816247|NCT03290937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6816248|NCT03290937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816249|NCT03290937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6816250|NCT03260894|Pembrolizumab|pembrolizumab|mesh-list
6816251|NCT03260894|Sunitinib|sunitinib|mesh-list
6816252|NCT03260894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6816253|NCT03260894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816254|NCT03260894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6816255|NCT03260894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6816256|NCT03260894|Growth Substances|growth substances|mesh-ancestor
6816257|NCT03260894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6816258|NCT03260894|Growth Inhibitors|growth inhibitors|mesh-ancestor
6816259|NCT03260894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6816260|NCT03260894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6816261|NCT03260894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816262|NCT03258554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6816263|NCT03258554|Cetuximab|cetuximab|mesh-list
6816264|NCT03258554|Durvalumab|durvalumab|mesh-list
6816265|NCT03258554|Antibodies|antibodies|mesh-list
6816266|NCT03258554|Immunoglobulins|immunoglobulins|mesh-list
6816267|NCT03258554|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6816268|NCT03258554|Immunoglobulin G|immunoglobulin g|mesh-list
6816269|NCT03258554|Immunologic Factors|immunologic factors|mesh-ancestor
6816270|NCT03258554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6816271|NCT03258554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816272|NCT03252587|BMS-986165|bms-986165|mesh-list
6816273|NCT03252587|Dermatologic Agents|dermatologic agents|mesh-ancestor
6816274|NCT03252587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6816275|NCT03252587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6816276|NCT03252587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816277|NCT03240211|Pembrolizumab|pembrolizumab|mesh-list
6816278|NCT03240211|Decitabine|decitabine|mesh-list
6816279|NCT03240211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6816280|NCT03240211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816281|NCT03240211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6816282|NCT03240211|Antimetabolites|antimetabolites|mesh-ancestor
6816283|NCT03240211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816284|NCT03240211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6816285|NCT03213652|Ensartinib|ensartinib|mesh-list
6816286|NCT03213652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816287|NCT03213652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6816288|NCT03213652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6816289|NCT03213652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816290|NCT03199885|Paclitaxel|paclitaxel|mesh-list
6816291|NCT03199885|Docetaxel|docetaxel|mesh-list
6816292|NCT03199885|Trastuzumab|trastuzumab|mesh-list
6816293|NCT03199885|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6816294|NCT03199885|Atezolizumab|atezolizumab|mesh-list
6816295|NCT03199885|Pertuzumab|pertuzumab|mesh-list
6816296|NCT03199885|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
6816297|NCT03199885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6816298|NCT03199885|Antibodies|antibodies|mesh-list
6816299|NCT03199885|Immunoglobulins|immunoglobulins|mesh-list
6816300|NCT03199885|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6816301|NCT03199885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6816302|NCT03199885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816303|NCT03199885|Tubulin Modulators|tubulin modulators|mesh-ancestor
6816304|NCT03199885|Antimitotic Agents|antimitotic agents|mesh-ancestor
6816305|NCT03199885|Mitosis Modulators|mitosis modulators|mesh-ancestor
6816306|NCT03199885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816307|NCT03199885|Immunologic Factors|immunologic factors|mesh-ancestor
6816308|NCT03199885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6816309|NCT03177460|Daratumumab|daratumumab|mesh-list
6816310|NCT03177460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816311|NCT03150732|Nalbuphine|nalbuphine|mesh-list
6816312|NCT03150732|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6816313|NCT03150732|Narcotics|narcotics|mesh-ancestor
6816314|NCT03150732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6816315|NCT03150732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6816316|NCT03150732|Analgesics|analgesics|mesh-ancestor
6816317|NCT03150732|Sensory System Agents|sensory system agents|mesh-ancestor
6816318|NCT03150732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6816319|NCT03125902|Paclitaxel|paclitaxel|mesh-list
6816320|NCT03125902|Atezolizumab|atezolizumab|mesh-list
6816321|NCT03125902|Antibodies|antibodies|mesh-list
6816322|NCT03125902|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6816323|NCT03125902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6816324|NCT03125902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816325|NCT03125902|Tubulin Modulators|tubulin modulators|mesh-ancestor
6816326|NCT03125902|Antimitotic Agents|antimitotic agents|mesh-ancestor
6816327|NCT03125902|Mitosis Modulators|mitosis modulators|mesh-ancestor
6816328|NCT03125902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816329|NCT03125902|Immunologic Factors|immunologic factors|mesh-ancestor
6816330|NCT03125902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6816331|NCT03109288|Pioglitazone|pioglitazone|mesh-list
6816332|NCT03109288|Clemastine|clemastine|mesh-list
6816333|NCT03109288|Pirfenidone|pirfenidone|mesh-list
6816334|NCT03109288|Dantrolene|dantrolene|mesh-list
6816335|NCT03109288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6816336|NCT03109288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6816337|NCT03109288|Analgesics|analgesics|mesh-ancestor
6816338|NCT03109288|Sensory System Agents|sensory system agents|mesh-ancestor
6816339|NCT03109288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6816340|NCT03109288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6816341|NCT03109288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6816342|NCT03109288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6816343|NCT03109288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6816344|NCT03109288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816345|NCT03109288|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6816346|NCT03109288|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6816347|NCT03109288|Antipruritics|antipruritics|mesh-ancestor
6816348|NCT03109288|Dermatologic Agents|dermatologic agents|mesh-ancestor
6816349|NCT03109288|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6816350|NCT03109288|Histamine Antagonists|histamine antagonists|mesh-ancestor
6816351|NCT03109288|Histamine Agents|histamine agents|mesh-ancestor
6816352|NCT03109288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6816353|NCT03109288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816354|NCT03109288|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6816355|NCT03108131|Atezolizumab|atezolizumab|mesh-list
6816356|NCT03108131|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6816357|NCT03108131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816358|NCT03108131|Immunologic Factors|immunologic factors|mesh-ancestor
6816359|NCT03108131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6816360|NCT03105843|Methacholine Chloride|methacholine chloride|mesh-list
6816361|NCT03105843|Miotics|miotics|mesh-ancestor
6816362|NCT03105843|Autonomic Agents|autonomic agents|mesh-ancestor
6816363|NCT03105843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6816364|NCT03105843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6816365|NCT03105843|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6816366|NCT03105843|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
6816367|NCT03105843|Respiratory System Agents|respiratory system agents|mesh-ancestor
6816368|NCT03105843|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6816369|NCT03105843|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6816370|NCT03105843|Cholinergic Agents|cholinergic agents|mesh-ancestor
6816371|NCT03105843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6816372|NCT03105843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816373|NCT03075696|Obinutuzumab|obinutuzumab|mesh-list
6816374|NCT03075696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6816375|NCT03075696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816376|NCT03047993|Azacitidine|azacitidine|mesh-list
6816377|NCT03047993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6816378|NCT03047993|Antimetabolites|antimetabolites|mesh-ancestor
6816379|NCT03047993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816380|NCT03047993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816381|NCT03047993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6816382|NCT03027388|LB100|lb100|mesh-list
6816383|NCT03027388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816384|NCT03027388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6816385|NCT03027388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816386|NCT03015740|Nivolumab|nivolumab|mesh-list
6816387|NCT03015740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6816388|NCT03015740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816389|NCT03015740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6816390|NCT03015740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816391|NCT02997228|Leucovorin|leucovorin|mesh-list
6816392|NCT02997228|Bevacizumab|bevacizumab|mesh-list
6816393|NCT02997228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6816394|NCT02997228|Fluorouracil|fluorouracil|mesh-list
6816395|NCT02997228|Oxaliplatin|oxaliplatin|mesh-list
6816396|NCT02997228|Atezolizumab|atezolizumab|mesh-list
6816397|NCT02997228|Endothelial Growth Factors|endothelial growth factors|mesh-list
6816398|NCT02997228|Antibodies|antibodies|mesh-list
6816399|NCT02997228|Immunoglobulins|immunoglobulins|mesh-list
6816400|NCT02997228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6816401|NCT02997228|Immunoglobulin G|immunoglobulin g|mesh-list
6816402|NCT02997228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816403|NCT02997228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6816404|NCT02997228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6816405|NCT02997228|Growth Substances|growth substances|mesh-ancestor
6816406|NCT02997228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6816407|NCT02997228|Growth Inhibitors|growth inhibitors|mesh-ancestor
6816408|NCT02997228|Immunologic Factors|immunologic factors|mesh-ancestor
6816409|NCT02997228|Antimetabolites|antimetabolites|mesh-ancestor
6816410|NCT02997228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816411|NCT02997228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6816412|NCT02997228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6816413|NCT02997228|Antidotes|antidotes|mesh-ancestor
6816414|NCT02997228|Protective Agents|protective agents|mesh-ancestor
6816415|NCT02997228|Vitamin B Complex|vitamin b complex|mesh-ancestor
6816416|NCT02997228|Vitamins|vitamins|mesh-ancestor
6816417|NCT02997228|Micronutrients|micronutrients|mesh-ancestor
6816418|NCT02986269|Anesthetics|anesthetics|mesh-list
6816419|NCT02986269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6816420|NCT02986269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6816421|NCT02940496|Ribavirin|ribavirin|mesh-list
6816422|NCT02940496|Grazoprevir|grazoprevir|mesh-list
6816423|NCT02940496|Pembrolizumab|pembrolizumab|mesh-list
6816424|NCT02940496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6816425|NCT02940496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816426|NCT02940496|Antimetabolites|antimetabolites|mesh-ancestor
6816427|NCT02940496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816428|NCT02940496|Antiviral Agents|antiviral agents|mesh-ancestor
6816429|NCT02940496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6816430|NCT02933255|Nivolumab|nivolumab|mesh-list
6816431|NCT02933255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6816432|NCT02933255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816433|NCT02933255|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6816434|NCT02933255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816435|NCT02912559|Calcium, Dietary|calcium, dietary|mesh-list
6816436|NCT02912559|Leucovorin|leucovorin|mesh-list
6816437|NCT02912559|Folic Acid|folic acid|mesh-list
6816438|NCT02912559|Fluorouracil|fluorouracil|mesh-list
6816439|NCT02912559|Oxaliplatin|oxaliplatin|mesh-list
6816440|NCT02912559|Atezolizumab|atezolizumab|mesh-list
6816441|NCT02912559|Calcium|calcium|mesh-list
6816442|NCT02912559|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6816443|NCT02912559|Levoleucovorin|levoleucovorin|mesh-list
6816444|NCT02912559|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6816445|NCT02912559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6816446|NCT02912559|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6816447|NCT02912559|Antimetabolites|antimetabolites|mesh-ancestor
6816448|NCT02912559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816449|NCT02912559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6816450|NCT02912559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816451|NCT02912559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6816452|NCT02912559|Immunologic Factors|immunologic factors|mesh-ancestor
6816453|NCT02912559|Antidotes|antidotes|mesh-ancestor
6816454|NCT02912559|Protective Agents|protective agents|mesh-ancestor
6816455|NCT02912559|Vitamin B Complex|vitamin b complex|mesh-ancestor
6816456|NCT02912559|Vitamins|vitamins|mesh-ancestor
6816457|NCT02912559|Micronutrients|micronutrients|mesh-ancestor
6816458|NCT02912559|Hematinics|hematinics|mesh-ancestor
6816459|NCT02899299|Carboplatin|carboplatin|mesh-list
6816460|NCT02899299|Nivolumab|nivolumab|mesh-list
6816461|NCT02899299|Pemetrexed|pemetrexed|mesh-list
6816462|NCT02899299|Ipilimumab|ipilimumab|mesh-list
6816463|NCT02899299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816464|NCT02899299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6816465|NCT02899299|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6816466|NCT02899299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816467|NCT02899299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6816468|NCT02899299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6816469|NCT02899299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6816470|NCT02891447|Cisplatin|cisplatin|mesh-list
6816471|NCT02891447|Mitomycins|mitomycins|mesh-list
6816472|NCT02891447|Mitomycin|mitomycin|mesh-list
6816473|NCT02891447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816474|NCT02891447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6816475|NCT02891447|Alkylating Agents|alkylating agents|mesh-ancestor
6816476|NCT02891447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816477|NCT02891447|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6816478|NCT02891447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6816479|NCT02891226|Mirikizumab|mirikizumab|mesh-list
6816480|NCT02891226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6816481|NCT02891226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6816482|NCT02891226|Analgesics|analgesics|mesh-ancestor
6816483|NCT02891226|Sensory System Agents|sensory system agents|mesh-ancestor
6816484|NCT02891226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6816485|NCT02891226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6816486|NCT02891226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6816487|NCT02891226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6816488|NCT02891226|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6816489|NCT02891226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6816490|NCT02830724|Aldesleukin|aldesleukin|mesh-list
6816491|NCT02830724|Cyclophosphamide|cyclophosphamide|mesh-list
6816492|NCT02830724|Fludarabine|fludarabine|mesh-list
6816493|NCT02830724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6816494|NCT02830724|Immunologic Factors|immunologic factors|mesh-ancestor
6816495|NCT02830724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6816496|NCT02830724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6816497|NCT02830724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6816498|NCT02830724|Alkylating Agents|alkylating agents|mesh-ancestor
6816499|NCT02830724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816500|NCT02830724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816501|NCT02830724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6816502|NCT02830724|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6816503|NCT02830724|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6816504|NCT02830724|Antiviral Agents|antiviral agents|mesh-ancestor
6816505|NCT02830724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6816506|NCT02829918|Nivolumab|nivolumab|mesh-list
6816507|NCT02829918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6816508|NCT02829918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816509|NCT02829918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6816510|NCT02829918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816511|NCT02781792|Temozolomide|temozolomide|mesh-list
6816512|NCT02781792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6816513|NCT02781792|Alkylating Agents|alkylating agents|mesh-ancestor
6816514|NCT02781792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816515|NCT02781792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816516|NCT02761694|Paclitaxel|paclitaxel|mesh-list
6816517|NCT02761694|Fulvestrant|fulvestrant|mesh-list
6816518|NCT02761694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6816519|NCT02761694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816520|NCT02761694|Tubulin Modulators|tubulin modulators|mesh-ancestor
6816521|NCT02761694|Antimitotic Agents|antimitotic agents|mesh-ancestor
6816522|NCT02761694|Mitosis Modulators|mitosis modulators|mesh-ancestor
6816523|NCT02761694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816524|NCT02761694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6816525|NCT02761694|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6816526|NCT02761694|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6816527|NCT02761694|Hormone Antagonists|hormone antagonists|mesh-ancestor
6816528|NCT02761694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6816529|NCT02761694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6816530|NCT02759835|Osimertinib|osimertinib|mesh-list
6816531|NCT02759835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816532|NCT02759835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6816533|NCT02759835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6816534|NCT02759835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816535|NCT02639273|Nalmefene|nalmefene|mesh-list
6816536|NCT02639273|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6816537|NCT02639273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6816538|NCT02639273|Sensory System Agents|sensory system agents|mesh-ancestor
6816539|NCT02639273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6816540|NCT02629120|Sirolimus|sirolimus|mesh-list
6816541|NCT02629120|Cyclophosphamide|cyclophosphamide|mesh-list
6816542|NCT02629120|Busulfan|busulfan|mesh-list
6816543|NCT02629120|Alemtuzumab|alemtuzumab|mesh-list
6816544|NCT02629120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6816545|NCT02629120|Immunologic Factors|immunologic factors|mesh-ancestor
6816546|NCT02629120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6816547|NCT02629120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6816548|NCT02629120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6816549|NCT02629120|Alkylating Agents|alkylating agents|mesh-ancestor
6816550|NCT02629120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816551|NCT02629120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816552|NCT02629120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6816553|NCT02629120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6816554|NCT02629120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6816555|NCT02629120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6816556|NCT02629120|Antifungal Agents|antifungal agents|mesh-ancestor
6816557|NCT02629120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6816558|NCT02627274|Trastuzumab|trastuzumab|mesh-list
6816559|NCT02627274|Cetuximab|cetuximab|mesh-list
6816560|NCT02627274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6816561|NCT02627274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816562|NCT02564978|Minocycline|minocycline|mesh-list
6816563|NCT02564978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6816564|NCT02564978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6816565|NCT02553161|Citalopram|citalopram|mesh-list
6816566|NCT02553161|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6816567|NCT02553161|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6816568|NCT02553161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6816569|NCT02553161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816570|NCT02553161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6816571|NCT02553161|Serotonin Agents|serotonin agents|mesh-ancestor
6816572|NCT02553161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993641|NCT00124176|Adrenergic Agents|adrenergic agents|mesh-ancestor
5993642|NCT00124176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5993643|NCT00124176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5993644|NCT00124449|Abatacept|abatacept|mesh-list
5993645|NCT00124449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5993646|NCT00124449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5993647|NCT00124449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5993648|NCT00124449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5993649|NCT00124449|Immunologic Factors|immunologic factors|mesh-ancestor
5993650|NCT00124449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993651|NCT00124449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5993652|NCT00124514|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5993653|NCT00124514|Luteolytic Agents|luteolytic agents|mesh-ancestor
5993654|NCT00124514|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5993655|NCT00124514|Contraceptive Agents|contraceptive agents|mesh-ancestor
5993656|NCT00124514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6816573|NCT02553161|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6816574|NCT02553161|Antidepressive Agents|antidepressive agents|mesh-ancestor
6816575|NCT02553161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6816576|NCT02549092|Levodopa|levodopa|mesh-list
6816577|NCT02549092|Carbidopa|carbidopa|mesh-list
6816578|NCT02549092|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
6816579|NCT02549092|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6816580|NCT02549092|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6816581|NCT02549092|Dopamine Agents|dopamine agents|mesh-ancestor
6816582|NCT02549092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6816583|NCT02549092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816584|NCT02549092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6816585|NCT02549092|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6816586|NCT02549092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6816587|NCT02549092|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6816588|NCT02549092|Immunologic Factors|immunologic factors|mesh-ancestor
6816589|NCT02549092|Dopamine Agonists|dopamine agonists|mesh-ancestor
6816590|NCT02518555|Vaccines|vaccines|mesh-list
6816591|NCT02518555|Immunologic Factors|immunologic factors|mesh-ancestor
6816592|NCT02518555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6816593|NCT02515773|Metformin|metformin|mesh-list
6816594|NCT02515773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6816595|NCT02515773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6816596|NCT02478788|Amphetamine|amphetamine|mesh-list
6816597|NCT02478788|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6816598|NCT02478788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6816599|NCT02478788|Sympathomimetics|sympathomimetics|mesh-ancestor
6816600|NCT02478788|Autonomic Agents|autonomic agents|mesh-ancestor
6816601|NCT02478788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6816602|NCT02478788|Dopamine Agents|dopamine agents|mesh-ancestor
6816603|NCT02478788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6816604|NCT02478788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816605|NCT02478788|Adrenergic Agents|adrenergic agents|mesh-ancestor
6816606|NCT02478788|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6816607|NCT02478788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6816608|NCT02478788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6816609|NCT02478788|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6816610|NCT02466971|Cisplatin|cisplatin|mesh-list
6816611|NCT02466971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816612|NCT02465060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6816613|NCT02465060|Nivolumab|nivolumab|mesh-list
6816614|NCT02465060|Trastuzumab|trastuzumab|mesh-list
6816615|NCT02465060|Pertuzumab|pertuzumab|mesh-list
6816616|NCT02465060|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
6816617|NCT02465060|Sunitinib|sunitinib|mesh-list
6816618|NCT02465060|Dasatinib|dasatinib|mesh-list
6816619|NCT02465060|Palbociclib|palbociclib|mesh-list
6816620|NCT02465060|Trametinib|trametinib|mesh-list
6816621|NCT02465060|Afatinib|afatinib|mesh-list
6816622|NCT02465060|Osimertinib|osimertinib|mesh-list
6816623|NCT02465060|Dabrafenib|dabrafenib|mesh-list
6816624|NCT02465060|Crizotinib|crizotinib|mesh-list
6816625|NCT02465060|Maytansine|maytansine|mesh-list
6816626|NCT02465060|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
6816627|NCT02465060|GSK2636771|gsk2636771|mesh-list
6816628|NCT02465060|Antibodies|antibodies|mesh-list
6816629|NCT02465060|Immunoglobulins|immunoglobulins|mesh-list
6816630|NCT02465060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6816631|NCT02465060|Immunoglobulin G|immunoglobulin g|mesh-list
5993657|NCT00124514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6816632|NCT02465060|Immunoconjugates|immunoconjugates|mesh-list
6816633|NCT02465060|Adavosertib|adavosertib|mesh-list
6816634|NCT02465060|Immunologic Factors|immunologic factors|mesh-ancestor
6816635|NCT02465060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6816636|NCT02465060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816637|NCT02465060|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6816638|NCT02465060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816639|NCT02465060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6816640|NCT02465060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6816641|NCT02465060|Growth Substances|growth substances|mesh-ancestor
6816642|NCT02465060|Growth Inhibitors|growth inhibitors|mesh-ancestor
6816643|NCT02465060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6816644|NCT02465060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6816645|NCT02465060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6816646|NCT02465060|Tubulin Modulators|tubulin modulators|mesh-ancestor
6816647|NCT02465060|Antimitotic Agents|antimitotic agents|mesh-ancestor
6816648|NCT02465060|Mitosis Modulators|mitosis modulators|mesh-ancestor
6816649|NCT02431715|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
6816650|NCT02431715|Dopamine Agents|dopamine agents|mesh-ancestor
6816651|NCT02431715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6816652|NCT02431715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816653|NCT02431715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6816654|NCT02335242|Sildenafil Citrate|sildenafil citrate|mesh-list
6816655|NCT02335242|Vasodilator Agents|vasodilator agents|mesh-ancestor
6816656|NCT02335242|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6816657|NCT02335242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6816658|NCT02335242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6816659|NCT02335242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816660|NCT02335242|Urological Agents|urological agents|mesh-ancestor
6816661|NCT02323126|Nivolumab|nivolumab|mesh-list
6816662|NCT02323126|Nazartinib|nazartinib|mesh-list
6816663|NCT02323126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6816664|NCT02323126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816665|NCT02323126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6816666|NCT02323126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816667|NCT02314169|Nivolumab|nivolumab|mesh-list
6816668|NCT02314169|Ipilimumab|ipilimumab|mesh-list
6816669|NCT02314169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6816670|NCT02314169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816671|NCT02314169|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6816672|NCT02314169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816673|NCT02193425|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6816674|NCT02193425|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6816675|NCT02193425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816676|NCT01902290|Brodalumab|brodalumab|mesh-list
6816677|NCT01902290|Dermatologic Agents|dermatologic agents|mesh-ancestor
6816678|NCT01810913|Cisplatin|cisplatin|mesh-list
6816679|NCT01810913|Docetaxel|docetaxel|mesh-list
6816680|NCT01810913|Cetuximab|cetuximab|mesh-list
6816681|NCT01810913|Atezolizumab|atezolizumab|mesh-list
6816682|NCT01810913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6816683|NCT01810913|Antibodies|antibodies|mesh-list
6816684|NCT01810913|Immunoglobulins|immunoglobulins|mesh-list
6816685|NCT01810913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6816686|NCT01810913|Immunologic Factors|immunologic factors|mesh-ancestor
6816687|NCT01810913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6816688|NCT01810913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816689|NCT01810913|Tubulin Modulators|tubulin modulators|mesh-ancestor
6816690|NCT01810913|Antimitotic Agents|antimitotic agents|mesh-ancestor
6816691|NCT01810913|Mitosis Modulators|mitosis modulators|mesh-ancestor
6816692|NCT01810913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816693|NCT01712763|Goserelin|goserelin|mesh-list
6816694|NCT01712763|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6816695|NCT01712763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6816696|NCT01712763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816697|NCT01712763|Luteolytic Agents|luteolytic agents|mesh-ancestor
6816698|NCT01712763|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6816699|NCT01712763|Contraceptive Agents|contraceptive agents|mesh-ancestor
6816700|NCT01712763|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6816701|NCT01712763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6816702|NCT01712763|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6816703|NCT01619085|Nintedanib|nintedanib|mesh-list
6816704|NCT01619085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816705|NCT01619085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6816706|NCT01619085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6816707|NCT01619085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816708|NCT01517100|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6816709|NCT01517100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6816710|NCT01495598|Pomalidomide|pomalidomide|mesh-list
6816711|NCT01495598|Immunologic Factors|immunologic factors|mesh-ancestor
6816712|NCT01495598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6816713|NCT01495598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6816714|NCT01495598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6816715|NCT01495598|Growth Substances|growth substances|mesh-ancestor
6816716|NCT01495598|Growth Inhibitors|growth inhibitors|mesh-ancestor
6816717|NCT01495598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816718|NCT01419561|Zidovudine|zidovudine|mesh-list
6816719|NCT01419561|Rituximab|rituximab|mesh-list
6816720|NCT01419561|Doxorubicin|doxorubicin|mesh-list
6816721|NCT01419561|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6816722|NCT01419561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6816723|NCT01419561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816724|NCT01419561|Immunologic Factors|immunologic factors|mesh-ancestor
6816725|NCT01419561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6816726|NCT01419561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6816727|NCT01419561|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6816728|NCT01419561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6816729|NCT01419561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6816730|NCT01419561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6816731|NCT01419561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816732|NCT01419561|Antimetabolites|antimetabolites|mesh-ancestor
6816733|NCT01419561|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6816734|NCT01419561|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6816735|NCT01419561|Antiviral Agents|antiviral agents|mesh-ancestor
6816736|NCT01419561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6816737|NCT01419561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6816738|NCT01419561|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6816739|NCT01366612|Vidarabine|vidarabine|mesh-list
6816740|NCT01366612|Fludarabine|fludarabine|mesh-list
6816741|NCT01366612|Fludarabine phosphate|fludarabine phosphate|mesh-list
6816742|NCT01366612|Busulfan|busulfan|mesh-list
6816743|NCT01366612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816744|NCT01366612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6816745|NCT01366612|Antimetabolites|antimetabolites|mesh-ancestor
6816746|NCT01366612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816747|NCT01366612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6816748|NCT01366612|Immunologic Factors|immunologic factors|mesh-ancestor
6816749|NCT01366612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6816750|NCT01366612|Antiviral Agents|antiviral agents|mesh-ancestor
6816751|NCT01366612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6816752|NCT01366612|Alkylating Agents|alkylating agents|mesh-ancestor
6816753|NCT01366612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6816754|NCT01366612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6816755|NCT01352962|Gemcitabine|gemcitabine|mesh-list
6816756|NCT01352962|Carboplatin|carboplatin|mesh-list
6816757|NCT01352962|Lenalidomide|lenalidomide|mesh-list
6816758|NCT01352962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816759|NCT01352962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6816760|NCT01352962|Antimetabolites|antimetabolites|mesh-ancestor
6816761|NCT01352962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816762|NCT01352962|Antiviral Agents|antiviral agents|mesh-ancestor
6816763|NCT01352962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6816764|NCT01352962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6816765|NCT01352962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6816766|NCT01352962|Immunologic Factors|immunologic factors|mesh-ancestor
6816767|NCT01352962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6816768|NCT01352962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6816769|NCT01352962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6816770|NCT01352962|Growth Substances|growth substances|mesh-ancestor
6816771|NCT01352962|Growth Inhibitors|growth inhibitors|mesh-ancestor
6816772|NCT01176006|Cyclophosphamide|cyclophosphamide|mesh-list
6816773|NCT01176006|Busulfan|busulfan|mesh-list
6816774|NCT01176006|Fludarabine|fludarabine|mesh-list
6816775|NCT01176006|Fludarabine phosphate|fludarabine phosphate|mesh-list
6816776|NCT01176006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6816777|NCT01176006|Immunologic Factors|immunologic factors|mesh-ancestor
6816778|NCT01176006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6816779|NCT01176006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6816780|NCT01176006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6816781|NCT01176006|Alkylating Agents|alkylating agents|mesh-ancestor
6816782|NCT01176006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816783|NCT01176006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816784|NCT01176006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6816785|NCT01176006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6816786|NCT01176006|Antimetabolites|antimetabolites|mesh-ancestor
6816787|NCT01126749|Gemcitabine|gemcitabine|mesh-list
6816788|NCT01126749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816789|NCT01126749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6816790|NCT01126749|Antimetabolites|antimetabolites|mesh-ancestor
6816791|NCT01126749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816792|NCT01126749|Antiviral Agents|antiviral agents|mesh-ancestor
6816793|NCT01126749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6816794|NCT01126749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6816795|NCT01126749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6816796|NCT01126749|Immunologic Factors|immunologic factors|mesh-ancestor
6816797|NCT01126749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6816798|NCT01064245|Mannitol|mannitol|mesh-list
6816799|NCT01064245|Methacholine Chloride|methacholine chloride|mesh-list
6816800|NCT01064245|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6816801|NCT01064245|Diuretics|diuretics|mesh-ancestor
6816802|NCT01064245|Natriuretic Agents|natriuretic agents|mesh-ancestor
6816803|NCT01064245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6816804|NCT01064245|Miotics|miotics|mesh-ancestor
6816805|NCT01064245|Autonomic Agents|autonomic agents|mesh-ancestor
6816806|NCT01064245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6816807|NCT01064245|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6816808|NCT01064245|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
6816809|NCT01064245|Respiratory System Agents|respiratory system agents|mesh-ancestor
6816810|NCT01064245|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6816811|NCT01064245|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6816812|NCT01064245|Cholinergic Agents|cholinergic agents|mesh-ancestor
6816813|NCT01064245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6816814|NCT01064245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816815|NCT01059448|Brodalumab|brodalumab|mesh-list
6816816|NCT01059448|Dermatologic Agents|dermatologic agents|mesh-ancestor
6816817|NCT00977977|Cyclosporine|cyclosporine|mesh-list
6816818|NCT00977977|Rituximab|rituximab|mesh-list
6816819|NCT00977977|Cyclosporins|cyclosporins|mesh-list
6816820|NCT00977977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6816821|NCT00977977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816822|NCT00977977|Immunologic Factors|immunologic factors|mesh-ancestor
6816823|NCT00977977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6816824|NCT00977977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6816825|NCT00977977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6816826|NCT00977977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816827|NCT00977977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6816828|NCT00977977|Antifungal Agents|antifungal agents|mesh-ancestor
6816829|NCT00977977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6816830|NCT00977977|Dermatologic Agents|dermatologic agents|mesh-ancestor
6816831|NCT00977977|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6816832|NCT00821587|Cyclosporine|cyclosporine|mesh-list
6816833|NCT00821587|Tacrolimus|tacrolimus|mesh-list
6816834|NCT00821587|Cyclosporins|cyclosporins|mesh-list
6816835|NCT00821587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6816836|NCT00821587|Immunologic Factors|immunologic factors|mesh-ancestor
6816837|NCT00821587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6816838|NCT00821587|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6816839|NCT00821587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6816840|NCT00821587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816841|NCT00821587|Antifungal Agents|antifungal agents|mesh-ancestor
6816842|NCT00821587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6816843|NCT00821587|Dermatologic Agents|dermatologic agents|mesh-ancestor
6816844|NCT00821587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6816845|NCT00720785|Bortezomib|bortezomib|mesh-list
6816846|NCT00720785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816847|NCT00652574|Dasatinib|dasatinib|mesh-list
6816848|NCT00652574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816849|NCT00652574|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6816850|NCT00652574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6816851|NCT00652574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816852|NCT00585195|Itraconazole|itraconazole|mesh-list
6816853|NCT00585195|Rifampin|rifampin|mesh-list
6816854|NCT00585195|Crizotinib|crizotinib|mesh-list
6816855|NCT00585195|Antifungal Agents|antifungal agents|mesh-ancestor
6816856|NCT00585195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6816857|NCT00585195|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6816858|NCT00585195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6816859|NCT00585195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6816860|NCT00585195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816861|NCT00585195|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6816862|NCT00585195|Hormone Antagonists|hormone antagonists|mesh-ancestor
6816863|NCT00585195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6816864|NCT00585195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6816865|NCT00585195|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6816866|NCT00585195|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6816867|NCT00585195|Antitubercular Agents|antitubercular agents|mesh-ancestor
6816868|NCT00585195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6816869|NCT00585195|Leprostatic Agents|leprostatic agents|mesh-ancestor
6816870|NCT00585195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6816871|NCT00585195|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6816872|NCT00585195|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6816873|NCT00585195|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6816874|NCT00585195|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6816875|NCT00585195|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6816876|NCT00585195|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6816877|NCT00585195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816878|NCT00585195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6816879|NCT00278915|Fulvestrant|fulvestrant|mesh-list
6816880|NCT00278915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6816881|NCT00278915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816882|NCT00278915|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6816883|NCT00278915|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6816884|NCT00278915|Hormone Antagonists|hormone antagonists|mesh-ancestor
6816885|NCT00278915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6816886|NCT00278915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6816887|NCT00065676|Quercetin|quercetin|mesh-list
6816888|NCT00065676|Antioxidants|antioxidants|mesh-ancestor
6816889|NCT00065676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6816890|NCT00065676|Protective Agents|protective agents|mesh-ancestor
6816891|NCT00065676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6816892|NCT00061568|Sirolimus|sirolimus|mesh-list
6816893|NCT00061568|Alemtuzumab|alemtuzumab|mesh-list
6816894|NCT00061568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6816895|NCT00061568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6816896|NCT00061568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6816897|NCT00061568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816898|NCT00061568|Antifungal Agents|antifungal agents|mesh-ancestor
6816899|NCT00061568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6816900|NCT00061568|Immunologic Factors|immunologic factors|mesh-ancestor
6816901|NCT00061568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6816902|NCT00061568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6816903|NCT00001379|Interferons|interferons|mesh-list
6816904|NCT00001379|Rituximab|rituximab|mesh-list
6816905|NCT00001379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816906|NCT00001379|Antiviral Agents|antiviral agents|mesh-ancestor
6816907|NCT00001379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6816908|NCT00001379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6816909|NCT00001379|Immunologic Factors|immunologic factors|mesh-ancestor
6816910|NCT00001379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6816911|NCT00001379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6816912|NCT00001337|Rituximab|rituximab|mesh-list
6816913|NCT00001337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6816914|NCT00001337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6816915|NCT00001337|Immunologic Factors|immunologic factors|mesh-ancestor
6816916|NCT00001337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6816917|NCT00001337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6536417|NCT00816959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6258714|NCT03096444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6258715|NCT03096444|Adrenergic Agents|adrenergic agents|mesh-ancestor
6258716|NCT03096444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6258717|NCT03096444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6258718|NCT03096730|Sufentanil|sufentanil|mesh-list
6258719|NCT03096730|Dexmedetomidine|dexmedetomidine|mesh-list
6258720|NCT03096730|Remifentanil|remifentanil|mesh-list
6258721|NCT03096730|Dsuvia|dsuvia|mesh-list
6258722|NCT03096730|Nalmefene|nalmefene|mesh-list
6536418|NCT00816959|Alkylating Agents|alkylating agents|mesh-ancestor
5993658|NCT00124514|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5993659|NCT00124514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5993660|NCT00124514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5993661|NCT00124579|Thalidomide|thalidomide|mesh-list
5993662|NCT00124579|Dexamethasone|dexamethasone|mesh-list
5993663|NCT00124579|Bortezomib|bortezomib|mesh-list
5993664|NCT00124579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5993665|NCT00124579|Antiemetics|antiemetics|mesh-ancestor
5993666|NCT00124579|Autonomic Agents|autonomic agents|mesh-ancestor
5993667|NCT00124579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5993668|NCT00124579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993669|NCT00124579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5993670|NCT00124579|Glucocorticoids|glucocorticoids|mesh-ancestor
5993671|NCT00124579|Hormones|hormones|mesh-ancestor
5993672|NCT00124579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5993673|NCT00124579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5993674|NCT00124579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5993675|NCT00124579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5993676|NCT00124579|Immunologic Factors|immunologic factors|mesh-ancestor
5993677|NCT00124579|Leprostatic Agents|leprostatic agents|mesh-ancestor
5993678|NCT00124579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5993679|NCT00124579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5993680|NCT00124579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5993681|NCT00124579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5993682|NCT00124579|Growth Substances|growth substances|mesh-ancestor
5993683|NCT00124579|Growth Inhibitors|growth inhibitors|mesh-ancestor
5993684|NCT00124618|Cetuximab|cetuximab|mesh-list
5993685|NCT00124618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5993686|NCT00124618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5993687|NCT00124657|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5993688|NCT00124657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5993689|NCT00124657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5993690|NCT00124657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5993691|NCT00124657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5993692|NCT00124709|Pimecrolimus|pimecrolimus|mesh-list
5993693|NCT00124709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5993694|NCT00124709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5993695|NCT00124709|Analgesics|analgesics|mesh-ancestor
5993696|NCT00124709|Sensory System Agents|sensory system agents|mesh-ancestor
5993697|NCT00124709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5993698|NCT00124709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993699|NCT00124709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5993700|NCT00124709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5993701|NCT00124709|Dermatologic Agents|dermatologic agents|mesh-ancestor
5993702|NCT00124709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5993703|NCT00124709|Immunologic Factors|immunologic factors|mesh-ancestor
5993704|NCT00124709|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5993705|NCT00124709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5993706|NCT00124709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5993707|NCT00124735|Rocuronium|rocuronium|mesh-list
5993708|NCT00124735|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5993709|NCT00124735|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5993710|NCT00124735|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5993711|NCT00124735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5993712|NCT00124735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993713|NCT00124748|Imatinib Mesylate|imatinib mesylate|mesh-list
5993714|NCT00124748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5993715|NCT00124748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5993716|NCT00124748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6017671|NCT00374556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5993717|NCT00124748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017672|NCT00374556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017673|NCT00374803|Mycophenolic Acid|mycophenolic acid|mesh-list
6017674|NCT00374803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6017675|NCT00374803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6017676|NCT00374803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6017677|NCT00374803|Antitubercular Agents|antitubercular agents|mesh-ancestor
6017678|NCT00374803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6017679|NCT00374803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6017680|NCT00374803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6017681|NCT00374803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017682|NCT00374868|Pemetrexed|pemetrexed|mesh-list
6017683|NCT00374868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6017684|NCT00374868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5993718|NCT00124943|Paclitaxel|paclitaxel|mesh-list
5993719|NCT00124943|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5993720|NCT00124943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5993721|NCT00124943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5993722|NCT00124943|Tubulin Modulators|tubulin modulators|mesh-ancestor
5993723|NCT00124943|Antimitotic Agents|antimitotic agents|mesh-ancestor
5993724|NCT00124943|Mitosis Modulators|mitosis modulators|mesh-ancestor
5993725|NCT00124943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5993726|NCT00124982|Abatacept|abatacept|mesh-list
5993727|NCT00124982|Antirheumatic Agents|antirheumatic agents|mesh-list
5993728|NCT00124982|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5993729|NCT00124982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5993730|NCT00124982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5993731|NCT00124982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5993732|NCT00124982|Immunologic Factors|immunologic factors|mesh-ancestor
5993733|NCT00124982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993734|NCT00125034|Oxaliplatin|oxaliplatin|mesh-list
5993735|NCT00125034|Cetuximab|cetuximab|mesh-list
5993736|NCT00125034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5993737|NCT00125034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5993738|NCT00125138|Metylperon|metylperon|mesh-list
5993739|NCT00125138|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5993740|NCT00125138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5993741|NCT00125138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5993742|NCT00125138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993743|NCT00125138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5993744|NCT00125164|Mecasermin|mecasermin|mesh-list
5993745|NCT00125164|Growth Substances|growth substances|mesh-ancestor
5993746|NCT00125164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993747|NCT00125190|Mecasermin|mecasermin|mesh-list
5993748|NCT00125190|Growth Substances|growth substances|mesh-ancestor
5993749|NCT00125190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993750|NCT00125359|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5993751|NCT00125359|Bexarotene|bexarotene|mesh-list
5993752|NCT00125359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5993753|NCT00125359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5993754|NCT00125359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5993755|NCT00125359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5993756|NCT00125372|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5993757|NCT00125372|Bexarotene|bexarotene|mesh-list
5993758|NCT00125372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5993759|NCT00125372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5993760|NCT00125372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5993761|NCT00125372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5993762|NCT00125515|Naltrexone|naltrexone|mesh-list
5993763|NCT00125515|Memantine|memantine|mesh-list
5993764|NCT00125515|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5993765|NCT00125515|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5993766|NCT00125515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993767|NCT00125515|Sensory System Agents|sensory system agents|mesh-ancestor
5993768|NCT00125515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5993769|NCT00125515|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6258723|NCT03096730|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6258724|NCT03096730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6258725|NCT03096730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258726|NCT03096730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6258727|NCT03096730|Analgesics|analgesics|mesh-ancestor
6258728|NCT03096730|Sensory System Agents|sensory system agents|mesh-ancestor
6258729|NCT03096730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6258730|NCT03096730|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6258731|NCT03096730|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6258732|NCT03096730|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6258733|NCT03096730|Adrenergic Agents|adrenergic agents|mesh-ancestor
6258734|NCT03096730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6258735|NCT03096730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258736|NCT03096730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6258737|NCT03096730|Narcotics|narcotics|mesh-ancestor
6258738|NCT03096730|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6258739|NCT03096730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6258740|NCT03096730|Anesthetics, General|anesthetics, general|mesh-ancestor
6258741|NCT03096730|Anesthetics|anesthetics|mesh-ancestor
6258742|NCT03096730|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6258743|NCT03096847|Letrozole|letrozole|mesh-list
6258744|NCT03096847|Goserelin|goserelin|mesh-list
6258745|NCT03096847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6258746|NCT03096847|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5993770|NCT00125515|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5993771|NCT00125515|Dopamine Agents|dopamine agents|mesh-ancestor
5993772|NCT00125515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5993773|NCT00125515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5993774|NCT00125515|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5993775|NCT00125515|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5993776|NCT00125528|Cycloserine|cycloserine|mesh-list
5993777|NCT00125528|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5993778|NCT00125528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5993779|NCT00125528|Renal Agents|renal agents|mesh-ancestor
5993780|NCT00125528|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5993781|NCT00125528|Antitubercular Agents|antitubercular agents|mesh-ancestor
5993782|NCT00125528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5993783|NCT00125528|Antimetabolites|antimetabolites|mesh-ancestor
5993784|NCT00125528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5993785|NCT00125593|Simvastatin|simvastatin|mesh-list
5993786|NCT00125593|Ezetimibe|ezetimibe|mesh-list
5993787|NCT00125593|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5993788|NCT00125593|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5993789|NCT00125593|Antimetabolites|antimetabolites|mesh-ancestor
5993790|NCT00125593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5993791|NCT00125593|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5993792|NCT00125593|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5993793|NCT00125593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5993794|NCT00125853|Atenolol|atenolol|mesh-list
5993795|NCT00125853|Nebivolol|nebivolol|mesh-list
5993796|NCT00125853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5993797|NCT00125853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5993798|NCT00125853|Sympatholytics|sympatholytics|mesh-ancestor
5993799|NCT00125853|Autonomic Agents|autonomic agents|mesh-ancestor
5993800|NCT00125853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5993801|NCT00125853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993802|NCT00125853|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5993803|NCT00125853|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5993804|NCT00125853|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5993805|NCT00125853|Adrenergic Agents|adrenergic agents|mesh-ancestor
5993806|NCT00125853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5993807|NCT00125853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5993808|NCT00125853|Vasodilator Agents|vasodilator agents|mesh-ancestor
5993809|NCT00125853|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5993810|NCT00125853|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5993811|NCT00125853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5993812|NCT00125931|Pentazocine|pentazocine|mesh-list
5993813|NCT00125931|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5993814|NCT00125931|Narcotics|narcotics|mesh-ancestor
5993815|NCT00125931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5993816|NCT00125931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993817|NCT00125931|Analgesics|analgesics|mesh-ancestor
5993818|NCT00125931|Sensory System Agents|sensory system agents|mesh-ancestor
5993819|NCT00125931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5993820|NCT00125931|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5993821|NCT00125931|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5993822|NCT00125957|Bupropion|bupropion|mesh-list
5993823|NCT00125957|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5993824|NCT00125957|Antidepressive Agents|antidepressive agents|mesh-ancestor
5993825|NCT00125957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5993826|NCT00125957|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5993827|NCT00125957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5993828|NCT00125957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5993829|NCT00125957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5993830|NCT00125957|Dopamine Agents|dopamine agents|mesh-ancestor
5993831|NCT00125957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5993832|NCT00125957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993833|NCT00125957|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5993834|NCT00125957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5993835|NCT00125957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5993836|NCT00126191|Leucovorin|leucovorin|mesh-list
5993837|NCT00126191|Cytarabine|cytarabine|mesh-list
5993838|NCT00126191|Cyclophosphamide|cyclophosphamide|mesh-list
5993839|NCT00126191|Ifosfamide|ifosfamide|mesh-list
5993840|NCT00126191|Rituximab|rituximab|mesh-list
5993841|NCT00126191|Doxorubicin|doxorubicin|mesh-list
5993842|NCT00126191|Methotrexate|methotrexate|mesh-list
5993843|NCT00126191|Etoposide|etoposide|mesh-list
5993844|NCT00126191|Vincristine|vincristine|mesh-list
5993845|NCT00126191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5993846|NCT00126191|Immunologic Factors|immunologic factors|mesh-ancestor
5993847|NCT00126191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993848|NCT00126191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5993849|NCT00126191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5993850|NCT00126191|Alkylating Agents|alkylating agents|mesh-ancestor
5993851|NCT00126191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5993852|NCT00126191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5993853|NCT00126191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5993854|NCT00126191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5993855|NCT00126191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5993856|NCT00126191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5993857|NCT00126191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5993858|NCT00126191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6258747|NCT03096847|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6258748|NCT03096847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5993859|NCT00126191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5993860|NCT00126191|Abortifacient Agents|abortifacient agents|mesh-ancestor
5993861|NCT00126191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5993862|NCT00126191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5993863|NCT00126191|Antimetabolites|antimetabolites|mesh-ancestor
5993864|NCT00126191|Dermatologic Agents|dermatologic agents|mesh-ancestor
5993865|NCT00126191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5993866|NCT00126191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5993867|NCT00126191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5993868|NCT00126191|Antiviral Agents|antiviral agents|mesh-ancestor
5993869|NCT00126191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5993870|NCT00126191|Antidotes|antidotes|mesh-ancestor
5993871|NCT00126191|Protective Agents|protective agents|mesh-ancestor
5993872|NCT00126191|Vitamin B Complex|vitamin b complex|mesh-ancestor
5993873|NCT00126191|Vitamins|vitamins|mesh-ancestor
5993874|NCT00126191|Micronutrients|micronutrients|mesh-ancestor
5993875|NCT00126191|Tubulin Modulators|tubulin modulators|mesh-ancestor
5993876|NCT00126191|Antimitotic Agents|antimitotic agents|mesh-ancestor
5993877|NCT00126191|Mitosis Modulators|mitosis modulators|mesh-ancestor
5993878|NCT00126425|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
5993879|NCT00126425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5993880|NCT00126425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5993881|NCT00126425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5993882|NCT00126425|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5993883|NCT00126438|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
5993884|NCT00126438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6258749|NCT03096847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258750|NCT03096847|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6258751|NCT03096847|Hormone Antagonists|hormone antagonists|mesh-ancestor
6258752|NCT03096847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5993885|NCT00126438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5993886|NCT00126438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5993887|NCT00126438|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5993888|NCT00126490|Aldesleukin|aldesleukin|mesh-list
5993889|NCT00126490|Bevacizumab|bevacizumab|mesh-list
5993890|NCT00126490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5993891|NCT00126490|Interleukin-2|interleukin-2|mesh-list
5993892|NCT00126490|Endothelial Growth Factors|endothelial growth factors|mesh-list
5993893|NCT00126490|Antibodies|antibodies|mesh-list
5993894|NCT00126490|Immunoglobulins|immunoglobulins|mesh-list
5993895|NCT00126490|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5993896|NCT00126490|Immunoglobulin G|immunoglobulin g|mesh-list
5993897|NCT00126490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5993898|NCT00126490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5993899|NCT00126490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5993900|NCT00126490|Growth Substances|growth substances|mesh-ancestor
5993901|NCT00126490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993902|NCT00126490|Growth Inhibitors|growth inhibitors|mesh-ancestor
5993903|NCT00126490|Immunologic Factors|immunologic factors|mesh-ancestor
5993904|NCT00126490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5993905|NCT00126490|Analgesics|analgesics|mesh-ancestor
5993906|NCT00126490|Sensory System Agents|sensory system agents|mesh-ancestor
6258753|NCT03096847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258754|NCT03096847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6258755|NCT03097133|Esketamine|esketamine|mesh-list
6258756|NCT03097133|Antidepressive Agents|antidepressive agents|mesh-ancestor
6258757|NCT03097133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6258758|NCT03097315|Triamcinolone|triamcinolone|mesh-list
6258759|NCT03097315|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6258760|NCT03097315|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6258761|NCT03097315|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6258762|NCT03097315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6258763|NCT03097315|Glucocorticoids|glucocorticoids|mesh-ancestor
6258764|NCT03097315|Hormones|hormones|mesh-ancestor
5993907|NCT00126490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5993908|NCT00126490|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5993909|NCT00126490|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5993910|NCT00126490|Antiviral Agents|antiviral agents|mesh-ancestor
5993911|NCT00126490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5993912|NCT00126503|Bevacizumab|bevacizumab|mesh-list
5993913|NCT00126503|Sorafenib|sorafenib|mesh-list
5993914|NCT00126503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5993915|NCT00126503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5993916|NCT00126503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5993917|NCT00126503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5993918|NCT00126503|Growth Substances|growth substances|mesh-ancestor
5993919|NCT00126503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993920|NCT00126503|Growth Inhibitors|growth inhibitors|mesh-ancestor
5993921|NCT00126503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5993922|NCT00126503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6018503|NCT00381303|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5993923|NCT00126503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5993924|NCT00126555|Gefitinib|gefitinib|mesh-list
5993925|NCT00126555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6258765|NCT03097315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6258766|NCT03097315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258767|NCT03097315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6258768|NCT03097315|Immunologic Factors|immunologic factors|mesh-ancestor
6258769|NCT03097315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6258770|NCT03097315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5993926|NCT00126555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5993927|NCT00126555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5993928|NCT00126555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5993929|NCT00126568|Sorafenib|sorafenib|mesh-list
5993930|NCT00126568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5993931|NCT00126568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5993932|NCT00126568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5993933|NCT00126568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5993934|NCT00126581|Paclitaxel|paclitaxel|mesh-list
5993935|NCT00126581|Carboplatin|carboplatin|mesh-list
5993936|NCT00126581|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5993937|NCT00126581|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5993938|NCT00126581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5993939|NCT00126581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5993940|NCT00126581|Tubulin Modulators|tubulin modulators|mesh-ancestor
6258771|NCT03097588|Palonosetron|palonosetron|mesh-list
5993941|NCT00126581|Antimitotic Agents|antimitotic agents|mesh-ancestor
6258772|NCT03097588|Antiemetics|antiemetics|mesh-ancestor
5993942|NCT00126581|Mitosis Modulators|mitosis modulators|mesh-ancestor
5993943|NCT00126581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5993944|NCT00126581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5993945|NCT00126581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5993946|NCT00126594|Interferons|interferons|mesh-list
5993947|NCT00126594|Interferon-alpha|interferon-alpha|mesh-list
5993948|NCT00126594|Interferon alpha-2|interferon alpha-2|mesh-list
5993949|NCT00126594|Sorafenib|sorafenib|mesh-list
5993950|NCT00126594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5993951|NCT00126594|Antiviral Agents|antiviral agents|mesh-ancestor
5993952|NCT00126594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5993953|NCT00126594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5993954|NCT00126594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5993955|NCT00126594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258773|NCT03097588|Autonomic Agents|autonomic agents|mesh-ancestor
5993956|NCT00126594|Immunologic Factors|immunologic factors|mesh-ancestor
6258774|NCT03097588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6258775|NCT03097588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258776|NCT03097588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6258777|NCT03097588|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6258778|NCT03097588|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6258779|NCT03097588|Serotonin Agents|serotonin agents|mesh-ancestor
6258780|NCT03097588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6258781|NCT03097588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258782|NCT03097783|Lidocaine|lidocaine|mesh-list
6258783|NCT03097783|Anesthetics, Local|anesthetics, local|mesh-ancestor
6258784|NCT03097783|Anesthetics|anesthetics|mesh-ancestor
5993957|NCT00126594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993958|NCT00127036|Bevacizumab|bevacizumab|mesh-list
5993959|NCT00127036|Capecitabine|capecitabine|mesh-list
5993960|NCT00127036|Oxaliplatin|oxaliplatin|mesh-list
5993961|NCT00127036|Irinotecan|irinotecan|mesh-list
5993962|NCT00127036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5993963|NCT00127036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5993964|NCT00127036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5993965|NCT00127036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5993966|NCT00127036|Growth Substances|growth substances|mesh-ancestor
5993967|NCT00127036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993968|NCT00127036|Growth Inhibitors|growth inhibitors|mesh-ancestor
5993969|NCT00127036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5993970|NCT00127036|Antimetabolites|antimetabolites|mesh-ancestor
5993971|NCT00127036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5993972|NCT00127036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5993973|NCT00127036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5993974|NCT00127036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5993975|NCT00127101|Vorinostat|vorinostat|mesh-list
5993976|NCT00127101|Bexarotene|bexarotene|mesh-list
5993977|NCT00127101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5993978|NCT00127101|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5993979|NCT00127101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5993980|NCT00127101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5993981|NCT00127166|Fluticasone|fluticasone|mesh-list
5993982|NCT00127166|Xhance|xhance|mesh-list
5993983|NCT00127166|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5993984|NCT00127166|Montelukast|montelukast|mesh-list
5993985|NCT00127166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5993986|NCT00127166|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5993987|NCT00127166|Autonomic Agents|autonomic agents|mesh-ancestor
5993988|NCT00127166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5993989|NCT00127166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5993990|NCT00127166|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5993991|NCT00127166|Respiratory System Agents|respiratory system agents|mesh-ancestor
5993992|NCT00127166|Dermatologic Agents|dermatologic agents|mesh-ancestor
5993993|NCT00127166|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5993994|NCT00127166|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5993995|NCT00127166|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5993996|NCT00127166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5993997|NCT00127166|Adrenergic Agents|adrenergic agents|mesh-ancestor
5993998|NCT00127166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5993999|NCT00127166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994000|NCT00127166|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5994001|NCT00127166|Hormone Antagonists|hormone antagonists|mesh-ancestor
5994002|NCT00127166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5994003|NCT00127166|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5994004|NCT00127166|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5994005|NCT00127192|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5994006|NCT00127192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5994007|NCT00127192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994008|NCT00127192|Incretins|incretins|mesh-ancestor
5994009|NCT00127192|Hormones|hormones|mesh-ancestor
5994010|NCT00127192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6536419|NCT00816959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6536420|NCT00816959|Tubulin Modulators|tubulin modulators|mesh-ancestor
6536421|NCT00816959|Antimitotic Agents|antimitotic agents|mesh-ancestor
6258785|NCT03097783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6258786|NCT03097783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258787|NCT03097783|Sensory System Agents|sensory system agents|mesh-ancestor
6258788|NCT03097783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6258789|NCT03097783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6536422|NCT00816959|Mitosis Modulators|mitosis modulators|mesh-ancestor
6258790|NCT03097783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6258791|NCT03097783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6258792|NCT03097783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6258793|NCT03097783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258794|NCT03097861|Lubiprostone|lubiprostone|mesh-list
6258795|NCT03097861|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6258796|NCT03097861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6258797|NCT03097861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258798|NCT03098030|Irinotecan|irinotecan|mesh-list
6258799|NCT03098030|Topotecan|topotecan|mesh-list
6258800|NCT03098030|Dinutuximab|dinutuximab|mesh-list
6258801|NCT03098030|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6258802|NCT03098030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6258803|NCT03098030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6258804|NCT03098030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258805|NCT03098030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6258806|NCT03098420|Dexamethasone|dexamethasone|mesh-list
6258807|NCT03098420|Dexamethasone acetate|dexamethasone acetate|mesh-list
6258808|NCT03098420|Morphine|morphine|mesh-list
6258809|NCT03098420|Bupivacaine|bupivacaine|mesh-list
6258810|NCT03098420|Ropivacaine|ropivacaine|mesh-list
6258811|NCT03098420|BB 1101|bb 1101|mesh-list
6258812|NCT03098420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6258813|NCT03098420|Antiemetics|antiemetics|mesh-ancestor
6258814|NCT03098420|Autonomic Agents|autonomic agents|mesh-ancestor
6258815|NCT03098420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6258816|NCT03098420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258817|NCT03098420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6258818|NCT03098420|Glucocorticoids|glucocorticoids|mesh-ancestor
6258819|NCT03098420|Hormones|hormones|mesh-ancestor
6396833|NCT00209742|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6396834|NCT00209755|Ribavirin|ribavirin|mesh-list
6396835|NCT00209755|Antimetabolites|antimetabolites|mesh-ancestor
5994011|NCT00127192|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5994012|NCT00127192|Protease Inhibitors|protease inhibitors|mesh-ancestor
5994013|NCT00127192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5994014|NCT00127192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994015|NCT00127205|Zoledronic Acid|zoledronic acid|mesh-list
5994016|NCT00127205|Ibandronic Acid|ibandronic acid|mesh-list
5994017|NCT00127205|Clodronic Acid|clodronic acid|mesh-list
5994018|NCT00127205|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5994019|NCT00127205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994020|NCT00127218|Niacin|niacin|mesh-list
5994021|NCT00127218|Atorvastatin|atorvastatin|mesh-list
5994022|NCT00127218|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5994023|NCT00127218|Simvastatin|simvastatin|mesh-list
5994024|NCT00127218|Pravastatin|pravastatin|mesh-list
5994025|NCT00127218|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5994026|NCT00127218|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5994027|NCT00127218|Antimetabolites|antimetabolites|mesh-ancestor
5994028|NCT00127218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994029|NCT00127218|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5994030|NCT00127218|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5994031|NCT00127218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5994032|NCT00127218|Vasodilator Agents|vasodilator agents|mesh-ancestor
5994033|NCT00127218|Vitamin B Complex|vitamin b complex|mesh-ancestor
5994034|NCT00127218|Vitamins|vitamins|mesh-ancestor
5994035|NCT00127218|Micronutrients|micronutrients|mesh-ancestor
5994036|NCT00127218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994037|NCT00127530|4-Aminopyridine|4-aminopyridine|mesh-list
5994038|NCT00127530|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5994039|NCT00127530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5994040|NCT00127530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994041|NCT00127712|Amiodarone|amiodarone|mesh-list
5994042|NCT00127712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5994043|NCT00127712|Vasodilator Agents|vasodilator agents|mesh-ancestor
5994044|NCT00127712|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5994045|NCT00127712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5994046|NCT00127712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994047|NCT00127712|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5994048|NCT00127712|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5994049|NCT00127712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5994050|NCT00127712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5994051|NCT00127712|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6258820|NCT03098420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6258821|NCT03098420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6258822|NCT03098420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6258823|NCT03098420|Protease Inhibitors|protease inhibitors|mesh-ancestor
5994052|NCT00127712|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5994053|NCT00127712|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5994054|NCT00127803|Vaccines|vaccines|mesh-list
5994055|NCT00127803|Immunologic Factors|immunologic factors|mesh-ancestor
5994056|NCT00127803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994057|NCT00127842|Etanercept|etanercept|mesh-list
5994058|NCT00127842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5994059|NCT00127842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5994060|NCT00127842|Analgesics|analgesics|mesh-ancestor
5994061|NCT00127842|Sensory System Agents|sensory system agents|mesh-ancestor
5994062|NCT00127842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5994063|NCT00127842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994064|NCT00127842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5994065|NCT00127842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5994066|NCT00127842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5994067|NCT00127842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5994068|NCT00127842|Immunologic Factors|immunologic factors|mesh-ancestor
5994069|NCT00127855|Vaccines|vaccines|mesh-list
5994070|NCT00127855|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6258824|NCT03098420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6258825|NCT03098420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258826|NCT03098420|Anesthetics, Local|anesthetics, local|mesh-ancestor
6258827|NCT03098420|Anesthetics|anesthetics|mesh-ancestor
6258828|NCT03098420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5994071|NCT00127855|Immunologic Factors|immunologic factors|mesh-ancestor
5994072|NCT00127855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994073|NCT00127933|Capecitabine|capecitabine|mesh-list
5994074|NCT00127933|Docetaxel|docetaxel|mesh-list
5994075|NCT00127933|Trastuzumab|trastuzumab|mesh-list
5994076|NCT00127933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5994077|NCT00127933|Antimetabolites|antimetabolites|mesh-ancestor
5994078|NCT00127933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994079|NCT00127933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5994080|NCT00127933|Tubulin Modulators|tubulin modulators|mesh-ancestor
5994081|NCT00127933|Antimitotic Agents|antimitotic agents|mesh-ancestor
5994082|NCT00127933|Mitosis Modulators|mitosis modulators|mesh-ancestor
5994083|NCT00127933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5994084|NCT00128102|Vorinostat|vorinostat|mesh-list
5994085|NCT00128102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5994086|NCT00128102|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5994087|NCT00128102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5994088|NCT00128102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994089|NCT00128180|Methylprednisolone|methylprednisolone|mesh-list
5994090|NCT00128180|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5994091|NCT00128180|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5994092|NCT00128180|Prednisolone|prednisolone|mesh-list
5994093|NCT00128180|Prednisolone acetate|prednisolone acetate|mesh-list
5994094|NCT00128180|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5994095|NCT00128180|Prednisolone phosphate|prednisolone phosphate|mesh-list
5994096|NCT00128180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5994097|NCT00128180|Antiemetics|antiemetics|mesh-ancestor
5994098|NCT00128180|Autonomic Agents|autonomic agents|mesh-ancestor
5994099|NCT00128180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5994100|NCT00128180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994101|NCT00128180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5994102|NCT00128180|Glucocorticoids|glucocorticoids|mesh-ancestor
5994103|NCT00128180|Hormones|hormones|mesh-ancestor
5994104|NCT00128180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5994105|NCT00128180|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5994106|NCT00128180|Protective Agents|protective agents|mesh-ancestor
5994107|NCT00128180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5994108|NCT00128180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5994109|NCT00128206|Rifampin|rifampin|mesh-list
5994110|NCT00128206|Isoniazid|isoniazid|mesh-list
5994111|NCT00128206|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5994112|NCT00128206|Antitubercular Agents|antitubercular agents|mesh-ancestor
5994113|NCT00128206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5994114|NCT00128206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5994115|NCT00128206|Leprostatic Agents|leprostatic agents|mesh-ancestor
5994116|NCT00128206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5994117|NCT00128206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5994118|NCT00128206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994119|NCT00128206|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5994120|NCT00128206|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5994121|NCT00128206|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5994122|NCT00128206|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6258829|NCT03098420|Sensory System Agents|sensory system agents|mesh-ancestor
6258830|NCT03098420|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6258831|NCT03098420|Narcotics|narcotics|mesh-ancestor
6258832|NCT03098420|Analgesics|analgesics|mesh-ancestor
6258833|NCT03098550|Nivolumab|nivolumab|mesh-list
6258834|NCT03098550|Daratumumab|daratumumab|mesh-list
6258835|NCT03098550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6258836|NCT03098550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6258837|NCT03098550|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6258838|NCT03098550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258839|NCT03098615|Efinaconazole|efinaconazole|mesh-list
6258840|NCT03098615|Antifungal Agents|antifungal agents|mesh-ancestor
6258841|NCT03098615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6258842|NCT03099161|Pembrolizumab|pembrolizumab|mesh-list
5994123|NCT00128206|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5994124|NCT00128206|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5994125|NCT00128206|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5994126|NCT00128206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5994127|NCT00128206|Antimetabolites|antimetabolites|mesh-ancestor
5994128|NCT00128206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5994129|NCT00128401|Cycloserine|cycloserine|mesh-list
5994130|NCT00128401|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5994131|NCT00128401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5994132|NCT00128401|Renal Agents|renal agents|mesh-ancestor
5994133|NCT00128401|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5994134|NCT00128401|Antitubercular Agents|antitubercular agents|mesh-ancestor
5994135|NCT00128401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5994136|NCT00128401|Antimetabolites|antimetabolites|mesh-ancestor
5994137|NCT00128401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994138|NCT00128661|Vaccines|vaccines|mesh-list
5994139|NCT00128661|Immunologic Factors|immunologic factors|mesh-ancestor
5994140|NCT00128661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994141|NCT00128830|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
5994142|NCT00128830|Etravirine|etravirine|mesh-list
5994143|NCT00128830|Enfuvirtide|enfuvirtide|mesh-list
5994144|NCT00128830|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
5994145|NCT00128830|Protease Inhibitors|protease inhibitors|mesh-list
5994146|NCT00128830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5994147|NCT00128830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5994148|NCT00128830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994149|NCT00128830|Antiviral Agents|antiviral agents|mesh-ancestor
5994150|NCT00128830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5994151|NCT00128830|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5994152|NCT00128830|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5994153|NCT00128830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5994154|NCT00128830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5994155|NCT00128830|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5994156|NCT00128921|Bortezomib|bortezomib|mesh-list
5994157|NCT00128921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5994158|NCT00129116|Vaccines|vaccines|mesh-list
5994159|NCT00129116|Immunologic Factors|immunologic factors|mesh-ancestor
6258843|NCT03099161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6258844|NCT03099161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5994160|NCT00129116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994161|NCT00129129|Vaccines|vaccines|mesh-list
5994162|NCT00129129|Immunologic Factors|immunologic factors|mesh-ancestor
5994163|NCT00129129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994164|NCT00129220|Haloperidol|haloperidol|mesh-list
5994165|NCT00129220|Olanzapine|olanzapine|mesh-list
5994166|NCT00129220|Haloperidol decanoate|haloperidol decanoate|mesh-list
5994167|NCT00129220|Antiemetics|antiemetics|mesh-ancestor
5994168|NCT00129220|Autonomic Agents|autonomic agents|mesh-ancestor
5994169|NCT00129220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5994170|NCT00129220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994171|NCT00129220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5994172|NCT00129220|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5994173|NCT00129220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5994174|NCT00129220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5994175|NCT00129220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5994176|NCT00129220|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5994177|NCT00129220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5994178|NCT00129220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5994179|NCT00129220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994180|NCT00129220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5994181|NCT00129220|Serotonin Agents|serotonin agents|mesh-ancestor
5994182|NCT00129220|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5994183|NCT00129220|Dopamine Agents|dopamine agents|mesh-ancestor
5994184|NCT00129220|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5994185|NCT00129246|Naltrexone|naltrexone|mesh-list
5994186|NCT00129246|Bupropion|bupropion|mesh-list
5994187|NCT00129246|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5994188|NCT00129246|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5994189|NCT00129246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994190|NCT00129246|Sensory System Agents|sensory system agents|mesh-ancestor
5994191|NCT00129246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5994192|NCT00129246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5994193|NCT00129246|Antidepressive Agents|antidepressive agents|mesh-ancestor
5994194|NCT00129246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5994195|NCT00129246|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5994196|NCT00129246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5994197|NCT00129246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5994198|NCT00129246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994199|NCT00129246|Dopamine Agents|dopamine agents|mesh-ancestor
5994200|NCT00129246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5994201|NCT00129246|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5994202|NCT00129246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5994203|NCT00129246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5994204|NCT00129259|Iron|iron|mesh-list
5994205|NCT00129259|Trace Elements|trace elements|mesh-ancestor
5994206|NCT00129259|Micronutrients|micronutrients|mesh-ancestor
5994207|NCT00129259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994208|NCT00129272|Bupropion|bupropion|mesh-list
5994209|NCT00129272|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5994210|NCT00129272|Antidepressive Agents|antidepressive agents|mesh-ancestor
5994211|NCT00129272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5994212|NCT00129272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5994213|NCT00129272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5994214|NCT00129272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5994215|NCT00129272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994216|NCT00129272|Dopamine Agents|dopamine agents|mesh-ancestor
5994217|NCT00129272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5994218|NCT00129272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994219|NCT00129272|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5994220|NCT00129272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5994221|NCT00129272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5994222|NCT00129285|Modafinil|modafinil|mesh-list
5994223|NCT00129285|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5994224|NCT00129285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994225|NCT00129285|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
5994226|NCT00129285|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5994227|NCT00129285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5994228|NCT00129285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994229|NCT00129311|Selegiline|selegiline|mesh-list
5994230|NCT00129311|Antidepressive Agents|antidepressive agents|mesh-ancestor
5994231|NCT00129311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5994232|NCT00129311|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6258845|NCT03099187|Pirfenidone|pirfenidone|mesh-list
5994233|NCT00129311|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5994234|NCT00129311|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
5994235|NCT00129311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5994236|NCT00129311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994237|NCT00129311|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5994238|NCT00129311|Protective Agents|protective agents|mesh-ancestor
5994239|NCT00129311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994240|NCT00129376|Cyclophosphamide|cyclophosphamide|mesh-list
5994241|NCT00129376|Docetaxel|docetaxel|mesh-list
5994242|NCT00129376|Doxorubicin|doxorubicin|mesh-list
5994243|NCT00129376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5994244|NCT00129376|Immunologic Factors|immunologic factors|mesh-ancestor
6258846|NCT03099187|Analgesics|analgesics|mesh-ancestor
6258847|NCT03099187|Sensory System Agents|sensory system agents|mesh-ancestor
6258848|NCT03099187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6258849|NCT03099187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258850|NCT03099187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6258851|NCT03099187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6258852|NCT03099187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6258853|NCT03099187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6258854|NCT03099187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6258855|NCT03099538|Ixekizumab|ixekizumab|mesh-list
5994245|NCT00129376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994246|NCT00129376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5994247|NCT00129376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5994248|NCT00129376|Alkylating Agents|alkylating agents|mesh-ancestor
5994249|NCT00129376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994250|NCT00129376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5994251|NCT00129376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5994252|NCT00129376|Tubulin Modulators|tubulin modulators|mesh-ancestor
5994253|NCT00129376|Antimitotic Agents|antimitotic agents|mesh-ancestor
5994254|NCT00129376|Mitosis Modulators|mitosis modulators|mesh-ancestor
5994255|NCT00129376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5994256|NCT00129376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5994257|NCT00129376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5994258|NCT00129376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5994259|NCT00129389|Paclitaxel|paclitaxel|mesh-list
5994260|NCT00129389|Cyclophosphamide|cyclophosphamide|mesh-list
5994261|NCT00129389|Doxorubicin|doxorubicin|mesh-list
5994262|NCT00129389|Fluorouracil|fluorouracil|mesh-list
5994263|NCT00129389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5994264|NCT00129389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5994265|NCT00129389|Tubulin Modulators|tubulin modulators|mesh-ancestor
5994266|NCT00129389|Antimitotic Agents|antimitotic agents|mesh-ancestor
5994267|NCT00129389|Mitosis Modulators|mitosis modulators|mesh-ancestor
5994268|NCT00129389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258856|NCT03099538|Dermatologic Agents|dermatologic agents|mesh-ancestor
5994269|NCT00129389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5994270|NCT00129389|Immunologic Factors|immunologic factors|mesh-ancestor
6258857|NCT03100058|Licogliflozin|licogliflozin|mesh-list
6258858|NCT03100058|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6258859|NCT03100058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258860|NCT03100058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6258861|NCT03100058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994271|NCT00129389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994272|NCT00129389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5994273|NCT00129389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5994274|NCT00129389|Alkylating Agents|alkylating agents|mesh-ancestor
5994275|NCT00129389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5994276|NCT00129389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5994277|NCT00129389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5994278|NCT00129389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5994279|NCT00129389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5994280|NCT00129389|Antimetabolites|antimetabolites|mesh-ancestor
5994281|NCT00129389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5994282|NCT00129467|Methylphenidate|methylphenidate|mesh-list
5994283|NCT00129467|Serotonin|serotonin|mesh-list
5994284|NCT00129467|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
5994285|NCT00129467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5994286|NCT00129467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994287|NCT00129467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5994288|NCT00129467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5994289|NCT00129467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5994290|NCT00129467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258862|NCT03100123|Aspirin|aspirin|mesh-list
6258863|NCT03100123|Heparin|heparin|mesh-list
6258864|NCT03100123|Enoxaparin|enoxaparin|mesh-list
6258865|NCT03100123|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6258866|NCT03100123|Tinzaparin|tinzaparin|mesh-list
6258867|NCT03100123|Dalteparin|dalteparin|mesh-list
6258868|NCT03100123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6258869|NCT03100123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6258870|NCT03100123|Analgesics|analgesics|mesh-ancestor
6258871|NCT03100123|Sensory System Agents|sensory system agents|mesh-ancestor
6258872|NCT03100123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6258873|NCT03100123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258874|NCT03100123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6258875|NCT03100123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6258876|NCT03100123|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6258877|NCT03100123|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6258878|NCT03100123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258879|NCT03100123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5994291|NCT00129467|Dopamine Agents|dopamine agents|mesh-ancestor
5994292|NCT00129467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5994293|NCT00129467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5994294|NCT00129467|Serotonin Agents|serotonin agents|mesh-ancestor
5994295|NCT00129545|Warfarin|warfarin|mesh-list
5994296|NCT00129545|Anticoagulants|anticoagulants|mesh-ancestor
6258880|NCT03100123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5994297|NCT00129623|Ibandronic Acid|ibandronic acid|mesh-list
5994298|NCT00129623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5994299|NCT00129623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994300|NCT00129727|Paclitaxel|paclitaxel|mesh-list
5994301|NCT00129727|Bevacizumab|bevacizumab|mesh-list
5994302|NCT00129727|Carboplatin|carboplatin|mesh-list
5994303|NCT00129727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6258881|NCT03100123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6258882|NCT03100123|Antipyretics|antipyretics|mesh-ancestor
6258883|NCT03100123|Anticoagulants|anticoagulants|mesh-ancestor
6258884|NCT03100838|Nifedipine|nifedipine|mesh-list
6258885|NCT03100838|Omeprazole|omeprazole|mesh-list
6258886|NCT03100838|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6258887|NCT03100838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6258888|NCT03100838|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6258889|NCT03100838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6258890|NCT03100838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258891|NCT03100838|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6258892|NCT03100838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6258893|NCT03100838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6258894|NCT03100838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258895|NCT03100838|Vasodilator Agents|vasodilator agents|mesh-ancestor
6258896|NCT03100838|Tocolytic Agents|tocolytic agents|mesh-ancestor
6258897|NCT03100838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6258898|NCT03101033|Betamethasone|betamethasone|mesh-list
5994304|NCT00129727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5994305|NCT00129727|Tubulin Modulators|tubulin modulators|mesh-ancestor
5994306|NCT00129727|Antimitotic Agents|antimitotic agents|mesh-ancestor
5994307|NCT00129727|Mitosis Modulators|mitosis modulators|mesh-ancestor
5994308|NCT00129727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994309|NCT00129727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5994310|NCT00129727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5994311|NCT00129727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5994312|NCT00129727|Growth Substances|growth substances|mesh-ancestor
5994313|NCT00129727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994314|NCT00129727|Growth Inhibitors|growth inhibitors|mesh-ancestor
5994315|NCT00129766|Palivizumab|palivizumab|mesh-list
5994316|NCT00129766|Antiviral Agents|antiviral agents|mesh-ancestor
5994317|NCT00129766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5994318|NCT00129935|Cyclophosphamide|cyclophosphamide|mesh-list
5994319|NCT00129935|Docetaxel|docetaxel|mesh-list
5994320|NCT00129935|Capecitabine|capecitabine|mesh-list
5994321|NCT00129935|Epirubicin|epirubicin|mesh-list
5994322|NCT00129935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5994323|NCT00129935|Immunologic Factors|immunologic factors|mesh-ancestor
5994324|NCT00129935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994325|NCT00129935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5994326|NCT00129935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5994327|NCT00129935|Alkylating Agents|alkylating agents|mesh-ancestor
5994328|NCT00129935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994329|NCT00129935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5994330|NCT00129935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5994331|NCT00129935|Tubulin Modulators|tubulin modulators|mesh-ancestor
5994332|NCT00129935|Antimitotic Agents|antimitotic agents|mesh-ancestor
5994333|NCT00129935|Mitosis Modulators|mitosis modulators|mesh-ancestor
5994334|NCT00129935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5994335|NCT00129935|Antimetabolites|antimetabolites|mesh-ancestor
5994336|NCT00129935|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5994337|NCT00129935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5994338|NCT00129935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5994339|NCT00129935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5994340|NCT00129961|Cyclosporine|cyclosporine|mesh-list
5994341|NCT00129961|Sirolimus|sirolimus|mesh-list
5994342|NCT00129961|Tacrolimus|tacrolimus|mesh-list
5994343|NCT00129961|Cyclosporins|cyclosporins|mesh-list
5994344|NCT00129961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5994345|NCT00129961|Immunologic Factors|immunologic factors|mesh-ancestor
5994346|NCT00129961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994347|NCT00129961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5994348|NCT00129961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5994349|NCT00129961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994350|NCT00129961|Antifungal Agents|antifungal agents|mesh-ancestor
5994351|NCT00129961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6258899|NCT03101033|Betamethasone Valerate|betamethasone valerate|mesh-list
6258900|NCT03101033|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
6258901|NCT03101033|Betamethasone benzoate|betamethasone benzoate|mesh-list
6258902|NCT03101033|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
6258903|NCT03101033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6258904|NCT03101033|Glucocorticoids|glucocorticoids|mesh-ancestor
6258905|NCT03101033|Hormones|hormones|mesh-ancestor
6258906|NCT03101033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6258907|NCT03101033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258908|NCT03101033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6258909|NCT03101033|Respiratory System Agents|respiratory system agents|mesh-ancestor
6258910|NCT03101111|Vaccines|vaccines|mesh-list
6258911|NCT03101111|Immunologic Factors|immunologic factors|mesh-ancestor
6258912|NCT03101111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258913|NCT03101150|Vitamin D|vitamin d|mesh-list
6258914|NCT03101150|Ergocalciferols|ergocalciferols|mesh-list
5994352|NCT00129961|Dermatologic Agents|dermatologic agents|mesh-ancestor
5994353|NCT00129961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5994354|NCT00129961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5994355|NCT00129961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5994356|NCT00129961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5994357|NCT00130039|Cilostazol|cilostazol|mesh-list
5994358|NCT00130039|Clopidogrel|clopidogrel|mesh-list
5994359|NCT00130039|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5994360|NCT00130039|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5994361|NCT00130039|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5994362|NCT00130039|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5994363|NCT00130039|Purinergic Agents|purinergic agents|mesh-ancestor
5994364|NCT00130039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5994365|NCT00130039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994366|NCT00130039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258915|NCT03101150|Cholecalciferol|cholecalciferol|mesh-list
5994367|NCT00130039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5994368|NCT00130039|Autonomic Agents|autonomic agents|mesh-ancestor
5994369|NCT00130039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5994370|NCT00130039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5994371|NCT00130039|Respiratory System Agents|respiratory system agents|mesh-ancestor
5994372|NCT00130039|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5994373|NCT00130039|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5994374|NCT00130039|Vasodilator Agents|vasodilator agents|mesh-ancestor
5994375|NCT00130039|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5994376|NCT00130039|Protective Agents|protective agents|mesh-ancestor
5994377|NCT00130039|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5994378|NCT00130039|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5994379|NCT00130039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5994380|NCT00130117|Contraceptive Agents|contraceptive agents|mesh-list
5994381|NCT00130117|Contraceptives, Oral|contraceptives, oral|mesh-list
5994382|NCT00130117|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
5994383|NCT00130117|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5994384|NCT00130117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994385|NCT00130117|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5994386|NCT00130208|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
5994387|NCT00130208|Anticoagulants|anticoagulants|mesh-ancestor
5994388|NCT00130208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5994389|NCT00130208|Antimetabolites|antimetabolites|mesh-ancestor
5994390|NCT00130208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994391|NCT00130208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5994392|NCT00130208|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5994393|NCT00130208|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5994394|NCT00130208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5994395|NCT00130208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994396|NCT00130247|Rifampin|rifampin|mesh-list
5994397|NCT00130247|Isoniazid|isoniazid|mesh-list
5994398|NCT00130247|Pyrazinamide|pyrazinamide|mesh-list
5994399|NCT00130247|Ethambutol|ethambutol|mesh-list
5994400|NCT00130247|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5994401|NCT00130247|Antitubercular Agents|antitubercular agents|mesh-ancestor
5994402|NCT00130247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5994403|NCT00130247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5994404|NCT00130247|Leprostatic Agents|leprostatic agents|mesh-ancestor
6258916|NCT03101150|Vitamins|vitamins|mesh-list
6258917|NCT03101150|Micronutrients|micronutrients|mesh-ancestor
5994405|NCT00130247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5994406|NCT00130247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5994407|NCT00130247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994408|NCT00130247|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5994409|NCT00130247|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5994410|NCT00130247|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5994411|NCT00130247|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5994412|NCT00130247|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6258918|NCT03101150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258919|NCT03101150|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6258920|NCT03101150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6258921|NCT03101358|Paclitaxel|paclitaxel|mesh-list
6258922|NCT03101358|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5994413|NCT00130247|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5994414|NCT00130247|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5994415|NCT00130247|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5994416|NCT00130247|Antimetabolites|antimetabolites|mesh-ancestor
5994417|NCT00130247|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5994418|NCT00130286|Rosiglitazone|rosiglitazone|mesh-list
5994419|NCT00130286|Hormones|hormones|mesh-list
5994420|NCT00130286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5994421|NCT00130286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994422|NCT00130286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5994423|NCT00130442|Dacarbazine|dacarbazine|mesh-list
5994424|NCT00130442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5994425|NCT00130442|Alkylating Agents|alkylating agents|mesh-ancestor
5994426|NCT00130442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994427|NCT00130442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5994428|NCT00130520|Bevacizumab|bevacizumab|mesh-list
5994429|NCT00130520|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5994430|NCT00130520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5994431|NCT00130520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5994432|NCT00130520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5994433|NCT00130520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5994434|NCT00130520|Growth Substances|growth substances|mesh-ancestor
5994435|NCT00130520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994436|NCT00130520|Growth Inhibitors|growth inhibitors|mesh-ancestor
5994437|NCT00130520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5994438|NCT00130520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5994439|NCT00130520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994440|NCT00130533|Capecitabine|capecitabine|mesh-list
5994441|NCT00130533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5994442|NCT00130533|Antimetabolites|antimetabolites|mesh-ancestor
6258923|NCT03101358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6258924|NCT03101358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6258925|NCT03101358|Tubulin Modulators|tubulin modulators|mesh-ancestor
6258926|NCT03101358|Antimitotic Agents|antimitotic agents|mesh-ancestor
6258927|NCT03101358|Mitosis Modulators|mitosis modulators|mesh-ancestor
6258928|NCT03101358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258929|NCT03101371|Iodine|iodine|mesh-list
6258930|NCT03101371|Povidone-Iodine|povidone-iodine|mesh-list
6258931|NCT03101371|Povidone|povidone|mesh-list
6258932|NCT03101371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6258933|NCT03101371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6258934|NCT03101371|Trace Elements|trace elements|mesh-ancestor
6258935|NCT03101371|Micronutrients|micronutrients|mesh-ancestor
6258936|NCT03101371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258937|NCT03101371|Plasma Substitutes|plasma substitutes|mesh-ancestor
6258938|NCT03101371|Blood Substitutes|blood substitutes|mesh-ancestor
6258939|NCT03101462|Vaccines|vaccines|mesh-list
6258940|NCT03101462|Immunologic Factors|immunologic factors|mesh-ancestor
6258941|NCT03101462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258942|NCT03102190|Verapamil|verapamil|mesh-list
6258943|NCT03102190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6258944|NCT03102190|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6258945|NCT03102190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6258946|NCT03102190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258947|NCT03102190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6258948|NCT03102190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258949|NCT03102190|Vasodilator Agents|vasodilator agents|mesh-ancestor
6258950|NCT03102645|Imipramine|imipramine|mesh-list
6258951|NCT03102645|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6258952|NCT03102645|Antidepressive Agents|antidepressive agents|mesh-ancestor
6258953|NCT03102645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6258954|NCT03102645|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6258955|NCT03102645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6258956|NCT03102645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6397089|NCT00210210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6397090|NCT00210210|Anesthetics, General|anesthetics, general|mesh-ancestor
6397091|NCT00210210|Anesthetics|anesthetics|mesh-ancestor
5994443|NCT00130533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994444|NCT00130533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5994445|NCT00130637|Daclizumab|daclizumab|mesh-list
5994446|NCT00130637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5994447|NCT00130637|Immunologic Factors|immunologic factors|mesh-ancestor
5994448|NCT00130637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994449|NCT00130689|Cetuximab|cetuximab|mesh-list
6258957|NCT03102645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258958|NCT03102645|Adrenergic Agents|adrenergic agents|mesh-ancestor
6258959|NCT03102645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6258960|NCT03102645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258961|NCT03102710|Lidocaine|lidocaine|mesh-list
6258962|NCT03102710|Capsaicin|capsaicin|mesh-list
6258963|NCT03102710|Anesthetics, Local|anesthetics, local|mesh-ancestor
6258964|NCT03102710|Anesthetics|anesthetics|mesh-ancestor
6258965|NCT03102710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6258966|NCT03102710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258967|NCT03102710|Sensory System Agents|sensory system agents|mesh-ancestor
6258968|NCT03102710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6258969|NCT03102710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6258970|NCT03102710|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6258971|NCT03102710|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6258972|NCT03102710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6258973|NCT03102710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258974|NCT03102710|Antipruritics|antipruritics|mesh-ancestor
6258975|NCT03102710|Dermatologic Agents|dermatologic agents|mesh-ancestor
6258976|NCT03102736|Nitroprusside|nitroprusside|mesh-list
6258977|NCT03102736|Ketamine|ketamine|mesh-list
6258978|NCT03102736|Analgesics|analgesics|mesh-ancestor
6258979|NCT03102736|Sensory System Agents|sensory system agents|mesh-ancestor
6258980|NCT03102736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6258981|NCT03102736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258982|NCT03102736|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6258983|NCT03102736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6258984|NCT03102736|Anesthetics, General|anesthetics, general|mesh-ancestor
6258985|NCT03102736|Anesthetics|anesthetics|mesh-ancestor
6258986|NCT03102736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6258987|NCT03102736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6258988|NCT03102736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6258989|NCT03102736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6258990|NCT03102736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258991|NCT03102736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6258992|NCT03102736|Vasodilator Agents|vasodilator agents|mesh-ancestor
6258993|NCT03102736|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6258994|NCT03102762|Botulinum Toxins|botulinum toxins|mesh-list
6258995|NCT03102762|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6258996|NCT03102762|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5994450|NCT00130689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5994451|NCT00130689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5994452|NCT00130728|Bevacizumab|bevacizumab|mesh-list
5994453|NCT00130728|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5994454|NCT00130728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5994455|NCT00130728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5994456|NCT00130728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5994457|NCT00130728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5994458|NCT00130728|Growth Substances|growth substances|mesh-ancestor
5994459|NCT00130728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994460|NCT00130728|Growth Inhibitors|growth inhibitors|mesh-ancestor
5994461|NCT00130728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6536423|NCT00817011|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6536424|NCT00817011|Mirtazapine|mirtazapine|mesh-list
6536425|NCT00817011|Trazodone|trazodone|mesh-list
6536426|NCT00817011|Bupropion|bupropion|mesh-list
6536427|NCT00817011|Fluoxetine|fluoxetine|mesh-list
6536428|NCT00817011|Paroxetine|paroxetine|mesh-list
6536429|NCT00817011|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6536430|NCT00817011|Citalopram|citalopram|mesh-list
6536431|NCT00817011|Sertraline|sertraline|mesh-list
6536432|NCT00817011|Nortriptyline|nortriptyline|mesh-list
5994462|NCT00130728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6536433|NCT00817011|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6536434|NCT00817011|Antidepressive Agents|antidepressive agents|mesh-ancestor
5994463|NCT00130728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994464|NCT00130780|Bevacizumab|bevacizumab|mesh-list
6258997|NCT03102762|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5994465|NCT00130780|Docetaxel|docetaxel|mesh-list
6258998|NCT03102762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6258999|NCT03102762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259000|NCT03102762|Cholinergic Agents|cholinergic agents|mesh-ancestor
6259001|NCT03102762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5994466|NCT00130780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5994467|NCT00130780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5994468|NCT00130780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5994469|NCT00130780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5994470|NCT00130780|Growth Substances|growth substances|mesh-ancestor
5994471|NCT00130780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994472|NCT00130780|Growth Inhibitors|growth inhibitors|mesh-ancestor
5994473|NCT00130780|Tubulin Modulators|tubulin modulators|mesh-ancestor
5994474|NCT00130780|Antimitotic Agents|antimitotic agents|mesh-ancestor
5994475|NCT00130780|Mitosis Modulators|mitosis modulators|mesh-ancestor
5994476|NCT00130780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994477|NCT00130793|Vaccines|vaccines|mesh-list
5994478|NCT00130793|Immunoglobulins|immunoglobulins|mesh-list
5994479|NCT00130793|Immunologic Factors|immunologic factors|mesh-ancestor
5994480|NCT00130793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994481|NCT00130832|Vaccines|vaccines|mesh-list
5994482|NCT00130832|Immunologic Factors|immunologic factors|mesh-ancestor
5994483|NCT00130832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994484|NCT00130923|Risperidone|risperidone|mesh-list
5994485|NCT00130923|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5994486|NCT00130923|Serotonin Agents|serotonin agents|mesh-ancestor
5994487|NCT00130923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5994488|NCT00130923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536435|NCT00817011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5994489|NCT00130923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994490|NCT00130923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5994491|NCT00130923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5994492|NCT00130923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5994493|NCT00130923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5994494|NCT00130923|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5994495|NCT00130923|Dopamine Agents|dopamine agents|mesh-ancestor
6017685|NCT00374868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259002|NCT03102762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259003|NCT03102762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6259004|NCT03102762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6259005|NCT03102918|Cannabidiol|cannabidiol|mesh-list
6259006|NCT03102918|Anticonvulsants|anticonvulsants|mesh-ancestor
6259007|NCT03103061|Regadenoson|regadenoson|mesh-list
6259008|NCT03103061|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
6259009|NCT03103061|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6259010|NCT03103061|Purinergic Agonists|purinergic agonists|mesh-ancestor
6259011|NCT03103061|Purinergic Agents|purinergic agents|mesh-ancestor
6259012|NCT03103061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6259013|NCT03103061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259014|NCT03103061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259015|NCT03103100|Lidocaine|lidocaine|mesh-list
6259016|NCT03103100|Bupivacaine|bupivacaine|mesh-list
6259017|NCT03103100|Anesthetics, Local|anesthetics, local|mesh-ancestor
6259018|NCT03103100|Anesthetics|anesthetics|mesh-ancestor
6259019|NCT03103100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6259020|NCT03103100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259021|NCT03103100|Sensory System Agents|sensory system agents|mesh-ancestor
6259022|NCT03103100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5994496|NCT00131248|Metoclopramide|metoclopramide|mesh-list
6259023|NCT03103100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5994497|NCT00131248|Ranitidine|ranitidine|mesh-list
5994498|NCT00131248|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
5994499|NCT00131248|Antiemetics|antiemetics|mesh-ancestor
5994500|NCT00131248|Autonomic Agents|autonomic agents|mesh-ancestor
5994501|NCT00131248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5994502|NCT00131248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994503|NCT00131248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5994504|NCT00131248|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5994505|NCT00131248|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5994506|NCT00131248|Dopamine Agents|dopamine agents|mesh-ancestor
5994507|NCT00131248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5994508|NCT00131248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994509|NCT00131248|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5994510|NCT00131248|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5994511|NCT00131248|Histamine Antagonists|histamine antagonists|mesh-ancestor
5994512|NCT00131248|Histamine Agents|histamine agents|mesh-ancestor
5994513|NCT00131352|Hylan|hylan|mesh-list
5994514|NCT00131352|Viscosupplements|viscosupplements|mesh-ancestor
5994515|NCT00131352|Protective Agents|protective agents|mesh-ancestor
5994516|NCT00131352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994517|NCT00131378|Hormones|hormones|mesh-list
6017686|NCT00374868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5994518|NCT00131378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5994519|NCT00131378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994520|NCT00131456|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6017687|NCT00374868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6017688|NCT00374907|Metformin|metformin|mesh-list
6259024|NCT03103100|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6259025|NCT03103100|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6259026|NCT03103100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6259027|NCT03103100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259028|NCT03103763|Warfarin|warfarin|mesh-list
6259029|NCT03103763|Anticoagulants|anticoagulants|mesh-ancestor
6259030|NCT03103906|Sunscreening Agents|sunscreening agents|mesh-list
6259031|NCT03103906|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6259032|NCT03103906|Protective Agents|protective agents|mesh-ancestor
6259033|NCT03103906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259034|NCT03103906|Dermatologic Agents|dermatologic agents|mesh-ancestor
6259035|NCT03103919|Rotigotine|rotigotine|mesh-list
6259036|NCT03103919|Dopamine Agonists|dopamine agonists|mesh-ancestor
5994521|NCT00131456|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5994522|NCT00131456|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5994523|NCT00131456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6017689|NCT00374907|Saxagliptin|saxagliptin|mesh-list
6017690|NCT00374907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5994524|NCT00131456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994525|NCT00131456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5994526|NCT00131456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994527|NCT00131456|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6259037|NCT03103919|Dopamine Agents|dopamine agents|mesh-ancestor
5994528|NCT00131456|Antidepressive Agents|antidepressive agents|mesh-ancestor
5994529|NCT00131456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5994530|NCT00131469|Teriparatide|teriparatide|mesh-list
5994531|NCT00131469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5994532|NCT00131469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994533|NCT00131469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5994534|NCT00131664|Metformin|metformin|mesh-list
5994535|NCT00131664|Glimepiride|glimepiride|mesh-list
5994536|NCT00131664|Rosiglitazone|rosiglitazone|mesh-list
5994537|NCT00131664|Maleic acid|maleic acid|mesh-list
5994538|NCT00131664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5994539|NCT00131664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994540|NCT00131664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5994541|NCT00131664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994542|NCT00131664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5994543|NCT00131664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5994544|NCT00131664|Immunologic Factors|immunologic factors|mesh-ancestor
5994545|NCT00131677|Tenofovir|tenofovir|mesh-list
5994546|NCT00131677|Antiviral Agents|antiviral agents|mesh-ancestor
6259038|NCT03103919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6259039|NCT03103919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994547|NCT00131677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5994548|NCT00131677|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5994549|NCT00131677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5994550|NCT00131677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5994551|NCT00131677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994552|NCT00131677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5994553|NCT00131677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5994554|NCT00131885|Levonorgestrel|levonorgestrel|mesh-list
5994555|NCT00131885|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5994556|NCT00131885|Contraceptive Agents|contraceptive agents|mesh-ancestor
5994557|NCT00131885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5994558|NCT00131885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994559|NCT00131885|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5994560|NCT00131885|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5994561|NCT00131885|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5994562|NCT00131911|Sorafenib|sorafenib|mesh-list
5994563|NCT00131911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5994564|NCT00131911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5994565|NCT00131911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5994566|NCT00131911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994567|NCT00131937|Sorafenib|sorafenib|mesh-list
5994568|NCT00131937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5994569|NCT00131937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5994570|NCT00131937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5994571|NCT00131937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994572|NCT00132002|Vorinostat|vorinostat|mesh-list
5994573|NCT00132002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5994574|NCT00132002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5994575|NCT00132002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5994576|NCT00132002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994577|NCT00132028|Vorinostat|vorinostat|mesh-list
5994578|NCT00132028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5994579|NCT00132028|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5994580|NCT00132028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5994581|NCT00132028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994582|NCT00132301|Prednisone|prednisone|mesh-list
5994583|NCT00132301|Docetaxel|docetaxel|mesh-list
5994584|NCT00132301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5994585|NCT00132301|Tubulin Modulators|tubulin modulators|mesh-ancestor
5994586|NCT00132301|Antimitotic Agents|antimitotic agents|mesh-ancestor
5994587|NCT00132301|Mitosis Modulators|mitosis modulators|mesh-ancestor
5994588|NCT00132301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994589|NCT00132301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5994590|NCT00132301|Glucocorticoids|glucocorticoids|mesh-ancestor
5994591|NCT00132301|Hormones|hormones|mesh-ancestor
5994592|NCT00132301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5994593|NCT00132301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994594|NCT00132301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5994595|NCT00132314|Risperidone|risperidone|mesh-list
5994596|NCT00132314|Antipsychotic Agents|antipsychotic agents|mesh-list
5994597|NCT00132314|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5994598|NCT00132314|Serotonin Agents|serotonin agents|mesh-ancestor
5994599|NCT00132314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5994600|NCT00132314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994601|NCT00132314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994602|NCT00132314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5994603|NCT00132314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5994604|NCT00132314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6259040|NCT03103919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389840|NCT00189501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6259041|NCT03104725|Acetylcysteine|acetylcysteine|mesh-list
6259042|NCT03104725|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5994605|NCT00132314|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5994606|NCT00132314|Dopamine Agents|dopamine agents|mesh-ancestor
5994607|NCT00132496|Rabeprazole|rabeprazole|mesh-list
5994608|NCT00132496|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5994609|NCT00132496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5994610|NCT00132496|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5994611|NCT00132496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5994612|NCT00132496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994613|NCT00132678|Risperidone|risperidone|mesh-list
5994614|NCT00132678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5994615|NCT00132678|Serotonin Agents|serotonin agents|mesh-ancestor
5994616|NCT00132678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5994617|NCT00132678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994618|NCT00132678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994619|NCT00132678|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5994620|NCT00132678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5994621|NCT00132678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5994622|NCT00132678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5994623|NCT00132678|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5994624|NCT00132678|Dopamine Agents|dopamine agents|mesh-ancestor
5994625|NCT00132691|Cyclosporine|cyclosporine|mesh-list
5994626|NCT00132691|Mycophenolic Acid|mycophenolic acid|mesh-list
5994627|NCT00132691|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
5994628|NCT00132691|Cyclophosphamide|cyclophosphamide|mesh-list
5994629|NCT00132691|Chlorambucil|chlorambucil|mesh-list
5994630|NCT00132691|Methotrexate|methotrexate|mesh-list
5994631|NCT00132691|Azathioprine|azathioprine|mesh-list
5994632|NCT00132691|Infliximab|infliximab|mesh-list
5994633|NCT00132691|Tacrolimus|tacrolimus|mesh-list
5994634|NCT00132691|Cyclosporins|cyclosporins|mesh-list
5994635|NCT00132691|Daclizumab|daclizumab|mesh-list
5994636|NCT00132691|Immunosuppressive Agents|immunosuppressive agents|mesh-list
5994637|NCT00132691|Alkylating Agents|alkylating agents|mesh-list
5994638|NCT00132691|Immunologic Factors|immunologic factors|mesh-ancestor
5994639|NCT00132691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994640|NCT00132691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5994641|NCT00132691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5994642|NCT00132691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994643|NCT00132691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5994644|NCT00132691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5994645|NCT00132691|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5994646|NCT00132691|Abortifacient Agents|abortifacient agents|mesh-ancestor
5994647|NCT00132691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5994648|NCT00132691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5994649|NCT00132691|Antimetabolites|antimetabolites|mesh-ancestor
5994650|NCT00132691|Dermatologic Agents|dermatologic agents|mesh-ancestor
5994651|NCT00132691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6259043|NCT03104725|Antiviral Agents|antiviral agents|mesh-ancestor
6259044|NCT03104725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6259045|NCT03104725|Expectorants|expectorants|mesh-ancestor
6259046|NCT03104725|Respiratory System Agents|respiratory system agents|mesh-ancestor
6259047|NCT03104725|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6259048|NCT03104725|Antioxidants|antioxidants|mesh-ancestor
6259049|NCT03104725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259050|NCT03104725|Protective Agents|protective agents|mesh-ancestor
6259051|NCT03104725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259052|NCT03104725|Antidotes|antidotes|mesh-ancestor
6259053|NCT03104738|Insulin|insulin|mesh-list
6259054|NCT03104738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6259055|NCT03104738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259056|NCT03104816|Acetaminophen|acetaminophen|mesh-list
6259057|NCT03104816|Hydromorphone|hydromorphone|mesh-list
6259058|NCT03104816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6259059|NCT03104816|Analgesics|analgesics|mesh-ancestor
6259060|NCT03104816|Sensory System Agents|sensory system agents|mesh-ancestor
6389841|NCT00189514|Pramlintide|pramlintide|mesh-list
5994652|NCT00132691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5994653|NCT00132691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5994654|NCT00132691|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5994655|NCT00132691|Antifungal Agents|antifungal agents|mesh-ancestor
5994656|NCT00132691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5994657|NCT00132691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5994658|NCT00132691|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5994659|NCT00132691|Antitubercular Agents|antitubercular agents|mesh-ancestor
5994660|NCT00132691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5994661|NCT00132691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5994662|NCT00132691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5994663|NCT00132691|Glucocorticoids|glucocorticoids|mesh-ancestor
5994664|NCT00132691|Hormones|hormones|mesh-ancestor
5994665|NCT00132691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5994666|NCT00132730|MK 0873|mk 0873|mesh-list
5994667|NCT00132730|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5994668|NCT00132730|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5994669|NCT00132730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5994670|NCT00132730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994671|NCT00132769|MK 0873|mk 0873|mesh-list
5994672|NCT00132769|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5994673|NCT00132769|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5994674|NCT00132769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5994675|NCT00132769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994676|NCT00132808|Zoledronic Acid|zoledronic acid|mesh-list
5994677|NCT00132808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5994678|NCT00132808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994679|NCT00132873|Sodium Oxybate|sodium oxybate|mesh-list
5994680|NCT00132873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5994681|NCT00132873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5994682|NCT00132873|Anesthetics, General|anesthetics, general|mesh-ancestor
5994683|NCT00132873|Anesthetics|anesthetics|mesh-ancestor
5994684|NCT00132873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5994685|NCT00132873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994686|NCT00133575|Vaccines|vaccines|mesh-list
5994687|NCT00133575|Immunologic Factors|immunologic factors|mesh-ancestor
5994688|NCT00133575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994689|NCT00133705|Mifepristone|mifepristone|mesh-list
5994690|NCT00133705|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5994691|NCT00133705|Abortifacient Agents|abortifacient agents|mesh-ancestor
5994692|NCT00133705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5994693|NCT00133705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994694|NCT00133705|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5994695|NCT00133705|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5994696|NCT00133705|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5994697|NCT00133705|Contraceptive Agents|contraceptive agents|mesh-ancestor
6259061|NCT03104816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5994698|NCT00133705|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5994699|NCT00133705|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5994700|NCT00133705|Hormone Antagonists|hormone antagonists|mesh-ancestor
5994701|NCT00133705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5994702|NCT00133705|Luteolytic Agents|luteolytic agents|mesh-ancestor
5994703|NCT00133705|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5994704|NCT00133705|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5994705|NCT00133952|Ruboxistaurin|ruboxistaurin|mesh-list
5994706|NCT00133952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5994707|NCT00133952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994708|NCT00133978|Selenium|selenium|mesh-list
5994709|NCT00133978|Antioxidants|antioxidants|mesh-list
5994710|NCT00133978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994711|NCT00133978|Protective Agents|protective agents|mesh-ancestor
5994712|NCT00133978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994713|NCT00133978|Trace Elements|trace elements|mesh-ancestor
5994714|NCT00133978|Micronutrients|micronutrients|mesh-ancestor
5994715|NCT00133991|Leucovorin|leucovorin|mesh-list
5994716|NCT00133991|Cytarabine|cytarabine|mesh-list
5994717|NCT00133991|Prednisone|prednisone|mesh-list
5994718|NCT00133991|Hydrocortisone|hydrocortisone|mesh-list
5994719|NCT00133991|Cyclophosphamide|cyclophosphamide|mesh-list
5994720|NCT00133991|Rituximab|rituximab|mesh-list
5994721|NCT00133991|Methotrexate|methotrexate|mesh-list
5994722|NCT00133991|Vincristine|vincristine|mesh-list
5994723|NCT00133991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5994724|NCT00133991|Immunologic Factors|immunologic factors|mesh-ancestor
5994725|NCT00133991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994726|NCT00133991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5994727|NCT00133991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5994728|NCT00133991|Alkylating Agents|alkylating agents|mesh-ancestor
5994729|NCT00133991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994730|NCT00133991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5994731|NCT00133991|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5994732|NCT00133991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5994733|NCT00133991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5994734|NCT00133991|Glucocorticoids|glucocorticoids|mesh-ancestor
5994735|NCT00133991|Hormones|hormones|mesh-ancestor
5994736|NCT00133991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5994737|NCT00133991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5994738|NCT00133991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5994739|NCT00133991|Abortifacient Agents|abortifacient agents|mesh-ancestor
5994740|NCT00133991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5994741|NCT00133991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5994742|NCT00133991|Antimetabolites|antimetabolites|mesh-ancestor
5994743|NCT00133991|Dermatologic Agents|dermatologic agents|mesh-ancestor
5994744|NCT00133991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5994745|NCT00133991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5994746|NCT00133991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5994747|NCT00133991|Antiviral Agents|antiviral agents|mesh-ancestor
5994748|NCT00133991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5994749|NCT00133991|Antidotes|antidotes|mesh-ancestor
5994750|NCT00133991|Protective Agents|protective agents|mesh-ancestor
5994751|NCT00133991|Vitamin B Complex|vitamin b complex|mesh-ancestor
5994752|NCT00133991|Vitamins|vitamins|mesh-ancestor
5994753|NCT00133991|Micronutrients|micronutrients|mesh-ancestor
5994754|NCT00133991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5994755|NCT00133991|Tubulin Modulators|tubulin modulators|mesh-ancestor
5994756|NCT00133991|Antimitotic Agents|antimitotic agents|mesh-ancestor
5994757|NCT00133991|Mitosis Modulators|mitosis modulators|mesh-ancestor
5994758|NCT00134004|Mycophenolic Acid|mycophenolic acid|mesh-list
5994759|NCT00134004|Cyclophosphamide|cyclophosphamide|mesh-list
5994760|NCT00134004|Fludarabine|fludarabine|mesh-list
5994761|NCT00134004|Fludarabine phosphate|fludarabine phosphate|mesh-list
5994762|NCT00134004|Tacrolimus|tacrolimus|mesh-list
5994763|NCT00134004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5994764|NCT00134004|Immunologic Factors|immunologic factors|mesh-ancestor
5994765|NCT00134004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994766|NCT00134004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5994767|NCT00134004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5994768|NCT00134004|Alkylating Agents|alkylating agents|mesh-ancestor
5994769|NCT00134004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994770|NCT00134004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5994771|NCT00134004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5994772|NCT00134004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5994773|NCT00134004|Antimetabolites|antimetabolites|mesh-ancestor
5994774|NCT00134004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5994775|NCT00134004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5994776|NCT00134004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5994777|NCT00134004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5994778|NCT00134004|Antitubercular Agents|antitubercular agents|mesh-ancestor
5994779|NCT00134004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5994780|NCT00134004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5994781|NCT00134017|Cyclophosphamide|cyclophosphamide|mesh-list
5994782|NCT00134017|Busulfan|busulfan|mesh-list
5994783|NCT00134017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5994784|NCT00134017|Immunologic Factors|immunologic factors|mesh-ancestor
5994785|NCT00134017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994786|NCT00134017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5994787|NCT00134017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5994788|NCT00134017|Alkylating Agents|alkylating agents|mesh-ancestor
5994789|NCT00134017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994790|NCT00134017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5994791|NCT00134017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5994792|NCT00134043|Vorinostat|vorinostat|mesh-list
5994793|NCT00134043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6389842|NCT00189514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5994794|NCT00134043|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5994795|NCT00134043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6017691|NCT00374907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017692|NCT00374907|Incretins|incretins|mesh-ancestor
6017693|NCT00374907|Hormones|hormones|mesh-ancestor
6017694|NCT00374907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6017695|NCT00374907|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6017696|NCT00374907|Protease Inhibitors|protease inhibitors|mesh-ancestor
6017697|NCT00374907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6017698|NCT00374907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017699|NCT00375219|Homoharringtonine|homoharringtonine|mesh-list
6017700|NCT00375219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6017701|NCT00375219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6017702|NCT00375219|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5994796|NCT00134043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994797|NCT00134056|Prednisone|prednisone|mesh-list
5994798|NCT00134056|Docetaxel|docetaxel|mesh-list
5994799|NCT00134056|Atrasentan|atrasentan|mesh-list
5994800|NCT00134056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5994801|NCT00134056|Tubulin Modulators|tubulin modulators|mesh-ancestor
5994802|NCT00134056|Antimitotic Agents|antimitotic agents|mesh-ancestor
5994803|NCT00134056|Mitosis Modulators|mitosis modulators|mesh-ancestor
5994804|NCT00134056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994805|NCT00134056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5994806|NCT00134056|Glucocorticoids|glucocorticoids|mesh-ancestor
5994807|NCT00134056|Hormones|hormones|mesh-ancestor
5994808|NCT00134056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5994809|NCT00134056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994810|NCT00134056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5994811|NCT00134056|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
5994812|NCT00134056|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5994813|NCT00134082|Cyclophosphamide|cyclophosphamide|mesh-list
5994814|NCT00134082|Rituximab|rituximab|mesh-list
5994815|NCT00134082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5994816|NCT00134082|Immunologic Factors|immunologic factors|mesh-ancestor
5994817|NCT00134082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994818|NCT00134082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5994819|NCT00134082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5994820|NCT00134082|Alkylating Agents|alkylating agents|mesh-ancestor
5994821|NCT00134082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994822|NCT00134082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5994823|NCT00134082|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5994824|NCT00134082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5994825|NCT00134563|Teriflunomide|teriflunomide|mesh-list
5994826|NCT00134563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5994827|NCT00134563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5994828|NCT00134563|Analgesics|analgesics|mesh-ancestor
5994829|NCT00134563|Sensory System Agents|sensory system agents|mesh-ancestor
5994830|NCT00134563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5994831|NCT00134563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994832|NCT00134563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5994833|NCT00134563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5994834|NCT00134563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5994835|NCT00134563|Immunologic Factors|immunologic factors|mesh-ancestor
5994836|NCT00134719|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5994837|NCT00134719|Immunologic Factors|immunologic factors|mesh-ancestor
5994838|NCT00134719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994839|NCT00134901|Memantine|memantine|mesh-list
5994840|NCT00134901|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5994841|NCT00134901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5994842|NCT00134901|Dopamine Agents|dopamine agents|mesh-ancestor
5994843|NCT00134901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5994844|NCT00134901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994845|NCT00134901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994846|NCT00134901|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5994847|NCT00134901|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5994848|NCT00135200|Tositumomab I-131|tositumomab i-131|mesh-list
5994849|NCT00135200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5994850|NCT00135226|Aspirin|aspirin|mesh-list
5994851|NCT00135226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5994852|NCT00135226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5994853|NCT00135226|Analgesics|analgesics|mesh-ancestor
5994854|NCT00135226|Sensory System Agents|sensory system agents|mesh-ancestor
5994855|NCT00135226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5994856|NCT00135226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994857|NCT00135226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5994858|NCT00135226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5994859|NCT00135226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5994860|NCT00135226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5994861|NCT00135226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994862|NCT00135226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5994863|NCT00135226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5994864|NCT00135226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5994865|NCT00135226|Antipyretics|antipyretics|mesh-ancestor
5994866|NCT00135330|Exenatide|exenatide|mesh-list
5994867|NCT00135330|Rosiglitazone|rosiglitazone|mesh-list
5994868|NCT00135330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5994869|NCT00135330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994870|NCT00135330|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5994871|NCT00135330|Incretins|incretins|mesh-ancestor
5994872|NCT00135330|Hormones|hormones|mesh-ancestor
5994873|NCT00135330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5994874|NCT00135356|Ritonavir|ritonavir|mesh-list
5994875|NCT00135356|Atazanavir Sulfate|atazanavir sulfate|mesh-list
5994876|NCT00135356|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
5994877|NCT00135356|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
5994878|NCT00135356|Protease Inhibitors|protease inhibitors|mesh-list
5994879|NCT00135356|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5994880|NCT00135356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5994881|NCT00135356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994882|NCT00135356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5994883|NCT00135356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5994884|NCT00135356|Antiviral Agents|antiviral agents|mesh-ancestor
5994885|NCT00135356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6017703|NCT00375219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5994886|NCT00135356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5994887|NCT00135356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5994888|NCT00135356|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5994889|NCT00135512|Bupropion|bupropion|mesh-list
5994890|NCT00135512|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5994891|NCT00135512|Antidepressive Agents|antidepressive agents|mesh-ancestor
5994892|NCT00135512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5994893|NCT00135512|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5994894|NCT00135512|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5994895|NCT00135512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5994896|NCT00135512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994897|NCT00135512|Dopamine Agents|dopamine agents|mesh-ancestor
5994898|NCT00135512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5994899|NCT00135512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994900|NCT00135512|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5994901|NCT00135512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5994902|NCT00135512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5994903|NCT00135694|Prednisone|prednisone|mesh-list
5994904|NCT00135694|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
5994905|NCT00135694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5994906|NCT00135694|Glucocorticoids|glucocorticoids|mesh-ancestor
5994907|NCT00135694|Hormones|hormones|mesh-ancestor
5994908|NCT00135694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5994909|NCT00135694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259062|NCT03104816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259063|NCT03104816|Antipyretics|antipyretics|mesh-ancestor
6259064|NCT03104816|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6259065|NCT03104816|Narcotics|narcotics|mesh-ancestor
6259066|NCT03104816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6259067|NCT03105479|Vancomycin|vancomycin|mesh-list
5994910|NCT00135694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5994911|NCT00135694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5994912|NCT00135694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5994913|NCT00135694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994914|NCT00135707|Vitamins|vitamins|mesh-list
5994915|NCT00135707|Ascorbic Acid|ascorbic acid|mesh-list
5994916|NCT00135707|Vitamin E|vitamin e|mesh-list
5994917|NCT00135707|alpha-Tocopherol|alpha-tocopherol|mesh-list
5994918|NCT00135707|Micronutrients|micronutrients|mesh-ancestor
5994919|NCT00135707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994920|NCT00135707|Antioxidants|antioxidants|mesh-ancestor
5994921|NCT00135707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994922|NCT00135707|Protective Agents|protective agents|mesh-ancestor
5994923|NCT00135798|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
5994924|NCT00135798|Antiviral Agents|antiviral agents|mesh-ancestor
5994925|NCT00135798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5994926|NCT00136084|Cytarabine|cytarabine|mesh-list
5994927|NCT00136084|Dexamethasone|dexamethasone|mesh-list
5994928|NCT00136084|Prednisone|prednisone|mesh-list
5994929|NCT00136084|Cyclophosphamide|cyclophosphamide|mesh-list
5994930|NCT00136084|Methotrexate|methotrexate|mesh-list
5994931|NCT00136084|Etoposide|etoposide|mesh-list
5994932|NCT00136084|Vincristine|vincristine|mesh-list
5994933|NCT00136084|Daunorubicin|daunorubicin|mesh-list
5994934|NCT00136084|Asparaginase|asparaginase|mesh-list
5994935|NCT00136084|Mercaptopurine|mercaptopurine|mesh-list
5994936|NCT00136084|Mitoxantrone|mitoxantrone|mesh-list
5994937|NCT00136084|Cladribine|cladribine|mesh-list
5994938|NCT00136084|Gemtuzumab|gemtuzumab|mesh-list
5994939|NCT00136084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5994940|NCT00136084|Immunologic Factors|immunologic factors|mesh-ancestor
5994941|NCT00136084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994942|NCT00136084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5994943|NCT00136084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5994944|NCT00136084|Alkylating Agents|alkylating agents|mesh-ancestor
5994945|NCT00136084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994946|NCT00136084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5994947|NCT00136084|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5994948|NCT00136084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5994949|NCT00136084|Antiemetics|antiemetics|mesh-ancestor
5994950|NCT00136084|Autonomic Agents|autonomic agents|mesh-ancestor
5994951|NCT00136084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5994952|NCT00136084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5994953|NCT00136084|Glucocorticoids|glucocorticoids|mesh-ancestor
5994954|NCT00136084|Hormones|hormones|mesh-ancestor
5994955|NCT00136084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5994956|NCT00136084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5994957|NCT00136084|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5994958|NCT00136084|Abortifacient Agents|abortifacient agents|mesh-ancestor
5994959|NCT00136084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5994960|NCT00136084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5994961|NCT00136084|Antimetabolites|antimetabolites|mesh-ancestor
5994962|NCT00136084|Dermatologic Agents|dermatologic agents|mesh-ancestor
5994963|NCT00136084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5994964|NCT00136084|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5994965|NCT00136084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5994966|NCT00136084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5994967|NCT00136084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5994968|NCT00136084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5994969|NCT00136084|Antiviral Agents|antiviral agents|mesh-ancestor
5994970|NCT00136084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5994971|NCT00136084|Tubulin Modulators|tubulin modulators|mesh-ancestor
5994972|NCT00136084|Antimitotic Agents|antimitotic agents|mesh-ancestor
5994973|NCT00136084|Mitosis Modulators|mitosis modulators|mesh-ancestor
6259068|NCT03105479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5994974|NCT00136084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6259069|NCT03105479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5994975|NCT00136084|Analgesics|analgesics|mesh-ancestor
5994976|NCT00136084|Sensory System Agents|sensory system agents|mesh-ancestor
5994977|NCT00136084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5994978|NCT00136318|Ribavirin|ribavirin|mesh-list
5994979|NCT00136318|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5994980|NCT00136318|Citalopram|citalopram|mesh-list
5994981|NCT00136318|Antimetabolites|antimetabolites|mesh-ancestor
5994982|NCT00136318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5994983|NCT00136318|Antiviral Agents|antiviral agents|mesh-ancestor
5994984|NCT00136318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5994985|NCT00136318|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5994986|NCT00136318|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5994987|NCT00136318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5994988|NCT00136318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5994989|NCT00136318|Serotonin Agents|serotonin agents|mesh-ancestor
5994990|NCT00136318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5994991|NCT00136318|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5994992|NCT00136318|Antidepressive Agents|antidepressive agents|mesh-ancestor
5994993|NCT00136318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5994994|NCT00136695|Anastrozole|anastrozole|mesh-list
5994995|NCT00136695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5994996|NCT00136695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5994997|NCT00136695|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5994998|NCT00136695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5994999|NCT00136695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5995000|NCT00136695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995001|NCT00136695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5995002|NCT00136695|Hormone Antagonists|hormone antagonists|mesh-ancestor
6018504|NCT00381303|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5995003|NCT00136695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5995004|NCT00136695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995005|NCT00136760|Bupropion|bupropion|mesh-list
5995006|NCT00136760|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5995007|NCT00136760|Antidepressive Agents|antidepressive agents|mesh-ancestor
5995008|NCT00136760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5995009|NCT00136760|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5995010|NCT00136760|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5995011|NCT00136760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5995012|NCT00136760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995013|NCT00136760|Dopamine Agents|dopamine agents|mesh-ancestor
5995014|NCT00136760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5995015|NCT00136760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995016|NCT00136760|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5995017|NCT00136760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5995018|NCT00136760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5995019|NCT00136916|Insulin|insulin|mesh-list
5995020|NCT00136916|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5995021|NCT00136916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5995022|NCT00136916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995023|NCT00136955|Irinotecan|irinotecan|mesh-list
5995024|NCT00136955|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5995025|NCT00136955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5995026|NCT00136955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5995027|NCT00136955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995028|NCT00136955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5995029|NCT00137046|Insulin|insulin|mesh-list
5995030|NCT00137046|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5995031|NCT00137046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5995032|NCT00137046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995033|NCT00137111|Cytarabine|cytarabine|mesh-list
5995034|NCT00137111|Dexamethasone|dexamethasone|mesh-list
5995035|NCT00137111|Prednisone|prednisone|mesh-list
5995036|NCT00137111|Cyclophosphamide|cyclophosphamide|mesh-list
5995037|NCT00137111|Doxorubicin|doxorubicin|mesh-list
5995038|NCT00137111|Methotrexate|methotrexate|mesh-list
6259070|NCT03105518|Acetaminophen|acetaminophen|mesh-list
6259071|NCT03105518|Fentanyl|fentanyl|mesh-list
6259072|NCT03105518|Oxycodone|oxycodone|mesh-list
6259073|NCT03105518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6259074|NCT03105518|Narcotics|narcotics|mesh-ancestor
6259075|NCT03105518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6259076|NCT03105518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259077|NCT03105518|Analgesics|analgesics|mesh-ancestor
6259078|NCT03105518|Sensory System Agents|sensory system agents|mesh-ancestor
6259079|NCT03105518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6259080|NCT03105518|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6259081|NCT03105518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6259082|NCT03105518|Anesthetics, General|anesthetics, general|mesh-ancestor
6259083|NCT03105518|Anesthetics|anesthetics|mesh-ancestor
6259084|NCT03105518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6259085|NCT03105518|Antipyretics|antipyretics|mesh-ancestor
6259086|NCT03106077|Maytansine|maytansine|mesh-list
6259087|NCT03106077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6259088|NCT03106077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6259089|NCT03106077|Tubulin Modulators|tubulin modulators|mesh-ancestor
6259090|NCT03106077|Antimitotic Agents|antimitotic agents|mesh-ancestor
6259091|NCT03106077|Mitosis Modulators|mitosis modulators|mesh-ancestor
6259092|NCT03106077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259093|NCT03106753|Bupivacaine|bupivacaine|mesh-list
6259094|NCT03106753|Terbutaline|terbutaline|mesh-list
6259095|NCT03106753|Anesthetics, Local|anesthetics, local|mesh-ancestor
6259096|NCT03106753|Anesthetics|anesthetics|mesh-ancestor
6259097|NCT03106753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6259098|NCT03106753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259099|NCT03106753|Sensory System Agents|sensory system agents|mesh-ancestor
6259100|NCT03106753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6259101|NCT03106753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6259102|NCT03106753|Autonomic Agents|autonomic agents|mesh-ancestor
6259103|NCT03106753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6259104|NCT03106753|Respiratory System Agents|respiratory system agents|mesh-ancestor
6259105|NCT03106753|Sympathomimetics|sympathomimetics|mesh-ancestor
6259106|NCT03106753|Tocolytic Agents|tocolytic agents|mesh-ancestor
5995039|NCT00137111|Etoposide|etoposide|mesh-list
5995040|NCT00137111|Vincristine|vincristine|mesh-list
5995041|NCT00137111|Daunorubicin|daunorubicin|mesh-list
6259107|NCT03106753|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5995042|NCT00137111|Asparaginase|asparaginase|mesh-list
5995043|NCT00137111|Mercaptopurine|mercaptopurine|mesh-list
5995044|NCT00137111|Pegaspargase|pegaspargase|mesh-list
5995045|NCT00137111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5995046|NCT00137111|Immunologic Factors|immunologic factors|mesh-ancestor
5995047|NCT00137111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995048|NCT00137111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5995049|NCT00137111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5995050|NCT00137111|Alkylating Agents|alkylating agents|mesh-ancestor
5995051|NCT00137111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995052|NCT00137111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5995053|NCT00137111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5995054|NCT00137111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5995055|NCT00137111|Antiemetics|antiemetics|mesh-ancestor
5995056|NCT00137111|Autonomic Agents|autonomic agents|mesh-ancestor
5995057|NCT00137111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5995058|NCT00137111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5995059|NCT00137111|Glucocorticoids|glucocorticoids|mesh-ancestor
5995060|NCT00137111|Hormones|hormones|mesh-ancestor
5995061|NCT00137111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5995062|NCT00137111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5995063|NCT00137111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5995064|NCT00137111|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5995065|NCT00137111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5995066|NCT00137111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5995067|NCT00137111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5995068|NCT00137111|Abortifacient Agents|abortifacient agents|mesh-ancestor
5995069|NCT00137111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5995070|NCT00137111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5995071|NCT00137111|Antimetabolites|antimetabolites|mesh-ancestor
5995072|NCT00137111|Dermatologic Agents|dermatologic agents|mesh-ancestor
5995073|NCT00137111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5995074|NCT00137111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5995075|NCT00137111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5995076|NCT00137111|Antiviral Agents|antiviral agents|mesh-ancestor
6259108|NCT03106753|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6259109|NCT03106753|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5995077|NCT00137111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5995078|NCT00137111|Tubulin Modulators|tubulin modulators|mesh-ancestor
5995079|NCT00137111|Antimitotic Agents|antimitotic agents|mesh-ancestor
5995080|NCT00137111|Mitosis Modulators|mitosis modulators|mesh-ancestor
5995081|NCT00137423|Sunitinib|sunitinib|mesh-list
5995082|NCT00137423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5995083|NCT00137423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5995084|NCT00137423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5995085|NCT00137423|Growth Substances|growth substances|mesh-ancestor
5995086|NCT00137423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995087|NCT00137423|Growth Inhibitors|growth inhibitors|mesh-ancestor
5995088|NCT00137423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5995089|NCT00137423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5995090|NCT00137423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995091|NCT00137436|Prednisone|prednisone|mesh-list
5995092|NCT00137436|Docetaxel|docetaxel|mesh-list
5995093|NCT00137436|Sunitinib|sunitinib|mesh-list
5995094|NCT00137436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5995095|NCT00137436|Tubulin Modulators|tubulin modulators|mesh-ancestor
5995096|NCT00137436|Antimitotic Agents|antimitotic agents|mesh-ancestor
5995097|NCT00137436|Mitosis Modulators|mitosis modulators|mesh-ancestor
5995098|NCT00137436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995099|NCT00137436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5995100|NCT00137436|Glucocorticoids|glucocorticoids|mesh-ancestor
5995101|NCT00137436|Hormones|hormones|mesh-ancestor
5995102|NCT00137436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5995103|NCT00137436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995104|NCT00137436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5995105|NCT00137436|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5995106|NCT00137436|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5995107|NCT00137436|Growth Substances|growth substances|mesh-ancestor
5995108|NCT00137436|Growth Inhibitors|growth inhibitors|mesh-ancestor
5995109|NCT00137436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5995110|NCT00137436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5995111|NCT00137449|Sunitinib|sunitinib|mesh-list
6259110|NCT03106753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6259111|NCT03106753|Adrenergic Agents|adrenergic agents|mesh-ancestor
6259112|NCT03106753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6259113|NCT03106753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259114|NCT03106870|Insulin|insulin|mesh-list
6259115|NCT03106870|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6259116|NCT03106870|Metformin|metformin|mesh-list
6259117|NCT03106870|Insulin, pork; isophane insulin, pork drug combination 30:70|insulin, pork; isophane insulin, pork drug combination 30:70|mesh-list
6259118|NCT03106870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6259119|NCT03106870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259120|NCT03107091|Terlipressin|terlipressin|mesh-list
6259121|NCT03107091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6259122|NCT03107091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6259123|NCT03107611|Pimecrolimus|pimecrolimus|mesh-list
6259124|NCT03107611|Tacrolimus|tacrolimus|mesh-list
6259125|NCT03107611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6259126|NCT03107611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6259127|NCT03107611|Analgesics|analgesics|mesh-ancestor
6259128|NCT03107611|Sensory System Agents|sensory system agents|mesh-ancestor
6259129|NCT03107611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6259130|NCT03107611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259131|NCT03107611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5995112|NCT00137449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5995113|NCT00137449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5995114|NCT00137449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5995115|NCT00137449|Growth Substances|growth substances|mesh-ancestor
5995116|NCT00137449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995117|NCT00137449|Growth Inhibitors|growth inhibitors|mesh-ancestor
5995118|NCT00137449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5995119|NCT00137449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5995120|NCT00137449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995121|NCT00137839|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5995122|NCT00137839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5995123|NCT00137839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5995124|NCT00137839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5995125|NCT00137839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995126|NCT00137969|Acetaminophen|acetaminophen|mesh-list
5995127|NCT00137969|Diphenhydramine|diphenhydramine|mesh-list
5995128|NCT00137969|Promethazine|promethazine|mesh-list
5995129|NCT00137969|Prednisone|prednisone|mesh-list
5995130|NCT00137969|Rituximab|rituximab|mesh-list
5995131|NCT00137969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5995132|NCT00137969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5995133|NCT00137969|Immunologic Factors|immunologic factors|mesh-ancestor
5995134|NCT00137969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995135|NCT00137969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5995136|NCT00137969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5995137|NCT00137969|Glucocorticoids|glucocorticoids|mesh-ancestor
5995138|NCT00137969|Hormones|hormones|mesh-ancestor
5995139|NCT00137969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6018505|NCT00381303|Protease Inhibitors|protease inhibitors|mesh-ancestor
5995140|NCT00137969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5995141|NCT00137969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5995142|NCT00137969|Analgesics|analgesics|mesh-ancestor
5995143|NCT00137969|Sensory System Agents|sensory system agents|mesh-ancestor
5995144|NCT00137969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5995145|NCT00137969|Antipyretics|antipyretics|mesh-ancestor
5995146|NCT00137969|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5995147|NCT00137969|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5995148|NCT00137969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5995149|NCT00137969|Anesthetics, Local|anesthetics, local|mesh-ancestor
5995150|NCT00137969|Anesthetics|anesthetics|mesh-ancestor
5995151|NCT00137969|Antiemetics|antiemetics|mesh-ancestor
5995152|NCT00137969|Autonomic Agents|autonomic agents|mesh-ancestor
5995153|NCT00137969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5995154|NCT00137969|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5995155|NCT00137969|Histamine Antagonists|histamine antagonists|mesh-ancestor
5995156|NCT00137969|Histamine Agents|histamine agents|mesh-ancestor
5995157|NCT00137969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5995158|NCT00137969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995159|NCT00137969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5995160|NCT00137969|Antipruritics|antipruritics|mesh-ancestor
5995161|NCT00137969|Dermatologic Agents|dermatologic agents|mesh-ancestor
5995162|NCT00138125|Trastuzumab|trastuzumab|mesh-list
5995163|NCT00138125|Fulvestrant|fulvestrant|mesh-list
5995164|NCT00138125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5995165|NCT00138125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5995166|NCT00138125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5995167|NCT00138125|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5995168|NCT00138125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5995169|NCT00138125|Hormone Antagonists|hormone antagonists|mesh-ancestor
5995170|NCT00138125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5995171|NCT00138125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995172|NCT00138203|Vorinostat|vorinostat|mesh-list
5995173|NCT00138203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5995174|NCT00138203|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5995175|NCT00138203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5995176|NCT00138203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995177|NCT00138424|Cidofovir|cidofovir|mesh-list
5995178|NCT00138424|Antiviral Agents|antiviral agents|mesh-ancestor
5995179|NCT00138424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5995180|NCT00138424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5995181|NCT00138424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995182|NCT00138671|Insulin|insulin|mesh-list
5995183|NCT00138671|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5995184|NCT00138671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5995185|NCT00138671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995186|NCT00139477|Metformin|metformin|mesh-list
5995187|NCT00139477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5995188|NCT00139477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259132|NCT03107611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5995189|NCT00139659|Insulin|insulin|mesh-list
5995190|NCT00139659|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5995191|NCT00139659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5995192|NCT00139659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995193|NCT00139737|Ziprasidone|ziprasidone|mesh-list
5995194|NCT00139737|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5995195|NCT00139737|Serotonin Agents|serotonin agents|mesh-ancestor
5995196|NCT00139737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5995197|NCT00139737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995198|NCT00139737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995199|NCT00139737|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5995200|NCT00139737|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5995201|NCT00139737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5995202|NCT00139737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5995203|NCT00139737|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5995204|NCT00139737|Dopamine Agents|dopamine agents|mesh-ancestor
5995205|NCT00139776|Celecoxib|celecoxib|mesh-list
5995206|NCT00139776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6259133|NCT03107611|Dermatologic Agents|dermatologic agents|mesh-ancestor
6259134|NCT03107611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6259135|NCT03107611|Immunologic Factors|immunologic factors|mesh-ancestor
6259136|NCT03107611|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6259137|NCT03107611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6259138|NCT03107611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259139|NCT03107754|Lidocaine|lidocaine|mesh-list
6259140|NCT03107754|Anesthetics|anesthetics|mesh-list
6259141|NCT03107754|Anesthetics, Local|anesthetics, local|mesh-ancestor
6259142|NCT03107754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6259143|NCT03107754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259144|NCT03107754|Sensory System Agents|sensory system agents|mesh-ancestor
6259145|NCT03107754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6259146|NCT03107754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6259147|NCT03107754|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6259148|NCT03107754|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6259149|NCT03107754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6259150|NCT03107754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259151|NCT03107793|Ustekinumab|ustekinumab|mesh-list
6259152|NCT03107793|Dermatologic Agents|dermatologic agents|mesh-ancestor
6259153|NCT03108482|Celecoxib|celecoxib|mesh-list
6259154|NCT03108482|Tramadol|tramadol|mesh-list
6259155|NCT03108482|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6259156|NCT03108482|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6259157|NCT03108482|Analgesics|analgesics|mesh-ancestor
6259158|NCT03108482|Sensory System Agents|sensory system agents|mesh-ancestor
5995207|NCT00139776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5995208|NCT00139776|Analgesics|analgesics|mesh-ancestor
5995209|NCT00139776|Sensory System Agents|sensory system agents|mesh-ancestor
6018506|NCT00381303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6259159|NCT03108482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6259160|NCT03108482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259161|NCT03108482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6259162|NCT03108482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6259163|NCT03108482|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5995210|NCT00139776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5995211|NCT00139776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995212|NCT00139776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5995213|NCT00139776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5995214|NCT00139776|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5995215|NCT00139776|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5995216|NCT00139776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5995217|NCT00139776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995218|NCT00140140|Paclitaxel|paclitaxel|mesh-list
5995219|NCT00140140|Vinorelbine|vinorelbine|mesh-list
5995220|NCT00140140|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5995221|NCT00140140|Trastuzumab|trastuzumab|mesh-list
5995222|NCT00140140|Sargramostim|sargramostim|mesh-list
5995223|NCT00140140|Lenograstim|lenograstim|mesh-list
5995224|NCT00140140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5995225|NCT00140140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5995226|NCT00140140|Tubulin Modulators|tubulin modulators|mesh-ancestor
5995227|NCT00140140|Antimitotic Agents|antimitotic agents|mesh-ancestor
5995228|NCT00140140|Mitosis Modulators|mitosis modulators|mesh-ancestor
5995229|NCT00140140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995230|NCT00140140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5995231|NCT00140140|Immunologic Factors|immunologic factors|mesh-ancestor
5995232|NCT00140140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995233|NCT00140140|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6259164|NCT03108482|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5995234|NCT00140426|Risperidone|risperidone|mesh-list
5995235|NCT00140426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5995236|NCT00140426|Serotonin Agents|serotonin agents|mesh-ancestor
5995237|NCT00140426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5995238|NCT00140426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995239|NCT00140426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995240|NCT00140426|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5995241|NCT00140426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5995242|NCT00140426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5995243|NCT00140426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5995244|NCT00140426|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5995245|NCT00140426|Dopamine Agents|dopamine agents|mesh-ancestor
5995246|NCT00140556|Bevacizumab|bevacizumab|mesh-list
5995247|NCT00140556|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5995248|NCT00140556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5995249|NCT00140556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5995250|NCT00140556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5995251|NCT00140556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5995252|NCT00140556|Growth Substances|growth substances|mesh-ancestor
5995253|NCT00140556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995254|NCT00140556|Growth Inhibitors|growth inhibitors|mesh-ancestor
5995255|NCT00140556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5995256|NCT00140556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5995257|NCT00140556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995258|NCT00140855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5995259|NCT00140855|Ipilimumab|ipilimumab|mesh-list
5995260|NCT00140855|Antibodies|antibodies|mesh-list
6259165|NCT03108482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6259166|NCT03108482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259167|NCT03108482|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6259168|NCT03108482|Narcotics|narcotics|mesh-ancestor
6259169|NCT03108482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6259170|NCT03108521|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6259171|NCT03108521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6259172|NCT03108521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259173|NCT03108521|Incretins|incretins|mesh-ancestor
6259174|NCT03108521|Hormones|hormones|mesh-ancestor
5995261|NCT00140855|Immunoglobulins|immunoglobulins|mesh-list
5995262|NCT00140855|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5995263|NCT00140855|Immunologic Factors|immunologic factors|mesh-ancestor
5995264|NCT00140855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995265|NCT00140855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5995266|NCT00140855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5995267|NCT00140855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995268|NCT00141037|Mycophenolic Acid|mycophenolic acid|mesh-list
5995269|NCT00141037|Trimethoprim|trimethoprim|mesh-list
5995270|NCT00141037|Sulfamethoxazole|sulfamethoxazole|mesh-list
5995271|NCT00141037|Valganciclovir|valganciclovir|mesh-list
5995272|NCT00141037|Ganciclovir|ganciclovir|mesh-list
5995273|NCT00141037|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
5995274|NCT00141037|Prednisone|prednisone|mesh-list
5995275|NCT00141037|Tacrolimus|tacrolimus|mesh-list
5995276|NCT00141037|Daclizumab|daclizumab|mesh-list
5995277|NCT00141037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5995278|NCT00141037|Glucocorticoids|glucocorticoids|mesh-ancestor
5995279|NCT00141037|Hormones|hormones|mesh-ancestor
5995280|NCT00141037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5995281|NCT00141037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995282|NCT00141037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5995283|NCT00141037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5995284|NCT00141037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5995285|NCT00141037|Immunologic Factors|immunologic factors|mesh-ancestor
5995286|NCT00141037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5995287|NCT00141037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5995288|NCT00141037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995289|NCT00141037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5995290|NCT00141037|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5995291|NCT00141037|Antitubercular Agents|antitubercular agents|mesh-ancestor
5995292|NCT00141037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5995293|NCT00141037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5995294|NCT00141037|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5995295|NCT00141037|Renal Agents|renal agents|mesh-ancestor
5995296|NCT00141037|Antimalarials|antimalarials|mesh-ancestor
5995297|NCT00141037|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5995298|NCT00141037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5995299|NCT00141037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5995300|NCT00141037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5995301|NCT00141037|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
5995302|NCT00141037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5995303|NCT00141037|Antiviral Agents|antiviral agents|mesh-ancestor
5995304|NCT00141037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5995305|NCT00141102|Celecoxib|celecoxib|mesh-list
5995306|NCT00141102|Diclofenac|diclofenac|mesh-list
5995307|NCT00141102|Omeprazole|omeprazole|mesh-list
5995308|NCT00141102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5995309|NCT00141102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5995310|NCT00141102|Analgesics|analgesics|mesh-ancestor
5995311|NCT00141102|Sensory System Agents|sensory system agents|mesh-ancestor
5995312|NCT00141102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5995313|NCT00141102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995314|NCT00141102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6389843|NCT00189514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995315|NCT00141102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5995316|NCT00141102|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5995317|NCT00141102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5995318|NCT00141102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6389844|NCT00189553|Paclitaxel|paclitaxel|mesh-list
5995319|NCT00141102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995320|NCT00141102|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5995321|NCT00141102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5995322|NCT00141102|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5995323|NCT00141115|Levetiracetam|levetiracetam|mesh-list
5995324|NCT00141115|Anticonvulsants|anticonvulsants|mesh-ancestor
5995325|NCT00141115|Nootropic Agents|nootropic agents|mesh-ancestor
5995326|NCT00141219|Pregabalin|pregabalin|mesh-list
5995327|NCT00141219|Analgesics|analgesics|mesh-ancestor
5995328|NCT00141219|Sensory System Agents|sensory system agents|mesh-ancestor
5995329|NCT00141219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5995330|NCT00141219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995331|NCT00141219|Anticonvulsants|anticonvulsants|mesh-ancestor
5995332|NCT00141219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5995333|NCT00141219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5995334|NCT00141219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995335|NCT00141219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5995336|NCT00141219|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5995337|NCT00141219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5995338|NCT00141219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5995339|NCT00141219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6389845|NCT00189553|Carboplatin|carboplatin|mesh-list
5995340|NCT00141271|Ziprasidone|ziprasidone|mesh-list
5995341|NCT00141271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5995342|NCT00141271|Serotonin Agents|serotonin agents|mesh-ancestor
5995343|NCT00141271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5995344|NCT00141271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995345|NCT00141271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995346|NCT00141271|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5995347|NCT00141271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5995348|NCT00141271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5995349|NCT00141271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5995350|NCT00141271|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5995351|NCT00141271|Dopamine Agents|dopamine agents|mesh-ancestor
5995352|NCT00141297|Palbociclib|palbociclib|mesh-list
5995353|NCT00141297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5995354|NCT00141297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5995355|NCT00141297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5995356|NCT00141297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995357|NCT00141453|Olmesartan|olmesartan|mesh-list
5995358|NCT00141453|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
5995359|NCT00141453|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5995360|NCT00141453|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5995361|NCT00141453|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5995362|NCT00141453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995363|NCT00141518|Levodopa|levodopa|mesh-list
5995364|NCT00141518|Carbidopa|carbidopa|mesh-list
5995365|NCT00141518|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
5995366|NCT00141518|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5995367|NCT00141518|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5995368|NCT00141518|Dopamine Agents|dopamine agents|mesh-ancestor
5995369|NCT00141518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5995370|NCT00141518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995371|NCT00141518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995372|NCT00141518|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5995373|NCT00141518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5995374|NCT00141518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5995375|NCT00141518|Immunologic Factors|immunologic factors|mesh-ancestor
5995376|NCT00141518|Dopamine Agonists|dopamine agonists|mesh-ancestor
5995377|NCT00141726|Etanercept|etanercept|mesh-list
5995378|NCT00141726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5995379|NCT00141726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5995380|NCT00141726|Analgesics|analgesics|mesh-ancestor
5995381|NCT00141726|Sensory System Agents|sensory system agents|mesh-ancestor
5995382|NCT00141726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5995383|NCT00141726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995384|NCT00141726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5995385|NCT00141726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5995386|NCT00141726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6259175|NCT03108521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6259176|NCT03108521|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6259177|NCT03108521|Protease Inhibitors|protease inhibitors|mesh-ancestor
6259178|NCT03108521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6259179|NCT03108521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259180|NCT03109015|Sunitinib|sunitinib|mesh-list
6259181|NCT03109015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6259182|NCT03109015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6259183|NCT03109015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6259184|NCT03109015|Growth Substances|growth substances|mesh-ancestor
6259185|NCT03109015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259186|NCT03109015|Growth Inhibitors|growth inhibitors|mesh-ancestor
6259187|NCT03109015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6259188|NCT03109015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6259189|NCT03109015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259190|NCT03110003|Bupivacaine|bupivacaine|mesh-list
6259191|NCT03110003|Anesthetics, Local|anesthetics, local|mesh-ancestor
6259192|NCT03110003|Anesthetics|anesthetics|mesh-ancestor
5995387|NCT00141726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5995388|NCT00141726|Immunologic Factors|immunologic factors|mesh-ancestor
5995389|NCT00141739|Etanercept|etanercept|mesh-list
5995390|NCT00141739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5995391|NCT00141739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5995392|NCT00141739|Analgesics|analgesics|mesh-ancestor
5995393|NCT00141739|Sensory System Agents|sensory system agents|mesh-ancestor
5995394|NCT00141739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5995395|NCT00141739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995396|NCT00141739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5995397|NCT00141739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5995398|NCT00141739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5995399|NCT00141739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5995400|NCT00141739|Immunologic Factors|immunologic factors|mesh-ancestor
5995401|NCT00141778|Ramipril|ramipril|mesh-list
6259193|NCT03110003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6389846|NCT00189553|Doxorubicin|doxorubicin|mesh-list
5995402|NCT00141778|Spironolactone|spironolactone|mesh-list
5995403|NCT00141778|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
5995404|NCT00141778|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
5995405|NCT00141778|Enzyme Inhibitors|enzyme inhibitors|mesh-list
5995406|NCT00141778|Mineralocorticoids|mineralocorticoids|mesh-list
5995407|NCT00141778|Hormone Antagonists|hormone antagonists|mesh-ancestor
5995408|NCT00141778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5995409|NCT00141778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995410|NCT00141778|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5995411|NCT00141778|Diuretics|diuretics|mesh-ancestor
5995412|NCT00141778|Natriuretic Agents|natriuretic agents|mesh-ancestor
5995413|NCT00141778|Protease Inhibitors|protease inhibitors|mesh-ancestor
5995414|NCT00141778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995415|NCT00141778|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5995416|NCT00141778|Hormones|hormones|mesh-ancestor
5995417|NCT00141817|Pantoprazole|pantoprazole|mesh-list
5995418|NCT00141817|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5995419|NCT00141817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5995420|NCT00141817|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5995421|NCT00141817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5995422|NCT00141817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995423|NCT00141921|Etanercept|etanercept|mesh-list
5995424|NCT00141921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5995425|NCT00141921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5995426|NCT00141921|Analgesics|analgesics|mesh-ancestor
5995427|NCT00141921|Sensory System Agents|sensory system agents|mesh-ancestor
5995428|NCT00141921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5995429|NCT00141921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995430|NCT00141921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5995431|NCT00141921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5995432|NCT00141921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5995433|NCT00141921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5995434|NCT00141921|Immunologic Factors|immunologic factors|mesh-ancestor
5995435|NCT00142116|Thalidomide|thalidomide|mesh-list
5995436|NCT00142116|Rituximab|rituximab|mesh-list
5995437|NCT00142116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5995438|NCT00142116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5995439|NCT00142116|Immunologic Factors|immunologic factors|mesh-ancestor
5995440|NCT00142116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995441|NCT00142116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5995442|NCT00142116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5995443|NCT00142116|Leprostatic Agents|leprostatic agents|mesh-ancestor
5995444|NCT00142116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5995445|NCT00142116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5995446|NCT00142116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5995447|NCT00142116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5995448|NCT00142116|Growth Substances|growth substances|mesh-ancestor
5995449|NCT00142116|Growth Inhibitors|growth inhibitors|mesh-ancestor
5995450|NCT00142168|Rituximab|rituximab|mesh-list
5995451|NCT00142168|Lenalidomide|lenalidomide|mesh-list
5995452|NCT00142168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5995453|NCT00142168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5995454|NCT00142168|Immunologic Factors|immunologic factors|mesh-ancestor
5995455|NCT00142168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995456|NCT00142168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5995457|NCT00142168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5995458|NCT00142168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5995459|NCT00142168|Growth Substances|growth substances|mesh-ancestor
5995460|NCT00142168|Growth Inhibitors|growth inhibitors|mesh-ancestor
5995461|NCT00142298|Telbivudine|telbivudine|mesh-list
5995462|NCT00142298|Antiviral Agents|antiviral agents|mesh-ancestor
5995463|NCT00142298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5995464|NCT00142298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5995465|NCT00142298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5995466|NCT00142298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995467|NCT00142415|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
5995468|NCT00142415|Chelating Agents|chelating agents|mesh-ancestor
5995469|NCT00142415|Sequestering Agents|sequestering agents|mesh-ancestor
5995470|NCT00142415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995471|NCT00142454|Imiquimod|imiquimod|mesh-list
5995472|NCT00142454|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5995473|NCT00142454|Immunologic Factors|immunologic factors|mesh-ancestor
5995474|NCT00142454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995475|NCT00142454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5995476|NCT00142454|Interferon Inducers|interferon inducers|mesh-ancestor
5995477|NCT00142506|Sildenafil Citrate|sildenafil citrate|mesh-list
5995478|NCT00142506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995479|NCT00142506|Vasodilator Agents|vasodilator agents|mesh-ancestor
5995480|NCT00142506|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5995481|NCT00142506|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5995482|NCT00142506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5995483|NCT00142506|Urological Agents|urological agents|mesh-ancestor
5995484|NCT00142818|Naltrexone|naltrexone|mesh-list
5995485|NCT00142818|Modafinil|modafinil|mesh-list
5995486|NCT00142818|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5995487|NCT00142818|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5995488|NCT00142818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995489|NCT00142818|Sensory System Agents|sensory system agents|mesh-ancestor
5995490|NCT00142818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5995491|NCT00142818|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5995492|NCT00142818|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
5995493|NCT00142818|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5995494|NCT00142818|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5995495|NCT00142818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995496|NCT00142909|Lofexidine|lofexidine|mesh-list
5995497|NCT00142909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5995498|NCT00142909|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5995499|NCT00142909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995500|NCT00142909|Sensory System Agents|sensory system agents|mesh-ancestor
5995501|NCT00142909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5995502|NCT00142909|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5995503|NCT00142909|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5995504|NCT00142909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5995505|NCT00142909|Adrenergic Agents|adrenergic agents|mesh-ancestor
5995506|NCT00142909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5995507|NCT00142909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995508|NCT00143247|Insulin|insulin|mesh-list
5995509|NCT00143247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5995510|NCT00143247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995511|NCT00143312|Voriconazole|voriconazole|mesh-list
5995512|NCT00143312|Antifungal Agents|antifungal agents|mesh-ancestor
5995513|NCT00143312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5995514|NCT00143312|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5995515|NCT00143312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5995516|NCT00143312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5995517|NCT00143312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995518|NCT00143312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5995519|NCT00143312|Hormone Antagonists|hormone antagonists|mesh-ancestor
5995520|NCT00143312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5995521|NCT00143312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995522|NCT00143312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5995523|NCT00143390|Anastrozole|anastrozole|mesh-list
5995524|NCT00143390|Exemestane|exemestane|mesh-list
5995525|NCT00143390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5995526|NCT00143390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5995527|NCT00143390|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5995528|NCT00143390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5995529|NCT00143390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5995530|NCT00143390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995531|NCT00143390|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5995532|NCT00143390|Hormone Antagonists|hormone antagonists|mesh-ancestor
5995533|NCT00143390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5995534|NCT00143390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995535|NCT00143403|Leucovorin|leucovorin|mesh-list
5995536|NCT00143403|Folic Acid|folic acid|mesh-list
5995537|NCT00143403|Irinotecan|irinotecan|mesh-list
5995538|NCT00143403|Fluorouracil|fluorouracil|mesh-list
5995539|NCT00143403|Levoleucovorin|levoleucovorin|mesh-list
5995540|NCT00143403|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5995541|NCT00143403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5995542|NCT00143403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5995543|NCT00143403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995544|NCT00143403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5995545|NCT00143403|Antimetabolites|antimetabolites|mesh-ancestor
5995546|NCT00143403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5995547|NCT00143403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5995548|NCT00143403|Immunologic Factors|immunologic factors|mesh-ancestor
5995549|NCT00143403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995550|NCT00143403|Antidotes|antidotes|mesh-ancestor
5995551|NCT00143403|Protective Agents|protective agents|mesh-ancestor
5995552|NCT00143403|Vitamin B Complex|vitamin b complex|mesh-ancestor
5995553|NCT00143403|Vitamins|vitamins|mesh-ancestor
5995554|NCT00143403|Micronutrients|micronutrients|mesh-ancestor
5995555|NCT00143403|Hematinics|hematinics|mesh-ancestor
5995556|NCT00143455|Cisplatin|cisplatin|mesh-list
5995557|NCT00143455|Irinotecan|irinotecan|mesh-list
5995558|NCT00143455|Etoposide|etoposide|mesh-list
5995559|NCT00143455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5995560|NCT00143455|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5995561|NCT00143455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5995562|NCT00143455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5995563|NCT00143455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995564|NCT00143455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5995565|NCT00143455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5995566|NCT00143845|Immunosuppressive Agents|immunosuppressive agents|mesh-list
5995567|NCT00143845|Immunologic Factors|immunologic factors|mesh-ancestor
5995568|NCT00143845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995569|NCT00144027|Antipsychotic Agents|antipsychotic agents|mesh-list
5995570|NCT00144027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5995571|NCT00144027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5995572|NCT00144027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995573|NCT00144027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5995574|NCT00144170|Ritonavir|ritonavir|mesh-list
5995575|NCT00144170|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
5995576|NCT00144170|Tipranavir|tipranavir|mesh-list
5995577|NCT00144170|Protease Inhibitors|protease inhibitors|mesh-list
5995578|NCT00144170|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5995579|NCT00144170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5995580|NCT00144170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995581|NCT00144170|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5995582|NCT00144170|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5995583|NCT00144170|Antiviral Agents|antiviral agents|mesh-ancestor
5995584|NCT00144170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5995585|NCT00144170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5995586|NCT00144170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5995587|NCT00144300|Pramipexole|pramipexole|mesh-list
5995588|NCT00144300|Antioxidants|antioxidants|mesh-ancestor
5995589|NCT00144300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995590|NCT00144300|Protective Agents|protective agents|mesh-ancestor
5995591|NCT00144300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995592|NCT00144300|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5995593|NCT00144300|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5995594|NCT00144300|Dopamine Agonists|dopamine agonists|mesh-ancestor
5995595|NCT00144300|Dopamine Agents|dopamine agents|mesh-ancestor
5995596|NCT00144300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5995597|NCT00144339|Tiotropium Bromide|tiotropium bromide|mesh-list
5995598|NCT00144339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5995599|NCT00144339|Autonomic Agents|autonomic agents|mesh-ancestor
5995600|NCT00144339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5995601|NCT00144339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259194|NCT03110003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259195|NCT03110003|Sensory System Agents|sensory system agents|mesh-ancestor
6259196|NCT03110003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6259197|NCT03110029|Efinaconazole|efinaconazole|mesh-list
6259198|NCT03110029|Antifungal Agents|antifungal agents|mesh-ancestor
6259199|NCT03110029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6259200|NCT03110562|Dexamethasone|dexamethasone|mesh-list
6259201|NCT03110562|Bortezomib|bortezomib|mesh-list
6259202|NCT03110562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6259203|NCT03110562|Antiemetics|antiemetics|mesh-ancestor
5995602|NCT00144339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6259204|NCT03110562|Autonomic Agents|autonomic agents|mesh-ancestor
6259205|NCT03110562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5995603|NCT00144339|Respiratory System Agents|respiratory system agents|mesh-ancestor
5995604|NCT00144339|Parasympatholytics|parasympatholytics|mesh-ancestor
5995605|NCT00144339|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5995606|NCT00144339|Cholinergic Agents|cholinergic agents|mesh-ancestor
5995607|NCT00144339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5995608|NCT00144339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995609|NCT00144391|Testosterone|testosterone|mesh-list
5995610|NCT00144391|Androgens|androgens|mesh-ancestor
5995611|NCT00144391|Hormones|hormones|mesh-ancestor
5995612|NCT00144391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5995613|NCT00144391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995614|NCT00144963|Dexamethasone|dexamethasone|mesh-list
5995615|NCT00144963|Vincristine|vincristine|mesh-list
5995616|NCT00144963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5995617|NCT00144963|Antiemetics|antiemetics|mesh-ancestor
5995618|NCT00144963|Autonomic Agents|autonomic agents|mesh-ancestor
5995619|NCT00144963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5995620|NCT00144963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995621|NCT00144963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5995622|NCT00144963|Glucocorticoids|glucocorticoids|mesh-ancestor
5995623|NCT00144963|Hormones|hormones|mesh-ancestor
5995624|NCT00144963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5995625|NCT00144963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5995626|NCT00144963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5995627|NCT00144963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5995628|NCT00144963|Tubulin Modulators|tubulin modulators|mesh-ancestor
5995629|NCT00144963|Antimitotic Agents|antimitotic agents|mesh-ancestor
5995630|NCT00144963|Mitosis Modulators|mitosis modulators|mesh-ancestor
5995631|NCT00144963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995632|NCT00145041|Vincristine|vincristine|mesh-list
5995633|NCT00145041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5995634|NCT00145041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5995635|NCT00145041|Tubulin Modulators|tubulin modulators|mesh-ancestor
5995636|NCT00145041|Antimitotic Agents|antimitotic agents|mesh-ancestor
5995637|NCT00145041|Mitosis Modulators|mitosis modulators|mesh-ancestor
5995638|NCT00145041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995639|NCT00145249|Fluconazole|fluconazole|mesh-list
5995640|NCT00145249|Amphotericin B|amphotericin b|mesh-list
5995641|NCT00145249|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
5995642|NCT00145249|Antifungal Agents|antifungal agents|mesh-ancestor
5995643|NCT00145249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5995644|NCT00145249|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5995645|NCT00145249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5995646|NCT00145249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5995647|NCT00145249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995648|NCT00145249|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5995649|NCT00145249|Hormone Antagonists|hormone antagonists|mesh-ancestor
5995650|NCT00145249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5995651|NCT00145249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995652|NCT00145249|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5995653|NCT00145249|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5995654|NCT00145249|Amebicides|amebicides|mesh-ancestor
5995655|NCT00145249|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5995656|NCT00145249|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5995657|NCT00145249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5995658|NCT00145327|Zoledronic Acid|zoledronic acid|mesh-list
5995659|NCT00145327|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5995660|NCT00145327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995661|NCT00145418|Docetaxel|docetaxel|mesh-list
5995662|NCT00145418|Oxaliplatin|oxaliplatin|mesh-list
5995663|NCT00145418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5995664|NCT00145418|Tubulin Modulators|tubulin modulators|mesh-ancestor
5995665|NCT00145418|Antimitotic Agents|antimitotic agents|mesh-ancestor
5995666|NCT00145418|Mitosis Modulators|mitosis modulators|mesh-ancestor
5995667|NCT00145418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995668|NCT00145574|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
5995669|NCT00145574|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5995670|NCT00145574|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5995671|NCT00145574|Antimetabolites|antimetabolites|mesh-ancestor
5995672|NCT00145574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995673|NCT00145574|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5995674|NCT00145587|Antibodies|antibodies|mesh-list
5995675|NCT00145587|Immunologic Factors|immunologic factors|mesh-ancestor
5995676|NCT00145587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995677|NCT00145626|Cyclophosphamide|cyclophosphamide|mesh-list
5995678|NCT00145626|Melphalan|melphalan|mesh-list
5995679|NCT00145626|Thiotepa|thiotepa|mesh-list
5995680|NCT00145626|Fludarabine|fludarabine|mesh-list
5995681|NCT00145626|Antibodies|antibodies|mesh-list
5995682|NCT00145626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5995683|NCT00145626|Immunologic Factors|immunologic factors|mesh-ancestor
5995684|NCT00145626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995685|NCT00145626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5995686|NCT00145626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5995687|NCT00145626|Alkylating Agents|alkylating agents|mesh-ancestor
5995688|NCT00145626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995689|NCT00145626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5995690|NCT00145626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5995691|NCT00145795|Ritonavir|ritonavir|mesh-list
5995692|NCT00145795|Lopinavir|lopinavir|mesh-list
5995693|NCT00145795|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5995694|NCT00145795|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5995695|NCT00145795|Protease Inhibitors|protease inhibitors|mesh-ancestor
5995696|NCT00145795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5995697|NCT00145795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995698|NCT00145795|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5995699|NCT00145795|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5995700|NCT00145795|Antiviral Agents|antiviral agents|mesh-ancestor
5995701|NCT00145795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5995702|NCT00145795|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5995703|NCT00145795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5995704|NCT00145977|Vitamin D|vitamin d|mesh-list
5995705|NCT00145977|Alendronate|alendronate|mesh-list
5995706|NCT00145977|Calcium|calcium|mesh-list
5995707|NCT00145977|Vitamins|vitamins|mesh-ancestor
5995708|NCT00145977|Micronutrients|micronutrients|mesh-ancestor
5995709|NCT00145977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995710|NCT00145977|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5995711|NCT00145977|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5995712|NCT00146328|Tipranavir|tipranavir|mesh-list
5995713|NCT00146328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5995714|NCT00146328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5995715|NCT00146328|Antiviral Agents|antiviral agents|mesh-ancestor
5995716|NCT00146328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5995717|NCT00146640|Prednisone|prednisone|mesh-list
5995718|NCT00146640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5995719|NCT00146640|Glucocorticoids|glucocorticoids|mesh-ancestor
5995720|NCT00146640|Hormones|hormones|mesh-ancestor
5995721|NCT00146640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5995722|NCT00146640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995723|NCT00146640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5995724|NCT00146640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5995725|NCT00147199|Treprostinil|treprostinil|mesh-list
5995726|NCT00147199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5995727|NCT00147212|Trabectedin|trabectedin|mesh-list
5995728|NCT00147212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5995729|NCT00147212|Alkylating Agents|alkylating agents|mesh-ancestor
5995730|NCT00147212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995731|NCT00147212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5995732|NCT00147225|Carboplatin|carboplatin|mesh-list
5995733|NCT00147225|Doxorubicin|doxorubicin|mesh-list
5995734|NCT00147225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5995735|NCT00147225|Ifosfamide|ifosfamide|mesh-list
5995736|NCT00147225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5995737|NCT00147225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5995738|NCT00147225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5995739|NCT00147225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5995740|NCT00147225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5995741|NCT00147225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995742|NCT00147225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5995743|NCT00147225|Alkylating Agents|alkylating agents|mesh-ancestor
5995744|NCT00147316|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5995745|NCT00147316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5995746|NCT00147316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5995747|NCT00147316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995748|NCT00147498|Tofacitinib|tofacitinib|mesh-list
5995749|NCT00147498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5995750|NCT00147498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5995751|NCT00147498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995752|NCT00147537|Paclitaxel|paclitaxel|mesh-list
5995753|NCT00147537|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5995754|NCT00147537|Carboplatin|carboplatin|mesh-list
5995755|NCT00147537|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5995756|NCT00147537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5995757|NCT00147537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5995758|NCT00147537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5995759|NCT00147537|Tubulin Modulators|tubulin modulators|mesh-ancestor
5995760|NCT00147537|Antimitotic Agents|antimitotic agents|mesh-ancestor
5995761|NCT00147537|Mitosis Modulators|mitosis modulators|mesh-ancestor
5995762|NCT00147537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995763|NCT00147537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5995764|NCT00147537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5995765|NCT00147537|Immunologic Factors|immunologic factors|mesh-ancestor
5995766|NCT00147537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995767|NCT00147745|Insulin Glargine|insulin glargine|mesh-list
5995768|NCT00147745|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
5995769|NCT00147745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5995770|NCT00147745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995771|NCT00147745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5995772|NCT00147745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5995773|NCT00147745|Antimetabolites|antimetabolites|mesh-ancestor
5995774|NCT00147745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995775|NCT00147745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5995776|NCT00147966|Rituximab|rituximab|mesh-list
5995777|NCT00147966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5995778|NCT00147966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5995779|NCT00147966|Immunologic Factors|immunologic factors|mesh-ancestor
5995780|NCT00147966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995781|NCT00147966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5995782|NCT00148109|Cetuximab|cetuximab|mesh-list
5995783|NCT00148109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5995784|NCT00148109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5995785|NCT00148122|Docetaxel|docetaxel|mesh-list
5995786|NCT00148122|Capecitabine|capecitabine|mesh-list
5995787|NCT00148122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5995788|NCT00148122|Tubulin Modulators|tubulin modulators|mesh-ancestor
5995789|NCT00148122|Antimitotic Agents|antimitotic agents|mesh-ancestor
5995790|NCT00148122|Mitosis Modulators|mitosis modulators|mesh-ancestor
5995791|NCT00148122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995792|NCT00148122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5995793|NCT00148122|Antimetabolites|antimetabolites|mesh-ancestor
5995794|NCT00148317|Dexamethasone|dexamethasone|mesh-list
5995795|NCT00148317|Doxorubicin|doxorubicin|mesh-list
5995796|NCT00148317|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5995797|NCT00148317|Bortezomib|bortezomib|mesh-list
5995798|NCT00148317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5995799|NCT00148317|Antiemetics|antiemetics|mesh-ancestor
5995800|NCT00148317|Autonomic Agents|autonomic agents|mesh-ancestor
5995801|NCT00148317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5995802|NCT00148317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995803|NCT00148317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5995804|NCT00148317|Glucocorticoids|glucocorticoids|mesh-ancestor
5995805|NCT00148317|Hormones|hormones|mesh-ancestor
5995806|NCT00148317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5995807|NCT00148317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5995808|NCT00148317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5995809|NCT00148317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5995810|NCT00148317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5995811|NCT00148317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5995812|NCT00148317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5995813|NCT00148317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995814|NCT00148668|Carboplatin|carboplatin|mesh-list
5995815|NCT00148668|Docetaxel|docetaxel|mesh-list
5995816|NCT00148668|Trastuzumab|trastuzumab|mesh-list
5995817|NCT00148668|Vinorelbine|vinorelbine|mesh-list
5995818|NCT00148668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5995819|NCT00148668|Tubulin Modulators|tubulin modulators|mesh-ancestor
5995820|NCT00148668|Antimitotic Agents|antimitotic agents|mesh-ancestor
5995821|NCT00148668|Mitosis Modulators|mitosis modulators|mesh-ancestor
5995822|NCT00148668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995823|NCT00148668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6259206|NCT03110562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259207|NCT03110562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6259208|NCT03110562|Glucocorticoids|glucocorticoids|mesh-ancestor
6259209|NCT03110562|Hormones|hormones|mesh-ancestor
6259210|NCT03110562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6259211|NCT03110562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6259212|NCT03110562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6259213|NCT03111108|Grazoprevir|grazoprevir|mesh-list
6259214|NCT03111108|Antiviral Agents|antiviral agents|mesh-ancestor
6259215|NCT03111108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6259216|NCT03111316|Dinoprostone|dinoprostone|mesh-list
6259217|NCT03111316|Oxytocics|oxytocics|mesh-ancestor
6259218|NCT03111316|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6259219|NCT03111316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259220|NCT03111381|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6259221|NCT03111381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6259222|NCT03111381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6259223|NCT03111381|Analgesics|analgesics|mesh-ancestor
6259224|NCT03111381|Sensory System Agents|sensory system agents|mesh-ancestor
6259225|NCT03111381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6259226|NCT03111381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259227|NCT03111381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6259228|NCT03111381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6259229|NCT03111381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6259230|NCT03111381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6259231|NCT03111381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259232|NCT03111628|Omalizumab|omalizumab|mesh-list
6259233|NCT03111628|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6259234|NCT03111628|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6259235|NCT03111628|Respiratory System Agents|respiratory system agents|mesh-ancestor
6259236|NCT03112863|Vitamin A|vitamin a|mesh-list
6259237|NCT03112863|Retinol palmitate|retinol palmitate|mesh-list
6259238|NCT03112863|Vitamins|vitamins|mesh-ancestor
6259239|NCT03112863|Micronutrients|micronutrients|mesh-ancestor
6259240|NCT03112863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259241|NCT03112863|Antioxidants|antioxidants|mesh-ancestor
6259242|NCT03112863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259243|NCT03112863|Protective Agents|protective agents|mesh-ancestor
6259244|NCT03112863|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6259245|NCT03112863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6259246|NCT03112993|Neostigmine|neostigmine|mesh-list
6259247|NCT03112993|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6259248|NCT03112993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6259249|NCT03112993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259250|NCT03112993|Cholinergic Agents|cholinergic agents|mesh-ancestor
6259251|NCT03112993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5995824|NCT00148668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5995825|NCT00148798|Cisplatin|cisplatin|mesh-list
5995826|NCT00148798|Cetuximab|cetuximab|mesh-list
5995827|NCT00148798|Vinorelbine|vinorelbine|mesh-list
5995828|NCT00148798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5995829|NCT00148798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5995830|NCT00148798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5995831|NCT00148798|Tubulin Modulators|tubulin modulators|mesh-ancestor
5995832|NCT00148798|Antimitotic Agents|antimitotic agents|mesh-ancestor
5995833|NCT00148798|Mitosis Modulators|mitosis modulators|mesh-ancestor
5995834|NCT00148798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995835|NCT00148941|Vaccines|vaccines|mesh-list
5995836|NCT00148941|Immunologic Factors|immunologic factors|mesh-ancestor
5995837|NCT00148941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995838|NCT00149214|Cyclophosphamide|cyclophosphamide|mesh-list
5995839|NCT00149214|Docetaxel|docetaxel|mesh-list
5995840|NCT00149214|Doxorubicin|doxorubicin|mesh-list
5995841|NCT00149214|Pemetrexed|pemetrexed|mesh-list
5995842|NCT00149214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5995843|NCT00149214|Immunologic Factors|immunologic factors|mesh-ancestor
5995844|NCT00149214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995845|NCT00149214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5995846|NCT00149214|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5995847|NCT00149214|Alkylating Agents|alkylating agents|mesh-ancestor
5995848|NCT00149214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995849|NCT00149214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5995850|NCT00149214|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5995851|NCT00149214|Tubulin Modulators|tubulin modulators|mesh-ancestor
5995852|NCT00149214|Antimitotic Agents|antimitotic agents|mesh-ancestor
5995853|NCT00149214|Mitosis Modulators|mitosis modulators|mesh-ancestor
5995854|NCT00149214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5995855|NCT00149214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5995856|NCT00149214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5995857|NCT00149214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5995858|NCT00149214|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5995859|NCT00149214|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5995860|NCT00149227|Valsartan|valsartan|mesh-list
5995861|NCT00149227|Antihypertensive Agents|antihypertensive agents|mesh-list
5995862|NCT00149227|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5995863|NCT00149227|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5995864|NCT00149227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995865|NCT00149630|Disulfiram|disulfiram|mesh-list
5995866|NCT00149630|Methadone|methadone|mesh-list
5995867|NCT00149630|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5995868|NCT00149630|Narcotics|narcotics|mesh-ancestor
5995869|NCT00149630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5995870|NCT00149630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995871|NCT00149630|Analgesics|analgesics|mesh-ancestor
5995872|NCT00149630|Sensory System Agents|sensory system agents|mesh-ancestor
5995873|NCT00149630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5995874|NCT00149630|Antitussive Agents|antitussive agents|mesh-ancestor
5995875|NCT00149630|Respiratory System Agents|respiratory system agents|mesh-ancestor
5995876|NCT00149630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5995877|NCT00149630|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
5995878|NCT00149630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5995879|NCT00149630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995880|NCT00149643|Fluoxetine|fluoxetine|mesh-list
5995881|NCT00149643|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5995882|NCT00149643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5995883|NCT00149643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5995884|NCT00149643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995885|NCT00149643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5995886|NCT00149643|Serotonin Agents|serotonin agents|mesh-ancestor
5995887|NCT00149643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995888|NCT00149643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5995889|NCT00149643|Antidepressive Agents|antidepressive agents|mesh-ancestor
5995890|NCT00149643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5995891|NCT00149643|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5995892|NCT00149643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5995893|NCT00149643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5995894|NCT00149734|Ondansetron|ondansetron|mesh-list
5995895|NCT00149734|Antiemetics|antiemetics|mesh-ancestor
5995896|NCT00149734|Autonomic Agents|autonomic agents|mesh-ancestor
5995897|NCT00149734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5995898|NCT00149734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995899|NCT00149734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5995900|NCT00149734|Antipruritics|antipruritics|mesh-ancestor
5995901|NCT00149734|Dermatologic Agents|dermatologic agents|mesh-ancestor
5995902|NCT00149734|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5995903|NCT00149734|Serotonin Agents|serotonin agents|mesh-ancestor
5995904|NCT00149734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5995905|NCT00149734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995906|NCT00149734|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5995907|NCT00149734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5995908|NCT00149734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5995909|NCT00149734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5995910|NCT00149734|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5995911|NCT00149799|Citalopram|citalopram|mesh-list
5995912|NCT00149799|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5995913|NCT00149799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5995914|NCT00149799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5995915|NCT00149799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995916|NCT00149799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5995917|NCT00149799|Serotonin Agents|serotonin agents|mesh-ancestor
5995918|NCT00149799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995919|NCT00149799|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5995920|NCT00149799|Antidepressive Agents|antidepressive agents|mesh-ancestor
5995921|NCT00149799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5995922|NCT00149825|Dexetimide|dexetimide|mesh-list
5995923|NCT00149825|Citalopram|citalopram|mesh-list
5995924|NCT00149825|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5995925|NCT00149825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5995926|NCT00149825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5995927|NCT00149825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995928|NCT00149825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5995929|NCT00149825|Serotonin Agents|serotonin agents|mesh-ancestor
5995930|NCT00149825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995931|NCT00149825|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5995932|NCT00149825|Antidepressive Agents|antidepressive agents|mesh-ancestor
5995933|NCT00149825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5995934|NCT00149825|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5995935|NCT00149825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5995936|NCT00149825|Parasympatholytics|parasympatholytics|mesh-ancestor
5995937|NCT00149825|Autonomic Agents|autonomic agents|mesh-ancestor
5995938|NCT00149825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5995939|NCT00149825|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5995940|NCT00149825|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5995941|NCT00149825|Cholinergic Agents|cholinergic agents|mesh-ancestor
5995942|NCT00149838|Antidepressive Agents|antidepressive agents|mesh-list
5995943|NCT00149838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5995944|NCT00149890|Cyclosporine|cyclosporine|mesh-list
5995945|NCT00149890|Cyclosporins|cyclosporins|mesh-list
5995946|NCT00149890|Basiliximab|basiliximab|mesh-list
5995947|NCT00149890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5995948|NCT00149890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995949|NCT00149890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5995950|NCT00149890|Immunologic Factors|immunologic factors|mesh-ancestor
5995951|NCT00149890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995952|NCT00149890|Antifungal Agents|antifungal agents|mesh-ancestor
5995953|NCT00149890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5995954|NCT00149890|Dermatologic Agents|dermatologic agents|mesh-ancestor
5995955|NCT00149890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5995956|NCT00149890|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5995957|NCT00149994|Cyclosporine|cyclosporine|mesh-list
5995958|NCT00149994|Prednisone|prednisone|mesh-list
5995959|NCT00149994|Methylprednisolone|methylprednisolone|mesh-list
5995960|NCT00149994|Tacrolimus|tacrolimus|mesh-list
5995961|NCT00149994|Cyclosporins|cyclosporins|mesh-list
5995962|NCT00149994|Basiliximab|basiliximab|mesh-list
5995963|NCT00149994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5995964|NCT00149994|Glucocorticoids|glucocorticoids|mesh-ancestor
5995965|NCT00149994|Hormones|hormones|mesh-ancestor
5995966|NCT00149994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5995967|NCT00149994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995968|NCT00149994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6389847|NCT00189553|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5995969|NCT00149994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5995970|NCT00149994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5995971|NCT00149994|Immunologic Factors|immunologic factors|mesh-ancestor
5995972|NCT00149994|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5995973|NCT00149994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5995974|NCT00149994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995975|NCT00149994|Antifungal Agents|antifungal agents|mesh-ancestor
5995976|NCT00149994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5995977|NCT00149994|Dermatologic Agents|dermatologic agents|mesh-ancestor
5995978|NCT00149994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5995979|NCT00149994|Antiemetics|antiemetics|mesh-ancestor
5995980|NCT00149994|Autonomic Agents|autonomic agents|mesh-ancestor
5995981|NCT00149994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5995982|NCT00149994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5995983|NCT00149994|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5995984|NCT00149994|Protective Agents|protective agents|mesh-ancestor
5995985|NCT00150345|Voriconazole|voriconazole|mesh-list
5995986|NCT00150345|Antifungal Agents|antifungal agents|mesh-ancestor
5995987|NCT00150345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5995988|NCT00150345|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5995989|NCT00150345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5995990|NCT00150345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5995991|NCT00150345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5995992|NCT00150345|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5995993|NCT00150345|Hormone Antagonists|hormone antagonists|mesh-ancestor
5995994|NCT00150345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5995995|NCT00150345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5995996|NCT00150345|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5995997|NCT00150462|Dexamethasone|dexamethasone|mesh-list
5995998|NCT00150462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5995999|NCT00150462|Antiemetics|antiemetics|mesh-ancestor
5996000|NCT00150462|Autonomic Agents|autonomic agents|mesh-ancestor
5996001|NCT00150462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5996002|NCT00150462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996003|NCT00150462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5996004|NCT00150462|Glucocorticoids|glucocorticoids|mesh-ancestor
5996005|NCT00150462|Hormones|hormones|mesh-ancestor
5996006|NCT00150462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5996007|NCT00150462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5996008|NCT00150462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5996009|NCT00150592|Guanfacine|guanfacine|mesh-list
5996010|NCT00150592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5996011|NCT00150592|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5996012|NCT00150592|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5996013|NCT00150592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5996014|NCT00150592|Adrenergic Agents|adrenergic agents|mesh-ancestor
5996015|NCT00150592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5996016|NCT00150592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996017|NCT00150592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996018|NCT00150618|Guanfacine|guanfacine|mesh-list
5996019|NCT00150618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5996020|NCT00150618|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5996021|NCT00150618|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5996022|NCT00150618|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5996023|NCT00150618|Adrenergic Agents|adrenergic agents|mesh-ancestor
5996024|NCT00150618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5996025|NCT00150618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996026|NCT00150618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996027|NCT00150800|Brivaracetam|brivaracetam|mesh-list
5996028|NCT00150800|Anticonvulsants|anticonvulsants|mesh-ancestor
5996029|NCT00150813|Levetiracetam|levetiracetam|mesh-list
5996030|NCT00150813|Anticonvulsants|anticonvulsants|mesh-ancestor
5996031|NCT00150813|Nootropic Agents|nootropic agents|mesh-ancestor
6017704|NCT00375219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017705|NCT00375427|Zoledronic Acid|zoledronic acid|mesh-list
6017706|NCT00375427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6017707|NCT00375427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017708|NCT00375492|Exenatide|exenatide|mesh-list
6017709|NCT00375492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6017710|NCT00375492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017711|NCT00375492|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6017712|NCT00375492|Incretins|incretins|mesh-ancestor
6017713|NCT00375492|Hormones|hormones|mesh-ancestor
6018507|NCT00381303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996032|NCT00150969|Vitamin K|vitamin k|mesh-list
5996033|NCT00150969|Vitamin K 1|vitamin k 1|mesh-list
5996034|NCT00150969|Vitamins|vitamins|mesh-ancestor
5996035|NCT00150969|Micronutrients|micronutrients|mesh-ancestor
5996036|NCT00150969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996037|NCT00150969|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5996038|NCT00150969|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5996039|NCT00150969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996040|NCT00150969|Hemostatics|hemostatics|mesh-ancestor
5996041|NCT00150969|Coagulants|coagulants|mesh-ancestor
5996042|NCT00151281|Thalidomide|thalidomide|mesh-list
5996043|NCT00151281|Prednisone|prednisone|mesh-list
5996044|NCT00151281|Cyclophosphamide|cyclophosphamide|mesh-list
5996045|NCT00151281|Rituximab|rituximab|mesh-list
6259252|NCT03112993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259253|NCT03112993|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6259254|NCT03112993|Autonomic Agents|autonomic agents|mesh-ancestor
6259255|NCT03112993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6259256|NCT03114969|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6259257|NCT03114969|Tiotropium Bromide|tiotropium bromide|mesh-list
6259258|NCT03114969|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6259259|NCT03114969|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6259260|NCT03114969|Respiratory System Agents|respiratory system agents|mesh-ancestor
6259261|NCT03114969|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6259262|NCT03114969|Autonomic Agents|autonomic agents|mesh-ancestor
6259263|NCT03114969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6259264|NCT03114969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259265|NCT03114969|Parasympatholytics|parasympatholytics|mesh-ancestor
6259266|NCT03114969|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6259267|NCT03114969|Cholinergic Agents|cholinergic agents|mesh-ancestor
6259268|NCT03114969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6259269|NCT03114969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259270|NCT03114969|Glucocorticoids|glucocorticoids|mesh-ancestor
5996046|NCT00151281|Etoposide|etoposide|mesh-list
5996047|NCT00151281|Procarbazine|procarbazine|mesh-list
5996048|NCT00151281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5996049|NCT00151281|Immunologic Factors|immunologic factors|mesh-ancestor
5996050|NCT00151281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996051|NCT00151281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5996052|NCT00151281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5996053|NCT00151281|Alkylating Agents|alkylating agents|mesh-ancestor
5996054|NCT00151281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996055|NCT00151281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5996056|NCT00151281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5996057|NCT00151281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5996058|NCT00151281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5996059|NCT00151281|Glucocorticoids|glucocorticoids|mesh-ancestor
5996060|NCT00151281|Hormones|hormones|mesh-ancestor
5996061|NCT00151281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5996062|NCT00151281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5996063|NCT00151281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5996064|NCT00151281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5996065|NCT00151281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5996066|NCT00151281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5996067|NCT00151281|Leprostatic Agents|leprostatic agents|mesh-ancestor
5996068|NCT00151281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5996069|NCT00151281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5996070|NCT00151281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5996071|NCT00151281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5996072|NCT00151281|Growth Substances|growth substances|mesh-ancestor
5996073|NCT00151281|Growth Inhibitors|growth inhibitors|mesh-ancestor
5996074|NCT00151320|Rituximab|rituximab|mesh-list
5996075|NCT00151320|Bortezomib|bortezomib|mesh-list
5996076|NCT00151320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5996077|NCT00151320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5996078|NCT00151320|Immunologic Factors|immunologic factors|mesh-ancestor
5996079|NCT00151320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996080|NCT00151320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5996081|NCT00151411|Metformin|metformin|mesh-list
5996082|NCT00151411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5996083|NCT00151411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996084|NCT00151476|Celecoxib|celecoxib|mesh-list
5996085|NCT00151476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5996086|NCT00151476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5996087|NCT00151476|Analgesics|analgesics|mesh-ancestor
5996088|NCT00151476|Sensory System Agents|sensory system agents|mesh-ancestor
5996089|NCT00151476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5996090|NCT00151476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996091|NCT00151476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5996092|NCT00151476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5996093|NCT00151476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5996094|NCT00151476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5996095|NCT00151476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5996096|NCT00151476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996097|NCT00151775|Olmesartan|olmesartan|mesh-list
5996098|NCT00151775|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
5996099|NCT00151775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5996100|NCT00151775|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5996101|NCT00151775|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5996102|NCT00151775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996103|NCT00151814|Olmesartan|olmesartan|mesh-list
5996104|NCT00151814|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
5996105|NCT00151814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5996106|NCT00151814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5996107|NCT00151814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5996108|NCT00151814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996109|NCT00151892|Mesalamine|mesalamine|mesh-list
5996110|NCT00151892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5996111|NCT00151892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5996112|NCT00151892|Analgesics|analgesics|mesh-ancestor
5996113|NCT00151892|Sensory System Agents|sensory system agents|mesh-ancestor
5996114|NCT00151892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5996115|NCT00151892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996116|NCT00151892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5996117|NCT00151892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5996118|NCT00151996|Guanfacine|guanfacine|mesh-list
5996119|NCT00151996|Methylphenidate|methylphenidate|mesh-list
5996120|NCT00151996|Amphetamine|amphetamine|mesh-list
5996121|NCT00151996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5996122|NCT00151996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996123|NCT00151996|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5996124|NCT00151996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5996125|NCT00151996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5996126|NCT00151996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996127|NCT00151996|Dopamine Agents|dopamine agents|mesh-ancestor
5996128|NCT00151996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5996129|NCT00151996|Sympathomimetics|sympathomimetics|mesh-ancestor
5996130|NCT00151996|Autonomic Agents|autonomic agents|mesh-ancestor
5996131|NCT00151996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5996132|NCT00151996|Adrenergic Agents|adrenergic agents|mesh-ancestor
5996133|NCT00151996|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5996134|NCT00151996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5996135|NCT00151996|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5996136|NCT00151996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5996137|NCT00151996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5996138|NCT00152009|Guanfacine|guanfacine|mesh-list
5996139|NCT00152009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5996140|NCT00152009|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5996141|NCT00152009|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5996142|NCT00152009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5996143|NCT00152009|Adrenergic Agents|adrenergic agents|mesh-ancestor
5996144|NCT00152009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5996145|NCT00152009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996146|NCT00152009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996147|NCT00152464|Levocetirizine|levocetirizine|mesh-list
5996148|NCT00152464|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5996149|NCT00152464|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5724140|NCT03189186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5724141|NCT03189069|Warfarin|warfarin|mesh-list
5724142|NCT03189069|Rivaroxaban|rivaroxaban|mesh-list
5724143|NCT03189069|Dabigatran|dabigatran|mesh-list
5724144|NCT03189069|Apixaban|apixaban|mesh-list
5724145|NCT03189069|Anticoagulants|anticoagulants|mesh-ancestor
5724146|NCT03189069|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5724147|NCT03189069|Antithrombins|antithrombins|mesh-ancestor
5724148|NCT03189069|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5724149|NCT03189069|Protease Inhibitors|protease inhibitors|mesh-ancestor
5724150|NCT03189069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5724151|NCT03189069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724152|NCT03189329|Lidocaine|lidocaine|mesh-list
5724153|NCT03189329|Levobupivacaine|levobupivacaine|mesh-list
5996150|NCT00152464|Histamine Antagonists|histamine antagonists|mesh-ancestor
5996151|NCT00152464|Histamine Agents|histamine agents|mesh-ancestor
5996152|NCT00152464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5996153|NCT00152464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996154|NCT00152464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724154|NCT03189329|Anesthetics, Local|anesthetics, local|mesh-ancestor
5724155|NCT03189329|Anesthetics|anesthetics|mesh-ancestor
5996155|NCT00152516|Levetiracetam|levetiracetam|mesh-list
5996156|NCT00152516|Anticonvulsants|anticonvulsants|mesh-ancestor
5996157|NCT00152516|Nootropic Agents|nootropic agents|mesh-ancestor
5996158|NCT00152971|Enoxaparin|enoxaparin|mesh-list
5996159|NCT00152971|Dabigatran|dabigatran|mesh-list
5996160|NCT00152971|Anticoagulants|anticoagulants|mesh-ancestor
5996161|NCT00152971|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5996162|NCT00152971|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5996163|NCT00152971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996164|NCT00152971|Antithrombins|antithrombins|mesh-ancestor
5996165|NCT00152971|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5996166|NCT00152971|Protease Inhibitors|protease inhibitors|mesh-ancestor
5996167|NCT00152971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5996168|NCT00153062|Telmisartan|telmisartan|mesh-list
5996169|NCT00153062|Clopidogrel|clopidogrel|mesh-list
5996170|NCT00153062|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
5996171|NCT00153062|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5996172|NCT00153062|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5996173|NCT00153062|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5996174|NCT00153062|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5996175|NCT00153062|Purinergic Agents|purinergic agents|mesh-ancestor
5996176|NCT00153062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5996177|NCT00153062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996178|NCT00153062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996179|NCT00153062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5996180|NCT00153062|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5996181|NCT00153062|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5996182|NCT00153101|Telmisartan|telmisartan|mesh-list
5996183|NCT00153101|Ramipril|ramipril|mesh-list
5996184|NCT00153101|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5996185|NCT00153101|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5996186|NCT00153101|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5996187|NCT00153101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996188|NCT00153101|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5996189|NCT00153101|Protease Inhibitors|protease inhibitors|mesh-ancestor
5996190|NCT00153101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5996191|NCT00153166|Pioglitazone|pioglitazone|mesh-list
5996192|NCT00153166|Atorvastatin|atorvastatin|mesh-list
5996193|NCT00153166|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5996194|NCT00153166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5996195|NCT00153166|Antimetabolites|antimetabolites|mesh-ancestor
5996196|NCT00153166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996197|NCT00153166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5996198|NCT00153166|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5996199|NCT00153166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5996200|NCT00153166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5996201|NCT00153166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996202|NCT00153179|Acipimox|acipimox|mesh-list
5996203|NCT00153179|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5996204|NCT00153179|Antimetabolites|antimetabolites|mesh-ancestor
5996205|NCT00153179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996206|NCT00153179|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5996207|NCT00153803|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5996208|NCT00153803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5996209|NCT00153803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5996210|NCT00153803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5996211|NCT00153803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996212|NCT00153816|Vitamin D|vitamin d|mesh-list
5996213|NCT00153816|Cholecalciferol|cholecalciferol|mesh-list
5996214|NCT00153816|Calcium Carbonate|calcium carbonate|mesh-list
5996215|NCT00153816|Calcium|calcium|mesh-list
5996216|NCT00153816|Vitamins|vitamins|mesh-ancestor
5996217|NCT00153816|Micronutrients|micronutrients|mesh-ancestor
5996218|NCT00153816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996219|NCT00153816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5996220|NCT00153816|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5996221|NCT00153816|Antacids|antacids|mesh-ancestor
5996222|NCT00153816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996223|NCT00153816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5996224|NCT00153842|Bexarotene|bexarotene|mesh-list
5996225|NCT00153842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5996226|NCT00153920|Bortezomib|bortezomib|mesh-list
5996227|NCT00153920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5996228|NCT00153985|Fludarabine|fludarabine|mesh-list
5996229|NCT00153985|Alemtuzumab|alemtuzumab|mesh-list
5996230|NCT00153985|Busulfan|busulfan|mesh-list
5996231|NCT00153985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5996232|NCT00153985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996233|NCT00153985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5996234|NCT00153985|Immunologic Factors|immunologic factors|mesh-ancestor
5996235|NCT00153985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996236|NCT00153985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5996237|NCT00153985|Alkylating Agents|alkylating agents|mesh-ancestor
5996238|NCT00153985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5996239|NCT00153985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5996240|NCT00154102|Leucovorin|leucovorin|mesh-list
5996241|NCT00154102|Folic Acid|folic acid|mesh-list
5996242|NCT00154102|Fluorouracil|fluorouracil|mesh-list
5996243|NCT00154102|Irinotecan|irinotecan|mesh-list
5996244|NCT00154102|Cetuximab|cetuximab|mesh-list
5996245|NCT00154102|Levoleucovorin|levoleucovorin|mesh-list
5996246|NCT00154102|Antimetabolites|antimetabolites|mesh-ancestor
5996247|NCT00154102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996248|NCT00154102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5996249|NCT00154102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5996250|NCT00154102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5996251|NCT00154102|Immunologic Factors|immunologic factors|mesh-ancestor
5996252|NCT00154102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996253|NCT00154102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5996254|NCT00154102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5996255|NCT00154102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5996256|NCT00154102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5996257|NCT00154102|Antidotes|antidotes|mesh-ancestor
5996258|NCT00154102|Protective Agents|protective agents|mesh-ancestor
5996259|NCT00154102|Vitamin B Complex|vitamin b complex|mesh-ancestor
5996260|NCT00154102|Vitamins|vitamins|mesh-ancestor
5996261|NCT00154102|Micronutrients|micronutrients|mesh-ancestor
5996262|NCT00154102|Hematinics|hematinics|mesh-ancestor
5996263|NCT00154284|Cyclosporine|cyclosporine|mesh-list
5996264|NCT00154284|Prednisone|prednisone|mesh-list
5996265|NCT00154284|Everolimus|everolimus|mesh-list
5996266|NCT00154284|Cyclosporins|cyclosporins|mesh-list
5996267|NCT00154284|Basiliximab|basiliximab|mesh-list
5996268|NCT00154284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5996269|NCT00154284|Glucocorticoids|glucocorticoids|mesh-ancestor
5996270|NCT00154284|Hormones|hormones|mesh-ancestor
5996271|NCT00154284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5996272|NCT00154284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996273|NCT00154284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5996274|NCT00154284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5996275|NCT00154284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5996276|NCT00154284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996277|NCT00154284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5996278|NCT00154284|Immunologic Factors|immunologic factors|mesh-ancestor
5996279|NCT00154284|Antifungal Agents|antifungal agents|mesh-ancestor
5996280|NCT00154284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5996281|NCT00154284|Dermatologic Agents|dermatologic agents|mesh-ancestor
5996282|NCT00154284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5996283|NCT00154284|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5996284|NCT00154297|Everolimus|everolimus|mesh-list
5996285|NCT00154297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5996286|NCT00154297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5996287|NCT00154297|Immunologic Factors|immunologic factors|mesh-ancestor
5996288|NCT00154297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996289|NCT00154310|Cyclosporine|cyclosporine|mesh-list
5996290|NCT00154310|Mycophenolic Acid|mycophenolic acid|mesh-list
5996291|NCT00154310|Everolimus|everolimus|mesh-list
5996292|NCT00154310|Cyclosporins|cyclosporins|mesh-list
5996293|NCT00154310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5996294|NCT00154310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996295|NCT00154310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5996296|NCT00154310|Immunologic Factors|immunologic factors|mesh-ancestor
5996297|NCT00154310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996298|NCT00154310|Antifungal Agents|antifungal agents|mesh-ancestor
5996299|NCT00154310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5996300|NCT00154310|Dermatologic Agents|dermatologic agents|mesh-ancestor
5996301|NCT00154310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5996302|NCT00154310|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5996303|NCT00154310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5996304|NCT00154310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5996305|NCT00154310|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5996306|NCT00154310|Antitubercular Agents|antitubercular agents|mesh-ancestor
5996307|NCT00154310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5996308|NCT00154375|Imatinib Mesylate|imatinib mesylate|mesh-list
5996309|NCT00154375|Hydroxyurea|hydroxyurea|mesh-list
5996310|NCT00154375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5996311|NCT00154375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5996312|NCT00154375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5996313|NCT00154375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996314|NCT00154375|Antisickling Agents|antisickling agents|mesh-ancestor
5996315|NCT00154375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5996316|NCT00156013|Clofarabine|clofarabine|mesh-list
5996317|NCT00156013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5996318|NCT00156013|Antimetabolites|antimetabolites|mesh-ancestor
5996319|NCT00156013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996320|NCT00156013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5996321|NCT00156247|Acitretin|acitretin|mesh-list
5996322|NCT00156247|Keratolytic Agents|keratolytic agents|mesh-ancestor
5996323|NCT00156247|Dermatologic Agents|dermatologic agents|mesh-ancestor
5996324|NCT00156533|Zolpidem|zolpidem|mesh-list
5996325|NCT00156533|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5996326|NCT00156533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5996327|NCT00156533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5996328|NCT00156533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996329|NCT00156533|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
5996330|NCT00156533|GABA Agonists|gaba agonists|mesh-ancestor
5996331|NCT00156533|GABA Agents|gaba agents|mesh-ancestor
5996332|NCT00156533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5996333|NCT00156533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996334|NCT00156715|Quetiapine Fumarate|quetiapine fumarate|mesh-list
5996335|NCT00156715|Antidepressive Agents|antidepressive agents|mesh-ancestor
5996336|NCT00156715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5996337|NCT00156715|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5996338|NCT00156715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5996339|NCT00156715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5996340|NCT00156715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996341|NCT00156819|Fluticasone|fluticasone|mesh-list
5996342|NCT00156819|Xhance|xhance|mesh-list
5996343|NCT00156819|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5996344|NCT00156819|Montelukast|montelukast|mesh-list
5996345|NCT00156819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5996346|NCT00156819|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5996347|NCT00156819|Autonomic Agents|autonomic agents|mesh-ancestor
5996348|NCT00156819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5996349|NCT00156819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996350|NCT00156819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5996351|NCT00156819|Respiratory System Agents|respiratory system agents|mesh-ancestor
5996352|NCT00156819|Dermatologic Agents|dermatologic agents|mesh-ancestor
5996353|NCT00156819|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5996354|NCT00156819|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5996355|NCT00156819|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6259271|NCT03114969|Hormones|hormones|mesh-ancestor
6259272|NCT03114969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6259273|NCT03114969|Sympathomimetics|sympathomimetics|mesh-ancestor
5996356|NCT00156819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5996357|NCT00156819|Adrenergic Agents|adrenergic agents|mesh-ancestor
5996358|NCT00156819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5996359|NCT00156819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996360|NCT00156819|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5996361|NCT00156819|Hormone Antagonists|hormone antagonists|mesh-ancestor
5996362|NCT00156819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5996363|NCT00156819|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5996364|NCT00156819|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5996365|NCT00156910|Botulinum Toxins|botulinum toxins|mesh-list
5996366|NCT00156910|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5996367|NCT00156910|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5996368|NCT00156910|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5996369|NCT00156910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5996370|NCT00156910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996371|NCT00156910|Cholinergic Agents|cholinergic agents|mesh-ancestor
6259274|NCT03114995|Tirofiban|tirofiban|mesh-list
5996372|NCT00156910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5996373|NCT00156910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996374|NCT00156910|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5996375|NCT00156910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5996376|NCT00156923|Naltrexone|naltrexone|mesh-list
5996377|NCT00156923|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5996378|NCT00156923|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5996379|NCT00156923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996380|NCT00156923|Sensory System Agents|sensory system agents|mesh-ancestor
5996381|NCT00156923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5996382|NCT00156936|Naltrexone|naltrexone|mesh-list
5996383|NCT00156936|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5996384|NCT00156936|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5996385|NCT00156936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996386|NCT00156936|Sensory System Agents|sensory system agents|mesh-ancestor
5996387|NCT00156936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5996388|NCT00157014|Cyclosporine|cyclosporine|mesh-list
5996389|NCT00157014|Mycophenolic Acid|mycophenolic acid|mesh-list
5996390|NCT00157014|Prednisone|prednisone|mesh-list
5996391|NCT00157014|Methylprednisolone|methylprednisolone|mesh-list
5996392|NCT00157014|Tacrolimus|tacrolimus|mesh-list
5996393|NCT00157014|Cyclosporins|cyclosporins|mesh-list
5996394|NCT00157014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5996395|NCT00157014|Glucocorticoids|glucocorticoids|mesh-ancestor
5996396|NCT00157014|Hormones|hormones|mesh-ancestor
5996397|NCT00157014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5996398|NCT00157014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996399|NCT00157014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5996400|NCT00157014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5996401|NCT00157014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5996402|NCT00157014|Immunologic Factors|immunologic factors|mesh-ancestor
5996403|NCT00157014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5996404|NCT00157014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5996405|NCT00157014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996406|NCT00157014|Antifungal Agents|antifungal agents|mesh-ancestor
5996407|NCT00157014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5996408|NCT00157014|Dermatologic Agents|dermatologic agents|mesh-ancestor
5996409|NCT00157014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5996410|NCT00157014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5996411|NCT00157014|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5996412|NCT00157014|Antitubercular Agents|antitubercular agents|mesh-ancestor
5996413|NCT00157014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5996414|NCT00157014|Antiemetics|antiemetics|mesh-ancestor
5996415|NCT00157014|Autonomic Agents|autonomic agents|mesh-ancestor
5996416|NCT00157014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5996417|NCT00157014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5996418|NCT00157014|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5996419|NCT00157014|Protective Agents|protective agents|mesh-ancestor
5996420|NCT00157157|Factor VIII|factor viii|mesh-list
5996421|NCT00157157|Coagulants|coagulants|mesh-ancestor
5996422|NCT00157196|Cyclophosphamide|cyclophosphamide|mesh-list
5996423|NCT00157196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5996424|NCT00157196|Immunologic Factors|immunologic factors|mesh-ancestor
5996425|NCT00157196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996426|NCT00157196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5996427|NCT00157196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5996428|NCT00157196|Alkylating Agents|alkylating agents|mesh-ancestor
5996429|NCT00157196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996430|NCT00157196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5996431|NCT00157196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5996432|NCT00157209|Cyclophosphamide|cyclophosphamide|mesh-list
5996433|NCT00157209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5996434|NCT00157209|Immunologic Factors|immunologic factors|mesh-ancestor
5996435|NCT00157209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996436|NCT00157209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5996437|NCT00157209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5996438|NCT00157209|Alkylating Agents|alkylating agents|mesh-ancestor
5996439|NCT00157209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996440|NCT00157209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5996441|NCT00157209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5996442|NCT00157248|Dabigatran|dabigatran|mesh-list
5996443|NCT00157248|Antithrombins|antithrombins|mesh-ancestor
5996444|NCT00157248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5996445|NCT00157248|Protease Inhibitors|protease inhibitors|mesh-ancestor
5996446|NCT00157248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5996447|NCT00157248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996448|NCT00157248|Anticoagulants|anticoagulants|mesh-ancestor
5996449|NCT00157573|Sargramostim|sargramostim|mesh-list
5996450|NCT00157573|Immunologic Factors|immunologic factors|mesh-ancestor
5996451|NCT00157573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996452|NCT00158184|Oxycodone|oxycodone|mesh-list
5996453|NCT00158184|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5996454|NCT00158184|Narcotics|narcotics|mesh-ancestor
5996455|NCT00158184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5996456|NCT00158184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996457|NCT00158184|Analgesics|analgesics|mesh-ancestor
5996458|NCT00158184|Sensory System Agents|sensory system agents|mesh-ancestor
5996459|NCT00158184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5996460|NCT00158223|Pimozide|pimozide|mesh-list
5996461|NCT00158223|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5996462|NCT00158223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5996463|NCT00158223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5996464|NCT00158223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996465|NCT00158223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5996466|NCT00158223|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5996467|NCT00158223|Dopamine Agents|dopamine agents|mesh-ancestor
5996468|NCT00158223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5996469|NCT00158223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996470|NCT00158223|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5996471|NCT00158249|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
5996472|NCT00158249|Nootropic Agents|nootropic agents|mesh-ancestor
5996473|NCT00158262|Propranolol|propranolol|mesh-list
5996474|NCT00158262|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5996475|NCT00158262|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5996476|NCT00158262|Adrenergic Agents|adrenergic agents|mesh-ancestor
5996477|NCT00158262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5996478|NCT00158262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996479|NCT00158262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996480|NCT00158262|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5996481|NCT00158262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5996482|NCT00158262|Vasodilator Agents|vasodilator agents|mesh-ancestor
5996483|NCT00158379|Paclitaxel|paclitaxel|mesh-list
5996484|NCT00158379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5996485|NCT00158379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5996486|NCT00158379|Tubulin Modulators|tubulin modulators|mesh-ancestor
5996487|NCT00158379|Antimitotic Agents|antimitotic agents|mesh-ancestor
5996488|NCT00158379|Mitosis Modulators|mitosis modulators|mesh-ancestor
5996489|NCT00158379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996490|NCT00158743|Digoxin|digoxin|mesh-list
5996491|NCT00158743|Antibodies|antibodies|mesh-list
5996492|NCT00158743|Immunoglobulin Fab Fragments|immunoglobulin fab fragments|mesh-list
5996493|NCT00158743|Immunologic Factors|immunologic factors|mesh-ancestor
5996494|NCT00158743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996495|NCT00158743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5996496|NCT00158743|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5996497|NCT00158743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5996498|NCT00158743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996499|NCT00158743|Protective Agents|protective agents|mesh-ancestor
5996500|NCT00158756|Vaccines|vaccines|mesh-list
5996501|NCT00158756|Immunologic Factors|immunologic factors|mesh-ancestor
5996502|NCT00158756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996503|NCT00158860|Valacyclovir|valacyclovir|mesh-list
5996504|NCT00158860|Antiviral Agents|antiviral agents|mesh-ancestor
5996505|NCT00158860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5996506|NCT00159263|Budesonide|budesonide|mesh-list
5996507|NCT00159263|Formoterol Fumarate|formoterol fumarate|mesh-list
5996508|NCT00159263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5996509|NCT00159263|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5996510|NCT00159263|Autonomic Agents|autonomic agents|mesh-ancestor
5996511|NCT00159263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5996512|NCT00159263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996513|NCT00159263|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5996514|NCT00159263|Respiratory System Agents|respiratory system agents|mesh-ancestor
5996515|NCT00159263|Glucocorticoids|glucocorticoids|mesh-ancestor
5996516|NCT00159263|Hormones|hormones|mesh-ancestor
5996517|NCT00159263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5996518|NCT00159263|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5996519|NCT00159263|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5996520|NCT00159263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5996521|NCT00159263|Adrenergic Agents|adrenergic agents|mesh-ancestor
5996522|NCT00159263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5996523|NCT00159263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996524|NCT00159419|Alendronate|alendronate|mesh-list
5996525|NCT00159419|Pamidronate|pamidronate|mesh-list
5996526|NCT00159419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5996527|NCT00159419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996528|NCT00159432|Bevacizumab|bevacizumab|mesh-list
5996529|NCT00159432|Capecitabine|capecitabine|mesh-list
5996530|NCT00159432|Oxaliplatin|oxaliplatin|mesh-list
5996531|NCT00159432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5996532|NCT00159432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5996533|NCT00159432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5996534|NCT00159432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5996535|NCT00159432|Growth Substances|growth substances|mesh-ancestor
5996536|NCT00159432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996537|NCT00159432|Growth Inhibitors|growth inhibitors|mesh-ancestor
5996538|NCT00159432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5996539|NCT00159432|Antimetabolites|antimetabolites|mesh-ancestor
6018508|NCT00381303|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5996540|NCT00159432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996541|NCT00159822|Voriconazole|voriconazole|mesh-list
5996542|NCT00159822|Antifungal Agents|antifungal agents|mesh-ancestor
5996543|NCT00159822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5996544|NCT00159822|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5996545|NCT00159822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5996546|NCT00159822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5996547|NCT00159822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996548|NCT00159822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5996549|NCT00159822|Hormone Antagonists|hormone antagonists|mesh-ancestor
5996550|NCT00159822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5996551|NCT00159822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996552|NCT00159822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5996553|NCT00159861|Sildenafil Citrate|sildenafil citrate|mesh-list
5996554|NCT00159861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996555|NCT00159861|Vasodilator Agents|vasodilator agents|mesh-ancestor
5996556|NCT00159861|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5996557|NCT00159861|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5996558|NCT00159861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5996559|NCT00159861|Urological Agents|urological agents|mesh-ancestor
5996560|NCT00159874|Sildenafil Citrate|sildenafil citrate|mesh-list
5996561|NCT00159874|Citric Acid|citric acid|mesh-list
5996562|NCT00159874|Sodium Citrate|sodium citrate|mesh-list
5996563|NCT00159874|Anticoagulants|anticoagulants|mesh-ancestor
5996564|NCT00159874|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5996565|NCT00159874|Chelating Agents|chelating agents|mesh-ancestor
5996566|NCT00159874|Sequestering Agents|sequestering agents|mesh-ancestor
5996567|NCT00159874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996568|NCT00159874|Vasodilator Agents|vasodilator agents|mesh-ancestor
5996569|NCT00159874|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5996570|NCT00159874|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5996571|NCT00159874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5996572|NCT00159874|Urological Agents|urological agents|mesh-ancestor
5996573|NCT00159913|Sildenafil Citrate|sildenafil citrate|mesh-list
5996574|NCT00159913|Citric Acid|citric acid|mesh-list
5996575|NCT00159913|Sodium Citrate|sodium citrate|mesh-list
5996576|NCT00159913|Anticoagulants|anticoagulants|mesh-ancestor
5996577|NCT00159913|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5996578|NCT00159913|Chelating Agents|chelating agents|mesh-ancestor
5996579|NCT00159913|Sequestering Agents|sequestering agents|mesh-ancestor
5996580|NCT00159913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996581|NCT00159913|Vasodilator Agents|vasodilator agents|mesh-ancestor
5996582|NCT00159913|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5996583|NCT00159913|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5996584|NCT00159913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5996585|NCT00159913|Urological Agents|urological agents|mesh-ancestor
5996586|NCT00159965|Sertraline|sertraline|mesh-list
5996587|NCT00159965|Antidepressive Agents|antidepressive agents|mesh-ancestor
5996588|NCT00159965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5996589|NCT00159965|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5996590|NCT00159965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5996591|NCT00159965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5996592|NCT00159965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996593|NCT00159965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5996594|NCT00159965|Serotonin Agents|serotonin agents|mesh-ancestor
5996595|NCT00159965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996596|NCT00160199|Progesterone|progesterone|mesh-list
5996597|NCT00160199|Progestins|progestins|mesh-ancestor
5996598|NCT00160199|Hormones|hormones|mesh-ancestor
5996599|NCT00160199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5996600|NCT00160199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996601|NCT00160251|Ribavirin|ribavirin|mesh-list
5996602|NCT00160251|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
5996603|NCT00160251|Antimetabolites|antimetabolites|mesh-ancestor
5996604|NCT00160251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996605|NCT00160251|Antiviral Agents|antiviral agents|mesh-ancestor
5996606|NCT00160251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5996607|NCT00160524|Certolizumab Pegol|certolizumab pegol|mesh-list
5996608|NCT00160524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5996609|NCT00160524|Immunologic Factors|immunologic factors|mesh-ancestor
5996610|NCT00160524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996611|NCT00160524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5996612|NCT00160615|Levetiracetam|levetiracetam|mesh-list
5996613|NCT00160615|Anticonvulsants|anticonvulsants|mesh-ancestor
5996614|NCT00160615|Nootropic Agents|nootropic agents|mesh-ancestor
5996615|NCT00160641|Certolizumab Pegol|certolizumab pegol|mesh-list
5996616|NCT00160641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5996617|NCT00160641|Immunologic Factors|immunologic factors|mesh-ancestor
5996618|NCT00160641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996619|NCT00160641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5996620|NCT00160654|Levetiracetam|levetiracetam|mesh-list
5996621|NCT00160654|Anticonvulsants|anticonvulsants|mesh-ancestor
5996622|NCT00160654|Nootropic Agents|nootropic agents|mesh-ancestor
5996623|NCT00160667|Brivaracetam|brivaracetam|mesh-list
5996624|NCT00160667|Anticonvulsants|anticonvulsants|mesh-ancestor
5996625|NCT00160680|Levocetirizine|levocetirizine|mesh-list
5996626|NCT00160680|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5996627|NCT00160680|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5996628|NCT00160680|Histamine Antagonists|histamine antagonists|mesh-ancestor
5996629|NCT00160680|Histamine Agents|histamine agents|mesh-ancestor
5996630|NCT00160680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5996631|NCT00160680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996632|NCT00160680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996633|NCT00160693|Certolizumab Pegol|certolizumab pegol|mesh-list
5996634|NCT00160693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5996635|NCT00160693|Immunologic Factors|immunologic factors|mesh-ancestor
5996636|NCT00160693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996637|NCT00160693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5996638|NCT00160706|Certolizumab Pegol|certolizumab pegol|mesh-list
5996639|NCT00160706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5996640|NCT00160706|Immunologic Factors|immunologic factors|mesh-ancestor
5996641|NCT00160706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996642|NCT00160706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5996643|NCT00161213|Gemcitabine|gemcitabine|mesh-list
5996644|NCT00161213|Imatinib Mesylate|imatinib mesylate|mesh-list
5996645|NCT00161213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5996646|NCT00161213|Antimetabolites|antimetabolites|mesh-ancestor
5996647|NCT00161213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996648|NCT00161213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5996649|NCT00161213|Antiviral Agents|antiviral agents|mesh-ancestor
5996650|NCT00161213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5996651|NCT00161213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5996652|NCT00161213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5996653|NCT00161213|Immunologic Factors|immunologic factors|mesh-ancestor
5996654|NCT00161213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996655|NCT00161213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5996656|NCT00161473|Prazosin|prazosin|mesh-list
5996657|NCT00161473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5996658|NCT00161473|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5996659|NCT00161473|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5996660|NCT00161473|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5996661|NCT00161473|Adrenergic Agents|adrenergic agents|mesh-ancestor
5996662|NCT00161473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5996663|NCT00161473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996664|NCT00161473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996665|NCT00162032|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
5996666|NCT00162032|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5996667|NCT00162032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996668|NCT00162097|Efavirenz|efavirenz|mesh-list
5996669|NCT00162097|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
5996670|NCT00162097|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5996671|NCT00162097|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5996672|NCT00162097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5996673|NCT00162097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996674|NCT00162097|Antiviral Agents|antiviral agents|mesh-ancestor
5996675|NCT00162097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5996676|NCT00162097|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5996677|NCT00162097|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5996678|NCT00162097|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5996679|NCT00162097|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5996680|NCT00162097|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5996681|NCT00162097|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5996682|NCT00162123|Ipilimumab|ipilimumab|mesh-list
5996683|NCT00162123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5996684|NCT00162123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5996685|NCT00162123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5996686|NCT00162123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996687|NCT00162266|Abatacept|abatacept|mesh-list
5996688|NCT00162266|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5996689|NCT00162266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996690|NCT00162266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5996691|NCT00162266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5996692|NCT00162266|Immunologic Factors|immunologic factors|mesh-ancestor
5996693|NCT00162266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996694|NCT00162266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5996695|NCT00162981|Clobazam|clobazam|mesh-list
5996696|NCT00162981|Anticonvulsants|anticonvulsants|mesh-ancestor
5996697|NCT00162981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5996698|NCT00162981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5996699|NCT00162981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5996700|NCT00162981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996701|NCT00162981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5996702|NCT00162981|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
5996703|NCT00162981|GABA Agonists|gaba agonists|mesh-ancestor
5996704|NCT00162981|GABA Agents|gaba agents|mesh-ancestor
5996705|NCT00162981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5996706|NCT00162981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996707|NCT00163020|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
5996708|NCT00163020|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
5996709|NCT00163020|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5996710|NCT00163020|Hormone Antagonists|hormone antagonists|mesh-ancestor
5996711|NCT00163020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5996712|NCT00163020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996713|NCT00163020|Progestins|progestins|mesh-ancestor
5996714|NCT00163020|Hormones|hormones|mesh-ancestor
5996715|NCT00163293|Ciclesonide|ciclesonide|mesh-list
5996716|NCT00163293|Glucocorticoids|glucocorticoids|mesh-ancestor
5996717|NCT00163293|Hormones|hormones|mesh-ancestor
5996718|NCT00163293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5996719|NCT00163293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996720|NCT00163293|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5996721|NCT00163657|Cyclosporine|cyclosporine|mesh-list
5996722|NCT00163657|Mycophenolic Acid|mycophenolic acid|mesh-list
5996723|NCT00163657|Tacrolimus|tacrolimus|mesh-list
5996724|NCT00163657|Cyclosporins|cyclosporins|mesh-list
6259275|NCT03114995|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6259276|NCT03114995|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6259277|NCT03114995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259278|NCT03114995|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6259279|NCT03115112|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6259280|NCT03115112|Bexagliflozin|bexagliflozin|mesh-list
6259281|NCT03115112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6259282|NCT03115112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259283|NCT03115112|Incretins|incretins|mesh-ancestor
6259284|NCT03115112|Hormones|hormones|mesh-ancestor
6259285|NCT03115112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6259286|NCT03115112|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5996725|NCT00163657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5996726|NCT00163657|Immunologic Factors|immunologic factors|mesh-ancestor
5996727|NCT00163657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996728|NCT00163657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5996729|NCT00163657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5996730|NCT00163657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996731|NCT00163657|Antifungal Agents|antifungal agents|mesh-ancestor
5996732|NCT00163657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5996733|NCT00163657|Dermatologic Agents|dermatologic agents|mesh-ancestor
5996734|NCT00163657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5996735|NCT00163657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5996736|NCT00163657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5996737|NCT00163657|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5996738|NCT00163657|Antitubercular Agents|antitubercular agents|mesh-ancestor
5996739|NCT00163657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5996740|NCT00165646|Rabeprazole|rabeprazole|mesh-list
5996741|NCT00165646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5996742|NCT00165646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5996743|NCT00165646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5996744|NCT00165646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5996745|NCT00165646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996746|NCT00165672|Rabeprazole|rabeprazole|mesh-list
5996747|NCT00165672|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5996748|NCT00165672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5996749|NCT00165672|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5996750|NCT00165672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5996751|NCT00165672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996752|NCT00165698|Alfacalcidol|alfacalcidol|mesh-list
5996753|NCT00165698|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
5996754|NCT00165698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5996755|NCT00165698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996756|NCT00165698|Vitamins|vitamins|mesh-ancestor
5996757|NCT00165698|Micronutrients|micronutrients|mesh-ancestor
5996758|NCT00165776|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
5996759|NCT00165776|Botulinum Toxins|botulinum toxins|mesh-list
5996760|NCT00165776|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5996761|NCT00165776|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5996762|NCT00165776|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5996763|NCT00165776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5996764|NCT00165776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996765|NCT00165776|Cholinergic Agents|cholinergic agents|mesh-ancestor
5996766|NCT00165776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5996767|NCT00165776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996768|NCT00165776|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5996769|NCT00165776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5996770|NCT00165776|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6017714|NCT00375492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6017715|NCT00375505|Zoledronic Acid|zoledronic acid|mesh-list
6017716|NCT00375505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6017717|NCT00375505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017718|NCT00375518|Atorvastatin|atorvastatin|mesh-list
6017719|NCT00375518|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6017720|NCT00375518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6017721|NCT00375518|Antimetabolites|antimetabolites|mesh-ancestor
6017722|NCT00375518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017723|NCT00375518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6017724|NCT00375518|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6017725|NCT00375518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6017726|NCT00375609|Enoxaparin|enoxaparin|mesh-list
6017727|NCT00375609|Betrixaban|betrixaban|mesh-list
6017728|NCT00375609|Anticoagulants|anticoagulants|mesh-ancestor
6017729|NCT00375609|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6017730|NCT00375609|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6017731|NCT00375609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017732|NCT00375609|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6017733|NCT00375609|Antithrombins|antithrombins|mesh-ancestor
6017734|NCT00375609|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6017735|NCT00375609|Protease Inhibitors|protease inhibitors|mesh-ancestor
6017736|NCT00375609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6017737|NCT00375674|Sunitinib|sunitinib|mesh-list
6017738|NCT00375674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6017739|NCT00375674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6017740|NCT00375674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6259287|NCT03115112|Protease Inhibitors|protease inhibitors|mesh-ancestor
5996771|NCT00165841|Rabeprazole|rabeprazole|mesh-list
5996772|NCT00165841|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5996773|NCT00165841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5996774|NCT00165841|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5996775|NCT00165841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5996776|NCT00165841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996777|NCT00166036|Atorvastatin|atorvastatin|mesh-list
5996778|NCT00166036|Pravastatin|pravastatin|mesh-list
5996779|NCT00166036|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5996780|NCT00166036|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5996781|NCT00166036|Antimetabolites|antimetabolites|mesh-ancestor
5996782|NCT00166036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996783|NCT00166036|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5996784|NCT00166036|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5996785|NCT00166036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5996786|NCT00166114|Citalopram|citalopram|mesh-list
5996787|NCT00166114|Desipramine|desipramine|mesh-list
5996788|NCT00166114|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5996789|NCT00166114|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5996790|NCT00166114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5996791|NCT00166114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996792|NCT00166114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5996793|NCT00166114|Serotonin Agents|serotonin agents|mesh-ancestor
5996794|NCT00166114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996795|NCT00166114|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5996796|NCT00166114|Antidepressive Agents|antidepressive agents|mesh-ancestor
5996797|NCT00166114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5996798|NCT00166114|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5996799|NCT00166114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5996800|NCT00166114|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5996801|NCT00166114|Adrenergic Agents|adrenergic agents|mesh-ancestor
5996802|NCT00166166|Fluconazole|fluconazole|mesh-list
5996803|NCT00166166|Nitroprusside|nitroprusside|mesh-list
5996804|NCT00166166|Tetraethylammonium|tetraethylammonium|mesh-list
5996805|NCT00166166|Acetylcholine|acetylcholine|mesh-list
5996806|NCT00166166|Bradykinin|bradykinin|mesh-list
5996807|NCT00166166|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
5996808|NCT00166166|Kininogens|kininogens|mesh-list
5996809|NCT00166166|Antifungal Agents|antifungal agents|mesh-ancestor
5996810|NCT00166166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5996811|NCT00166166|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5996812|NCT00166166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5996813|NCT00166166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5996814|NCT00166166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996815|NCT00166166|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5996816|NCT00166166|Hormone Antagonists|hormone antagonists|mesh-ancestor
5996817|NCT00166166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5996818|NCT00166166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996819|NCT00166166|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5996820|NCT00166166|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5996821|NCT00166166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5996822|NCT00166166|Vasodilator Agents|vasodilator agents|mesh-ancestor
5996823|NCT00166166|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5996824|NCT00166166|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5996825|NCT00166166|Cholinergic Agents|cholinergic agents|mesh-ancestor
5996826|NCT00166166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5996827|NCT00166166|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
5996828|NCT00166166|Protease Inhibitors|protease inhibitors|mesh-ancestor
5996829|NCT00166166|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5996830|NCT00166166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5996831|NCT00166296|Citalopram|citalopram|mesh-list
5996832|NCT00166296|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5996833|NCT00166296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5996834|NCT00166296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5996835|NCT00166296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996836|NCT00166296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5996837|NCT00166296|Serotonin Agents|serotonin agents|mesh-ancestor
5996838|NCT00166296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996839|NCT00166296|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5996840|NCT00166296|Antidepressive Agents|antidepressive agents|mesh-ancestor
5996841|NCT00166296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5996842|NCT00166439|Cytarabine|cytarabine|mesh-list
5996843|NCT00166439|Dexamethasone|dexamethasone|mesh-list
5996844|NCT00166439|Oxaliplatin|oxaliplatin|mesh-list
5996845|NCT00166439|Rituximab|rituximab|mesh-list
5996846|NCT00166439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5996847|NCT00166439|Antiemetics|antiemetics|mesh-ancestor
5996848|NCT00166439|Autonomic Agents|autonomic agents|mesh-ancestor
5996849|NCT00166439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5996850|NCT00166439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996851|NCT00166439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5996852|NCT00166439|Glucocorticoids|glucocorticoids|mesh-ancestor
5996853|NCT00166439|Hormones|hormones|mesh-ancestor
5996854|NCT00166439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5996855|NCT00166439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5996856|NCT00166439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5996857|NCT00166439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5996858|NCT00166439|Immunologic Factors|immunologic factors|mesh-ancestor
5996859|NCT00166439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5996860|NCT00166439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5996861|NCT00166439|Antimetabolites|antimetabolites|mesh-ancestor
5996862|NCT00166439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996863|NCT00166439|Antiviral Agents|antiviral agents|mesh-ancestor
5996864|NCT00166439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5996865|NCT00166439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5996866|NCT00166712|Mycophenolic Acid|mycophenolic acid|mesh-list
5996867|NCT00166712|Sirolimus|sirolimus|mesh-list
5996868|NCT00166712|Alemtuzumab|alemtuzumab|mesh-list
5996869|NCT00166712|Tacrolimus|tacrolimus|mesh-list
5996870|NCT00166712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5996871|NCT00166712|Immunologic Factors|immunologic factors|mesh-ancestor
5996872|NCT00166712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996873|NCT00166712|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6259288|NCT03115112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6259289|NCT03115112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259290|NCT03115177|Doxycycline|doxycycline|mesh-list
6259291|NCT03115177|Cefazolin|cefazolin|mesh-list
6259292|NCT03115177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6259293|NCT03115177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6259294|NCT03115177|Antimalarials|antimalarials|mesh-ancestor
6259295|NCT03115177|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6259296|NCT03115177|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6259297|NCT03115801|Pembrolizumab|pembrolizumab|mesh-list
6259298|NCT03115801|Nivolumab|nivolumab|mesh-list
6259299|NCT03115801|Atezolizumab|atezolizumab|mesh-list
6259300|NCT03115801|Immunologic Factors|immunologic factors|mesh-list
6259301|NCT03115801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5996874|NCT00166712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5996875|NCT00166712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996876|NCT00166712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5996877|NCT00166712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5996878|NCT00166712|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5996879|NCT00166712|Antitubercular Agents|antitubercular agents|mesh-ancestor
5996880|NCT00166712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5996881|NCT00166712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5996882|NCT00166712|Antifungal Agents|antifungal agents|mesh-ancestor
5996883|NCT00166712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5996884|NCT00167102|Alefacept|alefacept|mesh-list
5996885|NCT00167102|Dermatologic Agents|dermatologic agents|mesh-ancestor
5996886|NCT00167102|Immunologic Factors|immunologic factors|mesh-ancestor
5996887|NCT00167102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996888|NCT00167180|Cyclophosphamide|cyclophosphamide|mesh-list
5996889|NCT00167180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5996890|NCT00167180|Immunologic Factors|immunologic factors|mesh-ancestor
5996891|NCT00167180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996892|NCT00167180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5996893|NCT00167180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5996894|NCT00167180|Alkylating Agents|alkylating agents|mesh-ancestor
5996895|NCT00167180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996896|NCT00167180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5996897|NCT00167180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5996898|NCT00167206|Cyclophosphamide|cyclophosphamide|mesh-list
5996899|NCT00167206|Fludarabine|fludarabine|mesh-list
5996900|NCT00167206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6259302|NCT03115801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6259303|NCT03115801|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5996901|NCT00167206|Immunologic Factors|immunologic factors|mesh-ancestor
5996902|NCT00167206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996903|NCT00167206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5996904|NCT00167206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5996905|NCT00167206|Alkylating Agents|alkylating agents|mesh-ancestor
5996906|NCT00167206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996907|NCT00167206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5996908|NCT00167206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5996909|NCT00167245|Topiramate|topiramate|mesh-list
5996910|NCT00167245|Anticonvulsants|anticonvulsants|mesh-ancestor
5996911|NCT00167245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5996912|NCT00167245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996913|NCT00167544|Hydrocortisone|hydrocortisone|mesh-list
5996914|NCT00167544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5996915|NCT00167661|Alemtuzumab|alemtuzumab|mesh-list
5996916|NCT00167661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5996917|NCT00167661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5996918|NCT00167934|Valproic Acid|valproic acid|mesh-list
5996919|NCT00167934|Anticonvulsants|anticonvulsants|mesh-ancestor
5996920|NCT00167934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5996921|NCT00167934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996922|NCT00167934|GABA Agents|gaba agents|mesh-ancestor
5996923|NCT00167934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5996924|NCT00167934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996925|NCT00167934|Antimanic Agents|antimanic agents|mesh-ancestor
5996926|NCT00167934|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5996927|NCT00167934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5996928|NCT00167934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5996929|NCT00168038|Immunoglobulins|immunoglobulins|mesh-list
5996930|NCT00168038|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5996931|NCT00168038|Antibodies|antibodies|mesh-list
5996932|NCT00168038|Immunologic Factors|immunologic factors|mesh-ancestor
5996933|NCT00168038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259304|NCT03115801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259305|NCT03115801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259306|NCT03115827|Carbidopa|carbidopa|mesh-list
6259307|NCT03115827|Droxidopa|droxidopa|mesh-list
6259308|NCT03115827|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6259309|NCT03115827|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6259310|NCT03115827|Dopamine Agents|dopamine agents|mesh-ancestor
6259311|NCT03115827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6259312|NCT03115827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259313|NCT03115827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259314|NCT03115827|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6259315|NCT03115827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6259316|NCT03116152|Paclitaxel|paclitaxel|mesh-list
6259317|NCT03116152|Irinotecan|irinotecan|mesh-list
6259318|NCT03116152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6259319|NCT03116152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6259320|NCT03116152|Tubulin Modulators|tubulin modulators|mesh-ancestor
6259321|NCT03116152|Antimitotic Agents|antimitotic agents|mesh-ancestor
6259322|NCT03116152|Mitosis Modulators|mitosis modulators|mesh-ancestor
6259323|NCT03116152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259324|NCT03116152|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6259325|NCT03116152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6259326|NCT03116152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6259327|NCT03116828|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
6259328|NCT03116828|Anticonvulsants|anticonvulsants|mesh-ancestor
6259329|NCT03116828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5996934|NCT00168064|Mechlorethamine|mechlorethamine|mesh-list
5996935|NCT00168064|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
5996936|NCT00168064|Alkylating Agents|alkylating agents|mesh-ancestor
6259330|NCT03116828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5996937|NCT00168064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996938|NCT00168064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5996939|NCT00168064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5996940|NCT00168103|Complement C1s|complement c1s|mesh-list
5996941|NCT00168103|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
5996942|NCT00168103|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
5996943|NCT00168103|Immunologic Factors|immunologic factors|mesh-ancestor
5996944|NCT00168103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996945|NCT00168103|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5996946|NCT00168103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5996947|NCT00168298|Dexamethasone|dexamethasone|mesh-list
5996948|NCT00168298|Dexamethasone acetate|dexamethasone acetate|mesh-list
5996949|NCT00168298|BB 1101|bb 1101|mesh-list
5996950|NCT00168298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5996951|NCT00168298|Antiemetics|antiemetics|mesh-ancestor
5996952|NCT00168298|Autonomic Agents|autonomic agents|mesh-ancestor
5996953|NCT00168298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5996954|NCT00168298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996955|NCT00168298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5996956|NCT00168298|Glucocorticoids|glucocorticoids|mesh-ancestor
5996957|NCT00168298|Hormones|hormones|mesh-ancestor
5996958|NCT00168298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5996959|NCT00168298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5996960|NCT00168298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5996961|NCT00168298|Protease Inhibitors|protease inhibitors|mesh-ancestor
5996962|NCT00168298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5996963|NCT00168298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996964|NCT00168324|Dexamethasone|dexamethasone|mesh-list
5996965|NCT00168324|Dexamethasone acetate|dexamethasone acetate|mesh-list
5996966|NCT00168324|BB 1101|bb 1101|mesh-list
5996967|NCT00168324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5996968|NCT00168324|Antiemetics|antiemetics|mesh-ancestor
5996969|NCT00168324|Autonomic Agents|autonomic agents|mesh-ancestor
5996970|NCT00168324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5996971|NCT00168324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996972|NCT00168324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5996973|NCT00168324|Glucocorticoids|glucocorticoids|mesh-ancestor
5996974|NCT00168324|Hormones|hormones|mesh-ancestor
5996975|NCT00168324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5996976|NCT00168324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5996977|NCT00168324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5996978|NCT00168324|Protease Inhibitors|protease inhibitors|mesh-ancestor
5996979|NCT00168324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5996980|NCT00168324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5996981|NCT00168337|Dexamethasone|dexamethasone|mesh-list
5996982|NCT00168337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5996983|NCT00168337|Antiemetics|antiemetics|mesh-ancestor
5996984|NCT00168337|Autonomic Agents|autonomic agents|mesh-ancestor
5996985|NCT00168337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5996986|NCT00168337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996987|NCT00168337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5996988|NCT00168337|Glucocorticoids|glucocorticoids|mesh-ancestor
5996989|NCT00168337|Hormones|hormones|mesh-ancestor
5996990|NCT00168337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5996991|NCT00168337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5996992|NCT00168337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5996993|NCT00168389|Dexamethasone|dexamethasone|mesh-list
5996994|NCT00168389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5996995|NCT00168389|Antiemetics|antiemetics|mesh-ancestor
5996996|NCT00168389|Autonomic Agents|autonomic agents|mesh-ancestor
5996997|NCT00168389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5996998|NCT00168389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5996999|NCT00168389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5997000|NCT00168389|Glucocorticoids|glucocorticoids|mesh-ancestor
5997001|NCT00168389|Hormones|hormones|mesh-ancestor
5997002|NCT00168389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5997003|NCT00168389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5997004|NCT00168389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5997005|NCT00168428|Botulinum Toxins|botulinum toxins|mesh-list
5997006|NCT00168428|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5997007|NCT00168428|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5997008|NCT00168428|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5997009|NCT00168428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5997010|NCT00168428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997011|NCT00168428|Cholinergic Agents|cholinergic agents|mesh-ancestor
5997012|NCT00168428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5997013|NCT00168428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997014|NCT00168428|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5997015|NCT00168428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5997016|NCT00168454|Botulinum Toxins|botulinum toxins|mesh-list
5997017|NCT00168454|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5997018|NCT00168454|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5997019|NCT00168454|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5997020|NCT00168454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5997021|NCT00168454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997022|NCT00168454|Cholinergic Agents|cholinergic agents|mesh-ancestor
5997023|NCT00168454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5997024|NCT00168454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997025|NCT00168454|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5997026|NCT00168454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5997027|NCT00168805|Enoxaparin|enoxaparin|mesh-list
5997028|NCT00168805|Dabigatran|dabigatran|mesh-list
5997029|NCT00168805|Anticoagulants|anticoagulants|mesh-ancestor
5997030|NCT00168805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5997031|NCT00168805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5997032|NCT00168805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997033|NCT00168805|Antithrombins|antithrombins|mesh-ancestor
5997034|NCT00168805|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5997035|NCT00168805|Protease Inhibitors|protease inhibitors|mesh-ancestor
5997036|NCT00168805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5997037|NCT00168818|Enoxaparin|enoxaparin|mesh-list
5997038|NCT00168818|Dabigatran|dabigatran|mesh-list
5997039|NCT00168818|Anticoagulants|anticoagulants|mesh-ancestor
5997040|NCT00168818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5997041|NCT00168818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5997042|NCT00168818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997043|NCT00168818|Antithrombins|antithrombins|mesh-ancestor
5997044|NCT00168818|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5997045|NCT00168818|Protease Inhibitors|protease inhibitors|mesh-ancestor
5997046|NCT00168818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5997047|NCT00168831|Tiotropium Bromide|tiotropium bromide|mesh-list
5997048|NCT00168831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5997049|NCT00168831|Autonomic Agents|autonomic agents|mesh-ancestor
5997050|NCT00168831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5997051|NCT00168831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997052|NCT00168831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5997053|NCT00168831|Respiratory System Agents|respiratory system agents|mesh-ancestor
5997054|NCT00168831|Parasympatholytics|parasympatholytics|mesh-ancestor
5997055|NCT00168831|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5997056|NCT00168831|Cholinergic Agents|cholinergic agents|mesh-ancestor
5997057|NCT00168831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6017741|NCT00375674|Growth Substances|growth substances|mesh-ancestor
5997058|NCT00168831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997059|NCT00168844|Tiotropium Bromide|tiotropium bromide|mesh-list
5997060|NCT00168844|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5997061|NCT00168844|Autonomic Agents|autonomic agents|mesh-ancestor
5997062|NCT00168844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5997063|NCT00168844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997064|NCT00168844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5997065|NCT00168844|Respiratory System Agents|respiratory system agents|mesh-ancestor
5997066|NCT00168844|Parasympatholytics|parasympatholytics|mesh-ancestor
5997067|NCT00168844|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5997068|NCT00168844|Cholinergic Agents|cholinergic agents|mesh-ancestor
5997069|NCT00168844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5997070|NCT00168844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997071|NCT00169104|Trastuzumab|trastuzumab|mesh-list
5997072|NCT00169104|Vinorelbine|vinorelbine|mesh-list
5997073|NCT00169104|Lenograstim|lenograstim|mesh-list
5997074|NCT00169104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5997075|NCT00169104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5997076|NCT00169104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5997077|NCT00169104|Immunologic Factors|immunologic factors|mesh-ancestor
5997078|NCT00169104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997079|NCT00169104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5997080|NCT00169104|Tubulin Modulators|tubulin modulators|mesh-ancestor
5997081|NCT00169104|Antimitotic Agents|antimitotic agents|mesh-ancestor
5997082|NCT00169104|Mitosis Modulators|mitosis modulators|mesh-ancestor
5997083|NCT00169104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997084|NCT00170157|Ipilimumab|ipilimumab|mesh-list
5997085|NCT00170157|Leuprolide|leuprolide|mesh-list
5997086|NCT00170157|Goserelin|goserelin|mesh-list
5997087|NCT00170157|Bicalutamide|bicalutamide|mesh-list
5997088|NCT00170157|Flutamide|flutamide|mesh-list
5997089|NCT00170157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5997090|NCT00170157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5997091|NCT00170157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5997092|NCT00170157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997093|NCT00170157|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5997094|NCT00170157|Fertility Agents|fertility agents|mesh-ancestor
5997095|NCT00170157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5997096|NCT00170157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997097|NCT00170157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5997098|NCT00170157|Androgen Antagonists|androgen antagonists|mesh-ancestor
5997099|NCT00170157|Hormone Antagonists|hormone antagonists|mesh-ancestor
5997100|NCT00170157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5997101|NCT00170625|Topotecan|topotecan|mesh-list
5997102|NCT00170625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5997103|NCT00170625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5997104|NCT00170625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5997105|NCT00170625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997106|NCT00170625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5997107|NCT00170846|Everolimus|everolimus|mesh-list
5997108|NCT00170846|Azathioprine|azathioprine|mesh-list
5997109|NCT00170846|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
5997110|NCT00170846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5997111|NCT00170846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5997112|NCT00170846|Immunologic Factors|immunologic factors|mesh-ancestor
5997113|NCT00170846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997114|NCT00170846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5997115|NCT00170846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997116|NCT00170846|Antimetabolites|antimetabolites|mesh-ancestor
5997117|NCT00170846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5997118|NCT00170846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5997119|NCT00170950|Amlodipine|amlodipine|mesh-list
5997120|NCT00170950|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5997121|NCT00170950|Benazepril|benazepril|mesh-list
5997122|NCT00170950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5997123|NCT00170950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5997124|NCT00170950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5997125|NCT00170950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997126|NCT00170950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5997127|NCT00170950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997128|NCT00170950|Vasodilator Agents|vasodilator agents|mesh-ancestor
5997129|NCT00170950|Diuretics|diuretics|mesh-ancestor
5997130|NCT00170950|Natriuretic Agents|natriuretic agents|mesh-ancestor
5997131|NCT00170950|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5997132|NCT00170950|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5997133|NCT00170950|Protease Inhibitors|protease inhibitors|mesh-ancestor
5997134|NCT00170950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5997135|NCT00171054|Amlodipine|amlodipine|mesh-list
5997136|NCT00171054|Valsartan|valsartan|mesh-list
5997137|NCT00171054|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5997138|NCT00171054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5997139|NCT00171054|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5997140|NCT00171054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5997141|NCT00171054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997142|NCT00171054|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5997143|NCT00171054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997144|NCT00171054|Vasodilator Agents|vasodilator agents|mesh-ancestor
5997145|NCT00171054|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5997146|NCT00171054|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5997147|NCT00171054|Diuretics|diuretics|mesh-ancestor
5997148|NCT00171054|Natriuretic Agents|natriuretic agents|mesh-ancestor
5997149|NCT00171054|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5997150|NCT00171158|Imatinib Mesylate|imatinib mesylate|mesh-list
5997151|NCT00171158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5997152|NCT00171158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5997153|NCT00171158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5997154|NCT00171158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997155|NCT00171210|Deferasirox|deferasirox|mesh-list
5997156|NCT00171210|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5997157|NCT00171210|Chelating Agents|chelating agents|mesh-ancestor
5997158|NCT00171210|Sequestering Agents|sequestering agents|mesh-ancestor
5997159|NCT00171210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997160|NCT00171223|Imatinib Mesylate|imatinib mesylate|mesh-list
5997161|NCT00171223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5997162|NCT00171223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5997163|NCT00171223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5997164|NCT00171223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997165|NCT00171249|Imatinib Mesylate|imatinib mesylate|mesh-list
5997166|NCT00171249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5997167|NCT00171249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5997168|NCT00171249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5997169|NCT00171249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997170|NCT00171301|Deferasirox|deferasirox|mesh-list
5997171|NCT00171301|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5997172|NCT00171301|Chelating Agents|chelating agents|mesh-ancestor
5997173|NCT00171301|Sequestering Agents|sequestering agents|mesh-ancestor
5997174|NCT00171301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997175|NCT00171314|Zoledronic Acid|zoledronic acid|mesh-list
5997176|NCT00171314|Letrozole|letrozole|mesh-list
5997177|NCT00171314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5997178|NCT00171314|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5997179|NCT00171314|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5997180|NCT00171314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5997181|NCT00171314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997182|NCT00171314|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5997183|NCT00171314|Hormone Antagonists|hormone antagonists|mesh-ancestor
5997184|NCT00171314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5997185|NCT00171314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997186|NCT00171314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5997187|NCT00171340|Zoledronic Acid|zoledronic acid|mesh-list
5997188|NCT00171340|Letrozole|letrozole|mesh-list
5997189|NCT00171340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5997190|NCT00171340|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5997191|NCT00171340|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5997192|NCT00171340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5997193|NCT00171340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997194|NCT00171340|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5997195|NCT00171340|Hormone Antagonists|hormone antagonists|mesh-ancestor
5997196|NCT00171340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5997197|NCT00171340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997198|NCT00171340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5997199|NCT00171704|Tamoxifen|tamoxifen|mesh-list
5997200|NCT00171704|Letrozole|letrozole|mesh-list
5997201|NCT00171704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5997202|NCT00171704|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5997203|NCT00171704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5997204|NCT00171704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5997205|NCT00171704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997206|NCT00171704|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5997207|NCT00171704|Hormone Antagonists|hormone antagonists|mesh-ancestor
5997208|NCT00171704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5997209|NCT00171704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997210|NCT00171704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5997211|NCT00171704|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5997212|NCT00171704|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5997213|NCT00171704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5997214|NCT00171730|Pasireotide|pasireotide|mesh-list
5997215|NCT00171730|Hormones|hormones|mesh-ancestor
5997216|NCT00171730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5997217|NCT00171730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997218|NCT00171834|Epothilones|epothilones|mesh-list
5997219|NCT00171834|Epothilone B|epothilone b|mesh-list
5997220|NCT00171834|Tubulin Modulators|tubulin modulators|mesh-ancestor
5997221|NCT00171834|Antimitotic Agents|antimitotic agents|mesh-ancestor
5997222|NCT00171834|Mitosis Modulators|mitosis modulators|mesh-ancestor
5997223|NCT00171834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997224|NCT00171834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5997225|NCT00171873|Octreotide|octreotide|mesh-list
5997226|NCT00171873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5997227|NCT00171873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5997228|NCT00171873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5997229|NCT00171925|Vitamin D|vitamin d|mesh-list
5997230|NCT00171925|Zoledronic Acid|zoledronic acid|mesh-list
5997231|NCT00171925|Calcium|calcium|mesh-list
5997232|NCT00171925|Vitamins|vitamins|mesh-ancestor
5997233|NCT00171925|Micronutrients|micronutrients|mesh-ancestor
5997234|NCT00171925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997235|NCT00171925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5997236|NCT00171925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5997237|NCT00171951|Pasireotide|pasireotide|mesh-list
5997238|NCT00171951|Hormones|hormones|mesh-ancestor
5997239|NCT00171951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5997240|NCT00171951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997241|NCT00172042|Zoledronic Acid|zoledronic acid|mesh-list
5997242|NCT00172042|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5997243|NCT00172042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997244|NCT00172185|Teduglutide|teduglutide|mesh-list
5997245|NCT00172185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5997246|NCT00172185|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5997247|NCT00172185|Protective Agents|protective agents|mesh-ancestor
5997248|NCT00172185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997249|NCT00174382|Donepezil|donepezil|mesh-list
5997250|NCT00174382|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5997251|NCT00174382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5997252|NCT00174382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997253|NCT00174382|Cholinergic Agents|cholinergic agents|mesh-ancestor
5997254|NCT00174382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5997255|NCT00174382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259331|NCT03116828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6259332|NCT03116828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259333|NCT03117140|Dexamethasone|dexamethasone|mesh-list
6259334|NCT03117140|Clonidine|clonidine|mesh-list
6259335|NCT03117140|Buprenorphine|buprenorphine|mesh-list
6259336|NCT03117140|Ropivacaine|ropivacaine|mesh-list
6259337|NCT03117140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6259338|NCT03117140|Antiemetics|antiemetics|mesh-ancestor
6259339|NCT03117140|Autonomic Agents|autonomic agents|mesh-ancestor
6259340|NCT03117140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6259341|NCT03117140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259342|NCT03117140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6259343|NCT03117140|Glucocorticoids|glucocorticoids|mesh-ancestor
6259344|NCT03117140|Hormones|hormones|mesh-ancestor
6259345|NCT03117140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6259346|NCT03117140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6259347|NCT03117140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6259348|NCT03117140|Anesthetics, Local|anesthetics, local|mesh-ancestor
6259349|NCT03117140|Anesthetics|anesthetics|mesh-ancestor
6259350|NCT03117140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5997256|NCT00174382|Nootropic Agents|nootropic agents|mesh-ancestor
5997257|NCT00174447|Ziprasidone|ziprasidone|mesh-list
5997258|NCT00174447|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5997259|NCT00174447|Serotonin Agents|serotonin agents|mesh-ancestor
5997260|NCT00174447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5997261|NCT00174447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997262|NCT00174447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997263|NCT00174447|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5997264|NCT00174447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5997265|NCT00174447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5997266|NCT00174447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5997267|NCT00174447|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5997268|NCT00174447|Dopamine Agents|dopamine agents|mesh-ancestor
5997269|NCT00174785|Dronedarone|dronedarone|mesh-list
5997270|NCT00174785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5997271|NCT00174915|Allopurinol|allopurinol|mesh-list
5997272|NCT00174915|Febuxostat|febuxostat|mesh-list
5997273|NCT00174915|Antimetabolites|antimetabolites|mesh-ancestor
5997274|NCT00174915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997275|NCT00174915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5997276|NCT00174915|Gout Suppressants|gout suppressants|mesh-ancestor
5997277|NCT00174915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5997278|NCT00174915|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5997279|NCT00174915|Antioxidants|antioxidants|mesh-ancestor
5997280|NCT00174915|Protective Agents|protective agents|mesh-ancestor
5997281|NCT00174915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997282|NCT00174941|Febuxostat|febuxostat|mesh-list
5997283|NCT00174941|Gout Suppressants|gout suppressants|mesh-ancestor
5997284|NCT00174941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5997285|NCT00174967|Febuxostat|febuxostat|mesh-list
5997286|NCT00174967|Gout Suppressants|gout suppressants|mesh-ancestor
5997287|NCT00174967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5997288|NCT00175019|Allopurinol|allopurinol|mesh-list
5997289|NCT00175019|Febuxostat|febuxostat|mesh-list
5997290|NCT00175019|Antimetabolites|antimetabolites|mesh-ancestor
5997291|NCT00175019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997292|NCT00175019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5997293|NCT00175019|Gout Suppressants|gout suppressants|mesh-ancestor
5997294|NCT00175019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5997295|NCT00175019|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5997296|NCT00175019|Antioxidants|antioxidants|mesh-ancestor
5997297|NCT00175019|Protective Agents|protective agents|mesh-ancestor
5997298|NCT00175019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997299|NCT00175825|Brivaracetam|brivaracetam|mesh-list
5997300|NCT00175825|Anticonvulsants|anticonvulsants|mesh-ancestor
5997301|NCT00175877|Certolizumab Pegol|certolizumab pegol|mesh-list
5997302|NCT00175877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5997303|NCT00175877|Immunologic Factors|immunologic factors|mesh-ancestor
5997304|NCT00175877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997305|NCT00175877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5997306|NCT00175916|Brivaracetam|brivaracetam|mesh-list
5997307|NCT00175916|Anticonvulsants|anticonvulsants|mesh-ancestor
5997308|NCT00176202|Valproic Acid|valproic acid|mesh-list
5997309|NCT00176202|Anticonvulsants|anticonvulsants|mesh-list
5997310|NCT00176202|Risperidone|risperidone|mesh-list
5997311|NCT00176202|Antipsychotic Agents|antipsychotic agents|mesh-list
5997312|NCT00176202|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5997313|NCT00176202|Serotonin Agents|serotonin agents|mesh-ancestor
5997314|NCT00176202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5997315|NCT00176202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997316|NCT00176202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997317|NCT00176202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5997318|NCT00176202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5997319|NCT00176202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5997320|NCT00176202|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5997321|NCT00176202|Dopamine Agents|dopamine agents|mesh-ancestor
5997322|NCT00176202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5997323|NCT00176202|GABA Agents|gaba agents|mesh-ancestor
5997324|NCT00176202|Antimanic Agents|antimanic agents|mesh-ancestor
5997325|NCT00176228|Lamotrigine|lamotrigine|mesh-list
5997326|NCT00176228|Anticonvulsants|anticonvulsants|mesh-ancestor
5997327|NCT00176228|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5997328|NCT00176228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5997329|NCT00176228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997330|NCT00176228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5997331|NCT00176228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997332|NCT00176228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5997333|NCT00176228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5997334|NCT00176228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5997335|NCT00176228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5997336|NCT00176228|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5997337|NCT00176254|Paclitaxel|paclitaxel|mesh-list
5997338|NCT00176254|Carboplatin|carboplatin|mesh-list
5997339|NCT00176254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5997340|NCT00176254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5997341|NCT00176254|Tubulin Modulators|tubulin modulators|mesh-ancestor
5997342|NCT00176254|Antimitotic Agents|antimitotic agents|mesh-ancestor
5997343|NCT00176254|Mitosis Modulators|mitosis modulators|mesh-ancestor
5997344|NCT00176254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997345|NCT00176306|Levofloxacin|levofloxacin|mesh-list
5997346|NCT00176306|Ofloxacin|ofloxacin|mesh-list
5997347|NCT00176306|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5997348|NCT00176306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5997349|NCT00176306|Renal Agents|renal agents|mesh-ancestor
5997350|NCT00176306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5997351|NCT00176306|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5997352|NCT00176306|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5997353|NCT00176306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5997354|NCT00176306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997355|NCT00176306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5997356|NCT00176306|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5997357|NCT00176306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5997358|NCT00176423|Galantamine|galantamine|mesh-list
5997359|NCT00176423|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5997360|NCT00176423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5997361|NCT00176423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997362|NCT00176423|Cholinergic Agents|cholinergic agents|mesh-ancestor
5997363|NCT00176423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5997364|NCT00176423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997365|NCT00176423|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5997366|NCT00176423|Autonomic Agents|autonomic agents|mesh-ancestor
5997367|NCT00176423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5997368|NCT00176423|Nootropic Agents|nootropic agents|mesh-ancestor
5997369|NCT00176462|Leucovorin|leucovorin|mesh-list
5997370|NCT00176462|Cytarabine|cytarabine|mesh-list
5997371|NCT00176462|Dexamethasone|dexamethasone|mesh-list
5997372|NCT00176462|Hydrocortisone|hydrocortisone|mesh-list
5997373|NCT00176462|Cyclophosphamide|cyclophosphamide|mesh-list
5997374|NCT00176462|Methotrexate|methotrexate|mesh-list
5997375|NCT00176462|Vincristine|vincristine|mesh-list
5997376|NCT00176462|Asparaginase|asparaginase|mesh-list
5997377|NCT00176462|Mercaptopurine|mercaptopurine|mesh-list
5997378|NCT00176462|Thioguanine|thioguanine|mesh-list
5997379|NCT00176462|Daunorubicin|daunorubicin|mesh-list
5997380|NCT00176462|Aminopterin|aminopterin|mesh-list
5997381|NCT00176462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5997382|NCT00176462|Immunologic Factors|immunologic factors|mesh-ancestor
5997383|NCT00176462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997384|NCT00176462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5997385|NCT00176462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5997386|NCT00176462|Alkylating Agents|alkylating agents|mesh-ancestor
5997387|NCT00176462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997388|NCT00176462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5997389|NCT00176462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5997390|NCT00176462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5997391|NCT00176462|Antiemetics|antiemetics|mesh-ancestor
5997392|NCT00176462|Autonomic Agents|autonomic agents|mesh-ancestor
5997393|NCT00176462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5997394|NCT00176462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5997395|NCT00176462|Glucocorticoids|glucocorticoids|mesh-ancestor
5997396|NCT00176462|Hormones|hormones|mesh-ancestor
5997397|NCT00176462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5997398|NCT00176462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5997399|NCT00176462|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5997400|NCT00176462|Abortifacient Agents|abortifacient agents|mesh-ancestor
5997401|NCT00176462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5997402|NCT00176462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5997403|NCT00176462|Antimetabolites|antimetabolites|mesh-ancestor
5997404|NCT00176462|Dermatologic Agents|dermatologic agents|mesh-ancestor
5997405|NCT00176462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5997406|NCT00176462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5997407|NCT00176462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5997408|NCT00176462|Antiviral Agents|antiviral agents|mesh-ancestor
5997409|NCT00176462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5997410|NCT00176462|Antidotes|antidotes|mesh-ancestor
5997411|NCT00176462|Protective Agents|protective agents|mesh-ancestor
5997412|NCT00176462|Vitamin B Complex|vitamin b complex|mesh-ancestor
5997413|NCT00176462|Vitamins|vitamins|mesh-ancestor
5997414|NCT00176462|Micronutrients|micronutrients|mesh-ancestor
5997415|NCT00176462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5997416|NCT00176462|Tubulin Modulators|tubulin modulators|mesh-ancestor
5997417|NCT00176462|Antimitotic Agents|antimitotic agents|mesh-ancestor
5997418|NCT00176462|Mitosis Modulators|mitosis modulators|mesh-ancestor
5997419|NCT00176462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5997420|NCT00176462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5997421|NCT00176462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5997422|NCT00176592|Glatiramer Acetate|glatiramer acetate|mesh-list
5997423|NCT00176592|Interferon beta-1b|interferon beta-1b|mesh-list
5997424|NCT00176592|(T,G)-A-L|(t,g)-a-l|mesh-list
5997425|NCT00176592|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5997426|NCT00176592|Immunologic Factors|immunologic factors|mesh-ancestor
5997427|NCT00176592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997428|NCT00176592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5997429|NCT00176592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5997430|NCT00176605|Cyclophosphamide|cyclophosphamide|mesh-list
5997431|NCT00176605|Etoposide|etoposide|mesh-list
5997432|NCT00176605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5997433|NCT00176605|Immunologic Factors|immunologic factors|mesh-ancestor
5997434|NCT00176605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997435|NCT00176605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5997436|NCT00176605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5997437|NCT00176605|Alkylating Agents|alkylating agents|mesh-ancestor
5997438|NCT00176605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997439|NCT00176605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5997440|NCT00176605|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5997441|NCT00176605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5997442|NCT00176605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5997443|NCT00176605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5997444|NCT00176605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5997445|NCT00176644|Estradiol|estradiol|mesh-list
5997446|NCT00176644|Estrogens|estrogens|mesh-ancestor
5997447|NCT00176644|Hormones|hormones|mesh-ancestor
5997448|NCT00176644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5997449|NCT00176644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997450|NCT00176800|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
5997451|NCT00176800|Chelating Agents|chelating agents|mesh-ancestor
5997452|NCT00176800|Sequestering Agents|sequestering agents|mesh-ancestor
5997453|NCT00176800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997454|NCT00176800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5997455|NCT00176800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5997456|NCT00176800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5997457|NCT00176800|Growth Substances|growth substances|mesh-ancestor
5997458|NCT00176800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997459|NCT00176800|Growth Inhibitors|growth inhibitors|mesh-ancestor
5997460|NCT00176800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5997461|NCT00176826|Busulfan|busulfan|mesh-list
5997462|NCT00176826|Alkylating Agents|alkylating agents|mesh-ancestor
5997463|NCT00176826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997464|NCT00176826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5997465|NCT00176826|Immunologic Factors|immunologic factors|mesh-ancestor
5997466|NCT00176826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997467|NCT00176826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5997468|NCT00176826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5997469|NCT00176826|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5997470|NCT00176839|Cyclophosphamide|cyclophosphamide|mesh-list
5997471|NCT00176839|Melphalan|melphalan|mesh-list
5997472|NCT00176839|Busulfan|busulfan|mesh-list
5997473|NCT00176839|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5997474|NCT00176839|Lenograstim|lenograstim|mesh-list
5997475|NCT00176839|Sargramostim|sargramostim|mesh-list
5997476|NCT00176839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5997477|NCT00176839|Immunologic Factors|immunologic factors|mesh-ancestor
5997478|NCT00176839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997479|NCT00176839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5997480|NCT00176839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5997481|NCT00176839|Alkylating Agents|alkylating agents|mesh-ancestor
5997482|NCT00176839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997483|NCT00176839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5997484|NCT00176839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5997485|NCT00176839|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5997486|NCT00176852|Vidarabine|vidarabine|mesh-list
5997487|NCT00176852|Cyclophosphamide|cyclophosphamide|mesh-list
5997488|NCT00176852|Busulfan|busulfan|mesh-list
5997489|NCT00176852|Fludarabine|fludarabine|mesh-list
5997490|NCT00176852|Fludarabine phosphate|fludarabine phosphate|mesh-list
5997491|NCT00176852|Alemtuzumab|alemtuzumab|mesh-list
5997492|NCT00176852|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5997493|NCT00176852|Sargramostim|sargramostim|mesh-list
5997494|NCT00176852|Lenograstim|lenograstim|mesh-list
5997495|NCT00176852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5997496|NCT00176852|Immunologic Factors|immunologic factors|mesh-ancestor
5997497|NCT00176852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997498|NCT00176852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5997499|NCT00176852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5997500|NCT00176852|Alkylating Agents|alkylating agents|mesh-ancestor
5997501|NCT00176852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997502|NCT00176852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5997503|NCT00176852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5997504|NCT00176852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5997505|NCT00176852|Antimetabolites|antimetabolites|mesh-ancestor
5997506|NCT00176852|Antiviral Agents|antiviral agents|mesh-ancestor
5997507|NCT00176852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5997508|NCT00176852|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5997509|NCT00176852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5997510|NCT00176865|Cyclosporine|cyclosporine|mesh-list
5997511|NCT00176865|Mycophenolic Acid|mycophenolic acid|mesh-list
5997512|NCT00176865|Fludarabine|fludarabine|mesh-list
5997513|NCT00176865|Melphalan|melphalan|mesh-list
5997514|NCT00176865|Alemtuzumab|alemtuzumab|mesh-list
5997515|NCT00176865|Cyclosporins|cyclosporins|mesh-list
5997516|NCT00176865|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5997517|NCT00176865|Immunoglobulins|immunoglobulins|mesh-list
5997518|NCT00176865|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5997519|NCT00176865|Antibodies|antibodies|mesh-list
5997520|NCT00176865|gamma-Globulins|gamma-globulins|mesh-list
5997521|NCT00176865|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5997522|NCT00176865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5997523|NCT00176865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997524|NCT00176865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5997525|NCT00176865|Immunologic Factors|immunologic factors|mesh-ancestor
5997526|NCT00176865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997527|NCT00176865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5997528|NCT00176865|Antifungal Agents|antifungal agents|mesh-ancestor
5997529|NCT00176865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5997530|NCT00176865|Dermatologic Agents|dermatologic agents|mesh-ancestor
5997531|NCT00176865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5997532|NCT00176865|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5997533|NCT00176865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5997534|NCT00176865|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5997535|NCT00176865|Antitubercular Agents|antitubercular agents|mesh-ancestor
5997536|NCT00176865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5997537|NCT00176865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5997538|NCT00176865|Alkylating Agents|alkylating agents|mesh-ancestor
5997539|NCT00176865|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5997540|NCT00176865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5997541|NCT00176878|Fludarabine|fludarabine|mesh-list
5997542|NCT00176878|Fludarabine phosphate|fludarabine phosphate|mesh-list
5997543|NCT00176878|Busulfan|busulfan|mesh-list
5997544|NCT00176878|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5997545|NCT00176878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5997546|NCT00176878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5997547|NCT00176878|Antimetabolites|antimetabolites|mesh-ancestor
5997548|NCT00176878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997549|NCT00176878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5997550|NCT00176878|Immunologic Factors|immunologic factors|mesh-ancestor
5997551|NCT00176878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997552|NCT00176878|Alkylating Agents|alkylating agents|mesh-ancestor
5997553|NCT00176878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5997554|NCT00176878|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5997555|NCT00176904|Cyclophosphamide|cyclophosphamide|mesh-list
5997556|NCT00176904|Busulfan|busulfan|mesh-list
5997557|NCT00176904|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5997558|NCT00176904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5997559|NCT00176904|Immunologic Factors|immunologic factors|mesh-ancestor
5997560|NCT00176904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997561|NCT00176904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5997562|NCT00176904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5997563|NCT00176904|Alkylating Agents|alkylating agents|mesh-ancestor
5997564|NCT00176904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997565|NCT00176904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5997566|NCT00176904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5997567|NCT00176917|Cyclophosphamide|cyclophosphamide|mesh-list
5997568|NCT00176917|Busulfan|busulfan|mesh-list
5997569|NCT00176917|Thymoglobulin|thymoglobulin|mesh-list
5997570|NCT00176917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5997571|NCT00176917|Immunologic Factors|immunologic factors|mesh-ancestor
5997572|NCT00176917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997573|NCT00176917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5997574|NCT00176917|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5997575|NCT00176917|Alkylating Agents|alkylating agents|mesh-ancestor
5997576|NCT00176917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997577|NCT00176917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5997578|NCT00176917|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5997579|NCT00176930|Cyclophosphamide|cyclophosphamide|mesh-list
5997580|NCT00176930|Busulfan|busulfan|mesh-list
5997581|NCT00176930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5997582|NCT00176930|Immunologic Factors|immunologic factors|mesh-ancestor
5997583|NCT00176930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997584|NCT00176930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5997585|NCT00176930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5997586|NCT00176930|Alkylating Agents|alkylating agents|mesh-ancestor
5997587|NCT00176930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997588|NCT00176930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5997589|NCT00176930|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5997590|NCT00177047|Cyclophosphamide|cyclophosphamide|mesh-list
5997591|NCT00177047|Melphalan|melphalan|mesh-list
5997592|NCT00177047|Sargramostim|sargramostim|mesh-list
5997593|NCT00177047|Lenograstim|lenograstim|mesh-list
5997594|NCT00177047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5997595|NCT00177047|Immunologic Factors|immunologic factors|mesh-ancestor
5997596|NCT00177047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997597|NCT00177047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5997598|NCT00177047|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5997599|NCT00177047|Alkylating Agents|alkylating agents|mesh-ancestor
5997600|NCT00177047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997601|NCT00177047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5997602|NCT00177047|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5997603|NCT00177047|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5997604|NCT00177164|Olanzapine|olanzapine|mesh-list
5997605|NCT00177164|Risperidone|risperidone|mesh-list
5997606|NCT00177164|Quetiapine Fumarate|quetiapine fumarate|mesh-list
5997607|NCT00177164|Aripiprazole|aripiprazole|mesh-list
5997608|NCT00177164|Ziprasidone|ziprasidone|mesh-list
5997609|NCT00177164|Antipsychotic Agents|antipsychotic agents|mesh-list
5997610|NCT00177164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5997611|NCT00177164|Serotonin Agents|serotonin agents|mesh-ancestor
5997612|NCT00177164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5997613|NCT00177164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997614|NCT00177164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997615|NCT00177164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5997616|NCT00177164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5997617|NCT00177164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5997618|NCT00177164|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5997619|NCT00177164|Dopamine Agents|dopamine agents|mesh-ancestor
5997620|NCT00177164|Antiemetics|antiemetics|mesh-ancestor
5997621|NCT00177164|Autonomic Agents|autonomic agents|mesh-ancestor
5997622|NCT00177164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5997623|NCT00177164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5997624|NCT00177164|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5997625|NCT00177164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5997626|NCT00177164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5997627|NCT00177164|Antidepressive Agents|antidepressive agents|mesh-ancestor
5997628|NCT00177164|Dopamine Agonists|dopamine agonists|mesh-ancestor
5997629|NCT00177164|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5997630|NCT00177164|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5997631|NCT00177164|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5997632|NCT00177164|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5997633|NCT00177216|Zolpidem|zolpidem|mesh-list
5997634|NCT00177216|Citalopram|citalopram|mesh-list
5997635|NCT00177216|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5997636|NCT00177216|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5997637|NCT00177216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5997638|NCT00177216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997639|NCT00177216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5997640|NCT00177216|Serotonin Agents|serotonin agents|mesh-ancestor
5997641|NCT00177216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997642|NCT00177216|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5997643|NCT00177216|Antidepressive Agents|antidepressive agents|mesh-ancestor
5997644|NCT00177216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5997645|NCT00177216|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5997646|NCT00177216|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5997647|NCT00177216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5997648|NCT00177216|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
5997649|NCT00177216|GABA Agonists|gaba agonists|mesh-ancestor
5997650|NCT00177216|GABA Agents|gaba agents|mesh-ancestor
5997651|NCT00177255|Docetaxel|docetaxel|mesh-list
5997652|NCT00177255|Capecitabine|capecitabine|mesh-list
5997653|NCT00177255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5997654|NCT00177255|Tubulin Modulators|tubulin modulators|mesh-ancestor
5997655|NCT00177255|Antimitotic Agents|antimitotic agents|mesh-ancestor
5997656|NCT00177255|Mitosis Modulators|mitosis modulators|mesh-ancestor
5997657|NCT00177255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997658|NCT00177255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5997659|NCT00177255|Antimetabolites|antimetabolites|mesh-ancestor
5997660|NCT00177294|Citalopram|citalopram|mesh-list
5997661|NCT00177294|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5997662|NCT00177294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5997663|NCT00177294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5997664|NCT00177294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997665|NCT00177294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5997666|NCT00177294|Serotonin Agents|serotonin agents|mesh-ancestor
5997667|NCT00177294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997668|NCT00177294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5997669|NCT00177294|Antidepressive Agents|antidepressive agents|mesh-ancestor
5997670|NCT00177294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6017742|NCT00375674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017743|NCT00375674|Growth Inhibitors|growth inhibitors|mesh-ancestor
6017744|NCT00375674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6017745|NCT00375674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6017746|NCT00375674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017747|NCT00375713|Cetirizine|cetirizine|mesh-list
6017748|NCT00375713|Hydrocortisone|hydrocortisone|mesh-list
6017749|NCT00375713|Levocetirizine|levocetirizine|mesh-list
6017750|NCT00375713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6017751|NCT00375713|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6017752|NCT00375713|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6017753|NCT00375713|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6017754|NCT00375713|Histamine Antagonists|histamine antagonists|mesh-ancestor
6017755|NCT00375713|Histamine Agents|histamine agents|mesh-ancestor
6017756|NCT00375713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6017757|NCT00375713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017758|NCT00375713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017759|NCT00375752|Letrozole|letrozole|mesh-list
6017760|NCT00375752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6017761|NCT00375752|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6017762|NCT00375752|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6017763|NCT00375752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6017764|NCT00375752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017765|NCT00375752|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6017766|NCT00375752|Hormone Antagonists|hormone antagonists|mesh-ancestor
6017767|NCT00375752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6017768|NCT00375752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017769|NCT00375830|Diphosphonates|diphosphonates|mesh-list
6017770|NCT00375830|Methylene diphosphonate|methylene diphosphonate|mesh-list
6017771|NCT00375830|Listerine|listerine|mesh-list
6017772|NCT00375830|Deoxyglucose|deoxyglucose|mesh-list
6017773|NCT00375830|Fluorides|fluorides|mesh-list
6017774|NCT00375830|Sodium Fluoride|sodium fluoride|mesh-list
6017775|NCT00375830|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6017776|NCT00375830|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
6017777|NCT00375830|Cariostatic Agents|cariostatic agents|mesh-ancestor
6017778|NCT00375830|Protective Agents|protective agents|mesh-ancestor
6017779|NCT00375830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017780|NCT00375830|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6017781|NCT00375830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017782|NCT00375830|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6017783|NCT00375830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6017784|NCT00375830|Antimetabolites|antimetabolites|mesh-ancestor
6017785|NCT00375830|Antiviral Agents|antiviral agents|mesh-ancestor
6017786|NCT00375830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6017787|NCT00375934|Diclofenac|diclofenac|mesh-list
6017788|NCT00375934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6017789|NCT00375934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6017790|NCT00375934|Analgesics|analgesics|mesh-ancestor
6017791|NCT00375934|Sensory System Agents|sensory system agents|mesh-ancestor
6017792|NCT00375934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6017793|NCT00375934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017794|NCT00375934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6017795|NCT00375934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6017796|NCT00375934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6017797|NCT00375934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6017798|NCT00375934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017799|NCT00375973|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6017800|NCT00375973|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6017801|NCT00375973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5997671|NCT00177307|Bevacizumab|bevacizumab|mesh-list
5997672|NCT00177307|Capecitabine|capecitabine|mesh-list
5997673|NCT00177307|Oxaliplatin|oxaliplatin|mesh-list
5997674|NCT00177307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5997675|NCT00177307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5997676|NCT00177307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5997677|NCT00177307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5997678|NCT00177307|Growth Substances|growth substances|mesh-ancestor
5997679|NCT00177307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997680|NCT00177307|Growth Inhibitors|growth inhibitors|mesh-ancestor
5997681|NCT00177307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5997682|NCT00177307|Antimetabolites|antimetabolites|mesh-ancestor
5997683|NCT00177307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259351|NCT03117140|Sensory System Agents|sensory system agents|mesh-ancestor
6259352|NCT03117140|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6259353|NCT03117140|Narcotics|narcotics|mesh-ancestor
6259354|NCT03117140|Analgesics|analgesics|mesh-ancestor
6259355|NCT03117140|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6259356|NCT03117140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6259357|NCT03117140|Sympatholytics|sympatholytics|mesh-ancestor
6259358|NCT03117140|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6259359|NCT03117140|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6259360|NCT03117140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6259361|NCT03117140|Adrenergic Agents|adrenergic agents|mesh-ancestor
6259362|NCT03117140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6259363|NCT03117140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259364|NCT03117361|Dexamethasone|dexamethasone|mesh-list
6259365|NCT03117361|Bortezomib|bortezomib|mesh-list
6259366|NCT03117361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6259367|NCT03117361|Antiemetics|antiemetics|mesh-ancestor
6259368|NCT03117361|Autonomic Agents|autonomic agents|mesh-ancestor
6259369|NCT03117361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6259370|NCT03117361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259371|NCT03117361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6259372|NCT03117361|Glucocorticoids|glucocorticoids|mesh-ancestor
6259373|NCT03117361|Hormones|hormones|mesh-ancestor
6259374|NCT03117361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6259375|NCT03117361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6259376|NCT03117361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6259377|NCT03117517|Metformin|metformin|mesh-list
6259378|NCT03117517|Pioglitazone|pioglitazone|mesh-list
6259379|NCT03117517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6259380|NCT03117517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259381|NCT03117634|Aflibercept|aflibercept|mesh-list
6259382|NCT03117634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6259383|NCT03117634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6259384|NCT03117634|Growth Substances|growth substances|mesh-ancestor
6259385|NCT03117634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259386|NCT03117634|Growth Inhibitors|growth inhibitors|mesh-ancestor
6259387|NCT03117634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6259388|NCT03118297|Ulipristal acetate|ulipristal acetate|mesh-list
6259389|NCT03118297|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6259390|NCT03118297|Contraceptive Agents|contraceptive agents|mesh-ancestor
6259391|NCT03118297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6259392|NCT03118297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259393|NCT03118297|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6259394|NCT03118466|Cytarabine|cytarabine|mesh-list
6259395|NCT03118466|Etoposide|etoposide|mesh-list
6259396|NCT03118466|Mitoxantrone|mitoxantrone|mesh-list
6259397|NCT03118466|Lenalidomide|lenalidomide|mesh-list
6259398|NCT03118466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6259399|NCT03118466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6259400|NCT03118466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6259401|NCT03118466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6259402|NCT03118466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6259403|NCT03118466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259404|NCT03118466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6259405|NCT03118466|Antimetabolites|antimetabolites|mesh-ancestor
6259406|NCT03118466|Antiviral Agents|antiviral agents|mesh-ancestor
6259407|NCT03118466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6259408|NCT03118466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6259409|NCT03118466|Immunologic Factors|immunologic factors|mesh-ancestor
6259410|NCT03118466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259411|NCT03118466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6259412|NCT03118466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6259413|NCT03118466|Growth Substances|growth substances|mesh-ancestor
5997684|NCT00177671|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5997685|NCT00177671|Donepezil|donepezil|mesh-list
5997686|NCT00177671|Citalopram|citalopram|mesh-list
5997687|NCT00177671|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
5997688|NCT00177671|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5997689|NCT00177671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5997690|NCT00177671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5997691|NCT00177671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997692|NCT00177671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5997693|NCT00177671|Serotonin Agents|serotonin agents|mesh-ancestor
5997694|NCT00177671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997695|NCT00177671|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5997696|NCT00177671|Antidepressive Agents|antidepressive agents|mesh-ancestor
5997697|NCT00177671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5997698|NCT00177671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5997699|NCT00177671|Cholinergic Agents|cholinergic agents|mesh-ancestor
5997700|NCT00177671|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5997701|NCT00177671|Analgesics|analgesics|mesh-ancestor
5997702|NCT00177671|Sensory System Agents|sensory system agents|mesh-ancestor
5997703|NCT00177671|Dopamine Agents|dopamine agents|mesh-ancestor
5997704|NCT00177671|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5997705|NCT00177671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5997706|NCT00177671|Nootropic Agents|nootropic agents|mesh-ancestor
5997707|NCT00178178|Bupivacaine|bupivacaine|mesh-list
5997708|NCT00178178|Anesthetics, Local|anesthetics, local|mesh-ancestor
5997709|NCT00178178|Anesthetics|anesthetics|mesh-ancestor
5997710|NCT00178178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5997711|NCT00178178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997712|NCT00178178|Sensory System Agents|sensory system agents|mesh-ancestor
5997713|NCT00178178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5997714|NCT00178256|Paclitaxel|paclitaxel|mesh-list
5997715|NCT00178256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5997716|NCT00178256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5997717|NCT00178256|Tubulin Modulators|tubulin modulators|mesh-ancestor
5997718|NCT00178256|Antimitotic Agents|antimitotic agents|mesh-ancestor
5997719|NCT00178256|Mitosis Modulators|mitosis modulators|mesh-ancestor
5997720|NCT00178256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997721|NCT00178464|Aspirin|aspirin|mesh-list
5997722|NCT00178464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5997723|NCT00178464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5997724|NCT00178464|Analgesics|analgesics|mesh-ancestor
5997725|NCT00178464|Sensory System Agents|sensory system agents|mesh-ancestor
5997726|NCT00178464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5997727|NCT00178464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997728|NCT00178464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5997729|NCT00178464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5997730|NCT00178464|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5997731|NCT00178464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5997732|NCT00178464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997733|NCT00178464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5997734|NCT00178464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5997735|NCT00178464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5997736|NCT00178464|Antipyretics|antipyretics|mesh-ancestor
5997737|NCT00178503|Methylphenidate|methylphenidate|mesh-list
5997738|NCT00178503|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5997739|NCT00178503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997740|NCT00178503|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5997741|NCT00178503|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5997742|NCT00178503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5997743|NCT00178503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997744|NCT00178503|Dopamine Agents|dopamine agents|mesh-ancestor
5997745|NCT00178503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5997746|NCT00178646|Botulinum Toxins|botulinum toxins|mesh-list
5997747|NCT00178646|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5997748|NCT00178646|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5997749|NCT00178646|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5997750|NCT00178646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5997751|NCT00178646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997752|NCT00178646|Cholinergic Agents|cholinergic agents|mesh-ancestor
5997753|NCT00178646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5997754|NCT00178646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997755|NCT00178646|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5997756|NCT00178646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5997757|NCT00178841|Rosiglitazone|rosiglitazone|mesh-list
5997758|NCT00178841|Bexarotene|bexarotene|mesh-list
5997759|NCT00178841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5997760|NCT00178841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997761|NCT00178841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5997762|NCT00178919|Trimethaphan|trimethaphan|mesh-list
5997763|NCT00178919|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
5997764|NCT00178919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997765|NCT00178919|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5997766|NCT00178919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5997767|NCT00178919|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
5997768|NCT00178919|Autonomic Agents|autonomic agents|mesh-ancestor
5997769|NCT00178919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5997770|NCT00178919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997771|NCT00178919|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
5997772|NCT00178919|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5997773|NCT00178919|Cholinergic Agents|cholinergic agents|mesh-ancestor
5997774|NCT00178919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5997775|NCT00178919|Vasodilator Agents|vasodilator agents|mesh-ancestor
5997776|NCT00179010|Adenosine|adenosine|mesh-list
5997777|NCT00179010|Analgesics|analgesics|mesh-ancestor
5997778|NCT00179010|Sensory System Agents|sensory system agents|mesh-ancestor
5997779|NCT00179010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5997780|NCT00179010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997781|NCT00179010|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5997782|NCT00179010|Vasodilator Agents|vasodilator agents|mesh-ancestor
5997783|NCT00179010|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5997784|NCT00179010|Purinergic Agonists|purinergic agonists|mesh-ancestor
5997785|NCT00179010|Purinergic Agents|purinergic agents|mesh-ancestor
5997786|NCT00179010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5997787|NCT00179010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997788|NCT00179309|Docetaxel|docetaxel|mesh-list
5997789|NCT00179309|Sargramostim|sargramostim|mesh-list
5997790|NCT00179309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5997791|NCT00179309|Tubulin Modulators|tubulin modulators|mesh-ancestor
5997792|NCT00179309|Antimitotic Agents|antimitotic agents|mesh-ancestor
5997793|NCT00179309|Mitosis Modulators|mitosis modulators|mesh-ancestor
5997794|NCT00179309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997795|NCT00179309|Immunologic Factors|immunologic factors|mesh-ancestor
5997796|NCT00179309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997797|NCT00179413|Interferons|interferons|mesh-list
5997798|NCT00179413|Interferon-alpha|interferon-alpha|mesh-list
5997799|NCT00179413|Interferon alpha-2|interferon alpha-2|mesh-list
5997800|NCT00179413|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
5997801|NCT00179413|Colchicine|colchicine|mesh-list
5997802|NCT00179413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5997803|NCT00179413|Antiviral Agents|antiviral agents|mesh-ancestor
5997804|NCT00179413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5997805|NCT00179413|Immunologic Factors|immunologic factors|mesh-ancestor
5997806|NCT00179413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997807|NCT00179413|Gout Suppressants|gout suppressants|mesh-ancestor
5997808|NCT00179413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5997809|NCT00179413|Tubulin Modulators|tubulin modulators|mesh-ancestor
5997810|NCT00179413|Antimitotic Agents|antimitotic agents|mesh-ancestor
5997811|NCT00179413|Mitosis Modulators|mitosis modulators|mesh-ancestor
5997812|NCT00179413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997813|NCT00179478|Interferons|interferons|mesh-list
5997814|NCT00179478|Interferon-beta|interferon-beta|mesh-list
5997815|NCT00179478|Interferon beta-1a|interferon beta-1a|mesh-list
5997816|NCT00179478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5997817|NCT00179478|Antiviral Agents|antiviral agents|mesh-ancestor
5997818|NCT00179478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5997819|NCT00179478|Immunologic Factors|immunologic factors|mesh-ancestor
5997820|NCT00179478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997821|NCT00179478|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5997822|NCT00179517|Anastrozole|anastrozole|mesh-list
5997823|NCT00179517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5997824|NCT00179517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5997825|NCT00179517|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5997826|NCT00179517|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5997827|NCT00179517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5997828|NCT00179517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997829|NCT00179517|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5997830|NCT00179517|Hormone Antagonists|hormone antagonists|mesh-ancestor
5997831|NCT00179517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5997832|NCT00179517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997833|NCT00179621|Lenalidomide|lenalidomide|mesh-list
5997834|NCT00179621|Immunologic Factors|immunologic factors|mesh-ancestor
5997835|NCT00179621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997836|NCT00179621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5997837|NCT00179621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5997838|NCT00179621|Growth Substances|growth substances|mesh-ancestor
5997839|NCT00179621|Growth Inhibitors|growth inhibitors|mesh-ancestor
5997840|NCT00179621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5997841|NCT00179647|Dexamethasone|dexamethasone|mesh-list
5997842|NCT00179647|Lenalidomide|lenalidomide|mesh-list
5997843|NCT00179647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5997844|NCT00179647|Antiemetics|antiemetics|mesh-ancestor
5997845|NCT00179647|Autonomic Agents|autonomic agents|mesh-ancestor
5997846|NCT00179647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5997847|NCT00179647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997848|NCT00179647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5997849|NCT00179647|Glucocorticoids|glucocorticoids|mesh-ancestor
5997850|NCT00179647|Hormones|hormones|mesh-ancestor
5997851|NCT00179647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5997852|NCT00179647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5997853|NCT00179647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5997854|NCT00179647|Immunologic Factors|immunologic factors|mesh-ancestor
5997855|NCT00179647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5997856|NCT00179647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5997857|NCT00179647|Growth Substances|growth substances|mesh-ancestor
5997858|NCT00179647|Growth Inhibitors|growth inhibitors|mesh-ancestor
5997859|NCT00179660|Lenalidomide|lenalidomide|mesh-list
5997860|NCT00179660|Immunologic Factors|immunologic factors|mesh-ancestor
5997861|NCT00179660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997862|NCT00179660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5997863|NCT00179660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5997864|NCT00179660|Growth Substances|growth substances|mesh-ancestor
5997865|NCT00179660|Growth Inhibitors|growth inhibitors|mesh-ancestor
5997866|NCT00179660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5997867|NCT00179673|Lenalidomide|lenalidomide|mesh-list
5997868|NCT00179673|Immunologic Factors|immunologic factors|mesh-ancestor
5997869|NCT00179673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997870|NCT00179673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5997871|NCT00179673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5997872|NCT00179673|Growth Substances|growth substances|mesh-ancestor
5997873|NCT00179673|Growth Inhibitors|growth inhibitors|mesh-ancestor
5997874|NCT00179673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5997875|NCT00179959|Mupirocin|mupirocin|mesh-list
6259414|NCT03118466|Growth Inhibitors|growth inhibitors|mesh-ancestor
6259415|NCT03118466|Analgesics|analgesics|mesh-ancestor
6259416|NCT03118466|Sensory System Agents|sensory system agents|mesh-ancestor
6259417|NCT03118466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6259418|NCT03118518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
6259419|NCT03118739|Febuxostat|febuxostat|mesh-list
6259420|NCT03118739|Verinurad|verinurad|mesh-list
6259421|NCT03118739|Gout Suppressants|gout suppressants|mesh-ancestor
6259422|NCT03118739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6259423|NCT03118765|Bromides|bromides|mesh-list
6259424|NCT03118765|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6259425|NCT03118765|Tiotropium Bromide|tiotropium bromide|mesh-list
6259426|NCT03118765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6259427|NCT03118765|Autonomic Agents|autonomic agents|mesh-ancestor
6259428|NCT03118765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6259429|NCT03118765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259430|NCT03118765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6259431|NCT03118765|Respiratory System Agents|respiratory system agents|mesh-ancestor
6259432|NCT03118765|Parasympatholytics|parasympatholytics|mesh-ancestor
6259433|NCT03118765|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6259434|NCT03118765|Cholinergic Agents|cholinergic agents|mesh-ancestor
6259435|NCT03118765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6259436|NCT03118765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259437|NCT03118765|Anticonvulsants|anticonvulsants|mesh-ancestor
6259438|NCT03118843|Velpatasvir|velpatasvir|mesh-list
6259439|NCT03118843|Antiviral Agents|antiviral agents|mesh-ancestor
6259440|NCT03118843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6259441|NCT03118947|Pimavanserin|pimavanserin|mesh-list
6259442|NCT03118947|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6259443|NCT03118947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6259444|NCT03118947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6259445|NCT03118947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6259446|NCT03118947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5997876|NCT00179959|Sodium Hypochlorite|sodium hypochlorite|mesh-list
5997877|NCT00179959|Eusol|eusol|mesh-list
5997878|NCT00179959|Petrolatum|petrolatum|mesh-list
6259447|NCT03118947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997879|NCT00179959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5997880|NCT00179959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5997881|NCT00179959|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5997882|NCT00179959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5997883|NCT00179959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997884|NCT00179959|Disinfectants|disinfectants|mesh-ancestor
5997885|NCT00179959|Emollients|emollients|mesh-ancestor
5997886|NCT00179959|Dermatologic Agents|dermatologic agents|mesh-ancestor
5997887|NCT00180479|Paclitaxel|paclitaxel|mesh-list
5997888|NCT00180479|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5997889|NCT00180479|Everolimus|everolimus|mesh-list
5997890|NCT00180479|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5997891|NCT00180479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5997892|NCT00180479|Tubulin Modulators|tubulin modulators|mesh-ancestor
5997893|NCT00180479|Antimitotic Agents|antimitotic agents|mesh-ancestor
5997894|NCT00180479|Mitosis Modulators|mitosis modulators|mesh-ancestor
5997895|NCT00180479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997896|NCT00180479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5997897|NCT00180479|Immunologic Factors|immunologic factors|mesh-ancestor
5997898|NCT00180479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997899|NCT00180674|Warfarin|warfarin|mesh-list
5997900|NCT00180674|Anticoagulants|anticoagulants|mesh-ancestor
5997901|NCT00180687|Bupivacaine|bupivacaine|mesh-list
5997902|NCT00180687|Coal Tar|coal tar|mesh-list
5997903|NCT00180687|Anesthetics, Local|anesthetics, local|mesh-ancestor
5997904|NCT00180687|Anesthetics|anesthetics|mesh-ancestor
5997905|NCT00180687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5997906|NCT00180687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997907|NCT00180687|Sensory System Agents|sensory system agents|mesh-ancestor
5997908|NCT00180687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5997909|NCT00180687|Keratolytic Agents|keratolytic agents|mesh-ancestor
5997910|NCT00180687|Dermatologic Agents|dermatologic agents|mesh-ancestor
5997911|NCT00180713|Simvastatin|simvastatin|mesh-list
5997912|NCT00180713|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5997913|NCT00180713|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5997914|NCT00180713|Antimetabolites|antimetabolites|mesh-ancestor
5997915|NCT00180713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997916|NCT00180713|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5997917|NCT00180713|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5997918|NCT00180713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5997919|NCT00181155|Allopurinol|allopurinol|mesh-list
5997920|NCT00181155|Antimetabolites|antimetabolites|mesh-ancestor
5997921|NCT00181155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997922|NCT00181155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5997923|NCT00181155|Gout Suppressants|gout suppressants|mesh-ancestor
5997924|NCT00181155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5997925|NCT00181155|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5997926|NCT00181155|Antioxidants|antioxidants|mesh-ancestor
5997927|NCT00181155|Protective Agents|protective agents|mesh-ancestor
5997928|NCT00181155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997929|NCT00181714|Methylphenidate|methylphenidate|mesh-list
5997930|NCT00181714|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5997931|NCT00181714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997932|NCT00181714|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5997933|NCT00181714|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5997934|NCT00181714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5997935|NCT00181714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997936|NCT00181714|Dopamine Agents|dopamine agents|mesh-ancestor
5997937|NCT00181714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5997938|NCT00181766|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
5997939|NCT00181766|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5997940|NCT00181766|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5997941|NCT00181766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5997942|NCT00181766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997943|NCT00181766|Adrenergic Agents|adrenergic agents|mesh-ancestor
5997944|NCT00181766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5997945|NCT00181766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997946|NCT00181844|Lamotrigine|lamotrigine|mesh-list
5997947|NCT00181844|Anticonvulsants|anticonvulsants|mesh-ancestor
5997948|NCT00181844|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5997949|NCT00181844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5997950|NCT00181844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997951|NCT00181844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6259448|NCT03118947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5997952|NCT00181844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997953|NCT00181844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5997954|NCT00181844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5997955|NCT00181844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5997956|NCT00181844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5997957|NCT00181844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5997958|NCT00181883|Quetiapine Fumarate|quetiapine fumarate|mesh-list
5997959|NCT00181883|Antidepressive Agents|antidepressive agents|mesh-ancestor
5997960|NCT00181883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5997961|NCT00181883|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5997962|NCT00181883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5997963|NCT00181883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5997964|NCT00181883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997965|NCT00182000|Cycloserine|cycloserine|mesh-list
5997966|NCT00182000|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5997967|NCT00182000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5997968|NCT00182000|Renal Agents|renal agents|mesh-ancestor
5997969|NCT00182000|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5997970|NCT00182000|Antitubercular Agents|antitubercular agents|mesh-ancestor
5997971|NCT00182000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5997972|NCT00182000|Antimetabolites|antimetabolites|mesh-ancestor
5997973|NCT00182000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997974|NCT00182078|Sertraline|sertraline|mesh-list
5997975|NCT00182078|Antidepressive Agents|antidepressive agents|mesh-ancestor
5997976|NCT00182078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5997977|NCT00182078|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5997978|NCT00182078|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5997979|NCT00182078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5997980|NCT00182078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997981|NCT00182078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5997982|NCT00182078|Serotonin Agents|serotonin agents|mesh-ancestor
5997983|NCT00182078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997984|NCT00182091|Hormones|hormones|mesh-list
5997985|NCT00182091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5997986|NCT00182091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5997987|NCT00182689|Sorafenib|sorafenib|mesh-list
5997988|NCT00182689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5997989|NCT00182689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5997990|NCT00182689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5997991|NCT00182689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5997992|NCT00182754|Octreotide|octreotide|mesh-list
5997993|NCT00182754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5997994|NCT00182754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5997995|NCT00182754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5997996|NCT00182767|Doxorubicin|doxorubicin|mesh-list
5997997|NCT00182767|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5997998|NCT00182767|Epothilone B|epothilone b|mesh-list
5997999|NCT00182767|Epothilones|epothilones|mesh-list
5998000|NCT00182767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5998001|NCT00182767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5998002|NCT00182767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5998003|NCT00182767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5998004|NCT00182767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5998005|NCT00182767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5998006|NCT00182767|Tubulin Modulators|tubulin modulators|mesh-ancestor
5998007|NCT00182767|Antimitotic Agents|antimitotic agents|mesh-ancestor
5998008|NCT00182767|Mitosis Modulators|mitosis modulators|mesh-ancestor
5998009|NCT00182793|Cyclophosphamide|cyclophosphamide|mesh-list
5998010|NCT00182793|Melphalan|melphalan|mesh-list
5998011|NCT00182793|Thiotepa|thiotepa|mesh-list
5998012|NCT00182793|Carboplatin|carboplatin|mesh-list
5998013|NCT00182793|Trastuzumab|trastuzumab|mesh-list
5998014|NCT00182793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5998015|NCT00182793|Immunologic Factors|immunologic factors|mesh-ancestor
5998016|NCT00182793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998017|NCT00182793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5998018|NCT00182793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5998019|NCT00182793|Alkylating Agents|alkylating agents|mesh-ancestor
5998020|NCT00182793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5998021|NCT00182793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5998022|NCT00182793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5998023|NCT00182793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5998024|NCT00183092|Quinacrine|quinacrine|mesh-list
5998025|NCT00183092|Anticestodal Agents|anticestodal agents|mesh-ancestor
5998026|NCT00183092|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5998027|NCT00183092|Anthelmintics|anthelmintics|mesh-ancestor
5998028|NCT00183092|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5998029|NCT00183092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5998030|NCT00183092|Antimalarials|antimalarials|mesh-ancestor
5998031|NCT00183092|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5998032|NCT00183092|Antinematodal Agents|antinematodal agents|mesh-ancestor
5998033|NCT00183092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5998034|NCT00183092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5998035|NCT00183092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5998036|NCT00183196|Naltrexone|naltrexone|mesh-list
5998037|NCT00183196|Gabapentin|gabapentin|mesh-list
5998038|NCT00183196|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5998039|NCT00183196|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5998040|NCT00183196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998041|NCT00183196|Sensory System Agents|sensory system agents|mesh-ancestor
5998042|NCT00183196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5998043|NCT00183196|Analgesics|analgesics|mesh-ancestor
5998044|NCT00183196|Anticonvulsants|anticonvulsants|mesh-ancestor
5998045|NCT00183196|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5998046|NCT00183196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5998047|NCT00183196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5998048|NCT00183196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5998049|NCT00183196|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5998050|NCT00183196|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5998051|NCT00183196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5998052|NCT00183196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5998053|NCT00183196|Antimanic Agents|antimanic agents|mesh-ancestor
5998054|NCT00183248|Mycophenolic Acid|mycophenolic acid|mesh-list
5998055|NCT00183248|Sirolimus|sirolimus|mesh-list
5998056|NCT00183248|Alemtuzumab|alemtuzumab|mesh-list
5998057|NCT00183248|Tacrolimus|tacrolimus|mesh-list
5998058|NCT00183248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5998059|NCT00183248|Immunologic Factors|immunologic factors|mesh-ancestor
5998060|NCT00183248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998061|NCT00183248|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5998062|NCT00183248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5998063|NCT00183248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5998064|NCT00183248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5998065|NCT00183248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5998066|NCT00183248|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5998067|NCT00183248|Antitubercular Agents|antitubercular agents|mesh-ancestor
5998068|NCT00183248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5998069|NCT00183248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5998070|NCT00183248|Antifungal Agents|antifungal agents|mesh-ancestor
5998071|NCT00183248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5998072|NCT00183274|Norepinephrine|norepinephrine|mesh-list
5998073|NCT00183274|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
5998074|NCT00183274|Serotonin|serotonin|mesh-list
5998075|NCT00183274|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
5998076|NCT00183274|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5998077|NCT00183274|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5998078|NCT00183274|Adrenergic Agents|adrenergic agents|mesh-ancestor
5998079|NCT00183274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5998080|NCT00183274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5998081|NCT00183274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998082|NCT00183274|Sympathomimetics|sympathomimetics|mesh-ancestor
5998083|NCT00183274|Autonomic Agents|autonomic agents|mesh-ancestor
5998084|NCT00183274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5998085|NCT00183274|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5998086|NCT00183274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5998087|NCT00183274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5998088|NCT00183274|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5998089|NCT00183274|Antidepressive Agents|antidepressive agents|mesh-ancestor
5998090|NCT00183274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5998091|NCT00183274|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5998092|NCT00183274|Serotonin Agents|serotonin agents|mesh-ancestor
5998093|NCT00183339|Fluoxetine|fluoxetine|mesh-list
5998094|NCT00183339|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5998095|NCT00183339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5998096|NCT00183339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5998097|NCT00183339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5998098|NCT00183339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5998099|NCT00183339|Serotonin Agents|serotonin agents|mesh-ancestor
5998100|NCT00183339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998101|NCT00183339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5998102|NCT00183339|Antidepressive Agents|antidepressive agents|mesh-ancestor
5998103|NCT00183339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5998104|NCT00183339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5998105|NCT00183339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5998106|NCT00183339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5998107|NCT00183391|Methylphenidate|methylphenidate|mesh-list
5998108|NCT00183391|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
5998109|NCT00183391|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5998110|NCT00183391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998111|NCT00183391|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5998112|NCT00183391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5998113|NCT00183391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5998114|NCT00183391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5998115|NCT00183391|Dopamine Agents|dopamine agents|mesh-ancestor
5998116|NCT00183391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5998117|NCT00183391|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5998118|NCT00183391|Adrenergic Agents|adrenergic agents|mesh-ancestor
5998119|NCT00183430|Prazosin|prazosin|mesh-list
5998120|NCT00183430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5998121|NCT00183430|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6259449|NCT03118947|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6259450|NCT03118947|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6259451|NCT03118947|Serotonin Agents|serotonin agents|mesh-ancestor
6259452|NCT03118947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6259453|NCT03118947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259454|NCT03119168|Simethicone|simethicone|mesh-list
6259455|NCT03119168|Antifoaming Agents|antifoaming agents|mesh-ancestor
6259456|NCT03119168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259457|NCT03119168|Emollients|emollients|mesh-ancestor
6259458|NCT03119168|Dermatologic Agents|dermatologic agents|mesh-ancestor
6259459|NCT03119181|Lidocaine|lidocaine|mesh-list
6259460|NCT03119181|Epinephrine|epinephrine|mesh-list
6259461|NCT03119181|Racepinephrine|racepinephrine|mesh-list
6259462|NCT03119181|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6259463|NCT03119181|Epinephryl borate|epinephryl borate|mesh-list
6259464|NCT03119181|Anesthetics, Local|anesthetics, local|mesh-ancestor
6259465|NCT03119181|Anesthetics|anesthetics|mesh-ancestor
6259466|NCT03119181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6259467|NCT03119181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259468|NCT03119181|Sensory System Agents|sensory system agents|mesh-ancestor
6259469|NCT03119181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6259470|NCT03119181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6259471|NCT03119181|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6259472|NCT03119181|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6259473|NCT03119181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6259474|NCT03119181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259475|NCT03119181|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6259476|NCT03119181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6259477|NCT03119181|Adrenergic Agents|adrenergic agents|mesh-ancestor
6259478|NCT03119181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6259479|NCT03119181|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6259480|NCT03119181|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6259481|NCT03119181|Autonomic Agents|autonomic agents|mesh-ancestor
6259482|NCT03119181|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6259483|NCT03119181|Respiratory System Agents|respiratory system agents|mesh-ancestor
6259484|NCT03119181|Mydriatics|mydriatics|mesh-ancestor
6259485|NCT03119181|Sympathomimetics|sympathomimetics|mesh-ancestor
6259486|NCT03119181|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6259487|NCT03119610|Oxytocin|oxytocin|mesh-list
6259488|NCT03119610|Oxytocics|oxytocics|mesh-ancestor
6259489|NCT03119610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6259490|NCT03119610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259491|NCT03119701|Interferons|interferons|mesh-list
6259492|NCT03119701|Interferon-beta|interferon-beta|mesh-list
6259493|NCT03119701|Interferon beta-1a|interferon beta-1a|mesh-list
6259494|NCT03119701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6259495|NCT03119701|Antiviral Agents|antiviral agents|mesh-ancestor
6259496|NCT03119701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6259497|NCT03119701|Immunologic Factors|immunologic factors|mesh-ancestor
6259498|NCT03119701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259499|NCT03119701|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6259500|NCT03119831|Ethanol|ethanol|mesh-list
6259501|NCT03119831|Chlorhexidine|chlorhexidine|mesh-list
6259502|NCT03119831|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6259503|NCT03119831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6259504|NCT03119831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6259505|NCT03119831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6259506|NCT03119831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259507|NCT03119831|Disinfectants|disinfectants|mesh-ancestor
6259508|NCT03119831|Dermatologic Agents|dermatologic agents|mesh-ancestor
6259509|NCT03120351|Lidocaine|lidocaine|mesh-list
6259510|NCT03120351|Anesthetics, Local|anesthetics, local|mesh-ancestor
6259511|NCT03120351|Anesthetics|anesthetics|mesh-ancestor
6259512|NCT03120351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6259513|NCT03120351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259514|NCT03120351|Sensory System Agents|sensory system agents|mesh-ancestor
6259515|NCT03120351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6259516|NCT03120351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6259517|NCT03120351|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6259518|NCT03120351|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6259519|NCT03120351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6259520|NCT03120351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389848|NCT00189553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5998122|NCT00183430|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5998123|NCT00183430|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5998124|NCT00183430|Adrenergic Agents|adrenergic agents|mesh-ancestor
5998125|NCT00183430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5998126|NCT00183430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5998127|NCT00183430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998128|NCT00183443|Valproic Acid|valproic acid|mesh-list
5998129|NCT00183443|Quetiapine Fumarate|quetiapine fumarate|mesh-list
5998130|NCT00183443|Antidepressive Agents|antidepressive agents|mesh-ancestor
5998131|NCT00183443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5998132|NCT00183443|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5998133|NCT00183443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5998134|NCT00183443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5998135|NCT00183443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998136|NCT00183443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5998137|NCT00183443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5998138|NCT00183443|Antimanic Agents|antimanic agents|mesh-ancestor
5998139|NCT00183443|Anticonvulsants|anticonvulsants|mesh-ancestor
5998140|NCT00183443|GABA Agents|gaba agents|mesh-ancestor
5998141|NCT00183443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5998142|NCT00183469|Lamotrigine|lamotrigine|mesh-list
5998143|NCT00183469|Valproic Acid|valproic acid|mesh-list
5998144|NCT00183469|Anticonvulsants|anticonvulsants|mesh-ancestor
5998145|NCT00183469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5998146|NCT00183469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5998147|NCT00183469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5998148|NCT00183469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5998149|NCT00183469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998150|NCT00183469|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5998151|NCT00183469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5998152|NCT00183469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5998153|NCT00183469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5998154|NCT00183469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5998155|NCT00183469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5998156|NCT00183469|GABA Agents|gaba agents|mesh-ancestor
5998157|NCT00183469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5998158|NCT00183469|Antimanic Agents|antimanic agents|mesh-ancestor
5998159|NCT00183625|Olanzapine|olanzapine|mesh-list
5998160|NCT00183625|Risperidone|risperidone|mesh-list
5998161|NCT00183625|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5998162|NCT00183625|Serotonin Agents|serotonin agents|mesh-ancestor
5998163|NCT00183625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5998164|NCT00183625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5998165|NCT00183625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998166|NCT00183625|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5998167|NCT00183625|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5998168|NCT00183625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5998169|NCT00183625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5998170|NCT00183625|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5998171|NCT00183625|Dopamine Agents|dopamine agents|mesh-ancestor
5998172|NCT00183625|Antiemetics|antiemetics|mesh-ancestor
5998173|NCT00183625|Autonomic Agents|autonomic agents|mesh-ancestor
5998174|NCT00183625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5998175|NCT00183625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5998176|NCT00183625|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5998177|NCT00183625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5998178|NCT00183625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5998179|NCT00183677|Citalopram|citalopram|mesh-list
5998180|NCT00183677|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5998181|NCT00183677|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5998182|NCT00183677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5998183|NCT00183677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5998184|NCT00183677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5998185|NCT00183677|Serotonin Agents|serotonin agents|mesh-ancestor
5998186|NCT00183677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998187|NCT00183677|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5998188|NCT00183677|Antidepressive Agents|antidepressive agents|mesh-ancestor
5998189|NCT00183677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5998190|NCT00183729|Memantine|memantine|mesh-list
5998191|NCT00183729|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5998192|NCT00183729|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5998193|NCT00183729|Dopamine Agents|dopamine agents|mesh-ancestor
5998194|NCT00183729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5998195|NCT00183729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5998196|NCT00183729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998197|NCT00183729|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5998198|NCT00183729|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5998199|NCT00183794|Gemcitabine|gemcitabine|mesh-list
5998200|NCT00183794|Docetaxel|docetaxel|mesh-list
5998201|NCT00183794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5998202|NCT00183794|Antimetabolites|antimetabolites|mesh-ancestor
5998203|NCT00183794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5998204|NCT00183794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5998205|NCT00183794|Antiviral Agents|antiviral agents|mesh-ancestor
5998206|NCT00183794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5998207|NCT00183794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5998208|NCT00183794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5998209|NCT00183794|Immunologic Factors|immunologic factors|mesh-ancestor
5998210|NCT00183794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998211|NCT00183794|Tubulin Modulators|tubulin modulators|mesh-ancestor
5998212|NCT00183794|Antimitotic Agents|antimitotic agents|mesh-ancestor
5998213|NCT00183794|Mitosis Modulators|mitosis modulators|mesh-ancestor
5998214|NCT00183872|Docetaxel|docetaxel|mesh-list
5998215|NCT00183872|Irinotecan|irinotecan|mesh-list
5998216|NCT00183872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5998217|NCT00183872|Tubulin Modulators|tubulin modulators|mesh-ancestor
5998218|NCT00183872|Antimitotic Agents|antimitotic agents|mesh-ancestor
5998219|NCT00183872|Mitosis Modulators|mitosis modulators|mesh-ancestor
5998220|NCT00183872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5998221|NCT00183872|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5998222|NCT00183872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5998223|NCT00183872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5998224|NCT00184002|Prednisone|prednisone|mesh-list
5998225|NCT00184002|Cyclophosphamide|cyclophosphamide|mesh-list
5998226|NCT00184002|Doxorubicin|doxorubicin|mesh-list
5998227|NCT00184002|Vincristine|vincristine|mesh-list
5998228|NCT00184002|Rituximab|rituximab|mesh-list
5998229|NCT00184002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5998230|NCT00184002|Immunologic Factors|immunologic factors|mesh-ancestor
5998231|NCT00184002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998232|NCT00184002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5998233|NCT00184002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5998234|NCT00184002|Alkylating Agents|alkylating agents|mesh-ancestor
5998235|NCT00184002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5998236|NCT00184002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5998237|NCT00184002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5998238|NCT00184002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5998239|NCT00184002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5998240|NCT00184002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5998241|NCT00184002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5998242|NCT00184002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5998243|NCT00184002|Glucocorticoids|glucocorticoids|mesh-ancestor
5998244|NCT00184002|Hormones|hormones|mesh-ancestor
5998245|NCT00184002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5998246|NCT00184002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5998247|NCT00184002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5998248|NCT00184002|Tubulin Modulators|tubulin modulators|mesh-ancestor
5998249|NCT00184002|Antimitotic Agents|antimitotic agents|mesh-ancestor
5998250|NCT00184002|Mitosis Modulators|mitosis modulators|mesh-ancestor
5998251|NCT00184002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5998252|NCT00184028|Oxaliplatin|oxaliplatin|mesh-list
5998253|NCT00184028|Docetaxel|docetaxel|mesh-list
5998254|NCT00184028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5998255|NCT00184028|Tubulin Modulators|tubulin modulators|mesh-ancestor
5998256|NCT00184028|Antimitotic Agents|antimitotic agents|mesh-ancestor
5998257|NCT00184028|Mitosis Modulators|mitosis modulators|mesh-ancestor
5998258|NCT00184028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5998259|NCT00184054|Ascorbic Acid|ascorbic acid|mesh-list
5998260|NCT00184054|Arsenic Trioxide|arsenic trioxide|mesh-list
5998261|NCT00184054|Vitamins|vitamins|mesh-ancestor
5998262|NCT00184054|Micronutrients|micronutrients|mesh-ancestor
5998263|NCT00184054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998264|NCT00184054|Antioxidants|antioxidants|mesh-ancestor
5998265|NCT00184054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5998266|NCT00184054|Protective Agents|protective agents|mesh-ancestor
5998267|NCT00184054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5998268|NCT00184093|Gemcitabine|gemcitabine|mesh-list
5998269|NCT00184093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5998270|NCT00184093|Antimetabolites|antimetabolites|mesh-ancestor
5998271|NCT00184093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5998272|NCT00184093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5998273|NCT00184093|Antiviral Agents|antiviral agents|mesh-ancestor
5998274|NCT00184093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5998275|NCT00184093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5998276|NCT00184093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5998277|NCT00184093|Immunologic Factors|immunologic factors|mesh-ancestor
5998278|NCT00184093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998279|NCT00184600|Insulin|insulin|mesh-list
5998280|NCT00184600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5998281|NCT00184600|Insulin Aspart|insulin aspart|mesh-list
5998282|NCT00184600|Insulin, Long-Acting|insulin, long-acting|mesh-list
5998283|NCT00184600|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
5998284|NCT00184600|Insulin Detemir|insulin detemir|mesh-list
5998285|NCT00184600|Biphasic Insulins|biphasic insulins|mesh-list
5998286|NCT00184600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5998287|NCT00184600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998288|NCT00185211|Interferons|interferons|mesh-list
5998289|NCT00185211|Interferon-beta|interferon-beta|mesh-list
5998290|NCT00185211|Interferon beta-1b|interferon beta-1b|mesh-list
5998291|NCT00185211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5998292|NCT00185211|Antiviral Agents|antiviral agents|mesh-ancestor
5998293|NCT00185211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5998294|NCT00185211|Immunologic Factors|immunologic factors|mesh-ancestor
5998295|NCT00185211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998296|NCT00185211|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5998297|NCT00185380|Levonorgestrel|levonorgestrel|mesh-list
5998298|NCT00185380|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5998299|NCT00185380|Contraceptive Agents|contraceptive agents|mesh-ancestor
5998300|NCT00185380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5998301|NCT00185380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998302|NCT00185380|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5998303|NCT00185380|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5998304|NCT00185380|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5998305|NCT00185588|Gemcitabine|gemcitabine|mesh-list
5998306|NCT00185588|Vatalanib|vatalanib|mesh-list
5998307|NCT00185588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5998308|NCT00185588|Antimetabolites|antimetabolites|mesh-ancestor
5998309|NCT00185588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5998310|NCT00185588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5998311|NCT00185588|Antiviral Agents|antiviral agents|mesh-ancestor
5998312|NCT00185588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5998313|NCT00185588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5998314|NCT00185588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5998315|NCT00185588|Immunologic Factors|immunologic factors|mesh-ancestor
5998316|NCT00185588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998317|NCT00185588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5998318|NCT00185614|Cyclosporine|cyclosporine|mesh-list
5998319|NCT00185614|Mycophenolic Acid|mycophenolic acid|mesh-list
5998320|NCT00185614|Cyclophosphamide|cyclophosphamide|mesh-list
5998321|NCT00185614|Melphalan|melphalan|mesh-list
5998322|NCT00185614|Cyclosporins|cyclosporins|mesh-list
5998323|NCT00185614|Lenograstim|lenograstim|mesh-list
5998324|NCT00185614|Sargramostim|sargramostim|mesh-list
5998325|NCT00185614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5998326|NCT00185614|Immunologic Factors|immunologic factors|mesh-ancestor
5998327|NCT00185614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998328|NCT00185614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5998329|NCT00185614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5998330|NCT00185614|Alkylating Agents|alkylating agents|mesh-ancestor
5998331|NCT00185614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5998332|NCT00185614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5998333|NCT00185614|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5998334|NCT00185614|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5998335|NCT00185614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5998336|NCT00185614|Antifungal Agents|antifungal agents|mesh-ancestor
5998337|NCT00185614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5998338|NCT00185614|Dermatologic Agents|dermatologic agents|mesh-ancestor
5998339|NCT00185614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5998340|NCT00185614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5998341|NCT00185614|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5998342|NCT00185614|Antitubercular Agents|antitubercular agents|mesh-ancestor
5998343|NCT00185614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5998344|NCT00185640|Cyclosporine|cyclosporine|mesh-list
5998345|NCT00185640|Mycophenolic Acid|mycophenolic acid|mesh-list
5998346|NCT00185640|Lenograstim|lenograstim|mesh-list
6536436|NCT00817011|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6259521|NCT03120520|Plecanatide|plecanatide|mesh-list
6536437|NCT00817011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6536438|NCT00817011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5998347|NCT00185640|Cyclosporins|cyclosporins|mesh-list
5998348|NCT00185640|Sargramostim|sargramostim|mesh-list
5998349|NCT00185640|Thymoglobulin|thymoglobulin|mesh-list
5998350|NCT00185640|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5998351|NCT00185640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5998352|NCT00185640|Immunologic Factors|immunologic factors|mesh-ancestor
5998353|NCT00185640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998354|NCT00185640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5998355|NCT00185640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5998356|NCT00185640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5998357|NCT00185640|Antifungal Agents|antifungal agents|mesh-ancestor
5998358|NCT00185640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5998359|NCT00185640|Dermatologic Agents|dermatologic agents|mesh-ancestor
5998360|NCT00185640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5998361|NCT00185640|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5998362|NCT00185640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5998363|NCT00185640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5998364|NCT00185640|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5998365|NCT00185640|Antitubercular Agents|antitubercular agents|mesh-ancestor
5998366|NCT00185640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5998367|NCT00185692|Acetaminophen|acetaminophen|mesh-list
5998368|NCT00185692|Cyclosporine|cyclosporine|mesh-list
5998369|NCT00185692|Mycophenolic Acid|mycophenolic acid|mesh-list
5998370|NCT00185692|Methylprednisolone|methylprednisolone|mesh-list
5998371|NCT00185692|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5998372|NCT00185692|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5998373|NCT00185692|Prednisolone|prednisolone|mesh-list
5998374|NCT00185692|Prednisolone acetate|prednisolone acetate|mesh-list
5998375|NCT00185692|Hydrocortisone|hydrocortisone|mesh-list
5998376|NCT00185692|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
5998377|NCT00185692|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
5998378|NCT00185692|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
5998379|NCT00185692|Cyclosporins|cyclosporins|mesh-list
5998380|NCT00185692|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5998381|NCT00185692|Lenograstim|lenograstim|mesh-list
5998382|NCT00185692|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5998383|NCT00185692|Prednisolone phosphate|prednisolone phosphate|mesh-list
5998384|NCT00185692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5998385|NCT00185692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5998386|NCT00185692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5998387|NCT00185692|Immunologic Factors|immunologic factors|mesh-ancestor
5998388|NCT00185692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998389|NCT00185692|Antifungal Agents|antifungal agents|mesh-ancestor
5998390|NCT00185692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5998391|NCT00185692|Dermatologic Agents|dermatologic agents|mesh-ancestor
5998392|NCT00185692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5998393|NCT00185692|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5998394|NCT00185692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5998395|NCT00185692|Analgesics|analgesics|mesh-ancestor
5998396|NCT00185692|Sensory System Agents|sensory system agents|mesh-ancestor
5998397|NCT00185692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5998398|NCT00185692|Antipyretics|antipyretics|mesh-ancestor
5998399|NCT00185692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5998400|NCT00185692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5998401|NCT00185692|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5998402|NCT00185692|Antitubercular Agents|antitubercular agents|mesh-ancestor
5998403|NCT00185692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5998404|NCT00185692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5998405|NCT00185692|Antiemetics|antiemetics|mesh-ancestor
5998406|NCT00185692|Autonomic Agents|autonomic agents|mesh-ancestor
5998407|NCT00185692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5998408|NCT00185692|Glucocorticoids|glucocorticoids|mesh-ancestor
5998409|NCT00185692|Hormones|hormones|mesh-ancestor
5998410|NCT00185692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5998411|NCT00185692|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5998412|NCT00185692|Protective Agents|protective agents|mesh-ancestor
5998413|NCT00185692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5998414|NCT00185692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5998415|NCT00185731|Atorvastatin|atorvastatin|mesh-list
5998416|NCT00185731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5998417|NCT00185731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5998418|NCT00185731|Antimetabolites|antimetabolites|mesh-ancestor
5998419|NCT00185731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5998420|NCT00185731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5998421|NCT00185731|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5998422|NCT00185731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5998423|NCT00185900|Magnesium Sulfate|magnesium sulfate|mesh-list
5998424|NCT00185900|Nifedipine|nifedipine|mesh-list
5998425|NCT00185900|Analgesics|analgesics|mesh-ancestor
5998426|NCT00185900|Sensory System Agents|sensory system agents|mesh-ancestor
5998427|NCT00185900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5998428|NCT00185900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998429|NCT00185900|Anesthetics|anesthetics|mesh-ancestor
5998430|NCT00185900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5998431|NCT00185900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5998432|NCT00185900|Anticonvulsants|anticonvulsants|mesh-ancestor
5998433|NCT00185900|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5998434|NCT00185900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5998435|NCT00185900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5998436|NCT00185900|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5998437|NCT00185900|Tocolytic Agents|tocolytic agents|mesh-ancestor
5998438|NCT00185900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5998439|NCT00185900|Vasodilator Agents|vasodilator agents|mesh-ancestor
5998440|NCT00186017|Olanzapine|olanzapine|mesh-list
5998441|NCT00186017|Antiemetics|antiemetics|mesh-ancestor
5998442|NCT00186017|Autonomic Agents|autonomic agents|mesh-ancestor
5998443|NCT00186017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5998444|NCT00186017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998445|NCT00186017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5998446|NCT00186017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5998447|NCT00186017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5998448|NCT00186017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5998449|NCT00186017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5998450|NCT00186017|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5998451|NCT00186017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5998452|NCT00186017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5998453|NCT00186017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5998454|NCT00186017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5998455|NCT00186017|Serotonin Agents|serotonin agents|mesh-ancestor
5998456|NCT00186043|Quetiapine Fumarate|quetiapine fumarate|mesh-list
5998457|NCT00186043|Antidepressive Agents|antidepressive agents|mesh-ancestor
5998458|NCT00186043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5998459|NCT00186043|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5998460|NCT00186043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5998461|NCT00186043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5998462|NCT00186043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998463|NCT00186056|Mifepristone|mifepristone|mesh-list
5998464|NCT00186056|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5998465|NCT00186056|Abortifacient Agents|abortifacient agents|mesh-ancestor
5998466|NCT00186056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5998467|NCT00186056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998468|NCT00186056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5998469|NCT00186056|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5998470|NCT00186056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5998471|NCT00186056|Contraceptive Agents|contraceptive agents|mesh-ancestor
5998472|NCT00186056|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5998473|NCT00186056|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5998474|NCT00186056|Hormone Antagonists|hormone antagonists|mesh-ancestor
5998475|NCT00186056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5998476|NCT00186056|Luteolytic Agents|luteolytic agents|mesh-ancestor
5998477|NCT00186056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5998478|NCT00186056|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5998479|NCT00186069|Magnesium Sulfate|magnesium sulfate|mesh-list
5998480|NCT00186069|Analgesics|analgesics|mesh-ancestor
5998481|NCT00186069|Sensory System Agents|sensory system agents|mesh-ancestor
5998482|NCT00186069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5998483|NCT00186069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998484|NCT00186069|Anesthetics|anesthetics|mesh-ancestor
5998485|NCT00186069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5998486|NCT00186069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5998487|NCT00186069|Anticonvulsants|anticonvulsants|mesh-ancestor
5998488|NCT00186069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5998489|NCT00186069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5998490|NCT00186069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5998491|NCT00186069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5998492|NCT00186069|Tocolytic Agents|tocolytic agents|mesh-ancestor
5998493|NCT00186069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5998494|NCT00186121|Anastrozole|anastrozole|mesh-list
5998495|NCT00186121|Goserelin|goserelin|mesh-list
5998496|NCT00186121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5998497|NCT00186121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5998498|NCT00186121|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5998499|NCT00186121|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5998500|NCT00186121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5998501|NCT00186121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5998502|NCT00186121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5998503|NCT00186121|Hormone Antagonists|hormone antagonists|mesh-ancestor
5998504|NCT00186121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5998505|NCT00186121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998506|NCT00186186|Valproic Acid|valproic acid|mesh-list
5998507|NCT00186186|Anticonvulsants|anticonvulsants|mesh-ancestor
5998508|NCT00186186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5998509|NCT00186186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5998510|NCT00186186|GABA Agents|gaba agents|mesh-ancestor
5998511|NCT00186186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5998512|NCT00186186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998513|NCT00186186|Antimanic Agents|antimanic agents|mesh-ancestor
5998514|NCT00186186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5998515|NCT00186186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5998516|NCT00186186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5998517|NCT00186446|Bupropion|bupropion|mesh-list
5998518|NCT00186446|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5998519|NCT00186446|Antidepressive Agents|antidepressive agents|mesh-ancestor
5998520|NCT00186446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5998521|NCT00186446|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5998522|NCT00186446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5998523|NCT00186446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5998524|NCT00186446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5998525|NCT00186446|Dopamine Agents|dopamine agents|mesh-ancestor
5998526|NCT00186446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5998527|NCT00186446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998528|NCT00186446|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5998529|NCT00186446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5998530|NCT00186446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5998531|NCT00186498|Memantine|memantine|mesh-list
5998532|NCT00186498|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5998533|NCT00186498|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5998534|NCT00186498|Dopamine Agents|dopamine agents|mesh-ancestor
5998535|NCT00186498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5998536|NCT00186498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5998537|NCT00186498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998538|NCT00186498|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5998539|NCT00186498|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5998540|NCT00186537|Rosiglitazone|rosiglitazone|mesh-list
5998541|NCT00186537|Fenofibrate|fenofibrate|mesh-list
5998542|NCT00186537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5998543|NCT00186537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998544|NCT00186537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5998545|NCT00186537|Antimetabolites|antimetabolites|mesh-ancestor
5998546|NCT00186537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5998547|NCT00186537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5998548|NCT00186628|Acetaminophen|acetaminophen|mesh-list
5998549|NCT00186628|Diphenhydramine|diphenhydramine|mesh-list
5998550|NCT00186628|Promethazine|promethazine|mesh-list
5998551|NCT00186628|Cyclosporine|cyclosporine|mesh-list
5998552|NCT00186628|Hydrocortisone|hydrocortisone|mesh-list
5998553|NCT00186628|Methylprednisolone|methylprednisolone|mesh-list
5998554|NCT00186628|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5998555|NCT00186628|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5998556|NCT00186628|Prednisolone|prednisolone|mesh-list
5998557|NCT00186628|Prednisolone acetate|prednisolone acetate|mesh-list
5998558|NCT00186628|Rituximab|rituximab|mesh-list
5998559|NCT00186628|Granisetron|granisetron|mesh-list
5998560|NCT00186628|Lenograstim|lenograstim|mesh-list
5998561|NCT00186628|Cyclosporins|cyclosporins|mesh-list
5998562|NCT00186628|Thymoglobulin|thymoglobulin|mesh-list
5998563|NCT00186628|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5998564|NCT00186628|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5998565|NCT00186628|Prednisolone phosphate|prednisolone phosphate|mesh-list
5998566|NCT00186628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5998567|NCT00186628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5998568|NCT00186628|Immunologic Factors|immunologic factors|mesh-ancestor
5998569|NCT00186628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998570|NCT00186628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5998571|NCT00186628|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5998572|NCT00186628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5998573|NCT00186628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5998574|NCT00186628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5998575|NCT00186628|Antifungal Agents|antifungal agents|mesh-ancestor
5998576|NCT00186628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5998577|NCT00186628|Dermatologic Agents|dermatologic agents|mesh-ancestor
5998578|NCT00186628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5998579|NCT00186628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5998580|NCT00186628|Analgesics|analgesics|mesh-ancestor
5998581|NCT00186628|Sensory System Agents|sensory system agents|mesh-ancestor
5998582|NCT00186628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6259522|NCT03120520|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
6259523|NCT03120520|Enzyme Activators|enzyme activators|mesh-ancestor
6259524|NCT03120520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259525|NCT03120520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6259526|NCT03121820|Memantine|memantine|mesh-list
6259527|NCT03121820|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6259528|NCT03121820|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6259529|NCT03121820|Dopamine Agents|dopamine agents|mesh-ancestor
6259530|NCT03121820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6259531|NCT03121820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259532|NCT03121820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259533|NCT03121820|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6259534|NCT03121820|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6259535|NCT03122145|Capsaicin|capsaicin|mesh-list
6259536|NCT03122145|Antipruritics|antipruritics|mesh-ancestor
6259537|NCT03122145|Dermatologic Agents|dermatologic agents|mesh-ancestor
6259538|NCT03122145|Sensory System Agents|sensory system agents|mesh-ancestor
6259539|NCT03122145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6259540|NCT03122145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998583|NCT00186628|Antipyretics|antipyretics|mesh-ancestor
5998584|NCT00186628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5998585|NCT00186628|Antiemetics|antiemetics|mesh-ancestor
5998586|NCT00186628|Autonomic Agents|autonomic agents|mesh-ancestor
5998587|NCT00186628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5998588|NCT00186628|Glucocorticoids|glucocorticoids|mesh-ancestor
5998589|NCT00186628|Hormones|hormones|mesh-ancestor
5998590|NCT00186628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5998591|NCT00186628|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5998592|NCT00186628|Protective Agents|protective agents|mesh-ancestor
5998593|NCT00186628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5998594|NCT00186628|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5998595|NCT00186628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5998596|NCT00186628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5998597|NCT00186628|Anesthetics, Local|anesthetics, local|mesh-ancestor
5998598|NCT00186628|Anesthetics|anesthetics|mesh-ancestor
5998599|NCT00186628|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5998600|NCT00186628|Histamine Antagonists|histamine antagonists|mesh-ancestor
5998601|NCT00186628|Histamine Agents|histamine agents|mesh-ancestor
5998602|NCT00186628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5998603|NCT00186628|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5998604|NCT00186628|Antipruritics|antipruritics|mesh-ancestor
5998605|NCT00186628|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5998606|NCT00186628|Serotonin Agents|serotonin agents|mesh-ancestor
6017802|NCT00375973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6017803|NCT00375973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017804|NCT00375973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6017805|NCT00375973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017806|NCT00375973|Analgesics|analgesics|mesh-ancestor
6017807|NCT00375973|Sensory System Agents|sensory system agents|mesh-ancestor
6017808|NCT00375973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6017809|NCT00375973|Antidepressive Agents|antidepressive agents|mesh-ancestor
6017810|NCT00375973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6017811|NCT00375973|Dopamine Agents|dopamine agents|mesh-ancestor
6017812|NCT00375999|Docetaxel|docetaxel|mesh-list
6017813|NCT00375999|Epirubicin|epirubicin|mesh-list
6017814|NCT00375999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6017815|NCT00375999|Tubulin Modulators|tubulin modulators|mesh-ancestor
6017816|NCT00375999|Antimitotic Agents|antimitotic agents|mesh-ancestor
6017817|NCT00375999|Mitosis Modulators|mitosis modulators|mesh-ancestor
6017818|NCT00375999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017819|NCT00375999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6017820|NCT00375999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6017821|NCT00375999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6017822|NCT00375999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6017823|NCT00376220|Riluzole|riluzole|mesh-list
6017824|NCT00376220|Anticonvulsants|anticonvulsants|mesh-ancestor
6017825|NCT00376220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6017826|NCT00376220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6017827|NCT00376220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6017828|NCT00376220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017829|NCT00376220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017830|NCT00376220|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6017831|NCT00376220|Protective Agents|protective agents|mesh-ancestor
6017832|NCT00376246|Ezetimibe|ezetimibe|mesh-list
6017833|NCT00376246|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6017834|NCT00376246|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6017835|NCT00376246|Antimetabolites|antimetabolites|mesh-ancestor
6017836|NCT00376246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017837|NCT00376246|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6017838|NCT00376259|Adefovir|adefovir|mesh-list
6017839|NCT00376259|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6017840|NCT00376259|Telbivudine|telbivudine|mesh-list
6017841|NCT00376259|Antiviral Agents|antiviral agents|mesh-ancestor
6017842|NCT00376259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6017843|NCT00376259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6017844|NCT00376259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6017845|NCT00376259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6017846|NCT00376259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017847|NCT00376675|Methylphenidate|methylphenidate|mesh-list
6259541|NCT03122457|C 1027|c 1027|mesh-list
6259542|NCT03122457|Benzoyl Peroxide|benzoyl peroxide|mesh-list
5998607|NCT00186875|Cytarabine|cytarabine|mesh-list
5998608|NCT00186875|Dexamethasone|dexamethasone|mesh-list
5998609|NCT00186875|Dexamethasone acetate|dexamethasone acetate|mesh-list
5998610|NCT00186875|Cyclophosphamide|cyclophosphamide|mesh-list
5998611|NCT00186875|Methotrexate|methotrexate|mesh-list
5998612|NCT00186875|Etoposide|etoposide|mesh-list
5998613|NCT00186875|Etoposide phosphate|etoposide phosphate|mesh-list
5998614|NCT00186875|Vincristine|vincristine|mesh-list
5998615|NCT00186875|Asparaginase|asparaginase|mesh-list
5998616|NCT00186875|Mercaptopurine|mercaptopurine|mesh-list
5998617|NCT00186875|Mitoxantrone|mitoxantrone|mesh-list
5998618|NCT00186875|Vinblastine|vinblastine|mesh-list
5998619|NCT00186875|Pegaspargase|pegaspargase|mesh-list
5998620|NCT00186875|Teniposide|teniposide|mesh-list
5998621|NCT00186875|BB 1101|bb 1101|mesh-list
5998622|NCT00186875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5998623|NCT00186875|Immunologic Factors|immunologic factors|mesh-ancestor
5998624|NCT00186875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998625|NCT00186875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5998626|NCT00186875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5998627|NCT00186875|Alkylating Agents|alkylating agents|mesh-ancestor
5998628|NCT00186875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5998629|NCT00186875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5998630|NCT00186875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5998631|NCT00186875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5998632|NCT00186875|Antiemetics|antiemetics|mesh-ancestor
5998633|NCT00186875|Autonomic Agents|autonomic agents|mesh-ancestor
5998634|NCT00186875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5998635|NCT00186875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5998636|NCT00186875|Glucocorticoids|glucocorticoids|mesh-ancestor
5998637|NCT00186875|Hormones|hormones|mesh-ancestor
5998638|NCT00186875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5998639|NCT00186875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5998640|NCT00186875|Protease Inhibitors|protease inhibitors|mesh-ancestor
5998641|NCT00186875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5998642|NCT00186875|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5998643|NCT00186875|Abortifacient Agents|abortifacient agents|mesh-ancestor
5998644|NCT00186875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5998645|NCT00186875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5998646|NCT00186875|Antimetabolites|antimetabolites|mesh-ancestor
5998647|NCT00186875|Dermatologic Agents|dermatologic agents|mesh-ancestor
5998648|NCT00186875|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5998649|NCT00186875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5998650|NCT00186875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5998651|NCT00186875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5998652|NCT00186875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5998653|NCT00186875|Antiviral Agents|antiviral agents|mesh-ancestor
5998654|NCT00186875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5998655|NCT00186875|Tubulin Modulators|tubulin modulators|mesh-ancestor
5998656|NCT00186875|Antimitotic Agents|antimitotic agents|mesh-ancestor
5998657|NCT00186875|Mitosis Modulators|mitosis modulators|mesh-ancestor
5998658|NCT00186875|Analgesics|analgesics|mesh-ancestor
5998659|NCT00186875|Sensory System Agents|sensory system agents|mesh-ancestor
5998660|NCT00186901|Vitamin D|vitamin d|mesh-list
5998661|NCT00186901|Calcium Carbonate|calcium carbonate|mesh-list
5998662|NCT00186901|Calcium|calcium|mesh-list
5998663|NCT00186901|Vitamins|vitamins|mesh-ancestor
5998664|NCT00186901|Micronutrients|micronutrients|mesh-ancestor
5998665|NCT00186901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998666|NCT00186901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5998667|NCT00186901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5998668|NCT00186901|Antacids|antacids|mesh-ancestor
5998669|NCT00186901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5998670|NCT00186901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5998671|NCT00187096|Cyclophosphamide|cyclophosphamide|mesh-list
5998672|NCT00187096|Fludarabine|fludarabine|mesh-list
5998673|NCT00187096|Etoposide|etoposide|mesh-list
5998674|NCT00187096|Interleukin-2|interleukin-2|mesh-list
5998675|NCT00187096|Clofarabine|clofarabine|mesh-list
5998676|NCT00187096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5998677|NCT00187096|Immunologic Factors|immunologic factors|mesh-ancestor
5998678|NCT00187096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998679|NCT00187096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5998680|NCT00187096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5998681|NCT00187096|Alkylating Agents|alkylating agents|mesh-ancestor
6259543|NCT03122457|Dermatologic Agents|dermatologic agents|mesh-ancestor
5998682|NCT00187096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5998683|NCT00187096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5998684|NCT00187096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5998685|NCT00187096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5998686|NCT00187096|Antimetabolites|antimetabolites|mesh-ancestor
5998687|NCT00187096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5998688|NCT00187096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5998689|NCT00187096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5998690|NCT00187096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5998691|NCT00187096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5998692|NCT00187096|Analgesics|analgesics|mesh-ancestor
5998693|NCT00187096|Sensory System Agents|sensory system agents|mesh-ancestor
5998694|NCT00187096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5998695|NCT00187135|Fentanyl|fentanyl|mesh-list
5998696|NCT00187135|Propofol|propofol|mesh-list
5998697|NCT00187135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5998698|NCT00187135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5998699|NCT00187135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998700|NCT00187135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5998701|NCT00187135|Anesthetics, General|anesthetics, general|mesh-ancestor
5998702|NCT00187135|Anesthetics|anesthetics|mesh-ancestor
6259544|NCT03122457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6259545|NCT03122457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6259546|NCT03122548|Pembrolizumab|pembrolizumab|mesh-list
6259547|NCT03122548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6259548|NCT03122548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6259549|NCT03122587|Dihydrotachysterol|dihydrotachysterol|mesh-list
6259550|NCT03122587|Vitamins|vitamins|mesh-ancestor
6259551|NCT03122587|Micronutrients|micronutrients|mesh-ancestor
6259552|NCT03122587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259553|NCT03122587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6259554|NCT03122860|Lorecivivint|lorecivivint|mesh-list
6259555|NCT03122860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6259556|NCT03122886|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6259557|NCT03122886|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
6259558|NCT03122886|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6259559|NCT03122886|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6259560|NCT03123055|Pembrolizumab|pembrolizumab|mesh-list
6259561|NCT03123055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6259562|NCT03123055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6259563|NCT03123471|Apremilast|apremilast|mesh-list
6259564|NCT03123471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6259565|NCT03123471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6259566|NCT03123471|Analgesics|analgesics|mesh-ancestor
6259567|NCT03123471|Sensory System Agents|sensory system agents|mesh-ancestor
6259568|NCT03123471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6259569|NCT03123471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259570|NCT03123471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6259571|NCT03123471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6259572|NCT03123471|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6259573|NCT03123471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6259574|NCT03123471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6259575|NCT03123471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259576|NCT03123588|Anagrelide|anagrelide|mesh-list
6259577|NCT03123588|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6259578|NCT03123588|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6259579|NCT03123588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259580|NCT03123588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6259581|NCT03123614|Loteprednol Etabonate|loteprednol etabonate|mesh-list
6259582|NCT03123614|Prednisolone|prednisolone|mesh-list
6259583|NCT03123614|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6259584|NCT03123614|Methylprednisolone|methylprednisolone|mesh-list
6259585|NCT03123614|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6259586|NCT03123614|Prednisolone acetate|prednisolone acetate|mesh-list
6259587|NCT03123614|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6259588|NCT03123614|Prednisolone phosphate|prednisolone phosphate|mesh-list
6259589|NCT03123614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6259590|NCT03123614|Glucocorticoids|glucocorticoids|mesh-ancestor
6259591|NCT03123614|Hormones|hormones|mesh-ancestor
5998703|NCT00187135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5998704|NCT00187135|Narcotics|narcotics|mesh-ancestor
5998705|NCT00187135|Analgesics|analgesics|mesh-ancestor
5998706|NCT00187135|Sensory System Agents|sensory system agents|mesh-ancestor
5998707|NCT00187135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5998708|NCT00187135|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5998709|NCT00187486|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5998710|NCT00187486|Temozolomide|temozolomide|mesh-list
5998711|NCT00187486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5998712|NCT00187486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5998713|NCT00187486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5998714|NCT00187486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5998715|NCT00187486|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5998716|NCT00187486|Alkylating Agents|alkylating agents|mesh-ancestor
5998717|NCT00187655|Cefotaxime|cefotaxime|mesh-list
5998718|NCT00187655|Cefoxitin|cefoxitin|mesh-list
5998719|NCT00187655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5998720|NCT00187655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5998721|NCT00187681|Metformin|metformin|mesh-list
5998722|NCT00187681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5998723|NCT00187681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998724|NCT00187720|Metformin|metformin|mesh-list
5998725|NCT00187720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5998726|NCT00187720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998727|NCT00187889|Eplerenone|eplerenone|mesh-list
5998728|NCT00187889|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5998729|NCT00187889|Hormone Antagonists|hormone antagonists|mesh-ancestor
5998730|NCT00187889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5998731|NCT00187889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998732|NCT00187889|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5998733|NCT00187889|Diuretics|diuretics|mesh-ancestor
5998734|NCT00187889|Natriuretic Agents|natriuretic agents|mesh-ancestor
5998735|NCT00187889|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5998736|NCT00189098|Trimethoprim|trimethoprim|mesh-list
5998737|NCT00189098|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
5998738|NCT00189098|Sulfamethoxazole|sulfamethoxazole|mesh-list
5998739|NCT00189098|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5998740|NCT00189098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5998741|NCT00189098|Renal Agents|renal agents|mesh-ancestor
5998742|NCT00189098|Antimalarials|antimalarials|mesh-ancestor
5998743|NCT00189098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5998744|NCT00189098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5998745|NCT00189098|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5998746|NCT00189098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5998747|NCT00189098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5998748|NCT00189098|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5998749|NCT00189098|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
5998750|NCT00189098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5998751|NCT00189098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5998752|NCT00189137|Gemcitabine|gemcitabine|mesh-list
5998753|NCT00189137|Docetaxel|docetaxel|mesh-list
5998754|NCT00189137|Doxorubicin|doxorubicin|mesh-list
5998755|NCT00189137|Ifosfamide|ifosfamide|mesh-list
5998756|NCT00189137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5998757|NCT00189137|Antimetabolites|antimetabolites|mesh-ancestor
5998758|NCT00189137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5998759|NCT00189137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5998760|NCT00189137|Antiviral Agents|antiviral agents|mesh-ancestor
5998761|NCT00189137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5998762|NCT00189137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5998763|NCT00189137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5998764|NCT00189137|Immunologic Factors|immunologic factors|mesh-ancestor
5998765|NCT00189137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998766|NCT00189137|Tubulin Modulators|tubulin modulators|mesh-ancestor
5998767|NCT00189137|Antimitotic Agents|antimitotic agents|mesh-ancestor
5998768|NCT00189137|Mitosis Modulators|mitosis modulators|mesh-ancestor
5998769|NCT00189137|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5998770|NCT00189137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5998771|NCT00189137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5998772|NCT00189137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5998773|NCT00189137|Alkylating Agents|alkylating agents|mesh-ancestor
5998774|NCT00189202|Sirolimus|sirolimus|mesh-list
5998775|NCT00189202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5998776|NCT00189202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5998777|NCT00189202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5998778|NCT00189202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5998779|NCT00189202|Antifungal Agents|antifungal agents|mesh-ancestor
5998780|NCT00189202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5998781|NCT00189202|Immunologic Factors|immunologic factors|mesh-ancestor
5998782|NCT00189202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998783|NCT00189228|Omalizumab|omalizumab|mesh-list
5998784|NCT00189228|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5998785|NCT00189228|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5998786|NCT00189228|Respiratory System Agents|respiratory system agents|mesh-ancestor
5998787|NCT00189306|Imiquimod|imiquimod|mesh-list
5998788|NCT00189306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5998789|NCT00189306|Immunologic Factors|immunologic factors|mesh-ancestor
5998790|NCT00189306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998791|NCT00189306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5998792|NCT00189306|Interferon Inducers|interferon inducers|mesh-ancestor
5998793|NCT00189436|Budesonide|budesonide|mesh-list
5998794|NCT00189436|Albuterol|albuterol|mesh-list
5998795|NCT00189436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5998796|NCT00189436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5998797|NCT00189436|Autonomic Agents|autonomic agents|mesh-ancestor
5998798|NCT00189436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5998799|NCT00189436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998800|NCT00189436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5998801|NCT00189436|Respiratory System Agents|respiratory system agents|mesh-ancestor
5998802|NCT00189436|Glucocorticoids|glucocorticoids|mesh-ancestor
5998803|NCT00189436|Hormones|hormones|mesh-ancestor
5998804|NCT00189436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5998805|NCT00189436|Tocolytic Agents|tocolytic agents|mesh-ancestor
5998806|NCT00189436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5998807|NCT00189436|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5998808|NCT00189436|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5998809|NCT00189436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5998810|NCT00189436|Adrenergic Agents|adrenergic agents|mesh-ancestor
5998811|NCT00189436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5998812|NCT00189436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5998813|NCT00189462|Montelukast|montelukast|mesh-list
5998814|NCT00189462|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5998815|NCT00189462|Respiratory System Agents|respiratory system agents|mesh-ancestor
5998816|NCT00189462|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5998817|NCT00189462|Hormone Antagonists|hormone antagonists|mesh-ancestor
5998818|NCT00189462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5998819|NCT00189462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998820|NCT00189462|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5998821|NCT00189462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5998822|NCT00189462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5998823|NCT00189475|Montelukast|montelukast|mesh-list
5998824|NCT00189475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5998825|NCT00189475|Respiratory System Agents|respiratory system agents|mesh-ancestor
5998826|NCT00189475|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5998827|NCT00189475|Hormone Antagonists|hormone antagonists|mesh-ancestor
5998828|NCT00189475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5998829|NCT00189475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998830|NCT00189475|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5998831|NCT00189475|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5998832|NCT00189475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5998833|NCT00189488|Methotrexate|methotrexate|mesh-list
5998834|NCT00189488|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5998835|NCT00189488|Abortifacient Agents|abortifacient agents|mesh-ancestor
5998836|NCT00189488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5998837|NCT00189488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998838|NCT00189488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5998839|NCT00189488|Antimetabolites|antimetabolites|mesh-ancestor
5998840|NCT00189488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5998841|NCT00189488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5998842|NCT00189488|Dermatologic Agents|dermatologic agents|mesh-ancestor
5998843|NCT00189488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5998844|NCT00189488|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5998845|NCT00189488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5998846|NCT00189488|Immunologic Factors|immunologic factors|mesh-ancestor
5998847|NCT00189488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5998848|NCT00189488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5998849|NCT00190671|Cyclophosphamide|cyclophosphamide|mesh-list
5998850|NCT00190671|Pemetrexed|pemetrexed|mesh-list
5998851|NCT00190671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5998852|NCT00190671|Immunologic Factors|immunologic factors|mesh-ancestor
5998853|NCT00190671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998854|NCT00190671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5998855|NCT00190671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5998856|NCT00190671|Alkylating Agents|alkylating agents|mesh-ancestor
5998857|NCT00190671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5998858|NCT00190671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5998859|NCT00190671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5998860|NCT00190671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5998861|NCT00190671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5998862|NCT00190671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5998863|NCT00190684|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
5998864|NCT00190684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5998865|NCT00190684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5998866|NCT00190684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5998867|NCT00190684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5998868|NCT00190684|Adrenergic Agents|adrenergic agents|mesh-ancestor
5998869|NCT00190684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5998870|NCT00190684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998871|NCT00190749|Olanzapine|olanzapine|mesh-list
5998872|NCT00190749|Risperidone|risperidone|mesh-list
5998873|NCT00190749|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5998874|NCT00190749|Serotonin Agents|serotonin agents|mesh-ancestor
5998875|NCT00190749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5998876|NCT00190749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5998877|NCT00190749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998878|NCT00190749|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5998879|NCT00190749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5998880|NCT00190749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5998881|NCT00190749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5998882|NCT00190749|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5998883|NCT00190749|Dopamine Agents|dopamine agents|mesh-ancestor
5998884|NCT00190749|Antiemetics|antiemetics|mesh-ancestor
5998885|NCT00190749|Autonomic Agents|autonomic agents|mesh-ancestor
5998886|NCT00190749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5998887|NCT00190749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5998888|NCT00190749|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5998889|NCT00190749|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5998890|NCT00190749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5998891|NCT00190775|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
5998892|NCT00190775|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5998893|NCT00190775|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5998894|NCT00190775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5998895|NCT00190775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5998896|NCT00190775|Adrenergic Agents|adrenergic agents|mesh-ancestor
5998897|NCT00190775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5998898|NCT00190775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998899|NCT00190983|Pemetrexed|pemetrexed|mesh-list
5998900|NCT00190983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5998901|NCT00190983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5998902|NCT00190983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5998903|NCT00190983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5998904|NCT00190983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5998905|NCT00191100|Gemcitabine|gemcitabine|mesh-list
5998906|NCT00191100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5998907|NCT00191100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5998908|NCT00191100|Antimetabolites|antimetabolites|mesh-ancestor
5998909|NCT00191100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5998910|NCT00191100|Antiviral Agents|antiviral agents|mesh-ancestor
5998911|NCT00191100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5998912|NCT00191100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5998913|NCT00191100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5998914|NCT00191100|Immunologic Factors|immunologic factors|mesh-ancestor
5998915|NCT00191100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998916|NCT00191113|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
5998917|NCT00191113|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5998918|NCT00191113|Medroxyprogesterone|medroxyprogesterone|mesh-list
5998919|NCT00191113|Estradiol|estradiol|mesh-list
5998920|NCT00191113|Hormones|hormones|mesh-ancestor
5998921|NCT00191113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5998922|NCT00191113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998923|NCT00191113|Estrogens|estrogens|mesh-ancestor
5998924|NCT00191113|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5998925|NCT00191113|Contraceptive Agents|contraceptive agents|mesh-ancestor
5998926|NCT00191113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5998927|NCT00191113|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5998928|NCT00191113|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5998929|NCT00191113|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5998930|NCT00191113|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5998931|NCT00191113|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5998932|NCT00191113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5998933|NCT00191113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5998934|NCT00191139|Gemcitabine|gemcitabine|mesh-list
5998935|NCT00191139|Cisplatin|cisplatin|mesh-list
5998936|NCT00191139|Docetaxel|docetaxel|mesh-list
5998937|NCT00191139|Etoposide|etoposide|mesh-list
5998938|NCT00191139|Etoposide phosphate|etoposide phosphate|mesh-list
5998939|NCT00191139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5998940|NCT00191139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5998941|NCT00191139|Antimetabolites|antimetabolites|mesh-ancestor
5998942|NCT00191139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5998943|NCT00191139|Antiviral Agents|antiviral agents|mesh-ancestor
5998944|NCT00191139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5998945|NCT00191139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5998946|NCT00191139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5998947|NCT00191139|Immunologic Factors|immunologic factors|mesh-ancestor
5998948|NCT00191139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998949|NCT00191139|Tubulin Modulators|tubulin modulators|mesh-ancestor
5998950|NCT00191139|Antimitotic Agents|antimitotic agents|mesh-ancestor
5998951|NCT00191139|Mitosis Modulators|mitosis modulators|mesh-ancestor
5998952|NCT00191139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5998953|NCT00191139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5998954|NCT00191139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5998955|NCT00191152|Gemcitabine|gemcitabine|mesh-list
5998956|NCT00191152|Capecitabine|capecitabine|mesh-list
5998957|NCT00191152|Docetaxel|docetaxel|mesh-list
5998958|NCT00191152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5998959|NCT00191152|Antimetabolites|antimetabolites|mesh-ancestor
5998960|NCT00191152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5998961|NCT00191152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5998962|NCT00191152|Antiviral Agents|antiviral agents|mesh-ancestor
5998963|NCT00191152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5998964|NCT00191152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5998965|NCT00191152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5998966|NCT00191152|Immunologic Factors|immunologic factors|mesh-ancestor
5998967|NCT00191152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998968|NCT00191152|Tubulin Modulators|tubulin modulators|mesh-ancestor
5998969|NCT00191152|Antimitotic Agents|antimitotic agents|mesh-ancestor
5998970|NCT00191152|Mitosis Modulators|mitosis modulators|mesh-ancestor
5998971|NCT00191191|Pemetrexed|pemetrexed|mesh-list
5998972|NCT00191191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5998973|NCT00191191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5998974|NCT00191191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5998975|NCT00191191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5998976|NCT00191191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5998977|NCT00191269|Gemcitabine|gemcitabine|mesh-list
5998978|NCT00191269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5998979|NCT00191269|Antimetabolites|antimetabolites|mesh-ancestor
5998980|NCT00191269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5998981|NCT00191269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5998982|NCT00191269|Antiviral Agents|antiviral agents|mesh-ancestor
5998983|NCT00191269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5998984|NCT00191269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5998985|NCT00191269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5998986|NCT00191269|Immunologic Factors|immunologic factors|mesh-ancestor
5998987|NCT00191269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5998988|NCT00191282|Insulin|insulin|mesh-list
5998989|NCT00191282|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5998990|NCT00191282|Insulin Glargine|insulin glargine|mesh-list
5998991|NCT00191282|Insulin Lispro|insulin lispro|mesh-list
5998992|NCT00191282|Isophane Insulin, Human|isophane insulin, human|mesh-list
5998993|NCT00191282|Insulin, Isophane|insulin, isophane|mesh-list
5998994|NCT00191282|Isophane insulin, beef|isophane insulin, beef|mesh-list
5998995|NCT00191282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5998996|NCT00191282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259592|NCT03123614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6259593|NCT03123614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259594|NCT03123614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6259595|NCT03123614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6259596|NCT03123614|Antiemetics|antiemetics|mesh-ancestor
6259597|NCT03123614|Autonomic Agents|autonomic agents|mesh-ancestor
6259598|NCT03123614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6259599|NCT03123614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6259600|NCT03123614|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6259601|NCT03123614|Protective Agents|protective agents|mesh-ancestor
6259602|NCT03123614|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6259603|NCT03123848|Darunavir|darunavir|mesh-list
6259604|NCT03123848|Cobicistat|cobicistat|mesh-list
5998997|NCT00191308|Pemetrexed|pemetrexed|mesh-list
5998998|NCT00191308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6259605|NCT03123848|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5998999|NCT00191308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5999000|NCT00191308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999001|NCT00191308|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5999002|NCT00191308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5999003|NCT00191334|Gemcitabine|gemcitabine|mesh-list
5999004|NCT00191334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5999005|NCT00191334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5999006|NCT00191334|Antimetabolites|antimetabolites|mesh-ancestor
5999007|NCT00191334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999008|NCT00191334|Antiviral Agents|antiviral agents|mesh-ancestor
5999009|NCT00191334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5999010|NCT00191334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5999011|NCT00191334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5999012|NCT00191334|Immunologic Factors|immunologic factors|mesh-ancestor
5999013|NCT00191334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999014|NCT00191386|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
5999015|NCT00191386|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5999016|NCT00191386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5999017|NCT00191386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5999018|NCT00191386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999019|NCT00191386|Adrenergic Agents|adrenergic agents|mesh-ancestor
5999020|NCT00191386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5999021|NCT00191386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999022|NCT00191451|Gemcitabine|gemcitabine|mesh-list
5999023|NCT00191451|Carboplatin|carboplatin|mesh-list
5999024|NCT00191451|Trastuzumab|trastuzumab|mesh-list
5999025|NCT00191451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5999026|NCT00191451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5999027|NCT00191451|Antimetabolites|antimetabolites|mesh-ancestor
5999028|NCT00191451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999029|NCT00191451|Antiviral Agents|antiviral agents|mesh-ancestor
5999030|NCT00191451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5999031|NCT00191451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5999032|NCT00191451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5999033|NCT00191451|Immunologic Factors|immunologic factors|mesh-ancestor
5999034|NCT00191451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999035|NCT00191451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5999036|NCT00191477|Gemcitabine|gemcitabine|mesh-list
5999037|NCT00191477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5999038|NCT00191477|Antimetabolites|antimetabolites|mesh-ancestor
5999039|NCT00191477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999040|NCT00191477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5999041|NCT00191477|Antiviral Agents|antiviral agents|mesh-ancestor
5999042|NCT00191477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5999043|NCT00191477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5999044|NCT00191477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5999045|NCT00191477|Immunologic Factors|immunologic factors|mesh-ancestor
5999046|NCT00191477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999047|NCT00191646|Gemcitabine|gemcitabine|mesh-list
5999048|NCT00191646|Paclitaxel|paclitaxel|mesh-list
5999049|NCT00191646|Carboplatin|carboplatin|mesh-list
5999050|NCT00191646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5999051|NCT00191646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5999052|NCT00191646|Tubulin Modulators|tubulin modulators|mesh-ancestor
5999053|NCT00191646|Antimitotic Agents|antimitotic agents|mesh-ancestor
5999054|NCT00191646|Mitosis Modulators|mitosis modulators|mesh-ancestor
5999055|NCT00191646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999056|NCT00191646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5999057|NCT00191646|Antimetabolites|antimetabolites|mesh-ancestor
5999058|NCT00191646|Antiviral Agents|antiviral agents|mesh-ancestor
5999059|NCT00191646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5999060|NCT00191646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5999061|NCT00191646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5999062|NCT00191646|Immunologic Factors|immunologic factors|mesh-ancestor
5999063|NCT00191646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999064|NCT00191724|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
5999065|NCT00191724|Enoxaparin|enoxaparin|mesh-list
5999066|NCT00191724|Protein C|protein c|mesh-list
5999067|NCT00191724|Anticoagulants|anticoagulants|mesh-ancestor
5999068|NCT00191724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5999069|NCT00191724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5999070|NCT00191724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999071|NCT00191724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5999072|NCT00191789|Gemcitabine|gemcitabine|mesh-list
5999073|NCT00191789|Doxorubicin|doxorubicin|mesh-list
5999074|NCT00191789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5999075|NCT00191789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5999076|NCT00191789|Antimetabolites|antimetabolites|mesh-ancestor
5999077|NCT00191789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999078|NCT00191789|Antiviral Agents|antiviral agents|mesh-ancestor
5999079|NCT00191789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5999080|NCT00191789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5999081|NCT00191789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5999082|NCT00191789|Immunologic Factors|immunologic factors|mesh-ancestor
5999083|NCT00191789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999084|NCT00191789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5999085|NCT00191789|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5999086|NCT00191789|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5999087|NCT00191815|Gemcitabine|gemcitabine|mesh-list
5999088|NCT00191815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5999089|NCT00191815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5999090|NCT00191815|Antimetabolites|antimetabolites|mesh-ancestor
5999091|NCT00191815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999092|NCT00191815|Antiviral Agents|antiviral agents|mesh-ancestor
5999093|NCT00191815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5999094|NCT00191815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5999095|NCT00191815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5999096|NCT00191815|Immunologic Factors|immunologic factors|mesh-ancestor
5999097|NCT00191815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999098|NCT00191854|Gemcitabine|gemcitabine|mesh-list
5999099|NCT00191854|Paclitaxel|paclitaxel|mesh-list
5999100|NCT00191854|Carboplatin|carboplatin|mesh-list
5999101|NCT00191854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5999102|NCT00191854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5999103|NCT00191854|Tubulin Modulators|tubulin modulators|mesh-ancestor
5999104|NCT00191854|Antimitotic Agents|antimitotic agents|mesh-ancestor
5999105|NCT00191854|Mitosis Modulators|mitosis modulators|mesh-ancestor
5999106|NCT00191854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999107|NCT00191854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5999108|NCT00191854|Antimetabolites|antimetabolites|mesh-ancestor
5999109|NCT00191854|Antiviral Agents|antiviral agents|mesh-ancestor
5999110|NCT00191854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5999111|NCT00191854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5999112|NCT00191854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5999113|NCT00191854|Immunologic Factors|immunologic factors|mesh-ancestor
5999114|NCT00191854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999115|NCT00191906|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
5999116|NCT00191906|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5999117|NCT00191906|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5999118|NCT00191906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5999119|NCT00191906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999120|NCT00191906|Adrenergic Agents|adrenergic agents|mesh-ancestor
5999121|NCT00191906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5999122|NCT00191906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999123|NCT00191945|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
5999124|NCT00191945|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5999125|NCT00191945|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5999126|NCT00191945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5999127|NCT00191945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999128|NCT00191945|Adrenergic Agents|adrenergic agents|mesh-ancestor
5999129|NCT00191945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5999130|NCT00191945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999131|NCT00191984|Irinotecan|irinotecan|mesh-list
5999132|NCT00191984|Pemetrexed|pemetrexed|mesh-list
5999133|NCT00191984|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5999134|NCT00191984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5999135|NCT00191984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5999136|NCT00191984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999137|NCT00191984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5999138|NCT00191984|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5999139|NCT00191984|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5999140|NCT00192023|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
5999141|NCT00192023|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5999142|NCT00192023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5999143|NCT00192023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5999144|NCT00192023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999145|NCT00192023|Adrenergic Agents|adrenergic agents|mesh-ancestor
5999146|NCT00192023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5999147|NCT00192023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999148|NCT00192036|Gemcitabine|gemcitabine|mesh-list
5999149|NCT00192036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5999150|NCT00192036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5999151|NCT00192036|Antimetabolites|antimetabolites|mesh-ancestor
5999152|NCT00192036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999153|NCT00192036|Antiviral Agents|antiviral agents|mesh-ancestor
5999154|NCT00192036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5999155|NCT00192036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5999156|NCT00192036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5999157|NCT00192036|Immunologic Factors|immunologic factors|mesh-ancestor
5999158|NCT00192036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999159|NCT00192075|Leucovorin|leucovorin|mesh-list
5999160|NCT00192075|Folic Acid|folic acid|mesh-list
5999161|NCT00192075|Gemcitabine|gemcitabine|mesh-list
5999162|NCT00192075|Oxaliplatin|oxaliplatin|mesh-list
5999163|NCT00192075|Levoleucovorin|levoleucovorin|mesh-list
5999164|NCT00192075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5999165|NCT00192075|Antimetabolites|antimetabolites|mesh-ancestor
5999166|NCT00192075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999167|NCT00192075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5999168|NCT00192075|Antiviral Agents|antiviral agents|mesh-ancestor
5999169|NCT00192075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5999170|NCT00192075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5999171|NCT00192075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5999172|NCT00192075|Immunologic Factors|immunologic factors|mesh-ancestor
5999173|NCT00192075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999174|NCT00192075|Antidotes|antidotes|mesh-ancestor
5999175|NCT00192075|Protective Agents|protective agents|mesh-ancestor
5999176|NCT00192075|Vitamin B Complex|vitamin b complex|mesh-ancestor
5999177|NCT00192075|Vitamins|vitamins|mesh-ancestor
5999178|NCT00192075|Micronutrients|micronutrients|mesh-ancestor
5999179|NCT00192075|Hematinics|hematinics|mesh-ancestor
5999180|NCT00192647|Ribavirin|ribavirin|mesh-list
5999181|NCT00192647|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5999182|NCT00192647|Interferon alpha-2|interferon alpha-2|mesh-list
5999183|NCT00192647|Antimetabolites|antimetabolites|mesh-ancestor
5999184|NCT00192647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999185|NCT00192647|Antiviral Agents|antiviral agents|mesh-ancestor
6259606|NCT03123848|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6259607|NCT03123848|Protease Inhibitors|protease inhibitors|mesh-ancestor
6259608|NCT03123848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6259609|NCT03123848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259610|NCT03123848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6259611|NCT03123848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6259612|NCT03123848|Antiviral Agents|antiviral agents|mesh-ancestor
6259613|NCT03123848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6259614|NCT03123848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6259615|NCT03123848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6259616|NCT03123861|Gabapentin|gabapentin|mesh-list
6259617|NCT03123861|Analgesics|analgesics|mesh-ancestor
6259618|NCT03123861|Sensory System Agents|sensory system agents|mesh-ancestor
6259619|NCT03123861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6259620|NCT03123861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259621|NCT03123861|Anticonvulsants|anticonvulsants|mesh-ancestor
6259622|NCT03123861|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6259623|NCT03123861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6259624|NCT03123861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6259625|NCT03123861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6259626|NCT03123861|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6259627|NCT03123861|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6259628|NCT03123861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6259629|NCT03123861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259630|NCT03123861|Antimanic Agents|antimanic agents|mesh-ancestor
6259631|NCT03124121|Golimumab|golimumab|mesh-list
6259632|NCT03124121|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6259633|NCT03124121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6259634|NCT03124121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5999186|NCT00192647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5999187|NCT00192647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5999188|NCT00193037|Docetaxel|docetaxel|mesh-list
5999189|NCT00193037|Doxorubicin|doxorubicin|mesh-list
5999190|NCT00193037|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5999191|NCT00193037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5999192|NCT00193037|Tubulin Modulators|tubulin modulators|mesh-ancestor
5999193|NCT00193037|Antimitotic Agents|antimitotic agents|mesh-ancestor
5999194|NCT00193037|Mitosis Modulators|mitosis modulators|mesh-ancestor
5999195|NCT00193037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999196|NCT00193037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5999197|NCT00193037|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5999198|NCT00193037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5999199|NCT00193037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5999200|NCT00193050|Gemcitabine|gemcitabine|mesh-list
5999201|NCT00193050|Docetaxel|docetaxel|mesh-list
5999202|NCT00193050|Epirubicin|epirubicin|mesh-list
5999203|NCT00193050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5999204|NCT00193050|Antimetabolites|antimetabolites|mesh-ancestor
5999205|NCT00193050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999206|NCT00193050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5999207|NCT00193050|Antiviral Agents|antiviral agents|mesh-ancestor
5999208|NCT00193050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5999209|NCT00193050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5999210|NCT00193050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5999211|NCT00193050|Immunologic Factors|immunologic factors|mesh-ancestor
5999212|NCT00193050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999213|NCT00193050|Tubulin Modulators|tubulin modulators|mesh-ancestor
5999214|NCT00193050|Antimitotic Agents|antimitotic agents|mesh-ancestor
5999215|NCT00193050|Mitosis Modulators|mitosis modulators|mesh-ancestor
5999216|NCT00193050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5999217|NCT00193050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5999218|NCT00193050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5999219|NCT00193063|Gemcitabine|gemcitabine|mesh-list
5999220|NCT00193063|Trastuzumab|trastuzumab|mesh-list
5999221|NCT00193063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5999222|NCT00193063|Antimetabolites|antimetabolites|mesh-ancestor
5999223|NCT00193063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999224|NCT00193063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5999225|NCT00193063|Antiviral Agents|antiviral agents|mesh-ancestor
5999226|NCT00193063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5999227|NCT00193063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5999228|NCT00193063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5999229|NCT00193063|Immunologic Factors|immunologic factors|mesh-ancestor
5999230|NCT00193063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999231|NCT00193063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5999232|NCT00193128|Docetaxel|docetaxel|mesh-list
5999233|NCT00193128|Capecitabine|capecitabine|mesh-list
5999234|NCT00193128|Oxaliplatin|oxaliplatin|mesh-list
5999235|NCT00193128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5999236|NCT00193128|Tubulin Modulators|tubulin modulators|mesh-ancestor
5999237|NCT00193128|Antimitotic Agents|antimitotic agents|mesh-ancestor
5999238|NCT00193128|Mitosis Modulators|mitosis modulators|mesh-ancestor
5999239|NCT00193128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999240|NCT00193128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5999241|NCT00193128|Antimetabolites|antimetabolites|mesh-ancestor
5999242|NCT00193180|Docetaxel|docetaxel|mesh-list
5999243|NCT00193180|Imatinib Mesylate|imatinib mesylate|mesh-list
5999244|NCT00193180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5999245|NCT00193180|Tubulin Modulators|tubulin modulators|mesh-ancestor
5999246|NCT00193180|Antimitotic Agents|antimitotic agents|mesh-ancestor
5999247|NCT00193180|Mitosis Modulators|mitosis modulators|mesh-ancestor
5999248|NCT00193180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999249|NCT00193180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5999250|NCT00193180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5999251|NCT00193206|Gemcitabine|gemcitabine|mesh-list
5999252|NCT00193206|Paclitaxel|paclitaxel|mesh-list
5999253|NCT00193206|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5999254|NCT00193206|Epirubicin|epirubicin|mesh-list
5999255|NCT00193206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5999256|NCT00193206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5999257|NCT00193206|Tubulin Modulators|tubulin modulators|mesh-ancestor
5999258|NCT00193206|Antimitotic Agents|antimitotic agents|mesh-ancestor
5999259|NCT00193206|Mitosis Modulators|mitosis modulators|mesh-ancestor
5999260|NCT00193206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999261|NCT00193206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5999262|NCT00193206|Antimetabolites|antimetabolites|mesh-ancestor
5999263|NCT00193206|Antiviral Agents|antiviral agents|mesh-ancestor
5999264|NCT00193206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5999265|NCT00193206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5999266|NCT00193206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5999267|NCT00193206|Immunologic Factors|immunologic factors|mesh-ancestor
5999268|NCT00193206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999269|NCT00193206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5999270|NCT00193206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5999271|NCT00193206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5999272|NCT00193258|Bevacizumab|bevacizumab|mesh-list
5999273|NCT00193258|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5999274|NCT00193258|Imatinib Mesylate|imatinib mesylate|mesh-list
5999275|NCT00193258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5999276|NCT00193258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5999277|NCT00193258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5999278|NCT00193258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5999279|NCT00193258|Growth Substances|growth substances|mesh-ancestor
5999280|NCT00193258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999281|NCT00193258|Growth Inhibitors|growth inhibitors|mesh-ancestor
5999282|NCT00193258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5999283|NCT00193258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5999284|NCT00193258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999285|NCT00193375|Bevacizumab|bevacizumab|mesh-list
5999286|NCT00193375|Carboplatin|carboplatin|mesh-list
5999287|NCT00193375|Irinotecan|irinotecan|mesh-list
5999288|NCT00193375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5999289|NCT00193375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5999290|NCT00193375|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5999291|NCT00193375|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5999292|NCT00193375|Growth Substances|growth substances|mesh-ancestor
5999293|NCT00193375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999294|NCT00193375|Growth Inhibitors|growth inhibitors|mesh-ancestor
5999295|NCT00193375|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5999296|NCT00193375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5999297|NCT00193375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5999298|NCT00193375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999299|NCT00193414|Gemcitabine|gemcitabine|mesh-list
5999300|NCT00193414|Pemetrexed|pemetrexed|mesh-list
5999301|NCT00193414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5999302|NCT00193414|Antimetabolites|antimetabolites|mesh-ancestor
5999303|NCT00193414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999304|NCT00193414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5999305|NCT00193414|Antiviral Agents|antiviral agents|mesh-ancestor
5999306|NCT00193414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5999307|NCT00193414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5999308|NCT00193414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5999309|NCT00193414|Immunologic Factors|immunologic factors|mesh-ancestor
5999310|NCT00193414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999311|NCT00193414|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6259635|NCT03124121|Immunologic Factors|immunologic factors|mesh-ancestor
5999312|NCT00193414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5999313|NCT00193427|Gemcitabine|gemcitabine|mesh-list
5999314|NCT00193427|Carboplatin|carboplatin|mesh-list
5999315|NCT00193427|Docetaxel|docetaxel|mesh-list
5999316|NCT00193427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5999317|NCT00193427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5999318|NCT00193427|Antimetabolites|antimetabolites|mesh-ancestor
5999319|NCT00193427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999320|NCT00193427|Antiviral Agents|antiviral agents|mesh-ancestor
5999321|NCT00193427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5999322|NCT00193427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5999323|NCT00193427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5999324|NCT00193427|Immunologic Factors|immunologic factors|mesh-ancestor
5999325|NCT00193427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999326|NCT00193427|Tubulin Modulators|tubulin modulators|mesh-ancestor
5999327|NCT00193427|Antimitotic Agents|antimitotic agents|mesh-ancestor
5999328|NCT00193427|Mitosis Modulators|mitosis modulators|mesh-ancestor
5999329|NCT00193453|Gemcitabine|gemcitabine|mesh-list
5999330|NCT00193453|Docetaxel|docetaxel|mesh-list
5999331|NCT00193453|Cetuximab|cetuximab|mesh-list
5999332|NCT00193453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5999333|NCT00193453|Antimetabolites|antimetabolites|mesh-ancestor
5999334|NCT00193453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999335|NCT00193453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5999336|NCT00193453|Antiviral Agents|antiviral agents|mesh-ancestor
5999337|NCT00193453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5999338|NCT00193453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5999339|NCT00193453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5999340|NCT00193453|Immunologic Factors|immunologic factors|mesh-ancestor
5999341|NCT00193453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999342|NCT00193453|Tubulin Modulators|tubulin modulators|mesh-ancestor
5999343|NCT00193453|Antimitotic Agents|antimitotic agents|mesh-ancestor
5999344|NCT00193453|Mitosis Modulators|mitosis modulators|mesh-ancestor
5999345|NCT00193453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5999346|NCT00193479|Prednisone|prednisone|mesh-list
5999347|NCT00193479|Cyclophosphamide|cyclophosphamide|mesh-list
5999348|NCT00193479|Rituximab|rituximab|mesh-list
5999349|NCT00193479|Vincristine|vincristine|mesh-list
5999350|NCT00193479|Mitoxantrone|mitoxantrone|mesh-list
5999351|NCT00193479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5999352|NCT00193479|Immunologic Factors|immunologic factors|mesh-ancestor
5999353|NCT00193479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999354|NCT00193479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5999355|NCT00193479|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5999356|NCT00193479|Alkylating Agents|alkylating agents|mesh-ancestor
5999357|NCT00193479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999358|NCT00193479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5999359|NCT00193479|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5999360|NCT00193479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5999361|NCT00193479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5999362|NCT00193479|Glucocorticoids|glucocorticoids|mesh-ancestor
5999363|NCT00193479|Hormones|hormones|mesh-ancestor
5999364|NCT00193479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5999365|NCT00193479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5999366|NCT00193479|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5999367|NCT00193479|Tubulin Modulators|tubulin modulators|mesh-ancestor
5999368|NCT00193479|Antimitotic Agents|antimitotic agents|mesh-ancestor
5999369|NCT00193479|Mitosis Modulators|mitosis modulators|mesh-ancestor
5999370|NCT00193479|Analgesics|analgesics|mesh-ancestor
5999371|NCT00193479|Sensory System Agents|sensory system agents|mesh-ancestor
5999372|NCT00193479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5999373|NCT00193479|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5999374|NCT00193479|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5999375|NCT00193479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5999376|NCT00193492|Bevacizumab|bevacizumab|mesh-list
5999377|NCT00193492|Rituximab|rituximab|mesh-list
5999378|NCT00193492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5999379|NCT00193492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5999380|NCT00193492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5999381|NCT00193492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5999382|NCT00193492|Growth Substances|growth substances|mesh-ancestor
5999383|NCT00193492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999384|NCT00193492|Growth Inhibitors|growth inhibitors|mesh-ancestor
5999385|NCT00193492|Immunologic Factors|immunologic factors|mesh-ancestor
5999386|NCT00193492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5999387|NCT00193596|Gemcitabine|gemcitabine|mesh-list
5999388|NCT00193596|Paclitaxel|paclitaxel|mesh-list
5999389|NCT00193596|Etoposide|etoposide|mesh-list
5999390|NCT00193596|Carboplatin|carboplatin|mesh-list
5999391|NCT00193596|Irinotecan|irinotecan|mesh-list
5999392|NCT00193596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5999393|NCT00193596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5999394|NCT00193596|Tubulin Modulators|tubulin modulators|mesh-ancestor
5999395|NCT00193596|Antimitotic Agents|antimitotic agents|mesh-ancestor
5999396|NCT00193596|Mitosis Modulators|mitosis modulators|mesh-ancestor
5999397|NCT00193596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999398|NCT00193596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5999399|NCT00193596|Antimetabolites|antimetabolites|mesh-ancestor
5999400|NCT00193596|Antiviral Agents|antiviral agents|mesh-ancestor
5999401|NCT00193596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5999402|NCT00193596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5999403|NCT00193596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5999404|NCT00193596|Immunologic Factors|immunologic factors|mesh-ancestor
5999405|NCT00193596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999406|NCT00193596|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5999407|NCT00193596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5999408|NCT00193596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5999409|NCT00193609|Capecitabine|capecitabine|mesh-list
5999410|NCT00193609|Oxaliplatin|oxaliplatin|mesh-list
5999411|NCT00193609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5999412|NCT00193609|Antimetabolites|antimetabolites|mesh-ancestor
5999413|NCT00193609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999414|NCT00193609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5999415|NCT00194012|Aripiprazole|aripiprazole|mesh-list
5999416|NCT00194012|Antidepressive Agents|antidepressive agents|mesh-ancestor
5999417|NCT00194012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5999418|NCT00194012|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5999419|NCT00194012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5999420|NCT00194012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5999421|NCT00194012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259636|NCT03124121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999422|NCT00194012|Dopamine Agonists|dopamine agonists|mesh-ancestor
5999423|NCT00194012|Dopamine Agents|dopamine agents|mesh-ancestor
5999424|NCT00194012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5999425|NCT00194012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999426|NCT00194012|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5999427|NCT00194012|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5999428|NCT00194012|Serotonin Agents|serotonin agents|mesh-ancestor
5999429|NCT00194012|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5999430|NCT00194012|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5999431|NCT00194012|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5999432|NCT00194012|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5999433|NCT00194025|Valproic Acid|valproic acid|mesh-list
5999434|NCT00194025|Anticonvulsants|anticonvulsants|mesh-ancestor
5999435|NCT00194025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5999436|NCT00194025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999437|NCT00194025|GABA Agents|gaba agents|mesh-ancestor
5999438|NCT00194025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5999439|NCT00194025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999440|NCT00194025|Antimanic Agents|antimanic agents|mesh-ancestor
5999441|NCT00194025|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5999442|NCT00194025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5999443|NCT00194025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5999444|NCT00194077|Aripiprazole|aripiprazole|mesh-list
6259637|NCT03124199|Rifaximin|rifaximin|mesh-list
6259638|NCT03124199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6259639|NCT03124199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6259640|NCT03124199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6259641|NCT03124407|Capsaicin|capsaicin|mesh-list
6259642|NCT03124407|Antipruritics|antipruritics|mesh-ancestor
6259643|NCT03124407|Dermatologic Agents|dermatologic agents|mesh-ancestor
6259644|NCT03124407|Sensory System Agents|sensory system agents|mesh-ancestor
6259645|NCT03124407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6259646|NCT03124407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259647|NCT03125395|Ivacaftor|ivacaftor|mesh-list
6259648|NCT03125395|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6259649|NCT03125395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6259650|NCT03125395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259651|NCT03125629|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6259652|NCT03125629|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6259653|NCT03125629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999445|NCT00194077|Antidepressive Agents|antidepressive agents|mesh-ancestor
5999446|NCT00194077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5999447|NCT00194077|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5999448|NCT00194077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5999449|NCT00194077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5999450|NCT00194077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999451|NCT00194077|Dopamine Agonists|dopamine agonists|mesh-ancestor
5999452|NCT00194077|Dopamine Agents|dopamine agents|mesh-ancestor
5999453|NCT00194077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5999454|NCT00194077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999455|NCT00194077|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5999456|NCT00194077|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5999457|NCT00194077|Serotonin Agents|serotonin agents|mesh-ancestor
5999458|NCT00194077|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5999459|NCT00194077|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5999460|NCT00194077|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5999461|NCT00194077|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5999462|NCT00194116|Valproic Acid|valproic acid|mesh-list
5999463|NCT00194116|Anticonvulsants|anticonvulsants|mesh-ancestor
5999464|NCT00194116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5999465|NCT00194116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999466|NCT00194116|GABA Agents|gaba agents|mesh-ancestor
5999467|NCT00194116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5999468|NCT00194116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999469|NCT00194116|Antimanic Agents|antimanic agents|mesh-ancestor
5999470|NCT00194116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5999471|NCT00194116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5999472|NCT00194116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5999473|NCT00194129|Valproic Acid|valproic acid|mesh-list
5999474|NCT00194129|Lithium Carbonate|lithium carbonate|mesh-list
5999475|NCT00194129|Antidepressive Agents|antidepressive agents|mesh-ancestor
5999476|NCT00194129|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5999477|NCT00194129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5999478|NCT00194129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999479|NCT00194129|Antimanic Agents|antimanic agents|mesh-ancestor
5999480|NCT00194129|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5999481|NCT00194129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5999482|NCT00194129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999483|NCT00194129|Anticonvulsants|anticonvulsants|mesh-ancestor
5999484|NCT00194129|GABA Agents|gaba agents|mesh-ancestor
5999485|NCT00194129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5999486|NCT00194532|Ciprofloxacin|ciprofloxacin|mesh-list
5999487|NCT00194532|Cefpodoxime|cefpodoxime|mesh-list
5999488|NCT00194532|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
5999489|NCT00194532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5999490|NCT00194532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5999491|NCT00194532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5999492|NCT00194532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5999493|NCT00194532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5999494|NCT00194532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999495|NCT00194532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5999496|NCT00194532|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5999497|NCT00194532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5999498|NCT00194610|Botulinum Toxins|botulinum toxins|mesh-list
5999499|NCT00194610|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5999500|NCT00194610|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5999501|NCT00194610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5999502|NCT00194610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999503|NCT00194610|Cholinergic Agents|cholinergic agents|mesh-ancestor
5999504|NCT00194610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5999505|NCT00194610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999506|NCT00194610|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5999507|NCT00194610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5999508|NCT00194675|Testosterone|testosterone|mesh-list
5999509|NCT00194675|Dutasteride|dutasteride|mesh-list
5999510|NCT00194675|Androgens|androgens|mesh-ancestor
5999511|NCT00194675|Hormones|hormones|mesh-ancestor
5999512|NCT00194675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5999513|NCT00194675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999514|NCT00194675|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
5999515|NCT00194675|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5999516|NCT00194675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5999517|NCT00194675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999518|NCT00194675|Hormone Antagonists|hormone antagonists|mesh-ancestor
5999519|NCT00194779|Tamoxifen|tamoxifen|mesh-list
5999520|NCT00194779|Vinorelbine|vinorelbine|mesh-list
5999521|NCT00194779|Cyclophosphamide|cyclophosphamide|mesh-list
5999522|NCT00194779|Doxorubicin|doxorubicin|mesh-list
5999523|NCT00194779|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5999524|NCT00194779|Capecitabine|capecitabine|mesh-list
5999525|NCT00194779|Methotrexate|methotrexate|mesh-list
5999526|NCT00194779|Trastuzumab|trastuzumab|mesh-list
5999527|NCT00194779|Letrozole|letrozole|mesh-list
5999528|NCT00194779|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5999529|NCT00194779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5999530|NCT00194779|Tubulin Modulators|tubulin modulators|mesh-ancestor
5999531|NCT00194779|Antimitotic Agents|antimitotic agents|mesh-ancestor
5999532|NCT00194779|Mitosis Modulators|mitosis modulators|mesh-ancestor
5999533|NCT00194779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999534|NCT00194779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5999535|NCT00194779|Immunologic Factors|immunologic factors|mesh-ancestor
5999536|NCT00194779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999537|NCT00194779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5999538|NCT00194779|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5999539|NCT00194779|Alkylating Agents|alkylating agents|mesh-ancestor
5999540|NCT00194779|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5999541|NCT00194779|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5999542|NCT00194779|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5999543|NCT00194779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5999544|NCT00194779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5999545|NCT00194779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5999546|NCT00194779|Antimetabolites|antimetabolites|mesh-ancestor
5999547|NCT00194779|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5999548|NCT00194779|Abortifacient Agents|abortifacient agents|mesh-ancestor
5999549|NCT00194779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5999550|NCT00194779|Dermatologic Agents|dermatologic agents|mesh-ancestor
5999551|NCT00194779|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5999552|NCT00194779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5999553|NCT00194779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5999554|NCT00194779|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5999555|NCT00194779|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5999556|NCT00194779|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5999557|NCT00194779|Hormone Antagonists|hormone antagonists|mesh-ancestor
5999558|NCT00194779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5999559|NCT00194779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5999560|NCT00194779|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5999561|NCT00194779|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5999562|NCT00194779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5999563|NCT00194792|Paclitaxel|paclitaxel|mesh-list
5999564|NCT00194792|Vinorelbine|vinorelbine|mesh-list
5999565|NCT00194792|Capecitabine|capecitabine|mesh-list
5999566|NCT00194792|Methotrexate|methotrexate|mesh-list
5999567|NCT00194792|Exemestane|exemestane|mesh-list
5999568|NCT00194792|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5999569|NCT00194792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5999570|NCT00194792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5999571|NCT00194792|Tubulin Modulators|tubulin modulators|mesh-ancestor
5999572|NCT00194792|Antimitotic Agents|antimitotic agents|mesh-ancestor
5999573|NCT00194792|Mitosis Modulators|mitosis modulators|mesh-ancestor
5999574|NCT00194792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999575|NCT00194792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5999576|NCT00194792|Antimetabolites|antimetabolites|mesh-ancestor
5999577|NCT00194792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5999578|NCT00194792|Abortifacient Agents|abortifacient agents|mesh-ancestor
5999579|NCT00194792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5999580|NCT00194792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999581|NCT00194792|Dermatologic Agents|dermatologic agents|mesh-ancestor
5999582|NCT00194792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5999583|NCT00194792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5999584|NCT00194792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5999585|NCT00194792|Immunologic Factors|immunologic factors|mesh-ancestor
5999586|NCT00194792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5999587|NCT00194792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5999588|NCT00194792|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5999589|NCT00194792|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5999590|NCT00194792|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5999591|NCT00194792|Hormone Antagonists|hormone antagonists|mesh-ancestor
5999592|NCT00194792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5999593|NCT00194792|Luteolytic Agents|luteolytic agents|mesh-ancestor
5999594|NCT00194792|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5999595|NCT00194792|Contraceptive Agents|contraceptive agents|mesh-ancestor
5999596|NCT00194792|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5999597|NCT00194792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5999598|NCT00194896|Rosiglitazone|rosiglitazone|mesh-list
5999599|NCT00194896|Glyburide|glyburide|mesh-list
5999600|NCT00194896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5999601|NCT00194896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999602|NCT00194987|Prednisone|prednisone|mesh-list
5999603|NCT00194987|Immunoglobulins|immunoglobulins|mesh-list
5999604|NCT00194987|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5999605|NCT00194987|Antibodies|antibodies|mesh-list
5999606|NCT00194987|gamma-Globulins|gamma-globulins|mesh-list
5999607|NCT00194987|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5999608|NCT00194987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5999609|NCT00194987|Glucocorticoids|glucocorticoids|mesh-ancestor
5999610|NCT00194987|Hormones|hormones|mesh-ancestor
5999611|NCT00194987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5999612|NCT00194987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999613|NCT00194987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5999614|NCT00194987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5999615|NCT00194987|Immunologic Factors|immunologic factors|mesh-ancestor
5999616|NCT00195039|Antibodies|antibodies|mesh-list
5999617|NCT00195039|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5999618|NCT00195039|Immunologic Factors|immunologic factors|mesh-ancestor
5999619|NCT00195039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999620|NCT00195273|Cyclosporine|cyclosporine|mesh-list
5999621|NCT00195273|Sirolimus|sirolimus|mesh-list
5999622|NCT00195273|Mycophenolic Acid|mycophenolic acid|mesh-list
5999623|NCT00195273|Cyclosporins|cyclosporins|mesh-list
5999624|NCT00195273|Daclizumab|daclizumab|mesh-list
5999625|NCT00195273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5999626|NCT00195273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999627|NCT00195273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5999628|NCT00195273|Immunologic Factors|immunologic factors|mesh-ancestor
5999629|NCT00195273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999630|NCT00195273|Antifungal Agents|antifungal agents|mesh-ancestor
5999631|NCT00195273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5999632|NCT00195273|Dermatologic Agents|dermatologic agents|mesh-ancestor
5999633|NCT00195273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5999634|NCT00195273|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5999635|NCT00195273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5999636|NCT00195273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5999637|NCT00195273|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5999638|NCT00195273|Antitubercular Agents|antitubercular agents|mesh-ancestor
5999639|NCT00195273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5999640|NCT00195338|Etanercept|etanercept|mesh-list
5999641|NCT00195338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5999642|NCT00195338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5999643|NCT00195338|Analgesics|analgesics|mesh-ancestor
5999644|NCT00195338|Sensory System Agents|sensory system agents|mesh-ancestor
5999645|NCT00195338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5999646|NCT00195338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999647|NCT00195338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5999648|NCT00195338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5999649|NCT00195338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5999650|NCT00195338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5999651|NCT00195338|Immunologic Factors|immunologic factors|mesh-ancestor
5999652|NCT00195351|Metronidazole|metronidazole|mesh-list
5999653|NCT00195351|Ceftriaxone|ceftriaxone|mesh-list
5999654|NCT00195351|Tigecycline|tigecycline|mesh-list
5999655|NCT00195351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5999656|NCT00195351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5999657|NCT00195351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5999658|NCT00195351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5999659|NCT00195351|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5999660|NCT00195351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5999661|NCT00195351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999662|NCT00195403|Etanercept|etanercept|mesh-list
5999663|NCT00195403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5999664|NCT00195403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5999665|NCT00195403|Analgesics|analgesics|mesh-ancestor
5999666|NCT00195403|Sensory System Agents|sensory system agents|mesh-ancestor
5999667|NCT00195403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5999668|NCT00195403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999669|NCT00195403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5999670|NCT00195403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5999671|NCT00195403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5999672|NCT00195403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5999673|NCT00195403|Immunologic Factors|immunologic factors|mesh-ancestor
5999674|NCT00195429|Sirolimus|sirolimus|mesh-list
5999675|NCT00195429|Prednisone|prednisone|mesh-list
5999676|NCT00195429|Tacrolimus|tacrolimus|mesh-list
5999677|NCT00195429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5999678|NCT00195429|Glucocorticoids|glucocorticoids|mesh-ancestor
5999679|NCT00195429|Hormones|hormones|mesh-ancestor
5999680|NCT00195429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5999681|NCT00195429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999682|NCT00195429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5999683|NCT00195429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5999684|NCT00195429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5999685|NCT00195429|Immunologic Factors|immunologic factors|mesh-ancestor
5999686|NCT00195429|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5999687|NCT00195429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5999688|NCT00195429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999689|NCT00195429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5999690|NCT00195429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5999691|NCT00195429|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5999692|NCT00195429|Antifungal Agents|antifungal agents|mesh-ancestor
5999693|NCT00195442|Factor VIII|factor viii|mesh-list
5999694|NCT00195442|Coagulants|coagulants|mesh-ancestor
5999695|NCT00195494|Etanercept|etanercept|mesh-list
5999696|NCT00195494|Methotrexate|methotrexate|mesh-list
5999697|NCT00195494|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5999698|NCT00195494|Abortifacient Agents|abortifacient agents|mesh-ancestor
5999699|NCT00195494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5999700|NCT00195494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999701|NCT00195494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5999702|NCT00195494|Antimetabolites|antimetabolites|mesh-ancestor
5999703|NCT00195494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999704|NCT00195494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5999705|NCT00195494|Dermatologic Agents|dermatologic agents|mesh-ancestor
5999706|NCT00195494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5999707|NCT00195494|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5999708|NCT00195494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5999709|NCT00195494|Immunologic Factors|immunologic factors|mesh-ancestor
5999710|NCT00195494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5999711|NCT00195494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5999712|NCT00195494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5999713|NCT00195494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5999714|NCT00195494|Analgesics|analgesics|mesh-ancestor
5999715|NCT00195494|Sensory System Agents|sensory system agents|mesh-ancestor
5999716|NCT00195494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5999717|NCT00195494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5999718|NCT00195494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5999719|NCT00195507|Etanercept|etanercept|mesh-list
5999720|NCT00195507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5999721|NCT00195507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5999722|NCT00195507|Analgesics|analgesics|mesh-ancestor
5999723|NCT00195507|Sensory System Agents|sensory system agents|mesh-ancestor
5999724|NCT00195507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5999725|NCT00195507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999726|NCT00195507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5999727|NCT00195507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5999728|NCT00195507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5999729|NCT00195507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5999730|NCT00195507|Immunologic Factors|immunologic factors|mesh-ancestor
5999731|NCT00195624|Cyclosporine|cyclosporine|mesh-list
5999732|NCT00195624|Alemtuzumab|alemtuzumab|mesh-list
5999733|NCT00195624|Cyclosporins|cyclosporins|mesh-list
5999734|NCT00195624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5999735|NCT00195624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999736|NCT00195624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5999737|NCT00195624|Immunologic Factors|immunologic factors|mesh-ancestor
5999738|NCT00195624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999739|NCT00195624|Antifungal Agents|antifungal agents|mesh-ancestor
5999740|NCT00195624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5999741|NCT00195624|Dermatologic Agents|dermatologic agents|mesh-ancestor
5999742|NCT00195624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5999743|NCT00195624|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5999744|NCT00195624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5999745|NCT00195624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6259666|NCT03125941|Dexamethasone|dexamethasone|mesh-list
6259667|NCT03125941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6259668|NCT03125941|Antiemetics|antiemetics|mesh-ancestor
6259669|NCT03125941|Autonomic Agents|autonomic agents|mesh-ancestor
6259670|NCT03125941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6259671|NCT03125941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259672|NCT03125941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6259673|NCT03125941|Glucocorticoids|glucocorticoids|mesh-ancestor
6259674|NCT03125941|Hormones|hormones|mesh-ancestor
6259675|NCT03125941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6259676|NCT03125941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6259677|NCT03125941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6259678|NCT03126370|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
6259679|NCT03126370|Emtricitabine|emtricitabine|mesh-list
6259680|NCT03126370|Tenofovir|tenofovir|mesh-list
6259681|NCT03126370|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
6259682|NCT03126370|Protease Inhibitors|protease inhibitors|mesh-list
6259683|NCT03126370|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6259684|NCT03126370|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6259685|NCT03126370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6259686|NCT03126370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259687|NCT03126370|Antiviral Agents|antiviral agents|mesh-ancestor
6259688|NCT03126370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6259689|NCT03126370|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6259690|NCT03126370|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6259691|NCT03126370|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6259692|NCT03126539|Sulforaphane|sulforaphane|mesh-list
6259693|NCT03126539|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6259694|NCT03126539|Protective Agents|protective agents|mesh-ancestor
6259695|NCT03126539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259696|NCT03126539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6259697|NCT03126682|Bupropion|bupropion|mesh-list
6259698|NCT03126682|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6259699|NCT03126682|Antidepressive Agents|antidepressive agents|mesh-ancestor
6259700|NCT03126682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6259701|NCT03126682|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6259702|NCT03126682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6259703|NCT03126682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6259704|NCT03126682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259705|NCT03126682|Dopamine Agents|dopamine agents|mesh-ancestor
6259706|NCT03126682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6259707|NCT03126682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259708|NCT03126682|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6259709|NCT03126682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6259710|NCT03126682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6259711|NCT03126760|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6259712|NCT03126760|Hormones|hormones|mesh-ancestor
6259713|NCT03126760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6259714|NCT03126760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259715|NCT03126786|Triamcinolone|triamcinolone|mesh-list
6259716|NCT03126786|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6259717|NCT03126786|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6259718|NCT03126786|Aflibercept|aflibercept|mesh-list
6259719|NCT03126786|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6259720|NCT03126786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6259721|NCT03126786|Glucocorticoids|glucocorticoids|mesh-ancestor
6259722|NCT03126786|Hormones|hormones|mesh-ancestor
6389849|NCT00189553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5999746|NCT00195650|Adalimumab|adalimumab|mesh-list
5999747|NCT00195650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5999748|NCT00195650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5999749|NCT00195663|Adalimumab|adalimumab|mesh-list
5999750|NCT00195663|Methotrexate|methotrexate|mesh-list
5999751|NCT00195663|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5999752|NCT00195663|Abortifacient Agents|abortifacient agents|mesh-ancestor
5999753|NCT00195663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5999754|NCT00195663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999755|NCT00195663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5999756|NCT00195663|Antimetabolites|antimetabolites|mesh-ancestor
5999757|NCT00195663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999758|NCT00195663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5999759|NCT00195663|Dermatologic Agents|dermatologic agents|mesh-ancestor
5999760|NCT00195663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5999761|NCT00195663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5999762|NCT00195663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5999763|NCT00195663|Immunologic Factors|immunologic factors|mesh-ancestor
5999764|NCT00195663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5999765|NCT00195663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5999766|NCT00195663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5999767|NCT00195676|Adalimumab|adalimumab|mesh-list
5999768|NCT00195676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5999769|NCT00195676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6017848|NCT00376675|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6017849|NCT00376675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017850|NCT00376675|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6017851|NCT00376675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6017852|NCT00376675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6017853|NCT00376675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017854|NCT00376675|Dopamine Agents|dopamine agents|mesh-ancestor
6017855|NCT00376675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6017856|NCT00376688|Sirolimus|sirolimus|mesh-list
6017857|NCT00376688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6017858|NCT00376688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6017859|NCT00376688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6017860|NCT00376688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6017861|NCT00376688|Antifungal Agents|antifungal agents|mesh-ancestor
6017862|NCT00376688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6017863|NCT00376688|Immunologic Factors|immunologic factors|mesh-ancestor
6389850|NCT00189553|Tubulin Modulators|tubulin modulators|mesh-ancestor
5999770|NCT00195702|Adalimumab|adalimumab|mesh-list
5999771|NCT00195702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5999772|NCT00195702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5999773|NCT00195715|Adalimumab|adalimumab|mesh-list
5999774|NCT00195715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5999775|NCT00195715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5999776|NCT00195819|Adalimumab|adalimumab|mesh-list
5999777|NCT00195819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5999778|NCT00195819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5999779|NCT00196313|Levonorgestrel|levonorgestrel|mesh-list
5999780|NCT00196313|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5999781|NCT00196313|Contraceptive Agents|contraceptive agents|mesh-ancestor
5999782|NCT00196313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5999783|NCT00196313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999784|NCT00196313|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5999785|NCT00196313|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5999786|NCT00196313|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5999787|NCT00196326|Levonorgestrel|levonorgestrel|mesh-list
5999788|NCT00196326|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5999789|NCT00196326|Estradiol|estradiol|mesh-list
5999790|NCT00196326|Estrogens|estrogens|mesh-ancestor
5999791|NCT00196326|Hormones|hormones|mesh-ancestor
5999792|NCT00196326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5999793|NCT00196326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999794|NCT00196326|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5999795|NCT00196326|Contraceptive Agents|contraceptive agents|mesh-ancestor
5999796|NCT00196326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5999797|NCT00196326|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5999798|NCT00196326|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5999799|NCT00196326|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5999800|NCT00196326|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5999801|NCT00196976|Edetic Acid|edetic acid|mesh-list
5999802|NCT00196976|Vaccines|vaccines|mesh-list
5999803|NCT00196976|Pentetic Acid|pentetic acid|mesh-list
5999804|NCT00196976|Immunologic Factors|immunologic factors|mesh-ancestor
5999805|NCT00196976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999806|NCT00196976|Antidotes|antidotes|mesh-ancestor
5999807|NCT00196976|Protective Agents|protective agents|mesh-ancestor
5999808|NCT00196976|Chelating Agents|chelating agents|mesh-ancestor
5999809|NCT00196976|Sequestering Agents|sequestering agents|mesh-ancestor
5999810|NCT00196976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999811|NCT00196976|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5999812|NCT00196976|Anticoagulants|anticoagulants|mesh-ancestor
5999813|NCT00196976|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5999814|NCT00197002|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5999815|NCT00197002|Immunologic Factors|immunologic factors|mesh-ancestor
5999816|NCT00197002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999817|NCT00197106|Fluticasone|fluticasone|mesh-list
5999818|NCT00197106|Xhance|xhance|mesh-list
5999819|NCT00197106|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5999820|NCT00197106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5999821|NCT00197106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5999822|NCT00197106|Autonomic Agents|autonomic agents|mesh-ancestor
5999823|NCT00197106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5999824|NCT00197106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999825|NCT00197106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5999826|NCT00197106|Respiratory System Agents|respiratory system agents|mesh-ancestor
5999827|NCT00197106|Dermatologic Agents|dermatologic agents|mesh-ancestor
5999828|NCT00197106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5999829|NCT00197106|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5999830|NCT00197106|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5999831|NCT00197106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5999832|NCT00197106|Adrenergic Agents|adrenergic agents|mesh-ancestor
5999833|NCT00197106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5999834|NCT00197106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999835|NCT00197145|Aplaviroc|aplaviroc|mesh-list
5999836|NCT00197145|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5999837|NCT00197145|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5999838|NCT00197145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999839|NCT00197145|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5999840|NCT00197145|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5999841|NCT00197145|Antiviral Agents|antiviral agents|mesh-ancestor
5999842|NCT00197145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5999843|NCT00197184|Vaccines|vaccines|mesh-list
5999844|NCT00197184|Immunologic Factors|immunologic factors|mesh-ancestor
5999845|NCT00197184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999846|NCT00198029|Hylan|hylan|mesh-list
5999847|NCT00198029|Viscosupplements|viscosupplements|mesh-ancestor
5999848|NCT00198029|Protective Agents|protective agents|mesh-ancestor
5999849|NCT00198029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999850|NCT00198081|Celecoxib|celecoxib|mesh-list
5999851|NCT00198081|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
5999852|NCT00198081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5999853|NCT00198081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5999854|NCT00198081|Analgesics|analgesics|mesh-ancestor
5999855|NCT00198081|Sensory System Agents|sensory system agents|mesh-ancestor
5999856|NCT00198081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5999857|NCT00198081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999858|NCT00198081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5999859|NCT00198081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5999860|NCT00198081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5999861|NCT00198081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5999862|NCT00198081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999863|NCT00198107|Cycloserine|cycloserine|mesh-list
5999864|NCT00198107|Aripiprazole|aripiprazole|mesh-list
5999865|NCT00198107|Antidepressive Agents|antidepressive agents|mesh-ancestor
5999866|NCT00198107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5999867|NCT00198107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5999868|NCT00198107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5999869|NCT00198107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5999870|NCT00198107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999871|NCT00198107|Dopamine Agonists|dopamine agonists|mesh-ancestor
5999872|NCT00198107|Dopamine Agents|dopamine agents|mesh-ancestor
5999873|NCT00198107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5999874|NCT00198107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999875|NCT00198107|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5999876|NCT00198107|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5999877|NCT00198107|Serotonin Agents|serotonin agents|mesh-ancestor
5999878|NCT00198107|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5999879|NCT00198107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5999880|NCT00198107|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5999881|NCT00198107|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5999882|NCT00198107|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5999883|NCT00198107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5999884|NCT00198107|Renal Agents|renal agents|mesh-ancestor
5999885|NCT00198107|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5999886|NCT00198107|Antitubercular Agents|antitubercular agents|mesh-ancestor
5999887|NCT00198107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5999888|NCT00198107|Antimetabolites|antimetabolites|mesh-ancestor
5999889|NCT00198133|Pemetrexed|pemetrexed|mesh-list
5999890|NCT00198133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5999891|NCT00198133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5999892|NCT00198133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999893|NCT00198133|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5999894|NCT00198133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5999895|NCT00198822|Vitamin A|vitamin a|mesh-list
5999896|NCT00198822|Beta Carotene|beta carotene|mesh-list
5999897|NCT00198822|Carotenoids|carotenoids|mesh-list
5999898|NCT00198822|Vitamins|vitamins|mesh-ancestor
5999899|NCT00198822|Micronutrients|micronutrients|mesh-ancestor
5999900|NCT00198822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999901|NCT00198822|Antioxidants|antioxidants|mesh-ancestor
5999902|NCT00198822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999903|NCT00198822|Protective Agents|protective agents|mesh-ancestor
5999904|NCT00198822|Provitamins|provitamins|mesh-ancestor
5999905|NCT00199381|Istradefylline|istradefylline|mesh-list
5999906|NCT00199381|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
5999907|NCT00199381|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5999908|NCT00199381|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5999909|NCT00199381|Purinergic Agents|purinergic agents|mesh-ancestor
5999910|NCT00199381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5999911|NCT00199381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999912|NCT00199381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999913|NCT00199797|Leucovorin|leucovorin|mesh-list
5999914|NCT00199797|Fluorouracil|fluorouracil|mesh-list
5999915|NCT00199797|Oxaliplatin|oxaliplatin|mesh-list
5999916|NCT00199797|Antimetabolites|antimetabolites|mesh-ancestor
5999917|NCT00199797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999918|NCT00199797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5999919|NCT00199797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5999920|NCT00199797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5999921|NCT00199797|Immunologic Factors|immunologic factors|mesh-ancestor
5999922|NCT00199797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999923|NCT00199797|Antidotes|antidotes|mesh-ancestor
5999924|NCT00199797|Protective Agents|protective agents|mesh-ancestor
5999925|NCT00199797|Vitamin B Complex|vitamin b complex|mesh-ancestor
5999926|NCT00199797|Vitamins|vitamins|mesh-ancestor
5999927|NCT00199797|Micronutrients|micronutrients|mesh-ancestor
5999928|NCT00200161|Temozolomide|temozolomide|mesh-list
5999929|NCT00200161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5999930|NCT00200161|Alkylating Agents|alkylating agents|mesh-ancestor
5999931|NCT00200161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999932|NCT00200161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5999933|NCT00200343|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
5999934|NCT00200343|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5999935|NCT00200343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5999936|NCT00200356|Ozagrel|ozagrel|mesh-list
5999937|NCT00200356|Edaravone|edaravone|mesh-list
5999938|NCT00200356|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5999939|NCT00200356|Antioxidants|antioxidants|mesh-ancestor
5999940|NCT00200356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999941|NCT00200356|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5999942|NCT00200356|Protective Agents|protective agents|mesh-ancestor
5999943|NCT00200356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999944|NCT00200356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5999945|NCT00200356|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5999946|NCT00200356|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5999947|NCT00200356|Histamine Antagonists|histamine antagonists|mesh-ancestor
5999948|NCT00200356|Histamine Agents|histamine agents|mesh-ancestor
5999949|NCT00200356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5999950|NCT00200902|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5999951|NCT00200902|Citalopram|citalopram|mesh-list
5999952|NCT00200902|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
5999953|NCT00200902|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5999954|NCT00200902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5999955|NCT00200902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5999956|NCT00200902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999957|NCT00200902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5999958|NCT00200902|Serotonin Agents|serotonin agents|mesh-ancestor
5999959|NCT00200902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999960|NCT00200902|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5999961|NCT00200902|Antidepressive Agents|antidepressive agents|mesh-ancestor
5999962|NCT00200902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5999963|NCT00200902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5999964|NCT00200902|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5999965|NCT00200902|Analgesics|analgesics|mesh-ancestor
5999966|NCT00200902|Sensory System Agents|sensory system agents|mesh-ancestor
5999967|NCT00200902|Dopamine Agents|dopamine agents|mesh-ancestor
5999968|NCT00200967|Beclomethasone|beclomethasone|mesh-list
5999969|NCT00200967|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5999970|NCT00200967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5999971|NCT00200967|Autonomic Agents|autonomic agents|mesh-ancestor
5999972|NCT00200967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5999973|NCT00200967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999974|NCT00200967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5999975|NCT00200967|Respiratory System Agents|respiratory system agents|mesh-ancestor
5999976|NCT00200967|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5999977|NCT00200967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5999978|NCT00200967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5999979|NCT00200967|Adrenergic Agents|adrenergic agents|mesh-ancestor
5999980|NCT00200967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5999981|NCT00200967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5999982|NCT00200967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5999983|NCT00200967|Glucocorticoids|glucocorticoids|mesh-ancestor
5999984|NCT00200967|Hormones|hormones|mesh-ancestor
5999985|NCT00200967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5999986|NCT00201123|Interferons|interferons|mesh-list
5999987|NCT00201123|Interferon-gamma|interferon-gamma|mesh-list
5999988|NCT00201123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5999989|NCT00201123|Antiviral Agents|antiviral agents|mesh-ancestor
5999990|NCT00201123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5999991|NCT00201448|Vaccines|vaccines|mesh-list
5999992|NCT00201448|Immunologic Factors|immunologic factors|mesh-ancestor
5999993|NCT00201448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5999994|NCT00201643|Dexamethasone|dexamethasone|mesh-list
5999995|NCT00201643|Betamethasone|betamethasone|mesh-list
5999996|NCT00201643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5999997|NCT00201643|Antiemetics|antiemetics|mesh-ancestor
5999998|NCT00201643|Autonomic Agents|autonomic agents|mesh-ancestor
5999999|NCT00201643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6000000|NCT00201643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000001|NCT00201643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6000002|NCT00201643|Glucocorticoids|glucocorticoids|mesh-ancestor
6000003|NCT00201643|Hormones|hormones|mesh-ancestor
6000004|NCT00201643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6000005|NCT00201643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6000006|NCT00201643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6000007|NCT00201643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6000008|NCT00201643|Respiratory System Agents|respiratory system agents|mesh-ancestor
6000009|NCT00201734|Paclitaxel|paclitaxel|mesh-list
6000010|NCT00201734|Carboplatin|carboplatin|mesh-list
6000011|NCT00201734|Capecitabine|capecitabine|mesh-list
6000012|NCT00201734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6000013|NCT00201734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6000014|NCT00201734|Tubulin Modulators|tubulin modulators|mesh-ancestor
6000015|NCT00201734|Antimitotic Agents|antimitotic agents|mesh-ancestor
6000016|NCT00201734|Mitosis Modulators|mitosis modulators|mesh-ancestor
6000017|NCT00201734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000018|NCT00201734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6000019|NCT00201734|Antimetabolites|antimetabolites|mesh-ancestor
6000020|NCT00201760|Gemcitabine|gemcitabine|mesh-list
6000021|NCT00201760|Trastuzumab|trastuzumab|mesh-list
6000022|NCT00201760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6000023|NCT00201760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6000024|NCT00201760|Antimetabolites|antimetabolites|mesh-ancestor
6000025|NCT00201760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000026|NCT00201760|Antiviral Agents|antiviral agents|mesh-ancestor
6000027|NCT00201760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6000028|NCT00201760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6000029|NCT00201760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6000030|NCT00201760|Immunologic Factors|immunologic factors|mesh-ancestor
6000031|NCT00201760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000032|NCT00201760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6000033|NCT00201773|Celecoxib|celecoxib|mesh-list
6000034|NCT00201773|Exemestane|exemestane|mesh-list
6000035|NCT00201773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6000036|NCT00201773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6000037|NCT00201773|Analgesics|analgesics|mesh-ancestor
6000038|NCT00201773|Sensory System Agents|sensory system agents|mesh-ancestor
6000039|NCT00201773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6000040|NCT00201773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000041|NCT00201773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6000042|NCT00201773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6000043|NCT00201773|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6000044|NCT00201773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6000045|NCT00201773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6000046|NCT00201773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000047|NCT00201773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6000048|NCT00201773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6000049|NCT00201773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6000050|NCT00201773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6000051|NCT00201773|Hormone Antagonists|hormone antagonists|mesh-ancestor
6000052|NCT00201773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6000053|NCT00201825|Docetaxel|docetaxel|mesh-list
6000054|NCT00201825|Capecitabine|capecitabine|mesh-list
6000055|NCT00201825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6000056|NCT00201825|Tubulin Modulators|tubulin modulators|mesh-ancestor
6000057|NCT00201825|Antimitotic Agents|antimitotic agents|mesh-ancestor
6000058|NCT00201825|Mitosis Modulators|mitosis modulators|mesh-ancestor
6000059|NCT00201825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000060|NCT00201825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6000061|NCT00201825|Antimetabolites|antimetabolites|mesh-ancestor
6000062|NCT00201838|Gemcitabine|gemcitabine|mesh-list
6000063|NCT00201838|Etanercept|etanercept|mesh-list
6000064|NCT00201838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6000065|NCT00201838|Antimetabolites|antimetabolites|mesh-ancestor
6000066|NCT00201838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000067|NCT00201838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6000068|NCT00201838|Antiviral Agents|antiviral agents|mesh-ancestor
6000069|NCT00201838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6000070|NCT00201838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6000071|NCT00201838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6000072|NCT00201838|Immunologic Factors|immunologic factors|mesh-ancestor
6000073|NCT00201838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259723|NCT03126786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6259724|NCT03126786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259725|NCT03126786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6259726|NCT03126786|Immunologic Factors|immunologic factors|mesh-ancestor
6259727|NCT03126786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6259728|NCT03126786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259729|NCT03126786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6259730|NCT03126786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6259731|NCT03126786|Growth Substances|growth substances|mesh-ancestor
6259732|NCT03126786|Growth Inhibitors|growth inhibitors|mesh-ancestor
6259733|NCT03126786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6259734|NCT03127384|Lidocaine|lidocaine|mesh-list
6259735|NCT03127384|Anesthetics, Local|anesthetics, local|mesh-ancestor
6259736|NCT03127384|Anesthetics|anesthetics|mesh-ancestor
6259737|NCT03127384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6259738|NCT03127384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259739|NCT03127384|Sensory System Agents|sensory system agents|mesh-ancestor
6259740|NCT03127384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6259741|NCT03127384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6259742|NCT03127384|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6259743|NCT03127384|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6259744|NCT03127384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6259745|NCT03127384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259746|NCT03127514|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
6259747|NCT03127514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6259748|NCT03127943|Lidocaine|lidocaine|mesh-list
6259749|NCT03127943|Anesthetics, Local|anesthetics, local|mesh-ancestor
6259750|NCT03127943|Anesthetics|anesthetics|mesh-ancestor
6000074|NCT00201838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6000075|NCT00201838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6000076|NCT00201838|Analgesics|analgesics|mesh-ancestor
6000077|NCT00201838|Sensory System Agents|sensory system agents|mesh-ancestor
6000078|NCT00201838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6000079|NCT00201838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6000080|NCT00201838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6000081|NCT00201838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6000082|NCT00201851|Tamoxifen|tamoxifen|mesh-list
6000083|NCT00201851|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6000084|NCT00201851|Hormone Antagonists|hormone antagonists|mesh-ancestor
6000085|NCT00201851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6000086|NCT00201851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000087|NCT00201851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6000088|NCT00201851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6000089|NCT00201851|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6000090|NCT00201851|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6000091|NCT00201851|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6000092|NCT00201864|Fulvestrant|fulvestrant|mesh-list
6000093|NCT00201864|Exemestane|exemestane|mesh-list
6000094|NCT00201864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6000095|NCT00201864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6000096|NCT00201864|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6000097|NCT00201864|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6000098|NCT00201864|Hormone Antagonists|hormone antagonists|mesh-ancestor
6000099|NCT00201864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6000100|NCT00201864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000101|NCT00201864|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6000102|NCT00201864|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6000103|NCT00201864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6000104|NCT00201864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000105|NCT00201877|Rituximab|rituximab|mesh-list
6000106|NCT00201877|Bortezomib|bortezomib|mesh-list
6000107|NCT00201877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6000108|NCT00201877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6000109|NCT00201877|Immunologic Factors|immunologic factors|mesh-ancestor
6000110|NCT00201877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000111|NCT00201877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6000112|NCT00202449|Prazosin|prazosin|mesh-list
6000113|NCT00202449|Paroxetine|paroxetine|mesh-list
6000114|NCT00202449|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6000115|NCT00202449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6000116|NCT00202449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6000117|NCT00202449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000118|NCT00202449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6000119|NCT00202449|Serotonin Agents|serotonin agents|mesh-ancestor
6000120|NCT00202449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000121|NCT00202449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6000122|NCT00202449|Antidepressive Agents|antidepressive agents|mesh-ancestor
6000123|NCT00202449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6000124|NCT00202449|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6000125|NCT00202449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6000126|NCT00202449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6000127|NCT00202449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6000128|NCT00202449|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6000129|NCT00202449|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6000130|NCT00202449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6000131|NCT00202449|Adrenergic Agents|adrenergic agents|mesh-ancestor
6000132|NCT00202644|Hydroxyurea|hydroxyurea|mesh-list
6000133|NCT00202644|Anagrelide|anagrelide|mesh-list
6000134|NCT00202644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6000135|NCT00202644|Antisickling Agents|antisickling agents|mesh-ancestor
6000136|NCT00202644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6000137|NCT00202644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000138|NCT00202644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6000139|NCT00202644|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6000140|NCT00202644|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6000141|NCT00202644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6000142|NCT00202722|Remifentanil|remifentanil|mesh-list
6000143|NCT00202722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6000144|NCT00202722|Narcotics|narcotics|mesh-ancestor
6000145|NCT00202722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6000146|NCT00202722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000147|NCT00202722|Analgesics|analgesics|mesh-ancestor
6000148|NCT00202722|Sensory System Agents|sensory system agents|mesh-ancestor
6000149|NCT00202722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6000150|NCT00202839|Ribavirin|ribavirin|mesh-list
6000151|NCT00202839|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6000152|NCT00202839|Interferon-alpha|interferon-alpha|mesh-list
6000153|NCT00202839|Antimetabolites|antimetabolites|mesh-ancestor
6000154|NCT00202839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000155|NCT00202839|Antiviral Agents|antiviral agents|mesh-ancestor
6000156|NCT00202839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6000157|NCT00202839|Immunologic Factors|immunologic factors|mesh-ancestor
6000158|NCT00202839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000159|NCT00202930|Rituximab|rituximab|mesh-list
6000160|NCT00202930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6000161|NCT00202930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6000162|NCT00202930|Immunologic Factors|immunologic factors|mesh-ancestor
6000163|NCT00202930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000164|NCT00202930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6000165|NCT00203021|Glatiramer Acetate|glatiramer acetate|mesh-list
6000166|NCT00203021|(T,G)-A-L|(t,g)-a-l|mesh-list
6000167|NCT00203021|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6000168|NCT00203021|Immunologic Factors|immunologic factors|mesh-ancestor
6000169|NCT00203021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000170|NCT00203021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6000171|NCT00203021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6000172|NCT00203047|Prednisone|prednisone|mesh-list
6000173|NCT00203047|Glatiramer Acetate|glatiramer acetate|mesh-list
6000174|NCT00203047|(T,G)-A-L|(t,g)-a-l|mesh-list
6000175|NCT00203047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6000176|NCT00203047|Glucocorticoids|glucocorticoids|mesh-ancestor
6000177|NCT00203047|Hormones|hormones|mesh-ancestor
6000178|NCT00203047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6000179|NCT00203047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000180|NCT00203047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6000181|NCT00203047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6000182|NCT00203047|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6000183|NCT00203047|Immunologic Factors|immunologic factors|mesh-ancestor
6000184|NCT00203047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6000185|NCT00203047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6000186|NCT00203216|Levetiracetam|levetiracetam|mesh-list
6000187|NCT00203216|Anticonvulsants|anticonvulsants|mesh-ancestor
6000188|NCT00203216|Nootropic Agents|nootropic agents|mesh-ancestor
6000189|NCT00203229|Lamotrigine|lamotrigine|mesh-list
6000190|NCT00203229|Anticonvulsants|anticonvulsants|mesh-ancestor
6000191|NCT00203229|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6000192|NCT00203229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6000193|NCT00203229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000194|NCT00203229|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6000195|NCT00203229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000196|NCT00203229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6000197|NCT00203229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6000198|NCT00203229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6000199|NCT00203229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6000200|NCT00203229|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6000201|NCT00203242|Valproic Acid|valproic acid|mesh-list
6000202|NCT00203242|Anticonvulsants|anticonvulsants|mesh-ancestor
6000203|NCT00203242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6000204|NCT00203242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000205|NCT00203242|GABA Agents|gaba agents|mesh-ancestor
6000206|NCT00203242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6000207|NCT00203242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000208|NCT00203242|Antimanic Agents|antimanic agents|mesh-ancestor
6000209|NCT00203242|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6000210|NCT00203242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6000211|NCT00203242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6000212|NCT00203268|Dihydroergotamine|dihydroergotamine|mesh-list
6000213|NCT00203268|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6000214|NCT00203268|Dopamine Agonists|dopamine agonists|mesh-ancestor
6000215|NCT00203268|Dopamine Agents|dopamine agents|mesh-ancestor
6000216|NCT00203268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6000217|NCT00203268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000218|NCT00203268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000219|NCT00203268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6259751|NCT03127943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6000220|NCT00203268|Analgesics|analgesics|mesh-ancestor
6000221|NCT00203268|Sensory System Agents|sensory system agents|mesh-ancestor
6000222|NCT00203268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6000223|NCT00203294|Triamcinolone|triamcinolone|mesh-list
6000224|NCT00203294|Lidocaine|lidocaine|mesh-list
6000225|NCT00203294|Bupivacaine|bupivacaine|mesh-list
6000226|NCT00203294|Anesthetics, Local|anesthetics, local|mesh-ancestor
6000227|NCT00203294|Anesthetics|anesthetics|mesh-ancestor
6000228|NCT00203294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6000229|NCT00203294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000230|NCT00203294|Sensory System Agents|sensory system agents|mesh-ancestor
6000231|NCT00203294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6000232|NCT00203294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6000233|NCT00203294|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6000234|NCT00203294|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6000235|NCT00203294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6000236|NCT00203294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000237|NCT00203294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6000238|NCT00203294|Glucocorticoids|glucocorticoids|mesh-ancestor
6000239|NCT00203294|Hormones|hormones|mesh-ancestor
6000240|NCT00203294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6000241|NCT00203307|Olanzapine|olanzapine|mesh-list
6000242|NCT00203307|Antiemetics|antiemetics|mesh-ancestor
6000243|NCT00203307|Autonomic Agents|autonomic agents|mesh-ancestor
6000244|NCT00203307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6000245|NCT00203307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000246|NCT00203307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6000247|NCT00203307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6000248|NCT00203307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6000249|NCT00203307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6000250|NCT00203307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6000251|NCT00203307|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6000252|NCT00203307|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6000253|NCT00203307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6000254|NCT00203307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000255|NCT00203307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6000256|NCT00203307|Serotonin Agents|serotonin agents|mesh-ancestor
6000257|NCT00203411|Bevacizumab|bevacizumab|mesh-list
6000258|NCT00203411|Capecitabine|capecitabine|mesh-list
6000259|NCT00203411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6000260|NCT00203411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6000261|NCT00203411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6000262|NCT00203411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6000263|NCT00203411|Growth Substances|growth substances|mesh-ancestor
6000264|NCT00203411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000265|NCT00203411|Growth Inhibitors|growth inhibitors|mesh-ancestor
6000266|NCT00203411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6000267|NCT00203411|Antimetabolites|antimetabolites|mesh-ancestor
6000268|NCT00203411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000269|NCT00203424|Bevacizumab|bevacizumab|mesh-list
6000270|NCT00203424|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6000271|NCT00203424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6000272|NCT00203424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6000273|NCT00203424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6000274|NCT00203424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6000275|NCT00203424|Growth Substances|growth substances|mesh-ancestor
6000276|NCT00203424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000277|NCT00203424|Growth Inhibitors|growth inhibitors|mesh-ancestor
6000278|NCT00203424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6000279|NCT00203424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6000280|NCT00203424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000281|NCT00203476|Niacin|niacin|mesh-list
6000282|NCT00203476|Ezetimibe|ezetimibe|mesh-list
6000283|NCT00203476|Colestipol|colestipol|mesh-list
6000284|NCT00203476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6000285|NCT00203476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6000286|NCT00203476|Antimetabolites|antimetabolites|mesh-ancestor
6000287|NCT00203476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000288|NCT00203476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6000289|NCT00203476|Vasodilator Agents|vasodilator agents|mesh-ancestor
6000290|NCT00203476|Vitamin B Complex|vitamin b complex|mesh-ancestor
6000291|NCT00203476|Vitamins|vitamins|mesh-ancestor
6000292|NCT00203476|Micronutrients|micronutrients|mesh-ancestor
6000293|NCT00203476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000294|NCT00203476|Sequestering Agents|sequestering agents|mesh-ancestor
6000295|NCT00203502|Cyclophosphamide|cyclophosphamide|mesh-list
6000296|NCT00203502|Bevacizumab|bevacizumab|mesh-list
6000297|NCT00203502|Docetaxel|docetaxel|mesh-list
6000298|NCT00203502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6000299|NCT00203502|Immunologic Factors|immunologic factors|mesh-ancestor
6000300|NCT00203502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000301|NCT00203502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6000302|NCT00203502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6000303|NCT00203502|Alkylating Agents|alkylating agents|mesh-ancestor
6000304|NCT00203502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000305|NCT00203502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6000306|NCT00203502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6000307|NCT00203502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6000308|NCT00203502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6000309|NCT00203502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6000310|NCT00203502|Growth Substances|growth substances|mesh-ancestor
6000311|NCT00203502|Growth Inhibitors|growth inhibitors|mesh-ancestor
6000312|NCT00203502|Tubulin Modulators|tubulin modulators|mesh-ancestor
6000313|NCT00203502|Antimitotic Agents|antimitotic agents|mesh-ancestor
6000314|NCT00203502|Mitosis Modulators|mitosis modulators|mesh-ancestor
6000315|NCT00203931|Pemetrexed|pemetrexed|mesh-list
6000316|NCT00203931|Cetuximab|cetuximab|mesh-list
6000317|NCT00203931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6000318|NCT00203931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6000319|NCT00203931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000320|NCT00203931|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6000321|NCT00203931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6000322|NCT00203931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6000323|NCT00203996|Pioglitazone|pioglitazone|mesh-list
6000324|NCT00203996|Leuprolide|leuprolide|mesh-list
6000325|NCT00203996|Estrogens|estrogens|mesh-list
6000326|NCT00203996|Progestins|progestins|mesh-list
6000327|NCT00203996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6000328|NCT00203996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000329|NCT00203996|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6000330|NCT00203996|Fertility Agents|fertility agents|mesh-ancestor
6000331|NCT00203996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6000332|NCT00203996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6259752|NCT03127943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259753|NCT03127943|Sensory System Agents|sensory system agents|mesh-ancestor
6259754|NCT03127943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6000333|NCT00203996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6000334|NCT00203996|Hormones|hormones|mesh-ancestor
6000335|NCT00203996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6000336|NCT00204373|Lansoprazole|lansoprazole|mesh-list
6000337|NCT00204373|Dexlansoprazole|dexlansoprazole|mesh-list
6000338|NCT00204373|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6000339|NCT00204373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6000340|NCT00204373|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6000341|NCT00204373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6000342|NCT00204373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000343|NCT00205374|Cidofovir|cidofovir|mesh-list
6000344|NCT00205374|Antiviral Agents|antiviral agents|mesh-ancestor
6000345|NCT00205374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6000346|NCT00205374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6000347|NCT00205374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000348|NCT00205504|Moxifloxacin|moxifloxacin|mesh-list
6000349|NCT00205504|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6000350|NCT00205504|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6000351|NCT00205504|Contraceptive Agents|contraceptive agents|mesh-ancestor
6000352|NCT00205504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6000353|NCT00205504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000354|NCT00205504|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6000355|NCT00205504|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6000356|NCT00205504|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6000357|NCT00205504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6000358|NCT00205504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6000359|NCT00205504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6000360|NCT00205504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6000361|NCT00205504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6000362|NCT00205504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000363|NCT00205504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6000364|NCT00205699|Olanzapine|olanzapine|mesh-list
6000365|NCT00205699|Risperidone|risperidone|mesh-list
6000366|NCT00205699|Aripiprazole|aripiprazole|mesh-list
6000367|NCT00205699|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6000368|NCT00205699|Serotonin Agents|serotonin agents|mesh-ancestor
6000369|NCT00205699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6000370|NCT00205699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000371|NCT00205699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000372|NCT00205699|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6000373|NCT00205699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6000374|NCT00205699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6000375|NCT00205699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6000376|NCT00205699|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6000377|NCT00205699|Dopamine Agents|dopamine agents|mesh-ancestor
6000378|NCT00205699|Antiemetics|antiemetics|mesh-ancestor
6000379|NCT00205699|Autonomic Agents|autonomic agents|mesh-ancestor
6000380|NCT00205699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6000381|NCT00205699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6000382|NCT00205699|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6000383|NCT00205699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6000384|NCT00205699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6000385|NCT00205699|Antidepressive Agents|antidepressive agents|mesh-ancestor
6000386|NCT00205699|Dopamine Agonists|dopamine agonists|mesh-ancestor
6000387|NCT00205699|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6000388|NCT00205699|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6000389|NCT00205699|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6000390|NCT00205699|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6000391|NCT00205712|Dexmedetomidine|dexmedetomidine|mesh-list
6000392|NCT00205712|Ketamine|ketamine|mesh-list
6000393|NCT00205712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6000394|NCT00205712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6000395|NCT00205712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000396|NCT00205712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6000397|NCT00205712|Analgesics|analgesics|mesh-ancestor
6000398|NCT00205712|Sensory System Agents|sensory system agents|mesh-ancestor
6000399|NCT00205712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6000400|NCT00205712|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6000401|NCT00205712|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6000402|NCT00205712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6000403|NCT00205712|Adrenergic Agents|adrenergic agents|mesh-ancestor
6000404|NCT00205712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6000405|NCT00205712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000406|NCT00205712|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6000407|NCT00205712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6000408|NCT00205712|Anesthetics, General|anesthetics, general|mesh-ancestor
6000409|NCT00205712|Anesthetics|anesthetics|mesh-ancestor
6000410|NCT00205712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6000411|NCT00205712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6000412|NCT00205777|Bazedoxifene|bazedoxifene|mesh-list
6000413|NCT00205777|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6000414|NCT00205777|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6000415|NCT00205777|Hormone Antagonists|hormone antagonists|mesh-ancestor
6000416|NCT00205777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6000417|NCT00205777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000418|NCT00205777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6000419|NCT00205803|Vaccines|vaccines|mesh-list
6000420|NCT00205803|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6000421|NCT00205803|Immunologic Factors|immunologic factors|mesh-ancestor
6000422|NCT00205803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000423|NCT00206076|Mycophenolic Acid|mycophenolic acid|mesh-list
6000424|NCT00206076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6000425|NCT00206076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6000426|NCT00206076|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6000427|NCT00206076|Antitubercular Agents|antitubercular agents|mesh-ancestor
6000428|NCT00206076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6000429|NCT00206076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6000430|NCT00206076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6000431|NCT00206076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000432|NCT00206102|Risperidone|risperidone|mesh-list
6000433|NCT00206102|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6000434|NCT00206102|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6000435|NCT00206102|Serotonin Agents|serotonin agents|mesh-ancestor
6000436|NCT00206102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6000437|NCT00206102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000438|NCT00206102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000439|NCT00206102|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6000440|NCT00206102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6000441|NCT00206102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6000442|NCT00206102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6000443|NCT00206102|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6000444|NCT00206102|Dopamine Agents|dopamine agents|mesh-ancestor
6000445|NCT00206102|Antidepressive Agents|antidepressive agents|mesh-ancestor
6000446|NCT00206323|Topiramate|topiramate|mesh-list
6000447|NCT00206323|Anticonvulsants|anticonvulsants|mesh-ancestor
6000448|NCT00206323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6000449|NCT00206323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000450|NCT00206336|Topiramate|topiramate|mesh-list
6000451|NCT00206336|Anticonvulsants|anticonvulsants|mesh-ancestor
6000452|NCT00206336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6000453|NCT00206336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000454|NCT00206427|Lapatinib|lapatinib|mesh-list
6000455|NCT00206427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6000456|NCT00206427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6000457|NCT00206427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6000458|NCT00206427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000459|NCT00206440|Esomeprazole|esomeprazole|mesh-list
6000460|NCT00206440|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6000461|NCT00206440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6000462|NCT00206440|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6000463|NCT00206440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6000464|NCT00206440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000465|NCT00206518|Docetaxel|docetaxel|mesh-list
6000466|NCT00206518|Doxorubicin|doxorubicin|mesh-list
6000467|NCT00206518|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6000468|NCT00206518|Cyclophosphamide|cyclophosphamide|mesh-list
6000469|NCT00206518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6259755|NCT03127943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6000470|NCT00206518|Tubulin Modulators|tubulin modulators|mesh-ancestor
6000471|NCT00206518|Antimitotic Agents|antimitotic agents|mesh-ancestor
6000472|NCT00206518|Mitosis Modulators|mitosis modulators|mesh-ancestor
6000473|NCT00206518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000474|NCT00206518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6000475|NCT00206518|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6000476|NCT00206518|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6000477|NCT00206518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6000478|NCT00206518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6000479|NCT00206518|Immunologic Factors|immunologic factors|mesh-ancestor
6000480|NCT00206518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000481|NCT00206518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6000482|NCT00206518|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6000483|NCT00206518|Alkylating Agents|alkylating agents|mesh-ancestor
6000484|NCT00206518|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6000485|NCT00206726|Fludarabine|fludarabine|mesh-list
6000486|NCT00206726|Alemtuzumab|alemtuzumab|mesh-list
6000487|NCT00206726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6000488|NCT00206726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6017864|NCT00376688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017865|NCT00376805|Cyclophosphamide|cyclophosphamide|mesh-list
6017866|NCT00376805|Fludarabine|fludarabine|mesh-list
6017867|NCT00376805|Interleukin-2|interleukin-2|mesh-list
6017868|NCT00376805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6017869|NCT00376805|Immunologic Factors|immunologic factors|mesh-ancestor
6017870|NCT00376805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017871|NCT00376805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6017872|NCT00376805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6017873|NCT00376805|Alkylating Agents|alkylating agents|mesh-ancestor
6017874|NCT00376805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017875|NCT00376805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6017876|NCT00376805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6017877|NCT00376805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6017878|NCT00376805|Analgesics|analgesics|mesh-ancestor
6017879|NCT00376805|Sensory System Agents|sensory system agents|mesh-ancestor
6017880|NCT00376805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6017881|NCT00376948|Gemcitabine|gemcitabine|mesh-list
6017882|NCT00376948|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6017883|NCT00376948|Genistein|genistein|mesh-list
6017884|NCT00376948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6017885|NCT00376948|Antimetabolites|antimetabolites|mesh-ancestor
6017886|NCT00376948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017887|NCT00376948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6017888|NCT00376948|Antiviral Agents|antiviral agents|mesh-ancestor
6017889|NCT00376948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6017890|NCT00376948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6017891|NCT00376948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6017892|NCT00376948|Immunologic Factors|immunologic factors|mesh-ancestor
6017893|NCT00376948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017894|NCT00376948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6017895|NCT00376948|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6017896|NCT00376948|Protective Agents|protective agents|mesh-ancestor
6017897|NCT00376948|Phytoestrogens|phytoestrogens|mesh-ancestor
6017898|NCT00376948|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6017899|NCT00376948|Estrogens|estrogens|mesh-ancestor
6000489|NCT00207090|Rifampin|rifampin|mesh-list
6000490|NCT00207090|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6000491|NCT00207090|Antitubercular Agents|antitubercular agents|mesh-ancestor
6000492|NCT00207090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6000493|NCT00207090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6000494|NCT00207090|Leprostatic Agents|leprostatic agents|mesh-ancestor
6000495|NCT00207090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6000496|NCT00207090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6000497|NCT00207090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000498|NCT00207090|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6000499|NCT00207090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6000500|NCT00207090|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6000501|NCT00207090|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6000502|NCT00207090|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6000503|NCT00207090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6000504|NCT00207142|Ritonavir|ritonavir|mesh-list
6000505|NCT00207142|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6000506|NCT00207142|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6000507|NCT00207142|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6000508|NCT00207142|Protease Inhibitors|protease inhibitors|mesh-ancestor
6000509|NCT00207142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6000510|NCT00207142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000511|NCT00207142|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6000512|NCT00207142|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6000513|NCT00207142|Antiviral Agents|antiviral agents|mesh-ancestor
6000514|NCT00207142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6000515|NCT00207142|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6000516|NCT00207142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6000517|NCT00207714|Golimumab|golimumab|mesh-list
6000518|NCT00207714|Infliximab|infliximab|mesh-list
6000519|NCT00207714|Dermatologic Agents|dermatologic agents|mesh-ancestor
6000520|NCT00207714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6000521|NCT00207714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6000522|NCT00207714|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6000523|NCT00207714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6000524|NCT00207714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6000525|NCT00207714|Immunologic Factors|immunologic factors|mesh-ancestor
6000526|NCT00207714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000527|NCT00207727|Ustekinumab|ustekinumab|mesh-list
6000528|NCT00207727|Dermatologic Agents|dermatologic agents|mesh-ancestor
6000529|NCT00207740|Golimumab|golimumab|mesh-list
6000530|NCT00207740|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6000531|NCT00207740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6000532|NCT00207740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6000533|NCT00207740|Immunologic Factors|immunologic factors|mesh-ancestor
6000534|NCT00207740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000535|NCT00208026|Pimecrolimus|pimecrolimus|mesh-list
6000536|NCT00208026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6000537|NCT00208026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6000538|NCT00208026|Analgesics|analgesics|mesh-ancestor
6000539|NCT00208026|Sensory System Agents|sensory system agents|mesh-ancestor
6000540|NCT00208026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6000541|NCT00208026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000542|NCT00208026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6000543|NCT00208026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6000544|NCT00208026|Dermatologic Agents|dermatologic agents|mesh-ancestor
6000545|NCT00208026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6000546|NCT00208026|Immunologic Factors|immunologic factors|mesh-ancestor
6000547|NCT00208026|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6000548|NCT00208026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6000549|NCT00208026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000550|NCT00208091|Botulinum Toxins|botulinum toxins|mesh-list
6000551|NCT00208091|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6000552|NCT00208091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6000553|NCT00208091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000554|NCT00208091|Cholinergic Agents|cholinergic agents|mesh-ancestor
6000555|NCT00208091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6259756|NCT03127943|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6000556|NCT00208091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000557|NCT00208767|Valsartan|valsartan|mesh-list
6000558|NCT00208767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6000559|NCT00208767|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6000560|NCT00208767|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6000561|NCT00208767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000562|NCT00208975|Cyclophosphamide|cyclophosphamide|mesh-list
6000563|NCT00208975|Rituximab|rituximab|mesh-list
6000564|NCT00208975|Fludarabine|fludarabine|mesh-list
6000565|NCT00208975|Mitoxantrone|mitoxantrone|mesh-list
6000566|NCT00208975|Sargramostim|sargramostim|mesh-list
6000567|NCT00208975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6000568|NCT00208975|Immunologic Factors|immunologic factors|mesh-ancestor
6000569|NCT00208975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000570|NCT00208975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6000571|NCT00208975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6000572|NCT00208975|Alkylating Agents|alkylating agents|mesh-ancestor
6000573|NCT00208975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000574|NCT00208975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6000575|NCT00208975|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6000576|NCT00208975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6000577|NCT00208975|Analgesics|analgesics|mesh-ancestor
6000578|NCT00208975|Sensory System Agents|sensory system agents|mesh-ancestor
6000579|NCT00208975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6000580|NCT00208975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6000581|NCT00208975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6000582|NCT00208975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6000583|NCT00209092|Docetaxel|docetaxel|mesh-list
6000584|NCT00209092|Capecitabine|capecitabine|mesh-list
6000585|NCT00209092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6000586|NCT00209092|Tubulin Modulators|tubulin modulators|mesh-ancestor
6000587|NCT00209092|Antimitotic Agents|antimitotic agents|mesh-ancestor
6000588|NCT00209092|Mitosis Modulators|mitosis modulators|mesh-ancestor
6000589|NCT00209092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000590|NCT00209092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6000591|NCT00209092|Antimetabolites|antimetabolites|mesh-ancestor
6000592|NCT00209170|Citalopram|citalopram|mesh-list
6000593|NCT00209170|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6000594|NCT00209170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6000595|NCT00209170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6000596|NCT00209170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000597|NCT00209170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6000598|NCT00209170|Serotonin Agents|serotonin agents|mesh-ancestor
6000599|NCT00209170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000600|NCT00209170|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6000601|NCT00209170|Antidepressive Agents|antidepressive agents|mesh-ancestor
6000602|NCT00209170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6000603|NCT00209560|Fospropofol|fospropofol|mesh-list
6000604|NCT00209560|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6000605|NCT00209560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6000606|NCT00209560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000607|NCT00210119|Imatinib Mesylate|imatinib mesylate|mesh-list
6000608|NCT00210119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6000609|NCT00210119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6000610|NCT00210119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6000611|NCT00210119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000612|NCT00210184|Leucovorin|leucovorin|mesh-list
6000613|NCT00210184|Fluorouracil|fluorouracil|mesh-list
6000614|NCT00210184|Irinotecan|irinotecan|mesh-list
6000615|NCT00210184|Antimetabolites|antimetabolites|mesh-ancestor
6000616|NCT00210184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000617|NCT00210184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6000618|NCT00210184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6000619|NCT00210184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6000620|NCT00210184|Immunologic Factors|immunologic factors|mesh-ancestor
6000621|NCT00210184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000622|NCT00210184|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6000623|NCT00210184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6000624|NCT00210184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6000625|NCT00210184|Antidotes|antidotes|mesh-ancestor
6000626|NCT00210184|Protective Agents|protective agents|mesh-ancestor
6000627|NCT00210184|Vitamin B Complex|vitamin b complex|mesh-ancestor
6000628|NCT00210184|Vitamins|vitamins|mesh-ancestor
6259757|NCT03127943|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6259758|NCT03127943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6259759|NCT03127943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259760|NCT03128008|Paclitaxel|paclitaxel|mesh-list
6259761|NCT03128008|Carboplatin|carboplatin|mesh-list
6259762|NCT03128008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6259763|NCT03128008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6259764|NCT03128008|Tubulin Modulators|tubulin modulators|mesh-ancestor
6259765|NCT03128008|Antimitotic Agents|antimitotic agents|mesh-ancestor
6259766|NCT03128008|Mitosis Modulators|mitosis modulators|mesh-ancestor
6259767|NCT03128008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259768|NCT03129100|Ixekizumab|ixekizumab|mesh-list
6259769|NCT03129100|Dermatologic Agents|dermatologic agents|mesh-ancestor
6259770|NCT03129321|Econazole|econazole|mesh-list
6259771|NCT03129321|Antifungal Agents|antifungal agents|mesh-ancestor
6259772|NCT03129321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6259773|NCT03129321|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6259774|NCT03129321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6259775|NCT03129321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6259776|NCT03129321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259777|NCT03129321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6259778|NCT03129321|Hormone Antagonists|hormone antagonists|mesh-ancestor
6259779|NCT03129321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6259780|NCT03129321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259781|NCT03129945|Indomethacin|indomethacin|mesh-list
6259782|NCT03129945|Nifedipine|nifedipine|mesh-list
6259783|NCT03129945|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6259784|NCT03129945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6259785|NCT03129945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389851|NCT00189553|Antimitotic Agents|antimitotic agents|mesh-ancestor
6000629|NCT00210184|Micronutrients|micronutrients|mesh-ancestor
6000630|NCT00210353|Rituximab|rituximab|mesh-list
6000631|NCT00210353|Chlorambucil|chlorambucil|mesh-list
6017900|NCT00376948|Hormones|hormones|mesh-ancestor
6017901|NCT00376948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6017902|NCT00376961|Prednisone|prednisone|mesh-list
6017903|NCT00376961|Cyclophosphamide|cyclophosphamide|mesh-list
6017904|NCT00376961|Rituximab|rituximab|mesh-list
6017905|NCT00376961|Doxorubicin|doxorubicin|mesh-list
6017906|NCT00376961|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6017907|NCT00376961|Vincristine|vincristine|mesh-list
6017908|NCT00376961|Bortezomib|bortezomib|mesh-list
6017909|NCT00376961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6017910|NCT00376961|Immunologic Factors|immunologic factors|mesh-ancestor
6017911|NCT00376961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017912|NCT00376961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6017913|NCT00376961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6017914|NCT00376961|Alkylating Agents|alkylating agents|mesh-ancestor
6017915|NCT00376961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000632|NCT00210353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6000633|NCT00210353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6000634|NCT00210353|Immunologic Factors|immunologic factors|mesh-ancestor
6000635|NCT00210353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000636|NCT00210353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6000637|NCT00210353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6000638|NCT00210353|Alkylating Agents|alkylating agents|mesh-ancestor
6000639|NCT00210353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000640|NCT00210470|Zinc|zinc|mesh-list
6000641|NCT00210470|Indomethacin|indomethacin|mesh-list
6000642|NCT00210470|Cyclophosphamide|cyclophosphamide|mesh-list
6000643|NCT00210470|Omeprazole|omeprazole|mesh-list
6000644|NCT00210470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6000645|NCT00210470|Immunologic Factors|immunologic factors|mesh-ancestor
6000646|NCT00210470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000647|NCT00210470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6000648|NCT00210470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6000649|NCT00210470|Alkylating Agents|alkylating agents|mesh-ancestor
6000650|NCT00210470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000651|NCT00210470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6000652|NCT00210470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6000653|NCT00210470|Trace Elements|trace elements|mesh-ancestor
6000654|NCT00210470|Micronutrients|micronutrients|mesh-ancestor
6000655|NCT00210470|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6000656|NCT00210470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6000657|NCT00210470|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6000658|NCT00210470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6000659|NCT00210470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6000660|NCT00210470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6000661|NCT00210470|Analgesics|analgesics|mesh-ancestor
6000662|NCT00210470|Sensory System Agents|sensory system agents|mesh-ancestor
6000663|NCT00210470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6000664|NCT00210470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6000665|NCT00210470|Gout Suppressants|gout suppressants|mesh-ancestor
6000666|NCT00210470|Tocolytic Agents|tocolytic agents|mesh-ancestor
6000667|NCT00210470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6000668|NCT00210470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6000669|NCT00210626|Epoetin Alfa|epoetin alfa|mesh-list
6000670|NCT00210626|Hematinics|hematinics|mesh-ancestor
6000671|NCT00211081|Spironolactone|spironolactone|mesh-list
6000672|NCT00211081|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6000673|NCT00211081|Hormone Antagonists|hormone antagonists|mesh-ancestor
6000674|NCT00211081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6000675|NCT00211081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000676|NCT00211081|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6000677|NCT00211081|Diuretics|diuretics|mesh-ancestor
6000678|NCT00211081|Natriuretic Agents|natriuretic agents|mesh-ancestor
6000679|NCT00211172|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
6000680|NCT00211172|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6000681|NCT00211172|Adrenergic Agents|adrenergic agents|mesh-ancestor
6000682|NCT00211172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6000683|NCT00211172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000684|NCT00211172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000685|NCT00211185|Prednisone|prednisone|mesh-list
6000686|NCT00211185|Cyclophosphamide|cyclophosphamide|mesh-list
6000687|NCT00211185|Doxorubicin|doxorubicin|mesh-list
6000688|NCT00211185|Vincristine|vincristine|mesh-list
6000689|NCT00211185|Denileukin diftitox|denileukin diftitox|mesh-list
6000690|NCT00211185|Sargramostim|sargramostim|mesh-list
6000691|NCT00211185|Lenograstim|lenograstim|mesh-list
6000692|NCT00211185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6000693|NCT00211185|Immunologic Factors|immunologic factors|mesh-ancestor
6000694|NCT00211185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000695|NCT00211185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6000696|NCT00211185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6000697|NCT00211185|Alkylating Agents|alkylating agents|mesh-ancestor
6000698|NCT00211185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000699|NCT00211185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6000700|NCT00211185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6000701|NCT00211185|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6000702|NCT00211185|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6000703|NCT00211185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6000704|NCT00211185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6000705|NCT00211185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6000706|NCT00211185|Glucocorticoids|glucocorticoids|mesh-ancestor
6000707|NCT00211185|Hormones|hormones|mesh-ancestor
6000708|NCT00211185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6000709|NCT00211185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6000710|NCT00211185|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6000711|NCT00211185|Tubulin Modulators|tubulin modulators|mesh-ancestor
6000712|NCT00211185|Antimitotic Agents|antimitotic agents|mesh-ancestor
6000713|NCT00211185|Mitosis Modulators|mitosis modulators|mesh-ancestor
6000714|NCT00211185|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6000715|NCT00211510|Insulin|insulin|mesh-list
6000716|NCT00211510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6000717|NCT00211510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000718|NCT00211536|Insulin|insulin|mesh-list
6000719|NCT00211536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6000720|NCT00211536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6000721|NCT00211536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000722|NCT00211692|Interferons|interferons|mesh-list
6000723|NCT00211692|Ribavirin|ribavirin|mesh-list
6000724|NCT00211692|Interferon-alpha|interferon-alpha|mesh-list
6000725|NCT00211692|Interferon alfacon-1|interferon alfacon-1|mesh-list
6000726|NCT00211692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6000727|NCT00211692|Antiviral Agents|antiviral agents|mesh-ancestor
6000728|NCT00211692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6000729|NCT00211692|Antimetabolites|antimetabolites|mesh-ancestor
6000730|NCT00211692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000731|NCT00211692|Immunologic Factors|immunologic factors|mesh-ancestor
6000732|NCT00211692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000733|NCT00211757|Valproic Acid|valproic acid|mesh-list
6000734|NCT00211757|Anticonvulsants|anticonvulsants|mesh-ancestor
6000735|NCT00211757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6000736|NCT00211757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000737|NCT00211757|GABA Agents|gaba agents|mesh-ancestor
6000738|NCT00211757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6000739|NCT00211757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000740|NCT00211757|Antimanic Agents|antimanic agents|mesh-ancestor
6000741|NCT00211757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6000742|NCT00211757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6000743|NCT00211757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6000744|NCT00211809|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6000745|NCT00211809|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6000746|NCT00211809|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6000747|NCT00211809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6000748|NCT00211809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000749|NCT00211809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6000750|NCT00211809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000751|NCT00211809|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6000752|NCT00211809|Antidepressive Agents|antidepressive agents|mesh-ancestor
6000753|NCT00211809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6000754|NCT00211887|Interferons|interferons|mesh-list
6000755|NCT00211887|Interferon-beta|interferon-beta|mesh-list
6000756|NCT00211887|Interferon beta-1a|interferon beta-1a|mesh-list
6000757|NCT00211887|Glatiramer Acetate|glatiramer acetate|mesh-list
6000758|NCT00211887|(T,G)-A-L|(t,g)-a-l|mesh-list
6000759|NCT00211887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6000760|NCT00211887|Antiviral Agents|antiviral agents|mesh-ancestor
6000761|NCT00211887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6000762|NCT00211887|Immunologic Factors|immunologic factors|mesh-ancestor
6000763|NCT00211887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000764|NCT00211887|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6000765|NCT00211887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6000766|NCT00211887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6000767|NCT00212134|Dipivefrin|dipivefrin|mesh-list
6000768|NCT00212134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6000769|NCT00212134|Adrenergic Agents|adrenergic agents|mesh-ancestor
6000770|NCT00212134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6000771|NCT00212134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000772|NCT00212134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000773|NCT00212758|Hormones|hormones|mesh-list
6000774|NCT00212758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6000775|NCT00212758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000776|NCT00213135|Cladribine|cladribine|mesh-list
6000777|NCT00213135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6000778|NCT00213135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6000779|NCT00213135|Immunologic Factors|immunologic factors|mesh-ancestor
6000780|NCT00213135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000781|NCT00213148|Anastrozole|anastrozole|mesh-list
6000782|NCT00213148|Citric Acid|citric acid|mesh-list
6000783|NCT00213148|Sodium Citrate|sodium citrate|mesh-list
6000784|NCT00213148|Clomiphene|clomiphene|mesh-list
6000785|NCT00213148|Enclomiphene|enclomiphene|mesh-list
6000786|NCT00213148|Zuclomiphene|zuclomiphene|mesh-list
6000787|NCT00213148|Anticoagulants|anticoagulants|mesh-ancestor
6000788|NCT00213148|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6000789|NCT00213148|Chelating Agents|chelating agents|mesh-ancestor
6000790|NCT00213148|Sequestering Agents|sequestering agents|mesh-ancestor
6000791|NCT00213148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000792|NCT00213148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6000793|NCT00213148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6000794|NCT00213148|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6000795|NCT00213148|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6000796|NCT00213148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6000797|NCT00213148|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6000798|NCT00213148|Hormone Antagonists|hormone antagonists|mesh-ancestor
6000799|NCT00213148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6000800|NCT00213148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000801|NCT00213148|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6000802|NCT00213148|Fertility Agents|fertility agents|mesh-ancestor
6000803|NCT00213148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6000804|NCT00213148|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6000805|NCT00213148|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6000806|NCT00213239|Remifentanil|remifentanil|mesh-list
6000807|NCT00213239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6000808|NCT00213239|Narcotics|narcotics|mesh-ancestor
6000809|NCT00213239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6000810|NCT00213239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000811|NCT00213239|Analgesics|analgesics|mesh-ancestor
6000812|NCT00213239|Sensory System Agents|sensory system agents|mesh-ancestor
6000813|NCT00213239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6000814|NCT00213980|Zoledronic Acid|zoledronic acid|mesh-list
6000815|NCT00213980|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6000816|NCT00213980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000817|NCT00214019|Fluticasone|fluticasone|mesh-list
6000818|NCT00214019|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6000819|NCT00214019|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6000820|NCT00214019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6000821|NCT00214019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6000822|NCT00214019|Autonomic Agents|autonomic agents|mesh-ancestor
6000823|NCT00214019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6000824|NCT00214019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000825|NCT00214019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6000826|NCT00214019|Respiratory System Agents|respiratory system agents|mesh-ancestor
6000827|NCT00214019|Dermatologic Agents|dermatologic agents|mesh-ancestor
6000828|NCT00214019|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6000829|NCT00214019|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6000830|NCT00214019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6000831|NCT00214019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6000832|NCT00214019|Adrenergic Agents|adrenergic agents|mesh-ancestor
6000833|NCT00214019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6000834|NCT00214019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000835|NCT00214019|Glucocorticoids|glucocorticoids|mesh-ancestor
6000836|NCT00214019|Hormones|hormones|mesh-ancestor
6000837|NCT00214019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6000838|NCT00214019|Sympathomimetics|sympathomimetics|mesh-ancestor
6000839|NCT00214201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
6000840|NCT00214201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6000841|NCT00214201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000842|NCT00214461|Vaccines|vaccines|mesh-list
6000843|NCT00214461|Immunologic Factors|immunologic factors|mesh-ancestor
6000844|NCT00214461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000845|NCT00214890|Tenofovir|tenofovir|mesh-list
6000846|NCT00214890|Abacavir|abacavir|mesh-list
6000847|NCT00214890|Antiviral Agents|antiviral agents|mesh-ancestor
6000848|NCT00214890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6000849|NCT00214890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6000850|NCT00214890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6000851|NCT00214890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6000852|NCT00214890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000853|NCT00214890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6000854|NCT00214890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6000855|NCT00215137|Citalopram|citalopram|mesh-list
6000856|NCT00215137|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6000857|NCT00215137|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6000858|NCT00215137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6000859|NCT00215137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000860|NCT00215137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6000861|NCT00215137|Serotonin Agents|serotonin agents|mesh-ancestor
6000862|NCT00215137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000863|NCT00215137|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6000864|NCT00215137|Antidepressive Agents|antidepressive agents|mesh-ancestor
6000865|NCT00215137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6000866|NCT00215150|Ziprasidone|ziprasidone|mesh-list
6000867|NCT00215150|Sertraline|sertraline|mesh-list
6000868|NCT00215150|Antidepressive Agents|antidepressive agents|mesh-ancestor
6000869|NCT00215150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6000870|NCT00215150|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6000871|NCT00215150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6000872|NCT00215150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6000873|NCT00215150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000874|NCT00215150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6000875|NCT00215150|Serotonin Agents|serotonin agents|mesh-ancestor
6000876|NCT00215150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000877|NCT00215150|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6000878|NCT00215150|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6000879|NCT00215150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6000880|NCT00215150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6000881|NCT00215150|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6000882|NCT00215150|Dopamine Agents|dopamine agents|mesh-ancestor
6000883|NCT00215540|Pulmonary Surfactants|pulmonary surfactants|mesh-list
6000884|NCT00215540|Respiratory System Agents|respiratory system agents|mesh-ancestor
6000885|NCT00215553|Pulmonary Surfactants|pulmonary surfactants|mesh-list
6000886|NCT00215553|Respiratory System Agents|respiratory system agents|mesh-ancestor
6000887|NCT00215644|Capecitabine|capecitabine|mesh-list
6000888|NCT00215644|Epirubicin|epirubicin|mesh-list
6000889|NCT00215644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6000890|NCT00215644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6000891|NCT00215644|Antimetabolites|antimetabolites|mesh-ancestor
6000892|NCT00215644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000893|NCT00215644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6000894|NCT00215644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6000895|NCT00215644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6000896|NCT00215644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6000897|NCT00215787|Lansoprazole|lansoprazole|mesh-list
6000898|NCT00215787|Dexlansoprazole|dexlansoprazole|mesh-list
6000899|NCT00215787|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6000900|NCT00215787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6000901|NCT00215787|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6000902|NCT00215787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6000903|NCT00215787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000904|NCT00215930|Gemcitabine|gemcitabine|mesh-list
6000905|NCT00215930|Carboplatin|carboplatin|mesh-list
6000906|NCT00215930|Docetaxel|docetaxel|mesh-list
6000907|NCT00215930|Vinorelbine|vinorelbine|mesh-list
6000908|NCT00215930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6000909|NCT00215930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6000910|NCT00215930|Antimetabolites|antimetabolites|mesh-ancestor
6000911|NCT00215930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000912|NCT00215930|Antiviral Agents|antiviral agents|mesh-ancestor
6000913|NCT00215930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6000914|NCT00215930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6000915|NCT00215930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6000916|NCT00215930|Immunologic Factors|immunologic factors|mesh-ancestor
6000917|NCT00215930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000918|NCT00215930|Tubulin Modulators|tubulin modulators|mesh-ancestor
6000919|NCT00215930|Antimitotic Agents|antimitotic agents|mesh-ancestor
6000920|NCT00215930|Mitosis Modulators|mitosis modulators|mesh-ancestor
6000921|NCT00215930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6000922|NCT00215943|Zoledronic Acid|zoledronic acid|mesh-list
6000923|NCT00215943|Thalidomide|thalidomide|mesh-list
6000924|NCT00215943|Dexamethasone|dexamethasone|mesh-list
6000925|NCT00215943|Doxorubicin|doxorubicin|mesh-list
6000926|NCT00215943|Vincristine|vincristine|mesh-list
6000927|NCT00215943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6000928|NCT00215943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6000929|NCT00215943|Antiemetics|antiemetics|mesh-ancestor
6000930|NCT00215943|Autonomic Agents|autonomic agents|mesh-ancestor
6000931|NCT00215943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6000932|NCT00215943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000933|NCT00215943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6000934|NCT00215943|Glucocorticoids|glucocorticoids|mesh-ancestor
6000935|NCT00215943|Hormones|hormones|mesh-ancestor
6000936|NCT00215943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6000937|NCT00215943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6259786|NCT03129945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6389852|NCT00189553|Mitosis Modulators|mitosis modulators|mesh-ancestor
6000938|NCT00215943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6000939|NCT00215943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6000940|NCT00215943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6000941|NCT00215943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6000942|NCT00215943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6000943|NCT00215943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000944|NCT00215943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6000945|NCT00215943|Tubulin Modulators|tubulin modulators|mesh-ancestor
6000946|NCT00215943|Antimitotic Agents|antimitotic agents|mesh-ancestor
6000947|NCT00215943|Mitosis Modulators|mitosis modulators|mesh-ancestor
6000948|NCT00215943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6000949|NCT00215943|Immunologic Factors|immunologic factors|mesh-ancestor
6000950|NCT00215943|Leprostatic Agents|leprostatic agents|mesh-ancestor
6000951|NCT00215943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6000952|NCT00215943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6000953|NCT00215943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6000954|NCT00215943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6000955|NCT00215943|Growth Substances|growth substances|mesh-ancestor
6000956|NCT00215943|Growth Inhibitors|growth inhibitors|mesh-ancestor
6000957|NCT00215943|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6000958|NCT00216060|Risedronic Acid|risedronic acid|mesh-list
6000959|NCT00216060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6000960|NCT00216060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6000961|NCT00216060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000962|NCT00216060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6000963|NCT00216060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000964|NCT00216060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6000965|NCT00216086|Capecitabine|capecitabine|mesh-list
6000966|NCT00216086|Irinotecan|irinotecan|mesh-list
6000967|NCT00216086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6000968|NCT00216086|Antimetabolites|antimetabolites|mesh-ancestor
6000969|NCT00216086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000970|NCT00216086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6000971|NCT00216086|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6000972|NCT00216086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6000973|NCT00216086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6000974|NCT00216099|Folic Acid|folic acid|mesh-list
6000975|NCT00216099|Vitamin B 12|vitamin b 12|mesh-list
6000976|NCT00216099|Hydroxocobalamin|hydroxocobalamin|mesh-list
6000977|NCT00216099|Pemetrexed|pemetrexed|mesh-list
6000978|NCT00216099|Vitamins|vitamins|mesh-ancestor
6000979|NCT00216099|Micronutrients|micronutrients|mesh-ancestor
6000980|NCT00216099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6000981|NCT00216099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6000982|NCT00216099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6000983|NCT00216099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000984|NCT00216099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6000985|NCT00216099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6000986|NCT00216099|Hematinics|hematinics|mesh-ancestor
6000987|NCT00216099|Vitamin B Complex|vitamin b complex|mesh-ancestor
6000988|NCT00216125|Docetaxel|docetaxel|mesh-list
6000989|NCT00216125|Etoposide|etoposide|mesh-list
6000990|NCT00216125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6000991|NCT00216125|Tubulin Modulators|tubulin modulators|mesh-ancestor
6000992|NCT00216125|Antimitotic Agents|antimitotic agents|mesh-ancestor
6000993|NCT00216125|Mitosis Modulators|mitosis modulators|mesh-ancestor
6000994|NCT00216125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6000995|NCT00216125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6000996|NCT00216125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6000997|NCT00216125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6000998|NCT00216125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6000999|NCT00216203|Pemetrexed|pemetrexed|mesh-list
6001000|NCT00216203|Cetuximab|cetuximab|mesh-list
6001001|NCT00216203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6001002|NCT00216203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6001003|NCT00216203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001004|NCT00216203|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6001005|NCT00216203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6001006|NCT00216203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6001007|NCT00216476|Risperidone|risperidone|mesh-list
6001008|NCT00216476|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6001009|NCT00216476|Aripiprazole|aripiprazole|mesh-list
6001010|NCT00216476|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6001011|NCT00216476|Serotonin Agents|serotonin agents|mesh-ancestor
6001012|NCT00216476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6001013|NCT00216476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001014|NCT00216476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001015|NCT00216476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6001016|NCT00216476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6001017|NCT00216476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6001018|NCT00216476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6001019|NCT00216476|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6001020|NCT00216476|Dopamine Agents|dopamine agents|mesh-ancestor
6001021|NCT00216476|Antidepressive Agents|antidepressive agents|mesh-ancestor
6001022|NCT00216476|Dopamine Agonists|dopamine agonists|mesh-ancestor
6001023|NCT00216476|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6001024|NCT00216476|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6001025|NCT00216476|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6001026|NCT00216476|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6001027|NCT00216671|Risperidone|risperidone|mesh-list
6001028|NCT00216671|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6001029|NCT00216671|Serotonin Agents|serotonin agents|mesh-ancestor
6001030|NCT00216671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6001031|NCT00216671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001032|NCT00216671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001033|NCT00216671|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6001034|NCT00216671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6001035|NCT00216671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6001036|NCT00216671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6001037|NCT00216671|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6001038|NCT00216671|Dopamine Agents|dopamine agents|mesh-ancestor
6001039|NCT00216736|Dexamethasone|dexamethasone|mesh-list
6001040|NCT00216736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6001041|NCT00216736|Antiemetics|antiemetics|mesh-ancestor
6001042|NCT00216736|Autonomic Agents|autonomic agents|mesh-ancestor
6001043|NCT00216736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6001044|NCT00216736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536439|NCT00817011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536440|NCT00817011|Dopamine Agents|dopamine agents|mesh-ancestor
6536441|NCT00817011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6536442|NCT00817011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536443|NCT00817011|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6536444|NCT00817011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6536445|NCT00817011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6536446|NCT00817011|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6536447|NCT00817011|Analgesics|analgesics|mesh-ancestor
6536448|NCT00817011|Sensory System Agents|sensory system agents|mesh-ancestor
6536449|NCT00817011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6536450|NCT00817011|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6536451|NCT00817011|Serotonin Agents|serotonin agents|mesh-ancestor
6536452|NCT00817011|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6536453|NCT00817011|Histamine Antagonists|histamine antagonists|mesh-ancestor
6536454|NCT00817011|Histamine Agents|histamine agents|mesh-ancestor
6536455|NCT00817011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6536456|NCT00817011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6001045|NCT00216736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6001046|NCT00216736|Glucocorticoids|glucocorticoids|mesh-ancestor
6259787|NCT03129945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259788|NCT03129945|Vasodilator Agents|vasodilator agents|mesh-ancestor
6259789|NCT03129945|Tocolytic Agents|tocolytic agents|mesh-ancestor
6259790|NCT03129945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6259791|NCT03129945|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6259792|NCT03129945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6259793|NCT03129945|Analgesics|analgesics|mesh-ancestor
6259794|NCT03129945|Sensory System Agents|sensory system agents|mesh-ancestor
6259795|NCT03129945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6259796|NCT03129945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6259797|NCT03129945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6259798|NCT03129945|Gout Suppressants|gout suppressants|mesh-ancestor
6259799|NCT03129945|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6259800|NCT03129945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6001047|NCT00216736|Hormones|hormones|mesh-ancestor
6001048|NCT00216736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6001049|NCT00216736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6001050|NCT00216736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6001051|NCT00217022|Budesonide|budesonide|mesh-list
6001052|NCT00217022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6001053|NCT00217022|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6001054|NCT00217022|Autonomic Agents|autonomic agents|mesh-ancestor
6001055|NCT00217022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6001056|NCT00217022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001057|NCT00217022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6001058|NCT00217022|Respiratory System Agents|respiratory system agents|mesh-ancestor
6001059|NCT00217022|Glucocorticoids|glucocorticoids|mesh-ancestor
6001060|NCT00217022|Hormones|hormones|mesh-ancestor
6001061|NCT00217022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6001062|NCT00217087|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
6001063|NCT00217087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6001064|NCT00217087|Dermatologic Agents|dermatologic agents|mesh-ancestor
6001065|NCT00217087|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6001066|NCT00217399|Sorafenib|sorafenib|mesh-list
6001067|NCT00217399|Anastrozole|anastrozole|mesh-list
6001068|NCT00217399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6001069|NCT00217399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6001070|NCT00217399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6259801|NCT03130738|Miconazole|miconazole|mesh-list
6259802|NCT03130738|Clotrimazole|clotrimazole|mesh-list
6536457|NCT00817011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6001071|NCT00217399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001072|NCT00217399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6001073|NCT00217399|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6001074|NCT00217399|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6001075|NCT00217399|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6001076|NCT00217399|Hormone Antagonists|hormone antagonists|mesh-ancestor
6001077|NCT00217399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6001078|NCT00217399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001079|NCT00217425|Prednisone|prednisone|mesh-list
6001080|NCT00217425|Cyclophosphamide|cyclophosphamide|mesh-list
6001081|NCT00217425|Bevacizumab|bevacizumab|mesh-list
6001082|NCT00217425|Doxorubicin|doxorubicin|mesh-list
6259803|NCT03130738|Antifungal Agents|antifungal agents|mesh-ancestor
6259804|NCT03130738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6259805|NCT03130738|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6259806|NCT03130738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6259807|NCT03130738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6259808|NCT03130738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259809|NCT03130738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6259810|NCT03130738|Hormone Antagonists|hormone antagonists|mesh-ancestor
6259811|NCT03130738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6259812|NCT03130738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259813|NCT03130738|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6259814|NCT03130738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6259815|NCT03130738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6259816|NCT03130959|Nivolumab|nivolumab|mesh-list
6259817|NCT03130959|Ipilimumab|ipilimumab|mesh-list
6259818|NCT03130959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6259819|NCT03130959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6259820|NCT03130959|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6259821|NCT03130959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259822|NCT03131219|Ravulizumab|ravulizumab|mesh-list
6259823|NCT03131219|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6259824|NCT03131219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6259825|NCT03131219|Immunologic Factors|immunologic factors|mesh-ancestor
6259826|NCT03131219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259827|NCT03131453|CNP520|cnp520|mesh-list
6259828|NCT03131453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6259829|NCT03131453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259830|NCT03131479|Licogliflozin|licogliflozin|mesh-list
6259831|NCT03131479|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6259832|NCT03131479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259833|NCT03131479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6259834|NCT03131479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389853|NCT00189553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389854|NCT00189553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6389855|NCT00189553|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6389856|NCT00189553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6389857|NCT00189553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6389858|NCT00189566|Paclitaxel|paclitaxel|mesh-list
6389859|NCT00189566|Carboplatin|carboplatin|mesh-list
6389860|NCT00189566|Topotecan|topotecan|mesh-list
6389861|NCT00189566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6389862|NCT00189566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6389863|NCT00189566|Tubulin Modulators|tubulin modulators|mesh-ancestor
6389864|NCT00189566|Antimitotic Agents|antimitotic agents|mesh-ancestor
6389865|NCT00189566|Mitosis Modulators|mitosis modulators|mesh-ancestor
6389866|NCT00189566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389867|NCT00189566|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6389868|NCT00189566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6389869|NCT00189566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6389870|NCT00189579|Trastuzumab|trastuzumab|mesh-list
6389871|NCT00189579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6389872|NCT00189579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6389873|NCT00189618|Aspirin|aspirin|mesh-list
6389874|NCT00189618|Clopidogrel|clopidogrel|mesh-list
6389875|NCT00189618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6389876|NCT00189618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6389877|NCT00189618|Analgesics|analgesics|mesh-ancestor
6389878|NCT00189618|Sensory System Agents|sensory system agents|mesh-ancestor
6389879|NCT00189618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6001083|NCT00217425|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6001084|NCT00217425|Vincristine|vincristine|mesh-list
6001085|NCT00217425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6001086|NCT00217425|Immunologic Factors|immunologic factors|mesh-ancestor
6001087|NCT00217425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001088|NCT00217425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6001089|NCT00217425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6001090|NCT00217425|Alkylating Agents|alkylating agents|mesh-ancestor
6001091|NCT00217425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001092|NCT00217425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6001093|NCT00217425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6001094|NCT00217425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6001095|NCT00217425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6001096|NCT00217425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6001097|NCT00217425|Growth Substances|growth substances|mesh-ancestor
6001098|NCT00217425|Growth Inhibitors|growth inhibitors|mesh-ancestor
6001099|NCT00217425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6001100|NCT00217425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6001101|NCT00217425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6001102|NCT00217425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6001103|NCT00217425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6001104|NCT00217425|Glucocorticoids|glucocorticoids|mesh-ancestor
6001105|NCT00217425|Hormones|hormones|mesh-ancestor
6001106|NCT00217425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6001107|NCT00217425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6001108|NCT00217425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6001109|NCT00217425|Tubulin Modulators|tubulin modulators|mesh-ancestor
6001110|NCT00217425|Antimitotic Agents|antimitotic agents|mesh-ancestor
6001111|NCT00217425|Mitosis Modulators|mitosis modulators|mesh-ancestor
6001112|NCT00217438|Melphalan|melphalan|mesh-list
6001113|NCT00217438|Amifostine|amifostine|mesh-list
6001114|NCT00217438|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6001115|NCT00217438|Alkylating Agents|alkylating agents|mesh-ancestor
6001116|NCT00217438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001117|NCT00217438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6001118|NCT00217438|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6001119|NCT00217438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6001120|NCT00217438|Immunologic Factors|immunologic factors|mesh-ancestor
6001121|NCT00217438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001122|NCT00217438|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6001123|NCT00217438|Protective Agents|protective agents|mesh-ancestor
6001124|NCT00217464|Fulvestrant|fulvestrant|mesh-list
6001125|NCT00217464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6001126|NCT00217464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6001127|NCT00217464|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6001128|NCT00217464|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6001129|NCT00217464|Hormone Antagonists|hormone antagonists|mesh-ancestor
6001130|NCT00217464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6001131|NCT00217464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001132|NCT00217581|Bevacizumab|bevacizumab|mesh-list
6001133|NCT00217581|Docetaxel|docetaxel|mesh-list
6001134|NCT00217581|Oxaliplatin|oxaliplatin|mesh-list
6001135|NCT00217581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6001136|NCT00217581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6001137|NCT00217581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6001138|NCT00217581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6001139|NCT00217581|Growth Substances|growth substances|mesh-ancestor
6001140|NCT00217581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001141|NCT00217581|Growth Inhibitors|growth inhibitors|mesh-ancestor
6001142|NCT00217581|Tubulin Modulators|tubulin modulators|mesh-ancestor
6001143|NCT00217581|Antimitotic Agents|antimitotic agents|mesh-ancestor
6001144|NCT00217581|Mitosis Modulators|mitosis modulators|mesh-ancestor
6001145|NCT00217581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001146|NCT00217594|Alemtuzumab|alemtuzumab|mesh-list
6001147|NCT00217594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6001148|NCT00217594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6001149|NCT00217620|Sorafenib|sorafenib|mesh-list
6001150|NCT00217620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6001151|NCT00217620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6001152|NCT00217620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6001153|NCT00217620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001154|NCT00217672|Bevacizumab|bevacizumab|mesh-list
6001155|NCT00217672|Docetaxel|docetaxel|mesh-list
6001156|NCT00217672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6001157|NCT00217672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6001158|NCT00217672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6001159|NCT00217672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6001160|NCT00217672|Growth Substances|growth substances|mesh-ancestor
6001161|NCT00217672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001162|NCT00217672|Growth Inhibitors|growth inhibitors|mesh-ancestor
6001163|NCT00217672|Tubulin Modulators|tubulin modulators|mesh-ancestor
6001164|NCT00217672|Antimitotic Agents|antimitotic agents|mesh-ancestor
6001165|NCT00217672|Mitosis Modulators|mitosis modulators|mesh-ancestor
6001166|NCT00217672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001167|NCT00217971|Dronabinol|dronabinol|mesh-list
6001168|NCT00217971|Hallucinogens|hallucinogens|mesh-ancestor
6001169|NCT00217971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001170|NCT00217971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6001171|NCT00217971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6001172|NCT00217971|Analgesics|analgesics|mesh-ancestor
6001173|NCT00217971|Sensory System Agents|sensory system agents|mesh-ancestor
6001174|NCT00217971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6001175|NCT00217971|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6001176|NCT00217971|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6001177|NCT00217971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6001178|NCT00217971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001179|NCT00217971|Hormones|hormones|mesh-ancestor
6001180|NCT00217971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6001181|NCT00218023|Naltrexone|naltrexone|mesh-list
6001182|NCT00218023|Levodopa|levodopa|mesh-list
6001183|NCT00218023|Carbidopa|carbidopa|mesh-list
6001184|NCT00218023|Modafinil|modafinil|mesh-list
6001185|NCT00218023|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6001186|NCT00218023|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6001187|NCT00218023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001188|NCT00218023|Sensory System Agents|sensory system agents|mesh-ancestor
6001189|NCT00218023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6001190|NCT00218023|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6001191|NCT00218023|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6001192|NCT00218023|Dopamine Agents|dopamine agents|mesh-ancestor
6001193|NCT00218023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6001194|NCT00218023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001195|NCT00218023|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6001196|NCT00218023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6001197|NCT00218023|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6001198|NCT00218023|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6001199|NCT00218023|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6001200|NCT00218023|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6001201|NCT00218062|Modafinil|modafinil|mesh-list
6001202|NCT00218062|Amphetamine|amphetamine|mesh-list
6001203|NCT00218062|Dextroamphetamine|dextroamphetamine|mesh-list
6001204|NCT00218062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6001205|NCT00218062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001206|NCT00218062|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6001207|NCT00218062|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6001208|NCT00218062|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6001209|NCT00218062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001210|NCT00218062|Sympathomimetics|sympathomimetics|mesh-ancestor
6001211|NCT00218062|Autonomic Agents|autonomic agents|mesh-ancestor
6001212|NCT00218062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6001213|NCT00218062|Dopamine Agents|dopamine agents|mesh-ancestor
6001214|NCT00218062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6001215|NCT00218062|Adrenergic Agents|adrenergic agents|mesh-ancestor
6001216|NCT00218062|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6001217|NCT00218062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6001218|NCT00218062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6001219|NCT00218062|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6001220|NCT00218257|Progesterone|progesterone|mesh-list
6001221|NCT00218257|Progestins|progestins|mesh-ancestor
6001222|NCT00218257|Hormones|hormones|mesh-ancestor
6001223|NCT00218257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6001224|NCT00218257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001225|NCT00218296|Lobeline|lobeline|mesh-list
6001226|NCT00218296|Nicotine|nicotine|mesh-list
6001227|NCT00218296|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6001228|NCT00218296|Autonomic Agents|autonomic agents|mesh-ancestor
6001229|NCT00218296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6001230|NCT00218296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001231|NCT00218296|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6001232|NCT00218296|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6001233|NCT00218296|Cholinergic Agents|cholinergic agents|mesh-ancestor
6001234|NCT00218296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6259835|NCT03131570|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6259836|NCT03131570|Immunologic Factors|immunologic factors|mesh-ancestor
6259837|NCT03131570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259838|NCT03131687|Dulaglutide|dulaglutide|mesh-list
6259839|NCT03131687|Tirzepatide|tirzepatide|mesh-list
6259840|NCT03131687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6259841|NCT03131687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259842|NCT03131687|Incretins|incretins|mesh-ancestor
6259843|NCT03131687|Hormones|hormones|mesh-ancestor
6259844|NCT03131687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6259845|NCT03131713|Acetaminophen|acetaminophen|mesh-list
6259846|NCT03131713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6259847|NCT03131713|Analgesics|analgesics|mesh-ancestor
6259848|NCT03131713|Sensory System Agents|sensory system agents|mesh-ancestor
6259849|NCT03131713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6259850|NCT03131713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259851|NCT03131713|Antipyretics|antipyretics|mesh-ancestor
6259852|NCT03131895|Dexlansoprazole|dexlansoprazole|mesh-list
6259853|NCT03131895|Lansoprazole|lansoprazole|mesh-list
6259854|NCT03131895|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6259855|NCT03131895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6259856|NCT03131895|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6259857|NCT03131895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6259858|NCT03131895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259859|NCT03131999|Imatinib Mesylate|imatinib mesylate|mesh-list
6259860|NCT03131999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6259861|NCT03131999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6259862|NCT03131999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6259863|NCT03131999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259864|NCT03132571|Naltrexone|naltrexone|mesh-list
6259865|NCT03132571|Bupropion|bupropion|mesh-list
6259866|NCT03132571|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6001235|NCT00218296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001236|NCT00218296|Respiratory System Agents|respiratory system agents|mesh-ancestor
6001237|NCT00218387|Modafinil|modafinil|mesh-list
6001238|NCT00218387|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6001239|NCT00218387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001240|NCT00218387|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6001241|NCT00218387|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6001242|NCT00218387|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6001243|NCT00218387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001244|NCT00218426|Naltrexone|naltrexone|mesh-list
6001245|NCT00218426|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6001246|NCT00218426|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6001247|NCT00218426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001248|NCT00218426|Sensory System Agents|sensory system agents|mesh-ancestor
6001249|NCT00218426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6017916|NCT00376961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6017917|NCT00376961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6017918|NCT00376961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6017919|NCT00376961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6017920|NCT00376961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6017921|NCT00376961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6017922|NCT00376961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6017923|NCT00376961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6017924|NCT00376961|Glucocorticoids|glucocorticoids|mesh-ancestor
6017925|NCT00376961|Hormones|hormones|mesh-ancestor
6017926|NCT00376961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6017927|NCT00376961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6017928|NCT00376961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6017929|NCT00376961|Tubulin Modulators|tubulin modulators|mesh-ancestor
6017930|NCT00376961|Antimitotic Agents|antimitotic agents|mesh-ancestor
6017931|NCT00376961|Mitosis Modulators|mitosis modulators|mesh-ancestor
6017932|NCT00377234|Risedronic Acid|risedronic acid|mesh-list
6017933|NCT00377234|Ibandronic Acid|ibandronic acid|mesh-list
6017934|NCT00377234|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6017935|NCT00377234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6017936|NCT00377234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017937|NCT00377234|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6017938|NCT00377234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017939|NCT00377234|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6017940|NCT00377260|Amoxicillin|amoxicillin|mesh-list
6017941|NCT00377260|Clavulanic Acid|clavulanic acid|mesh-list
6017942|NCT00377260|Clavulanic Acids|clavulanic acids|mesh-list
6017943|NCT00377260|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6017944|NCT00377260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6017945|NCT00377260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6017946|NCT00377260|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6017947|NCT00377260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6017948|NCT00377260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017949|NCT00377299|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
6017950|NCT00377299|Nootropic Agents|nootropic agents|mesh-ancestor
6017951|NCT00377312|Hormones|hormones|mesh-list
6017952|NCT00377312|Parathyroid Hormone|parathyroid hormone|mesh-list
6017953|NCT00377312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6017954|NCT00377312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017955|NCT00377312|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6017956|NCT00377364|Acetaminophen|acetaminophen|mesh-list
6017957|NCT00377364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6017958|NCT00377364|Analgesics|analgesics|mesh-ancestor
6017959|NCT00377364|Sensory System Agents|sensory system agents|mesh-ancestor
6017960|NCT00377364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6017961|NCT00377364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017962|NCT00377364|Antipyretics|antipyretics|mesh-ancestor
6017963|NCT00377403|Acetaminophen|acetaminophen|mesh-list
6017964|NCT00377403|Amoxicillin|amoxicillin|mesh-list
6017965|NCT00377403|Phenylpropanolamine|phenylpropanolamine|mesh-list
6017966|NCT00377403|Pseudoephedrine|pseudoephedrine|mesh-list
6017967|NCT00377403|Ephedrine|ephedrine|mesh-list
6017968|NCT00377403|Dextromethorphan|dextromethorphan|mesh-list
6017969|NCT00377403|Guaifenesin|guaifenesin|mesh-list
6017970|NCT00377403|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
6017971|NCT00377403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6017972|NCT00377403|Analgesics|analgesics|mesh-ancestor
6001250|NCT00218439|Paroxetine|paroxetine|mesh-list
6001251|NCT00218439|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6001252|NCT00218439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6001253|NCT00218439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6001254|NCT00218439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001255|NCT00218439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6001256|NCT00218439|Serotonin Agents|serotonin agents|mesh-ancestor
6001257|NCT00218439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001258|NCT00218439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6001259|NCT00218439|Antidepressive Agents|antidepressive agents|mesh-ancestor
6001260|NCT00218439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6001261|NCT00218439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6001262|NCT00218439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6001263|NCT00218439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6001264|NCT00218465|Glycine|glycine|mesh-list
6001265|NCT00218465|Glycine Agents|glycine agents|mesh-ancestor
6001266|NCT00218465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6001267|NCT00218465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001268|NCT00218465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001269|NCT00218491|Acetylcysteine|acetylcysteine|mesh-list
6001270|NCT00218491|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6001271|NCT00218491|Antiviral Agents|antiviral agents|mesh-ancestor
6001272|NCT00218491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6001273|NCT00218491|Expectorants|expectorants|mesh-ancestor
6001274|NCT00218491|Respiratory System Agents|respiratory system agents|mesh-ancestor
6001275|NCT00218491|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6001276|NCT00218491|Antioxidants|antioxidants|mesh-ancestor
6001277|NCT00218491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001278|NCT00218491|Protective Agents|protective agents|mesh-ancestor
6001279|NCT00218491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001280|NCT00218491|Antidotes|antidotes|mesh-ancestor
6001281|NCT00218543|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6001282|NCT00218543|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6001283|NCT00218543|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6001284|NCT00218543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6001285|NCT00218543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001286|NCT00218543|Adrenergic Agents|adrenergic agents|mesh-ancestor
6001287|NCT00218543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6001288|NCT00218543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001289|NCT00219141|Losartan|losartan|mesh-list
6001290|NCT00219141|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6001291|NCT00219141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6001292|NCT00219141|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6001293|NCT00219141|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6001294|NCT00219141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001295|NCT00219284|Levodopa|levodopa|mesh-list
6001296|NCT00219284|Carbidopa|carbidopa|mesh-list
6001297|NCT00219284|Entacapone|entacapone|mesh-list
6001298|NCT00219284|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
6001299|NCT00219284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6001300|NCT00219284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6001301|NCT00219284|Dopamine Agents|dopamine agents|mesh-ancestor
6001302|NCT00219284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6001303|NCT00219284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001304|NCT00219284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001305|NCT00219284|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6001306|NCT00219284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6001307|NCT00219284|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6001308|NCT00219284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6001309|NCT00219284|Immunologic Factors|immunologic factors|mesh-ancestor
6001310|NCT00219284|Dopamine Agonists|dopamine agonists|mesh-ancestor
6001311|NCT00219349|Citalopram|citalopram|mesh-list
6001312|NCT00219349|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6001313|NCT00219349|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6001314|NCT00219349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6001315|NCT00219349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001316|NCT00219349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6001317|NCT00219349|Serotonin Agents|serotonin agents|mesh-ancestor
6001318|NCT00219349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001319|NCT00219349|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6001320|NCT00219349|Antidepressive Agents|antidepressive agents|mesh-ancestor
6001321|NCT00219349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6001322|NCT00219544|Pregabalin|pregabalin|mesh-list
6001323|NCT00219544|Analgesics|analgesics|mesh-ancestor
6001324|NCT00219544|Sensory System Agents|sensory system agents|mesh-ancestor
6001325|NCT00219544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6001326|NCT00219544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001327|NCT00219544|Anticonvulsants|anticonvulsants|mesh-ancestor
6001328|NCT00219544|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6001329|NCT00219544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6001330|NCT00219544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001331|NCT00219544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6001332|NCT00219544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6001333|NCT00219544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6001334|NCT00219544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6001335|NCT00219544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6001336|NCT00219557|Gemcitabine|gemcitabine|mesh-list
6001337|NCT00219557|Axitinib|axitinib|mesh-list
6001338|NCT00219557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6001339|NCT00219557|Antimetabolites|antimetabolites|mesh-ancestor
6001340|NCT00219557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001341|NCT00219557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6001342|NCT00219557|Antiviral Agents|antiviral agents|mesh-ancestor
6001343|NCT00219557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6001344|NCT00219557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6001345|NCT00219557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6001346|NCT00219557|Immunologic Factors|immunologic factors|mesh-ancestor
6001347|NCT00219557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001348|NCT00219557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6001349|NCT00220636|Aripiprazole|aripiprazole|mesh-list
6001350|NCT00220636|Antidepressive Agents|antidepressive agents|mesh-ancestor
6001351|NCT00220636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6001352|NCT00220636|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6001353|NCT00220636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6001354|NCT00220636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6001355|NCT00220636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001356|NCT00220636|Dopamine Agonists|dopamine agonists|mesh-ancestor
6001357|NCT00220636|Dopamine Agents|dopamine agents|mesh-ancestor
6001358|NCT00220636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6001359|NCT00220636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001360|NCT00220636|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6001361|NCT00220636|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6001362|NCT00220636|Serotonin Agents|serotonin agents|mesh-ancestor
6001363|NCT00220636|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6001364|NCT00220636|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6001365|NCT00220636|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6001366|NCT00220636|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6001367|NCT00220701|Dexetimide|dexetimide|mesh-list
6001368|NCT00220701|Citalopram|citalopram|mesh-list
6001369|NCT00220701|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6001370|NCT00220701|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6001371|NCT00220701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6001372|NCT00220701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001373|NCT00220701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6001374|NCT00220701|Serotonin Agents|serotonin agents|mesh-ancestor
6001375|NCT00220701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001376|NCT00220701|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6001377|NCT00220701|Antidepressive Agents|antidepressive agents|mesh-ancestor
6001378|NCT00220701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6001379|NCT00220701|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6001380|NCT00220701|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6001381|NCT00220701|Parasympatholytics|parasympatholytics|mesh-ancestor
6001382|NCT00220701|Autonomic Agents|autonomic agents|mesh-ancestor
6001383|NCT00220701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6001384|NCT00220701|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6001385|NCT00220701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6001386|NCT00220701|Cholinergic Agents|cholinergic agents|mesh-ancestor
6001387|NCT00220727|Immunoglobulins|immunoglobulins|mesh-list
6001388|NCT00220727|Antibodies|antibodies|mesh-list
6001389|NCT00220727|gamma-Globulins|gamma-globulins|mesh-list
6001390|NCT00220727|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6001391|NCT00220727|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6001392|NCT00220727|Immunoglobulin G|immunoglobulin g|mesh-list
6001393|NCT00220727|Immunologic Factors|immunologic factors|mesh-ancestor
6001394|NCT00220727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001395|NCT00220740|Immunoglobulins|immunoglobulins|mesh-list
6001396|NCT00220740|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6001397|NCT00220740|Antibodies|antibodies|mesh-list
6001398|NCT00220740|gamma-Globulins|gamma-globulins|mesh-list
6001399|NCT00220740|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6001400|NCT00220740|Immunoglobulin G|immunoglobulin g|mesh-list
6001401|NCT00220740|Immunologic Factors|immunologic factors|mesh-ancestor
6001402|NCT00220740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001403|NCT00220779|Immunoglobulins|immunoglobulins|mesh-list
6001404|NCT00220779|Antibodies|antibodies|mesh-list
6001405|NCT00220779|gamma-Globulins|gamma-globulins|mesh-list
6001406|NCT00220779|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6001407|NCT00220779|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6001408|NCT00220779|Immunoglobulin G|immunoglobulin g|mesh-list
6259867|NCT03132571|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6259868|NCT03132571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259869|NCT03132571|Sensory System Agents|sensory system agents|mesh-ancestor
6259870|NCT03132571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6259871|NCT03132571|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6259872|NCT03132571|Antidepressive Agents|antidepressive agents|mesh-ancestor
6259873|NCT03132571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6259874|NCT03132571|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6259875|NCT03132571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6259876|NCT03132571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6259877|NCT03132571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259878|NCT03132571|Dopamine Agents|dopamine agents|mesh-ancestor
6259879|NCT03132571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6259880|NCT03132571|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6259881|NCT03132571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6259882|NCT03132571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6259883|NCT03133481|Ropivacaine|ropivacaine|mesh-list
6259884|NCT03133481|Anesthetics, Local|anesthetics, local|mesh-ancestor
6259885|NCT03133481|Anesthetics|anesthetics|mesh-ancestor
6259886|NCT03133481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6259887|NCT03133481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259888|NCT03133481|Sensory System Agents|sensory system agents|mesh-ancestor
6259889|NCT03133481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6259890|NCT03133767|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6259891|NCT03134183|Misoprostol|misoprostol|mesh-list
6259892|NCT03134183|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6259893|NCT03134183|Abortifacient Agents|abortifacient agents|mesh-ancestor
6259894|NCT03134183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6259895|NCT03134183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259896|NCT03134183|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6259897|NCT03134183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6259898|NCT03134183|Oxytocics|oxytocics|mesh-ancestor
6259899|NCT03134703|Morphine|morphine|mesh-list
6259900|NCT03134703|Methadone|methadone|mesh-list
6259901|NCT03134703|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6001409|NCT00220779|Immunologic Factors|immunologic factors|mesh-ancestor
6259902|NCT03134703|Narcotics|narcotics|mesh-ancestor
6259903|NCT03134703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6259904|NCT03134703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259905|NCT03134703|Analgesics|analgesics|mesh-ancestor
6259906|NCT03134703|Sensory System Agents|sensory system agents|mesh-ancestor
6259907|NCT03134703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6259908|NCT03134703|Antitussive Agents|antitussive agents|mesh-ancestor
6259909|NCT03134703|Respiratory System Agents|respiratory system agents|mesh-ancestor
6259910|NCT03135028|Cytarabine|cytarabine|mesh-list
6259911|NCT03135028|Daunorubicin|daunorubicin|mesh-list
6259912|NCT03135028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6001410|NCT00220779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001411|NCT00220805|Immunoglobulins|immunoglobulins|mesh-list
6001412|NCT00220805|Antibodies|antibodies|mesh-list
6001413|NCT00220805|gamma-Globulins|gamma-globulins|mesh-list
6001414|NCT00220805|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6001415|NCT00220805|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6001416|NCT00220805|Immunoglobulin G|immunoglobulin g|mesh-list
6001417|NCT00220805|Immunologic Factors|immunologic factors|mesh-ancestor
6001418|NCT00220805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001419|NCT00220961|Pioglitazone|pioglitazone|mesh-list
6001420|NCT00220961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6001421|NCT00220961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001422|NCT00221104|Pravastatin|pravastatin|mesh-list
6001423|NCT00221104|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6001424|NCT00221104|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6001425|NCT00221104|Antimetabolites|antimetabolites|mesh-ancestor
6001426|NCT00221104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001427|NCT00221104|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6001428|NCT00221104|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6001429|NCT00221104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6001430|NCT00221195|Thrombin|thrombin|mesh-list
6001431|NCT00221195|Hemostatics|hemostatics|mesh-ancestor
6001432|NCT00221195|Coagulants|coagulants|mesh-ancestor
6001433|NCT00221299|Risedronic Acid|risedronic acid|mesh-list
6001434|NCT00221299|Hormones|hormones|mesh-list
6001435|NCT00221299|Parathyroid Hormone|parathyroid hormone|mesh-list
6001436|NCT00221299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6001437|NCT00221299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001438|NCT00221299|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6001439|NCT00221299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6001440|NCT00221299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001441|NCT00221299|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6001442|NCT00221299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6001443|NCT00221338|Gabapentin|gabapentin|mesh-list
6001444|NCT00221338|Analgesics|analgesics|mesh-ancestor
6001445|NCT00221338|Sensory System Agents|sensory system agents|mesh-ancestor
6001446|NCT00221338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6001447|NCT00221338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001448|NCT00221338|Anticonvulsants|anticonvulsants|mesh-ancestor
6001449|NCT00221338|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6001450|NCT00221338|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6001451|NCT00221338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6001452|NCT00221338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6001453|NCT00221338|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6001454|NCT00221338|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6001455|NCT00221338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6001456|NCT00221338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001457|NCT00221338|Antimanic Agents|antimanic agents|mesh-ancestor
6001458|NCT00221403|Valproic Acid|valproic acid|mesh-list
6001459|NCT00221403|Risperidone|risperidone|mesh-list
6001460|NCT00221403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6001461|NCT00221403|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6001462|NCT00221403|Serotonin Agents|serotonin agents|mesh-ancestor
6001463|NCT00221403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6001464|NCT00221403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001465|NCT00221403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001466|NCT00221403|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6001467|NCT00221403|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6001468|NCT00221403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6001469|NCT00221403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6001470|NCT00221403|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6001471|NCT00221403|Dopamine Agents|dopamine agents|mesh-ancestor
6001472|NCT00221403|Anticonvulsants|anticonvulsants|mesh-ancestor
6001473|NCT00221403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6001474|NCT00221403|GABA Agents|gaba agents|mesh-ancestor
6001475|NCT00221403|Antimanic Agents|antimanic agents|mesh-ancestor
6001476|NCT00222105|Thalidomide|thalidomide|mesh-list
6001477|NCT00222105|Dexamethasone|dexamethasone|mesh-list
6001478|NCT00222105|Doxorubicin|doxorubicin|mesh-list
6001479|NCT00222105|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6001480|NCT00222105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6001481|NCT00222105|Antiemetics|antiemetics|mesh-ancestor
6001482|NCT00222105|Autonomic Agents|autonomic agents|mesh-ancestor
6001483|NCT00222105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6001484|NCT00222105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001485|NCT00222105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6001486|NCT00222105|Glucocorticoids|glucocorticoids|mesh-ancestor
6001487|NCT00222105|Hormones|hormones|mesh-ancestor
6001488|NCT00222105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6001489|NCT00222105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6001490|NCT00222105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6001491|NCT00222105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6001492|NCT00222105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6001493|NCT00222105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6001494|NCT00222105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6001495|NCT00222105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001496|NCT00222105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6001497|NCT00222105|Immunologic Factors|immunologic factors|mesh-ancestor
6001498|NCT00222105|Leprostatic Agents|leprostatic agents|mesh-ancestor
6001499|NCT00222105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6001500|NCT00222105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6001501|NCT00222105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6001502|NCT00222105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6001503|NCT00222105|Growth Substances|growth substances|mesh-ancestor
6001504|NCT00222105|Growth Inhibitors|growth inhibitors|mesh-ancestor
6001505|NCT00222131|Esomeprazole|esomeprazole|mesh-list
6001506|NCT00222131|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6001507|NCT00222131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6001508|NCT00222131|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6001509|NCT00222131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6001510|NCT00222131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001511|NCT00222729|Bevacizumab|bevacizumab|mesh-list
6001512|NCT00222729|Pemetrexed|pemetrexed|mesh-list
6001513|NCT00222729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6001514|NCT00222729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6001515|NCT00222729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6001516|NCT00222729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6001517|NCT00222729|Growth Substances|growth substances|mesh-ancestor
6001518|NCT00222729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001519|NCT00222729|Growth Inhibitors|growth inhibitors|mesh-ancestor
6001520|NCT00222729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6001521|NCT00222729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001522|NCT00222729|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6001523|NCT00222729|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6001524|NCT00223080|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6001525|NCT00223080|Immunologic Factors|immunologic factors|mesh-ancestor
6001526|NCT00223080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001527|NCT00223080|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6001528|NCT00223080|Antacids|antacids|mesh-ancestor
6001529|NCT00223080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001530|NCT00223080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6001531|NCT00223236|Choline|choline|mesh-list
6001532|NCT00223236|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
6001533|NCT00223236|Lipotropic Agents|lipotropic agents|mesh-ancestor
6001534|NCT00223236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6001535|NCT00223236|Antimetabolites|antimetabolites|mesh-ancestor
6001536|NCT00223236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001537|NCT00223236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6001538|NCT00223236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6001539|NCT00223236|Nootropic Agents|nootropic agents|mesh-ancestor
6001540|NCT00223262|Lamotrigine|lamotrigine|mesh-list
6001541|NCT00223262|Anticonvulsants|anticonvulsants|mesh-ancestor
6001542|NCT00223262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6001543|NCT00223262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6001544|NCT00223262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001545|NCT00223262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6001546|NCT00223262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001547|NCT00223262|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6001548|NCT00223262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6001549|NCT00223262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6001550|NCT00223262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6001551|NCT00223262|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6001552|NCT00223496|Aripiprazole|aripiprazole|mesh-list
6001553|NCT00223496|Antidepressive Agents|antidepressive agents|mesh-ancestor
6001554|NCT00223496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6001555|NCT00223496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6001556|NCT00223496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6001557|NCT00223496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6001558|NCT00223496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001559|NCT00223496|Dopamine Agonists|dopamine agonists|mesh-ancestor
6001560|NCT00223496|Dopamine Agents|dopamine agents|mesh-ancestor
6001561|NCT00223496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6259913|NCT03135028|Antimetabolites|antimetabolites|mesh-ancestor
6259914|NCT03135028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259915|NCT03135028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6259916|NCT03135028|Antiviral Agents|antiviral agents|mesh-ancestor
6259917|NCT03135028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6259918|NCT03135028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6259919|NCT03135028|Immunologic Factors|immunologic factors|mesh-ancestor
6259920|NCT03135028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001562|NCT00223496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001563|NCT00223496|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6001564|NCT00223496|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6001565|NCT00223496|Serotonin Agents|serotonin agents|mesh-ancestor
6001566|NCT00223496|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6001567|NCT00223496|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6001568|NCT00223496|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6001569|NCT00223496|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6001570|NCT00223665|Leuprolide|leuprolide|mesh-list
6001571|NCT00223665|Flutamide|flutamide|mesh-list
6001572|NCT00223665|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6001573|NCT00223665|Fertility Agents|fertility agents|mesh-ancestor
6001574|NCT00223665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6001575|NCT00223665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001576|NCT00223665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6001577|NCT00223665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6001578|NCT00223665|Androgen Antagonists|androgen antagonists|mesh-ancestor
6001579|NCT00223665|Hormone Antagonists|hormone antagonists|mesh-ancestor
6001580|NCT00223665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6001581|NCT00223678|Sirolimus|sirolimus|mesh-list
6001582|NCT00223678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6001583|NCT00223678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6001584|NCT00223678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6001585|NCT00223678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6001586|NCT00223678|Antifungal Agents|antifungal agents|mesh-ancestor
6001587|NCT00223678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6001588|NCT00223678|Immunologic Factors|immunologic factors|mesh-ancestor
6001589|NCT00223678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001590|NCT00223704|Icatibant|icatibant|mesh-list
6001591|NCT00223704|Aminocaproic Acid|aminocaproic acid|mesh-list
6001592|NCT00223704|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6001593|NCT00223704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6001594|NCT00223704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001595|NCT00223704|Hemostatics|hemostatics|mesh-ancestor
6001596|NCT00223704|Coagulants|coagulants|mesh-ancestor
6001597|NCT00223704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6001598|NCT00223704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6001599|NCT00223704|Analgesics|analgesics|mesh-ancestor
6001600|NCT00223704|Sensory System Agents|sensory system agents|mesh-ancestor
6001601|NCT00223704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6001602|NCT00223704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001603|NCT00223704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6001604|NCT00223704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6001605|NCT00223704|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
6001606|NCT00223704|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
6001607|NCT00223704|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6001608|NCT00223704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6001609|NCT00223704|Immunologic Factors|immunologic factors|mesh-ancestor
6001610|NCT00223821|Oxybutynin|oxybutynin|mesh-list
6001611|NCT00223821|Parasympatholytics|parasympatholytics|mesh-ancestor
6001612|NCT00223821|Autonomic Agents|autonomic agents|mesh-ancestor
6001613|NCT00223821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6001614|NCT00223821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001615|NCT00223821|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6001616|NCT00223821|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6001617|NCT00223821|Cholinergic Agents|cholinergic agents|mesh-ancestor
6001618|NCT00223821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6001619|NCT00223821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001620|NCT00223821|Urological Agents|urological agents|mesh-ancestor
6001621|NCT00223977|Ferric gluconate|ferric gluconate|mesh-list
6001622|NCT00223977|Ferric Compounds|ferric compounds|mesh-list
6001623|NCT00223977|Hematinics|hematinics|mesh-ancestor
6001624|NCT00224016|Mandelic Acids|mandelic acids|mesh-list
6001625|NCT00224016|Oxybutynin|oxybutynin|mesh-list
6001626|NCT00224016|Parasympatholytics|parasympatholytics|mesh-ancestor
6001627|NCT00224016|Autonomic Agents|autonomic agents|mesh-ancestor
6001628|NCT00224016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6001629|NCT00224016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001630|NCT00224016|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6001631|NCT00224016|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6001632|NCT00224016|Cholinergic Agents|cholinergic agents|mesh-ancestor
6001633|NCT00224016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6001634|NCT00224016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001635|NCT00224016|Urological Agents|urological agents|mesh-ancestor
6001636|NCT00224016|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6001637|NCT00224016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6001638|NCT00224016|Renal Agents|renal agents|mesh-ancestor
6001639|NCT00224029|Oxybutynin|oxybutynin|mesh-list
6001640|NCT00224029|Parasympatholytics|parasympatholytics|mesh-ancestor
6001641|NCT00224029|Autonomic Agents|autonomic agents|mesh-ancestor
6001642|NCT00224029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6001643|NCT00224029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001644|NCT00224029|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6001645|NCT00224029|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6001646|NCT00224029|Cholinergic Agents|cholinergic agents|mesh-ancestor
6001647|NCT00224029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6001648|NCT00224029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001649|NCT00224029|Urological Agents|urological agents|mesh-ancestor
6001650|NCT00224042|Ferric gluconate|ferric gluconate|mesh-list
6001651|NCT00224042|Hematinics|hematinics|mesh-ancestor
6001652|NCT00224055|Ferric gluconate|ferric gluconate|mesh-list
6001653|NCT00224055|Hematinics|hematinics|mesh-ancestor
6001654|NCT00224107|Silodosin|silodosin|mesh-list
6001655|NCT00224107|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6001656|NCT00224107|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6001657|NCT00224107|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6001658|NCT00224107|Adrenergic Agents|adrenergic agents|mesh-ancestor
6001659|NCT00224107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6001660|NCT00224107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001661|NCT00224107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001662|NCT00224107|Urological Agents|urological agents|mesh-ancestor
6001663|NCT00224120|Silodosin|silodosin|mesh-list
6001664|NCT00224120|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6001665|NCT00224120|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6001666|NCT00224120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6001667|NCT00224120|Adrenergic Agents|adrenergic agents|mesh-ancestor
6001668|NCT00224120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6001669|NCT00224120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259921|NCT03135028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6001670|NCT00224120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001671|NCT00224120|Urological Agents|urological agents|mesh-ancestor
6001672|NCT00224133|Silodosin|silodosin|mesh-list
6001673|NCT00224133|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6001674|NCT00224133|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6001675|NCT00224133|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6259922|NCT03135028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6259923|NCT03135028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6259924|NCT03135028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6259925|NCT03136068|Digoxin|digoxin|mesh-list
6259926|NCT03136068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6259927|NCT03136068|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6259928|NCT03136068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6259929|NCT03136068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259930|NCT03136068|Protective Agents|protective agents|mesh-ancestor
6259931|NCT03136068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259932|NCT03136107|Sunscreening Agents|sunscreening agents|mesh-list
6259933|NCT03136107|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6259934|NCT03136107|Protective Agents|protective agents|mesh-ancestor
6259935|NCT03136107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259936|NCT03136107|Dermatologic Agents|dermatologic agents|mesh-ancestor
6259937|NCT03136159|Anti-Infective Agents|anti-infective agents|mesh-list
6259938|NCT03136159|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6259939|NCT03136198|Vasodilator Agents|vasodilator agents|mesh-list
6259940|NCT03136198|Diuretics|diuretics|mesh-list
6259941|NCT03136198|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
6259942|NCT03136198|Natriuretic Agents|natriuretic agents|mesh-ancestor
6259943|NCT03136198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259944|NCT03136198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6259945|NCT03136198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259946|NCT03136328|Edotreotide|edotreotide|mesh-list
6259947|NCT03136328|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6259948|NCT03136328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259949|NCT03136484|Canagliflozin|canagliflozin|mesh-list
6259950|NCT03136484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6259951|NCT03136484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259952|NCT03136484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6259953|NCT03136484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259954|NCT03136861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6259955|NCT03136861|Immunologic Factors|immunologic factors|mesh-ancestor
6259956|NCT03136861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259957|NCT03137121|Olanzapine|olanzapine|mesh-list
6259958|NCT03137121|Antiemetics|antiemetics|mesh-ancestor
6259959|NCT03137121|Autonomic Agents|autonomic agents|mesh-ancestor
6259960|NCT03137121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6259961|NCT03137121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259962|NCT03137121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6259963|NCT03137121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6259964|NCT03137121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6259965|NCT03137121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6259966|NCT03137121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6259967|NCT03137121|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6259968|NCT03137121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6259969|NCT03137121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6259970|NCT03137121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259971|NCT03137121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6259972|NCT03137121|Serotonin Agents|serotonin agents|mesh-ancestor
6259973|NCT03137173|Vancomycin|vancomycin|mesh-list
6259974|NCT03137173|Aztreonam|aztreonam|mesh-list
6259975|NCT03137173|Ceftobiprole|ceftobiprole|mesh-list
6259976|NCT03137173|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
6259977|NCT03137173|Cephalosporins|cephalosporins|mesh-list
6259978|NCT03137173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6259979|NCT03137173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6259980|NCT03137303|Albuterol|albuterol|mesh-list
6259981|NCT03137303|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6001676|NCT00224133|Adrenergic Agents|adrenergic agents|mesh-ancestor
6259982|NCT03137303|Autonomic Agents|autonomic agents|mesh-ancestor
6259983|NCT03137303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6001677|NCT00224133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6001678|NCT00224133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001679|NCT00224133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001680|NCT00224133|Urological Agents|urological agents|mesh-ancestor
6001681|NCT00224289|Latanoprost|latanoprost|mesh-list
6001682|NCT00224289|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6001683|NCT00224289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6001684|NCT00224484|Vaccines|vaccines|mesh-list
6001685|NCT00224484|Immunologic Factors|immunologic factors|mesh-ancestor
6001686|NCT00224484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001687|NCT00224770|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6001688|NCT00224770|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6001689|NCT00224770|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6001690|NCT00224770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001691|NCT00224874|Mycophenolic Acid|mycophenolic acid|mesh-list
6001692|NCT00224874|Etanercept|etanercept|mesh-list
6001693|NCT00224874|Pentostatin|pentostatin|mesh-list
6001694|NCT00224874|Denileukin diftitox|denileukin diftitox|mesh-list
6001695|NCT00224874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6001696|NCT00224874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6001697|NCT00224874|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6001698|NCT00224874|Antitubercular Agents|antitubercular agents|mesh-ancestor
6001699|NCT00224874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6001700|NCT00224874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6001701|NCT00224874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6001702|NCT00224874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001703|NCT00224874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6001704|NCT00224874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6001705|NCT00224874|Analgesics|analgesics|mesh-ancestor
6001706|NCT00224874|Sensory System Agents|sensory system agents|mesh-ancestor
6001707|NCT00224874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6001708|NCT00224874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001709|NCT00224874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6001710|NCT00224874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6001711|NCT00224874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6001712|NCT00224874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6001713|NCT00224874|Immunologic Factors|immunologic factors|mesh-ancestor
6001714|NCT00224874|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
6001715|NCT00224952|Carbamazepine|carbamazepine|mesh-list
6001716|NCT00224952|Valproic Acid|valproic acid|mesh-list
6001717|NCT00224952|Anticonvulsants|anticonvulsants|mesh-ancestor
6001718|NCT00224952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6001719|NCT00224952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001720|NCT00224952|GABA Agents|gaba agents|mesh-ancestor
6001721|NCT00224952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6001722|NCT00224952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001723|NCT00224952|Antimanic Agents|antimanic agents|mesh-ancestor
6001724|NCT00224952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6001725|NCT00224952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6001726|NCT00224952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6001727|NCT00224952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6001728|NCT00224952|Analgesics|analgesics|mesh-ancestor
6001729|NCT00224952|Sensory System Agents|sensory system agents|mesh-ancestor
6001730|NCT00224952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6001731|NCT00224952|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6001732|NCT00224952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6001733|NCT00224952|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6001734|NCT00224952|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6001735|NCT00225017|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6001736|NCT00225017|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6001737|NCT00225017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6001738|NCT00225017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6001739|NCT00225017|Protease Inhibitors|protease inhibitors|mesh-ancestor
6001740|NCT00225017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6001741|NCT00225017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001742|NCT00225017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6001743|NCT00225017|Antiviral Agents|antiviral agents|mesh-ancestor
6001744|NCT00225017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6001745|NCT00225147|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
6001746|NCT00225147|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6001747|NCT00225147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6001748|NCT00225147|Immunologic Factors|immunologic factors|mesh-ancestor
6001749|NCT00225147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001750|NCT00225212|Rituximab|rituximab|mesh-list
6001751|NCT00225212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6001752|NCT00225212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6001753|NCT00225212|Immunologic Factors|immunologic factors|mesh-ancestor
6001754|NCT00225212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001755|NCT00225212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6001756|NCT00225251|Bupropion|bupropion|mesh-list
6001757|NCT00225251|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6001758|NCT00225251|Antidepressive Agents|antidepressive agents|mesh-ancestor
6001759|NCT00225251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6001760|NCT00225251|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6001761|NCT00225251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6001762|NCT00225251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6001763|NCT00225251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001764|NCT00225251|Dopamine Agents|dopamine agents|mesh-ancestor
6001765|NCT00225251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6001766|NCT00225251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001767|NCT00225251|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6001768|NCT00225251|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6001769|NCT00225251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6001770|NCT00225277|Pioglitazone|pioglitazone|mesh-list
6001771|NCT00225277|Glimepiride|glimepiride|mesh-list
6001772|NCT00225277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6001773|NCT00225277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001774|NCT00225277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6001775|NCT00225277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6001776|NCT00225277|Immunologic Factors|immunologic factors|mesh-ancestor
6001777|NCT00225420|Docetaxel|docetaxel|mesh-list
6001778|NCT00225420|Leuprolide|leuprolide|mesh-list
6001779|NCT00225420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6001780|NCT00225420|Tubulin Modulators|tubulin modulators|mesh-ancestor
6001781|NCT00225420|Antimitotic Agents|antimitotic agents|mesh-ancestor
6001782|NCT00225420|Mitosis Modulators|mitosis modulators|mesh-ancestor
6001783|NCT00225420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001784|NCT00225420|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6001785|NCT00225420|Fertility Agents|fertility agents|mesh-ancestor
6001786|NCT00225420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6001787|NCT00225420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001788|NCT00225420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6001789|NCT00225498|Olanzapine|olanzapine|mesh-list
6001790|NCT00225498|Risperidone|risperidone|mesh-list
6001791|NCT00225498|Ziprasidone|ziprasidone|mesh-list
6001792|NCT00225498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6001793|NCT00225498|Serotonin Agents|serotonin agents|mesh-ancestor
6001794|NCT00225498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6001795|NCT00225498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001796|NCT00225498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001797|NCT00225498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6001798|NCT00225498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6001799|NCT00225498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6001800|NCT00225498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6001801|NCT00225498|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6001802|NCT00225498|Dopamine Agents|dopamine agents|mesh-ancestor
6001803|NCT00225498|Antiemetics|antiemetics|mesh-ancestor
6001804|NCT00225498|Autonomic Agents|autonomic agents|mesh-ancestor
6001805|NCT00225498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6001806|NCT00225498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6001807|NCT00225498|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6001808|NCT00225498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6001809|NCT00225498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6001810|NCT00225732|Ibuprofen|ibuprofen|mesh-list
6001811|NCT00225732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6001812|NCT00225732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6001813|NCT00225732|Analgesics|analgesics|mesh-ancestor
6001814|NCT00225732|Sensory System Agents|sensory system agents|mesh-ancestor
6001815|NCT00225732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6001816|NCT00225732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001817|NCT00225732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6001818|NCT00225732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6001819|NCT00225732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6001820|NCT00225732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6001821|NCT00225732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001822|NCT00225758|Lapatinib|lapatinib|mesh-list
6001823|NCT00225758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6001824|NCT00225758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6001825|NCT00225758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6001826|NCT00225758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001827|NCT00225784|Gemcitabine|gemcitabine|mesh-list
6001828|NCT00225784|Cetuximab|cetuximab|mesh-list
6001829|NCT00225784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6001830|NCT00225784|Antimetabolites|antimetabolites|mesh-ancestor
6001831|NCT00225784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001832|NCT00225784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6001833|NCT00225784|Antiviral Agents|antiviral agents|mesh-ancestor
6001834|NCT00225784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6001835|NCT00225784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6001836|NCT00225784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6001837|NCT00225784|Immunologic Factors|immunologic factors|mesh-ancestor
6001838|NCT00225784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001839|NCT00225784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6001840|NCT00226239|Docetaxel|docetaxel|mesh-list
6001841|NCT00226239|Cetuximab|cetuximab|mesh-list
6001842|NCT00226239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6001843|NCT00226239|Tubulin Modulators|tubulin modulators|mesh-ancestor
6001844|NCT00226239|Antimitotic Agents|antimitotic agents|mesh-ancestor
6001845|NCT00226239|Mitosis Modulators|mitosis modulators|mesh-ancestor
6001846|NCT00226239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001847|NCT00226239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6001848|NCT00226577|Gemcitabine|gemcitabine|mesh-list
6001849|NCT00226577|Pemetrexed|pemetrexed|mesh-list
6001850|NCT00226577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6001851|NCT00226577|Antimetabolites|antimetabolites|mesh-ancestor
6001852|NCT00226577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001853|NCT00226577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6001854|NCT00226577|Antiviral Agents|antiviral agents|mesh-ancestor
6001855|NCT00226577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6001856|NCT00226577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6001857|NCT00226577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6001858|NCT00226577|Immunologic Factors|immunologic factors|mesh-ancestor
6001859|NCT00226577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001860|NCT00226577|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6001861|NCT00226577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6001862|NCT00226590|Gemcitabine|gemcitabine|mesh-list
6001863|NCT00226590|Paclitaxel|paclitaxel|mesh-list
6001864|NCT00226590|Carboplatin|carboplatin|mesh-list
6001865|NCT00226590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6001866|NCT00226590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6001867|NCT00226590|Tubulin Modulators|tubulin modulators|mesh-ancestor
6001868|NCT00226590|Antimitotic Agents|antimitotic agents|mesh-ancestor
6001869|NCT00226590|Mitosis Modulators|mitosis modulators|mesh-ancestor
6001870|NCT00226590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001871|NCT00226590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6001872|NCT00226590|Antimetabolites|antimetabolites|mesh-ancestor
6001873|NCT00226590|Antiviral Agents|antiviral agents|mesh-ancestor
6001874|NCT00226590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6001875|NCT00226590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6001876|NCT00226590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6001877|NCT00226590|Immunologic Factors|immunologic factors|mesh-ancestor
6001878|NCT00226590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001879|NCT00226655|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
6001880|NCT00226655|Hormones|hormones|mesh-ancestor
6001881|NCT00226655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6001882|NCT00226655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001883|NCT00226811|Sunitinib|sunitinib|mesh-list
6001884|NCT00226811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6001885|NCT00226811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6001886|NCT00226811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6001887|NCT00226811|Growth Substances|growth substances|mesh-ancestor
6001888|NCT00226811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001889|NCT00226811|Growth Inhibitors|growth inhibitors|mesh-ancestor
6001890|NCT00226811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6001891|NCT00226811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6001892|NCT00226811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017973|NCT00377403|Sensory System Agents|sensory system agents|mesh-ancestor
6017974|NCT00377403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6017975|NCT00377403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017976|NCT00377403|Antipyretics|antipyretics|mesh-ancestor
6017977|NCT00377403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6017978|NCT00377403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6017979|NCT00377403|Antitussive Agents|antitussive agents|mesh-ancestor
6017980|NCT00377403|Respiratory System Agents|respiratory system agents|mesh-ancestor
6017981|NCT00377403|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6017982|NCT00377403|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6017983|NCT00377403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6017984|NCT00377403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017985|NCT00377403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6017986|NCT00377403|Autonomic Agents|autonomic agents|mesh-ancestor
6017987|NCT00377403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6017988|NCT00377403|Nasal Decongestants|nasal decongestants|mesh-ancestor
6017989|NCT00377403|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6017990|NCT00377403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6017991|NCT00377403|Sympathomimetics|sympathomimetics|mesh-ancestor
6017992|NCT00377403|Adrenergic Agents|adrenergic agents|mesh-ancestor
6017993|NCT00377403|Expectorants|expectorants|mesh-ancestor
6017994|NCT00377403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6017995|NCT00377403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6017996|NCT00377403|Appetite Depressants|appetite depressants|mesh-ancestor
6017997|NCT00377403|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6017998|NCT00377429|Catumaxomab|catumaxomab|mesh-list
6017999|NCT00377429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6018000|NCT00377520|Pemetrexed|pemetrexed|mesh-list
6018001|NCT00377520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6018002|NCT00377520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6018003|NCT00377520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001893|NCT00226941|Diphenhydramine|diphenhydramine|mesh-list
6001894|NCT00226941|Promethazine|promethazine|mesh-list
6001895|NCT00226941|Capecitabine|capecitabine|mesh-list
6001896|NCT00226941|Oxaliplatin|oxaliplatin|mesh-list
6001897|NCT00226941|Cetuximab|cetuximab|mesh-list
6001898|NCT00226941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6001899|NCT00226941|Antimetabolites|antimetabolites|mesh-ancestor
6001900|NCT00226941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001901|NCT00226941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6001902|NCT00226941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6001903|NCT00226941|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6001904|NCT00226941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6001905|NCT00226941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6259984|NCT03137303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6259985|NCT03137303|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6259986|NCT03137303|Respiratory System Agents|respiratory system agents|mesh-ancestor
6259987|NCT03137303|Tocolytic Agents|tocolytic agents|mesh-ancestor
6259988|NCT03137303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6259989|NCT03137303|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6259990|NCT03137303|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6259991|NCT03137303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6259992|NCT03137303|Adrenergic Agents|adrenergic agents|mesh-ancestor
6259993|NCT03137303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6259994|NCT03137303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6259995|NCT03137784|Glycopyrrolate|glycopyrrolate|mesh-list
6259996|NCT03137784|Bromides|bromides|mesh-list
6259997|NCT03137784|Anticonvulsants|anticonvulsants|mesh-ancestor
6259998|NCT03137784|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6259999|NCT03137784|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6260000|NCT03137784|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6260001|NCT03137784|Cholinergic Agents|cholinergic agents|mesh-ancestor
6260002|NCT03137784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6260003|NCT03137784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260004|NCT03137784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260005|NCT03137992|Bromides|bromides|mesh-list
6260006|NCT03137992|Tiotropium Bromide|tiotropium bromide|mesh-list
6260007|NCT03137992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6260008|NCT03137992|Autonomic Agents|autonomic agents|mesh-ancestor
6260009|NCT03137992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6001906|NCT00226941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001907|NCT00226941|Anesthetics, Local|anesthetics, local|mesh-ancestor
6001908|NCT00226941|Anesthetics|anesthetics|mesh-ancestor
6001909|NCT00226941|Sensory System Agents|sensory system agents|mesh-ancestor
6001910|NCT00226941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6001911|NCT00226941|Antiemetics|antiemetics|mesh-ancestor
6001912|NCT00226941|Autonomic Agents|autonomic agents|mesh-ancestor
6001913|NCT00226941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6001914|NCT00226941|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6001915|NCT00226941|Histamine Antagonists|histamine antagonists|mesh-ancestor
6001916|NCT00226941|Histamine Agents|histamine agents|mesh-ancestor
6001917|NCT00226941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6001918|NCT00226941|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6001919|NCT00226941|Antipruritics|antipruritics|mesh-ancestor
6001920|NCT00226941|Dermatologic Agents|dermatologic agents|mesh-ancestor
6001921|NCT00227019|Vitamins|vitamins|mesh-list
6001922|NCT00227019|Folic Acid|folic acid|mesh-list
6001923|NCT00227019|Vitamin B 12|vitamin b 12|mesh-list
6001924|NCT00227019|Hydroxocobalamin|hydroxocobalamin|mesh-list
6001925|NCT00227019|Vitamin B Complex|vitamin b complex|mesh-list
6001926|NCT00227019|Dexamethasone|dexamethasone|mesh-list
6001927|NCT00227019|Bevacizumab|bevacizumab|mesh-list
6001928|NCT00227019|Pemetrexed|pemetrexed|mesh-list
6001929|NCT00227019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6001930|NCT00227019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6001931|NCT00227019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6001932|NCT00227019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6001933|NCT00227019|Growth Substances|growth substances|mesh-ancestor
6001934|NCT00227019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001935|NCT00227019|Growth Inhibitors|growth inhibitors|mesh-ancestor
6001936|NCT00227019|Micronutrients|micronutrients|mesh-ancestor
6001937|NCT00227019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6001938|NCT00227019|Antiemetics|antiemetics|mesh-ancestor
6001939|NCT00227019|Autonomic Agents|autonomic agents|mesh-ancestor
6001940|NCT00227019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6001941|NCT00227019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6001942|NCT00227019|Glucocorticoids|glucocorticoids|mesh-ancestor
6001943|NCT00227019|Hormones|hormones|mesh-ancestor
6001944|NCT00227019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6001945|NCT00227019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6001946|NCT00227019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6001947|NCT00227019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001948|NCT00227019|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6001949|NCT00227019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6001950|NCT00227019|Hematinics|hematinics|mesh-ancestor
6001951|NCT00227266|Valproic Acid|valproic acid|mesh-list
6001952|NCT00227266|Anticonvulsants|anticonvulsants|mesh-ancestor
6001953|NCT00227266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6018004|NCT00377520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6001954|NCT00227266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001955|NCT00227266|GABA Agents|gaba agents|mesh-ancestor
6001956|NCT00227266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6001957|NCT00227266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001958|NCT00227266|Antimanic Agents|antimanic agents|mesh-ancestor
6001959|NCT00227266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6001960|NCT00227266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6001961|NCT00227266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6001962|NCT00227305|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6001963|NCT00227305|Antidepressive Agents|antidepressive agents|mesh-ancestor
6001964|NCT00227305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6001965|NCT00227305|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6001966|NCT00227305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6001967|NCT00227305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6001968|NCT00227305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001969|NCT00227344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
6001970|NCT00227370|Valganciclovir|valganciclovir|mesh-list
6001971|NCT00227370|Antiviral Agents|antiviral agents|mesh-ancestor
6001972|NCT00227370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6001973|NCT00227539|Pemetrexed|pemetrexed|mesh-list
6001974|NCT00227539|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6001975|NCT00227539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6001976|NCT00227539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6001977|NCT00227539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6001978|NCT00227539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6001979|NCT00227539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6001980|NCT00227539|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6001981|NCT00227591|Prednisone|prednisone|mesh-list
6001982|NCT00227591|Lenalidomide|lenalidomide|mesh-list
6001983|NCT00227591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6001984|NCT00227591|Glucocorticoids|glucocorticoids|mesh-ancestor
6001985|NCT00227591|Hormones|hormones|mesh-ancestor
6001986|NCT00227591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6001987|NCT00227591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6001988|NCT00227591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6001989|NCT00227591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6001990|NCT00227591|Immunologic Factors|immunologic factors|mesh-ancestor
6001991|NCT00227591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6001992|NCT00227591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6001993|NCT00227591|Growth Substances|growth substances|mesh-ancestor
6001994|NCT00227591|Growth Inhibitors|growth inhibitors|mesh-ancestor
6001995|NCT00227617|Leucovorin|leucovorin|mesh-list
6001996|NCT00227617|Bevacizumab|bevacizumab|mesh-list
6001997|NCT00227617|Fluorouracil|fluorouracil|mesh-list
6001998|NCT00227617|Oxaliplatin|oxaliplatin|mesh-list
6001999|NCT00227617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6002000|NCT00227617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6002001|NCT00227617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6002002|NCT00227617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6002003|NCT00227617|Growth Substances|growth substances|mesh-ancestor
6002004|NCT00227617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002005|NCT00227617|Growth Inhibitors|growth inhibitors|mesh-ancestor
6002006|NCT00227617|Antimetabolites|antimetabolites|mesh-ancestor
6002007|NCT00227617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002008|NCT00227617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6002009|NCT00227617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6002010|NCT00227617|Immunologic Factors|immunologic factors|mesh-ancestor
6002011|NCT00227617|Antidotes|antidotes|mesh-ancestor
6002012|NCT00227617|Protective Agents|protective agents|mesh-ancestor
6002013|NCT00227617|Vitamin B Complex|vitamin b complex|mesh-ancestor
6002014|NCT00227617|Vitamins|vitamins|mesh-ancestor
6002015|NCT00227617|Micronutrients|micronutrients|mesh-ancestor
6002016|NCT00227721|Gemcitabine|gemcitabine|mesh-list
6002017|NCT00227721|Docetaxel|docetaxel|mesh-list
6002018|NCT00227721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6002019|NCT00227721|Antimetabolites|antimetabolites|mesh-ancestor
6002020|NCT00227721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002021|NCT00227721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6002022|NCT00227721|Antiviral Agents|antiviral agents|mesh-ancestor
6002023|NCT00227721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6002024|NCT00227721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6002025|NCT00227721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6002026|NCT00227721|Immunologic Factors|immunologic factors|mesh-ancestor
6002027|NCT00227721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002028|NCT00227721|Tubulin Modulators|tubulin modulators|mesh-ancestor
6002029|NCT00227721|Antimitotic Agents|antimitotic agents|mesh-ancestor
6002030|NCT00227721|Mitosis Modulators|mitosis modulators|mesh-ancestor
6002031|NCT00227760|Cediranib|cediranib|mesh-list
6002032|NCT00227760|Maleic acid|maleic acid|mesh-list
6002033|NCT00227760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6002034|NCT00227760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002035|NCT00227760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6002036|NCT00227760|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6002037|NCT00227994|Donepezil|donepezil|mesh-list
6002038|NCT00227994|Galantamine|galantamine|mesh-list
6002039|NCT00227994|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6002040|NCT00227994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6002041|NCT00227994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002042|NCT00227994|Cholinergic Agents|cholinergic agents|mesh-ancestor
6002043|NCT00227994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6002044|NCT00227994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002045|NCT00227994|Nootropic Agents|nootropic agents|mesh-ancestor
6002046|NCT00227994|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6002047|NCT00227994|Autonomic Agents|autonomic agents|mesh-ancestor
6002048|NCT00227994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6002049|NCT00228423|Clopidogrel|clopidogrel|mesh-list
6260010|NCT03137992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260011|NCT03137992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6260012|NCT03137992|Respiratory System Agents|respiratory system agents|mesh-ancestor
6260013|NCT03137992|Parasympatholytics|parasympatholytics|mesh-ancestor
6260014|NCT03137992|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6260015|NCT03137992|Cholinergic Agents|cholinergic agents|mesh-ancestor
6260016|NCT03137992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6260017|NCT03137992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260018|NCT03137992|Anticonvulsants|anticonvulsants|mesh-ancestor
6260019|NCT03138655|Vedolizumab|vedolizumab|mesh-list
6260020|NCT03138655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6260021|NCT03138967|Glycopyrrolate|glycopyrrolate|mesh-list
6260022|NCT03138967|Bromides|bromides|mesh-list
6260023|NCT03138967|Rocuronium|rocuronium|mesh-list
6260024|NCT03138967|Neostigmine|neostigmine|mesh-list
6260025|NCT03138967|Anticonvulsants|anticonvulsants|mesh-ancestor
6260026|NCT03138967|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6260027|NCT03138967|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6260028|NCT03138967|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6260029|NCT03138967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6002050|NCT00228423|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6002051|NCT00228423|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6002052|NCT00228423|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6002053|NCT00228423|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6002054|NCT00228423|Purinergic Agents|purinergic agents|mesh-ancestor
6002055|NCT00228423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6002056|NCT00228423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002057|NCT00228423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260030|NCT03138967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260031|NCT03138967|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6260032|NCT03138967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6260033|NCT03138967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260034|NCT03138967|Cholinergic Agents|cholinergic agents|mesh-ancestor
6260035|NCT03138967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6260036|NCT03138967|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6260037|NCT03138967|Autonomic Agents|autonomic agents|mesh-ancestor
6260038|NCT03138967|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6260039|NCT03138967|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6260040|NCT03138967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6260041|NCT03139240|Oxycodone|oxycodone|mesh-list
6260042|NCT03139240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6002058|NCT00228553|Modafinil|modafinil|mesh-list
6002059|NCT00228553|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6002060|NCT00228553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260043|NCT03139240|Narcotics|narcotics|mesh-ancestor
6002061|NCT00228553|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6002062|NCT00228553|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6002063|NCT00228553|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6002064|NCT00228553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002065|NCT00228566|Modafinil|modafinil|mesh-list
6002066|NCT00228566|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6002067|NCT00228566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002068|NCT00228566|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6002069|NCT00228566|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6002070|NCT00228566|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6002071|NCT00228566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002072|NCT00228813|Sargramostim|sargramostim|mesh-list
6002073|NCT00228813|Lenograstim|lenograstim|mesh-list
6002074|NCT00228813|Immunologic Factors|immunologic factors|mesh-ancestor
6002075|NCT00228813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002076|NCT00228813|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6002077|NCT00228943|Tryptophan|tryptophan|mesh-list
6002078|NCT00228943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6002079|NCT00228943|Antidepressive Agents|antidepressive agents|mesh-ancestor
6002080|NCT00228943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6002081|NCT00229619|Rituximab|rituximab|mesh-list
6002082|NCT00229619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6002083|NCT00229619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6002084|NCT00229619|Immunologic Factors|immunologic factors|mesh-ancestor
6002085|NCT00229619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002086|NCT00229619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6002087|NCT00229658|Pramlintide|pramlintide|mesh-list
6002088|NCT00229658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6002089|NCT00229658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002090|NCT00229723|Gefitinib|gefitinib|mesh-list
6002091|NCT00229723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6002092|NCT00229723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6002093|NCT00229723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6002094|NCT00229723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002095|NCT00230126|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6002096|NCT00230126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6002097|NCT00230126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6002098|NCT00230126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6002099|NCT00230126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002100|NCT00230178|Allopurinol|allopurinol|mesh-list
6002101|NCT00230178|Rasburicase|rasburicase|mesh-list
6002102|NCT00230178|Antimetabolites|antimetabolites|mesh-ancestor
6002103|NCT00230178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002104|NCT00230178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6002105|NCT00230178|Gout Suppressants|gout suppressants|mesh-ancestor
6002106|NCT00230178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6002107|NCT00230178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6002108|NCT00230178|Antioxidants|antioxidants|mesh-ancestor
6002109|NCT00230178|Protective Agents|protective agents|mesh-ancestor
6002110|NCT00230178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018005|NCT00377520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6018006|NCT00377572|Omalizumab|omalizumab|mesh-list
6018007|NCT00377572|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6018008|NCT00377572|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6018009|NCT00377572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6018010|NCT00377572|Respiratory System Agents|respiratory system agents|mesh-ancestor
6018011|NCT00377572|Immunologic Factors|immunologic factors|mesh-ancestor
6018012|NCT00377572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018013|NCT00377637|Mycophenolic Acid|mycophenolic acid|mesh-list
6018014|NCT00377637|Cyclophosphamide|cyclophosphamide|mesh-list
6018015|NCT00377637|Azathioprine|azathioprine|mesh-list
6018016|NCT00377637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6018017|NCT00377637|Immunologic Factors|immunologic factors|mesh-ancestor
6018018|NCT00377637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018019|NCT00377637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6018020|NCT00377637|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6018021|NCT00377637|Alkylating Agents|alkylating agents|mesh-ancestor
6018022|NCT00377637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6018023|NCT00377637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6018024|NCT00377637|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6018025|NCT00377637|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6018026|NCT00377637|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6018027|NCT00377637|Antitubercular Agents|antitubercular agents|mesh-ancestor
6018028|NCT00377637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6018029|NCT00377637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6018030|NCT00377637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6018031|NCT00377637|Antimetabolites|antimetabolites|mesh-ancestor
6018032|NCT00377637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6018033|NCT00377676|Bromocriptine|bromocriptine|mesh-list
6018034|NCT00377676|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6018035|NCT00377676|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6018036|NCT00377676|Hormone Antagonists|hormone antagonists|mesh-ancestor
6018037|NCT00377676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6002111|NCT00230282|Cyclophosphamide|cyclophosphamide|mesh-list
6002112|NCT00230282|Fludarabine|fludarabine|mesh-list
6002113|NCT00230282|Alemtuzumab|alemtuzumab|mesh-list
6002114|NCT00230282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6002115|NCT00230282|Immunologic Factors|immunologic factors|mesh-ancestor
6002116|NCT00230282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002117|NCT00230282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6002118|NCT00230282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6002119|NCT00230282|Alkylating Agents|alkylating agents|mesh-ancestor
6002120|NCT00230282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002121|NCT00230282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6002122|NCT00230282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6002123|NCT00230282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6002124|NCT00230737|Melatonin|melatonin|mesh-list
6002125|NCT00230737|Antioxidants|antioxidants|mesh-ancestor
6002126|NCT00230737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002127|NCT00230737|Protective Agents|protective agents|mesh-ancestor
6002128|NCT00230737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002129|NCT00230737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6002130|NCT00230971|Metronidazole|metronidazole|mesh-list
6002131|NCT00230971|Ceftriaxone|ceftriaxone|mesh-list
6002132|NCT00230971|Tigecycline|tigecycline|mesh-list
6002133|NCT00230971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6002134|NCT00230971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6002135|NCT00230971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6002136|NCT00230971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6002137|NCT00230971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6002138|NCT00230971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6002139|NCT00230971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002140|NCT00231309|Sargramostim|sargramostim|mesh-list
6002141|NCT00231309|Lenograstim|lenograstim|mesh-list
6002142|NCT00231309|Immunologic Factors|immunologic factors|mesh-ancestor
6002143|NCT00231309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002144|NCT00231309|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6002145|NCT00231465|Docetaxel|docetaxel|mesh-list
6002146|NCT00231465|Gefitinib|gefitinib|mesh-list
6002147|NCT00231465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6002148|NCT00231465|Tubulin Modulators|tubulin modulators|mesh-ancestor
6002149|NCT00231465|Antimitotic Agents|antimitotic agents|mesh-ancestor
6002150|NCT00231465|Mitosis Modulators|mitosis modulators|mesh-ancestor
6002151|NCT00231465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002152|NCT00231465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6002153|NCT00231465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6002154|NCT00231478|Granisetron|granisetron|mesh-list
6002155|NCT00231478|Antiemetics|antiemetics|mesh-ancestor
6002156|NCT00231478|Autonomic Agents|autonomic agents|mesh-ancestor
6002157|NCT00231478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6002158|NCT00231478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002159|NCT00231478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6002160|NCT00231478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6002161|NCT00231478|Serotonin Agents|serotonin agents|mesh-ancestor
6002162|NCT00231478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6002163|NCT00231478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002164|NCT00231777|Ondansetron|ondansetron|mesh-list
6002165|NCT00231777|Aprepitant|aprepitant|mesh-list
6002166|NCT00231777|Antiemetics|antiemetics|mesh-ancestor
6002167|NCT00231777|Autonomic Agents|autonomic agents|mesh-ancestor
6002168|NCT00231777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6002169|NCT00231777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002170|NCT00231777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6002171|NCT00231777|Antipruritics|antipruritics|mesh-ancestor
6002172|NCT00231777|Dermatologic Agents|dermatologic agents|mesh-ancestor
6002173|NCT00231777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6002174|NCT00231777|Serotonin Agents|serotonin agents|mesh-ancestor
6002175|NCT00231777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6002176|NCT00231777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002177|NCT00231777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6002178|NCT00231777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6002179|NCT00231777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6002180|NCT00231777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6002181|NCT00231777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6002182|NCT00231777|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6002183|NCT00231842|Ifosfamide|ifosfamide|mesh-list
6002184|NCT00231842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6002185|NCT00231842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6002186|NCT00231842|Alkylating Agents|alkylating agents|mesh-ancestor
6002187|NCT00231842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260044|NCT03139240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6260045|NCT03139240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260046|NCT03139240|Analgesics|analgesics|mesh-ancestor
6260047|NCT03139240|Sensory System Agents|sensory system agents|mesh-ancestor
6260048|NCT03139240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6260049|NCT03139279|Dexmedetomidine|dexmedetomidine|mesh-list
6260050|NCT03139279|Propofol|propofol|mesh-list
6260051|NCT03139279|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6260052|NCT03139279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6260053|NCT03139279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260054|NCT03139279|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6260055|NCT03139279|Anesthetics, General|anesthetics, general|mesh-ancestor
6260056|NCT03139279|Anesthetics|anesthetics|mesh-ancestor
6260057|NCT03139279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6260058|NCT03139279|Analgesics|analgesics|mesh-ancestor
6260059|NCT03139279|Sensory System Agents|sensory system agents|mesh-ancestor
6002188|NCT00231868|Paclitaxel|paclitaxel|mesh-list
6002189|NCT00231868|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6002190|NCT00231868|Carboplatin|carboplatin|mesh-list
6002191|NCT00231868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6002192|NCT00231868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6002193|NCT00231868|Tubulin Modulators|tubulin modulators|mesh-ancestor
6002194|NCT00231868|Antimitotic Agents|antimitotic agents|mesh-ancestor
6002195|NCT00231868|Mitosis Modulators|mitosis modulators|mesh-ancestor
6002196|NCT00231868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002197|NCT00231894|Pioglitazone|pioglitazone|mesh-list
6002198|NCT00231894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6002199|NCT00231894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002200|NCT00232180|Eplerenone|eplerenone|mesh-list
6002201|NCT00232180|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6002202|NCT00232180|Hormone Antagonists|hormone antagonists|mesh-ancestor
6002203|NCT00232180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6002204|NCT00232180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002205|NCT00232180|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6002206|NCT00232180|Diuretics|diuretics|mesh-ancestor
6002207|NCT00232180|Natriuretic Agents|natriuretic agents|mesh-ancestor
6002208|NCT00232180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6002209|NCT00232479|Carboplatin|carboplatin|mesh-list
6002210|NCT00232479|Docetaxel|docetaxel|mesh-list
6002211|NCT00232479|Trastuzumab|trastuzumab|mesh-list
6002212|NCT00232479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6002213|NCT00232479|Tubulin Modulators|tubulin modulators|mesh-ancestor
6002214|NCT00232479|Antimitotic Agents|antimitotic agents|mesh-ancestor
6002215|NCT00232479|Mitosis Modulators|mitosis modulators|mesh-ancestor
6002216|NCT00232479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002217|NCT00232479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6002218|NCT00232505|Carboplatin|carboplatin|mesh-list
6002219|NCT00232505|Cetuximab|cetuximab|mesh-list
6002220|NCT00232505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6002221|NCT00232505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6002222|NCT00232583|Metformin|metformin|mesh-list
6002223|NCT00232583|Pioglitazone|pioglitazone|mesh-list
6002224|NCT00232583|Glyburide|glyburide|mesh-list
6002225|NCT00232583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6002226|NCT00232583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002227|NCT00232596|Ezogabine|ezogabine|mesh-list
6002228|NCT00232596|Anticonvulsants|anticonvulsants|mesh-ancestor
6002229|NCT00232596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6002230|NCT00232596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002231|NCT00232739|Sirolimus|sirolimus|mesh-list
6002232|NCT00232739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6002233|NCT00232739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6002234|NCT00232739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6002235|NCT00232739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6002236|NCT00232739|Antifungal Agents|antifungal agents|mesh-ancestor
6002237|NCT00232739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6002238|NCT00232739|Immunologic Factors|immunologic factors|mesh-ancestor
6002239|NCT00232739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002240|NCT00233064|Palivizumab|palivizumab|mesh-list
6002241|NCT00233064|Antiviral Agents|antiviral agents|mesh-ancestor
6002242|NCT00233064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6002243|NCT00233103|Sertraline|sertraline|mesh-list
6002244|NCT00233103|Antidepressive Agents|antidepressive agents|mesh-ancestor
6002245|NCT00233103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6002246|NCT00233103|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6002247|NCT00233103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6002248|NCT00233103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6002249|NCT00233103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002250|NCT00233103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6002251|NCT00233103|Serotonin Agents|serotonin agents|mesh-ancestor
6002252|NCT00233103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002253|NCT00233324|Pulmonary Surfactants|pulmonary surfactants|mesh-list
6002254|NCT00233324|Respiratory System Agents|respiratory system agents|mesh-ancestor
6002255|NCT00233363|Rebamipide|rebamipide|mesh-list
6002256|NCT00233363|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6002257|NCT00233363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6002258|NCT00233363|Antioxidants|antioxidants|mesh-ancestor
6002259|NCT00233363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002260|NCT00233363|Protective Agents|protective agents|mesh-ancestor
6002261|NCT00233363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002262|NCT00233363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6002263|NCT00233389|Rebamipide|rebamipide|mesh-list
6002264|NCT00233389|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6002265|NCT00233389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6002266|NCT00233389|Antioxidants|antioxidants|mesh-ancestor
6260060|NCT03139279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6260061|NCT03139279|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6260062|NCT03139279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6260063|NCT03139279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6260064|NCT03139279|Adrenergic Agents|adrenergic agents|mesh-ancestor
6260065|NCT03139279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6260066|NCT03139279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260067|NCT03139604|Prednisone|prednisone|mesh-list
6260068|NCT03139604|Methylprednisolone|methylprednisolone|mesh-list
6260069|NCT03139604|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6260070|NCT03139604|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6260071|NCT03139604|Prednisolone|prednisolone|mesh-list
6260072|NCT03139604|Prednisolone acetate|prednisolone acetate|mesh-list
6260073|NCT03139604|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6260074|NCT03139604|Prednisolone phosphate|prednisolone phosphate|mesh-list
6260075|NCT03139604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6260076|NCT03139604|Glucocorticoids|glucocorticoids|mesh-ancestor
6260077|NCT03139604|Hormones|hormones|mesh-ancestor
6260078|NCT03139604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6260079|NCT03139604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260080|NCT03139604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6260081|NCT03139604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6260082|NCT03139604|Antiemetics|antiemetics|mesh-ancestor
6260083|NCT03139604|Autonomic Agents|autonomic agents|mesh-ancestor
6260084|NCT03139604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6260085|NCT03139604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6260086|NCT03139604|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6260087|NCT03139604|Protective Agents|protective agents|mesh-ancestor
6260088|NCT03140254|Chlorhexidine|chlorhexidine|mesh-list
6260089|NCT03140254|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6260090|NCT03140254|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6260091|NCT03140254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6260092|NCT03140254|Disinfectants|disinfectants|mesh-ancestor
6260093|NCT03140254|Dermatologic Agents|dermatologic agents|mesh-ancestor
6260094|NCT03140631|Protamines|protamines|mesh-list
6260095|NCT03140631|Heparin Antagonists|heparin antagonists|mesh-ancestor
6260096|NCT03140631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260097|NCT03140631|Coagulants|coagulants|mesh-ancestor
6260098|NCT03140722|Epoetin Alfa|epoetin alfa|mesh-list
6260099|NCT03140722|Hematinics|hematinics|mesh-ancestor
6260100|NCT03142451|Minocycline|minocycline|mesh-list
6260101|NCT03142451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6260102|NCT03142451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6260103|NCT03142932|Carbon Monoxide|carbon monoxide|mesh-list
6260104|NCT03142932|Antimetabolites|antimetabolites|mesh-ancestor
6260105|NCT03142932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260106|NCT03142932|Gasotransmitters|gasotransmitters|mesh-ancestor
6260107|NCT03142932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6260108|NCT03142932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260109|NCT03143166|Telmisartan|telmisartan|mesh-list
6260110|NCT03143166|Dabigatran|dabigatran|mesh-list
6260111|NCT03143166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6260112|NCT03143166|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6260113|NCT03143166|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6260114|NCT03143166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260115|NCT03143166|Antithrombins|antithrombins|mesh-ancestor
6260116|NCT03143166|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6260117|NCT03143166|Protease Inhibitors|protease inhibitors|mesh-ancestor
6260118|NCT03143166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6260119|NCT03143166|Anticoagulants|anticoagulants|mesh-ancestor
6260120|NCT03143569|Heparin|heparin|mesh-list
6002267|NCT00233389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002268|NCT00233389|Protective Agents|protective agents|mesh-ancestor
6002269|NCT00233389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002270|NCT00233389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6002271|NCT00233454|Midostaurin|midostaurin|mesh-list
6002272|NCT00233454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6002273|NCT00233454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6002274|NCT00233454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6002275|NCT00233454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002276|NCT00233480|Atorvastatin|atorvastatin|mesh-list
6002277|NCT00233480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6002278|NCT00233480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6002279|NCT00233480|Antimetabolites|antimetabolites|mesh-ancestor
6002280|NCT00233480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002281|NCT00233480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6002282|NCT00233480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6002283|NCT00233480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6002284|NCT00233948|Nelfinavir|nelfinavir|mesh-list
6002285|NCT00233948|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6002286|NCT00233948|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6002287|NCT00233948|Protease Inhibitors|protease inhibitors|mesh-ancestor
6002288|NCT00233948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6002289|NCT00233948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002290|NCT00233948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6002291|NCT00233948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6002292|NCT00233948|Antiviral Agents|antiviral agents|mesh-ancestor
6002293|NCT00233948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6002294|NCT00233987|Cyclophosphamide|cyclophosphamide|mesh-list
6002295|NCT00233987|Melphalan|melphalan|mesh-list
6002296|NCT00233987|Carmustine|carmustine|mesh-list
6002297|NCT00233987|Etoposide|etoposide|mesh-list
6002298|NCT00233987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6002299|NCT00233987|Immunologic Factors|immunologic factors|mesh-ancestor
6002300|NCT00233987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002301|NCT00233987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6002302|NCT00233987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6002303|NCT00233987|Alkylating Agents|alkylating agents|mesh-ancestor
6002304|NCT00233987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002305|NCT00233987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6002306|NCT00233987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6002307|NCT00233987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6002308|NCT00233987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6002309|NCT00233987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6002310|NCT00233987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6002311|NCT00234039|Gemcitabine|gemcitabine|mesh-list
6002312|NCT00234039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6002313|NCT00234039|Antimetabolites|antimetabolites|mesh-ancestor
6002314|NCT00234039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002315|NCT00234039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6002316|NCT00234039|Antiviral Agents|antiviral agents|mesh-ancestor
6002317|NCT00234039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6002318|NCT00234039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6002319|NCT00234039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6002320|NCT00234039|Immunologic Factors|immunologic factors|mesh-ancestor
6002321|NCT00234039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002322|NCT00234052|Bevacizumab|bevacizumab|mesh-list
6002323|NCT00234052|Carboplatin|carboplatin|mesh-list
6002324|NCT00234052|Pemetrexed|pemetrexed|mesh-list
6002325|NCT00234052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6002326|NCT00234052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6002327|NCT00234052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6002328|NCT00234052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6002329|NCT00234052|Growth Substances|growth substances|mesh-ancestor
6002330|NCT00234052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002331|NCT00234052|Growth Inhibitors|growth inhibitors|mesh-ancestor
6002332|NCT00234052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6002333|NCT00234052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002334|NCT00234052|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6002335|NCT00234052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6002336|NCT00234065|Aspirin|aspirin|mesh-list
6002337|NCT00234065|Cilostazol|cilostazol|mesh-list
6002338|NCT00234065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6002339|NCT00234065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6002340|NCT00234065|Analgesics|analgesics|mesh-ancestor
6002341|NCT00234065|Sensory System Agents|sensory system agents|mesh-ancestor
6002342|NCT00234065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6002343|NCT00234065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002344|NCT00234065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6002345|NCT00234065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6002346|NCT00234065|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6002347|NCT00234065|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6002348|NCT00234065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002349|NCT00234065|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6002350|NCT00234065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6536458|NCT00817011|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6536459|NCT00817011|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6536460|NCT00817011|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6002351|NCT00234065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6002352|NCT00234065|Antipyretics|antipyretics|mesh-ancestor
6002353|NCT00234065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6002354|NCT00234065|Autonomic Agents|autonomic agents|mesh-ancestor
6002355|NCT00234065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6002356|NCT00234065|Respiratory System Agents|respiratory system agents|mesh-ancestor
6002357|NCT00234065|Vasodilator Agents|vasodilator agents|mesh-ancestor
6002358|NCT00234065|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6002359|NCT00234065|Protective Agents|protective agents|mesh-ancestor
6002360|NCT00234065|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6002361|NCT00234065|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6002362|NCT00234078|Rebamipide|rebamipide|mesh-list
6002363|NCT00234078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6002364|NCT00234078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6002365|NCT00234078|Antioxidants|antioxidants|mesh-ancestor
6002366|NCT00234078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002367|NCT00234078|Protective Agents|protective agents|mesh-ancestor
6002368|NCT00234078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002369|NCT00234078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6002370|NCT00234104|Tolvaptan|tolvaptan|mesh-list
6002371|NCT00234104|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6260121|NCT03143569|Calcium heparin|calcium heparin|mesh-list
6260122|NCT03143569|Anticoagulants|anticoagulants|mesh-ancestor
6260123|NCT03143569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6260124|NCT03143569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6002372|NCT00234104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002373|NCT00234104|Natriuretic Agents|natriuretic agents|mesh-ancestor
6002374|NCT00234104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002375|NCT00234494|Gemcitabine|gemcitabine|mesh-list
6002376|NCT00234494|Bevacizumab|bevacizumab|mesh-list
6002377|NCT00234494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6002378|NCT00234494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6002379|NCT00234494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6002380|NCT00234494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6002381|NCT00234494|Growth Substances|growth substances|mesh-ancestor
6002382|NCT00234494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002383|NCT00234494|Growth Inhibitors|growth inhibitors|mesh-ancestor
6002384|NCT00234494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6002385|NCT00234494|Antimetabolites|antimetabolites|mesh-ancestor
6002386|NCT00234494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002387|NCT00234494|Antiviral Agents|antiviral agents|mesh-ancestor
6002388|NCT00234494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6002389|NCT00234494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6002390|NCT00234494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6002391|NCT00234494|Immunologic Factors|immunologic factors|mesh-ancestor
6002392|NCT00234832|Sibutramine|sibutramine|mesh-list
6002393|NCT00234832|Antidepressive Agents|antidepressive agents|mesh-ancestor
6002394|NCT00234832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6002395|NCT00234832|Appetite Depressants|appetite depressants|mesh-ancestor
6002396|NCT00234832|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6002397|NCT00234884|Adalimumab|adalimumab|mesh-list
6002398|NCT00234884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6002399|NCT00234884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6002400|NCT00235391|Deferasirox|deferasirox|mesh-list
6002401|NCT00235391|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6002402|NCT00235391|Chelating Agents|chelating agents|mesh-ancestor
6002403|NCT00235391|Sequestering Agents|sequestering agents|mesh-ancestor
6002404|NCT00235391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002405|NCT00235443|Lacosamide|lacosamide|mesh-list
6002406|NCT00235443|Anticonvulsants|anticonvulsants|mesh-ancestor
6002407|NCT00235443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6002408|NCT00235443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6002409|NCT00235443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6002410|NCT00235443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002411|NCT00235573|Vitamin B 12|vitamin b 12|mesh-list
6002412|NCT00235573|Hydroxocobalamin|hydroxocobalamin|mesh-list
6002413|NCT00235573|Vitamins|vitamins|mesh-ancestor
6002414|NCT00235573|Micronutrients|micronutrients|mesh-ancestor
6002415|NCT00235573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002416|NCT00235573|Vitamin B Complex|vitamin b complex|mesh-ancestor
6002417|NCT00235573|Hematinics|hematinics|mesh-ancestor
6002418|NCT00235716|Vitamins|vitamins|mesh-list
6002419|NCT00235716|Vitamin E|vitamin e|mesh-list
6002420|NCT00235716|Tocopherols|tocopherols|mesh-list
6002421|NCT00235716|Tocotrienols|tocotrienols|mesh-list
6002422|NCT00235716|alpha-Tocopherol|alpha-tocopherol|mesh-list
6002423|NCT00235716|Memantine|memantine|mesh-list
6002424|NCT00235716|Micronutrients|micronutrients|mesh-ancestor
6002425|NCT00235716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002426|NCT00235716|Antioxidants|antioxidants|mesh-ancestor
6002427|NCT00235716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002428|NCT00235716|Protective Agents|protective agents|mesh-ancestor
6002429|NCT00235716|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6002430|NCT00235716|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6002431|NCT00235716|Dopamine Agents|dopamine agents|mesh-ancestor
6002432|NCT00235716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6002433|NCT00235716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6002434|NCT00235716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6002435|NCT00235755|Ezogabine|ezogabine|mesh-list
6002436|NCT00235755|Anticonvulsants|anticonvulsants|mesh-ancestor
6002437|NCT00235755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6002438|NCT00235755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002439|NCT00235833|Adalimumab|adalimumab|mesh-list
6002440|NCT00235833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6002441|NCT00235833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6002442|NCT00235872|Adalimumab|adalimumab|mesh-list
6002443|NCT00235872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6002444|NCT00235872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6002445|NCT00235989|Interferons|interferons|mesh-list
6002446|NCT00235989|Interferon-beta|interferon-beta|mesh-list
6002447|NCT00235989|Interferon beta-1b|interferon beta-1b|mesh-list
6002448|NCT00235989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6002449|NCT00235989|Antiviral Agents|antiviral agents|mesh-ancestor
6002450|NCT00235989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6002451|NCT00235989|Immunologic Factors|immunologic factors|mesh-ancestor
6002452|NCT00235989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002453|NCT00235989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6002454|NCT00236080|Modafinil|modafinil|mesh-list
6002455|NCT00236080|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6002456|NCT00236080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002457|NCT00236080|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6002458|NCT00236080|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6002459|NCT00236080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6002460|NCT00236080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002461|NCT00236184|Rabeprazole|rabeprazole|mesh-list
6002462|NCT00236184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6002463|NCT00236184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6002464|NCT00236184|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6002465|NCT00236184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6002466|NCT00236184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002467|NCT00236197|Rabeprazole|rabeprazole|mesh-list
6002468|NCT00236197|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6002469|NCT00236197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6002470|NCT00236197|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6002471|NCT00236197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6002472|NCT00236197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002473|NCT00236899|Gemcitabine|gemcitabine|mesh-list
6002474|NCT00236899|Paclitaxel|paclitaxel|mesh-list
6002475|NCT00236899|Docetaxel|docetaxel|mesh-list
6002476|NCT00236899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6002477|NCT00236899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6002478|NCT00236899|Tubulin Modulators|tubulin modulators|mesh-ancestor
6002479|NCT00236899|Antimitotic Agents|antimitotic agents|mesh-ancestor
6002480|NCT00236899|Mitosis Modulators|mitosis modulators|mesh-ancestor
6002481|NCT00236899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002482|NCT00236899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6002483|NCT00236899|Antimetabolites|antimetabolites|mesh-ancestor
6002484|NCT00236899|Antiviral Agents|antiviral agents|mesh-ancestor
6002485|NCT00236899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6002486|NCT00236899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6002487|NCT00236899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6002488|NCT00236899|Immunologic Factors|immunologic factors|mesh-ancestor
6002489|NCT00236899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002490|NCT00236938|Epoetin Alfa|epoetin alfa|mesh-list
6002491|NCT00236938|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6002492|NCT00236938|Hematinics|hematinics|mesh-ancestor
6002493|NCT00236951|Epoetin Alfa|epoetin alfa|mesh-list
6002494|NCT00236951|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6002495|NCT00236951|Hematinics|hematinics|mesh-ancestor
6002496|NCT00236977|Iron|iron|mesh-list
6002497|NCT00236977|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6002498|NCT00236977|Trace Elements|trace elements|mesh-ancestor
6002499|NCT00236977|Micronutrients|micronutrients|mesh-ancestor
6002500|NCT00236977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002501|NCT00236977|Hematinics|hematinics|mesh-ancestor
6002502|NCT00237042|Levonorgestrel|levonorgestrel|mesh-list
6002503|NCT00237042|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6002504|NCT00237042|Estradiol|estradiol|mesh-list
6002505|NCT00237042|Estrogens|estrogens|mesh-ancestor
6002506|NCT00237042|Hormones|hormones|mesh-ancestor
6002507|NCT00237042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6002508|NCT00237042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002509|NCT00237042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6002510|NCT00237042|Contraceptive Agents|contraceptive agents|mesh-ancestor
6002511|NCT00237042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6002512|NCT00237042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6002513|NCT00237042|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6002514|NCT00237042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6002515|NCT00237042|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6002516|NCT00237185|Imatinib Mesylate|imatinib mesylate|mesh-list
6002517|NCT00237185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6002518|NCT00237185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6002519|NCT00237185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6002520|NCT00237185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002521|NCT00237458|Lacosamide|lacosamide|mesh-list
6002522|NCT00237458|Anticonvulsants|anticonvulsants|mesh-ancestor
6002523|NCT00237458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6002524|NCT00237458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6002525|NCT00237458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6002526|NCT00237458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002527|NCT00237666|Ziprasidone|ziprasidone|mesh-list
6002528|NCT00237666|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6002529|NCT00237666|Serotonin Agents|serotonin agents|mesh-ancestor
6002530|NCT00237666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6002531|NCT00237666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002532|NCT00237666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002533|NCT00237666|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6002534|NCT00237666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6002535|NCT00237666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6002536|NCT00237666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6002537|NCT00237666|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6002538|NCT00237666|Dopamine Agents|dopamine agents|mesh-ancestor
6002539|NCT00237718|Vitamin E|vitamin e|mesh-list
6002540|NCT00237718|Tocopherols|tocopherols|mesh-list
6002541|NCT00237718|Tocotrienols|tocotrienols|mesh-list
6002542|NCT00237718|alpha-Tocopherol|alpha-tocopherol|mesh-list
6260125|NCT03143569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260126|NCT03144635|Grazoprevir|grazoprevir|mesh-list
6260127|NCT03144635|Antiviral Agents|antiviral agents|mesh-ancestor
6002543|NCT00237718|Thioctic Acid|thioctic acid|mesh-list
6002544|NCT00237718|Vitamins|vitamins|mesh-ancestor
6002545|NCT00237718|Micronutrients|micronutrients|mesh-ancestor
6002546|NCT00237718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002547|NCT00237718|Antioxidants|antioxidants|mesh-ancestor
6002548|NCT00237718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002549|NCT00237718|Protective Agents|protective agents|mesh-ancestor
6002550|NCT00237718|Vitamin B Complex|vitamin b complex|mesh-ancestor
6002551|NCT00238108|Melatonin|melatonin|mesh-list
6002552|NCT00238108|Antioxidants|antioxidants|mesh-ancestor
6002553|NCT00238108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002554|NCT00238108|Protective Agents|protective agents|mesh-ancestor
6002555|NCT00238108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002556|NCT00238108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6002557|NCT00238121|Sorafenib|sorafenib|mesh-list
6002558|NCT00238121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6002559|NCT00238121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6002560|NCT00238121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6260128|NCT03144635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6260129|NCT03144804|Lamivudine|lamivudine|mesh-list
6260130|NCT03144804|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6260131|NCT03144804|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6260132|NCT03144804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6260133|NCT03144804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260134|NCT03144804|Antiviral Agents|antiviral agents|mesh-ancestor
6260135|NCT03144804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6260136|NCT03144804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6260137|NCT03144804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6260138|NCT03145064|Zanubrutinib|zanubrutinib|mesh-list
6260139|NCT03145064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6260140|NCT03145064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6260141|NCT03145064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6002561|NCT00238121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002562|NCT00238238|Rituximab|rituximab|mesh-list
6002563|NCT00238238|Lenalidomide|lenalidomide|mesh-list
6002564|NCT00238238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6002565|NCT00238238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6002566|NCT00238238|Immunologic Factors|immunologic factors|mesh-ancestor
6002567|NCT00238238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002568|NCT00238238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6002569|NCT00238238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6002570|NCT00238238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6002571|NCT00238238|Growth Substances|growth substances|mesh-ancestor
6002572|NCT00238238|Growth Inhibitors|growth inhibitors|mesh-ancestor
6002573|NCT00238303|Vorinostat|vorinostat|mesh-list
6002574|NCT00238303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6002575|NCT00238303|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6002576|NCT00238303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6002577|NCT00238303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002578|NCT00238355|Voriconazole|voriconazole|mesh-list
6002579|NCT00238355|Caspofungin|caspofungin|mesh-list
6002580|NCT00238355|Antifungal Agents|antifungal agents|mesh-ancestor
6002581|NCT00238355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6002582|NCT00238355|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6002583|NCT00238355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6002584|NCT00238355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6002585|NCT00238355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002586|NCT00238355|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6002587|NCT00238355|Hormone Antagonists|hormone antagonists|mesh-ancestor
6002588|NCT00238355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6002589|NCT00238355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002590|NCT00238355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6002591|NCT00238433|Melphalan|melphalan|mesh-list
6002592|NCT00238433|Busulfan|busulfan|mesh-list
6002593|NCT00238433|Thiotepa|thiotepa|mesh-list
6002594|NCT00238433|Immunologic Factors|immunologic factors|mesh-ancestor
6002595|NCT00238433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002596|NCT00238433|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6002597|NCT00238433|Alkylating Agents|alkylating agents|mesh-ancestor
6002598|NCT00238433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002599|NCT00238433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6002600|NCT00238433|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6002601|NCT00238433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6002602|NCT00238615|Carboplatin|carboplatin|mesh-list
6002603|NCT00238615|Docetaxel|docetaxel|mesh-list
6002604|NCT00238615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6002605|NCT00238615|Tubulin Modulators|tubulin modulators|mesh-ancestor
6002606|NCT00238615|Antimitotic Agents|antimitotic agents|mesh-ancestor
6002607|NCT00238615|Mitosis Modulators|mitosis modulators|mesh-ancestor
6002608|NCT00238615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002609|NCT00239005|Mycophenolic Acid|mycophenolic acid|mesh-list
6002610|NCT00239005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6002611|NCT00239005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6002612|NCT00239005|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6002613|NCT00239005|Antitubercular Agents|antitubercular agents|mesh-ancestor
6002614|NCT00239005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6002615|NCT00239005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6002616|NCT00239005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6002617|NCT00239005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002618|NCT00239356|Aripiprazole|aripiprazole|mesh-list
6002619|NCT00239356|Antidepressive Agents|antidepressive agents|mesh-ancestor
6002620|NCT00239356|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6002621|NCT00239356|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6002622|NCT00239356|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6002623|NCT00239356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6260142|NCT03145064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260143|NCT03145207|Lidocaine|lidocaine|mesh-list
6260144|NCT03145207|Anesthetics, Local|anesthetics, local|mesh-ancestor
6260145|NCT03145207|Anesthetics|anesthetics|mesh-ancestor
6260146|NCT03145207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6260147|NCT03145207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260148|NCT03145207|Sensory System Agents|sensory system agents|mesh-ancestor
6260149|NCT03145207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6260150|NCT03145207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6260151|NCT03145207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6260152|NCT03145207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6260153|NCT03145207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6002624|NCT00239356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002625|NCT00239356|Dopamine Agonists|dopamine agonists|mesh-ancestor
6002626|NCT00239356|Dopamine Agents|dopamine agents|mesh-ancestor
6002627|NCT00239356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6002628|NCT00239356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002629|NCT00239356|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6002630|NCT00239356|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6002631|NCT00239356|Serotonin Agents|serotonin agents|mesh-ancestor
6002632|NCT00239356|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6002633|NCT00239356|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6002634|NCT00239356|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6002635|NCT00239356|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6002636|NCT00239590|Methyltestosterone|methyltestosterone|mesh-list
6002637|NCT00239590|Testosterone|testosterone|mesh-list
6002638|NCT00239590|Testosterone undecanoate|testosterone undecanoate|mesh-list
6002639|NCT00239590|Testosterone enanthate|testosterone enanthate|mesh-list
6002640|NCT00239590|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6002641|NCT00239590|Androgens|androgens|mesh-ancestor
6002642|NCT00239590|Hormones|hormones|mesh-ancestor
6002643|NCT00239590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6002644|NCT00239590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002645|NCT00239590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6002646|NCT00239590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6002647|NCT00239590|Anabolic Agents|anabolic agents|mesh-ancestor
6002648|NCT00239642|Iron|iron|mesh-list
6002649|NCT00239642|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6002650|NCT00239642|Trace Elements|trace elements|mesh-ancestor
6002651|NCT00239642|Micronutrients|micronutrients|mesh-ancestor
6002652|NCT00239642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002653|NCT00239642|Hematinics|hematinics|mesh-ancestor
6002654|NCT00239681|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6002655|NCT00239681|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6002656|NCT00239681|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6002657|NCT00239681|Antimetabolites|antimetabolites|mesh-ancestor
6002658|NCT00239681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002659|NCT00239681|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6002660|NCT00239681|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6002661|NCT00239681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6002662|NCT00240071|Tamoxifen|tamoxifen|mesh-list
6002663|NCT00240071|Bevacizumab|bevacizumab|mesh-list
6002664|NCT00240071|Letrozole|letrozole|mesh-list
6002665|NCT00240071|Exemestane|exemestane|mesh-list
6002666|NCT00240071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6002667|NCT00240071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6002668|NCT00240071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6002669|NCT00240071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6002670|NCT00240071|Growth Substances|growth substances|mesh-ancestor
6002671|NCT00240071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002672|NCT00240071|Growth Inhibitors|growth inhibitors|mesh-ancestor
6002673|NCT00240071|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6002674|NCT00240071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6002675|NCT00240071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6002676|NCT00240071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002677|NCT00240071|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6002678|NCT00240071|Hormone Antagonists|hormone antagonists|mesh-ancestor
6002679|NCT00240071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6002680|NCT00240071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6002681|NCT00240071|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6002682|NCT00240071|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6002683|NCT00240071|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6002684|NCT00240097|Carboplatin|carboplatin|mesh-list
6002685|NCT00240097|Oxaliplatin|oxaliplatin|mesh-list
6002686|NCT00240097|Irinotecan|irinotecan|mesh-list
6002687|NCT00240097|Etoposide|etoposide|mesh-list
6002688|NCT00240097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6002689|NCT00240097|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6002690|NCT00240097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6002691|NCT00240097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6002692|NCT00240097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002693|NCT00240097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6002694|NCT00240097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6002695|NCT00240110|Valproic Acid|valproic acid|mesh-list
6002696|NCT00240110|Lithium Carbonate|lithium carbonate|mesh-list
6002697|NCT00240110|Antidepressive Agents|antidepressive agents|mesh-ancestor
6002698|NCT00240110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6002699|NCT00240110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6002700|NCT00240110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002701|NCT00240110|Antimanic Agents|antimanic agents|mesh-ancestor
6002702|NCT00240110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6002703|NCT00240110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6002704|NCT00240110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002705|NCT00240110|Anticonvulsants|anticonvulsants|mesh-ancestor
6002706|NCT00240110|GABA Agents|gaba agents|mesh-ancestor
6002707|NCT00240110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6002708|NCT00240162|Vatalanib|vatalanib|mesh-list
6002709|NCT00240162|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6002710|NCT00240162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6002711|NCT00240162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002712|NCT00240331|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6260154|NCT03145207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389880|NCT00189618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389881|NCT00189618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6389882|NCT00189618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6002713|NCT00240331|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6002714|NCT00240331|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6002715|NCT00240331|Antimetabolites|antimetabolites|mesh-ancestor
6002716|NCT00240331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002717|NCT00240331|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6389883|NCT00189618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6389884|NCT00189618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6389885|NCT00189618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389886|NCT00189618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6389887|NCT00189618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6389888|NCT00189618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6389889|NCT00189618|Antipyretics|antipyretics|mesh-ancestor
6389890|NCT00189618|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6002718|NCT00240331|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6002719|NCT00240331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6002720|NCT00240487|Nitric Oxide|nitric oxide|mesh-list
6002721|NCT00240487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6002722|NCT00240487|Autonomic Agents|autonomic agents|mesh-ancestor
6002723|NCT00240487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6002724|NCT00240487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002725|NCT00240487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6002726|NCT00240487|Respiratory System Agents|respiratory system agents|mesh-ancestor
6002727|NCT00240487|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6002728|NCT00240487|Antioxidants|antioxidants|mesh-ancestor
6002729|NCT00240487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002730|NCT00240487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6002731|NCT00240487|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6002732|NCT00240487|Vasodilator Agents|vasodilator agents|mesh-ancestor
6002733|NCT00240487|Gasotransmitters|gasotransmitters|mesh-ancestor
6002734|NCT00240487|Protective Agents|protective agents|mesh-ancestor
6002735|NCT00240526|Immunoglobulins|immunoglobulins|mesh-list
6002736|NCT00240526|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6002737|NCT00240526|Antibodies|antibodies|mesh-list
6002738|NCT00240526|Immunologic Factors|immunologic factors|mesh-ancestor
6002739|NCT00240526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018038|NCT00377676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018039|NCT00377676|Dopamine Agonists|dopamine agonists|mesh-ancestor
6018040|NCT00377676|Dopamine Agents|dopamine agents|mesh-ancestor
6018041|NCT00377676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6018042|NCT00377676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6018043|NCT00377741|Valganciclovir|valganciclovir|mesh-list
6002740|NCT00240981|Testosterone|testosterone|mesh-list
6002741|NCT00240981|Androgens|androgens|mesh-ancestor
6002742|NCT00240981|Hormones|hormones|mesh-ancestor
6002743|NCT00240981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6002744|NCT00240981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002745|NCT00240994|Mycophenolic Acid|mycophenolic acid|mesh-list
6002746|NCT00240994|Sirolimus|sirolimus|mesh-list
6002747|NCT00240994|Alemtuzumab|alemtuzumab|mesh-list
6002748|NCT00240994|Tacrolimus|tacrolimus|mesh-list
6002749|NCT00240994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6002750|NCT00240994|Immunologic Factors|immunologic factors|mesh-ancestor
6002751|NCT00240994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002752|NCT00240994|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6002753|NCT00240994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6002754|NCT00240994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002755|NCT00240994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6002756|NCT00240994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6002757|NCT00240994|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6002758|NCT00240994|Antitubercular Agents|antitubercular agents|mesh-ancestor
6002759|NCT00240994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6002760|NCT00240994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6002761|NCT00240994|Antifungal Agents|antifungal agents|mesh-ancestor
6002762|NCT00240994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6002763|NCT00241176|Aripiprazole|aripiprazole|mesh-list
6002764|NCT00241176|Antidepressive Agents|antidepressive agents|mesh-ancestor
6002765|NCT00241176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6002766|NCT00241176|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6002767|NCT00241176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6002768|NCT00241176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6002769|NCT00241176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002770|NCT00241176|Dopamine Agonists|dopamine agonists|mesh-ancestor
6260155|NCT03145259|Diclofenac|diclofenac|mesh-list
6260156|NCT03145259|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
6260157|NCT03145259|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6260158|NCT03145259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6260159|NCT03145259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6260160|NCT03145259|Analgesics|analgesics|mesh-ancestor
6260161|NCT03145259|Sensory System Agents|sensory system agents|mesh-ancestor
6260162|NCT03145259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6260163|NCT03145259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260164|NCT03145259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6260165|NCT03145259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6260166|NCT03145259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6260167|NCT03145259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6260168|NCT03145259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260169|NCT03145766|Immunoglobulins|immunoglobulins|mesh-list
6260170|NCT03145766|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6260171|NCT03145766|Antibodies|antibodies|mesh-list
6260172|NCT03145766|Immunologic Factors|immunologic factors|mesh-ancestor
6260173|NCT03145766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260174|NCT03146403|Vaccines|vaccines|mesh-list
6260175|NCT03146403|Immunologic Factors|immunologic factors|mesh-ancestor
6260176|NCT03146403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260177|NCT03146741|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
6260178|NCT03146741|Antiviral Agents|antiviral agents|mesh-ancestor
6260179|NCT03146741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6260180|NCT03146806|Ketamine|ketamine|mesh-list
6260181|NCT03146806|Analgesics|analgesics|mesh-ancestor
6260182|NCT03146806|Sensory System Agents|sensory system agents|mesh-ancestor
6002771|NCT00241176|Dopamine Agents|dopamine agents|mesh-ancestor
6002772|NCT00241176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6002773|NCT00241176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002774|NCT00241176|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6002775|NCT00241176|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6002776|NCT00241176|Serotonin Agents|serotonin agents|mesh-ancestor
6002777|NCT00241176|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6002778|NCT00241176|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6002779|NCT00241176|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6002780|NCT00241176|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6002781|NCT00241358|Plerixafor|plerixafor|mesh-list
6002782|NCT00241358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6002783|NCT00241358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6002784|NCT00241358|Antiviral Agents|antiviral agents|mesh-ancestor
6002785|NCT00241358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6002786|NCT00241631|Fluticasone|fluticasone|mesh-list
6002787|NCT00241631|Xhance|xhance|mesh-list
6002788|NCT00241631|Theophylline|theophylline|mesh-list
6002789|NCT00241631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6002790|NCT00241631|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6002791|NCT00241631|Autonomic Agents|autonomic agents|mesh-ancestor
6002792|NCT00241631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6002793|NCT00241631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002794|NCT00241631|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6002795|NCT00241631|Respiratory System Agents|respiratory system agents|mesh-ancestor
6002796|NCT00241631|Dermatologic Agents|dermatologic agents|mesh-ancestor
6002797|NCT00241631|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6002798|NCT00241631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6002799|NCT00241631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6002800|NCT00241631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002801|NCT00241631|Vasodilator Agents|vasodilator agents|mesh-ancestor
6002802|NCT00241631|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6002803|NCT00241631|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6002804|NCT00241631|Purinergic Agents|purinergic agents|mesh-ancestor
6002805|NCT00241631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6002806|NCT00241644|Vaccines|vaccines|mesh-list
6002807|NCT00241644|Immunologic Factors|immunologic factors|mesh-ancestor
6002808|NCT00241644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002809|NCT00241839|Allopurinol|allopurinol|mesh-list
6002810|NCT00241839|Chlorthalidone|chlorthalidone|mesh-list
6002811|NCT00241839|Antimetabolites|antimetabolites|mesh-ancestor
6002812|NCT00241839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002813|NCT00241839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6002814|NCT00241839|Gout Suppressants|gout suppressants|mesh-ancestor
6002815|NCT00241839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6002816|NCT00241839|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6002817|NCT00241839|Antioxidants|antioxidants|mesh-ancestor
6002818|NCT00241839|Protective Agents|protective agents|mesh-ancestor
6002819|NCT00241839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002820|NCT00241839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6002821|NCT00241839|Diuretics|diuretics|mesh-ancestor
6002822|NCT00241839|Natriuretic Agents|natriuretic agents|mesh-ancestor
6002823|NCT00241839|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6002824|NCT00241839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6002825|NCT00241904|Propranolol|propranolol|mesh-list
6002826|NCT00241904|Metoprolol|metoprolol|mesh-list
6002827|NCT00241904|Atenolol|atenolol|mesh-list
6002828|NCT00241904|Lisinopril|lisinopril|mesh-list
6002829|NCT00241904|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
6002830|NCT00241904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
6002831|NCT00241904|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6002832|NCT00241904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6002833|NCT00241904|Adrenergic Agents|adrenergic agents|mesh-ancestor
6002834|NCT00241904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6002835|NCT00241904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002836|NCT00241904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002837|NCT00241904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6002838|NCT00241904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6002839|NCT00241904|Vasodilator Agents|vasodilator agents|mesh-ancestor
6002840|NCT00241904|Sympatholytics|sympatholytics|mesh-ancestor
6002841|NCT00241904|Autonomic Agents|autonomic agents|mesh-ancestor
6002842|NCT00241904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6018044|NCT00377741|Antiviral Agents|antiviral agents|mesh-ancestor
6002843|NCT00241904|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6002844|NCT00241904|Protease Inhibitors|protease inhibitors|mesh-ancestor
6002845|NCT00241904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6002846|NCT00241904|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6002847|NCT00241904|Protective Agents|protective agents|mesh-ancestor
6002848|NCT00242216|Ritonavir|ritonavir|mesh-list
6002849|NCT00242216|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6002850|NCT00242216|Fosamprenavir|fosamprenavir|mesh-list
6002851|NCT00242216|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6002852|NCT00242216|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6002853|NCT00242216|Protease Inhibitors|protease inhibitors|mesh-ancestor
6002854|NCT00242216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6002855|NCT00242216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002856|NCT00242216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6002857|NCT00242216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6002858|NCT00242216|Antiviral Agents|antiviral agents|mesh-ancestor
6002859|NCT00242216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6002860|NCT00242216|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6002861|NCT00242216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6002862|NCT00242385|Protease Inhibitors|protease inhibitors|mesh-list
6002863|NCT00242385|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
6002864|NCT00242385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6002865|NCT00242385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002866|NCT00242385|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6002867|NCT00242385|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6002868|NCT00242502|Bevacizumab|bevacizumab|mesh-list
6002869|NCT00242502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6002870|NCT00242502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6002871|NCT00242502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6002872|NCT00242502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6002873|NCT00242502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6002874|NCT00242502|Growth Substances|growth substances|mesh-ancestor
6002875|NCT00242502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002876|NCT00242502|Growth Inhibitors|growth inhibitors|mesh-ancestor
6002877|NCT00242502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6002878|NCT00242502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6002879|NCT00242502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002880|NCT00242567|Zoledronic Acid|zoledronic acid|mesh-list
6002881|NCT00242567|Androgens|androgens|mesh-list
6002882|NCT00242567|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6002883|NCT00242567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002884|NCT00242567|Hormones|hormones|mesh-ancestor
6002885|NCT00242567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6002886|NCT00242580|Triamcinolone|triamcinolone|mesh-list
6002887|NCT00242580|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6002888|NCT00242580|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6002889|NCT00242580|Verteporfin|verteporfin|mesh-list
6002890|NCT00242580|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6002891|NCT00242580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6002892|NCT00242580|Glucocorticoids|glucocorticoids|mesh-ancestor
6002893|NCT00242580|Hormones|hormones|mesh-ancestor
6002894|NCT00242580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6002895|NCT00242580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002896|NCT00242580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6002897|NCT00242580|Immunologic Factors|immunologic factors|mesh-ancestor
6002898|NCT00242580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6002899|NCT00242580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002900|NCT00242580|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6002901|NCT00242580|Dermatologic Agents|dermatologic agents|mesh-ancestor
6002902|NCT00242619|Rosiglitazone|rosiglitazone|mesh-list
6002903|NCT00242619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6002904|NCT00242619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002905|NCT00242632|Memantine|memantine|mesh-list
6002906|NCT00242632|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6002907|NCT00242632|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6002908|NCT00242632|Dopamine Agents|dopamine agents|mesh-ancestor
6002909|NCT00242632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6002910|NCT00242632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002911|NCT00242632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002912|NCT00242632|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6002913|NCT00242632|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6002914|NCT00242710|Bazedoxifene|bazedoxifene|mesh-list
6002915|NCT00242710|Estrogens|estrogens|mesh-list
6002916|NCT00242710|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6002917|NCT00242710|Hormones|hormones|mesh-ancestor
6002918|NCT00242710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6002919|NCT00242710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002920|NCT00242710|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6002921|NCT00242710|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6002922|NCT00242710|Hormone Antagonists|hormone antagonists|mesh-ancestor
6002923|NCT00242710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6002924|NCT00243022|Vitamin B 12|vitamin b 12|mesh-list
6002925|NCT00243022|Hydroxocobalamin|hydroxocobalamin|mesh-list
6002926|NCT00243022|Vitamins|vitamins|mesh-ancestor
6002927|NCT00243022|Micronutrients|micronutrients|mesh-ancestor
6002928|NCT00243022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002929|NCT00243022|Vitamin B Complex|vitamin b complex|mesh-ancestor
6002930|NCT00243022|Hematinics|hematinics|mesh-ancestor
6002931|NCT00243061|Cediranib|cediranib|mesh-list
6002932|NCT00243061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6002933|NCT00243061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002934|NCT00243061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6002935|NCT00243061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6002936|NCT00243074|Cediranib|cediranib|mesh-list
6002937|NCT00243074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6002938|NCT00243074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002939|NCT00243074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6002940|NCT00243074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6002941|NCT00243152|Lamotrigine|lamotrigine|mesh-list
6002942|NCT00243152|Anticonvulsants|anticonvulsants|mesh-list
6002943|NCT00243152|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6002944|NCT00243152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6002945|NCT00243152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002946|NCT00243152|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6002947|NCT00243152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002948|NCT00243152|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6002949|NCT00243152|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6002950|NCT00243152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6002951|NCT00243152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6002952|NCT00243152|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6002953|NCT00243191|Imatinib Mesylate|imatinib mesylate|mesh-list
6002954|NCT00243191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6002955|NCT00243191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6002956|NCT00243191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6002957|NCT00243191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002958|NCT00243347|Cediranib|cediranib|mesh-list
6002959|NCT00243347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6002960|NCT00243347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6002961|NCT00243347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6002962|NCT00243347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002963|NCT00243386|Factor VIII|factor viii|mesh-list
6002964|NCT00243386|Coagulants|coagulants|mesh-ancestor
6002965|NCT00243412|Methylprednisolone|methylprednisolone|mesh-list
6002966|NCT00243412|Rituximab|rituximab|mesh-list
6002967|NCT00243412|Methotrexate|methotrexate|mesh-list
6002968|NCT00243412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6002969|NCT00243412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6002970|NCT00243412|Immunologic Factors|immunologic factors|mesh-ancestor
6002971|NCT00243412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6002972|NCT00243412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6002973|NCT00243412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6002974|NCT00243412|Abortifacient Agents|abortifacient agents|mesh-ancestor
6002975|NCT00243412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6002976|NCT00243412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6002977|NCT00243412|Antimetabolites|antimetabolites|mesh-ancestor
6002978|NCT00243412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6002979|NCT00243412|Dermatologic Agents|dermatologic agents|mesh-ancestor
6002980|NCT00243412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6002981|NCT00243412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6002982|NCT00243412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6002983|NCT00243412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6002984|NCT00243412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6002985|NCT00243412|Antiemetics|antiemetics|mesh-ancestor
6002986|NCT00243412|Autonomic Agents|autonomic agents|mesh-ancestor
6002987|NCT00243412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6002988|NCT00243412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6002989|NCT00243412|Glucocorticoids|glucocorticoids|mesh-ancestor
6002990|NCT00243412|Hormones|hormones|mesh-ancestor
6002991|NCT00243412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6002992|NCT00243412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6002993|NCT00243412|Protective Agents|protective agents|mesh-ancestor
6002994|NCT00243503|Trastuzumab|trastuzumab|mesh-list
6002995|NCT00243503|Sunitinib|sunitinib|mesh-list
6002996|NCT00243503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6002997|NCT00243503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6002998|NCT00243503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6002999|NCT00243503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6003000|NCT00243503|Growth Substances|growth substances|mesh-ancestor
6003001|NCT00243503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003002|NCT00243503|Growth Inhibitors|growth inhibitors|mesh-ancestor
6003003|NCT00243503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6260183|NCT03146806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6260184|NCT03146806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260185|NCT03146806|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6260186|NCT03146806|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6260187|NCT03146806|Anesthetics, General|anesthetics, general|mesh-ancestor
6260188|NCT03146806|Anesthetics|anesthetics|mesh-ancestor
6260189|NCT03146806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6260190|NCT03146806|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6260191|NCT03146806|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6260192|NCT03146806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6260193|NCT03146806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260194|NCT03147248|Infliximab|infliximab|mesh-list
6260195|NCT03147248|Dermatologic Agents|dermatologic agents|mesh-ancestor
6260196|NCT03147248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6260197|NCT03147248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6260198|NCT03148236|Ascorbic Acid|ascorbic acid|mesh-list
6260199|NCT03148236|Vitamins|vitamins|mesh-ancestor
6260200|NCT03148236|Micronutrients|micronutrients|mesh-ancestor
6260201|NCT03148236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260202|NCT03148236|Antioxidants|antioxidants|mesh-ancestor
6260203|NCT03148236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260204|NCT03148236|Protective Agents|protective agents|mesh-ancestor
6260205|NCT03148756|Dalbavancin|dalbavancin|mesh-list
6260206|NCT03148756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6260207|NCT03148756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6260208|NCT03149055|Isavuconazole|isavuconazole|mesh-list
6260209|NCT03149055|Antifungal Agents|antifungal agents|mesh-ancestor
6260210|NCT03149055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6260211|NCT03149848|Rifabutin|rifabutin|mesh-list
6260212|NCT03149848|Cabotegravir|cabotegravir|mesh-list
6260213|NCT03149848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6260214|NCT03149848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6260215|NCT03149848|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6260216|NCT03149848|Antitubercular Agents|antitubercular agents|mesh-ancestor
6260217|NCT03149848|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6260218|NCT03149848|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6260219|NCT03149848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6260220|NCT03149848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260221|NCT03149848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6260222|NCT03149848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6260223|NCT03149848|Antiviral Agents|antiviral agents|mesh-ancestor
6260224|NCT03149887|Bupivacaine|bupivacaine|mesh-list
6260225|NCT03149887|Anesthetics, Local|anesthetics, local|mesh-ancestor
6260226|NCT03149887|Anesthetics|anesthetics|mesh-ancestor
6260227|NCT03149887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6260228|NCT03149887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003004|NCT00243503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6003005|NCT00243503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003006|NCT00243659|Factor VIII|factor viii|mesh-list
6003007|NCT00243659|Coagulants|coagulants|mesh-ancestor
6003008|NCT00243932|Ubiquinone|ubiquinone|mesh-list
6003009|NCT00243932|Coenzyme Q10|coenzyme q10|mesh-list
6003010|NCT00243932|Micronutrients|micronutrients|mesh-ancestor
6003011|NCT00243932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003012|NCT00243932|Vitamins|vitamins|mesh-ancestor
6003013|NCT00244101|Pulmonary Surfactants|pulmonary surfactants|mesh-list
6003014|NCT00244101|Respiratory System Agents|respiratory system agents|mesh-ancestor
6003015|NCT00244374|Vaccines|vaccines|mesh-list
6003016|NCT00244374|Immunologic Factors|immunologic factors|mesh-ancestor
6003017|NCT00244374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003018|NCT00244621|Candesartan|candesartan|mesh-list
6003019|NCT00244621|Candesartan cilexetil|candesartan cilexetil|mesh-list
6003020|NCT00244621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6003021|NCT00244621|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6003022|NCT00244621|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6003023|NCT00244621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003024|NCT00244712|Tenofovir|tenofovir|mesh-list
6003025|NCT00244712|Lamivudine|lamivudine|mesh-list
6003026|NCT00244712|Emtricitabine|emtricitabine|mesh-list
6003027|NCT00244712|Abacavir|abacavir|mesh-list
6003028|NCT00244712|Antiviral Agents|antiviral agents|mesh-ancestor
6003029|NCT00244712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6003030|NCT00244712|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6003031|NCT00244712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6003032|NCT00244712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6003033|NCT00244712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003034|NCT00244712|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6003035|NCT00244712|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6003036|NCT00244725|Warfarin|warfarin|mesh-list
6003037|NCT00244725|Anticoagulants|anticoagulants|mesh-ancestor
6003038|NCT00244855|Dexamethasone|dexamethasone|mesh-list
6003039|NCT00244855|Rituximab|rituximab|mesh-list
6003040|NCT00244855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6003041|NCT00244855|Antiemetics|antiemetics|mesh-ancestor
6003042|NCT00244855|Autonomic Agents|autonomic agents|mesh-ancestor
6003043|NCT00244855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6003044|NCT00244855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003045|NCT00244855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6003046|NCT00244855|Glucocorticoids|glucocorticoids|mesh-ancestor
6003047|NCT00244855|Hormones|hormones|mesh-ancestor
6003048|NCT00244855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6003049|NCT00244855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6003050|NCT00244855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6003051|NCT00244855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6003052|NCT00244855|Immunologic Factors|immunologic factors|mesh-ancestor
6003053|NCT00244855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6003054|NCT00244881|Cediranib|cediranib|mesh-list
6003055|NCT00244881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6018045|NCT00377741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6003056|NCT00244881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003057|NCT00244881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6003058|NCT00244881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6003059|NCT00244933|Gemcitabine|gemcitabine|mesh-list
6003060|NCT00244933|Genistein|genistein|mesh-list
6003061|NCT00244933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6003062|NCT00244933|Antimetabolites|antimetabolites|mesh-ancestor
6003063|NCT00244933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003064|NCT00244933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6003065|NCT00244933|Antiviral Agents|antiviral agents|mesh-ancestor
6003066|NCT00244933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6003067|NCT00244933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6003068|NCT00244933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6003069|NCT00244933|Immunologic Factors|immunologic factors|mesh-ancestor
6003070|NCT00244933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003071|NCT00244933|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6003072|NCT00244933|Protective Agents|protective agents|mesh-ancestor
6003073|NCT00244933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6003074|NCT00244933|Phytoestrogens|phytoestrogens|mesh-ancestor
6003075|NCT00244933|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6003076|NCT00244933|Estrogens|estrogens|mesh-ancestor
6003077|NCT00244933|Hormones|hormones|mesh-ancestor
6003078|NCT00244933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6003079|NCT00244985|Rituximab|rituximab|mesh-list
6003080|NCT00244985|Doxorubicin|doxorubicin|mesh-list
6003081|NCT00244985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6003082|NCT00244985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6003083|NCT00244985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6003084|NCT00244985|Immunologic Factors|immunologic factors|mesh-ancestor
6003085|NCT00244985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003086|NCT00244985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6003087|NCT00244985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6003088|NCT00244985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6003089|NCT00244985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6003090|NCT00244985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6003091|NCT00244985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003092|NCT00245011|Ifosfamide|ifosfamide|mesh-list
6003093|NCT00245011|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
6003094|NCT00245011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003095|NCT00245011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6003096|NCT00245011|Alkylating Agents|alkylating agents|mesh-ancestor
6003097|NCT00245011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003098|NCT00245011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6003099|NCT00245011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6003100|NCT00245011|Analgesics|analgesics|mesh-ancestor
6003101|NCT00245011|Sensory System Agents|sensory system agents|mesh-ancestor
6003102|NCT00245011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6003103|NCT00245037|Cyclosporine|cyclosporine|mesh-list
6003104|NCT00245037|Mycophenolic Acid|mycophenolic acid|mesh-list
6003105|NCT00245037|Methotrexate|methotrexate|mesh-list
6003106|NCT00245037|Fludarabine phosphate|fludarabine phosphate|mesh-list
6003107|NCT00245037|Fludarabine|fludarabine|mesh-list
6003108|NCT00245037|Busulfan|busulfan|mesh-list
6003109|NCT00245037|Phenytoin|phenytoin|mesh-list
6003110|NCT00245037|Cyclosporins|cyclosporins|mesh-list
6003111|NCT00245037|Sargramostim|sargramostim|mesh-list
6003112|NCT00245037|Lenograstim|lenograstim|mesh-list
6003113|NCT00245037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6003114|NCT00245037|Abortifacient Agents|abortifacient agents|mesh-ancestor
6003115|NCT00245037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6003116|NCT00245037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003117|NCT00245037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6003118|NCT00245037|Antimetabolites|antimetabolites|mesh-ancestor
6018046|NCT00377819|Denosumab|denosumab|mesh-list
6003119|NCT00245037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003120|NCT00245037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6003121|NCT00245037|Dermatologic Agents|dermatologic agents|mesh-ancestor
6003122|NCT00245037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6003123|NCT00245037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6003124|NCT00245037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6003125|NCT00245037|Immunologic Factors|immunologic factors|mesh-ancestor
6003126|NCT00245037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6003127|NCT00245037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6003128|NCT00245037|Antifungal Agents|antifungal agents|mesh-ancestor
6003129|NCT00245037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6003130|NCT00245037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6003131|NCT00245037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6003132|NCT00245037|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6003133|NCT00245037|Antitubercular Agents|antitubercular agents|mesh-ancestor
6003134|NCT00245037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6003135|NCT00245037|Alkylating Agents|alkylating agents|mesh-ancestor
6003136|NCT00245037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6003137|NCT00245037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6003138|NCT00245037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6003139|NCT00245037|Anticonvulsants|anticonvulsants|mesh-ancestor
6003140|NCT00245037|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6003141|NCT00245037|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6003142|NCT00245037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6003143|NCT00245037|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6003144|NCT00245037|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6003145|NCT00245050|Pyridoxine|pyridoxine|mesh-list
6003146|NCT00245050|Vitamin B 6|vitamin b 6|mesh-list
6003147|NCT00245050|Doxorubicin|doxorubicin|mesh-list
6003148|NCT00245050|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6003149|NCT00245050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6003150|NCT00245050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6003151|NCT00245050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6003152|NCT00245050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6003153|NCT00245050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6003154|NCT00245050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003155|NCT00245050|Vitamin B Complex|vitamin b complex|mesh-ancestor
6003156|NCT00245050|Vitamins|vitamins|mesh-ancestor
6003157|NCT00245050|Micronutrients|micronutrients|mesh-ancestor
6003158|NCT00245050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003159|NCT00245063|Cediranib|cediranib|mesh-list
6003160|NCT00245063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6003161|NCT00245063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003162|NCT00245063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6003163|NCT00245063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6003164|NCT00245102|Sorafenib|sorafenib|mesh-list
6003165|NCT00245102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6003166|NCT00245102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6003167|NCT00245102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6003168|NCT00245102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003169|NCT00245557|Sertraline|sertraline|mesh-list
6003170|NCT00245557|Antidepressive Agents|antidepressive agents|mesh-ancestor
6003171|NCT00245557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6003172|NCT00245557|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6003173|NCT00245557|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6003174|NCT00245557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6003175|NCT00245557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003176|NCT00245557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6003177|NCT00245557|Serotonin Agents|serotonin agents|mesh-ancestor
6003178|NCT00245557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003179|NCT00245583|Topiramate|topiramate|mesh-list
6003180|NCT00245583|Anticonvulsants|anticonvulsants|mesh-ancestor
6003181|NCT00245583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6003182|NCT00245583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003183|NCT00245635|Fluoxetine|fluoxetine|mesh-list
6003184|NCT00245635|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6003185|NCT00245635|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6003186|NCT00245635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6003187|NCT00245635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003188|NCT00245635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6003189|NCT00245635|Serotonin Agents|serotonin agents|mesh-ancestor
6003190|NCT00245635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003191|NCT00245635|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6003192|NCT00245635|Antidepressive Agents|antidepressive agents|mesh-ancestor
6003193|NCT00245635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6003194|NCT00245635|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6003195|NCT00245635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6003196|NCT00245635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6003197|NCT00245765|Certolizumab Pegol|certolizumab pegol|mesh-list
6003198|NCT00245765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6003199|NCT00245765|Immunologic Factors|immunologic factors|mesh-ancestor
6003200|NCT00245765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003201|NCT00245765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6003202|NCT00245856|Dalteparin|dalteparin|mesh-list
6003203|NCT00245856|Tinzaparin|tinzaparin|mesh-list
6003204|NCT00245856|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6003205|NCT00245856|Warfarin|warfarin|mesh-list
6003206|NCT00245856|Anticoagulants|anticoagulants|mesh-ancestor
6003207|NCT00245856|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6003208|NCT00245856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6003209|NCT00245856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003210|NCT00246012|Dacarbazine|dacarbazine|mesh-list
6003211|NCT00246012|Intetumumab|intetumumab|mesh-list
6260229|NCT03149887|Sensory System Agents|sensory system agents|mesh-ancestor
6260230|NCT03149887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6260231|NCT03149991|Ketamine|ketamine|mesh-list
6260232|NCT03149991|Brexpiprazole|brexpiprazole|mesh-list
6260233|NCT03149991|Analgesics|analgesics|mesh-ancestor
6260234|NCT03149991|Sensory System Agents|sensory system agents|mesh-ancestor
6260235|NCT03149991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6260236|NCT03149991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260237|NCT03149991|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6260238|NCT03149991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6260239|NCT03149991|Anesthetics, General|anesthetics, general|mesh-ancestor
6260240|NCT03149991|Anesthetics|anesthetics|mesh-ancestor
6260241|NCT03149991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6260242|NCT03149991|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6260243|NCT03149991|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6260244|NCT03149991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6260245|NCT03149991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260246|NCT03149991|Serotonin Agents|serotonin agents|mesh-ancestor
6260247|NCT03149991|Dopamine Agonists|dopamine agonists|mesh-ancestor
6260248|NCT03149991|Dopamine Agents|dopamine agents|mesh-ancestor
6260249|NCT03150056|Prednisone|prednisone|mesh-list
6260250|NCT03150056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6260251|NCT03150056|Glucocorticoids|glucocorticoids|mesh-ancestor
6260252|NCT03150056|Hormones|hormones|mesh-ancestor
6260253|NCT03150056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6260254|NCT03150056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260255|NCT03150056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6260256|NCT03150056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6260257|NCT03150082|Ciprofloxacin|ciprofloxacin|mesh-list
6260258|NCT03150082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6260259|NCT03150082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6260260|NCT03150082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6260261|NCT03150082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6260262|NCT03150082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6260263|NCT03150082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260264|NCT03150082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6260265|NCT03150082|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6260266|NCT03150082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6260267|NCT03150589|Ranibizumab|ranibizumab|mesh-list
6260268|NCT03150589|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6260269|NCT03150589|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6260270|NCT03150589|Growth Substances|growth substances|mesh-ancestor
6260271|NCT03150589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003212|NCT00246012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6003213|NCT00246012|Alkylating Agents|alkylating agents|mesh-ancestor
6003214|NCT00246012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003215|NCT00246012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6003216|NCT00246012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6003217|NCT00246025|Dabigatran|dabigatran|mesh-list
6003218|NCT00246025|Antithrombins|antithrombins|mesh-ancestor
6003219|NCT00246025|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6003220|NCT00246025|Protease Inhibitors|protease inhibitors|mesh-ancestor
6003221|NCT00246025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6003222|NCT00246025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003223|NCT00246025|Anticoagulants|anticoagulants|mesh-ancestor
6003224|NCT00246129|Alemtuzumab|alemtuzumab|mesh-list
6003225|NCT00246129|Daclizumab|daclizumab|mesh-list
6003226|NCT00246129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6003227|NCT00246129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6003228|NCT00246129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6003229|NCT00246129|Immunologic Factors|immunologic factors|mesh-ancestor
6003230|NCT00246129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003231|NCT00246259|Risperidone|risperidone|mesh-list
6003232|NCT00246259|Antipsychotic Agents|antipsychotic agents|mesh-list
6003233|NCT00246259|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6003234|NCT00246259|Serotonin Agents|serotonin agents|mesh-ancestor
6003235|NCT00246259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6003236|NCT00246259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003237|NCT00246259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003238|NCT00246259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6003239|NCT00246259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6003240|NCT00246259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6003241|NCT00246259|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6003242|NCT00246259|Dopamine Agents|dopamine agents|mesh-ancestor
6003243|NCT00246324|Interferons|interferons|mesh-list
6003244|NCT00246324|Interferon-beta|interferon-beta|mesh-list
6003245|NCT00246324|Interferon beta-1a|interferon beta-1a|mesh-list
6003246|NCT00246324|Doxycycline|doxycycline|mesh-list
6003247|NCT00246324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6003248|NCT00246324|Antiviral Agents|antiviral agents|mesh-ancestor
6003249|NCT00246324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6003250|NCT00246324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6003251|NCT00246324|Antimalarials|antimalarials|mesh-ancestor
6003252|NCT00246324|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6003253|NCT00246324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6003254|NCT00246324|Immunologic Factors|immunologic factors|mesh-ancestor
6003255|NCT00246324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003256|NCT00246324|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6003257|NCT00246337|Rizatriptan|rizatriptan|mesh-list
6003258|NCT00246337|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6003259|NCT00246337|Serotonin Agents|serotonin agents|mesh-ancestor
6003260|NCT00246337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6003261|NCT00246337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003262|NCT00246337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003263|NCT00246376|Niacin|niacin|mesh-list
6003264|NCT00246376|Fenofibrate|fenofibrate|mesh-list
6003265|NCT00246376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6003266|NCT00246376|Antimetabolites|antimetabolites|mesh-ancestor
6003267|NCT00246376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003268|NCT00246376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6003269|NCT00246376|Vasodilator Agents|vasodilator agents|mesh-ancestor
6003270|NCT00246376|Vitamin B Complex|vitamin b complex|mesh-ancestor
6003271|NCT00246376|Vitamins|vitamins|mesh-ancestor
6003272|NCT00246376|Micronutrients|micronutrients|mesh-ancestor
6003273|NCT00246376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003274|NCT00246441|Paroxetine|paroxetine|mesh-list
6003275|NCT00246441|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6003276|NCT00246441|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6003277|NCT00246441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6003278|NCT00246441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003279|NCT00246441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6003280|NCT00246441|Serotonin Agents|serotonin agents|mesh-ancestor
6003281|NCT00246441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003282|NCT00246441|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6003283|NCT00246441|Antidepressive Agents|antidepressive agents|mesh-ancestor
6003284|NCT00246441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6003285|NCT00246441|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6003286|NCT00246441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6003287|NCT00246441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6003288|NCT00246519|Atenolol|atenolol|mesh-list
6003289|NCT00246519|Metoprolol|metoprolol|mesh-list
6003290|NCT00246519|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6003291|NCT00246519|Trichlormethiazide|trichlormethiazide|mesh-list
6003292|NCT00246519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6003293|NCT00246519|Diuretics|diuretics|mesh-ancestor
6003294|NCT00246519|Natriuretic Agents|natriuretic agents|mesh-ancestor
6003295|NCT00246519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003296|NCT00246519|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6003297|NCT00246519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6003298|NCT00246519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003299|NCT00246519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6003300|NCT00246519|Sympatholytics|sympatholytics|mesh-ancestor
6003301|NCT00246519|Autonomic Agents|autonomic agents|mesh-ancestor
6003302|NCT00246519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6003303|NCT00246519|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6003304|NCT00246519|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6003305|NCT00246519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6003306|NCT00246519|Adrenergic Agents|adrenergic agents|mesh-ancestor
6003307|NCT00246519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6003308|NCT00246571|Sunitinib|sunitinib|mesh-list
6003309|NCT00246571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6003310|NCT00246571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6003311|NCT00246571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6003312|NCT00246571|Growth Substances|growth substances|mesh-ancestor
6003313|NCT00246571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003314|NCT00246571|Growth Inhibitors|growth inhibitors|mesh-ancestor
6003315|NCT00246571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6003316|NCT00246571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6003317|NCT00246571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003318|NCT00246740|Doxycycline|doxycycline|mesh-list
6003319|NCT00246740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6003320|NCT00246740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6003321|NCT00246740|Antimalarials|antimalarials|mesh-ancestor
6003322|NCT00246740|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6003323|NCT00246740|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6003324|NCT00246753|Lapatinib|lapatinib|mesh-list
6003325|NCT00246753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6003326|NCT00246753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6003327|NCT00246753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6003328|NCT00246753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003329|NCT00247273|Risedronic Acid|risedronic acid|mesh-list
6003330|NCT00247273|Etidronic Acid|etidronic acid|mesh-list
6003331|NCT00247273|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6003332|NCT00247273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6003333|NCT00247273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003334|NCT00247273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6003335|NCT00247273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003336|NCT00247273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6003337|NCT00247416|Gemcitabine|gemcitabine|mesh-list
6003338|NCT00247416|Dexamethasone|dexamethasone|mesh-list
6003339|NCT00247416|Carboplatin|carboplatin|mesh-list
6003340|NCT00247416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6003341|NCT00247416|Antiemetics|antiemetics|mesh-ancestor
6003342|NCT00247416|Autonomic Agents|autonomic agents|mesh-ancestor
6003343|NCT00247416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6003344|NCT00247416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003345|NCT00247416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6003346|NCT00247416|Glucocorticoids|glucocorticoids|mesh-ancestor
6003347|NCT00247416|Hormones|hormones|mesh-ancestor
6003348|NCT00247416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6003349|NCT00247416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6003350|NCT00247416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6003351|NCT00247416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6003352|NCT00247416|Antimetabolites|antimetabolites|mesh-ancestor
6003353|NCT00247416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003354|NCT00247416|Antiviral Agents|antiviral agents|mesh-ancestor
6003355|NCT00247416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6003356|NCT00247416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6003357|NCT00247416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6003358|NCT00247416|Immunologic Factors|immunologic factors|mesh-ancestor
6003359|NCT00247624|Eszopiclone|eszopiclone|mesh-list
6003360|NCT00247624|Fluoxetine|fluoxetine|mesh-list
6003361|NCT00247624|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6003362|NCT00247624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6003363|NCT00247624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6003364|NCT00247624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003365|NCT00247624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6003366|NCT00247624|Serotonin Agents|serotonin agents|mesh-ancestor
6003367|NCT00247624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003368|NCT00247624|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6003369|NCT00247624|Antidepressive Agents|antidepressive agents|mesh-ancestor
6003370|NCT00247624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6003371|NCT00247624|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6003372|NCT00247624|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6003373|NCT00247624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6003374|NCT00247624|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6003375|NCT00247624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6003376|NCT00247676|Sunitinib|sunitinib|mesh-list
6003377|NCT00247676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6003378|NCT00247676|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6003379|NCT00247676|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6003380|NCT00247676|Growth Substances|growth substances|mesh-ancestor
6003381|NCT00247676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003382|NCT00247676|Growth Inhibitors|growth inhibitors|mesh-ancestor
6003383|NCT00247676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6003384|NCT00247676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6003385|NCT00247676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003386|NCT00247962|Sulfasalazine|sulfasalazine|mesh-list
6003387|NCT00247962|Etanercept|etanercept|mesh-list
6003388|NCT00247962|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6003389|NCT00247962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6003390|NCT00247962|Analgesics|analgesics|mesh-ancestor
6003391|NCT00247962|Sensory System Agents|sensory system agents|mesh-ancestor
6003392|NCT00247962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6003393|NCT00247962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003394|NCT00247962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6003395|NCT00247962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6003396|NCT00247962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6003397|NCT00247962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6003398|NCT00247962|Immunologic Factors|immunologic factors|mesh-ancestor
6003399|NCT00247962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6003400|NCT00248170|Letrozole|letrozole|mesh-list
6003401|NCT00248170|Anastrozole|anastrozole|mesh-list
6003402|NCT00248170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6003403|NCT00248170|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6003404|NCT00248170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6003405|NCT00248170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6003406|NCT00248170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003407|NCT00248170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6003408|NCT00248170|Hormone Antagonists|hormone antagonists|mesh-ancestor
6003409|NCT00248170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6003410|NCT00248170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003411|NCT00248170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6003412|NCT00248495|Pemetrexed|pemetrexed|mesh-list
6003413|NCT00248495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6003414|NCT00248495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6003415|NCT00248495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003416|NCT00248495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6003417|NCT00248495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6003418|NCT00248534|Methylprednisolone|methylprednisolone|mesh-list
6003419|NCT00248534|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6003420|NCT00248534|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6003421|NCT00248534|Prednisolone|prednisolone|mesh-list
6003422|NCT00248534|Prednisolone acetate|prednisolone acetate|mesh-list
6003423|NCT00248534|Rituximab|rituximab|mesh-list
6003424|NCT00248534|Temozolomide|temozolomide|mesh-list
6003425|NCT00248534|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6003426|NCT00248534|Prednisolone phosphate|prednisolone phosphate|mesh-list
6003427|NCT00248534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6003428|NCT00248534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6003429|NCT00248534|Immunologic Factors|immunologic factors|mesh-ancestor
6003430|NCT00248534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003431|NCT00248534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6003432|NCT00248534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6003433|NCT00248534|Alkylating Agents|alkylating agents|mesh-ancestor
6003434|NCT00248534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003435|NCT00248534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6003436|NCT00248534|Antiemetics|antiemetics|mesh-ancestor
6003437|NCT00248534|Autonomic Agents|autonomic agents|mesh-ancestor
6003438|NCT00248534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6003439|NCT00248534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6003440|NCT00248534|Glucocorticoids|glucocorticoids|mesh-ancestor
6003441|NCT00248534|Hormones|hormones|mesh-ancestor
6003442|NCT00248534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6003443|NCT00248534|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6003444|NCT00248534|Protective Agents|protective agents|mesh-ancestor
6003445|NCT00248534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6003446|NCT00248547|Dexamethasone|dexamethasone|mesh-list
6003447|NCT00248547|Ondansetron|ondansetron|mesh-list
6003448|NCT00248547|Aprepitant|aprepitant|mesh-list
6003449|NCT00248547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6003450|NCT00248547|Antiemetics|antiemetics|mesh-ancestor
6003451|NCT00248547|Autonomic Agents|autonomic agents|mesh-ancestor
6003452|NCT00248547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6003453|NCT00248547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003454|NCT00248547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6003455|NCT00248547|Glucocorticoids|glucocorticoids|mesh-ancestor
6003456|NCT00248547|Hormones|hormones|mesh-ancestor
6003457|NCT00248547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6003458|NCT00248547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6003459|NCT00248547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6003460|NCT00248547|Antipruritics|antipruritics|mesh-ancestor
6003461|NCT00248547|Dermatologic Agents|dermatologic agents|mesh-ancestor
6003462|NCT00248547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6003463|NCT00248547|Serotonin Agents|serotonin agents|mesh-ancestor
6003464|NCT00248547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6003465|NCT00248547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003466|NCT00248547|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6003467|NCT00248547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6003468|NCT00248547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6003469|NCT00248547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6003470|NCT00248547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6003471|NCT00248547|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6003472|NCT00248560|Gemcitabine|gemcitabine|mesh-list
6003473|NCT00248560|Docetaxel|docetaxel|mesh-list
6003474|NCT00248560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6003475|NCT00248560|Antimetabolites|antimetabolites|mesh-ancestor
6003476|NCT00248560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003477|NCT00248560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6003478|NCT00248560|Antiviral Agents|antiviral agents|mesh-ancestor
6003479|NCT00248560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6003480|NCT00248560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6003481|NCT00248560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6003482|NCT00248560|Immunologic Factors|immunologic factors|mesh-ancestor
6003483|NCT00248560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003484|NCT00248560|Tubulin Modulators|tubulin modulators|mesh-ancestor
6003485|NCT00248560|Antimitotic Agents|antimitotic agents|mesh-ancestor
6260272|NCT03150589|Growth Inhibitors|growth inhibitors|mesh-ancestor
6260273|NCT03150589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6260274|NCT03150719|Ivacaftor|ivacaftor|mesh-list
6260275|NCT03150719|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6260276|NCT03150719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6260277|NCT03150719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260278|NCT03150875|Docetaxel|docetaxel|mesh-list
6260279|NCT03150875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6260280|NCT03150875|Tubulin Modulators|tubulin modulators|mesh-ancestor
6260281|NCT03150875|Antimitotic Agents|antimitotic agents|mesh-ancestor
6003486|NCT00248560|Mitosis Modulators|mitosis modulators|mesh-ancestor
6003487|NCT00248612|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6260282|NCT03150875|Mitosis Modulators|mitosis modulators|mesh-ancestor
6389891|NCT00189618|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6018047|NCT00377819|Alendronate|alendronate|mesh-list
6018048|NCT00377819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6018049|NCT00377819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018050|NCT00377832|Acetaminophen|acetaminophen|mesh-list
6018051|NCT00377832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6018052|NCT00377832|Analgesics|analgesics|mesh-ancestor
6018053|NCT00377832|Sensory System Agents|sensory system agents|mesh-ancestor
6003488|NCT00248612|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6003489|NCT00248612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6003490|NCT00248612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6003491|NCT00248612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003492|NCT00248612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6003493|NCT00248612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003494|NCT00248612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6003495|NCT00248612|Antidepressive Agents|antidepressive agents|mesh-ancestor
6003496|NCT00248612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6003497|NCT00248625|Acetylcysteine|acetylcysteine|mesh-list
6003498|NCT00248625|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6260283|NCT03150875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260284|NCT03151434|Hydromorphone|hydromorphone|mesh-list
6260285|NCT03151434|Bupivacaine|bupivacaine|mesh-list
6260286|NCT03151434|Anesthetics, Local|anesthetics, local|mesh-ancestor
6260287|NCT03151434|Anesthetics|anesthetics|mesh-ancestor
6260288|NCT03151434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6003499|NCT00248625|Antiviral Agents|antiviral agents|mesh-ancestor
6003500|NCT00248625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6003501|NCT00248625|Expectorants|expectorants|mesh-ancestor
6003502|NCT00248625|Respiratory System Agents|respiratory system agents|mesh-ancestor
6003503|NCT00248625|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6003504|NCT00248625|Antioxidants|antioxidants|mesh-ancestor
6003505|NCT00248625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003506|NCT00248625|Protective Agents|protective agents|mesh-ancestor
6003507|NCT00248625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003508|NCT00248625|Antidotes|antidotes|mesh-ancestor
6003509|NCT00248651|Amitriptyline|amitriptyline|mesh-list
6003510|NCT00248651|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6003511|NCT00248651|Citalopram|citalopram|mesh-list
6003512|NCT00248651|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6003513|NCT00248651|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6003514|NCT00248651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6003515|NCT00248651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003516|NCT00248651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6003517|NCT00248651|Serotonin Agents|serotonin agents|mesh-ancestor
6003518|NCT00248651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003519|NCT00248651|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6003520|NCT00248651|Antidepressive Agents|antidepressive agents|mesh-ancestor
6003521|NCT00248651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6003522|NCT00248651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6003523|NCT00248651|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6003524|NCT00248651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6003525|NCT00248651|Analgesics|analgesics|mesh-ancestor
6003526|NCT00248651|Sensory System Agents|sensory system agents|mesh-ancestor
6003527|NCT00248651|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6003528|NCT00248651|Adrenergic Agents|adrenergic agents|mesh-ancestor
6003529|NCT00248651|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6003530|NCT00248651|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6003531|NCT00248651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6003532|NCT00248807|Enalaprilat|enalaprilat|mesh-list
6003533|NCT00248807|Enalapril|enalapril|mesh-list
6003534|NCT00248807|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6003535|NCT00248807|Protease Inhibitors|protease inhibitors|mesh-ancestor
6003536|NCT00248807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6003537|NCT00248807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003538|NCT00248807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6003539|NCT00248833|Vaccines|vaccines|mesh-list
6003540|NCT00248833|Immunologic Factors|immunologic factors|mesh-ancestor
6003541|NCT00248833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003542|NCT00249002|Paclitaxel|paclitaxel|mesh-list
6003543|NCT00249002|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6003544|NCT00249002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6003545|NCT00249002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6003546|NCT00249002|Tubulin Modulators|tubulin modulators|mesh-ancestor
6003547|NCT00249002|Antimitotic Agents|antimitotic agents|mesh-ancestor
6003548|NCT00249002|Mitosis Modulators|mitosis modulators|mesh-ancestor
6536461|NCT00817011|Adrenergic Agents|adrenergic agents|mesh-ancestor
6003549|NCT00249002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003550|NCT00249249|Atorvastatin|atorvastatin|mesh-list
6003551|NCT00249249|Pitavastatin|pitavastatin|mesh-list
6003552|NCT00249249|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6003553|NCT00249249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6003554|NCT00249249|Antimetabolites|antimetabolites|mesh-ancestor
6003555|NCT00249249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003556|NCT00249249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6003557|NCT00249249|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6003558|NCT00249249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6003559|NCT00249288|Folic Acid|folic acid|mesh-list
6003560|NCT00249288|Vitamin B Complex|vitamin b complex|mesh-list
6003561|NCT00249288|Hematinics|hematinics|mesh-ancestor
6003562|NCT00249288|Vitamins|vitamins|mesh-ancestor
6003563|NCT00249288|Micronutrients|micronutrients|mesh-ancestor
6003564|NCT00249288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018054|NCT00377832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6018055|NCT00377832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018056|NCT00377832|Antipyretics|antipyretics|mesh-ancestor
6018057|NCT00377858|Insulin|insulin|mesh-list
6018058|NCT00377858|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6018059|NCT00377858|Insulin Glargine|insulin glargine|mesh-list
6018060|NCT00377858|Insulin Lispro|insulin lispro|mesh-list
6018061|NCT00377858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6018062|NCT00377858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018063|NCT00377962|Mycophenolic Acid|mycophenolic acid|mesh-list
6018064|NCT00377962|Everolimus|everolimus|mesh-list
6018065|NCT00377962|Azathioprine|azathioprine|mesh-list
6018066|NCT00377962|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
6018067|NCT00377962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6018068|NCT00377962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6018069|NCT00377962|Immunologic Factors|immunologic factors|mesh-ancestor
6018070|NCT00377962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018071|NCT00377962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6018072|NCT00377962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6018073|NCT00377962|Antimetabolites|antimetabolites|mesh-ancestor
6018074|NCT00377962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6018075|NCT00377962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6018076|NCT00377962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6018077|NCT00377962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6018078|NCT00377962|Antitubercular Agents|antitubercular agents|mesh-ancestor
6018079|NCT00377962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6003565|NCT00249379|Acamprosate|acamprosate|mesh-list
6003566|NCT00249379|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6003567|NCT00249444|Mirtazapine|mirtazapine|mesh-list
6003568|NCT00249444|Antidepressive Agents|antidepressive agents|mesh-ancestor
6003569|NCT00249444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6003570|NCT00249444|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6003571|NCT00249444|Histamine Antagonists|histamine antagonists|mesh-ancestor
6003572|NCT00249444|Histamine Agents|histamine agents|mesh-ancestor
6003573|NCT00249444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6003574|NCT00249444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003575|NCT00249444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003576|NCT00249444|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6003577|NCT00249444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6003578|NCT00249444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6003579|NCT00249444|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6003580|NCT00249444|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6003581|NCT00249444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6003582|NCT00249444|Adrenergic Agents|adrenergic agents|mesh-ancestor
6003583|NCT00249444|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6003584|NCT00249444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6003585|NCT00249444|Serotonin Agents|serotonin agents|mesh-ancestor
6003586|NCT00249444|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6003587|NCT00249769|Vaccines|vaccines|mesh-list
6003588|NCT00249769|Immunologic Factors|immunologic factors|mesh-ancestor
6003589|NCT00249769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003590|NCT00249795|Irbesartan|irbesartan|mesh-list
6003591|NCT00249795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6003592|NCT00249795|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6003593|NCT00249795|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6003594|NCT00249795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003595|NCT00249808|Antibodies|antibodies|mesh-list
6003596|NCT00249808|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6003597|NCT00249808|Immunologic Factors|immunologic factors|mesh-ancestor
6003598|NCT00249808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003599|NCT00249834|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6003600|NCT00249834|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6003601|NCT00249834|Hormones|hormones|mesh-ancestor
6003602|NCT00249834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6003603|NCT00249834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003604|NCT00249834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6003605|NCT00249873|Clopidogrel|clopidogrel|mesh-list
6003606|NCT00249873|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6003607|NCT00249873|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6003608|NCT00249873|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6003609|NCT00249873|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6003610|NCT00249873|Purinergic Agents|purinergic agents|mesh-ancestor
6003611|NCT00249873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6003612|NCT00249873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003613|NCT00249873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003614|NCT00250432|Caspofungin|caspofungin|mesh-list
6003615|NCT00250432|Antifungal Agents|antifungal agents|mesh-ancestor
6003616|NCT00250432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6003617|NCT00250432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6003618|NCT00250432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003619|NCT00250679|Formoterol Fumarate|formoterol fumarate|mesh-list
6003620|NCT00250679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6003621|NCT00250679|Autonomic Agents|autonomic agents|mesh-ancestor
6003622|NCT00250679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6003623|NCT00250679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003624|NCT00250679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6003625|NCT00250679|Respiratory System Agents|respiratory system agents|mesh-ancestor
6003626|NCT00250679|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6003627|NCT00250679|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6003628|NCT00250679|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6003629|NCT00250679|Adrenergic Agents|adrenergic agents|mesh-ancestor
6003630|NCT00250679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6003631|NCT00250679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003632|NCT00250705|Aripiprazole|aripiprazole|mesh-list
6003633|NCT00250705|Antidepressive Agents|antidepressive agents|mesh-ancestor
6003634|NCT00250705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6003635|NCT00250705|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6003636|NCT00250705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6003637|NCT00250705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6003638|NCT00250705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003639|NCT00250705|Dopamine Agonists|dopamine agonists|mesh-ancestor
6003640|NCT00250705|Dopamine Agents|dopamine agents|mesh-ancestor
6003641|NCT00250705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6003642|NCT00250705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003643|NCT00250705|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6003644|NCT00250705|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6003645|NCT00250705|Serotonin Agents|serotonin agents|mesh-ancestor
6003646|NCT00250705|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6003647|NCT00250705|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6003648|NCT00250705|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6003649|NCT00250705|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6003650|NCT00250835|Celecoxib|celecoxib|mesh-list
6003651|NCT00250835|Capecitabine|capecitabine|mesh-list
6003652|NCT00250835|Oxaliplatin|oxaliplatin|mesh-list
6003653|NCT00250835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6003654|NCT00250835|Antimetabolites|antimetabolites|mesh-ancestor
6003655|NCT00250835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003656|NCT00250835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6003657|NCT00250835|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6003658|NCT00250835|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6003659|NCT00250835|Analgesics|analgesics|mesh-ancestor
6003660|NCT00250835|Sensory System Agents|sensory system agents|mesh-ancestor
6003661|NCT00250835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6003662|NCT00250835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003663|NCT00250835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6003664|NCT00250835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6003665|NCT00250835|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6003666|NCT00250835|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6003667|NCT00250835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6003668|NCT00250926|Dexamethasone|dexamethasone|mesh-list
6003669|NCT00250926|Dexamethasone acetate|dexamethasone acetate|mesh-list
6003670|NCT00250926|Rituximab|rituximab|mesh-list
6003671|NCT00250926|Bortezomib|bortezomib|mesh-list
6003672|NCT00250926|BB 1101|bb 1101|mesh-list
6003673|NCT00250926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6003674|NCT00250926|Antiemetics|antiemetics|mesh-ancestor
6003675|NCT00250926|Autonomic Agents|autonomic agents|mesh-ancestor
6003676|NCT00250926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6003677|NCT00250926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003678|NCT00250926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6003679|NCT00250926|Glucocorticoids|glucocorticoids|mesh-ancestor
6003680|NCT00250926|Hormones|hormones|mesh-ancestor
6003681|NCT00250926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6260289|NCT03151434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260290|NCT03151434|Sensory System Agents|sensory system agents|mesh-ancestor
6003682|NCT00250926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6003683|NCT00250926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6003684|NCT00250926|Protease Inhibitors|protease inhibitors|mesh-ancestor
6003685|NCT00250926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6003686|NCT00250926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003687|NCT00250926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6003688|NCT00250926|Immunologic Factors|immunologic factors|mesh-ancestor
6003689|NCT00250926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6003690|NCT00251004|Cyclosporine|cyclosporine|mesh-list
6003691|NCT00251004|Mycophenolic Acid|mycophenolic acid|mesh-list
6003692|NCT00251004|Everolimus|everolimus|mesh-list
6003693|NCT00251004|Cyclosporins|cyclosporins|mesh-list
6003694|NCT00251004|Basiliximab|basiliximab|mesh-list
6003695|NCT00251004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6003696|NCT00251004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003697|NCT00251004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6003698|NCT00251004|Immunologic Factors|immunologic factors|mesh-ancestor
6003699|NCT00251004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003700|NCT00251004|Antifungal Agents|antifungal agents|mesh-ancestor
6003701|NCT00251004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6003702|NCT00251004|Dermatologic Agents|dermatologic agents|mesh-ancestor
6003703|NCT00251004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6003704|NCT00251004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6003705|NCT00251004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6003706|NCT00251004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6003707|NCT00251004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6003708|NCT00251004|Antitubercular Agents|antitubercular agents|mesh-ancestor
6003709|NCT00251004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6003710|NCT00251225|Docetaxel|docetaxel|mesh-list
6003711|NCT00251225|Imatinib Mesylate|imatinib mesylate|mesh-list
6003712|NCT00251225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6003713|NCT00251225|Tubulin Modulators|tubulin modulators|mesh-ancestor
6003714|NCT00251225|Antimitotic Agents|antimitotic agents|mesh-ancestor
6003715|NCT00251225|Mitosis Modulators|mitosis modulators|mesh-ancestor
6003716|NCT00251225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003717|NCT00251225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6003718|NCT00251225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6003719|NCT00251303|Riluzole|riluzole|mesh-list
6003720|NCT00251303|Anticonvulsants|anticonvulsants|mesh-ancestor
6003721|NCT00251303|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6003722|NCT00251303|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6003723|NCT00251303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6003724|NCT00251303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003725|NCT00251303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003726|NCT00251303|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6003727|NCT00251303|Protective Agents|protective agents|mesh-ancestor
6003728|NCT00251316|Lithium Carbonate|lithium carbonate|mesh-list
6003729|NCT00251316|Antidepressive Agents|antidepressive agents|mesh-ancestor
6003730|NCT00251316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6003731|NCT00251316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6003732|NCT00251316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003733|NCT00251316|Antimanic Agents|antimanic agents|mesh-ancestor
6003734|NCT00251316|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6003735|NCT00251316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6003736|NCT00251316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003737|NCT00251589|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6003738|NCT00251589|Vorinostat|vorinostat|mesh-list
6003739|NCT00251589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6003740|NCT00251589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6003741|NCT00251589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6003742|NCT00251589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003743|NCT00251589|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6003744|NCT00251641|Methotrexate|methotrexate|mesh-list
6003745|NCT00251641|Infliximab|infliximab|mesh-list
6003746|NCT00251641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6003747|NCT00251641|Abortifacient Agents|abortifacient agents|mesh-ancestor
6003748|NCT00251641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6003749|NCT00251641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003750|NCT00251641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6003751|NCT00251641|Antimetabolites|antimetabolites|mesh-ancestor
6003752|NCT00251641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003753|NCT00251641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6003754|NCT00251641|Dermatologic Agents|dermatologic agents|mesh-ancestor
6003755|NCT00251641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6003756|NCT00251641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6003757|NCT00251641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6003758|NCT00251641|Immunologic Factors|immunologic factors|mesh-ancestor
6003759|NCT00251641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6003760|NCT00251641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6003761|NCT00251641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6003762|NCT00251693|Lansoprazole|lansoprazole|mesh-list
6003763|NCT00251693|Dexlansoprazole|dexlansoprazole|mesh-list
6003764|NCT00251693|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6003765|NCT00251693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6003766|NCT00251693|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6003767|NCT00251693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6003768|NCT00251693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003769|NCT00251719|Lansoprazole|lansoprazole|mesh-list
6003770|NCT00251719|Dexlansoprazole|dexlansoprazole|mesh-list
6003771|NCT00251719|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6003772|NCT00251719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6003773|NCT00251719|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6003774|NCT00251719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6003775|NCT00251719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003776|NCT00251745|Dexlansoprazole|dexlansoprazole|mesh-list
6003777|NCT00251745|Lansoprazole|lansoprazole|mesh-list
6003778|NCT00251745|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6003779|NCT00251745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6260291|NCT03151434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6260292|NCT03151434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6260293|NCT03151434|Narcotics|narcotics|mesh-ancestor
6260294|NCT03151434|Analgesics|analgesics|mesh-ancestor
6260295|NCT03151551|Adalimumab|adalimumab|mesh-list
6260296|NCT03151551|Ixekizumab|ixekizumab|mesh-list
6260297|NCT03151551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6260298|NCT03151551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6260299|NCT03151551|Dermatologic Agents|dermatologic agents|mesh-ancestor
6260300|NCT03152019|Tacrolimus|tacrolimus|mesh-list
6260301|NCT03152019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6260302|NCT03152019|Immunologic Factors|immunologic factors|mesh-ancestor
6260303|NCT03152019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260304|NCT03152019|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6260305|NCT03152019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6260306|NCT03152019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260307|NCT03152084|Dapagliflozin|dapagliflozin|mesh-list
6260308|NCT03152084|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6260309|NCT03152084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260310|NCT03152084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6260311|NCT03152084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260312|NCT03152552|Empagliflozin|empagliflozin|mesh-list
6260313|NCT03152552|Licogliflozin|licogliflozin|mesh-list
6260314|NCT03152552|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6260315|NCT03152552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260316|NCT03152552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6260317|NCT03152552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260318|NCT03152591|Licogliflozin|licogliflozin|mesh-list
6260319|NCT03152591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6260320|NCT03152591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003780|NCT00251745|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6003781|NCT00251745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6003782|NCT00251745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003783|NCT00251758|Dexlansoprazole|dexlansoprazole|mesh-list
6003784|NCT00251758|Lansoprazole|lansoprazole|mesh-list
6003785|NCT00251758|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6003786|NCT00251758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6003787|NCT00251758|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6003788|NCT00251758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6003789|NCT00251758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003790|NCT00251927|Esomeprazole|esomeprazole|mesh-list
6003791|NCT00251927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6003792|NCT00251927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6003793|NCT00251927|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6003794|NCT00251927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6003795|NCT00251927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003796|NCT00251979|Esomeprazole|esomeprazole|mesh-list
6003797|NCT00251979|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6003798|NCT00251979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6003799|NCT00251979|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6003800|NCT00251979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6003801|NCT00251979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003802|NCT00252187|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6003803|NCT00252187|Natriuretic Agents|natriuretic agents|mesh-ancestor
6003804|NCT00252187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003805|NCT00252239|Plasminogen|plasminogen|mesh-list
6003806|NCT00252239|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6003807|NCT00252239|Tenecteplase|tenecteplase|mesh-list
6003808|NCT00252239|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6003809|NCT00252239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6003810|NCT00252239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003811|NCT00252499|Rosiglitazone|rosiglitazone|mesh-list
6003812|NCT00252499|Fenofibrate|fenofibrate|mesh-list
6003813|NCT00252499|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6003814|NCT00252499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003815|NCT00252499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6003816|NCT00252499|Antimetabolites|antimetabolites|mesh-ancestor
6003817|NCT00252499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003818|NCT00252499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6003819|NCT00252564|Leucovorin|leucovorin|mesh-list
6003820|NCT00252564|Bevacizumab|bevacizumab|mesh-list
6003821|NCT00252564|Cetuximab|cetuximab|mesh-list
6003822|NCT00252564|Fluorouracil|fluorouracil|mesh-list
6003823|NCT00252564|Oxaliplatin|oxaliplatin|mesh-list
6003824|NCT00252564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6003825|NCT00252564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6003826|NCT00252564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6003827|NCT00252564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6003828|NCT00252564|Growth Substances|growth substances|mesh-ancestor
6003829|NCT00252564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003830|NCT00252564|Growth Inhibitors|growth inhibitors|mesh-ancestor
6003831|NCT00252564|Antimetabolites|antimetabolites|mesh-ancestor
6003832|NCT00252564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003833|NCT00252564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6003834|NCT00252564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6003835|NCT00252564|Immunologic Factors|immunologic factors|mesh-ancestor
6003836|NCT00252564|Antidotes|antidotes|mesh-ancestor
6003837|NCT00252564|Protective Agents|protective agents|mesh-ancestor
6003838|NCT00252564|Vitamin B Complex|vitamin b complex|mesh-ancestor
6003839|NCT00252564|Vitamins|vitamins|mesh-ancestor
6003840|NCT00252564|Micronutrients|micronutrients|mesh-ancestor
6003841|NCT00252577|Lithium Carbonate|lithium carbonate|mesh-list
6003842|NCT00252577|Antidepressive Agents|antidepressive agents|mesh-ancestor
6003843|NCT00252577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6003844|NCT00252577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6003845|NCT00252577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003846|NCT00252577|Antimanic Agents|antimanic agents|mesh-ancestor
6003847|NCT00252577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6003848|NCT00252577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6003849|NCT00252577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003850|NCT00252694|Candesartan|candesartan|mesh-list
6003851|NCT00252694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6003852|NCT00252694|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6003853|NCT00252694|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6003854|NCT00252694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003855|NCT00252720|Candesartan|candesartan|mesh-list
6003856|NCT00252720|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6003857|NCT00252720|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6003858|NCT00252720|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6003859|NCT00252720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003860|NCT00252733|Candesartan|candesartan|mesh-list
6003861|NCT00252733|Candesartan cilexetil|candesartan cilexetil|mesh-list
6003862|NCT00252733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6003863|NCT00252733|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6003864|NCT00252733|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6003865|NCT00252733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003866|NCT00252967|Atorvastatin|atorvastatin|mesh-list
6003867|NCT00252967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6003868|NCT00252967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6003869|NCT00252967|Antimetabolites|antimetabolites|mesh-ancestor
6003870|NCT00252967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003871|NCT00252967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6003872|NCT00252967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6003873|NCT00252967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6003874|NCT00253370|Cisplatin|cisplatin|mesh-list
6003875|NCT00253370|Docetaxel|docetaxel|mesh-list
6003876|NCT00253370|Sorafenib|sorafenib|mesh-list
6003877|NCT00253370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6003878|NCT00253370|Tubulin Modulators|tubulin modulators|mesh-ancestor
6003879|NCT00253370|Antimitotic Agents|antimitotic agents|mesh-ancestor
6003880|NCT00253370|Mitosis Modulators|mitosis modulators|mesh-ancestor
6003881|NCT00253370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003882|NCT00253370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6003883|NCT00253370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6003884|NCT00253435|Carboplatin|carboplatin|mesh-list
6003885|NCT00253435|Etoposide|etoposide|mesh-list
6003886|NCT00253435|Melphalan|melphalan|mesh-list
6003887|NCT00253435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6003888|NCT00253435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6003889|NCT00253435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6003890|NCT00253435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6003891|NCT00253435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6003892|NCT00253435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003893|NCT00253435|Immunologic Factors|immunologic factors|mesh-ancestor
6003894|NCT00253435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003895|NCT00253435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6003896|NCT00253435|Alkylating Agents|alkylating agents|mesh-ancestor
6003897|NCT00253435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6003898|NCT00253435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6003899|NCT00253513|Fludarabine|fludarabine|mesh-list
6003900|NCT00253513|Treosulfan|treosulfan|mesh-list
6003901|NCT00253513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6003902|NCT00253513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003903|NCT00253513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6003904|NCT00253513|Alkylating Agents|alkylating agents|mesh-ancestor
6003905|NCT00253630|Vorinostat|vorinostat|mesh-list
6003906|NCT00253630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6003907|NCT00253630|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6003908|NCT00253630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6003909|NCT00253630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003910|NCT00253643|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
6003911|NCT00253643|Antioxidants|antioxidants|mesh-ancestor
6003912|NCT00253643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003913|NCT00253643|Protective Agents|protective agents|mesh-ancestor
6003914|NCT00253643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003915|NCT00253643|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
6003916|NCT00253643|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6003917|NCT00253643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6003918|NCT00253643|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6003919|NCT00253747|Methylphenidate|methylphenidate|mesh-list
6003920|NCT00253747|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6003921|NCT00253747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003922|NCT00253747|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6003923|NCT00253747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6003924|NCT00253747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6003925|NCT00253747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003926|NCT00253747|Dopamine Agents|dopamine agents|mesh-ancestor
6003927|NCT00253747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6003928|NCT00253890|Trazodone|trazodone|mesh-list
6003929|NCT00253890|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6003930|NCT00253890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6003931|NCT00253890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6003932|NCT00253890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003933|NCT00253890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6003934|NCT00253890|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6003935|NCT00253890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6003936|NCT00253890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6003937|NCT00253890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003938|NCT00253890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6003939|NCT00253890|Serotonin Agents|serotonin agents|mesh-ancestor
6003940|NCT00253890|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6003941|NCT00253890|Antidepressive Agents|antidepressive agents|mesh-ancestor
6003942|NCT00254163|Cyclophosphamide|cyclophosphamide|mesh-list
6003943|NCT00254163|Rituximab|rituximab|mesh-list
6003944|NCT00254163|Fludarabine|fludarabine|mesh-list
6003945|NCT00254163|Pentostatin|pentostatin|mesh-list
6003946|NCT00254163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6003947|NCT00254163|Immunologic Factors|immunologic factors|mesh-ancestor
6003948|NCT00254163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003949|NCT00254163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6003950|NCT00254163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6003951|NCT00254163|Alkylating Agents|alkylating agents|mesh-ancestor
6003952|NCT00254163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003953|NCT00254163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6003954|NCT00254163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6003955|NCT00254163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6003956|NCT00254163|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
6003957|NCT00254163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6003958|NCT00254293|Abatacept|abatacept|mesh-list
6003959|NCT00254293|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6003960|NCT00254293|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6003961|NCT00254293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003962|NCT00254293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6003963|NCT00254293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6003964|NCT00254293|Immunologic Factors|immunologic factors|mesh-ancestor
6003965|NCT00254293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003966|NCT00254293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6003967|NCT00254397|Leuprolide|leuprolide|mesh-list
6003968|NCT00254397|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6003969|NCT00254397|Fertility Agents|fertility agents|mesh-ancestor
6003970|NCT00254397|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6003971|NCT00254397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003972|NCT00254397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6003973|NCT00254397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6003974|NCT00254410|Cyclophosphamide|cyclophosphamide|mesh-list
6003975|NCT00254410|Rituximab|rituximab|mesh-list
6003976|NCT00254410|Fludarabine|fludarabine|mesh-list
6003977|NCT00254410|Mitoxantrone|mitoxantrone|mesh-list
6003978|NCT00254410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6003979|NCT00254410|Immunologic Factors|immunologic factors|mesh-ancestor
6003980|NCT00254410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6003981|NCT00254410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6003982|NCT00254410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6003983|NCT00254410|Alkylating Agents|alkylating agents|mesh-ancestor
6003984|NCT00254410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003985|NCT00254410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6003986|NCT00254410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6003987|NCT00254410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6003988|NCT00254410|Analgesics|analgesics|mesh-ancestor
6003989|NCT00254410|Sensory System Agents|sensory system agents|mesh-ancestor
6003990|NCT00254410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6003991|NCT00254410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6003992|NCT00254410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6003993|NCT00254410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6003994|NCT00254462|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6003995|NCT00254462|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6003996|NCT00254462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6003997|NCT00254462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6003998|NCT00254462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6003999|NCT00254462|Adrenergic Agents|adrenergic agents|mesh-ancestor
6004000|NCT00254462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6004001|NCT00254462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004002|NCT00254488|Valproic Acid|valproic acid|mesh-list
6004003|NCT00254488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6004004|NCT00254488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6004005|NCT00254488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004006|NCT00254488|Antimanic Agents|antimanic agents|mesh-ancestor
6004007|NCT00254488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6004008|NCT00254488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6004009|NCT00254488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004010|NCT00254488|Anticonvulsants|anticonvulsants|mesh-ancestor
6004011|NCT00254488|GABA Agents|gaba agents|mesh-ancestor
6004012|NCT00254488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6004013|NCT00254540|Sunitinib|sunitinib|mesh-list
6004014|NCT00254540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6004015|NCT00254540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6004016|NCT00254540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6004017|NCT00254540|Growth Substances|growth substances|mesh-ancestor
6260321|NCT03152591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6260322|NCT03152591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260323|NCT03154333|Diacetylrhein|diacetylrhein|mesh-list
6260324|NCT03154333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6260325|NCT03154476|Sildenafil Citrate|sildenafil citrate|mesh-list
6260326|NCT03154476|Vasodilator Agents|vasodilator agents|mesh-ancestor
6260327|NCT03154476|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6260328|NCT03154476|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6260329|NCT03154476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6260330|NCT03154476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260331|NCT03154476|Urological Agents|urological agents|mesh-ancestor
6260332|NCT03154658|Ropivacaine|ropivacaine|mesh-list
6260333|NCT03154658|Anesthetics, Local|anesthetics, local|mesh-ancestor
6260334|NCT03154658|Anesthetics|anesthetics|mesh-ancestor
6260335|NCT03154658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6260336|NCT03154658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260337|NCT03154658|Sensory System Agents|sensory system agents|mesh-ancestor
6260338|NCT03154658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6260339|NCT03155178|Ethanol|ethanol|mesh-list
6260340|NCT03155178|Chlorhexidine|chlorhexidine|mesh-list
6004018|NCT00254540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004019|NCT00254540|Growth Inhibitors|growth inhibitors|mesh-ancestor
6004020|NCT00254540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6004021|NCT00254540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6004022|NCT00254540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004023|NCT00254566|Azithromycin|azithromycin|mesh-list
6004024|NCT00254566|Moxifloxacin|moxifloxacin|mesh-list
6004025|NCT00254566|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6004026|NCT00254566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6004027|NCT00254566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6004028|NCT00254566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6004029|NCT00254566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6004030|NCT00254566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6004031|NCT00254566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004032|NCT00254566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6004033|NCT00254566|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6004034|NCT00254566|Contraceptive Agents|contraceptive agents|mesh-ancestor
6004035|NCT00254566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6004036|NCT00254566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004037|NCT00254566|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6004038|NCT00254566|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6004039|NCT00254566|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6004040|NCT00254592|Paclitaxel|paclitaxel|mesh-list
6004041|NCT00254592|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6004042|NCT00254592|Cyclophosphamide|cyclophosphamide|mesh-list
6004043|NCT00254592|Bevacizumab|bevacizumab|mesh-list
6004044|NCT00254592|Carboplatin|carboplatin|mesh-list
6004045|NCT00254592|Doxorubicin|doxorubicin|mesh-list
6004046|NCT00254592|Trastuzumab|trastuzumab|mesh-list
6004047|NCT00254592|Sargramostim|sargramostim|mesh-list
6004048|NCT00254592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6004049|NCT00254592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6004050|NCT00254592|Tubulin Modulators|tubulin modulators|mesh-ancestor
6004051|NCT00254592|Antimitotic Agents|antimitotic agents|mesh-ancestor
6004052|NCT00254592|Mitosis Modulators|mitosis modulators|mesh-ancestor
6004053|NCT00254592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004054|NCT00254592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6004055|NCT00254592|Immunologic Factors|immunologic factors|mesh-ancestor
6004056|NCT00254592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004057|NCT00254592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6004058|NCT00254592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6004059|NCT00254592|Alkylating Agents|alkylating agents|mesh-ancestor
6004060|NCT00254592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6004061|NCT00254592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6004062|NCT00254592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6004063|NCT00254592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6004064|NCT00254592|Growth Substances|growth substances|mesh-ancestor
6004065|NCT00254592|Growth Inhibitors|growth inhibitors|mesh-ancestor
6004066|NCT00254592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6004067|NCT00254592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6004068|NCT00254592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6004069|NCT00254592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6004070|NCT00254982|Infliximab|infliximab|mesh-list
6004071|NCT00254982|Dermatologic Agents|dermatologic agents|mesh-ancestor
6004072|NCT00254982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6004073|NCT00254982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6004074|NCT00255008|Ribavirin|ribavirin|mesh-list
6004075|NCT00255008|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6004076|NCT00255008|Interferon-alpha|interferon-alpha|mesh-list
6004077|NCT00255008|Antimetabolites|antimetabolites|mesh-ancestor
6004078|NCT00255008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004079|NCT00255008|Antiviral Agents|antiviral agents|mesh-ancestor
6004080|NCT00255008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6004081|NCT00255008|Immunologic Factors|immunologic factors|mesh-ancestor
6004082|NCT00255008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004083|NCT00255034|Ribavirin|ribavirin|mesh-list
6004084|NCT00255034|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6004085|NCT00255034|Interferon-alpha|interferon-alpha|mesh-list
6004086|NCT00255034|Antimetabolites|antimetabolites|mesh-ancestor
6004087|NCT00255034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004088|NCT00255034|Antiviral Agents|antiviral agents|mesh-ancestor
6004089|NCT00255034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6004090|NCT00255034|Immunologic Factors|immunologic factors|mesh-ancestor
6004091|NCT00255034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004092|NCT00255086|Memantine|memantine|mesh-list
6004093|NCT00255086|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6004094|NCT00255086|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6004095|NCT00255086|Dopamine Agents|dopamine agents|mesh-ancestor
6004096|NCT00255086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6004097|NCT00255086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004098|NCT00255086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004099|NCT00255086|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6004100|NCT00255086|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6004101|NCT00255151|Dexlansoprazole|dexlansoprazole|mesh-list
6004102|NCT00255151|Lansoprazole|lansoprazole|mesh-list
6004103|NCT00255151|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6004104|NCT00255151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6004105|NCT00255151|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6004106|NCT00255151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6004107|NCT00255151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004108|NCT00255164|Dexlansoprazole|dexlansoprazole|mesh-list
6004109|NCT00255164|Lansoprazole|lansoprazole|mesh-list
6004110|NCT00255164|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6004111|NCT00255164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6004112|NCT00255164|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6004113|NCT00255164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6004114|NCT00255164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004115|NCT00255177|Mifepristone|mifepristone|mesh-list
6004116|NCT00255177|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6004117|NCT00255177|Abortifacient Agents|abortifacient agents|mesh-ancestor
6004118|NCT00255177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6004119|NCT00255177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004120|NCT00255177|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6004121|NCT00255177|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6004122|NCT00255177|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6004123|NCT00255177|Contraceptive Agents|contraceptive agents|mesh-ancestor
6004124|NCT00255177|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6004125|NCT00255177|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6004126|NCT00255177|Hormone Antagonists|hormone antagonists|mesh-ancestor
6004127|NCT00255177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6004128|NCT00255177|Luteolytic Agents|luteolytic agents|mesh-ancestor
6004129|NCT00255177|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6004130|NCT00255177|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6004131|NCT00255190|Dexlansoprazole|dexlansoprazole|mesh-list
6004132|NCT00255190|Lansoprazole|lansoprazole|mesh-list
6004133|NCT00255190|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6004134|NCT00255190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6004135|NCT00255190|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6004136|NCT00255190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6004137|NCT00255190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004138|NCT00255346|Dasatinib|dasatinib|mesh-list
6004139|NCT00255346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6004140|NCT00255346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6004141|NCT00255346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6004142|NCT00255346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004143|NCT00255684|Cyclosporine|cyclosporine|mesh-list
6004144|NCT00255684|Mycophenolic Acid|mycophenolic acid|mesh-list
6004145|NCT00255684|Cyclophosphamide|cyclophosphamide|mesh-list
6004146|NCT00255684|Fludarabine|fludarabine|mesh-list
6004147|NCT00255684|Fludarabine phosphate|fludarabine phosphate|mesh-list
6004148|NCT00255684|Cyclosporins|cyclosporins|mesh-list
6004149|NCT00255684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6004150|NCT00255684|Immunologic Factors|immunologic factors|mesh-ancestor
6004151|NCT00255684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004152|NCT00255684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6004153|NCT00255684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6004154|NCT00255684|Alkylating Agents|alkylating agents|mesh-ancestor
6004155|NCT00255684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004156|NCT00255684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6004157|NCT00255684|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6004158|NCT00255684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6004159|NCT00255684|Antimetabolites|antimetabolites|mesh-ancestor
6004160|NCT00255684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6004161|NCT00255684|Antifungal Agents|antifungal agents|mesh-ancestor
6004162|NCT00255684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6004163|NCT00255684|Dermatologic Agents|dermatologic agents|mesh-ancestor
6004164|NCT00255684|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6004165|NCT00255684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6004166|NCT00255684|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6004167|NCT00255684|Antitubercular Agents|antitubercular agents|mesh-ancestor
6004168|NCT00255684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6004169|NCT00255723|Carboplatin|carboplatin|mesh-list
6004170|NCT00255723|Etoposide|etoposide|mesh-list
6004171|NCT00255723|Ifosfamide|ifosfamide|mesh-list
6004172|NCT00255723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6004173|NCT00255723|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6004174|NCT00255723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6004175|NCT00255723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6004176|NCT00255723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6004177|NCT00255723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004178|NCT00255723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6004179|NCT00255723|Alkylating Agents|alkylating agents|mesh-ancestor
6004180|NCT00255801|Doxorubicin|doxorubicin|mesh-list
6004181|NCT00255801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6004182|NCT00255801|Bexarotene|bexarotene|mesh-list
6004183|NCT00255801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6004184|NCT00255801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6004185|NCT00255801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6004186|NCT00255801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6004187|NCT00255801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6004188|NCT00255801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004189|NCT00255840|Ritonavir|ritonavir|mesh-list
6004190|NCT00255840|Lopinavir|lopinavir|mesh-list
6004191|NCT00255840|Lamivudine|lamivudine|mesh-list
6004192|NCT00255840|Nevirapine|nevirapine|mesh-list
6004193|NCT00255840|Stavudine|stavudine|mesh-list
6004194|NCT00255840|Efavirenz|efavirenz|mesh-list
6004195|NCT00255840|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6004196|NCT00255840|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6004197|NCT00255840|Protease Inhibitors|protease inhibitors|mesh-ancestor
6004198|NCT00255840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6004199|NCT00255840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004200|NCT00255840|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6004201|NCT00255840|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6004202|NCT00255840|Antiviral Agents|antiviral agents|mesh-ancestor
6004203|NCT00255840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6004204|NCT00255840|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6004205|NCT00255840|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6004206|NCT00255840|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6004207|NCT00255840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6004208|NCT00255840|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6004209|NCT00255840|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6004210|NCT00255840|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6004211|NCT00255840|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6004212|NCT00255840|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6004213|NCT00255840|Antimetabolites|antimetabolites|mesh-ancestor
6004214|NCT00256204|Rasagiline|rasagiline|mesh-list
6004215|NCT00256204|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6004216|NCT00256204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6004217|NCT00256204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004218|NCT00256204|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6004219|NCT00256204|Protective Agents|protective agents|mesh-ancestor
6004220|NCT00256204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004221|NCT00256217|Anastrozole|anastrozole|mesh-list
6004222|NCT00256217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6004223|NCT00256217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6004224|NCT00256217|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6004225|NCT00256217|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6004226|NCT00256217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6004227|NCT00256217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004228|NCT00256217|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6004229|NCT00256217|Hormone Antagonists|hormone antagonists|mesh-ancestor
6004230|NCT00256217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6004231|NCT00256217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004232|NCT00256243|Paclitaxel|paclitaxel|mesh-list
6004233|NCT00256243|Cyclophosphamide|cyclophosphamide|mesh-list
6004234|NCT00256243|Carboplatin|carboplatin|mesh-list
6004235|NCT00256243|Doxorubicin|doxorubicin|mesh-list
6004236|NCT00256243|Trastuzumab|trastuzumab|mesh-list
6004237|NCT00256243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6004238|NCT00256243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6004239|NCT00256243|Tubulin Modulators|tubulin modulators|mesh-ancestor
6004240|NCT00256243|Antimitotic Agents|antimitotic agents|mesh-ancestor
6004241|NCT00256243|Mitosis Modulators|mitosis modulators|mesh-ancestor
6004242|NCT00256243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004243|NCT00256243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6004244|NCT00256243|Immunologic Factors|immunologic factors|mesh-ancestor
6004245|NCT00256243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004246|NCT00256243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6004247|NCT00256243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6004248|NCT00256243|Alkylating Agents|alkylating agents|mesh-ancestor
6004249|NCT00256243|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6004250|NCT00256243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6004251|NCT00256243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6004252|NCT00256243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6004253|NCT00256243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6004254|NCT00256243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6004255|NCT00256282|Docetaxel|docetaxel|mesh-list
6004256|NCT00256282|Vinorelbine|vinorelbine|mesh-list
6004257|NCT00256282|Sargramostim|sargramostim|mesh-list
6004258|NCT00256282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6004259|NCT00256282|Tubulin Modulators|tubulin modulators|mesh-ancestor
6004260|NCT00256282|Antimitotic Agents|antimitotic agents|mesh-ancestor
6004261|NCT00256282|Mitosis Modulators|mitosis modulators|mesh-ancestor
6004262|NCT00256282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004263|NCT00256282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6004264|NCT00256282|Immunologic Factors|immunologic factors|mesh-ancestor
6004265|NCT00256282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004266|NCT00256308|Oxaliplatin|oxaliplatin|mesh-list
6004267|NCT00256308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6004268|NCT00256451|Ethanol|ethanol|mesh-list
6004269|NCT00256451|Naltrexone|naltrexone|mesh-list
6004270|NCT00256451|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6004271|NCT00256451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6004272|NCT00256451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6004273|NCT00256451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004274|NCT00256451|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6004275|NCT00256451|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6004276|NCT00256451|Sensory System Agents|sensory system agents|mesh-ancestor
6004277|NCT00256451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6004278|NCT00256698|Fulvestrant|fulvestrant|mesh-list
6004279|NCT00256698|Anastrozole|anastrozole|mesh-list
6004280|NCT00256698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6004281|NCT00256698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6004282|NCT00256698|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6004283|NCT00256698|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6004284|NCT00256698|Hormone Antagonists|hormone antagonists|mesh-ancestor
6004285|NCT00256698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6004286|NCT00256698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004287|NCT00256698|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6004288|NCT00256698|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6004289|NCT00256698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6004290|NCT00256698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004291|NCT00256750|Cyclosporine|cyclosporine|mesh-list
6004292|NCT00256750|Abatacept|abatacept|mesh-list
6004293|NCT00256750|Cyclosporins|cyclosporins|mesh-list
6004294|NCT00256750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6004295|NCT00256750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004296|NCT00256750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6004297|NCT00256750|Immunologic Factors|immunologic factors|mesh-ancestor
6004298|NCT00256750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004299|NCT00256750|Antifungal Agents|antifungal agents|mesh-ancestor
6004300|NCT00256750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6004301|NCT00256750|Dermatologic Agents|dermatologic agents|mesh-ancestor
6004302|NCT00256750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6004303|NCT00256750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6004304|NCT00256750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6004305|NCT00256750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6004306|NCT00256776|Thalidomide|thalidomide|mesh-list
6004307|NCT00256776|Dexamethasone|dexamethasone|mesh-list
6004308|NCT00256776|Bortezomib|bortezomib|mesh-list
6004309|NCT00256776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6004310|NCT00256776|Antiemetics|antiemetics|mesh-ancestor
6004311|NCT00256776|Autonomic Agents|autonomic agents|mesh-ancestor
6004312|NCT00256776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6004313|NCT00256776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004314|NCT00256776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6004315|NCT00256776|Glucocorticoids|glucocorticoids|mesh-ancestor
6004316|NCT00256776|Hormones|hormones|mesh-ancestor
6004317|NCT00256776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6004318|NCT00256776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6004319|NCT00256776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6004320|NCT00256776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6004321|NCT00256776|Immunologic Factors|immunologic factors|mesh-ancestor
6004322|NCT00256776|Leprostatic Agents|leprostatic agents|mesh-ancestor
6004323|NCT00256776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6004324|NCT00256776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6004325|NCT00256776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6004326|NCT00256776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6004327|NCT00256776|Growth Substances|growth substances|mesh-ancestor
6004328|NCT00256776|Growth Inhibitors|growth inhibitors|mesh-ancestor
6004329|NCT00256854|Ropinirole|ropinirole|mesh-list
6004330|NCT00256854|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6004331|NCT00256854|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6004332|NCT00256854|Dopamine Agonists|dopamine agonists|mesh-ancestor
6004333|NCT00256854|Dopamine Agents|dopamine agents|mesh-ancestor
6004334|NCT00256854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6004335|NCT00256854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004336|NCT00256854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018080|NCT00377962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6018081|NCT00378014|Everolimus|everolimus|mesh-list
6018082|NCT00378014|Basiliximab|basiliximab|mesh-list
6018083|NCT00378014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6018084|NCT00378014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6018085|NCT00378014|Immunologic Factors|immunologic factors|mesh-ancestor
6018086|NCT00378014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018087|NCT00378079|Methadone|methadone|mesh-list
6018088|NCT00378079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6018089|NCT00378079|Narcotics|narcotics|mesh-ancestor
6018090|NCT00378079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6018091|NCT00378079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018092|NCT00378079|Analgesics|analgesics|mesh-ancestor
6018093|NCT00378079|Sensory System Agents|sensory system agents|mesh-ancestor
6018094|NCT00378079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6018095|NCT00378079|Antitussive Agents|antitussive agents|mesh-ancestor
6018096|NCT00378079|Respiratory System Agents|respiratory system agents|mesh-ancestor
6018097|NCT00378105|Dexamethasone|dexamethasone|mesh-list
6018098|NCT00378105|Lenalidomide|lenalidomide|mesh-list
6018099|NCT00378105|Bortezomib|bortezomib|mesh-list
6018100|NCT00378105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6018101|NCT00378105|Antiemetics|antiemetics|mesh-ancestor
6018102|NCT00378105|Autonomic Agents|autonomic agents|mesh-ancestor
6018103|NCT00378105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6018104|NCT00378105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018105|NCT00378105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6018106|NCT00378105|Glucocorticoids|glucocorticoids|mesh-ancestor
6018107|NCT00378105|Hormones|hormones|mesh-ancestor
6018108|NCT00378105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6018109|NCT00378105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6018110|NCT00378105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6018111|NCT00378105|Immunologic Factors|immunologic factors|mesh-ancestor
6018112|NCT00378105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6018113|NCT00378105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6018114|NCT00378105|Growth Substances|growth substances|mesh-ancestor
6018115|NCT00378105|Growth Inhibitors|growth inhibitors|mesh-ancestor
6018116|NCT00378209|Dexamethasone|dexamethasone|mesh-list
6018117|NCT00378209|Lenalidomide|lenalidomide|mesh-list
6018118|NCT00378209|Bortezomib|bortezomib|mesh-list
6018119|NCT00378209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6018120|NCT00378209|Antiemetics|antiemetics|mesh-ancestor
6018121|NCT00378209|Autonomic Agents|autonomic agents|mesh-ancestor
6018122|NCT00378209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6018123|NCT00378209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018124|NCT00378209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6018125|NCT00378209|Glucocorticoids|glucocorticoids|mesh-ancestor
6018126|NCT00378209|Hormones|hormones|mesh-ancestor
6018127|NCT00378209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6018128|NCT00378209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6018129|NCT00378209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6018130|NCT00378209|Immunologic Factors|immunologic factors|mesh-ancestor
6018131|NCT00378209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6018132|NCT00378209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6018133|NCT00378209|Growth Substances|growth substances|mesh-ancestor
6018134|NCT00378209|Growth Inhibitors|growth inhibitors|mesh-ancestor
6260341|NCT03155178|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6260342|NCT03155178|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6260343|NCT03155178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6260344|NCT03155178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6260345|NCT03155178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018135|NCT00378326|Tacrolimus|tacrolimus|mesh-list
6018136|NCT00378326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6018137|NCT00378326|Immunologic Factors|immunologic factors|mesh-ancestor
6004337|NCT00256997|Risperidone|risperidone|mesh-list
6004338|NCT00256997|Antipsychotic Agents|antipsychotic agents|mesh-list
6004339|NCT00256997|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6004340|NCT00256997|Serotonin Agents|serotonin agents|mesh-ancestor
6004341|NCT00256997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6004342|NCT00256997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004343|NCT00256997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004344|NCT00256997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6004345|NCT00256997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6004346|NCT00256997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6004347|NCT00256997|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6004348|NCT00256997|Dopamine Agents|dopamine agents|mesh-ancestor
6004349|NCT00257010|Almotriptan|almotriptan|mesh-list
6004350|NCT00257010|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6004351|NCT00257010|Serotonin Agents|serotonin agents|mesh-ancestor
6004352|NCT00257010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6004353|NCT00257010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004354|NCT00257010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004355|NCT00257166|Ziprasidone|ziprasidone|mesh-list
6004356|NCT00257166|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6004357|NCT00257166|Serotonin Agents|serotonin agents|mesh-ancestor
6004358|NCT00257166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6004359|NCT00257166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004360|NCT00257166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004361|NCT00257166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6004362|NCT00257166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6004363|NCT00257166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6004364|NCT00257166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6004365|NCT00257166|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6004366|NCT00257166|Dopamine Agents|dopamine agents|mesh-ancestor
6004367|NCT00257192|Ziprasidone|ziprasidone|mesh-list
6004368|NCT00257192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6004369|NCT00257192|Serotonin Agents|serotonin agents|mesh-ancestor
6004370|NCT00257192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6004371|NCT00257192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004372|NCT00257192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004373|NCT00257192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6004374|NCT00257192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6004375|NCT00257192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6004376|NCT00257192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6004377|NCT00257192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6004378|NCT00257192|Dopamine Agents|dopamine agents|mesh-ancestor
6004379|NCT00257309|Tenecteplase|tenecteplase|mesh-list
6004380|NCT00257309|Clopidogrel|clopidogrel|mesh-list
6004381|NCT00257309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6004382|NCT00257309|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6004383|NCT00257309|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6004384|NCT00257309|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6004385|NCT00257309|Purinergic Agents|purinergic agents|mesh-ancestor
6004386|NCT00257309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6004387|NCT00257309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004388|NCT00257309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004389|NCT00257309|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6004390|NCT00257309|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6004391|NCT00257556|Menotropins|menotropins|mesh-list
6004392|NCT00257556|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6004393|NCT00257556|Hormones|hormones|mesh-ancestor
6004394|NCT00257556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6004395|NCT00257556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004396|NCT00257556|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6004397|NCT00257556|Fertility Agents|fertility agents|mesh-ancestor
6004398|NCT00257556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6004399|NCT00257608|Bevacizumab|bevacizumab|mesh-list
6004400|NCT00257608|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6004401|NCT00257608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6004402|NCT00257608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6004403|NCT00257608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6004404|NCT00257608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6004405|NCT00257608|Growth Substances|growth substances|mesh-ancestor
6004406|NCT00257608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004407|NCT00257608|Growth Inhibitors|growth inhibitors|mesh-ancestor
6004408|NCT00257608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6004409|NCT00257608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6018138|NCT00378326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004410|NCT00257608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004411|NCT00257660|Botulinum Toxins|botulinum toxins|mesh-list
6004412|NCT00257660|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6004413|NCT00257660|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6004414|NCT00257660|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6004415|NCT00257660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6004416|NCT00257660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004417|NCT00257660|Cholinergic Agents|cholinergic agents|mesh-ancestor
6004418|NCT00257660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6004419|NCT00257660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004420|NCT00257660|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6004421|NCT00257660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6004422|NCT00257686|Pravastatin|pravastatin|mesh-list
6004423|NCT00257686|Pitavastatin|pitavastatin|mesh-list
6004424|NCT00257686|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6004425|NCT00257686|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6004426|NCT00257686|Antimetabolites|antimetabolites|mesh-ancestor
6004427|NCT00257686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004428|NCT00257686|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6004429|NCT00257686|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6004430|NCT00257686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6004431|NCT00257725|Methylphenidate|methylphenidate|mesh-list
6004432|NCT00257725|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6004433|NCT00257725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004434|NCT00257725|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6004435|NCT00257725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6004436|NCT00257725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6004437|NCT00257725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004438|NCT00257725|Dopamine Agents|dopamine agents|mesh-ancestor
6004439|NCT00257725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6004440|NCT00257894|Baclofen|baclofen|mesh-list
6004441|NCT00257894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004442|NCT00257894|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6004443|NCT00257894|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6004444|NCT00257894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6004445|NCT00257894|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6004446|NCT00257894|GABA Agonists|gaba agonists|mesh-ancestor
6004447|NCT00257894|GABA Agents|gaba agents|mesh-ancestor
6004448|NCT00257894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6004449|NCT00257894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004450|NCT00257920|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
6004451|NCT00257920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004452|NCT00257920|Vitamins|vitamins|mesh-ancestor
6004453|NCT00257920|Micronutrients|micronutrients|mesh-ancestor
6004454|NCT00257920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6004455|NCT00257933|Prednisolone|prednisolone|mesh-list
6004456|NCT00257933|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6004457|NCT00257933|Methylprednisolone|methylprednisolone|mesh-list
6004458|NCT00257933|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6004459|NCT00257933|Prednisolone acetate|prednisolone acetate|mesh-list
6004460|NCT00257933|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6004461|NCT00257933|Prednisolone phosphate|prednisolone phosphate|mesh-list
6004462|NCT00257933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6004463|NCT00257933|Glucocorticoids|glucocorticoids|mesh-ancestor
6004464|NCT00257933|Hormones|hormones|mesh-ancestor
6004465|NCT00257933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6004466|NCT00257933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004467|NCT00257933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6004468|NCT00257933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6004469|NCT00257933|Antiemetics|antiemetics|mesh-ancestor
6004470|NCT00257933|Autonomic Agents|autonomic agents|mesh-ancestor
6004471|NCT00257933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6004472|NCT00257933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6004473|NCT00257933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6004474|NCT00257933|Protective Agents|protective agents|mesh-ancestor
6004475|NCT00258128|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
6004476|NCT00258128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6004477|NCT00258128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6004478|NCT00258128|Analgesics|analgesics|mesh-ancestor
6004479|NCT00258128|Sensory System Agents|sensory system agents|mesh-ancestor
6004480|NCT00258128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6004481|NCT00258128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004482|NCT00258128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6004483|NCT00258128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6004484|NCT00258180|Cyclophosphamide|cyclophosphamide|mesh-list
6004485|NCT00258180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6004486|NCT00258180|Immunologic Factors|immunologic factors|mesh-ancestor
6004487|NCT00258180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004488|NCT00258180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6004489|NCT00258180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6004490|NCT00258180|Alkylating Agents|alkylating agents|mesh-ancestor
6004491|NCT00258180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004492|NCT00258180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6004493|NCT00258180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6004494|NCT00258206|Cyclophosphamide|cyclophosphamide|mesh-list
6004495|NCT00258206|Rituximab|rituximab|mesh-list
6004496|NCT00258206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6004497|NCT00258206|Immunologic Factors|immunologic factors|mesh-ancestor
6260346|NCT03155178|Disinfectants|disinfectants|mesh-ancestor
6260347|NCT03155178|Dermatologic Agents|dermatologic agents|mesh-ancestor
6260348|NCT03157089|Pembrolizumab|pembrolizumab|mesh-list
6260349|NCT03157089|Afatinib|afatinib|mesh-list
6260350|NCT03157089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6004498|NCT00258206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004499|NCT00258206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6004500|NCT00258206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6004501|NCT00258206|Alkylating Agents|alkylating agents|mesh-ancestor
6004502|NCT00258206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004503|NCT00258206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6004504|NCT00258206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6004505|NCT00258206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6004506|NCT00258310|Capecitabine|capecitabine|mesh-list
6004507|NCT00258310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6004508|NCT00258310|Antimetabolites|antimetabolites|mesh-ancestor
6004509|NCT00258310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004510|NCT00258310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6004511|NCT00258349|Trastuzumab|trastuzumab|mesh-list
6004512|NCT00258349|Vorinostat|vorinostat|mesh-list
6004513|NCT00258349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6004514|NCT00258349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6004515|NCT00258349|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6004516|NCT00258349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6004517|NCT00258349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004518|NCT00258362|Carboplatin|carboplatin|mesh-list
6004519|NCT00258362|Docetaxel|docetaxel|mesh-list
6004520|NCT00258362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6004521|NCT00258362|Tubulin Modulators|tubulin modulators|mesh-ancestor
6004522|NCT00258362|Antimitotic Agents|antimitotic agents|mesh-ancestor
6004523|NCT00258362|Mitosis Modulators|mitosis modulators|mesh-ancestor
6004524|NCT00258362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004525|NCT00258440|Epoetin Alfa|epoetin alfa|mesh-list
6004526|NCT00258440|Hematinics|hematinics|mesh-ancestor
6004527|NCT00258817|Vaccines|vaccines|mesh-list
6004528|NCT00258817|Immunologic Factors|immunologic factors|mesh-ancestor
6004529|NCT00258817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004530|NCT00258830|Vaccines|vaccines|mesh-list
6004531|NCT00258830|Immunologic Factors|immunologic factors|mesh-ancestor
6004532|NCT00258830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260351|NCT03157089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6260352|NCT03157089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6260353|NCT03157089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6260354|NCT03157089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260355|NCT03157583|Sunscreening Agents|sunscreening agents|mesh-list
6260356|NCT03157583|Glycerol|glycerol|mesh-list
6260357|NCT03157583|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6260358|NCT03157583|Protective Agents|protective agents|mesh-ancestor
6260359|NCT03157583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260360|NCT03157583|Dermatologic Agents|dermatologic agents|mesh-ancestor
6260361|NCT03157583|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6260362|NCT03158116|Aztreonam|aztreonam|mesh-list
6260363|NCT03158116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6260364|NCT03158116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6260365|NCT03158220|Vaccines|vaccines|mesh-list
6260366|NCT03158220|Immunologic Factors|immunologic factors|mesh-ancestor
6260367|NCT03158220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260368|NCT03158272|Nivolumab|nivolumab|mesh-list
6260369|NCT03158272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6004533|NCT00258856|Vaccines|vaccines|mesh-list
6004534|NCT00258856|Immunologic Factors|immunologic factors|mesh-ancestor
6004535|NCT00258856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004536|NCT00258960|Cyclophosphamide|cyclophosphamide|mesh-list
6004537|NCT00258960|Doxorubicin|doxorubicin|mesh-list
6004538|NCT00258960|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6004539|NCT00258960|Trastuzumab|trastuzumab|mesh-list
6004540|NCT00258960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6004541|NCT00258960|Immunologic Factors|immunologic factors|mesh-ancestor
6004542|NCT00258960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004543|NCT00258960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6004544|NCT00258960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6004545|NCT00258960|Alkylating Agents|alkylating agents|mesh-ancestor
6004546|NCT00258960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004547|NCT00258960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6004548|NCT00258960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6004549|NCT00258960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6004550|NCT00258960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6004551|NCT00258960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6004552|NCT00258960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6004553|NCT00258960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6004554|NCT00259012|Pantoprazole|pantoprazole|mesh-list
6004555|NCT00259012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6004556|NCT00259012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6004557|NCT00259012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6004558|NCT00259012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6004559|NCT00259012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004560|NCT00259090|Fulvestrant|fulvestrant|mesh-list
6004561|NCT00259090|Anastrozole|anastrozole|mesh-list
6004562|NCT00259090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6004563|NCT00259090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6004564|NCT00259090|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6004565|NCT00259090|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6004566|NCT00259090|Hormone Antagonists|hormone antagonists|mesh-ancestor
6004567|NCT00259090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6004568|NCT00259090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004569|NCT00259090|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6004570|NCT00259090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6004571|NCT00259090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6004572|NCT00259090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004573|NCT00259272|Olanzapine|olanzapine|mesh-list
6004574|NCT00259272|Antiemetics|antiemetics|mesh-ancestor
6004575|NCT00259272|Autonomic Agents|autonomic agents|mesh-ancestor
6004576|NCT00259272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6004577|NCT00259272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004578|NCT00259272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6004579|NCT00259272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6004580|NCT00259272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6004581|NCT00259272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6004582|NCT00259272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6536462|NCT00817011|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6004583|NCT00259272|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6004584|NCT00259272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6004585|NCT00259272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6004586|NCT00259272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004587|NCT00259272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6004588|NCT00259272|Serotonin Agents|serotonin agents|mesh-ancestor
6004589|NCT00259285|Pemetrexed|pemetrexed|mesh-list
6004590|NCT00259285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6004591|NCT00259285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6004592|NCT00259285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004593|NCT00259285|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6004594|NCT00259285|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6004595|NCT00259298|Teriparatide|teriparatide|mesh-list
6004596|NCT00259298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6004597|NCT00259298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004598|NCT00259298|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6004599|NCT00259610|Hydroxychloroquine|hydroxychloroquine|mesh-list
6004600|NCT00259610|Sulfasalazine|sulfasalazine|mesh-list
6004601|NCT00259610|Etanercept|etanercept|mesh-list
6004602|NCT00259610|Methotrexate|methotrexate|mesh-list
6004603|NCT00259610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6004604|NCT00259610|Abortifacient Agents|abortifacient agents|mesh-ancestor
6004605|NCT00259610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6004606|NCT00259610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004607|NCT00259610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6004608|NCT00259610|Antimetabolites|antimetabolites|mesh-ancestor
6004609|NCT00259610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004610|NCT00259610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6004611|NCT00259610|Dermatologic Agents|dermatologic agents|mesh-ancestor
6004612|NCT00259610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6004613|NCT00259610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6004614|NCT00259610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6004615|NCT00259610|Immunologic Factors|immunologic factors|mesh-ancestor
6004616|NCT00259610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6004617|NCT00259610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6004618|NCT00259610|Antimalarials|antimalarials|mesh-ancestor
6004619|NCT00259610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6004620|NCT00259610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6004621|NCT00259610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6004622|NCT00259610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6004623|NCT00259610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6004624|NCT00259610|Analgesics|analgesics|mesh-ancestor
6004625|NCT00259610|Sensory System Agents|sensory system agents|mesh-ancestor
6004626|NCT00259610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6004627|NCT00259610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6004628|NCT00259610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6004629|NCT00259649|Eletriptan|eletriptan|mesh-list
6004630|NCT00259649|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6004631|NCT00259649|Serotonin Agents|serotonin agents|mesh-ancestor
6004632|NCT00259649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6004633|NCT00259649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004634|NCT00259649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004635|NCT00259740|Denosumab|denosumab|mesh-list
6004636|NCT00259740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6004637|NCT00259740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004638|NCT00259857|Alendronate|alendronate|mesh-list
6004639|NCT00259857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6004640|NCT00259857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004641|NCT00260065|Decitabine|decitabine|mesh-list
6004642|NCT00260065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6004643|NCT00260065|Antimetabolites|antimetabolites|mesh-ancestor
6004644|NCT00260065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004645|NCT00260065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6004646|NCT00260065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6004647|NCT00260208|Cyclosporine|cyclosporine|mesh-list
6004648|NCT00260208|Tacrolimus|tacrolimus|mesh-list
6004649|NCT00260208|Cyclosporins|cyclosporins|mesh-list
6004650|NCT00260208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6004651|NCT00260208|Immunologic Factors|immunologic factors|mesh-ancestor
6004652|NCT00260208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004653|NCT00260208|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6004654|NCT00260208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6004655|NCT00260208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004656|NCT00260208|Antifungal Agents|antifungal agents|mesh-ancestor
6004657|NCT00260208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6004658|NCT00260208|Dermatologic Agents|dermatologic agents|mesh-ancestor
6004659|NCT00260208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6004660|NCT00260533|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6004661|NCT00260533|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6004662|NCT00260533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6004663|NCT00260533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6004664|NCT00260533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004665|NCT00260533|Adrenergic Agents|adrenergic agents|mesh-ancestor
6004666|NCT00260533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6004667|NCT00260533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004668|NCT00260689|Cyclosporine|cyclosporine|mesh-list
6004669|NCT00260689|Alemtuzumab|alemtuzumab|mesh-list
6004670|NCT00260689|Cyclosporins|cyclosporins|mesh-list
6004671|NCT00260689|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6004672|NCT00260689|Thymoglobulin|thymoglobulin|mesh-list
6004673|NCT00260689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6004674|NCT00260689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004675|NCT00260689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6004676|NCT00260689|Immunologic Factors|immunologic factors|mesh-ancestor
6004677|NCT00260689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004678|NCT00260689|Antifungal Agents|antifungal agents|mesh-ancestor
6004679|NCT00260689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6004680|NCT00260689|Dermatologic Agents|dermatologic agents|mesh-ancestor
6004681|NCT00260689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6004682|NCT00260689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6004683|NCT00260689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6004684|NCT00260689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6004685|NCT00260832|Cytarabine|cytarabine|mesh-list
6004686|NCT00260832|Decitabine|decitabine|mesh-list
6004687|NCT00260832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6004688|NCT00260832|Antimetabolites|antimetabolites|mesh-ancestor
6004689|NCT00260832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004690|NCT00260832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6004691|NCT00260832|Antiviral Agents|antiviral agents|mesh-ancestor
6004692|NCT00260832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6004693|NCT00260832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6004694|NCT00260832|Immunologic Factors|immunologic factors|mesh-ancestor
6004695|NCT00260832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004696|NCT00260832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6004697|NCT00260962|Olanzapine|olanzapine|mesh-list
6004698|NCT00260962|Antiemetics|antiemetics|mesh-ancestor
6004699|NCT00260962|Autonomic Agents|autonomic agents|mesh-ancestor
6004700|NCT00260962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6004701|NCT00260962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004702|NCT00260962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6004703|NCT00260962|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6004704|NCT00260962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6004705|NCT00260962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6004706|NCT00260962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6004707|NCT00260962|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6004708|NCT00260962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6004709|NCT00260962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6004710|NCT00260962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004711|NCT00260962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6004712|NCT00260962|Serotonin Agents|serotonin agents|mesh-ancestor
6004713|NCT00261443|Valproic Acid|valproic acid|mesh-list
6004714|NCT00261443|Aripiprazole|aripiprazole|mesh-list
6004715|NCT00261443|Lithium Carbonate|lithium carbonate|mesh-list
6004716|NCT00261443|Antidepressive Agents|antidepressive agents|mesh-ancestor
6004717|NCT00261443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6004718|NCT00261443|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6004719|NCT00261443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6004720|NCT00261443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6004721|NCT00261443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004722|NCT00261443|Dopamine Agonists|dopamine agonists|mesh-ancestor
6004723|NCT00261443|Dopamine Agents|dopamine agents|mesh-ancestor
6004724|NCT00261443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6004725|NCT00261443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004726|NCT00261443|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6004727|NCT00261443|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6004728|NCT00261443|Serotonin Agents|serotonin agents|mesh-ancestor
6004729|NCT00261443|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6004730|NCT00261443|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6004731|NCT00261443|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6004732|NCT00261443|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6004733|NCT00261443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6004734|NCT00261443|Antimanic Agents|antimanic agents|mesh-ancestor
6004735|NCT00261443|Anticonvulsants|anticonvulsants|mesh-ancestor
6004736|NCT00261443|GABA Agents|gaba agents|mesh-ancestor
6004737|NCT00261495|Oxycodone|oxycodone|mesh-list
6004738|NCT00261495|Hydromorphone|hydromorphone|mesh-list
6004739|NCT00261495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6004740|NCT00261495|Narcotics|narcotics|mesh-ancestor
6004741|NCT00261495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6004742|NCT00261495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004743|NCT00261495|Analgesics|analgesics|mesh-ancestor
6004744|NCT00261495|Sensory System Agents|sensory system agents|mesh-ancestor
6004745|NCT00261495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6004746|NCT00261833|Protease Inhibitors|protease inhibitors|mesh-list
6004747|NCT00261833|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
6004748|NCT00261833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6004749|NCT00261833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004750|NCT00261833|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6004751|NCT00261833|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6004752|NCT00261950|Cinacalcet|cinacalcet|mesh-list
6004753|NCT00261950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6004754|NCT00261950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004755|NCT00261950|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6004756|NCT00261950|Hormone Antagonists|hormone antagonists|mesh-ancestor
6004757|NCT00261950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6004758|NCT00262002|Vaccines|vaccines|mesh-list
6004759|NCT00262002|Immunologic Factors|immunologic factors|mesh-ancestor
6004760|NCT00262002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004761|NCT00262028|Vaccines|vaccines|mesh-list
6004762|NCT00262028|Immunologic Factors|immunologic factors|mesh-ancestor
6004763|NCT00262028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004764|NCT00262041|Vaccines|vaccines|mesh-list
6004765|NCT00262041|Immunologic Factors|immunologic factors|mesh-ancestor
6004766|NCT00262041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004767|NCT00262067|Bevacizumab|bevacizumab|mesh-list
6004768|NCT00262067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6004769|NCT00262067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6004770|NCT00262067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6004771|NCT00262067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6004772|NCT00262067|Growth Substances|growth substances|mesh-ancestor
6004773|NCT00262067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004774|NCT00262067|Growth Inhibitors|growth inhibitors|mesh-ancestor
6004775|NCT00262080|Ecallantide|ecallantide|mesh-list
6004776|NCT00262080|Analgesics|analgesics|mesh-ancestor
6004777|NCT00262080|Sensory System Agents|sensory system agents|mesh-ancestor
6004778|NCT00262080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6004779|NCT00262080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004780|NCT00262080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6004781|NCT00262080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6004782|NCT00262080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6004783|NCT00262080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6004784|NCT00262223|Sertraline|sertraline|mesh-list
6004785|NCT00262223|Antidepressive Agents|antidepressive agents|mesh-ancestor
6004786|NCT00262223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6004787|NCT00262223|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6004788|NCT00262223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6004789|NCT00262223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6004790|NCT00262223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004791|NCT00262223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6004792|NCT00262223|Serotonin Agents|serotonin agents|mesh-ancestor
6004793|NCT00262223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004794|NCT00262301|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
6004795|NCT00262301|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6004796|NCT00262301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6260370|NCT03158272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6260371|NCT03158272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6260372|NCT03158272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260373|NCT03158311|Fluticasone|fluticasone|mesh-list
6260374|NCT03158311|Tiotropium Bromide|tiotropium bromide|mesh-list
6260375|NCT03158311|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6260376|NCT03158311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6260377|NCT03158311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6260378|NCT03158311|Autonomic Agents|autonomic agents|mesh-ancestor
6260379|NCT03158311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6260380|NCT03158311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260381|NCT03158311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6260382|NCT03158311|Respiratory System Agents|respiratory system agents|mesh-ancestor
6260383|NCT03158311|Dermatologic Agents|dermatologic agents|mesh-ancestor
6260384|NCT03158311|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6260385|NCT03158311|Parasympatholytics|parasympatholytics|mesh-ancestor
6260386|NCT03158311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6260387|NCT03158311|Cholinergic Agents|cholinergic agents|mesh-ancestor
6260388|NCT03158311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6260389|NCT03158311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260390|NCT03158311|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6260391|NCT03158311|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6260392|NCT03158311|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6260393|NCT03158311|Adrenergic Agents|adrenergic agents|mesh-ancestor
6260394|NCT03159143|Docetaxel|docetaxel|mesh-list
6260395|NCT03159143|Oxaliplatin|oxaliplatin|mesh-list
6260396|NCT03159143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6260397|NCT03159143|Tubulin Modulators|tubulin modulators|mesh-ancestor
6260398|NCT03159143|Antimitotic Agents|antimitotic agents|mesh-ancestor
6260399|NCT03159143|Mitosis Modulators|mitosis modulators|mesh-ancestor
6260400|NCT03159143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260401|NCT03159260|Allantoin|allantoin|mesh-list
6260402|NCT03159260|Dermatologic Agents|dermatologic agents|mesh-ancestor
6260403|NCT03160703|Fluorides|fluorides|mesh-list
6260404|NCT03160703|Tin Fluorides|tin fluorides|mesh-list
6260405|NCT03160703|Fluorophosphate|fluorophosphate|mesh-list
6260406|NCT03160703|Cariostatic Agents|cariostatic agents|mesh-ancestor
6260407|NCT03160703|Protective Agents|protective agents|mesh-ancestor
6260408|NCT03160703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260409|NCT03160716|Lidocaine|lidocaine|mesh-list
6260410|NCT03160716|Anesthetics, Local|anesthetics, local|mesh-ancestor
6260411|NCT03160716|Anesthetics|anesthetics|mesh-ancestor
6004797|NCT00262301|Immunologic Factors|immunologic factors|mesh-ancestor
6004798|NCT00262301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004799|NCT00262522|Ritonavir|ritonavir|mesh-list
6004800|NCT00262522|Lopinavir|lopinavir|mesh-list
6004801|NCT00262522|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
6004802|NCT00262522|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6004803|NCT00262522|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6004804|NCT00262522|Protease Inhibitors|protease inhibitors|mesh-ancestor
6004805|NCT00262522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6004806|NCT00262522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004807|NCT00262522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6004808|NCT00262522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6004809|NCT00262522|Antiviral Agents|antiviral agents|mesh-ancestor
6004810|NCT00262522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6004811|NCT00262522|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6004812|NCT00262522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6004813|NCT00262522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6004814|NCT00262600|Warfarin|warfarin|mesh-list
6004815|NCT00262600|Dabigatran|dabigatran|mesh-list
6004816|NCT00262600|Anticoagulants|anticoagulants|mesh-ancestor
6004817|NCT00262600|Antithrombins|antithrombins|mesh-ancestor
6004818|NCT00262600|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6004819|NCT00262600|Protease Inhibitors|protease inhibitors|mesh-ancestor
6004820|NCT00262600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6004821|NCT00262600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004822|NCT00262639|Gabapentin|gabapentin|mesh-list
6004823|NCT00262639|Flumazenil|flumazenil|mesh-list
6004824|NCT00262639|Analgesics|analgesics|mesh-ancestor
6004825|NCT00262639|Sensory System Agents|sensory system agents|mesh-ancestor
6004826|NCT00262639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6004827|NCT00262639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004828|NCT00262639|Anticonvulsants|anticonvulsants|mesh-ancestor
6004829|NCT00262639|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6004830|NCT00262639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6004831|NCT00262639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6004832|NCT00262639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6004833|NCT00262639|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6004834|NCT00262639|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6004835|NCT00262639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6004836|NCT00262639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004837|NCT00262639|Antimanic Agents|antimanic agents|mesh-ancestor
6004838|NCT00262639|Antidotes|antidotes|mesh-ancestor
6004839|NCT00262639|Protective Agents|protective agents|mesh-ancestor
6004840|NCT00262639|GABA Modulators|gaba modulators|mesh-ancestor
6004841|NCT00262639|GABA Agents|gaba agents|mesh-ancestor
6004842|NCT00262730|Temozolomide|temozolomide|mesh-list
6004843|NCT00262730|Poly ICLC|poly iclc|mesh-list
6004844|NCT00262730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6004845|NCT00262730|Alkylating Agents|alkylating agents|mesh-ancestor
6004846|NCT00262730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004847|NCT00262730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6004848|NCT00262730|Interferon Inducers|interferon inducers|mesh-ancestor
6004849|NCT00262730|Immunologic Factors|immunologic factors|mesh-ancestor
6004850|NCT00262730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004851|NCT00262821|Tirapazamine|tirapazamine|mesh-list
6004852|NCT00262821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6004853|NCT00262834|Vorinostat|vorinostat|mesh-list
6004854|NCT00262834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6004855|NCT00262834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6004856|NCT00262834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6004857|NCT00262834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004858|NCT00262847|Paclitaxel|paclitaxel|mesh-list
6004859|NCT00262847|Bevacizumab|bevacizumab|mesh-list
6004860|NCT00262847|Carboplatin|carboplatin|mesh-list
6004861|NCT00262847|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6004862|NCT00262847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6004863|NCT00262847|Endothelial Growth Factors|endothelial growth factors|mesh-list
6004864|NCT00262847|Antibodies|antibodies|mesh-list
6004865|NCT00262847|Immunoglobulins|immunoglobulins|mesh-list
6004866|NCT00262847|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6004867|NCT00262847|Immunoglobulin G|immunoglobulin g|mesh-list
6004868|NCT00262847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6004869|NCT00262847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6004870|NCT00262847|Tubulin Modulators|tubulin modulators|mesh-ancestor
6004871|NCT00262847|Antimitotic Agents|antimitotic agents|mesh-ancestor
6004872|NCT00262847|Mitosis Modulators|mitosis modulators|mesh-ancestor
6004873|NCT00262847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004874|NCT00262847|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6004875|NCT00262847|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6004876|NCT00262847|Growth Substances|growth substances|mesh-ancestor
6004877|NCT00262847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004878|NCT00262847|Growth Inhibitors|growth inhibitors|mesh-ancestor
6004879|NCT00262847|Immunologic Factors|immunologic factors|mesh-ancestor
6004880|NCT00262860|Gemcitabine|gemcitabine|mesh-list
6004881|NCT00262860|Bortezomib|bortezomib|mesh-list
6004882|NCT00262860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6004883|NCT00262860|Antimetabolites|antimetabolites|mesh-ancestor
6004884|NCT00262860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004885|NCT00262860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6004886|NCT00262860|Antiviral Agents|antiviral agents|mesh-ancestor
6004887|NCT00262860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6004888|NCT00262860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6004889|NCT00262860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6004890|NCT00262860|Immunologic Factors|immunologic factors|mesh-ancestor
6004891|NCT00262860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004892|NCT00262873|Bortezomib|bortezomib|mesh-list
6004893|NCT00262873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6004894|NCT00262925|Leucovorin|leucovorin|mesh-list
6004895|NCT00262925|Dexamethasone|dexamethasone|mesh-list
6004896|NCT00262925|Methotrexate|methotrexate|mesh-list
6004897|NCT00262925|Vincristine|vincristine|mesh-list
6004898|NCT00262925|Asparaginase|asparaginase|mesh-list
6004899|NCT00262925|Mercaptopurine|mercaptopurine|mesh-list
6004900|NCT00262925|Alemtuzumab|alemtuzumab|mesh-list
6004901|NCT00262925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6004902|NCT00262925|Antibodies|antibodies|mesh-list
6004903|NCT00262925|Immunoglobulins|immunoglobulins|mesh-list
6004904|NCT00262925|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6004905|NCT00262925|Levoleucovorin|levoleucovorin|mesh-list
6004906|NCT00262925|Immunologic Factors|immunologic factors|mesh-ancestor
6004907|NCT00262925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004908|NCT00262925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6004909|NCT00262925|Antiemetics|antiemetics|mesh-ancestor
6004910|NCT00262925|Autonomic Agents|autonomic agents|mesh-ancestor
6004911|NCT00262925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6004912|NCT00262925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6004913|NCT00262925|Glucocorticoids|glucocorticoids|mesh-ancestor
6004914|NCT00262925|Hormones|hormones|mesh-ancestor
6004915|NCT00262925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6004916|NCT00262925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6004917|NCT00262925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6004918|NCT00262925|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6004919|NCT00262925|Abortifacient Agents|abortifacient agents|mesh-ancestor
6004920|NCT00262925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6004921|NCT00262925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6004922|NCT00262925|Antimetabolites|antimetabolites|mesh-ancestor
6004923|NCT00262925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004924|NCT00262925|Dermatologic Agents|dermatologic agents|mesh-ancestor
6004925|NCT00262925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6004926|NCT00262925|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6004927|NCT00262925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6004928|NCT00262925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6004929|NCT00262925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6004930|NCT00262925|Antidotes|antidotes|mesh-ancestor
6004931|NCT00262925|Protective Agents|protective agents|mesh-ancestor
6004932|NCT00262925|Vitamin B Complex|vitamin b complex|mesh-ancestor
6004933|NCT00262925|Vitamins|vitamins|mesh-ancestor
6004934|NCT00262925|Micronutrients|micronutrients|mesh-ancestor
6004935|NCT00262925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6004936|NCT00262925|Tubulin Modulators|tubulin modulators|mesh-ancestor
6004937|NCT00262925|Antimitotic Agents|antimitotic agents|mesh-ancestor
6004938|NCT00262925|Mitosis Modulators|mitosis modulators|mesh-ancestor
6004939|NCT00262951|Interferons|interferons|mesh-list
6004940|NCT00262951|Interferon-alpha|interferon-alpha|mesh-list
6004941|NCT00262951|Interferon alpha-2|interferon alpha-2|mesh-list
6004942|NCT00262951|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
6004943|NCT00262951|Cisplatin|cisplatin|mesh-list
6004944|NCT00262951|Fluorouracil|fluorouracil|mesh-list
6004945|NCT00262951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6004946|NCT00262951|Antimetabolites|antimetabolites|mesh-ancestor
6004947|NCT00262951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004948|NCT00262951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6004949|NCT00262951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6004950|NCT00262951|Immunologic Factors|immunologic factors|mesh-ancestor
6004951|NCT00262951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004952|NCT00262951|Antiviral Agents|antiviral agents|mesh-ancestor
6004953|NCT00262951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6004954|NCT00262964|Niacin|niacin|mesh-list
6004955|NCT00262964|Fenofibrate|fenofibrate|mesh-list
6004956|NCT00262964|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6004957|NCT00262964|Antimetabolites|antimetabolites|mesh-ancestor
6004958|NCT00262964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004959|NCT00262964|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6004960|NCT00262964|Vasodilator Agents|vasodilator agents|mesh-ancestor
6004961|NCT00262964|Vitamin B Complex|vitamin b complex|mesh-ancestor
6004962|NCT00262964|Vitamins|vitamins|mesh-ancestor
6004963|NCT00262964|Micronutrients|micronutrients|mesh-ancestor
6004964|NCT00262964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004965|NCT00263211|Aspirin|aspirin|mesh-list
6004966|NCT00263211|Clopidogrel|clopidogrel|mesh-list
6004967|NCT00263211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6004968|NCT00263211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6004969|NCT00263211|Analgesics|analgesics|mesh-ancestor
6004970|NCT00263211|Sensory System Agents|sensory system agents|mesh-ancestor
6004971|NCT00263211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6004972|NCT00263211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004973|NCT00263211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6004974|NCT00263211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6004975|NCT00263211|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6004976|NCT00263211|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6004977|NCT00263211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004978|NCT00263211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6004979|NCT00263211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6004980|NCT00263211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6004981|NCT00263211|Antipyretics|antipyretics|mesh-ancestor
6004982|NCT00263211|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6004983|NCT00263211|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6004984|NCT00263211|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6004985|NCT00263211|Purinergic Agents|purinergic agents|mesh-ancestor
6004986|NCT00263211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6004987|NCT00263328|Tacrolimus|tacrolimus|mesh-list
6004988|NCT00263328|Tofacitinib|tofacitinib|mesh-list
6260412|NCT03160716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6260413|NCT03160716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260414|NCT03160716|Sensory System Agents|sensory system agents|mesh-ancestor
6260415|NCT03160716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6260416|NCT03160716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6260417|NCT03160716|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6260418|NCT03160716|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6260419|NCT03160716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6260420|NCT03160716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260421|NCT03161158|Diuretics|diuretics|mesh-list
6004989|NCT00263328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6004990|NCT00263328|Immunologic Factors|immunologic factors|mesh-ancestor
6004991|NCT00263328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6004992|NCT00263328|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6004993|NCT00263328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6004994|NCT00263328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6004995|NCT00263328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6004996|NCT00263575|Fentanyl|fentanyl|mesh-list
6004997|NCT00263575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6004998|NCT00263575|Narcotics|narcotics|mesh-ancestor
6004999|NCT00263575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6005000|NCT00263575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005001|NCT00263575|Analgesics|analgesics|mesh-ancestor
6005002|NCT00263575|Sensory System Agents|sensory system agents|mesh-ancestor
6005003|NCT00263575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6005004|NCT00263575|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6005005|NCT00263575|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6005006|NCT00263575|Anesthetics, General|anesthetics, general|mesh-ancestor
6005007|NCT00263575|Anesthetics|anesthetics|mesh-ancestor
6005008|NCT00263588|Lapatinib|lapatinib|mesh-list
6005009|NCT00263588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6005010|NCT00263588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6005011|NCT00263588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6005012|NCT00263588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005013|NCT00263887|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
6005014|NCT00263887|Protease Inhibitors|protease inhibitors|mesh-list
6005015|NCT00263887|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6005016|NCT00263887|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6005017|NCT00263887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6005018|NCT00263887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005019|NCT00264004|Cediranib|cediranib|mesh-list
6005020|NCT00264004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6005021|NCT00264004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6005022|NCT00264004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6005023|NCT00264004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005024|NCT00264238|Memantine|memantine|mesh-list
6005025|NCT00264238|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6005026|NCT00264238|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6005027|NCT00264238|Dopamine Agents|dopamine agents|mesh-ancestor
6005028|NCT00264238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6005029|NCT00264238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005030|NCT00264238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005031|NCT00264238|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6005032|NCT00264238|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6005033|NCT00264290|Valganciclovir|valganciclovir|mesh-list
6005034|NCT00264290|Antiviral Agents|antiviral agents|mesh-ancestor
6005035|NCT00264290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6005036|NCT00264303|Levocetirizine|levocetirizine|mesh-list
6005037|NCT00264303|Desloratadine|desloratadine|mesh-list
6005038|NCT00264303|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6005039|NCT00264303|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6005040|NCT00264303|Histamine Antagonists|histamine antagonists|mesh-ancestor
6005041|NCT00264303|Histamine Agents|histamine agents|mesh-ancestor
6005042|NCT00264303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6005043|NCT00264303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005044|NCT00264303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005045|NCT00264303|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6005046|NCT00264303|Cholinergic Agents|cholinergic agents|mesh-ancestor
6005047|NCT00264381|Dalteparin|dalteparin|mesh-list
6260422|NCT03161158|Natriuretic Agents|natriuretic agents|mesh-ancestor
6260423|NCT03161158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260424|NCT03161405|Itraconazole|itraconazole|mesh-list
6260425|NCT03161405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6260426|NCT03161405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260427|NCT03161405|Antifungal Agents|antifungal agents|mesh-ancestor
6260428|NCT03161405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6260429|NCT03161405|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6260430|NCT03161405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6260431|NCT03161405|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6260432|NCT03161405|Hormone Antagonists|hormone antagonists|mesh-ancestor
6260433|NCT03161405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6260434|NCT03161405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260435|NCT03161405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6260436|NCT03161938|Dexamethasone|dexamethasone|mesh-list
6260437|NCT03161938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6260438|NCT03161938|Antiemetics|antiemetics|mesh-ancestor
6005048|NCT00264381|Tinzaparin|tinzaparin|mesh-list
6005049|NCT00264381|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6005050|NCT00264381|Anticoagulants|anticoagulants|mesh-ancestor
6005051|NCT00264381|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6005052|NCT00264381|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6005053|NCT00264381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005054|NCT00264498|Gemcitabine|gemcitabine|mesh-list
6005055|NCT00264498|Carboplatin|carboplatin|mesh-list
6005056|NCT00264498|Gefitinib|gefitinib|mesh-list
6005057|NCT00264498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6005058|NCT00264498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6005059|NCT00264498|Antimetabolites|antimetabolites|mesh-ancestor
6005060|NCT00264498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005061|NCT00264498|Antiviral Agents|antiviral agents|mesh-ancestor
6005062|NCT00264498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6005063|NCT00264498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6005064|NCT00264498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6005065|NCT00264498|Immunologic Factors|immunologic factors|mesh-ancestor
6005066|NCT00264498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005067|NCT00264498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6005068|NCT00264537|Golimumab|golimumab|mesh-list
6005069|NCT00264537|Methotrexate|methotrexate|mesh-list
6005070|NCT00264537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6005071|NCT00264537|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6005072|NCT00264537|Abortifacient Agents|abortifacient agents|mesh-ancestor
6005073|NCT00264537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6005074|NCT00264537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005075|NCT00264537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6005076|NCT00264537|Antimetabolites|antimetabolites|mesh-ancestor
6005077|NCT00264537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005078|NCT00264537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6005079|NCT00264537|Dermatologic Agents|dermatologic agents|mesh-ancestor
6005080|NCT00264537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6005081|NCT00264537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6005082|NCT00264537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6005083|NCT00264537|Immunologic Factors|immunologic factors|mesh-ancestor
6005084|NCT00264537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6005085|NCT00264537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6005086|NCT00264537|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6005087|NCT00264537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6005088|NCT00264550|Golimumab|golimumab|mesh-list
6005089|NCT00264550|Methotrexate|methotrexate|mesh-list
6005090|NCT00264550|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6005091|NCT00264550|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6005092|NCT00264550|Abortifacient Agents|abortifacient agents|mesh-ancestor
6005093|NCT00264550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6005094|NCT00264550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005095|NCT00264550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6005096|NCT00264550|Antimetabolites|antimetabolites|mesh-ancestor
6005097|NCT00264550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005098|NCT00264550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6005099|NCT00264550|Dermatologic Agents|dermatologic agents|mesh-ancestor
6005100|NCT00264550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6005101|NCT00264550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6005102|NCT00264550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6005103|NCT00264550|Immunologic Factors|immunologic factors|mesh-ancestor
6005104|NCT00264550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6005105|NCT00264550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6005106|NCT00264550|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6005107|NCT00264550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6005108|NCT00264641|Insulin|insulin|mesh-list
6005109|NCT00264641|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6005110|NCT00264641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6005111|NCT00264641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005112|NCT00264797|Methylphenidate|methylphenidate|mesh-list
6005113|NCT00264797|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6005114|NCT00264797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005115|NCT00264797|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6005116|NCT00264797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6005117|NCT00264797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6005118|NCT00264797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005119|NCT00264797|Dopamine Agents|dopamine agents|mesh-ancestor
6005120|NCT00264797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6018139|NCT00378326|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6005121|NCT00264849|Omalizumab|omalizumab|mesh-list
6005122|NCT00264849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6005123|NCT00264849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6005124|NCT00264849|Respiratory System Agents|respiratory system agents|mesh-ancestor
6005125|NCT00264875|Pregabalin|pregabalin|mesh-list
6005126|NCT00264875|Analgesics|analgesics|mesh-ancestor
6005127|NCT00264875|Sensory System Agents|sensory system agents|mesh-ancestor
6005128|NCT00264875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6005129|NCT00264875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005130|NCT00264875|Anticonvulsants|anticonvulsants|mesh-ancestor
6005131|NCT00264875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6005132|NCT00264875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6005133|NCT00264875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005134|NCT00264875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6005135|NCT00264875|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6005136|NCT00264875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6005137|NCT00264875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6005138|NCT00264875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6005139|NCT00265083|Golimumab|golimumab|mesh-list
6005140|NCT00265083|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6005141|NCT00265083|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6005142|NCT00265083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6005143|NCT00265083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6005144|NCT00265083|Immunologic Factors|immunologic factors|mesh-ancestor
6005145|NCT00265083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005146|NCT00265096|Golimumab|golimumab|mesh-list
6005147|NCT00265096|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6005148|NCT00265096|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6005149|NCT00265096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6005150|NCT00265096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6005151|NCT00265096|Immunologic Factors|immunologic factors|mesh-ancestor
6005152|NCT00265096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005153|NCT00265109|Levetiracetam|levetiracetam|mesh-list
6005154|NCT00265109|Anticonvulsants|anticonvulsants|mesh-ancestor
6005155|NCT00265109|Nootropic Agents|nootropic agents|mesh-ancestor
6005156|NCT00265122|Ustekinumab|ustekinumab|mesh-list
6005157|NCT00265122|Dermatologic Agents|dermatologic agents|mesh-ancestor
6005158|NCT00265148|Rosiglitazone|rosiglitazone|mesh-list
6005159|NCT00265148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6005160|NCT00265148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005161|NCT00265200|Zoledronic Acid|zoledronic acid|mesh-list
6005162|NCT00265200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6005163|NCT00265200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005164|NCT00265239|Edaravone|edaravone|mesh-list
6005165|NCT00265239|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6005166|NCT00265239|Antioxidants|antioxidants|mesh-ancestor
6005167|NCT00265239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005168|NCT00265239|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6005169|NCT00265239|Protective Agents|protective agents|mesh-ancestor
6005170|NCT00265239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005171|NCT00265317|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6005172|NCT00265317|Sunitinib|sunitinib|mesh-list
6005173|NCT00265317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6005174|NCT00265317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6005175|NCT00265317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6005176|NCT00265317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005177|NCT00265317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6005178|NCT00265317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6005179|NCT00265317|Growth Substances|growth substances|mesh-ancestor
6005180|NCT00265317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005181|NCT00265317|Growth Inhibitors|growth inhibitors|mesh-ancestor
6005182|NCT00265330|Ziprasidone|ziprasidone|mesh-list
6005183|NCT00265330|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6005184|NCT00265330|Serotonin Agents|serotonin agents|mesh-ancestor
6005185|NCT00265330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6005186|NCT00265330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005187|NCT00265330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005188|NCT00265330|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6005189|NCT00265330|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6005190|NCT00265330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6005191|NCT00265330|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6005192|NCT00265330|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6005193|NCT00265330|Dopamine Agents|dopamine agents|mesh-ancestor
6005194|NCT00265382|Ziprasidone|ziprasidone|mesh-list
6005195|NCT00265382|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6005196|NCT00265382|Serotonin Agents|serotonin agents|mesh-ancestor
6005197|NCT00265382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6005198|NCT00265382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005199|NCT00265382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005200|NCT00265382|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6005201|NCT00265382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6005202|NCT00265382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6005203|NCT00265382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6005204|NCT00265382|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6005205|NCT00265382|Dopamine Agents|dopamine agents|mesh-ancestor
6005206|NCT00265395|Interferons|interferons|mesh-list
6005207|NCT00265395|Ribavirin|ribavirin|mesh-list
6005208|NCT00265395|Interferon-alpha|interferon-alpha|mesh-list
6005209|NCT00265395|Interferon alpha-2|interferon alpha-2|mesh-list
6005210|NCT00265395|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6005211|NCT00265395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6005212|NCT00265395|Antiviral Agents|antiviral agents|mesh-ancestor
6005213|NCT00265395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6005214|NCT00265395|Antimetabolites|antimetabolites|mesh-ancestor
6005215|NCT00265395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005216|NCT00265395|Immunologic Factors|immunologic factors|mesh-ancestor
6005217|NCT00265395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005218|NCT00265616|Pentobarbital|pentobarbital|mesh-list
6005219|NCT00265616|Thiopental|thiopental|mesh-list
6005220|NCT00265616|Propofol|propofol|mesh-list
6005221|NCT00265616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6005222|NCT00265616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6005223|NCT00265616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005224|NCT00265616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6005225|NCT00265616|Anesthetics, General|anesthetics, general|mesh-ancestor
6005226|NCT00265616|Anesthetics|anesthetics|mesh-ancestor
6005227|NCT00265616|Anticonvulsants|anticonvulsants|mesh-ancestor
6005228|NCT00265616|GABA Modulators|gaba modulators|mesh-ancestor
6005229|NCT00265616|GABA Agents|gaba agents|mesh-ancestor
6005230|NCT00265616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6005231|NCT00265616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005232|NCT00265616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6005233|NCT00265759|Letrozole|letrozole|mesh-list
6005234|NCT00265759|Anastrozole|anastrozole|mesh-list
6005235|NCT00265759|Exemestane|exemestane|mesh-list
6005236|NCT00265759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6005237|NCT00265759|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6005238|NCT00265759|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6005239|NCT00265759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6005240|NCT00265759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005241|NCT00265759|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6005242|NCT00265759|Hormone Antagonists|hormone antagonists|mesh-ancestor
6005243|NCT00265759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6005244|NCT00265759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005245|NCT00265759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6005246|NCT00265785|Pemetrexed|pemetrexed|mesh-list
6005247|NCT00265785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6005248|NCT00265785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6005249|NCT00265785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005250|NCT00265785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6005251|NCT00265785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6005252|NCT00265798|Sorafenib|sorafenib|mesh-list
6005253|NCT00265798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6005254|NCT00265798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6005255|NCT00265798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6005256|NCT00265798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005257|NCT00265850|Leucovorin|leucovorin|mesh-list
6005258|NCT00265850|Folic Acid|folic acid|mesh-list
6005259|NCT00265850|Bevacizumab|bevacizumab|mesh-list
6005260|NCT00265850|Cetuximab|cetuximab|mesh-list
6005261|NCT00265850|Fluorouracil|fluorouracil|mesh-list
6005262|NCT00265850|Oxaliplatin|oxaliplatin|mesh-list
6005263|NCT00265850|Irinotecan|irinotecan|mesh-list
6005264|NCT00265850|Levoleucovorin|levoleucovorin|mesh-list
6005265|NCT00265850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6005266|NCT00265850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6005267|NCT00265850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6260439|NCT03161938|Autonomic Agents|autonomic agents|mesh-ancestor
6260440|NCT03161938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6260441|NCT03161938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260442|NCT03161938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6260443|NCT03161938|Glucocorticoids|glucocorticoids|mesh-ancestor
6260444|NCT03161938|Hormones|hormones|mesh-ancestor
6260445|NCT03161938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6260446|NCT03161938|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6260447|NCT03161938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6260448|NCT03162055|Glycopyrrolate|glycopyrrolate|mesh-list
6260449|NCT03162055|Formoterol Fumarate|formoterol fumarate|mesh-list
6260450|NCT03162055|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6260451|NCT03162055|Autonomic Agents|autonomic agents|mesh-ancestor
6260452|NCT03162055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6260453|NCT03162055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260454|NCT03162055|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6260455|NCT03162055|Respiratory System Agents|respiratory system agents|mesh-ancestor
6260456|NCT03162055|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6260457|NCT03162055|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6260458|NCT03162055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6260459|NCT03162055|Adrenergic Agents|adrenergic agents|mesh-ancestor
6260460|NCT03162055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6260461|NCT03162055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260462|NCT03162055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6260463|NCT03162055|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6260464|NCT03162055|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6260465|NCT03162055|Cholinergic Agents|cholinergic agents|mesh-ancestor
6389892|NCT00189618|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6389893|NCT00189618|Purinergic Agents|purinergic agents|mesh-ancestor
6389894|NCT00189618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6389895|NCT00189644|Cyclophosphamide|cyclophosphamide|mesh-list
6389896|NCT00189644|Fluorouracil|fluorouracil|mesh-list
6389897|NCT00189644|Epirubicin|epirubicin|mesh-list
6389898|NCT00189644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6389899|NCT00189644|Immunologic Factors|immunologic factors|mesh-ancestor
6389900|NCT00189644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389901|NCT00189644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6389902|NCT00189644|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6389903|NCT00189644|Alkylating Agents|alkylating agents|mesh-ancestor
6389904|NCT00189644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389905|NCT00189644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6389906|NCT00189644|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6389907|NCT00189644|Antimetabolites|antimetabolites|mesh-ancestor
6389908|NCT00189644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6389909|NCT00189644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6389910|NCT00189644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6389911|NCT00189644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6389912|NCT00189644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6389913|NCT00189657|Irinotecan|irinotecan|mesh-list
6389914|NCT00189657|Fluorouracil|fluorouracil|mesh-list
6389915|NCT00189657|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6389916|NCT00189657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6389917|NCT00189657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6389918|NCT00189657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389919|NCT00189657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6389920|NCT00189657|Antimetabolites|antimetabolites|mesh-ancestor
6389921|NCT00189657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6389922|NCT00189657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6389923|NCT00189657|Immunologic Factors|immunologic factors|mesh-ancestor
6389924|NCT00189657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389925|NCT00189683|Capecitabine|capecitabine|mesh-list
6389926|NCT00189683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6005268|NCT00265850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6389927|NCT00189683|Antimetabolites|antimetabolites|mesh-ancestor
6389928|NCT00189683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389929|NCT00189683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6005269|NCT00265850|Growth Substances|growth substances|mesh-ancestor
6005270|NCT00265850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005271|NCT00265850|Growth Inhibitors|growth inhibitors|mesh-ancestor
6005272|NCT00265850|Antimetabolites|antimetabolites|mesh-ancestor
6005273|NCT00265850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005274|NCT00265850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6005275|NCT00265850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6005276|NCT00265850|Immunologic Factors|immunologic factors|mesh-ancestor
6005277|NCT00265850|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6005278|NCT00265850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6005279|NCT00265850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6005280|NCT00265850|Antidotes|antidotes|mesh-ancestor
6005281|NCT00265850|Protective Agents|protective agents|mesh-ancestor
6005282|NCT00265850|Vitamin B Complex|vitamin b complex|mesh-ancestor
6005283|NCT00265850|Vitamins|vitamins|mesh-ancestor
6005284|NCT00265850|Micronutrients|micronutrients|mesh-ancestor
6005285|NCT00265850|Hematinics|hematinics|mesh-ancestor
6005286|NCT00265889|Cyclophosphamide|cyclophosphamide|mesh-list
6005287|NCT00265889|Melphalan|melphalan|mesh-list
6005288|NCT00265889|Busulfan|busulfan|mesh-list
6005289|NCT00265889|Etoposide|etoposide|mesh-list
6005290|NCT00265889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6005291|NCT00265889|Immunologic Factors|immunologic factors|mesh-ancestor
6005292|NCT00265889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005293|NCT00265889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6005294|NCT00265889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6005295|NCT00265889|Alkylating Agents|alkylating agents|mesh-ancestor
6005296|NCT00265889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005297|NCT00265889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6005298|NCT00265889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6005299|NCT00265889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6005300|NCT00265889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6005301|NCT00265889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6005302|NCT00265889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6005303|NCT00265941|Cetuximab|cetuximab|mesh-list
6005304|NCT00265941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6005305|NCT00265941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6005306|NCT00266032|Drospirenone|drospirenone|mesh-list
6005307|NCT00266032|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6005308|NCT00266032|Hormone Antagonists|hormone antagonists|mesh-ancestor
6005309|NCT00266032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6005310|NCT00266032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005311|NCT00266032|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6005312|NCT00266032|Diuretics|diuretics|mesh-ancestor
6005313|NCT00266032|Natriuretic Agents|natriuretic agents|mesh-ancestor
6005314|NCT00266110|Trastuzumab|trastuzumab|mesh-list
6005315|NCT00266110|Vinorelbine|vinorelbine|mesh-list
6005316|NCT00266110|Sargramostim|sargramostim|mesh-list
6005317|NCT00266110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6005318|NCT00266110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6005319|NCT00266110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6005320|NCT00266110|Tubulin Modulators|tubulin modulators|mesh-ancestor
6005321|NCT00266110|Antimitotic Agents|antimitotic agents|mesh-ancestor
6005322|NCT00266110|Mitosis Modulators|mitosis modulators|mesh-ancestor
6005323|NCT00266110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005324|NCT00266110|Immunologic Factors|immunologic factors|mesh-ancestor
6005325|NCT00266110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005326|NCT00266227|Rituximab|rituximab|mesh-list
6005327|NCT00266227|Methotrexate|methotrexate|mesh-list
6005328|NCT00266227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6005329|NCT00266227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6005330|NCT00266227|Immunologic Factors|immunologic factors|mesh-ancestor
6005331|NCT00266227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005332|NCT00266227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6005333|NCT00266227|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6005334|NCT00266227|Abortifacient Agents|abortifacient agents|mesh-ancestor
6005335|NCT00266227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6005336|NCT00266227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6005337|NCT00266227|Antimetabolites|antimetabolites|mesh-ancestor
6005338|NCT00266227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005339|NCT00266227|Dermatologic Agents|dermatologic agents|mesh-ancestor
6005340|NCT00266227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6005341|NCT00266227|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6005342|NCT00266227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6005343|NCT00266227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6005344|NCT00266279|Capecitabine|capecitabine|mesh-list
6005345|NCT00266279|Oxaliplatin|oxaliplatin|mesh-list
6005346|NCT00266279|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6005347|NCT00266279|Antimetabolites|antimetabolites|mesh-ancestor
6005348|NCT00266279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005349|NCT00266279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6005350|NCT00266409|Alprazolam|alprazolam|mesh-list
6005351|NCT00266409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6005352|NCT00266409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6005353|NCT00266409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005354|NCT00266409|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6005355|NCT00266409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6005356|NCT00266409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6005357|NCT00266409|GABA Modulators|gaba modulators|mesh-ancestor
6005358|NCT00266409|GABA Agents|gaba agents|mesh-ancestor
6005359|NCT00266409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6005360|NCT00266409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005361|NCT00266630|Carbamazepine|carbamazepine|mesh-list
6005362|NCT00266630|Valproic Acid|valproic acid|mesh-list
6005363|NCT00266630|Olanzapine|olanzapine|mesh-list
6005364|NCT00266630|Antiemetics|antiemetics|mesh-ancestor
6005365|NCT00266630|Autonomic Agents|autonomic agents|mesh-ancestor
6005366|NCT00266630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6005367|NCT00266630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005368|NCT00266630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6005369|NCT00266630|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6005370|NCT00266630|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6005371|NCT00266630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6005372|NCT00266630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6005373|NCT00266630|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6005374|NCT00266630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6005375|NCT00266630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6005376|NCT00266630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005377|NCT00266630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6005378|NCT00266630|Serotonin Agents|serotonin agents|mesh-ancestor
6005379|NCT00266630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6005380|NCT00266630|Antimanic Agents|antimanic agents|mesh-ancestor
6005381|NCT00266630|Anticonvulsants|anticonvulsants|mesh-ancestor
6005382|NCT00266630|GABA Agents|gaba agents|mesh-ancestor
6005383|NCT00266630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6005384|NCT00266630|Analgesics|analgesics|mesh-ancestor
6005385|NCT00266630|Sensory System Agents|sensory system agents|mesh-ancestor
6005386|NCT00266630|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6005387|NCT00266630|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6005388|NCT00266630|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6005389|NCT00266656|Hormones|hormones|mesh-list
6005390|NCT00266656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6005391|NCT00266656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005392|NCT00266695|Ruboxistaurin|ruboxistaurin|mesh-list
6005393|NCT00266695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6005394|NCT00266695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005395|NCT00266708|Risedronic Acid|risedronic acid|mesh-list
6005396|NCT00266708|Etidronic Acid|etidronic acid|mesh-list
6005397|NCT00266708|Diphosphonates|diphosphonates|mesh-list
6005398|NCT00266708|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6005399|NCT00266708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6005400|NCT00266708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005401|NCT00266708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6005402|NCT00266708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005403|NCT00266708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6005404|NCT00266799|Doxorubicin|doxorubicin|mesh-list
6005405|NCT00266799|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6005406|NCT00266799|Capecitabine|capecitabine|mesh-list
6005407|NCT00266799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6005408|NCT00266799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6005409|NCT00266799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6005410|NCT00266799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6005411|NCT00266799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6005412|NCT00266799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005413|NCT00266799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6005414|NCT00266799|Antimetabolites|antimetabolites|mesh-ancestor
6005415|NCT00266812|Temozolomide|temozolomide|mesh-list
6005416|NCT00266812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6005417|NCT00266812|Alkylating Agents|alkylating agents|mesh-ancestor
6005418|NCT00266812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005419|NCT00266812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6005420|NCT00266851|Azithromycin|azithromycin|mesh-list
6005421|NCT00266851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6005422|NCT00266851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6005423|NCT00266864|Methyltestosterone|methyltestosterone|mesh-list
6005424|NCT00266864|Testosterone|testosterone|mesh-list
6260466|NCT03163303|Nicotine|nicotine|mesh-list
6260467|NCT03163303|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6260468|NCT03163303|Autonomic Agents|autonomic agents|mesh-ancestor
6005425|NCT00266864|Testosterone undecanoate|testosterone undecanoate|mesh-list
6005426|NCT00266864|Testosterone enanthate|testosterone enanthate|mesh-list
6005427|NCT00266864|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6005428|NCT00266864|Androgens|androgens|mesh-ancestor
6005429|NCT00266864|Hormones|hormones|mesh-ancestor
6005430|NCT00266864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6005431|NCT00266864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005432|NCT00266864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6005433|NCT00266864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6005434|NCT00266864|Anabolic Agents|anabolic agents|mesh-ancestor
6005435|NCT00267007|Epoetin Alfa|epoetin alfa|mesh-list
6005436|NCT00267007|Hematinics|hematinics|mesh-ancestor
6005437|NCT00267020|Gemcitabine|gemcitabine|mesh-list
6005438|NCT00267020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6005439|NCT00267020|Antimetabolites|antimetabolites|mesh-ancestor
6005440|NCT00267020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005441|NCT00267020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6005442|NCT00267020|Antiviral Agents|antiviral agents|mesh-ancestor
6005443|NCT00267020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6260469|NCT03163303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6005444|NCT00267020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6005445|NCT00267020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6005446|NCT00267020|Immunologic Factors|immunologic factors|mesh-ancestor
6005447|NCT00267020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005448|NCT00267046|Doxorubicin|doxorubicin|mesh-list
6005449|NCT00267046|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6005450|NCT00267046|Vincristine|vincristine|mesh-list
6005451|NCT00267046|Ifosfamide|ifosfamide|mesh-list
6005452|NCT00267046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6005453|NCT00267046|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6005454|NCT00267046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6005455|NCT00267046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6005456|NCT00267046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6005457|NCT00267046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005458|NCT00267046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6005459|NCT00267046|Tubulin Modulators|tubulin modulators|mesh-ancestor
6005460|NCT00267046|Antimitotic Agents|antimitotic agents|mesh-ancestor
6005461|NCT00267046|Mitosis Modulators|mitosis modulators|mesh-ancestor
6005462|NCT00267046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6005463|NCT00267046|Alkylating Agents|alkylating agents|mesh-ancestor
6005464|NCT00267059|Lenalidomide|lenalidomide|mesh-list
6005465|NCT00267059|Immunologic Factors|immunologic factors|mesh-ancestor
6005466|NCT00267059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005467|NCT00267059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6005468|NCT00267059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6005469|NCT00267059|Growth Substances|growth substances|mesh-ancestor
6005470|NCT00267059|Growth Inhibitors|growth inhibitors|mesh-ancestor
6005471|NCT00267059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6005472|NCT00267085|Imatinib Mesylate|imatinib mesylate|mesh-list
6005473|NCT00267085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6005474|NCT00267085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6005475|NCT00267085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6005476|NCT00267085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005477|NCT00267111|Tetracaine|tetracaine|mesh-list
6005478|NCT00267111|Anesthetics, Local|anesthetics, local|mesh-ancestor
6005479|NCT00267111|Anesthetics|anesthetics|mesh-ancestor
6005480|NCT00267111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6005481|NCT00267111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005482|NCT00267111|Sensory System Agents|sensory system agents|mesh-ancestor
6005483|NCT00267111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6005484|NCT00267150|Mycophenolic Acid|mycophenolic acid|mesh-list
6005485|NCT00267150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6005486|NCT00267150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6005487|NCT00267150|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6005488|NCT00267150|Antitubercular Agents|antitubercular agents|mesh-ancestor
6005489|NCT00267150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6005490|NCT00267150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6005491|NCT00267150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6005492|NCT00267150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005493|NCT00267189|Cyclosporine|cyclosporine|mesh-list
6005494|NCT00267189|Everolimus|everolimus|mesh-list
6005495|NCT00267189|Azathioprine|azathioprine|mesh-list
6005496|NCT00267189|Tacrolimus|tacrolimus|mesh-list
6005497|NCT00267189|Cyclosporins|cyclosporins|mesh-list
6005498|NCT00267189|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
6005499|NCT00267189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6005500|NCT00267189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6005501|NCT00267189|Immunologic Factors|immunologic factors|mesh-ancestor
6005502|NCT00267189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005503|NCT00267189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6005504|NCT00267189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6005505|NCT00267189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005506|NCT00267189|Antimetabolites|antimetabolites|mesh-ancestor
6005507|NCT00267189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6005508|NCT00267189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6260470|NCT03163303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260471|NCT03163303|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6260472|NCT03163303|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6005509|NCT00267189|Antifungal Agents|antifungal agents|mesh-ancestor
6005510|NCT00267189|Dermatologic Agents|dermatologic agents|mesh-ancestor
6005511|NCT00267202|Omalizumab|omalizumab|mesh-list
6005512|NCT00267202|Immunologic Factors|immunologic factors|mesh-list
6005513|NCT00267202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005514|NCT00267202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6005515|NCT00267202|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6005516|NCT00267202|Respiratory System Agents|respiratory system agents|mesh-ancestor
6005517|NCT00267293|Acetaminophen|acetaminophen|mesh-list
6005518|NCT00267293|Ibuprofen|ibuprofen|mesh-list
6005519|NCT00267293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6005520|NCT00267293|Analgesics|analgesics|mesh-ancestor
6005521|NCT00267293|Sensory System Agents|sensory system agents|mesh-ancestor
6005522|NCT00267293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6005523|NCT00267293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005524|NCT00267293|Antipyretics|antipyretics|mesh-ancestor
6005525|NCT00267293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6005526|NCT00267293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6005527|NCT00267293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6005528|NCT00267293|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6005529|NCT00267293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6005530|NCT00267293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005531|NCT00267488|Topotecan|topotecan|mesh-list
6005532|NCT00267488|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6005533|NCT00267488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6005534|NCT00267488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6005535|NCT00267488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005536|NCT00267488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6005537|NCT00267670|Pentoxifylline|pentoxifylline|mesh-list
6005538|NCT00267670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6005539|NCT00267670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6005540|NCT00267670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005541|NCT00267670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6005542|NCT00267670|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6005543|NCT00267670|Protective Agents|protective agents|mesh-ancestor
6005544|NCT00267670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005545|NCT00267670|Vasodilator Agents|vasodilator agents|mesh-ancestor
6005546|NCT00267670|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6005547|NCT00267670|Antioxidants|antioxidants|mesh-ancestor
6005548|NCT00267696|Gemcitabine|gemcitabine|mesh-list
6005549|NCT00267696|Bevacizumab|bevacizumab|mesh-list
6005550|NCT00267696|Carboplatin|carboplatin|mesh-list
6005551|NCT00267696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6005552|NCT00267696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6005553|NCT00267696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6005554|NCT00267696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6005555|NCT00267696|Growth Substances|growth substances|mesh-ancestor
6005556|NCT00267696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005557|NCT00267696|Growth Inhibitors|growth inhibitors|mesh-ancestor
6005558|NCT00267696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6005559|NCT00267696|Antimetabolites|antimetabolites|mesh-ancestor
6005560|NCT00267696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005561|NCT00267696|Antiviral Agents|antiviral agents|mesh-ancestor
6005562|NCT00267696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6005563|NCT00267696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6005564|NCT00267696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6005565|NCT00267696|Immunologic Factors|immunologic factors|mesh-ancestor
6005566|NCT00267748|Sunitinib|sunitinib|mesh-list
6005567|NCT00267748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6005568|NCT00267748|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6005569|NCT00267748|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6005570|NCT00267748|Growth Substances|growth substances|mesh-ancestor
6005571|NCT00267748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005572|NCT00267748|Growth Inhibitors|growth inhibitors|mesh-ancestor
6005573|NCT00267748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6005574|NCT00267748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6005575|NCT00267748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005576|NCT00267865|Leucovorin|leucovorin|mesh-list
6005577|NCT00267865|Rituximab|rituximab|mesh-list
6005578|NCT00267865|Methotrexate|methotrexate|mesh-list
6005579|NCT00267865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6005580|NCT00267865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6005581|NCT00267865|Immunologic Factors|immunologic factors|mesh-ancestor
6005582|NCT00267865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005583|NCT00267865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6005584|NCT00267865|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6005585|NCT00267865|Abortifacient Agents|abortifacient agents|mesh-ancestor
6005586|NCT00267865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6005587|NCT00267865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6005588|NCT00267865|Antimetabolites|antimetabolites|mesh-ancestor
6005589|NCT00267865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005590|NCT00267865|Dermatologic Agents|dermatologic agents|mesh-ancestor
6005591|NCT00267865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6005592|NCT00267865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6005593|NCT00267865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6005594|NCT00267865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6005595|NCT00267865|Antidotes|antidotes|mesh-ancestor
6005596|NCT00267865|Protective Agents|protective agents|mesh-ancestor
6005597|NCT00267865|Vitamin B Complex|vitamin b complex|mesh-ancestor
6005598|NCT00267865|Vitamins|vitamins|mesh-ancestor
6005599|NCT00267865|Micronutrients|micronutrients|mesh-ancestor
6005600|NCT00267956|Ustekinumab|ustekinumab|mesh-list
6005601|NCT00267956|Dermatologic Agents|dermatologic agents|mesh-ancestor
6005602|NCT00267969|Ustekinumab|ustekinumab|mesh-list
6005603|NCT00267969|Dermatologic Agents|dermatologic agents|mesh-ancestor
6005604|NCT00268203|Tositumomab I-131|tositumomab i-131|mesh-list
6005605|NCT00268203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6005606|NCT00268242|Gemcitabine|gemcitabine|mesh-list
6005607|NCT00268242|Mitoxantrone|mitoxantrone|mesh-list
6005608|NCT00268242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6005609|NCT00268242|Antimetabolites|antimetabolites|mesh-ancestor
6005610|NCT00268242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005611|NCT00268242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6005612|NCT00268242|Antiviral Agents|antiviral agents|mesh-ancestor
6005613|NCT00268242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6005614|NCT00268242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6005615|NCT00268242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6005616|NCT00268242|Immunologic Factors|immunologic factors|mesh-ancestor
6005617|NCT00268242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005618|NCT00268242|Analgesics|analgesics|mesh-ancestor
6005619|NCT00268242|Sensory System Agents|sensory system agents|mesh-ancestor
6005620|NCT00268242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6005621|NCT00268242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6005622|NCT00268242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6005623|NCT00268346|Gefitinib|gefitinib|mesh-list
6005624|NCT00268346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6005625|NCT00268346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6005626|NCT00268346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6005627|NCT00268346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005628|NCT00268437|Carboplatin|carboplatin|mesh-list
6005629|NCT00268437|Pemetrexed|pemetrexed|mesh-list
6005630|NCT00268437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6005631|NCT00268437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6005632|NCT00268437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005633|NCT00268437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6005634|NCT00268437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6005635|NCT00268762|Argatroban|argatroban|mesh-list
6005636|NCT00268762|Antithrombins|antithrombins|mesh-ancestor
6005637|NCT00268762|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6005638|NCT00268762|Protease Inhibitors|protease inhibitors|mesh-ancestor
6005639|NCT00268762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6005640|NCT00268762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005641|NCT00268762|Anticoagulants|anticoagulants|mesh-ancestor
6005642|NCT00268762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6005643|NCT00268905|Carboplatin|carboplatin|mesh-list
6005644|NCT00268905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6005645|NCT00268983|Iodine|iodine|mesh-list
6005646|NCT00268983|Rituximab|rituximab|mesh-list
6005647|NCT00268983|Tositumomab I-131|tositumomab i-131|mesh-list
6005648|NCT00268983|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6005649|NCT00268983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6005650|NCT00268983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6005651|NCT00268983|Immunologic Factors|immunologic factors|mesh-ancestor
6005652|NCT00268983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005653|NCT00268983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6005654|NCT00268983|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6005655|NCT00268983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6005656|NCT00268983|Trace Elements|trace elements|mesh-ancestor
6005657|NCT00268983|Micronutrients|micronutrients|mesh-ancestor
6005658|NCT00269087|Fluticasone|fluticasone|mesh-list
6005659|NCT00269087|Xhance|xhance|mesh-list
6005660|NCT00269087|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6005661|NCT00269087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6005662|NCT00269087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6005663|NCT00269087|Autonomic Agents|autonomic agents|mesh-ancestor
6005664|NCT00269087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6005665|NCT00269087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005666|NCT00269087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6005667|NCT00269087|Respiratory System Agents|respiratory system agents|mesh-ancestor
6005668|NCT00269087|Dermatologic Agents|dermatologic agents|mesh-ancestor
6005669|NCT00269087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6005670|NCT00269087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6005671|NCT00269087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6005672|NCT00269087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6005673|NCT00269087|Adrenergic Agents|adrenergic agents|mesh-ancestor
6005674|NCT00269087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6005675|NCT00269087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005676|NCT00269113|Rituximab|rituximab|mesh-list
6005677|NCT00269113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6005678|NCT00269113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6005679|NCT00269113|Immunologic Factors|immunologic factors|mesh-ancestor
6005680|NCT00269113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005681|NCT00269113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6005682|NCT00269152|Carboplatin|carboplatin|mesh-list
6005683|NCT00269152|Pemetrexed|pemetrexed|mesh-list
6005684|NCT00269152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6005685|NCT00269152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6005686|NCT00269152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005687|NCT00269152|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6005688|NCT00269152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6005689|NCT00269399|Vancomycin|vancomycin|mesh-list
6005690|NCT00269399|Rifaximin|rifaximin|mesh-list
6005691|NCT00269399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6005692|NCT00269399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6005693|NCT00269399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6005694|NCT00269919|Risperidone|risperidone|mesh-list
6005695|NCT00269919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6005696|NCT00269919|Serotonin Agents|serotonin agents|mesh-ancestor
6005697|NCT00269919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6005698|NCT00269919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005699|NCT00269919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005700|NCT00269919|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6005701|NCT00269919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6005702|NCT00269919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6005703|NCT00269919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6005704|NCT00269919|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6005705|NCT00269919|Dopamine Agents|dopamine agents|mesh-ancestor
6005706|NCT00270205|Vaccines|vaccines|mesh-list
6005707|NCT00270205|Immunologic Factors|immunologic factors|mesh-ancestor
6005708|NCT00270205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005709|NCT00270231|Naltrexone|naltrexone|mesh-list
6005710|NCT00270231|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6005711|NCT00270231|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6005712|NCT00270231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005713|NCT00270231|Sensory System Agents|sensory system agents|mesh-ancestor
6005714|NCT00270231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6005715|NCT00270257|Buprenorphine|buprenorphine|mesh-list
6005716|NCT00270257|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6005717|NCT00270257|Naloxone|naloxone|mesh-list
6005718|NCT00270257|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6005719|NCT00270257|Narcotics|narcotics|mesh-ancestor
6005720|NCT00270257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6005721|NCT00270257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005722|NCT00270257|Analgesics|analgesics|mesh-ancestor
6005723|NCT00270257|Sensory System Agents|sensory system agents|mesh-ancestor
6005724|NCT00270257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6005725|NCT00270257|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6005726|NCT00270296|Ritonavir|ritonavir|mesh-list
6005727|NCT00270296|Lopinavir|lopinavir|mesh-list
6005728|NCT00270296|Lamivudine|lamivudine|mesh-list
6005729|NCT00270296|Zidovudine|zidovudine|mesh-list
6005730|NCT00270296|Nevirapine|nevirapine|mesh-list
6005731|NCT00270296|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6005732|NCT00270296|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6005733|NCT00270296|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6005734|NCT00270296|Protease Inhibitors|protease inhibitors|mesh-ancestor
6005735|NCT00270296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6005736|NCT00270296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005737|NCT00270296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6005738|NCT00270296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6005739|NCT00270296|Antiviral Agents|antiviral agents|mesh-ancestor
6005740|NCT00270296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6005741|NCT00270296|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6260473|NCT03163303|Cholinergic Agents|cholinergic agents|mesh-ancestor
6260474|NCT03163303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6260475|NCT03163303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260476|NCT03163472|Anesthetics|anesthetics|mesh-list
6260477|NCT03163472|Anesthetics, Local|anesthetics, local|mesh-list
6260478|NCT03163472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6260479|NCT03163472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260480|NCT03163472|Sensory System Agents|sensory system agents|mesh-ancestor
6260481|NCT03163472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6260482|NCT03165955|Paclitaxel|paclitaxel|mesh-list
6260483|NCT03165955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6260484|NCT03165955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6260485|NCT03165955|Tubulin Modulators|tubulin modulators|mesh-ancestor
6260486|NCT03165955|Antimitotic Agents|antimitotic agents|mesh-ancestor
6260487|NCT03165955|Mitosis Modulators|mitosis modulators|mesh-ancestor
6260488|NCT03165955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260489|NCT03165981|Vaccines|vaccines|mesh-list
6260490|NCT03165981|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6260491|NCT03165981|Immunologic Factors|immunologic factors|mesh-ancestor
6260492|NCT03165981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260493|NCT03166124|Insulin Lispro|insulin lispro|mesh-list
6260494|NCT03166124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6260495|NCT03166124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260496|NCT03167151|Pembrolizumab|pembrolizumab|mesh-list
6018140|NCT00378326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6018141|NCT00378326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6018142|NCT00378352|Epoetin Alfa|epoetin alfa|mesh-list
6018143|NCT00378352|Hematinics|hematinics|mesh-ancestor
6018144|NCT00378482|Tremelimumab|tremelimumab|mesh-list
6018145|NCT00378482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6018146|NCT00378534|Cyclosporine|cyclosporine|mesh-list
6018147|NCT00378534|Cyclophosphamide|cyclophosphamide|mesh-list
6018148|NCT00378534|Fludarabine|fludarabine|mesh-list
6018149|NCT00378534|Cyclosporins|cyclosporins|mesh-list
6018150|NCT00378534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6018151|NCT00378534|Immunologic Factors|immunologic factors|mesh-ancestor
6018152|NCT00378534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018153|NCT00378534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6018154|NCT00378534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6018155|NCT00378534|Alkylating Agents|alkylating agents|mesh-ancestor
6018156|NCT00378534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6018157|NCT00378534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6005742|NCT00270296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6005743|NCT00270296|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6005744|NCT00270296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6005745|NCT00270296|Antimetabolites|antimetabolites|mesh-ancestor
6005746|NCT00270296|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6005747|NCT00270296|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6005748|NCT00270634|Tacrolimus|tacrolimus|mesh-list
6005749|NCT00270634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6005750|NCT00270634|Immunologic Factors|immunologic factors|mesh-ancestor
6005751|NCT00270634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005752|NCT00270634|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6005753|NCT00270634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6005754|NCT00270634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005755|NCT00270790|Carboplatin|carboplatin|mesh-list
6005756|NCT00270790|Amifostine|amifostine|mesh-list
6005757|NCT00270790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6005758|NCT00270790|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6005759|NCT00270790|Protective Agents|protective agents|mesh-ancestor
6005760|NCT00270790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005761|NCT00270894|Cyclophosphamide|cyclophosphamide|mesh-list
6005762|NCT00270894|Docetaxel|docetaxel|mesh-list
6005763|NCT00270894|Trastuzumab|trastuzumab|mesh-list
6005764|NCT00270894|Epirubicin|epirubicin|mesh-list
6005765|NCT00270894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6005766|NCT00270894|Immunologic Factors|immunologic factors|mesh-ancestor
6005767|NCT00270894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005768|NCT00270894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6005769|NCT00270894|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6005770|NCT00270894|Alkylating Agents|alkylating agents|mesh-ancestor
6005771|NCT00270894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005772|NCT00270894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6005773|NCT00270894|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6005774|NCT00270894|Tubulin Modulators|tubulin modulators|mesh-ancestor
6005775|NCT00270894|Antimitotic Agents|antimitotic agents|mesh-ancestor
6005776|NCT00270894|Mitosis Modulators|mitosis modulators|mesh-ancestor
6005777|NCT00270894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6005778|NCT00270894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6005779|NCT00270894|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6005780|NCT00270894|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6005781|NCT00270894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6005782|NCT00271024|Naltrexone|naltrexone|mesh-list
6005783|NCT00271024|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6005784|NCT00271024|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6005785|NCT00271024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005786|NCT00271024|Sensory System Agents|sensory system agents|mesh-ancestor
6005787|NCT00271024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6005788|NCT00271219|Buprenorphine|buprenorphine|mesh-list
6005789|NCT00271219|Methadone|methadone|mesh-list
6005790|NCT00271219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6005791|NCT00271219|Narcotics|narcotics|mesh-ancestor
6005792|NCT00271219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6005793|NCT00271219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005794|NCT00271219|Analgesics|analgesics|mesh-ancestor
6005795|NCT00271219|Sensory System Agents|sensory system agents|mesh-ancestor
6005796|NCT00271219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6005797|NCT00271219|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6005798|NCT00271219|Antitussive Agents|antitussive agents|mesh-ancestor
6005799|NCT00271219|Respiratory System Agents|respiratory system agents|mesh-ancestor
6005800|NCT00271505|Bevacizumab|bevacizumab|mesh-list
6005801|NCT00271505|Carboplatin|carboplatin|mesh-list
6005802|NCT00271505|Docetaxel|docetaxel|mesh-list
6005803|NCT00271505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6005804|NCT00271505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6005805|NCT00271505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6005806|NCT00271505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6005807|NCT00271505|Growth Substances|growth substances|mesh-ancestor
6005808|NCT00271505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005809|NCT00271505|Growth Inhibitors|growth inhibitors|mesh-ancestor
6005810|NCT00271505|Tubulin Modulators|tubulin modulators|mesh-ancestor
6005811|NCT00271505|Antimitotic Agents|antimitotic agents|mesh-ancestor
6005812|NCT00271505|Mitosis Modulators|mitosis modulators|mesh-ancestor
6005813|NCT00271505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005814|NCT00271570|Infliximab|infliximab|mesh-list
6005815|NCT00271570|Immunoglobulins|immunoglobulins|mesh-list
6005816|NCT00271570|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6005817|NCT00271570|Antibodies|antibodies|mesh-list
6005818|NCT00271570|gamma-Globulins|gamma-globulins|mesh-list
6005819|NCT00271570|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6005820|NCT00271570|Immunologic Factors|immunologic factors|mesh-ancestor
6005821|NCT00271570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005822|NCT00271570|Dermatologic Agents|dermatologic agents|mesh-ancestor
6005823|NCT00271570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6005824|NCT00271570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6005825|NCT00271596|Citalopram|citalopram|mesh-list
6005826|NCT00271596|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6005827|NCT00271596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6005828|NCT00271596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6005829|NCT00271596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005830|NCT00271596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6005831|NCT00271596|Serotonin Agents|serotonin agents|mesh-ancestor
6005832|NCT00271596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005833|NCT00271596|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6005834|NCT00271596|Antidepressive Agents|antidepressive agents|mesh-ancestor
6005835|NCT00271596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6005836|NCT00271609|Bevacizumab|bevacizumab|mesh-list
6005837|NCT00271609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6005838|NCT00271609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6005839|NCT00271609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6005840|NCT00271609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6005841|NCT00271609|Growth Substances|growth substances|mesh-ancestor
6005842|NCT00271609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005843|NCT00271609|Growth Inhibitors|growth inhibitors|mesh-ancestor
6005844|NCT00272038|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6005845|NCT00272038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6005846|NCT00272038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6005847|NCT00272038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6005848|NCT00272038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005849|NCT00272311|Aspirin|aspirin|mesh-list
6005850|NCT00272311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6005851|NCT00272311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6005852|NCT00272311|Analgesics|analgesics|mesh-ancestor
6005853|NCT00272311|Sensory System Agents|sensory system agents|mesh-ancestor
6005854|NCT00272311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6005855|NCT00272311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005856|NCT00272311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6005857|NCT00272311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6005858|NCT00272311|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6005859|NCT00272311|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6005860|NCT00272311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005861|NCT00272311|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6005862|NCT00272311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6005863|NCT00272311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6005864|NCT00272311|Antipyretics|antipyretics|mesh-ancestor
6018158|NCT00378534|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6018159|NCT00378534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6018160|NCT00378534|Antifungal Agents|antifungal agents|mesh-ancestor
6018161|NCT00378534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6018162|NCT00378534|Dermatologic Agents|dermatologic agents|mesh-ancestor
6018163|NCT00378534|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6018164|NCT00378573|Gemcitabine|gemcitabine|mesh-list
6018165|NCT00378573|Bevacizumab|bevacizumab|mesh-list
6018166|NCT00378573|Docetaxel|docetaxel|mesh-list
6018167|NCT00378573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6018168|NCT00378573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6018169|NCT00378573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6018170|NCT00378573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6018171|NCT00378573|Growth Substances|growth substances|mesh-ancestor
6018172|NCT00378573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018173|NCT00378573|Growth Inhibitors|growth inhibitors|mesh-ancestor
6018174|NCT00378573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6018175|NCT00378573|Antimetabolites|antimetabolites|mesh-ancestor
6018176|NCT00378573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6018177|NCT00378573|Antiviral Agents|antiviral agents|mesh-ancestor
6018178|NCT00378573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6018179|NCT00378573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6018180|NCT00378573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6018181|NCT00378573|Immunologic Factors|immunologic factors|mesh-ancestor
6018182|NCT00378573|Tubulin Modulators|tubulin modulators|mesh-ancestor
6018183|NCT00378573|Antimitotic Agents|antimitotic agents|mesh-ancestor
6018184|NCT00378573|Mitosis Modulators|mitosis modulators|mesh-ancestor
6018185|NCT00378599|Interferons|interferons|mesh-list
6018186|NCT00378599|Interferon-alpha|interferon-alpha|mesh-list
6018187|NCT00378599|Interferon alpha-2|interferon alpha-2|mesh-list
6018188|NCT00378599|Ribavirin|ribavirin|mesh-list
6018189|NCT00378599|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6018190|NCT00378599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6018191|NCT00378599|Antiviral Agents|antiviral agents|mesh-ancestor
6018192|NCT00378599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6018193|NCT00378599|Immunologic Factors|immunologic factors|mesh-ancestor
6018194|NCT00378599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018195|NCT00378599|Antimetabolites|antimetabolites|mesh-ancestor
6018196|NCT00378599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6018197|NCT00378703|Sirolimus|sirolimus|mesh-list
6018198|NCT00378703|Bevacizumab|bevacizumab|mesh-list
6018199|NCT00378703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6018200|NCT00378703|Sorafenib|sorafenib|mesh-list
6018201|NCT00378703|Endothelial Growth Factors|endothelial growth factors|mesh-list
6018202|NCT00378703|Antibodies|antibodies|mesh-list
6018203|NCT00378703|Immunoglobulins|immunoglobulins|mesh-list
6018204|NCT00378703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6018205|NCT00378703|Immunoglobulin G|immunoglobulin g|mesh-list
6018206|NCT00378703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6018207|NCT00378703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6018208|NCT00378703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6018209|NCT00378703|Growth Substances|growth substances|mesh-ancestor
6018210|NCT00378703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018211|NCT00378703|Growth Inhibitors|growth inhibitors|mesh-ancestor
6018212|NCT00378703|Immunologic Factors|immunologic factors|mesh-ancestor
6018213|NCT00378703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6018214|NCT00378703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6018215|NCT00378703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6018216|NCT00378703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6005865|NCT00272337|Aspirin|aspirin|mesh-list
6005866|NCT00272337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6005867|NCT00272337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6005868|NCT00272337|Analgesics|analgesics|mesh-ancestor
6005869|NCT00272337|Sensory System Agents|sensory system agents|mesh-ancestor
6005870|NCT00272337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6005871|NCT00272337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005872|NCT00272337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6005873|NCT00272337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6005874|NCT00272337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6005875|NCT00272337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6005876|NCT00272337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005877|NCT00272337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6005878|NCT00272337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6005879|NCT00272337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6005880|NCT00272337|Antipyretics|antipyretics|mesh-ancestor
6005881|NCT00272779|Emtricitabine|emtricitabine|mesh-list
6005882|NCT00272779|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6005883|NCT00272779|Antiviral Agents|antiviral agents|mesh-ancestor
6005884|NCT00272779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6005885|NCT00272779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6005886|NCT00272779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6005887|NCT00272779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6005888|NCT00272779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005889|NCT00272779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6005890|NCT00272779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6005891|NCT00272779|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6005892|NCT00272779|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6005893|NCT00272779|Protease Inhibitors|protease inhibitors|mesh-ancestor
6005894|NCT00272792|Verapamil|verapamil|mesh-list
6005895|NCT00272792|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6005896|NCT00272792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6005897|NCT00272792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6005898|NCT00272792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005899|NCT00272792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6005900|NCT00272792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005901|NCT00272792|Vasodilator Agents|vasodilator agents|mesh-ancestor
6005902|NCT00272961|N-(2-acetyl-4,6-dimethylphenyl)-3-(3,4-dimethylisoxazol-5-ylsulfamoyl)thiophene-2-carboxamide|n-(2-acetyl-4,6-dimethylphenyl)-3-(3,4-dimethylisoxazol-5-ylsulfamoyl)thiophene-2-carboxamide|mesh-list
6005903|NCT00272961|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
6005904|NCT00272961|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6005905|NCT00272961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005906|NCT00272987|Paclitaxel|paclitaxel|mesh-list
6005907|NCT00272987|Trastuzumab|trastuzumab|mesh-list
6005908|NCT00272987|Lapatinib|lapatinib|mesh-list
6005909|NCT00272987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6005910|NCT00272987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6005911|NCT00272987|Tubulin Modulators|tubulin modulators|mesh-ancestor
6005912|NCT00272987|Antimitotic Agents|antimitotic agents|mesh-ancestor
6005913|NCT00272987|Mitosis Modulators|mitosis modulators|mesh-ancestor
6005914|NCT00272987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005915|NCT00272987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6005916|NCT00272987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6005917|NCT00272987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6005918|NCT00273052|Metoprolol|metoprolol|mesh-list
6005919|NCT00273052|Carvedilol|carvedilol|mesh-list
6005920|NCT00273052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6005921|NCT00273052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6005922|NCT00273052|Sympatholytics|sympatholytics|mesh-ancestor
6005923|NCT00273052|Autonomic Agents|autonomic agents|mesh-ancestor
6005924|NCT00273052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6005925|NCT00273052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005926|NCT00273052|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6005927|NCT00273052|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6005928|NCT00273052|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6005929|NCT00273052|Adrenergic Agents|adrenergic agents|mesh-ancestor
6005930|NCT00273052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6005931|NCT00273052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005932|NCT00273052|Antioxidants|antioxidants|mesh-ancestor
6005933|NCT00273052|Protective Agents|protective agents|mesh-ancestor
6005934|NCT00273052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6005935|NCT00273052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6005936|NCT00273052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6005937|NCT00273052|Vasodilator Agents|vasodilator agents|mesh-ancestor
6005938|NCT00273052|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6005939|NCT00273052|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6005940|NCT00273754|Caffeine|caffeine|mesh-list
6005941|NCT00273754|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6005942|NCT00273754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005943|NCT00273754|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6005944|NCT00273754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6005945|NCT00273754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005946|NCT00273754|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6005947|NCT00273754|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6005948|NCT00273754|Purinergic Agents|purinergic agents|mesh-ancestor
6005949|NCT00273754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6005950|NCT00273910|Imiquimod|imiquimod|mesh-list
6005951|NCT00273910|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6005952|NCT00273910|Immunologic Factors|immunologic factors|mesh-ancestor
6005953|NCT00273910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005954|NCT00273910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6005955|NCT00273910|Interferon Inducers|interferon inducers|mesh-ancestor
6005956|NCT00274261|Nonoxynol|nonoxynol|mesh-list
6005957|NCT00274261|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
6005958|NCT00274261|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
6005959|NCT00274261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005960|NCT00274261|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6005961|NCT00274261|Contraceptive Agents|contraceptive agents|mesh-ancestor
6005962|NCT00274261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6005963|NCT00274261|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6005964|NCT00274287|Sargramostim|sargramostim|mesh-list
6005965|NCT00274287|Immunologic Factors|immunologic factors|mesh-ancestor
6005966|NCT00274287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005967|NCT00274456|Paclitaxel|paclitaxel|mesh-list
6005968|NCT00274456|Docetaxel|docetaxel|mesh-list
6005969|NCT00274456|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6005970|NCT00274456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6005971|NCT00274456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6005972|NCT00274456|Tubulin Modulators|tubulin modulators|mesh-ancestor
6005973|NCT00274456|Antimitotic Agents|antimitotic agents|mesh-ancestor
6005974|NCT00274456|Mitosis Modulators|mitosis modulators|mesh-ancestor
6005975|NCT00274456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005976|NCT00274469|Fulvestrant|fulvestrant|mesh-list
6005977|NCT00274469|Anastrozole|anastrozole|mesh-list
6005978|NCT00274469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6005979|NCT00274469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6005980|NCT00274469|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6005981|NCT00274469|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6005982|NCT00274469|Hormone Antagonists|hormone antagonists|mesh-ancestor
6005983|NCT00274469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6005984|NCT00274469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6005985|NCT00274469|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6005986|NCT00274469|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6005987|NCT00274469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6005988|NCT00274469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005989|NCT00274651|Belinostat|belinostat|mesh-list
6005990|NCT00274651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6005991|NCT00274651|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6005992|NCT00274651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6005993|NCT00274651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6005994|NCT00274742|Blinatumomab|blinatumomab|mesh-list
6005995|NCT00274742|Antibodies, Bispecific|antibodies, bispecific|mesh-list
6005996|NCT00274742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6005997|NCT00274742|Immunologic Factors|immunologic factors|mesh-ancestor
6005998|NCT00274742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260497|NCT03167151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6260498|NCT03167151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6260499|NCT03167411|Exenatide|exenatide|mesh-list
6260500|NCT03167411|Bexagliflozin|bexagliflozin|mesh-list
6260501|NCT03167411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6260502|NCT03167411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260503|NCT03167411|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6260504|NCT03167411|Incretins|incretins|mesh-ancestor
6260505|NCT03167411|Hormones|hormones|mesh-ancestor
6260506|NCT03167411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6260507|NCT03168022|Amitriptyline|amitriptyline|mesh-list
6260508|NCT03168022|Cyclobenzaprine|cyclobenzaprine|mesh-list
6260509|NCT03168022|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6260510|NCT03168022|Antidepressive Agents|antidepressive agents|mesh-ancestor
6260511|NCT03168022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6260512|NCT03168022|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6260513|NCT03168022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260514|NCT03168022|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6260515|NCT03168022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6260516|NCT03168022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6260517|NCT03168022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6260518|NCT03168022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6260519|NCT03168022|Analgesics|analgesics|mesh-ancestor
6260520|NCT03168022|Sensory System Agents|sensory system agents|mesh-ancestor
6260521|NCT03168022|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6260522|NCT03168022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6260523|NCT03168022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6260524|NCT03168022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260525|NCT03168022|Adrenergic Agents|adrenergic agents|mesh-ancestor
6260526|NCT03168022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6260527|NCT03168295|Dapagliflozin|dapagliflozin|mesh-list
6260528|NCT03168295|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6260529|NCT03168295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260530|NCT03168295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6260531|NCT03168295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260532|NCT03168308|Glycopyrrolate|glycopyrrolate|mesh-list
6260533|NCT03168308|Neostigmine|neostigmine|mesh-list
6260534|NCT03168308|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6260535|NCT03168308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6260536|NCT03168308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260537|NCT03168308|Cholinergic Agents|cholinergic agents|mesh-ancestor
6260538|NCT03168308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6260539|NCT03168308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260540|NCT03168308|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6260541|NCT03168308|Autonomic Agents|autonomic agents|mesh-ancestor
6260542|NCT03168308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6260543|NCT03168308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6260544|NCT03168308|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6260545|NCT03168308|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6260546|NCT03168841|Efinaconazole|efinaconazole|mesh-list
6260547|NCT03168841|Antifungal Agents|antifungal agents|mesh-ancestor
6260548|NCT03168841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6005999|NCT00274768|Capecitabine|capecitabine|mesh-list
6006000|NCT00274768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6006001|NCT00274768|Antimetabolites|antimetabolites|mesh-ancestor
6006002|NCT00274768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006003|NCT00274768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6006004|NCT00274781|Arsenic Trioxide|arsenic trioxide|mesh-list
6006005|NCT00274781|Gemtuzumab|gemtuzumab|mesh-list
6006006|NCT00274781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6006007|NCT00274781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6006008|NCT00274846|Aldesleukin|aldesleukin|mesh-list
6006009|NCT00274846|Cyclophosphamide|cyclophosphamide|mesh-list
6006010|NCT00274846|Fludarabine|fludarabine|mesh-list
6006011|NCT00274846|Fludarabine phosphate|fludarabine phosphate|mesh-list
6006012|NCT00274846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6006013|NCT00274846|Immunologic Factors|immunologic factors|mesh-ancestor
6006014|NCT00274846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006015|NCT00274846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6006016|NCT00274846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6006017|NCT00274846|Alkylating Agents|alkylating agents|mesh-ancestor
6006018|NCT00274846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006019|NCT00274846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6006020|NCT00274846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6006021|NCT00274846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6006022|NCT00274846|Antimetabolites|antimetabolites|mesh-ancestor
6006023|NCT00274846|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6006024|NCT00274846|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6006025|NCT00274846|Antiviral Agents|antiviral agents|mesh-ancestor
6006026|NCT00274846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6006027|NCT00274924|Prednisone|prednisone|mesh-list
6006028|NCT00274924|Cyclophosphamide|cyclophosphamide|mesh-list
6006029|NCT00274924|Ifosfamide|ifosfamide|mesh-list
6006030|NCT00274924|Rituximab|rituximab|mesh-list
6006031|NCT00274924|Carboplatin|carboplatin|mesh-list
6006032|NCT00274924|Doxorubicin|doxorubicin|mesh-list
6006033|NCT00274924|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6006034|NCT00274924|Etoposide|etoposide|mesh-list
6006035|NCT00274924|Vincristine|vincristine|mesh-list
6006036|NCT00274924|Podophyllotoxin|podophyllotoxin|mesh-list
6006037|NCT00274924|Lenograstim|lenograstim|mesh-list
6006038|NCT00274924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6006039|NCT00274924|Immunologic Factors|immunologic factors|mesh-ancestor
6006040|NCT00274924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006041|NCT00274924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6006042|NCT00274924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6006043|NCT00274924|Alkylating Agents|alkylating agents|mesh-ancestor
6006044|NCT00274924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006045|NCT00274924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6006046|NCT00274924|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6006047|NCT00274924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6006048|NCT00274924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6006049|NCT00274924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6006050|NCT00274924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6006051|NCT00274924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6006052|NCT00274924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6006053|NCT00274924|Glucocorticoids|glucocorticoids|mesh-ancestor
6006054|NCT00274924|Hormones|hormones|mesh-ancestor
6006055|NCT00274924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6006056|NCT00274924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6006057|NCT00274924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6006058|NCT00274924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6006059|NCT00274924|Tubulin Modulators|tubulin modulators|mesh-ancestor
6006060|NCT00274924|Antimitotic Agents|antimitotic agents|mesh-ancestor
6006061|NCT00274924|Mitosis Modulators|mitosis modulators|mesh-ancestor
6006062|NCT00274924|Keratolytic Agents|keratolytic agents|mesh-ancestor
6006063|NCT00274924|Dermatologic Agents|dermatologic agents|mesh-ancestor
6006064|NCT00274937|Fluorouracil|fluorouracil|mesh-list
6006065|NCT00274937|Amifostine|amifostine|mesh-list
6006066|NCT00274937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6006067|NCT00274937|Antimetabolites|antimetabolites|mesh-ancestor
6006068|NCT00274937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006069|NCT00274937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6006070|NCT00274937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6006071|NCT00274937|Immunologic Factors|immunologic factors|mesh-ancestor
6006072|NCT00274937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006073|NCT00274937|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6006074|NCT00274937|Protective Agents|protective agents|mesh-ancestor
6006075|NCT00275002|Temozolomide|temozolomide|mesh-list
6006076|NCT00275002|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
6006077|NCT00275002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6006078|NCT00275002|Alkylating Agents|alkylating agents|mesh-ancestor
6006079|NCT00275002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006080|NCT00275002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6006081|NCT00275002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6006082|NCT00275028|Cediranib|cediranib|mesh-list
6006083|NCT00275028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6006084|NCT00275028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006085|NCT00275028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6006086|NCT00275028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6006087|NCT00275262|Leuprolide|leuprolide|mesh-list
6006088|NCT00275262|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6006089|NCT00275262|Fertility Agents|fertility agents|mesh-ancestor
6006090|NCT00275262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6006091|NCT00275262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006092|NCT00275262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6006093|NCT00275262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6006094|NCT00275275|Pramipexole|pramipexole|mesh-list
6006095|NCT00275275|Ropinirole|ropinirole|mesh-list
6006096|NCT00275275|Antioxidants|antioxidants|mesh-ancestor
6006097|NCT00275275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006098|NCT00275275|Protective Agents|protective agents|mesh-ancestor
6006099|NCT00275275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006100|NCT00275275|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6006101|NCT00275275|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6006102|NCT00275275|Dopamine Agonists|dopamine agonists|mesh-ancestor
6006103|NCT00275275|Dopamine Agents|dopamine agents|mesh-ancestor
6006104|NCT00275275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6006105|NCT00275301|Olanzapine|olanzapine|mesh-list
6006106|NCT00275301|Antiemetics|antiemetics|mesh-ancestor
6006107|NCT00275301|Autonomic Agents|autonomic agents|mesh-ancestor
6006108|NCT00275301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6006109|NCT00275301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006110|NCT00275301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6006111|NCT00275301|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6006112|NCT00275301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6006113|NCT00275301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6006114|NCT00275301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6006115|NCT00275301|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6260549|NCT03168919|Temozolomide|temozolomide|mesh-list
6006116|NCT00275301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6006117|NCT00275301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6006118|NCT00275301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006119|NCT00275301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6006120|NCT00275301|Serotonin Agents|serotonin agents|mesh-ancestor
6006121|NCT00275509|Mycophenolic Acid|mycophenolic acid|mesh-list
6006122|NCT00275509|Dexamethasone|dexamethasone|mesh-list
6006123|NCT00275509|Prednisone|prednisone|mesh-list
6006124|NCT00275509|Tacrolimus|tacrolimus|mesh-list
6006125|NCT00275509|Thymoglobulin|thymoglobulin|mesh-list
6006126|NCT00275509|Daclizumab|daclizumab|mesh-list
6006127|NCT00275509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6006128|NCT00275509|Antiemetics|antiemetics|mesh-ancestor
6006129|NCT00275509|Autonomic Agents|autonomic agents|mesh-ancestor
6006130|NCT00275509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6006131|NCT00275509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006132|NCT00275509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6006133|NCT00275509|Glucocorticoids|glucocorticoids|mesh-ancestor
6006134|NCT00275509|Hormones|hormones|mesh-ancestor
6006135|NCT00275509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6006136|NCT00275509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6006137|NCT00275509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6006138|NCT00275509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6006139|NCT00275509|Immunologic Factors|immunologic factors|mesh-ancestor
6006140|NCT00275509|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6006141|NCT00275509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6006142|NCT00275509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006143|NCT00275509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6006144|NCT00275509|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6006145|NCT00275509|Antitubercular Agents|antitubercular agents|mesh-ancestor
6006146|NCT00275509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6006147|NCT00275509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6006148|NCT00275561|Fluticasone|fluticasone|mesh-list
6006149|NCT00275561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6006150|NCT00275561|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6006151|NCT00275561|Autonomic Agents|autonomic agents|mesh-ancestor
6006152|NCT00275561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6006153|NCT00275561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006154|NCT00275561|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6006155|NCT00275561|Respiratory System Agents|respiratory system agents|mesh-ancestor
6006156|NCT00275561|Dermatologic Agents|dermatologic agents|mesh-ancestor
6006157|NCT00275561|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6006158|NCT00275821|Ranibizumab|ranibizumab|mesh-list
6006159|NCT00275821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6006160|NCT00275821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6006161|NCT00275821|Growth Substances|growth substances|mesh-ancestor
6006162|NCT00275821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006163|NCT00275821|Growth Inhibitors|growth inhibitors|mesh-ancestor
6006164|NCT00275821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6006165|NCT00275834|Zonisamide|zonisamide|mesh-list
6006166|NCT00275834|Anticonvulsants|anticonvulsants|mesh-ancestor
6006167|NCT00275834|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6006168|NCT00275834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6006169|NCT00275834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006170|NCT00275834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6006171|NCT00275834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006172|NCT00276094|Tamoxifen|tamoxifen|mesh-list
6006173|NCT00276094|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6006174|NCT00276094|Hormone Antagonists|hormone antagonists|mesh-ancestor
6006175|NCT00276094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6006176|NCT00276094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006177|NCT00276094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6006178|NCT00276094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6006179|NCT00276094|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6006180|NCT00276094|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6006181|NCT00276094|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6006182|NCT00276250|Abatacept|abatacept|mesh-list
6006183|NCT00276250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6389930|NCT00189709|Fluconazole|fluconazole|mesh-list
6006184|NCT00276250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006185|NCT00276250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6006186|NCT00276250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6006187|NCT00276250|Immunologic Factors|immunologic factors|mesh-ancestor
6006188|NCT00276250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006189|NCT00276250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6006190|NCT00276380|Aspirin|aspirin|mesh-list
6006191|NCT00276380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6006192|NCT00276380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6006193|NCT00276380|Analgesics|analgesics|mesh-ancestor
6006194|NCT00276380|Sensory System Agents|sensory system agents|mesh-ancestor
6006195|NCT00276380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6006196|NCT00276380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006197|NCT00276380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6006198|NCT00276380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6006199|NCT00276380|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6006200|NCT00276380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6006201|NCT00276380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260550|NCT03168919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6260551|NCT03168919|Alkylating Agents|alkylating agents|mesh-ancestor
6260552|NCT03168919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260553|NCT03168919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6260554|NCT03169244|Bupropion|bupropion|mesh-list
6260555|NCT03169244|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6260556|NCT03169244|Antidepressive Agents|antidepressive agents|mesh-ancestor
6260557|NCT03169244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6260558|NCT03169244|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6260559|NCT03169244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6260560|NCT03169244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6260561|NCT03169244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260562|NCT03169244|Dopamine Agents|dopamine agents|mesh-ancestor
6260563|NCT03169244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6260564|NCT03169244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260565|NCT03169244|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6260566|NCT03169244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6260567|NCT03169244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6260568|NCT03170219|Furosemide|furosemide|mesh-list
6260569|NCT03170219|Diuretics|diuretics|mesh-ancestor
6260570|NCT03170219|Natriuretic Agents|natriuretic agents|mesh-ancestor
6260571|NCT03170219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260572|NCT03170219|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6260573|NCT03170219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6260574|NCT03170219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260575|NCT03170271|Benralizumab|benralizumab|mesh-list
6260576|NCT03170271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6260577|NCT03170271|Respiratory System Agents|respiratory system agents|mesh-ancestor
6260578|NCT03170544|Insulin Glargine|insulin glargine|mesh-list
6260579|NCT03170544|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6260580|NCT03170544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260581|NCT03170661|Rocuronium|rocuronium|mesh-list
6260582|NCT03170661|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6260583|NCT03170661|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6260584|NCT03170661|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6260585|NCT03170661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6260586|NCT03170661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260587|NCT03172325|Folic Acid|folic acid|mesh-list
6260588|NCT03172325|Prednisolone|prednisolone|mesh-list
6260589|NCT03172325|Adalimumab|adalimumab|mesh-list
6260590|NCT03172325|Methotrexate|methotrexate|mesh-list
6260591|NCT03172325|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6260592|NCT03172325|Abortifacient Agents|abortifacient agents|mesh-ancestor
6260593|NCT03172325|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6260594|NCT03172325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260595|NCT03172325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6260596|NCT03172325|Antimetabolites|antimetabolites|mesh-ancestor
6260597|NCT03172325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260598|NCT03172325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6006202|NCT00276380|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6006203|NCT00276380|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6006204|NCT00276380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6006205|NCT00276380|Antipyretics|antipyretics|mesh-ancestor
6006206|NCT00276406|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
6006207|NCT00276406|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6006208|NCT00276406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6006209|NCT00276406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006210|NCT00276406|Cholinergic Agents|cholinergic agents|mesh-ancestor
6006211|NCT00276406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6006212|NCT00276406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006213|NCT00276549|Gemcitabine|gemcitabine|mesh-list
6006214|NCT00276549|Docetaxel|docetaxel|mesh-list
6006215|NCT00276549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6006216|NCT00276549|Antimetabolites|antimetabolites|mesh-ancestor
6006217|NCT00276549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006218|NCT00276549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6006219|NCT00276549|Antiviral Agents|antiviral agents|mesh-ancestor
6006220|NCT00276549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6006221|NCT00276549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6006222|NCT00276549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6006223|NCT00276549|Immunologic Factors|immunologic factors|mesh-ancestor
6006224|NCT00276549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006225|NCT00276549|Tubulin Modulators|tubulin modulators|mesh-ancestor
6006226|NCT00276549|Antimitotic Agents|antimitotic agents|mesh-ancestor
6006227|NCT00276549|Mitosis Modulators|mitosis modulators|mesh-ancestor
6006228|NCT00276614|Bortezomib|bortezomib|mesh-list
6006229|NCT00276614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6006230|NCT00276744|Gemcitabine|gemcitabine|mesh-list
6006231|NCT00276744|Sirolimus|sirolimus|mesh-list
6006232|NCT00276744|Capecitabine|capecitabine|mesh-list
6006233|NCT00276744|Docetaxel|docetaxel|mesh-list
6006234|NCT00276744|Irinotecan|irinotecan|mesh-list
6006235|NCT00276744|Cetuximab|cetuximab|mesh-list
6006236|NCT00276744|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6006237|NCT00276744|Mitomycins|mitomycins|mesh-list
6006238|NCT00276744|Mitomycin|mitomycin|mesh-list
6006239|NCT00276744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6006240|NCT00276744|Antimetabolites|antimetabolites|mesh-ancestor
6006241|NCT00276744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006242|NCT00276744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6006243|NCT00276744|Antiviral Agents|antiviral agents|mesh-ancestor
6006244|NCT00276744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6006245|NCT00276744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6006246|NCT00276744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6006247|NCT00276744|Immunologic Factors|immunologic factors|mesh-ancestor
6006248|NCT00276744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006249|NCT00276744|Tubulin Modulators|tubulin modulators|mesh-ancestor
6006250|NCT00276744|Antimitotic Agents|antimitotic agents|mesh-ancestor
6006251|NCT00276744|Mitosis Modulators|mitosis modulators|mesh-ancestor
6006252|NCT00276744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6006253|NCT00276744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6006254|NCT00276744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6006255|NCT00276744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6006256|NCT00276744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6006257|NCT00276744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6006258|NCT00276744|Antifungal Agents|antifungal agents|mesh-ancestor
6006259|NCT00276744|Alkylating Agents|alkylating agents|mesh-ancestor
6006260|NCT00276744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6006261|NCT00276861|Gemcitabine|gemcitabine|mesh-list
6006262|NCT00276861|Oxaliplatin|oxaliplatin|mesh-list
6006263|NCT00276861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6006264|NCT00276861|Antimetabolites|antimetabolites|mesh-ancestor
6006265|NCT00276861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006266|NCT00276861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6006267|NCT00276861|Antiviral Agents|antiviral agents|mesh-ancestor
6006268|NCT00276861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6006269|NCT00276861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6006270|NCT00276861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6006271|NCT00276861|Immunologic Factors|immunologic factors|mesh-ancestor
6006272|NCT00276861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006273|NCT00277212|Lamotrigine|lamotrigine|mesh-list
6006274|NCT00277212|Anticonvulsants|anticonvulsants|mesh-list
6006275|NCT00277212|Aripiprazole|aripiprazole|mesh-list
6006276|NCT00277212|Antidepressive Agents|antidepressive agents|mesh-ancestor
6006277|NCT00277212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6006278|NCT00277212|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6006279|NCT00277212|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6006280|NCT00277212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6006281|NCT00277212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006282|NCT00277212|Dopamine Agonists|dopamine agonists|mesh-ancestor
6006283|NCT00277212|Dopamine Agents|dopamine agents|mesh-ancestor
6006284|NCT00277212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6006285|NCT00277212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006286|NCT00277212|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6006287|NCT00277212|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6006288|NCT00277212|Serotonin Agents|serotonin agents|mesh-ancestor
6006289|NCT00277212|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6006290|NCT00277212|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6006291|NCT00277212|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6006292|NCT00277212|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6006293|NCT00277212|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6006294|NCT00277212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6006295|NCT00277212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6006296|NCT00277212|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6006297|NCT00277355|Minocycline|minocycline|mesh-list
6006298|NCT00277355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6006299|NCT00277355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6006300|NCT00277394|Heparin|heparin|mesh-list
6006301|NCT00277394|Tinzaparin|tinzaparin|mesh-list
6006302|NCT00277394|Anticoagulants|anticoagulants|mesh-ancestor
6006303|NCT00277394|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6006304|NCT00277394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6006305|NCT00277394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006306|NCT00278109|Cyclophosphamide|cyclophosphamide|mesh-list
6006307|NCT00278109|Doxorubicin|doxorubicin|mesh-list
6006308|NCT00278109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6006309|NCT00278109|Immunologic Factors|immunologic factors|mesh-ancestor
6006310|NCT00278109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006311|NCT00278109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6006312|NCT00278109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6006313|NCT00278109|Alkylating Agents|alkylating agents|mesh-ancestor
6006314|NCT00278109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006315|NCT00278109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6006316|NCT00278109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6006317|NCT00278109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6006318|NCT00278109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6006319|NCT00278109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6006320|NCT00278109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6006321|NCT00278148|Paclitaxel|paclitaxel|mesh-list
6006322|NCT00278148|Carboplatin|carboplatin|mesh-list
6006323|NCT00278148|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6006324|NCT00278148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6006325|NCT00278148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6006326|NCT00278148|Tubulin Modulators|tubulin modulators|mesh-ancestor
6006327|NCT00278148|Antimitotic Agents|antimitotic agents|mesh-ancestor
6006328|NCT00278148|Mitosis Modulators|mitosis modulators|mesh-ancestor
6006329|NCT00278148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006330|NCT00278148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6006331|NCT00278148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6006332|NCT00278161|Cyclophosphamide|cyclophosphamide|mesh-list
6006333|NCT00278161|Rituximab|rituximab|mesh-list
6006334|NCT00278161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6006335|NCT00278161|Immunologic Factors|immunologic factors|mesh-ancestor
6006336|NCT00278161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006337|NCT00278161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6006338|NCT00278161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6006339|NCT00278161|Alkylating Agents|alkylating agents|mesh-ancestor
6006340|NCT00278161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006341|NCT00278161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6006342|NCT00278161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6006343|NCT00278161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6006344|NCT00278395|Vorinostat|vorinostat|mesh-list
6006345|NCT00278395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6006346|NCT00278395|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6006347|NCT00278395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6006348|NCT00278395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006349|NCT00278512|Cyclophosphamide|cyclophosphamide|mesh-list
6006350|NCT00278512|Fludarabine|fludarabine|mesh-list
6006351|NCT00278512|Alemtuzumab|alemtuzumab|mesh-list
6006352|NCT00278512|Tacrolimus|tacrolimus|mesh-list
6006353|NCT00278512|Thymoglobulin|thymoglobulin|mesh-list
6006354|NCT00278512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6006355|NCT00278512|Immunologic Factors|immunologic factors|mesh-ancestor
6006356|NCT00278512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006357|NCT00278512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6006358|NCT00278512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6006359|NCT00278512|Alkylating Agents|alkylating agents|mesh-ancestor
6006360|NCT00278512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006361|NCT00278512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6006362|NCT00278512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6006363|NCT00278512|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6006364|NCT00278512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6006365|NCT00278512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6006366|NCT00278564|Methylprednisolone|methylprednisolone|mesh-list
6006367|NCT00278564|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6006368|NCT00278564|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6006369|NCT00278564|Prednisolone|prednisolone|mesh-list
6006370|NCT00278564|Prednisolone acetate|prednisolone acetate|mesh-list
6006371|NCT00278564|Cyclophosphamide|cyclophosphamide|mesh-list
6006372|NCT00278564|Rituximab|rituximab|mesh-list
6006373|NCT00278564|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6006374|NCT00278564|Prednisolone phosphate|prednisolone phosphate|mesh-list
6006375|NCT00278564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6006376|NCT00278564|Immunologic Factors|immunologic factors|mesh-ancestor
6006377|NCT00278564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006378|NCT00278564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6006379|NCT00278564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6006380|NCT00278564|Alkylating Agents|alkylating agents|mesh-ancestor
6006381|NCT00278564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006382|NCT00278564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6006383|NCT00278564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6006384|NCT00278564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6006385|NCT00278564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6006386|NCT00278564|Antiemetics|antiemetics|mesh-ancestor
6006387|NCT00278564|Autonomic Agents|autonomic agents|mesh-ancestor
6006388|NCT00278564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6006389|NCT00278564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6006390|NCT00278564|Glucocorticoids|glucocorticoids|mesh-ancestor
6006391|NCT00278564|Hormones|hormones|mesh-ancestor
6006392|NCT00278564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6006393|NCT00278564|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6006394|NCT00278564|Protective Agents|protective agents|mesh-ancestor
6006395|NCT00278564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6006396|NCT00278863|Capecitabine|capecitabine|mesh-list
6006397|NCT00278863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6006398|NCT00278863|Antimetabolites|antimetabolites|mesh-ancestor
6006399|NCT00278863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260599|NCT03172325|Dermatologic Agents|dermatologic agents|mesh-ancestor
6260600|NCT03172325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6260601|NCT03172325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6260602|NCT03172325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6260603|NCT03172325|Immunologic Factors|immunologic factors|mesh-ancestor
6006400|NCT00278863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6006401|NCT00278876|Imatinib Mesylate|imatinib mesylate|mesh-list
6006402|NCT00278876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6006403|NCT00278876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6260604|NCT03172325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6260605|NCT03172325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6260606|NCT03172325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6260607|NCT03172325|Glucocorticoids|glucocorticoids|mesh-ancestor
6260608|NCT03172325|Hormones|hormones|mesh-ancestor
6260609|NCT03172325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6260610|NCT03172325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6260611|NCT03172325|Hematinics|hematinics|mesh-ancestor
6260612|NCT03172325|Vitamin B Complex|vitamin b complex|mesh-ancestor
6260613|NCT03172325|Vitamins|vitamins|mesh-ancestor
6260614|NCT03172325|Micronutrients|micronutrients|mesh-ancestor
6260615|NCT03172494|Insulin|insulin|mesh-list
6260616|NCT03172494|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6260617|NCT03172494|Liraglutide|liraglutide|mesh-list
6260618|NCT03172494|Insulin, Long-Acting|insulin, long-acting|mesh-list
6260619|NCT03172494|Xultophy|xultophy|mesh-list
6260620|NCT03172494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6260621|NCT03172494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260622|NCT03172494|Incretins|incretins|mesh-ancestor
6260623|NCT03172494|Hormones|hormones|mesh-ancestor
6260624|NCT03172494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6260625|NCT03172780|Diclofenac|diclofenac|mesh-list
6260626|NCT03172780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6260627|NCT03172780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6260628|NCT03172780|Analgesics|analgesics|mesh-ancestor
6260629|NCT03172780|Sensory System Agents|sensory system agents|mesh-ancestor
6260630|NCT03172780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6260631|NCT03172780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260632|NCT03172780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6260633|NCT03172780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6260634|NCT03172780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6260635|NCT03172780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6260636|NCT03172780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260637|NCT03173170|Itraconazole|itraconazole|mesh-list
6260638|NCT03173170|Antifungal Agents|antifungal agents|mesh-ancestor
6260639|NCT03173170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6260640|NCT03173170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6260641|NCT03173170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6260642|NCT03173170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6260643|NCT03173170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260644|NCT03173170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6260645|NCT03173170|Hormone Antagonists|hormone antagonists|mesh-ancestor
6260646|NCT03173170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6260647|NCT03173170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260648|NCT03173170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6260649|NCT03173560|Everolimus|everolimus|mesh-list
6260650|NCT03173560|Lenvatinib|lenvatinib|mesh-list
6260651|NCT03173560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6260652|NCT03173560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6260653|NCT03173560|Immunologic Factors|immunologic factors|mesh-ancestor
6260654|NCT03173560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260655|NCT03173560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6260656|NCT03173560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6260657|NCT03173560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260658|NCT03174132|Lidocaine|lidocaine|mesh-list
6260659|NCT03174132|Hyaluronic Acid|hyaluronic acid|mesh-list
6260660|NCT03174132|Anesthetics, Local|anesthetics, local|mesh-ancestor
6006404|NCT00278876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6006405|NCT00278876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006406|NCT00278889|Leucovorin|leucovorin|mesh-list
6006407|NCT00278889|Bevacizumab|bevacizumab|mesh-list
6006408|NCT00278889|Fluorouracil|fluorouracil|mesh-list
6006409|NCT00278889|Oxaliplatin|oxaliplatin|mesh-list
6006410|NCT00278889|Cediranib|cediranib|mesh-list
6006411|NCT00278889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6006412|NCT00278889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6006413|NCT00278889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6006414|NCT00278889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6006415|NCT00278889|Growth Substances|growth substances|mesh-ancestor
6006416|NCT00278889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006417|NCT00278889|Growth Inhibitors|growth inhibitors|mesh-ancestor
6006418|NCT00278889|Antimetabolites|antimetabolites|mesh-ancestor
6006419|NCT00278889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006420|NCT00278889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6006421|NCT00278889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6006422|NCT00278889|Immunologic Factors|immunologic factors|mesh-ancestor
6006423|NCT00278889|Antidotes|antidotes|mesh-ancestor
6006424|NCT00278889|Protective Agents|protective agents|mesh-ancestor
6006425|NCT00278889|Vitamin B Complex|vitamin b complex|mesh-ancestor
6006426|NCT00278889|Vitamins|vitamins|mesh-ancestor
6006427|NCT00278889|Micronutrients|micronutrients|mesh-ancestor
6006428|NCT00278889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6006429|NCT00278889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6006438|NCT00278954|Immunoglobulins|immunoglobulins|mesh-list
6006439|NCT00278954|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6006440|NCT00278954|Antibodies|antibodies|mesh-list
6006441|NCT00278954|gamma-Globulins|gamma-globulins|mesh-list
6006442|NCT00278954|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6006443|NCT00278954|Immunologic Factors|immunologic factors|mesh-ancestor
6006444|NCT00278954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006445|NCT00279201|Insulin Glargine|insulin glargine|mesh-list
6006446|NCT00279201|Insulin Lispro|insulin lispro|mesh-list
6006447|NCT00279201|Insulin, Isophane|insulin, isophane|mesh-list
6006448|NCT00279201|Biphasic Insulins|biphasic insulins|mesh-list
6006449|NCT00279201|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
6006450|NCT00279201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6006451|NCT00279201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006452|NCT00279214|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
6006453|NCT00279214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6006454|NCT00279305|Rituximab|rituximab|mesh-list
6006455|NCT00279305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6006456|NCT00279305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6006457|NCT00279305|Immunologic Factors|immunologic factors|mesh-ancestor
6006458|NCT00279305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006459|NCT00279305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6006460|NCT00279708|Atorvastatin|atorvastatin|mesh-list
6006461|NCT00279708|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6006462|NCT00279708|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6006463|NCT00279708|Antimetabolites|antimetabolites|mesh-ancestor
6006464|NCT00279708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006465|NCT00279708|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6006466|NCT00279708|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6006467|NCT00279708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6006468|NCT00279812|Selenium|selenium|mesh-list
6006469|NCT00279812|Antioxidants|antioxidants|mesh-ancestor
6006470|NCT00279812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006471|NCT00279812|Protective Agents|protective agents|mesh-ancestor
6006472|NCT00279812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006473|NCT00279812|Trace Elements|trace elements|mesh-ancestor
6006474|NCT00279812|Micronutrients|micronutrients|mesh-ancestor
6006475|NCT00279916|Triamcinolone|triamcinolone|mesh-list
6006476|NCT00279916|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6006477|NCT00279916|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6006478|NCT00279916|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6006479|NCT00279916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6006480|NCT00279916|Glucocorticoids|glucocorticoids|mesh-ancestor
6006481|NCT00279916|Hormones|hormones|mesh-ancestor
6006482|NCT00279916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6006483|NCT00279916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006484|NCT00279916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6006485|NCT00279916|Immunologic Factors|immunologic factors|mesh-ancestor
6006486|NCT00279916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6006487|NCT00279916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006488|NCT00280059|Pregabalin|pregabalin|mesh-list
6006489|NCT00280059|Lamotrigine|lamotrigine|mesh-list
6006490|NCT00280059|Analgesics|analgesics|mesh-ancestor
6006491|NCT00280059|Sensory System Agents|sensory system agents|mesh-ancestor
6006492|NCT00280059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6006493|NCT00280059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006494|NCT00280059|Anticonvulsants|anticonvulsants|mesh-ancestor
6006495|NCT00280059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6006496|NCT00280059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6006497|NCT00280059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006498|NCT00280059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6006499|NCT00280059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6006500|NCT00280059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6006501|NCT00280059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6006502|NCT00280059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6006503|NCT00280059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6006504|NCT00280059|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6006505|NCT00280150|Paclitaxel|paclitaxel|mesh-list
6006506|NCT00280150|Bevacizumab|bevacizumab|mesh-list
6006507|NCT00280150|Carboplatin|carboplatin|mesh-list
6006508|NCT00280150|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6006509|NCT00280150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6006510|NCT00280150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6006511|NCT00280150|Tubulin Modulators|tubulin modulators|mesh-ancestor
6006512|NCT00280150|Antimitotic Agents|antimitotic agents|mesh-ancestor
6006513|NCT00280150|Mitosis Modulators|mitosis modulators|mesh-ancestor
6006514|NCT00280150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006515|NCT00280150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6006516|NCT00280150|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6006517|NCT00280150|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6006518|NCT00280150|Growth Substances|growth substances|mesh-ancestor
6006519|NCT00280150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006520|NCT00280150|Growth Inhibitors|growth inhibitors|mesh-ancestor
6006521|NCT00280150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6006522|NCT00280150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6006523|NCT00280241|Cyclophosphamide|cyclophosphamide|mesh-list
6006524|NCT00280241|Rituximab|rituximab|mesh-list
6006525|NCT00280241|Fludarabine|fludarabine|mesh-list
6006526|NCT00280241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6006527|NCT00280241|Immunologic Factors|immunologic factors|mesh-ancestor
6006528|NCT00280241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006529|NCT00280241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6006530|NCT00280241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6006531|NCT00280241|Alkylating Agents|alkylating agents|mesh-ancestor
6006532|NCT00280241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006533|NCT00280241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6006534|NCT00280241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6006535|NCT00280241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6006536|NCT00280293|Lamotrigine|lamotrigine|mesh-list
6006537|NCT00280293|Anticonvulsants|anticonvulsants|mesh-ancestor
6006538|NCT00280293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6006539|NCT00280293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6006540|NCT00280293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006541|NCT00280293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6006542|NCT00280293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006543|NCT00280293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6006544|NCT00280293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6006545|NCT00280293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6006546|NCT00280293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6006547|NCT00280293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6006548|NCT00280384|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
6006549|NCT00280384|Botulinum Toxins|botulinum toxins|mesh-list
6006550|NCT00280384|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6006551|NCT00280384|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6006552|NCT00280384|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6006553|NCT00280384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6006554|NCT00280384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006555|NCT00280384|Cholinergic Agents|cholinergic agents|mesh-ancestor
6006556|NCT00280384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6006557|NCT00280384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006558|NCT00280384|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6006559|NCT00280384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6006560|NCT00280384|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6006561|NCT00280397|Lenvatinib|lenvatinib|mesh-list
6006562|NCT00280397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6006563|NCT00280397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6006564|NCT00280397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6006565|NCT00280397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006566|NCT00280566|Ziprasidone|ziprasidone|mesh-list
6006567|NCT00280566|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6006568|NCT00280566|Serotonin Agents|serotonin agents|mesh-ancestor
6006569|NCT00280566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6006570|NCT00280566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006571|NCT00280566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006572|NCT00280566|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6006573|NCT00280566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6006574|NCT00280566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6006575|NCT00280566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6006576|NCT00280566|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6006577|NCT00280566|Dopamine Agents|dopamine agents|mesh-ancestor
6006578|NCT00280735|Carboplatin|carboplatin|mesh-list
6006579|NCT00280735|Docetaxel|docetaxel|mesh-list
6006580|NCT00280735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6006581|NCT00280735|Tubulin Modulators|tubulin modulators|mesh-ancestor
6006582|NCT00280735|Antimitotic Agents|antimitotic agents|mesh-ancestor
6006583|NCT00280735|Mitosis Modulators|mitosis modulators|mesh-ancestor
6006584|NCT00280735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006585|NCT00280748|Pemetrexed|pemetrexed|mesh-list
6006586|NCT00280748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6006587|NCT00280748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6006588|NCT00280748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006589|NCT00280748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6006590|NCT00280748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6006591|NCT00281021|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6006592|NCT00281021|Digoxin|digoxin|mesh-list
6006593|NCT00281021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6006594|NCT00281021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6006595|NCT00281021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6006596|NCT00281021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006597|NCT00281021|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6006598|NCT00281021|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6006599|NCT00281021|Protective Agents|protective agents|mesh-ancestor
6006600|NCT00281021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006601|NCT00281528|Paclitaxel|paclitaxel|mesh-list
6006602|NCT00281528|Bevacizumab|bevacizumab|mesh-list
6006603|NCT00281528|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6006604|NCT00281528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6006605|NCT00281528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6006606|NCT00281528|Tubulin Modulators|tubulin modulators|mesh-ancestor
6006607|NCT00281528|Antimitotic Agents|antimitotic agents|mesh-ancestor
6006608|NCT00281528|Mitosis Modulators|mitosis modulators|mesh-ancestor
6006609|NCT00281528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006610|NCT00281528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6006611|NCT00281528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6006612|NCT00281528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6006613|NCT00281528|Growth Substances|growth substances|mesh-ancestor
6006614|NCT00281528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006615|NCT00281528|Growth Inhibitors|growth inhibitors|mesh-ancestor
6006616|NCT00281580|Amlodipine|amlodipine|mesh-list
6006617|NCT00281580|Telmisartan|telmisartan|mesh-list
6006618|NCT00281580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6006619|NCT00281580|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6006620|NCT00281580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6006621|NCT00281580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006622|NCT00281580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6006623|NCT00281580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006624|NCT00281580|Vasodilator Agents|vasodilator agents|mesh-ancestor
6006625|NCT00281580|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6006626|NCT00281580|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6006627|NCT00281671|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6006628|NCT00281671|Natriuretic Agents|natriuretic agents|mesh-ancestor
6006629|NCT00281671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006630|NCT00281697|Bevacizumab|bevacizumab|mesh-list
6006631|NCT00281697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6006632|NCT00281697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6006633|NCT00281697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6006634|NCT00281697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6006635|NCT00281697|Growth Substances|growth substances|mesh-ancestor
6006636|NCT00281697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006637|NCT00281697|Growth Inhibitors|growth inhibitors|mesh-ancestor
6018217|NCT00378703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6018218|NCT00378703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6018219|NCT00378703|Antifungal Agents|antifungal agents|mesh-ancestor
6018220|NCT00378703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6018221|NCT00379145|Trabectedin|trabectedin|mesh-list
6018222|NCT00379145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6018223|NCT00379145|Alkylating Agents|alkylating agents|mesh-ancestor
6018224|NCT00379145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6018225|NCT00379145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6018226|NCT00379197|Naltrexone|naltrexone|mesh-list
6018227|NCT00379197|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6018228|NCT00379197|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6006638|NCT00281827|Gemcitabine|gemcitabine|mesh-list
6006639|NCT00281827|Thalidomide|thalidomide|mesh-list
6006640|NCT00281827|Carboplatin|carboplatin|mesh-list
6006641|NCT00281827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6006642|NCT00281827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6006643|NCT00281827|Antimetabolites|antimetabolites|mesh-ancestor
6006644|NCT00281827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006645|NCT00281827|Antiviral Agents|antiviral agents|mesh-ancestor
6006646|NCT00281827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6006647|NCT00281827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6006648|NCT00281827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6006649|NCT00281827|Immunologic Factors|immunologic factors|mesh-ancestor
6006650|NCT00281827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006651|NCT00281827|Leprostatic Agents|leprostatic agents|mesh-ancestor
6006652|NCT00281827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6006653|NCT00281827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6006654|NCT00281827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6006655|NCT00281827|Growth Substances|growth substances|mesh-ancestor
6006656|NCT00281827|Growth Inhibitors|growth inhibitors|mesh-ancestor
6006657|NCT00281840|Bevacizumab|bevacizumab|mesh-list
6006658|NCT00281840|Docetaxel|docetaxel|mesh-list
6006659|NCT00281840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6006660|NCT00281840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6006661|NCT00281840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6006662|NCT00281840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6006663|NCT00281840|Growth Substances|growth substances|mesh-ancestor
6006664|NCT00281840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006665|NCT00281840|Growth Inhibitors|growth inhibitors|mesh-ancestor
6006666|NCT00281840|Tubulin Modulators|tubulin modulators|mesh-ancestor
6006667|NCT00281840|Antimitotic Agents|antimitotic agents|mesh-ancestor
6006668|NCT00281840|Mitosis Modulators|mitosis modulators|mesh-ancestor
6006669|NCT00281840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006670|NCT00281918|Cyclophosphamide|cyclophosphamide|mesh-list
6006671|NCT00281918|Rituximab|rituximab|mesh-list
6006672|NCT00281918|Fludarabine|fludarabine|mesh-list
6006673|NCT00281918|Fludarabine phosphate|fludarabine phosphate|mesh-list
6006674|NCT00281918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6006675|NCT00281918|Immunologic Factors|immunologic factors|mesh-ancestor
6006676|NCT00281918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006677|NCT00281918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6006678|NCT00281918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6006679|NCT00281918|Alkylating Agents|alkylating agents|mesh-ancestor
6006680|NCT00281918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006681|NCT00281918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6006682|NCT00281918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6006683|NCT00281918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6006684|NCT00281918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6006685|NCT00281918|Antimetabolites|antimetabolites|mesh-ancestor
6006686|NCT00281957|Sirolimus|sirolimus|mesh-list
6006687|NCT00281957|Sorafenib|sorafenib|mesh-list
6006688|NCT00281957|Tipifarnib|tipifarnib|mesh-list
6006689|NCT00281957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6006690|NCT00281957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6006691|NCT00281957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6006692|NCT00281957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006693|NCT00281957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6006694|NCT00281957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6006695|NCT00281957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6260661|NCT03174132|Anesthetics|anesthetics|mesh-ancestor
6260662|NCT03174132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6260663|NCT03174132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260664|NCT03174132|Sensory System Agents|sensory system agents|mesh-ancestor
6006696|NCT00281957|Antifungal Agents|antifungal agents|mesh-ancestor
6006697|NCT00281957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6006698|NCT00281957|Immunologic Factors|immunologic factors|mesh-ancestor
6006699|NCT00281957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006700|NCT00282048|Axitinib|axitinib|mesh-list
6006701|NCT00282048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6006702|NCT00282048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6006703|NCT00282048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6006704|NCT00282048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006705|NCT00282087|Gemcitabine|gemcitabine|mesh-list
6006706|NCT00282087|Docetaxel|docetaxel|mesh-list
6006707|NCT00282087|Doxorubicin|doxorubicin|mesh-list
6006708|NCT00282087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6006709|NCT00282087|Antimetabolites|antimetabolites|mesh-ancestor
6006710|NCT00282087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006711|NCT00282087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6006712|NCT00282087|Antiviral Agents|antiviral agents|mesh-ancestor
6006713|NCT00282087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6006714|NCT00282087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6006715|NCT00282087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6006716|NCT00282087|Immunologic Factors|immunologic factors|mesh-ancestor
6006717|NCT00282087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006718|NCT00282087|Tubulin Modulators|tubulin modulators|mesh-ancestor
6006719|NCT00282087|Antimitotic Agents|antimitotic agents|mesh-ancestor
6006720|NCT00282087|Mitosis Modulators|mitosis modulators|mesh-ancestor
6006721|NCT00282087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6006722|NCT00282087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6006723|NCT00282087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6006724|NCT00282243|Tacrolimus|tacrolimus|mesh-list
6006725|NCT00282243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6006726|NCT00282243|Immunologic Factors|immunologic factors|mesh-ancestor
6006727|NCT00282243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006728|NCT00282243|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6006729|NCT00282243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6006730|NCT00282243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006731|NCT00282256|Tacrolimus|tacrolimus|mesh-list
6006732|NCT00282256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6006733|NCT00282256|Immunologic Factors|immunologic factors|mesh-ancestor
6006734|NCT00282256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006735|NCT00282256|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6006736|NCT00282256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6006737|NCT00282256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006738|NCT00282282|Sirolimus|sirolimus|mesh-list
6006739|NCT00282282|Fludarabine|fludarabine|mesh-list
6006740|NCT00282282|Busulfan|busulfan|mesh-list
6006741|NCT00282282|Tacrolimus|tacrolimus|mesh-list
6006742|NCT00282282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6006743|NCT00282282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006744|NCT00282282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6006745|NCT00282282|Immunologic Factors|immunologic factors|mesh-ancestor
6006746|NCT00282282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006747|NCT00282282|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6006748|NCT00282282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6006749|NCT00282282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6006750|NCT00282282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6006751|NCT00282282|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6006752|NCT00282282|Antifungal Agents|antifungal agents|mesh-ancestor
6006753|NCT00282282|Alkylating Agents|alkylating agents|mesh-ancestor
6006754|NCT00282282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6006755|NCT00282282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6006756|NCT00282308|Rituximab|rituximab|mesh-list
6006757|NCT00282308|Methotrexate|methotrexate|mesh-list
6006758|NCT00282308|Vaccines|vaccines|mesh-list
6006759|NCT00282308|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6006760|NCT00282308|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
6006761|NCT00282308|Immunologic Factors|immunologic factors|mesh-ancestor
6006762|NCT00282308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006763|NCT00282308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6006764|NCT00282308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6006765|NCT00282308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6006766|NCT00282308|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6006767|NCT00282308|Abortifacient Agents|abortifacient agents|mesh-ancestor
6006768|NCT00282308|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6006769|NCT00282308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6006770|NCT00282308|Antimetabolites|antimetabolites|mesh-ancestor
6006771|NCT00282308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006772|NCT00282308|Dermatologic Agents|dermatologic agents|mesh-ancestor
6006773|NCT00282308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6006774|NCT00282308|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6006775|NCT00282308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6006776|NCT00282308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6006777|NCT00282308|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6006778|NCT00282347|Acetaminophen|acetaminophen|mesh-list
6006779|NCT00282347|Diphenhydramine|diphenhydramine|mesh-list
6006780|NCT00282347|Promethazine|promethazine|mesh-list
6006781|NCT00282347|Mycophenolic Acid|mycophenolic acid|mesh-list
6006782|NCT00282347|Prednisone|prednisone|mesh-list
6006783|NCT00282347|Methylprednisolone|methylprednisolone|mesh-list
6006784|NCT00282347|Rituximab|rituximab|mesh-list
6006785|NCT00282347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6006786|NCT00282347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6006787|NCT00282347|Immunologic Factors|immunologic factors|mesh-ancestor
6006788|NCT00282347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006789|NCT00282347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6006790|NCT00282347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6006791|NCT00282347|Glucocorticoids|glucocorticoids|mesh-ancestor
6006792|NCT00282347|Hormones|hormones|mesh-ancestor
6006793|NCT00282347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6006794|NCT00282347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6006795|NCT00282347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6006796|NCT00282347|Analgesics|analgesics|mesh-ancestor
6006797|NCT00282347|Sensory System Agents|sensory system agents|mesh-ancestor
6006798|NCT00282347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6006799|NCT00282347|Antipyretics|antipyretics|mesh-ancestor
6389931|NCT00189709|Micafungin|micafungin|mesh-list
6006800|NCT00282347|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6006801|NCT00282347|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6006802|NCT00282347|Antitubercular Agents|antitubercular agents|mesh-ancestor
6006803|NCT00282347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6006804|NCT00282347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6006805|NCT00282347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6006806|NCT00282347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006807|NCT00282347|Antiemetics|antiemetics|mesh-ancestor
6006808|NCT00282347|Autonomic Agents|autonomic agents|mesh-ancestor
6006809|NCT00282347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6006810|NCT00282347|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6006811|NCT00282347|Protective Agents|protective agents|mesh-ancestor
6006812|NCT00282347|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6006813|NCT00282347|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6006814|NCT00282347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6006815|NCT00282347|Anesthetics, Local|anesthetics, local|mesh-ancestor
6006816|NCT00282347|Anesthetics|anesthetics|mesh-ancestor
6006817|NCT00282347|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6006818|NCT00282347|Histamine Antagonists|histamine antagonists|mesh-ancestor
6006819|NCT00282347|Histamine Agents|histamine agents|mesh-ancestor
6006820|NCT00282347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6006821|NCT00282347|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6006822|NCT00282347|Antipruritics|antipruritics|mesh-ancestor
6006823|NCT00282347|Dermatologic Agents|dermatologic agents|mesh-ancestor
6006824|NCT00282412|Cyclosporine|cyclosporine|mesh-list
6006825|NCT00282412|Mycophenolic Acid|mycophenolic acid|mesh-list
6006826|NCT00282412|Cyclophosphamide|cyclophosphamide|mesh-list
6006827|NCT00282412|Fludarabine|fludarabine|mesh-list
6006828|NCT00282412|Alemtuzumab|alemtuzumab|mesh-list
6006829|NCT00282412|Cyclosporins|cyclosporins|mesh-list
6006830|NCT00282412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6006831|NCT00282412|Immunologic Factors|immunologic factors|mesh-ancestor
6006832|NCT00282412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006833|NCT00282412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6006834|NCT00282412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6006835|NCT00282412|Alkylating Agents|alkylating agents|mesh-ancestor
6006836|NCT00282412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006837|NCT00282412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6006838|NCT00282412|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6006839|NCT00282412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6006840|NCT00282412|Antifungal Agents|antifungal agents|mesh-ancestor
6006841|NCT00282412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6006842|NCT00282412|Dermatologic Agents|dermatologic agents|mesh-ancestor
6006843|NCT00282412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6006844|NCT00282412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6006845|NCT00282412|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6006846|NCT00282412|Antitubercular Agents|antitubercular agents|mesh-ancestor
6006847|NCT00282412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6006848|NCT00282412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6006849|NCT00282464|Ziprasidone|ziprasidone|mesh-list
6006850|NCT00282464|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6006851|NCT00282464|Serotonin Agents|serotonin agents|mesh-ancestor
6006852|NCT00282464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6006853|NCT00282464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006854|NCT00282464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006855|NCT00282464|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6006856|NCT00282464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6006857|NCT00282464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6006858|NCT00282464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6006859|NCT00282464|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6006860|NCT00282464|Dopamine Agents|dopamine agents|mesh-ancestor
6006861|NCT00282568|Tacrolimus|tacrolimus|mesh-list
6006862|NCT00282568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6006863|NCT00282568|Immunologic Factors|immunologic factors|mesh-ancestor
6006864|NCT00282568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006865|NCT00282568|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6006866|NCT00282568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6006867|NCT00282568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006868|NCT00282828|Clonazepam|clonazepam|mesh-list
6006869|NCT00282828|Sertraline|sertraline|mesh-list
6006870|NCT00282828|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6006871|NCT00282828|Antidepressive Agents|antidepressive agents|mesh-ancestor
6006872|NCT00282828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6006873|NCT00282828|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6006874|NCT00282828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6006875|NCT00282828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6006876|NCT00282828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006877|NCT00282828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6006878|NCT00282828|Serotonin Agents|serotonin agents|mesh-ancestor
6006879|NCT00282828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006880|NCT00282828|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6006881|NCT00282828|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6006882|NCT00282828|Anticonvulsants|anticonvulsants|mesh-ancestor
6006883|NCT00282828|GABA Modulators|gaba modulators|mesh-ancestor
6006884|NCT00282828|GABA Agents|gaba agents|mesh-ancestor
6006885|NCT00282919|Azithromycin|azithromycin|mesh-list
6006886|NCT00282919|Chloroquine|chloroquine|mesh-list
6006887|NCT00282919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6006888|NCT00282919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6006889|NCT00282919|Amebicides|amebicides|mesh-ancestor
6006890|NCT00282919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6006891|NCT00282919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6006892|NCT00282919|Antimalarials|antimalarials|mesh-ancestor
6006893|NCT00282919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6006894|NCT00282971|Insulin|insulin|mesh-list
6006895|NCT00282971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6006896|NCT00282971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006897|NCT00282984|Varenicline|varenicline|mesh-list
6006898|NCT00282984|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6006899|NCT00282984|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6006900|NCT00282984|Cholinergic Agents|cholinergic agents|mesh-ancestor
6006901|NCT00282984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6006902|NCT00282984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006903|NCT00282984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006904|NCT00283049|Insulin|insulin|mesh-list
6006905|NCT00283049|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6006906|NCT00283049|Insulin Glargine|insulin glargine|mesh-list
6006907|NCT00283049|Insulin glulisine|insulin glulisine|mesh-list
6006908|NCT00283049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6006909|NCT00283049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006910|NCT00283062|Docetaxel|docetaxel|mesh-list
6006911|NCT00283062|Leuprolide|leuprolide|mesh-list
6006912|NCT00283062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6006913|NCT00283062|Tubulin Modulators|tubulin modulators|mesh-ancestor
6006914|NCT00283062|Antimitotic Agents|antimitotic agents|mesh-ancestor
6006915|NCT00283062|Mitosis Modulators|mitosis modulators|mesh-ancestor
6006916|NCT00283062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006917|NCT00283062|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6006918|NCT00283062|Fertility Agents|fertility agents|mesh-ancestor
6006919|NCT00283062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6006920|NCT00283062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006921|NCT00283062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6006922|NCT00283244|Gemcitabine|gemcitabine|mesh-list
6006923|NCT00283244|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6006924|NCT00283244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6006925|NCT00283244|Antimetabolites|antimetabolites|mesh-ancestor
6006926|NCT00283244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006927|NCT00283244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6006928|NCT00283244|Antiviral Agents|antiviral agents|mesh-ancestor
6006929|NCT00283244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6006930|NCT00283244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6006931|NCT00283244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6006932|NCT00283244|Immunologic Factors|immunologic factors|mesh-ancestor
6006933|NCT00283244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006934|NCT00283244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6006935|NCT00283387|Betaine|betaine|mesh-list
6006936|NCT00283387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6006937|NCT00283387|Lipotropic Agents|lipotropic agents|mesh-ancestor
6006938|NCT00283387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6006939|NCT00283387|Antimetabolites|antimetabolites|mesh-ancestor
6006940|NCT00283387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006941|NCT00283387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6006942|NCT00283504|Omalizumab|omalizumab|mesh-list
6006943|NCT00283504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6006944|NCT00283504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6006945|NCT00283504|Respiratory System Agents|respiratory system agents|mesh-ancestor
6006946|NCT00283595|Hormones|hormones|mesh-list
6006947|NCT00283595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6006948|NCT00283595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006949|NCT00283686|Telmisartan|telmisartan|mesh-list
6006950|NCT00283686|Lisinopril|lisinopril|mesh-list
6006951|NCT00283686|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6006952|NCT00283686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6006953|NCT00283686|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6006954|NCT00283686|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6006955|NCT00283686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006956|NCT00283686|Protease Inhibitors|protease inhibitors|mesh-ancestor
6006957|NCT00283686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6006958|NCT00283686|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6006959|NCT00283686|Protective Agents|protective agents|mesh-ancestor
6006960|NCT00283686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006961|NCT00283712|Infliximab|infliximab|mesh-list
6006962|NCT00283712|Dermatologic Agents|dermatologic agents|mesh-ancestor
6006963|NCT00283712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6006964|NCT00283712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6006965|NCT00283803|Sulindac sulfone|sulindac sulfone|mesh-list
6006966|NCT00283803|Hormones|hormones|mesh-list
6006967|NCT00283803|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
6006968|NCT00283803|Androgen Antagonists|androgen antagonists|mesh-list
6006969|NCT00283803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6006970|NCT00283803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006971|NCT00283803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6006972|NCT00283803|Hormone Antagonists|hormone antagonists|mesh-ancestor
6006973|NCT00283803|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6006974|NCT00283803|Protective Agents|protective agents|mesh-ancestor
6006975|NCT00283803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6006976|NCT00283803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6006977|NCT00283803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6006978|NCT00283803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6006979|NCT00283803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6006980|NCT00283803|Analgesics|analgesics|mesh-ancestor
6006981|NCT00283803|Sensory System Agents|sensory system agents|mesh-ancestor
6006982|NCT00283803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6006983|NCT00283803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6006984|NCT00283803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6006985|NCT00283816|Metformin|metformin|mesh-list
6006986|NCT00283816|Contraceptive Agents|contraceptive agents|mesh-list
6006987|NCT00283816|Contraceptives, Oral|contraceptives, oral|mesh-list
6006988|NCT00283816|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
6006989|NCT00283816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6006990|NCT00283816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006991|NCT00283816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6006992|NCT00283816|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6006993|NCT00284050|Ranibizumab|ranibizumab|mesh-list
6006994|NCT00284050|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6006995|NCT00284050|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6006996|NCT00284050|Growth Substances|growth substances|mesh-ancestor
6006997|NCT00284050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6006998|NCT00284050|Growth Inhibitors|growth inhibitors|mesh-ancestor
6006999|NCT00284050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6007000|NCT00284089|Ranibizumab|ranibizumab|mesh-list
6007001|NCT00284089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6007002|NCT00284089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6007003|NCT00284089|Growth Substances|growth substances|mesh-ancestor
6007004|NCT00284089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007005|NCT00284089|Growth Inhibitors|growth inhibitors|mesh-ancestor
6007006|NCT00284089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6007007|NCT00284141|Aflibercept|aflibercept|mesh-list
6007008|NCT00284141|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6007009|NCT00284141|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6007010|NCT00284141|Growth Substances|growth substances|mesh-ancestor
6007011|NCT00284141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007012|NCT00284141|Growth Inhibitors|growth inhibitors|mesh-ancestor
6007013|NCT00284141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6007014|NCT00284180|Trastuzumab|trastuzumab|mesh-list
6007015|NCT00284180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6007016|NCT00284180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6007017|NCT00284518|Botulinum Toxins|botulinum toxins|mesh-list
6007018|NCT00284518|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6007019|NCT00284518|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6007020|NCT00284518|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6007021|NCT00284518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6007022|NCT00284518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6007023|NCT00284518|Cholinergic Agents|cholinergic agents|mesh-ancestor
6007024|NCT00284518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6007025|NCT00284518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007026|NCT00284518|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6007027|NCT00284518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6007028|NCT00284739|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6007029|NCT00284739|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6007030|NCT00284739|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6007031|NCT00284739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6007032|NCT00284934|Mycophenolic Acid|mycophenolic acid|mesh-list
6007033|NCT00284934|Prednisone|prednisone|mesh-list
6007034|NCT00284934|Tacrolimus|tacrolimus|mesh-list
6007035|NCT00284934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6007036|NCT00284934|Glucocorticoids|glucocorticoids|mesh-ancestor
6007037|NCT00284934|Hormones|hormones|mesh-ancestor
6007038|NCT00284934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6007039|NCT00284934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007040|NCT00284934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6007041|NCT00284934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6007042|NCT00284934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6007043|NCT00284934|Immunologic Factors|immunologic factors|mesh-ancestor
6007044|NCT00284934|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6007045|NCT00284934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6007046|NCT00284934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6007047|NCT00284934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6007048|NCT00284934|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6007049|NCT00284934|Antitubercular Agents|antitubercular agents|mesh-ancestor
6007050|NCT00284934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6007051|NCT00284934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6260665|NCT03174132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6260666|NCT03174132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6260667|NCT03174132|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6260668|NCT03174132|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6260669|NCT03174132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6260670|NCT03174132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260671|NCT03174132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6260672|NCT03174132|Immunologic Factors|immunologic factors|mesh-ancestor
6007052|NCT00285012|Varenicline|varenicline|mesh-list
6007053|NCT00285012|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6007054|NCT00285012|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6007055|NCT00285012|Cholinergic Agents|cholinergic agents|mesh-ancestor
6007056|NCT00285012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6007057|NCT00285012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6007058|NCT00285012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007059|NCT00285467|Vitamin D|vitamin d|mesh-list
6007060|NCT00285467|Cholecalciferol|cholecalciferol|mesh-list
6007061|NCT00285467|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
6007062|NCT00285467|Vitamins|vitamins|mesh-ancestor
6007063|NCT00285467|Micronutrients|micronutrients|mesh-ancestor
6007064|NCT00285467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007065|NCT00285467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6007066|NCT00285467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6007067|NCT00285584|Bupropion|bupropion|mesh-list
6007068|NCT00285584|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6007069|NCT00285584|Antidepressive Agents|antidepressive agents|mesh-ancestor
6007070|NCT00285584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6007071|NCT00285584|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6007072|NCT00285584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6007073|NCT00285584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6007074|NCT00285584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6007075|NCT00285584|Dopamine Agents|dopamine agents|mesh-ancestor
6007076|NCT00285584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6007077|NCT00285584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007078|NCT00285584|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6007079|NCT00285584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6007080|NCT00285584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6007081|NCT00285779|Etanercept|etanercept|mesh-list
6007082|NCT00285779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6007083|NCT00285779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6007084|NCT00285779|Analgesics|analgesics|mesh-ancestor
6007085|NCT00285779|Sensory System Agents|sensory system agents|mesh-ancestor
6007086|NCT00285779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6007087|NCT00285779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007088|NCT00285779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6007089|NCT00285779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6007090|NCT00285779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6007091|NCT00285779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6007092|NCT00285779|Immunologic Factors|immunologic factors|mesh-ancestor
6007093|NCT00285818|Mifepristone|mifepristone|mesh-list
6007094|NCT00285818|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6007095|NCT00285818|Abortifacient Agents|abortifacient agents|mesh-ancestor
6007096|NCT00285818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6007097|NCT00285818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007098|NCT00285818|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6007099|NCT00285818|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6007100|NCT00285818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6007101|NCT00285818|Contraceptive Agents|contraceptive agents|mesh-ancestor
6007102|NCT00285818|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6007103|NCT00285818|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6007104|NCT00285818|Hormone Antagonists|hormone antagonists|mesh-ancestor
6007105|NCT00285818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6007106|NCT00285818|Luteolytic Agents|luteolytic agents|mesh-ancestor
6007107|NCT00285818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6007108|NCT00285818|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6007109|NCT00285857|Lovastatin|lovastatin|mesh-list
6007110|NCT00285857|L 647318|l 647318|mesh-list
6007111|NCT00285857|Dihydromevinolin|dihydromevinolin|mesh-list
6007112|NCT00285857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6007113|NCT00285857|Antimetabolites|antimetabolites|mesh-ancestor
6007114|NCT00285857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6007115|NCT00285857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6007116|NCT00285857|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6007117|NCT00285857|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6007118|NCT00285857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6007119|NCT00286091|Denosumab|denosumab|mesh-list
6007120|NCT00286091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6007121|NCT00286091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007122|NCT00286156|Sirolimus|sirolimus|mesh-list
6007123|NCT00286156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6007124|NCT00286156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6007125|NCT00286156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6007126|NCT00286156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6007127|NCT00286156|Antifungal Agents|antifungal agents|mesh-ancestor
6007128|NCT00286156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6007129|NCT00286156|Immunologic Factors|immunologic factors|mesh-ancestor
6007130|NCT00286156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007131|NCT00286182|Epoetin Alfa|epoetin alfa|mesh-list
6007132|NCT00286182|Hematinics|hematinics|mesh-ancestor
6007133|NCT00286221|Fentanyl|fentanyl|mesh-list
6007134|NCT00286221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6007135|NCT00286221|Narcotics|narcotics|mesh-ancestor
6007136|NCT00286221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6007137|NCT00286221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007138|NCT00286221|Analgesics|analgesics|mesh-ancestor
6007139|NCT00286221|Sensory System Agents|sensory system agents|mesh-ancestor
6007140|NCT00286221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6007141|NCT00286221|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6007142|NCT00286221|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6007143|NCT00286221|Anesthetics, General|anesthetics, general|mesh-ancestor
6007144|NCT00286221|Anesthetics|anesthetics|mesh-ancestor
6007145|NCT00286234|Niacin|niacin|mesh-list
6007146|NCT00286234|Nicotinic Acids|nicotinic acids|mesh-list
6007147|NCT00286234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6007148|NCT00286234|Antimetabolites|antimetabolites|mesh-ancestor
6007149|NCT00286234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6007150|NCT00286234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6007151|NCT00286234|Vasodilator Agents|vasodilator agents|mesh-ancestor
6007152|NCT00286234|Vitamin B Complex|vitamin b complex|mesh-ancestor
6007153|NCT00286234|Vitamins|vitamins|mesh-ancestor
6007154|NCT00286234|Micronutrients|micronutrients|mesh-ancestor
6007155|NCT00286234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007156|NCT00286325|Rituximab|rituximab|mesh-list
6007157|NCT00286325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6007158|NCT00286325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6007159|NCT00286325|Immunologic Factors|immunologic factors|mesh-ancestor
6007160|NCT00286325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007161|NCT00286325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6007162|NCT00286429|Insulin|insulin|mesh-list
6007163|NCT00286429|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6260673|NCT03174132|Viscosupplements|viscosupplements|mesh-ancestor
6007164|NCT00286429|Alogliptin|alogliptin|mesh-list
6260674|NCT03174132|Protective Agents|protective agents|mesh-ancestor
6007165|NCT00286429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6007166|NCT00286429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007167|NCT00286429|Incretins|incretins|mesh-ancestor
6007168|NCT00286429|Hormones|hormones|mesh-ancestor
6007169|NCT00286429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6007170|NCT00286429|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6007171|NCT00286429|Protease Inhibitors|protease inhibitors|mesh-ancestor
6007172|NCT00286429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6007173|NCT00286429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6007174|NCT00286442|Metformin|metformin|mesh-list
6007175|NCT00286442|Alogliptin|alogliptin|mesh-list
6007176|NCT00286442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6007177|NCT00286442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007178|NCT00286442|Incretins|incretins|mesh-ancestor
6007179|NCT00286442|Hormones|hormones|mesh-ancestor
6007180|NCT00286442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6007181|NCT00286442|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6007182|NCT00286442|Protease Inhibitors|protease inhibitors|mesh-ancestor
6007183|NCT00286442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6007184|NCT00286442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6007185|NCT00286455|Alogliptin|alogliptin|mesh-list
6007186|NCT00286455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6007187|NCT00286455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007188|NCT00286455|Incretins|incretins|mesh-ancestor
6007189|NCT00286455|Hormones|hormones|mesh-ancestor
6007190|NCT00286455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6007191|NCT00286455|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6007192|NCT00286455|Protease Inhibitors|protease inhibitors|mesh-ancestor
6007193|NCT00286455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6007194|NCT00286455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6007195|NCT00286468|Alogliptin|alogliptin|mesh-list
6007196|NCT00286468|Glyburide|glyburide|mesh-list
6007197|NCT00286468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6007198|NCT00286468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007199|NCT00286468|Incretins|incretins|mesh-ancestor
6007200|NCT00286468|Hormones|hormones|mesh-ancestor
6007201|NCT00286468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6007202|NCT00286468|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6007203|NCT00286468|Protease Inhibitors|protease inhibitors|mesh-ancestor
6007204|NCT00286468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6007205|NCT00286468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6007206|NCT00286494|Pioglitazone|pioglitazone|mesh-list
6007207|NCT00286494|Alogliptin|alogliptin|mesh-list
6007208|NCT00286494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6007209|NCT00286494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007210|NCT00286494|Incretins|incretins|mesh-ancestor
6007211|NCT00286494|Hormones|hormones|mesh-ancestor
6007212|NCT00286494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6007213|NCT00286494|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6007214|NCT00286494|Protease Inhibitors|protease inhibitors|mesh-ancestor
6007215|NCT00286494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6007216|NCT00286494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6007217|NCT00286949|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6007218|NCT00286949|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6007219|NCT00286949|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6007220|NCT00286949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6007221|NCT00286949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6007222|NCT00286949|Adrenergic Agents|adrenergic agents|mesh-ancestor
6007223|NCT00286949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6007224|NCT00286949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007225|NCT00287053|Valproic Acid|valproic acid|mesh-list
6007226|NCT00287053|Anticonvulsants|anticonvulsants|mesh-ancestor
6007227|NCT00287053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6007228|NCT00287053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6007229|NCT00287053|GABA Agents|gaba agents|mesh-ancestor
6007230|NCT00287053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6007231|NCT00287053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007232|NCT00287053|Antimanic Agents|antimanic agents|mesh-ancestor
6007233|NCT00287053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6007234|NCT00287053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6007235|NCT00287053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6007236|NCT00287222|Bevacizumab|bevacizumab|mesh-list
6007237|NCT00287222|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6007238|NCT00287222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6007239|NCT00287222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6007240|NCT00287222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6007241|NCT00287222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6007242|NCT00287222|Growth Substances|growth substances|mesh-ancestor
6007243|NCT00287222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007244|NCT00287222|Growth Inhibitors|growth inhibitors|mesh-ancestor
6007245|NCT00287222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6007246|NCT00287222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6007247|NCT00287222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6007248|NCT00287287|Lenalidomide|lenalidomide|mesh-list
6007249|NCT00287287|Immunologic Factors|immunologic factors|mesh-ancestor
6007250|NCT00287287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007251|NCT00287287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6007252|NCT00287287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6007253|NCT00287287|Growth Substances|growth substances|mesh-ancestor
6007254|NCT00287287|Growth Inhibitors|growth inhibitors|mesh-ancestor
6007255|NCT00287287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6007256|NCT00287339|Esomeprazole|esomeprazole|mesh-list
6007257|NCT00287339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6007258|NCT00287339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6007259|NCT00287339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6007260|NCT00287339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6007261|NCT00287339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260675|NCT03174158|Nicotine|nicotine|mesh-list
6260676|NCT03174158|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6260677|NCT03174158|Autonomic Agents|autonomic agents|mesh-ancestor
6260678|NCT03174158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6260679|NCT03174158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260680|NCT03174158|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6260681|NCT03174158|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6260682|NCT03174158|Cholinergic Agents|cholinergic agents|mesh-ancestor
6260683|NCT03174158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6260684|NCT03174158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260685|NCT03174366|Denosumab|denosumab|mesh-list
6260686|NCT03174366|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6260687|NCT03174366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260688|NCT03175120|Insulin|insulin|mesh-list
6260689|NCT03175120|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6260690|NCT03175120|Liraglutide|liraglutide|mesh-list
6260691|NCT03175120|Insulin, Long-Acting|insulin, long-acting|mesh-list
6260692|NCT03175120|Xultophy|xultophy|mesh-list
6260693|NCT03175120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6260694|NCT03175120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260695|NCT03175120|Incretins|incretins|mesh-ancestor
6260696|NCT03175120|Hormones|hormones|mesh-ancestor
6260697|NCT03175120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6260698|NCT03175172|Pembrolizumab|pembrolizumab|mesh-list
6260699|NCT03175172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6260700|NCT03175172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6260701|NCT03175731|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
6260702|NCT03175731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6260703|NCT03175731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260704|NCT03176238|Everolimus|everolimus|mesh-list
6260705|NCT03176238|Exemestane|exemestane|mesh-list
6260706|NCT03176238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6260707|NCT03176238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6260708|NCT03176238|Immunologic Factors|immunologic factors|mesh-ancestor
6007262|NCT00287586|Testosterone|testosterone|mesh-list
6007263|NCT00287586|Androgens|androgens|mesh-ancestor
6007264|NCT00287586|Hormones|hormones|mesh-ancestor
6007265|NCT00287586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6007266|NCT00287586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007267|NCT00287690|Genistein|genistein|mesh-list
6007268|NCT00287690|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6007269|NCT00287690|Protective Agents|protective agents|mesh-ancestor
6007270|NCT00287690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007271|NCT00287690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6007272|NCT00287690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6007273|NCT00287690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6007274|NCT00287690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6007275|NCT00287690|Phytoestrogens|phytoestrogens|mesh-ancestor
6007276|NCT00287690|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6007277|NCT00287690|Estrogens|estrogens|mesh-ancestor
6007278|NCT00287690|Hormones|hormones|mesh-ancestor
6007279|NCT00287690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6007280|NCT00287716|Pirfenidone|pirfenidone|mesh-list
6007281|NCT00287716|Analgesics|analgesics|mesh-ancestor
6007282|NCT00287716|Sensory System Agents|sensory system agents|mesh-ancestor
6007283|NCT00287716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6007284|NCT00287716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007285|NCT00287716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6007286|NCT00287716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6007287|NCT00287716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6007288|NCT00287716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6007289|NCT00287716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6007290|NCT00287729|Pirfenidone|pirfenidone|mesh-list
6007291|NCT00287729|Analgesics|analgesics|mesh-ancestor
6007292|NCT00287729|Sensory System Agents|sensory system agents|mesh-ancestor
6007293|NCT00287729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6007294|NCT00287729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007295|NCT00287729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6007296|NCT00287729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6007297|NCT00287729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6007298|NCT00287729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6007299|NCT00287729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6007300|NCT00287872|Thalidomide|thalidomide|mesh-list
6007301|NCT00287872|Bortezomib|bortezomib|mesh-list
6007302|NCT00287872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6007303|NCT00287872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6007304|NCT00287872|Immunologic Factors|immunologic factors|mesh-ancestor
6007305|NCT00287872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007306|NCT00287872|Leprostatic Agents|leprostatic agents|mesh-ancestor
6007307|NCT00287872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6007308|NCT00287872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6007309|NCT00287872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6007310|NCT00287872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6007311|NCT00287872|Growth Substances|growth substances|mesh-ancestor
6007312|NCT00287872|Growth Inhibitors|growth inhibitors|mesh-ancestor
6007313|NCT00287989|Paclitaxel|paclitaxel|mesh-list
6007314|NCT00287989|Carboplatin|carboplatin|mesh-list
6007315|NCT00287989|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6007316|NCT00287989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6007317|NCT00287989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6007318|NCT00287989|Tubulin Modulators|tubulin modulators|mesh-ancestor
6007319|NCT00287989|Antimitotic Agents|antimitotic agents|mesh-ancestor
6007320|NCT00287989|Mitosis Modulators|mitosis modulators|mesh-ancestor
6007321|NCT00287989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6007322|NCT00287989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6007323|NCT00287989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6260709|NCT03176238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007324|NCT00288015|Bevacizumab|bevacizumab|mesh-list
6007325|NCT00288015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6007326|NCT00288015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6007327|NCT00288015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6007328|NCT00288015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6007329|NCT00288015|Growth Substances|growth substances|mesh-ancestor
6007330|NCT00288015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007331|NCT00288015|Growth Inhibitors|growth inhibitors|mesh-ancestor
6007332|NCT00288054|Docetaxel|docetaxel|mesh-list
6007333|NCT00288054|Cetuximab|cetuximab|mesh-list
6007334|NCT00288054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6007335|NCT00288054|Tubulin Modulators|tubulin modulators|mesh-ancestor
6007336|NCT00288054|Antimitotic Agents|antimitotic agents|mesh-ancestor
6007337|NCT00288054|Mitosis Modulators|mitosis modulators|mesh-ancestor
6007338|NCT00288054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6007339|NCT00288054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6007340|NCT00288067|Rituximab|rituximab|mesh-list
6007341|NCT00288067|Fenretinide|fenretinide|mesh-list
6007342|NCT00288067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6007343|NCT00288067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6007344|NCT00288067|Immunologic Factors|immunologic factors|mesh-ancestor
6007345|NCT00288067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007346|NCT00288067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6007347|NCT00288067|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6007348|NCT00288067|Protective Agents|protective agents|mesh-ancestor
6007349|NCT00288366|Aripiprazole|aripiprazole|mesh-list
6007350|NCT00288366|Ziprasidone|ziprasidone|mesh-list
6007351|NCT00288366|Antidepressive Agents|antidepressive agents|mesh-ancestor
6007352|NCT00288366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6007353|NCT00288366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6007354|NCT00288366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6007355|NCT00288366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6007356|NCT00288366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007357|NCT00288366|Dopamine Agonists|dopamine agonists|mesh-ancestor
6007358|NCT00288366|Dopamine Agents|dopamine agents|mesh-ancestor
6007359|NCT00288366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6007360|NCT00288366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6007361|NCT00288366|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6007362|NCT00288366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6007363|NCT00288366|Serotonin Agents|serotonin agents|mesh-ancestor
6007364|NCT00288366|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6007365|NCT00288366|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6007366|NCT00288366|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6007367|NCT00288366|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6007368|NCT00288509|Botulinum Toxins|botulinum toxins|mesh-list
6007369|NCT00288509|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6007370|NCT00288509|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6007371|NCT00288509|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6007372|NCT00288509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6007373|NCT00288509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6007374|NCT00288509|Cholinergic Agents|cholinergic agents|mesh-ancestor
6007375|NCT00288509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6007376|NCT00288509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007377|NCT00288509|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6007378|NCT00288509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6007379|NCT00288574|Fluoxetine|fluoxetine|mesh-list
6260710|NCT03176238|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6389932|NCT00189709|Antifungal Agents|antifungal agents|mesh-ancestor
6007380|NCT00288574|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6007381|NCT00288574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6007382|NCT00288574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6007383|NCT00288574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6007384|NCT00288574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6007385|NCT00288574|Serotonin Agents|serotonin agents|mesh-ancestor
6007386|NCT00288574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007387|NCT00288574|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6007388|NCT00288574|Antidepressive Agents|antidepressive agents|mesh-ancestor
6007389|NCT00288574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6007390|NCT00288574|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6007391|NCT00288574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6007392|NCT00288574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6007393|NCT00288587|Diuretics|diuretics|mesh-list
6007394|NCT00288587|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
6007395|NCT00288587|Natriuretic Agents|natriuretic agents|mesh-ancestor
6007396|NCT00288587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007397|NCT00288587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6007398|NCT00288587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6007399|NCT00288600|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6007400|NCT00288600|Immunoglobulins|immunoglobulins|mesh-list
6007401|NCT00288600|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6007402|NCT00288600|Antibodies|antibodies|mesh-list
6007403|NCT00288600|gamma-Globulins|gamma-globulins|mesh-list
6007404|NCT00288600|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6007405|NCT00288600|Immunologic Factors|immunologic factors|mesh-ancestor
6007406|NCT00288600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007407|NCT00288626|Cytarabine|cytarabine|mesh-list
6007408|NCT00288626|Prednisone|prednisone|mesh-list
6007409|NCT00288626|Etoposide|etoposide|mesh-list
6007410|NCT00288626|Melphalan|melphalan|mesh-list
6007411|NCT00288626|Carmustine|carmustine|mesh-list
6007412|NCT00288626|Sargramostim|sargramostim|mesh-list
6007413|NCT00288626|Lenograstim|lenograstim|mesh-list
6007414|NCT00288626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6007415|NCT00288626|Glucocorticoids|glucocorticoids|mesh-ancestor
6007416|NCT00288626|Hormones|hormones|mesh-ancestor
6007417|NCT00288626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6007418|NCT00288626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007419|NCT00288626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6260711|NCT03176238|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6260712|NCT03176238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6260713|NCT03176238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260714|NCT03176238|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6260715|NCT03176238|Hormone Antagonists|hormone antagonists|mesh-ancestor
6260716|NCT03176238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6260717|NCT03176459|Bupivacaine|bupivacaine|mesh-list
6260718|NCT03176459|Anesthetics, Local|anesthetics, local|mesh-ancestor
6260719|NCT03176459|Anesthetics|anesthetics|mesh-ancestor
6260720|NCT03176459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6260721|NCT03176459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260722|NCT03176459|Sensory System Agents|sensory system agents|mesh-ancestor
6260723|NCT03176459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6260724|NCT03176784|Nicotine|nicotine|mesh-list
6260725|NCT03176784|Varenicline|varenicline|mesh-list
6260726|NCT03176784|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6260727|NCT03176784|Autonomic Agents|autonomic agents|mesh-ancestor
6260728|NCT03176784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6260729|NCT03176784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260730|NCT03176784|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6260731|NCT03176784|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6260732|NCT03176784|Cholinergic Agents|cholinergic agents|mesh-ancestor
6260733|NCT03176784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6260734|NCT03176784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260735|NCT03177395|Acetylcysteine|acetylcysteine|mesh-list
6260736|NCT03177395|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6260737|NCT03177395|Antiviral Agents|antiviral agents|mesh-ancestor
6260738|NCT03177395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6260739|NCT03177395|Expectorants|expectorants|mesh-ancestor
6260740|NCT03177395|Respiratory System Agents|respiratory system agents|mesh-ancestor
6260741|NCT03177395|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6260742|NCT03177395|Antioxidants|antioxidants|mesh-ancestor
6260743|NCT03177395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260744|NCT03177395|Protective Agents|protective agents|mesh-ancestor
6260745|NCT03177395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260746|NCT03177395|Antidotes|antidotes|mesh-ancestor
6260747|NCT03177798|Icatibant|icatibant|mesh-list
6007420|NCT00288626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6007421|NCT00288626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6007422|NCT00288626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6007423|NCT00288626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6007424|NCT00288626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6007425|NCT00288626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6007426|NCT00288626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6007427|NCT00288626|Antimetabolites|antimetabolites|mesh-ancestor
6007428|NCT00288626|Antiviral Agents|antiviral agents|mesh-ancestor
6007429|NCT00288626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6007430|NCT00288626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6007431|NCT00288626|Immunologic Factors|immunologic factors|mesh-ancestor
6007432|NCT00288626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6007433|NCT00288626|Alkylating Agents|alkylating agents|mesh-ancestor
6007434|NCT00288626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6007435|NCT00288626|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6018229|NCT00379197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018230|NCT00379197|Sensory System Agents|sensory system agents|mesh-ancestor
6018231|NCT00379197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6018232|NCT00379340|Dactinomycin|dactinomycin|mesh-list
6018233|NCT00379340|Cactinomycin|cactinomycin|mesh-list
6018234|NCT00379340|Cyclophosphamide|cyclophosphamide|mesh-list
6018235|NCT00379340|Doxorubicin|doxorubicin|mesh-list
6018236|NCT00379340|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6018237|NCT00379340|Etoposide|etoposide|mesh-list
6018238|NCT00379340|Vincristine|vincristine|mesh-list
6018239|NCT00379340|Etoposide phosphate|etoposide phosphate|mesh-list
6018240|NCT00379340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6018241|NCT00379340|Immunologic Factors|immunologic factors|mesh-ancestor
6018242|NCT00379340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018243|NCT00379340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6018244|NCT00379340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6018245|NCT00379340|Alkylating Agents|alkylating agents|mesh-ancestor
6018246|NCT00379340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6018247|NCT00379340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6018248|NCT00379340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6018249|NCT00379340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6018250|NCT00379340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6018251|NCT00379340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6018252|NCT00379340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6018253|NCT00379340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6018254|NCT00379340|Tubulin Modulators|tubulin modulators|mesh-ancestor
6018255|NCT00379340|Antimitotic Agents|antimitotic agents|mesh-ancestor
6018256|NCT00379340|Mitosis Modulators|mitosis modulators|mesh-ancestor
6018257|NCT00379340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6260748|NCT03177798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6018258|NCT00379340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6007436|NCT00288639|Pregabalin|pregabalin|mesh-list
6007437|NCT00288639|Analgesics|analgesics|mesh-ancestor
6007438|NCT00288639|Sensory System Agents|sensory system agents|mesh-ancestor
6007439|NCT00288639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6007440|NCT00288639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007441|NCT00288639|Anticonvulsants|anticonvulsants|mesh-ancestor
6007442|NCT00288639|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6007443|NCT00288639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6007444|NCT00288639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6007445|NCT00288639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6007446|NCT00288639|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6007447|NCT00288639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6007448|NCT00288639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6007449|NCT00288639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6007450|NCT00288704|Rilonacept|rilonacept|mesh-list
6007451|NCT00288704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6007452|NCT00289016|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
6007453|NCT00289016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6007454|NCT00289016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6007455|NCT00289211|Complement C1s|complement c1s|mesh-list
6007456|NCT00289211|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
6007457|NCT00289211|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
6007458|NCT00289211|Immunologic Factors|immunologic factors|mesh-ancestor
6007459|NCT00289211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007460|NCT00289211|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6007461|NCT00289211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6007462|NCT00289536|Factor VIII|factor viii|mesh-list
6536463|NCT00817011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6536464|NCT00817011|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6536465|NCT00817011|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6536466|NCT00817011|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6536467|NCT00817037|Nifedipine|nifedipine|mesh-list
6536468|NCT00817037|Sitaxsentan|sitaxsentan|mesh-list
6007463|NCT00289536|Coagulants|coagulants|mesh-ancestor
6007464|NCT00289653|Nicotine|nicotine|mesh-list
6007465|NCT00289653|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6007466|NCT00289653|Autonomic Agents|autonomic agents|mesh-ancestor
6007467|NCT00289653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6007468|NCT00289653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007469|NCT00289653|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6260749|NCT03177798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6260750|NCT03177798|Analgesics|analgesics|mesh-ancestor
6260751|NCT03177798|Sensory System Agents|sensory system agents|mesh-ancestor
6260752|NCT03177798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6260753|NCT03177798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260754|NCT03177798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6260755|NCT03177798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6260756|NCT03177798|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
6260757|NCT03177798|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
6260758|NCT03177798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260759|NCT03177798|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6260760|NCT03177798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6260761|NCT03177798|Immunologic Factors|immunologic factors|mesh-ancestor
6260762|NCT03178487|Upadacitinib|upadacitinib|mesh-list
6260763|NCT03178487|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
6260764|NCT03178487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6260765|NCT03178487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6260766|NCT03178487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260767|NCT03178487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6260768|NCT03178851|Atezolizumab|atezolizumab|mesh-list
6260769|NCT03178851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6260770|NCT03178851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6260771|NCT03178851|Immunologic Factors|immunologic factors|mesh-ancestor
6260772|NCT03178851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260773|NCT03178942|Permethrin|permethrin|mesh-list
6260774|NCT03178942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6007470|NCT00289653|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6260775|NCT03178942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6007471|NCT00289653|Cholinergic Agents|cholinergic agents|mesh-ancestor
6007472|NCT00289653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6007473|NCT00289653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6007474|NCT00289783|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6007475|NCT00289783|Immunologic Factors|immunologic factors|mesh-ancestor
6007476|NCT00289783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007477|NCT00289848|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6007478|NCT00289848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6007479|NCT00289848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007480|NCT00289848|Incretins|incretins|mesh-ancestor
6007481|NCT00289848|Hormones|hormones|mesh-ancestor
6007482|NCT00289848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6007483|NCT00289848|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6007484|NCT00289848|Protease Inhibitors|protease inhibitors|mesh-ancestor
6007485|NCT00289848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6007486|NCT00289848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6007487|NCT00289900|Atorvastatin|atorvastatin|mesh-list
6007488|NCT00289900|Simvastatin|simvastatin|mesh-list
6007489|NCT00289900|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6007490|NCT00289900|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6007491|NCT00289900|Antimetabolites|antimetabolites|mesh-ancestor
6007492|NCT00289900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6007493|NCT00289900|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6007494|NCT00289900|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6007495|NCT00289900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6007496|NCT00289978|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6007497|NCT00289978|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6007498|NCT00289978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6007499|NCT00289978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6007500|NCT00289978|Immunologic Factors|immunologic factors|mesh-ancestor
6007501|NCT00289978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007502|NCT00289991|Itraconazole|itraconazole|mesh-list
6007503|NCT00289991|Voriconazole|voriconazole|mesh-list
6007504|NCT00289991|Antifungal Agents|antifungal agents|mesh-ancestor
6007505|NCT00289991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6007506|NCT00289991|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6007507|NCT00289991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6007508|NCT00289991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6007509|NCT00289991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6007510|NCT00289991|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6007511|NCT00289991|Hormone Antagonists|hormone antagonists|mesh-ancestor
6007512|NCT00289991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6007513|NCT00289991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007514|NCT00289991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6007515|NCT00290251|Ulipristal acetate|ulipristal acetate|mesh-list
6007516|NCT00290251|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6007517|NCT00290251|Contraceptive Agents|contraceptive agents|mesh-ancestor
6007518|NCT00290251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6007519|NCT00290251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007520|NCT00290251|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6007521|NCT00290290|Chlorhexidine|chlorhexidine|mesh-list
6007522|NCT00290290|Povidone-Iodine|povidone-iodine|mesh-list
6007523|NCT00290290|Povidone|povidone|mesh-list
6007524|NCT00290290|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6007525|NCT00290290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6007526|NCT00290290|Disinfectants|disinfectants|mesh-ancestor
6007527|NCT00290290|Plasma Substitutes|plasma substitutes|mesh-ancestor
6007528|NCT00290290|Blood Substitutes|blood substitutes|mesh-ancestor
6007529|NCT00290329|Vaccines|vaccines|mesh-list
6007530|NCT00290329|Immunologic Factors|immunologic factors|mesh-ancestor
6007531|NCT00290329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007532|NCT00290342|Edetic Acid|edetic acid|mesh-list
6007533|NCT00290342|Pentetic Acid|pentetic acid|mesh-list
6007534|NCT00290342|Antidotes|antidotes|mesh-ancestor
6007535|NCT00290342|Protective Agents|protective agents|mesh-ancestor
6007536|NCT00290342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007537|NCT00290342|Chelating Agents|chelating agents|mesh-ancestor
6007538|NCT00290342|Sequestering Agents|sequestering agents|mesh-ancestor
6007539|NCT00290342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6007540|NCT00290342|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6007541|NCT00290342|Anticoagulants|anticoagulants|mesh-ancestor
6007542|NCT00290342|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6007543|NCT00290433|Cytarabine|cytarabine|mesh-list
6007544|NCT00290433|Dexamethasone|dexamethasone|mesh-list
6007545|NCT00290433|Cyclophosphamide|cyclophosphamide|mesh-list
6007546|NCT00290433|Doxorubicin|doxorubicin|mesh-list
6007547|NCT00290433|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6007548|NCT00290433|Methotrexate|methotrexate|mesh-list
6007549|NCT00290433|Vincristine|vincristine|mesh-list
6007550|NCT00290433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6007551|NCT00290433|Immunologic Factors|immunologic factors|mesh-ancestor
6007552|NCT00290433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007553|NCT00290433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6007554|NCT00290433|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6007555|NCT00290433|Alkylating Agents|alkylating agents|mesh-ancestor
6007556|NCT00290433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6007557|NCT00290433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6007558|NCT00290433|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6007559|NCT00290433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6007560|NCT00290433|Antiemetics|antiemetics|mesh-ancestor
6007561|NCT00290433|Autonomic Agents|autonomic agents|mesh-ancestor
6007562|NCT00290433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6007563|NCT00290433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6007564|NCT00290433|Glucocorticoids|glucocorticoids|mesh-ancestor
6007565|NCT00290433|Hormones|hormones|mesh-ancestor
6007566|NCT00290433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6007567|NCT00290433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6007568|NCT00290433|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6007569|NCT00290433|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6007570|NCT00290433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6007571|NCT00290433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6007572|NCT00290433|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6007573|NCT00290433|Abortifacient Agents|abortifacient agents|mesh-ancestor
6007574|NCT00290433|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6007575|NCT00290433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6007576|NCT00290433|Antimetabolites|antimetabolites|mesh-ancestor
6007577|NCT00290433|Dermatologic Agents|dermatologic agents|mesh-ancestor
6007578|NCT00290433|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6007579|NCT00290433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6007580|NCT00290433|Antiviral Agents|antiviral agents|mesh-ancestor
6007581|NCT00290433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6007582|NCT00290433|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6007583|NCT00290433|Tubulin Modulators|tubulin modulators|mesh-ancestor
6007584|NCT00290433|Antimitotic Agents|antimitotic agents|mesh-ancestor
6007585|NCT00290433|Mitosis Modulators|mitosis modulators|mesh-ancestor
6007586|NCT00290472|Sirolimus|sirolimus|mesh-list
6007587|NCT00290472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6007588|NCT00290472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6007589|NCT00290472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6007590|NCT00290472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6007591|NCT00290472|Antifungal Agents|antifungal agents|mesh-ancestor
6007592|NCT00290472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6007593|NCT00290472|Immunologic Factors|immunologic factors|mesh-ancestor
6007594|NCT00290472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007595|NCT00290498|Cytarabine|cytarabine|mesh-list
6007596|NCT00290498|Dexamethasone|dexamethasone|mesh-list
6007597|NCT00290498|Prednisone|prednisone|mesh-list
6007598|NCT00290498|Cyclophosphamide|cyclophosphamide|mesh-list
6007599|NCT00290498|Rituximab|rituximab|mesh-list
6007600|NCT00290498|Doxorubicin|doxorubicin|mesh-list
6007601|NCT00290498|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6007602|NCT00290498|Methotrexate|methotrexate|mesh-list
6007603|NCT00290498|Vincristine|vincristine|mesh-list
6007604|NCT00290498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6007605|NCT00290498|Immunologic Factors|immunologic factors|mesh-ancestor
6007606|NCT00290498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007607|NCT00290498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6007608|NCT00290498|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6007609|NCT00290498|Alkylating Agents|alkylating agents|mesh-ancestor
6007610|NCT00290498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6007611|NCT00290498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6007612|NCT00290498|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6007613|NCT00290498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6007614|NCT00290498|Antiemetics|antiemetics|mesh-ancestor
6007615|NCT00290498|Autonomic Agents|autonomic agents|mesh-ancestor
6007616|NCT00290498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6007617|NCT00290498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6007618|NCT00290498|Glucocorticoids|glucocorticoids|mesh-ancestor
6007619|NCT00290498|Hormones|hormones|mesh-ancestor
6007620|NCT00290498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6007621|NCT00290498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6007622|NCT00290498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6007623|NCT00290498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6007624|NCT00290498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6007625|NCT00290498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6007626|NCT00290498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6007627|NCT00290498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6007628|NCT00290498|Abortifacient Agents|abortifacient agents|mesh-ancestor
6007629|NCT00290498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6007630|NCT00290498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6007631|NCT00290498|Antimetabolites|antimetabolites|mesh-ancestor
6007632|NCT00290498|Dermatologic Agents|dermatologic agents|mesh-ancestor
6007633|NCT00290498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6007634|NCT00290498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6007635|NCT00290498|Antiviral Agents|antiviral agents|mesh-ancestor
6007636|NCT00290498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6007637|NCT00290498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6007638|NCT00290498|Tubulin Modulators|tubulin modulators|mesh-ancestor
6007639|NCT00290498|Antimitotic Agents|antimitotic agents|mesh-ancestor
6007640|NCT00290498|Mitosis Modulators|mitosis modulators|mesh-ancestor
6007641|NCT00290537|Paclitaxel|paclitaxel|mesh-list
6007642|NCT00290537|Carboplatin|carboplatin|mesh-list
6007643|NCT00290537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6007644|NCT00290537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6007645|NCT00290537|Tubulin Modulators|tubulin modulators|mesh-ancestor
6007646|NCT00290537|Antimitotic Agents|antimitotic agents|mesh-ancestor
6007647|NCT00290537|Mitosis Modulators|mitosis modulators|mesh-ancestor
6007648|NCT00290537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6007649|NCT00290589|Methylprednisolone|methylprednisolone|mesh-list
6007650|NCT00290589|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6007651|NCT00290589|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6007652|NCT00290589|Prednisolone|prednisolone|mesh-list
6007653|NCT00290589|Prednisolone acetate|prednisolone acetate|mesh-list
6007654|NCT00290589|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6007655|NCT00290589|Prednisolone phosphate|prednisolone phosphate|mesh-list
6007656|NCT00290589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6007657|NCT00290589|Antiemetics|antiemetics|mesh-ancestor
6007658|NCT00290589|Autonomic Agents|autonomic agents|mesh-ancestor
6007659|NCT00290589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6007660|NCT00290589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007661|NCT00290589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6007662|NCT00290589|Glucocorticoids|glucocorticoids|mesh-ancestor
6007663|NCT00290589|Hormones|hormones|mesh-ancestor
6007664|NCT00290589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6007665|NCT00290589|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6007666|NCT00290589|Protective Agents|protective agents|mesh-ancestor
6007667|NCT00290589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6007668|NCT00290589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6007669|NCT00290615|Bevacizumab|bevacizumab|mesh-list
6007670|NCT00290615|Cetuximab|cetuximab|mesh-list
6007671|NCT00290615|Capecitabine|capecitabine|mesh-list
6007672|NCT00290615|Oxaliplatin|oxaliplatin|mesh-list
6007673|NCT00290615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6007674|NCT00290615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6007675|NCT00290615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6007676|NCT00290615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6007677|NCT00290615|Growth Substances|growth substances|mesh-ancestor
6007678|NCT00290615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007679|NCT00290615|Growth Inhibitors|growth inhibitors|mesh-ancestor
6007680|NCT00290615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6007681|NCT00290615|Antimetabolites|antimetabolites|mesh-ancestor
6007682|NCT00290615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6007683|NCT00290654|Tamoxifen|tamoxifen|mesh-list
6007684|NCT00290654|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6007685|NCT00290654|Hormone Antagonists|hormone antagonists|mesh-ancestor
6007686|NCT00290654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6007687|NCT00290654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007688|NCT00290654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6007689|NCT00290654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6007690|NCT00290654|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6007691|NCT00290654|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6007692|NCT00290654|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6007693|NCT00290693|Docetaxel|docetaxel|mesh-list
6007694|NCT00290693|Capecitabine|capecitabine|mesh-list
6007695|NCT00290693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6007696|NCT00290693|Tubulin Modulators|tubulin modulators|mesh-ancestor
6007697|NCT00290693|Antimitotic Agents|antimitotic agents|mesh-ancestor
6007698|NCT00290693|Mitosis Modulators|mitosis modulators|mesh-ancestor
6007699|NCT00290693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6007700|NCT00290693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6007701|NCT00290693|Antimetabolites|antimetabolites|mesh-ancestor
6007702|NCT00290706|Gemcitabine|gemcitabine|mesh-list
6007703|NCT00290706|Bortezomib|bortezomib|mesh-list
6260776|NCT03179345|Pregabalin|pregabalin|mesh-list
6260777|NCT03179345|Gabapentin|gabapentin|mesh-list
6260778|NCT03179345|Analgesics|analgesics|mesh-ancestor
6260779|NCT03179345|Sensory System Agents|sensory system agents|mesh-ancestor
6260780|NCT03179345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6007704|NCT00290706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6007705|NCT00290706|Antimetabolites|antimetabolites|mesh-ancestor
6007706|NCT00290706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6007707|NCT00290706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6007708|NCT00290706|Antiviral Agents|antiviral agents|mesh-ancestor
6007709|NCT00290706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6007710|NCT00290706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6007711|NCT00290706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6007712|NCT00290706|Immunologic Factors|immunologic factors|mesh-ancestor
6007713|NCT00290706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007714|NCT00290732|Doxorubicin|doxorubicin|mesh-list
6007715|NCT00290732|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6007716|NCT00290732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6007717|NCT00290732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6007718|NCT00290732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6007719|NCT00290732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6007720|NCT00290732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6007721|NCT00290732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6007722|NCT00290745|Tamoxifen|tamoxifen|mesh-list
6007723|NCT00290745|Letrozole|letrozole|mesh-list
6007724|NCT00290745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6007725|NCT00290745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6007726|NCT00290745|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6007727|NCT00290745|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6007728|NCT00290745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6007729|NCT00290745|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6007730|NCT00290745|Hormone Antagonists|hormone antagonists|mesh-ancestor
6007731|NCT00290745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6007732|NCT00290745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007733|NCT00290745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6007734|NCT00290745|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6007735|NCT00290745|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6007736|NCT00290745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6007737|NCT00290771|Imatinib Mesylate|imatinib mesylate|mesh-list
6007738|NCT00290771|Hydroxyurea|hydroxyurea|mesh-list
6007739|NCT00290771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6007740|NCT00290771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6007741|NCT00290771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6007742|NCT00290771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6007743|NCT00290771|Antisickling Agents|antisickling agents|mesh-ancestor
6007744|NCT00290771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6007745|NCT00290810|Bevacizumab|bevacizumab|mesh-list
6007746|NCT00290810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6007747|NCT00290810|Antibodies|antibodies|mesh-list
6007748|NCT00290810|Immunoglobulins|immunoglobulins|mesh-list
6007749|NCT00290810|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6007750|NCT00290810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6007751|NCT00290810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6007752|NCT00290810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6007753|NCT00290810|Growth Substances|growth substances|mesh-ancestor
6007754|NCT00290810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007755|NCT00290810|Growth Inhibitors|growth inhibitors|mesh-ancestor
6007756|NCT00290810|Immunologic Factors|immunologic factors|mesh-ancestor
6007757|NCT00291135|Letrozole|letrozole|mesh-list
6007758|NCT00291135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6007759|NCT00291135|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6007760|NCT00291135|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6007761|NCT00291135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6007762|NCT00291135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6007763|NCT00291135|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6007764|NCT00291135|Hormone Antagonists|hormone antagonists|mesh-ancestor
6007765|NCT00291135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6007766|NCT00291135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007767|NCT00291226|Glycine|glycine|mesh-list
6007768|NCT00291226|Glycine Agents|glycine agents|mesh-ancestor
6007769|NCT00291226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6007770|NCT00291226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6007771|NCT00291226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007772|NCT00291330|Warfarin|warfarin|mesh-list
6007773|NCT00291330|Dabigatran|dabigatran|mesh-list
6007774|NCT00291330|Anticoagulants|anticoagulants|mesh-ancestor
6007775|NCT00291330|Antithrombins|antithrombins|mesh-ancestor
6007776|NCT00291330|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6007777|NCT00291330|Protease Inhibitors|protease inhibitors|mesh-ancestor
6007778|NCT00291330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6007779|NCT00291330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6007780|NCT00291577|Docetaxel|docetaxel|mesh-list
6007781|NCT00291577|Sunitinib|sunitinib|mesh-list
6007782|NCT00291577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6007783|NCT00291577|Tubulin Modulators|tubulin modulators|mesh-ancestor
6007784|NCT00291577|Antimitotic Agents|antimitotic agents|mesh-ancestor
6007785|NCT00291577|Mitosis Modulators|mitosis modulators|mesh-ancestor
6007786|NCT00291577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6007787|NCT00291577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6007788|NCT00291577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6007789|NCT00291577|Growth Substances|growth substances|mesh-ancestor
6007790|NCT00291577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007791|NCT00291577|Growth Inhibitors|growth inhibitors|mesh-ancestor
6007792|NCT00291577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6007793|NCT00291577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6007794|NCT00291642|Cetirizine|cetirizine|mesh-list
6007795|NCT00291642|Levocetirizine|levocetirizine|mesh-list
6007796|NCT00291642|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6007797|NCT00291642|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6007798|NCT00291642|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6007799|NCT00291642|Histamine Antagonists|histamine antagonists|mesh-ancestor
6007800|NCT00291642|Histamine Agents|histamine agents|mesh-ancestor
6007801|NCT00291642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6007802|NCT00291642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6007803|NCT00291642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007804|NCT00291655|Levetiracetam|levetiracetam|mesh-list
6007805|NCT00291655|Anticonvulsants|anticonvulsants|mesh-ancestor
6007806|NCT00291655|Nootropic Agents|nootropic agents|mesh-ancestor
6007807|NCT00291668|Certolizumab Pegol|certolizumab pegol|mesh-list
6007808|NCT00291668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6007809|NCT00291668|Immunologic Factors|immunologic factors|mesh-ancestor
6007810|NCT00291668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007811|NCT00291668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6007812|NCT00291694|Celecoxib|celecoxib|mesh-list
6007813|NCT00291694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6007814|NCT00291694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6007815|NCT00291694|Analgesics|analgesics|mesh-ancestor
6007816|NCT00291694|Sensory System Agents|sensory system agents|mesh-ancestor
6007817|NCT00291694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6007818|NCT00291694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007819|NCT00291694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6007820|NCT00291694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6007821|NCT00291694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6007822|NCT00291694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6007823|NCT00291694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6007824|NCT00291694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6007825|NCT00292162|Metoprolol|metoprolol|mesh-list
6007826|NCT00292162|Carvedilol|carvedilol|mesh-list
6007827|NCT00292162|Ramipril|ramipril|mesh-list
6007828|NCT00292162|Enalapril|enalapril|mesh-list
6007829|NCT00292162|Lisinopril|lisinopril|mesh-list
6007830|NCT00292162|Bisoprolol|bisoprolol|mesh-list
6007831|NCT00292162|Perindopril|perindopril|mesh-list
6007832|NCT00292162|Captopril|captopril|mesh-list
6007833|NCT00292162|Spironolactone|spironolactone|mesh-list
6007834|NCT00292162|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
6007835|NCT00292162|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
6007836|NCT00292162|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6007837|NCT00292162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6007838|NCT00292162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6007839|NCT00292162|Sympatholytics|sympatholytics|mesh-ancestor
6007840|NCT00292162|Autonomic Agents|autonomic agents|mesh-ancestor
6007841|NCT00292162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6007842|NCT00292162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007843|NCT00292162|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6007844|NCT00292162|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6007845|NCT00292162|Adrenergic Agents|adrenergic agents|mesh-ancestor
6007846|NCT00292162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6007847|NCT00292162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6007848|NCT00292162|Hormone Antagonists|hormone antagonists|mesh-ancestor
6007849|NCT00292162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6007850|NCT00292162|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6007851|NCT00292162|Diuretics|diuretics|mesh-ancestor
6007852|NCT00292162|Natriuretic Agents|natriuretic agents|mesh-ancestor
6007853|NCT00292162|Antioxidants|antioxidants|mesh-ancestor
6007854|NCT00292162|Protective Agents|protective agents|mesh-ancestor
6007855|NCT00292162|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6007856|NCT00292162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6007857|NCT00292162|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6007858|NCT00292162|Vasodilator Agents|vasodilator agents|mesh-ancestor
6007859|NCT00292162|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6007860|NCT00292162|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6007861|NCT00292162|Protease Inhibitors|protease inhibitors|mesh-ancestor
6007862|NCT00292162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6007863|NCT00292162|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6007864|NCT00292188|Pregabalin|pregabalin|mesh-list
6007865|NCT00292188|Analgesics|analgesics|mesh-ancestor
6007866|NCT00292188|Sensory System Agents|sensory system agents|mesh-ancestor
6007867|NCT00292188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6007868|NCT00292188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007869|NCT00292188|Anticonvulsants|anticonvulsants|mesh-ancestor
6007870|NCT00292188|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6007871|NCT00292188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6007872|NCT00292188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6007873|NCT00292188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6007874|NCT00292188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6007875|NCT00292188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6007876|NCT00292188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6260781|NCT03179345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260782|NCT03179345|Anticonvulsants|anticonvulsants|mesh-ancestor
6260783|NCT03179345|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6260784|NCT03179345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6260785|NCT03179345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260786|NCT03179345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6260787|NCT03179345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6260788|NCT03179345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6260789|NCT03179345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6260790|NCT03179345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6260791|NCT03179345|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6260792|NCT03179345|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6260793|NCT03179345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6260794|NCT03179345|Antimanic Agents|antimanic agents|mesh-ancestor
6260795|NCT03179410|Avelumab|avelumab|mesh-list
6260796|NCT03179410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6260797|NCT03179410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6260798|NCT03179787|Aripiprazole|aripiprazole|mesh-list
6260799|NCT03179787|Antidepressive Agents|antidepressive agents|mesh-ancestor
6260800|NCT03179787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6260801|NCT03179787|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6260802|NCT03179787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6260803|NCT03179787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6260804|NCT03179787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260805|NCT03179787|Dopamine Agonists|dopamine agonists|mesh-ancestor
6260806|NCT03179787|Dopamine Agents|dopamine agents|mesh-ancestor
6260807|NCT03179787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6260808|NCT03179787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260809|NCT03179787|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6260810|NCT03179787|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6260811|NCT03179787|Serotonin Agents|serotonin agents|mesh-ancestor
6260812|NCT03179787|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6260813|NCT03179787|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6260814|NCT03179787|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6260815|NCT03179787|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6007877|NCT00292188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6007878|NCT00292227|Moxifloxacin|moxifloxacin|mesh-list
6007879|NCT00292227|Rotigotine|rotigotine|mesh-list
6007880|NCT00292227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6007881|NCT00292227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6007882|NCT00292227|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6007883|NCT00292227|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6007884|NCT00292227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6007885|NCT00292227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6007886|NCT00292227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6007887|NCT00292227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007888|NCT00292227|Dopamine Agonists|dopamine agonists|mesh-ancestor
6007889|NCT00292227|Dopamine Agents|dopamine agents|mesh-ancestor
6007890|NCT00292227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6007891|NCT00292370|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6007892|NCT00292370|Paroxetine|paroxetine|mesh-list
6007893|NCT00292370|Antidepressive Agents|antidepressive agents|mesh-ancestor
6007894|NCT00292370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6007895|NCT00292370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6007896|NCT00292370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6007897|NCT00292370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6007898|NCT00292370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007899|NCT00292370|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6007900|NCT00292370|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6007901|NCT00292370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6007902|NCT00292370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6007903|NCT00292370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6007904|NCT00292370|Serotonin Agents|serotonin agents|mesh-ancestor
6007905|NCT00292370|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6007906|NCT00292370|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6007907|NCT00292370|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6007908|NCT00292370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6007909|NCT00292461|Lamotrigine|lamotrigine|mesh-list
6007910|NCT00292461|Zonisamide|zonisamide|mesh-list
6007911|NCT00292461|Anticonvulsants|anticonvulsants|mesh-ancestor
6007912|NCT00292461|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6007913|NCT00292461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6007914|NCT00292461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6007915|NCT00292461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6007916|NCT00292461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007917|NCT00292461|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6007918|NCT00292461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6007919|NCT00292461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6007920|NCT00292461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6007921|NCT00292461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6007922|NCT00292591|Vitamin D|vitamin d|mesh-list
6007923|NCT00292591|Ergocalciferols|ergocalciferols|mesh-list
6007924|NCT00292591|Cholecalciferol|cholecalciferol|mesh-list
6007925|NCT00292591|Vitamins|vitamins|mesh-list
6007926|NCT00292591|Micronutrients|micronutrients|mesh-ancestor
6007927|NCT00292591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007928|NCT00292591|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6007929|NCT00292591|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6007930|NCT00292942|Artesunate|artesunate|mesh-list
6007931|NCT00292942|Mannitol|mannitol|mesh-list
6007932|NCT00292942|Antimalarials|antimalarials|mesh-ancestor
6007933|NCT00292942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6007934|NCT00292942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6007935|NCT00292942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6007936|NCT00292942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6007937|NCT00292942|Antiviral Agents|antiviral agents|mesh-ancestor
6007938|NCT00292942|Schistosomicides|schistosomicides|mesh-ancestor
6007939|NCT00292942|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6007940|NCT00292942|Anthelmintics|anthelmintics|mesh-ancestor
6007941|NCT00292942|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6007942|NCT00292942|Diuretics|diuretics|mesh-ancestor
6007943|NCT00292942|Natriuretic Agents|natriuretic agents|mesh-ancestor
6007944|NCT00292942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007945|NCT00292981|Complement C1s|complement c1s|mesh-list
6007946|NCT00292981|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
6007947|NCT00292981|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
6007948|NCT00292981|Immunologic Factors|immunologic factors|mesh-ancestor
6007949|NCT00292981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007950|NCT00292981|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6007951|NCT00292981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6007952|NCT00293020|Fentanyl|fentanyl|mesh-list
6007953|NCT00293020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6007954|NCT00293020|Narcotics|narcotics|mesh-ancestor
6007955|NCT00293020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6007956|NCT00293020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007957|NCT00293020|Analgesics|analgesics|mesh-ancestor
6007958|NCT00293020|Sensory System Agents|sensory system agents|mesh-ancestor
6007959|NCT00293020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6007960|NCT00293020|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6007961|NCT00293020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6007962|NCT00293020|Anesthetics, General|anesthetics, general|mesh-ancestor
6007963|NCT00293020|Anesthetics|anesthetics|mesh-ancestor
6007964|NCT00293033|Fentanyl|fentanyl|mesh-list
6007965|NCT00293033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6007966|NCT00293033|Narcotics|narcotics|mesh-ancestor
6007967|NCT00293033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6007968|NCT00293033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007969|NCT00293033|Analgesics|analgesics|mesh-ancestor
6007970|NCT00293033|Sensory System Agents|sensory system agents|mesh-ancestor
6007971|NCT00293033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6007972|NCT00293033|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6007973|NCT00293033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6007974|NCT00293033|Anesthetics, General|anesthetics, general|mesh-ancestor
6007975|NCT00293033|Anesthetics|anesthetics|mesh-ancestor
6007976|NCT00293059|Dienogest|dienogest|mesh-list
6007977|NCT00293059|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6007978|NCT00293059|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6007979|NCT00293059|Estradiol|estradiol|mesh-list
6007980|NCT00293059|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6007981|NCT00293059|Estrogens|estrogens|mesh-ancestor
6007982|NCT00293059|Hormones|hormones|mesh-ancestor
6007983|NCT00293059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6007984|NCT00293059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6007985|NCT00293059|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6007986|NCT00293059|Contraceptive Agents|contraceptive agents|mesh-ancestor
6007987|NCT00293059|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6007988|NCT00293059|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6007989|NCT00293059|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6007990|NCT00293059|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6007991|NCT00293059|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6007992|NCT00293059|Hormone Antagonists|hormone antagonists|mesh-ancestor
6007993|NCT00293059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6007994|NCT00293059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6007995|NCT00293202|Etanercept|etanercept|mesh-list
6007996|NCT00293202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6007997|NCT00293202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6007998|NCT00293202|Analgesics|analgesics|mesh-ancestor
6007999|NCT00293202|Sensory System Agents|sensory system agents|mesh-ancestor
6008000|NCT00293202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6008001|NCT00293202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008002|NCT00293202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6008003|NCT00293202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6008004|NCT00293202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6008005|NCT00293202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6008006|NCT00293202|Immunologic Factors|immunologic factors|mesh-ancestor
6008007|NCT00293254|Raltegravir Potassium|raltegravir potassium|mesh-list
6008008|NCT00293254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6008009|NCT00293254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6008010|NCT00293254|Antiviral Agents|antiviral agents|mesh-ancestor
6008011|NCT00293254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6008012|NCT00293254|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6008013|NCT00293254|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6008014|NCT00293254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6008015|NCT00293254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6008016|NCT00293267|Raltegravir Potassium|raltegravir potassium|mesh-list
6008017|NCT00293267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6008018|NCT00293267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6008019|NCT00293267|Antiviral Agents|antiviral agents|mesh-ancestor
6008020|NCT00293267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6008021|NCT00293267|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6008022|NCT00293267|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6008023|NCT00293267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6008024|NCT00293267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6008025|NCT00293293|Taxane|taxane|mesh-list
6008026|NCT00293293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6008027|NCT00293384|Dexamethasone|dexamethasone|mesh-list
6008028|NCT00293384|Dexamethasone acetate|dexamethasone acetate|mesh-list
6008029|NCT00293384|Cyclophosphamide|cyclophosphamide|mesh-list
6008030|NCT00293384|Aprepitant|aprepitant|mesh-list
6008031|NCT00293384|Granisetron|granisetron|mesh-list
6008032|NCT00293384|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
6008033|NCT00293384|BB 1101|bb 1101|mesh-list
6008034|NCT00293384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6008035|NCT00293384|Immunologic Factors|immunologic factors|mesh-ancestor
6008036|NCT00293384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008037|NCT00293384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6008038|NCT00293384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6008039|NCT00293384|Alkylating Agents|alkylating agents|mesh-ancestor
6008040|NCT00293384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6008041|NCT00293384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6008042|NCT00293384|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6008043|NCT00293384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6008044|NCT00293384|Antiemetics|antiemetics|mesh-ancestor
6008045|NCT00293384|Autonomic Agents|autonomic agents|mesh-ancestor
6008046|NCT00293384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6008047|NCT00293384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6008048|NCT00293384|Glucocorticoids|glucocorticoids|mesh-ancestor
6008049|NCT00293384|Hormones|hormones|mesh-ancestor
6008050|NCT00293384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6008051|NCT00293384|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6008052|NCT00293384|Protease Inhibitors|protease inhibitors|mesh-ancestor
6008053|NCT00293384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6008054|NCT00293384|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6008055|NCT00293384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6008056|NCT00293384|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6008057|NCT00293384|Serotonin Agents|serotonin agents|mesh-ancestor
6008058|NCT00293397|Doxorubicin|doxorubicin|mesh-list
6008059|NCT00293397|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6008060|NCT00293397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6008061|NCT00293397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6008062|NCT00293397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6008063|NCT00293397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6008064|NCT00293397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6008065|NCT00293397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6008066|NCT00293423|polysaccharide-K|polysaccharide-k|mesh-list
6008067|NCT00293423|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6008068|NCT00293423|Immunologic Factors|immunologic factors|mesh-ancestor
6008069|NCT00293423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008070|NCT00293423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6008071|NCT00293423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6008072|NCT00293423|Antiviral Agents|antiviral agents|mesh-ancestor
6008073|NCT00293423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6008074|NCT00293423|Interferon Inducers|interferon inducers|mesh-ancestor
6008075|NCT00293423|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6008076|NCT00293423|Protective Agents|protective agents|mesh-ancestor
6008077|NCT00293462|Sargramostim|sargramostim|mesh-list
6008078|NCT00293462|Immunologic Factors|immunologic factors|mesh-ancestor
6008079|NCT00293462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008080|NCT00293540|Tamoxifen|tamoxifen|mesh-list
6008081|NCT00293540|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6008082|NCT00293540|Hormone Antagonists|hormone antagonists|mesh-ancestor
6008083|NCT00293540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6008084|NCT00293540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260816|NCT03179891|Diazepam|diazepam|mesh-list
6008085|NCT00293540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6008086|NCT00293540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6008087|NCT00293540|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6008088|NCT00293540|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6008089|NCT00293540|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6008090|NCT00293579|Pemetrexed|pemetrexed|mesh-list
6008091|NCT00293579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6008092|NCT00293579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6008093|NCT00293579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6008094|NCT00293579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6008095|NCT00293579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6008096|NCT00293709|Etanercept|etanercept|mesh-list
6008097|NCT00293709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6008098|NCT00293709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6008099|NCT00293709|Analgesics|analgesics|mesh-ancestor
6008100|NCT00293709|Sensory System Agents|sensory system agents|mesh-ancestor
6008101|NCT00293709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6008102|NCT00293709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008103|NCT00293709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6008104|NCT00293709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6008105|NCT00293709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6008106|NCT00293709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6008107|NCT00293709|Immunologic Factors|immunologic factors|mesh-ancestor
6008108|NCT00293722|Etanercept|etanercept|mesh-list
6008109|NCT00293722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6008110|NCT00293722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6008111|NCT00293722|Analgesics|analgesics|mesh-ancestor
6008112|NCT00293722|Sensory System Agents|sensory system agents|mesh-ancestor
6008113|NCT00293722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6008114|NCT00293722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008115|NCT00293722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6008116|NCT00293722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6008117|NCT00293722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6008118|NCT00293722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6008119|NCT00293722|Immunologic Factors|immunologic factors|mesh-ancestor
6008120|NCT00293813|Denosumab|denosumab|mesh-list
6008121|NCT00293813|Alendronate|alendronate|mesh-list
6008122|NCT00293813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6008123|NCT00293813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018259|NCT00379340|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6018260|NCT00379340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6018261|NCT00379353|Thalidomide|thalidomide|mesh-list
6018262|NCT00379353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6018263|NCT00379353|Immunologic Factors|immunologic factors|mesh-ancestor
6018264|NCT00379353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018265|NCT00379353|Leprostatic Agents|leprostatic agents|mesh-ancestor
6018266|NCT00379353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6018267|NCT00379353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6018268|NCT00379353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6018269|NCT00379353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6018270|NCT00379353|Growth Substances|growth substances|mesh-ancestor
6018271|NCT00379353|Growth Inhibitors|growth inhibitors|mesh-ancestor
6018272|NCT00379353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6018273|NCT00379574|Prednisolone|prednisolone|mesh-list
6018274|NCT00379574|Cyclophosphamide|cyclophosphamide|mesh-list
6018275|NCT00379574|Doxorubicin|doxorubicin|mesh-list
6018276|NCT00379574|Vincristine|vincristine|mesh-list
6018277|NCT00379574|Bortezomib|bortezomib|mesh-list
6018278|NCT00379574|Lenograstim|lenograstim|mesh-list
6018279|NCT00379574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6018280|NCT00379574|Immunologic Factors|immunologic factors|mesh-ancestor
6018281|NCT00379574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018282|NCT00379574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6018283|NCT00379574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6018284|NCT00379574|Alkylating Agents|alkylating agents|mesh-ancestor
6018285|NCT00379574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6018286|NCT00379574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6018287|NCT00379574|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6018288|NCT00379574|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6018289|NCT00379574|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6018290|NCT00379574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6008124|NCT00294398|Fluticasone|fluticasone|mesh-list
6008125|NCT00294398|Xhance|xhance|mesh-list
6008126|NCT00294398|Budesonide|budesonide|mesh-list
6008127|NCT00294398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6008128|NCT00294398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6008129|NCT00294398|Autonomic Agents|autonomic agents|mesh-ancestor
6008130|NCT00294398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6008131|NCT00294398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008132|NCT00294398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6008133|NCT00294398|Respiratory System Agents|respiratory system agents|mesh-ancestor
6008134|NCT00294398|Dermatologic Agents|dermatologic agents|mesh-ancestor
6008135|NCT00294398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6008136|NCT00294398|Glucocorticoids|glucocorticoids|mesh-ancestor
6008137|NCT00294398|Hormones|hormones|mesh-ancestor
6008138|NCT00294398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6008139|NCT00294515|Valganciclovir|valganciclovir|mesh-list
6008140|NCT00294515|Antiviral Agents|antiviral agents|mesh-ancestor
6008141|NCT00294515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6008142|NCT00294554|Memantine|memantine|mesh-list
6008143|NCT00294554|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6008144|NCT00294554|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6008145|NCT00294554|Dopamine Agents|dopamine agents|mesh-ancestor
6008146|NCT00294554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6008147|NCT00294554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6008148|NCT00294554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008149|NCT00294554|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6008150|NCT00294554|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6008151|NCT00294632|Rituximab|rituximab|mesh-list
6008152|NCT00294632|Lenalidomide|lenalidomide|mesh-list
6008153|NCT00294632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6008154|NCT00294632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6008155|NCT00294632|Immunologic Factors|immunologic factors|mesh-ancestor
6008156|NCT00294632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008157|NCT00294632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6008158|NCT00294632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6008159|NCT00294632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6008160|NCT00294632|Growth Substances|growth substances|mesh-ancestor
6008161|NCT00294632|Growth Inhibitors|growth inhibitors|mesh-ancestor
6008162|NCT00294658|Prednisone|prednisone|mesh-list
6008163|NCT00294658|Prednisolone|prednisolone|mesh-list
6008164|NCT00294658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6008165|NCT00294658|Glucocorticoids|glucocorticoids|mesh-ancestor
6008166|NCT00294658|Hormones|hormones|mesh-ancestor
6008167|NCT00294658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6008168|NCT00294658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008169|NCT00294658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6008170|NCT00294658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6260817|NCT03179891|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6260818|NCT03179891|Anticonvulsants|anticonvulsants|mesh-ancestor
6260819|NCT03179891|Antiemetics|antiemetics|mesh-ancestor
6260820|NCT03179891|Autonomic Agents|autonomic agents|mesh-ancestor
6260821|NCT03179891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6260822|NCT03179891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260823|NCT03179891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6260824|NCT03179891|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6260825|NCT03179891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6260826|NCT03179891|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6260827|NCT03179891|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6260828|NCT03179891|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6260829|NCT03179891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6260830|NCT03179891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6260831|NCT03179891|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6260832|NCT03179891|Anesthetics, General|anesthetics, general|mesh-ancestor
6260833|NCT03179891|Anesthetics|anesthetics|mesh-ancestor
6260834|NCT03179891|GABA Modulators|gaba modulators|mesh-ancestor
6260835|NCT03179891|GABA Agents|gaba agents|mesh-ancestor
6260836|NCT03179891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6260837|NCT03179891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260838|NCT03180489|Dapagliflozin|dapagliflozin|mesh-list
6260839|NCT03180489|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6260840|NCT03180489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260841|NCT03180489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6260842|NCT03180489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260843|NCT03180528|Benzoic Acid|benzoic acid|mesh-list
6008171|NCT00294671|Diflunisal|diflunisal|mesh-list
6008172|NCT00294671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6008173|NCT00294671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6008174|NCT00294671|Analgesics|analgesics|mesh-ancestor
6008175|NCT00294671|Sensory System Agents|sensory system agents|mesh-ancestor
6008176|NCT00294671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6008177|NCT00294671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008178|NCT00294671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6008179|NCT00294671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6008180|NCT00294671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6008181|NCT00294671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6008182|NCT00294671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6008183|NCT00294684|Methylprednisolone|methylprednisolone|mesh-list
6008184|NCT00294684|Prednisolone|prednisolone|mesh-list
6008185|NCT00294684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6008186|NCT00294684|Antiemetics|antiemetics|mesh-ancestor
6008187|NCT00294684|Autonomic Agents|autonomic agents|mesh-ancestor
6008188|NCT00294684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6008189|NCT00294684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008190|NCT00294684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6008191|NCT00294684|Glucocorticoids|glucocorticoids|mesh-ancestor
6008192|NCT00294684|Hormones|hormones|mesh-ancestor
6008193|NCT00294684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6008194|NCT00294684|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6008195|NCT00294684|Protective Agents|protective agents|mesh-ancestor
6008196|NCT00294684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6008197|NCT00294684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6008198|NCT00294723|Liraglutide|liraglutide|mesh-list
6008199|NCT00294723|Glimepiride|glimepiride|mesh-list
6008200|NCT00294723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6008201|NCT00294723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008202|NCT00294723|Incretins|incretins|mesh-ancestor
6008203|NCT00294723|Hormones|hormones|mesh-ancestor
6008204|NCT00294723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6008205|NCT00294723|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6008206|NCT00294723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6008207|NCT00294723|Immunologic Factors|immunologic factors|mesh-ancestor
6008208|NCT00294762|Paclitaxel|paclitaxel|mesh-list
6008209|NCT00294762|Carboplatin|carboplatin|mesh-list
6008210|NCT00294762|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6008211|NCT00294762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6008212|NCT00294762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6008213|NCT00294762|Tubulin Modulators|tubulin modulators|mesh-ancestor
6008214|NCT00294762|Antimitotic Agents|antimitotic agents|mesh-ancestor
6008215|NCT00294762|Mitosis Modulators|mitosis modulators|mesh-ancestor
6008216|NCT00294762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6008217|NCT00294762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6008218|NCT00294762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6008219|NCT00295022|Montelukast|montelukast|mesh-list
6008220|NCT00295022|Levocetirizine|levocetirizine|mesh-list
6008221|NCT00295022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6008222|NCT00295022|Respiratory System Agents|respiratory system agents|mesh-ancestor
6008223|NCT00295022|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6008224|NCT00295022|Hormone Antagonists|hormone antagonists|mesh-ancestor
6008225|NCT00295022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6008226|NCT00295022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008227|NCT00295022|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6008228|NCT00295022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6008229|NCT00295022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6008230|NCT00295022|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6008231|NCT00295022|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6008232|NCT00295022|Histamine Antagonists|histamine antagonists|mesh-ancestor
6008233|NCT00295022|Histamine Agents|histamine agents|mesh-ancestor
6008234|NCT00295022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6008235|NCT00295061|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
6008236|NCT00295061|Protein C Inhibitor|protein c inhibitor|mesh-list
6008237|NCT00295061|Protease Inhibitors|protease inhibitors|mesh-list
6008238|NCT00295061|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6008239|NCT00295061|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6008240|NCT00295061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6008241|NCT00295061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6008242|NCT00295503|Bevacizumab|bevacizumab|mesh-list
6008243|NCT00295503|Pemetrexed|pemetrexed|mesh-list
6008244|NCT00295503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6008245|NCT00295503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6008246|NCT00295503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6008247|NCT00295503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6008248|NCT00295503|Growth Substances|growth substances|mesh-ancestor
6008249|NCT00295503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008250|NCT00295503|Growth Inhibitors|growth inhibitors|mesh-ancestor
6008251|NCT00295503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6008252|NCT00295503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6008253|NCT00295503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6008254|NCT00295503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6008255|NCT00295620|Anastrozole|anastrozole|mesh-list
6008256|NCT00295620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6008257|NCT00295620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6008258|NCT00295620|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6008259|NCT00295620|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6008260|NCT00295620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6008261|NCT00295620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6008262|NCT00295620|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6008263|NCT00295620|Hormone Antagonists|hormone antagonists|mesh-ancestor
6008264|NCT00295620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6008265|NCT00295620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008266|NCT00295633|Metformin|metformin|mesh-list
6008267|NCT00295633|Pioglitazone|pioglitazone|mesh-list
6008268|NCT00295633|Rosiglitazone|rosiglitazone|mesh-list
6008269|NCT00295633|Saxagliptin|saxagliptin|mesh-list
6008270|NCT00295633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6008271|NCT00295633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008272|NCT00295633|Incretins|incretins|mesh-ancestor
6008273|NCT00295633|Hormones|hormones|mesh-ancestor
6008274|NCT00295633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6008275|NCT00295633|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6008276|NCT00295633|Protease Inhibitors|protease inhibitors|mesh-ancestor
6008277|NCT00295633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6008278|NCT00295633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6008279|NCT00295750|Leuprolide|leuprolide|mesh-list
6008280|NCT00295750|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6008281|NCT00295750|Fertility Agents|fertility agents|mesh-ancestor
6008282|NCT00295750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6008283|NCT00295750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008284|NCT00295750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6008285|NCT00295750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6008286|NCT00295867|Zoledronic Acid|zoledronic acid|mesh-list
6008287|NCT00295867|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6008288|NCT00295867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008289|NCT00295932|Prednisone|prednisone|mesh-list
6008290|NCT00295932|Cyclophosphamide|cyclophosphamide|mesh-list
6008291|NCT00295932|Rituximab|rituximab|mesh-list
6008292|NCT00295932|Bortezomib|bortezomib|mesh-list
6008293|NCT00295932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6008294|NCT00295932|Immunologic Factors|immunologic factors|mesh-ancestor
6008295|NCT00295932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008296|NCT00295932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6008297|NCT00295932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6008298|NCT00295932|Alkylating Agents|alkylating agents|mesh-ancestor
6008299|NCT00295932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6008300|NCT00295932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6008301|NCT00295932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6008302|NCT00295932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6008303|NCT00295932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6008304|NCT00295932|Glucocorticoids|glucocorticoids|mesh-ancestor
6008305|NCT00295932|Hormones|hormones|mesh-ancestor
6008306|NCT00295932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6008307|NCT00295932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6008308|NCT00296036|Pyridoxine|pyridoxine|mesh-list
6008309|NCT00296036|Vitamin B 6|vitamin b 6|mesh-list
6008310|NCT00296036|Vitamin B Complex|vitamin b complex|mesh-ancestor
6008311|NCT00296036|Vitamins|vitamins|mesh-ancestor
6008312|NCT00296036|Micronutrients|micronutrients|mesh-ancestor
6008313|NCT00296036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008314|NCT00296192|Rotigotine|rotigotine|mesh-list
6008315|NCT00296192|Dopamine Agonists|dopamine agonists|mesh-ancestor
6008316|NCT00296192|Dopamine Agents|dopamine agents|mesh-ancestor
6008317|NCT00296192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6008318|NCT00296192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6008319|NCT00296192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008320|NCT00296244|Mycophenolic Acid|mycophenolic acid|mesh-list
6008321|NCT00296244|Prednisone|prednisone|mesh-list
6008322|NCT00296244|Methylprednisolone|methylprednisolone|mesh-list
6008323|NCT00296244|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6008324|NCT00296244|Tacrolimus|tacrolimus|mesh-list
6008325|NCT00296244|Basiliximab|basiliximab|mesh-list
6008326|NCT00296244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6008327|NCT00296244|Glucocorticoids|glucocorticoids|mesh-ancestor
6008328|NCT00296244|Hormones|hormones|mesh-ancestor
6008329|NCT00296244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6008330|NCT00296244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008331|NCT00296244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6008332|NCT00296244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6008333|NCT00296244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6008334|NCT00296244|Immunologic Factors|immunologic factors|mesh-ancestor
6008335|NCT00296244|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6008336|NCT00296244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6008337|NCT00296244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6008338|NCT00296244|Antiemetics|antiemetics|mesh-ancestor
6008339|NCT00296244|Autonomic Agents|autonomic agents|mesh-ancestor
6008340|NCT00296244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6008341|NCT00296244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6008342|NCT00296244|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6260844|NCT03180528|Antifungal Agents|antifungal agents|mesh-ancestor
6260845|NCT03180528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6260846|NCT03181009|Omalizumab|omalizumab|mesh-list
6260847|NCT03181009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6260848|NCT03181009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6260849|NCT03181009|Respiratory System Agents|respiratory system agents|mesh-ancestor
6389933|NCT00189709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6389934|NCT00189709|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6389935|NCT00189709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6389936|NCT00189709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6008343|NCT00296244|Protective Agents|protective agents|mesh-ancestor
6389937|NCT00189709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389938|NCT00189709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6389939|NCT00189709|Hormone Antagonists|hormone antagonists|mesh-ancestor
6389940|NCT00189709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6389941|NCT00189709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389942|NCT00189709|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6389943|NCT00189709|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6389944|NCT00189722|Tacrolimus|tacrolimus|mesh-list
6389945|NCT00189722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6389946|NCT00189722|Immunologic Factors|immunologic factors|mesh-ancestor
6389947|NCT00189722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389948|NCT00189722|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6389949|NCT00189722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6389950|NCT00189722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396836|NCT00209755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396837|NCT00209755|Antiviral Agents|antiviral agents|mesh-ancestor
6396838|NCT00209755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6396839|NCT00209781|Pyrimethamine|pyrimethamine|mesh-list
6396840|NCT00209781|Sulfadoxine|sulfadoxine|mesh-list
6396841|NCT00209781|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6396842|NCT00209781|Antimalarials|antimalarials|mesh-ancestor
6396843|NCT00209781|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6396844|NCT00209781|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6396845|NCT00209781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6396846|NCT00209781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6396847|NCT00209781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6396848|NCT00209781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396849|NCT00209781|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6396850|NCT00209781|Renal Agents|renal agents|mesh-ancestor
6396851|NCT00209794|Pyrimethamine|pyrimethamine|mesh-list
6396852|NCT00209794|Sulfadoxine|sulfadoxine|mesh-list
6396853|NCT00209794|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6008344|NCT00296244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6008345|NCT00296244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6008346|NCT00296244|Antitubercular Agents|antitubercular agents|mesh-ancestor
6008347|NCT00296244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6008348|NCT00296244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6008349|NCT00296296|Cyclosporine|cyclosporine|mesh-list
6008350|NCT00296296|Tacrolimus|tacrolimus|mesh-list
6008351|NCT00296296|Cyclosporins|cyclosporins|mesh-list
6008352|NCT00296296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6008353|NCT00296296|Immunologic Factors|immunologic factors|mesh-ancestor
6008354|NCT00296296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008355|NCT00296296|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6008356|NCT00296296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6008357|NCT00296296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6008358|NCT00296296|Antifungal Agents|antifungal agents|mesh-ancestor
6008359|NCT00296296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6008360|NCT00296296|Dermatologic Agents|dermatologic agents|mesh-ancestor
6008361|NCT00296296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6008362|NCT00296322|Mitomycins|mitomycins|mesh-list
6008363|NCT00296322|Mitomycin|mitomycin|mesh-list
6008364|NCT00296322|Doxifluridine|doxifluridine|mesh-list
6008365|NCT00296322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6008366|NCT00296322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6008367|NCT00296322|Alkylating Agents|alkylating agents|mesh-ancestor
6008368|NCT00296322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6008369|NCT00296322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6008370|NCT00296322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6008371|NCT00296322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6008372|NCT00296322|Antimetabolites|antimetabolites|mesh-ancestor
6008373|NCT00296322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6008374|NCT00296322|Immunologic Factors|immunologic factors|mesh-ancestor
6008375|NCT00296322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008376|NCT00296322|Appetite Stimulants|appetite stimulants|mesh-ancestor
6008377|NCT00296322|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6008378|NCT00296335|Mitomycins|mitomycins|mesh-list
6008379|NCT00296335|Mitomycin|mitomycin|mesh-list
6008380|NCT00296335|Doxifluridine|doxifluridine|mesh-list
6008381|NCT00296335|Floxuridine|floxuridine|mesh-list
6008382|NCT00296335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6008383|NCT00296335|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6008384|NCT00296335|Alkylating Agents|alkylating agents|mesh-ancestor
6008385|NCT00296335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6008386|NCT00296335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6008387|NCT00296335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6008388|NCT00296335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6008389|NCT00296335|Antimetabolites|antimetabolites|mesh-ancestor
6008390|NCT00296335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6008391|NCT00296335|Immunologic Factors|immunologic factors|mesh-ancestor
6008392|NCT00296335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008393|NCT00296335|Appetite Stimulants|appetite stimulants|mesh-ancestor
6008394|NCT00296335|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6008395|NCT00296374|Atorvastatin|atorvastatin|mesh-list
6008396|NCT00296374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6008397|NCT00296374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6008398|NCT00296374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6008399|NCT00296374|Antimetabolites|antimetabolites|mesh-ancestor
6008400|NCT00296374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6008401|NCT00296374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6008402|NCT00296374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6008403|NCT00296374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6008404|NCT00296400|Atorvastatin|atorvastatin|mesh-list
6008405|NCT00296400|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6008406|NCT00296400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6008407|NCT00296400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6008408|NCT00296400|Antimetabolites|antimetabolites|mesh-ancestor
6008409|NCT00296400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6008410|NCT00296400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6008411|NCT00296400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6008412|NCT00296400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6008413|NCT00296491|Fluticasone|fluticasone|mesh-list
6008414|NCT00296491|Xhance|xhance|mesh-list
6008415|NCT00296491|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6008416|NCT00296491|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6008417|NCT00296491|Montelukast|montelukast|mesh-list
6008418|NCT00296491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6008419|NCT00296491|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6008420|NCT00296491|Autonomic Agents|autonomic agents|mesh-ancestor
6008421|NCT00296491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6008422|NCT00296491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008423|NCT00296491|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6008424|NCT00296491|Respiratory System Agents|respiratory system agents|mesh-ancestor
6008425|NCT00296491|Dermatologic Agents|dermatologic agents|mesh-ancestor
6008426|NCT00296491|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6008427|NCT00296491|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6008428|NCT00296491|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6008429|NCT00296491|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6008430|NCT00296491|Adrenergic Agents|adrenergic agents|mesh-ancestor
6008431|NCT00296491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6008432|NCT00296491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6008433|NCT00296491|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6008434|NCT00296491|Hormone Antagonists|hormone antagonists|mesh-ancestor
6008435|NCT00296491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6008436|NCT00296491|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6008437|NCT00296491|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6008438|NCT00296491|Glucocorticoids|glucocorticoids|mesh-ancestor
6008439|NCT00296491|Hormones|hormones|mesh-ancestor
6008440|NCT00296491|Sympathomimetics|sympathomimetics|mesh-ancestor
6008441|NCT00296504|Ritonavir|ritonavir|mesh-list
6008442|NCT00296504|Fosamprenavir|fosamprenavir|mesh-list
6008443|NCT00296504|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6008444|NCT00296504|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6008445|NCT00296504|Protease Inhibitors|protease inhibitors|mesh-ancestor
6008446|NCT00296504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6008447|NCT00296504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6008448|NCT00296504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6008449|NCT00296504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6008450|NCT00296504|Antiviral Agents|antiviral agents|mesh-ancestor
6008451|NCT00296504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6008452|NCT00296504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6008453|NCT00296504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6008454|NCT00296517|Bupropion|bupropion|mesh-list
6008455|NCT00296517|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6008456|NCT00296517|Antidepressive Agents|antidepressive agents|mesh-ancestor
6008457|NCT00296517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6008458|NCT00296517|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6008459|NCT00296517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6008460|NCT00296517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6008461|NCT00296517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6008462|NCT00296517|Dopamine Agents|dopamine agents|mesh-ancestor
6008463|NCT00296517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6008464|NCT00296517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008465|NCT00296517|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6008466|NCT00296517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6008467|NCT00296517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6008468|NCT00296647|Bupropion|bupropion|mesh-list
6008469|NCT00296647|Nicotine|nicotine|mesh-list
6008470|NCT00296647|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6008471|NCT00296647|Autonomic Agents|autonomic agents|mesh-ancestor
6008472|NCT00296647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6008473|NCT00296647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008474|NCT00296647|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6008475|NCT00296647|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6008476|NCT00296647|Cholinergic Agents|cholinergic agents|mesh-ancestor
6008477|NCT00296647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6008478|NCT00296647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6008479|NCT00296647|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6008480|NCT00296647|Antidepressive Agents|antidepressive agents|mesh-ancestor
6008481|NCT00296647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6008482|NCT00296647|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6008483|NCT00296647|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6008484|NCT00296647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6008485|NCT00296647|Dopamine Agents|dopamine agents|mesh-ancestor
6008486|NCT00296647|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6008487|NCT00296647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6008488|NCT00296647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6008489|NCT00296725|Fluoxetine|fluoxetine|mesh-list
6008490|NCT00296725|Imipramine|imipramine|mesh-list
6008491|NCT00296725|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6008492|NCT00296725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6008493|NCT00296725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6008494|NCT00296725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6008495|NCT00296725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6008496|NCT00296725|Serotonin Agents|serotonin agents|mesh-ancestor
6008497|NCT00296725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008498|NCT00296725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6008499|NCT00296725|Antidepressive Agents|antidepressive agents|mesh-ancestor
6008500|NCT00296725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6008501|NCT00296725|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6008502|NCT00296725|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6008503|NCT00296725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6008504|NCT00296725|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6008505|NCT00296725|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6008506|NCT00296725|Adrenergic Agents|adrenergic agents|mesh-ancestor
6008507|NCT00296816|Bevacizumab|bevacizumab|mesh-list
6008508|NCT00296816|Docetaxel|docetaxel|mesh-list
6008509|NCT00296816|Oxaliplatin|oxaliplatin|mesh-list
6008510|NCT00296816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6008511|NCT00296816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6008512|NCT00296816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6536469|NCT00817037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6536470|NCT00817037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6536471|NCT00817037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536472|NCT00817037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6008513|NCT00296816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6008514|NCT00296816|Growth Substances|growth substances|mesh-ancestor
6008515|NCT00296816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008516|NCT00296816|Growth Inhibitors|growth inhibitors|mesh-ancestor
6008517|NCT00296816|Tubulin Modulators|tubulin modulators|mesh-ancestor
6008518|NCT00296816|Antimitotic Agents|antimitotic agents|mesh-ancestor
6008519|NCT00296816|Mitosis Modulators|mitosis modulators|mesh-ancestor
6008520|NCT00296816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6008521|NCT00297037|Pimecrolimus|pimecrolimus|mesh-list
6008522|NCT00297037|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6008523|NCT00297037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6008524|NCT00297037|Analgesics|analgesics|mesh-ancestor
6008525|NCT00297037|Sensory System Agents|sensory system agents|mesh-ancestor
6008526|NCT00297037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6008527|NCT00297037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008528|NCT00297037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6008529|NCT00297037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6008530|NCT00297037|Dermatologic Agents|dermatologic agents|mesh-ancestor
6008531|NCT00297037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6008532|NCT00297037|Immunologic Factors|immunologic factors|mesh-ancestor
6008533|NCT00297037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6008534|NCT00297037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6008535|NCT00297037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6008536|NCT00297232|Natalizumab|natalizumab|mesh-list
6008537|NCT00297232|Immunologic Factors|immunologic factors|mesh-ancestor
6008538|NCT00297232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008539|NCT00297479|Nicotine|nicotine|mesh-list
6008540|NCT00297479|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6008541|NCT00297479|Autonomic Agents|autonomic agents|mesh-ancestor
6008542|NCT00297479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6008543|NCT00297479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008544|NCT00297479|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6008545|NCT00297479|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6008546|NCT00297479|Cholinergic Agents|cholinergic agents|mesh-ancestor
6008547|NCT00297479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6008548|NCT00297479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6008549|NCT00297492|Nicotine|nicotine|mesh-list
6008550|NCT00297492|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6008551|NCT00297492|Autonomic Agents|autonomic agents|mesh-ancestor
6008552|NCT00297492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6008553|NCT00297492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008554|NCT00297492|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6008555|NCT00297492|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6008556|NCT00297492|Cholinergic Agents|cholinergic agents|mesh-ancestor
6008557|NCT00297492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6008558|NCT00297492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6008559|NCT00297596|Oxaliplatin|oxaliplatin|mesh-list
6008560|NCT00297596|Trastuzumab|trastuzumab|mesh-list
6008561|NCT00297596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6008562|NCT00297596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6008563|NCT00297648|Certolizumab Pegol|certolizumab pegol|mesh-list
6008564|NCT00297648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6008565|NCT00297648|Immunologic Factors|immunologic factors|mesh-ancestor
6008566|NCT00297648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008567|NCT00297648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6008568|NCT00297778|Pramipexole|pramipexole|mesh-list
6008569|NCT00297778|Antioxidants|antioxidants|mesh-ancestor
6008570|NCT00297778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6008571|NCT00297778|Protective Agents|protective agents|mesh-ancestor
6008572|NCT00297778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008573|NCT00297778|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6008574|NCT00297778|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6008575|NCT00297778|Dopamine Agonists|dopamine agonists|mesh-ancestor
6008576|NCT00297778|Dopamine Agents|dopamine agents|mesh-ancestor
6008577|NCT00297778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6008578|NCT00297830|Zoledronic Acid|zoledronic acid|mesh-list
6008579|NCT00297830|Alendronate|alendronate|mesh-list
6008580|NCT00297830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6008581|NCT00297830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008582|NCT00297882|Artesunate|artesunate|mesh-list
6008583|NCT00297882|Lumefantrine|lumefantrine|mesh-list
6008584|NCT00297882|Artemether|artemether|mesh-list
6008585|NCT00297882|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6008586|NCT00297882|Amodiaquine|amodiaquine|mesh-list
6008587|NCT00297882|Antimalarials|antimalarials|mesh-ancestor
6008588|NCT00297882|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6008589|NCT00297882|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6008590|NCT00297882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6008591|NCT00297882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6008592|NCT00297882|Antiviral Agents|antiviral agents|mesh-ancestor
6008593|NCT00297882|Schistosomicides|schistosomicides|mesh-ancestor
6008594|NCT00297882|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6008595|NCT00297882|Anthelmintics|anthelmintics|mesh-ancestor
6008596|NCT00298038|Rifaximin|rifaximin|mesh-list
6008597|NCT00298038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6008598|NCT00298038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6008599|NCT00298038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6008600|NCT00298155|Ketoconazole|ketoconazole|mesh-list
6008601|NCT00298155|Goserelin|goserelin|mesh-list
6008602|NCT00298155|Bicalutamide|bicalutamide|mesh-list
6008603|NCT00298155|Dutasteride|dutasteride|mesh-list
6008604|NCT00298155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6008605|NCT00298155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6008606|NCT00298155|Antifungal Agents|antifungal agents|mesh-ancestor
6008607|NCT00298155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6008608|NCT00298155|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6008609|NCT00298155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6260850|NCT03181308|Nivolumab|nivolumab|mesh-list
6260851|NCT03181308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6260852|NCT03181308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6260853|NCT03181308|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6260854|NCT03181308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260855|NCT03181451|Ferric maltol|ferric maltol|mesh-list
6260856|NCT03181451|Hematinics|hematinics|mesh-ancestor
6260857|NCT03181932|Vancomycin|vancomycin|mesh-list
6260858|NCT03181932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6260859|NCT03181932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6260860|NCT03182920|Lasmiditan|lasmiditan|mesh-list
6260861|NCT03182920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6260862|NCT03182920|Serotonin Agents|serotonin agents|mesh-ancestor
6260863|NCT03182920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6260864|NCT03182920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260865|NCT03182920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260866|NCT03183908|Vaccines|vaccines|mesh-list
6260867|NCT03183908|Immunologic Factors|immunologic factors|mesh-ancestor
6260868|NCT03183908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260869|NCT03184558|Pembrolizumab|pembrolizumab|mesh-list
6260870|NCT03184558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6260871|NCT03184558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6260872|NCT03184987|Albuterol|albuterol|mesh-list
6260873|NCT03184987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6260874|NCT03184987|Autonomic Agents|autonomic agents|mesh-ancestor
6260875|NCT03184987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6260876|NCT03184987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260877|NCT03184987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6260878|NCT03184987|Respiratory System Agents|respiratory system agents|mesh-ancestor
6260879|NCT03184987|Tocolytic Agents|tocolytic agents|mesh-ancestor
6260880|NCT03184987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6260881|NCT03184987|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6260882|NCT03184987|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6260883|NCT03184987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6260884|NCT03184987|Adrenergic Agents|adrenergic agents|mesh-ancestor
6260885|NCT03184987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6260886|NCT03184987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260887|NCT03185065|Amantadine|amantadine|mesh-list
6260888|NCT03185065|Methylphenidate|methylphenidate|mesh-list
6260889|NCT03185065|Modafinil|modafinil|mesh-list
6008610|NCT00298155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6008611|NCT00298155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6008612|NCT00298155|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6260890|NCT03185065|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6008613|NCT00298155|Hormone Antagonists|hormone antagonists|mesh-ancestor
6008614|NCT00298155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6008615|NCT00298155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008616|NCT00298155|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6008617|NCT00298155|Androgen Antagonists|androgen antagonists|mesh-ancestor
6008618|NCT00298155|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6008619|NCT00298233|Oseltamivir|oseltamivir|mesh-list
6008620|NCT00298233|Antiviral Agents|antiviral agents|mesh-ancestor
6008621|NCT00298233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6008622|NCT00298233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6008623|NCT00298233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6008624|NCT00298272|Methylprednisolone|methylprednisolone|mesh-list
6008625|NCT00298272|Adalimumab|adalimumab|mesh-list
6008626|NCT00298272|Etanercept|etanercept|mesh-list
6008627|NCT00298272|Rituximab|rituximab|mesh-list
6008628|NCT00298272|Methotrexate|methotrexate|mesh-list
6008629|NCT00298272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6008630|NCT00298272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6008631|NCT00298272|Immunologic Factors|immunologic factors|mesh-ancestor
6008632|NCT00298272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008633|NCT00298272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6008634|NCT00298272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6008635|NCT00298272|Abortifacient Agents|abortifacient agents|mesh-ancestor
6008636|NCT00298272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6008637|NCT00298272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6008638|NCT00298272|Antimetabolites|antimetabolites|mesh-ancestor
6008639|NCT00298272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6008640|NCT00298272|Dermatologic Agents|dermatologic agents|mesh-ancestor
6008641|NCT00298272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6008642|NCT00298272|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6008643|NCT00298272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6008644|NCT00298272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6008645|NCT00298272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6008646|NCT00298272|Antiemetics|antiemetics|mesh-ancestor
6008647|NCT00298272|Autonomic Agents|autonomic agents|mesh-ancestor
6008648|NCT00298272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6008649|NCT00298272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6008650|NCT00298272|Glucocorticoids|glucocorticoids|mesh-ancestor
6008651|NCT00298272|Hormones|hormones|mesh-ancestor
6008652|NCT00298272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6008653|NCT00298272|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6008654|NCT00298272|Protective Agents|protective agents|mesh-ancestor
6008655|NCT00298272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6008656|NCT00298272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6008657|NCT00298272|Analgesics|analgesics|mesh-ancestor
6008658|NCT00298272|Sensory System Agents|sensory system agents|mesh-ancestor
6008659|NCT00298363|Tenofovir|tenofovir|mesh-list
6008660|NCT00298363|Emtricitabine|emtricitabine|mesh-list
6008661|NCT00298363|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6008662|NCT00298363|Entecavir|entecavir|mesh-list
6008663|NCT00298363|Antiviral Agents|antiviral agents|mesh-ancestor
6008664|NCT00298363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6008665|NCT00298363|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6008666|NCT00298363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6008667|NCT00298363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6008668|NCT00298363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6008669|NCT00298363|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6008670|NCT00298363|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6008671|NCT00298610|Artesunate|artesunate|mesh-list
6008672|NCT00298610|Atovaquone|atovaquone|mesh-list
6008673|NCT00298610|Proguanil|proguanil|mesh-list
6008674|NCT00298610|Quinidine|quinidine|mesh-list
6008675|NCT00298610|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
6008676|NCT00298610|Antimalarials|antimalarials|mesh-ancestor
6008677|NCT00298610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6008678|NCT00298610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6008679|NCT00298610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6008680|NCT00298610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6008681|NCT00298610|Antiviral Agents|antiviral agents|mesh-ancestor
6008682|NCT00298610|Schistosomicides|schistosomicides|mesh-ancestor
6008683|NCT00298610|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6008684|NCT00298610|Anthelmintics|anthelmintics|mesh-ancestor
6008685|NCT00298610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6008686|NCT00298610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6008687|NCT00298610|Antimetabolites|antimetabolites|mesh-ancestor
6008688|NCT00298610|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6008689|NCT00298610|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6008690|NCT00298610|Adrenergic Agents|adrenergic agents|mesh-ancestor
6008691|NCT00298610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6008692|NCT00298610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008693|NCT00298610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6008694|NCT00298610|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6008695|NCT00298610|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6008696|NCT00298610|Cholinergic Agents|cholinergic agents|mesh-ancestor
6008697|NCT00298610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6008698|NCT00298610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6008699|NCT00298610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6008700|NCT00298610|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6008701|NCT00298610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6008702|NCT00298766|Bortezomib|bortezomib|mesh-list
6008703|NCT00298766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6008704|NCT00298831|Rocuronium|rocuronium|mesh-list
6008705|NCT00298831|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6008706|NCT00298831|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6008707|NCT00298831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6008708|NCT00298831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6008709|NCT00298831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008710|NCT00299104|Methylprednisolone|methylprednisolone|mesh-list
6008711|NCT00299104|Rituximab|rituximab|mesh-list
6008712|NCT00299104|Methotrexate|methotrexate|mesh-list
6008713|NCT00299104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6008714|NCT00299104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6008715|NCT00299104|Immunologic Factors|immunologic factors|mesh-ancestor
6008716|NCT00299104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008717|NCT00299104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6008718|NCT00299104|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6008719|NCT00299104|Abortifacient Agents|abortifacient agents|mesh-ancestor
6008720|NCT00299104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6008721|NCT00299104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6008722|NCT00299104|Antimetabolites|antimetabolites|mesh-ancestor
6008723|NCT00299104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6008724|NCT00299104|Dermatologic Agents|dermatologic agents|mesh-ancestor
6008725|NCT00299104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6008726|NCT00299104|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6008727|NCT00299104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6008728|NCT00299104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6008729|NCT00299104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6008730|NCT00299104|Antiemetics|antiemetics|mesh-ancestor
6008731|NCT00299104|Autonomic Agents|autonomic agents|mesh-ancestor
6008732|NCT00299104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6008733|NCT00299104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6008734|NCT00299104|Glucocorticoids|glucocorticoids|mesh-ancestor
6008735|NCT00299104|Hormones|hormones|mesh-ancestor
6008736|NCT00299104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6008737|NCT00299104|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6008738|NCT00299104|Protective Agents|protective agents|mesh-ancestor
6008739|NCT00299130|Methylprednisolone|methylprednisolone|mesh-list
6008740|NCT00299130|Rituximab|rituximab|mesh-list
6008741|NCT00299130|Methotrexate|methotrexate|mesh-list
6008742|NCT00299130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6008743|NCT00299130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6008744|NCT00299130|Immunologic Factors|immunologic factors|mesh-ancestor
6008745|NCT00299130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008746|NCT00299130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6008747|NCT00299130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6008748|NCT00299130|Abortifacient Agents|abortifacient agents|mesh-ancestor
6008749|NCT00299130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6008750|NCT00299130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6008751|NCT00299130|Antimetabolites|antimetabolites|mesh-ancestor
6008752|NCT00299130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6008753|NCT00299130|Dermatologic Agents|dermatologic agents|mesh-ancestor
6008754|NCT00299130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6008755|NCT00299130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6008756|NCT00299130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6008757|NCT00299130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6008758|NCT00299130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6008759|NCT00299130|Antiemetics|antiemetics|mesh-ancestor
6008760|NCT00299130|Autonomic Agents|autonomic agents|mesh-ancestor
6008761|NCT00299130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6260891|NCT03185065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260892|NCT03185065|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6260893|NCT03185065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6260894|NCT03185065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6260895|NCT03185065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260896|NCT03185065|Dopamine Agents|dopamine agents|mesh-ancestor
6260897|NCT03185065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6260898|NCT03185065|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6260899|NCT03185065|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6260900|NCT03185065|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6260901|NCT03185065|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6260902|NCT03185065|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6260903|NCT03185065|Antiviral Agents|antiviral agents|mesh-ancestor
6260904|NCT03185065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6260905|NCT03185065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6260906|NCT03185065|Analgesics|analgesics|mesh-ancestor
6260907|NCT03185065|Sensory System Agents|sensory system agents|mesh-ancestor
6260908|NCT03185065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6260909|NCT03185546|Nicotine|nicotine|mesh-list
6260910|NCT03185546|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6260911|NCT03185546|Autonomic Agents|autonomic agents|mesh-ancestor
6260912|NCT03185546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6260913|NCT03185546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260914|NCT03185546|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6260915|NCT03185546|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6260916|NCT03185546|Cholinergic Agents|cholinergic agents|mesh-ancestor
6260917|NCT03185546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6260918|NCT03185546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260919|NCT03186261|Chlorhexidine|chlorhexidine|mesh-list
6260920|NCT03186261|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6260921|NCT03186261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6260922|NCT03186261|Fluorides|fluorides|mesh-list
6260923|NCT03186261|Cariostatic Agents|cariostatic agents|mesh-ancestor
6260924|NCT03186261|Protective Agents|protective agents|mesh-ancestor
6260925|NCT03186261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260926|NCT03186261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6260927|NCT03186261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6260928|NCT03186261|Disinfectants|disinfectants|mesh-ancestor
6260929|NCT03186261|Dermatologic Agents|dermatologic agents|mesh-ancestor
6260930|NCT03187197|Dabigatran|dabigatran|mesh-list
6260931|NCT03187197|Antithrombins|antithrombins|mesh-ancestor
6260932|NCT03187197|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6260933|NCT03187197|Protease Inhibitors|protease inhibitors|mesh-ancestor
6260934|NCT03187197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6260935|NCT03187197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260936|NCT03187197|Anticoagulants|anticoagulants|mesh-ancestor
6260937|NCT03187262|Daratumumab|daratumumab|mesh-list
6260938|NCT03187262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6260939|NCT03187301|Moxifloxacin|moxifloxacin|mesh-list
6260940|NCT03187301|Apomorphine|apomorphine|mesh-list
6260941|NCT03187301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6260942|NCT03187301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6260943|NCT03187301|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6260944|NCT03187301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6260945|NCT03187301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6260946|NCT03187301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260947|NCT03187301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6260948|NCT03187301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260949|NCT03187301|Emetics|emetics|mesh-ancestor
6260950|NCT03187301|Autonomic Agents|autonomic agents|mesh-ancestor
6260951|NCT03187301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6260952|NCT03187301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6260953|NCT03187301|Dopamine Agonists|dopamine agonists|mesh-ancestor
6260954|NCT03187301|Dopamine Agents|dopamine agents|mesh-ancestor
6260955|NCT03187301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6260956|NCT03187678|Selexipag|selexipag|mesh-list
6260957|NCT03187678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6260958|NCT03187730|Nicotine|nicotine|mesh-list
6260959|NCT03187730|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6260960|NCT03187730|Autonomic Agents|autonomic agents|mesh-ancestor
6260961|NCT03187730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6260962|NCT03187730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260963|NCT03187730|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6260964|NCT03187730|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6260965|NCT03187730|Cholinergic Agents|cholinergic agents|mesh-ancestor
6008762|NCT00299130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6008763|NCT00299130|Glucocorticoids|glucocorticoids|mesh-ancestor
6008764|NCT00299130|Hormones|hormones|mesh-ancestor
6008765|NCT00299130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6008766|NCT00299130|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6008767|NCT00299130|Protective Agents|protective agents|mesh-ancestor
6008768|NCT00299156|Clofarabine|clofarabine|mesh-list
6008769|NCT00299156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6008770|NCT00299156|Antimetabolites|antimetabolites|mesh-ancestor
6008771|NCT00299156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6008772|NCT00299156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6008773|NCT00299182|Cytarabine|cytarabine|mesh-list
6008774|NCT00299182|Dexamethasone|dexamethasone|mesh-list
6008775|NCT00299182|Cyclophosphamide|cyclophosphamide|mesh-list
6008776|NCT00299182|Rituximab|rituximab|mesh-list
6008777|NCT00299182|Doxorubicin|doxorubicin|mesh-list
6008778|NCT00299182|Methotrexate|methotrexate|mesh-list
6008779|NCT00299182|Vincristine|vincristine|mesh-list
6008780|NCT00299182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6008781|NCT00299182|Immunologic Factors|immunologic factors|mesh-ancestor
6008782|NCT00299182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008783|NCT00299182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6008784|NCT00299182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6008785|NCT00299182|Alkylating Agents|alkylating agents|mesh-ancestor
6008786|NCT00299182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6008787|NCT00299182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6008788|NCT00299182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6008789|NCT00299182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6008790|NCT00299182|Antiemetics|antiemetics|mesh-ancestor
6008791|NCT00299182|Autonomic Agents|autonomic agents|mesh-ancestor
6008792|NCT00299182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6008793|NCT00299182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6008794|NCT00299182|Glucocorticoids|glucocorticoids|mesh-ancestor
6008795|NCT00299182|Hormones|hormones|mesh-ancestor
6008796|NCT00299182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6008797|NCT00299182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6008798|NCT00299182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6008799|NCT00299182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6008800|NCT00299182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6008801|NCT00299182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6008802|NCT00299182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6008803|NCT00299182|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6008804|NCT00299182|Abortifacient Agents|abortifacient agents|mesh-ancestor
6008805|NCT00299182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6008806|NCT00299182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6008807|NCT00299182|Antimetabolites|antimetabolites|mesh-ancestor
6008808|NCT00299182|Dermatologic Agents|dermatologic agents|mesh-ancestor
6008809|NCT00299182|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6008810|NCT00299182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6008811|NCT00299182|Antiviral Agents|antiviral agents|mesh-ancestor
6008812|NCT00299182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6008813|NCT00299182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6008814|NCT00299182|Tubulin Modulators|tubulin modulators|mesh-ancestor
6008815|NCT00299182|Antimitotic Agents|antimitotic agents|mesh-ancestor
6008816|NCT00299182|Mitosis Modulators|mitosis modulators|mesh-ancestor
6008817|NCT00299221|Mycophenolic Acid|mycophenolic acid|mesh-list
6008818|NCT00299221|Tacrolimus|tacrolimus|mesh-list
6008819|NCT00299221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6008820|NCT00299221|Immunologic Factors|immunologic factors|mesh-ancestor
6008821|NCT00299221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008822|NCT00299221|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6008823|NCT00299221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6008824|NCT00299221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6008825|NCT00299221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6008826|NCT00299221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6008827|NCT00299221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6008828|NCT00299221|Antitubercular Agents|antitubercular agents|mesh-ancestor
6008829|NCT00299221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6008830|NCT00299221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6008831|NCT00299494|Rituximab|rituximab|mesh-list
6008832|NCT00299494|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
6008833|NCT00299494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6008834|NCT00299494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6008835|NCT00299494|Immunologic Factors|immunologic factors|mesh-ancestor
6008836|NCT00299494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008837|NCT00299494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6008838|NCT00299494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6008839|NCT00299546|Golimumab|golimumab|mesh-list
6008840|NCT00299546|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6008841|NCT00299546|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6008842|NCT00299546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6008843|NCT00299546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6008844|NCT00299546|Immunologic Factors|immunologic factors|mesh-ancestor
6008845|NCT00299546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008846|NCT00299689|Denileukin diftitox|denileukin diftitox|mesh-list
6008847|NCT00299689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6008848|NCT00299702|Aripiprazole|aripiprazole|mesh-list
6008849|NCT00299702|Risperidone|risperidone|mesh-list
6008850|NCT00299702|Antidepressive Agents|antidepressive agents|mesh-ancestor
6008851|NCT00299702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6008852|NCT00299702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6008853|NCT00299702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6008854|NCT00299702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6008855|NCT00299702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008856|NCT00299702|Dopamine Agonists|dopamine agonists|mesh-ancestor
6008857|NCT00299702|Dopamine Agents|dopamine agents|mesh-ancestor
6008858|NCT00299702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6008859|NCT00299702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6008860|NCT00299702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6008861|NCT00299702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6008862|NCT00299702|Serotonin Agents|serotonin agents|mesh-ancestor
6008863|NCT00299702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6008864|NCT00299702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6008865|NCT00299702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6008866|NCT00299702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6008867|NCT00299741|Sunitinib|sunitinib|mesh-list
6008868|NCT00299741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6008869|NCT00299741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6008870|NCT00299741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6008871|NCT00299741|Growth Substances|growth substances|mesh-ancestor
6008872|NCT00299741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008873|NCT00299741|Growth Inhibitors|growth inhibitors|mesh-ancestor
6008874|NCT00299741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6008875|NCT00299741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6008876|NCT00299741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6008877|NCT00299988|Immunoglobulins|immunoglobulins|mesh-list
6008878|NCT00299988|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6008879|NCT00299988|Antibodies|antibodies|mesh-list
6008880|NCT00299988|gamma-Globulins|gamma-globulins|mesh-list
6008881|NCT00299988|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6008882|NCT00299988|Immunologic Factors|immunologic factors|mesh-ancestor
6008883|NCT00299988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008884|NCT00300053|Lenograstim|lenograstim|mesh-list
6008885|NCT00300053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6008886|NCT00300053|Immunologic Factors|immunologic factors|mesh-ancestor
6008887|NCT00300053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008888|NCT00300274|Cyclosporine|cyclosporine|mesh-list
6008889|NCT00300274|Mycophenolic Acid|mycophenolic acid|mesh-list
6008890|NCT00300274|Everolimus|everolimus|mesh-list
6008891|NCT00300274|Cyclosporins|cyclosporins|mesh-list
6008892|NCT00300274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6008893|NCT00300274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6008894|NCT00300274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6008895|NCT00300274|Immunologic Factors|immunologic factors|mesh-ancestor
6008896|NCT00300274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008897|NCT00300274|Antifungal Agents|antifungal agents|mesh-ancestor
6008898|NCT00300274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6008899|NCT00300274|Dermatologic Agents|dermatologic agents|mesh-ancestor
6008900|NCT00300274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6008901|NCT00300274|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6008902|NCT00300274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6008903|NCT00300274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6008904|NCT00300274|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6008905|NCT00300274|Antitubercular Agents|antitubercular agents|mesh-ancestor
6008906|NCT00300274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6008907|NCT00300365|Aspirin|aspirin|mesh-list
6008908|NCT00300365|Niacin|niacin|mesh-list
6008909|NCT00300365|Pioglitazone|pioglitazone|mesh-list
6008910|NCT00300365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6008911|NCT00300365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6008912|NCT00300365|Analgesics|analgesics|mesh-ancestor
6008913|NCT00300365|Sensory System Agents|sensory system agents|mesh-ancestor
6008914|NCT00300365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6008915|NCT00300365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008916|NCT00300365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6008917|NCT00300365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6536473|NCT00817037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536474|NCT00817037|Vasodilator Agents|vasodilator agents|mesh-ancestor
6536475|NCT00817037|Tocolytic Agents|tocolytic agents|mesh-ancestor
6536476|NCT00817037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6536477|NCT00817037|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6536478|NCT00817245|Amoxicillin|amoxicillin|mesh-list
6536479|NCT00817245|Metronidazole|metronidazole|mesh-list
6536480|NCT00817245|Omeprazole|omeprazole|mesh-list
6536481|NCT00817245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6536482|NCT00817245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6536483|NCT00817245|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6536484|NCT00817245|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6536485|NCT00817245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6536486|NCT00817245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6536487|NCT00817245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6008918|NCT00300365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6008919|NCT00300365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6008920|NCT00300365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260966|NCT03187730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6260967|NCT03187730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260968|NCT03187756|Cyclophosphamide|cyclophosphamide|mesh-list
6260969|NCT03187756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6260970|NCT03187756|Immunologic Factors|immunologic factors|mesh-ancestor
6260971|NCT03187756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260972|NCT03187756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6260973|NCT03187756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6260974|NCT03187756|Alkylating Agents|alkylating agents|mesh-ancestor
6260975|NCT03187756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260976|NCT03187756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6260977|NCT03187756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6260978|NCT03188120|Tiotropium Bromide|tiotropium bromide|mesh-list
6260979|NCT03188120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6260980|NCT03188120|Autonomic Agents|autonomic agents|mesh-ancestor
6260981|NCT03188120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6260982|NCT03188120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260983|NCT03188120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6260984|NCT03188120|Respiratory System Agents|respiratory system agents|mesh-ancestor
6260985|NCT03188120|Parasympatholytics|parasympatholytics|mesh-ancestor
6260986|NCT03188120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6260987|NCT03188120|Cholinergic Agents|cholinergic agents|mesh-ancestor
6260988|NCT03188120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6260989|NCT03188120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6260990|NCT03188185|Naltrexone|naltrexone|mesh-list
6260991|NCT03188185|Buprenorphine|buprenorphine|mesh-list
6260992|NCT03188185|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6260993|NCT03188185|Narcotics|narcotics|mesh-ancestor
6260994|NCT03188185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6260995|NCT03188185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6260996|NCT03188185|Analgesics|analgesics|mesh-ancestor
6260997|NCT03188185|Sensory System Agents|sensory system agents|mesh-ancestor
6260998|NCT03188185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6536488|NCT00817245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6008921|NCT00300365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6008922|NCT00300365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6008923|NCT00300365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6008924|NCT00300365|Antipyretics|antipyretics|mesh-ancestor
6008925|NCT00300365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6008926|NCT00300365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6008927|NCT00300365|Antimetabolites|antimetabolites|mesh-ancestor
6008928|NCT00300365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6008929|NCT00300365|Vasodilator Agents|vasodilator agents|mesh-ancestor
6008930|NCT00300365|Vitamin B Complex|vitamin b complex|mesh-ancestor
6008931|NCT00300365|Vitamins|vitamins|mesh-ancestor
6008932|NCT00300365|Micronutrients|micronutrients|mesh-ancestor
6008933|NCT00300391|Haloperidol|haloperidol|mesh-list
6008934|NCT00300391|Haloperidol decanoate|haloperidol decanoate|mesh-list
6008935|NCT00300391|Antiemetics|antiemetics|mesh-ancestor
6008936|NCT00300391|Autonomic Agents|autonomic agents|mesh-ancestor
6008937|NCT00300391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6008938|NCT00300391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008939|NCT00300391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6008940|NCT00300391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6008941|NCT00300391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6008942|NCT00300391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6008943|NCT00300391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6008944|NCT00300391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6008945|NCT00300391|Dopamine Agents|dopamine agents|mesh-ancestor
6008946|NCT00300391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6008947|NCT00300391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6008948|NCT00300391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6008949|NCT00300430|Calcium, Dietary|calcium, dietary|mesh-list
6008950|NCT00300430|Atorvastatin|atorvastatin|mesh-list
6008951|NCT00300430|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6008952|NCT00300430|Simvastatin|simvastatin|mesh-list
6008953|NCT00300430|Fenofibrate|fenofibrate|mesh-list
6008954|NCT00300430|Calcium|calcium|mesh-list
6008955|NCT00300430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6008956|NCT00300430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008957|NCT00300430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6008958|NCT00300430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6008959|NCT00300430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6008960|NCT00300430|Antimetabolites|antimetabolites|mesh-ancestor
6008961|NCT00300430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6008962|NCT00300430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6008963|NCT00300430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6008964|NCT00300430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6008965|NCT00300456|Simvastatin|simvastatin|mesh-list
6008966|NCT00300456|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6008967|NCT00300456|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6008968|NCT00300456|Antimetabolites|antimetabolites|mesh-ancestor
6008969|NCT00300456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6008970|NCT00300456|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6008971|NCT00300456|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6008972|NCT00300456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6008973|NCT00300469|Atorvastatin|atorvastatin|mesh-list
6008974|NCT00300469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6008975|NCT00300469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6008976|NCT00300469|Antimetabolites|antimetabolites|mesh-ancestor
6008977|NCT00300469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6008978|NCT00300469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6008979|NCT00300469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6008980|NCT00300469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6008981|NCT00300482|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6008982|NCT00300482|Calcium|calcium|mesh-list
6008983|NCT00300482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6008984|NCT00300482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6008985|NCT00300482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6008986|NCT00300482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6008987|NCT00300482|Antimetabolites|antimetabolites|mesh-ancestor
6008988|NCT00300482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6008989|NCT00300482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6008990|NCT00300482|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6008991|NCT00300482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6008992|NCT00300495|Amiodarone|amiodarone|mesh-list
6008993|NCT00300495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6008994|NCT00300495|Vasodilator Agents|vasodilator agents|mesh-ancestor
6008995|NCT00300495|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6008996|NCT00300495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6008997|NCT00300495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6008998|NCT00300495|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6008999|NCT00300495|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6009000|NCT00300495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6009001|NCT00300495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6009002|NCT00300495|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6009003|NCT00300495|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6009004|NCT00300495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6009005|NCT00300677|Voriconazole|voriconazole|mesh-list
6538060|NCT00825552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6009006|NCT00300677|Antifungal Agents|antifungal agents|mesh-ancestor
6009007|NCT00300677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6009008|NCT00300677|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6009009|NCT00300677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6009010|NCT00300677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6009011|NCT00300677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009012|NCT00300677|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6009013|NCT00300677|Hormone Antagonists|hormone antagonists|mesh-ancestor
6009014|NCT00300677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6009015|NCT00300677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009016|NCT00300677|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6009017|NCT00300742|Topiramate|topiramate|mesh-list
6009018|NCT00300742|Anticonvulsants|anticonvulsants|mesh-ancestor
6009019|NCT00300742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6009020|NCT00300742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009021|NCT00300755|Pantoprazole|pantoprazole|mesh-list
6009022|NCT00300755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6009023|NCT00300755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6009024|NCT00300755|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6009025|NCT00300755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6009026|NCT00300755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009027|NCT00300885|Paclitaxel|paclitaxel|mesh-list
6009028|NCT00300885|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6009029|NCT00300885|Carboplatin|carboplatin|mesh-list
6009030|NCT00300885|Sorafenib|sorafenib|mesh-list
6009031|NCT00300885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6009032|NCT00300885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6009033|NCT00300885|Tubulin Modulators|tubulin modulators|mesh-ancestor
6009034|NCT00300885|Antimitotic Agents|antimitotic agents|mesh-ancestor
6009035|NCT00300885|Mitosis Modulators|mitosis modulators|mesh-ancestor
6009036|NCT00300885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009037|NCT00300885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6009038|NCT00300885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6009039|NCT00301028|Paclitaxel|paclitaxel|mesh-list
6009040|NCT00301028|Carboplatin|carboplatin|mesh-list
6009041|NCT00301028|Cetuximab|cetuximab|mesh-list
6009042|NCT00301028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6009043|NCT00301028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6009044|NCT00301028|Tubulin Modulators|tubulin modulators|mesh-ancestor
6009045|NCT00301028|Antimitotic Agents|antimitotic agents|mesh-ancestor
6009046|NCT00301028|Mitosis Modulators|mitosis modulators|mesh-ancestor
6009047|NCT00301028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009048|NCT00301028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6009049|NCT00301067|Calcitriol|calcitriol|mesh-list
6009050|NCT00301067|Temozolomide|temozolomide|mesh-list
6009051|NCT00301067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6009052|NCT00301067|Alkylating Agents|alkylating agents|mesh-ancestor
6009053|NCT00301067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009054|NCT00301067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6009055|NCT00301067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6009056|NCT00301067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009057|NCT00301067|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6009058|NCT00301067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6009059|NCT00301067|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6009060|NCT00301067|Vitamins|vitamins|mesh-ancestor
6009061|NCT00301067|Micronutrients|micronutrients|mesh-ancestor
6009062|NCT00301067|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6009063|NCT00301366|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
6009064|NCT00301366|Protease Inhibitors|protease inhibitors|mesh-list
6009065|NCT00301366|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6009066|NCT00301366|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6009067|NCT00301366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6009068|NCT00301366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009069|NCT00301418|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6009070|NCT00301418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6009071|NCT00301418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6009072|NCT00301418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6009073|NCT00301418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009074|NCT00301756|Belinostat|belinostat|mesh-list
6009075|NCT00301756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6009076|NCT00301756|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6009077|NCT00301756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6009078|NCT00301756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009079|NCT00301808|Docetaxel|docetaxel|mesh-list
6009080|NCT00301808|Pemetrexed|pemetrexed|mesh-list
6009081|NCT00301808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6009082|NCT00301808|Tubulin Modulators|tubulin modulators|mesh-ancestor
6009083|NCT00301808|Antimitotic Agents|antimitotic agents|mesh-ancestor
6009084|NCT00301808|Mitosis Modulators|mitosis modulators|mesh-ancestor
6009085|NCT00301808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009086|NCT00301808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6009087|NCT00301808|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6009088|NCT00301808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6018291|NCT00379574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6018292|NCT00379574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6018293|NCT00379574|Tubulin Modulators|tubulin modulators|mesh-ancestor
6018294|NCT00379574|Antimitotic Agents|antimitotic agents|mesh-ancestor
6018295|NCT00379574|Mitosis Modulators|mitosis modulators|mesh-ancestor
6018296|NCT00379574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6018297|NCT00379574|Glucocorticoids|glucocorticoids|mesh-ancestor
6018298|NCT00379574|Hormones|hormones|mesh-ancestor
6018299|NCT00379574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6018300|NCT00379574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6018301|NCT00379574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6018302|NCT00379587|Rituximab|rituximab|mesh-list
6018303|NCT00379587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6018304|NCT00379587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6018305|NCT00379587|Immunologic Factors|immunologic factors|mesh-ancestor
6018306|NCT00379587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018307|NCT00379587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6018308|NCT00379639|Gemcitabine|gemcitabine|mesh-list
6018309|NCT00379639|Romidepsin|romidepsin|mesh-list
6018310|NCT00379639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6018311|NCT00379639|Antimetabolites|antimetabolites|mesh-ancestor
6018312|NCT00379639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6018313|NCT00379639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6018314|NCT00379639|Antiviral Agents|antiviral agents|mesh-ancestor
6018315|NCT00379639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6018316|NCT00379639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6018317|NCT00379639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6018318|NCT00379639|Immunologic Factors|immunologic factors|mesh-ancestor
6018319|NCT00379639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018320|NCT00379639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6018321|NCT00379769|Metformin|metformin|mesh-list
6018322|NCT00379769|Rosiglitazone|rosiglitazone|mesh-list
6018323|NCT00379769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6018324|NCT00379769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018325|NCT00379795|Ranibizumab|ranibizumab|mesh-list
6018326|NCT00379795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6018327|NCT00379795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6018328|NCT00379795|Growth Substances|growth substances|mesh-ancestor
6018329|NCT00379795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018330|NCT00379795|Growth Inhibitors|growth inhibitors|mesh-ancestor
6018331|NCT00379795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6018332|NCT00379808|Montelukast|montelukast|mesh-list
6018333|NCT00379808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6018334|NCT00379808|Respiratory System Agents|respiratory system agents|mesh-ancestor
6018335|NCT00379808|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6018336|NCT00379808|Hormone Antagonists|hormone antagonists|mesh-ancestor
6018337|NCT00379808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6018338|NCT00379808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009089|NCT00301821|Prednisone|prednisone|mesh-list
6009090|NCT00301821|Cyclophosphamide|cyclophosphamide|mesh-list
6009091|NCT00301821|Rituximab|rituximab|mesh-list
6009092|NCT00301821|Doxorubicin|doxorubicin|mesh-list
6009093|NCT00301821|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6009094|NCT00301821|Vincristine|vincristine|mesh-list
6009095|NCT00301821|Epratuzumab|epratuzumab|mesh-list
6009096|NCT00301821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6009097|NCT00301821|Immunologic Factors|immunologic factors|mesh-ancestor
6009098|NCT00301821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009099|NCT00301821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6009100|NCT00301821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6009101|NCT00301821|Alkylating Agents|alkylating agents|mesh-ancestor
6009102|NCT00301821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009103|NCT00301821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6009104|NCT00301821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6009105|NCT00301821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6009106|NCT00301821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6009107|NCT00301821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6009108|NCT00301821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6009109|NCT00301821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6009110|NCT00301821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6009111|NCT00301821|Glucocorticoids|glucocorticoids|mesh-ancestor
6009112|NCT00301821|Hormones|hormones|mesh-ancestor
6009113|NCT00301821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6009114|NCT00301821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6009115|NCT00301821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6009116|NCT00301821|Tubulin Modulators|tubulin modulators|mesh-ancestor
6009117|NCT00301821|Antimitotic Agents|antimitotic agents|mesh-ancestor
6009118|NCT00301821|Mitosis Modulators|mitosis modulators|mesh-ancestor
6009119|NCT00301834|Cyclosporine|cyclosporine|mesh-list
6009120|NCT00301834|Methylprednisolone|methylprednisolone|mesh-list
6009121|NCT00301834|Methotrexate|methotrexate|mesh-list
6009122|NCT00301834|Fludarabine phosphate|fludarabine phosphate|mesh-list
6009123|NCT00301834|Fludarabine|fludarabine|mesh-list
6009124|NCT00301834|Busulfan|busulfan|mesh-list
6009125|NCT00301834|Alemtuzumab|alemtuzumab|mesh-list
6009126|NCT00301834|Cyclosporins|cyclosporins|mesh-list
6009127|NCT00301834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6009128|NCT00301834|Abortifacient Agents|abortifacient agents|mesh-ancestor
6009129|NCT00301834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6009130|NCT00301834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009131|NCT00301834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6009132|NCT00301834|Antimetabolites|antimetabolites|mesh-ancestor
6009133|NCT00301834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009134|NCT00301834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6009135|NCT00301834|Dermatologic Agents|dermatologic agents|mesh-ancestor
6009136|NCT00301834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6009137|NCT00301834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6009138|NCT00301834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6009139|NCT00301834|Immunologic Factors|immunologic factors|mesh-ancestor
6009140|NCT00301834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6009141|NCT00301834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6009142|NCT00301834|Antifungal Agents|antifungal agents|mesh-ancestor
6009143|NCT00301834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6009144|NCT00301834|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6009145|NCT00301834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6009146|NCT00301834|Antiemetics|antiemetics|mesh-ancestor
6009147|NCT00301834|Autonomic Agents|autonomic agents|mesh-ancestor
6009148|NCT00301834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6009149|NCT00301834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6009150|NCT00301834|Glucocorticoids|glucocorticoids|mesh-ancestor
6009151|NCT00301834|Hormones|hormones|mesh-ancestor
6260999|NCT03188185|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6009152|NCT00301834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6009153|NCT00301834|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6009154|NCT00301834|Protective Agents|protective agents|mesh-ancestor
6009155|NCT00301834|Alkylating Agents|alkylating agents|mesh-ancestor
6261000|NCT03188185|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6261001|NCT03189446|Paclitaxel|paclitaxel|mesh-list
6261002|NCT03189446|Carboplatin|carboplatin|mesh-list
6261003|NCT03189446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6261004|NCT03189446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6261005|NCT03189446|Tubulin Modulators|tubulin modulators|mesh-ancestor
6261006|NCT03189446|Antimitotic Agents|antimitotic agents|mesh-ancestor
6261007|NCT03189446|Mitosis Modulators|mitosis modulators|mesh-ancestor
6261008|NCT03189446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261009|NCT03189524|Zanubrutinib|zanubrutinib|mesh-list
6261010|NCT03189524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6261011|NCT03189524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6261012|NCT03189524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6261013|NCT03189524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261014|NCT03189589|Nemiralisib|nemiralisib|mesh-list
6261015|NCT03189589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6261016|NCT03189589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6261017|NCT03189589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261018|NCT03190005|Clopidogrel|clopidogrel|mesh-list
6261019|NCT03190005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6261020|NCT03190005|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6261021|NCT03190005|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6261022|NCT03190005|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6261023|NCT03190005|Purinergic Agents|purinergic agents|mesh-ancestor
6261024|NCT03190005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6261025|NCT03190005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261026|NCT03190005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261027|NCT03190213|Pembrolizumab|pembrolizumab|mesh-list
6261028|NCT03190213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6261029|NCT03190213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6261030|NCT03190369|Hylan|hylan|mesh-list
6261031|NCT03190369|Viscosupplements|viscosupplements|mesh-ancestor
6261032|NCT03190369|Protective Agents|protective agents|mesh-ancestor
6261033|NCT03190369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261034|NCT03191396|Liraglutide|liraglutide|mesh-list
6261035|NCT03191396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6389951|NCT00189748|Tacrolimus|tacrolimus|mesh-list
6009156|NCT00301834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6009157|NCT00301834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6009158|NCT00301834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6009159|NCT00301873|Zoledronic Acid|zoledronic acid|mesh-list
6009160|NCT00301873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6009161|NCT00301873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009162|NCT00301964|Bevacizumab|bevacizumab|mesh-list
6009163|NCT00301964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6009164|NCT00301964|Antibodies|antibodies|mesh-list
6009165|NCT00301964|Immunoglobulins|immunoglobulins|mesh-list
6009166|NCT00301964|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6009167|NCT00301964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6009168|NCT00301964|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6009169|NCT00301964|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6009170|NCT00301964|Growth Substances|growth substances|mesh-ancestor
6009171|NCT00301964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009172|NCT00301964|Growth Inhibitors|growth inhibitors|mesh-ancestor
6009173|NCT00301964|Immunologic Factors|immunologic factors|mesh-ancestor
6009174|NCT00302003|Cytarabine|cytarabine|mesh-list
6009175|NCT00302003|Dexamethasone|dexamethasone|mesh-list
6009176|NCT00302003|Prednisone|prednisone|mesh-list
6009177|NCT00302003|Cyclophosphamide|cyclophosphamide|mesh-list
6009178|NCT00302003|Ifosfamide|ifosfamide|mesh-list
6009179|NCT00302003|Doxorubicin|doxorubicin|mesh-list
6009180|NCT00302003|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6009181|NCT00302003|Etoposide|etoposide|mesh-list
6009182|NCT00302003|Vincristine|vincristine|mesh-list
6009183|NCT00302003|Vinorelbine|vinorelbine|mesh-list
6009184|NCT00302003|Etoposide phosphate|etoposide phosphate|mesh-list
6009185|NCT00302003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6009186|NCT00302003|Immunologic Factors|immunologic factors|mesh-ancestor
6009187|NCT00302003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009188|NCT00302003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6009189|NCT00302003|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6009190|NCT00302003|Alkylating Agents|alkylating agents|mesh-ancestor
6009191|NCT00302003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009192|NCT00302003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6009193|NCT00302003|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6009194|NCT00302003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6009195|NCT00302003|Antiemetics|antiemetics|mesh-ancestor
6009196|NCT00302003|Autonomic Agents|autonomic agents|mesh-ancestor
6009197|NCT00302003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6009198|NCT00302003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6009199|NCT00302003|Glucocorticoids|glucocorticoids|mesh-ancestor
6009200|NCT00302003|Hormones|hormones|mesh-ancestor
6009201|NCT00302003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6009202|NCT00302003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6009203|NCT00302003|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6009204|NCT00302003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6009205|NCT00302003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6009206|NCT00302003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6009207|NCT00302003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6009208|NCT00302003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6009209|NCT00302003|Antimetabolites|antimetabolites|mesh-ancestor
6009210|NCT00302003|Antiviral Agents|antiviral agents|mesh-ancestor
6009211|NCT00302003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6009212|NCT00302003|Tubulin Modulators|tubulin modulators|mesh-ancestor
6009213|NCT00302003|Antimitotic Agents|antimitotic agents|mesh-ancestor
6009214|NCT00302003|Mitosis Modulators|mitosis modulators|mesh-ancestor
6009215|NCT00302068|Sertraline|sertraline|mesh-list
6009216|NCT00302068|Antidepressive Agents|antidepressive agents|mesh-ancestor
6009217|NCT00302068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6009218|NCT00302068|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6009219|NCT00302068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6009220|NCT00302068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6009221|NCT00302068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009222|NCT00302068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6009223|NCT00302068|Serotonin Agents|serotonin agents|mesh-ancestor
6009224|NCT00302068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009225|NCT00302081|Ribavirin|ribavirin|mesh-list
6009226|NCT00302081|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6009227|NCT00302081|Interferon-alpha|interferon-alpha|mesh-list
6009228|NCT00302081|Antimetabolites|antimetabolites|mesh-ancestor
6009229|NCT00302081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009230|NCT00302081|Antiviral Agents|antiviral agents|mesh-ancestor
6009231|NCT00302081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6009232|NCT00302081|Immunologic Factors|immunologic factors|mesh-ancestor
6009233|NCT00302081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009234|NCT00302107|Mirtazapine|mirtazapine|mesh-list
6009235|NCT00302107|Antidepressive Agents|antidepressive agents|mesh-ancestor
6009236|NCT00302107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6009237|NCT00302107|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6009238|NCT00302107|Histamine Antagonists|histamine antagonists|mesh-ancestor
6009239|NCT00302107|Histamine Agents|histamine agents|mesh-ancestor
6009240|NCT00302107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6009241|NCT00302107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009242|NCT00302107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009243|NCT00302107|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6009244|NCT00302107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6009245|NCT00302107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6009246|NCT00302107|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6009247|NCT00302107|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6009248|NCT00302107|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6009249|NCT00302107|Adrenergic Agents|adrenergic agents|mesh-ancestor
6009250|NCT00302107|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6009251|NCT00302107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6009252|NCT00302107|Serotonin Agents|serotonin agents|mesh-ancestor
6009253|NCT00302107|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6009254|NCT00302133|Naltrexone|naltrexone|mesh-list
6009255|NCT00302133|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6009256|NCT00302133|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6009257|NCT00302133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009258|NCT00302133|Sensory System Agents|sensory system agents|mesh-ancestor
6009259|NCT00302133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6009260|NCT00302159|Temozolomide|temozolomide|mesh-list
6009261|NCT00302159|Valproic Acid|valproic acid|mesh-list
6009262|NCT00302159|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6009263|NCT00302159|Alkylating Agents|alkylating agents|mesh-ancestor
6009264|NCT00302159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009265|NCT00302159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6009266|NCT00302159|Anticonvulsants|anticonvulsants|mesh-ancestor
6009267|NCT00302159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6009268|NCT00302159|GABA Agents|gaba agents|mesh-ancestor
6009269|NCT00302159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6009270|NCT00302159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009271|NCT00302159|Antimanic Agents|antimanic agents|mesh-ancestor
6009272|NCT00302159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6009273|NCT00302159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6009274|NCT00302159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6009275|NCT00302211|Bosentan|bosentan|mesh-list
6009276|NCT00302211|Sildenafil Citrate|sildenafil citrate|mesh-list
6009277|NCT00302211|Iloprost|iloprost|mesh-list
6009278|NCT00302211|Vasodilator Agents|vasodilator agents|mesh-ancestor
6009279|NCT00302211|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6009280|NCT00302211|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6009281|NCT00302211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6009282|NCT00302211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009283|NCT00302211|Urological Agents|urological agents|mesh-ancestor
6009284|NCT00302211|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6009285|NCT00302211|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6009286|NCT00302211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6009287|NCT00302458|Methylphenidate|methylphenidate|mesh-list
6009288|NCT00302458|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6009289|NCT00302458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009290|NCT00302458|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6009291|NCT00302458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6009292|NCT00302458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6009293|NCT00302458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009294|NCT00302458|Dopamine Agents|dopamine agents|mesh-ancestor
6009295|NCT00302458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6009296|NCT00302731|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6009297|NCT00302731|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6009298|NCT00302731|Hormones|hormones|mesh-list
6009299|NCT00302731|Estradiol|estradiol|mesh-list
6009300|NCT00302731|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6009301|NCT00302731|Progesterone|progesterone|mesh-list
6009302|NCT00302731|Estrogens|estrogens|mesh-list
6009303|NCT00302731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6009304|NCT00302731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009305|NCT00302731|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6009306|NCT00302731|Contraceptive Agents|contraceptive agents|mesh-ancestor
6009307|NCT00302731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6009308|NCT00302731|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6009309|NCT00302731|Progestins|progestins|mesh-ancestor
6009310|NCT00302848|Drospirenone|drospirenone|mesh-list
6009311|NCT00302848|Contraceptive Agents|contraceptive agents|mesh-list
6009312|NCT00302848|Levonorgestrel|levonorgestrel|mesh-list
6009313|NCT00302848|Contraceptives, Oral|contraceptives, oral|mesh-list
6009314|NCT00302848|Progestins|progestins|mesh-list
6009315|NCT00302848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6009316|NCT00302848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009317|NCT00302848|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6009318|NCT00302848|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6009319|NCT00302848|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6009320|NCT00302848|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6009321|NCT00302848|Hormone Antagonists|hormone antagonists|mesh-ancestor
6009322|NCT00302848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6009323|NCT00302848|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6009324|NCT00302848|Diuretics|diuretics|mesh-ancestor
6009325|NCT00302848|Natriuretic Agents|natriuretic agents|mesh-ancestor
6009326|NCT00302848|Hormones|hormones|mesh-ancestor
6009327|NCT00302952|Lovastatin|lovastatin|mesh-list
6009328|NCT00302952|L 647318|l 647318|mesh-list
6009329|NCT00302952|Dihydromevinolin|dihydromevinolin|mesh-list
6009330|NCT00302952|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6009331|NCT00302952|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6009332|NCT00302952|Antimetabolites|antimetabolites|mesh-ancestor
6009333|NCT00302952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009334|NCT00302952|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6009335|NCT00302952|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6009336|NCT00302952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6009337|NCT00303108|Carboplatin|carboplatin|mesh-list
6009338|NCT00303108|Doxorubicin|doxorubicin|mesh-list
6009339|NCT00303108|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6009340|NCT00303108|Trastuzumab|trastuzumab|mesh-list
6009341|NCT00303108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6009342|NCT00303108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6009343|NCT00303108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6009344|NCT00303108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6009345|NCT00303108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6009346|NCT00303108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009347|NCT00303108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6009348|NCT00303316|Vaccines|vaccines|mesh-list
6009349|NCT00303316|Immunologic Factors|immunologic factors|mesh-ancestor
6009350|NCT00303316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009351|NCT00303329|Deferasirox|deferasirox|mesh-list
6009352|NCT00303329|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6009353|NCT00303329|Chelating Agents|chelating agents|mesh-ancestor
6009354|NCT00303329|Sequestering Agents|sequestering agents|mesh-ancestor
6009355|NCT00303329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009356|NCT00303446|Dutasteride|dutasteride|mesh-list
6009357|NCT00303446|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6009358|NCT00303446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6009359|NCT00303446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6009360|NCT00303446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009361|NCT00303446|Hormone Antagonists|hormone antagonists|mesh-ancestor
6009362|NCT00303446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6009363|NCT00303446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009364|NCT00303459|Bosentan|bosentan|mesh-list
6009365|NCT00303459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6009366|NCT00303459|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6009367|NCT00303459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009368|NCT00303485|Vitamin D|vitamin d|mesh-list
6009369|NCT00303485|Ibandronic Acid|ibandronic acid|mesh-list
6009370|NCT00303485|Calcium|calcium|mesh-list
6009371|NCT00303485|Vitamins|vitamins|mesh-ancestor
6009372|NCT00303485|Micronutrients|micronutrients|mesh-ancestor
6009373|NCT00303485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009374|NCT00303485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6009375|NCT00303485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6009376|NCT00303602|Olanzapine|olanzapine|mesh-list
6009377|NCT00303602|Antiemetics|antiemetics|mesh-ancestor
6009378|NCT00303602|Autonomic Agents|autonomic agents|mesh-ancestor
6009379|NCT00303602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6009380|NCT00303602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009381|NCT00303602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6009382|NCT00303602|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6009383|NCT00303602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6009384|NCT00303602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6009385|NCT00303602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6009386|NCT00303602|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6009387|NCT00303602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6009388|NCT00303602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6009389|NCT00303602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009390|NCT00303602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6009391|NCT00303602|Serotonin Agents|serotonin agents|mesh-ancestor
6009392|NCT00303628|Leucovorin|leucovorin|mesh-list
6009393|NCT00303628|Bevacizumab|bevacizumab|mesh-list
6009394|NCT00303628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6009395|NCT00303628|Fluorouracil|fluorouracil|mesh-list
6009396|NCT00303628|Oxaliplatin|oxaliplatin|mesh-list
6009397|NCT00303628|Antibodies|antibodies|mesh-list
6009398|NCT00303628|Immunoglobulins|immunoglobulins|mesh-list
6009399|NCT00303628|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6009400|NCT00303628|Levoleucovorin|levoleucovorin|mesh-list
6009401|NCT00303628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6009402|NCT00303628|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6009403|NCT00303628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6009404|NCT00303628|Growth Substances|growth substances|mesh-ancestor
6009405|NCT00303628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009406|NCT00303628|Growth Inhibitors|growth inhibitors|mesh-ancestor
6009407|NCT00303628|Immunologic Factors|immunologic factors|mesh-ancestor
6261036|NCT03191396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261037|NCT03191396|Incretins|incretins|mesh-ancestor
6261038|NCT03191396|Hormones|hormones|mesh-ancestor
6261039|NCT03191396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6261040|NCT03192306|Ethanol|ethanol|mesh-list
6261041|NCT03192306|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6261042|NCT03192306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6261043|NCT03192306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6261044|NCT03192306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261045|NCT03192488|Cetirizine|cetirizine|mesh-list
6261046|NCT03192488|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6261047|NCT03192488|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6261048|NCT03192488|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6261049|NCT03192488|Histamine Antagonists|histamine antagonists|mesh-ancestor
6261050|NCT03192488|Histamine Agents|histamine agents|mesh-ancestor
6261051|NCT03192488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6261052|NCT03192488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261053|NCT03192488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261054|NCT03192826|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6009408|NCT00303628|Antimetabolites|antimetabolites|mesh-ancestor
6009409|NCT00303628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009410|NCT00303628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6009411|NCT00303628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6009412|NCT00303628|Antidotes|antidotes|mesh-ancestor
6009413|NCT00303628|Protective Agents|protective agents|mesh-ancestor
6009414|NCT00303628|Vitamin B Complex|vitamin b complex|mesh-ancestor
6009415|NCT00303628|Vitamins|vitamins|mesh-ancestor
6009416|NCT00303628|Micronutrients|micronutrients|mesh-ancestor
6009417|NCT00303667|Vidarabine|vidarabine|mesh-list
6009418|NCT00303667|Aldesleukin|aldesleukin|mesh-list
6009419|NCT00303667|Cyclosporine|cyclosporine|mesh-list
6009420|NCT00303667|Cyclophosphamide|cyclophosphamide|mesh-list
6009421|NCT00303667|Fludarabine|fludarabine|mesh-list
6009422|NCT00303667|Fludarabine phosphate|fludarabine phosphate|mesh-list
6009423|NCT00303667|Interleukin-2|interleukin-2|mesh-list
6009424|NCT00303667|Cyclosporins|cyclosporins|mesh-list
6009425|NCT00303667|Thymoglobulin|thymoglobulin|mesh-list
6009426|NCT00303667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6009427|NCT00303667|Immunologic Factors|immunologic factors|mesh-ancestor
6009428|NCT00303667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009429|NCT00303667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6009430|NCT00303667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6009431|NCT00303667|Alkylating Agents|alkylating agents|mesh-ancestor
6009432|NCT00303667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009433|NCT00303667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6009434|NCT00303667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6009435|NCT00303667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6009436|NCT00303667|Antimetabolites|antimetabolites|mesh-ancestor
6009437|NCT00303667|Antiviral Agents|antiviral agents|mesh-ancestor
6009438|NCT00303667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6009439|NCT00303667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6009440|NCT00303667|Antifungal Agents|antifungal agents|mesh-ancestor
6009441|NCT00303667|Dermatologic Agents|dermatologic agents|mesh-ancestor
6009442|NCT00303667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6009443|NCT00303667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6009444|NCT00303667|Analgesics|analgesics|mesh-ancestor
6009445|NCT00303667|Sensory System Agents|sensory system agents|mesh-ancestor
6009446|NCT00303667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6009447|NCT00303667|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6009448|NCT00303667|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6009449|NCT00303719|Cyclosporine|cyclosporine|mesh-list
6009450|NCT00303719|Mycophenolic Acid|mycophenolic acid|mesh-list
6009451|NCT00303719|Cyclophosphamide|cyclophosphamide|mesh-list
6009452|NCT00303719|Fludarabine|fludarabine|mesh-list
6009453|NCT00303719|Cyclosporins|cyclosporins|mesh-list
6009454|NCT00303719|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6009455|NCT00303719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6009456|NCT00303719|Immunologic Factors|immunologic factors|mesh-ancestor
6009457|NCT00303719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009458|NCT00303719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6009459|NCT00303719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6009460|NCT00303719|Alkylating Agents|alkylating agents|mesh-ancestor
6009461|NCT00303719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009462|NCT00303719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6009463|NCT00303719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6009464|NCT00303719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6009465|NCT00303719|Antifungal Agents|antifungal agents|mesh-ancestor
6009466|NCT00303719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6009467|NCT00303719|Dermatologic Agents|dermatologic agents|mesh-ancestor
6009468|NCT00303719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6009469|NCT00303719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6009470|NCT00303719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6009471|NCT00303719|Antitubercular Agents|antitubercular agents|mesh-ancestor
6009472|NCT00303719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6009473|NCT00303823|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
6009474|NCT00303823|Antioxidants|antioxidants|mesh-ancestor
6009475|NCT00303823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009476|NCT00303823|Protective Agents|protective agents|mesh-ancestor
6009477|NCT00303823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009478|NCT00303823|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
6009479|NCT00303823|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6009480|NCT00303823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6009481|NCT00303823|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6009482|NCT00303862|Cediranib|cediranib|mesh-list
6009483|NCT00303862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6009484|NCT00303862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009485|NCT00303862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6009486|NCT00303862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6009487|NCT00303953|Belinostat|belinostat|mesh-list
6009488|NCT00303953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6009489|NCT00303953|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6009490|NCT00303953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6009491|NCT00303953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009492|NCT00303966|Sorafenib|sorafenib|mesh-list
6009493|NCT00303966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6009494|NCT00303966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6009495|NCT00303966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6009496|NCT00303966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009497|NCT00304031|Temozolomide|temozolomide|mesh-list
6009498|NCT00304031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6009499|NCT00304031|Alkylating Agents|alkylating agents|mesh-ancestor
6009500|NCT00304031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009501|NCT00304031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6009502|NCT00304070|Doxorubicin|doxorubicin|mesh-list
6009503|NCT00304070|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6009504|NCT00304070|Etoposide|etoposide|mesh-list
6009505|NCT00304070|Etoposide phosphate|etoposide phosphate|mesh-list
6009506|NCT00304070|Mitotane|mitotane|mesh-list
6009507|NCT00304070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6009508|NCT00304070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6009509|NCT00304070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6009510|NCT00304070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6009511|NCT00304070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6009512|NCT00304070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009513|NCT00304070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6009514|NCT00304070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6009515|NCT00304083|Doxorubicin|doxorubicin|mesh-list
6009516|NCT00304083|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6009517|NCT00304083|Etoposide|etoposide|mesh-list
6009518|NCT00304083|Ifosfamide|ifosfamide|mesh-list
6009519|NCT00304083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6009520|NCT00304083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6009521|NCT00304083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6009522|NCT00304083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6009523|NCT00304083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6009524|NCT00304083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009525|NCT00304083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6009526|NCT00304083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6009527|NCT00304083|Alkylating Agents|alkylating agents|mesh-ancestor
6009528|NCT00304161|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6009529|NCT00304161|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6009530|NCT00304161|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6009531|NCT00304161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6009532|NCT00304161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009533|NCT00304161|Adrenergic Agents|adrenergic agents|mesh-ancestor
6009534|NCT00304161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6009535|NCT00304161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009536|NCT00304187|Erythromycin|erythromycin|mesh-list
6009537|NCT00304187|Erythromycin Estolate|erythromycin estolate|mesh-list
6009538|NCT00304187|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
6009539|NCT00304187|Erythromycin stearate|erythromycin stearate|mesh-list
6009540|NCT00304187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6009541|NCT00304187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6009542|NCT00304187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6536489|NCT00817245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536490|NCT00817258|Cisplatin|cisplatin|mesh-list
6536491|NCT00817258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6536492|NCT00817271|Glucagon|glucagon|mesh-list
6536493|NCT00817271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6536494|NCT00817271|Hormones|hormones|mesh-ancestor
6536495|NCT00817271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6536496|NCT00817271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536497|NCT00817284|Bevacizumab|bevacizumab|mesh-list
6536498|NCT00817284|Irinotecan|irinotecan|mesh-list
6536499|NCT00817284|Temozolomide|temozolomide|mesh-list
6536500|NCT00817284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6536501|NCT00817284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6536502|NCT00817284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6536503|NCT00817284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6009543|NCT00304187|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6009544|NCT00304187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6009545|NCT00304187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009546|NCT00304278|Cisplatin|cisplatin|mesh-list
6009547|NCT00304278|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6009548|NCT00304278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6009549|NCT00304278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6536504|NCT00817284|Growth Substances|growth substances|mesh-ancestor
6009550|NCT00304278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6009551|NCT00304278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009552|NCT00304356|Nitazoxanide|nitazoxanide|mesh-list
6009553|NCT00304356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6009554|NCT00304356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6009555|NCT00304707|Bupropion|bupropion|mesh-list
6009556|NCT00304707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6009557|NCT00304707|Antidepressive Agents|antidepressive agents|mesh-ancestor
6009558|NCT00304707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6009559|NCT00304707|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6009560|NCT00304707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6009561|NCT00304707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6009562|NCT00304707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009563|NCT00304707|Dopamine Agents|dopamine agents|mesh-ancestor
6009564|NCT00304707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6009565|NCT00304707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009566|NCT00304707|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6009567|NCT00304707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6009568|NCT00304707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6009569|NCT00304746|Testosterone|testosterone|mesh-list
6009570|NCT00304746|Androgens|androgens|mesh-ancestor
6009571|NCT00304746|Hormones|hormones|mesh-ancestor
6009572|NCT00304746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6009573|NCT00304746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009574|NCT00304954|Sirolimus|sirolimus|mesh-list
6009575|NCT00304954|Infliximab|infliximab|mesh-list
6009576|NCT00304954|Daclizumab|daclizumab|mesh-list
6009577|NCT00304954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6009578|NCT00304954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6009579|NCT00304954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6009580|NCT00304954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6009581|NCT00304954|Antifungal Agents|antifungal agents|mesh-ancestor
6009582|NCT00304954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6009583|NCT00304954|Immunologic Factors|immunologic factors|mesh-ancestor
6261055|NCT03192826|Lubricant Eye Drops|lubricant eye drops|mesh-list
6009584|NCT00304954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009585|NCT00304954|Dermatologic Agents|dermatologic agents|mesh-ancestor
6009586|NCT00304954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6009587|NCT00304954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6009588|NCT00305058|Morphine|morphine|mesh-list
6009589|NCT00305058|Hydromorphone|hydromorphone|mesh-list
6009590|NCT00305058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6009591|NCT00305058|Narcotics|narcotics|mesh-ancestor
6009592|NCT00305058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6009593|NCT00305058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009594|NCT00305058|Analgesics|analgesics|mesh-ancestor
6009595|NCT00305058|Sensory System Agents|sensory system agents|mesh-ancestor
6009596|NCT00305058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6009597|NCT00305084|Doxorubicin|doxorubicin|mesh-list
6009598|NCT00305084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6009599|NCT00305084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6009600|NCT00305084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6009601|NCT00305084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6009602|NCT00305084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6009603|NCT00305084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009604|NCT00305110|Hydromorphone|hydromorphone|mesh-list
6009605|NCT00305110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6009606|NCT00305110|Narcotics|narcotics|mesh-ancestor
6009607|NCT00305110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6009608|NCT00305110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009609|NCT00305110|Analgesics|analgesics|mesh-ancestor
6009610|NCT00305110|Sensory System Agents|sensory system agents|mesh-ancestor
6009611|NCT00305110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6009612|NCT00305162|Clopidogrel|clopidogrel|mesh-list
6009613|NCT00305162|Cangrelor|cangrelor|mesh-list
6009614|NCT00305162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6009615|NCT00305162|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6009616|NCT00305162|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6009617|NCT00305162|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6009618|NCT00305162|Purinergic Agents|purinergic agents|mesh-ancestor
6009619|NCT00305162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6009620|NCT00305162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009621|NCT00305162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009622|NCT00305448|Fulvestrant|fulvestrant|mesh-list
6009623|NCT00305448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6009624|NCT00305448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6009625|NCT00305448|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6009626|NCT00305448|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6009627|NCT00305448|Hormone Antagonists|hormone antagonists|mesh-ancestor
6009628|NCT00305448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6009629|NCT00305448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009630|NCT00305578|Memantine|memantine|mesh-list
6009631|NCT00305578|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6009632|NCT00305578|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6009633|NCT00305578|Dopamine Agents|dopamine agents|mesh-ancestor
6009634|NCT00305578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6009635|NCT00305578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009636|NCT00305578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009637|NCT00305578|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6009638|NCT00305578|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6261056|NCT03192826|Dipivefrin|dipivefrin|mesh-list
6261057|NCT03192826|Brinzolamide|brinzolamide|mesh-list
6261058|NCT03192826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6261059|NCT03192826|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6261060|NCT03192826|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6261061|NCT03192826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6261062|NCT03192826|Adrenergic Agents|adrenergic agents|mesh-ancestor
6261063|NCT03192826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6261064|NCT03192826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261065|NCT03192826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261066|NCT03192826|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6009639|NCT00305604|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6009640|NCT00305604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6009641|NCT00305604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009642|NCT00305604|Incretins|incretins|mesh-ancestor
6009643|NCT00305604|Hormones|hormones|mesh-ancestor
6009644|NCT00305604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6009645|NCT00305604|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6009646|NCT00305604|Protease Inhibitors|protease inhibitors|mesh-ancestor
6009647|NCT00305604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6009648|NCT00305604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009649|NCT00305682|Mycophenolic Acid|mycophenolic acid|mesh-list
6009650|NCT00305682|Sirolimus|sirolimus|mesh-list
6009651|NCT00305682|Cyclophosphamide|cyclophosphamide|mesh-list
6009652|NCT00305682|Fludarabine|fludarabine|mesh-list
6009653|NCT00305682|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6009654|NCT00305682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6009655|NCT00305682|Immunologic Factors|immunologic factors|mesh-ancestor
6009656|NCT00305682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009657|NCT00305682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6009658|NCT00305682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6009659|NCT00305682|Alkylating Agents|alkylating agents|mesh-ancestor
6009660|NCT00305682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009661|NCT00305682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6009662|NCT00305682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6009663|NCT00305682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6009664|NCT00305682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6009665|NCT00305682|Antitubercular Agents|antitubercular agents|mesh-ancestor
6009666|NCT00305682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6009667|NCT00305682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6009668|NCT00305682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6009669|NCT00305682|Antifungal Agents|antifungal agents|mesh-ancestor
6009670|NCT00305695|Zoledronic Acid|zoledronic acid|mesh-list
6009671|NCT00305695|Imidazole|imidazole|mesh-list
6009672|NCT00305695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6009673|NCT00305695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009674|NCT00305695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6018339|NCT00379808|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6009675|NCT00305695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009676|NCT00305760|Cyclophosphamide|cyclophosphamide|mesh-list
6009677|NCT00305760|Cetuximab|cetuximab|mesh-list
6009678|NCT00305760|Vaccines|vaccines|mesh-list
6009679|NCT00305760|Immunologic Factors|immunologic factors|mesh-ancestor
6009680|NCT00305760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009681|NCT00305760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6009682|NCT00305760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6009683|NCT00305760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6009684|NCT00305760|Alkylating Agents|alkylating agents|mesh-ancestor
6009685|NCT00305760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009686|NCT00305760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6009687|NCT00305760|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6009688|NCT00305760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6009689|NCT00305773|Vorinostat|vorinostat|mesh-list
6009690|NCT00305773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6009691|NCT00305773|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6009692|NCT00305773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6009693|NCT00305773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009694|NCT00305864|Temozolomide|temozolomide|mesh-list
6009695|NCT00305864|Motexafin gadolinium|motexafin gadolinium|mesh-list
6009696|NCT00305864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6009697|NCT00305864|Alkylating Agents|alkylating agents|mesh-ancestor
6009698|NCT00305864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009699|NCT00305864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6009700|NCT00305864|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6009701|NCT00305864|Dermatologic Agents|dermatologic agents|mesh-ancestor
6009702|NCT00305877|Gemcitabine|gemcitabine|mesh-list
6009703|NCT00305877|Bevacizumab|bevacizumab|mesh-list
6009704|NCT00305877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6009705|NCT00305877|Cetuximab|cetuximab|mesh-list
6009706|NCT00305877|Capecitabine|capecitabine|mesh-list
6009707|NCT00305877|Antibodies|antibodies|mesh-list
6009708|NCT00305877|Immunoglobulins|immunoglobulins|mesh-list
6009709|NCT00305877|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6009710|NCT00305877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6009711|NCT00305877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6009712|NCT00305877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6009713|NCT00305877|Growth Substances|growth substances|mesh-ancestor
6009714|NCT00305877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009715|NCT00305877|Growth Inhibitors|growth inhibitors|mesh-ancestor
6009716|NCT00305877|Immunologic Factors|immunologic factors|mesh-ancestor
6009717|NCT00305877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6009718|NCT00305877|Antimetabolites|antimetabolites|mesh-ancestor
6009719|NCT00305877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009720|NCT00305877|Antiviral Agents|antiviral agents|mesh-ancestor
6009721|NCT00305877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6009722|NCT00305877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6009723|NCT00305877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6009724|NCT00305942|Carboplatin|carboplatin|mesh-list
6009725|NCT00305942|Topotecan|topotecan|mesh-list
6009726|NCT00305942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6009727|NCT00305942|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6009728|NCT00305942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6009729|NCT00305942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6009730|NCT00305942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009731|NCT00306163|Fluticasone|fluticasone|mesh-list
6009732|NCT00306163|Ciclesonide|ciclesonide|mesh-list
6009733|NCT00306163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6009734|NCT00306163|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6009735|NCT00306163|Autonomic Agents|autonomic agents|mesh-ancestor
6009736|NCT00306163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6009737|NCT00306163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009738|NCT00306163|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6009739|NCT00306163|Respiratory System Agents|respiratory system agents|mesh-ancestor
6009740|NCT00306163|Dermatologic Agents|dermatologic agents|mesh-ancestor
6009741|NCT00306163|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6009742|NCT00306163|Glucocorticoids|glucocorticoids|mesh-ancestor
6009743|NCT00306163|Hormones|hormones|mesh-ancestor
6009744|NCT00306163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6009745|NCT00306189|Denosumab|denosumab|mesh-list
6009746|NCT00306189|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6009747|NCT00306189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009748|NCT00306202|Dasatinib|dasatinib|mesh-list
6009749|NCT00306202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6009750|NCT00306202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6009751|NCT00306202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6261067|NCT03192826|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6261068|NCT03192826|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6261069|NCT03192826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6261070|NCT03193047|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
6261071|NCT03193047|Evolocumab|evolocumab|mesh-list
6261072|NCT03193047|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6261073|NCT03193047|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6261074|NCT03193047|Antimetabolites|antimetabolites|mesh-ancestor
6261075|NCT03193047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261076|NCT03193047|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6261077|NCT03193047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6261078|NCT03193047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6261079|NCT03193047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261080|NCT03194373|Carboplatin|carboplatin|mesh-list
6261081|NCT03194373|Palbociclib|palbociclib|mesh-list
6261082|NCT03194373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6261083|NCT03194373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6261084|NCT03194373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6261085|NCT03194373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261086|NCT03196232|Pembrolizumab|pembrolizumab|mesh-list
6261087|NCT03196232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6261088|NCT03196232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6261089|NCT03196349|Warfarin|warfarin|mesh-list
6261090|NCT03196349|Rivaroxaban|rivaroxaban|mesh-list
6261091|NCT03196349|Apixaban|apixaban|mesh-list
6261092|NCT03196349|Anticoagulants|anticoagulants|mesh-ancestor
6261093|NCT03196349|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6261094|NCT03196349|Antithrombins|antithrombins|mesh-ancestor
6261095|NCT03196349|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6261096|NCT03196349|Protease Inhibitors|protease inhibitors|mesh-ancestor
6261097|NCT03196349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6261098|NCT03196349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261099|NCT03196505|Bupivacaine|bupivacaine|mesh-list
6261100|NCT03196505|Anesthetics, Local|anesthetics, local|mesh-ancestor
6261101|NCT03196505|Anesthetics|anesthetics|mesh-ancestor
6261102|NCT03196505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6261103|NCT03196505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261104|NCT03196505|Sensory System Agents|sensory system agents|mesh-ancestor
6261105|NCT03196505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6389952|NCT00189748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6389953|NCT00189748|Immunologic Factors|immunologic factors|mesh-ancestor
6389954|NCT00189748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009752|NCT00306202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009753|NCT00306293|Valacyclovir|valacyclovir|mesh-list
6009754|NCT00306293|Antiviral Agents|antiviral agents|mesh-ancestor
6009755|NCT00306293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6009756|NCT00306384|Alogliptin|alogliptin|mesh-list
6009757|NCT00306384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6009758|NCT00306384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009759|NCT00306384|Incretins|incretins|mesh-ancestor
6009760|NCT00306384|Hormones|hormones|mesh-ancestor
6009761|NCT00306384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6009762|NCT00306384|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6009763|NCT00306384|Protease Inhibitors|protease inhibitors|mesh-ancestor
6009764|NCT00306384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6009765|NCT00306384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009766|NCT00306488|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6009767|NCT00306488|Antioxidants|antioxidants|mesh-list
6009768|NCT00306488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6009769|NCT00306488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009770|NCT00306488|Protective Agents|protective agents|mesh-ancestor
6009771|NCT00306488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009772|NCT00306527|Vaccines|vaccines|mesh-list
6009773|NCT00306527|Immunologic Factors|immunologic factors|mesh-ancestor
6009774|NCT00306527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009775|NCT00306592|Natalizumab|natalizumab|mesh-list
6009776|NCT00306592|Immunologic Factors|immunologic factors|mesh-ancestor
6009777|NCT00306592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009778|NCT00306670|Prednisone|prednisone|mesh-list
6009779|NCT00306670|Rituximab|rituximab|mesh-list
6009780|NCT00306670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6009781|NCT00306670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6009782|NCT00306670|Immunologic Factors|immunologic factors|mesh-ancestor
6009783|NCT00306670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009784|NCT00306670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6009785|NCT00306670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6009786|NCT00306670|Glucocorticoids|glucocorticoids|mesh-ancestor
6009787|NCT00306670|Hormones|hormones|mesh-ancestor
6009788|NCT00306670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6009789|NCT00306670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6009790|NCT00306787|Valacyclovir|valacyclovir|mesh-list
6009791|NCT00306787|Famciclovir|famciclovir|mesh-list
6009792|NCT00306787|Antiviral Agents|antiviral agents|mesh-ancestor
6009793|NCT00306787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6009794|NCT00306787|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6009795|NCT00306787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6009796|NCT00306787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009797|NCT00306852|Mitomycins|mitomycins|mesh-list
6009798|NCT00306852|Mitomycin|mitomycin|mesh-list
6009799|NCT00306852|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6009800|NCT00306852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6009801|NCT00306852|Alkylating Agents|alkylating agents|mesh-ancestor
6009802|NCT00306852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009803|NCT00306852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6009804|NCT00306852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6009805|NCT00306891|Cediranib|cediranib|mesh-list
6009806|NCT00306891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6009807|NCT00306891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6009808|NCT00306891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6009809|NCT00306891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009810|NCT00307034|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6009811|NCT00307034|Immunologic Factors|immunologic factors|mesh-ancestor
6009812|NCT00307034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009813|NCT00307047|Paclitaxel|paclitaxel|mesh-list
6009814|NCT00307047|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6009815|NCT00307047|Everolimus|everolimus|mesh-list
6009816|NCT00307047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6009817|NCT00307047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6009818|NCT00307047|Tubulin Modulators|tubulin modulators|mesh-ancestor
6009819|NCT00307047|Antimitotic Agents|antimitotic agents|mesh-ancestor
6009820|NCT00307047|Mitosis Modulators|mitosis modulators|mesh-ancestor
6009821|NCT00307047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009822|NCT00307047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6009823|NCT00307047|Immunologic Factors|immunologic factors|mesh-ancestor
6009824|NCT00307047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009825|NCT00307086|Bortezomib|bortezomib|mesh-list
6009826|NCT00307086|Melphalan|melphalan|mesh-list
6009827|NCT00307086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6009828|NCT00307086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6009829|NCT00307086|Alkylating Agents|alkylating agents|mesh-ancestor
6009830|NCT00307086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009831|NCT00307086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6009832|NCT00307086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6009833|NCT00307086|Immunologic Factors|immunologic factors|mesh-ancestor
6009834|NCT00307086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009835|NCT00307125|Rituximab|rituximab|mesh-list
6009836|NCT00307125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6009837|NCT00307125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6009838|NCT00307125|Immunologic Factors|immunologic factors|mesh-ancestor
6009839|NCT00307125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009840|NCT00307125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6009841|NCT00307151|Ritonavir|ritonavir|mesh-list
6009842|NCT00307151|Lopinavir|lopinavir|mesh-list
6009843|NCT00307151|Lamivudine|lamivudine|mesh-list
6009844|NCT00307151|Zidovudine|zidovudine|mesh-list
6009845|NCT00307151|Nevirapine|nevirapine|mesh-list
6009846|NCT00307151|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6009847|NCT00307151|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6009848|NCT00307151|Protease Inhibitors|protease inhibitors|mesh-ancestor
6009849|NCT00307151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6009850|NCT00307151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009851|NCT00307151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6009852|NCT00307151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6009853|NCT00307151|Antiviral Agents|antiviral agents|mesh-ancestor
6009854|NCT00307151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6009855|NCT00307151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6009856|NCT00307151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6009857|NCT00307151|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6009858|NCT00307151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6009859|NCT00307151|Antimetabolites|antimetabolites|mesh-ancestor
6009860|NCT00307151|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6009861|NCT00307151|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6009862|NCT00307294|Thalidomide|thalidomide|mesh-list
6009863|NCT00307294|Doxorubicin|doxorubicin|mesh-list
6009864|NCT00307294|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6009865|NCT00307294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6009866|NCT00307294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6009867|NCT00307294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6009868|NCT00307294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6009869|NCT00307294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009870|NCT00307294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6009871|NCT00307294|Immunologic Factors|immunologic factors|mesh-ancestor
6009872|NCT00307294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009873|NCT00307294|Leprostatic Agents|leprostatic agents|mesh-ancestor
6009874|NCT00307294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6009875|NCT00307294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6009876|NCT00307294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6009877|NCT00307294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6009878|NCT00307294|Growth Substances|growth substances|mesh-ancestor
6009879|NCT00307294|Growth Inhibitors|growth inhibitors|mesh-ancestor
6009880|NCT00307437|Ustekinumab|ustekinumab|mesh-list
6009881|NCT00307437|Dermatologic Agents|dermatologic agents|mesh-ancestor
6009882|NCT00307489|Tenofovir|tenofovir|mesh-list
6009883|NCT00307489|Emtricitabine|emtricitabine|mesh-list
6009884|NCT00307489|Antiviral Agents|antiviral agents|mesh-ancestor
6009885|NCT00307489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6009886|NCT00307489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6009887|NCT00307489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6009888|NCT00307489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6009889|NCT00307489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009890|NCT00307489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6009891|NCT00307489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6009892|NCT00307684|Methylphenidate|methylphenidate|mesh-list
6009893|NCT00307684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6009894|NCT00307684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009895|NCT00307684|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6009896|NCT00307684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6009897|NCT00307684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6009898|NCT00307684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009899|NCT00307684|Dopamine Agents|dopamine agents|mesh-ancestor
6009900|NCT00307684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6009901|NCT00307736|Bevacizumab|bevacizumab|mesh-list
6009902|NCT00307736|Fluorouracil|fluorouracil|mesh-list
6009903|NCT00307736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6009904|NCT00307736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6009905|NCT00307736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6009906|NCT00307736|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6009907|NCT00307736|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6009908|NCT00307736|Growth Substances|growth substances|mesh-ancestor
6009909|NCT00307736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009910|NCT00307736|Growth Inhibitors|growth inhibitors|mesh-ancestor
6009911|NCT00307736|Antimetabolites|antimetabolites|mesh-ancestor
6009912|NCT00307736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009913|NCT00307736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6009914|NCT00307736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6009915|NCT00307736|Immunologic Factors|immunologic factors|mesh-ancestor
6009916|NCT00307736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6009917|NCT00307736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6009918|NCT00307801|Dienogest|dienogest|mesh-list
6009919|NCT00307801|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6009920|NCT00307801|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6009921|NCT00307801|Estradiol|estradiol|mesh-list
6009922|NCT00307801|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6009923|NCT00307801|Estrogens|estrogens|mesh-ancestor
6009924|NCT00307801|Hormones|hormones|mesh-ancestor
6009925|NCT00307801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6009926|NCT00307801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009927|NCT00307801|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6009928|NCT00307801|Contraceptive Agents|contraceptive agents|mesh-ancestor
6009929|NCT00307801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6009930|NCT00307801|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6009931|NCT00307801|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6009932|NCT00307801|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6009933|NCT00307801|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6009934|NCT00307801|Hormone Antagonists|hormone antagonists|mesh-ancestor
6009935|NCT00307801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6009936|NCT00307801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6009937|NCT00307931|Certolizumab Pegol|certolizumab pegol|mesh-list
6009938|NCT00307931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6009939|NCT00307931|Immunologic Factors|immunologic factors|mesh-ancestor
6009940|NCT00307931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009941|NCT00307931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6018340|NCT00379808|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6018341|NCT00379808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6018342|NCT00379821|Azithromycin|azithromycin|mesh-list
6018343|NCT00379821|Artesunate|artesunate|mesh-list
6018344|NCT00379821|Chloroquine|chloroquine|mesh-list
6018345|NCT00379821|Atovaquone|atovaquone|mesh-list
6018346|NCT00379821|Proguanil|proguanil|mesh-list
6018347|NCT00379821|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
6018348|NCT00379821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6018349|NCT00379821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6018350|NCT00379821|Antimalarials|antimalarials|mesh-ancestor
6018351|NCT00379821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6009942|NCT00308074|Aripiprazole|aripiprazole|mesh-list
6009943|NCT00308074|Antidepressive Agents|antidepressive agents|mesh-ancestor
6009944|NCT00308074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6009945|NCT00308074|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6009946|NCT00308074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6009947|NCT00308074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6009948|NCT00308074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009949|NCT00308074|Dopamine Agonists|dopamine agonists|mesh-ancestor
6009950|NCT00308074|Dopamine Agents|dopamine agents|mesh-ancestor
6009951|NCT00308074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6009952|NCT00308074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6009953|NCT00308074|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6261106|NCT03196973|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6261107|NCT03196973|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6261108|NCT03196973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6261109|NCT03196973|Antitubercular Agents|antitubercular agents|mesh-ancestor
6261110|NCT03197025|Aldesleukin|aldesleukin|mesh-list
6261111|NCT03197025|Interleukin-2|interleukin-2|mesh-list
6261112|NCT03197025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6261113|NCT03197025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6261114|NCT03197025|Analgesics|analgesics|mesh-ancestor
6261115|NCT03197025|Sensory System Agents|sensory system agents|mesh-ancestor
6261116|NCT03197025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6261117|NCT03197025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261118|NCT03197025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6261119|NCT03197025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6261120|NCT03197025|Antiviral Agents|antiviral agents|mesh-ancestor
6261121|NCT03197025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6261122|NCT03197324|Bexagliflozin|bexagliflozin|mesh-list
6261123|NCT03197324|Digoxin|digoxin|mesh-list
6261124|NCT03197324|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6261125|NCT03197324|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6261126|NCT03197324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6261127|NCT03197324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261128|NCT03197324|Protective Agents|protective agents|mesh-ancestor
6261129|NCT03197324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261130|NCT03197324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6261131|NCT03197389|Pembrolizumab|pembrolizumab|mesh-list
6261132|NCT03197389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6261133|NCT03197389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6261134|NCT03197883|Sunscreening Agents|sunscreening agents|mesh-list
6261135|NCT03197883|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6261136|NCT03197883|Protective Agents|protective agents|mesh-ancestor
6261137|NCT03197883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261138|NCT03197883|Dermatologic Agents|dermatologic agents|mesh-ancestor
6261139|NCT03198000|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6009954|NCT00308074|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6009955|NCT00308074|Serotonin Agents|serotonin agents|mesh-ancestor
6009956|NCT00308074|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6009957|NCT00308074|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6009958|NCT00308074|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6009959|NCT00308074|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6009960|NCT00308087|Rituximab|rituximab|mesh-list
6009961|NCT00308087|Molgramostim|molgramostim|mesh-list
6009962|NCT00308087|Sargramostim|sargramostim|mesh-list
6009963|NCT00308087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6009964|NCT00308087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6009965|NCT00308087|Immunologic Factors|immunologic factors|mesh-ancestor
6009966|NCT00308087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009967|NCT00308087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6009968|NCT00308139|Exenatide|exenatide|mesh-list
6009969|NCT00308139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6009970|NCT00308139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009971|NCT00308139|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6009972|NCT00308139|Incretins|incretins|mesh-ancestor
6009973|NCT00308139|Hormones|hormones|mesh-ancestor
6009974|NCT00308139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6009975|NCT00308308|Insulin|insulin|mesh-list
6009976|NCT00308308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6009977|NCT00308308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009978|NCT00308581|Certolizumab Pegol|certolizumab pegol|mesh-list
6009979|NCT00308581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6009980|NCT00308581|Immunologic Factors|immunologic factors|mesh-ancestor
6009981|NCT00308581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009982|NCT00308581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6009983|NCT00308620|Chloroquine|chloroquine|mesh-list
6009984|NCT00308620|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
6009985|NCT00308620|Amebicides|amebicides|mesh-ancestor
6009986|NCT00308620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6009987|NCT00308620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6009988|NCT00308620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6009989|NCT00308620|Antimalarials|antimalarials|mesh-ancestor
6009990|NCT00308620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6009991|NCT00308620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6009992|NCT00308620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6009993|NCT00308620|Analgesics|analgesics|mesh-ancestor
6009994|NCT00308620|Sensory System Agents|sensory system agents|mesh-ancestor
6009995|NCT00308620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6009996|NCT00308620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6009997|NCT00308620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6009998|NCT00308620|Filaricides|filaricides|mesh-ancestor
6009999|NCT00308620|Antinematodal Agents|antinematodal agents|mesh-ancestor
6010000|NCT00308620|Anthelmintics|anthelmintics|mesh-ancestor
6010001|NCT00308711|Misoprostol|misoprostol|mesh-list
6010002|NCT00308711|Dinoprostone|dinoprostone|mesh-list
6010003|NCT00308711|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6010004|NCT00308711|Abortifacient Agents|abortifacient agents|mesh-ancestor
6010005|NCT00308711|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6010006|NCT00308711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010007|NCT00308711|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6010008|NCT00308711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6010009|NCT00308711|Oxytocics|oxytocics|mesh-ancestor
6010010|NCT00308737|Insulin|insulin|mesh-list
6010011|NCT00308737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6010012|NCT00308737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010013|NCT00308750|Carboplatin|carboplatin|mesh-list
6010014|NCT00308750|Docetaxel|docetaxel|mesh-list
6010015|NCT00308750|Pemetrexed|pemetrexed|mesh-list
6010016|NCT00308750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6010017|NCT00308750|Tubulin Modulators|tubulin modulators|mesh-ancestor
6010018|NCT00308750|Antimitotic Agents|antimitotic agents|mesh-ancestor
6010019|NCT00308750|Mitosis Modulators|mitosis modulators|mesh-ancestor
6010020|NCT00308750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010021|NCT00308750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6010022|NCT00308750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6010023|NCT00308750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6010024|NCT00309166|Vaccines|vaccines|mesh-list
6010025|NCT00309166|Immunologic Factors|immunologic factors|mesh-ancestor
6010026|NCT00309166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010027|NCT00309244|Insulin|insulin|mesh-list
6010028|NCT00309244|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6010029|NCT00309244|Insulin Aspart|insulin aspart|mesh-list
6010030|NCT00309244|Protamines|protamines|mesh-list
6010031|NCT00309244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6010032|NCT00309244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010033|NCT00309244|Heparin Antagonists|heparin antagonists|mesh-ancestor
6010034|NCT00309244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261140|NCT03198000|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6010035|NCT00309244|Coagulants|coagulants|mesh-ancestor
6010036|NCT00309465|Insulin|insulin|mesh-list
6010037|NCT00309465|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6010038|NCT00309465|Insulin Glargine|insulin glargine|mesh-list
6010039|NCT00309465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6010040|NCT00309465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010041|NCT00309608|Glimepiride|glimepiride|mesh-list
6010042|NCT00309608|Linagliptin|linagliptin|mesh-list
6010043|NCT00309608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6010044|NCT00309608|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6010045|NCT00309608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010046|NCT00309608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6010047|NCT00309608|Immunologic Factors|immunologic factors|mesh-ancestor
6010048|NCT00309608|Incretins|incretins|mesh-ancestor
6010049|NCT00309608|Hormones|hormones|mesh-ancestor
6010050|NCT00309608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6010051|NCT00309608|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6010052|NCT00309608|Protease Inhibitors|protease inhibitors|mesh-ancestor
6010053|NCT00309608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6010054|NCT00309608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010055|NCT00309738|Simvastatin|simvastatin|mesh-list
6010056|NCT00309738|Pitavastatin|pitavastatin|mesh-list
6010057|NCT00309738|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6010058|NCT00309738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6010059|NCT00309738|Antimetabolites|antimetabolites|mesh-ancestor
6010060|NCT00309738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010061|NCT00309738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6010062|NCT00309738|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6010063|NCT00309738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6010064|NCT00309751|Atorvastatin|atorvastatin|mesh-list
6010065|NCT00309751|Pitavastatin|pitavastatin|mesh-list
6010066|NCT00309751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6010067|NCT00309751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6010068|NCT00309751|Antimetabolites|antimetabolites|mesh-ancestor
6010069|NCT00309751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010070|NCT00309751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6261141|NCT03198221|Picosulfate sodium|picosulfate sodium|mesh-list
6261142|NCT03198221|Magnesium Oxide|magnesium oxide|mesh-list
6261143|NCT03198221|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
6261144|NCT03198221|Citric Acid|citric acid|mesh-list
6261145|NCT03198221|Anticoagulants|anticoagulants|mesh-ancestor
6261146|NCT03198221|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6261147|NCT03198221|Chelating Agents|chelating agents|mesh-ancestor
6261148|NCT03198221|Sequestering Agents|sequestering agents|mesh-ancestor
6261149|NCT03198221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261150|NCT03198221|Cathartics|cathartics|mesh-ancestor
6010071|NCT00309751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6010072|NCT00309751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6010073|NCT00309777|Simvastatin|simvastatin|mesh-list
6010074|NCT00309777|Pitavastatin|pitavastatin|mesh-list
6010075|NCT00309777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6010076|NCT00309777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6010077|NCT00309777|Antimetabolites|antimetabolites|mesh-ancestor
6010078|NCT00309777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010079|NCT00309777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6010080|NCT00309777|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6010081|NCT00309777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6010082|NCT00309842|Cyclosporine|cyclosporine|mesh-list
6010083|NCT00309842|Mycophenolic Acid|mycophenolic acid|mesh-list
6010084|NCT00309842|Cyclophosphamide|cyclophosphamide|mesh-list
6010085|NCT00309842|Fludarabine|fludarabine|mesh-list
6010086|NCT00309842|Fludarabine phosphate|fludarabine phosphate|mesh-list
6010087|NCT00309842|Cyclosporins|cyclosporins|mesh-list
6010088|NCT00309842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6010089|NCT00309842|Immunologic Factors|immunologic factors|mesh-ancestor
6010090|NCT00309842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010091|NCT00309842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6010092|NCT00309842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6010093|NCT00309842|Alkylating Agents|alkylating agents|mesh-ancestor
6010094|NCT00309842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010095|NCT00309842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6010096|NCT00309842|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6010097|NCT00309842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6010098|NCT00309842|Antimetabolites|antimetabolites|mesh-ancestor
6010099|NCT00309842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6010100|NCT00309842|Antifungal Agents|antifungal agents|mesh-ancestor
6010101|NCT00309842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6010102|NCT00309842|Dermatologic Agents|dermatologic agents|mesh-ancestor
6010103|NCT00309842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6010104|NCT00309842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6010105|NCT00309842|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6010106|NCT00309842|Antitubercular Agents|antitubercular agents|mesh-ancestor
6010107|NCT00309842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6010108|NCT00309907|Methylprednisolone|methylprednisolone|mesh-list
6010109|NCT00309907|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6010110|NCT00309907|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6010111|NCT00309907|Prednisolone|prednisolone|mesh-list
6010112|NCT00309907|Prednisolone acetate|prednisolone acetate|mesh-list
6010113|NCT00309907|Etanercept|etanercept|mesh-list
6010114|NCT00309907|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6010115|NCT00309907|Prednisolone phosphate|prednisolone phosphate|mesh-list
6010116|NCT00309907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6010117|NCT00309907|Antiemetics|antiemetics|mesh-ancestor
6010118|NCT00309907|Autonomic Agents|autonomic agents|mesh-ancestor
6010119|NCT00309907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6010120|NCT00309907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010121|NCT00309907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6010122|NCT00309907|Glucocorticoids|glucocorticoids|mesh-ancestor
6010123|NCT00309907|Hormones|hormones|mesh-ancestor
6010124|NCT00309907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6010125|NCT00309907|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6010126|NCT00309907|Protective Agents|protective agents|mesh-ancestor
6010127|NCT00309907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6010128|NCT00309907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6010129|NCT00309907|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6010130|NCT00309907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6010131|NCT00309907|Analgesics|analgesics|mesh-ancestor
6010132|NCT00309907|Sensory System Agents|sensory system agents|mesh-ancestor
6010133|NCT00309907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6010134|NCT00309907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6010135|NCT00309907|Immunologic Factors|immunologic factors|mesh-ancestor
6010136|NCT00309946|Cediranib|cediranib|mesh-list
6010137|NCT00309946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6010138|NCT00309946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010139|NCT00309946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6010140|NCT00309946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6010141|NCT00309959|Paclitaxel|paclitaxel|mesh-list
6010142|NCT00309959|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6010143|NCT00309959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6010144|NCT00309959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6010145|NCT00309959|Tubulin Modulators|tubulin modulators|mesh-ancestor
6010146|NCT00309959|Antimitotic Agents|antimitotic agents|mesh-ancestor
6010147|NCT00309959|Mitosis Modulators|mitosis modulators|mesh-ancestor
6010148|NCT00309959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010149|NCT00309985|Docetaxel|docetaxel|mesh-list
6010150|NCT00309985|Androgens|androgens|mesh-list
6010151|NCT00309985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6010152|NCT00309985|Tubulin Modulators|tubulin modulators|mesh-ancestor
6010153|NCT00309985|Antimitotic Agents|antimitotic agents|mesh-ancestor
6010154|NCT00309985|Mitosis Modulators|mitosis modulators|mesh-ancestor
6010155|NCT00309985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010156|NCT00309985|Hormones|hormones|mesh-ancestor
6010157|NCT00309985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6010158|NCT00309985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010159|NCT00310037|Bortezomib|bortezomib|mesh-list
6010160|NCT00310037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6010161|NCT00310050|Pemetrexed|pemetrexed|mesh-list
6010162|NCT00310050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6010163|NCT00310050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6010164|NCT00310050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010165|NCT00310050|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6010166|NCT00310050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6010167|NCT00310076|Thalidomide|thalidomide|mesh-list
6010168|NCT00310076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6010169|NCT00310076|Immunologic Factors|immunologic factors|mesh-ancestor
6010170|NCT00310076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010171|NCT00310076|Leprostatic Agents|leprostatic agents|mesh-ancestor
6010172|NCT00310076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6010173|NCT00310076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6010174|NCT00310076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6010175|NCT00310076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6010176|NCT00310076|Growth Substances|growth substances|mesh-ancestor
6010177|NCT00310076|Growth Inhibitors|growth inhibitors|mesh-ancestor
6010178|NCT00310076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6010179|NCT00310375|Ezogabine|ezogabine|mesh-list
6010180|NCT00310375|Anticonvulsants|anticonvulsants|mesh-ancestor
6010181|NCT00310375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6010182|NCT00310375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010183|NCT00310401|Albuterol|albuterol|mesh-list
6010184|NCT00310401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6010185|NCT00310401|Autonomic Agents|autonomic agents|mesh-ancestor
6010186|NCT00310401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6010187|NCT00310401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010188|NCT00310401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6010189|NCT00310401|Respiratory System Agents|respiratory system agents|mesh-ancestor
6010190|NCT00310401|Tocolytic Agents|tocolytic agents|mesh-ancestor
6010191|NCT00310401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6010192|NCT00310401|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6010193|NCT00310401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6010194|NCT00310401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6010195|NCT00310401|Adrenergic Agents|adrenergic agents|mesh-ancestor
6010196|NCT00310401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6010197|NCT00310401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010198|NCT00310791|Levonorgestrel|levonorgestrel|mesh-list
6010199|NCT00310791|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6010200|NCT00310791|Hormones|hormones|mesh-list
6010201|NCT00310791|Estradiol|estradiol|mesh-list
6010202|NCT00310791|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6010203|NCT00310791|Estrogens|estrogens|mesh-list
6010204|NCT00310791|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
6010205|NCT00310791|Progestins|progestins|mesh-list
6010206|NCT00310791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6010207|NCT00310791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010208|NCT00310791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6010209|NCT00310791|Contraceptive Agents|contraceptive agents|mesh-ancestor
6010210|NCT00310791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6010211|NCT00310791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6010212|NCT00310791|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6010213|NCT00310791|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6010214|NCT00310791|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6010215|NCT00310791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6010216|NCT00310791|Immunologic Factors|immunologic factors|mesh-ancestor
6010217|NCT00310804|Vaccines|vaccines|mesh-list
6010218|NCT00310804|Immunologic Factors|immunologic factors|mesh-ancestor
6010219|NCT00310804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010220|NCT00310817|Vaccines|vaccines|mesh-list
6010221|NCT00310817|Immunologic Factors|immunologic factors|mesh-ancestor
6010222|NCT00310817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010223|NCT00310856|Vaccines|vaccines|mesh-list
6010224|NCT00310856|Immunologic Factors|immunologic factors|mesh-ancestor
6010225|NCT00310856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010226|NCT00311155|Amlodipine|amlodipine|mesh-list
6010227|NCT00311155|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6010228|NCT00311155|Olmesartan|olmesartan|mesh-list
6010229|NCT00311155|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6010230|NCT00311155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6010231|NCT00311155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6010232|NCT00311155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6010233|NCT00311155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010234|NCT00311155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6010235|NCT00311155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010236|NCT00311155|Vasodilator Agents|vasodilator agents|mesh-ancestor
6010237|NCT00311155|Diuretics|diuretics|mesh-ancestor
6010238|NCT00311155|Natriuretic Agents|natriuretic agents|mesh-ancestor
6010239|NCT00311155|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6010240|NCT00311155|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6010241|NCT00311155|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6010242|NCT00311246|Adalimumab|adalimumab|mesh-list
6010243|NCT00311246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6010244|NCT00311246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6010245|NCT00311311|Mycophenolic Acid|mycophenolic acid|mesh-list
6010246|NCT00311311|Sirolimus|sirolimus|mesh-list
6010247|NCT00311311|Prednisone|prednisone|mesh-list
6010248|NCT00311311|Tacrolimus|tacrolimus|mesh-list
6010249|NCT00311311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6010250|NCT00311311|Glucocorticoids|glucocorticoids|mesh-ancestor
6010251|NCT00311311|Hormones|hormones|mesh-ancestor
6010252|NCT00311311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6010253|NCT00311311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010254|NCT00311311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6010255|NCT00311311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6010256|NCT00311311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6010257|NCT00311311|Immunologic Factors|immunologic factors|mesh-ancestor
6010258|NCT00311311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6010259|NCT00311311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6010260|NCT00311311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010261|NCT00311311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6010262|NCT00311311|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6010263|NCT00311311|Antitubercular Agents|antitubercular agents|mesh-ancestor
6010264|NCT00311311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6010265|NCT00311311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6010266|NCT00311311|Antifungal Agents|antifungal agents|mesh-ancestor
6010267|NCT00311363|Gabapentin|gabapentin|mesh-list
6010268|NCT00311363|Analgesics|analgesics|mesh-ancestor
6010269|NCT00311363|Sensory System Agents|sensory system agents|mesh-ancestor
6010270|NCT00311363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6010271|NCT00311363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010272|NCT00311363|Anticonvulsants|anticonvulsants|mesh-ancestor
6010273|NCT00311363|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6010274|NCT00311363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6010275|NCT00311363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6010276|NCT00311363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6010277|NCT00311363|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6010278|NCT00311363|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6010279|NCT00311363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6010280|NCT00311363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010281|NCT00311363|Antimanic Agents|antimanic agents|mesh-ancestor
6010282|NCT00311376|Botulinum Toxins|botulinum toxins|mesh-list
6010283|NCT00311376|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6010284|NCT00311376|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6010285|NCT00311376|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6010286|NCT00311376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6010287|NCT00311376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010288|NCT00311376|Cholinergic Agents|cholinergic agents|mesh-ancestor
6010289|NCT00311376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6010290|NCT00311376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010291|NCT00311376|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6010292|NCT00311376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6010293|NCT00311402|Aspirin|aspirin|mesh-list
6010294|NCT00311402|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
6010295|NCT00311402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6010296|NCT00311402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6010297|NCT00311402|Analgesics|analgesics|mesh-ancestor
6010298|NCT00311402|Sensory System Agents|sensory system agents|mesh-ancestor
6010299|NCT00311402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6010300|NCT00311402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010301|NCT00311402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6010302|NCT00311402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6010303|NCT00311402|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6010304|NCT00311402|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6010305|NCT00311402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010306|NCT00311402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6010307|NCT00311402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6010308|NCT00311402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6010309|NCT00311402|Antipyretics|antipyretics|mesh-ancestor
6010310|NCT00311584|Irinotecan|irinotecan|mesh-list
6010311|NCT00311584|Temozolomide|temozolomide|mesh-list
6010312|NCT00311584|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6010313|NCT00311584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6010314|NCT00311584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6010315|NCT00311584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010316|NCT00311584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6010317|NCT00311584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6010318|NCT00311584|Alkylating Agents|alkylating agents|mesh-ancestor
6010319|NCT00311623|Sirolimus|sirolimus|mesh-list
6010320|NCT00311623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6010321|NCT00311623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6010322|NCT00311623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6010323|NCT00311623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6010324|NCT00311623|Antifungal Agents|antifungal agents|mesh-ancestor
6010325|NCT00311623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6010326|NCT00311623|Immunologic Factors|immunologic factors|mesh-ancestor
6010327|NCT00311623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010328|NCT00312195|Buprenorphine|buprenorphine|mesh-list
6010329|NCT00312195|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6010330|NCT00312195|Narcotics|narcotics|mesh-ancestor
6010331|NCT00312195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6010332|NCT00312195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010333|NCT00312195|Analgesics|analgesics|mesh-ancestor
6010334|NCT00312195|Sensory System Agents|sensory system agents|mesh-ancestor
6010335|NCT00312195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6010336|NCT00312195|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6010337|NCT00312208|Cyclophosphamide|cyclophosphamide|mesh-list
6010338|NCT00312208|Docetaxel|docetaxel|mesh-list
6010339|NCT00312208|Doxorubicin|doxorubicin|mesh-list
6010340|NCT00312208|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6010341|NCT00312208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6010342|NCT00312208|Immunologic Factors|immunologic factors|mesh-ancestor
6010343|NCT00312208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010344|NCT00312208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6010345|NCT00312208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6010346|NCT00312208|Alkylating Agents|alkylating agents|mesh-ancestor
6010347|NCT00312208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010348|NCT00312208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6010349|NCT00312208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6010350|NCT00312208|Tubulin Modulators|tubulin modulators|mesh-ancestor
6010351|NCT00312208|Antimitotic Agents|antimitotic agents|mesh-ancestor
6010352|NCT00312208|Mitosis Modulators|mitosis modulators|mesh-ancestor
6010353|NCT00312208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6010354|NCT00312208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6010355|NCT00312208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6010356|NCT00312208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6010357|NCT00312221|Oxycodone|oxycodone|mesh-list
6010358|NCT00312221|Buprenorphine|buprenorphine|mesh-list
6010359|NCT00312221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6010360|NCT00312221|Narcotics|narcotics|mesh-ancestor
6010361|NCT00312221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6010362|NCT00312221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010363|NCT00312221|Analgesics|analgesics|mesh-ancestor
6010364|NCT00312221|Sensory System Agents|sensory system agents|mesh-ancestor
6010365|NCT00312221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6010366|NCT00312221|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6261151|NCT03198221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6261152|NCT03198221|Antacids|antacids|mesh-ancestor
6261153|NCT03198221|Laxatives|laxatives|mesh-ancestor
6261154|NCT03198507|Amoxicillin|amoxicillin|mesh-list
6261155|NCT03198507|Rifabutin|rifabutin|mesh-list
6261156|NCT03198507|Omeprazole|omeprazole|mesh-list
6261157|NCT03198507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6261158|NCT03198507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6261159|NCT03198507|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6261160|NCT03198507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6261161|NCT03198507|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6261162|NCT03198507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6261163|NCT03198507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261164|NCT03198507|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6261165|NCT03198507|Antitubercular Agents|antitubercular agents|mesh-ancestor
6261166|NCT03198767|Licogliflozin|licogliflozin|mesh-list
6261167|NCT03198767|Calcium Carbonate|calcium carbonate|mesh-list
6261168|NCT03198767|Psyllium|psyllium|mesh-list
6261169|NCT03198767|Calcium|calcium|mesh-list
6261170|NCT03198767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6261171|NCT03198767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261172|NCT03198767|Antacids|antacids|mesh-ancestor
6261173|NCT03198767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261174|NCT03198767|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6261175|NCT03198767|Cathartics|cathartics|mesh-ancestor
6261176|NCT03198767|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6261177|NCT03198767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6261178|NCT03198871|Acetaminophen|acetaminophen|mesh-list
6261179|NCT03198871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6261180|NCT03198871|Analgesics|analgesics|mesh-ancestor
6261181|NCT03198871|Sensory System Agents|sensory system agents|mesh-ancestor
6261182|NCT03198871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6261183|NCT03198871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261184|NCT03198871|Antipyretics|antipyretics|mesh-ancestor
6261185|NCT03198884|Darunavir|darunavir|mesh-list
6261186|NCT03198884|Dolutegravir|dolutegravir|mesh-list
6261187|NCT03198884|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6261188|NCT03198884|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6261189|NCT03198884|Protease Inhibitors|protease inhibitors|mesh-ancestor
6010367|NCT00312338|Moxifloxacin|moxifloxacin|mesh-list
6010368|NCT00312338|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6261190|NCT03198884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6261191|NCT03198884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261192|NCT03198884|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6010369|NCT00312338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6010370|NCT00312338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6010371|NCT00312338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6010372|NCT00312338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6010373|NCT00312338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6010374|NCT00312338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010375|NCT00312338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6010376|NCT00312338|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6010377|NCT00312338|Contraceptive Agents|contraceptive agents|mesh-ancestor
6010378|NCT00312338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6010379|NCT00312338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010380|NCT00312338|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6010381|NCT00312338|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6010382|NCT00312338|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6010383|NCT00312377|Docetaxel|docetaxel|mesh-list
6010384|NCT00312377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6010385|NCT00312377|Tubulin Modulators|tubulin modulators|mesh-ancestor
6010386|NCT00312377|Antimitotic Agents|antimitotic agents|mesh-ancestor
6010387|NCT00312377|Mitosis Modulators|mitosis modulators|mesh-ancestor
6010388|NCT00312377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010389|NCT00312494|Ziprasidone|ziprasidone|mesh-list
6010390|NCT00312494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6010391|NCT00312494|Serotonin Agents|serotonin agents|mesh-ancestor
6010392|NCT00312494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6010393|NCT00312494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010394|NCT00312494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010395|NCT00312494|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6010396|NCT00312494|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6010397|NCT00312494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6010398|NCT00312494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6010399|NCT00312494|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6010400|NCT00312494|Dopamine Agents|dopamine agents|mesh-ancestor
6010401|NCT00312572|Buprenorphine|buprenorphine|mesh-list
6010402|NCT00312572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6010403|NCT00312572|Narcotics|narcotics|mesh-ancestor
6010404|NCT00312572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6010405|NCT00312572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010406|NCT00312572|Analgesics|analgesics|mesh-ancestor
6010407|NCT00312572|Sensory System Agents|sensory system agents|mesh-ancestor
6010408|NCT00312572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6010409|NCT00312572|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6010410|NCT00312728|Bevacizumab|bevacizumab|mesh-list
6010411|NCT00312728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6010412|NCT00312728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6010413|NCT00312728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6010414|NCT00312728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6010415|NCT00312728|Growth Substances|growth substances|mesh-ancestor
6010416|NCT00312728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010417|NCT00312728|Growth Inhibitors|growth inhibitors|mesh-ancestor
6010418|NCT00312845|Rituximab|rituximab|mesh-list
6010419|NCT00312845|Bortezomib|bortezomib|mesh-list
6010420|NCT00312845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6010421|NCT00312845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6010422|NCT00312845|Immunologic Factors|immunologic factors|mesh-ancestor
6010423|NCT00312845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010424|NCT00312845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6010425|NCT00312858|Vaccines|vaccines|mesh-list
6010426|NCT00312858|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6010427|NCT00312858|Immunologic Factors|immunologic factors|mesh-ancestor
6010428|NCT00312858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010429|NCT00312923|Policosanol|policosanol|mesh-list
6010430|NCT00312923|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6010431|NCT00312923|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6010432|NCT00312923|Antimetabolites|antimetabolites|mesh-ancestor
6010433|NCT00312923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010434|NCT00312923|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6010435|NCT00312923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6010436|NCT00313014|Oxycodone|oxycodone|mesh-list
6010437|NCT00313014|Buprenorphine|buprenorphine|mesh-list
6010438|NCT00313014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6010439|NCT00313014|Narcotics|narcotics|mesh-ancestor
6010440|NCT00313014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6010441|NCT00313014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010442|NCT00313014|Analgesics|analgesics|mesh-ancestor
6010443|NCT00313014|Sensory System Agents|sensory system agents|mesh-ancestor
6010444|NCT00313014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6010445|NCT00313014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6010446|NCT00313144|Protease Inhibitors|protease inhibitors|mesh-list
6010447|NCT00313144|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
6010448|NCT00313144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6010449|NCT00313144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010450|NCT00313144|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6010451|NCT00313144|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6010452|NCT00313170|Fulvestrant|fulvestrant|mesh-list
6010453|NCT00313170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6010454|NCT00313170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6010455|NCT00313170|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6010456|NCT00313170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6010457|NCT00313170|Hormone Antagonists|hormone antagonists|mesh-ancestor
6010458|NCT00313170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6010459|NCT00313170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010460|NCT00313300|Apixaban|apixaban|mesh-list
6010461|NCT00313300|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6010462|NCT00313300|Antithrombins|antithrombins|mesh-ancestor
6010463|NCT00313300|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6010464|NCT00313300|Protease Inhibitors|protease inhibitors|mesh-ancestor
6010465|NCT00313300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6010466|NCT00313300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010467|NCT00313300|Anticoagulants|anticoagulants|mesh-ancestor
6010468|NCT00313313|Metformin|metformin|mesh-list
6010469|NCT00313313|Saxagliptin|saxagliptin|mesh-list
6010470|NCT00313313|Glyburide|glyburide|mesh-list
6010471|NCT00313313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6010472|NCT00313313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010473|NCT00313313|Incretins|incretins|mesh-ancestor
6010474|NCT00313313|Hormones|hormones|mesh-ancestor
6010475|NCT00313313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6010476|NCT00313313|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6010477|NCT00313313|Protease Inhibitors|protease inhibitors|mesh-ancestor
6010478|NCT00313313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6010479|NCT00313313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010480|NCT00313560|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6010481|NCT00313560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6010482|NCT00313560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6010483|NCT00313560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6010484|NCT00313560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010485|NCT00313586|Azacitidine|azacitidine|mesh-list
6010486|NCT00313586|Entinostat|entinostat|mesh-list
6010487|NCT00313586|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
6010488|NCT00313586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6010489|NCT00313586|Antimetabolites|antimetabolites|mesh-ancestor
6010490|NCT00313586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010491|NCT00313586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6010492|NCT00313586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6010493|NCT00313612|Oxaliplatin|oxaliplatin|mesh-list
6261193|NCT03198884|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6010494|NCT00313612|Topotecan|topotecan|mesh-list
6010495|NCT00313612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6010496|NCT00313612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6010497|NCT00313612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6010498|NCT00313612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6010499|NCT00313612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010500|NCT00313716|Epoetin Alfa|epoetin alfa|mesh-list
6010501|NCT00313716|Hematinics|hematinics|mesh-ancestor
6010502|NCT00313729|Temozolomide|temozolomide|mesh-list
6010503|NCT00313729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6010504|NCT00313729|Alkylating Agents|alkylating agents|mesh-ancestor
6010505|NCT00313729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010506|NCT00313729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6010507|NCT00313781|Prednisone|prednisone|mesh-list
6010508|NCT00313781|Docetaxel|docetaxel|mesh-list
6010509|NCT00313781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6010510|NCT00313781|Tubulin Modulators|tubulin modulators|mesh-ancestor
6010511|NCT00313781|Antimitotic Agents|antimitotic agents|mesh-ancestor
6010512|NCT00313781|Mitosis Modulators|mitosis modulators|mesh-ancestor
6010513|NCT00313781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010514|NCT00313781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5724156|NCT03189329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6010515|NCT00313781|Glucocorticoids|glucocorticoids|mesh-ancestor
6010516|NCT00313781|Hormones|hormones|mesh-ancestor
6010517|NCT00313781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6010518|NCT00313781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010519|NCT00313781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6010520|NCT00313820|Pregabalin|pregabalin|mesh-list
6010521|NCT00313820|Analgesics|analgesics|mesh-ancestor
6010522|NCT00313820|Sensory System Agents|sensory system agents|mesh-ancestor
6010523|NCT00313820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6010524|NCT00313820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010525|NCT00313820|Anticonvulsants|anticonvulsants|mesh-ancestor
6010526|NCT00313820|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6010527|NCT00313820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6010528|NCT00313820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010529|NCT00313820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6010530|NCT00313820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6010531|NCT00313820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6010532|NCT00313820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6010533|NCT00313820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6010534|NCT00313846|Buprenorphine|buprenorphine|mesh-list
6010535|NCT00313846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6010536|NCT00313846|Narcotics|narcotics|mesh-ancestor
6010537|NCT00313846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6010538|NCT00313846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010539|NCT00313846|Analgesics|analgesics|mesh-ancestor
6010540|NCT00313846|Sensory System Agents|sensory system agents|mesh-ancestor
6010541|NCT00313846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6010542|NCT00313846|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6010543|NCT00314106|Aldesleukin|aldesleukin|mesh-list
6010544|NCT00314106|Cyclophosphamide|cyclophosphamide|mesh-list
6010545|NCT00314106|Fludarabine|fludarabine|mesh-list
6010546|NCT00314106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6010547|NCT00314106|Immunologic Factors|immunologic factors|mesh-ancestor
6010548|NCT00314106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010549|NCT00314106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6010550|NCT00314106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6010551|NCT00314106|Alkylating Agents|alkylating agents|mesh-ancestor
6010552|NCT00314106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010553|NCT00314106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6010554|NCT00314106|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6010555|NCT00314106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6010556|NCT00314106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6010557|NCT00314106|Antiviral Agents|antiviral agents|mesh-ancestor
6010558|NCT00314106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6010559|NCT00314249|Milnacipran|milnacipran|mesh-list
6010560|NCT00314249|Levomilnacipran|levomilnacipran|mesh-list
6010561|NCT00314249|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6010562|NCT00314249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6010563|NCT00314249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6010564|NCT00314249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010565|NCT00314249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6010566|NCT00314249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010567|NCT00314249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6010568|NCT00314249|Analgesics|analgesics|mesh-ancestor
6010569|NCT00314249|Sensory System Agents|sensory system agents|mesh-ancestor
6010570|NCT00314249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6010571|NCT00314249|Antidepressive Agents|antidepressive agents|mesh-ancestor
6010572|NCT00314249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6010573|NCT00314262|Celecoxib|celecoxib|mesh-list
6010574|NCT00314262|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6010575|NCT00314262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6010576|NCT00314262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6010577|NCT00314262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6010578|NCT00314262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010579|NCT00314262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6010580|NCT00314262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6010581|NCT00314262|Analgesics|analgesics|mesh-ancestor
6010582|NCT00314262|Sensory System Agents|sensory system agents|mesh-ancestor
6010583|NCT00314262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6010584|NCT00314262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010585|NCT00314262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6010586|NCT00314262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6010587|NCT00314262|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6010588|NCT00314262|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6010589|NCT00314340|Acetaminophen|acetaminophen|mesh-list
6010590|NCT00314340|Morphine|morphine|mesh-list
6010591|NCT00314340|Hydrocodone|hydrocodone|mesh-list
6010592|NCT00314340|Phenobarbital|phenobarbital|mesh-list
6010593|NCT00314340|Amphetamine|amphetamine|mesh-list
6010594|NCT00314340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6010595|NCT00314340|Narcotics|narcotics|mesh-ancestor
6010596|NCT00314340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6010597|NCT00314340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010598|NCT00314340|Analgesics|analgesics|mesh-ancestor
6010599|NCT00314340|Sensory System Agents|sensory system agents|mesh-ancestor
6010600|NCT00314340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6010601|NCT00314340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6010602|NCT00314340|Antipyretics|antipyretics|mesh-ancestor
6010603|NCT00314340|Antitussive Agents|antitussive agents|mesh-ancestor
6010604|NCT00314340|Respiratory System Agents|respiratory system agents|mesh-ancestor
6010605|NCT00314340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6010606|NCT00314340|Sympathomimetics|sympathomimetics|mesh-ancestor
6010607|NCT00314340|Autonomic Agents|autonomic agents|mesh-ancestor
6010608|NCT00314340|Dopamine Agents|dopamine agents|mesh-ancestor
6010609|NCT00314340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6010610|NCT00314340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010611|NCT00314340|Adrenergic Agents|adrenergic agents|mesh-ancestor
6010612|NCT00314340|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6010613|NCT00314340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6010614|NCT00314340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6010615|NCT00314340|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6010616|NCT00314340|Anticonvulsants|anticonvulsants|mesh-ancestor
6010617|NCT00314340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6010618|NCT00314340|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6010619|NCT00314340|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6010620|NCT00314340|GABA Modulators|gaba modulators|mesh-ancestor
6010621|NCT00314340|GABA Agents|gaba agents|mesh-ancestor
6010622|NCT00314340|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6010623|NCT00314340|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6010624|NCT00314340|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6010625|NCT00314574|Omalizumab|omalizumab|mesh-list
6010626|NCT00314574|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6010627|NCT00314574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6010628|NCT00314574|Respiratory System Agents|respiratory system agents|mesh-ancestor
6010629|NCT00314808|Dronabinol|dronabinol|mesh-list
6010630|NCT00314808|Hallucinogens|hallucinogens|mesh-ancestor
6010631|NCT00314808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010632|NCT00314808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6010633|NCT00314808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6010634|NCT00314808|Analgesics|analgesics|mesh-ancestor
6010635|NCT00314808|Sensory System Agents|sensory system agents|mesh-ancestor
6010636|NCT00314808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6010637|NCT00314808|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6010638|NCT00314808|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6010639|NCT00314808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6010640|NCT00314808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010641|NCT00314808|Hormones|hormones|mesh-ancestor
6010642|NCT00314808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6010643|NCT00314951|Vancomycin|vancomycin|mesh-list
6010644|NCT00314951|Fidaxomicin|fidaxomicin|mesh-list
6010645|NCT00314951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6010646|NCT00314951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6010647|NCT00315055|Vaccines|vaccines|mesh-list
6010648|NCT00315055|Immunologic Factors|immunologic factors|mesh-ancestor
6010649|NCT00315055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010650|NCT00315146|Pioglitazone|pioglitazone|mesh-list
6010651|NCT00315146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6010652|NCT00315146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018352|NCT00379821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6018353|NCT00379821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6018354|NCT00379821|Antiviral Agents|antiviral agents|mesh-ancestor
6018355|NCT00379821|Schistosomicides|schistosomicides|mesh-ancestor
6018356|NCT00379821|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6018357|NCT00379821|Anthelmintics|anthelmintics|mesh-ancestor
6018358|NCT00379821|Amebicides|amebicides|mesh-ancestor
6018359|NCT00379821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6018360|NCT00379821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6018361|NCT00379821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6018362|NCT00379821|Antimetabolites|antimetabolites|mesh-ancestor
6018363|NCT00379834|Timolol|timolol|mesh-list
6018364|NCT00379834|Dorzolamide|dorzolamide|mesh-list
6018365|NCT00379834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6018366|NCT00379834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6018367|NCT00379834|Adrenergic Agents|adrenergic agents|mesh-ancestor
6018368|NCT00379834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6010653|NCT00315302|Atropine|atropine|mesh-list
6010654|NCT00315302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6010655|NCT00315302|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6010656|NCT00315302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6010657|NCT00315302|Autonomic Agents|autonomic agents|mesh-ancestor
6010658|NCT00315302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6010659|NCT00315302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261194|NCT03198884|Antiviral Agents|antiviral agents|mesh-ancestor
6261195|NCT03198884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6261196|NCT03198884|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6261197|NCT03198884|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6261198|NCT03199911|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6261199|NCT03199911|Erythromycin|erythromycin|mesh-list
6261200|NCT03199911|Bacitracin|bacitracin|mesh-list
6261201|NCT03199911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6261202|NCT03199911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6261203|NCT03199911|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6261204|NCT03199911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6261205|NCT03199911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261206|NCT03199911|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6261207|NCT03199963|Tamoxifen|tamoxifen|mesh-list
6261208|NCT03199963|Afimoxifene|afimoxifene|mesh-list
6261209|NCT03199963|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6261210|NCT03199963|Hormone Antagonists|hormone antagonists|mesh-ancestor
6261211|NCT03199963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6261212|NCT03199963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261213|NCT03199963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6261214|NCT03199963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6261215|NCT03199963|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6261216|NCT03199963|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6261217|NCT03199963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6261218|NCT03200860|Empagliflozin|empagliflozin|mesh-list
6261219|NCT03200860|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6261220|NCT03200860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261221|NCT03200860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6261222|NCT03200860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261223|NCT03201211|Vaccines|vaccines|mesh-list
6261224|NCT03201211|Immunologic Factors|immunologic factors|mesh-ancestor
6261225|NCT03201211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261226|NCT03201419|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
6261227|NCT03201419|Hemostatics|hemostatics|mesh-ancestor
6261228|NCT03201419|Coagulants|coagulants|mesh-ancestor
6261229|NCT03201419|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6261230|NCT03201419|Natriuretic Agents|natriuretic agents|mesh-ancestor
6261231|NCT03201419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261232|NCT03201562|Tropicamide|tropicamide|mesh-list
6261233|NCT03201562|Aceclidine|aceclidine|mesh-list
6261234|NCT03201562|Mydriatics|mydriatics|mesh-ancestor
6261235|NCT03201562|Autonomic Agents|autonomic agents|mesh-ancestor
6261236|NCT03201562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6261237|NCT03201562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261238|NCT03201562|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6261239|NCT03201562|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6261240|NCT03201562|Cholinergic Agents|cholinergic agents|mesh-ancestor
6261241|NCT03201562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6261242|NCT03201562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261243|NCT03201562|Miotics|miotics|mesh-ancestor
6261244|NCT03201562|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6261245|NCT03202134|Analgesics, Opioid|analgesics, opioid|mesh-list
6261246|NCT03202134|Anesthetics|anesthetics|mesh-list
6010660|NCT00315302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6396854|NCT00209794|Antimalarials|antimalarials|mesh-ancestor
6010661|NCT00315302|Respiratory System Agents|respiratory system agents|mesh-ancestor
6010662|NCT00315302|Mydriatics|mydriatics|mesh-ancestor
6010663|NCT00315302|Parasympatholytics|parasympatholytics|mesh-ancestor
6010664|NCT00315302|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6010665|NCT00315302|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6010666|NCT00315302|Cholinergic Agents|cholinergic agents|mesh-ancestor
6010667|NCT00315302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6010668|NCT00315302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010669|NCT00315328|Atropine|atropine|mesh-list
6010670|NCT00315328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6010671|NCT00315328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6010672|NCT00315328|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6010673|NCT00315328|Autonomic Agents|autonomic agents|mesh-ancestor
6010674|NCT00315328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6010675|NCT00315328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010676|NCT00315328|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6010677|NCT00315328|Respiratory System Agents|respiratory system agents|mesh-ancestor
6010678|NCT00315328|Mydriatics|mydriatics|mesh-ancestor
6010679|NCT00315328|Parasympatholytics|parasympatholytics|mesh-ancestor
6010680|NCT00315328|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6010681|NCT00315328|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6010682|NCT00315328|Cholinergic Agents|cholinergic agents|mesh-ancestor
6010683|NCT00315328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6010684|NCT00315328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010685|NCT00315341|Buprenorphine|buprenorphine|mesh-list
6010686|NCT00315341|Methadone|methadone|mesh-list
6010687|NCT00315341|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6010688|NCT00315341|Naloxone|naloxone|mesh-list
6010689|NCT00315341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6010690|NCT00315341|Narcotics|narcotics|mesh-ancestor
6010691|NCT00315341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6010692|NCT00315341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010693|NCT00315341|Analgesics|analgesics|mesh-ancestor
6010694|NCT00315341|Sensory System Agents|sensory system agents|mesh-ancestor
6010695|NCT00315341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6010696|NCT00315341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6010697|NCT00315341|Antitussive Agents|antitussive agents|mesh-ancestor
6010698|NCT00315341|Respiratory System Agents|respiratory system agents|mesh-ancestor
6010699|NCT00315445|Acetaminophen|acetaminophen|mesh-list
6010700|NCT00315445|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
6010701|NCT00315445|Oxycodone|oxycodone|mesh-list
6010702|NCT00315445|Buprenorphine|buprenorphine|mesh-list
6010703|NCT00315445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6010704|NCT00315445|Analgesics|analgesics|mesh-ancestor
6010705|NCT00315445|Sensory System Agents|sensory system agents|mesh-ancestor
6010706|NCT00315445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6010707|NCT00315445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010708|NCT00315445|Antipyretics|antipyretics|mesh-ancestor
6010709|NCT00315445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6010710|NCT00315445|Narcotics|narcotics|mesh-ancestor
6010711|NCT00315445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6010712|NCT00315445|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6010713|NCT00315445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6010714|NCT00315445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6010715|NCT00315445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6010716|NCT00315458|Buprenorphine|buprenorphine|mesh-list
6010717|NCT00315458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6010718|NCT00315458|Narcotics|narcotics|mesh-ancestor
6010719|NCT00315458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6010720|NCT00315458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010721|NCT00315458|Analgesics|analgesics|mesh-ancestor
6010722|NCT00315458|Sensory System Agents|sensory system agents|mesh-ancestor
6010723|NCT00315458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6010724|NCT00315458|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6010725|NCT00315705|Cyclophosphamide|cyclophosphamide|mesh-list
6010726|NCT00315705|Etoposide|etoposide|mesh-list
6010727|NCT00315705|Clofarabine|clofarabine|mesh-list
6010728|NCT00315705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6010729|NCT00315705|Immunologic Factors|immunologic factors|mesh-ancestor
6010730|NCT00315705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010731|NCT00315705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6010732|NCT00315705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6010733|NCT00315705|Alkylating Agents|alkylating agents|mesh-ancestor
6010734|NCT00315705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010735|NCT00315705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6010736|NCT00315705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6010737|NCT00315705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6010738|NCT00315705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6010739|NCT00315705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6010740|NCT00315705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6010741|NCT00315705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6010742|NCT00315705|Antimetabolites|antimetabolites|mesh-ancestor
6010743|NCT00316004|Dextrans|dextrans|mesh-list
6010744|NCT00316004|Anticoagulants|anticoagulants|mesh-ancestor
6010745|NCT00316004|Plasma Substitutes|plasma substitutes|mesh-ancestor
6010746|NCT00316004|Blood Substitutes|blood substitutes|mesh-ancestor
6010747|NCT00316017|Dextrans|dextrans|mesh-list
6010748|NCT00316017|Anticoagulants|anticoagulants|mesh-ancestor
6010749|NCT00316017|Plasma Substitutes|plasma substitutes|mesh-ancestor
6010750|NCT00316017|Blood Substitutes|blood substitutes|mesh-ancestor
6010751|NCT00316082|Metformin|metformin|mesh-list
6010752|NCT00316082|Saxagliptin|saxagliptin|mesh-list
6010753|NCT00316082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6010754|NCT00316082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010755|NCT00316082|Incretins|incretins|mesh-ancestor
6010756|NCT00316082|Hormones|hormones|mesh-ancestor
6010757|NCT00316082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6010758|NCT00316082|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6010759|NCT00316082|Protease Inhibitors|protease inhibitors|mesh-ancestor
6010760|NCT00316082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6010761|NCT00316082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010762|NCT00316173|Carboplatin|carboplatin|mesh-list
6010763|NCT00316173|Topotecan|topotecan|mesh-list
6010764|NCT00316173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6010765|NCT00316173|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6010766|NCT00316173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6010767|NCT00316173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6010768|NCT00316173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010769|NCT00316186|Carboplatin|carboplatin|mesh-list
6010770|NCT00316186|Topotecan|topotecan|mesh-list
6010771|NCT00316186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6010772|NCT00316186|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6010773|NCT00316186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6010774|NCT00316186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6010775|NCT00316186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010776|NCT00316199|Gemcitabine|gemcitabine|mesh-list
6010777|NCT00316199|Paclitaxel|paclitaxel|mesh-list
6010778|NCT00316199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6010779|NCT00316199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6010780|NCT00316199|Tubulin Modulators|tubulin modulators|mesh-ancestor
6010781|NCT00316199|Antimitotic Agents|antimitotic agents|mesh-ancestor
6010782|NCT00316199|Mitosis Modulators|mitosis modulators|mesh-ancestor
6010783|NCT00316199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010784|NCT00316199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6010785|NCT00316199|Antimetabolites|antimetabolites|mesh-ancestor
6010786|NCT00316199|Antiviral Agents|antiviral agents|mesh-ancestor
6010787|NCT00316199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6010788|NCT00316199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6010789|NCT00316199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6010790|NCT00316199|Immunologic Factors|immunologic factors|mesh-ancestor
6010791|NCT00316199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010792|NCT00316225|Pemetrexed|pemetrexed|mesh-list
6010793|NCT00316225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6010794|NCT00316225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6010795|NCT00316225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010796|NCT00316225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6010797|NCT00316225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6010798|NCT00316264|Palivizumab|palivizumab|mesh-list
6010799|NCT00316264|Antiviral Agents|antiviral agents|mesh-ancestor
6010800|NCT00316264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6010801|NCT00316277|Opiate Alkaloids|opiate alkaloids|mesh-list
6010802|NCT00316277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6010803|NCT00316277|Narcotics|narcotics|mesh-ancestor
6396855|NCT00209794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6010804|NCT00316277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6010805|NCT00316277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010806|NCT00316277|Analgesics|analgesics|mesh-ancestor
6010807|NCT00316277|Sensory System Agents|sensory system agents|mesh-ancestor
6010808|NCT00316277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6010809|NCT00316719|Lamivudine|lamivudine|mesh-list
6010810|NCT00316719|Adefovir|adefovir|mesh-list
6010811|NCT00316719|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6010812|NCT00316719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6010813|NCT00316719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6010814|NCT00316719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6010815|NCT00316719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010816|NCT00316719|Antiviral Agents|antiviral agents|mesh-ancestor
6010817|NCT00316719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6010818|NCT00316719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6010819|NCT00316719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6010820|NCT00316862|Irinotecan|irinotecan|mesh-list
6010821|NCT00316862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6010822|NCT00316862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6010823|NCT00316862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6010824|NCT00316862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6010825|NCT00316862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010826|NCT00316888|Cisplatin|cisplatin|mesh-list
6010827|NCT00316888|Fluorouracil|fluorouracil|mesh-list
6010828|NCT00316888|Cetuximab|cetuximab|mesh-list
6010829|NCT00316888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6010830|NCT00316888|Antimetabolites|antimetabolites|mesh-ancestor
6010831|NCT00316888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010832|NCT00316888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6010833|NCT00316888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6010834|NCT00316888|Immunologic Factors|immunologic factors|mesh-ancestor
6010835|NCT00316888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010836|NCT00316888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6010837|NCT00316914|Magnesium Sulfate|magnesium sulfate|mesh-list
6010838|NCT00316914|Calcium|calcium|mesh-list
6010839|NCT00316914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6010840|NCT00316914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010841|NCT00316914|Analgesics|analgesics|mesh-ancestor
6010842|NCT00316914|Sensory System Agents|sensory system agents|mesh-ancestor
6261247|NCT03202134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6261248|NCT03202134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261249|NCT03202134|Narcotics|narcotics|mesh-ancestor
6261250|NCT03202134|Analgesics|analgesics|mesh-ancestor
6261251|NCT03202134|Sensory System Agents|sensory system agents|mesh-ancestor
6261252|NCT03202134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6261253|NCT03202511|Tenofovir|tenofovir|mesh-list
6261254|NCT03202511|Emtricitabine|emtricitabine|mesh-list
6010843|NCT00316914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6261255|NCT03202511|Probenecid|probenecid|mesh-list
6261256|NCT03202511|Antiviral Agents|antiviral agents|mesh-ancestor
6261257|NCT03202511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6261258|NCT03202511|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6261259|NCT03202511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6261260|NCT03202511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6261261|NCT03202511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261262|NCT03202511|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6261263|NCT03202511|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6261264|NCT03202511|Uricosuric Agents|uricosuric agents|mesh-ancestor
6261265|NCT03202511|Gout Suppressants|gout suppressants|mesh-ancestor
6261266|NCT03202511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6261267|NCT03202511|Renal Agents|renal agents|mesh-ancestor
6261268|NCT03202550|Oxycodone|oxycodone|mesh-list
6261269|NCT03202550|Lorazepam|lorazepam|mesh-list
6261270|NCT03202550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6261271|NCT03202550|Narcotics|narcotics|mesh-ancestor
6261272|NCT03202550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6261273|NCT03202550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261274|NCT03202550|Analgesics|analgesics|mesh-ancestor
6261275|NCT03202550|Sensory System Agents|sensory system agents|mesh-ancestor
6261276|NCT03202550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6010844|NCT00316914|Anesthetics|anesthetics|mesh-ancestor
6010845|NCT00316914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6010846|NCT00316914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6010847|NCT00316914|Anticonvulsants|anticonvulsants|mesh-ancestor
6010848|NCT00316914|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6010849|NCT00316914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6010850|NCT00316914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010851|NCT00316914|Tocolytic Agents|tocolytic agents|mesh-ancestor
6010852|NCT00316914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6010853|NCT00317044|Esomeprazole|esomeprazole|mesh-list
6010854|NCT00317044|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6010855|NCT00317044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6010856|NCT00317044|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6010857|NCT00317044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6010858|NCT00317044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010859|NCT00317473|Vaccines|vaccines|mesh-list
6010860|NCT00317473|Immunologic Factors|immunologic factors|mesh-ancestor
6010861|NCT00317473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010862|NCT00317642|Cytarabine|cytarabine|mesh-list
6010863|NCT00317642|Clofarabine|clofarabine|mesh-list
6010864|NCT00317642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6010865|NCT00317642|Antimetabolites|antimetabolites|mesh-ancestor
6010866|NCT00317642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010867|NCT00317642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6010868|NCT00317642|Antiviral Agents|antiviral agents|mesh-ancestor
6010869|NCT00317642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6010870|NCT00317642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6010871|NCT00317642|Immunologic Factors|immunologic factors|mesh-ancestor
6010872|NCT00317642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010873|NCT00317720|Trastuzumab|trastuzumab|mesh-list
6010874|NCT00317720|Everolimus|everolimus|mesh-list
6010875|NCT00317720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6010876|NCT00317720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6010877|NCT00317720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6010878|NCT00317720|Immunologic Factors|immunologic factors|mesh-ancestor
6010879|NCT00317720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010880|NCT00317941|Interferon beta-1b|interferon beta-1b|mesh-list
6010881|NCT00317941|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6010882|NCT00317941|Immunologic Factors|immunologic factors|mesh-ancestor
6010883|NCT00317941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010884|NCT00318136|Paclitaxel|paclitaxel|mesh-list
6010885|NCT00318136|Bevacizumab|bevacizumab|mesh-list
6010886|NCT00318136|Carboplatin|carboplatin|mesh-list
6010887|NCT00318136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6010888|NCT00318136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6010889|NCT00318136|Tubulin Modulators|tubulin modulators|mesh-ancestor
6010890|NCT00318136|Antimitotic Agents|antimitotic agents|mesh-ancestor
6010891|NCT00318136|Mitosis Modulators|mitosis modulators|mesh-ancestor
6010892|NCT00318136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010893|NCT00318136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6010894|NCT00318136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6010895|NCT00318136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6010896|NCT00318136|Growth Substances|growth substances|mesh-ancestor
6010897|NCT00318136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010898|NCT00318136|Growth Inhibitors|growth inhibitors|mesh-ancestor
6010899|NCT00318149|Vaccines|vaccines|mesh-list
6010900|NCT00318149|Immunologic Factors|immunologic factors|mesh-ancestor
6010901|NCT00318149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010902|NCT00318292|Epinephrine|epinephrine|mesh-list
6010903|NCT00318292|Bupivacaine|bupivacaine|mesh-list
6010904|NCT00318292|Anesthetics, Local|anesthetics, local|mesh-ancestor
6010905|NCT00318292|Anesthetics|anesthetics|mesh-ancestor
6010906|NCT00318292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6010907|NCT00318292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010908|NCT00318292|Sensory System Agents|sensory system agents|mesh-ancestor
6010909|NCT00318292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6010910|NCT00318292|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6010911|NCT00318292|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6010912|NCT00318292|Adrenergic Agents|adrenergic agents|mesh-ancestor
6010913|NCT00318292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6010914|NCT00318292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010915|NCT00318292|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6010916|NCT00318292|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6010917|NCT00318292|Autonomic Agents|autonomic agents|mesh-ancestor
6010918|NCT00318292|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6261277|NCT03202550|Anticonvulsants|anticonvulsants|mesh-ancestor
6010919|NCT00318292|Respiratory System Agents|respiratory system agents|mesh-ancestor
6010920|NCT00318292|Mydriatics|mydriatics|mesh-ancestor
6010921|NCT00318292|Sympathomimetics|sympathomimetics|mesh-ancestor
6010922|NCT00318292|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6010923|NCT00318370|Farletuzumab|farletuzumab|mesh-list
6010924|NCT00318370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6010925|NCT00318409|Bupropion|bupropion|mesh-list
6010926|NCT00318409|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6010927|NCT00318409|Antidepressive Agents|antidepressive agents|mesh-ancestor
6010928|NCT00318409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6010929|NCT00318409|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6010930|NCT00318409|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6010931|NCT00318409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6010932|NCT00318409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010933|NCT00318409|Dopamine Agents|dopamine agents|mesh-ancestor
6010934|NCT00318409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6010935|NCT00318409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010936|NCT00318409|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6010937|NCT00318409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6010938|NCT00318409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6010939|NCT00318461|Metformin|metformin|mesh-list
6010940|NCT00318461|Liraglutide|liraglutide|mesh-list
6010941|NCT00318461|Glimepiride|glimepiride|mesh-list
6010942|NCT00318461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6010943|NCT00318461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010944|NCT00318461|Incretins|incretins|mesh-ancestor
6010945|NCT00318461|Hormones|hormones|mesh-ancestor
6010946|NCT00318461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6010947|NCT00318461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6010948|NCT00318461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6010949|NCT00318461|Immunologic Factors|immunologic factors|mesh-ancestor
6010950|NCT00318474|Mycophenolic Acid|mycophenolic acid|mesh-list
6010951|NCT00318474|Enzyme Inhibitors|enzyme inhibitors|mesh-list
6010952|NCT00318474|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6010953|NCT00318474|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6010954|NCT00318474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6010955|NCT00318474|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6010956|NCT00318474|Antitubercular Agents|antitubercular agents|mesh-ancestor
6010957|NCT00318474|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6010958|NCT00318474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6010959|NCT00318474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010960|NCT00318474|Protease Inhibitors|protease inhibitors|mesh-ancestor
6010961|NCT00318643|Mitomycins|mitomycins|mesh-list
6010962|NCT00318643|Mitomycin|mitomycin|mesh-list
6010963|NCT00318643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6010964|NCT00318643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6010965|NCT00318643|Alkylating Agents|alkylating agents|mesh-ancestor
6010966|NCT00318643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010967|NCT00318643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6010968|NCT00318643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6010969|NCT00318708|Fluticasone|fluticasone|mesh-list
6010970|NCT00318708|Xhance|xhance|mesh-list
6010971|NCT00318708|Clarithromycin|clarithromycin|mesh-list
6010972|NCT00318708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6010973|NCT00318708|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6010974|NCT00318708|Autonomic Agents|autonomic agents|mesh-ancestor
6010975|NCT00318708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6010976|NCT00318708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010977|NCT00318708|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6010978|NCT00318708|Respiratory System Agents|respiratory system agents|mesh-ancestor
6010979|NCT00318708|Dermatologic Agents|dermatologic agents|mesh-ancestor
6010980|NCT00318708|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6010981|NCT00318708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6010982|NCT00318708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6010983|NCT00318708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6010984|NCT00318708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6010985|NCT00318708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010986|NCT00318708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6010987|NCT00318708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6010988|NCT00318812|Iron|iron|mesh-list
6010989|NCT00318812|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6010990|NCT00318812|Trace Elements|trace elements|mesh-ancestor
6010991|NCT00318812|Micronutrients|micronutrients|mesh-ancestor
6010992|NCT00318812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6010993|NCT00318812|Hematinics|hematinics|mesh-ancestor
6010994|NCT00318929|Valproic Acid|valproic acid|mesh-list
6010995|NCT00318929|Anticonvulsants|anticonvulsants|mesh-ancestor
6010996|NCT00318929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6010997|NCT00318929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6010998|NCT00318929|GABA Agents|gaba agents|mesh-ancestor
6010999|NCT00318929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6011000|NCT00318929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011001|NCT00318929|Antimanic Agents|antimanic agents|mesh-ancestor
6011002|NCT00318929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6011003|NCT00318929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6011004|NCT00318929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6011005|NCT00319020|Bosentan|bosentan|mesh-list
6011006|NCT00319020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6011007|NCT00319020|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6011008|NCT00319020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011009|NCT00319046|Miglustat|miglustat|mesh-list
6011010|NCT00319046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6011011|NCT00319046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011012|NCT00319046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6011013|NCT00319046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6011014|NCT00319046|Antiviral Agents|antiviral agents|mesh-ancestor
6011015|NCT00319046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6011016|NCT00319046|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6011017|NCT00319046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6011018|NCT00319046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011019|NCT00319111|Bosentan|bosentan|mesh-list
6011020|NCT00319111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6011021|NCT00319111|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6011022|NCT00319111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011023|NCT00319501|Diazepam|diazepam|mesh-list
6011024|NCT00319501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6011025|NCT00319501|Anticonvulsants|anticonvulsants|mesh-ancestor
6011026|NCT00319501|Antiemetics|antiemetics|mesh-ancestor
6011027|NCT00319501|Autonomic Agents|autonomic agents|mesh-ancestor
6011028|NCT00319501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6011029|NCT00319501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011030|NCT00319501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6011031|NCT00319501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6011032|NCT00319501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6011033|NCT00319501|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6011034|NCT00319501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6011035|NCT00319501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6011036|NCT00319501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6011037|NCT00319501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6011038|NCT00319501|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6011039|NCT00319501|Anesthetics, General|anesthetics, general|mesh-ancestor
6011040|NCT00319501|Anesthetics|anesthetics|mesh-ancestor
6011041|NCT00319501|GABA Modulators|gaba modulators|mesh-ancestor
6011042|NCT00319501|GABA Agents|gaba agents|mesh-ancestor
6011043|NCT00319501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6011044|NCT00319501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011045|NCT00319592|Vaccines|vaccines|mesh-list
6011046|NCT00319592|Immunologic Factors|immunologic factors|mesh-ancestor
6011047|NCT00319592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011048|NCT00319696|Bosentan|bosentan|mesh-list
6011049|NCT00319696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6011050|NCT00319696|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6018509|NCT00381303|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6011051|NCT00319696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011052|NCT00319956|Azithromycin|azithromycin|mesh-list
6011053|NCT00319956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6011054|NCT00319956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6011055|NCT00319982|Diltiazem|diltiazem|mesh-list
6011056|NCT00319982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6011057|NCT00319982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6011058|NCT00319982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6011059|NCT00319982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011060|NCT00319982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6011061|NCT00319982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011062|NCT00319982|Vasodilator Agents|vasodilator agents|mesh-ancestor
6011063|NCT00320190|Imatinib Mesylate|imatinib mesylate|mesh-list
6011064|NCT00320190|Dasatinib|dasatinib|mesh-list
6011065|NCT00320190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6011066|NCT00320190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6011067|NCT00320190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6011068|NCT00320190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011069|NCT00320216|Ustekinumab|ustekinumab|mesh-list
6011070|NCT00320216|Dermatologic Agents|dermatologic agents|mesh-ancestor
6011071|NCT00320255|Apixaban|apixaban|mesh-list
6011072|NCT00320255|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6011073|NCT00320255|Antithrombins|antithrombins|mesh-ancestor
6011074|NCT00320255|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6011075|NCT00320255|Protease Inhibitors|protease inhibitors|mesh-ancestor
6011076|NCT00320255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6011077|NCT00320255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011078|NCT00320255|Anticoagulants|anticoagulants|mesh-ancestor
6011079|NCT00320281|Botulinum Toxins|botulinum toxins|mesh-list
6011080|NCT00320281|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6011081|NCT00320281|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6011082|NCT00320281|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6011083|NCT00320281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6011084|NCT00320281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011085|NCT00320281|Cholinergic Agents|cholinergic agents|mesh-ancestor
6011086|NCT00320281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6011087|NCT00320281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011088|NCT00320281|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6011089|NCT00320281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6011090|NCT00320385|Trastuzumab|trastuzumab|mesh-list
6011091|NCT00320385|Lapatinib|lapatinib|mesh-list
6011092|NCT00320385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6011093|NCT00320385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6011094|NCT00320385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6011095|NCT00320385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6011096|NCT00320385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011097|NCT00320398|PENTA|penta|mesh-list
6011098|NCT00320398|Fondaparinux|fondaparinux|mesh-list
6011099|NCT00320398|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6011100|NCT00320398|Antithrombins|antithrombins|mesh-ancestor
6011101|NCT00320398|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6011102|NCT00320398|Protease Inhibitors|protease inhibitors|mesh-ancestor
6011103|NCT00320398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6011104|NCT00320398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011105|NCT00320398|Anticoagulants|anticoagulants|mesh-ancestor
6011106|NCT00320398|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6011107|NCT00320398|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6011108|NCT00320411|Lapatinib|lapatinib|mesh-list
6011109|NCT00320411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6011110|NCT00320411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6011111|NCT00320411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6011112|NCT00320411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011113|NCT00320424|PENTA|penta|mesh-list
6011114|NCT00320424|Fondaparinux|fondaparinux|mesh-list
6011115|NCT00320424|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6011116|NCT00320424|Antithrombins|antithrombins|mesh-ancestor
6011117|NCT00320424|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6011118|NCT00320424|Protease Inhibitors|protease inhibitors|mesh-ancestor
6011119|NCT00320424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6011120|NCT00320424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011121|NCT00320424|Anticoagulants|anticoagulants|mesh-ancestor
6011122|NCT00320424|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6011123|NCT00320424|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6011124|NCT00320489|Olanzapine|olanzapine|mesh-list
6011125|NCT00320489|Antiemetics|antiemetics|mesh-ancestor
6011126|NCT00320489|Autonomic Agents|autonomic agents|mesh-ancestor
6011127|NCT00320489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6011128|NCT00320489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011129|NCT00320489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6011130|NCT00320489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6011131|NCT00320489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6011132|NCT00320489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6011133|NCT00320489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6011134|NCT00320489|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6011135|NCT00320489|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6011136|NCT00320489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6011137|NCT00320489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011138|NCT00320489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6011139|NCT00320489|Serotonin Agents|serotonin agents|mesh-ancestor
6011140|NCT00320515|Pemetrexed|pemetrexed|mesh-list
6011141|NCT00320515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6011142|NCT00320515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6011143|NCT00320515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011144|NCT00320515|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6011145|NCT00320515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6011146|NCT00320528|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6011147|NCT00320528|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6011148|NCT00320528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6011149|NCT00320528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6011150|NCT00320528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011151|NCT00320528|Adrenergic Agents|adrenergic agents|mesh-ancestor
6011152|NCT00320528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6011153|NCT00320528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011154|NCT00320541|Gemcitabine|gemcitabine|mesh-list
6011155|NCT00320541|Paclitaxel|paclitaxel|mesh-list
6011156|NCT00320541|Bevacizumab|bevacizumab|mesh-list
6011157|NCT00320541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6011158|NCT00320541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6011159|NCT00320541|Tubulin Modulators|tubulin modulators|mesh-ancestor
6011160|NCT00320541|Antimitotic Agents|antimitotic agents|mesh-ancestor
6011161|NCT00320541|Mitosis Modulators|mitosis modulators|mesh-ancestor
6011162|NCT00320541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011163|NCT00320541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6011164|NCT00320541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6011165|NCT00320541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6011166|NCT00320541|Growth Substances|growth substances|mesh-ancestor
6011167|NCT00320541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011168|NCT00320541|Growth Inhibitors|growth inhibitors|mesh-ancestor
6011169|NCT00320541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6011170|NCT00320541|Antimetabolites|antimetabolites|mesh-ancestor
6011171|NCT00320541|Antiviral Agents|antiviral agents|mesh-ancestor
6011172|NCT00320541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6011173|NCT00320541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6011174|NCT00320541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6011175|NCT00320541|Immunologic Factors|immunologic factors|mesh-ancestor
6011176|NCT00320671|Risperidone|risperidone|mesh-list
6011177|NCT00320671|Aripiprazole|aripiprazole|mesh-list
6011178|NCT00320671|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6011179|NCT00320671|Serotonin Agents|serotonin agents|mesh-ancestor
6011180|NCT00320671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6011181|NCT00320671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011182|NCT00320671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011183|NCT00320671|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6011184|NCT00320671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6011185|NCT00320671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6011186|NCT00320671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6011187|NCT00320671|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6011188|NCT00320671|Dopamine Agents|dopamine agents|mesh-ancestor
6011189|NCT00320671|Antidepressive Agents|antidepressive agents|mesh-ancestor
6011190|NCT00320671|Dopamine Agonists|dopamine agonists|mesh-ancestor
6011191|NCT00320671|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6011192|NCT00320671|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6011193|NCT00320671|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6011194|NCT00320671|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6011195|NCT00320710|Zoledronic Acid|zoledronic acid|mesh-list
6011196|NCT00320710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6011197|NCT00320710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011198|NCT00320749|Gemcitabine|gemcitabine|mesh-list
6011199|NCT00320749|Capecitabine|capecitabine|mesh-list
6011200|NCT00320749|Docetaxel|docetaxel|mesh-list
6011201|NCT00320749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6011202|NCT00320749|Antimetabolites|antimetabolites|mesh-ancestor
6011203|NCT00320749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261278|NCT03202550|Antiemetics|antiemetics|mesh-ancestor
6261279|NCT03202550|Autonomic Agents|autonomic agents|mesh-ancestor
6261280|NCT03202550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6261281|NCT03202550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6261282|NCT03202550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6261283|NCT03202550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6261284|NCT03202550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6261285|NCT03202550|GABA Modulators|gaba modulators|mesh-ancestor
6261286|NCT03202550|GABA Agents|gaba agents|mesh-ancestor
6261287|NCT03202550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6261288|NCT03202550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261289|NCT03203447|Triamcinolone|triamcinolone|mesh-list
6261290|NCT03203447|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6261291|NCT03203447|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6261292|NCT03203447|Bevacizumab|bevacizumab|mesh-list
6261293|NCT03203447|Ranibizumab|ranibizumab|mesh-list
6261294|NCT03203447|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6261295|NCT03203447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6261296|NCT03203447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6261297|NCT03203447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6261298|NCT03203447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6261299|NCT03203447|Growth Substances|growth substances|mesh-ancestor
6261300|NCT03203447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261301|NCT03203447|Growth Inhibitors|growth inhibitors|mesh-ancestor
6261302|NCT03203447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6011204|NCT00320749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6011205|NCT00320749|Antiviral Agents|antiviral agents|mesh-ancestor
6011206|NCT00320749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6011207|NCT00320749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6011208|NCT00320749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6011209|NCT00320749|Immunologic Factors|immunologic factors|mesh-ancestor
6011210|NCT00320749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011211|NCT00320749|Tubulin Modulators|tubulin modulators|mesh-ancestor
6011212|NCT00320749|Antimitotic Agents|antimitotic agents|mesh-ancestor
6011213|NCT00320749|Mitosis Modulators|mitosis modulators|mesh-ancestor
6261303|NCT03203447|Glucocorticoids|glucocorticoids|mesh-ancestor
6261304|NCT03203447|Hormones|hormones|mesh-ancestor
6011214|NCT00320788|Aflibercept|aflibercept|mesh-list
6011215|NCT00320788|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6011216|NCT00320788|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6011217|NCT00320788|Growth Substances|growth substances|mesh-ancestor
6011218|NCT00320788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011219|NCT00320788|Growth Inhibitors|growth inhibitors|mesh-ancestor
6011220|NCT00320788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6011221|NCT00320801|Buprenorphine|buprenorphine|mesh-list
6011222|NCT00320801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6011223|NCT00320801|Narcotics|narcotics|mesh-ancestor
6011224|NCT00320801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6011225|NCT00320801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011226|NCT00320801|Analgesics|analgesics|mesh-ancestor
6011227|NCT00320801|Sensory System Agents|sensory system agents|mesh-ancestor
6011228|NCT00320801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6011229|NCT00320801|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6011230|NCT00321464|Zoledronic Acid|zoledronic acid|mesh-list
6011231|NCT00321464|Denosumab|denosumab|mesh-list
6011232|NCT00321464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6011233|NCT00321464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018369|NCT00379834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6018370|NCT00379834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018371|NCT00379834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6018372|NCT00379834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6018373|NCT00379834|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6018374|NCT00379834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6018375|NCT00379899|Vitamin D|vitamin d|mesh-list
6018376|NCT00379899|Cinacalcet|cinacalcet|mesh-list
6018377|NCT00379899|Vitamins|vitamins|mesh-ancestor
6018378|NCT00379899|Micronutrients|micronutrients|mesh-ancestor
6018379|NCT00379899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018380|NCT00379899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6018381|NCT00379899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6018382|NCT00379899|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6018383|NCT00379899|Hormone Antagonists|hormone antagonists|mesh-ancestor
6018384|NCT00379899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6018385|NCT00379912|Azacitidine|azacitidine|mesh-list
6018386|NCT00379912|Epoetin Alfa|epoetin alfa|mesh-list
6018387|NCT00379912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6018388|NCT00379912|Antimetabolites|antimetabolites|mesh-ancestor
6018389|NCT00379912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6018390|NCT00379912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6018391|NCT00379912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6018392|NCT00379912|Hematinics|hematinics|mesh-ancestor
6018393|NCT00380029|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6018394|NCT00380029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6018395|NCT00380029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6018396|NCT00380029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6018397|NCT00380029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011234|NCT00321555|Immunotoxins|immunotoxins|mesh-list
6011235|NCT00321555|Immunologic Factors|immunologic factors|mesh-ancestor
6011236|NCT00321555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011237|NCT00321594|Belinostat|belinostat|mesh-list
6011238|NCT00321594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6011239|NCT00321594|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6011240|NCT00321594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6011241|NCT00321594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011242|NCT00321620|Zoledronic Acid|zoledronic acid|mesh-list
6011243|NCT00321620|Denosumab|denosumab|mesh-list
6011244|NCT00321620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6011245|NCT00321620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011246|NCT00321646|Bevacizumab|bevacizumab|mesh-list
6011247|NCT00321646|Docetaxel|docetaxel|mesh-list
6011248|NCT00321646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6011249|NCT00321646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6011250|NCT00321646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6011251|NCT00321646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6011252|NCT00321646|Growth Substances|growth substances|mesh-ancestor
6011253|NCT00321646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011254|NCT00321646|Growth Inhibitors|growth inhibitors|mesh-ancestor
6011255|NCT00321646|Tubulin Modulators|tubulin modulators|mesh-ancestor
6011256|NCT00321646|Antimitotic Agents|antimitotic agents|mesh-ancestor
6011257|NCT00321646|Mitosis Modulators|mitosis modulators|mesh-ancestor
6011258|NCT00321646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011259|NCT00321672|Capsaicin|capsaicin|mesh-list
6011260|NCT00321672|Antipruritics|antipruritics|mesh-ancestor
6011261|NCT00321672|Dermatologic Agents|dermatologic agents|mesh-ancestor
6011262|NCT00321672|Sensory System Agents|sensory system agents|mesh-ancestor
6011263|NCT00321672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6011264|NCT00321672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011265|NCT00321685|Calcium, Dietary|calcium, dietary|mesh-list
6011266|NCT00321685|Leucovorin|leucovorin|mesh-list
6011267|NCT00321685|Folic Acid|folic acid|mesh-list
6011268|NCT00321685|Bevacizumab|bevacizumab|mesh-list
6011269|NCT00321685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6011270|NCT00321685|Fluorouracil|fluorouracil|mesh-list
6011271|NCT00321685|Capecitabine|capecitabine|mesh-list
6011272|NCT00321685|Oxaliplatin|oxaliplatin|mesh-list
6011273|NCT00321685|Endothelial Growth Factors|endothelial growth factors|mesh-list
6011274|NCT00321685|Antibodies|antibodies|mesh-list
6011275|NCT00321685|Immunoglobulins|immunoglobulins|mesh-list
6011276|NCT00321685|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6011277|NCT00321685|Immunoglobulin G|immunoglobulin g|mesh-list
6011278|NCT00321685|Calcium|calcium|mesh-list
6011279|NCT00321685|Levoleucovorin|levoleucovorin|mesh-list
6011280|NCT00321685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6011281|NCT00321685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6011282|NCT00321685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6011283|NCT00321685|Growth Substances|growth substances|mesh-ancestor
6011284|NCT00321685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011285|NCT00321685|Growth Inhibitors|growth inhibitors|mesh-ancestor
6011286|NCT00321685|Immunologic Factors|immunologic factors|mesh-ancestor
6011287|NCT00321685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6011288|NCT00321685|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6011289|NCT00321685|Antimetabolites|antimetabolites|mesh-ancestor
6011290|NCT00321685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011291|NCT00321685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6011292|NCT00321685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6011293|NCT00321685|Antidotes|antidotes|mesh-ancestor
6011294|NCT00321685|Protective Agents|protective agents|mesh-ancestor
6011295|NCT00321685|Vitamin B Complex|vitamin b complex|mesh-ancestor
6011296|NCT00321685|Vitamins|vitamins|mesh-ancestor
6011297|NCT00321685|Micronutrients|micronutrients|mesh-ancestor
6011298|NCT00321685|Hematinics|hematinics|mesh-ancestor
6011299|NCT00321698|Docetaxel|docetaxel|mesh-list
6011300|NCT00321698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6011301|NCT00321698|Tubulin Modulators|tubulin modulators|mesh-ancestor
6011302|NCT00321698|Antimitotic Agents|antimitotic agents|mesh-ancestor
6011303|NCT00321698|Mitosis Modulators|mitosis modulators|mesh-ancestor
6011304|NCT00321698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011305|NCT00321711|Azacitidine|azacitidine|mesh-list
6011306|NCT00321711|Decitabine|decitabine|mesh-list
6011307|NCT00321711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6011308|NCT00321711|Antimetabolites|antimetabolites|mesh-ancestor
6011309|NCT00321711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011310|NCT00321711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6011311|NCT00321711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6011312|NCT00321737|Dexlansoprazole|dexlansoprazole|mesh-list
6011313|NCT00321737|Lansoprazole|lansoprazole|mesh-list
6011314|NCT00321737|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6011315|NCT00321737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6011316|NCT00321737|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6011317|NCT00321737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6011318|NCT00321737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011319|NCT00321828|Leucovorin|leucovorin|mesh-list
6011320|NCT00321828|Bevacizumab|bevacizumab|mesh-list
6011321|NCT00321828|Fluorouracil|fluorouracil|mesh-list
6011322|NCT00321828|Oxaliplatin|oxaliplatin|mesh-list
6011323|NCT00321828|Levoleucovorin|levoleucovorin|mesh-list
6011324|NCT00321828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6011325|NCT00321828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6011326|NCT00321828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6011327|NCT00321828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6011328|NCT00321828|Growth Substances|growth substances|mesh-ancestor
6011329|NCT00321828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011330|NCT00321828|Growth Inhibitors|growth inhibitors|mesh-ancestor
6011331|NCT00321828|Antimetabolites|antimetabolites|mesh-ancestor
6011332|NCT00321828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011333|NCT00321828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6011334|NCT00321828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6011335|NCT00321828|Immunologic Factors|immunologic factors|mesh-ancestor
6011336|NCT00321828|Antidotes|antidotes|mesh-ancestor
6011337|NCT00321828|Protective Agents|protective agents|mesh-ancestor
6011338|NCT00321828|Vitamin B Complex|vitamin b complex|mesh-ancestor
6011339|NCT00321828|Vitamins|vitamins|mesh-ancestor
6011340|NCT00321828|Micronutrients|micronutrients|mesh-ancestor
6011341|NCT00321854|Pramipexole|pramipexole|mesh-list
6011342|NCT00321854|Antioxidants|antioxidants|mesh-ancestor
6011343|NCT00321854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011344|NCT00321854|Protective Agents|protective agents|mesh-ancestor
6011345|NCT00321854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011346|NCT00321854|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6011347|NCT00321854|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6011348|NCT00321854|Dopamine Agonists|dopamine agonists|mesh-ancestor
6011349|NCT00321854|Dopamine Agents|dopamine agents|mesh-ancestor
6011350|NCT00321854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6011351|NCT00321893|Budesonide|budesonide|mesh-list
6011352|NCT00321893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6011353|NCT00321893|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6011354|NCT00321893|Autonomic Agents|autonomic agents|mesh-ancestor
6011355|NCT00321893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6011356|NCT00321893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011357|NCT00321893|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6011358|NCT00321893|Respiratory System Agents|respiratory system agents|mesh-ancestor
6011359|NCT00321893|Glucocorticoids|glucocorticoids|mesh-ancestor
6011360|NCT00321893|Hormones|hormones|mesh-ancestor
6018398|NCT00380068|Ambrisentan|ambrisentan|mesh-list
6011361|NCT00321893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6011362|NCT00321906|Sirolimus|sirolimus|mesh-list
6011363|NCT00321906|Azathioprine|azathioprine|mesh-list
6011364|NCT00321906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6011365|NCT00321906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6011366|NCT00321906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6011367|NCT00321906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6011368|NCT00321906|Antifungal Agents|antifungal agents|mesh-ancestor
6011369|NCT00321906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6011370|NCT00321906|Immunologic Factors|immunologic factors|mesh-ancestor
6011371|NCT00321906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011372|NCT00321906|Antimetabolites|antimetabolites|mesh-ancestor
6011373|NCT00321906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011374|NCT00321906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6011375|NCT00321906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6011376|NCT00321919|Epoetin Alfa|epoetin alfa|mesh-list
6011377|NCT00321919|Hematinics|hematinics|mesh-ancestor
6011378|NCT00321932|Calcium, Dietary|calcium, dietary|mesh-list
6011379|NCT00321932|Cholecalciferol|cholecalciferol|mesh-list
6011380|NCT00321932|Zoledronic Acid|zoledronic acid|mesh-list
6011381|NCT00321932|Calcium Carbonate|calcium carbonate|mesh-list
6011382|NCT00321932|Calcium|calcium|mesh-list
6011383|NCT00321932|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6011384|NCT00321932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011385|NCT00321932|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6011386|NCT00321932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011387|NCT00321932|Vitamins|vitamins|mesh-ancestor
6011388|NCT00321932|Micronutrients|micronutrients|mesh-ancestor
6011389|NCT00321932|Antacids|antacids|mesh-ancestor
6011390|NCT00321932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6011391|NCT00321984|Dexlansoprazole|dexlansoprazole|mesh-list
6011392|NCT00321984|Lansoprazole|lansoprazole|mesh-list
6011393|NCT00321984|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6011394|NCT00321984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6011395|NCT00321984|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6011396|NCT00321984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6011397|NCT00321984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011398|NCT00322049|Vaccines|vaccines|mesh-list
6011399|NCT00322049|Immunologic Factors|immunologic factors|mesh-ancestor
6011400|NCT00322049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011401|NCT00322101|Cyclosporine|cyclosporine|mesh-list
6011402|NCT00322101|Mycophenolic Acid|mycophenolic acid|mesh-list
6011403|NCT00322101|Cyclophosphamide|cyclophosphamide|mesh-list
6011404|NCT00322101|Busulfan|busulfan|mesh-list
6011405|NCT00322101|Methotrexate|methotrexate|mesh-list
6011406|NCT00322101|Fludarabine|fludarabine|mesh-list
6011407|NCT00322101|Fludarabine phosphate|fludarabine phosphate|mesh-list
6011408|NCT00322101|Tacrolimus|tacrolimus|mesh-list
6011409|NCT00322101|Cyclosporins|cyclosporins|mesh-list
6011410|NCT00322101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6011411|NCT00322101|Immunologic Factors|immunologic factors|mesh-ancestor
6011412|NCT00322101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011413|NCT00322101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6011414|NCT00322101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6011415|NCT00322101|Alkylating Agents|alkylating agents|mesh-ancestor
6011416|NCT00322101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011417|NCT00322101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6011418|NCT00322101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6011419|NCT00322101|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6011420|NCT00322101|Abortifacient Agents|abortifacient agents|mesh-ancestor
6011421|NCT00322101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6011422|NCT00322101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6011423|NCT00322101|Antimetabolites|antimetabolites|mesh-ancestor
6011424|NCT00322101|Dermatologic Agents|dermatologic agents|mesh-ancestor
6011425|NCT00322101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6011426|NCT00322101|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6011427|NCT00322101|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6011428|NCT00322101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6011429|NCT00322101|Antifungal Agents|antifungal agents|mesh-ancestor
6011430|NCT00322101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6011431|NCT00322101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6011432|NCT00322101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6011433|NCT00322101|Antitubercular Agents|antitubercular agents|mesh-ancestor
6011434|NCT00322101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6011435|NCT00322153|Memantine|memantine|mesh-list
6011436|NCT00322153|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6011437|NCT00322153|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6011438|NCT00322153|Dopamine Agents|dopamine agents|mesh-ancestor
6011439|NCT00322153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6011440|NCT00322153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011441|NCT00322153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011442|NCT00322153|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6011443|NCT00322153|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6011444|NCT00322309|Mirtazapine|mirtazapine|mesh-list
6011445|NCT00322309|Antidepressive Agents|antidepressive agents|mesh-ancestor
6011446|NCT00322309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6011447|NCT00322309|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6011448|NCT00322309|Histamine Antagonists|histamine antagonists|mesh-ancestor
6011449|NCT00322309|Histamine Agents|histamine agents|mesh-ancestor
6011450|NCT00322309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6011451|NCT00322309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011452|NCT00322309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011453|NCT00322309|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6011454|NCT00322309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6011455|NCT00322309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6011456|NCT00322309|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6011457|NCT00322309|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6011458|NCT00322309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6011459|NCT00322309|Adrenergic Agents|adrenergic agents|mesh-ancestor
6011460|NCT00322309|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6011461|NCT00322309|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6011462|NCT00322309|Serotonin Agents|serotonin agents|mesh-ancestor
6011463|NCT00322309|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6011464|NCT00322335|PENTA|penta|mesh-list
6011465|NCT00322335|Anticoagulants|anticoagulants|mesh-ancestor
6011466|NCT00322335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6011467|NCT00322335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6011468|NCT00322335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011469|NCT00322348|Goserelin|goserelin|mesh-list
6011470|NCT00322348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6011471|NCT00322348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6011472|NCT00322374|Epirubicin|epirubicin|mesh-list
6011473|NCT00322374|Epothilones|epothilones|mesh-list
6011474|NCT00322374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6011475|NCT00322374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6011476|NCT00322374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6011477|NCT00322374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6011478|NCT00322374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6011479|NCT00322374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011480|NCT00322374|Tubulin Modulators|tubulin modulators|mesh-ancestor
6011481|NCT00322374|Antimitotic Agents|antimitotic agents|mesh-ancestor
6011482|NCT00322374|Mitosis Modulators|mitosis modulators|mesh-ancestor
6011483|NCT00322387|Plerixafor|plerixafor|mesh-list
6011484|NCT00322387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6011485|NCT00322387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6011486|NCT00322387|Antiviral Agents|antiviral agents|mesh-ancestor
6011487|NCT00322387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6011488|NCT00322439|Etanercept|etanercept|mesh-list
6011489|NCT00322439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6011490|NCT00322439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6011491|NCT00322439|Analgesics|analgesics|mesh-ancestor
6011492|NCT00322439|Sensory System Agents|sensory system agents|mesh-ancestor
6011493|NCT00322439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6011494|NCT00322439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011495|NCT00322439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6011496|NCT00322439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6011497|NCT00322439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6011498|NCT00322439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6011499|NCT00322439|Immunologic Factors|immunologic factors|mesh-ancestor
6011500|NCT00322452|Paclitaxel|paclitaxel|mesh-list
6011501|NCT00322452|Carboplatin|carboplatin|mesh-list
6011502|NCT00322452|Gefitinib|gefitinib|mesh-list
6011503|NCT00322452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6011504|NCT00322452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6011505|NCT00322452|Tubulin Modulators|tubulin modulators|mesh-ancestor
6011506|NCT00322452|Antimitotic Agents|antimitotic agents|mesh-ancestor
6011507|NCT00322452|Mitosis Modulators|mitosis modulators|mesh-ancestor
6011508|NCT00322452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011509|NCT00322452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6011510|NCT00322452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6011511|NCT00322465|Azithromycin|azithromycin|mesh-list
6011512|NCT00322465|Doxycycline|doxycycline|mesh-list
6011513|NCT00322465|Tinidazole|tinidazole|mesh-list
6011514|NCT00322465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6011515|NCT00322465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6011516|NCT00322465|Antimalarials|antimalarials|mesh-ancestor
6011517|NCT00322465|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6011518|NCT00322465|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6011519|NCT00322465|Alkylating Agents|alkylating agents|mesh-ancestor
6011520|NCT00322465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011521|NCT00322465|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
6011522|NCT00322491|Plerixafor|plerixafor|mesh-list
6011523|NCT00322491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6011524|NCT00322491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6011525|NCT00322491|Antiviral Agents|antiviral agents|mesh-ancestor
6011526|NCT00322491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6011527|NCT00322556|Immunoglobulins|immunoglobulins|mesh-list
6011528|NCT00322556|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6011529|NCT00322556|Antibodies|antibodies|mesh-list
6011530|NCT00322556|Immunologic Factors|immunologic factors|mesh-ancestor
6011531|NCT00322556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011532|NCT00322621|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6011533|NCT00322621|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6011534|NCT00322621|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6011535|NCT00322621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6011536|NCT00322621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011537|NCT00322621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6011538|NCT00322621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011539|NCT00322621|Analgesics|analgesics|mesh-ancestor
6011540|NCT00322621|Sensory System Agents|sensory system agents|mesh-ancestor
6011541|NCT00322621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6011542|NCT00322621|Antidepressive Agents|antidepressive agents|mesh-ancestor
6011543|NCT00322621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6011544|NCT00322621|Dopamine Agents|dopamine agents|mesh-ancestor
6011545|NCT00322842|Plerixafor|plerixafor|mesh-list
6011546|NCT00322842|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6011547|NCT00322842|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6011548|NCT00322842|Antiviral Agents|antiviral agents|mesh-ancestor
6011549|NCT00322842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6011550|NCT00322868|Pioglitazone|pioglitazone|mesh-list
6011551|NCT00322868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6011552|NCT00322868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011553|NCT00322881|Paclitaxel|paclitaxel|mesh-list
6011554|NCT00322881|Carboplatin|carboplatin|mesh-list
6011555|NCT00322881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6011556|NCT00322881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6011557|NCT00322881|Tubulin Modulators|tubulin modulators|mesh-ancestor
6011558|NCT00322881|Antimitotic Agents|antimitotic agents|mesh-ancestor
6011559|NCT00322881|Mitosis Modulators|mitosis modulators|mesh-ancestor
6011560|NCT00322881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011561|NCT00323063|Gemcitabine|gemcitabine|mesh-list
6011562|NCT00323063|Imatinib Mesylate|imatinib mesylate|mesh-list
6011563|NCT00323063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6011564|NCT00323063|Antimetabolites|antimetabolites|mesh-ancestor
6011565|NCT00323063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011566|NCT00323063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6011567|NCT00323063|Antiviral Agents|antiviral agents|mesh-ancestor
6011568|NCT00323063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6011569|NCT00323063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6011570|NCT00323063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6011571|NCT00323063|Immunologic Factors|immunologic factors|mesh-ancestor
6011572|NCT00323063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011573|NCT00323063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6011574|NCT00323115|Temozolomide|temozolomide|mesh-list
6011575|NCT00323115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6011576|NCT00323115|Alkylating Agents|alkylating agents|mesh-ancestor
6011577|NCT00323115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011578|NCT00323115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6261305|NCT03203447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6261306|NCT03203447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6261307|NCT03203447|Immunologic Factors|immunologic factors|mesh-ancestor
6261308|NCT03203447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6261309|NCT03203447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261310|NCT03203681|Methyltestosterone|methyltestosterone|mesh-list
6261311|NCT03203681|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6261312|NCT03203681|Testosterone|testosterone|mesh-list
6261313|NCT03203681|Testosterone undecanoate|testosterone undecanoate|mesh-list
6261314|NCT03203681|Testosterone enanthate|testosterone enanthate|mesh-list
6261315|NCT03203681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6261316|NCT03203681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6261317|NCT03203681|Anabolic Agents|anabolic agents|mesh-ancestor
6261318|NCT03203681|Hormones|hormones|mesh-ancestor
6261319|NCT03203681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6261320|NCT03203681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261321|NCT03203681|Androgens|androgens|mesh-ancestor
6261322|NCT03204279|Palonosetron|palonosetron|mesh-list
6261323|NCT03204279|Antiemetics|antiemetics|mesh-ancestor
6261324|NCT03204279|Autonomic Agents|autonomic agents|mesh-ancestor
6261325|NCT03204279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6261326|NCT03204279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261327|NCT03204279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6396856|NCT00209794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6011579|NCT00323297|Bosentan|bosentan|mesh-list
6011580|NCT00323297|Sildenafil Citrate|sildenafil citrate|mesh-list
6011581|NCT00323297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011582|NCT00323297|Vasodilator Agents|vasodilator agents|mesh-ancestor
6011583|NCT00323297|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6011584|NCT00323297|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6011585|NCT00323297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6011586|NCT00323297|Urological Agents|urological agents|mesh-ancestor
6011587|NCT00323297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6011588|NCT00323297|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6011589|NCT00323362|Gemcitabine|gemcitabine|mesh-list
6011590|NCT00323362|Imatinib Mesylate|imatinib mesylate|mesh-list
6011591|NCT00323362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6011592|NCT00323362|Antimetabolites|antimetabolites|mesh-ancestor
6011593|NCT00323362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011594|NCT00323362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6011595|NCT00323362|Antiviral Agents|antiviral agents|mesh-ancestor
6011596|NCT00323362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6011597|NCT00323362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6011598|NCT00323362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6011599|NCT00323362|Immunologic Factors|immunologic factors|mesh-ancestor
6011600|NCT00323362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011601|NCT00323362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6011602|NCT00323479|Anastrozole|anastrozole|mesh-list
6011603|NCT00323479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6011604|NCT00323479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6011605|NCT00323479|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6011606|NCT00323479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6011607|NCT00323479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6011608|NCT00323479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011609|NCT00323479|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6011610|NCT00323479|Hormone Antagonists|hormone antagonists|mesh-ancestor
6011611|NCT00323479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6011612|NCT00323479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011613|NCT00323492|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6011614|NCT00323492|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6011615|NCT00323492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6011616|NCT00323492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6011617|NCT00323492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011618|NCT00323492|Antiviral Agents|antiviral agents|mesh-ancestor
6011619|NCT00323492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6011620|NCT00323492|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6011621|NCT00323492|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6011622|NCT00323557|Molgramostim|molgramostim|mesh-list
6011623|NCT00323557|Sargramostim|sargramostim|mesh-list
6011624|NCT00323557|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6011625|NCT00323557|Immunologic Factors|immunologic factors|mesh-ancestor
6011626|NCT00323557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011627|NCT00323557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6011628|NCT00323622|Pyrimethamine|pyrimethamine|mesh-list
6011629|NCT00323622|Sulfadoxine|sulfadoxine|mesh-list
6011630|NCT00323622|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6011631|NCT00323622|Amodiaquine|amodiaquine|mesh-list
6011632|NCT00323622|Vaccines|vaccines|mesh-list
6011633|NCT00323622|Immunologic Factors|immunologic factors|mesh-ancestor
6011634|NCT00323622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011635|NCT00323622|Antimalarials|antimalarials|mesh-ancestor
6011636|NCT00323622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6011637|NCT00323622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6011638|NCT00323622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6011639|NCT00323622|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6011640|NCT00323622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6018510|NCT00381303|Antiviral Agents|antiviral agents|mesh-ancestor
6011641|NCT00323622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011642|NCT00323622|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6011643|NCT00323622|Renal Agents|renal agents|mesh-ancestor
6011644|NCT00323739|Bevacizumab|bevacizumab|mesh-list
6011645|NCT00323739|Everolimus|everolimus|mesh-list
6011646|NCT00323739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6011647|NCT00323739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6011648|NCT00323739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6011649|NCT00323739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6011650|NCT00323739|Growth Substances|growth substances|mesh-ancestor
6011651|NCT00323739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011652|NCT00323739|Growth Inhibitors|growth inhibitors|mesh-ancestor
6011653|NCT00323739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6011654|NCT00323739|Immunologic Factors|immunologic factors|mesh-ancestor
6011655|NCT00323869|Gemcitabine|gemcitabine|mesh-list
6011656|NCT00323869|Bevacizumab|bevacizumab|mesh-list
6011657|NCT00323869|Carboplatin|carboplatin|mesh-list
6011658|NCT00323869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6011659|NCT00323869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6011660|NCT00323869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6011661|NCT00323869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6011662|NCT00323869|Growth Substances|growth substances|mesh-ancestor
6011663|NCT00323869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011664|NCT00323869|Growth Inhibitors|growth inhibitors|mesh-ancestor
6011665|NCT00323869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6011666|NCT00323869|Antimetabolites|antimetabolites|mesh-ancestor
6011667|NCT00323869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011668|NCT00323869|Antiviral Agents|antiviral agents|mesh-ancestor
6011669|NCT00323869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6011670|NCT00323869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6011671|NCT00323869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6011672|NCT00323869|Immunologic Factors|immunologic factors|mesh-ancestor
6011673|NCT00323882|Ipilimumab|ipilimumab|mesh-list
6011674|NCT00323882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6011675|NCT00323882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6011676|NCT00323882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6011677|NCT00323882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011678|NCT00324038|Acetaminophen|acetaminophen|mesh-list
6011679|NCT00324038|Buprenorphine|buprenorphine|mesh-list
6011680|NCT00324038|Codeine|codeine|mesh-list
6011681|NCT00324038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6011682|NCT00324038|Analgesics|analgesics|mesh-ancestor
6011683|NCT00324038|Sensory System Agents|sensory system agents|mesh-ancestor
6011684|NCT00324038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6011685|NCT00324038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011686|NCT00324038|Antipyretics|antipyretics|mesh-ancestor
6011687|NCT00324038|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6011688|NCT00324038|Narcotics|narcotics|mesh-ancestor
6011689|NCT00324038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6011690|NCT00324038|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6011691|NCT00324038|Antitussive Agents|antitussive agents|mesh-ancestor
6011692|NCT00324038|Respiratory System Agents|respiratory system agents|mesh-ancestor
6011693|NCT00324155|Ipilimumab|ipilimumab|mesh-list
6011694|NCT00324155|Dacarbazine|dacarbazine|mesh-list
6011695|NCT00324155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6011696|NCT00324155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6011697|NCT00324155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6011698|NCT00324155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011699|NCT00324155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6011700|NCT00324155|Alkylating Agents|alkylating agents|mesh-ancestor
6011701|NCT00324168|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6011702|NCT00324168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6011703|NCT00324259|Estradiol|estradiol|mesh-list
6011704|NCT00324259|Estrogens|estrogens|mesh-ancestor
6011705|NCT00324259|Hormones|hormones|mesh-ancestor
6011706|NCT00324259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6011707|NCT00324259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011708|NCT00324272|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6011709|NCT00324272|Hemostatics|hemostatics|mesh-ancestor
6011710|NCT00324272|Coagulants|coagulants|mesh-ancestor
6011711|NCT00324350|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6011712|NCT00324350|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
6011713|NCT00324350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011714|NCT00324350|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6011715|NCT00324350|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6011716|NCT00324350|Antimetabolites|antimetabolites|mesh-ancestor
6011717|NCT00324350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011718|NCT00324350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6011719|NCT00324350|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6011720|NCT00324415|Fluorouracil|fluorouracil|mesh-list
6011721|NCT00324415|Cetuximab|cetuximab|mesh-list
6011722|NCT00324415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6011723|NCT00324415|Antimetabolites|antimetabolites|mesh-ancestor
6011724|NCT00324415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011725|NCT00324415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6011726|NCT00324415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6011727|NCT00324415|Immunologic Factors|immunologic factors|mesh-ancestor
6011728|NCT00324415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011729|NCT00324415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6011730|NCT00324649|Lamivudine|lamivudine|mesh-list
6011731|NCT00324649|Zidovudine|zidovudine|mesh-list
6011732|NCT00324649|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6011733|NCT00324649|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6011734|NCT00324649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6011735|NCT00324649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6011736|NCT00324649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011737|NCT00324649|Antiviral Agents|antiviral agents|mesh-ancestor
6011738|NCT00324649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6011739|NCT00324649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6011740|NCT00324649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6011741|NCT00324649|Antimetabolites|antimetabolites|mesh-ancestor
6011742|NCT00324675|Rosiglitazone|rosiglitazone|mesh-list
6011743|NCT00324675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6011744|NCT00324675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011745|NCT00324740|Vorinostat|vorinostat|mesh-list
6011746|NCT00324740|Isotretinoin|isotretinoin|mesh-list
6011747|NCT00324740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6011748|NCT00324740|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6011749|NCT00324740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6011750|NCT00324740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011751|NCT00324740|Dermatologic Agents|dermatologic agents|mesh-ancestor
6011752|NCT00324870|Bevacizumab|bevacizumab|mesh-list
6011753|NCT00324870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6011754|NCT00324870|Vorinostat|vorinostat|mesh-list
6011755|NCT00324870|Antibodies|antibodies|mesh-list
6011756|NCT00324870|Immunoglobulins|immunoglobulins|mesh-list
6011757|NCT00324870|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6011758|NCT00324870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6011759|NCT00324870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6011760|NCT00324870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6011761|NCT00324870|Growth Substances|growth substances|mesh-ancestor
6011762|NCT00324870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011763|NCT00324870|Growth Inhibitors|growth inhibitors|mesh-ancestor
6011764|NCT00324870|Immunologic Factors|immunologic factors|mesh-ancestor
6011765|NCT00324870|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6011766|NCT00324870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6011767|NCT00324870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011768|NCT00324896|Eszopiclone|eszopiclone|mesh-list
6011769|NCT00324896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6011770|NCT00324896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6011771|NCT00324896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011772|NCT00324961|Adefovir|adefovir|mesh-list
6011773|NCT00324961|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6011774|NCT00324961|Antiviral Agents|antiviral agents|mesh-ancestor
6011775|NCT00324961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6011776|NCT00324961|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6011777|NCT00324961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6011778|NCT00324961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6011779|NCT00324961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011780|NCT00324987|Bevacizumab|bevacizumab|mesh-list
6011781|NCT00324987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6011782|NCT00324987|Imatinib Mesylate|imatinib mesylate|mesh-list
6011783|NCT00324987|Endothelial Growth Factors|endothelial growth factors|mesh-list
6011784|NCT00324987|Antibodies|antibodies|mesh-list
6011785|NCT00324987|Immunoglobulins|immunoglobulins|mesh-list
6011786|NCT00324987|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6011787|NCT00324987|Immunoglobulin G|immunoglobulin g|mesh-list
6011788|NCT00324987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6011789|NCT00324987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6011790|NCT00324987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6011791|NCT00324987|Growth Substances|growth substances|mesh-ancestor
6011792|NCT00324987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011793|NCT00324987|Growth Inhibitors|growth inhibitors|mesh-ancestor
6011794|NCT00324987|Immunologic Factors|immunologic factors|mesh-ancestor
6011795|NCT00324987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6011796|NCT00324987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6011797|NCT00324987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011798|NCT00325078|Infliximab|infliximab|mesh-list
6011799|NCT00325078|Dermatologic Agents|dermatologic agents|mesh-ancestor
6011800|NCT00325078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6011801|NCT00325078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6011802|NCT00325143|Edetic Acid|edetic acid|mesh-list
6011803|NCT00325143|Pentetic Acid|pentetic acid|mesh-list
6011804|NCT00325143|Antidotes|antidotes|mesh-ancestor
6011805|NCT00325143|Protective Agents|protective agents|mesh-ancestor
6011806|NCT00325143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011807|NCT00325143|Chelating Agents|chelating agents|mesh-ancestor
6011808|NCT00325143|Sequestering Agents|sequestering agents|mesh-ancestor
6011809|NCT00325143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011810|NCT00325143|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6011811|NCT00325143|Anticoagulants|anticoagulants|mesh-ancestor
6011812|NCT00325143|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6011813|NCT00325234|Gemcitabine|gemcitabine|mesh-list
6011814|NCT00325234|Carboplatin|carboplatin|mesh-list
6011815|NCT00325234|Pemetrexed|pemetrexed|mesh-list
6011816|NCT00325234|Vinorelbine|vinorelbine|mesh-list
6011817|NCT00325234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6011818|NCT00325234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6011819|NCT00325234|Antimetabolites|antimetabolites|mesh-ancestor
6011820|NCT00325234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011821|NCT00325234|Antiviral Agents|antiviral agents|mesh-ancestor
6011822|NCT00325234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6011823|NCT00325234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6011824|NCT00325234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6011825|NCT00325234|Immunologic Factors|immunologic factors|mesh-ancestor
6011826|NCT00325234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011827|NCT00325234|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6011828|NCT00325234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6011829|NCT00325234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6011830|NCT00325234|Tubulin Modulators|tubulin modulators|mesh-ancestor
6011831|NCT00325234|Antimitotic Agents|antimitotic agents|mesh-ancestor
6011832|NCT00325234|Mitosis Modulators|mitosis modulators|mesh-ancestor
6011833|NCT00325403|Treprostinil|treprostinil|mesh-list
6011834|NCT00325403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6011835|NCT00325416|Melphalan|melphalan|mesh-list
6011836|NCT00325416|Topotecan|topotecan|mesh-list
6261328|NCT03204279|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6261329|NCT03204279|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6261330|NCT03204279|Serotonin Agents|serotonin agents|mesh-ancestor
6261331|NCT03204279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6261332|NCT03204279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261333|NCT03205046|Acalabrutinib|acalabrutinib|mesh-list
6261334|NCT03205046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6011837|NCT00325416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6011838|NCT00325416|Alkylating Agents|alkylating agents|mesh-ancestor
6011839|NCT00325416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011840|NCT00325416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6011841|NCT00325416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6011842|NCT00325416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6011843|NCT00325416|Immunologic Factors|immunologic factors|mesh-ancestor
6011844|NCT00325416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011845|NCT00325416|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6011846|NCT00325416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6011847|NCT00325416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6011848|NCT00325442|Treprostinil|treprostinil|mesh-list
6011849|NCT00325442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6011850|NCT00325468|Denosumab|denosumab|mesh-list
6011851|NCT00325468|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6011852|NCT00325468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011853|NCT00325780|Pitavastatin|pitavastatin|mesh-list
6011854|NCT00325780|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6011855|NCT00325780|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6011856|NCT00325780|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6011857|NCT00325780|Antimetabolites|antimetabolites|mesh-ancestor
6011858|NCT00325780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011859|NCT00325780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6011860|NCT00325780|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6011861|NCT00325819|Acetaminophen|acetaminophen|mesh-list
6011862|NCT00325819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6011863|NCT00325819|Analgesics|analgesics|mesh-ancestor
6011864|NCT00325819|Sensory System Agents|sensory system agents|mesh-ancestor
6011865|NCT00325819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6011866|NCT00325819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011867|NCT00325819|Antipyretics|antipyretics|mesh-ancestor
6011868|NCT00325897|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6011869|NCT00325897|Azithromycin|azithromycin|mesh-list
6011870|NCT00325897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6011871|NCT00326170|Azacitidine|azacitidine|mesh-list
6011872|NCT00326170|Tretinoin|tretinoin|mesh-list
6011873|NCT00326170|Valproic Acid|valproic acid|mesh-list
6011874|NCT00326170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6011875|NCT00326170|Antimetabolites|antimetabolites|mesh-ancestor
6011876|NCT00326170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011877|NCT00326170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6011878|NCT00326170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6011879|NCT00326170|Keratolytic Agents|keratolytic agents|mesh-ancestor
6011880|NCT00326170|Dermatologic Agents|dermatologic agents|mesh-ancestor
6011881|NCT00326170|Anticonvulsants|anticonvulsants|mesh-ancestor
6011882|NCT00326170|GABA Agents|gaba agents|mesh-ancestor
6011883|NCT00326170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6011884|NCT00326170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011885|NCT00326170|Antimanic Agents|antimanic agents|mesh-ancestor
6011886|NCT00326170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6011887|NCT00326170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6011888|NCT00326170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6018399|NCT00380068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6018400|NCT00380081|Zolpidem|zolpidem|mesh-list
6018401|NCT00380081|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6018402|NCT00380081|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6018403|NCT00380081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6018404|NCT00380081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018405|NCT00380081|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6018406|NCT00380081|GABA Agonists|gaba agonists|mesh-ancestor
6018407|NCT00380081|GABA Agents|gaba agents|mesh-ancestor
6018408|NCT00380081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6018409|NCT00380081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6018410|NCT00380250|Lubiprostone|lubiprostone|mesh-list
6018411|NCT00380250|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6018412|NCT00380250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6018413|NCT00380250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6018511|NCT00381303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6018512|NCT00381303|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6018513|NCT00381303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6018514|NCT00381550|Fludarabine|fludarabine|mesh-list
6018515|NCT00381550|Fludarabine phosphate|fludarabine phosphate|mesh-list
6018516|NCT00381550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6018517|NCT00381550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6011889|NCT00326209|Mesalamine|mesalamine|mesh-list
6011890|NCT00326209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6011891|NCT00326209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6011892|NCT00326209|Analgesics|analgesics|mesh-ancestor
6011893|NCT00326209|Sensory System Agents|sensory system agents|mesh-ancestor
6011894|NCT00326209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6011895|NCT00326209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011896|NCT00326209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6011897|NCT00326209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6011898|NCT00326417|Cyclophosphamide|cyclophosphamide|mesh-list
6011899|NCT00326417|Fludarabine|fludarabine|mesh-list
6011900|NCT00326417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6011901|NCT00326417|Immunologic Factors|immunologic factors|mesh-ancestor
6011902|NCT00326417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011903|NCT00326417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6011904|NCT00326417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6011905|NCT00326417|Alkylating Agents|alkylating agents|mesh-ancestor
6011906|NCT00326417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011907|NCT00326417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6011908|NCT00326417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6011909|NCT00326495|Cetuximab|cetuximab|mesh-list
6011910|NCT00326495|Sorafenib|sorafenib|mesh-list
6011911|NCT00326495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6011912|NCT00326495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6011913|NCT00326495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6011914|NCT00326495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6011915|NCT00326495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011916|NCT00326599|Gemcitabine|gemcitabine|mesh-list
6011917|NCT00326599|Carboplatin|carboplatin|mesh-list
6011918|NCT00326599|Cediranib|cediranib|mesh-list
6011919|NCT00326599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6011920|NCT00326599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6011921|NCT00326599|Antimetabolites|antimetabolites|mesh-ancestor
6011922|NCT00326599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011923|NCT00326599|Antiviral Agents|antiviral agents|mesh-ancestor
6011924|NCT00326599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6011925|NCT00326599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6011926|NCT00326599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6011927|NCT00326599|Immunologic Factors|immunologic factors|mesh-ancestor
6011928|NCT00326599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011929|NCT00326599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6011930|NCT00326612|Midazolam|midazolam|mesh-list
6011931|NCT00326612|Diazepam|diazepam|mesh-list
6011932|NCT00326612|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6011933|NCT00326612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6011934|NCT00326612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6011935|NCT00326612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011936|NCT00326612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6011937|NCT00326612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6011938|NCT00326612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6011939|NCT00326612|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6011940|NCT00326612|Anesthetics, General|anesthetics, general|mesh-ancestor
6011941|NCT00326612|Anesthetics|anesthetics|mesh-ancestor
6011942|NCT00326612|GABA Modulators|gaba modulators|mesh-ancestor
6011943|NCT00326612|GABA Agents|gaba agents|mesh-ancestor
6011944|NCT00326612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6011945|NCT00326612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011946|NCT00326612|Anticonvulsants|anticonvulsants|mesh-ancestor
6011947|NCT00326612|Antiemetics|antiemetics|mesh-ancestor
6011948|NCT00326612|Autonomic Agents|autonomic agents|mesh-ancestor
6018414|NCT00380393|Vaccines|vaccines|mesh-list
6011949|NCT00326612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6011950|NCT00326612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6011951|NCT00326612|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6011952|NCT00326612|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6011953|NCT00326625|Glatiramer Acetate|glatiramer acetate|mesh-list
6011954|NCT00326625|(T,G)-A-L|(t,g)-a-l|mesh-list
6011955|NCT00326625|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6011956|NCT00326625|Immunologic Factors|immunologic factors|mesh-ancestor
6011957|NCT00326625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011958|NCT00326625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6011959|NCT00326625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6011960|NCT00326716|Ritonavir|ritonavir|mesh-list
6011961|NCT00326716|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6011962|NCT00326716|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6011963|NCT00326716|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6011964|NCT00326716|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6011965|NCT00326716|Protease Inhibitors|protease inhibitors|mesh-ancestor
6011966|NCT00326716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6011967|NCT00326716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011968|NCT00326716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6011969|NCT00326716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6011970|NCT00326716|Antiviral Agents|antiviral agents|mesh-ancestor
6011971|NCT00326716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6011972|NCT00326716|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6011973|NCT00326716|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6011974|NCT00326716|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6011975|NCT00326716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6011976|NCT00326781|Nicotine|nicotine|mesh-list
6011977|NCT00326781|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6011978|NCT00326781|Autonomic Agents|autonomic agents|mesh-ancestor
6011979|NCT00326781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6011980|NCT00326781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6011981|NCT00326781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6011982|NCT00326781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6011983|NCT00326781|Cholinergic Agents|cholinergic agents|mesh-ancestor
6011984|NCT00326781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6011985|NCT00326781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011986|NCT00326872|Cediranib|cediranib|mesh-list
6011987|NCT00326872|Maleic acid|maleic acid|mesh-list
6011988|NCT00326872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6011989|NCT00326872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6011990|NCT00326872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6011991|NCT00326872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6011992|NCT00326885|Catumaxomab|catumaxomab|mesh-list
6011993|NCT00326885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6011994|NCT00326911|Gemcitabine|gemcitabine|mesh-list
6011995|NCT00326911|Bevacizumab|bevacizumab|mesh-list
6011996|NCT00326911|Cetuximab|cetuximab|mesh-list
6011997|NCT00326911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6011998|NCT00326911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6011999|NCT00326911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6012000|NCT00326911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6012001|NCT00326911|Growth Substances|growth substances|mesh-ancestor
6012002|NCT00326911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012003|NCT00326911|Growth Inhibitors|growth inhibitors|mesh-ancestor
6012004|NCT00326911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6012005|NCT00326911|Antimetabolites|antimetabolites|mesh-ancestor
6012006|NCT00326911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012007|NCT00326911|Antiviral Agents|antiviral agents|mesh-ancestor
6012008|NCT00326911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6012009|NCT00326911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6012010|NCT00326911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6012011|NCT00326911|Immunologic Factors|immunologic factors|mesh-ancestor
6012012|NCT00326963|Enfuvirtide|enfuvirtide|mesh-list
6012013|NCT00326963|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6012014|NCT00326963|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6012015|NCT00326963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012016|NCT00326963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6012017|NCT00326963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6012018|NCT00326963|Antiviral Agents|antiviral agents|mesh-ancestor
6012019|NCT00326963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6012020|NCT00327015|Metformin|metformin|mesh-list
6012021|NCT00327015|Pioglitazone|pioglitazone|mesh-list
6012022|NCT00327015|Saxagliptin|saxagliptin|mesh-list
6012023|NCT00327015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6012024|NCT00327015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012025|NCT00327015|Incretins|incretins|mesh-ancestor
6012026|NCT00327015|Hormones|hormones|mesh-ancestor
6012027|NCT00327015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6012028|NCT00327015|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6012029|NCT00327015|Protease Inhibitors|protease inhibitors|mesh-ancestor
6012030|NCT00327015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6012031|NCT00327015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012032|NCT00327171|Aflibercept|aflibercept|mesh-list
6012033|NCT00327171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6012034|NCT00327171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6012035|NCT00327171|Growth Substances|growth substances|mesh-ancestor
6012036|NCT00327171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012037|NCT00327171|Growth Inhibitors|growth inhibitors|mesh-ancestor
6012038|NCT00327171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6012039|NCT00327340|Docetaxel|docetaxel|mesh-list
6012040|NCT00327340|Mitoxantrone|mitoxantrone|mesh-list
6012041|NCT00327340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6012042|NCT00327340|Tubulin Modulators|tubulin modulators|mesh-ancestor
6012043|NCT00327340|Antimitotic Agents|antimitotic agents|mesh-ancestor
6012044|NCT00327340|Mitosis Modulators|mitosis modulators|mesh-ancestor
6012045|NCT00327340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012046|NCT00327340|Analgesics|analgesics|mesh-ancestor
6012047|NCT00327340|Sensory System Agents|sensory system agents|mesh-ancestor
6012048|NCT00327340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6012049|NCT00327340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012050|NCT00327340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6012051|NCT00327340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6012052|NCT00327340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6012053|NCT00327392|Fospropofol|fospropofol|mesh-list
6012054|NCT00327392|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6012055|NCT00327392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6012056|NCT00327392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012057|NCT00327444|Aflibercept|aflibercept|mesh-list
6012058|NCT00327444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6012059|NCT00327444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6012060|NCT00327444|Growth Substances|growth substances|mesh-ancestor
6012061|NCT00327444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012062|NCT00327444|Growth Inhibitors|growth inhibitors|mesh-ancestor
6012063|NCT00327444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6012064|NCT00327717|Zonisamide|zonisamide|mesh-list
6012065|NCT00327717|Anticonvulsants|anticonvulsants|mesh-ancestor
6012066|NCT00327717|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6012067|NCT00327717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6012068|NCT00327717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012069|NCT00327717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6012070|NCT00327717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012071|NCT00328094|Insulin|insulin|mesh-list
6012072|NCT00328094|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6012073|NCT00328094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6012074|NCT00328094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012075|NCT00328172|Metformin|metformin|mesh-list
6012076|NCT00328172|Linagliptin|linagliptin|mesh-list
6012077|NCT00328172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6012078|NCT00328172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012079|NCT00328172|Incretins|incretins|mesh-ancestor
6012080|NCT00328172|Hormones|hormones|mesh-ancestor
6012081|NCT00328172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6012082|NCT00328172|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6012083|NCT00328172|Protease Inhibitors|protease inhibitors|mesh-ancestor
6012084|NCT00328172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6012085|NCT00328172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012086|NCT00328198|Alemtuzumab|alemtuzumab|mesh-list
6012087|NCT00328198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6261335|NCT03205150|Licogliflozin|licogliflozin|mesh-list
6261336|NCT03205150|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6261337|NCT03205150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261338|NCT03205150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6261339|NCT03205150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261340|NCT03205163|Factor VIII|factor viii|mesh-list
6261341|NCT03205163|Coagulants|coagulants|mesh-ancestor
6261342|NCT03205358|Vaccines|vaccines|mesh-list
6261343|NCT03205358|Immunologic Factors|immunologic factors|mesh-ancestor
6261344|NCT03205358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261345|NCT03205566|Lamivudine|lamivudine|mesh-list
6261346|NCT03205566|Raltegravir Potassium|raltegravir potassium|mesh-list
6261347|NCT03205566|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6261348|NCT03205566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6261349|NCT03205566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6261350|NCT03205566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261351|NCT03205566|Antiviral Agents|antiviral agents|mesh-ancestor
6261352|NCT03205566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6261353|NCT03205566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6261354|NCT03205566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6261355|NCT03205566|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6261356|NCT03205566|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6261357|NCT03206788|Losartan|losartan|mesh-list
6261358|NCT03206788|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6261359|NCT03206788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6261360|NCT03206788|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6261361|NCT03206788|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6261362|NCT03206788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261363|NCT03206918|Zanubrutinib|zanubrutinib|mesh-list
6261364|NCT03206918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6261365|NCT03206918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6261366|NCT03206918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6261367|NCT03206918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261368|NCT03206970|Zanubrutinib|zanubrutinib|mesh-list
6261369|NCT03206970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6261370|NCT03206970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6261371|NCT03206970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6261372|NCT03206970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261373|NCT03207243|Fluticasone|fluticasone|mesh-list
6261374|NCT03207243|Xhance|xhance|mesh-list
6261375|NCT03207243|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6261376|NCT03207243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6261377|NCT03207243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6261378|NCT03207243|Autonomic Agents|autonomic agents|mesh-ancestor
6261379|NCT03207243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6261380|NCT03207243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261381|NCT03207243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6012088|NCT00328198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6012089|NCT00328562|Gefitinib|gefitinib|mesh-list
6012090|NCT00328562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6012091|NCT00328562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6012092|NCT00328562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6012093|NCT00328562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012094|NCT00328614|Ascorbic Acid|ascorbic acid|mesh-list
6012095|NCT00328614|Goserelin|goserelin|mesh-list
6012096|NCT00328614|Methyltestosterone|methyltestosterone|mesh-list
6012097|NCT00328614|Bicalutamide|bicalutamide|mesh-list
6012098|NCT00328614|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
6012099|NCT00328614|Androgens|androgens|mesh-list
6012100|NCT00328614|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6012101|NCT00328614|Ethylene|ethylene|mesh-list
6012102|NCT00328614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6012103|NCT00328614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6012104|NCT00328614|Androgen Antagonists|androgen antagonists|mesh-ancestor
6261382|NCT03207243|Respiratory System Agents|respiratory system agents|mesh-ancestor
6261383|NCT03207243|Dermatologic Agents|dermatologic agents|mesh-ancestor
6261384|NCT03207243|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6261385|NCT03207243|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6261386|NCT03207243|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6261387|NCT03207243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6261388|NCT03207243|Adrenergic Agents|adrenergic agents|mesh-ancestor
6012105|NCT00328614|Hormone Antagonists|hormone antagonists|mesh-ancestor
6012106|NCT00328614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6012107|NCT00328614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012108|NCT00328614|Hormones|hormones|mesh-ancestor
6012109|NCT00328614|Antioxidants|antioxidants|mesh-ancestor
6012110|NCT00328614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012111|NCT00328614|Protective Agents|protective agents|mesh-ancestor
6012112|NCT00328614|Vitamins|vitamins|mesh-ancestor
6012113|NCT00328614|Micronutrients|micronutrients|mesh-ancestor
6012114|NCT00328614|Estrogens|estrogens|mesh-ancestor
6012115|NCT00328614|Anabolic Agents|anabolic agents|mesh-ancestor
6012116|NCT00328614|Plant Growth Regulators|plant growth regulators|mesh-ancestor
6012117|NCT00328614|Growth Substances|growth substances|mesh-ancestor
6012118|NCT00328614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6012119|NCT00328614|Analgesics|analgesics|mesh-ancestor
6012120|NCT00328614|Sensory System Agents|sensory system agents|mesh-ancestor
6012121|NCT00328614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6012122|NCT00328627|Pioglitazone|pioglitazone|mesh-list
6012123|NCT00328627|Alogliptin|alogliptin|mesh-list
6012124|NCT00328627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6012125|NCT00328627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012126|NCT00328627|Incretins|incretins|mesh-ancestor
6012127|NCT00328627|Hormones|hormones|mesh-ancestor
6012128|NCT00328627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6012129|NCT00328627|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6012130|NCT00328627|Protease Inhibitors|protease inhibitors|mesh-ancestor
6012131|NCT00328627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6012132|NCT00328627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012133|NCT00328770|Sirolimus|sirolimus|mesh-list
6012134|NCT00328770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6012135|NCT00328770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6012136|NCT00328770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6012137|NCT00328770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6012138|NCT00328770|Antifungal Agents|antifungal agents|mesh-ancestor
6012139|NCT00328770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6012140|NCT00328770|Immunologic Factors|immunologic factors|mesh-ancestor
6012141|NCT00328770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012142|NCT00328861|Aldesleukin|aldesleukin|mesh-list
6012143|NCT00328861|Cyclophosphamide|cyclophosphamide|mesh-list
6012144|NCT00328861|Fludarabine|fludarabine|mesh-list
6012145|NCT00328861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6012146|NCT00328861|Immunologic Factors|immunologic factors|mesh-ancestor
6012147|NCT00328861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012148|NCT00328861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6012149|NCT00328861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6012150|NCT00328861|Alkylating Agents|alkylating agents|mesh-ancestor
6012151|NCT00328861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012152|NCT00328861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6012153|NCT00328861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6012154|NCT00328861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6012155|NCT00328861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6012156|NCT00328861|Antiviral Agents|antiviral agents|mesh-ancestor
6018415|NCT00380393|Immunologic Factors|immunologic factors|mesh-ancestor
6012157|NCT00328861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6012158|NCT00328926|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6012159|NCT00328926|Hormones|hormones|mesh-list
6012160|NCT00328926|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6012161|NCT00328926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6012162|NCT00328926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012163|NCT00328926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6012164|NCT00329030|Rituximab|rituximab|mesh-list
6012165|NCT00329030|Tositumomab I-131|tositumomab i-131|mesh-list
6012166|NCT00329030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6012167|NCT00329030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6012168|NCT00329030|Immunologic Factors|immunologic factors|mesh-ancestor
6012169|NCT00329030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012170|NCT00329030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6012171|NCT00329160|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6012172|NCT00329160|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6012173|NCT00329160|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6012174|NCT00329160|Antimetabolites|antimetabolites|mesh-ancestor
6012175|NCT00329160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012176|NCT00329160|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6012177|NCT00329160|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6012178|NCT00329160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6012179|NCT00329238|Warfarin|warfarin|mesh-list
6012180|NCT00329238|Dabigatran|dabigatran|mesh-list
6012181|NCT00329238|Anticoagulants|anticoagulants|mesh-ancestor
6012182|NCT00329238|Antithrombins|antithrombins|mesh-ancestor
6012183|NCT00329238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6012184|NCT00329238|Protease Inhibitors|protease inhibitors|mesh-ancestor
6012185|NCT00329238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6012186|NCT00329238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012187|NCT00329303|Certolizumab Pegol|certolizumab pegol|mesh-list
6012188|NCT00329303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6012189|NCT00329303|Immunologic Factors|immunologic factors|mesh-ancestor
6012190|NCT00329303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012191|NCT00329303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6012192|NCT00329407|Topiramate|topiramate|mesh-list
6012193|NCT00329407|Anticonvulsants|anticonvulsants|mesh-ancestor
6012194|NCT00329407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6012195|NCT00329407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012196|NCT00329420|Certolizumab Pegol|certolizumab pegol|mesh-list
6012197|NCT00329420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6012198|NCT00329420|Immunologic Factors|immunologic factors|mesh-ancestor
6012199|NCT00329420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012200|NCT00329420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6012201|NCT00329433|Heparin|heparin|mesh-list
6012202|NCT00329433|Desirudin|desirudin|mesh-list
6012203|NCT00329433|Anticoagulants|anticoagulants|mesh-ancestor
6012204|NCT00329433|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6012205|NCT00329433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6012206|NCT00329433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012207|NCT00329550|Certolizumab Pegol|certolizumab pegol|mesh-list
6012208|NCT00329550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6012209|NCT00329550|Immunologic Factors|immunologic factors|mesh-ancestor
6012210|NCT00329550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012211|NCT00329550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6012212|NCT00329602|Ropinirole|ropinirole|mesh-list
6012213|NCT00329602|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6012214|NCT00329602|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6012215|NCT00329602|Dopamine Agonists|dopamine agonists|mesh-ancestor
6012216|NCT00329602|Dopamine Agents|dopamine agents|mesh-ancestor
6012217|NCT00329602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6012218|NCT00329602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012219|NCT00329602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012220|NCT00329641|Paclitaxel|paclitaxel|mesh-list
6012221|NCT00329641|Carboplatin|carboplatin|mesh-list
6012222|NCT00329641|Sorafenib|sorafenib|mesh-list
6012223|NCT00329641|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6012224|NCT00329641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6012225|NCT00329641|Tubulin Modulators|tubulin modulators|mesh-ancestor
6012226|NCT00329641|Antimitotic Agents|antimitotic agents|mesh-ancestor
6012227|NCT00329641|Mitosis Modulators|mitosis modulators|mesh-ancestor
6012228|NCT00329641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012229|NCT00329641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6012230|NCT00329641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6012231|NCT00329719|Sirolimus|sirolimus|mesh-list
6012232|NCT00329719|Sorafenib|sorafenib|mesh-list
6012233|NCT00329719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6012234|NCT00329719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6012235|NCT00329719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6012236|NCT00329719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012237|NCT00329719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6012238|NCT00329719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6012239|NCT00329719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6012240|NCT00329719|Antifungal Agents|antifungal agents|mesh-ancestor
6012241|NCT00329719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6012242|NCT00329719|Immunologic Factors|immunologic factors|mesh-ancestor
6012243|NCT00329719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012244|NCT00329797|Vitamin D|vitamin d|mesh-list
6012245|NCT00329797|Zoledronic Acid|zoledronic acid|mesh-list
6012246|NCT00329797|Calcium|calcium|mesh-list
6012247|NCT00329797|Vitamins|vitamins|mesh-ancestor
6012248|NCT00329797|Micronutrients|micronutrients|mesh-ancestor
6012249|NCT00329797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012250|NCT00329797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6012251|NCT00329797|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6012252|NCT00329849|Vaccines|vaccines|mesh-list
6012253|NCT00329849|Immunologic Factors|immunologic factors|mesh-ancestor
6012254|NCT00329849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012255|NCT00329901|Vaccines|vaccines|mesh-list
6012256|NCT00329901|Immunologic Factors|immunologic factors|mesh-ancestor
6012257|NCT00329901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012258|NCT00330161|Vorinostat|vorinostat|mesh-list
6012259|NCT00330161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6012260|NCT00330161|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6012261|NCT00330161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6012262|NCT00330161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012263|NCT00330174|Acamprosate|acamprosate|mesh-list
6012264|NCT00330174|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6012265|NCT00330187|Bupropion|bupropion|mesh-list
6012266|NCT00330187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6012267|NCT00330187|Antidepressive Agents|antidepressive agents|mesh-ancestor
6012268|NCT00330187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6012269|NCT00330187|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6012270|NCT00330187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6012271|NCT00330187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6012272|NCT00330187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012273|NCT00330187|Dopamine Agents|dopamine agents|mesh-ancestor
6012274|NCT00330187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6012275|NCT00330187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012276|NCT00330187|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6012277|NCT00330187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6012278|NCT00330187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6012279|NCT00330343|Naloxone|naloxone|mesh-list
6012280|NCT00330343|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6012281|NCT00330343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012282|NCT00330343|Sensory System Agents|sensory system agents|mesh-ancestor
6012283|NCT00330343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6012284|NCT00330421|Sorafenib|sorafenib|mesh-list
6012285|NCT00330421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6012286|NCT00330421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6012287|NCT00330421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6012288|NCT00330421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012289|NCT00330460|Denosumab|denosumab|mesh-list
6261389|NCT03207243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6261390|NCT03207243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261391|NCT03207399|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
6261392|NCT03207399|Antiviral Agents|antiviral agents|mesh-ancestor
6012290|NCT00330460|Alendronate|alendronate|mesh-list
6012291|NCT00330460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6012292|NCT00330460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012293|NCT00330551|Risperidone|risperidone|mesh-list
6012294|NCT00330551|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6012295|NCT00330551|Serotonin Agents|serotonin agents|mesh-ancestor
6012296|NCT00330551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6012297|NCT00330551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012298|NCT00330551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012299|NCT00330551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6012300|NCT00330551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6012301|NCT00330551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6012302|NCT00330551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6012303|NCT00330551|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6012304|NCT00330551|Dopamine Agents|dopamine agents|mesh-ancestor
6012305|NCT00330564|Sunitinib|sunitinib|mesh-list
6012306|NCT00330564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6012307|NCT00330564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6012308|NCT00330564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6012309|NCT00330564|Growth Substances|growth substances|mesh-ancestor
6012310|NCT00330564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012311|NCT00330564|Growth Inhibitors|growth inhibitors|mesh-ancestor
6012312|NCT00330564|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6012313|NCT00330564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6012314|NCT00330564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012315|NCT00330668|Mecasermin|mecasermin|mesh-list
6012316|NCT00330668|Growth Substances|growth substances|mesh-ancestor
6012317|NCT00330668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012318|NCT00330681|Edaravone|edaravone|mesh-list
6012319|NCT00330681|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6012320|NCT00330681|Antioxidants|antioxidants|mesh-ancestor
6012321|NCT00330681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012322|NCT00330681|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6012323|NCT00330681|Protective Agents|protective agents|mesh-ancestor
6012324|NCT00330681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012325|NCT00330733|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
6012326|NCT00330733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6012327|NCT00330733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6012328|NCT00330733|Analgesics|analgesics|mesh-ancestor
6012329|NCT00330733|Sensory System Agents|sensory system agents|mesh-ancestor
6012330|NCT00330733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6012331|NCT00330733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012332|NCT00330733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6012333|NCT00330733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6012334|NCT00330759|Zoledronic Acid|zoledronic acid|mesh-list
6012335|NCT00330759|Denosumab|denosumab|mesh-list
6012336|NCT00330759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6012337|NCT00330759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012338|NCT00330863|Olanzapine|olanzapine|mesh-list
6012339|NCT00330863|Risperidone|risperidone|mesh-list
6012340|NCT00330863|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6012341|NCT00330863|Aripiprazole|aripiprazole|mesh-list
6012342|NCT00330863|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6012343|NCT00330863|Ziprasidone|ziprasidone|mesh-list
6012344|NCT00330863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6012345|NCT00330863|Serotonin Agents|serotonin agents|mesh-ancestor
6012346|NCT00330863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6012347|NCT00330863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012348|NCT00330863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012349|NCT00330863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6012350|NCT00330863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6012351|NCT00330863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6012352|NCT00330863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6012353|NCT00330863|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6012354|NCT00330863|Dopamine Agents|dopamine agents|mesh-ancestor
6012355|NCT00330863|Antiemetics|antiemetics|mesh-ancestor
6012356|NCT00330863|Autonomic Agents|autonomic agents|mesh-ancestor
6012357|NCT00330863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6012358|NCT00330863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6012359|NCT00330863|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6012360|NCT00330863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6012361|NCT00330863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6012362|NCT00330863|Antidepressive Agents|antidepressive agents|mesh-ancestor
6012363|NCT00330863|Dopamine Agonists|dopamine agonists|mesh-ancestor
6012364|NCT00330863|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6012365|NCT00330863|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6012366|NCT00330863|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6012367|NCT00330863|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6012368|NCT00330876|Pitavastatin|pitavastatin|mesh-list
6012369|NCT00330876|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6012370|NCT00330876|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6012371|NCT00330876|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6012372|NCT00330876|Antimetabolites|antimetabolites|mesh-ancestor
6012373|NCT00330876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012374|NCT00330876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6012375|NCT00330876|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6012376|NCT00330915|Pemetrexed|pemetrexed|mesh-list
6012377|NCT00330915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6012378|NCT00330915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6012379|NCT00330915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012380|NCT00330915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6012381|NCT00330915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6012382|NCT00330967|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6012383|NCT00330967|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6012384|NCT00330967|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6012385|NCT00330967|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6012386|NCT00331006|Rituximab|rituximab|mesh-list
6012387|NCT00331006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6012388|NCT00331006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6012389|NCT00331006|Immunologic Factors|immunologic factors|mesh-ancestor
6012390|NCT00331006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012391|NCT00331006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6012392|NCT00331136|Artesunate|artesunate|mesh-list
6012393|NCT00331136|Pyronaridine|pyronaridine|mesh-list
6012394|NCT00331136|Antimalarials|antimalarials|mesh-ancestor
6012395|NCT00331136|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6012396|NCT00331136|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6012397|NCT00331136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6012398|NCT00331136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6012399|NCT00331136|Antiviral Agents|antiviral agents|mesh-ancestor
6012400|NCT00331136|Schistosomicides|schistosomicides|mesh-ancestor
6012401|NCT00331136|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6012402|NCT00331136|Anthelmintics|anthelmintics|mesh-ancestor
6012403|NCT00331162|Alemtuzumab|alemtuzumab|mesh-list
6012404|NCT00331162|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6012405|NCT00331162|Immunologic Factors|immunologic factors|mesh-ancestor
6012406|NCT00331162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012407|NCT00331162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6012408|NCT00331162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6012409|NCT00331162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6012410|NCT00331344|Prednisone|prednisone|mesh-list
6012411|NCT00331344|Mitoxantrone|mitoxantrone|mesh-list
6012412|NCT00331344|Epothilone B|epothilone b|mesh-list
6012413|NCT00331344|Epothilones|epothilones|mesh-list
6012414|NCT00331344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6012415|NCT00331344|Glucocorticoids|glucocorticoids|mesh-ancestor
6012416|NCT00331344|Hormones|hormones|mesh-ancestor
6012417|NCT00331344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6012418|NCT00331344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012419|NCT00331344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6012420|NCT00331344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6012421|NCT00331344|Analgesics|analgesics|mesh-ancestor
6012422|NCT00331344|Sensory System Agents|sensory system agents|mesh-ancestor
6012423|NCT00331344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6012424|NCT00331344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6012425|NCT00331344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6012426|NCT00331344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6012427|NCT00331344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012428|NCT00331344|Tubulin Modulators|tubulin modulators|mesh-ancestor
6012429|NCT00331344|Antimitotic Agents|antimitotic agents|mesh-ancestor
6012430|NCT00331344|Mitosis Modulators|mitosis modulators|mesh-ancestor
6012431|NCT00331409|Everolimus|everolimus|mesh-list
6012432|NCT00331409|Imatinib Mesylate|imatinib mesylate|mesh-list
6012433|NCT00331409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6012434|NCT00331409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6012435|NCT00331409|Immunologic Factors|immunologic factors|mesh-ancestor
6012436|NCT00331409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012437|NCT00331409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6012438|NCT00331409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6012439|NCT00331409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012440|NCT00331422|Paclitaxel|paclitaxel|mesh-list
6012441|NCT00331422|Carboplatin|carboplatin|mesh-list
6012442|NCT00331422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6012443|NCT00331422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6012444|NCT00331422|Tubulin Modulators|tubulin modulators|mesh-ancestor
6012445|NCT00331422|Antimitotic Agents|antimitotic agents|mesh-ancestor
6012446|NCT00331422|Mitosis Modulators|mitosis modulators|mesh-ancestor
6012447|NCT00331422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012448|NCT00331552|Cyclophosphamide|cyclophosphamide|mesh-list
6012449|NCT00331552|Doxorubicin|doxorubicin|mesh-list
6012450|NCT00331552|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6012451|NCT00331552|Trastuzumab|trastuzumab|mesh-list
6012452|NCT00331552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6012453|NCT00331552|Antibodies|antibodies|mesh-list
6012454|NCT00331552|Immunoglobulins|immunoglobulins|mesh-list
6012455|NCT00331552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6012456|NCT00331552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6012457|NCT00331552|Immunologic Factors|immunologic factors|mesh-ancestor
6012458|NCT00331552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012459|NCT00331552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6012460|NCT00331552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6012461|NCT00331552|Alkylating Agents|alkylating agents|mesh-ancestor
6012462|NCT00331552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012463|NCT00331552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6012464|NCT00331552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6012465|NCT00331552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6012466|NCT00331552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6012467|NCT00331552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6012468|NCT00331552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6012469|NCT00331630|Paclitaxel|paclitaxel|mesh-list
6012470|NCT00331630|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6012471|NCT00331630|Lapatinib|lapatinib|mesh-list
6012472|NCT00331630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6012473|NCT00331630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6012474|NCT00331630|Tubulin Modulators|tubulin modulators|mesh-ancestor
6012475|NCT00331630|Antimitotic Agents|antimitotic agents|mesh-ancestor
6012476|NCT00331630|Mitosis Modulators|mitosis modulators|mesh-ancestor
6012477|NCT00331630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012478|NCT00331630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6012479|NCT00331630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6012480|NCT00331682|Docetaxel|docetaxel|mesh-list
6012481|NCT00331682|Alvocidib|alvocidib|mesh-list
6012482|NCT00331682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6012483|NCT00331682|Tubulin Modulators|tubulin modulators|mesh-ancestor
6012484|NCT00331682|Antimitotic Agents|antimitotic agents|mesh-ancestor
6012485|NCT00331682|Mitosis Modulators|mitosis modulators|mesh-ancestor
6012486|NCT00331682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012487|NCT00331682|Growth Inhibitors|growth inhibitors|mesh-ancestor
6012488|NCT00331682|Growth Substances|growth substances|mesh-ancestor
6012489|NCT00331682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012490|NCT00331682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6012491|NCT00331682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6012492|NCT00331760|Cisplatin|cisplatin|mesh-list
6012493|NCT00331760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6012494|NCT00331799|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6012495|NCT00331799|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6012496|NCT00331799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6012497|NCT00331799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6012498|NCT00331799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012499|NCT00331799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6012500|NCT00331799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012501|NCT00331799|Analgesics|analgesics|mesh-ancestor
6012502|NCT00331799|Sensory System Agents|sensory system agents|mesh-ancestor
6012503|NCT00331799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6012504|NCT00331799|Antidepressive Agents|antidepressive agents|mesh-ancestor
6012505|NCT00331799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6012506|NCT00331799|Dopamine Agents|dopamine agents|mesh-ancestor
6012507|NCT00331864|Ranibizumab|ranibizumab|mesh-list
6012508|NCT00331864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6012509|NCT00331864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6012510|NCT00331864|Growth Substances|growth substances|mesh-ancestor
6012511|NCT00331864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012512|NCT00331864|Growth Inhibitors|growth inhibitors|mesh-ancestor
6012513|NCT00331864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6012514|NCT00332163|Irinotecan|irinotecan|mesh-list
6012515|NCT00332163|Panitumumab|panitumumab|mesh-list
6012516|NCT00332163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6012517|NCT00332163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6012518|NCT00332163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6012519|NCT00332163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012520|NCT00332163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6012521|NCT00332163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6012522|NCT00332189|Verapamil|verapamil|mesh-list
6012523|NCT00332189|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6012524|NCT00332189|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6012525|NCT00332189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6012526|NCT00332189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012527|NCT00332189|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6012528|NCT00332189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012529|NCT00332189|Vasodilator Agents|vasodilator agents|mesh-ancestor
6012530|NCT00332241|Aripiprazole|aripiprazole|mesh-list
6012531|NCT00332241|Antidepressive Agents|antidepressive agents|mesh-ancestor
6012532|NCT00332241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6012533|NCT00332241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6012534|NCT00332241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6012535|NCT00332241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6012536|NCT00332241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012537|NCT00332241|Dopamine Agonists|dopamine agonists|mesh-ancestor
6012538|NCT00332241|Dopamine Agents|dopamine agents|mesh-ancestor
6012539|NCT00332241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6012540|NCT00332241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012541|NCT00332241|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6012542|NCT00332241|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6012543|NCT00332241|Serotonin Agents|serotonin agents|mesh-ancestor
6012544|NCT00332241|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6012545|NCT00332241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6012546|NCT00332241|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6012547|NCT00332241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6012548|NCT00332332|Etanercept|etanercept|mesh-list
6012549|NCT00332332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6012550|NCT00332332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6012551|NCT00332332|Analgesics|analgesics|mesh-ancestor
6012552|NCT00332332|Sensory System Agents|sensory system agents|mesh-ancestor
6012553|NCT00332332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6012554|NCT00332332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012555|NCT00332332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6012556|NCT00332332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6012557|NCT00332332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6012558|NCT00332332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6012559|NCT00332332|Immunologic Factors|immunologic factors|mesh-ancestor
6012560|NCT00332462|Cyclosporine|cyclosporine|mesh-list
6012561|NCT00332462|Cyclosporins|cyclosporins|mesh-list
6012562|NCT00332462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6012563|NCT00332462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012564|NCT00332462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6012565|NCT00332462|Immunologic Factors|immunologic factors|mesh-ancestor
6012566|NCT00332462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012567|NCT00332462|Antifungal Agents|antifungal agents|mesh-ancestor
6012568|NCT00332462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6012569|NCT00332462|Dermatologic Agents|dermatologic agents|mesh-ancestor
6261393|NCT03207399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6261394|NCT03207438|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6261395|NCT03207438|Antidepressive Agents|antidepressive agents|mesh-ancestor
6261396|NCT03207438|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6261397|NCT03207438|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6261398|NCT03207438|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6261399|NCT03207438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6261400|NCT03207438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261401|NCT03207750|Vaccines|vaccines|mesh-list
6261402|NCT03207750|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6261403|NCT03207750|Immunologic Factors|immunologic factors|mesh-ancestor
6261404|NCT03207750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261405|NCT03208933|Pirfenidone|pirfenidone|mesh-list
6261406|NCT03208933|Analgesics|analgesics|mesh-ancestor
6261407|NCT03208933|Sensory System Agents|sensory system agents|mesh-ancestor
6261408|NCT03208933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6261409|NCT03208933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261410|NCT03208933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6261411|NCT03208933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6261412|NCT03208933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6261413|NCT03208933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6261414|NCT03208933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6261415|NCT03209492|Leuprolide|leuprolide|mesh-list
6261416|NCT03209492|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6261417|NCT03209492|Fertility Agents|fertility agents|mesh-ancestor
6261418|NCT03209492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6261419|NCT03209492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261420|NCT03209492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6261421|NCT03209492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6261422|NCT03209518|Leuprolide|leuprolide|mesh-list
6261423|NCT03209518|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6261424|NCT03209518|Fertility Agents|fertility agents|mesh-ancestor
6261425|NCT03209518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6261426|NCT03209518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261427|NCT03209518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6261428|NCT03209518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6261429|NCT03209570|Zinc Oxide|zinc oxide|mesh-list
6261430|NCT03209570|Dermatologic Agents|dermatologic agents|mesh-ancestor
6261431|NCT03209570|Sunscreening Agents|sunscreening agents|mesh-ancestor
6261432|NCT03209570|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6261433|NCT03209570|Protective Agents|protective agents|mesh-ancestor
6261434|NCT03209570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261435|NCT03210259|Adalimumab|adalimumab|mesh-list
6261436|NCT03210259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6261437|NCT03210259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6261438|NCT03210337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6261439|NCT03210376|Neostigmine|neostigmine|mesh-list
6261440|NCT03210376|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6261441|NCT03210376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6261442|NCT03210376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261443|NCT03210376|Cholinergic Agents|cholinergic agents|mesh-ancestor
6261444|NCT03210376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6261445|NCT03210376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012570|NCT00332462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6012571|NCT00332462|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6012572|NCT00332488|Insulin|insulin|mesh-list
6012573|NCT00332488|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6012574|NCT00332488|Metformin|metformin|mesh-list
6012575|NCT00332488|Secretagogues|secretagogues|mesh-list
6012576|NCT00332488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6012577|NCT00332488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012578|NCT00332579|Naltrexone|naltrexone|mesh-list
6012579|NCT00332579|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6012580|NCT00332579|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6012581|NCT00332579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012582|NCT00332579|Sensory System Agents|sensory system agents|mesh-ancestor
6012583|NCT00332579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6012584|NCT00332605|Acetylcysteine|acetylcysteine|mesh-list
6012585|NCT00332605|Naltrexone|naltrexone|mesh-list
6012586|NCT00332605|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6012587|NCT00332605|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6012588|NCT00332605|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6012589|NCT00332605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012590|NCT00332605|Sensory System Agents|sensory system agents|mesh-ancestor
6012591|NCT00332605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6012592|NCT00332605|Antiviral Agents|antiviral agents|mesh-ancestor
6012593|NCT00332605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6012594|NCT00332605|Expectorants|expectorants|mesh-ancestor
6012595|NCT00332605|Respiratory System Agents|respiratory system agents|mesh-ancestor
6012596|NCT00332605|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6012597|NCT00332605|Antioxidants|antioxidants|mesh-ancestor
6012598|NCT00332605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012599|NCT00332605|Protective Agents|protective agents|mesh-ancestor
6012600|NCT00332605|Antidotes|antidotes|mesh-ancestor
6012601|NCT00332644|Bupropion|bupropion|mesh-list
6261446|NCT03210376|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6261447|NCT03210376|Autonomic Agents|autonomic agents|mesh-ancestor
6261448|NCT03210376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6261449|NCT03211117|Docetaxel|docetaxel|mesh-list
6261450|NCT03211117|Doxorubicin|doxorubicin|mesh-list
6261451|NCT03211117|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6261452|NCT03211117|Pembrolizumab|pembrolizumab|mesh-list
6012602|NCT00332644|Nicotine|nicotine|mesh-list
6012603|NCT00332644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6012604|NCT00332644|Autonomic Agents|autonomic agents|mesh-ancestor
6012605|NCT00332644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6012606|NCT00332644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012607|NCT00332644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6012608|NCT00332644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6012609|NCT00332644|Cholinergic Agents|cholinergic agents|mesh-ancestor
6012610|NCT00332644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6012611|NCT00332644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012612|NCT00332644|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6012613|NCT00332644|Antidepressive Agents|antidepressive agents|mesh-ancestor
6012614|NCT00332644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6012615|NCT00332644|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6012616|NCT00332644|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6012617|NCT00332644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6012618|NCT00332644|Dopamine Agents|dopamine agents|mesh-ancestor
6012619|NCT00332644|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6012620|NCT00332644|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6012621|NCT00332644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6012622|NCT00332696|Methylprednisolone|methylprednisolone|mesh-list
6012623|NCT00332696|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6012624|NCT00332696|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6012625|NCT00332696|Prednisolone|prednisolone|mesh-list
6012626|NCT00332696|Prednisolone acetate|prednisolone acetate|mesh-list
6012627|NCT00332696|Octreotide|octreotide|mesh-list
6012628|NCT00332696|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6012629|NCT00332696|Prednisolone phosphate|prednisolone phosphate|mesh-list
6012630|NCT00332696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6012631|NCT00332696|Antiemetics|antiemetics|mesh-ancestor
6012632|NCT00332696|Autonomic Agents|autonomic agents|mesh-ancestor
6012633|NCT00332696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6538061|NCT00825552|Serotonin Agents|serotonin agents|mesh-ancestor
6012634|NCT00332696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012635|NCT00332696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6012636|NCT00332696|Glucocorticoids|glucocorticoids|mesh-ancestor
6012637|NCT00332696|Hormones|hormones|mesh-ancestor
6012638|NCT00332696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6012639|NCT00332696|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6012640|NCT00332696|Protective Agents|protective agents|mesh-ancestor
6012641|NCT00332696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6012642|NCT00332696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6012643|NCT00332709|Zoledronic Acid|zoledronic acid|mesh-list
6012644|NCT00332709|Letrozole|letrozole|mesh-list
6012645|NCT00332709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6012646|NCT00332709|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6012647|NCT00332709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6012648|NCT00332709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6012649|NCT00332709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012650|NCT00332709|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6012651|NCT00332709|Hormone Antagonists|hormone antagonists|mesh-ancestor
6012652|NCT00332709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6012653|NCT00332709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012654|NCT00332709|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6012655|NCT00332839|Cyclosporine|cyclosporine|mesh-list
6012656|NCT00332839|Mycophenolic Acid|mycophenolic acid|mesh-list
6012657|NCT00332839|Everolimus|everolimus|mesh-list
6012658|NCT00332839|Tacrolimus|tacrolimus|mesh-list
6012659|NCT00332839|Cyclosporins|cyclosporins|mesh-list
6012660|NCT00332839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6012661|NCT00332839|Immunologic Factors|immunologic factors|mesh-ancestor
6012662|NCT00332839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012663|NCT00332839|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6012664|NCT00332839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6012665|NCT00332839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012666|NCT00332839|Antifungal Agents|antifungal agents|mesh-ancestor
6012667|NCT00332839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6012668|NCT00332839|Dermatologic Agents|dermatologic agents|mesh-ancestor
6012669|NCT00332839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6012670|NCT00332839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6012671|NCT00332839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6012672|NCT00332839|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6012673|NCT00332839|Antitubercular Agents|antitubercular agents|mesh-ancestor
6012674|NCT00332839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6018416|NCT00380393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018417|NCT00380588|Gemcitabine|gemcitabine|mesh-list
6018418|NCT00380588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6018419|NCT00380588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6018420|NCT00380588|Antimetabolites|antimetabolites|mesh-ancestor
6018421|NCT00380588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6018422|NCT00380588|Antiviral Agents|antiviral agents|mesh-ancestor
6018423|NCT00380588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6018424|NCT00380588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6018425|NCT00380588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6018426|NCT00380588|Immunologic Factors|immunologic factors|mesh-ancestor
6018427|NCT00380588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018428|NCT00380692|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6018429|NCT00380692|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6018430|NCT00380692|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6018431|NCT00380692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6018432|NCT00380692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6018433|NCT00380692|Adrenergic Agents|adrenergic agents|mesh-ancestor
6018434|NCT00380692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6018435|NCT00380692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012675|NCT00333138|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6012676|NCT00333138|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6012677|NCT00333138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012678|NCT00333138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6012679|NCT00333138|Immunologic Factors|immunologic factors|mesh-ancestor
6012680|NCT00333138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012681|NCT00333177|Risperidone|risperidone|mesh-list
6012682|NCT00333177|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6012683|NCT00333177|Serotonin Agents|serotonin agents|mesh-ancestor
6012684|NCT00333177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6012685|NCT00333177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012686|NCT00333177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012687|NCT00333177|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6012688|NCT00333177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6012689|NCT00333177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6012690|NCT00333177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6012691|NCT00333177|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6012692|NCT00333177|Dopamine Agents|dopamine agents|mesh-ancestor
6012693|NCT00333359|Gabapentin|gabapentin|mesh-list
6012694|NCT00333359|Analgesics|analgesics|mesh-ancestor
6012695|NCT00333359|Sensory System Agents|sensory system agents|mesh-ancestor
6012696|NCT00333359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6012697|NCT00333359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012698|NCT00333359|Anticonvulsants|anticonvulsants|mesh-ancestor
6012699|NCT00333359|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6012700|NCT00333359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6012701|NCT00333359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6012702|NCT00333359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6012703|NCT00333359|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6012704|NCT00333359|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6012705|NCT00333359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6012706|NCT00333359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012707|NCT00333359|Antimanic Agents|antimanic agents|mesh-ancestor
6012708|NCT00333437|Mycophenolic Acid|mycophenolic acid|mesh-list
6012709|NCT00333437|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6012710|NCT00333437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6012711|NCT00333437|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6012712|NCT00333437|Antitubercular Agents|antitubercular agents|mesh-ancestor
6012713|NCT00333437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6012714|NCT00333437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6012715|NCT00333437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6012716|NCT00333437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012717|NCT00333775|Bevacizumab|bevacizumab|mesh-list
6012718|NCT00333775|Docetaxel|docetaxel|mesh-list
6012719|NCT00333775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6012720|NCT00333775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6012721|NCT00333775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6012722|NCT00333775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6012723|NCT00333775|Growth Substances|growth substances|mesh-ancestor
6012724|NCT00333775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012725|NCT00333775|Growth Inhibitors|growth inhibitors|mesh-ancestor
6012726|NCT00333775|Tubulin Modulators|tubulin modulators|mesh-ancestor
6012727|NCT00333775|Antimitotic Agents|antimitotic agents|mesh-ancestor
6012728|NCT00333775|Mitosis Modulators|mitosis modulators|mesh-ancestor
6012729|NCT00333775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012730|NCT00333788|Certolizumab Pegol|certolizumab pegol|mesh-list
6012731|NCT00333788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6012732|NCT00333788|Immunologic Factors|immunologic factors|mesh-ancestor
6012733|NCT00333788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012734|NCT00333788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6012735|NCT00333814|Dexamethasone|dexamethasone|mesh-list
6012736|NCT00333814|Dexamethasone acetate|dexamethasone acetate|mesh-list
6012737|NCT00333814|BB 1101|bb 1101|mesh-list
6012738|NCT00333814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6012739|NCT00333814|Antiemetics|antiemetics|mesh-ancestor
6012740|NCT00333814|Autonomic Agents|autonomic agents|mesh-ancestor
6012741|NCT00333814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6012742|NCT00333814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012743|NCT00333814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6012744|NCT00333814|Glucocorticoids|glucocorticoids|mesh-ancestor
6012745|NCT00333814|Hormones|hormones|mesh-ancestor
6012746|NCT00333814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6012747|NCT00333814|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6261453|NCT03211117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6012748|NCT00333814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6012749|NCT00333814|Protease Inhibitors|protease inhibitors|mesh-ancestor
6012750|NCT00333814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6012751|NCT00333814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012752|NCT00333840|Interferons|interferons|mesh-list
6012753|NCT00333840|Cytarabine|cytarabine|mesh-list
6012754|NCT00333840|Interferon-alpha|interferon-alpha|mesh-list
6012755|NCT00333840|Interferon alpha-2|interferon alpha-2|mesh-list
6012756|NCT00333840|Imatinib Mesylate|imatinib mesylate|mesh-list
6012757|NCT00333840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6012758|NCT00333840|Antiviral Agents|antiviral agents|mesh-ancestor
6012759|NCT00333840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6012760|NCT00333840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6012761|NCT00333840|Antimetabolites|antimetabolites|mesh-ancestor
6012762|NCT00333840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012763|NCT00333840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6012764|NCT00333840|Immunologic Factors|immunologic factors|mesh-ancestor
6012765|NCT00333840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012766|NCT00333840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6012767|NCT00333840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6012768|NCT00333866|Pregabalin|pregabalin|mesh-list
6012769|NCT00333866|Analgesics|analgesics|mesh-ancestor
6012770|NCT00333866|Sensory System Agents|sensory system agents|mesh-ancestor
6012771|NCT00333866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6012772|NCT00333866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012773|NCT00333866|Anticonvulsants|anticonvulsants|mesh-ancestor
6012774|NCT00333866|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6012775|NCT00333866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6012776|NCT00333866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012777|NCT00333866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6012778|NCT00333866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6012779|NCT00333866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6012780|NCT00333866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6012781|NCT00333866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6012782|NCT00334074|Cytarabine|cytarabine|mesh-list
6012783|NCT00334074|Clofarabine|clofarabine|mesh-list
6012784|NCT00334074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6012785|NCT00334074|Antimetabolites|antimetabolites|mesh-ancestor
6012786|NCT00334074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012787|NCT00334074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6012788|NCT00334074|Antiviral Agents|antiviral agents|mesh-ancestor
6012789|NCT00334074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6012790|NCT00334074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6012791|NCT00334074|Immunologic Factors|immunologic factors|mesh-ancestor
6012792|NCT00334074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012793|NCT00334295|Fulvestrant|fulvestrant|mesh-list
6012794|NCT00334295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6012795|NCT00334295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6012796|NCT00334295|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6012797|NCT00334295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6012798|NCT00334295|Hormone Antagonists|hormone antagonists|mesh-ancestor
6012799|NCT00334295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6012800|NCT00334295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012801|NCT00334542|Simvastatin|simvastatin|mesh-list
6012802|NCT00334542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6012803|NCT00334542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6012804|NCT00334542|Antimetabolites|antimetabolites|mesh-ancestor
6012805|NCT00334542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012806|NCT00334542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6012807|NCT00334542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6012808|NCT00334542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6012809|NCT00334633|Metronidazole|metronidazole|mesh-list
6012810|NCT00334633|Tinidazole|tinidazole|mesh-list
6012811|NCT00334633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6012812|NCT00334633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6012813|NCT00334633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6012814|NCT00334633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6012815|NCT00334633|Alkylating Agents|alkylating agents|mesh-ancestor
6012816|NCT00334633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012817|NCT00334633|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
6012818|NCT00334737|Epoetin Alfa|epoetin alfa|mesh-list
6012819|NCT00334737|Darbepoetin alfa|darbepoetin alfa|mesh-list
6012820|NCT00334737|Hematinics|hematinics|mesh-ancestor
6012821|NCT00334802|Gemcitabine|gemcitabine|mesh-list
6012822|NCT00334802|Paclitaxel|paclitaxel|mesh-list
6012823|NCT00334802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6012824|NCT00334802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6012825|NCT00334802|Tubulin Modulators|tubulin modulators|mesh-ancestor
6012826|NCT00334802|Antimitotic Agents|antimitotic agents|mesh-ancestor
6012827|NCT00334802|Mitosis Modulators|mitosis modulators|mesh-ancestor
6012828|NCT00334802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012829|NCT00334802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6012830|NCT00334802|Antimetabolites|antimetabolites|mesh-ancestor
6012831|NCT00334802|Antiviral Agents|antiviral agents|mesh-ancestor
6012832|NCT00334802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6012833|NCT00334802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6012834|NCT00334802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6012835|NCT00334802|Immunologic Factors|immunologic factors|mesh-ancestor
6012836|NCT00334802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012837|NCT00334815|Bevacizumab|bevacizumab|mesh-list
6012838|NCT00334815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6012839|NCT00334815|Cisplatin|cisplatin|mesh-list
6012840|NCT00334815|Docetaxel|docetaxel|mesh-list
6012841|NCT00334815|Etoposide|etoposide|mesh-list
6012842|NCT00334815|Etoposide phosphate|etoposide phosphate|mesh-list
6012843|NCT00334815|Podophyllotoxin|podophyllotoxin|mesh-list
6012844|NCT00334815|Endothelial Growth Factors|endothelial growth factors|mesh-list
6012845|NCT00334815|Antibodies|antibodies|mesh-list
6012846|NCT00334815|Immunoglobulins|immunoglobulins|mesh-list
6012847|NCT00334815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6012848|NCT00334815|Lenograstim|lenograstim|mesh-list
6012849|NCT00334815|Immunoglobulin G|immunoglobulin g|mesh-list
6012850|NCT00334815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6012851|NCT00334815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6012852|NCT00334815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6261454|NCT03211117|Tubulin Modulators|tubulin modulators|mesh-ancestor
6261455|NCT03211117|Antimitotic Agents|antimitotic agents|mesh-ancestor
6261456|NCT03211117|Mitosis Modulators|mitosis modulators|mesh-ancestor
6261457|NCT03211117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261458|NCT03211117|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6261459|NCT03211117|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6261460|NCT03211117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6012853|NCT00334815|Growth Substances|growth substances|mesh-ancestor
6012854|NCT00334815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012855|NCT00334815|Growth Inhibitors|growth inhibitors|mesh-ancestor
6012856|NCT00334815|Immunologic Factors|immunologic factors|mesh-ancestor
6261461|NCT03211117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6261462|NCT03211117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6261463|NCT03211156|Amoxicillin|amoxicillin|mesh-list
6012857|NCT00334815|Tubulin Modulators|tubulin modulators|mesh-ancestor
6012858|NCT00334815|Antimitotic Agents|antimitotic agents|mesh-ancestor
6012859|NCT00334815|Mitosis Modulators|mitosis modulators|mesh-ancestor
6012860|NCT00334815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012861|NCT00334815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6012862|NCT00334815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6012863|NCT00334815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6012864|NCT00334815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6012865|NCT00334815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6012866|NCT00334815|Keratolytic Agents|keratolytic agents|mesh-ancestor
6012867|NCT00334815|Dermatologic Agents|dermatologic agents|mesh-ancestor
6012868|NCT00334958|Rufinamide|rufinamide|mesh-list
6012869|NCT00334958|Anticonvulsants|anticonvulsants|mesh-ancestor
6012870|NCT00334958|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6012871|NCT00334958|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6012872|NCT00334958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6012873|NCT00334958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012874|NCT00335140|Leucovorin|leucovorin|mesh-list
6012875|NCT00335140|Cytarabine|cytarabine|mesh-list
6012876|NCT00335140|Dexamethasone|dexamethasone|mesh-list
6012877|NCT00335140|Dexamethasone acetate|dexamethasone acetate|mesh-list
6012878|NCT00335140|Rituximab|rituximab|mesh-list
6012879|NCT00335140|Methotrexate|methotrexate|mesh-list
6012880|NCT00335140|Vincristine|vincristine|mesh-list
6012881|NCT00335140|Procarbazine|procarbazine|mesh-list
6012882|NCT00335140|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
6012883|NCT00335140|BB 1101|bb 1101|mesh-list
6012884|NCT00335140|Levoleucovorin|levoleucovorin|mesh-list
6012885|NCT00335140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6012886|NCT00335140|Antiemetics|antiemetics|mesh-ancestor
6012887|NCT00335140|Autonomic Agents|autonomic agents|mesh-ancestor
6012888|NCT00335140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6012889|NCT00335140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012890|NCT00335140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6012891|NCT00335140|Glucocorticoids|glucocorticoids|mesh-ancestor
6012892|NCT00335140|Hormones|hormones|mesh-ancestor
6012893|NCT00335140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6012894|NCT00335140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6012895|NCT00335140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6012896|NCT00335140|Protease Inhibitors|protease inhibitors|mesh-ancestor
6012897|NCT00335140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6012898|NCT00335140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012899|NCT00335140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6012900|NCT00335140|Immunologic Factors|immunologic factors|mesh-ancestor
6012901|NCT00335140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6012902|NCT00335140|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6012903|NCT00335140|Abortifacient Agents|abortifacient agents|mesh-ancestor
6012904|NCT00335140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6012905|NCT00335140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6012906|NCT00335140|Antimetabolites|antimetabolites|mesh-ancestor
6012907|NCT00335140|Dermatologic Agents|dermatologic agents|mesh-ancestor
6012908|NCT00335140|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6012909|NCT00335140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6012910|NCT00335140|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6012911|NCT00335140|Antiviral Agents|antiviral agents|mesh-ancestor
6012912|NCT00335140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6012913|NCT00335140|Antidotes|antidotes|mesh-ancestor
6012914|NCT00335140|Protective Agents|protective agents|mesh-ancestor
6012915|NCT00335140|Vitamin B Complex|vitamin b complex|mesh-ancestor
6012916|NCT00335140|Vitamins|vitamins|mesh-ancestor
6012917|NCT00335140|Micronutrients|micronutrients|mesh-ancestor
6012918|NCT00335140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6012919|NCT00335140|Tubulin Modulators|tubulin modulators|mesh-ancestor
6012920|NCT00335140|Antimitotic Agents|antimitotic agents|mesh-ancestor
6012921|NCT00335140|Mitosis Modulators|mitosis modulators|mesh-ancestor
6261464|NCT03211156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6261465|NCT03211156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6012922|NCT00335153|Levodopa|levodopa|mesh-list
6012923|NCT00335153|Carbidopa|carbidopa|mesh-list
6012924|NCT00335153|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
6012925|NCT00335153|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6012926|NCT00335153|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6012927|NCT00335153|Dopamine Agents|dopamine agents|mesh-ancestor
6012928|NCT00335153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6012929|NCT00335153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012930|NCT00335153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261466|NCT03211234|Ranibizumab|ranibizumab|mesh-list
6012931|NCT00335153|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6012932|NCT00335153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6012933|NCT00335153|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6012934|NCT00335153|Immunologic Factors|immunologic factors|mesh-ancestor
6012935|NCT00335153|Dopamine Agonists|dopamine agonists|mesh-ancestor
6012936|NCT00335283|Lansoprazole|lansoprazole|mesh-list
6012937|NCT00335283|Dexlansoprazole|dexlansoprazole|mesh-list
6012938|NCT00335283|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6012939|NCT00335283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6012940|NCT00335283|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6012941|NCT00335283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6012942|NCT00335283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012943|NCT00335322|Ritonavir|ritonavir|mesh-list
6012944|NCT00335322|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6012945|NCT00335322|Tenofovir|tenofovir|mesh-list
6012946|NCT00335322|Zidovudine|zidovudine|mesh-list
6012947|NCT00335322|Emtricitabine|emtricitabine|mesh-list
6012948|NCT00335322|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6012949|NCT00335322|Abacavir|abacavir|mesh-list
6012950|NCT00335322|Efavirenz|efavirenz|mesh-list
6012951|NCT00335322|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6012952|NCT00335322|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6012953|NCT00335322|Protease Inhibitors|protease inhibitors|mesh-ancestor
6012954|NCT00335322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6012955|NCT00335322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012956|NCT00335322|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6012957|NCT00335322|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6012958|NCT00335322|Antiviral Agents|antiviral agents|mesh-ancestor
6012959|NCT00335322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6012960|NCT00335322|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6012961|NCT00335322|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6012962|NCT00335322|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6012963|NCT00335322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6012964|NCT00335322|Antimetabolites|antimetabolites|mesh-ancestor
6012965|NCT00335322|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6012966|NCT00335322|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6012967|NCT00335322|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6012968|NCT00335322|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6012969|NCT00335322|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6012970|NCT00335452|Clopidogrel|clopidogrel|mesh-list
6012971|NCT00335452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6012972|NCT00335452|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6012973|NCT00335452|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6012974|NCT00335452|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6012975|NCT00335452|Purinergic Agents|purinergic agents|mesh-ancestor
6012976|NCT00335452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6012977|NCT00335452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012978|NCT00335452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012979|NCT00335478|Daptomycin|daptomycin|mesh-list
6012980|NCT00335478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6012981|NCT00335478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6012982|NCT00335504|Sulindac|sulindac|mesh-list
6012983|NCT00335504|Atorvastatin|atorvastatin|mesh-list
6012984|NCT00335504|Calcium|calcium|mesh-list
6012985|NCT00335504|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6012986|NCT00335504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6012987|NCT00335504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6012988|NCT00335504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6012989|NCT00335504|Antimetabolites|antimetabolites|mesh-ancestor
6012990|NCT00335504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6012991|NCT00335504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6012992|NCT00335504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6012993|NCT00335504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6012994|NCT00335504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6012995|NCT00335504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6012996|NCT00335504|Analgesics|analgesics|mesh-ancestor
6012997|NCT00335504|Sensory System Agents|sensory system agents|mesh-ancestor
6012998|NCT00335504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6012999|NCT00335504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6013000|NCT00335504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6013001|NCT00335504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6013002|NCT00335504|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6013003|NCT00335556|Dactinomycin|dactinomycin|mesh-list
6013004|NCT00335556|Cyclophosphamide|cyclophosphamide|mesh-list
6013005|NCT00335556|Carboplatin|carboplatin|mesh-list
6013006|NCT00335556|Doxorubicin|doxorubicin|mesh-list
6013007|NCT00335556|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6013008|NCT00335556|Irinotecan|irinotecan|mesh-list
6013009|NCT00335556|Etoposide|etoposide|mesh-list
6013010|NCT00335556|Vincristine|vincristine|mesh-list
6013011|NCT00335556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6013012|NCT00335556|Immunologic Factors|immunologic factors|mesh-ancestor
6013013|NCT00335556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013014|NCT00335556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6013015|NCT00335556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6013016|NCT00335556|Alkylating Agents|alkylating agents|mesh-ancestor
6013017|NCT00335556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013018|NCT00335556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6013019|NCT00335556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6013020|NCT00335556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6013021|NCT00335556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6013022|NCT00335556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6013023|NCT00335556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6013024|NCT00335556|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6013025|NCT00335556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6013026|NCT00335556|Tubulin Modulators|tubulin modulators|mesh-ancestor
6013027|NCT00335556|Antimitotic Agents|antimitotic agents|mesh-ancestor
6013028|NCT00335556|Mitosis Modulators|mitosis modulators|mesh-ancestor
6013029|NCT00335556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6013030|NCT00335556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6013031|NCT00335556|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6013032|NCT00335556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6013033|NCT00335725|Hormones|hormones|mesh-list
6013034|NCT00335725|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6013035|NCT00335725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6013036|NCT00335725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013037|NCT00335738|Carboplatin|carboplatin|mesh-list
6013038|NCT00335738|Etoposide|etoposide|mesh-list
6013039|NCT00335738|Vincristine|vincristine|mesh-list
6013040|NCT00335738|Etoposide phosphate|etoposide phosphate|mesh-list
6013041|NCT00335738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6013042|NCT00335738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6013043|NCT00335738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6013044|NCT00335738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6013045|NCT00335738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6013046|NCT00335738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013047|NCT00335738|Tubulin Modulators|tubulin modulators|mesh-ancestor
6013048|NCT00335738|Antimitotic Agents|antimitotic agents|mesh-ancestor
6013049|NCT00335738|Mitosis Modulators|mitosis modulators|mesh-ancestor
6013050|NCT00335764|Sirolimus|sirolimus|mesh-list
6013051|NCT00335764|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6013052|NCT00335764|Sorafenib|sorafenib|mesh-list
6013053|NCT00335764|Tipifarnib|tipifarnib|mesh-list
6013054|NCT00335764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6013055|NCT00335764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6013056|NCT00335764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6013057|NCT00335764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013058|NCT00335764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6013059|NCT00335764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6013060|NCT00335764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6013061|NCT00335764|Antifungal Agents|antifungal agents|mesh-ancestor
6013062|NCT00335764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6261467|NCT03211234|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6013063|NCT00335764|Immunologic Factors|immunologic factors|mesh-ancestor
6013064|NCT00335764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013065|NCT00335829|Bevacizumab|bevacizumab|mesh-list
6013066|NCT00335829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6013067|NCT00335829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6013068|NCT00335829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6013069|NCT00335829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6013070|NCT00335829|Growth Substances|growth substances|mesh-ancestor
6013071|NCT00335829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013072|NCT00335829|Growth Inhibitors|growth inhibitors|mesh-ancestor
6013073|NCT00335959|Capecitabine|capecitabine|mesh-list
6013074|NCT00335959|Oxaliplatin|oxaliplatin|mesh-list
6013075|NCT00335959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6013076|NCT00335959|Antimetabolites|antimetabolites|mesh-ancestor
6013077|NCT00335959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013078|NCT00335959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6013079|NCT00335972|Dexmedetomidine|dexmedetomidine|mesh-list
6013080|NCT00335972|Remifentanil|remifentanil|mesh-list
6013081|NCT00335972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6013082|NCT00335972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6013083|NCT00335972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013084|NCT00335972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6013085|NCT00335972|Analgesics|analgesics|mesh-ancestor
6013086|NCT00335972|Sensory System Agents|sensory system agents|mesh-ancestor
6013087|NCT00335972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6013088|NCT00335972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6013089|NCT00335972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6013090|NCT00335972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6013091|NCT00335972|Adrenergic Agents|adrenergic agents|mesh-ancestor
6013092|NCT00335972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6013093|NCT00335972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013094|NCT00335972|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6013095|NCT00335972|Narcotics|narcotics|mesh-ancestor
6013096|NCT00336024|Leucovorin|leucovorin|mesh-list
6013097|NCT00336024|Cyclophosphamide|cyclophosphamide|mesh-list
6013098|NCT00336024|Thiotepa|thiotepa|mesh-list
6013099|NCT00336024|Carboplatin|carboplatin|mesh-list
6013100|NCT00336024|Methotrexate|methotrexate|mesh-list
6013101|NCT00336024|Etoposide|etoposide|mesh-list
6013102|NCT00336024|Vincristine|vincristine|mesh-list
6013103|NCT00336024|Etoposide phosphate|etoposide phosphate|mesh-list
6013104|NCT00336024|Levoleucovorin|levoleucovorin|mesh-list
6013105|NCT00336024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6013106|NCT00336024|Immunologic Factors|immunologic factors|mesh-ancestor
6013107|NCT00336024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013108|NCT00336024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6013109|NCT00336024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6013110|NCT00336024|Alkylating Agents|alkylating agents|mesh-ancestor
6013111|NCT00336024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013112|NCT00336024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6013113|NCT00336024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6013114|NCT00336024|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6013115|NCT00336024|Abortifacient Agents|abortifacient agents|mesh-ancestor
6013116|NCT00336024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6013117|NCT00336024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6013118|NCT00336024|Antimetabolites|antimetabolites|mesh-ancestor
6013119|NCT00336024|Dermatologic Agents|dermatologic agents|mesh-ancestor
6013120|NCT00336024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6013121|NCT00336024|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6013122|NCT00336024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6013123|NCT00336024|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6013124|NCT00336024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6013125|NCT00336024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6013126|NCT00336024|Antidotes|antidotes|mesh-ancestor
6013127|NCT00336024|Protective Agents|protective agents|mesh-ancestor
6013128|NCT00336024|Vitamin B Complex|vitamin b complex|mesh-ancestor
6013129|NCT00336024|Vitamins|vitamins|mesh-ancestor
6013130|NCT00336024|Micronutrients|micronutrients|mesh-ancestor
6013131|NCT00336024|Tubulin Modulators|tubulin modulators|mesh-ancestor
6013132|NCT00336024|Antimitotic Agents|antimitotic agents|mesh-ancestor
6013133|NCT00336024|Mitosis Modulators|mitosis modulators|mesh-ancestor
6013134|NCT00336232|Vitamin K|vitamin k|mesh-list
6013135|NCT00336232|Vitamins|vitamins|mesh-ancestor
6013136|NCT00336232|Micronutrients|micronutrients|mesh-ancestor
6013137|NCT00336232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013138|NCT00336232|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6013139|NCT00336232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6013140|NCT00336232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013141|NCT00336232|Hemostatics|hemostatics|mesh-ancestor
6013142|NCT00336232|Coagulants|coagulants|mesh-ancestor
6013143|NCT00336323|Bevacizumab|bevacizumab|mesh-list
6013144|NCT00336323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6013145|NCT00336323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6013146|NCT00336323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6013147|NCT00336323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6013148|NCT00336323|Growth Substances|growth substances|mesh-ancestor
6013149|NCT00336323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013150|NCT00336323|Growth Inhibitors|growth inhibitors|mesh-ancestor
6013151|NCT00336479|Interferons|interferons|mesh-list
6013152|NCT00336479|Ribavirin|ribavirin|mesh-list
6013153|NCT00336479|Interferon-alpha|interferon-alpha|mesh-list
6013154|NCT00336479|Interferon alpha-2|interferon alpha-2|mesh-list
6013155|NCT00336479|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6261468|NCT03211234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6261469|NCT03211234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6261470|NCT03211234|Growth Substances|growth substances|mesh-ancestor
6261471|NCT03211234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261472|NCT03211234|Growth Inhibitors|growth inhibitors|mesh-ancestor
6261473|NCT03211234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6261474|NCT03211858|Insulin|insulin|mesh-list
6261475|NCT03211858|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6261476|NCT03211858|Insulin Glargine|insulin glargine|mesh-list
6013156|NCT00336479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6013157|NCT00336479|Antiviral Agents|antiviral agents|mesh-ancestor
6013158|NCT00336479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6013159|NCT00336479|Antimetabolites|antimetabolites|mesh-ancestor
6013160|NCT00336479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013161|NCT00336479|Immunologic Factors|immunologic factors|mesh-ancestor
6013162|NCT00336479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013163|NCT00336492|Infliximab|infliximab|mesh-list
6013164|NCT00336492|Dermatologic Agents|dermatologic agents|mesh-ancestor
6013165|NCT00336492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6013166|NCT00336492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6013167|NCT00336505|Clarithromycin|clarithromycin|mesh-list
6013168|NCT00336505|Cethromycin|cethromycin|mesh-list
6013169|NCT00336505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6013170|NCT00336505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6013171|NCT00336505|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6013172|NCT00336505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6261477|NCT03211858|Insulin Aspart|insulin aspart|mesh-list
6261478|NCT03211858|Insulin, Long-Acting|insulin, long-acting|mesh-list
6261479|NCT03211858|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6261480|NCT03211858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6261481|NCT03211858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389955|NCT00189748|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6389956|NCT00189748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6013173|NCT00336505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389957|NCT00189748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389958|NCT00189761|Tacrolimus|tacrolimus|mesh-list
6013174|NCT00336505|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6013175|NCT00336505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6013176|NCT00336544|Clarithromycin|clarithromycin|mesh-list
6013177|NCT00336544|Cethromycin|cethromycin|mesh-list
6013178|NCT00336544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6013179|NCT00336544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6013180|NCT00336544|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6013181|NCT00336544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6013182|NCT00336544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013183|NCT00336544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6013184|NCT00336544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6013185|NCT00336583|Cytarabine|cytarabine|mesh-list
6013186|NCT00336583|Methylprednisolone|methylprednisolone|mesh-list
6013187|NCT00336583|Oxaliplatin|oxaliplatin|mesh-list
6013188|NCT00336583|Etoposide|etoposide|mesh-list
6013189|NCT00336583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6013190|NCT00336583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6013191|NCT00336583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6013192|NCT00336583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6013193|NCT00336583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6013194|NCT00336583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013195|NCT00336583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6013196|NCT00336583|Antimetabolites|antimetabolites|mesh-ancestor
6013197|NCT00336583|Antiviral Agents|antiviral agents|mesh-ancestor
6013198|NCT00336583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6013199|NCT00336583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6013200|NCT00336583|Immunologic Factors|immunologic factors|mesh-ancestor
6013201|NCT00336583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013202|NCT00336583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6013203|NCT00336583|Antiemetics|antiemetics|mesh-ancestor
6013204|NCT00336583|Autonomic Agents|autonomic agents|mesh-ancestor
6013205|NCT00336583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6013206|NCT00336583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6013207|NCT00336583|Glucocorticoids|glucocorticoids|mesh-ancestor
6013208|NCT00336583|Hormones|hormones|mesh-ancestor
6013209|NCT00336583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6013210|NCT00336583|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6013211|NCT00336583|Protective Agents|protective agents|mesh-ancestor
6013212|NCT00336700|Gemcitabine|gemcitabine|mesh-list
6013213|NCT00336700|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6013214|NCT00336700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6013215|NCT00336700|Antimetabolites|antimetabolites|mesh-ancestor
6013216|NCT00336700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013217|NCT00336700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6013218|NCT00336700|Antiviral Agents|antiviral agents|mesh-ancestor
6013219|NCT00336700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6013220|NCT00336700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6013221|NCT00336700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6013222|NCT00336700|Immunologic Factors|immunologic factors|mesh-ancestor
6013223|NCT00336700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013224|NCT00336700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6013225|NCT00336817|Mycophenolic Acid|mycophenolic acid|mesh-list
6013226|NCT00336817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6013227|NCT00336817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6013228|NCT00336817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6261482|NCT03213626|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6013229|NCT00336817|Antitubercular Agents|antitubercular agents|mesh-ancestor
6013230|NCT00336817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6013231|NCT00336817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6013232|NCT00336817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6013233|NCT00336817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013234|NCT00336856|Irinotecan|irinotecan|mesh-list
6013235|NCT00336856|Cetuximab|cetuximab|mesh-list
6013236|NCT00336856|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6013237|NCT00336856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6013238|NCT00336856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6013239|NCT00336856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013240|NCT00336856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6013241|NCT00336856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6013242|NCT00336895|Mycophenolic Acid|mycophenolic acid|mesh-list
6013243|NCT00336895|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6013244|NCT00336895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6013245|NCT00336895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6013246|NCT00336895|Antitubercular Agents|antitubercular agents|mesh-ancestor
6013247|NCT00336895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6013248|NCT00336895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6013249|NCT00336895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6013250|NCT00336895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013251|NCT00337103|Capecitabine|capecitabine|mesh-list
6013252|NCT00337103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6013253|NCT00337103|Antimetabolites|antimetabolites|mesh-ancestor
6013254|NCT00337103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013255|NCT00337103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6013256|NCT00337168|Cytarabine|cytarabine|mesh-list
6013257|NCT00337168|Clofarabine|clofarabine|mesh-list
6013258|NCT00337168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6013259|NCT00337168|Antimetabolites|antimetabolites|mesh-ancestor
6013260|NCT00337168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013261|NCT00337168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6013262|NCT00337168|Antiviral Agents|antiviral agents|mesh-ancestor
6013263|NCT00337168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6013264|NCT00337168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6013265|NCT00337168|Immunologic Factors|immunologic factors|mesh-ancestor
6013266|NCT00337168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013267|NCT00337194|Gemcitabine|gemcitabine|mesh-list
6013268|NCT00337194|Doxorubicin|doxorubicin|mesh-list
6013269|NCT00337194|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6013270|NCT00337194|Vinorelbine|vinorelbine|mesh-list
6013271|NCT00337194|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6013272|NCT00337194|Antibodies|antibodies|mesh-list
6013273|NCT00337194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6013274|NCT00337194|Immunologic Factors|immunologic factors|mesh-ancestor
6013275|NCT00337194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013276|NCT00337194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6013277|NCT00337194|Antimetabolites|antimetabolites|mesh-ancestor
6013278|NCT00337194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013279|NCT00337194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6013280|NCT00337194|Antiviral Agents|antiviral agents|mesh-ancestor
6013281|NCT00337194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6013282|NCT00337194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6013283|NCT00337194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6013284|NCT00337194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6013285|NCT00337194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6013286|NCT00337194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6013287|NCT00337194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6013288|NCT00337194|Tubulin Modulators|tubulin modulators|mesh-ancestor
6013289|NCT00337194|Antimitotic Agents|antimitotic agents|mesh-ancestor
6013290|NCT00337194|Mitosis Modulators|mitosis modulators|mesh-ancestor
6013291|NCT00337194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6013292|NCT00337207|Bevacizumab|bevacizumab|mesh-list
6013293|NCT00337207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6013294|NCT00337207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6013295|NCT00337207|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6013296|NCT00337207|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6013297|NCT00337207|Growth Substances|growth substances|mesh-ancestor
6013298|NCT00337207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013299|NCT00337207|Growth Inhibitors|growth inhibitors|mesh-ancestor
6013300|NCT00337285|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6013301|NCT00337285|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6013302|NCT00337285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013303|NCT00337285|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6013304|NCT00337285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6013305|NCT00337285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6013306|NCT00337285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013307|NCT00337285|Dopamine Agents|dopamine agents|mesh-ancestor
6013308|NCT00337285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6013309|NCT00337350|Rosiglitazone|rosiglitazone|mesh-list
6013310|NCT00337350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6013311|NCT00337350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013312|NCT00337428|Vaccines|vaccines|mesh-list
6013313|NCT00337428|Immunologic Factors|immunologic factors|mesh-ancestor
6013314|NCT00337428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013315|NCT00337467|Ritonavir|ritonavir|mesh-list
6013316|NCT00337467|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6013317|NCT00337467|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6013318|NCT00337467|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6013319|NCT00337467|Protease Inhibitors|protease inhibitors|mesh-ancestor
6013320|NCT00337467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6013321|NCT00337467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013322|NCT00337467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6013323|NCT00337467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6013324|NCT00337467|Antiviral Agents|antiviral agents|mesh-ancestor
6013325|NCT00337467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6013326|NCT00337467|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6013327|NCT00337467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6013328|NCT00337571|Aripiprazole|aripiprazole|mesh-list
6013329|NCT00337571|Antidepressive Agents|antidepressive agents|mesh-ancestor
6013330|NCT00337571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6013331|NCT00337571|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6013332|NCT00337571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6013333|NCT00337571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6013334|NCT00337571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013335|NCT00337571|Dopamine Agonists|dopamine agonists|mesh-ancestor
6013336|NCT00337571|Dopamine Agents|dopamine agents|mesh-ancestor
6013337|NCT00337571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6013338|NCT00337571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013339|NCT00337571|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6013340|NCT00337571|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6013341|NCT00337571|Serotonin Agents|serotonin agents|mesh-ancestor
6013342|NCT00337571|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6013343|NCT00337571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6261483|NCT03213626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6261484|NCT03213626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6013344|NCT00337571|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6013345|NCT00337571|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6013346|NCT00337610|Metformin|metformin|mesh-list
6013347|NCT00337610|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6013348|NCT00337610|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6013349|NCT00337610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013350|NCT00337610|Incretins|incretins|mesh-ancestor
6013351|NCT00337610|Hormones|hormones|mesh-ancestor
6013352|NCT00337610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6013353|NCT00337610|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6013354|NCT00337610|Protease Inhibitors|protease inhibitors|mesh-ancestor
6013355|NCT00337610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6013356|NCT00337610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013357|NCT00337662|Olanzapine|olanzapine|mesh-list
6013358|NCT00337662|Risperidone|risperidone|mesh-list
6013359|NCT00337662|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6013360|NCT00337662|Serotonin Agents|serotonin agents|mesh-ancestor
6013361|NCT00337662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6013362|NCT00337662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013363|NCT00337662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013364|NCT00337662|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6013365|NCT00337662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6013366|NCT00337662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6013367|NCT00337662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6013368|NCT00337662|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6013369|NCT00337662|Dopamine Agents|dopamine agents|mesh-ancestor
6013370|NCT00337662|Antiemetics|antiemetics|mesh-ancestor
6013371|NCT00337662|Autonomic Agents|autonomic agents|mesh-ancestor
6013372|NCT00337662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6013373|NCT00337662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6013374|NCT00337662|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6013375|NCT00337662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6013376|NCT00337662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6013377|NCT00337727|Dexamethasone|dexamethasone|mesh-list
6013378|NCT00337727|Dexamethasone acetate|dexamethasone acetate|mesh-list
6013379|NCT00337727|Ondansetron|ondansetron|mesh-list
6013380|NCT00337727|Aprepitant|aprepitant|mesh-list
6013381|NCT00337727|Fosaprepitant|fosaprepitant|mesh-list
6013382|NCT00337727|BB 1101|bb 1101|mesh-list
6013383|NCT00337727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6013384|NCT00337727|Antiemetics|antiemetics|mesh-ancestor
6013385|NCT00337727|Autonomic Agents|autonomic agents|mesh-ancestor
6013386|NCT00337727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6013387|NCT00337727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013388|NCT00337727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6013389|NCT00337727|Glucocorticoids|glucocorticoids|mesh-ancestor
6013390|NCT00337727|Hormones|hormones|mesh-ancestor
6013391|NCT00337727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6013392|NCT00337727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6013393|NCT00337727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6013394|NCT00337727|Protease Inhibitors|protease inhibitors|mesh-ancestor
6013395|NCT00337727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6013396|NCT00337727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013397|NCT00337727|Antipruritics|antipruritics|mesh-ancestor
6013398|NCT00337727|Dermatologic Agents|dermatologic agents|mesh-ancestor
6013399|NCT00337727|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6013400|NCT00337727|Serotonin Agents|serotonin agents|mesh-ancestor
6013401|NCT00337727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6013402|NCT00337727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6013403|NCT00337727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6013404|NCT00337727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6013405|NCT00337727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6013406|NCT00337727|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6013407|NCT00337727|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6013408|NCT00337779|Glatiramer Acetate|glatiramer acetate|mesh-list
6013409|NCT00337779|(T,G)-A-L|(t,g)-a-l|mesh-list
6013410|NCT00337779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6013411|NCT00337779|Immunologic Factors|immunologic factors|mesh-ancestor
6013412|NCT00337779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013413|NCT00337779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6013414|NCT00337779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6013415|NCT00337935|Epoetin Alfa|epoetin alfa|mesh-list
6013416|NCT00337935|Hematinics|hematinics|mesh-ancestor
6013417|NCT00337987|Prednisone|prednisone|mesh-list
6013418|NCT00337987|Cyclophosphamide|cyclophosphamide|mesh-list
6013419|NCT00337987|Vincristine|vincristine|mesh-list
6013420|NCT00337987|Doxorubicin|doxorubicin|mesh-list
6013421|NCT00337987|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6013422|NCT00337987|Denileukin diftitox|denileukin diftitox|mesh-list
6013423|NCT00337987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6013424|NCT00337987|Immunologic Factors|immunologic factors|mesh-ancestor
6013425|NCT00337987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013426|NCT00337987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6013427|NCT00337987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6013428|NCT00337987|Alkylating Agents|alkylating agents|mesh-ancestor
6261485|NCT03213626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6261486|NCT03213626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261487|NCT03214367|Insulin|insulin|mesh-list
6261488|NCT03214367|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6261489|NCT03214367|Insulin Glargine|insulin glargine|mesh-list
6261490|NCT03214367|Insulin Lispro|insulin lispro|mesh-list
6261491|NCT03214367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6261492|NCT03214367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261493|NCT03214380|Insulin|insulin|mesh-list
6261494|NCT03214380|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6261495|NCT03214380|Metformin|metformin|mesh-list
6261496|NCT03214380|Insulin Glargine|insulin glargine|mesh-list
6261497|NCT03214380|Insulin Lispro|insulin lispro|mesh-list
6261498|NCT03214380|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
6261499|NCT03214380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6261500|NCT03214380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261501|NCT03214380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261502|NCT03215706|Paclitaxel|paclitaxel|mesh-list
6261503|NCT03215706|Carboplatin|carboplatin|mesh-list
6261504|NCT03215706|Nivolumab|nivolumab|mesh-list
6261505|NCT03215706|Pemetrexed|pemetrexed|mesh-list
6261506|NCT03215706|Ipilimumab|ipilimumab|mesh-list
6261507|NCT03215706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6261508|NCT03215706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6261509|NCT03215706|Tubulin Modulators|tubulin modulators|mesh-ancestor
6261510|NCT03215706|Antimitotic Agents|antimitotic agents|mesh-ancestor
6261511|NCT03215706|Mitosis Modulators|mitosis modulators|mesh-ancestor
6261512|NCT03215706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261513|NCT03215706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6261514|NCT03215706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6261515|NCT03215706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6261516|NCT03215706|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6261517|NCT03215706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6261518|NCT03216226|Glucagon|glucagon|mesh-list
6261519|NCT03216226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6261520|NCT03216226|Hormones|hormones|mesh-ancestor
6261521|NCT03216226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6261522|NCT03216226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261523|NCT03216902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6261524|NCT03216902|Latanoprost|latanoprost|mesh-list
6261525|NCT03216902|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6261526|NCT03216954|Acetylcysteine|acetylcysteine|mesh-list
6261527|NCT03216954|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6261528|NCT03216954|Antiviral Agents|antiviral agents|mesh-ancestor
6261529|NCT03216954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6261530|NCT03216954|Expectorants|expectorants|mesh-ancestor
6261531|NCT03216954|Respiratory System Agents|respiratory system agents|mesh-ancestor
6261532|NCT03216954|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6013429|NCT00337987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261533|NCT03216954|Antioxidants|antioxidants|mesh-ancestor
6261534|NCT03216954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013430|NCT00337987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6261535|NCT03216954|Protective Agents|protective agents|mesh-ancestor
6013431|NCT00337987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6013432|NCT00337987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6013433|NCT00337987|Glucocorticoids|glucocorticoids|mesh-ancestor
6013434|NCT00337987|Hormones|hormones|mesh-ancestor
6013435|NCT00337987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6013436|NCT00337987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6013437|NCT00337987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6013438|NCT00337987|Tubulin Modulators|tubulin modulators|mesh-ancestor
6013439|NCT00337987|Antimitotic Agents|antimitotic agents|mesh-ancestor
6013440|NCT00337987|Mitosis Modulators|mitosis modulators|mesh-ancestor
6013441|NCT00337987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6013442|NCT00337987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6013443|NCT00337987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6013444|NCT00337987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6013445|NCT00338039|Gemcitabine|gemcitabine|mesh-list
6013446|NCT00338039|Capecitabine|capecitabine|mesh-list
6013447|NCT00338039|Oxaliplatin|oxaliplatin|mesh-list
6013448|NCT00338039|Cetuximab|cetuximab|mesh-list
6013449|NCT00338039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6013450|NCT00338039|Antimetabolites|antimetabolites|mesh-ancestor
6013451|NCT00338039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013452|NCT00338039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6013453|NCT00338039|Antiviral Agents|antiviral agents|mesh-ancestor
6013454|NCT00338039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6013455|NCT00338039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6013456|NCT00338039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6013457|NCT00338039|Immunologic Factors|immunologic factors|mesh-ancestor
6013458|NCT00338039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013459|NCT00338039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6013460|NCT00338286|Epoetin Alfa|epoetin alfa|mesh-list
6013461|NCT00338286|Hematinics|hematinics|mesh-ancestor
6013462|NCT00338598|Glycine|glycine|mesh-list
6013463|NCT00338598|Glycine Agents|glycine agents|mesh-ancestor
6013464|NCT00338598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6013465|NCT00338598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013466|NCT00338598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013467|NCT00338728|Letrozole|letrozole|mesh-list
6013468|NCT00338728|Imatinib Mesylate|imatinib mesylate|mesh-list
6013469|NCT00338728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6013470|NCT00338728|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6013471|NCT00338728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6013472|NCT00338728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6013473|NCT00338728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013474|NCT00338728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6013475|NCT00338728|Hormone Antagonists|hormone antagonists|mesh-ancestor
6013476|NCT00338728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6013477|NCT00338728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013478|NCT00338728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6013479|NCT00338884|Sunitinib|sunitinib|mesh-list
6013480|NCT00338884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6013481|NCT00338884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6013482|NCT00338884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6013483|NCT00338884|Growth Substances|growth substances|mesh-ancestor
6013484|NCT00338884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013485|NCT00338884|Growth Inhibitors|growth inhibitors|mesh-ancestor
6013486|NCT00338884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6013487|NCT00338884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6013488|NCT00338884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013489|NCT00338949|Olanzapine|olanzapine|mesh-list
6013490|NCT00338949|Risperidone|risperidone|mesh-list
6013491|NCT00338949|Ziprasidone|ziprasidone|mesh-list
6013492|NCT00338949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6013493|NCT00338949|Serotonin Agents|serotonin agents|mesh-ancestor
6013494|NCT00338949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6013495|NCT00338949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013496|NCT00338949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013497|NCT00338949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6013498|NCT00338949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6013499|NCT00338949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6013500|NCT00338949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6013501|NCT00338949|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6013502|NCT00338949|Dopamine Agents|dopamine agents|mesh-ancestor
6013503|NCT00338949|Antiemetics|antiemetics|mesh-ancestor
6013504|NCT00338949|Autonomic Agents|autonomic agents|mesh-ancestor
6013505|NCT00338949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6013506|NCT00338949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6013507|NCT00338949|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6013508|NCT00338949|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6013509|NCT00338949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6013510|NCT00338962|Naltrexone|naltrexone|mesh-list
6013511|NCT00338962|Paroxetine|paroxetine|mesh-list
6013512|NCT00338962|Desipramine|desipramine|mesh-list
6013513|NCT00338962|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6013514|NCT00338962|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6013515|NCT00338962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013516|NCT00338962|Sensory System Agents|sensory system agents|mesh-ancestor
6013517|NCT00338962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6013518|NCT00338962|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6013519|NCT00338962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6013520|NCT00338962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6013521|NCT00338962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013522|NCT00338962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6013523|NCT00338962|Serotonin Agents|serotonin agents|mesh-ancestor
6013524|NCT00338962|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6013525|NCT00338962|Antidepressive Agents|antidepressive agents|mesh-ancestor
6013526|NCT00338962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6013527|NCT00338962|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6013528|NCT00338962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6013529|NCT00338962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6013530|NCT00338962|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6013531|NCT00338962|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6013532|NCT00338962|Adrenergic Agents|adrenergic agents|mesh-ancestor
6013533|NCT00338988|Capecitabine|capecitabine|mesh-list
6013534|NCT00338988|Oxaliplatin|oxaliplatin|mesh-list
6013535|NCT00338988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6013536|NCT00338988|Antimetabolites|antimetabolites|mesh-ancestor
6013537|NCT00338988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013538|NCT00338988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6013539|NCT00339079|Fluoxetine|fluoxetine|mesh-list
6013540|NCT00339079|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6013541|NCT00339079|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6013542|NCT00339079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6013543|NCT00339079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013544|NCT00339079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6013545|NCT00339079|Serotonin Agents|serotonin agents|mesh-ancestor
6013546|NCT00339079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013547|NCT00339079|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6013548|NCT00339079|Antidepressive Agents|antidepressive agents|mesh-ancestor
6013549|NCT00339079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6013550|NCT00339079|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6013551|NCT00339079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6013552|NCT00339079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6013553|NCT00339144|Dasatinib|dasatinib|mesh-list
6013554|NCT00339144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6013555|NCT00339144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6013556|NCT00339144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6013557|NCT00339144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013558|NCT00339183|Panitumumab|panitumumab|mesh-list
6013559|NCT00339183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6013560|NCT00339183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6013561|NCT00339833|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
6013562|NCT00339833|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6013563|NCT00339833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6013564|NCT00339833|Analgesics|analgesics|mesh-ancestor
6013565|NCT00339833|Sensory System Agents|sensory system agents|mesh-ancestor
6013566|NCT00339833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6013567|NCT00339833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013568|NCT00339833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6013569|NCT00339833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6013570|NCT00340379|Haloperidol|haloperidol|mesh-list
6013571|NCT00340379|Haloperidol decanoate|haloperidol decanoate|mesh-list
6013572|NCT00340379|Ziprasidone|ziprasidone|mesh-list
6013573|NCT00340379|Sertraline|sertraline|mesh-list
6013574|NCT00340379|Antidepressive Agents|antidepressive agents|mesh-ancestor
6013575|NCT00340379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6013576|NCT00340379|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6013577|NCT00340379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6013578|NCT00340379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6013579|NCT00340379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013580|NCT00340379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6013581|NCT00340379|Serotonin Agents|serotonin agents|mesh-ancestor
6013582|NCT00340379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013583|NCT00340379|Antiemetics|antiemetics|mesh-ancestor
6013584|NCT00340379|Autonomic Agents|autonomic agents|mesh-ancestor
6013585|NCT00340379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6013586|NCT00340379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6013587|NCT00340379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6013588|NCT00340379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6013589|NCT00340379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6013590|NCT00340379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6013591|NCT00340379|Dopamine Agents|dopamine agents|mesh-ancestor
6013592|NCT00340379|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6013593|NCT00340379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6013594|NCT00340678|Losartan|losartan|mesh-list
6013595|NCT00340678|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6013596|NCT00340678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6013597|NCT00340678|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6013598|NCT00340678|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6013599|NCT00340678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013600|NCT00340704|Tamsulosin|tamsulosin|mesh-list
6013601|NCT00340704|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6013602|NCT00340704|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6013603|NCT00340704|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6013604|NCT00340704|Adrenergic Agents|adrenergic agents|mesh-ancestor
6013605|NCT00340704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6013606|NCT00340704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013607|NCT00340704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013608|NCT00340704|Urological Agents|urological agents|mesh-ancestor
6013609|NCT00340834|Interferons|interferons|mesh-list
6013610|NCT00340834|Interferon-beta|interferon-beta|mesh-list
6013611|NCT00340834|Interferon beta-1a|interferon beta-1a|mesh-list
6013612|NCT00340834|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6013613|NCT00340834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6013614|NCT00340834|Antiviral Agents|antiviral agents|mesh-ancestor
6013615|NCT00340834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6013616|NCT00340834|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6013617|NCT00340834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013618|NCT00340834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6013619|NCT00340834|Immunologic Factors|immunologic factors|mesh-ancestor
6013620|NCT00340834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013621|NCT00340834|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6013622|NCT00342355|Ritonavir|ritonavir|mesh-list
6013623|NCT00342355|Lopinavir|lopinavir|mesh-list
6013624|NCT00342355|Lamivudine|lamivudine|mesh-list
6013625|NCT00342355|Zidovudine|zidovudine|mesh-list
6013626|NCT00342355|Stavudine|stavudine|mesh-list
6013627|NCT00342355|Didanosine|didanosine|mesh-list
6013628|NCT00342355|Efavirenz|efavirenz|mesh-list
6013629|NCT00342355|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6013630|NCT00342355|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6013631|NCT00342355|Protease Inhibitors|protease inhibitors|mesh-ancestor
6013632|NCT00342355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6013633|NCT00342355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013634|NCT00342355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6013635|NCT00342355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6013636|NCT00342355|Antiviral Agents|antiviral agents|mesh-ancestor
6013637|NCT00342355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6013638|NCT00342355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6013639|NCT00342355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6013640|NCT00342355|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6013641|NCT00342355|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6013642|NCT00342355|Antimetabolites|antimetabolites|mesh-ancestor
6013643|NCT00342355|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6013644|NCT00342355|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6013645|NCT00342355|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6013646|NCT00342355|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6013647|NCT00342355|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6013648|NCT00342563|Mecamylamine|mecamylamine|mesh-list
6013649|NCT00342563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6013650|NCT00342563|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
6013651|NCT00342563|Autonomic Agents|autonomic agents|mesh-ancestor
6013652|NCT00342563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6013653|NCT00342563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013654|NCT00342563|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
6013655|NCT00342563|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6013656|NCT00342563|Cholinergic Agents|cholinergic agents|mesh-ancestor
6013657|NCT00342563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6013658|NCT00342563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013659|NCT00342628|Vaccines|vaccines|mesh-list
6013660|NCT00342628|Immunologic Factors|immunologic factors|mesh-ancestor
6013661|NCT00342628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018436|NCT00380718|Pemetrexed|pemetrexed|mesh-list
6018437|NCT00380718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6018438|NCT00380718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6018439|NCT00380718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6018440|NCT00380718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6018441|NCT00380718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6018442|NCT00380874|Pregabalin|pregabalin|mesh-list
6018443|NCT00380874|Analgesics|analgesics|mesh-ancestor
6018444|NCT00380874|Sensory System Agents|sensory system agents|mesh-ancestor
6018445|NCT00380874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6018446|NCT00380874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018447|NCT00380874|Anticonvulsants|anticonvulsants|mesh-ancestor
6018448|NCT00380874|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6018449|NCT00380874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6018450|NCT00380874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6018451|NCT00380874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6018452|NCT00380874|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6018453|NCT00380874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6018454|NCT00380874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6018455|NCT00380874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6018456|NCT00380978|Narcotics|narcotics|mesh-list
6018457|NCT00380978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6018458|NCT00380978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018459|NCT00380978|Analgesics|analgesics|mesh-ancestor
6018460|NCT00380978|Sensory System Agents|sensory system agents|mesh-ancestor
6018461|NCT00380978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6018462|NCT00381004|Vidarabine|vidarabine|mesh-list
6018463|NCT00381004|Cyclophosphamide|cyclophosphamide|mesh-list
6018464|NCT00381004|Rituximab|rituximab|mesh-list
6018465|NCT00381004|Fludarabine|fludarabine|mesh-list
6018466|NCT00381004|Fludarabine phosphate|fludarabine phosphate|mesh-list
6018467|NCT00381004|Sargramostim|sargramostim|mesh-list
6018468|NCT00381004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6013662|NCT00343044|Bevacizumab|bevacizumab|mesh-list
6013663|NCT00343044|Topotecan|topotecan|mesh-list
6013664|NCT00343044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6013665|NCT00343044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6013666|NCT00343044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6013667|NCT00343044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6013668|NCT00343044|Growth Substances|growth substances|mesh-ancestor
6013669|NCT00343044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013670|NCT00343044|Growth Inhibitors|growth inhibitors|mesh-ancestor
6013671|NCT00343044|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6013672|NCT00343044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6261536|NCT03216954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261537|NCT03216954|Antidotes|antidotes|mesh-ancestor
6261538|NCT03218592|Tenofovir|tenofovir|mesh-list
6261539|NCT03218592|Emtricitabine|emtricitabine|mesh-list
6261540|NCT03218592|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6261541|NCT03218592|Maraviroc|maraviroc|mesh-list
6261542|NCT03218592|Dolutegravir|dolutegravir|mesh-list
6261543|NCT03218592|Antiviral Agents|antiviral agents|mesh-ancestor
6261544|NCT03218592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6261545|NCT03218592|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6261546|NCT03218592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6261547|NCT03218592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6261548|NCT03218592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261549|NCT03218592|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6261550|NCT03218592|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6261551|NCT03218592|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6261552|NCT03218592|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6261553|NCT03218592|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6261554|NCT03218592|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6261555|NCT03218592|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6261556|NCT03219294|Bromides|bromides|mesh-list
6261557|NCT03219294|Vecuronium Bromide|vecuronium bromide|mesh-list
6261558|NCT03219294|Anticonvulsants|anticonvulsants|mesh-ancestor
6261559|NCT03219294|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6261560|NCT03219294|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6261561|NCT03219294|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6261562|NCT03219294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6261563|NCT03219294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261564|NCT03219294|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
6261565|NCT03219294|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6261566|NCT03219294|Cholinergic Agents|cholinergic agents|mesh-ancestor
6261567|NCT03219294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6261568|NCT03219294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261569|NCT03219723|Amoxicillin|amoxicillin|mesh-list
6261570|NCT03219723|Metronidazole|metronidazole|mesh-list
6261571|NCT03219723|Clarithromycin|clarithromycin|mesh-list
6261572|NCT03219723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6261573|NCT03219723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6261574|NCT03219723|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6261575|NCT03219723|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6261576|NCT03219723|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6261577|NCT03219723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6261578|NCT03219723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261579|NCT03219723|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6261580|NCT03219723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6261581|NCT03219840|Cetylpyridinium|cetylpyridinium|mesh-list
6261582|NCT03219840|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6261583|NCT03219840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6261584|NCT03219866|Budesonide|budesonide|mesh-list
6261585|NCT03219866|Tiotropium Bromide|tiotropium bromide|mesh-list
6261586|NCT03219866|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6261587|NCT03219866|Ipratropium|ipratropium|mesh-list
6261588|NCT03219866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6261589|NCT03219866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6261590|NCT03219866|Autonomic Agents|autonomic agents|mesh-ancestor
6261591|NCT03219866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6261592|NCT03219866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261593|NCT03219866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6261594|NCT03219866|Respiratory System Agents|respiratory system agents|mesh-ancestor
6261595|NCT03219866|Glucocorticoids|glucocorticoids|mesh-ancestor
6261596|NCT03219866|Hormones|hormones|mesh-ancestor
6261597|NCT03219866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6261598|NCT03219866|Parasympatholytics|parasympatholytics|mesh-ancestor
6261599|NCT03219866|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6013673|NCT00343044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6013674|NCT00343044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013675|NCT00343083|Paclitaxel|paclitaxel|mesh-list
6013676|NCT00343083|Carboplatin|carboplatin|mesh-list
6013677|NCT00343083|Cetuximab|cetuximab|mesh-list
6013678|NCT00343083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6013679|NCT00343083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6013680|NCT00343083|Tubulin Modulators|tubulin modulators|mesh-ancestor
6013681|NCT00343083|Antimitotic Agents|antimitotic agents|mesh-ancestor
6013682|NCT00343083|Mitosis Modulators|mitosis modulators|mesh-ancestor
6013683|NCT00343083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013684|NCT00343083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6013685|NCT00343252|Teriparatide|teriparatide|mesh-list
6013686|NCT00343252|Risedronic Acid|risedronic acid|mesh-list
6013687|NCT00343252|Etidronic Acid|etidronic acid|mesh-list
6013688|NCT00343252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6013689|NCT00343252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013690|NCT00343252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6013691|NCT00343252|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6013692|NCT00343252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6013693|NCT00343252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013694|NCT00343291|Paclitaxel|paclitaxel|mesh-list
6013695|NCT00343291|Bevacizumab|bevacizumab|mesh-list
6013696|NCT00343291|Carboplatin|carboplatin|mesh-list
6013697|NCT00343291|Cetuximab|cetuximab|mesh-list
6013698|NCT00343291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6013699|NCT00343291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6013700|NCT00343291|Tubulin Modulators|tubulin modulators|mesh-ancestor
6013701|NCT00343291|Antimitotic Agents|antimitotic agents|mesh-ancestor
6013702|NCT00343291|Mitosis Modulators|mitosis modulators|mesh-ancestor
6013703|NCT00343291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013704|NCT00343291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6013705|NCT00343291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6013706|NCT00343291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6013707|NCT00343291|Growth Substances|growth substances|mesh-ancestor
6013708|NCT00343291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013709|NCT00343291|Growth Inhibitors|growth inhibitors|mesh-ancestor
6013710|NCT00343382|Pilocarpine|pilocarpine|mesh-list
6013711|NCT00343382|Miotics|miotics|mesh-ancestor
6013712|NCT00343382|Autonomic Agents|autonomic agents|mesh-ancestor
6013713|NCT00343382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6013714|NCT00343382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013715|NCT00343382|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6013716|NCT00343382|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6013717|NCT00343382|Cholinergic Agents|cholinergic agents|mesh-ancestor
6013718|NCT00343382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6013719|NCT00343382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013720|NCT00343460|Dexamethasone|dexamethasone|mesh-list
6013721|NCT00343460|Palonosetron|palonosetron|mesh-list
6013722|NCT00343460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6013723|NCT00343460|Antiemetics|antiemetics|mesh-ancestor
6013724|NCT00343460|Autonomic Agents|autonomic agents|mesh-ancestor
6013725|NCT00343460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6013726|NCT00343460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013727|NCT00343460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6013728|NCT00343460|Glucocorticoids|glucocorticoids|mesh-ancestor
6013729|NCT00343460|Hormones|hormones|mesh-ancestor
6013730|NCT00343460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6013731|NCT00343460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6013732|NCT00343460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6013733|NCT00343460|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6013734|NCT00343460|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6013735|NCT00343460|Serotonin Agents|serotonin agents|mesh-ancestor
6013736|NCT00343460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6013737|NCT00343460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013738|NCT00343512|Docetaxel|docetaxel|mesh-list
6013739|NCT00343512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6013740|NCT00343512|Tubulin Modulators|tubulin modulators|mesh-ancestor
6013741|NCT00343512|Antimitotic Agents|antimitotic agents|mesh-ancestor
6013742|NCT00343512|Mitosis Modulators|mitosis modulators|mesh-ancestor
6013743|NCT00343512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013744|NCT00343785|Cyclosporine|cyclosporine|mesh-list
6013745|NCT00343785|Cyclophosphamide|cyclophosphamide|mesh-list
6013746|NCT00343785|Methotrexate|methotrexate|mesh-list
6013747|NCT00343785|Cyclosporins|cyclosporins|mesh-list
6013748|NCT00343785|Thymoglobulin|thymoglobulin|mesh-list
6013749|NCT00343785|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6013750|NCT00343785|Immunoglobulins|immunoglobulins|mesh-list
6013751|NCT00343785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6013752|NCT00343785|Immunologic Factors|immunologic factors|mesh-ancestor
6013753|NCT00343785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013754|NCT00343785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6013755|NCT00343785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6013756|NCT00343785|Alkylating Agents|alkylating agents|mesh-ancestor
6013757|NCT00343785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013758|NCT00343785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6013759|NCT00343785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6013760|NCT00343785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6013761|NCT00343785|Abortifacient Agents|abortifacient agents|mesh-ancestor
6013762|NCT00343785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6013763|NCT00343785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6013764|NCT00343785|Antimetabolites|antimetabolites|mesh-ancestor
6013765|NCT00343785|Dermatologic Agents|dermatologic agents|mesh-ancestor
6013766|NCT00343785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6013767|NCT00343785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6013768|NCT00343785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6013769|NCT00343785|Antifungal Agents|antifungal agents|mesh-ancestor
6013770|NCT00343785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6013771|NCT00343785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6013772|NCT00343863|Dexamethasone|dexamethasone|mesh-list
6013773|NCT00343863|Cyclophosphamide|cyclophosphamide|mesh-list
6013774|NCT00343863|Doxorubicin|doxorubicin|mesh-list
6013775|NCT00343863|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6013776|NCT00343863|Ondansetron|ondansetron|mesh-list
6013777|NCT00343863|Palonosetron|palonosetron|mesh-list
6013778|NCT00343863|Antiemetics|antiemetics|mesh-list
6013779|NCT00343863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6013780|NCT00343863|Immunologic Factors|immunologic factors|mesh-ancestor
6013781|NCT00343863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013782|NCT00343863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6013783|NCT00343863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6013784|NCT00343863|Alkylating Agents|alkylating agents|mesh-ancestor
6013785|NCT00343863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013786|NCT00343863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6013787|NCT00343863|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6013788|NCT00343863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6013789|NCT00343863|Autonomic Agents|autonomic agents|mesh-ancestor
6013790|NCT00343863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6013791|NCT00343863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6013792|NCT00343863|Glucocorticoids|glucocorticoids|mesh-ancestor
6013793|NCT00343863|Hormones|hormones|mesh-ancestor
6013794|NCT00343863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6013795|NCT00343863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6013796|NCT00343863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6013797|NCT00343863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6013798|NCT00343863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6013799|NCT00343863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6013800|NCT00343863|Antipruritics|antipruritics|mesh-ancestor
6013801|NCT00343863|Dermatologic Agents|dermatologic agents|mesh-ancestor
6013802|NCT00343863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6013803|NCT00343863|Serotonin Agents|serotonin agents|mesh-ancestor
6013804|NCT00343863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6013805|NCT00343863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6013806|NCT00343863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6013807|NCT00343863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6013808|NCT00343863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6013809|NCT00343863|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6013810|NCT00343863|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6013811|NCT00343889|Vaccines|vaccines|mesh-list
6013812|NCT00343889|Immunologic Factors|immunologic factors|mesh-ancestor
6013813|NCT00343889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013814|NCT00344032|Vaccines|vaccines|mesh-list
6013815|NCT00344032|Immunologic Factors|immunologic factors|mesh-ancestor
6013816|NCT00344032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013817|NCT00344175|Simvastatin|simvastatin|mesh-list
6013818|NCT00344175|Pitavastatin|pitavastatin|mesh-list
6013819|NCT00344175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6013820|NCT00344175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6013821|NCT00344175|Antimetabolites|antimetabolites|mesh-ancestor
6013822|NCT00344175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013823|NCT00344175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6013824|NCT00344175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6013825|NCT00344175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6013826|NCT00344305|Vaccines|vaccines|mesh-list
6013827|NCT00344305|Immunologic Factors|immunologic factors|mesh-ancestor
6013828|NCT00344305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013829|NCT00344318|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6013830|NCT00344318|Immunologic Factors|immunologic factors|mesh-ancestor
6013831|NCT00344318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013832|NCT00344370|Atorvastatin|atorvastatin|mesh-list
6013833|NCT00344370|Pitavastatin|pitavastatin|mesh-list
6013834|NCT00344370|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6013835|NCT00344370|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6013836|NCT00344370|Antimetabolites|antimetabolites|mesh-ancestor
6013837|NCT00344370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013838|NCT00344370|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6013839|NCT00344370|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6013840|NCT00344370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6013841|NCT00344461|Tenofovir|tenofovir|mesh-list
6013842|NCT00344461|Nevirapine|nevirapine|mesh-list
6013843|NCT00344461|Antiviral Agents|antiviral agents|mesh-ancestor
6013844|NCT00344461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6013845|NCT00344461|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6013846|NCT00344461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6013847|NCT00344461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6013848|NCT00344461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013849|NCT00344461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6013850|NCT00344461|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6013851|NCT00344461|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6013852|NCT00344461|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6013853|NCT00344682|Memantine|memantine|mesh-list
6013854|NCT00344682|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6013855|NCT00344682|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6013856|NCT00344682|Dopamine Agents|dopamine agents|mesh-ancestor
6013857|NCT00344682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6013858|NCT00344682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013859|NCT00344682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013860|NCT00344682|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6013861|NCT00344682|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6013862|NCT00344773|Gefitinib|gefitinib|mesh-list
6013863|NCT00344773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6013864|NCT00344773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6013865|NCT00344773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6013866|NCT00344773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013867|NCT00344968|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
6013868|NCT00344968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6013869|NCT00344968|Glucocorticoids|glucocorticoids|mesh-ancestor
6013870|NCT00344968|Hormones|hormones|mesh-ancestor
6018469|NCT00381004|Immunologic Factors|immunologic factors|mesh-ancestor
6013871|NCT00344968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6013872|NCT00344968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013873|NCT00345033|Aripiprazole|aripiprazole|mesh-list
6013874|NCT00345033|Antidepressive Agents|antidepressive agents|mesh-ancestor
6013875|NCT00345033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6013876|NCT00345033|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6013877|NCT00345033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6013878|NCT00345033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6013879|NCT00345033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013880|NCT00345033|Dopamine Agonists|dopamine agonists|mesh-ancestor
6013881|NCT00345033|Dopamine Agents|dopamine agents|mesh-ancestor
6013882|NCT00345033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6013883|NCT00345033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013884|NCT00345033|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6013885|NCT00345033|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6013886|NCT00345033|Serotonin Agents|serotonin agents|mesh-ancestor
6013887|NCT00345033|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6013888|NCT00345033|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6013889|NCT00345033|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6013890|NCT00345033|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6013891|NCT00345046|Prednisolone|prednisolone|mesh-list
6013892|NCT00345046|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6013893|NCT00345046|Methylprednisolone|methylprednisolone|mesh-list
6013894|NCT00345046|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6013895|NCT00345046|Prednisolone acetate|prednisolone acetate|mesh-list
6013896|NCT00345046|Prednisone|prednisone|mesh-list
6013897|NCT00345046|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6013898|NCT00345046|Prednisolone phosphate|prednisolone phosphate|mesh-list
6013899|NCT00345046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6013900|NCT00345046|Glucocorticoids|glucocorticoids|mesh-ancestor
6013901|NCT00345046|Hormones|hormones|mesh-ancestor
6013902|NCT00345046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6013903|NCT00345046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013904|NCT00345046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6013905|NCT00345046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6013906|NCT00345046|Antiemetics|antiemetics|mesh-ancestor
6013907|NCT00345046|Autonomic Agents|autonomic agents|mesh-ancestor
6013908|NCT00345046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6013909|NCT00345046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6013910|NCT00345046|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6013911|NCT00345046|Protective Agents|protective agents|mesh-ancestor
6013912|NCT00345371|Topiramate|topiramate|mesh-list
6013913|NCT00345371|Anticonvulsants|anticonvulsants|mesh-ancestor
6013914|NCT00345371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6013915|NCT00345371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013916|NCT00345384|Dexmedetomidine|dexmedetomidine|mesh-list
6013917|NCT00345384|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6013918|NCT00345384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6013919|NCT00345384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013920|NCT00345384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6013921|NCT00345384|Analgesics|analgesics|mesh-ancestor
6013922|NCT00345384|Sensory System Agents|sensory system agents|mesh-ancestor
6013923|NCT00345384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6013924|NCT00345384|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6013925|NCT00345384|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6013926|NCT00345384|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6013927|NCT00345384|Adrenergic Agents|adrenergic agents|mesh-ancestor
6013928|NCT00345384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6013929|NCT00345384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013930|NCT00345540|Carboplatin|carboplatin|mesh-list
6013931|NCT00345540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5724157|NCT03189329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013932|NCT00345579|PENTA|penta|mesh-list
6013933|NCT00345579|Anticoagulants|anticoagulants|mesh-ancestor
6013934|NCT00345579|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6013935|NCT00345579|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6013936|NCT00345579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013937|NCT00345605|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
6013938|NCT00345605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6013939|NCT00345683|Vaccines|vaccines|mesh-list
6013940|NCT00345683|Immunologic Factors|immunologic factors|mesh-ancestor
5724158|NCT03189329|Sensory System Agents|sensory system agents|mesh-ancestor
6018518|NCT00381550|Antimetabolites|antimetabolites|mesh-ancestor
6013941|NCT00345683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013942|NCT00345839|Cinacalcet|cinacalcet|mesh-list
6013943|NCT00345839|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6013944|NCT00345839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013945|NCT00345839|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6013946|NCT00345839|Hormone Antagonists|hormone antagonists|mesh-ancestor
6013947|NCT00345839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6013948|NCT00345865|Cytarabine|cytarabine|mesh-list
6013949|NCT00345865|Cyclophosphamide|cyclophosphamide|mesh-list
6261600|NCT03219866|Cholinergic Agents|cholinergic agents|mesh-ancestor
6261601|NCT03219866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6261602|NCT03219866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261603|NCT03219866|Sympathomimetics|sympathomimetics|mesh-ancestor
6261604|NCT03220958|Diphenhydramine|diphenhydramine|mesh-list
6261605|NCT03220958|Promethazine|promethazine|mesh-list
6261606|NCT03220958|Metoclopramide|metoclopramide|mesh-list
6261607|NCT03220958|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6261608|NCT03220958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6261609|NCT03220958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6261610|NCT03220958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261611|NCT03220958|Anesthetics, Local|anesthetics, local|mesh-ancestor
6261612|NCT03220958|Anesthetics|anesthetics|mesh-ancestor
6261613|NCT03220958|Sensory System Agents|sensory system agents|mesh-ancestor
6261614|NCT03220958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6261615|NCT03220958|Antiemetics|antiemetics|mesh-ancestor
6261616|NCT03220958|Autonomic Agents|autonomic agents|mesh-ancestor
6261617|NCT03220958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6261618|NCT03220958|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6261619|NCT03220958|Histamine Antagonists|histamine antagonists|mesh-ancestor
6261620|NCT03220958|Histamine Agents|histamine agents|mesh-ancestor
6261621|NCT03220958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6261622|NCT03220958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261623|NCT03220958|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6261624|NCT03220958|Antipruritics|antipruritics|mesh-ancestor
6261625|NCT03220958|Dermatologic Agents|dermatologic agents|mesh-ancestor
6261626|NCT03220958|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6261627|NCT03220958|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6261628|NCT03220958|Dopamine Agents|dopamine agents|mesh-ancestor
6261629|NCT03221764|Amiodarone|amiodarone|mesh-list
6261630|NCT03221764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6261631|NCT03221764|Vasodilator Agents|vasodilator agents|mesh-ancestor
6261632|NCT03221764|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6261633|NCT03221764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6261634|NCT03221764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261635|NCT03221764|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6261636|NCT03221764|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6261637|NCT03221764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6261638|NCT03221764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6261639|NCT03221764|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6261640|NCT03221764|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6261641|NCT03221764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6261642|NCT03222349|Diazepam|diazepam|mesh-list
6261643|NCT03222349|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6261644|NCT03222349|Anticonvulsants|anticonvulsants|mesh-ancestor
6261645|NCT03222349|Antiemetics|antiemetics|mesh-ancestor
6261646|NCT03222349|Autonomic Agents|autonomic agents|mesh-ancestor
6261647|NCT03222349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6261648|NCT03222349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013950|NCT00345865|Carmustine|carmustine|mesh-list
6013951|NCT00345865|Etoposide|etoposide|mesh-list
6013952|NCT00345865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6013953|NCT00345865|Immunologic Factors|immunologic factors|mesh-ancestor
6013954|NCT00345865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013955|NCT00345865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6013956|NCT00345865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6013957|NCT00345865|Alkylating Agents|alkylating agents|mesh-ancestor
6013958|NCT00345865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013959|NCT00345865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6013960|NCT00345865|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6013961|NCT00345865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6013962|NCT00345865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6013963|NCT00345865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6013964|NCT00345865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6013965|NCT00345865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6013966|NCT00345865|Antimetabolites|antimetabolites|mesh-ancestor
6013967|NCT00345865|Antiviral Agents|antiviral agents|mesh-ancestor
6013968|NCT00345865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6013969|NCT00345878|Vaccines|vaccines|mesh-list
6013970|NCT00345878|Immunologic Factors|immunologic factors|mesh-ancestor
6013971|NCT00345878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013972|NCT00345969|Testosterone|testosterone|mesh-list
6013973|NCT00345969|Androgens|androgens|mesh-ancestor
6013974|NCT00345969|Hormones|hormones|mesh-ancestor
6013975|NCT00345969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6013976|NCT00345969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013977|NCT00346034|Pregabalin|pregabalin|mesh-list
6013978|NCT00346034|Analgesics|analgesics|mesh-ancestor
6013979|NCT00346034|Sensory System Agents|sensory system agents|mesh-ancestor
6013980|NCT00346034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6013981|NCT00346034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6013982|NCT00346034|Anticonvulsants|anticonvulsants|mesh-ancestor
6013983|NCT00346034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6013984|NCT00346034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6013985|NCT00346034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6013986|NCT00346034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6013987|NCT00346034|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6013988|NCT00346034|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6013989|NCT00346034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6013990|NCT00346034|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6013991|NCT00346151|Sirolimus|sirolimus|mesh-list
6013992|NCT00346151|Methylprednisolone|methylprednisolone|mesh-list
6013993|NCT00346151|Abatacept|abatacept|mesh-list
6013994|NCT00346151|Thymoglobulin|thymoglobulin|mesh-list
6013995|NCT00346151|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6013996|NCT00346151|Immunoglobulins|immunoglobulins|mesh-list
6013997|NCT00346151|Glucocorticoids|glucocorticoids|mesh-list
6013998|NCT00346151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6013999|NCT00346151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6014000|NCT00346151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6014001|NCT00346151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6014002|NCT00346151|Antifungal Agents|antifungal agents|mesh-ancestor
6014003|NCT00346151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6014004|NCT00346151|Immunologic Factors|immunologic factors|mesh-ancestor
6014005|NCT00346151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014006|NCT00346151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6014007|NCT00346151|Antiemetics|antiemetics|mesh-ancestor
6014008|NCT00346151|Autonomic Agents|autonomic agents|mesh-ancestor
6014009|NCT00346151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6014010|NCT00346151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6014011|NCT00346151|Hormones|hormones|mesh-ancestor
6014012|NCT00346151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6014013|NCT00346151|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6014014|NCT00346151|Protective Agents|protective agents|mesh-ancestor
6014015|NCT00346151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6014016|NCT00346151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014017|NCT00346151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6014018|NCT00346164|Doxorubicin|doxorubicin|mesh-list
6014019|NCT00346164|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6014020|NCT00346164|Ifosfamide|ifosfamide|mesh-list
6014021|NCT00346164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6014022|NCT00346164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6014023|NCT00346164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6014024|NCT00346164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6014025|NCT00346164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6014026|NCT00346164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014027|NCT00346164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6014028|NCT00346164|Alkylating Agents|alkylating agents|mesh-ancestor
6014029|NCT00346216|Ibuprofen|ibuprofen|mesh-list
6014030|NCT00346216|Celecoxib|celecoxib|mesh-list
6014031|NCT00346216|Naproxen|naproxen|mesh-list
6014032|NCT00346216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6014033|NCT00346216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6014034|NCT00346216|Analgesics|analgesics|mesh-ancestor
6014035|NCT00346216|Sensory System Agents|sensory system agents|mesh-ancestor
6014036|NCT00346216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6014037|NCT00346216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014038|NCT00346216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6014039|NCT00346216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6014040|NCT00346216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6014041|NCT00346216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6014042|NCT00346216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014043|NCT00346216|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6014044|NCT00346216|Gout Suppressants|gout suppressants|mesh-ancestor
6014045|NCT00346268|Parecoxib|parecoxib|mesh-list
6014046|NCT00346268|Morphine|morphine|mesh-list
6014047|NCT00346268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6014048|NCT00346268|Narcotics|narcotics|mesh-ancestor
6014049|NCT00346268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6014050|NCT00346268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014051|NCT00346268|Analgesics|analgesics|mesh-ancestor
6014052|NCT00346268|Sensory System Agents|sensory system agents|mesh-ancestor
6014053|NCT00346268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6014054|NCT00346268|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6014055|NCT00346268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6014056|NCT00346268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6014057|NCT00346268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014058|NCT00346268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6014059|NCT00346268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6014060|NCT00346268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6014061|NCT00346268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6014062|NCT00346775|Beclomethasone|beclomethasone|mesh-list
6014063|NCT00346775|Flunisolide|flunisolide|mesh-list
6014064|NCT00346775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6014065|NCT00346775|Glucocorticoids|glucocorticoids|mesh-ancestor
6014066|NCT00346775|Hormones|hormones|mesh-ancestor
6014067|NCT00346775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6014068|NCT00346775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014069|NCT00346775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6014070|NCT00346775|Respiratory System Agents|respiratory system agents|mesh-ancestor
6014071|NCT00347009|Adefovir|adefovir|mesh-list
6014072|NCT00347009|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6014073|NCT00347009|Antiviral Agents|antiviral agents|mesh-ancestor
6014074|NCT00347009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6014075|NCT00347009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6014076|NCT00347009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6014077|NCT00347009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6014078|NCT00347009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014079|NCT00347269|Psychotropic Drugs|psychotropic drugs|mesh-list
6014080|NCT00347360|Carvedilol|carvedilol|mesh-list
6014081|NCT00347360|Lisinopril|lisinopril|mesh-list
6014082|NCT00347360|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6014083|NCT00347360|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6014084|NCT00347360|Adrenergic Agents|adrenergic agents|mesh-ancestor
6014085|NCT00347360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6014086|NCT00347360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014087|NCT00347360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014088|NCT00347360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6014089|NCT00347360|Antioxidants|antioxidants|mesh-ancestor
6014090|NCT00347360|Protective Agents|protective agents|mesh-ancestor
6014091|NCT00347360|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6014092|NCT00347360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6014093|NCT00347360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6014094|NCT00347360|Vasodilator Agents|vasodilator agents|mesh-ancestor
6014095|NCT00347360|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6014096|NCT00347360|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6014097|NCT00347360|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6014098|NCT00347360|Protease Inhibitors|protease inhibitors|mesh-ancestor
6014099|NCT00347360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6014100|NCT00347360|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6014101|NCT00347438|Capecitabine|capecitabine|mesh-list
6014102|NCT00347438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6014103|NCT00347438|Antimetabolites|antimetabolites|mesh-ancestor
6014104|NCT00347438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014105|NCT00347438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6014106|NCT00347776|Azithromycin|azithromycin|mesh-list
6014107|NCT00347776|Tetracycline|tetracycline|mesh-list
6014108|NCT00347776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6014109|NCT00347776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6014110|NCT00347776|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6014111|NCT00347776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6014112|NCT00347776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014113|NCT00347919|Lapatinib|lapatinib|mesh-list
6014114|NCT00347919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6014115|NCT00347919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6014116|NCT00347919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6014117|NCT00347919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014118|NCT00347932|Besifloxacin|besifloxacin|mesh-list
6014119|NCT00347932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6014120|NCT00347932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6014121|NCT00347932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6014122|NCT00347932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6014123|NCT00347932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6014124|NCT00347932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014125|NCT00347932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6014126|NCT00348140|Rosiglitazone|rosiglitazone|mesh-list
6014127|NCT00348140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6014128|NCT00348140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014129|NCT00348283|Adalimumab|adalimumab|mesh-list
6014130|NCT00348283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6014131|NCT00348283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6014132|NCT00348309|Rosiglitazone|rosiglitazone|mesh-list
6014133|NCT00348309|Donepezil|donepezil|mesh-list
6014134|NCT00348309|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6014135|NCT00348309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6014136|NCT00348309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014137|NCT00348309|Cholinergic Agents|cholinergic agents|mesh-ancestor
6014138|NCT00348309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6014139|NCT00348309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014140|NCT00348309|Nootropic Agents|nootropic agents|mesh-ancestor
6014141|NCT00348309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6014142|NCT00348348|Moxifloxacin|moxifloxacin|mesh-list
6014143|NCT00348348|Besifloxacin|besifloxacin|mesh-list
6014144|NCT00348348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6014145|NCT00348348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6014146|NCT00348348|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6014147|NCT00348348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6014148|NCT00348348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6014149|NCT00348348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014150|NCT00348348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6014151|NCT00348374|Insulin Lispro|insulin lispro|mesh-list
6014152|NCT00348374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6014153|NCT00348374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014154|NCT00348595|Lenalidomide|lenalidomide|mesh-list
6014155|NCT00348595|Immunologic Factors|immunologic factors|mesh-ancestor
6014156|NCT00348595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014157|NCT00348595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6014158|NCT00348595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6014159|NCT00348595|Growth Substances|growth substances|mesh-ancestor
6014160|NCT00348595|Growth Inhibitors|growth inhibitors|mesh-ancestor
6014161|NCT00348595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6014162|NCT00348686|Felodipine|felodipine|mesh-list
6014163|NCT00348686|Candesartan|candesartan|mesh-list
6014164|NCT00348686|Candesartan cilexetil|candesartan cilexetil|mesh-list
6014165|NCT00348686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6014166|NCT00348686|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6014167|NCT00348686|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6014168|NCT00348686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014169|NCT00348686|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6014170|NCT00348686|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6014171|NCT00348686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6014172|NCT00348686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6014173|NCT00348686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014174|NCT00348686|Vasodilator Agents|vasodilator agents|mesh-ancestor
6014175|NCT00348790|Vatalanib|vatalanib|mesh-list
6261649|NCT03222349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6261650|NCT03222349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6261651|NCT03222349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6261652|NCT03222349|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6261653|NCT03222349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6261654|NCT03222349|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6261655|NCT03222349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6261656|NCT03222349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6261657|NCT03222349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6261658|NCT03222349|Anesthetics, General|anesthetics, general|mesh-ancestor
6261659|NCT03222349|Anesthetics|anesthetics|mesh-ancestor
6261660|NCT03222349|GABA Modulators|gaba modulators|mesh-ancestor
6261661|NCT03222349|GABA Agents|gaba agents|mesh-ancestor
6261662|NCT03222349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6261663|NCT03222349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261664|NCT03223272|Reserpine|reserpine|mesh-list
6261665|NCT03223272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6261666|NCT03223272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6261667|NCT03223272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6261668|NCT03223272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6261669|NCT03223272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261670|NCT03223272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6261671|NCT03223272|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6261672|NCT03223272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6261673|NCT03223272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6261674|NCT03223272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261675|NCT03223272|Adrenergic Agents|adrenergic agents|mesh-ancestor
6261676|NCT03223272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6261677|NCT03223909|Hyaluronic Acid|hyaluronic acid|mesh-list
6261678|NCT03223909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6261679|NCT03223909|Immunologic Factors|immunologic factors|mesh-ancestor
6261680|NCT03223909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261681|NCT03223909|Viscosupplements|viscosupplements|mesh-ancestor
6261682|NCT03223909|Protective Agents|protective agents|mesh-ancestor
6261683|NCT03224182|Apaziquone|apaziquone|mesh-list
6261684|NCT03224182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6261685|NCT03224351|Ivacaftor|ivacaftor|mesh-list
6261686|NCT03224351|VX-659|vx-659|mesh-list
6261687|NCT03224351|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6261688|NCT03224351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6261689|NCT03224351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261690|NCT03224403|Acetaminophen|acetaminophen|mesh-list
6261691|NCT03224403|Ibuprofen|ibuprofen|mesh-list
6261692|NCT03224403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6261693|NCT03224403|Analgesics|analgesics|mesh-ancestor
6261694|NCT03224403|Sensory System Agents|sensory system agents|mesh-ancestor
6261695|NCT03224403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6261696|NCT03224403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261697|NCT03224403|Antipyretics|antipyretics|mesh-ancestor
6261698|NCT03224403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6261699|NCT03224403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6261700|NCT03224403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6014176|NCT00348790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6014177|NCT00348790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6014178|NCT00348790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014179|NCT00348816|Prednisone|prednisone|mesh-list
6014180|NCT00348816|Docetaxel|docetaxel|mesh-list
6014181|NCT00348816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6014182|NCT00348816|Tubulin Modulators|tubulin modulators|mesh-ancestor
6014183|NCT00348816|Antimitotic Agents|antimitotic agents|mesh-ancestor
6014184|NCT00348816|Mitosis Modulators|mitosis modulators|mesh-ancestor
6014185|NCT00348816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014186|NCT00348816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6014187|NCT00348816|Glucocorticoids|glucocorticoids|mesh-ancestor
6014188|NCT00348816|Hormones|hormones|mesh-ancestor
6014189|NCT00348816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6014190|NCT00348816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014191|NCT00348816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6014192|NCT00348881|Vaccines|vaccines|mesh-list
6014193|NCT00348881|Immunologic Factors|immunologic factors|mesh-ancestor
6014194|NCT00348881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014195|NCT00348933|Vitamin B 12|vitamin b 12|mesh-list
6014196|NCT00348933|Hydroxocobalamin|hydroxocobalamin|mesh-list
6014197|NCT00348933|Betaine|betaine|mesh-list
6014198|NCT00348933|Vitamins|vitamins|mesh-ancestor
6014199|NCT00348933|Micronutrients|micronutrients|mesh-ancestor
6014200|NCT00348933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014201|NCT00348933|Vitamin B Complex|vitamin b complex|mesh-ancestor
6014202|NCT00348933|Hematinics|hematinics|mesh-ancestor
6014203|NCT00348933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6014204|NCT00348933|Lipotropic Agents|lipotropic agents|mesh-ancestor
6014205|NCT00348933|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6014206|NCT00348933|Antimetabolites|antimetabolites|mesh-ancestor
6014207|NCT00348933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014208|NCT00348933|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6014209|NCT00348946|Androgens|androgens|mesh-list
6014210|NCT00348946|Oxandrolone|oxandrolone|mesh-list
6014211|NCT00348946|Hormones|hormones|mesh-ancestor
6014212|NCT00348946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6014213|NCT00348946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014214|NCT00348946|Anabolic Agents|anabolic agents|mesh-ancestor
6014215|NCT00349336|Bevacizumab|bevacizumab|mesh-list
6014216|NCT00349336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6014217|NCT00349336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6014218|NCT00349336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6014219|NCT00349336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6014220|NCT00349336|Growth Substances|growth substances|mesh-ancestor
6014221|NCT00349336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014222|NCT00349336|Growth Inhibitors|growth inhibitors|mesh-ancestor
6014223|NCT00349349|Ofatumumab|ofatumumab|mesh-list
6014224|NCT00349349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6014225|NCT00349388|Mesalamine|mesalamine|mesh-list
6014226|NCT00349388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6014227|NCT00349388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6014228|NCT00349388|Analgesics|analgesics|mesh-ancestor
6014229|NCT00349388|Sensory System Agents|sensory system agents|mesh-ancestor
6014230|NCT00349388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6014231|NCT00349388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014232|NCT00349388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6014233|NCT00349388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6014234|NCT00349622|Ceftriaxone|ceftriaxone|mesh-list
6014235|NCT00349622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6014236|NCT00349622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6014237|NCT00349752|Certolizumab Pegol|certolizumab pegol|mesh-list
6014238|NCT00349752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6014239|NCT00349752|Immunologic Factors|immunologic factors|mesh-ancestor
6014240|NCT00349752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014241|NCT00349752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6014242|NCT00349778|Cyclophosphamide|cyclophosphamide|mesh-list
6014243|NCT00349778|Melphalan|melphalan|mesh-list
6014244|NCT00349778|Carmustine|carmustine|mesh-list
6014245|NCT00349778|Etoposide|etoposide|mesh-list
6014246|NCT00349778|Etoposide phosphate|etoposide phosphate|mesh-list
6014247|NCT00349778|Lenograstim|lenograstim|mesh-list
6014248|NCT00349778|Sargramostim|sargramostim|mesh-list
6014249|NCT00349778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6014250|NCT00349778|Immunologic Factors|immunologic factors|mesh-ancestor
6014251|NCT00349778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014252|NCT00349778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6014253|NCT00349778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6014254|NCT00349778|Alkylating Agents|alkylating agents|mesh-ancestor
6014255|NCT00349778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014256|NCT00349778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6014257|NCT00349778|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6014258|NCT00349778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6014259|NCT00349778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6014260|NCT00349778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6014261|NCT00349778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6014262|NCT00349778|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6014263|NCT00349921|Adenosine|adenosine|mesh-list
6014264|NCT00349921|Clonidine|clonidine|mesh-list
6014265|NCT00349921|Analgesics|analgesics|mesh-ancestor
6014266|NCT00349921|Sensory System Agents|sensory system agents|mesh-ancestor
6014267|NCT00349921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6014268|NCT00349921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014269|NCT00349921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6014270|NCT00349921|Sympatholytics|sympatholytics|mesh-ancestor
6014271|NCT00349921|Autonomic Agents|autonomic agents|mesh-ancestor
6014272|NCT00349921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6014273|NCT00349921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6014274|NCT00349921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6014275|NCT00349921|Adrenergic Agents|adrenergic agents|mesh-ancestor
6014276|NCT00349921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6014277|NCT00349921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014278|NCT00349921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6014279|NCT00349921|Vasodilator Agents|vasodilator agents|mesh-ancestor
6014280|NCT00349921|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6014281|NCT00349921|Purinergic Agonists|purinergic agonists|mesh-ancestor
6014282|NCT00349921|Purinergic Agents|purinergic agents|mesh-ancestor
6014283|NCT00349973|Dipyridamole|dipyridamole|mesh-list
6014284|NCT00349973|Olanzapine|olanzapine|mesh-list
6014285|NCT00349973|Antiemetics|antiemetics|mesh-ancestor
6014286|NCT00349973|Autonomic Agents|autonomic agents|mesh-ancestor
6014287|NCT00349973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6014288|NCT00349973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014289|NCT00349973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6014290|NCT00349973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6014291|NCT00349973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6014292|NCT00349973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6014293|NCT00349973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6014294|NCT00349973|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6014295|NCT00349973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6014296|NCT00349973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6014297|NCT00349973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014298|NCT00349973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6014299|NCT00349973|Serotonin Agents|serotonin agents|mesh-ancestor
6014300|NCT00349973|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6014301|NCT00349973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6014302|NCT00349973|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6014303|NCT00349973|Vasodilator Agents|vasodilator agents|mesh-ancestor
6014304|NCT00350025|Paclitaxel|paclitaxel|mesh-list
6014305|NCT00350025|Cetuximab|cetuximab|mesh-list
6014306|NCT00350025|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6014307|NCT00350025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6014308|NCT00350025|Tubulin Modulators|tubulin modulators|mesh-ancestor
6014309|NCT00350025|Antimitotic Agents|antimitotic agents|mesh-ancestor
6014310|NCT00350025|Mitosis Modulators|mitosis modulators|mesh-ancestor
6014311|NCT00350025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014312|NCT00350025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6014313|NCT00350142|Gemcitabine|gemcitabine|mesh-list
6014314|NCT00350142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6014315|NCT00350142|Antimetabolites|antimetabolites|mesh-ancestor
6014316|NCT00350142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014317|NCT00350142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6014318|NCT00350142|Antiviral Agents|antiviral agents|mesh-ancestor
6014319|NCT00350142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6014320|NCT00350142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6014321|NCT00350142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6014322|NCT00350142|Immunologic Factors|immunologic factors|mesh-ancestor
6014323|NCT00350142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014324|NCT00350207|Bromides|bromides|mesh-list
6014325|NCT00350207|Tiotropium Bromide|tiotropium bromide|mesh-list
6014326|NCT00350207|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6014327|NCT00350207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6014328|NCT00350207|Autonomic Agents|autonomic agents|mesh-ancestor
6014329|NCT00350207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6014330|NCT00350207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014331|NCT00350207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6014332|NCT00350207|Respiratory System Agents|respiratory system agents|mesh-ancestor
6014333|NCT00350207|Parasympatholytics|parasympatholytics|mesh-ancestor
6014334|NCT00350207|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6014335|NCT00350207|Cholinergic Agents|cholinergic agents|mesh-ancestor
6014336|NCT00350207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6014337|NCT00350207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014338|NCT00350207|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6014339|NCT00350207|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6014340|NCT00350207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6014341|NCT00350207|Adrenergic Agents|adrenergic agents|mesh-ancestor
6014342|NCT00350207|Anticonvulsants|anticonvulsants|mesh-ancestor
6014343|NCT00350272|Tenofovir|tenofovir|mesh-list
6014344|NCT00350272|Lamivudine|lamivudine|mesh-list
6014345|NCT00350272|Efavirenz|efavirenz|mesh-list
6014346|NCT00350272|Dexelvucitabine|dexelvucitabine|mesh-list
6014347|NCT00350272|Antiviral Agents|antiviral agents|mesh-ancestor
6014348|NCT00350272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6014349|NCT00350272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6014350|NCT00350272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6014351|NCT00350272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6014352|NCT00350272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014353|NCT00350272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6014354|NCT00350272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6014355|NCT00350272|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6014356|NCT00350272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6014357|NCT00350272|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6014358|NCT00350272|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6014359|NCT00350272|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6014360|NCT00350272|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6014361|NCT00350363|Gatifloxacin|gatifloxacin|mesh-list
6014362|NCT00350363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6014363|NCT00350363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6014364|NCT00350363|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6014365|NCT00350363|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6014366|NCT00350363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6014367|NCT00350363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6014368|NCT00350363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6014369|NCT00350363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014370|NCT00350363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6014371|NCT00350519|Epoetin Alfa|epoetin alfa|mesh-list
6014372|NCT00350519|Hematinics|hematinics|mesh-ancestor
6014373|NCT00350532|Clonidine|clonidine|mesh-list
6014374|NCT00350532|Analgesics|analgesics|mesh-ancestor
6014375|NCT00350532|Sensory System Agents|sensory system agents|mesh-ancestor
6014376|NCT00350532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6014377|NCT00350532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014378|NCT00350532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6014379|NCT00350532|Sympatholytics|sympatholytics|mesh-ancestor
6014380|NCT00350532|Autonomic Agents|autonomic agents|mesh-ancestor
6014381|NCT00350532|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6014382|NCT00350532|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6014383|NCT00350532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6014384|NCT00350532|Adrenergic Agents|adrenergic agents|mesh-ancestor
6014385|NCT00350532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6014386|NCT00350532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014387|NCT00350545|Cyclosporine|cyclosporine|mesh-list
6014388|NCT00350545|Prednisone|prednisone|mesh-list
6014389|NCT00350545|Rituximab|rituximab|mesh-list
6014390|NCT00350545|Tacrolimus|tacrolimus|mesh-list
6014391|NCT00350545|Cyclosporins|cyclosporins|mesh-list
6014392|NCT00350545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6014393|NCT00350545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6014394|NCT00350545|Immunologic Factors|immunologic factors|mesh-ancestor
6014395|NCT00350545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014396|NCT00350545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6014397|NCT00350545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6014398|NCT00350545|Glucocorticoids|glucocorticoids|mesh-ancestor
6014399|NCT00350545|Hormones|hormones|mesh-ancestor
6014400|NCT00350545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6014401|NCT00350545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6014402|NCT00350545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6014403|NCT00350545|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6014404|NCT00350545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6014405|NCT00350545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014406|NCT00350545|Antifungal Agents|antifungal agents|mesh-ancestor
6014407|NCT00350545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6014408|NCT00350545|Dermatologic Agents|dermatologic agents|mesh-ancestor
6014409|NCT00350636|Mandelic Acids|mandelic acids|mesh-list
6014410|NCT00350636|Oxybutynin|oxybutynin|mesh-list
6014411|NCT00350636|Parasympatholytics|parasympatholytics|mesh-ancestor
6014412|NCT00350636|Autonomic Agents|autonomic agents|mesh-ancestor
6014413|NCT00350636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6014414|NCT00350636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014415|NCT00350636|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6014416|NCT00350636|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6014417|NCT00350636|Cholinergic Agents|cholinergic agents|mesh-ancestor
6014418|NCT00350636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6014419|NCT00350636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014420|NCT00350636|Urological Agents|urological agents|mesh-ancestor
6014421|NCT00350636|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6014422|NCT00350636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6014423|NCT00350636|Renal Agents|renal agents|mesh-ancestor
6014424|NCT00350727|Lapatinib|lapatinib|mesh-list
6014425|NCT00350727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6014426|NCT00350727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6014427|NCT00350727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6014428|NCT00350727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014429|NCT00350779|Metformin|metformin|mesh-list
6014430|NCT00350779|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6014431|NCT00350779|Rosiglitazone|rosiglitazone|mesh-list
6014432|NCT00350779|Glipizide|glipizide|mesh-list
6014433|NCT00350779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6014434|NCT00350779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014435|NCT00350779|Incretins|incretins|mesh-ancestor
6014436|NCT00350779|Hormones|hormones|mesh-ancestor
6014437|NCT00350779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6014438|NCT00350779|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6014439|NCT00350779|Protease Inhibitors|protease inhibitors|mesh-ancestor
6014440|NCT00350779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6014441|NCT00350779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014442|NCT00350792|Carboplatin|carboplatin|mesh-list
6014443|NCT00350792|Pemetrexed|pemetrexed|mesh-list
6014444|NCT00350792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6014445|NCT00350792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6014446|NCT00350792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014447|NCT00350792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6014448|NCT00350792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6014449|NCT00350870|Disulfiram|disulfiram|mesh-list
6014450|NCT00350870|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6014451|NCT00350870|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
6014452|NCT00350870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6014453|NCT00350870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014454|NCT00351000|Ziprasidone|ziprasidone|mesh-list
6014455|NCT00351000|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6014456|NCT00351000|Serotonin Agents|serotonin agents|mesh-ancestor
6014457|NCT00351000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6014458|NCT00351000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014459|NCT00351000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014460|NCT00351000|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6014461|NCT00351000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6014462|NCT00351000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6014463|NCT00351000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6014464|NCT00351000|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6014465|NCT00351000|Dopamine Agents|dopamine agents|mesh-ancestor
6014466|NCT00351039|Bevacizumab|bevacizumab|mesh-list
6014467|NCT00351039|Pemetrexed|pemetrexed|mesh-list
6014468|NCT00351039|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6014469|NCT00351039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6014470|NCT00351039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6014471|NCT00351039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6014472|NCT00351039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6014473|NCT00351039|Growth Substances|growth substances|mesh-ancestor
6014474|NCT00351039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014475|NCT00351039|Growth Inhibitors|growth inhibitors|mesh-ancestor
6014476|NCT00351039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6014477|NCT00351039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014478|NCT00351039|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6014479|NCT00351039|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6014480|NCT00351039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6014481|NCT00351273|Azithromycin|azithromycin|mesh-list
6014482|NCT00351273|Doxycycline|doxycycline|mesh-list
6014483|NCT00351273|Rifampin|rifampin|mesh-list
6014484|NCT00351273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6014485|NCT00351273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6014486|NCT00351273|Antimalarials|antimalarials|mesh-ancestor
6014487|NCT00351273|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6014488|NCT00351273|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6014489|NCT00351273|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6014490|NCT00351273|Antitubercular Agents|antitubercular agents|mesh-ancestor
6014491|NCT00351273|Leprostatic Agents|leprostatic agents|mesh-ancestor
6014492|NCT00351273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6014493|NCT00351273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6014494|NCT00351273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014495|NCT00351273|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6014496|NCT00351273|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6014497|NCT00351273|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6014498|NCT00351273|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6014499|NCT00351273|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6014500|NCT00351273|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6014501|NCT00351299|Dexmedetomidine|dexmedetomidine|mesh-list
6014502|NCT00351299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6014503|NCT00351299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6014504|NCT00351299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014505|NCT00351299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6014506|NCT00351299|Analgesics|analgesics|mesh-ancestor
6014507|NCT00351299|Sensory System Agents|sensory system agents|mesh-ancestor
6014508|NCT00351299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6014509|NCT00351299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6014510|NCT00351299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6014511|NCT00351299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6014512|NCT00351299|Adrenergic Agents|adrenergic agents|mesh-ancestor
6014513|NCT00351299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6014514|NCT00351299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014515|NCT00351377|Mycophenolic Acid|mycophenolic acid|mesh-list
6014516|NCT00351377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6014517|NCT00351377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6014518|NCT00351377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6014519|NCT00351377|Antitubercular Agents|antitubercular agents|mesh-ancestor
6014520|NCT00351377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6014521|NCT00351377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6014522|NCT00351377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6014523|NCT00351377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014524|NCT00351416|Letrozole|letrozole|mesh-list
6014525|NCT00351416|Aromatase Inhibitors|aromatase inhibitors|mesh-list
6014526|NCT00351416|LHRH, N-Ac-2-Nal(1)-4-Cl-Phe(2)-3-Pal(3)-Arg(5)-Glu(6)-AlaNH2(10)-|lhrh, n-ac-2-nal(1)-4-cl-phe(2)-3-pal(3)-arg(5)-glu(6)-alanh2(10)-|mesh-list
6014527|NCT00351416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6014528|NCT00351416|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6014529|NCT00351416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6014530|NCT00351416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014531|NCT00351416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6014532|NCT00351416|Hormone Antagonists|hormone antagonists|mesh-ancestor
6014533|NCT00351416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6014534|NCT00351416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014535|NCT00351611|Pregabalin|pregabalin|mesh-list
6014536|NCT00351611|Analgesics|analgesics|mesh-ancestor
6014537|NCT00351611|Sensory System Agents|sensory system agents|mesh-ancestor
6014538|NCT00351611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6014539|NCT00351611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014540|NCT00351611|Anticonvulsants|anticonvulsants|mesh-ancestor
6014541|NCT00351611|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6014542|NCT00351611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6014543|NCT00351611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014544|NCT00351611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6014545|NCT00351611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6014546|NCT00351611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6014547|NCT00351611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6014548|NCT00351611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6014549|NCT00351819|Testosterone|testosterone|mesh-list
6014550|NCT00351819|Androgens|androgens|mesh-ancestor
6014551|NCT00351819|Hormones|hormones|mesh-ancestor
6014552|NCT00351819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6014553|NCT00351819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014554|NCT00351936|Aripiprazole|aripiprazole|mesh-list
6014555|NCT00351936|Antidepressive Agents|antidepressive agents|mesh-ancestor
6014556|NCT00351936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6014557|NCT00351936|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6014558|NCT00351936|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6014559|NCT00351936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6014560|NCT00351936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014561|NCT00351936|Dopamine Agonists|dopamine agonists|mesh-ancestor
6014562|NCT00351936|Dopamine Agents|dopamine agents|mesh-ancestor
6014563|NCT00351936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6014564|NCT00351936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014565|NCT00351936|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6014566|NCT00351936|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6014567|NCT00351936|Serotonin Agents|serotonin agents|mesh-ancestor
6014568|NCT00351936|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6014569|NCT00351936|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6014570|NCT00351936|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6014571|NCT00351936|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6014572|NCT00352001|Lenalidomide|lenalidomide|mesh-list
6014573|NCT00352001|Azacitidine|azacitidine|mesh-list
6014574|NCT00352001|Immunologic Factors|immunologic factors|mesh-ancestor
6014575|NCT00352001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014576|NCT00352001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6014577|NCT00352001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6014578|NCT00352001|Growth Substances|growth substances|mesh-ancestor
6014579|NCT00352001|Growth Inhibitors|growth inhibitors|mesh-ancestor
6014580|NCT00352001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6014581|NCT00352001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6261701|NCT03224403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6261702|NCT03224403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6261703|NCT03224403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261704|NCT03224585|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6261705|NCT03224585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6261706|NCT03225313|Bupivacaine|bupivacaine|mesh-list
6261707|NCT03225313|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6261708|NCT03225313|Anesthetics, Local|anesthetics, local|mesh-ancestor
6261709|NCT03225313|Anesthetics|anesthetics|mesh-ancestor
6261710|NCT03225313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6261711|NCT03225313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261712|NCT03225313|Sensory System Agents|sensory system agents|mesh-ancestor
6261713|NCT03225313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6261714|NCT03226223|Methamphetamine|methamphetamine|mesh-list
6261715|NCT03226223|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6261716|NCT03226223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261717|NCT03226223|Sympathomimetics|sympathomimetics|mesh-ancestor
6261718|NCT03226223|Autonomic Agents|autonomic agents|mesh-ancestor
6261719|NCT03226223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6261720|NCT03226223|Dopamine Agents|dopamine agents|mesh-ancestor
6261721|NCT03226223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6261722|NCT03226223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261723|NCT03226223|Adrenergic Agents|adrenergic agents|mesh-ancestor
6261724|NCT03226223|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6261725|NCT03226223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6261726|NCT03226223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6261727|NCT03226223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6261728|NCT03226249|Deoxyglucose|deoxyglucose|mesh-list
6261729|NCT03226249|Doxorubicin|doxorubicin|mesh-list
6261730|NCT03226249|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6261731|NCT03226249|Pembrolizumab|pembrolizumab|mesh-list
6261732|NCT03226249|Dacarbazine|dacarbazine|mesh-list
6261733|NCT03226249|Vinblastine|vinblastine|mesh-list
6261734|NCT03226249|Imidazole|imidazole|mesh-list
6261735|NCT03226249|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6261736|NCT03226249|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6261737|NCT03226249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6261738|NCT03226249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6261739|NCT03226249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6261740|NCT03226249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6261741|NCT03226249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261742|NCT03226249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6261743|NCT03226249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6261744|NCT03226249|Alkylating Agents|alkylating agents|mesh-ancestor
6261745|NCT03226249|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6261746|NCT03226249|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6261747|NCT03226249|Tubulin Modulators|tubulin modulators|mesh-ancestor
6261748|NCT03226249|Antimitotic Agents|antimitotic agents|mesh-ancestor
6261749|NCT03226249|Mitosis Modulators|mitosis modulators|mesh-ancestor
6261750|NCT03226249|Antimetabolites|antimetabolites|mesh-ancestor
6261751|NCT03226249|Antiviral Agents|antiviral agents|mesh-ancestor
6261752|NCT03226249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6261753|NCT03226275|Amlodipine|amlodipine|mesh-list
6261754|NCT03226275|Bisoprolol|bisoprolol|mesh-list
6261755|NCT03226275|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6261756|NCT03226275|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6261757|NCT03226275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6261758|NCT03226275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261759|NCT03226275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6261760|NCT03226275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261761|NCT03226275|Vasodilator Agents|vasodilator agents|mesh-ancestor
6261762|NCT03226275|Sympatholytics|sympatholytics|mesh-ancestor
6261763|NCT03226275|Autonomic Agents|autonomic agents|mesh-ancestor
6261764|NCT03226275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6261765|NCT03226275|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6261766|NCT03226275|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6261767|NCT03226275|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6261768|NCT03226275|Adrenergic Agents|adrenergic agents|mesh-ancestor
6261769|NCT03226275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6261770|NCT03226457|Empagliflozin|empagliflozin|mesh-list
6261771|NCT03226457|Furosemide|furosemide|mesh-list
6261772|NCT03226457|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6261773|NCT03226457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261774|NCT03226457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6261775|NCT03226457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261776|NCT03226457|Diuretics|diuretics|mesh-ancestor
6261777|NCT03226457|Natriuretic Agents|natriuretic agents|mesh-ancestor
6261778|NCT03226457|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6261779|NCT03226457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6261780|NCT03226691|Plerixafor|plerixafor|mesh-list
6261781|NCT03226691|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6261782|NCT03226691|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6261783|NCT03226691|Antiviral Agents|antiviral agents|mesh-ancestor
6261784|NCT03226691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6261785|NCT03226899|Colchicine|colchicine|mesh-list
6261786|NCT03226899|Allopurinol|allopurinol|mesh-list
6261787|NCT03226899|Febuxostat|febuxostat|mesh-list
6261788|NCT03226899|Lesinurad|lesinurad|mesh-list
6261789|NCT03226899|Gout Suppressants|gout suppressants|mesh-ancestor
6261790|NCT03226899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6261791|NCT03226899|Tubulin Modulators|tubulin modulators|mesh-ancestor
6261792|NCT03226899|Antimitotic Agents|antimitotic agents|mesh-ancestor
6261793|NCT03226899|Mitosis Modulators|mitosis modulators|mesh-ancestor
6261794|NCT03226899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261795|NCT03226899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6261796|NCT03226899|Antimetabolites|antimetabolites|mesh-ancestor
6261797|NCT03226899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6261798|NCT03226899|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6261799|NCT03226899|Antioxidants|antioxidants|mesh-ancestor
6261800|NCT03226899|Protective Agents|protective agents|mesh-ancestor
6261801|NCT03226899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261802|NCT03226899|Uricosuric Agents|uricosuric agents|mesh-ancestor
6261803|NCT03226899|Renal Agents|renal agents|mesh-ancestor
6261804|NCT03228017|Aspirin|aspirin|mesh-list
6261805|NCT03228017|Atorvastatin|atorvastatin|mesh-list
6261806|NCT03228017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6261807|NCT03228017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6261808|NCT03228017|Analgesics|analgesics|mesh-ancestor
6261809|NCT03228017|Sensory System Agents|sensory system agents|mesh-ancestor
6261810|NCT03228017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6261811|NCT03228017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261812|NCT03228017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6261813|NCT03228017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6261814|NCT03228017|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6261815|NCT03228017|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6261816|NCT03228017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261817|NCT03228017|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6261818|NCT03228017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6261819|NCT03228017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6261820|NCT03228017|Antipyretics|antipyretics|mesh-ancestor
6261821|NCT03228017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6261822|NCT03228017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6261823|NCT03228017|Antimetabolites|antimetabolites|mesh-ancestor
6261824|NCT03228017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6261825|NCT03228017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6389959|NCT00189761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6389960|NCT00189761|Immunologic Factors|immunologic factors|mesh-ancestor
6389961|NCT00189761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389962|NCT00189761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6389963|NCT00189761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6389964|NCT00189761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389965|NCT00189774|Nateglinide|nateglinide|mesh-list
6389966|NCT00189774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6389967|NCT00189774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389968|NCT00189787|Tacrolimus|tacrolimus|mesh-list
6389969|NCT00189787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6389970|NCT00189787|Immunologic Factors|immunologic factors|mesh-ancestor
6389971|NCT00189787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389972|NCT00189787|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6389973|NCT00189787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6389974|NCT00189787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389975|NCT00189800|Solifenacin Succinate|solifenacin succinate|mesh-list
6389976|NCT00189800|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6389977|NCT00189800|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6389978|NCT00189800|Cholinergic Agents|cholinergic agents|mesh-ancestor
6389979|NCT00189800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6389980|NCT00189800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389981|NCT00189800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389982|NCT00189800|Urological Agents|urological agents|mesh-ancestor
6389983|NCT00189826|Tacrolimus|tacrolimus|mesh-list
6389984|NCT00189826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6389985|NCT00189826|Immunologic Factors|immunologic factors|mesh-ancestor
6389986|NCT00189826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389987|NCT00189826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6389988|NCT00189826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6389989|NCT00189826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389990|NCT00189839|Tacrolimus|tacrolimus|mesh-list
6389991|NCT00189839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6389992|NCT00189839|Immunologic Factors|immunologic factors|mesh-ancestor
6389993|NCT00189839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389994|NCT00189839|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6261826|NCT03228914|Phenylephrine|phenylephrine|mesh-list
6261827|NCT03228914|Epinephrine|epinephrine|mesh-list
6261828|NCT03228914|Oxymetazoline|oxymetazoline|mesh-list
6261829|NCT03228914|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6261830|NCT03228914|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6261831|NCT03228914|Adrenergic Agents|adrenergic agents|mesh-ancestor
6261832|NCT03228914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6261833|NCT03228914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261834|NCT03228914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261835|NCT03228914|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6261836|NCT03228914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6261837|NCT03228914|Autonomic Agents|autonomic agents|mesh-ancestor
6261838|NCT03228914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6261839|NCT03228914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6261840|NCT03228914|Respiratory System Agents|respiratory system agents|mesh-ancestor
6261841|NCT03228914|Mydriatics|mydriatics|mesh-ancestor
6261842|NCT03228914|Sympathomimetics|sympathomimetics|mesh-ancestor
6261843|NCT03228914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6261844|NCT03228914|Nasal Decongestants|nasal decongestants|mesh-ancestor
6261845|NCT03228914|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6261846|NCT03228914|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6261847|NCT03228914|Protective Agents|protective agents|mesh-ancestor
6261848|NCT03229486|Glycopyrrolate|glycopyrrolate|mesh-list
6261849|NCT03229486|Neostigmine|neostigmine|mesh-list
6261850|NCT03229486|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6261851|NCT03229486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6261852|NCT03229486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261853|NCT03229486|Cholinergic Agents|cholinergic agents|mesh-ancestor
6261854|NCT03229486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6261855|NCT03229486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261856|NCT03229486|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6261857|NCT03229486|Autonomic Agents|autonomic agents|mesh-ancestor
6261858|NCT03229486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6261859|NCT03229486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6261860|NCT03229486|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6261861|NCT03229486|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6261862|NCT03229759|Octenidine|octenidine|mesh-list
6261863|NCT03229759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6261864|NCT03229759|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6261865|NCT03230175|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6261866|NCT03230175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6261867|NCT03230864|Olanzapine|olanzapine|mesh-list
6261868|NCT03230864|Risperidone|risperidone|mesh-list
6261869|NCT03230864|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6261870|NCT03230864|Serotonin Agents|serotonin agents|mesh-ancestor
6261871|NCT03230864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6261872|NCT03230864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261873|NCT03230864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261874|NCT03230864|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6261875|NCT03230864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6261876|NCT03230864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6261877|NCT03230864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6261878|NCT03230864|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6261879|NCT03230864|Dopamine Agents|dopamine agents|mesh-ancestor
6261880|NCT03230864|Antiemetics|antiemetics|mesh-ancestor
6261881|NCT03230864|Autonomic Agents|autonomic agents|mesh-ancestor
6261882|NCT03230864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6261883|NCT03230864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6261884|NCT03230864|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6261885|NCT03230864|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6261886|NCT03230864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6261887|NCT03231228|Cefazolin|cefazolin|mesh-list
6261888|NCT03231228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6261889|NCT03231228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6261890|NCT03231371|Adenosine|adenosine|mesh-list
6261891|NCT03231371|Analgesics|analgesics|mesh-ancestor
6261892|NCT03231371|Sensory System Agents|sensory system agents|mesh-ancestor
6261893|NCT03231371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6261894|NCT03231371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261895|NCT03231371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6261896|NCT03231371|Vasodilator Agents|vasodilator agents|mesh-ancestor
6261897|NCT03231371|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6261898|NCT03231371|Purinergic Agonists|purinergic agonists|mesh-ancestor
6261899|NCT03231371|Purinergic Agents|purinergic agents|mesh-ancestor
6261900|NCT03231371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6261901|NCT03231371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261902|NCT03231709|Alogliptin|alogliptin|mesh-list
6261903|NCT03231709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6261904|NCT03231709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261905|NCT03231709|Incretins|incretins|mesh-ancestor
6261906|NCT03231709|Hormones|hormones|mesh-ancestor
6261907|NCT03231709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6261908|NCT03231709|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6261909|NCT03231709|Protease Inhibitors|protease inhibitors|mesh-ancestor
6261910|NCT03231709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6261911|NCT03231709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261912|NCT03232281|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6261913|NCT03232281|Luteolytic Agents|luteolytic agents|mesh-ancestor
6261914|NCT03232281|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6261915|NCT03232281|Contraceptive Agents|contraceptive agents|mesh-ancestor
6261916|NCT03232281|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6261917|NCT03232281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261918|NCT03232281|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6261919|NCT03232281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6261920|NCT03232281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6261921|NCT03232749|Methylprednisolone|methylprednisolone|mesh-list
6261922|NCT03232749|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6261923|NCT03232749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6261924|NCT03232749|Antiemetics|antiemetics|mesh-ancestor
6261925|NCT03232749|Autonomic Agents|autonomic agents|mesh-ancestor
6261926|NCT03232749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6261927|NCT03232749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261928|NCT03232749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6261929|NCT03232749|Glucocorticoids|glucocorticoids|mesh-ancestor
6261930|NCT03232749|Hormones|hormones|mesh-ancestor
6261931|NCT03232749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6261932|NCT03232749|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6261933|NCT03232749|Protective Agents|protective agents|mesh-ancestor
6261934|NCT03232983|Insulin Lispro|insulin lispro|mesh-list
6261935|NCT03232983|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6261936|NCT03232983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261937|NCT03233217|Vaccines|vaccines|mesh-list
6261938|NCT03233217|Immunologic Factors|immunologic factors|mesh-ancestor
6261939|NCT03233217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261940|NCT03233308|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6261941|NCT03233308|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6261942|NCT03233438|Dalbavancin|dalbavancin|mesh-list
6261943|NCT03233438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6261944|NCT03233438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6261945|NCT03233737|Anesthetics|anesthetics|mesh-list
6261946|NCT03233737|Tetracaine|tetracaine|mesh-list
6261947|NCT03233737|Benzocaine|benzocaine|mesh-list
6261948|NCT03233737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6261949|NCT03233737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261950|NCT03233737|Anesthetics, Local|anesthetics, local|mesh-ancestor
6261951|NCT03233737|Sensory System Agents|sensory system agents|mesh-ancestor
6261952|NCT03233737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6261953|NCT03234036|Ritonavir|ritonavir|mesh-list
6261954|NCT03234036|GSK-2838232|gsk-2838232|mesh-list
6261955|NCT03234036|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6261956|NCT03234036|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6261957|NCT03234036|Protease Inhibitors|protease inhibitors|mesh-ancestor
6261958|NCT03234036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6261959|NCT03234036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261960|NCT03234036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6261961|NCT03234036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6261962|NCT03234036|Antiviral Agents|antiviral agents|mesh-ancestor
6261963|NCT03234036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6261964|NCT03234036|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6261965|NCT03234036|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6261966|NCT03234374|Bupivacaine|bupivacaine|mesh-list
6261967|NCT03234374|Anesthetics, Local|anesthetics, local|mesh-ancestor
6261968|NCT03234374|Anesthetics|anesthetics|mesh-ancestor
6261969|NCT03234374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6261970|NCT03234374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261971|NCT03234374|Sensory System Agents|sensory system agents|mesh-ancestor
6261972|NCT03234374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6261973|NCT03235050|Liraglutide|liraglutide|mesh-list
6261974|NCT03235050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6261975|NCT03235050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261976|NCT03235050|Incretins|incretins|mesh-ancestor
6261977|NCT03235050|Hormones|hormones|mesh-ancestor
6261978|NCT03235050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6261979|NCT03235154|Sofosbuvir|sofosbuvir|mesh-list
6261980|NCT03235154|Velpatasvir|velpatasvir|mesh-list
6261981|NCT03235154|Antiviral Agents|antiviral agents|mesh-ancestor
6261982|NCT03235154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6261983|NCT03236168|Ivermectin|ivermectin|mesh-list
6261984|NCT03236168|Permethrin|permethrin|mesh-list
6261985|NCT03236168|Malathion|malathion|mesh-list
6261986|NCT03236168|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6261987|NCT03236168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6261988|NCT03236168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6261989|NCT03236168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6261990|NCT03236168|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6261991|NCT03236168|Cholinergic Agents|cholinergic agents|mesh-ancestor
6261992|NCT03236168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6261993|NCT03236168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6261994|NCT03236311|Adenosine|adenosine|mesh-list
6261995|NCT03236311|Regadenoson|regadenoson|mesh-list
6261996|NCT03236311|Analgesics|analgesics|mesh-ancestor
6261997|NCT03236311|Sensory System Agents|sensory system agents|mesh-ancestor
6261998|NCT03236311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6261999|NCT03236311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262000|NCT03236311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6262001|NCT03236311|Vasodilator Agents|vasodilator agents|mesh-ancestor
6262002|NCT03236311|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6262003|NCT03236311|Purinergic Agonists|purinergic agonists|mesh-ancestor
6262004|NCT03236311|Purinergic Agents|purinergic agents|mesh-ancestor
6262005|NCT03236311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6262006|NCT03236311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262007|NCT03236311|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
6262008|NCT03236506|Sofosbuvir|sofosbuvir|mesh-list
6262009|NCT03236506|Grazoprevir|grazoprevir|mesh-list
6262010|NCT03236506|Antiviral Agents|antiviral agents|mesh-ancestor
6262011|NCT03236506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6262012|NCT03237065|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
6262013|NCT03237065|Hematinics|hematinics|mesh-ancestor
6262014|NCT03237481|Bupivacaine|bupivacaine|mesh-list
6262015|NCT03237481|Anesthetics, Local|anesthetics, local|mesh-ancestor
6262016|NCT03237481|Anesthetics|anesthetics|mesh-ancestor
6262017|NCT03237481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6262018|NCT03237481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262019|NCT03237481|Sensory System Agents|sensory system agents|mesh-ancestor
6262020|NCT03237481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6262021|NCT03238352|Listerine|listerine|mesh-list
6262022|NCT03238352|Fluorides|fluorides|mesh-list
6262023|NCT03238352|Sodium Fluoride|sodium fluoride|mesh-list
6262024|NCT03238352|Cariostatic Agents|cariostatic agents|mesh-ancestor
6262025|NCT03238352|Protective Agents|protective agents|mesh-ancestor
6262026|NCT03238352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262027|NCT03238352|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6262028|NCT03238352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6262029|NCT03238911|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
6262030|NCT03238911|Hematinics|hematinics|mesh-ancestor
6262031|NCT03238924|Oxytocin|oxytocin|mesh-list
6262032|NCT03238924|Oxytocics|oxytocics|mesh-ancestor
6262033|NCT03238924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6262034|NCT03238924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262035|NCT03239106|Apremilast|apremilast|mesh-list
6262036|NCT03239106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6262037|NCT03239106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6262038|NCT03239106|Analgesics|analgesics|mesh-ancestor
6262039|NCT03239106|Sensory System Agents|sensory system agents|mesh-ancestor
6262040|NCT03239106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6262041|NCT03239106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262042|NCT03239106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6262043|NCT03239106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6262044|NCT03239106|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6262045|NCT03239106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6262046|NCT03239106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6262047|NCT03239106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262048|NCT03239483|Dapivirine|dapivirine|mesh-list
6262049|NCT03239483|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6262050|NCT03239483|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6262051|NCT03239483|Antiviral Agents|antiviral agents|mesh-ancestor
6262052|NCT03239483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6262053|NCT03239522|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6262054|NCT03239522|Glycine|glycine|mesh-list
6262055|NCT03239522|Glycine Agents|glycine agents|mesh-ancestor
6262056|NCT03239522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6262057|NCT03239522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262058|NCT03239522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262059|NCT03240081|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6262060|NCT03240081|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6262061|NCT03240081|Estradiol|estradiol|mesh-list
6262062|NCT03240081|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6262063|NCT03240081|Estrogens|estrogens|mesh-ancestor
6262064|NCT03240081|Hormones|hormones|mesh-ancestor
6262065|NCT03240081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6262066|NCT03240081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262067|NCT03240081|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6262068|NCT03240081|Contraceptive Agents|contraceptive agents|mesh-ancestor
6262069|NCT03240081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6262070|NCT03240081|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6262071|NCT03240133|Berotralstat|berotralstat|mesh-list
6262072|NCT03240133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6262073|NCT03240133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262074|NCT03240575|Fluticasone|fluticasone|mesh-list
6262075|NCT03240575|Xhance|xhance|mesh-list
6262076|NCT03240575|Tiotropium Bromide|tiotropium bromide|mesh-list
6262077|NCT03240575|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6262078|NCT03240575|Olodaterol|olodaterol|mesh-list
6262079|NCT03240575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6262080|NCT03240575|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6262081|NCT03240575|Autonomic Agents|autonomic agents|mesh-ancestor
6262082|NCT03240575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6262083|NCT03240575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262084|NCT03240575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6262085|NCT03240575|Respiratory System Agents|respiratory system agents|mesh-ancestor
6262086|NCT03240575|Dermatologic Agents|dermatologic agents|mesh-ancestor
6262087|NCT03240575|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6262088|NCT03240575|Parasympatholytics|parasympatholytics|mesh-ancestor
6262089|NCT03240575|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6262090|NCT03240575|Cholinergic Agents|cholinergic agents|mesh-ancestor
6262091|NCT03240575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6262092|NCT03240575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262093|NCT03240575|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6262094|NCT03240575|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6262095|NCT03240575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6262096|NCT03240575|Adrenergic Agents|adrenergic agents|mesh-ancestor
6262097|NCT03241030|Acetaminophen|acetaminophen|mesh-list
6262098|NCT03241030|Ibuprofen|ibuprofen|mesh-list
6262099|NCT03241030|Sucralfate|sucralfate|mesh-list
6262100|NCT03241030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6262101|NCT03241030|Analgesics|analgesics|mesh-ancestor
6262102|NCT03241030|Sensory System Agents|sensory system agents|mesh-ancestor
6262103|NCT03241030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6262104|NCT03241030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262105|NCT03241030|Antipyretics|antipyretics|mesh-ancestor
6262106|NCT03241030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6262107|NCT03241030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6262108|NCT03241030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6262109|NCT03241030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6262110|NCT03241030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6262111|NCT03241030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262112|NCT03241030|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6262113|NCT03241030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6262114|NCT03241485|Morphine|morphine|mesh-list
6262115|NCT03241485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6262116|NCT03241485|Narcotics|narcotics|mesh-ancestor
6262117|NCT03241485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6262118|NCT03241485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262119|NCT03241485|Analgesics|analgesics|mesh-ancestor
6262120|NCT03241485|Sensory System Agents|sensory system agents|mesh-ancestor
6262121|NCT03241485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6262122|NCT03241810|Fulvestrant|fulvestrant|mesh-list
6262123|NCT03241810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6262124|NCT03241810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6262125|NCT03241810|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6262126|NCT03241810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6262127|NCT03241810|Hormone Antagonists|hormone antagonists|mesh-ancestor
6262128|NCT03241810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6262129|NCT03241810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262130|NCT03241927|Pembrolizumab|pembrolizumab|mesh-list
6262131|NCT03241927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6262132|NCT03241927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6262133|NCT03242018|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
6262134|NCT03242018|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6262135|NCT03242018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262136|NCT03242018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6262137|NCT03242018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262138|NCT03242252|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
6262139|NCT03242252|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6262140|NCT03242252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262141|NCT03242252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6262142|NCT03242252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262143|NCT03242408|Methyltestosterone|methyltestosterone|mesh-list
6262144|NCT03242408|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6262145|NCT03242408|Testosterone|testosterone|mesh-list
6262146|NCT03242408|Testosterone undecanoate|testosterone undecanoate|mesh-list
6262147|NCT03242408|Testosterone enanthate|testosterone enanthate|mesh-list
6262148|NCT03242408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6262149|NCT03242408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6262150|NCT03242408|Anabolic Agents|anabolic agents|mesh-ancestor
6262151|NCT03242408|Hormones|hormones|mesh-ancestor
6262152|NCT03242408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6262153|NCT03242408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262154|NCT03242408|Androgens|androgens|mesh-ancestor
6262155|NCT03242434|Mannitol|mannitol|mesh-list
6262156|NCT03242434|Lactulose|lactulose|mesh-list
6262157|NCT03242434|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6262158|NCT03242434|Diuretics|diuretics|mesh-ancestor
6262159|NCT03242434|Natriuretic Agents|natriuretic agents|mesh-ancestor
6262160|NCT03242434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262161|NCT03242434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6262162|NCT03242590|Methyltestosterone|methyltestosterone|mesh-list
6262163|NCT03242590|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6262164|NCT03242590|Testosterone|testosterone|mesh-list
6262165|NCT03242590|Testosterone undecanoate|testosterone undecanoate|mesh-list
6262166|NCT03242590|Testosterone enanthate|testosterone enanthate|mesh-list
6262167|NCT03242590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6262168|NCT03242590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6262169|NCT03242590|Anabolic Agents|anabolic agents|mesh-ancestor
6262170|NCT03242590|Hormones|hormones|mesh-ancestor
6262171|NCT03242590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6262172|NCT03242590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262173|NCT03242590|Androgens|androgens|mesh-ancestor
6262174|NCT03242759|Pirfenidone|pirfenidone|mesh-list
6262175|NCT03242759|Nintedanib|nintedanib|mesh-list
6262176|NCT03242759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6262177|NCT03242759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6262178|NCT03242759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6262179|NCT03242759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262180|NCT03242759|Analgesics|analgesics|mesh-ancestor
6262181|NCT03242759|Sensory System Agents|sensory system agents|mesh-ancestor
6262182|NCT03242759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6262183|NCT03242759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262184|NCT03242759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6262185|NCT03242759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6262186|NCT03242759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6262187|NCT03242759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6262188|NCT03243630|Menthol|menthol|mesh-list
6262189|NCT03243630|Nicotine|nicotine|mesh-list
6262190|NCT03243630|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6262191|NCT03243630|Autonomic Agents|autonomic agents|mesh-ancestor
6262192|NCT03243630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6262193|NCT03243630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262194|NCT03243630|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6262195|NCT03243630|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6262196|NCT03243630|Cholinergic Agents|cholinergic agents|mesh-ancestor
6262197|NCT03243630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6262198|NCT03243630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262199|NCT03243630|Antipruritics|antipruritics|mesh-ancestor
6262200|NCT03243630|Dermatologic Agents|dermatologic agents|mesh-ancestor
6262201|NCT03244618|Fluorides|fluorides|mesh-list
6262202|NCT03244618|Cariostatic Agents|cariostatic agents|mesh-ancestor
6262203|NCT03244618|Protective Agents|protective agents|mesh-ancestor
6262204|NCT03244618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389995|NCT00189839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6389996|NCT00189839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389997|NCT00189878|Methotrexate|methotrexate|mesh-list
6389998|NCT00189878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6389999|NCT00189878|Abortifacient Agents|abortifacient agents|mesh-ancestor
6390000|NCT00189878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6390001|NCT00189878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390002|NCT00189878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6390003|NCT00189878|Antimetabolites|antimetabolites|mesh-ancestor
6390004|NCT00189878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390005|NCT00189878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6390006|NCT00189878|Dermatologic Agents|dermatologic agents|mesh-ancestor
6390007|NCT00189878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6390008|NCT00189878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6390009|NCT00189878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6390010|NCT00189878|Immunologic Factors|immunologic factors|mesh-ancestor
6390011|NCT00189878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6390012|NCT00189878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6390013|NCT00189982|Factor VIII|factor viii|mesh-list
6390014|NCT00189982|Coagulants|coagulants|mesh-ancestor
6390015|NCT00189995|Haloperidol|haloperidol|mesh-list
6390016|NCT00189995|Haloperidol decanoate|haloperidol decanoate|mesh-list
6390017|NCT00189995|Clozapine|clozapine|mesh-list
6390018|NCT00189995|Antiemetics|antiemetics|mesh-ancestor
6390019|NCT00189995|Autonomic Agents|autonomic agents|mesh-ancestor
6390020|NCT00189995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6390021|NCT00189995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390022|NCT00189995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6390023|NCT00189995|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6390024|NCT00189995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6390025|NCT00189995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6390026|NCT00189995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6014582|NCT00352001|Antimetabolites|antimetabolites|mesh-ancestor
6014583|NCT00352001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014584|NCT00352001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6014585|NCT00352027|Prednisone|prednisone|mesh-list
6390027|NCT00189995|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6390028|NCT00189995|Dopamine Agents|dopamine agents|mesh-ancestor
6390029|NCT00189995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6390030|NCT00189995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390031|NCT00189995|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6390032|NCT00189995|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6390033|NCT00189995|Serotonin Agents|serotonin agents|mesh-ancestor
6390034|NCT00189995|GABA Antagonists|gaba antagonists|mesh-ancestor
6390035|NCT00189995|GABA Agents|gaba agents|mesh-ancestor
6390036|NCT00190008|Piracetam|piracetam|mesh-list
6390037|NCT00190008|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6390038|NCT00190008|Protective Agents|protective agents|mesh-ancestor
6014586|NCT00352027|Hydrocortisone|hydrocortisone|mesh-list
6014587|NCT00352027|Cyclophosphamide|cyclophosphamide|mesh-list
6014588|NCT00352027|Mechlorethamine|mechlorethamine|mesh-list
6014589|NCT00352027|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
6014590|NCT00352027|Doxorubicin|doxorubicin|mesh-list
6014591|NCT00352027|Etoposide|etoposide|mesh-list
6014592|NCT00352027|Vincristine|vincristine|mesh-list
6262205|NCT03245398|Mebendazole|mebendazole|mesh-list
6262206|NCT03245398|Piperazine|piperazine|mesh-list
6262207|NCT03245398|Piperazine citrate|piperazine citrate|mesh-list
6262208|NCT03245398|DMP 777|dmp 777|mesh-list
6262209|NCT03245398|Antinematodal Agents|antinematodal agents|mesh-ancestor
6262210|NCT03245398|Anthelmintics|anthelmintics|mesh-ancestor
6262211|NCT03245398|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6262212|NCT03245398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6262213|NCT03245398|Tubulin Modulators|tubulin modulators|mesh-ancestor
6262214|NCT03245398|Antimitotic Agents|antimitotic agents|mesh-ancestor
6262215|NCT03245398|Mitosis Modulators|mitosis modulators|mesh-ancestor
6262216|NCT03245398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262217|NCT03245398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6262218|NCT03245398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6262219|NCT03245463|Hyaluronic Acid|hyaluronic acid|mesh-list
6262220|NCT03245463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6262221|NCT03245463|Immunologic Factors|immunologic factors|mesh-ancestor
6262222|NCT03245463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262223|NCT03245463|Viscosupplements|viscosupplements|mesh-ancestor
6262224|NCT03245463|Protective Agents|protective agents|mesh-ancestor
6262225|NCT03245736|Tisotumab vedotin|tisotumab vedotin|mesh-list
6262226|NCT03245736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6262227|NCT03245736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6262228|NCT03245762|Oxytocin|oxytocin|mesh-list
6262229|NCT03245762|Oxytocics|oxytocics|mesh-ancestor
6262230|NCT03245762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6262231|NCT03245762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262232|NCT03246152|Bevacizumab|bevacizumab|mesh-list
6262233|NCT03246152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6262234|NCT03246152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6262235|NCT03246152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6262236|NCT03246152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6262237|NCT03246152|Growth Substances|growth substances|mesh-ancestor
6262238|NCT03246152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262239|NCT03246152|Growth Inhibitors|growth inhibitors|mesh-ancestor
6262240|NCT03246724|Midazolam|midazolam|mesh-list
6262241|NCT03246724|Triazolam|triazolam|mesh-list
6262242|NCT03246724|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6262243|NCT03246724|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6262244|NCT03246724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6262245|NCT03246724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262246|NCT03246724|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6262247|NCT03246724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6262248|NCT03246724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6262249|NCT03246724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6262250|NCT03246724|Anesthetics, General|anesthetics, general|mesh-ancestor
6262251|NCT03246724|Anesthetics|anesthetics|mesh-ancestor
6262252|NCT03246724|GABA Modulators|gaba modulators|mesh-ancestor
6262253|NCT03246724|GABA Agents|gaba agents|mesh-ancestor
6262254|NCT03246724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6262255|NCT03246724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262256|NCT03247673|Bevacizumab|bevacizumab|mesh-list
6262257|NCT03247673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6262258|NCT03247673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6262259|NCT03247673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6262260|NCT03247673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6262261|NCT03247673|Growth Substances|growth substances|mesh-ancestor
6262262|NCT03247673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262263|NCT03247673|Growth Inhibitors|growth inhibitors|mesh-ancestor
6262264|NCT03247738|Cangrelor|cangrelor|mesh-list
6262265|NCT03247738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6262266|NCT03247738|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6262267|NCT03247738|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6262268|NCT03247738|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6262269|NCT03247738|Purinergic Agents|purinergic agents|mesh-ancestor
6262270|NCT03247738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6262271|NCT03247738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262272|NCT03247738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262273|NCT03247790|Lasmiditan|lasmiditan|mesh-list
6262274|NCT03247790|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6262275|NCT03247790|Serotonin Agents|serotonin agents|mesh-ancestor
6262276|NCT03247790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6262277|NCT03247790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262278|NCT03247790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262279|NCT03248947|Buprenorphine|buprenorphine|mesh-list
6262280|NCT03248947|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6262281|NCT03248947|Naloxone|naloxone|mesh-list
6262282|NCT03248947|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6262283|NCT03248947|Narcotics|narcotics|mesh-ancestor
6262284|NCT03248947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6262285|NCT03248947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262286|NCT03248947|Analgesics|analgesics|mesh-ancestor
6262287|NCT03248947|Sensory System Agents|sensory system agents|mesh-ancestor
6262288|NCT03248947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6262289|NCT03248947|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6262290|NCT03249272|Adenosine|adenosine|mesh-list
6262291|NCT03249272|Regadenoson|regadenoson|mesh-list
6262292|NCT03249272|Analgesics|analgesics|mesh-ancestor
6262293|NCT03249272|Sensory System Agents|sensory system agents|mesh-ancestor
6262294|NCT03249272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6262295|NCT03249272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262296|NCT03249272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6262297|NCT03249272|Vasodilator Agents|vasodilator agents|mesh-ancestor
6262298|NCT03249272|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6262299|NCT03249272|Purinergic Agonists|purinergic agonists|mesh-ancestor
6262300|NCT03249272|Purinergic Agents|purinergic agents|mesh-ancestor
6262301|NCT03249272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6262302|NCT03249272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262303|NCT03249272|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
6262304|NCT03249909|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6262305|NCT03249909|Laxatives|laxatives|mesh-ancestor
6262306|NCT03249909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6262307|NCT03249935|Azithromycin|azithromycin|mesh-list
6262308|NCT03249935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6262309|NCT03249935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6262310|NCT03250182|Budesonide|budesonide|mesh-list
6262311|NCT03250182|Glycopyrrolate|glycopyrrolate|mesh-list
6262312|NCT03250182|Formoterol Fumarate|formoterol fumarate|mesh-list
6262313|NCT03250182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6262314|NCT03250182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6262315|NCT03250182|Autonomic Agents|autonomic agents|mesh-ancestor
6262316|NCT03250182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6262317|NCT03250182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262318|NCT03250182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6262319|NCT03250182|Respiratory System Agents|respiratory system agents|mesh-ancestor
6262320|NCT03250182|Glucocorticoids|glucocorticoids|mesh-ancestor
6262321|NCT03250182|Hormones|hormones|mesh-ancestor
6262322|NCT03250182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6262323|NCT03250182|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6262324|NCT03250182|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6262325|NCT03250182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6262326|NCT03250182|Adrenergic Agents|adrenergic agents|mesh-ancestor
6262327|NCT03250182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6262328|NCT03250182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262329|NCT03250182|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6262330|NCT03250182|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6262331|NCT03250182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6262332|NCT03250182|Cholinergic Agents|cholinergic agents|mesh-ancestor
6262333|NCT03251482|Apixaban|apixaban|mesh-list
6262334|NCT03251482|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6262335|NCT03251482|Antithrombins|antithrombins|mesh-ancestor
6262336|NCT03251482|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6262337|NCT03251482|Protease Inhibitors|protease inhibitors|mesh-ancestor
6262338|NCT03251482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6262339|NCT03251482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262340|NCT03251482|Anticoagulants|anticoagulants|mesh-ancestor
6262341|NCT03251963|Enoxaparin|enoxaparin|mesh-list
6262342|NCT03251963|Enoxaparin sodium|enoxaparin sodium|mesh-list
6262343|NCT03251963|Anticoagulants|anticoagulants|mesh-ancestor
6262344|NCT03251963|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6262345|NCT03251963|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6262346|NCT03251963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262347|NCT03252015|Lasmiditan|lasmiditan|mesh-list
6262348|NCT03252015|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6262349|NCT03252015|Serotonin Agents|serotonin agents|mesh-ancestor
6262350|NCT03252015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6262351|NCT03252015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262352|NCT03252015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262353|NCT03252353|Octreotide|octreotide|mesh-list
6262354|NCT03252353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6262355|NCT03252353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6262356|NCT03252353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6262357|NCT03253094|Fluconazole|fluconazole|mesh-list
6262358|NCT03253094|Ibrexafungerp|ibrexafungerp|mesh-list
6262359|NCT03253094|Antifungal Agents|antifungal agents|mesh-ancestor
6262360|NCT03253094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6262361|NCT03253094|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6262362|NCT03253094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6262363|NCT03253094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6262364|NCT03253094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262365|NCT03253094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6262366|NCT03253094|Hormone Antagonists|hormone antagonists|mesh-ancestor
6262367|NCT03253094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6262368|NCT03253094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262369|NCT03253094|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6262370|NCT03253094|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6262371|NCT03254108|Tolvaptan|tolvaptan|mesh-list
6262372|NCT03254108|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6262373|NCT03254108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262374|NCT03254108|Natriuretic Agents|natriuretic agents|mesh-ancestor
6262375|NCT03254108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262376|NCT03254134|Warfarin|warfarin|mesh-list
6262377|NCT03254134|Dabigatran|dabigatran|mesh-list
6262378|NCT03254134|Anticoagulants|anticoagulants|mesh-ancestor
6262379|NCT03254134|Antithrombins|antithrombins|mesh-ancestor
6262380|NCT03254134|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6262381|NCT03254134|Protease Inhibitors|protease inhibitors|mesh-ancestor
6262382|NCT03254134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6262383|NCT03254134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262384|NCT03254147|Warfarin|warfarin|mesh-list
6262385|NCT03254147|Rivaroxaban|rivaroxaban|mesh-list
6262386|NCT03254147|Dabigatran|dabigatran|mesh-list
6262387|NCT03254147|Apixaban|apixaban|mesh-list
6262388|NCT03254147|Edoxaban|edoxaban|mesh-list
6262389|NCT03254147|Anticoagulants|anticoagulants|mesh-ancestor
6262390|NCT03254147|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6262391|NCT03254147|Antithrombins|antithrombins|mesh-ancestor
6262392|NCT03254147|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6262393|NCT03254147|Protease Inhibitors|protease inhibitors|mesh-ancestor
6262394|NCT03254147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6262395|NCT03254147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262396|NCT03254459|Morphine|morphine|mesh-list
6262397|NCT03254459|Oxycodone|oxycodone|mesh-list
6262398|NCT03254459|Buprenorphine|buprenorphine|mesh-list
6262399|NCT03254459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6262400|NCT03254459|Narcotics|narcotics|mesh-ancestor
6262401|NCT03254459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6262402|NCT03254459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262403|NCT03254459|Analgesics|analgesics|mesh-ancestor
6262404|NCT03254459|Sensory System Agents|sensory system agents|mesh-ancestor
6262405|NCT03254459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6262406|NCT03254459|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6262407|NCT03255382|Dimethyl Fumarate|dimethyl fumarate|mesh-list
6262408|NCT03255382|Dermatologic Agents|dermatologic agents|mesh-ancestor
6262409|NCT03255382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6262410|NCT03255382|Immunologic Factors|immunologic factors|mesh-ancestor
6262411|NCT03255382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262412|NCT03255824|Fentanyl|fentanyl|mesh-list
6262413|NCT03255824|Midazolam|midazolam|mesh-list
6262414|NCT03255824|Dexmedetomidine|dexmedetomidine|mesh-list
6262415|NCT03255824|Propofol|propofol|mesh-list
6262416|NCT03255824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6262417|NCT03255824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6262418|NCT03255824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262419|NCT03255824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6262420|NCT03255824|Anesthetics, General|anesthetics, general|mesh-ancestor
6262421|NCT03255824|Anesthetics|anesthetics|mesh-ancestor
6262422|NCT03255824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6262423|NCT03255824|Analgesics|analgesics|mesh-ancestor
6262424|NCT03255824|Sensory System Agents|sensory system agents|mesh-ancestor
6262425|NCT03255824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6262426|NCT03255824|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6262427|NCT03255824|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6262428|NCT03255824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6262429|NCT03255824|Adrenergic Agents|adrenergic agents|mesh-ancestor
6262430|NCT03255824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6262431|NCT03255824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262432|NCT03255824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6262433|NCT03255824|Narcotics|narcotics|mesh-ancestor
6262434|NCT03255824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6262435|NCT03255824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6262436|NCT03255824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6262437|NCT03255824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6262438|NCT03255824|GABA Modulators|gaba modulators|mesh-ancestor
6262439|NCT03255824|GABA Agents|gaba agents|mesh-ancestor
6262440|NCT03256136|Carboplatin|carboplatin|mesh-list
6262441|NCT03256136|Nivolumab|nivolumab|mesh-list
6262442|NCT03256136|Pemetrexed|pemetrexed|mesh-list
6262443|NCT03256136|Ipilimumab|ipilimumab|mesh-list
6262444|NCT03256136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6262445|NCT03256136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6262446|NCT03256136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6262447|NCT03256136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262448|NCT03256136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6262449|NCT03256136|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6262450|NCT03256136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6262451|NCT03256162|Midazolam|midazolam|mesh-list
6262452|NCT03256162|Ketamine|ketamine|mesh-list
6262453|NCT03256162|Analgesics|analgesics|mesh-ancestor
6262454|NCT03256162|Sensory System Agents|sensory system agents|mesh-ancestor
6262455|NCT03256162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6262456|NCT03256162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262457|NCT03256162|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6262458|NCT03256162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6262459|NCT03256162|Anesthetics, General|anesthetics, general|mesh-ancestor
6262460|NCT03256162|Anesthetics|anesthetics|mesh-ancestor
6262461|NCT03256162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6262462|NCT03256162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6262463|NCT03256162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6262464|NCT03256162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6262465|NCT03256162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262466|NCT03256162|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6262467|NCT03256162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6262468|NCT03256162|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6262469|NCT03256162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6262470|NCT03256162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6262471|NCT03256162|GABA Modulators|gaba modulators|mesh-ancestor
6262472|NCT03256162|GABA Agents|gaba agents|mesh-ancestor
6262473|NCT03256253|Pregabalin|pregabalin|mesh-list
6262474|NCT03256253|Analgesics|analgesics|mesh-ancestor
6262475|NCT03256253|Sensory System Agents|sensory system agents|mesh-ancestor
6262476|NCT03256253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6262477|NCT03256253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262478|NCT03256253|Anticonvulsants|anticonvulsants|mesh-ancestor
6262479|NCT03256253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6262480|NCT03256253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6262481|NCT03256253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262482|NCT03256253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6262483|NCT03256253|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6262484|NCT03256253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6262485|NCT03256253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6262486|NCT03256253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6262487|NCT03256552|Glycopyrrolate|glycopyrrolate|mesh-list
6262488|NCT03256552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6262489|NCT03256552|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6262490|NCT03256552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6262491|NCT03256552|Cholinergic Agents|cholinergic agents|mesh-ancestor
6262492|NCT03256552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6262493|NCT03256552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262494|NCT03256552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262495|NCT03256695|Albuterol|albuterol|mesh-list
6262496|NCT03256695|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6262497|NCT03256695|Autonomic Agents|autonomic agents|mesh-ancestor
6262498|NCT03256695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6262499|NCT03256695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262500|NCT03256695|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6262501|NCT03256695|Respiratory System Agents|respiratory system agents|mesh-ancestor
6262502|NCT03256695|Tocolytic Agents|tocolytic agents|mesh-ancestor
6262503|NCT03256695|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6262504|NCT03256695|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6262505|NCT03256695|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6262506|NCT03256695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6262507|NCT03256695|Adrenergic Agents|adrenergic agents|mesh-ancestor
6262508|NCT03256695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6262509|NCT03256695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262510|NCT03256799|Ivacaftor|ivacaftor|mesh-list
6262511|NCT03256799|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6262512|NCT03256799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6262513|NCT03256799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262514|NCT03257202|Clindamycin|clindamycin|mesh-list
6262515|NCT03257202|Clindamycin palmitate|clindamycin palmitate|mesh-list
6262516|NCT03257202|Clindamycin phosphate|clindamycin phosphate|mesh-list
6262517|NCT03257202|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6262518|NCT03257202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6262519|NCT03257202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6262520|NCT03257202|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6262521|NCT03257202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6262522|NCT03257202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262523|NCT03257202|Dermatologic Agents|dermatologic agents|mesh-ancestor
6262524|NCT03257358|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6262525|NCT03257358|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6262526|NCT03257358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262527|NCT03257358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6262528|NCT03257358|Immunologic Factors|immunologic factors|mesh-ancestor
6262529|NCT03257358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262530|NCT03257631|Thalidomide|thalidomide|mesh-list
6262531|NCT03257631|Pomalidomide|pomalidomide|mesh-list
6262532|NCT03257631|Immunologic Factors|immunologic factors|mesh-ancestor
6262533|NCT03257631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262534|NCT03257631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6262535|NCT03257631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6262536|NCT03257631|Growth Substances|growth substances|mesh-ancestor
6262537|NCT03257631|Growth Inhibitors|growth inhibitors|mesh-ancestor
6262538|NCT03257631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6262539|NCT03257631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6262540|NCT03257631|Leprostatic Agents|leprostatic agents|mesh-ancestor
6262541|NCT03257631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6262542|NCT03257631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6262543|NCT03257813|Timolol|timolol|mesh-list
6262544|NCT03257813|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6262545|NCT03257813|Dorzolamide|dorzolamide|mesh-list
6262546|NCT03257813|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6262547|NCT03257813|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6262548|NCT03257813|Adrenergic Agents|adrenergic agents|mesh-ancestor
6262549|NCT03257813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6262550|NCT03257813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262551|NCT03257813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262552|NCT03257813|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6262553|NCT03257813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6262554|NCT03257813|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6262555|NCT03257813|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6262556|NCT03257813|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6262557|NCT03257813|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6262558|NCT03257813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6262559|NCT03257865|Brexpiprazole|brexpiprazole|mesh-list
6262560|NCT03257865|Serotonin Agents|serotonin agents|mesh-ancestor
6262561|NCT03257865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6262562|NCT03257865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262563|NCT03257865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262564|NCT03257865|Dopamine Agonists|dopamine agonists|mesh-ancestor
6262565|NCT03257865|Dopamine Agents|dopamine agents|mesh-ancestor
6262566|NCT03257995|Maleic acid|maleic acid|mesh-list
6262567|NCT03257995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6262568|NCT03257995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262569|NCT03258645|Dabigatran|dabigatran|mesh-list
6262570|NCT03258645|Antithrombins|antithrombins|mesh-ancestor
6262571|NCT03258645|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6262572|NCT03258645|Protease Inhibitors|protease inhibitors|mesh-ancestor
6262573|NCT03258645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6262574|NCT03258645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262575|NCT03258645|Anticoagulants|anticoagulants|mesh-ancestor
6262576|NCT03258710|Tenofovir|tenofovir|mesh-list
6262577|NCT03258710|Antiviral Agents|antiviral agents|mesh-ancestor
6262578|NCT03258710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6262579|NCT03258710|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6262580|NCT03258710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6262581|NCT03258710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6262582|NCT03258710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262583|NCT03258710|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6262584|NCT03258710|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6262585|NCT03258762|Leucovorin|leucovorin|mesh-list
6262586|NCT03258762|Pyrimethamine|pyrimethamine|mesh-list
6262587|NCT03258762|Calcium|calcium|mesh-list
6262588|NCT03258762|Levoleucovorin|levoleucovorin|mesh-list
6262589|NCT03258762|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6262590|NCT03258762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262591|NCT03258762|Antidotes|antidotes|mesh-ancestor
6262592|NCT03258762|Protective Agents|protective agents|mesh-ancestor
6262593|NCT03258762|Vitamin B Complex|vitamin b complex|mesh-ancestor
6262594|NCT03258762|Vitamins|vitamins|mesh-ancestor
6262595|NCT03258762|Micronutrients|micronutrients|mesh-ancestor
6262596|NCT03258762|Antimalarials|antimalarials|mesh-ancestor
6262597|NCT03258762|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6262598|NCT03258762|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6262599|NCT03258762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6262600|NCT03258762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6262601|NCT03258762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6262602|NCT03258762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262603|NCT03259425|Nivolumab|nivolumab|mesh-list
6262604|NCT03259425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6262605|NCT03259425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6262606|NCT03259425|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6262607|NCT03259425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262608|NCT03259490|Metformin|metformin|mesh-list
6262609|NCT03259490|Empagliflozin|empagliflozin|mesh-list
6262610|NCT03259490|Linagliptin|linagliptin|mesh-list
6262611|NCT03259490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6262612|NCT03259490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262613|NCT03259490|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6262614|NCT03259490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262615|NCT03259490|Incretins|incretins|mesh-ancestor
6262616|NCT03259490|Hormones|hormones|mesh-ancestor
6262617|NCT03259490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6262618|NCT03259490|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6262619|NCT03259490|Protease Inhibitors|protease inhibitors|mesh-ancestor
6262620|NCT03259490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6262621|NCT03259555|Brexpiprazole|brexpiprazole|mesh-list
6262622|NCT03259555|Serotonin Agents|serotonin agents|mesh-ancestor
6262623|NCT03259555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6262624|NCT03259555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262625|NCT03259555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262626|NCT03259555|Dopamine Agonists|dopamine agonists|mesh-ancestor
6262627|NCT03259555|Dopamine Agents|dopamine agents|mesh-ancestor
6262628|NCT03259789|Bexagliflozin|bexagliflozin|mesh-list
6262629|NCT03259789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6262630|NCT03259789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262631|NCT03260205|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6262632|NCT03260205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6262633|NCT03260205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262634|NCT03260205|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6262635|NCT03260205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6262636|NCT03260205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6262637|NCT03260205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262638|NCT03260205|Dopamine Agents|dopamine agents|mesh-ancestor
6262639|NCT03260205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6390039|NCT00190008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390040|NCT00190008|Nootropic Agents|nootropic agents|mesh-ancestor
6390041|NCT00190021|Donepezil|donepezil|mesh-list
6390042|NCT00190021|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6390043|NCT00190021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6390044|NCT00190021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390045|NCT00190021|Cholinergic Agents|cholinergic agents|mesh-ancestor
6390046|NCT00190021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6390047|NCT00190021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390048|NCT00190021|Nootropic Agents|nootropic agents|mesh-ancestor
6390049|NCT00190034|Acetylcysteine|acetylcysteine|mesh-list
6390050|NCT00190034|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6390051|NCT00190034|Antiviral Agents|antiviral agents|mesh-ancestor
6390052|NCT00190034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6390053|NCT00190034|Expectorants|expectorants|mesh-ancestor
6390054|NCT00190034|Respiratory System Agents|respiratory system agents|mesh-ancestor
6390055|NCT00190034|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6390056|NCT00190034|Antioxidants|antioxidants|mesh-ancestor
6390057|NCT00190034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390058|NCT00190034|Protective Agents|protective agents|mesh-ancestor
6390059|NCT00190034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390060|NCT00190034|Antidotes|antidotes|mesh-ancestor
6390061|NCT00190060|Testosterone|testosterone|mesh-list
6390062|NCT00190060|Androgens|androgens|mesh-ancestor
6390063|NCT00190060|Hormones|hormones|mesh-ancestor
6390064|NCT00190060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6390065|NCT00190060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390066|NCT00190099|Dexamethasone|dexamethasone|mesh-list
6390067|NCT00190099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6390068|NCT00190099|Antiemetics|antiemetics|mesh-ancestor
6390069|NCT00190099|Autonomic Agents|autonomic agents|mesh-ancestor
6390070|NCT00190099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6390071|NCT00190099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390072|NCT00190099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6390073|NCT00190099|Glucocorticoids|glucocorticoids|mesh-ancestor
6390074|NCT00190099|Hormones|hormones|mesh-ancestor
6390075|NCT00190099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6390076|NCT00190099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6390077|NCT00190099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6390078|NCT00190151|Ciprofloxacin|ciprofloxacin|mesh-list
6390079|NCT00190151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6390080|NCT00190151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6390081|NCT00190151|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6390082|NCT00190151|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6390083|NCT00190151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6390084|NCT00190151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390085|NCT00190151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6390086|NCT00190151|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6390087|NCT00190151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6390088|NCT00190229|Cyclophosphamide|cyclophosphamide|mesh-list
6390089|NCT00190229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6390090|NCT00190229|Immunologic Factors|immunologic factors|mesh-ancestor
6390091|NCT00190229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390092|NCT00190229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6390093|NCT00190229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6390094|NCT00190229|Alkylating Agents|alkylating agents|mesh-ancestor
6262640|NCT03260790|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6262641|NCT03260790|Immunologic Factors|immunologic factors|mesh-ancestor
6262642|NCT03260790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262643|NCT03260868|Insulin|insulin|mesh-list
6262644|NCT03260868|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6262645|NCT03260868|Insulin Glargine|insulin glargine|mesh-list
6262646|NCT03260868|Insulin Lispro|insulin lispro|mesh-list
6262647|NCT03260868|Insulin Aspart|insulin aspart|mesh-list
6262648|NCT03260868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6262649|NCT03260868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262662|NCT03261167|Botulinum Toxins|botulinum toxins|mesh-list
6262663|NCT03261167|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6262664|NCT03261167|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6262665|NCT03261167|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6262666|NCT03261167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6262667|NCT03261167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262668|NCT03261167|Cholinergic Agents|cholinergic agents|mesh-ancestor
6262669|NCT03261167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6262670|NCT03261167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262671|NCT03261167|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6262672|NCT03261167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6262673|NCT03261336|Vitamin D|vitamin d|mesh-list
6262674|NCT03261336|Calcitriol|calcitriol|mesh-list
6262675|NCT03261336|Ketoconazole|ketoconazole|mesh-list
6262676|NCT03261336|Hydrocortisone|hydrocortisone|mesh-list
6262677|NCT03261336|Vitamins|vitamins|mesh-ancestor
6262678|NCT03261336|Micronutrients|micronutrients|mesh-ancestor
6262679|NCT03261336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262680|NCT03261336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6262681|NCT03261336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6262682|NCT03261336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6262683|NCT03261336|Antifungal Agents|antifungal agents|mesh-ancestor
6262684|NCT03261336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6262685|NCT03261336|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6262686|NCT03261336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6262687|NCT03261336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6262688|NCT03261336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262689|NCT03261336|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6262690|NCT03261336|Hormone Antagonists|hormone antagonists|mesh-ancestor
6262691|NCT03261336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6262692|NCT03261336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6262693|NCT03261336|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6262694|NCT03261336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6262695|NCT03261336|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6262696|NCT03261999|Leuprolide|leuprolide|mesh-list
6262697|NCT03261999|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6262698|NCT03261999|Fertility Agents|fertility agents|mesh-ancestor
6262699|NCT03261999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6014593|NCT00352027|Bleomycin|bleomycin|mesh-list
6014594|NCT00352027|Vinblastine|vinblastine|mesh-list
6014595|NCT00352027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6014596|NCT00352027|Immunologic Factors|immunologic factors|mesh-ancestor
6014597|NCT00352027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014598|NCT00352027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6014599|NCT00352027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6014600|NCT00352027|Alkylating Agents|alkylating agents|mesh-ancestor
6014601|NCT00352027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014602|NCT00352027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6014603|NCT00352027|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6014604|NCT00352027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6014605|NCT00352027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6262700|NCT03261999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262701|NCT03261999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6262702|NCT03261999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6262703|NCT03262012|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6262704|NCT03262012|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6014606|NCT00352027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6014607|NCT00352027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6014608|NCT00352027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6014609|NCT00352027|Glucocorticoids|glucocorticoids|mesh-ancestor
6014610|NCT00352027|Hormones|hormones|mesh-ancestor
6014611|NCT00352027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6262705|NCT03262012|Respiratory System Agents|respiratory system agents|mesh-ancestor
6262706|NCT03262038|Ondansetron|ondansetron|mesh-list
6262707|NCT03262038|Antiemetics|antiemetics|mesh-ancestor
6262708|NCT03262038|Autonomic Agents|autonomic agents|mesh-ancestor
6262709|NCT03262038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6262710|NCT03262038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262711|NCT03262038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6262712|NCT03262038|Antipruritics|antipruritics|mesh-ancestor
6262713|NCT03262038|Dermatologic Agents|dermatologic agents|mesh-ancestor
6262714|NCT03262038|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6262715|NCT03262038|Serotonin Agents|serotonin agents|mesh-ancestor
6262716|NCT03262038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6262717|NCT03262038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262718|NCT03262038|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6262719|NCT03262038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6262720|NCT03262038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6262721|NCT03262038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6262722|NCT03262038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6262723|NCT03262233|Nicotine|nicotine|mesh-list
6262724|NCT03262233|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6262725|NCT03262233|Autonomic Agents|autonomic agents|mesh-ancestor
6262726|NCT03262233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6262727|NCT03262233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262728|NCT03262233|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6262729|NCT03262233|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6262730|NCT03262233|Cholinergic Agents|cholinergic agents|mesh-ancestor
6262731|NCT03262233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6262732|NCT03262233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262733|NCT03262389|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6262734|NCT03262389|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6262735|NCT03262389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262736|NCT03262441|Mycophenolic Acid|mycophenolic acid|mesh-list
6262737|NCT03262441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6262738|NCT03262441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6262739|NCT03262441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6262740|NCT03262441|Antitubercular Agents|antitubercular agents|mesh-ancestor
6262741|NCT03262441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6262742|NCT03262441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6262743|NCT03262441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6262744|NCT03262441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262745|NCT03263442|Thiamine|thiamine|mesh-list
6262746|NCT03263442|Vitamin B Complex|vitamin b complex|mesh-ancestor
6262747|NCT03263442|Vitamins|vitamins|mesh-ancestor
6262748|NCT03263442|Micronutrients|micronutrients|mesh-ancestor
6262749|NCT03263442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262750|NCT03264066|Atezolizumab|atezolizumab|mesh-list
6262751|NCT03264066|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6262752|NCT03264066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6262753|NCT03264066|Immunologic Factors|immunologic factors|mesh-ancestor
6262754|NCT03264066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262755|NCT03264157|Vaccines|vaccines|mesh-list
6262756|NCT03264157|Immunologic Factors|immunologic factors|mesh-ancestor
6262757|NCT03264157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262758|NCT03265132|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6262759|NCT03265132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6262760|NCT03266419|Rocuronium|rocuronium|mesh-list
6262761|NCT03266419|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6262762|NCT03266419|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6262763|NCT03266419|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6262764|NCT03266419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6262765|NCT03266419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262766|NCT03267576|Metformin|metformin|mesh-list
6262767|NCT03267576|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6262768|NCT03267576|Canagliflozin|canagliflozin|mesh-list
6262769|NCT03267576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6262770|NCT03267576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262771|NCT03267576|Incretins|incretins|mesh-ancestor
6262772|NCT03267576|Hormones|hormones|mesh-ancestor
6262773|NCT03267576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6262774|NCT03267576|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6262775|NCT03267576|Protease Inhibitors|protease inhibitors|mesh-ancestor
6262776|NCT03267576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6262777|NCT03267576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262778|NCT03267576|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6262779|NCT03267940|Atezolizumab|atezolizumab|mesh-list
6262780|NCT03267940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6262781|NCT03268941|Metoclopramide|metoclopramide|mesh-list
6262782|NCT03268941|Maleic acid|maleic acid|mesh-list
6262783|NCT03268941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6262784|NCT03268941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262785|NCT03268941|Antiemetics|antiemetics|mesh-ancestor
6262786|NCT03268941|Autonomic Agents|autonomic agents|mesh-ancestor
6262787|NCT03268941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6262788|NCT03268941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262789|NCT03268941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6262790|NCT03268941|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6262791|NCT03268941|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6262792|NCT03268941|Dopamine Agents|dopamine agents|mesh-ancestor
6262793|NCT03268941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6262794|NCT03269435|Metoclopramide|metoclopramide|mesh-list
6262795|NCT03269435|Bupivacaine|bupivacaine|mesh-list
6262796|NCT03269435|Anesthetics, Local|anesthetics, local|mesh-ancestor
6262797|NCT03269435|Anesthetics|anesthetics|mesh-ancestor
6262798|NCT03269435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6262799|NCT03269435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262800|NCT03269435|Sensory System Agents|sensory system agents|mesh-ancestor
6262801|NCT03269435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6262802|NCT03269435|Antiemetics|antiemetics|mesh-ancestor
6262803|NCT03269435|Autonomic Agents|autonomic agents|mesh-ancestor
6262804|NCT03269435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6262805|NCT03269435|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6262806|NCT03269435|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6262807|NCT03269435|Dopamine Agents|dopamine agents|mesh-ancestor
6262808|NCT03269435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6262809|NCT03269435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262810|NCT03269552|Rituximab|rituximab|mesh-list
6262811|NCT03269552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6262812|NCT03269552|Antibodies|antibodies|mesh-list
6262813|NCT03269552|Immunoglobulins|immunoglobulins|mesh-list
6262814|NCT03269552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6262815|NCT03269552|Immunologic Factors|immunologic factors|mesh-ancestor
6262816|NCT03269552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262817|NCT03269552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6262818|NCT03269552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6262819|NCT03270085|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
6262820|NCT03270085|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6014612|NCT00352027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6014613|NCT00352027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6262821|NCT03270085|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6262822|NCT03270085|Antimetabolites|antimetabolites|mesh-ancestor
6262823|NCT03270085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262824|NCT03270085|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6262825|NCT03270332|Albuterol|albuterol|mesh-list
6262826|NCT03270332|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6262827|NCT03270332|Autonomic Agents|autonomic agents|mesh-ancestor
6262828|NCT03270332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6262829|NCT03270332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262830|NCT03270332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6262831|NCT03270332|Respiratory System Agents|respiratory system agents|mesh-ancestor
6262832|NCT03270332|Tocolytic Agents|tocolytic agents|mesh-ancestor
6262833|NCT03270332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6262834|NCT03270332|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6262835|NCT03270332|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6262836|NCT03270332|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6262837|NCT03270332|Adrenergic Agents|adrenergic agents|mesh-ancestor
6262838|NCT03270332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6262839|NCT03270332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262840|NCT03270514|Bupivacaine|bupivacaine|mesh-list
6262841|NCT03270514|Anesthetics, Local|anesthetics, local|mesh-ancestor
6262842|NCT03270514|Anesthetics|anesthetics|mesh-ancestor
6262843|NCT03270514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6262844|NCT03270514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262845|NCT03270514|Sensory System Agents|sensory system agents|mesh-ancestor
6262846|NCT03270514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6262847|NCT03270644|Propranolol|propranolol|mesh-list
6262848|NCT03270644|Lasmiditan|lasmiditan|mesh-list
6262849|NCT03270644|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6262850|NCT03270644|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6262851|NCT03270644|Adrenergic Agents|adrenergic agents|mesh-ancestor
6262852|NCT03270644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6262853|NCT03270644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262854|NCT03270644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262855|NCT03270644|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6262856|NCT03270644|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6262857|NCT03270644|Vasodilator Agents|vasodilator agents|mesh-ancestor
6014614|NCT00352027|Tubulin Modulators|tubulin modulators|mesh-ancestor
6014615|NCT00352027|Antimitotic Agents|antimitotic agents|mesh-ancestor
6014616|NCT00352027|Mitosis Modulators|mitosis modulators|mesh-ancestor
6014617|NCT00352053|Tenofovir|tenofovir|mesh-list
6014618|NCT00352053|Antiviral Agents|antiviral agents|mesh-ancestor
6014619|NCT00352053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6014620|NCT00352053|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6014621|NCT00352053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6014622|NCT00352053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6014623|NCT00352053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014624|NCT00352053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6014625|NCT00352053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6014626|NCT00352105|Fluorouracil|fluorouracil|mesh-list
6014627|NCT00352105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6014628|NCT00352105|Antimetabolites|antimetabolites|mesh-ancestor
6014629|NCT00352105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014630|NCT00352105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6014631|NCT00352105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6262858|NCT03270644|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6262859|NCT03270644|Serotonin Agents|serotonin agents|mesh-ancestor
6262860|NCT03271528|Lacosamide|lacosamide|mesh-list
6262861|NCT03271528|Anticonvulsants|anticonvulsants|mesh-ancestor
6262862|NCT03271528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6262863|NCT03271528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6262864|NCT03271528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6262865|NCT03271528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262866|NCT03272139|Bupivacaine|bupivacaine|mesh-list
6262867|NCT03272139|Anesthetics, Local|anesthetics, local|mesh-ancestor
6262868|NCT03272139|Anesthetics|anesthetics|mesh-ancestor
6262869|NCT03272139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6262870|NCT03272139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262871|NCT03272139|Sensory System Agents|sensory system agents|mesh-ancestor
6262872|NCT03272139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6262873|NCT03273153|Pembrolizumab|pembrolizumab|mesh-list
6262874|NCT03273153|Atezolizumab|atezolizumab|mesh-list
6262875|NCT03273153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6262876|NCT03273153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6262877|NCT03273257|Riociguat|riociguat|mesh-list
6262878|NCT03273257|Enzyme Activators|enzyme activators|mesh-ancestor
6262879|NCT03273257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262880|NCT03273387|Trimetazidine|trimetazidine|mesh-list
6262881|NCT03273387|Vasodilator Agents|vasodilator agents|mesh-ancestor
6262882|NCT03273946|Fluticasone|fluticasone|mesh-list
6262883|NCT03273946|Xhance|xhance|mesh-list
6262884|NCT03273946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6262885|NCT03273946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6262886|NCT03273946|Autonomic Agents|autonomic agents|mesh-ancestor
6262887|NCT03273946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6262888|NCT03273946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262889|NCT03273946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6262890|NCT03273946|Respiratory System Agents|respiratory system agents|mesh-ancestor
6262891|NCT03273946|Dermatologic Agents|dermatologic agents|mesh-ancestor
6262892|NCT03273946|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6262893|NCT03274076|Tofacitinib|tofacitinib|mesh-list
6262894|NCT03274076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6262895|NCT03274076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6262896|NCT03274076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262897|NCT03274453|Ketamine|ketamine|mesh-list
6262898|NCT03274453|Analgesics|analgesics|mesh-ancestor
6262899|NCT03274453|Sensory System Agents|sensory system agents|mesh-ancestor
6262900|NCT03274453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6262901|NCT03274453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262902|NCT03274453|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6262903|NCT03274453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6262904|NCT03274453|Anesthetics, General|anesthetics, general|mesh-ancestor
6262905|NCT03274453|Anesthetics|anesthetics|mesh-ancestor
6262906|NCT03274453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6262907|NCT03274453|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6262908|NCT03274453|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6262909|NCT03274453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6262910|NCT03274453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262911|NCT03274466|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6262912|NCT03274466|Laxatives|laxatives|mesh-ancestor
6262913|NCT03274466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6262914|NCT03274804|Maraviroc|maraviroc|mesh-list
6262915|NCT03274804|Pembrolizumab|pembrolizumab|mesh-list
6262916|NCT03274804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6262917|NCT03274804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6262918|NCT03274804|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6262919|NCT03274804|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6262920|NCT03274804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262921|NCT03274804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6262922|NCT03274804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6262923|NCT03274804|Antiviral Agents|antiviral agents|mesh-ancestor
6262924|NCT03274804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6262925|NCT03274804|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6262926|NCT03275623|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6262927|NCT03275623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6262928|NCT03275870|Hydroxychloroquine|hydroxychloroquine|mesh-list
6262929|NCT03275870|Antimalarials|antimalarials|mesh-ancestor
6262930|NCT03275870|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6262931|NCT03275870|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6262932|NCT03275870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6262933|NCT03275870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6262934|NCT03275870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262935|NCT03275870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6262936|NCT03276026|Neostigmine|neostigmine|mesh-list
6262937|NCT03276026|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6262938|NCT03276026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6262939|NCT03276026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262940|NCT03276026|Cholinergic Agents|cholinergic agents|mesh-ancestor
6262941|NCT03276026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6262942|NCT03276026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262943|NCT03276026|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6262944|NCT03276026|Autonomic Agents|autonomic agents|mesh-ancestor
6262945|NCT03276026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6262946|NCT03276078|Bromides|bromides|mesh-list
6262947|NCT03276078|Formoterol Fumarate|formoterol fumarate|mesh-list
6262948|NCT03276078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6262949|NCT03276078|Autonomic Agents|autonomic agents|mesh-ancestor
6262950|NCT03276078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6262951|NCT03276078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262952|NCT03276078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6262953|NCT03276078|Respiratory System Agents|respiratory system agents|mesh-ancestor
6262954|NCT03276078|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6262955|NCT03276078|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6262956|NCT03276078|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6262957|NCT03276078|Adrenergic Agents|adrenergic agents|mesh-ancestor
6262958|NCT03276078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6262959|NCT03276078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262960|NCT03276078|Anticonvulsants|anticonvulsants|mesh-ancestor
6262961|NCT03276975|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6262962|NCT03276975|Hemostatics|hemostatics|mesh-ancestor
6262963|NCT03276975|Coagulants|coagulants|mesh-ancestor
6262964|NCT03277352|Pembrolizumab|pembrolizumab|mesh-list
6262965|NCT03277352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6262966|NCT03277352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6262967|NCT03278028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6262968|NCT03278106|Trifluridine|trifluridine|mesh-list
6262969|NCT03278106|Antimetabolites|antimetabolites|mesh-ancestor
6262970|NCT03278106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262971|NCT03278106|Antiviral Agents|antiviral agents|mesh-ancestor
6262972|NCT03278106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6262973|NCT03278223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6262974|NCT03278886|Naltrexone|naltrexone|mesh-list
6262975|NCT03278886|Nalmefene|nalmefene|mesh-list
6262976|NCT03278886|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6262977|NCT03278886|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6262978|NCT03278886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262979|NCT03278886|Sensory System Agents|sensory system agents|mesh-ancestor
6262980|NCT03278886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6262981|NCT03279237|Leucovorin|leucovorin|mesh-list
6262982|NCT03279237|Paclitaxel|paclitaxel|mesh-list
6262983|NCT03279237|Carboplatin|carboplatin|mesh-list
6262984|NCT03279237|Fluorouracil|fluorouracil|mesh-list
6262985|NCT03279237|Oxaliplatin|oxaliplatin|mesh-list
6262986|NCT03279237|Irinotecan|irinotecan|mesh-list
6262987|NCT03279237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6262988|NCT03279237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6262989|NCT03279237|Tubulin Modulators|tubulin modulators|mesh-ancestor
6262990|NCT03279237|Antimitotic Agents|antimitotic agents|mesh-ancestor
6262991|NCT03279237|Mitosis Modulators|mitosis modulators|mesh-ancestor
6014632|NCT00352105|Immunologic Factors|immunologic factors|mesh-ancestor
6014633|NCT00352105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014634|NCT00352365|Lenalidomide|lenalidomide|mesh-list
6014635|NCT00352365|Immunologic Factors|immunologic factors|mesh-ancestor
6262992|NCT03279237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6262993|NCT03279237|Antimetabolites|antimetabolites|mesh-ancestor
6262994|NCT03279237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6262995|NCT03279237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6262996|NCT03279237|Immunologic Factors|immunologic factors|mesh-ancestor
6262997|NCT03279237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6262998|NCT03279237|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6262999|NCT03279237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6263000|NCT03279237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6263001|NCT03279237|Antidotes|antidotes|mesh-ancestor
6263002|NCT03279237|Protective Agents|protective agents|mesh-ancestor
6263003|NCT03279237|Vitamin B Complex|vitamin b complex|mesh-ancestor
6263004|NCT03279237|Vitamins|vitamins|mesh-ancestor
6263005|NCT03279237|Micronutrients|micronutrients|mesh-ancestor
6263006|NCT03279731|Liraglutide|liraglutide|mesh-list
6263007|NCT03279731|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6263008|NCT03279731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263009|NCT03279731|Incretins|incretins|mesh-ancestor
6263010|NCT03279731|Hormones|hormones|mesh-ancestor
6263011|NCT03279731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6390095|NCT00190229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390096|NCT00190229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6390097|NCT00190229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6390098|NCT00190268|Amifampridine|amifampridine|mesh-list
6390099|NCT00190268|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6390100|NCT00190268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6390101|NCT00190268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390102|NCT00190268|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6390103|NCT00190268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6390104|NCT00190268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390105|NCT00190294|Misoprostol|misoprostol|mesh-list
6390106|NCT00190294|Mifepristone|mifepristone|mesh-list
6390107|NCT00190294|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6390108|NCT00190294|Abortifacient Agents|abortifacient agents|mesh-ancestor
6014636|NCT00352365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014637|NCT00352365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6014638|NCT00352365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6014639|NCT00352365|Growth Substances|growth substances|mesh-ancestor
6014640|NCT00352365|Growth Inhibitors|growth inhibitors|mesh-ancestor
6014641|NCT00352365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6014642|NCT00352417|Atreleuton|atreleuton|mesh-list
6014643|NCT00352417|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6014644|NCT00352417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6014645|NCT00352417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014646|NCT00352612|Clindamycin|clindamycin|mesh-list
6390109|NCT00190294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6390110|NCT00190294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390111|NCT00190294|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6390112|NCT00190294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6390113|NCT00190294|Oxytocics|oxytocics|mesh-ancestor
6390114|NCT00190294|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6390115|NCT00190294|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6014647|NCT00352612|Clindamycin palmitate|clindamycin palmitate|mesh-list
6014648|NCT00352612|Clindamycin phosphate|clindamycin phosphate|mesh-list
6014649|NCT00352612|Cephalexin|cephalexin|mesh-list
6014650|NCT00352612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6014651|NCT00352612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6014652|NCT00352612|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6014653|NCT00352612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6014654|NCT00352612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014655|NCT00352664|Donepezil|donepezil|mesh-list
6263012|NCT03280537|Omalizumab|omalizumab|mesh-list
6263013|NCT03280537|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6263014|NCT03280537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6263015|NCT03280537|Respiratory System Agents|respiratory system agents|mesh-ancestor
6263016|NCT03280550|Omalizumab|omalizumab|mesh-list
6263017|NCT03280550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6263018|NCT03280550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6263019|NCT03280550|Respiratory System Agents|respiratory system agents|mesh-ancestor
6263020|NCT03281200|Nintedanib|nintedanib|mesh-list
6263021|NCT03281200|Antineoplastic Agents|antineoplastic agents|mesh-list
6263022|NCT03281200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-list
6263023|NCT03281200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6263024|NCT03281200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6263025|NCT03281304|Tofacitinib|tofacitinib|mesh-list
6263026|NCT03281304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6263027|NCT03281304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6263028|NCT03281304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6263029|NCT03282227|Oxazolidinones|oxazolidinones|mesh-list
6263030|NCT03282227|Zolmitriptan|zolmitriptan|mesh-list
6263031|NCT03282227|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6263032|NCT03282227|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6263033|NCT03282227|Serotonin Agents|serotonin agents|mesh-ancestor
6263034|NCT03282227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6263035|NCT03282227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6263036|NCT03282227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263037|NCT03282227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6263038|NCT03282227|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6263039|NCT03282227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6263040|NCT03282240|Vaccines|vaccines|mesh-list
6263041|NCT03282240|Immunologic Factors|immunologic factors|mesh-ancestor
6263042|NCT03282240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263043|NCT03282357|Hyaluronic Acid|hyaluronic acid|mesh-list
6263044|NCT03282357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263045|NCT03282357|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6263046|NCT03282357|Immunologic Factors|immunologic factors|mesh-ancestor
6263047|NCT03282357|Viscosupplements|viscosupplements|mesh-ancestor
6263048|NCT03282357|Protective Agents|protective agents|mesh-ancestor
6263049|NCT03282591|Serlopitant|serlopitant|mesh-list
6263050|NCT03282591|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6263051|NCT03282591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6263052|NCT03282591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6263053|NCT03282591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263054|NCT03283436|Bupivacaine|bupivacaine|mesh-list
6263055|NCT03283436|Anesthetics, Local|anesthetics, local|mesh-ancestor
6263056|NCT03283436|Anesthetics|anesthetics|mesh-ancestor
6263057|NCT03283436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6263058|NCT03283436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263059|NCT03283436|Sensory System Agents|sensory system agents|mesh-ancestor
6263060|NCT03283436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6263061|NCT03283696|Doxorubicin|doxorubicin|mesh-list
6263062|NCT03283696|Ifosfamide|ifosfamide|mesh-list
6263063|NCT03283696|Olaratumab|olaratumab|mesh-list
6263064|NCT03283696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6263065|NCT03283696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6263066|NCT03283696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6263067|NCT03283696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6263068|NCT03283696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6263069|NCT03283696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6263070|NCT03283696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6263071|NCT03283696|Alkylating Agents|alkylating agents|mesh-ancestor
6263072|NCT03284424|Pembrolizumab|pembrolizumab|mesh-list
6263073|NCT03284424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6014656|NCT00352664|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6263074|NCT03284424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6263075|NCT03285295|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
6263076|NCT03285295|Immunologic Factors|immunologic factors|mesh-ancestor
6390116|NCT00190294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6263077|NCT03285295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263078|NCT03285477|Tirbanibulin|tirbanibulin|mesh-list
6263079|NCT03285477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6263080|NCT03285477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6263081|NCT03285490|Tirbanibulin|tirbanibulin|mesh-list
6263082|NCT03285490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6263083|NCT03285490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6263084|NCT03285594|Insulin Glargine|insulin glargine|mesh-list
6263085|NCT03285594|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
6263086|NCT03285594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6263087|NCT03285594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263088|NCT03285594|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6263089|NCT03285594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6263090|NCT03285646|Fasinumab|fasinumab|mesh-list
6263091|NCT03285646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6263092|NCT03285646|Analgesics|analgesics|mesh-ancestor
6263093|NCT03285646|Sensory System Agents|sensory system agents|mesh-ancestor
6263094|NCT03285646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6263095|NCT03285646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263096|NCT03285984|Listerine|listerine|mesh-list
6263097|NCT03285984|Fluorides|fluorides|mesh-list
6263098|NCT03285984|Sodium Fluoride|sodium fluoride|mesh-list
6263099|NCT03285984|Cariostatic Agents|cariostatic agents|mesh-ancestor
6263100|NCT03285984|Protective Agents|protective agents|mesh-ancestor
6263101|NCT03285984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263102|NCT03285984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6263103|NCT03285984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6263104|NCT03286218|Alprazolam|alprazolam|mesh-list
6263105|NCT03286218|Lasmiditan|lasmiditan|mesh-list
6263106|NCT03286218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6263107|NCT03286218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6263108|NCT03286218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263109|NCT03286218|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6263110|NCT03286218|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6263111|NCT03286218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6263112|NCT03286218|GABA Modulators|gaba modulators|mesh-ancestor
6263113|NCT03286218|GABA Agents|gaba agents|mesh-ancestor
6263114|NCT03286218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6263115|NCT03286218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6263116|NCT03286218|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6263117|NCT03286218|Serotonin Agents|serotonin agents|mesh-ancestor
6263118|NCT03286751|Insulin Lispro|insulin lispro|mesh-list
6263119|NCT03286751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6263120|NCT03286751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263121|NCT03286829|Metoprolol|metoprolol|mesh-list
6263122|NCT03286829|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6263123|NCT03286829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6263124|NCT03286829|Sympatholytics|sympatholytics|mesh-ancestor
6263125|NCT03286829|Autonomic Agents|autonomic agents|mesh-ancestor
6263126|NCT03286829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6263127|NCT03286829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263128|NCT03286829|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6263129|NCT03286829|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6263130|NCT03286829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6263131|NCT03286829|Adrenergic Agents|adrenergic agents|mesh-ancestor
6263132|NCT03286829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6263133|NCT03286829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6263134|NCT03287089|Nitrofurantoin|nitrofurantoin|mesh-list
6263135|NCT03287089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6263136|NCT03287089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6263137|NCT03287089|Renal Agents|renal agents|mesh-ancestor
6263138|NCT03287089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6263139|NCT03287219|Methylene Blue|methylene blue|mesh-list
6263140|NCT03287219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6263141|NCT03287219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6263142|NCT03287310|Albuterol|albuterol|mesh-list
6263143|NCT03287310|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6263144|NCT03287310|Autonomic Agents|autonomic agents|mesh-ancestor
6263145|NCT03287310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6263146|NCT03287310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263147|NCT03287310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6263148|NCT03287310|Respiratory System Agents|respiratory system agents|mesh-ancestor
6263149|NCT03287310|Tocolytic Agents|tocolytic agents|mesh-ancestor
6263150|NCT03287310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6263151|NCT03287310|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6263152|NCT03287310|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6263153|NCT03287310|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6263154|NCT03287310|Adrenergic Agents|adrenergic agents|mesh-ancestor
6263155|NCT03287310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6263156|NCT03287310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6263157|NCT03287635|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6263158|NCT03287635|Hormones|hormones|mesh-ancestor
6263159|NCT03287635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6263160|NCT03287635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263161|NCT03287674|Vidarabine|vidarabine|mesh-list
6263162|NCT03287674|Cyclophosphamide|cyclophosphamide|mesh-list
6263163|NCT03287674|Nivolumab|nivolumab|mesh-list
6263164|NCT03287674|Fludarabine|fludarabine|mesh-list
6263165|NCT03287674|Fludarabine phosphate|fludarabine phosphate|mesh-list
6263166|NCT03287674|Ipilimumab|ipilimumab|mesh-list
6263167|NCT03287674|Interleukin-2|interleukin-2|mesh-list
6263168|NCT03287674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6263169|NCT03287674|Immunologic Factors|immunologic factors|mesh-ancestor
6263170|NCT03287674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263171|NCT03287674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6263172|NCT03287674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6263173|NCT03287674|Alkylating Agents|alkylating agents|mesh-ancestor
6263174|NCT03287674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6263175|NCT03287674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6263176|NCT03287674|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6263177|NCT03287674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6263178|NCT03287674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6263179|NCT03287674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6263180|NCT03287674|Antimetabolites|antimetabolites|mesh-ancestor
6263181|NCT03287674|Antiviral Agents|antiviral agents|mesh-ancestor
6263182|NCT03287674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6263183|NCT03287674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6263184|NCT03287674|Analgesics|analgesics|mesh-ancestor
6263185|NCT03287674|Sensory System Agents|sensory system agents|mesh-ancestor
6263186|NCT03287674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6263187|NCT03287791|Azelaic acid|azelaic acid|mesh-list
6014657|NCT00352664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6014658|NCT00352664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014659|NCT00352664|Cholinergic Agents|cholinergic agents|mesh-ancestor
6014660|NCT00352664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6014661|NCT00352664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014662|NCT00352664|Nootropic Agents|nootropic agents|mesh-ancestor
6014663|NCT00352690|Paclitaxel|paclitaxel|mesh-list
6014664|NCT00352690|Carboplatin|carboplatin|mesh-list
6014665|NCT00352690|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
6014666|NCT00352690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6014667|NCT00352690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6014668|NCT00352690|Tubulin Modulators|tubulin modulators|mesh-ancestor
6014669|NCT00352690|Antimitotic Agents|antimitotic agents|mesh-ancestor
6014670|NCT00352690|Mitosis Modulators|mitosis modulators|mesh-ancestor
6014671|NCT00352690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014672|NCT00352755|Leucovorin|leucovorin|mesh-list
6014673|NCT00352755|Fluorouracil|fluorouracil|mesh-list
6014674|NCT00352755|Oxaliplatin|oxaliplatin|mesh-list
6014675|NCT00352755|Antimetabolites|antimetabolites|mesh-ancestor
6014676|NCT00352755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014677|NCT00352755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6263188|NCT03287791|Sunscreening Agents|sunscreening agents|mesh-list
6263189|NCT03287791|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6263190|NCT03287791|Protective Agents|protective agents|mesh-ancestor
6263191|NCT03287791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263192|NCT03287791|Dermatologic Agents|dermatologic agents|mesh-ancestor
6263193|NCT03287791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6263194|NCT03287869|Brexpiprazole|brexpiprazole|mesh-list
6263195|NCT03287869|Serotonin Agents|serotonin agents|mesh-ancestor
6263196|NCT03287869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6263197|NCT03287869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6263198|NCT03287869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263199|NCT03287869|Dopamine Agonists|dopamine agonists|mesh-ancestor
6263200|NCT03287869|Dopamine Agents|dopamine agents|mesh-ancestor
6263201|NCT03288987|Leucovorin|leucovorin|mesh-list
6263202|NCT03288987|Bevacizumab|bevacizumab|mesh-list
6263203|NCT03288987|Fluorouracil|fluorouracil|mesh-list
6263204|NCT03288987|Irinotecan|irinotecan|mesh-list
6263205|NCT03288987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6263206|NCT03288987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6263207|NCT03288987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6263208|NCT03288987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6263209|NCT03288987|Growth Substances|growth substances|mesh-ancestor
6263210|NCT03288987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263211|NCT03288987|Growth Inhibitors|growth inhibitors|mesh-ancestor
6263212|NCT03288987|Antimetabolites|antimetabolites|mesh-ancestor
6263213|NCT03288987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6263214|NCT03288987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6263215|NCT03288987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6263216|NCT03288987|Immunologic Factors|immunologic factors|mesh-ancestor
6263217|NCT03288987|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6263218|NCT03288987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6263219|NCT03288987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6263220|NCT03288987|Antidotes|antidotes|mesh-ancestor
6263221|NCT03288987|Protective Agents|protective agents|mesh-ancestor
6263222|NCT03288987|Vitamin B Complex|vitamin b complex|mesh-ancestor
6263223|NCT03288987|Vitamins|vitamins|mesh-ancestor
6263224|NCT03288987|Micronutrients|micronutrients|mesh-ancestor
6263225|NCT03289208|Edaravone|edaravone|mesh-list
6263226|NCT03289208|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6263227|NCT03289208|Antioxidants|antioxidants|mesh-ancestor
6263228|NCT03289208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6263229|NCT03289208|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6263230|NCT03289208|Protective Agents|protective agents|mesh-ancestor
6263231|NCT03289208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263232|NCT03289234|Edaravone|edaravone|mesh-list
6263233|NCT03289234|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6263234|NCT03289234|Antioxidants|antioxidants|mesh-ancestor
6263235|NCT03289234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6263236|NCT03289234|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6263237|NCT03289234|Protective Agents|protective agents|mesh-ancestor
6263238|NCT03289234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263239|NCT03289533|Avelumab|avelumab|mesh-list
6263240|NCT03289533|Axitinib|axitinib|mesh-list
6263241|NCT03289533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6263242|NCT03289533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6263243|NCT03289533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6263244|NCT03289533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6263245|NCT03289533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6263246|NCT03289676|Nicotine|nicotine|mesh-list
6263247|NCT03289676|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6263248|NCT03289676|Autonomic Agents|autonomic agents|mesh-ancestor
6263249|NCT03289676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6263250|NCT03289676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263251|NCT03289676|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6263252|NCT03289676|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6263253|NCT03289676|Cholinergic Agents|cholinergic agents|mesh-ancestor
6263254|NCT03289676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6263255|NCT03289676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6263256|NCT03289858|Bupivacaine|bupivacaine|mesh-list
6263257|NCT03289858|Anesthetics, Local|anesthetics, local|mesh-ancestor
6263258|NCT03289858|Anesthetics|anesthetics|mesh-ancestor
6263259|NCT03289858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6263260|NCT03289858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263261|NCT03289858|Sensory System Agents|sensory system agents|mesh-ancestor
6263262|NCT03289858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6263263|NCT03290027|Tazarotene|tazarotene|mesh-list
6263264|NCT03290027|Dermatologic Agents|dermatologic agents|mesh-ancestor
6263265|NCT03290027|Keratolytic Agents|keratolytic agents|mesh-ancestor
6263266|NCT03290378|Tramadol|tramadol|mesh-list
6263267|NCT03290378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6263268|NCT03290378|Narcotics|narcotics|mesh-ancestor
6263269|NCT03290378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6263270|NCT03290378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263271|NCT03290378|Analgesics|analgesics|mesh-ancestor
6263272|NCT03290378|Sensory System Agents|sensory system agents|mesh-ancestor
6263273|NCT03290378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6263274|NCT03291080|Tretinoin|tretinoin|mesh-list
6263275|NCT03291080|Isotretinoin|isotretinoin|mesh-list
6263276|NCT03291080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6263277|NCT03291080|Keratolytic Agents|keratolytic agents|mesh-ancestor
6263278|NCT03291080|Dermatologic Agents|dermatologic agents|mesh-ancestor
6263279|NCT03291197|Bupivacaine|bupivacaine|mesh-list
6263280|NCT03291197|Anesthetics, Local|anesthetics, local|mesh-ancestor
6263281|NCT03291197|Anesthetics|anesthetics|mesh-ancestor
6263282|NCT03291197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6263283|NCT03291197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263284|NCT03291197|Sensory System Agents|sensory system agents|mesh-ancestor
6263285|NCT03291197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6263286|NCT03291288|Tolbutamide|tolbutamide|mesh-list
6263287|NCT03291288|Midazolam|midazolam|mesh-list
6263288|NCT03291288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6263289|NCT03291288|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6263290|NCT03291288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6263291|NCT03291288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263292|NCT03291288|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6263293|NCT03291288|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6263294|NCT03291288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6263295|NCT03291288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6263296|NCT03291288|Anesthetics, General|anesthetics, general|mesh-ancestor
6263297|NCT03291288|Anesthetics|anesthetics|mesh-ancestor
6263298|NCT03291288|GABA Modulators|gaba modulators|mesh-ancestor
6263299|NCT03291288|GABA Agents|gaba agents|mesh-ancestor
6263300|NCT03291288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6263301|NCT03291288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6263302|NCT03291288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6263303|NCT03292016|Apomorphine|apomorphine|mesh-list
6263304|NCT03292016|Emetics|emetics|mesh-ancestor
6263305|NCT03292016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263306|NCT03292016|Autonomic Agents|autonomic agents|mesh-ancestor
6263307|NCT03292016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6263308|NCT03292016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6263309|NCT03292016|Dopamine Agonists|dopamine agonists|mesh-ancestor
6263310|NCT03292016|Dopamine Agents|dopamine agents|mesh-ancestor
6263311|NCT03292016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6263312|NCT03292016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6263313|NCT03292640|Nicotinic Acids|nicotinic acids|mesh-list
6263314|NCT03292640|Tazarotene|tazarotene|mesh-list
6263315|NCT03292640|Dermatologic Agents|dermatologic agents|mesh-ancestor
6263316|NCT03292640|Keratolytic Agents|keratolytic agents|mesh-ancestor
6263317|NCT03292640|Vitamin B Complex|vitamin b complex|mesh-ancestor
6263318|NCT03292640|Vitamins|vitamins|mesh-ancestor
6263319|NCT03292640|Micronutrients|micronutrients|mesh-ancestor
6263320|NCT03292640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263321|NCT03292653|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
6263322|NCT03292653|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6263323|NCT03292653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6263324|NCT03292653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6263325|NCT03292653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263326|NCT03292809|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6263327|NCT03292809|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6263328|NCT03293485|Imipenem|imipenem|mesh-list
6263329|NCT03293485|Relebactam|relebactam|mesh-list
6263330|NCT03293485|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
6263331|NCT03293485|Cilastatin|cilastatin|mesh-list
6263332|NCT03293485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6263333|NCT03293485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6263334|NCT03293485|Protease Inhibitors|protease inhibitors|mesh-ancestor
6263335|NCT03293485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6263336|NCT03293485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6263337|NCT03293485|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6263338|NCT03293654|Bevacizumab|bevacizumab|mesh-list
6263339|NCT03293654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6263340|NCT03293654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6263341|NCT03293654|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6263342|NCT03293654|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6263343|NCT03293654|Growth Substances|growth substances|mesh-ancestor
6263344|NCT03293654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263345|NCT03293654|Growth Inhibitors|growth inhibitors|mesh-ancestor
6390117|NCT00190294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6390118|NCT00190294|Contraceptive Agents|contraceptive agents|mesh-ancestor
6390119|NCT00190294|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6390120|NCT00190294|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6390121|NCT00190294|Hormone Antagonists|hormone antagonists|mesh-ancestor
6390122|NCT00190294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6390123|NCT00190294|Luteolytic Agents|luteolytic agents|mesh-ancestor
6390124|NCT00190294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6390125|NCT00190294|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6390126|NCT00190307|Aspirin|aspirin|mesh-list
6390127|NCT00190307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6390128|NCT00190307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6390129|NCT00190307|Analgesics|analgesics|mesh-ancestor
6390130|NCT00190307|Sensory System Agents|sensory system agents|mesh-ancestor
6390131|NCT00190307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6390132|NCT00190307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390133|NCT00190307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6390134|NCT00190307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6390135|NCT00190307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6390136|NCT00190307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6390137|NCT00190307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390138|NCT00190307|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6390139|NCT00190307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6390140|NCT00190307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6390141|NCT00190307|Antipyretics|antipyretics|mesh-ancestor
6390142|NCT00190333|Citalopram|citalopram|mesh-list
6390143|NCT00190333|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6390144|NCT00190333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6390145|NCT00190333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6390146|NCT00190333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390147|NCT00190333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6390148|NCT00190333|Serotonin Agents|serotonin agents|mesh-ancestor
6390149|NCT00190333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390150|NCT00190333|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6390151|NCT00190333|Antidepressive Agents|antidepressive agents|mesh-ancestor
6390152|NCT00190333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6390153|NCT00190372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
6390154|NCT00190372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6390155|NCT00190372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390156|NCT00190411|Celiprolol|celiprolol|mesh-list
6390157|NCT00190411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6390158|NCT00190411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6390159|NCT00190411|Sympathomimetics|sympathomimetics|mesh-ancestor
6390160|NCT00190411|Autonomic Agents|autonomic agents|mesh-ancestor
6390161|NCT00190411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6390162|NCT00190411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390163|NCT00190411|Vasodilator Agents|vasodilator agents|mesh-ancestor
6390164|NCT00190411|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6390165|NCT00190411|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6390166|NCT00190411|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6390167|NCT00190411|Adrenergic Agents|adrenergic agents|mesh-ancestor
6390168|NCT00190411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6390169|NCT00190411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390170|NCT00190424|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
6263346|NCT03294538|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6263347|NCT03294538|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6263348|NCT03294538|Estradiol|estradiol|mesh-list
6263349|NCT03294538|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6263350|NCT03294538|Estrogens|estrogens|mesh-ancestor
6263351|NCT03294538|Hormones|hormones|mesh-ancestor
6263352|NCT03294538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6263353|NCT03294538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263354|NCT03294538|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6263355|NCT03294538|Contraceptive Agents|contraceptive agents|mesh-ancestor
6263356|NCT03294538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6263357|NCT03294538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6263358|NCT03295721|Bupivacaine|bupivacaine|mesh-list
6263359|NCT03295721|Anesthetics, Local|anesthetics, local|mesh-ancestor
6263360|NCT03295721|Anesthetics|anesthetics|mesh-ancestor
6263361|NCT03295721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6263362|NCT03295721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263363|NCT03295721|Sensory System Agents|sensory system agents|mesh-ancestor
6263364|NCT03295721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6263365|NCT03296072|Listerine|listerine|mesh-list
6263366|NCT03296072|Fluorides|fluorides|mesh-list
6263367|NCT03296072|Sodium Fluoride|sodium fluoride|mesh-list
6263368|NCT03296072|Tin Fluorides|tin fluorides|mesh-list
6263369|NCT03296072|Cariostatic Agents|cariostatic agents|mesh-ancestor
6263370|NCT03296072|Protective Agents|protective agents|mesh-ancestor
6263371|NCT03296072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263372|NCT03296072|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6263373|NCT03296072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6263374|NCT03296163|Paclitaxel|paclitaxel|mesh-list
6263375|NCT03296163|Bevacizumab|bevacizumab|mesh-list
6263376|NCT03296163|Carboplatin|carboplatin|mesh-list
6263377|NCT03296163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6263378|NCT03296163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6263379|NCT03296163|Tubulin Modulators|tubulin modulators|mesh-ancestor
6263380|NCT03296163|Antimitotic Agents|antimitotic agents|mesh-ancestor
6263381|NCT03296163|Mitosis Modulators|mitosis modulators|mesh-ancestor
6263382|NCT03296163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6263383|NCT03296163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6263384|NCT03296163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6263385|NCT03296163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6263386|NCT03296163|Growth Substances|growth substances|mesh-ancestor
6263387|NCT03296163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263388|NCT03296163|Growth Inhibitors|growth inhibitors|mesh-ancestor
6263389|NCT03296345|Ketamine|ketamine|mesh-list
6263390|NCT03296345|Analgesics|analgesics|mesh-ancestor
6263391|NCT03296345|Sensory System Agents|sensory system agents|mesh-ancestor
6263392|NCT03296345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6263393|NCT03296345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263394|NCT03296345|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6263395|NCT03296345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6263396|NCT03296345|Anesthetics, General|anesthetics, general|mesh-ancestor
6263397|NCT03296345|Anesthetics|anesthetics|mesh-ancestor
6263398|NCT03296345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6263399|NCT03296345|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6263400|NCT03296345|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6263401|NCT03296345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6263402|NCT03296345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6263403|NCT03296527|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6263404|NCT03296527|Hormones|hormones|mesh-ancestor
6263405|NCT03296527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6263406|NCT03296527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263407|NCT03296800|Bexagliflozin|bexagliflozin|mesh-list
6263408|NCT03296800|Rifampin|rifampin|mesh-list
6263409|NCT03296800|Probenecid|probenecid|mesh-list
6263410|NCT03296800|Verapamil|verapamil|mesh-list
6263411|NCT03296800|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6263412|NCT03296800|Antitubercular Agents|antitubercular agents|mesh-ancestor
6263413|NCT03296800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6263414|NCT03296800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6263415|NCT03296800|Leprostatic Agents|leprostatic agents|mesh-ancestor
6263416|NCT03296800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6263417|NCT03296800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6263418|NCT03296800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6263419|NCT03296800|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6263420|NCT03296800|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6263421|NCT03296800|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6263422|NCT03296800|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6263423|NCT03296800|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6263424|NCT03296800|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6263425|NCT03296800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6263426|NCT03296800|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6263427|NCT03296800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6263428|NCT03296800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6263429|NCT03296800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263430|NCT03296800|Vasodilator Agents|vasodilator agents|mesh-ancestor
6263431|NCT03296800|Uricosuric Agents|uricosuric agents|mesh-ancestor
6263432|NCT03296800|Gout Suppressants|gout suppressants|mesh-ancestor
6263433|NCT03296800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6263434|NCT03296800|Renal Agents|renal agents|mesh-ancestor
6263435|NCT03296800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6263436|NCT03297021|Ondansetron|ondansetron|mesh-list
6263437|NCT03297021|Antiemetics|antiemetics|mesh-ancestor
6263438|NCT03297021|Autonomic Agents|autonomic agents|mesh-ancestor
6263439|NCT03297021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6263440|NCT03297021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263441|NCT03297021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6263442|NCT03297021|Antipruritics|antipruritics|mesh-ancestor
6263443|NCT03297021|Dermatologic Agents|dermatologic agents|mesh-ancestor
6263444|NCT03297021|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6263445|NCT03297021|Serotonin Agents|serotonin agents|mesh-ancestor
6263446|NCT03297021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6263447|NCT03297021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6263448|NCT03297021|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6263449|NCT03297021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6263450|NCT03297021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6263451|NCT03297021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6263452|NCT03297021|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6263453|NCT03297216|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
6263454|NCT03297216|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
6263455|NCT03297216|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6263456|NCT03297216|Hormone Antagonists|hormone antagonists|mesh-ancestor
6263457|NCT03297216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6263458|NCT03297216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263459|NCT03297216|Progestins|progestins|mesh-ancestor
6263460|NCT03297216|Hormones|hormones|mesh-ancestor
6263461|NCT03297398|Ascorbic Acid|ascorbic acid|mesh-list
6263462|NCT03297398|Methyltestosterone|methyltestosterone|mesh-list
6263463|NCT03297398|Androgens|androgens|mesh-list
6263464|NCT03297398|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6263465|NCT03297398|Hormones|hormones|mesh-ancestor
6263466|NCT03297398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6263467|NCT03297398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263468|NCT03297398|Antioxidants|antioxidants|mesh-ancestor
6263469|NCT03297398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6263470|NCT03297398|Protective Agents|protective agents|mesh-ancestor
6263471|NCT03297398|Vitamins|vitamins|mesh-ancestor
6263472|NCT03297398|Micronutrients|micronutrients|mesh-ancestor
6263473|NCT03297398|Estrogens|estrogens|mesh-ancestor
6263474|NCT03297398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6263475|NCT03297398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6263476|NCT03297398|Anabolic Agents|anabolic agents|mesh-ancestor
6263477|NCT03297944|Zolpidem|zolpidem|mesh-list
6263478|NCT03297944|Alprazolam|alprazolam|mesh-list
6263479|NCT03297944|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6263480|NCT03297944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6263481|NCT03297944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6263482|NCT03297944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263483|NCT03297944|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6263484|NCT03297944|GABA Agonists|gaba agonists|mesh-ancestor
6263485|NCT03297944|GABA Agents|gaba agents|mesh-ancestor
6263486|NCT03297944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6263487|NCT03297944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6263488|NCT03297944|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6263489|NCT03297944|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6263490|NCT03297944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6263491|NCT03297944|GABA Modulators|gaba modulators|mesh-ancestor
6263492|NCT03298113|Protective Agents|protective agents|mesh-list
6263493|NCT03298113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263494|NCT03298412|Blinatumomab|blinatumomab|mesh-list
6263495|NCT03298412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6263496|NCT03298984|Cytarabine|cytarabine|mesh-list
6263497|NCT03298984|Daunorubicin|daunorubicin|mesh-list
6263498|NCT03298984|Alvocidib|alvocidib|mesh-list
6263499|NCT03298984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6263500|NCT03298984|Antimetabolites|antimetabolites|mesh-ancestor
6014678|NCT00352755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6014679|NCT00352755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6014680|NCT00352755|Immunologic Factors|immunologic factors|mesh-ancestor
6263501|NCT03298984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6263502|NCT03298984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6263503|NCT03298984|Antiviral Agents|antiviral agents|mesh-ancestor
6263504|NCT03298984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6263505|NCT03298984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6263506|NCT03298984|Immunologic Factors|immunologic factors|mesh-ancestor
6263507|NCT03298984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263508|NCT03298984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6263509|NCT03298984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6263510|NCT03298984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6263511|NCT03298984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6263512|NCT03298984|Growth Inhibitors|growth inhibitors|mesh-ancestor
6263513|NCT03298984|Growth Substances|growth substances|mesh-ancestor
6263514|NCT03298984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6263515|NCT03299049|Rilpivirine|rilpivirine|mesh-list
6263516|NCT03299049|Cabotegravir|cabotegravir|mesh-list
6263517|NCT03299049|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6263518|NCT03299049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6263519|NCT03299049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6014681|NCT00352755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014682|NCT00352755|Antidotes|antidotes|mesh-ancestor
6014683|NCT00352755|Protective Agents|protective agents|mesh-ancestor
6014684|NCT00352755|Vitamin B Complex|vitamin b complex|mesh-ancestor
6014685|NCT00352755|Vitamins|vitamins|mesh-ancestor
6014686|NCT00352755|Micronutrients|micronutrients|mesh-ancestor
6014687|NCT00352781|Nicotine|nicotine|mesh-list
6014688|NCT00352781|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6014689|NCT00352781|Autonomic Agents|autonomic agents|mesh-ancestor
6014690|NCT00352781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6263520|NCT03299049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6263521|NCT03299049|Antiviral Agents|antiviral agents|mesh-ancestor
6263522|NCT03299049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6263523|NCT03299049|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6263524|NCT03299049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6263525|NCT03299049|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6263526|NCT03299049|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6263527|NCT03299244|Cinacalcet|cinacalcet|mesh-list
6263528|NCT03299244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6263529|NCT03299244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263530|NCT03299244|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6263531|NCT03299244|Hormone Antagonists|hormone antagonists|mesh-ancestor
6263532|NCT03299244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6263533|NCT03300570|Dolcanatide|dolcanatide|mesh-list
6263534|NCT03300570|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
6263535|NCT03300570|Enzyme Activators|enzyme activators|mesh-ancestor
6263536|NCT03300570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6263537|NCT03300570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6263538|NCT03300674|Lidocaine|lidocaine|mesh-list
6263539|NCT03300674|Hydromorphone|hydromorphone|mesh-list
6263540|NCT03300674|Anesthetics, Local|anesthetics, local|mesh-ancestor
6263541|NCT03300674|Anesthetics|anesthetics|mesh-ancestor
6263542|NCT03300674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6263543|NCT03300674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263544|NCT03300674|Sensory System Agents|sensory system agents|mesh-ancestor
6263545|NCT03300674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6263546|NCT03300674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6263547|NCT03300674|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6263548|NCT03300674|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6263549|NCT03300674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6263550|NCT03300674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6263551|NCT03300674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6263552|NCT03300674|Narcotics|narcotics|mesh-ancestor
6263553|NCT03300674|Analgesics|analgesics|mesh-ancestor
6263554|NCT03301272|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6263555|NCT03301272|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6263556|NCT03301272|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6263557|NCT03301272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6263558|NCT03301272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263559|NCT03301272|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6263560|NCT03301272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6263561|NCT03301272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6263562|NCT03301272|Cholinergic Agents|cholinergic agents|mesh-ancestor
6263563|NCT03301272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6263564|NCT03301649|Ivermectin|ivermectin|mesh-list
6263565|NCT03301649|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6263566|NCT03301649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6263567|NCT03302234|Pembrolizumab|pembrolizumab|mesh-list
6263568|NCT03302234|Ipilimumab|ipilimumab|mesh-list
6263569|NCT03302234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6263570|NCT03302234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6263571|NCT03302234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6263572|NCT03302234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6263573|NCT03302416|Hydrocortisone|hydrocortisone|mesh-list
6263574|NCT03302416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6263575|NCT03302559|Vitamin A|vitamin a|mesh-list
6263576|NCT03302559|Retinol palmitate|retinol palmitate|mesh-list
6263577|NCT03302559|Sunscreening Agents|sunscreening agents|mesh-list
6263578|NCT03302559|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6263579|NCT03302559|Protective Agents|protective agents|mesh-ancestor
6263580|NCT03302559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263581|NCT03302559|Dermatologic Agents|dermatologic agents|mesh-ancestor
6263582|NCT03302559|Vitamins|vitamins|mesh-ancestor
6263583|NCT03302559|Micronutrients|micronutrients|mesh-ancestor
6263584|NCT03302559|Antioxidants|antioxidants|mesh-ancestor
6263585|NCT03302559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6263586|NCT03302559|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6263587|NCT03302559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6263588|NCT03302741|Botulinum Toxins|botulinum toxins|mesh-list
6263589|NCT03302741|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6263590|NCT03302741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6263591|NCT03302741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6263592|NCT03302741|Cholinergic Agents|cholinergic agents|mesh-ancestor
6263593|NCT03302741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6263594|NCT03302741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263595|NCT03303079|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6263596|NCT03303079|Immunologic Factors|immunologic factors|mesh-ancestor
6263597|NCT03303079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263598|NCT03303092|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6263599|NCT03303092|Immunologic Factors|immunologic factors|mesh-ancestor
6263600|NCT03303092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263601|NCT03303105|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6263602|NCT03303105|Immunologic Factors|immunologic factors|mesh-ancestor
6263603|NCT03303105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263604|NCT03303196|Pancrelipase|pancrelipase|mesh-list
6263605|NCT03303196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6263606|NCT03303794|Bupivacaine|bupivacaine|mesh-list
6263607|NCT03303794|Anesthetics, Local|anesthetics, local|mesh-ancestor
6263608|NCT03303794|Anesthetics|anesthetics|mesh-ancestor
6263609|NCT03303794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6263610|NCT03303794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263611|NCT03303794|Sensory System Agents|sensory system agents|mesh-ancestor
6263612|NCT03303794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6263613|NCT03303950|Cyclophosphamide|cyclophosphamide|mesh-list
6263614|NCT03303950|Busulfan|busulfan|mesh-list
6263615|NCT03303950|Fludarabine|fludarabine|mesh-list
6263616|NCT03303950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6263617|NCT03303950|Immunologic Factors|immunologic factors|mesh-ancestor
6263618|NCT03303950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263619|NCT03303950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6263620|NCT03303950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6263621|NCT03303950|Alkylating Agents|alkylating agents|mesh-ancestor
6263622|NCT03303950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6263623|NCT03303950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6263624|NCT03303950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6263625|NCT03303989|Mycophenolic Acid|mycophenolic acid|mesh-list
6263626|NCT03303989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6263627|NCT03303989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6263628|NCT03303989|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6263629|NCT03303989|Antitubercular Agents|antitubercular agents|mesh-ancestor
6263630|NCT03303989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6263631|NCT03303989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6263632|NCT03303989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6263633|NCT03303989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6263634|NCT03304054|Amifampridine|amifampridine|mesh-list
6263635|NCT03304054|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6263636|NCT03304054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6263637|NCT03304054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263638|NCT03304054|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6263639|NCT03304054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6263640|NCT03304054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6263641|NCT03304626|Prednisone|prednisone|mesh-list
6263642|NCT03304626|Budesonide|budesonide|mesh-list
6263643|NCT03304626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6263644|NCT03304626|Glucocorticoids|glucocorticoids|mesh-ancestor
6263645|NCT03304626|Hormones|hormones|mesh-ancestor
6263646|NCT03304626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6263647|NCT03304626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263648|NCT03304626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6263649|NCT03304626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6263650|NCT03304626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6263651|NCT03304626|Autonomic Agents|autonomic agents|mesh-ancestor
6263652|NCT03304626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6263653|NCT03304626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6263654|NCT03304626|Respiratory System Agents|respiratory system agents|mesh-ancestor
6263655|NCT03304873|Retapamulin|retapamulin|mesh-list
6263656|NCT03304873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6263657|NCT03304873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6263658|NCT03305081|Copper|copper|mesh-list
6263659|NCT03305081|Levonorgestrel|levonorgestrel|mesh-list
6263660|NCT03305081|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6263661|NCT03305081|Contraceptive Agents|contraceptive agents|mesh-ancestor
6263662|NCT03305081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6263663|NCT03305081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263664|NCT03305081|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6263665|NCT03305081|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6263666|NCT03305081|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6263667|NCT03305081|Trace Elements|trace elements|mesh-ancestor
6263668|NCT03305081|Micronutrients|micronutrients|mesh-ancestor
6263669|NCT03305159|Chlorhexidine|chlorhexidine|mesh-list
6263670|NCT03305159|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6263671|NCT03305159|Povidone-Iodine|povidone-iodine|mesh-list
6263672|NCT03305159|Povidone|povidone|mesh-list
6263673|NCT03305159|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6263674|NCT03305159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6263675|NCT03305159|Disinfectants|disinfectants|mesh-ancestor
6263676|NCT03305159|Dermatologic Agents|dermatologic agents|mesh-ancestor
6263677|NCT03305159|Plasma Substitutes|plasma substitutes|mesh-ancestor
6263678|NCT03305159|Blood Substitutes|blood substitutes|mesh-ancestor
6263679|NCT03305575|Bupivacaine|bupivacaine|mesh-list
6263680|NCT03305575|Chloroprocaine|chloroprocaine|mesh-list
6263681|NCT03305575|Anesthetics, Local|anesthetics, local|mesh-ancestor
6263682|NCT03305575|Anesthetics|anesthetics|mesh-ancestor
6263683|NCT03305575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6263684|NCT03305575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263685|NCT03305575|Sensory System Agents|sensory system agents|mesh-ancestor
6263686|NCT03305575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6263687|NCT03305666|Bupivacaine|bupivacaine|mesh-list
6263688|NCT03305666|Anesthetics, Local|anesthetics, local|mesh-ancestor
6263689|NCT03305666|Anesthetics|anesthetics|mesh-ancestor
6263690|NCT03305666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6263691|NCT03305666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263692|NCT03305666|Sensory System Agents|sensory system agents|mesh-ancestor
6263693|NCT03305666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6263694|NCT03305822|Insulin Lispro|insulin lispro|mesh-list
6263695|NCT03305822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6263696|NCT03305822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263697|NCT03306589|Molgramostim|molgramostim|mesh-list
6263698|NCT03306589|Sargramostim|sargramostim|mesh-list
6263699|NCT03306589|Cantharidin|cantharidin|mesh-list
6263700|NCT03306589|Immunologic Factors|immunologic factors|mesh-ancestor
6263701|NCT03306589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263702|NCT03306589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6263703|NCT03306589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6263704|NCT03306589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390171|NCT00190424|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6390172|NCT00190424|Immunologic Factors|immunologic factors|mesh-ancestor
6390173|NCT00190424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390174|NCT00190437|Amoxicillin|amoxicillin|mesh-list
6390175|NCT00190437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6390176|NCT00190437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6390177|NCT00190463|Amphotericin B|amphotericin b|mesh-list
6390178|NCT00190463|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6390179|NCT00190463|Amebicides|amebicides|mesh-ancestor
6390180|NCT00190463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6390181|NCT00190463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6390182|NCT00190463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6390183|NCT00190463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6390184|NCT00190463|Antifungal Agents|antifungal agents|mesh-ancestor
6390185|NCT00190476|Docetaxel|docetaxel|mesh-list
6390186|NCT00190476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6390187|NCT00190476|Tubulin Modulators|tubulin modulators|mesh-ancestor
6390188|NCT00190476|Antimitotic Agents|antimitotic agents|mesh-ancestor
6390189|NCT00190476|Mitosis Modulators|mitosis modulators|mesh-ancestor
6390190|NCT00190476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390191|NCT00190489|Docetaxel|docetaxel|mesh-list
6390192|NCT00190489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6390193|NCT00190489|Tubulin Modulators|tubulin modulators|mesh-ancestor
6390194|NCT00190489|Antimitotic Agents|antimitotic agents|mesh-ancestor
6390195|NCT00190489|Mitosis Modulators|mitosis modulators|mesh-ancestor
6390196|NCT00190489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390197|NCT00190502|Antibodies|antibodies|mesh-list
6390198|NCT00190502|Immunologic Factors|immunologic factors|mesh-ancestor
6390199|NCT00190502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390200|NCT00190515|Leucovorin|leucovorin|mesh-list
6390201|NCT00190515|Levoleucovorin|levoleucovorin|mesh-list
6390202|NCT00190515|Antidotes|antidotes|mesh-ancestor
6390203|NCT00190515|Protective Agents|protective agents|mesh-ancestor
6390204|NCT00190515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390205|NCT00190515|Vitamin B Complex|vitamin b complex|mesh-ancestor
6390206|NCT00190515|Vitamins|vitamins|mesh-ancestor
6390207|NCT00190515|Micronutrients|micronutrients|mesh-ancestor
6390208|NCT00190554|Cisplatin|cisplatin|mesh-list
6390209|NCT00190554|Fluorouracil|fluorouracil|mesh-list
6390210|NCT00190554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6390211|NCT00190554|Antimetabolites|antimetabolites|mesh-ancestor
6390212|NCT00190554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390213|NCT00190554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6390214|NCT00190554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6390215|NCT00190554|Immunologic Factors|immunologic factors|mesh-ancestor
6263705|NCT03307005|Zolpidem|zolpidem|mesh-list
6263706|NCT03307005|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6263707|NCT03307005|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6263708|NCT03307005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6263709|NCT03307005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263710|NCT03307005|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6263711|NCT03307005|GABA Agonists|gaba agonists|mesh-ancestor
6263712|NCT03307005|GABA Agents|gaba agents|mesh-ancestor
6263713|NCT03307005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6263714|NCT03307005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6263715|NCT03307174|Fentanyl|fentanyl|mesh-list
6263716|NCT03307174|Bupivacaine|bupivacaine|mesh-list
6263717|NCT03307174|Anesthetics, Local|anesthetics, local|mesh-ancestor
6263718|NCT03307174|Anesthetics|anesthetics|mesh-ancestor
6263719|NCT03307174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6263720|NCT03307174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263721|NCT03307174|Sensory System Agents|sensory system agents|mesh-ancestor
6263722|NCT03307174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6263723|NCT03307174|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6263724|NCT03307174|Narcotics|narcotics|mesh-ancestor
6263725|NCT03307174|Analgesics|analgesics|mesh-ancestor
6263726|NCT03307174|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6263727|NCT03307174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6263728|NCT03307174|Anesthetics, General|anesthetics, general|mesh-ancestor
6263729|NCT03307252|Metformin|metformin|mesh-list
6263730|NCT03307252|Rifampin|rifampin|mesh-list
6263731|NCT03307252|Probenecid|probenecid|mesh-list
6263732|NCT03307252|Digoxin|digoxin|mesh-list
6263733|NCT03307252|Verapamil|verapamil|mesh-list
6263734|NCT03307252|Furosemide|furosemide|mesh-list
6263735|NCT03307252|Cimetidine|cimetidine|mesh-list
6263736|NCT03307252|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6263737|NCT03307252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6263738|NCT03307252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263739|NCT03307252|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6263740|NCT03307252|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6263741|NCT03307252|Antimetabolites|antimetabolites|mesh-ancestor
6263742|NCT03307252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6263743|NCT03307252|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6263744|NCT03307252|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6263745|NCT03307252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6263746|NCT03307252|Diuretics|diuretics|mesh-ancestor
6263747|NCT03307252|Natriuretic Agents|natriuretic agents|mesh-ancestor
6263748|NCT03307252|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6263749|NCT03307252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6263750|NCT03307252|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6263751|NCT03307252|Antitubercular Agents|antitubercular agents|mesh-ancestor
6263752|NCT03307252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6263753|NCT03307252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6263754|NCT03307252|Leprostatic Agents|leprostatic agents|mesh-ancestor
6263755|NCT03307252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6263756|NCT03307252|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6263757|NCT03307252|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6263758|NCT03307252|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6263759|NCT03307252|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6263760|NCT03307252|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6263761|NCT03307252|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6263762|NCT03307252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6263763|NCT03307252|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6263764|NCT03307252|Protective Agents|protective agents|mesh-ancestor
6263765|NCT03307252|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6263766|NCT03307252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6263767|NCT03307252|Vasodilator Agents|vasodilator agents|mesh-ancestor
6263768|NCT03307252|Uricosuric Agents|uricosuric agents|mesh-ancestor
6263769|NCT03307252|Gout Suppressants|gout suppressants|mesh-ancestor
6263770|NCT03307252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6263771|NCT03307252|Renal Agents|renal agents|mesh-ancestor
6263772|NCT03307252|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6263773|NCT03307252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6263774|NCT03307252|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6263775|NCT03307252|Histamine Antagonists|histamine antagonists|mesh-ancestor
6263776|NCT03307252|Histamine Agents|histamine agents|mesh-ancestor
6263777|NCT03307252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6263778|NCT03307252|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6263779|NCT03307252|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6263780|NCT03307785|Paclitaxel|paclitaxel|mesh-list
6263781|NCT03307785|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6263782|NCT03307785|Bevacizumab|bevacizumab|mesh-list
6263783|NCT03307785|Carboplatin|carboplatin|mesh-list
6263784|NCT03307785|Pemetrexed|pemetrexed|mesh-list
6263785|NCT03307785|Niraparib|niraparib|mesh-list
6263786|NCT03307785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6263787|NCT03307785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6263788|NCT03307785|Tubulin Modulators|tubulin modulators|mesh-ancestor
6263789|NCT03307785|Antimitotic Agents|antimitotic agents|mesh-ancestor
6263790|NCT03307785|Mitosis Modulators|mitosis modulators|mesh-ancestor
6263791|NCT03307785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6263792|NCT03307785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6263793|NCT03307785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6263794|NCT03307785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6263795|NCT03307785|Growth Substances|growth substances|mesh-ancestor
6263796|NCT03307785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263797|NCT03307785|Growth Inhibitors|growth inhibitors|mesh-ancestor
6263798|NCT03307785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6263799|NCT03307785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6263800|NCT03307785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6263801|NCT03307785|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6263802|NCT03308669|Topiramate|topiramate|mesh-list
6263803|NCT03308669|Lasmiditan|lasmiditan|mesh-list
6263804|NCT03308669|Anticonvulsants|anticonvulsants|mesh-ancestor
6263805|NCT03308669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6263806|NCT03308669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263807|NCT03308669|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6263808|NCT03308669|Serotonin Agents|serotonin agents|mesh-ancestor
6263809|NCT03308669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6263810|NCT03308669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6263811|NCT03308825|Vaccines|vaccines|mesh-list
6263812|NCT03308825|Immunologic Factors|immunologic factors|mesh-ancestor
6263813|NCT03308825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263814|NCT03308942|Pembrolizumab|pembrolizumab|mesh-list
6263815|NCT03308942|Niraparib|niraparib|mesh-list
6263816|NCT03308942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6263817|NCT03308942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6263818|NCT03308942|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6263819|NCT03308942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6263820|NCT03308942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6263821|NCT03309657|Tazobactam|tazobactam|mesh-list
6263822|NCT03309657|Ceftolozane|ceftolozane|mesh-list
6263823|NCT03309657|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
6263824|NCT03309657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6263825|NCT03309657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6263826|NCT03309657|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6263827|NCT03309657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6263828|NCT03309657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6263829|NCT03309657|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6263830|NCT03309657|Renal Agents|renal agents|mesh-ancestor
6263831|NCT03309943|Propranolol|propranolol|mesh-list
6263832|NCT03309943|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6263833|NCT03309943|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6263834|NCT03309943|Adrenergic Agents|adrenergic agents|mesh-ancestor
6263835|NCT03309943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6263836|NCT03309943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6263837|NCT03309943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263838|NCT03309943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6263839|NCT03309943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6263840|NCT03309943|Vasodilator Agents|vasodilator agents|mesh-ancestor
6263841|NCT03310021|Rivaroxaban|rivaroxaban|mesh-list
6263842|NCT03310021|Apixaban|apixaban|mesh-list
6263843|NCT03310021|Edoxaban|edoxaban|mesh-list
6263844|NCT03310021|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6263845|NCT03310021|Antithrombins|antithrombins|mesh-ancestor
6263846|NCT03310021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6263847|NCT03310021|Protease Inhibitors|protease inhibitors|mesh-ancestor
6263848|NCT03310021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6263849|NCT03310021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6263850|NCT03310021|Anticoagulants|anticoagulants|mesh-ancestor
6263851|NCT03310268|Listerine|listerine|mesh-list
6263852|NCT03310268|Fluorides|fluorides|mesh-list
6263853|NCT03310268|Sodium Fluoride|sodium fluoride|mesh-list
6263854|NCT03310268|Tin Fluorides|tin fluorides|mesh-list
6263855|NCT03310268|Fluorophosphate|fluorophosphate|mesh-list
6263856|NCT03310268|Cariostatic Agents|cariostatic agents|mesh-ancestor
6263857|NCT03310268|Protective Agents|protective agents|mesh-ancestor
6263858|NCT03310268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263859|NCT03310268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6263860|NCT03310268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6263861|NCT03310411|Sumatriptan|sumatriptan|mesh-list
6263862|NCT03310411|Lasmiditan|lasmiditan|mesh-list
6263863|NCT03310411|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6263864|NCT03310411|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6263865|NCT03310411|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6263866|NCT03310411|Serotonin Agents|serotonin agents|mesh-ancestor
6263867|NCT03310411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6263868|NCT03310411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6263869|NCT03310411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263870|NCT03310580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6263871|NCT03310580|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6263872|NCT03310970|Lidocaine|lidocaine|mesh-list
6263873|NCT03310970|Anesthetics, Local|anesthetics, local|mesh-ancestor
6263874|NCT03310970|Anesthetics|anesthetics|mesh-ancestor
6263875|NCT03310970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6263876|NCT03310970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263877|NCT03310970|Sensory System Agents|sensory system agents|mesh-ancestor
6263878|NCT03310970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6263879|NCT03310970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6263880|NCT03310970|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6263881|NCT03310970|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6263882|NCT03310970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6263883|NCT03310970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6263884|NCT03311646|Nicotine|nicotine|mesh-list
6263885|NCT03311646|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6263886|NCT03311646|Autonomic Agents|autonomic agents|mesh-ancestor
6263887|NCT03311646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6263888|NCT03311646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263889|NCT03311646|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6263890|NCT03311646|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6263891|NCT03311646|Cholinergic Agents|cholinergic agents|mesh-ancestor
6263892|NCT03311646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6263893|NCT03311646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6263894|NCT03311724|Tirzepatide|tirzepatide|mesh-list
6263895|NCT03311724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6263896|NCT03311724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263897|NCT03311724|Incretins|incretins|mesh-ancestor
6263898|NCT03311724|Hormones|hormones|mesh-ancestor
6263899|NCT03311724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6263900|NCT03311841|Rifampin|rifampin|mesh-list
6263901|NCT03311841|Midazolam|midazolam|mesh-list
6263902|NCT03311841|Dabigatran|dabigatran|mesh-list
6263903|NCT03311841|Atorvastatin|atorvastatin|mesh-list
6263904|NCT03311841|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6263905|NCT03311841|Pitavastatin|pitavastatin|mesh-list
6263906|NCT03311841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6263907|NCT03311841|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6263908|NCT03311841|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6263909|NCT03311841|Antimetabolites|antimetabolites|mesh-ancestor
6263910|NCT03311841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6263911|NCT03311841|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6263912|NCT03311841|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6263913|NCT03311841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6263914|NCT03311841|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6263915|NCT03311841|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6263916|NCT03311841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6263917|NCT03311841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263918|NCT03311841|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6263919|NCT03311841|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6263920|NCT03311841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6263921|NCT03311841|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6263922|NCT03311841|Anesthetics, General|anesthetics, general|mesh-ancestor
6263923|NCT03311841|Anesthetics|anesthetics|mesh-ancestor
6263924|NCT03311841|GABA Modulators|gaba modulators|mesh-ancestor
6263925|NCT03311841|GABA Agents|gaba agents|mesh-ancestor
6263926|NCT03311841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6263927|NCT03311841|Antithrombins|antithrombins|mesh-ancestor
6263928|NCT03311841|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6263929|NCT03311841|Protease Inhibitors|protease inhibitors|mesh-ancestor
6263930|NCT03311841|Anticoagulants|anticoagulants|mesh-ancestor
6263931|NCT03311841|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6263932|NCT03311841|Antitubercular Agents|antitubercular agents|mesh-ancestor
6263933|NCT03311841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6263934|NCT03311841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6263935|NCT03311841|Leprostatic Agents|leprostatic agents|mesh-ancestor
6263936|NCT03311841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6263937|NCT03311841|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6263938|NCT03311841|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6263939|NCT03311841|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6263940|NCT03311841|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6263941|NCT03311841|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6263942|NCT03311841|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6263943|NCT03312023|Sofosbuvir|sofosbuvir|mesh-list
6263944|NCT03312023|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
6263945|NCT03312023|Ledipasvir|ledipasvir|mesh-list
6263946|NCT03312023|Antiviral Agents|antiviral agents|mesh-ancestor
6263947|NCT03312023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6263948|NCT03312114|Avelumab|avelumab|mesh-list
6263949|NCT03312114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6263950|NCT03312114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6263951|NCT03312517|Suvorexant|suvorexant|mesh-list
6263952|NCT03312517|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6263953|NCT03312517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6263954|NCT03312517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6263955|NCT03312517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263956|NCT03312517|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
6263957|NCT03312517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6263958|NCT03312517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6263959|NCT03313037|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6263960|NCT03313037|Immunologic Factors|immunologic factors|mesh-ancestor
6263961|NCT03313037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263962|NCT03313076|Vitamin D|vitamin d|mesh-list
6263963|NCT03313076|Ergocalciferols|ergocalciferols|mesh-list
6263964|NCT03313076|Cholecalciferol|cholecalciferol|mesh-list
6263965|NCT03313076|Vitamins|vitamins|mesh-list
6263966|NCT03313076|Micronutrients|micronutrients|mesh-ancestor
6263967|NCT03313076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263968|NCT03313076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6263969|NCT03313076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6263970|NCT03314662|Vaccines|vaccines|mesh-list
6263971|NCT03314662|MF59 oil emulsion|mf59 oil emulsion|mesh-list
6263972|NCT03314662|Immunologic Factors|immunologic factors|mesh-ancestor
6263973|NCT03314662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263974|NCT03314662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6263975|NCT03315104|Immunoglobulins|immunoglobulins|mesh-list
6263976|NCT03315104|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6263977|NCT03315104|gamma-Globulins|gamma-globulins|mesh-list
6263978|NCT03315104|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6263979|NCT03315104|Immunologic Factors|immunologic factors|mesh-ancestor
6263980|NCT03315104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263981|NCT03315559|Nemiralisib|nemiralisib|mesh-list
6263982|NCT03315559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6263983|NCT03315559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6263984|NCT03315559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6263985|NCT03315780|Dulaglutide|dulaglutide|mesh-list
6263986|NCT03315780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6263987|NCT03315780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263988|NCT03315793|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6263989|NCT03315793|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6263990|NCT03315793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6263991|NCT03315793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6263992|NCT03315793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6263993|NCT03315793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6263994|NCT03315793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6263995|NCT03315793|Analgesics|analgesics|mesh-ancestor
6263996|NCT03315793|Sensory System Agents|sensory system agents|mesh-ancestor
6263997|NCT03315793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6263998|NCT03315793|Antidepressive Agents|antidepressive agents|mesh-ancestor
6263999|NCT03315793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6264000|NCT03315793|Dopamine Agents|dopamine agents|mesh-ancestor
6264001|NCT03316131|Dapagliflozin|dapagliflozin|mesh-list
6264002|NCT03316131|Febuxostat|febuxostat|mesh-list
6264003|NCT03316131|Verinurad|verinurad|mesh-list
6264004|NCT03316131|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6264005|NCT03316131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264006|NCT03316131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6264007|NCT03316131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264008|NCT03316131|Gout Suppressants|gout suppressants|mesh-ancestor
6264009|NCT03316131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6264010|NCT03316378|Ropivacaine|ropivacaine|mesh-list
6264011|NCT03316378|Anesthetics, Local|anesthetics, local|mesh-ancestor
6264012|NCT03316378|Anesthetics|anesthetics|mesh-ancestor
6264013|NCT03316378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6264014|NCT03316378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264015|NCT03316378|Sensory System Agents|sensory system agents|mesh-ancestor
6264016|NCT03316378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6264017|NCT03316807|Vaccines|vaccines|mesh-list
6264018|NCT03316807|Immunologic Factors|immunologic factors|mesh-ancestor
6264019|NCT03316807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264020|NCT03316976|Dexlansoprazole|dexlansoprazole|mesh-list
6264021|NCT03316976|Lansoprazole|lansoprazole|mesh-list
6264022|NCT03316976|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6264023|NCT03316976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6264024|NCT03316976|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6264025|NCT03316976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6264026|NCT03316976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264027|NCT03318315|Vaccines|vaccines|mesh-list
6264028|NCT03318315|Immunologic Factors|immunologic factors|mesh-ancestor
6264029|NCT03318315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264030|NCT03319277|Opiate Alkaloids|opiate alkaloids|mesh-list
6264031|NCT03319277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6264032|NCT03319277|Narcotics|narcotics|mesh-ancestor
6264033|NCT03319277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6264034|NCT03319277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264035|NCT03319277|Analgesics|analgesics|mesh-ancestor
6264036|NCT03319277|Sensory System Agents|sensory system agents|mesh-ancestor
6264037|NCT03319277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6264038|NCT03319719|Lidocaine|lidocaine|mesh-list
6264039|NCT03319719|Hyaluronic Acid|hyaluronic acid|mesh-list
6264040|NCT03319719|Anesthetics, Local|anesthetics, local|mesh-ancestor
6264041|NCT03319719|Anesthetics|anesthetics|mesh-ancestor
6264042|NCT03319719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6264043|NCT03319719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264044|NCT03319719|Sensory System Agents|sensory system agents|mesh-ancestor
6264045|NCT03319719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6264046|NCT03319719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6264047|NCT03319719|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6264048|NCT03319719|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6264049|NCT03319719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6264050|NCT03319719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264051|NCT03319719|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6264052|NCT03319719|Immunologic Factors|immunologic factors|mesh-ancestor
6264053|NCT03319719|Viscosupplements|viscosupplements|mesh-ancestor
6264054|NCT03319719|Protective Agents|protective agents|mesh-ancestor
6264055|NCT03319810|gamma-Globulins|gamma-globulins|mesh-list
6264056|NCT03319810|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6264057|NCT03319810|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6264058|NCT03319810|Immunologic Factors|immunologic factors|mesh-ancestor
6264059|NCT03319810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264060|NCT03319953|Antipsychotic Agents|antipsychotic agents|mesh-list
6264061|NCT03319953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6264062|NCT03319953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6264063|NCT03319953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264064|NCT03319953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6264065|NCT03320057|Mifepristone|mifepristone|mesh-list
6264066|NCT03320057|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6264067|NCT03320057|Abortifacient Agents|abortifacient agents|mesh-ancestor
6264068|NCT03320057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6264069|NCT03320057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264070|NCT03320057|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6264071|NCT03320057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6264072|NCT03320057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6264073|NCT03320057|Contraceptive Agents|contraceptive agents|mesh-ancestor
6264074|NCT03320057|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6264075|NCT03320057|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6264076|NCT03320057|Hormone Antagonists|hormone antagonists|mesh-ancestor
6264077|NCT03320057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6264078|NCT03320057|Luteolytic Agents|luteolytic agents|mesh-ancestor
6264079|NCT03320057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6264080|NCT03320057|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6264081|NCT03320564|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6264082|NCT03320564|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6264083|NCT03320564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264084|NCT03320850|Botulinum Toxins|botulinum toxins|mesh-list
6264085|NCT03320850|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6264086|NCT03320850|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6264087|NCT03320850|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6264088|NCT03320850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6264089|NCT03320850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264090|NCT03320850|Cholinergic Agents|cholinergic agents|mesh-ancestor
6264091|NCT03320850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6264092|NCT03320850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264093|NCT03320850|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6264094|NCT03320850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6264095|NCT03320941|Licogliflozin|licogliflozin|mesh-list
6264096|NCT03320941|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6264097|NCT03320941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264098|NCT03320941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6264099|NCT03320941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264100|NCT03321006|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6264101|NCT03321006|Citalopram|citalopram|mesh-list
6264102|NCT03321006|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6264103|NCT03321006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6264104|NCT03321006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6264105|NCT03321006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264106|NCT03321006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6264107|NCT03321006|Serotonin Agents|serotonin agents|mesh-ancestor
6264108|NCT03321006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264109|NCT03321006|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6264110|NCT03321006|Antidepressive Agents|antidepressive agents|mesh-ancestor
6264111|NCT03321006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6264112|NCT03321006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6264113|NCT03321006|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6264114|NCT03321006|Analgesics|analgesics|mesh-ancestor
6264115|NCT03321006|Sensory System Agents|sensory system agents|mesh-ancestor
6264116|NCT03321006|Dopamine Agents|dopamine agents|mesh-ancestor
6264117|NCT03321097|Botulinum Toxins|botulinum toxins|mesh-list
6264118|NCT03321097|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6264119|NCT03321097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6264120|NCT03321097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264121|NCT03321097|Cholinergic Agents|cholinergic agents|mesh-ancestor
6264122|NCT03321097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6264123|NCT03321097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264124|NCT03321396|Calcium|calcium|mesh-list
6264125|NCT03321396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6264126|NCT03321396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264127|NCT03322293|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6264128|NCT03322293|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6264129|NCT03322293|Dermatologic Agents|dermatologic agents|mesh-ancestor
6390216|NCT00190554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390217|NCT00190567|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6390218|NCT00190567|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6390219|NCT00190567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6390220|NCT00190567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6390221|NCT00190567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390222|NCT00190567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6390223|NCT00190567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390224|NCT00190567|Analgesics|analgesics|mesh-ancestor
6390225|NCT00190567|Sensory System Agents|sensory system agents|mesh-ancestor
6390226|NCT00190567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6390227|NCT00190567|Antidepressive Agents|antidepressive agents|mesh-ancestor
6390228|NCT00190567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6390229|NCT00190567|Dopamine Agents|dopamine agents|mesh-ancestor
6390230|NCT00190580|Valsartan|valsartan|mesh-list
6390231|NCT00190580|Antihypertensive Agents|antihypertensive agents|mesh-list
6390232|NCT00190580|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6390233|NCT00190580|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6390234|NCT00190580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390235|NCT00190593|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
6390236|NCT00190593|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6390237|NCT00190593|Hormone Antagonists|hormone antagonists|mesh-ancestor
6390238|NCT00190593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6390239|NCT00190593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390240|NCT00190593|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6390241|NCT00190593|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6390242|NCT00190593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6390243|NCT00190606|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6390244|NCT00190606|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6390245|NCT00190606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6390246|NCT00190606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6390247|NCT00190606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390248|NCT00190606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6390249|NCT00190606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390250|NCT00190606|Analgesics|analgesics|mesh-ancestor
6390251|NCT00190606|Sensory System Agents|sensory system agents|mesh-ancestor
6390252|NCT00190606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6390253|NCT00190606|Antidepressive Agents|antidepressive agents|mesh-ancestor
6390254|NCT00190606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6390255|NCT00190606|Dopamine Agents|dopamine agents|mesh-ancestor
6390256|NCT00190619|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6390257|NCT00190619|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6390258|NCT00190619|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6390259|NCT00190619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6390260|NCT00190619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390261|NCT00190619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6390262|NCT00190619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390263|NCT00190619|Analgesics|analgesics|mesh-ancestor
6390264|NCT00190619|Sensory System Agents|sensory system agents|mesh-ancestor
6390265|NCT00190619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6390266|NCT00190619|Antidepressive Agents|antidepressive agents|mesh-ancestor
6390267|NCT00190619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6390268|NCT00190619|Dopamine Agents|dopamine agents|mesh-ancestor
6390269|NCT00190632|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6390270|NCT00190632|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6390271|NCT00190632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6390272|NCT00190632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6390273|NCT00190632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390274|NCT00190632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6390275|NCT00190632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264130|NCT03322657|Glycopyrrolate|glycopyrrolate|mesh-list
6264131|NCT03322657|Neostigmine|neostigmine|mesh-list
6264132|NCT03322657|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6264133|NCT03322657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6264134|NCT03322657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264135|NCT03322657|Cholinergic Agents|cholinergic agents|mesh-ancestor
6264136|NCT03322657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6264137|NCT03322657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264138|NCT03322657|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6264139|NCT03322657|Autonomic Agents|autonomic agents|mesh-ancestor
6264140|NCT03322657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6264141|NCT03322657|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6264142|NCT03322657|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6264143|NCT03322657|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6264144|NCT03323164|Timolol|timolol|mesh-list
6264145|NCT03323164|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6264146|NCT03323164|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6264147|NCT03323164|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6264148|NCT03323164|Adrenergic Agents|adrenergic agents|mesh-ancestor
6264149|NCT03323164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6264150|NCT03323164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264151|NCT03323164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264152|NCT03323164|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6264153|NCT03323164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6264154|NCT03323164|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6264155|NCT03323164|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6264156|NCT03323164|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6264157|NCT03323801|Tretinoin|tretinoin|mesh-list
6264158|NCT03323801|Isotretinoin|isotretinoin|mesh-list
6264159|NCT03323801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6264160|NCT03323801|Keratolytic Agents|keratolytic agents|mesh-ancestor
6264161|NCT03323801|Dermatologic Agents|dermatologic agents|mesh-ancestor
6264162|NCT03324451|Insulin|insulin|mesh-list
6264163|NCT03324451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6264164|NCT03324451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264165|NCT03324581|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6264166|NCT03324581|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6264167|NCT03324581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6264168|NCT03324581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6264169|NCT03324581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264170|NCT03324581|Adrenergic Agents|adrenergic agents|mesh-ancestor
6264171|NCT03324581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6264172|NCT03324581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264173|NCT03325556|Pimavanserin|pimavanserin|mesh-list
6264174|NCT03325556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6264175|NCT03325556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6264176|NCT03325556|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6264177|NCT03325556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6264178|NCT03325556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6264179|NCT03325556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264180|NCT03325556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6264181|NCT03325556|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6264182|NCT03325556|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6264183|NCT03325556|Serotonin Agents|serotonin agents|mesh-ancestor
6264184|NCT03325556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6264185|NCT03325556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264186|NCT03325816|Nivolumab|nivolumab|mesh-list
6264187|NCT03325816|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
6264188|NCT03325816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6264189|NCT03325816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6264190|NCT03325816|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6264191|NCT03325816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264192|NCT03325816|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6264193|NCT03326856|Botulinum Toxins|botulinum toxins|mesh-list
6264194|NCT03326856|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6264195|NCT03326856|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6264196|NCT03326856|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6264197|NCT03326856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6264198|NCT03326856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264199|NCT03326856|Cholinergic Agents|cholinergic agents|mesh-ancestor
6264200|NCT03326856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6264201|NCT03326856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264202|NCT03326856|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6264203|NCT03326856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6264204|NCT03326999|Bupivacaine|bupivacaine|mesh-list
6264205|NCT03326999|Anesthetics, Local|anesthetics, local|mesh-ancestor
6264206|NCT03326999|Anesthetics|anesthetics|mesh-ancestor
6264207|NCT03326999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6264208|NCT03326999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264209|NCT03326999|Sensory System Agents|sensory system agents|mesh-ancestor
6264210|NCT03326999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6264211|NCT03327051|Omeprazole|omeprazole|mesh-list
6264212|NCT03327051|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6264213|NCT03327051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6264214|NCT03327051|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6264215|NCT03327051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6264216|NCT03327051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264217|NCT03328325|Vaccines|vaccines|mesh-list
6264218|NCT03328325|Immunologic Factors|immunologic factors|mesh-ancestor
6264219|NCT03328325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264220|NCT03328832|Tranylcypromine|tranylcypromine|mesh-list
6264221|NCT03328832|Rivaroxaban|rivaroxaban|mesh-list
6264222|NCT03328832|Tranexamic Acid|tranexamic acid|mesh-list
6264223|NCT03328832|Thrombin|thrombin|mesh-list
6264224|NCT03328832|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6264225|NCT03328832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6264226|NCT03328832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264227|NCT03328832|Hemostatics|hemostatics|mesh-ancestor
6264228|NCT03328832|Coagulants|coagulants|mesh-ancestor
6264229|NCT03328832|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6264230|NCT03328832|Antithrombins|antithrombins|mesh-ancestor
6264231|NCT03328832|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6264232|NCT03328832|Protease Inhibitors|protease inhibitors|mesh-ancestor
6264233|NCT03328832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6264234|NCT03328832|Anticoagulants|anticoagulants|mesh-ancestor
6264235|NCT03328832|Antidepressive Agents|antidepressive agents|mesh-ancestor
6264236|NCT03328832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6264237|NCT03328832|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6264238|NCT03328832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6264239|NCT03328832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6264240|NCT03328832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6264241|NCT03328832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264242|NCT03328897|Omalizumab|omalizumab|mesh-list
6264243|NCT03328897|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6264244|NCT03328897|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6264245|NCT03328897|Respiratory System Agents|respiratory system agents|mesh-ancestor
6264246|NCT03329196|Darbepoetin alfa|darbepoetin alfa|mesh-list
6264247|NCT03329196|Hematinics|hematinics|mesh-ancestor
6264248|NCT03329209|Vedolizumab|vedolizumab|mesh-list
6264249|NCT03329209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6264250|NCT03329573|Paroxetine|paroxetine|mesh-list
6264251|NCT03329573|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6264252|NCT03329573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6264253|NCT03329573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6264254|NCT03329573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264255|NCT03329573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6264256|NCT03329573|Serotonin Agents|serotonin agents|mesh-ancestor
6264257|NCT03329573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264258|NCT03329573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6264259|NCT03329573|Antidepressive Agents|antidepressive agents|mesh-ancestor
6264260|NCT03329573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6264261|NCT03329573|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6264262|NCT03329573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6264263|NCT03329573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6264264|NCT03329846|Nivolumab|nivolumab|mesh-list
6264265|NCT03329846|Linrodostat|linrodostat|mesh-list
6264266|NCT03329846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6264267|NCT03329846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6264268|NCT03329846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6390276|NCT00190632|Analgesics|analgesics|mesh-ancestor
6264269|NCT03329846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264270|NCT03329846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6264271|NCT03329911|Paclitaxel|paclitaxel|mesh-list
6264272|NCT03329911|Carboplatin|carboplatin|mesh-list
6264273|NCT03329911|Bevacizumab|bevacizumab|mesh-list
6264274|NCT03329911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6264275|NCT03329911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6264276|NCT03329911|Tubulin Modulators|tubulin modulators|mesh-ancestor
6264277|NCT03329911|Antimitotic Agents|antimitotic agents|mesh-ancestor
6264278|NCT03329911|Mitosis Modulators|mitosis modulators|mesh-ancestor
6264279|NCT03329911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264280|NCT03329911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6264281|NCT03329911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6264282|NCT03329911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6264283|NCT03329911|Growth Substances|growth substances|mesh-ancestor
6264284|NCT03329911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264285|NCT03329911|Growth Inhibitors|growth inhibitors|mesh-ancestor
6264286|NCT03329937|Niraparib|niraparib|mesh-list
6264287|NCT03329937|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6264288|NCT03329937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6264289|NCT03329937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264290|NCT03329937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6264291|NCT03330236|Anesthetics|anesthetics|mesh-list
6264292|NCT03330236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6264293|NCT03330236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264294|NCT03330457|Betrixaban|betrixaban|mesh-list
6264295|NCT03330457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6264296|NCT03330457|Antithrombins|antithrombins|mesh-ancestor
6264297|NCT03330457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6264298|NCT03330457|Protease Inhibitors|protease inhibitors|mesh-ancestor
6264299|NCT03330457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6264300|NCT03330457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264301|NCT03330457|Anticoagulants|anticoagulants|mesh-ancestor
6264302|NCT03331315|Celecoxib|celecoxib|mesh-list
6264303|NCT03331315|Ketorolac|ketorolac|mesh-list
6264304|NCT03331315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6264305|NCT03331315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6264306|NCT03331315|Analgesics|analgesics|mesh-ancestor
6264307|NCT03331315|Sensory System Agents|sensory system agents|mesh-ancestor
6264308|NCT03331315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6264309|NCT03331315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264310|NCT03331315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6264311|NCT03331315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6264312|NCT03331315|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6264313|NCT03331315|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6264314|NCT03331315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6264315|NCT03331315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264316|NCT03331666|Evolocumab|evolocumab|mesh-list
6264317|NCT03331666|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6264318|NCT03331666|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6264319|NCT03331666|Antimetabolites|antimetabolites|mesh-ancestor
6264320|NCT03331666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264321|NCT03331666|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6264322|NCT03331835|Brodalumab|brodalumab|mesh-list
6264323|NCT03331835|Dermatologic Agents|dermatologic agents|mesh-ancestor
6264324|NCT03331965|Metoclopramide|metoclopramide|mesh-list
6264325|NCT03331965|Antiemetics|antiemetics|mesh-ancestor
6264326|NCT03331965|Autonomic Agents|autonomic agents|mesh-ancestor
6264327|NCT03331965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6264328|NCT03331965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264329|NCT03331965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6264330|NCT03331965|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6264331|NCT03331965|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6264332|NCT03331965|Dopamine Agents|dopamine agents|mesh-ancestor
6264333|NCT03331965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6264334|NCT03331965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264335|NCT03332212|Empagliflozin|empagliflozin|mesh-list
6264336|NCT03332212|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6264337|NCT03332212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264338|NCT03332212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6264339|NCT03332212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264340|NCT03332771|Metformin|metformin|mesh-list
6264341|NCT03332771|Glimepiride|glimepiride|mesh-list
6390277|NCT00190632|Sensory System Agents|sensory system agents|mesh-ancestor
6264342|NCT03332771|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
6264343|NCT03332771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6264344|NCT03332771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264345|NCT03332771|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6264346|NCT03332771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6264347|NCT03332771|Immunologic Factors|immunologic factors|mesh-ancestor
6264348|NCT03332771|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6264349|NCT03332771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264350|NCT03333109|Erenumab|erenumab|mesh-list
6264351|NCT03333109|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
6264352|NCT03333109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264353|NCT03333109|Analgesics|analgesics|mesh-ancestor
6264354|NCT03333109|Sensory System Agents|sensory system agents|mesh-ancestor
6264355|NCT03333109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6264356|NCT03333109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264357|NCT03334448|Insulin Lispro|insulin lispro|mesh-list
6264358|NCT03334448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6264359|NCT03334448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264360|NCT03334721|Gabapentin|gabapentin|mesh-list
6264361|NCT03334721|Analgesics|analgesics|mesh-ancestor
6264362|NCT03334721|Sensory System Agents|sensory system agents|mesh-ancestor
6264363|NCT03334721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6264364|NCT03334721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264365|NCT03334721|Anticonvulsants|anticonvulsants|mesh-ancestor
6264366|NCT03334721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6264367|NCT03334721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6264368|NCT03334721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6264369|NCT03334721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6264370|NCT03334721|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6264371|NCT03334721|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6264372|NCT03334721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6264373|NCT03334721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264374|NCT03334721|Antimanic Agents|antimanic agents|mesh-ancestor
6264375|NCT03334734|Isoniazid|isoniazid|mesh-list
6264376|NCT03334734|Macozinone|macozinone|mesh-list
6264377|NCT03334734|Antitubercular Agents|antitubercular agents|mesh-ancestor
6264378|NCT03334734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6264379|NCT03334734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6264380|NCT03334734|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6264381|NCT03334734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6264382|NCT03334734|Antimetabolites|antimetabolites|mesh-ancestor
6264383|NCT03334734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264384|NCT03334734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6264385|NCT03334747|Lumefantrine|lumefantrine|mesh-list
6264386|NCT03334747|Artemether|artemether|mesh-list
6264387|NCT03334747|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6264388|NCT03334747|Antimalarials|antimalarials|mesh-ancestor
6264389|NCT03334747|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6264390|NCT03334747|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6264391|NCT03334747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6264392|NCT03334903|Gabapentin|gabapentin|mesh-list
6264393|NCT03334903|Analgesics|analgesics|mesh-ancestor
6264394|NCT03334903|Sensory System Agents|sensory system agents|mesh-ancestor
6264395|NCT03334903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6264396|NCT03334903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264397|NCT03334903|Anticonvulsants|anticonvulsants|mesh-ancestor
6264398|NCT03334903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6264399|NCT03334903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6264400|NCT03334903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6264401|NCT03334903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6264402|NCT03334903|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6264403|NCT03334903|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6014691|NCT00352781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014692|NCT00352781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6014693|NCT00352781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6014694|NCT00352781|Cholinergic Agents|cholinergic agents|mesh-ancestor
6014695|NCT00352781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6014696|NCT00352781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014697|NCT00352794|Prednisone|prednisone|mesh-list
6014698|NCT00352794|Lenalidomide|lenalidomide|mesh-list
6014699|NCT00352794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6014700|NCT00352794|Glucocorticoids|glucocorticoids|mesh-ancestor
6014701|NCT00352794|Hormones|hormones|mesh-ancestor
6264404|NCT03334903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6264405|NCT03334903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264406|NCT03334903|Antimanic Agents|antimanic agents|mesh-ancestor
6264407|NCT03336450|Midazolam|midazolam|mesh-list
6264408|NCT03336450|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6264409|NCT03336450|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6264410|NCT03336450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6264411|NCT03336450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264412|NCT03336450|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6264413|NCT03336450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6264414|NCT03336450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6264415|NCT03336450|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6264416|NCT03336450|Anesthetics, General|anesthetics, general|mesh-ancestor
6264417|NCT03336450|Anesthetics|anesthetics|mesh-ancestor
6264418|NCT03336450|GABA Modulators|gaba modulators|mesh-ancestor
6264419|NCT03336450|GABA Agents|gaba agents|mesh-ancestor
6264420|NCT03336450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6264421|NCT03336450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264422|NCT03336502|Posaconazole|posaconazole|mesh-list
6264423|NCT03336502|Antifungal Agents|antifungal agents|mesh-ancestor
6264424|NCT03336502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6264425|NCT03336502|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6264426|NCT03336502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6264427|NCT03336502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6264428|NCT03336502|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6264429|NCT03336502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6264430|NCT03336502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6264431|NCT03336502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264432|NCT03336502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6264433|NCT03336502|Hormone Antagonists|hormone antagonists|mesh-ancestor
6264434|NCT03336502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6264435|NCT03336502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264436|NCT03336645|Midazolam|midazolam|mesh-list
6264437|NCT03336645|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6264438|NCT03336645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6264439|NCT03336645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6264440|NCT03336645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264441|NCT03336645|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6264442|NCT03336645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6264443|NCT03336645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6264444|NCT03336645|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6264445|NCT03336645|Anesthetics, General|anesthetics, general|mesh-ancestor
6264446|NCT03336645|Anesthetics|anesthetics|mesh-ancestor
6264447|NCT03336645|GABA Modulators|gaba modulators|mesh-ancestor
6264448|NCT03336645|GABA Agents|gaba agents|mesh-ancestor
6264449|NCT03336645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6264450|NCT03336645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264451|NCT03336853|Hybenx|hybenx|mesh-list
6264452|NCT03336853|Dental Disinfectants|dental disinfectants|mesh-ancestor
6264453|NCT03336853|Disinfectants|disinfectants|mesh-ancestor
6264454|NCT03336853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6264455|NCT03337152|Chloroquine|chloroquine|mesh-list
6264456|NCT03337152|Primaquine|primaquine|mesh-list
6264457|NCT03337152|Amebicides|amebicides|mesh-ancestor
6264458|NCT03337152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6264459|NCT03337152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6264460|NCT03337152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6264461|NCT03337152|Antimalarials|antimalarials|mesh-ancestor
6264462|NCT03337152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6390278|NCT00190632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6390279|NCT00190632|Antidepressive Agents|antidepressive agents|mesh-ancestor
6390280|NCT00190632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6390281|NCT00190632|Dopamine Agents|dopamine agents|mesh-ancestor
6390282|NCT00190645|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6390283|NCT00190645|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6390284|NCT00190645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6390285|NCT00190645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6390286|NCT00190645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390287|NCT00190645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6264463|NCT03337308|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
6264464|NCT03337308|Ezetimibe|ezetimibe|mesh-list
6264465|NCT03337308|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6264466|NCT03337308|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6264467|NCT03337308|Antimetabolites|antimetabolites|mesh-ancestor
6264468|NCT03337308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264469|NCT03337308|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6264470|NCT03337308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6264471|NCT03337308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6264472|NCT03337308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264473|NCT03337477|Insulin|insulin|mesh-list
6264474|NCT03337477|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6264475|NCT03337477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6264476|NCT03337477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264477|NCT03337490|Ivermectin|ivermectin|mesh-list
6264478|NCT03337490|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6264479|NCT03337490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6264480|NCT03338010|Insulin Glargine|insulin glargine|mesh-list
6264481|NCT03338010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6264482|NCT03338010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264483|NCT03338023|Insulin Lispro|insulin lispro|mesh-list
6264484|NCT03338023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6264485|NCT03338023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264486|NCT03338062|Iminodiacetic acid|iminodiacetic acid|mesh-list
6264487|NCT03338062|Chelating Agents|chelating agents|mesh-ancestor
6264488|NCT03338062|Sequestering Agents|sequestering agents|mesh-ancestor
6264489|NCT03338062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264490|NCT03338400|Dexamethasone|dexamethasone|mesh-list
6264491|NCT03338400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6264492|NCT03338400|Antiemetics|antiemetics|mesh-ancestor
6264493|NCT03338400|Autonomic Agents|autonomic agents|mesh-ancestor
6264494|NCT03338400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6264495|NCT03338400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264496|NCT03338400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6264497|NCT03338400|Glucocorticoids|glucocorticoids|mesh-ancestor
6264498|NCT03338400|Hormones|hormones|mesh-ancestor
6264499|NCT03338400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6264500|NCT03338400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6264501|NCT03338400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6264502|NCT03338569|Ascorbic Acid|ascorbic acid|mesh-list
6264503|NCT03338569|Vitamins|vitamins|mesh-ancestor
6264504|NCT03338569|Micronutrients|micronutrients|mesh-ancestor
6264505|NCT03338569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264506|NCT03338569|Antioxidants|antioxidants|mesh-ancestor
6264507|NCT03338569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264508|NCT03338569|Protective Agents|protective agents|mesh-ancestor
6264509|NCT03338803|Linagliptin|linagliptin|mesh-list
6264510|NCT03338803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6264511|NCT03338803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264512|NCT03338803|Incretins|incretins|mesh-ancestor
6264513|NCT03338803|Hormones|hormones|mesh-ancestor
6264514|NCT03338803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6264515|NCT03338803|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6264516|NCT03338803|Protease Inhibitors|protease inhibitors|mesh-ancestor
6264517|NCT03338803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6264518|NCT03338803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264519|NCT03338855|Dapagliflozin|dapagliflozin|mesh-list
6264520|NCT03338855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6264521|NCT03338855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264522|NCT03338855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6264523|NCT03338855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264524|NCT03338998|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6264525|NCT03338998|Siponimod|siponimod|mesh-list
6390288|NCT00190645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264526|NCT03338998|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6264527|NCT03338998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264528|NCT03338998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6264529|NCT03338998|Immunologic Factors|immunologic factors|mesh-ancestor
6264530|NCT03338998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264531|NCT03339297|Defibrotide|defibrotide|mesh-list
6264532|NCT03339297|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6264533|NCT03339297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6264534|NCT03339297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264535|NCT03339297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6264536|NCT03339453|Glucagon|glucagon|mesh-list
6264537|NCT03339453|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6264538|NCT03339453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6264539|NCT03339453|Hormones|hormones|mesh-ancestor
6264540|NCT03339453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6264541|NCT03339453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264542|NCT03339453|Incretins|incretins|mesh-ancestor
6264543|NCT03339583|Zopiclone|zopiclone|mesh-list
6264544|NCT03339583|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6264545|NCT03339583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6264546|NCT03339583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264547|NCT03339726|Phenylephrine|phenylephrine|mesh-list
6264548|NCT03339726|Oxymetazoline|oxymetazoline|mesh-list
6264549|NCT03339726|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6264550|NCT03339726|Mydriatics|mydriatics|mesh-ancestor
6264551|NCT03339726|Autonomic Agents|autonomic agents|mesh-ancestor
6264552|NCT03339726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6264553|NCT03339726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264554|NCT03339726|Sympathomimetics|sympathomimetics|mesh-ancestor
6264555|NCT03339726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6264556|NCT03339726|Nasal Decongestants|nasal decongestants|mesh-ancestor
6264557|NCT03339726|Respiratory System Agents|respiratory system agents|mesh-ancestor
6264558|NCT03339726|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6264559|NCT03339726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6264560|NCT03339726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6264561|NCT03339726|Adrenergic Agents|adrenergic agents|mesh-ancestor
6264562|NCT03339726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6264563|NCT03339726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264564|NCT03339726|Protective Agents|protective agents|mesh-ancestor
6264565|NCT03340350|Minocycline|minocycline|mesh-list
6264566|NCT03340350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6264567|NCT03340350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6264568|NCT03340961|Doxycycline|doxycycline|mesh-list
6264569|NCT03340961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6264570|NCT03340961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6264571|NCT03340961|Antimalarials|antimalarials|mesh-ancestor
6264572|NCT03340961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6014702|NCT00352794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6014703|NCT00352794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014704|NCT00352794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6014705|NCT00352794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6014706|NCT00352794|Immunologic Factors|immunologic factors|mesh-ancestor
6014707|NCT00352794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6014708|NCT00352794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6014709|NCT00352794|Growth Substances|growth substances|mesh-ancestor
6014710|NCT00352794|Growth Inhibitors|growth inhibitors|mesh-ancestor
6014711|NCT00352846|Vitamin D|vitamin d|mesh-list
6014712|NCT00352846|Zoledronic Acid|zoledronic acid|mesh-list
6264573|NCT03340961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6264574|NCT03341273|Azithromycin|azithromycin|mesh-list
6264575|NCT03341273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6264576|NCT03341273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6264577|NCT03341299|Insulin Lispro|insulin lispro|mesh-list
6264578|NCT03341299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6264579|NCT03341299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264580|NCT03341312|Insulin Lispro|insulin lispro|mesh-list
6264581|NCT03341312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6264582|NCT03341312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264583|NCT03341910|Nicotinic Acids|nicotinic acids|mesh-list
6264584|NCT03341910|Tazarotene|tazarotene|mesh-list
6264585|NCT03341910|Dermatologic Agents|dermatologic agents|mesh-ancestor
6264586|NCT03341910|Keratolytic Agents|keratolytic agents|mesh-ancestor
6264587|NCT03341910|Vitamin B Complex|vitamin b complex|mesh-ancestor
6264588|NCT03341910|Vitamins|vitamins|mesh-ancestor
6264589|NCT03341910|Micronutrients|micronutrients|mesh-ancestor
6264590|NCT03341910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264591|NCT03342404|Luspatercept|luspatercept|mesh-list
6264592|NCT03342404|Hematinics|hematinics|mesh-ancestor
6264593|NCT03342690|Eplerenone|eplerenone|mesh-list
6264594|NCT03342690|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6264595|NCT03342690|Hormone Antagonists|hormone antagonists|mesh-ancestor
6264596|NCT03342690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6264597|NCT03342690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264598|NCT03342690|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6264599|NCT03342690|Diuretics|diuretics|mesh-ancestor
6264600|NCT03342690|Natriuretic Agents|natriuretic agents|mesh-ancestor
6264601|NCT03342690|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6264602|NCT03342963|Aripiprazole|aripiprazole|mesh-list
6264603|NCT03342963|Sertraline|sertraline|mesh-list
6264604|NCT03342963|Antidepressive Agents|antidepressive agents|mesh-ancestor
6264605|NCT03342963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6264606|NCT03342963|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6264607|NCT03342963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6264608|NCT03342963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6264609|NCT03342963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264610|NCT03342963|Dopamine Agonists|dopamine agonists|mesh-ancestor
6264611|NCT03342963|Dopamine Agents|dopamine agents|mesh-ancestor
6264612|NCT03342963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6264613|NCT03342963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264614|NCT03342963|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6264615|NCT03342963|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6264616|NCT03342963|Serotonin Agents|serotonin agents|mesh-ancestor
6264617|NCT03342963|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6264618|NCT03342963|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6264619|NCT03342963|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6264620|NCT03342963|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6264621|NCT03342963|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6264622|NCT03342963|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6264623|NCT03342963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6264624|NCT03343067|Norethindrone|norethindrone|mesh-list
6264625|NCT03343067|Norethindrone Acetate|norethindrone acetate|mesh-list
6264626|NCT03343067|Estradiol|estradiol|mesh-list
6264627|NCT03343067|Estrogens|estrogens|mesh-ancestor
6264628|NCT03343067|Hormones|hormones|mesh-ancestor
6264629|NCT03343067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6264630|NCT03343067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264631|NCT03343067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6264632|NCT03343067|Contraceptive Agents|contraceptive agents|mesh-ancestor
6264633|NCT03343067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6264634|NCT03343067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6264635|NCT03343067|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6264636|NCT03343067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6264637|NCT03343067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6264638|NCT03343080|Lidocaine|lidocaine|mesh-list
6264639|NCT03343080|Anesthetics, Local|anesthetics, local|mesh-ancestor
6264640|NCT03343080|Anesthetics|anesthetics|mesh-ancestor
6264641|NCT03343080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6264642|NCT03343080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264643|NCT03343080|Sensory System Agents|sensory system agents|mesh-ancestor
6264644|NCT03343080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6264645|NCT03343080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6264646|NCT03343080|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6264647|NCT03343080|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6264648|NCT03343080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6264649|NCT03343080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264650|NCT03343639|Serlopitant|serlopitant|mesh-list
6264651|NCT03343639|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6264652|NCT03343639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6264653|NCT03343639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264654|NCT03343639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264655|NCT03344172|Gemcitabine|gemcitabine|mesh-list
6264656|NCT03344172|Hydroxychloroquine|hydroxychloroquine|mesh-list
6264657|NCT03344172|Paclitaxel|paclitaxel|mesh-list
6264658|NCT03344172|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6264659|NCT03344172|Avelumab|avelumab|mesh-list
6264660|NCT03344172|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6264661|NCT03344172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6264662|NCT03344172|Tubulin Modulators|tubulin modulators|mesh-ancestor
6264663|NCT03344172|Antimitotic Agents|antimitotic agents|mesh-ancestor
6264664|NCT03344172|Mitosis Modulators|mitosis modulators|mesh-ancestor
6264665|NCT03344172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264666|NCT03344172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6264667|NCT03344172|Antimetabolites|antimetabolites|mesh-ancestor
6264668|NCT03344172|Antiviral Agents|antiviral agents|mesh-ancestor
6264669|NCT03344172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6264670|NCT03344172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6264671|NCT03344172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6264672|NCT03344172|Immunologic Factors|immunologic factors|mesh-ancestor
6264673|NCT03344172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264674|NCT03344172|Antimalarials|antimalarials|mesh-ancestor
6264675|NCT03344172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6264676|NCT03344172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6264677|NCT03344172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6264678|NCT03344172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6264679|NCT03344510|Anesthetics|anesthetics|mesh-list
6264680|NCT03344510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6264681|NCT03344510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264682|NCT03344861|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
6264683|NCT03344861|Trioxsalen|trioxsalen|mesh-list
6264684|NCT03344861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6264685|NCT03344861|Dermatologic Agents|dermatologic agents|mesh-ancestor
6264686|NCT03344861|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6264687|NCT03345407|Albuterol|albuterol|mesh-list
6264688|NCT03345407|Nemiralisib|nemiralisib|mesh-list
6264689|NCT03345407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6264690|NCT03345407|Autonomic Agents|autonomic agents|mesh-ancestor
6264691|NCT03345407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6264692|NCT03345407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264693|NCT03345407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6264694|NCT03345407|Respiratory System Agents|respiratory system agents|mesh-ancestor
6264695|NCT03345407|Tocolytic Agents|tocolytic agents|mesh-ancestor
6264696|NCT03345407|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6264697|NCT03345407|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6264698|NCT03345407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6264699|NCT03345407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6264700|NCT03345407|Adrenergic Agents|adrenergic agents|mesh-ancestor
6264701|NCT03345407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6264702|NCT03345407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264703|NCT03345407|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6264704|NCT03345407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6264705|NCT03345979|Aripiprazole|aripiprazole|mesh-list
6264706|NCT03345979|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6264707|NCT03345979|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
6264708|NCT03345979|Antidepressive Agents|antidepressive agents|mesh-ancestor
6264709|NCT03345979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6264710|NCT03345979|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6264711|NCT03345979|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6264712|NCT03345979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6264713|NCT03345979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264714|NCT03345979|Dopamine Agonists|dopamine agonists|mesh-ancestor
6264715|NCT03345979|Dopamine Agents|dopamine agents|mesh-ancestor
6264716|NCT03345979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6264717|NCT03345979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264718|NCT03345979|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6264719|NCT03345979|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6264720|NCT03345979|Serotonin Agents|serotonin agents|mesh-ancestor
6264721|NCT03345979|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6264722|NCT03345979|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6264723|NCT03345979|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6264724|NCT03345979|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6264725|NCT03346057|Glycopyrrolate|glycopyrrolate|mesh-list
6264726|NCT03346057|Rocuronium|rocuronium|mesh-list
6264727|NCT03346057|Vecuronium Bromide|vecuronium bromide|mesh-list
6264728|NCT03346057|Neostigmine|neostigmine|mesh-list
6264729|NCT03346057|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6264730|NCT03346057|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6264731|NCT03346057|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6264732|NCT03346057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6264733|NCT03346057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264734|NCT03346057|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6264735|NCT03346057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6264736|NCT03346057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264737|NCT03346057|Cholinergic Agents|cholinergic agents|mesh-ancestor
6264738|NCT03346057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6264739|NCT03346057|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6264740|NCT03346057|Autonomic Agents|autonomic agents|mesh-ancestor
6264741|NCT03346057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6264742|NCT03346057|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6264743|NCT03346057|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6264744|NCT03346057|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
6264745|NCT03346070|Glycopyrrolate|glycopyrrolate|mesh-list
6264746|NCT03346070|Rocuronium|rocuronium|mesh-list
6264747|NCT03346070|Vecuronium Bromide|vecuronium bromide|mesh-list
6264748|NCT03346070|Neostigmine|neostigmine|mesh-list
6264749|NCT03346070|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6264750|NCT03346070|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6264751|NCT03346070|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6264752|NCT03346070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6264753|NCT03346070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264754|NCT03346070|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6264755|NCT03346070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6264756|NCT03346070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264757|NCT03346070|Cholinergic Agents|cholinergic agents|mesh-ancestor
6264758|NCT03346070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6264759|NCT03346070|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6264760|NCT03346070|Autonomic Agents|autonomic agents|mesh-ancestor
6264761|NCT03346070|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6264762|NCT03346070|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6264763|NCT03346070|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6264764|NCT03346070|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
6264765|NCT03347279|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6264766|NCT03347279|Immunologic Factors|immunologic factors|mesh-ancestor
6264767|NCT03347279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264768|NCT03348683|Propranolol|propranolol|mesh-list
6264769|NCT03348683|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6264770|NCT03348683|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6264771|NCT03348683|Adrenergic Agents|adrenergic agents|mesh-ancestor
6264772|NCT03348683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6264773|NCT03348683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264774|NCT03348683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264775|NCT03348683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6264776|NCT03348683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6264777|NCT03348683|Vasodilator Agents|vasodilator agents|mesh-ancestor
6264778|NCT03349060|Abrocitinib|abrocitinib|mesh-list
6264779|NCT03349060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6264780|NCT03349060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6264781|NCT03349060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264782|NCT03349333|Folic Acid|folic acid|mesh-list
6264783|NCT03349333|Vitamin B 12|vitamin b 12|mesh-list
6264784|NCT03349333|Hydroxocobalamin|hydroxocobalamin|mesh-list
6264785|NCT03349333|Vitamins|vitamins|mesh-ancestor
6264786|NCT03349333|Micronutrients|micronutrients|mesh-ancestor
6264787|NCT03349333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264788|NCT03349333|Hematinics|hematinics|mesh-ancestor
6264789|NCT03349333|Vitamin B Complex|vitamin b complex|mesh-ancestor
6264790|NCT03349515|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6264791|NCT03349710|Nivolumab|nivolumab|mesh-list
6264792|NCT03349710|Cetuximab|cetuximab|mesh-list
6264793|NCT03349710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6264794|NCT03349710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6264795|NCT03349710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6264796|NCT03349710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264797|NCT03350217|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
6264798|NCT03350217|Plasma Substitutes|plasma substitutes|mesh-ancestor
6264799|NCT03350217|Blood Substitutes|blood substitutes|mesh-ancestor
6264800|NCT03351231|Nivolumab|nivolumab|mesh-list
6264801|NCT03351231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6264802|NCT03351231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6264803|NCT03351231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6264804|NCT03351231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390289|NCT00190645|Analgesics|analgesics|mesh-ancestor
6390290|NCT00190645|Sensory System Agents|sensory system agents|mesh-ancestor
6390291|NCT00190645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6390292|NCT00190645|Antidepressive Agents|antidepressive agents|mesh-ancestor
6390293|NCT00190645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6390294|NCT00190645|Dopamine Agents|dopamine agents|mesh-ancestor
6390295|NCT00190710|Gemcitabine|gemcitabine|mesh-list
6390296|NCT00190710|Carboplatin|carboplatin|mesh-list
6390297|NCT00190710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6390298|NCT00190710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6390299|NCT00190710|Antimetabolites|antimetabolites|mesh-ancestor
6390300|NCT00190710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390301|NCT00190710|Antiviral Agents|antiviral agents|mesh-ancestor
6390302|NCT00190710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6390303|NCT00190710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6390304|NCT00190710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6390305|NCT00190710|Immunologic Factors|immunologic factors|mesh-ancestor
6390306|NCT00190710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390307|NCT00190736|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6390308|NCT00190736|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6390309|NCT00190736|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6390310|NCT00190736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6390311|NCT00190736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390312|NCT00190736|Adrenergic Agents|adrenergic agents|mesh-ancestor
6390313|NCT00190736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6390314|NCT00190736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390315|NCT00190762|Pemetrexed|pemetrexed|mesh-list
6390316|NCT00190762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6390317|NCT00190762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6264805|NCT03351478|Empagliflozin|empagliflozin|mesh-list
6264806|NCT03351478|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
6264807|NCT03351478|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6264808|NCT03351478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264809|NCT03351478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6264810|NCT03351478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264811|NCT03351608|Atropine|atropine|mesh-list
6264812|NCT03351608|Glycopyrrolate|glycopyrrolate|mesh-list
6264813|NCT03351608|Neostigmine|neostigmine|mesh-list
6264814|NCT03351608|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6264815|NCT03351608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6264816|NCT03351608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6264817|NCT03351608|Autonomic Agents|autonomic agents|mesh-ancestor
6264818|NCT03351608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6264819|NCT03351608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264820|NCT03351608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6264821|NCT03351608|Respiratory System Agents|respiratory system agents|mesh-ancestor
6264822|NCT03351608|Mydriatics|mydriatics|mesh-ancestor
6264823|NCT03351608|Parasympatholytics|parasympatholytics|mesh-ancestor
6264824|NCT03351608|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6264825|NCT03351608|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6264826|NCT03351608|Cholinergic Agents|cholinergic agents|mesh-ancestor
6264827|NCT03351608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6264828|NCT03351608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264829|NCT03351608|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6264830|NCT03351608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6264831|NCT03351608|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6264832|NCT03351933|Immunoglobulins|immunoglobulins|mesh-list
6264833|NCT03351933|Antibodies|antibodies|mesh-list
6264834|NCT03351933|gamma-Globulins|gamma-globulins|mesh-list
6264835|NCT03351933|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6264836|NCT03351933|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6264837|NCT03351933|Immunologic Factors|immunologic factors|mesh-ancestor
6264838|NCT03351933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264839|NCT03352323|Phenylephrine|phenylephrine|mesh-list
6264840|NCT03352323|Oxymetazoline|oxymetazoline|mesh-list
6264841|NCT03352323|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6264842|NCT03352323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6264843|NCT03352323|Adrenergic Agents|adrenergic agents|mesh-ancestor
6264844|NCT03352323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6264845|NCT03352323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264846|NCT03352323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264847|NCT03352323|Sympathomimetics|sympathomimetics|mesh-ancestor
6264848|NCT03352323|Autonomic Agents|autonomic agents|mesh-ancestor
6264849|NCT03352323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6264850|NCT03352323|Nasal Decongestants|nasal decongestants|mesh-ancestor
6264851|NCT03352323|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6264852|NCT03352323|Respiratory System Agents|respiratory system agents|mesh-ancestor
6264853|NCT03352323|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6264854|NCT03352323|Mydriatics|mydriatics|mesh-ancestor
6264855|NCT03352323|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6264856|NCT03352323|Protective Agents|protective agents|mesh-ancestor
6264857|NCT03352414|Alvimopan|alvimopan|mesh-list
6264858|NCT03352414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6264859|NCT03353740|Edetic Acid|edetic acid|mesh-list
6264860|NCT03353740|Chelating Agents|chelating agents|mesh-ancestor
6264861|NCT03353740|Sequestering Agents|sequestering agents|mesh-ancestor
6264862|NCT03353740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264863|NCT03353740|Anticoagulants|anticoagulants|mesh-ancestor
6264864|NCT03353740|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6264865|NCT03354429|Ticagrelor|ticagrelor|mesh-list
6264866|NCT03354429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6264867|NCT03354429|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6264868|NCT03354429|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6264869|NCT03354429|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6264870|NCT03354429|Purinergic Agents|purinergic agents|mesh-ancestor
6264871|NCT03354429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6264872|NCT03354429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264873|NCT03354429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264874|NCT03354598|Ciprofloxacin|ciprofloxacin|mesh-list
6264875|NCT03354598|Probenecid|probenecid|mesh-list
6264876|NCT03354598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6264877|NCT03354598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6264878|NCT03354598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6264879|NCT03354598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6264880|NCT03354598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6264881|NCT03354598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264882|NCT03354598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6264883|NCT03354598|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6264884|NCT03354598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6264885|NCT03354598|Uricosuric Agents|uricosuric agents|mesh-ancestor
6264886|NCT03354598|Gout Suppressants|gout suppressants|mesh-ancestor
6264887|NCT03354598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6264888|NCT03354598|Renal Agents|renal agents|mesh-ancestor
6264889|NCT03355326|Glycerol|glycerol|mesh-list
6264890|NCT03355326|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6264891|NCT03355326|Protective Agents|protective agents|mesh-ancestor
6264892|NCT03355326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264893|NCT03355820|Antibodies|antibodies|mesh-list
6264894|NCT03355820|Immunologic Factors|immunologic factors|mesh-ancestor
6264895|NCT03355820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264896|NCT03357341|Albuterol|albuterol|mesh-list
6264897|NCT03357341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6264898|NCT03357341|Autonomic Agents|autonomic agents|mesh-ancestor
6264899|NCT03357341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6264900|NCT03357341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264901|NCT03357341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6264902|NCT03357341|Respiratory System Agents|respiratory system agents|mesh-ancestor
6264903|NCT03357341|Tocolytic Agents|tocolytic agents|mesh-ancestor
6264904|NCT03357341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6264905|NCT03357341|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6264906|NCT03357341|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6264907|NCT03357341|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6264908|NCT03357341|Adrenergic Agents|adrenergic agents|mesh-ancestor
6264909|NCT03357341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6264910|NCT03357341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264911|NCT03357393|Midazolam|midazolam|mesh-list
6264912|NCT03357393|Glycopyrrolate|glycopyrrolate|mesh-list
6264913|NCT03357393|Scopolamine|scopolamine|mesh-list
6264914|NCT03357393|Morphine|morphine|mesh-list
6264915|NCT03357393|Propofol|propofol|mesh-list
6264916|NCT03357393|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
6264917|NCT03357393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6264918|NCT03357393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6264919|NCT03357393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264920|NCT03357393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6264921|NCT03357393|Anesthetics, General|anesthetics, general|mesh-ancestor
6264922|NCT03357393|Anesthetics|anesthetics|mesh-ancestor
6264923|NCT03357393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6264924|NCT03357393|Narcotics|narcotics|mesh-ancestor
6264925|NCT03357393|Analgesics|analgesics|mesh-ancestor
6264926|NCT03357393|Sensory System Agents|sensory system agents|mesh-ancestor
6264927|NCT03357393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6264928|NCT03357393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6264929|NCT03357393|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6264930|NCT03357393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6264931|NCT03357393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6264932|NCT03357393|GABA Modulators|gaba modulators|mesh-ancestor
6264933|NCT03357393|GABA Agents|gaba agents|mesh-ancestor
6264934|NCT03357393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6264935|NCT03357393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264936|NCT03357393|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6264937|NCT03357393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6264938|NCT03357393|Cholinergic Agents|cholinergic agents|mesh-ancestor
6264939|NCT03357393|Antiemetics|antiemetics|mesh-ancestor
6264940|NCT03357393|Autonomic Agents|autonomic agents|mesh-ancestor
6264941|NCT03357393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6264942|NCT03357393|Mydriatics|mydriatics|mesh-ancestor
6264943|NCT03357393|Parasympatholytics|parasympatholytics|mesh-ancestor
6264944|NCT03357614|Amoxicillin|amoxicillin|mesh-list
6264945|NCT03357614|Ciprofloxacin|ciprofloxacin|mesh-list
6264946|NCT03357614|Clavulanic Acid|clavulanic acid|mesh-list
6264947|NCT03357614|Clavulanic Acids|clavulanic acids|mesh-list
6264948|NCT03357614|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6264949|NCT03357614|Ertapenem|ertapenem|mesh-list
6264950|NCT03357614|Lactams|lactams|mesh-list
6264951|NCT03357614|Probenecid|probenecid|mesh-list
6264952|NCT03357614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6264953|NCT03357614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6264954|NCT03357614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6264955|NCT03357614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6264956|NCT03357614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6264957|NCT03357614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264958|NCT03357614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6264959|NCT03357614|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6264960|NCT03357614|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6264961|NCT03357614|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6264962|NCT03357614|Uricosuric Agents|uricosuric agents|mesh-ancestor
6264963|NCT03357614|Gout Suppressants|gout suppressants|mesh-ancestor
6264964|NCT03357614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6264965|NCT03357614|Renal Agents|renal agents|mesh-ancestor
6264966|NCT03357731|Nitroglycerin|nitroglycerin|mesh-list
6264967|NCT03357731|Vasodilator Agents|vasodilator agents|mesh-ancestor
6264968|NCT03358147|Tiotropium Bromide|tiotropium bromide|mesh-list
6264969|NCT03358147|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6264970|NCT03358147|Autonomic Agents|autonomic agents|mesh-ancestor
6264971|NCT03358147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6264972|NCT03358147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264973|NCT03358147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6264974|NCT03358147|Respiratory System Agents|respiratory system agents|mesh-ancestor
6264975|NCT03358147|Parasympatholytics|parasympatholytics|mesh-ancestor
6264976|NCT03358147|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6264977|NCT03358147|Cholinergic Agents|cholinergic agents|mesh-ancestor
6264978|NCT03358147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6264979|NCT03358147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264980|NCT03358472|Carboplatin|carboplatin|mesh-list
6264981|NCT03358472|Fluorouracil|fluorouracil|mesh-list
6264982|NCT03358472|Pembrolizumab|pembrolizumab|mesh-list
6264983|NCT03358472|Cetuximab|cetuximab|mesh-list
6264984|NCT03358472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6264985|NCT03358472|Antimetabolites|antimetabolites|mesh-ancestor
6264986|NCT03358472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6264987|NCT03358472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6264988|NCT03358472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6264989|NCT03358472|Immunologic Factors|immunologic factors|mesh-ancestor
6264990|NCT03358472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6264991|NCT03358472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6264992|NCT03358576|Amoxicillin|amoxicillin|mesh-list
6264993|NCT03358576|Metronidazole|metronidazole|mesh-list
6264994|NCT03358576|Ciprofloxacin|ciprofloxacin|mesh-list
6264995|NCT03358576|Clavulanic Acid|clavulanic acid|mesh-list
6264996|NCT03358576|Clavulanic Acids|clavulanic acids|mesh-list
6264997|NCT03358576|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6264998|NCT03358576|Ertapenem|ertapenem|mesh-list
6264999|NCT03358576|Lactams|lactams|mesh-list
6265000|NCT03358576|Probenecid|probenecid|mesh-list
6265001|NCT03358576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6265002|NCT03358576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6265003|NCT03358576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6265004|NCT03358576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6265005|NCT03358576|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6265006|NCT03358576|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6265007|NCT03358576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6265008|NCT03358576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6265009|NCT03358576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6265010|NCT03358576|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6265011|NCT03358576|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6265012|NCT03358576|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6265013|NCT03358576|Uricosuric Agents|uricosuric agents|mesh-ancestor
6265014|NCT03358576|Gout Suppressants|gout suppressants|mesh-ancestor
6265015|NCT03358576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6265016|NCT03358576|Renal Agents|renal agents|mesh-ancestor
6265017|NCT03359395|Alfentanil|alfentanil|mesh-list
6265018|NCT03359395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6265019|NCT03359395|Narcotics|narcotics|mesh-ancestor
6265020|NCT03359395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6265021|NCT03359395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265022|NCT03359395|Analgesics|analgesics|mesh-ancestor
6265023|NCT03359395|Sensory System Agents|sensory system agents|mesh-ancestor
6265024|NCT03359395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6265025|NCT03359395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6265026|NCT03359395|Anesthetics, General|anesthetics, general|mesh-ancestor
6265027|NCT03359395|Anesthetics|anesthetics|mesh-ancestor
6265028|NCT03359473|GSK2881078|gsk2881078|mesh-list
6265029|NCT03359473|Anabolic Agents|anabolic agents|mesh-ancestor
6265030|NCT03359473|Hormones|hormones|mesh-ancestor
6265031|NCT03359473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6265032|NCT03359473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265033|NCT03359590|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6265034|NCT03359590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6265035|NCT03359590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265036|NCT03359590|Incretins|incretins|mesh-ancestor
6265037|NCT03359590|Hormones|hormones|mesh-ancestor
6265038|NCT03359590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6265039|NCT03359590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6265040|NCT03359590|Protease Inhibitors|protease inhibitors|mesh-ancestor
6265041|NCT03359590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6265042|NCT03359590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6265043|NCT03359850|Niraparib|niraparib|mesh-list
6265044|NCT03359850|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6265045|NCT03359850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6265046|NCT03359850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6265047|NCT03359850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6265048|NCT03360071|Immunologic Factors|immunologic factors|mesh-list
6265049|NCT03360071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265050|NCT03361176|Triamcinolone|triamcinolone|mesh-list
6265051|NCT03361176|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6265052|NCT03361176|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6265053|NCT03361176|Deoxycholic Acid|deoxycholic acid|mesh-list
6265054|NCT03361176|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6265055|NCT03361176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6265056|NCT03361176|Glucocorticoids|glucocorticoids|mesh-ancestor
6265057|NCT03361176|Hormones|hormones|mesh-ancestor
6265058|NCT03361176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6265059|NCT03361176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265060|NCT03361176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6265061|NCT03361176|Immunologic Factors|immunologic factors|mesh-ancestor
6265062|NCT03361176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6265063|NCT03361176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6265064|NCT03361176|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6265065|NCT03361176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6265066|NCT03361605|Propofol|propofol|mesh-list
6265067|NCT03361605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6265068|NCT03361605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6265069|NCT03361605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265070|NCT03361605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6265071|NCT03361605|Anesthetics, General|anesthetics, general|mesh-ancestor
6265072|NCT03361605|Anesthetics|anesthetics|mesh-ancestor
6265073|NCT03363776|Nivolumab|nivolumab|mesh-list
6265074|NCT03363776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6265075|NCT03363776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6265076|NCT03363776|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6265077|NCT03363776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6265078|NCT03363906|Dulaglutide|dulaglutide|mesh-list
6265079|NCT03363906|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
6265080|NCT03363906|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6265081|NCT03363906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265082|NCT03363906|Immunologic Factors|immunologic factors|mesh-ancestor
6265083|NCT03364036|Cladribine|cladribine|mesh-list
6265084|NCT03364036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6265085|NCT03364036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6265086|NCT03364036|Immunologic Factors|immunologic factors|mesh-ancestor
6265087|NCT03364036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265088|NCT03364049|Pembrolizumab|pembrolizumab|mesh-list
6265089|NCT03364049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6265090|NCT03364049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6265091|NCT03364309|Ixekizumab|ixekizumab|mesh-list
6265092|NCT03364309|Dermatologic Agents|dermatologic agents|mesh-ancestor
6265093|NCT03364608|Albuterol|albuterol|mesh-list
6265094|NCT03364608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6265095|NCT03364608|Autonomic Agents|autonomic agents|mesh-ancestor
6265096|NCT03364608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6265097|NCT03364608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265098|NCT03364608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6265099|NCT03364608|Respiratory System Agents|respiratory system agents|mesh-ancestor
6265100|NCT03364608|Tocolytic Agents|tocolytic agents|mesh-ancestor
6265101|NCT03364608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6265102|NCT03364608|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6265103|NCT03364608|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6265104|NCT03364608|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6265105|NCT03364608|Adrenergic Agents|adrenergic agents|mesh-ancestor
6265106|NCT03364608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6265107|NCT03364608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6265108|NCT03365011|Nitrous Oxide|nitrous oxide|mesh-list
6265109|NCT03365011|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6265110|NCT03365011|Anesthetics, General|anesthetics, general|mesh-ancestor
6265111|NCT03365011|Anesthetics|anesthetics|mesh-ancestor
6265112|NCT03365011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6265113|NCT03365011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265114|NCT03365011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6265115|NCT03365011|Analgesics|analgesics|mesh-ancestor
6265116|NCT03365011|Sensory System Agents|sensory system agents|mesh-ancestor
6265117|NCT03365011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6265118|NCT03365934|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6265119|NCT03365934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6265120|NCT03366207|Ciprofloxacin|ciprofloxacin|mesh-list
6265121|NCT03366207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6265122|NCT03366207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6265123|NCT03366207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6265124|NCT03366207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6265125|NCT03366207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6265126|NCT03366207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6265127|NCT03366207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6265128|NCT03366207|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6265129|NCT03366207|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6265130|NCT03366298|Epinephrine|epinephrine|mesh-list
6265131|NCT03366298|Racepinephrine|racepinephrine|mesh-list
6265132|NCT03366298|Epinephryl borate|epinephryl borate|mesh-list
6265133|NCT03366298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6265134|NCT03366298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6265135|NCT03366298|Adrenergic Agents|adrenergic agents|mesh-ancestor
6265136|NCT03366298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6265137|NCT03366298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6265138|NCT03366298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265139|NCT03366298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6265140|NCT03366298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6265141|NCT03366298|Autonomic Agents|autonomic agents|mesh-ancestor
6265142|NCT03366298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6265143|NCT03366298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6265144|NCT03366298|Respiratory System Agents|respiratory system agents|mesh-ancestor
6265145|NCT03366298|Mydriatics|mydriatics|mesh-ancestor
6265146|NCT03366298|Sympathomimetics|sympathomimetics|mesh-ancestor
6265147|NCT03366298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6265148|NCT03367793|Metronidazole|metronidazole|mesh-list
6265149|NCT03367793|Methamphetamine|methamphetamine|mesh-list
6265150|NCT03367793|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6265151|NCT03367793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265152|NCT03367793|Sympathomimetics|sympathomimetics|mesh-ancestor
6265153|NCT03367793|Autonomic Agents|autonomic agents|mesh-ancestor
6265154|NCT03367793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6265155|NCT03367793|Dopamine Agents|dopamine agents|mesh-ancestor
6265156|NCT03367793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6265157|NCT03367793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6265158|NCT03367793|Adrenergic Agents|adrenergic agents|mesh-ancestor
6265159|NCT03367793|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6265160|NCT03367793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6265161|NCT03367793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6265162|NCT03367793|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6265163|NCT03367793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6265164|NCT03367793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6265165|NCT03367793|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6265166|NCT03367793|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6265167|NCT03368235|Prednisolone|prednisolone|mesh-list
6265168|NCT03368235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6265169|NCT03368235|Glucocorticoids|glucocorticoids|mesh-ancestor
6265170|NCT03368235|Hormones|hormones|mesh-ancestor
6265171|NCT03368235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6265172|NCT03368235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265173|NCT03368235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6265174|NCT03368235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6265175|NCT03368807|Insulin Lispro|insulin lispro|mesh-list
6265176|NCT03368807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6265177|NCT03368807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265178|NCT03368859|Leucovorin|leucovorin|mesh-list
6265179|NCT03368859|Bevacizumab|bevacizumab|mesh-list
6265180|NCT03368859|Fluorouracil|fluorouracil|mesh-list
6265181|NCT03368859|Irinotecan|irinotecan|mesh-list
6265182|NCT03368859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6265183|NCT03368859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6265184|NCT03368859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6265185|NCT03368859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6265186|NCT03368859|Growth Substances|growth substances|mesh-ancestor
6265187|NCT03368859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265188|NCT03368859|Growth Inhibitors|growth inhibitors|mesh-ancestor
6265189|NCT03368859|Antimetabolites|antimetabolites|mesh-ancestor
6265190|NCT03368859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6265191|NCT03368859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6265192|NCT03368859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6265193|NCT03368859|Immunologic Factors|immunologic factors|mesh-ancestor
6265194|NCT03368859|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6265195|NCT03368859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6265196|NCT03368859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6265197|NCT03368859|Antidotes|antidotes|mesh-ancestor
6265198|NCT03368859|Protective Agents|protective agents|mesh-ancestor
6265199|NCT03368859|Vitamin B Complex|vitamin b complex|mesh-ancestor
6265200|NCT03368859|Vitamins|vitamins|mesh-ancestor
6265201|NCT03368859|Micronutrients|micronutrients|mesh-ancestor
6265202|NCT03369704|Omalizumab|omalizumab|mesh-list
6265203|NCT03369704|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6265204|NCT03369704|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6265205|NCT03369704|Respiratory System Agents|respiratory system agents|mesh-ancestor
6265206|NCT03369951|Minocycline|minocycline|mesh-list
6265207|NCT03369951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6265208|NCT03369951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6265209|NCT03370289|Vaccines|vaccines|mesh-list
6265210|NCT03370289|Immunologic Factors|immunologic factors|mesh-ancestor
6265211|NCT03370289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390318|NCT00190762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390319|NCT00190762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6390320|NCT00190762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6390321|NCT00190788|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
6390322|NCT00190788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6390323|NCT00190801|Pemetrexed|pemetrexed|mesh-list
6390324|NCT00190801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6390325|NCT00190801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6390326|NCT00190801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390327|NCT00190801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6390328|NCT00190801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6390329|NCT00190814|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6390330|NCT00190814|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6390331|NCT00190814|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6390332|NCT00190814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6390333|NCT00190814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390334|NCT00190814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6390335|NCT00190814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390336|NCT00190814|Analgesics|analgesics|mesh-ancestor
6390337|NCT00190814|Sensory System Agents|sensory system agents|mesh-ancestor
6390338|NCT00190814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6390339|NCT00190814|Antidepressive Agents|antidepressive agents|mesh-ancestor
6390340|NCT00190814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6390341|NCT00190814|Dopamine Agents|dopamine agents|mesh-ancestor
6390342|NCT00190827|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6390343|NCT00190827|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6390344|NCT00190827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6390345|NCT00190827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6265212|NCT03370770|Afatinib|afatinib|mesh-list
6265213|NCT03370770|Osimertinib|osimertinib|mesh-list
6265214|NCT03370770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6265215|NCT03370770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6265216|NCT03370770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6265217|NCT03370770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6265218|NCT03371381|Nivolumab|nivolumab|mesh-list
6265219|NCT03371381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6265220|NCT03371381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6265221|NCT03371381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6265222|NCT03371381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6265223|NCT03371459|Albuterol|albuterol|mesh-list
6265224|NCT03371459|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6265225|NCT03371459|Autonomic Agents|autonomic agents|mesh-ancestor
6265226|NCT03371459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6265227|NCT03371459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265228|NCT03371459|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6265229|NCT03371459|Respiratory System Agents|respiratory system agents|mesh-ancestor
6265230|NCT03371459|Tocolytic Agents|tocolytic agents|mesh-ancestor
6265231|NCT03371459|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6265232|NCT03371459|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6265233|NCT03371459|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6265234|NCT03371459|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6265235|NCT03371459|Adrenergic Agents|adrenergic agents|mesh-ancestor
6265236|NCT03371459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6265237|NCT03371459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6265238|NCT03371836|Clobazam|clobazam|mesh-list
6265239|NCT03371836|Anticonvulsants|anticonvulsants|mesh-ancestor
6265240|NCT03371836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6265241|NCT03371836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6265242|NCT03371836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6265243|NCT03371836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265244|NCT03371836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6265245|NCT03371836|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6265246|NCT03371836|GABA Agonists|gaba agonists|mesh-ancestor
6265247|NCT03371836|GABA Agents|gaba agents|mesh-ancestor
6265248|NCT03371836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6265249|NCT03371836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6265250|NCT03372083|Deferasirox|deferasirox|mesh-list
6265251|NCT03372083|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6265252|NCT03372083|Chelating Agents|chelating agents|mesh-ancestor
6265253|NCT03372083|Sequestering Agents|sequestering agents|mesh-ancestor
6265254|NCT03372083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6265255|NCT03372382|Acetaminophen|acetaminophen|mesh-list
6265256|NCT03372382|Ibuprofen|ibuprofen|mesh-list
6265257|NCT03372382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6265258|NCT03372382|Analgesics|analgesics|mesh-ancestor
6265259|NCT03372382|Sensory System Agents|sensory system agents|mesh-ancestor
6265260|NCT03372382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6265261|NCT03372382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265262|NCT03372382|Antipyretics|antipyretics|mesh-ancestor
6265263|NCT03372382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6265264|NCT03372382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6265265|NCT03372382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6265266|NCT03372382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6265267|NCT03372382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6265268|NCT03372382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6265269|NCT03373162|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6265270|NCT03373162|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6265271|NCT03373162|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6265272|NCT03373162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6265273|NCT03373162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265274|NCT03373162|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6265275|NCT03373162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6265276|NCT03373162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6265277|NCT03373162|Cholinergic Agents|cholinergic agents|mesh-ancestor
6265278|NCT03373162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6265279|NCT03373591|Bupivacaine|bupivacaine|mesh-list
6265280|NCT03373591|Anesthetics, Local|anesthetics, local|mesh-ancestor
6265281|NCT03373591|Anesthetics|anesthetics|mesh-ancestor
6265282|NCT03373591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6265283|NCT03373591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265284|NCT03373591|Sensory System Agents|sensory system agents|mesh-ancestor
6265285|NCT03373591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6265286|NCT03374176|Amoxicillin|amoxicillin|mesh-list
6265287|NCT03374176|Metronidazole|metronidazole|mesh-list
6265288|NCT03374176|Clindamycin|clindamycin|mesh-list
6265289|NCT03374176|Clindamycin palmitate|clindamycin palmitate|mesh-list
6265290|NCT03374176|Clindamycin phosphate|clindamycin phosphate|mesh-list
6265291|NCT03374176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6265292|NCT03374176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6265293|NCT03374176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6265294|NCT03374176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6265295|NCT03374176|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6265296|NCT03374176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6265297|NCT03374176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6265298|NCT03374358|Raltegravir Potassium|raltegravir potassium|mesh-list
6265299|NCT03374358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6265300|NCT03374358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6265301|NCT03374358|Antiviral Agents|antiviral agents|mesh-ancestor
6265302|NCT03374358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6265303|NCT03374358|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6265304|NCT03374358|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6265305|NCT03374358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6265306|NCT03374358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6265307|NCT03374488|Pembrolizumab|pembrolizumab|mesh-list
6265308|NCT03374488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6265309|NCT03374488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6265310|NCT03375294|Nitrous Oxide|nitrous oxide|mesh-list
6265311|NCT03375294|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6265312|NCT03375294|Anesthetics, General|anesthetics, general|mesh-ancestor
6265313|NCT03375294|Anesthetics|anesthetics|mesh-ancestor
6265314|NCT03375294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6265315|NCT03375294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265316|NCT03375294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6265317|NCT03375294|Analgesics|analgesics|mesh-ancestor
6265318|NCT03375294|Sensory System Agents|sensory system agents|mesh-ancestor
6265319|NCT03375294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6265320|NCT03376061|Tranexamic Acid|tranexamic acid|mesh-list
6265321|NCT03376061|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6265322|NCT03376061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6265323|NCT03376061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6265324|NCT03376061|Hemostatics|hemostatics|mesh-ancestor
6265325|NCT03376061|Coagulants|coagulants|mesh-ancestor
6265326|NCT03376295|Tiotropium Bromide|tiotropium bromide|mesh-list
6265327|NCT03376295|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6265328|NCT03376295|Autonomic Agents|autonomic agents|mesh-ancestor
6265329|NCT03376295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6265330|NCT03376295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265331|NCT03376295|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6265332|NCT03376295|Respiratory System Agents|respiratory system agents|mesh-ancestor
6265333|NCT03376295|Parasympatholytics|parasympatholytics|mesh-ancestor
6265334|NCT03376295|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6265335|NCT03376295|Cholinergic Agents|cholinergic agents|mesh-ancestor
6265336|NCT03376295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6265337|NCT03376295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6265338|NCT03377556|Talazoparib|talazoparib|mesh-list
6265339|NCT03377556|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6265340|NCT03377556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6265341|NCT03377556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6265342|NCT03377556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6265343|NCT03378076|Triamcinolone|triamcinolone|mesh-list
6265344|NCT03378076|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6265345|NCT03378076|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6265346|NCT03378076|FX006|fx006|mesh-list
6265347|NCT03378076|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6265348|NCT03378076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6265349|NCT03378076|Glucocorticoids|glucocorticoids|mesh-ancestor
6265350|NCT03378076|Hormones|hormones|mesh-ancestor
6265351|NCT03378076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6265352|NCT03378076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265353|NCT03378076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6265354|NCT03378076|Immunologic Factors|immunologic factors|mesh-ancestor
6265355|NCT03378076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6265356|NCT03378076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6265357|NCT03378635|Glucagon|glucagon|mesh-list
6265358|NCT03378635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6265359|NCT03378635|Hormones|hormones|mesh-ancestor
6265360|NCT03378635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6265361|NCT03378635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265362|NCT03378973|Dexmedetomidine|dexmedetomidine|mesh-list
6265363|NCT03378973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6265364|NCT03378973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6265365|NCT03378973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265366|NCT03378973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6265367|NCT03378973|Analgesics|analgesics|mesh-ancestor
6265368|NCT03378973|Sensory System Agents|sensory system agents|mesh-ancestor
6265369|NCT03378973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6265370|NCT03378973|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6265371|NCT03378973|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6265372|NCT03378973|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6265373|NCT03378973|Adrenergic Agents|adrenergic agents|mesh-ancestor
6265374|NCT03378973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6265375|NCT03378973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6265376|NCT03379506|Grazoprevir|grazoprevir|mesh-list
6265377|NCT03379506|Antiviral Agents|antiviral agents|mesh-ancestor
6265378|NCT03379506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6265379|NCT03380026|Triamcinolone|triamcinolone|mesh-list
6265380|NCT03380026|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6265381|NCT03380026|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6265382|NCT03380026|Mechlorethamine|mechlorethamine|mesh-list
6265383|NCT03380026|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6265384|NCT03380026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6265385|NCT03380026|Glucocorticoids|glucocorticoids|mesh-ancestor
6265386|NCT03380026|Hormones|hormones|mesh-ancestor
6265387|NCT03380026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6265388|NCT03380026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265389|NCT03380026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6265390|NCT03380026|Immunologic Factors|immunologic factors|mesh-ancestor
6265391|NCT03380026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6265392|NCT03380026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6265393|NCT03380026|Alkylating Agents|alkylating agents|mesh-ancestor
6265394|NCT03380026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6265395|NCT03380026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6265396|NCT03380091|Vitamin D|vitamin d|mesh-list
6265397|NCT03380091|Cholecalciferol|cholecalciferol|mesh-list
6265398|NCT03380091|Metformin|metformin|mesh-list
6265399|NCT03380091|Vitamins|vitamins|mesh-ancestor
6265400|NCT03380091|Micronutrients|micronutrients|mesh-ancestor
6265401|NCT03380091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265402|NCT03380091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6265403|NCT03380091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6265404|NCT03380091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6265405|NCT03380390|Phenylephrine|phenylephrine|mesh-list
6265406|NCT03380390|Oxymetazoline|oxymetazoline|mesh-list
6265407|NCT03380390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6265408|NCT03380390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6265409|NCT03380390|Adrenergic Agents|adrenergic agents|mesh-ancestor
6265410|NCT03380390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6265411|NCT03380390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6265412|NCT03380390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265413|NCT03380390|Sympathomimetics|sympathomimetics|mesh-ancestor
6265414|NCT03380390|Autonomic Agents|autonomic agents|mesh-ancestor
6265415|NCT03380390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6265416|NCT03380390|Nasal Decongestants|nasal decongestants|mesh-ancestor
6265417|NCT03380390|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6265418|NCT03380390|Respiratory System Agents|respiratory system agents|mesh-ancestor
6265419|NCT03380390|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6265420|NCT03380390|Mydriatics|mydriatics|mesh-ancestor
6265421|NCT03380390|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6265422|NCT03380390|Protective Agents|protective agents|mesh-ancestor
6265423|NCT03380429|Albuterol|albuterol|mesh-list
6265424|NCT03380429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6265425|NCT03380429|Autonomic Agents|autonomic agents|mesh-ancestor
6265426|NCT03380429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6265427|NCT03380429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265428|NCT03380429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6265429|NCT03380429|Respiratory System Agents|respiratory system agents|mesh-ancestor
6265430|NCT03380429|Tocolytic Agents|tocolytic agents|mesh-ancestor
6265431|NCT03380429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6265432|NCT03380429|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6265433|NCT03380429|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6265434|NCT03380429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6265435|NCT03380429|Adrenergic Agents|adrenergic agents|mesh-ancestor
6265436|NCT03380429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6265437|NCT03380429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6265438|NCT03381248|Hyaluronic Acid|hyaluronic acid|mesh-list
6265439|NCT03381248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6265440|NCT03381248|Immunologic Factors|immunologic factors|mesh-ancestor
6265441|NCT03381248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265442|NCT03381248|Viscosupplements|viscosupplements|mesh-ancestor
6265443|NCT03381248|Protective Agents|protective agents|mesh-ancestor
6265444|NCT03381742|Clopidogrel|clopidogrel|mesh-list
6265445|NCT03381742|Ticagrelor|ticagrelor|mesh-list
6265446|NCT03381742|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6265447|NCT03381742|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6265448|NCT03381742|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6265449|NCT03381742|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6265450|NCT03381742|Purinergic Agents|purinergic agents|mesh-ancestor
6265451|NCT03381742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6265452|NCT03381742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6265453|NCT03381742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265454|NCT03382262|Triamcinolone|triamcinolone|mesh-list
6265455|NCT03382262|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6265456|NCT03382262|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6265457|NCT03382262|FX006|fx006|mesh-list
6265458|NCT03382262|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6265459|NCT03382262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6265460|NCT03382262|Glucocorticoids|glucocorticoids|mesh-ancestor
6265461|NCT03382262|Hormones|hormones|mesh-ancestor
6265462|NCT03382262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6265463|NCT03382262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265464|NCT03382262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6265465|NCT03382262|Immunologic Factors|immunologic factors|mesh-ancestor
6265466|NCT03382262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6265467|NCT03382262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6265468|NCT03382418|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6265469|NCT03382418|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6265470|NCT03382418|Immunologic Factors|immunologic factors|mesh-ancestor
6265471|NCT03382418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265472|NCT03382418|Antacids|antacids|mesh-ancestor
6265473|NCT03382418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6265474|NCT03382418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6265475|NCT03382821|Dexamethasone|dexamethasone|mesh-list
6265476|NCT03382821|Dexamethasone acetate|dexamethasone acetate|mesh-list
6265477|NCT03382821|Triamcinolone|triamcinolone|mesh-list
6265478|NCT03382821|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6265479|NCT03382821|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6265480|NCT03382821|Lidocaine|lidocaine|mesh-list
6265481|NCT03382821|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
6265482|NCT03382821|BB 1101|bb 1101|mesh-list
6265483|NCT03382821|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6265484|NCT03382821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6265485|NCT03382821|Antiemetics|antiemetics|mesh-ancestor
6265486|NCT03382821|Autonomic Agents|autonomic agents|mesh-ancestor
6265487|NCT03382821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6265488|NCT03382821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265489|NCT03382821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6265490|NCT03382821|Glucocorticoids|glucocorticoids|mesh-ancestor
6265491|NCT03382821|Hormones|hormones|mesh-ancestor
6265492|NCT03382821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6265493|NCT03382821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6265494|NCT03382821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6265495|NCT03382821|Protease Inhibitors|protease inhibitors|mesh-ancestor
6265496|NCT03382821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6265497|NCT03382821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014713|NCT00352846|Calcium Carbonate|calcium carbonate|mesh-list
6014714|NCT00352846|Calcium|calcium|mesh-list
6014715|NCT00352846|Vitamins|vitamins|mesh-ancestor
6014716|NCT00352846|Micronutrients|micronutrients|mesh-ancestor
6014717|NCT00352846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014718|NCT00352846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6014719|NCT00352846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6265498|NCT03382821|Anesthetics, Local|anesthetics, local|mesh-ancestor
6265499|NCT03382821|Anesthetics|anesthetics|mesh-ancestor
6265500|NCT03382821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6265501|NCT03382821|Sensory System Agents|sensory system agents|mesh-ancestor
6265502|NCT03382821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6265503|NCT03382821|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6265504|NCT03382821|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6265505|NCT03382821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6265506|NCT03382821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6265507|NCT03382821|Immunologic Factors|immunologic factors|mesh-ancestor
6265508|NCT03382899|Pembrolizumab|pembrolizumab|mesh-list
6014720|NCT00352846|Antacids|antacids|mesh-ancestor
6018470|NCT00381004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265509|NCT03382899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6265510|NCT03382899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6265511|NCT03382912|Nivolumab|nivolumab|mesh-list
6265512|NCT03382912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6265513|NCT03382912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6265514|NCT03382912|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6265515|NCT03382912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6265516|NCT03383198|Bupivacaine|bupivacaine|mesh-list
6265517|NCT03383198|Anesthetics, Local|anesthetics, local|mesh-ancestor
6265518|NCT03383198|Anesthetics|anesthetics|mesh-ancestor
6265519|NCT03383198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6265520|NCT03383198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265521|NCT03383198|Sensory System Agents|sensory system agents|mesh-ancestor
6265522|NCT03383198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6265523|NCT03383523|Praziquantel|praziquantel|mesh-list
6265524|NCT03383523|Emodepside|emodepside|mesh-list
6265525|NCT03383523|Toltrazuril|toltrazuril|mesh-list
6265526|NCT03383523|Anthelmintics|anthelmintics|mesh-ancestor
6265527|NCT03383523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6265528|NCT03383523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6265529|NCT03383523|Coccidiostats|coccidiostats|mesh-ancestor
6265530|NCT03383523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6265531|NCT03383588|Epinephrine|epinephrine|mesh-list
6265532|NCT03383588|Fentanyl|fentanyl|mesh-list
6265533|NCT03383588|Morphine|morphine|mesh-list
6265534|NCT03383588|Bupivacaine|bupivacaine|mesh-list
6265535|NCT03383588|Anesthetics, Local|anesthetics, local|mesh-ancestor
6265536|NCT03383588|Anesthetics|anesthetics|mesh-ancestor
6265537|NCT03383588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6265538|NCT03383588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265539|NCT03383588|Sensory System Agents|sensory system agents|mesh-ancestor
6265540|NCT03383588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6265541|NCT03383588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6265542|NCT03383588|Narcotics|narcotics|mesh-ancestor
6265543|NCT03383588|Analgesics|analgesics|mesh-ancestor
6265544|NCT03383588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6265545|NCT03383588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6265546|NCT03383588|Anesthetics, General|anesthetics, general|mesh-ancestor
6265547|NCT03383588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6265548|NCT03383588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6265549|NCT03383588|Adrenergic Agents|adrenergic agents|mesh-ancestor
6265550|NCT03383588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6265551|NCT03383588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6265552|NCT03383588|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6265553|NCT03383588|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6265554|NCT03383588|Autonomic Agents|autonomic agents|mesh-ancestor
6265555|NCT03383588|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6265556|NCT03383588|Respiratory System Agents|respiratory system agents|mesh-ancestor
6265557|NCT03383588|Mydriatics|mydriatics|mesh-ancestor
6265558|NCT03383588|Sympathomimetics|sympathomimetics|mesh-ancestor
6265559|NCT03383588|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6265560|NCT03383614|Emodepside|emodepside|mesh-list
6265561|NCT03383614|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6265562|NCT03383614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6265563|NCT03383692|Ritonavir|ritonavir|mesh-list
6265564|NCT03383692|Itraconazole|itraconazole|mesh-list
6265565|NCT03383692|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6265566|NCT03383692|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6265567|NCT03383692|Protease Inhibitors|protease inhibitors|mesh-ancestor
6265568|NCT03383692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6265569|NCT03383692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6265570|NCT03383692|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6265571|NCT03383692|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6265572|NCT03383692|Antiviral Agents|antiviral agents|mesh-ancestor
6265573|NCT03383692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6265574|NCT03383692|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6265575|NCT03383692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6265576|NCT03383692|Antifungal Agents|antifungal agents|mesh-ancestor
6265577|NCT03383692|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6265578|NCT03383692|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6265579|NCT03383692|Hormone Antagonists|hormone antagonists|mesh-ancestor
6265580|NCT03383692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6265581|NCT03383692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265582|NCT03383783|Listerine|listerine|mesh-list
6265583|NCT03383783|Fluorides|fluorides|mesh-list
6265584|NCT03383783|Sodium Fluoride|sodium fluoride|mesh-list
6265585|NCT03383783|Cariostatic Agents|cariostatic agents|mesh-ancestor
6265586|NCT03383783|Protective Agents|protective agents|mesh-ancestor
6265587|NCT03383783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265588|NCT03383783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6265589|NCT03383783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6265590|NCT03384316|Vaccines|vaccines|mesh-list
6265591|NCT03384316|Immunologic Factors|immunologic factors|mesh-ancestor
6265592|NCT03384316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265593|NCT03384329|Resveratrol|resveratrol|mesh-list
6265594|NCT03384329|Antioxidants|antioxidants|mesh-ancestor
6265595|NCT03384329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6265596|NCT03384329|Protective Agents|protective agents|mesh-ancestor
6265597|NCT03384329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265598|NCT03384329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6265599|NCT03384329|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6265600|NCT03384693|Defibrotide|defibrotide|mesh-list
6265601|NCT03384693|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6265602|NCT03384693|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6265603|NCT03384693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6265604|NCT03384693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6265605|NCT03384940|Trastuzumab|trastuzumab|mesh-list
6265606|NCT03384940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6265607|NCT03384940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6265608|NCT03386032|Desonide|desonide|mesh-list
6265609|NCT03386032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6265610|NCT03386344|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
6265611|NCT03386344|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6265612|NCT03386344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6265613|NCT03386344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6265614|NCT03386344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265615|NCT03386448|Scopolamine|scopolamine|mesh-list
6265616|NCT03386448|Naltrexone|naltrexone|mesh-list
6265617|NCT03386448|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
6265618|NCT03386448|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6265619|NCT03386448|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6265620|NCT03386448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265621|NCT03386448|Sensory System Agents|sensory system agents|mesh-ancestor
6265622|NCT03386448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6265623|NCT03386448|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6265624|NCT03386448|Antiemetics|antiemetics|mesh-ancestor
6265625|NCT03386448|Autonomic Agents|autonomic agents|mesh-ancestor
6265626|NCT03386448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6265627|NCT03386448|Mydriatics|mydriatics|mesh-ancestor
6265628|NCT03386448|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6265629|NCT03386448|Cholinergic Agents|cholinergic agents|mesh-ancestor
6265630|NCT03386448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6265631|NCT03386448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6265632|NCT03386448|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6265633|NCT03386448|Parasympatholytics|parasympatholytics|mesh-ancestor
6265634|NCT03386474|Aflibercept|aflibercept|mesh-list
6265635|NCT03386474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6265636|NCT03386474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6265637|NCT03386474|Growth Substances|growth substances|mesh-ancestor
6265638|NCT03386474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265639|NCT03386474|Growth Inhibitors|growth inhibitors|mesh-ancestor
6265640|NCT03386474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6265641|NCT03387020|Everolimus|everolimus|mesh-list
6265642|NCT03387020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6265643|NCT03387020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6265644|NCT03387020|Immunologic Factors|immunologic factors|mesh-ancestor
6014721|NCT00352846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014722|NCT00352846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6014723|NCT00352885|Citalopram|citalopram|mesh-list
6014724|NCT00352885|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6014725|NCT00352885|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6014726|NCT00352885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6014727|NCT00352885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6265645|NCT03387020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265646|NCT03387046|Methylprednisolone|methylprednisolone|mesh-list
6265647|NCT03387046|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6265648|NCT03387046|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6265649|NCT03387046|Prednisolone|prednisolone|mesh-list
6014728|NCT00352885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6014729|NCT00352885|Serotonin Agents|serotonin agents|mesh-ancestor
6014730|NCT00352885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014731|NCT00352885|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6014732|NCT00352885|Antidepressive Agents|antidepressive agents|mesh-ancestor
6014733|NCT00352885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6014734|NCT00352911|Mifepristone|mifepristone|mesh-list
6014735|NCT00352911|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6014736|NCT00352911|Abortifacient Agents|abortifacient agents|mesh-ancestor
6014737|NCT00352911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6265650|NCT03387046|Prednisolone acetate|prednisolone acetate|mesh-list
6265651|NCT03387046|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6265652|NCT03387046|Prednisolone phosphate|prednisolone phosphate|mesh-list
6265653|NCT03387046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6265654|NCT03387046|Antiemetics|antiemetics|mesh-ancestor
6265655|NCT03387046|Autonomic Agents|autonomic agents|mesh-ancestor
6265656|NCT03387046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6265657|NCT03387046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265658|NCT03387046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6265659|NCT03387046|Glucocorticoids|glucocorticoids|mesh-ancestor
6265660|NCT03387046|Hormones|hormones|mesh-ancestor
6265661|NCT03387046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6265662|NCT03387046|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6265663|NCT03387046|Protective Agents|protective agents|mesh-ancestor
6265664|NCT03387046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6265665|NCT03387046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6265666|NCT03387462|Tenofovir|tenofovir|mesh-list
6265667|NCT03387462|Emtricitabine|emtricitabine|mesh-list
6265668|NCT03387462|Antiviral Agents|antiviral agents|mesh-ancestor
6265669|NCT03387462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6265670|NCT03387462|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6265671|NCT03387462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6265672|NCT03387462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6265673|NCT03387462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6265674|NCT03387462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6265675|NCT03387462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6390346|NCT00190827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390347|NCT00190827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6390348|NCT00190827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390349|NCT00190827|Analgesics|analgesics|mesh-ancestor
6390350|NCT00190827|Sensory System Agents|sensory system agents|mesh-ancestor
6390351|NCT00190827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6390352|NCT00190827|Antidepressive Agents|antidepressive agents|mesh-ancestor
6390353|NCT00190827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6390354|NCT00190827|Dopamine Agents|dopamine agents|mesh-ancestor
6390355|NCT00190840|Pemetrexed|pemetrexed|mesh-list
6390356|NCT00190840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6390357|NCT00190840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6390358|NCT00190840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390359|NCT00190840|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6390360|NCT00190840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6390361|NCT00190853|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6390362|NCT00190853|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6390363|NCT00190853|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6390364|NCT00190853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6390365|NCT00190853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390366|NCT00190853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6390367|NCT00190853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390368|NCT00190853|Analgesics|analgesics|mesh-ancestor
6390369|NCT00190853|Sensory System Agents|sensory system agents|mesh-ancestor
6390370|NCT00190853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6390371|NCT00190853|Antidepressive Agents|antidepressive agents|mesh-ancestor
6390372|NCT00190853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6390373|NCT00190853|Dopamine Agents|dopamine agents|mesh-ancestor
6390374|NCT00190866|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6390375|NCT00190866|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6390376|NCT00190866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6390377|NCT00190866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6018471|NCT00381004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6265676|NCT03387683|Dapagliflozin|dapagliflozin|mesh-list
6265677|NCT03387683|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6265678|NCT03387683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6265679|NCT03387683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6265680|NCT03387683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265681|NCT03388008|Mycophenolic Acid|mycophenolic acid|mesh-list
6265682|NCT03388008|Prednisone|prednisone|mesh-list
6265683|NCT03388008|Methylprednisolone|methylprednisolone|mesh-list
6265684|NCT03388008|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6265685|NCT03388008|Abatacept|abatacept|mesh-list
6265686|NCT03388008|Tacrolimus|tacrolimus|mesh-list
6265687|NCT03388008|Thymoglobulin|thymoglobulin|mesh-list
6265688|NCT03388008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6265689|NCT03388008|Glucocorticoids|glucocorticoids|mesh-ancestor
6265690|NCT03388008|Hormones|hormones|mesh-ancestor
6265691|NCT03388008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6265692|NCT03388008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265693|NCT03388008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6265694|NCT03388008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6265695|NCT03388008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6265696|NCT03388008|Immunologic Factors|immunologic factors|mesh-ancestor
6265697|NCT03388008|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6265698|NCT03388008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6265699|NCT03388008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6265700|NCT03388008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6265701|NCT03388008|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6265702|NCT03388008|Antitubercular Agents|antitubercular agents|mesh-ancestor
6265703|NCT03388008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6265704|NCT03388008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6265705|NCT03388008|Antiemetics|antiemetics|mesh-ancestor
6265706|NCT03388008|Autonomic Agents|autonomic agents|mesh-ancestor
6265707|NCT03388008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6265708|NCT03388008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6265709|NCT03388008|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6265710|NCT03388008|Protective Agents|protective agents|mesh-ancestor
6265711|NCT03388008|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6265712|NCT03388008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6265713|NCT03388164|Dexetimide|dexetimide|mesh-list
6265714|NCT03388164|Citalopram|citalopram|mesh-list
6265715|NCT03388164|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6265716|NCT03388164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6265717|NCT03388164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6265718|NCT03388164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6265719|NCT03388164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6265720|NCT03388164|Serotonin Agents|serotonin agents|mesh-ancestor
6265721|NCT03388164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265722|NCT03388164|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6265723|NCT03388164|Antidepressive Agents|antidepressive agents|mesh-ancestor
6265724|NCT03388164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6265725|NCT03388164|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6265726|NCT03388164|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6265727|NCT03388164|Parasympatholytics|parasympatholytics|mesh-ancestor
6265728|NCT03388164|Autonomic Agents|autonomic agents|mesh-ancestor
6265729|NCT03388164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6265730|NCT03388164|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6265731|NCT03388164|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6265732|NCT03388164|Cholinergic Agents|cholinergic agents|mesh-ancestor
6265733|NCT03388268|Vancomycin|vancomycin|mesh-list
6265734|NCT03388268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6265735|NCT03388268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6265736|NCT03389308|Diacetylrhein|diacetylrhein|mesh-list
6265737|NCT03389308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6265738|NCT03389555|Vitamins|vitamins|mesh-list
6265739|NCT03389555|Ascorbic Acid|ascorbic acid|mesh-list
6265740|NCT03389555|Thiamine|thiamine|mesh-list
6265741|NCT03389555|Hydrocortisone|hydrocortisone|mesh-list
6265742|NCT03389555|Micronutrients|micronutrients|mesh-ancestor
6265743|NCT03389555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265744|NCT03389555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6265745|NCT03389555|Antioxidants|antioxidants|mesh-ancestor
6265746|NCT03389555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6265747|NCT03389555|Protective Agents|protective agents|mesh-ancestor
6265748|NCT03389555|Vitamin B Complex|vitamin b complex|mesh-ancestor
6265749|NCT03389893|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6265750|NCT03389893|Immunologic Factors|immunologic factors|mesh-ancestor
6265751|NCT03389893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265752|NCT03390166|Vaccines|vaccines|mesh-list
6265753|NCT03390166|Immunologic Factors|immunologic factors|mesh-ancestor
6265754|NCT03390166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265755|NCT03390426|Anesthetics|anesthetics|mesh-list
6265756|NCT03390426|Mepivacaine|mepivacaine|mesh-list
6265757|NCT03390426|Anesthetics, Local|anesthetics, local|mesh-list
6265758|NCT03390426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6265759|NCT03390426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265760|NCT03390426|Sensory System Agents|sensory system agents|mesh-ancestor
6265761|NCT03390426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6265762|NCT03391765|Tilavonemab|tilavonemab|mesh-list
6265763|NCT03391765|Nootropic Agents|nootropic agents|mesh-ancestor
6265764|NCT03393000|Vitamin A|vitamin a|mesh-list
6265765|NCT03393000|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
6265766|NCT03393000|Antioxidants|antioxidants|mesh-ancestor
6265767|NCT03393000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6265768|NCT03393000|Protective Agents|protective agents|mesh-ancestor
6265769|NCT03393000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265770|NCT03393000|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6265771|NCT03393000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6265772|NCT03393000|Vitamins|vitamins|mesh-ancestor
6265773|NCT03393000|Micronutrients|micronutrients|mesh-ancestor
6265774|NCT03393208|Metformin|metformin|mesh-list
6265775|NCT03393208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6265776|NCT03393208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265777|NCT03393494|Adapalene|adapalene|mesh-list
6265778|NCT03393494|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6265779|NCT03393494|Dermatologic Agents|dermatologic agents|mesh-ancestor
6265780|NCT03393494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6265781|NCT03393494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6265782|NCT03393494|Analgesics|analgesics|mesh-ancestor
6265783|NCT03393494|Sensory System Agents|sensory system agents|mesh-ancestor
6265784|NCT03393494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6265785|NCT03393494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265786|NCT03393494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6265787|NCT03393494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6265788|NCT03393754|Vaccines|vaccines|mesh-list
6265789|NCT03393754|Immunologic Factors|immunologic factors|mesh-ancestor
6265790|NCT03393754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265791|NCT03394885|Paclitaxel|paclitaxel|mesh-list
6265792|NCT03394885|Bevacizumab|bevacizumab|mesh-list
6265793|NCT03394885|Carboplatin|carboplatin|mesh-list
6265794|NCT03394885|Atezolizumab|atezolizumab|mesh-list
6265795|NCT03394885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6265796|NCT03394885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6265797|NCT03394885|Tubulin Modulators|tubulin modulators|mesh-ancestor
6265798|NCT03394885|Antimitotic Agents|antimitotic agents|mesh-ancestor
6265799|NCT03394885|Mitosis Modulators|mitosis modulators|mesh-ancestor
6265800|NCT03394885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6265801|NCT03394885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6265802|NCT03394885|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6265803|NCT03394885|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6265804|NCT03394885|Growth Substances|growth substances|mesh-ancestor
6265805|NCT03394885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265806|NCT03394885|Growth Inhibitors|growth inhibitors|mesh-ancestor
6014738|NCT00352911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014739|NCT00352911|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6014740|NCT00352911|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6014741|NCT00352911|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6014742|NCT00352911|Contraceptive Agents|contraceptive agents|mesh-ancestor
6014743|NCT00352911|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6014744|NCT00352911|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6014745|NCT00352911|Hormone Antagonists|hormone antagonists|mesh-ancestor
6014746|NCT00352911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6265807|NCT03395353|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6265808|NCT03395353|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6265809|NCT03395353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6265810|NCT03395353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6265811|NCT03395353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6265812|NCT03395353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5724159|NCT03189329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5724160|NCT03189329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6265813|NCT03395353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265814|NCT03395353|Analgesics|analgesics|mesh-ancestor
6265815|NCT03395353|Sensory System Agents|sensory system agents|mesh-ancestor
6265816|NCT03395353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6265817|NCT03395353|Antidepressive Agents|antidepressive agents|mesh-ancestor
6265818|NCT03395353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6265819|NCT03395353|Dopamine Agents|dopamine agents|mesh-ancestor
6265820|NCT03395808|Tramadol|tramadol|mesh-list
6265821|NCT03395808|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6265822|NCT03395808|Narcotics|narcotics|mesh-ancestor
6265823|NCT03395808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6265824|NCT03395808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265825|NCT03395808|Analgesics|analgesics|mesh-ancestor
6265826|NCT03395808|Sensory System Agents|sensory system agents|mesh-ancestor
6265827|NCT03395808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6265828|NCT03395886|Dexmedetomidine|dexmedetomidine|mesh-list
6265829|NCT03395886|Remifentanil|remifentanil|mesh-list
6265830|NCT03395886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6265831|NCT03395886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6265832|NCT03395886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265833|NCT03395886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6265834|NCT03395886|Analgesics|analgesics|mesh-ancestor
6265835|NCT03395886|Sensory System Agents|sensory system agents|mesh-ancestor
6265836|NCT03395886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6265837|NCT03395886|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6265838|NCT03395886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6265839|NCT03395886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6265840|NCT03395886|Adrenergic Agents|adrenergic agents|mesh-ancestor
6265841|NCT03395886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6265842|NCT03395886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6265843|NCT03395886|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6265844|NCT03395886|Narcotics|narcotics|mesh-ancestor
6265845|NCT03395990|Chloroprocaine|chloroprocaine|mesh-list
6265846|NCT03395990|Procaine|procaine|mesh-list
6265847|NCT03395990|Anesthetics, Local|anesthetics, local|mesh-ancestor
6265848|NCT03395990|Anesthetics|anesthetics|mesh-ancestor
6265849|NCT03395990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6265850|NCT03395990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724161|NCT03189329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5724162|NCT03189329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5724163|NCT03189329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5724164|NCT03189329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724165|NCT03188978|Atorvastatin|atorvastatin|mesh-list
5724166|NCT03188978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6265851|NCT03395990|Sensory System Agents|sensory system agents|mesh-ancestor
6265852|NCT03395990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6265853|NCT03396952|Aspirin|aspirin|mesh-list
6265854|NCT03396952|Pembrolizumab|pembrolizumab|mesh-list
6265855|NCT03396952|Ipilimumab|ipilimumab|mesh-list
6265856|NCT03396952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6265857|NCT03396952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6265858|NCT03396952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6265859|NCT03396952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6265860|NCT03396952|Analgesics|analgesics|mesh-ancestor
6265861|NCT03396952|Sensory System Agents|sensory system agents|mesh-ancestor
6265862|NCT03396952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6265863|NCT03396952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265864|NCT03396952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6265865|NCT03396952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6265866|NCT03396952|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6265867|NCT03396952|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6265868|NCT03396952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6265869|NCT03396952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6265870|NCT03396952|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6265871|NCT03396952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6265872|NCT03396952|Antipyretics|antipyretics|mesh-ancestor
6265873|NCT03396952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6265874|NCT03397394|Rucaparib|rucaparib|mesh-list
6265875|NCT03397394|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6265876|NCT03397394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6265877|NCT03397394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6265878|NCT03397394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6265879|NCT03398278|Oxycodone|oxycodone|mesh-list
6265880|NCT03398278|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6265881|NCT03398278|Narcotics|narcotics|mesh-ancestor
6265882|NCT03398278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6265883|NCT03398278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265884|NCT03398278|Analgesics|analgesics|mesh-ancestor
6265885|NCT03398278|Sensory System Agents|sensory system agents|mesh-ancestor
6265886|NCT03398278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6265887|NCT03398330|Oxycodone|oxycodone|mesh-list
6265888|NCT03398330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6265889|NCT03398330|Narcotics|narcotics|mesh-ancestor
6265890|NCT03398330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6265891|NCT03398330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265892|NCT03398330|Analgesics|analgesics|mesh-ancestor
6265893|NCT03398330|Sensory System Agents|sensory system agents|mesh-ancestor
6265894|NCT03398330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6265895|NCT03398356|Metformin|metformin|mesh-list
6265896|NCT03398356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6265897|NCT03398356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265898|NCT03398421|Itraconazole|itraconazole|mesh-list
6265899|NCT03398421|Nemiralisib|nemiralisib|mesh-list
6265900|NCT03398421|Antifungal Agents|antifungal agents|mesh-ancestor
6265901|NCT03398421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6265902|NCT03398421|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6265903|NCT03398421|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6265904|NCT03398421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6265905|NCT03398421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6265906|NCT03398421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6265907|NCT03398421|Hormone Antagonists|hormone antagonists|mesh-ancestor
6265908|NCT03398421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6265909|NCT03398421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265910|NCT03398421|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6265911|NCT03398421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6265912|NCT03400033|Epoetin Alfa|epoetin alfa|mesh-list
6265913|NCT03400033|Hematinics|hematinics|mesh-ancestor
6265914|NCT03400475|Simvastatin|simvastatin|mesh-list
6265915|NCT03400475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6265916|NCT03400475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6265917|NCT03400475|Antimetabolites|antimetabolites|mesh-ancestor
6265918|NCT03400475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6265919|NCT03400475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6265920|NCT03400475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6265921|NCT03400475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6265922|NCT03400852|Cosyntropin|cosyntropin|mesh-list
6265923|NCT03400852|Hormones|hormones|mesh-ancestor
6265924|NCT03400852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6265925|NCT03400852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265926|NCT03401229|Mometasone Furoate|mometasone furoate|mesh-list
6265927|NCT03401229|Benralizumab|benralizumab|mesh-list
6265928|NCT03401229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6265929|NCT03401229|Dermatologic Agents|dermatologic agents|mesh-ancestor
6265930|NCT03401229|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6265931|NCT03401229|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6265932|NCT03401229|Respiratory System Agents|respiratory system agents|mesh-ancestor
6265933|NCT03401450|Bupivacaine|bupivacaine|mesh-list
6265934|NCT03401450|Anesthetics, Local|anesthetics, local|mesh-ancestor
6265935|NCT03401450|Anesthetics|anesthetics|mesh-ancestor
6265936|NCT03401450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6265937|NCT03401450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265938|NCT03401450|Sensory System Agents|sensory system agents|mesh-ancestor
6265939|NCT03401450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6265940|NCT03402243|Menthol|menthol|mesh-list
6265941|NCT03402243|Antipruritics|antipruritics|mesh-ancestor
6265942|NCT03402243|Dermatologic Agents|dermatologic agents|mesh-ancestor
6265943|NCT03403036|Brodalumab|brodalumab|mesh-list
6265944|NCT03403036|Dermatologic Agents|dermatologic agents|mesh-ancestor
6265945|NCT03403374|Evolocumab|evolocumab|mesh-list
6265946|NCT03403374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6265947|NCT03403374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6265948|NCT03403374|Antimetabolites|antimetabolites|mesh-ancestor
6265949|NCT03403374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6265950|NCT03403374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6265951|NCT03403504|Oxycodone|oxycodone|mesh-list
6265952|NCT03403504|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6265953|NCT03403504|Narcotics|narcotics|mesh-ancestor
6265954|NCT03403504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6265955|NCT03403504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265956|NCT03403504|Analgesics|analgesics|mesh-ancestor
6265957|NCT03403504|Sensory System Agents|sensory system agents|mesh-ancestor
6265958|NCT03403504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6265959|NCT03403517|Dexamethasone|dexamethasone|mesh-list
6265960|NCT03403517|Methylprednisolone|methylprednisolone|mesh-list
6265961|NCT03403517|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6265962|NCT03403517|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6265963|NCT03403517|Prednisolone|prednisolone|mesh-list
6265964|NCT03403517|Prednisolone acetate|prednisolone acetate|mesh-list
6265965|NCT03403517|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6265966|NCT03403517|Prednisolone phosphate|prednisolone phosphate|mesh-list
6265967|NCT03403517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6265968|NCT03403517|Antiemetics|antiemetics|mesh-ancestor
6265969|NCT03403517|Autonomic Agents|autonomic agents|mesh-ancestor
6265970|NCT03403517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6265971|NCT03403517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265972|NCT03403517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6265973|NCT03403517|Glucocorticoids|glucocorticoids|mesh-ancestor
6265974|NCT03403517|Hormones|hormones|mesh-ancestor
6265975|NCT03403517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6265976|NCT03403517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6265977|NCT03403517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6265978|NCT03403517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6265979|NCT03403517|Protective Agents|protective agents|mesh-ancestor
6265980|NCT03403712|Dexamethasone|dexamethasone|mesh-list
6265981|NCT03403712|Palonosetron|palonosetron|mesh-list
6265982|NCT03403712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6265983|NCT03403712|Antiemetics|antiemetics|mesh-ancestor
6265984|NCT03403712|Autonomic Agents|autonomic agents|mesh-ancestor
6265985|NCT03403712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6014747|NCT00352911|Luteolytic Agents|luteolytic agents|mesh-ancestor
6014748|NCT00352911|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6014749|NCT00352911|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6014750|NCT00352976|Mycophenolic Acid|mycophenolic acid|mesh-list
6014751|NCT00352976|Sirolimus|sirolimus|mesh-list
6014752|NCT00352976|Cyclophosphamide|cyclophosphamide|mesh-list
6014753|NCT00352976|Fludarabine|fludarabine|mesh-list
6014754|NCT00352976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6014755|NCT00352976|Immunologic Factors|immunologic factors|mesh-ancestor
6014756|NCT00352976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014757|NCT00352976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6014758|NCT00352976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6014759|NCT00352976|Alkylating Agents|alkylating agents|mesh-ancestor
6014760|NCT00352976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014761|NCT00352976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6014762|NCT00352976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6014763|NCT00352976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6014764|NCT00352976|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6014765|NCT00352976|Antitubercular Agents|antitubercular agents|mesh-ancestor
6265986|NCT03403712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6265987|NCT03403712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6265988|NCT03403712|Glucocorticoids|glucocorticoids|mesh-ancestor
6265989|NCT03403712|Hormones|hormones|mesh-ancestor
6265990|NCT03403712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6265991|NCT03403712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6265992|NCT03403712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6265993|NCT03403712|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6265994|NCT03403712|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6265995|NCT03403712|Serotonin Agents|serotonin agents|mesh-ancestor
6265996|NCT03403712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6265997|NCT03403712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6265998|NCT03404206|Ibuprofen|ibuprofen|mesh-list
6265999|NCT03404206|Naproxen|naproxen|mesh-list
6266000|NCT03404206|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6266001|NCT03404206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6266002|NCT03404206|Analgesics|analgesics|mesh-ancestor
6266003|NCT03404206|Sensory System Agents|sensory system agents|mesh-ancestor
6266004|NCT03404206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6266005|NCT03404206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266006|NCT03404206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6266007|NCT03404206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6266008|NCT03404206|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6266009|NCT03404206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6266010|NCT03404206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266011|NCT03404206|Gout Suppressants|gout suppressants|mesh-ancestor
6266012|NCT03404648|Choline|choline|mesh-list
6266013|NCT03404648|Lipotropic Agents|lipotropic agents|mesh-ancestor
6266014|NCT03404648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6266015|NCT03404648|Antimetabolites|antimetabolites|mesh-ancestor
6266016|NCT03404648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266017|NCT03404648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6266018|NCT03404648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6266019|NCT03404648|Nootropic Agents|nootropic agents|mesh-ancestor
6266020|NCT03404843|Fasudil|fasudil|mesh-list
6266021|NCT03404843|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6266022|NCT03404843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6266023|NCT03404843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266024|NCT03404843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6266025|NCT03404843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266026|NCT03404843|Vasodilator Agents|vasodilator agents|mesh-ancestor
6266027|NCT03404843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6266028|NCT03404843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6266029|NCT03405259|Fluorides|fluorides|mesh-list
6266030|NCT03405259|Fluorides, Topical|fluorides, topical|mesh-list
6266031|NCT03405259|Cariostatic Agents|cariostatic agents|mesh-ancestor
6266032|NCT03405259|Protective Agents|protective agents|mesh-ancestor
6266033|NCT03405259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390378|NCT00190866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390379|NCT00190866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6390380|NCT00190866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390381|NCT00190866|Analgesics|analgesics|mesh-ancestor
6390382|NCT00190866|Sensory System Agents|sensory system agents|mesh-ancestor
6390383|NCT00190866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6390384|NCT00190866|Antidepressive Agents|antidepressive agents|mesh-ancestor
6390385|NCT00190866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6390386|NCT00190866|Dopamine Agents|dopamine agents|mesh-ancestor
6390387|NCT00190879|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6390388|NCT00190879|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6390389|NCT00190879|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6390390|NCT00190879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6390391|NCT00190879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390392|NCT00190879|Adrenergic Agents|adrenergic agents|mesh-ancestor
6390393|NCT00190879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6390394|NCT00190879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390395|NCT00190892|Carbamazepine|carbamazepine|mesh-list
6390396|NCT00190892|Olanzapine|olanzapine|mesh-list
6390397|NCT00190892|Antiemetics|antiemetics|mesh-ancestor
6390398|NCT00190892|Autonomic Agents|autonomic agents|mesh-ancestor
6266034|NCT03405818|Tavaborole|tavaborole|mesh-list
6266035|NCT03405818|Antifungal Agents|antifungal agents|mesh-ancestor
6266036|NCT03405818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6266037|NCT03406260|Lasmiditan|lasmiditan|mesh-list
6266038|NCT03406260|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6266039|NCT03406260|Serotonin Agents|serotonin agents|mesh-ancestor
6266040|NCT03406260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6266041|NCT03406260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266042|NCT03406260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266043|NCT03407118|Insulin Lispro|insulin lispro|mesh-list
6266044|NCT03407118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6266045|NCT03407118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266046|NCT03407170|Pembrolizumab|pembrolizumab|mesh-list
6266047|NCT03407170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6266048|NCT03407170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6266049|NCT03407430|Pregabalin|pregabalin|mesh-list
6266050|NCT03407430|Analgesics|analgesics|mesh-ancestor
6266051|NCT03407430|Sensory System Agents|sensory system agents|mesh-ancestor
6266052|NCT03407430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6266053|NCT03407430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266054|NCT03407430|Anticonvulsants|anticonvulsants|mesh-ancestor
6266055|NCT03407430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6266056|NCT03407430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6266057|NCT03407430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266058|NCT03407430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6266059|NCT03407430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6266060|NCT03407430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6266061|NCT03407430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6266062|NCT03407430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6266063|NCT03407625|Misoprostol|misoprostol|mesh-list
6266064|NCT03407625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6266065|NCT03407625|Abortifacient Agents|abortifacient agents|mesh-ancestor
6266066|NCT03407625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6266067|NCT03407625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266068|NCT03407625|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6266069|NCT03407625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6266070|NCT03407625|Oxytocics|oxytocics|mesh-ancestor
6266071|NCT03408483|Epinephrine|epinephrine|mesh-list
6266072|NCT03408483|Analgesics, Opioid|analgesics, opioid|mesh-list
6266073|NCT03408483|Bupivacaine|bupivacaine|mesh-list
6266074|NCT03408483|Anesthetics, Local|anesthetics, local|mesh-ancestor
6266075|NCT03408483|Anesthetics|anesthetics|mesh-ancestor
6266076|NCT03408483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6266077|NCT03408483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266078|NCT03408483|Sensory System Agents|sensory system agents|mesh-ancestor
6266079|NCT03408483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6266080|NCT03408483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6266081|NCT03408483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6266082|NCT03408483|Adrenergic Agents|adrenergic agents|mesh-ancestor
6266083|NCT03408483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6266084|NCT03408483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266085|NCT03408483|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6266086|NCT03408483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6266087|NCT03408483|Autonomic Agents|autonomic agents|mesh-ancestor
6266088|NCT03408483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6266089|NCT03408483|Respiratory System Agents|respiratory system agents|mesh-ancestor
6266090|NCT03408483|Mydriatics|mydriatics|mesh-ancestor
6266091|NCT03408483|Sympathomimetics|sympathomimetics|mesh-ancestor
6266092|NCT03408483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6266093|NCT03408483|Narcotics|narcotics|mesh-ancestor
6266094|NCT03408483|Analgesics|analgesics|mesh-ancestor
6266095|NCT03408639|Vitamin B 12|vitamin b 12|mesh-list
6266096|NCT03408639|Hydroxocobalamin|hydroxocobalamin|mesh-list
6266097|NCT03408639|Epoetin Alfa|epoetin alfa|mesh-list
6266098|NCT03408639|Vitamins|vitamins|mesh-ancestor
6266099|NCT03408639|Micronutrients|micronutrients|mesh-ancestor
6266100|NCT03408639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266101|NCT03408639|Vitamin B Complex|vitamin b complex|mesh-ancestor
6266102|NCT03408639|Hematinics|hematinics|mesh-ancestor
6266103|NCT03408730|Vaccines|vaccines|mesh-list
6266104|NCT03408730|Immunologic Factors|immunologic factors|mesh-ancestor
6266105|NCT03408730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266106|NCT03411902|Risedronic Acid|risedronic acid|mesh-list
6266107|NCT03411902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6266108|NCT03411902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6266109|NCT03411902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266110|NCT03411902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6266111|NCT03411902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266112|NCT03411902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6266113|NCT03412734|Chlorhexidine|chlorhexidine|mesh-list
6266114|NCT03412734|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6266115|NCT03412734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6266116|NCT03412734|Disinfectants|disinfectants|mesh-ancestor
6266117|NCT03413618|Rivaroxaban|rivaroxaban|mesh-list
6266118|NCT03413618|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6266119|NCT03413618|Antithrombins|antithrombins|mesh-ancestor
6266120|NCT03413618|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6266121|NCT03413618|Protease Inhibitors|protease inhibitors|mesh-ancestor
6266122|NCT03413618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6266123|NCT03413618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266124|NCT03413618|Anticoagulants|anticoagulants|mesh-ancestor
6266125|NCT03414359|Lidocaine|lidocaine|mesh-list
6266126|NCT03414359|Chloroprocaine|chloroprocaine|mesh-list
6266127|NCT03414359|Anesthetics, Local|anesthetics, local|mesh-ancestor
6266128|NCT03414359|Anesthetics|anesthetics|mesh-ancestor
6266129|NCT03414359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6266130|NCT03414359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266131|NCT03414359|Sensory System Agents|sensory system agents|mesh-ancestor
6266132|NCT03414359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6266133|NCT03414359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6266134|NCT03414359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6266135|NCT03414359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6266136|NCT03414359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6266137|NCT03414359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266138|NCT03415178|Atorvastatin|atorvastatin|mesh-list
6266139|NCT03415178|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6266140|NCT03415178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6266141|NCT03415178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6266142|NCT03415178|Antimetabolites|antimetabolites|mesh-ancestor
6266143|NCT03415178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266144|NCT03415178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6266145|NCT03415178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6266146|NCT03415178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6266147|NCT03415243|Acetaminophen|acetaminophen|mesh-list
6266148|NCT03415243|Phenylephrine|phenylephrine|mesh-list
6266149|NCT03415243|Oxymetazoline|oxymetazoline|mesh-list
6266150|NCT03415243|Dextromethorphan|dextromethorphan|mesh-list
6266151|NCT03415243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6266152|NCT03415243|Analgesics|analgesics|mesh-ancestor
6266153|NCT03415243|Sensory System Agents|sensory system agents|mesh-ancestor
6266154|NCT03415243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6266155|NCT03415243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266156|NCT03415243|Antipyretics|antipyretics|mesh-ancestor
6266157|NCT03415243|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6266158|NCT03415243|Mydriatics|mydriatics|mesh-ancestor
6266159|NCT03415243|Autonomic Agents|autonomic agents|mesh-ancestor
6266160|NCT03415243|Sympathomimetics|sympathomimetics|mesh-ancestor
6266161|NCT03415243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6266162|NCT03415243|Nasal Decongestants|nasal decongestants|mesh-ancestor
6266163|NCT03415243|Respiratory System Agents|respiratory system agents|mesh-ancestor
6266164|NCT03415243|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6266165|NCT03415243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6266166|NCT03415243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6266167|NCT03415243|Adrenergic Agents|adrenergic agents|mesh-ancestor
6266168|NCT03415243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6266169|NCT03415243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266170|NCT03415243|Protective Agents|protective agents|mesh-ancestor
6266171|NCT03415243|Antitussive Agents|antitussive agents|mesh-ancestor
6266172|NCT03415243|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6266173|NCT03415243|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6266174|NCT03415581|Oxycodone|oxycodone|mesh-list
6266175|NCT03415581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6266176|NCT03415581|Narcotics|narcotics|mesh-ancestor
6266177|NCT03415581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6266178|NCT03415581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266179|NCT03415581|Analgesics|analgesics|mesh-ancestor
6266180|NCT03415581|Sensory System Agents|sensory system agents|mesh-ancestor
6266181|NCT03415581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6266182|NCT03416127|Metformin|metformin|mesh-list
6266183|NCT03416127|Propolis|propolis|mesh-list
6266184|NCT03416127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6266185|NCT03416127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266186|NCT03416127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6266187|NCT03417141|Mechlorethamine|mechlorethamine|mesh-list
6266188|NCT03417141|Alkylating Agents|alkylating agents|mesh-ancestor
6266189|NCT03417141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266190|NCT03417141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6266191|NCT03417141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6266192|NCT03418571|Gontivimab|gontivimab|mesh-list
6266193|NCT03418571|Antiviral Agents|antiviral agents|mesh-ancestor
6266194|NCT03418571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6266195|NCT03418714|Salvinorin A|salvinorin a|mesh-list
6266196|NCT03418714|Hallucinogens|hallucinogens|mesh-ancestor
6266197|NCT03418714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266198|NCT03418714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6266199|NCT03419403|Temozolomide|temozolomide|mesh-list
6266200|NCT03419403|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
6266201|NCT03419403|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6266202|NCT03419403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6266203|NCT03419403|Alkylating Agents|alkylating agents|mesh-ancestor
6266204|NCT03419403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266205|NCT03419403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6266206|NCT03419403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6266207|NCT03420300|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
6266208|NCT03420300|Antiviral Agents|antiviral agents|mesh-ancestor
6266209|NCT03420300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6266210|NCT03421210|Nicotine|nicotine|mesh-list
6266211|NCT03421210|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6266212|NCT03421210|Autonomic Agents|autonomic agents|mesh-ancestor
6266213|NCT03421210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6266214|NCT03421210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266215|NCT03421210|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6266216|NCT03421210|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6266217|NCT03421210|Cholinergic Agents|cholinergic agents|mesh-ancestor
6266218|NCT03421210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6266219|NCT03421210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266220|NCT03421379|Glucagon|glucagon|mesh-list
6266221|NCT03421379|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6266222|NCT03421379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6266223|NCT03421379|Hormones|hormones|mesh-ancestor
6266224|NCT03421379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6266225|NCT03421379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266226|NCT03421379|Incretins|incretins|mesh-ancestor
6266227|NCT03421730|Budesonide|budesonide|mesh-list
6266228|NCT03421730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6266229|NCT03421730|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6266230|NCT03421730|Autonomic Agents|autonomic agents|mesh-ancestor
6266231|NCT03421730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6266232|NCT03421730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266233|NCT03421730|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6266234|NCT03421730|Respiratory System Agents|respiratory system agents|mesh-ancestor
6266235|NCT03421730|Glucocorticoids|glucocorticoids|mesh-ancestor
6266236|NCT03421730|Hormones|hormones|mesh-ancestor
6266237|NCT03421730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6266238|NCT03422159|Ascorbic Acid|ascorbic acid|mesh-list
6266239|NCT03422159|Thiamine|thiamine|mesh-list
6266240|NCT03422159|Hydrocortisone|hydrocortisone|mesh-list
6266241|NCT03422159|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6266242|NCT03422159|Vitamins|vitamins|mesh-ancestor
6266243|NCT03422159|Micronutrients|micronutrients|mesh-ancestor
6266244|NCT03422159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266245|NCT03422159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6266246|NCT03422159|Antioxidants|antioxidants|mesh-ancestor
6266247|NCT03422159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266248|NCT03422159|Protective Agents|protective agents|mesh-ancestor
6266249|NCT03422159|Vitamin B Complex|vitamin b complex|mesh-ancestor
6266250|NCT03423641|Antiviral Agents|antiviral agents|mesh-list
6266251|NCT03423641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6266252|NCT03424044|Glucagon|glucagon|mesh-list
6266253|NCT03424044|Pancrelipase|pancrelipase|mesh-list
6266254|NCT03424044|Pancreatin|pancreatin|mesh-list
6266255|NCT03424044|Hormones|hormones|mesh-list
6266256|NCT03424044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6266257|NCT03424044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266258|NCT03424044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6266259|NCT03424239|Vitamin D|vitamin d|mesh-list
6266260|NCT03424239|Ergocalciferols|ergocalciferols|mesh-list
6266261|NCT03424239|Zoledronic Acid|zoledronic acid|mesh-list
6266262|NCT03424239|Vitamins|vitamins|mesh-list
6266263|NCT03424239|Micronutrients|micronutrients|mesh-ancestor
6266264|NCT03424239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266265|NCT03424239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6266266|NCT03424239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6266267|NCT03424681|Modafinil|modafinil|mesh-list
6266268|NCT03424681|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6266269|NCT03424681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266270|NCT03424681|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6266271|NCT03424681|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6266272|NCT03424681|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6266273|NCT03424681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266274|NCT03425097|Fexofenadine|fexofenadine|mesh-list
6266275|NCT03425097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6266276|NCT03425097|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6266277|NCT03425097|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6266278|NCT03425097|Histamine Antagonists|histamine antagonists|mesh-ancestor
6266279|NCT03425097|Histamine Agents|histamine agents|mesh-ancestor
6266280|NCT03425097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6266281|NCT03425097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266282|NCT03425097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266283|NCT03425253|Lidocaine|lidocaine|mesh-list
6266284|NCT03425253|Anesthetics, Local|anesthetics, local|mesh-ancestor
6266285|NCT03425253|Anesthetics|anesthetics|mesh-ancestor
6266286|NCT03425253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6266287|NCT03425253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266288|NCT03425253|Sensory System Agents|sensory system agents|mesh-ancestor
6266289|NCT03425253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6266290|NCT03425253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6266291|NCT03425253|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6266292|NCT03425253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6266293|NCT03425253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6266294|NCT03425253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266295|NCT03425396|Nitrofurantoin|nitrofurantoin|mesh-list
6266296|NCT03425396|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6266297|NCT03425396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6266298|NCT03425396|Renal Agents|renal agents|mesh-ancestor
6266299|NCT03425396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6266300|NCT03426228|Progesterone|progesterone|mesh-list
6266301|NCT03426228|Estrogens|estrogens|mesh-list
6266302|NCT03426228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266303|NCT03426228|Hormones|hormones|mesh-ancestor
6266304|NCT03426228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6266305|NCT03426228|Progestins|progestins|mesh-ancestor
6390399|NCT00190892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6390400|NCT00190892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390401|NCT00190892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6390402|NCT00190892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6390403|NCT00190892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6390404|NCT00190892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6390405|NCT00190892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6390406|NCT00190892|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6390407|NCT00190892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6390408|NCT00190892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6390409|NCT00190892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390410|NCT00190892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6390411|NCT00190892|Serotonin Agents|serotonin agents|mesh-ancestor
6390412|NCT00190892|Anticonvulsants|anticonvulsants|mesh-ancestor
6390413|NCT00190892|Antimanic Agents|antimanic agents|mesh-ancestor
6390414|NCT00190892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6390415|NCT00190892|Analgesics|analgesics|mesh-ancestor
6390416|NCT00190892|Sensory System Agents|sensory system agents|mesh-ancestor
6390417|NCT00190892|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6390418|NCT00190892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6390419|NCT00190892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6390420|NCT00190905|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6390421|NCT00190905|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6266306|NCT03426995|Cantharidin|cantharidin|mesh-list
6266307|NCT03426995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6266308|NCT03426995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266309|NCT03427619|Picibanil|picibanil|mesh-list
6266310|NCT03427619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6266311|NCT03427892|Brexpiprazole|brexpiprazole|mesh-list
6266312|NCT03427892|Serotonin Agents|serotonin agents|mesh-ancestor
6266313|NCT03427892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6266314|NCT03427892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266315|NCT03427892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266316|NCT03427892|Dopamine Agonists|dopamine agonists|mesh-ancestor
6266317|NCT03427892|Dopamine Agents|dopamine agents|mesh-ancestor
6266318|NCT03428230|Acetaminophen|acetaminophen|mesh-list
6266319|NCT03428230|Chloroprocaine|chloroprocaine|mesh-list
6266320|NCT03428230|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6266321|NCT03428230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6266322|NCT03428230|Analgesics|analgesics|mesh-ancestor
6266323|NCT03428230|Sensory System Agents|sensory system agents|mesh-ancestor
6266324|NCT03428230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6266325|NCT03428230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266326|NCT03428230|Antipyretics|antipyretics|mesh-ancestor
6266327|NCT03428230|Anesthetics, Local|anesthetics, local|mesh-ancestor
6266328|NCT03428230|Anesthetics|anesthetics|mesh-ancestor
6266329|NCT03428230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6266330|NCT03428360|Diazepam|diazepam|mesh-list
6266331|NCT03428360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6266332|NCT03428360|Anticonvulsants|anticonvulsants|mesh-ancestor
6266333|NCT03428360|Antiemetics|antiemetics|mesh-ancestor
6266334|NCT03428360|Autonomic Agents|autonomic agents|mesh-ancestor
6266335|NCT03428360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6266336|NCT03428360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266337|NCT03428360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6266338|NCT03428360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6266339|NCT03428360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6266340|NCT03428360|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6266341|NCT03428360|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6266342|NCT03428360|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6266343|NCT03428360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6266344|NCT03428360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6266345|NCT03428360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6266346|NCT03428360|Anesthetics, General|anesthetics, general|mesh-ancestor
6266347|NCT03428360|Anesthetics|anesthetics|mesh-ancestor
6266348|NCT03428360|GABA Modulators|gaba modulators|mesh-ancestor
6266349|NCT03428360|GABA Agents|gaba agents|mesh-ancestor
6266350|NCT03428360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6266351|NCT03428360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266352|NCT03429556|Botulinum Toxins|botulinum toxins|mesh-list
6266353|NCT03429556|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6266354|NCT03429556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6266355|NCT03429556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266356|NCT03429556|Cholinergic Agents|cholinergic agents|mesh-ancestor
6266357|NCT03429556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6266358|NCT03429556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266359|NCT03430050|Progesterone|progesterone|mesh-list
6266360|NCT03430050|Progestins|progestins|mesh-ancestor
6266361|NCT03430050|Hormones|hormones|mesh-ancestor
6266362|NCT03430050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6266363|NCT03430050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266364|NCT03430856|Insulin|insulin|mesh-list
6266365|NCT03430856|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6266366|NCT03430856|Insulin Aspart|insulin aspart|mesh-list
6266367|NCT03430856|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6266368|NCT03430856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266369|NCT03430986|Lidocaine|lidocaine|mesh-list
6266370|NCT03430986|Anesthetics, Local|anesthetics, local|mesh-ancestor
6266371|NCT03430986|Anesthetics|anesthetics|mesh-ancestor
6266372|NCT03430986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6266373|NCT03430986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266374|NCT03430986|Sensory System Agents|sensory system agents|mesh-ancestor
6266375|NCT03430986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6266376|NCT03430986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6266377|NCT03430986|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6266378|NCT03430986|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6266379|NCT03430986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6266380|NCT03430986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266381|NCT03431337|Amoxicillin|amoxicillin|mesh-list
6266382|NCT03431337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6266383|NCT03431337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6266384|NCT03432533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6266385|NCT03432533|Immunologic Factors|immunologic factors|mesh-ancestor
6266386|NCT03432533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266387|NCT03432858|Vancomycin|vancomycin|mesh-list
6266388|NCT03432858|Cefazolin|cefazolin|mesh-list
6266389|NCT03432858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6266390|NCT03432858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6266391|NCT03433677|Insulin Lispro|insulin lispro|mesh-list
6266392|NCT03433677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6266393|NCT03433677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266394|NCT03433703|Lenvatinib|lenvatinib|mesh-list
6266395|NCT03433703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6266396|NCT03433703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6266397|NCT03433703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6266398|NCT03433703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266399|NCT03433755|Evolocumab|evolocumab|mesh-list
6266400|NCT03433755|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6266401|NCT03433755|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6266402|NCT03433755|Antimetabolites|antimetabolites|mesh-ancestor
6266403|NCT03433755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266404|NCT03433755|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6266405|NCT03434119|Insulin|insulin|mesh-list
6266406|NCT03434119|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6266407|NCT03434119|Insulin Glargine|insulin glargine|mesh-list
6266408|NCT03434119|Lixisenatide|lixisenatide|mesh-list
6266409|NCT03434119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6266410|NCT03434119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266411|NCT03434977|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
6266412|NCT03434977|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6266413|NCT03434977|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6266414|NCT03434977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266415|NCT03435055|Nitrous Oxide|nitrous oxide|mesh-list
6266416|NCT03435055|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6266417|NCT03435055|Anesthetics, General|anesthetics, general|mesh-ancestor
6266418|NCT03435055|Anesthetics|anesthetics|mesh-ancestor
6266419|NCT03435055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6266420|NCT03435055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266421|NCT03435055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6266422|NCT03435055|Analgesics|analgesics|mesh-ancestor
6266423|NCT03435055|Sensory System Agents|sensory system agents|mesh-ancestor
6266424|NCT03435055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6266425|NCT03435185|Lidocaine|lidocaine|mesh-list
6266426|NCT03435185|Anesthetics, Local|anesthetics, local|mesh-ancestor
6266427|NCT03435185|Anesthetics|anesthetics|mesh-ancestor
6266428|NCT03435185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6266429|NCT03435185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266430|NCT03435185|Sensory System Agents|sensory system agents|mesh-ancestor
6266431|NCT03435185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6266432|NCT03435185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6266433|NCT03435185|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6266434|NCT03435185|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6266435|NCT03435185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6266436|NCT03435185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266437|NCT03435614|Analgesics|analgesics|mesh-list
6266438|NCT03435614|Narcotics|narcotics|mesh-list
6266439|NCT03435614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6266440|NCT03435614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266441|NCT03435614|Sensory System Agents|sensory system agents|mesh-ancestor
6266442|NCT03435614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6266443|NCT03435692|Acetaminophen|acetaminophen|mesh-list
6266444|NCT03435692|Diphenhydramine|diphenhydramine|mesh-list
6266445|NCT03435692|Promethazine|promethazine|mesh-list
6266446|NCT03435692|Fentanyl|fentanyl|mesh-list
6266447|NCT03435692|Morphine|morphine|mesh-list
6266448|NCT03435692|Oxycodone|oxycodone|mesh-list
6266449|NCT03435692|Lorazepam|lorazepam|mesh-list
6266450|NCT03435692|Ondansetron|ondansetron|mesh-list
6266451|NCT03435692|Ropivacaine|ropivacaine|mesh-list
6266452|NCT03435692|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6266453|NCT03435692|Narcotics|narcotics|mesh-ancestor
6266454|NCT03435692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6266455|NCT03435692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266456|NCT03435692|Analgesics|analgesics|mesh-ancestor
6266457|NCT03435692|Sensory System Agents|sensory system agents|mesh-ancestor
6266458|NCT03435692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6266459|NCT03435692|Anesthetics, Local|anesthetics, local|mesh-ancestor
6266460|NCT03435692|Anesthetics|anesthetics|mesh-ancestor
6266461|NCT03435692|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6266462|NCT03435692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6266463|NCT03435692|Anesthetics, General|anesthetics, general|mesh-ancestor
6266464|NCT03435692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6266465|NCT03435692|Antipyretics|antipyretics|mesh-ancestor
6266466|NCT03435692|Antiemetics|antiemetics|mesh-ancestor
6266467|NCT03435692|Autonomic Agents|autonomic agents|mesh-ancestor
6266468|NCT03435692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6266469|NCT03435692|Antipruritics|antipruritics|mesh-ancestor
6266470|NCT03435692|Dermatologic Agents|dermatologic agents|mesh-ancestor
6266471|NCT03435692|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6266472|NCT03435692|Serotonin Agents|serotonin agents|mesh-ancestor
6266473|NCT03435692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6266474|NCT03435692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266475|NCT03435692|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6266476|NCT03435692|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6266477|NCT03435692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6266478|NCT03435692|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6266479|NCT03435692|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6266480|NCT03435692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6266481|NCT03435692|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6266482|NCT03435692|Histamine Antagonists|histamine antagonists|mesh-ancestor
6266483|NCT03435692|Histamine Agents|histamine agents|mesh-ancestor
6266484|NCT03435692|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6266485|NCT03435692|Anticonvulsants|anticonvulsants|mesh-ancestor
6266486|NCT03435692|GABA Modulators|gaba modulators|mesh-ancestor
6266487|NCT03435692|GABA Agents|gaba agents|mesh-ancestor
6266488|NCT03436420|Calcium|calcium|mesh-list
6266489|NCT03436420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6266490|NCT03436420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266491|NCT03437044|Clopidogrel|clopidogrel|mesh-list
6266492|NCT03437044|Ticagrelor|ticagrelor|mesh-list
6266493|NCT03437044|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6266494|NCT03437044|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6266495|NCT03437044|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6266496|NCT03437044|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6266497|NCT03437044|Purinergic Agents|purinergic agents|mesh-ancestor
6266498|NCT03437044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6266499|NCT03437044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266500|NCT03437044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266501|NCT03437447|Praziquantel|praziquantel|mesh-list
6266502|NCT03437447|Anthelmintics|anthelmintics|mesh-ancestor
6266503|NCT03437447|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6266504|NCT03437447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6266505|NCT03437564|Vortioxetine|vortioxetine|mesh-list
6266506|NCT03437564|Antidepressive Agents|antidepressive agents|mesh-ancestor
6266507|NCT03437564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6266508|NCT03437564|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6266509|NCT03437564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6266510|NCT03437564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6266511|NCT03437564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266512|NCT03437564|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6266513|NCT03437564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6266514|NCT03437564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6266515|NCT03437564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266516|NCT03437564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6266517|NCT03437564|Serotonin Agents|serotonin agents|mesh-ancestor
6266518|NCT03437564|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6266519|NCT03437564|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6266520|NCT03437564|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6266521|NCT03437564|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6266522|NCT03437577|Tacrolimus|tacrolimus|mesh-list
6266523|NCT03437577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6266524|NCT03437577|Immunologic Factors|immunologic factors|mesh-ancestor
6266525|NCT03437577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266526|NCT03437577|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6266527|NCT03437577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6266528|NCT03437577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266529|NCT03438006|Vaccines|vaccines|mesh-list
6266530|NCT03438006|Immunologic Factors|immunologic factors|mesh-ancestor
6266531|NCT03438006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266532|NCT03438266|Hyaluronic Acid|hyaluronic acid|mesh-list
6266533|NCT03438266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6266534|NCT03438266|Immunologic Factors|immunologic factors|mesh-ancestor
6266535|NCT03438266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266536|NCT03438266|Viscosupplements|viscosupplements|mesh-ancestor
6266537|NCT03438266|Protective Agents|protective agents|mesh-ancestor
6266538|NCT03438396|Tisotumab vedotin|tisotumab vedotin|mesh-list
6266539|NCT03438396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6266540|NCT03438396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6266541|NCT03439072|Glucagon|glucagon|mesh-list
6266542|NCT03439072|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6266543|NCT03439072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6266544|NCT03439072|Hormones|hormones|mesh-ancestor
6266545|NCT03439072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6266546|NCT03439072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266547|NCT03439072|Incretins|incretins|mesh-ancestor
6266548|NCT03439124|Cephalosporins|cephalosporins|mesh-list
6266549|NCT03439124|Ceftobiprole|ceftobiprole|mesh-list
6266550|NCT03439124|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
6266551|NCT03439124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6266552|NCT03439124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6266553|NCT03439137|Darbepoetin alfa|darbepoetin alfa|mesh-list
6266554|NCT03439137|Hematinics|hematinics|mesh-ancestor
6266555|NCT03440229|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6266556|NCT03440229|Laxatives|laxatives|mesh-ancestor
6266557|NCT03440229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6266558|NCT03440411|Dexamethasone|dexamethasone|mesh-list
6266559|NCT03440411|Cyclophosphamide|cyclophosphamide|mesh-list
6266560|NCT03440411|Pomalidomide|pomalidomide|mesh-list
6266561|NCT03440411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6266562|NCT03440411|Immunologic Factors|immunologic factors|mesh-ancestor
6266563|NCT03440411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266564|NCT03440411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6266565|NCT03440411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6266566|NCT03440411|Alkylating Agents|alkylating agents|mesh-ancestor
6266567|NCT03440411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266568|NCT03440411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6266569|NCT03440411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6266570|NCT03440411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6266571|NCT03440411|Antiemetics|antiemetics|mesh-ancestor
6266572|NCT03440411|Autonomic Agents|autonomic agents|mesh-ancestor
6266573|NCT03440411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6266574|NCT03440411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6266575|NCT03440411|Glucocorticoids|glucocorticoids|mesh-ancestor
6266576|NCT03440411|Hormones|hormones|mesh-ancestor
6266577|NCT03440411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6266578|NCT03440411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6266579|NCT03440411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6266580|NCT03440411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6266581|NCT03440411|Growth Substances|growth substances|mesh-ancestor
6266582|NCT03440411|Growth Inhibitors|growth inhibitors|mesh-ancestor
6266583|NCT03440424|Lemborexant|lemborexant|mesh-list
6266584|NCT03440424|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
6266585|NCT03440424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6266586|NCT03440424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266587|NCT03440424|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6266588|NCT03440424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6266589|NCT03440424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6266590|NCT03440424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266591|NCT03440918|Anti-Infective Agents|anti-infective agents|mesh-list
6266592|NCT03440918|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6266593|NCT03441269|Ibuprofen|ibuprofen|mesh-list
6266594|NCT03441269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6266595|NCT03441269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6266596|NCT03441269|Analgesics|analgesics|mesh-ancestor
6266597|NCT03441269|Sensory System Agents|sensory system agents|mesh-ancestor
6266598|NCT03441269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6266599|NCT03441269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266600|NCT03441269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6266601|NCT03441269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6266602|NCT03441269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6266603|NCT03441269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6266604|NCT03441269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266605|NCT03441581|Eluxadoline|eluxadoline|mesh-list
6266606|NCT03441581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6266607|NCT03441633|Rivaroxaban|rivaroxaban|mesh-list
6266608|NCT03441633|Apixaban|apixaban|mesh-list
6266609|NCT03441633|Dabigatran|dabigatran|mesh-list
6266610|NCT03441633|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6266611|NCT03441633|Antithrombins|antithrombins|mesh-ancestor
6266612|NCT03441633|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6266613|NCT03441633|Protease Inhibitors|protease inhibitors|mesh-ancestor
6266614|NCT03441633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6266615|NCT03441633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266616|NCT03441633|Anticoagulants|anticoagulants|mesh-ancestor
6266617|NCT03441789|Betamethasone|betamethasone|mesh-list
6266618|NCT03441789|Betamethasone Valerate|betamethasone valerate|mesh-list
6266619|NCT03441789|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
6266620|NCT03441789|Betamethasone benzoate|betamethasone benzoate|mesh-list
6266621|NCT03441789|Calcipotriene|calcipotriene|mesh-list
6266622|NCT03441789|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
6266623|NCT03441789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6266624|NCT03441789|Glucocorticoids|glucocorticoids|mesh-ancestor
6266625|NCT03441789|Hormones|hormones|mesh-ancestor
6266626|NCT03441789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6266627|NCT03441789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266628|NCT03441789|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6266629|NCT03441789|Respiratory System Agents|respiratory system agents|mesh-ancestor
6266630|NCT03441789|Dermatologic Agents|dermatologic agents|mesh-ancestor
6266631|NCT03442569|Nivolumab|nivolumab|mesh-list
6266632|NCT03442569|Ipilimumab|ipilimumab|mesh-list
6266633|NCT03442569|Panitumumab|panitumumab|mesh-list
6266634|NCT03442569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6266635|NCT03442569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6266636|NCT03442569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6266637|NCT03442569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390422|NCT00190905|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6390423|NCT00190905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6390424|NCT00190905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390425|NCT00190905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6390426|NCT00190905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390427|NCT00190905|Analgesics|analgesics|mesh-ancestor
6390428|NCT00190905|Sensory System Agents|sensory system agents|mesh-ancestor
6390429|NCT00190905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6390430|NCT00190905|Antidepressive Agents|antidepressive agents|mesh-ancestor
6390431|NCT00190905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6390432|NCT00190905|Dopamine Agents|dopamine agents|mesh-ancestor
6390433|NCT00190918|Pemetrexed|pemetrexed|mesh-list
6390434|NCT00190918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6390435|NCT00190918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6390436|NCT00190918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390437|NCT00190918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6266638|NCT03443063|Lemborexant|lemborexant|mesh-list
6266639|NCT03443063|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
6266640|NCT03443063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6266641|NCT03443063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266642|NCT03443063|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6266643|NCT03443063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6266644|NCT03443063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6266645|NCT03443063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266646|NCT03444155|Folic Acid|folic acid|mesh-list
6266647|NCT03444155|Vitamin B Complex|vitamin b complex|mesh-list
6266648|NCT03444155|Vitamins|vitamins|mesh-ancestor
6266649|NCT03444155|Micronutrients|micronutrients|mesh-ancestor
6266650|NCT03444155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266651|NCT03444155|Hematinics|hematinics|mesh-ancestor
6266652|NCT03444584|Metformin|metformin|mesh-list
6266653|NCT03444584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6266654|NCT03444584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266655|NCT03444766|Nivolumab|nivolumab|mesh-list
6266656|NCT03444766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6266657|NCT03444766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6266658|NCT03444766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6266659|NCT03444766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266660|NCT03445195|Imipenem|imipenem|mesh-list
6266661|NCT03445195|Sulbactam|sulbactam|mesh-list
6266662|NCT03445195|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
6266663|NCT03445195|Cilastatin|cilastatin|mesh-list
6266664|NCT03445195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6266665|NCT03445195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6266666|NCT03445195|Protease Inhibitors|protease inhibitors|mesh-ancestor
6266667|NCT03445195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6266668|NCT03445195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266669|NCT03445195|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6266670|NCT03445390|Acetaminophen|acetaminophen|mesh-list
6266671|NCT03445390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6266672|NCT03445390|Analgesics|analgesics|mesh-ancestor
6266673|NCT03445390|Sensory System Agents|sensory system agents|mesh-ancestor
6266674|NCT03445390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6266675|NCT03445390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266676|NCT03445390|Antipyretics|antipyretics|mesh-ancestor
6266677|NCT03446885|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6266678|NCT03446885|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6266679|NCT03446885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266680|NCT03446885|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6266681|NCT03446885|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6266682|NCT03446885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6266683|NCT03446885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266684|NCT03446885|Dopamine Agents|dopamine agents|mesh-ancestor
6266685|NCT03446885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6266686|NCT03447249|Ivacaftor|ivacaftor|mesh-list
6266687|NCT03447249|VX-659|vx-659|mesh-list
6266688|NCT03447249|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6266689|NCT03447249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6266690|NCT03447249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266691|NCT03447314|Pembrolizumab|pembrolizumab|mesh-list
6266692|NCT03447314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6266693|NCT03447314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6266694|NCT03447353|Acetaminophen|acetaminophen|mesh-list
6266695|NCT03447353|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
6266696|NCT03447353|Hydrocodone|hydrocodone|mesh-list
6266697|NCT03447353|Alprazolam|alprazolam|mesh-list
6266698|NCT03447353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6266699|NCT03447353|Analgesics|analgesics|mesh-ancestor
6266700|NCT03447353|Sensory System Agents|sensory system agents|mesh-ancestor
6266701|NCT03447353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6266702|NCT03447353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266703|NCT03447353|Antipyretics|antipyretics|mesh-ancestor
6266704|NCT03447353|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6266705|NCT03447353|Narcotics|narcotics|mesh-ancestor
6266706|NCT03447353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6266707|NCT03447353|Antitussive Agents|antitussive agents|mesh-ancestor
6266708|NCT03447353|Respiratory System Agents|respiratory system agents|mesh-ancestor
6266709|NCT03447353|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6266710|NCT03447353|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6266711|NCT03447353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6266712|NCT03447353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6266713|NCT03447353|GABA Modulators|gaba modulators|mesh-ancestor
6266714|NCT03447353|GABA Agents|gaba agents|mesh-ancestor
6266715|NCT03447353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6266716|NCT03447353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266717|NCT03447353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6266718|NCT03447353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6266719|NCT03447353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6266720|NCT03447821|Rifamycins|rifamycins|mesh-list
6266721|NCT03447821|Rifamycin SV|rifamycin sv|mesh-list
6266722|NCT03447821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6266723|NCT03447821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6266724|NCT03447821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6266725|NCT03448068|Ketamine|ketamine|mesh-list
6266726|NCT03448068|Analgesics|analgesics|mesh-ancestor
6266727|NCT03448068|Sensory System Agents|sensory system agents|mesh-ancestor
6266728|NCT03448068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6266729|NCT03448068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266730|NCT03448068|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6266731|NCT03448068|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6266732|NCT03448068|Anesthetics, General|anesthetics, general|mesh-ancestor
6266733|NCT03448068|Anesthetics|anesthetics|mesh-ancestor
6266734|NCT03448068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6266735|NCT03448068|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6266736|NCT03448068|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6266737|NCT03448068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6266738|NCT03448068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266739|NCT03448406|Empagliflozin|empagliflozin|mesh-list
6266740|NCT03448406|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6266741|NCT03448406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266742|NCT03448406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6266743|NCT03448406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266744|NCT03448419|Empagliflozin|empagliflozin|mesh-list
6266745|NCT03448419|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6266746|NCT03448419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266747|NCT03448419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6266748|NCT03448419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266749|NCT03448536|Acetaminophen|acetaminophen|mesh-list
6266750|NCT03448536|Naproxen|naproxen|mesh-list
6266751|NCT03448536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6266752|NCT03448536|Analgesics|analgesics|mesh-ancestor
6266753|NCT03448536|Sensory System Agents|sensory system agents|mesh-ancestor
6266754|NCT03448536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6266755|NCT03448536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266756|NCT03448536|Antipyretics|antipyretics|mesh-ancestor
6266757|NCT03448536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6266758|NCT03448536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6266759|NCT03448536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6266760|NCT03448536|Gout Suppressants|gout suppressants|mesh-ancestor
6266761|NCT03448536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6266762|NCT03448536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6266763|NCT03448536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266764|NCT03449433|Insulin|insulin|mesh-list
6266765|NCT03449433|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6266766|NCT03449433|Insulin Aspart|insulin aspart|mesh-list
6266767|NCT03449433|Insulin, Long-Acting|insulin, long-acting|mesh-list
6266768|NCT03449433|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6266769|NCT03449433|Insulin Lispro|insulin lispro|mesh-list
6266770|NCT03449433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6266771|NCT03449433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266772|NCT03449446|Firsocostat|firsocostat|mesh-list
6266773|NCT03449446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6266774|NCT03449446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266775|NCT03449758|Hydroxychloroquine|hydroxychloroquine|mesh-list
6266776|NCT03449758|Chloroquine|chloroquine|mesh-list
6266777|NCT03449758|Sulfasalazine|sulfasalazine|mesh-list
6266778|NCT03449758|Methotrexate|methotrexate|mesh-list
6266779|NCT03449758|Azathioprine|azathioprine|mesh-list
6266780|NCT03449758|Leflunomide|leflunomide|mesh-list
6266781|NCT03449758|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6266782|NCT03449758|Abortifacient Agents|abortifacient agents|mesh-ancestor
6266783|NCT03449758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6266784|NCT03449758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266785|NCT03449758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6266786|NCT03449758|Antimetabolites|antimetabolites|mesh-ancestor
6266787|NCT03449758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266788|NCT03449758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6266789|NCT03449758|Dermatologic Agents|dermatologic agents|mesh-ancestor
6266790|NCT03449758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6266791|NCT03449758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6266792|NCT03449758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6266793|NCT03449758|Immunologic Factors|immunologic factors|mesh-ancestor
6266794|NCT03449758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6266795|NCT03449758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6266796|NCT03449758|Antimalarials|antimalarials|mesh-ancestor
6266797|NCT03449758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6266798|NCT03449758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6266799|NCT03449758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6266800|NCT03449758|Amebicides|amebicides|mesh-ancestor
6266801|NCT03449758|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6266802|NCT03449758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6266803|NCT03449758|Analgesics|analgesics|mesh-ancestor
6266804|NCT03449758|Sensory System Agents|sensory system agents|mesh-ancestor
6266805|NCT03449758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6266806|NCT03449758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6266807|NCT03449758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6266808|NCT03450083|Benralizumab|benralizumab|mesh-list
6266809|NCT03450083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6266810|NCT03450083|Respiratory System Agents|respiratory system agents|mesh-ancestor
6266811|NCT03451773|Gemcitabine|gemcitabine|mesh-list
6266812|NCT03451773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6266813|NCT03451773|Antimetabolites|antimetabolites|mesh-ancestor
6266814|NCT03451773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266815|NCT03451773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6266816|NCT03451773|Antiviral Agents|antiviral agents|mesh-ancestor
6266817|NCT03451773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6266818|NCT03451773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6266819|NCT03451773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6266820|NCT03451773|Immunologic Factors|immunologic factors|mesh-ancestor
6266821|NCT03451773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266822|NCT03452189|Vancomycin|vancomycin|mesh-list
6266823|NCT03452189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6266824|NCT03452189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6266825|NCT03452527|Aflibercept|aflibercept|mesh-list
6266826|NCT03452527|Immunoconjugates|immunoconjugates|mesh-list
6266827|NCT03452527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6266828|NCT03452527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6266829|NCT03452527|Growth Substances|growth substances|mesh-ancestor
6266830|NCT03452527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266831|NCT03452527|Growth Inhibitors|growth inhibitors|mesh-ancestor
6266832|NCT03452527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6266833|NCT03452527|Immunologic Factors|immunologic factors|mesh-ancestor
6266834|NCT03453060|Thrombin|thrombin|mesh-list
6266835|NCT03453060|Hemostatics|hemostatics|mesh-ancestor
6266836|NCT03453060|Coagulants|coagulants|mesh-ancestor
6266837|NCT03453151|Anesthetics|anesthetics|mesh-list
6266838|NCT03453151|Anesthetics, Local|anesthetics, local|mesh-list
6266839|NCT03453151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6266840|NCT03453151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266841|NCT03453151|Sensory System Agents|sensory system agents|mesh-ancestor
6266842|NCT03453151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6266843|NCT03454048|Pyrimethamine|pyrimethamine|mesh-list
6266844|NCT03454048|Piperaquine|piperaquine|mesh-list
6266845|NCT03454048|Sulfadoxine|sulfadoxine|mesh-list
6266846|NCT03454048|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6266847|NCT03454048|Atovaquone|atovaquone|mesh-list
6266848|NCT03454048|Proguanil|proguanil|mesh-list
6266849|NCT03454048|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
6266850|NCT03454048|Antimalarials|antimalarials|mesh-ancestor
6266851|NCT03454048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6266852|NCT03454048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6266853|NCT03454048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6266854|NCT03454048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6266855|NCT03454048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6266856|NCT03454048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266857|NCT03454048|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6266858|NCT03454048|Renal Agents|renal agents|mesh-ancestor
6266859|NCT03454048|Antimetabolites|antimetabolites|mesh-ancestor
6266860|NCT03455218|Nitric Oxide|nitric oxide|mesh-list
6266861|NCT03455218|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6266862|NCT03455218|Autonomic Agents|autonomic agents|mesh-ancestor
6266863|NCT03455218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6266864|NCT03455218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266865|NCT03455218|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6266866|NCT03455218|Respiratory System Agents|respiratory system agents|mesh-ancestor
6266867|NCT03455218|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6266868|NCT03455218|Antioxidants|antioxidants|mesh-ancestor
6266869|NCT03455218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266870|NCT03455218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6266871|NCT03455218|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6266872|NCT03455218|Vasodilator Agents|vasodilator agents|mesh-ancestor
6266873|NCT03455218|Gasotransmitters|gasotransmitters|mesh-ancestor
6266874|NCT03455218|Protective Agents|protective agents|mesh-ancestor
6266875|NCT03456700|Sirolimus|sirolimus|mesh-list
6266876|NCT03456700|Auranofin|auranofin|mesh-list
6266877|NCT03456700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6266878|NCT03456700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6266879|NCT03456700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6266880|NCT03456700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6266881|NCT03456700|Antifungal Agents|antifungal agents|mesh-ancestor
6266882|NCT03456700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6266883|NCT03456700|Immunologic Factors|immunologic factors|mesh-ancestor
6266884|NCT03456700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266885|NCT03456700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6266886|NCT03456960|Aspirin|aspirin|mesh-list
6266887|NCT03456960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6266888|NCT03456960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6266889|NCT03456960|Analgesics|analgesics|mesh-ancestor
6266890|NCT03456960|Sensory System Agents|sensory system agents|mesh-ancestor
6266891|NCT03456960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6266892|NCT03456960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266893|NCT03456960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6266894|NCT03456960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6266895|NCT03456960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6266896|NCT03456960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6266897|NCT03456960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266898|NCT03456960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6266899|NCT03456960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6266900|NCT03456960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6266901|NCT03456960|Antipyretics|antipyretics|mesh-ancestor
6266902|NCT03457636|Doxycycline|doxycycline|mesh-list
6266903|NCT03457636|Adapalene|adapalene|mesh-list
6266904|NCT03457636|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
6266905|NCT03457636|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6266906|NCT03457636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6266907|NCT03457636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6266908|NCT03457636|Antimalarials|antimalarials|mesh-ancestor
6266909|NCT03457636|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6266910|NCT03457636|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6266911|NCT03457636|Dermatologic Agents|dermatologic agents|mesh-ancestor
6266912|NCT03457636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6266913|NCT03457636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6266914|NCT03457636|Analgesics|analgesics|mesh-ancestor
6266915|NCT03457636|Sensory System Agents|sensory system agents|mesh-ancestor
6266916|NCT03457636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6266917|NCT03457636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266918|NCT03457636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6266919|NCT03457636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6266920|NCT03457727|Omeprazole|omeprazole|mesh-list
6266921|NCT03457727|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6266922|NCT03457727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6266923|NCT03457727|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6266924|NCT03457727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6266925|NCT03457727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266926|NCT03459040|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
6266927|NCT03459040|Protein C Inhibitor|protein c inhibitor|mesh-list
6266928|NCT03459040|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6266929|NCT03459040|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6266930|NCT03459040|Protease Inhibitors|protease inhibitors|mesh-ancestor
6266931|NCT03459040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6266932|NCT03459040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266933|NCT03459612|Diphenhydramine|diphenhydramine|mesh-list
6266934|NCT03459612|Promethazine|promethazine|mesh-list
6266935|NCT03459612|Lasmiditan|lasmiditan|mesh-list
6266936|NCT03459612|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6266937|NCT03459612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6266938|NCT03459612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6266939|NCT03459612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266940|NCT03459612|Anesthetics, Local|anesthetics, local|mesh-ancestor
6266941|NCT03459612|Anesthetics|anesthetics|mesh-ancestor
6266942|NCT03459612|Sensory System Agents|sensory system agents|mesh-ancestor
6266943|NCT03459612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6266944|NCT03459612|Antiemetics|antiemetics|mesh-ancestor
6266945|NCT03459612|Autonomic Agents|autonomic agents|mesh-ancestor
6266946|NCT03459612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6266947|NCT03459612|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6266948|NCT03459612|Histamine Antagonists|histamine antagonists|mesh-ancestor
6266949|NCT03459612|Histamine Agents|histamine agents|mesh-ancestor
6266950|NCT03459612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6266951|NCT03459612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266952|NCT03459612|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6266953|NCT03459612|Antipruritics|antipruritics|mesh-ancestor
6266954|NCT03459612|Dermatologic Agents|dermatologic agents|mesh-ancestor
6266955|NCT03459612|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6266956|NCT03459612|Serotonin Agents|serotonin agents|mesh-ancestor
6266957|NCT03459794|Ivermectin|ivermectin|mesh-list
6266958|NCT03459794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6266959|NCT03459794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6266960|NCT03460899|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6266961|NCT03460899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266962|NCT03460990|Ivacaftor|ivacaftor|mesh-list
6266963|NCT03460990|VX-659|vx-659|mesh-list
6266964|NCT03460990|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6266965|NCT03460990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6266966|NCT03460990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266967|NCT03462680|Niacin|niacin|mesh-list
6266968|NCT03462680|Vitamins|vitamins|mesh-ancestor
6266969|NCT03462680|Micronutrients|micronutrients|mesh-ancestor
6266970|NCT03462680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6266971|NCT03462680|Vitamin B Complex|vitamin b complex|mesh-ancestor
6266972|NCT03462680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6266973|NCT03462680|Antimetabolites|antimetabolites|mesh-ancestor
6266974|NCT03462680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266975|NCT03462680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6266976|NCT03462680|Vasodilator Agents|vasodilator agents|mesh-ancestor
6390438|NCT00190918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6390439|NCT00190931|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6390440|NCT00190931|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6390441|NCT00190931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6390442|NCT00190931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6390443|NCT00190931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390444|NCT00190931|Adrenergic Agents|adrenergic agents|mesh-ancestor
6390445|NCT00190931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6390446|NCT00190931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390447|NCT00190944|Teriparatide|teriparatide|mesh-list
6390448|NCT00190944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6390449|NCT00190944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390450|NCT00190944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6390451|NCT00190957|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6390452|NCT00190957|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6390453|NCT00190957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6390454|NCT00190957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6390455|NCT00190957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390456|NCT00190957|Adrenergic Agents|adrenergic agents|mesh-ancestor
6390457|NCT00190957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6390458|NCT00190957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390459|NCT00190970|Ruboxistaurin|ruboxistaurin|mesh-list
6390460|NCT00190970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6266977|NCT03463161|Pembrolizumab|pembrolizumab|mesh-list
6266978|NCT03463161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6266979|NCT03463161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6266980|NCT03463512|Racecadotril|racecadotril|mesh-list
6266981|NCT03463512|Antidiarrheals|antidiarrheals|mesh-ancestor
6266982|NCT03463512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6266983|NCT03463512|Protease Inhibitors|protease inhibitors|mesh-ancestor
6266984|NCT03463512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6266985|NCT03463512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266986|NCT03463889|Edetic Acid|edetic acid|mesh-list
6266987|NCT03463889|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
6266988|NCT03463889|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6266989|NCT03463889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6266990|NCT03463889|Anticoagulants|anticoagulants|mesh-ancestor
6266991|NCT03463889|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6266992|NCT03463889|Chelating Agents|chelating agents|mesh-ancestor
6266993|NCT03463889|Sequestering Agents|sequestering agents|mesh-ancestor
6266994|NCT03463915|Triamcinolone|triamcinolone|mesh-list
6266995|NCT03463915|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6266996|NCT03463915|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6266997|NCT03463915|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6266998|NCT03463915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6266999|NCT03463915|Glucocorticoids|glucocorticoids|mesh-ancestor
6267000|NCT03463915|Hormones|hormones|mesh-ancestor
6267001|NCT03463915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6267002|NCT03463915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267003|NCT03463915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6267004|NCT03463915|Immunologic Factors|immunologic factors|mesh-ancestor
6267005|NCT03463915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6267006|NCT03463915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267007|NCT03464383|Citalopram|citalopram|mesh-list
6267008|NCT03464383|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6267009|NCT03464383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6267010|NCT03464383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6267011|NCT03464383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267012|NCT03464383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6267013|NCT03464383|Serotonin Agents|serotonin agents|mesh-ancestor
6267014|NCT03464383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267015|NCT03464383|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6267016|NCT03464383|Antidepressive Agents|antidepressive agents|mesh-ancestor
6267017|NCT03464383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6267018|NCT03465436|Moxifloxacin|moxifloxacin|mesh-list
6267019|NCT03465436|Lasmiditan|lasmiditan|mesh-list
6267020|NCT03465436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6267021|NCT03465436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6267022|NCT03465436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6267023|NCT03465436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6267024|NCT03465436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6267025|NCT03465436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267026|NCT03465436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6267027|NCT03465436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267028|NCT03465436|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6267029|NCT03465436|Serotonin Agents|serotonin agents|mesh-ancestor
6267030|NCT03465436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6267031|NCT03465878|Insulin Lispro|insulin lispro|mesh-list
6267032|NCT03465878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6267033|NCT03465878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267034|NCT03466086|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6267035|NCT03466086|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6267036|NCT03467217|Losartan|losartan|mesh-list
6267037|NCT03467217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6267038|NCT03467217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6267039|NCT03467217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6267040|NCT03467217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6267041|NCT03467217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267042|NCT03467685|Anesthetics|anesthetics|mesh-list
6267043|NCT03467685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6267044|NCT03467685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267045|NCT03467763|Metformin|metformin|mesh-list
6267046|NCT03467763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6267047|NCT03467763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267048|NCT03467945|Metformin|metformin|mesh-list
6267049|NCT03467945|Gliclazide|gliclazide|mesh-list
6267050|NCT03467945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6267051|NCT03467945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267052|NCT03467971|Metformin|metformin|mesh-list
6267053|NCT03467971|Gliclazide|gliclazide|mesh-list
6267054|NCT03467971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6267055|NCT03467971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267056|NCT03468075|Ascorbic Acid|ascorbic acid|mesh-list
6267057|NCT03468075|Gemcitabine|gemcitabine|mesh-list
6267058|NCT03468075|Vitamins|vitamins|mesh-ancestor
6267059|NCT03468075|Micronutrients|micronutrients|mesh-ancestor
6267060|NCT03468075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267061|NCT03468075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6267062|NCT03468075|Antimetabolites|antimetabolites|mesh-ancestor
6267063|NCT03468075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267064|NCT03468075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6267065|NCT03468075|Antiviral Agents|antiviral agents|mesh-ancestor
6267066|NCT03468075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6267067|NCT03468075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6267068|NCT03468075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6267069|NCT03468075|Immunologic Factors|immunologic factors|mesh-ancestor
6267070|NCT03468075|Antioxidants|antioxidants|mesh-ancestor
6267071|NCT03468075|Protective Agents|protective agents|mesh-ancestor
6267072|NCT03468543|Memantine|memantine|mesh-list
6267073|NCT03468543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6267074|NCT03468543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6267075|NCT03468543|Dopamine Agents|dopamine agents|mesh-ancestor
6267076|NCT03468543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6267077|NCT03468543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267078|NCT03468543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267079|NCT03468543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6267080|NCT03468543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6267081|NCT03468920|Acetaminophen|acetaminophen|mesh-list
6267082|NCT03468920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6267083|NCT03468920|Analgesics|analgesics|mesh-ancestor
6267084|NCT03468920|Sensory System Agents|sensory system agents|mesh-ancestor
6267085|NCT03468920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6267086|NCT03468920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267087|NCT03468920|Antipyretics|antipyretics|mesh-ancestor
6267088|NCT03468933|Plasminogen|plasminogen|mesh-list
6267089|NCT03468933|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6267090|NCT03468933|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6267091|NCT03468933|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6267092|NCT03468933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267093|NCT03469336|Betamethasone|betamethasone|mesh-list
6267094|NCT03469336|Calcipotriene|calcipotriene|mesh-list
6267095|NCT03469336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6267096|NCT03469336|Glucocorticoids|glucocorticoids|mesh-ancestor
6267097|NCT03469336|Hormones|hormones|mesh-ancestor
6267098|NCT03469336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6267099|NCT03469336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267100|NCT03469336|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6267101|NCT03469336|Respiratory System Agents|respiratory system agents|mesh-ancestor
6267102|NCT03469336|Dermatologic Agents|dermatologic agents|mesh-ancestor
6267103|NCT03469349|Actovegin|actovegin|mesh-list
6267104|NCT03469349|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6267105|NCT03469349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267106|NCT03469349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6267107|NCT03469349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6267108|NCT03469349|Antioxidants|antioxidants|mesh-ancestor
6267109|NCT03469349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267110|NCT03469349|Protective Agents|protective agents|mesh-ancestor
6267111|NCT03469349|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6267112|NCT03471871|Lemborexant|lemborexant|mesh-list
6267113|NCT03471871|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
6267114|NCT03471871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6267115|NCT03471871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267116|NCT03471871|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6267117|NCT03471871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6267118|NCT03471871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6267119|NCT03471871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267120|NCT03472287|Diacetylrhein|diacetylrhein|mesh-list
6267121|NCT03472287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6267122|NCT03472326|GS-9131|gs-9131|mesh-list
6267123|NCT03472326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6267124|NCT03472326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267125|NCT03472326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6267126|NCT03472326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6267127|NCT03472326|Antiviral Agents|antiviral agents|mesh-ancestor
6267128|NCT03472326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6267129|NCT03472326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6267130|NCT03472326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6267131|NCT03472469|Acetaminophen|acetaminophen|mesh-list
6267132|NCT03472469|Ketorolac|ketorolac|mesh-list
6267133|NCT03472469|Naproxen|naproxen|mesh-list
6267134|NCT03472469|Celecoxib|celecoxib|mesh-list
6267135|NCT03472469|Lidocaine|lidocaine|mesh-list
6267136|NCT03472469|Pregabalin|pregabalin|mesh-list
6267137|NCT03472469|Gabapentin|gabapentin|mesh-list
6267138|NCT03472469|Tramadol|tramadol|mesh-list
6267139|NCT03472469|Anesthetics, Local|anesthetics, local|mesh-ancestor
6267140|NCT03472469|Anesthetics|anesthetics|mesh-ancestor
6267141|NCT03472469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6267142|NCT03472469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267143|NCT03472469|Sensory System Agents|sensory system agents|mesh-ancestor
6267144|NCT03472469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6267145|NCT03472469|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6267146|NCT03472469|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6267147|NCT03472469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6267148|NCT03472469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6267149|NCT03472469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267150|NCT03472469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6267151|NCT03472469|Analgesics|analgesics|mesh-ancestor
6267152|NCT03472469|Antipyretics|antipyretics|mesh-ancestor
6267153|NCT03472469|Anticonvulsants|anticonvulsants|mesh-ancestor
6267154|NCT03472469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6267155|NCT03472469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6267156|NCT03472469|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6267157|NCT03472469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6267158|NCT03472469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6267159|NCT03472469|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6267160|NCT03472469|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6267161|NCT03472469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6267162|NCT03472469|Antimanic Agents|antimanic agents|mesh-ancestor
6267163|NCT03472469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6267164|NCT03472469|Narcotics|narcotics|mesh-ancestor
6267165|NCT03472469|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6267166|NCT03472469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6267167|NCT03472469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6267168|NCT03472469|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6267169|NCT03472469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6267170|NCT03472469|Gout Suppressants|gout suppressants|mesh-ancestor
6267171|NCT03472469|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6267172|NCT03472521|Gabapentin|gabapentin|mesh-list
6267173|NCT03472521|Analgesics|analgesics|mesh-ancestor
6267174|NCT03472521|Sensory System Agents|sensory system agents|mesh-ancestor
6267175|NCT03472521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6267176|NCT03472521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267177|NCT03472521|Anticonvulsants|anticonvulsants|mesh-ancestor
6267178|NCT03472521|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6267179|NCT03472521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6267180|NCT03472521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6267181|NCT03472521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6267182|NCT03472521|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6267183|NCT03472521|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6267184|NCT03472521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6267185|NCT03472521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267186|NCT03472521|Antimanic Agents|antimanic agents|mesh-ancestor
6267187|NCT03472534|Diacetylrhein|diacetylrhein|mesh-list
6267188|NCT03472534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6267189|NCT03472547|Diacetylrhein|diacetylrhein|mesh-list
6267190|NCT03472547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6267191|NCT03472885|Eculizumab|eculizumab|mesh-list
6267192|NCT03472885|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6267193|NCT03472885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6267194|NCT03472885|Immunologic Factors|immunologic factors|mesh-ancestor
6267195|NCT03472885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267196|NCT03473184|Diacetylrhein|diacetylrhein|mesh-list
6267197|NCT03473184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6267198|NCT03473197|Diacetylrhein|diacetylrhein|mesh-list
6267199|NCT03473197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6267200|NCT03473665|Celecoxib|celecoxib|mesh-list
6267201|NCT03473665|Diclofenac|diclofenac|mesh-list
6267202|NCT03473665|Indomethacin|indomethacin|mesh-list
6267203|NCT03473665|Meloxicam|meloxicam|mesh-list
6267204|NCT03473665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6267205|NCT03473665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6267206|NCT03473665|Analgesics|analgesics|mesh-ancestor
6267207|NCT03473665|Sensory System Agents|sensory system agents|mesh-ancestor
6267208|NCT03473665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6267209|NCT03473665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267210|NCT03473665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6267211|NCT03473665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6267212|NCT03473665|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6267213|NCT03473665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6267214|NCT03473665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6267215|NCT03473665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267216|NCT03473665|Gout Suppressants|gout suppressants|mesh-ancestor
6267217|NCT03473665|Tocolytic Agents|tocolytic agents|mesh-ancestor
6267218|NCT03473665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6267219|NCT03474081|Albuterol|albuterol|mesh-list
6267220|NCT03474081|Tiotropium Bromide|tiotropium bromide|mesh-list
6267221|NCT03474081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6267222|NCT03474081|Autonomic Agents|autonomic agents|mesh-ancestor
6267223|NCT03474081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6267224|NCT03474081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267225|NCT03474081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6267226|NCT03474081|Respiratory System Agents|respiratory system agents|mesh-ancestor
6267227|NCT03474081|Parasympatholytics|parasympatholytics|mesh-ancestor
6267228|NCT03474081|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6267229|NCT03474081|Cholinergic Agents|cholinergic agents|mesh-ancestor
6267230|NCT03474081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6267231|NCT03474081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267232|NCT03474081|Tocolytic Agents|tocolytic agents|mesh-ancestor
6267233|NCT03474081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6267234|NCT03474081|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6267235|NCT03474081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6267236|NCT03474081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6267237|NCT03474081|Adrenergic Agents|adrenergic agents|mesh-ancestor
6267238|NCT03476798|Bevacizumab|bevacizumab|mesh-list
6267239|NCT03476798|Rucaparib|rucaparib|mesh-list
6267240|NCT03476798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6267241|NCT03476798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6267242|NCT03476798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6267243|NCT03476798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6267244|NCT03476798|Growth Substances|growth substances|mesh-ancestor
6267245|NCT03476798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267246|NCT03476798|Growth Inhibitors|growth inhibitors|mesh-ancestor
6267247|NCT03476798|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6267248|NCT03476798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6267249|NCT03476798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267250|NCT03478163|Clindamycin|clindamycin|mesh-list
6267251|NCT03478163|Clindamycin palmitate|clindamycin palmitate|mesh-list
6267252|NCT03478163|Clindamycin phosphate|clindamycin phosphate|mesh-list
6267253|NCT03478163|Cefazolin|cefazolin|mesh-list
6267254|NCT03478163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6267255|NCT03478163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6267256|NCT03478163|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6267257|NCT03478163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6267258|NCT03478163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267259|NCT03478254|Vaccines|vaccines|mesh-list
6267260|NCT03478254|Immunologic Factors|immunologic factors|mesh-ancestor
6267261|NCT03478254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267262|NCT03478683|Budesonide|budesonide|mesh-list
6267263|NCT03478683|Albuterol|albuterol|mesh-list
6267264|NCT03478683|Formoterol Fumarate|formoterol fumarate|mesh-list
6267265|NCT03478683|Tiotropium Bromide|tiotropium bromide|mesh-list
6267266|NCT03478683|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6267267|NCT03478683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6267268|NCT03478683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6267269|NCT03478683|Autonomic Agents|autonomic agents|mesh-ancestor
6267270|NCT03478683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6267271|NCT03478683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267272|NCT03478683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6267273|NCT03478683|Respiratory System Agents|respiratory system agents|mesh-ancestor
6267274|NCT03478683|Glucocorticoids|glucocorticoids|mesh-ancestor
6267275|NCT03478683|Hormones|hormones|mesh-ancestor
6267276|NCT03478683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6267277|NCT03478683|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6267278|NCT03478683|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6267279|NCT03478683|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6267280|NCT03478683|Adrenergic Agents|adrenergic agents|mesh-ancestor
6267281|NCT03478683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6267282|NCT03478683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267283|NCT03478683|Parasympatholytics|parasympatholytics|mesh-ancestor
6267284|NCT03478683|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6267285|NCT03478683|Cholinergic Agents|cholinergic agents|mesh-ancestor
6267286|NCT03478683|Tocolytic Agents|tocolytic agents|mesh-ancestor
6267287|NCT03478683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6267288|NCT03478696|Budesonide|budesonide|mesh-list
6267289|NCT03478696|Albuterol|albuterol|mesh-list
6267290|NCT03478696|Formoterol Fumarate|formoterol fumarate|mesh-list
6267291|NCT03478696|Tiotropium Bromide|tiotropium bromide|mesh-list
6267292|NCT03478696|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6267293|NCT03478696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6267294|NCT03478696|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6267295|NCT03478696|Autonomic Agents|autonomic agents|mesh-ancestor
6267296|NCT03478696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6267297|NCT03478696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267298|NCT03478696|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6267299|NCT03478696|Respiratory System Agents|respiratory system agents|mesh-ancestor
6267300|NCT03478696|Glucocorticoids|glucocorticoids|mesh-ancestor
6267301|NCT03478696|Hormones|hormones|mesh-ancestor
6267302|NCT03478696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6267303|NCT03478696|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6267304|NCT03478696|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6267305|NCT03478696|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6267306|NCT03478696|Adrenergic Agents|adrenergic agents|mesh-ancestor
6267307|NCT03478696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6267308|NCT03478696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267309|NCT03478696|Parasympatholytics|parasympatholytics|mesh-ancestor
6267310|NCT03478696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6267311|NCT03478696|Cholinergic Agents|cholinergic agents|mesh-ancestor
6267312|NCT03478696|Tocolytic Agents|tocolytic agents|mesh-ancestor
6267313|NCT03478696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6267314|NCT03478930|Omalizumab|omalizumab|mesh-list
6267315|NCT03478930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6267316|NCT03478930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6267317|NCT03478930|Respiratory System Agents|respiratory system agents|mesh-ancestor
6267318|NCT03478969|Insulin|insulin|mesh-list
6267319|NCT03478969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6267320|NCT03478969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267321|NCT03478982|Alprazolam|alprazolam|mesh-list
6267322|NCT03478982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6267323|NCT03478982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6267324|NCT03478982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267325|NCT03478982|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6267326|NCT03478982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6267327|NCT03478982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6267328|NCT03478982|GABA Modulators|gaba modulators|mesh-ancestor
6267329|NCT03478982|GABA Agents|gaba agents|mesh-ancestor
6267330|NCT03478982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6396857|NCT00209794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6267331|NCT03478982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267332|NCT03479216|Magnesium Sulfate|magnesium sulfate|mesh-list
6267333|NCT03479216|Dexmedetomidine|dexmedetomidine|mesh-list
6267334|NCT03479216|Bupivacaine|bupivacaine|mesh-list
6267335|NCT03479216|Anesthetics, Local|anesthetics, local|mesh-ancestor
6267336|NCT03479216|Anesthetics|anesthetics|mesh-ancestor
6267337|NCT03479216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6267338|NCT03479216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267339|NCT03479216|Sensory System Agents|sensory system agents|mesh-ancestor
6267340|NCT03479216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6267341|NCT03479216|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6267342|NCT03479216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6267343|NCT03479216|Analgesics|analgesics|mesh-ancestor
6267344|NCT03479216|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6267345|NCT03479216|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6267346|NCT03479216|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6267347|NCT03479216|Adrenergic Agents|adrenergic agents|mesh-ancestor
6267348|NCT03479216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6267349|NCT03479216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267350|NCT03479216|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6267351|NCT03479216|Anticonvulsants|anticonvulsants|mesh-ancestor
6267352|NCT03479216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6267353|NCT03479216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6267354|NCT03479216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6267355|NCT03479216|Tocolytic Agents|tocolytic agents|mesh-ancestor
6267356|NCT03479216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6267357|NCT03480009|Oxycodone|oxycodone|mesh-list
6267358|NCT03480009|Dextromethorphan|dextromethorphan|mesh-list
6267359|NCT03480009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6267360|NCT03480009|Narcotics|narcotics|mesh-ancestor
6267361|NCT03480009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6267362|NCT03480009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267363|NCT03480009|Analgesics|analgesics|mesh-ancestor
6267364|NCT03480009|Sensory System Agents|sensory system agents|mesh-ancestor
6267365|NCT03480009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6267366|NCT03480009|Antitussive Agents|antitussive agents|mesh-ancestor
6267367|NCT03480009|Respiratory System Agents|respiratory system agents|mesh-ancestor
6267368|NCT03480009|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6267369|NCT03480009|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6267370|NCT03480009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6267371|NCT03480009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267372|NCT03480022|Liraglutide|liraglutide|mesh-list
6267373|NCT03480022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6267374|NCT03480022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267375|NCT03480022|Incretins|incretins|mesh-ancestor
6267376|NCT03480022|Hormones|hormones|mesh-ancestor
6267377|NCT03480022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6267378|NCT03480243|Erythromycin|erythromycin|mesh-list
6267379|NCT03480243|Erythromycin Estolate|erythromycin estolate|mesh-list
6267380|NCT03480243|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
6267381|NCT03480243|Erythromycin stearate|erythromycin stearate|mesh-list
6267382|NCT03480243|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6267383|NCT03480243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6267384|NCT03480243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6267385|NCT03480243|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6267386|NCT03480243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6267387|NCT03480243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267388|NCT03480750|Carboplatin|carboplatin|mesh-list
6267389|NCT03480750|Doxorubicin|doxorubicin|mesh-list
6267390|NCT03480750|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6267391|NCT03480750|Trientine|trientine|mesh-list
6267392|NCT03480750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6267393|NCT03480750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6267394|NCT03480750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6267395|NCT03480750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6267396|NCT03480750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6267397|NCT03480750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267398|NCT03480750|Chelating Agents|chelating agents|mesh-ancestor
6267399|NCT03480750|Sequestering Agents|sequestering agents|mesh-ancestor
6390461|NCT00190970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390462|NCT00190996|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6267400|NCT03480763|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6267401|NCT03480763|Immunologic Factors|immunologic factors|mesh-ancestor
6267402|NCT03480763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267403|NCT03480802|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6267404|NCT03480802|Immunologic Factors|immunologic factors|mesh-ancestor
6267405|NCT03480802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267406|NCT03480932|Interferons|interferons|mesh-list
6267407|NCT03480932|Interferon-alpha|interferon-alpha|mesh-list
6267408|NCT03480932|Interferon alpha-2|interferon alpha-2|mesh-list
6267409|NCT03480932|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6267410|NCT03480932|Sofosbuvir|sofosbuvir|mesh-list
6267411|NCT03480932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6267412|NCT03480932|Antiviral Agents|antiviral agents|mesh-ancestor
6267413|NCT03480932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6267414|NCT03480932|Immunologic Factors|immunologic factors|mesh-ancestor
6267415|NCT03480932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267416|NCT03481725|Coal Tar|coal tar|mesh-list
6267417|NCT03481725|Keratolytic Agents|keratolytic agents|mesh-ancestor
6267418|NCT03481725|Dermatologic Agents|dermatologic agents|mesh-ancestor
6267419|NCT03481816|Vaccines|vaccines|mesh-list
6267420|NCT03481816|Immunologic Factors|immunologic factors|mesh-ancestor
6267421|NCT03481816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267422|NCT03482011|Mirikizumab|mirikizumab|mesh-list
6267423|NCT03482011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6267424|NCT03482011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6267425|NCT03482011|Analgesics|analgesics|mesh-ancestor
6267426|NCT03482011|Sensory System Agents|sensory system agents|mesh-ancestor
6267427|NCT03482011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6267428|NCT03482011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267429|NCT03482011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6267430|NCT03482011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6267431|NCT03482011|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6267432|NCT03482011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6267433|NCT03482583|Nicotine|nicotine|mesh-list
6014766|NCT00352976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6014767|NCT00352976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6014768|NCT00352976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6014769|NCT00352976|Antifungal Agents|antifungal agents|mesh-ancestor
6014770|NCT00353119|Etanercept|etanercept|mesh-list
6014771|NCT00353119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6014772|NCT00353119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6014773|NCT00353119|Analgesics|analgesics|mesh-ancestor
6014774|NCT00353119|Sensory System Agents|sensory system agents|mesh-ancestor
6014775|NCT00353119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6014776|NCT00353119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267434|NCT03482583|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6267435|NCT03482583|Autonomic Agents|autonomic agents|mesh-ancestor
6267436|NCT03482583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6267437|NCT03482583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267438|NCT03482583|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6267439|NCT03482583|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6267440|NCT03482583|Cholinergic Agents|cholinergic agents|mesh-ancestor
6267441|NCT03482583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6267442|NCT03482583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267443|NCT03482882|Pimavanserin|pimavanserin|mesh-list
6267444|NCT03482882|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6267445|NCT03482882|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6267446|NCT03482882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6267447|NCT03482882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6267448|NCT03482882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6267449|NCT03482882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267450|NCT03482882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6267451|NCT03482882|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6267452|NCT03482882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6267453|NCT03482882|Serotonin Agents|serotonin agents|mesh-ancestor
6267454|NCT03482882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6267455|NCT03482882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267456|NCT03482973|Bupivacaine|bupivacaine|mesh-list
6267457|NCT03482973|Anesthetics, Local|anesthetics, local|mesh-ancestor
6267458|NCT03482973|Anesthetics|anesthetics|mesh-ancestor
6267459|NCT03482973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6267460|NCT03482973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267461|NCT03482973|Sensory System Agents|sensory system agents|mesh-ancestor
6267462|NCT03482973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6267463|NCT03483675|Immunosuppressive Agents|immunosuppressive agents|mesh-list
6267464|NCT03483675|Immunologic Factors|immunologic factors|mesh-ancestor
6267465|NCT03483675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267466|NCT03485222|Empagliflozin|empagliflozin|mesh-list
6267467|NCT03485222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6267468|NCT03485222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267469|NCT03485222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6267470|NCT03485222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267471|NCT03485911|Berotralstat|berotralstat|mesh-list
6267472|NCT03485911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6267473|NCT03485911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267474|NCT03485950|Meropenem|meropenem|mesh-list
6267475|NCT03485950|Tazobactam|tazobactam|mesh-list
6267476|NCT03485950|Piperacillin|piperacillin|mesh-list
6267477|NCT03485950|Cefepime|cefepime|mesh-list
6267478|NCT03485950|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
6267479|NCT03485950|Ceftolozane|ceftolozane|mesh-list
6267480|NCT03485950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6267481|NCT03485950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6267482|NCT03485950|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6267483|NCT03485950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6267484|NCT03485950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267485|NCT03485976|Ixekizumab|ixekizumab|mesh-list
6267486|NCT03485976|Dermatologic Agents|dermatologic agents|mesh-ancestor
6267487|NCT03486392|Liraglutide|liraglutide|mesh-list
6267488|NCT03486392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6267489|NCT03486392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267490|NCT03486392|Incretins|incretins|mesh-ancestor
6267491|NCT03486392|Hormones|hormones|mesh-ancestor
6267492|NCT03486392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6267493|NCT03486834|Vaccines|vaccines|mesh-list
6267494|NCT03486834|Immunologic Factors|immunologic factors|mesh-ancestor
6267495|NCT03486834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267496|NCT03487276|Vilobelimab|vilobelimab|mesh-list
6267497|NCT03487276|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6267498|NCT03487276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6267499|NCT03487276|Immunologic Factors|immunologic factors|mesh-ancestor
6267500|NCT03487276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267501|NCT03487549|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6267502|NCT03487549|Cantharidin|cantharidin|mesh-list
6267503|NCT03487549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6267504|NCT03487549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267505|NCT03487848|Sofosbuvir|sofosbuvir|mesh-list
6267506|NCT03487848|Antiviral Agents|antiviral agents|mesh-ancestor
6267507|NCT03487848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6267508|NCT03488108|Minoxidil|minoxidil|mesh-list
6267509|NCT03488108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6267510|NCT03488108|Vasodilator Agents|vasodilator agents|mesh-ancestor
6267511|NCT03488225|Calcium, Dietary|calcium, dietary|mesh-list
6267512|NCT03488225|Leucovorin|leucovorin|mesh-list
6267513|NCT03488225|Folic Acid|folic acid|mesh-list
6267514|NCT03488225|Cytarabine|cytarabine|mesh-list
6267515|NCT03488225|Dexamethasone|dexamethasone|mesh-list
6267516|NCT03488225|Prednisone|prednisone|mesh-list
6267517|NCT03488225|Dexamethasone acetate|dexamethasone acetate|mesh-list
6267518|NCT03488225|Cortisone|cortisone|mesh-list
6267519|NCT03488225|Cyclophosphamide|cyclophosphamide|mesh-list
6267520|NCT03488225|Rituximab|rituximab|mesh-list
6267521|NCT03488225|Doxorubicin|doxorubicin|mesh-list
6267522|NCT03488225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6267523|NCT03488225|Methotrexate|methotrexate|mesh-list
6267524|NCT03488225|Vincristine|vincristine|mesh-list
6267525|NCT03488225|Mercaptopurine|mercaptopurine|mesh-list
6267526|NCT03488225|Ofatumumab|ofatumumab|mesh-list
6267527|NCT03488225|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
6267528|NCT03488225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6267529|NCT03488225|Antibodies|antibodies|mesh-list
6267530|NCT03488225|Immunoglobulins|immunoglobulins|mesh-list
6267531|NCT03488225|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6267532|NCT03488225|BB 1101|bb 1101|mesh-list
6267533|NCT03488225|Calcium|calcium|mesh-list
6267534|NCT03488225|Levoleucovorin|levoleucovorin|mesh-list
6267535|NCT03488225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6267536|NCT03488225|Immunologic Factors|immunologic factors|mesh-ancestor
6267537|NCT03488225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267538|NCT03488225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6267539|NCT03488225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6267540|NCT03488225|Alkylating Agents|alkylating agents|mesh-ancestor
6267541|NCT03488225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267542|NCT03488225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6267543|NCT03488225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6267544|NCT03488225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6267545|NCT03488225|Antiemetics|antiemetics|mesh-ancestor
6267546|NCT03488225|Autonomic Agents|autonomic agents|mesh-ancestor
6267547|NCT03488225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6267548|NCT03488225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6267549|NCT03488225|Glucocorticoids|glucocorticoids|mesh-ancestor
6267550|NCT03488225|Hormones|hormones|mesh-ancestor
6267551|NCT03488225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6267552|NCT03488225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6267553|NCT03488225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6267554|NCT03488225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6267555|NCT03488225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6267556|NCT03488225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6267557|NCT03488225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6267558|NCT03488225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6267559|NCT03488225|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6267560|NCT03488225|Abortifacient Agents|abortifacient agents|mesh-ancestor
6267561|NCT03488225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6267562|NCT03488225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6267563|NCT03488225|Antimetabolites|antimetabolites|mesh-ancestor
6267564|NCT03488225|Dermatologic Agents|dermatologic agents|mesh-ancestor
6267565|NCT03488225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6267566|NCT03488225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6267567|NCT03488225|Antiviral Agents|antiviral agents|mesh-ancestor
6267568|NCT03488225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6267569|NCT03488225|Antidotes|antidotes|mesh-ancestor
6267570|NCT03488225|Protective Agents|protective agents|mesh-ancestor
6267571|NCT03488225|Vitamin B Complex|vitamin b complex|mesh-ancestor
6267572|NCT03488225|Vitamins|vitamins|mesh-ancestor
6267573|NCT03488225|Micronutrients|micronutrients|mesh-ancestor
6267574|NCT03488225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6267575|NCT03488225|Tubulin Modulators|tubulin modulators|mesh-ancestor
6267576|NCT03488225|Antimitotic Agents|antimitotic agents|mesh-ancestor
6267577|NCT03488225|Mitosis Modulators|mitosis modulators|mesh-ancestor
6267578|NCT03488225|Hematinics|hematinics|mesh-ancestor
6267579|NCT03488225|Protease Inhibitors|protease inhibitors|mesh-ancestor
6267580|NCT03489304|Zaleplon|zaleplon|mesh-list
6267581|NCT03489304|Anticonvulsants|anticonvulsants|mesh-ancestor
6267582|NCT03489304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6267583|NCT03489304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6267584|NCT03489304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267585|NCT03489304|GABA Modulators|gaba modulators|mesh-ancestor
6267586|NCT03489304|GABA Agents|gaba agents|mesh-ancestor
6267587|NCT03489304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6267588|NCT03489304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267589|NCT03489551|Haloperidol|haloperidol|mesh-list
6267590|NCT03489551|Antiemetics|antiemetics|mesh-ancestor
6267591|NCT03489551|Autonomic Agents|autonomic agents|mesh-ancestor
6267592|NCT03489551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6267593|NCT03489551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267594|NCT03489551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6267595|NCT03489551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6267596|NCT03489551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6267597|NCT03489551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6267598|NCT03489551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6267599|NCT03489551|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6267600|NCT03489551|Dopamine Agents|dopamine agents|mesh-ancestor
6267601|NCT03489551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6267602|NCT03489551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267603|NCT03489551|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6267604|NCT03489850|Ibudilast|ibudilast|mesh-list
6267605|NCT03489850|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6267606|NCT03489850|Autonomic Agents|autonomic agents|mesh-ancestor
6267607|NCT03489850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6267608|NCT03489850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267609|NCT03489850|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6267610|NCT03489850|Respiratory System Agents|respiratory system agents|mesh-ancestor
6267611|NCT03489850|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6267612|NCT03489850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6267613|NCT03489850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267614|NCT03489850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6267615|NCT03489850|Vasodilator Agents|vasodilator agents|mesh-ancestor
6267616|NCT03489863|Ticagrelor|ticagrelor|mesh-list
6267617|NCT03489863|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6267618|NCT03489863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6267619|NCT03489863|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6267620|NCT03489863|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6267621|NCT03489863|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6267622|NCT03489863|Purinergic Agents|purinergic agents|mesh-ancestor
6267623|NCT03489863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6267624|NCT03489863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267625|NCT03489863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267626|NCT03490942|Glucagon|glucagon|mesh-list
6267627|NCT03490942|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6267628|NCT03490942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6267629|NCT03490942|Hormones|hormones|mesh-ancestor
6267630|NCT03490942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6267631|NCT03490942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267632|NCT03490942|Incretins|incretins|mesh-ancestor
6267633|NCT03492099|Buprenorphine|buprenorphine|mesh-list
6267634|NCT03492099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6267635|NCT03492099|Narcotics|narcotics|mesh-ancestor
6267636|NCT03492099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6267637|NCT03492099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267638|NCT03492099|Analgesics|analgesics|mesh-ancestor
6267639|NCT03492099|Sensory System Agents|sensory system agents|mesh-ancestor
6267640|NCT03492099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6267641|NCT03492099|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6267642|NCT03492281|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6267643|NCT03492281|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6267644|NCT03492281|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6267645|NCT03492281|Cholinergic Agents|cholinergic agents|mesh-ancestor
6267646|NCT03492281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6267647|NCT03492281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267648|NCT03492281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267649|NCT03492281|Urological Agents|urological agents|mesh-ancestor
6267650|NCT03493386|Glycine|glycine|mesh-list
6267651|NCT03493386|Glycine Agents|glycine agents|mesh-ancestor
6267652|NCT03493386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6267653|NCT03493386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267654|NCT03493386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267655|NCT03493542|Vaccines|vaccines|mesh-list
6267656|NCT03493542|Immunologic Factors|immunologic factors|mesh-ancestor
6267657|NCT03493542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267658|NCT03493698|Midazolam|midazolam|mesh-list
6267659|NCT03493698|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6267660|NCT03493698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6267661|NCT03493698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6267662|NCT03493698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267663|NCT03493698|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6267664|NCT03493698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6267665|NCT03493698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6267666|NCT03493698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6267667|NCT03493698|Anesthetics, General|anesthetics, general|mesh-ancestor
6267668|NCT03493698|Anesthetics|anesthetics|mesh-ancestor
6267669|NCT03493698|GABA Modulators|gaba modulators|mesh-ancestor
6267670|NCT03493698|GABA Agents|gaba agents|mesh-ancestor
6267671|NCT03493698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6267672|NCT03493698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267673|NCT03493828|Bupivacaine|bupivacaine|mesh-list
6267674|NCT03493828|Anesthetics, Local|anesthetics, local|mesh-ancestor
6267675|NCT03493828|Anesthetics|anesthetics|mesh-ancestor
6267676|NCT03493828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6267677|NCT03493828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267678|NCT03493828|Sensory System Agents|sensory system agents|mesh-ancestor
6267679|NCT03493828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6267680|NCT03494816|Axitinib|axitinib|mesh-list
6267681|NCT03494816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6267682|NCT03494816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6267683|NCT03494816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6267684|NCT03494816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267685|NCT03494985|Muramidase|muramidase|mesh-list
6267686|NCT03494985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6267687|NCT03495102|Dulaglutide|dulaglutide|mesh-list
6267688|NCT03495102|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6267689|NCT03495102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267690|NCT03496298|Efpeglenatide|efpeglenatide|mesh-list
6267691|NCT03496298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6267692|NCT03496298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267693|NCT03496324|Ibuprofen|ibuprofen|mesh-list
6267694|NCT03496324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6267695|NCT03496324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6267696|NCT03496324|Analgesics|analgesics|mesh-ancestor
6267697|NCT03496324|Sensory System Agents|sensory system agents|mesh-ancestor
6267698|NCT03496324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6267699|NCT03496324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267700|NCT03496324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6267701|NCT03496324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6267702|NCT03496324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6267703|NCT03496324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6267704|NCT03496324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267705|NCT03496467|Nepafenac|nepafenac|mesh-list
6267706|NCT03496467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6267707|NCT03496467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6267708|NCT03496467|Analgesics|analgesics|mesh-ancestor
6267709|NCT03496467|Sensory System Agents|sensory system agents|mesh-ancestor
6267710|NCT03496467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6267711|NCT03496467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267712|NCT03496467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6267713|NCT03496467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6267714|NCT03496545|Acetaminophen|acetaminophen|mesh-list
6267715|NCT03496545|Bromocriptine|bromocriptine|mesh-list
6267716|NCT03496545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6267717|NCT03496545|Analgesics|analgesics|mesh-ancestor
6267718|NCT03496545|Sensory System Agents|sensory system agents|mesh-ancestor
6267719|NCT03496545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6267720|NCT03496545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267721|NCT03496545|Antipyretics|antipyretics|mesh-ancestor
6267722|NCT03496545|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6267723|NCT03496545|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6267724|NCT03496545|Hormone Antagonists|hormone antagonists|mesh-ancestor
6267725|NCT03496545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6267726|NCT03496545|Dopamine Agonists|dopamine agonists|mesh-ancestor
6267727|NCT03496545|Dopamine Agents|dopamine agents|mesh-ancestor
6267728|NCT03496545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6267729|NCT03496545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267730|NCT03496974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6267731|NCT03496974|Antibodies|antibodies|mesh-list
6267732|NCT03496974|Immunoglobulins|immunoglobulins|mesh-list
6267733|NCT03496974|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6267734|NCT03496974|Immunologic Factors|immunologic factors|mesh-ancestor
6267735|NCT03496974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267736|NCT03496974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6267737|NCT03497039|Diclofenac|diclofenac|mesh-list
6267738|NCT03497039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6267739|NCT03497039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6267740|NCT03497039|Analgesics|analgesics|mesh-ancestor
6267741|NCT03497039|Sensory System Agents|sensory system agents|mesh-ancestor
6267742|NCT03497039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6267743|NCT03497039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267744|NCT03497039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6267745|NCT03497039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6014777|NCT00353119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6267746|NCT03497039|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6267747|NCT03497039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6267748|NCT03497039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267749|NCT03497429|Niraparib|niraparib|mesh-list
6267750|NCT03497429|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6267751|NCT03497429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6267752|NCT03497429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267753|NCT03497429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6267754|NCT03497845|Vaccines|vaccines|mesh-list
6267755|NCT03497845|Immunologic Factors|immunologic factors|mesh-ancestor
6267756|NCT03497845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267757|NCT03498196|Avelumab|avelumab|mesh-list
6267758|NCT03498196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6267759|NCT03498196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6390463|NCT00190996|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6390464|NCT00190996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6390465|NCT00190996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6390466|NCT00190996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390467|NCT00190996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6390468|NCT00190996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390469|NCT00190996|Analgesics|analgesics|mesh-ancestor
6390470|NCT00190996|Sensory System Agents|sensory system agents|mesh-ancestor
6390471|NCT00190996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6390472|NCT00190996|Antidepressive Agents|antidepressive agents|mesh-ancestor
6390473|NCT00190996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6390474|NCT00190996|Dopamine Agents|dopamine agents|mesh-ancestor
6390475|NCT00191009|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6390476|NCT00191009|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6390477|NCT00191009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6390478|NCT00191009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6390479|NCT00191009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390480|NCT00191009|Adrenergic Agents|adrenergic agents|mesh-ancestor
6390481|NCT00191009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6390482|NCT00191009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390483|NCT00191022|Paroxetine|paroxetine|mesh-list
6390484|NCT00191022|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6390485|NCT00191022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6390486|NCT00191022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6390487|NCT00191022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390488|NCT00191022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6390489|NCT00191022|Serotonin Agents|serotonin agents|mesh-ancestor
6390490|NCT00191022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390491|NCT00191022|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6390492|NCT00191022|Antidepressive Agents|antidepressive agents|mesh-ancestor
6390493|NCT00191022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6014778|NCT00353119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6014779|NCT00353119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6014780|NCT00353119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6014781|NCT00353119|Immunologic Factors|immunologic factors|mesh-ancestor
6014782|NCT00353262|Capecitabine|capecitabine|mesh-list
6014783|NCT00353262|Oxaliplatin|oxaliplatin|mesh-list
6014784|NCT00353262|Bevacizumab|bevacizumab|mesh-list
6014785|NCT00353262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6267760|NCT03499353|Talazoparib|talazoparib|mesh-list
6267761|NCT03499353|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6267762|NCT03499353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6267763|NCT03499353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267764|NCT03499353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6267765|NCT03499873|Nepafenac|nepafenac|mesh-list
6267766|NCT03499873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6267767|NCT03499873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6267768|NCT03499873|Analgesics|analgesics|mesh-ancestor
6267769|NCT03499873|Sensory System Agents|sensory system agents|mesh-ancestor
6267770|NCT03499873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6267771|NCT03499873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267772|NCT03499873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6267773|NCT03499873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6267774|NCT03500211|Lidocaine|lidocaine|mesh-list
6267775|NCT03500211|Anesthetics, Local|anesthetics, local|mesh-ancestor
6267776|NCT03500211|Anesthetics|anesthetics|mesh-ancestor
6267777|NCT03500211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6267778|NCT03500211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267779|NCT03500211|Sensory System Agents|sensory system agents|mesh-ancestor
6267780|NCT03500211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6267781|NCT03500211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6267782|NCT03500211|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6267783|NCT03500211|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6267784|NCT03500211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6267785|NCT03500211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267786|NCT03500289|Midazolam|midazolam|mesh-list
6267787|NCT03500289|Ketamine|ketamine|mesh-list
6267788|NCT03500289|Analgesics|analgesics|mesh-ancestor
6267789|NCT03500289|Sensory System Agents|sensory system agents|mesh-ancestor
6267790|NCT03500289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6267791|NCT03500289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267792|NCT03500289|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6267793|NCT03500289|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6267794|NCT03500289|Anesthetics, General|anesthetics, general|mesh-ancestor
6267795|NCT03500289|Anesthetics|anesthetics|mesh-ancestor
6267796|NCT03500289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6267797|NCT03500289|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6267798|NCT03500289|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6267799|NCT03500289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6267800|NCT03500289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267801|NCT03500289|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6267802|NCT03500289|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6267803|NCT03500289|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6267804|NCT03500289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6267805|NCT03500289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6267806|NCT03500289|GABA Modulators|gaba modulators|mesh-ancestor
6267807|NCT03500289|GABA Agents|gaba agents|mesh-ancestor
6267808|NCT03500302|Evolocumab|evolocumab|mesh-list
6267809|NCT03500302|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6267810|NCT03500302|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6267811|NCT03500302|Antimetabolites|antimetabolites|mesh-ancestor
6267812|NCT03500302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267813|NCT03500302|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6267814|NCT03501043|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6267815|NCT03501043|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6267816|NCT03501043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6267817|NCT03501043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267818|NCT03501043|Cholinergic Agents|cholinergic agents|mesh-ancestor
6267819|NCT03501043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6267820|NCT03501043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267821|NCT03501277|Pioglitazone|pioglitazone|mesh-list
6267822|NCT03501277|Alogliptin|alogliptin|mesh-list
6267823|NCT03501277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6267824|NCT03501277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267825|NCT03501277|Incretins|incretins|mesh-ancestor
6267826|NCT03501277|Hormones|hormones|mesh-ancestor
6267827|NCT03501277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6267828|NCT03501277|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6267829|NCT03501277|Protease Inhibitors|protease inhibitors|mesh-ancestor
6267830|NCT03501277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6267831|NCT03501277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267832|NCT03501550|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
6267833|NCT03501550|Antiviral Agents|antiviral agents|mesh-ancestor
6267834|NCT03501550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6267835|NCT03502070|Tobramycin|tobramycin|mesh-list
6267836|NCT03502070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6267837|NCT03502070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6267838|NCT03502616|Tofacitinib|tofacitinib|mesh-list
6267839|NCT03502616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6267840|NCT03502616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6267841|NCT03502616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267842|NCT03502681|Avelumab|avelumab|mesh-list
6267843|NCT03502681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6267844|NCT03502681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6267845|NCT03502915|Nitrous Oxide|nitrous oxide|mesh-list
6267846|NCT03502915|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6267847|NCT03502915|Anesthetics, General|anesthetics, general|mesh-ancestor
6267848|NCT03502915|Anesthetics|anesthetics|mesh-ancestor
6267849|NCT03502915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6267850|NCT03502915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267851|NCT03502915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6267852|NCT03502915|Analgesics|analgesics|mesh-ancestor
6267853|NCT03502915|Sensory System Agents|sensory system agents|mesh-ancestor
6267854|NCT03502915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6267855|NCT03503292|Ondansetron|ondansetron|mesh-list
6267856|NCT03503292|Granisetron|granisetron|mesh-list
6267857|NCT03503292|Antiemetics|antiemetics|mesh-ancestor
6267858|NCT03503292|Autonomic Agents|autonomic agents|mesh-ancestor
6267859|NCT03503292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6267860|NCT03503292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267861|NCT03503292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6267862|NCT03503292|Antipruritics|antipruritics|mesh-ancestor
6267863|NCT03503292|Dermatologic Agents|dermatologic agents|mesh-ancestor
6267864|NCT03503292|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6267865|NCT03503292|Serotonin Agents|serotonin agents|mesh-ancestor
6267866|NCT03503292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6267867|NCT03503292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267868|NCT03503292|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6267869|NCT03503292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6267870|NCT03503292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6267871|NCT03503292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6267872|NCT03503292|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6267873|NCT03503578|Ketamine|ketamine|mesh-list
6267874|NCT03503578|Sevoflurane|sevoflurane|mesh-list
6267875|NCT03503578|Analgesics|analgesics|mesh-ancestor
6267876|NCT03503578|Sensory System Agents|sensory system agents|mesh-ancestor
6267877|NCT03503578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6267878|NCT03503578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267879|NCT03503578|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6267880|NCT03503578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6267881|NCT03503578|Anesthetics, General|anesthetics, general|mesh-ancestor
6267882|NCT03503578|Anesthetics|anesthetics|mesh-ancestor
6267883|NCT03503578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6267884|NCT03503578|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6267885|NCT03503578|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6267886|NCT03503578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6267887|NCT03503578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267888|NCT03503578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6267889|NCT03503578|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6267890|NCT03505021|Simendan|simendan|mesh-list
6267891|NCT03505021|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6267892|NCT03505021|Vasodilator Agents|vasodilator agents|mesh-ancestor
6267893|NCT03505021|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6267894|NCT03505021|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6267895|NCT03505021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6267896|NCT03505021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267897|NCT03505021|Protective Agents|protective agents|mesh-ancestor
6267898|NCT03505021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267899|NCT03506347|Vancomycin|vancomycin|mesh-list
6267900|NCT03506347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6267901|NCT03506347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6267902|NCT03506724|Labetalol|labetalol|mesh-list
6267903|NCT03506724|Nifedipine|nifedipine|mesh-list
6267904|NCT03506724|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6267905|NCT03506724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6267906|NCT03506724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267907|NCT03506724|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6267908|NCT03506724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267909|NCT03506724|Vasodilator Agents|vasodilator agents|mesh-ancestor
6267910|NCT03506724|Tocolytic Agents|tocolytic agents|mesh-ancestor
6267911|NCT03506724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6267912|NCT03506724|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6267913|NCT03506724|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6267914|NCT03506724|Adrenergic Agents|adrenergic agents|mesh-ancestor
6267915|NCT03506724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6267916|NCT03506724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6267917|NCT03506724|Sympathomimetics|sympathomimetics|mesh-ancestor
6267918|NCT03506724|Autonomic Agents|autonomic agents|mesh-ancestor
6267919|NCT03506724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6267920|NCT03506724|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6267921|NCT03506724|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6267922|NCT03508830|Bupivacaine|bupivacaine|mesh-list
6267923|NCT03508830|Anesthetics, Local|anesthetics, local|mesh-ancestor
6267924|NCT03508830|Anesthetics|anesthetics|mesh-ancestor
6267925|NCT03508830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6267926|NCT03508830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267927|NCT03508830|Sensory System Agents|sensory system agents|mesh-ancestor
6267928|NCT03508830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6267929|NCT03509350|Vitamins|vitamins|mesh-list
6267930|NCT03509350|Ascorbic Acid|ascorbic acid|mesh-list
6267931|NCT03509350|Thiamine|thiamine|mesh-list
6267932|NCT03509350|Hydrocortisone|hydrocortisone|mesh-list
6267933|NCT03509350|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6267934|NCT03509350|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6267935|NCT03509350|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6267936|NCT03509350|Micronutrients|micronutrients|mesh-ancestor
6267937|NCT03509350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267938|NCT03509350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6267939|NCT03509350|Antioxidants|antioxidants|mesh-ancestor
6267940|NCT03509350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267941|NCT03509350|Protective Agents|protective agents|mesh-ancestor
6267942|NCT03509350|Vitamin B Complex|vitamin b complex|mesh-ancestor
6267943|NCT03509675|Ibuprofen|ibuprofen|mesh-list
6267944|NCT03509675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6267945|NCT03509675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6267946|NCT03509675|Analgesics|analgesics|mesh-ancestor
6267947|NCT03509675|Sensory System Agents|sensory system agents|mesh-ancestor
6267948|NCT03509675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6267949|NCT03509675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267950|NCT03509675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6267951|NCT03509675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6267952|NCT03509675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6267953|NCT03509675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6267954|NCT03509675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267955|NCT03509766|Histamine|histamine|mesh-list
6267956|NCT03509766|Histamine Agonists|histamine agonists|mesh-ancestor
6267957|NCT03509766|Histamine Agents|histamine agents|mesh-ancestor
6267958|NCT03509766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6267959|NCT03509766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267960|NCT03509766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6267961|NCT03509883|Apixaban|apixaban|mesh-list
6267962|NCT03509883|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6267963|NCT03509883|Antithrombins|antithrombins|mesh-ancestor
6267964|NCT03509883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6267965|NCT03509883|Protease Inhibitors|protease inhibitors|mesh-ancestor
6267966|NCT03509883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6267967|NCT03509883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267968|NCT03509883|Anticoagulants|anticoagulants|mesh-ancestor
6267969|NCT03510455|Infigratinib|infigratinib|mesh-list
6267970|NCT03510455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6267971|NCT03510481|Lumefantrine|lumefantrine|mesh-list
6267972|NCT03510481|Artemether|artemether|mesh-list
6267973|NCT03510481|Antimalarials|antimalarials|mesh-ancestor
6267974|NCT03510481|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6267975|NCT03510481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6267976|NCT03510481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6267977|NCT03510663|Moxifloxacin|moxifloxacin|mesh-list
6267978|NCT03510663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6267979|NCT03510663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6267980|NCT03510663|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6267981|NCT03510663|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6267982|NCT03510663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6267983|NCT03510663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6267984|NCT03510663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6267985|NCT03510715|Nicotinic Acids|nicotinic acids|mesh-list
6267986|NCT03510715|Niacin|niacin|mesh-list
6267987|NCT03510715|Niacinamide|niacinamide|mesh-list
6267988|NCT03510715|Atorvastatin|atorvastatin|mesh-list
6267989|NCT03510715|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6267990|NCT03510715|Simvastatin|simvastatin|mesh-list
6267991|NCT03510715|Ezetimibe|ezetimibe|mesh-list
6267992|NCT03510715|Pravastatin|pravastatin|mesh-list
6267993|NCT03510715|Lovastatin|lovastatin|mesh-list
6267994|NCT03510715|Cholestyramine Resin|cholestyramine resin|mesh-list
6267995|NCT03510715|Fenofibrate|fenofibrate|mesh-list
6267996|NCT03510715|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6267997|NCT03510715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6267998|NCT03510715|Antimetabolites|antimetabolites|mesh-ancestor
6267999|NCT03510715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6268000|NCT03510715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6268001|NCT03510715|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6268002|NCT03510715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6268003|NCT03510715|Vitamin B Complex|vitamin b complex|mesh-ancestor
6268004|NCT03510715|Vitamins|vitamins|mesh-ancestor
6268005|NCT03510715|Micronutrients|micronutrients|mesh-ancestor
6268006|NCT03510715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268007|NCT03510715|Vasodilator Agents|vasodilator agents|mesh-ancestor
6268008|NCT03510910|Acetaminophen|acetaminophen|mesh-list
6268009|NCT03510910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6268010|NCT03510910|Analgesics|analgesics|mesh-ancestor
6268011|NCT03510910|Sensory System Agents|sensory system agents|mesh-ancestor
6268012|NCT03510910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6268013|NCT03510910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268014|NCT03510910|Antipyretics|antipyretics|mesh-ancestor
6268015|NCT03511326|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6268016|NCT03511326|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
6268017|NCT03511326|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6268018|NCT03511326|Dermatologic Agents|dermatologic agents|mesh-ancestor
6268019|NCT03511521|Insulin|insulin|mesh-list
6268020|NCT03511521|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6268021|NCT03511521|Insulin Aspart|insulin aspart|mesh-list
6268022|NCT03511521|Insulin, Isophane|insulin, isophane|mesh-list
6268023|NCT03511521|Isophane Insulin, Human|isophane insulin, human|mesh-list
6268024|NCT03511521|Isophane insulin, beef|isophane insulin, beef|mesh-list
6268025|NCT03511521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6268026|NCT03511521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268027|NCT03512288|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6268028|NCT03512288|Immunologic Factors|immunologic factors|mesh-ancestor
6268029|NCT03512288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268030|NCT03512353|Dexamethasone|dexamethasone|mesh-list
6268031|NCT03512353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6268032|NCT03512353|Antiemetics|antiemetics|mesh-ancestor
6268033|NCT03512353|Autonomic Agents|autonomic agents|mesh-ancestor
6268034|NCT03512353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6268035|NCT03512353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268036|NCT03512353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6268037|NCT03512353|Glucocorticoids|glucocorticoids|mesh-ancestor
6268038|NCT03512353|Hormones|hormones|mesh-ancestor
6268039|NCT03512353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6268040|NCT03512353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6268041|NCT03512353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6268042|NCT03513757|Lidocaine|lidocaine|mesh-list
6268043|NCT03513757|Glycopyrrolate|glycopyrrolate|mesh-list
6268044|NCT03513757|Dexmedetomidine|dexmedetomidine|mesh-list
6268045|NCT03513757|Nitrous Oxide|nitrous oxide|mesh-list
6268046|NCT03513757|Propofol|propofol|mesh-list
6268047|NCT03513757|Sevoflurane|sevoflurane|mesh-list
6268048|NCT03513757|Anesthetics, Local|anesthetics, local|mesh-ancestor
6268049|NCT03513757|Anesthetics|anesthetics|mesh-ancestor
6268050|NCT03513757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6268051|NCT03513757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268052|NCT03513757|Sensory System Agents|sensory system agents|mesh-ancestor
6268053|NCT03513757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6268054|NCT03513757|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6268055|NCT03513757|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6268056|NCT03513757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6268057|NCT03513757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6268058|NCT03513757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6268059|NCT03513757|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6268060|NCT03513757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6268061|NCT03513757|Anesthetics, General|anesthetics, general|mesh-ancestor
6268062|NCT03513757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6268063|NCT03513757|Analgesics|analgesics|mesh-ancestor
6268064|NCT03513757|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6268065|NCT03513757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6268066|NCT03513757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6268067|NCT03513757|Adrenergic Agents|adrenergic agents|mesh-ancestor
6268068|NCT03513757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6268069|NCT03513757|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6268070|NCT03513757|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6268071|NCT03513757|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6268072|NCT03513757|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6268073|NCT03513757|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6268074|NCT03513757|Cholinergic Agents|cholinergic agents|mesh-ancestor
6268075|NCT03514277|Bupivacaine|bupivacaine|mesh-list
6268076|NCT03514277|Anesthetics, Local|anesthetics, local|mesh-ancestor
6268077|NCT03514277|Anesthetics|anesthetics|mesh-ancestor
6268078|NCT03514277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6268079|NCT03514277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268080|NCT03514277|Sensory System Agents|sensory system agents|mesh-ancestor
6268081|NCT03514277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6268082|NCT03514641|Bexagliflozin|bexagliflozin|mesh-list
6268083|NCT03514641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6268084|NCT03514641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268085|NCT03515941|Leucovorin|leucovorin|mesh-list
6268086|NCT03515941|Fluorouracil|fluorouracil|mesh-list
6268087|NCT03515941|Capecitabine|capecitabine|mesh-list
6268088|NCT03515941|Oxaliplatin|oxaliplatin|mesh-list
6268089|NCT03515941|Antimetabolites|antimetabolites|mesh-ancestor
6268090|NCT03515941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6268091|NCT03515941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6268092|NCT03515941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6268093|NCT03515941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6268094|NCT03515941|Immunologic Factors|immunologic factors|mesh-ancestor
6268095|NCT03515941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268096|NCT03515941|Antidotes|antidotes|mesh-ancestor
6268097|NCT03515941|Protective Agents|protective agents|mesh-ancestor
6268098|NCT03515941|Vitamin B Complex|vitamin b complex|mesh-ancestor
6268099|NCT03515941|Vitamins|vitamins|mesh-ancestor
6268100|NCT03515941|Micronutrients|micronutrients|mesh-ancestor
6268101|NCT03518125|Vaccines|vaccines|mesh-list
6268102|NCT03518125|Immunologic Factors|immunologic factors|mesh-ancestor
6268103|NCT03518125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268104|NCT03519204|Lidocaine|lidocaine|mesh-list
6268105|NCT03519204|Anesthetics, Local|anesthetics, local|mesh-ancestor
6268106|NCT03519204|Anesthetics|anesthetics|mesh-ancestor
6268107|NCT03519204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6268108|NCT03519204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268109|NCT03519204|Sensory System Agents|sensory system agents|mesh-ancestor
6268110|NCT03519204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6268111|NCT03519204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6268112|NCT03519204|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6268113|NCT03519204|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6268114|NCT03519204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6268115|NCT03519204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390494|NCT00191022|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6390495|NCT00191022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6390496|NCT00191022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6390497|NCT00191035|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6390498|NCT00191035|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6390499|NCT00191035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6390500|NCT00191035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6390501|NCT00191035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390502|NCT00191035|Adrenergic Agents|adrenergic agents|mesh-ancestor
6390503|NCT00191035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6390504|NCT00191035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390505|NCT00191048|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6390506|NCT00191048|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6390507|NCT00191048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6390508|NCT00191048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6390509|NCT00191048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390510|NCT00191048|Adrenergic Agents|adrenergic agents|mesh-ancestor
6390511|NCT00191048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6390512|NCT00191048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268116|NCT03519243|Darbepoetin alfa|darbepoetin alfa|mesh-list
6268117|NCT03519243|Hematinics|hematinics|mesh-ancestor
6268118|NCT03519516|Ciprofloxacin|ciprofloxacin|mesh-list
6268119|NCT03519516|Levofloxacin|levofloxacin|mesh-list
6268120|NCT03519516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6268121|NCT03519516|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6268122|NCT03519516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6268123|NCT03519516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6268124|NCT03519516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6268125|NCT03519516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6268126|NCT03519516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6268127|NCT03519516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6268128|NCT03519516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6268129|NCT03519516|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6268130|NCT03519516|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6268131|NCT03519516|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6268132|NCT03519516|Renal Agents|renal agents|mesh-ancestor
6268133|NCT03519854|Bromides|bromides|mesh-list
6268134|NCT03519854|Rocuronium|rocuronium|mesh-list
6268135|NCT03519854|Anticonvulsants|anticonvulsants|mesh-ancestor
6268136|NCT03519854|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6268137|NCT03519854|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6268138|NCT03519854|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6268139|NCT03519854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6268140|NCT03519854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268141|NCT03519867|Bromides|bromides|mesh-list
6268142|NCT03519867|Rocuronium|rocuronium|mesh-list
6268143|NCT03519867|Anticonvulsants|anticonvulsants|mesh-ancestor
6268144|NCT03519867|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6268145|NCT03519867|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6268146|NCT03519867|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6268147|NCT03519867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6268148|NCT03519867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268149|NCT03520348|Pantothenic Acid|pantothenic acid|mesh-list
6268150|NCT03520348|Vitamin B Complex|vitamin b complex|mesh-ancestor
6268151|NCT03520348|Vitamins|vitamins|mesh-ancestor
6268152|NCT03520348|Micronutrients|micronutrients|mesh-ancestor
6268153|NCT03520348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268154|NCT03520920|Rituximab|rituximab|mesh-list
6268155|NCT03520920|Zanubrutinib|zanubrutinib|mesh-list
6268156|NCT03520920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6268157|NCT03520920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6268158|NCT03520920|Immunologic Factors|immunologic factors|mesh-ancestor
6268159|NCT03520920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268160|NCT03520920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6268161|NCT03520920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6268162|NCT03520920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6268163|NCT03520920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6268164|NCT03521141|Nicotine|nicotine|mesh-list
6268165|NCT03521141|Varenicline|varenicline|mesh-list
6268166|NCT03521141|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6268167|NCT03521141|Autonomic Agents|autonomic agents|mesh-ancestor
6268168|NCT03521141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6268169|NCT03521141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268170|NCT03521141|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6268171|NCT03521141|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6268172|NCT03521141|Cholinergic Agents|cholinergic agents|mesh-ancestor
6268173|NCT03521141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6268174|NCT03521141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6268175|NCT03521193|Aspirin|aspirin|mesh-list
6268176|NCT03521193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6268177|NCT03521193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6268178|NCT03521193|Analgesics|analgesics|mesh-ancestor
6268179|NCT03521193|Sensory System Agents|sensory system agents|mesh-ancestor
6268180|NCT03521193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6268181|NCT03521193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268182|NCT03521193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6268183|NCT03521193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6268184|NCT03521193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6268185|NCT03521193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6268186|NCT03521193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6268187|NCT03521193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6268188|NCT03521193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6268189|NCT03521193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6268190|NCT03521193|Antipyretics|antipyretics|mesh-ancestor
6268191|NCT03521479|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
6268192|NCT03521479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6268193|NCT03521479|Immunologic Factors|immunologic factors|mesh-ancestor
6268194|NCT03521479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268195|NCT03521505|Dexmedetomidine|dexmedetomidine|mesh-list
6268196|NCT03521505|Propofol|propofol|mesh-list
6268197|NCT03521505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6268198|NCT03521505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6268199|NCT03521505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268200|NCT03521505|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6268201|NCT03521505|Anesthetics, General|anesthetics, general|mesh-ancestor
6268202|NCT03521505|Anesthetics|anesthetics|mesh-ancestor
6268203|NCT03521505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6268204|NCT03521505|Analgesics|analgesics|mesh-ancestor
6268205|NCT03521505|Sensory System Agents|sensory system agents|mesh-ancestor
6268206|NCT03521505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6268207|NCT03521505|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6268208|NCT03521505|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6268209|NCT03521505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6268210|NCT03521505|Adrenergic Agents|adrenergic agents|mesh-ancestor
6268211|NCT03521505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6268212|NCT03521505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6268213|NCT03521635|Pramipexole|pramipexole|mesh-list
6268214|NCT03521635|Antioxidants|antioxidants|mesh-ancestor
6268215|NCT03521635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6268216|NCT03521635|Protective Agents|protective agents|mesh-ancestor
6268217|NCT03521635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268218|NCT03521635|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6268219|NCT03521635|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6268220|NCT03521635|Dopamine Agonists|dopamine agonists|mesh-ancestor
6268221|NCT03521635|Dopamine Agents|dopamine agents|mesh-ancestor
6268222|NCT03521635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6268223|NCT03521791|Bromfenac|bromfenac|mesh-list
6268224|NCT03521791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6268225|NCT03521791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6268226|NCT03521791|Analgesics|analgesics|mesh-ancestor
6268227|NCT03521791|Sensory System Agents|sensory system agents|mesh-ancestor
6268228|NCT03521791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6268229|NCT03521791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268230|NCT03521791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6268231|NCT03521791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6268232|NCT03521817|Ethanol|ethanol|mesh-list
6268233|NCT03521817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6268234|NCT03521817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6268235|NCT03521817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6268236|NCT03521817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268237|NCT03522441|Clindamycin|clindamycin|mesh-list
6268238|NCT03522441|Clindamycin palmitate|clindamycin palmitate|mesh-list
6268239|NCT03522441|Clindamycin phosphate|clindamycin phosphate|mesh-list
6268240|NCT03522441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6268241|NCT03522441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6268242|NCT03522441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6268243|NCT03522441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6268244|NCT03522441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6268245|NCT03522506|Modafinil|modafinil|mesh-list
6268246|NCT03522506|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6268247|NCT03522506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268248|NCT03522506|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6268249|NCT03522506|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6268250|NCT03522506|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6268251|NCT03522506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6268252|NCT03523715|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
6268253|NCT03523715|Antidiarrheals|antidiarrheals|mesh-ancestor
6014786|NCT00353262|Antimetabolites|antimetabolites|mesh-ancestor
6014787|NCT00353262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014788|NCT00353262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6268254|NCT03523715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6268255|NCT03523988|Acetaminophen|acetaminophen|mesh-list
6268256|NCT03523988|Ibuprofen|ibuprofen|mesh-list
6268257|NCT03523988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6268258|NCT03523988|Analgesics|analgesics|mesh-ancestor
6268259|NCT03523988|Sensory System Agents|sensory system agents|mesh-ancestor
6268260|NCT03523988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6268261|NCT03523988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268262|NCT03523988|Antipyretics|antipyretics|mesh-ancestor
6268263|NCT03523988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6268264|NCT03523988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6268265|NCT03523988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6268266|NCT03523988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6268267|NCT03523988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6268268|NCT03523988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6268269|NCT03524157|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6268270|NCT03524157|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6268271|NCT03524157|Hyaluronic Acid|hyaluronic acid|mesh-list
6268272|NCT03524157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6268273|NCT03524157|Immunologic Factors|immunologic factors|mesh-ancestor
6268274|NCT03524157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268275|NCT03524157|Viscosupplements|viscosupplements|mesh-ancestor
6268276|NCT03524157|Protective Agents|protective agents|mesh-ancestor
6268277|NCT03524339|Tamsulosin|tamsulosin|mesh-list
6268278|NCT03524339|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6268279|NCT03524339|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6268280|NCT03524339|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6268281|NCT03524339|Adrenergic Agents|adrenergic agents|mesh-ancestor
6268282|NCT03524339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6268283|NCT03524339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6268284|NCT03524339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268285|NCT03524339|Urological Agents|urological agents|mesh-ancestor
6268286|NCT03525119|Vaccines|vaccines|mesh-list
6268287|NCT03525119|Immunologic Factors|immunologic factors|mesh-ancestor
6268288|NCT03525119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268289|NCT03525444|Ivacaftor|ivacaftor|mesh-list
6268290|NCT03525444|Elexacaftor|elexacaftor|mesh-list
6268291|NCT03525444|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6268292|NCT03525444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6268293|NCT03525444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6268294|NCT03525548|Ivacaftor|ivacaftor|mesh-list
6268295|NCT03525548|Elexacaftor|elexacaftor|mesh-list
6268296|NCT03525548|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6268297|NCT03525548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6268298|NCT03525548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6268299|NCT03525834|Everolimus|everolimus|mesh-list
6014789|NCT00353262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6014790|NCT00353262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6014791|NCT00353262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6014792|NCT00353262|Growth Substances|growth substances|mesh-ancestor
6014793|NCT00353262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014794|NCT00353262|Growth Inhibitors|growth inhibitors|mesh-ancestor
6014795|NCT00353301|Sirolimus|sirolimus|mesh-list
6014796|NCT00353301|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6268300|NCT03525834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6268301|NCT03525834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6268302|NCT03525834|Immunologic Factors|immunologic factors|mesh-ancestor
6268303|NCT03525834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268304|NCT03527173|Vaccines|vaccines|mesh-list
6268305|NCT03527173|Immunologic Factors|immunologic factors|mesh-ancestor
6268306|NCT03527173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268307|NCT03527745|Albendazole|albendazole|mesh-list
6268308|NCT03527745|Anthelmintics|anthelmintics|mesh-ancestor
6268309|NCT03527745|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6268310|NCT03527745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6268311|NCT03527745|Anticestodal Agents|anticestodal agents|mesh-ancestor
6268312|NCT03527745|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6268313|NCT03527745|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6268314|NCT03527745|Tubulin Modulators|tubulin modulators|mesh-ancestor
6268315|NCT03527745|Antimitotic Agents|antimitotic agents|mesh-ancestor
6268316|NCT03527745|Mitosis Modulators|mitosis modulators|mesh-ancestor
6268317|NCT03527745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6268318|NCT03527745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6268319|NCT03528174|Pancrelipase|pancrelipase|mesh-list
6268320|NCT03528174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6268321|NCT03528369|Capsaicin|capsaicin|mesh-list
6268322|NCT03528369|Antipruritics|antipruritics|mesh-ancestor
6268323|NCT03528369|Dermatologic Agents|dermatologic agents|mesh-ancestor
6268324|NCT03528369|Sensory System Agents|sensory system agents|mesh-ancestor
6268325|NCT03528369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6268326|NCT03528369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268327|NCT03528512|Fentanyl|fentanyl|mesh-list
6268328|NCT03528512|Midazolam|midazolam|mesh-list
6268329|NCT03528512|Ketamine|ketamine|mesh-list
6268330|NCT03528512|Analgesics|analgesics|mesh-ancestor
6268331|NCT03528512|Sensory System Agents|sensory system agents|mesh-ancestor
6268332|NCT03528512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6268333|NCT03528512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268334|NCT03528512|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6268335|NCT03528512|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6268336|NCT03528512|Anesthetics, General|anesthetics, general|mesh-ancestor
6268337|NCT03528512|Anesthetics|anesthetics|mesh-ancestor
6268338|NCT03528512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6268339|NCT03528512|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6268340|NCT03528512|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6268341|NCT03528512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6268342|NCT03528512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6268343|NCT03528512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6268344|NCT03528512|Narcotics|narcotics|mesh-ancestor
6268345|NCT03528512|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6268346|NCT03528512|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6268347|NCT03528512|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6268348|NCT03528512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6268349|NCT03528512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6268350|NCT03528512|GABA Modulators|gaba modulators|mesh-ancestor
6268351|NCT03528512|GABA Agents|gaba agents|mesh-ancestor
6268352|NCT03528551|Factor VIII|factor viii|mesh-list
6268353|NCT03528551|Coagulants|coagulants|mesh-ancestor
6268354|NCT03528577|Albuterol|albuterol|mesh-list
6268355|NCT03528577|Procaterol|procaterol|mesh-list
6268356|NCT03528577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6268357|NCT03528577|Autonomic Agents|autonomic agents|mesh-ancestor
6268358|NCT03528577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6268359|NCT03528577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268360|NCT03528577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6268361|NCT03528577|Respiratory System Agents|respiratory system agents|mesh-ancestor
6268362|NCT03528577|Tocolytic Agents|tocolytic agents|mesh-ancestor
6268363|NCT03528577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6268364|NCT03528577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6268365|NCT03528577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6268366|NCT03528577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6268367|NCT03528577|Adrenergic Agents|adrenergic agents|mesh-ancestor
6268368|NCT03528577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6268369|NCT03528577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014797|NCT00353301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6014798|NCT00353301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6014799|NCT00353301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6014800|NCT00353301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014801|NCT00353301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6268370|NCT03528577|Sympathomimetics|sympathomimetics|mesh-ancestor
6268371|NCT03530631|Adderall|adderall|mesh-list
6268372|NCT03530631|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6268373|NCT03530631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268374|NCT03530995|Itraconazole|itraconazole|mesh-list
6268375|NCT03530995|Rifampin|rifampin|mesh-list
6268376|NCT03530995|Omeprazole|omeprazole|mesh-list
6268377|NCT03530995|Rabeprazole|rabeprazole|mesh-list
6268378|NCT03530995|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6268379|NCT03530995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6268380|NCT03530995|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6268381|NCT03530995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6268382|NCT03530995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6268383|NCT03530995|Antifungal Agents|antifungal agents|mesh-ancestor
6268384|NCT03530995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6268385|NCT03530995|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6268386|NCT03530995|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6014802|NCT00353301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6014803|NCT00353301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6014804|NCT00353301|Antifungal Agents|antifungal agents|mesh-ancestor
6014805|NCT00353301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6014806|NCT00353301|Immunologic Factors|immunologic factors|mesh-ancestor
6014807|NCT00353301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014808|NCT00353418|Ribavirin|ribavirin|mesh-list
6014809|NCT00353418|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6014810|NCT00353418|Antimetabolites|antimetabolites|mesh-ancestor
6014811|NCT00353418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014812|NCT00353418|Antiviral Agents|antiviral agents|mesh-ancestor
6014813|NCT00353418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6014814|NCT00353431|Insulin Aspart|insulin aspart|mesh-list
6014815|NCT00353431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6014816|NCT00353431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014817|NCT00353496|Lanreotide|lanreotide|mesh-list
6268387|NCT03530995|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6268388|NCT03530995|Hormone Antagonists|hormone antagonists|mesh-ancestor
6268389|NCT03530995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6268390|NCT03530995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268391|NCT03530995|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6268392|NCT03530995|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6268393|NCT03530995|Antitubercular Agents|antitubercular agents|mesh-ancestor
6268394|NCT03530995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6268395|NCT03530995|Leprostatic Agents|leprostatic agents|mesh-ancestor
6268396|NCT03530995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6268397|NCT03530995|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6268398|NCT03530995|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6268399|NCT03530995|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6268400|NCT03530995|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6268401|NCT03530995|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6268402|NCT03530995|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6268403|NCT03531840|Olaparib|olaparib|mesh-list
6268404|NCT03531840|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6268405|NCT03531840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6268406|NCT03531840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6268407|NCT03531840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6268408|NCT03531905|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
6268409|NCT03531905|Ezetimibe|ezetimibe|mesh-list
6268410|NCT03531905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6268411|NCT03531905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6268412|NCT03531905|Antimetabolites|antimetabolites|mesh-ancestor
6268413|NCT03531905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6268414|NCT03531905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6268415|NCT03531905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6268416|NCT03531905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6268417|NCT03531905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268418|NCT03532776|Podophyllotoxin|podophyllotoxin|mesh-list
6268419|NCT03532776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6268420|NCT03532776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6268421|NCT03532776|Keratolytic Agents|keratolytic agents|mesh-ancestor
6268422|NCT03532776|Dermatologic Agents|dermatologic agents|mesh-ancestor
6268423|NCT03532776|Tubulin Modulators|tubulin modulators|mesh-ancestor
6268424|NCT03532776|Antimitotic Agents|antimitotic agents|mesh-ancestor
6268425|NCT03532776|Mitosis Modulators|mitosis modulators|mesh-ancestor
6268426|NCT03532776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6268427|NCT03533244|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6268428|NCT03533244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6268429|NCT03535194|Mirikizumab|mirikizumab|mesh-list
6268430|NCT03535194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6268431|NCT03535194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6268432|NCT03535194|Analgesics|analgesics|mesh-ancestor
6268433|NCT03535194|Sensory System Agents|sensory system agents|mesh-ancestor
6268434|NCT03535194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6268435|NCT03535194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268436|NCT03535194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6268437|NCT03535194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6268438|NCT03535194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6268439|NCT03535194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6268440|NCT03536949|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6268441|NCT03536949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6268442|NCT03537014|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
6268443|NCT03537014|Hallucinogens|hallucinogens|mesh-ancestor
6268444|NCT03537014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268445|NCT03537014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6268446|NCT03537014|Serotonin Agents|serotonin agents|mesh-ancestor
6268447|NCT03537014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6268448|NCT03537014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6268449|NCT03537014|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6268450|NCT03537014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6268451|NCT03537014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6268452|NCT03537014|Adrenergic Agents|adrenergic agents|mesh-ancestor
6268453|NCT03537274|Interferons|interferons|mesh-list
6268454|NCT03537274|Interferon-alpha|interferon-alpha|mesh-list
6268455|NCT03537274|Interferon alpha-2|interferon alpha-2|mesh-list
6268456|NCT03537274|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6268457|NCT03537274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6268458|NCT03537274|Antiviral Agents|antiviral agents|mesh-ancestor
6268459|NCT03537274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6268460|NCT03537274|Immunologic Factors|immunologic factors|mesh-ancestor
6268461|NCT03537274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268462|NCT03537404|Ritonavir|ritonavir|mesh-list
6268463|NCT03537404|Tenofovir|tenofovir|mesh-list
6268464|NCT03537404|Raltegravir Potassium|raltegravir potassium|mesh-list
6268465|NCT03537404|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6268466|NCT03537404|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6268467|NCT03537404|Protease Inhibitors|protease inhibitors|mesh-ancestor
6268468|NCT03537404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6268469|NCT03537404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6268470|NCT03537404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6268471|NCT03537404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6268472|NCT03537404|Antiviral Agents|antiviral agents|mesh-ancestor
6268473|NCT03537404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6268474|NCT03537404|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6268475|NCT03537404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6268476|NCT03537404|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6268477|NCT03537404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6268478|NCT03537404|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6268479|NCT03537404|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6268480|NCT03537651|Ivacaftor|ivacaftor|mesh-list
6268481|NCT03537651|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6268482|NCT03537651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6268483|NCT03537651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6268484|NCT03538431|Buspirone|buspirone|mesh-list
6268485|NCT03538431|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6268486|NCT03538431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6268487|NCT03538431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6268488|NCT03538431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268489|NCT03538431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6268490|NCT03538431|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6268491|NCT03538431|Serotonin Agents|serotonin agents|mesh-ancestor
6268492|NCT03538431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6268493|NCT03538431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6268494|NCT03538808|Varenicline|varenicline|mesh-list
6268495|NCT03538808|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6268496|NCT03538808|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6268497|NCT03538808|Cholinergic Agents|cholinergic agents|mesh-ancestor
6268498|NCT03538808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6268499|NCT03538808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6268500|NCT03538808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268501|NCT03539432|Gemfibrozil|gemfibrozil|mesh-list
6268502|NCT03539432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6268503|NCT03539432|Antimetabolites|antimetabolites|mesh-ancestor
6268504|NCT03539432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6268505|NCT03539432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6268506|NCT03539432|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6268507|NCT03539432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6268508|NCT03539432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6390513|NCT00191061|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6390514|NCT00191061|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6390515|NCT00191061|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6390516|NCT00191061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6268509|NCT03539484|Obinutuzumab|obinutuzumab|mesh-list
6268510|NCT03539484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6268511|NCT03539484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6268512|NCT03540030|Acetaminophen|acetaminophen|mesh-list
6268513|NCT03540030|Celecoxib|celecoxib|mesh-list
6268514|NCT03540030|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6268515|NCT03540030|Lidocaine|lidocaine|mesh-list
6268516|NCT03540030|Gabapentin|gabapentin|mesh-list
6268517|NCT03540030|Propofol|propofol|mesh-list
6268518|NCT03540030|Sevoflurane|sevoflurane|mesh-list
6268519|NCT03540030|Desflurane|desflurane|mesh-list
6268520|NCT03540030|Rocuronium|rocuronium|mesh-list
6268521|NCT03540030|Vecuronium Bromide|vecuronium bromide|mesh-list
6268522|NCT03540030|Anesthetics, Local|anesthetics, local|mesh-ancestor
6268523|NCT03540030|Anesthetics|anesthetics|mesh-ancestor
6268524|NCT03540030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6268525|NCT03540030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268526|NCT03540030|Sensory System Agents|sensory system agents|mesh-ancestor
6268527|NCT03540030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6268528|NCT03540030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6268529|NCT03540030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6268530|NCT03540030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6268531|NCT03540030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6268532|NCT03540030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6268533|NCT03540030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6268534|NCT03540030|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6268535|NCT03540030|Anesthetics, General|anesthetics, general|mesh-ancestor
6268536|NCT03540030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6268537|NCT03540030|Analgesics|analgesics|mesh-ancestor
6268538|NCT03540030|Antipyretics|antipyretics|mesh-ancestor
6268539|NCT03540030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6268540|NCT03540030|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6268541|NCT03540030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6268542|NCT03540030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6268543|NCT03540030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6268544|NCT03540030|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6268545|NCT03540030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6268546|NCT03540030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6268547|NCT03540030|Anticonvulsants|anticonvulsants|mesh-ancestor
5724167|NCT03188978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6268548|NCT03540030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6268549|NCT03540030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6268550|NCT03540030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6268551|NCT03540030|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6268552|NCT03540030|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6268553|NCT03540030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6268554|NCT03540030|Antimanic Agents|antimanic agents|mesh-ancestor
6268555|NCT03540030|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6268556|NCT03540030|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6268557|NCT03540030|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6268558|NCT03540030|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
6268559|NCT03540030|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6268560|NCT03540030|Cholinergic Agents|cholinergic agents|mesh-ancestor
6268561|NCT03540160|Serlopitant|serlopitant|mesh-list
6268562|NCT03540160|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6268563|NCT03540160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6268564|NCT03540160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6268565|NCT03540160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268566|NCT03541044|Nicotine|nicotine|mesh-list
6268567|NCT03541044|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6268568|NCT03541044|Autonomic Agents|autonomic agents|mesh-ancestor
6268569|NCT03541044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6268570|NCT03541044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268571|NCT03541044|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6268572|NCT03541044|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6268573|NCT03541044|Cholinergic Agents|cholinergic agents|mesh-ancestor
6268574|NCT03541044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6268575|NCT03541044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6268576|NCT03541356|Carbidopa|carbidopa|mesh-list
6268577|NCT03541356|Levodopa|levodopa|mesh-list
6268578|NCT03541356|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
6268579|NCT03541356|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6268580|NCT03541356|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6268581|NCT03541356|Dopamine Agents|dopamine agents|mesh-ancestor
6268582|NCT03541356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6268583|NCT03541356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6268584|NCT03541356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268585|NCT03541356|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6268586|NCT03541356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6268587|NCT03541941|Bupivacaine|bupivacaine|mesh-list
6268588|NCT03541941|Anesthetics, Local|anesthetics, local|mesh-ancestor
6268589|NCT03541941|Anesthetics|anesthetics|mesh-ancestor
6268590|NCT03541941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6268591|NCT03541941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268592|NCT03541941|Sensory System Agents|sensory system agents|mesh-ancestor
6268593|NCT03541941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6268594|NCT03541980|Acetaminophen|acetaminophen|mesh-list
6268595|NCT03541980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6268596|NCT03541980|Analgesics|analgesics|mesh-ancestor
6268597|NCT03541980|Sensory System Agents|sensory system agents|mesh-ancestor
6268598|NCT03541980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6268599|NCT03541980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268600|NCT03541980|Antipyretics|antipyretics|mesh-ancestor
6268601|NCT03542266|Azacitidine|azacitidine|mesh-list
6268602|NCT03542266|Cc-486|cc-486|mesh-list
6268603|NCT03542266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6268604|NCT03542266|Antimetabolites|antimetabolites|mesh-ancestor
6268605|NCT03542266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6268606|NCT03542266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6268607|NCT03542266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6268608|NCT03543137|Nicotine|nicotine|mesh-list
6268609|NCT03543137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6268610|NCT03543137|Autonomic Agents|autonomic agents|mesh-ancestor
6268611|NCT03543137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6268612|NCT03543137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268613|NCT03543137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6268614|NCT03543137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6268615|NCT03543137|Cholinergic Agents|cholinergic agents|mesh-ancestor
6268616|NCT03543137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6268617|NCT03543137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6268618|NCT03545165|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
6268619|NCT03545165|177Lu-PSMA-617|177lu-psma-617|mesh-list
6268620|NCT03545165|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6268621|NCT03545165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6268622|NCT03545503|Ketamine|ketamine|mesh-list
6268623|NCT03545503|Etomidate|etomidate|mesh-list
6268624|NCT03545503|Analgesics|analgesics|mesh-ancestor
6268625|NCT03545503|Sensory System Agents|sensory system agents|mesh-ancestor
6268626|NCT03545503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6268627|NCT03545503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268628|NCT03545503|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6268629|NCT03545503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6268630|NCT03545503|Anesthetics, General|anesthetics, general|mesh-ancestor
6268631|NCT03545503|Anesthetics|anesthetics|mesh-ancestor
6268632|NCT03545503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6268633|NCT03545503|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6268634|NCT03545503|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6268635|NCT03545503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6268636|NCT03545503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6268637|NCT03545503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6268638|NCT03545893|Ibuprofen|ibuprofen|mesh-list
6268639|NCT03545893|Oxycodone|oxycodone|mesh-list
6268640|NCT03545893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6268641|NCT03545893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6268642|NCT03545893|Analgesics|analgesics|mesh-ancestor
6268643|NCT03545893|Sensory System Agents|sensory system agents|mesh-ancestor
6268644|NCT03545893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6268645|NCT03545893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268646|NCT03545893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6268647|NCT03545893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6268648|NCT03545893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6268649|NCT03545893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6268650|NCT03545893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6268651|NCT03545893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6268652|NCT03545893|Narcotics|narcotics|mesh-ancestor
6268653|NCT03545893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6268654|NCT03546192|Vaccines|vaccines|mesh-list
6268655|NCT03546192|Immunologic Factors|immunologic factors|mesh-ancestor
6268656|NCT03546192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268657|NCT03546621|Tenofovir|tenofovir|mesh-list
6268658|NCT03546621|Antiviral Agents|antiviral agents|mesh-ancestor
6268659|NCT03546621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6268660|NCT03546621|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6268661|NCT03546621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6268662|NCT03546621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6268663|NCT03546621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6268664|NCT03546621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6268665|NCT03546621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6268666|NCT03546816|Serlopitant|serlopitant|mesh-list
6268667|NCT03546816|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6268668|NCT03546816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6268669|NCT03546816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6268670|NCT03546816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268671|NCT03547154|Interferons|interferons|mesh-list
6268672|NCT03547154|Interferon-alpha|interferon-alpha|mesh-list
6268673|NCT03547154|Interferon alpha-2|interferon alpha-2|mesh-list
6268674|NCT03547154|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6268675|NCT03547154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6268676|NCT03547154|Antiviral Agents|antiviral agents|mesh-ancestor
6268677|NCT03547154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6268678|NCT03547154|Immunologic Factors|immunologic factors|mesh-ancestor
6268679|NCT03547154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268680|NCT03547167|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6268681|NCT03547167|Immunologic Factors|immunologic factors|mesh-ancestor
6268682|NCT03547167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268683|NCT03549598|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6268684|NCT03549598|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6268685|NCT03549598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6268686|NCT03550313|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6268687|NCT03550313|Immunologic Factors|immunologic factors|mesh-ancestor
6268688|NCT03550313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268689|NCT03551730|Enoxaparin|enoxaparin|mesh-list
6268690|NCT03551730|Enoxaparin sodium|enoxaparin sodium|mesh-list
6268691|NCT03551730|Anticoagulants|anticoagulants|mesh-ancestor
6268692|NCT03551730|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6268693|NCT03551730|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6268694|NCT03551730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6268695|NCT03551743|Edoxaban|edoxaban|mesh-list
6268696|NCT03551743|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6268697|NCT03551743|Antithrombins|antithrombins|mesh-ancestor
6268698|NCT03551743|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6268699|NCT03551743|Protease Inhibitors|protease inhibitors|mesh-ancestor
6268700|NCT03551743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6268701|NCT03551743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6268702|NCT03551743|Anticoagulants|anticoagulants|mesh-ancestor
6268703|NCT03552523|Pancrelipase|pancrelipase|mesh-list
6268704|NCT03552523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6268705|NCT03552549|Interferons|interferons|mesh-list
6268706|NCT03552549|Interferon-alpha|interferon-alpha|mesh-list
6268707|NCT03552549|Interferon alpha-2|interferon alpha-2|mesh-list
6268708|NCT03552549|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6268709|NCT03552549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6268710|NCT03552549|Antiviral Agents|antiviral agents|mesh-ancestor
6268711|NCT03552549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6268712|NCT03552549|Immunologic Factors|immunologic factors|mesh-ancestor
6268713|NCT03552549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268714|NCT03553758|Ketamine|ketamine|mesh-list
6268715|NCT03553758|Analgesics|analgesics|mesh-ancestor
6268716|NCT03553758|Sensory System Agents|sensory system agents|mesh-ancestor
6268717|NCT03553758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6268718|NCT03553758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268719|NCT03553758|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6268720|NCT03553758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6268721|NCT03553758|Anesthetics, General|anesthetics, general|mesh-ancestor
6268722|NCT03553758|Anesthetics|anesthetics|mesh-ancestor
6268723|NCT03553758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6268724|NCT03553758|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6268725|NCT03553758|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6268726|NCT03553758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6268727|NCT03553758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6268728|NCT03553940|Vaccines|vaccines|mesh-list
6268729|NCT03553940|Immunologic Factors|immunologic factors|mesh-ancestor
6268730|NCT03553940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268731|NCT03554005|Acetaminophen|acetaminophen|mesh-list
6014818|NCT00353496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6014819|NCT00353522|Dalcetrapib|dalcetrapib|mesh-list
6014820|NCT00353522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6014821|NCT00353522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6014822|NCT00353522|Antimetabolites|antimetabolites|mesh-ancestor
6014823|NCT00353522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014824|NCT00353522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6014825|NCT00353652|Chlorthalidone|chlorthalidone|mesh-list
6014826|NCT00353652|Spironolactone|spironolactone|mesh-list
6014827|NCT00353652|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6014828|NCT00353652|Hormone Antagonists|hormone antagonists|mesh-ancestor
6014829|NCT00353652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6014830|NCT00353652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014831|NCT00353652|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6014832|NCT00353652|Diuretics|diuretics|mesh-ancestor
6014833|NCT00353652|Natriuretic Agents|natriuretic agents|mesh-ancestor
6014834|NCT00353652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6014835|NCT00353652|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6014836|NCT00353652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6014837|NCT00353652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014838|NCT00353704|Pregabalin|pregabalin|mesh-list
6014839|NCT00353704|Morphine|morphine|mesh-list
6014840|NCT00353704|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6014841|NCT00353704|Narcotics|narcotics|mesh-ancestor
6014842|NCT00353704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6014843|NCT00353704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014844|NCT00353704|Analgesics|analgesics|mesh-ancestor
6268732|NCT03554005|Interferons|interferons|mesh-list
6268733|NCT03554005|Interferon-alpha|interferon-alpha|mesh-list
6268734|NCT03554005|Interferon alpha-2|interferon alpha-2|mesh-list
6268735|NCT03554005|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6268736|NCT03554005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6268737|NCT03554005|Antiviral Agents|antiviral agents|mesh-ancestor
6268738|NCT03554005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6268739|NCT03554005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6268740|NCT03554005|Analgesics|analgesics|mesh-ancestor
6268741|NCT03554005|Sensory System Agents|sensory system agents|mesh-ancestor
6268742|NCT03554005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6268743|NCT03554005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268744|NCT03554005|Antipyretics|antipyretics|mesh-ancestor
6268745|NCT03554005|Immunologic Factors|immunologic factors|mesh-ancestor
6268746|NCT03554018|Acetaminophen|acetaminophen|mesh-list
6268747|NCT03554018|Ibuprofen|ibuprofen|mesh-list
6268748|NCT03554018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6268749|NCT03554018|Analgesics|analgesics|mesh-ancestor
6268750|NCT03554018|Sensory System Agents|sensory system agents|mesh-ancestor
6268751|NCT03554018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6268752|NCT03554018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268753|NCT03554018|Antipyretics|antipyretics|mesh-ancestor
6268754|NCT03554018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6268755|NCT03554018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6268756|NCT03554018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6268757|NCT03554018|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6268758|NCT03554018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6268759|NCT03554018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6268760|NCT03554486|Insulin|insulin|mesh-list
6268761|NCT03554486|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6268762|NCT03554486|Insulin Aspart|insulin aspart|mesh-list
6268763|NCT03554486|Insulin, Long-Acting|insulin, long-acting|mesh-list
6268764|NCT03554486|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6268765|NCT03554486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6268766|NCT03554486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268767|NCT03554772|Celecoxib|celecoxib|mesh-list
6268768|NCT03554772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6268769|NCT03554772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6268770|NCT03554772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6268771|NCT03554772|Analgesics|analgesics|mesh-ancestor
6268772|NCT03554772|Sensory System Agents|sensory system agents|mesh-ancestor
6268773|NCT03554772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6268774|NCT03554772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268775|NCT03554772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6268776|NCT03554772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6268777|NCT03554772|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6268778|NCT03554772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6268779|NCT03554772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6268780|NCT03554772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6268781|NCT03555305|Insulin|insulin|mesh-list
6268782|NCT03555305|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6268783|NCT03555305|Insulin Glargine|insulin glargine|mesh-list
6268784|NCT03555305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6268785|NCT03555305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268786|NCT03555565|Metformin|metformin|mesh-list
6268787|NCT03555565|Alogliptin|alogliptin|mesh-list
6268788|NCT03555565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6268789|NCT03555565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268790|NCT03555565|Incretins|incretins|mesh-ancestor
6268791|NCT03555565|Hormones|hormones|mesh-ancestor
6268792|NCT03555565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6268793|NCT03555565|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6268794|NCT03555565|Protease Inhibitors|protease inhibitors|mesh-ancestor
6268795|NCT03555565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6268796|NCT03555565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6268797|NCT03555890|Cetirizine|cetirizine|mesh-list
6268798|NCT03555890|Levocetirizine|levocetirizine|mesh-list
6268799|NCT03555890|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6268800|NCT03555890|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6268801|NCT03555890|Histamine Antagonists|histamine antagonists|mesh-ancestor
6268802|NCT03555890|Histamine Agents|histamine agents|mesh-ancestor
6268803|NCT03555890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6268804|NCT03555890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6268805|NCT03555890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268806|NCT03555890|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6268807|NCT03556761|Furosemide|furosemide|mesh-list
6268808|NCT03556761|Diuretics|diuretics|mesh-ancestor
6268809|NCT03556761|Natriuretic Agents|natriuretic agents|mesh-ancestor
6268810|NCT03556761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268811|NCT03556761|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6268812|NCT03556761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6268813|NCT03556761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6268814|NCT03557333|Dihydroergotamine|dihydroergotamine|mesh-list
6268815|NCT03557333|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6268816|NCT03557333|Dopamine Agonists|dopamine agonists|mesh-ancestor
6268817|NCT03557333|Dopamine Agents|dopamine agents|mesh-ancestor
6268818|NCT03557333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6268819|NCT03557333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6268820|NCT03557333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268821|NCT03557333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6268822|NCT03557333|Analgesics|analgesics|mesh-ancestor
6268823|NCT03557333|Sensory System Agents|sensory system agents|mesh-ancestor
6268824|NCT03557333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6268825|NCT03557658|Bexagliflozin|bexagliflozin|mesh-list
6268826|NCT03557658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6268827|NCT03557658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268828|NCT03557931|Olanzapine|olanzapine|mesh-list
6268829|NCT03557931|Risperidone|risperidone|mesh-list
6268830|NCT03557931|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6268831|NCT03557931|Aripiprazole|aripiprazole|mesh-list
6268832|NCT03557931|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6268833|NCT03557931|Ziprasidone|ziprasidone|mesh-list
6268834|NCT03557931|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
6268835|NCT03557931|Brexpiprazole|brexpiprazole|mesh-list
6268836|NCT03557931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6268837|NCT03557931|Serotonin Agents|serotonin agents|mesh-ancestor
6268838|NCT03557931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6268839|NCT03557931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6268840|NCT03557931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268841|NCT03557931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6268842|NCT03557931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6268843|NCT03557931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6268844|NCT03557931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6268845|NCT03557931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6268846|NCT03557931|Dopamine Agents|dopamine agents|mesh-ancestor
6268847|NCT03557931|Antiemetics|antiemetics|mesh-ancestor
5724168|NCT03188978|Antimetabolites|antimetabolites|mesh-ancestor
6268848|NCT03557931|Autonomic Agents|autonomic agents|mesh-ancestor
6268849|NCT03557931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6268850|NCT03557931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6268851|NCT03557931|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6268852|NCT03557931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6268853|NCT03557931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6268854|NCT03557931|Antidepressive Agents|antidepressive agents|mesh-ancestor
6268855|NCT03557931|Dopamine Agonists|dopamine agonists|mesh-ancestor
6268856|NCT03557931|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6268857|NCT03557931|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6268858|NCT03557931|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6268859|NCT03557931|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6268860|NCT03557931|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6268861|NCT03557931|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6268862|NCT03557931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6268863|NCT03557931|Adrenergic Agents|adrenergic agents|mesh-ancestor
6268864|NCT03558555|Acetaminophen|acetaminophen|mesh-list
6268865|NCT03558555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6268866|NCT03558555|Analgesics|analgesics|mesh-ancestor
6268867|NCT03558555|Sensory System Agents|sensory system agents|mesh-ancestor
6268868|NCT03558555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6268869|NCT03558555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268870|NCT03558555|Antipyretics|antipyretics|mesh-ancestor
6268871|NCT03558997|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6268872|NCT03558997|Immunologic Factors|immunologic factors|mesh-ancestor
6268873|NCT03558997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268874|NCT03559062|Ivacaftor|ivacaftor|mesh-list
6268875|NCT03559062|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6268876|NCT03559062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6268877|NCT03559062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6268878|NCT03559179|Analgesics, Opioid|analgesics, opioid|mesh-list
6268879|NCT03559179|Narcotics|narcotics|mesh-ancestor
6268880|NCT03559179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6268881|NCT03559179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268882|NCT03559179|Analgesics|analgesics|mesh-ancestor
6268883|NCT03559179|Sensory System Agents|sensory system agents|mesh-ancestor
6268884|NCT03559179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6390517|NCT00191061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390518|NCT00191061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6390519|NCT00191061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390520|NCT00191061|Analgesics|analgesics|mesh-ancestor
6390521|NCT00191061|Sensory System Agents|sensory system agents|mesh-ancestor
6390522|NCT00191061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6390523|NCT00191061|Antidepressive Agents|antidepressive agents|mesh-ancestor
6390524|NCT00191061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6390525|NCT00191061|Dopamine Agents|dopamine agents|mesh-ancestor
6390526|NCT00191087|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6390527|NCT00191087|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6390528|NCT00191087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6390529|NCT00191087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6390530|NCT00191087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390531|NCT00191087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6390532|NCT00191087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390533|NCT00191087|Analgesics|analgesics|mesh-ancestor
6390534|NCT00191087|Sensory System Agents|sensory system agents|mesh-ancestor
6390535|NCT00191087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6390536|NCT00191087|Antidepressive Agents|antidepressive agents|mesh-ancestor
6390537|NCT00191087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6390538|NCT00191087|Dopamine Agents|dopamine agents|mesh-ancestor
6390539|NCT00191126|Gemcitabine|gemcitabine|mesh-list
6390540|NCT00191126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6390541|NCT00191126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6390542|NCT00191126|Antimetabolites|antimetabolites|mesh-ancestor
6390543|NCT00191126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390544|NCT00191126|Antiviral Agents|antiviral agents|mesh-ancestor
6390545|NCT00191126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6390546|NCT00191126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6390547|NCT00191126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6390548|NCT00191126|Immunologic Factors|immunologic factors|mesh-ancestor
6390549|NCT00191126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390550|NCT00191178|Insulin|insulin|mesh-list
6390551|NCT00191178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6390552|NCT00191178|Insulin Glargine|insulin glargine|mesh-list
6390553|NCT00191178|Insulin Lispro|insulin lispro|mesh-list
6390554|NCT00191178|Protamines|protamines|mesh-list
6390555|NCT00191178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6390556|NCT00191178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390557|NCT00191178|Heparin Antagonists|heparin antagonists|mesh-ancestor
6390558|NCT00191178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390559|NCT00191178|Coagulants|coagulants|mesh-ancestor
6390560|NCT00191204|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6390561|NCT00191204|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6390562|NCT00191204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6268885|NCT03559530|Anti-Infective Agents|anti-infective agents|mesh-list
6268886|NCT03559530|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6268887|NCT03560245|Bryostatin 1|bryostatin 1|mesh-list
6268888|NCT03560245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6268889|NCT03560245|Immunologic Factors|immunologic factors|mesh-ancestor
6268890|NCT03560245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268891|NCT03560245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6268892|NCT03560739|Ofatumumab|ofatumumab|mesh-list
6268893|NCT03560739|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6268894|NCT03560739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6268895|NCT03560739|Immunologic Factors|immunologic factors|mesh-ancestor
6268896|NCT03560739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268897|NCT03562377|Vaccines|vaccines|mesh-list
6268898|NCT03562377|Immunologic Factors|immunologic factors|mesh-ancestor
6268899|NCT03562377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268900|NCT03562481|Lidocaine|lidocaine|mesh-list
6268901|NCT03562481|Epinephrine|epinephrine|mesh-list
6268902|NCT03562481|Racepinephrine|racepinephrine|mesh-list
6268903|NCT03562481|Epinephryl borate|epinephryl borate|mesh-list
6268904|NCT03562481|Anesthetics, Local|anesthetics, local|mesh-ancestor
6268905|NCT03562481|Anesthetics|anesthetics|mesh-ancestor
6268906|NCT03562481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6268907|NCT03562481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268908|NCT03562481|Sensory System Agents|sensory system agents|mesh-ancestor
6268909|NCT03562481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6268910|NCT03562481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6268911|NCT03562481|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6268912|NCT03562481|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6268913|NCT03562481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6268914|NCT03562481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6268915|NCT03562481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6268916|NCT03562481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6268917|NCT03562481|Adrenergic Agents|adrenergic agents|mesh-ancestor
6268918|NCT03562481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6268919|NCT03562481|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6268920|NCT03562481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6268921|NCT03562481|Autonomic Agents|autonomic agents|mesh-ancestor
6268922|NCT03562481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6268923|NCT03562481|Respiratory System Agents|respiratory system agents|mesh-ancestor
6268924|NCT03562481|Mydriatics|mydriatics|mesh-ancestor
6268925|NCT03562481|Sympathomimetics|sympathomimetics|mesh-ancestor
6268926|NCT03562481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6268927|NCT03562988|Vitamins|vitamins|mesh-list
6268928|NCT03562988|Ascorbic Acid|ascorbic acid|mesh-list
6268929|NCT03562988|Micronutrients|micronutrients|mesh-ancestor
6268930|NCT03562988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268931|NCT03562988|Antioxidants|antioxidants|mesh-ancestor
6268932|NCT03562988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6268933|NCT03562988|Protective Agents|protective agents|mesh-ancestor
6268934|NCT03563716|Atezolizumab|atezolizumab|mesh-list
6268935|NCT03563716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6268936|NCT03565211|Progesterone|progesterone|mesh-list
6268937|NCT03565211|Progestins|progestins|mesh-ancestor
6268938|NCT03565211|Hormones|hormones|mesh-ancestor
6268939|NCT03565211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6268940|NCT03565211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268941|NCT03565666|Insulin|insulin|mesh-list
6268942|NCT03565666|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6268943|NCT03565666|Insulin Lispro|insulin lispro|mesh-list
6268944|NCT03565666|Insulin Aspart|insulin aspart|mesh-list
6268945|NCT03565666|Pancrelipase|pancrelipase|mesh-list
6268946|NCT03565666|Pancreatin|pancreatin|mesh-list
6268947|NCT03565666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6268948|NCT03565666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268949|NCT03565666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6268950|NCT03565887|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6268951|NCT03565887|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6268952|NCT03566485|Atezolizumab|atezolizumab|mesh-list
6268953|NCT03566485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6268954|NCT03566810|Metformin|metformin|mesh-list
6268955|NCT03566810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6268956|NCT03566810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268957|NCT03566979|Naproxen|naproxen|mesh-list
6268958|NCT03566979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6268959|NCT03566979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6268960|NCT03566979|Analgesics|analgesics|mesh-ancestor
6268961|NCT03566979|Sensory System Agents|sensory system agents|mesh-ancestor
6268962|NCT03566979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6268963|NCT03566979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268964|NCT03566979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6268965|NCT03566979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6268966|NCT03566979|Gout Suppressants|gout suppressants|mesh-ancestor
6268967|NCT03566979|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6268968|NCT03566979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6268969|NCT03566979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6268970|NCT03567382|Tenofovir|tenofovir|mesh-list
6268971|NCT03567382|Antiviral Agents|antiviral agents|mesh-ancestor
6268972|NCT03567382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6268973|NCT03567382|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6268974|NCT03567382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6268975|NCT03567382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6268976|NCT03567382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6268977|NCT03567382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6268978|NCT03567382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6268979|NCT03567616|Dexamethasone|dexamethasone|mesh-list
6268980|NCT03567616|Venetoclax|venetoclax|mesh-list
6268981|NCT03567616|Pomalidomide|pomalidomide|mesh-list
6268982|NCT03567616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6268983|NCT03567616|Antiemetics|antiemetics|mesh-ancestor
6268984|NCT03567616|Autonomic Agents|autonomic agents|mesh-ancestor
6268985|NCT03567616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6268986|NCT03567616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6268987|NCT03567616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6268988|NCT03567616|Glucocorticoids|glucocorticoids|mesh-ancestor
6268989|NCT03567616|Hormones|hormones|mesh-ancestor
6268990|NCT03567616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6268991|NCT03567616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6268992|NCT03567616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6268993|NCT03567616|Immunologic Factors|immunologic factors|mesh-ancestor
6268994|NCT03567616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6268995|NCT03567616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6268996|NCT03567616|Growth Substances|growth substances|mesh-ancestor
6268997|NCT03567616|Growth Inhibitors|growth inhibitors|mesh-ancestor
6268998|NCT03568500|Olanzapine|olanzapine|mesh-list
6268999|NCT03568500|Risperidone|risperidone|mesh-list
6269000|NCT03568500|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6269001|NCT03568500|Aripiprazole|aripiprazole|mesh-list
6269002|NCT03568500|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6269003|NCT03568500|Serotonin Agents|serotonin agents|mesh-ancestor
6269004|NCT03568500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6269005|NCT03568500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269006|NCT03568500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269007|NCT03568500|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6269008|NCT03568500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6269009|NCT03568500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6269010|NCT03568500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6269011|NCT03568500|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6269012|NCT03568500|Dopamine Agents|dopamine agents|mesh-ancestor
6269013|NCT03568500|Antiemetics|antiemetics|mesh-ancestor
6269014|NCT03568500|Autonomic Agents|autonomic agents|mesh-ancestor
6269015|NCT03568500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6269016|NCT03568500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6269017|NCT03568500|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6269018|NCT03568500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6269019|NCT03568500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6269020|NCT03568500|Antidepressive Agents|antidepressive agents|mesh-ancestor
6269021|NCT03568500|Dopamine Agonists|dopamine agonists|mesh-ancestor
6269022|NCT03568500|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6269023|NCT03568500|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6269024|NCT03568500|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6269025|NCT03568500|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6269026|NCT03569098|Botulinum Toxins|botulinum toxins|mesh-list
6269027|NCT03569098|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6269028|NCT03569098|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6269029|NCT03569098|Hemagglutinins|hemagglutinins|mesh-list
6269030|NCT03569098|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6269031|NCT03569098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6269032|NCT03569098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269033|NCT03569098|Cholinergic Agents|cholinergic agents|mesh-ancestor
6269034|NCT03569098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6269035|NCT03569098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269036|NCT03569098|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6269037|NCT03569098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6269038|NCT03569098|Agglutinins|agglutinins|mesh-ancestor
6269039|NCT03569098|Immunologic Factors|immunologic factors|mesh-ancestor
6269040|NCT03569202|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6269041|NCT03569202|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6269042|NCT03570476|Olaparib|olaparib|mesh-list
6269043|NCT03570476|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
6269044|NCT03570476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6269045|NCT03570476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269046|NCT03570476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6269047|NCT03570554|Acetaminophen|acetaminophen|mesh-list
6269048|NCT03570554|Celecoxib|celecoxib|mesh-list
6269049|NCT03570554|Naproxen|naproxen|mesh-list
6269050|NCT03570554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6269051|NCT03570554|Analgesics|analgesics|mesh-ancestor
6269052|NCT03570554|Sensory System Agents|sensory system agents|mesh-ancestor
6269053|NCT03570554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6269054|NCT03570554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269055|NCT03570554|Antipyretics|antipyretics|mesh-ancestor
6269056|NCT03570554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6269057|NCT03570554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6269058|NCT03570554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6269059|NCT03570554|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6269060|NCT03570554|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6269061|NCT03570554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6269062|NCT03570554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269063|NCT03570554|Gout Suppressants|gout suppressants|mesh-ancestor
6269064|NCT03570697|Evolocumab|evolocumab|mesh-list
6269065|NCT03570697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6269066|NCT03570697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6269067|NCT03570697|Antimetabolites|antimetabolites|mesh-ancestor
6269068|NCT03570697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269069|NCT03570697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6269070|NCT03571516|Teduglutide|teduglutide|mesh-list
6269071|NCT03571516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6269072|NCT03571516|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6269073|NCT03571516|Protective Agents|protective agents|mesh-ancestor
6269074|NCT03571516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269075|NCT03571607|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6269076|NCT03571607|Immunologic Factors|immunologic factors|mesh-ancestor
6269077|NCT03571607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269078|NCT03571724|Menthol|menthol|mesh-list
6269079|NCT03571724|Nicotine|nicotine|mesh-list
6269080|NCT03571724|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6269081|NCT03571724|Autonomic Agents|autonomic agents|mesh-ancestor
6269082|NCT03571724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6269083|NCT03571724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269084|NCT03571724|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6269085|NCT03571724|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6269086|NCT03571724|Cholinergic Agents|cholinergic agents|mesh-ancestor
6269087|NCT03571724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6269088|NCT03571724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269089|NCT03571724|Antipruritics|antipruritics|mesh-ancestor
6269090|NCT03571724|Dermatologic Agents|dermatologic agents|mesh-ancestor
6269091|NCT03572478|Nivolumab|nivolumab|mesh-list
6269092|NCT03572478|Rucaparib|rucaparib|mesh-list
6269093|NCT03572478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6269094|NCT03572478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6269095|NCT03572478|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6269096|NCT03572478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269097|NCT03572478|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6269098|NCT03572478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6269099|NCT03572972|Warfarin|warfarin|mesh-list
6269100|NCT03572972|Rivaroxaban|rivaroxaban|mesh-list
6269101|NCT03572972|Dabigatran|dabigatran|mesh-list
6269102|NCT03572972|Apixaban|apixaban|mesh-list
6269103|NCT03572972|Anticoagulants|anticoagulants|mesh-ancestor
6269104|NCT03572972|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6269105|NCT03572972|Antithrombins|antithrombins|mesh-ancestor
6269106|NCT03572972|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6269107|NCT03572972|Protease Inhibitors|protease inhibitors|mesh-ancestor
6269108|NCT03572972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6269109|NCT03572972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269110|NCT03573323|Ixekizumab|ixekizumab|mesh-list
6269111|NCT03573323|Dermatologic Agents|dermatologic agents|mesh-ancestor
6269112|NCT03573908|Linaclotide|linaclotide|mesh-list
6269113|NCT03573908|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
6269114|NCT03573908|Enzyme Activators|enzyme activators|mesh-ancestor
6269115|NCT03573908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269116|NCT03573908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6269117|NCT03574818|Gemcitabine|gemcitabine|mesh-list
6269118|NCT03574818|Necitumumab|necitumumab|mesh-list
6269119|NCT03574818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6269120|NCT03574818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6269121|NCT03574818|Antimetabolites|antimetabolites|mesh-ancestor
6269122|NCT03574818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269123|NCT03574818|Antiviral Agents|antiviral agents|mesh-ancestor
6269124|NCT03574818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6269125|NCT03574818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6269126|NCT03574818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6269127|NCT03574818|Immunologic Factors|immunologic factors|mesh-ancestor
6269128|NCT03574818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269129|NCT03574818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6269130|NCT03575702|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6269131|NCT03575702|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6269132|NCT03575702|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6269133|NCT03575702|Cholinergic Agents|cholinergic agents|mesh-ancestor
6269134|NCT03575702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6269135|NCT03575702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269136|NCT03575702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269137|NCT03575702|Urological Agents|urological agents|mesh-ancestor
6269138|NCT03575806|Chlorotrianisene|chlorotrianisene|mesh-list
6269139|NCT03575806|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6269140|NCT03575806|Estrogens|estrogens|mesh-ancestor
6269141|NCT03575806|Hormones|hormones|mesh-ancestor
6269142|NCT03575806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6269143|NCT03575806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269144|NCT03575806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6269145|NCT03575806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6269146|NCT03575871|Abrocitinib|abrocitinib|mesh-list
6269147|NCT03575871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6269148|NCT03575871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6269149|NCT03575871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269150|NCT03576066|Tenofovir|tenofovir|mesh-list
6269151|NCT03576066|Entecavir|entecavir|mesh-list
6269152|NCT03576066|Antiviral Agents|antiviral agents|mesh-ancestor
6269153|NCT03576066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6269154|NCT03576066|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6269155|NCT03576066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6269156|NCT03576066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6269157|NCT03576066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269158|NCT03576066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6269159|NCT03576066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6269160|NCT03576716|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
6269161|NCT03576716|Calcifediol|calcifediol|mesh-list
6269162|NCT03576716|Vitamins|vitamins|mesh-ancestor
6269163|NCT03576716|Micronutrients|micronutrients|mesh-ancestor
6269164|NCT03576716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269165|NCT03576716|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6269166|NCT03577171|Entecavir|entecavir|mesh-list
6269167|NCT03577171|Antiviral Agents|antiviral agents|mesh-ancestor
6269168|NCT03577171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6269169|NCT03577275|Moxifloxacin|moxifloxacin|mesh-list
6269170|NCT03577275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6269171|NCT03577275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6269172|NCT03577275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6269173|NCT03577275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6269174|NCT03577275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6269175|NCT03577275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269176|NCT03577275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6269177|NCT03577730|Caffeine|caffeine|mesh-list
6269178|NCT03577730|Caffeine citrate|caffeine citrate|mesh-list
6269179|NCT03577730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269180|NCT03577730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6269181|NCT03577730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269182|NCT03577730|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6269183|NCT03577730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6269184|NCT03577730|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6269185|NCT03577730|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6269186|NCT03577730|Purinergic Agents|purinergic agents|mesh-ancestor
6269187|NCT03577730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6390563|NCT00191204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6390564|NCT00191204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390565|NCT00191204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6390566|NCT00191204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390567|NCT00191204|Analgesics|analgesics|mesh-ancestor
6390568|NCT00191204|Sensory System Agents|sensory system agents|mesh-ancestor
6390569|NCT00191204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6390570|NCT00191204|Antidepressive Agents|antidepressive agents|mesh-ancestor
6390571|NCT00191204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6390572|NCT00191204|Dopamine Agents|dopamine agents|mesh-ancestor
6396858|NCT00209794|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6396859|NCT00209794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6396860|NCT00209794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396861|NCT00209794|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6396862|NCT00209794|Renal Agents|renal agents|mesh-ancestor
6396863|NCT00209807|Citalopram|citalopram|mesh-list
6396864|NCT00209807|Reboxetine|reboxetine|mesh-list
6396865|NCT00209807|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6396866|NCT00209807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6396867|NCT00209807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6396868|NCT00209807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396869|NCT00209807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6396870|NCT00209807|Serotonin Agents|serotonin agents|mesh-ancestor
6396871|NCT00209807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269188|NCT03578146|Rivaroxaban|rivaroxaban|mesh-list
6269189|NCT03578146|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6269190|NCT03578146|Antithrombins|antithrombins|mesh-ancestor
6269191|NCT03578146|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6269192|NCT03578146|Protease Inhibitors|protease inhibitors|mesh-ancestor
6269193|NCT03578146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6269194|NCT03578146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269195|NCT03578146|Anticoagulants|anticoagulants|mesh-ancestor
6269196|NCT03579719|Itraconazole|itraconazole|mesh-list
6269197|NCT03579719|Antifungal Agents|antifungal agents|mesh-ancestor
6269198|NCT03579719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6269199|NCT03579719|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6269200|NCT03579719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6269201|NCT03579719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6269202|NCT03579719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269203|NCT03579719|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6269204|NCT03579719|Hormone Antagonists|hormone antagonists|mesh-ancestor
6269205|NCT03579719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6269206|NCT03579719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269207|NCT03579719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6269208|NCT03579940|Lasmiditan|lasmiditan|mesh-list
6269209|NCT03579940|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6269210|NCT03579940|Serotonin Agents|serotonin agents|mesh-ancestor
6269211|NCT03579940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6269212|NCT03579940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269213|NCT03579940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269214|NCT03580343|Tofacitinib|tofacitinib|mesh-list
6269215|NCT03580343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6269216|NCT03580343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6269217|NCT03580343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269218|NCT03581084|Acetylcysteine|acetylcysteine|mesh-list
6269219|NCT03581084|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6269220|NCT03581084|Antiviral Agents|antiviral agents|mesh-ancestor
6269221|NCT03581084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6269222|NCT03581084|Expectorants|expectorants|mesh-ancestor
6269223|NCT03581084|Respiratory System Agents|respiratory system agents|mesh-ancestor
6269224|NCT03581084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6269225|NCT03581084|Antioxidants|antioxidants|mesh-ancestor
6269226|NCT03581084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269227|NCT03581084|Protective Agents|protective agents|mesh-ancestor
6269228|NCT03581084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269229|NCT03581084|Antidotes|antidotes|mesh-ancestor
6269230|NCT03582215|Salicylates|salicylates|mesh-list
6269231|NCT03582215|Avobenzone|avobenzone|mesh-list
6269232|NCT03582215|Homosalate|homosalate|mesh-list
6269233|NCT03582215|Oxybenzone|oxybenzone|mesh-list
6269234|NCT03582215|2-ethylhexyl salicylate|2-ethylhexyl salicylate|mesh-list
6269235|NCT03582215|Octylmethoxycinnamate|octylmethoxycinnamate|mesh-list
6269236|NCT03582215|Sunscreening Agents|sunscreening agents|mesh-ancestor
6269237|NCT03582215|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6269238|NCT03582215|Protective Agents|protective agents|mesh-ancestor
6269239|NCT03582215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269240|NCT03582215|Dermatologic Agents|dermatologic agents|mesh-ancestor
6269241|NCT03582215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6269242|NCT03582215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6269243|NCT03582215|Analgesics|analgesics|mesh-ancestor
6269244|NCT03582215|Sensory System Agents|sensory system agents|mesh-ancestor
6269245|NCT03582215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6269246|NCT03582215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6269247|NCT03582215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6269248|NCT03582215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6269249|NCT03582215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6269250|NCT03582215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269251|NCT03582553|Naringenin|naringenin|mesh-list
6269252|NCT03582553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6269253|NCT03582553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6269254|NCT03582553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6269255|NCT03582553|Hormone Antagonists|hormone antagonists|mesh-ancestor
6269256|NCT03582553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6269257|NCT03582553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269258|NCT03583372|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6269259|NCT03583372|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6269260|NCT03583372|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6269261|NCT03583372|Cholinergic Agents|cholinergic agents|mesh-ancestor
6269262|NCT03583372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6269263|NCT03583372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269264|NCT03583372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269265|NCT03583372|Urological Agents|urological agents|mesh-ancestor
6269266|NCT03583385|Metformin|metformin|mesh-list
6269267|NCT03583385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6269268|NCT03583385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269269|NCT03584009|Venetoclax|venetoclax|mesh-list
6269270|NCT03584009|Fulvestrant|fulvestrant|mesh-list
6269271|NCT03584009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6269272|NCT03584009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6269273|NCT03584009|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6269274|NCT03584009|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6269275|NCT03584009|Hormone Antagonists|hormone antagonists|mesh-ancestor
6269276|NCT03584009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6269277|NCT03584009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269278|NCT03585504|Contraceptive Agents|contraceptive agents|mesh-list
6269279|NCT03585504|Etonogestrel|etonogestrel|mesh-list
6269280|NCT03585504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6269281|NCT03585504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269282|NCT03585504|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6269283|NCT03585504|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6269284|NCT03585712|Norgestrel|norgestrel|mesh-list
6269285|NCT03585712|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6269286|NCT03585712|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6269287|NCT03585712|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6269288|NCT03585712|Contraceptive Agents|contraceptive agents|mesh-ancestor
6269289|NCT03585712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6269290|NCT03585712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269291|NCT03585712|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6269292|NCT03585712|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6269293|NCT03586544|Albuterol|albuterol|mesh-list
6269294|NCT03586544|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6269295|NCT03586544|Autonomic Agents|autonomic agents|mesh-ancestor
6269296|NCT03586544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6269297|NCT03586544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269298|NCT03586544|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6269299|NCT03586544|Respiratory System Agents|respiratory system agents|mesh-ancestor
6269300|NCT03586544|Tocolytic Agents|tocolytic agents|mesh-ancestor
6269301|NCT03586544|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6269302|NCT03586544|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6269303|NCT03586544|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6269304|NCT03586544|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6269305|NCT03586544|Adrenergic Agents|adrenergic agents|mesh-ancestor
6269306|NCT03586544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6269307|NCT03586544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269308|NCT03586726|Rifampin|rifampin|mesh-list
6269309|NCT03586726|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6269310|NCT03586726|Antitubercular Agents|antitubercular agents|mesh-ancestor
6269311|NCT03586726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6269312|NCT03586726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6269313|NCT03586726|Leprostatic Agents|leprostatic agents|mesh-ancestor
6269314|NCT03586726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6269315|NCT03586726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6269316|NCT03586726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269317|NCT03586726|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6269318|NCT03586726|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6269319|NCT03586726|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6269320|NCT03586726|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6269321|NCT03586726|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6269322|NCT03586726|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6269323|NCT03587207|Vaccines|vaccines|mesh-list
6269324|NCT03587207|Immunologic Factors|immunologic factors|mesh-ancestor
6269325|NCT03587207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269326|NCT03587428|Zinc|zinc|mesh-list
6269327|NCT03587428|Trace Elements|trace elements|mesh-ancestor
6269328|NCT03587428|Micronutrients|micronutrients|mesh-ancestor
6269329|NCT03587428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269330|NCT03588572|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6269331|NCT03588572|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6269332|NCT03588572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6269333|NCT03588572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6269334|NCT03588572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269335|NCT03588572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6269336|NCT03588572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269337|NCT03588572|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6269338|NCT03588572|Antidepressive Agents|antidepressive agents|mesh-ancestor
6269339|NCT03588572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6269340|NCT03588806|Oxycodone|oxycodone|mesh-list
6269341|NCT03588806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6269342|NCT03588806|Narcotics|narcotics|mesh-ancestor
6269343|NCT03588806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6269344|NCT03588806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269345|NCT03588806|Analgesics|analgesics|mesh-ancestor
6269346|NCT03588806|Sensory System Agents|sensory system agents|mesh-ancestor
6269347|NCT03588806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6269348|NCT03588910|Acetaminophen|acetaminophen|mesh-list
6269349|NCT03588910|Ibuprofen|ibuprofen|mesh-list
6269350|NCT03588910|Oxycodone|oxycodone|mesh-list
6269351|NCT03588910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6269352|NCT03588910|Analgesics|analgesics|mesh-ancestor
6269353|NCT03588910|Sensory System Agents|sensory system agents|mesh-ancestor
6269354|NCT03588910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6269355|NCT03588910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269356|NCT03588910|Antipyretics|antipyretics|mesh-ancestor
6269357|NCT03588910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6269358|NCT03588910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6269359|NCT03588910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6269360|NCT03588910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6269361|NCT03588910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6269362|NCT03588910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269363|NCT03588910|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6269364|NCT03588910|Narcotics|narcotics|mesh-ancestor
6269365|NCT03588910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6269366|NCT03589469|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
6269367|NCT03589469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6269368|NCT03589469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6269369|NCT03589885|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6269370|NCT03589885|Immunologic Factors|immunologic factors|mesh-ancestor
6269371|NCT03589885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269372|NCT03591068|Fluticasone|fluticasone|mesh-list
6269373|NCT03591068|Xhance|xhance|mesh-list
6269374|NCT03591068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6269375|NCT03591068|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6269376|NCT03591068|Autonomic Agents|autonomic agents|mesh-ancestor
6269377|NCT03591068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6269378|NCT03591068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269379|NCT03591068|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6269380|NCT03591068|Respiratory System Agents|respiratory system agents|mesh-ancestor
6269381|NCT03591068|Dermatologic Agents|dermatologic agents|mesh-ancestor
6269382|NCT03591068|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6269383|NCT03591146|Ropivacaine|ropivacaine|mesh-list
6269384|NCT03591146|Anesthetics, Local|anesthetics, local|mesh-ancestor
6269385|NCT03591146|Anesthetics|anesthetics|mesh-ancestor
6269386|NCT03591146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6269387|NCT03591146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269388|NCT03591146|Sensory System Agents|sensory system agents|mesh-ancestor
6269389|NCT03591146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6269390|NCT03591406|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6269391|NCT03591406|Hematinics|hematinics|mesh-ancestor
6269392|NCT03592121|Phenylephrine|phenylephrine|mesh-list
6269393|NCT03592121|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6269394|NCT03592121|Mydriatics|mydriatics|mesh-ancestor
6269395|NCT03592121|Autonomic Agents|autonomic agents|mesh-ancestor
6269396|NCT03592121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6269397|NCT03592121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269398|NCT03592121|Sympathomimetics|sympathomimetics|mesh-ancestor
6269399|NCT03592121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6269400|NCT03592121|Nasal Decongestants|nasal decongestants|mesh-ancestor
6269401|NCT03592121|Respiratory System Agents|respiratory system agents|mesh-ancestor
6269402|NCT03592121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6269403|NCT03592121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6269404|NCT03592121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6269405|NCT03592121|Adrenergic Agents|adrenergic agents|mesh-ancestor
6269406|NCT03592121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6269407|NCT03592121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269408|NCT03592121|Protective Agents|protective agents|mesh-ancestor
6269409|NCT03593538|Metformin|metformin|mesh-list
6269410|NCT03593538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6269411|NCT03593538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269412|NCT03593902|Methylprednisolone|methylprednisolone|mesh-list
6269413|NCT03593902|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6269414|NCT03593902|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6269415|NCT03593902|Prednisolone|prednisolone|mesh-list
6269416|NCT03593902|Prednisolone acetate|prednisolone acetate|mesh-list
6269417|NCT03593902|Cyclophosphamide|cyclophosphamide|mesh-list
6269418|NCT03593902|Rituximab|rituximab|mesh-list
6269419|NCT03593902|Fludarabine|fludarabine|mesh-list
6014845|NCT00353704|Sensory System Agents|sensory system agents|mesh-ancestor
6014846|NCT00353704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6014847|NCT00353704|Anticonvulsants|anticonvulsants|mesh-ancestor
6014848|NCT00353704|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6014849|NCT00353704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6014850|NCT00353704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014851|NCT00353704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6014852|NCT00353704|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6014853|NCT00353704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6269420|NCT03593902|Thymoglobulin|thymoglobulin|mesh-list
6269421|NCT03593902|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6269422|NCT03593902|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6269423|NCT03593902|Prednisolone phosphate|prednisolone phosphate|mesh-list
6269424|NCT03593902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6269425|NCT03593902|Immunologic Factors|immunologic factors|mesh-ancestor
6269426|NCT03593902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269427|NCT03593902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6269428|NCT03593902|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6269429|NCT03593902|Alkylating Agents|alkylating agents|mesh-ancestor
6269430|NCT03593902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269431|NCT03593902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6269432|NCT03593902|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6269433|NCT03593902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6269434|NCT03593902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6269435|NCT03593902|Antiemetics|antiemetics|mesh-ancestor
6269436|NCT03593902|Autonomic Agents|autonomic agents|mesh-ancestor
6269437|NCT03593902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6269438|NCT03593902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6269439|NCT03593902|Glucocorticoids|glucocorticoids|mesh-ancestor
6269440|NCT03593902|Hormones|hormones|mesh-ancestor
6269441|NCT03593902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6269442|NCT03593902|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6269443|NCT03593902|Protective Agents|protective agents|mesh-ancestor
6269444|NCT03593902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6269445|NCT03594045|Apixaban|apixaban|mesh-list
6269446|NCT03594045|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6269447|NCT03594045|Antithrombins|antithrombins|mesh-ancestor
6269448|NCT03594045|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6269449|NCT03594045|Protease Inhibitors|protease inhibitors|mesh-ancestor
6269450|NCT03594045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6269451|NCT03594045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269452|NCT03594045|Anticoagulants|anticoagulants|mesh-ancestor
6269453|NCT03595449|Lidocaine|lidocaine|mesh-list
6269454|NCT03595449|Anesthetics, Local|anesthetics, local|mesh-ancestor
6269455|NCT03595449|Anesthetics|anesthetics|mesh-ancestor
6269456|NCT03595449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6269457|NCT03595449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269458|NCT03595449|Sensory System Agents|sensory system agents|mesh-ancestor
6269459|NCT03595449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6269460|NCT03595449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6269461|NCT03595449|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6269462|NCT03595449|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6269463|NCT03595449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6269464|NCT03595449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269465|NCT03595579|Bupropion|bupropion|mesh-list
6269466|NCT03595579|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6269467|NCT03595579|Antidepressive Agents|antidepressive agents|mesh-ancestor
6269468|NCT03595579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6269469|NCT03595579|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6269470|NCT03595579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6269471|NCT03595579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6269472|NCT03595579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269473|NCT03595579|Dopamine Agents|dopamine agents|mesh-ancestor
6269474|NCT03595579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6269475|NCT03595579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269476|NCT03595579|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6269477|NCT03595579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6269478|NCT03595579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6269479|NCT03596723|Prednisolone|prednisolone|mesh-list
6269480|NCT03596723|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6269481|NCT03596723|Methylprednisolone|methylprednisolone|mesh-list
6269482|NCT03596723|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6269483|NCT03596723|Prednisolone acetate|prednisolone acetate|mesh-list
6269484|NCT03596723|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6269485|NCT03596723|Prednisolone phosphate|prednisolone phosphate|mesh-list
6269486|NCT03596723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6269487|NCT03596723|Glucocorticoids|glucocorticoids|mesh-ancestor
6269488|NCT03596723|Hormones|hormones|mesh-ancestor
6269489|NCT03596723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6269490|NCT03596723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269491|NCT03596723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6269492|NCT03596723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6269493|NCT03596723|Antiemetics|antiemetics|mesh-ancestor
6269494|NCT03596723|Autonomic Agents|autonomic agents|mesh-ancestor
6269495|NCT03596723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6269496|NCT03596723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6269497|NCT03596723|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6269498|NCT03596723|Protective Agents|protective agents|mesh-ancestor
6269499|NCT03597009|Nivolumab|nivolumab|mesh-list
6269500|NCT03597009|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
6269501|NCT03597009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6269502|NCT03597009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6269503|NCT03597009|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6269504|NCT03597009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269505|NCT03597022|Lipoprotein-associated coagulation inhibitor|lipoprotein-associated coagulation inhibitor|mesh-list
6269506|NCT03597022|Immunoglobulins|immunoglobulins|mesh-list
6269507|NCT03597022|Immunoglobulin G|immunoglobulin g|mesh-list
6269508|NCT03597022|Immunologic Factors|immunologic factors|mesh-ancestor
6269509|NCT03597022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269510|NCT03597022|Anticoagulants|anticoagulants|mesh-ancestor
6269511|NCT03597022|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6269512|NCT03597022|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6269513|NCT03597022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269514|NCT03597022|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6269515|NCT03597022|Protease Inhibitors|protease inhibitors|mesh-ancestor
6269516|NCT03597022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6269517|NCT03597022|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6269518|NCT03597022|Antithrombins|antithrombins|mesh-ancestor
6269519|NCT03597139|Cyclosporine|cyclosporine|mesh-list
6269520|NCT03597139|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6269521|NCT03597139|Cyclosporins|cyclosporins|mesh-list
6269522|NCT03597139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6269523|NCT03597139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269524|NCT03597139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6269525|NCT03597139|Immunologic Factors|immunologic factors|mesh-ancestor
6269526|NCT03597139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269527|NCT03597139|Antifungal Agents|antifungal agents|mesh-ancestor
6269528|NCT03597139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6269529|NCT03597139|Dermatologic Agents|dermatologic agents|mesh-ancestor
6269530|NCT03597139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6269531|NCT03597139|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6269532|NCT03597139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6269533|NCT03597347|Molgramostim|molgramostim|mesh-list
6269534|NCT03597347|Sargramostim|sargramostim|mesh-list
6269535|NCT03597347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6269536|NCT03597347|Immunologic Factors|immunologic factors|mesh-ancestor
6269537|NCT03597347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269538|NCT03597529|Melatonin|melatonin|mesh-list
6269539|NCT03597529|Antioxidants|antioxidants|mesh-ancestor
6269540|NCT03597529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269541|NCT03597529|Protective Agents|protective agents|mesh-ancestor
6269542|NCT03597529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269543|NCT03597529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6269544|NCT03599089|Acetaminophen|acetaminophen|mesh-list
6269545|NCT03599089|Ketorolac|ketorolac|mesh-list
6269546|NCT03599089|Oxycodone|oxycodone|mesh-list
6269547|NCT03599089|Bupivacaine|bupivacaine|mesh-list
6269548|NCT03599089|Anesthetics, Local|anesthetics, local|mesh-ancestor
6269549|NCT03599089|Anesthetics|anesthetics|mesh-ancestor
6269550|NCT03599089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6269551|NCT03599089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269552|NCT03599089|Sensory System Agents|sensory system agents|mesh-ancestor
6269553|NCT03599089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6269554|NCT03599089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6269555|NCT03599089|Analgesics|analgesics|mesh-ancestor
6269556|NCT03599089|Antipyretics|antipyretics|mesh-ancestor
6269557|NCT03599089|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6269558|NCT03599089|Narcotics|narcotics|mesh-ancestor
6269559|NCT03599089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6269560|NCT03599089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6269561|NCT03599089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6269562|NCT03599089|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6269563|NCT03599089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6269564|NCT03599089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269565|NCT03599193|Nicotinic Acids|nicotinic acids|mesh-list
6269566|NCT03599193|Tazarotene|tazarotene|mesh-list
6269567|NCT03599193|Dermatologic Agents|dermatologic agents|mesh-ancestor
6269568|NCT03599193|Keratolytic Agents|keratolytic agents|mesh-ancestor
6269569|NCT03599193|Vitamin B Complex|vitamin b complex|mesh-ancestor
6269570|NCT03599193|Vitamins|vitamins|mesh-ancestor
6269571|NCT03599193|Micronutrients|micronutrients|mesh-ancestor
6269572|NCT03599193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269573|NCT03599362|Nivolumab|nivolumab|mesh-list
6269574|NCT03599362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6269575|NCT03599362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6269576|NCT03599362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6269577|NCT03599362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269578|NCT03600376|Dantrolene|dantrolene|mesh-list
6269579|NCT03600376|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6269580|NCT03600376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269581|NCT03600376|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6269582|NCT03600376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6269583|NCT03600428|Vaccines|vaccines|mesh-list
6269584|NCT03600428|Immunologic Factors|immunologic factors|mesh-ancestor
6269585|NCT03600428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269586|NCT03602339|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
6269587|NCT03602339|Chelating Agents|chelating agents|mesh-ancestor
6269588|NCT03602339|Sequestering Agents|sequestering agents|mesh-ancestor
6269589|NCT03602339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390573|NCT00191230|Gemcitabine|gemcitabine|mesh-list
6390574|NCT00191230|Carboplatin|carboplatin|mesh-list
6390575|NCT00191230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6390576|NCT00191230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6390577|NCT00191230|Antimetabolites|antimetabolites|mesh-ancestor
6390578|NCT00191230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390579|NCT00191230|Antiviral Agents|antiviral agents|mesh-ancestor
6390580|NCT00191230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6390581|NCT00191230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6390582|NCT00191230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6390583|NCT00191230|Immunologic Factors|immunologic factors|mesh-ancestor
6390584|NCT00191230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390585|NCT00191243|Gemcitabine|gemcitabine|mesh-list
6390586|NCT00191243|Docetaxel|docetaxel|mesh-list
6390587|NCT00191243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6390588|NCT00191243|Antimetabolites|antimetabolites|mesh-ancestor
6390589|NCT00191243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390590|NCT00191243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6390591|NCT00191243|Antiviral Agents|antiviral agents|mesh-ancestor
6390592|NCT00191243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6390593|NCT00191243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6390594|NCT00191243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6390595|NCT00191243|Immunologic Factors|immunologic factors|mesh-ancestor
6390596|NCT00191243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390597|NCT00191243|Tubulin Modulators|tubulin modulators|mesh-ancestor
6390598|NCT00191243|Antimitotic Agents|antimitotic agents|mesh-ancestor
6390599|NCT00191243|Mitosis Modulators|mitosis modulators|mesh-ancestor
6390600|NCT00191256|Gemcitabine|gemcitabine|mesh-list
6390601|NCT00191256|Paclitaxel|paclitaxel|mesh-list
6390602|NCT00191256|Carboplatin|carboplatin|mesh-list
6390603|NCT00191256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6390604|NCT00191256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6390605|NCT00191256|Tubulin Modulators|tubulin modulators|mesh-ancestor
6390606|NCT00191256|Antimitotic Agents|antimitotic agents|mesh-ancestor
6390607|NCT00191256|Mitosis Modulators|mitosis modulators|mesh-ancestor
6390608|NCT00191256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390609|NCT00191256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6390610|NCT00191256|Antimetabolites|antimetabolites|mesh-ancestor
6390611|NCT00191256|Antiviral Agents|antiviral agents|mesh-ancestor
6390612|NCT00191256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6390613|NCT00191256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6390614|NCT00191256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6390615|NCT00191256|Immunologic Factors|immunologic factors|mesh-ancestor
6390616|NCT00191256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390617|NCT00191295|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6390618|NCT00191295|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6390619|NCT00191295|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6390620|NCT00191295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6390621|NCT00191295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390622|NCT00191295|Adrenergic Agents|adrenergic agents|mesh-ancestor
6390623|NCT00191295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6390624|NCT00191295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390625|NCT00191321|Teriparatide|teriparatide|mesh-list
6390626|NCT00191321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6269590|NCT03604341|Dronabinol|dronabinol|mesh-list
6269591|NCT03604341|Hallucinogens|hallucinogens|mesh-ancestor
6269592|NCT03604341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269593|NCT03604341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6269594|NCT03604341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6269595|NCT03604341|Analgesics|analgesics|mesh-ancestor
6269596|NCT03604341|Sensory System Agents|sensory system agents|mesh-ancestor
6269597|NCT03604341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6269598|NCT03604341|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6269599|NCT03604341|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6269600|NCT03604341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6269601|NCT03604341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269602|NCT03604341|Hormones|hormones|mesh-ancestor
6269603|NCT03604341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6269604|NCT03605212|Febuxostat|febuxostat|mesh-list
6269605|NCT03605212|Gout Suppressants|gout suppressants|mesh-ancestor
6269606|NCT03605212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6269607|NCT03605914|Acetaminophen|acetaminophen|mesh-list
6269608|NCT03605914|Diclofenac|diclofenac|mesh-list
6269609|NCT03605914|Hydrocodone|hydrocodone|mesh-list
6269610|NCT03605914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6269611|NCT03605914|Analgesics|analgesics|mesh-ancestor
6269612|NCT03605914|Sensory System Agents|sensory system agents|mesh-ancestor
6269613|NCT03605914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6269614|NCT03605914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269615|NCT03605914|Antipyretics|antipyretics|mesh-ancestor
6269616|NCT03605914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6269617|NCT03605914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6269618|NCT03605914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6269619|NCT03605914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6269620|NCT03605914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6269621|NCT03605914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269622|NCT03605914|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6269623|NCT03605914|Narcotics|narcotics|mesh-ancestor
6269624|NCT03605914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6269625|NCT03605914|Antitussive Agents|antitussive agents|mesh-ancestor
6269626|NCT03605914|Respiratory System Agents|respiratory system agents|mesh-ancestor
6269627|NCT03606460|Ocrelizumab|ocrelizumab|mesh-list
6269628|NCT03606460|Immunologic Factors|immunologic factors|mesh-ancestor
6269629|NCT03606460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269630|NCT03607539|Pemetrexed|pemetrexed|mesh-list
6269631|NCT03607539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6269632|NCT03607539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6269633|NCT03607539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269634|NCT03607539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6269635|NCT03607539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6269636|NCT03608488|Vitamin D|vitamin d|mesh-list
6269637|NCT03608488|Vitamins|vitamins|mesh-ancestor
6269638|NCT03608488|Micronutrients|micronutrients|mesh-ancestor
6269639|NCT03608488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269640|NCT03608488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6269641|NCT03608774|Azithromycin|azithromycin|mesh-list
6269642|NCT03608774|Doxycycline|doxycycline|mesh-list
6269643|NCT03608774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6269644|NCT03608774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6269645|NCT03608774|Antimalarials|antimalarials|mesh-ancestor
6269646|NCT03608774|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6269647|NCT03608774|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6269648|NCT03608839|Dexamethasone|dexamethasone|mesh-list
6269649|NCT03608839|Dexamethasone acetate|dexamethasone acetate|mesh-list
6269650|NCT03608839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6269651|NCT03608839|BB 1101|bb 1101|mesh-list
6269652|NCT03608839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6269653|NCT03608839|Antiemetics|antiemetics|mesh-ancestor
6269654|NCT03608839|Autonomic Agents|autonomic agents|mesh-ancestor
6269655|NCT03608839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6269656|NCT03608839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269657|NCT03608839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6269658|NCT03608839|Glucocorticoids|glucocorticoids|mesh-ancestor
6269659|NCT03608839|Hormones|hormones|mesh-ancestor
6269660|NCT03608839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6269661|NCT03608839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6269662|NCT03608839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6269663|NCT03608839|Protease Inhibitors|protease inhibitors|mesh-ancestor
6269664|NCT03608839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6269665|NCT03608839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269666|NCT03610399|Primaquine|primaquine|mesh-list
6269667|NCT03610399|Antimalarials|antimalarials|mesh-ancestor
6269668|NCT03610399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6269669|NCT03610399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6269670|NCT03610399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6269671|NCT03610464|Amphetamine|amphetamine|mesh-list
6269672|NCT03610464|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6269673|NCT03610464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269674|NCT03610464|Sympathomimetics|sympathomimetics|mesh-ancestor
6269675|NCT03610464|Autonomic Agents|autonomic agents|mesh-ancestor
6269676|NCT03610464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6269677|NCT03610464|Dopamine Agents|dopamine agents|mesh-ancestor
6269678|NCT03610464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6269679|NCT03610464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269680|NCT03610464|Adrenergic Agents|adrenergic agents|mesh-ancestor
6269681|NCT03610464|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6269682|NCT03610464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6269683|NCT03610464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6269684|NCT03610464|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6269685|NCT03610633|Oxytocin|oxytocin|mesh-list
6269686|NCT03610633|Oxytocics|oxytocics|mesh-ancestor
6269687|NCT03610633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6269688|NCT03610633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269689|NCT03613649|Moxifloxacin|moxifloxacin|mesh-list
6269690|NCT03613649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6269691|NCT03613649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6269692|NCT03613649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6269693|NCT03613649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6269694|NCT03613649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6269695|NCT03613649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269696|NCT03613649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6269697|NCT03614975|Vaccines|vaccines|mesh-list
6269698|NCT03614975|Immunologic Factors|immunologic factors|mesh-ancestor
6269699|NCT03614975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269700|NCT03615404|Molgramostim|molgramostim|mesh-list
6269701|NCT03615404|Sargramostim|sargramostim|mesh-list
6269702|NCT03615404|Immunologic Factors|immunologic factors|mesh-ancestor
6269703|NCT03615404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269704|NCT03615404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6269705|NCT03615482|Vaccines|vaccines|mesh-list
6269706|NCT03615482|Immunologic Factors|immunologic factors|mesh-ancestor
6269707|NCT03615482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269708|NCT03615534|Niacin|niacin|mesh-list
6269709|NCT03615534|Fenofibrate|fenofibrate|mesh-list
6269710|NCT03615534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6269711|NCT03615534|Antimetabolites|antimetabolites|mesh-ancestor
6269712|NCT03615534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269713|NCT03615534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6269714|NCT03615534|Vasodilator Agents|vasodilator agents|mesh-ancestor
6269715|NCT03615534|Vitamin B Complex|vitamin b complex|mesh-ancestor
6269716|NCT03615534|Vitamins|vitamins|mesh-ancestor
6269717|NCT03615534|Micronutrients|micronutrients|mesh-ancestor
6269718|NCT03615534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269719|NCT03615807|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6269720|NCT03615807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6269721|NCT03615924|Ticagrelor|ticagrelor|mesh-list
6269722|NCT03615924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6269723|NCT03615924|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6269724|NCT03615924|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6269725|NCT03615924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6269726|NCT03615924|Purinergic Agents|purinergic agents|mesh-ancestor
6269727|NCT03615924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6269728|NCT03615924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014854|NCT00353704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6014855|NCT00353834|Insulin|insulin|mesh-list
6269729|NCT03615924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269730|NCT03616977|Insulin Lispro|insulin lispro|mesh-list
6269731|NCT03616977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6269732|NCT03616977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269733|NCT03617523|Vaccines|vaccines|mesh-list
6269734|NCT03617523|Immunologic Factors|immunologic factors|mesh-ancestor
6269735|NCT03617523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269736|NCT03617861|Secretin|secretin|mesh-list
6269737|NCT03617861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6269738|NCT03617861|Hormones|hormones|mesh-ancestor
6269739|NCT03617861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6269740|NCT03617861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269741|NCT03617913|Cisplatin|cisplatin|mesh-list
6269742|NCT03617913|Fluorouracil|fluorouracil|mesh-list
6269743|NCT03617913|Mitomycins|mitomycins|mesh-list
6269744|NCT03617913|Mitomycin|mitomycin|mesh-list
6014856|NCT00353834|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6269745|NCT03617913|Avelumab|avelumab|mesh-list
6269746|NCT03617913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6269747|NCT03617913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6269748|NCT03617913|Antimetabolites|antimetabolites|mesh-ancestor
6269749|NCT03617913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269750|NCT03617913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6269751|NCT03617913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6269752|NCT03617913|Immunologic Factors|immunologic factors|mesh-ancestor
6269753|NCT03617913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269754|NCT03617913|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6269755|NCT03617913|Alkylating Agents|alkylating agents|mesh-ancestor
6269756|NCT03617913|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6269757|NCT03617913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6269758|NCT03617913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6269759|NCT03618628|Carbon Fiber|carbon fiber|mesh-list
6269760|NCT03618628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6269761|NCT03618628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6269762|NCT03618641|Nivolumab|nivolumab|mesh-list
6269763|NCT03618641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6269764|NCT03618641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6269765|NCT03618641|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6269766|NCT03618641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269767|NCT03618823|Acetaminophen|acetaminophen|mesh-list
6269768|NCT03618823|Ibuprofen|ibuprofen|mesh-list
6269769|NCT03618823|Oxycodone|oxycodone|mesh-list
6269770|NCT03618823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6269771|NCT03618823|Analgesics|analgesics|mesh-ancestor
6269772|NCT03618823|Sensory System Agents|sensory system agents|mesh-ancestor
6269773|NCT03618823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6269774|NCT03618823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269775|NCT03618823|Antipyretics|antipyretics|mesh-ancestor
6269776|NCT03618823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6269777|NCT03618823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6269778|NCT03618823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6269779|NCT03618823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6269780|NCT03618823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6269781|NCT03618823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269782|NCT03618823|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6269783|NCT03618823|Narcotics|narcotics|mesh-ancestor
6014857|NCT00353834|Insulin Glargine|insulin glargine|mesh-list
6014858|NCT00353834|Exenatide|exenatide|mesh-list
6014859|NCT00353834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6014860|NCT00353834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014861|NCT00353834|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6014862|NCT00353834|Incretins|incretins|mesh-ancestor
6014863|NCT00353834|Hormones|hormones|mesh-ancestor
6014864|NCT00353834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6014865|NCT00353873|Fluticasone|fluticasone|mesh-list
6014866|NCT00353873|Xhance|xhance|mesh-list
6014867|NCT00353873|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6269784|NCT03618823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6269785|NCT03619837|Sofosbuvir|sofosbuvir|mesh-list
6269786|NCT03619837|Velpatasvir|velpatasvir|mesh-list
6269787|NCT03619837|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
6269788|NCT03619837|Antiviral Agents|antiviral agents|mesh-ancestor
6269789|NCT03619837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6269790|NCT03620162|Vaccines|vaccines|mesh-list
6269791|NCT03620162|Immunologic Factors|immunologic factors|mesh-ancestor
6269792|NCT03620162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269793|NCT03620708|Nicotine|nicotine|mesh-list
6269794|NCT03620708|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6269795|NCT03620708|Autonomic Agents|autonomic agents|mesh-ancestor
6269796|NCT03620708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6269797|NCT03620708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269798|NCT03620708|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6269799|NCT03620708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6269800|NCT03620708|Cholinergic Agents|cholinergic agents|mesh-ancestor
6269801|NCT03620708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6269802|NCT03620708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269803|NCT03620890|Protamines|protamines|mesh-list
6269804|NCT03620890|Heparin Antagonists|heparin antagonists|mesh-ancestor
6269805|NCT03620890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269806|NCT03620890|Coagulants|coagulants|mesh-ancestor
6269807|NCT03621085|Ketamine|ketamine|mesh-list
6269808|NCT03621085|Analgesics|analgesics|mesh-ancestor
6269809|NCT03621085|Sensory System Agents|sensory system agents|mesh-ancestor
6269810|NCT03621085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6269811|NCT03621085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269812|NCT03621085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6269813|NCT03621085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6269814|NCT03621085|Anesthetics, General|anesthetics, general|mesh-ancestor
6269815|NCT03621085|Anesthetics|anesthetics|mesh-ancestor
6269816|NCT03621085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6269817|NCT03621085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6269818|NCT03621085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6269819|NCT03621085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6269820|NCT03621085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269821|NCT03622619|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6269822|NCT03622619|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6269823|NCT03622619|Lubricant Eye Drops|lubricant eye drops|mesh-list
6269824|NCT03622619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6269825|NCT03622619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6269826|NCT03624946|Immunoglobulins|immunoglobulins|mesh-list
6269827|NCT03624946|Antibodies|antibodies|mesh-list
6269828|NCT03624946|gamma-Globulins|gamma-globulins|mesh-list
6269829|NCT03624946|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6269830|NCT03624946|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6269831|NCT03624946|Immunoglobulin G|immunoglobulin g|mesh-list
6269832|NCT03624946|Immunologic Factors|immunologic factors|mesh-ancestor
6269833|NCT03624946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269834|NCT03626415|Abrocitinib|abrocitinib|mesh-list
6014868|NCT00353873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6014869|NCT00353873|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6269835|NCT03626415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6269836|NCT03626415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6269837|NCT03626415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390627|NCT00191321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390628|NCT00191321|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6390629|NCT00191347|Gemcitabine|gemcitabine|mesh-list
6390630|NCT00191347|Pemetrexed|pemetrexed|mesh-list
6014870|NCT00353873|Autonomic Agents|autonomic agents|mesh-ancestor
6014871|NCT00353873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6014872|NCT00353873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014873|NCT00353873|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6014874|NCT00353873|Respiratory System Agents|respiratory system agents|mesh-ancestor
6014875|NCT00353873|Dermatologic Agents|dermatologic agents|mesh-ancestor
6014876|NCT00353873|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6014877|NCT00353873|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6269838|NCT03626714|Tacrolimus|tacrolimus|mesh-list
6269839|NCT03626714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6269840|NCT03626714|Immunologic Factors|immunologic factors|mesh-ancestor
6269841|NCT03626714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269842|NCT03626714|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6269843|NCT03626714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6269844|NCT03626714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269845|NCT03627195|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
6269846|NCT03627195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6269847|NCT03627195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6269848|NCT03627195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6269849|NCT03627195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269850|NCT03627195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6269851|NCT03627195|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6269852|NCT03627195|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6269853|NCT03627195|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6269854|NCT03627195|Adrenergic Agents|adrenergic agents|mesh-ancestor
6269855|NCT03627195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6269856|NCT03627195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269857|NCT03627195|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6269858|NCT03627195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6269859|NCT03627195|Serotonin Agents|serotonin agents|mesh-ancestor
6269860|NCT03627195|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6269861|NCT03627195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6269862|NCT03627195|Dopamine Agents|dopamine agents|mesh-ancestor
6269863|NCT03627767|Abrocitinib|abrocitinib|mesh-list
6269864|NCT03627767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6269865|NCT03627767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6269866|NCT03627767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269867|NCT03628417|Bleomycin|bleomycin|mesh-list
6269868|NCT03628417|Calcium|calcium|mesh-list
6269869|NCT03628417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6269870|NCT03628417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269871|NCT03628417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6269872|NCT03628417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6269873|NCT03628924|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6269874|NCT03628924|Immunologic Factors|immunologic factors|mesh-ancestor
6269875|NCT03628924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269876|NCT03629054|Metformin|metformin|mesh-list
6269877|NCT03629054|Empagliflozin|empagliflozin|mesh-list
6269878|NCT03629054|Linagliptin|linagliptin|mesh-list
6269879|NCT03629054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6269880|NCT03629054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269881|NCT03629054|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6269882|NCT03629054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269883|NCT03629054|Incretins|incretins|mesh-ancestor
6269884|NCT03629054|Hormones|hormones|mesh-ancestor
6269885|NCT03629054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6269886|NCT03629054|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6269887|NCT03629054|Protease Inhibitors|protease inhibitors|mesh-ancestor
6269888|NCT03629054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6269889|NCT03629184|Oseltamivir|oseltamivir|mesh-list
6269890|NCT03629184|Baloxavir|baloxavir|mesh-list
6269891|NCT03629184|Antiviral Agents|antiviral agents|mesh-ancestor
6269892|NCT03629184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6269893|NCT03629184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6269894|NCT03629184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390631|NCT00191347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6390632|NCT00191347|Antimetabolites|antimetabolites|mesh-ancestor
6390633|NCT00191347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269895|NCT03629249|Indoleacetic Acids|indoleacetic acids|mesh-list
6269896|NCT03629249|Plant Growth Regulators|plant growth regulators|mesh-ancestor
6269897|NCT03629249|Growth Substances|growth substances|mesh-ancestor
6269898|NCT03629249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269899|NCT03629925|Gemcitabine|gemcitabine|mesh-list
6269900|NCT03629925|Carboplatin|carboplatin|mesh-list
6269901|NCT03629925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6269902|NCT03629925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6269903|NCT03629925|Antimetabolites|antimetabolites|mesh-ancestor
6269904|NCT03629925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269905|NCT03629925|Antiviral Agents|antiviral agents|mesh-ancestor
6269906|NCT03629925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6269907|NCT03629925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6269908|NCT03629925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6269909|NCT03629925|Immunologic Factors|immunologic factors|mesh-ancestor
6269910|NCT03629925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269911|NCT03630198|Lidocaine|lidocaine|mesh-list
6269912|NCT03630198|Anesthetics, Local|anesthetics, local|mesh-ancestor
6269913|NCT03630198|Anesthetics|anesthetics|mesh-ancestor
6269914|NCT03630198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6269915|NCT03630198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269916|NCT03630198|Sensory System Agents|sensory system agents|mesh-ancestor
6269917|NCT03630198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6269918|NCT03630198|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6269919|NCT03630198|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6269920|NCT03630198|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6269921|NCT03630198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6269922|NCT03630198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269923|NCT03631355|Tranexamic Acid|tranexamic acid|mesh-list
6269924|NCT03631355|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6269925|NCT03631355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6269926|NCT03631355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269927|NCT03631355|Hemostatics|hemostatics|mesh-ancestor
6269928|NCT03631355|Coagulants|coagulants|mesh-ancestor
6269929|NCT03631433|Acetaminophen|acetaminophen|mesh-list
6269930|NCT03631433|Ibuprofen|ibuprofen|mesh-list
6269931|NCT03631433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6269932|NCT03631433|Analgesics|analgesics|mesh-ancestor
6269933|NCT03631433|Sensory System Agents|sensory system agents|mesh-ancestor
6269934|NCT03631433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6269935|NCT03631433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269936|NCT03631433|Antipyretics|antipyretics|mesh-ancestor
6269937|NCT03631433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6269938|NCT03631433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6269939|NCT03631433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6269940|NCT03631433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6269941|NCT03631433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6269942|NCT03631433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269943|NCT03632083|Contact Lens Solutions|contact lens solutions|mesh-list
6269944|NCT03632083|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6269945|NCT03632083|Disinfectants|disinfectants|mesh-ancestor
6269946|NCT03632083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6269947|NCT03632109|Gentamicins|gentamicins|mesh-list
6269948|NCT03632109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6269949|NCT03632109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6269950|NCT03632109|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6269951|NCT03632109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6269952|NCT03632109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269953|NCT03633331|Letrozole|letrozole|mesh-list
6269954|NCT03633331|Fulvestrant|fulvestrant|mesh-list
6269955|NCT03633331|Palbociclib|palbociclib|mesh-list
6269956|NCT03633331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6269957|NCT03633331|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6269958|NCT03633331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6269959|NCT03633331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6269960|NCT03633331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269961|NCT03633331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6269962|NCT03633331|Hormone Antagonists|hormone antagonists|mesh-ancestor
6269963|NCT03633331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6269964|NCT03633331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269965|NCT03633331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6269966|NCT03633331|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6269967|NCT03633331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6269968|NCT03633344|Silicon|silicon|mesh-list
6269969|NCT03633344|Trace Elements|trace elements|mesh-ancestor
6269970|NCT03633344|Micronutrients|micronutrients|mesh-ancestor
6269971|NCT03633344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269972|NCT03633448|Phenylpropanolamine|phenylpropanolamine|mesh-list
6269973|NCT03633448|Guaifenesin|guaifenesin|mesh-list
6269974|NCT03633448|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
6269975|NCT03633448|Expectorants|expectorants|mesh-ancestor
6269976|NCT03633448|Respiratory System Agents|respiratory system agents|mesh-ancestor
6269977|NCT03633448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6269978|NCT03633448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6269979|NCT03633448|Adrenergic Agents|adrenergic agents|mesh-ancestor
6269980|NCT03633448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6269981|NCT03633448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269982|NCT03633448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6269983|NCT03633448|Appetite Depressants|appetite depressants|mesh-ancestor
6269984|NCT03633448|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6269985|NCT03633448|Sympathomimetics|sympathomimetics|mesh-ancestor
6269986|NCT03633448|Autonomic Agents|autonomic agents|mesh-ancestor
6269987|NCT03633448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6269988|NCT03633448|Nasal Decongestants|nasal decongestants|mesh-ancestor
6269989|NCT03633448|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6269990|NCT03633487|Guaifenesin|guaifenesin|mesh-list
6269991|NCT03633487|Expectorants|expectorants|mesh-ancestor
6269992|NCT03633487|Respiratory System Agents|respiratory system agents|mesh-ancestor
6269993|NCT03633526|Ivacaftor|ivacaftor|mesh-list
6269994|NCT03633526|VX-659|vx-659|mesh-list
6269995|NCT03633526|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6269996|NCT03633526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6269997|NCT03633526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6269998|NCT03634800|Nivolumab|nivolumab|mesh-list
6269999|NCT03634800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6270000|NCT03634800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6270001|NCT03634800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6270002|NCT03634800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270003|NCT03635957|Folic Acid|folic acid|mesh-list
6270004|NCT03635957|Methotrexate|methotrexate|mesh-list
6270005|NCT03635957|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6270006|NCT03635957|Abortifacient Agents|abortifacient agents|mesh-ancestor
6270007|NCT03635957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6270008|NCT03635957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270009|NCT03635957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6270010|NCT03635957|Antimetabolites|antimetabolites|mesh-ancestor
6270011|NCT03635957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270012|NCT03635957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6270013|NCT03635957|Dermatologic Agents|dermatologic agents|mesh-ancestor
6270014|NCT03635957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6270015|NCT03635957|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6270016|NCT03635957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6270017|NCT03635957|Immunologic Factors|immunologic factors|mesh-ancestor
6270018|NCT03635957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6270019|NCT03635957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6270020|NCT03635957|Hematinics|hematinics|mesh-ancestor
6270021|NCT03635957|Vitamin B Complex|vitamin b complex|mesh-ancestor
6270022|NCT03635957|Vitamins|vitamins|mesh-ancestor
6270023|NCT03635957|Micronutrients|micronutrients|mesh-ancestor
6270024|NCT03636061|Varenicline|varenicline|mesh-list
6270025|NCT03636061|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6270026|NCT03636061|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6270027|NCT03636061|Cholinergic Agents|cholinergic agents|mesh-ancestor
6270028|NCT03636061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6270029|NCT03636061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270030|NCT03636061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270031|NCT03638622|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6270032|NCT03638622|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6270033|NCT03638622|Dermatologic Agents|dermatologic agents|mesh-ancestor
6270034|NCT03638635|Bupivacaine|bupivacaine|mesh-list
6270035|NCT03638635|Anesthetics, Local|anesthetics, local|mesh-ancestor
6270036|NCT03638635|Anesthetics|anesthetics|mesh-ancestor
6270037|NCT03638635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6270038|NCT03638635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270039|NCT03638635|Sensory System Agents|sensory system agents|mesh-ancestor
6270040|NCT03638635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6270041|NCT03638908|Fluoxetine|fluoxetine|mesh-list
6270042|NCT03638908|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6270043|NCT03638908|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6270044|NCT03638908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6270045|NCT03638908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270046|NCT03638908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6270047|NCT03638908|Serotonin Agents|serotonin agents|mesh-ancestor
6270048|NCT03638908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270049|NCT03638908|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6270050|NCT03638908|Antidepressive Agents|antidepressive agents|mesh-ancestor
6270051|NCT03638908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6270052|NCT03638908|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6270053|NCT03638908|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6270054|NCT03638908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6270055|NCT03639675|Aflibercept|aflibercept|mesh-list
6270056|NCT03639675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6270057|NCT03639675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6270058|NCT03639675|Growth Substances|growth substances|mesh-ancestor
6270059|NCT03639675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270060|NCT03639675|Growth Inhibitors|growth inhibitors|mesh-ancestor
6270061|NCT03639675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6270062|NCT03639766|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6270063|NCT03639766|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6270064|NCT03639766|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6270065|NCT03639766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6270066|NCT03639766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270067|NCT03639766|Cholinergic Agents|cholinergic agents|mesh-ancestor
6270068|NCT03639766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6270069|NCT03639766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270070|NCT03639766|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6270071|NCT03639766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6270072|NCT03639779|Sodium thiosulfate|sodium thiosulfate|mesh-list
6270073|NCT03639779|Antidotes|antidotes|mesh-ancestor
6270074|NCT03639779|Protective Agents|protective agents|mesh-ancestor
6270075|NCT03639779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270076|NCT03639779|Antioxidants|antioxidants|mesh-ancestor
6270077|NCT03639779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270078|NCT03639779|Antitubercular Agents|antitubercular agents|mesh-ancestor
6270079|NCT03639779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6270080|NCT03639779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6270081|NCT03639779|Chelating Agents|chelating agents|mesh-ancestor
6270082|NCT03639779|Sequestering Agents|sequestering agents|mesh-ancestor
6270083|NCT03640507|Chlorhexidine|chlorhexidine|mesh-list
6270084|NCT03640507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6270085|NCT03640507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6270086|NCT03640507|Disinfectants|disinfectants|mesh-ancestor
6270087|NCT03641508|Dexamethasone|dexamethasone|mesh-list
6270088|NCT03641508|Triamcinolone|triamcinolone|mesh-list
6270089|NCT03641508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6270090|NCT03641508|Antiemetics|antiemetics|mesh-ancestor
6270091|NCT03641508|Autonomic Agents|autonomic agents|mesh-ancestor
6270092|NCT03641508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6270093|NCT03641508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270094|NCT03641508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6270095|NCT03641508|Glucocorticoids|glucocorticoids|mesh-ancestor
6270096|NCT03641508|Hormones|hormones|mesh-ancestor
6270097|NCT03641508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6270098|NCT03641508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6270099|NCT03641508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6270100|NCT03642262|Guaifenesin|guaifenesin|mesh-list
6270101|NCT03642262|Expectorants|expectorants|mesh-ancestor
6270102|NCT03642262|Respiratory System Agents|respiratory system agents|mesh-ancestor
6270103|NCT03642457|Bupivacaine|bupivacaine|mesh-list
6270104|NCT03642457|Anesthetics, Local|anesthetics, local|mesh-ancestor
6270105|NCT03642457|Anesthetics|anesthetics|mesh-ancestor
6270106|NCT03642457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6270107|NCT03642457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270108|NCT03642457|Sensory System Agents|sensory system agents|mesh-ancestor
6270109|NCT03642457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6270110|NCT03642717|Empagliflozin|empagliflozin|mesh-list
6270111|NCT03642717|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6270112|NCT03642717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270113|NCT03642717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6270114|NCT03642717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270115|NCT03642873|Phenylpropanolamine|phenylpropanolamine|mesh-list
6270116|NCT03642873|Hydrocodone|hydrocodone|mesh-list
6270117|NCT03642873|Guaifenesin|guaifenesin|mesh-list
6270118|NCT03642873|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
6270119|NCT03642873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6270120|NCT03642873|Narcotics|narcotics|mesh-ancestor
6270121|NCT03642873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6270122|NCT03642873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270123|NCT03642873|Analgesics|analgesics|mesh-ancestor
6270124|NCT03642873|Sensory System Agents|sensory system agents|mesh-ancestor
6270125|NCT03642873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6270126|NCT03642873|Antitussive Agents|antitussive agents|mesh-ancestor
6270127|NCT03642873|Respiratory System Agents|respiratory system agents|mesh-ancestor
6270128|NCT03642873|Expectorants|expectorants|mesh-ancestor
6270129|NCT03642873|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6270130|NCT03642873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6270131|NCT03642873|Adrenergic Agents|adrenergic agents|mesh-ancestor
6270132|NCT03642873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6270133|NCT03642873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270134|NCT03642873|Appetite Depressants|appetite depressants|mesh-ancestor
6270135|NCT03642873|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6270136|NCT03642873|Sympathomimetics|sympathomimetics|mesh-ancestor
6270137|NCT03642873|Autonomic Agents|autonomic agents|mesh-ancestor
6270138|NCT03642873|Nasal Decongestants|nasal decongestants|mesh-ancestor
6270139|NCT03642873|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6270140|NCT03643575|Phenylpropanolamine|phenylpropanolamine|mesh-list
6270141|NCT03643575|Guaifenesin|guaifenesin|mesh-list
6270142|NCT03643575|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
6270143|NCT03643575|Expectorants|expectorants|mesh-ancestor
6270144|NCT03643575|Respiratory System Agents|respiratory system agents|mesh-ancestor
6270145|NCT03643575|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6270146|NCT03643575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6270147|NCT03643575|Adrenergic Agents|adrenergic agents|mesh-ancestor
6270148|NCT03643575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6270149|NCT03643575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270150|NCT03643575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270151|NCT03643575|Appetite Depressants|appetite depressants|mesh-ancestor
6270152|NCT03643575|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6270153|NCT03643575|Sympathomimetics|sympathomimetics|mesh-ancestor
6270154|NCT03643575|Autonomic Agents|autonomic agents|mesh-ancestor
6270155|NCT03643575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6270156|NCT03643575|Nasal Decongestants|nasal decongestants|mesh-ancestor
6270157|NCT03643575|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6270158|NCT03643952|Daptomycin|daptomycin|mesh-list
6270159|NCT03643952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6270160|NCT03643952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6270161|NCT03644095|Phenylpropanolamine|phenylpropanolamine|mesh-list
6270162|NCT03644095|Guaifenesin|guaifenesin|mesh-list
6270163|NCT03644095|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
6270164|NCT03644095|Expectorants|expectorants|mesh-ancestor
6270165|NCT03644095|Respiratory System Agents|respiratory system agents|mesh-ancestor
6270166|NCT03644095|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6270167|NCT03644095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6270168|NCT03644095|Adrenergic Agents|adrenergic agents|mesh-ancestor
6270169|NCT03644095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6270170|NCT03644095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270171|NCT03644095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270172|NCT03644095|Appetite Depressants|appetite depressants|mesh-ancestor
6270173|NCT03644095|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6270174|NCT03644095|Sympathomimetics|sympathomimetics|mesh-ancestor
6270175|NCT03644095|Autonomic Agents|autonomic agents|mesh-ancestor
6270176|NCT03644095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6270177|NCT03644095|Nasal Decongestants|nasal decongestants|mesh-ancestor
6270178|NCT03644095|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6270179|NCT03644108|Guaifenesin|guaifenesin|mesh-list
6270180|NCT03644108|Expectorants|expectorants|mesh-ancestor
6270181|NCT03644108|Respiratory System Agents|respiratory system agents|mesh-ancestor
6270182|NCT03644212|Vitamin D|vitamin d|mesh-list
6270183|NCT03644212|Cholecalciferol|cholecalciferol|mesh-list
6270184|NCT03644212|Vitamins|vitamins|mesh-list
6270185|NCT03644212|Micronutrients|micronutrients|mesh-ancestor
6270186|NCT03644212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270187|NCT03644212|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6270188|NCT03644212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6390634|NCT00191347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6390635|NCT00191347|Antiviral Agents|antiviral agents|mesh-ancestor
6390636|NCT00191347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6390637|NCT00191347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6390638|NCT00191347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6390639|NCT00191347|Immunologic Factors|immunologic factors|mesh-ancestor
6390640|NCT00191347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390641|NCT00191347|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6390642|NCT00191347|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6390643|NCT00191373|Gemcitabine|gemcitabine|mesh-list
6390644|NCT00191373|Trastuzumab|trastuzumab|mesh-list
6390645|NCT00191373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6390646|NCT00191373|Antimetabolites|antimetabolites|mesh-ancestor
6390647|NCT00191373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390648|NCT00191373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6390649|NCT00191373|Antiviral Agents|antiviral agents|mesh-ancestor
6390650|NCT00191373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6390651|NCT00191373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6390652|NCT00191373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6390653|NCT00191373|Immunologic Factors|immunologic factors|mesh-ancestor
6390654|NCT00191373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390655|NCT00191373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6390656|NCT00191399|Olanzapine|olanzapine|mesh-list
6390657|NCT00191399|Fluoxetine|fluoxetine|mesh-list
6390658|NCT00191399|Antiemetics|antiemetics|mesh-ancestor
6390659|NCT00191399|Autonomic Agents|autonomic agents|mesh-ancestor
6390660|NCT00191399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6390661|NCT00191399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390662|NCT00191399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6390663|NCT00191399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6390664|NCT00191399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6390665|NCT00191399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6390666|NCT00191399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6390667|NCT00191399|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6390668|NCT00191399|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6390669|NCT00191399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6390670|NCT00191399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390671|NCT00191399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6390672|NCT00191399|Serotonin Agents|serotonin agents|mesh-ancestor
6390673|NCT00191399|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6390674|NCT00191399|Antidepressive Agents|antidepressive agents|mesh-ancestor
6390675|NCT00191399|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6390676|NCT00191399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6390677|NCT00191399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6390678|NCT00191412|Pemetrexed|pemetrexed|mesh-list
6390679|NCT00191412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6390680|NCT00191412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6390681|NCT00191412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390682|NCT00191412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5724169|NCT03188978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390683|NCT00191412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6270189|NCT03647709|Analgesics, Opioid|analgesics, opioid|mesh-list
6270190|NCT03647709|Narcotics|narcotics|mesh-ancestor
6270191|NCT03647709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6270192|NCT03647709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270193|NCT03647709|Analgesics|analgesics|mesh-ancestor
6270194|NCT03647709|Sensory System Agents|sensory system agents|mesh-ancestor
6270195|NCT03647709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6270196|NCT03649477|Carbetocin|carbetocin|mesh-list
6270197|NCT03649477|Oxytocin|oxytocin|mesh-list
6270198|NCT03649477|Oxytocics|oxytocics|mesh-ancestor
6270199|NCT03649477|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6270200|NCT03649477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270201|NCT03649750|Guaifenesin|guaifenesin|mesh-list
6270202|NCT03649750|Expectorants|expectorants|mesh-ancestor
6270203|NCT03649750|Respiratory System Agents|respiratory system agents|mesh-ancestor
6270204|NCT03650387|Lidocaine|lidocaine|mesh-list
6270205|NCT03650387|Anesthetics, Local|anesthetics, local|mesh-ancestor
6270206|NCT03650387|Anesthetics|anesthetics|mesh-ancestor
6270207|NCT03650387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6270208|NCT03650387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270209|NCT03650387|Sensory System Agents|sensory system agents|mesh-ancestor
6270210|NCT03650387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6014878|NCT00353873|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6014879|NCT00353873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6014880|NCT00353873|Adrenergic Agents|adrenergic agents|mesh-ancestor
6014881|NCT00353873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6014882|NCT00353873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270211|NCT03650387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6270212|NCT03650387|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6270213|NCT03650387|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6270214|NCT03650387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6270215|NCT03650387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270216|NCT03652610|Vaccines|vaccines|mesh-list
6270217|NCT03652610|Immunologic Factors|immunologic factors|mesh-ancestor
6270218|NCT03652610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270219|NCT03652818|Acetaminophen|acetaminophen|mesh-list
6270220|NCT03652818|Pregabalin|pregabalin|mesh-list
6270221|NCT03652818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6270222|NCT03652818|Analgesics|analgesics|mesh-ancestor
6270223|NCT03652818|Sensory System Agents|sensory system agents|mesh-ancestor
6270224|NCT03652818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6270225|NCT03652818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270226|NCT03652818|Antipyretics|antipyretics|mesh-ancestor
6270227|NCT03652818|Anticonvulsants|anticonvulsants|mesh-ancestor
6270228|NCT03652818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6270229|NCT03652818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6270230|NCT03652818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270231|NCT03652818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6270232|NCT03652818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6270233|NCT03652818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6270234|NCT03652818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6270235|NCT03652818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6270236|NCT03653026|Upadacitinib|upadacitinib|mesh-list
6270237|NCT03653026|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
6014883|NCT00353977|Vaccines|vaccines|mesh-list
6014884|NCT00353977|Immunologic Factors|immunologic factors|mesh-ancestor
6014885|NCT00353977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014886|NCT00354029|Ketamine|ketamine|mesh-list
6014887|NCT00354029|Analgesics|analgesics|mesh-ancestor
6014888|NCT00354029|Sensory System Agents|sensory system agents|mesh-ancestor
6014889|NCT00354029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6014890|NCT00354029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270238|NCT03653026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6270239|NCT03653026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6014891|NCT00354029|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6270240|NCT03653026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270241|NCT03653026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6270242|NCT03653416|Bupivacaine|bupivacaine|mesh-list
6270243|NCT03653416|Anesthetics, Local|anesthetics, local|mesh-ancestor
6270244|NCT03653416|Anesthetics|anesthetics|mesh-ancestor
6270245|NCT03653416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6270246|NCT03653416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270247|NCT03653416|Sensory System Agents|sensory system agents|mesh-ancestor
6014892|NCT00354029|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6014893|NCT00354029|Anesthetics, General|anesthetics, general|mesh-ancestor
6014894|NCT00354029|Anesthetics|anesthetics|mesh-ancestor
6014895|NCT00354029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6014896|NCT00354029|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6014897|NCT00354029|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6014898|NCT00354029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6014899|NCT00354029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014900|NCT00354107|Cytarabine|cytarabine|mesh-list
6270248|NCT03653416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6270249|NCT03653429|Tranexamic Acid|tranexamic acid|mesh-list
6270250|NCT03653429|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6270251|NCT03653429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6270252|NCT03653429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270253|NCT03653429|Hemostatics|hemostatics|mesh-ancestor
6270254|NCT03653429|Coagulants|coagulants|mesh-ancestor
6270255|NCT03654326|Naproxen|naproxen|mesh-list
6270256|NCT03654326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6270257|NCT03654326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6270258|NCT03654326|Analgesics|analgesics|mesh-ancestor
6270259|NCT03654326|Sensory System Agents|sensory system agents|mesh-ancestor
6270260|NCT03654326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6270261|NCT03654326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270262|NCT03654326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6270263|NCT03654326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6270264|NCT03654326|Gout Suppressants|gout suppressants|mesh-ancestor
6270265|NCT03654326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6270266|NCT03654326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6270267|NCT03654326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270268|NCT03654417|Lidocaine|lidocaine|mesh-list
6270269|NCT03654417|Anesthetics, Local|anesthetics, local|mesh-ancestor
6270270|NCT03654417|Anesthetics|anesthetics|mesh-ancestor
6270271|NCT03654417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6270272|NCT03654417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270273|NCT03654417|Sensory System Agents|sensory system agents|mesh-ancestor
6270274|NCT03654417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6270275|NCT03654417|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6270276|NCT03654417|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6270277|NCT03654417|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6270278|NCT03654417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6390684|NCT00191425|Teriparatide|teriparatide|mesh-list
6014901|NCT00354107|Hydrocortisone|hydrocortisone|mesh-list
6014902|NCT00354107|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6270279|NCT03654417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270280|NCT03655080|Paclitaxel|paclitaxel|mesh-list
6270281|NCT03655080|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6270282|NCT03655080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6270283|NCT03655080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6270284|NCT03655080|Tubulin Modulators|tubulin modulators|mesh-ancestor
6270285|NCT03655080|Antimitotic Agents|antimitotic agents|mesh-ancestor
6270286|NCT03655080|Mitosis Modulators|mitosis modulators|mesh-ancestor
6270287|NCT03655080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270288|NCT03655301|Metformin|metformin|mesh-list
6270289|NCT03655301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6270290|NCT03655301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270291|NCT03655444|Nivolumab|nivolumab|mesh-list
6270292|NCT03655444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6270293|NCT03655444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6270294|NCT03655444|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6270295|NCT03655444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270296|NCT03657095|Beraprost|beraprost|mesh-list
6270297|NCT03657095|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6270298|NCT03657095|Vasodilator Agents|vasodilator agents|mesh-ancestor
6270299|NCT03657264|Moxifloxacin|moxifloxacin|mesh-list
6270300|NCT03657264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6270301|NCT03657264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6270302|NCT03657264|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6270303|NCT03657264|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6270304|NCT03657264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6270305|NCT03657264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270306|NCT03657264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6270307|NCT03657407|Glycerol|glycerol|mesh-list
6270308|NCT03657407|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6270309|NCT03657407|Protective Agents|protective agents|mesh-ancestor
6270310|NCT03657407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270311|NCT03658876|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6270312|NCT03658876|Hematinics|hematinics|mesh-ancestor
6270313|NCT03660241|Abrocitinib|abrocitinib|mesh-list
6270314|NCT03660241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6270315|NCT03660241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6270316|NCT03660241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270317|NCT03660839|Artefenomel|artefenomel|mesh-list
6270318|NCT03660839|Ferroquine|ferroquine|mesh-list
6270319|NCT03660839|Antimalarials|antimalarials|mesh-ancestor
6270320|NCT03660839|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6270321|NCT03660839|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6270322|NCT03660839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6270323|NCT03661346|Labetalol|labetalol|mesh-list
6270324|NCT03661346|Esmolol|esmolol|mesh-list
6270325|NCT03661346|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6270326|NCT03661346|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6270327|NCT03661346|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6270328|NCT03661346|Adrenergic Agents|adrenergic agents|mesh-ancestor
6270329|NCT03661346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6270330|NCT03661346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270331|NCT03661346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270332|NCT03661346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6270333|NCT03661346|Sympathomimetics|sympathomimetics|mesh-ancestor
6270334|NCT03661346|Autonomic Agents|autonomic agents|mesh-ancestor
6270335|NCT03661346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6270336|NCT03661346|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6270337|NCT03661346|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6270338|NCT03661541|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
6270339|NCT03661541|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6270340|NCT03661541|Immunologic Factors|immunologic factors|mesh-ancestor
6270341|NCT03661541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270342|NCT03661983|Aripiprazole|aripiprazole|mesh-list
6270343|NCT03661983|Antidepressive Agents|antidepressive agents|mesh-ancestor
6270344|NCT03661983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6270345|NCT03661983|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6270346|NCT03661983|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6270347|NCT03661983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6270348|NCT03661983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270349|NCT03661983|Dopamine Agonists|dopamine agonists|mesh-ancestor
6270350|NCT03661983|Dopamine Agents|dopamine agents|mesh-ancestor
6270351|NCT03661983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6270352|NCT03661983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270353|NCT03661983|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6270354|NCT03661983|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6270355|NCT03661983|Serotonin Agents|serotonin agents|mesh-ancestor
6270356|NCT03661983|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6270357|NCT03661983|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6270358|NCT03661983|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6270359|NCT03661983|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6270360|NCT03662074|Gemcitabine|gemcitabine|mesh-list
6270361|NCT03662074|Nivolumab|nivolumab|mesh-list
6270362|NCT03662074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6270363|NCT03662074|Antimetabolites|antimetabolites|mesh-ancestor
6270364|NCT03662074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270365|NCT03662074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6270366|NCT03662074|Antiviral Agents|antiviral agents|mesh-ancestor
6270367|NCT03662074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6270368|NCT03662074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6270369|NCT03662074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6270370|NCT03662074|Immunologic Factors|immunologic factors|mesh-ancestor
6270371|NCT03662074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270372|NCT03662074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6270373|NCT03662074|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6270374|NCT03662334|Insulin, Short-Acting|insulin, short-acting|mesh-list
6270375|NCT03662334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6270376|NCT03662334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270377|NCT03662789|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
6270378|NCT03662789|Hematinics|hematinics|mesh-ancestor
6270379|NCT03663101|Lidocaine|lidocaine|mesh-list
6270380|NCT03663101|Botulinum Toxins|botulinum toxins|mesh-list
6270381|NCT03663101|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6270382|NCT03663101|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6270383|NCT03663101|Anesthetics, Local|anesthetics, local|mesh-ancestor
6270384|NCT03663101|Anesthetics|anesthetics|mesh-ancestor
6270385|NCT03663101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6270386|NCT03663101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270387|NCT03663101|Sensory System Agents|sensory system agents|mesh-ancestor
6270388|NCT03663101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6270389|NCT03663101|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6270390|NCT03663101|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6270391|NCT03663101|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6270392|NCT03663101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6270393|NCT03663101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270394|NCT03663101|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6270395|NCT03663101|Cholinergic Agents|cholinergic agents|mesh-ancestor
6270396|NCT03663101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6270397|NCT03663101|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6270398|NCT03663283|Bupivacaine|bupivacaine|mesh-list
6270399|NCT03663283|Anesthetics, Local|anesthetics, local|mesh-ancestor
6270400|NCT03663283|Anesthetics|anesthetics|mesh-ancestor
6270401|NCT03663283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6270402|NCT03663283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270403|NCT03663283|Sensory System Agents|sensory system agents|mesh-ancestor
6270404|NCT03663283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6270405|NCT03663582|Teduglutide|teduglutide|mesh-list
6270406|NCT03663582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6270407|NCT03663582|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6270408|NCT03663582|Protective Agents|protective agents|mesh-ancestor
6270409|NCT03663582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270410|NCT03664544|Edaravone|edaravone|mesh-list
6270411|NCT03664544|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6270412|NCT03664544|Antioxidants|antioxidants|mesh-ancestor
6270413|NCT03664544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270414|NCT03664544|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6270415|NCT03664544|Protective Agents|protective agents|mesh-ancestor
6270416|NCT03664544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270417|NCT03665155|Daratumumab|daratumumab|mesh-list
6270418|NCT03665155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6270419|NCT03666663|Lidocaine|lidocaine|mesh-list
6270420|NCT03666663|Bupivacaine|bupivacaine|mesh-list
6270421|NCT03666663|Ropivacaine|ropivacaine|mesh-list
6270422|NCT03666663|Anesthetics, Local|anesthetics, local|mesh-ancestor
6270423|NCT03666663|Anesthetics|anesthetics|mesh-ancestor
6270424|NCT03666663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6270425|NCT03666663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270426|NCT03666663|Sensory System Agents|sensory system agents|mesh-ancestor
6270427|NCT03666663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6270428|NCT03666663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6270429|NCT03666663|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6270430|NCT03666663|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6270431|NCT03666663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6270432|NCT03666663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270433|NCT03667053|Glucagon|glucagon|mesh-list
6270434|NCT03667053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6270435|NCT03667053|Hormones|hormones|mesh-ancestor
6270436|NCT03667053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6270437|NCT03667053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270438|NCT03667547|Raltegravir Potassium|raltegravir potassium|mesh-list
6270439|NCT03667547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6270440|NCT03667547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6270441|NCT03667547|Antiviral Agents|antiviral agents|mesh-ancestor
6270442|NCT03667547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6270443|NCT03667547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6270444|NCT03667547|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6270445|NCT03667547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6270446|NCT03667547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270447|NCT03668613|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6270448|NCT03668613|Immunologic Factors|immunologic factors|mesh-ancestor
6270449|NCT03668613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270450|NCT03669081|Ketorolac|ketorolac|mesh-list
6270451|NCT03669081|Pregabalin|pregabalin|mesh-list
6270452|NCT03669081|Analgesics|analgesics|mesh-ancestor
6270453|NCT03669081|Sensory System Agents|sensory system agents|mesh-ancestor
6270454|NCT03669081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6270455|NCT03669081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270456|NCT03669081|Anticonvulsants|anticonvulsants|mesh-ancestor
6270457|NCT03669081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6270458|NCT03669081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6270459|NCT03669081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270460|NCT03669081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6270461|NCT03669081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6270462|NCT03669081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6270463|NCT03669081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6270464|NCT03669081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6270465|NCT03669081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6270466|NCT03669081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6270467|NCT03669081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6270468|NCT03669081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6270469|NCT03669081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6270470|NCT03669081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6270471|NCT03669861|Abatacept|abatacept|mesh-list
6270472|NCT03669861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6270473|NCT03669861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270474|NCT03669861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6270475|NCT03669861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6270476|NCT03669861|Immunologic Factors|immunologic factors|mesh-ancestor
6270477|NCT03669861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270478|NCT03669861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6270479|NCT03670030|Sirolimus|sirolimus|mesh-list
6270480|NCT03670030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6270481|NCT03670030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6270482|NCT03670030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6270483|NCT03670030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6270484|NCT03670030|Antifungal Agents|antifungal agents|mesh-ancestor
6014903|NCT00354107|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6014904|NCT00354107|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6014905|NCT00354107|Carboplatin|carboplatin|mesh-list
6014906|NCT00354107|Methotrexate|methotrexate|mesh-list
6014907|NCT00354107|Etoposide|etoposide|mesh-list
6270485|NCT03670030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6270486|NCT03670030|Immunologic Factors|immunologic factors|mesh-ancestor
6270487|NCT03670030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270488|NCT03670160|Clonidine|clonidine|mesh-list
6270489|NCT03670160|Phenobarbital|phenobarbital|mesh-list
6270490|NCT03670160|Analgesics|analgesics|mesh-ancestor
6270491|NCT03670160|Sensory System Agents|sensory system agents|mesh-ancestor
6270492|NCT03670160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6270493|NCT03670160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270494|NCT03670160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6270495|NCT03670160|Sympatholytics|sympatholytics|mesh-ancestor
6270496|NCT03670160|Autonomic Agents|autonomic agents|mesh-ancestor
6270497|NCT03670160|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6270498|NCT03670160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6270499|NCT03670160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6270500|NCT03670160|Adrenergic Agents|adrenergic agents|mesh-ancestor
6270501|NCT03670160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6270502|NCT03670160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270503|NCT03670160|Anticonvulsants|anticonvulsants|mesh-ancestor
6270504|NCT03670160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6270505|NCT03670160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6270506|NCT03670160|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6270507|NCT03670160|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6270508|NCT03670160|GABA Modulators|gaba modulators|mesh-ancestor
6270509|NCT03670160|GABA Agents|gaba agents|mesh-ancestor
6270510|NCT03670160|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6270511|NCT03670160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6270512|NCT03670160|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6270513|NCT03670641|Insulin Glargine|insulin glargine|mesh-list
6270514|NCT03670641|Insulin Lispro|insulin lispro|mesh-list
6270515|NCT03670641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6270516|NCT03670641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270517|NCT03670810|Lasmiditan|lasmiditan|mesh-list
6270518|NCT03670810|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6270519|NCT03670810|Serotonin Agents|serotonin agents|mesh-ancestor
6270520|NCT03670810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6270521|NCT03670810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270522|NCT03670810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014908|NCT00354107|Etoposide phosphate|etoposide phosphate|mesh-list
6014909|NCT00354107|Ifosfamide|ifosfamide|mesh-list
6014910|NCT00354107|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6014911|NCT00354107|Antibodies|antibodies|mesh-list
6014912|NCT00354107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6014913|NCT00354107|Immunologic Factors|immunologic factors|mesh-ancestor
6014914|NCT00354107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014915|NCT00354107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6014916|NCT00354107|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6014917|NCT00354107|Abortifacient Agents|abortifacient agents|mesh-ancestor
6014918|NCT00354107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6014919|NCT00354107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6014920|NCT00354107|Antimetabolites|antimetabolites|mesh-ancestor
6018472|NCT00381004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6270523|NCT03672006|Heparin|heparin|mesh-list
6270524|NCT03672006|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6270525|NCT03672006|Anticoagulants|anticoagulants|mesh-ancestor
6270526|NCT03672006|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6270527|NCT03672006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6270528|NCT03672006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270529|NCT03672097|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6270530|NCT03672097|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6270531|NCT03673670|Tiotropium Bromide|tiotropium bromide|mesh-list
6270532|NCT03673670|Olodaterol|olodaterol|mesh-list
6270533|NCT03673670|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6270534|NCT03673670|Autonomic Agents|autonomic agents|mesh-ancestor
6270535|NCT03673670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6270536|NCT03673670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270537|NCT03673670|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6270538|NCT03673670|Respiratory System Agents|respiratory system agents|mesh-ancestor
6270539|NCT03673670|Parasympatholytics|parasympatholytics|mesh-ancestor
6270540|NCT03673670|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6270541|NCT03673670|Cholinergic Agents|cholinergic agents|mesh-ancestor
6270542|NCT03673670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6270543|NCT03673670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270544|NCT03674177|Vaccines|vaccines|mesh-list
6270545|NCT03674177|Immunologic Factors|immunologic factors|mesh-ancestor
6270546|NCT03674177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390685|NCT00191425|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
6390686|NCT00191425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6390687|NCT00191425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390688|NCT00191425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6390689|NCT00191425|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6390690|NCT00191425|Hormone Antagonists|hormone antagonists|mesh-ancestor
6390691|NCT00191425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6390692|NCT00191425|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6390693|NCT00191425|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6390694|NCT00191438|Gemcitabine|gemcitabine|mesh-list
6390695|NCT00191438|Capecitabine|capecitabine|mesh-list
6390696|NCT00191438|Docetaxel|docetaxel|mesh-list
6390697|NCT00191438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6390698|NCT00191438|Antimetabolites|antimetabolites|mesh-ancestor
6390699|NCT00191438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390700|NCT00191438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6390701|NCT00191438|Antiviral Agents|antiviral agents|mesh-ancestor
6390702|NCT00191438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6390703|NCT00191438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6390704|NCT00191438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6390705|NCT00191438|Immunologic Factors|immunologic factors|mesh-ancestor
6390706|NCT00191438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390707|NCT00191438|Tubulin Modulators|tubulin modulators|mesh-ancestor
6390708|NCT00191438|Antimitotic Agents|antimitotic agents|mesh-ancestor
6390709|NCT00191438|Mitosis Modulators|mitosis modulators|mesh-ancestor
6390710|NCT00191464|Insulin|insulin|mesh-list
6390711|NCT00191464|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6390712|NCT00191464|Metformin|metformin|mesh-list
6390713|NCT00191464|Insulin Glargine|insulin glargine|mesh-list
6390714|NCT00191464|Insulin Lispro|insulin lispro|mesh-list
6390715|NCT00191464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6390716|NCT00191464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390717|NCT00191490|Gemcitabine|gemcitabine|mesh-list
6390718|NCT00191490|Docetaxel|docetaxel|mesh-list
6390719|NCT00191490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6390720|NCT00191490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6390721|NCT00191490|Antimetabolites|antimetabolites|mesh-ancestor
6390722|NCT00191490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390723|NCT00191490|Antiviral Agents|antiviral agents|mesh-ancestor
6390724|NCT00191490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6390725|NCT00191490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6390726|NCT00191490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6390727|NCT00191490|Immunologic Factors|immunologic factors|mesh-ancestor
6390728|NCT00191490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390729|NCT00191490|Tubulin Modulators|tubulin modulators|mesh-ancestor
6390730|NCT00191490|Antimitotic Agents|antimitotic agents|mesh-ancestor
6390731|NCT00191490|Mitosis Modulators|mitosis modulators|mesh-ancestor
6390732|NCT00191503|Gemcitabine|gemcitabine|mesh-list
6390733|NCT00191503|Pemetrexed|pemetrexed|mesh-list
6270547|NCT03674970|Nicotine|nicotine|mesh-list
6270548|NCT03674970|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6270549|NCT03674970|Autonomic Agents|autonomic agents|mesh-ancestor
6270550|NCT03674970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6270551|NCT03674970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270552|NCT03674970|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6270553|NCT03674970|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6270554|NCT03674970|Cholinergic Agents|cholinergic agents|mesh-ancestor
6270555|NCT03674970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6270556|NCT03674970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270557|NCT03675451|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
6270558|NCT03675451|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6270559|NCT03675451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270560|NCT03675581|Nintedanib|nintedanib|mesh-list
6270561|NCT03675581|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
6270562|NCT03675581|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
6270563|NCT03675581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6270564|NCT03675581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6270565|NCT03675581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6270566|NCT03675581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270567|NCT03675581|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6270568|NCT03675581|Contraceptive Agents|contraceptive agents|mesh-ancestor
6270569|NCT03675581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6270570|NCT03675581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270571|NCT03675581|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6270572|NCT03675581|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6270573|NCT03675581|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6270574|NCT03675581|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6270575|NCT03675581|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6270576|NCT03675581|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
6270577|NCT03675581|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6270578|NCT03675581|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6270579|NCT03676725|Lidocaine|lidocaine|mesh-list
6270580|NCT03676725|Anesthetics, Local|anesthetics, local|mesh-ancestor
6270581|NCT03676725|Anesthetics|anesthetics|mesh-ancestor
6270582|NCT03676725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6270583|NCT03676725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270584|NCT03676725|Sensory System Agents|sensory system agents|mesh-ancestor
6270585|NCT03676725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6270586|NCT03676725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6270587|NCT03676725|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6270588|NCT03676725|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6270589|NCT03676725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6270590|NCT03676725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270591|NCT03677401|Serlopitant|serlopitant|mesh-list
6270592|NCT03677401|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6270593|NCT03677401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6270594|NCT03677401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270595|NCT03677401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270596|NCT03678870|Analgesics, Opioid|analgesics, opioid|mesh-list
6270597|NCT03678870|Narcotics|narcotics|mesh-ancestor
6270598|NCT03678870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6270599|NCT03678870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270600|NCT03678870|Analgesics|analgesics|mesh-ancestor
6270601|NCT03678870|Sensory System Agents|sensory system agents|mesh-ancestor
6270602|NCT03678870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6270603|NCT03679975|Riluzole|riluzole|mesh-list
6270604|NCT03679975|Anticonvulsants|anticonvulsants|mesh-ancestor
6270605|NCT03679975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6270606|NCT03679975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6270607|NCT03679975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6270608|NCT03679975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270609|NCT03679975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270610|NCT03679975|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6270611|NCT03679975|Protective Agents|protective agents|mesh-ancestor
6270612|NCT03680521|Nivolumab|nivolumab|mesh-list
6270613|NCT03680521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6270614|NCT03680521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6270615|NCT03680521|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6270616|NCT03680521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270617|NCT03681093|Indoleacetic Acids|indoleacetic acids|mesh-list
6270618|NCT03681093|Plant Growth Regulators|plant growth regulators|mesh-ancestor
6270619|NCT03681093|Growth Substances|growth substances|mesh-ancestor
6270620|NCT03681093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270621|NCT03681951|Pembrolizumab|pembrolizumab|mesh-list
6270622|NCT03681951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6270623|NCT03681951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6270624|NCT03682302|Bupivacaine|bupivacaine|mesh-list
6270625|NCT03682302|Anesthetics, Local|anesthetics, local|mesh-ancestor
6270626|NCT03682302|Anesthetics|anesthetics|mesh-ancestor
6270627|NCT03682302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6270628|NCT03682302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270629|NCT03682302|Sensory System Agents|sensory system agents|mesh-ancestor
6270630|NCT03682302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6270631|NCT03682705|Upadacitinib|upadacitinib|mesh-list
6270632|NCT03682705|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
6270633|NCT03682705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6270634|NCT03682705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6270635|NCT03682705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270636|NCT03682705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6270637|NCT03684044|Baloxavir|baloxavir|mesh-list
6270638|NCT03684044|Antiviral Agents|antiviral agents|mesh-ancestor
6270639|NCT03684044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6270640|NCT03684044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6270641|NCT03684044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270642|NCT03684265|Meloxicam|meloxicam|mesh-list
6270643|NCT03684265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6270644|NCT03684265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6270645|NCT03684265|Analgesics|analgesics|mesh-ancestor
6270646|NCT03684265|Sensory System Agents|sensory system agents|mesh-ancestor
6270647|NCT03684265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6270648|NCT03684265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270649|NCT03684265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6270650|NCT03684265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6270651|NCT03684265|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6270652|NCT03684265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6270653|NCT03684265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6270654|NCT03684265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270655|NCT03684642|Metformin|metformin|mesh-list
6270656|NCT03684642|Dulaglutide|dulaglutide|mesh-list
6270657|NCT03684642|Efpeglenatide|efpeglenatide|mesh-list
6270658|NCT03684642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6270659|NCT03684642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270660|NCT03685344|Durvalumab|durvalumab|mesh-list
6270661|NCT03685344|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
6270662|NCT03685344|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6270663|NCT03685344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6270664|NCT03685344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6270665|NCT03685344|Immunologic Factors|immunologic factors|mesh-ancestor
6270666|NCT03685344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270667|NCT03685396|Hemostatics|hemostatics|mesh-list
6270668|NCT03685396|Coagulants|coagulants|mesh-ancestor
6270669|NCT03687372|Hydrogen Peroxide|hydrogen peroxide|mesh-list
6270670|NCT03687372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6270671|NCT03687372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6270672|NCT03687736|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6270673|NCT03687736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6270674|NCT03687736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6270675|NCT03687736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6270676|NCT03687736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270677|NCT03687736|Cholinergic Agents|cholinergic agents|mesh-ancestor
6270678|NCT03687736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6270679|NCT03687736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270680|NCT03687736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6270681|NCT03687736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6270682|NCT03687827|Insulin|insulin|mesh-list
6270683|NCT03687827|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6270684|NCT03687827|Insulin Glargine|insulin glargine|mesh-list
6270685|NCT03687827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6270686|NCT03687827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270687|NCT03691779|Ivacaftor|ivacaftor|mesh-list
6270688|NCT03691779|Elexacaftor|elexacaftor|mesh-list
6270689|NCT03691779|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6270690|NCT03691779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6270691|NCT03691779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270692|NCT03691831|Hydrogen Peroxide|hydrogen peroxide|mesh-list
6270693|NCT03691831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6270694|NCT03691831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6270695|NCT03691948|Analgesics, Opioid|analgesics, opioid|mesh-list
6270696|NCT03691948|Narcotics|narcotics|mesh-ancestor
6270697|NCT03691948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6270698|NCT03691948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270699|NCT03691948|Analgesics|analgesics|mesh-ancestor
6270700|NCT03691948|Sensory System Agents|sensory system agents|mesh-ancestor
6270701|NCT03691948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6270702|NCT03692676|Tiotropium Bromide|tiotropium bromide|mesh-list
6270703|NCT03692676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6270704|NCT03692676|Autonomic Agents|autonomic agents|mesh-ancestor
6270705|NCT03692676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6270706|NCT03692676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270707|NCT03692676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6270708|NCT03692676|Respiratory System Agents|respiratory system agents|mesh-ancestor
6270709|NCT03692676|Parasympatholytics|parasympatholytics|mesh-ancestor
6270710|NCT03692676|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6270711|NCT03692676|Cholinergic Agents|cholinergic agents|mesh-ancestor
6270712|NCT03692676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6270713|NCT03692676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270714|NCT03693950|Darbepoetin alfa|darbepoetin alfa|mesh-list
6270715|NCT03693950|Hematinics|hematinics|mesh-ancestor
6270716|NCT03693989|Fluprednisolone|fluprednisolone|mesh-list
6270717|NCT03693989|Difluprednate|difluprednate|mesh-list
6270718|NCT03693989|Glucocorticoids|glucocorticoids|mesh-ancestor
6270719|NCT03693989|Hormones|hormones|mesh-ancestor
6270720|NCT03693989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6270721|NCT03693989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270722|NCT03693989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6270723|NCT03695094|Lamotrigine|lamotrigine|mesh-list
6270724|NCT03695094|Oxcarbazepine|oxcarbazepine|mesh-list
6270725|NCT03695094|Levetiracetam|levetiracetam|mesh-list
6270726|NCT03695094|Brivaracetam|brivaracetam|mesh-list
6270727|NCT03695094|Anticonvulsants|anticonvulsants|mesh-ancestor
6270728|NCT03695094|Nootropic Agents|nootropic agents|mesh-ancestor
6270729|NCT03695094|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6270730|NCT03695094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6270731|NCT03695094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270732|NCT03695094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6270733|NCT03695094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270734|NCT03695094|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6270735|NCT03695094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6270736|NCT03695094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6270737|NCT03695094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6270738|NCT03695094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6270739|NCT03695094|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6270740|NCT03695094|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6270741|NCT03695094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6270742|NCT03695367|Acetaminophen|acetaminophen|mesh-list
6270743|NCT03695367|Ibuprofen|ibuprofen|mesh-list
6270744|NCT03695367|Ketorolac|ketorolac|mesh-list
6270745|NCT03695367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6270746|NCT03695367|Analgesics|analgesics|mesh-ancestor
6270747|NCT03695367|Sensory System Agents|sensory system agents|mesh-ancestor
6270748|NCT03695367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6270749|NCT03695367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270750|NCT03695367|Antipyretics|antipyretics|mesh-ancestor
6270751|NCT03695367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6270752|NCT03695367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6270753|NCT03695367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6270754|NCT03695367|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6270755|NCT03695367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6270756|NCT03695367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270757|NCT03696342|Gatifloxacin|gatifloxacin|mesh-list
6270758|NCT03696342|Pazufloxacin|pazufloxacin|mesh-list
6270759|NCT03696342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6270760|NCT03696342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6270761|NCT03696342|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6270762|NCT03696342|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6270763|NCT03696342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6270764|NCT03696342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6270765|NCT03696342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6270766|NCT03696342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270767|NCT03696342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6270768|NCT03696342|Antitubercular Agents|antitubercular agents|mesh-ancestor
6270769|NCT03696758|Metoprolol|metoprolol|mesh-list
6270770|NCT03696758|Sildenafil Citrate|sildenafil citrate|mesh-list
6270771|NCT03696758|Vasodilator Agents|vasodilator agents|mesh-ancestor
6270772|NCT03696758|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6270773|NCT03696758|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6270774|NCT03696758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6270775|NCT03696758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270776|NCT03696758|Urological Agents|urological agents|mesh-ancestor
6270777|NCT03696758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6270778|NCT03696758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6270779|NCT03696758|Sympatholytics|sympatholytics|mesh-ancestor
6270780|NCT03696758|Autonomic Agents|autonomic agents|mesh-ancestor
6270781|NCT03696758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6270782|NCT03696758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270783|NCT03696758|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6270784|NCT03696758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6270785|NCT03696758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6270786|NCT03696758|Adrenergic Agents|adrenergic agents|mesh-ancestor
6270787|NCT03696758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6270788|NCT03697252|Xanomeline|xanomeline|mesh-list
6270789|NCT03697252|Trospium chloride|trospium chloride|mesh-list
6270790|NCT03697252|Parasympatholytics|parasympatholytics|mesh-ancestor
6270791|NCT03697252|Autonomic Agents|autonomic agents|mesh-ancestor
6270792|NCT03697252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6270793|NCT03697252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270794|NCT03697252|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6270795|NCT03697252|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6270796|NCT03697252|Cholinergic Agents|cholinergic agents|mesh-ancestor
6270797|NCT03697252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6270798|NCT03697252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270799|NCT03697252|Urological Agents|urological agents|mesh-ancestor
6270800|NCT03697252|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6270801|NCT03697252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6270802|NCT03697252|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6270803|NCT03697252|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6270804|NCT03697993|Levofloxacin|levofloxacin|mesh-list
6270805|NCT03697993|Ofloxacin|ofloxacin|mesh-list
6270806|NCT03697993|Fosfomycin|fosfomycin|mesh-list
6270807|NCT03697993|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6270808|NCT03697993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6270809|NCT03697993|Renal Agents|renal agents|mesh-ancestor
6270810|NCT03697993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6270811|NCT03697993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6270812|NCT03697993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6270813|NCT03697993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6270814|NCT03697993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270815|NCT03697993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6270816|NCT03697993|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6270817|NCT03697993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6270818|NCT03698279|Vaccines|vaccines|mesh-list
6270819|NCT03698279|Immunologic Factors|immunologic factors|mesh-ancestor
6270820|NCT03698279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390734|NCT00191503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6390735|NCT00191503|Antimetabolites|antimetabolites|mesh-ancestor
6014921|NCT00354107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014922|NCT00354107|Dermatologic Agents|dermatologic agents|mesh-ancestor
6014923|NCT00354107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6014924|NCT00354107|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6014925|NCT00354107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6014926|NCT00354107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6014927|NCT00354107|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6014928|NCT00354107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6270821|NCT03700892|Cinnamaldehyde|cinnamaldehyde|mesh-list
6270822|NCT03700892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6270823|NCT03700892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6270824|NCT03700892|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
6270825|NCT03700892|Protective Agents|protective agents|mesh-ancestor
6270826|NCT03700892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270827|NCT03701061|Vaccines|vaccines|mesh-list
6270828|NCT03701061|Immunologic Factors|immunologic factors|mesh-ancestor
6270829|NCT03701061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270830|NCT03701074|Acetaminophen|acetaminophen|mesh-list
6270831|NCT03701074|Ibuprofen|ibuprofen|mesh-list
6270832|NCT03701074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6270833|NCT03701074|Analgesics|analgesics|mesh-ancestor
6270834|NCT03701074|Sensory System Agents|sensory system agents|mesh-ancestor
6270835|NCT03701074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6270836|NCT03701074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270837|NCT03701074|Antipyretics|antipyretics|mesh-ancestor
6270838|NCT03701074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6270839|NCT03701074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6270840|NCT03701074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6270841|NCT03701074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6270842|NCT03701074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6270843|NCT03701074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270844|NCT03704376|Clonidine|clonidine|mesh-list
6270845|NCT03704376|Ropivacaine|ropivacaine|mesh-list
6270846|NCT03704376|Anesthetics, Local|anesthetics, local|mesh-ancestor
6270847|NCT03704376|Anesthetics|anesthetics|mesh-ancestor
6270848|NCT03704376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6270849|NCT03704376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270850|NCT03704376|Sensory System Agents|sensory system agents|mesh-ancestor
6270851|NCT03704376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6270852|NCT03704376|Analgesics|analgesics|mesh-ancestor
6014929|NCT00354107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6014930|NCT00354107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6014931|NCT00354107|Antiviral Agents|antiviral agents|mesh-ancestor
6014932|NCT00354107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6014933|NCT00354107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6014934|NCT00354107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6014935|NCT00354107|Alkylating Agents|alkylating agents|mesh-ancestor
6014936|NCT00354107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6014937|NCT00354172|Cyclosporine|cyclosporine|mesh-list
6014938|NCT00354172|Mycophenolic Acid|mycophenolic acid|mesh-list
6014939|NCT00354172|Aldesleukin|aldesleukin|mesh-list
6014940|NCT00354172|Methylprednisolone|methylprednisolone|mesh-list
6014941|NCT00354172|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6014942|NCT00354172|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6014943|NCT00354172|Prednisolone|prednisolone|mesh-list
6014944|NCT00354172|Prednisolone acetate|prednisolone acetate|mesh-list
6014945|NCT00354172|Cyclophosphamide|cyclophosphamide|mesh-list
6014946|NCT00354172|Fludarabine|fludarabine|mesh-list
6014947|NCT00354172|Fludarabine phosphate|fludarabine phosphate|mesh-list
6014948|NCT00354172|Interleukin-2|interleukin-2|mesh-list
6270853|NCT03704376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6270854|NCT03704376|Sympatholytics|sympatholytics|mesh-ancestor
6270855|NCT03704376|Autonomic Agents|autonomic agents|mesh-ancestor
6270856|NCT03704376|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6014949|NCT00354172|Cyclosporins|cyclosporins|mesh-list
6270857|NCT03704376|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6014950|NCT00354172|Lenograstim|lenograstim|mesh-list
6270858|NCT03704376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6270859|NCT03704376|Adrenergic Agents|adrenergic agents|mesh-ancestor
6270860|NCT03704376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6270861|NCT03704376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270862|NCT03704467|Carboplatin|carboplatin|mesh-list
6270863|NCT03704467|Avelumab|avelumab|mesh-list
6270864|NCT03704467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6270865|NCT03704467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6270866|NCT03705273|Dexamethasone|dexamethasone|mesh-list
6270867|NCT03705273|Dexamethasone acetate|dexamethasone acetate|mesh-list
6270868|NCT03705273|BB 1101|bb 1101|mesh-list
6270869|NCT03705273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6270870|NCT03705273|Antiemetics|antiemetics|mesh-ancestor
6270871|NCT03705273|Autonomic Agents|autonomic agents|mesh-ancestor
6270872|NCT03705273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6270873|NCT03705273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270874|NCT03705273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6270875|NCT03705273|Glucocorticoids|glucocorticoids|mesh-ancestor
6270876|NCT03705273|Hormones|hormones|mesh-ancestor
6270877|NCT03705273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6270878|NCT03705273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6270879|NCT03705273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6270880|NCT03705273|Protease Inhibitors|protease inhibitors|mesh-ancestor
6270881|NCT03705273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6270882|NCT03705273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270883|NCT03705793|Mometasone Furoate|mometasone furoate|mesh-list
6270884|NCT03705793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6270885|NCT03705793|Dermatologic Agents|dermatologic agents|mesh-ancestor
6270886|NCT03705793|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6270887|NCT03706313|Bupivacaine|bupivacaine|mesh-list
6270888|NCT03706313|Anesthetics, Local|anesthetics, local|mesh-ancestor
6270889|NCT03706313|Anesthetics|anesthetics|mesh-ancestor
6270890|NCT03706313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6270891|NCT03706313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270892|NCT03706313|Sensory System Agents|sensory system agents|mesh-ancestor
6270893|NCT03706313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6270894|NCT03708211|Esomeprazole|esomeprazole|mesh-list
6270895|NCT03708211|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6270896|NCT03708211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6270897|NCT03708211|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6270898|NCT03708211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6270899|NCT03708211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270900|NCT03708744|Oxazolidinones|oxazolidinones|mesh-list
6270901|NCT03708744|Zolmitriptan|zolmitriptan|mesh-list
6270902|NCT03708744|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6270903|NCT03708744|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6270904|NCT03708744|Serotonin Agents|serotonin agents|mesh-ancestor
6270905|NCT03708744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6270906|NCT03708744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270907|NCT03708744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270908|NCT03708744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6270909|NCT03708744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6270910|NCT03708744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6270911|NCT03710161|Vitamin D|vitamin d|mesh-list
6270912|NCT03710161|Vitamins|vitamins|mesh-ancestor
6270913|NCT03710161|Micronutrients|micronutrients|mesh-ancestor
6270914|NCT03710161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270915|NCT03710161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6270916|NCT03710187|Hydrocortisone|hydrocortisone|mesh-list
6270917|NCT03710187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6270918|NCT03710590|Nicotine|nicotine|mesh-list
6270919|NCT03710590|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6270920|NCT03710590|Autonomic Agents|autonomic agents|mesh-ancestor
6270921|NCT03710590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6270922|NCT03710590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270923|NCT03710590|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6270924|NCT03710590|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6270925|NCT03710590|Cholinergic Agents|cholinergic agents|mesh-ancestor
6270926|NCT03710590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6270927|NCT03710590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270928|NCT03710889|Abaloparatide|abaloparatide|mesh-list
6270929|NCT03710889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6270930|NCT03710889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270931|NCT03711578|Tenalisib|tenalisib|mesh-list
6270932|NCT03711578|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
6270933|NCT03711578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6270934|NCT03711578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270935|NCT03712280|Rifaximin|rifaximin|mesh-list
6270936|NCT03712280|Phenylacetic acid|phenylacetic acid|mesh-list
6270937|NCT03712280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6270938|NCT03712280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6270939|NCT03712280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6270940|NCT03712280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6270941|NCT03712280|Antimetabolites|antimetabolites|mesh-ancestor
6270942|NCT03712280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270943|NCT03712280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6270944|NCT03712449|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6270945|NCT03712449|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6270946|NCT03712449|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6270947|NCT03712449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6270948|NCT03712449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270949|NCT03712449|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6270950|NCT03712449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6270951|NCT03712449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270952|NCT03712449|Cholinergic Agents|cholinergic agents|mesh-ancestor
6270953|NCT03712449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6270954|NCT03712917|Topiramate|topiramate|mesh-list
6270955|NCT03712917|Flunarizine|flunarizine|mesh-list
6270956|NCT03712917|Anticonvulsants|anticonvulsants|mesh-ancestor
6270957|NCT03712917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6270958|NCT03712917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270959|NCT03712917|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6270960|NCT03712917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6270961|NCT03712917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270962|NCT03712917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6270963|NCT03712917|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6270964|NCT03712917|Histamine Antagonists|histamine antagonists|mesh-ancestor
6270965|NCT03712917|Histamine Agents|histamine agents|mesh-ancestor
6270966|NCT03712917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6270967|NCT03712917|Vasodilator Agents|vasodilator agents|mesh-ancestor
6270968|NCT03714022|Abatacept|abatacept|mesh-list
6270969|NCT03714022|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6014951|NCT00354172|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6014952|NCT00354172|Prednisolone phosphate|prednisolone phosphate|mesh-list
6014953|NCT00354172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6270970|NCT03714022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270971|NCT03714022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6270972|NCT03714022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6270973|NCT03714022|Immunologic Factors|immunologic factors|mesh-ancestor
6014954|NCT00354172|Immunologic Factors|immunologic factors|mesh-ancestor
6014955|NCT00354172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014956|NCT00354172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6014957|NCT00354172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6014958|NCT00354172|Alkylating Agents|alkylating agents|mesh-ancestor
6014959|NCT00354172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270974|NCT03714022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270975|NCT03714022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6270976|NCT03714672|Diclofenac|diclofenac|mesh-list
6270977|NCT03714672|Tramadol|tramadol|mesh-list
6270978|NCT03714672|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6270979|NCT03714672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6270980|NCT03714672|Analgesics|analgesics|mesh-ancestor
6270981|NCT03714672|Sensory System Agents|sensory system agents|mesh-ancestor
6270982|NCT03714672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6270983|NCT03714672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270984|NCT03714672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6270985|NCT03714672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6270986|NCT03714672|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6270987|NCT03714672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6270988|NCT03714672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6270989|NCT03714672|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6270990|NCT03714672|Narcotics|narcotics|mesh-ancestor
6270991|NCT03714672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6270992|NCT03714919|Acetaminophen|acetaminophen|mesh-list
6270993|NCT03714919|Dexmedetomidine|dexmedetomidine|mesh-list
6270994|NCT03714919|Ketamine|ketamine|mesh-list
6270995|NCT03714919|Dextromethorphan|dextromethorphan|mesh-list
6270996|NCT03714919|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6270997|NCT03714919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6270998|NCT03714919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6270999|NCT03714919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6271000|NCT03714919|Analgesics|analgesics|mesh-ancestor
6271001|NCT03714919|Sensory System Agents|sensory system agents|mesh-ancestor
6271002|NCT03714919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6271003|NCT03714919|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6271004|NCT03714919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6271005|NCT03714919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6271006|NCT03714919|Adrenergic Agents|adrenergic agents|mesh-ancestor
6271007|NCT03714919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6271008|NCT03714919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271009|NCT03714919|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6271010|NCT03714919|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6271011|NCT03714919|Anesthetics, General|anesthetics, general|mesh-ancestor
6271012|NCT03714919|Anesthetics|anesthetics|mesh-ancestor
6271013|NCT03714919|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6271014|NCT03714919|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6271015|NCT03714919|Antipyretics|antipyretics|mesh-ancestor
6271016|NCT03714919|Antitussive Agents|antitussive agents|mesh-ancestor
6271017|NCT03714919|Respiratory System Agents|respiratory system agents|mesh-ancestor
6271018|NCT03716024|Linezolid|linezolid|mesh-list
6271019|NCT03716024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6271020|NCT03716024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6271021|NCT03716024|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6271022|NCT03716024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6271023|NCT03716024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271024|NCT03716050|Nitroglycerin|nitroglycerin|mesh-list
6271025|NCT03716050|Vasodilator Agents|vasodilator agents|mesh-ancestor
6271026|NCT03716076|Carbetocin|carbetocin|mesh-list
6271027|NCT03716076|Oxytocics|oxytocics|mesh-ancestor
6271028|NCT03716076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6271029|NCT03716076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271030|NCT03717012|Nintedanib|nintedanib|mesh-list
6271031|NCT03717012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6271032|NCT03717012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6271033|NCT03717012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6271034|NCT03717012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271035|NCT03717051|Nicotine|nicotine|mesh-list
6271036|NCT03717051|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6271037|NCT03717051|Autonomic Agents|autonomic agents|mesh-ancestor
6271038|NCT03717051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6271039|NCT03717051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271040|NCT03717051|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6271041|NCT03717051|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6271042|NCT03717051|Cholinergic Agents|cholinergic agents|mesh-ancestor
6271043|NCT03717051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6271044|NCT03717051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271045|NCT03717064|Pitavastatin|pitavastatin|mesh-list
6271046|NCT03717064|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6271047|NCT03717064|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6271048|NCT03717064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6271049|NCT03717064|Antimetabolites|antimetabolites|mesh-ancestor
6271050|NCT03717064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271051|NCT03717064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6271052|NCT03717064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6271053|NCT03717155|Gemcitabine|gemcitabine|mesh-list
6271054|NCT03717155|Carboplatin|carboplatin|mesh-list
6271055|NCT03717155|Cetuximab|cetuximab|mesh-list
6271056|NCT03717155|Avelumab|avelumab|mesh-list
6271057|NCT03717155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6271058|NCT03717155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6271059|NCT03717155|Antimetabolites|antimetabolites|mesh-ancestor
6271060|NCT03717155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271061|NCT03717155|Antiviral Agents|antiviral agents|mesh-ancestor
6271062|NCT03717155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6271063|NCT03717155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6271064|NCT03717155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6271065|NCT03717155|Immunologic Factors|immunologic factors|mesh-ancestor
6271066|NCT03717155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271067|NCT03717155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6271068|NCT03717506|Clindamycin|clindamycin|mesh-list
6271069|NCT03717506|Clindamycin palmitate|clindamycin palmitate|mesh-list
6271070|NCT03717506|Clindamycin phosphate|clindamycin phosphate|mesh-list
6271071|NCT03717506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6271072|NCT03717506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6271073|NCT03717506|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6271074|NCT03717506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6271075|NCT03717506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271076|NCT03719586|Remdesivir|remdesivir|mesh-list
6271077|NCT03719586|Antimetabolites|antimetabolites|mesh-ancestor
6271078|NCT03719586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271079|NCT03719586|Antiviral Agents|antiviral agents|mesh-ancestor
6271080|NCT03719586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6271081|NCT03720119|Lidocaine|lidocaine|mesh-list
6271082|NCT03720119|Anesthetics, Local|anesthetics, local|mesh-ancestor
6271083|NCT03720119|Anesthetics|anesthetics|mesh-ancestor
6271084|NCT03720119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6271085|NCT03720119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271086|NCT03720119|Sensory System Agents|sensory system agents|mesh-ancestor
6271087|NCT03720119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6271088|NCT03720119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6271089|NCT03720119|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6271090|NCT03720119|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6271091|NCT03720119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6271092|NCT03720119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271093|NCT03720470|Abrocitinib|abrocitinib|mesh-list
6271094|NCT03720470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6271095|NCT03720470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6271096|NCT03720470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271097|NCT03720847|Estradiol|estradiol|mesh-list
6271098|NCT03720847|Progesterone|progesterone|mesh-list
6271099|NCT03720847|Estrogens|estrogens|mesh-ancestor
6271100|NCT03720847|Hormones|hormones|mesh-ancestor
6271101|NCT03720847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6271102|NCT03720847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271103|NCT03720847|Progestins|progestins|mesh-ancestor
6271104|NCT03721172|Apremilast|apremilast|mesh-list
6271105|NCT03721172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6271106|NCT03721172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6271107|NCT03721172|Analgesics|analgesics|mesh-ancestor
6271108|NCT03721172|Sensory System Agents|sensory system agents|mesh-ancestor
6271109|NCT03721172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6271110|NCT03721172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271111|NCT03721172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6271112|NCT03721172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6271113|NCT03721172|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6271114|NCT03721172|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6271115|NCT03721172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6271116|NCT03721172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271117|NCT03722238|Ibuprofen|ibuprofen|mesh-list
6271118|NCT03722238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6271119|NCT03722238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6271120|NCT03722238|Analgesics|analgesics|mesh-ancestor
6271121|NCT03722238|Sensory System Agents|sensory system agents|mesh-ancestor
6271122|NCT03722238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6271123|NCT03722238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271124|NCT03722238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6271125|NCT03722238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6271126|NCT03722238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6271127|NCT03722238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6271128|NCT03722238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271129|NCT03722524|Amlodipine|amlodipine|mesh-list
6271130|NCT03722524|Perindopril|perindopril|mesh-list
6271131|NCT03722524|Indapamide|indapamide|mesh-list
6271132|NCT03722524|Indapamide, perindopril drug combination|indapamide, perindopril drug combination|mesh-list
6271133|NCT03722524|Diuretics|diuretics|mesh-list
6271134|NCT03722524|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6271135|NCT03722524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6271136|NCT03722524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6271137|NCT03722524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6271138|NCT03722524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271139|NCT03722524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6271140|NCT03722524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271141|NCT03722524|Vasodilator Agents|vasodilator agents|mesh-ancestor
6271142|NCT03722524|Natriuretic Agents|natriuretic agents|mesh-ancestor
6271143|NCT03722524|Protease Inhibitors|protease inhibitors|mesh-ancestor
6271144|NCT03722524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6271145|NCT03722524|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6271146|NCT03722576|Calcium|calcium|mesh-list
6271147|NCT03722576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6271148|NCT03722576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271149|NCT03723915|Pembrolizumab|pembrolizumab|mesh-list
6271150|NCT03723915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6271151|NCT03723915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6390736|NCT00191503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390737|NCT00191503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6390738|NCT00191503|Antiviral Agents|antiviral agents|mesh-ancestor
6390739|NCT00191503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6390740|NCT00191503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6390741|NCT00191503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6390742|NCT00191503|Immunologic Factors|immunologic factors|mesh-ancestor
6390743|NCT00191503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390744|NCT00191503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6390745|NCT00191503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6390746|NCT00191516|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6390747|NCT00191516|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6390748|NCT00191516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6390749|NCT00191516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6390750|NCT00191516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390751|NCT00191516|Adrenergic Agents|adrenergic agents|mesh-ancestor
6390752|NCT00191516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6390753|NCT00191516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390754|NCT00191542|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6390755|NCT00191542|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6390756|NCT00191542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6390757|NCT00191542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6390758|NCT00191542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390759|NCT00191542|Adrenergic Agents|adrenergic agents|mesh-ancestor
6390760|NCT00191542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6390761|NCT00191542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390762|NCT00191555|Haloperidol|haloperidol|mesh-list
6390763|NCT00191555|Olanzapine|olanzapine|mesh-list
6390764|NCT00191555|Haloperidol decanoate|haloperidol decanoate|mesh-list
6390765|NCT00191555|Antiemetics|antiemetics|mesh-ancestor
6390766|NCT00191555|Autonomic Agents|autonomic agents|mesh-ancestor
6390767|NCT00191555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6390768|NCT00191555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390769|NCT00191555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6390770|NCT00191555|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6390771|NCT00191555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6390772|NCT00191555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6390773|NCT00191555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6390774|NCT00191555|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6390775|NCT00191555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6390776|NCT00191555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6390777|NCT00191555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390778|NCT00191555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6390779|NCT00191555|Serotonin Agents|serotonin agents|mesh-ancestor
6390780|NCT00191555|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6390781|NCT00191555|Dopamine Agents|dopamine agents|mesh-ancestor
6390782|NCT00191555|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6390783|NCT00191568|Gemcitabine|gemcitabine|mesh-list
6390784|NCT00191568|Oxaliplatin|oxaliplatin|mesh-list
6390785|NCT00191568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6271152|NCT03736967|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6271153|NCT03736967|Immunologic Factors|immunologic factors|mesh-ancestor
6271154|NCT03736967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271155|NCT03746002|Metolazone|metolazone|mesh-list
6271156|NCT03746002|Furosemide|furosemide|mesh-list
6271157|NCT03746002|Diuretics|diuretics|mesh-ancestor
6271158|NCT03746002|Natriuretic Agents|natriuretic agents|mesh-ancestor
6271159|NCT03746002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271160|NCT03746002|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6271161|NCT03746002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6271162|NCT03746002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271163|NCT03746002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6271164|NCT03746002|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6271165|NCT03789292|Adalimumab|adalimumab|mesh-list
6271166|NCT03789292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6271167|NCT03789292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6271168|NCT03805438|Chloroprocaine|chloroprocaine|mesh-list
6271169|NCT03805438|Anesthetics, Local|anesthetics, local|mesh-ancestor
6271170|NCT03805438|Anesthetics|anesthetics|mesh-ancestor
6271171|NCT03805438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6271172|NCT03805438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271173|NCT03805438|Sensory System Agents|sensory system agents|mesh-ancestor
6271174|NCT03805438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6271175|NCT03812224|Erenumab|erenumab|mesh-list
6271176|NCT03812224|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
6271177|NCT03812224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271178|NCT03812224|Analgesics|analgesics|mesh-ancestor
6271179|NCT03812224|Sensory System Agents|sensory system agents|mesh-ancestor
6271180|NCT03812224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6271181|NCT03812224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271182|NCT03828422|Calcium|calcium|mesh-list
6271183|NCT03828422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6271184|NCT03828422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271185|NCT03829618|Lidocaine|lidocaine|mesh-list
6271186|NCT03829618|Anesthetics, Local|anesthetics, local|mesh-ancestor
6271187|NCT03829618|Anesthetics|anesthetics|mesh-ancestor
6271188|NCT03829618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6271189|NCT03829618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271190|NCT03829618|Sensory System Agents|sensory system agents|mesh-ancestor
6271191|NCT03829618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6271192|NCT03829618|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6271193|NCT03829618|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6271194|NCT03829618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6271195|NCT03829618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6271196|NCT03829618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271197|NCT03830333|Metronidazole|metronidazole|mesh-list
6271198|NCT03830333|Meropenem|meropenem|mesh-list
6271199|NCT03830333|Tazobactam|tazobactam|mesh-list
6271200|NCT03830333|Ceftolozane|ceftolozane|mesh-list
6271201|NCT03830333|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
6271202|NCT03830333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6271203|NCT03830333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6271204|NCT03830333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6271205|NCT03830333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6271206|NCT03830333|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6271207|NCT03830333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6271208|NCT03830333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271209|NCT03830333|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6271210|NCT03830333|Renal Agents|renal agents|mesh-ancestor
6271211|NCT03835728|Ocrelizumab|ocrelizumab|mesh-list
6271212|NCT03835728|Immunologic Factors|immunologic factors|mesh-ancestor
6271213|NCT03835728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271214|NCT03852524|Methylnaltrexone|methylnaltrexone|mesh-list
6271215|NCT03852524|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6271216|NCT03852524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271217|NCT03852524|Sensory System Agents|sensory system agents|mesh-ancestor
6271218|NCT03852524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6271219|NCT03862755|Heparin|heparin|mesh-list
6271220|NCT03862755|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6271221|NCT03862755|Tinzaparin|tinzaparin|mesh-list
6271222|NCT03862755|Dalteparin|dalteparin|mesh-list
6271223|NCT03862755|Anticoagulants|anticoagulants|mesh-ancestor
6271224|NCT03862755|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6271225|NCT03862755|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6271226|NCT03862755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271227|NCT03877224|Dapagliflozin|dapagliflozin|mesh-list
6271228|NCT03877224|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6271229|NCT03877224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271230|NCT03877224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6271231|NCT03877224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271232|NCT03885596|Acetaminophen|acetaminophen|mesh-list
6271233|NCT03885596|Celecoxib|celecoxib|mesh-list
6271234|NCT03885596|Ketorolac|ketorolac|mesh-list
6271235|NCT03885596|Lidocaine|lidocaine|mesh-list
6271236|NCT03885596|Fentanyl|fentanyl|mesh-list
6271237|NCT03885596|Bupivacaine|bupivacaine|mesh-list
6271238|NCT03885596|Anesthetics, Local|anesthetics, local|mesh-ancestor
6271239|NCT03885596|Anesthetics|anesthetics|mesh-ancestor
6271240|NCT03885596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6271241|NCT03885596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271242|NCT03885596|Sensory System Agents|sensory system agents|mesh-ancestor
6271243|NCT03885596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6271244|NCT03885596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6271245|NCT03885596|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6271246|NCT03885596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6271247|NCT03885596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6271248|NCT03885596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271249|NCT03885596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6271250|NCT03885596|Narcotics|narcotics|mesh-ancestor
6271251|NCT03885596|Analgesics|analgesics|mesh-ancestor
6271252|NCT03885596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6271253|NCT03885596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6271254|NCT03885596|Anesthetics, General|anesthetics, general|mesh-ancestor
6271255|NCT03885596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6271256|NCT03885596|Antipyretics|antipyretics|mesh-ancestor
6271257|NCT03885596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6271258|NCT03885596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6271259|NCT03885596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6271260|NCT03885596|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6271261|NCT03885596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6271262|NCT03885596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6271263|NCT03885661|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
6271264|NCT03885661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6271265|NCT03885661|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6271266|NCT03889158|Ascorbic Acid|ascorbic acid|mesh-list
6271267|NCT03889158|Vaccines|vaccines|mesh-list
6271268|NCT03889158|Immunologic Factors|immunologic factors|mesh-ancestor
6271269|NCT03889158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271270|NCT03889158|Antioxidants|antioxidants|mesh-ancestor
6271271|NCT03889158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271272|NCT03889158|Protective Agents|protective agents|mesh-ancestor
6271273|NCT03889158|Vitamins|vitamins|mesh-ancestor
6271274|NCT03889158|Micronutrients|micronutrients|mesh-ancestor
6271275|NCT03897348|Lacosamide|lacosamide|mesh-list
6271276|NCT03897348|Anticonvulsants|anticonvulsants|mesh-ancestor
6271277|NCT03897348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6271278|NCT03897348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6271279|NCT03897348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6271280|NCT03897348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271281|NCT03907033|Bupivacaine|bupivacaine|mesh-list
6271282|NCT03907033|Anesthetics, Local|anesthetics, local|mesh-ancestor
6271283|NCT03907033|Anesthetics|anesthetics|mesh-ancestor
6271284|NCT03907033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6271285|NCT03907033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271286|NCT03907033|Sensory System Agents|sensory system agents|mesh-ancestor
6271287|NCT03907033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6271288|NCT03920215|Varenicline|varenicline|mesh-list
6271289|NCT03920215|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6271290|NCT03920215|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6271291|NCT03920215|Cholinergic Agents|cholinergic agents|mesh-ancestor
6271292|NCT03920215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6271293|NCT03920215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271294|NCT03920215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271295|NCT03921151|Mirtazapine|mirtazapine|mesh-list
6271296|NCT03921151|Antidepressive Agents|antidepressive agents|mesh-ancestor
6271297|NCT03921151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6271298|NCT03921151|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6271299|NCT03921151|Histamine Antagonists|histamine antagonists|mesh-ancestor
6271300|NCT03921151|Histamine Agents|histamine agents|mesh-ancestor
6271301|NCT03921151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6271302|NCT03921151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271303|NCT03921151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271304|NCT03921151|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6271305|NCT03921151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6271306|NCT03921151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6271307|NCT03921151|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6271308|NCT03921151|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6271309|NCT03921151|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6271310|NCT03921151|Adrenergic Agents|adrenergic agents|mesh-ancestor
6271311|NCT03921151|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6014960|NCT00354172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6014961|NCT00354172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6014962|NCT00354172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6271312|NCT03921151|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6271313|NCT03921151|Serotonin Agents|serotonin agents|mesh-ancestor
6271314|NCT03921151|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6271315|NCT03927911|Bupivacaine|bupivacaine|mesh-list
6271316|NCT03927911|Anesthetics, Local|anesthetics, local|mesh-ancestor
6271317|NCT03927911|Anesthetics|anesthetics|mesh-ancestor
6271318|NCT03927911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6271319|NCT03927911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271320|NCT03927911|Sensory System Agents|sensory system agents|mesh-ancestor
6271321|NCT03927911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6271322|NCT03938857|Fentanyl|fentanyl|mesh-list
6271323|NCT03938857|Dexmedetomidine|dexmedetomidine|mesh-list
6271324|NCT03938857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6014963|NCT00354172|Antimetabolites|antimetabolites|mesh-ancestor
6014964|NCT00354172|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6014965|NCT00354172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6014966|NCT00354172|Antifungal Agents|antifungal agents|mesh-ancestor
6014967|NCT00354172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6014968|NCT00354172|Dermatologic Agents|dermatologic agents|mesh-ancestor
6014969|NCT00354172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6014970|NCT00354172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6014971|NCT00354172|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6018473|NCT00381004|Alkylating Agents|alkylating agents|mesh-ancestor
6271325|NCT03938857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6271326|NCT03938857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271327|NCT03938857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6271328|NCT03938857|Analgesics|analgesics|mesh-ancestor
6271329|NCT03938857|Sensory System Agents|sensory system agents|mesh-ancestor
6271330|NCT03938857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6271331|NCT03938857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6271332|NCT03938857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6271333|NCT03938857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6271334|NCT03938857|Adrenergic Agents|adrenergic agents|mesh-ancestor
6271335|NCT03938857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6271336|NCT03938857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271337|NCT03938857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6271338|NCT03938857|Narcotics|narcotics|mesh-ancestor
6271339|NCT03938857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6271340|NCT03938857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6271341|NCT03938857|Anesthetics, General|anesthetics, general|mesh-ancestor
6271342|NCT03938857|Anesthetics|anesthetics|mesh-ancestor
6271343|NCT03945981|Lamivudine|lamivudine|mesh-list
6271344|NCT03945981|Dolutegravir|dolutegravir|mesh-list
6271345|NCT03945981|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6271346|NCT03945981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6271347|NCT03945981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6271348|NCT03945981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271349|NCT03945981|Antiviral Agents|antiviral agents|mesh-ancestor
6271350|NCT03945981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6271351|NCT03945981|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6271352|NCT03945981|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6271353|NCT03945981|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6271354|NCT03945981|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6271355|NCT03950674|Folic Acid|folic acid|mesh-list
6271356|NCT03950674|Vitamin B 12|vitamin b 12|mesh-list
6271357|NCT03950674|Hydroxocobalamin|hydroxocobalamin|mesh-list
6271358|NCT03950674|Dexamethasone|dexamethasone|mesh-list
6271359|NCT03950674|Carboplatin|carboplatin|mesh-list
6271360|NCT03950674|Pembrolizumab|pembrolizumab|mesh-list
6271361|NCT03950674|Pemetrexed|pemetrexed|mesh-list
6271362|NCT03950674|Vitamins|vitamins|mesh-ancestor
6271363|NCT03950674|Micronutrients|micronutrients|mesh-ancestor
6271364|NCT03950674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271365|NCT03950674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6271366|NCT03950674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6271367|NCT03950674|Antiemetics|antiemetics|mesh-ancestor
6271368|NCT03950674|Autonomic Agents|autonomic agents|mesh-ancestor
6271369|NCT03950674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6271370|NCT03950674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6271371|NCT03950674|Glucocorticoids|glucocorticoids|mesh-ancestor
6271372|NCT03950674|Hormones|hormones|mesh-ancestor
6271373|NCT03950674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6271374|NCT03950674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6271375|NCT03950674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6271376|NCT03950674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6271377|NCT03950674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271378|NCT03950674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6271379|NCT03950674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6271380|NCT03950674|Hematinics|hematinics|mesh-ancestor
6271381|NCT03950674|Vitamin B Complex|vitamin b complex|mesh-ancestor
6271382|NCT03954834|Tirzepatide|tirzepatide|mesh-list
6271383|NCT03954834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6271384|NCT03954834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271385|NCT03954834|Incretins|incretins|mesh-ancestor
6271386|NCT03954834|Hormones|hormones|mesh-ancestor
6271387|NCT03954834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6271388|NCT03958071|Pirfenidone|pirfenidone|mesh-list
6271389|NCT03958071|Nintedanib|nintedanib|mesh-list
6271390|NCT03958071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6271391|NCT03958071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6271392|NCT03958071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6271393|NCT03958071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271394|NCT03958071|Analgesics|analgesics|mesh-ancestor
6271395|NCT03958071|Sensory System Agents|sensory system agents|mesh-ancestor
6271396|NCT03958071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6271397|NCT03958071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271398|NCT03958071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6271399|NCT03958071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6271400|NCT03958071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6271401|NCT03958071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6271402|NCT03968159|Pimavanserin|pimavanserin|mesh-list
6271403|NCT03968159|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6271404|NCT03968159|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6271405|NCT03968159|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6271406|NCT03968159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6271407|NCT03968159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6271408|NCT03968159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271409|NCT03968159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6271410|NCT03968159|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6271411|NCT03968159|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6271412|NCT03968159|Serotonin Agents|serotonin agents|mesh-ancestor
6271413|NCT03968159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6271414|NCT03968159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271415|NCT03970824|Adalimumab|adalimumab|mesh-list
6271416|NCT03970824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6271417|NCT03970824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6271418|NCT03978403|Zolmitriptan|zolmitriptan|mesh-list
6271419|NCT03978403|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6271420|NCT03978403|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6271421|NCT03978403|Serotonin Agents|serotonin agents|mesh-ancestor
6271422|NCT03978403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6271423|NCT03978403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271424|NCT03978403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271425|NCT03979807|Bromides|bromides|mesh-list
6271426|NCT03979807|Tiotropium Bromide|tiotropium bromide|mesh-list
6271427|NCT03979807|Olodaterol|olodaterol|mesh-list
6271428|NCT03979807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6271429|NCT03979807|Autonomic Agents|autonomic agents|mesh-ancestor
6271430|NCT03979807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6271431|NCT03979807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271432|NCT03979807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6271433|NCT03979807|Respiratory System Agents|respiratory system agents|mesh-ancestor
6271434|NCT03979807|Parasympatholytics|parasympatholytics|mesh-ancestor
6271435|NCT03979807|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6271436|NCT03979807|Cholinergic Agents|cholinergic agents|mesh-ancestor
6271437|NCT03979807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6271438|NCT03979807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271439|NCT03979807|Anticonvulsants|anticonvulsants|mesh-ancestor
6271440|NCT03982069|Vaccines|vaccines|mesh-list
6271441|NCT03982069|Immunologic Factors|immunologic factors|mesh-ancestor
6271442|NCT03982069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271443|NCT04005859|Lidocaine|lidocaine|mesh-list
6271444|NCT04005859|Anesthetics, Local|anesthetics, local|mesh-ancestor
6271445|NCT04005859|Anesthetics|anesthetics|mesh-ancestor
6271446|NCT04005859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6271447|NCT04005859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271448|NCT04005859|Sensory System Agents|sensory system agents|mesh-ancestor
6271449|NCT04005859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6271450|NCT04005859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6271451|NCT04005859|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6271452|NCT04005859|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6271453|NCT04005859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6271454|NCT04005859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271455|NCT04006171|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
6271456|NCT04006171|Natriuretic Agents|natriuretic agents|mesh-ancestor
6271457|NCT04006171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271458|NCT04011592|Ketamine|ketamine|mesh-list
6271459|NCT04011592|Analgesics|analgesics|mesh-ancestor
6271460|NCT04011592|Sensory System Agents|sensory system agents|mesh-ancestor
6271461|NCT04011592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6271462|NCT04011592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271463|NCT04011592|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6271464|NCT04011592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6271465|NCT04011592|Anesthetics, General|anesthetics, general|mesh-ancestor
6271466|NCT04011592|Anesthetics|anesthetics|mesh-ancestor
6271467|NCT04011592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6271468|NCT04011592|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6271469|NCT04011592|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6271470|NCT04011592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6271471|NCT04011592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271472|NCT04032327|Bupivacaine|bupivacaine|mesh-list
6271473|NCT04032327|Anesthetics, Local|anesthetics, local|mesh-ancestor
6271474|NCT04032327|Anesthetics|anesthetics|mesh-ancestor
6271475|NCT04032327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6271476|NCT04032327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271477|NCT04032327|Sensory System Agents|sensory system agents|mesh-ancestor
6271478|NCT04032327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6271479|NCT04036292|Varenicline|varenicline|mesh-list
6271480|NCT04036292|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6271481|NCT04036292|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6271482|NCT04036292|Cholinergic Agents|cholinergic agents|mesh-ancestor
6271483|NCT04036292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6271484|NCT04036292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271485|NCT04036292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271486|NCT04049123|Insulin Lispro|insulin lispro|mesh-list
6271487|NCT04049123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6271488|NCT04049123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271489|NCT04051463|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6271490|NCT04051463|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6271491|NCT04052204|Avelumab|avelumab|mesh-list
6271492|NCT04052204|Talazoparib|talazoparib|mesh-list
6271493|NCT04052204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6271494|NCT04052204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6271495|NCT04052204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6271496|NCT04052204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6271497|NCT04052204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271498|NCT04067011|Doxycycline|doxycycline|mesh-list
6271499|NCT04067011|Ciprofloxacin|ciprofloxacin|mesh-list
6271500|NCT04067011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6271501|NCT04067011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6271502|NCT04067011|Antimalarials|antimalarials|mesh-ancestor
6271503|NCT04067011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6271504|NCT04067011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6271505|NCT04067011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6271506|NCT04067011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6271507|NCT04067011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6271508|NCT04067011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271509|NCT04067011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6271510|NCT04067011|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6271511|NCT04067011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6271512|NCT04085341|Sunitinib|sunitinib|mesh-list
6271513|NCT04085341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6271514|NCT04085341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6271515|NCT04085341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6271516|NCT04085341|Growth Substances|growth substances|mesh-ancestor
6271517|NCT04085341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271518|NCT04085341|Growth Inhibitors|growth inhibitors|mesh-ancestor
6271519|NCT04085341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6271520|NCT04085341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6271521|NCT04085341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271522|NCT04094870|Sertraline|sertraline|mesh-list
6271523|NCT04094870|Antidepressive Agents|antidepressive agents|mesh-ancestor
6271524|NCT04094870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6271525|NCT04094870|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6271526|NCT04094870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6271527|NCT04094870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6271528|NCT04094870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271529|NCT04094870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6271530|NCT04094870|Serotonin Agents|serotonin agents|mesh-ancestor
6271531|NCT04094870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390786|NCT00191568|Antimetabolites|antimetabolites|mesh-ancestor
6390787|NCT00191568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390788|NCT00191568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6390789|NCT00191568|Antiviral Agents|antiviral agents|mesh-ancestor
6390790|NCT00191568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6390791|NCT00191568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6390792|NCT00191568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6390793|NCT00191568|Immunologic Factors|immunologic factors|mesh-ancestor
6390794|NCT00191568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390795|NCT00191581|Insulin|insulin|mesh-list
6390796|NCT00191581|Insulin Lispro|insulin lispro|mesh-list
6390797|NCT00191581|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6390798|NCT00191581|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
6390799|NCT00191581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6390800|NCT00191581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390801|NCT00191594|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6390802|NCT00191594|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6390803|NCT00191594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6390804|NCT00191594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6390805|NCT00191594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390806|NCT00191594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6390807|NCT00191594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390808|NCT00191594|Analgesics|analgesics|mesh-ancestor
6390809|NCT00191594|Sensory System Agents|sensory system agents|mesh-ancestor
6390810|NCT00191594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6390811|NCT00191594|Antidepressive Agents|antidepressive agents|mesh-ancestor
6390812|NCT00191594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6390813|NCT00191594|Dopamine Agents|dopamine agents|mesh-ancestor
6390814|NCT00191607|Gemcitabine|gemcitabine|mesh-list
6390815|NCT00191607|Doxorubicin|doxorubicin|mesh-list
6390816|NCT00191607|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6390817|NCT00191607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6390818|NCT00191607|Antimetabolites|antimetabolites|mesh-ancestor
6390819|NCT00191607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390820|NCT00191607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6390821|NCT00191607|Antiviral Agents|antiviral agents|mesh-ancestor
6390822|NCT00191607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6390823|NCT00191607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6390824|NCT00191607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6390825|NCT00191607|Immunologic Factors|immunologic factors|mesh-ancestor
6271532|NCT04103515|Cimetidine|cimetidine|mesh-list
6271533|NCT04103515|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6271534|NCT04103515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6271535|NCT04103515|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6271536|NCT04103515|Histamine Antagonists|histamine antagonists|mesh-ancestor
6271537|NCT04103515|Histamine Agents|histamine agents|mesh-ancestor
6271538|NCT04103515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6271539|NCT04103515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271540|NCT04103515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271541|NCT04103515|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6271542|NCT04103515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6271543|NCT04103515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6271544|NCT04123405|Acetylcysteine|acetylcysteine|mesh-list
6271545|NCT04123405|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6271546|NCT04123405|Antiviral Agents|antiviral agents|mesh-ancestor
6271547|NCT04123405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6271548|NCT04123405|Expectorants|expectorants|mesh-ancestor
6271549|NCT04123405|Respiratory System Agents|respiratory system agents|mesh-ancestor
6271550|NCT04123405|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6271551|NCT04123405|Antioxidants|antioxidants|mesh-ancestor
6271552|NCT04123405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271553|NCT04123405|Protective Agents|protective agents|mesh-ancestor
6271554|NCT04123405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271555|NCT04123405|Antidotes|antidotes|mesh-ancestor
6271556|NCT04138758|Bromides|bromides|mesh-list
6271557|NCT04138758|Tiotropium Bromide|tiotropium bromide|mesh-list
6271558|NCT04138758|Olodaterol|olodaterol|mesh-list
6271559|NCT04138758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6271560|NCT04138758|Autonomic Agents|autonomic agents|mesh-ancestor
6271561|NCT04138758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6271562|NCT04138758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271563|NCT04138758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6271564|NCT04138758|Respiratory System Agents|respiratory system agents|mesh-ancestor
6271565|NCT04138758|Parasympatholytics|parasympatholytics|mesh-ancestor
6271566|NCT04138758|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6271567|NCT04138758|Cholinergic Agents|cholinergic agents|mesh-ancestor
6271568|NCT04138758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6271569|NCT04138758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271570|NCT04138758|Anticonvulsants|anticonvulsants|mesh-ancestor
6271571|NCT04147715|Dolutegravir|dolutegravir|mesh-list
6271572|NCT04147715|Midazolam|midazolam|mesh-list
6271573|NCT04147715|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6271574|NCT04147715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6271575|NCT04147715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6271576|NCT04147715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271577|NCT04147715|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6271578|NCT04147715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6271579|NCT04147715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6271580|NCT04147715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6271581|NCT04147715|Anesthetics, General|anesthetics, general|mesh-ancestor
6271582|NCT04147715|Anesthetics|anesthetics|mesh-ancestor
6271583|NCT04147715|GABA Modulators|gaba modulators|mesh-ancestor
6271584|NCT04147715|GABA Agents|gaba agents|mesh-ancestor
6271585|NCT04147715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6271586|NCT04147715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271587|NCT04147715|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6271588|NCT04147715|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6271589|NCT04147715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6271590|NCT04147715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6271591|NCT04147715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6271592|NCT04147715|Antiviral Agents|antiviral agents|mesh-ancestor
6271593|NCT04147715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6271594|NCT04160091|FX006|fx006|mesh-list
6271595|NCT04160091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6271596|NCT04160091|Glucocorticoids|glucocorticoids|mesh-ancestor
6271597|NCT04160091|Hormones|hormones|mesh-ancestor
6271598|NCT04160091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6271599|NCT04160091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271600|NCT04160091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6271601|NCT04160091|Immunologic Factors|immunologic factors|mesh-ancestor
6271602|NCT04164758|Pimavanserin|pimavanserin|mesh-list
6014972|NCT00354172|Antitubercular Agents|antitubercular agents|mesh-ancestor
6014973|NCT00354172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6014974|NCT00354172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6271603|NCT04164758|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6271604|NCT04164758|Antidepressive Agents|antidepressive agents|mesh-ancestor
6271605|NCT04164758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6271606|NCT04164758|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6271607|NCT04164758|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6271608|NCT04164758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6271609|NCT04164758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271610|NCT04164758|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6271611|NCT04164758|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6271612|NCT04164758|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6271613|NCT04164758|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6271614|NCT04164758|Serotonin Agents|serotonin agents|mesh-ancestor
6271615|NCT04164758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6271616|NCT04164758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271617|NCT04165031|Docetaxel|docetaxel|mesh-list
6271618|NCT04165031|Cetuximab|cetuximab|mesh-list
6271619|NCT04165031|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6271620|NCT04165031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6271621|NCT04165031|Tubulin Modulators|tubulin modulators|mesh-ancestor
6271622|NCT04165031|Antimitotic Agents|antimitotic agents|mesh-ancestor
6014975|NCT00354172|Antiemetics|antiemetics|mesh-ancestor
6014976|NCT00354172|Autonomic Agents|autonomic agents|mesh-ancestor
6271623|NCT04165031|Mitosis Modulators|mitosis modulators|mesh-ancestor
6271624|NCT04165031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271625|NCT04165031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6271626|NCT04165031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6271627|NCT04165031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6271628|NCT04171414|Adalimumab|adalimumab|mesh-list
6271629|NCT04171414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6271630|NCT04171414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6271631|NCT04175808|Moxifloxacin|moxifloxacin|mesh-list
6271632|NCT04175808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6271633|NCT04175808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6271634|NCT04175808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6014977|NCT00354172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6014978|NCT00354172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6014979|NCT00354172|Glucocorticoids|glucocorticoids|mesh-ancestor
6014980|NCT00354172|Hormones|hormones|mesh-ancestor
6014981|NCT00354172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6014982|NCT00354172|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6014983|NCT00354172|Protective Agents|protective agents|mesh-ancestor
6014984|NCT00354172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6271635|NCT04175808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6271636|NCT04175808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6271637|NCT04175808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271638|NCT04175808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6271639|NCT04184297|Tiotropium Bromide|tiotropium bromide|mesh-list
6271640|NCT04184297|Olodaterol|olodaterol|mesh-list
6271641|NCT04184297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6271642|NCT04184297|Autonomic Agents|autonomic agents|mesh-ancestor
6271643|NCT04184297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6271644|NCT04184297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271645|NCT04184297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6271646|NCT04184297|Respiratory System Agents|respiratory system agents|mesh-ancestor
6271647|NCT04184297|Parasympatholytics|parasympatholytics|mesh-ancestor
6271648|NCT04184297|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6271649|NCT04184297|Cholinergic Agents|cholinergic agents|mesh-ancestor
6271650|NCT04184297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6271651|NCT04184297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271652|NCT04189848|Dulaglutide|dulaglutide|mesh-list
6271653|NCT04189848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6271654|NCT04189848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271655|NCT04211909|Sofosbuvir|sofosbuvir|mesh-list
6271656|NCT04211909|Velpatasvir|velpatasvir|mesh-list
6271657|NCT04211909|Antiviral Agents|antiviral agents|mesh-ancestor
6271658|NCT04211909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6271659|NCT04218110|Ethanol|ethanol|mesh-list
6271660|NCT04218110|Chlorhexidine|chlorhexidine|mesh-list
6271661|NCT04218110|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6271662|NCT04218110|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
6271663|NCT04218110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6271664|NCT04218110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6271665|NCT04218110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271666|NCT04218110|Disinfectants|disinfectants|mesh-ancestor
6271667|NCT04218110|Dermatologic Agents|dermatologic agents|mesh-ancestor
6271668|NCT04222725|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6271669|NCT04222725|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6271670|NCT04223843|Tiotropium Bromide|tiotropium bromide|mesh-list
6271671|NCT04223843|Olodaterol|olodaterol|mesh-list
6271672|NCT04223843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6271673|NCT04223843|Autonomic Agents|autonomic agents|mesh-ancestor
6271674|NCT04223843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6271675|NCT04223843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271676|NCT04223843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6271677|NCT04223843|Respiratory System Agents|respiratory system agents|mesh-ancestor
6271678|NCT04223843|Parasympatholytics|parasympatholytics|mesh-ancestor
6271679|NCT04223843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6271680|NCT04223843|Cholinergic Agents|cholinergic agents|mesh-ancestor
6271681|NCT04223843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6271682|NCT04223843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271683|NCT04229303|Voriconazole|voriconazole|mesh-list
6271684|NCT04229303|Antifungal Agents|antifungal agents|mesh-ancestor
6271685|NCT04229303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6271686|NCT04229303|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6271687|NCT04229303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6271688|NCT04229303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6271689|NCT04229303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271690|NCT04229303|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6271691|NCT04229303|Hormone Antagonists|hormone antagonists|mesh-ancestor
6271692|NCT04229303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6271693|NCT04229303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271694|NCT04229303|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6271695|NCT04256603|Gabapentin|gabapentin|mesh-list
6271696|NCT04256603|Analgesics|analgesics|mesh-ancestor
6271697|NCT04256603|Sensory System Agents|sensory system agents|mesh-ancestor
6271698|NCT04256603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6271699|NCT04256603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271700|NCT04256603|Anticonvulsants|anticonvulsants|mesh-ancestor
6271701|NCT04256603|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6271702|NCT04256603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6271703|NCT04256603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6271704|NCT04256603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6271705|NCT04256603|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6271706|NCT04256603|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6271707|NCT04256603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6271708|NCT04256603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271709|NCT04256603|Antimanic Agents|antimanic agents|mesh-ancestor
6271710|NCT04290494|Plasminogen|plasminogen|mesh-list
6271711|NCT04290494|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6271712|NCT04290494|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6271713|NCT04290494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271714|NCT04303156|Islatravir|islatravir|mesh-list
6271715|NCT04303156|Antiviral Agents|antiviral agents|mesh-ancestor
6271716|NCT04303156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6271717|NCT04303156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6271718|NCT04303156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271719|NCT04303156|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6271720|NCT04303156|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6271721|NCT04303156|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6271722|NCT04319159|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6271723|NCT04319159|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6271724|NCT04319159|Dermatologic Agents|dermatologic agents|mesh-ancestor
6271725|NCT04323852|Vitamin D|vitamin d|mesh-list
6271726|NCT04323852|Vitamins|vitamins|mesh-ancestor
6271727|NCT04323852|Micronutrients|micronutrients|mesh-ancestor
6271728|NCT04323852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271729|NCT04323852|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6271730|NCT04327843|Haloperidol|haloperidol|mesh-list
6271731|NCT04327843|Haloperidol decanoate|haloperidol decanoate|mesh-list
6271732|NCT04327843|Antiemetics|antiemetics|mesh-ancestor
6271733|NCT04327843|Autonomic Agents|autonomic agents|mesh-ancestor
6271734|NCT04327843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6271735|NCT04327843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271736|NCT04327843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6271737|NCT04327843|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6271738|NCT04327843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6271739|NCT04327843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6271740|NCT04327843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6271741|NCT04327843|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6271742|NCT04327843|Dopamine Agents|dopamine agents|mesh-ancestor
6271743|NCT04327843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6271744|NCT04327843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271745|NCT04327843|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6271746|NCT04334148|Hydroxychloroquine|hydroxychloroquine|mesh-list
6271747|NCT04334148|Antimalarials|antimalarials|mesh-ancestor
6271748|NCT04334148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6271749|NCT04334148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6271750|NCT04334148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6271751|NCT04334148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6271752|NCT04334148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271753|NCT04334148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6271754|NCT04347954|Iodine|iodine|mesh-list
6271755|NCT04347954|Cadexomer iodine|cadexomer iodine|mesh-list
6271756|NCT04347954|Povidone-Iodine|povidone-iodine|mesh-list
6271757|NCT04347954|Povidone|povidone|mesh-list
6271758|NCT04347954|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6271759|NCT04347954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6271760|NCT04347954|Trace Elements|trace elements|mesh-ancestor
6271761|NCT04347954|Micronutrients|micronutrients|mesh-ancestor
6271762|NCT04347954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271763|NCT04347954|Plasma Substitutes|plasma substitutes|mesh-ancestor
6271764|NCT04347954|Blood Substitutes|blood substitutes|mesh-ancestor
6271765|NCT04358068|Azithromycin|azithromycin|mesh-list
6271766|NCT04358068|Hydroxychloroquine|hydroxychloroquine|mesh-list
6271767|NCT04358068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6271768|NCT04358068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6271769|NCT04358068|Antimalarials|antimalarials|mesh-ancestor
6271770|NCT04358068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6271771|NCT04358068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6271772|NCT04358068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6271773|NCT04358068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271774|NCT04358068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6271775|NCT04373421|Chlorhexidine|chlorhexidine|mesh-list
6271776|NCT04373421|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6271777|NCT04373421|Benzydamine|benzydamine|mesh-list
6271778|NCT04373421|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6271779|NCT04373421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6271780|NCT04373421|Disinfectants|disinfectants|mesh-ancestor
6271781|NCT04373421|Dermatologic Agents|dermatologic agents|mesh-ancestor
6271782|NCT04373421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6271783|NCT04398732|Etanercept|etanercept|mesh-list
6271784|NCT04398732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6271785|NCT04398732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6271786|NCT04398732|Analgesics|analgesics|mesh-ancestor
6271787|NCT04398732|Sensory System Agents|sensory system agents|mesh-ancestor
6271788|NCT04398732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6271789|NCT04398732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271790|NCT04398732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6271791|NCT04398732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6271792|NCT04398732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6271793|NCT04398732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6271794|NCT04398732|Immunologic Factors|immunologic factors|mesh-ancestor
6271795|NCT04401293|Heparin|heparin|mesh-list
6271796|NCT04401293|Enoxaparin|enoxaparin|mesh-list
6271797|NCT04401293|Calcium heparin|calcium heparin|mesh-list
6271798|NCT04401293|Dalteparin|dalteparin|mesh-list
6271799|NCT04401293|Enoxaparin sodium|enoxaparin sodium|mesh-list
6271800|NCT04401293|Anticoagulants|anticoagulants|mesh-ancestor
6271801|NCT04401293|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6271802|NCT04401293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6271803|NCT04401293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271804|NCT04420572|Betamethasone|betamethasone|mesh-list
6271805|NCT04420572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6271806|NCT04420572|Glucocorticoids|glucocorticoids|mesh-ancestor
6271807|NCT04420572|Hormones|hormones|mesh-ancestor
6271808|NCT04420572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6271809|NCT04420572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271810|NCT04420572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6271811|NCT04420572|Respiratory System Agents|respiratory system agents|mesh-ancestor
6271812|NCT04428411|Etanercept|etanercept|mesh-list
6271813|NCT04428411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6271814|NCT04428411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6271815|NCT04428411|Analgesics|analgesics|mesh-ancestor
6271816|NCT04428411|Sensory System Agents|sensory system agents|mesh-ancestor
6271817|NCT04428411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6271818|NCT04428411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271819|NCT04428411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6271820|NCT04428411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6271821|NCT04428411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6271822|NCT04428411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6271823|NCT04428411|Immunologic Factors|immunologic factors|mesh-ancestor
6271824|NCT04492475|Interferons|interferons|mesh-list
6271825|NCT04492475|Interferon-beta|interferon-beta|mesh-list
6271826|NCT04492475|Interferon beta-1a|interferon beta-1a|mesh-list
6271827|NCT04492475|Remdesivir|remdesivir|mesh-list
6271828|NCT04492475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6271829|NCT04492475|Antiviral Agents|antiviral agents|mesh-ancestor
6271830|NCT04492475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6271831|NCT04492475|Immunologic Factors|immunologic factors|mesh-ancestor
6271832|NCT04492475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271833|NCT04492475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6271834|NCT04492475|Antimetabolites|antimetabolites|mesh-ancestor
6271835|NCT04492475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271836|NCT04495283|Acetaminophen|acetaminophen|mesh-list
6271837|NCT04495283|Pregabalin|pregabalin|mesh-list
6271838|NCT04495283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6271839|NCT04495283|Analgesics|analgesics|mesh-ancestor
6271840|NCT04495283|Sensory System Agents|sensory system agents|mesh-ancestor
6271841|NCT04495283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6271842|NCT04495283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271843|NCT04495283|Antipyretics|antipyretics|mesh-ancestor
6271844|NCT04495283|Anticonvulsants|anticonvulsants|mesh-ancestor
6271845|NCT04495283|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6271846|NCT04495283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6271847|NCT04495283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271848|NCT04495283|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6271849|NCT04495283|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6271850|NCT04495283|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6271851|NCT04495283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6271852|NCT04495283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6271853|NCT04497948|Acalabrutinib|acalabrutinib|mesh-list
6271854|NCT04497948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6271855|NCT04501640|Mirabegron|mirabegron|mesh-list
6271856|NCT04501640|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6271857|NCT04501640|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6271858|NCT04501640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6271859|NCT04501640|Adrenergic Agents|adrenergic agents|mesh-ancestor
6271860|NCT04501640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6271861|NCT04501640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271862|NCT04501640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271863|NCT04501640|Urological Agents|urological agents|mesh-ancestor
6271864|NCT04501952|Remdesivir|remdesivir|mesh-list
6271865|NCT04501952|Antimetabolites|antimetabolites|mesh-ancestor
6271866|NCT04501952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271867|NCT04501952|Antiviral Agents|antiviral agents|mesh-ancestor
6271868|NCT04501952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6271869|NCT04504032|Rivaroxaban|rivaroxaban|mesh-list
6271870|NCT04504032|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6271871|NCT04504032|Antithrombins|antithrombins|mesh-ancestor
6271872|NCT04504032|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6271873|NCT04504032|Protease Inhibitors|protease inhibitors|mesh-ancestor
6271874|NCT04504032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6271875|NCT04504032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271876|NCT04504032|Anticoagulants|anticoagulants|mesh-ancestor
6271877|NCT04507763|Etanercept|etanercept|mesh-list
6271878|NCT04507763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6271879|NCT04507763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6271880|NCT04507763|Analgesics|analgesics|mesh-ancestor
6271881|NCT04507763|Sensory System Agents|sensory system agents|mesh-ancestor
6271882|NCT04507763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6271883|NCT04507763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271884|NCT04507763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6271885|NCT04507763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6271886|NCT04507763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6271887|NCT04507763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6271888|NCT04507763|Immunologic Factors|immunologic factors|mesh-ancestor
6271889|NCT04537234|Vaccines|vaccines|mesh-list
6271890|NCT04537234|Immunologic Factors|immunologic factors|mesh-ancestor
6271891|NCT04537234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390826|NCT00191607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390827|NCT00191607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6390828|NCT00191607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6390829|NCT00191607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6390830|NCT00191620|Gemcitabine|gemcitabine|mesh-list
6390831|NCT00191620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6390832|NCT00191620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6390833|NCT00191620|Antimetabolites|antimetabolites|mesh-ancestor
6390834|NCT00191620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390835|NCT00191620|Antiviral Agents|antiviral agents|mesh-ancestor
6390836|NCT00191620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6390837|NCT00191620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6390838|NCT00191620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6390839|NCT00191620|Immunologic Factors|immunologic factors|mesh-ancestor
6390840|NCT00191620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390841|NCT00191633|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6390842|NCT00191633|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6390843|NCT00191633|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6390844|NCT00191633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6390845|NCT00191633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390846|NCT00191633|Adrenergic Agents|adrenergic agents|mesh-ancestor
6390847|NCT00191633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6390848|NCT00191633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390849|NCT00191659|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6390850|NCT00191659|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6390851|NCT00191659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6390852|NCT00191659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6390853|NCT00191659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390854|NCT00191659|Adrenergic Agents|adrenergic agents|mesh-ancestor
6390855|NCT00191659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6390856|NCT00191659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390857|NCT00191672|Gemcitabine|gemcitabine|mesh-list
6390858|NCT00191672|Paclitaxel|paclitaxel|mesh-list
6390859|NCT00191672|Docetaxel|docetaxel|mesh-list
6390860|NCT00191672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6390861|NCT00191672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6390862|NCT00191672|Tubulin Modulators|tubulin modulators|mesh-ancestor
6390863|NCT00191672|Antimitotic Agents|antimitotic agents|mesh-ancestor
6390864|NCT00191672|Mitosis Modulators|mitosis modulators|mesh-ancestor
6390865|NCT00191672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390866|NCT00191672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6390867|NCT00191672|Antimetabolites|antimetabolites|mesh-ancestor
6390868|NCT00191672|Antiviral Agents|antiviral agents|mesh-ancestor
6390869|NCT00191672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6390870|NCT00191672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6390871|NCT00191672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6390872|NCT00191672|Immunologic Factors|immunologic factors|mesh-ancestor
6390873|NCT00191672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390874|NCT00191685|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6390875|NCT00191685|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6390876|NCT00191685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6390877|NCT00191685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6390878|NCT00191685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390879|NCT00191685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6390880|NCT00191685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390881|NCT00191685|Analgesics|analgesics|mesh-ancestor
6390882|NCT00191685|Sensory System Agents|sensory system agents|mesh-ancestor
6390883|NCT00191685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6390884|NCT00191685|Antidepressive Agents|antidepressive agents|mesh-ancestor
6390885|NCT00191685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6390886|NCT00191685|Dopamine Agents|dopamine agents|mesh-ancestor
6390887|NCT00191698|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6390888|NCT00191698|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6390889|NCT00191698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6390890|NCT00191698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6390891|NCT00191698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390892|NCT00191698|Adrenergic Agents|adrenergic agents|mesh-ancestor
6390893|NCT00191698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6390894|NCT00191698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390895|NCT00191711|Gemcitabine|gemcitabine|mesh-list
6271892|NCT04854707|Menotropins|menotropins|mesh-list
6271893|NCT04854707|Hormones|hormones|mesh-list
6271894|NCT04854707|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6271895|NCT04854707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6271896|NCT04854707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271897|NCT04854707|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6271898|NCT04854707|Fertility Agents|fertility agents|mesh-ancestor
6271899|NCT04854707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6271900|NCT04926233|Bromides|bromides|mesh-list
6271901|NCT04926233|Tiotropium Bromide|tiotropium bromide|mesh-list
6271902|NCT04926233|Olodaterol|olodaterol|mesh-list
6271903|NCT04926233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6271904|NCT04926233|Autonomic Agents|autonomic agents|mesh-ancestor
6271905|NCT04926233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6271906|NCT04926233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271907|NCT04926233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6271908|NCT04926233|Respiratory System Agents|respiratory system agents|mesh-ancestor
6271909|NCT04926233|Parasympatholytics|parasympatholytics|mesh-ancestor
6271910|NCT04926233|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6271911|NCT04926233|Cholinergic Agents|cholinergic agents|mesh-ancestor
6271912|NCT04926233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6271913|NCT04926233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271914|NCT04926233|Anticonvulsants|anticonvulsants|mesh-ancestor
6271915|NCT04943159|Afamelanotide|afamelanotide|mesh-list
6271916|NCT04943159|Dermatologic Agents|dermatologic agents|mesh-ancestor
6271917|NCT04525157|Afamelanotide|afamelanotide|mesh-list
6271918|NCT04525157|Dermatologic Agents|dermatologic agents|mesh-ancestor
6271919|NCT04523831|Doxycycline|doxycycline|mesh-list
6271920|NCT04523831|Ivermectin|ivermectin|mesh-list
6271921|NCT04523831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6271922|NCT04523831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6271923|NCT04523831|Antimalarials|antimalarials|mesh-ancestor
6271924|NCT04523831|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6271925|NCT04523831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6271926|NCT04511520|Trimetazidine|trimetazidine|mesh-list
6271927|NCT04511520|Vasodilator Agents|vasodilator agents|mesh-ancestor
6271928|NCT04507776|Etanercept|etanercept|mesh-list
6271929|NCT04507776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6271930|NCT04507776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6271931|NCT04507776|Analgesics|analgesics|mesh-ancestor
6271932|NCT04507776|Sensory System Agents|sensory system agents|mesh-ancestor
6271933|NCT04507776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6271934|NCT04507776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271935|NCT04507776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6271936|NCT04507776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6271937|NCT04507776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6271938|NCT04507776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6271939|NCT04507776|Immunologic Factors|immunologic factors|mesh-ancestor
6271940|NCT04495374|Pregabalin|pregabalin|mesh-list
6271941|NCT04495374|Analgesics|analgesics|mesh-ancestor
6271942|NCT04495374|Sensory System Agents|sensory system agents|mesh-ancestor
6271943|NCT04495374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6271944|NCT04495374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271945|NCT04495374|Anticonvulsants|anticonvulsants|mesh-ancestor
6271946|NCT04495374|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6271947|NCT04495374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6271948|NCT04495374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271949|NCT04495374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6271950|NCT04495374|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6271951|NCT04495374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6271952|NCT04495374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6271953|NCT04495374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6271954|NCT04495712|Spironolactone|spironolactone|mesh-list
6271955|NCT04495712|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6271956|NCT04495712|Hormone Antagonists|hormone antagonists|mesh-ancestor
6271957|NCT04495712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6271958|NCT04495712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271959|NCT04495712|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6271960|NCT04495712|Diuretics|diuretics|mesh-ancestor
6271961|NCT04495712|Natriuretic Agents|natriuretic agents|mesh-ancestor
6271962|NCT04490499|Vaccines|vaccines|mesh-list
6271963|NCT04490499|Immunologic Factors|immunologic factors|mesh-ancestor
6271964|NCT04490499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271965|NCT04490239|Heparin|heparin|mesh-list
6271966|NCT04490239|Calcium heparin|calcium heparin|mesh-list
6271967|NCT04490239|Anticoagulants|anticoagulants|mesh-ancestor
6271968|NCT04490239|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6271969|NCT04490239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6271970|NCT04490239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6271971|NCT04467424|Lidocaine|lidocaine|mesh-list
6271972|NCT04467424|Ketamine|ketamine|mesh-list
6271973|NCT04467424|Propofol|propofol|mesh-list
6271974|NCT04467424|Anesthetics, Local|anesthetics, local|mesh-ancestor
6271975|NCT04467424|Anesthetics|anesthetics|mesh-ancestor
6271976|NCT04467424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6271977|NCT04467424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6271978|NCT04467424|Sensory System Agents|sensory system agents|mesh-ancestor
6271979|NCT04467424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6271980|NCT04467424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6271981|NCT04467424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6271982|NCT04467424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6271983|NCT04467424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6271984|NCT04467424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014985|NCT00354172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6014986|NCT00354172|Analgesics|analgesics|mesh-ancestor
6014987|NCT00354172|Sensory System Agents|sensory system agents|mesh-ancestor
6014988|NCT00354172|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6014989|NCT00354172|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6014990|NCT00354172|Antiviral Agents|antiviral agents|mesh-ancestor
6014991|NCT00354224|Capecitabine|capecitabine|mesh-list
6014992|NCT00354224|Oxaliplatin|oxaliplatin|mesh-list
6014993|NCT00354224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6014994|NCT00354224|Antimetabolites|antimetabolites|mesh-ancestor
6014995|NCT00354224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6014996|NCT00354224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6271985|NCT04467424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6271986|NCT04467424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6271987|NCT04467424|Anesthetics, General|anesthetics, general|mesh-ancestor
6271988|NCT04467424|Analgesics|analgesics|mesh-ancestor
6271989|NCT04467424|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6271990|NCT04467424|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6271991|NCT04467424|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6271992|NCT04467424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6271993|NCT04463004|Mavrilimumab|mavrilimumab|mesh-list
6271994|NCT04463004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6271995|NCT04448561|Morphine|morphine|mesh-list
6271996|NCT04448561|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6271997|NCT04448561|Narcotics|narcotics|mesh-ancestor
6271998|NCT04448561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6271999|NCT04448561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6014997|NCT00354341|Epoetin Alfa|epoetin alfa|mesh-list
6014998|NCT00354341|Hematinics|hematinics|mesh-ancestor
6014999|NCT00354432|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6272000|NCT04448561|Analgesics|analgesics|mesh-ancestor
6272001|NCT04448561|Sensory System Agents|sensory system agents|mesh-ancestor
6272002|NCT04448561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6272003|NCT04459585|Dabigatran|dabigatran|mesh-list
6272004|NCT04459585|Antithrombins|antithrombins|mesh-ancestor
6272005|NCT04459585|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6272006|NCT04459585|Protease Inhibitors|protease inhibitors|mesh-ancestor
6272007|NCT04459585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6272008|NCT04459585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272009|NCT04459585|Anticoagulants|anticoagulants|mesh-ancestor
6272010|NCT04456634|Lumefantrine|lumefantrine|mesh-list
6272011|NCT04456634|Artemether|artemether|mesh-list
6272012|NCT04456634|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6272013|NCT04456634|Antimalarials|antimalarials|mesh-ancestor
6272014|NCT04456634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6272015|NCT04456634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6272016|NCT04456634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6272017|NCT04439214|Nivolumab|nivolumab|mesh-list
6272018|NCT04439214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6272019|NCT04439214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6272020|NCT04439214|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6272021|NCT04439214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272022|NCT04428502|Etanercept|etanercept|mesh-list
6272023|NCT04428502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6272024|NCT04428502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6272025|NCT04428502|Analgesics|analgesics|mesh-ancestor
6272026|NCT04428502|Sensory System Agents|sensory system agents|mesh-ancestor
6272027|NCT04428502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6272028|NCT04428502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272029|NCT04428502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6272030|NCT04428502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6272031|NCT04428502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6272032|NCT04428502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6272033|NCT04428502|Immunologic Factors|immunologic factors|mesh-ancestor
6272034|NCT04428424|Etanercept|etanercept|mesh-list
6272035|NCT04428424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6272036|NCT04428424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6272037|NCT04428424|Analgesics|analgesics|mesh-ancestor
6272038|NCT04428424|Sensory System Agents|sensory system agents|mesh-ancestor
6272039|NCT04428424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6272040|NCT04428424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272041|NCT04428424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6272042|NCT04428424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6272043|NCT04428424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6272044|NCT04428424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6272045|NCT04428424|Immunologic Factors|immunologic factors|mesh-ancestor
6272046|NCT04428359|Vitamin D|vitamin d|mesh-list
6272047|NCT04428359|Vitamins|vitamins|mesh-ancestor
6272048|NCT04428359|Micronutrients|micronutrients|mesh-ancestor
6272049|NCT04428359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272050|NCT04428359|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6272051|NCT04410159|Povidone-Iodine|povidone-iodine|mesh-list
6272052|NCT04410159|Listerine|listerine|mesh-list
6272053|NCT04410159|Povidone|povidone|mesh-list
6272054|NCT04410159|Plasma Substitutes|plasma substitutes|mesh-ancestor
6272055|NCT04410159|Blood Substitutes|blood substitutes|mesh-ancestor
6272056|NCT04410159|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6272057|NCT04410159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6272058|NCT04425850|Ivermectin|ivermectin|mesh-list
6272059|NCT04425850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6272060|NCT04425850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6272061|NCT04425863|Aspirin|aspirin|mesh-list
6272062|NCT04425863|Ivermectin|ivermectin|mesh-list
6272063|NCT04425863|Dexamethasone|dexamethasone|mesh-list
6272064|NCT04425863|Dexamethasone acetate|dexamethasone acetate|mesh-list
6272065|NCT04425863|Enoxaparin|enoxaparin|mesh-list
6272066|NCT04425863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6272067|NCT04425863|BB 1101|bb 1101|mesh-list
6272068|NCT04425863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6272069|NCT04425863|Antiemetics|antiemetics|mesh-ancestor
6272070|NCT04425863|Autonomic Agents|autonomic agents|mesh-ancestor
6272071|NCT04425863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6272072|NCT04425863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272073|NCT04425863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6272074|NCT04425863|Glucocorticoids|glucocorticoids|mesh-ancestor
6272075|NCT04425863|Hormones|hormones|mesh-ancestor
6272076|NCT04425863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6272077|NCT04425863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6272078|NCT04425863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6272079|NCT04425863|Protease Inhibitors|protease inhibitors|mesh-ancestor
6272080|NCT04425863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6272081|NCT04425863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272082|NCT04425863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6272083|NCT04425863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6272084|NCT04425863|Analgesics|analgesics|mesh-ancestor
6272085|NCT04425863|Sensory System Agents|sensory system agents|mesh-ancestor
6272086|NCT04425863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6272087|NCT04425863|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6272088|NCT04425863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6272089|NCT04425863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6272090|NCT04425863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6272091|NCT04425863|Antipyretics|antipyretics|mesh-ancestor
6272092|NCT04425863|Anticoagulants|anticoagulants|mesh-ancestor
6272093|NCT04425863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6272094|NCT04425863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6272095|NCT04425746|Afamelanotide|afamelanotide|mesh-list
6272096|NCT04425746|Dermatologic Agents|dermatologic agents|mesh-ancestor
6272097|NCT04422561|Ivermectin|ivermectin|mesh-list
6272098|NCT04422561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6272099|NCT04422561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6272100|NCT04411667|gamma-Globulins|gamma-globulins|mesh-list
6272101|NCT04411667|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6272102|NCT04411667|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6272103|NCT04411667|Immunologic Factors|immunologic factors|mesh-ancestor
6272104|NCT04411667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272105|NCT04407507|Ivermectin|ivermectin|mesh-list
6272106|NCT04407507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6272107|NCT04407507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6272108|NCT04406194|Favipiravir|favipiravir|mesh-list
6272109|NCT04406194|Antiviral Agents|antiviral agents|mesh-ancestor
6272110|NCT04406194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6272111|NCT04403399|Varenicline|varenicline|mesh-list
6272112|NCT04403399|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6272113|NCT04403399|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6272114|NCT04403399|Cholinergic Agents|cholinergic agents|mesh-ancestor
6272115|NCT04403399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6272116|NCT04403399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272117|NCT04403399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272118|NCT04401579|Remdesivir|remdesivir|mesh-list
6272119|NCT04401579|Antimetabolites|antimetabolites|mesh-ancestor
6272120|NCT04401579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272121|NCT04401579|Antiviral Agents|antiviral agents|mesh-ancestor
6272122|NCT04401579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6272123|NCT04400682|Favipiravir|favipiravir|mesh-list
6272124|NCT04400682|Antiviral Agents|antiviral agents|mesh-ancestor
6272125|NCT04400682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6272126|NCT04399161|Chlorhexidine|chlorhexidine|mesh-list
6272127|NCT04399161|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6272128|NCT04399161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6272129|NCT04399161|Disinfectants|disinfectants|mesh-ancestor
6272130|NCT04399980|Mavrilimumab|mavrilimumab|mesh-list
6272131|NCT04399980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6272132|NCT04399122|Acetaminophen|acetaminophen|mesh-list
6272133|NCT04399122|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
6272134|NCT04399122|Oxycodone|oxycodone|mesh-list
6272135|NCT04399122|Codeine|codeine|mesh-list
6272136|NCT04399122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6272137|NCT04399122|Analgesics|analgesics|mesh-ancestor
6272138|NCT04399122|Sensory System Agents|sensory system agents|mesh-ancestor
6272139|NCT04399122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6272140|NCT04399122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272141|NCT04399122|Antipyretics|antipyretics|mesh-ancestor
6272142|NCT04399122|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6272143|NCT04399122|Narcotics|narcotics|mesh-ancestor
6272144|NCT04399122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6272145|NCT04399122|Antitussive Agents|antitussive agents|mesh-ancestor
6272146|NCT04399122|Respiratory System Agents|respiratory system agents|mesh-ancestor
6272147|NCT04399122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6272148|NCT04399122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6272149|NCT04399122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6272150|NCT04397445|Ranitidine|ranitidine|mesh-list
6272151|NCT04397445|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
6272152|NCT04397445|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6272153|NCT04397445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6272154|NCT04397445|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6272155|NCT04397445|Histamine Antagonists|histamine antagonists|mesh-ancestor
6272156|NCT04397445|Histamine Agents|histamine agents|mesh-ancestor
6272157|NCT04397445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6272158|NCT04397445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272159|NCT04397445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272160|NCT04396639|Factor VIII|factor viii|mesh-list
6272161|NCT04396639|Coagulants|coagulants|mesh-ancestor
6272162|NCT04393493|Chlorthalidone|chlorthalidone|mesh-list
6272163|NCT04393493|Furosemide|furosemide|mesh-list
6272164|NCT04393493|Spironolactone|spironolactone|mesh-list
6272165|NCT04393493|Diuretics|diuretics|mesh-ancestor
6272166|NCT04393493|Natriuretic Agents|natriuretic agents|mesh-ancestor
6272167|NCT04393493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272168|NCT04393493|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6272169|NCT04393493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6272170|NCT04393493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272171|NCT04393493|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6272172|NCT04393493|Hormone Antagonists|hormone antagonists|mesh-ancestor
6272173|NCT04393493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6272174|NCT04393493|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6272175|NCT04393493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6272176|NCT04393493|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6272177|NCT04392362|Adenosine|adenosine|mesh-list
6272178|NCT04392362|Analgesics|analgesics|mesh-ancestor
6272179|NCT04392362|Sensory System Agents|sensory system agents|mesh-ancestor
6272180|NCT04392362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6272181|NCT04392362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272182|NCT04392362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6272183|NCT04392362|Vasodilator Agents|vasodilator agents|mesh-ancestor
6272184|NCT04392362|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6272185|NCT04392362|Purinergic Agonists|purinergic agonists|mesh-ancestor
6272186|NCT04392362|Purinergic Agents|purinergic agents|mesh-ancestor
6272187|NCT04392362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6272188|NCT04392362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272189|NCT04392141|Colchicine|colchicine|mesh-list
6272190|NCT04392141|Gout Suppressants|gout suppressants|mesh-ancestor
6272191|NCT04392141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6272192|NCT04392141|Tubulin Modulators|tubulin modulators|mesh-ancestor
6272193|NCT04392141|Antimitotic Agents|antimitotic agents|mesh-ancestor
6272194|NCT04392141|Mitosis Modulators|mitosis modulators|mesh-ancestor
6272195|NCT04392141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272196|NCT04392141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6272197|NCT04391842|Diclofenac|diclofenac|mesh-list
6272198|NCT04391842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6272199|NCT04391842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6272200|NCT04391842|Analgesics|analgesics|mesh-ancestor
6272201|NCT04391842|Sensory System Agents|sensory system agents|mesh-ancestor
6272202|NCT04391842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6272203|NCT04391842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272204|NCT04391842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6272205|NCT04391842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6272206|NCT04391842|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6272207|NCT04391842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6272208|NCT04391842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272209|NCT04390022|Ivermectin|ivermectin|mesh-list
6272210|NCT04390022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6272211|NCT04390022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6390896|NCT00191711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6390897|NCT00191711|Antimetabolites|antimetabolites|mesh-ancestor
6390898|NCT00191711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272212|NCT04380688|Acalabrutinib|acalabrutinib|mesh-list
6272213|NCT04380688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6272214|NCT04374500|Verapamil|verapamil|mesh-list
6272215|NCT04374500|Nitroprusside|nitroprusside|mesh-list
6272216|NCT04374500|Acetylcholine|acetylcholine|mesh-list
6272217|NCT04374500|Bradykinin|bradykinin|mesh-list
6272218|NCT04374500|Vasodilator Agents|vasodilator agents|mesh-list
6272219|NCT04374500|Substance P|substance p|mesh-list
6272220|NCT04374500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6272221|NCT04374500|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6272222|NCT04374500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6272223|NCT04374500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272224|NCT04374500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6272225|NCT04374500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272226|NCT04374500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6272227|NCT04374500|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6272228|NCT04374500|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6272229|NCT04374500|Cholinergic Agents|cholinergic agents|mesh-ancestor
6272230|NCT04374500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6272231|NCT04370834|Immunoglobulins|immunoglobulins|mesh-list
6272232|NCT04370834|Immunoglobulin G|immunoglobulin g|mesh-list
6272233|NCT04370834|Immunologic Factors|immunologic factors|mesh-ancestor
6272234|NCT04370834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272235|NCT04370548|Clindamycin|clindamycin|mesh-list
6272236|NCT04370548|Clindamycin palmitate|clindamycin palmitate|mesh-list
6272237|NCT04370548|Clindamycin phosphate|clindamycin phosphate|mesh-list
6272238|NCT04370548|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6272239|NCT04370548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6272240|NCT04370548|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6272241|NCT04370548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6272242|NCT04370548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272243|NCT04368429|Vaccines|vaccines|mesh-list
6272244|NCT04368429|Immunologic Factors|immunologic factors|mesh-ancestor
6272245|NCT04368429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272246|NCT04365153|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6272247|NCT04365153|Immunologic Factors|immunologic factors|mesh-ancestor
6272248|NCT04365153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272249|NCT04358991|Ceftazidime|ceftazidime|mesh-list
6272250|NCT04358991|Avibactam|avibactam|mesh-list
6272251|NCT04358991|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
6272252|NCT04358991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6272253|NCT04358991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6272254|NCT04358991|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6272255|NCT04358991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6272256|NCT04358991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272257|NCT04354870|Hydroxychloroquine|hydroxychloroquine|mesh-list
6272258|NCT04354870|Antimalarials|antimalarials|mesh-ancestor
6272259|NCT04354870|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6272260|NCT04354870|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6272261|NCT04354870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6272262|NCT04354870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6272263|NCT04354870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272264|NCT04354870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6272265|NCT04352660|Mitomycins|mitomycins|mesh-list
6272266|NCT04352660|Mitomycin|mitomycin|mesh-list
6272267|NCT04352660|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6272268|NCT04352660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6272269|NCT04352660|Alkylating Agents|alkylating agents|mesh-ancestor
6272270|NCT04352660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272271|NCT04352660|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6272272|NCT04352660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6272273|NCT04349917|Methylphenidate|methylphenidate|mesh-list
6272274|NCT04349917|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6272275|NCT04349917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272276|NCT04349917|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6272277|NCT04349917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6272278|NCT04349917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6272279|NCT04349917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272280|NCT04349917|Dopamine Agents|dopamine agents|mesh-ancestor
6272281|NCT04349917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6272282|NCT04346199|Acalabrutinib|acalabrutinib|mesh-list
6272283|NCT04346199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6272284|NCT04345653|Hydroxychloroquine|hydroxychloroquine|mesh-list
6272285|NCT04345653|Antimalarials|antimalarials|mesh-ancestor
6272286|NCT04345653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6272287|NCT04345653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6272288|NCT04345653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6272289|NCT04345653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6272290|NCT04345653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272291|NCT04345653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6272292|NCT04343222|Bromfenac|bromfenac|mesh-list
6272293|NCT04343222|Lubricant Eye Drops|lubricant eye drops|mesh-list
6272294|NCT04343222|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6272295|NCT04343222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6272296|NCT04343222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6272297|NCT04343222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6272298|NCT04343222|Analgesics|analgesics|mesh-ancestor
6272299|NCT04343222|Sensory System Agents|sensory system agents|mesh-ancestor
6272300|NCT04343222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6272301|NCT04343222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272302|NCT04343222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6272303|NCT04343222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6272304|NCT04343092|Ivermectin|ivermectin|mesh-list
6272305|NCT04343092|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6272306|NCT04343092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6272307|NCT04342663|Fluvoxamine|fluvoxamine|mesh-list
6272308|NCT04342663|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6272309|NCT04342663|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6272310|NCT04342663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6272311|NCT04342663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272312|NCT04342663|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6272313|NCT04342663|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6272314|NCT04342663|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6272315|NCT04342663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6272316|NCT04342663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272317|NCT04342663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6272318|NCT04342663|Serotonin Agents|serotonin agents|mesh-ancestor
6272319|NCT04342663|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6272320|NCT04342663|Antidepressive Agents|antidepressive agents|mesh-ancestor
6272321|NCT04342663|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6272322|NCT04342663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6272323|NCT04342663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6272324|NCT04342663|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6272325|NCT04342130|Morphine|morphine|mesh-list
6272326|NCT04342130|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6272327|NCT04342130|Narcotics|narcotics|mesh-ancestor
6272328|NCT04342130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6272329|NCT04342130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272330|NCT04342130|Analgesics|analgesics|mesh-ancestor
6272331|NCT04342130|Sensory System Agents|sensory system agents|mesh-ancestor
6272332|NCT04342130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6272333|NCT04340557|Losartan|losartan|mesh-list
6272334|NCT04340557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6272335|NCT04340557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6272336|NCT04340557|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6272337|NCT04340557|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6272338|NCT04340557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272339|NCT04338009|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6272340|NCT04338009|Protease Inhibitors|protease inhibitors|mesh-ancestor
6272341|NCT04338009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6272342|NCT04338009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272343|NCT04338074|Tranexamic Acid|tranexamic acid|mesh-list
6272344|NCT04338074|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6272345|NCT04338074|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6272346|NCT04338074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272347|NCT04338074|Hemostatics|hemostatics|mesh-ancestor
6272348|NCT04338074|Coagulants|coagulants|mesh-ancestor
6272349|NCT04337138|Gemtuzumab|gemtuzumab|mesh-list
6272350|NCT04337138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6272351|NCT04337138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6272352|NCT04335552|Azithromycin|azithromycin|mesh-list
6272353|NCT04335552|Hydroxychloroquine|hydroxychloroquine|mesh-list
6272354|NCT04335552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6272355|NCT04335552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6272356|NCT04335552|Antimalarials|antimalarials|mesh-ancestor
6272357|NCT04335552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6272358|NCT04335552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6272359|NCT04335552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6272360|NCT04335552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272361|NCT04335552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6272362|NCT04334876|Antibodies|antibodies|mesh-list
6272363|NCT04334876|Immunoglobulin G|immunoglobulin g|mesh-list
6272364|NCT04334876|Immunologic Factors|immunologic factors|mesh-ancestor
6272365|NCT04334876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272366|NCT04333225|Hydroxychloroquine|hydroxychloroquine|mesh-list
6272367|NCT04333225|Antimalarials|antimalarials|mesh-ancestor
6272368|NCT04333225|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6272369|NCT04333225|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6272370|NCT04333225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6272371|NCT04333225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6272372|NCT04333225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272373|NCT04333225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6272374|NCT04332991|Hydroxychloroquine|hydroxychloroquine|mesh-list
6272375|NCT04332991|Antimalarials|antimalarials|mesh-ancestor
6272376|NCT04332991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6272377|NCT04332991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6272378|NCT04332991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6272379|NCT04332991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6272380|NCT04332991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272381|NCT04332991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6272382|NCT04322968|Ketorolac|ketorolac|mesh-list
6272383|NCT04322968|Ketamine|ketamine|mesh-list
6272384|NCT04322968|Analgesics|analgesics|mesh-ancestor
6272385|NCT04322968|Sensory System Agents|sensory system agents|mesh-ancestor
6272386|NCT04322968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6272387|NCT04322968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272388|NCT04322968|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6272389|NCT04322968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6272390|NCT04322968|Anesthetics, General|anesthetics, general|mesh-ancestor
6272391|NCT04322968|Anesthetics|anesthetics|mesh-ancestor
6272392|NCT04322968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6272393|NCT04322968|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6272394|NCT04322968|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6272395|NCT04322968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6272396|NCT04322968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272397|NCT04322968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6272398|NCT04322968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6272399|NCT04322968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6272400|NCT04322968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6272401|NCT04322968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6272402|NCT04322968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6272403|NCT04332107|Azithromycin|azithromycin|mesh-list
6272404|NCT04332107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6272405|NCT04332107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6272406|NCT04323592|Methylprednisolone|methylprednisolone|mesh-list
6272407|NCT04323592|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6272408|NCT04323592|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6272409|NCT04323592|Prednisolone|prednisolone|mesh-list
6272410|NCT04323592|Prednisolone acetate|prednisolone acetate|mesh-list
6272411|NCT04323592|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6272412|NCT04323592|Prednisolone phosphate|prednisolone phosphate|mesh-list
6272413|NCT04323592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6272414|NCT04323592|Antiemetics|antiemetics|mesh-ancestor
6272415|NCT04323592|Autonomic Agents|autonomic agents|mesh-ancestor
6272416|NCT04323592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6272417|NCT04323592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272418|NCT04323592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6272419|NCT04323592|Glucocorticoids|glucocorticoids|mesh-ancestor
6272420|NCT04323592|Hormones|hormones|mesh-ancestor
6272421|NCT04323592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6272422|NCT04323592|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6272423|NCT04323592|Protective Agents|protective agents|mesh-ancestor
6272424|NCT04323592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6272425|NCT04323592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6272426|NCT04329923|Hydroxychloroquine|hydroxychloroquine|mesh-list
6272427|NCT04329923|Antimalarials|antimalarials|mesh-ancestor
6272428|NCT04329923|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6272429|NCT04329923|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6272430|NCT04329923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6272431|NCT04329923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6272432|NCT04329923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272433|NCT04329923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6272434|NCT04328467|Hydroxychloroquine|hydroxychloroquine|mesh-list
6272435|NCT04328467|Antimalarials|antimalarials|mesh-ancestor
6272436|NCT04328467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6272437|NCT04328467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6272438|NCT04328467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6272439|NCT04328467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6272440|NCT04328467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272441|NCT04328467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6272442|NCT04322526|Naltrexone|naltrexone|mesh-list
6272443|NCT04322526|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6272444|NCT04322526|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6272445|NCT04322526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272446|NCT04322526|Sensory System Agents|sensory system agents|mesh-ancestor
6272447|NCT04322526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6272448|NCT04322682|Colchicine|colchicine|mesh-list
6272449|NCT04322682|Gout Suppressants|gout suppressants|mesh-ancestor
6272450|NCT04322682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6272451|NCT04322682|Tubulin Modulators|tubulin modulators|mesh-ancestor
6272452|NCT04322682|Antimitotic Agents|antimitotic agents|mesh-ancestor
6272453|NCT04322682|Mitosis Modulators|mitosis modulators|mesh-ancestor
6272454|NCT04322682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272455|NCT04322682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6272456|NCT04322396|Azithromycin|azithromycin|mesh-list
6272457|NCT04322396|Hydroxychloroquine|hydroxychloroquine|mesh-list
6272458|NCT04322396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6272459|NCT04322396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6272460|NCT04322396|Antimalarials|antimalarials|mesh-ancestor
6272461|NCT04322396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6272462|NCT04322396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6272463|NCT04322396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6272464|NCT04322396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272465|NCT04322396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6272466|NCT04318535|Griseofulvin|griseofulvin|mesh-list
6272467|NCT04318535|Antifungal Agents|antifungal agents|mesh-ancestor
6272468|NCT04318535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6272469|NCT04314037|Praziquantel|praziquantel|mesh-list
6272470|NCT04314037|Anthelmintics|anthelmintics|mesh-ancestor
6272471|NCT04314037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6272472|NCT04314037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6272473|NCT04310085|Lumefantrine|lumefantrine|mesh-list
6272474|NCT04310085|Artemether|artemether|mesh-list
6272475|NCT04310085|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6272476|NCT04310085|Antimalarials|antimalarials|mesh-ancestor
6272477|NCT04310085|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6272478|NCT04310085|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6272479|NCT04310085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6272480|NCT04308668|Hydroxychloroquine|hydroxychloroquine|mesh-list
6272481|NCT04308668|Antimalarials|antimalarials|mesh-ancestor
6272482|NCT04308668|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6272483|NCT04308668|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6272484|NCT04308668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6272485|NCT04308668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6272486|NCT04308668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272487|NCT04308668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6272488|NCT04307940|Acetaminophen|acetaminophen|mesh-list
6272489|NCT04307940|Naproxen|naproxen|mesh-list
6272490|NCT04307940|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
6272491|NCT04307940|Hydrocodone|hydrocodone|mesh-list
6272492|NCT04307940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6272493|NCT04307940|Analgesics|analgesics|mesh-ancestor
6272494|NCT04307940|Sensory System Agents|sensory system agents|mesh-ancestor
6272495|NCT04307940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6272496|NCT04307940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272497|NCT04307940|Antipyretics|antipyretics|mesh-ancestor
6272498|NCT04307940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6272499|NCT04307940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6272500|NCT04307940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6272501|NCT04307940|Gout Suppressants|gout suppressants|mesh-ancestor
6272502|NCT04307940|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6272503|NCT04307940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6272504|NCT04307940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272505|NCT04307940|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6272506|NCT04307940|Narcotics|narcotics|mesh-ancestor
6272507|NCT04307940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6272508|NCT04307940|Antitussive Agents|antitussive agents|mesh-ancestor
6272509|NCT04307940|Respiratory System Agents|respiratory system agents|mesh-ancestor
6272510|NCT04297631|Tobramycin|tobramycin|mesh-list
6272511|NCT04297631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6272512|NCT04297631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6272513|NCT04297241|Isosorbide|isosorbide|mesh-list
6272514|NCT04297241|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
6272515|NCT04297241|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
6272516|NCT04297241|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6272517|NCT04297241|Diuretics|diuretics|mesh-ancestor
6272518|NCT04297241|Natriuretic Agents|natriuretic agents|mesh-ancestor
6272519|NCT04297241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272520|NCT04297241|Vasodilator Agents|vasodilator agents|mesh-ancestor
6272521|NCT04297241|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6272522|NCT04297241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272523|NCT04292535|Insulin|insulin|mesh-list
6272524|NCT04292535|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6272525|NCT04292535|Insulin Aspart|insulin aspart|mesh-list
6272526|NCT04292535|Insulin, Long-Acting|insulin, long-acting|mesh-list
6272527|NCT04292535|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6272528|NCT04292535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6272529|NCT04292535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272530|NCT04292171|Gabapentin|gabapentin|mesh-list
6272531|NCT04292171|Analgesics|analgesics|mesh-ancestor
6272532|NCT04292171|Sensory System Agents|sensory system agents|mesh-ancestor
6272533|NCT04292171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6272534|NCT04292171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272535|NCT04292171|Anticonvulsants|anticonvulsants|mesh-ancestor
6272536|NCT04292171|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6272537|NCT04292171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6272538|NCT04292171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6272539|NCT04292171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6272540|NCT04292171|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6272541|NCT04292171|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6272542|NCT04292171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6272543|NCT04292171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272544|NCT04292171|Antimanic Agents|antimanic agents|mesh-ancestor
6272545|NCT04292899|Remdesivir|remdesivir|mesh-list
6272546|NCT04292899|Antimetabolites|antimetabolites|mesh-ancestor
6272547|NCT04292899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272548|NCT04292899|Antiviral Agents|antiviral agents|mesh-ancestor
6272549|NCT04292899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6272550|NCT04292730|Remdesivir|remdesivir|mesh-list
6272551|NCT04292730|Antimetabolites|antimetabolites|mesh-ancestor
6272552|NCT04292730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272553|NCT04292730|Antiviral Agents|antiviral agents|mesh-ancestor
6272554|NCT04292730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6272555|NCT04290676|Dexamethasone|dexamethasone|mesh-list
6272556|NCT04290676|Dexamethasone acetate|dexamethasone acetate|mesh-list
6272557|NCT04290676|BB 1101|bb 1101|mesh-list
6272558|NCT04290676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6272559|NCT04290676|Antiemetics|antiemetics|mesh-ancestor
6272560|NCT04290676|Autonomic Agents|autonomic agents|mesh-ancestor
6272561|NCT04290676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6272562|NCT04290676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272563|NCT04290676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6272564|NCT04290676|Glucocorticoids|glucocorticoids|mesh-ancestor
6272565|NCT04290676|Hormones|hormones|mesh-ancestor
6272566|NCT04290676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6272567|NCT04290676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6272568|NCT04290676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6272569|NCT04290676|Protease Inhibitors|protease inhibitors|mesh-ancestor
6272570|NCT04290676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6272571|NCT04290676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272572|NCT04290039|Atropine|atropine|mesh-list
6272573|NCT04290039|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6272574|NCT04290039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6272575|NCT04290039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6272576|NCT04290039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6272577|NCT04290039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6272578|NCT04290039|Autonomic Agents|autonomic agents|mesh-ancestor
6272579|NCT04290039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6272580|NCT04290039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272581|NCT04290039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6272582|NCT04290039|Respiratory System Agents|respiratory system agents|mesh-ancestor
6272583|NCT04290039|Mydriatics|mydriatics|mesh-ancestor
6272584|NCT04290039|Parasympatholytics|parasympatholytics|mesh-ancestor
6272585|NCT04290039|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6272586|NCT04290039|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6272587|NCT04290039|Cholinergic Agents|cholinergic agents|mesh-ancestor
6272588|NCT04290039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6272589|NCT04290039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272590|NCT04276207|Insulin Lispro|insulin lispro|mesh-list
6272591|NCT04276207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6272592|NCT04276207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272593|NCT04280705|Remdesivir|remdesivir|mesh-list
6272594|NCT04280705|Antimetabolites|antimetabolites|mesh-ancestor
6272595|NCT04280705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272596|NCT04280705|Antiviral Agents|antiviral agents|mesh-ancestor
6272597|NCT04280705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6390899|NCT00191711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6390900|NCT00191711|Antiviral Agents|antiviral agents|mesh-ancestor
6390901|NCT00191711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6390902|NCT00191711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6390903|NCT00191711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6390904|NCT00191711|Immunologic Factors|immunologic factors|mesh-ancestor
6390905|NCT00191711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390906|NCT00191737|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6390907|NCT00191737|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6390908|NCT00191737|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6390909|NCT00191737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6390910|NCT00191737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390911|NCT00191737|Adrenergic Agents|adrenergic agents|mesh-ancestor
6390912|NCT00191737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6390913|NCT00191737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390914|NCT00191750|Pemetrexed|pemetrexed|mesh-list
6390915|NCT00191750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6390916|NCT00191750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6390917|NCT00191750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390918|NCT00191750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6390919|NCT00191750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6390920|NCT00191763|Gemcitabine|gemcitabine|mesh-list
6390921|NCT00191763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6390922|NCT00191763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6390923|NCT00191763|Antimetabolites|antimetabolites|mesh-ancestor
6390924|NCT00191763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390925|NCT00191763|Antiviral Agents|antiviral agents|mesh-ancestor
6390926|NCT00191763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6390927|NCT00191763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6390928|NCT00191763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6390929|NCT00191763|Immunologic Factors|immunologic factors|mesh-ancestor
6390930|NCT00191763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390931|NCT00191802|Teriparatide|teriparatide|mesh-list
6390932|NCT00191802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6390933|NCT00191802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390934|NCT00191802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6390935|NCT00191828|Olanzapine|olanzapine|mesh-list
6390936|NCT00191828|Antiemetics|antiemetics|mesh-ancestor
6390937|NCT00191828|Autonomic Agents|autonomic agents|mesh-ancestor
6390938|NCT00191828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6390939|NCT00191828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390940|NCT00191828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6390941|NCT00191828|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6390942|NCT00191828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6390943|NCT00191828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6390944|NCT00191828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6390945|NCT00191828|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6390946|NCT00191828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6390947|NCT00191828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6390948|NCT00191828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390949|NCT00191828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6390950|NCT00191828|Serotonin Agents|serotonin agents|mesh-ancestor
6390951|NCT00191841|Gemcitabine|gemcitabine|mesh-list
6390952|NCT00191841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6390953|NCT00191841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6390954|NCT00191841|Antimetabolites|antimetabolites|mesh-ancestor
6390955|NCT00191841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390956|NCT00191841|Antiviral Agents|antiviral agents|mesh-ancestor
6390957|NCT00191841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6390958|NCT00191841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6272598|NCT04284930|Bupivacaine|bupivacaine|mesh-list
6272599|NCT04284930|Anesthetics, Local|anesthetics, local|mesh-ancestor
6272600|NCT04284930|Anesthetics|anesthetics|mesh-ancestor
6272601|NCT04284930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6272602|NCT04284930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272603|NCT04284930|Sensory System Agents|sensory system agents|mesh-ancestor
6272604|NCT04284930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6272605|NCT04283773|Antibodies|antibodies|mesh-list
6272606|NCT04283773|Immunoglobulins|immunoglobulins|mesh-list
6272607|NCT04283773|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6272608|NCT04283773|Immunologic Factors|immunologic factors|mesh-ancestor
6272609|NCT04283773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272610|NCT04277936|Levetiracetam|levetiracetam|mesh-list
6272611|NCT04277936|Anticonvulsants|anticonvulsants|mesh-ancestor
6272612|NCT04277936|Nootropic Agents|nootropic agents|mesh-ancestor
6272613|NCT04275336|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
6272614|NCT04275336|Anesthetics, Local|anesthetics, local|mesh-ancestor
6272615|NCT04275336|Anesthetics|anesthetics|mesh-ancestor
6272616|NCT04275336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6272617|NCT04275336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272618|NCT04275336|Sensory System Agents|sensory system agents|mesh-ancestor
6272619|NCT04275336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6272620|NCT04275336|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
6272621|NCT04272775|Dexamethasone|dexamethasone|mesh-list
6272622|NCT04272775|Lenalidomide|lenalidomide|mesh-list
6272623|NCT04272775|Ixazomib|ixazomib|mesh-list
6272624|NCT04272775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6272625|NCT04272775|Antiemetics|antiemetics|mesh-ancestor
6272626|NCT04272775|Autonomic Agents|autonomic agents|mesh-ancestor
6272627|NCT04272775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6272628|NCT04272775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272629|NCT04272775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6272630|NCT04272775|Glucocorticoids|glucocorticoids|mesh-ancestor
6272631|NCT04272775|Hormones|hormones|mesh-ancestor
6272632|NCT04272775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6272633|NCT04272775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6272634|NCT04272775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6272635|NCT04272775|Immunologic Factors|immunologic factors|mesh-ancestor
6272636|NCT04272775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6272637|NCT04272775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6272638|NCT04272775|Growth Substances|growth substances|mesh-ancestor
6272639|NCT04272775|Growth Inhibitors|growth inhibitors|mesh-ancestor
6272640|NCT04272775|Protease Inhibitors|protease inhibitors|mesh-ancestor
6272641|NCT04272775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6272642|NCT04272775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272643|NCT04267770|Insulin|insulin|mesh-list
6272644|NCT04267770|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6272645|NCT04267770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6272646|NCT04267770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272647|NCT04251884|Ropivacaine|ropivacaine|mesh-list
6272648|NCT04251884|Anesthetics, Local|anesthetics, local|mesh-list
6272649|NCT04251884|Anesthetics|anesthetics|mesh-list
6272650|NCT04251884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6272651|NCT04251884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272652|NCT04251884|Sensory System Agents|sensory system agents|mesh-ancestor
6272653|NCT04251884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6272654|NCT04249336|Listerine|listerine|mesh-list
6272655|NCT04249336|Calcium|calcium|mesh-list
6272656|NCT04249336|Fluorides|fluorides|mesh-list
6272657|NCT04249336|Sodium Fluoride|sodium fluoride|mesh-list
6272658|NCT04249336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6272659|NCT04249336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272660|NCT04249336|Cariostatic Agents|cariostatic agents|mesh-ancestor
6272661|NCT04249336|Protective Agents|protective agents|mesh-ancestor
6272662|NCT04249336|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6272663|NCT04249336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6272664|NCT04249310|Tiotropium Bromide|tiotropium bromide|mesh-list
6272665|NCT04249310|Olodaterol|olodaterol|mesh-list
6272666|NCT04249310|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6272667|NCT04249310|Autonomic Agents|autonomic agents|mesh-ancestor
6272668|NCT04249310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6272669|NCT04249310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272670|NCT04249310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6272671|NCT04249310|Respiratory System Agents|respiratory system agents|mesh-ancestor
6272672|NCT04249310|Parasympatholytics|parasympatholytics|mesh-ancestor
6272673|NCT04249310|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6272674|NCT04249310|Cholinergic Agents|cholinergic agents|mesh-ancestor
6272675|NCT04249310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6272676|NCT04249310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272677|NCT04238650|Bevacizumab|bevacizumab|mesh-list
6272678|NCT04238650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6272679|NCT04238650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6272680|NCT04238650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6272681|NCT04238650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6272682|NCT04238650|Growth Substances|growth substances|mesh-ancestor
6272683|NCT04238650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272684|NCT04238650|Growth Inhibitors|growth inhibitors|mesh-ancestor
6272685|NCT04238663|Bevacizumab|bevacizumab|mesh-list
6272686|NCT04238663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6272687|NCT04238663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6272688|NCT04238663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6272689|NCT04238663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6272690|NCT04238663|Growth Substances|growth substances|mesh-ancestor
6272691|NCT04238663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272692|NCT04238663|Growth Inhibitors|growth inhibitors|mesh-ancestor
6272693|NCT04203225|Lidocaine|lidocaine|mesh-list
6272694|NCT04203225|Epinephrine|epinephrine|mesh-list
6272695|NCT04203225|Tetracaine|tetracaine|mesh-list
6272696|NCT04203225|Anesthetics, Local|anesthetics, local|mesh-ancestor
6272697|NCT04203225|Anesthetics|anesthetics|mesh-ancestor
6272698|NCT04203225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6272699|NCT04203225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272700|NCT04203225|Sensory System Agents|sensory system agents|mesh-ancestor
6272701|NCT04203225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6272702|NCT04203225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6272703|NCT04203225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6272704|NCT04203225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6272705|NCT04203225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6272706|NCT04203225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272707|NCT04203225|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6272708|NCT04203225|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6272709|NCT04203225|Adrenergic Agents|adrenergic agents|mesh-ancestor
6272710|NCT04203225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6272711|NCT04203225|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6272712|NCT04203225|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6272713|NCT04203225|Autonomic Agents|autonomic agents|mesh-ancestor
6272714|NCT04203225|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6272715|NCT04203225|Respiratory System Agents|respiratory system agents|mesh-ancestor
6272716|NCT04203225|Mydriatics|mydriatics|mesh-ancestor
6272717|NCT04203225|Sympathomimetics|sympathomimetics|mesh-ancestor
6272718|NCT04203225|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6272719|NCT04222699|Chlorhexidine|chlorhexidine|mesh-list
6272720|NCT04222699|Mupirocin|mupirocin|mesh-list
6272721|NCT04222699|Calcium|calcium|mesh-list
6272722|NCT04222699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6272723|NCT04222699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272724|NCT04222699|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6272725|NCT04222699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6272726|NCT04222699|Disinfectants|disinfectants|mesh-ancestor
6272727|NCT04222699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6272728|NCT04222699|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6272729|NCT04222699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6272730|NCT04222699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272731|NCT04218799|Chlorhexidine|chlorhexidine|mesh-list
6272732|NCT04218799|Mupirocin|mupirocin|mesh-list
6272733|NCT04218799|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6272734|NCT04218799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6272735|NCT04218799|Disinfectants|disinfectants|mesh-ancestor
6272736|NCT04218799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6272737|NCT04218799|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6272738|NCT04218799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6272739|NCT04218799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272740|NCT04204057|Tenalisib|tenalisib|mesh-list
6272741|NCT04204057|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
6272742|NCT04204057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6272743|NCT04204057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272744|NCT04207840|Epinephrine|epinephrine|mesh-list
6272745|NCT04207840|Racepinephrine|racepinephrine|mesh-list
6272746|NCT04207840|Albuterol|albuterol|mesh-list
6272747|NCT04207840|Epinephryl borate|epinephryl borate|mesh-list
6272748|NCT04207840|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6272749|NCT04207840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6272750|NCT04207840|Adrenergic Agents|adrenergic agents|mesh-ancestor
6272751|NCT04207840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6272752|NCT04207840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272753|NCT04207840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272754|NCT04207840|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6272755|NCT04207840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6272756|NCT04207840|Autonomic Agents|autonomic agents|mesh-ancestor
6272757|NCT04207840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6272758|NCT04207840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6272759|NCT04207840|Respiratory System Agents|respiratory system agents|mesh-ancestor
6272760|NCT04207840|Mydriatics|mydriatics|mesh-ancestor
6272761|NCT04207840|Sympathomimetics|sympathomimetics|mesh-ancestor
6272762|NCT04207840|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6272763|NCT04207840|Tocolytic Agents|tocolytic agents|mesh-ancestor
6272764|NCT04207840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6272765|NCT04207840|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6272766|NCT04198948|Gliclazide|gliclazide|mesh-list
6272767|NCT04198948|Omeprazole|omeprazole|mesh-list
6272768|NCT04198948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6272769|NCT04198948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6272770|NCT04198948|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6272771|NCT04198948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6272772|NCT04198948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272773|NCT04198948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6272774|NCT04198948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272775|NCT04204200|Vitamins|vitamins|mesh-list
6272776|NCT04204200|Ascorbic Acid|ascorbic acid|mesh-list
6272777|NCT04204200|Micronutrients|micronutrients|mesh-ancestor
6272778|NCT04204200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272779|NCT04204200|Antioxidants|antioxidants|mesh-ancestor
6272780|NCT04204200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272781|NCT04204200|Protective Agents|protective agents|mesh-ancestor
6272782|NCT04194151|Propofol|propofol|mesh-list
6272783|NCT04194151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6272784|NCT04194151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6272785|NCT04194151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272786|NCT04194151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6272787|NCT04194151|Anesthetics, General|anesthetics, general|mesh-ancestor
6272788|NCT04194151|Anesthetics|anesthetics|mesh-ancestor
6272789|NCT04186806|Muramidase|muramidase|mesh-list
6272790|NCT04186806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6272791|NCT04184999|Dexamethasone|dexamethasone|mesh-list
6272792|NCT04184999|Prednisolone|prednisolone|mesh-list
6272793|NCT04184999|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6272794|NCT04184999|Methylprednisolone|methylprednisolone|mesh-list
6272795|NCT04184999|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6272796|NCT04184999|Prednisolone acetate|prednisolone acetate|mesh-list
6272797|NCT04184999|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6272798|NCT04184999|Prednisolone phosphate|prednisolone phosphate|mesh-list
6272799|NCT04184999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6272800|NCT04184999|Antiemetics|antiemetics|mesh-ancestor
6272801|NCT04184999|Autonomic Agents|autonomic agents|mesh-ancestor
6272802|NCT04184999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6272803|NCT04184999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272804|NCT04184999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6272805|NCT04184999|Glucocorticoids|glucocorticoids|mesh-ancestor
6272806|NCT04184999|Hormones|hormones|mesh-ancestor
6272807|NCT04184999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6272808|NCT04184999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6272809|NCT04184999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6272810|NCT04184999|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6272811|NCT04184999|Protective Agents|protective agents|mesh-ancestor
6272812|NCT04184271|Fluorides|fluorides|mesh-list
6272813|NCT04184271|Cariostatic Agents|cariostatic agents|mesh-ancestor
6272814|NCT04184271|Protective Agents|protective agents|mesh-ancestor
6272815|NCT04184271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272816|NCT04179461|Vitamin D|vitamin d|mesh-list
6272817|NCT04179461|Cholecalciferol|cholecalciferol|mesh-list
6272818|NCT04179461|Fluticasone|fluticasone|mesh-list
6272819|NCT04179461|Xhance|xhance|mesh-list
6272820|NCT04179461|Mometasone Furoate|mometasone furoate|mesh-list
6272821|NCT04179461|Cetirizine|cetirizine|mesh-list
6272822|NCT04179461|Loratadine|loratadine|mesh-list
6272823|NCT04179461|Azithromycin|azithromycin|mesh-list
6272824|NCT04179461|Budesonide|budesonide|mesh-list
6272825|NCT04179461|Beclomethasone|beclomethasone|mesh-list
6272826|NCT04179461|Emollients|emollients|mesh-list
6272827|NCT04179461|Formoterol Fumarate|formoterol fumarate|mesh-list
6272828|NCT04179461|Tiotropium Bromide|tiotropium bromide|mesh-list
6272829|NCT04179461|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6272830|NCT04179461|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6272831|NCT04179461|Histamine Antagonists|histamine antagonists|mesh-list
6272832|NCT04179461|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
6272833|NCT04179461|Vitamins|vitamins|mesh-ancestor
6272834|NCT04179461|Micronutrients|micronutrients|mesh-ancestor
6272835|NCT04179461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272836|NCT04179461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6272837|NCT04179461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6272838|NCT04179461|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6272839|NCT04179461|Autonomic Agents|autonomic agents|mesh-ancestor
6272840|NCT04179461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6272841|NCT04179461|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6272842|NCT04179461|Respiratory System Agents|respiratory system agents|mesh-ancestor
6272843|NCT04179461|Dermatologic Agents|dermatologic agents|mesh-ancestor
6272844|NCT04179461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6272845|NCT04179461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6272846|NCT04179461|Glucocorticoids|glucocorticoids|mesh-ancestor
6272847|NCT04179461|Hormones|hormones|mesh-ancestor
6272848|NCT04179461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6272849|NCT04179461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6272850|NCT04179461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6272851|NCT04179461|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6272852|NCT04179461|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6272853|NCT04179461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6272854|NCT04179461|Adrenergic Agents|adrenergic agents|mesh-ancestor
6272855|NCT04179461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6272856|NCT04179461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272857|NCT04179461|Parasympatholytics|parasympatholytics|mesh-ancestor
6272858|NCT04179461|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6272859|NCT04179461|Cholinergic Agents|cholinergic agents|mesh-ancestor
6272860|NCT04179461|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6272861|NCT04179461|Histamine Agents|histamine agents|mesh-ancestor
6272862|NCT04179461|Antipruritics|antipruritics|mesh-ancestor
6272863|NCT04179461|Sympathomimetics|sympathomimetics|mesh-ancestor
6272864|NCT04179474|Erenumab|erenumab|mesh-list
6272865|NCT04179474|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
6272866|NCT04179474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272867|NCT04179474|Analgesics|analgesics|mesh-ancestor
6272868|NCT04179474|Sensory System Agents|sensory system agents|mesh-ancestor
6272869|NCT04179474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6272870|NCT04179474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272871|NCT04177862|Fentanyl|fentanyl|mesh-list
6272872|NCT04177862|Sufentanil|sufentanil|mesh-list
6272873|NCT04177862|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6272874|NCT04177862|Narcotics|narcotics|mesh-ancestor
6272875|NCT04177862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6272876|NCT04177862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272877|NCT04177862|Analgesics|analgesics|mesh-ancestor
6272878|NCT04177862|Sensory System Agents|sensory system agents|mesh-ancestor
6272879|NCT04177862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6272880|NCT04177862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6272881|NCT04177862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6272882|NCT04177862|Anesthetics, General|anesthetics, general|mesh-ancestor
6272883|NCT04177862|Anesthetics|anesthetics|mesh-ancestor
6272884|NCT04175262|Sunitinib|sunitinib|mesh-list
6272885|NCT04175262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6272886|NCT04175262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6272887|NCT04175262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6272888|NCT04175262|Growth Substances|growth substances|mesh-ancestor
6272889|NCT04175262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272890|NCT04175262|Growth Inhibitors|growth inhibitors|mesh-ancestor
6272891|NCT04175262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6272892|NCT04175262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6272893|NCT04175262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272894|NCT04173429|Nadroparin|nadroparin|mesh-list
6272895|NCT04173429|Warfarin|warfarin|mesh-list
6272896|NCT04173429|Calcium|calcium|mesh-list
6272897|NCT04173429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6272898|NCT04173429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272899|NCT04173429|Anticoagulants|anticoagulants|mesh-ancestor
6272900|NCT04173429|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6272901|NCT04173429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6272902|NCT04173429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272903|NCT04169061|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6272904|NCT04169061|Hormones|hormones|mesh-ancestor
6272905|NCT04169061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6272906|NCT04169061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272907|NCT04157738|Insulin|insulin|mesh-list
6272908|NCT04157738|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6272909|NCT04157738|Insulin, Short-Acting|insulin, short-acting|mesh-list
6272910|NCT04157738|Insulin, Long-Acting|insulin, long-acting|mesh-list
6272911|NCT04157738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6272912|NCT04157738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272913|NCT04156646|Esomeprazole|esomeprazole|mesh-list
6272914|NCT04156646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6272915|NCT04156646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6272916|NCT04156646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6272917|NCT04156646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6272918|NCT04156646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272919|NCT04169113|Opiate Alkaloids|opiate alkaloids|mesh-list
6272920|NCT04169113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6272921|NCT04169113|Narcotics|narcotics|mesh-ancestor
6272922|NCT04169113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6272923|NCT04169113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272924|NCT04169113|Analgesics|analgesics|mesh-ancestor
6272925|NCT04169113|Sensory System Agents|sensory system agents|mesh-ancestor
6272926|NCT04169113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6272927|NCT04160975|Vaccines|vaccines|mesh-list
6272928|NCT04160975|Immunologic Factors|immunologic factors|mesh-ancestor
6272929|NCT04160975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390959|NCT00191841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6390960|NCT00191841|Immunologic Factors|immunologic factors|mesh-ancestor
6390961|NCT00191841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390962|NCT00191867|Teriparatide|teriparatide|mesh-list
6390963|NCT00191867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6390964|NCT00191867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390965|NCT00191867|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6390966|NCT00191880|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6390967|NCT00191880|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6390968|NCT00191880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6390969|NCT00191880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6390970|NCT00191880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390971|NCT00191880|Adrenergic Agents|adrenergic agents|mesh-ancestor
6390972|NCT00191880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6390973|NCT00191880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390974|NCT00191893|Teriparatide|teriparatide|mesh-list
6390975|NCT00191893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6390976|NCT00191893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390977|NCT00191893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6390978|NCT00191919|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6390979|NCT00191919|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6390980|NCT00191919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6390981|NCT00191919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6390982|NCT00191919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390983|NCT00191919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6390984|NCT00191919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390985|NCT00191919|Analgesics|analgesics|mesh-ancestor
6390986|NCT00191919|Sensory System Agents|sensory system agents|mesh-ancestor
6390987|NCT00191919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6390988|NCT00191919|Antidepressive Agents|antidepressive agents|mesh-ancestor
6390989|NCT00191919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6390990|NCT00191919|Dopamine Agents|dopamine agents|mesh-ancestor
6390991|NCT00191932|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6390992|NCT00191932|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6390993|NCT00191932|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6390994|NCT00191932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6390995|NCT00191932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6390996|NCT00191932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6390997|NCT00191932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6390998|NCT00191932|Analgesics|analgesics|mesh-ancestor
6272930|NCT04167189|Lidocaine|lidocaine|mesh-list
6272931|NCT04167189|Anesthetics, Local|anesthetics, local|mesh-ancestor
6272932|NCT04167189|Anesthetics|anesthetics|mesh-ancestor
6272933|NCT04167189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6272934|NCT04167189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272935|NCT04167189|Sensory System Agents|sensory system agents|mesh-ancestor
6272936|NCT04167189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6272937|NCT04167189|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6272938|NCT04167189|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6272939|NCT04167189|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6272940|NCT04167189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6272941|NCT04167189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272942|NCT04162795|Loratadine|loratadine|mesh-list
6272943|NCT04162795|Antipruritics|antipruritics|mesh-ancestor
6272944|NCT04162795|Dermatologic Agents|dermatologic agents|mesh-ancestor
6272945|NCT04162795|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6272946|NCT04162795|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6272947|NCT04162795|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6272948|NCT04162795|Histamine Antagonists|histamine antagonists|mesh-ancestor
6272949|NCT04162795|Histamine Agents|histamine agents|mesh-ancestor
6272950|NCT04162795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6272951|NCT04162795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272952|NCT04162795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272953|NCT04161144|Sirolimus|sirolimus|mesh-list
6272954|NCT04161144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6272955|NCT04161144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6272956|NCT04161144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6272957|NCT04161144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6272958|NCT04161144|Antifungal Agents|antifungal agents|mesh-ancestor
6272959|NCT04161144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6272960|NCT04161144|Immunologic Factors|immunologic factors|mesh-ancestor
6272961|NCT04161144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272962|NCT04150861|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6272963|NCT04150861|Hormones|hormones|mesh-ancestor
6272964|NCT04150861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6272965|NCT04150861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272966|NCT04150250|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6272967|NCT04150250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6272968|NCT04150224|Macozinone|macozinone|mesh-list
6272969|NCT04150224|Antitubercular Agents|antitubercular agents|mesh-ancestor
6272970|NCT04150224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6272971|NCT04150224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6272972|NCT04149405|Diphosphonates|diphosphonates|mesh-list
6272973|NCT04149405|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6272974|NCT04149405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272975|NCT04141930|Baloxavir|baloxavir|mesh-list
6272976|NCT04141930|Antiviral Agents|antiviral agents|mesh-ancestor
6272977|NCT04141930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6272978|NCT04141930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6272979|NCT04141930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272980|NCT04142242|Vaccines|vaccines|mesh-list
6272981|NCT04142242|Immunologic Factors|immunologic factors|mesh-ancestor
6272982|NCT04142242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272983|NCT04139018|Timolol|timolol|mesh-list
6272984|NCT04139018|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6272985|NCT04139018|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6272986|NCT04139018|Adrenergic Agents|adrenergic agents|mesh-ancestor
6272987|NCT04139018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6272988|NCT04139018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6272989|NCT04139018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272990|NCT04139018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6272991|NCT04139018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6272992|NCT04131556|Maribavir|maribavir|mesh-list
6272993|NCT04131556|Antiviral Agents|antiviral agents|mesh-ancestor
6272994|NCT04131556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6272995|NCT04138498|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
6272996|NCT04138498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6272997|NCT04138498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6272998|NCT04138498|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6272999|NCT04138498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6273000|NCT04138498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6273001|NCT04138498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273002|NCT04138498|Dopamine Agents|dopamine agents|mesh-ancestor
6273003|NCT04138498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6273004|NCT04137627|Melatonin|melatonin|mesh-list
6273005|NCT04137627|Antioxidants|antioxidants|mesh-ancestor
6273006|NCT04137627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273007|NCT04137627|Protective Agents|protective agents|mesh-ancestor
6273008|NCT04137627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273009|NCT04137627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6273010|NCT04136145|Belimumab|belimumab|mesh-list
6273011|NCT04136145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6273012|NCT04136145|Immunologic Factors|immunologic factors|mesh-ancestor
6273013|NCT04136145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273014|NCT04132336|Naproxen|naproxen|mesh-list
6273015|NCT04132336|Caffeine|caffeine|mesh-list
6273016|NCT04132336|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6273017|NCT04132336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273018|NCT04132336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6273019|NCT04132336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6273020|NCT04132336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273021|NCT04132336|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6273022|NCT04132336|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6273023|NCT04132336|Purinergic Agents|purinergic agents|mesh-ancestor
6273024|NCT04132336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6273025|NCT04132336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6273026|NCT04132336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6273027|NCT04132336|Analgesics|analgesics|mesh-ancestor
6273028|NCT04132336|Sensory System Agents|sensory system agents|mesh-ancestor
6273029|NCT04132336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6273030|NCT04132336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6273031|NCT04132336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6273032|NCT04132336|Gout Suppressants|gout suppressants|mesh-ancestor
6273033|NCT04132336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6273034|NCT04131517|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
6273035|NCT04131517|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
6273036|NCT04131517|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6273037|NCT04131517|Contraceptive Agents|contraceptive agents|mesh-ancestor
6273038|NCT04131517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6273039|NCT04131517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273040|NCT04131517|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6273041|NCT04131517|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6273042|NCT04131517|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6273043|NCT04131517|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6273044|NCT04131517|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6273045|NCT04131517|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
6273046|NCT04131517|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6273047|NCT04131517|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6273048|NCT04126343|Moxifloxacin|moxifloxacin|mesh-list
6273049|NCT04126343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6273050|NCT04126343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6273051|NCT04126343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6273052|NCT04126343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6273053|NCT04126343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6273054|NCT04126343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273055|NCT04126343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6273056|NCT04123665|Fluorides|fluorides|mesh-list
6273057|NCT04123665|Tin Fluorides|tin fluorides|mesh-list
6273058|NCT04123665|Fluorophosphate|fluorophosphate|mesh-list
6273059|NCT04123665|Cariostatic Agents|cariostatic agents|mesh-ancestor
6273060|NCT04123665|Protective Agents|protective agents|mesh-ancestor
6273061|NCT04123665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273062|NCT04121078|Rifampin|rifampin|mesh-list
6273063|NCT04121078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6273064|NCT04121078|Antitubercular Agents|antitubercular agents|mesh-ancestor
6273065|NCT04121078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6273066|NCT04121078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6273067|NCT04121078|Leprostatic Agents|leprostatic agents|mesh-ancestor
6273068|NCT04121078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6273069|NCT04121078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6273070|NCT04121078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273071|NCT04121078|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6273072|NCT04121078|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6273073|NCT04121078|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6273074|NCT04121078|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6273075|NCT04121078|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6273076|NCT04121078|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6273077|NCT04117607|Rezafungin|rezafungin|mesh-list
6273078|NCT04117607|Antifungal Agents|antifungal agents|mesh-ancestor
6273079|NCT04117607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6273080|NCT04115358|Hyaluronic Acid|hyaluronic acid|mesh-list
6273081|NCT04115358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6273082|NCT04115358|Immunologic Factors|immunologic factors|mesh-ancestor
6273083|NCT04115358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273084|NCT04115358|Viscosupplements|viscosupplements|mesh-ancestor
6273085|NCT04115358|Protective Agents|protective agents|mesh-ancestor
6273086|NCT04114058|Bupivacaine|bupivacaine|mesh-list
6273087|NCT04114058|Anesthetics, Local|anesthetics, local|mesh-ancestor
6273088|NCT04114058|Anesthetics|anesthetics|mesh-ancestor
6273089|NCT04114058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6273090|NCT04114058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273091|NCT04114058|Sensory System Agents|sensory system agents|mesh-ancestor
6273092|NCT04114058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6273093|NCT04112160|Ketorolac|ketorolac|mesh-list
6273094|NCT04112160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6273095|NCT04112160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6273096|NCT04112160|Analgesics|analgesics|mesh-ancestor
6273097|NCT04112160|Sensory System Agents|sensory system agents|mesh-ancestor
6273098|NCT04112160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6273099|NCT04112160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273100|NCT04112160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6273101|NCT04112160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6273102|NCT04112160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6273103|NCT04112160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6273104|NCT04112160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273105|NCT04112069|Insulin Lispro|insulin lispro|mesh-list
6273106|NCT04112069|Insulin Aspart|insulin aspart|mesh-list
6273107|NCT04112069|Pancrelipase|pancrelipase|mesh-list
6273108|NCT04112069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6273109|NCT04112069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273110|NCT04112069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6273111|NCT04109222|Vaccines|vaccines|mesh-list
6273112|NCT04109222|Immunologic Factors|immunologic factors|mesh-ancestor
6273113|NCT04109222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273114|NCT04105972|Ivacaftor|ivacaftor|mesh-list
6273115|NCT04105972|Elexacaftor|elexacaftor|mesh-list
6273116|NCT04105972|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6273117|NCT04105972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6273118|NCT04105972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273119|NCT04102956|Kallikreins|kallikreins|mesh-list
6273120|NCT04102956|Coagulants|coagulants|mesh-ancestor
6273121|NCT04102956|Fertility Agents, Male|fertility agents, male|mesh-ancestor
6273122|NCT04102956|Fertility Agents|fertility agents|mesh-ancestor
6273123|NCT04102956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6273124|NCT04102956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273125|NCT04102345|Zolpidem|zolpidem|mesh-list
6273126|NCT04102345|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6273127|NCT04102345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6273128|NCT04102345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6273129|NCT04102345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273130|NCT04102345|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6273131|NCT04102345|GABA Agonists|gaba agonists|mesh-ancestor
6273132|NCT04102345|GABA Agents|gaba agents|mesh-ancestor
6273133|NCT04102345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6273134|NCT04102345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273135|NCT04092907|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6273136|NCT04092907|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6273137|NCT04089982|Varenicline|varenicline|mesh-list
6273138|NCT04089982|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6273139|NCT04089982|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6273140|NCT04089982|Cholinergic Agents|cholinergic agents|mesh-ancestor
6273141|NCT04089982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6273142|NCT04089982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273143|NCT04089982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273144|NCT04099277|Pembrolizumab|pembrolizumab|mesh-list
6273145|NCT04099277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6273146|NCT04099277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6273147|NCT04098575|Empagliflozin|empagliflozin|mesh-list
6273148|NCT04098575|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6273149|NCT04098575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273150|NCT04098575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6273151|NCT04098575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273152|NCT04094883|Vaccines|vaccines|mesh-list
6273153|NCT04094883|Immunologic Factors|immunologic factors|mesh-ancestor
6273154|NCT04094883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273155|NCT04084769|Vaccines|vaccines|mesh-list
6273156|NCT04084769|Immunologic Factors|immunologic factors|mesh-ancestor
6273157|NCT04084769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273158|NCT04080882|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6273159|NCT04080882|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6273160|NCT04080882|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6273161|NCT04080882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6273162|NCT04080882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273163|NCT04080882|Cholinergic Agents|cholinergic agents|mesh-ancestor
6273164|NCT04080882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6273165|NCT04080882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273166|NCT04080882|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6273167|NCT04080882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6390999|NCT00191932|Sensory System Agents|sensory system agents|mesh-ancestor
6391000|NCT00191932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6391001|NCT00191932|Antidepressive Agents|antidepressive agents|mesh-ancestor
6391002|NCT00191932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6391003|NCT00191932|Dopamine Agents|dopamine agents|mesh-ancestor
6391004|NCT00191971|Gemcitabine|gemcitabine|mesh-list
6391005|NCT00191971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6391006|NCT00191971|Antimetabolites|antimetabolites|mesh-ancestor
6391007|NCT00191971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391008|NCT00191971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391009|NCT00191971|Antiviral Agents|antiviral agents|mesh-ancestor
6391010|NCT00191971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6391011|NCT00191971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6391012|NCT00191971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6391013|NCT00191971|Immunologic Factors|immunologic factors|mesh-ancestor
6391014|NCT00191971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6391015|NCT00191997|Olanzapine|olanzapine|mesh-list
6391016|NCT00191997|Antiemetics|antiemetics|mesh-ancestor
6391017|NCT00191997|Autonomic Agents|autonomic agents|mesh-ancestor
6391018|NCT00191997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6391019|NCT00191997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6391020|NCT00191997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6391021|NCT00191997|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6273168|NCT04081610|Hyaluronic Acid|hyaluronic acid|mesh-list
6273169|NCT04081610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6273170|NCT04081610|Immunologic Factors|immunologic factors|mesh-ancestor
6273171|NCT04081610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273172|NCT04081610|Viscosupplements|viscosupplements|mesh-ancestor
6273173|NCT04081610|Protective Agents|protective agents|mesh-ancestor
6273174|NCT04081324|Lasmiditan|lasmiditan|mesh-list
6273175|NCT04081324|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6273176|NCT04081324|Serotonin Agents|serotonin agents|mesh-ancestor
6273177|NCT04081324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6273178|NCT04081324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273179|NCT04081324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015000|NCT00354432|Caseins|caseins|mesh-list
6015001|NCT00354432|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6015002|NCT00354432|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6015003|NCT00354432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6015004|NCT00354432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015005|NCT00354432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6015006|NCT00354432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015007|NCT00354432|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6015008|NCT00354432|Antidepressive Agents|antidepressive agents|mesh-ancestor
6015009|NCT00354432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6015010|NCT00354432|Chelating Agents|chelating agents|mesh-ancestor
6015011|NCT00354432|Sequestering Agents|sequestering agents|mesh-ancestor
6015012|NCT00354601|Docetaxel|docetaxel|mesh-list
6015013|NCT00354601|Capecitabine|capecitabine|mesh-list
6015014|NCT00354601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6015015|NCT00354601|Tubulin Modulators|tubulin modulators|mesh-ancestor
6015016|NCT00354601|Antimitotic Agents|antimitotic agents|mesh-ancestor
6015017|NCT00354601|Mitosis Modulators|mitosis modulators|mesh-ancestor
6015018|NCT00354601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015019|NCT00354601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6015020|NCT00354601|Antimetabolites|antimetabolites|mesh-ancestor
6015021|NCT00354640|Anastrozole|anastrozole|mesh-list
6015022|NCT00354640|Simvastatin|simvastatin|mesh-list
6015023|NCT00354640|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6015024|NCT00354640|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6015025|NCT00354640|Antimetabolites|antimetabolites|mesh-ancestor
6015026|NCT00354640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015027|NCT00354640|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6015028|NCT00354640|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6015029|NCT00354640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6015030|NCT00354640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6015031|NCT00354640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6015032|NCT00354640|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6015033|NCT00354640|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6273180|NCT04076787|Sunitinib|sunitinib|mesh-list
6273181|NCT04076787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6273182|NCT04076787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6273183|NCT04076787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6273184|NCT04076787|Growth Substances|growth substances|mesh-ancestor
6273185|NCT04076787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273186|NCT04076787|Growth Inhibitors|growth inhibitors|mesh-ancestor
6273187|NCT04076787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6273188|NCT04076787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6273189|NCT04076787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273190|NCT04042324|Heparin|heparin|mesh-list
6273191|NCT04042324|Calcium heparin|calcium heparin|mesh-list
6273192|NCT04042324|Anticoagulants|anticoagulants|mesh-ancestor
6273193|NCT04042324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273194|NCT04042324|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6273195|NCT04042324|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6273196|NCT04070287|Antibodies|antibodies|mesh-list
6273197|NCT04070287|Immunoglobulins|immunoglobulins|mesh-list
6273198|NCT04070287|Immunologic Factors|immunologic factors|mesh-ancestor
6273199|NCT04070287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273200|NCT04050722|Listerine|listerine|mesh-list
6273201|NCT04050722|Sodium Fluoride|sodium fluoride|mesh-list
6273202|NCT04050722|Cariostatic Agents|cariostatic agents|mesh-ancestor
6273203|NCT04050722|Protective Agents|protective agents|mesh-ancestor
6273204|NCT04050722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273205|NCT04050722|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6273206|NCT04050722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6273207|NCT04069221|Cobicistat|cobicistat|mesh-list
6273208|NCT04069221|Artefenomel|artefenomel|mesh-list
6273209|NCT04069221|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6273210|NCT04069221|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6273211|NCT04069221|Antiviral Agents|antiviral agents|mesh-ancestor
6273212|NCT04069221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6273213|NCT04069221|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6273214|NCT04069221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6273215|NCT04069221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6273216|NCT04069221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273217|NCT04069221|Antimalarials|antimalarials|mesh-ancestor
6273218|NCT04069221|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6273219|NCT04069221|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6273220|NCT04066647|Dexamethasone|dexamethasone|mesh-list
6273221|NCT04066647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6273222|NCT04066647|Antiemetics|antiemetics|mesh-ancestor
6273223|NCT04066647|Autonomic Agents|autonomic agents|mesh-ancestor
6273224|NCT04066647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6273225|NCT04066647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273226|NCT04066647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6273227|NCT04066647|Glucocorticoids|glucocorticoids|mesh-ancestor
6273228|NCT04066647|Hormones|hormones|mesh-ancestor
6273229|NCT04066647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6273230|NCT04066647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6273231|NCT04066647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6273232|NCT04066426|Acetaminophen|acetaminophen|mesh-list
6273233|NCT04066426|Dexamethasone|dexamethasone|mesh-list
6273234|NCT04066426|Naproxen|naproxen|mesh-list
6273235|NCT04066426|Codeine|codeine|mesh-list
6273236|NCT04066426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6273237|NCT04066426|Antiemetics|antiemetics|mesh-ancestor
6273238|NCT04066426|Autonomic Agents|autonomic agents|mesh-ancestor
6273239|NCT04066426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6273240|NCT04066426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273241|NCT04066426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6273242|NCT04066426|Glucocorticoids|glucocorticoids|mesh-ancestor
6273243|NCT04066426|Hormones|hormones|mesh-ancestor
6273244|NCT04066426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6273245|NCT04066426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6273246|NCT04066426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6273247|NCT04066426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6273248|NCT04066426|Analgesics|analgesics|mesh-ancestor
6273249|NCT04066426|Sensory System Agents|sensory system agents|mesh-ancestor
6273250|NCT04066426|Antipyretics|antipyretics|mesh-ancestor
6273251|NCT04066426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6273252|NCT04066426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6273253|NCT04066426|Gout Suppressants|gout suppressants|mesh-ancestor
6273254|NCT04066426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6273255|NCT04066426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6273256|NCT04066426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273257|NCT04066426|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6273258|NCT04066426|Narcotics|narcotics|mesh-ancestor
6273259|NCT04066426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6273260|NCT04066426|Antitussive Agents|antitussive agents|mesh-ancestor
6273261|NCT04066426|Respiratory System Agents|respiratory system agents|mesh-ancestor
6273262|NCT04060654|Buprenorphine|buprenorphine|mesh-list
6273263|NCT04060654|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6273264|NCT04060654|Narcotics|narcotics|mesh-ancestor
6015034|NCT00354640|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6015035|NCT00354640|Hormone Antagonists|hormone antagonists|mesh-ancestor
6015036|NCT00354640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6015037|NCT00354640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015038|NCT00354679|Bevacizumab|bevacizumab|mesh-list
6015039|NCT00354679|Irinotecan|irinotecan|mesh-list
6015040|NCT00354679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6015041|NCT00354679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6015042|NCT00354679|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6015043|NCT00354679|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6015044|NCT00354679|Growth Substances|growth substances|mesh-ancestor
6015045|NCT00354679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015046|NCT00354679|Growth Inhibitors|growth inhibitors|mesh-ancestor
6015047|NCT00354679|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6015048|NCT00354679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6015049|NCT00354679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6273265|NCT04060654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6273266|NCT04060654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273267|NCT04060654|Analgesics|analgesics|mesh-ancestor
6273268|NCT04060654|Sensory System Agents|sensory system agents|mesh-ancestor
6273269|NCT04060654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6273270|NCT04060654|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6273271|NCT04058353|Ivacaftor|ivacaftor|mesh-list
6273272|NCT04058353|Elexacaftor|elexacaftor|mesh-list
6273273|NCT04058353|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6273274|NCT04058353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6273275|NCT04058353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273276|NCT04054011|Deoxycholic Acid|deoxycholic acid|mesh-list
6273277|NCT04054011|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6273278|NCT04054011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6273279|NCT04051684|Ropivacaine|ropivacaine|mesh-list
6273280|NCT04051684|Anesthetics, Local|anesthetics, local|mesh-ancestor
6273281|NCT04051684|Anesthetics|anesthetics|mesh-ancestor
6273282|NCT04051684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6273283|NCT04051684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273284|NCT04051684|Sensory System Agents|sensory system agents|mesh-ancestor
6273285|NCT04051684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6273286|NCT04045964|Nicotine|nicotine|mesh-list
6273287|NCT04045964|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6273288|NCT04045964|Autonomic Agents|autonomic agents|mesh-ancestor
6273289|NCT04045964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6273290|NCT04045964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273291|NCT04045964|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6273292|NCT04045964|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6273293|NCT04045964|Cholinergic Agents|cholinergic agents|mesh-ancestor
6273294|NCT04045964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6273295|NCT04045964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273296|NCT04054193|Dexamethasone|dexamethasone|mesh-list
6273297|NCT04054193|Fosaprepitant|fosaprepitant|mesh-list
6273298|NCT04054193|Aprepitant|aprepitant|mesh-list
6273299|NCT04054193|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
6273300|NCT04054193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6273301|NCT04054193|Antiemetics|antiemetics|mesh-ancestor
6273302|NCT04054193|Autonomic Agents|autonomic agents|mesh-ancestor
6273303|NCT04054193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6273304|NCT04054193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273305|NCT04054193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6273306|NCT04054193|Glucocorticoids|glucocorticoids|mesh-ancestor
6273307|NCT04054193|Hormones|hormones|mesh-ancestor
6273308|NCT04054193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6273309|NCT04054193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6273310|NCT04054193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6273311|NCT04054193|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6273312|NCT04054193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6273313|NCT04054193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273314|NCT04054193|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6273315|NCT04054193|Serotonin Agents|serotonin agents|mesh-ancestor
6273316|NCT04053270|Afamelanotide|afamelanotide|mesh-list
6273317|NCT04053270|Dermatologic Agents|dermatologic agents|mesh-ancestor
6273318|NCT04049552|Sirolimus|sirolimus|mesh-list
6273319|NCT04049552|Petrolatum|petrolatum|mesh-list
6273320|NCT04049552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6273321|NCT04049552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6273322|NCT04049552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6273323|NCT04049552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6273324|NCT04049552|Antifungal Agents|antifungal agents|mesh-ancestor
6273325|NCT04049552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6273326|NCT04049552|Immunologic Factors|immunologic factors|mesh-ancestor
6273327|NCT04049552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273328|NCT04049552|Emollients|emollients|mesh-ancestor
6273329|NCT04049552|Dermatologic Agents|dermatologic agents|mesh-ancestor
6273330|NCT04050865|Dexamethasone|dexamethasone|mesh-list
6273331|NCT04050865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6273332|NCT04050865|Antiemetics|antiemetics|mesh-ancestor
6273333|NCT04050865|Autonomic Agents|autonomic agents|mesh-ancestor
6273334|NCT04050865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6273335|NCT04050865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273336|NCT04050865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6273337|NCT04050865|Glucocorticoids|glucocorticoids|mesh-ancestor
6273338|NCT04050865|Hormones|hormones|mesh-ancestor
6273339|NCT04050865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6273340|NCT04050865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6273341|NCT04050865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6273342|NCT04050371|Tenofovir|tenofovir|mesh-list
6273343|NCT04050371|Emtricitabine|emtricitabine|mesh-list
6273344|NCT04050371|Antiviral Agents|antiviral agents|mesh-ancestor
6273345|NCT04050371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6273346|NCT04050371|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6273347|NCT04050371|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6273348|NCT04050371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6273349|NCT04050371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273350|NCT04050371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6273351|NCT04050371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6273352|NCT04048681|Cocaine|cocaine|mesh-list
6273353|NCT04048681|Anesthetics, Local|anesthetics, local|mesh-ancestor
6273354|NCT04048681|Anesthetics|anesthetics|mesh-ancestor
6273355|NCT04048681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6273356|NCT04048681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273357|NCT04048681|Sensory System Agents|sensory system agents|mesh-ancestor
6273358|NCT04048681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6273359|NCT04048681|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6273360|NCT04048681|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6273361|NCT04048681|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6273362|NCT04048681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6273363|NCT04048681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273364|NCT04048681|Dopamine Agents|dopamine agents|mesh-ancestor
6273365|NCT04048681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6273366|NCT04041453|Ivermectin|ivermectin|mesh-list
6273367|NCT04041453|Albendazole|albendazole|mesh-list
6273368|NCT04041453|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6273369|NCT04041453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6273370|NCT04041453|Anthelmintics|anthelmintics|mesh-ancestor
6273371|NCT04041453|Anticestodal Agents|anticestodal agents|mesh-ancestor
6273372|NCT04041453|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6273373|NCT04041453|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6273374|NCT04041453|Tubulin Modulators|tubulin modulators|mesh-ancestor
6273375|NCT04041453|Antimitotic Agents|antimitotic agents|mesh-ancestor
6273376|NCT04041453|Mitosis Modulators|mitosis modulators|mesh-ancestor
6273377|NCT04041453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273378|NCT04041453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6273379|NCT04041219|Tacrolimus|tacrolimus|mesh-list
6273380|NCT04041219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6273381|NCT04041219|Immunologic Factors|immunologic factors|mesh-ancestor
6273382|NCT04041219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273383|NCT04041219|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6273384|NCT04041219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6273385|NCT04041219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273386|NCT04039867|Gemcitabine|gemcitabine|mesh-list
6273387|NCT04039867|Oxaliplatin|oxaliplatin|mesh-list
6273388|NCT04039867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6273389|NCT04039867|Antimetabolites|antimetabolites|mesh-ancestor
6273390|NCT04039867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273391|NCT04039867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6273392|NCT04039867|Antiviral Agents|antiviral agents|mesh-ancestor
6273393|NCT04039867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6273394|NCT04039867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6273395|NCT04039867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6273396|NCT04039867|Immunologic Factors|immunologic factors|mesh-ancestor
6273397|NCT04039867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273398|NCT04039412|Levofloxacin|levofloxacin|mesh-list
6273399|NCT04039412|Ofloxacin|ofloxacin|mesh-list
6273400|NCT04039412|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6273401|NCT04039412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6273402|NCT04039412|Renal Agents|renal agents|mesh-ancestor
6273403|NCT04039412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6273404|NCT04039412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6273405|NCT04039412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6273406|NCT04039412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6273407|NCT04039412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273408|NCT04039412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6273409|NCT04039412|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6273410|NCT04039412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6273411|NCT04024228|Vaccines|vaccines|mesh-list
6273412|NCT04024228|Hemagglutinins|hemagglutinins|mesh-list
6273413|NCT04024228|Immunologic Factors|immunologic factors|mesh-ancestor
6273414|NCT04024228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273415|NCT04024228|Agglutinins|agglutinins|mesh-ancestor
6273416|NCT04036110|Vitamins|vitamins|mesh-list
6273417|NCT04036110|Ascorbic Acid|ascorbic acid|mesh-list
6273418|NCT04036110|Micronutrients|micronutrients|mesh-ancestor
6273419|NCT04036110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273420|NCT04036110|Antioxidants|antioxidants|mesh-ancestor
6273421|NCT04036110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273422|NCT04036110|Protective Agents|protective agents|mesh-ancestor
6273423|NCT04024501|Verinurad|verinurad|mesh-list
6273424|NCT04024501|Gout Suppressants|gout suppressants|mesh-ancestor
6273425|NCT04024501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6273426|NCT04032171|Interferon beta-1a|interferon beta-1a|mesh-list
6273427|NCT04032171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6273428|NCT04032171|Immunologic Factors|immunologic factors|mesh-ancestor
6273429|NCT04032171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273430|NCT04032171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6273431|NCT04032171|Antiviral Agents|antiviral agents|mesh-ancestor
6273432|NCT04032171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6273433|NCT04032158|Interferon beta-1a|interferon beta-1a|mesh-list
6015050|NCT00354679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015051|NCT00354744|Dactinomycin|dactinomycin|mesh-list
6015052|NCT00354744|Cyclophosphamide|cyclophosphamide|mesh-list
6015053|NCT00354744|Ifosfamide|ifosfamide|mesh-list
6015054|NCT00354744|Isophosphamide mustard|isophosphamide mustard|mesh-list
6015055|NCT00354744|Doxorubicin|doxorubicin|mesh-list
6015056|NCT00354744|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6015057|NCT00354744|Irinotecan|irinotecan|mesh-list
6015058|NCT00354744|Etoposide|etoposide|mesh-list
6015059|NCT00354744|Vincristine|vincristine|mesh-list
6015060|NCT00354744|Camptothecin|camptothecin|mesh-list
6015061|NCT00354744|Lenograstim|lenograstim|mesh-list
6015062|NCT00354744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6015063|NCT00354744|Immunologic Factors|immunologic factors|mesh-ancestor
6273434|NCT04032158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6273435|NCT04032158|Immunologic Factors|immunologic factors|mesh-ancestor
6273436|NCT04032158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273437|NCT04032158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6273438|NCT04032158|Antiviral Agents|antiviral agents|mesh-ancestor
6273439|NCT04032158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6273440|NCT04031885|Paclitaxel|paclitaxel|mesh-list
6273441|NCT04031885|Docetaxel|docetaxel|mesh-list
6273442|NCT04031885|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6273443|NCT04031885|Capecitabine|capecitabine|mesh-list
6273444|NCT04031885|Fulvestrant|fulvestrant|mesh-list
6273445|NCT04031885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6273446|NCT04031885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6273447|NCT04031885|Tubulin Modulators|tubulin modulators|mesh-ancestor
6015064|NCT00354744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015065|NCT00354744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6273448|NCT04031885|Antimitotic Agents|antimitotic agents|mesh-ancestor
6273449|NCT04031885|Mitosis Modulators|mitosis modulators|mesh-ancestor
6273450|NCT04031885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273451|NCT04031885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6273452|NCT04031885|Antimetabolites|antimetabolites|mesh-ancestor
6273453|NCT04031885|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6273454|NCT04031885|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6273455|NCT04031885|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6273456|NCT04031885|Hormone Antagonists|hormone antagonists|mesh-ancestor
6273457|NCT04031885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6273458|NCT04031885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273459|NCT04029584|Rifampin|rifampin|mesh-list
6273460|NCT04029584|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6273461|NCT04029584|Antitubercular Agents|antitubercular agents|mesh-ancestor
6273462|NCT04029584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6273463|NCT04029584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6273464|NCT04029584|Leprostatic Agents|leprostatic agents|mesh-ancestor
6273465|NCT04029584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6273466|NCT04029584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6273467|NCT04029584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273468|NCT04029584|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6273469|NCT04029584|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6273470|NCT04029584|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6273471|NCT04029584|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6273472|NCT04029584|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6273473|NCT04029584|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6391022|NCT00191997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6391023|NCT00191997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6391024|NCT00191997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6391025|NCT00191997|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6391026|NCT00191997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6391027|NCT00191997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6391028|NCT00191997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391029|NCT00191997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6391030|NCT00191997|Serotonin Agents|serotonin agents|mesh-ancestor
6391031|NCT00192049|Gemcitabine|gemcitabine|mesh-list
6391032|NCT00192049|Mitomycins|mitomycins|mesh-list
6391033|NCT00192049|Mitomycin|mitomycin|mesh-list
6391034|NCT00192049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6391035|NCT00192049|Antimetabolites|antimetabolites|mesh-ancestor
6391036|NCT00192049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391037|NCT00192049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391038|NCT00192049|Antiviral Agents|antiviral agents|mesh-ancestor
6391039|NCT00192049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6391040|NCT00192049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6391041|NCT00192049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6391042|NCT00192049|Immunologic Factors|immunologic factors|mesh-ancestor
6391043|NCT00192049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6391044|NCT00192049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6391045|NCT00192049|Alkylating Agents|alkylating agents|mesh-ancestor
6391046|NCT00192049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6391047|NCT00192062|Gemcitabine|gemcitabine|mesh-list
6391048|NCT00192062|Vinorelbine|vinorelbine|mesh-list
6391049|NCT00192062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6391050|NCT00192062|Antimetabolites|antimetabolites|mesh-ancestor
6391051|NCT00192062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391052|NCT00192062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391053|NCT00192062|Antiviral Agents|antiviral agents|mesh-ancestor
6391054|NCT00192062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6391055|NCT00192062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6391056|NCT00192062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6391057|NCT00192062|Immunologic Factors|immunologic factors|mesh-ancestor
6391058|NCT00192062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6391059|NCT00192062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6391060|NCT00192062|Tubulin Modulators|tubulin modulators|mesh-ancestor
6391061|NCT00192062|Antimitotic Agents|antimitotic agents|mesh-ancestor
6391062|NCT00192062|Mitosis Modulators|mitosis modulators|mesh-ancestor
6391063|NCT00192088|Oxaliplatin|oxaliplatin|mesh-list
6391064|NCT00192088|Pemetrexed|pemetrexed|mesh-list
6391065|NCT00192088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391066|NCT00192088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6391067|NCT00192088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391068|NCT00192088|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6391069|NCT00192088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6391070|NCT00192101|Gemcitabine|gemcitabine|mesh-list
6391071|NCT00192101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6273474|NCT04028960|Insulin|insulin|mesh-list
6273475|NCT04028960|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6273476|NCT04028960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6273477|NCT04028960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273478|NCT04023695|Lidocaine|lidocaine|mesh-list
6273479|NCT04023695|Epinephrine|epinephrine|mesh-list
6273480|NCT04023695|Anesthetics, Local|anesthetics, local|mesh-ancestor
6273481|NCT04023695|Anesthetics|anesthetics|mesh-ancestor
6273482|NCT04023695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6273483|NCT04023695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273484|NCT04023695|Sensory System Agents|sensory system agents|mesh-ancestor
6273485|NCT04023695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6273486|NCT04023695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6273487|NCT04023695|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6273488|NCT04023695|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6273489|NCT04023695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6273490|NCT04023695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273491|NCT04023695|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6273492|NCT04023695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6273493|NCT04023695|Adrenergic Agents|adrenergic agents|mesh-ancestor
6273494|NCT04023695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6273495|NCT04023695|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6273496|NCT04023695|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6273497|NCT04023695|Autonomic Agents|autonomic agents|mesh-ancestor
6273498|NCT04023695|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6273499|NCT04023695|Respiratory System Agents|respiratory system agents|mesh-ancestor
6273500|NCT04023695|Mydriatics|mydriatics|mesh-ancestor
6273501|NCT04023695|Sympathomimetics|sympathomimetics|mesh-ancestor
6273502|NCT04023695|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6273503|NCT04018664|Nalbuphine|nalbuphine|mesh-list
6273504|NCT04018664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6273505|NCT04018664|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6273506|NCT04018664|Narcotics|narcotics|mesh-ancestor
6273507|NCT04018664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6273508|NCT04018664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273509|NCT04018664|Analgesics|analgesics|mesh-ancestor
6273510|NCT04018664|Sensory System Agents|sensory system agents|mesh-ancestor
6273511|NCT04018664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6273512|NCT04027803|Eculizumab|eculizumab|mesh-list
6273513|NCT04027803|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6273514|NCT04027803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6273515|NCT04027803|Immunologic Factors|immunologic factors|mesh-ancestor
6273516|NCT04027803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273517|NCT04023682|Hand Sanitizers|hand sanitizers|mesh-list
6273518|NCT04023682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6273519|NCT04023682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6273520|NCT04023682|Disinfectants|disinfectants|mesh-ancestor
6273521|NCT04011735|Tiotropium Bromide|tiotropium bromide|mesh-list
6273522|NCT04011735|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6273523|NCT04011735|Autonomic Agents|autonomic agents|mesh-ancestor
6273524|NCT04011735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6273525|NCT04011735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273526|NCT04011735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6273527|NCT04011735|Respiratory System Agents|respiratory system agents|mesh-ancestor
6273528|NCT04011735|Parasympatholytics|parasympatholytics|mesh-ancestor
6273529|NCT04011735|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6273530|NCT04011735|Cholinergic Agents|cholinergic agents|mesh-ancestor
6273531|NCT04011735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6273532|NCT04011735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273533|NCT04009577|Lemborexant|lemborexant|mesh-list
6273534|NCT04009577|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
6273535|NCT04009577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6273536|NCT04009577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273537|NCT04009577|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6273538|NCT04009577|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6273539|NCT04009577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6273540|NCT04009577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273541|NCT04000815|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
6273542|NCT04000815|Natriuretic Agents|natriuretic agents|mesh-ancestor
6273543|NCT04000815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273544|NCT03995680|Mebendazole|mebendazole|mesh-list
6273545|NCT03995680|Piperazine|piperazine|mesh-list
6273546|NCT03995680|Piperazine citrate|piperazine citrate|mesh-list
6273547|NCT03995680|DMP 777|dmp 777|mesh-list
6273548|NCT03995680|Antinematodal Agents|antinematodal agents|mesh-ancestor
6273549|NCT03995680|Anthelmintics|anthelmintics|mesh-ancestor
6273550|NCT03995680|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6273551|NCT03995680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6273552|NCT03995680|Tubulin Modulators|tubulin modulators|mesh-ancestor
6273553|NCT03995680|Antimitotic Agents|antimitotic agents|mesh-ancestor
6273554|NCT03995680|Mitosis Modulators|mitosis modulators|mesh-ancestor
6273555|NCT03995680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273556|NCT03995680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6273557|NCT03995680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6273558|NCT04005404|Ropivacaine|ropivacaine|mesh-list
6273559|NCT04005404|Anesthetics, Local|anesthetics, local|mesh-ancestor
6273560|NCT04005404|Anesthetics|anesthetics|mesh-ancestor
6273561|NCT04005404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6273562|NCT04005404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273563|NCT04005404|Sensory System Agents|sensory system agents|mesh-ancestor
6273564|NCT04005404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6273565|NCT03993288|Iron|iron|mesh-list
6273566|NCT03993288|Trace Elements|trace elements|mesh-ancestor
6273567|NCT03993288|Micronutrients|micronutrients|mesh-ancestor
6273568|NCT03993288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273569|NCT03988647|Pembrolizumab|pembrolizumab|mesh-list
6273570|NCT03988647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6273571|NCT03988647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6273572|NCT03978832|Risperidone|risperidone|mesh-list
6273573|NCT03978832|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6273574|NCT03978832|Serotonin Agents|serotonin agents|mesh-ancestor
6273575|NCT03978832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6273576|NCT03978832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273577|NCT03978832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273578|NCT03978832|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6273579|NCT03978832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6273580|NCT03978832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6273581|NCT03978832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6273582|NCT03978832|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6273583|NCT03978832|Dopamine Agents|dopamine agents|mesh-ancestor
6273584|NCT04005391|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6273585|NCT04005391|Contraceptive Agents|contraceptive agents|mesh-list
6273586|NCT04005391|Levonorgestrel|levonorgestrel|mesh-list
6273587|NCT04005391|Medroxyprogesterone|medroxyprogesterone|mesh-list
6273588|NCT04005391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6273589|NCT04005391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273590|NCT04005391|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6273591|NCT04005391|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6273592|NCT04005391|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6273593|NCT04005391|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6273594|NCT04005391|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6273595|NCT04005391|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6273596|NCT04005391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6273597|NCT04005391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6273598|NCT04004481|Morphine|morphine|mesh-list
6273599|NCT04004481|Tramadol|tramadol|mesh-list
6273600|NCT04004481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6273601|NCT04004481|Narcotics|narcotics|mesh-ancestor
6273602|NCT04004481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6273603|NCT04004481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273604|NCT04004481|Analgesics|analgesics|mesh-ancestor
6273605|NCT04004481|Sensory System Agents|sensory system agents|mesh-ancestor
6273606|NCT04004481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6273607|NCT03997851|Acetaminophen|acetaminophen|mesh-list
6273608|NCT03997851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6273609|NCT03997851|Analgesics|analgesics|mesh-ancestor
6273610|NCT03997851|Sensory System Agents|sensory system agents|mesh-ancestor
6273611|NCT03997851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6273612|NCT03997851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273613|NCT03997851|Antipyretics|antipyretics|mesh-ancestor
6273614|NCT03996694|Oxycodone|oxycodone|mesh-list
6273615|NCT03996694|Buprenorphine|buprenorphine|mesh-list
6273616|NCT03996694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6273617|NCT03996694|Narcotics|narcotics|mesh-ancestor
6273618|NCT03996694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6273619|NCT03996694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273620|NCT03996694|Analgesics|analgesics|mesh-ancestor
6273621|NCT03996694|Sensory System Agents|sensory system agents|mesh-ancestor
6273622|NCT03996694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6273623|NCT03996694|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6273624|NCT03988907|Midazolam|midazolam|mesh-list
6273625|NCT03988907|Risdiplam|risdiplam|mesh-list
6273626|NCT03988907|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6273627|NCT03988907|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6273628|NCT03988907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6273629|NCT03988907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273630|NCT03988907|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6273631|NCT03988907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6273632|NCT03988907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6273633|NCT03988907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6273634|NCT03988907|Anesthetics, General|anesthetics, general|mesh-ancestor
6273635|NCT03988907|Anesthetics|anesthetics|mesh-ancestor
6273636|NCT03988907|GABA Modulators|gaba modulators|mesh-ancestor
6273637|NCT03988907|GABA Agents|gaba agents|mesh-ancestor
6273638|NCT03988907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6273639|NCT03988907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273640|NCT03988907|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6273641|NCT03988907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6273642|NCT03988088|Lasmiditan|lasmiditan|mesh-list
6273643|NCT03988088|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6273644|NCT03988088|Serotonin Agents|serotonin agents|mesh-ancestor
6273645|NCT03988088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6273646|NCT03988088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273647|NCT03988088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273648|NCT03980522|Rilonacept|rilonacept|mesh-list
6273649|NCT03980522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6273650|NCT03999684|Tretinoin|tretinoin|mesh-list
6273651|NCT03999684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6273652|NCT03999684|Keratolytic Agents|keratolytic agents|mesh-ancestor
6273653|NCT03999684|Dermatologic Agents|dermatologic agents|mesh-ancestor
6273654|NCT03993392|Buprenorphine|buprenorphine|mesh-list
6273655|NCT03993392|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6273656|NCT03993392|Narcotics|narcotics|mesh-ancestor
6273657|NCT03993392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6273658|NCT03993392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273659|NCT03993392|Analgesics|analgesics|mesh-ancestor
6273660|NCT03993392|Sensory System Agents|sensory system agents|mesh-ancestor
6273661|NCT03993392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6273662|NCT03993392|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6273663|NCT03989427|Listerine|listerine|mesh-list
6273664|NCT03989427|Sodium Fluoride|sodium fluoride|mesh-list
6273665|NCT03989427|Cariostatic Agents|cariostatic agents|mesh-ancestor
6273666|NCT03989427|Protective Agents|protective agents|mesh-ancestor
6273667|NCT03989427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273668|NCT03989427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6273669|NCT03989427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6273670|NCT03981822|Cantharidin|cantharidin|mesh-list
6273671|NCT03981822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6273672|NCT03981822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273673|NCT03992482|Immunoglobulins|immunoglobulins|mesh-list
6273674|NCT03992482|Antibodies|antibodies|mesh-list
6273675|NCT03992482|gamma-Globulins|gamma-globulins|mesh-list
6273676|NCT03992482|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6273677|NCT03992482|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6273678|NCT03992482|Immunologic Factors|immunologic factors|mesh-ancestor
6273679|NCT03992482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273680|NCT03993119|Anticoagulants|anticoagulants|mesh-list
6273681|NCT03988803|Memantine|memantine|mesh-list
6273682|NCT03988803|BI 425809|bi 425809|mesh-list
6273683|NCT03988803|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6273684|NCT03988803|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6273685|NCT03988803|Dopamine Agents|dopamine agents|mesh-ancestor
6273686|NCT03988803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6273687|NCT03988803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273688|NCT03988803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273689|NCT03988803|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6273690|NCT03988803|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6273691|NCT03988803|Nootropic Agents|nootropic agents|mesh-ancestor
6273692|NCT03987191|Insulin|insulin|mesh-list
6273693|NCT03987191|Insulin Aspart|insulin aspart|mesh-list
6273694|NCT03987191|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6273695|NCT03987191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6273696|NCT03987191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273697|NCT03988842|Heparin|heparin|mesh-list
6273698|NCT03988842|Calcium heparin|calcium heparin|mesh-list
6273699|NCT03988842|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6273700|NCT03988842|Plasminogen|plasminogen|mesh-list
6273701|NCT03988842|Apixaban|apixaban|mesh-list
6273702|NCT03988842|Anticoagulants|anticoagulants|mesh-ancestor
6273703|NCT03988842|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6273704|NCT03988842|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6273705|NCT03988842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273706|NCT03988842|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6273707|NCT03988842|Antithrombins|antithrombins|mesh-ancestor
6273708|NCT03988842|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6273709|NCT03988842|Protease Inhibitors|protease inhibitors|mesh-ancestor
6273710|NCT03988842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6273711|NCT03981861|Metformin|metformin|mesh-list
6273712|NCT03981861|Spironolactone|spironolactone|mesh-list
6273713|NCT03981861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6273714|NCT03981861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273715|NCT03981861|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6273716|NCT03981861|Hormone Antagonists|hormone antagonists|mesh-ancestor
6273717|NCT03981861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6273718|NCT03981861|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6273719|NCT03981861|Diuretics|diuretics|mesh-ancestor
6273720|NCT03981861|Natriuretic Agents|natriuretic agents|mesh-ancestor
6273721|NCT03987074|Firsocostat|firsocostat|mesh-list
6273722|NCT03987074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6273723|NCT03987074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273724|NCT03979820|Phenelzine|phenelzine|mesh-list
6273725|NCT03979820|Tyramine|tyramine|mesh-list
6273726|NCT03979820|Antidepressive Agents|antidepressive agents|mesh-ancestor
6273727|NCT03979820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6273728|NCT03979820|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6273729|NCT03979820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6273730|NCT03979820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273731|NCT03979820|Sympathomimetics|sympathomimetics|mesh-ancestor
6273732|NCT03979820|Autonomic Agents|autonomic agents|mesh-ancestor
6273733|NCT03979820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6273734|NCT03979820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273735|NCT03979820|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6273736|NCT03979820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6273737|NCT03979820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6273738|NCT03979820|Adrenergic Agents|adrenergic agents|mesh-ancestor
6273739|NCT03979820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6273740|NCT03972137|Nicotine|nicotine|mesh-list
6273741|NCT03972137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6273742|NCT03972137|Autonomic Agents|autonomic agents|mesh-ancestor
6273743|NCT03972137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6273744|NCT03972137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273745|NCT03972137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6273746|NCT03972137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6273747|NCT03972137|Cholinergic Agents|cholinergic agents|mesh-ancestor
6273748|NCT03972137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6273749|NCT03972137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273750|NCT03987620|Ibrexafungerp|ibrexafungerp|mesh-list
6273751|NCT03987620|Antifungal Agents|antifungal agents|mesh-ancestor
6273752|NCT03987620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6273753|NCT03984838|Dolutegravir|dolutegravir|mesh-list
6273754|NCT03984838|Rilpivirine|rilpivirine|mesh-list
6273755|NCT03984838|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6273756|NCT03984838|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6273757|NCT03984838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6273758|NCT03984838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273759|NCT03984838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6273760|NCT03984838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6273761|NCT03984838|Antiviral Agents|antiviral agents|mesh-ancestor
6273762|NCT03984838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6273763|NCT03984838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6273764|NCT03984838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6273765|NCT03983941|Ropivacaine|ropivacaine|mesh-list
6273766|NCT03983941|Anesthetics, Local|anesthetics, local|mesh-ancestor
6273767|NCT03983941|Anesthetics|anesthetics|mesh-ancestor
6273768|NCT03983941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6273769|NCT03983941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273770|NCT03983941|Sensory System Agents|sensory system agents|mesh-ancestor
6273771|NCT03983941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6273772|NCT03976752|Tenofovir|tenofovir|mesh-list
6273773|NCT03976752|Emtricitabine|emtricitabine|mesh-list
6273774|NCT03976752|Cobicistat|cobicistat|mesh-list
6273775|NCT03976752|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
6273776|NCT03976752|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6273777|NCT03976752|Elvitegravir|elvitegravir|mesh-list
6273778|NCT03976752|Antiviral Agents|antiviral agents|mesh-ancestor
6273779|NCT03976752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6273780|NCT03976752|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6273781|NCT03976752|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6273782|NCT03976752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6273783|NCT03976752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273784|NCT03976752|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6273785|NCT03976752|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6273786|NCT03976752|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6273787|NCT03976752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6273788|NCT03976752|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6391072|NCT00192101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6391073|NCT00192101|Antimetabolites|antimetabolites|mesh-ancestor
6391074|NCT00192101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391075|NCT00192101|Antiviral Agents|antiviral agents|mesh-ancestor
6391076|NCT00192101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6391077|NCT00192101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6391078|NCT00192101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6391079|NCT00192101|Immunologic Factors|immunologic factors|mesh-ancestor
6391080|NCT00192101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6391081|NCT00192413|Vaccines|vaccines|mesh-list
6391082|NCT00192413|Immunologic Factors|immunologic factors|mesh-ancestor
6391083|NCT00192413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6391084|NCT00192569|Interferons|interferons|mesh-list
6391085|NCT00192569|Ribavirin|ribavirin|mesh-list
6391086|NCT00192569|Interferon-alpha|interferon-alpha|mesh-list
6391087|NCT00192569|Interferon alpha-2|interferon alpha-2|mesh-list
6391088|NCT00192569|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6391089|NCT00192569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391090|NCT00192569|Antiviral Agents|antiviral agents|mesh-ancestor
6391091|NCT00192569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6391092|NCT00192569|Antimetabolites|antimetabolites|mesh-ancestor
6391093|NCT00192569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391094|NCT00192569|Immunologic Factors|immunologic factors|mesh-ancestor
6391095|NCT00192569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6391096|NCT00192595|Tenofovir|tenofovir|mesh-list
6391097|NCT00192595|Lamivudine|lamivudine|mesh-list
6391098|NCT00192595|Zidovudine|zidovudine|mesh-list
6391099|NCT00192595|Efavirenz|efavirenz|mesh-list
6391100|NCT00192595|Antiviral Agents|antiviral agents|mesh-ancestor
6391101|NCT00192595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6391102|NCT00192595|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6391103|NCT00192595|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6391104|NCT00192595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6391105|NCT00192595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391106|NCT00192595|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6391107|NCT00192595|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6391108|NCT00192595|Antimetabolites|antimetabolites|mesh-ancestor
6273789|NCT03976466|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6273790|NCT03976466|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6273791|NCT03976466|Calcium|calcium|mesh-list
6273792|NCT03976466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6273793|NCT03976466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273794|NCT03976466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6273795|NCT03976466|Antitubercular Agents|antitubercular agents|mesh-ancestor
6273796|NCT03979066|Atezolizumab|atezolizumab|mesh-list
6273797|NCT03979066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6273798|NCT03977727|Insulin Aspart|insulin aspart|mesh-list
6273799|NCT03977727|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6273800|NCT03977727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273801|NCT03968978|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6273802|NCT03968978|Immunologic Factors|immunologic factors|mesh-ancestor
6273803|NCT03968978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273804|NCT03968848|Acalabrutinib|acalabrutinib|mesh-list
6273805|NCT03968848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6273806|NCT03967444|Hyaluronic Acid|hyaluronic acid|mesh-list
6273807|NCT03967444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6273808|NCT03967444|Immunologic Factors|immunologic factors|mesh-ancestor
6273809|NCT03967444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273810|NCT03967444|Viscosupplements|viscosupplements|mesh-ancestor
6273811|NCT03967444|Protective Agents|protective agents|mesh-ancestor
6273812|NCT03966365|Timolol|timolol|mesh-list
6273813|NCT03966365|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6273814|NCT03966365|Dorzolamide|dorzolamide|mesh-list
6273815|NCT03966365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6273816|NCT03966365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6273817|NCT03966365|Adrenergic Agents|adrenergic agents|mesh-ancestor
6273818|NCT03966365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6273819|NCT03966365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273820|NCT03966365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273821|NCT03966365|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6273822|NCT03966365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6273823|NCT03966365|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6273824|NCT03966365|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6273825|NCT03966365|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6273826|NCT03966365|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6273827|NCT03966365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6273828|NCT03965351|Probenecid|probenecid|mesh-list
6273829|NCT03965351|Uricosuric Agents|uricosuric agents|mesh-ancestor
6273830|NCT03965351|Gout Suppressants|gout suppressants|mesh-ancestor
6273831|NCT03965351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6273832|NCT03965351|Renal Agents|renal agents|mesh-ancestor
6273833|NCT03964220|Tiotropium Bromide|tiotropium bromide|mesh-list
6273834|NCT03964220|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6273835|NCT03964220|Autonomic Agents|autonomic agents|mesh-ancestor
6273836|NCT03964220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6273837|NCT03964220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273838|NCT03964220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6273839|NCT03964220|Respiratory System Agents|respiratory system agents|mesh-ancestor
6273840|NCT03964220|Parasympatholytics|parasympatholytics|mesh-ancestor
6273841|NCT03964220|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6273842|NCT03964220|Cholinergic Agents|cholinergic agents|mesh-ancestor
6273843|NCT03964220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6273844|NCT03964220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273845|NCT03965052|Travoprost|travoprost|mesh-list
6273846|NCT03965052|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6273847|NCT03965052|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6273848|NCT03965052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6273849|NCT03965039|Fluorides|fluorides|mesh-list
6273850|NCT03965039|Tin Fluorides|tin fluorides|mesh-list
6273851|NCT03965039|Fluorophosphate|fluorophosphate|mesh-list
6273852|NCT03965039|Cariostatic Agents|cariostatic agents|mesh-ancestor
6273853|NCT03965039|Protective Agents|protective agents|mesh-ancestor
6273854|NCT03965039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273855|NCT03963401|PF-06700841|pf-06700841|mesh-list
6273856|NCT03963401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6273857|NCT03963401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6273858|NCT03963401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273859|NCT03962634|Oxymetazoline|oxymetazoline|mesh-list
6273860|NCT03962634|Tetracaine|tetracaine|mesh-list
6273861|NCT03962634|Carticaine|carticaine|mesh-list
6273862|NCT03962634|Anesthetics, Local|anesthetics, local|mesh-ancestor
6273863|NCT03962634|Anesthetics|anesthetics|mesh-ancestor
6273864|NCT03962634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6273865|NCT03962634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273866|NCT03962634|Sensory System Agents|sensory system agents|mesh-ancestor
6273867|NCT03962634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6273868|NCT03962634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6273869|NCT03962634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6273870|NCT03962634|Adrenergic Agents|adrenergic agents|mesh-ancestor
6273871|NCT03962634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6273872|NCT03962634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273873|NCT03962634|Sympathomimetics|sympathomimetics|mesh-ancestor
6273874|NCT03962634|Autonomic Agents|autonomic agents|mesh-ancestor
6273875|NCT03962634|Nasal Decongestants|nasal decongestants|mesh-ancestor
6273876|NCT03962634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6273877|NCT03962634|Respiratory System Agents|respiratory system agents|mesh-ancestor
6273878|NCT03962738|Lasmiditan|lasmiditan|mesh-list
6273879|NCT03962738|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6273880|NCT03962738|Serotonin Agents|serotonin agents|mesh-ancestor
6273881|NCT03962738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6273882|NCT03962738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273883|NCT03962738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273884|NCT03946124|Fesoterodine|fesoterodine|mesh-list
6273885|NCT03946124|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6273886|NCT03946124|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6273887|NCT03946124|Cholinergic Agents|cholinergic agents|mesh-ancestor
6273888|NCT03946124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6273889|NCT03946124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273890|NCT03946124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273891|NCT03946124|Urological Agents|urological agents|mesh-ancestor
6273892|NCT03961308|Vedolizumab|vedolizumab|mesh-list
6273893|NCT03961308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6273894|NCT03961295|Vedolizumab|vedolizumab|mesh-list
6273895|NCT03961295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6273896|NCT03960957|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6273897|NCT03960957|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6273898|NCT03960957|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6273899|NCT03960957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6273900|NCT03960957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273901|NCT03960957|Cholinergic Agents|cholinergic agents|mesh-ancestor
6273902|NCT03960957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6273903|NCT03960957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273904|NCT03960957|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6273905|NCT03960957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6273906|NCT03954444|Phenylephrine|phenylephrine|mesh-list
6273907|NCT03954444|Oxymetazoline|oxymetazoline|mesh-list
6273908|NCT03954444|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6273909|NCT03954444|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6273910|NCT03954444|Adrenergic Agents|adrenergic agents|mesh-ancestor
6273911|NCT03954444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6273912|NCT03954444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273913|NCT03954444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273914|NCT03954444|Sympathomimetics|sympathomimetics|mesh-ancestor
6273915|NCT03954444|Autonomic Agents|autonomic agents|mesh-ancestor
6273916|NCT03954444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6273917|NCT03954444|Nasal Decongestants|nasal decongestants|mesh-ancestor
6273918|NCT03954444|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6273919|NCT03954444|Respiratory System Agents|respiratory system agents|mesh-ancestor
6273920|NCT03954444|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6273921|NCT03954444|Mydriatics|mydriatics|mesh-ancestor
6273922|NCT03954444|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6273923|NCT03954444|Protective Agents|protective agents|mesh-ancestor
6273924|NCT03953820|Diazepam|diazepam|mesh-list
6273925|NCT03953820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6273926|NCT03953820|Anticonvulsants|anticonvulsants|mesh-ancestor
6273927|NCT03953820|Antiemetics|antiemetics|mesh-ancestor
6273928|NCT03953820|Autonomic Agents|autonomic agents|mesh-ancestor
6273929|NCT03953820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6273930|NCT03953820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273931|NCT03953820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6273932|NCT03953820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6273933|NCT03953820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6273934|NCT03953820|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6273935|NCT03953820|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6273936|NCT03953820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6273937|NCT03953820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6273938|NCT03953820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6273939|NCT03953820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6273940|NCT03953820|Anesthetics, General|anesthetics, general|mesh-ancestor
6273941|NCT03953820|Anesthetics|anesthetics|mesh-ancestor
6273942|NCT03953820|GABA Modulators|gaba modulators|mesh-ancestor
6273943|NCT03953820|GABA Agents|gaba agents|mesh-ancestor
6273944|NCT03953820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6273945|NCT03953820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273946|NCT03961100|Entrectinib|entrectinib|mesh-list
6273947|NCT03961100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6273948|NCT03961100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6273949|NCT03961100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273950|NCT03950856|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6273951|NCT03950856|Immunologic Factors|immunologic factors|mesh-ancestor
6273952|NCT03950856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273953|NCT03960658|Ketamine|ketamine|mesh-list
6273954|NCT03960658|Analgesics|analgesics|mesh-ancestor
6273955|NCT03960658|Sensory System Agents|sensory system agents|mesh-ancestor
6273956|NCT03960658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6273957|NCT03960658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273958|NCT03960658|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6273959|NCT03960658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6273960|NCT03960658|Anesthetics, General|anesthetics, general|mesh-ancestor
6273961|NCT03960658|Anesthetics|anesthetics|mesh-ancestor
6273962|NCT03960658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6273963|NCT03960658|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6273964|NCT03960658|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6273965|NCT03960658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6273966|NCT03960658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273967|NCT03959332|Baloxavir|baloxavir|mesh-list
6273968|NCT03959332|Antiviral Agents|antiviral agents|mesh-ancestor
6273969|NCT03959332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6273970|NCT03959332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6273971|NCT03959332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273972|NCT03958656|Cyclophosphamide|cyclophosphamide|mesh-list
6273973|NCT03958656|Fludarabine|fludarabine|mesh-list
6273974|NCT03958656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6273975|NCT03958656|Immunologic Factors|immunologic factors|mesh-ancestor
6273976|NCT03958656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273977|NCT03958656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6273978|NCT03958656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6273979|NCT03958656|Alkylating Agents|alkylating agents|mesh-ancestor
6273980|NCT03958656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6273981|NCT03958656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6273982|NCT03958656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6273983|NCT03954743|Vaccines|vaccines|mesh-list
6273984|NCT03954743|Immunologic Factors|immunologic factors|mesh-ancestor
6273985|NCT03954743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273986|NCT03951805|Insulin|insulin|mesh-list
6273987|NCT03951805|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6273988|NCT03951805|Insulin Glargine|insulin glargine|mesh-list
6273989|NCT03951805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6273990|NCT03951805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273991|NCT03950622|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6273992|NCT03950622|Immunologic Factors|immunologic factors|mesh-ancestor
6273993|NCT03950622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6273994|NCT03949621|Vedolizumab|vedolizumab|mesh-list
6273995|NCT03949621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6273996|NCT03949244|Latanoprost|latanoprost|mesh-list
6273997|NCT03949244|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6273998|NCT03949244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6273999|NCT03948581|Vedolizumab|vedolizumab|mesh-list
6274000|NCT03948581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6274001|NCT03948386|Bupivacaine|bupivacaine|mesh-list
6274002|NCT03948386|Mepivacaine|mepivacaine|mesh-list
6274003|NCT03948386|Anesthetics, Local|anesthetics, local|mesh-ancestor
6274004|NCT03948386|Anesthetics|anesthetics|mesh-ancestor
6274005|NCT03948386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6274006|NCT03948386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274007|NCT03948386|Sensory System Agents|sensory system agents|mesh-ancestor
6274008|NCT03948386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6274009|NCT03943095|Fluorides|fluorides|mesh-list
6274010|NCT03943095|Tin Fluorides|tin fluorides|mesh-list
6274011|NCT03943095|Cariostatic Agents|cariostatic agents|mesh-ancestor
6274012|NCT03943095|Protective Agents|protective agents|mesh-ancestor
6274013|NCT03943095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274014|NCT03942042|Ixekizumab|ixekizumab|mesh-list
6274015|NCT03942042|Dermatologic Agents|dermatologic agents|mesh-ancestor
6274016|NCT03923530|Eplerenone|eplerenone|mesh-list
6274017|NCT03923530|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6274018|NCT03923530|Hormone Antagonists|hormone antagonists|mesh-ancestor
6274019|NCT03923530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6274020|NCT03923530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274021|NCT03923530|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6274022|NCT03923530|Diuretics|diuretics|mesh-ancestor
6274023|NCT03923530|Natriuretic Agents|natriuretic agents|mesh-ancestor
6274024|NCT03923530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6274025|NCT03914417|Imiquimod|imiquimod|mesh-list
6274026|NCT03914417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6274027|NCT03914417|Immunologic Factors|immunologic factors|mesh-ancestor
6274028|NCT03914417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274029|NCT03914417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6274030|NCT03914417|Interferon Inducers|interferon inducers|mesh-ancestor
6274031|NCT03937479|Tiotropium Bromide|tiotropium bromide|mesh-list
6274032|NCT03937479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6274033|NCT03937479|Autonomic Agents|autonomic agents|mesh-ancestor
6274034|NCT03937479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6274035|NCT03937479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274036|NCT03937479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6274037|NCT03937479|Respiratory System Agents|respiratory system agents|mesh-ancestor
6274038|NCT03937479|Parasympatholytics|parasympatholytics|mesh-ancestor
6274039|NCT03937479|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6274040|NCT03937479|Cholinergic Agents|cholinergic agents|mesh-ancestor
6274041|NCT03937479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6274042|NCT03937479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274043|NCT03936387|Ropivacaine|ropivacaine|mesh-list
6274044|NCT03936387|Anesthetics, Local|anesthetics, local|mesh-ancestor
6274045|NCT03936387|Anesthetics|anesthetics|mesh-ancestor
6274046|NCT03936387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6274047|NCT03936387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274048|NCT03936387|Sensory System Agents|sensory system agents|mesh-ancestor
6274049|NCT03936387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6274050|NCT03935399|Oxytocin|oxytocin|mesh-list
6274051|NCT03935399|Oxytocics|oxytocics|mesh-ancestor
6274052|NCT03935399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6274053|NCT03935399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274054|NCT03928327|Itraconazole|itraconazole|mesh-list
6274055|NCT03928327|Rifampin|rifampin|mesh-list
6274056|NCT03928327|Antifungal Agents|antifungal agents|mesh-ancestor
6274057|NCT03928327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6274058|NCT03928327|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6274059|NCT03928327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6274060|NCT03928327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6274061|NCT03928327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274062|NCT03928327|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6274063|NCT03928327|Hormone Antagonists|hormone antagonists|mesh-ancestor
6274064|NCT03928327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6274065|NCT03928327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274066|NCT03928327|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6274067|NCT03928327|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6274068|NCT03928327|Antitubercular Agents|antitubercular agents|mesh-ancestor
6274069|NCT03928327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6274070|NCT03928327|Leprostatic Agents|leprostatic agents|mesh-ancestor
6274071|NCT03928327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6274072|NCT03928327|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6274073|NCT03928327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6274074|NCT03928327|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6274075|NCT03928327|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6274076|NCT03928327|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6274077|NCT03928327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6274078|NCT03933774|Tretinoin|tretinoin|mesh-list
6274079|NCT03933774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6274080|NCT03933774|Keratolytic Agents|keratolytic agents|mesh-ancestor
6274081|NCT03933774|Dermatologic Agents|dermatologic agents|mesh-ancestor
6274082|NCT03912259|Emollients|emollients|mesh-list
6274083|NCT03912259|Dermatologic Agents|dermatologic agents|mesh-ancestor
6274084|NCT03933618|Anastrozole|anastrozole|mesh-list
6274085|NCT03933618|Clomiphene|clomiphene|mesh-list
6274086|NCT03933618|Enclomiphene|enclomiphene|mesh-list
6274087|NCT03933618|Zuclomiphene|zuclomiphene|mesh-list
6274088|NCT03933618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274089|NCT03933618|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6274090|NCT03933618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6274091|NCT03933618|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6274092|NCT03933618|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6274093|NCT03933618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6274094|NCT03933618|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6274095|NCT03933618|Hormone Antagonists|hormone antagonists|mesh-ancestor
6274096|NCT03933618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6274097|NCT03933618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274098|NCT03933618|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6274099|NCT03933618|Fertility Agents|fertility agents|mesh-ancestor
6274100|NCT03933618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6274101|NCT03933618|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6274102|NCT03933618|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6274103|NCT03927105|Nivolumab|nivolumab|mesh-list
6274104|NCT03927105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6274105|NCT03927105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6274106|NCT03927105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6274107|NCT03927105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274108|NCT03923933|Chlorthalidone|chlorthalidone|mesh-list
6274109|NCT03923933|Bumetanide|bumetanide|mesh-list
6274110|NCT03923933|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6274111|NCT03923933|Diuretics|diuretics|mesh-ancestor
6274112|NCT03923933|Natriuretic Agents|natriuretic agents|mesh-ancestor
6274113|NCT03923933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274114|NCT03923933|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6274115|NCT03923933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6274116|NCT03923933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274117|NCT03923933|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6274118|NCT03909295|Valsartan|valsartan|mesh-list
6274119|NCT03909295|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
6274120|NCT03909295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6274121|NCT03909295|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6274122|NCT03909295|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6274123|NCT03909295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274124|NCT03930264|Azathioprine|azathioprine|mesh-list
6274125|NCT03930264|Antimetabolites|antimetabolites|mesh-ancestor
6274126|NCT03930264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274127|NCT03930264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6274128|NCT03930264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6274129|NCT03930264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6274130|NCT03930264|Immunologic Factors|immunologic factors|mesh-ancestor
6274131|NCT03930264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274132|NCT03930264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6274133|NCT03929367|Oxytocin|oxytocin|mesh-list
6274134|NCT03929367|Oxytocics|oxytocics|mesh-ancestor
6274135|NCT03929367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6274136|NCT03929367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274137|NCT03928522|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6274138|NCT03928522|Vancomycin|vancomycin|mesh-list
6274139|NCT03928522|Tobramycin|tobramycin|mesh-list
6274140|NCT03928522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6391109|NCT00192595|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6391110|NCT00192595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6391111|NCT00192595|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6391112|NCT00192595|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6391113|NCT00192595|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6391114|NCT00192595|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6391115|NCT00192608|Saquinavir|saquinavir|mesh-list
6391116|NCT00192608|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6391117|NCT00192608|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6391118|NCT00192608|Protease Inhibitors|protease inhibitors|mesh-ancestor
6274141|NCT03910439|Avelumab|avelumab|mesh-list
6274142|NCT03910439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6274143|NCT03910439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6274144|NCT03927950|Citalopram|citalopram|mesh-list
6274145|NCT03927950|Bupropion|bupropion|mesh-list
6274146|NCT03927950|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6274147|NCT03927950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6274148|NCT03927950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6274149|NCT03927950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274150|NCT03927950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6274151|NCT03927950|Serotonin Agents|serotonin agents|mesh-ancestor
6274152|NCT03927950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274153|NCT03927950|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6274154|NCT03927950|Antidepressive Agents|antidepressive agents|mesh-ancestor
6274155|NCT03927950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6274156|NCT03927950|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6274157|NCT03927950|Dopamine Agents|dopamine agents|mesh-ancestor
6274158|NCT03927950|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6274159|NCT03927950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6274160|NCT03927950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6274161|NCT03927781|Pregabalin|pregabalin|mesh-list
6274162|NCT03927781|Analgesics|analgesics|mesh-ancestor
6274163|NCT03927781|Sensory System Agents|sensory system agents|mesh-ancestor
6274164|NCT03927781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6274165|NCT03927781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274166|NCT03927781|Anticonvulsants|anticonvulsants|mesh-ancestor
6274167|NCT03927781|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6274168|NCT03927781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6274169|NCT03927781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274170|NCT03927781|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6274171|NCT03927781|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6274172|NCT03927781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6274173|NCT03927781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6274174|NCT03927781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6274175|NCT03905811|Terazosin|terazosin|mesh-list
6274176|NCT03905811|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6274177|NCT03905811|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6274178|NCT03905811|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6274179|NCT03905811|Adrenergic Agents|adrenergic agents|mesh-ancestor
6274180|NCT03905811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6274181|NCT03905811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274182|NCT03905811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274183|NCT03905811|Urological Agents|urological agents|mesh-ancestor
6274184|NCT03895307|Anesthetics|anesthetics|mesh-list
6274185|NCT03895307|Anesthetics, Local|anesthetics, local|mesh-list
6274186|NCT03895307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6274187|NCT03895307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274188|NCT03895307|Sensory System Agents|sensory system agents|mesh-ancestor
6274189|NCT03895307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6274190|NCT03905642|Amikacin|amikacin|mesh-list
6274191|NCT03905642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6274192|NCT03905642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6274193|NCT03892889|Aripiprazole|aripiprazole|mesh-list
6274194|NCT03892889|Antidepressive Agents|antidepressive agents|mesh-ancestor
6274195|NCT03892889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6274196|NCT03892889|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6274197|NCT03892889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6274198|NCT03892889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6274199|NCT03892889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274200|NCT03892889|Dopamine Agonists|dopamine agonists|mesh-ancestor
6274201|NCT03892889|Dopamine Agents|dopamine agents|mesh-ancestor
6274202|NCT03892889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6274203|NCT03892889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274204|NCT03892889|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6274205|NCT03892889|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6274206|NCT03892889|Serotonin Agents|serotonin agents|mesh-ancestor
6274207|NCT03892889|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6274208|NCT03892889|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6274209|NCT03892889|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6274210|NCT03892889|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6274211|NCT03921723|Dolutegravir|dolutegravir|mesh-list
6274212|NCT03921723|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6274213|NCT03921723|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6274214|NCT03921723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6274215|NCT03921723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274216|NCT03921723|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6274217|NCT03921723|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6274218|NCT03921723|Antiviral Agents|antiviral agents|mesh-ancestor
6274219|NCT03921723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6274220|NCT03921190|Anesthetics|anesthetics|mesh-list
6274221|NCT03921190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6274222|NCT03921190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274223|NCT03920865|Risdiplam|risdiplam|mesh-list
6274224|NCT03920865|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6274225|NCT03920865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6274226|NCT03920865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274227|NCT03902613|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
6274228|NCT03902613|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6274229|NCT03902613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6274230|NCT03902613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6274231|NCT03902613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274232|NCT03902613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6274233|NCT03902613|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6274234|NCT03902613|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6274235|NCT03902613|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6274236|NCT03902613|Adrenergic Agents|adrenergic agents|mesh-ancestor
6274237|NCT03902613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6274238|NCT03902613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274239|NCT03902613|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6274240|NCT03902613|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6274241|NCT03902613|Serotonin Agents|serotonin agents|mesh-ancestor
6274242|NCT03902613|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6274243|NCT03902613|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6274244|NCT03902613|Dopamine Agents|dopamine agents|mesh-ancestor
6274245|NCT03902574|Brexpiprazole|brexpiprazole|mesh-list
6274246|NCT03902574|Serotonin Agents|serotonin agents|mesh-ancestor
6274247|NCT03902574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6274248|NCT03902574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274249|NCT03902574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274250|NCT03902574|Dopamine Agonists|dopamine agonists|mesh-ancestor
6274251|NCT03902574|Dopamine Agents|dopamine agents|mesh-ancestor
6274252|NCT03911843|Vitamin D|vitamin d|mesh-list
6274253|NCT03911843|Vitamins|vitamins|mesh-ancestor
6274254|NCT03911843|Micronutrients|micronutrients|mesh-ancestor
6274255|NCT03911843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274256|NCT03911843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6274257|NCT03896633|Brinzolamide|brinzolamide|mesh-list
6274258|NCT03896633|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6274259|NCT03896633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6274260|NCT03896633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274261|NCT03894813|Metronidazole|metronidazole|mesh-list
6274262|NCT03894813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6274263|NCT03894813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6274264|NCT03894813|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6274265|NCT03894813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6274266|NCT03906448|Temozolomide|temozolomide|mesh-list
6274267|NCT03906448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6274268|NCT03906448|Alkylating Agents|alkylating agents|mesh-ancestor
6274269|NCT03906448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274270|NCT03906448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6274271|NCT03909763|Danazol|danazol|mesh-list
6274272|NCT03909763|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6274273|NCT03909763|Hormone Antagonists|hormone antagonists|mesh-ancestor
6274274|NCT03909763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6274275|NCT03909763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274276|NCT03903822|PF-06700841|pf-06700841|mesh-list
6274277|NCT03903822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6274278|NCT03903822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6274279|NCT03903822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274280|NCT03905096|Donepezil|donepezil|mesh-list
6274281|NCT03905096|BI 425809|bi 425809|mesh-list
6274282|NCT03905096|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6274283|NCT03905096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6274284|NCT03905096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274285|NCT03905096|Cholinergic Agents|cholinergic agents|mesh-ancestor
6274286|NCT03905096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6274287|NCT03905096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274288|NCT03905096|Nootropic Agents|nootropic agents|mesh-ancestor
6274289|NCT03894969|Vaccines|vaccines|mesh-list
6274290|NCT03894969|Immunologic Factors|immunologic factors|mesh-ancestor
6274291|NCT03894969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274292|NCT03892707|Folic Acid|folic acid|mesh-list
6274293|NCT03892707|Vitamin B Complex|vitamin b complex|mesh-list
6274294|NCT03892707|Celecoxib|celecoxib|mesh-list
6274295|NCT03892707|Etoricoxib|etoricoxib|mesh-list
6274296|NCT03892707|Meloxicam|meloxicam|mesh-list
6274297|NCT03892707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
6274298|NCT03892707|Nimesulide|nimesulide|mesh-list
6274299|NCT03892707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
6274300|NCT03892707|Benphothiamine|benphothiamine|mesh-list
6274301|NCT03892707|Vitamins|vitamins|mesh-ancestor
6274302|NCT03892707|Micronutrients|micronutrients|mesh-ancestor
6274303|NCT03892707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274304|NCT03892707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6274305|NCT03892707|Analgesics|analgesics|mesh-ancestor
6274306|NCT03892707|Sensory System Agents|sensory system agents|mesh-ancestor
6274307|NCT03892707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6274308|NCT03892707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6274309|NCT03892707|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6274310|NCT03892707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6274311|NCT03892707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6274312|NCT03892707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274313|NCT03892707|Hematinics|hematinics|mesh-ancestor
6274314|NCT03892707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6274315|NCT03892707|Immunologic Factors|immunologic factors|mesh-ancestor
6274316|NCT03892707|Chelating Agents|chelating agents|mesh-ancestor
6274317|NCT03892707|Sequestering Agents|sequestering agents|mesh-ancestor
6274318|NCT03890367|Vaccines|vaccines|mesh-list
6274319|NCT03890367|Immunologic Factors|immunologic factors|mesh-ancestor
6274320|NCT03890367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274321|NCT03889444|Dexamethasone|dexamethasone|mesh-list
6274322|NCT03889444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6274323|NCT03889444|Antiemetics|antiemetics|mesh-ancestor
6274324|NCT03889444|Autonomic Agents|autonomic agents|mesh-ancestor
6274325|NCT03889444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6274326|NCT03889444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274327|NCT03889444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6274328|NCT03889444|Glucocorticoids|glucocorticoids|mesh-ancestor
6274329|NCT03889444|Hormones|hormones|mesh-ancestor
6274330|NCT03889444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6274331|NCT03889444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6274332|NCT03889444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6274333|NCT03888755|Icatibant|icatibant|mesh-list
6274334|NCT03888755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6274335|NCT03888755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6274336|NCT03888755|Analgesics|analgesics|mesh-ancestor
6274337|NCT03888755|Sensory System Agents|sensory system agents|mesh-ancestor
6274338|NCT03888755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6274339|NCT03888755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274340|NCT03888755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6274341|NCT03888755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6274342|NCT03888755|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
6274343|NCT03888755|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
6274344|NCT03888755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274345|NCT03888755|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6274346|NCT03888755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6274347|NCT03888755|Immunologic Factors|immunologic factors|mesh-ancestor
6274348|NCT03888365|Treprostinil|treprostinil|mesh-list
6274349|NCT03888365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6274350|NCT03887442|Paclitaxel|paclitaxel|mesh-list
6274351|NCT03887442|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6274352|NCT03887442|Cetuximab|cetuximab|mesh-list
6274353|NCT03887442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6274354|NCT03887442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6274355|NCT03887442|Tubulin Modulators|tubulin modulators|mesh-ancestor
6274356|NCT03887442|Antimitotic Agents|antimitotic agents|mesh-ancestor
6274357|NCT03887442|Mitosis Modulators|mitosis modulators|mesh-ancestor
6274358|NCT03887442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274359|NCT03887442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6274360|NCT03873987|Oritavancin|oritavancin|mesh-list
6274361|NCT03873987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6274362|NCT03873987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6274363|NCT03887299|Disinfectants|disinfectants|mesh-list
6274364|NCT03887299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6274365|NCT03886701|Isoniazid|isoniazid|mesh-list
6274366|NCT03886701|Rifapentine|rifapentine|mesh-list
6274367|NCT03886701|Antitubercular Agents|antitubercular agents|mesh-ancestor
6274368|NCT03886701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6274369|NCT03886701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6274370|NCT03886701|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6274371|NCT03886701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6274372|NCT03886701|Antimetabolites|antimetabolites|mesh-ancestor
6274373|NCT03886701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274374|NCT03886701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6274375|NCT03886701|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6274376|NCT03886701|Leprostatic Agents|leprostatic agents|mesh-ancestor
6274377|NCT03885934|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6274378|NCT03885934|Immunologic Factors|immunologic factors|mesh-ancestor
6274379|NCT03885934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274380|NCT03885154|Dihydroergotamine|dihydroergotamine|mesh-list
6274381|NCT03885154|Valproic Acid|valproic acid|mesh-list
6274382|NCT03885154|Anticonvulsants|anticonvulsants|mesh-ancestor
6274383|NCT03885154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6274384|NCT03885154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274385|NCT03885154|GABA Agents|gaba agents|mesh-ancestor
6274386|NCT03885154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6274387|NCT03885154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274388|NCT03885154|Antimanic Agents|antimanic agents|mesh-ancestor
6274389|NCT03885154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6274390|NCT03885154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6274391|NCT03885154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6274392|NCT03885154|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6274393|NCT03885154|Dopamine Agonists|dopamine agonists|mesh-ancestor
6015066|NCT00354744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6274394|NCT03885154|Dopamine Agents|dopamine agents|mesh-ancestor
6274395|NCT03885154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6274396|NCT03885154|Analgesics|analgesics|mesh-ancestor
6274397|NCT03885154|Sensory System Agents|sensory system agents|mesh-ancestor
6274398|NCT03885154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6015067|NCT00354744|Alkylating Agents|alkylating agents|mesh-ancestor
6015068|NCT00354744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015069|NCT00354744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6015070|NCT00354744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6015071|NCT00354744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6015072|NCT00354744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6015073|NCT00354744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6015074|NCT00354744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6274399|NCT03883386|Loratadine|loratadine|mesh-list
6274400|NCT03883386|Antipruritics|antipruritics|mesh-ancestor
6274401|NCT03883386|Dermatologic Agents|dermatologic agents|mesh-ancestor
6274402|NCT03883386|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6274403|NCT03883386|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6274404|NCT03883386|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6274405|NCT03883386|Histamine Antagonists|histamine antagonists|mesh-ancestor
6274406|NCT03883386|Histamine Agents|histamine agents|mesh-ancestor
6274407|NCT03883386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6274408|NCT03883386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274409|NCT03883386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274410|NCT03882424|Bevacizumab|bevacizumab|mesh-list
6274411|NCT03882424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6274412|NCT03882424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6274413|NCT03882424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6274414|NCT03882424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6274415|NCT03882424|Growth Substances|growth substances|mesh-ancestor
6274416|NCT03882424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274417|NCT03882424|Growth Inhibitors|growth inhibitors|mesh-ancestor
6274418|NCT03881163|Acetylcysteine|acetylcysteine|mesh-list
6274419|NCT03881163|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6274420|NCT03881163|Antiviral Agents|antiviral agents|mesh-ancestor
6274421|NCT03881163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6274422|NCT03881163|Expectorants|expectorants|mesh-ancestor
6274423|NCT03881163|Respiratory System Agents|respiratory system agents|mesh-ancestor
6274424|NCT03881163|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6274425|NCT03881163|Antioxidants|antioxidants|mesh-ancestor
6274426|NCT03881163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274427|NCT03881163|Protective Agents|protective agents|mesh-ancestor
6274428|NCT03881163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274429|NCT03881163|Antidotes|antidotes|mesh-ancestor
6274430|NCT03880266|Glycopyrrolate|glycopyrrolate|mesh-list
6274431|NCT03880266|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6274432|NCT03880266|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6274433|NCT03880266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6274434|NCT03880266|Cholinergic Agents|cholinergic agents|mesh-ancestor
6274435|NCT03880266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6274436|NCT03880266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274437|NCT03880266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274438|NCT03875664|Bupivacaine|bupivacaine|mesh-list
6274439|NCT03875664|Anesthetics, Local|anesthetics, local|mesh-ancestor
6274440|NCT03875664|Anesthetics|anesthetics|mesh-ancestor
6274441|NCT03875664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6274442|NCT03875664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274443|NCT03875664|Sensory System Agents|sensory system agents|mesh-ancestor
6274444|NCT03875664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6274445|NCT03848871|Betamethasone|betamethasone|mesh-list
6274446|NCT03848871|Betamethasone Valerate|betamethasone valerate|mesh-list
6274447|NCT03848871|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
6274448|NCT03848871|Betamethasone benzoate|betamethasone benzoate|mesh-list
6274449|NCT03848871|Calcipotriene|calcipotriene|mesh-list
6274450|NCT03848871|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
6274451|NCT03848871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6274452|NCT03848871|Glucocorticoids|glucocorticoids|mesh-ancestor
6274453|NCT03848871|Hormones|hormones|mesh-ancestor
6274454|NCT03848871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6274455|NCT03848871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274456|NCT03848871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6274457|NCT03848871|Respiratory System Agents|respiratory system agents|mesh-ancestor
6274458|NCT03848871|Dermatologic Agents|dermatologic agents|mesh-ancestor
6391119|NCT00192608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6391120|NCT00192608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391121|NCT00192608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6391122|NCT00192608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6391123|NCT00192608|Antiviral Agents|antiviral agents|mesh-ancestor
6391124|NCT00192608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6391125|NCT00192608|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6391126|NCT00192608|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6391127|NCT00192621|Lamivudine|lamivudine|mesh-list
6391128|NCT00192621|Zidovudine|zidovudine|mesh-list
6391129|NCT00192621|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6391130|NCT00192621|Lopinavir|lopinavir|mesh-list
6391131|NCT00192621|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6391132|NCT00192621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6391133|NCT00192621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6274459|NCT03848403|Ixekizumab|ixekizumab|mesh-list
6274460|NCT03848403|Dermatologic Agents|dermatologic agents|mesh-ancestor
6274461|NCT03879603|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6274462|NCT03879603|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6274463|NCT03879603|Immunologic Factors|immunologic factors|mesh-ancestor
6274464|NCT03879603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274465|NCT03879603|Antacids|antacids|mesh-ancestor
6274466|NCT03879603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274467|NCT03879603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6274468|NCT03877237|Dapagliflozin|dapagliflozin|mesh-list
6274469|NCT03877237|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6274470|NCT03877237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274471|NCT03877237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6274472|NCT03877237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274473|NCT03866434|Anagrelide|anagrelide|mesh-list
6274474|NCT03866434|Omeprazole|omeprazole|mesh-list
6274475|NCT03866434|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6274476|NCT03866434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6274477|NCT03866434|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6274478|NCT03866434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6274479|NCT03866434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274480|NCT03866434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6274481|NCT03866434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6274482|NCT03866434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6274483|NCT03855059|Dexamethasone|dexamethasone|mesh-list
6274484|NCT03855059|Dexamethasone acetate|dexamethasone acetate|mesh-list
6274485|NCT03855059|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
6274486|NCT03855059|BB 1101|bb 1101|mesh-list
6274487|NCT03855059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6274488|NCT03855059|Antiemetics|antiemetics|mesh-ancestor
6274489|NCT03855059|Autonomic Agents|autonomic agents|mesh-ancestor
6274490|NCT03855059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6274491|NCT03855059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274492|NCT03855059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6274493|NCT03855059|Glucocorticoids|glucocorticoids|mesh-ancestor
6274494|NCT03855059|Hormones|hormones|mesh-ancestor
6274495|NCT03855059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6274496|NCT03855059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6274497|NCT03855059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6274498|NCT03855059|Protease Inhibitors|protease inhibitors|mesh-ancestor
6274499|NCT03855059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6274500|NCT03855059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274501|NCT03852537|Methylprednisolone|methylprednisolone|mesh-list
6274502|NCT03852537|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6274503|NCT03852537|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6274504|NCT03852537|Prednisolone|prednisolone|mesh-list
6274505|NCT03852537|Prednisolone acetate|prednisolone acetate|mesh-list
6274506|NCT03852537|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6274507|NCT03852537|Prednisolone phosphate|prednisolone phosphate|mesh-list
6274508|NCT03852537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6274509|NCT03852537|Antiemetics|antiemetics|mesh-ancestor
6274510|NCT03852537|Autonomic Agents|autonomic agents|mesh-ancestor
6274511|NCT03852537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6274512|NCT03852537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274513|NCT03852537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6274514|NCT03852537|Glucocorticoids|glucocorticoids|mesh-ancestor
6274515|NCT03852537|Hormones|hormones|mesh-ancestor
6274516|NCT03852537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6274517|NCT03852537|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6274518|NCT03852537|Protective Agents|protective agents|mesh-ancestor
6274519|NCT03852537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6274520|NCT03852537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6274521|NCT03875859|Benzoic Acid|benzoic acid|mesh-list
6274522|NCT03875859|Antifungal Agents|antifungal agents|mesh-ancestor
6274523|NCT03875859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6274524|NCT03875482|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6274525|NCT03875482|Immunologic Factors|immunologic factors|mesh-ancestor
6274526|NCT03875482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274527|NCT03873116|Berotralstat|berotralstat|mesh-list
6274528|NCT03873116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6274529|NCT03873116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274530|NCT03872843|Ibuprofen|ibuprofen|mesh-list
6274531|NCT03872843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6274532|NCT03872843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6274533|NCT03872843|Analgesics|analgesics|mesh-ancestor
6274534|NCT03872843|Sensory System Agents|sensory system agents|mesh-ancestor
6274535|NCT03872843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6274536|NCT03872843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274537|NCT03872843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6274538|NCT03872843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6274539|NCT03872843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6274540|NCT03872843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6274541|NCT03872843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274542|NCT03861338|Buprenorphine|buprenorphine|mesh-list
6274543|NCT03861338|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6274544|NCT03861338|Narcotics|narcotics|mesh-ancestor
6274545|NCT03861338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6274546|NCT03861338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274547|NCT03861338|Analgesics|analgesics|mesh-ancestor
6274548|NCT03861338|Sensory System Agents|sensory system agents|mesh-ancestor
6274549|NCT03861338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6274550|NCT03861338|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6274551|NCT03848416|Ixekizumab|ixekizumab|mesh-list
6274552|NCT03848416|Dermatologic Agents|dermatologic agents|mesh-ancestor
6274553|NCT03853551|Osimertinib|osimertinib|mesh-list
6274554|NCT03853551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6274555|NCT03853551|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6274556|NCT03853551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6274557|NCT03853551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274558|NCT03869450|Lidocaine|lidocaine|mesh-list
6274559|NCT03869450|Hyaluronic Acid|hyaluronic acid|mesh-list
6274560|NCT03869450|Anesthetics, Local|anesthetics, local|mesh-ancestor
6274561|NCT03869450|Anesthetics|anesthetics|mesh-ancestor
6274562|NCT03869450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6274563|NCT03869450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274564|NCT03869450|Sensory System Agents|sensory system agents|mesh-ancestor
6274565|NCT03869450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6274566|NCT03869450|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6274567|NCT03869450|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6274568|NCT03869450|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6274569|NCT03869450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6274570|NCT03869450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274571|NCT03869450|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6274572|NCT03869450|Immunologic Factors|immunologic factors|mesh-ancestor
6274573|NCT03869450|Viscosupplements|viscosupplements|mesh-ancestor
6274574|NCT03869450|Protective Agents|protective agents|mesh-ancestor
6274575|NCT03859960|Insulin|insulin|mesh-list
6274576|NCT03859960|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6274577|NCT03859960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6274578|NCT03859960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274579|NCT03868059|Methyltestosterone|methyltestosterone|mesh-list
6274580|NCT03868059|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6274581|NCT03868059|Testosterone|testosterone|mesh-list
6274582|NCT03868059|Testosterone undecanoate|testosterone undecanoate|mesh-list
6274583|NCT03868059|Testosterone enanthate|testosterone enanthate|mesh-list
6274584|NCT03868059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6274585|NCT03868059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6274586|NCT03868059|Anabolic Agents|anabolic agents|mesh-ancestor
6274587|NCT03868059|Hormones|hormones|mesh-ancestor
6274588|NCT03868059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6274589|NCT03868059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274590|NCT03868059|Androgens|androgens|mesh-ancestor
6274591|NCT03850444|Paclitaxel|paclitaxel|mesh-list
6274592|NCT03850444|Carboplatin|carboplatin|mesh-list
6274593|NCT03850444|Pembrolizumab|pembrolizumab|mesh-list
6274594|NCT03850444|Pemetrexed|pemetrexed|mesh-list
6274595|NCT03850444|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6274596|NCT03850444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6274597|NCT03850444|Tubulin Modulators|tubulin modulators|mesh-ancestor
6274598|NCT03850444|Antimitotic Agents|antimitotic agents|mesh-ancestor
6274599|NCT03850444|Mitosis Modulators|mitosis modulators|mesh-ancestor
6274600|NCT03850444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274601|NCT03850444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6274602|NCT03850444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6274603|NCT03850444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6274604|NCT03850444|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6274605|NCT03865407|Allopurinol|allopurinol|mesh-list
6274606|NCT03865407|Antimetabolites|antimetabolites|mesh-ancestor
6274607|NCT03865407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274608|NCT03865407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6274609|NCT03865407|Gout Suppressants|gout suppressants|mesh-ancestor
6274610|NCT03865407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6274611|NCT03865407|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6274612|NCT03865407|Antioxidants|antioxidants|mesh-ancestor
6274613|NCT03865407|Protective Agents|protective agents|mesh-ancestor
6274614|NCT03865407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274615|NCT03857230|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6274616|NCT03857230|Hormones|hormones|mesh-ancestor
6274617|NCT03857230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6274618|NCT03857230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274619|NCT03847610|Penicillins|penicillins|mesh-list
6274620|NCT03847610|Penicillin V|penicillin v|mesh-list
6274621|NCT03847610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6274622|NCT03847610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6274623|NCT03850093|Bisoprolol|bisoprolol|mesh-list
6274624|NCT03850093|Gabapentin|gabapentin|mesh-list
6274625|NCT03850093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274626|NCT03850093|Analgesics|analgesics|mesh-ancestor
6274627|NCT03850093|Sensory System Agents|sensory system agents|mesh-ancestor
6274628|NCT03850093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6274629|NCT03850093|Anticonvulsants|anticonvulsants|mesh-ancestor
6274630|NCT03850093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6274631|NCT03850093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6274632|NCT03850093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6274633|NCT03850093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6274634|NCT03850093|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6274635|NCT03850093|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6274636|NCT03850093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6274637|NCT03850093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274638|NCT03850093|Antimanic Agents|antimanic agents|mesh-ancestor
6274639|NCT03850093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6274640|NCT03850093|Sympatholytics|sympatholytics|mesh-ancestor
6274641|NCT03850093|Autonomic Agents|autonomic agents|mesh-ancestor
6274642|NCT03850093|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6274643|NCT03850093|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6274644|NCT03850093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6274645|NCT03850093|Adrenergic Agents|adrenergic agents|mesh-ancestor
6274646|NCT03847389|Clobetasol|clobetasol|mesh-list
6274647|NCT03847389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6274648|NCT03847389|Glucocorticoids|glucocorticoids|mesh-ancestor
6274649|NCT03847389|Hormones|hormones|mesh-ancestor
6274650|NCT03847389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6274651|NCT03847389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274652|NCT03862040|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6274653|NCT03862040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6274654|NCT03861936|Botulinum Toxins|botulinum toxins|mesh-list
6274655|NCT03861936|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6274656|NCT03861936|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6274657|NCT03861936|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6274658|NCT03861936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6274659|NCT03861936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274660|NCT03861936|Cholinergic Agents|cholinergic agents|mesh-ancestor
6274661|NCT03861936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6274662|NCT03861936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274663|NCT03861936|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6274664|NCT03861936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6274665|NCT03857750|Rocuronium|rocuronium|mesh-list
6274666|NCT03857750|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6274667|NCT03857750|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6274668|NCT03857750|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6274669|NCT03857750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6274670|NCT03857750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274671|NCT03860753|Pioglitazone|pioglitazone|mesh-list
6274672|NCT03860753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6274673|NCT03860753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274674|NCT03858894|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6274675|NCT03858894|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6274676|NCT03856164|Tranexamic Acid|tranexamic acid|mesh-list
6274677|NCT03856164|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6274678|NCT03856164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6274679|NCT03856164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274680|NCT03856164|Hemostatics|hemostatics|mesh-ancestor
6274681|NCT03856164|Coagulants|coagulants|mesh-ancestor
6274682|NCT03849690|Esomeprazole|esomeprazole|mesh-list
6274683|NCT03849690|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6274684|NCT03849690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6274685|NCT03849690|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6274686|NCT03849690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6274687|NCT03849690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274688|NCT03844945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6274689|NCT03844945|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6274690|NCT03840811|Ciprofloxacin|ciprofloxacin|mesh-list
6274691|NCT03840811|Ceftriaxone|ceftriaxone|mesh-list
6274692|NCT03840811|Cefixime|cefixime|mesh-list
6274693|NCT03840811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6274694|NCT03840811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6274695|NCT03840811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6274696|NCT03840811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6274697|NCT03840811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6274698|NCT03840811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274699|NCT03840811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6274700|NCT03840811|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6274701|NCT03840811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6274702|NCT03825939|Tranexamic Acid|tranexamic acid|mesh-list
6274703|NCT03825939|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6274704|NCT03825939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6274705|NCT03825939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274706|NCT03825939|Hemostatics|hemostatics|mesh-ancestor
6274707|NCT03825939|Coagulants|coagulants|mesh-ancestor
6274708|NCT03841331|Serlopitant|serlopitant|mesh-list
6274709|NCT03841331|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6274710|NCT03841331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6274711|NCT03841331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274712|NCT03841331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274713|NCT03840278|Pancrelipase|pancrelipase|mesh-list
6274714|NCT03840278|Pancreatin|pancreatin|mesh-list
6274715|NCT03840278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6274716|NCT03839355|Warfarin|warfarin|mesh-list
6274717|NCT03839355|Apixaban|apixaban|mesh-list
6274718|NCT03839355|Anticoagulants|anticoagulants|mesh-ancestor
6274719|NCT03839355|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6274720|NCT03839355|Antithrombins|antithrombins|mesh-ancestor
6274721|NCT03839355|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6274722|NCT03839355|Protease Inhibitors|protease inhibitors|mesh-ancestor
6274723|NCT03839355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6274724|NCT03839355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274725|NCT03838874|Bupivacaine|bupivacaine|mesh-list
6274726|NCT03838874|Mepivacaine|mepivacaine|mesh-list
6274727|NCT03838874|Anesthetics, Local|anesthetics, local|mesh-ancestor
6274728|NCT03838874|Anesthetics|anesthetics|mesh-ancestor
6274729|NCT03838874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6274730|NCT03838874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274731|NCT03838874|Sensory System Agents|sensory system agents|mesh-ancestor
6274732|NCT03838874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6274733|NCT03822078|Denosumab|denosumab|mesh-list
6274734|NCT03822078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6274735|NCT03822078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6391134|NCT00192621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391135|NCT00192621|Antiviral Agents|antiviral agents|mesh-ancestor
6391136|NCT00192621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6391137|NCT00192621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6274736|NCT03811951|Insulin|insulin|mesh-list
6274737|NCT03811951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6274738|NCT03811951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274739|NCT03810235|Lidocaine|lidocaine|mesh-list
6274740|NCT03810235|Anesthetics, Local|anesthetics, local|mesh-ancestor
6274741|NCT03810235|Anesthetics|anesthetics|mesh-ancestor
6274742|NCT03810235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6274743|NCT03810235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274744|NCT03810235|Sensory System Agents|sensory system agents|mesh-ancestor
6274745|NCT03810235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6274746|NCT03810235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6274747|NCT03810235|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6274748|NCT03810235|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6274749|NCT03810235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6274750|NCT03810235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274751|NCT03806556|Tranexamic Acid|tranexamic acid|mesh-list
6274752|NCT03806556|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6274753|NCT03806556|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6274754|NCT03806556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274755|NCT03806556|Hemostatics|hemostatics|mesh-ancestor
6274756|NCT03806556|Coagulants|coagulants|mesh-ancestor
6274757|NCT03836664|Timolol|timolol|mesh-list
6274758|NCT03836664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6274759|NCT03836664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6274760|NCT03836664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6274761|NCT03836664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6274762|NCT03836664|Adrenergic Agents|adrenergic agents|mesh-ancestor
6274763|NCT03836664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6274764|NCT03836664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274765|NCT03836664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274766|NCT03836664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6274767|NCT03836664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6274768|NCT03823391|Adalimumab|adalimumab|mesh-list
6274769|NCT03823391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6274770|NCT03823391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6274771|NCT03808298|Moxifloxacin|moxifloxacin|mesh-list
6274772|NCT03808298|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6274773|NCT03808298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6274774|NCT03808298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6274775|NCT03808298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6274776|NCT03808298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6274777|NCT03808298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6274778|NCT03808298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274779|NCT03808298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6274780|NCT03808298|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6274781|NCT03808298|Contraceptive Agents|contraceptive agents|mesh-ancestor
6274782|NCT03808298|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6274783|NCT03808298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274784|NCT03808298|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6274785|NCT03808298|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6274786|NCT03808298|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6274787|NCT03836729|Tenofovir|tenofovir|mesh-list
6274788|NCT03836729|Emtricitabine|emtricitabine|mesh-list
6274789|NCT03836729|Antiviral Agents|antiviral agents|mesh-ancestor
6274790|NCT03836729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6274791|NCT03836729|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6274792|NCT03836729|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6274793|NCT03836729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6274794|NCT03836729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274795|NCT03836729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6274796|NCT03836729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6274797|NCT03835975|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6274798|NCT03835975|Immunologic Factors|immunologic factors|mesh-ancestor
6274799|NCT03835975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274800|NCT03801148|Dexlansoprazole|dexlansoprazole|mesh-list
6274801|NCT03801148|Lansoprazole|lansoprazole|mesh-list
6274802|NCT03801148|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6274803|NCT03801148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6274804|NCT03801148|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6274805|NCT03801148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6274806|NCT03801148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274807|NCT03831854|Lamotrigine|lamotrigine|mesh-list
6274808|NCT03831854|Ketamine|ketamine|mesh-list
6274809|NCT03831854|Analgesics|analgesics|mesh-ancestor
6274810|NCT03831854|Sensory System Agents|sensory system agents|mesh-ancestor
6274811|NCT03831854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6274812|NCT03831854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274813|NCT03831854|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6274814|NCT03831854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6274815|NCT03831854|Anesthetics, General|anesthetics, general|mesh-ancestor
6274816|NCT03831854|Anesthetics|anesthetics|mesh-ancestor
6274817|NCT03831854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6274818|NCT03831854|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6274819|NCT03831854|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6274820|NCT03831854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6274821|NCT03831854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274822|NCT03831854|Anticonvulsants|anticonvulsants|mesh-ancestor
6274823|NCT03831854|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6274824|NCT03831854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6274825|NCT03831854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6274826|NCT03831854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6274827|NCT03831854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6274828|NCT03831854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6274829|NCT03831854|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6274830|NCT03824912|Ketoconazole|ketoconazole|mesh-list
6274831|NCT03824912|Antifungal Agents|antifungal agents|mesh-ancestor
6274832|NCT03824912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6274833|NCT03824912|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6274834|NCT03824912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6274835|NCT03824912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6274836|NCT03824912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274837|NCT03824912|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6274838|NCT03824912|Hormone Antagonists|hormone antagonists|mesh-ancestor
6274839|NCT03824912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6274840|NCT03824912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274841|NCT03824912|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6274842|NCT03822884|Epoetin Alfa|epoetin alfa|mesh-list
6274843|NCT03822884|Hematinics|hematinics|mesh-ancestor
6274844|NCT03806270|Midazolam|midazolam|mesh-list
6274845|NCT03806270|Hydroxyzine|hydroxyzine|mesh-list
6274846|NCT03806270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6274847|NCT03806270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6274848|NCT03806270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6274849|NCT03806270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274850|NCT03806270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6274851|NCT03806270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6274852|NCT03806270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6274853|NCT03806270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6274854|NCT03806270|Anesthetics, General|anesthetics, general|mesh-ancestor
6274855|NCT03806270|Anesthetics|anesthetics|mesh-ancestor
6274856|NCT03806270|GABA Modulators|gaba modulators|mesh-ancestor
6274857|NCT03806270|GABA Agents|gaba agents|mesh-ancestor
6274858|NCT03806270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6274859|NCT03806270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274860|NCT03806270|Antipruritics|antipruritics|mesh-ancestor
6274861|NCT03806270|Dermatologic Agents|dermatologic agents|mesh-ancestor
6274862|NCT03806270|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6274863|NCT03806270|Histamine Antagonists|histamine antagonists|mesh-ancestor
6274864|NCT03806270|Histamine Agents|histamine agents|mesh-ancestor
6274865|NCT03830892|Nicotine|nicotine|mesh-list
6274866|NCT03830892|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6274867|NCT03830892|Autonomic Agents|autonomic agents|mesh-ancestor
6274868|NCT03830892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6274869|NCT03830892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274870|NCT03830892|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6274871|NCT03830892|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6274872|NCT03830892|Cholinergic Agents|cholinergic agents|mesh-ancestor
6274873|NCT03830892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6274874|NCT03830892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274875|NCT03823378|Upadacitinib|upadacitinib|mesh-list
6274876|NCT03823378|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
6274877|NCT03823378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6274878|NCT03823378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6274879|NCT03823378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274880|NCT03823378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6274881|NCT03830281|Insulin|insulin|mesh-list
6274882|NCT03830281|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6274883|NCT03830281|Insulin Lispro|insulin lispro|mesh-list
6274884|NCT03830281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6274885|NCT03830281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274886|NCT03818815|Amoxicillin|amoxicillin|mesh-list
6274887|NCT03818815|Clavulanic Acid|clavulanic acid|mesh-list
6274888|NCT03818815|Clavulanic Acids|clavulanic acids|mesh-list
6274889|NCT03818815|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6274890|NCT03818815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6274891|NCT03818815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6274892|NCT03818815|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6274893|NCT03818815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6274894|NCT03818815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274895|NCT03828539|Topiramate|topiramate|mesh-list
6274896|NCT03828539|Erenumab|erenumab|mesh-list
6274897|NCT03828539|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6274898|NCT03828539|Anticonvulsants|anticonvulsants|mesh-ancestor
6274899|NCT03828539|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6274900|NCT03828539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274901|NCT03828539|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
6274902|NCT03828539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274903|NCT03828539|Analgesics|analgesics|mesh-ancestor
6274904|NCT03828539|Sensory System Agents|sensory system agents|mesh-ancestor
6274905|NCT03828539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6274906|NCT03828539|Immunologic Factors|immunologic factors|mesh-ancestor
6274907|NCT03824704|Nivolumab|nivolumab|mesh-list
6274908|NCT03824704|Rucaparib|rucaparib|mesh-list
6274909|NCT03824704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6274910|NCT03824704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6274911|NCT03824704|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6274912|NCT03824704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274913|NCT03824704|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6274914|NCT03824704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6274915|NCT03827473|Ascorbic Acid|ascorbic acid|mesh-list
6274916|NCT03827473|Prednisone|prednisone|mesh-list
6274917|NCT03827473|Cortisone|cortisone|mesh-list
6274918|NCT03827473|Docetaxel|docetaxel|mesh-list
6274919|NCT03827473|Abiraterone Acetate|abiraterone acetate|mesh-list
6274920|NCT03827473|Methyltestosterone|methyltestosterone|mesh-list
6274921|NCT03827473|Hormones|hormones|mesh-list
6274922|NCT03827473|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6274923|NCT03827473|Androgens|androgens|mesh-list
6274924|NCT03827473|Androgen Antagonists|androgen antagonists|mesh-list
6274925|NCT03827473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6274926|NCT03827473|Tubulin Modulators|tubulin modulators|mesh-ancestor
6274927|NCT03827473|Antimitotic Agents|antimitotic agents|mesh-ancestor
6274928|NCT03827473|Mitosis Modulators|mitosis modulators|mesh-ancestor
6274929|NCT03827473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274930|NCT03827473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6274931|NCT03827473|Glucocorticoids|glucocorticoids|mesh-ancestor
6274932|NCT03827473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6274933|NCT03827473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274934|NCT03827473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6274935|NCT03827473|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6274936|NCT03827473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6274937|NCT03827473|Hormone Antagonists|hormone antagonists|mesh-ancestor
6274938|NCT03827473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6274939|NCT03827473|Antioxidants|antioxidants|mesh-ancestor
6274940|NCT03827473|Protective Agents|protective agents|mesh-ancestor
6274941|NCT03827473|Vitamins|vitamins|mesh-ancestor
6274942|NCT03827473|Micronutrients|micronutrients|mesh-ancestor
6274943|NCT03827473|Estrogens|estrogens|mesh-ancestor
6274944|NCT03827473|Anabolic Agents|anabolic agents|mesh-ancestor
6274945|NCT03812328|Enoxaparin|enoxaparin|mesh-list
6274946|NCT03812328|Anticoagulants|anticoagulants|mesh-ancestor
6274947|NCT03812328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6274948|NCT03812328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6274949|NCT03812328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274950|NCT03808688|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6274951|NCT03808688|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6274952|NCT03822182|Dexamethasone|dexamethasone|mesh-list
6274953|NCT03822182|Bupivacaine|bupivacaine|mesh-list
6274954|NCT03822182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6274955|NCT03822182|Antiemetics|antiemetics|mesh-ancestor
6274956|NCT03822182|Autonomic Agents|autonomic agents|mesh-ancestor
6274957|NCT03822182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6274958|NCT03822182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274959|NCT03822182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6274960|NCT03822182|Glucocorticoids|glucocorticoids|mesh-ancestor
6274961|NCT03822182|Hormones|hormones|mesh-ancestor
6274962|NCT03822182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6274963|NCT03822182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6274964|NCT03822182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6274965|NCT03822182|Anesthetics, Local|anesthetics, local|mesh-ancestor
6274966|NCT03822182|Anesthetics|anesthetics|mesh-ancestor
6274967|NCT03822182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6274968|NCT03822182|Sensory System Agents|sensory system agents|mesh-ancestor
6274969|NCT03822416|Nicotine|nicotine|mesh-list
6274970|NCT03822416|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6274971|NCT03822416|Autonomic Agents|autonomic agents|mesh-ancestor
6274972|NCT03822416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6274973|NCT03822416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274974|NCT03822416|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6274975|NCT03822416|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6274976|NCT03822416|Cholinergic Agents|cholinergic agents|mesh-ancestor
6274977|NCT03822416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6274978|NCT03822416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274979|NCT03806231|Dinoprostone|dinoprostone|mesh-list
6274980|NCT03806231|Oxytocics|oxytocics|mesh-ancestor
6274981|NCT03806231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6274982|NCT03806231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274983|NCT03822377|Ticagrelor|ticagrelor|mesh-list
6274984|NCT03822377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6274985|NCT03822377|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6274986|NCT03822377|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6274987|NCT03822377|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6274988|NCT03822377|Purinergic Agents|purinergic agents|mesh-ancestor
6274989|NCT03822377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6274990|NCT03822377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6274991|NCT03822377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274992|NCT03820388|Propofol|propofol|mesh-list
6274993|NCT03820388|Etomidate|etomidate|mesh-list
6274994|NCT03820388|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6274995|NCT03820388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6274996|NCT03820388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6274997|NCT03820388|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6274998|NCT03820388|Anesthetics, General|anesthetics, general|mesh-ancestor
6274999|NCT03820388|Anesthetics|anesthetics|mesh-ancestor
6275000|NCT03809182|Fentanyl|fentanyl|mesh-list
6275001|NCT03809182|Dexmedetomidine|dexmedetomidine|mesh-list
6275002|NCT03809182|Morphine|morphine|mesh-list
6275003|NCT03809182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6275004|NCT03809182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6275005|NCT03809182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275006|NCT03809182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6275007|NCT03809182|Analgesics|analgesics|mesh-ancestor
6275008|NCT03809182|Sensory System Agents|sensory system agents|mesh-ancestor
6275009|NCT03809182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6275010|NCT03809182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6275011|NCT03809182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6275012|NCT03809182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6275013|NCT03809182|Adrenergic Agents|adrenergic agents|mesh-ancestor
6275014|NCT03809182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6275015|NCT03809182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275016|NCT03809182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6275017|NCT03809182|Narcotics|narcotics|mesh-ancestor
6275018|NCT03809182|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6275019|NCT03809182|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6275020|NCT03809182|Anesthetics, General|anesthetics, general|mesh-ancestor
6275021|NCT03809182|Anesthetics|anesthetics|mesh-ancestor
6275022|NCT03816761|Insulin Aspart|insulin aspart|mesh-list
6275023|NCT03816761|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6275024|NCT03816761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275025|NCT03805672|Enoxaparin|enoxaparin|mesh-list
6275026|NCT03805672|Enoxaparin sodium|enoxaparin sodium|mesh-list
6275027|NCT03805672|Anticoagulants|anticoagulants|mesh-ancestor
6275028|NCT03805672|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6015075|NCT00354744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6015076|NCT00354744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6015077|NCT00354744|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6015078|NCT00354744|Tubulin Modulators|tubulin modulators|mesh-ancestor
6015079|NCT00354744|Antimitotic Agents|antimitotic agents|mesh-ancestor
6275029|NCT03805672|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6275030|NCT03805672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275031|NCT03812510|Hydrogen Peroxide|hydrogen peroxide|mesh-list
6275032|NCT03812510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6275033|NCT03812510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6275034|NCT03802994|Vaccines|vaccines|mesh-list
6275035|NCT03802994|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6275036|NCT03802994|Immunologic Factors|immunologic factors|mesh-ancestor
6275037|NCT03802994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275038|NCT03809611|Choline|choline|mesh-list
6275039|NCT03809611|Lipotropic Agents|lipotropic agents|mesh-ancestor
6275040|NCT03809611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6275041|NCT03809611|Antimetabolites|antimetabolites|mesh-ancestor
6275042|NCT03809611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275043|NCT03809611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6275044|NCT03809611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6275045|NCT03809611|Nootropic Agents|nootropic agents|mesh-ancestor
6275046|NCT03807245|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6275047|NCT03807245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6275048|NCT03807245|Immunologic Factors|immunologic factors|mesh-ancestor
6275049|NCT03807245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275050|NCT03807245|Antacids|antacids|mesh-ancestor
6275051|NCT03807245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275052|NCT03807245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6275053|NCT03802916|Deferiprone|deferiprone|mesh-list
6275054|NCT03802916|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6275055|NCT03802916|Chelating Agents|chelating agents|mesh-ancestor
6275056|NCT03802916|Sequestering Agents|sequestering agents|mesh-ancestor
6275057|NCT03802916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275058|NCT03805386|Analgesics, Opioid|analgesics, opioid|mesh-list
6275059|NCT03805386|Narcotics|narcotics|mesh-ancestor
6275060|NCT03805386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6275061|NCT03805386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275062|NCT03805386|Analgesics|analgesics|mesh-ancestor
6275063|NCT03805386|Sensory System Agents|sensory system agents|mesh-ancestor
6275064|NCT03805386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6275065|NCT03803475|Edetic Acid|edetic acid|mesh-list
6275066|NCT03803475|Chelating Agents|chelating agents|mesh-ancestor
6275067|NCT03803475|Sequestering Agents|sequestering agents|mesh-ancestor
6275068|NCT03803475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275069|NCT03803475|Anticoagulants|anticoagulants|mesh-ancestor
6275070|NCT03803475|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6275071|NCT03802227|Oxycodone|oxycodone|mesh-list
6275072|NCT03802227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6275073|NCT03802227|Narcotics|narcotics|mesh-ancestor
6275074|NCT03802227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6275075|NCT03802227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275076|NCT03802227|Analgesics|analgesics|mesh-ancestor
6275077|NCT03802227|Sensory System Agents|sensory system agents|mesh-ancestor
6275078|NCT03802227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6275079|NCT03802864|Bupivacaine|bupivacaine|mesh-list
6275080|NCT03802864|Anesthetics, Local|anesthetics, local|mesh-ancestor
6275081|NCT03802864|Anesthetics|anesthetics|mesh-ancestor
6275082|NCT03802864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6015080|NCT00354744|Mitosis Modulators|mitosis modulators|mesh-ancestor
6015081|NCT00354744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6015082|NCT00354744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6015083|NCT00354744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6015084|NCT00354744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6015085|NCT00354770|Acetylcysteine|acetylcysteine|mesh-list
6275083|NCT03802864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275084|NCT03802864|Sensory System Agents|sensory system agents|mesh-ancestor
6275085|NCT03802864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6275086|NCT03801265|Ropivacaine|ropivacaine|mesh-list
6275087|NCT03801265|Anesthetics, Local|anesthetics, local|mesh-ancestor
6275088|NCT03801265|Anesthetics|anesthetics|mesh-ancestor
6275089|NCT03801265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6275090|NCT03801265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275091|NCT03801265|Sensory System Agents|sensory system agents|mesh-ancestor
6275092|NCT03801265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6275093|NCT03801928|Infliximab|infliximab|mesh-list
6275094|NCT03801928|Dermatologic Agents|dermatologic agents|mesh-ancestor
6275095|NCT03801928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6275096|NCT03801928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6275097|NCT03800173|Galidesivir|galidesivir|mesh-list
6275098|NCT03800173|Antiviral Agents|antiviral agents|mesh-ancestor
6275099|NCT03800173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6391138|NCT00192621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6391139|NCT00192621|Antimetabolites|antimetabolites|mesh-ancestor
6391140|NCT00192621|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6391141|NCT00192621|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6391142|NCT00192621|Protease Inhibitors|protease inhibitors|mesh-ancestor
6391143|NCT00192621|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6391144|NCT00192621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6391145|NCT00192634|Tenofovir|tenofovir|mesh-list
6391146|NCT00192634|Lamivudine|lamivudine|mesh-list
6391147|NCT00192634|Emtricitabine|emtricitabine|mesh-list
6391148|NCT00192634|Abacavir|abacavir|mesh-list
6391149|NCT00192634|Antiviral Agents|antiviral agents|mesh-ancestor
6391150|NCT00192634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6391151|NCT00192634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6391152|NCT00192634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6391153|NCT00192634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6391154|NCT00192634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391155|NCT00192634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6391156|NCT00192634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6391157|NCT00192660|Ritonavir|ritonavir|mesh-list
6391158|NCT00192660|Nelfinavir|nelfinavir|mesh-list
6391159|NCT00192660|Indinavir|indinavir|mesh-list
6391160|NCT00192660|Saquinavir|saquinavir|mesh-list
6391161|NCT00192660|Amprenavir|amprenavir|mesh-list
6391162|NCT00192660|Tenofovir|tenofovir|mesh-list
6391163|NCT00192660|Lamivudine|lamivudine|mesh-list
6391164|NCT00192660|Zidovudine|zidovudine|mesh-list
6391165|NCT00192660|Nevirapine|nevirapine|mesh-list
6391166|NCT00192660|Abacavir|abacavir|mesh-list
6275100|NCT03799783|Dexmedetomidine|dexmedetomidine|mesh-list
6275101|NCT03799783|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6275102|NCT03799783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6275103|NCT03799783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275104|NCT03799783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6275105|NCT03799783|Analgesics|analgesics|mesh-ancestor
6275106|NCT03799783|Sensory System Agents|sensory system agents|mesh-ancestor
6275107|NCT03799783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6275108|NCT03799783|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6275109|NCT03799783|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6275110|NCT03799783|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6275111|NCT03799783|Adrenergic Agents|adrenergic agents|mesh-ancestor
6275112|NCT03799783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6275113|NCT03799783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275114|NCT03797872|Sulfasalazine|sulfasalazine|mesh-list
6275115|NCT03797872|Methylprednisolone|methylprednisolone|mesh-list
6275116|NCT03797872|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6275117|NCT03797872|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6275118|NCT03797872|Prednisolone|prednisolone|mesh-list
6275119|NCT03797872|Prednisolone acetate|prednisolone acetate|mesh-list
6275120|NCT03797872|Triamcinolone|triamcinolone|mesh-list
6275121|NCT03797872|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6275122|NCT03797872|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6275123|NCT03797872|Methotrexate|methotrexate|mesh-list
6275124|NCT03797872|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6275125|NCT03797872|Leflunomide|leflunomide|mesh-list
6275126|NCT03797872|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6275127|NCT03797872|Prednisolone phosphate|prednisolone phosphate|mesh-list
6275128|NCT03797872|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6275129|NCT03797872|Abortifacient Agents|abortifacient agents|mesh-ancestor
6275130|NCT03797872|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6275131|NCT03797872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275132|NCT03797872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6275133|NCT03797872|Antimetabolites|antimetabolites|mesh-ancestor
6275134|NCT03797872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275135|NCT03797872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6275136|NCT03797872|Dermatologic Agents|dermatologic agents|mesh-ancestor
6275137|NCT03797872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6275138|NCT03797872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6275139|NCT03797872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6275140|NCT03797872|Immunologic Factors|immunologic factors|mesh-ancestor
6275141|NCT03797872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6275142|NCT03797872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6275143|NCT03797872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6275144|NCT03797872|Antiemetics|antiemetics|mesh-ancestor
6275145|NCT03797872|Autonomic Agents|autonomic agents|mesh-ancestor
6275146|NCT03797872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6275147|NCT03797872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6275148|NCT03797872|Glucocorticoids|glucocorticoids|mesh-ancestor
6275149|NCT03797872|Hormones|hormones|mesh-ancestor
6275150|NCT03797872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6275151|NCT03797872|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6275152|NCT03797872|Protective Agents|protective agents|mesh-ancestor
6275153|NCT03797872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6275154|NCT03797872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6275155|NCT03797872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6275156|NCT03797872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6275157|NCT03797872|Analgesics|analgesics|mesh-ancestor
6275158|NCT03797872|Sensory System Agents|sensory system agents|mesh-ancestor
6275159|NCT03799484|Lidocaine|lidocaine|mesh-list
6275160|NCT03799484|Prilocaine|prilocaine|mesh-list
6275161|NCT03799484|Petrolatum|petrolatum|mesh-list
6275162|NCT03799484|Botulinum Toxins|botulinum toxins|mesh-list
6275163|NCT03799484|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6275164|NCT03799484|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6275165|NCT03799484|Anesthetics, Local|anesthetics, local|mesh-ancestor
6275166|NCT03799484|Anesthetics|anesthetics|mesh-ancestor
6275167|NCT03799484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6275168|NCT03799484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275169|NCT03799484|Sensory System Agents|sensory system agents|mesh-ancestor
6275170|NCT03799484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6275171|NCT03799484|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6275172|NCT03799484|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6275173|NCT03799484|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6275174|NCT03799484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6275175|NCT03799484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275176|NCT03799484|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6275177|NCT03799484|Cholinergic Agents|cholinergic agents|mesh-ancestor
6275178|NCT03799484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6275179|NCT03799484|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6275180|NCT03799484|Emollients|emollients|mesh-ancestor
6275181|NCT03799484|Dermatologic Agents|dermatologic agents|mesh-ancestor
6275182|NCT03796728|Lidocaine|lidocaine|mesh-list
6275183|NCT03796728|Anesthetics, Local|anesthetics, local|mesh-ancestor
6275184|NCT03796728|Anesthetics|anesthetics|mesh-ancestor
6275185|NCT03796728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6275186|NCT03796728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275187|NCT03796728|Sensory System Agents|sensory system agents|mesh-ancestor
6275188|NCT03796728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6275189|NCT03796728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6275190|NCT03796728|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6275191|NCT03796728|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6275192|NCT03796728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6275193|NCT03796728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275194|NCT03796260|Entrectinib|entrectinib|mesh-list
6275195|NCT03796260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6275196|NCT03796260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6275197|NCT03796260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275198|NCT03780959|Etanercept|etanercept|mesh-list
6275199|NCT03780959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6275200|NCT03780959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6275201|NCT03780959|Analgesics|analgesics|mesh-ancestor
6275202|NCT03780959|Sensory System Agents|sensory system agents|mesh-ancestor
6275203|NCT03780959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6275204|NCT03780959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275205|NCT03780959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6275206|NCT03780959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6275207|NCT03780959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6275208|NCT03780959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6275209|NCT03780959|Immunologic Factors|immunologic factors|mesh-ancestor
6275210|NCT03796182|Metformin|metformin|mesh-list
6275211|NCT03796182|Abrocitinib|abrocitinib|mesh-list
6275212|NCT03796182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6275213|NCT03796182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275214|NCT03796182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6275215|NCT03796182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6275216|NCT03796182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275217|NCT03796013|Entrectinib|entrectinib|mesh-list
6275218|NCT03796013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6275219|NCT03796013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6015086|NCT00354770|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6015087|NCT00354770|Antiviral Agents|antiviral agents|mesh-ancestor
6015088|NCT00354770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6275220|NCT03796013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275221|NCT03796676|Abrocitinib|abrocitinib|mesh-list
6015089|NCT00354770|Expectorants|expectorants|mesh-ancestor
6015090|NCT00354770|Respiratory System Agents|respiratory system agents|mesh-ancestor
6015091|NCT00354770|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6015092|NCT00354770|Antioxidants|antioxidants|mesh-ancestor
6015093|NCT00354770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015094|NCT00354770|Protective Agents|protective agents|mesh-ancestor
6015095|NCT00354770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015096|NCT00354770|Antidotes|antidotes|mesh-ancestor
6015097|NCT00354887|Capecitabine|capecitabine|mesh-list
6275222|NCT03796676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6275223|NCT03796676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6275224|NCT03796676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275225|NCT03793751|Dexmedetomidine|dexmedetomidine|mesh-list
6275226|NCT03793751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6275227|NCT03793751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6275228|NCT03793751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275229|NCT03793751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6275230|NCT03793751|Analgesics|analgesics|mesh-ancestor
6275231|NCT03793751|Sensory System Agents|sensory system agents|mesh-ancestor
6275232|NCT03793751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6275233|NCT03793751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6275234|NCT03793751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6275235|NCT03793751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6275236|NCT03793751|Adrenergic Agents|adrenergic agents|mesh-ancestor
6275237|NCT03793751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6275238|NCT03793751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275239|NCT03793556|Omeprazole|omeprazole|mesh-list
6275240|NCT03793556|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6275241|NCT03793556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6275242|NCT03793556|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6275243|NCT03793556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6275244|NCT03793556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275245|NCT03782701|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6275246|NCT03782701|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6275247|NCT03782701|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6275248|NCT03782701|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6275249|NCT03782701|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6275250|NCT03782701|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6275251|NCT03782701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6275252|NCT03782701|Adrenergic Agents|adrenergic agents|mesh-ancestor
6275253|NCT03782701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6275254|NCT03782701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275255|NCT03782701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275256|NCT03773133|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
6275257|NCT03773133|Chelating Agents|chelating agents|mesh-ancestor
6275258|NCT03773133|Sequestering Agents|sequestering agents|mesh-ancestor
6275259|NCT03773133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275260|NCT03792672|Ketamine|ketamine|mesh-list
6275261|NCT03792672|Analgesics|analgesics|mesh-ancestor
6275262|NCT03792672|Sensory System Agents|sensory system agents|mesh-ancestor
6275263|NCT03792672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6275264|NCT03792672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275265|NCT03792672|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6275266|NCT03792672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6275267|NCT03792672|Anesthetics, General|anesthetics, general|mesh-ancestor
6275268|NCT03792672|Anesthetics|anesthetics|mesh-ancestor
6275269|NCT03792672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6275270|NCT03792672|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6275271|NCT03792672|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6275272|NCT03792672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6275273|NCT03792672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275274|NCT03792191|Fentanyl|fentanyl|mesh-list
6275275|NCT03792191|Bupivacaine|bupivacaine|mesh-list
6275276|NCT03792191|Anesthetics, Local|anesthetics, local|mesh-ancestor
6275277|NCT03792191|Anesthetics|anesthetics|mesh-ancestor
6275278|NCT03792191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6275279|NCT03792191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275280|NCT03792191|Sensory System Agents|sensory system agents|mesh-ancestor
6275281|NCT03792191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6275282|NCT03792191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6275283|NCT03792191|Narcotics|narcotics|mesh-ancestor
6275284|NCT03792191|Analgesics|analgesics|mesh-ancestor
6275285|NCT03792191|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6275286|NCT03792191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6275287|NCT03792191|Anesthetics, General|anesthetics, general|mesh-ancestor
6275288|NCT03789175|Niacinamide|niacinamide|mesh-list
6275289|NCT03789175|Niacin|niacin|mesh-list
6275290|NCT03789175|Nicotinic Acids|nicotinic acids|mesh-list
6275291|NCT03789175|Vitamin B Complex|vitamin b complex|mesh-ancestor
6275292|NCT03789175|Vitamins|vitamins|mesh-ancestor
6275293|NCT03789175|Micronutrients|micronutrients|mesh-ancestor
6275294|NCT03789175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275295|NCT03789175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6275296|NCT03789175|Antimetabolites|antimetabolites|mesh-ancestor
6275297|NCT03789175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275298|NCT03789175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6275299|NCT03789175|Vasodilator Agents|vasodilator agents|mesh-ancestor
6275300|NCT03783702|Acetaminophen|acetaminophen|mesh-list
6275301|NCT03783702|Ibuprofen|ibuprofen|mesh-list
6275302|NCT03783702|Oxycodone|oxycodone|mesh-list
6275303|NCT03783702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6275304|NCT03783702|Analgesics|analgesics|mesh-ancestor
6275305|NCT03783702|Sensory System Agents|sensory system agents|mesh-ancestor
6275306|NCT03783702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6275307|NCT03783702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275308|NCT03783702|Antipyretics|antipyretics|mesh-ancestor
6275309|NCT03783702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6275310|NCT03783702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6275311|NCT03783702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6275312|NCT03783702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6275313|NCT03783702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6275314|NCT03783702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275315|NCT03783702|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6275316|NCT03783702|Narcotics|narcotics|mesh-ancestor
6275317|NCT03783702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6275318|NCT03781479|Amifampridine|amifampridine|mesh-list
6275319|NCT03781479|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6275320|NCT03781479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6275321|NCT03781479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275322|NCT03781479|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6275323|NCT03781479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6275324|NCT03781479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275325|NCT03783039|Cellulose, Oxidized|cellulose, oxidized|mesh-list
6275326|NCT03783039|Hemostatics|hemostatics|mesh-ancestor
6275327|NCT03783039|Coagulants|coagulants|mesh-ancestor
6275328|NCT03783130|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6275329|NCT03783130|Aluminum sulfate|aluminum sulfate|mesh-list
6275330|NCT03783130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6275331|NCT03783130|Immunologic Factors|immunologic factors|mesh-ancestor
6275332|NCT03783130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275333|NCT03783130|Antacids|antacids|mesh-ancestor
6275334|NCT03783130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275335|NCT03783130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6275336|NCT03773796|Nabilone|nabilone|mesh-list
6275337|NCT03773796|Antiemetics|antiemetics|mesh-ancestor
6275338|NCT03773796|Autonomic Agents|autonomic agents|mesh-ancestor
6275339|NCT03773796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6275340|NCT03773796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275341|NCT03773796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6275342|NCT03773796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6275343|NCT03773796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6275344|NCT03773796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6275345|NCT03773796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6275346|NCT03782233|Bromides|bromides|mesh-list
6275347|NCT03782233|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6275348|NCT03782233|Rocuronium|rocuronium|mesh-list
6275349|NCT03782233|Anticonvulsants|anticonvulsants|mesh-ancestor
6275350|NCT03782233|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6275351|NCT03782233|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6275352|NCT03782233|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6275353|NCT03782233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6275354|NCT03782233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275355|NCT03781375|Etanercept|etanercept|mesh-list
6275356|NCT03781375|Methotrexate|methotrexate|mesh-list
6275357|NCT03781375|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6275358|NCT03781375|Abortifacient Agents|abortifacient agents|mesh-ancestor
6275359|NCT03781375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6275360|NCT03781375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275361|NCT03781375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6275362|NCT03781375|Antimetabolites|antimetabolites|mesh-ancestor
6275363|NCT03781375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275364|NCT03781375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6275365|NCT03781375|Dermatologic Agents|dermatologic agents|mesh-ancestor
6275366|NCT03781375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6275367|NCT03781375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6275368|NCT03781375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6275369|NCT03781375|Immunologic Factors|immunologic factors|mesh-ancestor
6275370|NCT03781375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6275371|NCT03781375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6275372|NCT03781375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6275373|NCT03781375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6275374|NCT03781375|Analgesics|analgesics|mesh-ancestor
6275375|NCT03781375|Sensory System Agents|sensory system agents|mesh-ancestor
6275376|NCT03781375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6275377|NCT03781375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6275378|NCT03781375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6275379|NCT03780010|Paclitaxel|paclitaxel|mesh-list
6275380|NCT03780010|Carboplatin|carboplatin|mesh-list
6275381|NCT03780010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6275382|NCT03780010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6275383|NCT03780010|Tubulin Modulators|tubulin modulators|mesh-ancestor
6275384|NCT03780010|Antimitotic Agents|antimitotic agents|mesh-ancestor
6275385|NCT03780010|Mitosis Modulators|mitosis modulators|mesh-ancestor
6275386|NCT03780010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275387|NCT03774576|Itraconazole|itraconazole|mesh-list
6275388|NCT03774576|Antifungal Agents|antifungal agents|mesh-ancestor
6275389|NCT03774576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6275390|NCT03774576|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6275391|NCT03774576|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6275392|NCT03774576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6275393|NCT03774576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275394|NCT03774576|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6275395|NCT03774576|Hormone Antagonists|hormone antagonists|mesh-ancestor
6275396|NCT03774576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6275397|NCT03774576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275398|NCT03774576|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6275399|NCT03772041|Tolvaptan|tolvaptan|mesh-list
6275400|NCT03772041|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6275401|NCT03772041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275402|NCT03772041|Natriuretic Agents|natriuretic agents|mesh-ancestor
6275403|NCT03772041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275404|NCT03774745|Mifepristone|mifepristone|mesh-list
6275405|NCT03774745|Progesterone|progesterone|mesh-list
6275406|NCT03774745|Progestins|progestins|mesh-ancestor
6275407|NCT03774745|Hormones|hormones|mesh-ancestor
6275408|NCT03774745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6275409|NCT03774745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275410|NCT03774745|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6275411|NCT03774745|Abortifacient Agents|abortifacient agents|mesh-ancestor
6275412|NCT03774745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6275413|NCT03774745|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6275414|NCT03774745|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6275415|NCT03774745|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6275416|NCT03774745|Contraceptive Agents|contraceptive agents|mesh-ancestor
6275417|NCT03774745|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6275418|NCT03774745|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6275419|NCT03774745|Hormone Antagonists|hormone antagonists|mesh-ancestor
6275420|NCT03774745|Luteolytic Agents|luteolytic agents|mesh-ancestor
6275421|NCT03774745|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6275422|NCT03774745|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6275423|NCT03771560|Leucovorin|leucovorin|mesh-list
6275424|NCT03771560|Folic Acid|folic acid|mesh-list
6275425|NCT03771560|Levoleucovorin|levoleucovorin|mesh-list
6275426|NCT03771560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275427|NCT03771560|Antidotes|antidotes|mesh-ancestor
6275428|NCT03771560|Protective Agents|protective agents|mesh-ancestor
6275429|NCT03771560|Vitamin B Complex|vitamin b complex|mesh-ancestor
6275430|NCT03771560|Vitamins|vitamins|mesh-ancestor
6275431|NCT03771560|Micronutrients|micronutrients|mesh-ancestor
6275432|NCT03771560|Hematinics|hematinics|mesh-ancestor
6275433|NCT03770091|Allantoin|allantoin|mesh-list
6275434|NCT03770091|Dermatologic Agents|dermatologic agents|mesh-ancestor
6275435|NCT03769896|Nabilone|nabilone|mesh-list
6275436|NCT03769896|Antiemetics|antiemetics|mesh-ancestor
6275437|NCT03769896|Autonomic Agents|autonomic agents|mesh-ancestor
6275438|NCT03769896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6275439|NCT03769896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275440|NCT03769896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6275441|NCT03769896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6275442|NCT03769896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6275443|NCT03769896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6275444|NCT03769896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6275445|NCT03768726|Ziprasidone|ziprasidone|mesh-list
6275446|NCT03768726|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6275447|NCT03768726|Serotonin Agents|serotonin agents|mesh-ancestor
6275448|NCT03768726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6275449|NCT03768726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275450|NCT03768726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275451|NCT03768726|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6275452|NCT03768726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6275453|NCT03768726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6275454|NCT03768726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6275455|NCT03768726|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6275456|NCT03768726|Dopamine Agents|dopamine agents|mesh-ancestor
6275457|NCT03767738|Aflibercept|aflibercept|mesh-list
6275458|NCT03767738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6275459|NCT03767738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6275460|NCT03767738|Growth Substances|growth substances|mesh-ancestor
6275461|NCT03767738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275462|NCT03767738|Growth Inhibitors|growth inhibitors|mesh-ancestor
6275463|NCT03767738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6275464|NCT03767062|Topiramate|topiramate|mesh-list
6275465|NCT03767062|Anticonvulsants|anticonvulsants|mesh-ancestor
6275466|NCT03767062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6275467|NCT03767062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275468|NCT03765502|Glucagon|glucagon|mesh-list
6275469|NCT03765502|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6275470|NCT03765502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6275471|NCT03765502|Hormones|hormones|mesh-ancestor
6275472|NCT03765502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6275473|NCT03765502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275474|NCT03765502|Incretins|incretins|mesh-ancestor
6391167|NCT00192660|Stavudine|stavudine|mesh-list
6391168|NCT00192660|Didanosine|didanosine|mesh-list
6391169|NCT00192660|Tipranavir|tipranavir|mesh-list
6391170|NCT00192660|Enfuvirtide|enfuvirtide|mesh-list
6391171|NCT00192660|Efavirenz|efavirenz|mesh-list
6391172|NCT00192660|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6391173|NCT00192660|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6391174|NCT00192660|Protease Inhibitors|protease inhibitors|mesh-ancestor
6391175|NCT00192660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6391176|NCT00192660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391177|NCT00192660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6391178|NCT00192660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6391179|NCT00192660|Antiviral Agents|antiviral agents|mesh-ancestor
6391180|NCT00192660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6391181|NCT00192660|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6391182|NCT00192660|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6391183|NCT00192660|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6391184|NCT00192660|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6391185|NCT00192660|Antimetabolites|antimetabolites|mesh-ancestor
6391186|NCT00192660|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6391187|NCT00192660|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6391188|NCT00192660|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6391189|NCT00192660|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6391190|NCT00192660|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6391191|NCT00192660|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6391192|NCT00192660|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6391193|NCT00192660|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6391194|NCT00192660|Antitubercular Agents|antitubercular agents|mesh-ancestor
6391195|NCT00192660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6391196|NCT00192673|Asparaginase|asparaginase|mesh-list
6391197|NCT00192673|Pegaspargase|pegaspargase|mesh-list
6391198|NCT00192673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391199|NCT00192712|Gemcitabine|gemcitabine|mesh-list
6391200|NCT00192712|Irinotecan|irinotecan|mesh-list
6391201|NCT00192712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6391202|NCT00192712|Antimetabolites|antimetabolites|mesh-ancestor
6391203|NCT00192712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391204|NCT00192712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391205|NCT00192712|Antiviral Agents|antiviral agents|mesh-ancestor
6391206|NCT00192712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6391207|NCT00192712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6391208|NCT00192712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6391209|NCT00192712|Immunologic Factors|immunologic factors|mesh-ancestor
6391210|NCT00192712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6391211|NCT00192712|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6391212|NCT00192712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6391213|NCT00192725|Tryptophan|tryptophan|mesh-list
6391214|NCT00192725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6391215|NCT00192725|Antidepressive Agents|antidepressive agents|mesh-ancestor
6391216|NCT00192725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6391217|NCT00192764|Cyclophosphamide|cyclophosphamide|mesh-list
6391218|NCT00192764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6391219|NCT00192764|Immunologic Factors|immunologic factors|mesh-ancestor
6391220|NCT00192764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6391221|NCT00192764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6391222|NCT00192764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6275475|NCT03765138|Pramipexole|pramipexole|mesh-list
6275476|NCT03765138|Antioxidants|antioxidants|mesh-ancestor
6275477|NCT03765138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275478|NCT03765138|Protective Agents|protective agents|mesh-ancestor
6275479|NCT03765138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275480|NCT03765138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6275481|NCT03765138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6275482|NCT03765138|Dopamine Agonists|dopamine agonists|mesh-ancestor
6275483|NCT03765138|Dopamine Agents|dopamine agents|mesh-ancestor
6275484|NCT03765138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6275485|NCT03763929|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
6275486|NCT03763929|Antioxidants|antioxidants|mesh-ancestor
6275487|NCT03763929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275488|NCT03763929|Protective Agents|protective agents|mesh-ancestor
6275489|NCT03763929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275490|NCT03763929|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6275491|NCT03763929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6275492|NCT03763175|Lovastatin|lovastatin|mesh-list
6275493|NCT03763175|L 647318|l 647318|mesh-list
6275494|NCT03763175|Dihydromevinolin|dihydromevinolin|mesh-list
6275495|NCT03763175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6275496|NCT03763175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6275497|NCT03763175|Antimetabolites|antimetabolites|mesh-ancestor
6275498|NCT03763175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275499|NCT03763175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6275500|NCT03763175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6275501|NCT03763175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6275502|NCT03760640|Insulin Lispro|insulin lispro|mesh-list
6275503|NCT03760640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6275504|NCT03760640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275505|NCT03760250|Imiquimod|imiquimod|mesh-list
6275506|NCT03760250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6275507|NCT03760250|Immunologic Factors|immunologic factors|mesh-ancestor
6275508|NCT03760250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275509|NCT03760250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6275510|NCT03760250|Interferon Inducers|interferon inducers|mesh-ancestor
6275511|NCT03759600|Niraparib|niraparib|mesh-list
6275512|NCT03759600|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6275513|NCT03759600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6275514|NCT03759600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275515|NCT03759600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6275516|NCT03758365|Triamcinolone|triamcinolone|mesh-list
6275517|NCT03758365|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6275518|NCT03758365|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6275519|NCT03758365|Hydrocortisone|hydrocortisone|mesh-list
6275520|NCT03758365|Betamethasone|betamethasone|mesh-list
6275521|NCT03758365|Betamethasone Valerate|betamethasone valerate|mesh-list
6275522|NCT03758365|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
6275523|NCT03758365|Betamethasone benzoate|betamethasone benzoate|mesh-list
6275524|NCT03758365|Clobetasol|clobetasol|mesh-list
6275525|NCT03758365|Desonide|desonide|mesh-list
6275526|NCT03758365|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
6275527|NCT03758365|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
6275528|NCT03758365|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6275529|NCT03758365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6275530|NCT03758365|Glucocorticoids|glucocorticoids|mesh-ancestor
6275531|NCT03758365|Hormones|hormones|mesh-ancestor
6275532|NCT03758365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6275533|NCT03758365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275534|NCT03758365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6275535|NCT03758365|Immunologic Factors|immunologic factors|mesh-ancestor
6275536|NCT03758365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6275537|NCT03758365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275538|NCT03758365|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6275539|NCT03758365|Respiratory System Agents|respiratory system agents|mesh-ancestor
6275540|NCT03758365|Dermatologic Agents|dermatologic agents|mesh-ancestor
6275541|NCT03757234|Levofloxacin|levofloxacin|mesh-list
6275542|NCT03757234|Ofloxacin|ofloxacin|mesh-list
6275543|NCT03757234|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6275544|NCT03757234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6275545|NCT03757234|Renal Agents|renal agents|mesh-ancestor
6275546|NCT03757234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6275547|NCT03757234|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6275548|NCT03757234|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6275549|NCT03757234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6391223|NCT00192764|Alkylating Agents|alkylating agents|mesh-ancestor
6275550|NCT03757234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275551|NCT03757234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6275552|NCT03757234|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6275553|NCT03757234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6275554|NCT03756883|Fluticasone|fluticasone|mesh-list
6275555|NCT03756883|Xhance|xhance|mesh-list
6275556|NCT03756883|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6275557|NCT03756883|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6275558|NCT03756883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6275559|NCT03756883|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6275560|NCT03756883|Autonomic Agents|autonomic agents|mesh-ancestor
6275561|NCT03756883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6275562|NCT03756883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275563|NCT03756883|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6275564|NCT03756883|Respiratory System Agents|respiratory system agents|mesh-ancestor
6275565|NCT03756883|Dermatologic Agents|dermatologic agents|mesh-ancestor
6275566|NCT03756883|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6275567|NCT03756883|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6275568|NCT03756883|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6275569|NCT03756883|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6275570|NCT03756883|Adrenergic Agents|adrenergic agents|mesh-ancestor
6275571|NCT03756883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6275572|NCT03756883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275573|NCT03756883|Glucocorticoids|glucocorticoids|mesh-ancestor
6275574|NCT03756883|Hormones|hormones|mesh-ancestor
6275575|NCT03756883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6275576|NCT03756883|Sympathomimetics|sympathomimetics|mesh-ancestor
6275577|NCT03756129|Ketamine|ketamine|mesh-list
6275578|NCT03756129|Analgesics|analgesics|mesh-ancestor
6275579|NCT03756129|Sensory System Agents|sensory system agents|mesh-ancestor
6275580|NCT03756129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6275581|NCT03756129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275582|NCT03756129|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6275583|NCT03756129|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6275584|NCT03756129|Anesthetics, General|anesthetics, general|mesh-ancestor
6275585|NCT03756129|Anesthetics|anesthetics|mesh-ancestor
6275586|NCT03756129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6275587|NCT03756129|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6275588|NCT03756129|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6275589|NCT03756129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6275590|NCT03756129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275591|NCT03756038|Lorazepam|lorazepam|mesh-list
6275592|NCT03756038|Anticonvulsants|anticonvulsants|mesh-ancestor
6275593|NCT03756038|Antiemetics|antiemetics|mesh-ancestor
6275594|NCT03756038|Autonomic Agents|autonomic agents|mesh-ancestor
6275595|NCT03756038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6275596|NCT03756038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275597|NCT03756038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6275598|NCT03756038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6275599|NCT03756038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6275600|NCT03756038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6275601|NCT03756038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6275602|NCT03756038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6275603|NCT03756038|GABA Modulators|gaba modulators|mesh-ancestor
6275604|NCT03756038|GABA Agents|gaba agents|mesh-ancestor
6275605|NCT03756038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6275606|NCT03756038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724170|NCT03188978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6275607|NCT03754556|Levonorgestrel|levonorgestrel|mesh-list
6275608|NCT03754556|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6275609|NCT03754556|Contraceptive Agents|contraceptive agents|mesh-ancestor
6275610|NCT03754556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6275611|NCT03754556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275612|NCT03754556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6275613|NCT03754556|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6275614|NCT03754556|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6275615|NCT03753113|Minoxidil|minoxidil|mesh-list
6275616|NCT03753113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6275617|NCT03753113|Vasodilator Agents|vasodilator agents|mesh-ancestor
6275618|NCT03751657|Insulin|insulin|mesh-list
6275619|NCT03751657|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6275620|NCT03751657|Metformin|metformin|mesh-list
6275621|NCT03751657|Insulin Glargine|insulin glargine|mesh-list
6275622|NCT03751657|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
6275623|NCT03751657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6275624|NCT03751657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275625|NCT03751657|Protease Inhibitors|protease inhibitors|mesh-ancestor
6275626|NCT03751657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6275627|NCT03751657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275628|NCT03747497|Linezolid|linezolid|mesh-list
6275629|NCT03747497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6275630|NCT03747497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6275631|NCT03747497|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6275632|NCT03747497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6275633|NCT03747497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275634|NCT03743038|Minocycline|minocycline|mesh-list
6275635|NCT03743038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6275636|NCT03743038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6275637|NCT03742154|Varenicline|varenicline|mesh-list
6275638|NCT03742154|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6275639|NCT03742154|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6275640|NCT03742154|Cholinergic Agents|cholinergic agents|mesh-ancestor
6275641|NCT03742154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6275642|NCT03742154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275643|NCT03742154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275644|NCT03740659|Levofloxacin|levofloxacin|mesh-list
6275645|NCT03740659|Ofloxacin|ofloxacin|mesh-list
6275646|NCT03740659|Dexamethasone|dexamethasone|mesh-list
6275647|NCT03740659|Dexamethasone acetate|dexamethasone acetate|mesh-list
6275648|NCT03740659|BB 1101|bb 1101|mesh-list
6275649|NCT03740659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6275650|NCT03740659|Antiemetics|antiemetics|mesh-ancestor
6275651|NCT03740659|Autonomic Agents|autonomic agents|mesh-ancestor
6275652|NCT03740659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6275653|NCT03740659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275654|NCT03740659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6275655|NCT03740659|Glucocorticoids|glucocorticoids|mesh-ancestor
6275656|NCT03740659|Hormones|hormones|mesh-ancestor
6275657|NCT03740659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6275658|NCT03740659|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6275659|NCT03740659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6275660|NCT03740659|Protease Inhibitors|protease inhibitors|mesh-ancestor
6275661|NCT03740659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6275662|NCT03740659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275663|NCT03740659|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6275664|NCT03740659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6275665|NCT03740659|Renal Agents|renal agents|mesh-ancestor
6275666|NCT03740659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6275667|NCT03740659|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6275668|NCT03740659|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6275669|NCT03740659|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6275670|NCT03740659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6275671|NCT03739528|Levofloxacin|levofloxacin|mesh-list
6275672|NCT03739528|Ofloxacin|ofloxacin|mesh-list
6275673|NCT03739528|Tobramycin|tobramycin|mesh-list
6275674|NCT03739528|Dexamethasone|dexamethasone|mesh-list
6275675|NCT03739528|Dexamethasone acetate|dexamethasone acetate|mesh-list
6275676|NCT03739528|BB 1101|bb 1101|mesh-list
6275677|NCT03739528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6275678|NCT03739528|Antiemetics|antiemetics|mesh-ancestor
6275679|NCT03739528|Autonomic Agents|autonomic agents|mesh-ancestor
6275680|NCT03739528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6275681|NCT03739528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275682|NCT03739528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6275683|NCT03739528|Glucocorticoids|glucocorticoids|mesh-ancestor
6275684|NCT03739528|Hormones|hormones|mesh-ancestor
6275685|NCT03739528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6275686|NCT03739528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6275687|NCT03739528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6275688|NCT03739528|Protease Inhibitors|protease inhibitors|mesh-ancestor
6275689|NCT03739528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6275690|NCT03739528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275691|NCT03739528|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6275692|NCT03739528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6275693|NCT03739528|Renal Agents|renal agents|mesh-ancestor
6275694|NCT03739528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6275695|NCT03739528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6275696|NCT03739528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6275697|NCT03739528|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6275698|NCT03739528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6275699|NCT03738865|Glucagon|glucagon|mesh-list
6275700|NCT03738865|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6275701|NCT03738865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6275702|NCT03738865|Hormones|hormones|mesh-ancestor
6275703|NCT03738865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6275704|NCT03738865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275705|NCT03738865|Incretins|incretins|mesh-ancestor
6275706|NCT03736928|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6275707|NCT03736928|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6275708|NCT03736928|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6275709|NCT03736928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6275710|NCT03736928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275711|NCT03736928|Cholinergic Agents|cholinergic agents|mesh-ancestor
6275712|NCT03736928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6275713|NCT03736928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275714|NCT03736928|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6015098|NCT00354887|Oxaliplatin|oxaliplatin|mesh-list
6275715|NCT03736928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6275716|NCT03736785|Insulin|insulin|mesh-list
6275717|NCT03736785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6275718|NCT03736785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275719|NCT03734991|Ibrexafungerp|ibrexafungerp|mesh-list
6275720|NCT03734991|Antifungal Agents|antifungal agents|mesh-ancestor
6275721|NCT03734991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6275722|NCT03734601|Mycophenolic Acid|mycophenolic acid|mesh-list
6275723|NCT03734601|Tacrolimus|tacrolimus|mesh-list
6275724|NCT03734601|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6275725|NCT03734601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6275726|NCT03734601|Immunologic Factors|immunologic factors|mesh-ancestor
6275727|NCT03734601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275728|NCT03734601|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6275729|NCT03734601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6275730|NCT03734601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275731|NCT03734601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6275732|NCT03734601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6275733|NCT03734601|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6275734|NCT03734601|Antitubercular Agents|antitubercular agents|mesh-ancestor
6275735|NCT03734601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6275736|NCT03734601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6275737|NCT03733899|Anesthetics|anesthetics|mesh-list
6275738|NCT03733899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6275739|NCT03733899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275740|NCT03733470|Sildenafil Citrate|sildenafil citrate|mesh-list
6275741|NCT03733470|Vasodilator Agents|vasodilator agents|mesh-ancestor
6275742|NCT03733470|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6275743|NCT03733470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6275744|NCT03733470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6275745|NCT03733470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275746|NCT03733470|Urological Agents|urological agents|mesh-ancestor
6015099|NCT00354887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6015100|NCT00354887|Antimetabolites|antimetabolites|mesh-ancestor
6015101|NCT00354887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015102|NCT00354887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6015103|NCT00354913|Imatinib Mesylate|imatinib mesylate|mesh-list
6015104|NCT00354913|Hydroxyurea|hydroxyurea|mesh-list
6275747|NCT03732248|Sirolimus|sirolimus|mesh-list
6275748|NCT03732248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6275749|NCT03732248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6275750|NCT03732248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6275751|NCT03732248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6275752|NCT03732248|Antifungal Agents|antifungal agents|mesh-ancestor
6275753|NCT03732248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6275754|NCT03732248|Immunologic Factors|immunologic factors|mesh-ancestor
6275755|NCT03732248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275756|NCT03731182|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6015105|NCT00354913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6015106|NCT00354913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6275757|NCT03731182|Immunologic Factors|immunologic factors|mesh-ancestor
6275758|NCT03731182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275759|NCT03730961|Furosemide|furosemide|mesh-list
6275760|NCT03730961|Diuretics|diuretics|mesh-ancestor
6275761|NCT03730961|Natriuretic Agents|natriuretic agents|mesh-ancestor
6275762|NCT03730961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275763|NCT03730961|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6275764|NCT03730961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6275765|NCT03730961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275766|NCT03730116|Bisoprolol|bisoprolol|mesh-list
6275767|NCT03730116|Perindopril|perindopril|mesh-list
6275768|NCT03730116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6275769|NCT03730116|Sympatholytics|sympatholytics|mesh-ancestor
6275770|NCT03730116|Autonomic Agents|autonomic agents|mesh-ancestor
6275771|NCT03730116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6275772|NCT03730116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275773|NCT03730116|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6275774|NCT03730116|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6275775|NCT03730116|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6275776|NCT03730116|Adrenergic Agents|adrenergic agents|mesh-ancestor
6275777|NCT03730116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6275778|NCT03730116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275779|NCT03730116|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6275780|NCT03730116|Protease Inhibitors|protease inhibitors|mesh-ancestor
6275781|NCT03730116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6391224|NCT00192764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391225|NCT00192764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391226|NCT00192764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6391227|NCT00192777|Capecitabine|capecitabine|mesh-list
6391228|NCT00192777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6391229|NCT00192777|Antimetabolites|antimetabolites|mesh-ancestor
6391230|NCT00192777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275782|NCT03726996|Desipramine|desipramine|mesh-list
6275783|NCT03726996|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6275784|NCT03726996|Antidepressive Agents|antidepressive agents|mesh-ancestor
6275785|NCT03726996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6275786|NCT03726996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6275787|NCT03726996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275788|NCT03726996|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6275789|NCT03726996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6275790|NCT03726996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6275791|NCT03726996|Adrenergic Agents|adrenergic agents|mesh-ancestor
6275792|NCT03726996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6275793|NCT03726996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275794|NCT03725085|Guaifenesin|guaifenesin|mesh-list
6275795|NCT03725085|Expectorants|expectorants|mesh-ancestor
6275796|NCT03725085|Respiratory System Agents|respiratory system agents|mesh-ancestor
6275797|NCT03724981|Dulaglutide|dulaglutide|mesh-list
6275798|NCT03724981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6275799|NCT03724981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275800|NCT03724968|Nivolumab|nivolumab|mesh-list
6275801|NCT03724968|Ipilimumab|ipilimumab|mesh-list
6275802|NCT03724968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6275803|NCT03724968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6275804|NCT03724968|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6275805|NCT03724968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275806|NCT03724877|Cholinergic Agents|cholinergic agents|mesh-list
6275807|NCT03724877|Muscarinic Antagonists|muscarinic antagonists|mesh-list
6275808|NCT03724877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6275809|NCT03724877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275810|NCT03724877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275811|NCT03724877|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6275812|NCT03723980|Propolis|propolis|mesh-list
6275813|NCT03723980|Calcium|calcium|mesh-list
6275814|NCT03723980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6275815|NCT03723980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275816|NCT03723980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6275817|NCT03723447|Dexamethasone|dexamethasone|mesh-list
6275818|NCT03723447|Epinephrine|epinephrine|mesh-list
6275819|NCT03723447|Bupivacaine|bupivacaine|mesh-list
6275820|NCT03723447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6275821|NCT03723447|Antiemetics|antiemetics|mesh-ancestor
6275822|NCT03723447|Autonomic Agents|autonomic agents|mesh-ancestor
6275823|NCT03723447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6275824|NCT03723447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275825|NCT03723447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6275826|NCT03723447|Glucocorticoids|glucocorticoids|mesh-ancestor
6275827|NCT03723447|Hormones|hormones|mesh-ancestor
6275828|NCT03723447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6275829|NCT03723447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6275830|NCT03723447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6275831|NCT03723447|Anesthetics, Local|anesthetics, local|mesh-ancestor
6275832|NCT03723447|Anesthetics|anesthetics|mesh-ancestor
6275833|NCT03723447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6275834|NCT03723447|Sensory System Agents|sensory system agents|mesh-ancestor
6275835|NCT03723447|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6275836|NCT03723447|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6275837|NCT03723447|Adrenergic Agents|adrenergic agents|mesh-ancestor
6275838|NCT03723447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6275839|NCT03723447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275840|NCT03723447|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6275841|NCT03723447|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6275842|NCT03723447|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6275843|NCT03723447|Respiratory System Agents|respiratory system agents|mesh-ancestor
6275844|NCT03723447|Mydriatics|mydriatics|mesh-ancestor
6275845|NCT03723447|Sympathomimetics|sympathomimetics|mesh-ancestor
6275846|NCT03723447|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6275847|NCT03718143|Adavosertib|adavosertib|mesh-list
6275848|NCT03718143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6275849|NCT03718143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275850|NCT03709576|Azacitidine|azacitidine|mesh-list
6275851|NCT03709576|Pevonedistat|pevonedistat|mesh-list
6275852|NCT03709576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6275853|NCT03709576|Antimetabolites|antimetabolites|mesh-ancestor
6275854|NCT03709576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275855|NCT03709576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6275856|NCT03709576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6275857|NCT03701295|Azacitidine|azacitidine|mesh-list
6275858|NCT03701295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6275859|NCT03701295|Antimetabolites|antimetabolites|mesh-ancestor
6275860|NCT03701295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275861|NCT03701295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6275862|NCT03701295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6275863|NCT03694821|Methylprednisolone|methylprednisolone|mesh-list
6275864|NCT03694821|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6275865|NCT03694821|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6275866|NCT03694821|Prednisolone|prednisolone|mesh-list
6275867|NCT03694821|Prednisolone acetate|prednisolone acetate|mesh-list
6275868|NCT03694821|Ketorolac|ketorolac|mesh-list
6275869|NCT03694821|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6275870|NCT03694821|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6275871|NCT03694821|Prednisolone phosphate|prednisolone phosphate|mesh-list
6275872|NCT03694821|Hylan|hylan|mesh-list
6275873|NCT03694821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6275874|NCT03694821|Antiemetics|antiemetics|mesh-ancestor
6275875|NCT03694821|Autonomic Agents|autonomic agents|mesh-ancestor
6275876|NCT03694821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6275877|NCT03694821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275878|NCT03694821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6275879|NCT03694821|Glucocorticoids|glucocorticoids|mesh-ancestor
6275880|NCT03694821|Hormones|hormones|mesh-ancestor
6275881|NCT03694821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6275882|NCT03694821|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6275883|NCT03694821|Protective Agents|protective agents|mesh-ancestor
6275884|NCT03694821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6275885|NCT03694821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6275886|NCT03694821|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6275887|NCT03694821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6275888|NCT03694821|Analgesics|analgesics|mesh-ancestor
6275889|NCT03694821|Sensory System Agents|sensory system agents|mesh-ancestor
6275890|NCT03694821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6275891|NCT03694821|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6275892|NCT03694821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6275893|NCT03694821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275894|NCT03694821|Viscosupplements|viscosupplements|mesh-ancestor
6275895|NCT03682367|Gabapentin|gabapentin|mesh-list
6275896|NCT03682367|Analgesics|analgesics|mesh-ancestor
6275897|NCT03682367|Sensory System Agents|sensory system agents|mesh-ancestor
6275898|NCT03682367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6275899|NCT03682367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275900|NCT03682367|Anticonvulsants|anticonvulsants|mesh-ancestor
6275901|NCT03682367|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6275902|NCT03682367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6275903|NCT03682367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6275904|NCT03682367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6275905|NCT03682367|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6275906|NCT03682367|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6275907|NCT03682367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6275908|NCT03682367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275909|NCT03682367|Antimanic Agents|antimanic agents|mesh-ancestor
6275910|NCT03680911|Acetylcysteine|acetylcysteine|mesh-list
6275911|NCT03680911|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6275912|NCT03680911|Antiviral Agents|antiviral agents|mesh-ancestor
6275913|NCT03680911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6275914|NCT03680911|Expectorants|expectorants|mesh-ancestor
6275915|NCT03680911|Respiratory System Agents|respiratory system agents|mesh-ancestor
6275916|NCT03680911|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6275917|NCT03680911|Antioxidants|antioxidants|mesh-ancestor
6275918|NCT03680911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275919|NCT03680911|Protective Agents|protective agents|mesh-ancestor
6275920|NCT03680911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275921|NCT03680911|Antidotes|antidotes|mesh-ancestor
6275922|NCT03656692|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6275923|NCT03656692|Hormones|hormones|mesh-ancestor
6275924|NCT03656692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6275925|NCT03656692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275926|NCT03643159|Aripiprazole|aripiprazole|mesh-list
6275927|NCT03643159|Antipsychotic Agents|antipsychotic agents|mesh-list
6275928|NCT03643159|Antidepressive Agents|antidepressive agents|mesh-ancestor
6275929|NCT03643159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6275930|NCT03643159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6275931|NCT03643159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6275932|NCT03643159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275933|NCT03643159|Dopamine Agonists|dopamine agonists|mesh-ancestor
6275934|NCT03643159|Dopamine Agents|dopamine agents|mesh-ancestor
6275935|NCT03643159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6275936|NCT03643159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275937|NCT03643159|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6275938|NCT03643159|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6275939|NCT03643159|Serotonin Agents|serotonin agents|mesh-ancestor
6275940|NCT03643159|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6275941|NCT03643159|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6275942|NCT03643159|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6275943|NCT03643159|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6275944|NCT03630120|Sorafenib|sorafenib|mesh-list
6275945|NCT03630120|Lenvatinib|lenvatinib|mesh-list
6275946|NCT03630120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6275947|NCT03630120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6275948|NCT03630120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6275949|NCT03630120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275950|NCT03615508|Phenylephrine|phenylephrine|mesh-list
6275951|NCT03615508|Oxymetazoline|oxymetazoline|mesh-list
6275952|NCT03615508|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6275953|NCT03615508|Mydriatics|mydriatics|mesh-ancestor
6275954|NCT03615508|Autonomic Agents|autonomic agents|mesh-ancestor
6275955|NCT03615508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6275956|NCT03615508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275957|NCT03615508|Sympathomimetics|sympathomimetics|mesh-ancestor
6275958|NCT03615508|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6275959|NCT03615508|Nasal Decongestants|nasal decongestants|mesh-ancestor
6275960|NCT03615508|Respiratory System Agents|respiratory system agents|mesh-ancestor
6275961|NCT03615508|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6275962|NCT03615508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6275963|NCT03615508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6275964|NCT03615508|Adrenergic Agents|adrenergic agents|mesh-ancestor
6275965|NCT03615508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6275966|NCT03615508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275967|NCT03615508|Protective Agents|protective agents|mesh-ancestor
6275968|NCT03615144|Fludarabine|fludarabine|mesh-list
6275969|NCT03615144|Melphalan|melphalan|mesh-list
6275970|NCT03615144|Thiotepa|thiotepa|mesh-list
6275971|NCT03615144|Clofarabine|clofarabine|mesh-list
6275972|NCT03615144|Thymoglobulin|thymoglobulin|mesh-list
6275973|NCT03615144|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6275974|NCT03615144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6275975|NCT03615144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6275976|NCT03615144|Antimetabolites|antimetabolites|mesh-ancestor
6275977|NCT03615144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275978|NCT03615144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6275979|NCT03615144|Immunologic Factors|immunologic factors|mesh-ancestor
6275980|NCT03615144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6275981|NCT03615144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6275982|NCT03615144|Alkylating Agents|alkylating agents|mesh-ancestor
6275983|NCT03615144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6275984|NCT03598140|Sildenafil Citrate|sildenafil citrate|mesh-list
6275985|NCT03598140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6275986|NCT03598140|Vasodilator Agents|vasodilator agents|mesh-ancestor
6275987|NCT03598140|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6275988|NCT03598140|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6275989|NCT03598140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6275990|NCT03598140|Urological Agents|urological agents|mesh-ancestor
6275991|NCT03591458|Amitriptyline|amitriptyline|mesh-list
6275992|NCT03591458|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6275993|NCT03591458|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6275994|NCT03591458|Antidepressive Agents|antidepressive agents|mesh-ancestor
6275995|NCT03591458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6275996|NCT03591458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6275997|NCT03591458|Analgesics|analgesics|mesh-ancestor
6275998|NCT03591458|Sensory System Agents|sensory system agents|mesh-ancestor
6275999|NCT03591458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6276000|NCT03591458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276001|NCT03591458|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6276002|NCT03591458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6276003|NCT03591458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6276004|NCT03591458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276005|NCT03591458|Adrenergic Agents|adrenergic agents|mesh-ancestor
6276006|NCT03591458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6276007|NCT03591458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6276008|NCT03591458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6276009|NCT03591458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6276010|NCT03590743|Apixaban|apixaban|mesh-list
6276011|NCT03590743|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6276012|NCT03590743|Antithrombins|antithrombins|mesh-ancestor
6276013|NCT03590743|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6276014|NCT03590743|Protease Inhibitors|protease inhibitors|mesh-ancestor
6276015|NCT03590743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6276016|NCT03590743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276017|NCT03590743|Anticoagulants|anticoagulants|mesh-ancestor
6276018|NCT03580382|Trametinib|trametinib|mesh-list
6276019|NCT03580382|Antibodies|antibodies|mesh-list
6276020|NCT03580382|Immunologic Factors|immunologic factors|mesh-ancestor
6276021|NCT03580382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276022|NCT03580382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6276023|NCT03580382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6276024|NCT03580382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6276025|NCT03580382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276026|NCT03565328|Niacinamide|niacinamide|mesh-list
6276027|NCT03565328|Niacin|niacin|mesh-list
6276028|NCT03565328|Nicotinic Acids|nicotinic acids|mesh-list
6276029|NCT03565328|Vitamin B Complex|vitamin b complex|mesh-ancestor
6276030|NCT03565328|Vitamins|vitamins|mesh-ancestor
6276031|NCT03565328|Micronutrients|micronutrients|mesh-ancestor
6276032|NCT03565328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276033|NCT03565328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6276034|NCT03565328|Antimetabolites|antimetabolites|mesh-ancestor
6276035|NCT03565328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276036|NCT03565328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6276037|NCT03565328|Vasodilator Agents|vasodilator agents|mesh-ancestor
6276038|NCT03543358|Immunoconjugates|immunoconjugates|mesh-list
6276039|NCT03543358|Immunologic Factors|immunologic factors|mesh-ancestor
6276040|NCT03543358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276041|NCT03538015|Carvedilol|carvedilol|mesh-list
6276042|NCT03538015|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6276043|NCT03538015|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6276044|NCT03538015|Adrenergic Agents|adrenergic agents|mesh-ancestor
6276045|NCT03538015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6276046|NCT03538015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276047|NCT03538015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276048|NCT03538015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6276049|NCT03538015|Antioxidants|antioxidants|mesh-ancestor
6276050|NCT03538015|Protective Agents|protective agents|mesh-ancestor
6276051|NCT03538015|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6276052|NCT03538015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6276053|NCT03538015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6276054|NCT03538015|Vasodilator Agents|vasodilator agents|mesh-ancestor
6276055|NCT03538015|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6276056|NCT03538015|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6276057|NCT03509207|Vorinostat|vorinostat|mesh-list
6276058|NCT03509207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6276059|NCT03509207|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6276060|NCT03509207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6276061|NCT03509207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276062|NCT03490916|Acetazolamide|acetazolamide|mesh-list
6276063|NCT03490916|Anticonvulsants|anticonvulsants|mesh-ancestor
6276064|NCT03490916|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6276065|NCT03490916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6276066|NCT03490916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276067|NCT03490916|Diuretics|diuretics|mesh-ancestor
6276068|NCT03490916|Natriuretic Agents|natriuretic agents|mesh-ancestor
6276069|NCT03490916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276070|NCT03477903|Metoclopramide|metoclopramide|mesh-list
6276071|NCT03477903|Antiemetics|antiemetics|mesh-ancestor
6276072|NCT03477903|Autonomic Agents|autonomic agents|mesh-ancestor
6276073|NCT03477903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6276074|NCT03477903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276075|NCT03477903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6276076|NCT03477903|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6276077|NCT03477903|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6276078|NCT03477903|Dopamine Agents|dopamine agents|mesh-ancestor
6276079|NCT03477903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6276080|NCT03477903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276081|NCT03469258|Pancrelipase|pancrelipase|mesh-list
6276082|NCT03469258|Pancreatin|pancreatin|mesh-list
6276083|NCT03469258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6276084|NCT03466658|Anti-Infective Agents|anti-infective agents|mesh-list
6276085|NCT03466658|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6276086|NCT03465891|Atezolizumab|atezolizumab|mesh-list
6276087|NCT03465891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6276088|NCT03465735|Heparin|heparin|mesh-list
6276089|NCT03465735|Enoxaparin|enoxaparin|mesh-list
6276090|NCT03465735|Dalteparin|dalteparin|mesh-list
6276091|NCT03465735|Warfarin|warfarin|mesh-list
6276092|NCT03465735|Rivaroxaban|rivaroxaban|mesh-list
6276093|NCT03465735|Dabigatran|dabigatran|mesh-list
6276094|NCT03465735|Apixaban|apixaban|mesh-list
6276095|NCT03465735|Edoxaban|edoxaban|mesh-list
6276096|NCT03465735|Anticoagulants|anticoagulants|mesh-ancestor
6276097|NCT03465735|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6276098|NCT03465735|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6276099|NCT03465735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276100|NCT03465735|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6276101|NCT03465735|Antithrombins|antithrombins|mesh-ancestor
6276102|NCT03465735|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6276103|NCT03465735|Protease Inhibitors|protease inhibitors|mesh-ancestor
6276104|NCT03465735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6276105|NCT03457818|Denosumab|denosumab|mesh-list
6276106|NCT03457818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6276107|NCT03457818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276108|NCT03455556|Atezolizumab|atezolizumab|mesh-list
6276109|NCT03455556|Maytansine|maytansine|mesh-list
6276110|NCT03455556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6276111|NCT03455556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6276112|NCT03455556|Immunologic Factors|immunologic factors|mesh-ancestor
6276113|NCT03455556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276114|NCT03455556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6276115|NCT03455556|Tubulin Modulators|tubulin modulators|mesh-ancestor
6276116|NCT03455556|Antimitotic Agents|antimitotic agents|mesh-ancestor
6276117|NCT03455556|Mitosis Modulators|mitosis modulators|mesh-ancestor
6276118|NCT03455556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276119|NCT03447639|Povidone-Iodine|povidone-iodine|mesh-list
6276120|NCT03447639|Povidone|povidone|mesh-list
6276121|NCT03447639|Plasma Substitutes|plasma substitutes|mesh-ancestor
6276122|NCT03447639|Blood Substitutes|blood substitutes|mesh-ancestor
6276123|NCT03447639|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6276124|NCT03447639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6276125|NCT03426137|Ketorolac|ketorolac|mesh-list
6276126|NCT03426137|Oxycodone|oxycodone|mesh-list
6276127|NCT03426137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6276128|NCT03426137|Narcotics|narcotics|mesh-ancestor
6276129|NCT03426137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6276130|NCT03426137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276131|NCT03426137|Analgesics|analgesics|mesh-ancestor
6276132|NCT03426137|Sensory System Agents|sensory system agents|mesh-ancestor
6276133|NCT03426137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6276134|NCT03426137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6276135|NCT03426137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6276136|NCT03426137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6276137|NCT03426137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6276138|NCT03426137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6276139|NCT03426137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6276140|NCT03426137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276141|NCT03425799|Tranexamic Acid|tranexamic acid|mesh-list
6276142|NCT03425799|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6276143|NCT03425799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6276144|NCT03425799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276145|NCT03425799|Hemostatics|hemostatics|mesh-ancestor
6276146|NCT03425799|Coagulants|coagulants|mesh-ancestor
6276147|NCT03382925|Triamcinolone|triamcinolone|mesh-list
6276148|NCT03382925|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6276149|NCT03382925|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6276150|NCT03382925|Lidocaine|lidocaine|mesh-list
6276151|NCT03382925|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6276152|NCT03382925|Anesthetics, Local|anesthetics, local|mesh-ancestor
6276153|NCT03382925|Anesthetics|anesthetics|mesh-ancestor
6276154|NCT03382925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6276155|NCT03382925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276156|NCT03382925|Sensory System Agents|sensory system agents|mesh-ancestor
6276157|NCT03382925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6276158|NCT03382925|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6276159|NCT03382925|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6276160|NCT03382925|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6276161|NCT03382925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5724670|NCT03185611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6276162|NCT03382925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276163|NCT03382925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6276164|NCT03382925|Glucocorticoids|glucocorticoids|mesh-ancestor
6276165|NCT03382925|Hormones|hormones|mesh-ancestor
6276166|NCT03382925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6276167|NCT03382925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6276168|NCT03382925|Immunologic Factors|immunologic factors|mesh-ancestor
6276169|NCT03382925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6276170|NCT03370536|Ibutilide|ibutilide|mesh-list
6276171|NCT03370536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6276172|NCT03363633|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
6276173|NCT03363633|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
6276174|NCT03363633|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6276175|NCT03361228|Pembrolizumab|pembrolizumab|mesh-list
6276176|NCT03361228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6276177|NCT03361228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6276178|NCT03360903|Caffeine|caffeine|mesh-list
6276179|NCT03360903|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6276180|NCT03360903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276181|NCT03360903|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6276182|NCT03360903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6276183|NCT03360903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276184|NCT03360903|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6276185|NCT03360903|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6276186|NCT03360903|Purinergic Agents|purinergic agents|mesh-ancestor
6276187|NCT03360903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6276188|NCT03359174|Tretinoin|tretinoin|mesh-list
6276189|NCT03359174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6276190|NCT03359174|Keratolytic Agents|keratolytic agents|mesh-ancestor
6276191|NCT03359174|Dermatologic Agents|dermatologic agents|mesh-ancestor
6276192|NCT03348904|Gemcitabine|gemcitabine|mesh-list
6276193|NCT03348904|Paclitaxel|paclitaxel|mesh-list
6276194|NCT03348904|Carboplatin|carboplatin|mesh-list
6276195|NCT03348904|Nivolumab|nivolumab|mesh-list
6276196|NCT03348904|Pemetrexed|pemetrexed|mesh-list
6276197|NCT03348904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6276198|NCT03348904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6276199|NCT03348904|Tubulin Modulators|tubulin modulators|mesh-ancestor
6276200|NCT03348904|Antimitotic Agents|antimitotic agents|mesh-ancestor
6276201|NCT03348904|Mitosis Modulators|mitosis modulators|mesh-ancestor
6276202|NCT03348904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276203|NCT03348904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6276204|NCT03348904|Antimetabolites|antimetabolites|mesh-ancestor
6276205|NCT03348904|Antiviral Agents|antiviral agents|mesh-ancestor
6276206|NCT03348904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6276207|NCT03348904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6276208|NCT03348904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6276209|NCT03348904|Immunologic Factors|immunologic factors|mesh-ancestor
6276210|NCT03348904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276211|NCT03348904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6276212|NCT03348904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6276213|NCT03348904|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6276214|NCT03348904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6276215|NCT03342638|Methylprednisolone|methylprednisolone|mesh-list
6276216|NCT03342638|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6276217|NCT03342638|Cyclophosphamide|cyclophosphamide|mesh-list
6276218|NCT03342638|Thymoglobulin|thymoglobulin|mesh-list
6276219|NCT03342638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6276220|NCT03342638|Immunologic Factors|immunologic factors|mesh-ancestor
6276221|NCT03342638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276222|NCT03342638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6276223|NCT03342638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6276224|NCT03342638|Alkylating Agents|alkylating agents|mesh-ancestor
6276225|NCT03342638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276226|NCT03342638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6276227|NCT03342638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6276228|NCT03342638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6276229|NCT03342638|Antiemetics|antiemetics|mesh-ancestor
6276230|NCT03342638|Autonomic Agents|autonomic agents|mesh-ancestor
6276231|NCT03342638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6276232|NCT03342638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6276233|NCT03342638|Glucocorticoids|glucocorticoids|mesh-ancestor
6276234|NCT03342638|Hormones|hormones|mesh-ancestor
6276235|NCT03342638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6276236|NCT03342638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6276237|NCT03342638|Protective Agents|protective agents|mesh-ancestor
6276238|NCT03342638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6276239|NCT03342157|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
6276240|NCT03342157|Sennosides|sennosides|mesh-list
6276241|NCT03342157|Antidiarrheals|antidiarrheals|mesh-ancestor
6276242|NCT03342157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6276243|NCT03342157|Laxatives|laxatives|mesh-ancestor
6276244|NCT03339401|Brincidofovir|brincidofovir|mesh-list
6276245|NCT03339401|Antiviral Agents|antiviral agents|mesh-ancestor
6276246|NCT03339401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6276247|NCT03339245|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6276248|NCT03333746|Nivolumab|nivolumab|mesh-list
6276249|NCT03333746|Lenalidomide|lenalidomide|mesh-list
6276250|NCT03333746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6276251|NCT03333746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6276252|NCT03333746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6276253|NCT03333746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276254|NCT03333746|Immunologic Factors|immunologic factors|mesh-ancestor
6276255|NCT03333746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276256|NCT03333746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6276257|NCT03333746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6276258|NCT03333746|Growth Substances|growth substances|mesh-ancestor
6276259|NCT03333746|Growth Inhibitors|growth inhibitors|mesh-ancestor
6276260|NCT03325114|Chlorthalidone|chlorthalidone|mesh-list
6276261|NCT03325114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6276262|NCT03325114|Diuretics|diuretics|mesh-ancestor
6276263|NCT03325114|Natriuretic Agents|natriuretic agents|mesh-ancestor
6276264|NCT03325114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276265|NCT03325114|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6276266|NCT03325114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6276267|NCT03325114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276268|NCT03305055|Fentanyl|fentanyl|mesh-list
6276269|NCT03305055|Ketamine|ketamine|mesh-list
6276270|NCT03305055|Analgesics|analgesics|mesh-ancestor
6276271|NCT03305055|Sensory System Agents|sensory system agents|mesh-ancestor
6276272|NCT03305055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6276273|NCT03305055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276274|NCT03305055|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6276275|NCT03305055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6276276|NCT03305055|Anesthetics, General|anesthetics, general|mesh-ancestor
6276277|NCT03305055|Anesthetics|anesthetics|mesh-ancestor
6276278|NCT03305055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6276279|NCT03305055|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6276280|NCT03305055|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6276281|NCT03305055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6276282|NCT03305055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276283|NCT03305055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6276284|NCT03305055|Narcotics|narcotics|mesh-ancestor
6276285|NCT03305055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6276286|NCT03302247|Gemcitabine|gemcitabine|mesh-list
6276287|NCT03302247|Nivolumab|nivolumab|mesh-list
6276288|NCT03302247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6276289|NCT03302247|Antimetabolites|antimetabolites|mesh-ancestor
6276290|NCT03302247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276291|NCT03302247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6276292|NCT03302247|Antiviral Agents|antiviral agents|mesh-ancestor
6276293|NCT03302247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6276294|NCT03302247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6276295|NCT03302247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6276296|NCT03302247|Immunologic Factors|immunologic factors|mesh-ancestor
6276297|NCT03302247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276298|NCT03302247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6276299|NCT03302247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6391231|NCT00192777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391232|NCT00192803|Candesartan|candesartan|mesh-list
6391233|NCT00192803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6391234|NCT00192803|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6391235|NCT00192803|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6391236|NCT00192803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391237|NCT00192842|Gemcitabine|gemcitabine|mesh-list
6391238|NCT00192842|Curcumin|curcumin|mesh-list
6391239|NCT00192842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6276300|NCT03277183|Epoetin Alfa|epoetin alfa|mesh-list
6276301|NCT03277183|Hematinics|hematinics|mesh-ancestor
6276302|NCT03248141|Factor VIII|factor viii|mesh-list
6276303|NCT03248141|Coagulants|coagulants|mesh-ancestor
6276304|NCT03251326|Propranolol|propranolol|mesh-list
6276305|NCT03251326|Nabilone|nabilone|mesh-list
6276306|NCT03251326|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6276307|NCT03251326|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6276308|NCT03251326|Adrenergic Agents|adrenergic agents|mesh-ancestor
6276309|NCT03251326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6276310|NCT03251326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276311|NCT03251326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276312|NCT03251326|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6276313|NCT03251326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6276314|NCT03251326|Vasodilator Agents|vasodilator agents|mesh-ancestor
6276315|NCT03251326|Antiemetics|antiemetics|mesh-ancestor
6276316|NCT03251326|Autonomic Agents|autonomic agents|mesh-ancestor
6276317|NCT03251326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6276318|NCT03251326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6276319|NCT03251326|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6276320|NCT03251326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6276321|NCT03251326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6276322|NCT03251326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6276323|NCT03219372|Pravastatin|pravastatin|mesh-list
6276324|NCT03219372|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6276325|NCT03219372|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6276326|NCT03219372|Antimetabolites|antimetabolites|mesh-ancestor
6276327|NCT03219372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276328|NCT03219372|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6276329|NCT03219372|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6276330|NCT03219372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6276331|NCT03217175|Glucagon|glucagon|mesh-list
6276332|NCT03217175|Pancrelipase|pancrelipase|mesh-list
6276333|NCT03217175|Pancreatin|pancreatin|mesh-list
6276334|NCT03217175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276335|NCT03217175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6276336|NCT03217175|Hormones|hormones|mesh-ancestor
6276337|NCT03217175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6276338|NCT03231397|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6276339|NCT03231397|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6276340|NCT03231397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276341|NCT03232892|Trametinib|trametinib|mesh-list
6276342|NCT03232892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6276343|NCT03232892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6276344|NCT03232892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6276345|NCT03232892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276346|NCT03169530|Ethanol|ethanol|mesh-list
6276347|NCT03169530|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6276348|NCT03169530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6276349|NCT03169530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6276350|NCT03169530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276351|NCT03189433|Dantrolene|dantrolene|mesh-list
6276352|NCT03189433|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6276353|NCT03189433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276354|NCT03189433|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6276355|NCT03189433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6276356|NCT03172026|Maraviroc|maraviroc|mesh-list
6276357|NCT03172026|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6276358|NCT03172026|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6276359|NCT03172026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276360|NCT03172026|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6276361|NCT03172026|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6276362|NCT03172026|Antiviral Agents|antiviral agents|mesh-ancestor
6276363|NCT03172026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6276364|NCT03172026|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6276365|NCT03161964|Propranolol|propranolol|mesh-list
6276366|NCT03161964|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6276367|NCT03161964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6276368|NCT03161964|Adrenergic Agents|adrenergic agents|mesh-ancestor
6276369|NCT03161964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6276370|NCT03161964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276371|NCT03161964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276372|NCT03161964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6276373|NCT03161964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6276374|NCT03161964|Vasodilator Agents|vasodilator agents|mesh-ancestor
6276375|NCT03150160|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6276376|NCT03150160|Travoprost|travoprost|mesh-list
6276377|NCT03150160|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6276378|NCT03150160|Brinzolamide|brinzolamide|mesh-list
6276379|NCT03150160|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6276380|NCT03150160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6276381|NCT03150160|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6276382|NCT03150160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6276383|NCT03150160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6276384|NCT03150160|Adrenergic Agents|adrenergic agents|mesh-ancestor
6276385|NCT03150160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6276386|NCT03150160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276387|NCT03150160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276388|NCT03150160|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6276389|NCT03150160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6276390|NCT03109418|Ketamine|ketamine|mesh-list
6276391|NCT03109418|Analgesics|analgesics|mesh-ancestor
6276392|NCT03109418|Sensory System Agents|sensory system agents|mesh-ancestor
6276393|NCT03109418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6276394|NCT03109418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276395|NCT03109418|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6276396|NCT03109418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6276397|NCT03109418|Anesthetics, General|anesthetics, general|mesh-ancestor
6276398|NCT03109418|Anesthetics|anesthetics|mesh-ancestor
6276399|NCT03109418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6276400|NCT03109418|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6276401|NCT03109418|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6276402|NCT03109418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6276403|NCT03109418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276404|NCT03120676|Atezolizumab|atezolizumab|mesh-list
6276405|NCT03120676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6276406|NCT03109873|Metformin|metformin|mesh-list
6276407|NCT03109873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6276408|NCT03109873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276409|NCT03113071|Decitabine|decitabine|mesh-list
6276410|NCT03113071|Digoxin|digoxin|mesh-list
6276411|NCT03113071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6276412|NCT03113071|Antimetabolites|antimetabolites|mesh-ancestor
6276413|NCT03113071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276414|NCT03113071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6276415|NCT03113071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6276416|NCT03113071|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6276417|NCT03113071|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6276418|NCT03113071|Protective Agents|protective agents|mesh-ancestor
6276419|NCT03113071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276420|NCT03110900|Lorazepam|lorazepam|mesh-list
6276421|NCT03110900|Haloperidol|haloperidol|mesh-list
6276422|NCT03110900|Haloperidol decanoate|haloperidol decanoate|mesh-list
6276423|NCT03110900|Loxapine|loxapine|mesh-list
6276424|NCT03110900|Antiemetics|antiemetics|mesh-ancestor
6276425|NCT03110900|Autonomic Agents|autonomic agents|mesh-ancestor
6276426|NCT03110900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6276427|NCT03110900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276428|NCT03110900|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6276429|NCT03110900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6276430|NCT03110900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6276431|NCT03110900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6276432|NCT03110900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6276433|NCT03110900|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6276434|NCT03110900|Dopamine Agents|dopamine agents|mesh-ancestor
6276435|NCT03110900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6276436|NCT03110900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276437|NCT03110900|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6276438|NCT03110900|Anticonvulsants|anticonvulsants|mesh-ancestor
6276439|NCT03110900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6276440|NCT03110900|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6276441|NCT03110900|GABA Modulators|gaba modulators|mesh-ancestor
6276442|NCT03110900|GABA Agents|gaba agents|mesh-ancestor
6276443|NCT03078270|Botulinum Toxins|botulinum toxins|mesh-list
6276444|NCT03078270|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6276445|NCT03078270|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6276446|NCT03078270|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6276447|NCT03078270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6276448|NCT03078270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276449|NCT03078270|Cholinergic Agents|cholinergic agents|mesh-ancestor
6276450|NCT03078270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6276451|NCT03078270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276452|NCT03078270|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6276453|NCT03078270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6276454|NCT03065933|Clonidine|clonidine|mesh-list
6276455|NCT03065933|Analgesics|analgesics|mesh-ancestor
6276456|NCT03065933|Sensory System Agents|sensory system agents|mesh-ancestor
6276457|NCT03065933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6276458|NCT03065933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276459|NCT03065933|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6276460|NCT03065933|Sympatholytics|sympatholytics|mesh-ancestor
6276461|NCT03065933|Autonomic Agents|autonomic agents|mesh-ancestor
6276462|NCT03065933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6276463|NCT03065933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6276464|NCT03065933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6276465|NCT03065933|Adrenergic Agents|adrenergic agents|mesh-ancestor
6276466|NCT03065933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6276467|NCT03065933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276468|NCT03070002|Denosumab|denosumab|mesh-list
6276469|NCT03070002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6276470|NCT03070002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276471|NCT03050398|Letrozole|letrozole|mesh-list
6276472|NCT03050398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6276473|NCT03050398|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6276474|NCT03050398|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6276475|NCT03050398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6276476|NCT03050398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276477|NCT03050398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6276478|NCT03050398|Hormone Antagonists|hormone antagonists|mesh-ancestor
6276479|NCT03050398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6276480|NCT03050398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276481|NCT03042780|Folfirinox|folfirinox|mesh-list
6276482|NCT03042780|Lenograstim|lenograstim|mesh-list
6276483|NCT03042780|Sargramostim|sargramostim|mesh-list
6276484|NCT03042780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6276485|NCT03042780|Immunologic Factors|immunologic factors|mesh-ancestor
6276486|NCT03042780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276487|NCT03042780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6276488|NCT03029832|Atezolizumab|atezolizumab|mesh-list
6276489|NCT03029832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6276490|NCT03031340|Pregabalin|pregabalin|mesh-list
6276491|NCT03031340|Analgesics|analgesics|mesh-ancestor
6276492|NCT03031340|Sensory System Agents|sensory system agents|mesh-ancestor
6276493|NCT03031340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6276494|NCT03031340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276495|NCT03031340|Anticonvulsants|anticonvulsants|mesh-ancestor
6276496|NCT03031340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6276497|NCT03031340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6276498|NCT03031340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276499|NCT03031340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6276500|NCT03031340|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6276501|NCT03031340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6276502|NCT03031340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6276503|NCT03031340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6276504|NCT03007719|Fluorides|fluorides|mesh-list
6276505|NCT03007719|Cariostatic Agents|cariostatic agents|mesh-ancestor
6276506|NCT03007719|Protective Agents|protective agents|mesh-ancestor
6276507|NCT03007719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276508|NCT03010423|Nicorandil|nicorandil|mesh-list
6276509|NCT03010423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6276510|NCT03010423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6276511|NCT03010423|Vasodilator Agents|vasodilator agents|mesh-ancestor
6276512|NCT03010423|Vitamin B Complex|vitamin b complex|mesh-ancestor
6276513|NCT03010423|Vitamins|vitamins|mesh-ancestor
6276514|NCT03010423|Micronutrients|micronutrients|mesh-ancestor
6276515|NCT03010423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276516|NCT02985801|Pancrelipase|pancrelipase|mesh-list
6276517|NCT02985801|Pancreatin|pancreatin|mesh-list
6276518|NCT02985801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6276519|NCT02995967|Botulinum Toxins|botulinum toxins|mesh-list
6276520|NCT02995967|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6276521|NCT02995967|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6276522|NCT02995967|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6276523|NCT02995967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6276524|NCT02995967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276525|NCT02995967|Cholinergic Agents|cholinergic agents|mesh-ancestor
6276526|NCT02995967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6276527|NCT02995967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276528|NCT02995967|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6276529|NCT02995967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6276530|NCT02994251|Gemcitabine|gemcitabine|mesh-list
6276531|NCT02994251|Doxorubicin|doxorubicin|mesh-list
6276532|NCT02994251|Mitomycins|mitomycins|mesh-list
6276533|NCT02994251|Mitomycin|mitomycin|mesh-list
6276534|NCT02994251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6276535|NCT02994251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6276536|NCT02994251|Antimetabolites|antimetabolites|mesh-ancestor
6276537|NCT02994251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276538|NCT02994251|Antiviral Agents|antiviral agents|mesh-ancestor
6276539|NCT02994251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6276540|NCT02994251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6276541|NCT02994251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6276542|NCT02994251|Immunologic Factors|immunologic factors|mesh-ancestor
6276543|NCT02994251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276544|NCT02994251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6276545|NCT02994251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6276546|NCT02994251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6276547|NCT02994251|Alkylating Agents|alkylating agents|mesh-ancestor
6276548|NCT02994251|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6276549|NCT02971839|Ivacaftor|ivacaftor|mesh-list
6276550|NCT02971839|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6276551|NCT02971839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6276552|NCT02971839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276553|NCT02985840|Dexamethasone|dexamethasone|mesh-list
6276554|NCT02985840|Ondansetron|ondansetron|mesh-list
6276555|NCT02985840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6276556|NCT02985840|Antiemetics|antiemetics|mesh-ancestor
6276557|NCT02985840|Autonomic Agents|autonomic agents|mesh-ancestor
6276558|NCT02985840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6276559|NCT02985840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276560|NCT02985840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6276561|NCT02985840|Glucocorticoids|glucocorticoids|mesh-ancestor
6276562|NCT02985840|Hormones|hormones|mesh-ancestor
6276563|NCT02985840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6276564|NCT02985840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6276565|NCT02985840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6276566|NCT02985840|Antipruritics|antipruritics|mesh-ancestor
6276567|NCT02985840|Dermatologic Agents|dermatologic agents|mesh-ancestor
6276568|NCT02985840|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6276569|NCT02985840|Serotonin Agents|serotonin agents|mesh-ancestor
6276570|NCT02985840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6276571|NCT02985840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276572|NCT02985840|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6276573|NCT02985840|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6276574|NCT02985840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6276575|NCT02985840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6276576|NCT02985840|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6276577|NCT02974803|Trametinib|trametinib|mesh-list
6276578|NCT02974803|Dabrafenib|dabrafenib|mesh-list
6276579|NCT02974803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6276580|NCT02974803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6276581|NCT02974803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6276582|NCT02974803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276583|NCT02974686|Mycophenolic Acid|mycophenolic acid|mesh-list
6276584|NCT02974686|Everolimus|everolimus|mesh-list
6276585|NCT02974686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6276586|NCT02974686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6276587|NCT02974686|Immunologic Factors|immunologic factors|mesh-ancestor
6276588|NCT02974686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276589|NCT02974686|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6276590|NCT02974686|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6276591|NCT02974686|Antitubercular Agents|antitubercular agents|mesh-ancestor
6276592|NCT02974686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6276593|NCT02974686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6276594|NCT02974686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6276595|NCT02974686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276596|NCT02956005|Tacrolimus|tacrolimus|mesh-list
6276597|NCT02956005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6276598|NCT02956005|Immunologic Factors|immunologic factors|mesh-ancestor
6276599|NCT02956005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276600|NCT02956005|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6276601|NCT02956005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6276602|NCT02956005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276603|NCT02966184|Albuterol|albuterol|mesh-list
6276604|NCT02966184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6276605|NCT02966184|Autonomic Agents|autonomic agents|mesh-ancestor
6276606|NCT02966184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6276607|NCT02966184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276608|NCT02966184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6276609|NCT02966184|Respiratory System Agents|respiratory system agents|mesh-ancestor
6276610|NCT02966184|Tocolytic Agents|tocolytic agents|mesh-ancestor
6276611|NCT02966184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6276612|NCT02966184|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6276613|NCT02966184|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6276614|NCT02966184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6276615|NCT02966184|Adrenergic Agents|adrenergic agents|mesh-ancestor
6276616|NCT02966184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6276617|NCT02966184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276618|NCT02940223|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
6276619|NCT02940223|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6276620|NCT02940223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6276621|NCT02954159|Vedolizumab|vedolizumab|mesh-list
6276622|NCT02954159|Tacrolimus|tacrolimus|mesh-list
6276623|NCT02954159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6276624|NCT02954159|Immunologic Factors|immunologic factors|mesh-ancestor
6276625|NCT02954159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276626|NCT02954159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6276627|NCT02954159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6276628|NCT02954159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276629|NCT02954159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6276630|NCT02947022|Calcium, Dietary|calcium, dietary|mesh-list
6276631|NCT02947022|Zinc|zinc|mesh-list
6276632|NCT02947022|Edetic Acid|edetic acid|mesh-list
6276633|NCT02947022|Calcium|calcium|mesh-list
6276634|NCT02947022|Pentetic Acid|pentetic acid|mesh-list
6276635|NCT02947022|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6276636|NCT02947022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276637|NCT02947022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6276638|NCT02947022|Trace Elements|trace elements|mesh-ancestor
6276639|NCT02947022|Micronutrients|micronutrients|mesh-ancestor
6276640|NCT02947022|Antidotes|antidotes|mesh-ancestor
6276641|NCT02947022|Protective Agents|protective agents|mesh-ancestor
6276642|NCT02947022|Chelating Agents|chelating agents|mesh-ancestor
6276643|NCT02947022|Sequestering Agents|sequestering agents|mesh-ancestor
6276644|NCT02947022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276645|NCT02947022|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6276646|NCT02947022|Anticoagulants|anticoagulants|mesh-ancestor
6276647|NCT02947022|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6276648|NCT02936999|Vitamin D|vitamin d|mesh-list
6276649|NCT02936999|Cholecalciferol|cholecalciferol|mesh-list
6276650|NCT02936999|Vitamins|vitamins|mesh-ancestor
6015107|NCT00354913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6015108|NCT00354913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015109|NCT00354913|Antisickling Agents|antisickling agents|mesh-ancestor
6015110|NCT00354913|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6015111|NCT00354978|Leucovorin|leucovorin|mesh-list
6015112|NCT00354978|Bevacizumab|bevacizumab|mesh-list
6015113|NCT00354978|Fluorouracil|fluorouracil|mesh-list
6015114|NCT00354978|Irinotecan|irinotecan|mesh-list
6015115|NCT00354978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6015116|NCT00354978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6015117|NCT00354978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6015118|NCT00354978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6015119|NCT00354978|Growth Substances|growth substances|mesh-ancestor
6015120|NCT00354978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015121|NCT00354978|Growth Inhibitors|growth inhibitors|mesh-ancestor
6015122|NCT00354978|Antimetabolites|antimetabolites|mesh-ancestor
6015123|NCT00354978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015124|NCT00354978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6015125|NCT00354978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6276651|NCT02936999|Micronutrients|micronutrients|mesh-ancestor
6276652|NCT02936999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276653|NCT02936999|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6276654|NCT02936999|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6276655|NCT02950480|Zafirlukast|zafirlukast|mesh-list
6276656|NCT02950480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6276657|NCT02950480|Respiratory System Agents|respiratory system agents|mesh-ancestor
6276658|NCT02950480|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6276659|NCT02950480|Hormone Antagonists|hormone antagonists|mesh-ancestor
6276660|NCT02950480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6276661|NCT02950480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276662|NCT02936206|Tamoxifen|tamoxifen|mesh-list
6276663|NCT02936206|Fulvestrant|fulvestrant|mesh-list
6276664|NCT02936206|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6276665|NCT02936206|Hormone Antagonists|hormone antagonists|mesh-ancestor
6276666|NCT02936206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6276667|NCT02936206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276668|NCT02936206|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6276669|NCT02936206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6276670|NCT02936206|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6276671|NCT02936206|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6276672|NCT02936206|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6276673|NCT02936206|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6276674|NCT02934932|Brexpiprazole|brexpiprazole|mesh-list
6276675|NCT02934932|Serotonin Agents|serotonin agents|mesh-ancestor
6276676|NCT02934932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6276677|NCT02934932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276678|NCT02934932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276679|NCT02934932|Dopamine Agonists|dopamine agonists|mesh-ancestor
6276680|NCT02934932|Dopamine Agents|dopamine agents|mesh-ancestor
6276681|NCT02908516|Tranexamic Acid|tranexamic acid|mesh-list
6276682|NCT02908516|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6276683|NCT02908516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6276684|NCT02908516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276685|NCT02908516|Hemostatics|hemostatics|mesh-ancestor
6276686|NCT02908516|Coagulants|coagulants|mesh-ancestor
6276687|NCT02920450|Paclitaxel|paclitaxel|mesh-list
6276688|NCT02920450|Carboplatin|carboplatin|mesh-list
6276689|NCT02920450|Gedatolisib|gedatolisib|mesh-list
6276690|NCT02920450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6276691|NCT02920450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6276692|NCT02920450|Tubulin Modulators|tubulin modulators|mesh-ancestor
6276693|NCT02920450|Antimitotic Agents|antimitotic agents|mesh-ancestor
6276694|NCT02920450|Mitosis Modulators|mitosis modulators|mesh-ancestor
6276695|NCT02920450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276696|NCT02920450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6276697|NCT02920450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6276698|NCT02920177|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6276699|NCT02920177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6276700|NCT02920177|Glucocorticoids|glucocorticoids|mesh-ancestor
6276701|NCT02920177|Hormones|hormones|mesh-ancestor
6276702|NCT02920177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6276703|NCT02920177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276704|NCT02920177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6276705|NCT02920177|Immunologic Factors|immunologic factors|mesh-ancestor
6276706|NCT02926638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6276707|NCT02926638|Rilotumumab|rilotumumab|mesh-list
6276708|NCT02926638|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6276709|NCT02926638|Antibodies|antibodies|mesh-list
6276710|NCT02926638|Immunoglobulins|immunoglobulins|mesh-list
6276711|NCT02926638|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6276712|NCT02926638|Immunologic Factors|immunologic factors|mesh-ancestor
6276713|NCT02926638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276714|NCT02926638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6276715|NCT02926638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6276716|NCT02926638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6276717|NCT02926638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276718|NCT02920242|Rifaximin|rifaximin|mesh-list
6276719|NCT02920242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6276720|NCT02920242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6276721|NCT02920242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6276722|NCT02892500|Betamethasone|betamethasone|mesh-list
6276723|NCT02892500|Betamethasone Valerate|betamethasone valerate|mesh-list
6276724|NCT02892500|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
6276725|NCT02892500|Betamethasone benzoate|betamethasone benzoate|mesh-list
6276726|NCT02892500|Bupivacaine|bupivacaine|mesh-list
6276727|NCT02892500|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
6276728|NCT02892500|Anesthetics, Local|anesthetics, local|mesh-ancestor
6276729|NCT02892500|Anesthetics|anesthetics|mesh-ancestor
6276730|NCT02892500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6276731|NCT02892500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276732|NCT02892500|Sensory System Agents|sensory system agents|mesh-ancestor
6276733|NCT02892500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6276734|NCT02892500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6276735|NCT02892500|Glucocorticoids|glucocorticoids|mesh-ancestor
6276736|NCT02892500|Hormones|hormones|mesh-ancestor
6276737|NCT02892500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6276738|NCT02892500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6276739|NCT02892500|Respiratory System Agents|respiratory system agents|mesh-ancestor
6276740|NCT02899728|Cisplatin|cisplatin|mesh-list
6276741|NCT02899728|Carboplatin|carboplatin|mesh-list
6276742|NCT02899728|Etoposide|etoposide|mesh-list
6276743|NCT02899728|Etoposide phosphate|etoposide phosphate|mesh-list
6276744|NCT02899728|Olaparib|olaparib|mesh-list
6276745|NCT02899728|Podophyllotoxin|podophyllotoxin|mesh-list
6276746|NCT02899728|Cediranib|cediranib|mesh-list
6276747|NCT02899728|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
6276748|NCT02899728|Maleic acid|maleic acid|mesh-list
6276749|NCT02899728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6276750|NCT02899728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6276751|NCT02899728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6276752|NCT02899728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6276753|NCT02899728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6276754|NCT02899728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276755|NCT02899728|Keratolytic Agents|keratolytic agents|mesh-ancestor
6276756|NCT02899728|Dermatologic Agents|dermatologic agents|mesh-ancestor
6276757|NCT02899728|Tubulin Modulators|tubulin modulators|mesh-ancestor
6276758|NCT02899728|Antimitotic Agents|antimitotic agents|mesh-ancestor
6276759|NCT02899728|Mitosis Modulators|mitosis modulators|mesh-ancestor
6276760|NCT02899728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6276761|NCT02875067|Pembrolizumab|pembrolizumab|mesh-list
6276762|NCT02875067|Lenalidomide|lenalidomide|mesh-list
6276763|NCT02875067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6276764|NCT02875067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6276765|NCT02875067|Immunologic Factors|immunologic factors|mesh-ancestor
6276766|NCT02875067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276767|NCT02875067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6276768|NCT02875067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6276769|NCT02875067|Growth Substances|growth substances|mesh-ancestor
6276770|NCT02875067|Growth Inhibitors|growth inhibitors|mesh-ancestor
6276771|NCT02868892|Pemetrexed|pemetrexed|mesh-list
6276772|NCT02868892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6276773|NCT02868892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6276774|NCT02868892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276775|NCT02868892|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6276776|NCT02868892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6391240|NCT00192842|Antimetabolites|antimetabolites|mesh-ancestor
6391241|NCT00192842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391242|NCT00192842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391243|NCT00192842|Antiviral Agents|antiviral agents|mesh-ancestor
6391244|NCT00192842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6391245|NCT00192842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6391246|NCT00192842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6391247|NCT00192842|Immunologic Factors|immunologic factors|mesh-ancestor
6391248|NCT00192842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6391249|NCT00192842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6391250|NCT00192842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6391251|NCT00192842|Analgesics|analgesics|mesh-ancestor
6391252|NCT00192842|Sensory System Agents|sensory system agents|mesh-ancestor
6391253|NCT00192842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6391254|NCT00192842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6391255|NCT00192842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6391256|NCT00192855|Entacapone|entacapone|mesh-list
6391257|NCT00192855|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6391258|NCT00192855|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6276777|NCT02826161|Paclitaxel|paclitaxel|mesh-list
6276778|NCT02826161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6276779|NCT02826161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6276780|NCT02826161|Tubulin Modulators|tubulin modulators|mesh-ancestor
6276781|NCT02826161|Antimitotic Agents|antimitotic agents|mesh-ancestor
6276782|NCT02826161|Mitosis Modulators|mitosis modulators|mesh-ancestor
6276783|NCT02826161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276784|NCT02828124|Nivolumab|nivolumab|mesh-list
6276785|NCT02828124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6276786|NCT02828124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6276787|NCT02828124|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6276788|NCT02828124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276789|NCT02826551|Bupivacaine|bupivacaine|mesh-list
6276790|NCT02826551|Anesthetics, Local|anesthetics, local|mesh-ancestor
6276791|NCT02826551|Anesthetics|anesthetics|mesh-ancestor
6276792|NCT02826551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6276793|NCT02826551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276794|NCT02826551|Sensory System Agents|sensory system agents|mesh-ancestor
6276795|NCT02826551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6276796|NCT02819804|Nivolumab|nivolumab|mesh-list
6276797|NCT02819804|Dasatinib|dasatinib|mesh-list
6276798|NCT02819804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6276799|NCT02819804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6276800|NCT02819804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6276801|NCT02819804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276802|NCT02819804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6276803|NCT02819804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6276804|NCT02806960|Glucagon|glucagon|mesh-list
6276805|NCT02806960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6276806|NCT02806960|Hormones|hormones|mesh-ancestor
6276807|NCT02806960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6276808|NCT02806960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276809|NCT02815397|Metformin|metformin|mesh-list
6276810|NCT02815397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6276811|NCT02815397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276812|NCT02802592|Epoetin Alfa|epoetin alfa|mesh-list
6276813|NCT02802592|Hematinics|hematinics|mesh-ancestor
6276814|NCT02774148|Acetaminophen|acetaminophen|mesh-list
6276815|NCT02774148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6276816|NCT02774148|Analgesics|analgesics|mesh-ancestor
6276817|NCT02774148|Sensory System Agents|sensory system agents|mesh-ancestor
6276818|NCT02774148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6276819|NCT02774148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276820|NCT02774148|Antipyretics|antipyretics|mesh-ancestor
6276821|NCT02773576|Risperidone|risperidone|mesh-list
6276822|NCT02773576|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6276823|NCT02773576|Serotonin Agents|serotonin agents|mesh-ancestor
6276824|NCT02773576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6276825|NCT02773576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276826|NCT02773576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276827|NCT02773576|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6276828|NCT02773576|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6276829|NCT02773576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6276830|NCT02773576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6276831|NCT02773576|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6276832|NCT02773576|Dopamine Agents|dopamine agents|mesh-ancestor
6276833|NCT02730793|Aztreonam|aztreonam|mesh-list
6276834|NCT02730793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6276835|NCT02730793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6276836|NCT02744352|Ropivacaine|ropivacaine|mesh-list
6276837|NCT02744352|Anesthetics, Local|anesthetics, local|mesh-ancestor
6276838|NCT02744352|Anesthetics|anesthetics|mesh-ancestor
6276839|NCT02744352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6276840|NCT02744352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276841|NCT02744352|Sensory System Agents|sensory system agents|mesh-ancestor
6276842|NCT02744352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6276843|NCT02757521|Nitrous Oxide|nitrous oxide|mesh-list
6276844|NCT02757521|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6276845|NCT02757521|Anesthetics, General|anesthetics, general|mesh-ancestor
6276846|NCT02757521|Anesthetics|anesthetics|mesh-ancestor
6276847|NCT02757521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6276848|NCT02757521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276849|NCT02757521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6276850|NCT02757521|Analgesics|analgesics|mesh-ancestor
6276851|NCT02757521|Sensory System Agents|sensory system agents|mesh-ancestor
6276852|NCT02757521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6276853|NCT02758132|Denosumab|denosumab|mesh-list
6276854|NCT02758132|Prednisone|prednisone|mesh-list
6276855|NCT02758132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6276856|NCT02758132|Glucocorticoids|glucocorticoids|mesh-ancestor
6276857|NCT02758132|Hormones|hormones|mesh-ancestor
6276858|NCT02758132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6276859|NCT02758132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276860|NCT02758132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6276861|NCT02758132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6276862|NCT02758132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6276863|NCT02734940|Lidocaine|lidocaine|mesh-list
6276864|NCT02734940|Fentanyl|fentanyl|mesh-list
6276865|NCT02734940|Ketamine|ketamine|mesh-list
6276866|NCT02734940|Dexmedetomidine|dexmedetomidine|mesh-list
6276867|NCT02734940|Morphine|morphine|mesh-list
6276868|NCT02734940|Anesthetics, Local|anesthetics, local|mesh-ancestor
6276869|NCT02734940|Anesthetics|anesthetics|mesh-ancestor
6276870|NCT02734940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6276871|NCT02734940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276872|NCT02734940|Sensory System Agents|sensory system agents|mesh-ancestor
6276873|NCT02734940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6276874|NCT02734940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6276875|NCT02734940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6276876|NCT02734940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6276877|NCT02734940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6276878|NCT02734940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276879|NCT02734940|Analgesics|analgesics|mesh-ancestor
6276880|NCT02734940|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6276881|NCT02734940|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6276882|NCT02734940|Anesthetics, General|anesthetics, general|mesh-ancestor
6276883|NCT02734940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6276884|NCT02734940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6276885|NCT02734940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6276886|NCT02734940|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6276887|NCT02734940|Narcotics|narcotics|mesh-ancestor
6276888|NCT02734940|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6276889|NCT02734940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6276890|NCT02734940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6015126|NCT00354978|Immunologic Factors|immunologic factors|mesh-ancestor
6276891|NCT02734940|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6276892|NCT02734940|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6276893|NCT02734940|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6276894|NCT02734940|Adrenergic Agents|adrenergic agents|mesh-ancestor
6276895|NCT02749617|Apixaban|apixaban|mesh-list
6276896|NCT02749617|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6276897|NCT02749617|Antithrombins|antithrombins|mesh-ancestor
6276898|NCT02749617|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6276899|NCT02749617|Protease Inhibitors|protease inhibitors|mesh-ancestor
6276900|NCT02749617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6276901|NCT02749617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276902|NCT02749617|Anticoagulants|anticoagulants|mesh-ancestor
6276903|NCT02749227|Pasireotide|pasireotide|mesh-list
6276904|NCT02749227|Hormones|hormones|mesh-ancestor
6276905|NCT02749227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6276906|NCT02749227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276907|NCT02746263|Acetaminophen|acetaminophen|mesh-list
6276908|NCT02746263|Morphine|morphine|mesh-list
6276909|NCT02746263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6276910|NCT02746263|Narcotics|narcotics|mesh-ancestor
6276911|NCT02746263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6276912|NCT02746263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276913|NCT02746263|Analgesics|analgesics|mesh-ancestor
6276914|NCT02746263|Sensory System Agents|sensory system agents|mesh-ancestor
6276915|NCT02746263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6276916|NCT02746263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6276917|NCT02746263|Antipyretics|antipyretics|mesh-ancestor
6276918|NCT02721277|SMOFlipid|smoflipid|mesh-list
6276919|NCT02721277|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6276920|NCT02721277|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6276921|NCT02721277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6276922|NCT02732327|Vancomycin|vancomycin|mesh-list
6276923|NCT02732327|Meropenem|meropenem|mesh-list
6276924|NCT02732327|Tazobactam|tazobactam|mesh-list
6276925|NCT02732327|Linezolid|linezolid|mesh-list
6276926|NCT02732327|Piperacillin|piperacillin|mesh-list
6276927|NCT02732327|Cefepime|cefepime|mesh-list
6276928|NCT02732327|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
6276929|NCT02732327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6276930|NCT02732327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6276931|NCT02732327|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6276932|NCT02732327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6276933|NCT02732327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276934|NCT02732327|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6276935|NCT02726399|Capecitabine|capecitabine|mesh-list
6276936|NCT02726399|Trastuzumab|trastuzumab|mesh-list
6276937|NCT02726399|Ramucirumab|ramucirumab|mesh-list
6276938|NCT02726399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6276939|NCT02726399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6276940|NCT02726399|Antimetabolites|antimetabolites|mesh-ancestor
6276941|NCT02726399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276942|NCT02726399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6015127|NCT00354978|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6276943|NCT02720510|Dexamethasone|dexamethasone|mesh-list
6276944|NCT02720510|Lenalidomide|lenalidomide|mesh-list
6276945|NCT02720510|Bortezomib|bortezomib|mesh-list
6276946|NCT02720510|Panobinostat|panobinostat|mesh-list
6276947|NCT02720510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6276948|NCT02720510|Antiemetics|antiemetics|mesh-ancestor
6276949|NCT02720510|Autonomic Agents|autonomic agents|mesh-ancestor
6276950|NCT02720510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6276951|NCT02720510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276952|NCT02720510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6276953|NCT02720510|Glucocorticoids|glucocorticoids|mesh-ancestor
6276954|NCT02720510|Hormones|hormones|mesh-ancestor
6276955|NCT02720510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6276956|NCT02720510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6276957|NCT02720510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6276958|NCT02720510|Immunologic Factors|immunologic factors|mesh-ancestor
6276959|NCT02720510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6276960|NCT02720510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6276961|NCT02720510|Growth Substances|growth substances|mesh-ancestor
6276962|NCT02720510|Growth Inhibitors|growth inhibitors|mesh-ancestor
6276963|NCT02720510|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6276964|NCT02720510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6276965|NCT02720510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276966|NCT02717949|Ribavirin|ribavirin|mesh-list
6276967|NCT02717949|Sofosbuvir|sofosbuvir|mesh-list
6276968|NCT02717949|Ledipasvir|ledipasvir|mesh-list
6276969|NCT02717949|Antimetabolites|antimetabolites|mesh-ancestor
6276970|NCT02717949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276971|NCT02717949|Antiviral Agents|antiviral agents|mesh-ancestor
6276972|NCT02717949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6276973|NCT02717130|Aripiprazole|aripiprazole|mesh-list
6276974|NCT02717130|Antidepressive Agents|antidepressive agents|mesh-ancestor
6276975|NCT02717130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6276976|NCT02717130|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6276977|NCT02717130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6276978|NCT02717130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6276979|NCT02717130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6276980|NCT02717130|Dopamine Agonists|dopamine agonists|mesh-ancestor
6276981|NCT02717130|Dopamine Agents|dopamine agents|mesh-ancestor
6276982|NCT02717130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6276983|NCT02717130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276984|NCT02717130|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6276985|NCT02717130|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6276986|NCT02717130|Serotonin Agents|serotonin agents|mesh-ancestor
6276987|NCT02717130|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6276988|NCT02717130|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6276989|NCT02717130|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6276990|NCT02717130|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6276991|NCT02709083|Imatinib Mesylate|imatinib mesylate|mesh-list
6276992|NCT02709083|Dasatinib|dasatinib|mesh-list
6276993|NCT02709083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6276994|NCT02709083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6276995|NCT02709083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6276996|NCT02709083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6276997|NCT02693171|Dinutuximab|dinutuximab|mesh-list
6276998|NCT02693171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6276999|NCT02696226|Aspirin|aspirin|mesh-list
6277000|NCT02696226|Warfarin|warfarin|mesh-list
6277001|NCT02696226|Clopidogrel|clopidogrel|mesh-list
6277002|NCT02696226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6277003|NCT02696226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6277004|NCT02696226|Analgesics|analgesics|mesh-ancestor
6277005|NCT02696226|Sensory System Agents|sensory system agents|mesh-ancestor
6277006|NCT02696226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6277007|NCT02696226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277008|NCT02696226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6277009|NCT02696226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6277010|NCT02696226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6277011|NCT02696226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6277012|NCT02696226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6277013|NCT02696226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6277014|NCT02696226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6277015|NCT02696226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6277016|NCT02696226|Antipyretics|antipyretics|mesh-ancestor
6277017|NCT02696226|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6277018|NCT02696226|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6277019|NCT02696226|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6277020|NCT02696226|Purinergic Agents|purinergic agents|mesh-ancestor
6277021|NCT02696226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6277022|NCT02696226|Anticoagulants|anticoagulants|mesh-ancestor
6277023|NCT02706691|Infigratinib|infigratinib|mesh-list
6277024|NCT02706691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6277025|NCT02708849|Lamotrigine|lamotrigine|mesh-list
6277026|NCT02708849|Ketamine|ketamine|mesh-list
6277027|NCT02708849|Analgesics|analgesics|mesh-ancestor
6277028|NCT02708849|Sensory System Agents|sensory system agents|mesh-ancestor
6277029|NCT02708849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6277030|NCT02708849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277031|NCT02708849|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6277032|NCT02708849|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6277033|NCT02708849|Anesthetics, General|anesthetics, general|mesh-ancestor
6277034|NCT02708849|Anesthetics|anesthetics|mesh-ancestor
6277035|NCT02708849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6277036|NCT02708849|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6277037|NCT02708849|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6277038|NCT02708849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6277039|NCT02708849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724171|NCT03188978|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5724172|NCT03188978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5724173|NCT03188835|Glycerol|glycerol|mesh-list
5724174|NCT03188835|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
5724175|NCT03188835|Protective Agents|protective agents|mesh-ancestor
5724176|NCT03188835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724177|NCT03188445|Ascorbic Acid|ascorbic acid|mesh-list
5724178|NCT03188445|Ferrous fumarate|ferrous fumarate|mesh-list
6277040|NCT02708849|Anticonvulsants|anticonvulsants|mesh-ancestor
6277041|NCT02708849|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6277042|NCT02708849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6277043|NCT02708849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6277044|NCT02708849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6277045|NCT02708849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6277046|NCT02708849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6277047|NCT02708849|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6277048|NCT02693717|Pemetrexed|pemetrexed|mesh-list
6277049|NCT02693717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6277050|NCT02693717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6277051|NCT02693717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6277052|NCT02693717|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6277053|NCT02693717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6277054|NCT02693002|Norethindrone|norethindrone|mesh-list
6277055|NCT02693002|Norethindrone Acetate|norethindrone acetate|mesh-list
6277056|NCT02693002|Estradiol|estradiol|mesh-list
6277057|NCT02693002|Estrogens|estrogens|mesh-ancestor
6277058|NCT02693002|Hormones|hormones|mesh-ancestor
6277059|NCT02693002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6277060|NCT02693002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277061|NCT02693002|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6277062|NCT02693002|Contraceptive Agents|contraceptive agents|mesh-ancestor
6277063|NCT02693002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6277064|NCT02693002|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6277065|NCT02693002|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6277066|NCT02693002|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6277067|NCT02693002|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6277068|NCT02689518|Aflibercept|aflibercept|mesh-list
6277069|NCT02689518|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6277070|NCT02689518|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6277071|NCT02689518|Growth Substances|growth substances|mesh-ancestor
6277072|NCT02689518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277073|NCT02689518|Growth Inhibitors|growth inhibitors|mesh-ancestor
6277074|NCT02689518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6277075|NCT02687165|Cycloserine|cycloserine|mesh-list
6277076|NCT02687165|Milnacipran|milnacipran|mesh-list
6277077|NCT02687165|Levomilnacipran|levomilnacipran|mesh-list
6277078|NCT02687165|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6277079|NCT02687165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6277080|NCT02687165|Renal Agents|renal agents|mesh-ancestor
6277081|NCT02687165|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6277082|NCT02687165|Antitubercular Agents|antitubercular agents|mesh-ancestor
6277083|NCT02687165|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6277084|NCT02687165|Antimetabolites|antimetabolites|mesh-ancestor
6277085|NCT02687165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6277086|NCT02687165|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6277087|NCT02687165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6277088|NCT02687165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6277089|NCT02687165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6277090|NCT02687165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277091|NCT02687165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6277092|NCT02687165|Analgesics|analgesics|mesh-ancestor
6277093|NCT02687165|Sensory System Agents|sensory system agents|mesh-ancestor
6277094|NCT02687165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6277095|NCT02687165|Antidepressive Agents|antidepressive agents|mesh-ancestor
6277096|NCT02687165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6277097|NCT02679560|Bupivacaine|bupivacaine|mesh-list
6277098|NCT02679560|Ropivacaine|ropivacaine|mesh-list
6277099|NCT02679560|Anesthetics, Local|anesthetics, local|mesh-ancestor
6277100|NCT02679560|Anesthetics|anesthetics|mesh-ancestor
6277101|NCT02679560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6277102|NCT02679560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277103|NCT02679560|Sensory System Agents|sensory system agents|mesh-ancestor
6277104|NCT02679560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6277105|NCT02674204|Atorvastatin|atorvastatin|mesh-list
6277106|NCT02674204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6277107|NCT02674204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6277108|NCT02674204|Antimetabolites|antimetabolites|mesh-ancestor
6277109|NCT02674204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6277110|NCT02674204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6277111|NCT02674204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6277112|NCT02674204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6277113|NCT02671461|Aspirin|aspirin|mesh-list
6277114|NCT02671461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6277115|NCT02671461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6277116|NCT02671461|Analgesics|analgesics|mesh-ancestor
6277117|NCT02671461|Sensory System Agents|sensory system agents|mesh-ancestor
6277118|NCT02671461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6277119|NCT02671461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277120|NCT02671461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6277121|NCT02671461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6277122|NCT02671461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6277123|NCT02671461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6277124|NCT02671461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6277125|NCT02671461|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6277126|NCT02671461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6277127|NCT02671461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6277128|NCT02671461|Antipyretics|antipyretics|mesh-ancestor
6277129|NCT02663752|Deferasirox|deferasirox|mesh-list
6277130|NCT02663752|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6277131|NCT02663752|Chelating Agents|chelating agents|mesh-ancestor
6277132|NCT02663752|Sequestering Agents|sequestering agents|mesh-ancestor
6277133|NCT02663752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6277134|NCT02658357|Risperidone|risperidone|mesh-list
6277135|NCT02658357|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6277136|NCT02658357|Serotonin Agents|serotonin agents|mesh-ancestor
6277137|NCT02658357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6277138|NCT02658357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6277139|NCT02658357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277140|NCT02658357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6277141|NCT02658357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6277142|NCT02658357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6277143|NCT02658357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6277144|NCT02658357|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6277145|NCT02658357|Dopamine Agents|dopamine agents|mesh-ancestor
6277146|NCT02658877|Omalizumab|omalizumab|mesh-list
6277147|NCT02658877|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6277148|NCT02658877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6277149|NCT02658877|Respiratory System Agents|respiratory system agents|mesh-ancestor
6277150|NCT02654639|Bevacizumab|bevacizumab|mesh-list
6277151|NCT02654639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6277152|NCT02654639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6277153|NCT02654639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6277154|NCT02654639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6277155|NCT02654639|Growth Substances|growth substances|mesh-ancestor
6277156|NCT02654639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277157|NCT02654639|Growth Inhibitors|growth inhibitors|mesh-ancestor
6277158|NCT02640573|Hydroxyurea|hydroxyurea|mesh-list
6277159|NCT02640573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6277160|NCT02640573|Antisickling Agents|antisickling agents|mesh-ancestor
6277161|NCT02640573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6277162|NCT02640573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6277163|NCT02640573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6277164|NCT02634606|Tocotrienols|tocotrienols|mesh-list
6277165|NCT02634606|Vitamin E|vitamin e|mesh-list
6277166|NCT02634606|Tocopherols|tocopherols|mesh-list
6277167|NCT02634606|Antioxidants|antioxidants|mesh-ancestor
6277168|NCT02634606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6277169|NCT02634606|Protective Agents|protective agents|mesh-ancestor
6277170|NCT02634606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277171|NCT02634606|Vitamins|vitamins|mesh-ancestor
6277172|NCT02634606|Micronutrients|micronutrients|mesh-ancestor
6277173|NCT02634827|Decitabine|decitabine|mesh-list
6277174|NCT02634827|Midostaurin|midostaurin|mesh-list
6277175|NCT02634827|Staurosporine|staurosporine|mesh-list
6277176|NCT02634827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6277177|NCT02634827|Antimetabolites|antimetabolites|mesh-ancestor
6277178|NCT02634827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6277179|NCT02634827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6277180|NCT02634827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6277181|NCT02634827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6277182|NCT02636283|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
6277183|NCT02636283|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6277184|NCT02636283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6277185|NCT02638129|Naltrexone|naltrexone|mesh-list
6277186|NCT02638129|Bupropion|bupropion|mesh-list
6277187|NCT02638129|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6277188|NCT02638129|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6277189|NCT02638129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277190|NCT02638129|Sensory System Agents|sensory system agents|mesh-ancestor
6277191|NCT02638129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6277192|NCT02638129|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6277193|NCT02638129|Antidepressive Agents|antidepressive agents|mesh-ancestor
6277194|NCT02638129|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6277195|NCT02638129|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6277196|NCT02638129|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6277197|NCT02638129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6277198|NCT02638129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6277199|NCT02638129|Dopamine Agents|dopamine agents|mesh-ancestor
6277200|NCT02638129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6277201|NCT02638129|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6277202|NCT02638129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6277203|NCT02638129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6277204|NCT02623959|Doxycycline|doxycycline|mesh-list
6277205|NCT02623959|Fentanyl|fentanyl|mesh-list
6277206|NCT02623959|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6277207|NCT02623959|Narcotics|narcotics|mesh-ancestor
6277208|NCT02623959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6277209|NCT02623959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277210|NCT02623959|Analgesics|analgesics|mesh-ancestor
6277211|NCT02623959|Sensory System Agents|sensory system agents|mesh-ancestor
6277212|NCT02623959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6277213|NCT02623959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6277214|NCT02623959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6277215|NCT02623959|Anesthetics, General|anesthetics, general|mesh-ancestor
6277216|NCT02623959|Anesthetics|anesthetics|mesh-ancestor
6277217|NCT02623959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6277218|NCT02623959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6277219|NCT02623959|Antimalarials|antimalarials|mesh-ancestor
6277220|NCT02623959|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6277221|NCT02623959|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6277222|NCT02631148|Melatonin|melatonin|mesh-list
6277223|NCT02631148|Antioxidants|antioxidants|mesh-ancestor
6277224|NCT02631148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6277225|NCT02631148|Protective Agents|protective agents|mesh-ancestor
6277226|NCT02631148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277227|NCT02631148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6277228|NCT02630472|Quinine|quinine|mesh-list
6277229|NCT02630472|Antimalarials|antimalarials|mesh-ancestor
6277230|NCT02630472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6277231|NCT02630472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6277232|NCT02630472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6277233|NCT02630472|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6277234|NCT02630472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277235|NCT02630472|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6277236|NCT02630472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6277237|NCT02630472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6277238|NCT02630472|Analgesics|analgesics|mesh-ancestor
6277239|NCT02630472|Sensory System Agents|sensory system agents|mesh-ancestor
6277240|NCT02626520|Gemcitabine|gemcitabine|mesh-list
6277241|NCT02626520|Paclitaxel|paclitaxel|mesh-list
6277242|NCT02626520|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6277243|NCT02626520|Fluorouracil|fluorouracil|mesh-list
6277244|NCT02626520|Irinotecan|irinotecan|mesh-list
6277245|NCT02626520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6277246|NCT02626520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6277247|NCT02626520|Tubulin Modulators|tubulin modulators|mesh-ancestor
6277248|NCT02626520|Antimitotic Agents|antimitotic agents|mesh-ancestor
6277249|NCT02626520|Mitosis Modulators|mitosis modulators|mesh-ancestor
6277250|NCT02626520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6277251|NCT02626520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6277252|NCT02626520|Antimetabolites|antimetabolites|mesh-ancestor
6277253|NCT02626520|Antiviral Agents|antiviral agents|mesh-ancestor
6277254|NCT02626520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6277255|NCT02626520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6277256|NCT02626520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6277257|NCT02626520|Immunologic Factors|immunologic factors|mesh-ancestor
6277258|NCT02626520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277259|NCT02626520|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6277260|NCT02626520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6277261|NCT02614898|Eculizumab|eculizumab|mesh-list
6277262|NCT02614898|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6277263|NCT02614898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6277264|NCT02614898|Immunologic Factors|immunologic factors|mesh-ancestor
6277265|NCT02614898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277266|NCT02608905|Dapagliflozin|dapagliflozin|mesh-list
6277267|NCT02608905|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6277268|NCT02608905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6277269|NCT02608905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6277270|NCT02608905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277271|NCT02619812|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
6277272|NCT02619812|Immunoglobulins|immunoglobulins|mesh-list
6277273|NCT02619812|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6277274|NCT02619812|Antibodies|antibodies|mesh-list
6277275|NCT02619812|Immunologic Factors|immunologic factors|mesh-ancestor
6277276|NCT02619812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277277|NCT02619812|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6277278|NCT02619812|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6277279|NCT02619812|Antimetabolites|antimetabolites|mesh-ancestor
6277280|NCT02619812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6277281|NCT02619812|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6277282|NCT02614586|Ondansetron|ondansetron|mesh-list
6277283|NCT02614586|Antiemetics|antiemetics|mesh-ancestor
6277284|NCT02614586|Autonomic Agents|autonomic agents|mesh-ancestor
6277285|NCT02614586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6277286|NCT02614586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277287|NCT02614586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6277288|NCT02614586|Antipruritics|antipruritics|mesh-ancestor
6277289|NCT02614586|Dermatologic Agents|dermatologic agents|mesh-ancestor
6277290|NCT02614586|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6277291|NCT02614586|Serotonin Agents|serotonin agents|mesh-ancestor
6277292|NCT02614586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6277293|NCT02614586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6277294|NCT02614586|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6277295|NCT02614586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6277296|NCT02614586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6277297|NCT02614586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6277298|NCT02614586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6277299|NCT02606279|Valsartan|valsartan|mesh-list
6277300|NCT02606279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6277301|NCT02606279|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6277302|NCT02606279|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6277303|NCT02606279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6277304|NCT02605824|Acetylcysteine|acetylcysteine|mesh-list
6277305|NCT02605824|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6277306|NCT02605824|Antiviral Agents|antiviral agents|mesh-ancestor
6277307|NCT02605824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6277308|NCT02605824|Expectorants|expectorants|mesh-ancestor
6277309|NCT02605824|Respiratory System Agents|respiratory system agents|mesh-ancestor
6277310|NCT02605824|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6277311|NCT02605824|Antioxidants|antioxidants|mesh-ancestor
6277312|NCT02605824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6277313|NCT02605824|Protective Agents|protective agents|mesh-ancestor
6277314|NCT02605824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277315|NCT02605824|Antidotes|antidotes|mesh-ancestor
6277316|NCT02598622|Acetylcarnitine|acetylcarnitine|mesh-list
6277317|NCT02598622|Vitamin B Complex|vitamin b complex|mesh-ancestor
6277318|NCT02598622|Vitamins|vitamins|mesh-ancestor
6277319|NCT02598622|Micronutrients|micronutrients|mesh-ancestor
6277320|NCT02598622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277321|NCT02598622|Nootropic Agents|nootropic agents|mesh-ancestor
6277322|NCT02589145|Pyridoxine|pyridoxine|mesh-list
6277323|NCT02589145|Gemcitabine|gemcitabine|mesh-list
6277324|NCT02589145|Dexamethasone|dexamethasone|mesh-list
6277325|NCT02589145|Rituximab|rituximab|mesh-list
6277326|NCT02589145|Lenalidomide|lenalidomide|mesh-list
6277327|NCT02589145|Melphalan|melphalan|mesh-list
6277328|NCT02589145|Busulfan|busulfan|mesh-list
6277329|NCT02589145|Vorinostat|vorinostat|mesh-list
6277330|NCT02589145|Enoxaparin|enoxaparin|mesh-list
6277331|NCT02589145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6277332|NCT02589145|Antiemetics|antiemetics|mesh-ancestor
6277333|NCT02589145|Autonomic Agents|autonomic agents|mesh-ancestor
6277334|NCT02589145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6277335|NCT02589145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277336|NCT02589145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6277337|NCT02589145|Glucocorticoids|glucocorticoids|mesh-ancestor
6277338|NCT02589145|Hormones|hormones|mesh-ancestor
6277339|NCT02589145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6277340|NCT02589145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6277341|NCT02589145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6277342|NCT02589145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6277343|NCT02589145|Immunologic Factors|immunologic factors|mesh-ancestor
6277344|NCT02589145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6277345|NCT02589145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6277346|NCT02589145|Antimetabolites|antimetabolites|mesh-ancestor
6277347|NCT02589145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6277348|NCT02589145|Antiviral Agents|antiviral agents|mesh-ancestor
6277349|NCT02589145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6277350|NCT02589145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6277351|NCT02589145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6277352|NCT02589145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6277353|NCT02589145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6277354|NCT02589145|Growth Substances|growth substances|mesh-ancestor
6277355|NCT02589145|Growth Inhibitors|growth inhibitors|mesh-ancestor
6277356|NCT02589145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6277357|NCT02589145|Alkylating Agents|alkylating agents|mesh-ancestor
6277358|NCT02589145|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6277359|NCT02589145|Anticoagulants|anticoagulants|mesh-ancestor
6277360|NCT02589145|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6277361|NCT02589145|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6277362|NCT02589145|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6277363|NCT02589145|Vitamin B Complex|vitamin b complex|mesh-ancestor
6277364|NCT02589145|Vitamins|vitamins|mesh-ancestor
6277365|NCT02589145|Micronutrients|micronutrients|mesh-ancestor
6277366|NCT02582749|Bicalutamide|bicalutamide|mesh-list
6277367|NCT02582749|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
6277368|NCT02582749|Androgen Antagonists|androgen antagonists|mesh-ancestor
6277369|NCT02582749|Hormone Antagonists|hormone antagonists|mesh-ancestor
6277370|NCT02582749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6277371|NCT02582749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277372|NCT02582749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6277373|NCT02593682|Suvorexant|suvorexant|mesh-list
6277374|NCT02593682|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6277375|NCT02593682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6277376|NCT02593682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6277377|NCT02593682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277378|NCT02593682|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
6277379|NCT02593682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6277380|NCT02593682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6277381|NCT02587650|Ceritinib|ceritinib|mesh-list
6277382|NCT02587650|Entrectinib|entrectinib|mesh-list
6277383|NCT02587650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6277384|NCT02587650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6277385|NCT02587650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6277386|NCT02587650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6277387|NCT02569957|Acetylcysteine|acetylcysteine|mesh-list
6277388|NCT02569957|Topotecan|topotecan|mesh-list
6277389|NCT02569957|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6277390|NCT02569957|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6277391|NCT02569957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6277392|NCT02569957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6277393|NCT02569957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6277394|NCT02569957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6277395|NCT02569957|Antiviral Agents|antiviral agents|mesh-ancestor
6277396|NCT02569957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6277397|NCT02569957|Expectorants|expectorants|mesh-ancestor
6277398|NCT02569957|Respiratory System Agents|respiratory system agents|mesh-ancestor
6277399|NCT02569957|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6277400|NCT02569957|Antioxidants|antioxidants|mesh-ancestor
6277401|NCT02569957|Protective Agents|protective agents|mesh-ancestor
6277402|NCT02569957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277403|NCT02569957|Antidotes|antidotes|mesh-ancestor
6277404|NCT02568007|Cyproheptadine|cyproheptadine|mesh-list
6277405|NCT02568007|Antipruritics|antipruritics|mesh-ancestor
6277406|NCT02568007|Dermatologic Agents|dermatologic agents|mesh-ancestor
6277407|NCT02568007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6277408|NCT02568007|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6277409|NCT02568007|Histamine Antagonists|histamine antagonists|mesh-ancestor
6277410|NCT02568007|Histamine Agents|histamine agents|mesh-ancestor
6277411|NCT02568007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6277412|NCT02568007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6277413|NCT02568007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277414|NCT02568007|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6277415|NCT02568007|Serotonin Agents|serotonin agents|mesh-ancestor
6277416|NCT02568007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6277417|NCT02575365|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6277418|NCT02575365|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6277419|NCT02575365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6277420|NCT02575365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6277421|NCT02575365|Immunologic Factors|immunologic factors|mesh-ancestor
6277422|NCT02575365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277423|NCT02547129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6277424|NCT02547129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6277425|NCT02547129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6277426|NCT02547129|Antitubercular Agents|antitubercular agents|mesh-ancestor
6391259|NCT00192855|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6391260|NCT00192855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6391261|NCT00192855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396872|NCT00209807|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6396873|NCT00209807|Antidepressive Agents|antidepressive agents|mesh-ancestor
6396874|NCT00209807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6396875|NCT00209807|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6396876|NCT00209807|Adrenergic Agents|adrenergic agents|mesh-ancestor
6396877|NCT00209833|Cytarabine|cytarabine|mesh-list
6396878|NCT00209833|Fludarabine|fludarabine|mesh-list
6396879|NCT00209833|Etoposide|etoposide|mesh-list
6396880|NCT00209833|Idarubicin|idarubicin|mesh-list
6396881|NCT00209833|Daunorubicin|daunorubicin|mesh-list
6396882|NCT00209833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6396883|NCT00209833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6396884|NCT00209833|Antimetabolites|antimetabolites|mesh-ancestor
6277427|NCT02549716|Acetaminophen|acetaminophen|mesh-list
6277428|NCT02549716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6277429|NCT02549716|Analgesics|analgesics|mesh-ancestor
6277430|NCT02549716|Sensory System Agents|sensory system agents|mesh-ancestor
6277431|NCT02549716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6277432|NCT02549716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277433|NCT02549716|Antipyretics|antipyretics|mesh-ancestor
6277434|NCT02531308|Metformin|metformin|mesh-list
6277435|NCT02531308|Prednisone|prednisone|mesh-list
6277436|NCT02531308|Cyclophosphamide|cyclophosphamide|mesh-list
6277437|NCT02531308|Rituximab|rituximab|mesh-list
6277438|NCT02531308|Doxorubicin|doxorubicin|mesh-list
6277439|NCT02531308|Vincristine|vincristine|mesh-list
6277440|NCT02531308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6277441|NCT02531308|Immunologic Factors|immunologic factors|mesh-ancestor
6277442|NCT02531308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277443|NCT02531308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6277444|NCT02531308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6277445|NCT02531308|Alkylating Agents|alkylating agents|mesh-ancestor
6277446|NCT02531308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6277447|NCT02531308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6277448|NCT02531308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6277449|NCT02531308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6277450|NCT02531308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6277451|NCT02531308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6277452|NCT02531308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6277453|NCT02531308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6277454|NCT02531308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6277455|NCT02531308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6277456|NCT02531308|Glucocorticoids|glucocorticoids|mesh-ancestor
6277457|NCT02531308|Hormones|hormones|mesh-ancestor
6277458|NCT02531308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6277459|NCT02531308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6277460|NCT02531308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6277461|NCT02531308|Tubulin Modulators|tubulin modulators|mesh-ancestor
6277462|NCT02531308|Antimitotic Agents|antimitotic agents|mesh-ancestor
6277463|NCT02531308|Mitosis Modulators|mitosis modulators|mesh-ancestor
6277464|NCT02534038|Quinidine|quinidine|mesh-list
6277465|NCT02534038|Dextromethorphan|dextromethorphan|mesh-list
6277466|NCT02534038|Antitussive Agents|antitussive agents|mesh-ancestor
6277467|NCT02534038|Respiratory System Agents|respiratory system agents|mesh-ancestor
6277468|NCT02534038|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6277469|NCT02534038|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6277470|NCT02534038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6277471|NCT02534038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6277472|NCT02534038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277473|NCT02534038|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6277474|NCT02534038|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6277475|NCT02534038|Adrenergic Agents|adrenergic agents|mesh-ancestor
6277476|NCT02534038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6277477|NCT02534038|Antimalarials|antimalarials|mesh-ancestor
6277478|NCT02534038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6277479|NCT02534038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6277480|NCT02534038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6277481|NCT02534038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6277482|NCT02534038|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6277483|NCT02534038|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6277484|NCT02534038|Cholinergic Agents|cholinergic agents|mesh-ancestor
6277485|NCT02534038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6277486|NCT02534038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6277487|NCT02534038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6277488|NCT02534038|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6277489|NCT02534038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6277490|NCT02520726|Sertraline|sertraline|mesh-list
6277491|NCT02520726|Antidepressive Agents|antidepressive agents|mesh-ancestor
6277492|NCT02520726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6277493|NCT02520726|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6277494|NCT02520726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6277495|NCT02520726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6277496|NCT02520726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6277497|NCT02520726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6277498|NCT02520726|Serotonin Agents|serotonin agents|mesh-ancestor
6277499|NCT02520726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277500|NCT02518750|Cytarabine|cytarabine|mesh-list
6277501|NCT02518750|Dexamethasone|dexamethasone|mesh-list
6277502|NCT02518750|Hydrocortisone|hydrocortisone|mesh-list
6277503|NCT02518750|Cyclophosphamide|cyclophosphamide|mesh-list
6277504|NCT02518750|Methotrexate|methotrexate|mesh-list
6277505|NCT02518750|Etoposide|etoposide|mesh-list
6277506|NCT02518750|Vincristine|vincristine|mesh-list
6277507|NCT02518750|Bortezomib|bortezomib|mesh-list
6277508|NCT02518750|Asparaginase|asparaginase|mesh-list
6277509|NCT02518750|Mercaptopurine|mercaptopurine|mesh-list
6277510|NCT02518750|Mitoxantrone|mitoxantrone|mesh-list
6277511|NCT02518750|Clofarabine|clofarabine|mesh-list
6277512|NCT02518750|Panobinostat|panobinostat|mesh-list
6277513|NCT02518750|Pegaspargase|pegaspargase|mesh-list
6277514|NCT02518750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6277515|NCT02518750|Immunologic Factors|immunologic factors|mesh-ancestor
6277516|NCT02518750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277517|NCT02518750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6277518|NCT02518750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6277519|NCT02518750|Alkylating Agents|alkylating agents|mesh-ancestor
6277520|NCT02518750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6277521|NCT02518750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5724179|NCT03188445|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
6277522|NCT02518750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6277523|NCT02518750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6277524|NCT02518750|Antiemetics|antiemetics|mesh-ancestor
6277525|NCT02518750|Autonomic Agents|autonomic agents|mesh-ancestor
6277526|NCT02518750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6277527|NCT02518750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6277528|NCT02518750|Glucocorticoids|glucocorticoids|mesh-ancestor
6277529|NCT02518750|Hormones|hormones|mesh-ancestor
6277530|NCT02518750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6277531|NCT02518750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6277532|NCT02518750|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6277533|NCT02518750|Abortifacient Agents|abortifacient agents|mesh-ancestor
6277534|NCT02518750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6277535|NCT02518750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6277536|NCT02518750|Antimetabolites|antimetabolites|mesh-ancestor
6277537|NCT02518750|Dermatologic Agents|dermatologic agents|mesh-ancestor
6277538|NCT02518750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6277539|NCT02518750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6277540|NCT02518750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6277541|NCT02518750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6277542|NCT02518750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6277543|NCT02518750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6277544|NCT02518750|Antiviral Agents|antiviral agents|mesh-ancestor
6277545|NCT02518750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6277546|NCT02518750|Tubulin Modulators|tubulin modulators|mesh-ancestor
6277547|NCT02518750|Antimitotic Agents|antimitotic agents|mesh-ancestor
6277548|NCT02518750|Mitosis Modulators|mitosis modulators|mesh-ancestor
6277549|NCT02518750|Analgesics|analgesics|mesh-ancestor
6277550|NCT02518750|Sensory System Agents|sensory system agents|mesh-ancestor
6277551|NCT02518750|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6277552|NCT02515851|Bupivacaine|bupivacaine|mesh-list
6277553|NCT02515851|Anesthetics, Local|anesthetics, local|mesh-ancestor
6277554|NCT02515851|Anesthetics|anesthetics|mesh-ancestor
6277555|NCT02515851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6277556|NCT02515851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277557|NCT02515851|Sensory System Agents|sensory system agents|mesh-ancestor
6277558|NCT02515851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6277559|NCT02506985|Warfarin|warfarin|mesh-list
6277560|NCT02506985|Rivaroxaban|rivaroxaban|mesh-list
6277561|NCT02506985|Anticoagulants|anticoagulants|mesh-ancestor
6277562|NCT02506985|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6277563|NCT02506985|Antithrombins|antithrombins|mesh-ancestor
6277564|NCT02506985|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6277565|NCT02506985|Protease Inhibitors|protease inhibitors|mesh-ancestor
6277566|NCT02506985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6277567|NCT02506985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6277568|NCT02514252|Fentanyl|fentanyl|mesh-list
6277569|NCT02514252|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6277570|NCT02514252|Narcotics|narcotics|mesh-ancestor
6277571|NCT02514252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6277572|NCT02514252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277573|NCT02514252|Analgesics|analgesics|mesh-ancestor
6277574|NCT02514252|Sensory System Agents|sensory system agents|mesh-ancestor
6277575|NCT02514252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6277576|NCT02514252|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6277577|NCT02514252|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6277578|NCT02514252|Anesthetics, General|anesthetics, general|mesh-ancestor
6277579|NCT02514252|Anesthetics|anesthetics|mesh-ancestor
6277580|NCT02501759|Pentetic Acid|pentetic acid|mesh-list
6277581|NCT02501759|Antidotes|antidotes|mesh-ancestor
6277582|NCT02501759|Protective Agents|protective agents|mesh-ancestor
6277583|NCT02501759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277584|NCT02501759|Chelating Agents|chelating agents|mesh-ancestor
6277585|NCT02501759|Sequestering Agents|sequestering agents|mesh-ancestor
6277586|NCT02501759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6277587|NCT02501759|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6277588|NCT02487277|Gemcitabine|gemcitabine|mesh-list
6277589|NCT02487277|Paclitaxel|paclitaxel|mesh-list
6277590|NCT02487277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6277591|NCT02487277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6277592|NCT02487277|Tubulin Modulators|tubulin modulators|mesh-ancestor
6277593|NCT02487277|Antimitotic Agents|antimitotic agents|mesh-ancestor
6277594|NCT02487277|Mitosis Modulators|mitosis modulators|mesh-ancestor
6277595|NCT02487277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6277596|NCT02487277|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6277597|NCT02487277|Antimetabolites|antimetabolites|mesh-ancestor
6277598|NCT02487277|Antiviral Agents|antiviral agents|mesh-ancestor
6277599|NCT02487277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6277600|NCT02487277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6277601|NCT02487277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6277602|NCT02487277|Immunologic Factors|immunologic factors|mesh-ancestor
6277603|NCT02487277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277604|NCT02499887|Prednisone|prednisone|mesh-list
6277605|NCT02499887|Albuterol|albuterol|mesh-list
6277606|NCT02499887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6277607|NCT02499887|Glucocorticoids|glucocorticoids|mesh-ancestor
6277608|NCT02499887|Hormones|hormones|mesh-ancestor
6277609|NCT02499887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6277610|NCT02499887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277611|NCT02499887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6277612|NCT02499887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6277613|NCT02499887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6277614|NCT02499887|Autonomic Agents|autonomic agents|mesh-ancestor
6277615|NCT02499887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6277616|NCT02499887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6277617|NCT02499887|Respiratory System Agents|respiratory system agents|mesh-ancestor
6277618|NCT02499887|Tocolytic Agents|tocolytic agents|mesh-ancestor
6277619|NCT02499887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6277620|NCT02499887|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6277621|NCT02499887|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6277622|NCT02499887|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6277623|NCT02499887|Adrenergic Agents|adrenergic agents|mesh-ancestor
6277624|NCT02499887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6277625|NCT02499887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6277626|NCT02504099|Ritonavir|ritonavir|mesh-list
6277627|NCT02504099|Ribavirin|ribavirin|mesh-list
6277628|NCT02504099|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6277629|NCT02504099|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6277630|NCT02504099|Protease Inhibitors|protease inhibitors|mesh-ancestor
6277631|NCT02504099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6277632|NCT02504099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6277633|NCT02504099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6277634|NCT02504099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6277635|NCT02504099|Antiviral Agents|antiviral agents|mesh-ancestor
6277636|NCT02504099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6277637|NCT02504099|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6277638|NCT02504099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6277639|NCT02504099|Antimetabolites|antimetabolites|mesh-ancestor
6277640|NCT02500901|Niraparib|niraparib|mesh-list
6277641|NCT02500901|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6277642|NCT02500901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6277643|NCT02500901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6277644|NCT02500901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6277645|NCT02496039|Quinidine|quinidine|mesh-list
6277646|NCT02496039|Dextromethorphan|dextromethorphan|mesh-list
6277647|NCT02496039|Antitussive Agents|antitussive agents|mesh-ancestor
6277648|NCT02496039|Respiratory System Agents|respiratory system agents|mesh-ancestor
6277649|NCT02496039|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6277650|NCT02496039|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6277651|NCT02496039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6277652|NCT02496039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6277653|NCT02496039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277654|NCT02496039|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6277655|NCT02496039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6277656|NCT02496039|Adrenergic Agents|adrenergic agents|mesh-ancestor
6277657|NCT02496039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6277658|NCT02496039|Antimalarials|antimalarials|mesh-ancestor
6277659|NCT02496039|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6277660|NCT02496039|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6277661|NCT02496039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6277662|NCT02496039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6277663|NCT02496039|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6277664|NCT02496039|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6277665|NCT02496039|Cholinergic Agents|cholinergic agents|mesh-ancestor
6277666|NCT02496039|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6277667|NCT02496039|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6277668|NCT02496039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6277669|NCT02496039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6277670|NCT02496039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6277671|NCT02492295|Propofol|propofol|mesh-list
6277672|NCT02492295|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6277673|NCT02492295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6277674|NCT02492295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277675|NCT02492295|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6277676|NCT02492295|Anesthetics, General|anesthetics, general|mesh-ancestor
6277677|NCT02492295|Anesthetics|anesthetics|mesh-ancestor
6277678|NCT02473445|Cysteamine|cysteamine|mesh-list
6277679|NCT02473445|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
6277680|NCT02473445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6277681|NCT02491411|Dexamethasone|dexamethasone|mesh-list
6277682|NCT02491411|Dexamethasone acetate|dexamethasone acetate|mesh-list
6277683|NCT02491411|Ichthammol|ichthammol|mesh-list
6277684|NCT02491411|BB 1101|bb 1101|mesh-list
6277685|NCT02491411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6277686|NCT02491411|Antiemetics|antiemetics|mesh-ancestor
6277687|NCT02491411|Autonomic Agents|autonomic agents|mesh-ancestor
6277688|NCT02491411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6277689|NCT02491411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277690|NCT02491411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6277691|NCT02491411|Glucocorticoids|glucocorticoids|mesh-ancestor
6277692|NCT02491411|Hormones|hormones|mesh-ancestor
6277693|NCT02491411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6277694|NCT02491411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6277695|NCT02491411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6277696|NCT02491411|Protease Inhibitors|protease inhibitors|mesh-ancestor
6277697|NCT02491411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6277698|NCT02491411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6277699|NCT02491411|Dermatologic Agents|dermatologic agents|mesh-ancestor
6277700|NCT02476994|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6277701|NCT02476994|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6277702|NCT02476994|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6277703|NCT02476994|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6277704|NCT02468583|Triamcinolone|triamcinolone|mesh-list
6277705|NCT02468583|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6277706|NCT02468583|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6277707|NCT02468583|FX006|fx006|mesh-list
6277708|NCT02468583|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6277709|NCT02468583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6277710|NCT02468583|Glucocorticoids|glucocorticoids|mesh-ancestor
6277711|NCT02468583|Hormones|hormones|mesh-ancestor
6277712|NCT02468583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6277713|NCT02468583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277714|NCT02468583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6277715|NCT02468583|Immunologic Factors|immunologic factors|mesh-ancestor
6277716|NCT02468583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6277717|NCT02468583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6277718|NCT02450591|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6277719|NCT02450591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6277720|NCT02450591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6277721|NCT02450591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6277722|NCT02450591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6277723|NCT02469415|Azacitidine|azacitidine|mesh-list
6277724|NCT02469415|Decitabine|decitabine|mesh-list
6277725|NCT02469415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6277726|NCT02469415|Antimetabolites|antimetabolites|mesh-ancestor
6277727|NCT02469415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6277728|NCT02469415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6277729|NCT02469415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6277730|NCT02434146|Phenylephrine|phenylephrine|mesh-list
6277731|NCT02434146|Oxymetazoline|oxymetazoline|mesh-list
6277732|NCT02434146|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6277733|NCT02434146|Mydriatics|mydriatics|mesh-ancestor
6277734|NCT02434146|Autonomic Agents|autonomic agents|mesh-ancestor
6277735|NCT02434146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6277736|NCT02434146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277737|NCT02434146|Sympathomimetics|sympathomimetics|mesh-ancestor
6277738|NCT02434146|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6277739|NCT02434146|Nasal Decongestants|nasal decongestants|mesh-ancestor
6277740|NCT02434146|Respiratory System Agents|respiratory system agents|mesh-ancestor
6277741|NCT02434146|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6277742|NCT02434146|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6277743|NCT02434146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6277744|NCT02434146|Adrenergic Agents|adrenergic agents|mesh-ancestor
6277745|NCT02434146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6277746|NCT02434146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6277747|NCT02434146|Protective Agents|protective agents|mesh-ancestor
6277748|NCT02447887|Interferon alpha-2|interferon alpha-2|mesh-list
6277749|NCT02447887|Ixazomib|ixazomib|mesh-list
6277750|NCT02447887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6277751|NCT02447887|Protease Inhibitors|protease inhibitors|mesh-ancestor
6277752|NCT02447887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6277753|NCT02447887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6277754|NCT02447887|Antiviral Agents|antiviral agents|mesh-ancestor
6277755|NCT02447887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6277756|NCT02439970|Valganciclovir|valganciclovir|mesh-list
6277757|NCT02439970|Brincidofovir|brincidofovir|mesh-list
6277758|NCT02439970|Antiviral Agents|antiviral agents|mesh-ancestor
6277759|NCT02439970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6277760|NCT02439957|Valganciclovir|valganciclovir|mesh-list
6277761|NCT02439957|Brincidofovir|brincidofovir|mesh-list
6277762|NCT02439957|Antiviral Agents|antiviral agents|mesh-ancestor
6277763|NCT02439957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6277764|NCT02436265|Dexamethasone|dexamethasone|mesh-list
6277765|NCT02436265|Ropivacaine|ropivacaine|mesh-list
6277766|NCT02436265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6277767|NCT02436265|Antiemetics|antiemetics|mesh-ancestor
6277768|NCT02436265|Autonomic Agents|autonomic agents|mesh-ancestor
6277769|NCT02436265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6277770|NCT02436265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277771|NCT02436265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6277772|NCT02436265|Glucocorticoids|glucocorticoids|mesh-ancestor
6277773|NCT02436265|Hormones|hormones|mesh-ancestor
6277774|NCT02436265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6277775|NCT02436265|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6277776|NCT02436265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6277777|NCT02436265|Anesthetics, Local|anesthetics, local|mesh-ancestor
6277778|NCT02436265|Anesthetics|anesthetics|mesh-ancestor
6277779|NCT02436265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6277780|NCT02436265|Sensory System Agents|sensory system agents|mesh-ancestor
6277781|NCT02429583|Vaccines|vaccines|mesh-list
6277782|NCT02429583|Immunologic Factors|immunologic factors|mesh-ancestor
6277783|NCT02429583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277784|NCT02417870|Aldesleukin|aldesleukin|mesh-list
6277785|NCT02417870|Interleukin-2|interleukin-2|mesh-list
6277786|NCT02417870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6277787|NCT02417870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6277788|NCT02417870|Analgesics|analgesics|mesh-ancestor
6277789|NCT02417870|Sensory System Agents|sensory system agents|mesh-ancestor
6277790|NCT02417870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6277791|NCT02417870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277792|NCT02417870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6277793|NCT02417870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6277794|NCT02417870|Antiviral Agents|antiviral agents|mesh-ancestor
6277795|NCT02417870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6277796|NCT02430532|Dimethyl Fumarate|dimethyl fumarate|mesh-list
6277797|NCT02430532|Dermatologic Agents|dermatologic agents|mesh-ancestor
6277798|NCT02430532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6277799|NCT02430532|Immunologic Factors|immunologic factors|mesh-ancestor
6277800|NCT02430532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277801|NCT02428231|Dimethyl Fumarate|dimethyl fumarate|mesh-list
6277802|NCT02428231|Dermatologic Agents|dermatologic agents|mesh-ancestor
6277803|NCT02428231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6277804|NCT02428231|Immunologic Factors|immunologic factors|mesh-ancestor
6277805|NCT02428231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277806|NCT02413047|Methotrexate|methotrexate|mesh-list
6277807|NCT02413047|Mercaptopurine|mercaptopurine|mesh-list
6277808|NCT02413047|Azathioprine|azathioprine|mesh-list
6277809|NCT02413047|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6277810|NCT02413047|Abortifacient Agents|abortifacient agents|mesh-ancestor
6277811|NCT02413047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6277812|NCT02413047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277813|NCT02413047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6277814|NCT02413047|Antimetabolites|antimetabolites|mesh-ancestor
6277815|NCT02413047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6277816|NCT02413047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6277817|NCT02413047|Dermatologic Agents|dermatologic agents|mesh-ancestor
6277818|NCT02413047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6277819|NCT02413047|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6277820|NCT02413047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6277821|NCT02413047|Immunologic Factors|immunologic factors|mesh-ancestor
6277822|NCT02413047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6277823|NCT02413047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6277824|NCT02422303|Ketamine|ketamine|mesh-list
6277825|NCT02422303|Analgesics|analgesics|mesh-ancestor
6277826|NCT02422303|Sensory System Agents|sensory system agents|mesh-ancestor
6277827|NCT02422303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6277828|NCT02422303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277829|NCT02422303|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6277830|NCT02422303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6277831|NCT02422303|Anesthetics, General|anesthetics, general|mesh-ancestor
6277832|NCT02422303|Anesthetics|anesthetics|mesh-ancestor
6277833|NCT02422303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6277834|NCT02422303|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6277835|NCT02422303|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6277836|NCT02422303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6277837|NCT02422303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6277838|NCT02414152|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6277839|NCT02414152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6277840|NCT02410551|Vidarabine|vidarabine|mesh-list
6277841|NCT02410551|Fludarabine|fludarabine|mesh-list
6277842|NCT02410551|Fludarabine phosphate|fludarabine phosphate|mesh-list
6277843|NCT02410551|Busulfan|busulfan|mesh-list
6277844|NCT02410551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6277845|NCT02410551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6277846|NCT02410551|Antimetabolites|antimetabolites|mesh-ancestor
6277847|NCT02410551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6277848|NCT02410551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6277849|NCT02410551|Immunologic Factors|immunologic factors|mesh-ancestor
6277850|NCT02410551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277851|NCT02410551|Antiviral Agents|antiviral agents|mesh-ancestor
6277852|NCT02410551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6277853|NCT02410551|Alkylating Agents|alkylating agents|mesh-ancestor
6277854|NCT02410551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6277855|NCT02410551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6277856|NCT02411643|Calcipotriene|calcipotriene|mesh-list
6277857|NCT02411643|Dermatologic Agents|dermatologic agents|mesh-ancestor
6277858|NCT02409355|Gemcitabine|gemcitabine|mesh-list
6277859|NCT02409355|Carboplatin|carboplatin|mesh-list
6277860|NCT02409355|Atezolizumab|atezolizumab|mesh-list
6277861|NCT02409355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6277862|NCT02409355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6277863|NCT02409355|Antimetabolites|antimetabolites|mesh-ancestor
6277864|NCT02409355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6277865|NCT02409355|Antiviral Agents|antiviral agents|mesh-ancestor
6277866|NCT02409355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6277867|NCT02409355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6277868|NCT02409355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6277869|NCT02409355|Immunologic Factors|immunologic factors|mesh-ancestor
6277870|NCT02409355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277871|NCT02392377|Leucovorin|leucovorin|mesh-list
6277872|NCT02392377|Paclitaxel|paclitaxel|mesh-list
6277873|NCT02392377|Carboplatin|carboplatin|mesh-list
6277874|NCT02392377|Fluorouracil|fluorouracil|mesh-list
6277875|NCT02392377|Oxaliplatin|oxaliplatin|mesh-list
6277876|NCT02392377|Calcium|calcium|mesh-list
6277877|NCT02392377|Levoleucovorin|levoleucovorin|mesh-list
6277878|NCT02392377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6277879|NCT02392377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6277880|NCT02392377|Tubulin Modulators|tubulin modulators|mesh-ancestor
6277881|NCT02392377|Antimitotic Agents|antimitotic agents|mesh-ancestor
6277882|NCT02392377|Mitosis Modulators|mitosis modulators|mesh-ancestor
6277883|NCT02392377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6277884|NCT02392377|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6277885|NCT02392377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277886|NCT02392377|Antimetabolites|antimetabolites|mesh-ancestor
6277887|NCT02392377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6277888|NCT02392377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6277889|NCT02392377|Immunologic Factors|immunologic factors|mesh-ancestor
6277890|NCT02392377|Antidotes|antidotes|mesh-ancestor
6277891|NCT02392377|Protective Agents|protective agents|mesh-ancestor
6277892|NCT02392377|Vitamin B Complex|vitamin b complex|mesh-ancestor
6277893|NCT02392377|Vitamins|vitamins|mesh-ancestor
6277894|NCT02392377|Micronutrients|micronutrients|mesh-ancestor
6277895|NCT02394665|Temozolomide|temozolomide|mesh-list
6277896|NCT02394665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6277897|NCT02394665|Alkylating Agents|alkylating agents|mesh-ancestor
6277898|NCT02394665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6277899|NCT02394665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6277900|NCT02389712|Lamotrigine|lamotrigine|mesh-list
6277901|NCT02389712|Fluoxetine|fluoxetine|mesh-list
6277902|NCT02389712|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6277903|NCT02389712|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6277904|NCT02389712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6277905|NCT02389712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6277906|NCT02389712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6277907|NCT02389712|Serotonin Agents|serotonin agents|mesh-ancestor
6277908|NCT02389712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277909|NCT02389712|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6277910|NCT02389712|Antidepressive Agents|antidepressive agents|mesh-ancestor
6277911|NCT02389712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6277912|NCT02389712|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6277913|NCT02389712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6277914|NCT02389712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6277915|NCT02389712|Anticonvulsants|anticonvulsants|mesh-ancestor
6277916|NCT02389712|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6277917|NCT02389712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6277918|NCT02389712|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6277919|NCT02389712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6277920|NCT02389712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6277921|NCT02389712|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6277922|NCT02390362|Rituximab|rituximab|mesh-list
6277923|NCT02390362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6277924|NCT02390362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6277925|NCT02390362|Immunologic Factors|immunologic factors|mesh-ancestor
6277926|NCT02390362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277927|NCT02390362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6277928|NCT02383433|Gemcitabine|gemcitabine|mesh-list
6277929|NCT02383433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6277930|NCT02383433|Antimetabolites|antimetabolites|mesh-ancestor
6277931|NCT02383433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6277932|NCT02383433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6277933|NCT02383433|Antiviral Agents|antiviral agents|mesh-ancestor
6277934|NCT02383433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6277935|NCT02383433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6277936|NCT02383433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6277937|NCT02383433|Immunologic Factors|immunologic factors|mesh-ancestor
6277938|NCT02383433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277939|NCT02382588|Ganciclovir|ganciclovir|mesh-list
6277940|NCT02382588|Antiviral Agents|antiviral agents|mesh-ancestor
6277941|NCT02382588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6277942|NCT02379390|Prednisone|prednisone|mesh-list
6277943|NCT02379390|Abiraterone Acetate|abiraterone acetate|mesh-list
6277944|NCT02379390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6277945|NCT02379390|Glucocorticoids|glucocorticoids|mesh-ancestor
6277946|NCT02379390|Hormones|hormones|mesh-ancestor
6277947|NCT02379390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6277948|NCT02379390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277949|NCT02379390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6277950|NCT02379390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6277951|NCT02379390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6277952|NCT02379390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6277953|NCT02379390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6277954|NCT02379390|Hormone Antagonists|hormone antagonists|mesh-ancestor
6277955|NCT02379390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6277956|NCT02373865|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6277957|NCT02373865|Glimepiride|glimepiride|mesh-list
6277958|NCT02373865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6277959|NCT02373865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277960|NCT02373865|Incretins|incretins|mesh-ancestor
6277961|NCT02373865|Hormones|hormones|mesh-ancestor
6277962|NCT02373865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6277963|NCT02373865|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6277964|NCT02373865|Protease Inhibitors|protease inhibitors|mesh-ancestor
6277965|NCT02373865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6277966|NCT02373865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6277967|NCT02373865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6277968|NCT02373865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6277969|NCT02373865|Immunologic Factors|immunologic factors|mesh-ancestor
6277970|NCT02369744|Tamsulosin|tamsulosin|mesh-list
6277971|NCT02369744|Silodosin|silodosin|mesh-list
6277972|NCT02369744|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6277973|NCT02369744|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6277974|NCT02369744|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6277975|NCT02369744|Adrenergic Agents|adrenergic agents|mesh-ancestor
6277976|NCT02369744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6277977|NCT02369744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6277978|NCT02369744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277979|NCT02369744|Urological Agents|urological agents|mesh-ancestor
6277980|NCT02379585|Paclitaxel|paclitaxel|mesh-list
6277981|NCT02379585|Docetaxel|docetaxel|mesh-list
6277982|NCT02379585|Cyclophosphamide|cyclophosphamide|mesh-list
6277983|NCT02379585|Doxorubicin|doxorubicin|mesh-list
6277984|NCT02379585|Trastuzumab|trastuzumab|mesh-list
6277985|NCT02379585|Pertuzumab|pertuzumab|mesh-list
6277986|NCT02379585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6277987|NCT02379585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6277988|NCT02379585|Tubulin Modulators|tubulin modulators|mesh-ancestor
6277989|NCT02379585|Antimitotic Agents|antimitotic agents|mesh-ancestor
6277990|NCT02379585|Mitosis Modulators|mitosis modulators|mesh-ancestor
6277991|NCT02379585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6277992|NCT02379585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6277993|NCT02379585|Immunologic Factors|immunologic factors|mesh-ancestor
6277994|NCT02379585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6277995|NCT02379585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6277996|NCT02379585|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6277997|NCT02379585|Alkylating Agents|alkylating agents|mesh-ancestor
6277998|NCT02379585|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6277999|NCT02379585|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6278000|NCT02379585|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5724180|NCT03188445|Antioxidants|antioxidants|mesh-ancestor
6278001|NCT02379585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6278002|NCT02379585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6278003|NCT02379585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6278004|NCT02370888|Lenalidomide|lenalidomide|mesh-list
6278005|NCT02370888|Immunologic Factors|immunologic factors|mesh-ancestor
6278006|NCT02370888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278007|NCT02370888|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6278008|NCT02370888|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6278009|NCT02370888|Growth Substances|growth substances|mesh-ancestor
6278010|NCT02370888|Growth Inhibitors|growth inhibitors|mesh-ancestor
6278011|NCT02370888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6278012|NCT02367170|Midazolam|midazolam|mesh-list
6278013|NCT02367170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6278014|NCT02367170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6278015|NCT02367170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6278016|NCT02367170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278017|NCT02367170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6278018|NCT02367170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6278019|NCT02367170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6278020|NCT02367170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6278021|NCT02367170|Anesthetics, General|anesthetics, general|mesh-ancestor
6278022|NCT02367170|Anesthetics|anesthetics|mesh-ancestor
6278023|NCT02367170|GABA Modulators|gaba modulators|mesh-ancestor
6278024|NCT02367170|GABA Agents|gaba agents|mesh-ancestor
6278025|NCT02367170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6278026|NCT02367170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278027|NCT02365233|Insulin|insulin|mesh-list
6278028|NCT02365233|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6278029|NCT02365233|Pioglitazone|pioglitazone|mesh-list
6278030|NCT02365233|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6278031|NCT02365233|Insulin Glargine|insulin glargine|mesh-list
6278032|NCT02365233|Saxagliptin|saxagliptin|mesh-list
6278033|NCT02365233|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
6278034|NCT02365233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6278035|NCT02365233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278036|NCT02365233|Incretins|incretins|mesh-ancestor
6278037|NCT02365233|Hormones|hormones|mesh-ancestor
6278038|NCT02365233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6278039|NCT02365233|Protease Inhibitors|protease inhibitors|mesh-ancestor
6278040|NCT02365233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6278041|NCT02365233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278042|NCT02360111|Cyclophosphamide|cyclophosphamide|mesh-list
6278043|NCT02360111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6278044|NCT02360111|Immunologic Factors|immunologic factors|mesh-ancestor
6278045|NCT02360111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278046|NCT02360111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6278047|NCT02360111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6278048|NCT02360111|Alkylating Agents|alkylating agents|mesh-ancestor
6278049|NCT02360111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278050|NCT02360111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6278051|NCT02360111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6278052|NCT02353468|Dexamethasone|dexamethasone|mesh-list
6278053|NCT02353468|Lenalidomide|lenalidomide|mesh-list
6278054|NCT02353468|Bortezomib|bortezomib|mesh-list
6278055|NCT02353468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6278056|NCT02353468|Antiemetics|antiemetics|mesh-ancestor
6278057|NCT02353468|Autonomic Agents|autonomic agents|mesh-ancestor
6278058|NCT02353468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6278059|NCT02353468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278060|NCT02353468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6278061|NCT02353468|Glucocorticoids|glucocorticoids|mesh-ancestor
6278062|NCT02353468|Hormones|hormones|mesh-ancestor
6278063|NCT02353468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6278064|NCT02353468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6278065|NCT02353468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6278066|NCT02353468|Immunologic Factors|immunologic factors|mesh-ancestor
6278067|NCT02353468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6278068|NCT02353468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6278069|NCT02353468|Growth Substances|growth substances|mesh-ancestor
6278070|NCT02353468|Growth Inhibitors|growth inhibitors|mesh-ancestor
6278071|NCT02360059|Metformin|metformin|mesh-list
6278072|NCT02360059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6278073|NCT02360059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278074|NCT02345460|Leucovorin|leucovorin|mesh-list
6278075|NCT02345460|Fluorouracil|fluorouracil|mesh-list
6278076|NCT02345460|Oxaliplatin|oxaliplatin|mesh-list
6278077|NCT02345460|Irinotecan|irinotecan|mesh-list
6278078|NCT02345460|Calcium|calcium|mesh-list
6278079|NCT02345460|Levoleucovorin|levoleucovorin|mesh-list
6278080|NCT02345460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6278081|NCT02345460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278082|NCT02345460|Antimetabolites|antimetabolites|mesh-ancestor
6278083|NCT02345460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278084|NCT02345460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6278085|NCT02345460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6278086|NCT02345460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6278087|NCT02345460|Immunologic Factors|immunologic factors|mesh-ancestor
6278088|NCT02345460|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6278089|NCT02345460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6278090|NCT02345460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6278091|NCT02345460|Antidotes|antidotes|mesh-ancestor
6278092|NCT02345460|Protective Agents|protective agents|mesh-ancestor
6278093|NCT02345460|Vitamin B Complex|vitamin b complex|mesh-ancestor
6278094|NCT02345460|Vitamins|vitamins|mesh-ancestor
6278095|NCT02345460|Micronutrients|micronutrients|mesh-ancestor
6278096|NCT02351063|Angiotensin II|angiotensin ii|mesh-list
6278097|NCT02351063|Diuretics|diuretics|mesh-list
6278098|NCT02351063|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6278099|NCT02351063|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
6278100|NCT02351063|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
6278101|NCT02351063|Natriuretic Agents|natriuretic agents|mesh-ancestor
6278102|NCT02351063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278103|NCT02351063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278104|NCT02351063|Protease Inhibitors|protease inhibitors|mesh-ancestor
6278105|NCT02351063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6278106|NCT02351063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6278107|NCT02351063|Hormone Antagonists|hormone antagonists|mesh-ancestor
6278108|NCT02351063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6278109|NCT02351063|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6278110|NCT02345772|Docetaxel|docetaxel|mesh-list
6278111|NCT02345772|Trastuzumab|trastuzumab|mesh-list
6278112|NCT02345772|Fulvestrant|fulvestrant|mesh-list
6278113|NCT02345772|Pertuzumab|pertuzumab|mesh-list
6278114|NCT02345772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6278115|NCT02345772|Tubulin Modulators|tubulin modulators|mesh-ancestor
6278116|NCT02345772|Antimitotic Agents|antimitotic agents|mesh-ancestor
6278117|NCT02345772|Mitosis Modulators|mitosis modulators|mesh-ancestor
6391262|NCT00192959|Propofol|propofol|mesh-list
6278118|NCT02345772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278119|NCT02345772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6278120|NCT02345772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6278121|NCT02345772|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6278122|NCT02345772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6278123|NCT02345772|Hormone Antagonists|hormone antagonists|mesh-ancestor
6278124|NCT02345772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6278125|NCT02345772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278126|NCT02353572|Dexamethasone|dexamethasone|mesh-list
6278127|NCT02353572|Bortezomib|bortezomib|mesh-list
6278128|NCT02353572|Melphalan|melphalan|mesh-list
6278129|NCT02353572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6278130|NCT02353572|Antiemetics|antiemetics|mesh-ancestor
6278131|NCT02353572|Autonomic Agents|autonomic agents|mesh-ancestor
6278132|NCT02353572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6278133|NCT02353572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278134|NCT02353572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6278135|NCT02353572|Glucocorticoids|glucocorticoids|mesh-ancestor
6278136|NCT02353572|Hormones|hormones|mesh-ancestor
6278137|NCT02353572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6278138|NCT02353572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6278139|NCT02353572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6278140|NCT02353572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6278141|NCT02353572|Alkylating Agents|alkylating agents|mesh-ancestor
6278142|NCT02353572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278143|NCT02353572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6278144|NCT02353572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6278145|NCT02353572|Immunologic Factors|immunologic factors|mesh-ancestor
6278146|NCT02343263|Bupivacaine|bupivacaine|mesh-list
6278147|NCT02343263|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6278148|NCT02343263|Anesthetics, Local|anesthetics, local|mesh-ancestor
6278149|NCT02343263|Anesthetics|anesthetics|mesh-ancestor
6278150|NCT02343263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6278151|NCT02343263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278152|NCT02343263|Sensory System Agents|sensory system agents|mesh-ancestor
6278153|NCT02343263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6278154|NCT02343263|Hemostatics|hemostatics|mesh-ancestor
6278155|NCT02343263|Coagulants|coagulants|mesh-ancestor
6278156|NCT02343159|Dimethyl Fumarate|dimethyl fumarate|mesh-list
6278157|NCT02343159|Dermatologic Agents|dermatologic agents|mesh-ancestor
6278158|NCT02343159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6278159|NCT02343159|Immunologic Factors|immunologic factors|mesh-ancestor
6278160|NCT02343159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278161|NCT02341495|Vitamin D|vitamin d|mesh-list
6278162|NCT02341495|Cholecalciferol|cholecalciferol|mesh-list
6278163|NCT02341495|Azacitidine|azacitidine|mesh-list
6278164|NCT02341495|Deferasirox|deferasirox|mesh-list
6278165|NCT02341495|Vitamins|vitamins|mesh-ancestor
6278166|NCT02341495|Micronutrients|micronutrients|mesh-ancestor
6278167|NCT02341495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278168|NCT02341495|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6278169|NCT02341495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6278170|NCT02341495|Antimetabolites|antimetabolites|mesh-ancestor
6278171|NCT02341495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278172|NCT02341495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6278173|NCT02341495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6278174|NCT02341495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6278175|NCT02341495|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6278176|NCT02341495|Chelating Agents|chelating agents|mesh-ancestor
6278177|NCT02341495|Sequestering Agents|sequestering agents|mesh-ancestor
6278178|NCT02318901|Pembrolizumab|pembrolizumab|mesh-list
6278179|NCT02318901|Trastuzumab|trastuzumab|mesh-list
6278180|NCT02318901|Cetuximab|cetuximab|mesh-list
6278181|NCT02318901|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
6278182|NCT02318901|Maytansine|maytansine|mesh-list
6278183|NCT02318901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6278184|NCT02318901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6278185|NCT02318901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6278186|NCT02318901|Tubulin Modulators|tubulin modulators|mesh-ancestor
6278187|NCT02318901|Antimitotic Agents|antimitotic agents|mesh-ancestor
6278188|NCT02318901|Mitosis Modulators|mitosis modulators|mesh-ancestor
6278189|NCT02318901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391263|NCT00192959|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6391264|NCT00192959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6391265|NCT00192959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6391266|NCT00192959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6391267|NCT00192959|Anesthetics, General|anesthetics, general|mesh-ancestor
6391268|NCT00192959|Anesthetics|anesthetics|mesh-ancestor
6391269|NCT00193011|Cyclophosphamide|cyclophosphamide|mesh-list
6391270|NCT00193011|Docetaxel|docetaxel|mesh-list
6391271|NCT00193011|Fluorouracil|fluorouracil|mesh-list
6391272|NCT00193011|Methotrexate|methotrexate|mesh-list
6391273|NCT00193011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6391274|NCT00193011|Immunologic Factors|immunologic factors|mesh-ancestor
6391275|NCT00193011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6391276|NCT00193011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6391277|NCT00193011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6015128|NCT00354978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6391278|NCT00193011|Alkylating Agents|alkylating agents|mesh-ancestor
6391279|NCT00193011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391280|NCT00193011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391281|NCT00193011|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6391282|NCT00193011|Tubulin Modulators|tubulin modulators|mesh-ancestor
6391283|NCT00193011|Antimitotic Agents|antimitotic agents|mesh-ancestor
6391284|NCT00193011|Mitosis Modulators|mitosis modulators|mesh-ancestor
6391285|NCT00193011|Antimetabolites|antimetabolites|mesh-ancestor
6391286|NCT00193011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6391287|NCT00193011|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6391288|NCT00193011|Abortifacient Agents|abortifacient agents|mesh-ancestor
6391289|NCT00193011|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6391290|NCT00193011|Dermatologic Agents|dermatologic agents|mesh-ancestor
6391291|NCT00193011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6391292|NCT00193011|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6391293|NCT00193011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6391294|NCT00193024|Docetaxel|docetaxel|mesh-list
6391295|NCT00193024|Epirubicin|epirubicin|mesh-list
6391296|NCT00193024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391297|NCT00193024|Tubulin Modulators|tubulin modulators|mesh-ancestor
6391298|NCT00193024|Antimitotic Agents|antimitotic agents|mesh-ancestor
6391299|NCT00193024|Mitosis Modulators|mitosis modulators|mesh-ancestor
6391300|NCT00193024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391301|NCT00193024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6391302|NCT00193024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6391303|NCT00193024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6391304|NCT00193024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6391305|NCT00193076|Gemcitabine|gemcitabine|mesh-list
6391306|NCT00193076|Carboplatin|carboplatin|mesh-list
6391307|NCT00193076|Trastuzumab|trastuzumab|mesh-list
6391308|NCT00193076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391309|NCT00193076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6391310|NCT00193076|Antimetabolites|antimetabolites|mesh-ancestor
6391311|NCT00193076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391312|NCT00193076|Antiviral Agents|antiviral agents|mesh-ancestor
6391313|NCT00193076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6391314|NCT00193076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6391315|NCT00193076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6391316|NCT00193076|Immunologic Factors|immunologic factors|mesh-ancestor
6391317|NCT00193076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6391318|NCT00193076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6391319|NCT00193089|Docetaxel|docetaxel|mesh-list
6391320|NCT00193089|Trastuzumab|trastuzumab|mesh-list
6391321|NCT00193089|Vinorelbine|vinorelbine|mesh-list
6391322|NCT00193089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391323|NCT00193089|Tubulin Modulators|tubulin modulators|mesh-ancestor
6015129|NCT00354978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6015130|NCT00354978|Antidotes|antidotes|mesh-ancestor
6015131|NCT00354978|Protective Agents|protective agents|mesh-ancestor
6015132|NCT00354978|Vitamin B Complex|vitamin b complex|mesh-ancestor
6015133|NCT00354978|Vitamins|vitamins|mesh-ancestor
6015134|NCT00354978|Micronutrients|micronutrients|mesh-ancestor
6015135|NCT00355030|Leuprolide|leuprolide|mesh-list
6015136|NCT00355030|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6391324|NCT00193089|Antimitotic Agents|antimitotic agents|mesh-ancestor
6278190|NCT02317276|Triamcinolone|triamcinolone|mesh-list
6278191|NCT02317276|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6278192|NCT02317276|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6278193|NCT02317276|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6278194|NCT02317276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6278195|NCT02317276|Glucocorticoids|glucocorticoids|mesh-ancestor
6278196|NCT02317276|Hormones|hormones|mesh-ancestor
6278197|NCT02317276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6278198|NCT02317276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278199|NCT02317276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6278200|NCT02317276|Immunologic Factors|immunologic factors|mesh-ancestor
6278201|NCT02317276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6278202|NCT02317276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278203|NCT02299206|Zinc Oxide|zinc oxide|mesh-list
6278204|NCT02299206|Dermatologic Agents|dermatologic agents|mesh-ancestor
6278205|NCT02299206|Sunscreening Agents|sunscreening agents|mesh-ancestor
6278206|NCT02299206|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6278207|NCT02299206|Protective Agents|protective agents|mesh-ancestor
6278208|NCT02299206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278209|NCT02302859|Nicotine|nicotine|mesh-list
6278210|NCT02302859|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6278211|NCT02302859|Autonomic Agents|autonomic agents|mesh-ancestor
6278212|NCT02302859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6278213|NCT02302859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278214|NCT02302859|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6278215|NCT02302859|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6278216|NCT02302859|Cholinergic Agents|cholinergic agents|mesh-ancestor
6278217|NCT02302859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6278218|NCT02302859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278219|NCT02297230|Paclitaxel|paclitaxel|mesh-list
6278220|NCT02297230|Capecitabine|capecitabine|mesh-list
6278221|NCT02297230|Trastuzumab|trastuzumab|mesh-list
6278222|NCT02297230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6278223|NCT02297230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6278224|NCT02297230|Tubulin Modulators|tubulin modulators|mesh-ancestor
6278225|NCT02297230|Antimitotic Agents|antimitotic agents|mesh-ancestor
6278226|NCT02297230|Mitosis Modulators|mitosis modulators|mesh-ancestor
6278227|NCT02297230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278228|NCT02297230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6278229|NCT02297230|Antimetabolites|antimetabolites|mesh-ancestor
6278230|NCT02297230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6278231|NCT02284906|Pioglitazone|pioglitazone|mesh-list
6278232|NCT02284906|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6278233|NCT02284906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278234|NCT02282332|Ticagrelor|ticagrelor|mesh-list
6278235|NCT02282332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6278236|NCT02282332|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6278237|NCT02282332|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6278238|NCT02282332|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6278239|NCT02282332|Purinergic Agents|purinergic agents|mesh-ancestor
6278240|NCT02282332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6278241|NCT02282332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278242|NCT02282332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278243|NCT02287636|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6278244|NCT02287636|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6278245|NCT02287636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278246|NCT02276560|Gemcitabine|gemcitabine|mesh-list
6278247|NCT02276560|Paclitaxel|paclitaxel|mesh-list
6278248|NCT02276560|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6278249|NCT02276560|Cisplatin|cisplatin|mesh-list
6278250|NCT02276560|Pemetrexed|pemetrexed|mesh-list
6278251|NCT02276560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6278252|NCT02276560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6278253|NCT02276560|Tubulin Modulators|tubulin modulators|mesh-ancestor
6278254|NCT02276560|Antimitotic Agents|antimitotic agents|mesh-ancestor
6278255|NCT02276560|Mitosis Modulators|mitosis modulators|mesh-ancestor
6278256|NCT02276560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278257|NCT02276560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6278258|NCT02276560|Antimetabolites|antimetabolites|mesh-ancestor
6278259|NCT02276560|Antiviral Agents|antiviral agents|mesh-ancestor
6278260|NCT02276560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6278261|NCT02276560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6278262|NCT02276560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6278263|NCT02276560|Immunologic Factors|immunologic factors|mesh-ancestor
6278264|NCT02276560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278265|NCT02276560|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6278266|NCT02276560|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6278267|NCT02280252|Paclitaxel|paclitaxel|mesh-list
6278268|NCT02280252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6278269|NCT02280252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6278270|NCT02280252|Tubulin Modulators|tubulin modulators|mesh-ancestor
6278271|NCT02280252|Antimitotic Agents|antimitotic agents|mesh-ancestor
6278272|NCT02280252|Mitosis Modulators|mitosis modulators|mesh-ancestor
6278273|NCT02280252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278274|NCT02275481|Tiotropium Bromide|tiotropium bromide|mesh-list
6278275|NCT02275481|Formoterol Fumarate|formoterol fumarate|mesh-list
6278276|NCT02275481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6278277|NCT02275481|Autonomic Agents|autonomic agents|mesh-ancestor
6278278|NCT02275481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6278279|NCT02275481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278280|NCT02275481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6278281|NCT02275481|Respiratory System Agents|respiratory system agents|mesh-ancestor
6278282|NCT02275481|Parasympatholytics|parasympatholytics|mesh-ancestor
6278283|NCT02275481|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6278284|NCT02275481|Cholinergic Agents|cholinergic agents|mesh-ancestor
6278285|NCT02275481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6278286|NCT02275481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278287|NCT02275481|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6278288|NCT02275481|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6278289|NCT02275481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6278290|NCT02275481|Adrenergic Agents|adrenergic agents|mesh-ancestor
6278291|NCT02273752|Everolimus|everolimus|mesh-list
6278292|NCT02273752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6278293|NCT02273752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6278294|NCT02273752|Immunologic Factors|immunologic factors|mesh-ancestor
6278295|NCT02273752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278296|NCT02271594|Insulin|insulin|mesh-list
6278297|NCT02271594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6278298|NCT02271594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278299|NCT02263365|Loperamide|loperamide|mesh-list
6278300|NCT02263365|Antidiarrheals|antidiarrheals|mesh-list
6278301|NCT02263365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6278302|NCT02266797|Dexamethasone|dexamethasone|mesh-list
6278303|NCT02266797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6278304|NCT02266797|Antiemetics|antiemetics|mesh-ancestor
6278305|NCT02266797|Autonomic Agents|autonomic agents|mesh-ancestor
6278306|NCT02266797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6278307|NCT02266797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278308|NCT02266797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6278309|NCT02266797|Glucocorticoids|glucocorticoids|mesh-ancestor
6278310|NCT02266797|Hormones|hormones|mesh-ancestor
6278311|NCT02266797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6278312|NCT02266797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6278313|NCT02266797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6278314|NCT02253394|Ambrisentan|ambrisentan|mesh-list
6278315|NCT02253394|Spironolactone|spironolactone|mesh-list
6278316|NCT02253394|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6278317|NCT02253394|Hormone Antagonists|hormone antagonists|mesh-ancestor
6278318|NCT02253394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6278319|NCT02253394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278320|NCT02253394|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6278321|NCT02253394|Diuretics|diuretics|mesh-ancestor
6278322|NCT02253394|Natriuretic Agents|natriuretic agents|mesh-ancestor
6278323|NCT02253394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6278324|NCT02241551|Gemcitabine|gemcitabine|mesh-list
6278325|NCT02241551|Paclitaxel|paclitaxel|mesh-list
6278326|NCT02241551|Fluorouracil|fluorouracil|mesh-list
6278327|NCT02241551|Oxaliplatin|oxaliplatin|mesh-list
6278328|NCT02241551|Irinotecan|irinotecan|mesh-list
6278329|NCT02241551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6278330|NCT02241551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6278331|NCT02241551|Tubulin Modulators|tubulin modulators|mesh-ancestor
6278332|NCT02241551|Antimitotic Agents|antimitotic agents|mesh-ancestor
6278333|NCT02241551|Mitosis Modulators|mitosis modulators|mesh-ancestor
6278334|NCT02241551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278335|NCT02241551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6278336|NCT02241551|Antimetabolites|antimetabolites|mesh-ancestor
6278337|NCT02241551|Antiviral Agents|antiviral agents|mesh-ancestor
6278338|NCT02241551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6278339|NCT02241551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6278340|NCT02241551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6278341|NCT02241551|Immunologic Factors|immunologic factors|mesh-ancestor
6278342|NCT02241551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278343|NCT02241551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6278344|NCT02241551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6278345|NCT02232880|Abatacept|abatacept|mesh-list
6278346|NCT02232880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6278347|NCT02232880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278348|NCT02232880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6278349|NCT02232880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6278350|NCT02232880|Immunologic Factors|immunologic factors|mesh-ancestor
6278351|NCT02232880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278352|NCT02232880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6278353|NCT02239627|Clonidine|clonidine|mesh-list
6278354|NCT02239627|Analgesics|analgesics|mesh-ancestor
6278355|NCT02239627|Sensory System Agents|sensory system agents|mesh-ancestor
6278356|NCT02239627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6278357|NCT02239627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278358|NCT02239627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6278359|NCT02239627|Sympatholytics|sympatholytics|mesh-ancestor
6278360|NCT02239627|Autonomic Agents|autonomic agents|mesh-ancestor
6278361|NCT02239627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6278362|NCT02239627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6278363|NCT02239627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6278364|NCT02239627|Adrenergic Agents|adrenergic agents|mesh-ancestor
6278365|NCT02239627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6278366|NCT02239627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278367|NCT02244944|Ezetimibe|ezetimibe|mesh-list
6278368|NCT02244944|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6278369|NCT02244944|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6278370|NCT02244944|Antimetabolites|antimetabolites|mesh-ancestor
6278371|NCT02244944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278372|NCT02244944|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6278373|NCT02241187|Cetuximab|cetuximab|mesh-list
6278374|NCT02241187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6278375|NCT02241187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6278376|NCT02239926|Ranolazine|ranolazine|mesh-list
6278377|NCT02239926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6278378|NCT02239926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6278379|NCT02239926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278380|NCT02234011|Ketamine|ketamine|mesh-list
6278381|NCT02234011|Analgesics|analgesics|mesh-ancestor
6278382|NCT02234011|Sensory System Agents|sensory system agents|mesh-ancestor
6278383|NCT02234011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6278384|NCT02234011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278385|NCT02234011|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6278386|NCT02234011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6278387|NCT02234011|Anesthetics, General|anesthetics, general|mesh-ancestor
6278388|NCT02234011|Anesthetics|anesthetics|mesh-ancestor
6278389|NCT02234011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6278390|NCT02234011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6278391|NCT02234011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6278392|NCT02234011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6278393|NCT02234011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278394|NCT02236546|Deoxyglucose|deoxyglucose|mesh-list
6278395|NCT02236546|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6278396|NCT02236546|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6278397|NCT02236546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278398|NCT02236546|Antimetabolites|antimetabolites|mesh-ancestor
6278399|NCT02236546|Antiviral Agents|antiviral agents|mesh-ancestor
6278400|NCT02236546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6278401|NCT02224599|Cyclophosphamide|cyclophosphamide|mesh-list
6278402|NCT02224599|Imiquimod|imiquimod|mesh-list
6278403|NCT02224599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6278404|NCT02224599|Immunologic Factors|immunologic factors|mesh-ancestor
6278405|NCT02224599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278406|NCT02224599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6391325|NCT00193089|Mitosis Modulators|mitosis modulators|mesh-ancestor
6278407|NCT02224599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6278408|NCT02224599|Alkylating Agents|alkylating agents|mesh-ancestor
6278409|NCT02224599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278410|NCT02224599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6278411|NCT02224599|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6278412|NCT02224599|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6278413|NCT02224599|Interferon Inducers|interferon inducers|mesh-ancestor
6278414|NCT02200328|Metronidazole|metronidazole|mesh-list
6278415|NCT02200328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6278416|NCT02200328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6278417|NCT02200328|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6278418|NCT02200328|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6278419|NCT02181790|Acitretin|acitretin|mesh-list
6278420|NCT02181790|Keratolytic Agents|keratolytic agents|mesh-ancestor
6278421|NCT02181790|Dermatologic Agents|dermatologic agents|mesh-ancestor
6278422|NCT02177266|Colchicine|colchicine|mesh-list
6278423|NCT02177266|Gout Suppressants|gout suppressants|mesh-ancestor
6278424|NCT02177266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6278425|NCT02177266|Tubulin Modulators|tubulin modulators|mesh-ancestor
6278426|NCT02177266|Antimitotic Agents|antimitotic agents|mesh-ancestor
6278427|NCT02177266|Mitosis Modulators|mitosis modulators|mesh-ancestor
6278428|NCT02177266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278429|NCT02177266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6278430|NCT02170298|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6278431|NCT02170298|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6278432|NCT02170298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278433|NCT02170298|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6278434|NCT02170298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6278435|NCT02170298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6278436|NCT02170298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278437|NCT02170298|Dopamine Agents|dopamine agents|mesh-ancestor
6278438|NCT02170298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6278439|NCT02177773|Octreotide|octreotide|mesh-list
6278440|NCT02177773|Edotreotide|edotreotide|mesh-list
6015137|NCT00355030|Fertility Agents|fertility agents|mesh-ancestor
6015138|NCT00355030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6015139|NCT00355030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015140|NCT00355030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6015141|NCT00355030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6015142|NCT00355082|Lamotrigine|lamotrigine|mesh-list
6015143|NCT00355082|Anticonvulsants|anticonvulsants|mesh-list
6015144|NCT00355082|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6015145|NCT00355082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6015146|NCT00355082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015147|NCT00355082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6278441|NCT02177773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6278442|NCT02177773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6278443|NCT02177773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6278444|NCT02177773|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6278445|NCT02177773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278446|NCT02162979|Sildenafil Citrate|sildenafil citrate|mesh-list
6278447|NCT02162979|Vasodilator Agents|vasodilator agents|mesh-ancestor
6278448|NCT02162979|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6278449|NCT02162979|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6278450|NCT02162979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6278451|NCT02162979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278452|NCT02162979|Urological Agents|urological agents|mesh-ancestor
6278453|NCT02169830|Topiramate|topiramate|mesh-list
6278454|NCT02169830|Nortriptyline|nortriptyline|mesh-list
6278455|NCT02169830|Anticonvulsants|anticonvulsants|mesh-ancestor
6278456|NCT02169830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6278457|NCT02169830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278458|NCT02169830|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6278459|NCT02169830|Antidepressive Agents|antidepressive agents|mesh-ancestor
6278460|NCT02169830|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6278461|NCT02169830|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6278462|NCT02169830|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6278463|NCT02169830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6278464|NCT02169830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278465|NCT02169830|Adrenergic Agents|adrenergic agents|mesh-ancestor
6278466|NCT02169830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6278467|NCT02159040|Azacitidine|azacitidine|mesh-list
6278468|NCT02159040|Deferasirox|deferasirox|mesh-list
6278469|NCT02159040|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6278470|NCT02159040|Antimetabolites|antimetabolites|mesh-ancestor
6278471|NCT02159040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278472|NCT02159040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6278473|NCT02159040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6278474|NCT02159040|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6278475|NCT02159040|Chelating Agents|chelating agents|mesh-ancestor
6278476|NCT02159040|Sequestering Agents|sequestering agents|mesh-ancestor
6278477|NCT02168270|Ascorbic Acid|ascorbic acid|mesh-list
6278478|NCT02168270|Temozolomide|temozolomide|mesh-list
6278479|NCT02168270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6278480|NCT02168270|Alkylating Agents|alkylating agents|mesh-ancestor
6278481|NCT02168270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278482|NCT02168270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6278483|NCT02168270|Antioxidants|antioxidants|mesh-ancestor
6278484|NCT02168270|Protective Agents|protective agents|mesh-ancestor
6278485|NCT02168270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278486|NCT02168270|Vitamins|vitamins|mesh-ancestor
6278487|NCT02168270|Micronutrients|micronutrients|mesh-ancestor
6278488|NCT02157116|Docetaxel|docetaxel|mesh-list
6278489|NCT02157116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6278490|NCT02157116|Tubulin Modulators|tubulin modulators|mesh-ancestor
6278491|NCT02157116|Antimitotic Agents|antimitotic agents|mesh-ancestor
6278492|NCT02157116|Mitosis Modulators|mitosis modulators|mesh-ancestor
6278493|NCT02157116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278494|NCT02152670|Raclopride|raclopride|mesh-list
6278495|NCT02152670|Methylphenidate|methylphenidate|mesh-list
6278496|NCT02152670|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
6278497|NCT02152670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6278498|NCT02152670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278499|NCT02152670|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6278500|NCT02152670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6278501|NCT02152670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6278502|NCT02152670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278503|NCT02152670|Dopamine Agents|dopamine agents|mesh-ancestor
6278504|NCT02152670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6278505|NCT02152670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6278506|NCT02152670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6278507|NCT02152670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6278508|NCT02152670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6278509|NCT02152670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6278510|NCT02152670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6278511|NCT02137096|Carboplatin|carboplatin|mesh-list
6278512|NCT02137096|Etoposide|etoposide|mesh-list
6278513|NCT02137096|Ifosfamide|ifosfamide|mesh-list
6278514|NCT02137096|Etoposide phosphate|etoposide phosphate|mesh-list
6278515|NCT02137096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6278516|NCT02137096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6278517|NCT02137096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6278518|NCT02137096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6278519|NCT02137096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6278520|NCT02137096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278521|NCT02137096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6278522|NCT02137096|Alkylating Agents|alkylating agents|mesh-ancestor
6278523|NCT02147834|Ranolazine|ranolazine|mesh-list
6278524|NCT02147834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6278525|NCT02147834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6278526|NCT02147834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278527|NCT02144155|Oxytocin|oxytocin|mesh-list
6278528|NCT02144155|Oxytocics|oxytocics|mesh-ancestor
6278529|NCT02144155|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6278530|NCT02144155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278531|NCT02140788|Metformin|metformin|mesh-list
6278532|NCT02140788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6278533|NCT02140788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278534|NCT02145169|Nitrous Oxide|nitrous oxide|mesh-list
6278535|NCT02145169|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6278536|NCT02145169|Anesthetics, General|anesthetics, general|mesh-ancestor
6278537|NCT02145169|Anesthetics|anesthetics|mesh-ancestor
6278538|NCT02145169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6278539|NCT02145169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278540|NCT02145169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6278541|NCT02145169|Analgesics|analgesics|mesh-ancestor
6278542|NCT02145169|Sensory System Agents|sensory system agents|mesh-ancestor
6278543|NCT02145169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6278544|NCT02130622|Promethazine|promethazine|mesh-list
6278545|NCT02130622|Diphenhydramine|diphenhydramine|mesh-list
6278546|NCT02130622|Antipruritics|antipruritics|mesh-ancestor
6278547|NCT02130622|Dermatologic Agents|dermatologic agents|mesh-ancestor
6278548|NCT02130622|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6278549|NCT02130622|Histamine Antagonists|histamine antagonists|mesh-ancestor
6278550|NCT02130622|Histamine Agents|histamine agents|mesh-ancestor
6278551|NCT02130622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6278552|NCT02130622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278553|NCT02130622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278554|NCT02130622|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6278555|NCT02130622|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6278556|NCT02130622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6278557|NCT02130622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6015148|NCT00355082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015149|NCT00355082|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6015150|NCT00355082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6015151|NCT00355082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6015152|NCT00355082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6015153|NCT00355082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6278558|NCT02130622|Anesthetics, Local|anesthetics, local|mesh-ancestor
6278559|NCT02130622|Anesthetics|anesthetics|mesh-ancestor
6278560|NCT02130622|Sensory System Agents|sensory system agents|mesh-ancestor
6278561|NCT02130622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6278562|NCT02130622|Antiemetics|antiemetics|mesh-ancestor
6278563|NCT02130622|Autonomic Agents|autonomic agents|mesh-ancestor
6278564|NCT02130622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6278565|NCT02133534|Atorvastatin|atorvastatin|mesh-list
6278566|NCT02133534|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6278567|NCT02133534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6278568|NCT02133534|Antimetabolites|antimetabolites|mesh-ancestor
6278569|NCT02133534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278570|NCT02133534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6015154|NCT00355121|Vaccines|vaccines|mesh-list
6015155|NCT00355121|Immunologic Factors|immunologic factors|mesh-ancestor
6015156|NCT00355121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015157|NCT00355134|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6015158|NCT00355134|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6015159|NCT00355134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015160|NCT00355134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6015161|NCT00355134|Immunologic Factors|immunologic factors|mesh-ancestor
6015162|NCT00355134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015163|NCT00355199|Rituximab|rituximab|mesh-list
6015164|NCT00355199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6278571|NCT02133534|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6278572|NCT02133534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6278573|NCT02134912|Pemetrexed|pemetrexed|mesh-list
6278574|NCT02134912|Crizotinib|crizotinib|mesh-list
6278575|NCT02134912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6278576|NCT02134912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6278577|NCT02134912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278578|NCT02134912|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6278579|NCT02134912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6278580|NCT02134912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6278581|NCT02131155|Afatinib|afatinib|mesh-list
6278582|NCT02131155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6278583|NCT02131155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6278584|NCT02131155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6278585|NCT02131155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278586|NCT02117050|Interferons|interferons|mesh-list
6278587|NCT02117050|Interferon-beta|interferon-beta|mesh-list
6278588|NCT02117050|Interferon beta-1a|interferon beta-1a|mesh-list
6278589|NCT02117050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6278590|NCT02117050|Antiviral Agents|antiviral agents|mesh-ancestor
6278591|NCT02117050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6278592|NCT02117050|Immunologic Factors|immunologic factors|mesh-ancestor
6278593|NCT02117050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278594|NCT02117050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6278595|NCT02110069|Sirolimus|sirolimus|mesh-list
6278596|NCT02110069|Vincristine|vincristine|mesh-list
6278597|NCT02110069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6278598|NCT02110069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6278599|NCT02110069|Tubulin Modulators|tubulin modulators|mesh-ancestor
6278600|NCT02110069|Antimitotic Agents|antimitotic agents|mesh-ancestor
6278601|NCT02110069|Mitosis Modulators|mitosis modulators|mesh-ancestor
6278602|NCT02110069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278603|NCT02110069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6278604|NCT02110069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6278605|NCT02110069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6278606|NCT02110069|Antifungal Agents|antifungal agents|mesh-ancestor
6278607|NCT02110069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6278608|NCT02110069|Immunologic Factors|immunologic factors|mesh-ancestor
6278609|NCT02110069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278610|NCT02105116|Cytarabine|cytarabine|mesh-list
6278611|NCT02105116|Fludarabine|fludarabine|mesh-list
6278612|NCT02105116|Fludarabine phosphate|fludarabine phosphate|mesh-list
6278613|NCT02105116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6278614|NCT02105116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6278615|NCT02105116|Antimetabolites|antimetabolites|mesh-ancestor
6278616|NCT02105116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278617|NCT02105116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6278618|NCT02105116|Immunologic Factors|immunologic factors|mesh-ancestor
6278619|NCT02105116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278620|NCT02105116|Antiviral Agents|antiviral agents|mesh-ancestor
6278621|NCT02105116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6278622|NCT02094352|Ketamine|ketamine|mesh-list
6278623|NCT02094352|Analgesics|analgesics|mesh-ancestor
6278624|NCT02094352|Sensory System Agents|sensory system agents|mesh-ancestor
6278625|NCT02094352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6278626|NCT02094352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278627|NCT02094352|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6278628|NCT02094352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6278629|NCT02094352|Anesthetics, General|anesthetics, general|mesh-ancestor
6278630|NCT02094352|Anesthetics|anesthetics|mesh-ancestor
6278631|NCT02094352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6278632|NCT02094352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6278633|NCT02094352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6278634|NCT02094352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6278635|NCT02094352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278636|NCT02096042|Azacitidine|azacitidine|mesh-list
6278637|NCT02096042|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6278638|NCT02096042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6278639|NCT02096042|Antimetabolites|antimetabolites|mesh-ancestor
6278640|NCT02096042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278641|NCT02096042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6278642|NCT02096042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6278643|NCT02096042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6278644|NCT02088957|Phenytoin|phenytoin|mesh-list
6278645|NCT02088957|Brivaracetam|brivaracetam|mesh-list
6278646|NCT02088957|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6278647|NCT02088957|Anticonvulsants|anticonvulsants|mesh-ancestor
6278648|NCT02088957|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6278649|NCT02088957|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6015165|NCT00355199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6015166|NCT00355199|Immunologic Factors|immunologic factors|mesh-ancestor
6015167|NCT00355199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015168|NCT00355199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6015169|NCT00355342|Fluticasone|fluticasone|mesh-list
6278650|NCT02088957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6278651|NCT02088957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278652|NCT02088957|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6278653|NCT02088957|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6278654|NCT02075411|Bupivacaine|bupivacaine|mesh-list
6015170|NCT00355342|Xhance|xhance|mesh-list
6015171|NCT00355342|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6015172|NCT00355342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6015173|NCT00355342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6015174|NCT00355342|Autonomic Agents|autonomic agents|mesh-ancestor
6015175|NCT00355342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6015176|NCT00355342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015177|NCT00355342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6015178|NCT00355342|Respiratory System Agents|respiratory system agents|mesh-ancestor
6015179|NCT00355342|Dermatologic Agents|dermatologic agents|mesh-ancestor
6015180|NCT00355342|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6015181|NCT00355342|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6015182|NCT00355342|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6015183|NCT00355342|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6015184|NCT00355342|Adrenergic Agents|adrenergic agents|mesh-ancestor
6015185|NCT00355342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6015186|NCT00355342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015187|NCT00355368|Rocuronium|rocuronium|mesh-list
6015188|NCT00355368|Succinylcholine|succinylcholine|mesh-list
6015189|NCT00355368|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6015190|NCT00355368|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6015191|NCT00355368|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6278655|NCT02075411|Anesthetics, Local|anesthetics, local|mesh-ancestor
6278656|NCT02075411|Anesthetics|anesthetics|mesh-ancestor
6278657|NCT02075411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6278658|NCT02075411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278659|NCT02075411|Sensory System Agents|sensory system agents|mesh-ancestor
6278660|NCT02075411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6278661|NCT02074904|Topiramate|topiramate|mesh-list
6278662|NCT02074904|Anticonvulsants|anticonvulsants|mesh-ancestor
6278663|NCT02074904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6278664|NCT02074904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278665|NCT02081183|Mycophenolic Acid|mycophenolic acid|mesh-list
6278666|NCT02081183|Prednisone|prednisone|mesh-list
6278667|NCT02081183|Cyclophosphamide|cyclophosphamide|mesh-list
6278668|NCT02081183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6278669|NCT02081183|Immunologic Factors|immunologic factors|mesh-ancestor
6278670|NCT02081183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015192|NCT00355368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6278671|NCT02081183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6278672|NCT02081183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6278673|NCT02081183|Alkylating Agents|alkylating agents|mesh-ancestor
6278674|NCT02081183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278675|NCT02081183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6278676|NCT02081183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6278677|NCT02081183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6278678|NCT02081183|Glucocorticoids|glucocorticoids|mesh-ancestor
6278679|NCT02081183|Hormones|hormones|mesh-ancestor
6278680|NCT02081183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6278681|NCT02081183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6278682|NCT02081183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6278683|NCT02081183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6278684|NCT02081183|Antitubercular Agents|antitubercular agents|mesh-ancestor
6278685|NCT02081183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6015193|NCT00355368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015194|NCT00355368|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
6278686|NCT02081183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6278687|NCT02081183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6278688|NCT02075021|Paclitaxel|paclitaxel|mesh-list
6278689|NCT02075021|Lenalidomide|lenalidomide|mesh-list
6278690|NCT02075021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6278691|NCT02075021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6278692|NCT02075021|Tubulin Modulators|tubulin modulators|mesh-ancestor
6278693|NCT02075021|Antimitotic Agents|antimitotic agents|mesh-ancestor
6015195|NCT00355394|Metoclopramide|metoclopramide|mesh-list
6015196|NCT00355394|Antiemetics|antiemetics|mesh-ancestor
6015197|NCT00355394|Autonomic Agents|autonomic agents|mesh-ancestor
6278694|NCT02075021|Mitosis Modulators|mitosis modulators|mesh-ancestor
6278695|NCT02075021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278696|NCT02075021|Immunologic Factors|immunologic factors|mesh-ancestor
6278697|NCT02075021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278698|NCT02075021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6278699|NCT02075021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6278700|NCT02075021|Growth Substances|growth substances|mesh-ancestor
6278701|NCT02075021|Growth Inhibitors|growth inhibitors|mesh-ancestor
6278702|NCT02057237|Mitotane|mitotane|mesh-list
6278703|NCT02057237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6278704|NCT02057237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6278705|NCT02058537|Bethanechol|bethanechol|mesh-list
6278706|NCT02058537|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6278707|NCT02058537|Autonomic Agents|autonomic agents|mesh-ancestor
6278708|NCT02058537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6278709|NCT02058537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278710|NCT02058537|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6278711|NCT02058537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6278712|NCT02058537|Cholinergic Agents|cholinergic agents|mesh-ancestor
6278713|NCT02058537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6278714|NCT02058537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391326|NCT00193089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391327|NCT00193089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6391328|NCT00193089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6391329|NCT00193102|Thalidomide|thalidomide|mesh-list
6391330|NCT00193102|Capecitabine|capecitabine|mesh-list
6391331|NCT00193102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6391332|NCT00193102|Antimetabolites|antimetabolites|mesh-ancestor
6391333|NCT00193102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391334|NCT00193102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391335|NCT00193102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6391336|NCT00193102|Immunologic Factors|immunologic factors|mesh-ancestor
6391337|NCT00193102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6391338|NCT00193102|Leprostatic Agents|leprostatic agents|mesh-ancestor
6391339|NCT00193102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6391340|NCT00193102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6391341|NCT00193102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6391342|NCT00193102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6391343|NCT00193102|Growth Substances|growth substances|mesh-ancestor
6391344|NCT00193102|Growth Inhibitors|growth inhibitors|mesh-ancestor
6391345|NCT00193115|Cyclophosphamide|cyclophosphamide|mesh-list
6391346|NCT00193115|Docetaxel|docetaxel|mesh-list
6391347|NCT00193115|Doxorubicin|doxorubicin|mesh-list
6391348|NCT00193115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6391349|NCT00193115|Immunologic Factors|immunologic factors|mesh-ancestor
6391350|NCT00193115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6391351|NCT00193115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6391352|NCT00193115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6391353|NCT00193115|Alkylating Agents|alkylating agents|mesh-ancestor
6391354|NCT00193115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391355|NCT00193115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391356|NCT00193115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6391357|NCT00193115|Tubulin Modulators|tubulin modulators|mesh-ancestor
6391358|NCT00193115|Antimitotic Agents|antimitotic agents|mesh-ancestor
6391359|NCT00193115|Mitosis Modulators|mitosis modulators|mesh-ancestor
6391360|NCT00193115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6391361|NCT00193115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6391362|NCT00193115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6391363|NCT00193115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6391364|NCT00193141|Paclitaxel|paclitaxel|mesh-list
6391365|NCT00193141|Carboplatin|carboplatin|mesh-list
6278715|NCT02038153|Lenalidomide|lenalidomide|mesh-list
6278716|NCT02038153|Immunologic Factors|immunologic factors|mesh-ancestor
6278717|NCT02038153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278718|NCT02038153|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6278719|NCT02038153|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6278720|NCT02038153|Growth Substances|growth substances|mesh-ancestor
6278721|NCT02038153|Growth Inhibitors|growth inhibitors|mesh-ancestor
6278722|NCT02038153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6278723|NCT02044302|Morphine|morphine|mesh-list
6278724|NCT02044302|Narcotics|narcotics|mesh-list
6278725|NCT02044302|Analgesics|analgesics|mesh-list
6278726|NCT02044302|Bupivacaine|bupivacaine|mesh-list
6278727|NCT02044302|Botulinum Toxins|botulinum toxins|mesh-list
6278728|NCT02044302|Anesthetics, Local|anesthetics, local|mesh-ancestor
6278729|NCT02044302|Anesthetics|anesthetics|mesh-ancestor
6278730|NCT02044302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6278731|NCT02044302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278732|NCT02044302|Sensory System Agents|sensory system agents|mesh-ancestor
6278733|NCT02044302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6278734|NCT02044302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6278735|NCT02044302|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6278736|NCT02044302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6278737|NCT02044302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278738|NCT02044302|Cholinergic Agents|cholinergic agents|mesh-ancestor
6278739|NCT02044302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6278740|NCT02048904|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6278741|NCT02048904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6278742|NCT02048904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278743|NCT02048904|Incretins|incretins|mesh-ancestor
6278744|NCT02048904|Hormones|hormones|mesh-ancestor
6278745|NCT02048904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6278746|NCT02048904|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6278747|NCT02048904|Protease Inhibitors|protease inhibitors|mesh-ancestor
6278748|NCT02048904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6278749|NCT02048904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278750|NCT02044822|Rituximab|rituximab|mesh-list
6278751|NCT02044822|Idelalisib|idelalisib|mesh-list
6278752|NCT02044822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6278753|NCT02044822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6278754|NCT02044822|Immunologic Factors|immunologic factors|mesh-ancestor
6278755|NCT02044822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278756|NCT02044822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6278757|NCT02044822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6278758|NCT02044822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278759|NCT02043860|Melphalan|melphalan|mesh-list
6278760|NCT02043860|Immunologic Factors|immunologic factors|mesh-ancestor
6278761|NCT02043860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278762|NCT02043860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6278763|NCT02043860|Alkylating Agents|alkylating agents|mesh-ancestor
6278764|NCT02043860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278765|NCT02043860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6278766|NCT02043860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6278767|NCT02043860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6278768|NCT02030015|Miglustat|miglustat|mesh-list
6278769|NCT02030015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6278770|NCT02030015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278771|NCT02030015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6278772|NCT02030015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6278773|NCT02030015|Antiviral Agents|antiviral agents|mesh-ancestor
6278774|NCT02030015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6278775|NCT02030015|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6278776|NCT02030015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6278777|NCT02030015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278778|NCT02015663|Tobramycin|tobramycin|mesh-list
6278779|NCT02015663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6278780|NCT02015663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6278781|NCT02029846|Metformin|metformin|mesh-list
6278782|NCT02029846|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
6278783|NCT02029846|Incretins|incretins|mesh-list
6278784|NCT02029846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6278785|NCT02029846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278786|NCT02029846|Protease Inhibitors|protease inhibitors|mesh-ancestor
6278787|NCT02029846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6278788|NCT02029846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278789|NCT02029846|Hormones|hormones|mesh-ancestor
6278790|NCT02029846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6278791|NCT02027272|Dexamethasone|dexamethasone|mesh-list
6278792|NCT02027272|Glucocorticoids|glucocorticoids|mesh-list
6278793|NCT02027272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6278794|NCT02027272|Antiemetics|antiemetics|mesh-ancestor
6278795|NCT02027272|Autonomic Agents|autonomic agents|mesh-ancestor
6278796|NCT02027272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6278797|NCT02027272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278798|NCT02027272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6278799|NCT02027272|Hormones|hormones|mesh-ancestor
6278800|NCT02027272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6278801|NCT02027272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6278802|NCT02027272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6278803|NCT02017379|Erythromycin|erythromycin|mesh-list
6278804|NCT02017379|Erythromycin Estolate|erythromycin estolate|mesh-list
6278805|NCT02017379|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
6278806|NCT02017379|Erythromycin stearate|erythromycin stearate|mesh-list
6278807|NCT02017379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6278808|NCT02017379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6278809|NCT02017379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6278810|NCT02017379|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6278811|NCT02017379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6278812|NCT02017379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278813|NCT02008370|Bupivacaine|bupivacaine|mesh-list
6278814|NCT02008370|Anesthetics, Local|anesthetics, local|mesh-ancestor
6278815|NCT02008370|Anesthetics|anesthetics|mesh-ancestor
6278816|NCT02008370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6278817|NCT02008370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278818|NCT02008370|Sensory System Agents|sensory system agents|mesh-ancestor
6278819|NCT02008370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6278820|NCT02015910|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6278821|NCT02015910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6278822|NCT02015910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278823|NCT02015910|Incretins|incretins|mesh-ancestor
6278824|NCT02015910|Hormones|hormones|mesh-ancestor
6278825|NCT02015910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6278826|NCT02015910|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6278827|NCT02015910|Protease Inhibitors|protease inhibitors|mesh-ancestor
6278828|NCT02015910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6015198|NCT00355394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6015199|NCT00355394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015200|NCT00355394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6015201|NCT00355394|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6015202|NCT00355394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6015203|NCT00355394|Dopamine Agents|dopamine agents|mesh-ancestor
6015204|NCT00355394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6015205|NCT00355394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015206|NCT00355472|Mogamulizumab|mogamulizumab|mesh-list
6015207|NCT00355472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6015208|NCT00355615|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6015209|NCT00355615|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6015210|NCT00355615|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6015211|NCT00355615|Antimetabolites|antimetabolites|mesh-ancestor
6015212|NCT00355615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015213|NCT00355615|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6015214|NCT00355615|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6015215|NCT00355615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6015216|NCT00355784|Hormones|hormones|mesh-list
6015217|NCT00355784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6015218|NCT00355784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015219|NCT00356031|Bevacizumab|bevacizumab|mesh-list
6278829|NCT02015910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278830|NCT01986751|Clonidine|clonidine|mesh-list
6278831|NCT01986751|Ropivacaine|ropivacaine|mesh-list
6278832|NCT01986751|Anesthetics, Local|anesthetics, local|mesh-ancestor
6278833|NCT01986751|Anesthetics|anesthetics|mesh-ancestor
6278834|NCT01986751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6278835|NCT01986751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278836|NCT01986751|Sensory System Agents|sensory system agents|mesh-ancestor
6278837|NCT01986751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6278838|NCT01986751|Analgesics|analgesics|mesh-ancestor
6278839|NCT01986751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6278840|NCT01986751|Sympatholytics|sympatholytics|mesh-ancestor
6278841|NCT01986751|Autonomic Agents|autonomic agents|mesh-ancestor
6278842|NCT01986751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6278843|NCT01986751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6278844|NCT01986751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6278845|NCT01986751|Adrenergic Agents|adrenergic agents|mesh-ancestor
6278846|NCT01986751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6278847|NCT01986751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278848|NCT01996852|Sildenafil Citrate|sildenafil citrate|mesh-list
6278849|NCT01996852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278850|NCT01996852|Vasodilator Agents|vasodilator agents|mesh-ancestor
6278851|NCT01996852|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6278852|NCT01996852|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6278853|NCT01996852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6278854|NCT01996852|Urological Agents|urological agents|mesh-ancestor
6278855|NCT01997567|Ropivacaine|ropivacaine|mesh-list
6278856|NCT01997567|Anesthetics, Local|anesthetics, local|mesh-ancestor
6278857|NCT01997567|Anesthetics|anesthetics|mesh-ancestor
6278858|NCT01997567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6278859|NCT01997567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278860|NCT01997567|Sensory System Agents|sensory system agents|mesh-ancestor
6278861|NCT01997567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6278862|NCT01977729|Sertraline|sertraline|mesh-list
6278863|NCT01977729|Antidepressive Agents|antidepressive agents|mesh-ancestor
6278864|NCT01977729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6278865|NCT01977729|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6278866|NCT01977729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6278867|NCT01977729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6278868|NCT01977729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278869|NCT01977729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6278870|NCT01977729|Serotonin Agents|serotonin agents|mesh-ancestor
6278871|NCT01977729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278872|NCT01973062|Rituximab|rituximab|mesh-list
6278873|NCT01973062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6278874|NCT01973062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6278875|NCT01973062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6278876|NCT01973062|Immunologic Factors|immunologic factors|mesh-ancestor
6278877|NCT01973062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278878|NCT01973062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6278879|NCT01984268|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6278880|NCT01984268|Hormones|hormones|mesh-ancestor
6278881|NCT01984268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6278882|NCT01984268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278883|NCT01974284|Ethanol|ethanol|mesh-list
6278884|NCT01974284|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6278885|NCT01974284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6278886|NCT01974284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6278887|NCT01974284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278888|NCT01971853|Analgesics|analgesics|mesh-list
6015220|NCT00356031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6015221|NCT00356031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6278889|NCT01971853|Sensory System Agents|sensory system agents|mesh-ancestor
6015222|NCT00356031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6015223|NCT00356031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6015224|NCT00356031|Growth Substances|growth substances|mesh-ancestor
6015225|NCT00356031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015226|NCT00356031|Growth Inhibitors|growth inhibitors|mesh-ancestor
6015227|NCT00356122|Bevacizumab|bevacizumab|mesh-list
6278890|NCT01971853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6278891|NCT01971853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278892|NCT01980875|Obinutuzumab|obinutuzumab|mesh-list
6278893|NCT01980875|Idelalisib|idelalisib|mesh-list
6278894|NCT01980875|Chlorambucil|chlorambucil|mesh-list
6278895|NCT01980875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6278896|NCT01980875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6278897|NCT01980875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6278898|NCT01980875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278899|NCT01980875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6278900|NCT01980875|Alkylating Agents|alkylating agents|mesh-ancestor
6278901|NCT01980342|Efavirenz|efavirenz|mesh-list
6278902|NCT01980342|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6278903|NCT01980342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6278904|NCT01980342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6278905|NCT01980342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278906|NCT01980342|Antiviral Agents|antiviral agents|mesh-ancestor
6278907|NCT01980342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6278908|NCT01980342|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6278909|NCT01980342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6278910|NCT01980342|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6278911|NCT01980342|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6278912|NCT01980342|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6278913|NCT01980342|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6278914|NCT01978535|Iron|iron|mesh-list
6278915|NCT01978535|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6278916|NCT01978535|Trace Elements|trace elements|mesh-ancestor
6278917|NCT01978535|Micronutrients|micronutrients|mesh-ancestor
6278918|NCT01978535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278919|NCT01978535|Hematinics|hematinics|mesh-ancestor
6278920|NCT01970462|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6278921|NCT01970462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6278922|NCT01970462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278923|NCT01970462|Incretins|incretins|mesh-ancestor
6278924|NCT01970462|Hormones|hormones|mesh-ancestor
6278925|NCT01970462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6278926|NCT01970462|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6278927|NCT01970462|Protease Inhibitors|protease inhibitors|mesh-ancestor
6278928|NCT01970462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6278929|NCT01970462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278930|NCT01969565|Dexamethasone|dexamethasone|mesh-list
6278931|NCT01969565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6278932|NCT01969565|Antiemetics|antiemetics|mesh-ancestor
6278933|NCT01969565|Autonomic Agents|autonomic agents|mesh-ancestor
6278934|NCT01969565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6278935|NCT01969565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278936|NCT01969565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6278937|NCT01969565|Glucocorticoids|glucocorticoids|mesh-ancestor
6278938|NCT01969565|Hormones|hormones|mesh-ancestor
6278939|NCT01969565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6278940|NCT01969565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6278941|NCT01969565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6278942|NCT01962974|Golimumab|golimumab|mesh-list
6278943|NCT01962974|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6278944|NCT01962974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6278945|NCT01962974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6278946|NCT01962974|Immunologic Factors|immunologic factors|mesh-ancestor
6278947|NCT01962974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278948|NCT01951378|Albuterol|albuterol|mesh-list
6278949|NCT01951378|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6278950|NCT01951378|Autonomic Agents|autonomic agents|mesh-ancestor
6278951|NCT01951378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6278952|NCT01951378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278953|NCT01951378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6278954|NCT01951378|Respiratory System Agents|respiratory system agents|mesh-ancestor
6278955|NCT01951378|Tocolytic Agents|tocolytic agents|mesh-ancestor
6278956|NCT01951378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6278957|NCT01951378|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6278958|NCT01951378|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6278959|NCT01951378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6278960|NCT01951378|Adrenergic Agents|adrenergic agents|mesh-ancestor
6278961|NCT01951378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6278962|NCT01951378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278963|NCT01941615|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
6278964|NCT01941615|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
6278965|NCT01941615|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6278966|NCT01941615|Contraceptive Agents|contraceptive agents|mesh-ancestor
6278967|NCT01941615|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6278968|NCT01941615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278969|NCT01941615|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6278970|NCT01941615|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6278971|NCT01941615|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6278972|NCT01941615|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6278973|NCT01941615|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6278974|NCT01941615|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
6278975|NCT01941615|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6278976|NCT01941615|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6278977|NCT01935947|Gemcitabine|gemcitabine|mesh-list
6278978|NCT01935947|Azacitidine|azacitidine|mesh-list
6278979|NCT01935947|Docetaxel|docetaxel|mesh-list
6278980|NCT01935947|Irinotecan|irinotecan|mesh-list
6278981|NCT01935947|Pemetrexed|pemetrexed|mesh-list
6278982|NCT01935947|Camptothecin|camptothecin|mesh-list
6278983|NCT01935947|Entinostat|entinostat|mesh-list
6278984|NCT01935947|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
6278985|NCT01935947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6278986|NCT01935947|Antimetabolites|antimetabolites|mesh-ancestor
6278987|NCT01935947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6278988|NCT01935947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6278989|NCT01935947|Antiviral Agents|antiviral agents|mesh-ancestor
6278990|NCT01935947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6278991|NCT01935947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6278992|NCT01935947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6278993|NCT01935947|Immunologic Factors|immunologic factors|mesh-ancestor
6278994|NCT01935947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6278995|NCT01935947|Tubulin Modulators|tubulin modulators|mesh-ancestor
6278996|NCT01935947|Antimitotic Agents|antimitotic agents|mesh-ancestor
6278997|NCT01935947|Mitosis Modulators|mitosis modulators|mesh-ancestor
6278998|NCT01935947|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6278999|NCT01935947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6279000|NCT01935947|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6279001|NCT01935947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6279002|NCT01935947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6279003|NCT01938716|Gemcitabine|gemcitabine|mesh-list
6279004|NCT01938716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6279005|NCT01938716|Antimetabolites|antimetabolites|mesh-ancestor
6279006|NCT01938716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6279007|NCT01938716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6279008|NCT01938716|Antiviral Agents|antiviral agents|mesh-ancestor
6279009|NCT01938716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6279010|NCT01938716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6279011|NCT01938716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6279012|NCT01938716|Immunologic Factors|immunologic factors|mesh-ancestor
6279013|NCT01938716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279014|NCT01936974|Gemcitabine|gemcitabine|mesh-list
6279015|NCT01936974|Bevacizumab|bevacizumab|mesh-list
6279016|NCT01936974|Carboplatin|carboplatin|mesh-list
6279017|NCT01936974|Oxaliplatin|oxaliplatin|mesh-list
6279018|NCT01936974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6279019|NCT01936974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6279020|NCT01936974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6279021|NCT01936974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6279022|NCT01936974|Growth Substances|growth substances|mesh-ancestor
6279023|NCT01936974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279024|NCT01936974|Growth Inhibitors|growth inhibitors|mesh-ancestor
6279025|NCT01936974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6279026|NCT01936974|Antimetabolites|antimetabolites|mesh-ancestor
6279027|NCT01936974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6279028|NCT01936974|Antiviral Agents|antiviral agents|mesh-ancestor
6279029|NCT01936974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6279030|NCT01936974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6279031|NCT01936974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6279032|NCT01936974|Immunologic Factors|immunologic factors|mesh-ancestor
6279033|NCT01938833|Paclitaxel|paclitaxel|mesh-list
6279034|NCT01938833|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6279035|NCT01938833|Romidepsin|romidepsin|mesh-list
6279036|NCT01938833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6279037|NCT01938833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6279038|NCT01938833|Tubulin Modulators|tubulin modulators|mesh-ancestor
6279039|NCT01938833|Antimitotic Agents|antimitotic agents|mesh-ancestor
6279040|NCT01938833|Mitosis Modulators|mitosis modulators|mesh-ancestor
6279041|NCT01938833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6279042|NCT01938833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6279043|NCT01928082|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6279044|NCT01928082|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6279045|NCT01928082|Estradiol|estradiol|mesh-list
6279046|NCT01928082|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6279047|NCT01928082|Estrogens|estrogens|mesh-ancestor
6279048|NCT01928082|Hormones|hormones|mesh-ancestor
6279049|NCT01928082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6279050|NCT01928082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279051|NCT01928082|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6279052|NCT01928082|Contraceptive Agents|contraceptive agents|mesh-ancestor
6279053|NCT01928082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6279054|NCT01928082|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6279055|NCT01928615|Trastuzumab|trastuzumab|mesh-list
6279056|NCT01928615|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6279057|NCT01928615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6279058|NCT01928615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6279059|NCT01910389|Tadalafil|tadalafil|mesh-list
6279060|NCT01910389|Vasodilator Agents|vasodilator agents|mesh-ancestor
6279061|NCT01910389|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6279062|NCT01910389|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6279063|NCT01910389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6279064|NCT01910389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6279065|NCT01910389|Urological Agents|urological agents|mesh-ancestor
6279066|NCT01916590|Bupivacaine|bupivacaine|mesh-list
6279067|NCT01916590|Anesthetics, Local|anesthetics, local|mesh-ancestor
6279068|NCT01916590|Anesthetics|anesthetics|mesh-ancestor
6279069|NCT01916590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6279070|NCT01916590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279071|NCT01916590|Sensory System Agents|sensory system agents|mesh-ancestor
6279072|NCT01916590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6279073|NCT01913327|Risperidone|risperidone|mesh-list
6279074|NCT01913327|Aripiprazole|aripiprazole|mesh-list
6279075|NCT01913327|Modafinil|modafinil|mesh-list
6279076|NCT01913327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6279077|NCT01913327|Serotonin Agents|serotonin agents|mesh-ancestor
6279078|NCT01913327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6279079|NCT01913327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6279080|NCT01913327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279081|NCT01913327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6279082|NCT01913327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6279083|NCT01913327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6279084|NCT01913327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6279085|NCT01913327|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6279086|NCT01913327|Dopamine Agents|dopamine agents|mesh-ancestor
6279087|NCT01913327|Antidepressive Agents|antidepressive agents|mesh-ancestor
6279088|NCT01913327|Dopamine Agonists|dopamine agonists|mesh-ancestor
6279089|NCT01913327|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6279090|NCT01913327|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6279091|NCT01913327|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6279092|NCT01913327|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6279093|NCT01913327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6279094|NCT01913327|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6279095|NCT01913327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6279096|NCT01913327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6279097|NCT01901224|Metformin|metformin|mesh-list
6279098|NCT01901224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6279099|NCT01901224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279100|NCT01910441|Metformin|metformin|mesh-list
6279101|NCT01910441|Glimepiride|glimepiride|mesh-list
6279102|NCT01910441|Vildagliptin|vildagliptin|mesh-list
6279103|NCT01910441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6279104|NCT01910441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279105|NCT01910441|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6279106|NCT01910441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6279107|NCT01910441|Immunologic Factors|immunologic factors|mesh-ancestor
6279108|NCT01910441|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6279109|NCT01910441|Protease Inhibitors|protease inhibitors|mesh-ancestor
6279110|NCT01910441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6279111|NCT01910441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6279112|NCT01902966|Propranolol|propranolol|mesh-list
6279113|NCT01902966|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6279114|NCT01902966|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6279115|NCT01902966|Adrenergic Agents|adrenergic agents|mesh-ancestor
6279116|NCT01902966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6279117|NCT01902966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6279118|NCT01902966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279119|NCT01902966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6279120|NCT01902966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6279121|NCT01902966|Vasodilator Agents|vasodilator agents|mesh-ancestor
6279122|NCT01901679|Celecoxib|celecoxib|mesh-list
6279123|NCT01901679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6279124|NCT01901679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6279125|NCT01901679|Analgesics|analgesics|mesh-ancestor
6279126|NCT01901679|Sensory System Agents|sensory system agents|mesh-ancestor
6279127|NCT01901679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6279128|NCT01901679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279129|NCT01901679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6279130|NCT01901679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6279131|NCT01901679|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6279132|NCT01901679|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6279133|NCT01901679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6391366|NCT00193141|Fluorouracil|fluorouracil|mesh-list
6279134|NCT01901679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6279135|NCT01900730|Valproic Acid|valproic acid|mesh-list
6279136|NCT01900730|Anticonvulsants|anticonvulsants|mesh-ancestor
6279137|NCT01900730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6279138|NCT01900730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6279139|NCT01900730|GABA Agents|gaba agents|mesh-ancestor
6279140|NCT01900730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6279141|NCT01900730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279142|NCT01900730|Antimanic Agents|antimanic agents|mesh-ancestor
6279143|NCT01900730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6279144|NCT01900730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6279145|NCT01900730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6279146|NCT01877564|Metformin|metformin|mesh-list
6279147|NCT01877564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6279148|NCT01877564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279149|NCT01890694|Tolvaptan|tolvaptan|mesh-list
6279150|NCT01890694|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6279151|NCT01890694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6279152|NCT01890694|Natriuretic Agents|natriuretic agents|mesh-ancestor
6279153|NCT01890694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279154|NCT01890577|Darbepoetin alfa|darbepoetin alfa|mesh-list
6279155|NCT01890577|Hematinics|hematinics|mesh-ancestor
6279156|NCT01895959|Hyaluronic Acid|hyaluronic acid|mesh-list
6279157|NCT01895959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6279158|NCT01895959|Immunologic Factors|immunologic factors|mesh-ancestor
6279159|NCT01895959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279160|NCT01895959|Viscosupplements|viscosupplements|mesh-ancestor
6279161|NCT01895959|Protective Agents|protective agents|mesh-ancestor
6279162|NCT01889420|Everolimus|everolimus|mesh-list
6279163|NCT01889420|Pomalidomide|pomalidomide|mesh-list
6279164|NCT01889420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6279165|NCT01889420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6279166|NCT01889420|Immunologic Factors|immunologic factors|mesh-ancestor
6279167|NCT01889420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279168|NCT01889420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6279169|NCT01889420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6279170|NCT01889420|Growth Substances|growth substances|mesh-ancestor
6279171|NCT01889420|Growth Inhibitors|growth inhibitors|mesh-ancestor
6279172|NCT01881984|Glycerol|glycerol|mesh-list
6279173|NCT01881984|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6279174|NCT01881984|Protective Agents|protective agents|mesh-ancestor
6279175|NCT01881984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279176|NCT01893359|Riboflavin|riboflavin|mesh-list
6279177|NCT01893359|Dextrans|dextrans|mesh-list
6279178|NCT01893359|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6279179|NCT01893359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6279180|NCT01893359|Vitamin B Complex|vitamin b complex|mesh-ancestor
6279181|NCT01893359|Vitamins|vitamins|mesh-ancestor
6279182|NCT01893359|Micronutrients|micronutrients|mesh-ancestor
6279183|NCT01893359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279184|NCT01893359|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6279185|NCT01893359|Dermatologic Agents|dermatologic agents|mesh-ancestor
6279186|NCT01893359|Anticoagulants|anticoagulants|mesh-ancestor
6279187|NCT01893359|Plasma Substitutes|plasma substitutes|mesh-ancestor
6279188|NCT01893359|Blood Substitutes|blood substitutes|mesh-ancestor
6279189|NCT01887288|Capecitabine|capecitabine|mesh-list
6279190|NCT01887288|Digoxin|digoxin|mesh-list
6279191|NCT01887288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6279192|NCT01887288|Antimetabolites|antimetabolites|mesh-ancestor
6279193|NCT01887288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6279194|NCT01887288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6279195|NCT01887288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6279196|NCT01887288|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6279197|NCT01887288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6279198|NCT01887288|Protective Agents|protective agents|mesh-ancestor
6279199|NCT01887288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279200|NCT01878786|Mycophenolic Acid|mycophenolic acid|mesh-list
6279201|NCT01878786|Everolimus|everolimus|mesh-list
6279202|NCT01878786|Tacrolimus|tacrolimus|mesh-list
6279203|NCT01878786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6279204|NCT01878786|Immunologic Factors|immunologic factors|mesh-ancestor
6279205|NCT01878786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279206|NCT01878786|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6279207|NCT01878786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6279208|NCT01878786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6279209|NCT01878786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6279210|NCT01878786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6279211|NCT01878786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6279212|NCT01878786|Antitubercular Agents|antitubercular agents|mesh-ancestor
6279213|NCT01878786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6279214|NCT01878786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6279215|NCT01861717|Lanreotide|lanreotide|mesh-list
6279216|NCT01861717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6279217|NCT01866709|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
6279218|NCT01866709|Chelating Agents|chelating agents|mesh-ancestor
6279219|NCT01866709|Sequestering Agents|sequestering agents|mesh-ancestor
6279220|NCT01866709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6279221|NCT01860040|Gemcitabine|gemcitabine|mesh-list
6279222|NCT01860040|Pemetrexed|pemetrexed|mesh-list
6279223|NCT01860040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6279224|NCT01860040|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6279225|NCT01860040|Antimetabolites|antimetabolites|mesh-ancestor
6279226|NCT01860040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6279227|NCT01860040|Antiviral Agents|antiviral agents|mesh-ancestor
6279228|NCT01860040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6279229|NCT01860040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6279230|NCT01860040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6279231|NCT01860040|Immunologic Factors|immunologic factors|mesh-ancestor
6279232|NCT01860040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279233|NCT01860040|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6279234|NCT01860040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6279235|NCT01851174|Gemcitabine|gemcitabine|mesh-list
6279236|NCT01851174|Paclitaxel|paclitaxel|mesh-list
6279237|NCT01851174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6279238|NCT01851174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6279239|NCT01851174|Tubulin Modulators|tubulin modulators|mesh-ancestor
6279240|NCT01851174|Antimitotic Agents|antimitotic agents|mesh-ancestor
6279241|NCT01851174|Mitosis Modulators|mitosis modulators|mesh-ancestor
6279242|NCT01851174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6279243|NCT01851174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6279244|NCT01851174|Antimetabolites|antimetabolites|mesh-ancestor
6279245|NCT01851174|Antiviral Agents|antiviral agents|mesh-ancestor
6279246|NCT01851174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6279247|NCT01851174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6279248|NCT01851174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6279249|NCT01851174|Immunologic Factors|immunologic factors|mesh-ancestor
6279250|NCT01851174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279251|NCT01846182|Pregabalin|pregabalin|mesh-list
6279252|NCT01846182|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6279253|NCT01846182|Analgesics|analgesics|mesh-ancestor
6279254|NCT01846182|Sensory System Agents|sensory system agents|mesh-ancestor
6279255|NCT01846182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6279256|NCT01846182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279257|NCT01846182|Anticonvulsants|anticonvulsants|mesh-ancestor
6279258|NCT01846182|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6279259|NCT01846182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6279260|NCT01846182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6279261|NCT01846182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6279262|NCT01846182|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6279263|NCT01846182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6279264|NCT01846182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6279265|NCT01846182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6279266|NCT01846182|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6279267|NCT01846182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6279268|NCT01846182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6279269|NCT01846182|Antidepressive Agents|antidepressive agents|mesh-ancestor
6279270|NCT01846182|Dopamine Agents|dopamine agents|mesh-ancestor
6279271|NCT01844206|Morphine|morphine|mesh-list
6279272|NCT01844206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6279273|NCT01844206|Narcotics|narcotics|mesh-ancestor
6279274|NCT01844206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6279275|NCT01844206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279276|NCT01844206|Analgesics|analgesics|mesh-ancestor
6279277|NCT01844206|Sensory System Agents|sensory system agents|mesh-ancestor
6279278|NCT01844206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6279279|NCT01856322|Sulindac|sulindac|mesh-list
6279280|NCT01856322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6279281|NCT01856322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6279282|NCT01856322|Analgesics|analgesics|mesh-ancestor
6279283|NCT01856322|Sensory System Agents|sensory system agents|mesh-ancestor
6279284|NCT01856322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6279285|NCT01856322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279286|NCT01856322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6279287|NCT01856322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6279288|NCT01856322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6279289|NCT01856322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6279290|NCT01856322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6279291|NCT01856322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391367|NCT00193141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6391368|NCT00193141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391369|NCT00193141|Tubulin Modulators|tubulin modulators|mesh-ancestor
6391370|NCT00193141|Antimitotic Agents|antimitotic agents|mesh-ancestor
6391371|NCT00193141|Mitosis Modulators|mitosis modulators|mesh-ancestor
6391372|NCT00193141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391373|NCT00193141|Antimetabolites|antimetabolites|mesh-ancestor
6391374|NCT00193141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6391375|NCT00193141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6391376|NCT00193141|Immunologic Factors|immunologic factors|mesh-ancestor
6391377|NCT00193141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6391378|NCT00193154|Bevacizumab|bevacizumab|mesh-list
6391379|NCT00193154|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6391380|NCT00193154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6391381|NCT00193154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391382|NCT00193154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6391383|NCT00193154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6391384|NCT00193154|Growth Substances|growth substances|mesh-ancestor
6391385|NCT00193154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6391386|NCT00193154|Growth Inhibitors|growth inhibitors|mesh-ancestor
6391387|NCT00193154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6391388|NCT00193154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6391389|NCT00193154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391390|NCT00193167|Topotecan|topotecan|mesh-list
6391391|NCT00193167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6391392|NCT00193167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6391393|NCT00193167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6391394|NCT00193167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391395|NCT00193167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391396|NCT00193193|Paclitaxel|paclitaxel|mesh-list
6391397|NCT00193193|Carboplatin|carboplatin|mesh-list
6391398|NCT00193193|Estramustine|estramustine|mesh-list
6391399|NCT00193193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6391400|NCT00193193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391401|NCT00193193|Tubulin Modulators|tubulin modulators|mesh-ancestor
6391402|NCT00193193|Antimitotic Agents|antimitotic agents|mesh-ancestor
6391403|NCT00193193|Mitosis Modulators|mitosis modulators|mesh-ancestor
6391404|NCT00193193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391405|NCT00193193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6391406|NCT00193193|Alkylating Agents|alkylating agents|mesh-ancestor
6391407|NCT00193193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6391408|NCT00193232|Docetaxel|docetaxel|mesh-list
6391409|NCT00193232|Bortezomib|bortezomib|mesh-list
6391410|NCT00193232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391411|NCT00193232|Tubulin Modulators|tubulin modulators|mesh-ancestor
6391412|NCT00193232|Antimitotic Agents|antimitotic agents|mesh-ancestor
6391413|NCT00193232|Mitosis Modulators|mitosis modulators|mesh-ancestor
6391414|NCT00193232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391415|NCT00193245|Docetaxel|docetaxel|mesh-list
6391416|NCT00193245|Topotecan|topotecan|mesh-list
6391417|NCT00193245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391418|NCT00193245|Tubulin Modulators|tubulin modulators|mesh-ancestor
6279292|NCT01853176|Bupivacaine|bupivacaine|mesh-list
6279293|NCT01853176|Anesthetics, Local|anesthetics, local|mesh-ancestor
6279294|NCT01853176|Anesthetics|anesthetics|mesh-ancestor
6279295|NCT01853176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6279296|NCT01853176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279297|NCT01853176|Sensory System Agents|sensory system agents|mesh-ancestor
6279298|NCT01853176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6279299|NCT01857271|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6279300|NCT01857271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6279301|NCT01857271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6279302|NCT01857271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6279303|NCT01857271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6279304|NCT01856361|Ramipril|ramipril|mesh-list
6279305|NCT01856361|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6279306|NCT01856361|Protease Inhibitors|protease inhibitors|mesh-ancestor
6279307|NCT01856361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6279308|NCT01856361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6279309|NCT01856361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6279310|NCT01853982|Tazobactam|tazobactam|mesh-list
6279311|NCT01853982|Piperacillin|piperacillin|mesh-list
6279312|NCT01853982|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
6279313|NCT01853982|Ceftolozane|ceftolozane|mesh-list
6279314|NCT01853982|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
6279315|NCT01853982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6279316|NCT01853982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6279317|NCT01853982|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6279318|NCT01853982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6279319|NCT01853982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6279320|NCT01853982|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6279321|NCT01853982|Renal Agents|renal agents|mesh-ancestor
6279322|NCT01841931|Buprenorphine|buprenorphine|mesh-list
6279323|NCT01841931|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6279324|NCT01841931|Naloxone|naloxone|mesh-list
6279325|NCT01841931|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6279326|NCT01841931|Narcotics|narcotics|mesh-ancestor
6279327|NCT01841931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6279328|NCT01841931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279329|NCT01841931|Analgesics|analgesics|mesh-ancestor
6279330|NCT01841931|Sensory System Agents|sensory system agents|mesh-ancestor
6279331|NCT01841931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6279332|NCT01841931|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6279333|NCT01836809|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6279334|NCT01836809|Natriuretic Agents|natriuretic agents|mesh-ancestor
6279335|NCT01836809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279336|NCT01821963|Interferons|interferons|mesh-list
6279337|NCT01821963|Ribavirin|ribavirin|mesh-list
6279338|NCT01821963|Interferon-alpha|interferon-alpha|mesh-list
6279339|NCT01821963|Interferon alpha-2|interferon alpha-2|mesh-list
6279340|NCT01821963|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6279341|NCT01821963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6279342|NCT01821963|Antiviral Agents|antiviral agents|mesh-ancestor
6279343|NCT01821963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6279344|NCT01821963|Antimetabolites|antimetabolites|mesh-ancestor
6279345|NCT01821963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6279346|NCT01821963|Immunologic Factors|immunologic factors|mesh-ancestor
6279347|NCT01821963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279348|NCT01821898|Budesonide|budesonide|mesh-list
6279349|NCT01821898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6279350|NCT01821898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6279351|NCT01821898|Autonomic Agents|autonomic agents|mesh-ancestor
6279352|NCT01821898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6279353|NCT01821898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279354|NCT01821898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6279355|NCT01821898|Respiratory System Agents|respiratory system agents|mesh-ancestor
6279356|NCT01821898|Glucocorticoids|glucocorticoids|mesh-ancestor
6279357|NCT01821898|Hormones|hormones|mesh-ancestor
6279358|NCT01821898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6279359|NCT01830790|Sildenafil Citrate|sildenafil citrate|mesh-list
6279360|NCT01830790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6279361|NCT01830790|Vasodilator Agents|vasodilator agents|mesh-ancestor
6279362|NCT01830790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6279363|NCT01830790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6279364|NCT01830790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6279365|NCT01830790|Urological Agents|urological agents|mesh-ancestor
6279366|NCT01829477|Glimepiride|glimepiride|mesh-list
6279367|NCT01829477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6279368|NCT01829477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6279369|NCT01829477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279370|NCT01829477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6279371|NCT01829477|Immunologic Factors|immunologic factors|mesh-ancestor
6279372|NCT01803711|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6279373|NCT01803711|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6279374|NCT01803711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6279375|NCT01803711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6279376|NCT01803711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6279377|NCT01803711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6279378|NCT01803711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279379|NCT01803711|Antidepressive Agents|antidepressive agents|mesh-ancestor
6279380|NCT01803711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6279381|NCT01821859|Bevacizumab|bevacizumab|mesh-list
6279382|NCT01821859|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6279383|NCT01821859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6279384|NCT01821859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6279385|NCT01821859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6279386|NCT01821859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6279387|NCT01821859|Growth Substances|growth substances|mesh-ancestor
6279388|NCT01821859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279389|NCT01821859|Growth Inhibitors|growth inhibitors|mesh-ancestor
6279390|NCT01810302|Nicardipine|nicardipine|mesh-list
6279391|NCT01810302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6279392|NCT01810302|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6279393|NCT01810302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6279394|NCT01810302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6279395|NCT01810302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6279396|NCT01810302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279397|NCT01810302|Vasodilator Agents|vasodilator agents|mesh-ancestor
6279398|NCT01804166|Golimumab|golimumab|mesh-list
6279399|NCT01804166|Infliximab|infliximab|mesh-list
6279400|NCT01804166|Dermatologic Agents|dermatologic agents|mesh-ancestor
6279401|NCT01804166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6279402|NCT01804166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6279403|NCT01804166|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6279404|NCT01804166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6279405|NCT01804166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6279406|NCT01804166|Immunologic Factors|immunologic factors|mesh-ancestor
6279407|NCT01804166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279408|NCT01783015|Etanercept|etanercept|mesh-list
6279409|NCT01783015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6279410|NCT01783015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6279411|NCT01783015|Analgesics|analgesics|mesh-ancestor
6279412|NCT01783015|Sensory System Agents|sensory system agents|mesh-ancestor
6279413|NCT01783015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6279414|NCT01783015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279415|NCT01783015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6279416|NCT01783015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6279417|NCT01783015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6279418|NCT01783015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6279419|NCT01783015|Immunologic Factors|immunologic factors|mesh-ancestor
6279420|NCT01800162|Methotrexate|methotrexate|mesh-list
6279421|NCT01800162|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6279422|NCT01800162|Abortifacient Agents|abortifacient agents|mesh-ancestor
6279423|NCT01800162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6279424|NCT01800162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279425|NCT01800162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6279426|NCT01800162|Antimetabolites|antimetabolites|mesh-ancestor
6279427|NCT01800162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6279428|NCT01800162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6279429|NCT01800162|Dermatologic Agents|dermatologic agents|mesh-ancestor
6279430|NCT01800162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6279431|NCT01800162|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6279432|NCT01800162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6279433|NCT01800162|Immunologic Factors|immunologic factors|mesh-ancestor
6279434|NCT01800162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6279435|NCT01800162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6279436|NCT01797380|Citalopram|citalopram|mesh-list
6279437|NCT01797380|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6279438|NCT01797380|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6279439|NCT01797380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6279440|NCT01797380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6279441|NCT01797380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6279442|NCT01797380|Serotonin Agents|serotonin agents|mesh-ancestor
6279443|NCT01797380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279444|NCT01797380|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6279445|NCT01797380|Antidepressive Agents|antidepressive agents|mesh-ancestor
6279446|NCT01797380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6279447|NCT01781026|Vemurafenib|vemurafenib|mesh-list
6279448|NCT01781026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6279449|NCT01781026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6279450|NCT01781026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6279451|NCT01781026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6279452|NCT01788475|Dexamethasone|dexamethasone|mesh-list
6279453|NCT01788475|Dexamethasone acetate|dexamethasone acetate|mesh-list
6279454|NCT01788475|BB 1101|bb 1101|mesh-list
6279455|NCT01788475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6279456|NCT01788475|Antiemetics|antiemetics|mesh-ancestor
6279457|NCT01788475|Autonomic Agents|autonomic agents|mesh-ancestor
6279458|NCT01788475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6279459|NCT01788475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279460|NCT01788475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6279461|NCT01788475|Glucocorticoids|glucocorticoids|mesh-ancestor
6279462|NCT01788475|Hormones|hormones|mesh-ancestor
6279463|NCT01788475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6279464|NCT01788475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6279465|NCT01788475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6279466|NCT01788475|Protease Inhibitors|protease inhibitors|mesh-ancestor
6279467|NCT01788475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6279468|NCT01788475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6279469|NCT01784991|Morphine|morphine|mesh-list
6279470|NCT01784991|Hydromorphone|hydromorphone|mesh-list
6279471|NCT01784991|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6279472|NCT01784991|Narcotics|narcotics|mesh-ancestor
6279473|NCT01784991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6279474|NCT01784991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279475|NCT01784991|Analgesics|analgesics|mesh-ancestor
6279476|NCT01784991|Sensory System Agents|sensory system agents|mesh-ancestor
6279477|NCT01784991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6279478|NCT01777854|Omeprazole|omeprazole|mesh-list
6279479|NCT01777854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6279480|NCT01777854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6279481|NCT01777854|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6279482|NCT01777854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6279483|NCT01777854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6279484|NCT01760993|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6279485|NCT01760993|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6279486|NCT01760993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279487|NCT01760993|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6279488|NCT01760993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6279489|NCT01760993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6279490|NCT01760993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6279491|NCT01760993|Dopamine Agents|dopamine agents|mesh-ancestor
6279492|NCT01760993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6279493|NCT01772719|Zoledronic Acid|zoledronic acid|mesh-list
6279494|NCT01772719|Simvastatin|simvastatin|mesh-list
6279495|NCT01772719|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6279496|NCT01772719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6279497|NCT01772719|Antimetabolites|antimetabolites|mesh-ancestor
6279498|NCT01772719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6279499|NCT01772719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6279500|NCT01772719|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6279501|NCT01772719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6279502|NCT01772719|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6279503|NCT01772719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279504|NCT01764997|Adalimumab|adalimumab|mesh-list
6279505|NCT01764997|Etanercept|etanercept|mesh-list
6279506|NCT01764997|Methotrexate|methotrexate|mesh-list
6279507|NCT01764997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6279508|NCT01764997|Abortifacient Agents|abortifacient agents|mesh-ancestor
6279509|NCT01764997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6279510|NCT01764997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279511|NCT01764997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6279512|NCT01764997|Antimetabolites|antimetabolites|mesh-ancestor
6279513|NCT01764997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6279514|NCT01764997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6279515|NCT01764997|Dermatologic Agents|dermatologic agents|mesh-ancestor
6279516|NCT01764997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6279517|NCT01764997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6279518|NCT01764997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6279519|NCT01764997|Immunologic Factors|immunologic factors|mesh-ancestor
6279520|NCT01764997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6279521|NCT01764997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6279522|NCT01764997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6279523|NCT01764997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6279524|NCT01764997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6279525|NCT01764997|Analgesics|analgesics|mesh-ancestor
6279526|NCT01764997|Sensory System Agents|sensory system agents|mesh-ancestor
6279527|NCT01764997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6279528|NCT01764997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6279529|NCT01769443|Bortezomib|bortezomib|mesh-list
6279530|NCT01769443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6279531|NCT01760889|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6279532|NCT01760889|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6279533|NCT01760889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279534|NCT01760889|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6279535|NCT01760889|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6279536|NCT01760889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6279537|NCT01760889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6279538|NCT01760889|Dopamine Agents|dopamine agents|mesh-ancestor
6279539|NCT01760889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6279540|NCT01749826|Morphine|morphine|mesh-list
6279541|NCT01749826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6279542|NCT01749826|Narcotics|narcotics|mesh-ancestor
6279543|NCT01749826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6279544|NCT01749826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279545|NCT01749826|Analgesics|analgesics|mesh-ancestor
6279546|NCT01749826|Sensory System Agents|sensory system agents|mesh-ancestor
6279547|NCT01749826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6279548|NCT01756586|Dexamethasone|dexamethasone|mesh-list
6279549|NCT01756586|Bupivacaine|bupivacaine|mesh-list
6279550|NCT01756586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6279551|NCT01756586|Antiemetics|antiemetics|mesh-ancestor
6279552|NCT01756586|Autonomic Agents|autonomic agents|mesh-ancestor
6279553|NCT01756586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6279554|NCT01756586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279555|NCT01756586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6279556|NCT01756586|Glucocorticoids|glucocorticoids|mesh-ancestor
6279557|NCT01756586|Hormones|hormones|mesh-ancestor
6279558|NCT01756586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6279559|NCT01756586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6279560|NCT01756586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6279561|NCT01756586|Anesthetics, Local|anesthetics, local|mesh-ancestor
6279562|NCT01756586|Anesthetics|anesthetics|mesh-ancestor
6279563|NCT01756586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6279564|NCT01756586|Sensory System Agents|sensory system agents|mesh-ancestor
6279565|NCT01754987|Ascorbic Acid|ascorbic acid|mesh-list
6279566|NCT01754987|Sorafenib|sorafenib|mesh-list
6279567|NCT01754987|Vitamins|vitamins|mesh-ancestor
6279568|NCT01754987|Micronutrients|micronutrients|mesh-ancestor
6279569|NCT01754987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279570|NCT01754987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6279571|NCT01754987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6279572|NCT01754987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6279573|NCT01754987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6279574|NCT01754987|Antioxidants|antioxidants|mesh-ancestor
6279575|NCT01754987|Protective Agents|protective agents|mesh-ancestor
6279576|NCT01756560|Bupivacaine|bupivacaine|mesh-list
6279577|NCT01756560|Anesthetics, Local|anesthetics, local|mesh-ancestor
6279578|NCT01756560|Anesthetics|anesthetics|mesh-ancestor
6279579|NCT01756560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6279580|NCT01756560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279581|NCT01756560|Sensory System Agents|sensory system agents|mesh-ancestor
6279582|NCT01756560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6279583|NCT01756573|Bupivacaine|bupivacaine|mesh-list
6279584|NCT01756573|Anesthetics, Local|anesthetics, local|mesh-ancestor
6279585|NCT01756573|Anesthetics|anesthetics|mesh-ancestor
6279586|NCT01756573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6279587|NCT01756573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279588|NCT01756573|Sensory System Agents|sensory system agents|mesh-ancestor
6279589|NCT01756573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6279590|NCT01745913|Fludarabine|fludarabine|mesh-list
6279591|NCT01745913|Melphalan|melphalan|mesh-list
6279592|NCT01745913|Thymoglobulin|thymoglobulin|mesh-list
6279593|NCT01745913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6279594|NCT01745913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6279595|NCT01745913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6279596|NCT01745913|Immunologic Factors|immunologic factors|mesh-ancestor
6279597|NCT01745913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279598|NCT01745913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6279599|NCT01745913|Alkylating Agents|alkylating agents|mesh-ancestor
6279600|NCT01745913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6279601|NCT01752023|Gemcitabine|gemcitabine|mesh-list
6279602|NCT01752023|Itraconazole|itraconazole|mesh-list
6279603|NCT01752023|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
6279604|NCT01752023|Cisplatin|cisplatin|mesh-list
6279605|NCT01752023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6279606|NCT01752023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6279607|NCT01752023|Antimetabolites|antimetabolites|mesh-ancestor
6279608|NCT01752023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6279609|NCT01752023|Antiviral Agents|antiviral agents|mesh-ancestor
6279610|NCT01752023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6279611|NCT01752023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6279612|NCT01752023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6279613|NCT01752023|Immunologic Factors|immunologic factors|mesh-ancestor
6279614|NCT01752023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279615|NCT01752023|Antifungal Agents|antifungal agents|mesh-ancestor
6279616|NCT01752023|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6279617|NCT01752023|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6279618|NCT01752023|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6279619|NCT01752023|Hormone Antagonists|hormone antagonists|mesh-ancestor
6279620|NCT01752023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6279621|NCT01752023|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6279622|NCT01740154|Sunitinib|sunitinib|mesh-list
6279623|NCT01740154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6279624|NCT01740154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6279625|NCT01740154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6279626|NCT01740154|Growth Substances|growth substances|mesh-ancestor
6279627|NCT01740154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279628|NCT01740154|Growth Inhibitors|growth inhibitors|mesh-ancestor
6279629|NCT01740154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6279630|NCT01740154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6279631|NCT01740154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6279632|NCT01748162|Fluticasone|fluticasone|mesh-list
6279633|NCT01748162|Prednisolone|prednisolone|mesh-list
6279634|NCT01748162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6279635|NCT01748162|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6279636|NCT01748162|Autonomic Agents|autonomic agents|mesh-ancestor
6279637|NCT01748162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6279638|NCT01748162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279639|NCT01748162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6279640|NCT01748162|Respiratory System Agents|respiratory system agents|mesh-ancestor
6279641|NCT01748162|Dermatologic Agents|dermatologic agents|mesh-ancestor
6279642|NCT01748162|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6279643|NCT01748162|Glucocorticoids|glucocorticoids|mesh-ancestor
6279644|NCT01748162|Hormones|hormones|mesh-ancestor
6279645|NCT01748162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6279646|NCT01748162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6279647|NCT01748162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6279648|NCT01738698|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6279649|NCT01738698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6279650|NCT01738698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279651|NCT01738698|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6279652|NCT01738698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6279653|NCT01738698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6279654|NCT01738698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6279655|NCT01738698|Dopamine Agents|dopamine agents|mesh-ancestor
6279656|NCT01738698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6279657|NCT01732926|Rituximab|rituximab|mesh-list
6279658|NCT01732926|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6279659|NCT01732926|Idelalisib|idelalisib|mesh-list
6279660|NCT01732926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6279661|NCT01732926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6279662|NCT01732926|Immunologic Factors|immunologic factors|mesh-ancestor
6279663|NCT01732926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279664|NCT01732926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6279665|NCT01732926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6279666|NCT01732926|Alkylating Agents|alkylating agents|mesh-ancestor
6279667|NCT01732926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6279668|NCT01732926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6279669|NCT01732913|Rituximab|rituximab|mesh-list
6279670|NCT01732913|Idelalisib|idelalisib|mesh-list
6279671|NCT01732913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6279672|NCT01732913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6279673|NCT01732913|Immunologic Factors|immunologic factors|mesh-ancestor
6279674|NCT01732913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279675|NCT01732913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6279676|NCT01732913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6279677|NCT01732913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6279678|NCT01716052|Ibuprofen|ibuprofen|mesh-list
6279679|NCT01716052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6279680|NCT01716052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6279681|NCT01716052|Analgesics|analgesics|mesh-ancestor
6279682|NCT01716052|Sensory System Agents|sensory system agents|mesh-ancestor
6279683|NCT01716052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6279684|NCT01716052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279685|NCT01716052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6279686|NCT01716052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6279687|NCT01716052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6279688|NCT01716052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6279689|NCT01716052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6279690|NCT01718444|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6279691|NCT01718444|Clomiphene|clomiphene|mesh-list
6279692|NCT01718444|Enclomiphene|enclomiphene|mesh-list
6279693|NCT01718444|Zuclomiphene|zuclomiphene|mesh-list
6279694|NCT01718444|Medroxyprogesterone|medroxyprogesterone|mesh-list
6279695|NCT01718444|Progestins|progestins|mesh-list
6279696|NCT01718444|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6279697|NCT01718444|Hormone Antagonists|hormone antagonists|mesh-ancestor
6279698|NCT01718444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6279699|NCT01718444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279700|NCT01718444|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6279701|NCT01718444|Fertility Agents|fertility agents|mesh-ancestor
6279702|NCT01718444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6279703|NCT01718444|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6279704|NCT01718444|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6279705|NCT01718444|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6279706|NCT01718444|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6279707|NCT01718444|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6279708|NCT01718444|Contraceptive Agents|contraceptive agents|mesh-ancestor
6279709|NCT01718444|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6279710|NCT01718444|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6279711|NCT01718444|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6279712|NCT01718444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6279713|NCT01718444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6279714|NCT01718444|Hormones|hormones|mesh-ancestor
6279715|NCT01712854|Budesonide|budesonide|mesh-list
6279716|NCT01712854|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6279717|NCT01712854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6279718|NCT01712854|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6279719|NCT01712854|Autonomic Agents|autonomic agents|mesh-ancestor
6279720|NCT01712854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6279721|NCT01712854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279722|NCT01712854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6279723|NCT01712854|Respiratory System Agents|respiratory system agents|mesh-ancestor
6279724|NCT01712854|Glucocorticoids|glucocorticoids|mesh-ancestor
6279725|NCT01712854|Hormones|hormones|mesh-ancestor
6279726|NCT01712854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6279727|NCT01717482|Metformin|metformin|mesh-list
6279728|NCT01717482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6279729|NCT01717482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279730|NCT01702896|Interleukin-2|interleukin-2|mesh-list
6279731|NCT01702896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6279732|NCT01702896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6279733|NCT01702896|Analgesics|analgesics|mesh-ancestor
6279734|NCT01702896|Sensory System Agents|sensory system agents|mesh-ancestor
6279735|NCT01702896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6279736|NCT01702896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279737|NCT01709136|Sirolimus|sirolimus|mesh-list
6279738|NCT01709136|Tacrolimus|tacrolimus|mesh-list
6279739|NCT01709136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6279740|NCT01709136|Immunologic Factors|immunologic factors|mesh-ancestor
6279741|NCT01709136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279742|NCT01709136|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6279743|NCT01709136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6279744|NCT01709136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6279745|NCT01709136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6279746|NCT01709136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6279747|NCT01709136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6279748|NCT01709136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6279749|NCT01709136|Antifungal Agents|antifungal agents|mesh-ancestor
6279750|NCT01708057|Tiotropium Bromide|tiotropium bromide|mesh-list
6279751|NCT01708057|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6279752|NCT01708057|Autonomic Agents|autonomic agents|mesh-ancestor
6279753|NCT01708057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6279754|NCT01708057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279755|NCT01708057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6279756|NCT01708057|Respiratory System Agents|respiratory system agents|mesh-ancestor
6279757|NCT01708057|Parasympatholytics|parasympatholytics|mesh-ancestor
6279758|NCT01708057|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6279759|NCT01708057|Cholinergic Agents|cholinergic agents|mesh-ancestor
6279760|NCT01708057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6279761|NCT01708057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6279762|NCT01705106|Celecoxib|celecoxib|mesh-list
6279763|NCT01705106|Capecitabine|capecitabine|mesh-list
6279764|NCT01705106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6279765|NCT01705106|Antimetabolites|antimetabolites|mesh-ancestor
6279766|NCT01705106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6279767|NCT01705106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6279768|NCT01705106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6279769|NCT01705106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6279770|NCT01705106|Analgesics|analgesics|mesh-ancestor
6279771|NCT01705106|Sensory System Agents|sensory system agents|mesh-ancestor
6279772|NCT01705106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6279773|NCT01705106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279774|NCT01705106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6279775|NCT01705106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6279776|NCT01705106|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6279777|NCT01705106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6279778|NCT01705106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6279779|NCT01702909|Interleukin-2|interleukin-2|mesh-list
6279780|NCT01702909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6015228|NCT00356122|Docetaxel|docetaxel|mesh-list
6015229|NCT00356122|Oxaliplatin|oxaliplatin|mesh-list
6015230|NCT00356122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6015231|NCT00356122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6015232|NCT00356122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6015233|NCT00356122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6015234|NCT00356122|Growth Substances|growth substances|mesh-ancestor
6015235|NCT00356122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015236|NCT00356122|Growth Inhibitors|growth inhibitors|mesh-ancestor
6279781|NCT01702909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6279782|NCT01702909|Analgesics|analgesics|mesh-ancestor
6279783|NCT01702909|Sensory System Agents|sensory system agents|mesh-ancestor
6279784|NCT01702909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6279785|NCT01702909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279786|NCT01701622|Febuxostat|febuxostat|mesh-list
6279787|NCT01701622|Gout Suppressants|gout suppressants|mesh-ancestor
6279788|NCT01701622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6279789|NCT01697800|Tadalafil|tadalafil|mesh-list
6279790|NCT01697800|Vasodilator Agents|vasodilator agents|mesh-ancestor
6279791|NCT01697800|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6279792|NCT01697800|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6279793|NCT01697800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6279794|NCT01697800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6279795|NCT01697800|Urological Agents|urological agents|mesh-ancestor
6279796|NCT01692691|Dacarbazine|dacarbazine|mesh-list
6279797|NCT01692691|Carmustine|carmustine|mesh-list
6279798|NCT01692691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6279799|NCT01692691|Alkylating Agents|alkylating agents|mesh-ancestor
6279800|NCT01692691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6279801|NCT01692691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6279802|NCT01691079|Bromides|bromides|mesh-list
6279803|NCT01691079|Ipratropium|ipratropium|mesh-list
6279804|NCT01691079|Anticonvulsants|anticonvulsants|mesh-ancestor
6279805|NCT01691079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6279806|NCT01691079|Autonomic Agents|autonomic agents|mesh-ancestor
6279807|NCT01691079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6279808|NCT01691079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279809|NCT01691079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6279810|NCT01691079|Respiratory System Agents|respiratory system agents|mesh-ancestor
6279811|NCT01691079|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6279812|NCT01691079|Cholinergic Agents|cholinergic agents|mesh-ancestor
6279813|NCT01691079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6279814|NCT01691079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6279815|NCT01689974|Ipilimumab|ipilimumab|mesh-list
6279816|NCT01689974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6279817|NCT01689974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6279818|NCT01689974|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6279819|NCT01689974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6279820|NCT01663285|Gemcitabine|gemcitabine|mesh-list
6279821|NCT01663285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6279822|NCT01663285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6279823|NCT01663285|Antimetabolites|antimetabolites|mesh-ancestor
6279824|NCT01663285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6279825|NCT01663285|Antiviral Agents|antiviral agents|mesh-ancestor
6279826|NCT01663285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6279827|NCT01663285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6279828|NCT01663285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6279829|NCT01663285|Immunologic Factors|immunologic factors|mesh-ancestor
6279830|NCT01663285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279831|NCT01683864|Cisplatin|cisplatin|mesh-list
6279832|NCT01683864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6279833|NCT01673061|Lidocaine|lidocaine|mesh-list
6279834|NCT01673061|Epinephrine|epinephrine|mesh-list
6279835|NCT01673061|Norflurane|norflurane|mesh-list
6279836|NCT01673061|Anesthetics, Local|anesthetics, local|mesh-ancestor
6279837|NCT01673061|Anesthetics|anesthetics|mesh-ancestor
6279838|NCT01673061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6279839|NCT01673061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279840|NCT01673061|Sensory System Agents|sensory system agents|mesh-ancestor
6279841|NCT01673061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6279842|NCT01673061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6279843|NCT01673061|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6279844|NCT01673061|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6279845|NCT01673061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6279846|NCT01673061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6279847|NCT01673061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6279848|NCT01673061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6279849|NCT01673061|Adrenergic Agents|adrenergic agents|mesh-ancestor
6279850|NCT01673061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6279851|NCT01673061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6279852|NCT01673061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6279853|NCT01673061|Autonomic Agents|autonomic agents|mesh-ancestor
6279854|NCT01673061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6279855|NCT01673061|Respiratory System Agents|respiratory system agents|mesh-ancestor
6279856|NCT01673061|Mydriatics|mydriatics|mesh-ancestor
6279857|NCT01673061|Sympathomimetics|sympathomimetics|mesh-ancestor
6279858|NCT01673061|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6279859|NCT01675960|Gabapentin|gabapentin|mesh-list
6279860|NCT01675960|Analgesics|analgesics|mesh-ancestor
6279861|NCT01675960|Sensory System Agents|sensory system agents|mesh-ancestor
6279862|NCT01675960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6279863|NCT01675960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279864|NCT01675960|Anticonvulsants|anticonvulsants|mesh-ancestor
6279865|NCT01675960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6279866|NCT01675960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6279867|NCT01675960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6279868|NCT01675960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6279869|NCT01675960|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6279870|NCT01675960|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6279871|NCT01675960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6279872|NCT01675960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6279873|NCT01675960|Antimanic Agents|antimanic agents|mesh-ancestor
6279874|NCT01668147|Ritonavir|ritonavir|mesh-list
6279875|NCT01668147|Efavirenz|efavirenz|mesh-list
6279876|NCT01668147|Loperamide|loperamide|mesh-list
6279877|NCT01668147|Antidiarrheals|antidiarrheals|mesh-list
6279878|NCT01668147|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6279879|NCT01668147|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6279880|NCT01668147|Protease Inhibitors|protease inhibitors|mesh-ancestor
6279881|NCT01668147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6279882|NCT01668147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6279883|NCT01668147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6279884|NCT01668147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6279885|NCT01668147|Antiviral Agents|antiviral agents|mesh-ancestor
6279886|NCT01668147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6279887|NCT01668147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6279888|NCT01668147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6279889|NCT01668147|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6279890|NCT01668147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6279891|NCT01668147|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6279892|NCT01668147|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6279893|NCT01668147|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6279894|NCT01668147|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6279895|NCT01668147|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6279896|NCT01668147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6279897|NCT01676701|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6279898|NCT01676701|Immunologic Factors|immunologic factors|mesh-ancestor
6279899|NCT01676701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279900|NCT01662102|Rituximab|rituximab|mesh-list
6279901|NCT01662102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6279902|NCT01662102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6279903|NCT01662102|Immunologic Factors|immunologic factors|mesh-ancestor
6279904|NCT01662102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279905|NCT01662102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6279906|NCT01659554|Cisplatin|cisplatin|mesh-list
6279907|NCT01659554|Doxorubicin|doxorubicin|mesh-list
6279908|NCT01659554|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6279909|NCT01659554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6279910|NCT01659554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6279911|NCT01659554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6279912|NCT01659554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6279913|NCT01659554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6279914|NCT01659554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6279915|NCT01658813|Interferons|interferons|mesh-list
6279916|NCT01658813|Fluorouracil|fluorouracil|mesh-list
6279917|NCT01658813|Antimetabolites|antimetabolites|mesh-ancestor
6279918|NCT01658813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6279919|NCT01658813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6279920|NCT01658813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6279921|NCT01658813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6279922|NCT01658813|Immunologic Factors|immunologic factors|mesh-ancestor
6279923|NCT01658813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279924|NCT01658813|Antiviral Agents|antiviral agents|mesh-ancestor
6279925|NCT01658813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6279926|NCT01649505|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6279927|NCT01649505|Hemostatics|hemostatics|mesh-ancestor
6279928|NCT01649505|Coagulants|coagulants|mesh-ancestor
6279929|NCT01642732|Everolimus|everolimus|mesh-list
6279930|NCT01642732|Leuprolide|leuprolide|mesh-list
6279931|NCT01642732|Bicalutamide|bicalutamide|mesh-list
6279932|NCT01642732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6279933|NCT01642732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6279934|NCT01642732|Immunologic Factors|immunologic factors|mesh-ancestor
6279935|NCT01642732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279936|NCT01642732|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6279937|NCT01642732|Fertility Agents|fertility agents|mesh-ancestor
6279938|NCT01642732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6279939|NCT01642732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6279940|NCT01642732|Androgen Antagonists|androgen antagonists|mesh-ancestor
6279941|NCT01642732|Hormone Antagonists|hormone antagonists|mesh-ancestor
6391419|NCT00193245|Antimitotic Agents|antimitotic agents|mesh-ancestor
6279942|NCT01642732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6279943|NCT01645709|Verapamil|verapamil|mesh-list
6279944|NCT01645709|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6279945|NCT01645709|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6279946|NCT01645709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6279947|NCT01645709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6279948|NCT01645709|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6279949|NCT01645709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279950|NCT01645709|Vasodilator Agents|vasodilator agents|mesh-ancestor
6279951|NCT01648270|Buprenorphine|buprenorphine|mesh-list
6279952|NCT01648270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6279953|NCT01648270|Narcotics|narcotics|mesh-ancestor
6279954|NCT01648270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6279955|NCT01648270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279956|NCT01648270|Analgesics|analgesics|mesh-ancestor
6279957|NCT01648270|Sensory System Agents|sensory system agents|mesh-ancestor
6279958|NCT01648270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6279959|NCT01648270|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6279960|NCT01633814|Estradiol|estradiol|mesh-list
6279961|NCT01633814|Estrogens|estrogens|mesh-ancestor
6279962|NCT01633814|Hormones|hormones|mesh-ancestor
6279963|NCT01633814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6279964|NCT01633814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279965|NCT01636466|Everolimus|everolimus|mesh-list
6279966|NCT01636466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6279967|NCT01636466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6279968|NCT01636466|Immunologic Factors|immunologic factors|mesh-ancestor
6279969|NCT01636466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279970|NCT01629329|Aspirin|aspirin|mesh-list
6279971|NCT01629329|Acetaminophen|acetaminophen|mesh-list
6279972|NCT01629329|Prochlorperazine|prochlorperazine|mesh-list
6279973|NCT01629329|Caffeine|caffeine|mesh-list
6279974|NCT01629329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6279975|NCT01629329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6279976|NCT01629329|Analgesics|analgesics|mesh-ancestor
6279977|NCT01629329|Sensory System Agents|sensory system agents|mesh-ancestor
6279978|NCT01629329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6279979|NCT01629329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6279980|NCT01629329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6279981|NCT01629329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6279982|NCT01629329|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6279983|NCT01629329|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6279984|NCT01629329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6279985|NCT01629329|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6279986|NCT01629329|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6279987|NCT01629329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6279988|NCT01629329|Antipyretics|antipyretics|mesh-ancestor
6279989|NCT01629329|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6279990|NCT01629329|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6279991|NCT01629329|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6279992|NCT01629329|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6279993|NCT01629329|Purinergic Agents|purinergic agents|mesh-ancestor
6279994|NCT01629329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6279995|NCT01629329|Antiemetics|antiemetics|mesh-ancestor
6279996|NCT01629329|Autonomic Agents|autonomic agents|mesh-ancestor
6279997|NCT01629329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6279998|NCT01629329|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6279999|NCT01629329|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6280000|NCT01629329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6280001|NCT01629329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6280002|NCT01629329|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6280003|NCT01629329|Dopamine Agents|dopamine agents|mesh-ancestor
6280004|NCT01632020|Metformin|metformin|mesh-list
6280005|NCT01632020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6280006|NCT01632020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6391420|NCT00193245|Mitosis Modulators|mitosis modulators|mesh-ancestor
6391421|NCT00193245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391422|NCT00193245|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6391423|NCT00193245|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6391424|NCT00193245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6391425|NCT00193271|Docetaxel|docetaxel|mesh-list
6391426|NCT00193271|Estramustine|estramustine|mesh-list
6391427|NCT00193271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391428|NCT00193271|Tubulin Modulators|tubulin modulators|mesh-ancestor
6391429|NCT00193271|Antimitotic Agents|antimitotic agents|mesh-ancestor
6391430|NCT00193271|Mitosis Modulators|mitosis modulators|mesh-ancestor
6391431|NCT00193271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391432|NCT00193271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6391433|NCT00193271|Alkylating Agents|alkylating agents|mesh-ancestor
6391434|NCT00193271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6391435|NCT00193284|Carboplatin|carboplatin|mesh-list
6391436|NCT00193284|Docetaxel|docetaxel|mesh-list
6391437|NCT00193284|Fluorouracil|fluorouracil|mesh-list
6391438|NCT00193284|Gefitinib|gefitinib|mesh-list
6391439|NCT00193284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391440|NCT00193284|Tubulin Modulators|tubulin modulators|mesh-ancestor
6391441|NCT00193284|Antimitotic Agents|antimitotic agents|mesh-ancestor
6391442|NCT00193284|Mitosis Modulators|mitosis modulators|mesh-ancestor
6391443|NCT00193284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391444|NCT00193284|Antimetabolites|antimetabolites|mesh-ancestor
6391445|NCT00193284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6391446|NCT00193284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6391447|NCT00193284|Immunologic Factors|immunologic factors|mesh-ancestor
6391448|NCT00193284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6391449|NCT00193284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6391450|NCT00193284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6391451|NCT00193297|Paclitaxel|paclitaxel|mesh-list
6391452|NCT00193297|Carboplatin|carboplatin|mesh-list
6391453|NCT00193297|Topotecan|topotecan|mesh-list
6391454|NCT00193297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6391455|NCT00193297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391456|NCT00193297|Tubulin Modulators|tubulin modulators|mesh-ancestor
6391457|NCT00193297|Antimitotic Agents|antimitotic agents|mesh-ancestor
6391458|NCT00193297|Mitosis Modulators|mitosis modulators|mesh-ancestor
6391459|NCT00193297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391460|NCT00193297|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6391461|NCT00193297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6391462|NCT00193297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6391463|NCT00193310|Paclitaxel|paclitaxel|mesh-list
6391464|NCT00193310|Carboplatin|carboplatin|mesh-list
6391465|NCT00193310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6391466|NCT00193310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391467|NCT00193310|Tubulin Modulators|tubulin modulators|mesh-ancestor
6391468|NCT00193310|Antimitotic Agents|antimitotic agents|mesh-ancestor
6391469|NCT00193310|Mitosis Modulators|mitosis modulators|mesh-ancestor
6391470|NCT00193310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391471|NCT00193323|Gemcitabine|gemcitabine|mesh-list
6280007|NCT01608906|Heparin|heparin|mesh-list
6280008|NCT01608906|Calcium heparin|calcium heparin|mesh-list
6280009|NCT01608906|Anticoagulants|anticoagulants|mesh-ancestor
6280010|NCT01608906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6280011|NCT01608906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6280012|NCT01608906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280013|NCT01621737|Oxytocin|oxytocin|mesh-list
6280014|NCT01621737|Oxytocics|oxytocics|mesh-ancestor
6280015|NCT01621737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6280016|NCT01621737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280017|NCT01614067|Ganirelix|ganirelix|mesh-list
6280018|NCT01614067|Hormone Antagonists|hormone antagonists|mesh-ancestor
6280019|NCT01614067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6280020|NCT01614067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280021|NCT01607320|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
6280022|NCT01607320|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6280023|NCT01607320|Clomiphene|clomiphene|mesh-list
6280024|NCT01607320|Medroxyprogesterone|medroxyprogesterone|mesh-list
6280025|NCT01607320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6280026|NCT01607320|Hormone Antagonists|hormone antagonists|mesh-ancestor
6280027|NCT01607320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6280028|NCT01607320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280029|NCT01607320|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6280030|NCT01607320|Fertility Agents|fertility agents|mesh-ancestor
6280031|NCT01607320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6280032|NCT01607320|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6280033|NCT01607320|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6280034|NCT01607320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6280035|NCT01607320|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6280036|NCT01607320|Contraceptive Agents|contraceptive agents|mesh-ancestor
6280037|NCT01607320|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6280038|NCT01607320|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6280039|NCT01607320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6280040|NCT01607320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6280041|NCT01607320|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6280042|NCT01607320|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6280043|NCT01607320|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6280044|NCT01609231|Irinotecan|irinotecan|mesh-list
6280045|NCT01609231|Cetuximab|cetuximab|mesh-list
6280046|NCT01609231|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6280047|NCT01609231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6280048|NCT01609231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6280049|NCT01609231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280050|NCT01609231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6280051|NCT01609231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6280052|NCT01602198|Rivastigmine|rivastigmine|mesh-list
6280053|NCT01602198|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6280054|NCT01602198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6280055|NCT01602198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280056|NCT01602198|Cholinergic Agents|cholinergic agents|mesh-ancestor
6280057|NCT01602198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6280058|NCT01602198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280059|NCT01602198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6280060|NCT01602198|Protective Agents|protective agents|mesh-ancestor
6280061|NCT01606150|Lidocaine|lidocaine|mesh-list
6280062|NCT01606150|Anesthetics, Local|anesthetics, local|mesh-ancestor
6280063|NCT01606150|Anesthetics|anesthetics|mesh-ancestor
6280064|NCT01606150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6280065|NCT01606150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280066|NCT01606150|Sensory System Agents|sensory system agents|mesh-ancestor
6280067|NCT01606150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6280068|NCT01606150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6280069|NCT01606150|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6280070|NCT01606150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6280071|NCT01606150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6280072|NCT01606150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280073|NCT01605370|Metoprolol|metoprolol|mesh-list
6280074|NCT01605370|Nebivolol|nebivolol|mesh-list
6280075|NCT01605370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6280076|NCT01605370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6280077|NCT01605370|Sympatholytics|sympatholytics|mesh-ancestor
6280078|NCT01605370|Autonomic Agents|autonomic agents|mesh-ancestor
6280079|NCT01605370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6280080|NCT01605370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280081|NCT01605370|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6280082|NCT01605370|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6280083|NCT01605370|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6280084|NCT01605370|Adrenergic Agents|adrenergic agents|mesh-ancestor
6280085|NCT01605370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6280086|NCT01605370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280087|NCT01605370|Vasodilator Agents|vasodilator agents|mesh-ancestor
6280088|NCT01605370|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6280089|NCT01605370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6280090|NCT01605370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6280091|NCT01605617|Fesoterodine|fesoterodine|mesh-list
6280092|NCT01605617|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6280093|NCT01605617|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6280094|NCT01605617|Cholinergic Agents|cholinergic agents|mesh-ancestor
6280095|NCT01605617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6280096|NCT01605617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280097|NCT01605617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280098|NCT01605617|Urological Agents|urological agents|mesh-ancestor
6280099|NCT01606709|Leuprolide|leuprolide|mesh-list
6280100|NCT01606709|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6280101|NCT01606709|Fertility Agents|fertility agents|mesh-ancestor
6280102|NCT01606709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6280103|NCT01606709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280104|NCT01606709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6280105|NCT01606709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6280106|NCT01603121|Lisofylline|lisofylline|mesh-list
6280107|NCT01603121|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6280108|NCT01603121|Immunologic Factors|immunologic factors|mesh-ancestor
6280109|NCT01603121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280110|NCT01603121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6280111|NCT01603121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6280112|NCT01603121|Analgesics|analgesics|mesh-ancestor
6280113|NCT01603121|Sensory System Agents|sensory system agents|mesh-ancestor
6280114|NCT01603121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6280115|NCT01603121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6280116|NCT01603121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6280117|NCT01603121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6280118|NCT01602016|Leucovorin|leucovorin|mesh-list
6280119|NCT01602016|Folic Acid|folic acid|mesh-list
6280120|NCT01602016|Levoleucovorin|levoleucovorin|mesh-list
6280121|NCT01602016|Antidotes|antidotes|mesh-ancestor
6280122|NCT01602016|Protective Agents|protective agents|mesh-ancestor
6280123|NCT01602016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280124|NCT01602016|Vitamin B Complex|vitamin b complex|mesh-ancestor
6280125|NCT01602016|Vitamins|vitamins|mesh-ancestor
6280126|NCT01602016|Micronutrients|micronutrients|mesh-ancestor
6280127|NCT01602016|Hematinics|hematinics|mesh-ancestor
6280128|NCT01603394|Pregabalin|pregabalin|mesh-list
6280129|NCT01603394|Analgesics|analgesics|mesh-ancestor
6280130|NCT01603394|Sensory System Agents|sensory system agents|mesh-ancestor
6280131|NCT01603394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6280132|NCT01603394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280133|NCT01603394|Anticonvulsants|anticonvulsants|mesh-ancestor
6280134|NCT01603394|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6280135|NCT01603394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6280136|NCT01603394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280137|NCT01603394|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6280138|NCT01603394|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6280139|NCT01603394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6280140|NCT01603394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6280141|NCT01603394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6280142|NCT01592383|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6280143|NCT01592383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6280144|NCT01592383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6280145|NCT01592383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6280146|NCT01592383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280147|NCT01598025|Fludarabine|fludarabine|mesh-list
6280148|NCT01598025|Fludarabine phosphate|fludarabine phosphate|mesh-list
6280149|NCT01598025|Melphalan|melphalan|mesh-list
6280150|NCT01598025|Thiotepa|thiotepa|mesh-list
6280151|NCT01598025|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6280152|NCT01598025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6280153|NCT01598025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6280154|NCT01598025|Antimetabolites|antimetabolites|mesh-ancestor
6391472|NCT00193323|Docetaxel|docetaxel|mesh-list
6280155|NCT01598025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280156|NCT01598025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6280157|NCT01598025|Immunologic Factors|immunologic factors|mesh-ancestor
6280158|NCT01598025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280159|NCT01598025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6280160|NCT01598025|Alkylating Agents|alkylating agents|mesh-ancestor
6280161|NCT01598025|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6280162|NCT01587963|Ascorbic Acid|ascorbic acid|mesh-list
6280163|NCT01587963|Antioxidants|antioxidants|mesh-ancestor
6280164|NCT01587963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280165|NCT01587963|Protective Agents|protective agents|mesh-ancestor
6280166|NCT01587963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280167|NCT01587963|Vitamins|vitamins|mesh-ancestor
6280168|NCT01587963|Micronutrients|micronutrients|mesh-ancestor
6280169|NCT01591096|Plasminogen|plasminogen|mesh-list
6280170|NCT01591096|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6280171|NCT01591096|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6280172|NCT01591096|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6280173|NCT01591096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280174|NCT01576575|Rifampin|rifampin|mesh-list
6280175|NCT01576575|Ketoconazole|ketoconazole|mesh-list
6280176|NCT01576575|Buprenorphine|buprenorphine|mesh-list
6280177|NCT01576575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6280178|NCT01576575|Narcotics|narcotics|mesh-ancestor
6280179|NCT01576575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6280180|NCT01576575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280181|NCT01576575|Analgesics|analgesics|mesh-ancestor
6280182|NCT01576575|Sensory System Agents|sensory system agents|mesh-ancestor
6280183|NCT01576575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6280184|NCT01576575|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6280185|NCT01576575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6280186|NCT01576575|Antitubercular Agents|antitubercular agents|mesh-ancestor
6280187|NCT01576575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6280188|NCT01576575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6280189|NCT01576575|Leprostatic Agents|leprostatic agents|mesh-ancestor
6280190|NCT01576575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6280191|NCT01576575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6280192|NCT01576575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280193|NCT01576575|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6280194|NCT01576575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6280195|NCT01576575|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6280196|NCT01576575|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6280197|NCT01576575|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6280198|NCT01576575|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6280199|NCT01576575|Antifungal Agents|antifungal agents|mesh-ancestor
6280200|NCT01576575|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6280201|NCT01576575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6280202|NCT01576575|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6280203|NCT01576575|Hormone Antagonists|hormone antagonists|mesh-ancestor
6280204|NCT01576575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6280205|NCT01576575|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6280206|NCT01583647|Niacin|niacin|mesh-list
6280207|NCT01583647|Niacinamide|niacinamide|mesh-list
6280208|NCT01583647|Nicotinic Acids|nicotinic acids|mesh-list
6280209|NCT01583647|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6280210|NCT01583647|Antimetabolites|antimetabolites|mesh-ancestor
6280211|NCT01583647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280212|NCT01583647|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6280213|NCT01583647|Vasodilator Agents|vasodilator agents|mesh-ancestor
6280214|NCT01583647|Vitamin B Complex|vitamin b complex|mesh-ancestor
6280215|NCT01583647|Vitamins|vitamins|mesh-ancestor
6280216|NCT01583647|Micronutrients|micronutrients|mesh-ancestor
6280217|NCT01583647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280218|NCT01575028|Bupivacaine|bupivacaine|mesh-list
6280219|NCT01575028|Ropivacaine|ropivacaine|mesh-list
6280220|NCT01575028|Anesthetics, Local|anesthetics, local|mesh-ancestor
6280221|NCT01575028|Anesthetics|anesthetics|mesh-ancestor
6280222|NCT01575028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6280223|NCT01575028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280224|NCT01575028|Sensory System Agents|sensory system agents|mesh-ancestor
6280225|NCT01575028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6280226|NCT01578785|Glatiramer Acetate|glatiramer acetate|mesh-list
6280227|NCT01578785|(T,G)-A-L|(t,g)-a-l|mesh-list
6280228|NCT01578785|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6280229|NCT01578785|Immunologic Factors|immunologic factors|mesh-ancestor
6280230|NCT01578785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280231|NCT01578785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6280232|NCT01578785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6280233|NCT01570634|Antidiarrheals|antidiarrheals|mesh-list
6280234|NCT01570634|Loperamide|loperamide|mesh-list
6280235|NCT01570634|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
6280236|NCT01570634|Calcium|calcium|mesh-list
6280237|NCT01570634|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6280238|NCT01570634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280239|NCT01570634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6280240|NCT01566370|Zonisamide|zonisamide|mesh-list
6280241|NCT01566370|Anticonvulsants|anticonvulsants|mesh-ancestor
6280242|NCT01566370|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6280243|NCT01566370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6280244|NCT01566370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280245|NCT01566370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6280246|NCT01566370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280247|NCT01561989|Vitamin D|vitamin d|mesh-list
6280248|NCT01561989|Cholecalciferol|cholecalciferol|mesh-list
6280249|NCT01561989|Vaccines|vaccines|mesh-list
6280250|NCT01561989|Immunologic Factors|immunologic factors|mesh-ancestor
6280251|NCT01561989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280252|NCT01561989|Vitamins|vitamins|mesh-ancestor
6280253|NCT01561989|Micronutrients|micronutrients|mesh-ancestor
6280254|NCT01561989|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6280255|NCT01561989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6280256|NCT01560507|Bupropion|bupropion|mesh-list
6280257|NCT01560507|Nicotine|nicotine|mesh-list
6280258|NCT01560507|Varenicline|varenicline|mesh-list
6280259|NCT01560507|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6280260|NCT01560507|Autonomic Agents|autonomic agents|mesh-ancestor
6280261|NCT01560507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6280262|NCT01560507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280263|NCT01560507|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6280264|NCT01560507|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6280265|NCT01560507|Cholinergic Agents|cholinergic agents|mesh-ancestor
6280266|NCT01560507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6280267|NCT01560507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280268|NCT01560507|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6280269|NCT01560507|Antidepressive Agents|antidepressive agents|mesh-ancestor
6280270|NCT01560507|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6280271|NCT01560507|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6280272|NCT01560507|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6280273|NCT01560507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6280274|NCT01560507|Dopamine Agents|dopamine agents|mesh-ancestor
6280275|NCT01560507|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6280276|NCT01560507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6280277|NCT01560507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6280278|NCT01555489|Ascorbic Acid|ascorbic acid|mesh-list
6280279|NCT01555489|Vitamins|vitamins|mesh-ancestor
6280280|NCT01555489|Micronutrients|micronutrients|mesh-ancestor
6280281|NCT01555489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280282|NCT01555489|Antioxidants|antioxidants|mesh-ancestor
6280283|NCT01555489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280284|NCT01555489|Protective Agents|protective agents|mesh-ancestor
6280285|NCT01549977|Febuxostat|febuxostat|mesh-list
6280286|NCT01549977|Gout Suppressants|gout suppressants|mesh-ancestor
6280287|NCT01549977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6280288|NCT01558492|Paclitaxel|paclitaxel|mesh-list
6280289|NCT01558492|Carboplatin|carboplatin|mesh-list
6280290|NCT01558492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6280291|NCT01558492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6280292|NCT01558492|Tubulin Modulators|tubulin modulators|mesh-ancestor
6280293|NCT01558492|Antimitotic Agents|antimitotic agents|mesh-ancestor
6280294|NCT01558492|Mitosis Modulators|mitosis modulators|mesh-ancestor
6280295|NCT01558492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280296|NCT01555073|Celecoxib|celecoxib|mesh-list
6280297|NCT01555073|Pregabalin|pregabalin|mesh-list
6280298|NCT01555073|Analgesics|analgesics|mesh-ancestor
6280299|NCT01555073|Sensory System Agents|sensory system agents|mesh-ancestor
6280300|NCT01555073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6280301|NCT01555073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280302|NCT01555073|Anticonvulsants|anticonvulsants|mesh-ancestor
6280303|NCT01555073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6280304|NCT01555073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6280305|NCT01555073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280306|NCT01555073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6280307|NCT01555073|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6280308|NCT01555073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6280309|NCT01555073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6280310|NCT01555073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6280311|NCT01555073|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6280312|NCT01555073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6280313|NCT01555073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6280314|NCT01555073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6280315|NCT01555073|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6280316|NCT01555073|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6280317|NCT01555073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6280318|NCT01556009|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6280319|NCT01556009|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6280320|NCT01556009|Dermatologic Agents|dermatologic agents|mesh-ancestor
6280321|NCT01550510|Ascorbic Acid|ascorbic acid|mesh-list
6280322|NCT01550510|Irinotecan|irinotecan|mesh-list
6280323|NCT01550510|Camptothecin|camptothecin|mesh-list
6280324|NCT01550510|Vitamins|vitamins|mesh-ancestor
6280325|NCT01550510|Micronutrients|micronutrients|mesh-ancestor
6280326|NCT01550510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280327|NCT01550510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6280328|NCT01550510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6280329|NCT01550510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6280330|NCT01550510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280331|NCT01550510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6280332|NCT01550510|Antioxidants|antioxidants|mesh-ancestor
6280333|NCT01550510|Protective Agents|protective agents|mesh-ancestor
6280334|NCT01550510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6280335|NCT01547728|Antithrombins|antithrombins|mesh-list
6280336|NCT01547728|Antithrombin III|antithrombin iii|mesh-list
6280337|NCT01547728|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6280338|NCT01547728|Protease Inhibitors|protease inhibitors|mesh-ancestor
6280339|NCT01547728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6280340|NCT01547728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280341|NCT01547728|Anticoagulants|anticoagulants|mesh-ancestor
6280342|NCT01548651|Saxagliptin|saxagliptin|mesh-list
6280343|NCT01548651|Incretins|incretins|mesh-ancestor
6280344|NCT01548651|Hormones|hormones|mesh-ancestor
6280345|NCT01548651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6280346|NCT01548651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280347|NCT01548651|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6280348|NCT01548651|Protease Inhibitors|protease inhibitors|mesh-ancestor
6280349|NCT01548651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6280350|NCT01548651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280351|NCT01548651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6280352|NCT01545648|Denosumab|denosumab|mesh-list
6280353|NCT01545648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6280354|NCT01545648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280355|NCT01546883|Dabigatran|dabigatran|mesh-list
6280356|NCT01546883|Antithrombins|antithrombins|mesh-ancestor
6280357|NCT01546883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6280358|NCT01546883|Protease Inhibitors|protease inhibitors|mesh-ancestor
6280359|NCT01546883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6280360|NCT01546883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280361|NCT01546883|Anticoagulants|anticoagulants|mesh-ancestor
6280362|NCT01545518|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6280363|NCT01545518|Immunologic Factors|immunologic factors|mesh-ancestor
6280364|NCT01545518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280365|NCT01536015|Rotigotine|rotigotine|mesh-list
6280366|NCT01536015|Dopamine Agonists|dopamine agonists|mesh-ancestor
6280367|NCT01536015|Dopamine Agents|dopamine agents|mesh-ancestor
6280368|NCT01536015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6280369|NCT01536015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280370|NCT01536015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280371|NCT01539811|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6280372|NCT01539811|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6280373|NCT01539811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6280374|NCT01539811|Antitubercular Agents|antitubercular agents|mesh-ancestor
6280375|NCT01533753|Gabapentin|gabapentin|mesh-list
6280376|NCT01533753|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6280377|NCT01533753|Analgesics|analgesics|mesh-ancestor
6280378|NCT01533753|Sensory System Agents|sensory system agents|mesh-ancestor
6280379|NCT01533753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6280380|NCT01533753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280381|NCT01533753|Anticonvulsants|anticonvulsants|mesh-ancestor
6280382|NCT01533753|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6280383|NCT01533753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6280384|NCT01533753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6280385|NCT01533753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6280386|NCT01533753|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6280387|NCT01533753|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6280388|NCT01533753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6280389|NCT01533753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280390|NCT01533753|Antimanic Agents|antimanic agents|mesh-ancestor
6280391|NCT01533753|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6280392|NCT01533753|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6280393|NCT01533753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6280394|NCT01533753|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6280395|NCT01533753|Antidepressive Agents|antidepressive agents|mesh-ancestor
6280396|NCT01534143|Sirolimus|sirolimus|mesh-list
6280397|NCT01534143|Fludarabine|fludarabine|mesh-list
6280398|NCT01534143|Fludarabine phosphate|fludarabine phosphate|mesh-list
6280399|NCT01534143|Bortezomib|bortezomib|mesh-list
6280400|NCT01534143|Busulfan|busulfan|mesh-list
6280401|NCT01534143|Tacrolimus|tacrolimus|mesh-list
6280402|NCT01534143|Thymoglobulin|thymoglobulin|mesh-list
6280403|NCT01534143|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6280404|NCT01534143|Immunoglobulins|immunoglobulins|mesh-list
6280405|NCT01534143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6280406|NCT01534143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6280407|NCT01534143|Antimetabolites|antimetabolites|mesh-ancestor
6280408|NCT01534143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280409|NCT01534143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6280410|NCT01534143|Immunologic Factors|immunologic factors|mesh-ancestor
6280411|NCT01534143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280412|NCT01534143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6280413|NCT01534143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6280414|NCT01534143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6280415|NCT01534143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6280416|NCT01534143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6280417|NCT01534143|Antifungal Agents|antifungal agents|mesh-ancestor
6280418|NCT01534143|Alkylating Agents|alkylating agents|mesh-ancestor
6280419|NCT01534143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6280420|NCT01534143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6280421|NCT01530880|Acetaminophen|acetaminophen|mesh-list
6280422|NCT01530880|Ibuprofen|ibuprofen|mesh-list
6280423|NCT01530880|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6280424|NCT01530880|Analgesics|analgesics|mesh-ancestor
6280425|NCT01530880|Sensory System Agents|sensory system agents|mesh-ancestor
6280426|NCT01530880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6280427|NCT01530880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280428|NCT01530880|Antipyretics|antipyretics|mesh-ancestor
6280429|NCT01530880|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6280430|NCT01530880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6280431|NCT01530880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6280432|NCT01530880|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6280433|NCT01530880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6280434|NCT01530880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280435|NCT01527942|Acetaminophen|acetaminophen|mesh-list
6280436|NCT01527942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6280437|NCT01527942|Analgesics|analgesics|mesh-ancestor
6280438|NCT01527942|Sensory System Agents|sensory system agents|mesh-ancestor
6280439|NCT01527942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6280440|NCT01527942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280441|NCT01527942|Antipyretics|antipyretics|mesh-ancestor
6280442|NCT01532635|Mycophenolic Acid|mycophenolic acid|mesh-list
6280443|NCT01532635|Cyclophosphamide|cyclophosphamide|mesh-list
6280444|NCT01532635|Tacrolimus|tacrolimus|mesh-list
6280445|NCT01532635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6280446|NCT01532635|Immunologic Factors|immunologic factors|mesh-ancestor
6280447|NCT01532635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280448|NCT01532635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6280449|NCT01532635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6280450|NCT01532635|Alkylating Agents|alkylating agents|mesh-ancestor
6280451|NCT01532635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280452|NCT01532635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6280453|NCT01532635|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6280454|NCT01532635|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6280455|NCT01532635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6280456|NCT01532635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6280457|NCT01532635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6280458|NCT01532635|Antitubercular Agents|antitubercular agents|mesh-ancestor
6280459|NCT01532635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6280460|NCT01532635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6280461|NCT01531387|Hydroxyurea|hydroxyurea|mesh-list
6280462|NCT01531387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6280463|NCT01531387|Antisickling Agents|antisickling agents|mesh-ancestor
6280464|NCT01531387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6280465|NCT01531387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280466|NCT01531387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6280467|NCT01526408|Famciclovir|famciclovir|mesh-list
6280468|NCT01526408|Antiviral Agents|antiviral agents|mesh-ancestor
6280469|NCT01526408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6280470|NCT01526408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6280471|NCT01526408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6280472|NCT01526408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280473|NCT01525927|Cisplatin|cisplatin|mesh-list
6280474|NCT01525927|Carboplatin|carboplatin|mesh-list
6280475|NCT01525927|Etoposide|etoposide|mesh-list
6280476|NCT01525927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6280477|NCT01525927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6280478|NCT01525927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6280479|NCT01525927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6280480|NCT01525927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6280481|NCT01525927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280482|NCT01507233|Morphine|morphine|mesh-list
6280483|NCT01507233|Bupivacaine|bupivacaine|mesh-list
6280484|NCT01507233|Anesthetics, Local|anesthetics, local|mesh-ancestor
6280485|NCT01507233|Anesthetics|anesthetics|mesh-ancestor
6280486|NCT01507233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6280487|NCT01507233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280488|NCT01507233|Sensory System Agents|sensory system agents|mesh-ancestor
6280489|NCT01507233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6280490|NCT01507233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6280491|NCT01507233|Narcotics|narcotics|mesh-ancestor
6280492|NCT01507233|Analgesics|analgesics|mesh-ancestor
6280493|NCT01500772|Ribavirin|ribavirin|mesh-list
6280494|NCT01500772|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6280495|NCT01500772|Antimetabolites|antimetabolites|mesh-ancestor
6280496|NCT01500772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280497|NCT01500772|Antiviral Agents|antiviral agents|mesh-ancestor
6280498|NCT01500772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6280499|NCT01517763|Immunoconjugates|immunoconjugates|mesh-list
6280500|NCT01517763|Immunologic Factors|immunologic factors|mesh-ancestor
6015237|NCT00356122|Tubulin Modulators|tubulin modulators|mesh-ancestor
6280501|NCT01517763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280502|NCT01507584|Bimatoprost|bimatoprost|mesh-list
6280503|NCT01507584|Brinzolamide|brinzolamide|mesh-list
6280504|NCT01507584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6280505|NCT01507584|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6280506|NCT01507584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6280507|NCT01507584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280508|NCT01510756|Sorafenib|sorafenib|mesh-list
6015238|NCT00356122|Antimitotic Agents|antimitotic agents|mesh-ancestor
6015239|NCT00356122|Mitosis Modulators|mitosis modulators|mesh-ancestor
6015240|NCT00356122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015241|NCT00356135|Clopidogrel|clopidogrel|mesh-list
6015242|NCT00356135|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6015243|NCT00356135|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6280509|NCT01510756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6280510|NCT01510756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6280511|NCT01510756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6015244|NCT00356135|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6015245|NCT00356135|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6015246|NCT00356135|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6280512|NCT01510756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280513|NCT01500109|Acetaminophen|acetaminophen|mesh-list
6280514|NCT01500109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6280515|NCT01500109|Analgesics|analgesics|mesh-ancestor
6280516|NCT01500109|Sensory System Agents|sensory system agents|mesh-ancestor
6280517|NCT01500109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6280518|NCT01500109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280519|NCT01500109|Antipyretics|antipyretics|mesh-ancestor
6280520|NCT01509053|Aripiprazole|aripiprazole|mesh-list
6280521|NCT01509053|Antidepressive Agents|antidepressive agents|mesh-ancestor
6280522|NCT01509053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6280523|NCT01509053|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6280524|NCT01509053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6280525|NCT01509053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6280526|NCT01509053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280527|NCT01509053|Dopamine Agonists|dopamine agonists|mesh-ancestor
6280528|NCT01509053|Dopamine Agents|dopamine agents|mesh-ancestor
6280529|NCT01509053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6280530|NCT01509053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280531|NCT01509053|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6280532|NCT01509053|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6280533|NCT01509053|Serotonin Agents|serotonin agents|mesh-ancestor
6280534|NCT01509053|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6280535|NCT01509053|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6280536|NCT01509053|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6280537|NCT01509053|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6280538|NCT01495988|Bevacizumab|bevacizumab|mesh-list
6280539|NCT01495988|Vemurafenib|vemurafenib|mesh-list
6280540|NCT01495988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6280541|NCT01495988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6280542|NCT01495988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6280543|NCT01495988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6280544|NCT01495988|Growth Substances|growth substances|mesh-ancestor
6280545|NCT01495988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280546|NCT01495988|Growth Inhibitors|growth inhibitors|mesh-ancestor
6280547|NCT01495988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6280548|NCT01495988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6280549|NCT01495988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280550|NCT01483872|Tigecycline|tigecycline|mesh-list
6280551|NCT01483872|Heparin|heparin|mesh-list
6280552|NCT01483872|Calcium heparin|calcium heparin|mesh-list
6280553|NCT01483872|Anticoagulants|anticoagulants|mesh-list
6280554|NCT01483872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280555|NCT01483872|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6280556|NCT01483872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6280557|NCT01483872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6280558|NCT01483872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6280559|NCT01483872|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6280560|NCT01483872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6280561|NCT01487499|Cisplatin|cisplatin|mesh-list
6280562|NCT01487499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6280563|NCT01478113|Amphetamine|amphetamine|mesh-list
6280564|NCT01478113|Adderall|adderall|mesh-list
6280565|NCT01478113|Dextroamphetamine|dextroamphetamine|mesh-list
6280566|NCT01478113|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6280567|NCT01478113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280568|NCT01478113|Sympathomimetics|sympathomimetics|mesh-ancestor
6280569|NCT01478113|Autonomic Agents|autonomic agents|mesh-ancestor
6280570|NCT01478113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6280571|NCT01478113|Dopamine Agents|dopamine agents|mesh-ancestor
6280572|NCT01478113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6280573|NCT01478113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280574|NCT01478113|Adrenergic Agents|adrenergic agents|mesh-ancestor
6280575|NCT01478113|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6280576|NCT01478113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6280577|NCT01478113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6280578|NCT01478113|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6280579|NCT01483209|Botulinum Toxins|botulinum toxins|mesh-list
6280580|NCT01483209|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6280581|NCT01483209|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6280582|NCT01483209|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6280583|NCT01483209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6280584|NCT01483209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280585|NCT01483209|Cholinergic Agents|cholinergic agents|mesh-ancestor
6280586|NCT01483209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6280587|NCT01483209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280588|NCT01483209|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6280589|NCT01483209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6280590|NCT01479010|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6280591|NCT01479010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6280592|NCT01473732|Mycophenolic Acid|mycophenolic acid|mesh-list
6280593|NCT01473732|Everolimus|everolimus|mesh-list
6280594|NCT01473732|Tacrolimus|tacrolimus|mesh-list
6280595|NCT01473732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6280596|NCT01473732|Immunologic Factors|immunologic factors|mesh-ancestor
6280597|NCT01473732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280598|NCT01473732|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6280599|NCT01473732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6280600|NCT01473732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280601|NCT01473732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6280602|NCT01473732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6280603|NCT01473732|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6280604|NCT01473732|Antitubercular Agents|antitubercular agents|mesh-ancestor
6280605|NCT01473732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6280606|NCT01473732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6280607|NCT01472692|Febuxostat|febuxostat|mesh-list
6280608|NCT01472692|Gout Suppressants|gout suppressants|mesh-ancestor
6280609|NCT01472692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6280610|NCT01465230|Lenalidomide|lenalidomide|mesh-list
6280611|NCT01465230|Immunologic Factors|immunologic factors|mesh-ancestor
6280612|NCT01465230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280613|NCT01465230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6280614|NCT01465230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6280615|NCT01465230|Growth Substances|growth substances|mesh-ancestor
6280616|NCT01465230|Growth Inhibitors|growth inhibitors|mesh-ancestor
6280617|NCT01465230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6280618|NCT01464723|Ranibizumab|ranibizumab|mesh-list
6280619|NCT01464723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6280620|NCT01464723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6280621|NCT01464723|Growth Substances|growth substances|mesh-ancestor
6280622|NCT01464723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280623|NCT01464723|Growth Inhibitors|growth inhibitors|mesh-ancestor
6280624|NCT01464723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6280625|NCT01446250|Ribavirin|ribavirin|mesh-list
6280626|NCT01446250|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6280627|NCT01446250|Antimetabolites|antimetabolites|mesh-ancestor
6280628|NCT01446250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280629|NCT01446250|Antiviral Agents|antiviral agents|mesh-ancestor
6280630|NCT01446250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6391473|NCT00193323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6391474|NCT00193323|Antimetabolites|antimetabolites|mesh-ancestor
6391475|NCT00193323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391476|NCT00193323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391477|NCT00193323|Antiviral Agents|antiviral agents|mesh-ancestor
6391478|NCT00193323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6391479|NCT00193323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6391480|NCT00193323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6391481|NCT00193323|Immunologic Factors|immunologic factors|mesh-ancestor
6391482|NCT00193323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6391483|NCT00193323|Tubulin Modulators|tubulin modulators|mesh-ancestor
6391484|NCT00193323|Antimitotic Agents|antimitotic agents|mesh-ancestor
6280631|NCT01457053|Torsemide|torsemide|mesh-list
6280632|NCT01457053|Furosemide|furosemide|mesh-list
6280633|NCT01457053|Bumetanide|bumetanide|mesh-list
6280634|NCT01457053|Diuretics|diuretics|mesh-list
6280635|NCT01457053|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
6280636|NCT01457053|Natriuretic Agents|natriuretic agents|mesh-ancestor
6280637|NCT01457053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280638|NCT01457053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6280639|NCT01457053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280640|NCT01457053|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6280641|NCT01451723|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
6280642|NCT01451723|Antioxidants|antioxidants|mesh-ancestor
6280643|NCT01451723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280644|NCT01451723|Protective Agents|protective agents|mesh-ancestor
6280645|NCT01451723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280646|NCT01451723|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
6280647|NCT01451723|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6280648|NCT01451723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6280649|NCT01451723|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6280650|NCT01440595|Ribavirin|ribavirin|mesh-list
6280651|NCT01440595|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6280652|NCT01440595|Grazoprevir|grazoprevir|mesh-list
6280653|NCT01440595|Antimetabolites|antimetabolites|mesh-ancestor
6280654|NCT01440595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280655|NCT01440595|Antiviral Agents|antiviral agents|mesh-ancestor
6280656|NCT01440595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6280657|NCT01443923|Interferons|interferons|mesh-list
6280658|NCT01443923|Ribavirin|ribavirin|mesh-list
6280659|NCT01443923|Interferon-alpha|interferon-alpha|mesh-list
6280660|NCT01443923|Interferon alpha-2|interferon alpha-2|mesh-list
6280661|NCT01443923|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6280662|NCT01443923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6280663|NCT01443923|Antiviral Agents|antiviral agents|mesh-ancestor
6280664|NCT01443923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6280665|NCT01443923|Antimetabolites|antimetabolites|mesh-ancestor
6280666|NCT01443923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280667|NCT01443923|Immunologic Factors|immunologic factors|mesh-ancestor
6280668|NCT01443923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280669|NCT01439347|Vincristine|vincristine|mesh-list
6280670|NCT01439347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6280671|NCT01439347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6280672|NCT01439347|Tubulin Modulators|tubulin modulators|mesh-ancestor
6280673|NCT01439347|Antimitotic Agents|antimitotic agents|mesh-ancestor
6280674|NCT01439347|Mitosis Modulators|mitosis modulators|mesh-ancestor
6280675|NCT01439347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280676|NCT01426555|Zoledronic Acid|zoledronic acid|mesh-list
6280677|NCT01426555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6280678|NCT01426555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280679|NCT01434745|Simvastatin|simvastatin|mesh-list
6280680|NCT01434745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6280681|NCT01434745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6280682|NCT01434745|Antimetabolites|antimetabolites|mesh-ancestor
6280683|NCT01434745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280684|NCT01434745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6280685|NCT01434745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6280686|NCT01434745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6280687|NCT01415986|Temoporfin|temoporfin|mesh-list
6280688|NCT01415986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6280689|NCT01415986|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6280690|NCT01415986|Dermatologic Agents|dermatologic agents|mesh-ancestor
6280691|NCT01410799|Hormones|hormones|mesh-list
6280692|NCT01410799|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
6280693|NCT01410799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6280694|NCT01410799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280695|NCT01426113|Timolol|timolol|mesh-list
6280696|NCT01426113|Bimatoprost|bimatoprost|mesh-list
6280697|NCT01426113|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6280698|NCT01426113|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6280699|NCT01426113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6280700|NCT01426113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6280701|NCT01426113|Adrenergic Agents|adrenergic agents|mesh-ancestor
6280702|NCT01426113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6280703|NCT01426113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280704|NCT01426113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280705|NCT01426113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6280706|NCT01426113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6280707|NCT01420965|Cyclophosphamide|cyclophosphamide|mesh-list
6280708|NCT01420965|Antibodies|antibodies|mesh-list
6280709|NCT01420965|Immunoglobulins|immunoglobulins|mesh-list
6280710|NCT01420965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6280711|NCT01420965|Immunologic Factors|immunologic factors|mesh-ancestor
6280712|NCT01420965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280713|NCT01420965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6280714|NCT01420965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6280715|NCT01420965|Alkylating Agents|alkylating agents|mesh-ancestor
6280716|NCT01420965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280717|NCT01420965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6280718|NCT01420965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6280719|NCT01406860|Diphenhydramine|diphenhydramine|mesh-list
6280720|NCT01406860|Promethazine|promethazine|mesh-list
6280721|NCT01406860|Droperidol|droperidol|mesh-list
6280722|NCT01406860|Metoclopramide|metoclopramide|mesh-list
6280723|NCT01406860|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6280724|NCT01406860|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6280725|NCT01406860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6280726|NCT01406860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280727|NCT01406860|Anesthetics, Local|anesthetics, local|mesh-ancestor
6280728|NCT01406860|Anesthetics|anesthetics|mesh-ancestor
6280729|NCT01406860|Sensory System Agents|sensory system agents|mesh-ancestor
6280730|NCT01406860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6280731|NCT01406860|Antiemetics|antiemetics|mesh-ancestor
6280732|NCT01406860|Autonomic Agents|autonomic agents|mesh-ancestor
6280733|NCT01406860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6280734|NCT01406860|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6280735|NCT01406860|Histamine Antagonists|histamine antagonists|mesh-ancestor
6280736|NCT01406860|Histamine Agents|histamine agents|mesh-ancestor
6280737|NCT01406860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6280738|NCT01406860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280739|NCT01406860|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6280740|NCT01406860|Antipruritics|antipruritics|mesh-ancestor
6280741|NCT01406860|Dermatologic Agents|dermatologic agents|mesh-ancestor
6280742|NCT01406860|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6280743|NCT01406860|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6280744|NCT01406860|Dopamine Agents|dopamine agents|mesh-ancestor
6280745|NCT01406860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6280746|NCT01406860|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6280747|NCT01406860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6280748|NCT01406860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6280749|NCT01401049|Lidocaine|lidocaine|mesh-list
6280750|NCT01401049|Propofol|propofol|mesh-list
6280751|NCT01401049|Fospropofol|fospropofol|mesh-list
6280752|NCT01401049|Anesthetics, Local|anesthetics, local|mesh-ancestor
6280753|NCT01401049|Anesthetics|anesthetics|mesh-ancestor
6280754|NCT01401049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6280755|NCT01401049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280756|NCT01401049|Sensory System Agents|sensory system agents|mesh-ancestor
6280757|NCT01401049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6280758|NCT01401049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6280759|NCT01401049|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6280760|NCT01401049|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6280761|NCT01401049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6280762|NCT01401049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280763|NCT01401049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6280764|NCT01401049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6280765|NCT01401049|Anesthetics, General|anesthetics, general|mesh-ancestor
6280766|NCT01408641|Topiramate|topiramate|mesh-list
6280767|NCT01408641|Anticonvulsants|anticonvulsants|mesh-ancestor
6280768|NCT01408641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6280769|NCT01408641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280770|NCT01409031|Sildenafil Citrate|sildenafil citrate|mesh-list
6280771|NCT01409031|Vasodilator Agents|vasodilator agents|mesh-ancestor
6280772|NCT01409031|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6280773|NCT01409031|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6280774|NCT01409031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6280775|NCT01409031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280776|NCT01409031|Urological Agents|urological agents|mesh-ancestor
6280777|NCT01402531|Bevacizumab|bevacizumab|mesh-list
6280778|NCT01402531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6280779|NCT01402531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6280780|NCT01402531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6280781|NCT01402531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6280782|NCT01402531|Growth Substances|growth substances|mesh-ancestor
6280783|NCT01402531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280784|NCT01402531|Growth Inhibitors|growth inhibitors|mesh-ancestor
6280785|NCT01397552|Dexamethasone|dexamethasone|mesh-list
6280786|NCT01397552|Methylprednisolone|methylprednisolone|mesh-list
6280787|NCT01397552|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6280788|NCT01397552|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6280789|NCT01397552|Prednisolone|prednisolone|mesh-list
6280790|NCT01397552|Prednisolone acetate|prednisolone acetate|mesh-list
6280791|NCT01397552|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6280792|NCT01397552|Prednisolone phosphate|prednisolone phosphate|mesh-list
6280793|NCT01397552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6280794|NCT01397552|Antiemetics|antiemetics|mesh-ancestor
6280795|NCT01397552|Autonomic Agents|autonomic agents|mesh-ancestor
6280796|NCT01397552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6280797|NCT01397552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280798|NCT01397552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6280799|NCT01397552|Glucocorticoids|glucocorticoids|mesh-ancestor
6280800|NCT01397552|Hormones|hormones|mesh-ancestor
6280801|NCT01397552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6280802|NCT01397552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6280803|NCT01397552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6280804|NCT01397552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6280805|NCT01397552|Protective Agents|protective agents|mesh-ancestor
6280806|NCT01392170|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6280807|NCT01392170|Antiviral Agents|antiviral agents|mesh-ancestor
6280808|NCT01392170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6280809|NCT01397695|Bevacizumab|bevacizumab|mesh-list
6280810|NCT01397695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6280811|NCT01397695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6280812|NCT01397695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6280813|NCT01397695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6280814|NCT01397695|Growth Substances|growth substances|mesh-ancestor
6280815|NCT01397695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280816|NCT01397695|Growth Inhibitors|growth inhibitors|mesh-ancestor
6280817|NCT01390181|Losartan|losartan|mesh-list
6280818|NCT01390181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6280819|NCT01390181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6280820|NCT01390181|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6280821|NCT01390181|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6280822|NCT01390181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280823|NCT01394211|Anastrozole|anastrozole|mesh-list
6280824|NCT01394211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6280825|NCT01394211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6280826|NCT01394211|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6280827|NCT01394211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6280828|NCT01394211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6280829|NCT01394211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280830|NCT01394211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6280831|NCT01394211|Hormone Antagonists|hormone antagonists|mesh-ancestor
6280832|NCT01394211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6280833|NCT01394211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280834|NCT01388920|Tesamorelin|tesamorelin|mesh-list
6280835|NCT01388920|Growth Substances|growth substances|mesh-ancestor
6280836|NCT01388920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280837|NCT01377441|Ibuprofen|ibuprofen|mesh-list
6280838|NCT01377441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
6280839|NCT01377441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
6280840|NCT01377441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6280841|NCT01377441|Analgesics|analgesics|mesh-ancestor
6280842|NCT01377441|Sensory System Agents|sensory system agents|mesh-ancestor
6280843|NCT01377441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6280844|NCT01377441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280845|NCT01377441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6280846|NCT01377441|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6280847|NCT01377441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6280848|NCT01377441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280849|NCT01383447|Imatinib Mesylate|imatinib mesylate|mesh-list
6280850|NCT01383447|Entinostat|entinostat|mesh-list
6280851|NCT01383447|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
6280852|NCT01383447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6280853|NCT01383447|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6280854|NCT01383447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6280855|NCT01383447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280856|NCT01372618|Pasireotide|pasireotide|mesh-list
6280857|NCT01372618|Hormones|hormones|mesh-ancestor
6280858|NCT01372618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6280859|NCT01372618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280860|NCT01385280|Exemestane|exemestane|mesh-list
6280861|NCT01385280|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6280862|NCT01385280|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6280863|NCT01385280|Estradiol|estradiol|mesh-list
6280864|NCT01385280|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6280865|NCT01385280|Estrogens|estrogens|mesh-ancestor
6280866|NCT01385280|Hormones|hormones|mesh-ancestor
6280867|NCT01385280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6280868|NCT01385280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280869|NCT01385280|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6280870|NCT01385280|Contraceptive Agents|contraceptive agents|mesh-ancestor
6280871|NCT01385280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6280872|NCT01385280|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6280873|NCT01385280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6280874|NCT01385280|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6280875|NCT01385280|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6280876|NCT01385280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6280877|NCT01385280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280878|NCT01385280|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6280879|NCT01385280|Hormone Antagonists|hormone antagonists|mesh-ancestor
6280880|NCT01379274|Lenalidomide|lenalidomide|mesh-list
6280881|NCT01379274|Azacitidine|azacitidine|mesh-list
6280882|NCT01379274|Immunologic Factors|immunologic factors|mesh-ancestor
6280883|NCT01379274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280884|NCT01379274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6280885|NCT01379274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6015247|NCT00356135|Purinergic Agents|purinergic agents|mesh-ancestor
6015248|NCT00356135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6015249|NCT00356135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015250|NCT00356135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015251|NCT00356148|Ampicillin|ampicillin|mesh-list
6015252|NCT00356148|Sulbactam|sulbactam|mesh-list
6280886|NCT01379274|Growth Substances|growth substances|mesh-ancestor
6280887|NCT01379274|Growth Inhibitors|growth inhibitors|mesh-ancestor
6280888|NCT01379274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6280889|NCT01379274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6280890|NCT01379274|Antimetabolites|antimetabolites|mesh-ancestor
6280891|NCT01379274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280892|NCT01379274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6280893|NCT01379469|Carbamazepine|carbamazepine|mesh-list
6280894|NCT01379469|Anticonvulsants|anticonvulsants|mesh-ancestor
6280895|NCT01379469|Antimanic Agents|antimanic agents|mesh-ancestor
6280896|NCT01379469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6280897|NCT01379469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6280898|NCT01379469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015253|NCT00356148|Sultamicillin|sultamicillin|mesh-list
6280899|NCT01379469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6280900|NCT01379469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6280901|NCT01379469|Analgesics|analgesics|mesh-ancestor
6280902|NCT01379469|Sensory System Agents|sensory system agents|mesh-ancestor
6280903|NCT01379469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6280904|NCT01379469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6280905|NCT01379469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6280906|NCT01379469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280907|NCT01379469|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6280908|NCT01379469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6280909|NCT01369641|Sodium thiosulfate|sodium thiosulfate|mesh-list
6280910|NCT01369641|Cisplatin|cisplatin|mesh-list
6280911|NCT01369641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6280912|NCT01369641|Antidotes|antidotes|mesh-ancestor
6280913|NCT01369641|Protective Agents|protective agents|mesh-ancestor
6280914|NCT01369641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280915|NCT01369641|Antioxidants|antioxidants|mesh-ancestor
6280916|NCT01369641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280917|NCT01369641|Antitubercular Agents|antitubercular agents|mesh-ancestor
6280918|NCT01369641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6280919|NCT01369641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6280920|NCT01369641|Chelating Agents|chelating agents|mesh-ancestor
6280921|NCT01369641|Sequestering Agents|sequestering agents|mesh-ancestor
6280922|NCT01359254|Vidarabine|vidarabine|mesh-list
6280923|NCT01359254|Fludarabine|fludarabine|mesh-list
6280924|NCT01359254|Fludarabine phosphate|fludarabine phosphate|mesh-list
6280925|NCT01359254|Melphalan|melphalan|mesh-list
6280926|NCT01359254|Busulfan|busulfan|mesh-list
6280927|NCT01359254|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6280928|NCT01359254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6280929|NCT01359254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6280930|NCT01359254|Antimetabolites|antimetabolites|mesh-ancestor
6280931|NCT01359254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280932|NCT01359254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6280933|NCT01359254|Immunologic Factors|immunologic factors|mesh-ancestor
6280934|NCT01359254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280935|NCT01359254|Antiviral Agents|antiviral agents|mesh-ancestor
6280936|NCT01359254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6280937|NCT01359254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6280938|NCT01359254|Alkylating Agents|alkylating agents|mesh-ancestor
6280939|NCT01359254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6015254|NCT00356148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6015255|NCT00356148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6015256|NCT00356148|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6015257|NCT00356148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6015258|NCT00356148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015259|NCT00356200|Fluphenazine|fluphenazine|mesh-list
6015260|NCT00356200|Fluphenazine depot|fluphenazine depot|mesh-list
6015261|NCT00356200|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
6015262|NCT00356200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6015263|NCT00356200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6280940|NCT01347632|Metronidazole|metronidazole|mesh-list
6280941|NCT01347632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6280942|NCT01347632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6280943|NCT01347632|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6280944|NCT01347632|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6280945|NCT01350232|Cytarabine|cytarabine|mesh-list
6280946|NCT01350232|Cyclophosphamide|cyclophosphamide|mesh-list
6280947|NCT01350232|Rituximab|rituximab|mesh-list
6280948|NCT01350232|Fludarabine|fludarabine|mesh-list
6280949|NCT01350232|Bortezomib|bortezomib|mesh-list
6280950|NCT01350232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6280951|NCT01350232|Immunologic Factors|immunologic factors|mesh-ancestor
6280952|NCT01350232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280953|NCT01350232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6280954|NCT01350232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6280955|NCT01350232|Alkylating Agents|alkylating agents|mesh-ancestor
6280956|NCT01350232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280957|NCT01350232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6280958|NCT01350232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6280959|NCT01350232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6280960|NCT01350232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6280961|NCT01350232|Antimetabolites|antimetabolites|mesh-ancestor
6280962|NCT01350232|Antiviral Agents|antiviral agents|mesh-ancestor
6280963|NCT01350232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6015264|NCT00356200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6015265|NCT00356200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015266|NCT00356200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6015267|NCT00356200|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6015268|NCT00356200|Dopamine Agents|dopamine agents|mesh-ancestor
6015269|NCT00356200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6015270|NCT00356200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015271|NCT00356265|Phenylephrine|phenylephrine|mesh-list
6280964|NCT01352416|Ranolazine|ranolazine|mesh-list
6280965|NCT01352416|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6280966|NCT01352416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6280967|NCT01352416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280968|NCT01350258|Vidarabine|vidarabine|mesh-list
6280969|NCT01350258|Fludarabine|fludarabine|mesh-list
6280970|NCT01350258|Fludarabine phosphate|fludarabine phosphate|mesh-list
6280971|NCT01350258|Melphalan|melphalan|mesh-list
6280972|NCT01350258|Thiotepa|thiotepa|mesh-list
6280973|NCT01350258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6280974|NCT01350258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6280975|NCT01350258|Antimetabolites|antimetabolites|mesh-ancestor
6280976|NCT01350258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280977|NCT01350258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6280978|NCT01350258|Immunologic Factors|immunologic factors|mesh-ancestor
6280979|NCT01350258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6280980|NCT01350258|Antiviral Agents|antiviral agents|mesh-ancestor
6280981|NCT01350258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6280982|NCT01350258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6280983|NCT01350258|Alkylating Agents|alkylating agents|mesh-ancestor
6280984|NCT01350258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6280985|NCT01349595|Bortezomib|bortezomib|mesh-list
6280986|NCT01349595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6280987|NCT01340573|Interferons|interferons|mesh-list
6280988|NCT01340573|Ribavirin|ribavirin|mesh-list
6280989|NCT01340573|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6280990|NCT01340573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6280991|NCT01340573|Antiviral Agents|antiviral agents|mesh-ancestor
6280992|NCT01340573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6280993|NCT01340573|Antimetabolites|antimetabolites|mesh-ancestor
6280994|NCT01340573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6280995|NCT01335997|Niacin|niacin|mesh-list
6280996|NCT01335997|Niacinamide|niacinamide|mesh-list
6280997|NCT01335997|Nicotinic Acids|nicotinic acids|mesh-list
6280998|NCT01335997|Simvastatin|simvastatin|mesh-list
6280999|NCT01335997|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6281000|NCT01335997|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6281001|NCT01335997|Antimetabolites|antimetabolites|mesh-ancestor
6281002|NCT01335997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281003|NCT01335997|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6281004|NCT01335997|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6281005|NCT01335997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6281006|NCT01335997|Vasodilator Agents|vasodilator agents|mesh-ancestor
6281007|NCT01335997|Vitamin B Complex|vitamin b complex|mesh-ancestor
6281008|NCT01335997|Vitamins|vitamins|mesh-ancestor
6281009|NCT01335997|Micronutrients|micronutrients|mesh-ancestor
6281010|NCT01335997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281011|NCT01340885|Rivastigmine|rivastigmine|mesh-list
6281012|NCT01340885|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6281013|NCT01340885|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6281014|NCT01340885|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6281015|NCT01340885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6281016|NCT01340885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281017|NCT01340885|Adrenergic Agents|adrenergic agents|mesh-ancestor
6015272|NCT00356265|Oxymetazoline|oxymetazoline|mesh-list
6015273|NCT00356265|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6015274|NCT00356265|Mydriatics|mydriatics|mesh-ancestor
6015275|NCT00356265|Autonomic Agents|autonomic agents|mesh-ancestor
6015276|NCT00356265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6015277|NCT00356265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015278|NCT00356265|Sympathomimetics|sympathomimetics|mesh-ancestor
6015279|NCT00356265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6015280|NCT00356265|Nasal Decongestants|nasal decongestants|mesh-ancestor
6015281|NCT00356265|Respiratory System Agents|respiratory system agents|mesh-ancestor
6281018|NCT01340885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6281019|NCT01340885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281020|NCT01340885|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6281021|NCT01340885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6281022|NCT01340885|Cholinergic Agents|cholinergic agents|mesh-ancestor
6281023|NCT01340885|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6281024|NCT01340885|Protective Agents|protective agents|mesh-ancestor
6281025|NCT01334606|Insulin|insulin|mesh-list
6281026|NCT01334606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6281027|NCT01334606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281028|NCT01326923|Cetuximab|cetuximab|mesh-list
6281029|NCT01326923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6281030|NCT01326923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6281031|NCT01332799|Allopurinol|allopurinol|mesh-list
6281032|NCT01332799|Antimetabolites|antimetabolites|mesh-ancestor
6281033|NCT01332799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281034|NCT01332799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6281035|NCT01332799|Gout Suppressants|gout suppressants|mesh-ancestor
6281036|NCT01332799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6281037|NCT01332799|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6281038|NCT01332799|Antioxidants|antioxidants|mesh-ancestor
6281039|NCT01332799|Protective Agents|protective agents|mesh-ancestor
6281040|NCT01332799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281041|NCT01329549|Carboplatin|carboplatin|mesh-list
6281042|NCT01329549|Nintedanib|nintedanib|mesh-list
6281043|NCT01329549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6281044|NCT01329549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6281045|NCT01329549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6281046|NCT01329549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281047|NCT01326845|Deferasirox|deferasirox|mesh-list
6281048|NCT01326845|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6281049|NCT01326845|Chelating Agents|chelating agents|mesh-ancestor
6281050|NCT01326845|Sequestering Agents|sequestering agents|mesh-ancestor
6281051|NCT01326845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281052|NCT01320683|Leucovorin|leucovorin|mesh-list
6281053|NCT01320683|Bevacizumab|bevacizumab|mesh-list
6281054|NCT01320683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6281055|NCT01320683|Fluorouracil|fluorouracil|mesh-list
6281056|NCT01320683|Oxaliplatin|oxaliplatin|mesh-list
6281057|NCT01320683|Irinotecan|irinotecan|mesh-list
6281058|NCT01320683|Antibodies|antibodies|mesh-list
6281059|NCT01320683|Immunoglobulins|immunoglobulins|mesh-list
6281060|NCT01320683|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6281061|NCT01320683|Levoleucovorin|levoleucovorin|mesh-list
6281062|NCT01320683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6281063|NCT01320683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6281064|NCT01320683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6281065|NCT01320683|Growth Substances|growth substances|mesh-ancestor
6281066|NCT01320683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281067|NCT01320683|Growth Inhibitors|growth inhibitors|mesh-ancestor
6281068|NCT01320683|Immunologic Factors|immunologic factors|mesh-ancestor
6281069|NCT01320683|Antimetabolites|antimetabolites|mesh-ancestor
6281070|NCT01320683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281071|NCT01320683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6281072|NCT01320683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6281073|NCT01320683|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6281074|NCT01320683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6281075|NCT01320683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6281076|NCT01320683|Antidotes|antidotes|mesh-ancestor
6015282|NCT00356265|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6015283|NCT00356265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6281077|NCT01320683|Protective Agents|protective agents|mesh-ancestor
6281078|NCT01320683|Vitamin B Complex|vitamin b complex|mesh-ancestor
6281079|NCT01320683|Vitamins|vitamins|mesh-ancestor
6281080|NCT01320683|Micronutrients|micronutrients|mesh-ancestor
6281081|NCT01313273|Ascorbic Acid|ascorbic acid|mesh-list
6281082|NCT01313273|Methyltestosterone|methyltestosterone|mesh-list
6281083|NCT01313273|Lanreotide|lanreotide|mesh-list
6281084|NCT01313273|Androgens|androgens|mesh-list
6281085|NCT01313273|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6281086|NCT01313273|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
6281087|NCT01313273|Androgen Antagonists|androgen antagonists|mesh-list
6281088|NCT01313273|Nonsteroidal Anti-Androgens|nonsteroidal anti-androgens|mesh-list
6281089|NCT01313273|Hormones|hormones|mesh-ancestor
6281090|NCT01313273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6281091|NCT01313273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281092|NCT01313273|Antioxidants|antioxidants|mesh-ancestor
6281093|NCT01313273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281094|NCT01313273|Protective Agents|protective agents|mesh-ancestor
6281095|NCT01313273|Vitamins|vitamins|mesh-ancestor
6281096|NCT01313273|Micronutrients|micronutrients|mesh-ancestor
6281097|NCT01313273|Estrogens|estrogens|mesh-ancestor
6281098|NCT01313273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6281099|NCT01313273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6281100|NCT01313273|Anabolic Agents|anabolic agents|mesh-ancestor
6281101|NCT01313273|Hormone Antagonists|hormone antagonists|mesh-ancestor
6281102|NCT01321008|Prednisone|prednisone|mesh-list
6281103|NCT01321008|Cyclophosphamide|cyclophosphamide|mesh-list
6281104|NCT01321008|Doxorubicin|doxorubicin|mesh-list
6281105|NCT01321008|Vincristine|vincristine|mesh-list
6281106|NCT01321008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6281107|NCT01321008|Immunologic Factors|immunologic factors|mesh-ancestor
6281108|NCT01321008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281109|NCT01321008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6281110|NCT01321008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6281111|NCT01321008|Alkylating Agents|alkylating agents|mesh-ancestor
6281112|NCT01321008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281113|NCT01321008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6281114|NCT01321008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6281115|NCT01321008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6281116|NCT01321008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6281117|NCT01321008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6281118|NCT01321008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6281119|NCT01321008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6281120|NCT01321008|Glucocorticoids|glucocorticoids|mesh-ancestor
6281121|NCT01321008|Hormones|hormones|mesh-ancestor
6281122|NCT01321008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6281123|NCT01321008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6281124|NCT01321008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6281125|NCT01321008|Tubulin Modulators|tubulin modulators|mesh-ancestor
6281126|NCT01321008|Antimitotic Agents|antimitotic agents|mesh-ancestor
6281127|NCT01321008|Mitosis Modulators|mitosis modulators|mesh-ancestor
6281128|NCT01310803|Valrubicin|valrubicin|mesh-list
6281129|NCT01310803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6281130|NCT01310803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6281131|NCT01310803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6281132|NCT01310803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6281133|NCT01310803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281134|NCT01309581|Ketamine|ketamine|mesh-list
6281135|NCT01309581|Methohexital|methohexital|mesh-list
6281136|NCT01309581|Analgesics|analgesics|mesh-ancestor
6281137|NCT01309581|Sensory System Agents|sensory system agents|mesh-ancestor
6281138|NCT01309581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6281139|NCT01309581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281140|NCT01309581|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6281141|NCT01309581|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6281142|NCT01309581|Anesthetics, General|anesthetics, general|mesh-ancestor
6281143|NCT01309581|Anesthetics|anesthetics|mesh-ancestor
6281144|NCT01309581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6281145|NCT01309581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6281146|NCT01309581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6281147|NCT01309581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6281148|NCT01309581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281149|NCT01315873|Bortezomib|bortezomib|mesh-list
6281150|NCT01315873|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6281151|NCT01315873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6281152|NCT01315873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6281153|NCT01315873|Alkylating Agents|alkylating agents|mesh-ancestor
6281154|NCT01315873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281155|NCT01313923|Sirolimus|sirolimus|mesh-list
6281156|NCT01313923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6281157|NCT01313923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6281158|NCT01313923|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6281159|NCT01313923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6281160|NCT01313923|Antifungal Agents|antifungal agents|mesh-ancestor
6281161|NCT01313923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6281162|NCT01313923|Immunologic Factors|immunologic factors|mesh-ancestor
6281163|NCT01313923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281164|NCT01313416|Gemcitabine|gemcitabine|mesh-list
6281165|NCT01313416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6281166|NCT01313416|Antimetabolites|antimetabolites|mesh-ancestor
6281167|NCT01313416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281168|NCT01313416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6281169|NCT01313416|Antiviral Agents|antiviral agents|mesh-ancestor
6281170|NCT01313416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6281171|NCT01313416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6281172|NCT01313416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6281173|NCT01313416|Immunologic Factors|immunologic factors|mesh-ancestor
6281174|NCT01313416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281175|NCT01303003|Dexamethasone|dexamethasone|mesh-list
6281176|NCT01303003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6281177|NCT01303003|Antiemetics|antiemetics|mesh-ancestor
6281178|NCT01303003|Autonomic Agents|autonomic agents|mesh-ancestor
6281179|NCT01303003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6281180|NCT01303003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281181|NCT01303003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6281182|NCT01303003|Glucocorticoids|glucocorticoids|mesh-ancestor
6281183|NCT01303003|Hormones|hormones|mesh-ancestor
6281184|NCT01303003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6281185|NCT01303003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6281186|NCT01303003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6281187|NCT01302444|Tadalafil|tadalafil|mesh-list
6281188|NCT01302444|Vasodilator Agents|vasodilator agents|mesh-ancestor
6281189|NCT01302444|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6281190|NCT01302444|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6281191|NCT01302444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6281192|NCT01302444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281193|NCT01302444|Urological Agents|urological agents|mesh-ancestor
6281194|NCT01301963|Plerixafor|plerixafor|mesh-list
6281195|NCT01301963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6281196|NCT01301963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6281197|NCT01301963|Antiviral Agents|antiviral agents|mesh-ancestor
6281198|NCT01301963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6281199|NCT01292070|Histamine|histamine|mesh-list
6281200|NCT01292070|Histamine Agonists|histamine agonists|mesh-ancestor
6281201|NCT01292070|Histamine Agents|histamine agents|mesh-ancestor
6281202|NCT01292070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6281203|NCT01292070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281204|NCT01292070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281205|NCT01292265|Certolizumab Pegol|certolizumab pegol|mesh-list
6281206|NCT01292265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6281207|NCT01292265|Immunologic Factors|immunologic factors|mesh-ancestor
6281208|NCT01292265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281209|NCT01292265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6281210|NCT01290718|Capecitabine|capecitabine|mesh-list
6281211|NCT01290718|Trastuzumab|trastuzumab|mesh-list
6281212|NCT01290718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6281213|NCT01290718|Antimetabolites|antimetabolites|mesh-ancestor
6281214|NCT01290718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281215|NCT01290718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6281216|NCT01290718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6281217|NCT01293123|Tenofovir|tenofovir|mesh-list
6281218|NCT01293123|Emtricitabine|emtricitabine|mesh-list
6281219|NCT01293123|Efavirenz|efavirenz|mesh-list
6281220|NCT01293123|Raltegravir Potassium|raltegravir potassium|mesh-list
6281221|NCT01293123|Antiviral Agents|antiviral agents|mesh-ancestor
6281222|NCT01293123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6281223|NCT01293123|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6281224|NCT01293123|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6281225|NCT01293123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6281226|NCT01293123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281227|NCT01293123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6281228|NCT01293123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6281229|NCT01293123|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6281230|NCT01293123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6281231|NCT01293123|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6281232|NCT01293123|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6281233|NCT01293123|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6281234|NCT01293123|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6281235|NCT01293123|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6281236|NCT01293123|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6281237|NCT01280643|Leucovorin|leucovorin|mesh-list
6281238|NCT01280643|Bevacizumab|bevacizumab|mesh-list
6281239|NCT01280643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6281240|NCT01280643|Cetuximab|cetuximab|mesh-list
6281241|NCT01280643|Fluorouracil|fluorouracil|mesh-list
6281242|NCT01280643|Capecitabine|capecitabine|mesh-list
6281243|NCT01280643|Oxaliplatin|oxaliplatin|mesh-list
6281244|NCT01280643|Irinotecan|irinotecan|mesh-list
6281245|NCT01280643|Antibodies|antibodies|mesh-list
6281246|NCT01280643|Immunoglobulins|immunoglobulins|mesh-list
6281247|NCT01280643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6281248|NCT01280643|Levoleucovorin|levoleucovorin|mesh-list
6281249|NCT01280643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6281250|NCT01280643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6281251|NCT01280643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6281252|NCT01280643|Growth Substances|growth substances|mesh-ancestor
6281253|NCT01280643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281254|NCT01280643|Growth Inhibitors|growth inhibitors|mesh-ancestor
6281255|NCT01280643|Immunologic Factors|immunologic factors|mesh-ancestor
6281256|NCT01280643|Antimetabolites|antimetabolites|mesh-ancestor
6281257|NCT01280643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281258|NCT01280643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6281259|NCT01280643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6281260|NCT01280643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6281261|NCT01280643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6281262|NCT01280643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6281263|NCT01280643|Antidotes|antidotes|mesh-ancestor
6281264|NCT01280643|Protective Agents|protective agents|mesh-ancestor
6281265|NCT01280643|Vitamin B Complex|vitamin b complex|mesh-ancestor
6281266|NCT01280643|Vitamins|vitamins|mesh-ancestor
6281267|NCT01280643|Micronutrients|micronutrients|mesh-ancestor
6281268|NCT01281124|Azacitidine|azacitidine|mesh-list
6281269|NCT01281124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6281270|NCT01281124|Antimetabolites|antimetabolites|mesh-ancestor
6281271|NCT01281124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281272|NCT01281124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6281273|NCT01281124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6281274|NCT01272141|Everolimus|everolimus|mesh-list
6281275|NCT01272141|Lapatinib|lapatinib|mesh-list
6281276|NCT01272141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6281277|NCT01272141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6281278|NCT01272141|Immunologic Factors|immunologic factors|mesh-ancestor
6281279|NCT01272141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281280|NCT01272141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6281281|NCT01272141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6281282|NCT01272141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281283|NCT01282216|Vaccines|vaccines|mesh-list
6281284|NCT01282216|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6281285|NCT01282216|Immunologic Factors|immunologic factors|mesh-ancestor
6281286|NCT01282216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281287|NCT01284504|Celecoxib|celecoxib|mesh-list
6281288|NCT01284504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6281289|NCT01284504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6281290|NCT01284504|Analgesics|analgesics|mesh-ancestor
6281291|NCT01284504|Sensory System Agents|sensory system agents|mesh-ancestor
6281292|NCT01284504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6281293|NCT01284504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281294|NCT01284504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6281295|NCT01284504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6281296|NCT01284504|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6281297|NCT01284504|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6281298|NCT01284504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6281299|NCT01284504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281300|NCT01269034|Insulin|insulin|mesh-list
6281301|NCT01269034|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6281302|NCT01269034|Exenatide|exenatide|mesh-list
6281303|NCT01269034|Insulin Glargine|insulin glargine|mesh-list
6281304|NCT01269034|Insulin Detemir|insulin detemir|mesh-list
6281305|NCT01269034|Insulin, Long-Acting|insulin, long-acting|mesh-list
6281306|NCT01269034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6281307|NCT01269034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281308|NCT01269034|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6281309|NCT01269034|Incretins|incretins|mesh-ancestor
6281310|NCT01269034|Hormones|hormones|mesh-ancestor
6281311|NCT01269034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6281312|NCT01274533|Lenalidomide|lenalidomide|mesh-list
6281313|NCT01274533|Immunologic Factors|immunologic factors|mesh-ancestor
6281314|NCT01274533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281315|NCT01274533|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6281316|NCT01274533|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6281317|NCT01274533|Growth Substances|growth substances|mesh-ancestor
6281318|NCT01274533|Growth Inhibitors|growth inhibitors|mesh-ancestor
6281319|NCT01274533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6281320|NCT01279616|Mycophenolic Acid|mycophenolic acid|mesh-list
6281321|NCT01279616|Cyclophosphamide|cyclophosphamide|mesh-list
6281322|NCT01279616|Busulfan|busulfan|mesh-list
6281323|NCT01279616|Rituximab|rituximab|mesh-list
6281324|NCT01279616|Fludarabine|fludarabine|mesh-list
6281325|NCT01279616|Fludarabine phosphate|fludarabine phosphate|mesh-list
6281326|NCT01279616|Tacrolimus|tacrolimus|mesh-list
6281327|NCT01279616|Thymoglobulin|thymoglobulin|mesh-list
6281328|NCT01279616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6281329|NCT01279616|Immunologic Factors|immunologic factors|mesh-ancestor
6281330|NCT01279616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281331|NCT01279616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6281332|NCT01279616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6281333|NCT01279616|Alkylating Agents|alkylating agents|mesh-ancestor
6281334|NCT01279616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281335|NCT01279616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6281336|NCT01279616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6281337|NCT01279616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6281338|NCT01279616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6281339|NCT01279616|Antimetabolites|antimetabolites|mesh-ancestor
6281340|NCT01279616|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6281341|NCT01279616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6281342|NCT01279616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6281343|NCT01279616|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6281344|NCT01279616|Antitubercular Agents|antitubercular agents|mesh-ancestor
6281345|NCT01279616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6281346|NCT01279616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6281347|NCT01276054|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6281348|NCT01276054|Methylene Blue|methylene blue|mesh-list
6281349|NCT01276054|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
6281350|NCT01276054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6281351|NCT01276054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281352|NCT01276054|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6281353|NCT01264965|Acetaminophen|acetaminophen|mesh-list
6281354|NCT01264965|Oxycodone|oxycodone|mesh-list
6281355|NCT01264965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6281356|NCT01264965|Analgesics|analgesics|mesh-ancestor
6281357|NCT01264965|Sensory System Agents|sensory system agents|mesh-ancestor
6281358|NCT01264965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6281359|NCT01264965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281360|NCT01264965|Antipyretics|antipyretics|mesh-ancestor
6281361|NCT01264965|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6281362|NCT01264965|Narcotics|narcotics|mesh-ancestor
6281363|NCT01264965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6391485|NCT00193323|Mitosis Modulators|mitosis modulators|mesh-ancestor
6391486|NCT00193336|Gefitinib|gefitinib|mesh-list
6391487|NCT00193336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391488|NCT00193336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6391489|NCT00193336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6391490|NCT00193336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391491|NCT00193349|Carboplatin|carboplatin|mesh-list
6391492|NCT00193349|Irinotecan|irinotecan|mesh-list
6391493|NCT00193349|Imatinib Mesylate|imatinib mesylate|mesh-list
6391494|NCT00193349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391495|NCT00193349|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6391496|NCT00193349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6391497|NCT00193349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6391498|NCT00193349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391499|NCT00193349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6391500|NCT00193362|Gemcitabine|gemcitabine|mesh-list
6391501|NCT00193362|Paclitaxel|paclitaxel|mesh-list
6391502|NCT00193362|Vinorelbine|vinorelbine|mesh-list
6391503|NCT00193362|Carboplatin|carboplatin|mesh-list
6391504|NCT00193362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6391505|NCT00193362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391506|NCT00193362|Tubulin Modulators|tubulin modulators|mesh-ancestor
6391507|NCT00193362|Antimitotic Agents|antimitotic agents|mesh-ancestor
6391508|NCT00193362|Mitosis Modulators|mitosis modulators|mesh-ancestor
6391509|NCT00193362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391510|NCT00193362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6391511|NCT00193362|Antimetabolites|antimetabolites|mesh-ancestor
6391512|NCT00193362|Antiviral Agents|antiviral agents|mesh-ancestor
6391513|NCT00193362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6391514|NCT00193362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6391515|NCT00193362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6391516|NCT00193362|Immunologic Factors|immunologic factors|mesh-ancestor
6391517|NCT00193362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6391518|NCT00193388|Topotecan|topotecan|mesh-list
6391519|NCT00193388|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6391520|NCT00193388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6391521|NCT00193388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6391522|NCT00193388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391523|NCT00193388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391524|NCT00193401|Topotecan|topotecan|mesh-list
6391525|NCT00193401|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6391526|NCT00193401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6391527|NCT00193401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6391528|NCT00193401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391529|NCT00193401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391530|NCT00193440|Rituximab|rituximab|mesh-list
6391531|NCT00193440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6391532|NCT00193440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391533|NCT00193440|Immunologic Factors|immunologic factors|mesh-ancestor
6391534|NCT00193440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6391535|NCT00193440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6391536|NCT00193466|Rituximab|rituximab|mesh-list
6391537|NCT00193466|Fludarabine|fludarabine|mesh-list
6391538|NCT00193466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6391539|NCT00193466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391540|NCT00193466|Immunologic Factors|immunologic factors|mesh-ancestor
6391541|NCT00193466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281364|NCT01266824|Proxymetacaine|proxymetacaine|mesh-list
6281365|NCT01266824|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6281366|NCT01266824|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6281367|NCT01266824|Anesthetics, Local|anesthetics, local|mesh-ancestor
6281368|NCT01266824|Anesthetics|anesthetics|mesh-ancestor
6281369|NCT01266824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6281370|NCT01266824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281371|NCT01266824|Sensory System Agents|sensory system agents|mesh-ancestor
6281372|NCT01266824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6281373|NCT01273064|Interferons|interferons|mesh-list
6281374|NCT01273064|Ribavirin|ribavirin|mesh-list
6281375|NCT01273064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6281376|NCT01273064|Antiviral Agents|antiviral agents|mesh-ancestor
6281377|NCT01273064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6281378|NCT01273064|Antimetabolites|antimetabolites|mesh-ancestor
6281379|NCT01273064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281380|NCT01274559|Niacin|niacin|mesh-list
6281381|NCT01274559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6281382|NCT01274559|Antimetabolites|antimetabolites|mesh-ancestor
6281383|NCT01274559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281384|NCT01274559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6281385|NCT01274559|Vasodilator Agents|vasodilator agents|mesh-ancestor
6281386|NCT01274559|Vitamin B Complex|vitamin b complex|mesh-ancestor
6281387|NCT01274559|Vitamins|vitamins|mesh-ancestor
6281388|NCT01274559|Micronutrients|micronutrients|mesh-ancestor
6281389|NCT01274559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281390|NCT01262339|Botulinum Toxins|botulinum toxins|mesh-list
6281391|NCT01262339|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6281392|NCT01262339|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6281393|NCT01262339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6281394|NCT01262339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281395|NCT01262339|Cholinergic Agents|cholinergic agents|mesh-ancestor
6281396|NCT01262339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6281397|NCT01262339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281398|NCT01262339|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6281399|NCT01262339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6281400|NCT01267825|Bupivacaine|bupivacaine|mesh-list
6281401|NCT01267825|Anesthetics, Local|anesthetics, local|mesh-ancestor
6281402|NCT01267825|Anesthetics|anesthetics|mesh-ancestor
6281403|NCT01267825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6281404|NCT01267825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281405|NCT01267825|Sensory System Agents|sensory system agents|mesh-ancestor
6281406|NCT01267825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6281407|NCT01264679|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
6281408|NCT01264679|Hematinics|hematinics|mesh-ancestor
6281409|NCT01264679|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6281410|NCT01264679|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6281411|NCT01259284|Atorvastatin|atorvastatin|mesh-list
6281412|NCT01259284|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6281413|NCT01259284|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6281414|NCT01259284|Antimetabolites|antimetabolites|mesh-ancestor
6281415|NCT01259284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281416|NCT01259284|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6281417|NCT01259284|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6281418|NCT01259284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6281419|NCT01263028|Ergocalciferols|ergocalciferols|mesh-list
6281420|NCT01263028|Vitamin D|vitamin d|mesh-list
6281421|NCT01263028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6281422|NCT01263028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281423|NCT01263028|Vitamins|vitamins|mesh-ancestor
6281424|NCT01263028|Micronutrients|micronutrients|mesh-ancestor
6281425|NCT01263028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6281426|NCT01253668|Antibodies|antibodies|mesh-list
6281427|NCT01253668|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6281428|NCT01253668|Immunologic Factors|immunologic factors|mesh-ancestor
6281429|NCT01253668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281430|NCT01259024|Chlorotrianisene|chlorotrianisene|mesh-list
6281431|NCT01259024|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6281432|NCT01259024|Estrogens|estrogens|mesh-ancestor
6281433|NCT01259024|Hormones|hormones|mesh-ancestor
6281434|NCT01259024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6281435|NCT01259024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281436|NCT01259024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6281437|NCT01259024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6281438|NCT01251952|Denileukin diftitox|denileukin diftitox|mesh-list
6281439|NCT01251952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6281440|NCT01246011|Warfarin|warfarin|mesh-list
6281441|NCT01246011|Argatroban|argatroban|mesh-list
6281442|NCT01246011|Anticoagulants|anticoagulants|mesh-ancestor
6281443|NCT01246011|Antithrombins|antithrombins|mesh-ancestor
6281444|NCT01246011|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6281445|NCT01246011|Protease Inhibitors|protease inhibitors|mesh-ancestor
6281446|NCT01246011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6281447|NCT01246011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281448|NCT01246011|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6281449|NCT01244620|Sildenafil Citrate|sildenafil citrate|mesh-list
6281450|NCT01244620|Tadalafil|tadalafil|mesh-list
6281451|NCT01244620|Sitaxsentan|sitaxsentan|mesh-list
6281452|NCT01244620|Vasodilator Agents|vasodilator agents|mesh-ancestor
6281453|NCT01244620|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6281454|NCT01244620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6281455|NCT01244620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6281456|NCT01244620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281457|NCT01244620|Urological Agents|urological agents|mesh-ancestor
6281458|NCT01244620|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6281459|NCT01240304|Gemcitabine|gemcitabine|mesh-list
6281460|NCT01240304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6281461|NCT01240304|Antimetabolites|antimetabolites|mesh-ancestor
6281462|NCT01240304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281463|NCT01240304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6281464|NCT01240304|Antiviral Agents|antiviral agents|mesh-ancestor
6281465|NCT01240304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6281466|NCT01240304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6281467|NCT01240304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6281468|NCT01240304|Immunologic Factors|immunologic factors|mesh-ancestor
6281469|NCT01240304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281470|NCT01230788|Rituximab|rituximab|mesh-list
6281471|NCT01230788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6281472|NCT01230788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6281473|NCT01230788|Immunologic Factors|immunologic factors|mesh-ancestor
6281474|NCT01230788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281475|NCT01230788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6281476|NCT01231750|Capsaicin|capsaicin|mesh-list
6281477|NCT01231750|Antipruritics|antipruritics|mesh-ancestor
6281478|NCT01231750|Dermatologic Agents|dermatologic agents|mesh-ancestor
6281479|NCT01231750|Sensory System Agents|sensory system agents|mesh-ancestor
6281480|NCT01231750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6281481|NCT01231750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281482|NCT01230307|Vitamin D|vitamin d|mesh-list
6281483|NCT01230307|Cholecalciferol|cholecalciferol|mesh-list
6281484|NCT01230307|Vitamins|vitamins|mesh-ancestor
6281485|NCT01230307|Micronutrients|micronutrients|mesh-ancestor
6281486|NCT01230307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281487|NCT01230307|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6281488|NCT01230307|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6281489|NCT01222871|Triamcinolone|triamcinolone|mesh-list
6281490|NCT01222871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6281491|NCT01222871|Glucocorticoids|glucocorticoids|mesh-ancestor
6281492|NCT01222871|Hormones|hormones|mesh-ancestor
6281493|NCT01222871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6281494|NCT01222871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281495|NCT01219673|Minocycline|minocycline|mesh-list
6281496|NCT01219673|Modafinil|modafinil|mesh-list
6281497|NCT01219673|Bupropion|bupropion|mesh-list
6281498|NCT01219673|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6281499|NCT01219673|Antidepressive Agents|antidepressive agents|mesh-ancestor
6281500|NCT01219673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6281501|NCT01219673|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6281502|NCT01219673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6281503|NCT01219673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6281504|NCT01219673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281505|NCT01219673|Dopamine Agents|dopamine agents|mesh-ancestor
6281506|NCT01219673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6281507|NCT01219673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281508|NCT01219673|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6281509|NCT01219673|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6281510|NCT01219673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6281511|NCT01219673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6281512|NCT01219673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6281513|NCT01219673|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6281514|NCT01219673|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6281515|NCT01219673|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6281516|NCT01219673|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6281517|NCT01223001|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6281518|NCT01223001|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6281519|NCT01223001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6281520|NCT01223001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6281521|NCT01223001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281522|NCT01223001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6281523|NCT01223001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281524|NCT01223001|Analgesics|analgesics|mesh-ancestor
6281525|NCT01223001|Sensory System Agents|sensory system agents|mesh-ancestor
6281526|NCT01223001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6281527|NCT01223001|Antidepressive Agents|antidepressive agents|mesh-ancestor
6281528|NCT01223001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6281529|NCT01223001|Dopamine Agents|dopamine agents|mesh-ancestor
6281530|NCT01217060|Dexamethasone|dexamethasone|mesh-list
6281531|NCT01217060|Docetaxel|docetaxel|mesh-list
6281532|NCT01217060|Fluorouracil|fluorouracil|mesh-list
6281533|NCT01217060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6281534|NCT01217060|Antiemetics|antiemetics|mesh-ancestor
6281535|NCT01217060|Autonomic Agents|autonomic agents|mesh-ancestor
6281536|NCT01217060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6281537|NCT01217060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281538|NCT01217060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6281539|NCT01217060|Glucocorticoids|glucocorticoids|mesh-ancestor
6281540|NCT01217060|Hormones|hormones|mesh-ancestor
6281541|NCT01217060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6281542|NCT01217060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6281543|NCT01217060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6281544|NCT01217060|Tubulin Modulators|tubulin modulators|mesh-ancestor
6281545|NCT01217060|Antimitotic Agents|antimitotic agents|mesh-ancestor
6281546|NCT01217060|Mitosis Modulators|mitosis modulators|mesh-ancestor
6281547|NCT01217060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281548|NCT01217060|Antimetabolites|antimetabolites|mesh-ancestor
6281549|NCT01217060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6281550|NCT01217060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6281551|NCT01217060|Immunologic Factors|immunologic factors|mesh-ancestor
6281552|NCT01206101|Liraglutide|liraglutide|mesh-list
6281553|NCT01206101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6281554|NCT01206101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281555|NCT01206101|Incretins|incretins|mesh-ancestor
6281556|NCT01206101|Hormones|hormones|mesh-ancestor
6281557|NCT01206101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6281558|NCT01216631|Methylprednisolone|methylprednisolone|mesh-list
6281559|NCT01216631|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6281560|NCT01216631|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6281561|NCT01216631|Prednisolone|prednisolone|mesh-list
6281562|NCT01216631|Prednisolone acetate|prednisolone acetate|mesh-list
6281563|NCT01216631|Infliximab|infliximab|mesh-list
6281564|NCT01216631|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6281565|NCT01216631|Prednisolone phosphate|prednisolone phosphate|mesh-list
6281566|NCT01216631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6281567|NCT01216631|Antiemetics|antiemetics|mesh-ancestor
6281568|NCT01216631|Autonomic Agents|autonomic agents|mesh-ancestor
6281569|NCT01216631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6281570|NCT01216631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281571|NCT01216631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6281572|NCT01216631|Glucocorticoids|glucocorticoids|mesh-ancestor
6281573|NCT01216631|Hormones|hormones|mesh-ancestor
6281574|NCT01216631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6281575|NCT01216631|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6281576|NCT01216631|Protective Agents|protective agents|mesh-ancestor
6281577|NCT01216631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6281578|NCT01216631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6281579|NCT01216631|Dermatologic Agents|dermatologic agents|mesh-ancestor
6281580|NCT01216631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6281581|NCT01211756|Oxytocin|oxytocin|mesh-list
6281582|NCT01211756|Oxytocics|oxytocics|mesh-ancestor
6281583|NCT01211756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6281584|NCT01211756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281585|NCT01209520|Paclitaxel|paclitaxel|mesh-list
6281586|NCT01209520|Vinorelbine|vinorelbine|mesh-list
6281587|NCT01209520|Docetaxel|docetaxel|mesh-list
6281588|NCT01209520|Cisplatin|cisplatin|mesh-list
6281589|NCT01209520|Carboplatin|carboplatin|mesh-list
6281590|NCT01209520|Pemetrexed|pemetrexed|mesh-list
6281591|NCT01209520|Azacitidine|azacitidine|mesh-list
6281592|NCT01209520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6281593|NCT01209520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6281594|NCT01209520|Tubulin Modulators|tubulin modulators|mesh-ancestor
6281595|NCT01209520|Antimitotic Agents|antimitotic agents|mesh-ancestor
6281596|NCT01209520|Mitosis Modulators|mitosis modulators|mesh-ancestor
6281597|NCT01209520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281598|NCT01209520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6281599|NCT01209520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6281600|NCT01209520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6281601|NCT01209520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6281602|NCT01209520|Antimetabolites|antimetabolites|mesh-ancestor
6281603|NCT01207726|Azacitidine|azacitidine|mesh-list
6281604|NCT01207726|Entinostat|entinostat|mesh-list
6281605|NCT01207726|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
6281606|NCT01207726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6281607|NCT01207726|Antimetabolites|antimetabolites|mesh-ancestor
6281608|NCT01207726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281609|NCT01207726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6281610|NCT01207726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6281611|NCT01206296|Gemcitabine|gemcitabine|mesh-list
6281612|NCT01206296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6281613|NCT01206296|Antimetabolites|antimetabolites|mesh-ancestor
6281614|NCT01206296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281615|NCT01206296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6281616|NCT01206296|Antiviral Agents|antiviral agents|mesh-ancestor
6281617|NCT01206296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6281618|NCT01206296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6281619|NCT01206296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6281620|NCT01206296|Immunologic Factors|immunologic factors|mesh-ancestor
6281621|NCT01206296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281622|NCT01207102|Paclitaxel|paclitaxel|mesh-list
6281623|NCT01207102|Carboplatin|carboplatin|mesh-list
6281624|NCT01207102|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6281625|NCT01207102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6281626|NCT01207102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6281627|NCT01207102|Tubulin Modulators|tubulin modulators|mesh-ancestor
6281628|NCT01207102|Antimitotic Agents|antimitotic agents|mesh-ancestor
6281629|NCT01207102|Mitosis Modulators|mitosis modulators|mesh-ancestor
6281630|NCT01207102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281631|NCT01213329|Alemtuzumab|alemtuzumab|mesh-list
6281632|NCT01213329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6281633|NCT01213329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6281634|NCT01202110|Propranolol|propranolol|mesh-list
6281635|NCT01202110|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6281636|NCT01202110|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6281637|NCT01202110|Adrenergic Agents|adrenergic agents|mesh-ancestor
6281638|NCT01202110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6281639|NCT01202110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281640|NCT01202110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281641|NCT01202110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6281642|NCT01202110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6281643|NCT01202110|Vasodilator Agents|vasodilator agents|mesh-ancestor
6281644|NCT01206439|Nebivolol|nebivolol|mesh-list
6281645|NCT01206439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6281646|NCT01206439|Vasodilator Agents|vasodilator agents|mesh-ancestor
6281647|NCT01206439|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6281648|NCT01206439|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6281649|NCT01206439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6281650|NCT01206439|Adrenergic Agents|adrenergic agents|mesh-ancestor
6281651|NCT01206439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6281652|NCT01206439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281653|NCT01206439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281654|NCT01200602|Megestrol|megestrol|mesh-list
6281655|NCT01200602|Megestrol Acetate|megestrol acetate|mesh-list
6281656|NCT01200602|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6281657|NCT01200602|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6281658|NCT01200602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6281659|NCT01200602|Contraceptive Agents|contraceptive agents|mesh-ancestor
6281660|NCT01200602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6281661|NCT01200602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281662|NCT01200602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6281663|NCT01200602|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6281664|NCT01200602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6281665|NCT01200602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6281666|NCT01200602|Appetite Stimulants|appetite stimulants|mesh-ancestor
6281667|NCT01200602|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6281668|NCT01198548|Vitamin D|vitamin d|mesh-list
6281669|NCT01198548|Cholecalciferol|cholecalciferol|mesh-list
6281670|NCT01198548|Leucovorin|leucovorin|mesh-list
6281671|NCT01198548|Bevacizumab|bevacizumab|mesh-list
6281672|NCT01198548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6281673|NCT01198548|Fluorouracil|fluorouracil|mesh-list
6281674|NCT01198548|Oxaliplatin|oxaliplatin|mesh-list
6281675|NCT01198548|Antibodies|antibodies|mesh-list
6281676|NCT01198548|Immunoglobulins|immunoglobulins|mesh-list
6281677|NCT01198548|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6281678|NCT01198548|Levoleucovorin|levoleucovorin|mesh-list
6281679|NCT01198548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6281680|NCT01198548|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6281681|NCT01198548|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6281682|NCT01198548|Growth Substances|growth substances|mesh-ancestor
6281683|NCT01198548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281684|NCT01198548|Growth Inhibitors|growth inhibitors|mesh-ancestor
6281685|NCT01198548|Vitamins|vitamins|mesh-ancestor
6281686|NCT01198548|Micronutrients|micronutrients|mesh-ancestor
6281687|NCT01198548|Immunologic Factors|immunologic factors|mesh-ancestor
6281688|NCT01198548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6281689|NCT01198548|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6281690|NCT01198548|Antimetabolites|antimetabolites|mesh-ancestor
6281691|NCT01198548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281692|NCT01198548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6281693|NCT01198548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6281694|NCT01198548|Antidotes|antidotes|mesh-ancestor
6281695|NCT01198548|Protective Agents|protective agents|mesh-ancestor
6281696|NCT01198548|Vitamin B Complex|vitamin b complex|mesh-ancestor
6281697|NCT01194908|Tamoxifen|tamoxifen|mesh-list
6281698|NCT01194908|Decitabine|decitabine|mesh-list
6281699|NCT01194908|Panobinostat|panobinostat|mesh-list
6281700|NCT01194908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6281701|NCT01194908|Antimetabolites|antimetabolites|mesh-ancestor
6281702|NCT01194908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281703|NCT01194908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6281704|NCT01194908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6281705|NCT01194908|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6281706|NCT01194908|Hormone Antagonists|hormone antagonists|mesh-ancestor
6281707|NCT01194908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6281708|NCT01194908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281709|NCT01194908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6281710|NCT01194908|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6281711|NCT01194908|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6281712|NCT01194908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6281713|NCT01194908|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6281714|NCT01194856|Ritonavir|ritonavir|mesh-list
6281715|NCT01194856|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6281716|NCT01194856|Efavirenz|efavirenz|mesh-list
6281717|NCT01194856|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6281718|NCT01194856|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6281719|NCT01194856|Protease Inhibitors|protease inhibitors|mesh-ancestor
6281720|NCT01194856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6281721|NCT01194856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281722|NCT01194856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6281723|NCT01194856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6281724|NCT01194856|Antiviral Agents|antiviral agents|mesh-ancestor
6281725|NCT01194856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6281726|NCT01194856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6281727|NCT01194856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6281728|NCT01194856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6281729|NCT01194856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6281730|NCT01194856|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6281731|NCT01194856|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6281732|NCT01194856|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6281733|NCT01194856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6281734|NCT01194856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6281735|NCT01194427|Tamoxifen|tamoxifen|mesh-list
6281736|NCT01194427|Vorinostat|vorinostat|mesh-list
6281737|NCT01194427|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6281738|NCT01194427|Hormone Antagonists|hormone antagonists|mesh-ancestor
6281739|NCT01194427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6281740|NCT01194427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281741|NCT01194427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6281742|NCT01194427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6281743|NCT01194427|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6281744|NCT01194427|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6281745|NCT01194427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6281746|NCT01194427|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6281747|NCT01194427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6281748|NCT01194427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281749|NCT01189435|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6281750|NCT01189435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6281751|NCT01189435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6281752|NCT01189435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6281753|NCT01189435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281754|NCT01182610|Paclitaxel|paclitaxel|mesh-list
6281755|NCT01182610|Carboplatin|carboplatin|mesh-list
6281756|NCT01182610|Fluorouracil|fluorouracil|mesh-list
6281757|NCT01182610|Panitumumab|panitumumab|mesh-list
6281758|NCT01182610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6281759|NCT01182610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6281760|NCT01182610|Tubulin Modulators|tubulin modulators|mesh-ancestor
6281761|NCT01182610|Antimitotic Agents|antimitotic agents|mesh-ancestor
6281762|NCT01182610|Mitosis Modulators|mitosis modulators|mesh-ancestor
6281763|NCT01182610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281764|NCT01182610|Antimetabolites|antimetabolites|mesh-ancestor
6281765|NCT01182610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6281766|NCT01182610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6281767|NCT01182610|Immunologic Factors|immunologic factors|mesh-ancestor
6281768|NCT01182610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281769|NCT01182610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6281770|NCT01189071|Darifenacin|darifenacin|mesh-list
6281771|NCT01189071|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6281772|NCT01189071|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6281773|NCT01189071|Cholinergic Agents|cholinergic agents|mesh-ancestor
6281774|NCT01189071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6281775|NCT01189071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281776|NCT01189071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281777|NCT01189071|Urological Agents|urological agents|mesh-ancestor
6281778|NCT01183416|Tretinoin|tretinoin|mesh-list
6281779|NCT01183416|Isotretinoin|isotretinoin|mesh-list
6281780|NCT01183416|Antibodies|antibodies|mesh-list
6281781|NCT01183416|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6281782|NCT01183416|Immunologic Factors|immunologic factors|mesh-ancestor
6281783|NCT01183416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281784|NCT01183416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6281785|NCT01183416|Keratolytic Agents|keratolytic agents|mesh-ancestor
6281786|NCT01183416|Dermatologic Agents|dermatologic agents|mesh-ancestor
6281787|NCT01183221|Oxytocin|oxytocin|mesh-list
6281788|NCT01183221|Oxytocics|oxytocics|mesh-ancestor
6281789|NCT01183221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6281790|NCT01183221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281791|NCT01190306|Riboflavin|riboflavin|mesh-list
6281792|NCT01190306|Vitamin B Complex|vitamin b complex|mesh-ancestor
6281793|NCT01190306|Vitamins|vitamins|mesh-ancestor
6281794|NCT01190306|Micronutrients|micronutrients|mesh-ancestor
6281795|NCT01190306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281796|NCT01190306|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6281797|NCT01190306|Dermatologic Agents|dermatologic agents|mesh-ancestor
6281798|NCT01183468|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
6281799|NCT01183468|Protein C Inhibitor|protein c inhibitor|mesh-list
6281800|NCT01183468|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6281801|NCT01183468|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6281802|NCT01183468|Protease Inhibitors|protease inhibitors|mesh-ancestor
6281803|NCT01183468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6281804|NCT01183468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281805|NCT01181921|Galantamine|galantamine|mesh-list
6281806|NCT01181921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6281807|NCT01181921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6281808|NCT01181921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281809|NCT01181921|Cholinergic Agents|cholinergic agents|mesh-ancestor
6281810|NCT01181921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6281811|NCT01181921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281812|NCT01181921|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6281813|NCT01181921|Autonomic Agents|autonomic agents|mesh-ancestor
6281814|NCT01181921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6281815|NCT01181921|Nootropic Agents|nootropic agents|mesh-ancestor
6281816|NCT01188798|Methotrexate|methotrexate|mesh-list
6281817|NCT01188798|Pentostatin|pentostatin|mesh-list
6281818|NCT01188798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6281819|NCT01188798|Abortifacient Agents|abortifacient agents|mesh-ancestor
6281820|NCT01188798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6281821|NCT01188798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281822|NCT01188798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6281823|NCT01188798|Antimetabolites|antimetabolites|mesh-ancestor
6281824|NCT01188798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281825|NCT01188798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6281826|NCT01188798|Dermatologic Agents|dermatologic agents|mesh-ancestor
6281827|NCT01188798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6281828|NCT01188798|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6281829|NCT01188798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6281830|NCT01188798|Immunologic Factors|immunologic factors|mesh-ancestor
6281831|NCT01188798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6281832|NCT01188798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6281833|NCT01188798|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
6281834|NCT01183884|Tretinoin|tretinoin|mesh-list
6281835|NCT01183884|Isotretinoin|isotretinoin|mesh-list
6281836|NCT01183884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6281837|NCT01183884|Keratolytic Agents|keratolytic agents|mesh-ancestor
6281838|NCT01183884|Dermatologic Agents|dermatologic agents|mesh-ancestor
6281839|NCT01183429|Tretinoin|tretinoin|mesh-list
6281840|NCT01183429|Isotretinoin|isotretinoin|mesh-list
6281841|NCT01183429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6281842|NCT01183429|Keratolytic Agents|keratolytic agents|mesh-ancestor
6281843|NCT01183429|Dermatologic Agents|dermatologic agents|mesh-ancestor
6281844|NCT01166178|Vitamin D|vitamin d|mesh-list
6281845|NCT01166178|Zoledronic Acid|zoledronic acid|mesh-list
6281846|NCT01166178|Calcium|calcium|mesh-list
6281847|NCT01166178|Vitamins|vitamins|mesh-ancestor
6281848|NCT01166178|Micronutrients|micronutrients|mesh-ancestor
6281849|NCT01166178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281850|NCT01166178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6281851|NCT01166178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6281852|NCT01169753|Modafinil|modafinil|mesh-list
6281853|NCT01169753|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6281854|NCT01169753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281855|NCT01169753|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6281856|NCT01169753|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6281857|NCT01169753|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6281858|NCT01169753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281859|NCT01169610|Varenicline|varenicline|mesh-list
6281860|NCT01169610|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6281861|NCT01169610|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6281862|NCT01169610|Cholinergic Agents|cholinergic agents|mesh-ancestor
6281863|NCT01169610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6281864|NCT01169610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281865|NCT01169610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281866|NCT01155388|Ferrous fumarate|ferrous fumarate|mesh-list
6281867|NCT01155388|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
6281868|NCT01155388|Hematinics|hematinics|mesh-ancestor
6281869|NCT01155388|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6281870|NCT01155388|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6281871|NCT01155388|Trace Elements|trace elements|mesh-ancestor
6281872|NCT01155388|Micronutrients|micronutrients|mesh-ancestor
6281873|NCT01155388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281874|NCT01163084|Leuprolide|leuprolide|mesh-list
6281875|NCT01163084|Goserelin|goserelin|mesh-list
6281876|NCT01163084|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6281877|NCT01163084|Fertility Agents|fertility agents|mesh-ancestor
6281878|NCT01163084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6281879|NCT01163084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281880|NCT01163084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6281881|NCT01163084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6281882|NCT01166724|Sirolimus|sirolimus|mesh-list
6281883|NCT01166724|Tacrolimus|tacrolimus|mesh-list
6281884|NCT01166724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6281885|NCT01166724|Immunologic Factors|immunologic factors|mesh-ancestor
6281886|NCT01166724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281887|NCT01166724|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6281888|NCT01166724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6281889|NCT01166724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281890|NCT01166724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6281891|NCT01166724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6281892|NCT01166724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6281893|NCT01166724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6281894|NCT01166724|Antifungal Agents|antifungal agents|mesh-ancestor
6281895|NCT01155375|Ferrous fumarate|ferrous fumarate|mesh-list
6281896|NCT01155375|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
6281897|NCT01155375|Hematinics|hematinics|mesh-ancestor
6281898|NCT01155375|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6281899|NCT01155375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6281900|NCT01155375|Trace Elements|trace elements|mesh-ancestor
6281901|NCT01155375|Micronutrients|micronutrients|mesh-ancestor
6281902|NCT01155375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281903|NCT01157533|Vancomycin|vancomycin|mesh-list
6281904|NCT01157533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6281905|NCT01157533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6281906|NCT01162304|Oxycodone|oxycodone|mesh-list
6281907|NCT01162304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6281908|NCT01162304|Narcotics|narcotics|mesh-ancestor
6281909|NCT01162304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6281910|NCT01162304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281911|NCT01162304|Analgesics|analgesics|mesh-ancestor
6281912|NCT01162304|Sensory System Agents|sensory system agents|mesh-ancestor
6281913|NCT01162304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6281914|NCT01151904|Timolol|timolol|mesh-list
6281915|NCT01151904|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6281916|NCT01151904|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6281917|NCT01151904|Latanoprost|latanoprost|mesh-list
6281918|NCT01151904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6281919|NCT01151904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6281920|NCT01151904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6281921|NCT01151904|Adrenergic Agents|adrenergic agents|mesh-ancestor
6281922|NCT01151904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6281923|NCT01151904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281924|NCT01151904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281925|NCT01151904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6281926|NCT01151904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6281927|NCT01151904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6281928|NCT01151904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6281929|NCT01151904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6281930|NCT01155518|Clomiphene|clomiphene|mesh-list
6281931|NCT01155518|Testosterone|testosterone|mesh-list
6281932|NCT01155518|Androgens|androgens|mesh-ancestor
6281933|NCT01155518|Hormones|hormones|mesh-ancestor
6281934|NCT01155518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6281935|NCT01155518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281936|NCT01155518|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6281937|NCT01155518|Hormone Antagonists|hormone antagonists|mesh-ancestor
6281938|NCT01155518|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6281939|NCT01155518|Fertility Agents|fertility agents|mesh-ancestor
6281940|NCT01155518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6281941|NCT01155518|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6281942|NCT01155518|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6281943|NCT01150409|Hydrocortisone|hydrocortisone|mesh-list
6281944|NCT01150409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6281945|NCT01147393|Epratuzumab|epratuzumab|mesh-list
6281946|NCT01147393|Veltuzumab|veltuzumab|mesh-list
6281947|NCT01147393|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
6281948|NCT01147393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6281949|NCT01147393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6281950|NCT01147393|Chelating Agents|chelating agents|mesh-ancestor
6281951|NCT01147393|Sequestering Agents|sequestering agents|mesh-ancestor
6281952|NCT01147393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281953|NCT01147042|Interferons|interferons|mesh-list
6281954|NCT01147042|Interferon-gamma|interferon-gamma|mesh-list
6281955|NCT01147042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6281956|NCT01147042|Antiviral Agents|antiviral agents|mesh-ancestor
6281957|NCT01147042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6281958|NCT01139996|Clonidine|clonidine|mesh-list
6281959|NCT01139996|Analgesics|analgesics|mesh-ancestor
6281960|NCT01139996|Sensory System Agents|sensory system agents|mesh-ancestor
6281961|NCT01139996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6281962|NCT01139996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281963|NCT01139996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6281964|NCT01139996|Sympatholytics|sympatholytics|mesh-ancestor
6281965|NCT01139996|Autonomic Agents|autonomic agents|mesh-ancestor
6281966|NCT01139996|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6281967|NCT01139996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6281968|NCT01139996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6281969|NCT01139996|Adrenergic Agents|adrenergic agents|mesh-ancestor
6281970|NCT01139996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6281971|NCT01139996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281972|NCT01142128|Esomeprazole|esomeprazole|mesh-list
6281973|NCT01142128|Pancrelipase|pancrelipase|mesh-list
6281974|NCT01142128|Pancreatin|pancreatin|mesh-list
6281975|NCT01142128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6281976|NCT01142128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6281977|NCT01142128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6281978|NCT01142128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6281979|NCT01142128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281980|NCT01131884|Alendronate|alendronate|mesh-list
6281981|NCT01131884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6281982|NCT01131884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281983|NCT01128114|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6281984|NCT01128114|Antidepressive Agents|antidepressive agents|mesh-ancestor
6281985|NCT01128114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6281986|NCT01128114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6281987|NCT01128114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6281988|NCT01128114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6281989|NCT01128114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281990|NCT01126879|Genistein|genistein|mesh-list
6281991|NCT01126879|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6281992|NCT01126879|Protective Agents|protective agents|mesh-ancestor
6281993|NCT01126879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6281994|NCT01126879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6281995|NCT01126879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6281996|NCT01126879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6281997|NCT01126879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6281998|NCT01126879|Phytoestrogens|phytoestrogens|mesh-ancestor
6281999|NCT01126879|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6282000|NCT01126879|Estrogens|estrogens|mesh-ancestor
6282001|NCT01126879|Hormones|hormones|mesh-ancestor
6282002|NCT01126879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6391542|NCT00193466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6391543|NCT00193505|Rituximab|rituximab|mesh-list
6391544|NCT00193505|Carboplatin|carboplatin|mesh-list
6391545|NCT00193505|Etoposide|etoposide|mesh-list
6391546|NCT00193505|Ifosfamide|ifosfamide|mesh-list
6391547|NCT00193505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6282003|NCT01139125|Cysteamine|cysteamine|mesh-list
6282004|NCT01139125|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
6282005|NCT01139125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282006|NCT01133639|Ketorolac|ketorolac|mesh-list
6282007|NCT01133639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6282008|NCT01133639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6282009|NCT01133639|Analgesics|analgesics|mesh-ancestor
6282010|NCT01133639|Sensory System Agents|sensory system agents|mesh-ancestor
6282011|NCT01133639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6282012|NCT01133639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282013|NCT01133639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6282014|NCT01133639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6282015|NCT01133639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6282016|NCT01133639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6282017|NCT01133639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282018|NCT01126801|Estradiol|estradiol|mesh-list
6282019|NCT01126801|Estrogens|estrogens|mesh-ancestor
6282020|NCT01126801|Hormones|hormones|mesh-ancestor
6282021|NCT01126801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6282022|NCT01126801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282023|NCT01126957|Fentanyl|fentanyl|mesh-list
6282024|NCT01126957|Ketamine|ketamine|mesh-list
6282025|NCT01126957|Propofol|propofol|mesh-list
6282026|NCT01126957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6282027|NCT01126957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6282028|NCT01126957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282029|NCT01126957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6282030|NCT01126957|Anesthetics, General|anesthetics, general|mesh-ancestor
6282031|NCT01126957|Anesthetics|anesthetics|mesh-ancestor
6282032|NCT01126957|Analgesics|analgesics|mesh-ancestor
6282033|NCT01126957|Sensory System Agents|sensory system agents|mesh-ancestor
6282034|NCT01126957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6282035|NCT01126957|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6282036|NCT01126957|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6282037|NCT01126957|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6282038|NCT01126957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6282039|NCT01126957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282040|NCT01126957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6282041|NCT01126957|Narcotics|narcotics|mesh-ancestor
6282042|NCT01126957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6282043|NCT01127503|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
6282044|NCT01127503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6282045|NCT01127503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282046|NCT01122511|Dexamethasone|dexamethasone|mesh-list
6282047|NCT01122511|Ranibizumab|ranibizumab|mesh-list
6282048|NCT01122511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6282049|NCT01122511|Antiemetics|antiemetics|mesh-ancestor
6282050|NCT01122511|Autonomic Agents|autonomic agents|mesh-ancestor
6282051|NCT01122511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6282052|NCT01122511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282053|NCT01122511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6282054|NCT01122511|Glucocorticoids|glucocorticoids|mesh-ancestor
6282055|NCT01122511|Hormones|hormones|mesh-ancestor
6282056|NCT01122511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6282057|NCT01122511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6282058|NCT01122511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6282059|NCT01122511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6282060|NCT01122511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6282061|NCT01122511|Growth Substances|growth substances|mesh-ancestor
6282062|NCT01122511|Growth Inhibitors|growth inhibitors|mesh-ancestor
6282063|NCT01118013|Mycophenolic Acid|mycophenolic acid|mesh-list
6282064|NCT01118013|Methotrexate|methotrexate|mesh-list
6282065|NCT01118013|Fludarabine phosphate|fludarabine phosphate|mesh-list
6282066|NCT01118013|Fludarabine|fludarabine|mesh-list
6282067|NCT01118013|Busulfan|busulfan|mesh-list
6282068|NCT01118013|Tacrolimus|tacrolimus|mesh-list
6282069|NCT01118013|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6282070|NCT01118013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6282071|NCT01118013|Abortifacient Agents|abortifacient agents|mesh-ancestor
6282072|NCT01118013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6282073|NCT01118013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282074|NCT01118013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6282075|NCT01118013|Antimetabolites|antimetabolites|mesh-ancestor
6282076|NCT01118013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282077|NCT01118013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6282078|NCT01118013|Dermatologic Agents|dermatologic agents|mesh-ancestor
6282079|NCT01118013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6282080|NCT01118013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6282081|NCT01118013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6282082|NCT01118013|Immunologic Factors|immunologic factors|mesh-ancestor
6282083|NCT01118013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6282084|NCT01118013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6282085|NCT01118013|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6282086|NCT01118013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6282087|NCT01118013|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6282088|NCT01118013|Antitubercular Agents|antitubercular agents|mesh-ancestor
6282089|NCT01118013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6282090|NCT01118013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6282091|NCT01118013|Alkylating Agents|alkylating agents|mesh-ancestor
6282092|NCT01118013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6282093|NCT01118013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6282094|NCT01122381|Ethosuximide|ethosuximide|mesh-list
6282095|NCT01122381|Anticonvulsants|anticonvulsants|mesh-ancestor
6282096|NCT01116232|Sirolimus|sirolimus|mesh-list
6282097|NCT01116232|Rituximab|rituximab|mesh-list
6282098|NCT01116232|Tacrolimus|tacrolimus|mesh-list
6282099|NCT01116232|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6282100|NCT01116232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6282101|NCT01116232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6282102|NCT01116232|Immunologic Factors|immunologic factors|mesh-ancestor
6282103|NCT01116232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282104|NCT01116232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6282105|NCT01116232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6282106|NCT01116232|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6282107|NCT01116232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6282108|NCT01116232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282109|NCT01116232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6282110|NCT01116232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6282111|NCT01116232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6282112|NCT01116232|Antifungal Agents|antifungal agents|mesh-ancestor
6282113|NCT01108666|Nelfinavir|nelfinavir|mesh-list
6282114|NCT01108666|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6282115|NCT01108666|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6282116|NCT01108666|Protease Inhibitors|protease inhibitors|mesh-ancestor
6282117|NCT01108666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6282118|NCT01108666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282119|NCT01108666|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6282120|NCT01108666|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6282121|NCT01108666|Antiviral Agents|antiviral agents|mesh-ancestor
6282122|NCT01108666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6282123|NCT01115244|Dapsone|dapsone|mesh-list
6282124|NCT01115244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6282125|NCT01115244|Antimalarials|antimalarials|mesh-ancestor
6282126|NCT01115244|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6282127|NCT01115244|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6282128|NCT01115244|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6282129|NCT01115244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6282130|NCT01115244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282131|NCT01115244|Leprostatic Agents|leprostatic agents|mesh-ancestor
6282132|NCT01115244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6282133|NCT01106534|Aspirin|aspirin|mesh-list
6282134|NCT01106534|Everolimus|everolimus|mesh-list
6282135|NCT01106534|Clopidogrel|clopidogrel|mesh-list
6282136|NCT01106534|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6282137|NCT01106534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6282138|NCT01106534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6282139|NCT01106534|Analgesics|analgesics|mesh-ancestor
6282140|NCT01106534|Sensory System Agents|sensory system agents|mesh-ancestor
6282141|NCT01106534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6282142|NCT01106534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282143|NCT01106534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6282144|NCT01106534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6282145|NCT01106534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6282146|NCT01106534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6282147|NCT01106534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282148|NCT01106534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6282149|NCT01106534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6282150|NCT01106534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6282151|NCT01106534|Antipyretics|antipyretics|mesh-ancestor
6015284|NCT00356265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6015285|NCT00356265|Adrenergic Agents|adrenergic agents|mesh-ancestor
6282152|NCT01106534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6282153|NCT01106534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6282154|NCT01106534|Immunologic Factors|immunologic factors|mesh-ancestor
6282155|NCT01106534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6282156|NCT01106534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6282157|NCT01106534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6282158|NCT01106534|Purinergic Agents|purinergic agents|mesh-ancestor
6282159|NCT01106534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6282160|NCT01100658|Methylphenidate|methylphenidate|mesh-list
6282161|NCT01100658|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6282162|NCT01100658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282163|NCT01100658|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6282164|NCT01100658|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6282165|NCT01100658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6282166|NCT01100658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282167|NCT01100658|Dopamine Agents|dopamine agents|mesh-ancestor
6282168|NCT01100658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6282169|NCT01103180|Citalopram|citalopram|mesh-list
6282170|NCT01103180|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6282171|NCT01103180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6282172|NCT01103180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6282173|NCT01103180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282174|NCT01103180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6282175|NCT01103180|Serotonin Agents|serotonin agents|mesh-ancestor
6282176|NCT01103180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282177|NCT01103180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6282178|NCT01103180|Antidepressive Agents|antidepressive agents|mesh-ancestor
6282179|NCT01103180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6282180|NCT01090141|Micafungin|micafungin|mesh-list
6282181|NCT01090141|Antifungal Agents|antifungal agents|mesh-ancestor
6282182|NCT01090141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6282183|NCT01095250|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6282184|NCT01095250|Immunologic Factors|immunologic factors|mesh-ancestor
6282185|NCT01095250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015286|NCT00356265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6015287|NCT00356265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015288|NCT00356265|Protective Agents|protective agents|mesh-ancestor
6015289|NCT00356278|Cycloserine|cycloserine|mesh-list
6015290|NCT00356278|Alprazolam|alprazolam|mesh-list
6015291|NCT00356278|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6015292|NCT00356278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6015293|NCT00356278|Renal Agents|renal agents|mesh-ancestor
6015294|NCT00356278|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6282186|NCT01094561|Secretin|secretin|mesh-list
6282187|NCT01094561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6282188|NCT01094561|Hormones|hormones|mesh-ancestor
6282189|NCT01094561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6282190|NCT01094561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015295|NCT00356278|Antitubercular Agents|antitubercular agents|mesh-ancestor
6015296|NCT00356278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6015297|NCT00356278|Antimetabolites|antimetabolites|mesh-ancestor
6015298|NCT00356278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015299|NCT00356278|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6282191|NCT01093846|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6282192|NCT01093846|Immunologic Factors|immunologic factors|mesh-ancestor
6282193|NCT01093846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282194|NCT01078844|Memantine|memantine|mesh-list
6282195|NCT01078844|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6282196|NCT01078844|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6282197|NCT01078844|Dopamine Agents|dopamine agents|mesh-ancestor
6282198|NCT01078844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6282199|NCT01078844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282200|NCT01078844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282201|NCT01078844|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6282202|NCT01078844|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6282203|NCT01085643|Lubiprostone|lubiprostone|mesh-list
6282204|NCT01085643|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6282205|NCT01085643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6282206|NCT01085643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282207|NCT01080768|Amlodipine|amlodipine|mesh-list
6282208|NCT01080768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6282209|NCT01080768|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6282210|NCT01080768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6282211|NCT01080768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282212|NCT01080768|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6282213|NCT01080768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282214|NCT01080768|Vasodilator Agents|vasodilator agents|mesh-ancestor
6282215|NCT01074502|Apremilast|apremilast|mesh-list
6282216|NCT01074502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6282217|NCT01074502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6282218|NCT01074502|Analgesics|analgesics|mesh-ancestor
6282219|NCT01074502|Sensory System Agents|sensory system agents|mesh-ancestor
6282220|NCT01074502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6282221|NCT01074502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282222|NCT01074502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6282223|NCT01074502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6282224|NCT01074502|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6282225|NCT01074502|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6282226|NCT01074502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6282227|NCT01074502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282228|NCT01074437|Prednisolone|prednisolone|mesh-list
6282229|NCT01074437|Propranolol|propranolol|mesh-list
6282230|NCT01074437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6282231|NCT01074437|Glucocorticoids|glucocorticoids|mesh-ancestor
6282232|NCT01074437|Hormones|hormones|mesh-ancestor
6282233|NCT01074437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6282234|NCT01074437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282235|NCT01074437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6282236|NCT01074437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6282237|NCT01074437|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6282238|NCT01074437|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6282239|NCT01074437|Adrenergic Agents|adrenergic agents|mesh-ancestor
6282240|NCT01074437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6282241|NCT01074437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282242|NCT01074437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6282243|NCT01074437|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6015300|NCT00356278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6015301|NCT00356278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015302|NCT00356278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6015303|NCT00356278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6282244|NCT01074437|Vasodilator Agents|vasodilator agents|mesh-ancestor
6282245|NCT01072526|Cyclosporine|cyclosporine|mesh-list
6282246|NCT01072526|Lubricant Eye Drops|lubricant eye drops|mesh-list
6282247|NCT01072526|Cyclosporins|cyclosporins|mesh-list
6282248|NCT01072526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6282249|NCT01072526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282250|NCT01072526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6282251|NCT01072526|Immunologic Factors|immunologic factors|mesh-ancestor
6282252|NCT01072526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282253|NCT01072526|Antifungal Agents|antifungal agents|mesh-ancestor
6282254|NCT01072526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6282255|NCT01072526|Dermatologic Agents|dermatologic agents|mesh-ancestor
6282256|NCT01072526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6282257|NCT01072526|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6282258|NCT01072526|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6282259|NCT01072526|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6282260|NCT01071993|Atorvastatin|atorvastatin|mesh-list
6282261|NCT01071993|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6282262|NCT01071993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6282263|NCT01071993|Antimetabolites|antimetabolites|mesh-ancestor
6282264|NCT01071993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282265|NCT01071993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6282266|NCT01071993|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6282267|NCT01071993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6282268|NCT01065051|Riociguat|riociguat|mesh-list
6282269|NCT01065051|Enzyme Activators|enzyme activators|mesh-ancestor
6282270|NCT01065051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282271|NCT01058642|Pregabalin|pregabalin|mesh-list
6282272|NCT01058642|Analgesics|analgesics|mesh-ancestor
6282273|NCT01058642|Sensory System Agents|sensory system agents|mesh-ancestor
6282274|NCT01058642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6282275|NCT01058642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282276|NCT01058642|Anticonvulsants|anticonvulsants|mesh-ancestor
6282277|NCT01058642|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6282278|NCT01058642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6282279|NCT01058642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282280|NCT01058642|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6282281|NCT01058642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6282282|NCT01058642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6282283|NCT01058642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6282284|NCT01058642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6282285|NCT01065818|Telbivudine|telbivudine|mesh-list
6282286|NCT01065818|Antiviral Agents|antiviral agents|mesh-ancestor
6282287|NCT01065818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6282288|NCT01065818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6282289|NCT01065818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6282290|NCT01065818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282291|NCT01051921|Interferons|interferons|mesh-list
6282292|NCT01051921|Ribavirin|ribavirin|mesh-list
6282293|NCT01051921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6282294|NCT01051921|Antiviral Agents|antiviral agents|mesh-ancestor
6282295|NCT01051921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6282296|NCT01051921|Antimetabolites|antimetabolites|mesh-ancestor
6282297|NCT01051921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282298|NCT01048125|Nitroprusside|nitroprusside|mesh-list
6282299|NCT01048125|Phenylephrine|phenylephrine|mesh-list
6282300|NCT01048125|Oxymetazoline|oxymetazoline|mesh-list
6282301|NCT01048125|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6282302|NCT01048125|Mydriatics|mydriatics|mesh-ancestor
6282303|NCT01048125|Autonomic Agents|autonomic agents|mesh-ancestor
6282304|NCT01048125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6282305|NCT01048125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282306|NCT01048125|Sympathomimetics|sympathomimetics|mesh-ancestor
6282307|NCT01048125|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6282308|NCT01048125|Nasal Decongestants|nasal decongestants|mesh-ancestor
6282309|NCT01048125|Respiratory System Agents|respiratory system agents|mesh-ancestor
6282310|NCT01048125|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6282311|NCT01048125|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6282312|NCT01048125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6282313|NCT01048125|Adrenergic Agents|adrenergic agents|mesh-ancestor
6282314|NCT01048125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6282315|NCT01048125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282316|NCT01048125|Protective Agents|protective agents|mesh-ancestor
6282317|NCT01048125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6282318|NCT01048125|Vasodilator Agents|vasodilator agents|mesh-ancestor
6282319|NCT01048125|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6282320|NCT01058369|Deferasirox|deferasirox|mesh-list
6282321|NCT01058369|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6282322|NCT01058369|Chelating Agents|chelating agents|mesh-ancestor
6282323|NCT01058369|Sequestering Agents|sequestering agents|mesh-ancestor
6282324|NCT01058369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282325|NCT01048723|Everolimus|everolimus|mesh-list
6282326|NCT01048723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6282327|NCT01048723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6282328|NCT01048723|Immunologic Factors|immunologic factors|mesh-ancestor
6282329|NCT01048723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282330|NCT01053221|Mycophenolic Acid|mycophenolic acid|mesh-list
6282331|NCT01053221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6282332|NCT01053221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6282333|NCT01053221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6282334|NCT01053221|Antitubercular Agents|antitubercular agents|mesh-ancestor
6282335|NCT01053221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6282336|NCT01053221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6282337|NCT01053221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6282338|NCT01053221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282339|NCT01038752|Suramin|suramin|mesh-list
6282340|NCT01038752|Carboplatin|carboplatin|mesh-list
6282341|NCT01038752|Docetaxel|docetaxel|mesh-list
6282342|NCT01038752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6282343|NCT01038752|Tubulin Modulators|tubulin modulators|mesh-ancestor
6282344|NCT01038752|Antimitotic Agents|antimitotic agents|mesh-ancestor
6282345|NCT01038752|Mitosis Modulators|mitosis modulators|mesh-ancestor
6282346|NCT01038752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282347|NCT01038752|Antinematodal Agents|antinematodal agents|mesh-ancestor
6282348|NCT01038752|Anthelmintics|anthelmintics|mesh-ancestor
6282349|NCT01038752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6282350|NCT01038752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6282351|NCT01038752|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6282352|NCT01038752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6282353|NCT01050218|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6282354|NCT01050218|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6282355|NCT01050218|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6282356|NCT01050218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6282357|NCT01050218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282358|NCT01050218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6282359|NCT01050218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282360|NCT01050218|Antidepressive Agents|antidepressive agents|mesh-ancestor
6282361|NCT01050218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6282362|NCT01045694|Triamcinolone|triamcinolone|mesh-list
6282363|NCT01045694|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6282364|NCT01045694|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6282365|NCT01045694|Lidocaine|lidocaine|mesh-list
6282366|NCT01045694|Botulinum Toxins|botulinum toxins|mesh-list
6282367|NCT01045694|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6282368|NCT01045694|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6282369|NCT01045694|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6282370|NCT01045694|Anesthetics, Local|anesthetics, local|mesh-ancestor
6282371|NCT01045694|Anesthetics|anesthetics|mesh-ancestor
6282372|NCT01045694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6282373|NCT01045694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282374|NCT01045694|Sensory System Agents|sensory system agents|mesh-ancestor
6282375|NCT01045694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6282376|NCT01045694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6282377|NCT01045694|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6282378|NCT01045694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6282379|NCT01045694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6282380|NCT01045694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282381|NCT01045694|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6282382|NCT01045694|Cholinergic Agents|cholinergic agents|mesh-ancestor
6282383|NCT01045694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6282384|NCT01045694|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6282385|NCT01045694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6282386|NCT01045694|Glucocorticoids|glucocorticoids|mesh-ancestor
6282387|NCT01045694|Hormones|hormones|mesh-ancestor
6282388|NCT01045694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6282389|NCT01045694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6282390|NCT01045694|Immunologic Factors|immunologic factors|mesh-ancestor
6282391|NCT01045694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6282392|NCT01035944|Chitosan|chitosan|mesh-list
6282393|NCT01035944|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6282394|NCT01035944|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6282395|NCT01035944|Antimetabolites|antimetabolites|mesh-ancestor
6282396|NCT01035944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282397|NCT01035944|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6282398|NCT01035944|Chelating Agents|chelating agents|mesh-ancestor
6282399|NCT01035944|Sequestering Agents|sequestering agents|mesh-ancestor
6282400|NCT01035944|Hemostatics|hemostatics|mesh-ancestor
6282401|NCT01035944|Coagulants|coagulants|mesh-ancestor
6282402|NCT01031628|Imatinib Mesylate|imatinib mesylate|mesh-list
6282403|NCT01031628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6282404|NCT01031628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6282405|NCT01031628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6282406|NCT01031628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282407|NCT01035073|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6282408|NCT01035073|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6282409|NCT01035073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6282410|NCT01035073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6282411|NCT01035073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282412|NCT01035073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6282413|NCT01035073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282414|NCT01035073|Analgesics|analgesics|mesh-ancestor
6282415|NCT01035073|Sensory System Agents|sensory system agents|mesh-ancestor
6282416|NCT01035073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6282417|NCT01035073|Antidepressive Agents|antidepressive agents|mesh-ancestor
6282418|NCT01035073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6282419|NCT01035073|Dopamine Agents|dopamine agents|mesh-ancestor
6282420|NCT01031550|Propofol|propofol|mesh-list
6282421|NCT01031550|Isoflurane|isoflurane|mesh-list
6282422|NCT01031550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6282423|NCT01031550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6282424|NCT01031550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282425|NCT01031550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6282426|NCT01031550|Anesthetics, General|anesthetics, general|mesh-ancestor
6282427|NCT01031550|Anesthetics|anesthetics|mesh-ancestor
6282428|NCT01031550|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6282429|NCT01025271|Daptomycin|daptomycin|mesh-list
6282430|NCT01025271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6282431|NCT01025271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6282432|NCT01022398|Vitamin D|vitamin d|mesh-list
6282433|NCT01022398|Cholecalciferol|cholecalciferol|mesh-list
6282434|NCT01022398|Vitamins|vitamins|mesh-ancestor
6282435|NCT01022398|Micronutrients|micronutrients|mesh-ancestor
6282436|NCT01022398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282437|NCT01022398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6282438|NCT01022398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6282439|NCT01019980|Acetaminophen|acetaminophen|mesh-list
6282440|NCT01019980|Diclofenac|diclofenac|mesh-list
6282441|NCT01019980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6282442|NCT01019980|Analgesics|analgesics|mesh-ancestor
6282443|NCT01019980|Sensory System Agents|sensory system agents|mesh-ancestor
6282444|NCT01019980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6282445|NCT01019980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282446|NCT01019980|Antipyretics|antipyretics|mesh-ancestor
6282447|NCT01019980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6282448|NCT01019980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6282449|NCT01019980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6282450|NCT01019980|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6282451|NCT01019980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6282452|NCT01019980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282453|NCT01025492|Fenofibric acid|fenofibric acid|mesh-list
6282454|NCT01025492|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6282455|NCT01025492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6282456|NCT01025492|Antimetabolites|antimetabolites|mesh-ancestor
6282457|NCT01025492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282458|NCT01025492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6282459|NCT01017263|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6282460|NCT01017263|Dextroamphetamine|dextroamphetamine|mesh-list
6282461|NCT01017263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6282462|NCT01017263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282463|NCT01017263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6282464|NCT01017263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6282465|NCT01017263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6282466|NCT01017263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282467|NCT01017263|Dopamine Agents|dopamine agents|mesh-ancestor
6282468|NCT01017263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6282469|NCT01020903|Aprepitant|aprepitant|mesh-list
6282470|NCT01020903|Antiemetics|antiemetics|mesh-ancestor
6282471|NCT01020903|Autonomic Agents|autonomic agents|mesh-ancestor
6282472|NCT01020903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6282473|NCT01020903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282474|NCT01020903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6282475|NCT01020903|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6282476|NCT01020903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6282477|NCT01020903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282478|NCT01023620|Pioglitazone|pioglitazone|mesh-list
6282479|NCT01023620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6282480|NCT01023620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282481|NCT01018810|Interleukin-23|interleukin-23|mesh-list
6282482|NCT01018810|Antibodies|antibodies|mesh-list
6282483|NCT01018810|Immunoglobulins|immunoglobulins|mesh-list
6282484|NCT01018810|Immunologic Factors|immunologic factors|mesh-ancestor
6282485|NCT01018810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282486|NCT01018810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6282487|NCT01018810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6282488|NCT01018810|Growth Substances|growth substances|mesh-ancestor
6282489|NCT01018810|Growth Inhibitors|growth inhibitors|mesh-ancestor
6282490|NCT01018810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6282491|NCT01016561|Cisplatin|cisplatin|mesh-list
6282492|NCT01016561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6282493|NCT01016847|Montelukast|montelukast|mesh-list
6282494|NCT01016847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6282495|NCT01016847|Respiratory System Agents|respiratory system agents|mesh-ancestor
6282496|NCT01016847|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6282497|NCT01016847|Hormone Antagonists|hormone antagonists|mesh-ancestor
6282498|NCT01016847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6282499|NCT01016847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282500|NCT01016847|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6282501|NCT01016847|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6282502|NCT01016847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282503|NCT01014767|Leucovorin|leucovorin|mesh-list
6282504|NCT01014767|Dactinomycin|dactinomycin|mesh-list
6282505|NCT01014767|Cyclophosphamide|cyclophosphamide|mesh-list
6282506|NCT01014767|Temozolomide|temozolomide|mesh-list
6282507|NCT01014767|Cisplatin|cisplatin|mesh-list
6282508|NCT01014767|Carboplatin|carboplatin|mesh-list
6282509|NCT01014767|Doxorubicin|doxorubicin|mesh-list
6282510|NCT01014767|Methotrexate|methotrexate|mesh-list
6282511|NCT01014767|Irinotecan|irinotecan|mesh-list
6282512|NCT01014767|Etoposide|etoposide|mesh-list
6282513|NCT01014767|Vincristine|vincristine|mesh-list
6282514|NCT01014767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6282515|NCT01014767|Immunologic Factors|immunologic factors|mesh-ancestor
6282516|NCT01014767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282517|NCT01014767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6282518|NCT01014767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6282519|NCT01014767|Alkylating Agents|alkylating agents|mesh-ancestor
6282520|NCT01014767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282521|NCT01014767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6282522|NCT01014767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6282523|NCT01014767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6282524|NCT01014767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6282525|NCT01014767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6282526|NCT01014767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6282527|NCT01014767|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6282528|NCT01014767|Abortifacient Agents|abortifacient agents|mesh-ancestor
6282529|NCT01014767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6282530|NCT01014767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6282531|NCT01014767|Antimetabolites|antimetabolites|mesh-ancestor
6282532|NCT01014767|Dermatologic Agents|dermatologic agents|mesh-ancestor
6282533|NCT01014767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6282534|NCT01014767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6282535|NCT01014767|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6282536|NCT01014767|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6282537|NCT01014767|Antidotes|antidotes|mesh-ancestor
6282538|NCT01014767|Protective Agents|protective agents|mesh-ancestor
6282539|NCT01014767|Vitamin B Complex|vitamin b complex|mesh-ancestor
6282540|NCT01014767|Vitamins|vitamins|mesh-ancestor
6282541|NCT01014767|Micronutrients|micronutrients|mesh-ancestor
6282542|NCT01014767|Tubulin Modulators|tubulin modulators|mesh-ancestor
6282543|NCT01014767|Antimitotic Agents|antimitotic agents|mesh-ancestor
6282544|NCT01014767|Mitosis Modulators|mitosis modulators|mesh-ancestor
6282545|NCT01014767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6282546|NCT01014767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6282547|NCT01014767|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6282548|NCT01013701|Fluticasone|fluticasone|mesh-list
6282549|NCT01013701|Xhance|xhance|mesh-list
6282550|NCT01013701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6282551|NCT01013701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6282552|NCT01013701|Autonomic Agents|autonomic agents|mesh-ancestor
6282553|NCT01013701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6282554|NCT01013701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282555|NCT01013701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6282556|NCT01013701|Respiratory System Agents|respiratory system agents|mesh-ancestor
6282557|NCT01013701|Dermatologic Agents|dermatologic agents|mesh-ancestor
6282558|NCT01013701|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6282559|NCT01009931|Dexamethasone|dexamethasone|mesh-list
6282560|NCT01009931|Dexamethasone acetate|dexamethasone acetate|mesh-list
6282561|NCT01009931|Choline magnesium trisalicylate|choline magnesium trisalicylate|mesh-list
6282562|NCT01009931|Choline|choline|mesh-list
6282563|NCT01009931|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
6282564|NCT01009931|BB 1101|bb 1101|mesh-list
6282565|NCT01009931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6282566|NCT01009931|Antiemetics|antiemetics|mesh-ancestor
6282567|NCT01009931|Autonomic Agents|autonomic agents|mesh-ancestor
6282568|NCT01009931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6282569|NCT01009931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282570|NCT01009931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6282571|NCT01009931|Glucocorticoids|glucocorticoids|mesh-ancestor
6282572|NCT01009931|Hormones|hormones|mesh-ancestor
6282573|NCT01009931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6282574|NCT01009931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6282575|NCT01009931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6282576|NCT01009931|Protease Inhibitors|protease inhibitors|mesh-ancestor
6282577|NCT01009931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6282578|NCT01009931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282579|NCT01009931|Lipotropic Agents|lipotropic agents|mesh-ancestor
6282580|NCT01009931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6282581|NCT01009931|Antimetabolites|antimetabolites|mesh-ancestor
6282582|NCT01009931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6282583|NCT01009931|Nootropic Agents|nootropic agents|mesh-ancestor
6282584|NCT01009931|Analgesics|analgesics|mesh-ancestor
6282585|NCT01009931|Sensory System Agents|sensory system agents|mesh-ancestor
6282586|NCT01009931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6282587|NCT01009931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6282588|NCT01009931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6282589|NCT01006018|Pioglitazone|pioglitazone|mesh-list
6282590|NCT01006018|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6282591|NCT01006018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6282592|NCT01006018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282593|NCT01006018|Incretins|incretins|mesh-ancestor
6282594|NCT01006018|Hormones|hormones|mesh-ancestor
6282595|NCT01006018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6282596|NCT01006018|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6282597|NCT01006018|Protease Inhibitors|protease inhibitors|mesh-ancestor
6282598|NCT01006018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6282599|NCT01006018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282600|NCT01004510|Zoledronic Acid|zoledronic acid|mesh-list
6282601|NCT01004510|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6282602|NCT01004510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282603|NCT01005914|Cytarabine|cytarabine|mesh-list
6282604|NCT01005914|Dexamethasone|dexamethasone|mesh-list
6282605|NCT01005914|Methylprednisolone|methylprednisolone|mesh-list
6282606|NCT01005914|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6282607|NCT01005914|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6282608|NCT01005914|Cyclophosphamide|cyclophosphamide|mesh-list
6282609|NCT01005914|Doxorubicin|doxorubicin|mesh-list
6282610|NCT01005914|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6282611|NCT01005914|Methotrexate|methotrexate|mesh-list
6282612|NCT01005914|Vincristine|vincristine|mesh-list
6282613|NCT01005914|Imatinib Mesylate|imatinib mesylate|mesh-list
6282614|NCT01005914|Asparaginase|asparaginase|mesh-list
6282615|NCT01005914|Pegaspargase|pegaspargase|mesh-list
6282616|NCT01005914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6282617|NCT01005914|Immunologic Factors|immunologic factors|mesh-ancestor
6282618|NCT01005914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282619|NCT01005914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6282620|NCT01005914|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6282621|NCT01005914|Alkylating Agents|alkylating agents|mesh-ancestor
6282622|NCT01005914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282623|NCT01005914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6282624|NCT01005914|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6282625|NCT01005914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6282626|NCT01005914|Antiemetics|antiemetics|mesh-ancestor
6282627|NCT01005914|Autonomic Agents|autonomic agents|mesh-ancestor
6282628|NCT01005914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6282629|NCT01005914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6282630|NCT01005914|Glucocorticoids|glucocorticoids|mesh-ancestor
6282631|NCT01005914|Hormones|hormones|mesh-ancestor
6282632|NCT01005914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6282633|NCT01005914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6282634|NCT01005914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6282635|NCT01005914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6282636|NCT01005914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6282637|NCT01005914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6282638|NCT01005914|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6282639|NCT01005914|Abortifacient Agents|abortifacient agents|mesh-ancestor
6282640|NCT01005914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6282641|NCT01005914|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6282642|NCT01005914|Antimetabolites|antimetabolites|mesh-ancestor
6282643|NCT01005914|Dermatologic Agents|dermatologic agents|mesh-ancestor
6282644|NCT01005914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6282645|NCT01005914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6282646|NCT01005914|Antiviral Agents|antiviral agents|mesh-ancestor
6282647|NCT01005914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6282648|NCT01005914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6282649|NCT01005914|Tubulin Modulators|tubulin modulators|mesh-ancestor
6282650|NCT01005914|Antimitotic Agents|antimitotic agents|mesh-ancestor
6282651|NCT01005914|Mitosis Modulators|mitosis modulators|mesh-ancestor
6282652|NCT01005914|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6282653|NCT01005914|Protective Agents|protective agents|mesh-ancestor
6282654|NCT01005914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6282655|NCT00996333|Gemcitabine|gemcitabine|mesh-list
6282656|NCT00996333|Capecitabine|capecitabine|mesh-list
6282657|NCT00996333|Docetaxel|docetaxel|mesh-list
6282658|NCT00996333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6282659|NCT00996333|Antimetabolites|antimetabolites|mesh-ancestor
6282660|NCT00996333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282661|NCT00996333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6282662|NCT00996333|Antiviral Agents|antiviral agents|mesh-ancestor
6282663|NCT00996333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6282664|NCT00996333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6282665|NCT00996333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6282666|NCT00996333|Immunologic Factors|immunologic factors|mesh-ancestor
6282667|NCT00996333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282668|NCT00996333|Tubulin Modulators|tubulin modulators|mesh-ancestor
6282669|NCT00996333|Antimitotic Agents|antimitotic agents|mesh-ancestor
6282670|NCT00996333|Mitosis Modulators|mitosis modulators|mesh-ancestor
6282671|NCT00998738|Calcium, Dietary|calcium, dietary|mesh-list
6282672|NCT00998738|Magnesium Sulfate|magnesium sulfate|mesh-list
6282673|NCT00998738|Calcium|calcium|mesh-list
6282674|NCT00998738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6282675|NCT00998738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282676|NCT00998738|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6282677|NCT00998738|Analgesics|analgesics|mesh-ancestor
6282678|NCT00998738|Sensory System Agents|sensory system agents|mesh-ancestor
6282679|NCT00998738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6282680|NCT00998738|Anesthetics|anesthetics|mesh-ancestor
6282681|NCT00998738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6282682|NCT00998738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6282683|NCT00998738|Anticonvulsants|anticonvulsants|mesh-ancestor
6282684|NCT00998738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6282685|NCT00998738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6282686|NCT00998738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282687|NCT00998738|Tocolytic Agents|tocolytic agents|mesh-ancestor
6282688|NCT00998738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6282689|NCT00996502|Prednisone|prednisone|mesh-list
6282690|NCT00996502|Bevacizumab|bevacizumab|mesh-list
6282691|NCT00996502|Docetaxel|docetaxel|mesh-list
6282692|NCT00996502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6282693|NCT00996502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6282694|NCT00996502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6282695|NCT00996502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6282696|NCT00996502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6282697|NCT00996502|Growth Substances|growth substances|mesh-ancestor
6282698|NCT00996502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282699|NCT00996502|Growth Inhibitors|growth inhibitors|mesh-ancestor
6015304|NCT00356278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6282700|NCT00996502|Tubulin Modulators|tubulin modulators|mesh-ancestor
6282701|NCT00996502|Antimitotic Agents|antimitotic agents|mesh-ancestor
6282702|NCT00996502|Mitosis Modulators|mitosis modulators|mesh-ancestor
6282703|NCT00996502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282704|NCT00996502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6282705|NCT00996502|Glucocorticoids|glucocorticoids|mesh-ancestor
6282706|NCT00996502|Hormones|hormones|mesh-ancestor
6282707|NCT00996502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6282708|NCT00996502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6282709|NCT00996502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6282710|NCT00996502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6282711|NCT00997386|Melphalan|melphalan|mesh-list
6282712|NCT00997386|Busulfan|busulfan|mesh-list
6282713|NCT00997386|Alemtuzumab|alemtuzumab|mesh-list
6282714|NCT00997386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6282715|NCT00997386|Alkylating Agents|alkylating agents|mesh-ancestor
6282716|NCT00997386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282717|NCT00997386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6282718|NCT00997386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6282719|NCT00997386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6282720|NCT00997386|Immunologic Factors|immunologic factors|mesh-ancestor
6282721|NCT00997386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282722|NCT00997386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6282723|NCT00985738|Dutasteride|dutasteride|mesh-list
6282724|NCT00985738|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6282725|NCT00985738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6282726|NCT00985738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6282727|NCT00985738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282728|NCT00985738|Hormone Antagonists|hormone antagonists|mesh-ancestor
6015305|NCT00356278|GABA Modulators|gaba modulators|mesh-ancestor
6015306|NCT00356278|GABA Agents|gaba agents|mesh-ancestor
6015307|NCT00356278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6015308|NCT00356408|Certolizumab Pegol|certolizumab pegol|mesh-list
6015309|NCT00356408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6015310|NCT00356408|Immunologic Factors|immunologic factors|mesh-ancestor
6015311|NCT00356408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015312|NCT00356408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6015313|NCT00356525|Gemcitabine|gemcitabine|mesh-list
6015314|NCT00356525|Carboplatin|carboplatin|mesh-list
6015315|NCT00356525|Pemetrexed|pemetrexed|mesh-list
6282729|NCT00985738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6282730|NCT00985738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282731|NCT00986999|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6282732|NCT00986999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6282733|NCT00986999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6282734|NCT00986999|Antimetabolites|antimetabolites|mesh-ancestor
6282735|NCT00986999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282736|NCT00986999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6282737|NCT00986999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6282738|NCT00986999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6282739|NCT00989937|Oxytocin|oxytocin|mesh-list
6282740|NCT00989937|Oxytocics|oxytocics|mesh-ancestor
6282741|NCT00989937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6282742|NCT00989937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282743|NCT00986947|Rituximab|rituximab|mesh-list
6282744|NCT00986947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6282745|NCT00986947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6282746|NCT00986947|Immunologic Factors|immunologic factors|mesh-ancestor
6282747|NCT00986947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282748|NCT00986947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6282749|NCT00982995|Palonosetron|palonosetron|mesh-list
6282750|NCT00982995|Antiemetics|antiemetics|mesh-ancestor
6282751|NCT00982995|Autonomic Agents|autonomic agents|mesh-ancestor
6282752|NCT00982995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6282753|NCT00982995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282754|NCT00982995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6282755|NCT00982995|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6282756|NCT00982995|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6282757|NCT00982995|Serotonin Agents|serotonin agents|mesh-ancestor
6282758|NCT00982995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6282759|NCT00982995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282760|NCT00984490|Metformin|metformin|mesh-list
6282761|NCT00984490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6282762|NCT00984490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282763|NCT00986310|Fluoxetine|fluoxetine|mesh-list
6282764|NCT00986310|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6282765|NCT00986310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6282766|NCT00986310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6282767|NCT00986310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282768|NCT00986310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6282769|NCT00986310|Serotonin Agents|serotonin agents|mesh-ancestor
6282770|NCT00986310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282771|NCT00986310|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6282772|NCT00986310|Antidepressive Agents|antidepressive agents|mesh-ancestor
6282773|NCT00986310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6282774|NCT00986310|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6282775|NCT00986310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6282776|NCT00986310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6282777|NCT00978874|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6282778|NCT00978874|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6282779|NCT00978874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282780|NCT00983645|Cyclosporine|cyclosporine|mesh-list
6282781|NCT00983645|Tacrolimus|tacrolimus|mesh-list
6282782|NCT00983645|Cyclosporins|cyclosporins|mesh-list
6282783|NCT00983645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6282784|NCT00983645|Immunologic Factors|immunologic factors|mesh-ancestor
6282785|NCT00983645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282786|NCT00983645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6282787|NCT00983645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6282788|NCT00983645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282789|NCT00983645|Antifungal Agents|antifungal agents|mesh-ancestor
6282790|NCT00983645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6282791|NCT00983645|Dermatologic Agents|dermatologic agents|mesh-ancestor
6282792|NCT00983645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6282793|NCT00970606|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6282794|NCT00970606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6282795|NCT00970606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6282796|NCT00970606|Antimetabolites|antimetabolites|mesh-ancestor
6282797|NCT00970606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282798|NCT00970606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6282799|NCT00970606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6282800|NCT00970606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6282801|NCT00979550|Imiquimod|imiquimod|mesh-list
6282802|NCT00979550|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6282803|NCT00979550|Immunologic Factors|immunologic factors|mesh-ancestor
6282804|NCT00979550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282805|NCT00979550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6282806|NCT00979550|Interferon Inducers|interferon inducers|mesh-ancestor
6282807|NCT00966992|Zoledronic Acid|zoledronic acid|mesh-list
6282808|NCT00966992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6282809|NCT00966992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282810|NCT00981370|Deferasirox|deferasirox|mesh-list
6282811|NCT00981370|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6282812|NCT00981370|Chelating Agents|chelating agents|mesh-ancestor
6282813|NCT00981370|Sequestering Agents|sequestering agents|mesh-ancestor
6282814|NCT00981370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282815|NCT00975611|Amantadine|amantadine|mesh-list
6282816|NCT00975611|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6282817|NCT00975611|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6282818|NCT00975611|Antiviral Agents|antiviral agents|mesh-ancestor
6282819|NCT00975611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6282820|NCT00975611|Dopamine Agents|dopamine agents|mesh-ancestor
6282821|NCT00975611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6282822|NCT00975611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282823|NCT00975611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282824|NCT00975611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6282825|NCT00975611|Analgesics|analgesics|mesh-ancestor
6282826|NCT00975611|Sensory System Agents|sensory system agents|mesh-ancestor
6282827|NCT00975611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6391548|NCT00193505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391549|NCT00193505|Immunologic Factors|immunologic factors|mesh-ancestor
6391550|NCT00193505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6391551|NCT00193505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6391552|NCT00193505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6391553|NCT00193505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6391554|NCT00193505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6391555|NCT00193505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6391556|NCT00193505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391557|NCT00193505|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6391558|NCT00193505|Alkylating Agents|alkylating agents|mesh-ancestor
6391559|NCT00193518|Arsenic Trioxide|arsenic trioxide|mesh-list
6391560|NCT00193518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391561|NCT00193531|Paclitaxel|paclitaxel|mesh-list
6391562|NCT00193531|Etoposide|etoposide|mesh-list
6391563|NCT00193531|Carboplatin|carboplatin|mesh-list
6391564|NCT00193531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6391565|NCT00193531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6282828|NCT00978419|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6282829|NCT00978419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6282830|NCT00978419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6282831|NCT00978419|Antimetabolites|antimetabolites|mesh-ancestor
6282832|NCT00978419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282833|NCT00978419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6282834|NCT00978419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6282835|NCT00978419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6282836|NCT00979810|Alovudine|alovudine|mesh-list
6282837|NCT00979810|Antiviral Agents|antiviral agents|mesh-ancestor
6282838|NCT00979810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6282839|NCT00974922|Vitamin D|vitamin d|mesh-list
6282840|NCT00974922|Cholecalciferol|cholecalciferol|mesh-list
6282841|NCT00974922|Vitamins|vitamins|mesh-ancestor
6282842|NCT00974922|Micronutrients|micronutrients|mesh-ancestor
6282843|NCT00974922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282844|NCT00974922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6282845|NCT00974922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6282846|NCT00976339|Vitamin D|vitamin d|mesh-list
6282847|NCT00976339|Cholecalciferol|cholecalciferol|mesh-list
6282848|NCT00976339|Vitamins|vitamins|mesh-ancestor
6282849|NCT00976339|Micronutrients|micronutrients|mesh-ancestor
6282850|NCT00976339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282851|NCT00976339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6282852|NCT00976339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6282853|NCT00972023|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
6282854|NCT00972023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6282855|NCT00972023|Immunologic Factors|immunologic factors|mesh-ancestor
6282856|NCT00972023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282857|NCT00957827|Cephalexin|cephalexin|mesh-list
6282858|NCT00957827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6282859|NCT00957827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6282860|NCT00953329|Alefacept|alefacept|mesh-list
6282861|NCT00953329|Dermatologic Agents|dermatologic agents|mesh-ancestor
6282862|NCT00953329|Immunologic Factors|immunologic factors|mesh-ancestor
6282863|NCT00953329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282864|NCT00965055|Atorvastatin|atorvastatin|mesh-list
6282865|NCT00965055|Ezetimibe|ezetimibe|mesh-list
6282866|NCT00965055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6282867|NCT00965055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6282868|NCT00965055|Antimetabolites|antimetabolites|mesh-ancestor
6282869|NCT00965055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282870|NCT00965055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6282871|NCT00965055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6282872|NCT00965055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6282873|NCT00962429|Thioctic Acid|thioctic acid|mesh-list
6282874|NCT00962429|Antioxidants|antioxidants|mesh-ancestor
6391566|NCT00193531|Tubulin Modulators|tubulin modulators|mesh-ancestor
6282875|NCT00962429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282876|NCT00962429|Protective Agents|protective agents|mesh-ancestor
6282877|NCT00962429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282878|NCT00962429|Vitamin B Complex|vitamin b complex|mesh-ancestor
6282879|NCT00962429|Vitamins|vitamins|mesh-ancestor
6282880|NCT00962429|Micronutrients|micronutrients|mesh-ancestor
6282881|NCT00966654|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6282882|NCT00966654|Incretins|incretins|mesh-ancestor
6282883|NCT00966654|Hormones|hormones|mesh-ancestor
6282884|NCT00966654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6282885|NCT00966654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282886|NCT00954187|Pregabalin|pregabalin|mesh-list
6282887|NCT00954187|Gabapentin|gabapentin|mesh-list
6282888|NCT00954187|Analgesics|analgesics|mesh-ancestor
6282889|NCT00954187|Sensory System Agents|sensory system agents|mesh-ancestor
6282890|NCT00954187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6282891|NCT00954187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282892|NCT00954187|Anticonvulsants|anticonvulsants|mesh-ancestor
6282893|NCT00954187|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6282894|NCT00954187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6282895|NCT00954187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282896|NCT00954187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6282897|NCT00954187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6282898|NCT00954187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6282899|NCT00954187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6282900|NCT00954187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6282901|NCT00954187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6282902|NCT00954187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6282903|NCT00954187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6282904|NCT00954187|Antimanic Agents|antimanic agents|mesh-ancestor
6282905|NCT00953615|Thalidomide|thalidomide|mesh-list
6282906|NCT00953615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6282907|NCT00953615|Immunologic Factors|immunologic factors|mesh-ancestor
6282908|NCT00953615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282909|NCT00953615|Leprostatic Agents|leprostatic agents|mesh-ancestor
6282910|NCT00953615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6282911|NCT00953615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6282912|NCT00953615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6282913|NCT00953615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6282914|NCT00953615|Growth Substances|growth substances|mesh-ancestor
6282915|NCT00953615|Growth Inhibitors|growth inhibitors|mesh-ancestor
6282916|NCT00953615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6282917|NCT00947284|Nalbuphine|nalbuphine|mesh-list
6282918|NCT00947284|Naloxone|naloxone|mesh-list
6282919|NCT00947284|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6282920|NCT00947284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282921|NCT00947284|Sensory System Agents|sensory system agents|mesh-ancestor
6282922|NCT00947284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6282923|NCT00947284|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6282924|NCT00947284|Narcotics|narcotics|mesh-ancestor
6282925|NCT00947284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6282926|NCT00947284|Analgesics|analgesics|mesh-ancestor
6282927|NCT00957034|Testosterone|testosterone|mesh-list
6282928|NCT00957034|Androgens|androgens|mesh-ancestor
6282929|NCT00957034|Hormones|hormones|mesh-ancestor
6282930|NCT00957034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6282931|NCT00957034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282932|NCT00949988|Rituximab|rituximab|mesh-list
6282933|NCT00949988|Dasatinib|dasatinib|mesh-list
6282934|NCT00949988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6282935|NCT00949988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6282936|NCT00949988|Immunologic Factors|immunologic factors|mesh-ancestor
6282937|NCT00949988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282938|NCT00949988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6282939|NCT00949988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6282940|NCT00949988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6282941|NCT00949988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282942|NCT00948194|Nitric Oxide|nitric oxide|mesh-list
6282943|NCT00948194|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6282944|NCT00948194|Autonomic Agents|autonomic agents|mesh-ancestor
6282945|NCT00948194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6282946|NCT00948194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282947|NCT00948194|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6282948|NCT00948194|Respiratory System Agents|respiratory system agents|mesh-ancestor
6282949|NCT00948194|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6282950|NCT00948194|Antioxidants|antioxidants|mesh-ancestor
6282951|NCT00948194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282952|NCT00948194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6282953|NCT00948194|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6282954|NCT00948194|Vasodilator Agents|vasodilator agents|mesh-ancestor
6282955|NCT00948194|Gasotransmitters|gasotransmitters|mesh-ancestor
6282956|NCT00948194|Protective Agents|protective agents|mesh-ancestor
6282957|NCT00946985|Risperidone|risperidone|mesh-list
6282958|NCT00946985|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6282959|NCT00946985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6282960|NCT00946985|Serotonin Agents|serotonin agents|mesh-ancestor
6282961|NCT00946985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6282962|NCT00946985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282963|NCT00946985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282964|NCT00946985|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6282965|NCT00946985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6282966|NCT00946985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6282967|NCT00946985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6282968|NCT00946985|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6282969|NCT00946985|Dopamine Agents|dopamine agents|mesh-ancestor
6282970|NCT00946985|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6282971|NCT00946985|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6282972|NCT00950690|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6282973|NCT00950690|Latanoprost|latanoprost|mesh-list
6282974|NCT00950690|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6282975|NCT00941928|Vidarabine|vidarabine|mesh-list
6282976|NCT00941928|Cyclophosphamide|cyclophosphamide|mesh-list
6282977|NCT00941928|Fludarabine|fludarabine|mesh-list
6282978|NCT00941928|Fludarabine phosphate|fludarabine phosphate|mesh-list
6282979|NCT00941928|Interleukin-2|interleukin-2|mesh-list
6282980|NCT00941928|Epratuzumab|epratuzumab|mesh-list
6282981|NCT00941928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6282982|NCT00941928|Immunologic Factors|immunologic factors|mesh-ancestor
6282983|NCT00941928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6282984|NCT00941928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6282985|NCT00941928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6282986|NCT00941928|Alkylating Agents|alkylating agents|mesh-ancestor
6282987|NCT00941928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6282988|NCT00941928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6282989|NCT00941928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6282990|NCT00941928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6282991|NCT00941928|Antimetabolites|antimetabolites|mesh-ancestor
6282992|NCT00941928|Antiviral Agents|antiviral agents|mesh-ancestor
6282993|NCT00941928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6282994|NCT00941928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6282995|NCT00941928|Analgesics|analgesics|mesh-ancestor
6282996|NCT00941928|Sensory System Agents|sensory system agents|mesh-ancestor
6282997|NCT00941928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6282998|NCT00941928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6282999|NCT00949403|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
6283000|NCT00949403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283001|NCT00947791|Midazolam|midazolam|mesh-list
6283002|NCT00947791|Ketamine|ketamine|mesh-list
6283003|NCT00947791|Analgesics|analgesics|mesh-ancestor
6283004|NCT00947791|Sensory System Agents|sensory system agents|mesh-ancestor
6283005|NCT00947791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6283006|NCT00947791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283007|NCT00947791|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6283008|NCT00947791|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6283009|NCT00947791|Anesthetics, General|anesthetics, general|mesh-ancestor
6283010|NCT00947791|Anesthetics|anesthetics|mesh-ancestor
6283011|NCT00947791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6283012|NCT00947791|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6283013|NCT00947791|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6283014|NCT00947791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6283015|NCT00947791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283016|NCT00947791|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6283017|NCT00947791|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6283018|NCT00947791|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6283019|NCT00947791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6283020|NCT00947791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6283021|NCT00947791|GABA Modulators|gaba modulators|mesh-ancestor
6283022|NCT00947791|GABA Agents|gaba agents|mesh-ancestor
6283023|NCT00947011|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6283024|NCT00947011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6283025|NCT00947011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283026|NCT00947011|Incretins|incretins|mesh-ancestor
6283027|NCT00947011|Hormones|hormones|mesh-ancestor
6283028|NCT00947011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6283029|NCT00947011|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6283030|NCT00947011|Protease Inhibitors|protease inhibitors|mesh-ancestor
6283031|NCT00947011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6283032|NCT00947011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283033|NCT00936598|Zolpidem|zolpidem|mesh-list
6283034|NCT00936598|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6283035|NCT00936598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6283036|NCT00936598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6283037|NCT00936598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283038|NCT00936598|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6283039|NCT00936598|GABA Agonists|gaba agonists|mesh-ancestor
6283040|NCT00936598|GABA Agents|gaba agents|mesh-ancestor
6283041|NCT00936598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6283042|NCT00936598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283043|NCT00920309|Sirolimus|sirolimus|mesh-list
6283044|NCT00920309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6283045|NCT00920309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6283046|NCT00920309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6283047|NCT00920309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6015316|NCT00356525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6015317|NCT00356525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6015318|NCT00356525|Antimetabolites|antimetabolites|mesh-ancestor
6015319|NCT00356525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015320|NCT00356525|Antiviral Agents|antiviral agents|mesh-ancestor
6015321|NCT00356525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6015322|NCT00356525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6015323|NCT00356525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6015324|NCT00356525|Immunologic Factors|immunologic factors|mesh-ancestor
6015325|NCT00356525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015326|NCT00356525|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6283048|NCT00920309|Antifungal Agents|antifungal agents|mesh-ancestor
6283049|NCT00920309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6283050|NCT00920309|Immunologic Factors|immunologic factors|mesh-ancestor
6283051|NCT00920309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283052|NCT00934791|Mycophenolic Acid|mycophenolic acid|mesh-list
6283053|NCT00934791|Sirolimus|sirolimus|mesh-list
6283054|NCT00934791|Prednisone|prednisone|mesh-list
6283055|NCT00934791|Tacrolimus|tacrolimus|mesh-list
6283056|NCT00934791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6283057|NCT00934791|Glucocorticoids|glucocorticoids|mesh-ancestor
6283058|NCT00934791|Hormones|hormones|mesh-ancestor
6283059|NCT00934791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6283060|NCT00934791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283061|NCT00934791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6283062|NCT00934791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6283063|NCT00934791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6283064|NCT00934791|Immunologic Factors|immunologic factors|mesh-ancestor
6283065|NCT00934791|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6283066|NCT00934791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6283067|NCT00934791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283068|NCT00934791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6283069|NCT00934791|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6283070|NCT00934791|Antitubercular Agents|antitubercular agents|mesh-ancestor
6283071|NCT00934791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6283072|NCT00934791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6283073|NCT00934791|Antifungal Agents|antifungal agents|mesh-ancestor
6283074|NCT00932152|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6283075|NCT00932152|Bevacizumab|bevacizumab|mesh-list
6283076|NCT00932152|Fulvestrant|fulvestrant|mesh-list
6283077|NCT00932152|Anastrozole|anastrozole|mesh-list
6283078|NCT00932152|Analgesics|analgesics|mesh-list
6283079|NCT00932152|Antiemetics|antiemetics|mesh-list
6283080|NCT00932152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6283081|NCT00932152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6283082|NCT00932152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6283083|NCT00932152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6283084|NCT00932152|Growth Substances|growth substances|mesh-ancestor
6283085|NCT00932152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283086|NCT00932152|Growth Inhibitors|growth inhibitors|mesh-ancestor
6283087|NCT00932152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6283088|NCT00932152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6283089|NCT00932152|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6283090|NCT00932152|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6283091|NCT00932152|Hormone Antagonists|hormone antagonists|mesh-ancestor
6283092|NCT00932152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6283093|NCT00932152|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6283094|NCT00932152|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6283095|NCT00932152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6283096|NCT00932152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283097|NCT00932152|Sensory System Agents|sensory system agents|mesh-ancestor
6283098|NCT00932152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6283099|NCT00932152|Autonomic Agents|autonomic agents|mesh-ancestor
6283100|NCT00932152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6283101|NCT00924807|Sorafenib|sorafenib|mesh-list
6283102|NCT00924807|Leuprolide|leuprolide|mesh-list
6283103|NCT00924807|Bicalutamide|bicalutamide|mesh-list
6283104|NCT00924807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6283105|NCT00924807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6283106|NCT00924807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6283107|NCT00924807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283108|NCT00924807|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6283109|NCT00924807|Fertility Agents|fertility agents|mesh-ancestor
6283110|NCT00924807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6283111|NCT00924807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283112|NCT00924807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6283113|NCT00924807|Androgen Antagonists|androgen antagonists|mesh-ancestor
6283114|NCT00924807|Hormone Antagonists|hormone antagonists|mesh-ancestor
6283115|NCT00924807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6283116|NCT00925548|Cyclophosphamide|cyclophosphamide|mesh-list
6283117|NCT00925548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6283118|NCT00925548|Immunologic Factors|immunologic factors|mesh-ancestor
6283119|NCT00925548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283120|NCT00925548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6283121|NCT00925548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6283122|NCT00925548|Alkylating Agents|alkylating agents|mesh-ancestor
6283123|NCT00925548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283124|NCT00925548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6283125|NCT00925548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6283126|NCT00926575|Beclomethasone|beclomethasone|mesh-list
6283127|NCT00926575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6283128|NCT00926575|Glucocorticoids|glucocorticoids|mesh-ancestor
6283129|NCT00926575|Hormones|hormones|mesh-ancestor
6283130|NCT00926575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6283131|NCT00926575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283132|NCT00926575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6283133|NCT00926575|Respiratory System Agents|respiratory system agents|mesh-ancestor
6283134|NCT00911053|Melatonin|melatonin|mesh-list
6283135|NCT00911053|Antioxidants|antioxidants|mesh-ancestor
6283136|NCT00911053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283137|NCT00911053|Protective Agents|protective agents|mesh-ancestor
6283138|NCT00911053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283139|NCT00911053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6283140|NCT00918463|Dasatinib|dasatinib|mesh-list
6283141|NCT00918463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6283142|NCT00918463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6283143|NCT00918463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6283144|NCT00918463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283145|NCT00913692|Glycine|glycine|mesh-list
6283146|NCT00913692|Glycine Agents|glycine agents|mesh-ancestor
6283147|NCT00913692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6283148|NCT00913692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283149|NCT00913692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283150|NCT00918645|Calcium|calcium|mesh-list
6283151|NCT00918645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6283152|NCT00918645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283153|NCT00907218|Varenicline|varenicline|mesh-list
6283154|NCT00907218|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6283155|NCT00907218|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6283156|NCT00907218|Cholinergic Agents|cholinergic agents|mesh-ancestor
6283157|NCT00907218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6283158|NCT00907218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283159|NCT00907218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283160|NCT00906035|Aspirin|aspirin|mesh-list
6283161|NCT00906035|Dipyridamole|dipyridamole|mesh-list
6283162|NCT00906035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6283163|NCT00906035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6283164|NCT00906035|Analgesics|analgesics|mesh-ancestor
6283165|NCT00906035|Sensory System Agents|sensory system agents|mesh-ancestor
6283166|NCT00906035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6283167|NCT00906035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283168|NCT00906035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6283169|NCT00906035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6283170|NCT00906035|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6283171|NCT00906035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6283172|NCT00906035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283173|NCT00906035|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6283174|NCT00906035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6283175|NCT00906035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6283176|NCT00906035|Antipyretics|antipyretics|mesh-ancestor
6283177|NCT00906035|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6283178|NCT00906035|Vasodilator Agents|vasodilator agents|mesh-ancestor
6283179|NCT00904423|Vitamin D|vitamin d|mesh-list
6283180|NCT00904423|Vitamins|vitamins|mesh-ancestor
6283181|NCT00904423|Micronutrients|micronutrients|mesh-ancestor
6283182|NCT00904423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283183|NCT00904423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6283184|NCT00903396|Palonosetron|palonosetron|mesh-list
6283185|NCT00903396|Antiemetics|antiemetics|mesh-ancestor
6283186|NCT00903396|Autonomic Agents|autonomic agents|mesh-ancestor
6283187|NCT00903396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6283188|NCT00903396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283189|NCT00903396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6283190|NCT00903396|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6283191|NCT00903396|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6283192|NCT00903396|Serotonin Agents|serotonin agents|mesh-ancestor
6283193|NCT00903396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6283194|NCT00903396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283195|NCT00894790|Celecoxib|celecoxib|mesh-list
6283196|NCT00894790|Diclofenac|diclofenac|mesh-list
6283197|NCT00894790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6283198|NCT00894790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6283199|NCT00894790|Analgesics|analgesics|mesh-ancestor
6283200|NCT00894790|Sensory System Agents|sensory system agents|mesh-ancestor
6283201|NCT00894790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6283202|NCT00894790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283203|NCT00894790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6283204|NCT00894790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6283205|NCT00894790|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6283206|NCT00894790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6283207|NCT00894790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6283208|NCT00894790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283209|NCT00902668|Lovastatin|lovastatin|mesh-list
6283210|NCT00902668|L 647318|l 647318|mesh-list
6283211|NCT00902668|Dihydromevinolin|dihydromevinolin|mesh-list
6283212|NCT00902668|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6283213|NCT00902668|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6283214|NCT00902668|Antimetabolites|antimetabolites|mesh-ancestor
6283215|NCT00902668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283216|NCT00902668|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6283217|NCT00902668|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6283218|NCT00902668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6283219|NCT00881205|Rivastigmine|rivastigmine|mesh-list
6283220|NCT00881205|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6283221|NCT00881205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6283222|NCT00881205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283223|NCT00881205|Cholinergic Agents|cholinergic agents|mesh-ancestor
6283224|NCT00881205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6283225|NCT00881205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283226|NCT00881205|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6283227|NCT00881205|Protective Agents|protective agents|mesh-ancestor
6283228|NCT00896025|Acetylcysteine|acetylcysteine|mesh-list
6283229|NCT00896025|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6283230|NCT00896025|Antiviral Agents|antiviral agents|mesh-ancestor
6283231|NCT00896025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6283232|NCT00896025|Expectorants|expectorants|mesh-ancestor
6283233|NCT00896025|Respiratory System Agents|respiratory system agents|mesh-ancestor
6283234|NCT00896025|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6283235|NCT00896025|Antioxidants|antioxidants|mesh-ancestor
6283236|NCT00896025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283237|NCT00896025|Protective Agents|protective agents|mesh-ancestor
6283238|NCT00896025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283239|NCT00896025|Antidotes|antidotes|mesh-ancestor
6283240|NCT00903006|Dasatinib|dasatinib|mesh-list
6283241|NCT00903006|Fulvestrant|fulvestrant|mesh-list
6283242|NCT00903006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6283243|NCT00903006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6283244|NCT00903006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6283245|NCT00903006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283246|NCT00903006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6283247|NCT00903006|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6283248|NCT00903006|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6283249|NCT00903006|Hormone Antagonists|hormone antagonists|mesh-ancestor
6283250|NCT00903006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6283251|NCT00903006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283252|NCT00887315|Cisplatin|cisplatin|mesh-list
6283253|NCT00887315|Docetaxel|docetaxel|mesh-list
6283254|NCT00887315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6283255|NCT00887315|Tubulin Modulators|tubulin modulators|mesh-ancestor
6283256|NCT00887315|Antimitotic Agents|antimitotic agents|mesh-ancestor
6283257|NCT00887315|Mitosis Modulators|mitosis modulators|mesh-ancestor
6283258|NCT00887315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283259|NCT00891904|Cetuximab|cetuximab|mesh-list
6283260|NCT00891904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6283261|NCT00891904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6283262|NCT00889421|Apremilast|apremilast|mesh-list
6283263|NCT00889421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6283264|NCT00889421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6283265|NCT00889421|Analgesics|analgesics|mesh-ancestor
6283266|NCT00889421|Sensory System Agents|sensory system agents|mesh-ancestor
6283267|NCT00889421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6283268|NCT00889421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283269|NCT00889421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6283270|NCT00889421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6283271|NCT00889421|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6283272|NCT00889421|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6283273|NCT00889421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6283274|NCT00889421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283275|NCT00875394|Metformin|metformin|mesh-list
6283276|NCT00875394|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6283277|NCT00875394|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6283278|NCT00875394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283279|NCT00875394|Incretins|incretins|mesh-ancestor
6283280|NCT00875394|Hormones|hormones|mesh-ancestor
6283281|NCT00875394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6283282|NCT00875394|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6283283|NCT00875394|Protease Inhibitors|protease inhibitors|mesh-ancestor
6283284|NCT00875394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6283285|NCT00875394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283286|NCT00882310|Gemcitabine|gemcitabine|mesh-list
6283287|NCT00882310|Capecitabine|capecitabine|mesh-list
6283288|NCT00882310|Docetaxel|docetaxel|mesh-list
6283289|NCT00882310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6283290|NCT00882310|Antimetabolites|antimetabolites|mesh-ancestor
6283291|NCT00882310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283292|NCT00882310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6283293|NCT00882310|Antiviral Agents|antiviral agents|mesh-ancestor
6283294|NCT00882310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6283295|NCT00882310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6283296|NCT00882310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6283297|NCT00882310|Immunologic Factors|immunologic factors|mesh-ancestor
6283298|NCT00882310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283299|NCT00882310|Tubulin Modulators|tubulin modulators|mesh-ancestor
6283300|NCT00882310|Antimitotic Agents|antimitotic agents|mesh-ancestor
6283301|NCT00882310|Mitosis Modulators|mitosis modulators|mesh-ancestor
6283302|NCT00880542|Sorafenib|sorafenib|mesh-list
6283303|NCT00880542|Ifosfamide|ifosfamide|mesh-list
6283304|NCT00880542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6283305|NCT00880542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6283306|NCT00880542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6283307|NCT00880542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283308|NCT00880542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6283309|NCT00880542|Alkylating Agents|alkylating agents|mesh-ancestor
6283310|NCT00879619|Prednisone|prednisone|mesh-list
6283311|NCT00879619|Cortisone|cortisone|mesh-list
6283312|NCT00879619|Docetaxel|docetaxel|mesh-list
6283313|NCT00879619|Sunitinib|sunitinib|mesh-list
6283314|NCT00879619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6283315|NCT00879619|Tubulin Modulators|tubulin modulators|mesh-ancestor
6283316|NCT00879619|Antimitotic Agents|antimitotic agents|mesh-ancestor
6283317|NCT00879619|Mitosis Modulators|mitosis modulators|mesh-ancestor
6283318|NCT00879619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283319|NCT00879619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6283320|NCT00879619|Glucocorticoids|glucocorticoids|mesh-ancestor
6283321|NCT00879619|Hormones|hormones|mesh-ancestor
6283322|NCT00879619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6283323|NCT00879619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283324|NCT00879619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6283325|NCT00879619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6283326|NCT00879619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6283327|NCT00879619|Growth Substances|growth substances|mesh-ancestor
6283328|NCT00879619|Growth Inhibitors|growth inhibitors|mesh-ancestor
6283329|NCT00879619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6283330|NCT00879619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6283331|NCT00874939|Donepezil|donepezil|mesh-list
6283332|NCT00874939|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6283333|NCT00874939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6283334|NCT00874939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283335|NCT00874939|Cholinergic Agents|cholinergic agents|mesh-ancestor
6283336|NCT00874939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6283337|NCT00874939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283338|NCT00874939|Nootropic Agents|nootropic agents|mesh-ancestor
6283339|NCT00877071|Doxorubicin|doxorubicin|mesh-list
6283340|NCT00877071|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6283341|NCT00877071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6283342|NCT00877071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6283343|NCT00877071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6283344|NCT00877071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6283345|NCT00877071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283346|NCT00878969|Valsartan|valsartan|mesh-list
6283347|NCT00878969|Ramipril|ramipril|mesh-list
6283348|NCT00878969|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6283349|NCT00878969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6283350|NCT00878969|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6283351|NCT00878969|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6283352|NCT00878969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283353|NCT00878969|Protease Inhibitors|protease inhibitors|mesh-ancestor
6283354|NCT00878969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6283355|NCT00869414|Insulin|insulin|mesh-list
6283356|NCT00869414|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6283357|NCT00869414|Insulin Glargine|insulin glargine|mesh-list
6283358|NCT00869414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6283359|NCT00869414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283360|NCT00863512|Gemcitabine|gemcitabine|mesh-list
6283361|NCT00863512|Docetaxel|docetaxel|mesh-list
6283362|NCT00863512|Pemetrexed|pemetrexed|mesh-list
6283363|NCT00863512|Vinorelbine|vinorelbine|mesh-list
6283364|NCT00863512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6283365|NCT00863512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6283366|NCT00863512|Antimetabolites|antimetabolites|mesh-ancestor
6283367|NCT00863512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283368|NCT00863512|Antiviral Agents|antiviral agents|mesh-ancestor
6283369|NCT00863512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6283370|NCT00863512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6283371|NCT00863512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6283372|NCT00863512|Immunologic Factors|immunologic factors|mesh-ancestor
6283373|NCT00863512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283374|NCT00863512|Tubulin Modulators|tubulin modulators|mesh-ancestor
6283375|NCT00863512|Antimitotic Agents|antimitotic agents|mesh-ancestor
6283376|NCT00863512|Mitosis Modulators|mitosis modulators|mesh-ancestor
6283377|NCT00863512|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6283378|NCT00863512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6283379|NCT00863512|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6283380|NCT00868998|Gemcitabine|gemcitabine|mesh-list
6283381|NCT00868998|Capecitabine|capecitabine|mesh-list
6283382|NCT00868998|Docetaxel|docetaxel|mesh-list
6283383|NCT00868998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6283384|NCT00868998|Antimetabolites|antimetabolites|mesh-ancestor
6283385|NCT00868998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283386|NCT00868998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6283387|NCT00868998|Antiviral Agents|antiviral agents|mesh-ancestor
6283388|NCT00868998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6283389|NCT00868998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6283390|NCT00868998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6283391|NCT00868998|Immunologic Factors|immunologic factors|mesh-ancestor
6283392|NCT00868998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283393|NCT00868998|Tubulin Modulators|tubulin modulators|mesh-ancestor
6283394|NCT00868998|Antimitotic Agents|antimitotic agents|mesh-ancestor
6283395|NCT00868998|Mitosis Modulators|mitosis modulators|mesh-ancestor
6283396|NCT00869258|Gemcitabine|gemcitabine|mesh-list
6283397|NCT00869258|Capecitabine|capecitabine|mesh-list
6283398|NCT00869258|Docetaxel|docetaxel|mesh-list
6283399|NCT00869258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6283400|NCT00869258|Antimetabolites|antimetabolites|mesh-ancestor
6283401|NCT00869258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283402|NCT00869258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6283403|NCT00869258|Antiviral Agents|antiviral agents|mesh-ancestor
6283404|NCT00869258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6283405|NCT00869258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6283406|NCT00869258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6283407|NCT00869258|Immunologic Factors|immunologic factors|mesh-ancestor
6283408|NCT00869258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283409|NCT00869258|Tubulin Modulators|tubulin modulators|mesh-ancestor
6283410|NCT00869258|Antimitotic Agents|antimitotic agents|mesh-ancestor
6283411|NCT00869258|Mitosis Modulators|mitosis modulators|mesh-ancestor
6283412|NCT00853229|Pregabalin|pregabalin|mesh-list
6283413|NCT00853229|Analgesics|analgesics|mesh-ancestor
6283414|NCT00853229|Sensory System Agents|sensory system agents|mesh-ancestor
6283415|NCT00853229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6283416|NCT00853229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283417|NCT00853229|Anticonvulsants|anticonvulsants|mesh-ancestor
6283418|NCT00853229|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6283419|NCT00853229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6283420|NCT00853229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283421|NCT00853229|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6283422|NCT00853229|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6283423|NCT00853229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6283424|NCT00853229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6283425|NCT00853229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6283426|NCT00860158|Dasatinib|dasatinib|mesh-list
6283427|NCT00860158|Leuprolide|leuprolide|mesh-list
6283428|NCT00860158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6283429|NCT00860158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6283430|NCT00860158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6283431|NCT00860158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283432|NCT00860158|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6283433|NCT00860158|Fertility Agents|fertility agents|mesh-ancestor
6283434|NCT00860158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6283435|NCT00860158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283436|NCT00860158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6283437|NCT00843986|Conivaptan|conivaptan|mesh-list
6283438|NCT00843986|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6283439|NCT00843986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283440|NCT00843986|Natriuretic Agents|natriuretic agents|mesh-ancestor
6283441|NCT00843986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283442|NCT00850421|Botulinum Toxins|botulinum toxins|mesh-list
6283443|NCT00850421|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6283444|NCT00850421|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6283445|NCT00850421|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6283446|NCT00850421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6283447|NCT00850421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283448|NCT00850421|Cholinergic Agents|cholinergic agents|mesh-ancestor
6283449|NCT00850421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6283450|NCT00850421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283451|NCT00850421|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6283452|NCT00850421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6283453|NCT00851747|Deoxycholic Acid|deoxycholic acid|mesh-list
6283454|NCT00851747|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6283455|NCT00851747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6283456|NCT00852241|Hyaluronic Acid|hyaluronic acid|mesh-list
6283457|NCT00852241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6283458|NCT00852241|Immunologic Factors|immunologic factors|mesh-ancestor
6283459|NCT00852241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283460|NCT00852241|Viscosupplements|viscosupplements|mesh-ancestor
6283461|NCT00852241|Protective Agents|protective agents|mesh-ancestor
6283462|NCT00851552|Rituximab|rituximab|mesh-list
6283463|NCT00851552|Doxorubicin|doxorubicin|mesh-list
6283464|NCT00851552|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6283465|NCT00851552|Bortezomib|bortezomib|mesh-list
6283466|NCT00851552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6283467|NCT00851552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6283468|NCT00851552|Immunologic Factors|immunologic factors|mesh-ancestor
6283469|NCT00851552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283470|NCT00851552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6283471|NCT00851552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6283472|NCT00851552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6283473|NCT00851552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6283474|NCT00851552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6283475|NCT00851552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283476|NCT00850720|Hydrocortisone|hydrocortisone|mesh-list
6283477|NCT00850720|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6283478|NCT00850720|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6283479|NCT00850720|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6283480|NCT00850720|Vasopressins|vasopressins|mesh-list
6283481|NCT00850720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283482|NCT00850720|Hemostatics|hemostatics|mesh-ancestor
6283483|NCT00850720|Coagulants|coagulants|mesh-ancestor
6283484|NCT00850720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6283485|NCT00850720|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6283486|NCT00850720|Natriuretic Agents|natriuretic agents|mesh-ancestor
6283487|NCT00850720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6283488|NCT00851591|Psyllium|psyllium|mesh-list
6283489|NCT00851591|Cathartics|cathartics|mesh-ancestor
6283490|NCT00851591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6283491|NCT00843310|Dexamethasone|dexamethasone|mesh-list
6283492|NCT00843310|Lenalidomide|lenalidomide|mesh-list
6283493|NCT00843310|Melphalan|melphalan|mesh-list
6283494|NCT00843310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6283495|NCT00843310|Antiemetics|antiemetics|mesh-ancestor
6283496|NCT00843310|Autonomic Agents|autonomic agents|mesh-ancestor
6283497|NCT00843310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6283498|NCT00843310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283499|NCT00843310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6283500|NCT00843310|Glucocorticoids|glucocorticoids|mesh-ancestor
6283501|NCT00843310|Hormones|hormones|mesh-ancestor
6283502|NCT00843310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6283503|NCT00843310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6283504|NCT00843310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6283505|NCT00843310|Immunologic Factors|immunologic factors|mesh-ancestor
6283506|NCT00843310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6283507|NCT00843310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6283508|NCT00843310|Growth Substances|growth substances|mesh-ancestor
6283509|NCT00843310|Growth Inhibitors|growth inhibitors|mesh-ancestor
6283510|NCT00843310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6283511|NCT00843310|Alkylating Agents|alkylating agents|mesh-ancestor
6283512|NCT00843310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283513|NCT00843310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6283514|NCT00843310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6283515|NCT00847002|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6283516|NCT00847002|Laxatives|laxatives|mesh-ancestor
6283517|NCT00847002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6283518|NCT00845702|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
6283519|NCT00845702|Chelating Agents|chelating agents|mesh-ancestor
6283520|NCT00845702|Sequestering Agents|sequestering agents|mesh-ancestor
6283521|NCT00845702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283522|NCT00843830|Vaccines|vaccines|mesh-list
6283523|NCT00843830|Immunologic Factors|immunologic factors|mesh-ancestor
6283524|NCT00843830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6391567|NCT00193531|Antimitotic Agents|antimitotic agents|mesh-ancestor
6391568|NCT00193531|Mitosis Modulators|mitosis modulators|mesh-ancestor
6391569|NCT00193531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391570|NCT00193531|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6391571|NCT00193531|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6391572|NCT00193531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6391573|NCT00193544|Thalidomide|thalidomide|mesh-list
6391574|NCT00193544|Arsenic Trioxide|arsenic trioxide|mesh-list
6391575|NCT00193544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6391576|NCT00193544|Immunologic Factors|immunologic factors|mesh-ancestor
6391577|NCT00193544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6391578|NCT00193544|Leprostatic Agents|leprostatic agents|mesh-ancestor
6391579|NCT00193544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6391580|NCT00193544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6283525|NCT00835679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6283526|NCT00835679|Cetuximab|cetuximab|mesh-list
6283527|NCT00835679|Dasatinib|dasatinib|mesh-list
6283528|NCT00835679|Antibodies|antibodies|mesh-list
6283529|NCT00835679|Immunoglobulins|immunoglobulins|mesh-list
6283530|NCT00835679|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6283531|NCT00835679|Immunologic Factors|immunologic factors|mesh-ancestor
6283532|NCT00835679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283533|NCT00835679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6283534|NCT00835679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6283535|NCT00835679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6283536|NCT00835679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283537|NCT00841035|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6283538|NCT00841035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6283539|NCT00841035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6283540|NCT00841035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6283541|NCT00841035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283542|NCT00832520|Mirtazapine|mirtazapine|mesh-list
6283543|NCT00832520|Antidepressive Agents|antidepressive agents|mesh-ancestor
6283544|NCT00832520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6283545|NCT00832520|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6283546|NCT00832520|Histamine Antagonists|histamine antagonists|mesh-ancestor
6283547|NCT00832520|Histamine Agents|histamine agents|mesh-ancestor
6283548|NCT00832520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6283549|NCT00832520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283550|NCT00832520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283551|NCT00832520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6283552|NCT00832520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6283553|NCT00832520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6283554|NCT00832520|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6283555|NCT00832520|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6283556|NCT00832520|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6283557|NCT00832520|Adrenergic Agents|adrenergic agents|mesh-ancestor
6283558|NCT00832520|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6283559|NCT00832520|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6283560|NCT00832520|Serotonin Agents|serotonin agents|mesh-ancestor
6283561|NCT00832520|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6283562|NCT00833859|Gemcitabine|gemcitabine|mesh-list
6283563|NCT00833859|Capecitabine|capecitabine|mesh-list
6283564|NCT00833859|Docetaxel|docetaxel|mesh-list
6283565|NCT00833859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6283566|NCT00833859|Antimetabolites|antimetabolites|mesh-ancestor
6283567|NCT00833859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283568|NCT00833859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6283569|NCT00833859|Antiviral Agents|antiviral agents|mesh-ancestor
6283570|NCT00833859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6283571|NCT00833859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6283572|NCT00833859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6283573|NCT00833859|Immunologic Factors|immunologic factors|mesh-ancestor
6283574|NCT00833859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283575|NCT00833859|Tubulin Modulators|tubulin modulators|mesh-ancestor
6283576|NCT00833859|Antimitotic Agents|antimitotic agents|mesh-ancestor
6283577|NCT00833859|Mitosis Modulators|mitosis modulators|mesh-ancestor
6283578|NCT00840827|Cyclosporine|cyclosporine|mesh-list
6283579|NCT00840827|Lenalidomide|lenalidomide|mesh-list
6283580|NCT00840827|Cyclosporins|cyclosporins|mesh-list
6283581|NCT00840827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6283582|NCT00840827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283583|NCT00840827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6283584|NCT00840827|Immunologic Factors|immunologic factors|mesh-ancestor
6283585|NCT00840827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283586|NCT00840827|Antifungal Agents|antifungal agents|mesh-ancestor
6283587|NCT00840827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6283588|NCT00840827|Dermatologic Agents|dermatologic agents|mesh-ancestor
6283589|NCT00840827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6283590|NCT00840827|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6283591|NCT00840827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6283592|NCT00840827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6283593|NCT00840827|Growth Substances|growth substances|mesh-ancestor
6283594|NCT00840827|Growth Inhibitors|growth inhibitors|mesh-ancestor
6283595|NCT00840827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6283596|NCT00832572|Ranolazine|ranolazine|mesh-list
6283597|NCT00832572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6283598|NCT00832572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6283599|NCT00832572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283600|NCT00832624|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6283601|NCT00832624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6283602|NCT00832624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283603|NCT00832624|Incretins|incretins|mesh-ancestor
6283604|NCT00832624|Hormones|hormones|mesh-ancestor
6283605|NCT00832624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6283606|NCT00832624|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6283607|NCT00832624|Protease Inhibitors|protease inhibitors|mesh-ancestor
6283608|NCT00832624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6283609|NCT00832624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283610|NCT00832299|Leucovorin|leucovorin|mesh-list
6283611|NCT00832299|Fluorouracil|fluorouracil|mesh-list
6283612|NCT00832299|Oxaliplatin|oxaliplatin|mesh-list
6283613|NCT00832299|Antimetabolites|antimetabolites|mesh-ancestor
6283614|NCT00832299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283615|NCT00832299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6283616|NCT00832299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6283617|NCT00832299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6283618|NCT00832299|Immunologic Factors|immunologic factors|mesh-ancestor
6283619|NCT00832299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283620|NCT00832299|Antidotes|antidotes|mesh-ancestor
6283621|NCT00832299|Protective Agents|protective agents|mesh-ancestor
6283622|NCT00832299|Vitamin B Complex|vitamin b complex|mesh-ancestor
6283623|NCT00832299|Vitamins|vitamins|mesh-ancestor
6283624|NCT00832299|Micronutrients|micronutrients|mesh-ancestor
6283625|NCT00836355|Minocycline|minocycline|mesh-list
6283626|NCT00836355|Enoxaparin|enoxaparin|mesh-list
6283627|NCT00836355|Anticoagulants|anticoagulants|mesh-ancestor
6283628|NCT00836355|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6283629|NCT00836355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6283630|NCT00836355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283631|NCT00836355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6283632|NCT00836355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6283633|NCT00816777|Irinotecan|irinotecan|mesh-list
6283634|NCT00816777|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6283635|NCT00816777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6283636|NCT00816777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6283637|NCT00816777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283638|NCT00816777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6283639|NCT00823095|Nitric Oxide|nitric oxide|mesh-list
6283640|NCT00823095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6283641|NCT00823095|Autonomic Agents|autonomic agents|mesh-ancestor
6283642|NCT00823095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6283643|NCT00823095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283644|NCT00823095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6283645|NCT00823095|Respiratory System Agents|respiratory system agents|mesh-ancestor
6283646|NCT00823095|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6283647|NCT00823095|Antioxidants|antioxidants|mesh-ancestor
6283648|NCT00823095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283649|NCT00823095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6283650|NCT00823095|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6283651|NCT00823095|Vasodilator Agents|vasodilator agents|mesh-ancestor
6283652|NCT00823095|Gasotransmitters|gasotransmitters|mesh-ancestor
6283653|NCT00823095|Protective Agents|protective agents|mesh-ancestor
6283654|NCT00827567|Everolimus|everolimus|mesh-list
6283655|NCT00827567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6283656|NCT00827567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6283657|NCT00827567|Immunologic Factors|immunologic factors|mesh-ancestor
6283658|NCT00827567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283659|NCT00815633|Alefacept|alefacept|mesh-list
6283660|NCT00815633|Dermatologic Agents|dermatologic agents|mesh-ancestor
6283661|NCT00815633|Immunologic Factors|immunologic factors|mesh-ancestor
6283662|NCT00815633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283663|NCT00825227|Modafinil|modafinil|mesh-list
6283664|NCT00825227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6283665|NCT00825227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283666|NCT00825227|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6283667|NCT00825227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6283668|NCT00825227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6283669|NCT00825227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283670|NCT00822679|Eszopiclone|eszopiclone|mesh-list
6283671|NCT00822679|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6283672|NCT00822679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6283673|NCT00822679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283674|NCT00809458|Vitamin E|vitamin e|mesh-list
6283675|NCT00809458|Tocopherols|tocopherols|mesh-list
6283676|NCT00809458|Tocotrienols|tocotrienols|mesh-list
6283677|NCT00809458|alpha-Tocopherol|alpha-tocopherol|mesh-list
6283678|NCT00809458|Vitamins|vitamins|mesh-ancestor
6283679|NCT00809458|Micronutrients|micronutrients|mesh-ancestor
6283680|NCT00809458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283681|NCT00809458|Antioxidants|antioxidants|mesh-ancestor
6283682|NCT00809458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283683|NCT00809458|Protective Agents|protective agents|mesh-ancestor
6283684|NCT00807365|Hormones|hormones|mesh-list
6283685|NCT00807365|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
6283686|NCT00807365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6283687|NCT00807365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283688|NCT00814333|Thrombin|thrombin|mesh-list
6283689|NCT00814333|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
6283690|NCT00814333|Hemostatics|hemostatics|mesh-ancestor
6283691|NCT00814333|Coagulants|coagulants|mesh-ancestor
6283692|NCT00809341|Prednisone|prednisone|mesh-list
6283693|NCT00809341|Cyclophosphamide|cyclophosphamide|mesh-list
6283694|NCT00809341|Ifosfamide|ifosfamide|mesh-list
6283695|NCT00809341|Rituximab|rituximab|mesh-list
6283696|NCT00809341|Carboplatin|carboplatin|mesh-list
6283697|NCT00809341|Doxorubicin|doxorubicin|mesh-list
6283698|NCT00809341|Etoposide|etoposide|mesh-list
6283699|NCT00809341|Vincristine|vincristine|mesh-list
6283700|NCT00809341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6283701|NCT00809341|Immunologic Factors|immunologic factors|mesh-ancestor
6283702|NCT00809341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283703|NCT00809341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6283704|NCT00809341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6283705|NCT00809341|Alkylating Agents|alkylating agents|mesh-ancestor
6283706|NCT00809341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283707|NCT00809341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6283708|NCT00809341|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6283709|NCT00809341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6283710|NCT00809341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6283711|NCT00809341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6283712|NCT00809341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6283713|NCT00809341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6283714|NCT00809341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6283715|NCT00809341|Glucocorticoids|glucocorticoids|mesh-ancestor
6283716|NCT00809341|Hormones|hormones|mesh-ancestor
6283717|NCT00809341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6283718|NCT00809341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6283719|NCT00809341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6283720|NCT00809341|Tubulin Modulators|tubulin modulators|mesh-ancestor
6283721|NCT00809341|Antimitotic Agents|antimitotic agents|mesh-ancestor
6283722|NCT00809341|Mitosis Modulators|mitosis modulators|mesh-ancestor
6283723|NCT00803283|Morphine|morphine|mesh-list
6283724|NCT00803283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6283725|NCT00803283|Narcotics|narcotics|mesh-ancestor
6283726|NCT00803283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6283727|NCT00803283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283728|NCT00803283|Analgesics|analgesics|mesh-ancestor
6283729|NCT00803283|Sensory System Agents|sensory system agents|mesh-ancestor
6283730|NCT00803283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6283731|NCT00811590|Everolimus|everolimus|mesh-list
6283732|NCT00811590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6283733|NCT00811590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6283734|NCT00811590|Immunologic Factors|immunologic factors|mesh-ancestor
6283735|NCT00811590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283736|NCT00808899|Sirolimus|sirolimus|mesh-list
6283737|NCT00808899|Cyclophosphamide|cyclophosphamide|mesh-list
6283738|NCT00808899|Doxorubicin|doxorubicin|mesh-list
6283739|NCT00808899|Irinotecan|irinotecan|mesh-list
6283740|NCT00808899|Etoposide|etoposide|mesh-list
6283741|NCT00808899|Topotecan|topotecan|mesh-list
6283742|NCT00808899|Tretinoin|tretinoin|mesh-list
6283743|NCT00808899|Isotretinoin|isotretinoin|mesh-list
6283744|NCT00808899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6283745|NCT00808899|Immunologic Factors|immunologic factors|mesh-ancestor
6283746|NCT00808899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283747|NCT00808899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6283748|NCT00808899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6283749|NCT00808899|Alkylating Agents|alkylating agents|mesh-ancestor
6283750|NCT00808899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283751|NCT00808899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6283752|NCT00808899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6283753|NCT00808899|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6283754|NCT00808899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6283755|NCT00808899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6283756|NCT00808899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6283757|NCT00808899|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6283758|NCT00808899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6283759|NCT00808899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6283760|NCT00808899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6283761|NCT00808899|Antifungal Agents|antifungal agents|mesh-ancestor
6283762|NCT00808899|Keratolytic Agents|keratolytic agents|mesh-ancestor
6283763|NCT00808899|Dermatologic Agents|dermatologic agents|mesh-ancestor
6283764|NCT00808769|Omeprazole|omeprazole|mesh-list
6283765|NCT00808769|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
6283766|NCT00808769|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6283767|NCT00808769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6283768|NCT00808769|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6283769|NCT00808769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6283770|NCT00808769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283771|NCT00803179|Hormones|hormones|mesh-list
6283772|NCT00803179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6283773|NCT00803179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283774|NCT00801931|Cyclophosphamide|cyclophosphamide|mesh-list
6283775|NCT00801931|Melphalan|melphalan|mesh-list
6283776|NCT00801931|Busulfan|busulfan|mesh-list
6283777|NCT00801931|Thiotepa|thiotepa|mesh-list
6283778|NCT00801931|Fludarabine|fludarabine|mesh-list
6283779|NCT00801931|Alemtuzumab|alemtuzumab|mesh-list
6283780|NCT00801931|Phenytoin|phenytoin|mesh-list
6283781|NCT00801931|Fosphenytoin|fosphenytoin|mesh-list
6283782|NCT00801931|Thymoglobulin|thymoglobulin|mesh-list
6283783|NCT00801931|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6283784|NCT00801931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6283785|NCT00801931|Immunologic Factors|immunologic factors|mesh-ancestor
6283786|NCT00801931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283787|NCT00801931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6283788|NCT00801931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6283789|NCT00801931|Alkylating Agents|alkylating agents|mesh-ancestor
6283790|NCT00801931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283791|NCT00801931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6283792|NCT00801931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6283793|NCT00801931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6283794|NCT00801931|Anticonvulsants|anticonvulsants|mesh-ancestor
6283795|NCT00801931|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6283796|NCT00801931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6283797|NCT00801931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6283798|NCT00801931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6283799|NCT00801931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6283800|NCT00793520|Milnacipran|milnacipran|mesh-list
6283801|NCT00793520|Levomilnacipran|levomilnacipran|mesh-list
6283802|NCT00793520|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6283803|NCT00793520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6283804|NCT00793520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6283805|NCT00793520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283806|NCT00793520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6283807|NCT00793520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015327|NCT00356525|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6015328|NCT00356590|Etanercept|etanercept|mesh-list
6015329|NCT00356590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6015330|NCT00356590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6015331|NCT00356590|Analgesics|analgesics|mesh-ancestor
6015332|NCT00356590|Sensory System Agents|sensory system agents|mesh-ancestor
6015333|NCT00356590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6015334|NCT00356590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015335|NCT00356590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6283808|NCT00793520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6283809|NCT00793520|Analgesics|analgesics|mesh-ancestor
6283810|NCT00793520|Sensory System Agents|sensory system agents|mesh-ancestor
6283811|NCT00793520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6283812|NCT00793520|Antidepressive Agents|antidepressive agents|mesh-ancestor
6283813|NCT00793520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6283814|NCT00795236|Melatonin|melatonin|mesh-list
6283815|NCT00795236|Antioxidants|antioxidants|mesh-ancestor
6283816|NCT00795236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283817|NCT00795236|Protective Agents|protective agents|mesh-ancestor
6283818|NCT00795236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283819|NCT00795236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6283820|NCT00799773|Rituximab|rituximab|mesh-list
6283821|NCT00799773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6283822|NCT00799773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6283823|NCT00799773|Immunologic Factors|immunologic factors|mesh-ancestor
6283824|NCT00799773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283825|NCT00799773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6283826|NCT00790452|Aspirin|aspirin|mesh-list
6283827|NCT00790452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6283828|NCT00790452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6283829|NCT00790452|Analgesics|analgesics|mesh-ancestor
6283830|NCT00790452|Sensory System Agents|sensory system agents|mesh-ancestor
6283831|NCT00790452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6283832|NCT00790452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283833|NCT00790452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6283834|NCT00790452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6283835|NCT00790452|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6283836|NCT00790452|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6283837|NCT00790452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283838|NCT00790452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6283839|NCT00790452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6283840|NCT00790452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6283841|NCT00790452|Antipyretics|antipyretics|mesh-ancestor
6283842|NCT00795665|Bevacizumab|bevacizumab|mesh-list
6283843|NCT00795665|Carmustine|carmustine|mesh-list
6283844|NCT00795665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6283845|NCT00795665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6283846|NCT00795665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6283847|NCT00795665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6283848|NCT00795665|Growth Substances|growth substances|mesh-ancestor
6283849|NCT00795665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283850|NCT00795665|Growth Inhibitors|growth inhibitors|mesh-ancestor
6283851|NCT00795665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6283852|NCT00795665|Alkylating Agents|alkylating agents|mesh-ancestor
6283853|NCT00795665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283854|NCT00787917|Omalizumab|omalizumab|mesh-list
6283855|NCT00787917|Itraconazole|itraconazole|mesh-list
6283856|NCT00787917|Antifungal Agents|antifungal agents|mesh-ancestor
6283857|NCT00787917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6283858|NCT00787917|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6283859|NCT00787917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6283860|NCT00787917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6283861|NCT00787917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283862|NCT00787917|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6283863|NCT00787917|Hormone Antagonists|hormone antagonists|mesh-ancestor
6283864|NCT00787917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6283865|NCT00787917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283866|NCT00787917|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6283867|NCT00787917|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6283868|NCT00787917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6283869|NCT00787917|Respiratory System Agents|respiratory system agents|mesh-ancestor
6283870|NCT00798590|Glucagon|glucagon|mesh-list
6283871|NCT00798590|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6283872|NCT00798590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6283873|NCT00798590|Hormones|hormones|mesh-ancestor
6283874|NCT00798590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6283875|NCT00798590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283876|NCT00798590|Incretins|incretins|mesh-ancestor
6283877|NCT00796510|Sildenafil Citrate|sildenafil citrate|mesh-list
6283878|NCT00796510|Sitaxsentan|sitaxsentan|mesh-list
6283879|NCT00796510|Vasodilator Agents|vasodilator agents|mesh-ancestor
6283880|NCT00796510|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6283881|NCT00796510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6283882|NCT00796510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6283883|NCT00796510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283884|NCT00796510|Urological Agents|urological agents|mesh-ancestor
6283885|NCT00796510|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6283886|NCT00796861|Sunitinib|sunitinib|mesh-list
6283887|NCT00796861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6283888|NCT00796861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6283889|NCT00796861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6283890|NCT00796861|Growth Substances|growth substances|mesh-ancestor
6283891|NCT00796861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283892|NCT00796861|Growth Inhibitors|growth inhibitors|mesh-ancestor
6283893|NCT00796861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6283894|NCT00796861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6283895|NCT00796861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283896|NCT00791076|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
6283897|NCT00791076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6283898|NCT00791076|Hormones|hormones|mesh-ancestor
6283899|NCT00791076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6283900|NCT00791076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283901|NCT00790478|Melatonin|melatonin|mesh-list
6283902|NCT00790478|Antioxidants|antioxidants|mesh-ancestor
6283903|NCT00790478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283904|NCT00790478|Protective Agents|protective agents|mesh-ancestor
6283905|NCT00790478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283906|NCT00790478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6283907|NCT00796107|Letrozole|letrozole|mesh-list
6283908|NCT00796107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6283909|NCT00796107|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6283910|NCT00796107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6283911|NCT00796107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6283912|NCT00796107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283913|NCT00796107|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6283914|NCT00796107|Hormone Antagonists|hormone antagonists|mesh-ancestor
6283915|NCT00796107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6283916|NCT00796107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283917|NCT00791336|Nelfinavir|nelfinavir|mesh-list
6283918|NCT00791336|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6283919|NCT00791336|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6283920|NCT00791336|Protease Inhibitors|protease inhibitors|mesh-ancestor
6283921|NCT00791336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6283922|NCT00791336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283923|NCT00791336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6283924|NCT00791336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6015336|NCT00356590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6015337|NCT00356590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6283925|NCT00791336|Antiviral Agents|antiviral agents|mesh-ancestor
6283926|NCT00791336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6283927|NCT00786682|Hydroxychloroquine|hydroxychloroquine|mesh-list
6283928|NCT00786682|Docetaxel|docetaxel|mesh-list
6283929|NCT00786682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6283930|NCT00786682|Tubulin Modulators|tubulin modulators|mesh-ancestor
6283931|NCT00786682|Antimitotic Agents|antimitotic agents|mesh-ancestor
6283932|NCT00786682|Mitosis Modulators|mitosis modulators|mesh-ancestor
6283933|NCT00786682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283934|NCT00786682|Antimalarials|antimalarials|mesh-ancestor
6283935|NCT00786682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6283936|NCT00786682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6283937|NCT00786682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6283938|NCT00786682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6283939|NCT00786682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6283940|NCT00791843|Hormones|hormones|mesh-list
6283941|NCT00791843|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
6283942|NCT00791843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6283943|NCT00791843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283944|NCT00774306|Phenytoin|phenytoin|mesh-list
6283945|NCT00774306|Levetiracetam|levetiracetam|mesh-list
6283946|NCT00774306|Valproic Acid|valproic acid|mesh-list
6283947|NCT00774306|Anticonvulsants|anticonvulsants|mesh-ancestor
6283948|NCT00774306|Nootropic Agents|nootropic agents|mesh-ancestor
6015338|NCT00356590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6015339|NCT00356590|Immunologic Factors|immunologic factors|mesh-ancestor
6015340|NCT00356603|Sumatriptan|sumatriptan|mesh-list
6015341|NCT00356603|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6015342|NCT00356603|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6015343|NCT00356603|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6015344|NCT00356603|Serotonin Agents|serotonin agents|mesh-ancestor
6015345|NCT00356603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6015346|NCT00356603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015347|NCT00356603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018474|NCT00381004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6018475|NCT00381004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6018476|NCT00381004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6018477|NCT00381004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6018478|NCT00381004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6018479|NCT00381004|Antimetabolites|antimetabolites|mesh-ancestor
6018480|NCT00381004|Antiviral Agents|antiviral agents|mesh-ancestor
6283949|NCT00774306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6283950|NCT00774306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6283951|NCT00774306|GABA Agents|gaba agents|mesh-ancestor
6283952|NCT00774306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6283953|NCT00774306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283954|NCT00774306|Antimanic Agents|antimanic agents|mesh-ancestor
6283955|NCT00774306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6283956|NCT00774306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6283957|NCT00774306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6283958|NCT00774306|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6283959|NCT00774306|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6283960|NCT00774306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6283961|NCT00774306|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6015348|NCT00356759|Warfarin|warfarin|mesh-list
6015349|NCT00356759|Anticoagulants|anticoagulants|mesh-ancestor
6015350|NCT00356811|Paclitaxel|paclitaxel|mesh-list
6283962|NCT00774306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6283963|NCT00771602|Rituximab|rituximab|mesh-list
6283964|NCT00771602|Alemtuzumab|alemtuzumab|mesh-list
6283965|NCT00771602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6283966|NCT00771602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6283967|NCT00771602|Immunologic Factors|immunologic factors|mesh-ancestor
6283968|NCT00771602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283969|NCT00771602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6283970|NCT00779038|Fentanyl|fentanyl|mesh-list
6283971|NCT00779038|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6283972|NCT00779038|Narcotics|narcotics|mesh-ancestor
6283973|NCT00779038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6283974|NCT00779038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283975|NCT00779038|Analgesics|analgesics|mesh-ancestor
6283976|NCT00779038|Sensory System Agents|sensory system agents|mesh-ancestor
6283977|NCT00779038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6283978|NCT00779038|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6283979|NCT00779038|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6283980|NCT00779038|Anesthetics, General|anesthetics, general|mesh-ancestor
6283981|NCT00779038|Anesthetics|anesthetics|mesh-ancestor
6283982|NCT00780455|Interferons|interferons|mesh-list
6283983|NCT00780455|Interferon-beta|interferon-beta|mesh-list
6283984|NCT00780455|Interferon beta-1b|interferon beta-1b|mesh-list
6283985|NCT00780455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6283986|NCT00780455|Antiviral Agents|antiviral agents|mesh-ancestor
6283987|NCT00780455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6283988|NCT00780455|Immunologic Factors|immunologic factors|mesh-ancestor
6283989|NCT00780455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6283990|NCT00780455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6283991|NCT00771316|Meropenem|meropenem|mesh-list
6283992|NCT00771316|Ertapenem|ertapenem|mesh-list
6283993|NCT00771316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6283994|NCT00771316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6283995|NCT00780481|Bradykinin|bradykinin|mesh-list
6283996|NCT00780481|Kininogens|kininogens|mesh-list
6283997|NCT00780481|Vasodilator Agents|vasodilator agents|mesh-ancestor
6283998|NCT00780481|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
6283999|NCT00780481|Protease Inhibitors|protease inhibitors|mesh-ancestor
6284000|NCT00780481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6015351|NCT00356811|Lapatinib|lapatinib|mesh-list
6015352|NCT00356811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6015353|NCT00356811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6015354|NCT00356811|Tubulin Modulators|tubulin modulators|mesh-ancestor
6015355|NCT00356811|Antimitotic Agents|antimitotic agents|mesh-ancestor
6015356|NCT00356811|Mitosis Modulators|mitosis modulators|mesh-ancestor
6015357|NCT00356811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015358|NCT00356811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6015359|NCT00356811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6015360|NCT00356889|Bevacizumab|bevacizumab|mesh-list
6015361|NCT00356889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6015362|NCT00356889|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6015363|NCT00356889|Antibodies|antibodies|mesh-list
6015364|NCT00356889|Immunoglobulins|immunoglobulins|mesh-list
6015365|NCT00356889|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6015366|NCT00356889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6284001|NCT00780481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284002|NCT00776555|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6015367|NCT00356889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6284003|NCT00776555|Dextroamphetamine|dextroamphetamine|mesh-list
6284004|NCT00776555|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6284005|NCT00776555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284006|NCT00776555|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6284007|NCT00776555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6284008|NCT00776555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6284009|NCT00776555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284010|NCT00776555|Dopamine Agents|dopamine agents|mesh-ancestor
6284011|NCT00776555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6284012|NCT00775190|Moxifloxacin|moxifloxacin|mesh-list
6284013|NCT00775190|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6284014|NCT00775190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6284015|NCT00775190|Contraceptive Agents|contraceptive agents|mesh-ancestor
6284016|NCT00775190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6284017|NCT00775190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284018|NCT00775190|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6284019|NCT00775190|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6284020|NCT00775190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6284021|NCT00775190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6284022|NCT00775190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6284023|NCT00775190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6284024|NCT00775190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6015368|NCT00356889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6015369|NCT00356889|Growth Substances|growth substances|mesh-ancestor
6015370|NCT00356889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015371|NCT00356889|Growth Inhibitors|growth inhibitors|mesh-ancestor
6015372|NCT00356889|Immunologic Factors|immunologic factors|mesh-ancestor
6015373|NCT00356889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6015374|NCT00356889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6015375|NCT00356889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015376|NCT00356915|Itraconazole|itraconazole|mesh-list
6015377|NCT00356915|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
6284025|NCT00775190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6284026|NCT00775190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284027|NCT00775190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6284028|NCT00755261|Bevacizumab|bevacizumab|mesh-list
6284029|NCT00755261|Doxorubicin|doxorubicin|mesh-list
6284030|NCT00755261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6284031|NCT00755261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6284032|NCT00755261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6284033|NCT00755261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6284034|NCT00755261|Growth Substances|growth substances|mesh-ancestor
6284035|NCT00755261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284036|NCT00755261|Growth Inhibitors|growth inhibitors|mesh-ancestor
6284037|NCT00755261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6284038|NCT00755261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6284039|NCT00755261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6284040|NCT00755261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6284041|NCT00755261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284042|NCT00766636|Gemcitabine|gemcitabine|mesh-list
6284043|NCT00766636|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6284044|NCT00766636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6284045|NCT00766636|Antimetabolites|antimetabolites|mesh-ancestor
6284046|NCT00766636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284047|NCT00766636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6284048|NCT00766636|Antiviral Agents|antiviral agents|mesh-ancestor
6284049|NCT00766636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6284050|NCT00766636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6284051|NCT00766636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6015378|NCT00356915|Antifungal Agents|antifungal agents|mesh-ancestor
6015379|NCT00356915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6284052|NCT00766636|Immunologic Factors|immunologic factors|mesh-ancestor
6284053|NCT00766636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284054|NCT00766636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6284055|NCT00768248|Ropivacaine|ropivacaine|mesh-list
6284056|NCT00768248|Anesthetics, Local|anesthetics, local|mesh-ancestor
6284057|NCT00768248|Anesthetics|anesthetics|mesh-ancestor
6284058|NCT00768248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6284059|NCT00768248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284060|NCT00768248|Sensory System Agents|sensory system agents|mesh-ancestor
6284061|NCT00768248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6284062|NCT00765765|Hydroxychloroquine|hydroxychloroquine|mesh-list
6284063|NCT00765765|Antimalarials|antimalarials|mesh-ancestor
6284064|NCT00765765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6284065|NCT00765765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6284066|NCT00765765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6284067|NCT00765765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6284068|NCT00765765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284069|NCT00765765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6284070|NCT00764699|Mecasermin|mecasermin|mesh-list
6284071|NCT00764699|Growth Substances|growth substances|mesh-ancestor
6284072|NCT00764699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284073|NCT00759577|Solifenacin Succinate|solifenacin succinate|mesh-list
6284074|NCT00759577|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6284075|NCT00759577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6284076|NCT00759577|Cholinergic Agents|cholinergic agents|mesh-ancestor
6284077|NCT00759577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6284078|NCT00759577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284079|NCT00759577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284080|NCT00759577|Urological Agents|urological agents|mesh-ancestor
6284081|NCT00763009|Dipyridamole|dipyridamole|mesh-list
6284082|NCT00763009|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6284083|NCT00763009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6284084|NCT00763009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284085|NCT00763009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6284086|NCT00763009|Vasodilator Agents|vasodilator agents|mesh-ancestor
6284087|NCT00760461|Domperidone|domperidone|mesh-list
6284088|NCT00760461|Antiemetics|antiemetics|mesh-ancestor
6015380|NCT00356915|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6284089|NCT00760461|Autonomic Agents|autonomic agents|mesh-ancestor
6284090|NCT00760461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6284091|NCT00760461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284092|NCT00760461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6284093|NCT00760461|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6284094|NCT00760461|Dopamine Agents|dopamine agents|mesh-ancestor
6284095|NCT00760461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6284096|NCT00760461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284097|NCT00749658|Bupropion|bupropion|mesh-list
6284098|NCT00749658|Varenicline|varenicline|mesh-list
6284099|NCT00749658|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6284100|NCT00749658|Antidepressive Agents|antidepressive agents|mesh-ancestor
6284101|NCT00749658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6284102|NCT00749658|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6284103|NCT00749658|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6284104|NCT00749658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6284105|NCT00749658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284106|NCT00749658|Dopamine Agents|dopamine agents|mesh-ancestor
6284107|NCT00749658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6284108|NCT00749658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015381|NCT00356915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6015382|NCT00356915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6015383|NCT00356915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015384|NCT00356915|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6015385|NCT00356915|Hormone Antagonists|hormone antagonists|mesh-ancestor
6015386|NCT00356915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6015387|NCT00356915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015388|NCT00356915|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6284109|NCT00749658|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6284110|NCT00749658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6284111|NCT00749658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6284112|NCT00749658|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6284113|NCT00749658|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6284114|NCT00749658|Cholinergic Agents|cholinergic agents|mesh-ancestor
6284115|NCT00754793|Dexetimide|dexetimide|mesh-list
6284116|NCT00754793|Citalopram|citalopram|mesh-list
6284117|NCT00754793|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6284118|NCT00754793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6284119|NCT00754793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6284120|NCT00754793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284121|NCT00754793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6284122|NCT00754793|Serotonin Agents|serotonin agents|mesh-ancestor
6284123|NCT00754793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284124|NCT00754793|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6284125|NCT00754793|Antidepressive Agents|antidepressive agents|mesh-ancestor
6284126|NCT00754793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6284127|NCT00754793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6284128|NCT00754793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6284129|NCT00754793|Parasympatholytics|parasympatholytics|mesh-ancestor
6284130|NCT00754793|Autonomic Agents|autonomic agents|mesh-ancestor
6284131|NCT00754793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6284132|NCT00754793|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6284133|NCT00754793|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6284134|NCT00754793|Cholinergic Agents|cholinergic agents|mesh-ancestor
6284135|NCT00754052|Donepezil|donepezil|mesh-list
6284136|NCT00754052|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6284137|NCT00754052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6284138|NCT00754052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284139|NCT00754052|Cholinergic Agents|cholinergic agents|mesh-ancestor
6284140|NCT00754052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6284141|NCT00754052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284142|NCT00754052|Nootropic Agents|nootropic agents|mesh-ancestor
6284143|NCT00750555|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6284144|NCT00750555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6284145|NCT00750555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6284146|NCT00750555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6284147|NCT00750555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284148|NCT00752986|Fulvestrant|fulvestrant|mesh-list
6284149|NCT00752986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6284150|NCT00752986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6284151|NCT00752986|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6284152|NCT00752986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6284153|NCT00752986|Hormone Antagonists|hormone antagonists|mesh-ancestor
6284154|NCT00752986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6284155|NCT00752986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284156|NCT00746239|Dexetimide|dexetimide|mesh-list
6284157|NCT00746239|Citalopram|citalopram|mesh-list
6284158|NCT00746239|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6284159|NCT00746239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6284160|NCT00746239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6284161|NCT00746239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284162|NCT00746239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6284163|NCT00746239|Serotonin Agents|serotonin agents|mesh-ancestor
6284164|NCT00746239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284165|NCT00746239|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6284166|NCT00746239|Antidepressive Agents|antidepressive agents|mesh-ancestor
6284167|NCT00746239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6284168|NCT00746239|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6284169|NCT00746239|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6284170|NCT00746239|Parasympatholytics|parasympatholytics|mesh-ancestor
6284171|NCT00746239|Autonomic Agents|autonomic agents|mesh-ancestor
5724181|NCT03188445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724182|NCT03188445|Protective Agents|protective agents|mesh-ancestor
5724183|NCT03188445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724184|NCT03188445|Vitamins|vitamins|mesh-ancestor
5724185|NCT03188445|Micronutrients|micronutrients|mesh-ancestor
5724186|NCT03188445|Trace Elements|trace elements|mesh-ancestor
5724187|NCT03188445|Hematinics|hematinics|mesh-ancestor
5724188|NCT03188471|Aspirin|aspirin|mesh-list
6284172|NCT00746239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6284173|NCT00746239|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6284174|NCT00746239|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6284175|NCT00746239|Cholinergic Agents|cholinergic agents|mesh-ancestor
6284176|NCT00754013|Donepezil|donepezil|mesh-list
6284177|NCT00754013|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6284178|NCT00754013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6284179|NCT00754013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284180|NCT00754013|Cholinergic Agents|cholinergic agents|mesh-ancestor
6284181|NCT00754013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6284182|NCT00754013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284183|NCT00754013|Nootropic Agents|nootropic agents|mesh-ancestor
6284184|NCT00751933|Vaccines|vaccines|mesh-list
6284185|NCT00751933|Immunologic Factors|immunologic factors|mesh-ancestor
6284186|NCT00751933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284187|NCT00746603|Simvastatin|simvastatin|mesh-list
6284188|NCT00746603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6284189|NCT00746603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6284190|NCT00746603|Antimetabolites|antimetabolites|mesh-ancestor
6284191|NCT00746603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284192|NCT00746603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6284193|NCT00746603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6284194|NCT00746603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6284195|NCT00736385|Metformin|metformin|mesh-list
6284196|NCT00736385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6284197|NCT00736385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284198|NCT00738972|Valsartan|valsartan|mesh-list
6284199|NCT00738972|Simvastatin|simvastatin|mesh-list
6284200|NCT00738972|Ezetimibe|ezetimibe|mesh-list
6284201|NCT00738972|Pravastatin|pravastatin|mesh-list
6284202|NCT00738972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6284203|NCT00738972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6284204|NCT00738972|Antimetabolites|antimetabolites|mesh-ancestor
6284205|NCT00738972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284206|NCT00738972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6284207|NCT00738972|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6284208|NCT00738972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6284209|NCT00738972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6284210|NCT00738972|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6284211|NCT00738972|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6391581|NCT00193544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6391582|NCT00193544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6391583|NCT00193544|Growth Substances|growth substances|mesh-ancestor
6284212|NCT00743197|Aspirin|aspirin|mesh-list
6284213|NCT00743197|Lisinopril|lisinopril|mesh-list
6284214|NCT00743197|Simvastatin|simvastatin|mesh-list
6284215|NCT00743197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6284216|NCT00743197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6284217|NCT00743197|Analgesics|analgesics|mesh-ancestor
6284218|NCT00743197|Sensory System Agents|sensory system agents|mesh-ancestor
6284219|NCT00743197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6284220|NCT00743197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284221|NCT00743197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6284222|NCT00743197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6284223|NCT00743197|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6284224|NCT00743197|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6284225|NCT00743197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284226|NCT00743197|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6284227|NCT00743197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6284228|NCT00743197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6284229|NCT00743197|Antipyretics|antipyretics|mesh-ancestor
6284230|NCT00743197|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6284231|NCT00743197|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6284232|NCT00743197|Antimetabolites|antimetabolites|mesh-ancestor
6284233|NCT00743197|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6284234|NCT00743197|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6284235|NCT00743197|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6284236|NCT00743197|Protease Inhibitors|protease inhibitors|mesh-ancestor
6284237|NCT00743197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6284238|NCT00743197|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6284239|NCT00743197|Protective Agents|protective agents|mesh-ancestor
6284240|NCT00739063|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6284241|NCT00739063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6284242|NCT00739063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6284243|NCT00739063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6284244|NCT00739063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284245|NCT00739882|Antibodies|antibodies|mesh-list
6284246|NCT00739882|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6284247|NCT00739882|Immunologic Factors|immunologic factors|mesh-ancestor
6284248|NCT00739882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284249|NCT00731770|Fluticasone|fluticasone|mesh-list
6284250|NCT00731770|Xhance|xhance|mesh-list
6284251|NCT00731770|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6284252|NCT00731770|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6284253|NCT00731770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6284254|NCT00731770|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6284255|NCT00731770|Autonomic Agents|autonomic agents|mesh-ancestor
6284256|NCT00731770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6284257|NCT00731770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284258|NCT00731770|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6284259|NCT00731770|Respiratory System Agents|respiratory system agents|mesh-ancestor
6284260|NCT00731770|Dermatologic Agents|dermatologic agents|mesh-ancestor
6284261|NCT00731770|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6284262|NCT00731770|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6284263|NCT00731770|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6284264|NCT00731770|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6284265|NCT00731770|Adrenergic Agents|adrenergic agents|mesh-ancestor
6015389|NCT00356993|Nicotine|nicotine|mesh-list
6015390|NCT00356993|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6015391|NCT00356993|Autonomic Agents|autonomic agents|mesh-ancestor
6015392|NCT00356993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6015393|NCT00356993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015394|NCT00356993|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6015395|NCT00356993|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6015396|NCT00356993|Cholinergic Agents|cholinergic agents|mesh-ancestor
6015397|NCT00356993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6015398|NCT00356993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015399|NCT00357006|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6015400|NCT00357006|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6015401|NCT00357006|Estradiol|estradiol|mesh-list
6015402|NCT00357006|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6015403|NCT00357006|Estrogens|estrogens|mesh-ancestor
6015404|NCT00357006|Hormones|hormones|mesh-ancestor
6015405|NCT00357006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6015406|NCT00357006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284266|NCT00731770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6284267|NCT00731770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284268|NCT00731770|Glucocorticoids|glucocorticoids|mesh-ancestor
6284269|NCT00731770|Hormones|hormones|mesh-ancestor
6284270|NCT00731770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6284271|NCT00731770|Sympathomimetics|sympathomimetics|mesh-ancestor
6284272|NCT00729365|Ramipril|ramipril|mesh-list
6284273|NCT00729365|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6284274|NCT00729365|Protease Inhibitors|protease inhibitors|mesh-ancestor
6284275|NCT00729365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6284276|NCT00729365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284277|NCT00729365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6284278|NCT00732680|Botulinum Toxins|botulinum toxins|mesh-list
6284279|NCT00732680|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6284280|NCT00732680|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6284281|NCT00732680|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6284282|NCT00732680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6284283|NCT00732680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284284|NCT00732680|Cholinergic Agents|cholinergic agents|mesh-ancestor
6284285|NCT00732680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6284286|NCT00732680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284287|NCT00732680|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6284288|NCT00732680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6284289|NCT00726180|Trastuzumab|trastuzumab|mesh-list
6284290|NCT00726180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6284291|NCT00726180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6284292|NCT00724282|Eszopiclone|eszopiclone|mesh-list
6284293|NCT00724282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6284294|NCT00724282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6284295|NCT00724282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284296|NCT00728845|Hydroxychloroquine|hydroxychloroquine|mesh-list
6284297|NCT00728845|Paclitaxel|paclitaxel|mesh-list
6284298|NCT00728845|Bevacizumab|bevacizumab|mesh-list
6284299|NCT00728845|Carboplatin|carboplatin|mesh-list
6284300|NCT00728845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6284301|NCT00728845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6284302|NCT00728845|Tubulin Modulators|tubulin modulators|mesh-ancestor
6284303|NCT00728845|Antimitotic Agents|antimitotic agents|mesh-ancestor
6284304|NCT00728845|Mitosis Modulators|mitosis modulators|mesh-ancestor
6284305|NCT00728845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284306|NCT00728845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6284307|NCT00728845|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6284308|NCT00728845|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6284309|NCT00728845|Growth Substances|growth substances|mesh-ancestor
6284310|NCT00728845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284311|NCT00728845|Growth Inhibitors|growth inhibitors|mesh-ancestor
6284312|NCT00728845|Antimalarials|antimalarials|mesh-ancestor
6284313|NCT00728845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6284314|NCT00728845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6284315|NCT00728845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6284316|NCT00728845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6284317|NCT00728845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6284318|NCT00726830|Morphine|morphine|mesh-list
6284319|NCT00726830|Oxycodone|oxycodone|mesh-list
6284320|NCT00726830|Methadone|methadone|mesh-list
6284321|NCT00726830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6284322|NCT00726830|Narcotics|narcotics|mesh-ancestor
6284323|NCT00726830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6284324|NCT00726830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284325|NCT00726830|Analgesics|analgesics|mesh-ancestor
6284326|NCT00726830|Sensory System Agents|sensory system agents|mesh-ancestor
6284327|NCT00726830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6284328|NCT00726830|Antitussive Agents|antitussive agents|mesh-ancestor
6284329|NCT00726830|Respiratory System Agents|respiratory system agents|mesh-ancestor
6284330|NCT00726037|Denileukin diftitox|denileukin diftitox|mesh-list
6284331|NCT00726037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6284332|NCT00729560|Flutamide|flutamide|mesh-list
6284333|NCT00729560|Androgen Antagonists|androgen antagonists|mesh-ancestor
6284334|NCT00729560|Hormone Antagonists|hormone antagonists|mesh-ancestor
6284335|NCT00729560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6284336|NCT00729560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284337|NCT00729560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6284338|NCT00729560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6284339|NCT00716807|Nalbuphine|nalbuphine|mesh-list
6284340|NCT00716807|Naloxone|naloxone|mesh-list
6284341|NCT00716807|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6284342|NCT00716807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284343|NCT00716807|Sensory System Agents|sensory system agents|mesh-ancestor
6284344|NCT00716807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6284345|NCT00716807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6284346|NCT00716807|Narcotics|narcotics|mesh-ancestor
6284347|NCT00716807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6284348|NCT00716807|Analgesics|analgesics|mesh-ancestor
6284349|NCT00714948|Gemcitabine|gemcitabine|mesh-list
6284350|NCT00714948|Sorafenib|sorafenib|mesh-list
6284351|NCT00714948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6284352|NCT00714948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6284353|NCT00714948|Antimetabolites|antimetabolites|mesh-ancestor
6284354|NCT00714948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284355|NCT00714948|Antiviral Agents|antiviral agents|mesh-ancestor
6284356|NCT00714948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6284357|NCT00714948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6284358|NCT00714948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6284359|NCT00714948|Immunologic Factors|immunologic factors|mesh-ancestor
6284360|NCT00714948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284361|NCT00714948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6284362|NCT00720343|Choline|choline|mesh-list
6284363|NCT00720343|Lipotropic Agents|lipotropic agents|mesh-ancestor
6284364|NCT00720343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6284365|NCT00720343|Antimetabolites|antimetabolites|mesh-ancestor
6284366|NCT00720343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284367|NCT00720343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6284368|NCT00720343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6284369|NCT00720343|Nootropic Agents|nootropic agents|mesh-ancestor
6284370|NCT00719914|Eptifibatide|eptifibatide|mesh-list
6284371|NCT00719914|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6284372|NCT00718640|Dexamethasone|dexamethasone|mesh-list
6015407|NCT00357006|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6015408|NCT00357006|Contraceptive Agents|contraceptive agents|mesh-ancestor
6015409|NCT00357006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6284373|NCT00718640|Bortezomib|bortezomib|mesh-list
6284374|NCT00718640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6284375|NCT00718640|Antiemetics|antiemetics|mesh-ancestor
6284376|NCT00718640|Autonomic Agents|autonomic agents|mesh-ancestor
6284377|NCT00718640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6284378|NCT00718640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284379|NCT00718640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6284380|NCT00718640|Glucocorticoids|glucocorticoids|mesh-ancestor
6284381|NCT00718640|Hormones|hormones|mesh-ancestor
6284382|NCT00718640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6284383|NCT00718640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6284384|NCT00718640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6284385|NCT00720083|Cisplatin|cisplatin|mesh-list
6284386|NCT00720083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6284387|NCT00717275|Temozolomide|temozolomide|mesh-list
6284388|NCT00717275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6284389|NCT00717275|Alkylating Agents|alkylating agents|mesh-ancestor
6391584|NCT00193544|Growth Inhibitors|growth inhibitors|mesh-ancestor
6015410|NCT00357006|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6015411|NCT00357032|Belinostat|belinostat|mesh-list
6015412|NCT00357032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6015413|NCT00357032|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6015414|NCT00357032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6284390|NCT00717275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284391|NCT00717275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6284392|NCT00711087|Botulinum Toxins|botulinum toxins|mesh-list
6284393|NCT00711087|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6284394|NCT00711087|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6284395|NCT00711087|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6284396|NCT00711087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6284397|NCT00711087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284398|NCT00711087|Cholinergic Agents|cholinergic agents|mesh-ancestor
6284399|NCT00711087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6284400|NCT00711087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284401|NCT00711087|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6284402|NCT00711087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6284403|NCT00706797|Etanercept|etanercept|mesh-list
6284404|NCT00706797|Methotrexate|methotrexate|mesh-list
6284405|NCT00706797|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6284406|NCT00706797|Abortifacient Agents|abortifacient agents|mesh-ancestor
6284407|NCT00706797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6284408|NCT00706797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284409|NCT00706797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6284410|NCT00706797|Antimetabolites|antimetabolites|mesh-ancestor
6284411|NCT00706797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284412|NCT00706797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6284413|NCT00706797|Dermatologic Agents|dermatologic agents|mesh-ancestor
6284414|NCT00706797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6284415|NCT00706797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6284416|NCT00706797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6284417|NCT00706797|Immunologic Factors|immunologic factors|mesh-ancestor
6284418|NCT00706797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6284419|NCT00706797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6284420|NCT00706797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6284421|NCT00706797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6284422|NCT00706797|Analgesics|analgesics|mesh-ancestor
6284423|NCT00706797|Sensory System Agents|sensory system agents|mesh-ancestor
6284424|NCT00706797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6284425|NCT00706797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6284426|NCT00706797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6284427|NCT00713596|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6284428|NCT00713596|Hemostatics|hemostatics|mesh-ancestor
6284429|NCT00713596|Coagulants|coagulants|mesh-ancestor
6284430|NCT00703885|Alprazolam|alprazolam|mesh-list
6284431|NCT00703885|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6284432|NCT00703885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6284433|NCT00703885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284434|NCT00703885|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6284435|NCT00703885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6284436|NCT00703885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6284437|NCT00703885|GABA Modulators|gaba modulators|mesh-ancestor
6284438|NCT00703885|GABA Agents|gaba agents|mesh-ancestor
6284439|NCT00703885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6284440|NCT00703885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284441|NCT00713258|Alendronate|alendronate|mesh-list
6284442|NCT00713258|Hormones|hormones|mesh-list
6284443|NCT00713258|Parathyroid Hormone|parathyroid hormone|mesh-list
6284444|NCT00713258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6284445|NCT00713258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284446|NCT00713258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6284447|NCT00713258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6284448|NCT00707161|Cisplatin|cisplatin|mesh-list
6284449|NCT00707161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6284450|NCT00704496|Pseudoephedrine|pseudoephedrine|mesh-list
6284451|NCT00704496|Ephedrine|ephedrine|mesh-list
6284452|NCT00704496|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6284453|NCT00704496|Autonomic Agents|autonomic agents|mesh-ancestor
6284454|NCT00704496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6284455|NCT00704496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284456|NCT00704496|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6284457|NCT00704496|Respiratory System Agents|respiratory system agents|mesh-ancestor
6284458|NCT00704496|Nasal Decongestants|nasal decongestants|mesh-ancestor
6284459|NCT00704496|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6284460|NCT00704496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6284461|NCT00704496|Sympathomimetics|sympathomimetics|mesh-ancestor
6284462|NCT00704496|Adrenergic Agents|adrenergic agents|mesh-ancestor
6284463|NCT00704496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6284464|NCT00704496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284465|NCT00708916|Apremilast|apremilast|mesh-list
6284466|NCT00708916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6284467|NCT00708916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6284468|NCT00708916|Analgesics|analgesics|mesh-ancestor
6284469|NCT00708916|Sensory System Agents|sensory system agents|mesh-ancestor
6284470|NCT00708916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6284471|NCT00708916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284472|NCT00708916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6284473|NCT00708916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6284474|NCT00708916|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6284475|NCT00708916|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6284476|NCT00708916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6284477|NCT00708916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284478|NCT00700778|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6284479|NCT00700778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6284480|NCT00700778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284481|NCT00699842|Lenalidomide|lenalidomide|mesh-list
6284482|NCT00699842|Immunologic Factors|immunologic factors|mesh-ancestor
6284483|NCT00699842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284484|NCT00699842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6284485|NCT00699842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6284486|NCT00699842|Growth Substances|growth substances|mesh-ancestor
6284487|NCT00699842|Growth Inhibitors|growth inhibitors|mesh-ancestor
6284488|NCT00699842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6284489|NCT00702962|Carboplatin|carboplatin|mesh-list
6284490|NCT00702962|Etoposide|etoposide|mesh-list
6284491|NCT00702962|Vorinostat|vorinostat|mesh-list
6284492|NCT00702962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6284493|NCT00702962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6284494|NCT00702962|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6284495|NCT00702962|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6284496|NCT00702962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6284497|NCT00702962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284498|NCT00702962|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6284499|NCT00703534|Lesogaberan|lesogaberan|mesh-list
6284500|NCT00703534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6284501|NCT00703534|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6284502|NCT00703534|GABA Agonists|gaba agonists|mesh-ancestor
6284503|NCT00703534|GABA Agents|gaba agents|mesh-ancestor
6284504|NCT00703534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6284505|NCT00703534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284506|NCT00703534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284507|NCT00698009|Vidarabine|vidarabine|mesh-list
6284508|NCT00698009|Cyclophosphamide|cyclophosphamide|mesh-list
6284509|NCT00698009|Fludarabine|fludarabine|mesh-list
6284510|NCT00698009|Fludarabine phosphate|fludarabine phosphate|mesh-list
6284511|NCT00698009|Interleukin-2|interleukin-2|mesh-list
6284512|NCT00698009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6284513|NCT00698009|Immunologic Factors|immunologic factors|mesh-ancestor
6284514|NCT00698009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284515|NCT00698009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6284516|NCT00698009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6284517|NCT00698009|Alkylating Agents|alkylating agents|mesh-ancestor
6284518|NCT00698009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284519|NCT00698009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6284520|NCT00698009|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6284521|NCT00698009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6284522|NCT00698009|Antimetabolites|antimetabolites|mesh-ancestor
6284523|NCT00698009|Antiviral Agents|antiviral agents|mesh-ancestor
6284524|NCT00698009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6284525|NCT00698009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6284526|NCT00698009|Analgesics|analgesics|mesh-ancestor
6284527|NCT00698009|Sensory System Agents|sensory system agents|mesh-ancestor
6284528|NCT00698009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6284529|NCT00703339|Treprostinil|treprostinil|mesh-list
6284530|NCT00703339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6284531|NCT00691444|Melatonin|melatonin|mesh-list
6284532|NCT00691444|Antioxidants|antioxidants|mesh-ancestor
6284533|NCT00691444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284534|NCT00691444|Protective Agents|protective agents|mesh-ancestor
6284535|NCT00691444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284536|NCT00691444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6284537|NCT00691652|Rituximab|rituximab|mesh-list
6284538|NCT00691652|Clofarabine|clofarabine|mesh-list
6284539|NCT00691652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6284540|NCT00691652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6284541|NCT00691652|Immunologic Factors|immunologic factors|mesh-ancestor
6284542|NCT00691652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284543|NCT00691652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6284544|NCT00691652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6284545|NCT00691652|Antimetabolites|antimetabolites|mesh-ancestor
6284546|NCT00691652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284547|NCT00686972|Glucagon|glucagon|mesh-list
6284548|NCT00686972|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6284549|NCT00686972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6284550|NCT00686972|Hormones|hormones|mesh-ancestor
6284551|NCT00686972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6284552|NCT00686972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284553|NCT00686972|Incretins|incretins|mesh-ancestor
6284554|NCT00693017|Zonisamide|zonisamide|mesh-list
6284555|NCT00693017|Anticonvulsants|anticonvulsants|mesh-ancestor
6284556|NCT00693017|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6284557|NCT00693017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6284558|NCT00693017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284559|NCT00693017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6284560|NCT00693017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284561|NCT00691574|Melatonin|melatonin|mesh-list
6284562|NCT00691574|Antioxidants|antioxidants|mesh-ancestor
6284563|NCT00691574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284564|NCT00691574|Protective Agents|protective agents|mesh-ancestor
6284565|NCT00691574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284566|NCT00691574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6284567|NCT00692094|Melatonin|melatonin|mesh-list
6284568|NCT00692094|Antioxidants|antioxidants|mesh-ancestor
6284569|NCT00692094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284570|NCT00692094|Protective Agents|protective agents|mesh-ancestor
6284571|NCT00692094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284572|NCT00692094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6284573|NCT00692003|Zonisamide|zonisamide|mesh-list
6284574|NCT00692003|Anticonvulsants|anticonvulsants|mesh-ancestor
6284575|NCT00692003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6284576|NCT00692003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6284577|NCT00692003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284578|NCT00692003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6284579|NCT00692003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284580|NCT00678288|Interferons|interferons|mesh-list
6284581|NCT00678288|Sorafenib|sorafenib|mesh-list
6284582|NCT00678288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6284583|NCT00678288|Antiviral Agents|antiviral agents|mesh-ancestor
6284584|NCT00678288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6284585|NCT00678288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6284586|NCT00678288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6284587|NCT00678288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284588|NCT00676026|Zolpidem|zolpidem|mesh-list
6284589|NCT00676026|Fluoxetine|fluoxetine|mesh-list
6284590|NCT00676026|Progesterone|progesterone|mesh-list
6284591|NCT00676026|Progestins|progestins|mesh-ancestor
6284592|NCT00676026|Hormones|hormones|mesh-ancestor
6284593|NCT00676026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6284594|NCT00676026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284595|NCT00676026|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6284596|NCT00676026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6284597|NCT00676026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6284598|NCT00676026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284599|NCT00676026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6284600|NCT00676026|Serotonin Agents|serotonin agents|mesh-ancestor
6284601|NCT00676026|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6284602|NCT00676026|Antidepressive Agents|antidepressive agents|mesh-ancestor
6284603|NCT00676026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6284604|NCT00676026|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6284605|NCT00676026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6284606|NCT00676026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6284607|NCT00676026|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6284608|NCT00676026|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6284609|NCT00676026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6284610|NCT00676026|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6284611|NCT00676026|GABA Agonists|gaba agonists|mesh-ancestor
6284612|NCT00676026|GABA Agents|gaba agents|mesh-ancestor
6284613|NCT00689052|Pramipexole|pramipexole|mesh-list
6284614|NCT00689052|Antioxidants|antioxidants|mesh-ancestor
6284615|NCT00689052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284616|NCT00689052|Protective Agents|protective agents|mesh-ancestor
6284617|NCT00689052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284618|NCT00689052|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6284619|NCT00689052|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6284620|NCT00689052|Dopamine Agonists|dopamine agonists|mesh-ancestor
6284621|NCT00689052|Dopamine Agents|dopamine agents|mesh-ancestor
6284622|NCT00689052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6284623|NCT00678574|Fluoxetine|fluoxetine|mesh-list
6284624|NCT00678574|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6284625|NCT00678574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6284626|NCT00678574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6284627|NCT00678574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284628|NCT00678574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6284629|NCT00678574|Serotonin Agents|serotonin agents|mesh-ancestor
6284630|NCT00678574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284631|NCT00678574|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6284632|NCT00678574|Antidepressive Agents|antidepressive agents|mesh-ancestor
6284633|NCT00678574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6284634|NCT00678574|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6284635|NCT00678574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6284636|NCT00678574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6284637|NCT00683917|Leuprolide|leuprolide|mesh-list
6284638|NCT00683917|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6284639|NCT00683917|Fertility Agents|fertility agents|mesh-ancestor
6284640|NCT00683917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6284641|NCT00683917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284642|NCT00683917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6284643|NCT00683917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6284644|NCT00688935|Melatonin|melatonin|mesh-list
6284645|NCT00688935|Antioxidants|antioxidants|mesh-ancestor
6284646|NCT00688935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284647|NCT00688935|Protective Agents|protective agents|mesh-ancestor
6284648|NCT00688935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284649|NCT00688935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6284650|NCT00685880|Betamethasone|betamethasone|mesh-list
6284651|NCT00685880|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
6284652|NCT00685880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6284653|NCT00685880|Glucocorticoids|glucocorticoids|mesh-ancestor
6284654|NCT00685880|Hormones|hormones|mesh-ancestor
6284655|NCT00685880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6284656|NCT00685880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284657|NCT00685880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6284658|NCT00685880|Respiratory System Agents|respiratory system agents|mesh-ancestor
6284659|NCT00685880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6284660|NCT00685880|Autonomic Agents|autonomic agents|mesh-ancestor
6284661|NCT00685880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6284662|NCT00681044|Melphalan|melphalan|mesh-list
6284663|NCT00681044|Immunologic Factors|immunologic factors|mesh-ancestor
6284664|NCT00681044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284665|NCT00681044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6284666|NCT00681044|Alkylating Agents|alkylating agents|mesh-ancestor
6284667|NCT00681044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284668|NCT00681044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6284669|NCT00681044|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6284670|NCT00681044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6284671|NCT00684255|Fludarabine|fludarabine|mesh-list
6284672|NCT00684255|Busulfan|busulfan|mesh-list
6284673|NCT00684255|Alemtuzumab|alemtuzumab|mesh-list
6284674|NCT00684255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6284675|NCT00684255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284676|NCT00684255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6284677|NCT00684255|Immunologic Factors|immunologic factors|mesh-ancestor
6284678|NCT00684255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284679|NCT00684255|Alkylating Agents|alkylating agents|mesh-ancestor
6284680|NCT00684255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6284681|NCT00684255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6284682|NCT00684255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6284683|NCT00683787|Docetaxel|docetaxel|mesh-list
6284684|NCT00683787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6284685|NCT00683787|Tubulin Modulators|tubulin modulators|mesh-ancestor
6284686|NCT00683787|Antimitotic Agents|antimitotic agents|mesh-ancestor
6284687|NCT00683787|Mitosis Modulators|mitosis modulators|mesh-ancestor
6284688|NCT00683787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284689|NCT00678041|Nitrofurantoin|nitrofurantoin|mesh-list
6284690|NCT00678041|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6284691|NCT00678041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6284692|NCT00678041|Renal Agents|renal agents|mesh-ancestor
6284693|NCT00678041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6284694|NCT00681629|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6284695|NCT00681629|Antidepressive Agents|antidepressive agents|mesh-ancestor
6284696|NCT00681629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6284697|NCT00681629|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6284698|NCT00681629|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6284699|NCT00681629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6284700|NCT00681629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284701|NCT00669461|Lubiprostone|lubiprostone|mesh-list
6284702|NCT00669461|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6284703|NCT00669461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6284704|NCT00669461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284705|NCT00673309|Insulin|insulin|mesh-list
6284706|NCT00673309|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6284707|NCT00673309|Itraconazole|itraconazole|mesh-list
6284708|NCT00673309|Propranolol|propranolol|mesh-list
6284709|NCT00673309|Hormones|hormones|mesh-list
6284710|NCT00673309|Oxandrolone|oxandrolone|mesh-list
6284711|NCT00673309|Nandrolone|nandrolone|mesh-list
6284712|NCT00673309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6284713|NCT00673309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284714|NCT00673309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6284715|NCT00673309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284716|NCT00673309|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6284717|NCT00673309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6284718|NCT00673309|Adrenergic Agents|adrenergic agents|mesh-ancestor
6284719|NCT00673309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6284720|NCT00673309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6284721|NCT00673309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6284722|NCT00673309|Vasodilator Agents|vasodilator agents|mesh-ancestor
6284723|NCT00673309|Antifungal Agents|antifungal agents|mesh-ancestor
6284724|NCT00673309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6284725|NCT00673309|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6284726|NCT00673309|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6284727|NCT00673309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6284728|NCT00673309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6284729|NCT00673309|Hormone Antagonists|hormone antagonists|mesh-ancestor
6284730|NCT00673309|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6284731|NCT00673309|Androgens|androgens|mesh-ancestor
6284732|NCT00673309|Anabolic Agents|anabolic agents|mesh-ancestor
6284733|NCT00673595|Varenicline|varenicline|mesh-list
6284734|NCT00673595|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6284735|NCT00673595|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6284736|NCT00673595|Cholinergic Agents|cholinergic agents|mesh-ancestor
6284737|NCT00673595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6284738|NCT00673595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284739|NCT00673595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284740|NCT00673361|Temozolomide|temozolomide|mesh-list
6284741|NCT00673361|Sorafenib|sorafenib|mesh-list
6284742|NCT00673361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6284743|NCT00673361|Alkylating Agents|alkylating agents|mesh-ancestor
6284744|NCT00673361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284745|NCT00673361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6284746|NCT00673361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6284747|NCT00673361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6284748|NCT00668785|Ranibizumab|ranibizumab|mesh-list
6284749|NCT00668785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6284750|NCT00668785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6284751|NCT00668785|Growth Substances|growth substances|mesh-ancestor
6284752|NCT00668785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284753|NCT00668785|Growth Inhibitors|growth inhibitors|mesh-ancestor
6284754|NCT00668785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6284755|NCT00673179|Leucovorin|leucovorin|mesh-list
6284756|NCT00673179|Gemcitabine|gemcitabine|mesh-list
6284757|NCT00673179|Doxorubicin|doxorubicin|mesh-list
6284758|NCT00673179|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6284759|NCT00673179|Methotrexate|methotrexate|mesh-list
6284760|NCT00673179|Ifosfamide|ifosfamide|mesh-list
6284761|NCT00673179|Dexrazoxane|dexrazoxane|mesh-list
6284762|NCT00673179|Razoxane|razoxane|mesh-list
6284763|NCT00673179|Sargramostim|sargramostim|mesh-list
6284764|NCT00673179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6284765|NCT00673179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6284766|NCT00673179|Antimetabolites|antimetabolites|mesh-ancestor
6284767|NCT00673179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284768|NCT00673179|Antiviral Agents|antiviral agents|mesh-ancestor
6284769|NCT00673179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6284770|NCT00673179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6284771|NCT00673179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6284772|NCT00673179|Immunologic Factors|immunologic factors|mesh-ancestor
6284773|NCT00673179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284774|NCT00673179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6284775|NCT00673179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6284776|NCT00673179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6284777|NCT00673179|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6284778|NCT00673179|Abortifacient Agents|abortifacient agents|mesh-ancestor
6284779|NCT00673179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6284780|NCT00673179|Dermatologic Agents|dermatologic agents|mesh-ancestor
6284781|NCT00673179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6284782|NCT00673179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6284783|NCT00673179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6284784|NCT00673179|Antidotes|antidotes|mesh-ancestor
6284785|NCT00673179|Protective Agents|protective agents|mesh-ancestor
6284786|NCT00673179|Vitamin B Complex|vitamin b complex|mesh-ancestor
6284787|NCT00673179|Vitamins|vitamins|mesh-ancestor
6284788|NCT00673179|Micronutrients|micronutrients|mesh-ancestor
6284789|NCT00673179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6284790|NCT00673179|Alkylating Agents|alkylating agents|mesh-ancestor
6284791|NCT00673179|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6284792|NCT00673179|Antimitotic Agents|antimitotic agents|mesh-ancestor
6284793|NCT00673179|Mitosis Modulators|mitosis modulators|mesh-ancestor
6284794|NCT00668265|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6284795|NCT00668265|Antidepressive Agents|antidepressive agents|mesh-ancestor
6284796|NCT00668265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6284797|NCT00668265|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6284798|NCT00668265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6284799|NCT00668265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6284800|NCT00668265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284801|NCT00660348|Morphine|morphine|mesh-list
6284802|NCT00660348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6284803|NCT00660348|Narcotics|narcotics|mesh-ancestor
6284804|NCT00660348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6284805|NCT00660348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284806|NCT00660348|Analgesics|analgesics|mesh-ancestor
6284807|NCT00660348|Sensory System Agents|sensory system agents|mesh-ancestor
6284808|NCT00660348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6284809|NCT00664066|Epoetin Alfa|epoetin alfa|mesh-list
6284810|NCT00664066|Hematinics|hematinics|mesh-ancestor
6284811|NCT00667017|Immunotoxins|immunotoxins|mesh-list
6284812|NCT00667017|Immunologic Factors|immunologic factors|mesh-ancestor
6284813|NCT00667017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284814|NCT00665444|Aripiprazole|aripiprazole|mesh-list
6284815|NCT00665444|Antidepressive Agents|antidepressive agents|mesh-ancestor
6284816|NCT00665444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6284817|NCT00665444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6284818|NCT00665444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6284819|NCT00665444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6284820|NCT00665444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284821|NCT00665444|Dopamine Agonists|dopamine agonists|mesh-ancestor
6284822|NCT00665444|Dopamine Agents|dopamine agents|mesh-ancestor
6284823|NCT00665444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6284824|NCT00665444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284825|NCT00665444|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6284826|NCT00665444|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6284827|NCT00665444|Serotonin Agents|serotonin agents|mesh-ancestor
6284828|NCT00665444|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6284829|NCT00665444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6284830|NCT00665444|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6284831|NCT00665444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6284832|NCT00656916|Fluticasone|fluticasone|mesh-list
6284833|NCT00656916|Xhance|xhance|mesh-list
6284834|NCT00656916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6284835|NCT00656916|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6284836|NCT00656916|Autonomic Agents|autonomic agents|mesh-ancestor
6284837|NCT00656916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6284838|NCT00656916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284839|NCT00656916|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6284840|NCT00656916|Respiratory System Agents|respiratory system agents|mesh-ancestor
6284841|NCT00656916|Dermatologic Agents|dermatologic agents|mesh-ancestor
6284842|NCT00656916|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6284843|NCT00660595|Risperidone|risperidone|mesh-list
6284844|NCT00660595|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6284845|NCT00660595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6284846|NCT00660595|Serotonin Agents|serotonin agents|mesh-ancestor
6284847|NCT00660595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6284848|NCT00660595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284849|NCT00660595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284850|NCT00660595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6284851|NCT00660595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6284852|NCT00660595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6284853|NCT00660595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6284854|NCT00660595|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6284855|NCT00660595|Dopamine Agents|dopamine agents|mesh-ancestor
6284856|NCT00660595|Antidepressive Agents|antidepressive agents|mesh-ancestor
6284857|NCT00661466|Bupivacaine|bupivacaine|mesh-list
6284858|NCT00661466|Anesthetics, Local|anesthetics, local|mesh-ancestor
6284859|NCT00661466|Anesthetics|anesthetics|mesh-ancestor
6284860|NCT00661466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6284861|NCT00661466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284862|NCT00661466|Sensory System Agents|sensory system agents|mesh-ancestor
6284863|NCT00661466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6284864|NCT00646282|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
6284865|NCT00646282|Vitamins|vitamins|mesh-ancestor
6284866|NCT00646282|Micronutrients|micronutrients|mesh-ancestor
6284867|NCT00646282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284868|NCT00646282|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6284869|NCT00657553|Bortezomib|bortezomib|mesh-list
6284870|NCT00657553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6284871|NCT00655057|Citalopram|citalopram|mesh-list
6284872|NCT00655057|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6284873|NCT00655057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6284874|NCT00655057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6284875|NCT00655057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284876|NCT00655057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6284877|NCT00655057|Serotonin Agents|serotonin agents|mesh-ancestor
6284878|NCT00655057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284879|NCT00655057|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6284880|NCT00655057|Antidepressive Agents|antidepressive agents|mesh-ancestor
6284881|NCT00655057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6284882|NCT00648895|Metoprolol|metoprolol|mesh-list
6284883|NCT00648895|Nebivolol|nebivolol|mesh-list
6284884|NCT00648895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6284885|NCT00648895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6284886|NCT00648895|Sympatholytics|sympatholytics|mesh-ancestor
6284887|NCT00648895|Autonomic Agents|autonomic agents|mesh-ancestor
6284888|NCT00648895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6284889|NCT00648895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284890|NCT00648895|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6284891|NCT00648895|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6284892|NCT00648895|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6284893|NCT00648895|Adrenergic Agents|adrenergic agents|mesh-ancestor
6284894|NCT00648895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6284895|NCT00648895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284896|NCT00648895|Vasodilator Agents|vasodilator agents|mesh-ancestor
6284897|NCT00648895|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6284898|NCT00648895|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6284899|NCT00648895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6284900|NCT00647426|Carboplatin|carboplatin|mesh-list
6284901|NCT00647426|Docetaxel|docetaxel|mesh-list
6284902|NCT00647426|Sorafenib|sorafenib|mesh-list
6284903|NCT00647426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6284904|NCT00647426|Tubulin Modulators|tubulin modulators|mesh-ancestor
6284905|NCT00647426|Antimitotic Agents|antimitotic agents|mesh-ancestor
6284906|NCT00647426|Mitosis Modulators|mitosis modulators|mesh-ancestor
6284907|NCT00647426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284908|NCT00647426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6284909|NCT00647426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6284910|NCT00637806|Megestrol|megestrol|mesh-list
6284911|NCT00637806|Megestrol Acetate|megestrol acetate|mesh-list
6284912|NCT00637806|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6284913|NCT00637806|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6284914|NCT00637806|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6284915|NCT00637806|Contraceptive Agents|contraceptive agents|mesh-ancestor
6284916|NCT00637806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6284917|NCT00637806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284918|NCT00637806|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6284919|NCT00637806|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6284920|NCT00637806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6284921|NCT00637806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6284922|NCT00637806|Appetite Stimulants|appetite stimulants|mesh-ancestor
6284923|NCT00637806|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6284924|NCT00652457|Memantine|memantine|mesh-list
6284925|NCT00652457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6284926|NCT00652457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6284927|NCT00652457|Dopamine Agents|dopamine agents|mesh-ancestor
6284928|NCT00652457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6284929|NCT00652457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284930|NCT00652457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284931|NCT00652457|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6284932|NCT00652457|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6284933|NCT00642603|Bevacizumab|bevacizumab|mesh-list
6284934|NCT00642603|Capecitabine|capecitabine|mesh-list
6284935|NCT00642603|Oxaliplatin|oxaliplatin|mesh-list
6284936|NCT00642603|Irinotecan|irinotecan|mesh-list
6284937|NCT00642603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6284938|NCT00642603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6284939|NCT00642603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6284940|NCT00642603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6284941|NCT00642603|Growth Substances|growth substances|mesh-ancestor
6284942|NCT00642603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284943|NCT00642603|Growth Inhibitors|growth inhibitors|mesh-ancestor
6284944|NCT00642603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6284945|NCT00642603|Antimetabolites|antimetabolites|mesh-ancestor
6284946|NCT00642603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284947|NCT00642603|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6284948|NCT00642603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6284949|NCT00642603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6284950|NCT00629798|Fludarabine|fludarabine|mesh-list
6284951|NCT00629798|Melphalan|melphalan|mesh-list
6284952|NCT00629798|Busulfan|busulfan|mesh-list
6284953|NCT00629798|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6284954|NCT00629798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6284955|NCT00629798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284956|NCT00629798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6284957|NCT00629798|Immunologic Factors|immunologic factors|mesh-ancestor
6284958|NCT00629798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284959|NCT00629798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6284960|NCT00629798|Alkylating Agents|alkylating agents|mesh-ancestor
6284961|NCT00629798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6284962|NCT00637728|Megestrol|megestrol|mesh-list
6284963|NCT00637728|Megestrol Acetate|megestrol acetate|mesh-list
6284964|NCT00637728|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6284965|NCT00637728|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6284966|NCT00637728|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6284967|NCT00637728|Contraceptive Agents|contraceptive agents|mesh-ancestor
6284968|NCT00637728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6284969|NCT00637728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284970|NCT00637728|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6284971|NCT00637728|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6284972|NCT00637728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6284973|NCT00637728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6284974|NCT00637728|Appetite Stimulants|appetite stimulants|mesh-ancestor
6284975|NCT00637728|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6284976|NCT00639626|Insulin Detemir|insulin detemir|mesh-list
6284977|NCT00639626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6284978|NCT00639626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6391585|NCT00193544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391586|NCT00193557|Bortezomib|bortezomib|mesh-list
6391587|NCT00193557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391588|NCT00193570|Docetaxel|docetaxel|mesh-list
6391589|NCT00193570|Topotecan|topotecan|mesh-list
6391590|NCT00193570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391591|NCT00193570|Tubulin Modulators|tubulin modulators|mesh-ancestor
6391592|NCT00193570|Antimitotic Agents|antimitotic agents|mesh-ancestor
6391593|NCT00193570|Mitosis Modulators|mitosis modulators|mesh-ancestor
6391594|NCT00193570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391595|NCT00193570|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6391596|NCT00193570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6391597|NCT00193570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6391598|NCT00193583|Carboplatin|carboplatin|mesh-list
6391599|NCT00193583|Topotecan|topotecan|mesh-list
6391600|NCT00193583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391601|NCT00193583|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6391602|NCT00193583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6391603|NCT00193583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6391604|NCT00193583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391605|NCT00193622|Bevacizumab|bevacizumab|mesh-list
6391606|NCT00193622|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6391607|NCT00193622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6391608|NCT00193622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391609|NCT00193622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6391610|NCT00193622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6391611|NCT00193622|Growth Substances|growth substances|mesh-ancestor
6391612|NCT00193622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6391613|NCT00193622|Growth Inhibitors|growth inhibitors|mesh-ancestor
6391614|NCT00193622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6391615|NCT00193622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6391616|NCT00193622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391617|NCT00193635|Mycophenolic Acid|mycophenolic acid|mesh-list
6391618|NCT00193635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6391619|NCT00193635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391620|NCT00193635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6391621|NCT00193635|Antitubercular Agents|antitubercular agents|mesh-ancestor
6391622|NCT00193635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6391623|NCT00193635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6391624|NCT00193635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6391625|NCT00193635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391626|NCT00193648|Rosiglitazone|rosiglitazone|mesh-list
6391627|NCT00193648|Adalimumab|adalimumab|mesh-list
6391628|NCT00193648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6391629|NCT00193648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6391630|NCT00193648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6391631|NCT00193648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284979|NCT00642382|Hyaluronic Acid|hyaluronic acid|mesh-list
6284980|NCT00642382|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6284981|NCT00642382|Immunologic Factors|immunologic factors|mesh-ancestor
6284982|NCT00642382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6284983|NCT00642382|Viscosupplements|viscosupplements|mesh-ancestor
6284984|NCT00642382|Protective Agents|protective agents|mesh-ancestor
6284985|NCT00637416|Lansoprazole|lansoprazole|mesh-list
6284986|NCT00637416|Dexlansoprazole|dexlansoprazole|mesh-list
6284987|NCT00637416|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6284988|NCT00637416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6284989|NCT00637416|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6284990|NCT00637416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6284991|NCT00637416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284992|NCT00638222|Carvedilol|carvedilol|mesh-list
6284993|NCT00638222|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6284994|NCT00638222|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6284995|NCT00638222|Adrenergic Agents|adrenergic agents|mesh-ancestor
6284996|NCT00638222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6284997|NCT00638222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284998|NCT00638222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015415|NCT00357032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6284999|NCT00638222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6285000|NCT00638222|Antioxidants|antioxidants|mesh-ancestor
6285001|NCT00638222|Protective Agents|protective agents|mesh-ancestor
6285002|NCT00638222|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6285003|NCT00638222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6285004|NCT00638222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6285005|NCT00638222|Vasodilator Agents|vasodilator agents|mesh-ancestor
6285006|NCT00638222|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6285007|NCT00638222|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6285008|NCT00634322|Leucovorin|leucovorin|mesh-list
6285009|NCT00634322|Antidotes|antidotes|mesh-ancestor
6285010|NCT00634322|Protective Agents|protective agents|mesh-ancestor
6285011|NCT00634322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6285012|NCT00634322|Vitamin B Complex|vitamin b complex|mesh-ancestor
6285013|NCT00634322|Vitamins|vitamins|mesh-ancestor
6285014|NCT00634322|Micronutrients|micronutrients|mesh-ancestor
6285015|NCT00633087|Deoxyglucose|deoxyglucose|mesh-list
6285016|NCT00633087|Antimetabolites|antimetabolites|mesh-ancestor
6285017|NCT00633087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285018|NCT00633087|Antiviral Agents|antiviral agents|mesh-ancestor
6285019|NCT00633087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6285020|NCT00631137|Testosterone|testosterone|mesh-list
6285021|NCT00631137|Androgens|androgens|mesh-ancestor
6285022|NCT00631137|Hormones|hormones|mesh-ancestor
6285023|NCT00631137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6015416|NCT00357097|Ropinirole|ropinirole|mesh-list
6015417|NCT00357097|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6015418|NCT00357097|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6015419|NCT00357097|Dopamine Agonists|dopamine agonists|mesh-ancestor
6015420|NCT00357097|Dopamine Agents|dopamine agents|mesh-ancestor
6015421|NCT00357097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6015422|NCT00357097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285024|NCT00631137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6285025|NCT00634972|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6285026|NCT00634972|Ketorolac|ketorolac|mesh-list
6285027|NCT00634972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6285028|NCT00634972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6285029|NCT00634972|Analgesics|analgesics|mesh-ancestor
6285030|NCT00634972|Sensory System Agents|sensory system agents|mesh-ancestor
6285031|NCT00634972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6285032|NCT00634972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6285033|NCT00634972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6285034|NCT00634972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6285035|NCT00634972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6285036|NCT00634972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6285037|NCT00634972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285038|NCT00633061|Enoxaparin|enoxaparin|mesh-list
6285039|NCT00633061|Anticoagulants|anticoagulants|mesh-ancestor
6285040|NCT00633061|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6285041|NCT00633061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6285042|NCT00633061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285043|NCT00626444|Ascorbic Acid|ascorbic acid|mesh-list
6285044|NCT00626444|Vitamins|vitamins|mesh-ancestor
6285045|NCT00626444|Micronutrients|micronutrients|mesh-ancestor
6285046|NCT00626444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6285047|NCT00626444|Antioxidants|antioxidants|mesh-ancestor
6285048|NCT00626444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285049|NCT00626444|Protective Agents|protective agents|mesh-ancestor
6285050|NCT00634010|Morphine|morphine|mesh-list
6285051|NCT00634010|Methadone|methadone|mesh-list
6285052|NCT00634010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6285053|NCT00634010|Narcotics|narcotics|mesh-ancestor
6285054|NCT00634010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6285055|NCT00634010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6285056|NCT00634010|Analgesics|analgesics|mesh-ancestor
6285057|NCT00634010|Sensory System Agents|sensory system agents|mesh-ancestor
6285058|NCT00634010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6285059|NCT00634010|Antitussive Agents|antitussive agents|mesh-ancestor
6285060|NCT00634010|Respiratory System Agents|respiratory system agents|mesh-ancestor
6285061|NCT00623974|Teriparatide|teriparatide|mesh-list
6285062|NCT00623974|Calcitriol|calcitriol|mesh-list
6285063|NCT00623974|Calcium|calcium|mesh-list
6285064|NCT00623974|Parathyroid Hormone|parathyroid hormone|mesh-list
6285065|NCT00623974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6285066|NCT00623974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6285067|NCT00623974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6285068|NCT00623974|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6285069|NCT00623974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6285070|NCT00623974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285071|NCT00623974|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6285072|NCT00623974|Vitamins|vitamins|mesh-ancestor
6285073|NCT00623974|Micronutrients|micronutrients|mesh-ancestor
6285074|NCT00624650|Phenylephrine|phenylephrine|mesh-list
6285075|NCT00624650|Dobutamine|dobutamine|mesh-list
6285076|NCT00624650|Furosemide|furosemide|mesh-list
6285077|NCT00624650|Vasopressins|vasopressins|mesh-list
6285078|NCT00624650|Arginine Vasopressin|arginine vasopressin|mesh-list
6285079|NCT00624650|Epinephrine|epinephrine|mesh-list
6285080|NCT00624650|Racepinephrine|racepinephrine|mesh-list
6285081|NCT00624650|Oxymetazoline|oxymetazoline|mesh-list
6285082|NCT00624650|Norepinephrine|norepinephrine|mesh-list
6285083|NCT00624650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
6285084|NCT00624650|Epinephryl borate|epinephryl borate|mesh-list
6285085|NCT00624650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6285086|NCT00624650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6285087|NCT00624650|Adrenergic Agents|adrenergic agents|mesh-ancestor
6285088|NCT00624650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6285089|NCT00624650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285090|NCT00624650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6285091|NCT00624650|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6285092|NCT00624650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6285093|NCT00624650|Autonomic Agents|autonomic agents|mesh-ancestor
6285094|NCT00624650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6285095|NCT00624650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6285096|NCT00624650|Respiratory System Agents|respiratory system agents|mesh-ancestor
6285097|NCT00624650|Mydriatics|mydriatics|mesh-ancestor
6285098|NCT00624650|Sympathomimetics|sympathomimetics|mesh-ancestor
6285099|NCT00624650|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6285100|NCT00624650|Nasal Decongestants|nasal decongestants|mesh-ancestor
6285101|NCT00624650|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6285102|NCT00624650|Protective Agents|protective agents|mesh-ancestor
6285103|NCT00624650|Diuretics|diuretics|mesh-ancestor
6285104|NCT00624650|Natriuretic Agents|natriuretic agents|mesh-ancestor
6285105|NCT00624650|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6285106|NCT00624650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6285107|NCT00624650|Hemostatics|hemostatics|mesh-ancestor
6285108|NCT00624650|Coagulants|coagulants|mesh-ancestor
6285109|NCT00624650|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6285110|NCT00624650|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6285111|NCT00626561|Paclitaxel|paclitaxel|mesh-list
6285112|NCT00626561|Bevacizumab|bevacizumab|mesh-list
6285113|NCT00626561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6285114|NCT00626561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6285115|NCT00626561|Tubulin Modulators|tubulin modulators|mesh-ancestor
6285116|NCT00626561|Antimitotic Agents|antimitotic agents|mesh-ancestor
6285117|NCT00626561|Mitosis Modulators|mitosis modulators|mesh-ancestor
6285118|NCT00626561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285119|NCT00626561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6285120|NCT00626561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6285121|NCT00626561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6285122|NCT00626561|Growth Substances|growth substances|mesh-ancestor
6285123|NCT00626561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6285124|NCT00626561|Growth Inhibitors|growth inhibitors|mesh-ancestor
6285125|NCT00613730|Gemcitabine|gemcitabine|mesh-list
6285126|NCT00613730|Panitumumab|panitumumab|mesh-list
6285127|NCT00613730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6285128|NCT00613730|Antimetabolites|antimetabolites|mesh-ancestor
6285129|NCT00613730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285130|NCT00613730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6285131|NCT00613730|Antiviral Agents|antiviral agents|mesh-ancestor
6285132|NCT00613730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6285133|NCT00613730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6285134|NCT00613730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6285135|NCT00613730|Immunologic Factors|immunologic factors|mesh-ancestor
6285136|NCT00613730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6285137|NCT00613730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6285138|NCT00625586|Gemcitabine|gemcitabine|mesh-list
6285139|NCT00625586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6285140|NCT00625586|Antimetabolites|antimetabolites|mesh-ancestor
6285141|NCT00625586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285142|NCT00625586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6285143|NCT00625586|Antiviral Agents|antiviral agents|mesh-ancestor
6285144|NCT00625586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6285145|NCT00625586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6285146|NCT00625586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6285147|NCT00625586|Immunologic Factors|immunologic factors|mesh-ancestor
6285148|NCT00625586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6285149|NCT00625703|Linezolid|linezolid|mesh-list
6285150|NCT00625703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6285151|NCT00625703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6285152|NCT00625703|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6285153|NCT00625703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6285154|NCT00625703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285155|NCT00625742|Ibuprofen|ibuprofen|mesh-list
6285156|NCT00625742|Atenolol|atenolol|mesh-list
6285157|NCT00625742|Melatonin|melatonin|mesh-list
6285158|NCT00625742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6285159|NCT00625742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6285160|NCT00625742|Analgesics|analgesics|mesh-ancestor
6285161|NCT00625742|Sensory System Agents|sensory system agents|mesh-ancestor
6285162|NCT00625742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6285163|NCT00625742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6285164|NCT00625742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6285165|NCT00625742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6285166|NCT00625742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6285167|NCT00625742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6285168|NCT00625742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285169|NCT00625742|Antioxidants|antioxidants|mesh-ancestor
6285170|NCT00625742|Protective Agents|protective agents|mesh-ancestor
6285171|NCT00625742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6285172|NCT00625742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6015423|NCT00357097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015424|NCT00357110|Fulvestrant|fulvestrant|mesh-list
6015425|NCT00357110|Anastrozole|anastrozole|mesh-list
6015426|NCT00357110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6015427|NCT00357110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6015428|NCT00357110|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6015429|NCT00357110|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6285173|NCT00625742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6285174|NCT00625742|Sympatholytics|sympatholytics|mesh-ancestor
6285175|NCT00625742|Autonomic Agents|autonomic agents|mesh-ancestor
6285176|NCT00625742|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6285177|NCT00625742|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6285178|NCT00625742|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6285179|NCT00625742|Adrenergic Agents|adrenergic agents|mesh-ancestor
6285180|NCT00625742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6285181|NCT00619242|Sorafenib|sorafenib|mesh-list
6285182|NCT00619242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6285183|NCT00619242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6285184|NCT00619242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6285185|NCT00619242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285186|NCT00616577|Ropivacaine|ropivacaine|mesh-list
6285187|NCT00616577|Anesthetics, Local|anesthetics, local|mesh-ancestor
6285188|NCT00616577|Anesthetics|anesthetics|mesh-ancestor
6285189|NCT00616577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6285190|NCT00616577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6285191|NCT00616577|Sensory System Agents|sensory system agents|mesh-ancestor
6285192|NCT00616577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6285193|NCT00616759|Propofol|propofol|mesh-list
6285194|NCT00616759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6285195|NCT00616759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6285196|NCT00616759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6285197|NCT00616759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6285198|NCT00616759|Anesthetics, General|anesthetics, general|mesh-ancestor
6285199|NCT00616759|Anesthetics|anesthetics|mesh-ancestor
6285200|NCT00616642|Rosiglitazone|rosiglitazone|mesh-list
6285201|NCT00616642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6285202|NCT00616642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6285203|NCT00616343|Zonisamide|zonisamide|mesh-list
6285204|NCT00616343|Anticonvulsants|anticonvulsants|mesh-ancestor
6285205|NCT00616343|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6285206|NCT00616343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6285207|NCT00616343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285208|NCT00616343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6285209|NCT00616343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6285210|NCT00612677|Oxaliplatin|oxaliplatin|mesh-list
6285211|NCT00612677|Pemetrexed|pemetrexed|mesh-list
6285212|NCT00612677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6285213|NCT00612677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6285214|NCT00612677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285215|NCT00612677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6015430|NCT00357110|Hormone Antagonists|hormone antagonists|mesh-ancestor
6391632|NCT00193661|Testosterone|testosterone|mesh-list
6285216|NCT00612677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6285217|NCT00616603|Dexamethasone|dexamethasone|mesh-list
6285218|NCT00616603|Dexamethasone acetate|dexamethasone acetate|mesh-list
6285219|NCT00616603|Ropivacaine|ropivacaine|mesh-list
6285220|NCT00616603|BB 1101|bb 1101|mesh-list
6285221|NCT00616603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6285222|NCT00616603|Antiemetics|antiemetics|mesh-ancestor
6285223|NCT00616603|Autonomic Agents|autonomic agents|mesh-ancestor
6285224|NCT00616603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6285225|NCT00616603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6285226|NCT00616603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6285227|NCT00616603|Glucocorticoids|glucocorticoids|mesh-ancestor
6285228|NCT00616603|Hormones|hormones|mesh-ancestor
6285229|NCT00616603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6285230|NCT00616603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6285231|NCT00616603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6285232|NCT00616603|Protease Inhibitors|protease inhibitors|mesh-ancestor
6285233|NCT00616603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6285234|NCT00616603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285235|NCT00616603|Anesthetics, Local|anesthetics, local|mesh-ancestor
6285236|NCT00616603|Anesthetics|anesthetics|mesh-ancestor
6285237|NCT00616603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6285238|NCT00616603|Sensory System Agents|sensory system agents|mesh-ancestor
6285239|NCT00610532|Probenecid|probenecid|mesh-list
6285240|NCT00610532|Phenytoin|phenytoin|mesh-list
6285241|NCT00610532|Anticonvulsants|anticonvulsants|mesh-ancestor
6285242|NCT00610532|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6285243|NCT00610532|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6285244|NCT00610532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6285245|NCT00610532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285246|NCT00610532|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6285247|NCT00610532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6285248|NCT00610532|Uricosuric Agents|uricosuric agents|mesh-ancestor
6285249|NCT00610532|Gout Suppressants|gout suppressants|mesh-ancestor
6285250|NCT00610532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6285251|NCT00610532|Renal Agents|renal agents|mesh-ancestor
6285252|NCT00609765|Dexamethasone|dexamethasone|mesh-list
6285253|NCT00609765|Bevacizumab|bevacizumab|mesh-list
6285254|NCT00609765|Doxorubicin|doxorubicin|mesh-list
6285255|NCT00609765|Fluorouracil|fluorouracil|mesh-list
6285256|NCT00609765|Streptozocin|streptozocin|mesh-list
6285257|NCT00609765|Ondansetron|ondansetron|mesh-list
6285258|NCT00609765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6285259|NCT00609765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6285260|NCT00609765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6285261|NCT00609765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6285262|NCT00609765|Growth Substances|growth substances|mesh-ancestor
6285263|NCT00609765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6285264|NCT00609765|Growth Inhibitors|growth inhibitors|mesh-ancestor
6285265|NCT00609765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6285266|NCT00609765|Antiemetics|antiemetics|mesh-ancestor
6285267|NCT00609765|Autonomic Agents|autonomic agents|mesh-ancestor
6285268|NCT00609765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6285269|NCT00609765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6285270|NCT00609765|Glucocorticoids|glucocorticoids|mesh-ancestor
6285271|NCT00609765|Hormones|hormones|mesh-ancestor
6285272|NCT00609765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6285273|NCT00609765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6285274|NCT00609765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6285275|NCT00609765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6285276|NCT00609765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6285277|NCT00609765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6285278|NCT00609765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285279|NCT00609765|Antimetabolites|antimetabolites|mesh-ancestor
6285280|NCT00609765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6285281|NCT00609765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6285282|NCT00609765|Immunologic Factors|immunologic factors|mesh-ancestor
6285283|NCT00609765|Antipruritics|antipruritics|mesh-ancestor
6285284|NCT00609765|Dermatologic Agents|dermatologic agents|mesh-ancestor
6285285|NCT00609765|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6285286|NCT00609765|Serotonin Agents|serotonin agents|mesh-ancestor
6285287|NCT00609765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6285288|NCT00609765|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6285289|NCT00609765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6285290|NCT00609765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6285291|NCT00609765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6285292|NCT00609765|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6285293|NCT00608465|Ramipril|ramipril|mesh-list
6285294|NCT00608465|Eplerenone|eplerenone|mesh-list
6285295|NCT00608465|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6285296|NCT00608465|Protease Inhibitors|protease inhibitors|mesh-ancestor
6285297|NCT00608465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6285298|NCT00608465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285299|NCT00608465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6285300|NCT00608465|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6285301|NCT00608465|Hormone Antagonists|hormone antagonists|mesh-ancestor
6285302|NCT00608465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6285303|NCT00608465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6285304|NCT00608465|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6285305|NCT00608465|Diuretics|diuretics|mesh-ancestor
6285306|NCT00608465|Natriuretic Agents|natriuretic agents|mesh-ancestor
6285307|NCT00608777|Betamethasone|betamethasone|mesh-list
6285308|NCT00608777|Calcipotriene|calcipotriene|mesh-list
6285309|NCT00608777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6285310|NCT00608777|Glucocorticoids|glucocorticoids|mesh-ancestor
6285311|NCT00608777|Hormones|hormones|mesh-ancestor
6285312|NCT00608777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6285313|NCT00608777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6285314|NCT00608777|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6285315|NCT00608777|Respiratory System Agents|respiratory system agents|mesh-ancestor
6285316|NCT00608777|Dermatologic Agents|dermatologic agents|mesh-ancestor
6285317|NCT00601848|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
6285318|NCT00601848|Trioxsalen|trioxsalen|mesh-list
6285319|NCT00601848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6285320|NCT00601848|Dermatologic Agents|dermatologic agents|mesh-ancestor
6285321|NCT00601848|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6285322|NCT00607477|Minoxidil|minoxidil|mesh-list
6285323|NCT00607477|Hydralazine|hydralazine|mesh-list
6285324|NCT00607477|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6285325|NCT00607477|Vasodilator Agents|vasodilator agents|mesh-ancestor
6285326|NCT00595920|Vaccines|vaccines|mesh-list
6285327|NCT00595920|Immunologic Factors|immunologic factors|mesh-ancestor
6285328|NCT00595920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6285329|NCT00596947|Mycophenolic Acid|mycophenolic acid|mesh-list
6285330|NCT00596947|Prednisone|prednisone|mesh-list
6285331|NCT00596947|Methylprednisolone|methylprednisolone|mesh-list
6285332|NCT00596947|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6285333|NCT00596947|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6285334|NCT00596947|Prednisolone|prednisolone|mesh-list
6285335|NCT00596947|Prednisolone acetate|prednisolone acetate|mesh-list
6285336|NCT00596947|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6285337|NCT00596947|Prednisolone phosphate|prednisolone phosphate|mesh-list
6285338|NCT00596947|Tacrolimus|tacrolimus|mesh-list
6015431|NCT00357110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6285339|NCT00596947|Thymoglobulin|thymoglobulin|mesh-list
6285340|NCT00596947|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6285341|NCT00596947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6285342|NCT00596947|Glucocorticoids|glucocorticoids|mesh-ancestor
6285343|NCT00596947|Hormones|hormones|mesh-ancestor
6285344|NCT00596947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6285345|NCT00596947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6285346|NCT00596947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6285347|NCT00596947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6015432|NCT00357110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015433|NCT00357110|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6015434|NCT00357110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6015435|NCT00357110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6285348|NCT00596947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6285349|NCT00596947|Immunologic Factors|immunologic factors|mesh-ancestor
6285350|NCT00596947|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6285351|NCT00596947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6285352|NCT00596947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285353|NCT00596947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6285354|NCT00596947|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6285355|NCT00596947|Antitubercular Agents|antitubercular agents|mesh-ancestor
6285356|NCT00596947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6285357|NCT00596947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6285358|NCT00596947|Antiemetics|antiemetics|mesh-ancestor
6285359|NCT00596947|Autonomic Agents|autonomic agents|mesh-ancestor
6285360|NCT00596947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6285361|NCT00596947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6285362|NCT00596947|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6285363|NCT00596947|Protective Agents|protective agents|mesh-ancestor
6285364|NCT00584012|Docetaxel|docetaxel|mesh-list
6285365|NCT00584012|Lovastatin|lovastatin|mesh-list
6285366|NCT00584012|L 647318|l 647318|mesh-list
6285367|NCT00584012|Dihydromevinolin|dihydromevinolin|mesh-list
6285368|NCT00584012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6285369|NCT00584012|Tubulin Modulators|tubulin modulators|mesh-ancestor
6285370|NCT00584012|Antimitotic Agents|antimitotic agents|mesh-ancestor
6285371|NCT00584012|Mitosis Modulators|mitosis modulators|mesh-ancestor
6285372|NCT00584012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285373|NCT00584012|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6285374|NCT00584012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6285375|NCT00584012|Antimetabolites|antimetabolites|mesh-ancestor
6285376|NCT00584012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6285377|NCT00584012|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6285378|NCT00584012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6285379|NCT00599131|Docetaxel|docetaxel|mesh-list
6285380|NCT00599131|Fluorouracil|fluorouracil|mesh-list
6285381|NCT00599131|Cetuximab|cetuximab|mesh-list
6285382|NCT00599131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6285383|NCT00599131|Tubulin Modulators|tubulin modulators|mesh-ancestor
6285384|NCT00599131|Antimitotic Agents|antimitotic agents|mesh-ancestor
6285385|NCT00599131|Mitosis Modulators|mitosis modulators|mesh-ancestor
6285386|NCT00599131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285387|NCT00599131|Antimetabolites|antimetabolites|mesh-ancestor
6285388|NCT00599131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6285389|NCT00599131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6285390|NCT00599131|Immunologic Factors|immunologic factors|mesh-ancestor
6285391|NCT00599131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6285392|NCT00599131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6285393|NCT00597909|Sodium Benzoate|sodium benzoate|mesh-list
6285394|NCT00597909|Phenylacetic acid|phenylacetic acid|mesh-list
6285395|NCT00597909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6285396|NCT00597909|Antimetabolites|antimetabolites|mesh-ancestor
6285397|NCT00597909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285398|NCT00597909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6285399|NCT00597909|Antifungal Agents|antifungal agents|mesh-ancestor
6285400|NCT00597909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6285401|NCT00589550|Interferons|interferons|mesh-list
6285402|NCT00589550|Interferon-alpha|interferon-alpha|mesh-list
6285403|NCT00589550|Interferon alpha-2|interferon alpha-2|mesh-list
6285404|NCT00589550|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6285405|NCT00589550|Sorafenib|sorafenib|mesh-list
6285406|NCT00589550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6285407|NCT00589550|Antiviral Agents|antiviral agents|mesh-ancestor
6285408|NCT00589550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6285409|NCT00589550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6285410|NCT00589550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6285411|NCT00589550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285412|NCT00589550|Immunologic Factors|immunologic factors|mesh-ancestor
6285413|NCT00589550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6285414|NCT00577772|Rifaximin|rifaximin|mesh-list
6285415|NCT00577772|Lactulose|lactulose|mesh-list
6285416|NCT00577772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6285417|NCT00577772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6285418|NCT00577772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6285419|NCT00592007|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6285420|NCT00592007|Fulvestrant|fulvestrant|mesh-list
6285421|NCT00592007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6285422|NCT00592007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6285423|NCT00592007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6285424|NCT00592007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285425|NCT00592007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6285426|NCT00592007|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6285427|NCT00592007|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6285428|NCT00592007|Hormone Antagonists|hormone antagonists|mesh-ancestor
6285429|NCT00592007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6285430|NCT00592007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6285431|NCT00595582|Curcumin|curcumin|mesh-list
6285432|NCT00595582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6285433|NCT00595582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6285434|NCT00595582|Analgesics|analgesics|mesh-ancestor
6285435|NCT00595582|Sensory System Agents|sensory system agents|mesh-ancestor
6285436|NCT00595582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6285437|NCT00595582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6285438|NCT00595582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6285439|NCT00595582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6285440|NCT00595582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6285441|NCT00595582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6285442|NCT00595582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285443|NCT00588146|Interferons|interferons|mesh-list
6285444|NCT00588146|Interferon-alpha|interferon-alpha|mesh-list
6285445|NCT00588146|Interferon alpha-2|interferon alpha-2|mesh-list
6285446|NCT00588146|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6285447|NCT00588146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6285448|NCT00588146|Antiviral Agents|antiviral agents|mesh-ancestor
6285449|NCT00588146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6285450|NCT00588146|Immunologic Factors|immunologic factors|mesh-ancestor
6285451|NCT00588146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6285452|NCT00590538|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
6285453|NCT00590538|Genistein|genistein|mesh-list
6285454|NCT00590538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6285455|NCT00590538|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6285456|NCT00590538|Protective Agents|protective agents|mesh-ancestor
6285457|NCT00590538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6285458|NCT00590538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6285459|NCT00590538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6285460|NCT00590538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285461|NCT00590538|Phytoestrogens|phytoestrogens|mesh-ancestor
6285462|NCT00590538|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6285463|NCT00590538|Estrogens|estrogens|mesh-ancestor
6285464|NCT00590538|Hormones|hormones|mesh-ancestor
6285465|NCT00590538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6285466|NCT00583115|Imatinib Mesylate|imatinib mesylate|mesh-list
6285467|NCT00583115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6285468|NCT00583115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6285469|NCT00583115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6285470|NCT00583115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285471|NCT00582712|Lithium Carbonate|lithium carbonate|mesh-list
6285472|NCT00582712|Antidepressive Agents|antidepressive agents|mesh-ancestor
6285473|NCT00582712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6285474|NCT00582712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6285475|NCT00582712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285476|NCT00582712|Antimanic Agents|antimanic agents|mesh-ancestor
6285477|NCT00582712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6285478|NCT00582712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6285479|NCT00582712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6285480|NCT00586716|Immunoglobulins|immunoglobulins|mesh-list
6285481|NCT00586716|Antibodies|antibodies|mesh-list
6285482|NCT00586716|gamma-Globulins|gamma-globulins|mesh-list
6285483|NCT00586716|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6285484|NCT00586716|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6285485|NCT00586716|Immunologic Factors|immunologic factors|mesh-ancestor
6285486|NCT00586716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6285487|NCT00588471|Simvastatin|simvastatin|mesh-list
6285488|NCT00588471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6285489|NCT00588471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6285490|NCT00588471|Antimetabolites|antimetabolites|mesh-ancestor
6285491|NCT00588471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285492|NCT00588471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6285493|NCT00588471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6285494|NCT00588471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6285495|NCT00590135|Atorvastatin|atorvastatin|mesh-list
6285496|NCT00590135|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6285497|NCT00590135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6285498|NCT00590135|Antimetabolites|antimetabolites|mesh-ancestor
6285499|NCT00590135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285500|NCT00590135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6285501|NCT00590135|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6285502|NCT00590135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6285503|NCT00582036|Insulin|insulin|mesh-list
6285504|NCT00582036|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6285505|NCT00582036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6285506|NCT00582036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6285507|NCT00585585|Betahistine|betahistine|mesh-list
6285508|NCT00585585|Vasodilator Agents|vasodilator agents|mesh-ancestor
6285509|NCT00585585|Histamine Agonists|histamine agonists|mesh-ancestor
6285510|NCT00585585|Histamine Agents|histamine agents|mesh-ancestor
6285511|NCT00585585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6285512|NCT00585585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285513|NCT00585585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6285514|NCT00585221|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6285515|NCT00585221|Imatinib Mesylate|imatinib mesylate|mesh-list
6285516|NCT00585221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6285517|NCT00585221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6285518|NCT00585221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6285519|NCT00585221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285520|NCT00585221|Antiviral Agents|antiviral agents|mesh-ancestor
6285521|NCT00585221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6285522|NCT00579254|Amlodipine|amlodipine|mesh-list
6285523|NCT00579254|Atorvastatin|atorvastatin|mesh-list
6285524|NCT00579254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6285525|NCT00579254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6285526|NCT00579254|Antimetabolites|antimetabolites|mesh-ancestor
6285527|NCT00579254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285528|NCT00579254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6285529|NCT00579254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6285530|NCT00579254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6285531|NCT00579254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6285532|NCT00579254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6285533|NCT00579254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6285534|NCT00579254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6285535|NCT00579254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6285536|NCT00579254|Vasodilator Agents|vasodilator agents|mesh-ancestor
6285537|NCT00585611|Atorvastatin|atorvastatin|mesh-list
6285538|NCT00585611|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6285539|NCT00585611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6285540|NCT00585611|Antimetabolites|antimetabolites|mesh-ancestor
6285541|NCT00585611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285542|NCT00585611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6285543|NCT00585611|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6285544|NCT00585611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6285545|NCT00572260|Daptomycin|daptomycin|mesh-list
6285546|NCT00572260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6285547|NCT00572260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6285548|NCT00571194|Pravastatin|pravastatin|mesh-list
6285549|NCT00571194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6285550|NCT00571194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6285551|NCT00571194|Antimetabolites|antimetabolites|mesh-ancestor
6285552|NCT00571194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285553|NCT00571194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6285554|NCT00571194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6285555|NCT00571194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6285556|NCT00584935|Rituximab|rituximab|mesh-list
6285557|NCT00584935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6285558|NCT00584935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6285559|NCT00584935|Immunologic Factors|immunologic factors|mesh-ancestor
6285560|NCT00584935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6285561|NCT00584935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6285562|NCT00577395|Risedronic Acid|risedronic acid|mesh-list
6285563|NCT00577395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6285564|NCT00577395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6285565|NCT00577395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285566|NCT00577395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6285567|NCT00577395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6285568|NCT00577395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6285569|NCT00573391|Thalidomide|thalidomide|mesh-list
6285570|NCT00573391|Dexamethasone|dexamethasone|mesh-list
6285571|NCT00573391|Dexamethasone acetate|dexamethasone acetate|mesh-list
6285572|NCT00573391|Melphalan|melphalan|mesh-list
6285573|NCT00573391|Bortezomib|bortezomib|mesh-list
6285574|NCT00573391|BB 1101|bb 1101|mesh-list
6285575|NCT00573391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6285576|NCT00573391|Antiemetics|antiemetics|mesh-ancestor
6285577|NCT00573391|Autonomic Agents|autonomic agents|mesh-ancestor
6285578|NCT00573391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6285579|NCT00573391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6285580|NCT00573391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6285581|NCT00573391|Glucocorticoids|glucocorticoids|mesh-ancestor
6285582|NCT00573391|Hormones|hormones|mesh-ancestor
6285583|NCT00573391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6285584|NCT00573391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6285585|NCT00573391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6285586|NCT00573391|Protease Inhibitors|protease inhibitors|mesh-ancestor
6285587|NCT00573391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6285588|NCT00573391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285589|NCT00573391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6285590|NCT00573391|Alkylating Agents|alkylating agents|mesh-ancestor
6285591|NCT00573391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6285592|NCT00573391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6285593|NCT00573391|Immunologic Factors|immunologic factors|mesh-ancestor
6285594|NCT00573391|Leprostatic Agents|leprostatic agents|mesh-ancestor
6285595|NCT00573391|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6285596|NCT00573391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6285597|NCT00573391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6285598|NCT00573391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6285599|NCT00573391|Growth Substances|growth substances|mesh-ancestor
6285600|NCT00573391|Growth Inhibitors|growth inhibitors|mesh-ancestor
6285601|NCT00570258|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6285602|NCT00570258|Fulvestrant|fulvestrant|mesh-list
6285603|NCT00570258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6285604|NCT00570258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6285605|NCT00570258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6285606|NCT00570258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285607|NCT00570258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6285608|NCT00570258|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6285609|NCT00570258|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6285610|NCT00570258|Hormone Antagonists|hormone antagonists|mesh-ancestor
6285611|NCT00570258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6285612|NCT00570258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6285613|NCT00568802|Hydroxyurea|hydroxyurea|mesh-list
6285614|NCT00568802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6285615|NCT00568802|Antisickling Agents|antisickling agents|mesh-ancestor
6285616|NCT00568802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6285617|NCT00568802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391633|NCT00193661|Androgens|androgens|mesh-ancestor
6285618|NCT00568802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6285619|NCT00568698|Hydroxyurea|hydroxyurea|mesh-list
6285620|NCT00568698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6285621|NCT00568698|Antisickling Agents|antisickling agents|mesh-ancestor
6285622|NCT00568698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6285623|NCT00568698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285624|NCT00568698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6285625|NCT00574080|Cytarabine|cytarabine|mesh-list
6285626|NCT00574080|Thalidomide|thalidomide|mesh-list
6285627|NCT00574080|Dexamethasone|dexamethasone|mesh-list
6285628|NCT00574080|Dexamethasone acetate|dexamethasone acetate|mesh-list
6285629|NCT00574080|Cyclophosphamide|cyclophosphamide|mesh-list
6285630|NCT00574080|Melphalan|melphalan|mesh-list
6285631|NCT00574080|Carmustine|carmustine|mesh-list
6285632|NCT00574080|Cisplatin|cisplatin|mesh-list
6285633|NCT00574080|Etoposide|etoposide|mesh-list
6285634|NCT00574080|Etoposide phosphate|etoposide phosphate|mesh-list
6285635|NCT00574080|Doxorubicin|doxorubicin|mesh-list
6285636|NCT00574080|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6285637|NCT00574080|Bortezomib|bortezomib|mesh-list
6285638|NCT00574080|BB 1101|bb 1101|mesh-list
6285639|NCT00574080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6285640|NCT00574080|Immunologic Factors|immunologic factors|mesh-ancestor
6285641|NCT00574080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6285642|NCT00574080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6285643|NCT00574080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6285644|NCT00574080|Alkylating Agents|alkylating agents|mesh-ancestor
6285645|NCT00574080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285646|NCT00574080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6285647|NCT00574080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6285648|NCT00574080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6285649|NCT00574080|Antiemetics|antiemetics|mesh-ancestor
6285650|NCT00574080|Autonomic Agents|autonomic agents|mesh-ancestor
6285651|NCT00574080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6285652|NCT00574080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6285653|NCT00574080|Glucocorticoids|glucocorticoids|mesh-ancestor
6285654|NCT00574080|Hormones|hormones|mesh-ancestor
6285655|NCT00574080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6285656|NCT00574080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6285657|NCT00574080|Protease Inhibitors|protease inhibitors|mesh-ancestor
6285658|NCT00574080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6285659|NCT00574080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6285660|NCT00574080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6285661|NCT00574080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6285662|NCT00574080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6285663|NCT00574080|Antimetabolites|antimetabolites|mesh-ancestor
6285664|NCT00574080|Antiviral Agents|antiviral agents|mesh-ancestor
6285665|NCT00574080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6285666|NCT00574080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6285667|NCT00574080|Leprostatic Agents|leprostatic agents|mesh-ancestor
6285668|NCT00574080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6285669|NCT00574080|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6285670|NCT00574080|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6285671|NCT00574080|Growth Substances|growth substances|mesh-ancestor
6285672|NCT00574080|Growth Inhibitors|growth inhibitors|mesh-ancestor
6285673|NCT00558558|Flurandrenolone|flurandrenolone|mesh-list
6285674|NCT00558558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6285675|NCT00558558|Glucocorticoids|glucocorticoids|mesh-ancestor
6285676|NCT00558558|Hormones|hormones|mesh-ancestor
6285677|NCT00558558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6285678|NCT00558558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6285679|NCT00577356|Docetaxel|docetaxel|mesh-list
6285680|NCT00577356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6285681|NCT00577356|Tubulin Modulators|tubulin modulators|mesh-ancestor
6285682|NCT00577356|Antimitotic Agents|antimitotic agents|mesh-ancestor
6285683|NCT00577356|Mitosis Modulators|mitosis modulators|mesh-ancestor
6285684|NCT00577356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285685|NCT00573937|Morphine|morphine|mesh-list
6285686|NCT00573937|Methadone|methadone|mesh-list
6285687|NCT00573937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6285688|NCT00573937|Narcotics|narcotics|mesh-ancestor
6285689|NCT00573937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6285690|NCT00573937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6285691|NCT00573937|Analgesics|analgesics|mesh-ancestor
6285692|NCT00573937|Sensory System Agents|sensory system agents|mesh-ancestor
6285693|NCT00573937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6285694|NCT00573937|Antitussive Agents|antitussive agents|mesh-ancestor
6285695|NCT00573937|Respiratory System Agents|respiratory system agents|mesh-ancestor
6285696|NCT00571922|Acamprosate|acamprosate|mesh-list
6285697|NCT00571922|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6285698|NCT00569868|Bortezomib|bortezomib|mesh-list
6285699|NCT00569868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6285700|NCT00573157|Mycophenolic Acid|mycophenolic acid|mesh-list
6285701|NCT00573157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6285702|NCT00573157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6285703|NCT00573157|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6285704|NCT00573157|Antitubercular Agents|antitubercular agents|mesh-ancestor
6285705|NCT00573157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6285706|NCT00573157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6285707|NCT00573157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6285708|NCT00573157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285709|NCT00570531|Paclitaxel|paclitaxel|mesh-list
6285710|NCT00570531|Bevacizumab|bevacizumab|mesh-list
6285711|NCT00570531|Fluorouracil|fluorouracil|mesh-list
6285712|NCT00570531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6285713|NCT00570531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6285714|NCT00570531|Tubulin Modulators|tubulin modulators|mesh-ancestor
6285715|NCT00570531|Antimitotic Agents|antimitotic agents|mesh-ancestor
6285716|NCT00570531|Mitosis Modulators|mitosis modulators|mesh-ancestor
6285717|NCT00570531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285718|NCT00570531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6285719|NCT00570531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6285720|NCT00570531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6285721|NCT00570531|Growth Substances|growth substances|mesh-ancestor
6285722|NCT00570531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6285723|NCT00570531|Growth Inhibitors|growth inhibitors|mesh-ancestor
6285724|NCT00570531|Antimetabolites|antimetabolites|mesh-ancestor
6285725|NCT00570531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6285726|NCT00570531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6285727|NCT00570531|Immunologic Factors|immunologic factors|mesh-ancestor
6285728|NCT00561912|Interferons|interferons|mesh-list
6285729|NCT00561912|Interferon-alpha|interferon-alpha|mesh-list
6285730|NCT00561912|Interferon alpha-2|interferon alpha-2|mesh-list
6285731|NCT00561912|Decitabine|decitabine|mesh-list
6285732|NCT00561912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6285733|NCT00561912|Antiviral Agents|antiviral agents|mesh-ancestor
6285734|NCT00561912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6285735|NCT00561912|Immunologic Factors|immunologic factors|mesh-ancestor
6285736|NCT00561912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6285737|NCT00561912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6285738|NCT00561912|Antimetabolites|antimetabolites|mesh-ancestor
6285739|NCT00561912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285740|NCT00561912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6285741|NCT00561795|Paclitaxel|paclitaxel|mesh-list
6285742|NCT00561795|Carboplatin|carboplatin|mesh-list
6285743|NCT00561795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6285744|NCT00561795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6285745|NCT00561795|Tubulin Modulators|tubulin modulators|mesh-ancestor
6285746|NCT00561795|Antimitotic Agents|antimitotic agents|mesh-ancestor
6285747|NCT00561795|Mitosis Modulators|mitosis modulators|mesh-ancestor
6285748|NCT00561795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285749|NCT00564876|Dasatinib|dasatinib|mesh-list
6285750|NCT00564876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6285751|NCT00564876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6285752|NCT00564876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6285753|NCT00564876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285754|NCT00558870|Morphine|morphine|mesh-list
6285755|NCT00558870|Methadone|methadone|mesh-list
6285756|NCT00558870|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6285757|NCT00558870|Narcotics|narcotics|mesh-ancestor
6285758|NCT00558870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6285759|NCT00558870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6285760|NCT00558870|Analgesics|analgesics|mesh-ancestor
6285761|NCT00558870|Sensory System Agents|sensory system agents|mesh-ancestor
6285762|NCT00558870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6285763|NCT00558870|Antitussive Agents|antitussive agents|mesh-ancestor
6285764|NCT00558870|Respiratory System Agents|respiratory system agents|mesh-ancestor
6285765|NCT00556400|Contraceptive Agents|contraceptive agents|mesh-list
6285766|NCT00556400|Contraceptives, Oral|contraceptives, oral|mesh-list
6285767|NCT00556400|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
6285768|NCT00556400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6285769|NCT00556400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6285770|NCT00556400|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6285771|NCT00521924|Cyclosporine|cyclosporine|mesh-list
6285772|NCT00521924|Chloroquine|chloroquine|mesh-list
6285773|NCT00521924|Sulfasalazine|sulfasalazine|mesh-list
6285774|NCT00521924|Methotrexate|methotrexate|mesh-list
6285775|NCT00521924|Infliximab|infliximab|mesh-list
6285776|NCT00521924|Antirheumatic Agents|antirheumatic agents|mesh-list
6285777|NCT00521924|Cyclosporins|cyclosporins|mesh-list
6285778|NCT00521924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6285779|NCT00521924|Abortifacient Agents|abortifacient agents|mesh-ancestor
6285780|NCT00521924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6285781|NCT00521924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6285782|NCT00521924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6285783|NCT00521924|Antimetabolites|antimetabolites|mesh-ancestor
6285784|NCT00521924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285785|NCT00521924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6285786|NCT00521924|Dermatologic Agents|dermatologic agents|mesh-ancestor
6285787|NCT00521924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6285788|NCT00521924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6285789|NCT00521924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6285790|NCT00521924|Immunologic Factors|immunologic factors|mesh-ancestor
6285791|NCT00521924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6285792|NCT00521924|Antifungal Agents|antifungal agents|mesh-ancestor
6285793|NCT00521924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6285794|NCT00521924|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6285795|NCT00521924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6285796|NCT00521924|Amebicides|amebicides|mesh-ancestor
6285797|NCT00521924|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6285798|NCT00521924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6285799|NCT00521924|Antimalarials|antimalarials|mesh-ancestor
6285800|NCT00521924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6285801|NCT00521924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6285802|NCT00521924|Analgesics|analgesics|mesh-ancestor
6285803|NCT00521924|Sensory System Agents|sensory system agents|mesh-ancestor
6285804|NCT00521924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6285805|NCT00521924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6285806|NCT00548886|Epinephrine|epinephrine|mesh-list
6285807|NCT00548886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6285808|NCT00548886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6285809|NCT00548886|Adrenergic Agents|adrenergic agents|mesh-ancestor
6285810|NCT00548886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6285811|NCT00548886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285812|NCT00548886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6285813|NCT00548886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6285814|NCT00548886|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6285815|NCT00548886|Autonomic Agents|autonomic agents|mesh-ancestor
6285816|NCT00548886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6285817|NCT00548886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6285818|NCT00548886|Respiratory System Agents|respiratory system agents|mesh-ancestor
6285819|NCT00548886|Mydriatics|mydriatics|mesh-ancestor
6285820|NCT00548886|Sympathomimetics|sympathomimetics|mesh-ancestor
6285821|NCT00548886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6391634|NCT00193661|Hormones|hormones|mesh-ancestor
6391635|NCT00193661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6391636|NCT00193661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6391637|NCT00193674|Dydrogesterone|dydrogesterone|mesh-list
6391638|NCT00193674|Progestins|progestins|mesh-ancestor
6391639|NCT00193674|Hormones|hormones|mesh-ancestor
6391640|NCT00193674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6391641|NCT00193674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6391642|NCT00193700|Testosterone|testosterone|mesh-list
6391643|NCT00193700|Androgens|androgens|mesh-ancestor
6391644|NCT00193700|Hormones|hormones|mesh-ancestor
6391645|NCT00193700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6391646|NCT00193700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6391647|NCT00193726|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6391648|NCT00193726|Estradiol|estradiol|mesh-list
6391649|NCT00193726|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6391650|NCT00193726|Estrogens|estrogens|mesh-ancestor
6391651|NCT00193726|Hormones|hormones|mesh-ancestor
6391652|NCT00193726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6391653|NCT00193726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6391654|NCT00193726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6391655|NCT00193726|Contraceptive Agents|contraceptive agents|mesh-ancestor
6391656|NCT00193726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6391657|NCT00193726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6391658|NCT00193726|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6391659|NCT00193726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6391660|NCT00193739|Paclitaxel|paclitaxel|mesh-list
6391661|NCT00193739|Carboplatin|carboplatin|mesh-list
6391662|NCT00193739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6391663|NCT00193739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6285822|NCT00539838|Mycophenolic Acid|mycophenolic acid|mesh-list
6285823|NCT00539838|Prednisone|prednisone|mesh-list
6285824|NCT00539838|Methylprednisolone|methylprednisolone|mesh-list
6285825|NCT00539838|Methotrexate|methotrexate|mesh-list
6285826|NCT00539838|Azathioprine|azathioprine|mesh-list
6285827|NCT00539838|Immunosuppressive Agents|immunosuppressive agents|mesh-list
6285828|NCT00539838|Ocrelizumab|ocrelizumab|mesh-list
6285829|NCT00539838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6285830|NCT00539838|Glucocorticoids|glucocorticoids|mesh-ancestor
6285831|NCT00539838|Hormones|hormones|mesh-ancestor
6285832|NCT00539838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6285833|NCT00539838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6285834|NCT00539838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6285835|NCT00539838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6285836|NCT00539838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6285837|NCT00539838|Abortifacient Agents|abortifacient agents|mesh-ancestor
6285838|NCT00539838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6285839|NCT00539838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6285840|NCT00539838|Antimetabolites|antimetabolites|mesh-ancestor
6285841|NCT00539838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285842|NCT00539838|Dermatologic Agents|dermatologic agents|mesh-ancestor
6285843|NCT00539838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6285844|NCT00539838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6285845|NCT00539838|Immunologic Factors|immunologic factors|mesh-ancestor
6285846|NCT00539838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6285847|NCT00539838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6285848|NCT00539838|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6285849|NCT00539838|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6285850|NCT00539838|Antitubercular Agents|antitubercular agents|mesh-ancestor
6285851|NCT00539838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6285852|NCT00539838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6285853|NCT00539838|Antiemetics|antiemetics|mesh-ancestor
6285854|NCT00539838|Autonomic Agents|autonomic agents|mesh-ancestor
6285855|NCT00539838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6285856|NCT00539838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6285857|NCT00539838|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6285858|NCT00539838|Protective Agents|protective agents|mesh-ancestor
6285859|NCT00548327|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6285860|NCT00548327|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6285861|NCT00548327|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6285862|NCT00548327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6285863|NCT00548327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285864|NCT00548327|Adrenergic Agents|adrenergic agents|mesh-ancestor
6285865|NCT00548327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6285866|NCT00548327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6285867|NCT00542542|Fentanyl|fentanyl|mesh-list
6285868|NCT00542542|Midazolam|midazolam|mesh-list
6285869|NCT00542542|Propofol|propofol|mesh-list
6285870|NCT00542542|Ropivacaine|ropivacaine|mesh-list
6285871|NCT00542542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6285872|NCT00542542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6285873|NCT00542542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6285874|NCT00542542|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6285875|NCT00542542|Anesthetics, General|anesthetics, general|mesh-ancestor
6285876|NCT00542542|Anesthetics|anesthetics|mesh-ancestor
6285877|NCT00542542|Anesthetics, Local|anesthetics, local|mesh-ancestor
6285878|NCT00542542|Sensory System Agents|sensory system agents|mesh-ancestor
6285879|NCT00542542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6285880|NCT00542542|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6285881|NCT00542542|Narcotics|narcotics|mesh-ancestor
6285882|NCT00542542|Analgesics|analgesics|mesh-ancestor
6285883|NCT00542542|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6285884|NCT00542542|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6285885|NCT00542542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6285886|NCT00542542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6285887|NCT00542542|GABA Modulators|gaba modulators|mesh-ancestor
6285888|NCT00542542|GABA Agents|gaba agents|mesh-ancestor
6285889|NCT00542542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6285890|NCT00542542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285891|NCT00547300|Metoprolol|metoprolol|mesh-list
6285892|NCT00547300|Nebivolol|nebivolol|mesh-list
6285893|NCT00547300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6285894|NCT00547300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6285895|NCT00547300|Sympatholytics|sympatholytics|mesh-ancestor
6285896|NCT00547300|Autonomic Agents|autonomic agents|mesh-ancestor
6285897|NCT00547300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6285898|NCT00547300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6285899|NCT00547300|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6285900|NCT00547300|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6285901|NCT00547300|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6285902|NCT00547300|Adrenergic Agents|adrenergic agents|mesh-ancestor
6285903|NCT00547300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6285904|NCT00547300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285905|NCT00547300|Vasodilator Agents|vasodilator agents|mesh-ancestor
6285906|NCT00547300|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6285907|NCT00547300|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6285908|NCT00547300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6285909|NCT00539617|Leucovorin|leucovorin|mesh-list
6285910|NCT00539617|Fluorouracil|fluorouracil|mesh-list
6285911|NCT00539617|Oxaliplatin|oxaliplatin|mesh-list
6285912|NCT00539617|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6285913|NCT00539617|Antimetabolites|antimetabolites|mesh-ancestor
6285914|NCT00539617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285915|NCT00539617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6285916|NCT00539617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6285917|NCT00539617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6285918|NCT00539617|Immunologic Factors|immunologic factors|mesh-ancestor
6285919|NCT00539617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6285920|NCT00539617|Antidotes|antidotes|mesh-ancestor
6285921|NCT00539617|Protective Agents|protective agents|mesh-ancestor
6285922|NCT00539617|Vitamin B Complex|vitamin b complex|mesh-ancestor
6285923|NCT00539617|Vitamins|vitamins|mesh-ancestor
6285924|NCT00539617|Micronutrients|micronutrients|mesh-ancestor
6285925|NCT00539617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6285926|NCT00539617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6285927|NCT00546455|Fenretinide|fenretinide|mesh-list
6285928|NCT00546455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6285929|NCT00546455|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6285930|NCT00546455|Protective Agents|protective agents|mesh-ancestor
6285931|NCT00546455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6285932|NCT00538980|Dasatinib|dasatinib|mesh-list
6285933|NCT00538980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6285934|NCT00538980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6285935|NCT00538980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6285936|NCT00538980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285937|NCT00535262|Selegiline|selegiline|mesh-list
6285938|NCT00535262|Antidepressive Agents|antidepressive agents|mesh-ancestor
6285939|NCT00535262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6285940|NCT00535262|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6285941|NCT00535262|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6285942|NCT00535262|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6285943|NCT00535262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6285944|NCT00535262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285945|NCT00535262|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6285946|NCT00535262|Protective Agents|protective agents|mesh-ancestor
6285947|NCT00535262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6285948|NCT00536978|Cytarabine|cytarabine|mesh-list
6285949|NCT00536978|Cyclophosphamide|cyclophosphamide|mesh-list
6285950|NCT00536978|Melphalan|melphalan|mesh-list
6285951|NCT00536978|Carmustine|carmustine|mesh-list
6285952|NCT00536978|Rituximab|rituximab|mesh-list
6285953|NCT00536978|Methotrexate|methotrexate|mesh-list
6285954|NCT00536978|Fludarabine|fludarabine|mesh-list
6285955|NCT00536978|Fludarabine phosphate|fludarabine phosphate|mesh-list
6285956|NCT00536978|Etoposide|etoposide|mesh-list
6285957|NCT00536978|Alemtuzumab|alemtuzumab|mesh-list
6285958|NCT00536978|Tacrolimus|tacrolimus|mesh-list
6285959|NCT00536978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6285960|NCT00536978|Immunologic Factors|immunologic factors|mesh-ancestor
6285961|NCT00536978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6285962|NCT00536978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6285963|NCT00536978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6285964|NCT00536978|Alkylating Agents|alkylating agents|mesh-ancestor
6285965|NCT00536978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285966|NCT00536978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6285967|NCT00536978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6285968|NCT00536978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6285969|NCT00536978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6285970|NCT00536978|Abortifacient Agents|abortifacient agents|mesh-ancestor
6285971|NCT00536978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6285972|NCT00536978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6285973|NCT00536978|Antimetabolites|antimetabolites|mesh-ancestor
6285974|NCT00536978|Dermatologic Agents|dermatologic agents|mesh-ancestor
6285975|NCT00536978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6285976|NCT00536978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6285977|NCT00536978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6285978|NCT00536978|Antiviral Agents|antiviral agents|mesh-ancestor
6285979|NCT00536978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6285980|NCT00536978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6285981|NCT00536978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6285982|NCT00536978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6285983|NCT00536978|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6285984|NCT00524485|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6285985|NCT00524485|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6285986|NCT00524485|Dermatologic Agents|dermatologic agents|mesh-ancestor
6285987|NCT00529282|Vancomycin|vancomycin|mesh-list
6285988|NCT00529282|Cefepime|cefepime|mesh-list
6285989|NCT00529282|Ceftobiprole|ceftobiprole|mesh-list
6285990|NCT00529282|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
6285991|NCT00529282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6285992|NCT00529282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6285993|NCT00524134|Carvedilol|carvedilol|mesh-list
6285994|NCT00524134|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6285995|NCT00524134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6285996|NCT00524134|Adrenergic Agents|adrenergic agents|mesh-ancestor
6285997|NCT00524134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6285998|NCT00524134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6285999|NCT00524134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286000|NCT00524134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6286001|NCT00524134|Antioxidants|antioxidants|mesh-ancestor
6286002|NCT00524134|Protective Agents|protective agents|mesh-ancestor
6286003|NCT00524134|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6286004|NCT00524134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6286005|NCT00524134|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6286006|NCT00524134|Vasodilator Agents|vasodilator agents|mesh-ancestor
6286007|NCT00524134|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6286008|NCT00524134|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6286009|NCT00517699|Cytarabine|cytarabine|mesh-list
6286010|NCT00517699|Rituximab|rituximab|mesh-list
6286011|NCT00517699|Methotrexate|methotrexate|mesh-list
6286012|NCT00517699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6286013|NCT00517699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6286014|NCT00517699|Immunologic Factors|immunologic factors|mesh-ancestor
6286015|NCT00517699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286016|NCT00517699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6286017|NCT00517699|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6286018|NCT00517699|Abortifacient Agents|abortifacient agents|mesh-ancestor
6286019|NCT00517699|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6286020|NCT00517699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6286021|NCT00517699|Antimetabolites|antimetabolites|mesh-ancestor
6286022|NCT00517699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286023|NCT00517699|Dermatologic Agents|dermatologic agents|mesh-ancestor
6286024|NCT00517699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6286025|NCT00517699|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6286026|NCT00517699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6286027|NCT00517699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6286028|NCT00517699|Antiviral Agents|antiviral agents|mesh-ancestor
6286029|NCT00517699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6286030|NCT00528437|Carboplatin|carboplatin|mesh-list
6286031|NCT00528437|Temozolomide|temozolomide|mesh-list
6286032|NCT00528437|Thiotepa|thiotepa|mesh-list
6286033|NCT00528437|Tretinoin|tretinoin|mesh-list
6286034|NCT00528437|Isotretinoin|isotretinoin|mesh-list
6286035|NCT00528437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6286036|NCT00528437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6286037|NCT00528437|Alkylating Agents|alkylating agents|mesh-ancestor
6286038|NCT00528437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286039|NCT00528437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6286040|NCT00528437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6286041|NCT00528437|Immunologic Factors|immunologic factors|mesh-ancestor
6286042|NCT00528437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286043|NCT00528437|Keratolytic Agents|keratolytic agents|mesh-ancestor
6286044|NCT00528437|Dermatologic Agents|dermatologic agents|mesh-ancestor
6286045|NCT00527982|Celecoxib|celecoxib|mesh-list
6286046|NCT00527982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6286047|NCT00527982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6286048|NCT00527982|Analgesics|analgesics|mesh-ancestor
6286049|NCT00527982|Sensory System Agents|sensory system agents|mesh-ancestor
6286050|NCT00527982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6286051|NCT00527982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286052|NCT00527982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6286053|NCT00527982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6286054|NCT00527982|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6286055|NCT00527982|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6286056|NCT00527982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6286057|NCT00527982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286058|NCT00524459|Docetaxel|docetaxel|mesh-list
6286059|NCT00524459|Doxorubicin|doxorubicin|mesh-list
6286060|NCT00524459|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6286061|NCT00524459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6286062|NCT00524459|Tubulin Modulators|tubulin modulators|mesh-ancestor
6286063|NCT00524459|Antimitotic Agents|antimitotic agents|mesh-ancestor
6286064|NCT00524459|Mitosis Modulators|mitosis modulators|mesh-ancestor
6286065|NCT00524459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286066|NCT00524459|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6286067|NCT00524459|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6286068|NCT00524459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6286069|NCT00524459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6286070|NCT00517361|Bevacizumab|bevacizumab|mesh-list
6286071|NCT00517361|Carboplatin|carboplatin|mesh-list
6286072|NCT00517361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6286073|NCT00517361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6286074|NCT00517361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6286075|NCT00517361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6286076|NCT00517361|Growth Substances|growth substances|mesh-ancestor
6286077|NCT00517361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724189|NCT03188471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724190|NCT03188471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5724191|NCT03188471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5724192|NCT03188471|Analgesics|analgesics|mesh-ancestor
5724193|NCT03188471|Sensory System Agents|sensory system agents|mesh-ancestor
5724194|NCT03188471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6286078|NCT00517361|Growth Inhibitors|growth inhibitors|mesh-ancestor
6286079|NCT00523939|Cytarabine|cytarabine|mesh-list
6286080|NCT00523939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6286081|NCT00523939|Antimetabolites|antimetabolites|mesh-ancestor
5724195|NCT03188471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6286082|NCT00523939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286083|NCT00523939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6286084|NCT00523939|Antiviral Agents|antiviral agents|mesh-ancestor
6286085|NCT00523939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6286086|NCT00523939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6286087|NCT00523939|Immunologic Factors|immunologic factors|mesh-ancestor
6286088|NCT00523939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286089|NCT00519090|Imatinib Mesylate|imatinib mesylate|mesh-list
6286090|NCT00519090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6286091|NCT00519090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6286092|NCT00519090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6286093|NCT00519090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286094|NCT00523809|Vidarabine|vidarabine|mesh-list
6286095|NCT00523809|Bevacizumab|bevacizumab|mesh-list
6286096|NCT00523809|Fludarabine|fludarabine|mesh-list
6286097|NCT00523809|Fludarabine phosphate|fludarabine phosphate|mesh-list
6286098|NCT00523809|Melphalan|melphalan|mesh-list
6286099|NCT00523809|Thymoglobulin|thymoglobulin|mesh-list
6286100|NCT00523809|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6286101|NCT00523809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6286102|NCT00523809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6286103|NCT00523809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6286104|NCT00523809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6286105|NCT00523809|Growth Substances|growth substances|mesh-ancestor
6286106|NCT00523809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286107|NCT00523809|Growth Inhibitors|growth inhibitors|mesh-ancestor
6286108|NCT00523809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6286109|NCT00523809|Antimetabolites|antimetabolites|mesh-ancestor
6286110|NCT00523809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286111|NCT00523809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6286112|NCT00523809|Immunologic Factors|immunologic factors|mesh-ancestor
6286113|NCT00523809|Antiviral Agents|antiviral agents|mesh-ancestor
6286114|NCT00523809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6286115|NCT00523809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6286116|NCT00523809|Alkylating Agents|alkylating agents|mesh-ancestor
6286117|NCT00523809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6286118|NCT00522301|Sorafenib|sorafenib|mesh-list
6286119|NCT00522301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6286120|NCT00522301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6286121|NCT00522301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6286122|NCT00522301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286123|NCT00517192|Ritonavir|ritonavir|mesh-list
6286124|NCT00517192|Darunavir|darunavir|mesh-list
6286125|NCT00517192|Tipranavir|tipranavir|mesh-list
6286126|NCT00517192|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6286127|NCT00517192|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6286128|NCT00517192|Protease Inhibitors|protease inhibitors|mesh-ancestor
6286129|NCT00517192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6286130|NCT00517192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286131|NCT00517192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6286132|NCT00517192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6286133|NCT00517192|Antiviral Agents|antiviral agents|mesh-ancestor
6286134|NCT00517192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6286135|NCT00517192|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6286136|NCT00517192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6286137|NCT00503581|Megestrol|megestrol|mesh-list
6286138|NCT00503581|Megestrol Acetate|megestrol acetate|mesh-list
6286139|NCT00503581|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6286140|NCT00503581|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6286141|NCT00503581|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6286142|NCT00503581|Contraceptive Agents|contraceptive agents|mesh-ancestor
6286143|NCT00503581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6286144|NCT00503581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286145|NCT00503581|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6286146|NCT00503581|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6286147|NCT00503581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6286148|NCT00503581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6286149|NCT00503581|Appetite Stimulants|appetite stimulants|mesh-ancestor
6286150|NCT00503581|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6286151|NCT00509600|Etanercept|etanercept|mesh-list
6286152|NCT00509600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6286153|NCT00509600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6286154|NCT00509600|Analgesics|analgesics|mesh-ancestor
6286155|NCT00509600|Sensory System Agents|sensory system agents|mesh-ancestor
6286156|NCT00509600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6286157|NCT00509600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286158|NCT00509600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6286159|NCT00509600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6286160|NCT00509600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6286161|NCT00509600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6286162|NCT00509600|Immunologic Factors|immunologic factors|mesh-ancestor
6286163|NCT00515112|Testosterone|testosterone|mesh-list
6286164|NCT00515112|Androgens|androgens|mesh-ancestor
6286165|NCT00515112|Hormones|hormones|mesh-ancestor
6286166|NCT00515112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6286167|NCT00515112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286168|NCT00508872|Leucovorin|leucovorin|mesh-list
6286169|NCT00508872|Bevacizumab|bevacizumab|mesh-list
6286170|NCT00508872|Fluorouracil|fluorouracil|mesh-list
6286171|NCT00508872|Oxaliplatin|oxaliplatin|mesh-list
6286172|NCT00508872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6286173|NCT00508872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6286174|NCT00508872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6286175|NCT00508872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6286176|NCT00508872|Growth Substances|growth substances|mesh-ancestor
6286177|NCT00508872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286178|NCT00508872|Growth Inhibitors|growth inhibitors|mesh-ancestor
6286179|NCT00508872|Antimetabolites|antimetabolites|mesh-ancestor
6286180|NCT00508872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286181|NCT00508872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6286182|NCT00508872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6286183|NCT00508872|Immunologic Factors|immunologic factors|mesh-ancestor
6286184|NCT00508872|Antidotes|antidotes|mesh-ancestor
6286185|NCT00508872|Protective Agents|protective agents|mesh-ancestor
6286186|NCT00508872|Vitamin B Complex|vitamin b complex|mesh-ancestor
6286187|NCT00508872|Vitamins|vitamins|mesh-ancestor
6286188|NCT00508872|Micronutrients|micronutrients|mesh-ancestor
6286189|NCT00506064|Melatonin|melatonin|mesh-list
6286190|NCT00506064|Antioxidants|antioxidants|mesh-ancestor
6286191|NCT00506064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286192|NCT00506064|Protective Agents|protective agents|mesh-ancestor
6286193|NCT00506064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286194|NCT00506064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6286195|NCT00503880|Cytarabine|cytarabine|mesh-list
6286196|NCT00503880|Clofarabine|clofarabine|mesh-list
6286197|NCT00503880|Immunologic Factors|immunologic factors|mesh-ancestor
6286198|NCT00503880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286199|NCT00503880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6286200|NCT00503880|Antimetabolites|antimetabolites|mesh-ancestor
6286201|NCT00503880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286202|NCT00503880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6286203|NCT00503880|Antiviral Agents|antiviral agents|mesh-ancestor
6286204|NCT00503880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6286205|NCT00503880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6286206|NCT00501228|Lenograstim|lenograstim|mesh-list
6286207|NCT00501228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6286208|NCT00501228|Immunologic Factors|immunologic factors|mesh-ancestor
6286209|NCT00501228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286210|NCT00496782|Maraviroc|maraviroc|mesh-list
6286211|NCT00496782|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6286212|NCT00496782|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6286213|NCT00496782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286214|NCT00496782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6286215|NCT00496782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6286216|NCT00496782|Antiviral Agents|antiviral agents|mesh-ancestor
6286217|NCT00496782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6286218|NCT00496782|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6286219|NCT00506909|Oxytocin|oxytocin|mesh-list
6286220|NCT00506909|Oxytocics|oxytocics|mesh-ancestor
6286221|NCT00506909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6286222|NCT00506909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286223|NCT00487578|Naratriptan|naratriptan|mesh-list
6286224|NCT00487578|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6391664|NCT00193739|Tubulin Modulators|tubulin modulators|mesh-ancestor
6286225|NCT00487578|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6286226|NCT00487578|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6286227|NCT00487578|Serotonin Agents|serotonin agents|mesh-ancestor
6286228|NCT00487578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6286229|NCT00487578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286230|NCT00487578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286231|NCT00503009|Fluticasone|fluticasone|mesh-list
6286232|NCT00503009|Xhance|xhance|mesh-list
6286233|NCT00503009|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6286234|NCT00503009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6286235|NCT00503009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6286236|NCT00503009|Autonomic Agents|autonomic agents|mesh-ancestor
6286237|NCT00503009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6286238|NCT00503009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286239|NCT00503009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6286240|NCT00503009|Respiratory System Agents|respiratory system agents|mesh-ancestor
6286241|NCT00503009|Dermatologic Agents|dermatologic agents|mesh-ancestor
6286242|NCT00503009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6286243|NCT00503009|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6286244|NCT00503009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6286245|NCT00503009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6286246|NCT00503009|Adrenergic Agents|adrenergic agents|mesh-ancestor
6286247|NCT00503009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6286248|NCT00503009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286249|NCT00500045|Niacin|niacin|mesh-list
6286250|NCT00500045|Nicotinic Acids|nicotinic acids|mesh-list
6286251|NCT00500045|Niacinamide|niacinamide|mesh-list
6286252|NCT00500045|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6286253|NCT00500045|Antimetabolites|antimetabolites|mesh-ancestor
6286254|NCT00500045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286255|NCT00500045|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6286256|NCT00500045|Vasodilator Agents|vasodilator agents|mesh-ancestor
6286257|NCT00500045|Vitamin B Complex|vitamin b complex|mesh-ancestor
6286258|NCT00500045|Vitamins|vitamins|mesh-ancestor
6286259|NCT00500045|Micronutrients|micronutrients|mesh-ancestor
6286260|NCT00500045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286261|NCT00499590|Ranibizumab|ranibizumab|mesh-list
6286262|NCT00499590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6286263|NCT00499590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6286264|NCT00499590|Growth Substances|growth substances|mesh-ancestor
6286265|NCT00499590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286266|NCT00499590|Growth Inhibitors|growth inhibitors|mesh-ancestor
6286267|NCT00499590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6286268|NCT00501345|Aspirin|aspirin|mesh-list
6286269|NCT00501345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6286270|NCT00501345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6286271|NCT00501345|Analgesics|analgesics|mesh-ancestor
6286272|NCT00501345|Sensory System Agents|sensory system agents|mesh-ancestor
6286273|NCT00501345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6286274|NCT00501345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286275|NCT00501345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6286276|NCT00501345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6286277|NCT00501345|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6286278|NCT00501345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6286279|NCT00501345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286280|NCT00501345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6286281|NCT00501345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6286282|NCT00501345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6286283|NCT00501345|Antipyretics|antipyretics|mesh-ancestor
6286284|NCT00496756|Sorafenib|sorafenib|mesh-list
6286285|NCT00496756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6286286|NCT00496756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6286287|NCT00496756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6286288|NCT00496756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286289|NCT00495716|Acyclovir|acyclovir|mesh-list
6286290|NCT00495716|Antiviral Agents|antiviral agents|mesh-ancestor
6286291|NCT00495716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6286292|NCT00500890|Cyclophosphamide|cyclophosphamide|mesh-list
6286293|NCT00500890|Carboplatin|carboplatin|mesh-list
6286294|NCT00500890|Etoposide|etoposide|mesh-list
6286295|NCT00500890|Vincristine|vincristine|mesh-list
6286296|NCT00500890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6286297|NCT00500890|Immunologic Factors|immunologic factors|mesh-ancestor
6286298|NCT00500890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286299|NCT00500890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6286300|NCT00500890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6286301|NCT00500890|Alkylating Agents|alkylating agents|mesh-ancestor
6286302|NCT00500890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286303|NCT00500890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6286304|NCT00500890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6286305|NCT00500890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6286306|NCT00500890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6286307|NCT00500890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6286308|NCT00500890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6286309|NCT00500890|Tubulin Modulators|tubulin modulators|mesh-ancestor
6286310|NCT00500890|Antimitotic Agents|antimitotic agents|mesh-ancestor
6286311|NCT00500890|Mitosis Modulators|mitosis modulators|mesh-ancestor
6286312|NCT00503841|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6286313|NCT00503841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6286314|NCT00503841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6286315|NCT00503841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6286316|NCT00503841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286317|NCT00493025|Paclitaxel|paclitaxel|mesh-list
6286318|NCT00493025|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6286319|NCT00493025|Cisplatin|cisplatin|mesh-list
6286320|NCT00493025|Gefitinib|gefitinib|mesh-list
6286321|NCT00493025|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6286322|NCT00493025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6286323|NCT00493025|Tubulin Modulators|tubulin modulators|mesh-ancestor
6286324|NCT00493025|Antimitotic Agents|antimitotic agents|mesh-ancestor
6286325|NCT00493025|Mitosis Modulators|mitosis modulators|mesh-ancestor
6286326|NCT00493025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286327|NCT00493025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6286328|NCT00493025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6286329|NCT00491400|Atorvastatin|atorvastatin|mesh-list
6286330|NCT00491400|Fenofibrate|fenofibrate|mesh-list
6286331|NCT00491400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6286332|NCT00491400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6286333|NCT00491400|Antimetabolites|antimetabolites|mesh-ancestor
6286334|NCT00491400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286335|NCT00491400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6286336|NCT00491400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6286337|NCT00491400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6286338|NCT00490776|Panobinostat|panobinostat|mesh-list
6286339|NCT00490776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6286340|NCT00490776|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6286341|NCT00490776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6286342|NCT00490776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286343|NCT00487162|Insulin|insulin|mesh-list
6286344|NCT00487162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6286345|NCT00487162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286346|NCT00491387|Metoprolol|metoprolol|mesh-list
6286347|NCT00491387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6286348|NCT00491387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6286349|NCT00491387|Sympatholytics|sympatholytics|mesh-ancestor
6286350|NCT00491387|Autonomic Agents|autonomic agents|mesh-ancestor
6286351|NCT00491387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5724196|NCT03188471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6286352|NCT00491387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286353|NCT00491387|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6286354|NCT00491387|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6286355|NCT00491387|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6286356|NCT00491387|Adrenergic Agents|adrenergic agents|mesh-ancestor
6286357|NCT00491387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6286358|NCT00491387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286359|NCT00475332|Tositumomab I-131|tositumomab i-131|mesh-list
6286360|NCT00475332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6286361|NCT00483119|Cyclophosphamide|cyclophosphamide|mesh-list
6286362|NCT00483119|Immunoglobulins|immunoglobulins|mesh-list
6286363|NCT00483119|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6286364|NCT00483119|Antibodies|antibodies|mesh-list
6286365|NCT00483119|gamma-Globulins|gamma-globulins|mesh-list
6286366|NCT00483119|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6286367|NCT00483119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6286368|NCT00483119|Immunologic Factors|immunologic factors|mesh-ancestor
6286369|NCT00483119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286370|NCT00483119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6286371|NCT00483119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6286372|NCT00483119|Alkylating Agents|alkylating agents|mesh-ancestor
6286373|NCT00483119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286374|NCT00483119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6286375|NCT00483119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6286376|NCT00487461|Simvastatin|simvastatin|mesh-list
6286377|NCT00487461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6286378|NCT00487461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6286379|NCT00487461|Antimetabolites|antimetabolites|mesh-ancestor
6286380|NCT00487461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286381|NCT00487461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6286382|NCT00487461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6286383|NCT00487461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6286384|NCT00484718|Celecoxib|celecoxib|mesh-list
6286385|NCT00484718|Oxycodone|oxycodone|mesh-list
6286386|NCT00484718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6286387|NCT00484718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6286388|NCT00484718|Analgesics|analgesics|mesh-ancestor
6286389|NCT00484718|Sensory System Agents|sensory system agents|mesh-ancestor
6286390|NCT00484718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6286391|NCT00484718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286392|NCT00484718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6286393|NCT00484718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6286394|NCT00484718|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6286395|NCT00484718|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6286396|NCT00484718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6286397|NCT00484718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286398|NCT00484718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6286399|NCT00484718|Narcotics|narcotics|mesh-ancestor
6286400|NCT00484718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6286401|NCT00477230|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
6286402|NCT00470067|Carboplatin|carboplatin|mesh-list
6286403|NCT00470067|Doxorubicin|doxorubicin|mesh-list
6286404|NCT00470067|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6286405|NCT00470067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6286406|NCT00470067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6286407|NCT00470067|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6286408|NCT00470067|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6286409|NCT00470067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6286410|NCT00470067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286411|NCT00476827|Gemcitabine|gemcitabine|mesh-list
6286412|NCT00476827|Paclitaxel|paclitaxel|mesh-list
6286413|NCT00476827|Vinorelbine|vinorelbine|mesh-list
6286414|NCT00476827|Docetaxel|docetaxel|mesh-list
6286415|NCT00476827|Bevacizumab|bevacizumab|mesh-list
6286416|NCT00476827|Irinotecan|irinotecan|mesh-list
6286417|NCT00476827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6286418|NCT00476827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6286419|NCT00476827|Tubulin Modulators|tubulin modulators|mesh-ancestor
6286420|NCT00476827|Antimitotic Agents|antimitotic agents|mesh-ancestor
6286421|NCT00476827|Mitosis Modulators|mitosis modulators|mesh-ancestor
6286422|NCT00476827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286423|NCT00476827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6286424|NCT00476827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6286425|NCT00476827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6286426|NCT00476827|Growth Substances|growth substances|mesh-ancestor
5724197|NCT03188471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6286427|NCT00476827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286428|NCT00476827|Growth Inhibitors|growth inhibitors|mesh-ancestor
6286429|NCT00476827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6286430|NCT00476827|Antimetabolites|antimetabolites|mesh-ancestor
6015436|NCT00357110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015437|NCT00357162|Belinostat|belinostat|mesh-list
6286431|NCT00476827|Antiviral Agents|antiviral agents|mesh-ancestor
6286432|NCT00476827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6286433|NCT00476827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6286434|NCT00476827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6286435|NCT00476827|Immunologic Factors|immunologic factors|mesh-ancestor
6286436|NCT00476827|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6286437|NCT00476827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6286438|NCT00475657|Pemetrexed|pemetrexed|mesh-list
6286439|NCT00475657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6286440|NCT00475657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6286441|NCT00475657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286442|NCT00475657|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6286443|NCT00475657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6286444|NCT00470574|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
6286445|NCT00470574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6286446|NCT00470574|Immunologic Factors|immunologic factors|mesh-ancestor
6286447|NCT00470574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286448|NCT00467753|Oxcarbazepine|oxcarbazepine|mesh-list
6286449|NCT00467753|Anticonvulsants|anticonvulsants|mesh-ancestor
6286450|NCT00467753|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6286451|NCT00467753|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6286452|NCT00467753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6286453|NCT00467753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286454|NCT00467753|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6286455|NCT00467753|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6286456|NCT00461812|Mometasone Furoate|mometasone furoate|mesh-list
6286457|NCT00461812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6286458|NCT00461812|Dermatologic Agents|dermatologic agents|mesh-ancestor
6286459|NCT00461812|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6286460|NCT00459121|Paclitaxel|paclitaxel|mesh-list
6286461|NCT00459121|Carboplatin|carboplatin|mesh-list
6286462|NCT00459121|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6286463|NCT00459121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6286464|NCT00459121|Tubulin Modulators|tubulin modulators|mesh-ancestor
6286465|NCT00459121|Antimitotic Agents|antimitotic agents|mesh-ancestor
6286466|NCT00459121|Mitosis Modulators|mitosis modulators|mesh-ancestor
6286467|NCT00459121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286468|NCT00450333|Epoetin Alfa|epoetin alfa|mesh-list
6286469|NCT00450333|Hematinics|hematinics|mesh-ancestor
6286470|NCT00455143|Dexmedetomidine|dexmedetomidine|mesh-list
6286471|NCT00455143|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6286472|NCT00455143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6286473|NCT00455143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286474|NCT00455143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6286475|NCT00455143|Analgesics|analgesics|mesh-ancestor
6286476|NCT00455143|Sensory System Agents|sensory system agents|mesh-ancestor
6286477|NCT00455143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6286478|NCT00455143|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6286479|NCT00455143|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6286480|NCT00455143|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6286481|NCT00455143|Adrenergic Agents|adrenergic agents|mesh-ancestor
6286482|NCT00455143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6286483|NCT00455143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286484|NCT00456989|Docetaxel|docetaxel|mesh-list
6286485|NCT00456989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6286486|NCT00456989|Tubulin Modulators|tubulin modulators|mesh-ancestor
6286487|NCT00456989|Antimitotic Agents|antimitotic agents|mesh-ancestor
6286488|NCT00456989|Mitosis Modulators|mitosis modulators|mesh-ancestor
6286489|NCT00456989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286490|NCT00448682|Leucovorin|leucovorin|mesh-list
6286491|NCT00448682|Docetaxel|docetaxel|mesh-list
6286492|NCT00448682|Oxaliplatin|oxaliplatin|mesh-list
6286493|NCT00448682|Floxuridine|floxuridine|mesh-list
6286494|NCT00448682|Levoleucovorin|levoleucovorin|mesh-list
6286495|NCT00448682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6286496|NCT00448682|Tubulin Modulators|tubulin modulators|mesh-ancestor
6286497|NCT00448682|Antimitotic Agents|antimitotic agents|mesh-ancestor
6286498|NCT00448682|Mitosis Modulators|mitosis modulators|mesh-ancestor
6286499|NCT00448682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286500|NCT00448682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286501|NCT00448682|Antidotes|antidotes|mesh-ancestor
6286502|NCT00448682|Protective Agents|protective agents|mesh-ancestor
6286503|NCT00448682|Vitamin B Complex|vitamin b complex|mesh-ancestor
6286504|NCT00448682|Vitamins|vitamins|mesh-ancestor
6286505|NCT00448682|Micronutrients|micronutrients|mesh-ancestor
6286506|NCT00448682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6286507|NCT00448682|Antimetabolites|antimetabolites|mesh-ancestor
6286508|NCT00454571|Leuprolide|leuprolide|mesh-list
6286509|NCT00454571|Goserelin|goserelin|mesh-list
6286510|NCT00454571|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6286511|NCT00454571|Fertility Agents|fertility agents|mesh-ancestor
6286512|NCT00454571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6286513|NCT00454571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286514|NCT00454571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6286515|NCT00454571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6286516|NCT00452361|Cyclosporine|cyclosporine|mesh-list
6286517|NCT00452361|Sirolimus|sirolimus|mesh-list
6286518|NCT00452361|Tacrolimus|tacrolimus|mesh-list
6286519|NCT00452361|Cyclosporins|cyclosporins|mesh-list
6286520|NCT00452361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
6286521|NCT00452361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6286522|NCT00452361|Immunologic Factors|immunologic factors|mesh-ancestor
6286523|NCT00452361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286524|NCT00452361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6286525|NCT00452361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286526|NCT00452361|Antifungal Agents|antifungal agents|mesh-ancestor
6286527|NCT00452361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6286528|NCT00452361|Dermatologic Agents|dermatologic agents|mesh-ancestor
6286529|NCT00452361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6286530|NCT00452361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6286531|NCT00452361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6286532|NCT00452361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6286533|NCT00447421|Pemetrexed|pemetrexed|mesh-list
6286534|NCT00447421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6286535|NCT00447421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6286536|NCT00447421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286537|NCT00447421|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6286538|NCT00447421|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6286539|NCT00441272|Pioglitazone|pioglitazone|mesh-list
6286540|NCT00441272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6286541|NCT00441272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286542|NCT00440271|Ritonavir|ritonavir|mesh-list
6286543|NCT00440271|Raltegravir Potassium|raltegravir potassium|mesh-list
6286544|NCT00440271|Maraviroc|maraviroc|mesh-list
6286545|NCT00440271|Tipranavir|tipranavir|mesh-list
6286546|NCT00440271|Enfuvirtide|enfuvirtide|mesh-list
6286547|NCT00440271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
6286548|NCT00440271|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6286549|NCT00440271|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6286550|NCT00440271|Protease Inhibitors|protease inhibitors|mesh-ancestor
6286551|NCT00440271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6286552|NCT00440271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286553|NCT00440271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6286554|NCT00440271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6286555|NCT00440271|Antiviral Agents|antiviral agents|mesh-ancestor
6286556|NCT00440271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6286557|NCT00440271|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6286558|NCT00440271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6286559|NCT00440271|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6286560|NCT00440271|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6286561|NCT00440271|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6286562|NCT00440271|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6286563|NCT00440271|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6286564|NCT00440271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6286565|NCT00442260|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6286566|NCT00442260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6286567|NCT00429026|Cyclophosphamide|cyclophosphamide|mesh-list
6286568|NCT00429026|Melphalan|melphalan|mesh-list
6286569|NCT00429026|Fludarabine|fludarabine|mesh-list
6286570|NCT00429026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6286571|NCT00429026|Immunologic Factors|immunologic factors|mesh-ancestor
6286572|NCT00429026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286573|NCT00429026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6286574|NCT00429026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6286575|NCT00429026|Alkylating Agents|alkylating agents|mesh-ancestor
6286576|NCT00429026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286577|NCT00429026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6286578|NCT00429026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6286579|NCT00428207|Insulin|insulin|mesh-list
6286580|NCT00428207|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6286581|NCT00428207|Insulin Aspart|insulin aspart|mesh-list
6286582|NCT00428207|Insulin, Long-Acting|insulin, long-acting|mesh-list
6286583|NCT00428207|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6286584|NCT00428207|Insulin Lispro|insulin lispro|mesh-list
6286585|NCT00428207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6286586|NCT00428207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286587|NCT00439569|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
6286588|NCT00439569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6286589|NCT00434590|Mycophenolic Acid|mycophenolic acid|mesh-list
6286590|NCT00434590|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6286591|NCT00434590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6286592|NCT00434590|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6286593|NCT00434590|Antitubercular Agents|antitubercular agents|mesh-ancestor
6286594|NCT00434590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6286595|NCT00434590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6286596|NCT00434590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6286597|NCT00434590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391665|NCT00193739|Antimitotic Agents|antimitotic agents|mesh-ancestor
6391666|NCT00193739|Mitosis Modulators|mitosis modulators|mesh-ancestor
6391667|NCT00193739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391668|NCT00193856|Zoledronic Acid|zoledronic acid|mesh-list
6391669|NCT00193856|Leuprolide|leuprolide|mesh-list
6391670|NCT00193856|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6391671|NCT00193856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286598|NCT00430027|Capecitabine|capecitabine|mesh-list
6286599|NCT00430027|Oxaliplatin|oxaliplatin|mesh-list
6286600|NCT00430027|Cetuximab|cetuximab|mesh-list
6286601|NCT00430027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6286602|NCT00430027|Antimetabolites|antimetabolites|mesh-ancestor
6286603|NCT00430027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286604|NCT00430027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6286605|NCT00430027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6286606|NCT00429858|Gemcitabine|gemcitabine|mesh-list
6286607|NCT00429858|Tegafur|tegafur|mesh-list
6286608|NCT00429858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6286609|NCT00429858|Antimetabolites|antimetabolites|mesh-ancestor
6286610|NCT00429858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286611|NCT00429858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6286612|NCT00429858|Antiviral Agents|antiviral agents|mesh-ancestor
6286613|NCT00429858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6286614|NCT00429858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6286615|NCT00429858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6286616|NCT00429858|Immunologic Factors|immunologic factors|mesh-ancestor
6286617|NCT00429858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286618|NCT00425438|Mycophenolic Acid|mycophenolic acid|mesh-list
6286619|NCT00425438|Prednisolone|prednisolone|mesh-list
6286620|NCT00425438|Cyclophosphamide|cyclophosphamide|mesh-list
6286621|NCT00425438|Azathioprine|azathioprine|mesh-list
6286622|NCT00425438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6286623|NCT00425438|Immunologic Factors|immunologic factors|mesh-ancestor
6286624|NCT00425438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286625|NCT00425438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6286626|NCT00425438|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6286627|NCT00425438|Alkylating Agents|alkylating agents|mesh-ancestor
6286628|NCT00425438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286629|NCT00425438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6286630|NCT00425438|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6286631|NCT00425438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6286632|NCT00425438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6286633|NCT00425438|Antitubercular Agents|antitubercular agents|mesh-ancestor
6286634|NCT00425438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6286635|NCT00425438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6286636|NCT00425438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6286637|NCT00425438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6286638|NCT00425438|Glucocorticoids|glucocorticoids|mesh-ancestor
6286639|NCT00425438|Hormones|hormones|mesh-ancestor
6286640|NCT00425438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6286641|NCT00425438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6286642|NCT00425438|Antimetabolites|antimetabolites|mesh-ancestor
6286643|NCT00425438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6286644|NCT00421954|Ziprasidone|ziprasidone|mesh-list
6286645|NCT00421954|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6286646|NCT00421954|Serotonin Agents|serotonin agents|mesh-ancestor
6286647|NCT00421954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6286648|NCT00421954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286649|NCT00421954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286650|NCT00421954|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6286651|NCT00421954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6286652|NCT00421954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6286653|NCT00421954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6286654|NCT00421954|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6286655|NCT00421954|Dopamine Agents|dopamine agents|mesh-ancestor
6286656|NCT00422942|Rituximab|rituximab|mesh-list
6286657|NCT00422942|Methotrexate|methotrexate|mesh-list
6286658|NCT00422942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6286659|NCT00422942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6286660|NCT00422942|Immunologic Factors|immunologic factors|mesh-ancestor
6286661|NCT00422942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286662|NCT00422942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6286663|NCT00422942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6286664|NCT00422942|Abortifacient Agents|abortifacient agents|mesh-ancestor
6286665|NCT00422942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6286666|NCT00422942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6286667|NCT00422942|Antimetabolites|antimetabolites|mesh-ancestor
6286668|NCT00422942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286669|NCT00422942|Dermatologic Agents|dermatologic agents|mesh-ancestor
6286670|NCT00422942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6286671|NCT00422942|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6286672|NCT00422942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6286673|NCT00422942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6286674|NCT00409344|Dexmedetomidine|dexmedetomidine|mesh-list
6286675|NCT00409344|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6286676|NCT00409344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6286677|NCT00409344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286678|NCT00409344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6286679|NCT00409344|Analgesics|analgesics|mesh-ancestor
6286680|NCT00409344|Sensory System Agents|sensory system agents|mesh-ancestor
6286681|NCT00409344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6286682|NCT00409344|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6286683|NCT00409344|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6286684|NCT00409344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6286685|NCT00409344|Adrenergic Agents|adrenergic agents|mesh-ancestor
6286686|NCT00409344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6286687|NCT00409344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286688|NCT00414453|Lidocaine|lidocaine|mesh-list
6286689|NCT00414453|Oxycodone|oxycodone|mesh-list
6286690|NCT00414453|Anesthetics, Local|anesthetics, local|mesh-ancestor
6286691|NCT00414453|Anesthetics|anesthetics|mesh-ancestor
6286692|NCT00414453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6286693|NCT00414453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286694|NCT00414453|Sensory System Agents|sensory system agents|mesh-ancestor
6286695|NCT00414453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6286696|NCT00414453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6286697|NCT00414453|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6286698|NCT00414453|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6286699|NCT00414453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6286700|NCT00414453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286701|NCT00414453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6286702|NCT00414453|Narcotics|narcotics|mesh-ancestor
6286703|NCT00414453|Analgesics|analgesics|mesh-ancestor
6286704|NCT00417248|Etoposide|etoposide|mesh-list
6286705|NCT00417248|Sorafenib|sorafenib|mesh-list
6286706|NCT00417248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6286707|NCT00417248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6286708|NCT00417248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6286709|NCT00417248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6286710|NCT00417248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6286711|NCT00417248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286712|NCT00417248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6286713|NCT00418145|Methylprednisolone|methylprednisolone|mesh-list
6286714|NCT00418145|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6286715|NCT00418145|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6286716|NCT00418145|Prednisolone|prednisolone|mesh-list
6286717|NCT00418145|Prednisolone acetate|prednisolone acetate|mesh-list
6286718|NCT00418145|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6286719|NCT00418145|Prednisolone phosphate|prednisolone phosphate|mesh-list
6286720|NCT00418145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6286721|NCT00418145|Antiemetics|antiemetics|mesh-ancestor
6286722|NCT00418145|Autonomic Agents|autonomic agents|mesh-ancestor
6286723|NCT00418145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6286724|NCT00418145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286725|NCT00418145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6286726|NCT00418145|Glucocorticoids|glucocorticoids|mesh-ancestor
6286727|NCT00418145|Hormones|hormones|mesh-ancestor
6286728|NCT00418145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6286729|NCT00418145|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6286730|NCT00418145|Protective Agents|protective agents|mesh-ancestor
6286731|NCT00418145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6286732|NCT00418145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6286733|NCT00409331|Amifostine|amifostine|mesh-list
6286734|NCT00409331|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6286735|NCT00409331|Protective Agents|protective agents|mesh-ancestor
6286736|NCT00409331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286737|NCT00391430|Sertraline|sertraline|mesh-list
6286738|NCT00391430|Antidepressive Agents|antidepressive agents|mesh-ancestor
6286739|NCT00391430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6286740|NCT00391430|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6286741|NCT00391430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6286742|NCT00391430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6286743|NCT00391430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286744|NCT00391430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6286745|NCT00391430|Serotonin Agents|serotonin agents|mesh-ancestor
6286746|NCT00391430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286747|NCT00384293|Niacin|niacin|mesh-list
6286748|NCT00384293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6286749|NCT00384293|Antimetabolites|antimetabolites|mesh-ancestor
6286750|NCT00384293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286751|NCT00384293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6286752|NCT00384293|Vasodilator Agents|vasodilator agents|mesh-ancestor
6286753|NCT00384293|Vitamin B Complex|vitamin b complex|mesh-ancestor
6286754|NCT00384293|Vitamins|vitamins|mesh-ancestor
6286755|NCT00384293|Micronutrients|micronutrients|mesh-ancestor
6286756|NCT00384293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286757|NCT00374543|Ziprasidone|ziprasidone|mesh-list
6286758|NCT00374543|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6286759|NCT00374543|Serotonin Agents|serotonin agents|mesh-ancestor
6286760|NCT00374543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6286761|NCT00374543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286762|NCT00374543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286763|NCT00374543|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6286764|NCT00374543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6286765|NCT00374543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6286766|NCT00374543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6286767|NCT00374543|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6286768|NCT00374543|Dopamine Agents|dopamine agents|mesh-ancestor
6286769|NCT00377455|Bosentan|bosentan|mesh-list
6286770|NCT00377455|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6286771|NCT00377455|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6286772|NCT00377455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286773|NCT00369265|Lansoprazole|lansoprazole|mesh-list
6286774|NCT00369265|Dexlansoprazole|dexlansoprazole|mesh-list
6286775|NCT00369265|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6286776|NCT00369265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6286777|NCT00369265|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6286778|NCT00369265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6286779|NCT00369265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286780|NCT00364689|Rifaximin|rifaximin|mesh-list
6286781|NCT00364689|Lactulose|lactulose|mesh-list
6286782|NCT00364689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6286783|NCT00364689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6286784|NCT00364689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6286785|NCT00352118|Docetaxel|docetaxel|mesh-list
6286786|NCT00352118|Fluorouracil|fluorouracil|mesh-list
6286787|NCT00352118|Lenograstim|lenograstim|mesh-list
6286788|NCT00352118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6286789|NCT00352118|Tubulin Modulators|tubulin modulators|mesh-ancestor
6286790|NCT00352118|Antimitotic Agents|antimitotic agents|mesh-ancestor
6286791|NCT00352118|Mitosis Modulators|mitosis modulators|mesh-ancestor
6286792|NCT00352118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286793|NCT00352118|Antimetabolites|antimetabolites|mesh-ancestor
6286794|NCT00352118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6286795|NCT00352118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6286796|NCT00352118|Immunologic Factors|immunologic factors|mesh-ancestor
6286797|NCT00352118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286798|NCT00352118|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6286799|NCT00368654|Methotrexate|methotrexate|mesh-list
6286800|NCT00368654|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6286801|NCT00368654|Abortifacient Agents|abortifacient agents|mesh-ancestor
6286802|NCT00368654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6286803|NCT00368654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286804|NCT00368654|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6286805|NCT00368654|Antimetabolites|antimetabolites|mesh-ancestor
6286806|NCT00368654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286807|NCT00368654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6286808|NCT00368654|Dermatologic Agents|dermatologic agents|mesh-ancestor
6286809|NCT00368654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6286810|NCT00368654|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6286811|NCT00368654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6286812|NCT00368654|Immunologic Factors|immunologic factors|mesh-ancestor
6286813|NCT00368654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6286814|NCT00368654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6286815|NCT00356421|Insulin|insulin|mesh-list
6286816|NCT00356421|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6286817|NCT00356421|Insulin Lispro|insulin lispro|mesh-list
6286818|NCT00356421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6286819|NCT00356421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286820|NCT00356187|Propranolol|propranolol|mesh-list
6286821|NCT00356187|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6286822|NCT00356187|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6286823|NCT00356187|Adrenergic Agents|adrenergic agents|mesh-ancestor
6286824|NCT00356187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6286825|NCT00356187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286826|NCT00356187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286827|NCT00356187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6286828|NCT00356187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6286829|NCT00356187|Vasodilator Agents|vasodilator agents|mesh-ancestor
6286830|NCT00350844|Hydroxyurea|hydroxyurea|mesh-list
6286831|NCT00350844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6286832|NCT00350844|Antisickling Agents|antisickling agents|mesh-ancestor
6286833|NCT00350844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6286834|NCT00350844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286835|NCT00350844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6286836|NCT00348556|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6286837|NCT00348556|Natriuretic Agents|natriuretic agents|mesh-ancestor
6286838|NCT00348556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286839|NCT00319839|Paclitaxel|paclitaxel|mesh-list
6286840|NCT00319839|Cetuximab|cetuximab|mesh-list
6286841|NCT00319839|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6286842|NCT00319839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6286843|NCT00319839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6286844|NCT00319839|Tubulin Modulators|tubulin modulators|mesh-ancestor
6286845|NCT00319839|Antimitotic Agents|antimitotic agents|mesh-ancestor
6286846|NCT00319839|Mitosis Modulators|mitosis modulators|mesh-ancestor
6286847|NCT00319839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286848|NCT00319839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6286849|NCT00344019|Atorvastatin|atorvastatin|mesh-list
6286850|NCT00344019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6286851|NCT00344019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6286852|NCT00344019|Antimetabolites|antimetabolites|mesh-ancestor
6286853|NCT00344019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286854|NCT00344019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6286855|NCT00344019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6286856|NCT00344019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6286857|NCT00338455|Dobutamine|dobutamine|mesh-list
6286858|NCT00338455|Milrinone|milrinone|mesh-list
6286859|NCT00338455|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6286860|NCT00338455|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6286861|NCT00338455|Sympathomimetics|sympathomimetics|mesh-ancestor
6286862|NCT00338455|Autonomic Agents|autonomic agents|mesh-ancestor
6286863|NCT00338455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6286864|NCT00338455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286865|NCT00338455|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6286866|NCT00338455|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6286867|NCT00338455|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6286868|NCT00338455|Adrenergic Agents|adrenergic agents|mesh-ancestor
6286869|NCT00338455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6286870|NCT00338455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286871|NCT00338455|Protective Agents|protective agents|mesh-ancestor
6286872|NCT00338455|Natriuretic Agents|natriuretic agents|mesh-ancestor
6286873|NCT00338455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6286874|NCT00338455|Vasodilator Agents|vasodilator agents|mesh-ancestor
6286875|NCT00338455|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6286876|NCT00338455|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6286877|NCT00338455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6286878|NCT00329108|Olanzapine|olanzapine|mesh-list
6286879|NCT00329108|Ziprasidone|ziprasidone|mesh-list
6286880|NCT00329108|Antiemetics|antiemetics|mesh-ancestor
6286881|NCT00329108|Autonomic Agents|autonomic agents|mesh-ancestor
6286882|NCT00329108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6286883|NCT00329108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286884|NCT00329108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6286885|NCT00329108|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6286886|NCT00329108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6286887|NCT00329108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6286888|NCT00329108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6286889|NCT00329108|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6286890|NCT00329108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6286891|NCT00329108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6286892|NCT00329108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286893|NCT00329108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6286894|NCT00329108|Serotonin Agents|serotonin agents|mesh-ancestor
6286895|NCT00329108|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6286896|NCT00329108|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6286897|NCT00329108|Dopamine Agents|dopamine agents|mesh-ancestor
6286898|NCT00325572|Ascorbic Acid|ascorbic acid|mesh-list
6286899|NCT00325572|Vitamins|vitamins|mesh-ancestor
6286900|NCT00325572|Micronutrients|micronutrients|mesh-ancestor
6286901|NCT00325572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286902|NCT00325572|Antioxidants|antioxidants|mesh-ancestor
6286903|NCT00325572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286904|NCT00325572|Protective Agents|protective agents|mesh-ancestor
6286905|NCT00333229|Zoledronic Acid|zoledronic acid|mesh-list
6286906|NCT00333229|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6286907|NCT00333229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286908|NCT00323635|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6286909|NCT00323635|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6286910|NCT00323635|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6286911|NCT00323635|Cholinergic Agents|cholinergic agents|mesh-ancestor
6286912|NCT00323635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6286913|NCT00323635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286914|NCT00323635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286915|NCT00323635|Urological Agents|urological agents|mesh-ancestor
6286916|NCT00329732|Lidocaine|lidocaine|mesh-list
6286917|NCT00329732|Bupivacaine|bupivacaine|mesh-list
6286918|NCT00329732|Anesthetics, Local|anesthetics, local|mesh-ancestor
6286919|NCT00329732|Anesthetics|anesthetics|mesh-ancestor
6286920|NCT00329732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6286921|NCT00329732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286922|NCT00329732|Sensory System Agents|sensory system agents|mesh-ancestor
6286923|NCT00329732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6286924|NCT00329732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6286925|NCT00329732|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6286926|NCT00329732|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6286927|NCT00329732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6286928|NCT00329732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286929|NCT00314353|Bevacizumab|bevacizumab|mesh-list
6286930|NCT00314353|Capecitabine|capecitabine|mesh-list
6286931|NCT00314353|Oxaliplatin|oxaliplatin|mesh-list
6286932|NCT00314353|Irinotecan|irinotecan|mesh-list
6286933|NCT00314353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6286934|NCT00314353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6286935|NCT00314353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6286936|NCT00314353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6286937|NCT00314353|Growth Substances|growth substances|mesh-ancestor
6286938|NCT00314353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286939|NCT00314353|Growth Inhibitors|growth inhibitors|mesh-ancestor
6286940|NCT00314353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6286941|NCT00314353|Antimetabolites|antimetabolites|mesh-ancestor
6286942|NCT00314353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286943|NCT00314353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6286944|NCT00314353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6286945|NCT00314353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6286946|NCT00314327|Risperidone|risperidone|mesh-list
6286947|NCT00314327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6286948|NCT00314327|Serotonin Agents|serotonin agents|mesh-ancestor
6286949|NCT00314327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6286950|NCT00314327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286951|NCT00314327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286952|NCT00314327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6286953|NCT00314327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6286954|NCT00314327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6286955|NCT00314327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6286956|NCT00314327|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6286957|NCT00314327|Dopamine Agents|dopamine agents|mesh-ancestor
6286958|NCT00308113|Ubiquinone|ubiquinone|mesh-list
6286959|NCT00308113|Coenzyme Q10|coenzyme q10|mesh-list
6286960|NCT00308113|Prednisone|prednisone|mesh-list
6286961|NCT00308113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6286962|NCT00308113|Glucocorticoids|glucocorticoids|mesh-ancestor
6286963|NCT00308113|Hormones|hormones|mesh-ancestor
6286964|NCT00308113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6286965|NCT00308113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286966|NCT00308113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6286967|NCT00308113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6286968|NCT00308113|Micronutrients|micronutrients|mesh-ancestor
6286969|NCT00308113|Vitamins|vitamins|mesh-ancestor
6286970|NCT00305643|Celecoxib|celecoxib|mesh-list
6286971|NCT00305643|Capecitabine|capecitabine|mesh-list
6286972|NCT00305643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6286973|NCT00305643|Antimetabolites|antimetabolites|mesh-ancestor
6286974|NCT00305643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286975|NCT00305643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6286976|NCT00305643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6286977|NCT00305643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6286978|NCT00305643|Analgesics|analgesics|mesh-ancestor
6286979|NCT00305643|Sensory System Agents|sensory system agents|mesh-ancestor
6286980|NCT00305643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6286981|NCT00305643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286982|NCT00305643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6286983|NCT00305643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6286984|NCT00305643|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6286985|NCT00305643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6286986|NCT00305643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6286987|NCT00298740|Insulin|insulin|mesh-list
6286988|NCT00298740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6286989|NCT00298740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6286990|NCT00301080|Cycloserine|cycloserine|mesh-list
6286991|NCT00301080|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6286992|NCT00301080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6286993|NCT00301080|Renal Agents|renal agents|mesh-ancestor
6286994|NCT00301080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6286995|NCT00301080|Antitubercular Agents|antitubercular agents|mesh-ancestor
6286996|NCT00301080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6286997|NCT00301080|Antimetabolites|antimetabolites|mesh-ancestor
6286998|NCT00301080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6286999|NCT00299195|Sulindac|sulindac|mesh-list
6287000|NCT00299195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6287001|NCT00299195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6287002|NCT00299195|Analgesics|analgesics|mesh-ancestor
6287003|NCT00299195|Sensory System Agents|sensory system agents|mesh-ancestor
6287004|NCT00299195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6287005|NCT00299195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287006|NCT00299195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6287007|NCT00299195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6287008|NCT00299195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6287009|NCT00299195|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6287010|NCT00299195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6287011|NCT00299195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287012|NCT00290407|Rituximab|rituximab|mesh-list
6287013|NCT00290407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6287014|NCT00290407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6287015|NCT00290407|Immunologic Factors|immunologic factors|mesh-ancestor
6287016|NCT00290407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287017|NCT00290407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6287018|NCT00268463|Capecitabine|capecitabine|mesh-list
6287019|NCT00268463|Floxuridine|floxuridine|mesh-list
6287020|NCT00268463|Oxaliplatin|oxaliplatin|mesh-list
6287021|NCT00268463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6287022|NCT00268463|Antimetabolites|antimetabolites|mesh-ancestor
6287023|NCT00268463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287024|NCT00268463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6287025|NCT00276419|Diclofenac|diclofenac|mesh-list
6287026|NCT00276419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6287027|NCT00276419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6287028|NCT00276419|Analgesics|analgesics|mesh-ancestor
6287029|NCT00276419|Sensory System Agents|sensory system agents|mesh-ancestor
6287030|NCT00276419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6287031|NCT00276419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287032|NCT00276419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6287033|NCT00276419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6287034|NCT00276419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6287035|NCT00276419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6287036|NCT00276419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287037|NCT00279409|Aripiprazole|aripiprazole|mesh-list
6287038|NCT00279409|Antidepressive Agents|antidepressive agents|mesh-ancestor
6287039|NCT00279409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6287040|NCT00279409|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6287041|NCT00279409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6287042|NCT00279409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6287043|NCT00279409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287044|NCT00279409|Dopamine Agonists|dopamine agonists|mesh-ancestor
6287045|NCT00279409|Dopamine Agents|dopamine agents|mesh-ancestor
6287046|NCT00279409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6287047|NCT00279409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287048|NCT00279409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6287049|NCT00279409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6287050|NCT00279409|Serotonin Agents|serotonin agents|mesh-ancestor
6287051|NCT00279409|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6287052|NCT00279409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6287053|NCT00279409|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6287054|NCT00279409|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6287055|NCT00281879|Cytarabine|cytarabine|mesh-list
6287056|NCT00281879|Cyclosporine|cyclosporine|mesh-list
6287057|NCT00281879|Mycophenolic Acid|mycophenolic acid|mesh-list
6287058|NCT00281879|Methylprednisolone|methylprednisolone|mesh-list
6287059|NCT00281879|Cyclophosphamide|cyclophosphamide|mesh-list
6287060|NCT00281879|Melphalan|melphalan|mesh-list
6287061|NCT00281879|Busulfan|busulfan|mesh-list
6287062|NCT00281879|Carmustine|carmustine|mesh-list
6287063|NCT00281879|Methotrexate|methotrexate|mesh-list
6287064|NCT00281879|Fludarabine|fludarabine|mesh-list
6287065|NCT00281879|Fludarabine phosphate|fludarabine phosphate|mesh-list
6287066|NCT00281879|Etoposide|etoposide|mesh-list
6287067|NCT00281879|Tacrolimus|tacrolimus|mesh-list
6287068|NCT00281879|Cyclosporins|cyclosporins|mesh-list
6287069|NCT00281879|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6287070|NCT00281879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6287071|NCT00281879|Immunologic Factors|immunologic factors|mesh-ancestor
6287072|NCT00281879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287073|NCT00281879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6287074|NCT00281879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6287075|NCT00281879|Alkylating Agents|alkylating agents|mesh-ancestor
6287076|NCT00281879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287077|NCT00281879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6287078|NCT00281879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6287079|NCT00281879|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6287080|NCT00281879|Abortifacient Agents|abortifacient agents|mesh-ancestor
6287081|NCT00281879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6287082|NCT00281879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6287083|NCT00281879|Antimetabolites|antimetabolites|mesh-ancestor
6287084|NCT00281879|Dermatologic Agents|dermatologic agents|mesh-ancestor
6287085|NCT00281879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6287086|NCT00281879|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6287087|NCT00281879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6287088|NCT00281879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6287089|NCT00281879|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6287090|NCT00281879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6287091|NCT00281879|Antiviral Agents|antiviral agents|mesh-ancestor
6287092|NCT00281879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6287093|NCT00281879|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6287094|NCT00281879|Antifungal Agents|antifungal agents|mesh-ancestor
6287095|NCT00281879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6287096|NCT00281879|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6287097|NCT00281879|Antitubercular Agents|antitubercular agents|mesh-ancestor
6287098|NCT00281879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6287099|NCT00281879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6287100|NCT00281879|Antiemetics|antiemetics|mesh-ancestor
6287101|NCT00281879|Autonomic Agents|autonomic agents|mesh-ancestor
6287102|NCT00281879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6287103|NCT00281879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6287104|NCT00281879|Glucocorticoids|glucocorticoids|mesh-ancestor
6287105|NCT00281879|Hormones|hormones|mesh-ancestor
6287106|NCT00281879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6287107|NCT00281879|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6287108|NCT00281879|Protective Agents|protective agents|mesh-ancestor
6287109|NCT00271011|Irinotecan|irinotecan|mesh-list
6287110|NCT00271011|Cetuximab|cetuximab|mesh-list
6287111|NCT00271011|Mitomycins|mitomycins|mesh-list
6287112|NCT00271011|Mitomycin|mitomycin|mesh-list
6287113|NCT00271011|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6287114|NCT00271011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6287115|NCT00271011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6287116|NCT00271011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287117|NCT00271011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6287118|NCT00271011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6287119|NCT00271011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6287120|NCT00271011|Alkylating Agents|alkylating agents|mesh-ancestor
6287121|NCT00271011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6287122|NCT00252174|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
6287123|NCT00252174|Hallucinogens|hallucinogens|mesh-ancestor
6287124|NCT00252174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287125|NCT00252174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6287126|NCT00252174|Serotonin Agents|serotonin agents|mesh-ancestor
6287127|NCT00252174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6287128|NCT00252174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287129|NCT00252174|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6287130|NCT00252174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6287131|NCT00252174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6287132|NCT00252174|Adrenergic Agents|adrenergic agents|mesh-ancestor
6287133|NCT00256295|Gemcitabine|gemcitabine|mesh-list
6287134|NCT00256295|Oxaliplatin|oxaliplatin|mesh-list
6287135|NCT00256295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6287136|NCT00256295|Antimetabolites|antimetabolites|mesh-ancestor
6287137|NCT00256295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287138|NCT00256295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6287139|NCT00256295|Antiviral Agents|antiviral agents|mesh-ancestor
6287140|NCT00256295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6287141|NCT00256295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6287142|NCT00256295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6287143|NCT00256295|Immunologic Factors|immunologic factors|mesh-ancestor
6287144|NCT00256295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287145|NCT00245128|Imatinib Mesylate|imatinib mesylate|mesh-list
6287146|NCT00245128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6287147|NCT00245128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6287148|NCT00245128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6287149|NCT00245128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287150|NCT00268450|Gemcitabine|gemcitabine|mesh-list
6287151|NCT00268450|Paclitaxel|paclitaxel|mesh-list
6287152|NCT00268450|Bevacizumab|bevacizumab|mesh-list
6287153|NCT00268450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6287154|NCT00268450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6287155|NCT00268450|Tubulin Modulators|tubulin modulators|mesh-ancestor
6287156|NCT00268450|Antimitotic Agents|antimitotic agents|mesh-ancestor
6287157|NCT00268450|Mitosis Modulators|mitosis modulators|mesh-ancestor
6287158|NCT00268450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287159|NCT00268450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6287160|NCT00268450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6287161|NCT00268450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6287162|NCT00268450|Growth Substances|growth substances|mesh-ancestor
6287163|NCT00268450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287164|NCT00268450|Growth Inhibitors|growth inhibitors|mesh-ancestor
6287165|NCT00268450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6287166|NCT00268450|Antimetabolites|antimetabolites|mesh-ancestor
6287167|NCT00268450|Antiviral Agents|antiviral agents|mesh-ancestor
6287168|NCT00268450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6287169|NCT00268450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6287170|NCT00268450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6287171|NCT00268450|Immunologic Factors|immunologic factors|mesh-ancestor
6287172|NCT00239720|Muromonab-CD3|muromonab-cd3|mesh-list
6287173|NCT00239720|Immunologic Factors|immunologic factors|mesh-ancestor
6287174|NCT00239720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287175|NCT00239720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6287176|NCT00250718|Levofloxacin|levofloxacin|mesh-list
6287177|NCT00250718|Ofloxacin|ofloxacin|mesh-list
6287178|NCT00250718|Dexamethasone|dexamethasone|mesh-list
6287179|NCT00250718|Rituximab|rituximab|mesh-list
6287180|NCT00250718|Etoposide|etoposide|mesh-list
6287181|NCT00250718|Vincristine|vincristine|mesh-list
6287182|NCT00250718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6287183|NCT00250718|Antiemetics|antiemetics|mesh-ancestor
6287184|NCT00250718|Autonomic Agents|autonomic agents|mesh-ancestor
6287185|NCT00250718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6287186|NCT00250718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287187|NCT00250718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6287188|NCT00250718|Glucocorticoids|glucocorticoids|mesh-ancestor
6287189|NCT00250718|Hormones|hormones|mesh-ancestor
6287190|NCT00250718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6287191|NCT00250718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6287192|NCT00250718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6287193|NCT00250718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6287194|NCT00250718|Immunologic Factors|immunologic factors|mesh-ancestor
6287195|NCT00250718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6287196|NCT00250718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6287197|NCT00250718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6287198|NCT00250718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6287199|NCT00250718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6287200|NCT00250718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287201|NCT00250718|Tubulin Modulators|tubulin modulators|mesh-ancestor
6287202|NCT00250718|Antimitotic Agents|antimitotic agents|mesh-ancestor
6287203|NCT00250718|Mitosis Modulators|mitosis modulators|mesh-ancestor
6287204|NCT00250718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6287205|NCT00250718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6287206|NCT00250718|Renal Agents|renal agents|mesh-ancestor
6287207|NCT00250718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6287208|NCT00250718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6287209|NCT00250718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6287210|NCT00218036|Dexetimide|dexetimide|mesh-list
6287211|NCT00218036|Modafinil|modafinil|mesh-list
6287212|NCT00218036|Citalopram|citalopram|mesh-list
6287213|NCT00218036|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6287214|NCT00218036|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6287215|NCT00218036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6287216|NCT00218036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287217|NCT00218036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6287218|NCT00218036|Serotonin Agents|serotonin agents|mesh-ancestor
6287219|NCT00218036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287220|NCT00218036|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6287221|NCT00218036|Antidepressive Agents|antidepressive agents|mesh-ancestor
6287222|NCT00218036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6287223|NCT00218036|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6287224|NCT00218036|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6287225|NCT00218036|Parasympatholytics|parasympatholytics|mesh-ancestor
6287226|NCT00218036|Autonomic Agents|autonomic agents|mesh-ancestor
6287227|NCT00218036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6287228|NCT00218036|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6287229|NCT00218036|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6287230|NCT00218036|Cholinergic Agents|cholinergic agents|mesh-ancestor
6287231|NCT00218036|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6287232|NCT00218036|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6287233|NCT00218036|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6287234|NCT00218036|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6287235|NCT00240227|Prazosin|prazosin|mesh-list
6287236|NCT00240227|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6287237|NCT00240227|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6287238|NCT00240227|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6287239|NCT00240227|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6287240|NCT00240227|Adrenergic Agents|adrenergic agents|mesh-ancestor
6287241|NCT00240227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6287242|NCT00240227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287243|NCT00240227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287244|NCT00206375|Hormones|hormones|mesh-list
6287245|NCT00206375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6287246|NCT00206375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287247|NCT00229931|Triamcinolone|triamcinolone|mesh-list
6287248|NCT00229931|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6287249|NCT00229931|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6287250|NCT00229931|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6287251|NCT00229931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6287252|NCT00229931|Glucocorticoids|glucocorticoids|mesh-ancestor
6287253|NCT00229931|Hormones|hormones|mesh-ancestor
6287254|NCT00229931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6287255|NCT00229931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287256|NCT00229931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6287257|NCT00229931|Immunologic Factors|immunologic factors|mesh-ancestor
6287258|NCT00229931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6287259|NCT00229931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287260|NCT00209131|Tamsulosin|tamsulosin|mesh-list
6287261|NCT00209131|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6287262|NCT00209131|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6287263|NCT00209131|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6287264|NCT00209131|Adrenergic Agents|adrenergic agents|mesh-ancestor
6287265|NCT00209131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6287266|NCT00209131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287267|NCT00209131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287268|NCT00209131|Urological Agents|urological agents|mesh-ancestor
6287269|NCT00233090|Modafinil|modafinil|mesh-list
6287270|NCT00233090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6287271|NCT00233090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287272|NCT00233090|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6287273|NCT00233090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6287274|NCT00233090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6287275|NCT00233090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287276|NCT00205049|Pentoxifylline|pentoxifylline|mesh-list
6287277|NCT00205049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6287278|NCT00205049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6287279|NCT00205049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287280|NCT00205049|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6287281|NCT00205049|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6287282|NCT00205049|Protective Agents|protective agents|mesh-ancestor
6287283|NCT00205049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287284|NCT00205049|Vasodilator Agents|vasodilator agents|mesh-ancestor
6287285|NCT00205049|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6287286|NCT00205049|Antioxidants|antioxidants|mesh-ancestor
6287287|NCT00209027|Aripiprazole|aripiprazole|mesh-list
6287288|NCT00209027|Antidepressive Agents|antidepressive agents|mesh-ancestor
6287289|NCT00209027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6287290|NCT00209027|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6287291|NCT00209027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6287292|NCT00209027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6287293|NCT00209027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287294|NCT00209027|Dopamine Agonists|dopamine agonists|mesh-ancestor
6287295|NCT00209027|Dopamine Agents|dopamine agents|mesh-ancestor
6287296|NCT00209027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6287297|NCT00209027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287298|NCT00209027|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6287299|NCT00209027|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6287300|NCT00209027|Serotonin Agents|serotonin agents|mesh-ancestor
6287301|NCT00209027|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6287302|NCT00209027|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6287303|NCT00209027|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6287304|NCT00209027|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6287305|NCT00182637|Bortezomib|bortezomib|mesh-list
6287306|NCT00182637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6287307|NCT00176488|Vinorelbine|vinorelbine|mesh-list
6287308|NCT00176488|Epirubicin|epirubicin|mesh-list
6287309|NCT00176488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6287310|NCT00176488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6287311|NCT00176488|Tubulin Modulators|tubulin modulators|mesh-ancestor
6287312|NCT00176488|Antimitotic Agents|antimitotic agents|mesh-ancestor
6287313|NCT00176488|Mitosis Modulators|mitosis modulators|mesh-ancestor
6287314|NCT00176488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287315|NCT00176488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6287316|NCT00176488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6287317|NCT00176488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6287318|NCT00176488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6287319|NCT00179127|Insulin Glargine|insulin glargine|mesh-list
6287320|NCT00179127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6287321|NCT00179127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287322|NCT00183963|Tamoxifen|tamoxifen|mesh-list
6287323|NCT00183963|Fulvestrant|fulvestrant|mesh-list
6287324|NCT00183963|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6287325|NCT00183963|Hormone Antagonists|hormone antagonists|mesh-ancestor
6287326|NCT00183963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6287327|NCT00183963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287328|NCT00183963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6287329|NCT00183963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6287330|NCT00183963|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6287331|NCT00183963|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6287332|NCT00183963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6287333|NCT00183963|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6287334|NCT00162773|Omalizumab|omalizumab|mesh-list
6287335|NCT00162773|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6287336|NCT00162773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6287337|NCT00162773|Respiratory System Agents|respiratory system agents|mesh-ancestor
6287338|NCT00176631|Docetaxel|docetaxel|mesh-list
6287339|NCT00176631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6287340|NCT00176631|Tubulin Modulators|tubulin modulators|mesh-ancestor
6287341|NCT00176631|Antimitotic Agents|antimitotic agents|mesh-ancestor
6287342|NCT00176631|Mitosis Modulators|mitosis modulators|mesh-ancestor
6287343|NCT00176631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287344|NCT00177970|Immunoglobulins|immunoglobulins|mesh-list
6287345|NCT00177970|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6287346|NCT00177970|Antibodies|antibodies|mesh-list
6287347|NCT00177970|Immunoglobulin G|immunoglobulin g|mesh-list
6287348|NCT00177970|gamma-Globulins|gamma-globulins|mesh-list
6287349|NCT00177970|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6287350|NCT00177970|Immunologic Factors|immunologic factors|mesh-ancestor
6287351|NCT00177970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287352|NCT00177866|Celecoxib|celecoxib|mesh-list
6287353|NCT00177866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6287354|NCT00177866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6287355|NCT00177866|Analgesics|analgesics|mesh-ancestor
6287356|NCT00177866|Sensory System Agents|sensory system agents|mesh-ancestor
6287357|NCT00177866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6287358|NCT00177866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287359|NCT00177866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6287360|NCT00177866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6287361|NCT00177866|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6287362|NCT00177866|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6287363|NCT00177866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6287364|NCT00177866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287365|NCT00165503|Sodium thiosulfate|sodium thiosulfate|mesh-list
6287366|NCT00165503|Pemetrexed|pemetrexed|mesh-list
6287367|NCT00165503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6287368|NCT00165503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6287369|NCT00165503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287370|NCT00165503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6287371|NCT00165503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6287372|NCT00165503|Antidotes|antidotes|mesh-ancestor
6287373|NCT00165503|Protective Agents|protective agents|mesh-ancestor
6287374|NCT00165503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287375|NCT00165503|Antioxidants|antioxidants|mesh-ancestor
6287376|NCT00165503|Antitubercular Agents|antitubercular agents|mesh-ancestor
6287377|NCT00165503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6287378|NCT00165503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6287379|NCT00165503|Chelating Agents|chelating agents|mesh-ancestor
6287380|NCT00165503|Sequestering Agents|sequestering agents|mesh-ancestor
6287381|NCT00160563|Levocetirizine|levocetirizine|mesh-list
6287382|NCT00160563|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6287383|NCT00160563|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6287384|NCT00160563|Histamine Antagonists|histamine antagonists|mesh-ancestor
6287385|NCT00160563|Histamine Agents|histamine agents|mesh-ancestor
6287386|NCT00160563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6287387|NCT00160563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287388|NCT00160563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287389|NCT00142519|Morphine|morphine|mesh-list
6287390|NCT00142519|Methadone|methadone|mesh-list
6287391|NCT00142519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6287392|NCT00142519|Narcotics|narcotics|mesh-ancestor
6287393|NCT00142519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6287394|NCT00142519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287395|NCT00142519|Analgesics|analgesics|mesh-ancestor
6287396|NCT00142519|Sensory System Agents|sensory system agents|mesh-ancestor
6287397|NCT00142519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6287398|NCT00142519|Antitussive Agents|antitussive agents|mesh-ancestor
6287399|NCT00142519|Respiratory System Agents|respiratory system agents|mesh-ancestor
6287400|NCT00145704|Vitamin D|vitamin d|mesh-list
6287401|NCT00145704|Ergocalciferols|ergocalciferols|mesh-list
6287402|NCT00145704|Risedronic Acid|risedronic acid|mesh-list
6287403|NCT00145704|Diphosphonates|diphosphonates|mesh-list
6287404|NCT00145704|Vitamins|vitamins|mesh-list
6287405|NCT00145704|Calcium|calcium|mesh-list
6287406|NCT00145704|Micronutrients|micronutrients|mesh-ancestor
6287407|NCT00145704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287408|NCT00145704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6287409|NCT00145704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6287410|NCT00145704|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6287411|NCT00145704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6287412|NCT00145704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287413|NCT00113386|Docetaxel|docetaxel|mesh-list
6287414|NCT00113386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6287415|NCT00113386|Tubulin Modulators|tubulin modulators|mesh-ancestor
6287416|NCT00113386|Antimitotic Agents|antimitotic agents|mesh-ancestor
6287417|NCT00113386|Mitosis Modulators|mitosis modulators|mesh-ancestor
6287418|NCT00113386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287419|NCT00138151|Interferons|interferons|mesh-list
6287420|NCT00138151|Interferon-alpha|interferon-alpha|mesh-list
6287421|NCT00138151|Interferon alpha-2|interferon alpha-2|mesh-list
6287422|NCT00138151|Paclitaxel|paclitaxel|mesh-list
6287423|NCT00138151|Isotretinoin|isotretinoin|mesh-list
6287424|NCT00138151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6287425|NCT00138151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6287426|NCT00138151|Tubulin Modulators|tubulin modulators|mesh-ancestor
6287427|NCT00138151|Antimitotic Agents|antimitotic agents|mesh-ancestor
6287428|NCT00138151|Mitosis Modulators|mitosis modulators|mesh-ancestor
6287429|NCT00138151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287430|NCT00138151|Antiviral Agents|antiviral agents|mesh-ancestor
6287431|NCT00138151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6287432|NCT00138151|Immunologic Factors|immunologic factors|mesh-ancestor
6287433|NCT00138151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287434|NCT00138151|Dermatologic Agents|dermatologic agents|mesh-ancestor
6287435|NCT00129974|Gemcitabine|gemcitabine|mesh-list
6287436|NCT00129974|Pemetrexed|pemetrexed|mesh-list
6287437|NCT00129974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6287438|NCT00129974|Antimetabolites|antimetabolites|mesh-ancestor
6287439|NCT00129974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287440|NCT00129974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6287441|NCT00129974|Antiviral Agents|antiviral agents|mesh-ancestor
6287442|NCT00129974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6287443|NCT00129974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6287444|NCT00129974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6287445|NCT00129974|Immunologic Factors|immunologic factors|mesh-ancestor
6287446|NCT00129974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287447|NCT00129974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6287448|NCT00129974|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6287449|NCT00126659|Sorafenib|sorafenib|mesh-list
6287450|NCT00126659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6287451|NCT00126659|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6287452|NCT00126659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6287453|NCT00126659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287454|NCT00133679|Sildenafil Citrate|sildenafil citrate|mesh-list
6287455|NCT00133679|Vasodilator Agents|vasodilator agents|mesh-ancestor
6287456|NCT00133679|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6287457|NCT00133679|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6287458|NCT00133679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6287459|NCT00133679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287460|NCT00133679|Urological Agents|urological agents|mesh-ancestor
6391672|NCT00193856|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6391673|NCT00193856|Fertility Agents|fertility agents|mesh-ancestor
6391674|NCT00193856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6391675|NCT00193856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6391676|NCT00193856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391677|NCT00193869|Dexamethasone|dexamethasone|mesh-list
6391678|NCT00193869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6287461|NCT00113399|Paclitaxel|paclitaxel|mesh-list
6287462|NCT00113399|Docetaxel|docetaxel|mesh-list
6287463|NCT00113399|Fluorouracil|fluorouracil|mesh-list
6287464|NCT00113399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6287465|NCT00113399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6287466|NCT00113399|Tubulin Modulators|tubulin modulators|mesh-ancestor
6287467|NCT00113399|Antimitotic Agents|antimitotic agents|mesh-ancestor
6287468|NCT00113399|Mitosis Modulators|mitosis modulators|mesh-ancestor
6287469|NCT00113399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287470|NCT00113399|Antimetabolites|antimetabolites|mesh-ancestor
6287471|NCT00113399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6287472|NCT00113399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6287473|NCT00113399|Immunologic Factors|immunologic factors|mesh-ancestor
6287474|NCT00113399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287475|NCT00118053|Carboplatin|carboplatin|mesh-list
6287476|NCT00118053|Docetaxel|docetaxel|mesh-list
6287477|NCT00118053|Trastuzumab|trastuzumab|mesh-list
6287478|NCT00118053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6287479|NCT00118053|Tubulin Modulators|tubulin modulators|mesh-ancestor
6287480|NCT00118053|Antimitotic Agents|antimitotic agents|mesh-ancestor
6287481|NCT00118053|Mitosis Modulators|mitosis modulators|mesh-ancestor
6287482|NCT00118053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287483|NCT00118053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6287484|NCT00107614|Rituximab|rituximab|mesh-list
6287485|NCT00107614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6287486|NCT00107614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6287487|NCT00107614|Immunologic Factors|immunologic factors|mesh-ancestor
6287488|NCT00107614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287489|NCT00107614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6287490|NCT00107315|Bevacizumab|bevacizumab|mesh-list
6287491|NCT00107315|Capecitabine|capecitabine|mesh-list
6287492|NCT00107315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6287493|NCT00107315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6287494|NCT00107315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6287495|NCT00107315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6287496|NCT00107315|Growth Substances|growth substances|mesh-ancestor
6287497|NCT00107315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287498|NCT00107315|Growth Inhibitors|growth inhibitors|mesh-ancestor
6287499|NCT00107315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6287500|NCT00107315|Antimetabolites|antimetabolites|mesh-ancestor
6287501|NCT00107315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287502|NCT00108433|Vancomycin|vancomycin|mesh-list
6287503|NCT00108433|Cefazolin|cefazolin|mesh-list
6287504|NCT00108433|Linezolid|linezolid|mesh-list
6287505|NCT00108433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6287506|NCT00108433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6287507|NCT00108433|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6287508|NCT00108433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6287509|NCT00108433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287510|NCT00113919|Busulfan|busulfan|mesh-list
6287511|NCT00113919|Alkylating Agents|alkylating agents|mesh-ancestor
6287512|NCT00113919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287513|NCT00113919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6287514|NCT00113919|Immunologic Factors|immunologic factors|mesh-ancestor
6287515|NCT00113919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287516|NCT00113919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6287517|NCT00113919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6287518|NCT00113919|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6287519|NCT00108342|Nicotine|nicotine|mesh-list
6287520|NCT00108342|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6287521|NCT00108342|Autonomic Agents|autonomic agents|mesh-ancestor
6287522|NCT00108342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6287523|NCT00108342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287524|NCT00108342|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6287525|NCT00108342|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6287526|NCT00108342|Cholinergic Agents|cholinergic agents|mesh-ancestor
6287527|NCT00108342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6287528|NCT00108342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287529|NCT00100828|Irinotecan|irinotecan|mesh-list
6287530|NCT00100828|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6287531|NCT00100828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6287532|NCT00100828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6287533|NCT00100828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287534|NCT00100828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6287535|NCT00104728|Gefitinib|gefitinib|mesh-list
6287536|NCT00104728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6287537|NCT00104728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6287538|NCT00104728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6287539|NCT00104728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287540|NCT00089414|Drospirenone|drospirenone|mesh-list
6287541|NCT00089414|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6287542|NCT00089414|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
6287543|NCT00089414|Estradiol|estradiol|mesh-list
6287544|NCT00089414|Progesterone|progesterone|mesh-list
6287545|NCT00089414|Estrogens|estrogens|mesh-ancestor
6287546|NCT00089414|Hormones|hormones|mesh-ancestor
6287547|NCT00089414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6287548|NCT00089414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287549|NCT00089414|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6287550|NCT00089414|Contraceptive Agents|contraceptive agents|mesh-ancestor
6287551|NCT00089414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6287552|NCT00089414|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6287553|NCT00089414|Progestins|progestins|mesh-ancestor
6287554|NCT00089414|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6287555|NCT00089414|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6287556|NCT00089414|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6287557|NCT00089414|Hormone Antagonists|hormone antagonists|mesh-ancestor
6287558|NCT00089414|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6287559|NCT00089414|Diuretics|diuretics|mesh-ancestor
6287560|NCT00089414|Natriuretic Agents|natriuretic agents|mesh-ancestor
6287561|NCT00083915|Thalidomide|thalidomide|mesh-list
6287562|NCT00083915|Dexamethasone|dexamethasone|mesh-list
6287563|NCT00083915|Cyclophosphamide|cyclophosphamide|mesh-list
6287564|NCT00083915|Melphalan|melphalan|mesh-list
6287565|NCT00083915|Cisplatin|cisplatin|mesh-list
6287566|NCT00083915|Doxorubicin|doxorubicin|mesh-list
6287567|NCT00083915|Etoposide|etoposide|mesh-list
6287568|NCT00083915|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6287569|NCT00083915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6287570|NCT00083915|Immunologic Factors|immunologic factors|mesh-ancestor
6287571|NCT00083915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287572|NCT00083915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6287573|NCT00083915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6287574|NCT00083915|Alkylating Agents|alkylating agents|mesh-ancestor
6391679|NCT00193869|Antiemetics|antiemetics|mesh-ancestor
6287575|NCT00083915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287576|NCT00083915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6287577|NCT00083915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6287578|NCT00083915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6287579|NCT00083915|Antiemetics|antiemetics|mesh-ancestor
6287580|NCT00083915|Autonomic Agents|autonomic agents|mesh-ancestor
6287581|NCT00083915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6287582|NCT00083915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6287583|NCT00083915|Glucocorticoids|glucocorticoids|mesh-ancestor
6287584|NCT00083915|Hormones|hormones|mesh-ancestor
6287585|NCT00083915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6287586|NCT00083915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6287587|NCT00083915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6287588|NCT00083915|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6287589|NCT00083915|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6287590|NCT00083915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6287591|NCT00083915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6287592|NCT00083915|Leprostatic Agents|leprostatic agents|mesh-ancestor
6287593|NCT00083915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6287594|NCT00083915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6287595|NCT00083915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6287596|NCT00083915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6287597|NCT00083915|Growth Substances|growth substances|mesh-ancestor
6287598|NCT00083915|Growth Inhibitors|growth inhibitors|mesh-ancestor
6287599|NCT00090870|Interferons|interferons|mesh-list
6287600|NCT00090870|Interferon-alpha|interferon-alpha|mesh-list
6287601|NCT00090870|Interferon alpha-2|interferon alpha-2|mesh-list
6287602|NCT00090870|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6287603|NCT00090870|Thalidomide|thalidomide|mesh-list
6287604|NCT00090870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6287605|NCT00090870|Antiviral Agents|antiviral agents|mesh-ancestor
6287606|NCT00090870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6287607|NCT00090870|Immunologic Factors|immunologic factors|mesh-ancestor
6287608|NCT00090870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287609|NCT00090870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6287610|NCT00090870|Leprostatic Agents|leprostatic agents|mesh-ancestor
6287611|NCT00090870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6287612|NCT00090870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6287613|NCT00090870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6287614|NCT00090870|Growth Substances|growth substances|mesh-ancestor
6287615|NCT00090870|Growth Inhibitors|growth inhibitors|mesh-ancestor
6287616|NCT00088972|Celecoxib|celecoxib|mesh-list
6287617|NCT00088972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6287618|NCT00088972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6287619|NCT00088972|Analgesics|analgesics|mesh-ancestor
6287620|NCT00088972|Sensory System Agents|sensory system agents|mesh-ancestor
6287621|NCT00088972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6287622|NCT00088972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287623|NCT00088972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6287624|NCT00088972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6287625|NCT00088972|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6287626|NCT00088972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6287627|NCT00088972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6287628|NCT00088972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287629|NCT00088829|Paclitaxel|paclitaxel|mesh-list
6287630|NCT00088829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6287631|NCT00088829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6287632|NCT00088829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6287633|NCT00088829|Tubulin Modulators|tubulin modulators|mesh-ancestor
6287634|NCT00088829|Antimitotic Agents|antimitotic agents|mesh-ancestor
6287635|NCT00088829|Mitosis Modulators|mitosis modulators|mesh-ancestor
6287636|NCT00088829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287637|NCT00089128|Gemcitabine|gemcitabine|mesh-list
6287638|NCT00089128|Irinotecan|irinotecan|mesh-list
6287639|NCT00089128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6287640|NCT00089128|Antimetabolites|antimetabolites|mesh-ancestor
6287641|NCT00089128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287642|NCT00089128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6287643|NCT00089128|Antiviral Agents|antiviral agents|mesh-ancestor
6287644|NCT00089128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6287645|NCT00089128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6287646|NCT00089128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6287647|NCT00089128|Immunologic Factors|immunologic factors|mesh-ancestor
6287648|NCT00089128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287649|NCT00089128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6287650|NCT00089128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6287651|NCT00075608|Melphalan|melphalan|mesh-list
6287652|NCT00075608|Immunologic Factors|immunologic factors|mesh-ancestor
6287653|NCT00075608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287654|NCT00075608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6287655|NCT00075608|Alkylating Agents|alkylating agents|mesh-ancestor
6287656|NCT00075608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287657|NCT00075608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6287658|NCT00075608|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6287659|NCT00075608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6287660|NCT00074724|Dobutamine|dobutamine|mesh-list
6287661|NCT00074724|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6287662|NCT00074724|Sympathomimetics|sympathomimetics|mesh-ancestor
6287663|NCT00074724|Autonomic Agents|autonomic agents|mesh-ancestor
6287664|NCT00074724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6287665|NCT00074724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287666|NCT00074724|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6287667|NCT00074724|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6287668|NCT00074724|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6287669|NCT00074724|Adrenergic Agents|adrenergic agents|mesh-ancestor
6287670|NCT00074724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6287671|NCT00074724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287672|NCT00074724|Protective Agents|protective agents|mesh-ancestor
6287673|NCT00085631|Cisplatin|cisplatin|mesh-list
6287674|NCT00085631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6287675|NCT00062751|Sirolimus|sirolimus|mesh-list
6287676|NCT00062751|Letrozole|letrozole|mesh-list
6287677|NCT00062751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6287678|NCT00062751|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6287679|NCT00062751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6287680|NCT00062751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6287681|NCT00062751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287682|NCT00062751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6287683|NCT00062751|Hormone Antagonists|hormone antagonists|mesh-ancestor
6287684|NCT00062751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6287685|NCT00062751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287686|NCT00062751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6287687|NCT00062751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6287688|NCT00062751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6287689|NCT00062751|Antifungal Agents|antifungal agents|mesh-ancestor
6287690|NCT00062751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6287691|NCT00062751|Immunologic Factors|immunologic factors|mesh-ancestor
6287692|NCT00066807|Tamoxifen|tamoxifen|mesh-list
6287693|NCT00066807|Epirubicin|epirubicin|mesh-list
6287694|NCT00066807|Exemestane|exemestane|mesh-list
6287695|NCT00066807|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6287696|NCT00066807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6287697|NCT00066807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6287698|NCT00066807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6287699|NCT00066807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6287700|NCT00066807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6287701|NCT00066807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287702|NCT00066807|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6287703|NCT00066807|Hormone Antagonists|hormone antagonists|mesh-ancestor
6287704|NCT00066807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6287705|NCT00066807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287706|NCT00066807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6287707|NCT00066807|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6287708|NCT00066807|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6287709|NCT00066807|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6287710|NCT00066807|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6287711|NCT00066807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6287712|NCT00066807|Luteolytic Agents|luteolytic agents|mesh-ancestor
6287713|NCT00066807|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6287714|NCT00066807|Contraceptive Agents|contraceptive agents|mesh-ancestor
6287715|NCT00066807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6287716|NCT00066807|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6287717|NCT00058188|Cholecalciferol|cholecalciferol|mesh-list
6287718|NCT00058188|Zoledronic Acid|zoledronic acid|mesh-list
6287719|NCT00058188|Calcium|calcium|mesh-list
6287720|NCT00058188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6287721|NCT00058188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287722|NCT00058188|Vitamins|vitamins|mesh-ancestor
6287723|NCT00058188|Micronutrients|micronutrients|mesh-ancestor
6287724|NCT00058188|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6287725|NCT00014560|Antibodies|antibodies|mesh-list
6287726|NCT00014560|Sargramostim|sargramostim|mesh-list
6287727|NCT00014560|Antibodies, Bispecific|antibodies, bispecific|mesh-list
6287728|NCT00014560|Immunologic Factors|immunologic factors|mesh-ancestor
6287729|NCT00014560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287730|NCT00038142|Cyclophosphamide|cyclophosphamide|mesh-list
6287731|NCT00038142|Doxorubicin|doxorubicin|mesh-list
6287732|NCT00038142|Vincristine|vincristine|mesh-list
6287733|NCT00038142|Dexrazoxane|dexrazoxane|mesh-list
6287734|NCT00038142|Razoxane|razoxane|mesh-list
6287735|NCT00038142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6287736|NCT00038142|Immunologic Factors|immunologic factors|mesh-ancestor
6287737|NCT00038142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287738|NCT00038142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6287739|NCT00038142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6287740|NCT00038142|Alkylating Agents|alkylating agents|mesh-ancestor
6287741|NCT00038142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287742|NCT00038142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6287743|NCT00038142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6287744|NCT00038142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6287745|NCT00038142|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6287746|NCT00038142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6287747|NCT00038142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6287748|NCT00038142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6287749|NCT00038142|Tubulin Modulators|tubulin modulators|mesh-ancestor
6287750|NCT00038142|Antimitotic Agents|antimitotic agents|mesh-ancestor
6287751|NCT00038142|Mitosis Modulators|mitosis modulators|mesh-ancestor
6287752|NCT00038142|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6287753|NCT00038142|Protective Agents|protective agents|mesh-ancestor
6287754|NCT00020722|Cyclophosphamide|cyclophosphamide|mesh-list
6287755|NCT00020722|Ifosfamide|ifosfamide|mesh-list
6287756|NCT00020722|Thiotepa|thiotepa|mesh-list
6287757|NCT00020722|Carboplatin|carboplatin|mesh-list
6287758|NCT00020722|Etoposide|etoposide|mesh-list
6287759|NCT00020722|Etoposide phosphate|etoposide phosphate|mesh-list
6287760|NCT00020722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6287761|NCT00020722|Immunologic Factors|immunologic factors|mesh-ancestor
6287762|NCT00020722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287763|NCT00020722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6287764|NCT00020722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6287765|NCT00020722|Alkylating Agents|alkylating agents|mesh-ancestor
6287766|NCT00020722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287767|NCT00020722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6287768|NCT00020722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6287769|NCT00020722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6287770|NCT00020722|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6287771|NCT00020722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6287772|NCT00020722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6287773|NCT00002975|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6287774|NCT00002975|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6287775|NCT00002975|Dermatologic Agents|dermatologic agents|mesh-ancestor
6287776|NCT00006478|Sargramostim|sargramostim|mesh-list
6287777|NCT00006478|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
6287778|NCT00006478|Immunologic Factors|immunologic factors|mesh-ancestor
6287779|NCT00006478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287780|NCT00006478|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6287781|NCT00019747|Thalidomide|thalidomide|mesh-list
6287782|NCT00019747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6287783|NCT00019747|Immunologic Factors|immunologic factors|mesh-ancestor
6287784|NCT00019747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287785|NCT00019747|Leprostatic Agents|leprostatic agents|mesh-ancestor
6287786|NCT00019747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6287787|NCT00019747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6287788|NCT00019747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6287789|NCT00019747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6287790|NCT00019747|Growth Substances|growth substances|mesh-ancestor
6287791|NCT00019747|Growth Inhibitors|growth inhibitors|mesh-ancestor
6287792|NCT00019747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6287793|NCT00006916|Bleomycin|bleomycin|mesh-list
6287794|NCT00006916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6287795|NCT00006916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6287796|NCT00003726|Lepirudin|lepirudin|mesh-list
6287797|NCT00003726|Antithrombins|antithrombins|mesh-ancestor
6287798|NCT00003726|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6287799|NCT00003726|Protease Inhibitors|protease inhibitors|mesh-ancestor
6287800|NCT00003726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6287801|NCT00003726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287802|NCT00003726|Anticoagulants|anticoagulants|mesh-ancestor
6287803|NCT00003726|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6287804|NCT00003726|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6287805|NCT04051996|Decitabine|decitabine|mesh-list
6287806|NCT04051996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6287807|NCT04051996|Antimetabolites|antimetabolites|mesh-ancestor
6287808|NCT04051996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287809|NCT04051996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6287810|NCT04051996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6287811|NCT02126878|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6287812|NCT02126878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6287813|NCT02126878|Glucocorticoids|glucocorticoids|mesh-ancestor
6287814|NCT02126878|Hormones|hormones|mesh-ancestor
6287815|NCT02126878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6287816|NCT02126878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287817|NCT02126878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6287818|NCT02126878|Immunologic Factors|immunologic factors|mesh-ancestor
6287819|NCT02595996|Propranolol|propranolol|mesh-list
6287820|NCT02595996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6287821|NCT02595996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6287822|NCT02595996|Adrenergic Agents|adrenergic agents|mesh-ancestor
6287823|NCT02595996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6287824|NCT02595996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287825|NCT02595996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287826|NCT02595996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6287827|NCT02595996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6287828|NCT02595996|Vasodilator Agents|vasodilator agents|mesh-ancestor
6287829|NCT02009384|Ipilimumab|ipilimumab|mesh-list
6287830|NCT02009384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6287831|NCT02009384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6287832|NCT02009384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6287833|NCT02009384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287834|NCT04558125|Heparin|heparin|mesh-list
6287835|NCT04558125|Calcium heparin|calcium heparin|mesh-list
6287836|NCT04558125|Enoxaparin|enoxaparin|mesh-list
6287837|NCT04558125|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6287838|NCT04558125|Tinzaparin|tinzaparin|mesh-list
6287839|NCT04558125|Dalteparin|dalteparin|mesh-list
6287840|NCT04558125|Tenecteplase|tenecteplase|mesh-list
6287841|NCT04558125|Enoxaparin sodium|enoxaparin sodium|mesh-list
6287842|NCT04558125|Anticoagulants|anticoagulants|mesh-ancestor
6287843|NCT04558125|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6287844|NCT04558125|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6287845|NCT04558125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287846|NCT04381988|Hydroxychloroquine|hydroxychloroquine|mesh-list
6287847|NCT04381988|Antimalarials|antimalarials|mesh-ancestor
6287848|NCT04381988|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6287849|NCT04381988|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6287850|NCT04381988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6287851|NCT04381988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6287852|NCT04381988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287853|NCT04381988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6287854|NCT00521885|Enoxaparin|enoxaparin|mesh-list
6287855|NCT00521885|Fondaparinux|fondaparinux|mesh-list
6287856|NCT00521885|Anticoagulants|anticoagulants|mesh-ancestor
6287857|NCT00521885|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6287858|NCT00521885|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6287859|NCT00521885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287860|NCT00521885|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6287861|NCT00521885|Antithrombins|antithrombins|mesh-ancestor
6287862|NCT00521885|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6287863|NCT00521885|Protease Inhibitors|protease inhibitors|mesh-ancestor
6287864|NCT00521885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6287865|NCT01780636|Botulinum Toxins|botulinum toxins|mesh-list
6287866|NCT01780636|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6287867|NCT01780636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6287868|NCT01780636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287869|NCT01780636|Cholinergic Agents|cholinergic agents|mesh-ancestor
6287870|NCT01780636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6287871|NCT01780636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287872|NCT00479167|Bortezomib|bortezomib|mesh-list
6287873|NCT00479167|Tositumomab I-131|tositumomab i-131|mesh-list
6287874|NCT00479167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6287875|NCT02212574|Cyclophosphamide|cyclophosphamide|mesh-list
6287876|NCT02212574|Lomustine|lomustine|mesh-list
6287877|NCT02212574|Vincristine|vincristine|mesh-list
6287878|NCT02212574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6287879|NCT02212574|Immunologic Factors|immunologic factors|mesh-ancestor
6287880|NCT02212574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287881|NCT02212574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6287882|NCT02212574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6287883|NCT02212574|Alkylating Agents|alkylating agents|mesh-ancestor
6287884|NCT02212574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287885|NCT02212574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6287886|NCT02212574|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6287887|NCT02212574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6287888|NCT02212574|Tubulin Modulators|tubulin modulators|mesh-ancestor
6287889|NCT02212574|Antimitotic Agents|antimitotic agents|mesh-ancestor
6287890|NCT02212574|Mitosis Modulators|mitosis modulators|mesh-ancestor
6287891|NCT04422210|Carboplatin|carboplatin|mesh-list
6287892|NCT04422210|Etoposide|etoposide|mesh-list
6287893|NCT04422210|Atezolizumab|atezolizumab|mesh-list
6287894|NCT04422210|Venetoclax|venetoclax|mesh-list
6287895|NCT04422210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6287896|NCT04422210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6287897|NCT04422210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6287898|NCT04422210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6287899|NCT04422210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6287900|NCT04422210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287901|NCT04298918|Trastuzumab|trastuzumab|mesh-list
6287902|NCT04298918|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
6287903|NCT04298918|Venetoclax|venetoclax|mesh-list
6287904|NCT04298918|Maytansine|maytansine|mesh-list
6287905|NCT04298918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6287906|NCT04298918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6287907|NCT04298918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6287908|NCT04298918|Tubulin Modulators|tubulin modulators|mesh-ancestor
6287909|NCT04298918|Antimitotic Agents|antimitotic agents|mesh-ancestor
6287910|NCT04298918|Mitosis Modulators|mitosis modulators|mesh-ancestor
6287911|NCT04298918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287912|NCT01561378|Insulin Aspart|insulin aspart|mesh-list
6287913|NCT01561378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6287914|NCT01561378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287915|NCT00955929|Sildenafil Citrate|sildenafil citrate|mesh-list
6287916|NCT00955929|Alprostadil|alprostadil|mesh-list
6287917|NCT00955929|Vasodilator Agents|vasodilator agents|mesh-ancestor
6287918|NCT00955929|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6287919|NCT00955929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6287920|NCT00955929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6287921|NCT00955929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287922|NCT00955929|Urological Agents|urological agents|mesh-ancestor
6287923|NCT00955929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6287924|NCT00402883|Folic Acid|folic acid|mesh-list
6287925|NCT00402883|Vitamin B 12|vitamin b 12|mesh-list
6287926|NCT00402883|Hydroxocobalamin|hydroxocobalamin|mesh-list
6287927|NCT00402883|Bevacizumab|bevacizumab|mesh-list
6287928|NCT00402883|Carboplatin|carboplatin|mesh-list
6287929|NCT00402883|Pemetrexed|pemetrexed|mesh-list
6287930|NCT00402883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6287931|NCT00402883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6287932|NCT00402883|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6287933|NCT00402883|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6287934|NCT00402883|Growth Substances|growth substances|mesh-ancestor
6287935|NCT00402883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287936|NCT00402883|Growth Inhibitors|growth inhibitors|mesh-ancestor
6287937|NCT00402883|Vitamins|vitamins|mesh-ancestor
6287938|NCT00402883|Micronutrients|micronutrients|mesh-ancestor
6287939|NCT00402883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6287940|NCT00402883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287941|NCT00402883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6287942|NCT00402883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6287943|NCT00402883|Hematinics|hematinics|mesh-ancestor
6287944|NCT00402883|Vitamin B Complex|vitamin b complex|mesh-ancestor
6287945|NCT02934503|Carboplatin|carboplatin|mesh-list
6287946|NCT02934503|Pembrolizumab|pembrolizumab|mesh-list
6287947|NCT02934503|Etoposide|etoposide|mesh-list
6287948|NCT02934503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6287949|NCT02934503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6287950|NCT02934503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6287951|NCT02934503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6287952|NCT02934503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6287953|NCT02934503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6287954|NCT02934503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287955|NCT02137252|Naltrexone|naltrexone|mesh-list
6287956|NCT02137252|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6287957|NCT02137252|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6287958|NCT02137252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287959|NCT02137252|Sensory System Agents|sensory system agents|mesh-ancestor
6287960|NCT02137252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6287961|NCT01294670|Etoposide|etoposide|mesh-list
6287962|NCT01294670|Vorinostat|vorinostat|mesh-list
6287963|NCT01294670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6287964|NCT01294670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6287965|NCT01294670|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6287966|NCT01294670|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6287967|NCT01294670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6287968|NCT01294670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287969|NCT01294670|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6287970|NCT03095287|Factor VIII|factor viii|mesh-list
6287971|NCT03095287|Coagulants|coagulants|mesh-ancestor
6287972|NCT02930122|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6287973|NCT02930122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6287974|NCT00000105|Freund's Adjuvant|freund's adjuvant|mesh-list
6287975|NCT00000105|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
6287976|NCT00000105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6287977|NCT00000105|Immunologic Factors|immunologic factors|mesh-ancestor
6287978|NCT00000105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287979|NCT00000114|Vitamins|vitamins|mesh-list
6287980|NCT00000114|Vitamin E|vitamin e|mesh-list
6287981|NCT00000114|Vitamin A|vitamin a|mesh-list
6287982|NCT00000114|Micronutrients|micronutrients|mesh-ancestor
6287983|NCT00000114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287984|NCT00000114|Antioxidants|antioxidants|mesh-ancestor
6287985|NCT00000114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287986|NCT00000114|Protective Agents|protective agents|mesh-ancestor
6287987|NCT00000115|Acetazolamide|acetazolamide|mesh-list
6287988|NCT00000115|Anticonvulsants|anticonvulsants|mesh-ancestor
6287989|NCT00000115|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6287990|NCT00000115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6287991|NCT00000115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6287992|NCT00000115|Diuretics|diuretics|mesh-ancestor
6287993|NCT00000115|Natriuretic Agents|natriuretic agents|mesh-ancestor
6287994|NCT00000115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287995|NCT00000116|Vitamin A|vitamin a|mesh-list
6287996|NCT00000116|Vitamins|vitamins|mesh-ancestor
6287997|NCT00000116|Micronutrients|micronutrients|mesh-ancestor
6287998|NCT00000116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6287999|NCT00000117|Immunoglobulins|immunoglobulins|mesh-list
6288000|NCT00000117|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6288001|NCT00000117|Antibodies|antibodies|mesh-list
6288002|NCT00000117|Immunologic Factors|immunologic factors|mesh-ancestor
6288003|NCT00000117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288004|NCT00000119|Heparin|heparin|mesh-list
6288005|NCT00000119|Anticoagulants|anticoagulants|mesh-ancestor
6288006|NCT00000119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6288007|NCT00000119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6288008|NCT00000119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6288009|NCT00000120|Erythromycin|erythromycin|mesh-list
6288010|NCT00000120|Erythromycin Estolate|erythromycin estolate|mesh-list
6288011|NCT00000120|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
6288012|NCT00000120|Erythromycin stearate|erythromycin stearate|mesh-list
6288013|NCT00000120|Silver Nitrate|silver nitrate|mesh-list
6288014|NCT00000120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6288015|NCT00000120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6288016|NCT00000120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6288017|NCT00000120|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6288018|NCT00000120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6288019|NCT00000120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6288020|NCT00000120|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6288021|NCT00000122|Fluorouracil|fluorouracil|mesh-list
6288022|NCT00000122|Antimetabolites|antimetabolites|mesh-ancestor
6288023|NCT00000122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6288024|NCT00000122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6288025|NCT00000122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6288026|NCT00000122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6288027|NCT00000122|Immunologic Factors|immunologic factors|mesh-ancestor
6288028|NCT00000122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288029|NCT00000123|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
6288030|NCT00000123|Vasodilator Agents|vasodilator agents|mesh-ancestor
6288031|NCT00000123|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
6288032|NCT00000123|Protective Agents|protective agents|mesh-ancestor
6288033|NCT00000123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6391680|NCT00193869|Autonomic Agents|autonomic agents|mesh-ancestor
6391681|NCT00193869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6391682|NCT00193869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6391683|NCT00193869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6391684|NCT00193869|Glucocorticoids|glucocorticoids|mesh-ancestor
6391685|NCT00193869|Hormones|hormones|mesh-ancestor
6391686|NCT00193869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6391687|NCT00193869|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6391688|NCT00193869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391689|NCT00193882|Cisplatin|cisplatin|mesh-list
6391690|NCT00193882|Fluorouracil|fluorouracil|mesh-list
6391691|NCT00193882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391692|NCT00193882|Antimetabolites|antimetabolites|mesh-ancestor
6391693|NCT00193882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391694|NCT00193882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6391695|NCT00193882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6391696|NCT00193882|Immunologic Factors|immunologic factors|mesh-ancestor
6288034|NCT00000130|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6288035|NCT00000130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6288036|NCT00000132|Betaxolol|betaxolol|mesh-list
6288037|NCT00000132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6288038|NCT00000132|Sympatholytics|sympatholytics|mesh-ancestor
6288039|NCT00000132|Autonomic Agents|autonomic agents|mesh-ancestor
6288040|NCT00000132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288041|NCT00000132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288042|NCT00000132|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6288043|NCT00000132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6288044|NCT00000132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6288045|NCT00000132|Adrenergic Agents|adrenergic agents|mesh-ancestor
6288046|NCT00000132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6288047|NCT00000132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6288048|NCT00000138|Acyclovir|acyclovir|mesh-list
6288049|NCT00000138|Prednisolone|prednisolone|mesh-list
6288050|NCT00000138|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6288051|NCT00000138|Methylprednisolone|methylprednisolone|mesh-list
6288052|NCT00000138|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6288053|NCT00000138|Prednisolone acetate|prednisolone acetate|mesh-list
6288054|NCT00000138|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6288055|NCT00000138|Prednisolone phosphate|prednisolone phosphate|mesh-list
6288056|NCT00000138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6288057|NCT00000138|Glucocorticoids|glucocorticoids|mesh-ancestor
6288058|NCT00000138|Hormones|hormones|mesh-ancestor
6288059|NCT00000138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6288060|NCT00000138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288061|NCT00000138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6288062|NCT00000138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6288063|NCT00000138|Antiemetics|antiemetics|mesh-ancestor
6288064|NCT00000138|Autonomic Agents|autonomic agents|mesh-ancestor
6288065|NCT00000138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288066|NCT00000138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6288067|NCT00000138|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6288068|NCT00000138|Protective Agents|protective agents|mesh-ancestor
6288069|NCT00000138|Antiviral Agents|antiviral agents|mesh-ancestor
6288070|NCT00000138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6288071|NCT00000139|Acyclovir|acyclovir|mesh-list
6288072|NCT00000139|Antiviral Agents|antiviral agents|mesh-ancestor
6288073|NCT00000139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6288074|NCT00000145|Zinc|zinc|mesh-list
6288075|NCT00000145|Antioxidants|antioxidants|mesh-list
6288076|NCT00000145|Trace Elements|trace elements|mesh-ancestor
6288077|NCT00000145|Micronutrients|micronutrients|mesh-ancestor
6288078|NCT00000145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288079|NCT00000145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6288080|NCT00000145|Protective Agents|protective agents|mesh-ancestor
6288081|NCT00000146|Prednisone|prednisone|mesh-list
6288082|NCT00000146|Methylprednisolone|methylprednisolone|mesh-list
6288083|NCT00000146|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6288084|NCT00000146|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6288085|NCT00000146|Prednisolone|prednisolone|mesh-list
6288086|NCT00000146|Prednisolone acetate|prednisolone acetate|mesh-list
6288087|NCT00000146|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6288088|NCT00000146|Prednisolone phosphate|prednisolone phosphate|mesh-list
6288089|NCT00000146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6288090|NCT00000146|Glucocorticoids|glucocorticoids|mesh-ancestor
6288091|NCT00000146|Hormones|hormones|mesh-ancestor
6288092|NCT00000146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6288093|NCT00000146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288094|NCT00000146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6288095|NCT00000146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6288096|NCT00000146|Antiemetics|antiemetics|mesh-ancestor
6288097|NCT00000146|Autonomic Agents|autonomic agents|mesh-ancestor
6288098|NCT00000146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288099|NCT00000146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6288100|NCT00000146|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6288101|NCT00000146|Protective Agents|protective agents|mesh-ancestor
6288102|NCT00000147|Prednisone|prednisone|mesh-list
6288103|NCT00000147|Methylprednisolone|methylprednisolone|mesh-list
6288104|NCT00000147|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6288105|NCT00000147|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6288106|NCT00000147|Prednisolone|prednisolone|mesh-list
6288107|NCT00000147|Prednisolone acetate|prednisolone acetate|mesh-list
6288108|NCT00000147|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6288109|NCT00000147|Prednisolone phosphate|prednisolone phosphate|mesh-list
6288110|NCT00000147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6288111|NCT00000147|Glucocorticoids|glucocorticoids|mesh-ancestor
6288112|NCT00000147|Hormones|hormones|mesh-ancestor
6288113|NCT00000147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6288114|NCT00000147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288115|NCT00000147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6288116|NCT00000147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6288117|NCT00000147|Antiemetics|antiemetics|mesh-ancestor
6288118|NCT00000147|Autonomic Agents|autonomic agents|mesh-ancestor
6288119|NCT00000147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288120|NCT00000147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6288121|NCT00000147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6288122|NCT00000147|Protective Agents|protective agents|mesh-ancestor
6288123|NCT00000149|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
6288124|NCT00000149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6288125|NCT00000149|Adrenergic Agents|adrenergic agents|mesh-ancestor
6288126|NCT00000149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6288127|NCT00000149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6288128|NCT00000149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288129|NCT00000151|Aspirin|aspirin|mesh-list
6288130|NCT00000151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6288131|NCT00000151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6288132|NCT00000151|Analgesics|analgesics|mesh-ancestor
6288133|NCT00000151|Sensory System Agents|sensory system agents|mesh-ancestor
6288134|NCT00000151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288135|NCT00000151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288136|NCT00000151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6288137|NCT00000151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6288138|NCT00000151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6288139|NCT00000151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6288140|NCT00000151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6288141|NCT00000151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6288142|NCT00000151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6288143|NCT00000151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6288144|NCT00000151|Antipyretics|antipyretics|mesh-ancestor
6288145|NCT00000152|Aspirin|aspirin|mesh-list
6288146|NCT00000152|Beta Carotene|beta carotene|mesh-list
6288147|NCT00000152|Carotenoids|carotenoids|mesh-list
6288148|NCT00000152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6288149|NCT00000152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6288150|NCT00000152|Analgesics|analgesics|mesh-ancestor
6288151|NCT00000152|Sensory System Agents|sensory system agents|mesh-ancestor
6288152|NCT00000152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288153|NCT00000152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288154|NCT00000152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6288155|NCT00000152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6288156|NCT00000152|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6288157|NCT00000152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6288158|NCT00000152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6288159|NCT00000152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6288160|NCT00000152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6288161|NCT00000152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6288162|NCT00000152|Antipyretics|antipyretics|mesh-ancestor
6288163|NCT00000152|Antioxidants|antioxidants|mesh-ancestor
6288164|NCT00000152|Protective Agents|protective agents|mesh-ancestor
6288165|NCT00000152|Provitamins|provitamins|mesh-ancestor
6288166|NCT00000152|Vitamins|vitamins|mesh-ancestor
6288167|NCT00000152|Micronutrients|micronutrients|mesh-ancestor
6288168|NCT00000157|Aspirin|aspirin|mesh-list
6288169|NCT00000157|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6288170|NCT00000157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6288171|NCT00000157|Analgesics|analgesics|mesh-ancestor
6288172|NCT00000157|Sensory System Agents|sensory system agents|mesh-ancestor
6288173|NCT00000157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288174|NCT00000157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288175|NCT00000157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6288176|NCT00000157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6288177|NCT00000157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6288178|NCT00000157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6288179|NCT00000157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6288180|NCT00000157|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6288181|NCT00000157|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6288182|NCT00000157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6288183|NCT00000157|Antipyretics|antipyretics|mesh-ancestor
6288184|NCT00000160|Xenon|xenon|mesh-list
6288185|NCT00000160|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6288186|NCT00000160|Anesthetics, General|anesthetics, general|mesh-ancestor
6288187|NCT00000160|Anesthetics|anesthetics|mesh-ancestor
6288188|NCT00000160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288189|NCT00000160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288190|NCT00000161|Aspirin|aspirin|mesh-list
6288191|NCT00000161|Vitamins|vitamins|mesh-list
6288192|NCT00000161|Ascorbic Acid|ascorbic acid|mesh-list
6288193|NCT00000161|Vitamin E|vitamin e|mesh-list
6288194|NCT00000161|Beta Carotene|beta carotene|mesh-list
6288195|NCT00000161|Carotenoids|carotenoids|mesh-list
6288196|NCT00000161|Micronutrients|micronutrients|mesh-ancestor
6288197|NCT00000161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288198|NCT00000161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6288199|NCT00000161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6288200|NCT00000161|Analgesics|analgesics|mesh-ancestor
6288201|NCT00000161|Sensory System Agents|sensory system agents|mesh-ancestor
6288202|NCT00000161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288203|NCT00000161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6288204|NCT00000161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6288205|NCT00000161|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6288206|NCT00000161|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6288207|NCT00000161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6288208|NCT00000161|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6288209|NCT00000161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6288210|NCT00000161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6288211|NCT00000161|Antipyretics|antipyretics|mesh-ancestor
6288212|NCT00000161|Antioxidants|antioxidants|mesh-ancestor
6288213|NCT00000161|Protective Agents|protective agents|mesh-ancestor
6288214|NCT00000161|Provitamins|provitamins|mesh-ancestor
6288215|NCT00000170|Atropine|atropine|mesh-list
6288216|NCT00000170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6288217|NCT00000170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6288218|NCT00000170|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6288219|NCT00000170|Autonomic Agents|autonomic agents|mesh-ancestor
6288220|NCT00000170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288221|NCT00000170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288222|NCT00000170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6288223|NCT00000170|Respiratory System Agents|respiratory system agents|mesh-ancestor
6288224|NCT00000170|Mydriatics|mydriatics|mesh-ancestor
6288225|NCT00000170|Parasympatholytics|parasympatholytics|mesh-ancestor
6288226|NCT00000170|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6288227|NCT00000170|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6288228|NCT00000170|Cholinergic Agents|cholinergic agents|mesh-ancestor
6288229|NCT00000170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6288230|NCT00000170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6288231|NCT00000171|Melatonin|melatonin|mesh-list
6288232|NCT00000171|Antioxidants|antioxidants|mesh-ancestor
6288233|NCT00000171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6288234|NCT00000171|Protective Agents|protective agents|mesh-ancestor
6288235|NCT00000171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288236|NCT00000171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288237|NCT00000172|Galantamine|galantamine|mesh-list
6288238|NCT00000172|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6288239|NCT00000172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6288240|NCT00000172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6288241|NCT00000172|Cholinergic Agents|cholinergic agents|mesh-ancestor
6288242|NCT00000172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6288243|NCT00000172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288244|NCT00000172|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6288245|NCT00000172|Autonomic Agents|autonomic agents|mesh-ancestor
6288246|NCT00000172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288247|NCT00000172|Nootropic Agents|nootropic agents|mesh-ancestor
6288248|NCT00000173|Vitamin E|vitamin e|mesh-list
6288249|NCT00000173|Donepezil|donepezil|mesh-list
6288250|NCT00000173|Vitamins|vitamins|mesh-ancestor
6288251|NCT00000173|Micronutrients|micronutrients|mesh-ancestor
6288252|NCT00000173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288253|NCT00000173|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6288254|NCT00000173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6288255|NCT00000173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6288256|NCT00000173|Cholinergic Agents|cholinergic agents|mesh-ancestor
6288257|NCT00000173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6288258|NCT00000173|Nootropic Agents|nootropic agents|mesh-ancestor
6288259|NCT00000173|Antioxidants|antioxidants|mesh-ancestor
6288260|NCT00000173|Protective Agents|protective agents|mesh-ancestor
6288261|NCT00000174|Rivastigmine|rivastigmine|mesh-list
6288262|NCT00000174|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6288263|NCT00000174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6288264|NCT00000174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6288265|NCT00000174|Cholinergic Agents|cholinergic agents|mesh-ancestor
6288266|NCT00000174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6288267|NCT00000174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288268|NCT00000174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6288269|NCT00000174|Protective Agents|protective agents|mesh-ancestor
6288270|NCT00000175|Testosterone|testosterone|mesh-list
6288271|NCT00000175|Estrogens|estrogens|mesh-list
6288272|NCT00000175|Androgens|androgens|mesh-ancestor
6288273|NCT00000175|Hormones|hormones|mesh-ancestor
6288274|NCT00000175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6288275|NCT00000175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288276|NCT00000176|Progesterone|progesterone|mesh-list
6288277|NCT00000176|Estrogens|estrogens|mesh-list
6288278|NCT00000176|Progestins|progestins|mesh-ancestor
6288279|NCT00000176|Hormones|hormones|mesh-ancestor
6288280|NCT00000176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6288281|NCT00000176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288282|NCT00000177|Estrogens|estrogens|mesh-list
6288283|NCT00000177|Hormones|hormones|mesh-ancestor
6288284|NCT00000177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6288285|NCT00000177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288286|NCT00000178|Prednisone|prednisone|mesh-list
6288287|NCT00000178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6288288|NCT00000178|Glucocorticoids|glucocorticoids|mesh-ancestor
6288289|NCT00000178|Hormones|hormones|mesh-ancestor
6288290|NCT00000178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6288291|NCT00000178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288292|NCT00000178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6288293|NCT00000178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6288294|NCT00000179|Haloperidol|haloperidol|mesh-list
6288295|NCT00000179|Haloperidol decanoate|haloperidol decanoate|mesh-list
6288296|NCT00000179|Trazodone|trazodone|mesh-list
6288297|NCT00000179|Antiemetics|antiemetics|mesh-ancestor
6288298|NCT00000179|Autonomic Agents|autonomic agents|mesh-ancestor
6288299|NCT00000179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288300|NCT00000179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288301|NCT00000179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6288302|NCT00000179|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6288303|NCT00000179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6288304|NCT00000179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288305|NCT00000179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6288306|NCT00000179|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6288307|NCT00000179|Dopamine Agents|dopamine agents|mesh-ancestor
6288308|NCT00000179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6288309|NCT00000179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6288310|NCT00000179|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6288311|NCT00000179|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6288312|NCT00000179|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6288313|NCT00000179|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6288314|NCT00000179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6288315|NCT00000179|Serotonin Agents|serotonin agents|mesh-ancestor
6288316|NCT00000179|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6288317|NCT00000179|Antidepressive Agents|antidepressive agents|mesh-ancestor
6288318|NCT00000187|Ritanserin|ritanserin|mesh-list
6288319|NCT00000187|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6288320|NCT00000187|Serotonin Agents|serotonin agents|mesh-ancestor
6288321|NCT00000187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6288322|NCT00000187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6288323|NCT00000187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288324|NCT00000187|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6288325|NCT00000187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6288326|NCT00000187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288327|NCT00000187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6288328|NCT00000187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6288329|NCT00000187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6288330|NCT00000187|Antidepressive Agents|antidepressive agents|mesh-ancestor
6288331|NCT00000188|Selegiline|selegiline|mesh-list
6288332|NCT00000188|Antidepressive Agents|antidepressive agents|mesh-ancestor
6288333|NCT00000188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6288334|NCT00000188|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6288335|NCT00000188|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6288336|NCT00000188|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6288337|NCT00000188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6288338|NCT00000188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6288339|NCT00000188|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6288340|NCT00000188|Protective Agents|protective agents|mesh-ancestor
6288341|NCT00000188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288342|NCT00000189|Gepirone|gepirone|mesh-list
6288343|NCT00000189|Antidepressive Agents|antidepressive agents|mesh-ancestor
6288344|NCT00000189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6288345|NCT00000189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6288346|NCT00000189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6288347|NCT00000189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288348|NCT00000189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288349|NCT00000189|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6288350|NCT00000189|Serotonin Agents|serotonin agents|mesh-ancestor
6288351|NCT00000189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6288352|NCT00000189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6288353|NCT00000191|Carbamazepine|carbamazepine|mesh-list
6288354|NCT00000191|Anticonvulsants|anticonvulsants|mesh-ancestor
6288355|NCT00000191|Antimanic Agents|antimanic agents|mesh-ancestor
6288356|NCT00000191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6288357|NCT00000191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288358|NCT00000191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288359|NCT00000191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6288360|NCT00000191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6288361|NCT00000191|Analgesics|analgesics|mesh-ancestor
6288362|NCT00000191|Sensory System Agents|sensory system agents|mesh-ancestor
6288363|NCT00000191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288364|NCT00000191|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6288365|NCT00000191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6288366|NCT00000191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6288367|NCT00000191|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6288368|NCT00000191|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6288369|NCT00000192|Lamotrigine|lamotrigine|mesh-list
6288370|NCT00000192|Anticonvulsants|anticonvulsants|mesh-ancestor
6288371|NCT00000192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6288372|NCT00000192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6288373|NCT00000192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6288374|NCT00000192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6288375|NCT00000192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288376|NCT00000192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6288377|NCT00000192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6288378|NCT00000192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288379|NCT00000192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6288380|NCT00000192|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6288381|NCT00000194|Cycloserine|cycloserine|mesh-list
6288382|NCT00000194|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6288383|NCT00000194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6288384|NCT00000194|Renal Agents|renal agents|mesh-ancestor
6288385|NCT00000194|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6288386|NCT00000194|Antitubercular Agents|antitubercular agents|mesh-ancestor
6288387|NCT00000194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6288388|NCT00000194|Antimetabolites|antimetabolites|mesh-ancestor
6288389|NCT00000194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6288390|NCT00000195|Naltrexone|naltrexone|mesh-list
6288391|NCT00000195|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6288392|NCT00000195|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6288393|NCT00000195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288394|NCT00000195|Sensory System Agents|sensory system agents|mesh-ancestor
6288395|NCT00000195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288396|NCT00000196|Naltrexone|naltrexone|mesh-list
6288397|NCT00000196|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6288398|NCT00000196|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6288399|NCT00000196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288400|NCT00000196|Sensory System Agents|sensory system agents|mesh-ancestor
6288401|NCT00000196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288402|NCT00000197|Propranolol|propranolol|mesh-list
6288403|NCT00000197|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6288404|NCT00000197|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6288405|NCT00000197|Adrenergic Agents|adrenergic agents|mesh-ancestor
6288406|NCT00000197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6288407|NCT00000197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6288408|NCT00000197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288409|NCT00000197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6288410|NCT00000197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6288411|NCT00000197|Vasodilator Agents|vasodilator agents|mesh-ancestor
6288412|NCT00000198|Piracetam|piracetam|mesh-list
6288413|NCT00000198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6288414|NCT00000198|Protective Agents|protective agents|mesh-ancestor
6288415|NCT00000198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288416|NCT00000198|Nootropic Agents|nootropic agents|mesh-ancestor
6288417|NCT00000199|Piracetam|piracetam|mesh-list
6288418|NCT00000199|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6288419|NCT00000199|Protective Agents|protective agents|mesh-ancestor
6288420|NCT00000199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288421|NCT00000199|Nootropic Agents|nootropic agents|mesh-ancestor
6288422|NCT00000200|Methadone|methadone|mesh-list
6288423|NCT00000200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6288424|NCT00000200|Narcotics|narcotics|mesh-ancestor
6288425|NCT00000200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288426|NCT00000200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288427|NCT00000200|Analgesics|analgesics|mesh-ancestor
6288428|NCT00000200|Sensory System Agents|sensory system agents|mesh-ancestor
6288429|NCT00000200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288430|NCT00000200|Antitussive Agents|antitussive agents|mesh-ancestor
6288431|NCT00000200|Respiratory System Agents|respiratory system agents|mesh-ancestor
6288432|NCT00000201|Selegiline|selegiline|mesh-list
6288433|NCT00000201|Antidepressive Agents|antidepressive agents|mesh-ancestor
6288434|NCT00000201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6288435|NCT00000201|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6288436|NCT00000201|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6288437|NCT00000201|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6288438|NCT00000201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6288439|NCT00000201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6288440|NCT00000201|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6288441|NCT00000201|Protective Agents|protective agents|mesh-ancestor
6288442|NCT00000201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288443|NCT00000202|Buprenorphine|buprenorphine|mesh-list
6288444|NCT00000202|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6288445|NCT00000202|Narcotics|narcotics|mesh-ancestor
6288446|NCT00000202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288447|NCT00000202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288448|NCT00000202|Analgesics|analgesics|mesh-ancestor
6288449|NCT00000202|Sensory System Agents|sensory system agents|mesh-ancestor
6288450|NCT00000202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288451|NCT00000202|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6288452|NCT00000203|Buprenorphine|buprenorphine|mesh-list
6288453|NCT00000203|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6288454|NCT00000203|Narcotics|narcotics|mesh-ancestor
6288455|NCT00000203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288456|NCT00000203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288457|NCT00000203|Analgesics|analgesics|mesh-ancestor
6288458|NCT00000203|Sensory System Agents|sensory system agents|mesh-ancestor
6288459|NCT00000203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288460|NCT00000203|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6288461|NCT00000204|Buprenorphine|buprenorphine|mesh-list
6288462|NCT00000204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6288463|NCT00000204|Narcotics|narcotics|mesh-ancestor
6288464|NCT00000204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288465|NCT00000204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288466|NCT00000204|Analgesics|analgesics|mesh-ancestor
6288467|NCT00000204|Sensory System Agents|sensory system agents|mesh-ancestor
6288468|NCT00000204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288469|NCT00000204|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6288470|NCT00000205|Buprenorphine|buprenorphine|mesh-list
6288471|NCT00000205|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6288472|NCT00000205|Narcotics|narcotics|mesh-ancestor
6288473|NCT00000205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288474|NCT00000205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288475|NCT00000205|Analgesics|analgesics|mesh-ancestor
6288476|NCT00000205|Sensory System Agents|sensory system agents|mesh-ancestor
6288477|NCT00000205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288478|NCT00000205|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6288479|NCT00000206|Buprenorphine|buprenorphine|mesh-list
6288480|NCT00000206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6288481|NCT00000206|Narcotics|narcotics|mesh-ancestor
6288482|NCT00000206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288483|NCT00000206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288484|NCT00000206|Analgesics|analgesics|mesh-ancestor
6288485|NCT00000206|Sensory System Agents|sensory system agents|mesh-ancestor
6288486|NCT00000206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288487|NCT00000206|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6288488|NCT00000207|Buprenorphine|buprenorphine|mesh-list
6288489|NCT00000207|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6288490|NCT00000207|Narcotics|narcotics|mesh-ancestor
6288491|NCT00000207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288492|NCT00000207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288493|NCT00000207|Analgesics|analgesics|mesh-ancestor
6288494|NCT00000207|Sensory System Agents|sensory system agents|mesh-ancestor
6288495|NCT00000207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288496|NCT00000207|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6288497|NCT00000208|Buprenorphine|buprenorphine|mesh-list
6288498|NCT00000208|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6288499|NCT00000208|Narcotics|narcotics|mesh-ancestor
6288500|NCT00000208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288501|NCT00000208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288502|NCT00000208|Analgesics|analgesics|mesh-ancestor
6288503|NCT00000208|Sensory System Agents|sensory system agents|mesh-ancestor
6288504|NCT00000208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288505|NCT00000208|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6288506|NCT00000209|Buprenorphine|buprenorphine|mesh-list
6288507|NCT00000209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6288508|NCT00000209|Narcotics|narcotics|mesh-ancestor
6288509|NCT00000209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288510|NCT00000209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288511|NCT00000209|Analgesics|analgesics|mesh-ancestor
6288512|NCT00000209|Sensory System Agents|sensory system agents|mesh-ancestor
6288513|NCT00000209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288514|NCT00000209|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6288515|NCT00000210|Buprenorphine|buprenorphine|mesh-list
6288516|NCT00000210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6288517|NCT00000210|Narcotics|narcotics|mesh-ancestor
6288518|NCT00000210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288519|NCT00000210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288520|NCT00000210|Analgesics|analgesics|mesh-ancestor
6288521|NCT00000210|Sensory System Agents|sensory system agents|mesh-ancestor
6288522|NCT00000210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288523|NCT00000210|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6288524|NCT00000211|Buprenorphine|buprenorphine|mesh-list
6288525|NCT00000211|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6288526|NCT00000211|Narcotics|narcotics|mesh-ancestor
6288527|NCT00000211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288528|NCT00000211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288529|NCT00000211|Analgesics|analgesics|mesh-ancestor
6288530|NCT00000211|Sensory System Agents|sensory system agents|mesh-ancestor
6288531|NCT00000211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288532|NCT00000211|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6288533|NCT00000212|Desipramine|desipramine|mesh-list
6288534|NCT00000212|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6288535|NCT00000212|Antidepressive Agents|antidepressive agents|mesh-ancestor
6288536|NCT00000212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6288537|NCT00000212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6288538|NCT00000212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6288539|NCT00000212|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6288540|NCT00000212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6288541|NCT00000212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6288542|NCT00000212|Adrenergic Agents|adrenergic agents|mesh-ancestor
6288543|NCT00000212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6288544|NCT00000212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288545|NCT00000213|Fluoxetine|fluoxetine|mesh-list
6288546|NCT00000213|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6288547|NCT00000213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6288548|NCT00000213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6288549|NCT00000213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6288550|NCT00000213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6288551|NCT00000213|Serotonin Agents|serotonin agents|mesh-ancestor
6288552|NCT00000213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288553|NCT00000213|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6288554|NCT00000213|Antidepressive Agents|antidepressive agents|mesh-ancestor
6288555|NCT00000213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6288556|NCT00000213|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6288557|NCT00000213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6288558|NCT00000213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6288559|NCT00000214|Buprenorphine|buprenorphine|mesh-list
6288560|NCT00000214|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6288561|NCT00000214|Narcotics|narcotics|mesh-ancestor
6288562|NCT00000214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288563|NCT00000214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288564|NCT00000214|Analgesics|analgesics|mesh-ancestor
6288565|NCT00000214|Sensory System Agents|sensory system agents|mesh-ancestor
6288566|NCT00000214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288567|NCT00000214|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6288568|NCT00000215|Pergolide|pergolide|mesh-list
6288569|NCT00000215|Dopamine Agonists|dopamine agonists|mesh-ancestor
6288570|NCT00000215|Dopamine Agents|dopamine agents|mesh-ancestor
6288571|NCT00000215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6288572|NCT00000215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6288573|NCT00000215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288574|NCT00000216|Buprenorphine|buprenorphine|mesh-list
6288575|NCT00000216|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6288576|NCT00000216|Narcotics|narcotics|mesh-ancestor
6288577|NCT00000216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288578|NCT00000216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288579|NCT00000216|Analgesics|analgesics|mesh-ancestor
6288580|NCT00000216|Sensory System Agents|sensory system agents|mesh-ancestor
6288581|NCT00000216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288582|NCT00000216|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6288583|NCT00000217|Carbamazepine|carbamazepine|mesh-list
6288584|NCT00000217|Anticonvulsants|anticonvulsants|mesh-ancestor
6288585|NCT00000217|Antimanic Agents|antimanic agents|mesh-ancestor
6288586|NCT00000217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6288587|NCT00000217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288588|NCT00000217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288589|NCT00000217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6288590|NCT00000217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6288591|NCT00000217|Analgesics|analgesics|mesh-ancestor
6288592|NCT00000217|Sensory System Agents|sensory system agents|mesh-ancestor
6288593|NCT00000217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288594|NCT00000217|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6288595|NCT00000217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6288596|NCT00000217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6288597|NCT00000217|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6288598|NCT00000217|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6288599|NCT00000218|Carbamazepine|carbamazepine|mesh-list
6288600|NCT00000218|Anticonvulsants|anticonvulsants|mesh-ancestor
6288601|NCT00000218|Antimanic Agents|antimanic agents|mesh-ancestor
6288602|NCT00000218|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6288603|NCT00000218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288604|NCT00000218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288605|NCT00000218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6288606|NCT00000218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6288607|NCT00000218|Analgesics|analgesics|mesh-ancestor
6288608|NCT00000218|Sensory System Agents|sensory system agents|mesh-ancestor
6288609|NCT00000218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288610|NCT00000218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6288611|NCT00000218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6288612|NCT00000218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6288613|NCT00000218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6288614|NCT00000218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6288615|NCT00000219|Buprenorphine|buprenorphine|mesh-list
6288616|NCT00000219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6288617|NCT00000219|Narcotics|narcotics|mesh-ancestor
6288618|NCT00000219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288619|NCT00000219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288620|NCT00000219|Analgesics|analgesics|mesh-ancestor
6288621|NCT00000219|Sensory System Agents|sensory system agents|mesh-ancestor
6288622|NCT00000219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288623|NCT00000219|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6288624|NCT00000220|Buprenorphine|buprenorphine|mesh-list
6288625|NCT00000220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6288626|NCT00000220|Narcotics|narcotics|mesh-ancestor
6288627|NCT00000220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288628|NCT00000220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288629|NCT00000220|Analgesics|analgesics|mesh-ancestor
6288630|NCT00000220|Sensory System Agents|sensory system agents|mesh-ancestor
6288631|NCT00000220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288632|NCT00000220|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6288633|NCT00000221|Buprenorphine|buprenorphine|mesh-list
6288634|NCT00000221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6288635|NCT00000221|Narcotics|narcotics|mesh-ancestor
6288636|NCT00000221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288637|NCT00000221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288638|NCT00000221|Analgesics|analgesics|mesh-ancestor
6288639|NCT00000221|Sensory System Agents|sensory system agents|mesh-ancestor
6288640|NCT00000221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288641|NCT00000221|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6288642|NCT00000222|Buprenorphine|buprenorphine|mesh-list
6288643|NCT00000222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6288644|NCT00000222|Narcotics|narcotics|mesh-ancestor
6288645|NCT00000222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288646|NCT00000222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288647|NCT00000222|Analgesics|analgesics|mesh-ancestor
6288648|NCT00000222|Sensory System Agents|sensory system agents|mesh-ancestor
6288649|NCT00000222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288650|NCT00000222|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6288651|NCT00000223|Buprenorphine|buprenorphine|mesh-list
6288652|NCT00000223|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6288653|NCT00000223|Narcotics|narcotics|mesh-ancestor
6288654|NCT00000223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288655|NCT00000223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288656|NCT00000223|Analgesics|analgesics|mesh-ancestor
6288657|NCT00000223|Sensory System Agents|sensory system agents|mesh-ancestor
6288658|NCT00000223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288659|NCT00000223|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6288660|NCT00000224|Buprenorphine|buprenorphine|mesh-list
6288661|NCT00000224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6288662|NCT00000224|Narcotics|narcotics|mesh-ancestor
6288663|NCT00000224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288664|NCT00000224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288665|NCT00000224|Analgesics|analgesics|mesh-ancestor
6288666|NCT00000224|Sensory System Agents|sensory system agents|mesh-ancestor
6288667|NCT00000224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288668|NCT00000224|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6288669|NCT00000225|Buprenorphine|buprenorphine|mesh-list
6288670|NCT00000225|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6288671|NCT00000225|Narcotics|narcotics|mesh-ancestor
6288672|NCT00000225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288673|NCT00000225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288674|NCT00000225|Analgesics|analgesics|mesh-ancestor
6288675|NCT00000225|Sensory System Agents|sensory system agents|mesh-ancestor
6288676|NCT00000225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288677|NCT00000225|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6288678|NCT00000226|Buprenorphine|buprenorphine|mesh-list
6288679|NCT00000226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6288680|NCT00000226|Narcotics|narcotics|mesh-ancestor
6288681|NCT00000226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288682|NCT00000226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288683|NCT00000226|Analgesics|analgesics|mesh-ancestor
6288684|NCT00000226|Sensory System Agents|sensory system agents|mesh-ancestor
6288685|NCT00000226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288686|NCT00000226|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6288687|NCT00000227|Buprenorphine|buprenorphine|mesh-list
6288688|NCT00000227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6288689|NCT00000227|Narcotics|narcotics|mesh-ancestor
6288690|NCT00000227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288691|NCT00000227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288692|NCT00000227|Analgesics|analgesics|mesh-ancestor
6288693|NCT00000227|Sensory System Agents|sensory system agents|mesh-ancestor
6288694|NCT00000227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288695|NCT00000227|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6288696|NCT00000228|Buprenorphine|buprenorphine|mesh-list
6288697|NCT00000228|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6288698|NCT00000228|Narcotics|narcotics|mesh-ancestor
6288699|NCT00000228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288700|NCT00000228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288701|NCT00000228|Analgesics|analgesics|mesh-ancestor
6288702|NCT00000228|Sensory System Agents|sensory system agents|mesh-ancestor
6288703|NCT00000228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288704|NCT00000228|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6288705|NCT00000229|Buprenorphine|buprenorphine|mesh-list
6288706|NCT00000229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6288707|NCT00000229|Narcotics|narcotics|mesh-ancestor
6288708|NCT00000229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288709|NCT00000229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288710|NCT00000229|Analgesics|analgesics|mesh-ancestor
6288711|NCT00000229|Sensory System Agents|sensory system agents|mesh-ancestor
6288712|NCT00000229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288713|NCT00000229|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6288714|NCT00000230|Buprenorphine|buprenorphine|mesh-list
6288715|NCT00000230|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6288716|NCT00000230|Narcotics|narcotics|mesh-ancestor
6288717|NCT00000230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288718|NCT00000230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288719|NCT00000230|Analgesics|analgesics|mesh-ancestor
6288720|NCT00000230|Sensory System Agents|sensory system agents|mesh-ancestor
6288721|NCT00000230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288722|NCT00000230|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6288723|NCT00000231|Buprenorphine|buprenorphine|mesh-list
6288724|NCT00000231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6288725|NCT00000231|Narcotics|narcotics|mesh-ancestor
6288726|NCT00000231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288727|NCT00000231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288728|NCT00000231|Analgesics|analgesics|mesh-ancestor
6288729|NCT00000231|Sensory System Agents|sensory system agents|mesh-ancestor
6288730|NCT00000231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288731|NCT00000231|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6288732|NCT00000232|Buprenorphine|buprenorphine|mesh-list
6288733|NCT00000232|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6288734|NCT00000232|Narcotics|narcotics|mesh-ancestor
6288735|NCT00000232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288736|NCT00000232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288737|NCT00000232|Analgesics|analgesics|mesh-ancestor
6288738|NCT00000232|Sensory System Agents|sensory system agents|mesh-ancestor
6288739|NCT00000232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288740|NCT00000232|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6288741|NCT00000233|Buprenorphine|buprenorphine|mesh-list
6288742|NCT00000233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6288743|NCT00000233|Narcotics|narcotics|mesh-ancestor
6288744|NCT00000233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288745|NCT00000233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288746|NCT00000233|Analgesics|analgesics|mesh-ancestor
6288747|NCT00000233|Sensory System Agents|sensory system agents|mesh-ancestor
6288748|NCT00000233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288749|NCT00000233|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6288750|NCT00000234|Buprenorphine|buprenorphine|mesh-list
6288751|NCT00000234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6288752|NCT00000234|Narcotics|narcotics|mesh-ancestor
6288753|NCT00000234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288754|NCT00000234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288755|NCT00000234|Analgesics|analgesics|mesh-ancestor
6288756|NCT00000234|Sensory System Agents|sensory system agents|mesh-ancestor
6288757|NCT00000234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288758|NCT00000234|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6288759|NCT00000235|Buprenorphine|buprenorphine|mesh-list
6288760|NCT00000235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6288761|NCT00000235|Narcotics|narcotics|mesh-ancestor
6288762|NCT00000235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288763|NCT00000235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288764|NCT00000235|Analgesics|analgesics|mesh-ancestor
6288765|NCT00000235|Sensory System Agents|sensory system agents|mesh-ancestor
6288766|NCT00000235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288767|NCT00000235|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6288768|NCT00000236|Buprenorphine|buprenorphine|mesh-list
6288769|NCT00000236|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6288770|NCT00000236|Naloxone|naloxone|mesh-list
6288771|NCT00000236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6288772|NCT00000236|Narcotics|narcotics|mesh-ancestor
6288773|NCT00000236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288774|NCT00000236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288775|NCT00000236|Analgesics|analgesics|mesh-ancestor
6288776|NCT00000236|Sensory System Agents|sensory system agents|mesh-ancestor
6288777|NCT00000236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288778|NCT00000236|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6288779|NCT00000237|Buprenorphine|buprenorphine|mesh-list
6288780|NCT00000237|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6288781|NCT00000237|Narcotics|narcotics|mesh-ancestor
6288782|NCT00000237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288783|NCT00000237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288784|NCT00000237|Analgesics|analgesics|mesh-ancestor
6288785|NCT00000237|Sensory System Agents|sensory system agents|mesh-ancestor
6288786|NCT00000237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288787|NCT00000237|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6288788|NCT00000238|Buprenorphine|buprenorphine|mesh-list
6288789|NCT00000238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6288790|NCT00000238|Narcotics|narcotics|mesh-ancestor
6288791|NCT00000238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288792|NCT00000238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288793|NCT00000238|Analgesics|analgesics|mesh-ancestor
6288794|NCT00000238|Sensory System Agents|sensory system agents|mesh-ancestor
6288795|NCT00000238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288796|NCT00000238|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6288797|NCT00000239|Buprenorphine|buprenorphine|mesh-list
6288798|NCT00000239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6288799|NCT00000239|Narcotics|narcotics|mesh-ancestor
6288800|NCT00000239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288801|NCT00000239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288802|NCT00000239|Analgesics|analgesics|mesh-ancestor
6288803|NCT00000239|Sensory System Agents|sensory system agents|mesh-ancestor
6288804|NCT00000239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288805|NCT00000239|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6288806|NCT00000240|Buprenorphine|buprenorphine|mesh-list
6288807|NCT00000240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6288808|NCT00000240|Narcotics|narcotics|mesh-ancestor
6288809|NCT00000240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288810|NCT00000240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288811|NCT00000240|Analgesics|analgesics|mesh-ancestor
6288812|NCT00000240|Sensory System Agents|sensory system agents|mesh-ancestor
6288813|NCT00000240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288814|NCT00000240|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6288815|NCT00000241|Flupenthixol|flupenthixol|mesh-list
6288816|NCT00000241|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
6288817|NCT00000241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6288818|NCT00000241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6288819|NCT00000241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288820|NCT00000241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288821|NCT00000241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6288822|NCT00000241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6288823|NCT00000241|Dopamine Agents|dopamine agents|mesh-ancestor
6288824|NCT00000241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6288825|NCT00000241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6288826|NCT00000242|Carbamazepine|carbamazepine|mesh-list
6288827|NCT00000242|Anticonvulsants|anticonvulsants|mesh-ancestor
6288828|NCT00000242|Antimanic Agents|antimanic agents|mesh-ancestor
6288829|NCT00000242|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6288830|NCT00000242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288831|NCT00000242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288832|NCT00000242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6288833|NCT00000242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6288834|NCT00000242|Analgesics|analgesics|mesh-ancestor
6288835|NCT00000242|Sensory System Agents|sensory system agents|mesh-ancestor
6288836|NCT00000242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288837|NCT00000242|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6288838|NCT00000242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6288839|NCT00000242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6288840|NCT00000242|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6288841|NCT00000242|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6391697|NCT00193882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6391698|NCT00193895|Carboplatin|carboplatin|mesh-list
6391699|NCT00193895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391700|NCT00193921|Gemcitabine|gemcitabine|mesh-list
6391701|NCT00193921|Cisplatin|cisplatin|mesh-list
6391702|NCT00193921|Vinorelbine|vinorelbine|mesh-list
6391703|NCT00193921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391704|NCT00193921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6391705|NCT00193921|Antimetabolites|antimetabolites|mesh-ancestor
6391706|NCT00193921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391707|NCT00193921|Antiviral Agents|antiviral agents|mesh-ancestor
6391708|NCT00193921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6288842|NCT00000243|Buprenorphine|buprenorphine|mesh-list
6288843|NCT00000243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6288844|NCT00000243|Narcotics|narcotics|mesh-ancestor
6288845|NCT00000243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288846|NCT00000243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288847|NCT00000243|Analgesics|analgesics|mesh-ancestor
6288848|NCT00000243|Sensory System Agents|sensory system agents|mesh-ancestor
6288849|NCT00000243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288850|NCT00000243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6288851|NCT00000244|Dynorphins|dynorphins|mesh-list
6288852|NCT00000244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6288853|NCT00000244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6288854|NCT00000244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288855|NCT00000245|Desipramine|desipramine|mesh-list
6288856|NCT00000245|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6288857|NCT00000245|Antidepressive Agents|antidepressive agents|mesh-ancestor
6288858|NCT00000245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6288859|NCT00000245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6288860|NCT00000245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6288861|NCT00000245|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6288862|NCT00000245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6288863|NCT00000245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6288864|NCT00000245|Adrenergic Agents|adrenergic agents|mesh-ancestor
6288865|NCT00000245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6288866|NCT00000245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288867|NCT00000246|Flumazenil|flumazenil|mesh-list
6288868|NCT00000246|Antidotes|antidotes|mesh-ancestor
6288869|NCT00000246|Protective Agents|protective agents|mesh-ancestor
6288870|NCT00000246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288871|NCT00000246|GABA Modulators|gaba modulators|mesh-ancestor
6288872|NCT00000246|GABA Agents|gaba agents|mesh-ancestor
6288873|NCT00000246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6288874|NCT00000246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6288875|NCT00000248|Pergolide|pergolide|mesh-list
6288876|NCT00000248|Dopamine Agonists|dopamine agonists|mesh-ancestor
6288877|NCT00000248|Dopamine Agents|dopamine agents|mesh-ancestor
6288878|NCT00000248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6288879|NCT00000248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6288880|NCT00000248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288881|NCT00000249|Nitrous Oxide|nitrous oxide|mesh-list
6288882|NCT00000249|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6288883|NCT00000249|Anesthetics, General|anesthetics, general|mesh-ancestor
6288884|NCT00000249|Anesthetics|anesthetics|mesh-ancestor
6288885|NCT00000249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288886|NCT00000249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288887|NCT00000249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6288888|NCT00000249|Analgesics|analgesics|mesh-ancestor
6288889|NCT00000249|Sensory System Agents|sensory system agents|mesh-ancestor
6288890|NCT00000249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288891|NCT00000250|Nitrous Oxide|nitrous oxide|mesh-list
6288892|NCT00000250|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6288893|NCT00000250|Anesthetics, General|anesthetics, general|mesh-ancestor
6288894|NCT00000250|Anesthetics|anesthetics|mesh-ancestor
6288895|NCT00000250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288896|NCT00000250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288897|NCT00000250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6288898|NCT00000250|Analgesics|analgesics|mesh-ancestor
6288899|NCT00000250|Sensory System Agents|sensory system agents|mesh-ancestor
6288900|NCT00000250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288901|NCT00000251|Isoflurane|isoflurane|mesh-list
6288902|NCT00000251|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6288903|NCT00000251|Anesthetics, General|anesthetics, general|mesh-ancestor
6288904|NCT00000251|Anesthetics|anesthetics|mesh-ancestor
6288905|NCT00000251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288906|NCT00000251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288907|NCT00000252|Nitrous Oxide|nitrous oxide|mesh-list
6288908|NCT00000252|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6288909|NCT00000252|Anesthetics, General|anesthetics, general|mesh-ancestor
6288910|NCT00000252|Anesthetics|anesthetics|mesh-ancestor
6288911|NCT00000252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288912|NCT00000252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288913|NCT00000252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6288914|NCT00000252|Analgesics|analgesics|mesh-ancestor
6288915|NCT00000252|Sensory System Agents|sensory system agents|mesh-ancestor
6288916|NCT00000252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288917|NCT00000253|Nitrous Oxide|nitrous oxide|mesh-list
6288918|NCT00000253|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6288919|NCT00000253|Anesthetics, General|anesthetics, general|mesh-ancestor
6288920|NCT00000253|Anesthetics|anesthetics|mesh-ancestor
6288921|NCT00000253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288922|NCT00000253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288923|NCT00000253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6288924|NCT00000253|Analgesics|analgesics|mesh-ancestor
6288925|NCT00000253|Sensory System Agents|sensory system agents|mesh-ancestor
6288926|NCT00000253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288927|NCT00000254|Nitrous Oxide|nitrous oxide|mesh-list
6288928|NCT00000254|Isoflurane|isoflurane|mesh-list
6288929|NCT00000254|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6288930|NCT00000254|Anesthetics, General|anesthetics, general|mesh-ancestor
6288931|NCT00000254|Anesthetics|anesthetics|mesh-ancestor
6288932|NCT00000254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288933|NCT00000254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288934|NCT00000254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6288935|NCT00000254|Analgesics|analgesics|mesh-ancestor
6288936|NCT00000254|Sensory System Agents|sensory system agents|mesh-ancestor
6288937|NCT00000254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288938|NCT00000255|Nitrous Oxide|nitrous oxide|mesh-list
6288939|NCT00000255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6288940|NCT00000255|Anesthetics, General|anesthetics, general|mesh-ancestor
6288941|NCT00000255|Anesthetics|anesthetics|mesh-ancestor
6288942|NCT00000255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288943|NCT00000255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288944|NCT00000255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6288945|NCT00000255|Analgesics|analgesics|mesh-ancestor
6288946|NCT00000255|Sensory System Agents|sensory system agents|mesh-ancestor
6288947|NCT00000255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288948|NCT00000256|Nitrous Oxide|nitrous oxide|mesh-list
6288949|NCT00000256|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6288950|NCT00000256|Anesthetics, General|anesthetics, general|mesh-ancestor
6288951|NCT00000256|Anesthetics|anesthetics|mesh-ancestor
6288952|NCT00000256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288953|NCT00000256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288954|NCT00000256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6288955|NCT00000256|Analgesics|analgesics|mesh-ancestor
6288956|NCT00000256|Sensory System Agents|sensory system agents|mesh-ancestor
6288957|NCT00000256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288958|NCT00000257|Nitrous Oxide|nitrous oxide|mesh-list
6288959|NCT00000257|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6288960|NCT00000257|Anesthetics, General|anesthetics, general|mesh-ancestor
6288961|NCT00000257|Anesthetics|anesthetics|mesh-ancestor
6288962|NCT00000257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288963|NCT00000257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288964|NCT00000257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6288965|NCT00000257|Analgesics|analgesics|mesh-ancestor
6288966|NCT00000257|Sensory System Agents|sensory system agents|mesh-ancestor
6288967|NCT00000257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288968|NCT00000258|Nitrous Oxide|nitrous oxide|mesh-list
6288969|NCT00000258|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6288970|NCT00000258|Anesthetics, General|anesthetics, general|mesh-ancestor
6288971|NCT00000258|Anesthetics|anesthetics|mesh-ancestor
6288972|NCT00000258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288973|NCT00000258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288974|NCT00000258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6288975|NCT00000258|Analgesics|analgesics|mesh-ancestor
6288976|NCT00000258|Sensory System Agents|sensory system agents|mesh-ancestor
6288977|NCT00000258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288978|NCT00000259|Nitrous Oxide|nitrous oxide|mesh-list
6288979|NCT00000259|Sevoflurane|sevoflurane|mesh-list
6288980|NCT00000259|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6288981|NCT00000259|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6288982|NCT00000259|Anesthetics, General|anesthetics, general|mesh-ancestor
6288983|NCT00000259|Anesthetics|anesthetics|mesh-ancestor
6288984|NCT00000259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288985|NCT00000259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288986|NCT00000259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6288987|NCT00000259|Analgesics|analgesics|mesh-ancestor
6288988|NCT00000259|Sensory System Agents|sensory system agents|mesh-ancestor
6288989|NCT00000259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6288990|NCT00000260|Nitrous Oxide|nitrous oxide|mesh-list
6288991|NCT00000260|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6288992|NCT00000260|Anesthetics, General|anesthetics, general|mesh-ancestor
6288993|NCT00000260|Anesthetics|anesthetics|mesh-ancestor
6288994|NCT00000260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6288995|NCT00000260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6288996|NCT00000260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6288997|NCT00000260|Analgesics|analgesics|mesh-ancestor
6288998|NCT00000260|Sensory System Agents|sensory system agents|mesh-ancestor
6288999|NCT00000260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6289000|NCT00000261|Nitrous Oxide|nitrous oxide|mesh-list
6289001|NCT00000261|Sevoflurane|sevoflurane|mesh-list
6289002|NCT00000261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6289003|NCT00000261|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6289004|NCT00000261|Anesthetics, General|anesthetics, general|mesh-ancestor
6289005|NCT00000261|Anesthetics|anesthetics|mesh-ancestor
6289006|NCT00000261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6289007|NCT00000261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289008|NCT00000261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6289009|NCT00000261|Analgesics|analgesics|mesh-ancestor
6289010|NCT00000261|Sensory System Agents|sensory system agents|mesh-ancestor
6289011|NCT00000261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6289012|NCT00000262|Nitrous Oxide|nitrous oxide|mesh-list
6289013|NCT00000262|Sevoflurane|sevoflurane|mesh-list
6289014|NCT00000262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6289015|NCT00000262|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6289016|NCT00000262|Anesthetics, General|anesthetics, general|mesh-ancestor
6289017|NCT00000262|Anesthetics|anesthetics|mesh-ancestor
6289018|NCT00000262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6289019|NCT00000262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289020|NCT00000262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6289021|NCT00000262|Analgesics|analgesics|mesh-ancestor
6289022|NCT00000262|Sensory System Agents|sensory system agents|mesh-ancestor
6289023|NCT00000262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6289024|NCT00000263|Ethanol|ethanol|mesh-list
6289025|NCT00000263|Nitrous Oxide|nitrous oxide|mesh-list
6289026|NCT00000263|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6289027|NCT00000263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6289028|NCT00000263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6289029|NCT00000263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289030|NCT00000263|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6289031|NCT00000263|Anesthetics, General|anesthetics, general|mesh-ancestor
6289032|NCT00000263|Anesthetics|anesthetics|mesh-ancestor
6289033|NCT00000263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6289034|NCT00000263|Analgesics|analgesics|mesh-ancestor
6289035|NCT00000263|Sensory System Agents|sensory system agents|mesh-ancestor
6289036|NCT00000263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6289037|NCT00000264|Ethanol|ethanol|mesh-list
6289038|NCT00000264|Nitrous Oxide|nitrous oxide|mesh-list
6289039|NCT00000264|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6289040|NCT00000264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6289041|NCT00000264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6289042|NCT00000264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289043|NCT00000264|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6289044|NCT00000264|Anesthetics, General|anesthetics, general|mesh-ancestor
6289045|NCT00000264|Anesthetics|anesthetics|mesh-ancestor
6289046|NCT00000264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6289047|NCT00000264|Analgesics|analgesics|mesh-ancestor
6289048|NCT00000264|Sensory System Agents|sensory system agents|mesh-ancestor
6289049|NCT00000264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6289050|NCT00000266|Flupenthixol|flupenthixol|mesh-list
6289051|NCT00000266|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
6289052|NCT00000266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6289053|NCT00000266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6289054|NCT00000266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6289055|NCT00000266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289056|NCT00000266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6289057|NCT00000266|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6289058|NCT00000266|Dopamine Agents|dopamine agents|mesh-ancestor
6289059|NCT00000266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6289060|NCT00000266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289061|NCT00000267|Risperidone|risperidone|mesh-list
6289062|NCT00000267|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6289063|NCT00000267|Serotonin Agents|serotonin agents|mesh-ancestor
6289064|NCT00000267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6289065|NCT00000267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289066|NCT00000267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289067|NCT00000267|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6289068|NCT00000267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6289069|NCT00000267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6289070|NCT00000267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6289071|NCT00000267|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6289072|NCT00000267|Dopamine Agents|dopamine agents|mesh-ancestor
6289073|NCT00000268|Bupropion|bupropion|mesh-list
6289074|NCT00000268|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6289075|NCT00000268|Antidepressive Agents|antidepressive agents|mesh-ancestor
6289076|NCT00000268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6289077|NCT00000268|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6289078|NCT00000268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6289079|NCT00000268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6289080|NCT00000268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289081|NCT00000268|Dopamine Agents|dopamine agents|mesh-ancestor
6289082|NCT00000268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6289083|NCT00000268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289084|NCT00000268|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6289085|NCT00000268|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6289086|NCT00000268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6289087|NCT00000269|Pergolide|pergolide|mesh-list
6289088|NCT00000269|Dopamine Agonists|dopamine agonists|mesh-ancestor
6289089|NCT00000269|Dopamine Agents|dopamine agents|mesh-ancestor
6289090|NCT00000269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6289091|NCT00000269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289092|NCT00000269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289093|NCT00000270|Cocaine|cocaine|mesh-list
6289094|NCT00000270|Anesthetics, Local|anesthetics, local|mesh-ancestor
6289095|NCT00000270|Anesthetics|anesthetics|mesh-ancestor
6289096|NCT00000270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6289097|NCT00000270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289098|NCT00000270|Sensory System Agents|sensory system agents|mesh-ancestor
6289099|NCT00000270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6289100|NCT00000270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6289101|NCT00000270|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6289102|NCT00000270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6289103|NCT00000270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6289104|NCT00000270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289105|NCT00000270|Dopamine Agents|dopamine agents|mesh-ancestor
6289106|NCT00000270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6289107|NCT00000271|Desipramine|desipramine|mesh-list
6289108|NCT00000271|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6289109|NCT00000271|Antidepressive Agents|antidepressive agents|mesh-ancestor
6289110|NCT00000271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6289111|NCT00000271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6289112|NCT00000271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289113|NCT00000271|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6289114|NCT00000271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6289115|NCT00000271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6289116|NCT00000271|Adrenergic Agents|adrenergic agents|mesh-ancestor
6289117|NCT00000271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6289118|NCT00000271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289119|NCT00000273|Fentanyl|fentanyl|mesh-list
6289120|NCT00000273|Morphine|morphine|mesh-list
6289121|NCT00000273|Oxycodone|oxycodone|mesh-list
6289122|NCT00000273|Buprenorphine|buprenorphine|mesh-list
6289123|NCT00000273|Methadone|methadone|mesh-list
6289124|NCT00000273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6289125|NCT00000273|Narcotics|narcotics|mesh-ancestor
6289126|NCT00000273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6289127|NCT00000273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289128|NCT00000273|Analgesics|analgesics|mesh-ancestor
6289129|NCT00000273|Sensory System Agents|sensory system agents|mesh-ancestor
6289130|NCT00000273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6289131|NCT00000273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6289132|NCT00000273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6289133|NCT00000273|Anesthetics, General|anesthetics, general|mesh-ancestor
6289134|NCT00000273|Anesthetics|anesthetics|mesh-ancestor
6289135|NCT00000273|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6289136|NCT00000273|Antitussive Agents|antitussive agents|mesh-ancestor
6289137|NCT00000273|Respiratory System Agents|respiratory system agents|mesh-ancestor
6289138|NCT00000274|Flupenthixol|flupenthixol|mesh-list
6289139|NCT00000274|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
6289140|NCT00000274|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6289141|NCT00000274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6289142|NCT00000274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6289143|NCT00000274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289144|NCT00000274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6289145|NCT00000274|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6289146|NCT00000274|Dopamine Agents|dopamine agents|mesh-ancestor
6289147|NCT00000274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6289148|NCT00000274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289149|NCT00000275|Flupenthixol|flupenthixol|mesh-list
6289150|NCT00000275|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
6289151|NCT00000275|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6289152|NCT00000275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6289153|NCT00000275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6289154|NCT00000275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289155|NCT00000275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6289156|NCT00000275|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6289157|NCT00000275|Dopamine Agents|dopamine agents|mesh-ancestor
6289158|NCT00000275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6289159|NCT00000275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289160|NCT00000276|Bupropion|bupropion|mesh-list
6289161|NCT00000276|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6289162|NCT00000276|Antidepressive Agents|antidepressive agents|mesh-ancestor
6289163|NCT00000276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6289164|NCT00000276|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6289165|NCT00000276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6289166|NCT00000276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6289167|NCT00000276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289168|NCT00000276|Dopamine Agents|dopamine agents|mesh-ancestor
6289169|NCT00000276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6289170|NCT00000276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289171|NCT00000276|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6289172|NCT00000276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6289173|NCT00000276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6289174|NCT00000277|Mazindol|mazindol|mesh-list
6289175|NCT00000277|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6289176|NCT00000277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289177|NCT00000277|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6289178|NCT00000277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6289179|NCT00000277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6289180|NCT00000277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289181|NCT00000277|Adrenergic Agents|adrenergic agents|mesh-ancestor
6289182|NCT00000277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6289183|NCT00000277|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6289184|NCT00000277|Dopamine Agents|dopamine agents|mesh-ancestor
6289185|NCT00000278|Disulfiram|disulfiram|mesh-list
6289186|NCT00000278|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6289187|NCT00000278|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
6289188|NCT00000278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6289189|NCT00000278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289190|NCT00000279|Clonidine|clonidine|mesh-list
6289191|NCT00000279|Analgesics|analgesics|mesh-ancestor
6289192|NCT00000279|Sensory System Agents|sensory system agents|mesh-ancestor
6289193|NCT00000279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6289194|NCT00000279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289195|NCT00000279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6289196|NCT00000279|Sympatholytics|sympatholytics|mesh-ancestor
6289197|NCT00000279|Autonomic Agents|autonomic agents|mesh-ancestor
6289198|NCT00000279|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6289199|NCT00000279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6289200|NCT00000279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6289201|NCT00000279|Adrenergic Agents|adrenergic agents|mesh-ancestor
6289202|NCT00000279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6289203|NCT00000279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289204|NCT00000280|Nimodipine|nimodipine|mesh-list
6289205|NCT00000280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6289206|NCT00000280|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6289207|NCT00000280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6289208|NCT00000280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289209|NCT00000280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6289210|NCT00000280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289211|NCT00000280|Vasodilator Agents|vasodilator agents|mesh-ancestor
6289212|NCT00000281|Amantadine|amantadine|mesh-list
6289213|NCT00000281|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6289214|NCT00000281|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6289215|NCT00000281|Antiviral Agents|antiviral agents|mesh-ancestor
6289216|NCT00000281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6289217|NCT00000281|Dopamine Agents|dopamine agents|mesh-ancestor
6289218|NCT00000281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6289219|NCT00000281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289220|NCT00000281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289221|NCT00000281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6289222|NCT00000281|Analgesics|analgesics|mesh-ancestor
6289223|NCT00000281|Sensory System Agents|sensory system agents|mesh-ancestor
6289224|NCT00000281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6289225|NCT00000282|Pemoline|pemoline|mesh-list
6289226|NCT00000282|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6289227|NCT00000282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289228|NCT00000285|Phenytoin|phenytoin|mesh-list
6289229|NCT00000285|Anticonvulsants|anticonvulsants|mesh-ancestor
6289230|NCT00000285|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6289231|NCT00000285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6289232|NCT00000285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6289233|NCT00000285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289234|NCT00000285|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6289235|NCT00000285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6289236|NCT00000286|Nefazodone|nefazodone|mesh-list
6289237|NCT00000286|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6289238|NCT00000286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6289239|NCT00000286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6289240|NCT00000286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289241|NCT00000286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6289242|NCT00000286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289243|NCT00000286|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6289244|NCT00000286|Antidepressive Agents|antidepressive agents|mesh-ancestor
6289245|NCT00000286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6289246|NCT00000286|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6289247|NCT00000286|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6289248|NCT00000286|Serotonin Agents|serotonin agents|mesh-ancestor
6289249|NCT00000289|Ondansetron|ondansetron|mesh-list
6289250|NCT00000289|Antiemetics|antiemetics|mesh-ancestor
6289251|NCT00000289|Autonomic Agents|autonomic agents|mesh-ancestor
6289252|NCT00000289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6289253|NCT00000289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289254|NCT00000289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6289255|NCT00000289|Antipruritics|antipruritics|mesh-ancestor
6289256|NCT00000289|Dermatologic Agents|dermatologic agents|mesh-ancestor
6289257|NCT00000289|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6289258|NCT00000289|Serotonin Agents|serotonin agents|mesh-ancestor
6289259|NCT00000289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6289260|NCT00000289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289261|NCT00000289|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6289262|NCT00000289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6289263|NCT00000289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6289264|NCT00000289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6289265|NCT00000289|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6289266|NCT00000290|Cocaine|cocaine|mesh-list
6289267|NCT00000290|Anesthetics, Local|anesthetics, local|mesh-ancestor
6289268|NCT00000290|Anesthetics|anesthetics|mesh-ancestor
6289269|NCT00000290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6289270|NCT00000290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289271|NCT00000290|Sensory System Agents|sensory system agents|mesh-ancestor
6289272|NCT00000290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6289273|NCT00000290|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6289274|NCT00000290|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6289275|NCT00000290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6289276|NCT00000290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6289277|NCT00000290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289278|NCT00000290|Dopamine Agents|dopamine agents|mesh-ancestor
6289279|NCT00000290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6289280|NCT00000291|Labetalol|labetalol|mesh-list
6289281|NCT00000291|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6289282|NCT00000291|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6289283|NCT00000291|Adrenergic Agents|adrenergic agents|mesh-ancestor
6289284|NCT00000291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6289285|NCT00000291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289286|NCT00000291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289287|NCT00000291|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6289288|NCT00000291|Sympathomimetics|sympathomimetics|mesh-ancestor
6289289|NCT00000291|Autonomic Agents|autonomic agents|mesh-ancestor
6289290|NCT00000291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6289291|NCT00000291|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6289292|NCT00000291|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6289293|NCT00000292|Cocaine|cocaine|mesh-list
6289294|NCT00000292|Anesthetics, Local|anesthetics, local|mesh-ancestor
6289295|NCT00000292|Anesthetics|anesthetics|mesh-ancestor
6289296|NCT00000292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6289297|NCT00000292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289298|NCT00000292|Sensory System Agents|sensory system agents|mesh-ancestor
6289299|NCT00000292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6289300|NCT00000292|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6289301|NCT00000292|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6289302|NCT00000292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6289303|NCT00000292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6289304|NCT00000292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289305|NCT00000292|Dopamine Agents|dopamine agents|mesh-ancestor
6289306|NCT00000292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6289307|NCT00000293|Nefazodone|nefazodone|mesh-list
6289308|NCT00000293|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6289309|NCT00000293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6289310|NCT00000293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6289311|NCT00000293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289312|NCT00000293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6289313|NCT00000293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289314|NCT00000293|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6289315|NCT00000293|Antidepressive Agents|antidepressive agents|mesh-ancestor
6289316|NCT00000293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6289317|NCT00000293|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6289318|NCT00000293|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6289319|NCT00000293|Serotonin Agents|serotonin agents|mesh-ancestor
6289320|NCT00000294|Carvedilol|carvedilol|mesh-list
6289321|NCT00000294|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6289322|NCT00000294|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6289323|NCT00000294|Adrenergic Agents|adrenergic agents|mesh-ancestor
6289324|NCT00000294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6289325|NCT00000294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289326|NCT00000294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289327|NCT00000294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6289328|NCT00000294|Antioxidants|antioxidants|mesh-ancestor
6289329|NCT00000294|Protective Agents|protective agents|mesh-ancestor
6289330|NCT00000294|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6289331|NCT00000294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6289332|NCT00000294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6289333|NCT00000294|Vasodilator Agents|vasodilator agents|mesh-ancestor
6289334|NCT00000294|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6289335|NCT00000294|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6289336|NCT00000295|Progesterone|progesterone|mesh-list
6289337|NCT00000295|Progestins|progestins|mesh-ancestor
6289338|NCT00000295|Hormones|hormones|mesh-ancestor
6289339|NCT00000295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6289340|NCT00000295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289341|NCT00000297|Labetalol|labetalol|mesh-list
6289342|NCT00000297|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6289343|NCT00000297|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6289344|NCT00000297|Adrenergic Agents|adrenergic agents|mesh-ancestor
6289345|NCT00000297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6289346|NCT00000297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289347|NCT00000297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289348|NCT00000297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6289349|NCT00000297|Sympathomimetics|sympathomimetics|mesh-ancestor
6289350|NCT00000297|Autonomic Agents|autonomic agents|mesh-ancestor
6289351|NCT00000297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6289352|NCT00000297|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6289353|NCT00000297|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6289354|NCT00000298|Buprenorphine|buprenorphine|mesh-list
6289355|NCT00000298|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6289356|NCT00000298|Naloxone|naloxone|mesh-list
6289357|NCT00000298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6289358|NCT00000298|Narcotics|narcotics|mesh-ancestor
6289359|NCT00000298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6289360|NCT00000298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289361|NCT00000298|Analgesics|analgesics|mesh-ancestor
6289362|NCT00000298|Sensory System Agents|sensory system agents|mesh-ancestor
6289363|NCT00000298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6289364|NCT00000298|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6289365|NCT00000299|Buprenorphine|buprenorphine|mesh-list
6289366|NCT00000299|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6289367|NCT00000299|Narcotics|narcotics|mesh-ancestor
6289368|NCT00000299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6289369|NCT00000299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289370|NCT00000299|Analgesics|analgesics|mesh-ancestor
6289371|NCT00000299|Sensory System Agents|sensory system agents|mesh-ancestor
6289372|NCT00000299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6289373|NCT00000299|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6289374|NCT00000301|Amantadine|amantadine|mesh-list
6289375|NCT00000301|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6289376|NCT00000301|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6289377|NCT00000301|Antiviral Agents|antiviral agents|mesh-ancestor
6289378|NCT00000301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6289379|NCT00000301|Dopamine Agents|dopamine agents|mesh-ancestor
6289380|NCT00000301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6289381|NCT00000301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289382|NCT00000301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289383|NCT00000301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6289384|NCT00000301|Analgesics|analgesics|mesh-ancestor
6289385|NCT00000301|Sensory System Agents|sensory system agents|mesh-ancestor
6289386|NCT00000301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6289387|NCT00000302|Buprenorphine|buprenorphine|mesh-list
6289388|NCT00000302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6289389|NCT00000302|Narcotics|narcotics|mesh-ancestor
6289390|NCT00000302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6289391|NCT00000302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289392|NCT00000302|Analgesics|analgesics|mesh-ancestor
6289393|NCT00000302|Sensory System Agents|sensory system agents|mesh-ancestor
6289394|NCT00000302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6289395|NCT00000302|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6289396|NCT00000303|Baclofen|baclofen|mesh-list
6289397|NCT00000303|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6289398|NCT00000303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289399|NCT00000303|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6289400|NCT00000303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6289401|NCT00000303|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6289402|NCT00000303|GABA Agonists|gaba agonists|mesh-ancestor
6289403|NCT00000303|GABA Agents|gaba agents|mesh-ancestor
6289404|NCT00000303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6289405|NCT00000303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289406|NCT00000304|Amphetamine|amphetamine|mesh-list
6289407|NCT00000304|Dextroamphetamine|dextroamphetamine|mesh-list
6289408|NCT00000304|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6289409|NCT00000304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289410|NCT00000304|Sympathomimetics|sympathomimetics|mesh-ancestor
6289411|NCT00000304|Autonomic Agents|autonomic agents|mesh-ancestor
6289412|NCT00000304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6289413|NCT00000304|Dopamine Agents|dopamine agents|mesh-ancestor
6289414|NCT00000304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6289415|NCT00000304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289416|NCT00000304|Adrenergic Agents|adrenergic agents|mesh-ancestor
6289417|NCT00000304|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6289418|NCT00000304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6289419|NCT00000304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6289420|NCT00000304|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6289421|NCT00000305|Dextroamphetamine|dextroamphetamine|mesh-list
6289422|NCT00000305|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6289423|NCT00000305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289424|NCT00000305|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6289425|NCT00000305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6289426|NCT00000305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6289427|NCT00000305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289428|NCT00000305|Dopamine Agents|dopamine agents|mesh-ancestor
6289429|NCT00000305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6289430|NCT00000306|Dextroamphetamine|dextroamphetamine|mesh-list
6289431|NCT00000306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6289432|NCT00000306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289433|NCT00000306|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6289434|NCT00000306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6289435|NCT00000306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6289436|NCT00000306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289437|NCT00000306|Dopamine Agents|dopamine agents|mesh-ancestor
6289438|NCT00000306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6289439|NCT00000307|Naltrexone|naltrexone|mesh-list
6289440|NCT00000307|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6289441|NCT00000307|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6289442|NCT00000307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289443|NCT00000307|Sensory System Agents|sensory system agents|mesh-ancestor
6289444|NCT00000307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6289445|NCT00000308|Amphetamine|amphetamine|mesh-list
6289446|NCT00000308|Dextroamphetamine|dextroamphetamine|mesh-list
6289447|NCT00000308|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6289448|NCT00000308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289449|NCT00000308|Sympathomimetics|sympathomimetics|mesh-ancestor
6289450|NCT00000308|Autonomic Agents|autonomic agents|mesh-ancestor
6289451|NCT00000308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6289452|NCT00000308|Dopamine Agents|dopamine agents|mesh-ancestor
6289453|NCT00000308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6289454|NCT00000308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289455|NCT00000308|Adrenergic Agents|adrenergic agents|mesh-ancestor
6289456|NCT00000308|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6289457|NCT00000308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6289458|NCT00000308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6289459|NCT00000308|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6289460|NCT00000309|Risperidone|risperidone|mesh-list
6289461|NCT00000309|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6289462|NCT00000309|Serotonin Agents|serotonin agents|mesh-ancestor
6289463|NCT00000309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6289464|NCT00000309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289465|NCT00000309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289466|NCT00000309|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6289467|NCT00000309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6289468|NCT00000309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6289469|NCT00000309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6289470|NCT00000309|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6289471|NCT00000309|Dopamine Agents|dopamine agents|mesh-ancestor
6289472|NCT00000310|Risperidone|risperidone|mesh-list
6289473|NCT00000310|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6289474|NCT00000310|Serotonin Agents|serotonin agents|mesh-ancestor
6289475|NCT00000310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6289476|NCT00000310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289477|NCT00000310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289478|NCT00000310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6289479|NCT00000310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6289480|NCT00000310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6289481|NCT00000310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6289482|NCT00000310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6289483|NCT00000310|Dopamine Agents|dopamine agents|mesh-ancestor
6289484|NCT00000311|Buprenorphine|buprenorphine|mesh-list
6289485|NCT00000311|Methadone|methadone|mesh-list
6289486|NCT00000311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6289487|NCT00000311|Narcotics|narcotics|mesh-ancestor
6289488|NCT00000311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6289489|NCT00000311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289490|NCT00000311|Analgesics|analgesics|mesh-ancestor
6289491|NCT00000311|Sensory System Agents|sensory system agents|mesh-ancestor
6289492|NCT00000311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6289493|NCT00000311|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6289494|NCT00000311|Antitussive Agents|antitussive agents|mesh-ancestor
6289495|NCT00000311|Respiratory System Agents|respiratory system agents|mesh-ancestor
6289496|NCT00000313|Fenfluramine|fenfluramine|mesh-list
6289497|NCT00000313|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6289498|NCT00000313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6289499|NCT00000313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6289500|NCT00000313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289501|NCT00000313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6289502|NCT00000313|Serotonin Agents|serotonin agents|mesh-ancestor
6289503|NCT00000313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289504|NCT00000315|Cocaine|cocaine|mesh-list
6289505|NCT00000315|Anesthetics, Local|anesthetics, local|mesh-ancestor
6289506|NCT00000315|Anesthetics|anesthetics|mesh-ancestor
6289507|NCT00000315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6289508|NCT00000315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289509|NCT00000315|Sensory System Agents|sensory system agents|mesh-ancestor
6289510|NCT00000315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6289511|NCT00000315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6289512|NCT00000315|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6289513|NCT00000315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6289514|NCT00000315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6289515|NCT00000315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289516|NCT00000315|Dopamine Agents|dopamine agents|mesh-ancestor
6289517|NCT00000315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6289518|NCT00000316|Cocaine|cocaine|mesh-list
6289519|NCT00000316|Anesthetics, Local|anesthetics, local|mesh-ancestor
6289520|NCT00000316|Anesthetics|anesthetics|mesh-ancestor
6289521|NCT00000316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6289522|NCT00000316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289523|NCT00000316|Sensory System Agents|sensory system agents|mesh-ancestor
6289524|NCT00000316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6289525|NCT00000316|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6289526|NCT00000316|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6289527|NCT00000316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6289528|NCT00000316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6289529|NCT00000316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289530|NCT00000316|Dopamine Agents|dopamine agents|mesh-ancestor
6289531|NCT00000316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6289532|NCT00000317|Risperidone|risperidone|mesh-list
6289533|NCT00000317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6289534|NCT00000317|Serotonin Agents|serotonin agents|mesh-ancestor
6289535|NCT00000317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6289536|NCT00000317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289537|NCT00000317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289538|NCT00000317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6289539|NCT00000317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6289540|NCT00000317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6289541|NCT00000317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6289542|NCT00000317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6289543|NCT00000317|Dopamine Agents|dopamine agents|mesh-ancestor
6289544|NCT00000318|Buprenorphine|buprenorphine|mesh-list
6289545|NCT00000318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6289546|NCT00000318|Narcotics|narcotics|mesh-ancestor
6289547|NCT00000318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6289548|NCT00000318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289549|NCT00000318|Analgesics|analgesics|mesh-ancestor
6289550|NCT00000318|Sensory System Agents|sensory system agents|mesh-ancestor
6289551|NCT00000318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6289552|NCT00000318|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6289553|NCT00000319|Buprenorphine|buprenorphine|mesh-list
6289554|NCT00000319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6289555|NCT00000319|Narcotics|narcotics|mesh-ancestor
6289556|NCT00000319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6289557|NCT00000319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289558|NCT00000319|Analgesics|analgesics|mesh-ancestor
6289559|NCT00000319|Sensory System Agents|sensory system agents|mesh-ancestor
6289560|NCT00000319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6289561|NCT00000319|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6289562|NCT00000320|Buprenorphine|buprenorphine|mesh-list
6289563|NCT00000320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6289564|NCT00000320|Narcotics|narcotics|mesh-ancestor
6289565|NCT00000320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6289566|NCT00000320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289567|NCT00000320|Analgesics|analgesics|mesh-ancestor
6289568|NCT00000320|Sensory System Agents|sensory system agents|mesh-ancestor
6289569|NCT00000320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6289570|NCT00000320|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6289571|NCT00000321|Desipramine|desipramine|mesh-list
6289572|NCT00000321|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6289573|NCT00000321|Antidepressive Agents|antidepressive agents|mesh-ancestor
6289574|NCT00000321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6289575|NCT00000321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6289576|NCT00000321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289577|NCT00000321|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6289578|NCT00000321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6289579|NCT00000321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6289580|NCT00000321|Adrenergic Agents|adrenergic agents|mesh-ancestor
6289581|NCT00000321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6289582|NCT00000321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289583|NCT00000324|Tryptophan|tryptophan|mesh-list
6289584|NCT00000324|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6289585|NCT00000324|Antidepressive Agents|antidepressive agents|mesh-ancestor
6289586|NCT00000324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6289587|NCT00000325|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
6289588|NCT00000325|Hormones|hormones|mesh-ancestor
6289589|NCT00000325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6289590|NCT00000325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289591|NCT00000326|Heroin|heroin|mesh-list
6289592|NCT00000326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6289593|NCT00000326|Narcotics|narcotics|mesh-ancestor
6289594|NCT00000326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6289595|NCT00000326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289596|NCT00000326|Analgesics|analgesics|mesh-ancestor
6289597|NCT00000326|Sensory System Agents|sensory system agents|mesh-ancestor
6289598|NCT00000326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6289599|NCT00000327|Heroin|heroin|mesh-list
6289600|NCT00000327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6289601|NCT00000327|Narcotics|narcotics|mesh-ancestor
6289602|NCT00000327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6289603|NCT00000327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289604|NCT00000327|Analgesics|analgesics|mesh-ancestor
6289605|NCT00000327|Sensory System Agents|sensory system agents|mesh-ancestor
6289606|NCT00000327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6289607|NCT00000328|Analgesics, Opioid|analgesics, opioid|mesh-list
6289608|NCT00000328|Narcotics|narcotics|mesh-ancestor
6289609|NCT00000328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6289610|NCT00000328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289611|NCT00000328|Analgesics|analgesics|mesh-ancestor
6289612|NCT00000328|Sensory System Agents|sensory system agents|mesh-ancestor
6289613|NCT00000328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6289614|NCT00000329|Analgesics, Opioid|analgesics, opioid|mesh-list
6289615|NCT00000329|Narcotics|narcotics|mesh-ancestor
6289616|NCT00000329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6289617|NCT00000329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289618|NCT00000329|Analgesics|analgesics|mesh-ancestor
6289619|NCT00000329|Sensory System Agents|sensory system agents|mesh-ancestor
6289620|NCT00000329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6289621|NCT00000330|Analgesics, Opioid|analgesics, opioid|mesh-list
6289622|NCT00000330|Narcotics|narcotics|mesh-ancestor
6289623|NCT00000330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6289624|NCT00000330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289625|NCT00000330|Analgesics|analgesics|mesh-ancestor
6289626|NCT00000330|Sensory System Agents|sensory system agents|mesh-ancestor
6289627|NCT00000330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6289628|NCT00000332|Nimodipine|nimodipine|mesh-list
6289629|NCT00000332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6289630|NCT00000332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6289631|NCT00000332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6289632|NCT00000332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289633|NCT00000332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6289634|NCT00000332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289635|NCT00000332|Vasodilator Agents|vasodilator agents|mesh-ancestor
6289636|NCT00000333|Benztropine|benztropine|mesh-list
6289637|NCT00000333|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6289638|NCT00000333|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6289639|NCT00000333|Parasympatholytics|parasympatholytics|mesh-ancestor
6289640|NCT00000333|Autonomic Agents|autonomic agents|mesh-ancestor
6289641|NCT00000333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6289642|NCT00000333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289643|NCT00000333|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6289644|NCT00000333|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6289645|NCT00000333|Cholinergic Agents|cholinergic agents|mesh-ancestor
6289646|NCT00000333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6289647|NCT00000333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289648|NCT00000333|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6289649|NCT00000333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6289650|NCT00000333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6289651|NCT00000333|Dopamine Agents|dopamine agents|mesh-ancestor
6289652|NCT00000334|Buprenorphine|buprenorphine|mesh-list
6289653|NCT00000334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6289654|NCT00000334|Narcotics|narcotics|mesh-ancestor
6289655|NCT00000334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6289656|NCT00000334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289657|NCT00000334|Analgesics|analgesics|mesh-ancestor
6289658|NCT00000334|Sensory System Agents|sensory system agents|mesh-ancestor
6289659|NCT00000334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6289660|NCT00000334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6289661|NCT00000335|Morphine|morphine|mesh-list
6289662|NCT00000335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6289663|NCT00000335|Narcotics|narcotics|mesh-ancestor
6289664|NCT00000335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6289665|NCT00000335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289666|NCT00000335|Analgesics|analgesics|mesh-ancestor
6289667|NCT00000335|Sensory System Agents|sensory system agents|mesh-ancestor
6289668|NCT00000335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6289669|NCT00000336|Selegiline|selegiline|mesh-list
6289670|NCT00000336|Antidepressive Agents|antidepressive agents|mesh-ancestor
6289671|NCT00000336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6289672|NCT00000336|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6289673|NCT00000336|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6289674|NCT00000336|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6289675|NCT00000336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6289676|NCT00000336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289677|NCT00000336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6289678|NCT00000336|Protective Agents|protective agents|mesh-ancestor
6289679|NCT00000336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289680|NCT00000337|Selegiline|selegiline|mesh-list
6289681|NCT00000337|Antidepressive Agents|antidepressive agents|mesh-ancestor
6289682|NCT00000337|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6289683|NCT00000337|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6289684|NCT00000337|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6289685|NCT00000337|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6289686|NCT00000337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6289687|NCT00000337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289688|NCT00000337|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6289689|NCT00000337|Protective Agents|protective agents|mesh-ancestor
6289690|NCT00000337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289691|NCT00000338|Lisuride|lisuride|mesh-list
6289692|NCT00000338|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6289693|NCT00000338|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6289694|NCT00000338|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6289695|NCT00000338|Serotonin Agents|serotonin agents|mesh-ancestor
6289696|NCT00000338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6289697|NCT00000338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289698|NCT00000338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289699|NCT00000338|Dopamine Agonists|dopamine agonists|mesh-ancestor
6289700|NCT00000338|Dopamine Agents|dopamine agents|mesh-ancestor
6289701|NCT00000339|Risperidone|risperidone|mesh-list
6289702|NCT00000339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6289703|NCT00000339|Serotonin Agents|serotonin agents|mesh-ancestor
6289704|NCT00000339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6289705|NCT00000339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289706|NCT00000339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289707|NCT00000339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6289708|NCT00000339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6289709|NCT00000339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6289710|NCT00000339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6289711|NCT00000339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6289712|NCT00000339|Dopamine Agents|dopamine agents|mesh-ancestor
6289713|NCT00000340|Pemoline|pemoline|mesh-list
6289714|NCT00000340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6289715|NCT00000340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289716|NCT00000341|Buprenorphine|buprenorphine|mesh-list
6289717|NCT00000341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6289718|NCT00000341|Narcotics|narcotics|mesh-ancestor
6289719|NCT00000341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6289720|NCT00000341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289721|NCT00000341|Analgesics|analgesics|mesh-ancestor
6289722|NCT00000341|Sensory System Agents|sensory system agents|mesh-ancestor
6289723|NCT00000341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6289724|NCT00000341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6289725|NCT00000342|Risperidone|risperidone|mesh-list
6289726|NCT00000342|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6289727|NCT00000342|Serotonin Agents|serotonin agents|mesh-ancestor
6289728|NCT00000342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6289729|NCT00000342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289730|NCT00000342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289731|NCT00000342|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6289732|NCT00000342|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6289733|NCT00000342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6289734|NCT00000342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6289735|NCT00000342|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6289736|NCT00000342|Dopamine Agents|dopamine agents|mesh-ancestor
6289737|NCT00000344|Buprenorphine|buprenorphine|mesh-list
6289738|NCT00000344|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6289739|NCT00000344|Naloxone|naloxone|mesh-list
6289740|NCT00000344|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6289741|NCT00000344|Narcotics|narcotics|mesh-ancestor
6289742|NCT00000344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6289743|NCT00000344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289744|NCT00000344|Analgesics|analgesics|mesh-ancestor
6289745|NCT00000344|Sensory System Agents|sensory system agents|mesh-ancestor
6289746|NCT00000344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6289747|NCT00000344|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6289748|NCT00000345|Lofexidine|lofexidine|mesh-list
6289749|NCT00000345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6289750|NCT00000345|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6289751|NCT00000345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289752|NCT00000345|Sensory System Agents|sensory system agents|mesh-ancestor
6289753|NCT00000345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6289754|NCT00000345|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6289755|NCT00000345|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6289756|NCT00000345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6289757|NCT00000345|Adrenergic Agents|adrenergic agents|mesh-ancestor
6289758|NCT00000345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6289759|NCT00000345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391709|NCT00193921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6391710|NCT00193921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6391711|NCT00193921|Immunologic Factors|immunologic factors|mesh-ancestor
6391712|NCT00193921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6391713|NCT00193921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6391714|NCT00193921|Tubulin Modulators|tubulin modulators|mesh-ancestor
6391715|NCT00193921|Antimitotic Agents|antimitotic agents|mesh-ancestor
6391716|NCT00193921|Mitosis Modulators|mitosis modulators|mesh-ancestor
6391717|NCT00193973|Methotrexate|methotrexate|mesh-list
6391718|NCT00193973|Idarubicin|idarubicin|mesh-list
6391719|NCT00193973|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6391720|NCT00193973|Abortifacient Agents|abortifacient agents|mesh-ancestor
6391721|NCT00193973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6391722|NCT00193973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6391723|NCT00193973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6391724|NCT00193973|Antimetabolites|antimetabolites|mesh-ancestor
6391725|NCT00193973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391726|NCT00193973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391727|NCT00193973|Dermatologic Agents|dermatologic agents|mesh-ancestor
6391728|NCT00193973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6391729|NCT00193973|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6391730|NCT00193973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6289760|NCT00000347|Risperidone|risperidone|mesh-list
6289761|NCT00000347|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6289762|NCT00000347|Serotonin Agents|serotonin agents|mesh-ancestor
6289763|NCT00000347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6289764|NCT00000347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289765|NCT00000347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289766|NCT00000347|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6289767|NCT00000347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6289768|NCT00000347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6289769|NCT00000347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6289770|NCT00000347|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6289771|NCT00000347|Dopamine Agents|dopamine agents|mesh-ancestor
6289772|NCT00000348|Dihydrexidine|dihydrexidine|mesh-list
6289773|NCT00000348|Dopamine Agonists|dopamine agonists|mesh-ancestor
6289774|NCT00000348|Dopamine Agents|dopamine agents|mesh-ancestor
6289775|NCT00000348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6289776|NCT00000348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289777|NCT00000348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289778|NCT00000349|Flupenthixol|flupenthixol|mesh-list
6289779|NCT00000349|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
6289780|NCT00000349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6289781|NCT00000349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6289782|NCT00000349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6289783|NCT00000349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289784|NCT00000349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6289785|NCT00000349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6289786|NCT00000349|Dopamine Agents|dopamine agents|mesh-ancestor
6289787|NCT00000349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6289788|NCT00000349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289789|NCT00000352|Dextromethorphan|dextromethorphan|mesh-list
6289790|NCT00000352|Antitussive Agents|antitussive agents|mesh-ancestor
6289791|NCT00000352|Respiratory System Agents|respiratory system agents|mesh-ancestor
6289792|NCT00000352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6289793|NCT00000352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6289794|NCT00000352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6289795|NCT00000352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289796|NCT00000352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289797|NCT00000353|Buprenorphine|buprenorphine|mesh-list
6289798|NCT00000353|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6289799|NCT00000353|Naloxone|naloxone|mesh-list
6289800|NCT00000353|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6289801|NCT00000353|Narcotics|narcotics|mesh-ancestor
6391731|NCT00193973|Immunologic Factors|immunologic factors|mesh-ancestor
6289802|NCT00000353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6289803|NCT00000353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289804|NCT00000353|Analgesics|analgesics|mesh-ancestor
6289805|NCT00000353|Sensory System Agents|sensory system agents|mesh-ancestor
6289806|NCT00000353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6289807|NCT00000353|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6289808|NCT00000354|Lofexidine|lofexidine|mesh-list
6289809|NCT00000354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6289810|NCT00000354|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6289811|NCT00000354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289812|NCT00000354|Sensory System Agents|sensory system agents|mesh-ancestor
6289813|NCT00000354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6289814|NCT00000354|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6289815|NCT00000354|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6289816|NCT00000354|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6289817|NCT00000354|Adrenergic Agents|adrenergic agents|mesh-ancestor
6289818|NCT00000354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6289819|NCT00000354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289820|NCT00000355|Buprenorphine|buprenorphine|mesh-list
6289821|NCT00000355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6289822|NCT00000355|Narcotics|narcotics|mesh-ancestor
6289823|NCT00000355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6289824|NCT00000355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289825|NCT00000355|Analgesics|analgesics|mesh-ancestor
6289826|NCT00000355|Sensory System Agents|sensory system agents|mesh-ancestor
6289827|NCT00000355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6289828|NCT00000355|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6289829|NCT00000357|Buprenorphine|buprenorphine|mesh-list
6289830|NCT00000357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6289831|NCT00000357|Narcotics|narcotics|mesh-ancestor
6289832|NCT00000357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6289833|NCT00000357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289834|NCT00000357|Analgesics|analgesics|mesh-ancestor
6289835|NCT00000357|Sensory System Agents|sensory system agents|mesh-ancestor
6289836|NCT00000357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6289837|NCT00000357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6289838|NCT00000358|Lofexidine|lofexidine|mesh-list
6289839|NCT00000358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6289840|NCT00000358|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6289841|NCT00000358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289842|NCT00000358|Sensory System Agents|sensory system agents|mesh-ancestor
6289843|NCT00000358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6289844|NCT00000358|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6289845|NCT00000358|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6289846|NCT00000358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6289847|NCT00000358|Adrenergic Agents|adrenergic agents|mesh-ancestor
6289848|NCT00000358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6289849|NCT00000358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289850|NCT00000361|Methotrexate|methotrexate|mesh-list
6289851|NCT00000361|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6289852|NCT00000361|Abortifacient Agents|abortifacient agents|mesh-ancestor
6289853|NCT00000361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6289854|NCT00000361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289855|NCT00000361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6289856|NCT00000361|Antimetabolites|antimetabolites|mesh-ancestor
6289857|NCT00000361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289858|NCT00000361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6289859|NCT00000361|Dermatologic Agents|dermatologic agents|mesh-ancestor
6289860|NCT00000361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6289861|NCT00000361|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6289862|NCT00000361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6289863|NCT00000361|Immunologic Factors|immunologic factors|mesh-ancestor
6289864|NCT00000361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6289865|NCT00000361|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6289866|NCT00000363|Histamine Antagonists|histamine antagonists|mesh-list
6289867|NCT00000363|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
6289868|NCT00000363|Histamine Agents|histamine agents|mesh-ancestor
6289869|NCT00000363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6289870|NCT00000363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391732|NCT00193973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6289871|NCT00000363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289872|NCT00000368|Paroxetine|paroxetine|mesh-list
6289873|NCT00000368|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6289874|NCT00000368|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6289875|NCT00000368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6289876|NCT00000368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289877|NCT00000368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6289878|NCT00000368|Serotonin Agents|serotonin agents|mesh-ancestor
6289879|NCT00000368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289880|NCT00000368|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6289881|NCT00000368|Antidepressive Agents|antidepressive agents|mesh-ancestor
6289882|NCT00000368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6289883|NCT00000368|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6289884|NCT00000368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6289885|NCT00000368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6289886|NCT00000369|Lithium Carbonate|lithium carbonate|mesh-list
6289887|NCT00000369|Antidepressive Agents|antidepressive agents|mesh-ancestor
6289888|NCT00000369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6289889|NCT00000369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6289890|NCT00000369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289891|NCT00000369|Antimanic Agents|antimanic agents|mesh-ancestor
6289892|NCT00000369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6289893|NCT00000369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6289894|NCT00000369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289895|NCT00000372|Cycloserine|cycloserine|mesh-list
6289896|NCT00000372|Clozapine|clozapine|mesh-list
6289897|NCT00000372|Glycine|glycine|mesh-list
6289898|NCT00000372|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6289899|NCT00000372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6289900|NCT00000372|Renal Agents|renal agents|mesh-ancestor
6289901|NCT00000372|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6289902|NCT00000372|Antitubercular Agents|antitubercular agents|mesh-ancestor
6289903|NCT00000372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6289904|NCT00000372|Antimetabolites|antimetabolites|mesh-ancestor
6289905|NCT00000372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289906|NCT00000372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6289907|NCT00000372|Serotonin Agents|serotonin agents|mesh-ancestor
6289908|NCT00000372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6289909|NCT00000372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289910|NCT00000372|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6289911|NCT00000372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6289912|NCT00000372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6289913|NCT00000372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6289914|NCT00000372|GABA Antagonists|gaba antagonists|mesh-ancestor
6289915|NCT00000372|GABA Agents|gaba agents|mesh-ancestor
6289916|NCT00000372|Glycine Agents|glycine agents|mesh-ancestor
6289917|NCT00000373|Olanzapine|olanzapine|mesh-list
6289918|NCT00000373|Fluoxetine|fluoxetine|mesh-list
6289919|NCT00000373|Antiemetics|antiemetics|mesh-ancestor
6289920|NCT00000373|Autonomic Agents|autonomic agents|mesh-ancestor
6289921|NCT00000373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6289922|NCT00000373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289923|NCT00000373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6289924|NCT00000373|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6289925|NCT00000373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6289926|NCT00000373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6289927|NCT00000373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6289928|NCT00000373|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6289929|NCT00000373|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6289930|NCT00000373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6289931|NCT00000373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289932|NCT00000373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6289933|NCT00000373|Serotonin Agents|serotonin agents|mesh-ancestor
6289934|NCT00000373|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6289935|NCT00000373|Antidepressive Agents|antidepressive agents|mesh-ancestor
6289936|NCT00000373|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6289937|NCT00000373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6289938|NCT00000373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6289939|NCT00000374|Olanzapine|olanzapine|mesh-list
6289940|NCT00000374|Risperidone|risperidone|mesh-list
6289941|NCT00000374|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6289942|NCT00000374|Serotonin Agents|serotonin agents|mesh-ancestor
6289943|NCT00000374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6289944|NCT00000374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289945|NCT00000374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289946|NCT00000374|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6289947|NCT00000374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6289948|NCT00000374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6289949|NCT00000374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6289950|NCT00000374|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6289951|NCT00000374|Dopamine Agents|dopamine agents|mesh-ancestor
6289952|NCT00000374|Antiemetics|antiemetics|mesh-ancestor
6289953|NCT00000374|Autonomic Agents|autonomic agents|mesh-ancestor
6289954|NCT00000374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6289955|NCT00000374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6289956|NCT00000374|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6289957|NCT00000374|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6289958|NCT00000374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6289959|NCT00000375|Nortriptyline|nortriptyline|mesh-list
6289960|NCT00000375|Antidepressive Agents|antidepressive agents|mesh-ancestor
6289961|NCT00000375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6289962|NCT00000375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289963|NCT00000375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289964|NCT00000375|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6289965|NCT00000375|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6289966|NCT00000375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6289967|NCT00000375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6289968|NCT00000375|Adrenergic Agents|adrenergic agents|mesh-ancestor
6289969|NCT00000375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6289970|NCT00000376|Desipramine|desipramine|mesh-list
6289971|NCT00000376|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6289972|NCT00000376|Antidepressive Agents|antidepressive agents|mesh-ancestor
6289973|NCT00000376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6289974|NCT00000376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6289975|NCT00000376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289976|NCT00000376|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6289977|NCT00000376|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6289978|NCT00000376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6289979|NCT00000376|Adrenergic Agents|adrenergic agents|mesh-ancestor
6289980|NCT00000376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6289981|NCT00000376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289982|NCT00000377|Nortriptyline|nortriptyline|mesh-list
6289983|NCT00000377|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6289984|NCT00000377|Antidepressive Agents|antidepressive agents|mesh-ancestor
6289985|NCT00000377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6289986|NCT00000377|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6289987|NCT00000377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6289988|NCT00000377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6289989|NCT00000377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289990|NCT00000377|Adrenergic Agents|adrenergic agents|mesh-ancestor
6289991|NCT00000377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6289992|NCT00000377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6289993|NCT00000379|Fluoxetine|fluoxetine|mesh-list
6289994|NCT00000379|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6289995|NCT00000379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6289996|NCT00000379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6289997|NCT00000379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6289998|NCT00000379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6289999|NCT00000379|Serotonin Agents|serotonin agents|mesh-ancestor
6290000|NCT00000379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290001|NCT00000379|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6290002|NCT00000379|Antidepressive Agents|antidepressive agents|mesh-ancestor
6290003|NCT00000379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6290004|NCT00000379|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6290005|NCT00000379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6290006|NCT00000379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6290007|NCT00000381|Fluoxetine|fluoxetine|mesh-list
6290008|NCT00000381|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6290009|NCT00000381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6290010|NCT00000381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6290011|NCT00000381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6290012|NCT00000381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6290013|NCT00000381|Serotonin Agents|serotonin agents|mesh-ancestor
6290014|NCT00000381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290015|NCT00000381|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6290016|NCT00000381|Antidepressive Agents|antidepressive agents|mesh-ancestor
6290017|NCT00000381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6290018|NCT00000381|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6290019|NCT00000381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6290020|NCT00000381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6290021|NCT00000384|Sertraline|sertraline|mesh-list
6290022|NCT00000384|Antidepressive Agents|antidepressive agents|mesh-ancestor
6290023|NCT00000384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6290024|NCT00000384|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6290025|NCT00000384|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6290026|NCT00000384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6290027|NCT00000384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6290028|NCT00000384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6290029|NCT00000384|Serotonin Agents|serotonin agents|mesh-ancestor
6290030|NCT00000384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290031|NCT00000385|Lithium Carbonate|lithium carbonate|mesh-list
6290032|NCT00000385|Antidepressive Agents|antidepressive agents|mesh-ancestor
6290033|NCT00000385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6290034|NCT00000385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6290035|NCT00000385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6290036|NCT00000385|Antimanic Agents|antimanic agents|mesh-ancestor
6290037|NCT00000385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6290038|NCT00000385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6290039|NCT00000385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290040|NCT00000389|Fluvoxamine|fluvoxamine|mesh-list
6290041|NCT00000389|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6290042|NCT00000389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6290043|NCT00000389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6290044|NCT00000389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290045|NCT00000389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6290046|NCT00000389|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6290047|NCT00000389|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6290048|NCT00000389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6290049|NCT00000389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6290050|NCT00000389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6290051|NCT00000389|Serotonin Agents|serotonin agents|mesh-ancestor
6290052|NCT00000389|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6290053|NCT00000389|Antidepressive Agents|antidepressive agents|mesh-ancestor
6290054|NCT00000389|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6290055|NCT00000389|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6290056|NCT00000389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6290057|NCT00000389|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6290058|NCT00000390|Imipramine|imipramine|mesh-list
6290059|NCT00000390|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6290060|NCT00000390|Antidepressive Agents|antidepressive agents|mesh-ancestor
6290061|NCT00000390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6290062|NCT00000390|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6290063|NCT00000390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6290064|NCT00000390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6290065|NCT00000390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6290066|NCT00000390|Adrenergic Agents|adrenergic agents|mesh-ancestor
6290067|NCT00000390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6290068|NCT00000390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290069|NCT00000395|Folic Acid|folic acid|mesh-list
6290070|NCT00000395|Leucovorin|leucovorin|mesh-list
6290071|NCT00000395|Methotrexate|methotrexate|mesh-list
6290072|NCT00000395|Levoleucovorin|levoleucovorin|mesh-list
6290073|NCT00000395|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6290074|NCT00000395|Abortifacient Agents|abortifacient agents|mesh-ancestor
6290075|NCT00000395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6290076|NCT00000395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290077|NCT00000395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6290078|NCT00000395|Antimetabolites|antimetabolites|mesh-ancestor
6290079|NCT00000395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6290080|NCT00000395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6290081|NCT00000395|Dermatologic Agents|dermatologic agents|mesh-ancestor
6290082|NCT00000395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6290083|NCT00000395|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6290084|NCT00000395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6290085|NCT00000395|Immunologic Factors|immunologic factors|mesh-ancestor
6290086|NCT00000395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6290087|NCT00000395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6290088|NCT00000395|Hematinics|hematinics|mesh-ancestor
6290089|NCT00000395|Vitamin B Complex|vitamin b complex|mesh-ancestor
6290090|NCT00000395|Vitamins|vitamins|mesh-ancestor
6290091|NCT00000395|Micronutrients|micronutrients|mesh-ancestor
6290092|NCT00000395|Antidotes|antidotes|mesh-ancestor
6290093|NCT00000395|Protective Agents|protective agents|mesh-ancestor
6290094|NCT00000399|Hormones|hormones|mesh-list
6290095|NCT00000399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6290096|NCT00000399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290097|NCT00000400|Alendronate|alendronate|mesh-list
6290098|NCT00000400|Teriparatide|teriparatide|mesh-list
6290099|NCT00000400|Hormones|hormones|mesh-list
6290100|NCT00000400|Parathyroid Hormone|parathyroid hormone|mesh-list
6290101|NCT00000400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6290102|NCT00000400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290103|NCT00000400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6290104|NCT00000400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6290105|NCT00000402|Calcium|calcium|mesh-list
6290106|NCT00000402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6290107|NCT00000402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290108|NCT00000403|Doxycycline|doxycycline|mesh-list
6290109|NCT00000403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6290110|NCT00000403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6290111|NCT00000403|Antimalarials|antimalarials|mesh-ancestor
6290112|NCT00000403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6290113|NCT00000403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6290114|NCT00000412|Alendronate|alendronate|mesh-list
6290115|NCT00000412|Calcitriol|calcitriol|mesh-list
6290116|NCT00000412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6290117|NCT00000412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290118|NCT00000412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6290119|NCT00000412|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6290120|NCT00000412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6290121|NCT00000412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6290122|NCT00000412|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6290123|NCT00000412|Vitamins|vitamins|mesh-ancestor
6290124|NCT00000412|Micronutrients|micronutrients|mesh-ancestor
6290125|NCT00000415|Calcium|calcium|mesh-list
6290126|NCT00000415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6290127|NCT00000415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290128|NCT00000419|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6290129|NCT00000419|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6290130|NCT00000419|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6290131|NCT00000419|Contraceptive Agents|contraceptive agents|mesh-ancestor
6290132|NCT00000419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6290133|NCT00000419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290134|NCT00000419|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6290135|NCT00000419|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6290136|NCT00000419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6290137|NCT00000419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6290138|NCT00000419|Estrogens|estrogens|mesh-ancestor
6290139|NCT00000419|Hormones|hormones|mesh-ancestor
6290140|NCT00000419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6290141|NCT00000420|Norinyl|norinyl|mesh-list
6290142|NCT00000420|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
6290143|NCT00000420|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6290144|NCT00000420|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6290145|NCT00000420|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6290146|NCT00000420|Contraceptive Agents|contraceptive agents|mesh-ancestor
6290147|NCT00000420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6290148|NCT00000420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290149|NCT00000420|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6290150|NCT00000420|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6290151|NCT00000420|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
6290152|NCT00000420|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6290153|NCT00000421|Prednisone|prednisone|mesh-list
6290154|NCT00000421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6290155|NCT00000421|Glucocorticoids|glucocorticoids|mesh-ancestor
6290156|NCT00000421|Hormones|hormones|mesh-ancestor
6290157|NCT00000421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6290158|NCT00000421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290159|NCT00000421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6290160|NCT00000421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6290161|NCT00000425|Acetaminophen|acetaminophen|mesh-list
6290162|NCT00000425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
6290163|NCT00000425|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
6290164|NCT00000425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6290165|NCT00000425|Analgesics|analgesics|mesh-ancestor
6290166|NCT00000425|Sensory System Agents|sensory system agents|mesh-ancestor
6290167|NCT00000425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6290168|NCT00000425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290169|NCT00000425|Antipyretics|antipyretics|mesh-ancestor
6290170|NCT00000425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6290171|NCT00000426|Calcium|calcium|mesh-list
6290172|NCT00000426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6290173|NCT00000426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290174|NCT00000427|Alendronate|alendronate|mesh-list
6290175|NCT00000427|Hormones|hormones|mesh-list
6290176|NCT00000427|Parathyroid Hormone|parathyroid hormone|mesh-list
6290177|NCT00000427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6290178|NCT00000427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290179|NCT00000427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6290180|NCT00000427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6290181|NCT00000428|Amitriptyline|amitriptyline|mesh-list
6290182|NCT00000428|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6290183|NCT00000428|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6290184|NCT00000428|Antidepressive Agents|antidepressive agents|mesh-ancestor
6290185|NCT00000428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6290186|NCT00000428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6290187|NCT00000428|Analgesics|analgesics|mesh-ancestor
6290188|NCT00000428|Sensory System Agents|sensory system agents|mesh-ancestor
6290189|NCT00000428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6290190|NCT00000428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290191|NCT00000428|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6290192|NCT00000428|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6290193|NCT00000428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6290194|NCT00000428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6290195|NCT00000428|Adrenergic Agents|adrenergic agents|mesh-ancestor
6290196|NCT00000428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6290197|NCT00000428|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6290198|NCT00000428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6290199|NCT00000428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6290200|NCT00000429|Calcium Carbonate|calcium carbonate|mesh-list
6290201|NCT00000429|Calcium|calcium|mesh-list
6290202|NCT00000429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6290203|NCT00000429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290204|NCT00000429|Antacids|antacids|mesh-ancestor
6290205|NCT00000429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6290206|NCT00000429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6290207|NCT00000430|Alendronate|alendronate|mesh-list
6290208|NCT00000430|Estrogens|estrogens|mesh-list
6290209|NCT00000430|Progestins|progestins|mesh-list
6290210|NCT00000430|Hormones|hormones|mesh-ancestor
6290211|NCT00000430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6290212|NCT00000430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290213|NCT00000430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6290214|NCT00000437|Naltrexone|naltrexone|mesh-list
6290215|NCT00000437|Nicotine|nicotine|mesh-list
6290216|NCT00000437|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6290217|NCT00000437|Autonomic Agents|autonomic agents|mesh-ancestor
6290218|NCT00000437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6290219|NCT00000437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290220|NCT00000437|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6290221|NCT00000437|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6290222|NCT00000437|Cholinergic Agents|cholinergic agents|mesh-ancestor
6290223|NCT00000437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6290224|NCT00000437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6290225|NCT00000437|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6290226|NCT00000437|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6290227|NCT00000437|Sensory System Agents|sensory system agents|mesh-ancestor
6290228|NCT00000438|Naltrexone|naltrexone|mesh-list
6290229|NCT00000438|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6290230|NCT00000438|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6290231|NCT00000438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290232|NCT00000438|Sensory System Agents|sensory system agents|mesh-ancestor
6290233|NCT00000438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6290234|NCT00000439|Valproic Acid|valproic acid|mesh-list
6290235|NCT00000439|Anticonvulsants|anticonvulsants|mesh-ancestor
6290236|NCT00000439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6290237|NCT00000439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6290238|NCT00000439|GABA Agents|gaba agents|mesh-ancestor
6290239|NCT00000439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6290240|NCT00000439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290241|NCT00000439|Antimanic Agents|antimanic agents|mesh-ancestor
6290242|NCT00000439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6290243|NCT00000439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6290244|NCT00000439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6290245|NCT00000440|Naltrexone|naltrexone|mesh-list
6290246|NCT00000440|Sertraline|sertraline|mesh-list
6290247|NCT00000440|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6290248|NCT00000440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6290249|NCT00000440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290250|NCT00000440|Sensory System Agents|sensory system agents|mesh-ancestor
6290251|NCT00000440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6290252|NCT00000440|Antidepressive Agents|antidepressive agents|mesh-ancestor
6290253|NCT00000440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6290254|NCT00000440|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6290255|NCT00000440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6290256|NCT00000440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6290257|NCT00000440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6290258|NCT00000440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6290259|NCT00000440|Serotonin Agents|serotonin agents|mesh-ancestor
6290260|NCT00000441|Carbamazepine|carbamazepine|mesh-list
6290261|NCT00000441|Lorazepam|lorazepam|mesh-list
6290262|NCT00000441|Anticonvulsants|anticonvulsants|mesh-ancestor
6290263|NCT00000441|Antiemetics|antiemetics|mesh-ancestor
6290264|NCT00000441|Autonomic Agents|autonomic agents|mesh-ancestor
6290265|NCT00000441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6290266|NCT00000441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290267|NCT00000441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6290268|NCT00000441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6290269|NCT00000441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6290270|NCT00000441|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6290271|NCT00000441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6290272|NCT00000441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6290273|NCT00000441|GABA Modulators|gaba modulators|mesh-ancestor
6290274|NCT00000441|GABA Agents|gaba agents|mesh-ancestor
6290275|NCT00000441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6290276|NCT00000441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6290277|NCT00000441|Antimanic Agents|antimanic agents|mesh-ancestor
6290278|NCT00000441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6290279|NCT00000441|Analgesics|analgesics|mesh-ancestor
6290280|NCT00000441|Sensory System Agents|sensory system agents|mesh-ancestor
6290281|NCT00000441|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6290282|NCT00000441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6290283|NCT00000441|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6290284|NCT00000441|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6290285|NCT00000442|Naltrexone|naltrexone|mesh-list
6290286|NCT00000442|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6290287|NCT00000442|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6290288|NCT00000442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290289|NCT00000442|Sensory System Agents|sensory system agents|mesh-ancestor
6290290|NCT00000442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6290291|NCT00000443|Ondansetron|ondansetron|mesh-list
6290292|NCT00000443|Antiemetics|antiemetics|mesh-ancestor
6290293|NCT00000443|Autonomic Agents|autonomic agents|mesh-ancestor
6290294|NCT00000443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6290295|NCT00000443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290296|NCT00000443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6290297|NCT00000443|Antipruritics|antipruritics|mesh-ancestor
6290298|NCT00000443|Dermatologic Agents|dermatologic agents|mesh-ancestor
6290299|NCT00000443|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6290300|NCT00000443|Serotonin Agents|serotonin agents|mesh-ancestor
6290301|NCT00000443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6290302|NCT00000443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6290303|NCT00000443|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6290304|NCT00000443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6290305|NCT00000443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6290306|NCT00000443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6290307|NCT00000443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6290308|NCT00000444|Nicotine|nicotine|mesh-list
6290309|NCT00000444|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6290310|NCT00000444|Autonomic Agents|autonomic agents|mesh-ancestor
6290311|NCT00000444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6290312|NCT00000444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290313|NCT00000444|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6290314|NCT00000444|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6290315|NCT00000444|Cholinergic Agents|cholinergic agents|mesh-ancestor
6290316|NCT00000444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6290317|NCT00000444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6290318|NCT00000445|Naltrexone|naltrexone|mesh-list
6290319|NCT00000445|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6290320|NCT00000445|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6290321|NCT00000445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290322|NCT00000445|Sensory System Agents|sensory system agents|mesh-ancestor
6290323|NCT00000445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6290324|NCT00000446|Sertraline|sertraline|mesh-list
6290325|NCT00000446|Antidepressive Agents|antidepressive agents|mesh-ancestor
6290326|NCT00000446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6290327|NCT00000446|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6290328|NCT00000446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6290329|NCT00000446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6290330|NCT00000446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6290331|NCT00000446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6290332|NCT00000446|Serotonin Agents|serotonin agents|mesh-ancestor
6290333|NCT00000446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290334|NCT00000447|Naltrexone|naltrexone|mesh-list
6290335|NCT00000447|Nicotine|nicotine|mesh-list
6290336|NCT00000447|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6290337|NCT00000447|Autonomic Agents|autonomic agents|mesh-ancestor
6290338|NCT00000447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6290339|NCT00000447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290340|NCT00000447|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6290341|NCT00000447|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6290342|NCT00000447|Cholinergic Agents|cholinergic agents|mesh-ancestor
6290343|NCT00000447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6290344|NCT00000447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6290345|NCT00000447|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6290346|NCT00000447|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6290347|NCT00000447|Sensory System Agents|sensory system agents|mesh-ancestor
6290348|NCT00000448|Naltrexone|naltrexone|mesh-list
6290349|NCT00000448|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6290350|NCT00000448|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6290351|NCT00000448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290352|NCT00000448|Sensory System Agents|sensory system agents|mesh-ancestor
6290353|NCT00000448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6290354|NCT00000449|Naltrexone|naltrexone|mesh-list
6290355|NCT00000449|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6290356|NCT00000449|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6290357|NCT00000449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290358|NCT00000449|Sensory System Agents|sensory system agents|mesh-ancestor
6290359|NCT00000449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6290360|NCT00000450|Naltrexone|naltrexone|mesh-list
6290361|NCT00000450|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6290362|NCT00000450|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6290363|NCT00000450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290364|NCT00000450|Sensory System Agents|sensory system agents|mesh-ancestor
6290365|NCT00000450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6290366|NCT00000451|Naltrexone|naltrexone|mesh-list
6290367|NCT00000451|Sertraline|sertraline|mesh-list
6290368|NCT00000451|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6290369|NCT00000451|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6290370|NCT00000451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290371|NCT00000451|Sensory System Agents|sensory system agents|mesh-ancestor
6290372|NCT00000451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6290373|NCT00000451|Antidepressive Agents|antidepressive agents|mesh-ancestor
6290374|NCT00000451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6290375|NCT00000451|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6290376|NCT00000451|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6290377|NCT00000451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6290378|NCT00000451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6290379|NCT00000451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6290380|NCT00000451|Serotonin Agents|serotonin agents|mesh-ancestor
6290381|NCT00000452|Naltrexone|naltrexone|mesh-list
6290382|NCT00000452|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6290383|NCT00000452|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6290384|NCT00000452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290385|NCT00000452|Sensory System Agents|sensory system agents|mesh-ancestor
6290386|NCT00000452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6391733|NCT00193973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6391734|NCT00193973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6391735|NCT00193973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6391736|NCT00193973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6391737|NCT00194038|Aripiprazole|aripiprazole|mesh-list
6391738|NCT00194038|Antidepressive Agents|antidepressive agents|mesh-ancestor
6391739|NCT00194038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6391740|NCT00194038|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6391741|NCT00194038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6391742|NCT00194038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6391743|NCT00194038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6391744|NCT00194038|Dopamine Agonists|dopamine agonists|mesh-ancestor
6391745|NCT00194038|Dopamine Agents|dopamine agents|mesh-ancestor
6391746|NCT00194038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6391747|NCT00194038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391748|NCT00194038|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6391749|NCT00194038|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6391750|NCT00194038|Serotonin Agents|serotonin agents|mesh-ancestor
6391751|NCT00194038|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6391752|NCT00194038|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6391753|NCT00194038|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6391754|NCT00194038|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6391755|NCT00194064|Olanzapine|olanzapine|mesh-list
6391756|NCT00194064|Antiemetics|antiemetics|mesh-ancestor
6391757|NCT00194064|Autonomic Agents|autonomic agents|mesh-ancestor
6391758|NCT00194064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6391759|NCT00194064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6391760|NCT00194064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6391761|NCT00194064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6391762|NCT00194064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6391763|NCT00194064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6391764|NCT00194064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6391765|NCT00194064|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6391766|NCT00194064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6391767|NCT00194064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6391768|NCT00194064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391769|NCT00194064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6391770|NCT00194064|Serotonin Agents|serotonin agents|mesh-ancestor
6391771|NCT00194090|Celecoxib|celecoxib|mesh-list
6391772|NCT00194090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6391773|NCT00194090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6391774|NCT00194090|Analgesics|analgesics|mesh-ancestor
6391775|NCT00194090|Sensory System Agents|sensory system agents|mesh-ancestor
6391776|NCT00194090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6391777|NCT00194090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6391778|NCT00194090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6391779|NCT00194090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6391780|NCT00194090|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6391781|NCT00194090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6391782|NCT00194090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6391783|NCT00194090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391784|NCT00194272|Methotrexate|methotrexate|mesh-list
6391785|NCT00194272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6290387|NCT00000454|Nicotine|nicotine|mesh-list
6290388|NCT00000454|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6290389|NCT00000454|Autonomic Agents|autonomic agents|mesh-ancestor
6290390|NCT00000454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6290391|NCT00000454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290392|NCT00000454|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6290393|NCT00000454|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6290394|NCT00000454|Cholinergic Agents|cholinergic agents|mesh-ancestor
6290395|NCT00000454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6290396|NCT00000454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6290397|NCT00000455|Naltrexone|naltrexone|mesh-list
6290398|NCT00000455|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6290399|NCT00000455|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6290400|NCT00000455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290401|NCT00000455|Sensory System Agents|sensory system agents|mesh-ancestor
6290402|NCT00000455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6290403|NCT00000456|Naltrexone|naltrexone|mesh-list
6290404|NCT00000456|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6290405|NCT00000456|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6290406|NCT00000456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290407|NCT00000456|Sensory System Agents|sensory system agents|mesh-ancestor
6290408|NCT00000456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6290409|NCT00000457|Bupropion|bupropion|mesh-list
6290410|NCT00000457|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6290411|NCT00000457|Antidepressive Agents|antidepressive agents|mesh-ancestor
6290412|NCT00000457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6290413|NCT00000457|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6290414|NCT00000457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6290415|NCT00000457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6290416|NCT00000457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6290417|NCT00000457|Dopamine Agents|dopamine agents|mesh-ancestor
6290418|NCT00000457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6290419|NCT00000457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290420|NCT00000457|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6290421|NCT00000457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6290422|NCT00000457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6290423|NCT00000458|Sertraline|sertraline|mesh-list
6290424|NCT00000458|Antidepressive Agents|antidepressive agents|mesh-ancestor
6290425|NCT00000458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6290426|NCT00000458|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6290427|NCT00000458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6290428|NCT00000458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6290429|NCT00000458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6290430|NCT00000458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6290431|NCT00000458|Serotonin Agents|serotonin agents|mesh-ancestor
6290432|NCT00000458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290433|NCT00000461|Niacin|niacin|mesh-list
6290434|NCT00000461|Pravastatin|pravastatin|mesh-list
6290435|NCT00000461|Gemfibrozil|gemfibrozil|mesh-list
6290436|NCT00000461|Cholestyramine Resin|cholestyramine resin|mesh-list
6290437|NCT00000461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6290438|NCT00000461|Antimetabolites|antimetabolites|mesh-ancestor
6290439|NCT00000461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6290440|NCT00000461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6290441|NCT00000461|Vasodilator Agents|vasodilator agents|mesh-ancestor
6290442|NCT00000461|Vitamin B Complex|vitamin b complex|mesh-ancestor
6290443|NCT00000461|Vitamins|vitamins|mesh-ancestor
6290444|NCT00000461|Micronutrients|micronutrients|mesh-ancestor
6290445|NCT00000461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290446|NCT00000461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6290447|NCT00000461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6290448|NCT00000461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6290449|NCT00000461|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6290450|NCT00000461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6290451|NCT00000463|Warfarin|warfarin|mesh-list
6290452|NCT00000463|Lovastatin|lovastatin|mesh-list
6290453|NCT00000463|L 647318|l 647318|mesh-list
6290454|NCT00000463|Dihydromevinolin|dihydromevinolin|mesh-list
6290455|NCT00000463|Cholestyramine Resin|cholestyramine resin|mesh-list
6290456|NCT00000463|Anticoagulants|anticoagulants|mesh-ancestor
6290457|NCT00000463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6290458|NCT00000463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6290459|NCT00000463|Antimetabolites|antimetabolites|mesh-ancestor
6290460|NCT00000463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6290461|NCT00000463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6290462|NCT00000463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6290463|NCT00000463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6290464|NCT00000464|Quinidine|quinidine|mesh-list
6290465|NCT00000464|Amiodarone|amiodarone|mesh-list
6290466|NCT00000464|Sotalol|sotalol|mesh-list
6290467|NCT00000464|Propafenone|propafenone|mesh-list
6290468|NCT00000464|Mexiletine|mexiletine|mesh-list
6290469|NCT00000464|Procainamide|procainamide|mesh-list
6290470|NCT00000464|Imipramine|imipramine|mesh-list
6290471|NCT00000464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6290472|NCT00000464|Vasodilator Agents|vasodilator agents|mesh-ancestor
6290473|NCT00000464|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6290474|NCT00000464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6290475|NCT00000464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6290476|NCT00000464|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6290477|NCT00000464|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6290478|NCT00000464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6290479|NCT00000464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6290480|NCT00000464|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6290481|NCT00000464|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6290482|NCT00000464|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6290483|NCT00000464|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6290484|NCT00000464|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6290485|NCT00000464|Adrenergic Agents|adrenergic agents|mesh-ancestor
6290486|NCT00000464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6290487|NCT00000464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290488|NCT00000464|Sympatholytics|sympatholytics|mesh-ancestor
6290489|NCT00000464|Autonomic Agents|autonomic agents|mesh-ancestor
6290490|NCT00000464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6290491|NCT00000464|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6290492|NCT00000464|Antimalarials|antimalarials|mesh-ancestor
6290493|NCT00000464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6290494|NCT00000464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6290495|NCT00000464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6290496|NCT00000464|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6290497|NCT00000464|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6290498|NCT00000464|Cholinergic Agents|cholinergic agents|mesh-ancestor
6290499|NCT00000464|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6290500|NCT00000464|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6290501|NCT00000464|Antidepressive Agents|antidepressive agents|mesh-ancestor
6290502|NCT00000464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6290503|NCT00000464|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6290504|NCT00000464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6290505|NCT00000466|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6290506|NCT00000466|Medroxyprogesterone|medroxyprogesterone|mesh-list
6290507|NCT00000466|Progesterone|progesterone|mesh-list
6290508|NCT00000466|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6290509|NCT00000466|Estrogens|estrogens|mesh-list
6290510|NCT00000466|Progestins|progestins|mesh-ancestor
6290511|NCT00000466|Hormones|hormones|mesh-ancestor
6290512|NCT00000466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6290513|NCT00000466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290514|NCT00000466|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6290515|NCT00000466|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6290516|NCT00000466|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6290517|NCT00000466|Contraceptive Agents|contraceptive agents|mesh-ancestor
6290518|NCT00000466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6290519|NCT00000466|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6290520|NCT00000466|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6290521|NCT00000466|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6290522|NCT00000466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6290523|NCT00000466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6290524|NCT00000468|Plasminogen|plasminogen|mesh-list
6290525|NCT00000468|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6290526|NCT00000468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6290527|NCT00000468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6290528|NCT00000468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6290529|NCT00000469|Aspirin|aspirin|mesh-list
6290530|NCT00000469|Lovastatin|lovastatin|mesh-list
6290531|NCT00000469|L 647318|l 647318|mesh-list
6290532|NCT00000469|Dihydromevinolin|dihydromevinolin|mesh-list
6290533|NCT00000469|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6290534|NCT00000469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6290535|NCT00000469|Analgesics|analgesics|mesh-ancestor
6290536|NCT00000469|Sensory System Agents|sensory system agents|mesh-ancestor
6290537|NCT00000469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6290538|NCT00000469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290539|NCT00000469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6290540|NCT00000469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6290541|NCT00000469|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6290542|NCT00000469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6290543|NCT00000469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6290544|NCT00000469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6290545|NCT00000469|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6290546|NCT00000469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6290547|NCT00000469|Antipyretics|antipyretics|mesh-ancestor
6290548|NCT00000469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6290549|NCT00000469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6290550|NCT00000469|Antimetabolites|antimetabolites|mesh-ancestor
6290551|NCT00000469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6290552|NCT00000469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6290553|NCT00000472|Heparin|heparin|mesh-list
6290554|NCT00000472|Plasminogen|plasminogen|mesh-list
6290555|NCT00000472|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6290556|NCT00000472|Anticoagulants|anticoagulants|mesh-ancestor
6290557|NCT00000472|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6290558|NCT00000472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6290559|NCT00000472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6290560|NCT00000477|Lovastatin|lovastatin|mesh-list
6290561|NCT00000477|L 647318|l 647318|mesh-list
6290562|NCT00000477|Dihydromevinolin|dihydromevinolin|mesh-list
6290563|NCT00000477|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6290564|NCT00000477|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6290565|NCT00000477|Antimetabolites|antimetabolites|mesh-ancestor
6290566|NCT00000477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6290567|NCT00000477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6290568|NCT00000477|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6290569|NCT00000477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6290570|NCT00000478|Atenolol|atenolol|mesh-list
6290571|NCT00000478|Diltiazem|diltiazem|mesh-list
6290572|NCT00000478|Nifedipine|nifedipine|mesh-list
6290573|NCT00000478|Isosorbide|isosorbide|mesh-list
6290574|NCT00000478|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
6290575|NCT00000478|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
6290576|NCT00000478|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6290577|NCT00000478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6290578|NCT00000478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6290579|NCT00000478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6290580|NCT00000478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290581|NCT00000478|Vasodilator Agents|vasodilator agents|mesh-ancestor
6290582|NCT00000478|Tocolytic Agents|tocolytic agents|mesh-ancestor
6290583|NCT00000478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6290584|NCT00000478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6290585|NCT00000478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6290586|NCT00000478|Sympatholytics|sympatholytics|mesh-ancestor
6290587|NCT00000478|Autonomic Agents|autonomic agents|mesh-ancestor
6290588|NCT00000478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6290589|NCT00000478|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6290590|NCT00000478|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6290591|NCT00000478|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6290592|NCT00000478|Adrenergic Agents|adrenergic agents|mesh-ancestor
6290593|NCT00000478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6290594|NCT00000478|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6290595|NCT00000478|Diuretics|diuretics|mesh-ancestor
6290596|NCT00000478|Natriuretic Agents|natriuretic agents|mesh-ancestor
6290597|NCT00000478|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6290598|NCT00000480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
6290599|NCT00000482|Niacin|niacin|mesh-list
6290600|NCT00000482|Clofibrate|clofibrate|mesh-list
6290601|NCT00000482|Estrogens|estrogens|mesh-list
6290602|NCT00000482|Hormones|hormones|mesh-ancestor
6290603|NCT00000482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6290604|NCT00000482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290605|NCT00000482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6290606|NCT00000482|Antimetabolites|antimetabolites|mesh-ancestor
6290607|NCT00000482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6290608|NCT00000482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6290609|NCT00000482|Vasodilator Agents|vasodilator agents|mesh-ancestor
6290610|NCT00000482|Vitamin B Complex|vitamin b complex|mesh-ancestor
6290611|NCT00000482|Vitamins|vitamins|mesh-ancestor
6290612|NCT00000482|Micronutrients|micronutrients|mesh-ancestor
6290613|NCT00000482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6290614|NCT00000483|Niacin|niacin|mesh-list
6290615|NCT00000483|Clofibrate|clofibrate|mesh-list
6290616|NCT00000483|Estrogens|estrogens|mesh-list
6290617|NCT00000483|Hormones|hormones|mesh-ancestor
6290618|NCT00000483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6290619|NCT00000483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290620|NCT00000483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6290621|NCT00000483|Antimetabolites|antimetabolites|mesh-ancestor
6290622|NCT00000483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6290623|NCT00000483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6290624|NCT00000483|Vasodilator Agents|vasodilator agents|mesh-ancestor
6290625|NCT00000483|Vitamin B Complex|vitamin b complex|mesh-ancestor
6290626|NCT00000483|Vitamins|vitamins|mesh-ancestor
6290627|NCT00000483|Micronutrients|micronutrients|mesh-ancestor
6290628|NCT00000483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6290629|NCT00000484|Chlorothiazide|chlorothiazide|mesh-list
6290630|NCT00000484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6290631|NCT00000484|Diuretics|diuretics|mesh-ancestor
6290632|NCT00000484|Natriuretic Agents|natriuretic agents|mesh-ancestor
6290633|NCT00000484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290634|NCT00000484|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6290635|NCT00000484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6290636|NCT00000484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6290637|NCT00000485|Antihypertensive Agents|antihypertensive agents|mesh-list
6290638|NCT00000485|Diuretics|diuretics|mesh-list
6290639|NCT00000485|Natriuretic Agents|natriuretic agents|mesh-ancestor
6290640|NCT00000485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290641|NCT00000487|Antihypertensive Agents|antihypertensive agents|mesh-list
6290642|NCT00000487|Diuretics|diuretics|mesh-list
6290643|NCT00000487|Natriuretic Agents|natriuretic agents|mesh-ancestor
6290644|NCT00000487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290645|NCT00000488|Cholestyramine Resin|cholestyramine resin|mesh-list
6290646|NCT00000488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6290647|NCT00000488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6290648|NCT00000488|Antimetabolites|antimetabolites|mesh-ancestor
6290649|NCT00000488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6290650|NCT00000488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6290651|NCT00000491|Aspirin|aspirin|mesh-list
6290652|NCT00000491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6290653|NCT00000491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6290654|NCT00000491|Analgesics|analgesics|mesh-ancestor
6290655|NCT00000491|Sensory System Agents|sensory system agents|mesh-ancestor
6290656|NCT00000491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6290657|NCT00000491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290658|NCT00000491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6290659|NCT00000491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6290660|NCT00000491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6290661|NCT00000491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6290662|NCT00000491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6290663|NCT00000491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6290664|NCT00000491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6290665|NCT00000491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6290666|NCT00000491|Antipyretics|antipyretics|mesh-ancestor
6290667|NCT00000492|Propranolol|propranolol|mesh-list
6290668|NCT00000492|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6290669|NCT00000492|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6290670|NCT00000492|Adrenergic Agents|adrenergic agents|mesh-ancestor
6290671|NCT00000492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6290672|NCT00000492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6290673|NCT00000492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290674|NCT00000492|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6290675|NCT00000492|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6290676|NCT00000492|Vasodilator Agents|vasodilator agents|mesh-ancestor
6290677|NCT00000493|Propranolol|propranolol|mesh-list
6290678|NCT00000493|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6290679|NCT00000493|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6290680|NCT00000493|Adrenergic Agents|adrenergic agents|mesh-ancestor
6290681|NCT00000493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6290682|NCT00000493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6290683|NCT00000493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290684|NCT00000493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6290685|NCT00000493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6290686|NCT00000493|Vasodilator Agents|vasodilator agents|mesh-ancestor
6290687|NCT00000494|Indomethacin|indomethacin|mesh-list
6290688|NCT00000494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6290689|NCT00000494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6290690|NCT00000494|Analgesics|analgesics|mesh-ancestor
6290691|NCT00000494|Sensory System Agents|sensory system agents|mesh-ancestor
6290692|NCT00000494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6290693|NCT00000494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290694|NCT00000494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6290695|NCT00000494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6290696|NCT00000494|Gout Suppressants|gout suppressants|mesh-ancestor
6290697|NCT00000494|Tocolytic Agents|tocolytic agents|mesh-ancestor
6290698|NCT00000494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6290699|NCT00000494|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6290700|NCT00000494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6290701|NCT00000494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6290702|NCT00000496|Aspirin|aspirin|mesh-list
6290703|NCT00000496|Dipyridamole|dipyridamole|mesh-list
6290704|NCT00000496|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6290705|NCT00000496|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6290706|NCT00000496|Analgesics|analgesics|mesh-ancestor
6290707|NCT00000496|Sensory System Agents|sensory system agents|mesh-ancestor
6290708|NCT00000496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6290709|NCT00000496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290710|NCT00000496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6290711|NCT00000496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6290712|NCT00000496|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6290713|NCT00000496|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6290714|NCT00000496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6290715|NCT00000496|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6290716|NCT00000496|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6290717|NCT00000496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6290718|NCT00000496|Antipyretics|antipyretics|mesh-ancestor
6290719|NCT00000496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6290720|NCT00000496|Vasodilator Agents|vasodilator agents|mesh-ancestor
6290721|NCT00000498|Antihypertensive Agents|antihypertensive agents|mesh-list
6290722|NCT00000499|Metoprolol|metoprolol|mesh-list
6290723|NCT00000499|Chlorthalidone|chlorthalidone|mesh-list
6290724|NCT00000499|Hydralazine|hydralazine|mesh-list
6290725|NCT00000499|Reserpine|reserpine|mesh-list
6290726|NCT00000499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6290727|NCT00000499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6290728|NCT00000499|Sympatholytics|sympatholytics|mesh-ancestor
6290729|NCT00000499|Autonomic Agents|autonomic agents|mesh-ancestor
6290730|NCT00000499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6290731|NCT00000499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290732|NCT00000499|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6290733|NCT00000499|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6290734|NCT00000499|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6290735|NCT00000499|Adrenergic Agents|adrenergic agents|mesh-ancestor
6290736|NCT00000499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6290737|NCT00000499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6290738|NCT00000499|Diuretics|diuretics|mesh-ancestor
6290739|NCT00000499|Natriuretic Agents|natriuretic agents|mesh-ancestor
6290740|NCT00000499|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6290741|NCT00000499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6290742|NCT00000499|Vasodilator Agents|vasodilator agents|mesh-ancestor
6290743|NCT00000499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6290744|NCT00000499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6290745|NCT00000499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6290746|NCT00000499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6290747|NCT00000499|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6290748|NCT00000499|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6290749|NCT00000500|Aspirin|aspirin|mesh-list
6290750|NCT00000500|Carotenoids|carotenoids|mesh-list
6290751|NCT00000500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6290752|NCT00000500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6290753|NCT00000500|Analgesics|analgesics|mesh-ancestor
6290754|NCT00000500|Sensory System Agents|sensory system agents|mesh-ancestor
6290755|NCT00000500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6290756|NCT00000500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290757|NCT00000500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6290758|NCT00000500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6290759|NCT00000500|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6290760|NCT00000500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6290761|NCT00000500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6290762|NCT00000500|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6290763|NCT00000500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6290764|NCT00000500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6290765|NCT00000500|Antipyretics|antipyretics|mesh-ancestor
6290766|NCT00000500|Antioxidants|antioxidants|mesh-ancestor
6290767|NCT00000500|Protective Agents|protective agents|mesh-ancestor
6290768|NCT00000503|Streptokinase|streptokinase|mesh-list
6290769|NCT00000503|Nitroglycerin|nitroglycerin|mesh-list
6290770|NCT00000503|Vasodilator Agents|vasodilator agents|mesh-ancestor
6290771|NCT00000503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6290772|NCT00000503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6290773|NCT00000503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6290774|NCT00000504|Flecainide|flecainide|mesh-list
6290775|NCT00000504|Moricizine|moricizine|mesh-list
6290776|NCT00000504|Encainide|encainide|mesh-list
6290777|NCT00000504|Imipramine|imipramine|mesh-list
6290778|NCT00000504|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6290779|NCT00000504|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6290780|NCT00000504|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6290781|NCT00000504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6290782|NCT00000504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6290783|NCT00000504|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6290784|NCT00000504|Antidepressive Agents|antidepressive agents|mesh-ancestor
6290785|NCT00000504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6290786|NCT00000504|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6290787|NCT00000504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6290788|NCT00000504|Adrenergic Agents|adrenergic agents|mesh-ancestor
6290789|NCT00000504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6290790|NCT00000504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290791|NCT00000505|Plasminogen|plasminogen|mesh-list
6290792|NCT00000505|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6290793|NCT00000505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6290794|NCT00000505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6290795|NCT00000505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6290796|NCT00000506|Phentermine|phentermine|mesh-list
6290797|NCT00000506|Fenfluramine|fenfluramine|mesh-list
6290798|NCT00000506|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6290799|NCT00000506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290800|NCT00000506|Appetite Depressants|appetite depressants|mesh-ancestor
6290801|NCT00000506|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6290802|NCT00000506|Sympathomimetics|sympathomimetics|mesh-ancestor
6290803|NCT00000506|Autonomic Agents|autonomic agents|mesh-ancestor
6290804|NCT00000506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6290805|NCT00000506|Adrenergic Agents|adrenergic agents|mesh-ancestor
6290806|NCT00000506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6290807|NCT00000506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6290808|NCT00000506|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6290809|NCT00000506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6290810|NCT00000506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6290811|NCT00000506|Serotonin Agents|serotonin agents|mesh-ancestor
6290812|NCT00000507|Streptokinase|streptokinase|mesh-list
6290813|NCT00000507|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6290814|NCT00000507|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6290815|NCT00000507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6290816|NCT00000510|Aspirin|aspirin|mesh-list
6290817|NCT00000510|Dipyridamole|dipyridamole|mesh-list
6290818|NCT00000510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6290819|NCT00000510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6290820|NCT00000510|Analgesics|analgesics|mesh-ancestor
6290821|NCT00000510|Sensory System Agents|sensory system agents|mesh-ancestor
6290822|NCT00000510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6290823|NCT00000510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290824|NCT00000510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6290825|NCT00000510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6290826|NCT00000510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6290827|NCT00000510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6290828|NCT00000510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6290829|NCT00000510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6290830|NCT00000510|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6290831|NCT00000510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6290832|NCT00000510|Antipyretics|antipyretics|mesh-ancestor
6290833|NCT00000510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6290834|NCT00000510|Vasodilator Agents|vasodilator agents|mesh-ancestor
6290835|NCT00000512|Niacin|niacin|mesh-list
6290836|NCT00000512|Nicotinic Acids|nicotinic acids|mesh-list
6290837|NCT00000512|Lovastatin|lovastatin|mesh-list
6290838|NCT00000512|L 647318|l 647318|mesh-list
6290839|NCT00000512|Dihydromevinolin|dihydromevinolin|mesh-list
6290840|NCT00000512|Colestipol|colestipol|mesh-list
6290841|NCT00000512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6290842|NCT00000512|Antimetabolites|antimetabolites|mesh-ancestor
6290843|NCT00000512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6290844|NCT00000512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6290845|NCT00000512|Vasodilator Agents|vasodilator agents|mesh-ancestor
6290846|NCT00000512|Vitamin B Complex|vitamin b complex|mesh-ancestor
6290847|NCT00000512|Vitamins|vitamins|mesh-ancestor
6290848|NCT00000512|Micronutrients|micronutrients|mesh-ancestor
6290849|NCT00000512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290850|NCT00000512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6290851|NCT00000512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6290852|NCT00000512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6290853|NCT00000512|Sequestering Agents|sequestering agents|mesh-ancestor
6290854|NCT00000513|Atenolol|atenolol|mesh-list
6290855|NCT00000513|Chlorthalidone|chlorthalidone|mesh-list
6290856|NCT00000513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6391786|NCT00194272|Abortifacient Agents|abortifacient agents|mesh-ancestor
6290857|NCT00000513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6290858|NCT00000513|Sympatholytics|sympatholytics|mesh-ancestor
6290859|NCT00000513|Autonomic Agents|autonomic agents|mesh-ancestor
6290860|NCT00000513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6290861|NCT00000513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290862|NCT00000513|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6290863|NCT00000513|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6290864|NCT00000513|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6290865|NCT00000513|Adrenergic Agents|adrenergic agents|mesh-ancestor
6290866|NCT00000513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6290867|NCT00000513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6290868|NCT00000513|Diuretics|diuretics|mesh-ancestor
6290869|NCT00000513|Natriuretic Agents|natriuretic agents|mesh-ancestor
6290870|NCT00000513|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6290871|NCT00000513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6290872|NCT00000514|Atenolol|atenolol|mesh-list
6290873|NCT00000514|Chlorthalidone|chlorthalidone|mesh-list
6290874|NCT00000514|Reserpine|reserpine|mesh-list
6290875|NCT00000514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6290876|NCT00000514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6290877|NCT00000514|Sympatholytics|sympatholytics|mesh-ancestor
6290878|NCT00000514|Autonomic Agents|autonomic agents|mesh-ancestor
6290879|NCT00000514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6290880|NCT00000514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290881|NCT00000514|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6290882|NCT00000514|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6290883|NCT00000514|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6290884|NCT00000514|Adrenergic Agents|adrenergic agents|mesh-ancestor
6290885|NCT00000514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6290886|NCT00000514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6290887|NCT00000514|Diuretics|diuretics|mesh-ancestor
6290888|NCT00000514|Natriuretic Agents|natriuretic agents|mesh-ancestor
6290889|NCT00000514|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6290890|NCT00000514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6290891|NCT00000514|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6290892|NCT00000514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6290893|NCT00000514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6290894|NCT00000514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6290895|NCT00000514|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6290896|NCT00000514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6290897|NCT00000516|Enalapril|enalapril|mesh-list
6290898|NCT00000516|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6290899|NCT00000516|Protease Inhibitors|protease inhibitors|mesh-ancestor
6290900|NCT00000516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6290901|NCT00000516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6290902|NCT00000516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6290903|NCT00000517|Warfarin|warfarin|mesh-list
6290904|NCT00000517|Anticoagulants|anticoagulants|mesh-ancestor
6290905|NCT00000518|Quinidine|quinidine|mesh-list
6290906|NCT00000518|Sotalol|sotalol|mesh-list
6290907|NCT00000518|Mexiletine|mexiletine|mesh-list
6290908|NCT00000518|Procainamide|procainamide|mesh-list
6290909|NCT00000518|Imipramine|imipramine|mesh-list
6290910|NCT00000518|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6290911|NCT00000518|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6290912|NCT00000518|Adrenergic Agents|adrenergic agents|mesh-ancestor
6290913|NCT00000518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6290914|NCT00000518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6290915|NCT00000518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290916|NCT00000518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6290917|NCT00000518|Sympatholytics|sympatholytics|mesh-ancestor
6290918|NCT00000518|Autonomic Agents|autonomic agents|mesh-ancestor
6290919|NCT00000518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6290920|NCT00000518|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6290921|NCT00000518|Antimalarials|antimalarials|mesh-ancestor
6290922|NCT00000518|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6290923|NCT00000518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6290924|NCT00000518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6290925|NCT00000518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6290926|NCT00000518|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6290927|NCT00000518|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6290928|NCT00000518|Cholinergic Agents|cholinergic agents|mesh-ancestor
6290929|NCT00000518|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6290930|NCT00000518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6290931|NCT00000518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6290932|NCT00000518|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6290933|NCT00000518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6290934|NCT00000518|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6290935|NCT00000518|Antidepressive Agents|antidepressive agents|mesh-ancestor
6290936|NCT00000518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6290937|NCT00000518|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6290938|NCT00000518|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6290939|NCT00000520|Aspirin|aspirin|mesh-list
6290940|NCT00000520|Immunoglobulins|immunoglobulins|mesh-list
6290941|NCT00000520|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6290942|NCT00000520|Antibodies|antibodies|mesh-list
6290943|NCT00000520|gamma-Globulins|gamma-globulins|mesh-list
6290944|NCT00000520|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6290945|NCT00000520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6290946|NCT00000520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6290947|NCT00000520|Analgesics|analgesics|mesh-ancestor
6290948|NCT00000520|Sensory System Agents|sensory system agents|mesh-ancestor
6290949|NCT00000520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6290950|NCT00000520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290951|NCT00000520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6290952|NCT00000520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6290953|NCT00000520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6290954|NCT00000520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6290955|NCT00000520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6290956|NCT00000520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6290957|NCT00000520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6290958|NCT00000520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6290959|NCT00000520|Antipyretics|antipyretics|mesh-ancestor
6290960|NCT00000520|Immunologic Factors|immunologic factors|mesh-ancestor
6290961|NCT00000522|Acebutolol|acebutolol|mesh-list
6290962|NCT00000522|Amlodipine|amlodipine|mesh-list
6290963|NCT00000522|Enalapril|enalapril|mesh-list
6290964|NCT00000522|Chlorthalidone|chlorthalidone|mesh-list
6290965|NCT00000522|Doxazosin|doxazosin|mesh-list
6290966|NCT00000522|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6290967|NCT00000522|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6290968|NCT00000522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6290969|NCT00000522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6290970|NCT00000522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6290971|NCT00000522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290972|NCT00000522|Vasodilator Agents|vasodilator agents|mesh-ancestor
6290973|NCT00000522|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6290974|NCT00000522|Protease Inhibitors|protease inhibitors|mesh-ancestor
6290975|NCT00000522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6290976|NCT00000522|Diuretics|diuretics|mesh-ancestor
6290977|NCT00000522|Natriuretic Agents|natriuretic agents|mesh-ancestor
6290978|NCT00000522|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6290979|NCT00000522|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6290980|NCT00000522|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6290981|NCT00000522|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6290982|NCT00000522|Adrenergic Agents|adrenergic agents|mesh-ancestor
6290983|NCT00000522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6290984|NCT00000522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6290985|NCT00000522|Sympathomimetics|sympathomimetics|mesh-ancestor
6290986|NCT00000522|Autonomic Agents|autonomic agents|mesh-ancestor
6290987|NCT00000522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6290988|NCT00000522|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6290989|NCT00000522|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6290990|NCT00000524|Cyclosporine|cyclosporine|mesh-list
6290991|NCT00000524|Prednisone|prednisone|mesh-list
6290992|NCT00000524|Cyclosporins|cyclosporins|mesh-list
6290993|NCT00000524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6290994|NCT00000524|Glucocorticoids|glucocorticoids|mesh-ancestor
6290995|NCT00000524|Hormones|hormones|mesh-ancestor
6290996|NCT00000524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6290997|NCT00000524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6290998|NCT00000524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6290999|NCT00000524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6291000|NCT00000524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6291001|NCT00000524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291002|NCT00000524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6291003|NCT00000524|Immunologic Factors|immunologic factors|mesh-ancestor
6291004|NCT00000524|Antifungal Agents|antifungal agents|mesh-ancestor
6291005|NCT00000524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6291006|NCT00000524|Dermatologic Agents|dermatologic agents|mesh-ancestor
6291007|NCT00000524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6291008|NCT00000524|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6291009|NCT00000525|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6291010|NCT00000525|Chlorthalidone|chlorthalidone|mesh-list
6291011|NCT00000525|Triamterene|triamterene|mesh-list
6291012|NCT00000525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6291013|NCT00000525|Diuretics|diuretics|mesh-ancestor
6291014|NCT00000525|Natriuretic Agents|natriuretic agents|mesh-ancestor
6291015|NCT00000525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6291016|NCT00000525|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6291017|NCT00000525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6291018|NCT00000525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291019|NCT00000525|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
6291020|NCT00000525|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6291021|NCT00000525|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6291022|NCT00000526|Flecainide|flecainide|mesh-list
6291023|NCT00000526|Moricizine|moricizine|mesh-list
6291024|NCT00000526|Encainide|encainide|mesh-list
6291025|NCT00000526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6291026|NCT00000526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6291027|NCT00000526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6291028|NCT00000526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6291029|NCT00000526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291030|NCT00000527|Aspirin|aspirin|mesh-list
6291031|NCT00000527|Dipyridamole|dipyridamole|mesh-list
6291032|NCT00000527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6291033|NCT00000527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6291034|NCT00000527|Analgesics|analgesics|mesh-ancestor
6291035|NCT00000527|Sensory System Agents|sensory system agents|mesh-ancestor
6291036|NCT00000527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6291037|NCT00000527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6291038|NCT00000527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6291039|NCT00000527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6291040|NCT00000527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6291041|NCT00000527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6291042|NCT00000527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291043|NCT00000527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6291044|NCT00000527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6291045|NCT00000527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6291046|NCT00000527|Antipyretics|antipyretics|mesh-ancestor
6291047|NCT00000527|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6291048|NCT00000527|Vasodilator Agents|vasodilator agents|mesh-ancestor
6291049|NCT00000529|Tamoxifen|tamoxifen|mesh-list
6291050|NCT00000529|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6291051|NCT00000529|Hormone Antagonists|hormone antagonists|mesh-ancestor
6291052|NCT00000529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6291053|NCT00000529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6291054|NCT00000529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6291055|NCT00000529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6291056|NCT00000529|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6291057|NCT00000529|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6291058|NCT00000529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6291059|NCT00000530|Nifedipine|nifedipine|mesh-list
6291060|NCT00000530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6291061|NCT00000530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6291062|NCT00000530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291063|NCT00000530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6291064|NCT00000530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6291065|NCT00000530|Vasodilator Agents|vasodilator agents|mesh-ancestor
6291066|NCT00000530|Tocolytic Agents|tocolytic agents|mesh-ancestor
6291067|NCT00000530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6291068|NCT00000531|Amiodarone|amiodarone|mesh-list
6291069|NCT00000531|Sotalol|sotalol|mesh-list
6291070|NCT00000531|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6291071|NCT00000531|Vasodilator Agents|vasodilator agents|mesh-ancestor
6291072|NCT00000531|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6291073|NCT00000531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6291074|NCT00000531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291075|NCT00000531|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6291076|NCT00000531|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6291077|NCT00000531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6291078|NCT00000531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6291079|NCT00000531|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6291080|NCT00000531|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6291081|NCT00000531|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6291082|NCT00000531|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6291083|NCT00000531|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6291084|NCT00000531|Adrenergic Agents|adrenergic agents|mesh-ancestor
6291085|NCT00000531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6291086|NCT00000531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6291087|NCT00000531|Sympatholytics|sympatholytics|mesh-ancestor
6291088|NCT00000531|Autonomic Agents|autonomic agents|mesh-ancestor
6291089|NCT00000531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6291090|NCT00000534|Calcium|calcium|mesh-list
6291091|NCT00000534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6291092|NCT00000534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6291093|NCT00000539|Vitamins|vitamins|mesh-list
6291094|NCT00000539|Vitamin E|vitamin e|mesh-list
6291095|NCT00000539|Beta Carotene|beta carotene|mesh-list
6291096|NCT00000539|Warfarin|warfarin|mesh-list
6291097|NCT00000539|Pravastatin|pravastatin|mesh-list
6291098|NCT00000539|Carotenoids|carotenoids|mesh-list
6291099|NCT00000539|Micronutrients|micronutrients|mesh-ancestor
6291100|NCT00000539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6291101|NCT00000539|Anticoagulants|anticoagulants|mesh-ancestor
6291102|NCT00000539|Antioxidants|antioxidants|mesh-ancestor
6291103|NCT00000539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291104|NCT00000539|Protective Agents|protective agents|mesh-ancestor
6291105|NCT00000539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6291106|NCT00000539|Antimetabolites|antimetabolites|mesh-ancestor
6291107|NCT00000539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6291108|NCT00000539|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6291109|NCT00000539|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6291110|NCT00000539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6291111|NCT00000539|Provitamins|provitamins|mesh-ancestor
6291112|NCT00000541|Vitamins|vitamins|mesh-list
6291113|NCT00000541|Folic Acid|folic acid|mesh-list
6291114|NCT00000541|Vitamin E|vitamin e|mesh-list
6291115|NCT00000541|Vitamin B 12|vitamin b 12|mesh-list
6291116|NCT00000541|Hydroxocobalamin|hydroxocobalamin|mesh-list
6291117|NCT00000541|Vitamin B 6|vitamin b 6|mesh-list
6291118|NCT00000541|Pyridoxal|pyridoxal|mesh-list
6291119|NCT00000541|Pyridoxine|pyridoxine|mesh-list
6291120|NCT00000541|Beta Carotene|beta carotene|mesh-list
6291121|NCT00000541|Vitamin B Complex|vitamin b complex|mesh-list
6291122|NCT00000541|Carotenoids|carotenoids|mesh-list
6291123|NCT00000541|Micronutrients|micronutrients|mesh-ancestor
6291124|NCT00000541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6291125|NCT00000541|Antioxidants|antioxidants|mesh-ancestor
6291126|NCT00000541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291127|NCT00000541|Protective Agents|protective agents|mesh-ancestor
6291128|NCT00000541|Hematinics|hematinics|mesh-ancestor
6291129|NCT00000541|Provitamins|provitamins|mesh-ancestor
6291130|NCT00000542|Amlodipine|amlodipine|mesh-list
6291131|NCT00000542|Lisinopril|lisinopril|mesh-list
6291132|NCT00000542|Chlorthalidone|chlorthalidone|mesh-list
6291133|NCT00000542|Doxazosin|doxazosin|mesh-list
6291134|NCT00000542|Pravastatin|pravastatin|mesh-list
6291135|NCT00000542|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6291136|NCT00000542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6291137|NCT00000542|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6291138|NCT00000542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6291139|NCT00000542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291140|NCT00000542|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6291141|NCT00000542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6291142|NCT00000542|Vasodilator Agents|vasodilator agents|mesh-ancestor
6291143|NCT00000542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6291144|NCT00000542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6291145|NCT00000542|Antimetabolites|antimetabolites|mesh-ancestor
6291146|NCT00000542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6291147|NCT00000542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6291148|NCT00000542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6291149|NCT00000542|Protease Inhibitors|protease inhibitors|mesh-ancestor
6291150|NCT00000542|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6291151|NCT00000542|Protective Agents|protective agents|mesh-ancestor
6291152|NCT00000542|Diuretics|diuretics|mesh-ancestor
6291153|NCT00000542|Natriuretic Agents|natriuretic agents|mesh-ancestor
6291154|NCT00000542|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6291155|NCT00000542|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6291156|NCT00000542|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6291157|NCT00000542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6291158|NCT00000542|Adrenergic Agents|adrenergic agents|mesh-ancestor
6291159|NCT00000542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6291160|NCT00000543|Calcium|calcium|mesh-list
6291161|NCT00000543|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6291162|NCT00000543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6291163|NCT00000547|Enalapril|enalapril|mesh-list
6291164|NCT00000547|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6291165|NCT00000547|Protease Inhibitors|protease inhibitors|mesh-ancestor
6291166|NCT00000547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6291167|NCT00000547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291168|NCT00000547|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6291169|NCT00000549|Hormones|hormones|mesh-list
6291170|NCT00000549|Estrogens|estrogens|mesh-list
6291171|NCT00000549|Progestins|progestins|mesh-list
6291172|NCT00000549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6291173|NCT00000549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6291174|NCT00000552|Fibrinolytic Agents|fibrinolytic agents|mesh-list
6291175|NCT00000552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6291176|NCT00000552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291177|NCT00000553|Niacin|niacin|mesh-list
6291178|NCT00000553|Simvastatin|simvastatin|mesh-list
6291179|NCT00000553|Antioxidants|antioxidants|mesh-list
6291180|NCT00000553|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6291181|NCT00000553|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6291182|NCT00000553|Antimetabolites|antimetabolites|mesh-ancestor
6291183|NCT00000553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291184|NCT00000553|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6291185|NCT00000553|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6291186|NCT00000553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6291187|NCT00000553|Vasodilator Agents|vasodilator agents|mesh-ancestor
6291188|NCT00000553|Vitamin B Complex|vitamin b complex|mesh-ancestor
6291189|NCT00000553|Vitamins|vitamins|mesh-ancestor
6291190|NCT00000553|Micronutrients|micronutrients|mesh-ancestor
6291191|NCT00000553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6291192|NCT00000553|Protective Agents|protective agents|mesh-ancestor
6291193|NCT00000554|Dobutamine|dobutamine|mesh-list
6291194|NCT00000554|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6291195|NCT00000554|Sympathomimetics|sympathomimetics|mesh-ancestor
6291196|NCT00000554|Autonomic Agents|autonomic agents|mesh-ancestor
6291197|NCT00000554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6291198|NCT00000554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6291199|NCT00000554|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6291200|NCT00000554|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6291201|NCT00000554|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6291202|NCT00000554|Adrenergic Agents|adrenergic agents|mesh-ancestor
6291203|NCT00000554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6291204|NCT00000554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291205|NCT00000554|Protective Agents|protective agents|mesh-ancestor
6391787|NCT00194272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6391788|NCT00194272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6391789|NCT00194272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6391790|NCT00194272|Antimetabolites|antimetabolites|mesh-ancestor
6391791|NCT00194272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391792|NCT00194272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391793|NCT00194272|Dermatologic Agents|dermatologic agents|mesh-ancestor
6391794|NCT00194272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6391795|NCT00194272|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6391796|NCT00194272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6391797|NCT00194272|Immunologic Factors|immunologic factors|mesh-ancestor
6391798|NCT00194272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6391799|NCT00194272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6391800|NCT00194324|Miconazole|miconazole|mesh-list
6391801|NCT00194324|Clotrimazole|clotrimazole|mesh-list
6391802|NCT00194324|Antifungal Agents|antifungal agents|mesh-ancestor
6391803|NCT00194324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6391804|NCT00194324|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6391805|NCT00194324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6391806|NCT00194324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6391807|NCT00194324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391808|NCT00194324|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6391809|NCT00194324|Hormone Antagonists|hormone antagonists|mesh-ancestor
6391810|NCT00194324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6391811|NCT00194324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6391812|NCT00194324|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6391813|NCT00194324|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6391814|NCT00194324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6391815|NCT00194402|Niacin|niacin|mesh-list
6391816|NCT00194402|Niacinamide|niacinamide|mesh-list
6391817|NCT00194402|Nicotinic Acids|nicotinic acids|mesh-list
6291206|NCT00000555|Ascorbic Acid|ascorbic acid|mesh-list
6291207|NCT00000555|Vitamin E|vitamin e|mesh-list
6291208|NCT00000555|Hormones|hormones|mesh-list
6291209|NCT00000555|Progesterone|progesterone|mesh-list
6291210|NCT00000555|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6291211|NCT00000555|Estrogens|estrogens|mesh-list
6291212|NCT00000555|Vitamins|vitamins|mesh-ancestor
6291213|NCT00000555|Micronutrients|micronutrients|mesh-ancestor
6291214|NCT00000555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6291215|NCT00000555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6291216|NCT00000555|Progestins|progestins|mesh-ancestor
6291217|NCT00000555|Antioxidants|antioxidants|mesh-ancestor
6291218|NCT00000555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291219|NCT00000555|Protective Agents|protective agents|mesh-ancestor
6291220|NCT00000556|Quinidine|quinidine|mesh-list
6291221|NCT00000556|Digoxin|digoxin|mesh-list
6291222|NCT00000556|Amiodarone|amiodarone|mesh-list
6291223|NCT00000556|Verapamil|verapamil|mesh-list
6291224|NCT00000556|Sotalol|sotalol|mesh-list
6291225|NCT00000556|Flecainide|flecainide|mesh-list
6291226|NCT00000556|Propafenone|propafenone|mesh-list
6291227|NCT00000556|Procainamide|procainamide|mesh-list
6291228|NCT00000556|Moricizine|moricizine|mesh-list
6291229|NCT00000556|Disopyramide|disopyramide|mesh-list
6291230|NCT00000556|Diltiazem|diltiazem|mesh-list
6291231|NCT00000556|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
6291232|NCT00000556|Adrenergic Agents|adrenergic agents|mesh-list
6291233|NCT00000556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6291234|NCT00000556|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6291235|NCT00000556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6291236|NCT00000556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291237|NCT00000556|Protective Agents|protective agents|mesh-ancestor
6291238|NCT00000556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6291239|NCT00000556|Vasodilator Agents|vasodilator agents|mesh-ancestor
6291240|NCT00000556|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6291241|NCT00000556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6291242|NCT00000556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6291243|NCT00000556|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6291244|NCT00000556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6291245|NCT00000556|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6291246|NCT00000556|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6291247|NCT00000556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6291248|NCT00000556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6291249|NCT00000556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6291250|NCT00000556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6291251|NCT00000556|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6291252|NCT00000556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6291253|NCT00000556|Sympatholytics|sympatholytics|mesh-ancestor
6291254|NCT00000556|Autonomic Agents|autonomic agents|mesh-ancestor
6291255|NCT00000556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6291256|NCT00000556|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6291257|NCT00000556|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6291258|NCT00000556|Antimalarials|antimalarials|mesh-ancestor
6291259|NCT00000556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6291260|NCT00000556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6291261|NCT00000556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6291262|NCT00000556|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6291263|NCT00000556|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6291264|NCT00000556|Cholinergic Agents|cholinergic agents|mesh-ancestor
6291265|NCT00000558|Enzyme Inhibitors|enzyme inhibitors|mesh-list
6291266|NCT00000558|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6291267|NCT00000558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291268|NCT00000558|Protease Inhibitors|protease inhibitors|mesh-ancestor
6291269|NCT00000559|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6291270|NCT00000559|Medroxyprogesterone|medroxyprogesterone|mesh-list
6291271|NCT00000559|Hormones|hormones|mesh-list
6291272|NCT00000559|Estradiol|estradiol|mesh-list
6291273|NCT00000559|Estrogens|estrogens|mesh-list
6291274|NCT00000559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6291275|NCT00000559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6291276|NCT00000559|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6291277|NCT00000559|Contraceptive Agents|contraceptive agents|mesh-ancestor
6291278|NCT00000559|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6291279|NCT00000559|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6291280|NCT00000559|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6291281|NCT00000559|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6291282|NCT00000559|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6291283|NCT00000559|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6291284|NCT00000559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6291285|NCT00000559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6291286|NCT00000560|Adrenergic Agents|adrenergic agents|mesh-list
6291287|NCT00000560|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
6291288|NCT00000560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6291289|NCT00000560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291290|NCT00000560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6291291|NCT00000560|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6291292|NCT00000563|Dexamethasone|dexamethasone|mesh-list
6291293|NCT00000563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6291294|NCT00000563|Antiemetics|antiemetics|mesh-ancestor
6291295|NCT00000563|Autonomic Agents|autonomic agents|mesh-ancestor
6291296|NCT00000563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6291297|NCT00000563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6291298|NCT00000563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6291299|NCT00000563|Glucocorticoids|glucocorticoids|mesh-ancestor
6291300|NCT00000563|Hormones|hormones|mesh-ancestor
6291301|NCT00000563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6291302|NCT00000563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6291303|NCT00000563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6291304|NCT00000568|Ipratropium|ipratropium|mesh-list
6291305|NCT00000568|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6291306|NCT00000568|Autonomic Agents|autonomic agents|mesh-ancestor
6291307|NCT00000568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6291308|NCT00000568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6291309|NCT00000568|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6291310|NCT00000568|Respiratory System Agents|respiratory system agents|mesh-ancestor
6291311|NCT00000568|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6291312|NCT00000568|Cholinergic Agents|cholinergic agents|mesh-ancestor
6291313|NCT00000568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6291314|NCT00000568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291315|NCT00000569|Triamcinolone|triamcinolone|mesh-list
6291316|NCT00000569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6291317|NCT00000569|Glucocorticoids|glucocorticoids|mesh-ancestor
6291318|NCT00000569|Hormones|hormones|mesh-ancestor
6291319|NCT00000569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6291320|NCT00000569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6291321|NCT00000570|Pulmonary Surfactants|pulmonary surfactants|mesh-list
6291322|NCT00000570|Respiratory System Agents|respiratory system agents|mesh-ancestor
6291323|NCT00000574|Ibuprofen|ibuprofen|mesh-list
6291324|NCT00000574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6291325|NCT00000574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6291326|NCT00000574|Analgesics|analgesics|mesh-ancestor
6291327|NCT00000574|Sensory System Agents|sensory system agents|mesh-ancestor
6291328|NCT00000574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6291329|NCT00000574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6291330|NCT00000574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6291331|NCT00000574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6291332|NCT00000574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6291333|NCT00000574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6291334|NCT00000574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291335|NCT00000576|Beclomethasone|beclomethasone|mesh-list
6291336|NCT00000576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6291337|NCT00000576|Glucocorticoids|glucocorticoids|mesh-ancestor
6291338|NCT00000576|Hormones|hormones|mesh-ancestor
6291339|NCT00000576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6291340|NCT00000576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6291341|NCT00000576|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6291342|NCT00000576|Respiratory System Agents|respiratory system agents|mesh-ancestor
6291343|NCT00000577|Colchicine|colchicine|mesh-list
6291344|NCT00000577|Albuterol|albuterol|mesh-list
6291345|NCT00000577|Hormones|hormones|mesh-list
6291346|NCT00000577|Adrenergic Agents|adrenergic agents|mesh-list
6291347|NCT00000577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-list
6291348|NCT00000577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6291349|NCT00000577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6291350|NCT00000577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6291351|NCT00000577|Autonomic Agents|autonomic agents|mesh-ancestor
6291352|NCT00000577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6291353|NCT00000577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6391818|NCT00194402|Atorvastatin|atorvastatin|mesh-list
6291354|NCT00000577|Respiratory System Agents|respiratory system agents|mesh-ancestor
6291355|NCT00000577|Tocolytic Agents|tocolytic agents|mesh-ancestor
6291356|NCT00000577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6291357|NCT00000577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6291358|NCT00000577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6291359|NCT00000577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6291360|NCT00000577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291361|NCT00000577|Gout Suppressants|gout suppressants|mesh-ancestor
6291362|NCT00000577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6291363|NCT00000577|Tubulin Modulators|tubulin modulators|mesh-ancestor
6291364|NCT00000577|Antimitotic Agents|antimitotic agents|mesh-ancestor
6291365|NCT00000577|Mitosis Modulators|mitosis modulators|mesh-ancestor
6291366|NCT00000577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6291367|NCT00000578|Beclomethasone|beclomethasone|mesh-list
6291368|NCT00000578|Theophylline|theophylline|mesh-list
6291369|NCT00000578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6291370|NCT00000578|Glucocorticoids|glucocorticoids|mesh-ancestor
6291371|NCT00000578|Hormones|hormones|mesh-ancestor
6291372|NCT00000578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6291373|NCT00000578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6291374|NCT00000578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6291375|NCT00000578|Respiratory System Agents|respiratory system agents|mesh-ancestor
6291376|NCT00000578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6291377|NCT00000578|Autonomic Agents|autonomic agents|mesh-ancestor
6291378|NCT00000578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6291379|NCT00000578|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6291380|NCT00000578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6291381|NCT00000578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291382|NCT00000578|Vasodilator Agents|vasodilator agents|mesh-ancestor
6291383|NCT00000578|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6291384|NCT00000578|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6291385|NCT00000578|Purinergic Agents|purinergic agents|mesh-ancestor
6291386|NCT00000578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6291387|NCT00000579|Ketoconazole|ketoconazole|mesh-list
6291388|NCT00000579|Methylprednisolone|methylprednisolone|mesh-list
6291389|NCT00000579|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6291390|NCT00000579|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6291391|NCT00000579|Prednisolone|prednisolone|mesh-list
6291392|NCT00000579|Prednisolone acetate|prednisolone acetate|mesh-list
6291393|NCT00000579|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6291394|NCT00000579|Prednisolone phosphate|prednisolone phosphate|mesh-list
6291395|NCT00000579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6291396|NCT00000579|Antiemetics|antiemetics|mesh-ancestor
6291397|NCT00000579|Autonomic Agents|autonomic agents|mesh-ancestor
6291398|NCT00000579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6291399|NCT00000579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6291400|NCT00000579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6291401|NCT00000579|Glucocorticoids|glucocorticoids|mesh-ancestor
6291402|NCT00000579|Hormones|hormones|mesh-ancestor
6291403|NCT00000579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6291404|NCT00000579|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6291405|NCT00000579|Protective Agents|protective agents|mesh-ancestor
6291406|NCT00000579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6291407|NCT00000579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6291408|NCT00000579|Antifungal Agents|antifungal agents|mesh-ancestor
6291409|NCT00000579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6291410|NCT00000579|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6291411|NCT00000579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6291412|NCT00000579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6291413|NCT00000579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291414|NCT00000579|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6291415|NCT00000579|Hormone Antagonists|hormone antagonists|mesh-ancestor
6291416|NCT00000579|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6291417|NCT00000580|Immunoglobulins|immunoglobulins|mesh-list
6291418|NCT00000580|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6291419|NCT00000580|Antibodies|antibodies|mesh-list
6291420|NCT00000580|gamma-Globulins|gamma-globulins|mesh-list
6291421|NCT00000580|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6291422|NCT00000580|Immunologic Factors|immunologic factors|mesh-ancestor
6291423|NCT00000580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6291424|NCT00000584|Immunoglobulins|immunoglobulins|mesh-list
6291425|NCT00000584|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6291426|NCT00000584|Antibodies|antibodies|mesh-list
6291427|NCT00000584|Immunologic Factors|immunologic factors|mesh-ancestor
6291428|NCT00000584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6291429|NCT00000585|Penicillins|penicillins|mesh-list
6291430|NCT00000585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6291431|NCT00000585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6291432|NCT00000586|Hydroxyurea|hydroxyurea|mesh-list
6291433|NCT00000586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6291434|NCT00000586|Antisickling Agents|antisickling agents|mesh-ancestor
6291435|NCT00000586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6291436|NCT00000586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291437|NCT00000586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6291438|NCT00000590|Immunoglobulins|immunoglobulins|mesh-list
6291439|NCT00000590|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6291440|NCT00000590|Antibodies|antibodies|mesh-list
6291441|NCT00000590|Immunologic Factors|immunologic factors|mesh-ancestor
6291442|NCT00000590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6291443|NCT00000594|Cholestyramine Resin|cholestyramine resin|mesh-list
6291444|NCT00000594|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6291445|NCT00000594|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6291446|NCT00000594|Antimetabolites|antimetabolites|mesh-ancestor
6291447|NCT00000594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291448|NCT00000594|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6291449|NCT00000595|Deferoxamine|deferoxamine|mesh-list
6291450|NCT00000595|Siderophores|siderophores|mesh-ancestor
6291451|NCT00000595|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6291452|NCT00000595|Chelating Agents|chelating agents|mesh-ancestor
6291453|NCT00000595|Sequestering Agents|sequestering agents|mesh-ancestor
6291454|NCT00000595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291455|NCT00000596|Dapsone|dapsone|mesh-list
6291456|NCT00000596|Prednisone|prednisone|mesh-list
6291457|NCT00000596|Cyclophosphamide|cyclophosphamide|mesh-list
6291458|NCT00000596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6291459|NCT00000596|Immunologic Factors|immunologic factors|mesh-ancestor
6291460|NCT00000596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6291461|NCT00000596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6291462|NCT00000596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6291463|NCT00000596|Alkylating Agents|alkylating agents|mesh-ancestor
6291464|NCT00000596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291465|NCT00000596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6291466|NCT00000596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6291467|NCT00000596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6291468|NCT00000596|Glucocorticoids|glucocorticoids|mesh-ancestor
6291469|NCT00000596|Hormones|hormones|mesh-ancestor
6291470|NCT00000596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6291471|NCT00000596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6291472|NCT00000596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6291473|NCT00000596|Antimalarials|antimalarials|mesh-ancestor
6291474|NCT00000596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6291475|NCT00000596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6291476|NCT00000596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6291477|NCT00000596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6291478|NCT00000596|Leprostatic Agents|leprostatic agents|mesh-ancestor
6291479|NCT00000596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6291480|NCT00000597|Nandrolone Decanoate|nandrolone decanoate|mesh-list
6291481|NCT00000597|Nandrolone|nandrolone|mesh-list
6291482|NCT00000597|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
6291483|NCT00000597|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6291484|NCT00000597|Androgens|androgens|mesh-ancestor
6291485|NCT00000597|Hormones|hormones|mesh-ancestor
6291486|NCT00000597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6291487|NCT00000597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6291488|NCT00000597|Anabolic Agents|anabolic agents|mesh-ancestor
6291489|NCT00000597|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6291490|NCT00000597|Immunologic Factors|immunologic factors|mesh-ancestor
6291491|NCT00000597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6291492|NCT00000599|Niacin|niacin|mesh-list
6291493|NCT00000599|Colestipol|colestipol|mesh-list
6291494|NCT00000599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6291495|NCT00000599|Antimetabolites|antimetabolites|mesh-ancestor
6291496|NCT00000599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291497|NCT00000599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6291498|NCT00000599|Vasodilator Agents|vasodilator agents|mesh-ancestor
6291499|NCT00000599|Vitamin B Complex|vitamin b complex|mesh-ancestor
6291500|NCT00000599|Vitamins|vitamins|mesh-ancestor
6291501|NCT00000599|Micronutrients|micronutrients|mesh-ancestor
6291502|NCT00000599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6291503|NCT00000599|Sequestering Agents|sequestering agents|mesh-ancestor
6291504|NCT00000600|Vitamins|vitamins|mesh-list
6291505|NCT00000600|Ascorbic Acid|ascorbic acid|mesh-list
6291506|NCT00000600|Vitamin E|vitamin e|mesh-list
6291507|NCT00000600|Micronutrients|micronutrients|mesh-ancestor
6291508|NCT00000600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6291509|NCT00000600|Antioxidants|antioxidants|mesh-ancestor
6291510|NCT00000600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291511|NCT00000600|Protective Agents|protective agents|mesh-ancestor
6291512|NCT00000601|Hormones|hormones|mesh-list
6291513|NCT00000601|Progesterone|progesterone|mesh-list
6291514|NCT00000601|Estrogens|estrogens|mesh-list
6291515|NCT00000601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6291516|NCT00000601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6291517|NCT00000601|Progestins|progestins|mesh-ancestor
6291518|NCT00000602|Hydroxyurea|hydroxyurea|mesh-list
6291519|NCT00000602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6291520|NCT00000602|Antisickling Agents|antisickling agents|mesh-ancestor
6291521|NCT00000602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6291522|NCT00000602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291523|NCT00000602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6291524|NCT00000605|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6291525|NCT00000605|Medroxyprogesterone|medroxyprogesterone|mesh-list
6291526|NCT00000605|Hormones|hormones|mesh-list
6291527|NCT00000605|Estrogens|estrogens|mesh-list
6291528|NCT00000605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6291529|NCT00000605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6291530|NCT00000605|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6291531|NCT00000605|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6291532|NCT00000605|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6291533|NCT00000605|Contraceptive Agents|contraceptive agents|mesh-ancestor
6291534|NCT00000605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6291535|NCT00000605|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6291536|NCT00000605|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6291537|NCT00000605|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6291538|NCT00000605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6291539|NCT00000605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6291540|NCT00000609|Amiodarone|amiodarone|mesh-list
6291541|NCT00000609|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6291542|NCT00000609|Vasodilator Agents|vasodilator agents|mesh-ancestor
6291543|NCT00000609|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6291544|NCT00000609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6291545|NCT00000609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291546|NCT00000609|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6291547|NCT00000609|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6291548|NCT00000609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6291549|NCT00000609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6291550|NCT00000609|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6291551|NCT00000609|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6291552|NCT00000609|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6291553|NCT00000611|Vitamin D|vitamin d|mesh-list
6291554|NCT00000611|Calcium|calcium|mesh-list
6291555|NCT00000611|Hormones|hormones|mesh-list
6291556|NCT00000611|Estrogens|estrogens|mesh-list
6291557|NCT00000611|Progestins|progestins|mesh-list
6291558|NCT00000611|Vitamins|vitamins|mesh-ancestor
6291559|NCT00000611|Micronutrients|micronutrients|mesh-ancestor
6291560|NCT00000611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6291561|NCT00000611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6291562|NCT00000611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6291563|NCT00000611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6291564|NCT00000612|Estrogens|estrogens|mesh-list
6291565|NCT00000612|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6291566|NCT00000612|Hormones|hormones|mesh-ancestor
6291567|NCT00000612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6291568|NCT00000612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6291569|NCT00000613|Genistein|genistein|mesh-list
6291570|NCT00000613|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6291571|NCT00000613|Protective Agents|protective agents|mesh-ancestor
6291572|NCT00000613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6291573|NCT00000613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6291574|NCT00000613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6291575|NCT00000613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6291576|NCT00000613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291577|NCT00000613|Phytoestrogens|phytoestrogens|mesh-ancestor
6291578|NCT00000613|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6291579|NCT00000613|Estrogens|estrogens|mesh-ancestor
6291580|NCT00000613|Hormones|hormones|mesh-ancestor
6291581|NCT00000613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6291582|NCT00000614|Warfarin|warfarin|mesh-list
6291583|NCT00000614|Anticoagulants|anticoagulants|mesh-ancestor
6291584|NCT00000617|Azithromycin|azithromycin|mesh-list
6291585|NCT00000617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6291586|NCT00000617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6291587|NCT00000621|Tretinoin|tretinoin|mesh-list
6291588|NCT00000621|Isotretinoin|isotretinoin|mesh-list
6291589|NCT00000621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6291590|NCT00000621|Keratolytic Agents|keratolytic agents|mesh-ancestor
6291591|NCT00000621|Dermatologic Agents|dermatologic agents|mesh-ancestor
6291592|NCT00000623|Decitabine|decitabine|mesh-list
6291593|NCT00000623|Sildenafil Citrate|sildenafil citrate|mesh-list
6291594|NCT00000623|Deferiprone|deferiprone|mesh-list
6291595|NCT00000623|Deferoxamine|deferoxamine|mesh-list
6291596|NCT00000623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6291597|NCT00000623|Antimetabolites|antimetabolites|mesh-ancestor
6291598|NCT00000623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291599|NCT00000623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6291600|NCT00000623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6291601|NCT00000623|Vasodilator Agents|vasodilator agents|mesh-ancestor
6291602|NCT00000623|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6291603|NCT00000623|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6291604|NCT00000623|Urological Agents|urological agents|mesh-ancestor
6291605|NCT00000623|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6291606|NCT00000623|Chelating Agents|chelating agents|mesh-ancestor
6291607|NCT00000623|Sequestering Agents|sequestering agents|mesh-ancestor
6291608|NCT00000623|Siderophores|siderophores|mesh-ancestor
6291609|NCT00000625|Zidovudine|zidovudine|mesh-list
6291610|NCT00000625|Didanosine|didanosine|mesh-list
6291611|NCT00000625|Zalcitabine|zalcitabine|mesh-list
6291612|NCT00000625|Antimetabolites|antimetabolites|mesh-ancestor
6291613|NCT00000625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291614|NCT00000625|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6291615|NCT00000625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6291616|NCT00000625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6291617|NCT00000625|Antiviral Agents|antiviral agents|mesh-ancestor
6291618|NCT00000625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6291619|NCT00000625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6291620|NCT00000625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6291621|NCT00000626|Doxorubicin|doxorubicin|mesh-list
6291622|NCT00000626|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6291623|NCT00000626|Bleomycin|bleomycin|mesh-list
6291624|NCT00000626|Dacarbazine|dacarbazine|mesh-list
6291625|NCT00000626|Vinblastine|vinblastine|mesh-list
6291626|NCT00000626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6291627|NCT00000626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6291628|NCT00000626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6291629|NCT00000626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6291630|NCT00000626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6291631|NCT00000626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291632|NCT00000626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6291633|NCT00000626|Alkylating Agents|alkylating agents|mesh-ancestor
6291634|NCT00000626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6291635|NCT00000626|Tubulin Modulators|tubulin modulators|mesh-ancestor
6291636|NCT00000626|Antimitotic Agents|antimitotic agents|mesh-ancestor
6291637|NCT00000626|Mitosis Modulators|mitosis modulators|mesh-ancestor
6291638|NCT00000627|Fluconazole|fluconazole|mesh-list
6291639|NCT00000627|Antifungal Agents|antifungal agents|mesh-ancestor
6291640|NCT00000627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6291641|NCT00000627|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6291642|NCT00000627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6291643|NCT00000627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6291644|NCT00000627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291645|NCT00000627|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6291646|NCT00000627|Hormone Antagonists|hormone antagonists|mesh-ancestor
6291647|NCT00000627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6291648|NCT00000627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6291649|NCT00000627|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6291650|NCT00000627|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6291651|NCT00000628|Zidovudine|zidovudine|mesh-list
6291652|NCT00000628|L-697661|l-697661|mesh-list
6291653|NCT00000628|Antimetabolites|antimetabolites|mesh-ancestor
6291654|NCT00000628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291655|NCT00000628|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6291656|NCT00000628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6291657|NCT00000628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6291658|NCT00000628|Antiviral Agents|antiviral agents|mesh-ancestor
6291659|NCT00000628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6291660|NCT00000628|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6291661|NCT00000628|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6291662|NCT00000629|Zidovudine|zidovudine|mesh-list
6291663|NCT00000629|Valproic Acid|valproic acid|mesh-list
6291664|NCT00000629|Antimetabolites|antimetabolites|mesh-ancestor
6291665|NCT00000629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291666|NCT00000629|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6291667|NCT00000629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6291668|NCT00000629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6291669|NCT00000629|Antiviral Agents|antiviral agents|mesh-ancestor
6291670|NCT00000629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6291671|NCT00000629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6291672|NCT00000629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6291673|NCT00000629|Anticonvulsants|anticonvulsants|mesh-ancestor
6291674|NCT00000629|GABA Agents|gaba agents|mesh-ancestor
6291675|NCT00000629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6291676|NCT00000629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6291677|NCT00000629|Antimanic Agents|antimanic agents|mesh-ancestor
6291678|NCT00000629|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6291679|NCT00000629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6291680|NCT00000629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6291681|NCT00000633|Vaccines|vaccines|mesh-list
6291682|NCT00000633|Immunologic Factors|immunologic factors|mesh-ancestor
6291683|NCT00000633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6291684|NCT00000634|Nevirapine|nevirapine|mesh-list
6291685|NCT00000634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6291686|NCT00000634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6291687|NCT00000634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6291688|NCT00000634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291689|NCT00000634|Antiviral Agents|antiviral agents|mesh-ancestor
6291690|NCT00000634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6291691|NCT00000634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6291692|NCT00000634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6291693|NCT00000634|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6291694|NCT00000634|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6291695|NCT00000635|Trifluridine|trifluridine|mesh-list
6291696|NCT00000635|Polymyxins|polymyxins|mesh-list
6291697|NCT00000635|Bacitracin|bacitracin|mesh-list
6291698|NCT00000635|Polymyxin B|polymyxin b|mesh-list
6291699|NCT00000635|Antimetabolites|antimetabolites|mesh-ancestor
6291700|NCT00000635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291701|NCT00000635|Antiviral Agents|antiviral agents|mesh-ancestor
6291702|NCT00000635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6291703|NCT00000635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6291704|NCT00000635|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6291705|NCT00000636|Pyridoxine|pyridoxine|mesh-list
6291706|NCT00000636|Vitamin B 6|vitamin b 6|mesh-list
6291707|NCT00000636|Rifampin|rifampin|mesh-list
6291708|NCT00000636|Isoniazid|isoniazid|mesh-list
6291709|NCT00000636|Pyrazinamide|pyrazinamide|mesh-list
6291710|NCT00000636|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6291711|NCT00000636|Antitubercular Agents|antitubercular agents|mesh-ancestor
6291712|NCT00000636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6291713|NCT00000636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6291714|NCT00000636|Leprostatic Agents|leprostatic agents|mesh-ancestor
6291715|NCT00000636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6291716|NCT00000636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6291717|NCT00000636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291718|NCT00000636|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6291719|NCT00000636|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6291720|NCT00000636|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6291721|NCT00000636|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6291722|NCT00000636|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6291723|NCT00000636|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6291724|NCT00000636|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6291725|NCT00000636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6291726|NCT00000636|Antimetabolites|antimetabolites|mesh-ancestor
6291727|NCT00000636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6291728|NCT00000636|Vitamin B Complex|vitamin b complex|mesh-ancestor
6291729|NCT00000636|Vitamins|vitamins|mesh-ancestor
6291730|NCT00000636|Micronutrients|micronutrients|mesh-ancestor
6291731|NCT00000636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6291732|NCT00000637|Zidovudine|zidovudine|mesh-list
6291733|NCT00000637|Didanosine|didanosine|mesh-list
6291734|NCT00000637|Antimetabolites|antimetabolites|mesh-ancestor
6291735|NCT00000637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291736|NCT00000637|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6291737|NCT00000637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6291738|NCT00000637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6291739|NCT00000637|Antiviral Agents|antiviral agents|mesh-ancestor
6291740|NCT00000637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6291741|NCT00000637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6291742|NCT00000637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6291743|NCT00000638|Pyridoxine|pyridoxine|mesh-list
6291744|NCT00000638|Vitamin B 6|vitamin b 6|mesh-list
6291745|NCT00000638|Rifampin|rifampin|mesh-list
6291746|NCT00000638|Isoniazid|isoniazid|mesh-list
6291747|NCT00000638|Pyrazinamide|pyrazinamide|mesh-list
6291748|NCT00000638|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6291749|NCT00000638|Antitubercular Agents|antitubercular agents|mesh-ancestor
6291750|NCT00000638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6291751|NCT00000638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6291752|NCT00000638|Leprostatic Agents|leprostatic agents|mesh-ancestor
6291753|NCT00000638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6291754|NCT00000638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6291755|NCT00000638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291756|NCT00000638|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6291757|NCT00000638|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6291758|NCT00000638|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6291759|NCT00000638|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6291760|NCT00000638|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6291761|NCT00000638|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6291762|NCT00000638|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6291763|NCT00000638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6291764|NCT00000638|Antimetabolites|antimetabolites|mesh-ancestor
6291765|NCT00000638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6291766|NCT00000638|Vitamin B Complex|vitamin b complex|mesh-ancestor
6291767|NCT00000638|Vitamins|vitamins|mesh-ancestor
6291768|NCT00000638|Micronutrients|micronutrients|mesh-ancestor
6291769|NCT00000638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6291770|NCT00000639|Itraconazole|itraconazole|mesh-list
6291771|NCT00000639|Fluconazole|fluconazole|mesh-list
6291772|NCT00000639|Amphotericin B|amphotericin b|mesh-list
6291773|NCT00000639|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6291774|NCT00000639|Flucytosine|flucytosine|mesh-list
6291775|NCT00000639|Antifungal Agents|antifungal agents|mesh-ancestor
6291776|NCT00000639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6291777|NCT00000639|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6291778|NCT00000639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6291779|NCT00000639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6291780|NCT00000639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291781|NCT00000639|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6291782|NCT00000639|Hormone Antagonists|hormone antagonists|mesh-ancestor
6291783|NCT00000639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6291784|NCT00000639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6291785|NCT00000639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6291786|NCT00000639|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6291787|NCT00000639|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6291788|NCT00000639|Amebicides|amebicides|mesh-ancestor
6291789|NCT00000639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6291790|NCT00000639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6291791|NCT00000639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6291792|NCT00000639|Antimetabolites|antimetabolites|mesh-ancestor
6291793|NCT00000640|Clindamycin|clindamycin|mesh-list
6291794|NCT00000640|Clindamycin palmitate|clindamycin palmitate|mesh-list
6291795|NCT00000640|Clindamycin phosphate|clindamycin phosphate|mesh-list
6291796|NCT00000640|Dapsone|dapsone|mesh-list
6291797|NCT00000640|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6291798|NCT00000640|Primaquine|primaquine|mesh-list
6291799|NCT00000640|Trimethoprim|trimethoprim|mesh-list
6291800|NCT00000640|Sulfamethoxazole|sulfamethoxazole|mesh-list
6291801|NCT00000640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6291802|NCT00000640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6291803|NCT00000640|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6291804|NCT00000640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6291805|NCT00000640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291806|NCT00000640|Antimalarials|antimalarials|mesh-ancestor
6291807|NCT00000640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6291808|NCT00000640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6291809|NCT00000640|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6291810|NCT00000640|Renal Agents|renal agents|mesh-ancestor
6291811|NCT00000640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6291812|NCT00000640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6291813|NCT00000640|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6291814|NCT00000640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6291815|NCT00000640|Leprostatic Agents|leprostatic agents|mesh-ancestor
6291816|NCT00000641|Azithromycin|azithromycin|mesh-list
6291817|NCT00000641|Ciprofloxacin|ciprofloxacin|mesh-list
6291818|NCT00000641|Rifampin|rifampin|mesh-list
6291819|NCT00000641|Amikacin|amikacin|mesh-list
6291820|NCT00000641|Ethambutol|ethambutol|mesh-list
6291821|NCT00000641|Clofazimine|clofazimine|mesh-list
6291822|NCT00000641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6291823|NCT00000641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6291824|NCT00000641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6291825|NCT00000641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6291826|NCT00000641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6291827|NCT00000641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291828|NCT00000641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6291829|NCT00000641|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6291830|NCT00000641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6291831|NCT00000641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6291832|NCT00000641|Antitubercular Agents|antitubercular agents|mesh-ancestor
6291833|NCT00000641|Leprostatic Agents|leprostatic agents|mesh-ancestor
6291834|NCT00000641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6291835|NCT00000641|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6291836|NCT00000641|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6291837|NCT00000641|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6291838|NCT00000641|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6291839|NCT00000641|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6291840|NCT00000641|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6291841|NCT00000641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6291842|NCT00000642|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
6291843|NCT00000642|Immunologic Factors|immunologic factors|mesh-ancestor
6291844|NCT00000642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6291845|NCT00000643|Leucovorin|leucovorin|mesh-list
6291846|NCT00000643|Pyrimethamine|pyrimethamine|mesh-list
6291847|NCT00000643|Calcium|calcium|mesh-list
6291848|NCT00000643|Levoleucovorin|levoleucovorin|mesh-list
6291849|NCT00000643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6291850|NCT00000643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6291851|NCT00000643|Antidotes|antidotes|mesh-ancestor
6291852|NCT00000643|Protective Agents|protective agents|mesh-ancestor
6291853|NCT00000643|Vitamin B Complex|vitamin b complex|mesh-ancestor
6291854|NCT00000643|Vitamins|vitamins|mesh-ancestor
6291855|NCT00000643|Micronutrients|micronutrients|mesh-ancestor
6291856|NCT00000643|Antimalarials|antimalarials|mesh-ancestor
6291857|NCT00000643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6291858|NCT00000643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6291859|NCT00000643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6291860|NCT00000643|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6291861|NCT00000643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6291862|NCT00000643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291863|NCT00000644|Clarithromycin|clarithromycin|mesh-list
6291864|NCT00000644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6291865|NCT00000644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6291866|NCT00000644|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6291867|NCT00000644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6291868|NCT00000644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291869|NCT00000644|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6291870|NCT00000644|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6291871|NCT00000645|Hypericin|hypericin|mesh-list
6291872|NCT00000645|Antidepressive Agents|antidepressive agents|mesh-ancestor
6291873|NCT00000645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6291874|NCT00000645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6291875|NCT00000645|Antiviral Agents|antiviral agents|mesh-ancestor
6291876|NCT00000645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6291877|NCT00000645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6291878|NCT00000645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291879|NCT00000645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6291880|NCT00000645|Immunologic Factors|immunologic factors|mesh-ancestor
6291881|NCT00000645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6291882|NCT00000646|Pentoxifylline|pentoxifylline|mesh-list
6291883|NCT00000646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6291884|NCT00000646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6291885|NCT00000646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291886|NCT00000646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6291887|NCT00000646|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6291888|NCT00000646|Protective Agents|protective agents|mesh-ancestor
6291889|NCT00000646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6291890|NCT00000646|Vasodilator Agents|vasodilator agents|mesh-ancestor
6291891|NCT00000646|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6291892|NCT00000646|Antioxidants|antioxidants|mesh-ancestor
6291893|NCT00000647|Interferons|interferons|mesh-list
6291894|NCT00000647|Interferon-alpha|interferon-alpha|mesh-list
6291895|NCT00000647|Zidovudine|zidovudine|mesh-list
6291896|NCT00000647|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
6291897|NCT00000647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6291898|NCT00000647|Antiviral Agents|antiviral agents|mesh-ancestor
6291899|NCT00000647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6291900|NCT00000647|Immunologic Factors|immunologic factors|mesh-ancestor
6291901|NCT00000647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6291902|NCT00000647|Antimetabolites|antimetabolites|mesh-ancestor
6291903|NCT00000647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291904|NCT00000647|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6291905|NCT00000647|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6291906|NCT00000647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6291907|NCT00000647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6291908|NCT00000647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6291909|NCT00000648|Ceftriaxone|ceftriaxone|mesh-list
6291910|NCT00000648|Penicillins|penicillins|mesh-list
6291911|NCT00000648|Penicillin G|penicillin g|mesh-list
6291912|NCT00000648|Penicillin G Benzathine|penicillin g benzathine|mesh-list
6291913|NCT00000648|Penicillin G Procaine|penicillin g procaine|mesh-list
6291914|NCT00000648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6291915|NCT00000648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6291916|NCT00000649|Zidovudine|zidovudine|mesh-list
6291917|NCT00000649|Nevirapine|nevirapine|mesh-list
6291918|NCT00000649|Antimetabolites|antimetabolites|mesh-ancestor
6291919|NCT00000649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291920|NCT00000649|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6291921|NCT00000649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6291922|NCT00000649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6291923|NCT00000649|Antiviral Agents|antiviral agents|mesh-ancestor
6291924|NCT00000649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6291925|NCT00000649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6291926|NCT00000649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6291927|NCT00000649|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6291928|NCT00000649|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6291929|NCT00000650|Ditiocarb|ditiocarb|mesh-list
6291930|NCT00000650|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6291931|NCT00000650|Immunologic Factors|immunologic factors|mesh-ancestor
6291932|NCT00000650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6291933|NCT00000650|Antiviral Agents|antiviral agents|mesh-ancestor
6291934|NCT00000650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6291935|NCT00000650|Chelating Agents|chelating agents|mesh-ancestor
6291936|NCT00000650|Sequestering Agents|sequestering agents|mesh-ancestor
6291937|NCT00000650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291938|NCT00000651|Zidovudine|zidovudine|mesh-list
6291939|NCT00000651|Zalcitabine|zalcitabine|mesh-list
6291940|NCT00000651|Antimetabolites|antimetabolites|mesh-ancestor
6291941|NCT00000651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291942|NCT00000651|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6291943|NCT00000651|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6291944|NCT00000651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6291945|NCT00000651|Antiviral Agents|antiviral agents|mesh-ancestor
6291946|NCT00000651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6291947|NCT00000651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6291948|NCT00000651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6015438|NCT00357162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6015439|NCT00357162|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6015440|NCT00357162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6291949|NCT00000652|Zidovudine|zidovudine|mesh-list
6291950|NCT00000652|Didanosine|didanosine|mesh-list
6291951|NCT00000652|Antimetabolites|antimetabolites|mesh-ancestor
6291952|NCT00000652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291953|NCT00000652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6291954|NCT00000652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6291955|NCT00000652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6291956|NCT00000652|Antiviral Agents|antiviral agents|mesh-ancestor
6291957|NCT00000652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6291958|NCT00000652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6291959|NCT00000652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6291960|NCT00000653|Zalcitabine|zalcitabine|mesh-list
6291961|NCT00000653|Antimetabolites|antimetabolites|mesh-ancestor
6291962|NCT00000653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291963|NCT00000653|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6291964|NCT00000653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6291965|NCT00000653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6291966|NCT00000653|Antiviral Agents|antiviral agents|mesh-ancestor
6291967|NCT00000653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6291968|NCT00000653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6291969|NCT00000653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6291970|NCT00000654|Fialuridine|fialuridine|mesh-list
6291971|NCT00000654|Antiviral Agents|antiviral agents|mesh-ancestor
6015441|NCT00357162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015442|NCT00357331|Potassium Citrate|potassium citrate|mesh-list
6015443|NCT00357331|Diuretics|diuretics|mesh-ancestor
6015444|NCT00357331|Natriuretic Agents|natriuretic agents|mesh-ancestor
6015445|NCT00357331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015446|NCT00357331|Expectorants|expectorants|mesh-ancestor
6291972|NCT00000654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6291973|NCT00000654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6291974|NCT00000654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6291975|NCT00000654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291976|NCT00000655|Trimethoprim|trimethoprim|mesh-list
6291977|NCT00000655|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6291978|NCT00000655|Atovaquone|atovaquone|mesh-list
6291979|NCT00000655|Sulfamethoxazole|sulfamethoxazole|mesh-list
6291980|NCT00000655|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6291981|NCT00000655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6291982|NCT00000655|Renal Agents|renal agents|mesh-ancestor
6291983|NCT00000655|Antimalarials|antimalarials|mesh-ancestor
6291984|NCT00000655|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6291985|NCT00000655|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6291986|NCT00000655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6291987|NCT00000655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6291988|NCT00000655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291989|NCT00000655|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6291990|NCT00000655|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6291991|NCT00000655|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6291992|NCT00000655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6291993|NCT00000656|Zidovudine|zidovudine|mesh-list
6291994|NCT00000656|Didanosine|didanosine|mesh-list
6291995|NCT00000656|Antimetabolites|antimetabolites|mesh-ancestor
6291996|NCT00000656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6291997|NCT00000656|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6291998|NCT00000656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6291999|NCT00000656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292000|NCT00000656|Antiviral Agents|antiviral agents|mesh-ancestor
6292001|NCT00000656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292002|NCT00000656|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6292003|NCT00000656|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6292004|NCT00000657|Zidovudine|zidovudine|mesh-list
6292005|NCT00000657|Didanosine|didanosine|mesh-list
6292006|NCT00000657|Antimetabolites|antimetabolites|mesh-ancestor
6292007|NCT00000657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292008|NCT00000657|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6292009|NCT00000657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6292010|NCT00000657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292011|NCT00000657|Antiviral Agents|antiviral agents|mesh-ancestor
6292012|NCT00000657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292013|NCT00000657|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6292014|NCT00000657|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6292015|NCT00000658|Leucovorin|leucovorin|mesh-list
6292016|NCT00000658|Cytarabine|cytarabine|mesh-list
6292017|NCT00000658|Dexamethasone|dexamethasone|mesh-list
6292018|NCT00000658|Cyclophosphamide|cyclophosphamide|mesh-list
6292019|NCT00000658|Doxorubicin|doxorubicin|mesh-list
6292020|NCT00000658|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6292021|NCT00000658|Methotrexate|methotrexate|mesh-list
6292022|NCT00000658|Vincristine|vincristine|mesh-list
6292023|NCT00000658|Bleomycin|bleomycin|mesh-list
6292024|NCT00000658|Allopurinol|allopurinol|mesh-list
6292025|NCT00000658|Sargramostim|sargramostim|mesh-list
6292026|NCT00000658|Levoleucovorin|levoleucovorin|mesh-list
6292027|NCT00000658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6292028|NCT00000658|Immunologic Factors|immunologic factors|mesh-ancestor
6292029|NCT00000658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6292030|NCT00000658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6292031|NCT00000658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6292032|NCT00000658|Alkylating Agents|alkylating agents|mesh-ancestor
6292033|NCT00000658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292034|NCT00000658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6292035|NCT00000658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6292036|NCT00000658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6292037|NCT00000658|Antiemetics|antiemetics|mesh-ancestor
6292038|NCT00000658|Autonomic Agents|autonomic agents|mesh-ancestor
6292039|NCT00000658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6292040|NCT00000658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6292041|NCT00000658|Glucocorticoids|glucocorticoids|mesh-ancestor
6292042|NCT00000658|Hormones|hormones|mesh-ancestor
6292043|NCT00000658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6292044|NCT00000658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6292045|NCT00000658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6292046|NCT00000658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6292047|NCT00000658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6292048|NCT00000658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292049|NCT00000658|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6292050|NCT00000658|Abortifacient Agents|abortifacient agents|mesh-ancestor
6292051|NCT00000658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6292052|NCT00000658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6292053|NCT00000658|Antimetabolites|antimetabolites|mesh-ancestor
6292054|NCT00000658|Dermatologic Agents|dermatologic agents|mesh-ancestor
6292055|NCT00000658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6292056|NCT00000658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6292057|NCT00000658|Antiviral Agents|antiviral agents|mesh-ancestor
6292058|NCT00000658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292059|NCT00000658|Antidotes|antidotes|mesh-ancestor
6292060|NCT00000658|Protective Agents|protective agents|mesh-ancestor
6292061|NCT00000658|Vitamin B Complex|vitamin b complex|mesh-ancestor
6292062|NCT00000658|Vitamins|vitamins|mesh-ancestor
6292063|NCT00000658|Micronutrients|micronutrients|mesh-ancestor
6292064|NCT00000658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6292065|NCT00000658|Tubulin Modulators|tubulin modulators|mesh-ancestor
6292066|NCT00000658|Antimitotic Agents|antimitotic agents|mesh-ancestor
6292067|NCT00000658|Mitosis Modulators|mitosis modulators|mesh-ancestor
6292068|NCT00000658|Gout Suppressants|gout suppressants|mesh-ancestor
6292069|NCT00000658|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6292070|NCT00000658|Antioxidants|antioxidants|mesh-ancestor
6292071|NCT00000659|Zidovudine|zidovudine|mesh-list
6292072|NCT00000659|Antimetabolites|antimetabolites|mesh-ancestor
6292073|NCT00000659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292074|NCT00000659|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6292075|NCT00000659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6292076|NCT00000659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292077|NCT00000659|Antiviral Agents|antiviral agents|mesh-ancestor
6292078|NCT00000659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292079|NCT00000659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6292080|NCT00000659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6292081|NCT00000660|Etoposide|etoposide|mesh-list
6292082|NCT00000660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6292083|NCT00000660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6292084|NCT00000660|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6292085|NCT00000660|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6292086|NCT00000660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292087|NCT00000660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391819|NCT00194402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6391820|NCT00194402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6391821|NCT00194402|Antimetabolites|antimetabolites|mesh-ancestor
6391822|NCT00194402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391823|NCT00194402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6391824|NCT00194402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6391825|NCT00194402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6391826|NCT00194402|Vasodilator Agents|vasodilator agents|mesh-ancestor
6391827|NCT00194402|Vitamin B Complex|vitamin b complex|mesh-ancestor
6391828|NCT00194402|Vitamins|vitamins|mesh-ancestor
6391829|NCT00194402|Micronutrients|micronutrients|mesh-ancestor
6292088|NCT00000661|Zidovudine|zidovudine|mesh-list
6292089|NCT00000661|Oxazepam|oxazepam|mesh-list
6292090|NCT00000661|Antimetabolites|antimetabolites|mesh-ancestor
6292091|NCT00000661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292092|NCT00000661|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6292093|NCT00000661|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6292094|NCT00000661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292095|NCT00000661|Antiviral Agents|antiviral agents|mesh-ancestor
6015447|NCT00357331|Respiratory System Agents|respiratory system agents|mesh-ancestor
6015448|NCT00357370|Dapagliflozin|dapagliflozin|mesh-list
6015449|NCT00357370|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6015450|NCT00357370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292096|NCT00000661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292097|NCT00000661|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6292098|NCT00000661|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6292099|NCT00000661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6292100|NCT00000661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6292101|NCT00000661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6292102|NCT00000661|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6292103|NCT00000661|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6292104|NCT00000661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6292105|NCT00000661|GABA Modulators|gaba modulators|mesh-ancestor
6292106|NCT00000661|GABA Agents|gaba agents|mesh-ancestor
6292107|NCT00000661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6292108|NCT00000662|Zidovudine|zidovudine|mesh-list
6292109|NCT00000662|Antimetabolites|antimetabolites|mesh-ancestor
6292110|NCT00000662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292111|NCT00000662|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6292112|NCT00000662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6292113|NCT00000662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292114|NCT00000662|Antiviral Agents|antiviral agents|mesh-ancestor
6292115|NCT00000662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292116|NCT00000662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6292117|NCT00000662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6292118|NCT00000663|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
6292119|NCT00000663|Immunologic Factors|immunologic factors|mesh-ancestor
6292120|NCT00000663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6292121|NCT00000664|Zidovudine|zidovudine|mesh-list
6292122|NCT00000664|Interleukin-2|interleukin-2|mesh-list
6292123|NCT00000664|Antimetabolites|antimetabolites|mesh-ancestor
6292124|NCT00000664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292125|NCT00000664|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6292126|NCT00000664|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6292127|NCT00000664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292128|NCT00000664|Antiviral Agents|antiviral agents|mesh-ancestor
6292129|NCT00000664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292130|NCT00000664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6292131|NCT00000664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6292132|NCT00000664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6292133|NCT00000664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6292134|NCT00000664|Analgesics|analgesics|mesh-ancestor
6292135|NCT00000664|Sensory System Agents|sensory system agents|mesh-ancestor
6292136|NCT00000664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6292137|NCT00000664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6292138|NCT00000665|Ganciclovir|ganciclovir|mesh-list
6292139|NCT00000665|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6292140|NCT00000665|Foscarnet|foscarnet|mesh-list
6292141|NCT00000665|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
6292142|NCT00000665|Antiviral Agents|antiviral agents|mesh-ancestor
6292143|NCT00000665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292144|NCT00000665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6292145|NCT00000665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292146|NCT00000665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292147|NCT00000665|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6292148|NCT00000666|Pyrimethamine|pyrimethamine|mesh-list
6292149|NCT00000666|Antimalarials|antimalarials|mesh-ancestor
6292150|NCT00000666|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6292151|NCT00000666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6292152|NCT00000666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292153|NCT00000666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6292154|NCT00000666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292155|NCT00000666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292156|NCT00000668|Ganciclovir|ganciclovir|mesh-list
6292157|NCT00000668|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6292158|NCT00000668|Antiviral Agents|antiviral agents|mesh-ancestor
6292159|NCT00000668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292160|NCT00000668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6292161|NCT00000668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292162|NCT00000668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292163|NCT00000669|Didanosine|didanosine|mesh-list
6292164|NCT00000669|Antimetabolites|antimetabolites|mesh-ancestor
6292165|NCT00000669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292166|NCT00000669|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6292167|NCT00000669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6292168|NCT00000669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292169|NCT00000669|Antiviral Agents|antiviral agents|mesh-ancestor
6292170|NCT00000669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292171|NCT00000669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6292172|NCT00000669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6292173|NCT00000670|Zidovudine|zidovudine|mesh-list
6292174|NCT00000670|Probenecid|probenecid|mesh-list
6292175|NCT00000670|Antimetabolites|antimetabolites|mesh-ancestor
6292176|NCT00000670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292177|NCT00000670|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6292178|NCT00000670|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6292179|NCT00000670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292180|NCT00000670|Antiviral Agents|antiviral agents|mesh-ancestor
6292181|NCT00000670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292182|NCT00000670|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6292183|NCT00000670|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6292184|NCT00000670|Uricosuric Agents|uricosuric agents|mesh-ancestor
6292185|NCT00000670|Gout Suppressants|gout suppressants|mesh-ancestor
6292186|NCT00000670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6292187|NCT00000670|Renal Agents|renal agents|mesh-ancestor
6292188|NCT00000671|Zidovudine|zidovudine|mesh-list
6292189|NCT00000671|Didanosine|didanosine|mesh-list
6292190|NCT00000671|Antimetabolites|antimetabolites|mesh-ancestor
6292191|NCT00000671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292192|NCT00000671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6292193|NCT00000671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6292194|NCT00000671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292195|NCT00000671|Antiviral Agents|antiviral agents|mesh-ancestor
6292196|NCT00000671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292197|NCT00000671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6292198|NCT00000671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6292199|NCT00000672|Didanosine|didanosine|mesh-list
6292200|NCT00000672|Antimetabolites|antimetabolites|mesh-ancestor
6292201|NCT00000672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292202|NCT00000672|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6292203|NCT00000672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6292204|NCT00000672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292205|NCT00000672|Antiviral Agents|antiviral agents|mesh-ancestor
6292206|NCT00000672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292207|NCT00000672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6292208|NCT00000672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6292209|NCT00000673|Ganciclovir|ganciclovir|mesh-list
6292210|NCT00000673|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6292211|NCT00000673|Antiviral Agents|antiviral agents|mesh-ancestor
6292212|NCT00000673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292213|NCT00000673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6292214|NCT00000673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292215|NCT00000673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292216|NCT00000674|Leucovorin|leucovorin|mesh-list
6292217|NCT00000674|Clindamycin|clindamycin|mesh-list
6292218|NCT00000674|Clindamycin palmitate|clindamycin palmitate|mesh-list
6292219|NCT00000674|Clindamycin phosphate|clindamycin phosphate|mesh-list
6292220|NCT00000674|Pyrimethamine|pyrimethamine|mesh-list
6292221|NCT00000674|Calcium|calcium|mesh-list
6292222|NCT00000674|Levoleucovorin|levoleucovorin|mesh-list
6292223|NCT00000674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6292224|NCT00000674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6292225|NCT00000674|Antidotes|antidotes|mesh-ancestor
6292226|NCT00000674|Protective Agents|protective agents|mesh-ancestor
6292227|NCT00000674|Vitamin B Complex|vitamin b complex|mesh-ancestor
6292228|NCT00000674|Vitamins|vitamins|mesh-ancestor
6292229|NCT00000674|Micronutrients|micronutrients|mesh-ancestor
6292230|NCT00000674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6292231|NCT00000674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292232|NCT00000674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6292233|NCT00000674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292234|NCT00000674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292235|NCT00000674|Antimalarials|antimalarials|mesh-ancestor
6292236|NCT00000674|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6292237|NCT00000674|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6292238|NCT00000674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6292239|NCT00000675|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
6292240|NCT00000675|Immunologic Factors|immunologic factors|mesh-ancestor
6292241|NCT00000675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6292242|NCT00000676|Fluconazole|fluconazole|mesh-list
6292243|NCT00000676|Clotrimazole|clotrimazole|mesh-list
6292244|NCT00000676|Miconazole|miconazole|mesh-list
6292245|NCT00000676|Antifungal Agents|antifungal agents|mesh-ancestor
6292246|NCT00000676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292247|NCT00000676|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6292248|NCT00000676|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6292249|NCT00000676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292250|NCT00000676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292251|NCT00000676|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6292252|NCT00000676|Hormone Antagonists|hormone antagonists|mesh-ancestor
6292253|NCT00000676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6292254|NCT00000676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6292255|NCT00000676|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6292256|NCT00000676|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6292257|NCT00000676|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6292258|NCT00000676|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6292259|NCT00000677|Sch 39304|sch 39304|mesh-list
6292260|NCT00000677|Antifungal Agents|antifungal agents|mesh-ancestor
6292261|NCT00000677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292262|NCT00000678|Zidovudine|zidovudine|mesh-list
6292263|NCT00000678|Zalcitabine|zalcitabine|mesh-list
6292264|NCT00000678|Antimetabolites|antimetabolites|mesh-ancestor
6292265|NCT00000678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292266|NCT00000678|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6292267|NCT00000678|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6292268|NCT00000678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292269|NCT00000678|Antiviral Agents|antiviral agents|mesh-ancestor
6292270|NCT00000678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292271|NCT00000678|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6292272|NCT00000678|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6292273|NCT00000679|Zidovudine|zidovudine|mesh-list
6292274|NCT00000679|Zalcitabine|zalcitabine|mesh-list
6292275|NCT00000679|Antimetabolites|antimetabolites|mesh-ancestor
6292276|NCT00000679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292277|NCT00000679|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6292278|NCT00000679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6292279|NCT00000679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292280|NCT00000679|Antiviral Agents|antiviral agents|mesh-ancestor
6292281|NCT00000679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292282|NCT00000679|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6292283|NCT00000679|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6292284|NCT00000680|Zidovudine|zidovudine|mesh-list
6292285|NCT00000680|Aldesleukin|aldesleukin|mesh-list
6292286|NCT00000680|Antimetabolites|antimetabolites|mesh-ancestor
6292287|NCT00000680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292288|NCT00000680|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6292289|NCT00000680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6292290|NCT00000680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292291|NCT00000680|Antiviral Agents|antiviral agents|mesh-ancestor
6292292|NCT00000680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292293|NCT00000680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6292294|NCT00000680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6292295|NCT00000680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6292296|NCT00000681|Zidovudine|zidovudine|mesh-list
6292297|NCT00000681|Doxorubicin|doxorubicin|mesh-list
6292298|NCT00000681|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6292299|NCT00000681|Bleomycin|bleomycin|mesh-list
6292300|NCT00000681|Vincristine|vincristine|mesh-list
6292301|NCT00000681|Sargramostim|sargramostim|mesh-list
6292302|NCT00000681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6292303|NCT00000681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6292304|NCT00000681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6292305|NCT00000681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6292306|NCT00000681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292307|NCT00000681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292308|NCT00000681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6292309|NCT00000681|Tubulin Modulators|tubulin modulators|mesh-ancestor
6292310|NCT00000681|Antimitotic Agents|antimitotic agents|mesh-ancestor
6292311|NCT00000681|Mitosis Modulators|mitosis modulators|mesh-ancestor
6292312|NCT00000681|Antimetabolites|antimetabolites|mesh-ancestor
6292313|NCT00000681|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6292314|NCT00000681|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6292315|NCT00000681|Antiviral Agents|antiviral agents|mesh-ancestor
6292316|NCT00000681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292317|NCT00000681|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6292318|NCT00000681|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6292319|NCT00000681|Immunologic Factors|immunologic factors|mesh-ancestor
6292320|NCT00000681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6292321|NCT00000682|Zidovudine|zidovudine|mesh-list
6292322|NCT00000682|Zalcitabine|zalcitabine|mesh-list
6292323|NCT00000682|Antimetabolites|antimetabolites|mesh-ancestor
6292324|NCT00000682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292325|NCT00000682|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6292326|NCT00000682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6292327|NCT00000682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292328|NCT00000682|Antiviral Agents|antiviral agents|mesh-ancestor
6292329|NCT00000682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292330|NCT00000682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6292331|NCT00000682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6292332|NCT00000684|Dextrans|dextrans|mesh-list
6292333|NCT00000684|Anticoagulants|anticoagulants|mesh-ancestor
6292334|NCT00000684|Plasma Substitutes|plasma substitutes|mesh-ancestor
6292335|NCT00000684|Blood Substitutes|blood substitutes|mesh-ancestor
6292336|NCT00000685|Zidovudine|zidovudine|mesh-list
6292337|NCT00000685|Antimetabolites|antimetabolites|mesh-ancestor
6292338|NCT00000685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292339|NCT00000685|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6292340|NCT00000685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6292341|NCT00000685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292342|NCT00000685|Antiviral Agents|antiviral agents|mesh-ancestor
6292343|NCT00000685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292344|NCT00000685|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6292345|NCT00000685|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6292346|NCT00000686|Stavudine|stavudine|mesh-list
6292347|NCT00000686|Antimetabolites|antimetabolites|mesh-ancestor
6292348|NCT00000686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292349|NCT00000686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6292350|NCT00000686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6292351|NCT00000686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292352|NCT00000686|Antiviral Agents|antiviral agents|mesh-ancestor
6292353|NCT00000686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292354|NCT00000686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6292355|NCT00000686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6292356|NCT00000687|Interferons|interferons|mesh-list
6292357|NCT00000687|Interferon-alpha|interferon-alpha|mesh-list
6292358|NCT00000687|Interferon alpha-2|interferon alpha-2|mesh-list
6292359|NCT00000687|Zidovudine|zidovudine|mesh-list
6292360|NCT00000687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6292361|NCT00000687|Antiviral Agents|antiviral agents|mesh-ancestor
6292362|NCT00000687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292363|NCT00000687|Immunologic Factors|immunologic factors|mesh-ancestor
6292364|NCT00000687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6292365|NCT00000687|Antimetabolites|antimetabolites|mesh-ancestor
6292366|NCT00000687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292367|NCT00000687|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6292368|NCT00000687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6292369|NCT00000687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292370|NCT00000687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6292371|NCT00000687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6292372|NCT00000688|Ganciclovir|ganciclovir|mesh-list
6292373|NCT00000688|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6292374|NCT00000688|Antiviral Agents|antiviral agents|mesh-ancestor
6292375|NCT00000688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292376|NCT00000688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6292377|NCT00000688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292378|NCT00000688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292379|NCT00000689|Leucovorin|leucovorin|mesh-list
6292380|NCT00000689|Cytarabine|cytarabine|mesh-list
6292381|NCT00000689|Dexamethasone|dexamethasone|mesh-list
6292382|NCT00000689|Cyclophosphamide|cyclophosphamide|mesh-list
6292383|NCT00000689|Doxorubicin|doxorubicin|mesh-list
6292384|NCT00000689|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6292385|NCT00000689|Methotrexate|methotrexate|mesh-list
6292386|NCT00000689|Vincristine|vincristine|mesh-list
6292387|NCT00000689|Bleomycin|bleomycin|mesh-list
6292388|NCT00000689|Sargramostim|sargramostim|mesh-list
6292389|NCT00000689|Levoleucovorin|levoleucovorin|mesh-list
6292390|NCT00000689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6292391|NCT00000689|Immunologic Factors|immunologic factors|mesh-ancestor
6292392|NCT00000689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6292393|NCT00000689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6292394|NCT00000689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6292395|NCT00000689|Alkylating Agents|alkylating agents|mesh-ancestor
6292396|NCT00000689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292397|NCT00000689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6292398|NCT00000689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6292399|NCT00000689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6292400|NCT00000689|Antiemetics|antiemetics|mesh-ancestor
6292401|NCT00000689|Autonomic Agents|autonomic agents|mesh-ancestor
6292402|NCT00000689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6292403|NCT00000689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6292404|NCT00000689|Glucocorticoids|glucocorticoids|mesh-ancestor
6292405|NCT00000689|Hormones|hormones|mesh-ancestor
6292406|NCT00000689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6292407|NCT00000689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6292408|NCT00000689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6292409|NCT00000689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6292410|NCT00000689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6292411|NCT00000689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292412|NCT00000689|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6292413|NCT00000689|Abortifacient Agents|abortifacient agents|mesh-ancestor
6292414|NCT00000689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6292415|NCT00000689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6292416|NCT00000689|Antimetabolites|antimetabolites|mesh-ancestor
6292417|NCT00000689|Dermatologic Agents|dermatologic agents|mesh-ancestor
6292418|NCT00000689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6292419|NCT00000689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6292420|NCT00000689|Antiviral Agents|antiviral agents|mesh-ancestor
6292421|NCT00000689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292422|NCT00000689|Antidotes|antidotes|mesh-ancestor
6292423|NCT00000689|Protective Agents|protective agents|mesh-ancestor
6292424|NCT00000689|Vitamin B Complex|vitamin b complex|mesh-ancestor
6292425|NCT00000689|Vitamins|vitamins|mesh-ancestor
6292426|NCT00000689|Micronutrients|micronutrients|mesh-ancestor
6292427|NCT00000689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6292428|NCT00000689|Tubulin Modulators|tubulin modulators|mesh-ancestor
6292429|NCT00000689|Antimitotic Agents|antimitotic agents|mesh-ancestor
6292430|NCT00000689|Mitosis Modulators|mitosis modulators|mesh-ancestor
6292431|NCT00000690|Dextrans|dextrans|mesh-list
6292432|NCT00000690|Anticoagulants|anticoagulants|mesh-ancestor
6292433|NCT00000690|Plasma Substitutes|plasma substitutes|mesh-ancestor
6292434|NCT00000690|Blood Substitutes|blood substitutes|mesh-ancestor
6292435|NCT00000691|Foscarnet|foscarnet|mesh-list
6292436|NCT00000691|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
6292437|NCT00000691|Antiviral Agents|antiviral agents|mesh-ancestor
6292438|NCT00000691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292439|NCT00000691|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6292440|NCT00000691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6292441|NCT00000691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292442|NCT00000691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292443|NCT00000692|Miglustat|miglustat|mesh-list
6292444|NCT00000692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292445|NCT00000692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292446|NCT00000692|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6292447|NCT00000692|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6292448|NCT00000692|Antiviral Agents|antiviral agents|mesh-ancestor
6292449|NCT00000692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292450|NCT00000692|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6292451|NCT00000692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6292452|NCT00000692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6292453|NCT00000693|Zidovudine|zidovudine|mesh-list
6292454|NCT00000693|Acyclovir|acyclovir|mesh-list
6292455|NCT00000693|Antimetabolites|antimetabolites|mesh-ancestor
6292456|NCT00000693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292457|NCT00000693|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6292458|NCT00000693|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6292459|NCT00000693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292460|NCT00000693|Antiviral Agents|antiviral agents|mesh-ancestor
6292461|NCT00000693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292462|NCT00000693|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6292463|NCT00000693|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6292464|NCT00000694|Interferons|interferons|mesh-list
6292465|NCT00000694|Interferon-alpha|interferon-alpha|mesh-list
6292466|NCT00000694|Interferon alpha-2|interferon alpha-2|mesh-list
6292467|NCT00000694|Zidovudine|zidovudine|mesh-list
6292468|NCT00000694|Sargramostim|sargramostim|mesh-list
6292469|NCT00000694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6292470|NCT00000694|Antiviral Agents|antiviral agents|mesh-ancestor
6292471|NCT00000694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292472|NCT00000694|Immunologic Factors|immunologic factors|mesh-ancestor
6292473|NCT00000694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6292474|NCT00000694|Antimetabolites|antimetabolites|mesh-ancestor
6292475|NCT00000694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292476|NCT00000694|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6292477|NCT00000694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6292478|NCT00000694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292479|NCT00000694|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6292480|NCT00000694|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6292481|NCT00000695|Interferons|interferons|mesh-list
6292482|NCT00000695|Zidovudine|zidovudine|mesh-list
6292483|NCT00000695|Interferon-beta|interferon-beta|mesh-list
6292484|NCT00000695|Interferon beta-1b|interferon beta-1b|mesh-list
6292485|NCT00000695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6292486|NCT00000695|Antiviral Agents|antiviral agents|mesh-ancestor
6292487|NCT00000695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292488|NCT00000695|Antimetabolites|antimetabolites|mesh-ancestor
6292489|NCT00000695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292490|NCT00000695|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6292491|NCT00000695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6292492|NCT00000695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292493|NCT00000695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6292494|NCT00000695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6292495|NCT00000695|Immunologic Factors|immunologic factors|mesh-ancestor
6292496|NCT00000695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6292497|NCT00000695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6292498|NCT00000696|Interferons|interferons|mesh-list
6292499|NCT00000696|Interferon-alpha|interferon-alpha|mesh-list
6292500|NCT00000696|Interferon alpha-2|interferon alpha-2|mesh-list
6292501|NCT00000696|Zidovudine|zidovudine|mesh-list
6292502|NCT00000696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6292503|NCT00000696|Antiviral Agents|antiviral agents|mesh-ancestor
6292504|NCT00000696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292505|NCT00000696|Immunologic Factors|immunologic factors|mesh-ancestor
6292506|NCT00000696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6292507|NCT00000696|Antimetabolites|antimetabolites|mesh-ancestor
6292508|NCT00000696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292509|NCT00000696|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6292510|NCT00000696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6292511|NCT00000696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292512|NCT00000696|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6292513|NCT00000696|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6292514|NCT00000697|Foscarnet|foscarnet|mesh-list
6292515|NCT00000697|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
6292516|NCT00000697|Antiviral Agents|antiviral agents|mesh-ancestor
6292517|NCT00000697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292518|NCT00000697|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6292519|NCT00000697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6292520|NCT00000697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292521|NCT00000697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292522|NCT00000698|Ganciclovir|ganciclovir|mesh-list
6292523|NCT00000698|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6292524|NCT00000698|Antiviral Agents|antiviral agents|mesh-ancestor
6292525|NCT00000698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292526|NCT00000698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6292527|NCT00000698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292528|NCT00000698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292529|NCT00000699|Ribavirin|ribavirin|mesh-list
6292530|NCT00000699|Inosine Pranobex|inosine pranobex|mesh-list
6292531|NCT00000699|Antimetabolites|antimetabolites|mesh-ancestor
6292532|NCT00000699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292533|NCT00000699|Antiviral Agents|antiviral agents|mesh-ancestor
6292534|NCT00000699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292535|NCT00000699|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6292536|NCT00000699|Immunologic Factors|immunologic factors|mesh-ancestor
6292537|NCT00000699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6292538|NCT00000700|Zidovudine|zidovudine|mesh-list
6292539|NCT00000700|Antimetabolites|antimetabolites|mesh-ancestor
6292540|NCT00000700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292541|NCT00000700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6292542|NCT00000700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6292543|NCT00000700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292544|NCT00000700|Antiviral Agents|antiviral agents|mesh-ancestor
6292545|NCT00000700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292546|NCT00000700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6292547|NCT00000700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6292548|NCT00000701|Zidovudine|zidovudine|mesh-list
6292549|NCT00000701|Antimetabolites|antimetabolites|mesh-ancestor
6292550|NCT00000701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292551|NCT00000701|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6292552|NCT00000701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6292553|NCT00000701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292554|NCT00000701|Antiviral Agents|antiviral agents|mesh-ancestor
6292555|NCT00000701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292556|NCT00000701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6292557|NCT00000701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6292558|NCT00000702|Zidovudine|zidovudine|mesh-list
6292559|NCT00000702|Antimetabolites|antimetabolites|mesh-ancestor
6292560|NCT00000702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292561|NCT00000702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6015451|NCT00357370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6015452|NCT00357370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015453|NCT00357396|Melphalan|melphalan|mesh-list
6015454|NCT00357396|Busulfan|busulfan|mesh-list
6015455|NCT00357396|Thiotepa|thiotepa|mesh-list
6015456|NCT00357396|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6015457|NCT00357396|Alkylating Agents|alkylating agents|mesh-ancestor
6015458|NCT00357396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292562|NCT00000702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6292563|NCT00000702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292564|NCT00000702|Antiviral Agents|antiviral agents|mesh-ancestor
6292565|NCT00000702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292566|NCT00000702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6292567|NCT00000702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6292568|NCT00000703|Leucovorin|leucovorin|mesh-list
6292569|NCT00000703|Cytarabine|cytarabine|mesh-list
6292570|NCT00000703|Zidovudine|zidovudine|mesh-list
6292571|NCT00000703|Dexamethasone|dexamethasone|mesh-list
6292572|NCT00000703|Cyclophosphamide|cyclophosphamide|mesh-list
6292573|NCT00000703|Doxorubicin|doxorubicin|mesh-list
6292574|NCT00000703|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6292575|NCT00000703|Methotrexate|methotrexate|mesh-list
6292576|NCT00000703|Vincristine|vincristine|mesh-list
6292577|NCT00000703|Bleomycin|bleomycin|mesh-list
6292578|NCT00000703|Allopurinol|allopurinol|mesh-list
6292579|NCT00000703|Levoleucovorin|levoleucovorin|mesh-list
6292580|NCT00000703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6292581|NCT00000703|Immunologic Factors|immunologic factors|mesh-ancestor
6292582|NCT00000703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6292583|NCT00000703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6292584|NCT00000703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6292585|NCT00000703|Alkylating Agents|alkylating agents|mesh-ancestor
6292586|NCT00000703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292587|NCT00000703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6292588|NCT00000703|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6292589|NCT00000703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6292590|NCT00000703|Antiemetics|antiemetics|mesh-ancestor
6292591|NCT00000703|Autonomic Agents|autonomic agents|mesh-ancestor
6292592|NCT00000703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6292593|NCT00000703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6292594|NCT00000703|Glucocorticoids|glucocorticoids|mesh-ancestor
6292595|NCT00000703|Hormones|hormones|mesh-ancestor
6292596|NCT00000703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6292597|NCT00000703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6292598|NCT00000703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6292599|NCT00000703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6292600|NCT00000703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6292601|NCT00000703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292602|NCT00000703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6292603|NCT00000703|Abortifacient Agents|abortifacient agents|mesh-ancestor
6292604|NCT00000703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6292605|NCT00000703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6292606|NCT00000703|Antimetabolites|antimetabolites|mesh-ancestor
6292607|NCT00000703|Dermatologic Agents|dermatologic agents|mesh-ancestor
6292608|NCT00000703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6292609|NCT00000703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6292610|NCT00000703|Antiviral Agents|antiviral agents|mesh-ancestor
6292611|NCT00000703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292612|NCT00000703|Antidotes|antidotes|mesh-ancestor
6292613|NCT00000703|Protective Agents|protective agents|mesh-ancestor
6292614|NCT00000703|Vitamin B Complex|vitamin b complex|mesh-ancestor
6292615|NCT00000703|Vitamins|vitamins|mesh-ancestor
6292616|NCT00000703|Micronutrients|micronutrients|mesh-ancestor
6292617|NCT00000703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6292618|NCT00000703|Tubulin Modulators|tubulin modulators|mesh-ancestor
6292619|NCT00000703|Antimitotic Agents|antimitotic agents|mesh-ancestor
6292620|NCT00000703|Mitosis Modulators|mitosis modulators|mesh-ancestor
6292621|NCT00000703|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6292622|NCT00000703|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6292623|NCT00000703|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6292624|NCT00000703|Gout Suppressants|gout suppressants|mesh-ancestor
6292625|NCT00000703|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6292626|NCT00000703|Antioxidants|antioxidants|mesh-ancestor
6292627|NCT00000704|Zalcitabine|zalcitabine|mesh-list
6292628|NCT00000704|Antimetabolites|antimetabolites|mesh-ancestor
6292629|NCT00000704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292630|NCT00000704|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6292631|NCT00000704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6292632|NCT00000704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292633|NCT00000704|Antiviral Agents|antiviral agents|mesh-ancestor
6292634|NCT00000704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292635|NCT00000704|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6292636|NCT00000704|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6292637|NCT00000705|Zidovudine|zidovudine|mesh-list
6292638|NCT00000705|Antimetabolites|antimetabolites|mesh-ancestor
6292639|NCT00000705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292640|NCT00000705|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6292641|NCT00000705|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6292642|NCT00000705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292643|NCT00000705|Antiviral Agents|antiviral agents|mesh-ancestor
6292644|NCT00000705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292645|NCT00000705|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6292646|NCT00000705|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6292647|NCT00000706|Zidovudine|zidovudine|mesh-list
6292648|NCT00000706|Quinine|quinine|mesh-list
6292649|NCT00000706|Probenecid|probenecid|mesh-list
6292650|NCT00000706|Antimetabolites|antimetabolites|mesh-ancestor
6292651|NCT00000706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292652|NCT00000706|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6292653|NCT00000706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6292654|NCT00000706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292655|NCT00000706|Antiviral Agents|antiviral agents|mesh-ancestor
6292656|NCT00000706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292657|NCT00000706|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6292658|NCT00000706|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6292659|NCT00000706|Antimalarials|antimalarials|mesh-ancestor
6292660|NCT00000706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6292661|NCT00000706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6292662|NCT00000706|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6292663|NCT00000706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6292664|NCT00000706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6292665|NCT00000706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6292666|NCT00000706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6292667|NCT00000706|Analgesics|analgesics|mesh-ancestor
6292668|NCT00000706|Sensory System Agents|sensory system agents|mesh-ancestor
6292669|NCT00000706|Uricosuric Agents|uricosuric agents|mesh-ancestor
6292670|NCT00000706|Gout Suppressants|gout suppressants|mesh-ancestor
6292671|NCT00000706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6292672|NCT00000706|Renal Agents|renal agents|mesh-ancestor
6292673|NCT00000707|Pentamidine|pentamidine|mesh-list
6292674|NCT00000707|Antifungal Agents|antifungal agents|mesh-ancestor
6292675|NCT00000707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292676|NCT00000707|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6292677|NCT00000707|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6292678|NCT00000707|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6292679|NCT00000708|Fluconazole|fluconazole|mesh-list
6292680|NCT00000708|Amphotericin B|amphotericin b|mesh-list
6292681|NCT00000708|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6292682|NCT00000708|Flucytosine|flucytosine|mesh-list
6292683|NCT00000708|Antifungal Agents|antifungal agents|mesh-ancestor
6292684|NCT00000708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292685|NCT00000708|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6292686|NCT00000708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6292687|NCT00000708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292688|NCT00000708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292689|NCT00000708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6292690|NCT00000708|Hormone Antagonists|hormone antagonists|mesh-ancestor
6292691|NCT00000708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6292692|NCT00000708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6292693|NCT00000708|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6292694|NCT00000708|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6292695|NCT00000708|Amebicides|amebicides|mesh-ancestor
6292696|NCT00000708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6292697|NCT00000708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6292698|NCT00000708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6292699|NCT00000708|Antimetabolites|antimetabolites|mesh-ancestor
6292700|NCT00000709|Zidovudine|zidovudine|mesh-list
6292701|NCT00000709|Antimetabolites|antimetabolites|mesh-ancestor
6292702|NCT00000709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292703|NCT00000709|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6292704|NCT00000709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6292705|NCT00000709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292706|NCT00000709|Antiviral Agents|antiviral agents|mesh-ancestor
6292707|NCT00000709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292708|NCT00000709|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6292709|NCT00000709|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6292710|NCT00000710|Didanosine|didanosine|mesh-list
6292711|NCT00000710|Antimetabolites|antimetabolites|mesh-ancestor
6292712|NCT00000710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292713|NCT00000710|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6292714|NCT00000710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6292715|NCT00000710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292716|NCT00000710|Antiviral Agents|antiviral agents|mesh-ancestor
6292717|NCT00000710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292718|NCT00000710|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6292719|NCT00000710|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6292720|NCT00000711|Zidovudine|zidovudine|mesh-list
6292721|NCT00000711|Sargramostim|sargramostim|mesh-list
6292722|NCT00000711|Antimetabolites|antimetabolites|mesh-ancestor
6292723|NCT00000711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292724|NCT00000711|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6292725|NCT00000711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6292726|NCT00000711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292727|NCT00000711|Antiviral Agents|antiviral agents|mesh-ancestor
6292728|NCT00000711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292729|NCT00000711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6292730|NCT00000711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6292731|NCT00000711|Immunologic Factors|immunologic factors|mesh-ancestor
6292732|NCT00000711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6292733|NCT00000712|Zidovudine|zidovudine|mesh-list
6292734|NCT00000712|Acyclovir|acyclovir|mesh-list
6292735|NCT00000712|Antimetabolites|antimetabolites|mesh-ancestor
6292736|NCT00000712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292737|NCT00000712|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6292738|NCT00000712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6292739|NCT00000712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292740|NCT00000712|Antiviral Agents|antiviral agents|mesh-ancestor
6292741|NCT00000712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292742|NCT00000712|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6292743|NCT00000712|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6292744|NCT00000713|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
6292745|NCT00000713|Antiviral Agents|antiviral agents|mesh-ancestor
6292746|NCT00000713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292747|NCT00000714|Leucovorin|leucovorin|mesh-list
6292748|NCT00000714|Trimetrexate|trimetrexate|mesh-list
6292749|NCT00000714|Calcium|calcium|mesh-list
6292750|NCT00000714|Levoleucovorin|levoleucovorin|mesh-list
6292751|NCT00000714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6292752|NCT00000714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6292753|NCT00000714|Antidotes|antidotes|mesh-ancestor
6292754|NCT00000714|Protective Agents|protective agents|mesh-ancestor
6292755|NCT00000714|Vitamin B Complex|vitamin b complex|mesh-ancestor
6292756|NCT00000714|Vitamins|vitamins|mesh-ancestor
6292757|NCT00000714|Micronutrients|micronutrients|mesh-ancestor
6292758|NCT00000714|Antifungal Agents|antifungal agents|mesh-ancestor
6292759|NCT00000714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292760|NCT00000714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6292761|NCT00000714|Antimetabolites|antimetabolites|mesh-ancestor
6292762|NCT00000714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292763|NCT00000714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6292764|NCT00000714|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6292765|NCT00000714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292766|NCT00000715|Trimethoprim|trimethoprim|mesh-list
6292767|NCT00000715|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6292768|NCT00000715|Sulfamethoxazole|sulfamethoxazole|mesh-list
6292769|NCT00000715|Pentamidine|pentamidine|mesh-list
6292770|NCT00000715|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6292771|NCT00000715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292772|NCT00000715|Renal Agents|renal agents|mesh-ancestor
6292773|NCT00000715|Antimalarials|antimalarials|mesh-ancestor
6292774|NCT00000715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6292775|NCT00000715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6292776|NCT00000715|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6292777|NCT00000715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292778|NCT00000715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292779|NCT00000715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6292780|NCT00000715|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6292781|NCT00000715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6292782|NCT00000715|Antifungal Agents|antifungal agents|mesh-ancestor
6292783|NCT00000715|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6292784|NCT00000715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6292785|NCT00000716|Zidovudine|zidovudine|mesh-list
6292786|NCT00000716|Antimetabolites|antimetabolites|mesh-ancestor
6292787|NCT00000716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292788|NCT00000716|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6292789|NCT00000716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6292790|NCT00000716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292791|NCT00000716|Antiviral Agents|antiviral agents|mesh-ancestor
6292792|NCT00000716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292793|NCT00000716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6292794|NCT00000716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6292795|NCT00000717|Clindamycin|clindamycin|mesh-list
6292796|NCT00000717|Clindamycin palmitate|clindamycin palmitate|mesh-list
6292797|NCT00000717|Clindamycin phosphate|clindamycin phosphate|mesh-list
6292798|NCT00000717|Primaquine|primaquine|mesh-list
6292799|NCT00000717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6292800|NCT00000717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292801|NCT00000717|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6292802|NCT00000717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292803|NCT00000717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292804|NCT00000717|Antimalarials|antimalarials|mesh-ancestor
6292805|NCT00000717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6292806|NCT00000717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6292807|NCT00000718|Zidovudine|zidovudine|mesh-list
6292808|NCT00000718|Zalcitabine|zalcitabine|mesh-list
6292809|NCT00000718|Antimetabolites|antimetabolites|mesh-ancestor
6292810|NCT00000718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292811|NCT00000718|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6292812|NCT00000718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6292813|NCT00000718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292814|NCT00000718|Antiviral Agents|antiviral agents|mesh-ancestor
6292815|NCT00000718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292816|NCT00000718|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6292817|NCT00000718|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6292818|NCT00000719|Zidovudine|zidovudine|mesh-list
6292819|NCT00000719|Zalcitabine|zalcitabine|mesh-list
6292820|NCT00000719|Antimetabolites|antimetabolites|mesh-ancestor
6292821|NCT00000719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292822|NCT00000719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6292823|NCT00000719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6292824|NCT00000719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292825|NCT00000719|Antiviral Agents|antiviral agents|mesh-ancestor
6292826|NCT00000719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292827|NCT00000719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6292828|NCT00000719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6292829|NCT00000720|Zidovudine|zidovudine|mesh-list
6292830|NCT00000720|Immunoglobulins|immunoglobulins|mesh-list
6292831|NCT00000720|Antibodies|antibodies|mesh-list
6292832|NCT00000720|Antimetabolites|antimetabolites|mesh-ancestor
6292833|NCT00000720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292834|NCT00000720|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6292835|NCT00000720|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6292836|NCT00000720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292837|NCT00000720|Antiviral Agents|antiviral agents|mesh-ancestor
6292838|NCT00000720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292839|NCT00000720|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6292840|NCT00000720|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6292841|NCT00000720|Immunologic Factors|immunologic factors|mesh-ancestor
6292842|NCT00000720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6292843|NCT00000722|Pentamidine|pentamidine|mesh-list
6292844|NCT00000722|Antifungal Agents|antifungal agents|mesh-ancestor
6292845|NCT00000722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292846|NCT00000722|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6292847|NCT00000722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6292848|NCT00000722|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6292849|NCT00000723|Leucovorin|leucovorin|mesh-list
6292850|NCT00000723|Zidovudine|zidovudine|mesh-list
6292851|NCT00000723|Dexamethasone|dexamethasone|mesh-list
6292852|NCT00000723|Methotrexate|methotrexate|mesh-list
6292853|NCT00000723|Calcium|calcium|mesh-list
6292854|NCT00000723|Levoleucovorin|levoleucovorin|mesh-list
6292855|NCT00000723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6292856|NCT00000723|Antiemetics|antiemetics|mesh-ancestor
6292857|NCT00000723|Autonomic Agents|autonomic agents|mesh-ancestor
6292858|NCT00000723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6292859|NCT00000723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6292860|NCT00000723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6292861|NCT00000723|Glucocorticoids|glucocorticoids|mesh-ancestor
6292862|NCT00000723|Hormones|hormones|mesh-ancestor
6292863|NCT00000723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6292864|NCT00000723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6292865|NCT00000723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6292866|NCT00000723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6292867|NCT00000723|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6292868|NCT00000723|Abortifacient Agents|abortifacient agents|mesh-ancestor
6292869|NCT00000723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6015459|NCT00357396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6015460|NCT00357396|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6015461|NCT00357396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6015462|NCT00357396|Immunologic Factors|immunologic factors|mesh-ancestor
6015463|NCT00357396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6292870|NCT00000723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6292871|NCT00000723|Antimetabolites|antimetabolites|mesh-ancestor
6292872|NCT00000723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292873|NCT00000723|Dermatologic Agents|dermatologic agents|mesh-ancestor
6292874|NCT00000723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292875|NCT00000723|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6292876|NCT00000723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6292877|NCT00000723|Immunologic Factors|immunologic factors|mesh-ancestor
6292878|NCT00000723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6292879|NCT00000723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6292880|NCT00000723|Antidotes|antidotes|mesh-ancestor
6292881|NCT00000723|Protective Agents|protective agents|mesh-ancestor
6292882|NCT00000723|Vitamin B Complex|vitamin b complex|mesh-ancestor
6292883|NCT00000723|Vitamins|vitamins|mesh-ancestor
6292884|NCT00000723|Micronutrients|micronutrients|mesh-ancestor
6292885|NCT00000723|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6292886|NCT00000723|Antiviral Agents|antiviral agents|mesh-ancestor
6292887|NCT00000723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292888|NCT00000723|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6292889|NCT00000723|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6292890|NCT00000724|Leucovorin|leucovorin|mesh-list
6292891|NCT00000724|Trimetrexate|trimetrexate|mesh-list
6292892|NCT00000724|Calcium|calcium|mesh-list
6292893|NCT00000724|Levoleucovorin|levoleucovorin|mesh-list
6292894|NCT00000724|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6292895|NCT00000724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6292896|NCT00000724|Antidotes|antidotes|mesh-ancestor
6292897|NCT00000724|Protective Agents|protective agents|mesh-ancestor
6292898|NCT00000724|Vitamin B Complex|vitamin b complex|mesh-ancestor
6292899|NCT00000724|Vitamins|vitamins|mesh-ancestor
6292900|NCT00000724|Micronutrients|micronutrients|mesh-ancestor
6292901|NCT00000724|Antifungal Agents|antifungal agents|mesh-ancestor
6292902|NCT00000724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292903|NCT00000724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6292904|NCT00000724|Antimetabolites|antimetabolites|mesh-ancestor
6292905|NCT00000724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292906|NCT00000724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6292907|NCT00000724|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6292908|NCT00000724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292909|NCT00000725|Interferons|interferons|mesh-list
6292910|NCT00000725|Interferon-alpha|interferon-alpha|mesh-list
6292911|NCT00000725|Interferon alpha-2|interferon alpha-2|mesh-list
6292912|NCT00000725|Zidovudine|zidovudine|mesh-list
6292913|NCT00000725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6292914|NCT00000725|Antiviral Agents|antiviral agents|mesh-ancestor
6292915|NCT00000725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292916|NCT00000725|Immunologic Factors|immunologic factors|mesh-ancestor
6292917|NCT00000725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6292918|NCT00000725|Antimetabolites|antimetabolites|mesh-ancestor
6292919|NCT00000725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292920|NCT00000725|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6292921|NCT00000725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6292922|NCT00000725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292923|NCT00000725|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6292924|NCT00000725|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6292925|NCT00000726|Foscarnet|foscarnet|mesh-list
6292926|NCT00000726|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
6292927|NCT00000726|Antiviral Agents|antiviral agents|mesh-ancestor
6292928|NCT00000726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292929|NCT00000726|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6292930|NCT00000726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6292931|NCT00000726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292932|NCT00000726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292933|NCT00000727|Zidovudine|zidovudine|mesh-list
6292934|NCT00000727|Pyrimethamine|pyrimethamine|mesh-list
6292935|NCT00000727|Sulfadoxine|sulfadoxine|mesh-list
6292936|NCT00000727|Trimethoprim|trimethoprim|mesh-list
6292937|NCT00000727|Sulfamethoxazole|sulfamethoxazole|mesh-list
6292938|NCT00000727|Pentamidine|pentamidine|mesh-list
6292939|NCT00000727|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6292940|NCT00000727|Antimetabolites|antimetabolites|mesh-ancestor
6292941|NCT00000727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292942|NCT00000727|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6292943|NCT00000727|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6292944|NCT00000727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292945|NCT00000727|Antiviral Agents|antiviral agents|mesh-ancestor
6292946|NCT00000727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292947|NCT00000727|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6292948|NCT00000727|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6292949|NCT00000727|Antimalarials|antimalarials|mesh-ancestor
6292950|NCT00000727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6292951|NCT00000727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6292952|NCT00000727|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6292953|NCT00000727|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6292954|NCT00000727|Renal Agents|renal agents|mesh-ancestor
6292955|NCT00000727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6292956|NCT00000727|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6292957|NCT00000727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6292958|NCT00000727|Antifungal Agents|antifungal agents|mesh-ancestor
6292959|NCT00000727|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6292960|NCT00000727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6292961|NCT00000728|Zidovudine|zidovudine|mesh-list
6292962|NCT00000728|Aldesleukin|aldesleukin|mesh-list
6292963|NCT00000728|Antimetabolites|antimetabolites|mesh-ancestor
6292964|NCT00000728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292965|NCT00000728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6292966|NCT00000728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6292967|NCT00000728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292968|NCT00000728|Antiviral Agents|antiviral agents|mesh-ancestor
6292969|NCT00000728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292970|NCT00000728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6292971|NCT00000728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6292972|NCT00000728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6292973|NCT00000729|Foscarnet|foscarnet|mesh-list
6292974|NCT00000729|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
6292975|NCT00000729|Antiviral Agents|antiviral agents|mesh-ancestor
6292976|NCT00000729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6292977|NCT00000729|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6292978|NCT00000729|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6292979|NCT00000729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6292980|NCT00000729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6292981|NCT00000730|Leucovorin|leucovorin|mesh-list
6292982|NCT00000730|Trimethoprim|trimethoprim|mesh-list
6292983|NCT00000730|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6292984|NCT00000730|Sulfamethoxazole|sulfamethoxazole|mesh-list
6292985|NCT00000730|Pentamidine|pentamidine|mesh-list
6292986|NCT00000730|Trimetrexate|trimetrexate|mesh-list
6292987|NCT00000730|Methylprednisolone|methylprednisolone|mesh-list
6292988|NCT00000730|Levoleucovorin|levoleucovorin|mesh-list
6292989|NCT00000730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6292990|NCT00000730|Antidotes|antidotes|mesh-ancestor
6292991|NCT00000730|Protective Agents|protective agents|mesh-ancestor
6292992|NCT00000730|Vitamin B Complex|vitamin b complex|mesh-ancestor
6292993|NCT00000730|Vitamins|vitamins|mesh-ancestor
6292994|NCT00000730|Micronutrients|micronutrients|mesh-ancestor
6292995|NCT00000730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6292996|NCT00000730|Antiemetics|antiemetics|mesh-ancestor
6292997|NCT00000730|Autonomic Agents|autonomic agents|mesh-ancestor
6292998|NCT00000730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6292999|NCT00000730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6293000|NCT00000730|Glucocorticoids|glucocorticoids|mesh-ancestor
6293001|NCT00000730|Hormones|hormones|mesh-ancestor
6293002|NCT00000730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6293003|NCT00000730|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6293004|NCT00000730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6293005|NCT00000730|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6293006|NCT00000730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293007|NCT00000730|Renal Agents|renal agents|mesh-ancestor
6293008|NCT00000730|Antimalarials|antimalarials|mesh-ancestor
6293009|NCT00000730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6293010|NCT00000730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6293011|NCT00000730|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6293012|NCT00000730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6293013|NCT00000730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293014|NCT00000730|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6293015|NCT00000730|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6293016|NCT00000730|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6293017|NCT00000730|Antifungal Agents|antifungal agents|mesh-ancestor
6293018|NCT00000730|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6293019|NCT00000730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6293020|NCT00000730|Antimetabolites|antimetabolites|mesh-ancestor
6293021|NCT00000730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6293022|NCT00000731|Acetaminophen|acetaminophen|mesh-list
6293023|NCT00000731|Zidovudine|zidovudine|mesh-list
6293024|NCT00000731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6293025|NCT00000731|Analgesics|analgesics|mesh-ancestor
6293026|NCT00000731|Sensory System Agents|sensory system agents|mesh-ancestor
6293027|NCT00000731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6293028|NCT00000731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6293029|NCT00000731|Antipyretics|antipyretics|mesh-ancestor
6293030|NCT00000731|Antimetabolites|antimetabolites|mesh-ancestor
6293031|NCT00000731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293032|NCT00000731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6293033|NCT00000731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6293034|NCT00000731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6293035|NCT00000731|Antiviral Agents|antiviral agents|mesh-ancestor
6293036|NCT00000731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293037|NCT00000731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6293038|NCT00000731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6293039|NCT00000732|Zidovudine|zidovudine|mesh-list
6293040|NCT00000732|Trimethoprim|trimethoprim|mesh-list
6293041|NCT00000732|Sulfamethoxazole|sulfamethoxazole|mesh-list
6015464|NCT00357500|Thalidomide|thalidomide|mesh-list
6015465|NCT00357500|Celecoxib|celecoxib|mesh-list
6015466|NCT00357500|Cyclophosphamide|cyclophosphamide|mesh-list
6015467|NCT00357500|Etoposide|etoposide|mesh-list
6015468|NCT00357500|Fenofibrate|fenofibrate|mesh-list
6015469|NCT00357500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6015470|NCT00357500|Immunologic Factors|immunologic factors|mesh-ancestor
6015471|NCT00357500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015472|NCT00357500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6015473|NCT00357500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6015474|NCT00357500|Alkylating Agents|alkylating agents|mesh-ancestor
6293042|NCT00000732|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6293043|NCT00000732|Antimetabolites|antimetabolites|mesh-ancestor
6293044|NCT00000732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293045|NCT00000732|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6293046|NCT00000732|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6293047|NCT00000732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6293048|NCT00000732|Antiviral Agents|antiviral agents|mesh-ancestor
6293049|NCT00000732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293050|NCT00000732|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6293051|NCT00000732|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6293052|NCT00000732|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6293053|NCT00000732|Renal Agents|renal agents|mesh-ancestor
6293054|NCT00000732|Antimalarials|antimalarials|mesh-ancestor
6293055|NCT00000732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6293056|NCT00000732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6293057|NCT00000732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6293058|NCT00000732|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6293059|NCT00000732|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6293060|NCT00000732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6293061|NCT00000732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6293062|NCT00000733|Ribavirin|ribavirin|mesh-list
6293063|NCT00000733|Antimetabolites|antimetabolites|mesh-ancestor
6293064|NCT00000733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293065|NCT00000733|Antiviral Agents|antiviral agents|mesh-ancestor
6293066|NCT00000733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293067|NCT00000734|Zidovudine|zidovudine|mesh-list
6015475|NCT00357500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293068|NCT00000734|Trimethoprim|trimethoprim|mesh-list
6293069|NCT00000734|Sulfamethoxazole|sulfamethoxazole|mesh-list
6293070|NCT00000734|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6293071|NCT00000734|Antimetabolites|antimetabolites|mesh-ancestor
6293072|NCT00000734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293073|NCT00000734|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6293074|NCT00000734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6293075|NCT00000734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6293076|NCT00000734|Antiviral Agents|antiviral agents|mesh-ancestor
6293077|NCT00000734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293078|NCT00000734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6293079|NCT00000734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6293080|NCT00000734|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6293081|NCT00000734|Renal Agents|renal agents|mesh-ancestor
6293082|NCT00000734|Antimalarials|antimalarials|mesh-ancestor
6293083|NCT00000734|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6293084|NCT00000734|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6293085|NCT00000734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6293086|NCT00000734|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6293087|NCT00000734|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6293088|NCT00000734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6293089|NCT00000734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6293090|NCT00000735|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
6293091|NCT00000735|Antiviral Agents|antiviral agents|mesh-ancestor
6293092|NCT00000735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293093|NCT00000736|Zidovudine|zidovudine|mesh-list
6293094|NCT00000736|Antimetabolites|antimetabolites|mesh-ancestor
6293095|NCT00000736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293096|NCT00000736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6293097|NCT00000736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6293098|NCT00000736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6293099|NCT00000736|Antiviral Agents|antiviral agents|mesh-ancestor
6293100|NCT00000736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293101|NCT00000736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6293102|NCT00000736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6293103|NCT00000737|Megestrol|megestrol|mesh-list
6293104|NCT00000737|Megestrol Acetate|megestrol acetate|mesh-list
6293105|NCT00000737|Dronabinol|dronabinol|mesh-list
6293106|NCT00000737|Hallucinogens|hallucinogens|mesh-ancestor
6293107|NCT00000737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6293108|NCT00000737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6293109|NCT00000737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6293110|NCT00000737|Analgesics|analgesics|mesh-ancestor
6293111|NCT00000737|Sensory System Agents|sensory system agents|mesh-ancestor
6293112|NCT00000737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6293113|NCT00000737|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6293114|NCT00000737|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6293115|NCT00000737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6293116|NCT00000737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293117|NCT00000737|Hormones|hormones|mesh-ancestor
6293118|NCT00000737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6293119|NCT00000737|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6293120|NCT00000737|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6293121|NCT00000737|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6293122|NCT00000737|Contraceptive Agents|contraceptive agents|mesh-ancestor
6293123|NCT00000737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6293124|NCT00000737|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6293125|NCT00000737|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6293126|NCT00000737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6293127|NCT00000737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6293128|NCT00000737|Appetite Stimulants|appetite stimulants|mesh-ancestor
6293129|NCT00000737|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6293130|NCT00000738|Zidovudine|zidovudine|mesh-list
6293131|NCT00000738|Nimodipine|nimodipine|mesh-list
6293132|NCT00000738|Antimetabolites|antimetabolites|mesh-ancestor
6293133|NCT00000738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293134|NCT00000738|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6293135|NCT00000738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6293136|NCT00000738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6293137|NCT00000738|Antiviral Agents|antiviral agents|mesh-ancestor
6293138|NCT00000738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293139|NCT00000738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6293140|NCT00000738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6293141|NCT00000738|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6293142|NCT00000738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6293143|NCT00000738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6293144|NCT00000738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6293145|NCT00000738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6293146|NCT00000738|Vasodilator Agents|vasodilator agents|mesh-ancestor
6293147|NCT00000739|Dapsone|dapsone|mesh-list
6293148|NCT00000739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293149|NCT00000739|Antimalarials|antimalarials|mesh-ancestor
6293150|NCT00000739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6293151|NCT00000739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6293152|NCT00000739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6293153|NCT00000739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6293154|NCT00000739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293155|NCT00000739|Leprostatic Agents|leprostatic agents|mesh-ancestor
6293156|NCT00000739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6293157|NCT00000741|Methylprednisolone|methylprednisolone|mesh-list
6293158|NCT00000741|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6293159|NCT00000741|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6293160|NCT00000741|Prednisolone|prednisolone|mesh-list
6293161|NCT00000741|Prednisolone acetate|prednisolone acetate|mesh-list
6293162|NCT00000741|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6293163|NCT00000741|Prednisolone phosphate|prednisolone phosphate|mesh-list
6293164|NCT00000741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6293165|NCT00000741|Antiemetics|antiemetics|mesh-ancestor
6293166|NCT00000741|Autonomic Agents|autonomic agents|mesh-ancestor
6293167|NCT00000741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6293168|NCT00000741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6293169|NCT00000741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6293170|NCT00000741|Glucocorticoids|glucocorticoids|mesh-ancestor
6293171|NCT00000741|Hormones|hormones|mesh-ancestor
6293172|NCT00000741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6293173|NCT00000741|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6293174|NCT00000741|Protective Agents|protective agents|mesh-ancestor
6293175|NCT00000741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6293176|NCT00000741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6293177|NCT00000742|Zidovudine|zidovudine|mesh-list
6293178|NCT00000742|Didanosine|didanosine|mesh-list
6293179|NCT00000742|Atevirdine|atevirdine|mesh-list
6293180|NCT00000742|Antimetabolites|antimetabolites|mesh-ancestor
6293181|NCT00000742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293182|NCT00000742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6293183|NCT00000742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6293184|NCT00000742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6293185|NCT00000742|Antiviral Agents|antiviral agents|mesh-ancestor
6293186|NCT00000742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293187|NCT00000742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6293188|NCT00000742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6293189|NCT00000743|Zidovudine|zidovudine|mesh-list
6293190|NCT00000743|Antimetabolites|antimetabolites|mesh-ancestor
6293191|NCT00000743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293192|NCT00000743|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6293193|NCT00000743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6293194|NCT00000743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6293195|NCT00000743|Antiviral Agents|antiviral agents|mesh-ancestor
6293196|NCT00000743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293197|NCT00000743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6293198|NCT00000743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6293199|NCT00000744|Fluconazole|fluconazole|mesh-list
6293200|NCT00000744|Antifungal Agents|antifungal agents|mesh-ancestor
6293201|NCT00000744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293202|NCT00000744|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6293203|NCT00000744|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6293204|NCT00000744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6293205|NCT00000744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293206|NCT00000744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6293207|NCT00000744|Hormone Antagonists|hormone antagonists|mesh-ancestor
6293208|NCT00000744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6293209|NCT00000744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6293210|NCT00000744|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6293211|NCT00000744|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6293212|NCT00000745|Vaccines|vaccines|mesh-list
6293213|NCT00000745|Immunologic Factors|immunologic factors|mesh-ancestor
6293214|NCT00000745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6293215|NCT00000747|Nevirapine|nevirapine|mesh-list
6293216|NCT00000747|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6293217|NCT00000747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6293218|NCT00000747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6293219|NCT00000747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293220|NCT00000747|Antiviral Agents|antiviral agents|mesh-ancestor
6293221|NCT00000747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293222|NCT00000747|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6293223|NCT00000747|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6293224|NCT00000747|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6293225|NCT00000747|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6293226|NCT00000748|Trimethoprim|trimethoprim|mesh-list
6391830|NCT00194402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6293227|NCT00000748|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6293228|NCT00000748|Sulfamethoxazole|sulfamethoxazole|mesh-list
6293229|NCT00000748|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6293230|NCT00000748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293231|NCT00000748|Renal Agents|renal agents|mesh-ancestor
6293232|NCT00000748|Antimalarials|antimalarials|mesh-ancestor
6293233|NCT00000748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6293234|NCT00000748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6293235|NCT00000748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6293236|NCT00000748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6293237|NCT00000748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293238|NCT00000748|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6293239|NCT00000748|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6293240|NCT00000748|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6293241|NCT00000748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6293242|NCT00000750|Zidovudine|zidovudine|mesh-list
6293243|NCT00000750|Antimetabolites|antimetabolites|mesh-ancestor
6293244|NCT00000750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293245|NCT00000750|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6293246|NCT00000750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6293247|NCT00000750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6293248|NCT00000750|Antiviral Agents|antiviral agents|mesh-ancestor
6293249|NCT00000750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293250|NCT00000750|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6293251|NCT00000750|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6293252|NCT00000751|Zidovudine|zidovudine|mesh-list
6293253|NCT00000751|Immune Sera|immune sera|mesh-list
6293254|NCT00000751|Immunoglobulins|immunoglobulins|mesh-list
6293255|NCT00000751|Antibodies|antibodies|mesh-list
6293256|NCT00000751|Antimetabolites|antimetabolites|mesh-ancestor
6293257|NCT00000751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293258|NCT00000751|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6293259|NCT00000751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6293260|NCT00000751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6293261|NCT00000751|Antiviral Agents|antiviral agents|mesh-ancestor
6293262|NCT00000751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293263|NCT00000751|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6293264|NCT00000751|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6293265|NCT00000751|Immunologic Factors|immunologic factors|mesh-ancestor
6293266|NCT00000751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6293267|NCT00000752|Cefuroxime|cefuroxime|mesh-list
6293268|NCT00000752|Cefuroxime axetil|cefuroxime axetil|mesh-list
6293269|NCT00000752|Beclomethasone|beclomethasone|mesh-list
6293270|NCT00000752|Phenylpropanolamine|phenylpropanolamine|mesh-list
6293271|NCT00000752|Pseudoephedrine|pseudoephedrine|mesh-list
6293272|NCT00000752|Ephedrine|ephedrine|mesh-list
6293273|NCT00000752|Guaifenesin|guaifenesin|mesh-list
6293274|NCT00000752|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
6293275|NCT00000752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6293276|NCT00000752|Glucocorticoids|glucocorticoids|mesh-ancestor
6293277|NCT00000752|Hormones|hormones|mesh-ancestor
6293278|NCT00000752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6293279|NCT00000752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6293280|NCT00000752|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6293281|NCT00000752|Respiratory System Agents|respiratory system agents|mesh-ancestor
6293282|NCT00000752|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6293283|NCT00000752|Autonomic Agents|autonomic agents|mesh-ancestor
6293284|NCT00000752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6293285|NCT00000752|Nasal Decongestants|nasal decongestants|mesh-ancestor
6293286|NCT00000752|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6293287|NCT00000752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6293288|NCT00000752|Sympathomimetics|sympathomimetics|mesh-ancestor
6293289|NCT00000752|Adrenergic Agents|adrenergic agents|mesh-ancestor
6293290|NCT00000752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6293291|NCT00000752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293292|NCT00000752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6391831|NCT00194467|Valganciclovir|valganciclovir|mesh-list
6293293|NCT00000752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293294|NCT00000752|Expectorants|expectorants|mesh-ancestor
6293295|NCT00000752|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6293296|NCT00000752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6293297|NCT00000752|Appetite Depressants|appetite depressants|mesh-ancestor
6293298|NCT00000752|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6293299|NCT00000753|Zidovudine|zidovudine|mesh-list
6293300|NCT00000753|Didanosine|didanosine|mesh-list
6293301|NCT00000753|Zalcitabine|zalcitabine|mesh-list
6293302|NCT00000753|Atevirdine|atevirdine|mesh-list
6293303|NCT00000753|Antimetabolites|antimetabolites|mesh-ancestor
6293304|NCT00000753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293305|NCT00000753|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6293306|NCT00000753|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6293307|NCT00000753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6293308|NCT00000753|Antiviral Agents|antiviral agents|mesh-ancestor
6293309|NCT00000753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293310|NCT00000753|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6293311|NCT00000753|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6293312|NCT00000754|Interferons|interferons|mesh-list
6293313|NCT00000754|Interferon-alpha|interferon-alpha|mesh-list
6293314|NCT00000754|Interferon alpha-2|interferon alpha-2|mesh-list
6293315|NCT00000754|Zidovudine|zidovudine|mesh-list
6293316|NCT00000754|Zalcitabine|zalcitabine|mesh-list
6293317|NCT00000754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6293318|NCT00000754|Antiviral Agents|antiviral agents|mesh-ancestor
6293319|NCT00000754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293320|NCT00000754|Immunologic Factors|immunologic factors|mesh-ancestor
6293321|NCT00000754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6293322|NCT00000754|Antimetabolites|antimetabolites|mesh-ancestor
6293323|NCT00000754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293324|NCT00000754|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6293325|NCT00000754|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6293326|NCT00000754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6293327|NCT00000754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6293328|NCT00000754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6293329|NCT00000755|Zidovudine|zidovudine|mesh-list
6293330|NCT00000755|Antimetabolites|antimetabolites|mesh-ancestor
6293331|NCT00000755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293332|NCT00000755|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6293333|NCT00000755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6293334|NCT00000755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6293335|NCT00000755|Antiviral Agents|antiviral agents|mesh-ancestor
6293336|NCT00000755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293337|NCT00000755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6293338|NCT00000755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6293339|NCT00000758|Fluorouracil|fluorouracil|mesh-list
6293340|NCT00000758|Antimetabolites|antimetabolites|mesh-ancestor
6293341|NCT00000758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293342|NCT00000758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6293343|NCT00000758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6293344|NCT00000758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6293345|NCT00000758|Immunologic Factors|immunologic factors|mesh-ancestor
6293346|NCT00000758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6293347|NCT00000760|Zidovudine|zidovudine|mesh-list
6293348|NCT00000760|Didanosine|didanosine|mesh-list
6293349|NCT00000760|Antimetabolites|antimetabolites|mesh-ancestor
6293350|NCT00000760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293351|NCT00000760|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6293352|NCT00000760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6293353|NCT00000760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6293354|NCT00000760|Antiviral Agents|antiviral agents|mesh-ancestor
6293355|NCT00000760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293356|NCT00000760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6293357|NCT00000760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6391832|NCT00194467|Antiviral Agents|antiviral agents|mesh-ancestor
6293358|NCT00000761|Interferons|interferons|mesh-list
6293359|NCT00000761|Interferon-gamma|interferon-gamma|mesh-list
6293360|NCT00000761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6293361|NCT00000761|Antiviral Agents|antiviral agents|mesh-ancestor
6293362|NCT00000761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293363|NCT00000763|O-(Chloroacetylcarbamoyl)fumagillol|o-(chloroacetylcarbamoyl)fumagillol|mesh-list
6293364|NCT00000763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6293365|NCT00000763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6293366|NCT00000763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6293367|NCT00000763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6293368|NCT00000763|Growth Substances|growth substances|mesh-ancestor
6293369|NCT00000763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6293370|NCT00000763|Growth Inhibitors|growth inhibitors|mesh-ancestor
6293371|NCT00000764|Interferons|interferons|mesh-list
6293372|NCT00000764|Interferon-alpha|interferon-alpha|mesh-list
6293373|NCT00000764|Interferon alpha-2|interferon alpha-2|mesh-list
6293374|NCT00000764|Isotretinoin|isotretinoin|mesh-list
6293375|NCT00000764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6293376|NCT00000764|Antiviral Agents|antiviral agents|mesh-ancestor
6293377|NCT00000764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293378|NCT00000764|Immunologic Factors|immunologic factors|mesh-ancestor
6293379|NCT00000764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6293380|NCT00000764|Dermatologic Agents|dermatologic agents|mesh-ancestor
6293381|NCT00000765|Zidovudine|zidovudine|mesh-list
6293382|NCT00000765|Antimetabolites|antimetabolites|mesh-ancestor
6293383|NCT00000765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293384|NCT00000765|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6293385|NCT00000765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6293386|NCT00000765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6293387|NCT00000765|Antiviral Agents|antiviral agents|mesh-ancestor
6293388|NCT00000765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293389|NCT00000765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6293390|NCT00000765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6293391|NCT00000766|Ganciclovir|ganciclovir|mesh-list
6293392|NCT00000766|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6293393|NCT00000766|Foscarnet|foscarnet|mesh-list
6293394|NCT00000766|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
6293395|NCT00000766|Antiviral Agents|antiviral agents|mesh-ancestor
6293396|NCT00000766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293397|NCT00000766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6293398|NCT00000766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6293399|NCT00000766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293400|NCT00000766|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6293401|NCT00000767|Vaccines|vaccines|mesh-list
6293402|NCT00000767|Immunologic Factors|immunologic factors|mesh-ancestor
6293403|NCT00000767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6293404|NCT00000768|Ganciclovir|ganciclovir|mesh-list
6293405|NCT00000768|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6293406|NCT00000768|Antiviral Agents|antiviral agents|mesh-ancestor
6293407|NCT00000768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293408|NCT00000768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6293409|NCT00000768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6293410|NCT00000768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293411|NCT00000769|Interleukin-4|interleukin-4|mesh-list
6293412|NCT00000769|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6293413|NCT00000769|Immunologic Factors|immunologic factors|mesh-ancestor
6293414|NCT00000769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6293415|NCT00000769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6293416|NCT00000769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6293417|NCT00000770|Zidovudine|zidovudine|mesh-list
6293418|NCT00000770|Nevirapine|nevirapine|mesh-list
6293419|NCT00000770|Didanosine|didanosine|mesh-list
6293420|NCT00000770|Antimetabolites|antimetabolites|mesh-ancestor
6293421|NCT00000770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293422|NCT00000770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6293423|NCT00000770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6293424|NCT00000770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6293425|NCT00000770|Antiviral Agents|antiviral agents|mesh-ancestor
6293426|NCT00000770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293427|NCT00000770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6293428|NCT00000770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6293429|NCT00000770|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6293430|NCT00000770|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6293431|NCT00000771|Paromomycin|paromomycin|mesh-list
6293432|NCT00000771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6293433|NCT00000771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293434|NCT00000771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6293435|NCT00000771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6293436|NCT00000772|Ribavirin|ribavirin|mesh-list
6293437|NCT00000772|Didanosine|didanosine|mesh-list
6293438|NCT00000772|Antimetabolites|antimetabolites|mesh-ancestor
6293439|NCT00000772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293440|NCT00000772|Antiviral Agents|antiviral agents|mesh-ancestor
6293441|NCT00000772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293442|NCT00000772|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6293443|NCT00000772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6293444|NCT00000772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6293445|NCT00000772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6293446|NCT00000772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6293447|NCT00000773|Atovaquone|atovaquone|mesh-list
6293448|NCT00000773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293449|NCT00000773|Antimalarials|antimalarials|mesh-ancestor
6293450|NCT00000773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6293451|NCT00000773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6293452|NCT00000773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6293453|NCT00000773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293454|NCT00000776|Fluconazole|fluconazole|mesh-list
6293455|NCT00000776|Amphotericin B|amphotericin b|mesh-list
6293456|NCT00000776|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6293457|NCT00000776|Flucytosine|flucytosine|mesh-list
6293458|NCT00000776|Dexamethasone|dexamethasone|mesh-list
6293459|NCT00000776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6293460|NCT00000776|Antiemetics|antiemetics|mesh-ancestor
6293461|NCT00000776|Autonomic Agents|autonomic agents|mesh-ancestor
6293462|NCT00000776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6293463|NCT00000776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6293464|NCT00000776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6293465|NCT00000776|Glucocorticoids|glucocorticoids|mesh-ancestor
6293466|NCT00000776|Hormones|hormones|mesh-ancestor
6293467|NCT00000776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6293468|NCT00000776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6293469|NCT00000776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6293470|NCT00000776|Antifungal Agents|antifungal agents|mesh-ancestor
6293471|NCT00000776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293472|NCT00000776|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6293473|NCT00000776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6293474|NCT00000776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6293475|NCT00000776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293476|NCT00000776|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6293477|NCT00000776|Hormone Antagonists|hormone antagonists|mesh-ancestor
6293478|NCT00000776|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6293479|NCT00000776|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6293480|NCT00000776|Amebicides|amebicides|mesh-ancestor
6293481|NCT00000776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6293482|NCT00000776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6293483|NCT00000776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6293484|NCT00000776|Antimetabolites|antimetabolites|mesh-ancestor
6293485|NCT00000778|Pyridoxine|pyridoxine|mesh-list
6293486|NCT00000778|Vitamin B 6|vitamin b 6|mesh-list
6293487|NCT00000778|Levofloxacin|levofloxacin|mesh-list
6293488|NCT00000778|Ofloxacin|ofloxacin|mesh-list
6293489|NCT00000778|Isoniazid|isoniazid|mesh-list
6293490|NCT00000778|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6293491|NCT00000778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293492|NCT00000778|Renal Agents|renal agents|mesh-ancestor
6293493|NCT00000778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6293494|NCT00000778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6293495|NCT00000778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6293496|NCT00000778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6293497|NCT00000778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293498|NCT00000778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6293499|NCT00000778|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6293500|NCT00000778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6293501|NCT00000778|Antitubercular Agents|antitubercular agents|mesh-ancestor
6293502|NCT00000778|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6293503|NCT00000778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6293504|NCT00000778|Antimetabolites|antimetabolites|mesh-ancestor
6293505|NCT00000778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6293506|NCT00000778|Vitamin B Complex|vitamin b complex|mesh-ancestor
6293507|NCT00000778|Vitamins|vitamins|mesh-ancestor
6293508|NCT00000778|Micronutrients|micronutrients|mesh-ancestor
6293509|NCT00000778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6293510|NCT00000779|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6293511|NCT00000779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6293512|NCT00000779|Immunologic Factors|immunologic factors|mesh-ancestor
6293513|NCT00000779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6293514|NCT00000779|Antacids|antacids|mesh-ancestor
6293515|NCT00000779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293516|NCT00000779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6293517|NCT00000781|Zidovudine|zidovudine|mesh-list
6293518|NCT00000781|Nevirapine|nevirapine|mesh-list
6293519|NCT00000781|Didanosine|didanosine|mesh-list
6293520|NCT00000781|Zalcitabine|zalcitabine|mesh-list
6293521|NCT00000781|Antimetabolites|antimetabolites|mesh-ancestor
6293522|NCT00000781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293523|NCT00000781|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6293524|NCT00000781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6293525|NCT00000781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6293526|NCT00000781|Antiviral Agents|antiviral agents|mesh-ancestor
6293527|NCT00000781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293528|NCT00000781|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6293529|NCT00000781|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6293530|NCT00000781|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6293531|NCT00000781|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6293532|NCT00000782|Vaccines|vaccines|mesh-list
6293533|NCT00000782|Immunologic Factors|immunologic factors|mesh-ancestor
6293534|NCT00000782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6293535|NCT00000788|Fluconazole|fluconazole|mesh-list
6293536|NCT00000788|Methadone|methadone|mesh-list
6293537|NCT00000788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6293538|NCT00000788|Narcotics|narcotics|mesh-ancestor
6293539|NCT00000788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6293540|NCT00000788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6293541|NCT00000788|Analgesics|analgesics|mesh-ancestor
6293542|NCT00000788|Sensory System Agents|sensory system agents|mesh-ancestor
6293543|NCT00000788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6293544|NCT00000788|Antitussive Agents|antitussive agents|mesh-ancestor
6293545|NCT00000788|Respiratory System Agents|respiratory system agents|mesh-ancestor
6293546|NCT00000788|Antifungal Agents|antifungal agents|mesh-ancestor
6293547|NCT00000788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293548|NCT00000788|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6293549|NCT00000788|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6293550|NCT00000788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6293551|NCT00000788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293552|NCT00000788|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6293553|NCT00000788|Hormone Antagonists|hormone antagonists|mesh-ancestor
6293554|NCT00000788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6293555|NCT00000788|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6293556|NCT00000788|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6293557|NCT00000789|Zidovudine|zidovudine|mesh-list
6293558|NCT00000789|Stavudine|stavudine|mesh-list
6293559|NCT00000789|Antimetabolites|antimetabolites|mesh-ancestor
6293560|NCT00000789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293561|NCT00000789|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6293562|NCT00000789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6293563|NCT00000789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6293564|NCT00000789|Antiviral Agents|antiviral agents|mesh-ancestor
6293565|NCT00000789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293566|NCT00000789|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6293567|NCT00000789|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6293568|NCT00000790|Thalidomide|thalidomide|mesh-list
6293569|NCT00000790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6293570|NCT00000790|Immunologic Factors|immunologic factors|mesh-ancestor
6293571|NCT00000790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6293572|NCT00000790|Leprostatic Agents|leprostatic agents|mesh-ancestor
6293573|NCT00000790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6293574|NCT00000790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293575|NCT00000790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6293576|NCT00000790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6293577|NCT00000790|Growth Substances|growth substances|mesh-ancestor
6293578|NCT00000790|Growth Inhibitors|growth inhibitors|mesh-ancestor
6293579|NCT00000790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6293580|NCT00000791|Zidovudine|zidovudine|mesh-list
6293581|NCT00000791|Antimetabolites|antimetabolites|mesh-ancestor
6293582|NCT00000791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293583|NCT00000791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6293584|NCT00000791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6293585|NCT00000791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6293586|NCT00000791|Antiviral Agents|antiviral agents|mesh-ancestor
6293587|NCT00000791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293588|NCT00000791|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6293589|NCT00000791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6293590|NCT00000792|Hypericin|hypericin|mesh-list
6293591|NCT00000792|Antidepressive Agents|antidepressive agents|mesh-ancestor
6293592|NCT00000792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6293593|NCT00000792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6293594|NCT00000792|Antiviral Agents|antiviral agents|mesh-ancestor
6293595|NCT00000792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293596|NCT00000792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6293597|NCT00000792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293598|NCT00000792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6293599|NCT00000792|Immunologic Factors|immunologic factors|mesh-ancestor
6293600|NCT00000792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6293601|NCT00000793|Mexiletine|mexiletine|mesh-list
6293602|NCT00000793|Amitriptyline|amitriptyline|mesh-list
6293603|NCT00000793|Benztropine|benztropine|mesh-list
6293604|NCT00000793|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6293605|NCT00000793|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6293606|NCT00000793|Antidepressive Agents|antidepressive agents|mesh-ancestor
6293607|NCT00000793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6293608|NCT00000793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6293609|NCT00000793|Analgesics|analgesics|mesh-ancestor
6293610|NCT00000793|Sensory System Agents|sensory system agents|mesh-ancestor
6293611|NCT00000793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6293612|NCT00000793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6293613|NCT00000793|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6293614|NCT00000793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6293615|NCT00000793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6293616|NCT00000793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293617|NCT00000793|Adrenergic Agents|adrenergic agents|mesh-ancestor
6293618|NCT00000793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6293619|NCT00000793|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6293620|NCT00000793|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6293621|NCT00000793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6293622|NCT00000793|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6293623|NCT00000793|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6293624|NCT00000793|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6293625|NCT00000793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6293626|NCT00000793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6293627|NCT00000793|Parasympatholytics|parasympatholytics|mesh-ancestor
6293628|NCT00000793|Autonomic Agents|autonomic agents|mesh-ancestor
6293629|NCT00000793|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6293630|NCT00000793|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6293631|NCT00000793|Cholinergic Agents|cholinergic agents|mesh-ancestor
6293632|NCT00000793|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6293633|NCT00000793|Dopamine Agents|dopamine agents|mesh-ancestor
6293634|NCT00000794|Leucovorin|leucovorin|mesh-list
6293635|NCT00000794|Clarithromycin|clarithromycin|mesh-list
6293636|NCT00000794|Sulfadiazine|sulfadiazine|mesh-list
6293637|NCT00000794|Pyrimethamine|pyrimethamine|mesh-list
6293638|NCT00000794|Atovaquone|atovaquone|mesh-list
6293639|NCT00000794|Calcium|calcium|mesh-list
6293640|NCT00000794|Levoleucovorin|levoleucovorin|mesh-list
6293641|NCT00000794|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6293642|NCT00000794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6293643|NCT00000794|Antidotes|antidotes|mesh-ancestor
6293644|NCT00000794|Protective Agents|protective agents|mesh-ancestor
6293645|NCT00000794|Vitamin B Complex|vitamin b complex|mesh-ancestor
6293646|NCT00000794|Vitamins|vitamins|mesh-ancestor
6293647|NCT00000794|Micronutrients|micronutrients|mesh-ancestor
6293648|NCT00000794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6293649|NCT00000794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293650|NCT00000794|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6293651|NCT00000794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6293652|NCT00000794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293653|NCT00000794|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6293654|NCT00000794|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6293655|NCT00000794|Antimalarials|antimalarials|mesh-ancestor
6293656|NCT00000794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6293657|NCT00000794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6293658|NCT00000794|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6293659|NCT00000794|Coccidiostats|coccidiostats|mesh-ancestor
6293660|NCT00000796|Pyridoxine|pyridoxine|mesh-list
6293661|NCT00000796|Vitamin B 6|vitamin b 6|mesh-list
6293662|NCT00000796|Levofloxacin|levofloxacin|mesh-list
6293663|NCT00000796|Cycloserine|cycloserine|mesh-list
6293664|NCT00000796|Rifampin|rifampin|mesh-list
6293665|NCT00000796|Isoniazid|isoniazid|mesh-list
6293666|NCT00000796|Amikacin|amikacin|mesh-list
6293667|NCT00000796|Pyrazinamide|pyrazinamide|mesh-list
6293668|NCT00000796|Ethambutol|ethambutol|mesh-list
6293669|NCT00000796|Clofazimine|clofazimine|mesh-list
6293670|NCT00000796|Aminosalicylic Acid|aminosalicylic acid|mesh-list
6293671|NCT00000796|Streptomycin|streptomycin|mesh-list
6293672|NCT00000796|Ethionamide|ethionamide|mesh-list
6293673|NCT00000796|Capreomycin|capreomycin|mesh-list
6293674|NCT00000796|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6293675|NCT00000796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293676|NCT00000796|Renal Agents|renal agents|mesh-ancestor
6293677|NCT00000796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6293678|NCT00000796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6293679|NCT00000796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6293680|NCT00000796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6293681|NCT00000796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293682|NCT00000796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6293683|NCT00000796|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6293684|NCT00000796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6293685|NCT00000796|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6293686|NCT00000796|Antitubercular Agents|antitubercular agents|mesh-ancestor
6293687|NCT00000796|Leprostatic Agents|leprostatic agents|mesh-ancestor
6293688|NCT00000796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6293689|NCT00000796|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6293690|NCT00000796|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6293691|NCT00000796|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6293692|NCT00000796|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6293693|NCT00000796|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6293694|NCT00000796|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6293695|NCT00000796|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6293696|NCT00000796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6293697|NCT00000796|Antimetabolites|antimetabolites|mesh-ancestor
6293698|NCT00000796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6293699|NCT00000796|Vitamin B Complex|vitamin b complex|mesh-ancestor
6293700|NCT00000796|Vitamins|vitamins|mesh-ancestor
6293701|NCT00000796|Micronutrients|micronutrients|mesh-ancestor
6293702|NCT00000796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6293703|NCT00000796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6293704|NCT00000796|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6293705|NCT00000799|Cidofovir|cidofovir|mesh-list
6293706|NCT00000799|Probenecid|probenecid|mesh-list
6293707|NCT00000799|Uricosuric Agents|uricosuric agents|mesh-ancestor
6293708|NCT00000799|Gout Suppressants|gout suppressants|mesh-ancestor
6293709|NCT00000799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6293710|NCT00000799|Renal Agents|renal agents|mesh-ancestor
6293711|NCT00000799|Antiviral Agents|antiviral agents|mesh-ancestor
6293712|NCT00000799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293713|NCT00000799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6293714|NCT00000799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293715|NCT00000800|Zidovudine|zidovudine|mesh-list
6293716|NCT00000800|Methadone|methadone|mesh-list
6293717|NCT00000800|Antimetabolites|antimetabolites|mesh-ancestor
6293718|NCT00000800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293719|NCT00000800|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6293720|NCT00000800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6293721|NCT00000800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6293722|NCT00000800|Antiviral Agents|antiviral agents|mesh-ancestor
6293723|NCT00000800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293724|NCT00000800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6293725|NCT00000800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6293726|NCT00000800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6293727|NCT00000800|Narcotics|narcotics|mesh-ancestor
6293728|NCT00000800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6293729|NCT00000800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6293730|NCT00000800|Analgesics|analgesics|mesh-ancestor
6293731|NCT00000800|Sensory System Agents|sensory system agents|mesh-ancestor
6293732|NCT00000800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6293733|NCT00000800|Antitussive Agents|antitussive agents|mesh-ancestor
6293734|NCT00000800|Respiratory System Agents|respiratory system agents|mesh-ancestor
6293735|NCT00000801|Cytarabine|cytarabine|mesh-list
6293736|NCT00000801|Dexamethasone|dexamethasone|mesh-list
6293737|NCT00000801|Cyclophosphamide|cyclophosphamide|mesh-list
6293738|NCT00000801|Doxorubicin|doxorubicin|mesh-list
6293739|NCT00000801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6293740|NCT00000801|Vincristine|vincristine|mesh-list
6293741|NCT00000801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6293742|NCT00000801|Immunologic Factors|immunologic factors|mesh-ancestor
6293743|NCT00000801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6293744|NCT00000801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6293745|NCT00000801|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6293746|NCT00000801|Alkylating Agents|alkylating agents|mesh-ancestor
6293747|NCT00000801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293748|NCT00000801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6293749|NCT00000801|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6293750|NCT00000801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6293751|NCT00000801|Antiemetics|antiemetics|mesh-ancestor
6293752|NCT00000801|Autonomic Agents|autonomic agents|mesh-ancestor
6293753|NCT00000801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6293754|NCT00000801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6293755|NCT00000801|Glucocorticoids|glucocorticoids|mesh-ancestor
6293756|NCT00000801|Hormones|hormones|mesh-ancestor
6293757|NCT00000801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6293758|NCT00000801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6293759|NCT00000801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6293760|NCT00000801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6293761|NCT00000801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6293762|NCT00000801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6293763|NCT00000801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6293764|NCT00000801|Antimetabolites|antimetabolites|mesh-ancestor
6293765|NCT00000801|Antiviral Agents|antiviral agents|mesh-ancestor
6293766|NCT00000801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293767|NCT00000801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6293768|NCT00000801|Tubulin Modulators|tubulin modulators|mesh-ancestor
6293769|NCT00000801|Antimitotic Agents|antimitotic agents|mesh-ancestor
6293770|NCT00000801|Mitosis Modulators|mitosis modulators|mesh-ancestor
6293771|NCT00000802|Dapsone|dapsone|mesh-list
6293772|NCT00000802|Atovaquone|atovaquone|mesh-list
6293773|NCT00000802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293774|NCT00000802|Antimalarials|antimalarials|mesh-ancestor
6293775|NCT00000802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6293776|NCT00000802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6293777|NCT00000802|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6293778|NCT00000802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6293779|NCT00000802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293780|NCT00000802|Leprostatic Agents|leprostatic agents|mesh-ancestor
6293781|NCT00000802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6293782|NCT00000803|Zidovudine|zidovudine|mesh-list
6293783|NCT00000803|Didanosine|didanosine|mesh-list
6293784|NCT00000803|Delavirdine|delavirdine|mesh-list
6293785|NCT00000803|Antimetabolites|antimetabolites|mesh-ancestor
6293786|NCT00000803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293787|NCT00000803|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6293788|NCT00000803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6293789|NCT00000803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6293790|NCT00000803|Antiviral Agents|antiviral agents|mesh-ancestor
6293791|NCT00000803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293792|NCT00000803|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6293793|NCT00000803|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6293794|NCT00000804|Indinavir|indinavir|mesh-list
6293795|NCT00000804|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6293796|NCT00000804|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6293797|NCT00000804|Protease Inhibitors|protease inhibitors|mesh-ancestor
6293798|NCT00000804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6293799|NCT00000804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293800|NCT00000804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6293801|NCT00000804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6293802|NCT00000804|Antiviral Agents|antiviral agents|mesh-ancestor
6293803|NCT00000804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293804|NCT00000805|Ganciclovir|ganciclovir|mesh-list
6293805|NCT00000805|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6293806|NCT00000805|Antiviral Agents|antiviral agents|mesh-ancestor
6293807|NCT00000805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293808|NCT00000805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6293809|NCT00000805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6293810|NCT00000805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293811|NCT00000807|Etoposide|etoposide|mesh-list
6293812|NCT00000807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6293813|NCT00000807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6293814|NCT00000807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6293815|NCT00000807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6293816|NCT00000807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6293817|NCT00000807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293818|NCT00000808|Nevirapine|nevirapine|mesh-list
6293819|NCT00000808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6293820|NCT00000808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6293821|NCT00000808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6293822|NCT00000808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293823|NCT00000808|Antiviral Agents|antiviral agents|mesh-ancestor
6293824|NCT00000808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293825|NCT00000808|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6293826|NCT00000808|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6293827|NCT00000808|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6293828|NCT00000808|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6293829|NCT00000809|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6293830|NCT00000809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6293831|NCT00000809|Immunologic Factors|immunologic factors|mesh-ancestor
6293832|NCT00000809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6293833|NCT00000809|Antacids|antacids|mesh-ancestor
6293834|NCT00000809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293835|NCT00000809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6293836|NCT00000810|Zidovudine|zidovudine|mesh-list
6293837|NCT00000810|Didanosine|didanosine|mesh-list
6293838|NCT00000810|Delavirdine|delavirdine|mesh-list
6293839|NCT00000810|Antimetabolites|antimetabolites|mesh-ancestor
6293840|NCT00000810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293841|NCT00000810|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6293842|NCT00000810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6293843|NCT00000810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6293844|NCT00000810|Antiviral Agents|antiviral agents|mesh-ancestor
6293845|NCT00000810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293846|NCT00000810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6293847|NCT00000810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6293848|NCT00000811|Azithromycin|azithromycin|mesh-list
6293849|NCT00000811|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6293850|NCT00000811|Trimethoprim|trimethoprim|mesh-list
6293851|NCT00000811|Sulfamethoxazole|sulfamethoxazole|mesh-list
6293852|NCT00000811|Atovaquone|atovaquone|mesh-list
6293853|NCT00000811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6293854|NCT00000811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293855|NCT00000811|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6293856|NCT00000811|Renal Agents|renal agents|mesh-ancestor
6293857|NCT00000811|Antimalarials|antimalarials|mesh-ancestor
6293858|NCT00000811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6293859|NCT00000811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6293860|NCT00000811|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6293861|NCT00000811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6293862|NCT00000811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293863|NCT00000811|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6293864|NCT00000811|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6293865|NCT00000811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6293866|NCT00000812|Thalidomide|thalidomide|mesh-list
6293867|NCT00000812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6293868|NCT00000812|Immunologic Factors|immunologic factors|mesh-ancestor
6293869|NCT00000812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6293870|NCT00000812|Leprostatic Agents|leprostatic agents|mesh-ancestor
6293871|NCT00000812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6293872|NCT00000812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293873|NCT00000812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6293874|NCT00000812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6293875|NCT00000812|Growth Substances|growth substances|mesh-ancestor
6293876|NCT00000812|Growth Inhibitors|growth inhibitors|mesh-ancestor
6293877|NCT00000812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6293878|NCT00000813|polysaccharide-K|polysaccharide-k|mesh-list
6293879|NCT00000813|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6293880|NCT00000813|Immunologic Factors|immunologic factors|mesh-ancestor
6293881|NCT00000813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6293882|NCT00000813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6293883|NCT00000813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6293884|NCT00000813|Antiviral Agents|antiviral agents|mesh-ancestor
6293885|NCT00000813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293886|NCT00000813|Interferon Inducers|interferon inducers|mesh-ancestor
6293887|NCT00000813|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6293888|NCT00000813|Protective Agents|protective agents|mesh-ancestor
6293889|NCT00000814|Zidovudine|zidovudine|mesh-list
6293890|NCT00000814|Nevirapine|nevirapine|mesh-list
6293891|NCT00000814|Didanosine|didanosine|mesh-list
6293892|NCT00000814|Antimetabolites|antimetabolites|mesh-ancestor
6293893|NCT00000814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293894|NCT00000814|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6293895|NCT00000814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6293896|NCT00000814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6293897|NCT00000814|Antiviral Agents|antiviral agents|mesh-ancestor
6293898|NCT00000814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293899|NCT00000814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6293900|NCT00000814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6293901|NCT00000814|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6293902|NCT00000814|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6293903|NCT00000816|Trimethoprim|trimethoprim|mesh-list
6293904|NCT00000816|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6293905|NCT00000816|Sulfamethoxazole|sulfamethoxazole|mesh-list
6293906|NCT00000816|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6015476|NCT00357500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6015477|NCT00357500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6293907|NCT00000816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293908|NCT00000816|Renal Agents|renal agents|mesh-ancestor
6293909|NCT00000816|Antimalarials|antimalarials|mesh-ancestor
6293910|NCT00000816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6293911|NCT00000816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6293912|NCT00000816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6293913|NCT00000816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6293914|NCT00000816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293915|NCT00000816|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6015478|NCT00357500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6015479|NCT00357500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6015480|NCT00357500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6015481|NCT00357500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6015482|NCT00357500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6015483|NCT00357500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6015484|NCT00357500|Analgesics|analgesics|mesh-ancestor
6293916|NCT00000816|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6293917|NCT00000816|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6293918|NCT00000816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6293919|NCT00000817|Amitriptyline|amitriptyline|mesh-list
6293920|NCT00000817|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6293921|NCT00000817|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6293922|NCT00000817|Antidepressive Agents|antidepressive agents|mesh-ancestor
6293923|NCT00000817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6293924|NCT00000817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6293925|NCT00000817|Analgesics|analgesics|mesh-ancestor
6293926|NCT00000817|Sensory System Agents|sensory system agents|mesh-ancestor
6293927|NCT00000817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6293928|NCT00000817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6293929|NCT00000817|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6293930|NCT00000817|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6293931|NCT00000817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6293932|NCT00000817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293933|NCT00000817|Adrenergic Agents|adrenergic agents|mesh-ancestor
6293934|NCT00000817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6293935|NCT00000817|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6293936|NCT00000817|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6293937|NCT00000817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6293938|NCT00000818|Zidovudine|zidovudine|mesh-list
6293939|NCT00000818|Antimetabolites|antimetabolites|mesh-ancestor
6293940|NCT00000818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293941|NCT00000818|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6293942|NCT00000818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6293943|NCT00000818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6293944|NCT00000818|Antiviral Agents|antiviral agents|mesh-ancestor
6293945|NCT00000818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293946|NCT00000818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6293947|NCT00000818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6293948|NCT00000819|Prednisone|prednisone|mesh-list
6293949|NCT00000819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6293950|NCT00000819|Glucocorticoids|glucocorticoids|mesh-ancestor
6293951|NCT00000819|Hormones|hormones|mesh-ancestor
6293952|NCT00000819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6293953|NCT00000819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6293954|NCT00000819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6293955|NCT00000819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6293956|NCT00000820|Aldesleukin|aldesleukin|mesh-list
6293957|NCT00000820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6293958|NCT00000820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6293959|NCT00000820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6293960|NCT00000820|Antiviral Agents|antiviral agents|mesh-ancestor
6293961|NCT00000820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293962|NCT00000821|Aldesleukin|aldesleukin|mesh-list
6293963|NCT00000821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6293964|NCT00000821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6293965|NCT00000821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6293966|NCT00000821|Antiviral Agents|antiviral agents|mesh-ancestor
6293967|NCT00000821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293968|NCT00000822|Ritonavir|ritonavir|mesh-list
6293969|NCT00000822|Stavudine|stavudine|mesh-list
6293970|NCT00000822|Didanosine|didanosine|mesh-list
6293971|NCT00000822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6293972|NCT00000822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6293973|NCT00000822|Protease Inhibitors|protease inhibitors|mesh-ancestor
6293974|NCT00000822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6293975|NCT00000822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293976|NCT00000822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6293977|NCT00000822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6293978|NCT00000822|Antiviral Agents|antiviral agents|mesh-ancestor
6293979|NCT00000822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293980|NCT00000822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6293981|NCT00000822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6293982|NCT00000822|Antimetabolites|antimetabolites|mesh-ancestor
6293983|NCT00000822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6293984|NCT00000822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6293985|NCT00000823|Zidovudine|zidovudine|mesh-list
6293986|NCT00000823|Didanosine|didanosine|mesh-list
6293987|NCT00000823|Antimetabolites|antimetabolites|mesh-ancestor
6293988|NCT00000823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6293989|NCT00000823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6293990|NCT00000823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6293991|NCT00000823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6293992|NCT00000823|Antiviral Agents|antiviral agents|mesh-ancestor
6015485|NCT00357500|Sensory System Agents|sensory system agents|mesh-ancestor
6015486|NCT00357500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6015487|NCT00357500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6015488|NCT00357500|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6015489|NCT00357500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6015490|NCT00357500|Leprostatic Agents|leprostatic agents|mesh-ancestor
6015491|NCT00357500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6015492|NCT00357500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293993|NCT00000823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6293994|NCT00000823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6293995|NCT00000823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6293996|NCT00000825|Aldesleukin|aldesleukin|mesh-list
6293997|NCT00000825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6293998|NCT00000825|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6293999|NCT00000825|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6294000|NCT00000825|Antiviral Agents|antiviral agents|mesh-ancestor
6294001|NCT00000825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294002|NCT00000826|Clarithromycin|clarithromycin|mesh-list
6294003|NCT00000826|Dapsone|dapsone|mesh-list
6294004|NCT00000826|Rifabutin|rifabutin|mesh-list
6294005|NCT00000826|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6294006|NCT00000826|Fluconazole|fluconazole|mesh-list
6294007|NCT00000826|Trimethoprim|trimethoprim|mesh-list
6294008|NCT00000826|Sulfamethoxazole|sulfamethoxazole|mesh-list
6294009|NCT00000826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6294010|NCT00000826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294011|NCT00000826|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6294012|NCT00000826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6294013|NCT00000826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6294014|NCT00000826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6294015|NCT00000826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6294016|NCT00000826|Antifungal Agents|antifungal agents|mesh-ancestor
6294017|NCT00000826|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6294018|NCT00000826|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6294019|NCT00000826|Hormone Antagonists|hormone antagonists|mesh-ancestor
6294020|NCT00000826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6294021|NCT00000826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6294022|NCT00000826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6294023|NCT00000826|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6294024|NCT00000826|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6294025|NCT00000826|Renal Agents|renal agents|mesh-ancestor
6294026|NCT00000826|Antimalarials|antimalarials|mesh-ancestor
6294027|NCT00000826|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6294028|NCT00000826|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6294029|NCT00000826|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6294030|NCT00000826|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6294031|NCT00000826|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6294032|NCT00000826|Leprostatic Agents|leprostatic agents|mesh-ancestor
6294033|NCT00000826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6294034|NCT00000826|Antitubercular Agents|antitubercular agents|mesh-ancestor
6294035|NCT00000827|Immune Sera|immune sera|mesh-list
6294036|NCT00000827|Immunologic Factors|immunologic factors|mesh-ancestor
6294037|NCT00000827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6294038|NCT00000829|Vaccines|vaccines|mesh-list
6294039|NCT00000829|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6294040|NCT00000829|Immunologic Factors|immunologic factors|mesh-ancestor
6294041|NCT00000829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6294042|NCT00000831|Lamivudine|lamivudine|mesh-list
6294043|NCT00000831|Zidovudine|zidovudine|mesh-list
6294044|NCT00000831|Stavudine|stavudine|mesh-list
6294045|NCT00000831|Didanosine|didanosine|mesh-list
6294046|NCT00000831|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6294047|NCT00000831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6294048|NCT00000831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6294049|NCT00000831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6294050|NCT00000831|Antiviral Agents|antiviral agents|mesh-ancestor
6294051|NCT00000831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294052|NCT00000831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6294053|NCT00000831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6294054|NCT00000831|Antimetabolites|antimetabolites|mesh-ancestor
6294055|NCT00000833|Ribavirin|ribavirin|mesh-list
6294056|NCT00000833|Didanosine|didanosine|mesh-list
6294057|NCT00000833|Antimetabolites|antimetabolites|mesh-ancestor
6294058|NCT00000833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6294059|NCT00000833|Antiviral Agents|antiviral agents|mesh-ancestor
6294060|NCT00000833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294061|NCT00000833|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6294062|NCT00000833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6294063|NCT00000833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6294064|NCT00000833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6294065|NCT00000833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6294066|NCT00000834|Lamivudine|lamivudine|mesh-list
6294067|NCT00000834|Zidovudine|zidovudine|mesh-list
6294068|NCT00000834|Methotrexate|methotrexate|mesh-list
6294069|NCT00000834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6294070|NCT00000834|Abortifacient Agents|abortifacient agents|mesh-ancestor
6294071|NCT00000834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6294072|NCT00000834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6294073|NCT00000834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6294074|NCT00000834|Antimetabolites|antimetabolites|mesh-ancestor
6294075|NCT00000834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6294076|NCT00000834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6294077|NCT00000834|Dermatologic Agents|dermatologic agents|mesh-ancestor
6294078|NCT00000834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6294079|NCT00000834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6294080|NCT00000834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6294081|NCT00000834|Immunologic Factors|immunologic factors|mesh-ancestor
6294082|NCT00000834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6294083|NCT00000834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6294084|NCT00000834|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6294085|NCT00000834|Antiviral Agents|antiviral agents|mesh-ancestor
6294086|NCT00000834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294087|NCT00000834|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6294088|NCT00000834|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6294089|NCT00000838|Lamivudine|lamivudine|mesh-list
6294090|NCT00000838|Zidovudine|zidovudine|mesh-list
6294091|NCT00000838|Stavudine|stavudine|mesh-list
6294092|NCT00000838|Didanosine|didanosine|mesh-list
6294093|NCT00000838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6294094|NCT00000838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6294095|NCT00000838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6294096|NCT00000838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6294097|NCT00000838|Antiviral Agents|antiviral agents|mesh-ancestor
6294098|NCT00000838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294099|NCT00000838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6294100|NCT00000838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6294101|NCT00000838|Antimetabolites|antimetabolites|mesh-ancestor
6294102|NCT00000839|Didanosine|didanosine|mesh-list
6294103|NCT00000839|Antimetabolites|antimetabolites|mesh-ancestor
6294104|NCT00000839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6294105|NCT00000839|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6294106|NCT00000839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6294107|NCT00000839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6294108|NCT00000839|Antiviral Agents|antiviral agents|mesh-ancestor
6294109|NCT00000839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294110|NCT00000839|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6294111|NCT00000839|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6294112|NCT00000841|Lamivudine|lamivudine|mesh-list
6294113|NCT00000841|Zidovudine|zidovudine|mesh-list
6294114|NCT00000841|Stavudine|stavudine|mesh-list
6294115|NCT00000841|Indinavir|indinavir|mesh-list
6294116|NCT00000841|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6294117|NCT00000841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6294118|NCT00000841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6294119|NCT00000841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6294120|NCT00000841|Antiviral Agents|antiviral agents|mesh-ancestor
6294121|NCT00000841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294122|NCT00000841|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6294123|NCT00000841|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6294124|NCT00000841|Antimetabolites|antimetabolites|mesh-ancestor
6294125|NCT00000841|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6294126|NCT00000841|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6294127|NCT00000841|Protease Inhibitors|protease inhibitors|mesh-ancestor
6294128|NCT00000842|Mitogens|mitogens|mesh-list
6294129|NCT00000842|Mitosis Modulators|mitosis modulators|mesh-ancestor
6294130|NCT00000842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6294131|NCT00000843|Adefovir|adefovir|mesh-list
6294132|NCT00000843|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6294133|NCT00000843|Antiviral Agents|antiviral agents|mesh-ancestor
6294134|NCT00000843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294135|NCT00000843|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6294136|NCT00000843|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6294137|NCT00000843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6294138|NCT00000843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6294139|NCT00000844|Interferons|interferons|mesh-list
6294140|NCT00000844|Interferon-alpha|interferon-alpha|mesh-list
6294141|NCT00000844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6294142|NCT00000844|Antiviral Agents|antiviral agents|mesh-ancestor
6294143|NCT00000844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294144|NCT00000844|Immunologic Factors|immunologic factors|mesh-ancestor
6294145|NCT00000844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6294146|NCT00000847|polysaccharide-K|polysaccharide-k|mesh-list
6294147|NCT00000847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6294148|NCT00000847|Immunologic Factors|immunologic factors|mesh-ancestor
6294149|NCT00000847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6294150|NCT00000847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6294151|NCT00000847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6294152|NCT00000847|Antiviral Agents|antiviral agents|mesh-ancestor
6294153|NCT00000847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294154|NCT00000847|Interferon Inducers|interferon inducers|mesh-ancestor
6294155|NCT00000847|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6294156|NCT00000847|Protective Agents|protective agents|mesh-ancestor
6294157|NCT00000848|Indinavir|indinavir|mesh-list
6294158|NCT00000848|Saquinavir|saquinavir|mesh-list
6294159|NCT00000848|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6294160|NCT00000848|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6294161|NCT00000848|Protease Inhibitors|protease inhibitors|mesh-ancestor
6294162|NCT00000848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6294163|NCT00000848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6294164|NCT00000848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6294165|NCT00000848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6294166|NCT00000848|Antiviral Agents|antiviral agents|mesh-ancestor
6294167|NCT00000848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294168|NCT00000848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6294169|NCT00000848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6294170|NCT00000849|Aldesleukin|aldesleukin|mesh-list
6294171|NCT00000849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6294172|NCT00000849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6294173|NCT00000849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6294174|NCT00000849|Antiviral Agents|antiviral agents|mesh-ancestor
6294175|NCT00000849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294176|NCT00000850|Indinavir|indinavir|mesh-list
6294177|NCT00000850|Sargramostim|sargramostim|mesh-list
6294178|NCT00000850|Immunologic Factors|immunologic factors|mesh-ancestor
6294179|NCT00000850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6294180|NCT00000850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6294181|NCT00000850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6294182|NCT00000850|Protease Inhibitors|protease inhibitors|mesh-ancestor
6294183|NCT00000850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6294184|NCT00000850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6294185|NCT00000850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6294186|NCT00000850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6294187|NCT00000850|Antiviral Agents|antiviral agents|mesh-ancestor
6294188|NCT00000850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294189|NCT00000851|Stavudine|stavudine|mesh-list
6294190|NCT00000851|Didanosine|didanosine|mesh-list
6294191|NCT00000851|Antimetabolites|antimetabolites|mesh-ancestor
6294192|NCT00000851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6294193|NCT00000851|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6294194|NCT00000851|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6294195|NCT00000851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6294196|NCT00000851|Antiviral Agents|antiviral agents|mesh-ancestor
6294197|NCT00000851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294198|NCT00000851|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6294199|NCT00000851|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6294200|NCT00000854|Nandrolone Decanoate|nandrolone decanoate|mesh-list
6294201|NCT00000854|Nandrolone|nandrolone|mesh-list
6294202|NCT00000854|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
6294203|NCT00000854|Androgens|androgens|mesh-ancestor
6294204|NCT00000854|Hormones|hormones|mesh-ancestor
6294205|NCT00000854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6294206|NCT00000854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6294207|NCT00000854|Anabolic Agents|anabolic agents|mesh-ancestor
6294208|NCT00000854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6294209|NCT00000855|Zidovudine|zidovudine|mesh-list
6294210|NCT00000855|Antimetabolites|antimetabolites|mesh-ancestor
6294211|NCT00000855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6294212|NCT00000855|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6294213|NCT00000855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6294214|NCT00000855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6294215|NCT00000855|Antiviral Agents|antiviral agents|mesh-ancestor
6294216|NCT00000855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294217|NCT00000855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6294218|NCT00000855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6294219|NCT00000856|Ganciclovir|ganciclovir|mesh-list
6294220|NCT00000856|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6294221|NCT00000856|Foscarnet|foscarnet|mesh-list
6294222|NCT00000856|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
6294223|NCT00000856|Antiviral Agents|antiviral agents|mesh-ancestor
6294224|NCT00000856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294225|NCT00000856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6294226|NCT00000856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6294227|NCT00000856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6294228|NCT00000856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6294229|NCT00000857|Interleukin-12|interleukin-12|mesh-list
6294230|NCT00000857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6294231|NCT00000857|Immunologic Factors|immunologic factors|mesh-ancestor
6294232|NCT00000857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6294233|NCT00000857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6294234|NCT00000857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6294235|NCT00000857|Growth Substances|growth substances|mesh-ancestor
6294236|NCT00000857|Growth Inhibitors|growth inhibitors|mesh-ancestor
6294237|NCT00000857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6294238|NCT00000859|Ritonavir|ritonavir|mesh-list
6294239|NCT00000859|Nelfinavir|nelfinavir|mesh-list
6294240|NCT00000859|Indinavir|indinavir|mesh-list
6294241|NCT00000859|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6294242|NCT00000859|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6294243|NCT00000859|Protease Inhibitors|protease inhibitors|mesh-ancestor
6294244|NCT00000859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6294245|NCT00000859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6294246|NCT00000859|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6294247|NCT00000859|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6294248|NCT00000859|Antiviral Agents|antiviral agents|mesh-ancestor
6294249|NCT00000859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294250|NCT00000859|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6294251|NCT00000859|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6294252|NCT00000861|Indinavir|indinavir|mesh-list
6294253|NCT00000861|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6294254|NCT00000861|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6294255|NCT00000861|Protease Inhibitors|protease inhibitors|mesh-ancestor
6294256|NCT00000861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6294257|NCT00000861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6294258|NCT00000861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6294259|NCT00000861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6294260|NCT00000861|Antiviral Agents|antiviral agents|mesh-ancestor
6294261|NCT00000861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6391833|NCT00194467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6391834|NCT00194480|Interferons|interferons|mesh-list
6391835|NCT00194480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391836|NCT00194480|Antiviral Agents|antiviral agents|mesh-ancestor
6391837|NCT00194480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6391838|NCT00194519|Acyclovir|acyclovir|mesh-list
6391839|NCT00194519|Antiviral Agents|antiviral agents|mesh-ancestor
6391840|NCT00194519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6391841|NCT00194597|Sildenafil Citrate|sildenafil citrate|mesh-list
6391842|NCT00194597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391843|NCT00194597|Vasodilator Agents|vasodilator agents|mesh-ancestor
6391844|NCT00194597|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6391845|NCT00194597|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6391846|NCT00194597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6391847|NCT00194597|Urological Agents|urological agents|mesh-ancestor
6391848|NCT00194623|Botulinum Toxins|botulinum toxins|mesh-list
6391849|NCT00194623|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6391850|NCT00194623|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6391851|NCT00194623|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6391852|NCT00194623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6391853|NCT00194623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391854|NCT00194623|Cholinergic Agents|cholinergic agents|mesh-ancestor
6391855|NCT00194623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6391856|NCT00194623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6391857|NCT00194623|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6391858|NCT00194623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6391859|NCT00194649|Miglustat|miglustat|mesh-list
6391860|NCT00194649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6391861|NCT00194649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391862|NCT00194649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6391863|NCT00194649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6391864|NCT00194649|Antiviral Agents|antiviral agents|mesh-ancestor
6391865|NCT00194649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6391866|NCT00194649|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6391867|NCT00194649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6391868|NCT00194649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6391869|NCT00194714|Vaccines|vaccines|mesh-list
6391870|NCT00194714|Immunologic Factors|immunologic factors|mesh-ancestor
6391871|NCT00194714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6391872|NCT00194727|Capecitabine|capecitabine|mesh-list
6391873|NCT00194727|Vinorelbine|vinorelbine|mesh-list
6391874|NCT00194727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6294262|NCT00000862|Zidovudine|zidovudine|mesh-list
6294263|NCT00000862|Antimetabolites|antimetabolites|mesh-ancestor
6294264|NCT00000862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6294265|NCT00000862|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6294266|NCT00000862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6294267|NCT00000862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6294268|NCT00000862|Antiviral Agents|antiviral agents|mesh-ancestor
6294269|NCT00000862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294270|NCT00000862|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6294271|NCT00000862|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6294272|NCT00000864|Zidovudine|zidovudine|mesh-list
6294273|NCT00000864|Abacavir|abacavir|mesh-list
6294274|NCT00000864|Antimetabolites|antimetabolites|mesh-ancestor
6294275|NCT00000864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6294276|NCT00000864|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6294277|NCT00000864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6294278|NCT00000864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6294279|NCT00000864|Antiviral Agents|antiviral agents|mesh-ancestor
6294280|NCT00000864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294281|NCT00000864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6294282|NCT00000864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6294283|NCT00000865|Lamivudine|lamivudine|mesh-list
6294284|NCT00000865|Zidovudine|zidovudine|mesh-list
6294285|NCT00000865|Abacavir|abacavir|mesh-list
6294286|NCT00000865|Stavudine|stavudine|mesh-list
6294287|NCT00000865|Didanosine|didanosine|mesh-list
6294288|NCT00000865|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6294289|NCT00000865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6294290|NCT00000865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6294291|NCT00000865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6294292|NCT00000865|Antiviral Agents|antiviral agents|mesh-ancestor
6294293|NCT00000865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294294|NCT00000865|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6294295|NCT00000865|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6294296|NCT00000865|Antimetabolites|antimetabolites|mesh-ancestor
6294297|NCT00000867|Memantine|memantine|mesh-list
6294298|NCT00000867|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6294299|NCT00000867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6294300|NCT00000867|Dopamine Agents|dopamine agents|mesh-ancestor
6294301|NCT00000867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6294302|NCT00000867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6294303|NCT00000867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6294304|NCT00000867|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6294305|NCT00000867|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6294306|NCT00000868|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6294307|NCT00000868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6294308|NCT00000868|Immunologic Factors|immunologic factors|mesh-ancestor
6294309|NCT00000868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6294310|NCT00000868|Antacids|antacids|mesh-ancestor
6294311|NCT00000868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6294312|NCT00000868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6294313|NCT00000869|Nevirapine|nevirapine|mesh-list
6294314|NCT00000869|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6294315|NCT00000869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6294316|NCT00000869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6294317|NCT00000869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6294318|NCT00000869|Antiviral Agents|antiviral agents|mesh-ancestor
6294319|NCT00000869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294320|NCT00000869|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6294321|NCT00000869|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6294322|NCT00000869|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6294323|NCT00000869|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6294324|NCT00000870|Lamivudine|lamivudine|mesh-list
6294325|NCT00000870|Zidovudine|zidovudine|mesh-list
6294326|NCT00000870|Stavudine|stavudine|mesh-list
6294327|NCT00000870|Didanosine|didanosine|mesh-list
6294328|NCT00000870|Aldesleukin|aldesleukin|mesh-list
6294329|NCT00000870|Indinavir|indinavir|mesh-list
6294330|NCT00000870|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6294331|NCT00000870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6294332|NCT00000870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6294333|NCT00000870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6294334|NCT00000870|Antiviral Agents|antiviral agents|mesh-ancestor
6294335|NCT00000870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294336|NCT00000870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6294337|NCT00000870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6294338|NCT00000870|Antimetabolites|antimetabolites|mesh-ancestor
6294339|NCT00000870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6294340|NCT00000870|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6294341|NCT00000870|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6294342|NCT00000870|Protease Inhibitors|protease inhibitors|mesh-ancestor
6294343|NCT00000872|Lamivudine|lamivudine|mesh-list
6294344|NCT00000872|Zidovudine|zidovudine|mesh-list
6294345|NCT00000872|Nevirapine|nevirapine|mesh-list
6294346|NCT00000872|Abacavir|abacavir|mesh-list
6294347|NCT00000872|Stavudine|stavudine|mesh-list
6294348|NCT00000872|Nelfinavir|nelfinavir|mesh-list
6294349|NCT00000872|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6294350|NCT00000872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6294351|NCT00000872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6294352|NCT00000872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6294353|NCT00000872|Antiviral Agents|antiviral agents|mesh-ancestor
6294354|NCT00000872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294355|NCT00000872|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6294356|NCT00000872|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6294357|NCT00000872|Antimetabolites|antimetabolites|mesh-ancestor
6294358|NCT00000872|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6294359|NCT00000872|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6294360|NCT00000872|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6294361|NCT00000872|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6294362|NCT00000872|Protease Inhibitors|protease inhibitors|mesh-ancestor
6294363|NCT00000875|Acetaminophen|acetaminophen|mesh-list
6294364|NCT00000875|Diphenhydramine|diphenhydramine|mesh-list
6294365|NCT00000875|Promethazine|promethazine|mesh-list
6294366|NCT00000875|Lamivudine|lamivudine|mesh-list
6294367|NCT00000875|Zidovudine|zidovudine|mesh-list
6294368|NCT00000875|Aldesleukin|aldesleukin|mesh-list
6294369|NCT00000875|Indinavir|indinavir|mesh-list
6294370|NCT00000875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6294371|NCT00000875|Analgesics|analgesics|mesh-ancestor
6294372|NCT00000875|Sensory System Agents|sensory system agents|mesh-ancestor
6294373|NCT00000875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6294374|NCT00000875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6294375|NCT00000875|Antipyretics|antipyretics|mesh-ancestor
6294376|NCT00000875|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6294377|NCT00000875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6294378|NCT00000875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6294379|NCT00000875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6294380|NCT00000875|Antiviral Agents|antiviral agents|mesh-ancestor
6294381|NCT00000875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294382|NCT00000875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6294383|NCT00000875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6294384|NCT00000875|Antimetabolites|antimetabolites|mesh-ancestor
6294385|NCT00000875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6294386|NCT00000875|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6294387|NCT00000875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6294388|NCT00000875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6294389|NCT00000875|Anesthetics, Local|anesthetics, local|mesh-ancestor
6294390|NCT00000875|Anesthetics|anesthetics|mesh-ancestor
6294391|NCT00000875|Antiemetics|antiemetics|mesh-ancestor
6294392|NCT00000875|Autonomic Agents|autonomic agents|mesh-ancestor
6294393|NCT00000875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6294394|NCT00000875|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6294395|NCT00000875|Histamine Antagonists|histamine antagonists|mesh-ancestor
6294396|NCT00000875|Histamine Agents|histamine agents|mesh-ancestor
6294397|NCT00000875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6294398|NCT00000875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6294399|NCT00000875|Antipruritics|antipruritics|mesh-ancestor
6294400|NCT00000875|Dermatologic Agents|dermatologic agents|mesh-ancestor
6294401|NCT00000875|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6294402|NCT00000875|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6294403|NCT00000875|Protease Inhibitors|protease inhibitors|mesh-ancestor
6294404|NCT00000876|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
6294405|NCT00000876|Immunologic Factors|immunologic factors|mesh-ancestor
6294406|NCT00000876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6294407|NCT00000877|Indinavir|indinavir|mesh-list
6294408|NCT00000877|Rifabutin|rifabutin|mesh-list
6294409|NCT00000877|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6294410|NCT00000877|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6294411|NCT00000877|Protease Inhibitors|protease inhibitors|mesh-ancestor
6294412|NCT00000877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6391875|NCT00194727|Antimetabolites|antimetabolites|mesh-ancestor
6294413|NCT00000877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6294414|NCT00000877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6294415|NCT00000877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6294416|NCT00000877|Antiviral Agents|antiviral agents|mesh-ancestor
6294417|NCT00000877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294418|NCT00000877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6294419|NCT00000877|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6294420|NCT00000877|Antitubercular Agents|antitubercular agents|mesh-ancestor
6294421|NCT00000878|Lamivudine|lamivudine|mesh-list
6294422|NCT00000878|Zidovudine|zidovudine|mesh-list
6294423|NCT00000878|Stavudine|stavudine|mesh-list
6294424|NCT00000878|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6294425|NCT00000878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6294426|NCT00000878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6294427|NCT00000878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6294428|NCT00000878|Antiviral Agents|antiviral agents|mesh-ancestor
6294429|NCT00000878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294430|NCT00000878|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6294431|NCT00000878|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6294432|NCT00000878|Antimetabolites|antimetabolites|mesh-ancestor
6294433|NCT00000880|Cyclosporine|cyclosporine|mesh-list
6294434|NCT00000880|Cyclosporins|cyclosporins|mesh-list
6294435|NCT00000880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6294436|NCT00000880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6294437|NCT00000880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6294438|NCT00000880|Immunologic Factors|immunologic factors|mesh-ancestor
6294439|NCT00000880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6294440|NCT00000880|Antifungal Agents|antifungal agents|mesh-ancestor
6294441|NCT00000880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294442|NCT00000880|Dermatologic Agents|dermatologic agents|mesh-ancestor
6294443|NCT00000880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6294444|NCT00000880|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6294445|NCT00000881|Cidofovir|cidofovir|mesh-list
6294446|NCT00000881|Probenecid|probenecid|mesh-list
6294447|NCT00000881|Uricosuric Agents|uricosuric agents|mesh-ancestor
6294448|NCT00000881|Gout Suppressants|gout suppressants|mesh-ancestor
6294449|NCT00000881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6294450|NCT00000881|Renal Agents|renal agents|mesh-ancestor
6294451|NCT00000881|Antiviral Agents|antiviral agents|mesh-ancestor
6294452|NCT00000881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294453|NCT00000881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6294454|NCT00000881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6294455|NCT00000882|Lamivudine|lamivudine|mesh-list
6294456|NCT00000882|Zidovudine|zidovudine|mesh-list
6294457|NCT00000882|Stavudine|stavudine|mesh-list
6294458|NCT00000882|Delavirdine|delavirdine|mesh-list
6294459|NCT00000882|Indinavir|indinavir|mesh-list
6294460|NCT00000882|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6294461|NCT00000882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6294462|NCT00000882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6294463|NCT00000882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6294464|NCT00000882|Antiviral Agents|antiviral agents|mesh-ancestor
6294465|NCT00000882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294466|NCT00000882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6294467|NCT00000882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6294468|NCT00000882|Antimetabolites|antimetabolites|mesh-ancestor
6294469|NCT00000882|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6294470|NCT00000882|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6294471|NCT00000882|Protease Inhibitors|protease inhibitors|mesh-ancestor
6294472|NCT00000883|Azithromycin|azithromycin|mesh-list
6294473|NCT00000883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6294474|NCT00000883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294475|NCT00000884|polysaccharide-K|polysaccharide-k|mesh-list
6294476|NCT00000884|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6294477|NCT00000884|Immunologic Factors|immunologic factors|mesh-ancestor
6294478|NCT00000884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6294479|NCT00000884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6294480|NCT00000884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6294481|NCT00000884|Antiviral Agents|antiviral agents|mesh-ancestor
6294482|NCT00000884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294483|NCT00000884|Interferon Inducers|interferon inducers|mesh-ancestor
6294484|NCT00000884|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6294485|NCT00000884|Protective Agents|protective agents|mesh-ancestor
6294486|NCT00000885|Lamivudine|lamivudine|mesh-list
6294487|NCT00000885|Zidovudine|zidovudine|mesh-list
6294488|NCT00000885|Efavirenz|efavirenz|mesh-list
6294489|NCT00000885|Abacavir|abacavir|mesh-list
6294490|NCT00000885|Stavudine|stavudine|mesh-list
6294491|NCT00000885|Didanosine|didanosine|mesh-list
6294492|NCT00000885|Adefovir|adefovir|mesh-list
6294493|NCT00000885|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6294494|NCT00000885|Nelfinavir|nelfinavir|mesh-list
6294495|NCT00000885|Indinavir|indinavir|mesh-list
6294496|NCT00000885|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6294497|NCT00000885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6294498|NCT00000885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6294499|NCT00000885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6294500|NCT00000885|Antiviral Agents|antiviral agents|mesh-ancestor
6294501|NCT00000885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294502|NCT00000885|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6294503|NCT00000885|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6015493|NCT00357500|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6015494|NCT00357500|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6015495|NCT00357500|Growth Substances|growth substances|mesh-ancestor
6015496|NCT00357500|Growth Inhibitors|growth inhibitors|mesh-ancestor
6015497|NCT00357500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6294504|NCT00000885|Antimetabolites|antimetabolites|mesh-ancestor
6294505|NCT00000885|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6294506|NCT00000885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6294507|NCT00000885|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6294508|NCT00000885|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6294509|NCT00000885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6294510|NCT00000885|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6294511|NCT00000885|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6294512|NCT00000885|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6294513|NCT00000885|Protease Inhibitors|protease inhibitors|mesh-ancestor
6294514|NCT00000887|Lamivudine|lamivudine|mesh-list
6294515|NCT00000887|Zidovudine|zidovudine|mesh-list
6294516|NCT00000887|Nelfinavir|nelfinavir|mesh-list
6294517|NCT00000887|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6294518|NCT00000887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6294519|NCT00000887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6294520|NCT00000887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6294521|NCT00000887|Antiviral Agents|antiviral agents|mesh-ancestor
6294522|NCT00000887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294523|NCT00000887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6294524|NCT00000887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6294525|NCT00000887|Antimetabolites|antimetabolites|mesh-ancestor
6294526|NCT00000887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6294527|NCT00000887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6294528|NCT00000887|Protease Inhibitors|protease inhibitors|mesh-ancestor
6294529|NCT00000888|Ritonavir|ritonavir|mesh-list
6294530|NCT00000888|Lamivudine|lamivudine|mesh-list
6294531|NCT00000888|Zidovudine|zidovudine|mesh-list
6294532|NCT00000888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6294533|NCT00000888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6294534|NCT00000888|Protease Inhibitors|protease inhibitors|mesh-ancestor
6294535|NCT00000888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6294536|NCT00000888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6294537|NCT00000888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6294538|NCT00000888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6294539|NCT00000888|Antiviral Agents|antiviral agents|mesh-ancestor
6294540|NCT00000888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294541|NCT00000888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6294542|NCT00000888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6294543|NCT00000888|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6294544|NCT00000888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6294545|NCT00000888|Antimetabolites|antimetabolites|mesh-ancestor
6294546|NCT00000889|Aldesleukin|aldesleukin|mesh-list
6294547|NCT00000889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6294548|NCT00000889|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6294549|NCT00000889|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6294550|NCT00000889|Antiviral Agents|antiviral agents|mesh-ancestor
6294551|NCT00000889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294552|NCT00000891|Ritonavir|ritonavir|mesh-list
6294553|NCT00000891|Saquinavir|saquinavir|mesh-list
6294554|NCT00000891|Lamivudine|lamivudine|mesh-list
6294555|NCT00000891|Zidovudine|zidovudine|mesh-list
6294556|NCT00000891|Stavudine|stavudine|mesh-list
6294557|NCT00000891|Didanosine|didanosine|mesh-list
6294558|NCT00000891|Delavirdine|delavirdine|mesh-list
6294559|NCT00000891|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6294560|NCT00000891|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6294561|NCT00000891|Protease Inhibitors|protease inhibitors|mesh-ancestor
6294562|NCT00000891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6294563|NCT00000891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6294564|NCT00000891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6294565|NCT00000891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6294566|NCT00000891|Antiviral Agents|antiviral agents|mesh-ancestor
6294567|NCT00000891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294568|NCT00000891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6294569|NCT00000891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6294570|NCT00000891|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6294571|NCT00000891|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6294572|NCT00000891|Antimetabolites|antimetabolites|mesh-ancestor
6294573|NCT00000892|Ritonavir|ritonavir|mesh-list
6294574|NCT00000892|Nelfinavir|nelfinavir|mesh-list
6294575|NCT00000892|Saquinavir|saquinavir|mesh-list
6294576|NCT00000892|Delavirdine|delavirdine|mesh-list
6294577|NCT00000892|Adefovir|adefovir|mesh-list
6294578|NCT00000892|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6294579|NCT00000892|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6294580|NCT00000892|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6294581|NCT00000892|Protease Inhibitors|protease inhibitors|mesh-ancestor
6294582|NCT00000892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6294583|NCT00000892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6294584|NCT00000892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6294585|NCT00000892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6294586|NCT00000892|Antiviral Agents|antiviral agents|mesh-ancestor
6294587|NCT00000892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294588|NCT00000892|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6294589|NCT00000892|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6294590|NCT00000892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6294591|NCT00000892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6294592|NCT00000893|Efavirenz|efavirenz|mesh-list
6294593|NCT00000893|Nelfinavir|nelfinavir|mesh-list
6294594|NCT00000893|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6294595|NCT00000893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6294596|NCT00000893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6294597|NCT00000893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6294598|NCT00000893|Antiviral Agents|antiviral agents|mesh-ancestor
6294599|NCT00000893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294600|NCT00000893|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6294601|NCT00000893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6294602|NCT00000893|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6294603|NCT00000893|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6294604|NCT00000893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6294605|NCT00000893|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6294606|NCT00000893|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6294607|NCT00000893|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6294608|NCT00000893|Protease Inhibitors|protease inhibitors|mesh-ancestor
6294609|NCT00000893|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6294610|NCT00000893|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6294611|NCT00000894|Ganciclovir|ganciclovir|mesh-list
6294612|NCT00000894|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6294613|NCT00000894|Cidofovir|cidofovir|mesh-list
6294614|NCT00000894|Probenecid|probenecid|mesh-list
6294615|NCT00000894|Antiviral Agents|antiviral agents|mesh-ancestor
6294616|NCT00000894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294617|NCT00000894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6294618|NCT00000894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6294619|NCT00000894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6294620|NCT00000894|Uricosuric Agents|uricosuric agents|mesh-ancestor
6294621|NCT00000894|Gout Suppressants|gout suppressants|mesh-ancestor
6294622|NCT00000894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6294623|NCT00000894|Renal Agents|renal agents|mesh-ancestor
6294624|NCT00000895|Azithromycin|azithromycin|mesh-list
6294625|NCT00000895|Nevirapine|nevirapine|mesh-list
6294626|NCT00000895|Nelfinavir|nelfinavir|mesh-list
6294627|NCT00000895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6294628|NCT00000895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294629|NCT00000895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6294630|NCT00000895|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6294631|NCT00000895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6294632|NCT00000895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6294633|NCT00000895|Antiviral Agents|antiviral agents|mesh-ancestor
6294634|NCT00000895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6294635|NCT00000895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6294636|NCT00000895|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6294637|NCT00000895|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6294638|NCT00000895|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6294639|NCT00000895|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6294640|NCT00000895|Protease Inhibitors|protease inhibitors|mesh-ancestor
6294641|NCT00000896|Lamivudine|lamivudine|mesh-list
6294642|NCT00000896|Zidovudine|zidovudine|mesh-list
6294643|NCT00000896|Nevirapine|nevirapine|mesh-list
6294644|NCT00000896|Stavudine|stavudine|mesh-list
6294645|NCT00000896|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6294646|NCT00000896|Indinavir|indinavir|mesh-list
6294647|NCT00000896|Interleukin-12|interleukin-12|mesh-list
6294648|NCT00000896|Sargramostim|sargramostim|mesh-list
6294649|NCT00000896|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6294650|NCT00000896|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6294651|NCT00000896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6294652|NCT00000896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6294653|NCT00000896|Antiviral Agents|antiviral agents|mesh-ancestor
6294654|NCT00000896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294655|NCT00000896|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6294656|NCT00000896|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6294657|NCT00000896|Antimetabolites|antimetabolites|mesh-ancestor
6294658|NCT00000896|Immunologic Factors|immunologic factors|mesh-ancestor
6294659|NCT00000896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6294660|NCT00000896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6294661|NCT00000896|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6294662|NCT00000896|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6294663|NCT00000896|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6294664|NCT00000896|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6294665|NCT00000896|Protease Inhibitors|protease inhibitors|mesh-ancestor
6294666|NCT00000896|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6294667|NCT00000896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6294668|NCT00000896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6294669|NCT00000896|Growth Substances|growth substances|mesh-ancestor
6294670|NCT00000896|Growth Inhibitors|growth inhibitors|mesh-ancestor
6294671|NCT00000897|Zidovudine|zidovudine|mesh-list
6294672|NCT00000897|Antimetabolites|antimetabolites|mesh-ancestor
6294673|NCT00000897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6294674|NCT00000897|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6294675|NCT00000897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6294676|NCT00000897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6294677|NCT00000897|Antiviral Agents|antiviral agents|mesh-ancestor
6294678|NCT00000897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294679|NCT00000897|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6294680|NCT00000897|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6294681|NCT00000898|Ritonavir|ritonavir|mesh-list
6294682|NCT00000898|Nelfinavir|nelfinavir|mesh-list
6294683|NCT00000898|Saquinavir|saquinavir|mesh-list
6294684|NCT00000898|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6294685|NCT00000898|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6294686|NCT00000898|Protease Inhibitors|protease inhibitors|mesh-ancestor
6294687|NCT00000898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6294688|NCT00000898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6294689|NCT00000898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6294690|NCT00000898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6294691|NCT00000898|Antiviral Agents|antiviral agents|mesh-ancestor
6294692|NCT00000898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294693|NCT00000898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6294694|NCT00000898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6294695|NCT00000899|Lamivudine|lamivudine|mesh-list
6294696|NCT00000899|Stavudine|stavudine|mesh-list
6294697|NCT00000899|Nelfinavir|nelfinavir|mesh-list
6294698|NCT00000899|Cyclophosphamide|cyclophosphamide|mesh-list
6294699|NCT00000899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6294700|NCT00000899|Immunologic Factors|immunologic factors|mesh-ancestor
6294701|NCT00000899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6294702|NCT00000899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6294703|NCT00000899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6294704|NCT00000899|Alkylating Agents|alkylating agents|mesh-ancestor
6294705|NCT00000899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6294706|NCT00000899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6294707|NCT00000899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6294708|NCT00000899|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6294709|NCT00000899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6294710|NCT00000899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6294711|NCT00000899|Antiviral Agents|antiviral agents|mesh-ancestor
6294712|NCT00000899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294713|NCT00000899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6294714|NCT00000899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6294715|NCT00000899|Antimetabolites|antimetabolites|mesh-ancestor
6294716|NCT00000899|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6294717|NCT00000899|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6294718|NCT00000899|Protease Inhibitors|protease inhibitors|mesh-ancestor
6294719|NCT00000901|Lamivudine|lamivudine|mesh-list
6294720|NCT00000901|Stavudine|stavudine|mesh-list
6294721|NCT00000901|Indinavir|indinavir|mesh-list
6294722|NCT00000901|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6294723|NCT00000901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6294724|NCT00000901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6294725|NCT00000901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6294726|NCT00000901|Antiviral Agents|antiviral agents|mesh-ancestor
6294727|NCT00000901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294728|NCT00000901|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6294729|NCT00000901|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6294730|NCT00000901|Antimetabolites|antimetabolites|mesh-ancestor
6294731|NCT00000901|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6294732|NCT00000901|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6294733|NCT00000901|Protease Inhibitors|protease inhibitors|mesh-ancestor
6294734|NCT00000902|Ritonavir|ritonavir|mesh-list
6294735|NCT00000902|Nelfinavir|nelfinavir|mesh-list
6294736|NCT00000902|Lamivudine|lamivudine|mesh-list
6294737|NCT00000902|Zidovudine|zidovudine|mesh-list
6294738|NCT00000902|Nevirapine|nevirapine|mesh-list
6294739|NCT00000902|Stavudine|stavudine|mesh-list
6294740|NCT00000902|Didanosine|didanosine|mesh-list
6294741|NCT00000902|Zalcitabine|zalcitabine|mesh-list
6294742|NCT00000902|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6294743|NCT00000902|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6294744|NCT00000902|Protease Inhibitors|protease inhibitors|mesh-ancestor
6294745|NCT00000902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6294746|NCT00000902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6294747|NCT00000902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6294748|NCT00000902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6294749|NCT00000902|Antiviral Agents|antiviral agents|mesh-ancestor
6294750|NCT00000902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294751|NCT00000902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6294752|NCT00000902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6294753|NCT00000902|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6294754|NCT00000902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6294755|NCT00000902|Antimetabolites|antimetabolites|mesh-ancestor
6294756|NCT00000902|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6294757|NCT00000902|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6294758|NCT00000903|Lamivudine|lamivudine|mesh-list
6294759|NCT00000903|Zidovudine|zidovudine|mesh-list
6294760|NCT00000903|Efavirenz|efavirenz|mesh-list
6294761|NCT00000903|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6294762|NCT00000903|Nelfinavir|nelfinavir|mesh-list
6294763|NCT00000903|Indinavir|indinavir|mesh-list
6294764|NCT00000903|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6294765|NCT00000903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6294766|NCT00000903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6294767|NCT00000903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6294768|NCT00000903|Antiviral Agents|antiviral agents|mesh-ancestor
6294769|NCT00000903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294770|NCT00000903|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6294771|NCT00000903|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6294772|NCT00000903|Antimetabolites|antimetabolites|mesh-ancestor
6294773|NCT00000903|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6294774|NCT00000903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6294775|NCT00000903|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6294776|NCT00000903|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6294777|NCT00000903|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6294778|NCT00000903|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6294779|NCT00000903|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6294780|NCT00000903|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6294781|NCT00000903|Protease Inhibitors|protease inhibitors|mesh-ancestor
6294782|NCT00000904|polysaccharide-K|polysaccharide-k|mesh-list
6294783|NCT00000904|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6294784|NCT00000904|Immunologic Factors|immunologic factors|mesh-ancestor
6294785|NCT00000904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6294786|NCT00000904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6294787|NCT00000904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6294788|NCT00000904|Antiviral Agents|antiviral agents|mesh-ancestor
6294789|NCT00000904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294790|NCT00000904|Interferon Inducers|interferon inducers|mesh-ancestor
6294791|NCT00000904|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6294792|NCT00000904|Protective Agents|protective agents|mesh-ancestor
6294793|NCT00000906|Ritonavir|ritonavir|mesh-list
6294794|NCT00000906|Saquinavir|saquinavir|mesh-list
6294795|NCT00000906|Methadone|methadone|mesh-list
6294796|NCT00000906|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6294797|NCT00000906|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6294798|NCT00000906|Protease Inhibitors|protease inhibitors|mesh-ancestor
6294799|NCT00000906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6294800|NCT00000906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6294801|NCT00000906|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6294802|NCT00000906|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6294803|NCT00000906|Antiviral Agents|antiviral agents|mesh-ancestor
6294804|NCT00000906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294805|NCT00000906|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6294806|NCT00000906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6294807|NCT00000906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6294808|NCT00000906|Narcotics|narcotics|mesh-ancestor
6294809|NCT00000906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6294810|NCT00000906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6294811|NCT00000906|Analgesics|analgesics|mesh-ancestor
6294812|NCT00000906|Sensory System Agents|sensory system agents|mesh-ancestor
6294813|NCT00000906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6294814|NCT00000906|Antitussive Agents|antitussive agents|mesh-ancestor
6294815|NCT00000906|Respiratory System Agents|respiratory system agents|mesh-ancestor
6294816|NCT00000909|Aldesleukin|aldesleukin|mesh-list
6294817|NCT00000909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6294818|NCT00000909|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6294819|NCT00000909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6294820|NCT00000909|Antiviral Agents|antiviral agents|mesh-ancestor
6294821|NCT00000909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294822|NCT00000912|Efavirenz|efavirenz|mesh-list
6294823|NCT00000912|Abacavir|abacavir|mesh-list
6294824|NCT00000912|Adefovir|adefovir|mesh-list
6294825|NCT00000912|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6294826|NCT00000912|Nelfinavir|nelfinavir|mesh-list
6294827|NCT00000912|Indinavir|indinavir|mesh-list
6294828|NCT00000912|Saquinavir|saquinavir|mesh-list
6294829|NCT00000912|Amprenavir|amprenavir|mesh-list
6294830|NCT00000912|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6294831|NCT00000912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6294832|NCT00000912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6294833|NCT00000912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6294834|NCT00000912|Antiviral Agents|antiviral agents|mesh-ancestor
6294835|NCT00000912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294836|NCT00000912|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6294837|NCT00000912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6294838|NCT00000912|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6294839|NCT00000912|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6294840|NCT00000912|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6294841|NCT00000912|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6294842|NCT00000912|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6294843|NCT00000912|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6294844|NCT00000912|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6294845|NCT00000912|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6294846|NCT00000912|Protease Inhibitors|protease inhibitors|mesh-ancestor
6294847|NCT00000912|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6294848|NCT00000912|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6294849|NCT00000912|Antitubercular Agents|antitubercular agents|mesh-ancestor
6294850|NCT00000912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6294851|NCT00000913|Ritonavir|ritonavir|mesh-list
6294852|NCT00000913|Nelfinavir|nelfinavir|mesh-list
6294853|NCT00000913|Saquinavir|saquinavir|mesh-list
6294854|NCT00000913|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6294855|NCT00000913|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6294856|NCT00000913|Protease Inhibitors|protease inhibitors|mesh-ancestor
6294857|NCT00000913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6294858|NCT00000913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6294859|NCT00000913|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6294860|NCT00000913|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6294861|NCT00000913|Antiviral Agents|antiviral agents|mesh-ancestor
6294862|NCT00000913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294863|NCT00000913|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6294864|NCT00000913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6294865|NCT00000914|Ritonavir|ritonavir|mesh-list
6294866|NCT00000914|Nelfinavir|nelfinavir|mesh-list
6294867|NCT00000914|Indinavir|indinavir|mesh-list
6294868|NCT00000914|Efavirenz|efavirenz|mesh-list
6294869|NCT00000914|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6294870|NCT00000914|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6294871|NCT00000914|Protease Inhibitors|protease inhibitors|mesh-ancestor
6294872|NCT00000914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6294873|NCT00000914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6294874|NCT00000914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6294875|NCT00000914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6294876|NCT00000914|Antiviral Agents|antiviral agents|mesh-ancestor
6294877|NCT00000914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294878|NCT00000914|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6294879|NCT00000914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6294880|NCT00000914|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6294881|NCT00000914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6294882|NCT00000914|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6294883|NCT00000914|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6294884|NCT00000914|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6294885|NCT00000914|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6294886|NCT00000914|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6294887|NCT00000916|Lamivudine|lamivudine|mesh-list
6294888|NCT00000916|Zidovudine|zidovudine|mesh-list
6294889|NCT00000916|Stavudine|stavudine|mesh-list
6294890|NCT00000916|Didanosine|didanosine|mesh-list
6294891|NCT00000916|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6294892|NCT00000916|Indinavir|indinavir|mesh-list
6294893|NCT00000916|Hydroxyurea|hydroxyurea|mesh-list
6294894|NCT00000916|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6294895|NCT00000916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6294896|NCT00000916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6294897|NCT00000916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6294898|NCT00000916|Antiviral Agents|antiviral agents|mesh-ancestor
6294899|NCT00000916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294900|NCT00000916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6294901|NCT00000916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6294902|NCT00000916|Antimetabolites|antimetabolites|mesh-ancestor
6294903|NCT00000916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6294904|NCT00000916|Antisickling Agents|antisickling agents|mesh-ancestor
6294905|NCT00000916|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6294906|NCT00000916|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6294907|NCT00000916|Protease Inhibitors|protease inhibitors|mesh-ancestor
6294908|NCT00000918|Ritonavir|ritonavir|mesh-list
6294909|NCT00000918|Indinavir|indinavir|mesh-list
6294910|NCT00000918|Saquinavir|saquinavir|mesh-list
6294911|NCT00000918|Amprenavir|amprenavir|mesh-list
6294912|NCT00000918|Lamivudine|lamivudine|mesh-list
6294913|NCT00000918|Zidovudine|zidovudine|mesh-list
6294914|NCT00000918|Stavudine|stavudine|mesh-list
6294915|NCT00000918|Didanosine|didanosine|mesh-list
6294916|NCT00000918|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6294917|NCT00000918|Efavirenz|efavirenz|mesh-list
6294918|NCT00000918|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6294919|NCT00000918|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6294920|NCT00000918|Protease Inhibitors|protease inhibitors|mesh-ancestor
6294921|NCT00000918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6294922|NCT00000918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6294923|NCT00000918|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6294924|NCT00000918|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6294925|NCT00000918|Antiviral Agents|antiviral agents|mesh-ancestor
6294926|NCT00000918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294927|NCT00000918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6294928|NCT00000918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6294929|NCT00000918|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6294930|NCT00000918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6294931|NCT00000918|Antimetabolites|antimetabolites|mesh-ancestor
6294932|NCT00000918|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6294933|NCT00000918|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6294934|NCT00000918|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6294935|NCT00000918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6294936|NCT00000918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6294937|NCT00000918|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6294938|NCT00000918|Antitubercular Agents|antitubercular agents|mesh-ancestor
6294939|NCT00000918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6294940|NCT00000919|Ritonavir|ritonavir|mesh-list
6294941|NCT00000919|Nelfinavir|nelfinavir|mesh-list
6294942|NCT00000919|Indinavir|indinavir|mesh-list
6294943|NCT00000919|Amprenavir|amprenavir|mesh-list
6294944|NCT00000919|Lamivudine|lamivudine|mesh-list
6294945|NCT00000919|Zidovudine|zidovudine|mesh-list
6294946|NCT00000919|Abacavir|abacavir|mesh-list
6294947|NCT00000919|Stavudine|stavudine|mesh-list
6294948|NCT00000919|Didanosine|didanosine|mesh-list
6294949|NCT00000919|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6294950|NCT00000919|Efavirenz|efavirenz|mesh-list
6294951|NCT00000919|Hydroxyurea|hydroxyurea|mesh-list
6294952|NCT00000919|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6294953|NCT00000919|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6294954|NCT00000919|Protease Inhibitors|protease inhibitors|mesh-ancestor
6294955|NCT00000919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6294956|NCT00000919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6294957|NCT00000919|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6294958|NCT00000919|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6294959|NCT00000919|Antiviral Agents|antiviral agents|mesh-ancestor
6294960|NCT00000919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294961|NCT00000919|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6294962|NCT00000919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6294963|NCT00000919|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6294964|NCT00000919|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6294965|NCT00000919|Antimetabolites|antimetabolites|mesh-ancestor
6294966|NCT00000919|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6294967|NCT00000919|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6294968|NCT00000919|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6294969|NCT00000919|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6294970|NCT00000919|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6294971|NCT00000919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6294972|NCT00000919|Antisickling Agents|antisickling agents|mesh-ancestor
6294973|NCT00000919|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6294974|NCT00000919|Antitubercular Agents|antitubercular agents|mesh-ancestor
6294975|NCT00000919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6294976|NCT00000920|Ritonavir|ritonavir|mesh-list
6294977|NCT00000920|Saquinavir|saquinavir|mesh-list
6294978|NCT00000920|Lamivudine|lamivudine|mesh-list
6294979|NCT00000920|Zidovudine|zidovudine|mesh-list
6294980|NCT00000920|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6294981|NCT00000920|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6294982|NCT00000920|Protease Inhibitors|protease inhibitors|mesh-ancestor
6294983|NCT00000920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6294984|NCT00000920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6294985|NCT00000920|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6294986|NCT00000920|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6294987|NCT00000920|Antiviral Agents|antiviral agents|mesh-ancestor
6294988|NCT00000920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6294989|NCT00000920|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6294990|NCT00000920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6294991|NCT00000920|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6294992|NCT00000920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6294993|NCT00000920|Antimetabolites|antimetabolites|mesh-ancestor
6294994|NCT00000921|Prednisone|prednisone|mesh-list
6294995|NCT00000921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6294996|NCT00000921|Glucocorticoids|glucocorticoids|mesh-ancestor
6294997|NCT00000921|Hormones|hormones|mesh-ancestor
6294998|NCT00000921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6294999|NCT00000921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6295000|NCT00000921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6295001|NCT00000921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6295002|NCT00000922|Lamivudine|lamivudine|mesh-list
6295003|NCT00000922|Efavirenz|efavirenz|mesh-list
6295004|NCT00000922|Nevirapine|nevirapine|mesh-list
6295005|NCT00000922|Abacavir|abacavir|mesh-list
6295006|NCT00000922|Stavudine|stavudine|mesh-list
6295007|NCT00000922|Didanosine|didanosine|mesh-list
6295008|NCT00000922|Nelfinavir|nelfinavir|mesh-list
6295009|NCT00000922|Indinavir|indinavir|mesh-list
6295010|NCT00000922|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6295011|NCT00000922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6295012|NCT00000922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295013|NCT00000922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295014|NCT00000922|Antiviral Agents|antiviral agents|mesh-ancestor
6295015|NCT00000922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295016|NCT00000922|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6295017|NCT00000922|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6295018|NCT00000922|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6295019|NCT00000922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6295020|NCT00000922|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6295021|NCT00000922|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6295022|NCT00000922|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6295023|NCT00000922|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6295024|NCT00000922|Antimetabolites|antimetabolites|mesh-ancestor
6295025|NCT00000922|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6295026|NCT00000922|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6295027|NCT00000922|Protease Inhibitors|protease inhibitors|mesh-ancestor
6295028|NCT00000923|Lamivudine|lamivudine|mesh-list
6295029|NCT00000923|Zidovudine|zidovudine|mesh-list
6295030|NCT00000923|Stavudine|stavudine|mesh-list
6295031|NCT00000923|Didanosine|didanosine|mesh-list
6295032|NCT00000923|Aldesleukin|aldesleukin|mesh-list
6295033|NCT00000923|Indinavir|indinavir|mesh-list
6295034|NCT00000923|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6295035|NCT00000923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6295036|NCT00000923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295037|NCT00000923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295038|NCT00000923|Antiviral Agents|antiviral agents|mesh-ancestor
6295039|NCT00000923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295040|NCT00000923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6295041|NCT00000923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6295042|NCT00000923|Antimetabolites|antimetabolites|mesh-ancestor
6295043|NCT00000923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6295044|NCT00000923|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6295045|NCT00000923|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6295046|NCT00000923|Protease Inhibitors|protease inhibitors|mesh-ancestor
6295047|NCT00000924|Ritonavir|ritonavir|mesh-list
6295048|NCT00000924|Nelfinavir|nelfinavir|mesh-list
6295049|NCT00000924|Nevirapine|nevirapine|mesh-list
6295050|NCT00000924|Stavudine|stavudine|mesh-list
6295051|NCT00000924|Didanosine|didanosine|mesh-list
6295052|NCT00000924|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6295053|NCT00000924|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6295054|NCT00000924|Protease Inhibitors|protease inhibitors|mesh-ancestor
6295055|NCT00000924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295056|NCT00000924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295057|NCT00000924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6295058|NCT00000924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6295059|NCT00000924|Antiviral Agents|antiviral agents|mesh-ancestor
6295060|NCT00000924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295061|NCT00000924|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6295062|NCT00000924|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6295063|NCT00000924|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6295064|NCT00000924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6295065|NCT00000924|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6295066|NCT00000924|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6295067|NCT00000924|Antimetabolites|antimetabolites|mesh-ancestor
6295068|NCT00000926|Nonoxynol|nonoxynol|mesh-list
6295069|NCT00000926|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
6295070|NCT00000926|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
6295071|NCT00000926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6295072|NCT00000926|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6295073|NCT00000926|Contraceptive Agents|contraceptive agents|mesh-ancestor
6295074|NCT00000926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6295075|NCT00000926|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6295076|NCT00000929|Nonoxynol|nonoxynol|mesh-list
6295077|NCT00000929|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
6295078|NCT00000929|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
6295079|NCT00000929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6295080|NCT00000929|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6295081|NCT00000929|Contraceptive Agents|contraceptive agents|mesh-ancestor
6295082|NCT00000929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6295083|NCT00000929|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6295084|NCT00000935|Immunoglobulins|immunoglobulins|mesh-list
6295085|NCT00000935|Antibodies|antibodies|mesh-list
6295086|NCT00000935|gamma-Globulins|gamma-globulins|mesh-list
6295087|NCT00000935|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6295088|NCT00000935|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6295089|NCT00000935|Immunologic Factors|immunologic factors|mesh-ancestor
6295090|NCT00000935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6295091|NCT00000936|Cyclosporine|cyclosporine|mesh-list
6295092|NCT00000936|Cyclosporins|cyclosporins|mesh-list
6295093|NCT00000936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6397092|NCT00210210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6295094|NCT00000936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295095|NCT00000936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6295096|NCT00000936|Immunologic Factors|immunologic factors|mesh-ancestor
6295097|NCT00000936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6295098|NCT00000936|Antifungal Agents|antifungal agents|mesh-ancestor
6295099|NCT00000936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295100|NCT00000936|Dermatologic Agents|dermatologic agents|mesh-ancestor
6295101|NCT00000936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6295102|NCT00000936|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6295103|NCT00000937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6295104|NCT00000937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295105|NCT00000938|Doxycycline|doxycycline|mesh-list
6295106|NCT00000938|Ceftriaxone|ceftriaxone|mesh-list
6295107|NCT00000938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6295108|NCT00000938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295109|NCT00000938|Antimalarials|antimalarials|mesh-ancestor
6295110|NCT00000938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6295111|NCT00000938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6295112|NCT00000939|Efavirenz|efavirenz|mesh-list
6295113|NCT00000939|Stavudine|stavudine|mesh-list
6295114|NCT00000939|Didanosine|didanosine|mesh-list
6295115|NCT00000939|Hydroxyurea|hydroxyurea|mesh-list
6295116|NCT00000939|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6295117|NCT00000939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6295118|NCT00000939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295119|NCT00000939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295120|NCT00000939|Antiviral Agents|antiviral agents|mesh-ancestor
6295121|NCT00000939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295122|NCT00000939|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6295123|NCT00000939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6295124|NCT00000939|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6295125|NCT00000939|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6295126|NCT00000939|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6295127|NCT00000939|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6295128|NCT00000939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6295129|NCT00000939|Antisickling Agents|antisickling agents|mesh-ancestor
6295130|NCT00000939|Antimetabolites|antimetabolites|mesh-ancestor
6295131|NCT00000939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6295132|NCT00000939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6295133|NCT00000940|Ritonavir|ritonavir|mesh-list
6295134|NCT00000940|Amprenavir|amprenavir|mesh-list
6295135|NCT00000940|Lamivudine|lamivudine|mesh-list
6295136|NCT00000940|Abacavir|abacavir|mesh-list
6295137|NCT00000940|Stavudine|stavudine|mesh-list
6295138|NCT00000940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6295139|NCT00000940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6295140|NCT00000940|Protease Inhibitors|protease inhibitors|mesh-ancestor
6295141|NCT00000940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295142|NCT00000940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295143|NCT00000940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6295144|NCT00000940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6295145|NCT00000940|Antiviral Agents|antiviral agents|mesh-ancestor
6295146|NCT00000940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295147|NCT00000940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6295148|NCT00000940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6295149|NCT00000940|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6295150|NCT00000940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6295151|NCT00000940|Antimetabolites|antimetabolites|mesh-ancestor
6295152|NCT00000940|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6295153|NCT00000940|Antitubercular Agents|antitubercular agents|mesh-ancestor
6295154|NCT00000940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6295155|NCT00000941|Ritonavir|ritonavir|mesh-list
6295156|NCT00000941|Nelfinavir|nelfinavir|mesh-list
6295157|NCT00000941|Saquinavir|saquinavir|mesh-list
6295158|NCT00000941|Atorvastatin|atorvastatin|mesh-list
6295159|NCT00000941|Simvastatin|simvastatin|mesh-list
6295160|NCT00000941|Pravastatin|pravastatin|mesh-list
6295161|NCT00000941|Calcium|calcium|mesh-list
6295162|NCT00000941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6295163|NCT00000941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6295164|NCT00000941|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6295165|NCT00000941|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6295166|NCT00000941|Antimetabolites|antimetabolites|mesh-ancestor
6295167|NCT00000941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295168|NCT00000941|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6295169|NCT00000941|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6295170|NCT00000941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295171|NCT00000941|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6295172|NCT00000941|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6295173|NCT00000941|Protease Inhibitors|protease inhibitors|mesh-ancestor
6295174|NCT00000941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6295175|NCT00000941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6295176|NCT00000941|Antiviral Agents|antiviral agents|mesh-ancestor
6295177|NCT00000941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295178|NCT00000941|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6295179|NCT00000941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6295180|NCT00000942|Nevirapine|nevirapine|mesh-list
6295181|NCT00000942|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6295182|NCT00000942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6295183|NCT00000942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295184|NCT00000942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295185|NCT00000942|Antiviral Agents|antiviral agents|mesh-ancestor
6295186|NCT00000942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295187|NCT00000942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6295188|NCT00000942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6295189|NCT00000942|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6295190|NCT00000942|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6295191|NCT00000943|Vaccines|vaccines|mesh-list
6295192|NCT00000943|Immunologic Factors|immunologic factors|mesh-ancestor
6295193|NCT00000943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6295194|NCT00000944|Lamivudine|lamivudine|mesh-list
6295195|NCT00000944|Zidovudine|zidovudine|mesh-list
6295196|NCT00000944|Indinavir|indinavir|mesh-list
6295197|NCT00000944|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6295198|NCT00000944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6295199|NCT00000944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295200|NCT00000944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295201|NCT00000944|Antiviral Agents|antiviral agents|mesh-ancestor
6295202|NCT00000944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295203|NCT00000944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6295204|NCT00000944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6295205|NCT00000944|Antimetabolites|antimetabolites|mesh-ancestor
6295206|NCT00000944|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6295207|NCT00000944|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6295208|NCT00000944|Protease Inhibitors|protease inhibitors|mesh-ancestor
6295209|NCT00000945|Cidofovir|cidofovir|mesh-list
6295210|NCT00000945|Probenecid|probenecid|mesh-list
6295211|NCT00000945|Uricosuric Agents|uricosuric agents|mesh-ancestor
6295212|NCT00000945|Gout Suppressants|gout suppressants|mesh-ancestor
6295213|NCT00000945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6295214|NCT00000945|Renal Agents|renal agents|mesh-ancestor
6295215|NCT00000945|Antiviral Agents|antiviral agents|mesh-ancestor
6295216|NCT00000945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295217|NCT00000945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295218|NCT00000945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295219|NCT00000946|polysaccharide-K|polysaccharide-k|mesh-list
6295220|NCT00000946|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6295221|NCT00000946|Immunologic Factors|immunologic factors|mesh-ancestor
6295222|NCT00000946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6295223|NCT00000946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6295224|NCT00000946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6295225|NCT00000946|Antiviral Agents|antiviral agents|mesh-ancestor
6295226|NCT00000946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295227|NCT00000946|Interferon Inducers|interferon inducers|mesh-ancestor
6295228|NCT00000946|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6295229|NCT00000946|Protective Agents|protective agents|mesh-ancestor
6295230|NCT00000947|Azithromycin|azithromycin|mesh-list
6295231|NCT00000947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6295232|NCT00000947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295233|NCT00000948|Aldesleukin|aldesleukin|mesh-list
6295234|NCT00000948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6295235|NCT00000948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6295236|NCT00000948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6295237|NCT00000948|Antiviral Agents|antiviral agents|mesh-ancestor
6295238|NCT00000948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295239|NCT00000949|Aldesleukin|aldesleukin|mesh-list
6295240|NCT00000949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6295241|NCT00000949|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6295242|NCT00000949|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6295243|NCT00000949|Antiviral Agents|antiviral agents|mesh-ancestor
6295244|NCT00000949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295245|NCT00000950|Pyridoxine|pyridoxine|mesh-list
6295246|NCT00000950|Vitamin B 6|vitamin b 6|mesh-list
6295247|NCT00000950|Rifampin|rifampin|mesh-list
6295248|NCT00000950|Isoniazid|isoniazid|mesh-list
6295249|NCT00000950|Pyrazinamide|pyrazinamide|mesh-list
6295250|NCT00000950|Ethambutol|ethambutol|mesh-list
6295251|NCT00000950|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6295252|NCT00000950|Antitubercular Agents|antitubercular agents|mesh-ancestor
6295253|NCT00000950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6295254|NCT00000950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295255|NCT00000950|Leprostatic Agents|leprostatic agents|mesh-ancestor
6295256|NCT00000950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6295257|NCT00000950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295258|NCT00000950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295259|NCT00000950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6295260|NCT00000950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6295261|NCT00000950|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6295262|NCT00000950|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6295263|NCT00000950|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6295264|NCT00000950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6295265|NCT00000950|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6295266|NCT00000950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6295267|NCT00000950|Antimetabolites|antimetabolites|mesh-ancestor
6295268|NCT00000950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6295269|NCT00000950|Vitamin B Complex|vitamin b complex|mesh-ancestor
6295270|NCT00000950|Vitamins|vitamins|mesh-ancestor
6295271|NCT00000950|Micronutrients|micronutrients|mesh-ancestor
6295272|NCT00000950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6295273|NCT00000951|Fluconazole|fluconazole|mesh-list
6295274|NCT00000951|Antifungal Agents|antifungal agents|mesh-ancestor
6295275|NCT00000951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295276|NCT00000951|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6295277|NCT00000951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6295278|NCT00000951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295279|NCT00000951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295280|NCT00000951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6295281|NCT00000951|Hormone Antagonists|hormone antagonists|mesh-ancestor
6295282|NCT00000951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6295283|NCT00000951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6295284|NCT00000951|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6295285|NCT00000951|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6295286|NCT00000952|Ritonavir|ritonavir|mesh-list
6295287|NCT00000952|Lamivudine|lamivudine|mesh-list
6295288|NCT00000952|Zidovudine|zidovudine|mesh-list
6295289|NCT00000952|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6295290|NCT00000952|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6295291|NCT00000952|Protease Inhibitors|protease inhibitors|mesh-ancestor
6295292|NCT00000952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295293|NCT00000952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295294|NCT00000952|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6295295|NCT00000952|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6295296|NCT00000952|Antiviral Agents|antiviral agents|mesh-ancestor
6295297|NCT00000952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295298|NCT00000952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6295299|NCT00000952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6295300|NCT00000952|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6295301|NCT00000952|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6295302|NCT00000952|Antimetabolites|antimetabolites|mesh-ancestor
6295303|NCT00000953|Acyclovir|acyclovir|mesh-list
6295304|NCT00000953|Sorivudine|sorivudine|mesh-list
6295305|NCT00000953|Antiviral Agents|antiviral agents|mesh-ancestor
6295306|NCT00000953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295307|NCT00000953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295308|NCT00000953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295309|NCT00000954|Didanosine|didanosine|mesh-list
6295310|NCT00000954|Zalcitabine|zalcitabine|mesh-list
6295311|NCT00000954|Doxorubicin|doxorubicin|mesh-list
6295312|NCT00000954|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6295313|NCT00000954|Bleomycin|bleomycin|mesh-list
6295314|NCT00000954|Vincristine|vincristine|mesh-list
6295315|NCT00000954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6295316|NCT00000954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6295317|NCT00000954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6295318|NCT00000954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6295319|NCT00000954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295320|NCT00000954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295321|NCT00000954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6295322|NCT00000954|Tubulin Modulators|tubulin modulators|mesh-ancestor
6295323|NCT00000954|Antimitotic Agents|antimitotic agents|mesh-ancestor
6295324|NCT00000954|Mitosis Modulators|mitosis modulators|mesh-ancestor
6295325|NCT00000954|Antimetabolites|antimetabolites|mesh-ancestor
6295326|NCT00000954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6295327|NCT00000954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6295328|NCT00000954|Antiviral Agents|antiviral agents|mesh-ancestor
6295329|NCT00000954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295330|NCT00000954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6295331|NCT00000954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6295332|NCT00000959|Pyridoxine|pyridoxine|mesh-list
6295333|NCT00000959|Vitamin B 6|vitamin b 6|mesh-list
6295334|NCT00000959|Isoniazid|isoniazid|mesh-list
6295335|NCT00000959|Antitubercular Agents|antitubercular agents|mesh-ancestor
6295336|NCT00000959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6295337|NCT00000959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295338|NCT00000959|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6295339|NCT00000959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6295340|NCT00000959|Antimetabolites|antimetabolites|mesh-ancestor
6295341|NCT00000959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295342|NCT00000959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6295343|NCT00000959|Vitamin B Complex|vitamin b complex|mesh-ancestor
6295344|NCT00000959|Vitamins|vitamins|mesh-ancestor
6295345|NCT00000959|Micronutrients|micronutrients|mesh-ancestor
6295346|NCT00000959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6295347|NCT00000960|Zidovudine|zidovudine|mesh-list
6295348|NCT00000960|Antimetabolites|antimetabolites|mesh-ancestor
6295349|NCT00000960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295350|NCT00000960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6295351|NCT00000960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6295352|NCT00000960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295353|NCT00000960|Antiviral Agents|antiviral agents|mesh-ancestor
6295354|NCT00000960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295355|NCT00000960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6295356|NCT00000960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6295357|NCT00000961|Zidovudine|zidovudine|mesh-list
6295358|NCT00000961|Immune Sera|immune sera|mesh-list
6295359|NCT00000961|Antimetabolites|antimetabolites|mesh-ancestor
6295360|NCT00000961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295361|NCT00000961|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6295362|NCT00000961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6295363|NCT00000961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295364|NCT00000961|Antiviral Agents|antiviral agents|mesh-ancestor
6295365|NCT00000961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295366|NCT00000961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6295367|NCT00000961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6295368|NCT00000961|Immunologic Factors|immunologic factors|mesh-ancestor
6295369|NCT00000961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6295370|NCT00000962|Nevirapine|nevirapine|mesh-list
6295371|NCT00000962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6295372|NCT00000962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6295373|NCT00000962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295374|NCT00000962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295375|NCT00000962|Antiviral Agents|antiviral agents|mesh-ancestor
6295376|NCT00000962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295377|NCT00000962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6295378|NCT00000962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6295379|NCT00000962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6295380|NCT00000962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6391876|NCT00194727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391877|NCT00194727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391878|NCT00194727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6391879|NCT00194727|Tubulin Modulators|tubulin modulators|mesh-ancestor
6391880|NCT00194727|Antimitotic Agents|antimitotic agents|mesh-ancestor
6391881|NCT00194727|Mitosis Modulators|mitosis modulators|mesh-ancestor
6391882|NCT00194740|Docetaxel|docetaxel|mesh-list
6391883|NCT00194740|Vinorelbine|vinorelbine|mesh-list
6391884|NCT00194740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391885|NCT00194740|Tubulin Modulators|tubulin modulators|mesh-ancestor
6391886|NCT00194740|Antimitotic Agents|antimitotic agents|mesh-ancestor
6391887|NCT00194740|Mitosis Modulators|mitosis modulators|mesh-ancestor
6391888|NCT00194740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391889|NCT00194740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6391890|NCT00194753|Paclitaxel|paclitaxel|mesh-list
6391891|NCT00194753|Cyclophosphamide|cyclophosphamide|mesh-list
6391892|NCT00194753|Doxorubicin|doxorubicin|mesh-list
6391893|NCT00194753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6391894|NCT00194753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391895|NCT00194753|Tubulin Modulators|tubulin modulators|mesh-ancestor
6391896|NCT00194753|Antimitotic Agents|antimitotic agents|mesh-ancestor
6391897|NCT00194753|Mitosis Modulators|mitosis modulators|mesh-ancestor
6391898|NCT00194753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391899|NCT00194753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6391900|NCT00194753|Immunologic Factors|immunologic factors|mesh-ancestor
6391901|NCT00194753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6391902|NCT00194753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6391903|NCT00194753|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6391904|NCT00194753|Alkylating Agents|alkylating agents|mesh-ancestor
6391905|NCT00194753|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6391906|NCT00194753|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6391907|NCT00194753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6391908|NCT00194753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6391909|NCT00194753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6391910|NCT00194766|Temozolomide|temozolomide|mesh-list
6391911|NCT00194766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6391912|NCT00194766|Alkylating Agents|alkylating agents|mesh-ancestor
6391913|NCT00194766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391914|NCT00194766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391915|NCT00194818|Mesalamine|mesalamine|mesh-list
6391916|NCT00194818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6391917|NCT00194818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6391918|NCT00194818|Analgesics|analgesics|mesh-ancestor
6391919|NCT00194818|Sensory System Agents|sensory system agents|mesh-ancestor
6391920|NCT00194818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6391921|NCT00194818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6391922|NCT00194818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6391923|NCT00194818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6391924|NCT00194857|Epoetin Alfa|epoetin alfa|mesh-list
6391925|NCT00194857|Hematinics|hematinics|mesh-ancestor
6391926|NCT00194883|Hormones|hormones|mesh-list
6391927|NCT00194883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6391928|NCT00194883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6391929|NCT00194909|Sildenafil Citrate|sildenafil citrate|mesh-list
6391930|NCT00194909|Vasodilator Agents|vasodilator agents|mesh-ancestor
6391931|NCT00194909|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6295381|NCT00000963|Didanosine|didanosine|mesh-list
6295382|NCT00000963|Antimetabolites|antimetabolites|mesh-ancestor
6295383|NCT00000963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295384|NCT00000963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6295385|NCT00000963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6295386|NCT00000963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295387|NCT00000963|Antiviral Agents|antiviral agents|mesh-ancestor
6295388|NCT00000963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295389|NCT00000963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6295390|NCT00000963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6295391|NCT00000964|Foscarnet|foscarnet|mesh-list
6295392|NCT00000964|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
6295393|NCT00000964|Ranitidine|ranitidine|mesh-list
6295394|NCT00000964|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
6295395|NCT00000964|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6295396|NCT00000964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6295397|NCT00000964|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6295398|NCT00000964|Histamine Antagonists|histamine antagonists|mesh-ancestor
6295399|NCT00000964|Histamine Agents|histamine agents|mesh-ancestor
6295400|NCT00000964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6295401|NCT00000964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295402|NCT00000964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6295403|NCT00000964|Antiviral Agents|antiviral agents|mesh-ancestor
6295404|NCT00000964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295405|NCT00000964|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6295406|NCT00000964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6295407|NCT00000964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295408|NCT00000965|Zidovudine|zidovudine|mesh-list
6295409|NCT00000965|Antimetabolites|antimetabolites|mesh-ancestor
6295410|NCT00000965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295411|NCT00000965|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6295412|NCT00000965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6295413|NCT00000965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295414|NCT00000965|Antiviral Agents|antiviral agents|mesh-ancestor
6295415|NCT00000965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295416|NCT00000965|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6295417|NCT00000965|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6295418|NCT00000966|Leucovorin|leucovorin|mesh-list
6295419|NCT00000966|Azithromycin|azithromycin|mesh-list
6295420|NCT00000966|Pyrimethamine|pyrimethamine|mesh-list
6295421|NCT00000966|Calcium|calcium|mesh-list
6295422|NCT00000966|Levoleucovorin|levoleucovorin|mesh-list
6295423|NCT00000966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6295424|NCT00000966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6295425|NCT00000966|Antidotes|antidotes|mesh-ancestor
6295426|NCT00000966|Protective Agents|protective agents|mesh-ancestor
6295427|NCT00000966|Vitamin B Complex|vitamin b complex|mesh-ancestor
6015498|NCT00357500|Antimetabolites|antimetabolites|mesh-ancestor
6015499|NCT00357500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6015500|NCT00357552|Ritonavir|ritonavir|mesh-list
6015501|NCT00357552|Lopinavir|lopinavir|mesh-list
6015502|NCT00357552|Tenofovir|tenofovir|mesh-list
6015503|NCT00357552|Emtricitabine|emtricitabine|mesh-list
6015504|NCT00357552|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6015505|NCT00357552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6015506|NCT00357552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6015507|NCT00357552|Protease Inhibitors|protease inhibitors|mesh-ancestor
6015508|NCT00357552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295428|NCT00000966|Vitamins|vitamins|mesh-ancestor
6295429|NCT00000966|Micronutrients|micronutrients|mesh-ancestor
6295430|NCT00000966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6295431|NCT00000966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295432|NCT00000966|Antimalarials|antimalarials|mesh-ancestor
6295433|NCT00000966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6295434|NCT00000966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6295435|NCT00000966|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6295436|NCT00000966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295437|NCT00000966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295438|NCT00000967|Interferons|interferons|mesh-list
6295439|NCT00000967|Interferon-alpha|interferon-alpha|mesh-list
6015509|NCT00357552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295440|NCT00000967|Interferon alpha-2|interferon alpha-2|mesh-list
6295441|NCT00000967|Zidovudine|zidovudine|mesh-list
6295442|NCT00000967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6295443|NCT00000967|Antiviral Agents|antiviral agents|mesh-ancestor
6295444|NCT00000967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295445|NCT00000967|Immunologic Factors|immunologic factors|mesh-ancestor
6295446|NCT00000967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6295447|NCT00000967|Antimetabolites|antimetabolites|mesh-ancestor
6295448|NCT00000967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295449|NCT00000967|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6295450|NCT00000967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6295451|NCT00000967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295452|NCT00000967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6295453|NCT00000967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6295454|NCT00000969|Didanosine|didanosine|mesh-list
6295455|NCT00000969|Zalcitabine|zalcitabine|mesh-list
6295456|NCT00000969|Antimetabolites|antimetabolites|mesh-ancestor
6295457|NCT00000969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295458|NCT00000969|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6295459|NCT00000969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6295460|NCT00000969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295461|NCT00000969|Antiviral Agents|antiviral agents|mesh-ancestor
6295462|NCT00000969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295463|NCT00000969|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6295464|NCT00000969|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6295465|NCT00000970|Ganciclovir|ganciclovir|mesh-list
6295466|NCT00000970|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6295467|NCT00000970|Foscarnet|foscarnet|mesh-list
6295468|NCT00000970|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
6295469|NCT00000970|Antiviral Agents|antiviral agents|mesh-ancestor
6295470|NCT00000970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295471|NCT00000970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6295472|NCT00000970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295473|NCT00000970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295474|NCT00000970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6295475|NCT00000971|Zidovudine|zidovudine|mesh-list
6295476|NCT00000971|Didanosine|didanosine|mesh-list
6295477|NCT00000971|Clarithromycin|clarithromycin|mesh-list
6295478|NCT00000971|Antimetabolites|antimetabolites|mesh-ancestor
6295479|NCT00000971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295480|NCT00000971|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6295481|NCT00000971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6295482|NCT00000971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295483|NCT00000971|Antiviral Agents|antiviral agents|mesh-ancestor
6295484|NCT00000971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295485|NCT00000971|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6295486|NCT00000971|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6295487|NCT00000971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6295488|NCT00000971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6295489|NCT00000971|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6295490|NCT00000971|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6295491|NCT00000973|Leucovorin|leucovorin|mesh-list
6295492|NCT00000973|Zidovudine|zidovudine|mesh-list
6295493|NCT00000973|Pyrimethamine|pyrimethamine|mesh-list
6295494|NCT00000973|Calcium|calcium|mesh-list
6295495|NCT00000973|Levoleucovorin|levoleucovorin|mesh-list
6295496|NCT00000973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6295497|NCT00000973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6295498|NCT00000973|Antidotes|antidotes|mesh-ancestor
6295499|NCT00000973|Protective Agents|protective agents|mesh-ancestor
6295500|NCT00000973|Vitamin B Complex|vitamin b complex|mesh-ancestor
6295501|NCT00000973|Vitamins|vitamins|mesh-ancestor
6295502|NCT00000973|Micronutrients|micronutrients|mesh-ancestor
6295503|NCT00000973|Antimetabolites|antimetabolites|mesh-ancestor
6295504|NCT00000973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295505|NCT00000973|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6295506|NCT00000973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6295507|NCT00000973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295508|NCT00000973|Antiviral Agents|antiviral agents|mesh-ancestor
6295509|NCT00000973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295510|NCT00000973|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6295511|NCT00000973|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6295512|NCT00000973|Antimalarials|antimalarials|mesh-ancestor
6295513|NCT00000973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6295514|NCT00000973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6295515|NCT00000973|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6295516|NCT00000974|Pentamidine|pentamidine|mesh-list
6295517|NCT00000974|Antifungal Agents|antifungal agents|mesh-ancestor
6295518|NCT00000974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295519|NCT00000974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6295520|NCT00000974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6295521|NCT00000974|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6295522|NCT00000975|Itraconazole|itraconazole|mesh-list
6295523|NCT00000975|Antifungal Agents|antifungal agents|mesh-ancestor
6295524|NCT00000975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295525|NCT00000975|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6295526|NCT00000975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6295527|NCT00000975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295528|NCT00000975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295529|NCT00000975|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6295530|NCT00000975|Hormone Antagonists|hormone antagonists|mesh-ancestor
6295531|NCT00000975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6295532|NCT00000975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6295533|NCT00000975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6295534|NCT00000976|Zidovudine|zidovudine|mesh-list
6295535|NCT00000976|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
6295536|NCT00000976|Antimetabolites|antimetabolites|mesh-ancestor
6295537|NCT00000976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295538|NCT00000976|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6295539|NCT00000976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6295540|NCT00000976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295541|NCT00000976|Antiviral Agents|antiviral agents|mesh-ancestor
6295542|NCT00000976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295543|NCT00000976|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6295544|NCT00000976|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6295545|NCT00000976|Immunologic Factors|immunologic factors|mesh-ancestor
6295546|NCT00000976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6295547|NCT00000978|Zidovudine|zidovudine|mesh-list
6295548|NCT00000978|Zalcitabine|zalcitabine|mesh-list
6295549|NCT00000978|Antimetabolites|antimetabolites|mesh-ancestor
6295550|NCT00000978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295551|NCT00000978|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6295552|NCT00000978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6295553|NCT00000978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295554|NCT00000978|Antiviral Agents|antiviral agents|mesh-ancestor
6295555|NCT00000978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295556|NCT00000978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6295557|NCT00000978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6295558|NCT00000979|Zidovudine|zidovudine|mesh-list
6295559|NCT00000979|Didanosine|didanosine|mesh-list
6295560|NCT00000979|Antimetabolites|antimetabolites|mesh-ancestor
6295561|NCT00000979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295562|NCT00000979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6295563|NCT00000979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6295564|NCT00000979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295565|NCT00000979|Antiviral Agents|antiviral agents|mesh-ancestor
6295566|NCT00000979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295567|NCT00000979|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6295568|NCT00000979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6295569|NCT00000980|Spiramycin|spiramycin|mesh-list
6295570|NCT00000980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6295571|NCT00000980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295572|NCT00000980|Coccidiostats|coccidiostats|mesh-ancestor
6295573|NCT00000980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6295574|NCT00000980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6295575|NCT00000981|Fiacitabine|fiacitabine|mesh-list
6295576|NCT00000981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6295577|NCT00000981|Antiviral Agents|antiviral agents|mesh-ancestor
6295578|NCT00000981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295579|NCT00000982|Zidovudine|zidovudine|mesh-list
6295580|NCT00000982|Didanosine|didanosine|mesh-list
6295581|NCT00000982|Antimetabolites|antimetabolites|mesh-ancestor
6295582|NCT00000982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295583|NCT00000982|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6295584|NCT00000982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6295585|NCT00000982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295586|NCT00000982|Antiviral Agents|antiviral agents|mesh-ancestor
6295587|NCT00000982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295588|NCT00000982|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6295589|NCT00000982|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6295590|NCT00000983|Zidovudine|zidovudine|mesh-list
6295591|NCT00000983|Antimetabolites|antimetabolites|mesh-ancestor
6295592|NCT00000983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295593|NCT00000983|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6295594|NCT00000983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6295595|NCT00000983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295596|NCT00000983|Antiviral Agents|antiviral agents|mesh-ancestor
6295597|NCT00000983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295598|NCT00000983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6295599|NCT00000983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6295600|NCT00000985|Acyclovir|acyclovir|mesh-list
6295601|NCT00000985|Foscarnet|foscarnet|mesh-list
6295602|NCT00000985|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
6295603|NCT00000985|Vidarabine|vidarabine|mesh-list
6295604|NCT00000985|Antiviral Agents|antiviral agents|mesh-ancestor
6295605|NCT00000985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295606|NCT00000985|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6295607|NCT00000985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6295608|NCT00000985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295609|NCT00000985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295610|NCT00000985|Antimetabolites|antimetabolites|mesh-ancestor
6295611|NCT00000986|Zidovudine|zidovudine|mesh-list
6295612|NCT00000986|Aldesleukin|aldesleukin|mesh-list
6295613|NCT00000986|Antimetabolites|antimetabolites|mesh-ancestor
6295614|NCT00000986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295615|NCT00000986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6295616|NCT00000986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6295617|NCT00000986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295618|NCT00000986|Antiviral Agents|antiviral agents|mesh-ancestor
6295619|NCT00000986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295620|NCT00000986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6295621|NCT00000986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6295622|NCT00000986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6295623|NCT00000987|Zidovudine|zidovudine|mesh-list
6295624|NCT00000987|Doxorubicin|doxorubicin|mesh-list
6295625|NCT00000987|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6295626|NCT00000987|Bleomycin|bleomycin|mesh-list
6295627|NCT00000987|Vincristine|vincristine|mesh-list
6295628|NCT00000987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6295629|NCT00000987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6295630|NCT00000987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6295631|NCT00000987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6295632|NCT00000987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295633|NCT00000987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295634|NCT00000987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6295635|NCT00000987|Tubulin Modulators|tubulin modulators|mesh-ancestor
6295636|NCT00000987|Antimitotic Agents|antimitotic agents|mesh-ancestor
6295637|NCT00000987|Mitosis Modulators|mitosis modulators|mesh-ancestor
6295638|NCT00000987|Antimetabolites|antimetabolites|mesh-ancestor
6295639|NCT00000987|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6295640|NCT00000987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6295641|NCT00000987|Antiviral Agents|antiviral agents|mesh-ancestor
6295642|NCT00000987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295643|NCT00000987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6295644|NCT00000987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6295645|NCT00000988|Stavudine|stavudine|mesh-list
6295646|NCT00000988|Antimetabolites|antimetabolites|mesh-ancestor
6295647|NCT00000988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295648|NCT00000988|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6295649|NCT00000988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6295650|NCT00000988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295651|NCT00000988|Antiviral Agents|antiviral agents|mesh-ancestor
6295652|NCT00000988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295653|NCT00000988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6295654|NCT00000988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6295655|NCT00000989|Zidovudine|zidovudine|mesh-list
6295656|NCT00000989|Ganciclovir|ganciclovir|mesh-list
6295657|NCT00000989|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6295658|NCT00000989|Sargramostim|sargramostim|mesh-list
6295659|NCT00000989|Antimetabolites|antimetabolites|mesh-ancestor
6295660|NCT00000989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295661|NCT00000989|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6295662|NCT00000989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6295663|NCT00000989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295664|NCT00000989|Antiviral Agents|antiviral agents|mesh-ancestor
6295665|NCT00000989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295666|NCT00000989|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6295667|NCT00000989|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6295668|NCT00000989|Immunologic Factors|immunologic factors|mesh-ancestor
6295669|NCT00000989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6295670|NCT00000990|Zidovudine|zidovudine|mesh-list
6295671|NCT00000990|Antimetabolites|antimetabolites|mesh-ancestor
6295672|NCT00000990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295673|NCT00000990|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6295674|NCT00000990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6295675|NCT00000990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295676|NCT00000990|Antiviral Agents|antiviral agents|mesh-ancestor
6295677|NCT00000990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295678|NCT00000990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6295679|NCT00000990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6295680|NCT00000991|Zidovudine|zidovudine|mesh-list
6295681|NCT00000991|Trimethoprim|trimethoprim|mesh-list
6295682|NCT00000991|Sulfamethoxazole|sulfamethoxazole|mesh-list
6295683|NCT00000991|Dapsone|dapsone|mesh-list
6295684|NCT00000991|Pentamidine|pentamidine|mesh-list
6295685|NCT00000991|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6295686|NCT00000991|Antimetabolites|antimetabolites|mesh-ancestor
6295687|NCT00000991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295688|NCT00000991|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6295689|NCT00000991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6295690|NCT00000991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295691|NCT00000991|Antiviral Agents|antiviral agents|mesh-ancestor
6295692|NCT00000991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295693|NCT00000991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6295694|NCT00000991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6295695|NCT00000991|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6295696|NCT00000991|Renal Agents|renal agents|mesh-ancestor
6295697|NCT00000991|Antimalarials|antimalarials|mesh-ancestor
6295698|NCT00000991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6295699|NCT00000991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6295700|NCT00000991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6295701|NCT00000991|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6295702|NCT00000991|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6295703|NCT00000991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6295704|NCT00000991|Leprostatic Agents|leprostatic agents|mesh-ancestor
6295705|NCT00000991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6295706|NCT00000991|Antifungal Agents|antifungal agents|mesh-ancestor
6295707|NCT00000991|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6295708|NCT00000992|Itraconazole|itraconazole|mesh-list
6295709|NCT00000992|Antifungal Agents|antifungal agents|mesh-ancestor
6295710|NCT00000992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295711|NCT00000992|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6295712|NCT00000992|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6295713|NCT00000992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295714|NCT00000992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295715|NCT00000992|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6295716|NCT00000992|Hormone Antagonists|hormone antagonists|mesh-ancestor
6295717|NCT00000992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6295718|NCT00000992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6295719|NCT00000992|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6295720|NCT00000993|Zidovudine|zidovudine|mesh-list
6295721|NCT00000993|Antimetabolites|antimetabolites|mesh-ancestor
6295722|NCT00000993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295723|NCT00000993|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6295724|NCT00000993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6295725|NCT00000993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295726|NCT00000993|Antiviral Agents|antiviral agents|mesh-ancestor
6295727|NCT00000993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295728|NCT00000993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6295729|NCT00000993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6295730|NCT00000994|Zidovudine|zidovudine|mesh-list
6295731|NCT00000994|Antimetabolites|antimetabolites|mesh-ancestor
6295732|NCT00000994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295733|NCT00000994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6295734|NCT00000994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6295735|NCT00000994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295736|NCT00000994|Antiviral Agents|antiviral agents|mesh-ancestor
6295737|NCT00000994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295738|NCT00000994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6295739|NCT00000994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6295740|NCT00000995|Zidovudine|zidovudine|mesh-list
6295741|NCT00000995|Ganciclovir|ganciclovir|mesh-list
6295742|NCT00000995|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6295743|NCT00000995|Antimetabolites|antimetabolites|mesh-ancestor
6295744|NCT00000995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295745|NCT00000995|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6295746|NCT00000995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6295747|NCT00000995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295748|NCT00000995|Antiviral Agents|antiviral agents|mesh-ancestor
6295749|NCT00000995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295750|NCT00000995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6295751|NCT00000995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6295752|NCT00000996|Doxorubicin|doxorubicin|mesh-list
6295753|NCT00000996|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6295754|NCT00000996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6295755|NCT00000996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6295756|NCT00000996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6295757|NCT00000996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6295758|NCT00000996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295759|NCT00000996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295760|NCT00000997|Zalcitabine|zalcitabine|mesh-list
6295761|NCT00000997|Antimetabolites|antimetabolites|mesh-ancestor
6295762|NCT00000997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295763|NCT00000997|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6295764|NCT00000997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6295765|NCT00000997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295766|NCT00000997|Antiviral Agents|antiviral agents|mesh-ancestor
6295767|NCT00000997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295768|NCT00000997|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6295769|NCT00000997|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6295770|NCT00000998|Leucovorin|leucovorin|mesh-list
6295771|NCT00000998|Trimetrexate|trimetrexate|mesh-list
6295772|NCT00000998|Calcium|calcium|mesh-list
6295773|NCT00000998|Levoleucovorin|levoleucovorin|mesh-list
6295774|NCT00000998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6295775|NCT00000998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6295776|NCT00000998|Antidotes|antidotes|mesh-ancestor
6295777|NCT00000998|Protective Agents|protective agents|mesh-ancestor
6295778|NCT00000998|Vitamin B Complex|vitamin b complex|mesh-ancestor
6295779|NCT00000998|Vitamins|vitamins|mesh-ancestor
6295780|NCT00000998|Micronutrients|micronutrients|mesh-ancestor
6295781|NCT00000998|Antifungal Agents|antifungal agents|mesh-ancestor
6295782|NCT00000998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295783|NCT00000998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6295784|NCT00000998|Antimetabolites|antimetabolites|mesh-ancestor
6295785|NCT00000998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295786|NCT00000998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6295787|NCT00000998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6295788|NCT00000998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295789|NCT00000999|Zidovudine|zidovudine|mesh-list
6295790|NCT00000999|Antimetabolites|antimetabolites|mesh-ancestor
6295791|NCT00000999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295792|NCT00000999|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6295793|NCT00000999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6295794|NCT00000999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295795|NCT00000999|Antiviral Agents|antiviral agents|mesh-ancestor
6295796|NCT00000999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295797|NCT00000999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6295798|NCT00000999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6295799|NCT00001000|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
6295800|NCT00001000|Antiviral Agents|antiviral agents|mesh-ancestor
6295801|NCT00001000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295802|NCT00001001|Zidovudine|zidovudine|mesh-list
6295803|NCT00001001|Antimetabolites|antimetabolites|mesh-ancestor
6295804|NCT00001001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295805|NCT00001001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6295806|NCT00001001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6295807|NCT00001001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295808|NCT00001001|Antiviral Agents|antiviral agents|mesh-ancestor
6295809|NCT00001001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295810|NCT00001001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6295811|NCT00001001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6295812|NCT00001002|Zidovudine|zidovudine|mesh-list
6295813|NCT00001002|Foscarnet|foscarnet|mesh-list
6295814|NCT00001002|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
6295815|NCT00001002|Antimetabolites|antimetabolites|mesh-ancestor
6295816|NCT00001002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295817|NCT00001002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6295818|NCT00001002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6295819|NCT00001002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295820|NCT00001002|Antiviral Agents|antiviral agents|mesh-ancestor
6295821|NCT00001002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295822|NCT00001002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6295823|NCT00001002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6295824|NCT00001003|Zidovudine|zidovudine|mesh-list
6295825|NCT00001003|Pentamidine|pentamidine|mesh-list
6295826|NCT00001003|Antimetabolites|antimetabolites|mesh-ancestor
6295827|NCT00001003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295828|NCT00001003|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6295829|NCT00001003|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6295830|NCT00001003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295831|NCT00001003|Antiviral Agents|antiviral agents|mesh-ancestor
6295832|NCT00001003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295833|NCT00001003|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6295834|NCT00001003|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6295835|NCT00001003|Antifungal Agents|antifungal agents|mesh-ancestor
6295836|NCT00001003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6295837|NCT00001003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6295838|NCT00001003|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6295839|NCT00001004|Interferons|interferons|mesh-list
6295840|NCT00001004|Interferon-gamma|interferon-gamma|mesh-list
6295841|NCT00001004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6295842|NCT00001004|Antiviral Agents|antiviral agents|mesh-ancestor
6295843|NCT00001004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295844|NCT00001005|Zidovudine|zidovudine|mesh-list
6295845|NCT00001005|Aldesleukin|aldesleukin|mesh-list
6295846|NCT00001005|Antimetabolites|antimetabolites|mesh-ancestor
6295847|NCT00001005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295848|NCT00001005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6295849|NCT00001005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6295850|NCT00001005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295851|NCT00001005|Antiviral Agents|antiviral agents|mesh-ancestor
6295852|NCT00001005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295853|NCT00001005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6295854|NCT00001005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6295855|NCT00001005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6295856|NCT00001006|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
6295857|NCT00001006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6295858|NCT00001006|Immunologic Factors|immunologic factors|mesh-ancestor
6295859|NCT00001006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6295860|NCT00001006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6295861|NCT00001006|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6295862|NCT00001006|Protective Agents|protective agents|mesh-ancestor
6295863|NCT00001006|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6295864|NCT00001006|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6295865|NCT00001006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295866|NCT00001006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295867|NCT00001006|Antiviral Agents|antiviral agents|mesh-ancestor
6295868|NCT00001006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295869|NCT00001007|Zidovudine|zidovudine|mesh-list
6295870|NCT00001007|Antimetabolites|antimetabolites|mesh-ancestor
6295871|NCT00001007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295872|NCT00001007|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6295873|NCT00001007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6295874|NCT00001007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295875|NCT00001007|Antiviral Agents|antiviral agents|mesh-ancestor
6295876|NCT00001007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295877|NCT00001007|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6295878|NCT00001007|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6295879|NCT00001008|Zidovudine|zidovudine|mesh-list
6295880|NCT00001008|Methadone|methadone|mesh-list
6295881|NCT00001008|Antimetabolites|antimetabolites|mesh-ancestor
6295882|NCT00001008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295883|NCT00001008|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6295884|NCT00001008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6295885|NCT00001008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295886|NCT00001008|Antiviral Agents|antiviral agents|mesh-ancestor
6295887|NCT00001008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295888|NCT00001008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6295889|NCT00001008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6295890|NCT00001008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6295891|NCT00001008|Narcotics|narcotics|mesh-ancestor
6295892|NCT00001008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6295893|NCT00001008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6295894|NCT00001008|Analgesics|analgesics|mesh-ancestor
6295895|NCT00001008|Sensory System Agents|sensory system agents|mesh-ancestor
6295896|NCT00001008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6295897|NCT00001008|Antitussive Agents|antitussive agents|mesh-ancestor
6295898|NCT00001008|Respiratory System Agents|respiratory system agents|mesh-ancestor
6295899|NCT00001009|Dextrans|dextrans|mesh-list
6295900|NCT00001009|Anticoagulants|anticoagulants|mesh-ancestor
6295901|NCT00001009|Plasma Substitutes|plasma substitutes|mesh-ancestor
6295902|NCT00001009|Blood Substitutes|blood substitutes|mesh-ancestor
6295903|NCT00001010|Zidovudine|zidovudine|mesh-list
6295904|NCT00001010|Acyclovir|acyclovir|mesh-list
6295905|NCT00001010|Antimetabolites|antimetabolites|mesh-ancestor
6295906|NCT00001010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295907|NCT00001010|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6295908|NCT00001010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6295909|NCT00001010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295910|NCT00001010|Antiviral Agents|antiviral agents|mesh-ancestor
6295911|NCT00001010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295912|NCT00001010|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6295913|NCT00001010|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6295914|NCT00001011|Zidovudine|zidovudine|mesh-list
6295915|NCT00001011|Antimetabolites|antimetabolites|mesh-ancestor
6295916|NCT00001011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295917|NCT00001011|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6295918|NCT00001011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6295919|NCT00001011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295920|NCT00001011|Antiviral Agents|antiviral agents|mesh-ancestor
6295921|NCT00001011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295922|NCT00001011|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6295923|NCT00001011|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6295924|NCT00001013|Leucovorin|leucovorin|mesh-list
6295925|NCT00001013|Trimethoprim|trimethoprim|mesh-list
6295926|NCT00001013|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6295927|NCT00001013|Sulfamethoxazole|sulfamethoxazole|mesh-list
6295928|NCT00001013|Pentamidine|pentamidine|mesh-list
6295929|NCT00001013|Trimetrexate|trimetrexate|mesh-list
6295930|NCT00001013|Calcium|calcium|mesh-list
6295931|NCT00001013|Levoleucovorin|levoleucovorin|mesh-list
6295932|NCT00001013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6295933|NCT00001013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6295934|NCT00001013|Antidotes|antidotes|mesh-ancestor
6295935|NCT00001013|Protective Agents|protective agents|mesh-ancestor
6295936|NCT00001013|Vitamin B Complex|vitamin b complex|mesh-ancestor
6295937|NCT00001013|Vitamins|vitamins|mesh-ancestor
6015510|NCT00357552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6015511|NCT00357552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6295938|NCT00001013|Micronutrients|micronutrients|mesh-ancestor
6295939|NCT00001013|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6295940|NCT00001013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295941|NCT00001013|Renal Agents|renal agents|mesh-ancestor
6295942|NCT00001013|Antimalarials|antimalarials|mesh-ancestor
6295943|NCT00001013|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6295944|NCT00001013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6295945|NCT00001013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6295946|NCT00001013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295947|NCT00001013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295948|NCT00001013|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6295949|NCT00001013|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6295950|NCT00001013|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6295951|NCT00001013|Antifungal Agents|antifungal agents|mesh-ancestor
6295952|NCT00001013|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6295953|NCT00001013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6295954|NCT00001013|Antimetabolites|antimetabolites|mesh-ancestor
6295955|NCT00001013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6295956|NCT00001013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6295957|NCT00001014|Leucovorin|leucovorin|mesh-list
6295958|NCT00001014|Trimethoprim|trimethoprim|mesh-list
6295959|NCT00001014|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6295960|NCT00001014|Sulfamethoxazole|sulfamethoxazole|mesh-list
6295961|NCT00001014|Trimetrexate|trimetrexate|mesh-list
6295962|NCT00001014|Calcium|calcium|mesh-list
6295963|NCT00001014|Levoleucovorin|levoleucovorin|mesh-list
6295964|NCT00001014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6295965|NCT00001014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6295966|NCT00001014|Antidotes|antidotes|mesh-ancestor
6295967|NCT00001014|Protective Agents|protective agents|mesh-ancestor
6295968|NCT00001014|Vitamin B Complex|vitamin b complex|mesh-ancestor
6015512|NCT00357552|Antiviral Agents|antiviral agents|mesh-ancestor
6015513|NCT00357552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6015514|NCT00357552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6015515|NCT00357552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6015516|NCT00357552|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6295969|NCT00001014|Vitamins|vitamins|mesh-ancestor
6295970|NCT00001014|Micronutrients|micronutrients|mesh-ancestor
6295971|NCT00001014|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6295972|NCT00001014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295973|NCT00001014|Renal Agents|renal agents|mesh-ancestor
6295974|NCT00001014|Antimalarials|antimalarials|mesh-ancestor
6295975|NCT00001014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6295976|NCT00001014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6295977|NCT00001014|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6295978|NCT00001014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6295979|NCT00001014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295980|NCT00001014|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6295981|NCT00001014|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6295982|NCT00001014|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6295983|NCT00001014|Antifungal Agents|antifungal agents|mesh-ancestor
6295984|NCT00001014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6295985|NCT00001014|Antimetabolites|antimetabolites|mesh-ancestor
6295986|NCT00001014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6295987|NCT00001014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6295988|NCT00001015|Ribavirin|ribavirin|mesh-list
6295989|NCT00001015|Antimetabolites|antimetabolites|mesh-ancestor
6295990|NCT00001015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6295991|NCT00001015|Antiviral Agents|antiviral agents|mesh-ancestor
6295992|NCT00001015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6295993|NCT00001016|Leucovorin|leucovorin|mesh-list
6295994|NCT00001016|Trimetrexate|trimetrexate|mesh-list
6295995|NCT00001016|Calcium|calcium|mesh-list
6295996|NCT00001016|Levoleucovorin|levoleucovorin|mesh-list
6295997|NCT00001016|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6295998|NCT00001016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6295999|NCT00001016|Antidotes|antidotes|mesh-ancestor
6296000|NCT00001016|Protective Agents|protective agents|mesh-ancestor
6296001|NCT00001016|Vitamin B Complex|vitamin b complex|mesh-ancestor
6296002|NCT00001016|Vitamins|vitamins|mesh-ancestor
6296003|NCT00001016|Micronutrients|micronutrients|mesh-ancestor
6296004|NCT00001016|Antifungal Agents|antifungal agents|mesh-ancestor
6296005|NCT00001016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296006|NCT00001016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6296007|NCT00001016|Antimetabolites|antimetabolites|mesh-ancestor
6296008|NCT00001016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296009|NCT00001016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6296010|NCT00001016|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6296011|NCT00001016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6296012|NCT00001017|Fluconazole|fluconazole|mesh-list
6296013|NCT00001017|Amphotericin B|amphotericin b|mesh-list
6296014|NCT00001017|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6296015|NCT00001017|Antifungal Agents|antifungal agents|mesh-ancestor
6296016|NCT00001017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296017|NCT00001017|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6296018|NCT00001017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6296019|NCT00001017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6296020|NCT00001017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296021|NCT00001017|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6296022|NCT00001017|Hormone Antagonists|hormone antagonists|mesh-ancestor
6296023|NCT00001017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6296024|NCT00001017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6296025|NCT00001017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6296026|NCT00001017|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6296027|NCT00001017|Amebicides|amebicides|mesh-ancestor
6296028|NCT00001017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6296029|NCT00001017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6296030|NCT00001017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6296031|NCT00001022|Zidovudine|zidovudine|mesh-list
6296032|NCT00001022|Didanosine|didanosine|mesh-list
6296033|NCT00001022|Zalcitabine|zalcitabine|mesh-list
6296034|NCT00001022|Antimetabolites|antimetabolites|mesh-ancestor
6296035|NCT00001022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296036|NCT00001022|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6296037|NCT00001022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6296038|NCT00001022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6296039|NCT00001022|Antiviral Agents|antiviral agents|mesh-ancestor
6296040|NCT00001022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296041|NCT00001022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6296042|NCT00001022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6296043|NCT00001023|Azithromycin|azithromycin|mesh-list
6296044|NCT00001023|Clarithromycin|clarithromycin|mesh-list
6296045|NCT00001023|Rifabutin|rifabutin|mesh-list
6296046|NCT00001023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6296047|NCT00001023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296048|NCT00001023|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6296049|NCT00001023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6296050|NCT00001023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296051|NCT00001023|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6296052|NCT00001023|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6296053|NCT00001023|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6296054|NCT00001023|Antitubercular Agents|antitubercular agents|mesh-ancestor
6296055|NCT00001024|Zidovudine|zidovudine|mesh-list
6296056|NCT00001024|Didanosine|didanosine|mesh-list
6296057|NCT00001024|Antimetabolites|antimetabolites|mesh-ancestor
6296058|NCT00001024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296059|NCT00001024|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6296060|NCT00001024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6296061|NCT00001024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6296062|NCT00001024|Antiviral Agents|antiviral agents|mesh-ancestor
6296063|NCT00001024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296064|NCT00001024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6296065|NCT00001024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6296066|NCT00001025|Zidovudine|zidovudine|mesh-list
6296067|NCT00001025|Didanosine|didanosine|mesh-list
6296068|NCT00001025|Antimetabolites|antimetabolites|mesh-ancestor
6296069|NCT00001025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296070|NCT00001025|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6296071|NCT00001025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6296072|NCT00001025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6296073|NCT00001025|Antiviral Agents|antiviral agents|mesh-ancestor
6296074|NCT00001025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296075|NCT00001025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6296076|NCT00001025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6296077|NCT00001027|Pentamidine|pentamidine|mesh-list
6296078|NCT00001027|Antifungal Agents|antifungal agents|mesh-ancestor
6296079|NCT00001027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296080|NCT00001027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6296081|NCT00001027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6296082|NCT00001027|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6296083|NCT00001028|Dapsone|dapsone|mesh-list
6296084|NCT00001028|Pentamidine|pentamidine|mesh-list
6296085|NCT00001028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296086|NCT00001028|Antimalarials|antimalarials|mesh-ancestor
6296087|NCT00001028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6296088|NCT00001028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6296089|NCT00001028|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6296090|NCT00001028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6296091|NCT00001028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296092|NCT00001028|Leprostatic Agents|leprostatic agents|mesh-ancestor
6296093|NCT00001028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6296094|NCT00001028|Antifungal Agents|antifungal agents|mesh-ancestor
6296095|NCT00001028|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6296096|NCT00001029|Zidovudine|zidovudine|mesh-list
6296097|NCT00001029|Didanosine|didanosine|mesh-list
6296098|NCT00001029|Zalcitabine|zalcitabine|mesh-list
6296099|NCT00001029|Antimetabolites|antimetabolites|mesh-ancestor
6296100|NCT00001029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296101|NCT00001029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6296102|NCT00001029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6296103|NCT00001029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6296104|NCT00001029|Antiviral Agents|antiviral agents|mesh-ancestor
6296105|NCT00001029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296106|NCT00001029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6296107|NCT00001029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6296108|NCT00001030|Clarithromycin|clarithromycin|mesh-list
6296109|NCT00001030|Rifabutin|rifabutin|mesh-list
6296110|NCT00001030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6296111|NCT00001030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296112|NCT00001030|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6296113|NCT00001030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6296114|NCT00001030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296115|NCT00001030|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6296116|NCT00001030|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6296117|NCT00001030|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6296118|NCT00001030|Antitubercular Agents|antitubercular agents|mesh-ancestor
6296119|NCT00001032|Zidovudine|zidovudine|mesh-list
6296120|NCT00001032|Zalcitabine|zalcitabine|mesh-list
6296121|NCT00001032|Antimetabolites|antimetabolites|mesh-ancestor
6296122|NCT00001032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296123|NCT00001032|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6296124|NCT00001032|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6296125|NCT00001032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6296126|NCT00001032|Antiviral Agents|antiviral agents|mesh-ancestor
6296127|NCT00001032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296128|NCT00001032|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6296129|NCT00001032|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6296130|NCT00001033|Pyridoxine|pyridoxine|mesh-list
6296131|NCT00001033|Vitamin B 6|vitamin b 6|mesh-list
6296132|NCT00001033|Levofloxacin|levofloxacin|mesh-list
6296133|NCT00001033|Rifampin|rifampin|mesh-list
6296134|NCT00001033|Isoniazid|isoniazid|mesh-list
6296135|NCT00001033|Pyrazinamide|pyrazinamide|mesh-list
6296136|NCT00001033|Ethambutol|ethambutol|mesh-list
6296137|NCT00001033|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6296138|NCT00001033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296139|NCT00001033|Renal Agents|renal agents|mesh-ancestor
6296140|NCT00001033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6296141|NCT00001033|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6296142|NCT00001033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6296143|NCT00001033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6296144|NCT00001033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296145|NCT00001033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6296146|NCT00001033|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6296147|NCT00001033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6296148|NCT00001033|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6296149|NCT00001033|Antitubercular Agents|antitubercular agents|mesh-ancestor
6296150|NCT00001033|Leprostatic Agents|leprostatic agents|mesh-ancestor
6296151|NCT00001033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6015517|NCT00357552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6015518|NCT00357656|Factor VIII|factor viii|mesh-list
6015519|NCT00357656|Coagulants|coagulants|mesh-ancestor
6015520|NCT00357734|Gefitinib|gefitinib|mesh-list
6015521|NCT00357734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6296152|NCT00001033|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6296153|NCT00001033|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6296154|NCT00001033|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6296155|NCT00001033|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6015522|NCT00357734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6015523|NCT00357734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6015524|NCT00357734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015525|NCT00357760|Aflibercept|aflibercept|mesh-list
6015526|NCT00357760|Endothelial Growth Factors|endothelial growth factors|mesh-list
6296156|NCT00001033|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6296157|NCT00001033|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6296158|NCT00001033|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6296159|NCT00001033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6296160|NCT00001033|Antimetabolites|antimetabolites|mesh-ancestor
6296161|NCT00001033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6296162|NCT00001033|Vitamin B Complex|vitamin b complex|mesh-ancestor
6296163|NCT00001033|Vitamins|vitamins|mesh-ancestor
6296164|NCT00001033|Micronutrients|micronutrients|mesh-ancestor
6296165|NCT00001033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6296166|NCT00001034|Ganciclovir|ganciclovir|mesh-list
6296167|NCT00001034|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6296168|NCT00001034|Antiviral Agents|antiviral agents|mesh-ancestor
6296169|NCT00001034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296170|NCT00001034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6296171|NCT00001034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6296172|NCT00001034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296173|NCT00001035|Interferons|interferons|mesh-list
6296174|NCT00001035|Interferon-alpha|interferon-alpha|mesh-list
6296175|NCT00001035|Interferon alpha-2|interferon alpha-2|mesh-list
6296176|NCT00001035|Zidovudine|zidovudine|mesh-list
6296177|NCT00001035|Didanosine|didanosine|mesh-list
6296178|NCT00001035|Zalcitabine|zalcitabine|mesh-list
6296179|NCT00001035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6296180|NCT00001035|Antiviral Agents|antiviral agents|mesh-ancestor
6296181|NCT00001035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296182|NCT00001035|Immunologic Factors|immunologic factors|mesh-ancestor
6296183|NCT00001035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6296184|NCT00001035|Antimetabolites|antimetabolites|mesh-ancestor
6296185|NCT00001035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296186|NCT00001035|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6296187|NCT00001035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6015527|NCT00357760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6296188|NCT00001035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6296189|NCT00001035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6296190|NCT00001035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6015528|NCT00357760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6296191|NCT00001036|Zidovudine|zidovudine|mesh-list
6296192|NCT00001036|Interleukin-2|interleukin-2|mesh-list
6296193|NCT00001036|Thymalfasin|thymalfasin|mesh-list
6296194|NCT00001036|Antimetabolites|antimetabolites|mesh-ancestor
6296195|NCT00001036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296196|NCT00001036|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6296197|NCT00001036|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6296198|NCT00001036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6296199|NCT00001036|Antiviral Agents|antiviral agents|mesh-ancestor
6296200|NCT00001036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296201|NCT00001036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6296202|NCT00001036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6296203|NCT00001036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6296204|NCT00001036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6296205|NCT00001036|Analgesics|analgesics|mesh-ancestor
6296206|NCT00001036|Sensory System Agents|sensory system agents|mesh-ancestor
6296207|NCT00001036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6296208|NCT00001036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6296209|NCT00001036|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6296210|NCT00001036|Immunologic Factors|immunologic factors|mesh-ancestor
6296211|NCT00001038|Valacyclovir|valacyclovir|mesh-list
6296212|NCT00001038|Acyclovir|acyclovir|mesh-list
6296213|NCT00001038|Antiviral Agents|antiviral agents|mesh-ancestor
6296214|NCT00001038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296215|NCT00001039|Clarithromycin|clarithromycin|mesh-list
6296216|NCT00001039|Ethambutol|ethambutol|mesh-list
6296217|NCT00001039|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6296218|NCT00001039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296219|NCT00001039|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6296220|NCT00001039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6296221|NCT00001039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296222|NCT00001039|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6296223|NCT00001039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6296224|NCT00001039|Antitubercular Agents|antitubercular agents|mesh-ancestor
6296225|NCT00001040|Zidovudine|zidovudine|mesh-list
6296226|NCT00001040|Zalcitabine|zalcitabine|mesh-list
6296227|NCT00001040|Saquinavir|saquinavir|mesh-list
6296228|NCT00001040|Antimetabolites|antimetabolites|mesh-ancestor
6296229|NCT00001040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296230|NCT00001040|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6296231|NCT00001040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6296232|NCT00001040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6296233|NCT00001040|Antiviral Agents|antiviral agents|mesh-ancestor
6296234|NCT00001040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296235|NCT00001040|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6296236|NCT00001040|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6296237|NCT00001040|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6296238|NCT00001040|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6296239|NCT00001040|Protease Inhibitors|protease inhibitors|mesh-ancestor
6296240|NCT00001040|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6296241|NCT00001040|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6296242|NCT00001042|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6296243|NCT00001042|MF59 oil emulsion|mf59 oil emulsion|mesh-list
6296244|NCT00001042|Acetylmuramyl-Alanyl-Isoglutamine|acetylmuramyl-alanyl-isoglutamine|mesh-list
6296245|NCT00001042|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6296246|NCT00001042|Immunologic Factors|immunologic factors|mesh-ancestor
6296247|NCT00001042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6296248|NCT00001042|Antacids|antacids|mesh-ancestor
6296249|NCT00001042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296250|NCT00001042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6296251|NCT00001044|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6296252|NCT00001044|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6296253|NCT00001044|Immunologic Factors|immunologic factors|mesh-ancestor
6296254|NCT00001044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6296255|NCT00001044|Antacids|antacids|mesh-ancestor
6296256|NCT00001044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296257|NCT00001044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6296258|NCT00001045|Zidovudine|zidovudine|mesh-list
6296259|NCT00001045|Nevirapine|nevirapine|mesh-list
6296260|NCT00001045|Didanosine|didanosine|mesh-list
6296261|NCT00001045|Antimetabolites|antimetabolites|mesh-ancestor
6296262|NCT00001045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296263|NCT00001045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6296264|NCT00001045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6296265|NCT00001045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6296266|NCT00001045|Antiviral Agents|antiviral agents|mesh-ancestor
6296267|NCT00001045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296268|NCT00001045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6296269|NCT00001045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6296270|NCT00001045|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6296271|NCT00001045|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6296272|NCT00001047|Clarithromycin|clarithromycin|mesh-list
6296273|NCT00001047|Ethambutol|ethambutol|mesh-list
6296274|NCT00001047|Rifabutin|rifabutin|mesh-list
6296275|NCT00001047|Clofazimine|clofazimine|mesh-list
6296276|NCT00001047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6296277|NCT00001047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296278|NCT00001047|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6296279|NCT00001047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6296280|NCT00001047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296281|NCT00001047|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6296282|NCT00001047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6296283|NCT00001047|Antitubercular Agents|antitubercular agents|mesh-ancestor
6296284|NCT00001047|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6296285|NCT00001047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6296286|NCT00001047|Leprostatic Agents|leprostatic agents|mesh-ancestor
6296287|NCT00001048|Cytarabine|cytarabine|mesh-list
6296288|NCT00001048|Zidovudine|zidovudine|mesh-list
6296289|NCT00001048|Didanosine|didanosine|mesh-list
6296290|NCT00001048|Zalcitabine|zalcitabine|mesh-list
6296291|NCT00001048|Immunologic Factors|immunologic factors|mesh-ancestor
6296292|NCT00001048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6296293|NCT00001048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6296294|NCT00001048|Antimetabolites|antimetabolites|mesh-ancestor
6296295|NCT00001048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296296|NCT00001048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6296297|NCT00001048|Antiviral Agents|antiviral agents|mesh-ancestor
6296298|NCT00001048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296299|NCT00001048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6296300|NCT00001048|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6296301|NCT00001048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6296302|NCT00001048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6296303|NCT00001048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6296304|NCT00001048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6296305|NCT00001049|Zidovudine|zidovudine|mesh-list
6296306|NCT00001049|Didanosine|didanosine|mesh-list
6296307|NCT00001049|Antimetabolites|antimetabolites|mesh-ancestor
6296308|NCT00001049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296309|NCT00001049|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6296310|NCT00001049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6296311|NCT00001049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6296312|NCT00001049|Antiviral Agents|antiviral agents|mesh-ancestor
6296313|NCT00001049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296314|NCT00001049|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6296315|NCT00001049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6296316|NCT00001052|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6296317|NCT00001052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6296318|NCT00001052|Immunologic Factors|immunologic factors|mesh-ancestor
6296319|NCT00001052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6296320|NCT00001052|Antacids|antacids|mesh-ancestor
6296321|NCT00001052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296322|NCT00001052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6296323|NCT00001053|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6296324|NCT00001053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6296325|NCT00001053|Immunologic Factors|immunologic factors|mesh-ancestor
6296326|NCT00001053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6296327|NCT00001053|Antacids|antacids|mesh-ancestor
6296328|NCT00001053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296329|NCT00001053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6296330|NCT00001054|Valacyclovir|valacyclovir|mesh-list
6296331|NCT00001054|Antiviral Agents|antiviral agents|mesh-ancestor
6296332|NCT00001054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296333|NCT00001055|polysaccharide-K|polysaccharide-k|mesh-list
6296334|NCT00001055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6296335|NCT00001055|Immunologic Factors|immunologic factors|mesh-ancestor
6296336|NCT00001055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6296337|NCT00001055|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6296338|NCT00001055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6296339|NCT00001055|Antiviral Agents|antiviral agents|mesh-ancestor
6296340|NCT00001055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296341|NCT00001055|Interferon Inducers|interferon inducers|mesh-ancestor
6296342|NCT00001055|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6296343|NCT00001055|Protective Agents|protective agents|mesh-ancestor
6296344|NCT00001057|Zidovudine|zidovudine|mesh-list
6296345|NCT00001057|Didanosine|didanosine|mesh-list
6296346|NCT00001057|Antimetabolites|antimetabolites|mesh-ancestor
6296347|NCT00001057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296348|NCT00001057|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6296349|NCT00001057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6296350|NCT00001057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6296351|NCT00001057|Antiviral Agents|antiviral agents|mesh-ancestor
6296352|NCT00001057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296353|NCT00001057|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6296354|NCT00001057|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6296355|NCT00001058|Ritonavir|ritonavir|mesh-list
6296356|NCT00001058|Indinavir|indinavir|mesh-list
6296357|NCT00001058|Clarithromycin|clarithromycin|mesh-list
6296358|NCT00001058|Ethambutol|ethambutol|mesh-list
6296359|NCT00001058|Rifabutin|rifabutin|mesh-list
6296360|NCT00001058|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6296361|NCT00001058|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6296362|NCT00001058|Protease Inhibitors|protease inhibitors|mesh-ancestor
6296363|NCT00001058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6296364|NCT00001058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296365|NCT00001058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6296366|NCT00001058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6296367|NCT00001058|Antiviral Agents|antiviral agents|mesh-ancestor
6296368|NCT00001058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296369|NCT00001058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6296370|NCT00001058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6296371|NCT00001058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6296372|NCT00001058|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6296373|NCT00001058|Antitubercular Agents|antitubercular agents|mesh-ancestor
6296374|NCT00001058|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6296375|NCT00001059|Doxorubicin|doxorubicin|mesh-list
6296376|NCT00001059|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6296377|NCT00001059|Bleomycin|bleomycin|mesh-list
6296378|NCT00001059|Vincristine|vincristine|mesh-list
6296379|NCT00001059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6296380|NCT00001059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6296381|NCT00001059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6296382|NCT00001059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6296383|NCT00001059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6296384|NCT00001059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296385|NCT00001059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6296386|NCT00001059|Tubulin Modulators|tubulin modulators|mesh-ancestor
6296387|NCT00001059|Antimitotic Agents|antimitotic agents|mesh-ancestor
6296388|NCT00001059|Mitosis Modulators|mitosis modulators|mesh-ancestor
6296389|NCT00001061|Ganciclovir|ganciclovir|mesh-list
6296390|NCT00001061|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6296391|NCT00001061|Foscarnet|foscarnet|mesh-list
6296392|NCT00001061|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
6296393|NCT00001061|Antiviral Agents|antiviral agents|mesh-ancestor
6296394|NCT00001061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296395|NCT00001061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6296396|NCT00001061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6296397|NCT00001061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296398|NCT00001061|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6296399|NCT00001062|Ganciclovir|ganciclovir|mesh-list
6296400|NCT00001062|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6296401|NCT00001062|Antiviral Agents|antiviral agents|mesh-ancestor
6296402|NCT00001062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296403|NCT00001062|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6296404|NCT00001062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6296405|NCT00001062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296406|NCT00001063|Zidovudine|zidovudine|mesh-list
6296407|NCT00001063|Stavudine|stavudine|mesh-list
6296408|NCT00001063|Didanosine|didanosine|mesh-list
6296409|NCT00001063|Antimetabolites|antimetabolites|mesh-ancestor
6296410|NCT00001063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296411|NCT00001063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6296412|NCT00001063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6296413|NCT00001063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6296414|NCT00001063|Antiviral Agents|antiviral agents|mesh-ancestor
6296415|NCT00001063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296416|NCT00001063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6296417|NCT00001063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6391932|NCT00194909|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6391933|NCT00194909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6391934|NCT00194909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391935|NCT00194909|Urological Agents|urological agents|mesh-ancestor
6391936|NCT00194935|Topotecan|topotecan|mesh-list
6391937|NCT00194935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6391938|NCT00194935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6391939|NCT00194935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6391940|NCT00194935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391941|NCT00194935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391942|NCT00194948|Citalopram|citalopram|mesh-list
6391943|NCT00194948|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6391944|NCT00194948|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6391945|NCT00194948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6391946|NCT00194948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391947|NCT00194948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6391948|NCT00194948|Serotonin Agents|serotonin agents|mesh-ancestor
6296418|NCT00001065|Amphotericin B|amphotericin b|mesh-list
6296419|NCT00001065|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6296420|NCT00001065|Amebicides|amebicides|mesh-ancestor
6296421|NCT00001065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6296422|NCT00001065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6296423|NCT00001065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296424|NCT00001065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6296425|NCT00001065|Antifungal Agents|antifungal agents|mesh-ancestor
6296426|NCT00001066|Lamivudine|lamivudine|mesh-list
6296427|NCT00001066|Zidovudine|zidovudine|mesh-list
6296428|NCT00001066|Didanosine|didanosine|mesh-list
6296429|NCT00001066|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6296430|NCT00001066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6296431|NCT00001066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6296432|NCT00001066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296433|NCT00001066|Antiviral Agents|antiviral agents|mesh-ancestor
6296434|NCT00001066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296435|NCT00001066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6296436|NCT00001066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6296437|NCT00001066|Antimetabolites|antimetabolites|mesh-ancestor
6296438|NCT00001067|Lamivudine|lamivudine|mesh-list
6296439|NCT00001067|Zidovudine|zidovudine|mesh-list
6296440|NCT00001067|Stavudine|stavudine|mesh-list
6296441|NCT00001067|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6296442|NCT00001067|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6296443|NCT00001067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6296444|NCT00001067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296445|NCT00001067|Antiviral Agents|antiviral agents|mesh-ancestor
6296446|NCT00001067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296447|NCT00001067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6296448|NCT00001067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6296449|NCT00001067|Antimetabolites|antimetabolites|mesh-ancestor
6296450|NCT00001068|Lamivudine|lamivudine|mesh-list
6296451|NCT00001068|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6296452|NCT00001068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6296453|NCT00001068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6015529|NCT00357760|Growth Substances|growth substances|mesh-ancestor
6296454|NCT00001068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296455|NCT00001068|Antiviral Agents|antiviral agents|mesh-ancestor
6296456|NCT00001068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296457|NCT00001068|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6015530|NCT00357760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015531|NCT00357760|Growth Inhibitors|growth inhibitors|mesh-ancestor
6015532|NCT00357760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6015533|NCT00357877|Chlorhexidine|chlorhexidine|mesh-list
6015534|NCT00357877|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6015535|NCT00357877|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6015536|NCT00357877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296458|NCT00001068|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6296459|NCT00001070|Ascorbic Acid|ascorbic acid|mesh-list
6296460|NCT00001070|Vitamins|vitamins|mesh-ancestor
6296461|NCT00001070|Micronutrients|micronutrients|mesh-ancestor
6296462|NCT00001070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6296463|NCT00001070|Antioxidants|antioxidants|mesh-ancestor
6296464|NCT00001070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296465|NCT00001070|Protective Agents|protective agents|mesh-ancestor
6296466|NCT00001071|Lenograstim|lenograstim|mesh-list
6296467|NCT00001071|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6296468|NCT00001071|Immunologic Factors|immunologic factors|mesh-ancestor
6296469|NCT00001071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6296470|NCT00001072|polysaccharide-K|polysaccharide-k|mesh-list
6296471|NCT00001072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6296472|NCT00001072|Immunologic Factors|immunologic factors|mesh-ancestor
6296473|NCT00001072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6296474|NCT00001072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6296475|NCT00001072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6296476|NCT00001072|Antiviral Agents|antiviral agents|mesh-ancestor
6296477|NCT00001072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296478|NCT00001072|Interferon Inducers|interferon inducers|mesh-ancestor
6296479|NCT00001072|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6296480|NCT00001072|Protective Agents|protective agents|mesh-ancestor
6296481|NCT00001073|Isotretinoin|isotretinoin|mesh-list
6296482|NCT00001073|Dermatologic Agents|dermatologic agents|mesh-ancestor
6296483|NCT00001074|Didanosine|didanosine|mesh-list
6296484|NCT00001074|Hydroxyurea|hydroxyurea|mesh-list
6296485|NCT00001074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6296486|NCT00001074|Antisickling Agents|antisickling agents|mesh-ancestor
6296487|NCT00001074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6296488|NCT00001074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296489|NCT00001074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6296490|NCT00001074|Antimetabolites|antimetabolites|mesh-ancestor
6296491|NCT00001074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6296492|NCT00001074|Antiviral Agents|antiviral agents|mesh-ancestor
6296493|NCT00001074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296494|NCT00001074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6296495|NCT00001074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6296496|NCT00001075|Ritonavir|ritonavir|mesh-list
6296497|NCT00001075|Lamivudine|lamivudine|mesh-list
6296498|NCT00001075|Zidovudine|zidovudine|mesh-list
6296499|NCT00001075|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6296500|NCT00001075|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6296501|NCT00001075|Protease Inhibitors|protease inhibitors|mesh-ancestor
6296502|NCT00001075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6296503|NCT00001075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296504|NCT00001075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6296505|NCT00001075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6296506|NCT00001075|Antiviral Agents|antiviral agents|mesh-ancestor
6296507|NCT00001075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296508|NCT00001075|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6296509|NCT00001075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6296510|NCT00001075|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6296511|NCT00001075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6296512|NCT00001075|Antimetabolites|antimetabolites|mesh-ancestor
6296513|NCT00001076|polysaccharide-K|polysaccharide-k|mesh-list
6296514|NCT00001076|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6296515|NCT00001076|Immunologic Factors|immunologic factors|mesh-ancestor
6296516|NCT00001076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6296517|NCT00001076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6296518|NCT00001076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6296519|NCT00001076|Antiviral Agents|antiviral agents|mesh-ancestor
6296520|NCT00001076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296521|NCT00001076|Interferon Inducers|interferon inducers|mesh-ancestor
6296522|NCT00001076|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6296523|NCT00001076|Protective Agents|protective agents|mesh-ancestor
6296524|NCT00001079|Methyltestosterone|methyltestosterone|mesh-list
6296525|NCT00001079|Megestrol|megestrol|mesh-list
6296526|NCT00001079|Megestrol Acetate|megestrol acetate|mesh-list
6296527|NCT00001079|Testosterone|testosterone|mesh-list
6296528|NCT00001079|Testosterone undecanoate|testosterone undecanoate|mesh-list
6296529|NCT00001079|Testosterone enanthate|testosterone enanthate|mesh-list
6296530|NCT00001079|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6296531|NCT00001079|Androgens|androgens|mesh-ancestor
6296532|NCT00001079|Hormones|hormones|mesh-ancestor
6296533|NCT00001079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6296534|NCT00001079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6296535|NCT00001079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6296536|NCT00001079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6296537|NCT00001079|Anabolic Agents|anabolic agents|mesh-ancestor
6296538|NCT00001079|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6296539|NCT00001079|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6296540|NCT00001079|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6296541|NCT00001079|Contraceptive Agents|contraceptive agents|mesh-ancestor
6296542|NCT00001079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6296543|NCT00001079|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6296544|NCT00001079|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6296545|NCT00001079|Appetite Stimulants|appetite stimulants|mesh-ancestor
6296546|NCT00001079|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6296547|NCT00001080|Lamivudine|lamivudine|mesh-list
6296548|NCT00001080|Vaccines|vaccines|mesh-list
6296549|NCT00001080|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6296550|NCT00001080|Immunologic Factors|immunologic factors|mesh-ancestor
6296551|NCT00001080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6296552|NCT00001080|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6296553|NCT00001080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6296554|NCT00001080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6296555|NCT00001080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296556|NCT00001080|Antiviral Agents|antiviral agents|mesh-ancestor
6296557|NCT00001080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296558|NCT00001080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6296559|NCT00001080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6296560|NCT00001081|Nitazoxanide|nitazoxanide|mesh-list
6296561|NCT00001081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6296562|NCT00001081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296563|NCT00001082|Adefovir|adefovir|mesh-list
6296564|NCT00001082|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6296565|NCT00001082|Antiviral Agents|antiviral agents|mesh-ancestor
6296566|NCT00001082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296567|NCT00001082|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6296568|NCT00001082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6296569|NCT00001082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6296570|NCT00001082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296571|NCT00001083|Ritonavir|ritonavir|mesh-list
6296572|NCT00001083|Indinavir|indinavir|mesh-list
6296573|NCT00001083|Lamivudine|lamivudine|mesh-list
6296574|NCT00001083|Zidovudine|zidovudine|mesh-list
6296575|NCT00001083|Nevirapine|nevirapine|mesh-list
6296576|NCT00001083|Stavudine|stavudine|mesh-list
6296577|NCT00001083|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6296578|NCT00001083|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6296579|NCT00001083|Protease Inhibitors|protease inhibitors|mesh-ancestor
6296580|NCT00001083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6296581|NCT00001083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296582|NCT00001083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6296583|NCT00001083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6296584|NCT00001083|Antiviral Agents|antiviral agents|mesh-ancestor
6296585|NCT00001083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296586|NCT00001083|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6296587|NCT00001083|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6296588|NCT00001083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6296589|NCT00001083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6296590|NCT00001083|Antimetabolites|antimetabolites|mesh-ancestor
6296591|NCT00001083|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6296592|NCT00001083|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6296593|NCT00001084|Lamivudine|lamivudine|mesh-list
6296594|NCT00001084|Zidovudine|zidovudine|mesh-list
6296595|NCT00001084|Stavudine|stavudine|mesh-list
6296596|NCT00001084|Indinavir|indinavir|mesh-list
6296597|NCT00001084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6296598|NCT00001084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6296599|NCT00001084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6296600|NCT00001084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296601|NCT00001084|Antiviral Agents|antiviral agents|mesh-ancestor
6296602|NCT00001084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296603|NCT00001084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6296604|NCT00001084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6296605|NCT00001084|Antimetabolites|antimetabolites|mesh-ancestor
6296606|NCT00001084|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6296607|NCT00001084|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6296608|NCT00001084|Protease Inhibitors|protease inhibitors|mesh-ancestor
6296609|NCT00001085|Lamivudine|lamivudine|mesh-list
6296610|NCT00001085|Zidovudine|zidovudine|mesh-list
6296611|NCT00001085|Amprenavir|amprenavir|mesh-list
6296612|NCT00001085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6296613|NCT00001085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6296614|NCT00001085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6296615|NCT00001085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296616|NCT00001085|Antiviral Agents|antiviral agents|mesh-ancestor
6296617|NCT00001085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296618|NCT00001085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6296619|NCT00001085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6296620|NCT00001085|Antimetabolites|antimetabolites|mesh-ancestor
6296621|NCT00001085|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6296622|NCT00001085|Antitubercular Agents|antitubercular agents|mesh-ancestor
6296623|NCT00001085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6296624|NCT00001085|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6296625|NCT00001085|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6296626|NCT00001085|Protease Inhibitors|protease inhibitors|mesh-ancestor
6296627|NCT00001086|Efavirenz|efavirenz|mesh-list
6296628|NCT00001086|Abacavir|abacavir|mesh-list
6296629|NCT00001086|Indinavir|indinavir|mesh-list
6296630|NCT00001086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6296631|NCT00001086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6296632|NCT00001086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6296633|NCT00001086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296634|NCT00001086|Antiviral Agents|antiviral agents|mesh-ancestor
6296635|NCT00001086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296636|NCT00001086|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6296637|NCT00001086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6296638|NCT00001086|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6296639|NCT00001086|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6296640|NCT00001086|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6296641|NCT00001086|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6296642|NCT00001086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6296643|NCT00001086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6296644|NCT00001086|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6296645|NCT00001086|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6296646|NCT00001086|Protease Inhibitors|protease inhibitors|mesh-ancestor
6296647|NCT00001087|Ritonavir|ritonavir|mesh-list
6296648|NCT00001087|Nelfinavir|nelfinavir|mesh-list
6296649|NCT00001087|Saquinavir|saquinavir|mesh-list
6296650|NCT00001087|Lamivudine|lamivudine|mesh-list
6296651|NCT00001087|Zidovudine|zidovudine|mesh-list
6296652|NCT00001087|Stavudine|stavudine|mesh-list
6296653|NCT00001087|Didanosine|didanosine|mesh-list
6296654|NCT00001087|Zalcitabine|zalcitabine|mesh-list
6296655|NCT00001087|Efavirenz|efavirenz|mesh-list
6296656|NCT00001087|Adefovir|adefovir|mesh-list
6296657|NCT00001087|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6296658|NCT00001087|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6296659|NCT00001087|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6296660|NCT00001087|Protease Inhibitors|protease inhibitors|mesh-ancestor
6296661|NCT00001087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6296662|NCT00001087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296663|NCT00001087|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6296664|NCT00001087|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6296665|NCT00001087|Antiviral Agents|antiviral agents|mesh-ancestor
6296666|NCT00001087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296667|NCT00001087|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6296668|NCT00001087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6296669|NCT00001087|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6296670|NCT00001087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6296671|NCT00001087|Antimetabolites|antimetabolites|mesh-ancestor
6296672|NCT00001087|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6296673|NCT00001087|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6296674|NCT00001087|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6296675|NCT00001087|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6296676|NCT00001087|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6296677|NCT00001088|Bupivacaine|bupivacaine|mesh-list
6296678|NCT00001088|Anesthetics, Local|anesthetics, local|mesh-ancestor
6296679|NCT00001088|Anesthetics|anesthetics|mesh-ancestor
6296680|NCT00001088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6296681|NCT00001088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6296682|NCT00001088|Sensory System Agents|sensory system agents|mesh-ancestor
6296683|NCT00001088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6296684|NCT00001090|Sargramostim|sargramostim|mesh-list
6296685|NCT00001090|Immunologic Factors|immunologic factors|mesh-ancestor
6296686|NCT00001090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6296687|NCT00001091|Ritonavir|ritonavir|mesh-list
6296688|NCT00001091|Nelfinavir|nelfinavir|mesh-list
6296689|NCT00001091|Lamivudine|lamivudine|mesh-list
6296690|NCT00001091|Nevirapine|nevirapine|mesh-list
6296691|NCT00001091|Stavudine|stavudine|mesh-list
6296692|NCT00001091|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6296693|NCT00001091|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6296694|NCT00001091|Protease Inhibitors|protease inhibitors|mesh-ancestor
6296695|NCT00001091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6296696|NCT00001091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296697|NCT00001091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6296698|NCT00001091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6296699|NCT00001091|Antiviral Agents|antiviral agents|mesh-ancestor
6296700|NCT00001091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296701|NCT00001091|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6296702|NCT00001091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6296703|NCT00001091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6296704|NCT00001091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6296705|NCT00001091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6296706|NCT00001091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6296707|NCT00001091|Antimetabolites|antimetabolites|mesh-ancestor
6296708|NCT00001094|Lamivudine|lamivudine|mesh-list
6296709|NCT00001094|Zidovudine|zidovudine|mesh-list
6296710|NCT00001094|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6296711|NCT00001094|Delavirdine|delavirdine|mesh-list
6296712|NCT00001094|Nelfinavir|nelfinavir|mesh-list
6296713|NCT00001094|Saquinavir|saquinavir|mesh-list
6296714|NCT00001094|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6296715|NCT00001094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6296716|NCT00001094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6296717|NCT00001094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296718|NCT00001094|Antiviral Agents|antiviral agents|mesh-ancestor
6296719|NCT00001094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296720|NCT00001094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6296721|NCT00001094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6296722|NCT00001094|Antimetabolites|antimetabolites|mesh-ancestor
6296723|NCT00001094|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6296724|NCT00001094|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6296725|NCT00001094|Protease Inhibitors|protease inhibitors|mesh-ancestor
6296726|NCT00001094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6296727|NCT00001094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6296728|NCT00001095|Lamivudine|lamivudine|mesh-list
6296729|NCT00001095|Zidovudine|zidovudine|mesh-list
6296730|NCT00001095|Nevirapine|nevirapine|mesh-list
6296731|NCT00001095|Stavudine|stavudine|mesh-list
6296732|NCT00001095|Indinavir|indinavir|mesh-list
6296733|NCT00001095|Amprenavir|amprenavir|mesh-list
6296734|NCT00001095|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6296735|NCT00001095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6296736|NCT00001095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6296737|NCT00001095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296738|NCT00001095|Antiviral Agents|antiviral agents|mesh-ancestor
6296739|NCT00001095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296740|NCT00001095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6296741|NCT00001095|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6296742|NCT00001095|Antimetabolites|antimetabolites|mesh-ancestor
6296743|NCT00001095|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6296744|NCT00001095|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6296745|NCT00001095|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6296746|NCT00001095|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6296747|NCT00001095|Protease Inhibitors|protease inhibitors|mesh-ancestor
6296748|NCT00001095|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6296749|NCT00001095|Antitubercular Agents|antitubercular agents|mesh-ancestor
6296750|NCT00001095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6296751|NCT00001100|Ganciclovir|ganciclovir|mesh-list
6296752|NCT00001100|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6296753|NCT00001100|Antiviral Agents|antiviral agents|mesh-ancestor
6296754|NCT00001100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296755|NCT00001100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6296756|NCT00001100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6296757|NCT00001100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296758|NCT00001101|Doxycycline|doxycycline|mesh-list
6296759|NCT00001101|Ceftriaxone|ceftriaxone|mesh-list
6296760|NCT00001101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6296761|NCT00001101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296762|NCT00001101|Antimalarials|antimalarials|mesh-ancestor
6296763|NCT00001101|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6296764|NCT00001101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6296765|NCT00001104|Zidovudine|zidovudine|mesh-list
6296766|NCT00001104|Antimetabolites|antimetabolites|mesh-ancestor
6296767|NCT00001104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296768|NCT00001104|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6296769|NCT00001104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6296770|NCT00001104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6296771|NCT00001104|Antiviral Agents|antiviral agents|mesh-ancestor
6296772|NCT00001104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296773|NCT00001104|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6296774|NCT00001104|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6296775|NCT00001105|Antibodies|antibodies|mesh-list
6296776|NCT00001105|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6296777|NCT00001105|Immunologic Factors|immunologic factors|mesh-ancestor
6296778|NCT00001105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6296779|NCT00001106|Zidovudine|zidovudine|mesh-list
6296780|NCT00001106|Antimetabolites|antimetabolites|mesh-ancestor
6296781|NCT00001106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296782|NCT00001106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6296783|NCT00001106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6296784|NCT00001106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6296785|NCT00001106|Antiviral Agents|antiviral agents|mesh-ancestor
6296786|NCT00001106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296787|NCT00001106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6296788|NCT00001106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6296789|NCT00001107|Fluconazole|fluconazole|mesh-list
6296790|NCT00001107|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6296791|NCT00001107|Antifungal Agents|antifungal agents|mesh-ancestor
6296792|NCT00001107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296793|NCT00001107|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6296794|NCT00001107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6296795|NCT00001107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6296796|NCT00001107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296797|NCT00001107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6296798|NCT00001107|Hormone Antagonists|hormone antagonists|mesh-ancestor
6296799|NCT00001107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6296800|NCT00001107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6296801|NCT00001107|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6296802|NCT00001107|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6296803|NCT00001107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6296804|NCT00001107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6296805|NCT00001108|Ritonavir|ritonavir|mesh-list
6296806|NCT00001108|Nelfinavir|nelfinavir|mesh-list
6296807|NCT00001108|Saquinavir|saquinavir|mesh-list
6296808|NCT00001108|Lamivudine|lamivudine|mesh-list
6296809|NCT00001108|Nevirapine|nevirapine|mesh-list
6296810|NCT00001108|Stavudine|stavudine|mesh-list
6296811|NCT00001108|Didanosine|didanosine|mesh-list
6296812|NCT00001108|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6296813|NCT00001108|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6296814|NCT00001108|Protease Inhibitors|protease inhibitors|mesh-ancestor
6296815|NCT00001108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6296816|NCT00001108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296817|NCT00001108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6296818|NCT00001108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6296819|NCT00001108|Antiviral Agents|antiviral agents|mesh-ancestor
6296820|NCT00001108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296821|NCT00001108|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6296822|NCT00001108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6296823|NCT00001108|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6296824|NCT00001108|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6296825|NCT00001108|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6296826|NCT00001108|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6296827|NCT00001108|Antimetabolites|antimetabolites|mesh-ancestor
6296828|NCT00001111|Zidovudine|zidovudine|mesh-list
6296829|NCT00001111|Nevirapine|nevirapine|mesh-list
6296830|NCT00001111|Antimetabolites|antimetabolites|mesh-ancestor
6296831|NCT00001111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296832|NCT00001111|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6296833|NCT00001111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6296834|NCT00001111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6296835|NCT00001111|Antiviral Agents|antiviral agents|mesh-ancestor
6296836|NCT00001111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296837|NCT00001111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6296838|NCT00001111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6296839|NCT00001111|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6296840|NCT00001111|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6296841|NCT00001112|Interferons|interferons|mesh-list
6296842|NCT00001112|Zidovudine|zidovudine|mesh-list
6296843|NCT00001112|Interferon-gamma|interferon-gamma|mesh-list
6296844|NCT00001112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6296845|NCT00001112|Antiviral Agents|antiviral agents|mesh-ancestor
6296846|NCT00001112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296847|NCT00001112|Antimetabolites|antimetabolites|mesh-ancestor
6296848|NCT00001112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296849|NCT00001112|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6296850|NCT00001112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6296851|NCT00001112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6296852|NCT00001112|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6296853|NCT00001112|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6296854|NCT00001113|Interferons|interferons|mesh-list
6296855|NCT00001113|Interferon-alpha|interferon-alpha|mesh-list
6296856|NCT00001113|Interferon alpha-2|interferon alpha-2|mesh-list
6296857|NCT00001113|Zidovudine|zidovudine|mesh-list
6296858|NCT00001113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6296859|NCT00001113|Antiviral Agents|antiviral agents|mesh-ancestor
6296860|NCT00001113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296861|NCT00001113|Immunologic Factors|immunologic factors|mesh-ancestor
6296862|NCT00001113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6296863|NCT00001113|Antimetabolites|antimetabolites|mesh-ancestor
6296864|NCT00001113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296865|NCT00001113|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6296866|NCT00001113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6296867|NCT00001113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6296868|NCT00001113|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6296869|NCT00001113|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6296870|NCT00001114|Interferons|interferons|mesh-list
6296871|NCT00001114|Interferon-alpha|interferon-alpha|mesh-list
6296872|NCT00001114|Interferon alpha-2|interferon alpha-2|mesh-list
6296873|NCT00001114|Didanosine|didanosine|mesh-list
6296874|NCT00001114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6296875|NCT00001114|Antiviral Agents|antiviral agents|mesh-ancestor
6296876|NCT00001114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296877|NCT00001114|Immunologic Factors|immunologic factors|mesh-ancestor
6296878|NCT00001114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6296879|NCT00001114|Antimetabolites|antimetabolites|mesh-ancestor
6296880|NCT00001114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296881|NCT00001114|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6296882|NCT00001114|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6296883|NCT00001114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6296884|NCT00001114|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6296885|NCT00001114|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6296886|NCT00001115|Acyclovir|acyclovir|mesh-list
6296887|NCT00001115|Antiviral Agents|antiviral agents|mesh-ancestor
6296888|NCT00001115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296889|NCT00001118|Enfuvirtide|enfuvirtide|mesh-list
6296890|NCT00001118|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6296891|NCT00001118|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6296892|NCT00001118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296893|NCT00001118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6296894|NCT00001118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6296895|NCT00001118|Antiviral Agents|antiviral agents|mesh-ancestor
6296896|NCT00001118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296897|NCT00001119|Ritonavir|ritonavir|mesh-list
6296898|NCT00001119|Indinavir|indinavir|mesh-list
6296899|NCT00001119|Amprenavir|amprenavir|mesh-list
6296900|NCT00001119|Lamivudine|lamivudine|mesh-list
6296901|NCT00001119|Zidovudine|zidovudine|mesh-list
6296902|NCT00001119|Abacavir|abacavir|mesh-list
6296903|NCT00001119|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6296904|NCT00001119|Efavirenz|efavirenz|mesh-list
6296905|NCT00001119|Vaccines|vaccines|mesh-list
6296906|NCT00001119|Immunologic Factors|immunologic factors|mesh-ancestor
6296907|NCT00001119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6296908|NCT00001119|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6296909|NCT00001119|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6296910|NCT00001119|Protease Inhibitors|protease inhibitors|mesh-ancestor
6296911|NCT00001119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6296912|NCT00001119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296913|NCT00001119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6296914|NCT00001119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6296915|NCT00001119|Antiviral Agents|antiviral agents|mesh-ancestor
6296916|NCT00001119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296917|NCT00001119|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6296918|NCT00001119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6296919|NCT00001119|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6296920|NCT00001119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6296921|NCT00001119|Antimetabolites|antimetabolites|mesh-ancestor
6296922|NCT00001119|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6296923|NCT00001119|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6296924|NCT00001119|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6296925|NCT00001119|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6296926|NCT00001119|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6296927|NCT00001119|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6296928|NCT00001119|Antitubercular Agents|antitubercular agents|mesh-ancestor
6296929|NCT00001119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6296930|NCT00001122|Efavirenz|efavirenz|mesh-list
6296931|NCT00001122|Stavudine|stavudine|mesh-list
6296932|NCT00001122|Didanosine|didanosine|mesh-list
6296933|NCT00001122|Nelfinavir|nelfinavir|mesh-list
6296934|NCT00001122|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6296935|NCT00001122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6296936|NCT00001122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6296937|NCT00001122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296938|NCT00001122|Antiviral Agents|antiviral agents|mesh-ancestor
6296939|NCT00001122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296940|NCT00001122|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6296941|NCT00001122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6296942|NCT00001122|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6296943|NCT00001122|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6296944|NCT00001122|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6296945|NCT00001122|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6296946|NCT00001122|Antimetabolites|antimetabolites|mesh-ancestor
6296947|NCT00001122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6296948|NCT00001122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6296949|NCT00001122|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6296950|NCT00001122|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6296951|NCT00001122|Protease Inhibitors|protease inhibitors|mesh-ancestor
6296952|NCT00001123|Ribavirin|ribavirin|mesh-list
6296953|NCT00001123|Antimetabolites|antimetabolites|mesh-ancestor
6296954|NCT00001123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296955|NCT00001123|Antiviral Agents|antiviral agents|mesh-ancestor
6296956|NCT00001123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296957|NCT00001126|Cidofovir|cidofovir|mesh-list
6296958|NCT00001126|Antiviral Agents|antiviral agents|mesh-ancestor
6296959|NCT00001126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296960|NCT00001126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6296961|NCT00001126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296962|NCT00001128|Azithromycin|azithromycin|mesh-list
6296963|NCT00001128|Paromomycin|paromomycin|mesh-list
6296964|NCT00001128|Interleukin-12|interleukin-12|mesh-list
6296965|NCT00001128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6296966|NCT00001128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296967|NCT00001128|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6296968|NCT00001128|Immunologic Factors|immunologic factors|mesh-ancestor
6296969|NCT00001128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6296970|NCT00001128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6296971|NCT00001128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6296972|NCT00001128|Growth Substances|growth substances|mesh-ancestor
6296973|NCT00001128|Growth Inhibitors|growth inhibitors|mesh-ancestor
6296974|NCT00001128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6296975|NCT00001128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6296976|NCT00001128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6296977|NCT00001131|Aldesleukin|aldesleukin|mesh-list
6296978|NCT00001131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6296979|NCT00001131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6296980|NCT00001131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6296981|NCT00001131|Antiviral Agents|antiviral agents|mesh-ancestor
6296982|NCT00001131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296983|NCT00001132|Abacavir|abacavir|mesh-list
6296984|NCT00001132|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6296985|NCT00001132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6296986|NCT00001132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6296987|NCT00001132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296988|NCT00001132|Antiviral Agents|antiviral agents|mesh-ancestor
6296989|NCT00001132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6296990|NCT00001132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6296991|NCT00001132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6296992|NCT00001133|Ritonavir|ritonavir|mesh-list
6296993|NCT00001133|Indinavir|indinavir|mesh-list
6296994|NCT00001133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6296995|NCT00001133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6296996|NCT00001133|Protease Inhibitors|protease inhibitors|mesh-ancestor
6296997|NCT00001133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6296998|NCT00001133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6296999|NCT00001133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6297000|NCT00001133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6297001|NCT00001133|Antiviral Agents|antiviral agents|mesh-ancestor
6297002|NCT00001133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6297003|NCT00001133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6297004|NCT00001133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6297005|NCT00001135|Nevirapine|nevirapine|mesh-list
6015537|NCT00357877|Disinfectants|disinfectants|mesh-ancestor
6015538|NCT00357877|Dermatologic Agents|dermatologic agents|mesh-ancestor
6015539|NCT00357903|Etanercept|etanercept|mesh-list
6015540|NCT00357903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6015541|NCT00357903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6015542|NCT00357903|Analgesics|analgesics|mesh-ancestor
6015543|NCT00357903|Sensory System Agents|sensory system agents|mesh-ancestor
6015544|NCT00357903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6015545|NCT00357903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015546|NCT00357903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6015547|NCT00357903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6297006|NCT00001135|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6297007|NCT00001135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6297008|NCT00001135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6297009|NCT00001135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297010|NCT00001135|Antiviral Agents|antiviral agents|mesh-ancestor
6297011|NCT00001135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6297012|NCT00001135|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6297013|NCT00001135|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6297014|NCT00001135|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6297015|NCT00001135|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6297016|NCT00001146|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
6297017|NCT00001146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6297018|NCT00001146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6297019|NCT00001155|Cyclophosphamide|cyclophosphamide|mesh-list
6297020|NCT00001155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6297021|NCT00001155|Immunologic Factors|immunologic factors|mesh-ancestor
6297022|NCT00001155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297023|NCT00001155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6297024|NCT00001155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6297025|NCT00001155|Alkylating Agents|alkylating agents|mesh-ancestor
6297026|NCT00001155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297027|NCT00001155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297028|NCT00001155|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6297029|NCT00001165|Doxorubicin|doxorubicin|mesh-list
6297030|NCT00001165|Streptozocin|streptozocin|mesh-list
6297031|NCT00001165|Fluorouracil|fluorouracil|mesh-list
6297032|NCT00001165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6297033|NCT00001165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297034|NCT00001165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6297035|NCT00001165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6297036|NCT00001165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6297037|NCT00001165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297038|NCT00001165|Antimetabolites|antimetabolites|mesh-ancestor
6297039|NCT00001165|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6297040|NCT00001165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6297041|NCT00001165|Immunologic Factors|immunologic factors|mesh-ancestor
6297042|NCT00001165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297043|NCT00001180|Hormones|hormones|mesh-list
6297044|NCT00001180|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6297045|NCT00001180|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
6297046|NCT00001180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6297047|NCT00001180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297048|NCT00001181|Testolactone|testolactone|mesh-list
6297049|NCT00001181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6297050|NCT00001181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391949|NCT00194948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6391950|NCT00194948|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6391951|NCT00194948|Antidepressive Agents|antidepressive agents|mesh-ancestor
6391952|NCT00194948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6391953|NCT00194961|Hormones|hormones|mesh-list
6391954|NCT00194961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6391955|NCT00194961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6391956|NCT00194974|Clonidine|clonidine|mesh-list
6391957|NCT00194974|Labetalol|labetalol|mesh-list
6391958|NCT00194974|Methyldopa|methyldopa|mesh-list
6391959|NCT00194974|Nifedipine|nifedipine|mesh-list
6391960|NCT00194974|Analgesics|analgesics|mesh-ancestor
6391961|NCT00194974|Sensory System Agents|sensory system agents|mesh-ancestor
6391962|NCT00194974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6391963|NCT00194974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6391964|NCT00194974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6391965|NCT00194974|Sympatholytics|sympatholytics|mesh-ancestor
6297051|NCT00001190|Deslorelin|deslorelin|mesh-list
6297052|NCT00001190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6297053|NCT00001190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297054|NCT00001191|Omeprazole|omeprazole|mesh-list
6297055|NCT00001191|Pantoprazole|pantoprazole|mesh-list
6297056|NCT00001191|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6297057|NCT00001191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6297058|NCT00001191|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6297059|NCT00001191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6297060|NCT00001191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297061|NCT00001193|Melphalan|melphalan|mesh-list
6297062|NCT00001193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6297063|NCT00001193|Alkylating Agents|alkylating agents|mesh-ancestor
6297064|NCT00001193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297065|NCT00001193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297066|NCT00001193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6297067|NCT00001193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6297068|NCT00001193|Immunologic Factors|immunologic factors|mesh-ancestor
6297069|NCT00001193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297070|NCT00001197|Hydroxyurea|hydroxyurea|mesh-list
6297071|NCT00001197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297072|NCT00001197|Antisickling Agents|antisickling agents|mesh-ancestor
6297073|NCT00001197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6297074|NCT00001197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297075|NCT00001197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6297076|NCT00001202|Testolactone|testolactone|mesh-list
6297077|NCT00001202|Spironolactone|spironolactone|mesh-list
6297078|NCT00001202|Deslorelin|deslorelin|mesh-list
6297079|NCT00001202|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6297080|NCT00001202|Hormone Antagonists|hormone antagonists|mesh-ancestor
6297081|NCT00001202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6297082|NCT00001202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297083|NCT00001202|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6297084|NCT00001202|Diuretics|diuretics|mesh-ancestor
6297085|NCT00001202|Natriuretic Agents|natriuretic agents|mesh-ancestor
6297086|NCT00001202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6297087|NCT00001202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297088|NCT00001202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6297089|NCT00001202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297090|NCT00001209|Cyclophosphamide|cyclophosphamide|mesh-list
6297091|NCT00001209|Ifosfamide|ifosfamide|mesh-list
6297092|NCT00001209|Vincristine|vincristine|mesh-list
6297093|NCT00001209|Doxorubicin|doxorubicin|mesh-list
6297094|NCT00001209|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6297095|NCT00001209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6297096|NCT00001209|Immunologic Factors|immunologic factors|mesh-ancestor
6297097|NCT00001209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297098|NCT00001209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6297099|NCT00001209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6297100|NCT00001209|Alkylating Agents|alkylating agents|mesh-ancestor
6297101|NCT00001209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297102|NCT00001209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297103|NCT00001209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6297104|NCT00001209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6297105|NCT00001209|Tubulin Modulators|tubulin modulators|mesh-ancestor
6297106|NCT00001209|Antimitotic Agents|antimitotic agents|mesh-ancestor
6297107|NCT00001209|Mitosis Modulators|mitosis modulators|mesh-ancestor
6297108|NCT00001209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6297109|NCT00001209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6297110|NCT00001209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6297111|NCT00001209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6297112|NCT00001212|Cyclosporine|cyclosporine|mesh-list
6297113|NCT00001212|Prednisone|prednisone|mesh-list
6297114|NCT00001212|Cyclophosphamide|cyclophosphamide|mesh-list
6297115|NCT00001212|Cyclosporins|cyclosporins|mesh-list
6297116|NCT00001212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6297117|NCT00001212|Immunologic Factors|immunologic factors|mesh-ancestor
6297118|NCT00001212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297119|NCT00001212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6297120|NCT00001212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6297121|NCT00001212|Alkylating Agents|alkylating agents|mesh-ancestor
6297122|NCT00001212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297123|NCT00001212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297124|NCT00001212|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6297125|NCT00001212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6297126|NCT00001212|Glucocorticoids|glucocorticoids|mesh-ancestor
6297127|NCT00001212|Hormones|hormones|mesh-ancestor
6297128|NCT00001212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6297129|NCT00001212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6297130|NCT00001212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6297131|NCT00001212|Antifungal Agents|antifungal agents|mesh-ancestor
6297132|NCT00001212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6297133|NCT00001212|Dermatologic Agents|dermatologic agents|mesh-ancestor
6297134|NCT00001212|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6297135|NCT00001221|Hormones|hormones|mesh-list
6297136|NCT00001221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6297137|NCT00001221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297138|NCT00001228|Interferons|interferons|mesh-list
6297139|NCT00001228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297140|NCT00001228|Antiviral Agents|antiviral agents|mesh-ancestor
6297141|NCT00001228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6297142|NCT00001237|Molgramostim|molgramostim|mesh-list
6297143|NCT00001237|Sargramostim|sargramostim|mesh-list
6297144|NCT00001237|Immunologic Factors|immunologic factors|mesh-ancestor
6297145|NCT00001237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297146|NCT00001237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297147|NCT00001249|Antibodies|antibodies|mesh-list
6297148|NCT00001249|Immunologic Factors|immunologic factors|mesh-ancestor
6297149|NCT00001249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015548|NCT00357903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6015549|NCT00357903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6015550|NCT00357903|Immunologic Factors|immunologic factors|mesh-ancestor
6015551|NCT00357968|Clopidogrel|clopidogrel|mesh-list
6015552|NCT00357968|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6015553|NCT00357968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6015554|NCT00357968|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6015555|NCT00357968|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6015556|NCT00357968|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6015557|NCT00357968|Purinergic Agents|purinergic agents|mesh-ancestor
6015558|NCT00357968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6297150|NCT00001251|Mafosfamide|mafosfamide|mesh-list
6297151|NCT00001251|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6297152|NCT00001251|Immunologic Factors|immunologic factors|mesh-ancestor
6297153|NCT00001251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297154|NCT00001251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297155|NCT00001256|Prednisone|prednisone|mesh-list
6297156|NCT00001256|Methotrexate|methotrexate|mesh-list
6297157|NCT00001256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6297158|NCT00001256|Glucocorticoids|glucocorticoids|mesh-ancestor
6297159|NCT00001256|Hormones|hormones|mesh-ancestor
6297160|NCT00001256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6297161|NCT00001256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297162|NCT00001256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6297163|NCT00001256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297164|NCT00001256|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6297165|NCT00001256|Abortifacient Agents|abortifacient agents|mesh-ancestor
6297166|NCT00001256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6018481|NCT00381004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6297167|NCT00001256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6297168|NCT00001256|Antimetabolites|antimetabolites|mesh-ancestor
6391966|NCT00194974|Autonomic Agents|autonomic agents|mesh-ancestor
6297169|NCT00001256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297170|NCT00001256|Dermatologic Agents|dermatologic agents|mesh-ancestor
6297171|NCT00001256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6297172|NCT00001256|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6297173|NCT00001256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6297174|NCT00001256|Immunologic Factors|immunologic factors|mesh-ancestor
6297175|NCT00001256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6297176|NCT00001256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6297177|NCT00001259|Leuprolide|leuprolide|mesh-list
6297178|NCT00001259|Estradiol|estradiol|mesh-list
6297179|NCT00001259|Progesterone|progesterone|mesh-list
6297180|NCT00001259|Estrogens|estrogens|mesh-ancestor
6297181|NCT00001259|Hormones|hormones|mesh-ancestor
6297182|NCT00001259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6297183|NCT00001259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297184|NCT00001259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6297185|NCT00001259|Progestins|progestins|mesh-ancestor
6297186|NCT00001259|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6297187|NCT00001259|Fertility Agents|fertility agents|mesh-ancestor
6297188|NCT00001259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6297189|NCT00001259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297190|NCT00001261|gamma-Globulins|gamma-globulins|mesh-list
6297191|NCT00001261|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6297192|NCT00001261|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6297193|NCT00001261|Immunologic Factors|immunologic factors|mesh-ancestor
6297194|NCT00001261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297195|NCT00001266|Suramin|suramin|mesh-list
6297196|NCT00001266|Antinematodal Agents|antinematodal agents|mesh-ancestor
6297197|NCT00001266|Anthelmintics|anthelmintics|mesh-ancestor
6297198|NCT00001266|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6297199|NCT00001266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6297200|NCT00001266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297201|NCT00001266|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6297202|NCT00001266|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6297203|NCT00001267|Zidovudine|zidovudine|mesh-list
6297204|NCT00001267|Didanosine|didanosine|mesh-list
6297205|NCT00001267|Antimetabolites|antimetabolites|mesh-ancestor
6297206|NCT00001267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297207|NCT00001267|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6297208|NCT00001267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6297209|NCT00001267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6297210|NCT00001267|Antiviral Agents|antiviral agents|mesh-ancestor
6297211|NCT00001267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6297212|NCT00001267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6297213|NCT00001267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6297214|NCT00001280|Itraconazole|itraconazole|mesh-list
6297215|NCT00001280|Antifungal Agents|antifungal agents|mesh-ancestor
6297216|NCT00001280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6297217|NCT00001280|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6297218|NCT00001280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6297219|NCT00001280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6297220|NCT00001280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297221|NCT00001280|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6297222|NCT00001280|Hormone Antagonists|hormone antagonists|mesh-ancestor
6297223|NCT00001280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6297224|NCT00001280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297225|NCT00001280|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6297226|NCT00001282|Zidovudine|zidovudine|mesh-list
6297227|NCT00001282|Interleukin-2|interleukin-2|mesh-list
6297228|NCT00001282|Antimetabolites|antimetabolites|mesh-ancestor
6297229|NCT00001282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297230|NCT00001282|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6297231|NCT00001282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6297232|NCT00001282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6297233|NCT00001282|Antiviral Agents|antiviral agents|mesh-ancestor
6297234|NCT00001282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6297235|NCT00001282|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6297236|NCT00001282|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6297237|NCT00001282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297238|NCT00001282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6297239|NCT00001282|Analgesics|analgesics|mesh-ancestor
6297240|NCT00001282|Sensory System Agents|sensory system agents|mesh-ancestor
6297241|NCT00001282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6297242|NCT00001282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297243|NCT00001287|Immunoglobulins|immunoglobulins|mesh-list
6297244|NCT00001287|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6297245|NCT00001287|Antibodies|antibodies|mesh-list
6297246|NCT00001287|gamma-Globulins|gamma-globulins|mesh-list
6297247|NCT00001287|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6297248|NCT00001287|Immunologic Factors|immunologic factors|mesh-ancestor
6297249|NCT00001287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297250|NCT00001296|Interferons|interferons|mesh-list
6297251|NCT00001296|Interferon-gamma|interferon-gamma|mesh-list
6297252|NCT00001296|Melphalan|melphalan|mesh-list
6297253|NCT00001296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297254|NCT00001296|Antiviral Agents|antiviral agents|mesh-ancestor
6297255|NCT00001296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6297256|NCT00001296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6297257|NCT00001296|Alkylating Agents|alkylating agents|mesh-ancestor
6297258|NCT00001296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297259|NCT00001296|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6297260|NCT00001296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6297261|NCT00001296|Immunologic Factors|immunologic factors|mesh-ancestor
6297262|NCT00001296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297263|NCT00001300|Doxorubicin|doxorubicin|mesh-list
6297264|NCT00001300|Ifosfamide|ifosfamide|mesh-list
6297265|NCT00001300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6297266|NCT00001300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297267|NCT00001300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6297268|NCT00001300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6297269|NCT00001300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6297270|NCT00001300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297271|NCT00001300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6297272|NCT00001300|Alkylating Agents|alkylating agents|mesh-ancestor
6297273|NCT00001303|Nitric Oxide|nitric oxide|mesh-list
6297274|NCT00001303|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6297275|NCT00001303|Autonomic Agents|autonomic agents|mesh-ancestor
6297276|NCT00001303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6297277|NCT00001303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297278|NCT00001303|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6297279|NCT00001303|Respiratory System Agents|respiratory system agents|mesh-ancestor
6297280|NCT00001303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6297281|NCT00001303|Antioxidants|antioxidants|mesh-ancestor
6297282|NCT00001303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297283|NCT00001303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6297284|NCT00001303|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6297285|NCT00001303|Vasodilator Agents|vasodilator agents|mesh-ancestor
6297286|NCT00001303|Gasotransmitters|gasotransmitters|mesh-ancestor
6297287|NCT00001303|Protective Agents|protective agents|mesh-ancestor
6297288|NCT00001307|Capsaicin|capsaicin|mesh-list
6297289|NCT00001307|Antipruritics|antipruritics|mesh-ancestor
6297290|NCT00001307|Dermatologic Agents|dermatologic agents|mesh-ancestor
6297291|NCT00001307|Sensory System Agents|sensory system agents|mesh-ancestor
6297292|NCT00001307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6297293|NCT00001307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297294|NCT00001311|Heparin|heparin|mesh-list
6297295|NCT00001311|Anticoagulants|anticoagulants|mesh-ancestor
6297296|NCT00001311|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6297297|NCT00001311|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6297298|NCT00001311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297299|NCT00001317|Interferons|interferons|mesh-list
6297300|NCT00001317|Interferon-gamma|interferon-gamma|mesh-list
6297301|NCT00001317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297302|NCT00001317|Antiviral Agents|antiviral agents|mesh-ancestor
6297303|NCT00001317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6297304|NCT00001318|Interferons|interferons|mesh-list
6297305|NCT00001318|Interferon-gamma|interferon-gamma|mesh-list
6297306|NCT00001318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297307|NCT00001318|Antiviral Agents|antiviral agents|mesh-ancestor
6297308|NCT00001318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6297309|NCT00001325|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6297310|NCT00001325|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6297311|NCT00001325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297312|NCT00001328|Ganciclovir|ganciclovir|mesh-list
6297313|NCT00001328|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6297314|NCT00001328|Antiviral Agents|antiviral agents|mesh-ancestor
6297315|NCT00001328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6297316|NCT00001328|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6297317|NCT00001328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6297318|NCT00001328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297319|NCT00001332|Cisplatin|cisplatin|mesh-list
6297320|NCT00001332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297321|NCT00001333|Topotecan|topotecan|mesh-list
6297322|NCT00001333|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6297323|NCT00001333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6297324|NCT00001333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6297325|NCT00001333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297326|NCT00001333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391967|NCT00194974|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6391968|NCT00194974|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6391969|NCT00194974|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6391970|NCT00194974|Adrenergic Agents|adrenergic agents|mesh-ancestor
6391971|NCT00194974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6391972|NCT00194974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391973|NCT00194974|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6391974|NCT00194974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6391975|NCT00194974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6391976|NCT00194974|Vasodilator Agents|vasodilator agents|mesh-ancestor
6391977|NCT00194974|Tocolytic Agents|tocolytic agents|mesh-ancestor
6391978|NCT00194974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6391979|NCT00194974|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6391980|NCT00194974|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6391981|NCT00194974|Sympathomimetics|sympathomimetics|mesh-ancestor
6391982|NCT00194974|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6391983|NCT00194974|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6391984|NCT00195000|Cytarabine|cytarabine|mesh-list
6391985|NCT00195000|Gemtuzumab|gemtuzumab|mesh-list
6391986|NCT00195000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6391987|NCT00195000|Antimetabolites|antimetabolites|mesh-ancestor
6391988|NCT00195000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6391989|NCT00195000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391990|NCT00195000|Antiviral Agents|antiviral agents|mesh-ancestor
6391991|NCT00195000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6391992|NCT00195000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6391993|NCT00195000|Immunologic Factors|immunologic factors|mesh-ancestor
6391994|NCT00195000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6391995|NCT00195000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6391996|NCT00195078|Gefitinib|gefitinib|mesh-list
6391997|NCT00195078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6391998|NCT00195078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6391999|NCT00195078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6392000|NCT00195078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392001|NCT00195091|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
6392002|NCT00195091|Chelating Agents|chelating agents|mesh-ancestor
6392003|NCT00195091|Sequestering Agents|sequestering agents|mesh-ancestor
6392004|NCT00195091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392005|NCT00195091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6392006|NCT00195091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6392007|NCT00195091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6392008|NCT00195091|Growth Substances|growth substances|mesh-ancestor
6392009|NCT00195091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392010|NCT00195091|Growth Inhibitors|growth inhibitors|mesh-ancestor
6392011|NCT00195091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6392012|NCT00195104|Cytarabine|cytarabine|mesh-list
6392013|NCT00195104|Arsenic Trioxide|arsenic trioxide|mesh-list
6297327|NCT00001335|Topotecan|topotecan|mesh-list
6297328|NCT00001335|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6297329|NCT00001335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6297330|NCT00001335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6297331|NCT00001335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297332|NCT00001335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297333|NCT00001339|Doxorubicin|doxorubicin|mesh-list
6297334|NCT00001339|Etoposide|etoposide|mesh-list
6297335|NCT00001339|Vincristine|vincristine|mesh-list
6297336|NCT00001339|Mitotane|mitotane|mesh-list
6297337|NCT00001339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6297338|NCT00001339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297339|NCT00001339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6297340|NCT00001339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6297341|NCT00001339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6297342|NCT00001339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297343|NCT00001339|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6297344|NCT00001339|Tubulin Modulators|tubulin modulators|mesh-ancestor
6297345|NCT00001339|Antimitotic Agents|antimitotic agents|mesh-ancestor
6297346|NCT00001339|Mitosis Modulators|mitosis modulators|mesh-ancestor
6297347|NCT00001339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6297348|NCT00001341|Raltitrexed|raltitrexed|mesh-list
6297349|NCT00001341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6297350|NCT00001341|Antimetabolites|antimetabolites|mesh-ancestor
6297351|NCT00001341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297352|NCT00001341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297353|NCT00001341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6297354|NCT00001341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6297355|NCT00001343|Oxandrolone|oxandrolone|mesh-list
6297356|NCT00001343|Androgens|androgens|mesh-ancestor
6297357|NCT00001343|Hormones|hormones|mesh-ancestor
6297358|NCT00001343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6297359|NCT00001343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297360|NCT00001343|Anabolic Agents|anabolic agents|mesh-ancestor
6297361|NCT00001344|Dextromethorphan|dextromethorphan|mesh-list
6297362|NCT00001344|Antitussive Agents|antitussive agents|mesh-ancestor
6297363|NCT00001344|Respiratory System Agents|respiratory system agents|mesh-ancestor
6297364|NCT00001344|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6297365|NCT00001344|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6297366|NCT00001344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6297367|NCT00001344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297368|NCT00001344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297369|NCT00001354|Zidovudine|zidovudine|mesh-list
6297370|NCT00001354|Interleukin-2|interleukin-2|mesh-list
6297371|NCT00001354|Antimetabolites|antimetabolites|mesh-ancestor
6297372|NCT00001354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297373|NCT00001354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6297374|NCT00001354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6297375|NCT00001354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6297376|NCT00001354|Antiviral Agents|antiviral agents|mesh-ancestor
6297377|NCT00001354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6297378|NCT00001354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6297379|NCT00001354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6297380|NCT00001354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297381|NCT00001354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6297382|NCT00001354|Analgesics|analgesics|mesh-ancestor
6297383|NCT00001354|Sensory System Agents|sensory system agents|mesh-ancestor
6297384|NCT00001354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6297385|NCT00001354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297386|NCT00001357|Interleukin-2|interleukin-2|mesh-list
6297387|NCT00001357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297388|NCT00001357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6297389|NCT00001357|Analgesics|analgesics|mesh-ancestor
6297390|NCT00001357|Sensory System Agents|sensory system agents|mesh-ancestor
6297391|NCT00001357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6297392|NCT00001357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297393|NCT00001359|Penicillins|penicillins|mesh-list
6297394|NCT00001359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6297395|NCT00001359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6297396|NCT00001365|Dextromethorphan|dextromethorphan|mesh-list
6297397|NCT00001365|Antitussive Agents|antitussive agents|mesh-ancestor
6297398|NCT00001365|Respiratory System Agents|respiratory system agents|mesh-ancestor
6297399|NCT00001365|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6297400|NCT00001365|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6297401|NCT00001365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6297402|NCT00001365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297403|NCT00001365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297404|NCT00001378|Fenretinide|fenretinide|mesh-list
6297405|NCT00001378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297406|NCT00001378|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6297407|NCT00001378|Protective Agents|protective agents|mesh-ancestor
6297408|NCT00001378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297409|NCT00001381|Suramin|suramin|mesh-list
6297410|NCT00001381|Antinematodal Agents|antinematodal agents|mesh-ancestor
6297411|NCT00001381|Anthelmintics|anthelmintics|mesh-ancestor
6297412|NCT00001381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6297413|NCT00001381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6297414|NCT00001381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297415|NCT00001381|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6297416|NCT00001381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6297417|NCT00001383|Paclitaxel|paclitaxel|mesh-list
6297418|NCT00001383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6297419|NCT00001383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297420|NCT00001383|Tubulin Modulators|tubulin modulators|mesh-ancestor
6297421|NCT00001383|Antimitotic Agents|antimitotic agents|mesh-ancestor
6297422|NCT00001383|Mitosis Modulators|mitosis modulators|mesh-ancestor
6297423|NCT00001383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297424|NCT00001384|Paclitaxel|paclitaxel|mesh-list
6297425|NCT00001384|Cyclophosphamide|cyclophosphamide|mesh-list
6297426|NCT00001384|Doxorubicin|doxorubicin|mesh-list
6297427|NCT00001384|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6297428|NCT00001384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6297429|NCT00001384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6015559|NCT00357968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297430|NCT00001384|Tubulin Modulators|tubulin modulators|mesh-ancestor
6297431|NCT00001384|Antimitotic Agents|antimitotic agents|mesh-ancestor
6297432|NCT00001384|Mitosis Modulators|mitosis modulators|mesh-ancestor
6297433|NCT00001384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297434|NCT00001384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6297435|NCT00001384|Immunologic Factors|immunologic factors|mesh-ancestor
6297436|NCT00001384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297437|NCT00001384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6297438|NCT00001384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6297439|NCT00001384|Alkylating Agents|alkylating agents|mesh-ancestor
6297440|NCT00001384|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6297441|NCT00001384|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6297442|NCT00001384|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6297443|NCT00001384|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6297444|NCT00001384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6297445|NCT00001387|Paclitaxel|paclitaxel|mesh-list
6297446|NCT00001387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6297447|NCT00001387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297448|NCT00001387|Tubulin Modulators|tubulin modulators|mesh-ancestor
6297449|NCT00001387|Antimitotic Agents|antimitotic agents|mesh-ancestor
6297450|NCT00001387|Mitosis Modulators|mitosis modulators|mesh-ancestor
6297451|NCT00001387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297452|NCT00001407|Interferons|interferons|mesh-list
6297453|NCT00001407|Interferon-gamma|interferon-gamma|mesh-list
6297454|NCT00001407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297455|NCT00001407|Antiviral Agents|antiviral agents|mesh-ancestor
6297456|NCT00001407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6297457|NCT00001409|Interleukin-2|interleukin-2|mesh-list
6297458|NCT00001409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297459|NCT00001409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6297460|NCT00001409|Analgesics|analgesics|mesh-ancestor
6297461|NCT00001409|Sensory System Agents|sensory system agents|mesh-ancestor
6297462|NCT00001409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6297463|NCT00001409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297464|NCT00001421|Methimazole|methimazole|mesh-list
6297465|NCT00001421|Antithyroid Agents|antithyroid agents|mesh-ancestor
6297466|NCT00001421|Hormone Antagonists|hormone antagonists|mesh-ancestor
6297467|NCT00001421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6297468|NCT00001421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297469|NCT00001422|Fludarabine|fludarabine|mesh-list
6297470|NCT00001422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297471|NCT00001426|Paclitaxel|paclitaxel|mesh-list
6297472|NCT00001426|Cyclophosphamide|cyclophosphamide|mesh-list
6297473|NCT00001426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6297474|NCT00001426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297475|NCT00001426|Tubulin Modulators|tubulin modulators|mesh-ancestor
6297476|NCT00001426|Antimitotic Agents|antimitotic agents|mesh-ancestor
6297477|NCT00001426|Mitosis Modulators|mitosis modulators|mesh-ancestor
6297478|NCT00001426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297479|NCT00001426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6297480|NCT00001426|Immunologic Factors|immunologic factors|mesh-ancestor
6297481|NCT00001426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297482|NCT00001426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6297483|NCT00001426|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6297484|NCT00001426|Alkylating Agents|alkylating agents|mesh-ancestor
6297485|NCT00001426|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6297486|NCT00001427|9-aminocamptothecin|9-aminocamptothecin|mesh-list
6297487|NCT00001427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297488|NCT00001428|Fluorouracil|fluorouracil|mesh-list
6297489|NCT00001428|Antimetabolites|antimetabolites|mesh-ancestor
6297490|NCT00001428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297491|NCT00001428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6297492|NCT00001428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297493|NCT00001428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6297494|NCT00001428|Immunologic Factors|immunologic factors|mesh-ancestor
6297495|NCT00001428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297496|NCT00001431|Gemcitabine|gemcitabine|mesh-list
6297497|NCT00001431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6297498|NCT00001431|Antimetabolites|antimetabolites|mesh-ancestor
6297499|NCT00001431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297500|NCT00001431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297501|NCT00001431|Antiviral Agents|antiviral agents|mesh-ancestor
6297502|NCT00001431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6297503|NCT00001431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6297504|NCT00001431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6297505|NCT00001431|Immunologic Factors|immunologic factors|mesh-ancestor
6297506|NCT00001431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297507|NCT00001436|Tamoxifen|tamoxifen|mesh-list
6297508|NCT00001436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6297509|NCT00001436|Hormone Antagonists|hormone antagonists|mesh-ancestor
6297510|NCT00001436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6297511|NCT00001436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297512|NCT00001436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6297513|NCT00001436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297514|NCT00001436|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6297515|NCT00001436|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6297516|NCT00001436|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6297517|NCT00001437|Pentoxifylline|pentoxifylline|mesh-list
6297518|NCT00001437|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6297519|NCT00001437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6297520|NCT00001437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297521|NCT00001437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6297522|NCT00001437|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6297523|NCT00001437|Protective Agents|protective agents|mesh-ancestor
6297524|NCT00001437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297525|NCT00001437|Vasodilator Agents|vasodilator agents|mesh-ancestor
6297526|NCT00001437|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6297527|NCT00001437|Antioxidants|antioxidants|mesh-ancestor
6297528|NCT00001438|Interferon alpha-2|interferon alpha-2|mesh-list
6297529|NCT00001438|Tretinoin|tretinoin|mesh-list
6297530|NCT00001438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297531|NCT00001438|Keratolytic Agents|keratolytic agents|mesh-ancestor
6297532|NCT00001438|Dermatologic Agents|dermatologic agents|mesh-ancestor
6297533|NCT00001438|Antiviral Agents|antiviral agents|mesh-ancestor
6297534|NCT00001438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6297535|NCT00001440|Interleukin-2|interleukin-2|mesh-list
6297536|NCT00001440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297537|NCT00001440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6297538|NCT00001440|Analgesics|analgesics|mesh-ancestor
6297539|NCT00001440|Sensory System Agents|sensory system agents|mesh-ancestor
6297540|NCT00001440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6297541|NCT00001440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297542|NCT00001442|Paclitaxel|paclitaxel|mesh-list
6297543|NCT00001442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6297544|NCT00001442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297545|NCT00001442|Tubulin Modulators|tubulin modulators|mesh-ancestor
6297546|NCT00001442|Antimitotic Agents|antimitotic agents|mesh-ancestor
6297547|NCT00001442|Mitosis Modulators|mitosis modulators|mesh-ancestor
6297548|NCT00001442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297549|NCT00001443|Indinavir|indinavir|mesh-list
6297550|NCT00001443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6297551|NCT00001443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6297552|NCT00001443|Protease Inhibitors|protease inhibitors|mesh-ancestor
6297553|NCT00001443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6297554|NCT00001443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297555|NCT00001443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6297556|NCT00001443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6297557|NCT00001443|Antiviral Agents|antiviral agents|mesh-ancestor
6297558|NCT00001443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6297559|NCT00001444|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
6297560|NCT00001444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297561|NCT00001444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6297562|NCT00001444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6297563|NCT00001444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297564|NCT00001446|Thalidomide|thalidomide|mesh-list
6297565|NCT00001446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6297566|NCT00001446|Immunologic Factors|immunologic factors|mesh-ancestor
6297567|NCT00001446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297568|NCT00001446|Leprostatic Agents|leprostatic agents|mesh-ancestor
6297569|NCT00001446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6297570|NCT00001446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6297571|NCT00001446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6297572|NCT00001446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6297573|NCT00001446|Growth Substances|growth substances|mesh-ancestor
6297574|NCT00001446|Growth Inhibitors|growth inhibitors|mesh-ancestor
6297575|NCT00001446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297576|NCT00001449|Leucovorin|leucovorin|mesh-list
6297577|NCT00001449|Gemcitabine|gemcitabine|mesh-list
6297578|NCT00001449|Floxuridine|floxuridine|mesh-list
6297579|NCT00001449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6297580|NCT00001449|Antimetabolites|antimetabolites|mesh-ancestor
6297581|NCT00001449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297582|NCT00001449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297583|NCT00001449|Antiviral Agents|antiviral agents|mesh-ancestor
6297584|NCT00001449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6297585|NCT00001449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6297586|NCT00001449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6297587|NCT00001449|Immunologic Factors|immunologic factors|mesh-ancestor
6297588|NCT00001449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297589|NCT00001449|Antidotes|antidotes|mesh-ancestor
6297590|NCT00001449|Protective Agents|protective agents|mesh-ancestor
6297591|NCT00001449|Vitamin B Complex|vitamin b complex|mesh-ancestor
6297592|NCT00001449|Vitamins|vitamins|mesh-ancestor
6297593|NCT00001449|Micronutrients|micronutrients|mesh-ancestor
6297594|NCT00001450|Paclitaxel|paclitaxel|mesh-list
6297595|NCT00001450|Cisplatin|cisplatin|mesh-list
6297596|NCT00001450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6297597|NCT00001450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297598|NCT00001450|Tubulin Modulators|tubulin modulators|mesh-ancestor
6297599|NCT00001450|Antimitotic Agents|antimitotic agents|mesh-ancestor
6297600|NCT00001450|Mitosis Modulators|mitosis modulators|mesh-ancestor
6297601|NCT00001450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297602|NCT00001457|Lamivudine|lamivudine|mesh-list
6297603|NCT00001457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6297604|NCT00001457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6297605|NCT00001457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6297606|NCT00001457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297607|NCT00001457|Antiviral Agents|antiviral agents|mesh-ancestor
6297608|NCT00001457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6297609|NCT00001457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6297610|NCT00001457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6297611|NCT00001474|Interleukin-2|interleukin-2|mesh-list
6297612|NCT00001474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297613|NCT00001474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6297614|NCT00001474|Analgesics|analgesics|mesh-ancestor
6297615|NCT00001474|Sensory System Agents|sensory system agents|mesh-ancestor
6297616|NCT00001474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6297617|NCT00001474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297618|NCT00001475|Thalidomide|thalidomide|mesh-list
6297619|NCT00001475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6297620|NCT00001475|Immunologic Factors|immunologic factors|mesh-ancestor
6297621|NCT00001475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297622|NCT00001475|Leprostatic Agents|leprostatic agents|mesh-ancestor
6297623|NCT00001475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6297624|NCT00001475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6297625|NCT00001475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6297626|NCT00001475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6297627|NCT00001475|Growth Substances|growth substances|mesh-ancestor
6297628|NCT00001475|Growth Inhibitors|growth inhibitors|mesh-ancestor
6297629|NCT00001475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6392014|NCT00195104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6392015|NCT00195104|Antimetabolites|antimetabolites|mesh-ancestor
6392016|NCT00195104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392017|NCT00195104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6392018|NCT00195104|Antiviral Agents|antiviral agents|mesh-ancestor
6392019|NCT00195104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6392020|NCT00195104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6392021|NCT00195104|Immunologic Factors|immunologic factors|mesh-ancestor
6392022|NCT00195104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392023|NCT00195156|Valproic Acid|valproic acid|mesh-list
6392024|NCT00195156|Anticonvulsants|anticonvulsants|mesh-ancestor
6392025|NCT00195156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6392026|NCT00195156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392027|NCT00195156|GABA Agents|gaba agents|mesh-ancestor
6392028|NCT00195156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6392029|NCT00195156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392030|NCT00195156|Antimanic Agents|antimanic agents|mesh-ancestor
6392031|NCT00195156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6392032|NCT00195156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6392033|NCT00195156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6392034|NCT00195195|Sirolimus|sirolimus|mesh-list
6392035|NCT00195195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6392036|NCT00195195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6392037|NCT00195195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6392038|NCT00195195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6392039|NCT00195195|Antifungal Agents|antifungal agents|mesh-ancestor
6392040|NCT00195195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6392041|NCT00195195|Immunologic Factors|immunologic factors|mesh-ancestor
6392042|NCT00195195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392043|NCT00195208|Pantoprazole|pantoprazole|mesh-list
6392044|NCT00195208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6392045|NCT00195208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6392046|NCT00195208|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6392047|NCT00195208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6392048|NCT00195208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392049|NCT00195286|Tazobactam|tazobactam|mesh-list
6392050|NCT00195286|Piperacillin|piperacillin|mesh-list
6392051|NCT00195286|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
6392052|NCT00195286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6392053|NCT00195286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6392054|NCT00195286|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6297630|NCT00001482|Lamotrigine|lamotrigine|mesh-list
6297631|NCT00001482|Gabapentin|gabapentin|mesh-list
6297632|NCT00001482|Analgesics|analgesics|mesh-ancestor
6297633|NCT00001482|Sensory System Agents|sensory system agents|mesh-ancestor
6297634|NCT00001482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6297635|NCT00001482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297636|NCT00001482|Anticonvulsants|anticonvulsants|mesh-ancestor
6297637|NCT00001482|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6297638|NCT00001482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6297639|NCT00001482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6297640|NCT00001482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6297641|NCT00001482|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6297642|NCT00001482|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6297643|NCT00001482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6297644|NCT00001482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297645|NCT00001482|Antimanic Agents|antimanic agents|mesh-ancestor
6297646|NCT00001482|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6297647|NCT00001482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6297648|NCT00001482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6297649|NCT00001482|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6297650|NCT00001482|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6297651|NCT00001483|Sertraline|sertraline|mesh-list
6297652|NCT00001483|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6297653|NCT00001483|Bupropion|bupropion|mesh-list
6297654|NCT00001483|Antidepressive Agents|antidepressive agents|mesh-ancestor
6297655|NCT00001483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6297656|NCT00001483|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6297657|NCT00001483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6297658|NCT00001483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6297659|NCT00001483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297660|NCT00001483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6297661|NCT00001483|Serotonin Agents|serotonin agents|mesh-ancestor
6297662|NCT00001483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297663|NCT00001483|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6297664|NCT00001483|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6297665|NCT00001483|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6297666|NCT00001483|Dopamine Agents|dopamine agents|mesh-ancestor
6297667|NCT00001483|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6297668|NCT00001483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6297669|NCT00001483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6297670|NCT00001487|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
6297671|NCT00001487|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6297672|NCT00001487|Immunologic Factors|immunologic factors|mesh-ancestor
6297673|NCT00001487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297674|NCT00001495|Irinotecan|irinotecan|mesh-list
6297675|NCT00001495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6297676|NCT00001495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6297677|NCT00001495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6297678|NCT00001495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297679|NCT00001495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297680|NCT00001498|Leucovorin|leucovorin|mesh-list
6297681|NCT00001498|Paclitaxel|paclitaxel|mesh-list
6297682|NCT00001498|Cyclophosphamide|cyclophosphamide|mesh-list
6297683|NCT00001498|Doxorubicin|doxorubicin|mesh-list
6297684|NCT00001498|Fluorouracil|fluorouracil|mesh-list
6297685|NCT00001498|Methotrexate|methotrexate|mesh-list
6297686|NCT00001498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6297687|NCT00001498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297688|NCT00001498|Tubulin Modulators|tubulin modulators|mesh-ancestor
5724198|NCT03188471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6297689|NCT00001498|Antimitotic Agents|antimitotic agents|mesh-ancestor
6297690|NCT00001498|Mitosis Modulators|mitosis modulators|mesh-ancestor
6297691|NCT00001498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297692|NCT00001498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6297693|NCT00001498|Immunologic Factors|immunologic factors|mesh-ancestor
6297694|NCT00001498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297695|NCT00001498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6297696|NCT00001498|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6297697|NCT00001498|Alkylating Agents|alkylating agents|mesh-ancestor
6297698|NCT00001498|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6297699|NCT00001498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6297700|NCT00001498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6297701|NCT00001498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6297702|NCT00001498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6297703|NCT00001498|Antimetabolites|antimetabolites|mesh-ancestor
6297704|NCT00001498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6297705|NCT00001498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6297706|NCT00001498|Abortifacient Agents|abortifacient agents|mesh-ancestor
6297707|NCT00001498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6297708|NCT00001498|Dermatologic Agents|dermatologic agents|mesh-ancestor
6297709|NCT00001498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6297710|NCT00001498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6297711|NCT00001498|Antidotes|antidotes|mesh-ancestor
6297712|NCT00001498|Protective Agents|protective agents|mesh-ancestor
6297713|NCT00001498|Vitamin B Complex|vitamin b complex|mesh-ancestor
6297714|NCT00001498|Vitamins|vitamins|mesh-ancestor
6297715|NCT00001498|Micronutrients|micronutrients|mesh-ancestor
6297716|NCT00001499|Paclitaxel|paclitaxel|mesh-list
6297717|NCT00001499|Cisplatin|cisplatin|mesh-list
6297718|NCT00001499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6297719|NCT00001499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297720|NCT00001499|Tubulin Modulators|tubulin modulators|mesh-ancestor
6297721|NCT00001499|Antimitotic Agents|antimitotic agents|mesh-ancestor
6297722|NCT00001499|Mitosis Modulators|mitosis modulators|mesh-ancestor
6297723|NCT00001499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297724|NCT00001502|Carboplatin|carboplatin|mesh-list
6297725|NCT00001502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297726|NCT00001504|Tretinoin|tretinoin|mesh-list
6297727|NCT00001504|Alitretinoin|alitretinoin|mesh-list
6297728|NCT00001504|Isotretinoin|isotretinoin|mesh-list
6297729|NCT00001504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297730|NCT00001504|Keratolytic Agents|keratolytic agents|mesh-ancestor
6297731|NCT00001504|Dermatologic Agents|dermatologic agents|mesh-ancestor
6297732|NCT00001507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6297733|NCT00001507|Antibodies|antibodies|mesh-list
6297734|NCT00001507|Immunoglobulins|immunoglobulins|mesh-list
6297735|NCT00001507|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6297736|NCT00001507|Immunologic Factors|immunologic factors|mesh-ancestor
6297737|NCT00001507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297738|NCT00001507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297739|NCT00001509|Tretinoin|tretinoin|mesh-list
6297740|NCT00001509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297741|NCT00001509|Keratolytic Agents|keratolytic agents|mesh-ancestor
6297742|NCT00001509|Dermatologic Agents|dermatologic agents|mesh-ancestor
6297743|NCT00001520|Neostigmine|neostigmine|mesh-list
6297744|NCT00001520|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6297745|NCT00001520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6297746|NCT00001520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297747|NCT00001520|Cholinergic Agents|cholinergic agents|mesh-ancestor
6297748|NCT00001520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6297749|NCT00001520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297750|NCT00001520|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6297751|NCT00001520|Autonomic Agents|autonomic agents|mesh-ancestor
6297752|NCT00001520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6297753|NCT00001524|Thalidomide|thalidomide|mesh-list
6297754|NCT00001524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6297755|NCT00001524|Immunologic Factors|immunologic factors|mesh-ancestor
6297756|NCT00001524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297757|NCT00001524|Leprostatic Agents|leprostatic agents|mesh-ancestor
6297758|NCT00001524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6297759|NCT00001524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6297760|NCT00001524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6297761|NCT00001524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6297762|NCT00001524|Growth Substances|growth substances|mesh-ancestor
6297763|NCT00001524|Growth Inhibitors|growth inhibitors|mesh-ancestor
6297764|NCT00001524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297765|NCT00001526|Daclizumab|daclizumab|mesh-list
6297766|NCT00001526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6297767|NCT00001526|Immunologic Factors|immunologic factors|mesh-ancestor
6297768|NCT00001526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297769|NCT00001533|Cyclosporine|cyclosporine|mesh-list
6297770|NCT00001533|Cyclosporins|cyclosporins|mesh-list
6297771|NCT00001533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6297772|NCT00001533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297773|NCT00001533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6297774|NCT00001533|Immunologic Factors|immunologic factors|mesh-ancestor
6297775|NCT00001533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297776|NCT00001533|Antifungal Agents|antifungal agents|mesh-ancestor
6297777|NCT00001533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6297778|NCT00001533|Dermatologic Agents|dermatologic agents|mesh-ancestor
6297779|NCT00001533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6297780|NCT00001533|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6297781|NCT00001534|Losartan|losartan|mesh-list
6297782|NCT00001534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6297783|NCT00001534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6297784|NCT00001534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6297785|NCT00001534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6297786|NCT00001534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297787|NCT00001535|Interleukin-2|interleukin-2|mesh-list
6297788|NCT00001535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297789|NCT00001535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6297790|NCT00001535|Analgesics|analgesics|mesh-ancestor
6297791|NCT00001535|Sensory System Agents|sensory system agents|mesh-ancestor
6297792|NCT00001535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6297793|NCT00001535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297794|NCT00001542|Fluconazole|fluconazole|mesh-list
6297795|NCT00001542|Antifungal Agents|antifungal agents|mesh-ancestor
6297796|NCT00001542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6297797|NCT00001542|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6297798|NCT00001542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6297799|NCT00001542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6297800|NCT00001542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297801|NCT00001542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6297802|NCT00001542|Hormone Antagonists|hormone antagonists|mesh-ancestor
6297803|NCT00001542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6297804|NCT00001542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297805|NCT00001542|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6297806|NCT00001542|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6297807|NCT00001561|Immunoglobulins|immunoglobulins|mesh-list
6297808|NCT00001561|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6297809|NCT00001561|Antibodies|antibodies|mesh-list
6297810|NCT00001561|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
6297811|NCT00001561|Immunologic Factors|immunologic factors|mesh-ancestor
6297812|NCT00001561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297813|NCT00001565|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
6297814|NCT00001565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297815|NCT00001567|Interferon alpha-2|interferon alpha-2|mesh-list
6297816|NCT00001567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297817|NCT00001567|Antiviral Agents|antiviral agents|mesh-ancestor
6297818|NCT00001567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6297819|NCT00001568|Deoxyglucose|deoxyglucose|mesh-list
6297820|NCT00001568|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6297821|NCT00001568|Antimetabolites|antimetabolites|mesh-ancestor
6297822|NCT00001568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297823|NCT00001568|Antiviral Agents|antiviral agents|mesh-ancestor
6297824|NCT00001568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6297825|NCT00001568|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6297826|NCT00001569|Paclitaxel|paclitaxel|mesh-list
6297827|NCT00001569|Cisplatin|cisplatin|mesh-list
6297828|NCT00001569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6297829|NCT00001569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297830|NCT00001569|Tubulin Modulators|tubulin modulators|mesh-ancestor
6297831|NCT00001569|Antimitotic Agents|antimitotic agents|mesh-ancestor
6297832|NCT00001569|Mitosis Modulators|mitosis modulators|mesh-ancestor
6297833|NCT00001569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297834|NCT00001570|Vinblastine|vinblastine|mesh-list
6297835|NCT00001570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6297836|NCT00001570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297837|NCT00001570|Tubulin Modulators|tubulin modulators|mesh-ancestor
6297838|NCT00001570|Antimitotic Agents|antimitotic agents|mesh-ancestor
6297839|NCT00001570|Mitosis Modulators|mitosis modulators|mesh-ancestor
6297840|NCT00001570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297841|NCT00001572|Saponin QA-21V1|saponin qa-21v1|mesh-list
6297842|NCT00001572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6297843|NCT00001572|Immunologic Factors|immunologic factors|mesh-ancestor
6297844|NCT00001572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297845|NCT00001576|Leucovorin|leucovorin|mesh-list
6297846|NCT00001576|Melphalan|melphalan|mesh-list
6297847|NCT00001576|Floxuridine|floxuridine|mesh-list
6297848|NCT00001576|Antidotes|antidotes|mesh-ancestor
6297849|NCT00001576|Protective Agents|protective agents|mesh-ancestor
6297850|NCT00001576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297851|NCT00001576|Vitamin B Complex|vitamin b complex|mesh-ancestor
6297852|NCT00001576|Vitamins|vitamins|mesh-ancestor
6297853|NCT00001576|Micronutrients|micronutrients|mesh-ancestor
6297854|NCT00001576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6297855|NCT00001576|Alkylating Agents|alkylating agents|mesh-ancestor
6297856|NCT00001576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297857|NCT00001576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297858|NCT00001576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6297859|NCT00001576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6297860|NCT00001576|Immunologic Factors|immunologic factors|mesh-ancestor
6297861|NCT00001576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6297862|NCT00001576|Antimetabolites|antimetabolites|mesh-ancestor
6297863|NCT00001577|Melphalan|melphalan|mesh-list
6297864|NCT00001577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6297865|NCT00001577|Alkylating Agents|alkylating agents|mesh-ancestor
6297866|NCT00001577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297867|NCT00001577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297868|NCT00001577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6297869|NCT00001577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6297870|NCT00001577|Immunologic Factors|immunologic factors|mesh-ancestor
6297871|NCT00001577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297872|NCT00001579|Leucovorin|leucovorin|mesh-list
6297873|NCT00001579|Fluorouracil|fluorouracil|mesh-list
6297874|NCT00001579|Eniluracil|eniluracil|mesh-list
6297875|NCT00001579|Antimetabolites|antimetabolites|mesh-ancestor
6297876|NCT00001579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297877|NCT00001579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6297878|NCT00001579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297879|NCT00001579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6297880|NCT00001579|Immunologic Factors|immunologic factors|mesh-ancestor
6297881|NCT00001579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297882|NCT00001579|Antidotes|antidotes|mesh-ancestor
6297883|NCT00001579|Protective Agents|protective agents|mesh-ancestor
6297884|NCT00001579|Vitamin B Complex|vitamin b complex|mesh-ancestor
6297885|NCT00001579|Vitamins|vitamins|mesh-ancestor
6297886|NCT00001579|Micronutrients|micronutrients|mesh-ancestor
6297887|NCT00001579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6297888|NCT00001587|Melphalan|melphalan|mesh-list
6297889|NCT00001587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6297890|NCT00001587|Alkylating Agents|alkylating agents|mesh-ancestor
6297891|NCT00001587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297892|NCT00001587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297893|NCT00001587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6297894|NCT00001587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6297895|NCT00001587|Immunologic Factors|immunologic factors|mesh-ancestor
6297896|NCT00001587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297897|NCT00001598|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
6297898|NCT00001598|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6297899|NCT00001598|Immunologic Factors|immunologic factors|mesh-ancestor
6297900|NCT00001598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297901|NCT00001599|Thalidomide|thalidomide|mesh-list
6297902|NCT00001599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6297903|NCT00001599|Immunologic Factors|immunologic factors|mesh-ancestor
6297904|NCT00001599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297905|NCT00001599|Leprostatic Agents|leprostatic agents|mesh-ancestor
6297906|NCT00001599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6297907|NCT00001599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6297908|NCT00001599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6297909|NCT00001599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6297910|NCT00001599|Growth Substances|growth substances|mesh-ancestor
6297911|NCT00001599|Growth Inhibitors|growth inhibitors|mesh-ancestor
6297912|NCT00001599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297913|NCT00001624|Insulin|insulin|mesh-list
6297914|NCT00001624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6297915|NCT00001624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297916|NCT00001626|Cyclosporine|cyclosporine|mesh-list
6297917|NCT00001626|Cyclophosphamide|cyclophosphamide|mesh-list
6297918|NCT00001626|Cyclosporins|cyclosporins|mesh-list
6297919|NCT00001626|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6297920|NCT00001626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6297921|NCT00001626|Immunologic Factors|immunologic factors|mesh-ancestor
6297922|NCT00001626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297923|NCT00001626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6297924|NCT00001626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6297925|NCT00001626|Alkylating Agents|alkylating agents|mesh-ancestor
6297926|NCT00001626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297927|NCT00001626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6297928|NCT00001626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6297929|NCT00001626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6297930|NCT00001626|Antifungal Agents|antifungal agents|mesh-ancestor
6297931|NCT00001626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6297932|NCT00001626|Dermatologic Agents|dermatologic agents|mesh-ancestor
6297933|NCT00001626|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6297934|NCT00001628|Angiotensin II|angiotensin ii|mesh-list
6297935|NCT00001628|Giapreza|giapreza|mesh-list
6297936|NCT00001628|Angiotensinogen|angiotensinogen|mesh-list
6297937|NCT00001628|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-list
6297938|NCT00001628|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6297939|NCT00001628|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6297940|NCT00001628|Protease Inhibitors|protease inhibitors|mesh-ancestor
6297941|NCT00001628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6297942|NCT00001628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297943|NCT00001628|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6392055|NCT00195286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6392056|NCT00195286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392057|NCT00195299|Sirolimus|sirolimus|mesh-list
6392058|NCT00195299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6392059|NCT00195299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6392060|NCT00195299|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6392061|NCT00195299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6392062|NCT00195299|Antifungal Agents|antifungal agents|mesh-ancestor
6297944|NCT00001629|Angiotensin II|angiotensin ii|mesh-list
6297945|NCT00001629|Giapreza|giapreza|mesh-list
6297946|NCT00001629|Angiotensinogen|angiotensinogen|mesh-list
6297947|NCT00001629|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-list
6297948|NCT00001629|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6297949|NCT00001629|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6297950|NCT00001629|Protease Inhibitors|protease inhibitors|mesh-ancestor
6297951|NCT00001629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6297952|NCT00001629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297953|NCT00001629|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6297954|NCT00001644|Lamivudine|lamivudine|mesh-list
6297955|NCT00001644|Zidovudine|zidovudine|mesh-list
6297956|NCT00001644|Nevirapine|nevirapine|mesh-list
6297957|NCT00001644|Indinavir|indinavir|mesh-list
6297958|NCT00001644|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6297959|NCT00001644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6297960|NCT00001644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6297961|NCT00001644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297962|NCT00001644|Antiviral Agents|antiviral agents|mesh-ancestor
6297963|NCT00001644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6297964|NCT00001644|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6297965|NCT00001644|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6297966|NCT00001644|Antimetabolites|antimetabolites|mesh-ancestor
6297967|NCT00001644|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6297968|NCT00001644|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6297969|NCT00001644|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6297970|NCT00001644|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6297971|NCT00001644|Protease Inhibitors|protease inhibitors|mesh-ancestor
6297972|NCT00001646|Voriconazole|voriconazole|mesh-list
6297973|NCT00001646|Amphotericin B|amphotericin b|mesh-list
6297974|NCT00001646|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6297975|NCT00001646|Antifungal Agents|antifungal agents|mesh-ancestor
6297976|NCT00001646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6297977|NCT00001646|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6297978|NCT00001646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6297979|NCT00001646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6297980|NCT00001646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6297981|NCT00001646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6297982|NCT00001646|Hormone Antagonists|hormone antagonists|mesh-ancestor
6297983|NCT00001646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6297984|NCT00001646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297985|NCT00001646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6297986|NCT00001646|Amebicides|amebicides|mesh-ancestor
6297987|NCT00001646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6297988|NCT00001646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6297989|NCT00001646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6297990|NCT00001649|Valacyclovir|valacyclovir|mesh-list
6297991|NCT00001649|Antiviral Agents|antiviral agents|mesh-ancestor
6297992|NCT00001649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6297993|NCT00001658|Amoxicillin|amoxicillin|mesh-list
6297994|NCT00001658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6297995|NCT00001658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6297996|NCT00001666|Methamphetamine|methamphetamine|mesh-list
6297997|NCT00001666|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6297998|NCT00001666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6297999|NCT00001666|Sympathomimetics|sympathomimetics|mesh-ancestor
6298000|NCT00001666|Autonomic Agents|autonomic agents|mesh-ancestor
6298001|NCT00001666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6298002|NCT00001666|Dopamine Agents|dopamine agents|mesh-ancestor
6298003|NCT00001666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6392063|NCT00195299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6298004|NCT00001666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298005|NCT00001666|Adrenergic Agents|adrenergic agents|mesh-ancestor
6298006|NCT00001666|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6298007|NCT00001666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6298008|NCT00001666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6298009|NCT00001666|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6298010|NCT00001669|Mecasermin|mecasermin|mesh-list
6298011|NCT00001669|Growth Substances|growth substances|mesh-ancestor
6298012|NCT00001669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298013|NCT00001676|Fludarabine|fludarabine|mesh-list
6298014|NCT00001676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6298015|NCT00001677|Methotrexate|methotrexate|mesh-list
6298016|NCT00001677|Fludarabine|fludarabine|mesh-list
6298017|NCT00001677|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6298018|NCT00001677|Abortifacient Agents|abortifacient agents|mesh-ancestor
6298019|NCT00001677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6298020|NCT00001677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298021|NCT00001677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6298022|NCT00001677|Antimetabolites|antimetabolites|mesh-ancestor
6298023|NCT00001677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298024|NCT00001677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6298025|NCT00001677|Dermatologic Agents|dermatologic agents|mesh-ancestor
6298026|NCT00001677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6298027|NCT00001677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6298028|NCT00001677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6298029|NCT00001677|Immunologic Factors|immunologic factors|mesh-ancestor
6298030|NCT00001677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6298031|NCT00001677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6298032|NCT00001680|Thalidomide|thalidomide|mesh-list
6298033|NCT00001680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6298034|NCT00001680|Immunologic Factors|immunologic factors|mesh-ancestor
6298035|NCT00001680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298036|NCT00001680|Leprostatic Agents|leprostatic agents|mesh-ancestor
6298037|NCT00001680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6298038|NCT00001680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6298039|NCT00001680|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6298040|NCT00001680|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6298041|NCT00001680|Growth Substances|growth substances|mesh-ancestor
6298042|NCT00001680|Growth Inhibitors|growth inhibitors|mesh-ancestor
6298043|NCT00001680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6298044|NCT00001688|Ritonavir|ritonavir|mesh-list
6298045|NCT00001688|Nevirapine|nevirapine|mesh-list
6298046|NCT00001688|Stavudine|stavudine|mesh-list
6298047|NCT00001688|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6298048|NCT00001688|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6298049|NCT00001688|Protease Inhibitors|protease inhibitors|mesh-ancestor
6298050|NCT00001688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6298051|NCT00001688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298052|NCT00001688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6298053|NCT00001688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6298054|NCT00001688|Antiviral Agents|antiviral agents|mesh-ancestor
6298055|NCT00001688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6298056|NCT00001688|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6298057|NCT00001688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6298058|NCT00001688|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6298059|NCT00001688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6298060|NCT00001688|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6298061|NCT00001688|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6298062|NCT00001688|Antimetabolites|antimetabolites|mesh-ancestor
6298063|NCT00001689|Vincristine|vincristine|mesh-list
6298064|NCT00001689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6298065|NCT00001689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6298066|NCT00001689|Tubulin Modulators|tubulin modulators|mesh-ancestor
6298067|NCT00001689|Antimitotic Agents|antimitotic agents|mesh-ancestor
6298068|NCT00001689|Mitosis Modulators|mitosis modulators|mesh-ancestor
6298069|NCT00001689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298070|NCT00001693|Celecoxib|celecoxib|mesh-list
6298071|NCT00001693|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6298072|NCT00001693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6298073|NCT00001693|Analgesics|analgesics|mesh-ancestor
6298074|NCT00001693|Sensory System Agents|sensory system agents|mesh-ancestor
6298075|NCT00001693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6298076|NCT00001693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298077|NCT00001693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6298078|NCT00001693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6298079|NCT00001693|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6298080|NCT00001693|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6298081|NCT00001693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6298082|NCT00001693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298083|NCT00001696|Genistein|genistein|mesh-list
6298084|NCT00001696|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6298085|NCT00001696|Protective Agents|protective agents|mesh-ancestor
6298086|NCT00001696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298087|NCT00001696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6298088|NCT00001696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6298089|NCT00001696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6298090|NCT00001696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298091|NCT00001696|Phytoestrogens|phytoestrogens|mesh-ancestor
6298092|NCT00001696|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6298093|NCT00001696|Estrogens|estrogens|mesh-ancestor
6298094|NCT00001696|Hormones|hormones|mesh-ancestor
6298095|NCT00001696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6298096|NCT00001698|Ketorolac|ketorolac|mesh-list
6298097|NCT00001698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6298098|NCT00001698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6298099|NCT00001698|Analgesics|analgesics|mesh-ancestor
6298100|NCT00001698|Sensory System Agents|sensory system agents|mesh-ancestor
6298101|NCT00001698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6298102|NCT00001698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298103|NCT00001698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6298104|NCT00001698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6298105|NCT00001698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6298106|NCT00001698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6298107|NCT00001698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298108|NCT00001713|Heparin|heparin|mesh-list
6298109|NCT00001713|Plasminogen|plasminogen|mesh-list
6298110|NCT00001713|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6298111|NCT00001713|Warfarin|warfarin|mesh-list
6298112|NCT00001713|Anticoagulants|anticoagulants|mesh-ancestor
6298113|NCT00001713|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6298114|NCT00001713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6298115|NCT00001713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298116|NCT00001716|Nitric Oxide|nitric oxide|mesh-list
6298117|NCT00001716|Nitroglycerin|nitroglycerin|mesh-list
6298118|NCT00001716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6298119|NCT00001716|Autonomic Agents|autonomic agents|mesh-ancestor
6298120|NCT00001716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6298121|NCT00001716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298122|NCT00001716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6298123|NCT00001716|Respiratory System Agents|respiratory system agents|mesh-ancestor
6298124|NCT00001716|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6298125|NCT00001716|Antioxidants|antioxidants|mesh-ancestor
6298126|NCT00001716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298127|NCT00001716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6298128|NCT00001716|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6298129|NCT00001716|Vasodilator Agents|vasodilator agents|mesh-ancestor
6298130|NCT00001716|Gasotransmitters|gasotransmitters|mesh-ancestor
6298131|NCT00001716|Protective Agents|protective agents|mesh-ancestor
6298132|NCT00001720|Alendronate|alendronate|mesh-list
6298133|NCT00001720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6298134|NCT00001720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298135|NCT00001724|Flurbiprofen|flurbiprofen|mesh-list
6298136|NCT00001724|Analgesics|analgesics|mesh-ancestor
6298137|NCT00001724|Sensory System Agents|sensory system agents|mesh-ancestor
6298138|NCT00001724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6298139|NCT00001724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298140|NCT00001724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6298141|NCT00001724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6298142|NCT00001724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6298143|NCT00001724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6298144|NCT00001724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6298145|NCT00001724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6298146|NCT00001724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298147|NCT00001725|Dextromethorphan|dextromethorphan|mesh-list
6298148|NCT00001725|Antitussive Agents|antitussive agents|mesh-ancestor
6298149|NCT00001725|Respiratory System Agents|respiratory system agents|mesh-ancestor
6298150|NCT00001725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6298151|NCT00001725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6298152|NCT00001725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6298153|NCT00001725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298154|NCT00001725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298155|NCT00001728|Alendronate|alendronate|mesh-list
6298156|NCT00001728|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6298157|NCT00001728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298158|NCT00001729|Ribavirin|ribavirin|mesh-list
6298159|NCT00001729|Antimetabolites|antimetabolites|mesh-ancestor
6298160|NCT00001729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298161|NCT00001729|Antiviral Agents|antiviral agents|mesh-ancestor
6298162|NCT00001729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6298163|NCT00001731|Cyclosporine|cyclosporine|mesh-list
6298164|NCT00001731|Cyclosporins|cyclosporins|mesh-list
6298165|NCT00001731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6298166|NCT00001731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298167|NCT00001731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6298168|NCT00001731|Immunologic Factors|immunologic factors|mesh-ancestor
6298169|NCT00001731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298170|NCT00001731|Antifungal Agents|antifungal agents|mesh-ancestor
6298171|NCT00001731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6298172|NCT00001731|Dermatologic Agents|dermatologic agents|mesh-ancestor
6298173|NCT00001731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6298174|NCT00001731|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6298175|NCT00001736|Cysteamine|cysteamine|mesh-list
6298176|NCT00001736|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
6298177|NCT00001736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298178|NCT00001737|Cyclosporine|cyclosporine|mesh-list
6298179|NCT00001737|Cyclosporins|cyclosporins|mesh-list
6298180|NCT00001737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6298181|NCT00001737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298182|NCT00001737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6298183|NCT00001737|Immunologic Factors|immunologic factors|mesh-ancestor
6298184|NCT00001737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298185|NCT00001737|Antifungal Agents|antifungal agents|mesh-ancestor
6298186|NCT00001737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6298187|NCT00001737|Dermatologic Agents|dermatologic agents|mesh-ancestor
6298188|NCT00001737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6298189|NCT00001737|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6298190|NCT00001741|Losartan|losartan|mesh-list
6298191|NCT00001741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6298192|NCT00001741|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6298193|NCT00001741|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6298194|NCT00001741|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6298195|NCT00001741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298196|NCT00001749|Cyclosporine|cyclosporine|mesh-list
6298197|NCT00001749|Cyclosporins|cyclosporins|mesh-list
6298198|NCT00001749|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6298199|NCT00001749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6298200|NCT00001749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298201|NCT00001749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6298202|NCT00001749|Immunologic Factors|immunologic factors|mesh-ancestor
6298203|NCT00001749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298204|NCT00001749|Antifungal Agents|antifungal agents|mesh-ancestor
6298205|NCT00001749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6298206|NCT00001749|Dermatologic Agents|dermatologic agents|mesh-ancestor
6298207|NCT00001749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6298208|NCT00001749|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6298209|NCT00001752|Estrogens|estrogens|mesh-list
6298210|NCT00001752|Hormones|hormones|mesh-ancestor
6298211|NCT00001752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6298212|NCT00001752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298213|NCT00001757|Voriconazole|voriconazole|mesh-list
6298214|NCT00001757|Antifungal Agents|antifungal agents|mesh-ancestor
6298215|NCT00001757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6298216|NCT00001757|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6298217|NCT00001757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6298218|NCT00001757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6298219|NCT00001757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298220|NCT00001757|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6298221|NCT00001757|Hormone Antagonists|hormone antagonists|mesh-ancestor
6298222|NCT00001757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6298223|NCT00001757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298224|NCT00001757|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6298225|NCT00001758|Efavirenz|efavirenz|mesh-list
6298226|NCT00001758|Abacavir|abacavir|mesh-list
6298227|NCT00001758|Amprenavir|amprenavir|mesh-list
6298228|NCT00001758|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6298229|NCT00001758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6298230|NCT00001758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6298231|NCT00001758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298232|NCT00001758|Antiviral Agents|antiviral agents|mesh-ancestor
6298233|NCT00001758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6298234|NCT00001758|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6298235|NCT00001758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6298236|NCT00001758|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6298237|NCT00001758|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6298238|NCT00001758|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6298239|NCT00001758|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6298240|NCT00001758|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6298241|NCT00001758|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6298242|NCT00001758|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6298243|NCT00001758|Antitubercular Agents|antitubercular agents|mesh-ancestor
6298244|NCT00001758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6298245|NCT00001758|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6298246|NCT00001758|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6298247|NCT00001758|Protease Inhibitors|protease inhibitors|mesh-ancestor
6298248|NCT00001763|Interleukin-12|interleukin-12|mesh-list
6298249|NCT00001763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6298250|NCT00001763|Immunologic Factors|immunologic factors|mesh-ancestor
6298251|NCT00001763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298252|NCT00001763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6298253|NCT00001763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6298254|NCT00001763|Growth Substances|growth substances|mesh-ancestor
6298255|NCT00001763|Growth Inhibitors|growth inhibitors|mesh-ancestor
6298256|NCT00001763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6298257|NCT00001764|Mycophenolic Acid|mycophenolic acid|mesh-list
6298258|NCT00001764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6298259|NCT00001764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6298260|NCT00001764|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6298261|NCT00001764|Antitubercular Agents|antitubercular agents|mesh-ancestor
6298262|NCT00001764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6298263|NCT00001764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6298264|NCT00001764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6298265|NCT00001764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392064|NCT00195299|Immunologic Factors|immunologic factors|mesh-ancestor
6392065|NCT00195299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392066|NCT00195312|Bupivacaine|bupivacaine|mesh-list
6392067|NCT00195312|Anesthetics, Local|anesthetics, local|mesh-ancestor
6392068|NCT00195312|Anesthetics|anesthetics|mesh-ancestor
6392069|NCT00195312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6392070|NCT00195312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392071|NCT00195312|Sensory System Agents|sensory system agents|mesh-ancestor
6392072|NCT00195312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6392073|NCT00195364|Etanercept|etanercept|mesh-list
6392074|NCT00195364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6392075|NCT00195364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6392076|NCT00195364|Analgesics|analgesics|mesh-ancestor
6392077|NCT00195364|Sensory System Agents|sensory system agents|mesh-ancestor
6392078|NCT00195364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6392079|NCT00195364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392080|NCT00195364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6392081|NCT00195364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6392082|NCT00195364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6392083|NCT00195364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6392084|NCT00195364|Immunologic Factors|immunologic factors|mesh-ancestor
6392085|NCT00195377|Etanercept|etanercept|mesh-list
6392086|NCT00195377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6392087|NCT00195377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6392088|NCT00195377|Analgesics|analgesics|mesh-ancestor
6392089|NCT00195377|Sensory System Agents|sensory system agents|mesh-ancestor
6392090|NCT00195377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6392091|NCT00195377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392092|NCT00195377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6392093|NCT00195377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6392094|NCT00195377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6392095|NCT00195377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6392096|NCT00195377|Immunologic Factors|immunologic factors|mesh-ancestor
6392097|NCT00195390|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6392098|NCT00195390|Immunologic Factors|immunologic factors|mesh-ancestor
6392099|NCT00195390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392100|NCT00195416|Etanercept|etanercept|mesh-list
6392101|NCT00195416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6392102|NCT00195416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6392103|NCT00195416|Analgesics|analgesics|mesh-ancestor
6392104|NCT00195416|Sensory System Agents|sensory system agents|mesh-ancestor
6392105|NCT00195416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6392106|NCT00195416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392107|NCT00195416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6392108|NCT00195416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6392109|NCT00195416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6392110|NCT00195416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6392111|NCT00195416|Immunologic Factors|immunologic factors|mesh-ancestor
6392112|NCT00195455|Estradiol|estradiol|mesh-list
6392113|NCT00195455|Estrogens|estrogens|mesh-ancestor
6392114|NCT00195455|Hormones|hormones|mesh-ancestor
6392115|NCT00195455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6392116|NCT00195455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392117|NCT00195468|Cyclosporine|cyclosporine|mesh-list
6392118|NCT00195468|Cyclosporins|cyclosporins|mesh-list
6392119|NCT00195468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6392120|NCT00195468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392121|NCT00195468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6392122|NCT00195468|Immunologic Factors|immunologic factors|mesh-ancestor
6392123|NCT00195468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392124|NCT00195468|Antifungal Agents|antifungal agents|mesh-ancestor
6298266|NCT00001766|Ritonavir|ritonavir|mesh-list
6298267|NCT00001766|Nelfinavir|nelfinavir|mesh-list
6298268|NCT00001766|Amprenavir|amprenavir|mesh-list
6298269|NCT00001766|Abacavir|abacavir|mesh-list
6298270|NCT00001766|Efavirenz|efavirenz|mesh-list
6298271|NCT00001766|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6298272|NCT00001766|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6298273|NCT00001766|Protease Inhibitors|protease inhibitors|mesh-ancestor
6298274|NCT00001766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6298275|NCT00001766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298276|NCT00001766|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6298277|NCT00001766|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6298278|NCT00001766|Antiviral Agents|antiviral agents|mesh-ancestor
6298279|NCT00001766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6298280|NCT00001766|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6298281|NCT00001766|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6298282|NCT00001766|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6298283|NCT00001766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6298284|NCT00001766|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6298285|NCT00001766|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6298286|NCT00001766|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6298287|NCT00001766|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6298288|NCT00001766|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6298289|NCT00001766|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6298290|NCT00001766|Antitubercular Agents|antitubercular agents|mesh-ancestor
6298291|NCT00001766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6298292|NCT00001768|Immunoglobulins|immunoglobulins|mesh-list
6298293|NCT00001768|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6298294|NCT00001768|Antibodies|antibodies|mesh-list
6298295|NCT00001768|gamma-Globulins|gamma-globulins|mesh-list
6298296|NCT00001768|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6298297|NCT00001768|Immunologic Factors|immunologic factors|mesh-ancestor
6298298|NCT00001768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298299|NCT00001777|Sertraline|sertraline|mesh-list
6298300|NCT00001777|Antidepressive Agents|antidepressive agents|mesh-ancestor
6298301|NCT00001777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6298302|NCT00001777|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6298303|NCT00001777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6298304|NCT00001777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6298305|NCT00001777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298306|NCT00001777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6298307|NCT00001777|Serotonin Agents|serotonin agents|mesh-ancestor
6298308|NCT00001777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298309|NCT00001784|Mexiletine|mexiletine|mesh-list
6298310|NCT00001784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6298311|NCT00001784|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6298312|NCT00001784|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6298313|NCT00001784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6298314|NCT00001784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298315|NCT00001785|Interferons|interferons|mesh-list
6298316|NCT00001785|Interferon-beta|interferon-beta|mesh-list
6298317|NCT00001785|Interferon beta-1a|interferon beta-1a|mesh-list
6298318|NCT00001785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6298319|NCT00001785|Antiviral Agents|antiviral agents|mesh-ancestor
6298320|NCT00001785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6298321|NCT00001785|Immunologic Factors|immunologic factors|mesh-ancestor
6298322|NCT00001785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298323|NCT00001785|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6298324|NCT00001790|Micafungin|micafungin|mesh-list
6298325|NCT00001790|Antifungal Agents|antifungal agents|mesh-ancestor
6298326|NCT00001790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6298327|NCT00001805|Rituximab|rituximab|mesh-list
6298328|NCT00001805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6298329|NCT00001805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6298330|NCT00001805|Immunologic Factors|immunologic factors|mesh-ancestor
6298331|NCT00001805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298332|NCT00001805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6018482|NCT00381043|Acamprosate|acamprosate|mesh-list
6298333|NCT00001810|Voriconazole|voriconazole|mesh-list
6298334|NCT00001810|Antifungal Agents|antifungal agents|mesh-ancestor
6298335|NCT00001810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6298336|NCT00001810|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6298337|NCT00001810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6298338|NCT00001810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6298339|NCT00001810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298340|NCT00001810|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6298341|NCT00001810|Hormone Antagonists|hormone antagonists|mesh-ancestor
6298342|NCT00001810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6298343|NCT00001810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298344|NCT00001810|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6298345|NCT00001812|Nystatin|nystatin|mesh-list
6298346|NCT00001812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6298347|NCT00001812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6298348|NCT00001812|Antifungal Agents|antifungal agents|mesh-ancestor
6298349|NCT00001812|Ionophores|ionophores|mesh-ancestor
6298350|NCT00001812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6298351|NCT00001812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298352|NCT00001818|Hydroxyurea|hydroxyurea|mesh-list
6298353|NCT00001818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6298354|NCT00001818|Antisickling Agents|antisickling agents|mesh-ancestor
6298355|NCT00001818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6298356|NCT00001818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298357|NCT00001818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6298358|NCT00001827|Aldesleukin|aldesleukin|mesh-list
6298359|NCT00001827|Sargramostim|sargramostim|mesh-list
6298360|NCT00001827|Freund's Adjuvant|freund's adjuvant|mesh-list
6298361|NCT00001827|Immunologic Factors|immunologic factors|mesh-ancestor
6298362|NCT00001827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298363|NCT00001827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6298364|NCT00001827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6298365|NCT00001827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6298366|NCT00001827|Antiviral Agents|antiviral agents|mesh-ancestor
6298367|NCT00001827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6298368|NCT00001827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6298369|NCT00001835|Oxaliplatin|oxaliplatin|mesh-list
6298370|NCT00001835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6298371|NCT00001839|Cyclosporine|cyclosporine|mesh-list
6298372|NCT00001839|Cyclosporins|cyclosporins|mesh-list
6298373|NCT00001839|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6298374|NCT00001839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6298375|NCT00001839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298376|NCT00001839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6298377|NCT00001839|Immunologic Factors|immunologic factors|mesh-ancestor
6298378|NCT00001839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298379|NCT00001839|Antifungal Agents|antifungal agents|mesh-ancestor
6298380|NCT00001839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6298381|NCT00001839|Dermatologic Agents|dermatologic agents|mesh-ancestor
6298382|NCT00001839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6298383|NCT00001839|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6298384|NCT00001842|Dexamethasone|dexamethasone|mesh-list
6298385|NCT00001842|Sargramostim|sargramostim|mesh-list
6298386|NCT00001842|Lenograstim|lenograstim|mesh-list
6298387|NCT00001842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6298388|NCT00001842|Antiemetics|antiemetics|mesh-ancestor
6298389|NCT00001842|Autonomic Agents|autonomic agents|mesh-ancestor
6298390|NCT00001842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6298391|NCT00001842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298392|NCT00001842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6298393|NCT00001842|Glucocorticoids|glucocorticoids|mesh-ancestor
6298394|NCT00001842|Hormones|hormones|mesh-ancestor
6298395|NCT00001842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6298396|NCT00001842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6298397|NCT00001842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6298398|NCT00001842|Immunologic Factors|immunologic factors|mesh-ancestor
6298399|NCT00001842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6298400|NCT00001848|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
6298401|NCT00001848|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6298402|NCT00001848|Hormone Antagonists|hormone antagonists|mesh-ancestor
6298403|NCT00001848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6298404|NCT00001848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298405|NCT00001848|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6298406|NCT00001848|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6298407|NCT00001848|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6298408|NCT00001854|Ribavirin|ribavirin|mesh-list
6298409|NCT00001854|Antimetabolites|antimetabolites|mesh-ancestor
6298410|NCT00001854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298411|NCT00001854|Antiviral Agents|antiviral agents|mesh-ancestor
6298412|NCT00001854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6298413|NCT00001860|Octreotide|octreotide|mesh-list
6298414|NCT00001860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6298415|NCT00001860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6298416|NCT00001860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6298417|NCT00001862|Etanercept|etanercept|mesh-list
6298418|NCT00001862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6298419|NCT00001862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6298420|NCT00001862|Analgesics|analgesics|mesh-ancestor
6298421|NCT00001862|Sensory System Agents|sensory system agents|mesh-ancestor
6298422|NCT00001862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6298423|NCT00001862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298424|NCT00001862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6298425|NCT00001862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6298426|NCT00001862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6298427|NCT00001862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6298428|NCT00001862|Immunologic Factors|immunologic factors|mesh-ancestor
6298429|NCT00001863|Leflunomide|leflunomide|mesh-list
6298430|NCT00001863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6298431|NCT00001863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298432|NCT00001863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6298433|NCT00001863|Immunologic Factors|immunologic factors|mesh-ancestor
6298434|NCT00001863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298435|NCT00001864|Atropine|atropine|mesh-list
6298436|NCT00001864|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6298437|NCT00001864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6298438|NCT00001864|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6298439|NCT00001864|Autonomic Agents|autonomic agents|mesh-ancestor
6298440|NCT00001864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6298441|NCT00001864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298442|NCT00001864|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6298443|NCT00001864|Respiratory System Agents|respiratory system agents|mesh-ancestor
6298444|NCT00001864|Mydriatics|mydriatics|mesh-ancestor
6298445|NCT00001864|Parasympatholytics|parasympatholytics|mesh-ancestor
6298446|NCT00001864|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6298447|NCT00001864|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6298448|NCT00001864|Cholinergic Agents|cholinergic agents|mesh-ancestor
6298449|NCT00001864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6298450|NCT00001864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298451|NCT00001865|Daclizumab|daclizumab|mesh-list
6298452|NCT00001865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6298453|NCT00001865|Immunologic Factors|immunologic factors|mesh-ancestor
6298454|NCT00001865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298455|NCT00001870|Acetylcholine|acetylcholine|mesh-list
6298456|NCT00001870|Vasodilator Agents|vasodilator agents|mesh-ancestor
6298457|NCT00001870|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6298458|NCT00001870|Cholinergic Agents|cholinergic agents|mesh-ancestor
6298459|NCT00001870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6298460|NCT00001870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298461|NCT00001870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298462|NCT00001877|Pentoxifylline|pentoxifylline|mesh-list
6298463|NCT00001877|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6298464|NCT00001877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6298465|NCT00001877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298466|NCT00001877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6298467|NCT00001877|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6298468|NCT00001877|Protective Agents|protective agents|mesh-ancestor
6298469|NCT00001877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298470|NCT00001877|Vasodilator Agents|vasodilator agents|mesh-ancestor
6298471|NCT00001877|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6298472|NCT00001877|Antioxidants|antioxidants|mesh-ancestor
6298473|NCT00001889|Dobutamine|dobutamine|mesh-list
6298474|NCT00001889|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6298475|NCT00001889|Sympathomimetics|sympathomimetics|mesh-ancestor
6298476|NCT00001889|Autonomic Agents|autonomic agents|mesh-ancestor
6298477|NCT00001889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6298478|NCT00001889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298479|NCT00001889|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6298480|NCT00001889|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6298481|NCT00001889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6298482|NCT00001889|Adrenergic Agents|adrenergic agents|mesh-ancestor
6298483|NCT00001889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6298484|NCT00001889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298485|NCT00001889|Protective Agents|protective agents|mesh-ancestor
6298486|NCT00001890|Estrogens|estrogens|mesh-list
6298487|NCT00001890|Hormones|hormones|mesh-ancestor
6298488|NCT00001890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6298489|NCT00001890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298490|NCT00001891|Dobutamine|dobutamine|mesh-list
6298491|NCT00001891|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6298492|NCT00001891|Sympathomimetics|sympathomimetics|mesh-ancestor
6298493|NCT00001891|Autonomic Agents|autonomic agents|mesh-ancestor
6298494|NCT00001891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6298495|NCT00001891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298496|NCT00001891|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6298497|NCT00001891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6298498|NCT00001891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6298499|NCT00001891|Adrenergic Agents|adrenergic agents|mesh-ancestor
6298500|NCT00001891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6298501|NCT00001891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298502|NCT00001891|Protective Agents|protective agents|mesh-ancestor
6298503|NCT00001893|Etanercept|etanercept|mesh-list
6298504|NCT00001893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6298505|NCT00001893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6298506|NCT00001893|Analgesics|analgesics|mesh-ancestor
6298507|NCT00001893|Sensory System Agents|sensory system agents|mesh-ancestor
6298508|NCT00001893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6298509|NCT00001893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298510|NCT00001893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6298511|NCT00001893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6298512|NCT00001893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6298513|NCT00001893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6298514|NCT00001893|Immunologic Factors|immunologic factors|mesh-ancestor
6298515|NCT00001901|Etanercept|etanercept|mesh-list
6298516|NCT00001901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6298517|NCT00001901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6298518|NCT00001901|Analgesics|analgesics|mesh-ancestor
6298519|NCT00001901|Sensory System Agents|sensory system agents|mesh-ancestor
6298520|NCT00001901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6298521|NCT00001901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298522|NCT00001901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6298523|NCT00001901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6298524|NCT00001901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6298525|NCT00001901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6298526|NCT00001901|Immunologic Factors|immunologic factors|mesh-ancestor
6298527|NCT00001903|Immunoglobulins|immunoglobulins|mesh-list
6298528|NCT00001903|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6298529|NCT00001903|Antibodies|antibodies|mesh-list
6298530|NCT00001903|Immunologic Factors|immunologic factors|mesh-ancestor
6298531|NCT00001903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298532|NCT00001905|Interferons|interferons|mesh-list
6298533|NCT00001905|Interferon-gamma|interferon-gamma|mesh-list
6298534|NCT00001905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6298535|NCT00001905|Antiviral Agents|antiviral agents|mesh-ancestor
6298536|NCT00001905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6298537|NCT00001906|Interleukin-12|interleukin-12|mesh-list
6298538|NCT00001906|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6298539|NCT00001906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6298540|NCT00001906|Immunologic Factors|immunologic factors|mesh-ancestor
6298541|NCT00001906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298542|NCT00001906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6298543|NCT00001906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6298544|NCT00001906|Growth Substances|growth substances|mesh-ancestor
6298545|NCT00001906|Growth Inhibitors|growth inhibitors|mesh-ancestor
6298546|NCT00001906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6298547|NCT00001906|Antacids|antacids|mesh-ancestor
6298548|NCT00001906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298549|NCT00001906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6298550|NCT00001911|Interleukin-12|interleukin-12|mesh-list
6298551|NCT00001911|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6298552|NCT00001911|Immunologic Factors|immunologic factors|mesh-ancestor
6298553|NCT00001911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298554|NCT00001911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6298555|NCT00001911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6298556|NCT00001911|Growth Substances|growth substances|mesh-ancestor
6298557|NCT00001911|Growth Inhibitors|growth inhibitors|mesh-ancestor
6298558|NCT00001911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6392125|NCT00195468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6392126|NCT00195468|Dermatologic Agents|dermatologic agents|mesh-ancestor
6392127|NCT00195468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6392128|NCT00195468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6392129|NCT00195481|Sirolimus|sirolimus|mesh-list
6392130|NCT00195481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6392131|NCT00195481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6392132|NCT00195481|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6392133|NCT00195481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6392134|NCT00195481|Antifungal Agents|antifungal agents|mesh-ancestor
6392135|NCT00195481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6392136|NCT00195481|Immunologic Factors|immunologic factors|mesh-ancestor
6392137|NCT00195481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392138|NCT00195533|Tazobactam|tazobactam|mesh-list
6392139|NCT00195533|Piperacillin|piperacillin|mesh-list
6392140|NCT00195533|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
6392141|NCT00195533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6392142|NCT00195533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6392143|NCT00195533|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6392144|NCT00195533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6392145|NCT00195533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392146|NCT00195559|Levonorgestrel|levonorgestrel|mesh-list
6392147|NCT00195559|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6392148|NCT00195559|Estradiol|estradiol|mesh-list
6392149|NCT00195559|Estrogens|estrogens|mesh-ancestor
6392150|NCT00195559|Hormones|hormones|mesh-ancestor
6392151|NCT00195559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6392152|NCT00195559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392153|NCT00195559|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6298559|NCT00001929|Eliprodil|eliprodil|mesh-list
6298560|NCT00001929|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6298561|NCT00001929|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6298562|NCT00001929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6298563|NCT00001929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298564|NCT00001929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298565|NCT00001929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6298566|NCT00001929|Protective Agents|protective agents|mesh-ancestor
6298567|NCT00001930|Amantadine|amantadine|mesh-list
6298568|NCT00001930|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6298569|NCT00001930|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6298570|NCT00001930|Antiviral Agents|antiviral agents|mesh-ancestor
6298571|NCT00001930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6298572|NCT00001930|Dopamine Agents|dopamine agents|mesh-ancestor
6298573|NCT00001930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6298574|NCT00001930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298575|NCT00001930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298576|NCT00001930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6298577|NCT00001930|Analgesics|analgesics|mesh-ancestor
6298578|NCT00001930|Sensory System Agents|sensory system agents|mesh-ancestor
6298579|NCT00001930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6298580|NCT00001933|Nefiracetam|nefiracetam|mesh-list
6298581|NCT00001933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6298582|NCT00001933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6298583|NCT00001933|Protective Agents|protective agents|mesh-ancestor
6298584|NCT00001933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298585|NCT00001933|Nootropic Agents|nootropic agents|mesh-ancestor
6298586|NCT00001934|Daclizumab|daclizumab|mesh-list
6298587|NCT00001934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6298588|NCT00001934|Immunologic Factors|immunologic factors|mesh-ancestor
6298589|NCT00001934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298590|NCT00001937|Fluconazole|fluconazole|mesh-list
6298591|NCT00001937|Antifungal Agents|antifungal agents|mesh-ancestor
6298592|NCT00001937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6298593|NCT00001937|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6298594|NCT00001937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6298595|NCT00001937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6298596|NCT00001937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298597|NCT00001937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6298598|NCT00001937|Hormone Antagonists|hormone antagonists|mesh-ancestor
6298599|NCT00001937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6298600|NCT00001937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298601|NCT00001937|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6298602|NCT00001937|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6298603|NCT00001940|Voriconazole|voriconazole|mesh-list
6298604|NCT00001940|Antifungal Agents|antifungal agents|mesh-ancestor
6298605|NCT00001940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6298606|NCT00001940|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6298607|NCT00001940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6298608|NCT00001940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6298609|NCT00001940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298610|NCT00001940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6298611|NCT00001940|Hormone Antagonists|hormone antagonists|mesh-ancestor
6298612|NCT00001940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6298613|NCT00001940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298614|NCT00001940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6298615|NCT00001944|Vinorelbine|vinorelbine|mesh-list
6298616|NCT00001944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6298617|NCT00001944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6298618|NCT00001944|Tubulin Modulators|tubulin modulators|mesh-ancestor
6298619|NCT00001944|Antimitotic Agents|antimitotic agents|mesh-ancestor
6298620|NCT00001944|Mitosis Modulators|mitosis modulators|mesh-ancestor
6298621|NCT00001944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298622|NCT00001954|Etanercept|etanercept|mesh-list
6298623|NCT00001954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6298624|NCT00001954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6298625|NCT00001954|Analgesics|analgesics|mesh-ancestor
6298626|NCT00001954|Sensory System Agents|sensory system agents|mesh-ancestor
6298627|NCT00001954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6298628|NCT00001954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298629|NCT00001954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6298630|NCT00001954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6298631|NCT00001954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6298632|NCT00001954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6298633|NCT00001954|Immunologic Factors|immunologic factors|mesh-ancestor
6298634|NCT00001955|Celecoxib|celecoxib|mesh-list
6298635|NCT00001955|Etanercept|etanercept|mesh-list
6298636|NCT00001955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6298637|NCT00001955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6298638|NCT00001955|Analgesics|analgesics|mesh-ancestor
6298639|NCT00001955|Sensory System Agents|sensory system agents|mesh-ancestor
6298640|NCT00001955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6298641|NCT00001955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298642|NCT00001955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6298643|NCT00001955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6298644|NCT00001955|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6298645|NCT00001955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6298646|NCT00001955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6298647|NCT00001955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298648|NCT00001955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6298649|NCT00001955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6015560|NCT00357968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015561|NCT00357994|Levodopa|levodopa|mesh-list
6015562|NCT00357994|Carbidopa|carbidopa|mesh-list
6015563|NCT00357994|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
6015564|NCT00357994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6015565|NCT00357994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6015566|NCT00357994|Dopamine Agents|dopamine agents|mesh-ancestor
6015567|NCT00357994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6015568|NCT00357994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015569|NCT00357994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015570|NCT00357994|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6015571|NCT00357994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6298650|NCT00001955|Immunologic Factors|immunologic factors|mesh-ancestor
6298651|NCT00001958|Hydroxyurea|hydroxyurea|mesh-list
6298652|NCT00001958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6298653|NCT00001958|Antisickling Agents|antisickling agents|mesh-ancestor
6298654|NCT00001958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6298655|NCT00001958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298656|NCT00001958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6298657|NCT00001963|Nitric Oxide|nitric oxide|mesh-list
6298658|NCT00001963|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6298659|NCT00001963|Autonomic Agents|autonomic agents|mesh-ancestor
6298660|NCT00001963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6298661|NCT00001963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298662|NCT00001963|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6298663|NCT00001963|Respiratory System Agents|respiratory system agents|mesh-ancestor
6298664|NCT00001963|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6298665|NCT00001963|Antioxidants|antioxidants|mesh-ancestor
6298666|NCT00001963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298667|NCT00001963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6298668|NCT00001963|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6298669|NCT00001963|Vasodilator Agents|vasodilator agents|mesh-ancestor
6298670|NCT00001963|Gasotransmitters|gasotransmitters|mesh-ancestor
6298671|NCT00001963|Protective Agents|protective agents|mesh-ancestor
6298672|NCT00001964|Cyclosporine|cyclosporine|mesh-list
6298673|NCT00001964|Cyclosporins|cyclosporins|mesh-list
6298674|NCT00001964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6298675|NCT00001964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298676|NCT00001964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6298677|NCT00001964|Immunologic Factors|immunologic factors|mesh-ancestor
6298678|NCT00001964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298679|NCT00001964|Antifungal Agents|antifungal agents|mesh-ancestor
6298680|NCT00001964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6298681|NCT00001964|Dermatologic Agents|dermatologic agents|mesh-ancestor
6298682|NCT00001964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6298683|NCT00001964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6298684|NCT00001965|Cyclosporine|cyclosporine|mesh-list
6298685|NCT00001965|Cyclosporins|cyclosporins|mesh-list
6298686|NCT00001965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6298687|NCT00001965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298688|NCT00001965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6298689|NCT00001965|Immunologic Factors|immunologic factors|mesh-ancestor
6298690|NCT00001965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298691|NCT00001965|Antifungal Agents|antifungal agents|mesh-ancestor
6298692|NCT00001965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6298693|NCT00001965|Dermatologic Agents|dermatologic agents|mesh-ancestor
6298694|NCT00001965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6298695|NCT00001965|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6298696|NCT00001968|Ritonavir|ritonavir|mesh-list
6298697|NCT00001968|Amprenavir|amprenavir|mesh-list
6298698|NCT00001968|Lamivudine|lamivudine|mesh-list
6298699|NCT00001968|Abacavir|abacavir|mesh-list
6298700|NCT00001968|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6298701|NCT00001968|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6298702|NCT00001968|Protease Inhibitors|protease inhibitors|mesh-ancestor
6298703|NCT00001968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6298704|NCT00001968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298705|NCT00001968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6298706|NCT00001968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6298707|NCT00001968|Antiviral Agents|antiviral agents|mesh-ancestor
6298708|NCT00001968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6298709|NCT00001968|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6298710|NCT00001968|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6298711|NCT00001968|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6298712|NCT00001968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6298713|NCT00001968|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6298714|NCT00001968|Antitubercular Agents|antitubercular agents|mesh-ancestor
6298715|NCT00001968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6298716|NCT00001989|Zidovudine|zidovudine|mesh-list
6298717|NCT00001989|Trichosanthin|trichosanthin|mesh-list
6298718|NCT00001989|Antimetabolites|antimetabolites|mesh-ancestor
6298719|NCT00001989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298720|NCT00001989|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6298721|NCT00001989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6298722|NCT00001989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6298723|NCT00001989|Antiviral Agents|antiviral agents|mesh-ancestor
6298724|NCT00001989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6298725|NCT00001989|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6298726|NCT00001989|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6298727|NCT00001989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6298728|NCT00001989|Abortifacient Agents|abortifacient agents|mesh-ancestor
6298729|NCT00001989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6298730|NCT00001989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298731|NCT00001989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6298732|NCT00001989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6298733|NCT00001990|Atovaquone|atovaquone|mesh-list
6298734|NCT00001990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6298735|NCT00001990|Antimalarials|antimalarials|mesh-ancestor
6298736|NCT00001990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6298737|NCT00001990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6298738|NCT00001990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6298739|NCT00001990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298740|NCT00001991|Atovaquone|atovaquone|mesh-list
6298741|NCT00001991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6298742|NCT00001991|Antimalarials|antimalarials|mesh-ancestor
6298743|NCT00001991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6298744|NCT00001991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6298745|NCT00001991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6298746|NCT00001991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298747|NCT00001993|Miglustat|miglustat|mesh-list
6298748|NCT00001993|Zidovudine|zidovudine|mesh-list
6298749|NCT00001993|Antimetabolites|antimetabolites|mesh-ancestor
6298750|NCT00001993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298751|NCT00001993|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6298752|NCT00001993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6298753|NCT00001993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6298754|NCT00001993|Antiviral Agents|antiviral agents|mesh-ancestor
6298755|NCT00001993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6298756|NCT00001993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6298757|NCT00001993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6298758|NCT00001993|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6298759|NCT00001993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6298760|NCT00001993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298761|NCT00001994|Atovaquone|atovaquone|mesh-list
6298762|NCT00001994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6298763|NCT00001994|Antimalarials|antimalarials|mesh-ancestor
6298764|NCT00001994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6298765|NCT00001994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6298766|NCT00001994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6298767|NCT00001994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298768|NCT00001995|Rifabutin|rifabutin|mesh-list
6298769|NCT00001995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6298770|NCT00001995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6298771|NCT00001995|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6298772|NCT00001995|Antitubercular Agents|antitubercular agents|mesh-ancestor
6298773|NCT00001996|Atovaquone|atovaquone|mesh-list
6298774|NCT00001996|Pentamidine|pentamidine|mesh-list
6298775|NCT00001996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6298776|NCT00001996|Antimalarials|antimalarials|mesh-ancestor
6298777|NCT00001996|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6298778|NCT00001996|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6298779|NCT00001996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6298780|NCT00001996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298781|NCT00001996|Antifungal Agents|antifungal agents|mesh-ancestor
6298782|NCT00001996|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6298783|NCT00001997|Zidovudine|zidovudine|mesh-list
6298784|NCT00001997|Didanosine|didanosine|mesh-list
6298785|NCT00001997|Interleukin-2|interleukin-2|mesh-list
6298786|NCT00001997|Antimetabolites|antimetabolites|mesh-ancestor
6298787|NCT00001997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298788|NCT00001997|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6298789|NCT00001997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6298790|NCT00001997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6298791|NCT00001997|Antiviral Agents|antiviral agents|mesh-ancestor
6298792|NCT00001997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6298793|NCT00001997|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6298794|NCT00001997|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6298795|NCT00001997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6298796|NCT00001997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6298797|NCT00001997|Analgesics|analgesics|mesh-ancestor
6298798|NCT00001997|Sensory System Agents|sensory system agents|mesh-ancestor
6298799|NCT00001997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6298800|NCT00001997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298801|NCT00001998|Nystatin|nystatin|mesh-list
6298802|NCT00001998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6298803|NCT00001998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6298804|NCT00001998|Antifungal Agents|antifungal agents|mesh-ancestor
6298805|NCT00001998|Ionophores|ionophores|mesh-ancestor
6298806|NCT00001998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6298807|NCT00001998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298808|NCT00001999|Ganciclovir|ganciclovir|mesh-list
6298809|NCT00001999|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6298810|NCT00001999|Immunoglobulins|immunoglobulins|mesh-list
6298811|NCT00001999|Antibodies|antibodies|mesh-list
6298812|NCT00001999|Antiviral Agents|antiviral agents|mesh-ancestor
6298813|NCT00001999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6298814|NCT00001999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6298815|NCT00001999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6298816|NCT00001999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298817|NCT00001999|Immunologic Factors|immunologic factors|mesh-ancestor
6298818|NCT00001999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298819|NCT00002000|Valacyclovir|valacyclovir|mesh-list
6298820|NCT00002000|Acyclovir|acyclovir|mesh-list
6298821|NCT00002000|Antiviral Agents|antiviral agents|mesh-ancestor
6298822|NCT00002000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6298823|NCT00002001|Zidovudine|zidovudine|mesh-list
6298824|NCT00002001|Didanosine|didanosine|mesh-list
6298825|NCT00002001|Zalcitabine|zalcitabine|mesh-list
6298826|NCT00002001|Antimetabolites|antimetabolites|mesh-ancestor
6298827|NCT00002001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298828|NCT00002001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6298829|NCT00002001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6298830|NCT00002001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6298831|NCT00002001|Antiviral Agents|antiviral agents|mesh-ancestor
6298832|NCT00002001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6298833|NCT00002001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6298834|NCT00002001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6298835|NCT00002002|Leucovorin|leucovorin|mesh-list
6298836|NCT00002002|Trimethoprim|trimethoprim|mesh-list
6298837|NCT00002002|Sulfamethoxazole|sulfamethoxazole|mesh-list
6298838|NCT00002002|Calcium|calcium|mesh-list
6298839|NCT00002002|Levoleucovorin|levoleucovorin|mesh-list
6298840|NCT00002002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6298841|NCT00002002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298842|NCT00002002|Antidotes|antidotes|mesh-ancestor
6298843|NCT00002002|Protective Agents|protective agents|mesh-ancestor
6298844|NCT00002002|Vitamin B Complex|vitamin b complex|mesh-ancestor
6298845|NCT00002002|Vitamins|vitamins|mesh-ancestor
6298846|NCT00002002|Micronutrients|micronutrients|mesh-ancestor
6298847|NCT00002002|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6298848|NCT00002002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6298849|NCT00002002|Renal Agents|renal agents|mesh-ancestor
6298850|NCT00002002|Antimalarials|antimalarials|mesh-ancestor
6298851|NCT00002002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6298852|NCT00002002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6298853|NCT00002002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6298854|NCT00002002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6298855|NCT00002002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298856|NCT00002002|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6298857|NCT00002002|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6298858|NCT00002002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6298859|NCT00002003|Etoposide|etoposide|mesh-list
6298860|NCT00002003|Mitoxantrone|mitoxantrone|mesh-list
6298861|NCT00002003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6298862|NCT00002003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6298863|NCT00002003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6298864|NCT00002003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6298865|NCT00002003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6298866|NCT00002003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298867|NCT00002003|Analgesics|analgesics|mesh-ancestor
6298868|NCT00002003|Sensory System Agents|sensory system agents|mesh-ancestor
6298869|NCT00002003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6298870|NCT00002003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298871|NCT00002006|Zidovudine|zidovudine|mesh-list
6298872|NCT00002006|Sargramostim|sargramostim|mesh-list
6298873|NCT00002006|Antimetabolites|antimetabolites|mesh-ancestor
6298874|NCT00002006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015572|NCT00357994|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6015573|NCT00357994|Immunologic Factors|immunologic factors|mesh-ancestor
6015574|NCT00357994|Dopamine Agonists|dopamine agonists|mesh-ancestor
6015575|NCT00358150|Eliglustat|eliglustat|mesh-list
6298875|NCT00002006|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6298876|NCT00002006|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6298877|NCT00002006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6298878|NCT00002006|Antiviral Agents|antiviral agents|mesh-ancestor
6298879|NCT00002006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6298880|NCT00002006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6298881|NCT00002006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6298882|NCT00002006|Immunologic Factors|immunologic factors|mesh-ancestor
6298883|NCT00002006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298884|NCT00002007|Zidovudine|zidovudine|mesh-list
6298885|NCT00002007|Sargramostim|sargramostim|mesh-list
6298886|NCT00002007|Antimetabolites|antimetabolites|mesh-ancestor
6298887|NCT00002007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298888|NCT00002007|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6298889|NCT00002007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6298890|NCT00002007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6298891|NCT00002007|Antiviral Agents|antiviral agents|mesh-ancestor
6298892|NCT00002007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6298893|NCT00002007|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6298894|NCT00002007|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6298895|NCT00002007|Immunologic Factors|immunologic factors|mesh-ancestor
6298896|NCT00002007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298897|NCT00002008|Sargramostim|sargramostim|mesh-list
6298898|NCT00002008|Immunologic Factors|immunologic factors|mesh-ancestor
6298899|NCT00002008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298900|NCT00002009|Sargramostim|sargramostim|mesh-list
6298901|NCT00002009|Immunologic Factors|immunologic factors|mesh-ancestor
6298902|NCT00002009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298903|NCT00002010|Fluconazole|fluconazole|mesh-list
6298904|NCT00002010|Antifungal Agents|antifungal agents|mesh-ancestor
6298905|NCT00002010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6015576|NCT00358150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6298906|NCT00002010|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6298907|NCT00002010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6298908|NCT00002010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6298909|NCT00002010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298910|NCT00002010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6298911|NCT00002010|Hormone Antagonists|hormone antagonists|mesh-ancestor
6298912|NCT00002010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6298913|NCT00002010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298914|NCT00002010|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6298915|NCT00002010|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6298916|NCT00002011|Methoxsalen|methoxsalen|mesh-list
6298917|NCT00002011|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6298918|NCT00002011|Dermatologic Agents|dermatologic agents|mesh-ancestor
6298919|NCT00002012|Interferons|interferons|mesh-list
6298920|NCT00002012|Interferon-alpha|interferon-alpha|mesh-list
6298921|NCT00002012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6298922|NCT00002012|Antiviral Agents|antiviral agents|mesh-ancestor
6298923|NCT00002012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6298924|NCT00002012|Immunologic Factors|immunologic factors|mesh-ancestor
6298925|NCT00002012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298926|NCT00002013|Zidovudine|zidovudine|mesh-list
6298927|NCT00002013|Antimetabolites|antimetabolites|mesh-ancestor
6298928|NCT00002013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298929|NCT00002013|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6298930|NCT00002013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6298931|NCT00002013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6298932|NCT00002013|Antiviral Agents|antiviral agents|mesh-ancestor
6298933|NCT00002013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6298934|NCT00002013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6298935|NCT00002013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6298936|NCT00002014|Zidovudine|zidovudine|mesh-list
6298937|NCT00002014|Didanosine|didanosine|mesh-list
6298938|NCT00002014|Antimetabolites|antimetabolites|mesh-ancestor
6298939|NCT00002014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298940|NCT00002014|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6298941|NCT00002014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6298942|NCT00002014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6298943|NCT00002014|Antiviral Agents|antiviral agents|mesh-ancestor
6298944|NCT00002014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6298945|NCT00002014|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6298946|NCT00002014|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6298947|NCT00002015|Ganciclovir|ganciclovir|mesh-list
6298948|NCT00002015|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6298949|NCT00002015|Antiviral Agents|antiviral agents|mesh-ancestor
6298950|NCT00002015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6298951|NCT00002015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6298952|NCT00002015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6298953|NCT00002015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298954|NCT00002017|Interleukin-2|interleukin-2|mesh-list
6298955|NCT00002017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6298956|NCT00002017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6298957|NCT00002017|Analgesics|analgesics|mesh-ancestor
6298958|NCT00002017|Sensory System Agents|sensory system agents|mesh-ancestor
6298959|NCT00002017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6298960|NCT00002017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298961|NCT00002018|Interferons|interferons|mesh-list
6298962|NCT00002018|Interferon-alpha|interferon-alpha|mesh-list
6298963|NCT00002018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6298964|NCT00002018|Antiviral Agents|antiviral agents|mesh-ancestor
6298965|NCT00002018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6298966|NCT00002018|Immunologic Factors|immunologic factors|mesh-ancestor
6298967|NCT00002018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6298968|NCT00002019|Amphotericin B|amphotericin b|mesh-list
6298969|NCT00002019|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6298970|NCT00002019|Amebicides|amebicides|mesh-ancestor
6298971|NCT00002019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6298972|NCT00002019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6298973|NCT00002019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6298974|NCT00002019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6298975|NCT00002019|Antifungal Agents|antifungal agents|mesh-ancestor
6298976|NCT00002020|Zidovudine|zidovudine|mesh-list
6298977|NCT00002020|Antimetabolites|antimetabolites|mesh-ancestor
6298978|NCT00002020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298979|NCT00002020|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6298980|NCT00002020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6298981|NCT00002020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6298982|NCT00002020|Antiviral Agents|antiviral agents|mesh-ancestor
6298983|NCT00002020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6298984|NCT00002020|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6298985|NCT00002020|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6298986|NCT00002021|Foscarnet|foscarnet|mesh-list
6298987|NCT00002021|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
6298988|NCT00002021|Antiviral Agents|antiviral agents|mesh-ancestor
6298989|NCT00002021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6298990|NCT00002021|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6298991|NCT00002021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6298992|NCT00002021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6298993|NCT00002021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298994|NCT00002022|Epoetin Alfa|epoetin alfa|mesh-list
6298995|NCT00002022|Hematinics|hematinics|mesh-ancestor
6298996|NCT00002023|Zidovudine|zidovudine|mesh-list
6298997|NCT00002023|Antimetabolites|antimetabolites|mesh-ancestor
6298998|NCT00002023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6298999|NCT00002023|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6299000|NCT00002023|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6299001|NCT00002023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299002|NCT00002023|Antiviral Agents|antiviral agents|mesh-ancestor
6299003|NCT00002023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299004|NCT00002023|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6299005|NCT00002023|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6299006|NCT00002024|Ganciclovir|ganciclovir|mesh-list
6299007|NCT00002024|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6299008|NCT00002024|Antiviral Agents|antiviral agents|mesh-ancestor
6299009|NCT00002024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299010|NCT00002024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6299011|NCT00002024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299012|NCT00002024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299013|NCT00002025|Ganciclovir|ganciclovir|mesh-list
6299014|NCT00002025|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6299015|NCT00002025|Antiviral Agents|antiviral agents|mesh-ancestor
6299016|NCT00002025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299017|NCT00002025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6299018|NCT00002025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299019|NCT00002025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299020|NCT00002026|Acyclovir|acyclovir|mesh-list
6299021|NCT00002026|Antiviral Agents|antiviral agents|mesh-ancestor
6299022|NCT00002026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299023|NCT00002027|Diclazuril|diclazuril|mesh-list
6299024|NCT00002027|Coccidiostats|coccidiostats|mesh-ancestor
6299025|NCT00002027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6299026|NCT00002027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6299027|NCT00002027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299028|NCT00002028|Didanosine|didanosine|mesh-list
6299029|NCT00002028|Antimetabolites|antimetabolites|mesh-ancestor
6299030|NCT00002028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299031|NCT00002028|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6299032|NCT00002028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6299033|NCT00002028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299034|NCT00002028|Antiviral Agents|antiviral agents|mesh-ancestor
6299035|NCT00002028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299036|NCT00002028|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6299037|NCT00002028|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6299038|NCT00002029|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6299039|NCT00002029|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6299040|NCT00002029|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6299041|NCT00002029|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6299042|NCT00002030|Pentamidine|pentamidine|mesh-list
6299043|NCT00002030|Antifungal Agents|antifungal agents|mesh-ancestor
6299044|NCT00002030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299045|NCT00002030|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6299046|NCT00002030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6299047|NCT00002030|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6299048|NCT00002032|Rifabutin|rifabutin|mesh-list
6299049|NCT00002032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6299050|NCT00002032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299051|NCT00002032|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6299052|NCT00002032|Antitubercular Agents|antitubercular agents|mesh-ancestor
6299053|NCT00002033|Zidovudine|zidovudine|mesh-list
6299054|NCT00002033|Antimetabolites|antimetabolites|mesh-ancestor
5724199|NCT03188471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299055|NCT00002033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299056|NCT00002033|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6299057|NCT00002033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6299058|NCT00002033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299059|NCT00002033|Antiviral Agents|antiviral agents|mesh-ancestor
6299060|NCT00002033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299061|NCT00002033|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6299062|NCT00002033|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6299063|NCT00002034|Zidovudine|zidovudine|mesh-list
6299064|NCT00002034|Ganciclovir|ganciclovir|mesh-list
6299065|NCT00002034|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6299066|NCT00002034|Antimetabolites|antimetabolites|mesh-ancestor
6299067|NCT00002034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299068|NCT00002034|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6299069|NCT00002034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6299070|NCT00002034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299071|NCT00002034|Antiviral Agents|antiviral agents|mesh-ancestor
6299072|NCT00002034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299073|NCT00002034|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6299074|NCT00002034|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6299075|NCT00002035|Zidovudine|zidovudine|mesh-list
6299076|NCT00002035|Didanosine|didanosine|mesh-list
6299077|NCT00002035|Antimetabolites|antimetabolites|mesh-ancestor
6299078|NCT00002035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299079|NCT00002035|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6299080|NCT00002035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6299081|NCT00002035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299082|NCT00002035|Antiviral Agents|antiviral agents|mesh-ancestor
6299083|NCT00002035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299084|NCT00002035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6299085|NCT00002035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6299086|NCT00002036|Immune Sera|immune sera|mesh-list
6299087|NCT00002036|Immunologic Factors|immunologic factors|mesh-ancestor
6299088|NCT00002036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6299089|NCT00002037|Trifluridine|trifluridine|mesh-list
6299090|NCT00002037|Antimetabolites|antimetabolites|mesh-ancestor
6299091|NCT00002037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299092|NCT00002037|Antiviral Agents|antiviral agents|mesh-ancestor
6299093|NCT00002037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299094|NCT00002038|Fluconazole|fluconazole|mesh-list
6299095|NCT00002038|Antifungal Agents|antifungal agents|mesh-ancestor
6299096|NCT00002038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299097|NCT00002038|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6299098|NCT00002038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6299099|NCT00002038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299100|NCT00002038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299101|NCT00002038|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6299102|NCT00002038|Hormone Antagonists|hormone antagonists|mesh-ancestor
6299103|NCT00002038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6299104|NCT00002038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392154|NCT00195559|Contraceptive Agents|contraceptive agents|mesh-ancestor
6299105|NCT00002038|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6299106|NCT00002038|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6299107|NCT00002039|Foscarnet|foscarnet|mesh-list
6299108|NCT00002039|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
6299109|NCT00002039|Antiviral Agents|antiviral agents|mesh-ancestor
6299110|NCT00002039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299111|NCT00002039|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6299112|NCT00002039|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6299113|NCT00002039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299114|NCT00002039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299115|NCT00002040|Fluconazole|fluconazole|mesh-list
6299116|NCT00002040|Antifungal Agents|antifungal agents|mesh-ancestor
6299117|NCT00002040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299118|NCT00002040|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6299119|NCT00002040|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6299120|NCT00002040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299121|NCT00002040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015577|NCT00358150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015578|NCT00358215|Darbepoetin alfa|darbepoetin alfa|mesh-list
6015579|NCT00358215|Hematinics|hematinics|mesh-ancestor
6299122|NCT00002040|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6299123|NCT00002040|Hormone Antagonists|hormone antagonists|mesh-ancestor
6299124|NCT00002040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6299125|NCT00002040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6299126|NCT00002040|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6299127|NCT00002040|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6299128|NCT00002041|Amphotericin B|amphotericin b|mesh-list
6299129|NCT00002041|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6299130|NCT00002041|Amebicides|amebicides|mesh-ancestor
6299131|NCT00002041|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6299132|NCT00002041|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6299133|NCT00002041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299134|NCT00002041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6299135|NCT00002041|Antifungal Agents|antifungal agents|mesh-ancestor
6299136|NCT00002042|Epoetin Alfa|epoetin alfa|mesh-list
6299137|NCT00002042|Hematinics|hematinics|mesh-ancestor
6299138|NCT00002043|Dapsone|dapsone|mesh-list
6299139|NCT00002043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299140|NCT00002043|Antimalarials|antimalarials|mesh-ancestor
6299141|NCT00002043|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6299142|NCT00002043|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6299143|NCT00002043|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6299144|NCT00002043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299145|NCT00002043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299146|NCT00002043|Leprostatic Agents|leprostatic agents|mesh-ancestor
6299147|NCT00002043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6299148|NCT00002044|Zidovudine|zidovudine|mesh-list
6299149|NCT00002044|Antimetabolites|antimetabolites|mesh-ancestor
6299150|NCT00002044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299151|NCT00002044|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6299152|NCT00002044|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6299153|NCT00002044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299154|NCT00002044|Antiviral Agents|antiviral agents|mesh-ancestor
6299155|NCT00002044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299156|NCT00002044|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6299157|NCT00002044|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6392155|NCT00195559|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6392156|NCT00195559|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6392157|NCT00195559|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6392158|NCT00195559|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6392159|NCT00195559|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6392160|NCT00195572|Leucovorin|leucovorin|mesh-list
6392161|NCT00195572|Levoleucovorin|levoleucovorin|mesh-list
6392162|NCT00195572|Antidotes|antidotes|mesh-ancestor
6392163|NCT00195572|Protective Agents|protective agents|mesh-ancestor
6392164|NCT00195572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392165|NCT00195572|Vitamin B Complex|vitamin b complex|mesh-ancestor
6392166|NCT00195572|Vitamins|vitamins|mesh-ancestor
6392167|NCT00195572|Micronutrients|micronutrients|mesh-ancestor
6392168|NCT00195585|Leucovorin|leucovorin|mesh-list
6392169|NCT00195585|Levoleucovorin|levoleucovorin|mesh-list
6392170|NCT00195585|Antidotes|antidotes|mesh-ancestor
6392171|NCT00195585|Protective Agents|protective agents|mesh-ancestor
6392172|NCT00195585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392173|NCT00195585|Vitamin B Complex|vitamin b complex|mesh-ancestor
6015580|NCT00358436|Bromides|bromides|mesh-list
6299158|NCT00002045|Zidovudine|zidovudine|mesh-list
6299159|NCT00002045|Antimetabolites|antimetabolites|mesh-ancestor
6299160|NCT00002045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299161|NCT00002045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6299162|NCT00002045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6299163|NCT00002045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299164|NCT00002045|Antiviral Agents|antiviral agents|mesh-ancestor
6299165|NCT00002045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299166|NCT00002045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6299167|NCT00002045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6299168|NCT00002046|Zidovudine|zidovudine|mesh-list
6299169|NCT00002046|Antimetabolites|antimetabolites|mesh-ancestor
6299170|NCT00002046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299171|NCT00002046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6299172|NCT00002046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6299173|NCT00002046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299174|NCT00002046|Antiviral Agents|antiviral agents|mesh-ancestor
6299175|NCT00002046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299176|NCT00002046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6299177|NCT00002046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6299178|NCT00002047|Zidovudine|zidovudine|mesh-list
6299179|NCT00002047|Antimetabolites|antimetabolites|mesh-ancestor
6299180|NCT00002047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299181|NCT00002047|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6299182|NCT00002047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6299183|NCT00002047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299184|NCT00002047|Antiviral Agents|antiviral agents|mesh-ancestor
6299185|NCT00002047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299186|NCT00002047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6299187|NCT00002047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6299188|NCT00002048|Zidovudine|zidovudine|mesh-list
6299189|NCT00002048|Antimetabolites|antimetabolites|mesh-ancestor
6299190|NCT00002048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299191|NCT00002048|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6299192|NCT00002048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6299193|NCT00002048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299194|NCT00002048|Antiviral Agents|antiviral agents|mesh-ancestor
6299195|NCT00002048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299196|NCT00002048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6299197|NCT00002048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6299198|NCT00002049|Thymopentin|thymopentin|mesh-list
6299199|NCT00002049|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6299200|NCT00002049|Immunologic Factors|immunologic factors|mesh-ancestor
6299201|NCT00002049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6299202|NCT00002050|Thymopentin|thymopentin|mesh-list
6299203|NCT00002050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6299204|NCT00002050|Immunologic Factors|immunologic factors|mesh-ancestor
6299205|NCT00002050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6299206|NCT00002051|Thymopentin|thymopentin|mesh-list
6299207|NCT00002051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6299208|NCT00002051|Immunologic Factors|immunologic factors|mesh-ancestor
6299209|NCT00002051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6299210|NCT00002052|Amoxicillin|amoxicillin|mesh-list
6299211|NCT00002052|Ceftriaxone|ceftriaxone|mesh-list
6299212|NCT00002052|Ampicillin|ampicillin|mesh-list
6299213|NCT00002052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6299214|NCT00002052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299215|NCT00002053|Pentamidine|pentamidine|mesh-list
6299216|NCT00002053|Antifungal Agents|antifungal agents|mesh-ancestor
6299217|NCT00002053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299218|NCT00002053|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6299219|NCT00002053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6299220|NCT00002053|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6299221|NCT00002054|Pentamidine|pentamidine|mesh-list
6299222|NCT00002054|Antifungal Agents|antifungal agents|mesh-ancestor
6299223|NCT00002054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299224|NCT00002054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6299225|NCT00002054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6299226|NCT00002054|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6299227|NCT00002055|Pentamidine|pentamidine|mesh-list
6299228|NCT00002055|Antifungal Agents|antifungal agents|mesh-ancestor
6299229|NCT00002055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299230|NCT00002055|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6299231|NCT00002055|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6299232|NCT00002055|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6299233|NCT00002056|Pentamidine|pentamidine|mesh-list
6299234|NCT00002056|Antifungal Agents|antifungal agents|mesh-ancestor
6299235|NCT00002056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6015581|NCT00358436|Anticonvulsants|anticonvulsants|mesh-ancestor
6015582|NCT00358462|Azithromycin|azithromycin|mesh-list
6015583|NCT00358462|Doxycycline|doxycycline|mesh-list
6015584|NCT00358462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6015585|NCT00358462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6015586|NCT00358462|Antimalarials|antimalarials|mesh-ancestor
6015587|NCT00358462|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6015588|NCT00358462|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6299236|NCT00002056|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6299237|NCT00002056|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6299238|NCT00002056|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6299239|NCT00002057|Nystatin|nystatin|mesh-list
6299240|NCT00002057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6299241|NCT00002057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299242|NCT00002057|Antifungal Agents|antifungal agents|mesh-ancestor
6299243|NCT00002057|Ionophores|ionophores|mesh-ancestor
6299244|NCT00002057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6299245|NCT00002057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299246|NCT00002058|Clofazimine|clofazimine|mesh-list
6299247|NCT00002058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6299248|NCT00002058|Leprostatic Agents|leprostatic agents|mesh-ancestor
6299249|NCT00002058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6299250|NCT00002058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299251|NCT00002059|Inosine Pranobex|inosine pranobex|mesh-list
6299252|NCT00002059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6299253|NCT00002059|Immunologic Factors|immunologic factors|mesh-ancestor
6299254|NCT00002059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6299255|NCT00002059|Antiviral Agents|antiviral agents|mesh-ancestor
6299256|NCT00002059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299257|NCT00002060|Inosine Pranobex|inosine pranobex|mesh-list
6299258|NCT00002060|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6299259|NCT00002060|Immunologic Factors|immunologic factors|mesh-ancestor
6299260|NCT00002060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6299261|NCT00002060|Antiviral Agents|antiviral agents|mesh-ancestor
6299262|NCT00002060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299263|NCT00002061|Inosine Pranobex|inosine pranobex|mesh-list
6299264|NCT00002061|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6299265|NCT00002061|Immunologic Factors|immunologic factors|mesh-ancestor
6299266|NCT00002061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015589|NCT00358501|Defibrotide|defibrotide|mesh-list
6015590|NCT00358501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6299267|NCT00002061|Antiviral Agents|antiviral agents|mesh-ancestor
6299268|NCT00002061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299269|NCT00002062|Spiramycin|spiramycin|mesh-list
6299270|NCT00002062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6299271|NCT00002062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299272|NCT00002062|Coccidiostats|coccidiostats|mesh-ancestor
6299273|NCT00002062|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6299274|NCT00002062|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6299275|NCT00002063|Zidovudine|zidovudine|mesh-list
6299276|NCT00002063|Antimetabolites|antimetabolites|mesh-ancestor
6299277|NCT00002063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299278|NCT00002063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6299279|NCT00002063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6299280|NCT00002063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299281|NCT00002063|Antiviral Agents|antiviral agents|mesh-ancestor
6299282|NCT00002063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299283|NCT00002063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6299284|NCT00002063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6299285|NCT00002064|Clindamycin|clindamycin|mesh-list
6299286|NCT00002064|Clindamycin palmitate|clindamycin palmitate|mesh-list
6299287|NCT00002064|Clindamycin phosphate|clindamycin phosphate|mesh-list
6299288|NCT00002064|Pyrimethamine|pyrimethamine|mesh-list
6299289|NCT00002064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6299290|NCT00002064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299291|NCT00002064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6299292|NCT00002064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299293|NCT00002064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299294|NCT00002064|Antimalarials|antimalarials|mesh-ancestor
6299295|NCT00002064|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6299296|NCT00002064|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6015591|NCT00358501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6299297|NCT00002064|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6299298|NCT00002065|Disulfiram|disulfiram|mesh-list
6299299|NCT00002065|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6299300|NCT00002065|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
6299301|NCT00002065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299302|NCT00002065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299303|NCT00002066|Thymopentin|thymopentin|mesh-list
6299304|NCT00002066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6299305|NCT00002066|Immunologic Factors|immunologic factors|mesh-ancestor
6299306|NCT00002066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6299307|NCT00002067|Megestrol|megestrol|mesh-list
6299308|NCT00002067|Megestrol Acetate|megestrol acetate|mesh-list
6299309|NCT00002067|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6299310|NCT00002067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6299311|NCT00002067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6299312|NCT00002067|Contraceptive Agents|contraceptive agents|mesh-ancestor
6299313|NCT00002067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6299314|NCT00002067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6299315|NCT00002067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6299316|NCT00002067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6299317|NCT00002067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6299318|NCT00002067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6299319|NCT00002067|Appetite Stimulants|appetite stimulants|mesh-ancestor
6299320|NCT00002067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6299321|NCT00002068|Fluconazole|fluconazole|mesh-list
6299322|NCT00002068|Amphotericin B|amphotericin b|mesh-list
6299323|NCT00002068|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6299324|NCT00002068|Antifungal Agents|antifungal agents|mesh-ancestor
6299325|NCT00002068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299326|NCT00002068|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6299327|NCT00002068|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6299328|NCT00002068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299329|NCT00002068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299330|NCT00002068|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6299331|NCT00002068|Hormone Antagonists|hormone antagonists|mesh-ancestor
6299332|NCT00002068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6299333|NCT00002068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6299334|NCT00002068|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6299335|NCT00002068|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6299336|NCT00002068|Amebicides|amebicides|mesh-ancestor
6299337|NCT00002068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6299338|NCT00002068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6299339|NCT00002068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6299340|NCT00002069|Ditiocarb|ditiocarb|mesh-list
6299341|NCT00002069|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6299342|NCT00002069|Immunologic Factors|immunologic factors|mesh-ancestor
6299343|NCT00002069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6299344|NCT00002069|Antiviral Agents|antiviral agents|mesh-ancestor
6299345|NCT00002069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299346|NCT00002069|Chelating Agents|chelating agents|mesh-ancestor
6299347|NCT00002069|Sequestering Agents|sequestering agents|mesh-ancestor
6299348|NCT00002069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299349|NCT00002070|Ganciclovir|ganciclovir|mesh-list
6299350|NCT00002070|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6299351|NCT00002070|Sargramostim|sargramostim|mesh-list
6299352|NCT00002070|Immunologic Factors|immunologic factors|mesh-ancestor
6299353|NCT00002070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6299354|NCT00002070|Antiviral Agents|antiviral agents|mesh-ancestor
6299355|NCT00002070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299356|NCT00002070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6299357|NCT00002070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299358|NCT00002070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299359|NCT00002071|Epoetin Alfa|epoetin alfa|mesh-list
6299360|NCT00002071|Hematinics|hematinics|mesh-ancestor
6299361|NCT00002072|Epoetin Alfa|epoetin alfa|mesh-list
6299362|NCT00002072|Hematinics|hematinics|mesh-ancestor
6299363|NCT00002073|Epoetin Alfa|epoetin alfa|mesh-list
6299364|NCT00002073|Hematinics|hematinics|mesh-ancestor
6299365|NCT00002074|Fluconazole|fluconazole|mesh-list
6299366|NCT00002074|Amphotericin B|amphotericin b|mesh-list
6299367|NCT00002074|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6299368|NCT00002074|Antifungal Agents|antifungal agents|mesh-ancestor
6299369|NCT00002074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299370|NCT00002074|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6299371|NCT00002074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6299372|NCT00002074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6392174|NCT00195585|Vitamins|vitamins|mesh-ancestor
6299373|NCT00002074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299374|NCT00002074|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6299375|NCT00002074|Hormone Antagonists|hormone antagonists|mesh-ancestor
6299376|NCT00002074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6299377|NCT00002074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6299378|NCT00002074|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6299379|NCT00002074|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6299380|NCT00002074|Amebicides|amebicides|mesh-ancestor
6299381|NCT00002074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6299382|NCT00002074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6299383|NCT00002074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6299384|NCT00002075|Fluconazole|fluconazole|mesh-list
6299385|NCT00002075|Amphotericin B|amphotericin b|mesh-list
6299386|NCT00002075|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6299387|NCT00002075|Flucytosine|flucytosine|mesh-list
6299388|NCT00002075|Antifungal Agents|antifungal agents|mesh-ancestor
6299389|NCT00002075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299390|NCT00002075|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6299391|NCT00002075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6299392|NCT00002075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299393|NCT00002075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299394|NCT00002075|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6299395|NCT00002075|Hormone Antagonists|hormone antagonists|mesh-ancestor
6299396|NCT00002075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6299397|NCT00002075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6299398|NCT00002075|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6299399|NCT00002075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6015592|NCT00358501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015593|NCT00358501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6015594|NCT00358579|Vasopressins|vasopressins|mesh-list
6015595|NCT00358579|Arginine Vasopressin|arginine vasopressin|mesh-list
6015596|NCT00358579|Epinephrine|epinephrine|mesh-list
6015597|NCT00358579|Racepinephrine|racepinephrine|mesh-list
6015598|NCT00358579|Epinephryl borate|epinephryl borate|mesh-list
6015599|NCT00358579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015600|NCT00358579|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6299400|NCT00002075|Amebicides|amebicides|mesh-ancestor
6299401|NCT00002075|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6299402|NCT00002075|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6299403|NCT00002075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6299404|NCT00002075|Antimetabolites|antimetabolites|mesh-ancestor
6299405|NCT00002076|Fluconazole|fluconazole|mesh-list
6299406|NCT00002076|Antifungal Agents|antifungal agents|mesh-ancestor
6299407|NCT00002076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299408|NCT00002076|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6299409|NCT00002076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6299410|NCT00002076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299411|NCT00002076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015601|NCT00358579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6299412|NCT00002076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6299413|NCT00002076|Hormone Antagonists|hormone antagonists|mesh-ancestor
6299414|NCT00002076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6299415|NCT00002076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6299416|NCT00002076|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6299417|NCT00002076|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6299418|NCT00002077|Fluconazole|fluconazole|mesh-list
6299419|NCT00002077|Antifungal Agents|antifungal agents|mesh-ancestor
6299420|NCT00002077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299421|NCT00002077|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6299422|NCT00002077|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6299423|NCT00002077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299424|NCT00002077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299425|NCT00002077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6299426|NCT00002077|Hormone Antagonists|hormone antagonists|mesh-ancestor
6299427|NCT00002077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6299428|NCT00002077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6299429|NCT00002077|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6299430|NCT00002077|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6299431|NCT00002078|Interferons|interferons|mesh-list
6299432|NCT00002078|Interferon-alpha|interferon-alpha|mesh-list
6299433|NCT00002078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6299434|NCT00002078|Antiviral Agents|antiviral agents|mesh-ancestor
6299435|NCT00002078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299436|NCT00002078|Immunologic Factors|immunologic factors|mesh-ancestor
6299437|NCT00002078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6299438|NCT00002079|Miglustat|miglustat|mesh-list
6299439|NCT00002079|Zidovudine|zidovudine|mesh-list
6299440|NCT00002079|Antimetabolites|antimetabolites|mesh-ancestor
6299441|NCT00002079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299442|NCT00002079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6299443|NCT00002079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6299444|NCT00002079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299445|NCT00002079|Antiviral Agents|antiviral agents|mesh-ancestor
6299446|NCT00002079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299447|NCT00002079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6299448|NCT00002079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6299449|NCT00002079|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6299450|NCT00002079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6299451|NCT00002079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6299452|NCT00002080|Rifabutin|rifabutin|mesh-list
6299453|NCT00002080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6299454|NCT00002080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299455|NCT00002080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6299456|NCT00002080|Antitubercular Agents|antitubercular agents|mesh-ancestor
6299457|NCT00002081|Zidovudine|zidovudine|mesh-list
6299458|NCT00002081|Zalcitabine|zalcitabine|mesh-list
6299459|NCT00002081|Antimetabolites|antimetabolites|mesh-ancestor
6299460|NCT00002081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299461|NCT00002081|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6299462|NCT00002081|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6299463|NCT00002081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299464|NCT00002081|Antiviral Agents|antiviral agents|mesh-ancestor
6299465|NCT00002081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299466|NCT00002081|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6299467|NCT00002081|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6299468|NCT00002082|Azithromycin|azithromycin|mesh-list
6299469|NCT00002082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6299470|NCT00002082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299471|NCT00002084|Valacyclovir|valacyclovir|mesh-list
6299472|NCT00002084|Acyclovir|acyclovir|mesh-list
6299473|NCT00002084|Antiviral Agents|antiviral agents|mesh-ancestor
6299474|NCT00002084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299475|NCT00002085|Azithromycin|azithromycin|mesh-list
6299476|NCT00002085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6299477|NCT00002085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299478|NCT00002086|Interferons|interferons|mesh-list
6299479|NCT00002086|Interferon-alpha|interferon-alpha|mesh-list
6299480|NCT00002086|Zidovudine|zidovudine|mesh-list
6299481|NCT00002086|Zalcitabine|zalcitabine|mesh-list
6299482|NCT00002086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6299483|NCT00002086|Antiviral Agents|antiviral agents|mesh-ancestor
6299484|NCT00002086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299485|NCT00002086|Immunologic Factors|immunologic factors|mesh-ancestor
6299486|NCT00002086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6299487|NCT00002086|Antimetabolites|antimetabolites|mesh-ancestor
6299488|NCT00002086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299489|NCT00002086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6299490|NCT00002086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6299491|NCT00002086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299492|NCT00002086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6299493|NCT00002086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6299494|NCT00002089|Azithromycin|azithromycin|mesh-list
6299495|NCT00002089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6299496|NCT00002089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299497|NCT00002090|Azithromycin|azithromycin|mesh-list
6299498|NCT00002090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6299499|NCT00002090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299500|NCT00002091|Pentoxifylline|pentoxifylline|mesh-list
6299501|NCT00002091|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6299502|NCT00002091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299503|NCT00002091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299504|NCT00002091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6299505|NCT00002091|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6299506|NCT00002091|Protective Agents|protective agents|mesh-ancestor
6299507|NCT00002091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6299508|NCT00002091|Vasodilator Agents|vasodilator agents|mesh-ancestor
6299509|NCT00002091|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6299510|NCT00002091|Antioxidants|antioxidants|mesh-ancestor
6299511|NCT00002092|Cimetidine|cimetidine|mesh-list
6299512|NCT00002092|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6299513|NCT00002092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6299514|NCT00002092|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6299515|NCT00002092|Histamine Antagonists|histamine antagonists|mesh-ancestor
6299516|NCT00002092|Histamine Agents|histamine agents|mesh-ancestor
6299517|NCT00002092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6299518|NCT00002092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299519|NCT00002092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6299520|NCT00002092|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6299521|NCT00002092|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6299522|NCT00002092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299523|NCT00002093|Doxorubicin|doxorubicin|mesh-list
6299524|NCT00002093|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6299525|NCT00002093|Daunorubicin|daunorubicin|mesh-list
6299526|NCT00002093|Bleomycin|bleomycin|mesh-list
6299527|NCT00002093|Vincristine|vincristine|mesh-list
6299528|NCT00002093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6299529|NCT00002093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6299530|NCT00002093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6299531|NCT00002093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6299532|NCT00002093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299533|NCT00002093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299534|NCT00002093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6299535|NCT00002093|Tubulin Modulators|tubulin modulators|mesh-ancestor
6299536|NCT00002093|Antimitotic Agents|antimitotic agents|mesh-ancestor
6299537|NCT00002093|Mitosis Modulators|mitosis modulators|mesh-ancestor
6299538|NCT00002094|Atevirdine|atevirdine|mesh-list
6299539|NCT00002094|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6299540|NCT00002094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6299541|NCT00002094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299542|NCT00002094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299543|NCT00002094|Antiviral Agents|antiviral agents|mesh-ancestor
6299544|NCT00002094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299545|NCT00002095|Ganciclovir|ganciclovir|mesh-list
6299546|NCT00002095|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6299547|NCT00002095|Antiviral Agents|antiviral agents|mesh-ancestor
6299548|NCT00002095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299549|NCT00002095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6299550|NCT00002095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299551|NCT00002095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299552|NCT00002096|Zidovudine|zidovudine|mesh-list
6299553|NCT00002096|Didanosine|didanosine|mesh-list
6299554|NCT00002096|Ganciclovir|ganciclovir|mesh-list
6299555|NCT00002096|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6299556|NCT00002096|Antimetabolites|antimetabolites|mesh-ancestor
6299557|NCT00002096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299558|NCT00002096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6299559|NCT00002096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6299560|NCT00002096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299561|NCT00002096|Antiviral Agents|antiviral agents|mesh-ancestor
6299562|NCT00002096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299563|NCT00002096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6299564|NCT00002096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6299565|NCT00002097|Nystatin|nystatin|mesh-list
6299566|NCT00002097|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6299567|NCT00002097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299568|NCT00002097|Antifungal Agents|antifungal agents|mesh-ancestor
6299569|NCT00002097|Ionophores|ionophores|mesh-ancestor
6299570|NCT00002097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6299571|NCT00002097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299572|NCT00002098|Didanosine|didanosine|mesh-list
6299573|NCT00002098|Lentinan|lentinan|mesh-list
6299574|NCT00002098|Antimetabolites|antimetabolites|mesh-ancestor
6299575|NCT00002098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299576|NCT00002098|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6299577|NCT00002098|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6299578|NCT00002098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299579|NCT00002098|Antiviral Agents|antiviral agents|mesh-ancestor
6299580|NCT00002098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299581|NCT00002098|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6299582|NCT00002098|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6299583|NCT00002098|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6299584|NCT00002098|Immunologic Factors|immunologic factors|mesh-ancestor
6299585|NCT00002098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6299586|NCT00002098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6299587|NCT00002099|Didanosine|didanosine|mesh-list
6299588|NCT00002099|Lentinan|lentinan|mesh-list
6299589|NCT00002099|Antimetabolites|antimetabolites|mesh-ancestor
6299590|NCT00002099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299591|NCT00002099|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6299592|NCT00002099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6299593|NCT00002099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299594|NCT00002099|Antiviral Agents|antiviral agents|mesh-ancestor
6299595|NCT00002099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299596|NCT00002099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6299597|NCT00002099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6299598|NCT00002099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6299599|NCT00002099|Immunologic Factors|immunologic factors|mesh-ancestor
6299600|NCT00002099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6299601|NCT00002099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6299602|NCT00002100|Curdlan sulfate|curdlan sulfate|mesh-list
6299603|NCT00002100|Antimalarials|antimalarials|mesh-ancestor
6299604|NCT00002100|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6299605|NCT00002100|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6299606|NCT00002100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299607|NCT00002100|Antiviral Agents|antiviral agents|mesh-ancestor
6299608|NCT00002101|Clarithromycin|clarithromycin|mesh-list
6299609|NCT00002101|Ethambutol|ethambutol|mesh-list
6299610|NCT00002101|Rifabutin|rifabutin|mesh-list
6299611|NCT00002101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6299612|NCT00002101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299613|NCT00002101|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6299614|NCT00002101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299615|NCT00002101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299616|NCT00002101|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6299617|NCT00002101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6299618|NCT00002101|Antitubercular Agents|antitubercular agents|mesh-ancestor
6299619|NCT00002101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6299620|NCT00002102|Leucovorin|leucovorin|mesh-list
6299621|NCT00002102|Trimetrexate|trimetrexate|mesh-list
6299622|NCT00002102|Calcium|calcium|mesh-list
6299623|NCT00002102|Levoleucovorin|levoleucovorin|mesh-list
6299624|NCT00002102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6299625|NCT00002102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6299626|NCT00002102|Antidotes|antidotes|mesh-ancestor
6299627|NCT00002102|Protective Agents|protective agents|mesh-ancestor
6299628|NCT00002102|Vitamin B Complex|vitamin b complex|mesh-ancestor
6299629|NCT00002102|Vitamins|vitamins|mesh-ancestor
6299630|NCT00002102|Micronutrients|micronutrients|mesh-ancestor
6299631|NCT00002102|Antifungal Agents|antifungal agents|mesh-ancestor
6299632|NCT00002102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299633|NCT00002102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6299634|NCT00002102|Antimetabolites|antimetabolites|mesh-ancestor
6299635|NCT00002102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299636|NCT00002102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6299637|NCT00002102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6299638|NCT00002102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299639|NCT00002103|Leucovorin|leucovorin|mesh-list
6299640|NCT00002103|Trimetrexate|trimetrexate|mesh-list
6299641|NCT00002103|Calcium|calcium|mesh-list
6299642|NCT00002103|Levoleucovorin|levoleucovorin|mesh-list
6299643|NCT00002103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6299644|NCT00002103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6299645|NCT00002103|Antidotes|antidotes|mesh-ancestor
6299646|NCT00002103|Protective Agents|protective agents|mesh-ancestor
6299647|NCT00002103|Vitamin B Complex|vitamin b complex|mesh-ancestor
6299648|NCT00002103|Vitamins|vitamins|mesh-ancestor
6299649|NCT00002103|Micronutrients|micronutrients|mesh-ancestor
6299650|NCT00002103|Antifungal Agents|antifungal agents|mesh-ancestor
6299651|NCT00002103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299652|NCT00002103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6299653|NCT00002103|Antimetabolites|antimetabolites|mesh-ancestor
6299654|NCT00002103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299655|NCT00002103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6299656|NCT00002103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6299657|NCT00002103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299658|NCT00002104|Thalidomide|thalidomide|mesh-list
6299659|NCT00002104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6299660|NCT00002104|Immunologic Factors|immunologic factors|mesh-ancestor
6299661|NCT00002104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6299662|NCT00002104|Leprostatic Agents|leprostatic agents|mesh-ancestor
6299663|NCT00002104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6299664|NCT00002104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299665|NCT00002104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6299666|NCT00002104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6299667|NCT00002104|Growth Substances|growth substances|mesh-ancestor
6299668|NCT00002104|Growth Inhibitors|growth inhibitors|mesh-ancestor
6299669|NCT00002104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6299670|NCT00002105|Doxorubicin|doxorubicin|mesh-list
6299671|NCT00002105|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6299672|NCT00002105|Bleomycin|bleomycin|mesh-list
6299673|NCT00002105|Vincristine|vincristine|mesh-list
6299674|NCT00002105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6299675|NCT00002105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6299676|NCT00002105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6299677|NCT00002105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6299678|NCT00002105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299679|NCT00002105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299680|NCT00002105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6299681|NCT00002105|Tubulin Modulators|tubulin modulators|mesh-ancestor
6299682|NCT00002105|Antimitotic Agents|antimitotic agents|mesh-ancestor
6299683|NCT00002105|Mitosis Modulators|mitosis modulators|mesh-ancestor
6299684|NCT00002106|Ranitidine|ranitidine|mesh-list
6299685|NCT00002106|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
6299686|NCT00002106|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6299687|NCT00002106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6299688|NCT00002106|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6299689|NCT00002106|Histamine Antagonists|histamine antagonists|mesh-ancestor
6299690|NCT00002106|Histamine Agents|histamine agents|mesh-ancestor
6299691|NCT00002106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6299692|NCT00002106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299693|NCT00002106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6299694|NCT00002107|Aldesleukin|aldesleukin|mesh-list
6299695|NCT00002107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6299696|NCT00002107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6299697|NCT00002107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6299698|NCT00002107|Antiviral Agents|antiviral agents|mesh-ancestor
6299699|NCT00002107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299700|NCT00002108|Lamivudine|lamivudine|mesh-list
6299701|NCT00002108|Zidovudine|zidovudine|mesh-list
6299702|NCT00002108|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6299703|NCT00002108|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6299704|NCT00002108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299705|NCT00002108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299706|NCT00002108|Antiviral Agents|antiviral agents|mesh-ancestor
6299707|NCT00002108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299708|NCT00002108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6299709|NCT00002108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6299710|NCT00002108|Antimetabolites|antimetabolites|mesh-ancestor
6299711|NCT00002109|Zidovudine|zidovudine|mesh-list
6299712|NCT00002109|Stavudine|stavudine|mesh-list
6299713|NCT00002109|Didanosine|didanosine|mesh-list
6299714|NCT00002109|Zalcitabine|zalcitabine|mesh-list
6299715|NCT00002109|Thymopentin|thymopentin|mesh-list
6299716|NCT00002109|Antimetabolites|antimetabolites|mesh-ancestor
6299717|NCT00002109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299718|NCT00002109|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6299719|NCT00002109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6299720|NCT00002109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299721|NCT00002109|Antiviral Agents|antiviral agents|mesh-ancestor
6299722|NCT00002109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299723|NCT00002109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6299724|NCT00002109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6299725|NCT00002109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6299726|NCT00002109|Immunologic Factors|immunologic factors|mesh-ancestor
6299727|NCT00002109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6299728|NCT00002110|Zidovudine|zidovudine|mesh-list
6299729|NCT00002110|Cysteamine|cysteamine|mesh-list
6299730|NCT00002110|Antimetabolites|antimetabolites|mesh-ancestor
6299731|NCT00002110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299732|NCT00002110|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6299733|NCT00002110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6299734|NCT00002110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299735|NCT00002110|Antiviral Agents|antiviral agents|mesh-ancestor
6299736|NCT00002110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299737|NCT00002110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6299738|NCT00002110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6299739|NCT00002110|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
6299740|NCT00002111|Saquinavir|saquinavir|mesh-list
6299741|NCT00002111|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6299742|NCT00002111|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6299743|NCT00002111|Protease Inhibitors|protease inhibitors|mesh-ancestor
6299744|NCT00002111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299745|NCT00002111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299746|NCT00002111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6299747|NCT00002111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6299748|NCT00002111|Antiviral Agents|antiviral agents|mesh-ancestor
6299749|NCT00002111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299750|NCT00002111|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6299751|NCT00002111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6299752|NCT00002112|Fluconazole|fluconazole|mesh-list
6299753|NCT00002112|Nystatin|nystatin|mesh-list
6299754|NCT00002112|Antifungal Agents|antifungal agents|mesh-ancestor
6299755|NCT00002112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299756|NCT00002112|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6299757|NCT00002112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6299758|NCT00002112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299759|NCT00002112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299760|NCT00002112|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6299761|NCT00002112|Hormone Antagonists|hormone antagonists|mesh-ancestor
6299762|NCT00002112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6299763|NCT00002112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6299764|NCT00002112|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6299765|NCT00002112|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6299766|NCT00002112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6299767|NCT00002112|Ionophores|ionophores|mesh-ancestor
6299768|NCT00002112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6299769|NCT00002113|Fluconazole|fluconazole|mesh-list
6299770|NCT00002113|Flucytosine|flucytosine|mesh-list
6299771|NCT00002113|Antifungal Agents|antifungal agents|mesh-ancestor
6299772|NCT00002113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299773|NCT00002113|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6299774|NCT00002113|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6299775|NCT00002113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299776|NCT00002113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299777|NCT00002113|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6299778|NCT00002113|Hormone Antagonists|hormone antagonists|mesh-ancestor
6299779|NCT00002113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6299780|NCT00002113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6299781|NCT00002113|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6299782|NCT00002113|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6299783|NCT00002113|Antimetabolites|antimetabolites|mesh-ancestor
6299784|NCT00002115|Adefovir|adefovir|mesh-list
6299785|NCT00002115|Antiviral Agents|antiviral agents|mesh-ancestor
6299786|NCT00002115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299787|NCT00002115|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6299788|NCT00002115|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6299789|NCT00002115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299790|NCT00002115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299791|NCT00002116|Cidofovir|cidofovir|mesh-list
6299792|NCT00002116|Antiviral Agents|antiviral agents|mesh-ancestor
6299793|NCT00002116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299794|NCT00002116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299795|NCT00002116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299796|NCT00002117|Zidovudine|zidovudine|mesh-list
6299797|NCT00002117|Zalcitabine|zalcitabine|mesh-list
6299798|NCT00002117|Antimetabolites|antimetabolites|mesh-ancestor
6299799|NCT00002117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299800|NCT00002117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6299801|NCT00002117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6299802|NCT00002117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299803|NCT00002117|Antiviral Agents|antiviral agents|mesh-ancestor
6299804|NCT00002117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299805|NCT00002117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6299806|NCT00002117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6299807|NCT00002118|Zalcitabine|zalcitabine|mesh-list
6299808|NCT00002118|Antimetabolites|antimetabolites|mesh-ancestor
6299809|NCT00002118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299810|NCT00002118|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6299811|NCT00002118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6299812|NCT00002118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299813|NCT00002118|Antiviral Agents|antiviral agents|mesh-ancestor
6299814|NCT00002118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299815|NCT00002118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6299816|NCT00002118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6299817|NCT00002120|Leucovorin|leucovorin|mesh-list
6299818|NCT00002120|Trimethoprim|trimethoprim|mesh-list
6299819|NCT00002120|Dapsone|dapsone|mesh-list
6299820|NCT00002120|Sulfamethoxazole|sulfamethoxazole|mesh-list
6299821|NCT00002120|Trimetrexate|trimetrexate|mesh-list
6299822|NCT00002120|Calcium|calcium|mesh-list
6299823|NCT00002120|Levoleucovorin|levoleucovorin|mesh-list
6299824|NCT00002120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6299825|NCT00002120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6299826|NCT00002120|Antidotes|antidotes|mesh-ancestor
6299827|NCT00002120|Protective Agents|protective agents|mesh-ancestor
6299828|NCT00002120|Vitamin B Complex|vitamin b complex|mesh-ancestor
6299829|NCT00002120|Vitamins|vitamins|mesh-ancestor
6299830|NCT00002120|Micronutrients|micronutrients|mesh-ancestor
6299831|NCT00002120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6299832|NCT00002120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299833|NCT00002120|Renal Agents|renal agents|mesh-ancestor
6299834|NCT00002120|Antimalarials|antimalarials|mesh-ancestor
6299835|NCT00002120|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6299836|NCT00002120|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6299837|NCT00002120|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6299838|NCT00002120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299839|NCT00002120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299840|NCT00002120|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6299841|NCT00002120|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6299842|NCT00002120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6299843|NCT00002120|Leprostatic Agents|leprostatic agents|mesh-ancestor
6299844|NCT00002120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6299845|NCT00002120|Antifungal Agents|antifungal agents|mesh-ancestor
6299846|NCT00002120|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6299847|NCT00002120|Antimetabolites|antimetabolites|mesh-ancestor
6299848|NCT00002120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6299849|NCT00002122|Azithromycin|azithromycin|mesh-list
6299850|NCT00002122|Rifabutin|rifabutin|mesh-list
6299851|NCT00002122|Fluconazole|fluconazole|mesh-list
6299852|NCT00002122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6299853|NCT00002122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299854|NCT00002122|Antifungal Agents|antifungal agents|mesh-ancestor
6299855|NCT00002122|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6299856|NCT00002122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6299857|NCT00002122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299858|NCT00002122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299859|NCT00002122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6299860|NCT00002122|Hormone Antagonists|hormone antagonists|mesh-ancestor
6299861|NCT00002122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6299862|NCT00002122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6299863|NCT00002122|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6299864|NCT00002122|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6299865|NCT00002122|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6299866|NCT00002122|Antitubercular Agents|antitubercular agents|mesh-ancestor
6299867|NCT00002123|Didanosine|didanosine|mesh-list
6299868|NCT00002123|Delavirdine|delavirdine|mesh-list
6299869|NCT00002123|Antimetabolites|antimetabolites|mesh-ancestor
6299870|NCT00002123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299871|NCT00002123|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6299872|NCT00002123|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6299873|NCT00002123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299874|NCT00002123|Antiviral Agents|antiviral agents|mesh-ancestor
6299875|NCT00002123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299876|NCT00002123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6299877|NCT00002123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6299878|NCT00002124|Lamivudine|lamivudine|mesh-list
6299879|NCT00002124|Zidovudine|zidovudine|mesh-list
6299880|NCT00002124|Delavirdine|delavirdine|mesh-list
6299881|NCT00002124|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6299882|NCT00002124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6299883|NCT00002124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299884|NCT00002124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299885|NCT00002124|Antiviral Agents|antiviral agents|mesh-ancestor
6299886|NCT00002124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299887|NCT00002124|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6299888|NCT00002124|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6299889|NCT00002124|Antimetabolites|antimetabolites|mesh-ancestor
6299890|NCT00002125|Foscarnet|foscarnet|mesh-list
6299891|NCT00002125|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
6299892|NCT00002125|Antiviral Agents|antiviral agents|mesh-ancestor
6299893|NCT00002125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299894|NCT00002125|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6299895|NCT00002125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6299896|NCT00002125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299897|NCT00002125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299898|NCT00002126|Lenograstim|lenograstim|mesh-list
6299899|NCT00002126|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6299900|NCT00002126|Immunologic Factors|immunologic factors|mesh-ancestor
6299901|NCT00002126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6299902|NCT00002127|Thalidomide|thalidomide|mesh-list
6299903|NCT00002127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6299904|NCT00002127|Immunologic Factors|immunologic factors|mesh-ancestor
6299905|NCT00002127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6299906|NCT00002127|Leprostatic Agents|leprostatic agents|mesh-ancestor
6299907|NCT00002127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6299908|NCT00002127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299909|NCT00002127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6299910|NCT00002127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6299911|NCT00002127|Growth Substances|growth substances|mesh-ancestor
6299912|NCT00002127|Growth Inhibitors|growth inhibitors|mesh-ancestor
6299913|NCT00002127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6299914|NCT00002128|Adefovir|adefovir|mesh-list
6299915|NCT00002128|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6299916|NCT00002128|Antiviral Agents|antiviral agents|mesh-ancestor
6299917|NCT00002128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299918|NCT00002128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6299919|NCT00002128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6299920|NCT00002128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299921|NCT00002128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299922|NCT00002129|Vesnarinone|vesnarinone|mesh-list
6299923|NCT00002129|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6299924|NCT00002129|Immunologic Factors|immunologic factors|mesh-ancestor
6299925|NCT00002129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6299926|NCT00002129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6299927|NCT00002129|Antiviral Agents|antiviral agents|mesh-ancestor
6299928|NCT00002129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299929|NCT00002129|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6299930|NCT00002129|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6299931|NCT00002129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299932|NCT00002129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299933|NCT00002129|Protective Agents|protective agents|mesh-ancestor
6299934|NCT00002130|Vesnarinone|vesnarinone|mesh-list
6299935|NCT00002130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6299936|NCT00002130|Immunologic Factors|immunologic factors|mesh-ancestor
6299937|NCT00002130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6299938|NCT00002130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6299939|NCT00002130|Antiviral Agents|antiviral agents|mesh-ancestor
6299940|NCT00002130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299941|NCT00002130|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6299942|NCT00002130|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6299943|NCT00002130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299944|NCT00002130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299945|NCT00002130|Protective Agents|protective agents|mesh-ancestor
6299946|NCT00002131|Vesnarinone|vesnarinone|mesh-list
6299947|NCT00002131|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6299948|NCT00002131|Immunologic Factors|immunologic factors|mesh-ancestor
6299949|NCT00002131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6299950|NCT00002131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6299951|NCT00002131|Antiviral Agents|antiviral agents|mesh-ancestor
6299952|NCT00002131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299953|NCT00002131|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6299954|NCT00002131|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6299955|NCT00002131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299956|NCT00002131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299957|NCT00002131|Protective Agents|protective agents|mesh-ancestor
6299958|NCT00002132|Itraconazole|itraconazole|mesh-list
6299959|NCT00002132|Fluconazole|fluconazole|mesh-list
6299960|NCT00002132|Antifungal Agents|antifungal agents|mesh-ancestor
6299961|NCT00002132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299962|NCT00002132|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6299963|NCT00002132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6299964|NCT00002132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299965|NCT00002132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299966|NCT00002132|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6299967|NCT00002132|Hormone Antagonists|hormone antagonists|mesh-ancestor
6299968|NCT00002132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6299969|NCT00002132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6299970|NCT00002132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6299971|NCT00002132|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6299972|NCT00002132|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6299973|NCT00002133|Itraconazole|itraconazole|mesh-list
6299974|NCT00002133|Antifungal Agents|antifungal agents|mesh-ancestor
6299975|NCT00002133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299976|NCT00002133|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6299977|NCT00002133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6299978|NCT00002133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299979|NCT00002133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299980|NCT00002133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6299981|NCT00002133|Hormone Antagonists|hormone antagonists|mesh-ancestor
6299982|NCT00002133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6299983|NCT00002133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6299984|NCT00002133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6299985|NCT00002134|Ganciclovir|ganciclovir|mesh-list
6299986|NCT00002134|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6299987|NCT00002134|Antiviral Agents|antiviral agents|mesh-ancestor
6299988|NCT00002134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299989|NCT00002134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6299990|NCT00002134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299991|NCT00002134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299992|NCT00002135|Ganciclovir|ganciclovir|mesh-list
6299993|NCT00002135|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6299994|NCT00002135|Antiviral Agents|antiviral agents|mesh-ancestor
6299995|NCT00002135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6299996|NCT00002135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6299997|NCT00002135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6299998|NCT00002135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6299999|NCT00002139|Azithromycin|azithromycin|mesh-list
6300000|NCT00002139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6300001|NCT00002139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300002|NCT00002140|Azithromycin|azithromycin|mesh-list
6300003|NCT00002140|Clarithromycin|clarithromycin|mesh-list
6300004|NCT00002140|Ethambutol|ethambutol|mesh-list
6300005|NCT00002140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6300006|NCT00002140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300007|NCT00002140|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6300008|NCT00002140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300009|NCT00002140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300010|NCT00002140|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6300011|NCT00002140|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6300012|NCT00002140|Antitubercular Agents|antitubercular agents|mesh-ancestor
6300013|NCT00002141|Abacavir|abacavir|mesh-list
6300014|NCT00002141|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6300015|NCT00002141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6300016|NCT00002141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300017|NCT00002141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300018|NCT00002141|Antiviral Agents|antiviral agents|mesh-ancestor
6300019|NCT00002141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300020|NCT00002141|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6300021|NCT00002141|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6300022|NCT00002142|Cidofovir|cidofovir|mesh-list
6300023|NCT00002142|Probenecid|probenecid|mesh-list
6300024|NCT00002142|Uricosuric Agents|uricosuric agents|mesh-ancestor
6300025|NCT00002142|Gout Suppressants|gout suppressants|mesh-ancestor
6300026|NCT00002142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6300027|NCT00002142|Renal Agents|renal agents|mesh-ancestor
6300028|NCT00002142|Antiviral Agents|antiviral agents|mesh-ancestor
6300029|NCT00002142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300030|NCT00002142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300031|NCT00002142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300032|NCT00002143|Acitretin|acitretin|mesh-list
6300033|NCT00002143|Keratolytic Agents|keratolytic agents|mesh-ancestor
6300034|NCT00002143|Dermatologic Agents|dermatologic agents|mesh-ancestor
6300035|NCT00002144|Foscarnet|foscarnet|mesh-list
6300036|NCT00002144|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
6300037|NCT00002144|Antiviral Agents|antiviral agents|mesh-ancestor
6300038|NCT00002144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300039|NCT00002144|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6300040|NCT00002144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6300041|NCT00002144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300042|NCT00002144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392175|NCT00195585|Micronutrients|micronutrients|mesh-ancestor
6392176|NCT00195598|Paroxetine|paroxetine|mesh-list
6392177|NCT00195598|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6392178|NCT00195598|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6392179|NCT00195598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6392180|NCT00195598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6392181|NCT00195598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392182|NCT00195598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6392183|NCT00195598|Serotonin Agents|serotonin agents|mesh-ancestor
6392184|NCT00195598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392185|NCT00195598|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6392186|NCT00195598|Antidepressive Agents|antidepressive agents|mesh-ancestor
6392187|NCT00195598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6392188|NCT00195598|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6392189|NCT00195598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6392190|NCT00195598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6392191|NCT00195598|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6392192|NCT00195611|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6392193|NCT00195611|Immunologic Factors|immunologic factors|mesh-ancestor
6392194|NCT00195611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392195|NCT00195637|Immunoglobulins|immunoglobulins|mesh-list
6392196|NCT00195637|Antibodies|antibodies|mesh-list
6392197|NCT00195637|gamma-Globulins|gamma-globulins|mesh-list
6392198|NCT00195637|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6392199|NCT00195637|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6392200|NCT00195637|Immunologic Factors|immunologic factors|mesh-ancestor
6392201|NCT00195637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392202|NCT00195689|Adalimumab|adalimumab|mesh-list
6392203|NCT00195689|Antibodies|antibodies|mesh-list
6392204|NCT00195689|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6392205|NCT00195689|Immunologic Factors|immunologic factors|mesh-ancestor
6392206|NCT00195689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392207|NCT00195689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6392208|NCT00195689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6300043|NCT00002145|Foscarnet|foscarnet|mesh-list
6300044|NCT00002145|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
6300045|NCT00002145|Antiviral Agents|antiviral agents|mesh-ancestor
6300046|NCT00002145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300047|NCT00002145|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6300048|NCT00002145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6300049|NCT00002145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300050|NCT00002145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300051|NCT00002146|Foscarnet|foscarnet|mesh-list
6300052|NCT00002146|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
6300053|NCT00002146|Magnesium Sulfate|magnesium sulfate|mesh-list
6300054|NCT00002146|Analgesics|analgesics|mesh-ancestor
6300055|NCT00002146|Sensory System Agents|sensory system agents|mesh-ancestor
6300056|NCT00002146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6300057|NCT00002146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6300058|NCT00002146|Anesthetics|anesthetics|mesh-ancestor
6300059|NCT00002146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6300060|NCT00002146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6300061|NCT00002146|Anticonvulsants|anticonvulsants|mesh-ancestor
6300062|NCT00002146|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6300063|NCT00002146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6300064|NCT00002146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300065|NCT00002146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6300066|NCT00002146|Tocolytic Agents|tocolytic agents|mesh-ancestor
6300067|NCT00002146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6300068|NCT00002146|Antiviral Agents|antiviral agents|mesh-ancestor
6300069|NCT00002146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300070|NCT00002146|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6300071|NCT00002146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6300072|NCT00002146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300073|NCT00002147|Doxorubicin|doxorubicin|mesh-list
6300074|NCT00002147|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6300075|NCT00002147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6300076|NCT00002147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6300077|NCT00002147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6300078|NCT00002147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6300079|NCT00002147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300080|NCT00002147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300081|NCT00002148|OPC 14117|opc 14117|mesh-list
6300082|NCT00002148|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6300083|NCT00002148|Antioxidants|antioxidants|mesh-ancestor
6300084|NCT00002148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300085|NCT00002148|Protective Agents|protective agents|mesh-ancestor
6300086|NCT00002148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6300087|NCT00002149|Amoxicillin|amoxicillin|mesh-list
6300088|NCT00002149|Clavulanic Acid|clavulanic acid|mesh-list
6300089|NCT00002149|Clavulanic Acids|clavulanic acids|mesh-list
6300090|NCT00002149|Pseudoephedrine|pseudoephedrine|mesh-list
6300091|NCT00002149|Ephedrine|ephedrine|mesh-list
6300092|NCT00002149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6300093|NCT00002149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300094|NCT00002149|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6300095|NCT00002149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300096|NCT00002149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300097|NCT00002149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6300098|NCT00002149|Autonomic Agents|autonomic agents|mesh-ancestor
6300099|NCT00002149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6300100|NCT00002149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6300101|NCT00002149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6300102|NCT00002149|Respiratory System Agents|respiratory system agents|mesh-ancestor
6300103|NCT00002149|Nasal Decongestants|nasal decongestants|mesh-ancestor
6300104|NCT00002149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6300105|NCT00002149|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6300106|NCT00002149|Sympathomimetics|sympathomimetics|mesh-ancestor
6300107|NCT00002149|Adrenergic Agents|adrenergic agents|mesh-ancestor
6300108|NCT00002149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6300109|NCT00002154|Thioctic Acid|thioctic acid|mesh-list
6300110|NCT00002154|Selegiline|selegiline|mesh-list
6300111|NCT00002154|Antidepressive Agents|antidepressive agents|mesh-ancestor
6300112|NCT00002154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6300113|NCT00002154|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6300114|NCT00002154|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6300115|NCT00002154|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6300116|NCT00002154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300117|NCT00002154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300118|NCT00002154|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6300119|NCT00002154|Protective Agents|protective agents|mesh-ancestor
6300120|NCT00002154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6300121|NCT00002154|Antioxidants|antioxidants|mesh-ancestor
6300122|NCT00002154|Vitamin B Complex|vitamin b complex|mesh-ancestor
6300123|NCT00002154|Vitamins|vitamins|mesh-ancestor
6015602|NCT00358579|Adrenergic Agents|adrenergic agents|mesh-ancestor
6018483|NCT00381043|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6300124|NCT00002154|Micronutrients|micronutrients|mesh-ancestor
6300125|NCT00002155|Lamivudine|lamivudine|mesh-list
6300126|NCT00002155|Zidovudine|zidovudine|mesh-list
6300127|NCT00002155|Indinavir|indinavir|mesh-list
6300128|NCT00002155|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6300129|NCT00002155|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6300130|NCT00002155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300131|NCT00002155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300132|NCT00002155|Antiviral Agents|antiviral agents|mesh-ancestor
6300133|NCT00002155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300134|NCT00002155|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6300135|NCT00002155|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6300136|NCT00002155|Antimetabolites|antimetabolites|mesh-ancestor
6300137|NCT00002155|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6300138|NCT00002155|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6300139|NCT00002155|Protease Inhibitors|protease inhibitors|mesh-ancestor
6300140|NCT00002156|Ganciclovir|ganciclovir|mesh-list
6300141|NCT00002156|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6300142|NCT00002156|Fomivirsen|fomivirsen|mesh-list
6300143|NCT00002156|Antiviral Agents|antiviral agents|mesh-ancestor
6300144|NCT00002156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300145|NCT00002156|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6300146|NCT00002156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300147|NCT00002156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300148|NCT00002157|Thalidomide|thalidomide|mesh-list
6300149|NCT00002157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6300150|NCT00002157|Immunologic Factors|immunologic factors|mesh-ancestor
6300151|NCT00002157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6300152|NCT00002157|Leprostatic Agents|leprostatic agents|mesh-ancestor
6300153|NCT00002157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6300154|NCT00002157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300155|NCT00002157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6300156|NCT00002157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6300157|NCT00002157|Growth Substances|growth substances|mesh-ancestor
6300158|NCT00002157|Growth Inhibitors|growth inhibitors|mesh-ancestor
6300159|NCT00002157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6300160|NCT00002158|Nitazoxanide|nitazoxanide|mesh-list
6300161|NCT00002158|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6300162|NCT00002158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300163|NCT00002159|Itraconazole|itraconazole|mesh-list
6300164|NCT00002159|Amphotericin B|amphotericin b|mesh-list
6300165|NCT00002159|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6300166|NCT00002159|Antifungal Agents|antifungal agents|mesh-ancestor
6300167|NCT00002159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300168|NCT00002159|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6300169|NCT00002159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6300170|NCT00002159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300171|NCT00002159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300172|NCT00002159|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6300173|NCT00002159|Hormone Antagonists|hormone antagonists|mesh-ancestor
6300174|NCT00002159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6300175|NCT00002159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6300176|NCT00002159|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6300177|NCT00002159|Amebicides|amebicides|mesh-ancestor
6300178|NCT00002159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6300179|NCT00002159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6300180|NCT00002159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6536505|NCT00817284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536506|NCT00817284|Growth Inhibitors|growth inhibitors|mesh-ancestor
6536507|NCT00817284|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6300181|NCT00002160|Ziconotide|ziconotide|mesh-list
6300182|NCT00002160|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6300183|NCT00002160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6300184|NCT00002160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300185|NCT00002160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6300186|NCT00002160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6300187|NCT00002160|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6300188|NCT00002160|Protective Agents|protective agents|mesh-ancestor
6300189|NCT00002160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6300190|NCT00002160|Analgesics|analgesics|mesh-ancestor
6300191|NCT00002160|Sensory System Agents|sensory system agents|mesh-ancestor
6300192|NCT00002160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6300193|NCT00002161|Adefovir|adefovir|mesh-list
6300194|NCT00002161|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6300195|NCT00002161|Antiviral Agents|antiviral agents|mesh-ancestor
6300196|NCT00002161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300197|NCT00002161|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6300198|NCT00002161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6300199|NCT00002161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300200|NCT00002161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300201|NCT00002162|Lamivudine|lamivudine|mesh-list
6300202|NCT00002162|Zidovudine|zidovudine|mesh-list
6300203|NCT00002162|Stavudine|stavudine|mesh-list
6300204|NCT00002162|Didanosine|didanosine|mesh-list
6300205|NCT00002162|Zalcitabine|zalcitabine|mesh-list
6300206|NCT00002162|Saquinavir|saquinavir|mesh-list
6300207|NCT00002162|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6300208|NCT00002162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6300209|NCT00002162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300210|NCT00002162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300211|NCT00002162|Antiviral Agents|antiviral agents|mesh-ancestor
6300212|NCT00002162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300213|NCT00002162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6300214|NCT00002162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6300215|NCT00002162|Antimetabolites|antimetabolites|mesh-ancestor
6300216|NCT00002162|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6300217|NCT00002162|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6300218|NCT00002162|Protease Inhibitors|protease inhibitors|mesh-ancestor
6300219|NCT00002162|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6300220|NCT00002162|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6300221|NCT00002163|Abacavir|abacavir|mesh-list
6300222|NCT00002163|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6300223|NCT00002163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6300224|NCT00002163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300225|NCT00002163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300226|NCT00002163|Antiviral Agents|antiviral agents|mesh-ancestor
6300227|NCT00002163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300228|NCT00002163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6300229|NCT00002163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6300230|NCT00002164|Nelfinavir|nelfinavir|mesh-list
6300231|NCT00002164|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6300232|NCT00002164|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6300233|NCT00002164|Protease Inhibitors|protease inhibitors|mesh-ancestor
6300234|NCT00002164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300235|NCT00002164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300236|NCT00002164|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6300237|NCT00002164|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6300238|NCT00002164|Antiviral Agents|antiviral agents|mesh-ancestor
6300239|NCT00002164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300240|NCT00002165|Nelfinavir|nelfinavir|mesh-list
6300241|NCT00002165|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6300242|NCT00002165|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6300243|NCT00002165|Protease Inhibitors|protease inhibitors|mesh-ancestor
6300244|NCT00002165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300245|NCT00002165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300246|NCT00002165|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6300247|NCT00002165|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6300248|NCT00002165|Antiviral Agents|antiviral agents|mesh-ancestor
6300249|NCT00002165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300250|NCT00002166|Nevirapine|nevirapine|mesh-list
6300251|NCT00002166|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6300252|NCT00002166|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6300253|NCT00002166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300254|NCT00002166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300255|NCT00002166|Antiviral Agents|antiviral agents|mesh-ancestor
6300256|NCT00002166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300257|NCT00002166|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6300258|NCT00002166|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6300259|NCT00002166|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6300260|NCT00002166|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6300261|NCT00002167|Tin etiopurpurin|tin etiopurpurin|mesh-list
6300262|NCT00002167|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6300263|NCT00002167|Dermatologic Agents|dermatologic agents|mesh-ancestor
6300264|NCT00002168|Lamivudine|lamivudine|mesh-list
6300265|NCT00002168|Zidovudine|zidovudine|mesh-list
6300266|NCT00002168|Stavudine|stavudine|mesh-list
6300267|NCT00002168|Didanosine|didanosine|mesh-list
6300268|NCT00002168|Indinavir|indinavir|mesh-list
6300269|NCT00002168|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6300270|NCT00002168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6300271|NCT00002168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300272|NCT00002168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300273|NCT00002168|Antiviral Agents|antiviral agents|mesh-ancestor
6300274|NCT00002168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300275|NCT00002168|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6536508|NCT00817284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6536509|NCT00817284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6536510|NCT00817284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536511|NCT00817284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6536512|NCT00817284|Alkylating Agents|alkylating agents|mesh-ancestor
6536513|NCT00817375|Milnacipran|milnacipran|mesh-list
6536514|NCT00817375|Mirtazapine|mirtazapine|mesh-list
6536515|NCT00817375|Sertraline|sertraline|mesh-list
6536516|NCT00817375|Fluoxetine|fluoxetine|mesh-list
6536517|NCT00817375|Paroxetine|paroxetine|mesh-list
6536518|NCT00817375|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6536519|NCT00817375|Nortriptyline|nortriptyline|mesh-list
6536520|NCT00817375|Antidepressive Agents|antidepressive agents|mesh-ancestor
6536521|NCT00817375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6536522|NCT00817375|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6536523|NCT00817375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6536524|NCT00817375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6536525|NCT00817375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536526|NCT00817375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6300276|NCT00002168|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6300277|NCT00002168|Antimetabolites|antimetabolites|mesh-ancestor
6536527|NCT00817375|Serotonin Agents|serotonin agents|mesh-ancestor
6300278|NCT00002168|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6300279|NCT00002168|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6300280|NCT00002168|Protease Inhibitors|protease inhibitors|mesh-ancestor
6300281|NCT00002169|Nelfinavir|nelfinavir|mesh-list
6300282|NCT00002169|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6300283|NCT00002169|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6300284|NCT00002169|Protease Inhibitors|protease inhibitors|mesh-ancestor
6300285|NCT00002169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300286|NCT00002169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300287|NCT00002169|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6300288|NCT00002169|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6300289|NCT00002169|Antiviral Agents|antiviral agents|mesh-ancestor
6300290|NCT00002169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300291|NCT00002170|Nelfinavir|nelfinavir|mesh-list
6300292|NCT00002170|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6300293|NCT00002170|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6300294|NCT00002170|Protease Inhibitors|protease inhibitors|mesh-ancestor
6300295|NCT00002170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300296|NCT00002170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300297|NCT00002170|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6300298|NCT00002170|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6300299|NCT00002170|Antiviral Agents|antiviral agents|mesh-ancestor
6300300|NCT00002170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300301|NCT00002171|Nelfinavir|nelfinavir|mesh-list
6300302|NCT00002171|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6300303|NCT00002171|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6300304|NCT00002171|Protease Inhibitors|protease inhibitors|mesh-ancestor
6300305|NCT00002171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300306|NCT00002171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300307|NCT00002171|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6300308|NCT00002171|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6300309|NCT00002171|Antiviral Agents|antiviral agents|mesh-ancestor
6300310|NCT00002171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300311|NCT00002174|Thalidomide|thalidomide|mesh-list
6300312|NCT00002174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6300313|NCT00002174|Immunologic Factors|immunologic factors|mesh-ancestor
6300314|NCT00002174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6300315|NCT00002174|Leprostatic Agents|leprostatic agents|mesh-ancestor
6300316|NCT00002174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6300317|NCT00002174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300318|NCT00002174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6300319|NCT00002174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6300320|NCT00002174|Growth Substances|growth substances|mesh-ancestor
6300321|NCT00002174|Growth Inhibitors|growth inhibitors|mesh-ancestor
6300322|NCT00002174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6300323|NCT00002176|Stavudine|stavudine|mesh-list
6300324|NCT00002176|Didanosine|didanosine|mesh-list
6300325|NCT00002176|Nelfinavir|nelfinavir|mesh-list
6300326|NCT00002176|Hydroxyurea|hydroxyurea|mesh-list
6300327|NCT00002176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6300328|NCT00002176|Antisickling Agents|antisickling agents|mesh-ancestor
6300329|NCT00002176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300330|NCT00002176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536528|NCT00817375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536529|NCT00817375|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6536530|NCT00817375|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6536531|NCT00817375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6536532|NCT00817375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6536533|NCT00817375|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6300331|NCT00002176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6300332|NCT00002176|Antimetabolites|antimetabolites|mesh-ancestor
6300333|NCT00002176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6300334|NCT00002176|Antiviral Agents|antiviral agents|mesh-ancestor
6300335|NCT00002176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300336|NCT00002176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6300337|NCT00002176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6300338|NCT00002176|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6300339|NCT00002176|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6300340|NCT00002176|Protease Inhibitors|protease inhibitors|mesh-ancestor
6300341|NCT00002177|Stavudine|stavudine|mesh-list
6300342|NCT00002177|Didanosine|didanosine|mesh-list
6300343|NCT00002177|Nelfinavir|nelfinavir|mesh-list
6300344|NCT00002177|Hydroxyurea|hydroxyurea|mesh-list
6300345|NCT00002177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6300346|NCT00002177|Antisickling Agents|antisickling agents|mesh-ancestor
6300347|NCT00002177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6392209|NCT00195728|Acetaminophen|acetaminophen|mesh-list
6300348|NCT00002177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300349|NCT00002177|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6015603|NCT00358579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6015604|NCT00358579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015605|NCT00358579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6015606|NCT00358579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6015607|NCT00358579|Autonomic Agents|autonomic agents|mesh-ancestor
6015608|NCT00358579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6300350|NCT00002177|Antimetabolites|antimetabolites|mesh-ancestor
6300351|NCT00002177|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6300352|NCT00002177|Antiviral Agents|antiviral agents|mesh-ancestor
6300353|NCT00002177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300354|NCT00002177|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6300355|NCT00002177|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6536534|NCT00817375|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6536535|NCT00817375|Histamine Antagonists|histamine antagonists|mesh-ancestor
6536536|NCT00817375|Histamine Agents|histamine agents|mesh-ancestor
6300356|NCT00002177|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6300357|NCT00002177|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6300358|NCT00002177|Protease Inhibitors|protease inhibitors|mesh-ancestor
6300359|NCT00002178|Ritonavir|ritonavir|mesh-list
6300360|NCT00002178|Nelfinavir|nelfinavir|mesh-list
6300361|NCT00002178|Saquinavir|saquinavir|mesh-list
6015609|NCT00358579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6300362|NCT00002178|Delavirdine|delavirdine|mesh-list
6300363|NCT00002178|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6300364|NCT00002178|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6300365|NCT00002178|Protease Inhibitors|protease inhibitors|mesh-ancestor
6300366|NCT00002178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300367|NCT00002178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300368|NCT00002178|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6300369|NCT00002178|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6300370|NCT00002178|Antiviral Agents|antiviral agents|mesh-ancestor
6300371|NCT00002178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300372|NCT00002178|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6300373|NCT00002178|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6300374|NCT00002178|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6300375|NCT00002178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6300376|NCT00002179|Lamivudine|lamivudine|mesh-list
6300377|NCT00002179|Zidovudine|zidovudine|mesh-list
6300378|NCT00002179|Indinavir|indinavir|mesh-list
6536537|NCT00817375|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6536538|NCT00817375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6536539|NCT00817375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6536540|NCT00817375|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6536541|NCT00817375|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6536542|NCT00817375|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6536543|NCT00817375|Adrenergic Agents|adrenergic agents|mesh-ancestor
6536544|NCT00817375|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6300379|NCT00002179|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6300380|NCT00002179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6300381|NCT00002179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300382|NCT00002179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300383|NCT00002179|Antiviral Agents|antiviral agents|mesh-ancestor
6300384|NCT00002179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300385|NCT00002179|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6300386|NCT00002179|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6300387|NCT00002179|Antimetabolites|antimetabolites|mesh-ancestor
6300388|NCT00002179|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6536545|NCT00817375|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6536546|NCT00817375|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6536547|NCT00817375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6536548|NCT00817375|Analgesics|analgesics|mesh-ancestor
6536549|NCT00817375|Sensory System Agents|sensory system agents|mesh-ancestor
6300389|NCT00002179|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6300390|NCT00002179|Protease Inhibitors|protease inhibitors|mesh-ancestor
6300391|NCT00002180|Tenofovir|tenofovir|mesh-list
6300392|NCT00002180|Antiviral Agents|antiviral agents|mesh-ancestor
6300393|NCT00002180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300394|NCT00002180|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6300395|NCT00002180|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6300396|NCT00002180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300397|NCT00002180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300398|NCT00002180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6300399|NCT00002180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6300400|NCT00002181|Cidofovir|cidofovir|mesh-list
6300401|NCT00002181|Antiviral Agents|antiviral agents|mesh-ancestor
6300402|NCT00002181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300403|NCT00002181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300404|NCT00002181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300405|NCT00002182|Megestrol|megestrol|mesh-list
6300406|NCT00002182|Megestrol Acetate|megestrol acetate|mesh-list
6300407|NCT00002182|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6300408|NCT00002182|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6300409|NCT00002182|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6300410|NCT00002182|Contraceptive Agents|contraceptive agents|mesh-ancestor
6300411|NCT00002182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6300412|NCT00002182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6300413|NCT00002182|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6300414|NCT00002182|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6300415|NCT00002182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6300416|NCT00002182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6300417|NCT00002182|Appetite Stimulants|appetite stimulants|mesh-ancestor
6300418|NCT00002182|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6300419|NCT00002183|Lamivudine|lamivudine|mesh-list
6300420|NCT00002183|Zidovudine|zidovudine|mesh-list
6300421|NCT00002183|Abacavir|abacavir|mesh-list
6300422|NCT00002183|Amprenavir|amprenavir|mesh-list
6300423|NCT00002183|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6300424|NCT00002183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6300425|NCT00002183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300426|NCT00002183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300427|NCT00002183|Antiviral Agents|antiviral agents|mesh-ancestor
6300428|NCT00002183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300429|NCT00002183|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6300430|NCT00002183|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6536550|NCT00817375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6536551|NCT00817375|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6536552|NCT00817375|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6536553|NCT00817466|Epinephrine|epinephrine|mesh-list
6536554|NCT00817466|Racepinephrine|racepinephrine|mesh-list
6536555|NCT00817466|Epinephryl borate|epinephryl borate|mesh-list
6536556|NCT00817466|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6536557|NCT00817466|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6536558|NCT00817466|Adrenergic Agents|adrenergic agents|mesh-ancestor
6536559|NCT00817466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6536560|NCT00817466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300431|NCT00002183|Antimetabolites|antimetabolites|mesh-ancestor
6300432|NCT00002183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6300433|NCT00002183|Antitubercular Agents|antitubercular agents|mesh-ancestor
6300434|NCT00002183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6300435|NCT00002183|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6300436|NCT00002183|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6300437|NCT00002183|Protease Inhibitors|protease inhibitors|mesh-ancestor
6300438|NCT00002184|Lamivudine|lamivudine|mesh-list
6300439|NCT00002184|Zidovudine|zidovudine|mesh-list
6300440|NCT00002184|Stavudine|stavudine|mesh-list
6300441|NCT00002184|Adefovir|adefovir|mesh-list
6300442|NCT00002184|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6300443|NCT00002184|Nelfinavir|nelfinavir|mesh-list
6300444|NCT00002184|Saquinavir|saquinavir|mesh-list
6300445|NCT00002184|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6300446|NCT00002184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6300447|NCT00002184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300448|NCT00002184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300449|NCT00002184|Antiviral Agents|antiviral agents|mesh-ancestor
6300450|NCT00002184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300451|NCT00002184|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6300452|NCT00002184|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6300453|NCT00002184|Antimetabolites|antimetabolites|mesh-ancestor
6300454|NCT00002184|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6300455|NCT00002184|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6300456|NCT00002184|Protease Inhibitors|protease inhibitors|mesh-ancestor
6300457|NCT00002184|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6300458|NCT00002184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6300459|NCT00002185|Nelfinavir|nelfinavir|mesh-list
6300460|NCT00002185|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6300461|NCT00002185|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6300462|NCT00002185|Protease Inhibitors|protease inhibitors|mesh-ancestor
6300463|NCT00002185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300464|NCT00002185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300465|NCT00002185|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6300466|NCT00002185|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6536561|NCT00817466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536562|NCT00817466|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6536563|NCT00817466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6300467|NCT00002185|Antiviral Agents|antiviral agents|mesh-ancestor
6300468|NCT00002185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300469|NCT00002186|Acyclovir|acyclovir|mesh-list
6300470|NCT00002186|Antiviral Agents|antiviral agents|mesh-ancestor
6300471|NCT00002186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300472|NCT00002187|Fomivirsen|fomivirsen|mesh-list
6300473|NCT00002187|Antiviral Agents|antiviral agents|mesh-ancestor
6300474|NCT00002187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300475|NCT00002188|Alitretinoin|alitretinoin|mesh-list
6300476|NCT00002188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6300477|NCT00002188|Dermatologic Agents|dermatologic agents|mesh-ancestor
6300478|NCT00002189|Paclitaxel|paclitaxel|mesh-list
6300479|NCT00002189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6300480|NCT00002189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6300481|NCT00002189|Tubulin Modulators|tubulin modulators|mesh-ancestor
6300482|NCT00002189|Antimitotic Agents|antimitotic agents|mesh-ancestor
6300483|NCT00002189|Mitosis Modulators|mitosis modulators|mesh-ancestor
6300484|NCT00002189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300485|NCT00002190|Lamivudine|lamivudine|mesh-list
6300486|NCT00002190|Zidovudine|zidovudine|mesh-list
6300487|NCT00002190|Saquinavir|saquinavir|mesh-list
6300488|NCT00002190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6300489|NCT00002190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6300490|NCT00002190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6397093|NCT00210210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6300491|NCT00002190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300492|NCT00002190|Antiviral Agents|antiviral agents|mesh-ancestor
6300493|NCT00002190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300494|NCT00002190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6300495|NCT00002190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6300496|NCT00002190|Antimetabolites|antimetabolites|mesh-ancestor
6300497|NCT00002190|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6300498|NCT00002190|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6300499|NCT00002190|Protease Inhibitors|protease inhibitors|mesh-ancestor
6300500|NCT00002190|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6300501|NCT00002190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6300502|NCT00002191|Albendazole|albendazole|mesh-list
6300503|NCT00002191|Anthelmintics|anthelmintics|mesh-ancestor
6300504|NCT00002191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6300505|NCT00002191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300506|NCT00002191|Anticestodal Agents|anticestodal agents|mesh-ancestor
6300507|NCT00002191|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6300508|NCT00002191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6300509|NCT00002191|Tubulin Modulators|tubulin modulators|mesh-ancestor
6300510|NCT00002191|Antimitotic Agents|antimitotic agents|mesh-ancestor
6300511|NCT00002191|Mitosis Modulators|mitosis modulators|mesh-ancestor
6300512|NCT00002191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300513|NCT00002191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6300514|NCT00002192|Azithromycin|azithromycin|mesh-list
6300515|NCT00002192|Clarithromycin|clarithromycin|mesh-list
6300516|NCT00002192|Ethambutol|ethambutol|mesh-list
6300517|NCT00002192|Rifapentine|rifapentine|mesh-list
6300518|NCT00002192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6300519|NCT00002192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300520|NCT00002192|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6300521|NCT00002192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300522|NCT00002192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300523|NCT00002192|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6300524|NCT00002192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5724200|NCT03188471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5724201|NCT03188471|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5724202|NCT03188471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5724203|NCT03188471|Antipyretics|antipyretics|mesh-ancestor
5724204|NCT03188510|Mirikizumab|mirikizumab|mesh-list
5724205|NCT03188510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5724206|NCT03188510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5724207|NCT03188510|Analgesics|analgesics|mesh-ancestor
6300525|NCT00002192|Antitubercular Agents|antitubercular agents|mesh-ancestor
6300526|NCT00002192|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6300527|NCT00002192|Leprostatic Agents|leprostatic agents|mesh-ancestor
6300528|NCT00002193|Amprenavir|amprenavir|mesh-list
6300529|NCT00002193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5724208|NCT03188510|Sensory System Agents|sensory system agents|mesh-ancestor
6300530|NCT00002193|Antitubercular Agents|antitubercular agents|mesh-ancestor
6300531|NCT00002193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6300532|NCT00002193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300533|NCT00002193|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6300534|NCT00002193|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6300535|NCT00002193|Protease Inhibitors|protease inhibitors|mesh-ancestor
6300536|NCT00002193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300537|NCT00002193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300538|NCT00002193|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6300539|NCT00002193|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6300540|NCT00002193|Antiviral Agents|antiviral agents|mesh-ancestor
6300541|NCT00002194|Clarithromycin|clarithromycin|mesh-list
6300542|NCT00002194|Erythromycin|erythromycin|mesh-list
6300543|NCT00002194|Erythromycin Estolate|erythromycin estolate|mesh-list
6300544|NCT00002194|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
6300545|NCT00002194|Erythromycin stearate|erythromycin stearate|mesh-list
6300546|NCT00002194|Nevirapine|nevirapine|mesh-list
6300547|NCT00002194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6300548|NCT00002194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300549|NCT00002194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6300550|NCT00002194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300551|NCT00002194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300552|NCT00002194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6300553|NCT00002194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6300554|NCT00002194|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6300555|NCT00002194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6300556|NCT00002194|Antiviral Agents|antiviral agents|mesh-ancestor
6300557|NCT00002194|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6300558|NCT00002194|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6300559|NCT00002194|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6300560|NCT00002194|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6300561|NCT00002194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6300562|NCT00002195|Lamivudine|lamivudine|mesh-list
6300563|NCT00002195|Zidovudine|zidovudine|mesh-list
6300564|NCT00002195|Amprenavir|amprenavir|mesh-list
6300565|NCT00002195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6300566|NCT00002195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6300567|NCT00002195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300568|NCT00002195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300569|NCT00002195|Antiviral Agents|antiviral agents|mesh-ancestor
6300570|NCT00002195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6536564|NCT00817466|Autonomic Agents|autonomic agents|mesh-ancestor
6536565|NCT00817466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6536566|NCT00817466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6536567|NCT00817466|Respiratory System Agents|respiratory system agents|mesh-ancestor
6536568|NCT00817466|Mydriatics|mydriatics|mesh-ancestor
6300571|NCT00002195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6300572|NCT00002195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6300573|NCT00002195|Antimetabolites|antimetabolites|mesh-ancestor
6300574|NCT00002195|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6300575|NCT00002195|Antitubercular Agents|antitubercular agents|mesh-ancestor
6300576|NCT00002195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6300577|NCT00002195|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6300578|NCT00002195|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6300579|NCT00002195|Protease Inhibitors|protease inhibitors|mesh-ancestor
6300580|NCT00002197|Abacavir|abacavir|mesh-list
6536569|NCT00817466|Sympathomimetics|sympathomimetics|mesh-ancestor
6536570|NCT00817466|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6536571|NCT00817557|Loteprednol Etabonate|loteprednol etabonate|mesh-list
6536572|NCT00817557|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6536573|NCT00817583|Docetaxel|docetaxel|mesh-list
6536574|NCT00817583|Fluorouracil|fluorouracil|mesh-list
6536575|NCT00817583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6536576|NCT00817583|Tubulin Modulators|tubulin modulators|mesh-ancestor
6536577|NCT00817583|Antimitotic Agents|antimitotic agents|mesh-ancestor
6536578|NCT00817583|Mitosis Modulators|mitosis modulators|mesh-ancestor
6536579|NCT00817583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536580|NCT00817583|Antimetabolites|antimetabolites|mesh-ancestor
6536581|NCT00817583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6536582|NCT00817583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6536583|NCT00817583|Immunologic Factors|immunologic factors|mesh-ancestor
6300581|NCT00002197|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6300582|NCT00002197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6300583|NCT00002197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300584|NCT00002197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300585|NCT00002197|Antiviral Agents|antiviral agents|mesh-ancestor
6300586|NCT00002197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300587|NCT00002197|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6300588|NCT00002197|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6300589|NCT00002198|Abacavir|abacavir|mesh-list
6300590|NCT00002198|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6300591|NCT00002198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6300592|NCT00002198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300593|NCT00002198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300594|NCT00002198|Antiviral Agents|antiviral agents|mesh-ancestor
6300595|NCT00002198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300596|NCT00002198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6300597|NCT00002198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6300598|NCT00002199|Lamivudine|lamivudine|mesh-list
6300599|NCT00002199|Zidovudine|zidovudine|mesh-list
6300600|NCT00002199|Abacavir|abacavir|mesh-list
6300601|NCT00002199|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6300602|NCT00002199|Indinavir|indinavir|mesh-list
6300603|NCT00002199|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6300604|NCT00002199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6300605|NCT00002199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300606|NCT00002199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300607|NCT00002199|Antiviral Agents|antiviral agents|mesh-ancestor
6300608|NCT00002199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300609|NCT00002199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6300610|NCT00002199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6300611|NCT00002199|Antimetabolites|antimetabolites|mesh-ancestor
6300612|NCT00002199|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6300613|NCT00002199|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6300614|NCT00002199|Protease Inhibitors|protease inhibitors|mesh-ancestor
6300615|NCT00002200|Abacavir|abacavir|mesh-list
6300616|NCT00002200|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6300617|NCT00002200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6300618|NCT00002200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300619|NCT00002200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300620|NCT00002200|Antiviral Agents|antiviral agents|mesh-ancestor
6300621|NCT00002200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300622|NCT00002200|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6300623|NCT00002200|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6300624|NCT00002201|Ritonavir|ritonavir|mesh-list
6300625|NCT00002201|Nelfinavir|nelfinavir|mesh-list
6300626|NCT00002201|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6300627|NCT00002201|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6300628|NCT00002201|Protease Inhibitors|protease inhibitors|mesh-ancestor
6300629|NCT00002201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300630|NCT00002201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300631|NCT00002201|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6300632|NCT00002201|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6300633|NCT00002201|Antiviral Agents|antiviral agents|mesh-ancestor
6300634|NCT00002201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6536584|NCT00817583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536585|NCT00817622|Vitamin E|vitamin e|mesh-list
6536586|NCT00817622|Vitamins|vitamins|mesh-ancestor
6536587|NCT00817622|Micronutrients|micronutrients|mesh-ancestor
6536588|NCT00817622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536589|NCT00817622|Antioxidants|antioxidants|mesh-ancestor
6536590|NCT00817622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536591|NCT00817622|Protective Agents|protective agents|mesh-ancestor
6536592|NCT00817648|Risperidone|risperidone|mesh-list
6536593|NCT00817648|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6536594|NCT00817648|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6536595|NCT00817648|Serotonin Agents|serotonin agents|mesh-ancestor
6536596|NCT00817648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6536597|NCT00817648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300635|NCT00002201|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6536598|NCT00817648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536599|NCT00817648|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6536600|NCT00817648|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6536601|NCT00817648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6536602|NCT00817648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6536603|NCT00817648|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6300636|NCT00002201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6300637|NCT00002202|Indinavir|indinavir|mesh-list
6300638|NCT00002202|Amprenavir|amprenavir|mesh-list
6300639|NCT00002202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6300640|NCT00002202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6300641|NCT00002202|Protease Inhibitors|protease inhibitors|mesh-ancestor
6300642|NCT00002202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300643|NCT00002202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300644|NCT00002202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6300645|NCT00002202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6300646|NCT00002202|Antiviral Agents|antiviral agents|mesh-ancestor
6300647|NCT00002202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300648|NCT00002202|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6300649|NCT00002202|Antitubercular Agents|antitubercular agents|mesh-ancestor
6300650|NCT00002202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6300651|NCT00002203|Lamivudine|lamivudine|mesh-list
6300652|NCT00002203|Zidovudine|zidovudine|mesh-list
6300653|NCT00002203|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6300654|NCT00002203|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6300655|NCT00002203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6300656|NCT00002203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300657|NCT00002203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300658|NCT00002203|Antiviral Agents|antiviral agents|mesh-ancestor
6300659|NCT00002203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300660|NCT00002203|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6300661|NCT00002203|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6300662|NCT00002203|Antimetabolites|antimetabolites|mesh-ancestor
6300663|NCT00002205|Abacavir|abacavir|mesh-list
6300664|NCT00002205|Amprenavir|amprenavir|mesh-list
6300665|NCT00002205|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6300666|NCT00002205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6300667|NCT00002205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300668|NCT00002205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300669|NCT00002205|Antiviral Agents|antiviral agents|mesh-ancestor
6300670|NCT00002205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300671|NCT00002205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6536604|NCT00817648|Dopamine Agents|dopamine agents|mesh-ancestor
6536605|NCT00817648|Antidepressive Agents|antidepressive agents|mesh-ancestor
6536606|NCT00817661|Vitamin A|vitamin a|mesh-list
6300672|NCT00002205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6300673|NCT00002205|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6300674|NCT00002205|Antitubercular Agents|antitubercular agents|mesh-ancestor
6300675|NCT00002205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6300676|NCT00002205|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6015610|NCT00358579|Respiratory System Agents|respiratory system agents|mesh-ancestor
6015611|NCT00358579|Mydriatics|mydriatics|mesh-ancestor
6015612|NCT00358579|Sympathomimetics|sympathomimetics|mesh-ancestor
6015613|NCT00358579|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6015614|NCT00358579|Hemostatics|hemostatics|mesh-ancestor
6015615|NCT00358579|Coagulants|coagulants|mesh-ancestor
6015616|NCT00358579|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6015617|NCT00358579|Natriuretic Agents|natriuretic agents|mesh-ancestor
6015618|NCT00358644|Decitabine|decitabine|mesh-list
6015619|NCT00358644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6015620|NCT00358644|Antimetabolites|antimetabolites|mesh-ancestor
6018484|NCT00381095|Pregabalin|pregabalin|mesh-list
6015621|NCT00358644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015622|NCT00358644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6015623|NCT00358644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6015624|NCT00358657|Mycophenolic Acid|mycophenolic acid|mesh-list
6015625|NCT00358657|Sirolimus|sirolimus|mesh-list
6015626|NCT00358657|Cyclophosphamide|cyclophosphamide|mesh-list
6015627|NCT00358657|Fludarabine|fludarabine|mesh-list
6015628|NCT00358657|Fludarabine phosphate|fludarabine phosphate|mesh-list
6015629|NCT00358657|Tacrolimus|tacrolimus|mesh-list
6300677|NCT00002205|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6300678|NCT00002205|Protease Inhibitors|protease inhibitors|mesh-ancestor
6300679|NCT00002206|Adefovir|adefovir|mesh-list
6300680|NCT00002206|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6300681|NCT00002206|Antiviral Agents|antiviral agents|mesh-ancestor
6300682|NCT00002206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300683|NCT00002206|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6015630|NCT00358657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6015631|NCT00358657|Immunologic Factors|immunologic factors|mesh-ancestor
6300684|NCT00002206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6300685|NCT00002206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300686|NCT00002206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300687|NCT00002208|Lamivudine|lamivudine|mesh-list
6300688|NCT00002208|Zidovudine|zidovudine|mesh-list
6015632|NCT00358657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6300689|NCT00002208|Stavudine|stavudine|mesh-list
6300690|NCT00002208|Indinavir|indinavir|mesh-list
6300691|NCT00002208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6300692|NCT00002208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6300693|NCT00002208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300694|NCT00002208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300695|NCT00002208|Antiviral Agents|antiviral agents|mesh-ancestor
6300696|NCT00002208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300697|NCT00002208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6300698|NCT00002208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6300699|NCT00002208|Antimetabolites|antimetabolites|mesh-ancestor
6300700|NCT00002208|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6536607|NCT00817661|Vitamins|vitamins|mesh-ancestor
6536608|NCT00817661|Micronutrients|micronutrients|mesh-ancestor
6536609|NCT00817661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536610|NCT00817687|Mycophenolic Acid|mycophenolic acid|mesh-list
6536611|NCT00817687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6536612|NCT00817687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6536613|NCT00817687|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6536614|NCT00817687|Antitubercular Agents|antitubercular agents|mesh-ancestor
6536615|NCT00817687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6536616|NCT00817687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6536617|NCT00817687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6536618|NCT00817687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536619|NCT00817713|Ivermectin|ivermectin|mesh-list
6536620|NCT00817713|Albendazole|albendazole|mesh-list
6536621|NCT00817713|Praziquantel|praziquantel|mesh-list
6536622|NCT00817713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6536623|NCT00817713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6536624|NCT00817713|Anthelmintics|anthelmintics|mesh-ancestor
6536625|NCT00817713|Anticestodal Agents|anticestodal agents|mesh-ancestor
6536626|NCT00817713|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6536627|NCT00817713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6536628|NCT00817713|Tubulin Modulators|tubulin modulators|mesh-ancestor
6536629|NCT00817713|Antimitotic Agents|antimitotic agents|mesh-ancestor
6536630|NCT00817713|Mitosis Modulators|mitosis modulators|mesh-ancestor
6536631|NCT00817713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536632|NCT00817713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6536633|NCT00817739|Leuprolide|leuprolide|mesh-list
6536634|NCT00817739|Flutamide|flutamide|mesh-list
6536635|NCT00817739|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6536636|NCT00817739|Fertility Agents|fertility agents|mesh-ancestor
6536637|NCT00817739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6536638|NCT00817739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536639|NCT00817739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6536640|NCT00817739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6536641|NCT00817739|Androgen Antagonists|androgen antagonists|mesh-ancestor
6300701|NCT00002208|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6300702|NCT00002208|Protease Inhibitors|protease inhibitors|mesh-ancestor
6300703|NCT00002210|Delavirdine|delavirdine|mesh-list
6300704|NCT00002210|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6300705|NCT00002210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6536642|NCT00817739|Hormone Antagonists|hormone antagonists|mesh-ancestor
6536643|NCT00817739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6536644|NCT00817765|Ritonavir|ritonavir|mesh-list
6300706|NCT00002210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300707|NCT00002210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300708|NCT00002210|Antiviral Agents|antiviral agents|mesh-ancestor
6300709|NCT00002210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300710|NCT00002210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6300711|NCT00002210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6300712|NCT00002211|Stavudine|stavudine|mesh-list
6300713|NCT00002211|Didanosine|didanosine|mesh-list
6300714|NCT00002211|Delavirdine|delavirdine|mesh-list
6300715|NCT00002211|Nelfinavir|nelfinavir|mesh-list
6300716|NCT00002211|Antimetabolites|antimetabolites|mesh-ancestor
6300717|NCT00002211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300718|NCT00002211|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6300719|NCT00002211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6300720|NCT00002211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300721|NCT00002211|Antiviral Agents|antiviral agents|mesh-ancestor
6300722|NCT00002211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300723|NCT00002211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6300724|NCT00002211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6300725|NCT00002211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6300726|NCT00002211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6300727|NCT00002211|Protease Inhibitors|protease inhibitors|mesh-ancestor
6300728|NCT00002212|Bexarotene|bexarotene|mesh-list
6300729|NCT00002212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6300730|NCT00002213|Efavirenz|efavirenz|mesh-list
6300731|NCT00002213|Abacavir|abacavir|mesh-list
6300732|NCT00002213|Amprenavir|amprenavir|mesh-list
6300733|NCT00002213|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6300734|NCT00002213|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6300735|NCT00002213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300736|NCT00002213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300737|NCT00002213|Antiviral Agents|antiviral agents|mesh-ancestor
6300738|NCT00002213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300739|NCT00002213|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6300740|NCT00002213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6300741|NCT00002213|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6300742|NCT00002213|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6300743|NCT00002213|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6300744|NCT00002213|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6300745|NCT00002213|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6536645|NCT00817765|Fosamprenavir|fosamprenavir|mesh-list
6536646|NCT00817765|Posaconazole|posaconazole|mesh-list
6536647|NCT00817765|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6536648|NCT00817765|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6536649|NCT00817765|Protease Inhibitors|protease inhibitors|mesh-ancestor
6536650|NCT00817765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6536651|NCT00817765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536652|NCT00817765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6300746|NCT00002213|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6300747|NCT00002213|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6300748|NCT00002213|Antitubercular Agents|antitubercular agents|mesh-ancestor
6300749|NCT00002213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6300750|NCT00002213|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6300751|NCT00002213|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6536653|NCT00817765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6536654|NCT00817765|Antiviral Agents|antiviral agents|mesh-ancestor
6536655|NCT00817765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6536656|NCT00817765|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6536657|NCT00817765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6536658|NCT00817765|Antifungal Agents|antifungal agents|mesh-ancestor
6300752|NCT00002213|Protease Inhibitors|protease inhibitors|mesh-ancestor
6300753|NCT00002214|Capravirine|capravirine|mesh-list
6300754|NCT00002214|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6536659|NCT00817765|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6536660|NCT00817765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6536661|NCT00817765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6536662|NCT00817765|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6536663|NCT00817765|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6536664|NCT00817765|Hormone Antagonists|hormone antagonists|mesh-ancestor
6536665|NCT00817765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6536666|NCT00817765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536667|NCT00817895|Cisplatin|cisplatin|mesh-list
6536668|NCT00817895|Fluorouracil|fluorouracil|mesh-list
6300755|NCT00002214|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6300756|NCT00002214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300757|NCT00002214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300758|NCT00002214|Antiviral Agents|antiviral agents|mesh-ancestor
6300759|NCT00002214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300760|NCT00002214|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6300761|NCT00002214|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6300762|NCT00002215|Nelfinavir|nelfinavir|mesh-list
6300763|NCT00002215|Emivirine|emivirine|mesh-list
6300764|NCT00002215|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6300765|NCT00002215|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6300766|NCT00002215|Protease Inhibitors|protease inhibitors|mesh-ancestor
6300767|NCT00002215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300768|NCT00002215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300769|NCT00002215|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6300770|NCT00002215|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6300771|NCT00002215|Antiviral Agents|antiviral agents|mesh-ancestor
6300772|NCT00002215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300773|NCT00002215|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6300774|NCT00002215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6300775|NCT00002216|Lamivudine|lamivudine|mesh-list
6300776|NCT00002216|Zidovudine|zidovudine|mesh-list
6300777|NCT00002216|Abacavir|abacavir|mesh-list
6300778|NCT00002216|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6300779|NCT00002216|Nelfinavir|nelfinavir|mesh-list
6300780|NCT00002216|Amprenavir|amprenavir|mesh-list
6300781|NCT00002216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6300782|NCT00002216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6300783|NCT00002216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300784|NCT00002216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300785|NCT00002216|Antiviral Agents|antiviral agents|mesh-ancestor
6300786|NCT00002216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300787|NCT00002216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6300788|NCT00002216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6300789|NCT00002216|Antimetabolites|antimetabolites|mesh-ancestor
6300790|NCT00002216|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6300791|NCT00002216|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6300792|NCT00002216|Protease Inhibitors|protease inhibitors|mesh-ancestor
6300793|NCT00002216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6300794|NCT00002216|Antitubercular Agents|antitubercular agents|mesh-ancestor
6300795|NCT00002216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6300796|NCT00002217|Lamivudine|lamivudine|mesh-list
6300797|NCT00002217|Zidovudine|zidovudine|mesh-list
6300798|NCT00002217|Abacavir|abacavir|mesh-list
6300799|NCT00002217|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6300800|NCT00002217|Amprenavir|amprenavir|mesh-list
6300801|NCT00002217|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6300802|NCT00002217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6300803|NCT00002217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300804|NCT00002217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300805|NCT00002217|Antiviral Agents|antiviral agents|mesh-ancestor
6300806|NCT00002217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300807|NCT00002217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6300808|NCT00002217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6300809|NCT00002217|Antimetabolites|antimetabolites|mesh-ancestor
6300810|NCT00002217|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6300811|NCT00002217|Antitubercular Agents|antitubercular agents|mesh-ancestor
6300812|NCT00002217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6300813|NCT00002217|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6300814|NCT00002217|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6300815|NCT00002217|Protease Inhibitors|protease inhibitors|mesh-ancestor
6300816|NCT00002219|Nelfinavir|nelfinavir|mesh-list
6300817|NCT00002219|Adefovir|adefovir|mesh-list
6300818|NCT00002219|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6300819|NCT00002219|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6300820|NCT00002219|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6300821|NCT00002219|Protease Inhibitors|protease inhibitors|mesh-ancestor
6300822|NCT00002219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300823|NCT00002219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300824|NCT00002219|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6300825|NCT00002219|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6300826|NCT00002219|Antiviral Agents|antiviral agents|mesh-ancestor
6300827|NCT00002219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300828|NCT00002219|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6300829|NCT00002219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6300830|NCT00002220|Efavirenz|efavirenz|mesh-list
6300831|NCT00002220|Adefovir|adefovir|mesh-list
6536669|NCT00817895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6536670|NCT00817895|Antimetabolites|antimetabolites|mesh-ancestor
6536671|NCT00817895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536672|NCT00817895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6536673|NCT00817895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6015633|NCT00358657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6300832|NCT00002220|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6300833|NCT00002220|Indinavir|indinavir|mesh-list
6300834|NCT00002220|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6300835|NCT00002220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6300836|NCT00002220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300837|NCT00002220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300838|NCT00002220|Antiviral Agents|antiviral agents|mesh-ancestor
6300839|NCT00002220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300840|NCT00002220|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6300841|NCT00002220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6536674|NCT00817895|Immunologic Factors|immunologic factors|mesh-ancestor
6300842|NCT00002220|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6300843|NCT00002220|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6300844|NCT00002220|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6300845|NCT00002220|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6300846|NCT00002220|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6300847|NCT00002220|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6300848|NCT00002220|Protease Inhibitors|protease inhibitors|mesh-ancestor
6300849|NCT00002220|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6300850|NCT00002220|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6300851|NCT00002222|Valganciclovir|valganciclovir|mesh-list
6300852|NCT00002222|Antiviral Agents|antiviral agents|mesh-ancestor
6300853|NCT00002222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300854|NCT00002223|Ritonavir|ritonavir|mesh-list
6300855|NCT00002223|Indinavir|indinavir|mesh-list
6300856|NCT00002223|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6300857|NCT00002223|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6300858|NCT00002223|Protease Inhibitors|protease inhibitors|mesh-ancestor
6300859|NCT00002223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300860|NCT00002223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300861|NCT00002223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6300862|NCT00002223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6300863|NCT00002223|Antiviral Agents|antiviral agents|mesh-ancestor
6300864|NCT00002223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300865|NCT00002223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6300866|NCT00002223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6300867|NCT00002225|Efavirenz|efavirenz|mesh-list
6300868|NCT00002225|Stavudine|stavudine|mesh-list
6300869|NCT00002225|Didanosine|didanosine|mesh-list
6300870|NCT00002225|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6300871|NCT00002225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6300872|NCT00002225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300873|NCT00002225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300874|NCT00002225|Antiviral Agents|antiviral agents|mesh-ancestor
6300875|NCT00002225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300876|NCT00002225|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6300877|NCT00002225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6300878|NCT00002225|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6300879|NCT00002225|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6300880|NCT00002225|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6300881|NCT00002225|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6300882|NCT00002225|Antimetabolites|antimetabolites|mesh-ancestor
6300883|NCT00002225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6300884|NCT00002225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6300885|NCT00002226|Semaxinib|semaxinib|mesh-list
6300886|NCT00002226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6300887|NCT00002226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6300888|NCT00002226|Growth Substances|growth substances|mesh-ancestor
6300889|NCT00002226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6300890|NCT00002226|Growth Inhibitors|growth inhibitors|mesh-ancestor
6300891|NCT00002226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6300892|NCT00002226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6300893|NCT00002226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300894|NCT00002226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300895|NCT00002227|Lamivudine|lamivudine|mesh-list
6300896|NCT00002227|Efavirenz|efavirenz|mesh-list
6300897|NCT00002227|Stavudine|stavudine|mesh-list
6300898|NCT00002227|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6300899|NCT00002227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6300900|NCT00002227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300901|NCT00002227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300902|NCT00002227|Antiviral Agents|antiviral agents|mesh-ancestor
6300903|NCT00002227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300904|NCT00002227|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6300905|NCT00002227|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6300906|NCT00002227|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6300907|NCT00002227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6300908|NCT00002227|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6300909|NCT00002227|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6300910|NCT00002227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6300911|NCT00002227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6300912|NCT00002227|Antimetabolites|antimetabolites|mesh-ancestor
6300913|NCT00002228|Enfuvirtide|enfuvirtide|mesh-list
6300914|NCT00002228|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6300915|NCT00002228|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6300916|NCT00002228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300917|NCT00002228|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6300918|NCT00002228|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6300919|NCT00002228|Antiviral Agents|antiviral agents|mesh-ancestor
6300920|NCT00002228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300921|NCT00002229|Saquinavir|saquinavir|mesh-list
6300922|NCT00002229|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6300923|NCT00002229|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6300924|NCT00002229|Protease Inhibitors|protease inhibitors|mesh-ancestor
6300925|NCT00002229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300926|NCT00002229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300927|NCT00002229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6300928|NCT00002229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6300929|NCT00002229|Antiviral Agents|antiviral agents|mesh-ancestor
6300930|NCT00002229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300931|NCT00002229|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6300932|NCT00002229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6300933|NCT00002230|Efavirenz|efavirenz|mesh-list
6300934|NCT00002230|Stavudine|stavudine|mesh-list
6300935|NCT00002230|Didanosine|didanosine|mesh-list
6300936|NCT00002230|Hydroxyurea|hydroxyurea|mesh-list
6300937|NCT00002230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6300938|NCT00002230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6300939|NCT00002230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300940|NCT00002230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300941|NCT00002230|Antiviral Agents|antiviral agents|mesh-ancestor
6300942|NCT00002230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300943|NCT00002230|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6300944|NCT00002230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6300945|NCT00002230|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6300946|NCT00002230|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6300947|NCT00002230|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6300948|NCT00002230|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6300949|NCT00002230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6300950|NCT00002230|Antisickling Agents|antisickling agents|mesh-ancestor
6300951|NCT00002230|Antimetabolites|antimetabolites|mesh-ancestor
6300952|NCT00002230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6300953|NCT00002230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6300954|NCT00002233|Lamivudine|lamivudine|mesh-list
6300955|NCT00002233|Abacavir|abacavir|mesh-list
6300956|NCT00002233|Indinavir|indinavir|mesh-list
6300957|NCT00002233|Amprenavir|amprenavir|mesh-list
6300958|NCT00002233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6300959|NCT00002233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6300960|NCT00002233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300961|NCT00002233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300962|NCT00002233|Antiviral Agents|antiviral agents|mesh-ancestor
6300963|NCT00002233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300964|NCT00002233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6300965|NCT00002233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6300966|NCT00002233|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6300967|NCT00002233|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6300968|NCT00002233|Protease Inhibitors|protease inhibitors|mesh-ancestor
6300969|NCT00002233|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6300970|NCT00002233|Antitubercular Agents|antitubercular agents|mesh-ancestor
6300971|NCT00002233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6300972|NCT00002234|Lamivudine|lamivudine|mesh-list
6300973|NCT00002234|Efavirenz|efavirenz|mesh-list
6300974|NCT00002234|Didanosine|didanosine|mesh-list
6300975|NCT00002234|Adefovir|adefovir|mesh-list
6300976|NCT00002234|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6300977|NCT00002234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6300978|NCT00002234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6300979|NCT00002234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300980|NCT00002234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300981|NCT00002234|Antiviral Agents|antiviral agents|mesh-ancestor
6300982|NCT00002234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6300983|NCT00002234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6300984|NCT00002234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6300985|NCT00002234|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6300986|NCT00002234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6300987|NCT00002234|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6300988|NCT00002234|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6300989|NCT00002234|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6300990|NCT00002234|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6300991|NCT00002234|Antimetabolites|antimetabolites|mesh-ancestor
6300992|NCT00002235|Efavirenz|efavirenz|mesh-list
6300993|NCT00002235|Nelfinavir|nelfinavir|mesh-list
6300994|NCT00002235|Indinavir|indinavir|mesh-list
6300995|NCT00002235|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6300996|NCT00002235|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6300997|NCT00002235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6300998|NCT00002235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6300999|NCT00002235|Antiviral Agents|antiviral agents|mesh-ancestor
6301000|NCT00002235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301001|NCT00002235|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6301002|NCT00002235|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6301003|NCT00002235|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6301004|NCT00002235|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6301005|NCT00002235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6301006|NCT00002235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6301007|NCT00002235|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6301008|NCT00002235|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6301009|NCT00002235|Protease Inhibitors|protease inhibitors|mesh-ancestor
6301010|NCT00002235|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6301011|NCT00002235|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6301012|NCT00002236|Zidovudine|zidovudine|mesh-list
6301013|NCT00002236|Delavirdine|delavirdine|mesh-list
6301014|NCT00002236|Indinavir|indinavir|mesh-list
6301015|NCT00002236|Antimetabolites|antimetabolites|mesh-ancestor
6301016|NCT00002236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301017|NCT00002236|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6301018|NCT00002236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6301019|NCT00002236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301020|NCT00002236|Antiviral Agents|antiviral agents|mesh-ancestor
6015634|NCT00358657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6015635|NCT00358657|Alkylating Agents|alkylating agents|mesh-ancestor
6015636|NCT00358657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015637|NCT00358657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6015638|NCT00358657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6015639|NCT00358657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6015640|NCT00358657|Antimetabolites|antimetabolites|mesh-ancestor
6015641|NCT00358657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6015642|NCT00358657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6015643|NCT00358657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6015644|NCT00358657|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6015645|NCT00358657|Antitubercular Agents|antitubercular agents|mesh-ancestor
6301021|NCT00002236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301022|NCT00002236|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6301023|NCT00002236|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6301024|NCT00002236|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5724209|NCT03188510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5724210|NCT03188510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724211|NCT03188510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5724212|NCT03188510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5724213|NCT03188510|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5724214|NCT03188510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5724215|NCT03188198|Prednisone|prednisone|mesh-list
5724216|NCT03188198|Cyclophosphamide|cyclophosphamide|mesh-list
5724217|NCT03188198|Rituximab|rituximab|mesh-list
5724218|NCT03188198|Doxorubicin|doxorubicin|mesh-list
5724219|NCT03188198|Etoposide|etoposide|mesh-list
5724220|NCT03188198|Etoposide phosphate|etoposide phosphate|mesh-list
5724221|NCT03188198|Vincristine|vincristine|mesh-list
5724222|NCT03188198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5724223|NCT03188198|Immunologic Factors|immunologic factors|mesh-ancestor
5724224|NCT03188198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724225|NCT03188198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5724226|NCT03188198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5724227|NCT03188198|Alkylating Agents|alkylating agents|mesh-ancestor
5724228|NCT03188198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724229|NCT03188198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5724230|NCT03188198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5724231|NCT03188198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5724232|NCT03188198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5724233|NCT03188198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5724234|NCT03188198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5724235|NCT03188198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5724236|NCT03188198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5724237|NCT03188198|Glucocorticoids|glucocorticoids|mesh-ancestor
5724238|NCT03188198|Hormones|hormones|mesh-ancestor
5724239|NCT03188198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5724240|NCT03188198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5724241|NCT03188198|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5724242|NCT03188198|Tubulin Modulators|tubulin modulators|mesh-ancestor
5724243|NCT03188198|Antimitotic Agents|antimitotic agents|mesh-ancestor
5724244|NCT03188198|Mitosis Modulators|mitosis modulators|mesh-ancestor
5724245|NCT03188289|Chitosan|chitosan|mesh-list
5724246|NCT03188289|Hyaluronic Acid|hyaluronic acid|mesh-list
5724247|NCT03188289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5724248|NCT03188289|Immunologic Factors|immunologic factors|mesh-ancestor
5724249|NCT03188289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724250|NCT03188289|Viscosupplements|viscosupplements|mesh-ancestor
5724251|NCT03188289|Protective Agents|protective agents|mesh-ancestor
5724252|NCT03188289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5724253|NCT03188289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5724254|NCT03188289|Antimetabolites|antimetabolites|mesh-ancestor
5724255|NCT03188289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724256|NCT03188289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5724257|NCT03188289|Chelating Agents|chelating agents|mesh-ancestor
5724258|NCT03188289|Sequestering Agents|sequestering agents|mesh-ancestor
5724259|NCT03188289|Hemostatics|hemostatics|mesh-ancestor
5724260|NCT03188289|Coagulants|coagulants|mesh-ancestor
5724261|NCT03188276|Sofosbuvir|sofosbuvir|mesh-list
5724262|NCT03188276|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
5724263|NCT03188276|Ledipasvir|ledipasvir|mesh-list
6301025|NCT00002236|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6301026|NCT00002236|Protease Inhibitors|protease inhibitors|mesh-ancestor
6301027|NCT00002238|Interferons|interferons|mesh-list
6301028|NCT00002238|Zidovudine|zidovudine|mesh-list
6301029|NCT00002238|Interferon-beta|interferon-beta|mesh-list
6301030|NCT00002238|Interferon beta-1b|interferon beta-1b|mesh-list
6301031|NCT00002238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6301032|NCT00002238|Antiviral Agents|antiviral agents|mesh-ancestor
6301033|NCT00002238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301034|NCT00002238|Antimetabolites|antimetabolites|mesh-ancestor
6301035|NCT00002238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301036|NCT00002238|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6301037|NCT00002238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6301038|NCT00002238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301039|NCT00002238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6301040|NCT00002238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6015646|NCT00358657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6015647|NCT00358657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6015648|NCT00358657|Antifungal Agents|antifungal agents|mesh-ancestor
6015649|NCT00358670|Infliximab|infliximab|mesh-list
6015650|NCT00358670|Dermatologic Agents|dermatologic agents|mesh-ancestor
6015651|NCT00358670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6301041|NCT00002238|Immunologic Factors|immunologic factors|mesh-ancestor
6301042|NCT00002238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6301043|NCT00002238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6301044|NCT00002239|Ritonavir|ritonavir|mesh-list
6301045|NCT00002239|Amprenavir|amprenavir|mesh-list
6301046|NCT00002239|Abacavir|abacavir|mesh-list
6301047|NCT00002239|Enfuvirtide|enfuvirtide|mesh-list
6301048|NCT00002239|Efavirenz|efavirenz|mesh-list
6301049|NCT00002239|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6301050|NCT00002239|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6301051|NCT00002239|Protease Inhibitors|protease inhibitors|mesh-ancestor
6301052|NCT00002239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301053|NCT00002239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301054|NCT00002239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6301055|NCT00002239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5724264|NCT03188276|Antiviral Agents|antiviral agents|mesh-ancestor
6301056|NCT00002239|Antiviral Agents|antiviral agents|mesh-ancestor
6301057|NCT00002239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301058|NCT00002239|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6301059|NCT00002239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6301060|NCT00002239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6301061|NCT00002239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6301062|NCT00002239|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6301063|NCT00002239|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6301064|NCT00002239|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6301065|NCT00002239|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6301066|NCT00002239|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6301067|NCT00002239|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6301068|NCT00002239|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6301069|NCT00002239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6301070|NCT00002239|Antitubercular Agents|antitubercular agents|mesh-ancestor
6301071|NCT00002239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6301072|NCT00002241|Ritonavir|ritonavir|mesh-list
6301073|NCT00002241|Indinavir|indinavir|mesh-list
6301074|NCT00002241|Lamivudine|lamivudine|mesh-list
6301075|NCT00002241|Stavudine|stavudine|mesh-list
6301076|NCT00002241|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6301077|NCT00002241|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6301078|NCT00002241|Protease Inhibitors|protease inhibitors|mesh-ancestor
6301079|NCT00002241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301080|NCT00002241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301081|NCT00002241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6301082|NCT00002241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6301083|NCT00002241|Antiviral Agents|antiviral agents|mesh-ancestor
6301084|NCT00002241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301085|NCT00002241|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6301086|NCT00002241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6301087|NCT00002241|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6301088|NCT00002241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6301089|NCT00002241|Antimetabolites|antimetabolites|mesh-ancestor
6301090|NCT00002243|Calanolide A|calanolide a|mesh-list
6015652|NCT00358670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6015653|NCT00358735|Enoxaparin|enoxaparin|mesh-list
6015654|NCT00358735|Anticoagulants|anticoagulants|mesh-ancestor
6015655|NCT00358735|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6015656|NCT00358735|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6015657|NCT00358735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015658|NCT00358826|Atreleuton|atreleuton|mesh-list
6301091|NCT00002243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6301092|NCT00002243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6301093|NCT00002243|Antiviral Agents|antiviral agents|mesh-ancestor
6301094|NCT00002243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301095|NCT00002245|Lamivudine|lamivudine|mesh-list
6301096|NCT00002245|Abacavir|abacavir|mesh-list
6301097|NCT00002245|Amprenavir|amprenavir|mesh-list
6301098|NCT00002245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6301099|NCT00002245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6301100|NCT00002245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301101|NCT00002245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301102|NCT00002245|Antiviral Agents|antiviral agents|mesh-ancestor
6301103|NCT00002245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301104|NCT00002245|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6301105|NCT00002245|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6301106|NCT00002245|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6301107|NCT00002245|Antitubercular Agents|antitubercular agents|mesh-ancestor
6301108|NCT00002245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6301109|NCT00002245|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6301110|NCT00002245|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6301111|NCT00002245|Protease Inhibitors|protease inhibitors|mesh-ancestor
6301112|NCT00002247|Ganciclovir|ganciclovir|mesh-list
6301113|NCT00002247|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6301114|NCT00002247|Antiviral Agents|antiviral agents|mesh-ancestor
6301115|NCT00002247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301116|NCT00002247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6301117|NCT00002247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301118|NCT00002247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301119|NCT00002249|Levofloxacin|levofloxacin|mesh-list
6301120|NCT00002249|Ofloxacin|ofloxacin|mesh-list
6301121|NCT00002249|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6536675|NCT00817895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536676|NCT00817934|Bisacodyl|bisacodyl|mesh-list
6536677|NCT00817934|Cathartics|cathartics|mesh-ancestor
6536678|NCT00817934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6536679|NCT00817934|Laxatives|laxatives|mesh-ancestor
6301122|NCT00002249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301123|NCT00002249|Renal Agents|renal agents|mesh-ancestor
6301124|NCT00002249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6301125|NCT00002249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6301126|NCT00002249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6301127|NCT00002249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301128|NCT00002249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301129|NCT00002249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6301130|NCT00002249|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6301131|NCT00002249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6392210|NCT00195728|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
6536680|NCT00817960|Methylphenidate|methylphenidate|mesh-list
6536681|NCT00817960|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6536682|NCT00817960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536683|NCT00817960|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6536684|NCT00817960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6536685|NCT00817960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6536686|NCT00817960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536687|NCT00817960|Dopamine Agents|dopamine agents|mesh-ancestor
6536688|NCT00817960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6536689|NCT00817973|Caseins|caseins|mesh-list
6536690|NCT00817973|Chelating Agents|chelating agents|mesh-ancestor
6392211|NCT00195728|Hydrocodone|hydrocodone|mesh-list
6392212|NCT00195728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6392213|NCT00195728|Analgesics|analgesics|mesh-ancestor
6392214|NCT00195728|Sensory System Agents|sensory system agents|mesh-ancestor
6392215|NCT00195728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6392216|NCT00195728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392217|NCT00195728|Antipyretics|antipyretics|mesh-ancestor
6392218|NCT00195728|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6392219|NCT00195728|Narcotics|narcotics|mesh-ancestor
6392220|NCT00195728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6392221|NCT00195728|Antitussive Agents|antitussive agents|mesh-ancestor
6392222|NCT00195728|Respiratory System Agents|respiratory system agents|mesh-ancestor
6392223|NCT00195728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6392224|NCT00195728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6392225|NCT00195728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6536691|NCT00817973|Sequestering Agents|sequestering agents|mesh-ancestor
6301132|NCT00002250|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
6301133|NCT00002250|Immunologic Factors|immunologic factors|mesh-ancestor
6301134|NCT00002250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6301135|NCT00002251|Ganciclovir|ganciclovir|mesh-list
6301136|NCT00002251|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6301137|NCT00002251|Antiviral Agents|antiviral agents|mesh-ancestor
6301138|NCT00002251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301139|NCT00002251|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6301140|NCT00002251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301141|NCT00002251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301142|NCT00002252|Octreotide|octreotide|mesh-list
6301143|NCT00002252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6301144|NCT00002252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6301145|NCT00002252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6301146|NCT00002253|Octreotide|octreotide|mesh-list
6301147|NCT00002253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6301148|NCT00002253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6301149|NCT00002253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6301150|NCT00002254|Alovudine|alovudine|mesh-list
6301151|NCT00002254|Antiviral Agents|antiviral agents|mesh-ancestor
6301152|NCT00002254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301153|NCT00002255|Zidovudine|zidovudine|mesh-list
6301154|NCT00002255|Epoetin Alfa|epoetin alfa|mesh-list
6301155|NCT00002255|Antimetabolites|antimetabolites|mesh-ancestor
6301156|NCT00002255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301157|NCT00002255|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6301158|NCT00002255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6301159|NCT00002255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301160|NCT00002255|Antiviral Agents|antiviral agents|mesh-ancestor
6301161|NCT00002255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301162|NCT00002255|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6301163|NCT00002255|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6301164|NCT00002255|Hematinics|hematinics|mesh-ancestor
6301165|NCT00002256|Zalcitabine|zalcitabine|mesh-list
6301166|NCT00002256|Antimetabolites|antimetabolites|mesh-ancestor
6301167|NCT00002256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301168|NCT00002256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6301169|NCT00002256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6301170|NCT00002256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301171|NCT00002256|Antiviral Agents|antiviral agents|mesh-ancestor
6301172|NCT00002256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301173|NCT00002256|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6301174|NCT00002256|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6301175|NCT00002257|Ganciclovir|ganciclovir|mesh-list
6301176|NCT00002257|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6301177|NCT00002257|Antiviral Agents|antiviral agents|mesh-ancestor
6301178|NCT00002257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301179|NCT00002257|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6301180|NCT00002257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301181|NCT00002257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301182|NCT00002259|Mitoxantrone|mitoxantrone|mesh-list
6301183|NCT00002259|Analgesics|analgesics|mesh-ancestor
6301184|NCT00002259|Sensory System Agents|sensory system agents|mesh-ancestor
6301185|NCT00002259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6301186|NCT00002259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6301187|NCT00002259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6301188|NCT00002259|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6301189|NCT00002259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6301190|NCT00002259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301191|NCT00002259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301192|NCT00002260|Alovudine|alovudine|mesh-list
6301193|NCT00002260|Antiviral Agents|antiviral agents|mesh-ancestor
6301194|NCT00002260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301195|NCT00002261|Vaccines|vaccines|mesh-list
6301196|NCT00002261|Immunologic Factors|immunologic factors|mesh-ancestor
6301197|NCT00002261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6301198|NCT00002263|Zidovudine|zidovudine|mesh-list
6301199|NCT00002263|Sargramostim|sargramostim|mesh-list
6301200|NCT00002263|Antimetabolites|antimetabolites|mesh-ancestor
6301201|NCT00002263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301202|NCT00002263|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6301203|NCT00002263|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6301204|NCT00002263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301205|NCT00002263|Antiviral Agents|antiviral agents|mesh-ancestor
6301206|NCT00002263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301207|NCT00002263|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6301208|NCT00002263|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6301209|NCT00002263|Immunologic Factors|immunologic factors|mesh-ancestor
6301210|NCT00002263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6301211|NCT00002265|Zalcitabine|zalcitabine|mesh-list
6301212|NCT00002265|Antimetabolites|antimetabolites|mesh-ancestor
6301213|NCT00002265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301214|NCT00002265|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6301215|NCT00002265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6301216|NCT00002265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301217|NCT00002265|Antiviral Agents|antiviral agents|mesh-ancestor
6301218|NCT00002265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301219|NCT00002265|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6301220|NCT00002265|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6301221|NCT00002266|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
6301222|NCT00002266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6301223|NCT00002266|Immunologic Factors|immunologic factors|mesh-ancestor
6301224|NCT00002266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6301225|NCT00002266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6301226|NCT00002266|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6301227|NCT00002266|Protective Agents|protective agents|mesh-ancestor
6301228|NCT00002266|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6301229|NCT00002266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6301230|NCT00002266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301231|NCT00002266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301232|NCT00002266|Antiviral Agents|antiviral agents|mesh-ancestor
6301233|NCT00002266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301234|NCT00002267|Rifabutin|rifabutin|mesh-list
6301235|NCT00002267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6301236|NCT00002267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301237|NCT00002267|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6301238|NCT00002267|Antitubercular Agents|antitubercular agents|mesh-ancestor
6301239|NCT00002269|Zidovudine|zidovudine|mesh-list
6301240|NCT00002269|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
6301241|NCT00002269|Antimetabolites|antimetabolites|mesh-ancestor
6301242|NCT00002269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301243|NCT00002269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6301244|NCT00002269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6301245|NCT00002269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301246|NCT00002269|Antiviral Agents|antiviral agents|mesh-ancestor
6301247|NCT00002269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301248|NCT00002269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6301249|NCT00002269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6301250|NCT00002270|Interferons|interferons|mesh-list
6301251|NCT00002270|Interferon-alpha|interferon-alpha|mesh-list
6301252|NCT00002270|Interferon alpha-2|interferon alpha-2|mesh-list
6301253|NCT00002270|Zidovudine|zidovudine|mesh-list
6301254|NCT00002270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6301255|NCT00002270|Antiviral Agents|antiviral agents|mesh-ancestor
6301256|NCT00002270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301257|NCT00002270|Immunologic Factors|immunologic factors|mesh-ancestor
6301258|NCT00002270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6301259|NCT00002270|Antimetabolites|antimetabolites|mesh-ancestor
6301260|NCT00002270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301261|NCT00002270|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6301262|NCT00002270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6301263|NCT00002270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301264|NCT00002270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6301265|NCT00002270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6301266|NCT00002271|Alovudine|alovudine|mesh-list
6301267|NCT00002271|Antiviral Agents|antiviral agents|mesh-ancestor
6301268|NCT00002271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301269|NCT00002272|Foscarnet|foscarnet|mesh-list
6301270|NCT00002272|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
6301271|NCT00002272|Antiviral Agents|antiviral agents|mesh-ancestor
6301272|NCT00002272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301273|NCT00002272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6301274|NCT00002272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6301275|NCT00002272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301276|NCT00002272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301277|NCT00002273|Ganciclovir|ganciclovir|mesh-list
6301278|NCT00002273|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6301279|NCT00002273|Antiviral Agents|antiviral agents|mesh-ancestor
6301280|NCT00002273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301281|NCT00002273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6301282|NCT00002273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301283|NCT00002273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301284|NCT00002274|Didanosine|didanosine|mesh-list
6301285|NCT00002274|Antimetabolites|antimetabolites|mesh-ancestor
6301286|NCT00002274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301287|NCT00002274|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6301288|NCT00002274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6301289|NCT00002274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301290|NCT00002274|Antiviral Agents|antiviral agents|mesh-ancestor
6301291|NCT00002274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301292|NCT00002274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6301293|NCT00002274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6301294|NCT00002275|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6301295|NCT00002275|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6301296|NCT00002275|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6301297|NCT00002275|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6301298|NCT00002276|Zidovudine|zidovudine|mesh-list
6301299|NCT00002276|Ibuprofen|ibuprofen|mesh-list
6301300|NCT00002276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6301301|NCT00002276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6301302|NCT00002276|Analgesics|analgesics|mesh-ancestor
6301303|NCT00002276|Sensory System Agents|sensory system agents|mesh-ancestor
6301304|NCT00002276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6301305|NCT00002276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6301306|NCT00002276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6301307|NCT00002276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6301308|NCT00002276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6301309|NCT00002276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301310|NCT00002276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301311|NCT00002276|Antimetabolites|antimetabolites|mesh-ancestor
6301312|NCT00002276|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6301313|NCT00002276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6301314|NCT00002276|Antiviral Agents|antiviral agents|mesh-ancestor
6301315|NCT00002276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301316|NCT00002276|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6301317|NCT00002276|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6301318|NCT00002277|Fluconazole|fluconazole|mesh-list
6301319|NCT00002277|Amphotericin B|amphotericin b|mesh-list
6301320|NCT00002277|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6301321|NCT00002277|Antifungal Agents|antifungal agents|mesh-ancestor
6301322|NCT00002277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301323|NCT00002277|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6301324|NCT00002277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6301325|NCT00002277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301326|NCT00002277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301327|NCT00002277|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6301328|NCT00002277|Hormone Antagonists|hormone antagonists|mesh-ancestor
6301329|NCT00002277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6301330|NCT00002277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6301331|NCT00002277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6301332|NCT00002277|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6301333|NCT00002277|Amebicides|amebicides|mesh-ancestor
6301334|NCT00002277|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6301335|NCT00002277|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6301336|NCT00002277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6301337|NCT00002278|Diclazuril|diclazuril|mesh-list
6301338|NCT00002278|Coccidiostats|coccidiostats|mesh-ancestor
6301339|NCT00002278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6301340|NCT00002278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6301341|NCT00002278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301342|NCT00002279|Zalcitabine|zalcitabine|mesh-list
6301343|NCT00002279|Antimetabolites|antimetabolites|mesh-ancestor
6301344|NCT00002279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301345|NCT00002279|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6301346|NCT00002279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6301347|NCT00002279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301348|NCT00002279|Antiviral Agents|antiviral agents|mesh-ancestor
6301349|NCT00002279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301350|NCT00002279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6301351|NCT00002279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6301352|NCT00002280|Didanosine|didanosine|mesh-list
6301353|NCT00002280|Antimetabolites|antimetabolites|mesh-ancestor
6301354|NCT00002280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301355|NCT00002280|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6301356|NCT00002280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6301357|NCT00002280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301358|NCT00002280|Antiviral Agents|antiviral agents|mesh-ancestor
6301359|NCT00002280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301360|NCT00002280|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6301361|NCT00002280|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6301362|NCT00002281|Zidovudine|zidovudine|mesh-list
6301363|NCT00002281|Epoetin Alfa|epoetin alfa|mesh-list
6301364|NCT00002281|Antimetabolites|antimetabolites|mesh-ancestor
6301365|NCT00002281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301366|NCT00002281|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6301367|NCT00002281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6301368|NCT00002281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301369|NCT00002281|Antiviral Agents|antiviral agents|mesh-ancestor
6301370|NCT00002281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301371|NCT00002281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6301372|NCT00002281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6301373|NCT00002281|Hematinics|hematinics|mesh-ancestor
6301374|NCT00002282|Fluconazole|fluconazole|mesh-list
6301375|NCT00002282|Clotrimazole|clotrimazole|mesh-list
6301376|NCT00002282|Miconazole|miconazole|mesh-list
6301377|NCT00002282|Antifungal Agents|antifungal agents|mesh-ancestor
6301378|NCT00002282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6536692|NCT00817973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536693|NCT00818038|Natalizumab|natalizumab|mesh-list
6536694|NCT00818038|Immunologic Factors|immunologic factors|mesh-ancestor
6536695|NCT00818038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536696|NCT00818090|Paclitaxel|paclitaxel|mesh-list
6536697|NCT00818090|Cisplatin|cisplatin|mesh-list
6536698|NCT00818090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6536699|NCT00818090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6536700|NCT00818090|Tubulin Modulators|tubulin modulators|mesh-ancestor
6301379|NCT00002282|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6301380|NCT00002282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6301381|NCT00002282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301382|NCT00002282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301383|NCT00002282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6301384|NCT00002282|Hormone Antagonists|hormone antagonists|mesh-ancestor
6301385|NCT00002282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6301386|NCT00002282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6301387|NCT00002282|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6301388|NCT00002282|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6301389|NCT00002282|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6301390|NCT00002282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6536701|NCT00818090|Antimitotic Agents|antimitotic agents|mesh-ancestor
6536702|NCT00818090|Mitosis Modulators|mitosis modulators|mesh-ancestor
6536703|NCT00818090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536704|NCT00818103|Interferons|interferons|mesh-list
6536705|NCT00818103|Atorvastatin|atorvastatin|mesh-list
6536706|NCT00818103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6536707|NCT00818103|Antiviral Agents|antiviral agents|mesh-ancestor
6536708|NCT00818103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6536709|NCT00818103|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6536710|NCT00818103|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6536711|NCT00818103|Antimetabolites|antimetabolites|mesh-ancestor
6536712|NCT00818103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536713|NCT00818103|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6301391|NCT00002283|Trimethoprim|trimethoprim|mesh-list
6301392|NCT00002283|Dapsone|dapsone|mesh-list
6301393|NCT00002283|Sulfamethoxazole|sulfamethoxazole|mesh-list
6301394|NCT00002283|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6301395|NCT00002283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301396|NCT00002283|Renal Agents|renal agents|mesh-ancestor
6301397|NCT00002283|Antimalarials|antimalarials|mesh-ancestor
6301398|NCT00002283|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6301399|NCT00002283|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6301400|NCT00002283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6301401|NCT00002283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301402|NCT00002283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301403|NCT00002283|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6301404|NCT00002283|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6301405|NCT00002283|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6301406|NCT00002283|Leprostatic Agents|leprostatic agents|mesh-ancestor
6301407|NCT00002283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6301408|NCT00002284|Zidovudine|zidovudine|mesh-list
6301409|NCT00002284|Antimetabolites|antimetabolites|mesh-ancestor
6301410|NCT00002284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301411|NCT00002284|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6301412|NCT00002284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6301413|NCT00002284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301414|NCT00002284|Antiviral Agents|antiviral agents|mesh-ancestor
6301415|NCT00002284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301416|NCT00002284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6301417|NCT00002284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6301418|NCT00002285|Zidovudine|zidovudine|mesh-list
6301419|NCT00002285|Antimetabolites|antimetabolites|mesh-ancestor
6301420|NCT00002285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301421|NCT00002285|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6536714|NCT00818103|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6536715|NCT00818103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6536716|NCT00818155|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6536717|NCT00818155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6536718|NCT00818155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6301422|NCT00002285|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6301423|NCT00002285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301424|NCT00002285|Antiviral Agents|antiviral agents|mesh-ancestor
6301425|NCT00002285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301426|NCT00002285|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6301427|NCT00002285|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6301428|NCT00002286|Zidovudine|zidovudine|mesh-list
6301429|NCT00002286|Antimetabolites|antimetabolites|mesh-ancestor
6301430|NCT00002286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301431|NCT00002286|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6301432|NCT00002286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6301433|NCT00002286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301434|NCT00002286|Antiviral Agents|antiviral agents|mesh-ancestor
6301435|NCT00002286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301436|NCT00002286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6301437|NCT00002286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6301438|NCT00002287|Zidovudine|zidovudine|mesh-list
6301439|NCT00002287|Antimetabolites|antimetabolites|mesh-ancestor
6301440|NCT00002287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301441|NCT00002287|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6301442|NCT00002287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6301443|NCT00002287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301444|NCT00002287|Antiviral Agents|antiviral agents|mesh-ancestor
6301445|NCT00002287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301446|NCT00002287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6301447|NCT00002287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6301448|NCT00002288|Zidovudine|zidovudine|mesh-list
6301449|NCT00002288|Antimetabolites|antimetabolites|mesh-ancestor
6301450|NCT00002288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301451|NCT00002288|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6301452|NCT00002288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6301453|NCT00002288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301454|NCT00002288|Antiviral Agents|antiviral agents|mesh-ancestor
6301455|NCT00002288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301456|NCT00002288|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6301457|NCT00002288|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6301458|NCT00002289|Thymopentin|thymopentin|mesh-list
6301459|NCT00002289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6301460|NCT00002289|Immunologic Factors|immunologic factors|mesh-ancestor
6301461|NCT00002289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6301462|NCT00002290|Zidovudine|zidovudine|mesh-list
6301463|NCT00002290|Acyclovir|acyclovir|mesh-list
6301464|NCT00002290|Antimetabolites|antimetabolites|mesh-ancestor
6301465|NCT00002290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301466|NCT00002290|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6301467|NCT00002290|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6301468|NCT00002290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301469|NCT00002290|Antiviral Agents|antiviral agents|mesh-ancestor
6301470|NCT00002290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301471|NCT00002290|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6301472|NCT00002290|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6301473|NCT00002291|Pentamidine|pentamidine|mesh-list
6301474|NCT00002291|Antifungal Agents|antifungal agents|mesh-ancestor
6301475|NCT00002291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301476|NCT00002291|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6301477|NCT00002291|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6301478|NCT00002291|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6301479|NCT00002292|Pentamidine|pentamidine|mesh-list
6301480|NCT00002292|Antifungal Agents|antifungal agents|mesh-ancestor
6301481|NCT00002292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301482|NCT00002292|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6301483|NCT00002292|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6301484|NCT00002292|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6301485|NCT00002293|Nystatin|nystatin|mesh-list
6301486|NCT00002293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6301487|NCT00002293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301488|NCT00002293|Antifungal Agents|antifungal agents|mesh-ancestor
6301489|NCT00002293|Ionophores|ionophores|mesh-ancestor
6015659|NCT00358826|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6015660|NCT00358826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6015661|NCT00358826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015662|NCT00358917|Ritonavir|ritonavir|mesh-list
6015663|NCT00358917|Lopinavir|lopinavir|mesh-list
6015664|NCT00358917|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
6015665|NCT00358917|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6015666|NCT00358917|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6015667|NCT00358917|Protease Inhibitors|protease inhibitors|mesh-ancestor
6015668|NCT00358917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6015669|NCT00358917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015670|NCT00358917|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6015671|NCT00358917|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6015672|NCT00358917|Antiviral Agents|antiviral agents|mesh-ancestor
6015673|NCT00358917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6015674|NCT00358917|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6015675|NCT00358917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6015676|NCT00358917|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6015677|NCT00359021|Etravirine|etravirine|mesh-list
6015678|NCT00359021|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6015679|NCT00359021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6015680|NCT00359021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6015681|NCT00359021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015682|NCT00359021|Antiviral Agents|antiviral agents|mesh-ancestor
6015683|NCT00359021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6015684|NCT00359073|Montelukast|montelukast|mesh-list
6015685|NCT00359073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6015686|NCT00359073|Respiratory System Agents|respiratory system agents|mesh-ancestor
6015687|NCT00359073|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6015688|NCT00359073|Hormone Antagonists|hormone antagonists|mesh-ancestor
6015689|NCT00359073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6015690|NCT00359073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015691|NCT00359073|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6015692|NCT00359073|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6015693|NCT00359073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015694|NCT00359281|Niacin|niacin|mesh-list
6015695|NCT00359281|Dextromethorphan|dextromethorphan|mesh-list
6015696|NCT00359281|Atorvastatin|atorvastatin|mesh-list
6301490|NCT00002293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5724265|NCT03188276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5724266|NCT03188159|Vinorelbine|vinorelbine|mesh-list
5724267|NCT03188159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5724268|NCT03188159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5724269|NCT03188159|Tubulin Modulators|tubulin modulators|mesh-ancestor
5724270|NCT03188159|Antimitotic Agents|antimitotic agents|mesh-ancestor
5724271|NCT03188159|Mitosis Modulators|mitosis modulators|mesh-ancestor
5724272|NCT03188159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724273|NCT03188172|Dexamethasone|dexamethasone|mesh-list
5724274|NCT03188172|Cyclophosphamide|cyclophosphamide|mesh-list
5724275|NCT03188172|Melphalan|melphalan|mesh-list
5724276|NCT03188172|Lenalidomide|lenalidomide|mesh-list
5724277|NCT03188172|Bortezomib|bortezomib|mesh-list
6301491|NCT00002293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301492|NCT00002294|Fluconazole|fluconazole|mesh-list
6301493|NCT00002294|Antifungal Agents|antifungal agents|mesh-ancestor
6301494|NCT00002294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301495|NCT00002294|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6301496|NCT00002294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6301497|NCT00002294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301498|NCT00002294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301499|NCT00002294|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6301500|NCT00002294|Hormone Antagonists|hormone antagonists|mesh-ancestor
5724278|NCT03188172|Daratumumab|daratumumab|mesh-list
6301501|NCT00002294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6301502|NCT00002294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6301503|NCT00002294|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6301504|NCT00002294|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6301505|NCT00002295|Inosine Pranobex|inosine pranobex|mesh-list
6301506|NCT00002295|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6301507|NCT00002295|Immunologic Factors|immunologic factors|mesh-ancestor
6301508|NCT00002295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6301509|NCT00002295|Antiviral Agents|antiviral agents|mesh-ancestor
6301510|NCT00002295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301511|NCT00002296|Inosine Pranobex|inosine pranobex|mesh-list
6301512|NCT00002296|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6301513|NCT00002296|Immunologic Factors|immunologic factors|mesh-ancestor
6301514|NCT00002296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6301515|NCT00002296|Antiviral Agents|antiviral agents|mesh-ancestor
6301516|NCT00002296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301517|NCT00002297|Inosine Pranobex|inosine pranobex|mesh-list
6301518|NCT00002297|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6301519|NCT00002297|Immunologic Factors|immunologic factors|mesh-ancestor
6301520|NCT00002297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6301521|NCT00002297|Antiviral Agents|antiviral agents|mesh-ancestor
6301522|NCT00002297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301523|NCT00002298|Ribavirin|ribavirin|mesh-list
6301524|NCT00002298|Antimetabolites|antimetabolites|mesh-ancestor
6301525|NCT00002298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301526|NCT00002298|Antiviral Agents|antiviral agents|mesh-ancestor
6301527|NCT00002298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301528|NCT00002299|Interferons|interferons|mesh-list
6301529|NCT00002299|Interferon-beta|interferon-beta|mesh-list
6301530|NCT00002299|Ganciclovir|ganciclovir|mesh-list
6301531|NCT00002299|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6301532|NCT00002299|Interferon beta-1b|interferon beta-1b|mesh-list
6301533|NCT00002299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6301534|NCT00002299|Antiviral Agents|antiviral agents|mesh-ancestor
6301535|NCT00002299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6536719|NCT00818155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6536720|NCT00818155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536721|NCT00818155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6536722|NCT00818155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536723|NCT00818155|Antidepressive Agents|antidepressive agents|mesh-ancestor
6301536|NCT00002299|Immunologic Factors|immunologic factors|mesh-ancestor
6301537|NCT00002299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6301538|NCT00002299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6301539|NCT00002299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301540|NCT00002299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301541|NCT00002299|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6301542|NCT00002300|Megestrol|megestrol|mesh-list
6301543|NCT00002300|Megestrol Acetate|megestrol acetate|mesh-list
6301544|NCT00002300|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6301545|NCT00002300|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6301546|NCT00002300|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6301547|NCT00002300|Contraceptive Agents|contraceptive agents|mesh-ancestor
6301548|NCT00002300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6301549|NCT00002300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6301550|NCT00002300|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6301551|NCT00002300|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6301552|NCT00002300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6301553|NCT00002300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6301554|NCT00002300|Appetite Stimulants|appetite stimulants|mesh-ancestor
6301555|NCT00002300|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6301556|NCT00002301|Foscarnet|foscarnet|mesh-list
6301557|NCT00002301|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
6301558|NCT00002301|Antiviral Agents|antiviral agents|mesh-ancestor
6301559|NCT00002301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301560|NCT00002301|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6301561|NCT00002301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6301562|NCT00002301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301563|NCT00002301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301564|NCT00002302|Epoetin Alfa|epoetin alfa|mesh-list
6301565|NCT00002302|Hematinics|hematinics|mesh-ancestor
6301566|NCT00002303|Epoetin Alfa|epoetin alfa|mesh-list
6301567|NCT00002303|Hematinics|hematinics|mesh-ancestor
6301568|NCT00002304|Fluconazole|fluconazole|mesh-list
6301569|NCT00002304|Ketoconazole|ketoconazole|mesh-list
6301570|NCT00002304|Antifungal Agents|antifungal agents|mesh-ancestor
6301571|NCT00002304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301572|NCT00002304|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6301573|NCT00002304|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6301574|NCT00002304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301575|NCT00002304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301576|NCT00002304|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6301577|NCT00002304|Hormone Antagonists|hormone antagonists|mesh-ancestor
6301578|NCT00002304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6301579|NCT00002304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6301580|NCT00002304|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6301581|NCT00002304|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6301582|NCT00002304|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6301583|NCT00002305|Fluconazole|fluconazole|mesh-list
6301584|NCT00002305|Amphotericin B|amphotericin b|mesh-list
6301585|NCT00002305|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6301586|NCT00002305|Flucytosine|flucytosine|mesh-list
6301587|NCT00002305|Antifungal Agents|antifungal agents|mesh-ancestor
6301588|NCT00002305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301589|NCT00002305|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6301590|NCT00002305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6301591|NCT00002305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301592|NCT00002305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301593|NCT00002305|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6301594|NCT00002305|Hormone Antagonists|hormone antagonists|mesh-ancestor
6301595|NCT00002305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6301596|NCT00002305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6301597|NCT00002305|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6301598|NCT00002305|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6301599|NCT00002305|Amebicides|amebicides|mesh-ancestor
6301600|NCT00002305|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6301601|NCT00002305|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6301602|NCT00002305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6301603|NCT00002305|Antimetabolites|antimetabolites|mesh-ancestor
6301604|NCT00002306|Fluconazole|fluconazole|mesh-list
6301605|NCT00002306|Antifungal Agents|antifungal agents|mesh-ancestor
6301606|NCT00002306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6536724|NCT00818155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6536725|NCT00818194|Cyclosporine|cyclosporine|mesh-list
6536726|NCT00818194|Tacrolimus|tacrolimus|mesh-list
6536727|NCT00818194|Cyclosporins|cyclosporins|mesh-list
6536728|NCT00818194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6301607|NCT00002306|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6301608|NCT00002306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6301609|NCT00002306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301610|NCT00002306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536729|NCT00818194|Immunologic Factors|immunologic factors|mesh-ancestor
6536730|NCT00818194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6301611|NCT00002306|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6301612|NCT00002306|Hormone Antagonists|hormone antagonists|mesh-ancestor
6301613|NCT00002306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6301614|NCT00002306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6301615|NCT00002306|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6301616|NCT00002306|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6301617|NCT00002307|Zidovudine|zidovudine|mesh-list
6301618|NCT00002307|Stavudine|stavudine|mesh-list
6301619|NCT00002307|Antimetabolites|antimetabolites|mesh-ancestor
6301620|NCT00002307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301621|NCT00002307|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6301622|NCT00002307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6301623|NCT00002307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301624|NCT00002307|Antiviral Agents|antiviral agents|mesh-ancestor
6301625|NCT00002307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301626|NCT00002307|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6301627|NCT00002307|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6301628|NCT00002308|Stavudine|stavudine|mesh-list
6301629|NCT00002308|Antimetabolites|antimetabolites|mesh-ancestor
6301630|NCT00002308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301631|NCT00002308|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6301632|NCT00002308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6301633|NCT00002308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301634|NCT00002308|Antiviral Agents|antiviral agents|mesh-ancestor
6301635|NCT00002308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301636|NCT00002308|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6301637|NCT00002308|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6301638|NCT00002309|Azithromycin|azithromycin|mesh-list
6301639|NCT00002309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6301640|NCT00002309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301641|NCT00002311|Wobenzym|wobenzym|mesh-list
6301642|NCT00002311|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6301643|NCT00002311|Immunologic Factors|immunologic factors|mesh-ancestor
6301644|NCT00002311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6301645|NCT00002312|Zidovudine|zidovudine|mesh-list
6301646|NCT00002312|Delavirdine|delavirdine|mesh-list
6301647|NCT00002312|Antimetabolites|antimetabolites|mesh-ancestor
6301648|NCT00002312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301649|NCT00002312|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6301650|NCT00002312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6301651|NCT00002312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301652|NCT00002312|Antiviral Agents|antiviral agents|mesh-ancestor
6301653|NCT00002312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5724279|NCT03188172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5724280|NCT03188172|Immunologic Factors|immunologic factors|mesh-ancestor
5724281|NCT03188172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724282|NCT03188172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6301654|NCT00002312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6301655|NCT00002312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6301656|NCT00002313|Didanosine|didanosine|mesh-list
6301657|NCT00002313|Nystatin|nystatin|mesh-list
6301658|NCT00002313|Antimetabolites|antimetabolites|mesh-ancestor
6301659|NCT00002313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536731|NCT00818194|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6536732|NCT00818194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6536733|NCT00818194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301660|NCT00002313|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6301661|NCT00002313|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6301662|NCT00002313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301663|NCT00002313|Antiviral Agents|antiviral agents|mesh-ancestor
6301664|NCT00002313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301665|NCT00002313|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6301666|NCT00002313|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6301667|NCT00002313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6301668|NCT00002313|Antifungal Agents|antifungal agents|mesh-ancestor
6301669|NCT00002313|Ionophores|ionophores|mesh-ancestor
6301670|NCT00002313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6301671|NCT00002315|Acyclovir|acyclovir|mesh-list
6301672|NCT00002315|5-propynylarabinofuranosyluracil|5-propynylarabinofuranosyluracil|mesh-list
6301673|NCT00002315|Antiviral Agents|antiviral agents|mesh-ancestor
6301674|NCT00002315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301675|NCT00002316|Amphotericin B|amphotericin b|mesh-list
6301676|NCT00002316|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6301677|NCT00002316|Amebicides|amebicides|mesh-ancestor
6301678|NCT00002316|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6301679|NCT00002316|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6301680|NCT00002316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301681|NCT00002316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6301682|NCT00002316|Antifungal Agents|antifungal agents|mesh-ancestor
6301683|NCT00002317|Leucovorin|leucovorin|mesh-list
6301684|NCT00002317|Trimetrexate|trimetrexate|mesh-list
6301685|NCT00002317|Calcium|calcium|mesh-list
6301686|NCT00002317|Levoleucovorin|levoleucovorin|mesh-list
6301687|NCT00002317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6301688|NCT00002317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6301689|NCT00002317|Antidotes|antidotes|mesh-ancestor
6301690|NCT00002317|Protective Agents|protective agents|mesh-ancestor
6301691|NCT00002317|Vitamin B Complex|vitamin b complex|mesh-ancestor
6301692|NCT00002317|Vitamins|vitamins|mesh-ancestor
6301693|NCT00002317|Micronutrients|micronutrients|mesh-ancestor
6301694|NCT00002317|Antifungal Agents|antifungal agents|mesh-ancestor
6301695|NCT00002317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301696|NCT00002317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6301697|NCT00002317|Antimetabolites|antimetabolites|mesh-ancestor
6301698|NCT00002317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301699|NCT00002317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6301700|NCT00002317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6301701|NCT00002317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301702|NCT00002318|Doxorubicin|doxorubicin|mesh-list
6301703|NCT00002318|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6301704|NCT00002318|Bleomycin|bleomycin|mesh-list
6301705|NCT00002318|Vincristine|vincristine|mesh-list
6301706|NCT00002318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6301707|NCT00002318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6301708|NCT00002318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6301709|NCT00002318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6301710|NCT00002318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301711|NCT00002318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301712|NCT00002318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6301713|NCT00002318|Tubulin Modulators|tubulin modulators|mesh-ancestor
6301714|NCT00002318|Antimitotic Agents|antimitotic agents|mesh-ancestor
6301715|NCT00002318|Mitosis Modulators|mitosis modulators|mesh-ancestor
6301716|NCT00002319|Doxorubicin|doxorubicin|mesh-list
6301717|NCT00002319|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6301718|NCT00002319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6301719|NCT00002319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6301720|NCT00002319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6301721|NCT00002319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6301722|NCT00002319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301723|NCT00002319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301724|NCT00002320|Lamivudine|lamivudine|mesh-list
6301725|NCT00002320|Zidovudine|zidovudine|mesh-list
6301726|NCT00002320|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6301727|NCT00002320|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6301728|NCT00002320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301729|NCT00002320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301730|NCT00002320|Antiviral Agents|antiviral agents|mesh-ancestor
6301731|NCT00002320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301732|NCT00002320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6301733|NCT00002320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6301734|NCT00002320|Antimetabolites|antimetabolites|mesh-ancestor
6301735|NCT00002321|Aldesleukin|aldesleukin|mesh-list
6301736|NCT00002321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6301737|NCT00002321|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6015697|NCT00359281|Simvastatin|simvastatin|mesh-list
6015698|NCT00359281|Ezetimibe|ezetimibe|mesh-list
6015699|NCT00359281|Fenofibrate|fenofibrate|mesh-list
6015700|NCT00359281|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6015701|NCT00359281|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6015702|NCT00359281|Antimetabolites|antimetabolites|mesh-ancestor
6015703|NCT00359281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015704|NCT00359281|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6015705|NCT00359281|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6015706|NCT00359281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6015707|NCT00359281|Vasodilator Agents|vasodilator agents|mesh-ancestor
6015708|NCT00359281|Vitamin B Complex|vitamin b complex|mesh-ancestor
6015709|NCT00359281|Vitamins|vitamins|mesh-ancestor
6015710|NCT00359281|Micronutrients|micronutrients|mesh-ancestor
6015711|NCT00359281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015712|NCT00359281|Antitussive Agents|antitussive agents|mesh-ancestor
6015713|NCT00359281|Respiratory System Agents|respiratory system agents|mesh-ancestor
6015714|NCT00359281|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6015715|NCT00359281|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6015716|NCT00359281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6015717|NCT00359424|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6301738|NCT00002321|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6301739|NCT00002321|Antiviral Agents|antiviral agents|mesh-ancestor
6301740|NCT00002321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301741|NCT00002322|Zidovudine|zidovudine|mesh-list
6301742|NCT00002322|Atevirdine|atevirdine|mesh-list
6301743|NCT00002322|Antimetabolites|antimetabolites|mesh-ancestor
6301744|NCT00002322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301745|NCT00002322|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6301746|NCT00002322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6301747|NCT00002322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301748|NCT00002322|Antiviral Agents|antiviral agents|mesh-ancestor
6301749|NCT00002322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301750|NCT00002322|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6301751|NCT00002322|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6301752|NCT00002323|Zidovudine|zidovudine|mesh-list
6301753|NCT00002323|Nevirapine|nevirapine|mesh-list
6301754|NCT00002323|Antimetabolites|antimetabolites|mesh-ancestor
6301755|NCT00002323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015718|NCT00359424|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6015719|NCT00359424|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6015720|NCT00359424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015721|NCT00359632|Linezolid|linezolid|mesh-list
6015722|NCT00359632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6015723|NCT00359632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6015724|NCT00359632|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6015725|NCT00359632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6015726|NCT00359632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015727|NCT00359736|Sildenafil Citrate|sildenafil citrate|mesh-list
6015728|NCT00359736|Vasodilator Agents|vasodilator agents|mesh-ancestor
6015729|NCT00359736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6015730|NCT00359736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6015731|NCT00359736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6015732|NCT00359736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015733|NCT00359736|Urological Agents|urological agents|mesh-ancestor
6015734|NCT00359762|Exenatide|exenatide|mesh-list
6015735|NCT00359762|Glimepiride|glimepiride|mesh-list
6015736|NCT00359762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6015737|NCT00359762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015738|NCT00359762|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6015739|NCT00359762|Incretins|incretins|mesh-ancestor
6015740|NCT00359762|Hormones|hormones|mesh-ancestor
6015741|NCT00359762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6015742|NCT00359762|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6015743|NCT00359762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6301756|NCT00002323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6301757|NCT00002323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6015744|NCT00359762|Immunologic Factors|immunologic factors|mesh-ancestor
6015745|NCT00359788|Albuterol|albuterol|mesh-list
6015746|NCT00359788|Tiotropium Bromide|tiotropium bromide|mesh-list
6015747|NCT00359788|Ipratropium|ipratropium|mesh-list
6015748|NCT00359788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6015749|NCT00359788|Autonomic Agents|autonomic agents|mesh-ancestor
6015750|NCT00359788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6015751|NCT00359788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015752|NCT00359788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6015753|NCT00359788|Respiratory System Agents|respiratory system agents|mesh-ancestor
6015754|NCT00359788|Parasympatholytics|parasympatholytics|mesh-ancestor
6015755|NCT00359788|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6015756|NCT00359788|Cholinergic Agents|cholinergic agents|mesh-ancestor
6015757|NCT00359788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6015758|NCT00359788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015759|NCT00359788|Tocolytic Agents|tocolytic agents|mesh-ancestor
6015760|NCT00359788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6015761|NCT00359788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6015762|NCT00359788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6015763|NCT00359788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6015764|NCT00359788|Adrenergic Agents|adrenergic agents|mesh-ancestor
6015765|NCT00359801|Insulin|insulin|mesh-list
6015766|NCT00359801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6015767|NCT00359801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6015768|NCT00359801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015769|NCT00360126|Lamotrigine|lamotrigine|mesh-list
6015770|NCT00360126|Anticonvulsants|anticonvulsants|mesh-ancestor
6015771|NCT00360126|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6015772|NCT00360126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6015773|NCT00360126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015774|NCT00360126|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6015775|NCT00360126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015776|NCT00360126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6015777|NCT00360126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6015778|NCT00360126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6015779|NCT00360126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6015780|NCT00360126|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6015781|NCT00360230|Vaccines|vaccines|mesh-list
6015782|NCT00360230|Immunologic Factors|immunologic factors|mesh-ancestor
6015783|NCT00360230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015784|NCT00360269|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6015785|NCT00360269|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6015786|NCT00360269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6015787|NCT00360269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6015788|NCT00360269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015789|NCT00360269|Adrenergic Agents|adrenergic agents|mesh-ancestor
6015790|NCT00360269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6015791|NCT00360269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015792|NCT00360282|Rizatriptan|rizatriptan|mesh-list
6015793|NCT00360282|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6015794|NCT00360282|Serotonin Agents|serotonin agents|mesh-ancestor
6015795|NCT00360282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6536734|NCT00818194|Antifungal Agents|antifungal agents|mesh-ancestor
6536735|NCT00818194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5724283|NCT03188172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5724284|NCT03188172|Alkylating Agents|alkylating agents|mesh-ancestor
5724285|NCT03188172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724286|NCT03188172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5724287|NCT03188172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5724288|NCT03188172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5724289|NCT03188172|Antiemetics|antiemetics|mesh-ancestor
5724290|NCT03188172|Autonomic Agents|autonomic agents|mesh-ancestor
5724291|NCT03188172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5724292|NCT03188172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5724293|NCT03188172|Glucocorticoids|glucocorticoids|mesh-ancestor
6536736|NCT00818194|Dermatologic Agents|dermatologic agents|mesh-ancestor
6536737|NCT00818194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6536738|NCT00818285|Psychotropic Drugs|psychotropic drugs|mesh-list
6536739|NCT00818298|Ziprasidone|ziprasidone|mesh-list
6536740|NCT00818298|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6536741|NCT00818298|Serotonin Agents|serotonin agents|mesh-ancestor
6536742|NCT00818298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6536743|NCT00818298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536744|NCT00818298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536745|NCT00818298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6536746|NCT00818298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6536747|NCT00818298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6536748|NCT00818298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6536749|NCT00818298|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6536750|NCT00818298|Dopamine Agents|dopamine agents|mesh-ancestor
6536751|NCT00818350|Sunitinib|sunitinib|mesh-list
6536752|NCT00818350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6536753|NCT00818350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6536754|NCT00818350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6536755|NCT00818350|Growth Substances|growth substances|mesh-ancestor
6536756|NCT00818350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536757|NCT00818350|Growth Inhibitors|growth inhibitors|mesh-ancestor
6536758|NCT00818350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6536759|NCT00818350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6536760|NCT00818350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301758|NCT00002323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301759|NCT00002323|Antiviral Agents|antiviral agents|mesh-ancestor
6301760|NCT00002323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301761|NCT00002323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6301762|NCT00002323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6301763|NCT00002323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6301764|NCT00002323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6301765|NCT00002324|Zidovudine|zidovudine|mesh-list
6301766|NCT00002324|Nevirapine|nevirapine|mesh-list
6301767|NCT00002324|Antimetabolites|antimetabolites|mesh-ancestor
6301768|NCT00002324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301769|NCT00002324|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6301770|NCT00002324|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6301771|NCT00002324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301772|NCT00002324|Antiviral Agents|antiviral agents|mesh-ancestor
6301773|NCT00002324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301774|NCT00002324|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6301775|NCT00002324|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6536761|NCT00818415|Naproxen|naproxen|mesh-list
6536762|NCT00818415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6536763|NCT00818415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6536764|NCT00818415|Analgesics|analgesics|mesh-ancestor
6536765|NCT00818415|Sensory System Agents|sensory system agents|mesh-ancestor
6536766|NCT00818415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6536767|NCT00818415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536768|NCT00818415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6301776|NCT00002324|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6301777|NCT00002324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6301778|NCT00002325|Fluconazole|fluconazole|mesh-list
6301779|NCT00002325|Antifungal Agents|antifungal agents|mesh-ancestor
6301780|NCT00002325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301781|NCT00002325|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6301782|NCT00002325|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6301783|NCT00002325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301784|NCT00002325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301785|NCT00002325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6301786|NCT00002325|Hormone Antagonists|hormone antagonists|mesh-ancestor
6301787|NCT00002325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6301788|NCT00002325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6301789|NCT00002325|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6301790|NCT00002325|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6301791|NCT00002326|Zidovudine|zidovudine|mesh-list
6301792|NCT00002326|Adefovir|adefovir|mesh-list
6301793|NCT00002326|Antimetabolites|antimetabolites|mesh-ancestor
6301794|NCT00002326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301795|NCT00002326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6301796|NCT00002326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6301797|NCT00002326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301798|NCT00002326|Antiviral Agents|antiviral agents|mesh-ancestor
6301799|NCT00002326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301800|NCT00002326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6301801|NCT00002326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6301802|NCT00002327|Cidofovir|cidofovir|mesh-list
6301803|NCT00002327|Antiviral Agents|antiviral agents|mesh-ancestor
6015796|NCT00360282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015797|NCT00360282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015798|NCT00360334|Insulin Glargine|insulin glargine|mesh-list
6015799|NCT00360334|Exenatide|exenatide|mesh-list
6015800|NCT00360334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6015801|NCT00360334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015802|NCT00360334|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6015803|NCT00360334|Incretins|incretins|mesh-ancestor
6015804|NCT00360334|Hormones|hormones|mesh-ancestor
6536769|NCT00818415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6536770|NCT00818415|Gout Suppressants|gout suppressants|mesh-ancestor
6536771|NCT00818415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6536772|NCT00818415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6536773|NCT00818415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536774|NCT00818584|Micafungin|micafungin|mesh-list
6536775|NCT00818584|Antifungal Agents|antifungal agents|mesh-ancestor
6536776|NCT00818584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6536777|NCT00818610|Amoxicillin|amoxicillin|mesh-list
6536778|NCT00818610|Clarithromycin|clarithromycin|mesh-list
6536779|NCT00818610|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6536780|NCT00818610|Cefuroxime|cefuroxime|mesh-list
6536781|NCT00818610|Cefuroxime axetil|cefuroxime axetil|mesh-list
6536782|NCT00818610|Lactams|lactams|mesh-list
6536783|NCT00818610|beta-Lactams|beta-lactams|mesh-list
6536784|NCT00818610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6536785|NCT00818610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6536786|NCT00818610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6536787|NCT00818610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6536788|NCT00818610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301804|NCT00002327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301805|NCT00002327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301806|NCT00002327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301807|NCT00002328|Azithromycin|azithromycin|mesh-list
6301808|NCT00002328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6301809|NCT00002328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301810|NCT00002330|Ganciclovir|ganciclovir|mesh-list
6301811|NCT00002330|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6301812|NCT00002330|Antiviral Agents|antiviral agents|mesh-ancestor
6301813|NCT00002330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301814|NCT00002330|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6301815|NCT00002330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6536789|NCT00818610|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6536790|NCT00818610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6536791|NCT00818610|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6538062|NCT00825552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6538063|NCT00825552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538064|NCT00825552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538065|NCT00825552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6538066|NCT00825552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6018485|NCT00381095|Analgesics|analgesics|mesh-ancestor
6301816|NCT00002330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724294|NCT03188172|Hormones|hormones|mesh-ancestor
5724295|NCT03188172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5724296|NCT03188172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5724297|NCT03188172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5724298|NCT03188172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5724299|NCT03188172|Growth Substances|growth substances|mesh-ancestor
5724300|NCT03188172|Growth Inhibitors|growth inhibitors|mesh-ancestor
5724301|NCT03188432|Carboplatin|carboplatin|mesh-list
5724302|NCT03188432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5724303|NCT03187912|Riboflavin|riboflavin|mesh-list
5724304|NCT03187912|Vitamin B Complex|vitamin b complex|mesh-ancestor
5724305|NCT03187912|Vitamins|vitamins|mesh-ancestor
5724306|NCT03187912|Micronutrients|micronutrients|mesh-ancestor
5724307|NCT03187912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724308|NCT03187912|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5724309|NCT03187912|Dermatologic Agents|dermatologic agents|mesh-ancestor
5724310|NCT03188146|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
5724311|NCT03188146|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5724312|NCT03188146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6301817|NCT00002331|Clarithromycin|clarithromycin|mesh-list
6301818|NCT00002331|Ethambutol|ethambutol|mesh-list
6301819|NCT00002331|Clofazimine|clofazimine|mesh-list
6301820|NCT00002331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6301821|NCT00002331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301822|NCT00002331|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6301823|NCT00002331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6392226|NCT00195741|Valproic Acid|valproic acid|mesh-list
6301824|NCT00002331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301825|NCT00002331|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6301826|NCT00002331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6301827|NCT00002331|Antitubercular Agents|antitubercular agents|mesh-ancestor
6301828|NCT00002331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6536792|NCT00818675|Sirolimus|sirolimus|mesh-list
6536793|NCT00818675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6536794|NCT00818675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6536795|NCT00818675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6536796|NCT00818675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6536797|NCT00818675|Antifungal Agents|antifungal agents|mesh-ancestor
6536798|NCT00818675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6536799|NCT00818675|Immunologic Factors|immunologic factors|mesh-ancestor
6536800|NCT00818675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6301829|NCT00002331|Leprostatic Agents|leprostatic agents|mesh-ancestor
6301830|NCT00002332|Thymopentin|thymopentin|mesh-list
6301831|NCT00002332|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6301832|NCT00002332|Immunologic Factors|immunologic factors|mesh-ancestor
6301833|NCT00002332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6301834|NCT00002333|Saquinavir|saquinavir|mesh-list
6301835|NCT00002333|Zalcitabine|zalcitabine|mesh-list
6301836|NCT00002333|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6301837|NCT00002333|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6301838|NCT00002333|Protease Inhibitors|protease inhibitors|mesh-ancestor
6301839|NCT00002333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301840|NCT00002333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301841|NCT00002333|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6301842|NCT00002333|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6301843|NCT00002333|Antiviral Agents|antiviral agents|mesh-ancestor
6301844|NCT00002333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301845|NCT00002333|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6301846|NCT00002333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6301847|NCT00002333|Antimetabolites|antimetabolites|mesh-ancestor
6301848|NCT00002333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6301849|NCT00002333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6301850|NCT00002334|Zidovudine|zidovudine|mesh-list
6301851|NCT00002334|Zalcitabine|zalcitabine|mesh-list
6301852|NCT00002334|Saquinavir|saquinavir|mesh-list
6301853|NCT00002334|Antimetabolites|antimetabolites|mesh-ancestor
6301854|NCT00002334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301855|NCT00002334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6301856|NCT00002334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6301857|NCT00002334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301858|NCT00002334|Antiviral Agents|antiviral agents|mesh-ancestor
6301859|NCT00002334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301860|NCT00002334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6301861|NCT00002334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6301862|NCT00002334|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6301863|NCT00002334|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6301864|NCT00002334|Protease Inhibitors|protease inhibitors|mesh-ancestor
6301865|NCT00002334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6301866|NCT00002334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6301867|NCT00002335|Emtricitabine|emtricitabine|mesh-list
6301868|NCT00002335|Antiviral Agents|antiviral agents|mesh-ancestor
6301869|NCT00002335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301870|NCT00002335|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6301871|NCT00002335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6301872|NCT00002335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301873|NCT00002335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301874|NCT00002335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6301875|NCT00002335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6301876|NCT00002336|Clarithromycin|clarithromycin|mesh-list
6301877|NCT00002336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6301878|NCT00002336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301879|NCT00002336|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6301880|NCT00002336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301881|NCT00002336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301882|NCT00002336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6301883|NCT00002336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6301884|NCT00002337|Vesnarinone|vesnarinone|mesh-list
6301885|NCT00002337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6301886|NCT00002337|Immunologic Factors|immunologic factors|mesh-ancestor
6301887|NCT00002337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6301888|NCT00002337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6301889|NCT00002337|Antiviral Agents|antiviral agents|mesh-ancestor
6301890|NCT00002337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301891|NCT00002337|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6301892|NCT00002337|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6301893|NCT00002337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301894|NCT00002337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301895|NCT00002337|Protective Agents|protective agents|mesh-ancestor
6301896|NCT00002339|Fluconazole|fluconazole|mesh-list
6536801|NCT00818701|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6536802|NCT00818701|Sildenafil Citrate|sildenafil citrate|mesh-list
6536803|NCT00818701|Vasodilator Agents|vasodilator agents|mesh-ancestor
6536804|NCT00818701|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6536805|NCT00818701|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6536806|NCT00818701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6536807|NCT00818701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536808|NCT00818701|Urological Agents|urological agents|mesh-ancestor
6301897|NCT00002339|Antifungal Agents|antifungal agents|mesh-ancestor
6301898|NCT00002339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301899|NCT00002339|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6301900|NCT00002339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6301901|NCT00002339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301902|NCT00002339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301903|NCT00002339|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6301904|NCT00002339|Hormone Antagonists|hormone antagonists|mesh-ancestor
6301905|NCT00002339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6301906|NCT00002339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6301907|NCT00002339|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6301908|NCT00002339|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6301909|NCT00002340|Atovaquone|atovaquone|mesh-list
6301910|NCT00002340|Pentamidine|pentamidine|mesh-list
6301911|NCT00002340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301912|NCT00002340|Antimalarials|antimalarials|mesh-ancestor
6301913|NCT00002340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6301914|NCT00002340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6301915|NCT00002340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301916|NCT00002340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301917|NCT00002340|Antifungal Agents|antifungal agents|mesh-ancestor
6301918|NCT00002340|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6015805|NCT00360334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6015806|NCT00360360|Paclitaxel|paclitaxel|mesh-list
6015807|NCT00360360|Bevacizumab|bevacizumab|mesh-list
6015808|NCT00360360|Carboplatin|carboplatin|mesh-list
6015809|NCT00360360|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6015810|NCT00360360|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6301919|NCT00002341|Itraconazole|itraconazole|mesh-list
6301920|NCT00002341|Antifungal Agents|antifungal agents|mesh-ancestor
6015811|NCT00360360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6015812|NCT00360360|Tubulin Modulators|tubulin modulators|mesh-ancestor
6015813|NCT00360360|Antimitotic Agents|antimitotic agents|mesh-ancestor
6015814|NCT00360360|Mitosis Modulators|mitosis modulators|mesh-ancestor
6015815|NCT00360360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015816|NCT00360360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6015817|NCT00360360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6015818|NCT00360360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6015819|NCT00360360|Growth Substances|growth substances|mesh-ancestor
6301921|NCT00002341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301922|NCT00002341|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6301923|NCT00002341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6301924|NCT00002341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301925|NCT00002341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301926|NCT00002341|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6301927|NCT00002341|Hormone Antagonists|hormone antagonists|mesh-ancestor
6301928|NCT00002341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6301929|NCT00002341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6301930|NCT00002341|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6301931|NCT00002343|Ethambutol|ethambutol|mesh-list
6301932|NCT00002343|Rifabutin|rifabutin|mesh-list
6301933|NCT00002343|Antitubercular Agents|antitubercular agents|mesh-ancestor
6301934|NCT00002343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6301935|NCT00002343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301936|NCT00002343|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6301937|NCT00002344|Azithromycin|azithromycin|mesh-list
6301938|NCT00002344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6301939|NCT00002344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301940|NCT00002345|Megestrol|megestrol|mesh-list
6301941|NCT00002345|Megestrol Acetate|megestrol acetate|mesh-list
6301942|NCT00002345|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6301943|NCT00002345|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6536809|NCT00818701|Natriuretic Agents|natriuretic agents|mesh-ancestor
6536810|NCT00818701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536811|NCT00818818|Meglumine Antimoniate|meglumine antimoniate|mesh-list
6536812|NCT00818818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6536813|NCT00818818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6536814|NCT00818818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301944|NCT00002345|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6301945|NCT00002345|Contraceptive Agents|contraceptive agents|mesh-ancestor
6301946|NCT00002345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6301947|NCT00002345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6301948|NCT00002345|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6301949|NCT00002345|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6301950|NCT00002345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6301951|NCT00002345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6301952|NCT00002345|Appetite Stimulants|appetite stimulants|mesh-ancestor
6301953|NCT00002345|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6301954|NCT00002346|Adefovir|adefovir|mesh-list
6301955|NCT00002346|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6301956|NCT00002346|Antiviral Agents|antiviral agents|mesh-ancestor
6301957|NCT00002346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301958|NCT00002346|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6301959|NCT00002346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6301960|NCT00002346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301961|NCT00002346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536815|NCT00818870|Omeprazole|omeprazole|mesh-list
6301962|NCT00002347|Zidovudine|zidovudine|mesh-list
6301963|NCT00002347|Nevirapine|nevirapine|mesh-list
6301964|NCT00002347|Zalcitabine|zalcitabine|mesh-list
6301965|NCT00002347|Saquinavir|saquinavir|mesh-list
6301966|NCT00002347|Antimetabolites|antimetabolites|mesh-ancestor
6301967|NCT00002347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301968|NCT00002347|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6015820|NCT00360360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015821|NCT00360360|Growth Inhibitors|growth inhibitors|mesh-ancestor
6015822|NCT00360360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6015823|NCT00360360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6015824|NCT00360399|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6301969|NCT00002347|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6301970|NCT00002347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301971|NCT00002347|Antiviral Agents|antiviral agents|mesh-ancestor
6301972|NCT00002347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301973|NCT00002347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6301974|NCT00002347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6301975|NCT00002347|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6301976|NCT00002347|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6301977|NCT00002347|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6301978|NCT00002347|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6301979|NCT00002347|Protease Inhibitors|protease inhibitors|mesh-ancestor
6301980|NCT00002347|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6301981|NCT00002347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6301982|NCT00002348|Mitoguazone|mitoguazone|mesh-list
6301983|NCT00002348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6301984|NCT00002348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301985|NCT00002348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301986|NCT00002349|Stavudine|stavudine|mesh-list
6301987|NCT00002349|Antimetabolites|antimetabolites|mesh-ancestor
6301988|NCT00002349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6301989|NCT00002349|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6301990|NCT00002349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6301991|NCT00002349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6301992|NCT00002349|Antiviral Agents|antiviral agents|mesh-ancestor
6301993|NCT00002349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6301994|NCT00002349|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6301995|NCT00002349|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6392227|NCT00195741|Anticonvulsants|anticonvulsants|mesh-ancestor
6392228|NCT00195741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6392229|NCT00195741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392230|NCT00195741|GABA Agents|gaba agents|mesh-ancestor
6392231|NCT00195741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6392232|NCT00195741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392233|NCT00195741|Antimanic Agents|antimanic agents|mesh-ancestor
6392234|NCT00195741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6392235|NCT00195741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6392236|NCT00195741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6392237|NCT00195754|Valproic Acid|valproic acid|mesh-list
6392238|NCT00195754|Anticonvulsants|anticonvulsants|mesh-ancestor
5724313|NCT03188068|Sirolimus|sirolimus|mesh-list
6392239|NCT00195754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6536816|NCT00818870|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6301996|NCT00002351|Indinavir|indinavir|mesh-list
6301997|NCT00002351|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6301998|NCT00002351|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6301999|NCT00002351|Protease Inhibitors|protease inhibitors|mesh-ancestor
6302000|NCT00002351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302001|NCT00002351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302002|NCT00002351|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6302003|NCT00002351|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6302004|NCT00002351|Antiviral Agents|antiviral agents|mesh-ancestor
6302005|NCT00002351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302006|NCT00002352|Lobucavir|lobucavir|mesh-list
6302007|NCT00002352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302008|NCT00002352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302009|NCT00002352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6302010|NCT00002352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6302011|NCT00002352|Antiviral Agents|antiviral agents|mesh-ancestor
6302012|NCT00002352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302013|NCT00002352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6302014|NCT00002354|Stavudine|stavudine|mesh-list
6302015|NCT00002354|Indinavir|indinavir|mesh-list
6302016|NCT00002354|Antimetabolites|antimetabolites|mesh-ancestor
6302017|NCT00002354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015825|NCT00360399|Citalopram|citalopram|mesh-list
6015826|NCT00360399|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6015827|NCT00360399|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6015828|NCT00360399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6015829|NCT00360399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015830|NCT00360399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6015831|NCT00360399|Serotonin Agents|serotonin agents|mesh-ancestor
6015832|NCT00360399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015833|NCT00360399|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6015834|NCT00360399|Antidepressive Agents|antidepressive agents|mesh-ancestor
6015835|NCT00360399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6015836|NCT00360399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6302018|NCT00002354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6302019|NCT00002354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6302020|NCT00002354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302021|NCT00002354|Antiviral Agents|antiviral agents|mesh-ancestor
6302022|NCT00002354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302023|NCT00002354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5724314|NCT03188068|Prednisolone|prednisolone|mesh-list
6302024|NCT00002354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6302025|NCT00002354|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6302026|NCT00002354|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6536817|NCT00818870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6536818|NCT00818870|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6536819|NCT00818870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6536820|NCT00818870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536821|NCT00819000|Interferon-beta|interferon-beta|mesh-list
6302027|NCT00002354|Protease Inhibitors|protease inhibitors|mesh-ancestor
6302028|NCT00002355|Fomivirsen|fomivirsen|mesh-list
6302029|NCT00002355|Antiviral Agents|antiviral agents|mesh-ancestor
6302030|NCT00002355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302031|NCT00002356|Fomivirsen|fomivirsen|mesh-list
6302032|NCT00002356|Antiviral Agents|antiviral agents|mesh-ancestor
6302033|NCT00002356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6536822|NCT00819000|Glatiramer Acetate|glatiramer acetate|mesh-list
6536823|NCT00819000|Interferon beta-1b|interferon beta-1b|mesh-list
6536824|NCT00819000|(T,G)-A-L|(t,g)-a-l|mesh-list
6536825|NCT00819000|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6536826|NCT00819000|Immunologic Factors|immunologic factors|mesh-ancestor
6536827|NCT00819000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536828|NCT00819000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6536829|NCT00819000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6536830|NCT00819000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6536831|NCT00819000|Antiviral Agents|antiviral agents|mesh-ancestor
6536832|NCT00819000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6536833|NCT00819065|Botulinum Toxins|botulinum toxins|mesh-list
6536834|NCT00819065|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6302034|NCT00002357|Zidovudine|zidovudine|mesh-list
6302035|NCT00002357|Antimetabolites|antimetabolites|mesh-ancestor
6302036|NCT00002357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302037|NCT00002357|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6302038|NCT00002357|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6015837|NCT00360399|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6015838|NCT00360399|Analgesics|analgesics|mesh-ancestor
6015839|NCT00360399|Sensory System Agents|sensory system agents|mesh-ancestor
6015840|NCT00360399|Dopamine Agents|dopamine agents|mesh-ancestor
6015841|NCT00360490|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6536835|NCT00819065|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6536836|NCT00819065|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6536837|NCT00819065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6015842|NCT00360490|Levonorgestrel|levonorgestrel|mesh-list
6536838|NCT00819065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536839|NCT00819065|Cholinergic Agents|cholinergic agents|mesh-ancestor
6536840|NCT00819065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6536841|NCT00819065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536842|NCT00819065|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6536843|NCT00819065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6536844|NCT00819078|Bupropion|bupropion|mesh-list
6536845|NCT00819078|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6536846|NCT00819078|Antidepressive Agents|antidepressive agents|mesh-ancestor
6536847|NCT00819078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6536848|NCT00819078|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6536849|NCT00819078|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6536850|NCT00819078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6538067|NCT00825552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6015843|NCT00360490|Medroxyprogesterone|medroxyprogesterone|mesh-list
6302039|NCT00002357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302040|NCT00002357|Antiviral Agents|antiviral agents|mesh-ancestor
6302041|NCT00002357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302042|NCT00002357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6302043|NCT00002357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6302044|NCT00002358|Sorivudine|sorivudine|mesh-list
6302045|NCT00002358|Antiviral Agents|antiviral agents|mesh-ancestor
6302046|NCT00002358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302047|NCT00002358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302048|NCT00002358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302049|NCT00002360|Didanosine|didanosine|mesh-list
6302050|NCT00002360|Antimetabolites|antimetabolites|mesh-ancestor
6302051|NCT00002360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302052|NCT00002360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6302053|NCT00002360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6302054|NCT00002360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302055|NCT00002360|Antiviral Agents|antiviral agents|mesh-ancestor
6302056|NCT00002360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302057|NCT00002360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6302058|NCT00002360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6302059|NCT00002361|Ritonavir|ritonavir|mesh-list
6302060|NCT00002361|Indinavir|indinavir|mesh-list
6302061|NCT00002361|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6302062|NCT00002361|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6302063|NCT00002361|Protease Inhibitors|protease inhibitors|mesh-ancestor
6302064|NCT00002361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302065|NCT00002361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302066|NCT00002361|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6302067|NCT00002361|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6302068|NCT00002361|Antiviral Agents|antiviral agents|mesh-ancestor
6302069|NCT00002361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302070|NCT00002361|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6015844|NCT00360490|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6015845|NCT00360490|Contraceptive Agents|contraceptive agents|mesh-ancestor
6015846|NCT00360490|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6015847|NCT00360490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015848|NCT00360490|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6015849|NCT00360490|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6015850|NCT00360490|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6015851|NCT00360490|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6015852|NCT00360490|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6015853|NCT00360490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6015854|NCT00360490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6015855|NCT00360568|Levodopa|levodopa|mesh-list
6015856|NCT00360568|Carbidopa|carbidopa|mesh-list
6015857|NCT00360568|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
6015858|NCT00360568|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6015859|NCT00360568|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6302071|NCT00002361|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6302072|NCT00002362|Emtricitabine|emtricitabine|mesh-list
6302073|NCT00002362|Efavirenz|efavirenz|mesh-list
6302074|NCT00002362|Abacavir|abacavir|mesh-list
6302075|NCT00002362|Stavudine|stavudine|mesh-list
6302076|NCT00002362|Antiviral Agents|antiviral agents|mesh-ancestor
6302077|NCT00002362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302078|NCT00002362|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6302079|NCT00002362|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6302080|NCT00002362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302081|NCT00002362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302082|NCT00002362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6302083|NCT00002362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6302084|NCT00002362|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6302085|NCT00002362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6302086|NCT00002362|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6536851|NCT00819078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536852|NCT00819078|Dopamine Agents|dopamine agents|mesh-ancestor
6536853|NCT00819078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6536854|NCT00819078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536855|NCT00819078|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6536856|NCT00819078|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6536857|NCT00819078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6536858|NCT00819104|Metoprolol|metoprolol|mesh-list
6536859|NCT00819104|Amlodipine|amlodipine|mesh-list
6536860|NCT00819104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6536861|NCT00819104|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6536862|NCT00819104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6536863|NCT00819104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536864|NCT00819104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6536865|NCT00819104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536866|NCT00819104|Vasodilator Agents|vasodilator agents|mesh-ancestor
6536867|NCT00819104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6536868|NCT00819104|Sympatholytics|sympatholytics|mesh-ancestor
6536869|NCT00819104|Autonomic Agents|autonomic agents|mesh-ancestor
6536870|NCT00819104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6536871|NCT00819104|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6536872|NCT00819104|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6536873|NCT00819104|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6536874|NCT00819104|Adrenergic Agents|adrenergic agents|mesh-ancestor
6536875|NCT00819104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6536876|NCT00819195|Glatiramer Acetate|glatiramer acetate|mesh-list
6536877|NCT00819195|(T,G)-A-L|(t,g)-a-l|mesh-list
6302087|NCT00002362|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6302088|NCT00002362|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6302089|NCT00002362|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6302090|NCT00002362|Antimetabolites|antimetabolites|mesh-ancestor
6302091|NCT00002364|Abacavir|abacavir|mesh-list
6302092|NCT00002364|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6302093|NCT00002364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6302094|NCT00002364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302095|NCT00002364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302096|NCT00002364|Antiviral Agents|antiviral agents|mesh-ancestor
6302097|NCT00002364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302098|NCT00002364|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6302099|NCT00002364|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6302100|NCT00002366|Ritonavir|ritonavir|mesh-list
6302101|NCT00002366|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6302102|NCT00002366|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6302103|NCT00002366|Protease Inhibitors|protease inhibitors|mesh-ancestor
6302104|NCT00002366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302105|NCT00002366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302106|NCT00002366|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6302107|NCT00002366|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6302108|NCT00002366|Antiviral Agents|antiviral agents|mesh-ancestor
6302109|NCT00002366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302110|NCT00002366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6302111|NCT00002366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6302112|NCT00002367|Lamivudine|lamivudine|mesh-list
6302113|NCT00002367|Zidovudine|zidovudine|mesh-list
6302114|NCT00002367|Saquinavir|saquinavir|mesh-list
6302115|NCT00002367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6302116|NCT00002367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6302117|NCT00002367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302118|NCT00002367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302119|NCT00002367|Antiviral Agents|antiviral agents|mesh-ancestor
6302120|NCT00002367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302121|NCT00002367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6302122|NCT00002367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6302123|NCT00002367|Antimetabolites|antimetabolites|mesh-ancestor
6302124|NCT00002367|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6302125|NCT00002367|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6536878|NCT00819195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6536879|NCT00819195|Immunologic Factors|immunologic factors|mesh-ancestor
6536880|NCT00819195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536881|NCT00819195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6536882|NCT00819195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6536883|NCT00819325|Pioglitazone|pioglitazone|mesh-list
6536884|NCT00819325|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6536885|NCT00819325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536886|NCT00819351|Asparaginase|asparaginase|mesh-list
6536887|NCT00819351|Pegaspargase|pegaspargase|mesh-list
6536888|NCT00819351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6536889|NCT00819377|Milrinone|milrinone|mesh-list
6536890|NCT00819377|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6536891|NCT00819377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6536892|NCT00819377|Vasodilator Agents|vasodilator agents|mesh-ancestor
6536893|NCT00819377|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6536894|NCT00819377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6536895|NCT00819377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302126|NCT00002367|Protease Inhibitors|protease inhibitors|mesh-ancestor
6302127|NCT00002367|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6302128|NCT00002367|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6302129|NCT00002368|Lamivudine|lamivudine|mesh-list
6302130|NCT00002368|Nevirapine|nevirapine|mesh-list
6302131|NCT00002368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6302132|NCT00002368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6302133|NCT00002368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302134|NCT00002368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302135|NCT00002368|Antiviral Agents|antiviral agents|mesh-ancestor
6302136|NCT00002368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302137|NCT00002368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6302138|NCT00002368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6302139|NCT00002368|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6302140|NCT00002368|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6302141|NCT00002369|Lamivudine|lamivudine|mesh-list
6302142|NCT00002369|Zidovudine|zidovudine|mesh-list
6302143|NCT00002369|Stavudine|stavudine|mesh-list
6302144|NCT00002369|Indinavir|indinavir|mesh-list
6302145|NCT00002369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6302146|NCT00002369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6302147|NCT00002369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302148|NCT00002369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302149|NCT00002369|Antiviral Agents|antiviral agents|mesh-ancestor
6302150|NCT00002369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302151|NCT00002369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6302152|NCT00002369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6302153|NCT00002369|Antimetabolites|antimetabolites|mesh-ancestor
6302154|NCT00002369|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6302155|NCT00002369|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6302156|NCT00002369|Protease Inhibitors|protease inhibitors|mesh-ancestor
6302157|NCT00002370|Itraconazole|itraconazole|mesh-list
6302158|NCT00002370|Antifungal Agents|antifungal agents|mesh-ancestor
6302159|NCT00002370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302160|NCT00002370|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6302161|NCT00002370|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6302162|NCT00002370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302163|NCT00002370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302164|NCT00002370|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6302165|NCT00002370|Hormone Antagonists|hormone antagonists|mesh-ancestor
6302166|NCT00002370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6302167|NCT00002370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6302168|NCT00002370|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6302169|NCT00002372|Nelfinavir|nelfinavir|mesh-list
6302170|NCT00002372|Indinavir|indinavir|mesh-list
6302171|NCT00002372|Saquinavir|saquinavir|mesh-list
6302172|NCT00002372|Amprenavir|amprenavir|mesh-list
6302173|NCT00002372|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6302174|NCT00002372|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6302175|NCT00002372|Protease Inhibitors|protease inhibitors|mesh-ancestor
6302176|NCT00002372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302177|NCT00002372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302178|NCT00002372|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6302179|NCT00002372|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6302180|NCT00002372|Antiviral Agents|antiviral agents|mesh-ancestor
6302181|NCT00002372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302182|NCT00002372|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6302183|NCT00002372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6302184|NCT00002372|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6536896|NCT00819377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302185|NCT00002372|Antitubercular Agents|antitubercular agents|mesh-ancestor
6302186|NCT00002372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6302187|NCT00002373|Maribavir|maribavir|mesh-list
6302188|NCT00002373|Antiviral Agents|antiviral agents|mesh-ancestor
6302189|NCT00002373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302190|NCT00002374|Ritonavir|ritonavir|mesh-list
6302191|NCT00002374|Nelfinavir|nelfinavir|mesh-list
6302192|NCT00002374|Saquinavir|saquinavir|mesh-list
6302193|NCT00002374|Stavudine|stavudine|mesh-list
6302194|NCT00002374|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6302195|NCT00002374|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6302196|NCT00002374|Protease Inhibitors|protease inhibitors|mesh-ancestor
6302197|NCT00002374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302198|NCT00002374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302199|NCT00002374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6302200|NCT00002374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6302201|NCT00002374|Antiviral Agents|antiviral agents|mesh-ancestor
6302202|NCT00002374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302203|NCT00002374|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6302204|NCT00002374|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6302205|NCT00002374|Antimetabolites|antimetabolites|mesh-ancestor
6302206|NCT00002374|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6302207|NCT00002374|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6302208|NCT00002375|Nelfinavir|nelfinavir|mesh-list
6302209|NCT00002375|Indinavir|indinavir|mesh-list
6302210|NCT00002375|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6302211|NCT00002375|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6302212|NCT00002375|Protease Inhibitors|protease inhibitors|mesh-ancestor
6302213|NCT00002375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302214|NCT00002375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302215|NCT00002375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6302216|NCT00002375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6302217|NCT00002375|Antiviral Agents|antiviral agents|mesh-ancestor
6302218|NCT00002375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302219|NCT00002376|Lamivudine|lamivudine|mesh-list
6302220|NCT00002376|Zidovudine|zidovudine|mesh-list
6302221|NCT00002376|Stavudine|stavudine|mesh-list
6302222|NCT00002376|Didanosine|didanosine|mesh-list
6302223|NCT00002376|Indinavir|indinavir|mesh-list
6302224|NCT00002376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6302225|NCT00002376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6302226|NCT00002376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302227|NCT00002376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302228|NCT00002376|Antiviral Agents|antiviral agents|mesh-ancestor
6302229|NCT00002376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302230|NCT00002376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6302231|NCT00002376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6302232|NCT00002376|Antimetabolites|antimetabolites|mesh-ancestor
6302233|NCT00002376|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6302234|NCT00002376|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6302235|NCT00002376|Protease Inhibitors|protease inhibitors|mesh-ancestor
6302236|NCT00002377|Valganciclovir|valganciclovir|mesh-list
6302237|NCT00002377|Ganciclovir|ganciclovir|mesh-list
6302238|NCT00002377|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6302239|NCT00002377|Antiviral Agents|antiviral agents|mesh-ancestor
6015860|NCT00360568|Dopamine Agents|dopamine agents|mesh-ancestor
6015861|NCT00360568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6015862|NCT00360568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015863|NCT00360568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015864|NCT00360568|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6015865|NCT00360568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6015866|NCT00360568|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6015867|NCT00360568|Immunologic Factors|immunologic factors|mesh-ancestor
6015868|NCT00360568|Dopamine Agonists|dopamine agonists|mesh-ancestor
6015869|NCT00360672|Lenalidomide|lenalidomide|mesh-list
6015870|NCT00360672|Immunologic Factors|immunologic factors|mesh-ancestor
6302240|NCT00002377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302241|NCT00002377|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6302242|NCT00002377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6015871|NCT00360672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015872|NCT00360672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6015873|NCT00360672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6015874|NCT00360672|Growth Substances|growth substances|mesh-ancestor
6015875|NCT00360672|Growth Inhibitors|growth inhibitors|mesh-ancestor
6015876|NCT00360672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6015877|NCT00360685|Mycophenolic Acid|mycophenolic acid|mesh-list
6015878|NCT00360685|Methotrexate|methotrexate|mesh-list
6015879|NCT00360685|Tacrolimus|tacrolimus|mesh-list
6015880|NCT00360685|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6015881|NCT00360685|Abortifacient Agents|abortifacient agents|mesh-ancestor
6015882|NCT00360685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6015883|NCT00360685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015884|NCT00360685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6015885|NCT00360685|Antimetabolites|antimetabolites|mesh-ancestor
6015886|NCT00360685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015887|NCT00360685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6302243|NCT00002377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302244|NCT00002378|Ritonavir|ritonavir|mesh-list
6302245|NCT00002378|Nelfinavir|nelfinavir|mesh-list
6302246|NCT00002378|Saquinavir|saquinavir|mesh-list
6302247|NCT00002378|Lamivudine|lamivudine|mesh-list
6302248|NCT00002378|Zidovudine|zidovudine|mesh-list
6302249|NCT00002378|Stavudine|stavudine|mesh-list
6302250|NCT00002378|Delavirdine|delavirdine|mesh-list
6302251|NCT00002378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6302252|NCT00002378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6536897|NCT00819377|Protective Agents|protective agents|mesh-ancestor
6536898|NCT00819377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536899|NCT00819468|Teduglutide|teduglutide|mesh-list
6536900|NCT00819468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6536901|NCT00819468|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6536902|NCT00819468|Protective Agents|protective agents|mesh-ancestor
6536903|NCT00819468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536904|NCT00819520|Ivermectin|ivermectin|mesh-list
6536905|NCT00819520|Malathion|malathion|mesh-list
6536906|NCT00819520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6536907|NCT00819520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6536908|NCT00819520|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6536909|NCT00819520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6536910|NCT00819520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536911|NCT00819520|Cholinergic Agents|cholinergic agents|mesh-ancestor
6536912|NCT00819520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6536913|NCT00819520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536914|NCT00819546|Everolimus|everolimus|mesh-list
6536915|NCT00819546|Midostaurin|midostaurin|mesh-list
6536916|NCT00819546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6536917|NCT00819546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6536918|NCT00819546|Immunologic Factors|immunologic factors|mesh-ancestor
6536919|NCT00819546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536920|NCT00819546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6536921|NCT00819546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302253|NCT00002378|Protease Inhibitors|protease inhibitors|mesh-ancestor
6536922|NCT00819546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536923|NCT00819572|Antibodies|antibodies|mesh-list
6536924|NCT00819572|Immunoglobulin Fragments|immunoglobulin fragments|mesh-list
6536925|NCT00819572|Immunologic Factors|immunologic factors|mesh-ancestor
6536926|NCT00819572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536927|NCT00819676|Nitric Oxide|nitric oxide|mesh-list
6536928|NCT00819676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6536929|NCT00819676|Autonomic Agents|autonomic agents|mesh-ancestor
6536930|NCT00819676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6536931|NCT00819676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015888|NCT00360685|Dermatologic Agents|dermatologic agents|mesh-ancestor
6536932|NCT00819676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6302254|NCT00002378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302255|NCT00002378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302256|NCT00002378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6302257|NCT00002378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6302258|NCT00002378|Antiviral Agents|antiviral agents|mesh-ancestor
6302259|NCT00002378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302260|NCT00002378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6302261|NCT00002378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6302262|NCT00002378|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6302263|NCT00002378|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6302264|NCT00002378|Antimetabolites|antimetabolites|mesh-ancestor
6302265|NCT00002379|Lamivudine|lamivudine|mesh-list
6302266|NCT00002379|Zidovudine|zidovudine|mesh-list
6302267|NCT00002379|Stavudine|stavudine|mesh-list
6302268|NCT00002379|Adefovir|adefovir|mesh-list
6302269|NCT00002379|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6302270|NCT00002379|Indinavir|indinavir|mesh-list
6302271|NCT00002379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6302272|NCT00002379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6302273|NCT00002379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302274|NCT00002379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302275|NCT00002379|Antiviral Agents|antiviral agents|mesh-ancestor
6302276|NCT00002379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302277|NCT00002379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6302278|NCT00002379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6302279|NCT00002379|Antimetabolites|antimetabolites|mesh-ancestor
6302280|NCT00002379|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6302281|NCT00002379|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6302282|NCT00002379|Protease Inhibitors|protease inhibitors|mesh-ancestor
6302283|NCT00002380|Nelfinavir|nelfinavir|mesh-list
6302284|NCT00002380|Saquinavir|saquinavir|mesh-list
6302285|NCT00002380|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6302286|NCT00002380|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6536933|NCT00819676|Respiratory System Agents|respiratory system agents|mesh-ancestor
6536934|NCT00819676|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6536935|NCT00819676|Antioxidants|antioxidants|mesh-ancestor
6536936|NCT00819676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536937|NCT00819676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6536938|NCT00819676|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6536939|NCT00819676|Vasodilator Agents|vasodilator agents|mesh-ancestor
6536940|NCT00819676|Gasotransmitters|gasotransmitters|mesh-ancestor
6536941|NCT00819676|Protective Agents|protective agents|mesh-ancestor
6536942|NCT00819728|Docetaxel|docetaxel|mesh-list
6536943|NCT00819728|Irinotecan|irinotecan|mesh-list
6536944|NCT00819728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6536945|NCT00819728|Tubulin Modulators|tubulin modulators|mesh-ancestor
6536946|NCT00819728|Antimitotic Agents|antimitotic agents|mesh-ancestor
6536947|NCT00819728|Mitosis Modulators|mitosis modulators|mesh-ancestor
6536948|NCT00819728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536949|NCT00819728|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6536950|NCT00819728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6536951|NCT00819728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6536952|NCT00819754|Bevacizumab|bevacizumab|mesh-list
6536953|NCT00819754|Capecitabine|capecitabine|mesh-list
6536954|NCT00819754|Oxaliplatin|oxaliplatin|mesh-list
6536955|NCT00819754|Irinotecan|irinotecan|mesh-list
6536956|NCT00819754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6536957|NCT00819754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6302287|NCT00002380|Protease Inhibitors|protease inhibitors|mesh-ancestor
6302288|NCT00002380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6536958|NCT00819754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6536959|NCT00819754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6536960|NCT00819754|Growth Substances|growth substances|mesh-ancestor
6536961|NCT00819754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536962|NCT00819754|Growth Inhibitors|growth inhibitors|mesh-ancestor
6302289|NCT00002380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302290|NCT00002380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6302291|NCT00002380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6302292|NCT00002380|Antiviral Agents|antiviral agents|mesh-ancestor
6302293|NCT00002380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302294|NCT00002380|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6302295|NCT00002380|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6302296|NCT00002381|Nevirapine|nevirapine|mesh-list
6302297|NCT00002381|Stavudine|stavudine|mesh-list
6302298|NCT00002381|Nelfinavir|nelfinavir|mesh-list
6302299|NCT00002381|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6302300|NCT00002381|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6302301|NCT00002381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302302|NCT00002381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302303|NCT00002381|Antiviral Agents|antiviral agents|mesh-ancestor
6302304|NCT00002381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302305|NCT00002381|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6302306|NCT00002381|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6302307|NCT00002381|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6302308|NCT00002381|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6302309|NCT00002381|Antimetabolites|antimetabolites|mesh-ancestor
6302310|NCT00002381|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6302311|NCT00002381|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6302312|NCT00002381|Protease Inhibitors|protease inhibitors|mesh-ancestor
6302313|NCT00002382|Saquinavir|saquinavir|mesh-list
6302314|NCT00002382|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6302315|NCT00002382|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6302316|NCT00002382|Protease Inhibitors|protease inhibitors|mesh-ancestor
6302317|NCT00002382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302318|NCT00002382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302319|NCT00002382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6302320|NCT00002382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6302321|NCT00002382|Antiviral Agents|antiviral agents|mesh-ancestor
6302322|NCT00002382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302323|NCT00002382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6302324|NCT00002382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6302325|NCT00002383|Saquinavir|saquinavir|mesh-list
6302326|NCT00002383|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6302327|NCT00002383|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6302328|NCT00002383|Protease Inhibitors|protease inhibitors|mesh-ancestor
6302329|NCT00002383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302330|NCT00002383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302331|NCT00002383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6302332|NCT00002383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6302333|NCT00002383|Antiviral Agents|antiviral agents|mesh-ancestor
6302334|NCT00002383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302335|NCT00002383|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6302336|NCT00002383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6302337|NCT00002384|Cidofovir|cidofovir|mesh-list
6302338|NCT00002384|Antiviral Agents|antiviral agents|mesh-ancestor
6302339|NCT00002384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6536963|NCT00819754|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6536964|NCT00819754|Antimetabolites|antimetabolites|mesh-ancestor
6536965|NCT00819754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536966|NCT00819754|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6536967|NCT00819754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6536968|NCT00819754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6536969|NCT00819806|Cyclophosphamide|cyclophosphamide|mesh-list
6536970|NCT00819806|Vaccines|vaccines|mesh-list
6536971|NCT00819806|Immunologic Factors|immunologic factors|mesh-ancestor
6302340|NCT00002384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302341|NCT00002384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302342|NCT00002386|Lamivudine|lamivudine|mesh-list
6302343|NCT00002386|Zidovudine|zidovudine|mesh-list
6302344|NCT00002386|Stavudine|stavudine|mesh-list
6302345|NCT00002386|Didanosine|didanosine|mesh-list
6302346|NCT00002386|Zalcitabine|zalcitabine|mesh-list
6302347|NCT00002386|Indinavir|indinavir|mesh-list
6302348|NCT00002386|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6302349|NCT00002386|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6302350|NCT00002386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302351|NCT00002386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302352|NCT00002386|Antiviral Agents|antiviral agents|mesh-ancestor
6302353|NCT00002386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302354|NCT00002386|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6302355|NCT00002386|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6302356|NCT00002386|Antimetabolites|antimetabolites|mesh-ancestor
6302357|NCT00002386|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6302358|NCT00002386|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6302359|NCT00002386|Protease Inhibitors|protease inhibitors|mesh-ancestor
6302360|NCT00002387|Efavirenz|efavirenz|mesh-list
6302361|NCT00002387|Indinavir|indinavir|mesh-list
6302362|NCT00002387|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6302363|NCT00002387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6302364|NCT00002387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302365|NCT00002387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302366|NCT00002387|Antiviral Agents|antiviral agents|mesh-ancestor
6302367|NCT00002387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302368|NCT00002387|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6302369|NCT00002387|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6302370|NCT00002387|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6302371|NCT00002387|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6302372|NCT00002387|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6302373|NCT00002387|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6302374|NCT00002387|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6302375|NCT00002387|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6302376|NCT00002387|Protease Inhibitors|protease inhibitors|mesh-ancestor
6302377|NCT00002387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6302378|NCT00002387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6536972|NCT00819806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6302379|NCT00002388|Abacavir|abacavir|mesh-list
6536973|NCT00819806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6536974|NCT00819806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6536975|NCT00819806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6536976|NCT00819806|Alkylating Agents|alkylating agents|mesh-ancestor
6536977|NCT00819806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536978|NCT00819806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6536979|NCT00819806|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6536980|NCT00819845|Carvedilol|carvedilol|mesh-list
6536981|NCT00819845|Ramipril|ramipril|mesh-list
6536982|NCT00819845|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6536983|NCT00819845|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6536984|NCT00819845|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6536985|NCT00819845|Adrenergic Agents|adrenergic agents|mesh-ancestor
6536986|NCT00819845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6536987|NCT00819845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6536988|NCT00819845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6536989|NCT00819845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6536990|NCT00819845|Antioxidants|antioxidants|mesh-ancestor
6536991|NCT00819845|Protective Agents|protective agents|mesh-ancestor
6536992|NCT00819845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6536993|NCT00819845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6536994|NCT00819845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6536995|NCT00819845|Vasodilator Agents|vasodilator agents|mesh-ancestor
6536996|NCT00819845|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6302380|NCT00002388|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6302381|NCT00002388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6302382|NCT00002388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302383|NCT00002388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302384|NCT00002388|Antiviral Agents|antiviral agents|mesh-ancestor
6302385|NCT00002388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302386|NCT00002388|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6302387|NCT00002388|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6302388|NCT00002389|Lamivudine|lamivudine|mesh-list
6302389|NCT00002389|Zidovudine|zidovudine|mesh-list
6302390|NCT00002389|Abacavir|abacavir|mesh-list
6302391|NCT00002389|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6302392|NCT00002389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6302393|NCT00002389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302394|NCT00002389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302395|NCT00002389|Antiviral Agents|antiviral agents|mesh-ancestor
6302396|NCT00002389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302397|NCT00002389|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6302398|NCT00002389|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6302399|NCT00002389|Antimetabolites|antimetabolites|mesh-ancestor
6302400|NCT00002390|Abacavir|abacavir|mesh-list
6302401|NCT00002390|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6302402|NCT00002390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6302403|NCT00002390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302404|NCT00002390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302405|NCT00002390|Antiviral Agents|antiviral agents|mesh-ancestor
6302406|NCT00002390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302407|NCT00002390|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6302408|NCT00002390|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6302409|NCT00002391|Lamivudine|lamivudine|mesh-list
6302410|NCT00002391|Zidovudine|zidovudine|mesh-list
6302411|NCT00002391|Abacavir|abacavir|mesh-list
6302412|NCT00002391|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6302413|NCT00002391|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6302414|NCT00002391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302415|NCT00002391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302416|NCT00002391|Antiviral Agents|antiviral agents|mesh-ancestor
6302417|NCT00002391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302418|NCT00002391|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6015889|NCT00360685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302419|NCT00002391|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6302420|NCT00002391|Antimetabolites|antimetabolites|mesh-ancestor
6302421|NCT00002392|Thalidomide|thalidomide|mesh-list
6302422|NCT00002392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6302423|NCT00002392|Immunologic Factors|immunologic factors|mesh-ancestor
6302424|NCT00002392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6302425|NCT00002392|Leprostatic Agents|leprostatic agents|mesh-ancestor
6302426|NCT00002392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6302427|NCT00002392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302428|NCT00002392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6302429|NCT00002392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6302430|NCT00002392|Growth Substances|growth substances|mesh-ancestor
6302431|NCT00002392|Growth Inhibitors|growth inhibitors|mesh-ancestor
6302432|NCT00002392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6302433|NCT00002393|Efavirenz|efavirenz|mesh-list
6302434|NCT00002393|Indinavir|indinavir|mesh-list
6302435|NCT00002393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6302436|NCT00002393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6302437|NCT00002393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302438|NCT00002393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302439|NCT00002393|Antiviral Agents|antiviral agents|mesh-ancestor
6302440|NCT00002393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302441|NCT00002393|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6302442|NCT00002393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6302443|NCT00002393|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6302444|NCT00002393|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6302445|NCT00002393|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6302446|NCT00002393|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6302447|NCT00002393|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6302448|NCT00002393|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6302449|NCT00002393|Protease Inhibitors|protease inhibitors|mesh-ancestor
6302450|NCT00002393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6302451|NCT00002393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6302452|NCT00002394|Terbinafine|terbinafine|mesh-list
6302453|NCT00002394|Antifungal Agents|antifungal agents|mesh-ancestor
6302454|NCT00002394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6015890|NCT00360685|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6302455|NCT00002394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302456|NCT00002394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302457|NCT00002395|Topotecan|topotecan|mesh-list
6302458|NCT00002395|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6302459|NCT00002395|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6302460|NCT00002395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302461|NCT00002395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302462|NCT00002395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6302463|NCT00002396|Tenofovir|tenofovir|mesh-list
6302464|NCT00002396|Antiviral Agents|antiviral agents|mesh-ancestor
6302465|NCT00002396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302466|NCT00002396|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6302467|NCT00002396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6302468|NCT00002396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302469|NCT00002396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302470|NCT00002396|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6302471|NCT00002396|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6302472|NCT00002397|Lamivudine|lamivudine|mesh-list
6302473|NCT00002397|Stavudine|stavudine|mesh-list
6302474|NCT00002397|Nelfinavir|nelfinavir|mesh-list
6302475|NCT00002397|Saquinavir|saquinavir|mesh-list
6302476|NCT00002397|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6302477|NCT00002397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6302478|NCT00002397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302479|NCT00002397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302480|NCT00002397|Antiviral Agents|antiviral agents|mesh-ancestor
6302481|NCT00002397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302482|NCT00002397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6302483|NCT00002397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6302484|NCT00002397|Antimetabolites|antimetabolites|mesh-ancestor
6302485|NCT00002397|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6302486|NCT00002397|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6015891|NCT00360685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6015892|NCT00360685|Immunologic Factors|immunologic factors|mesh-ancestor
6015893|NCT00360685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6015894|NCT00360685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6015895|NCT00360685|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6302487|NCT00002397|Protease Inhibitors|protease inhibitors|mesh-ancestor
6302488|NCT00002397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6302489|NCT00002397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6302490|NCT00002398|Adefovir|adefovir|mesh-list
6302491|NCT00002398|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6302492|NCT00002398|Antiviral Agents|antiviral agents|mesh-ancestor
6302493|NCT00002398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302494|NCT00002398|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6302495|NCT00002398|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6302496|NCT00002398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302497|NCT00002398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302498|NCT00002399|Fluconazole|fluconazole|mesh-list
6302499|NCT00002399|Posaconazole|posaconazole|mesh-list
6302500|NCT00002399|Antifungal Agents|antifungal agents|mesh-ancestor
6302501|NCT00002399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302502|NCT00002399|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6302503|NCT00002399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6302504|NCT00002399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302505|NCT00002399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302506|NCT00002399|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6302507|NCT00002399|Hormone Antagonists|hormone antagonists|mesh-ancestor
6302508|NCT00002399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6302509|NCT00002399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6302510|NCT00002399|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6302511|NCT00002399|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6302512|NCT00002399|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6302513|NCT00002399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6302514|NCT00002399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6302515|NCT00002400|Lamivudine|lamivudine|mesh-list
6302516|NCT00002400|Zidovudine|zidovudine|mesh-list
6302517|NCT00002400|Delavirdine|delavirdine|mesh-list
6302518|NCT00002400|Indinavir|indinavir|mesh-list
6302519|NCT00002400|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6302520|NCT00002400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6302521|NCT00002400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302522|NCT00002400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302523|NCT00002400|Antiviral Agents|antiviral agents|mesh-ancestor
6302524|NCT00002400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302525|NCT00002400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6302526|NCT00002400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6302527|NCT00002400|Antimetabolites|antimetabolites|mesh-ancestor
6302528|NCT00002400|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6302529|NCT00002400|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6302530|NCT00002400|Protease Inhibitors|protease inhibitors|mesh-ancestor
6302531|NCT00002401|Lamivudine|lamivudine|mesh-list
6302532|NCT00002401|Zidovudine|zidovudine|mesh-list
6302533|NCT00002401|Delavirdine|delavirdine|mesh-list
6302534|NCT00002401|Indinavir|indinavir|mesh-list
6302535|NCT00002401|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6302536|NCT00002401|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6302537|NCT00002401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302538|NCT00002401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302539|NCT00002401|Antiviral Agents|antiviral agents|mesh-ancestor
6302540|NCT00002401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302541|NCT00002401|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6302542|NCT00002401|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6302543|NCT00002401|Antimetabolites|antimetabolites|mesh-ancestor
6302544|NCT00002401|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6302545|NCT00002401|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6302546|NCT00002401|Protease Inhibitors|protease inhibitors|mesh-ancestor
6302547|NCT00002402|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6302548|NCT00002402|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6302549|NCT00002402|Immunologic Factors|immunologic factors|mesh-ancestor
6302550|NCT00002402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6302551|NCT00002402|Antacids|antacids|mesh-ancestor
6302552|NCT00002402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302553|NCT00002402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6302554|NCT00002404|Valacyclovir|valacyclovir|mesh-list
6302555|NCT00002404|Antiviral Agents|antiviral agents|mesh-ancestor
6302556|NCT00002404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302557|NCT00002405|Amprenavir|amprenavir|mesh-list
6302558|NCT00002405|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6302559|NCT00002405|Antitubercular Agents|antitubercular agents|mesh-ancestor
6302560|NCT00002405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6302561|NCT00002405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302562|NCT00002405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6302563|NCT00002405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6302564|NCT00002405|Protease Inhibitors|protease inhibitors|mesh-ancestor
6302565|NCT00002405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302566|NCT00002405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302567|NCT00002405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6302568|NCT00002405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6302569|NCT00002405|Antiviral Agents|antiviral agents|mesh-ancestor
6302570|NCT00002406|Indinavir|indinavir|mesh-list
6302571|NCT00002406|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6302572|NCT00002406|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6302573|NCT00002406|Protease Inhibitors|protease inhibitors|mesh-ancestor
6302574|NCT00002406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302575|NCT00002406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302576|NCT00002406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6302577|NCT00002406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6302578|NCT00002406|Antiviral Agents|antiviral agents|mesh-ancestor
6302579|NCT00002406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302580|NCT00002407|Lamivudine|lamivudine|mesh-list
6302581|NCT00002407|Nevirapine|nevirapine|mesh-list
6302582|NCT00002407|Stavudine|stavudine|mesh-list
6302583|NCT00002407|Didanosine|didanosine|mesh-list
6302584|NCT00002407|Indinavir|indinavir|mesh-list
6302585|NCT00002407|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6302586|NCT00002407|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6302587|NCT00002407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302588|NCT00002407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302589|NCT00002407|Antiviral Agents|antiviral agents|mesh-ancestor
6302590|NCT00002407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302591|NCT00002407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6302592|NCT00002407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6302593|NCT00002407|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6302594|NCT00002407|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6302595|NCT00002407|Antimetabolites|antimetabolites|mesh-ancestor
6302596|NCT00002407|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6302597|NCT00002407|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6302598|NCT00002407|Protease Inhibitors|protease inhibitors|mesh-ancestor
6302599|NCT00002409|Lamivudine|lamivudine|mesh-list
6302600|NCT00002409|Zidovudine|zidovudine|mesh-list
6302601|NCT00002409|Abacavir|abacavir|mesh-list
6302602|NCT00002409|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6302603|NCT00002409|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6302604|NCT00002409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6302605|NCT00002409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302606|NCT00002409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302607|NCT00002409|Antiviral Agents|antiviral agents|mesh-ancestor
6302608|NCT00002409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302609|NCT00002409|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6302610|NCT00002409|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6302611|NCT00002409|Antimetabolites|antimetabolites|mesh-ancestor
6302612|NCT00002410|Lamivudine|lamivudine|mesh-list
6302613|NCT00002410|Zidovudine|zidovudine|mesh-list
6302614|NCT00002410|Indinavir|indinavir|mesh-list
6302615|NCT00002410|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6302616|NCT00002410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6302617|NCT00002410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302618|NCT00002410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302619|NCT00002410|Antiviral Agents|antiviral agents|mesh-ancestor
6302620|NCT00002410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302621|NCT00002410|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6302622|NCT00002410|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6302623|NCT00002410|Antimetabolites|antimetabolites|mesh-ancestor
6302624|NCT00002410|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6302625|NCT00002410|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6302626|NCT00002410|Protease Inhibitors|protease inhibitors|mesh-ancestor
6302627|NCT00002412|Stavudine|stavudine|mesh-list
6302628|NCT00002412|Didanosine|didanosine|mesh-list
6302629|NCT00002412|Emivirine|emivirine|mesh-list
6302630|NCT00002412|Hydroxyurea|hydroxyurea|mesh-list
6302631|NCT00002412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6302632|NCT00002412|Antisickling Agents|antisickling agents|mesh-ancestor
6302633|NCT00002412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302634|NCT00002412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302635|NCT00002412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6302636|NCT00002412|Antimetabolites|antimetabolites|mesh-ancestor
6302637|NCT00002412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6302638|NCT00002412|Antiviral Agents|antiviral agents|mesh-ancestor
6302639|NCT00002412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302640|NCT00002412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6302641|NCT00002412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6302642|NCT00002413|Emivirine|emivirine|mesh-list
6302643|NCT00002413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6302644|NCT00002413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6302645|NCT00002413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302646|NCT00002413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302647|NCT00002413|Antiviral Agents|antiviral agents|mesh-ancestor
6302648|NCT00002413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302649|NCT00002415|Tenofovir|tenofovir|mesh-list
6302650|NCT00002415|Antiviral Agents|antiviral agents|mesh-ancestor
6302651|NCT00002415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302652|NCT00002415|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6302653|NCT00002415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6302654|NCT00002415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302655|NCT00002415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302656|NCT00002415|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6302657|NCT00002415|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6302658|NCT00002416|Lamivudine|lamivudine|mesh-list
6302659|NCT00002416|Emtricitabine|emtricitabine|mesh-list
6302660|NCT00002416|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6302661|NCT00002416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6302662|NCT00002416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302663|NCT00002416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302664|NCT00002416|Antiviral Agents|antiviral agents|mesh-ancestor
6302665|NCT00002416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302666|NCT00002416|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6302667|NCT00002416|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6302668|NCT00002417|Amprenavir|amprenavir|mesh-list
6302669|NCT00002417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6302670|NCT00002417|Antitubercular Agents|antitubercular agents|mesh-ancestor
6302671|NCT00002417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6302672|NCT00002417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302673|NCT00002417|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6302674|NCT00002417|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6302675|NCT00002417|Protease Inhibitors|protease inhibitors|mesh-ancestor
6302676|NCT00002417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302677|NCT00002417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302678|NCT00002417|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6302679|NCT00002417|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6302680|NCT00002417|Antiviral Agents|antiviral agents|mesh-ancestor
6302681|NCT00002418|Nevirapine|nevirapine|mesh-list
6302682|NCT00002418|Stavudine|stavudine|mesh-list
6302683|NCT00002418|Didanosine|didanosine|mesh-list
6302684|NCT00002418|Emivirine|emivirine|mesh-list
6302685|NCT00002418|Hydroxyurea|hydroxyurea|mesh-list
6302686|NCT00002418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6302687|NCT00002418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6302688|NCT00002418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302689|NCT00002418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302690|NCT00002418|Antiviral Agents|antiviral agents|mesh-ancestor
6302691|NCT00002418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302692|NCT00002418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6302693|NCT00002418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6302694|NCT00002418|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6302695|NCT00002418|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6302696|NCT00002418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6302697|NCT00002418|Antisickling Agents|antisickling agents|mesh-ancestor
6302698|NCT00002418|Antimetabolites|antimetabolites|mesh-ancestor
6302699|NCT00002419|Efavirenz|efavirenz|mesh-list
6302700|NCT00002419|Abacavir|abacavir|mesh-list
6302701|NCT00002419|Adefovir|adefovir|mesh-list
6302702|NCT00002419|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6302703|NCT00002419|Amprenavir|amprenavir|mesh-list
6302704|NCT00002419|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6302705|NCT00002419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6302706|NCT00002419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302707|NCT00002419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302708|NCT00002419|Antiviral Agents|antiviral agents|mesh-ancestor
6302709|NCT00002419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302710|NCT00002419|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6302711|NCT00002419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6302712|NCT00002419|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6302713|NCT00002419|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6302714|NCT00002419|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6302715|NCT00002419|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6302716|NCT00002419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6302717|NCT00002419|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6302718|NCT00002419|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6302719|NCT00002419|Antitubercular Agents|antitubercular agents|mesh-ancestor
6302720|NCT00002419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6302721|NCT00002419|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6302722|NCT00002419|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6302723|NCT00002419|Protease Inhibitors|protease inhibitors|mesh-ancestor
6302724|NCT00002420|Stavudine|stavudine|mesh-list
6302725|NCT00002420|Didanosine|didanosine|mesh-list
6302726|NCT00002420|Delavirdine|delavirdine|mesh-list
6302727|NCT00002420|Emivirine|emivirine|mesh-list
6302728|NCT00002420|Hydroxyurea|hydroxyurea|mesh-list
6302729|NCT00002420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6302730|NCT00002420|Antisickling Agents|antisickling agents|mesh-ancestor
6302731|NCT00002420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302732|NCT00002420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302733|NCT00002420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6302734|NCT00002420|Antimetabolites|antimetabolites|mesh-ancestor
6302735|NCT00002420|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6302736|NCT00002420|Antiviral Agents|antiviral agents|mesh-ancestor
6302737|NCT00002420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302738|NCT00002420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6302739|NCT00002420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6302740|NCT00002423|Lamivudine|lamivudine|mesh-list
6302741|NCT00002423|Abacavir|abacavir|mesh-list
6302742|NCT00002423|Nelfinavir|nelfinavir|mesh-list
6302743|NCT00002423|Indinavir|indinavir|mesh-list
6302744|NCT00002423|Amprenavir|amprenavir|mesh-list
6302745|NCT00002423|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6302746|NCT00002423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6302747|NCT00002423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302748|NCT00002423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302749|NCT00002423|Antiviral Agents|antiviral agents|mesh-ancestor
6302750|NCT00002423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302751|NCT00002423|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6302752|NCT00002423|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6302753|NCT00002423|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6302754|NCT00002423|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6302755|NCT00002423|Protease Inhibitors|protease inhibitors|mesh-ancestor
6302756|NCT00002423|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6302757|NCT00002423|Antitubercular Agents|antitubercular agents|mesh-ancestor
6302758|NCT00002423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6302759|NCT00002424|Lamivudine|lamivudine|mesh-list
6302760|NCT00002424|Stavudine|stavudine|mesh-list
6302761|NCT00002424|Indinavir|indinavir|mesh-list
6302762|NCT00002424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6302763|NCT00002424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6302764|NCT00002424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302765|NCT00002424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302766|NCT00002424|Antiviral Agents|antiviral agents|mesh-ancestor
6302767|NCT00002424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302768|NCT00002424|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6302769|NCT00002424|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6302770|NCT00002424|Antimetabolites|antimetabolites|mesh-ancestor
6302771|NCT00002424|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6302772|NCT00002424|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6302773|NCT00002424|Protease Inhibitors|protease inhibitors|mesh-ancestor
6302774|NCT00002425|Saquinavir|saquinavir|mesh-list
6302775|NCT00002425|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6302776|NCT00002425|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6302777|NCT00002425|Protease Inhibitors|protease inhibitors|mesh-ancestor
6302778|NCT00002425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302779|NCT00002425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302780|NCT00002425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6302781|NCT00002425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6302782|NCT00002425|Antiviral Agents|antiviral agents|mesh-ancestor
6302783|NCT00002425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302784|NCT00002425|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6302785|NCT00002425|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6302786|NCT00002426|Adefovir|adefovir|mesh-list
6302787|NCT00002426|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6302788|NCT00002426|Antiviral Agents|antiviral agents|mesh-ancestor
6302789|NCT00002426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302790|NCT00002426|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6302791|NCT00002426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6302792|NCT00002426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302793|NCT00002426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302794|NCT00002427|Stavudine|stavudine|mesh-list
6302795|NCT00002427|Didanosine|didanosine|mesh-list
6302796|NCT00002427|Hydroxyurea|hydroxyurea|mesh-list
6302797|NCT00002427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6302798|NCT00002427|Antisickling Agents|antisickling agents|mesh-ancestor
6302799|NCT00002427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302800|NCT00002427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302801|NCT00002427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6302802|NCT00002427|Antimetabolites|antimetabolites|mesh-ancestor
6302803|NCT00002427|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6302804|NCT00002427|Antiviral Agents|antiviral agents|mesh-ancestor
6302805|NCT00002427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302806|NCT00002427|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6302807|NCT00002427|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6302808|NCT00002428|Vaccines|vaccines|mesh-list
6302809|NCT00002428|Immunologic Factors|immunologic factors|mesh-ancestor
6302810|NCT00002428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6302811|NCT00002430|Lamivudine|lamivudine|mesh-list
6302812|NCT00002430|Stavudine|stavudine|mesh-list
6302813|NCT00002430|Nelfinavir|nelfinavir|mesh-list
6302814|NCT00002430|Indinavir|indinavir|mesh-list
6302815|NCT00002430|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6302816|NCT00002430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6302817|NCT00002430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302818|NCT00002430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302819|NCT00002430|Antiviral Agents|antiviral agents|mesh-ancestor
6302820|NCT00002430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302821|NCT00002430|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6302822|NCT00002430|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6302823|NCT00002430|Antimetabolites|antimetabolites|mesh-ancestor
6302824|NCT00002430|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6302825|NCT00002430|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6302826|NCT00002430|Protease Inhibitors|protease inhibitors|mesh-ancestor
6302827|NCT00002431|Chlorhexidine|chlorhexidine|mesh-list
6302828|NCT00002431|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6302829|NCT00002431|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6302830|NCT00002431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302831|NCT00002431|Disinfectants|disinfectants|mesh-ancestor
6302832|NCT00002431|Dermatologic Agents|dermatologic agents|mesh-ancestor
6302833|NCT00002432|Foscarnet|foscarnet|mesh-list
6302834|NCT00002432|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
6302835|NCT00002432|Antiviral Agents|antiviral agents|mesh-ancestor
6302836|NCT00002432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302837|NCT00002432|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6302838|NCT00002432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6302839|NCT00002432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302840|NCT00002432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302841|NCT00002433|Interferons|interferons|mesh-list
6302842|NCT00002433|Interferon-gamma|interferon-gamma|mesh-list
6302843|NCT00002433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6302844|NCT00002433|Antiviral Agents|antiviral agents|mesh-ancestor
6302845|NCT00002433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302846|NCT00002434|Leucovorin|leucovorin|mesh-list
6302847|NCT00002434|Trimetrexate|trimetrexate|mesh-list
6302848|NCT00002434|Calcium|calcium|mesh-list
6302849|NCT00002434|Levoleucovorin|levoleucovorin|mesh-list
6302850|NCT00002434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6302851|NCT00002434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6302852|NCT00002434|Antidotes|antidotes|mesh-ancestor
6302853|NCT00002434|Protective Agents|protective agents|mesh-ancestor
6302854|NCT00002434|Vitamin B Complex|vitamin b complex|mesh-ancestor
6302855|NCT00002434|Vitamins|vitamins|mesh-ancestor
6302856|NCT00002434|Micronutrients|micronutrients|mesh-ancestor
6302857|NCT00002434|Antifungal Agents|antifungal agents|mesh-ancestor
6302858|NCT00002434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302859|NCT00002434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6302860|NCT00002434|Antimetabolites|antimetabolites|mesh-ancestor
6302861|NCT00002434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302862|NCT00002434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6302863|NCT00002434|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6302864|NCT00002434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302865|NCT00002435|Zidovudine|zidovudine|mesh-list
6302866|NCT00002435|Antimetabolites|antimetabolites|mesh-ancestor
6397094|NCT00210210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6302867|NCT00002435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302868|NCT00002435|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6302869|NCT00002435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6302870|NCT00002435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302871|NCT00002435|Antiviral Agents|antiviral agents|mesh-ancestor
6302872|NCT00002435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302873|NCT00002435|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6302874|NCT00002435|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6302875|NCT00002436|Lamivudine|lamivudine|mesh-list
6302876|NCT00002436|Zidovudine|zidovudine|mesh-list
6302877|NCT00002436|Zalcitabine|zalcitabine|mesh-list
6302878|NCT00002436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6302879|NCT00002436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6302880|NCT00002436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302881|NCT00002436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302882|NCT00002436|Antiviral Agents|antiviral agents|mesh-ancestor
6302883|NCT00002436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302884|NCT00002436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6302885|NCT00002436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6302886|NCT00002436|Antimetabolites|antimetabolites|mesh-ancestor
6302887|NCT00002437|Cidofovir|cidofovir|mesh-list
6302888|NCT00002437|Probenecid|probenecid|mesh-list
6302889|NCT00002437|Uricosuric Agents|uricosuric agents|mesh-ancestor
6302890|NCT00002437|Gout Suppressants|gout suppressants|mesh-ancestor
6302891|NCT00002437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6302892|NCT00002437|Renal Agents|renal agents|mesh-ancestor
6302893|NCT00002437|Antiviral Agents|antiviral agents|mesh-ancestor
6302894|NCT00002437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302895|NCT00002437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302896|NCT00002437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302897|NCT00002438|Itraconazole|itraconazole|mesh-list
6302898|NCT00002438|Antifungal Agents|antifungal agents|mesh-ancestor
6302899|NCT00002438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302900|NCT00002438|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6302901|NCT00002438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6302902|NCT00002438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302903|NCT00002438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302904|NCT00002438|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6302905|NCT00002438|Hormone Antagonists|hormone antagonists|mesh-ancestor
6302906|NCT00002438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6302907|NCT00002438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6302908|NCT00002438|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6302909|NCT00002439|Alitretinoin|alitretinoin|mesh-list
6302910|NCT00002439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6302911|NCT00002439|Dermatologic Agents|dermatologic agents|mesh-ancestor
6302912|NCT00002440|Ritonavir|ritonavir|mesh-list
6302913|NCT00002440|Nelfinavir|nelfinavir|mesh-list
6302914|NCT00002440|Indinavir|indinavir|mesh-list
6302915|NCT00002440|Saquinavir|saquinavir|mesh-list
6302916|NCT00002440|Amprenavir|amprenavir|mesh-list
6302917|NCT00002440|Abacavir|abacavir|mesh-list
6302918|NCT00002440|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6302919|NCT00002440|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6302920|NCT00002440|Protease Inhibitors|protease inhibitors|mesh-ancestor
6302921|NCT00002440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302922|NCT00002440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302923|NCT00002440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6302924|NCT00002440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6302925|NCT00002440|Antiviral Agents|antiviral agents|mesh-ancestor
6302926|NCT00002440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302927|NCT00002440|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6302928|NCT00002440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6302929|NCT00002440|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6302930|NCT00002440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6302931|NCT00002440|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6302932|NCT00002440|Antitubercular Agents|antitubercular agents|mesh-ancestor
6302933|NCT00002440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6302934|NCT00002442|Lamivudine|lamivudine|mesh-list
6302935|NCT00002442|Stavudine|stavudine|mesh-list
6302936|NCT00002442|Nelfinavir|nelfinavir|mesh-list
6302937|NCT00002442|Indinavir|indinavir|mesh-list
6302938|NCT00002442|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6302939|NCT00002442|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6302940|NCT00002442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302941|NCT00002442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302942|NCT00002442|Antiviral Agents|antiviral agents|mesh-ancestor
6302943|NCT00002442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302944|NCT00002442|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6302945|NCT00002442|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6302946|NCT00002442|Antimetabolites|antimetabolites|mesh-ancestor
6302947|NCT00002442|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6302948|NCT00002442|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6302949|NCT00002442|Protease Inhibitors|protease inhibitors|mesh-ancestor
6302950|NCT00002443|Zidovudine|zidovudine|mesh-list
6302951|NCT00002443|Indinavir|indinavir|mesh-list
6302952|NCT00002443|Antimetabolites|antimetabolites|mesh-ancestor
6302953|NCT00002443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302954|NCT00002443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6302955|NCT00002443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6302956|NCT00002443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302957|NCT00002443|Antiviral Agents|antiviral agents|mesh-ancestor
6302958|NCT00002443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302959|NCT00002443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6302960|NCT00002443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6302961|NCT00002443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6302962|NCT00002443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6302963|NCT00002443|Protease Inhibitors|protease inhibitors|mesh-ancestor
6302964|NCT00002444|Nitazoxanide|nitazoxanide|mesh-list
6302965|NCT00002444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6302966|NCT00002444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302967|NCT00002446|Fluconazole|fluconazole|mesh-list
6302968|NCT00002446|Posaconazole|posaconazole|mesh-list
6302969|NCT00002446|Antifungal Agents|antifungal agents|mesh-ancestor
6302970|NCT00002446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302971|NCT00002446|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6302972|NCT00002446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6302973|NCT00002446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302974|NCT00002446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302975|NCT00002446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6302976|NCT00002446|Hormone Antagonists|hormone antagonists|mesh-ancestor
6302977|NCT00002446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6302978|NCT00002446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6302979|NCT00002446|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6302980|NCT00002446|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6302981|NCT00002446|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6302982|NCT00002446|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6302983|NCT00002446|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6302984|NCT00002447|Ritonavir|ritonavir|mesh-list
6302985|NCT00002447|Saquinavir|saquinavir|mesh-list
6302986|NCT00002447|Efavirenz|efavirenz|mesh-list
6302987|NCT00002447|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6302988|NCT00002447|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6302989|NCT00002447|Protease Inhibitors|protease inhibitors|mesh-ancestor
6302990|NCT00002447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6302991|NCT00002447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6302992|NCT00002447|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6302993|NCT00002447|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6302994|NCT00002447|Antiviral Agents|antiviral agents|mesh-ancestor
6302995|NCT00002447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6302996|NCT00002447|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6302997|NCT00002447|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6538068|NCT00825552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6302998|NCT00002447|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6302999|NCT00002447|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6303000|NCT00002447|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6303001|NCT00002447|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6303002|NCT00002447|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6303003|NCT00002447|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6303004|NCT00002447|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6303005|NCT00002448|Ritonavir|ritonavir|mesh-list
6303006|NCT00002448|Saquinavir|saquinavir|mesh-list
6303007|NCT00002448|Efavirenz|efavirenz|mesh-list
6303008|NCT00002448|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6303009|NCT00002448|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6303010|NCT00002448|Protease Inhibitors|protease inhibitors|mesh-ancestor
6303011|NCT00002448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6303012|NCT00002448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6303013|NCT00002448|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6303014|NCT00002448|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6303015|NCT00002448|Antiviral Agents|antiviral agents|mesh-ancestor
6303016|NCT00002448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6303017|NCT00002448|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6303018|NCT00002448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6303019|NCT00002448|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6015896|NCT00360685|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6303020|NCT00002448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6303021|NCT00002448|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6303022|NCT00002448|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6303023|NCT00002448|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6303024|NCT00002448|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6303025|NCT00002448|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6303026|NCT00002449|Aldesleukin|aldesleukin|mesh-list
6303027|NCT00002449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6303028|NCT00002449|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6303029|NCT00002449|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6303030|NCT00002449|Antiviral Agents|antiviral agents|mesh-ancestor
6303031|NCT00002449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6303032|NCT00002450|Tenofovir|tenofovir|mesh-list
6303033|NCT00002450|Antiviral Agents|antiviral agents|mesh-ancestor
6303034|NCT00002450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6303035|NCT00002450|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6303036|NCT00002450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6303037|NCT00002450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6303038|NCT00002450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6303039|NCT00002450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6303040|NCT00002450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6303041|NCT00002451|Ritonavir|ritonavir|mesh-list
6303042|NCT00002451|Indinavir|indinavir|mesh-list
6303043|NCT00002451|Lamivudine|lamivudine|mesh-list
6303044|NCT00002451|Stavudine|stavudine|mesh-list
6303045|NCT00002451|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6303046|NCT00002451|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6303047|NCT00002451|Protease Inhibitors|protease inhibitors|mesh-ancestor
6303048|NCT00002451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6303049|NCT00002451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6303050|NCT00002451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6303051|NCT00002451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6303052|NCT00002451|Antiviral Agents|antiviral agents|mesh-ancestor
6303053|NCT00002451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6303054|NCT00002451|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6303055|NCT00002451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6303056|NCT00002451|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6303057|NCT00002451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6303058|NCT00002451|Antimetabolites|antimetabolites|mesh-ancestor
6303059|NCT00002452|Indinavir|indinavir|mesh-list
6303060|NCT00002452|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6303061|NCT00002452|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6303062|NCT00002452|Protease Inhibitors|protease inhibitors|mesh-ancestor
6303063|NCT00002452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6303064|NCT00002452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6303065|NCT00002452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6303066|NCT00002452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6303067|NCT00002452|Antiviral Agents|antiviral agents|mesh-ancestor
6303068|NCT00002452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6303069|NCT00002453|Tenofovir|tenofovir|mesh-list
6303070|NCT00002453|Antiviral Agents|antiviral agents|mesh-ancestor
6303071|NCT00002453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6303072|NCT00002453|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6303073|NCT00002453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6303074|NCT00002453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6303075|NCT00002453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6303076|NCT00002453|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6303077|NCT00002453|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6392240|NCT00195754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392241|NCT00195754|GABA Agents|gaba agents|mesh-ancestor
6392242|NCT00195754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6392243|NCT00195754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392244|NCT00195754|Antimanic Agents|antimanic agents|mesh-ancestor
6392245|NCT00195754|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6392246|NCT00195754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6392247|NCT00195754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6392248|NCT00195767|Valproic Acid|valproic acid|mesh-list
6392249|NCT00195767|Anticonvulsants|anticonvulsants|mesh-ancestor
6392250|NCT00195767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6392251|NCT00195767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392252|NCT00195767|GABA Agents|gaba agents|mesh-ancestor
6392253|NCT00195767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6392254|NCT00195767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392255|NCT00195767|Antimanic Agents|antimanic agents|mesh-ancestor
6392256|NCT00195767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6392257|NCT00195767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6392258|NCT00195767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6392259|NCT00195780|Valproic Acid|valproic acid|mesh-list
6392260|NCT00195780|Anticonvulsants|anticonvulsants|mesh-ancestor
6392261|NCT00195780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6392262|NCT00195780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392263|NCT00195780|GABA Agents|gaba agents|mesh-ancestor
6392264|NCT00195780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6392265|NCT00195780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392266|NCT00195780|Antimanic Agents|antimanic agents|mesh-ancestor
6392267|NCT00195780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6392268|NCT00195780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6392269|NCT00195780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6392270|NCT00195793|Atorvastatin|atorvastatin|mesh-list
6392271|NCT00195793|Ezetimibe|ezetimibe|mesh-list
6392272|NCT00195793|Fenofibrate|fenofibrate|mesh-list
6392273|NCT00195793|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6392274|NCT00195793|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6392275|NCT00195793|Antimetabolites|antimetabolites|mesh-ancestor
6303078|NCT00002456|Cyclosporine|cyclosporine|mesh-list
6303079|NCT00002456|Methotrexate|methotrexate|mesh-list
6303080|NCT00002456|Cyclosporins|cyclosporins|mesh-list
6303081|NCT00002456|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6303082|NCT00002456|Abortifacient Agents|abortifacient agents|mesh-ancestor
6303083|NCT00002456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6303084|NCT00002456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6303085|NCT00002456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6303086|NCT00002456|Antimetabolites|antimetabolites|mesh-ancestor
6303087|NCT00002456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6303088|NCT00002456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6303089|NCT00002456|Dermatologic Agents|dermatologic agents|mesh-ancestor
6303090|NCT00002456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6303091|NCT00002456|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6303092|NCT00002456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6303093|NCT00002456|Immunologic Factors|immunologic factors|mesh-ancestor
6303094|NCT00002456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6303095|NCT00002456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6303096|NCT00002456|Antifungal Agents|antifungal agents|mesh-ancestor
6303097|NCT00002456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6303098|NCT00002456|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6303099|NCT00002458|Antibodies|antibodies|mesh-list
6303100|NCT00002458|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6303101|NCT00002458|Immunologic Factors|immunologic factors|mesh-ancestor
6303102|NCT00002458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6303103|NCT00002460|Tamoxifen|tamoxifen|mesh-list
6303104|NCT00002460|Goserelin|goserelin|mesh-list
6303105|NCT00002460|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6303106|NCT00002460|Hormone Antagonists|hormone antagonists|mesh-ancestor
6303107|NCT00002460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6303108|NCT00002460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6303109|NCT00002460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6303110|NCT00002460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6303111|NCT00002460|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6303112|NCT00002460|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6303113|NCT00002460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6303114|NCT00002461|Cyclophosphamide|cyclophosphamide|mesh-list
6303115|NCT00002461|Carmustine|carmustine|mesh-list
6303116|NCT00002461|Etoposide|etoposide|mesh-list
6303117|NCT00002461|Sargramostim|sargramostim|mesh-list
6303118|NCT00002461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6303119|NCT00002461|Immunologic Factors|immunologic factors|mesh-ancestor
6303120|NCT00002461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6303121|NCT00002461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6303122|NCT00002461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6303123|NCT00002461|Alkylating Agents|alkylating agents|mesh-ancestor
6303124|NCT00002461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6303125|NCT00002461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6303126|NCT00002461|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6303127|NCT00002461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6303128|NCT00002461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6303129|NCT00002461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6303130|NCT00002461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6303131|NCT00002462|Cobalt|cobalt|mesh-list
6303132|NCT00002462|Prednisone|prednisone|mesh-list
6303133|NCT00002462|Doxorubicin|doxorubicin|mesh-list
6303134|NCT00002462|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6303135|NCT00002462|Bleomycin|bleomycin|mesh-list
6303136|NCT00002462|Vincristine|vincristine|mesh-list
6303137|NCT00002462|Vinblastine|vinblastine|mesh-list
6303138|NCT00002462|Procarbazine|procarbazine|mesh-list
6303139|NCT00002462|Mechlorethamine|mechlorethamine|mesh-list
6303140|NCT00002462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6303141|NCT00002462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6303142|NCT00002462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6303143|NCT00002462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6303144|NCT00002462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6303145|NCT00002462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6303146|NCT00002462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6303147|NCT00002462|Glucocorticoids|glucocorticoids|mesh-ancestor
6303148|NCT00002462|Hormones|hormones|mesh-ancestor
6303149|NCT00002462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6303150|NCT00002462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6303151|NCT00002462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6303152|NCT00002462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6303153|NCT00002462|Tubulin Modulators|tubulin modulators|mesh-ancestor
6303154|NCT00002462|Antimitotic Agents|antimitotic agents|mesh-ancestor
6303155|NCT00002462|Mitosis Modulators|mitosis modulators|mesh-ancestor
6303156|NCT00002462|Trace Elements|trace elements|mesh-ancestor
6303157|NCT00002462|Micronutrients|micronutrients|mesh-ancestor
6303158|NCT00002462|Alkylating Agents|alkylating agents|mesh-ancestor
6303159|NCT00002462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6303160|NCT00002463|Leucovorin|leucovorin|mesh-list
6303161|NCT00002463|Prednisone|prednisone|mesh-list
6303162|NCT00002463|Methotrexate|methotrexate|mesh-list
6303163|NCT00002463|Vincristine|vincristine|mesh-list
6303164|NCT00002463|Procarbazine|procarbazine|mesh-list
6303165|NCT00002463|Mechlorethamine|mechlorethamine|mesh-list
6303166|NCT00002463|Calcium|calcium|mesh-list
6303167|NCT00002463|Levoleucovorin|levoleucovorin|mesh-list
6303168|NCT00002463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6303169|NCT00002463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6303170|NCT00002463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6303171|NCT00002463|Glucocorticoids|glucocorticoids|mesh-ancestor
6303172|NCT00002463|Hormones|hormones|mesh-ancestor
6303173|NCT00002463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6303174|NCT00002463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6303175|NCT00002463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6303176|NCT00002463|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6303177|NCT00002463|Abortifacient Agents|abortifacient agents|mesh-ancestor
6303178|NCT00002463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6303179|NCT00002463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6303180|NCT00002463|Antimetabolites|antimetabolites|mesh-ancestor
6303181|NCT00002463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6303182|NCT00002463|Dermatologic Agents|dermatologic agents|mesh-ancestor
6303183|NCT00002463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6303184|NCT00002463|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6303185|NCT00002463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6303186|NCT00002463|Immunologic Factors|immunologic factors|mesh-ancestor
6303187|NCT00002463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6303188|NCT00002463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6303189|NCT00002463|Antidotes|antidotes|mesh-ancestor
6303190|NCT00002463|Protective Agents|protective agents|mesh-ancestor
6303191|NCT00002463|Vitamin B Complex|vitamin b complex|mesh-ancestor
6303192|NCT00002463|Vitamins|vitamins|mesh-ancestor
6303193|NCT00002463|Micronutrients|micronutrients|mesh-ancestor
6303194|NCT00002463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6303195|NCT00002463|Tubulin Modulators|tubulin modulators|mesh-ancestor
6303196|NCT00002463|Antimitotic Agents|antimitotic agents|mesh-ancestor
6303197|NCT00002463|Mitosis Modulators|mitosis modulators|mesh-ancestor
6303198|NCT00002463|Alkylating Agents|alkylating agents|mesh-ancestor
6303199|NCT00002463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6303200|NCT00002465|Megestrol|megestrol|mesh-list
6303201|NCT00002465|Megestrol Acetate|megestrol acetate|mesh-list
6303202|NCT00002465|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6303203|NCT00002465|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6303204|NCT00002465|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6303205|NCT00002465|Contraceptive Agents|contraceptive agents|mesh-ancestor
6303206|NCT00002465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6303207|NCT00002465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6303208|NCT00002465|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6303209|NCT00002465|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6303210|NCT00002465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6303211|NCT00002465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6303212|NCT00002465|Appetite Stimulants|appetite stimulants|mesh-ancestor
6303213|NCT00002465|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6303214|NCT00002466|Cyclophosphamide|cyclophosphamide|mesh-list
6303215|NCT00002466|Ifosfamide|ifosfamide|mesh-list
6303216|NCT00002466|Doxorubicin|doxorubicin|mesh-list
6303217|NCT00002466|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6303218|NCT00002466|Etoposide|etoposide|mesh-list
6303219|NCT00002466|Vincristine|vincristine|mesh-list
6303220|NCT00002466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6303221|NCT00002466|Immunologic Factors|immunologic factors|mesh-ancestor
6303222|NCT00002466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6303223|NCT00002466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6303224|NCT00002466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6303225|NCT00002466|Alkylating Agents|alkylating agents|mesh-ancestor
6303226|NCT00002466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6303227|NCT00002466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6303228|NCT00002466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6303229|NCT00002466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6303230|NCT00002466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6303231|NCT00002466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6303232|NCT00002466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6303233|NCT00002466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6303234|NCT00002466|Tubulin Modulators|tubulin modulators|mesh-ancestor
6303235|NCT00002466|Antimitotic Agents|antimitotic agents|mesh-ancestor
6303236|NCT00002466|Mitosis Modulators|mitosis modulators|mesh-ancestor
6303237|NCT00002470|Interferons|interferons|mesh-list
6303238|NCT00002470|Interferon-alpha|interferon-alpha|mesh-list
6303239|NCT00002470|Fluorouracil|fluorouracil|mesh-list
6303240|NCT00002470|Antimetabolites|antimetabolites|mesh-ancestor
6303241|NCT00002470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6303242|NCT00002470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6303243|NCT00002470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6303244|NCT00002470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6303245|NCT00002470|Immunologic Factors|immunologic factors|mesh-ancestor
6303246|NCT00002470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6303247|NCT00002470|Antiviral Agents|antiviral agents|mesh-ancestor
6303248|NCT00002470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6303249|NCT00002471|Leucovorin|leucovorin|mesh-list
6303250|NCT00002471|Cytarabine|cytarabine|mesh-list
6303251|NCT00002471|Dexamethasone|dexamethasone|mesh-list
6303252|NCT00002471|Methylprednisolone|methylprednisolone|mesh-list
6303253|NCT00002471|Hydrocortisone|hydrocortisone|mesh-list
6303254|NCT00002471|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6303255|NCT00002471|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6303256|NCT00002471|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6303257|NCT00002471|Cyclophosphamide|cyclophosphamide|mesh-list
6303258|NCT00002471|Thiotepa|thiotepa|mesh-list
6303259|NCT00002471|Methotrexate|methotrexate|mesh-list
6303260|NCT00002471|Etoposide|etoposide|mesh-list
6303261|NCT00002471|Vincristine|vincristine|mesh-list
6303262|NCT00002471|Daunorubicin|daunorubicin|mesh-list
6303263|NCT00002471|Asparaginase|asparaginase|mesh-list
6303264|NCT00002471|Levoleucovorin|levoleucovorin|mesh-list
6303265|NCT00002471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6303266|NCT00002471|Immunologic Factors|immunologic factors|mesh-ancestor
6303267|NCT00002471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6303268|NCT00002471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6303269|NCT00002471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6303270|NCT00002471|Alkylating Agents|alkylating agents|mesh-ancestor
6303271|NCT00002471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6303272|NCT00002471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6303273|NCT00002471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6303274|NCT00002471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6303275|NCT00002471|Antiemetics|antiemetics|mesh-ancestor
6303276|NCT00002471|Autonomic Agents|autonomic agents|mesh-ancestor
6303277|NCT00002471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6303278|NCT00002471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6303279|NCT00002471|Glucocorticoids|glucocorticoids|mesh-ancestor
6303280|NCT00002471|Hormones|hormones|mesh-ancestor
6303281|NCT00002471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6303282|NCT00002471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6303283|NCT00002471|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6303284|NCT00002471|Abortifacient Agents|abortifacient agents|mesh-ancestor
6303285|NCT00002471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6303286|NCT00002471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6303287|NCT00002471|Antimetabolites|antimetabolites|mesh-ancestor
6303288|NCT00002471|Dermatologic Agents|dermatologic agents|mesh-ancestor
6303289|NCT00002471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6303290|NCT00002471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6303291|NCT00002471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6303292|NCT00002471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6303293|NCT00002471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6303294|NCT00002471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6303295|NCT00002471|Antiviral Agents|antiviral agents|mesh-ancestor
6303296|NCT00002471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6303297|NCT00002471|Antidotes|antidotes|mesh-ancestor
6303298|NCT00002471|Protective Agents|protective agents|mesh-ancestor
6303299|NCT00002471|Vitamin B Complex|vitamin b complex|mesh-ancestor
6303300|NCT00002471|Vitamins|vitamins|mesh-ancestor
6303301|NCT00002471|Micronutrients|micronutrients|mesh-ancestor
6303302|NCT00002471|Tubulin Modulators|tubulin modulators|mesh-ancestor
6303303|NCT00002471|Antimitotic Agents|antimitotic agents|mesh-ancestor
6303304|NCT00002471|Mitosis Modulators|mitosis modulators|mesh-ancestor
6303305|NCT00002471|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6303306|NCT00002471|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6303307|NCT00002472|Etoposide|etoposide|mesh-list
6303308|NCT00002472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6303309|NCT00002472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6303310|NCT00002472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6303311|NCT00002472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6303312|NCT00002472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6303313|NCT00002472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6303314|NCT00002474|Cyclophosphamide|cyclophosphamide|mesh-list
6303315|NCT00002474|Carboplatin|carboplatin|mesh-list
6303316|NCT00002474|Mitoxantrone|mitoxantrone|mesh-list
6303317|NCT00002474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6303318|NCT00002474|Immunologic Factors|immunologic factors|mesh-ancestor
6303319|NCT00002474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6303320|NCT00002474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6303321|NCT00002474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6303322|NCT00002474|Alkylating Agents|alkylating agents|mesh-ancestor
6303323|NCT00002474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6303324|NCT00002474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6303325|NCT00002474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6303326|NCT00002474|Analgesics|analgesics|mesh-ancestor
6303327|NCT00002474|Sensory System Agents|sensory system agents|mesh-ancestor
6303328|NCT00002474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6303329|NCT00002474|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6303330|NCT00002474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6303331|NCT00002474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6303332|NCT00002475|Interferons|interferons|mesh-list
6303333|NCT00002475|Interferon-alpha|interferon-alpha|mesh-list
6303334|NCT00002475|Interferon-gamma|interferon-gamma|mesh-list
6303335|NCT00002475|Cyclophosphamide|cyclophosphamide|mesh-list
6303336|NCT00002475|Vaccines|vaccines|mesh-list
6303337|NCT00002475|Sargramostim|sargramostim|mesh-list
6303338|NCT00002475|Immunologic Factors|immunologic factors|mesh-ancestor
6303339|NCT00002475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6303340|NCT00002475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6303341|NCT00002475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6303342|NCT00002475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6303343|NCT00002475|Alkylating Agents|alkylating agents|mesh-ancestor
6303344|NCT00002475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6303345|NCT00002475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6303346|NCT00002475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6303347|NCT00002475|Antiviral Agents|antiviral agents|mesh-ancestor
6303348|NCT00002475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6303349|NCT00002476|Leucovorin|leucovorin|mesh-list
6303350|NCT00002476|Cobalt|cobalt|mesh-list
6303351|NCT00002476|Fluorouracil|fluorouracil|mesh-list
6303352|NCT00002476|Methotrexate|methotrexate|mesh-list
6303353|NCT00002476|Vincristine|vincristine|mesh-list
6303354|NCT00002476|Bleomycin|bleomycin|mesh-list
6303355|NCT00002476|Calcium|calcium|mesh-list
6303356|NCT00002476|Levoleucovorin|levoleucovorin|mesh-list
6303357|NCT00002476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6303358|NCT00002476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6303359|NCT00002476|Antimetabolites|antimetabolites|mesh-ancestor
6303360|NCT00002476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6303361|NCT00002476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6303362|NCT00002476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6303363|NCT00002476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6303364|NCT00002476|Immunologic Factors|immunologic factors|mesh-ancestor
6303365|NCT00002476|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6303366|NCT00002476|Abortifacient Agents|abortifacient agents|mesh-ancestor
6303367|NCT00002476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6303368|NCT00002476|Dermatologic Agents|dermatologic agents|mesh-ancestor
6303369|NCT00002476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6303370|NCT00002476|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6303371|NCT00002476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6303372|NCT00002476|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6303373|NCT00002476|Antidotes|antidotes|mesh-ancestor
6303374|NCT00002476|Protective Agents|protective agents|mesh-ancestor
6303375|NCT00002476|Vitamin B Complex|vitamin b complex|mesh-ancestor
6303376|NCT00002476|Vitamins|vitamins|mesh-ancestor
6303377|NCT00002476|Micronutrients|micronutrients|mesh-ancestor
6303378|NCT00002476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6303379|NCT00002476|Tubulin Modulators|tubulin modulators|mesh-ancestor
6303380|NCT00002476|Antimitotic Agents|antimitotic agents|mesh-ancestor
6303381|NCT00002476|Mitosis Modulators|mitosis modulators|mesh-ancestor
6303382|NCT00002476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6303383|NCT00002476|Trace Elements|trace elements|mesh-ancestor
6303384|NCT00002477|Cyclophosphamide|cyclophosphamide|mesh-list
6303385|NCT00002477|Carboplatin|carboplatin|mesh-list
6303386|NCT00002477|Doxorubicin|doxorubicin|mesh-list
6303387|NCT00002477|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6303388|NCT00002477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6303389|NCT00002477|Immunologic Factors|immunologic factors|mesh-ancestor
6303390|NCT00002477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6303391|NCT00002477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6303392|NCT00002477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6303393|NCT00002477|Alkylating Agents|alkylating agents|mesh-ancestor
6303394|NCT00002477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6303395|NCT00002477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6303396|NCT00002477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6303397|NCT00002477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6303398|NCT00002477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6303399|NCT00002477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6303400|NCT00002477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6303401|NCT00002478|Etoposide|etoposide|mesh-list
6303402|NCT00002478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6303403|NCT00002478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6303404|NCT00002478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6303405|NCT00002478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6303406|NCT00002478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6303407|NCT00002478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6303408|NCT00002481|Cytarabine|cytarabine|mesh-list
6303409|NCT00002481|Dexamethasone|dexamethasone|mesh-list
6303410|NCT00002481|Cyclophosphamide|cyclophosphamide|mesh-list
6303411|NCT00002481|Etoposide|etoposide|mesh-list
6303412|NCT00002481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6303413|NCT00002481|Immunologic Factors|immunologic factors|mesh-ancestor
6303414|NCT00002481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6303415|NCT00002481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6303416|NCT00002481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6303417|NCT00002481|Alkylating Agents|alkylating agents|mesh-ancestor
6303418|NCT00002481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6303419|NCT00002481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6303420|NCT00002481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6303421|NCT00002481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6303422|NCT00002481|Antiemetics|antiemetics|mesh-ancestor
6303423|NCT00002481|Autonomic Agents|autonomic agents|mesh-ancestor
6303424|NCT00002481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6303425|NCT00002481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6303426|NCT00002481|Glucocorticoids|glucocorticoids|mesh-ancestor
6303427|NCT00002481|Hormones|hormones|mesh-ancestor
6303428|NCT00002481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6303429|NCT00002481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6303430|NCT00002481|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6303431|NCT00002481|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6303432|NCT00002481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6303433|NCT00002481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6303434|NCT00002481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6303435|NCT00002481|Antimetabolites|antimetabolites|mesh-ancestor
6303436|NCT00002481|Antiviral Agents|antiviral agents|mesh-ancestor
6303437|NCT00002481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6303438|NCT00002482|Cyclophosphamide|cyclophosphamide|mesh-list
6303439|NCT00002482|Muromonab-CD3|muromonab-cd3|mesh-list
6303440|NCT00002482|Antibodies|antibodies|mesh-list
6303441|NCT00002482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6303442|NCT00002482|Immunologic Factors|immunologic factors|mesh-ancestor
6303443|NCT00002482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6303444|NCT00002482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6303445|NCT00002482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6303446|NCT00002482|Alkylating Agents|alkylating agents|mesh-ancestor
6303447|NCT00002482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6303448|NCT00002482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6303449|NCT00002482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6303450|NCT00002487|Methotrexate|methotrexate|mesh-list
6303451|NCT00002487|Dipyridamole|dipyridamole|mesh-list
6303452|NCT00002487|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6303453|NCT00002487|Abortifacient Agents|abortifacient agents|mesh-ancestor
6303454|NCT00002487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6303455|NCT00002487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6303456|NCT00002487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6303457|NCT00002487|Antimetabolites|antimetabolites|mesh-ancestor
6303458|NCT00002487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6303459|NCT00002487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6303460|NCT00002487|Dermatologic Agents|dermatologic agents|mesh-ancestor
6303461|NCT00002487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6303462|NCT00002487|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6303463|NCT00002487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6303464|NCT00002487|Immunologic Factors|immunologic factors|mesh-ancestor
6303465|NCT00002487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6303466|NCT00002487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6303467|NCT00002487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6303468|NCT00002487|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6303469|NCT00002487|Vasodilator Agents|vasodilator agents|mesh-ancestor
6303470|NCT00002488|Cyclophosphamide|cyclophosphamide|mesh-list
6303471|NCT00002488|Etoposide|etoposide|mesh-list
6303472|NCT00002488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6303473|NCT00002488|Immunologic Factors|immunologic factors|mesh-ancestor
6303474|NCT00002488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6303475|NCT00002488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6303476|NCT00002488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6303477|NCT00002488|Alkylating Agents|alkylating agents|mesh-ancestor
6303478|NCT00002488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6303479|NCT00002488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6303480|NCT00002488|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6303481|NCT00002488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6303482|NCT00002488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6303483|NCT00002488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6303484|NCT00002488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6303485|NCT00002489|Leucovorin|leucovorin|mesh-list
6303486|NCT00002489|Dactinomycin|dactinomycin|mesh-list
6303487|NCT00002489|Cyclophosphamide|cyclophosphamide|mesh-list
6303488|NCT00002489|Carboplatin|carboplatin|mesh-list
6303489|NCT00002489|Doxorubicin|doxorubicin|mesh-list
6303490|NCT00002489|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6303491|NCT00002489|Methotrexate|methotrexate|mesh-list
6303492|NCT00002489|Etoposide|etoposide|mesh-list
6303493|NCT00002489|Vincristine|vincristine|mesh-list
6303494|NCT00002489|Levoleucovorin|levoleucovorin|mesh-list
6303495|NCT00002489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6303496|NCT00002489|Immunologic Factors|immunologic factors|mesh-ancestor
6303497|NCT00002489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6303498|NCT00002489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6303499|NCT00002489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6015897|NCT00360685|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6303500|NCT00002489|Alkylating Agents|alkylating agents|mesh-ancestor
6303501|NCT00002489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6303502|NCT00002489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6303503|NCT00002489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6303504|NCT00002489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6303505|NCT00002489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6303506|NCT00002489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6303507|NCT00002489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6303508|NCT00002489|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6303509|NCT00002489|Abortifacient Agents|abortifacient agents|mesh-ancestor
6303510|NCT00002489|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6303511|NCT00002489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6303512|NCT00002489|Antimetabolites|antimetabolites|mesh-ancestor
6303513|NCT00002489|Dermatologic Agents|dermatologic agents|mesh-ancestor
6303514|NCT00002489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6303515|NCT00002489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6303516|NCT00002489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6303517|NCT00002489|Antidotes|antidotes|mesh-ancestor
6303518|NCT00002489|Protective Agents|protective agents|mesh-ancestor
6303519|NCT00002489|Vitamin B Complex|vitamin b complex|mesh-ancestor
6303520|NCT00002489|Vitamins|vitamins|mesh-ancestor
6303521|NCT00002489|Micronutrients|micronutrients|mesh-ancestor
6303522|NCT00002489|Tubulin Modulators|tubulin modulators|mesh-ancestor
6303523|NCT00002489|Antimitotic Agents|antimitotic agents|mesh-ancestor
6303524|NCT00002489|Mitosis Modulators|mitosis modulators|mesh-ancestor
6303525|NCT00002489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6303526|NCT00002489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6303527|NCT00002489|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6303528|NCT00002490|Mitomycins|mitomycins|mesh-list
6303529|NCT00002490|Mitomycin|mitomycin|mesh-list
6303530|NCT00002490|BCG Vaccine|bcg vaccine|mesh-list
6303531|NCT00002490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6303532|NCT00002490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6303533|NCT00002490|Alkylating Agents|alkylating agents|mesh-ancestor
6303534|NCT00002490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6303535|NCT00002490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6303536|NCT00002490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6303537|NCT00002490|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6303538|NCT00002490|Immunologic Factors|immunologic factors|mesh-ancestor
6303539|NCT00002490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6303540|NCT00002492|Doxorubicin|doxorubicin|mesh-list
6303541|NCT00002492|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6303542|NCT00002492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6303543|NCT00002492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6303544|NCT00002492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6303545|NCT00002492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6303546|NCT00002492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6303547|NCT00002492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6303548|NCT00002493|Doxorubicin|doxorubicin|mesh-list
6303549|NCT00002493|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6303550|NCT00002493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6303551|NCT00002493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6303552|NCT00002493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6303553|NCT00002493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6303554|NCT00002493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6303555|NCT00002493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6303556|NCT00002494|Leucovorin|leucovorin|mesh-list
6303557|NCT00002494|Cobalt|cobalt|mesh-list
6303558|NCT00002494|Cytarabine|cytarabine|mesh-list
6303559|NCT00002494|Dexamethasone|dexamethasone|mesh-list
6303560|NCT00002494|Prednisone|prednisone|mesh-list
6303561|NCT00002494|Hydrocortisone|hydrocortisone|mesh-list
6303562|NCT00002494|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6303563|NCT00002494|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6303564|NCT00002494|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6303565|NCT00002494|Cyclophosphamide|cyclophosphamide|mesh-list
6303566|NCT00002494|Ifosfamide|ifosfamide|mesh-list
6303567|NCT00002494|Doxorubicin|doxorubicin|mesh-list
6303568|NCT00002494|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6303569|NCT00002494|Methotrexate|methotrexate|mesh-list
6303570|NCT00002494|Etoposide|etoposide|mesh-list
6303571|NCT00002494|Vincristine|vincristine|mesh-list
6303572|NCT00002494|Levoleucovorin|levoleucovorin|mesh-list
6303573|NCT00002494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6303574|NCT00002494|Immunologic Factors|immunologic factors|mesh-ancestor
6303575|NCT00002494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6303576|NCT00002494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6303577|NCT00002494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6303578|NCT00002494|Alkylating Agents|alkylating agents|mesh-ancestor
6303579|NCT00002494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6303580|NCT00002494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6303581|NCT00002494|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6303582|NCT00002494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6303583|NCT00002494|Antiemetics|antiemetics|mesh-ancestor
6303584|NCT00002494|Autonomic Agents|autonomic agents|mesh-ancestor
6303585|NCT00002494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6303586|NCT00002494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6303587|NCT00002494|Glucocorticoids|glucocorticoids|mesh-ancestor
6303588|NCT00002494|Hormones|hormones|mesh-ancestor
6303589|NCT00002494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6303590|NCT00002494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6303591|NCT00002494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6303592|NCT00002494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6303593|NCT00002494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6303594|NCT00002494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6303595|NCT00002494|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6303596|NCT00002494|Abortifacient Agents|abortifacient agents|mesh-ancestor
6303597|NCT00002494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6303598|NCT00002494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6303599|NCT00002494|Antimetabolites|antimetabolites|mesh-ancestor
6303600|NCT00002494|Dermatologic Agents|dermatologic agents|mesh-ancestor
6303601|NCT00002494|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6303602|NCT00002494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6303603|NCT00002494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6303604|NCT00002494|Antiviral Agents|antiviral agents|mesh-ancestor
6303605|NCT00002494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6303606|NCT00002494|Antidotes|antidotes|mesh-ancestor
6303607|NCT00002494|Protective Agents|protective agents|mesh-ancestor
6303608|NCT00002494|Vitamin B Complex|vitamin b complex|mesh-ancestor
6303609|NCT00002494|Vitamins|vitamins|mesh-ancestor
6303610|NCT00002494|Micronutrients|micronutrients|mesh-ancestor
6303611|NCT00002494|Tubulin Modulators|tubulin modulators|mesh-ancestor
6303612|NCT00002494|Antimitotic Agents|antimitotic agents|mesh-ancestor
6303613|NCT00002494|Mitosis Modulators|mitosis modulators|mesh-ancestor
6303614|NCT00002494|Trace Elements|trace elements|mesh-ancestor
6303615|NCT00002495|Doxorubicin|doxorubicin|mesh-list
6303616|NCT00002495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6303617|NCT00002495|Vinblastine|vinblastine|mesh-list
6303618|NCT00002495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6303619|NCT00002495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6303620|NCT00002495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6303621|NCT00002495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6303622|NCT00002495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6303623|NCT00002495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6303624|NCT00002495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6303625|NCT00002495|Tubulin Modulators|tubulin modulators|mesh-ancestor
6303626|NCT00002495|Antimitotic Agents|antimitotic agents|mesh-ancestor
6303627|NCT00002495|Mitosis Modulators|mitosis modulators|mesh-ancestor
6303628|NCT00002496|Cobalt|cobalt|mesh-list
6303629|NCT00002496|Fluorouracil|fluorouracil|mesh-list
6303630|NCT00002496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6303631|NCT00002496|Antimetabolites|antimetabolites|mesh-ancestor
6303632|NCT00002496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6303633|NCT00002496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6303634|NCT00002496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6303635|NCT00002496|Immunologic Factors|immunologic factors|mesh-ancestor
6303636|NCT00002496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6303637|NCT00002496|Trace Elements|trace elements|mesh-ancestor
6303638|NCT00002496|Micronutrients|micronutrients|mesh-ancestor
6303639|NCT00002498|Cyclophosphamide|cyclophosphamide|mesh-list
6303640|NCT00002498|Fluorouracil|fluorouracil|mesh-list
6303641|NCT00002498|Methotrexate|methotrexate|mesh-list
6303642|NCT00002498|Mitoxantrone|mitoxantrone|mesh-list
6303643|NCT00002498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6303644|NCT00002498|Immunologic Factors|immunologic factors|mesh-ancestor
6303645|NCT00002498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6303646|NCT00002498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6303647|NCT00002498|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6303648|NCT00002498|Alkylating Agents|alkylating agents|mesh-ancestor
6303649|NCT00002498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6303650|NCT00002498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6303651|NCT00002498|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6303652|NCT00002498|Antimetabolites|antimetabolites|mesh-ancestor
6303653|NCT00002498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6303654|NCT00002498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6303655|NCT00002498|Abortifacient Agents|abortifacient agents|mesh-ancestor
6303656|NCT00002498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6303657|NCT00002498|Dermatologic Agents|dermatologic agents|mesh-ancestor
6303658|NCT00002498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6303659|NCT00002498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6303660|NCT00002498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6303661|NCT00002498|Analgesics|analgesics|mesh-ancestor
6303662|NCT00002498|Sensory System Agents|sensory system agents|mesh-ancestor
6303663|NCT00002498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6303664|NCT00002498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6303665|NCT00002498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6303666|NCT00002499|Cytarabine|cytarabine|mesh-list
6303667|NCT00002499|Dexamethasone|dexamethasone|mesh-list
6303668|NCT00002499|Prednisone|prednisone|mesh-list
6303669|NCT00002499|Methotrexate|methotrexate|mesh-list
6303670|NCT00002499|Vincristine|vincristine|mesh-list
6303671|NCT00002499|Daunorubicin|daunorubicin|mesh-list
6303672|NCT00002499|Asparaginase|asparaginase|mesh-list
6303673|NCT00002499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6303674|NCT00002499|Antiemetics|antiemetics|mesh-ancestor
6303675|NCT00002499|Autonomic Agents|autonomic agents|mesh-ancestor
6303676|NCT00002499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6303677|NCT00002499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6303678|NCT00002499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6303679|NCT00002499|Glucocorticoids|glucocorticoids|mesh-ancestor
6303680|NCT00002499|Hormones|hormones|mesh-ancestor
6303681|NCT00002499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6303682|NCT00002499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6303683|NCT00002499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6303684|NCT00002499|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6303685|NCT00002499|Abortifacient Agents|abortifacient agents|mesh-ancestor
6303686|NCT00002499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6303687|NCT00002499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6303688|NCT00002499|Antimetabolites|antimetabolites|mesh-ancestor
6303689|NCT00002499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6303690|NCT00002499|Dermatologic Agents|dermatologic agents|mesh-ancestor
6303691|NCT00002499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6303692|NCT00002499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6303693|NCT00002499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6303694|NCT00002499|Immunologic Factors|immunologic factors|mesh-ancestor
6303695|NCT00002499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6303696|NCT00002499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6303697|NCT00002499|Antiviral Agents|antiviral agents|mesh-ancestor
6303698|NCT00002499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6303699|NCT00002499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6303700|NCT00002499|Tubulin Modulators|tubulin modulators|mesh-ancestor
6303701|NCT00002499|Antimitotic Agents|antimitotic agents|mesh-ancestor
6303702|NCT00002499|Mitosis Modulators|mitosis modulators|mesh-ancestor
6303703|NCT00002499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6303704|NCT00002499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6303705|NCT00002499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6303706|NCT00002501|Cyclophosphamide|cyclophosphamide|mesh-list
6303707|NCT00002501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6303708|NCT00002501|Immunologic Factors|immunologic factors|mesh-ancestor
6303709|NCT00002501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6303710|NCT00002501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6303711|NCT00002501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6303712|NCT00002501|Alkylating Agents|alkylating agents|mesh-ancestor
6397095|NCT00210210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6303713|NCT00002501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6303714|NCT00002501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6303715|NCT00002501|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6303716|NCT00002502|Cytarabine|cytarabine|mesh-list
6303717|NCT00002502|Cyclophosphamide|cyclophosphamide|mesh-list
6303718|NCT00002502|Busulfan|busulfan|mesh-list
6303719|NCT00002502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6303720|NCT00002502|Immunologic Factors|immunologic factors|mesh-ancestor
6303721|NCT00002502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6303722|NCT00002502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6303723|NCT00002502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6303724|NCT00002502|Alkylating Agents|alkylating agents|mesh-ancestor
6303725|NCT00002502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015898|NCT00360685|Antitubercular Agents|antitubercular agents|mesh-ancestor
6015899|NCT00360685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6303726|NCT00002502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6303727|NCT00002502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6303728|NCT00002502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6303729|NCT00002502|Antimetabolites|antimetabolites|mesh-ancestor
6303730|NCT00002502|Antiviral Agents|antiviral agents|mesh-ancestor
6303731|NCT00002502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6303732|NCT00002504|Interferons|interferons|mesh-list
6303733|NCT00002504|Interferon-alpha|interferon-alpha|mesh-list
6303734|NCT00002504|Aldesleukin|aldesleukin|mesh-list
6303735|NCT00002504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6303736|NCT00002504|Antiviral Agents|antiviral agents|mesh-ancestor
6303737|NCT00002504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6303738|NCT00002504|Immunologic Factors|immunologic factors|mesh-ancestor
6303739|NCT00002504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6303740|NCT00002504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6303741|NCT00002504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6303742|NCT00002505|Interferons|interferons|mesh-list
6303743|NCT00002505|Interferon-gamma|interferon-gamma|mesh-list
6303744|NCT00002505|Vaccines|vaccines|mesh-list
6303745|NCT00002505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6303746|NCT00002505|Antiviral Agents|antiviral agents|mesh-ancestor
6303747|NCT00002505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6303748|NCT00002505|Immunologic Factors|immunologic factors|mesh-ancestor
6303749|NCT00002505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6303750|NCT00002506|Interferons|interferons|mesh-list
6303751|NCT00002506|Interferon-alpha|interferon-alpha|mesh-list
6303752|NCT00002506|Isotretinoin|isotretinoin|mesh-list
6303753|NCT00002506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6303754|NCT00002506|Antiviral Agents|antiviral agents|mesh-ancestor
6303755|NCT00002506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6303756|NCT00002506|Immunologic Factors|immunologic factors|mesh-ancestor
6303757|NCT00002506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6303758|NCT00002506|Dermatologic Agents|dermatologic agents|mesh-ancestor
6303759|NCT00002507|Mitomycins|mitomycins|mesh-list
6303760|NCT00002507|Mitomycin|mitomycin|mesh-list
6303761|NCT00002507|Porfiromycin|porfiromycin|mesh-list
6303762|NCT00002507|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6303763|NCT00002507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6303764|NCT00002507|Alkylating Agents|alkylating agents|mesh-ancestor
6303765|NCT00002507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6303766|NCT00002507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6303767|NCT00002507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6303768|NCT00002508|Carboplatin|carboplatin|mesh-list
6303769|NCT00002508|Etoposide|etoposide|mesh-list
6303770|NCT00002508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6303771|NCT00002508|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6303772|NCT00002508|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6303773|NCT00002508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6303774|NCT00002508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6303775|NCT00002508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6303776|NCT00002509|Cyclophosphamide|cyclophosphamide|mesh-list
6303777|NCT00002509|Carboplatin|carboplatin|mesh-list
6303778|NCT00002509|Etoposide|etoposide|mesh-list
6303779|NCT00002509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6303780|NCT00002509|Immunologic Factors|immunologic factors|mesh-ancestor
6303781|NCT00002509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6303782|NCT00002509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6303783|NCT00002509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6015900|NCT00360685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6303784|NCT00002509|Alkylating Agents|alkylating agents|mesh-ancestor
6303785|NCT00002509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6303786|NCT00002509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6538069|NCT00825552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6303787|NCT00002509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6303788|NCT00002509|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6303789|NCT00002509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6303790|NCT00002509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6303791|NCT00002509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6303792|NCT00002510|Cyclophosphamide|cyclophosphamide|mesh-list
6303793|NCT00002510|Etoposide|etoposide|mesh-list
6303794|NCT00002510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6303795|NCT00002510|Immunologic Factors|immunologic factors|mesh-ancestor
6303796|NCT00002510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6303797|NCT00002510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6303798|NCT00002510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6303799|NCT00002510|Alkylating Agents|alkylating agents|mesh-ancestor
6303800|NCT00002510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6303801|NCT00002510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6303802|NCT00002510|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6303803|NCT00002510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6303804|NCT00002510|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6303805|NCT00002510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6303806|NCT00002510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6303807|NCT00002514|Leucovorin|leucovorin|mesh-list
6303808|NCT00002514|Cytarabine|cytarabine|mesh-list
6303809|NCT00002514|Dexamethasone|dexamethasone|mesh-list
6303810|NCT00002514|Prednisone|prednisone|mesh-list
6303811|NCT00002514|Cyclophosphamide|cyclophosphamide|mesh-list
6303812|NCT00002514|Methotrexate|methotrexate|mesh-list
6303813|NCT00002514|Etoposide|etoposide|mesh-list
6303814|NCT00002514|Vincristine|vincristine|mesh-list
6303815|NCT00002514|Imatinib Mesylate|imatinib mesylate|mesh-list
6303816|NCT00002514|Daunorubicin|daunorubicin|mesh-list
6303817|NCT00002514|Asparaginase|asparaginase|mesh-list
6303818|NCT00002514|Mercaptopurine|mercaptopurine|mesh-list
6303819|NCT00002514|Thioguanine|thioguanine|mesh-list
6303820|NCT00002514|Sargramostim|sargramostim|mesh-list
6303821|NCT00002514|Levoleucovorin|levoleucovorin|mesh-list
6303822|NCT00002514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6303823|NCT00002514|Immunologic Factors|immunologic factors|mesh-ancestor
6303824|NCT00002514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6303825|NCT00002514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6303826|NCT00002514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6303827|NCT00002514|Alkylating Agents|alkylating agents|mesh-ancestor
6303828|NCT00002514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6303829|NCT00002514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6303830|NCT00002514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6303831|NCT00002514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6303832|NCT00002514|Antiemetics|antiemetics|mesh-ancestor
6303833|NCT00002514|Autonomic Agents|autonomic agents|mesh-ancestor
6303834|NCT00002514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6303835|NCT00002514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6303836|NCT00002514|Glucocorticoids|glucocorticoids|mesh-ancestor
6303837|NCT00002514|Hormones|hormones|mesh-ancestor
6303838|NCT00002514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6303839|NCT00002514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6303840|NCT00002514|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6303841|NCT00002514|Abortifacient Agents|abortifacient agents|mesh-ancestor
6303842|NCT00002514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6303843|NCT00002514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6303844|NCT00002514|Antimetabolites|antimetabolites|mesh-ancestor
6303845|NCT00002514|Dermatologic Agents|dermatologic agents|mesh-ancestor
6303846|NCT00002514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6303847|NCT00002514|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6303848|NCT00002514|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6303849|NCT00002514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6303850|NCT00002514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6303851|NCT00002514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6303852|NCT00002514|Antiviral Agents|antiviral agents|mesh-ancestor
6303853|NCT00002514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6303854|NCT00002514|Antidotes|antidotes|mesh-ancestor
6303855|NCT00002514|Protective Agents|protective agents|mesh-ancestor
6303856|NCT00002514|Vitamin B Complex|vitamin b complex|mesh-ancestor
6303857|NCT00002514|Vitamins|vitamins|mesh-ancestor
6303858|NCT00002514|Micronutrients|micronutrients|mesh-ancestor
6303859|NCT00002514|Tubulin Modulators|tubulin modulators|mesh-ancestor
6303860|NCT00002514|Antimitotic Agents|antimitotic agents|mesh-ancestor
6303861|NCT00002514|Mitosis Modulators|mitosis modulators|mesh-ancestor
6303862|NCT00002514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6303863|NCT00002514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6303864|NCT00002515|Carboplatin|carboplatin|mesh-list
6303865|NCT00002515|Topotecan|topotecan|mesh-list
6303866|NCT00002515|Thiotepa|thiotepa|mesh-list
6303867|NCT00002515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6303868|NCT00002515|Immunologic Factors|immunologic factors|mesh-ancestor
6303869|NCT00002515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6303870|NCT00002515|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6303871|NCT00002515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6303872|NCT00002515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6303873|NCT00002515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6303874|NCT00002515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6303875|NCT00002515|Alkylating Agents|alkylating agents|mesh-ancestor
6303876|NCT00002515|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6303877|NCT00002515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6303878|NCT00002516|Cobalt|cobalt|mesh-list
6303879|NCT00002516|Dactinomycin|dactinomycin|mesh-list
6303880|NCT00002516|Cyclophosphamide|cyclophosphamide|mesh-list
6303881|NCT00002516|Ifosfamide|ifosfamide|mesh-list
6303882|NCT00002516|Doxorubicin|doxorubicin|mesh-list
6303883|NCT00002516|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6303884|NCT00002516|Etoposide|etoposide|mesh-list
6303885|NCT00002516|Vincristine|vincristine|mesh-list
6303886|NCT00002516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6303887|NCT00002516|Immunologic Factors|immunologic factors|mesh-ancestor
6303888|NCT00002516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6303889|NCT00002516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6303890|NCT00002516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6303891|NCT00002516|Alkylating Agents|alkylating agents|mesh-ancestor
6303892|NCT00002516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6303893|NCT00002516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6303894|NCT00002516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6303895|NCT00002516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6303896|NCT00002516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6303897|NCT00002516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6303898|NCT00002516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6303899|NCT00002516|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6303900|NCT00002516|Tubulin Modulators|tubulin modulators|mesh-ancestor
6303901|NCT00002516|Antimitotic Agents|antimitotic agents|mesh-ancestor
6303902|NCT00002516|Mitosis Modulators|mitosis modulators|mesh-ancestor
6303903|NCT00002516|Trace Elements|trace elements|mesh-ancestor
6303904|NCT00002516|Micronutrients|micronutrients|mesh-ancestor
6303905|NCT00002516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6303906|NCT00002516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6303907|NCT00002516|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6303908|NCT00002516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6303909|NCT00002517|Cytarabine|cytarabine|mesh-list
6303910|NCT00002517|Dexamethasone|dexamethasone|mesh-list
6303911|NCT00002517|Etoposide|etoposide|mesh-list
6303912|NCT00002517|Daunorubicin|daunorubicin|mesh-list
6303913|NCT00002517|Mitoxantrone|mitoxantrone|mesh-list
6303914|NCT00002517|Idarubicin|idarubicin|mesh-list
6303915|NCT00002517|Thioguanine|thioguanine|mesh-list
6303916|NCT00002517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6303917|NCT00002517|Antiemetics|antiemetics|mesh-ancestor
6303918|NCT00002517|Autonomic Agents|autonomic agents|mesh-ancestor
6303919|NCT00002517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6303920|NCT00002517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6303921|NCT00002517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6303922|NCT00002517|Glucocorticoids|glucocorticoids|mesh-ancestor
6303923|NCT00002517|Hormones|hormones|mesh-ancestor
6303924|NCT00002517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6303925|NCT00002517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6303926|NCT00002517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6303927|NCT00002517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6303928|NCT00002517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6303929|NCT00002517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6303930|NCT00002517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6303931|NCT00002517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6303932|NCT00002517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6303933|NCT00002517|Antimetabolites|antimetabolites|mesh-ancestor
6303934|NCT00002517|Antiviral Agents|antiviral agents|mesh-ancestor
6303935|NCT00002517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6303936|NCT00002517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6303937|NCT00002517|Immunologic Factors|immunologic factors|mesh-ancestor
6303938|NCT00002517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6303939|NCT00002517|Analgesics|analgesics|mesh-ancestor
6303940|NCT00002517|Sensory System Agents|sensory system agents|mesh-ancestor
6303941|NCT00002519|Paclitaxel|paclitaxel|mesh-list
6303942|NCT00002519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6303943|NCT00002519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6303944|NCT00002519|Tubulin Modulators|tubulin modulators|mesh-ancestor
6303945|NCT00002519|Antimitotic Agents|antimitotic agents|mesh-ancestor
6303946|NCT00002519|Mitosis Modulators|mitosis modulators|mesh-ancestor
6303947|NCT00002519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6303948|NCT00002520|Nicotine|nicotine|mesh-list
6303949|NCT00002520|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6303950|NCT00002520|Autonomic Agents|autonomic agents|mesh-ancestor
6303951|NCT00002520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6303952|NCT00002520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6303953|NCT00002520|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6303954|NCT00002520|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6303955|NCT00002520|Cholinergic Agents|cholinergic agents|mesh-ancestor
6303956|NCT00002520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6303957|NCT00002520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6303958|NCT00002521|Cyclophosphamide|cyclophosphamide|mesh-list
6303959|NCT00002521|Etoposide|etoposide|mesh-list
6303960|NCT00002521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6303961|NCT00002521|Immunologic Factors|immunologic factors|mesh-ancestor
6303962|NCT00002521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6303963|NCT00002521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6303964|NCT00002521|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6303965|NCT00002521|Alkylating Agents|alkylating agents|mesh-ancestor
6303966|NCT00002521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6303967|NCT00002521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6303968|NCT00002521|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6303969|NCT00002521|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6303970|NCT00002521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6303971|NCT00002521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6303972|NCT00002521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6303973|NCT00002522|Cyclophosphamide|cyclophosphamide|mesh-list
6303974|NCT00002522|Etoposide|etoposide|mesh-list
6303975|NCT00002522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6303976|NCT00002522|Immunologic Factors|immunologic factors|mesh-ancestor
6303977|NCT00002522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6303978|NCT00002522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6303979|NCT00002522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6303980|NCT00002522|Alkylating Agents|alkylating agents|mesh-ancestor
6303981|NCT00002522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6303982|NCT00002522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6303983|NCT00002522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6303984|NCT00002522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6303985|NCT00002522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6303986|NCT00002522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6303987|NCT00002522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6303988|NCT00002523|Leucovorin|leucovorin|mesh-list
6303989|NCT00002523|Fluorouracil|fluorouracil|mesh-list
6303990|NCT00002523|Calcium|calcium|mesh-list
6303991|NCT00002523|Levoleucovorin|levoleucovorin|mesh-list
6303992|NCT00002523|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6303993|NCT00002523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6303994|NCT00002523|Antimetabolites|antimetabolites|mesh-ancestor
6303995|NCT00002523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6303996|NCT00002523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6303997|NCT00002523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6303998|NCT00002523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6303999|NCT00002523|Immunologic Factors|immunologic factors|mesh-ancestor
6304000|NCT00002523|Antidotes|antidotes|mesh-ancestor
6304001|NCT00002523|Protective Agents|protective agents|mesh-ancestor
6304002|NCT00002523|Vitamin B Complex|vitamin b complex|mesh-ancestor
6304003|NCT00002523|Vitamins|vitamins|mesh-ancestor
6304004|NCT00002523|Micronutrients|micronutrients|mesh-ancestor
6304005|NCT00002524|Leucovorin|leucovorin|mesh-list
6304006|NCT00002524|Cytarabine|cytarabine|mesh-list
6304007|NCT00002524|Zidovudine|zidovudine|mesh-list
6304008|NCT00002524|Trimethoprim|trimethoprim|mesh-list
6304009|NCT00002524|Sulfamethoxazole|sulfamethoxazole|mesh-list
6304010|NCT00002524|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6304011|NCT00002524|Pentamidine|pentamidine|mesh-list
6304012|NCT00002524|Prednisone|prednisone|mesh-list
6304013|NCT00002524|Methylprednisolone|methylprednisolone|mesh-list
6304014|NCT00002524|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6304015|NCT00002524|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6304016|NCT00002524|Prednisolone|prednisolone|mesh-list
6304017|NCT00002524|Prednisolone acetate|prednisolone acetate|mesh-list
6304018|NCT00002524|Cyclophosphamide|cyclophosphamide|mesh-list
6304019|NCT00002524|Ifosfamide|ifosfamide|mesh-list
6304020|NCT00002524|Doxorubicin|doxorubicin|mesh-list
6304021|NCT00002524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6304022|NCT00002524|Fluorouracil|fluorouracil|mesh-list
6304023|NCT00002524|Methotrexate|methotrexate|mesh-list
6304024|NCT00002524|Etoposide|etoposide|mesh-list
6304025|NCT00002524|Vincristine|vincristine|mesh-list
6304026|NCT00002524|Bleomycin|bleomycin|mesh-list
6304027|NCT00002524|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6304028|NCT00002524|Prednisolone phosphate|prednisolone phosphate|mesh-list
6304029|NCT00002524|Levoleucovorin|levoleucovorin|mesh-list
6304030|NCT00002524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6304031|NCT00002524|Immunologic Factors|immunologic factors|mesh-ancestor
6304032|NCT00002524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6304033|NCT00002524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6304034|NCT00002524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6304035|NCT00002524|Alkylating Agents|alkylating agents|mesh-ancestor
6304036|NCT00002524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6304037|NCT00002524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6304038|NCT00002524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6304039|NCT00002524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6304040|NCT00002524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6304041|NCT00002524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6304042|NCT00002524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6304043|NCT00002524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6304044|NCT00002524|Glucocorticoids|glucocorticoids|mesh-ancestor
6304045|NCT00002524|Hormones|hormones|mesh-ancestor
6015901|NCT00360698|Insulin|insulin|mesh-list
6304046|NCT00002524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6304047|NCT00002524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6304048|NCT00002524|Antimetabolites|antimetabolites|mesh-ancestor
6304049|NCT00002524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6304050|NCT00002524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6304051|NCT00002524|Abortifacient Agents|abortifacient agents|mesh-ancestor
6304052|NCT00002524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6304053|NCT00002524|Dermatologic Agents|dermatologic agents|mesh-ancestor
6304054|NCT00002524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6304055|NCT00002524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6304056|NCT00002524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6304057|NCT00002524|Antiviral Agents|antiviral agents|mesh-ancestor
6304058|NCT00002524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6304059|NCT00002524|Antidotes|antidotes|mesh-ancestor
6304060|NCT00002524|Protective Agents|protective agents|mesh-ancestor
6304061|NCT00002524|Vitamin B Complex|vitamin b complex|mesh-ancestor
6304062|NCT00002524|Vitamins|vitamins|mesh-ancestor
6304063|NCT00002524|Micronutrients|micronutrients|mesh-ancestor
6304064|NCT00002524|Tubulin Modulators|tubulin modulators|mesh-ancestor
6304065|NCT00002524|Antimitotic Agents|antimitotic agents|mesh-ancestor
6304066|NCT00002524|Mitosis Modulators|mitosis modulators|mesh-ancestor
6304067|NCT00002524|Antiemetics|antiemetics|mesh-ancestor
6304068|NCT00002524|Autonomic Agents|autonomic agents|mesh-ancestor
6304069|NCT00002524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6304070|NCT00002524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6304071|NCT00002524|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6304072|NCT00002524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6304073|NCT00002524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6304074|NCT00002524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6304075|NCT00002524|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6304076|NCT00002524|Renal Agents|renal agents|mesh-ancestor
6304077|NCT00002524|Antimalarials|antimalarials|mesh-ancestor
6304078|NCT00002524|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6304079|NCT00002524|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6304080|NCT00002524|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6304081|NCT00002524|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6304082|NCT00002524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6304083|NCT00002524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6304084|NCT00002524|Antifungal Agents|antifungal agents|mesh-ancestor
6304085|NCT00002524|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6304086|NCT00002526|Doxorubicin|doxorubicin|mesh-list
6304087|NCT00002526|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6304088|NCT00002526|Ifosfamide|ifosfamide|mesh-list
6304089|NCT00002526|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6304090|NCT00002526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6304091|NCT00002526|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6304092|NCT00002526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6304093|NCT00002526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6304094|NCT00002526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6304095|NCT00002526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6304096|NCT00002526|Alkylating Agents|alkylating agents|mesh-ancestor
6304097|NCT00002527|Aspirin|aspirin|mesh-list
6304098|NCT00002527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6304099|NCT00002527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6304100|NCT00002527|Analgesics|analgesics|mesh-ancestor
6304101|NCT00002527|Sensory System Agents|sensory system agents|mesh-ancestor
6304102|NCT00002527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6304103|NCT00002527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6304104|NCT00002527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6304105|NCT00002527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6304106|NCT00002527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6304107|NCT00002527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6304108|NCT00002527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6304109|NCT00002527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6304110|NCT00002527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6304111|NCT00002527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6304112|NCT00002527|Antipyretics|antipyretics|mesh-ancestor
6304113|NCT00002528|Tamoxifen|tamoxifen|mesh-list
6304114|NCT00002528|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6304115|NCT00002528|Hormone Antagonists|hormone antagonists|mesh-ancestor
6304116|NCT00002528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6304117|NCT00002528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6304118|NCT00002528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6304119|NCT00002528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6304120|NCT00002528|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6304121|NCT00002528|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6304122|NCT00002528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6304123|NCT00002529|Tamoxifen|tamoxifen|mesh-list
6304124|NCT00002529|Toremifene|toremifene|mesh-list
6304125|NCT00002529|Cyclophosphamide|cyclophosphamide|mesh-list
6304126|NCT00002529|Doxorubicin|doxorubicin|mesh-list
6304127|NCT00002529|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6304128|NCT00002529|Epirubicin|epirubicin|mesh-list
6304129|NCT00002529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6304130|NCT00002529|Immunologic Factors|immunologic factors|mesh-ancestor
6304131|NCT00002529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6304132|NCT00002529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6304133|NCT00002529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6304134|NCT00002529|Alkylating Agents|alkylating agents|mesh-ancestor
6304135|NCT00002529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6304136|NCT00002529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6304137|NCT00002529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6304138|NCT00002529|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6304139|NCT00002529|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6304140|NCT00002529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6304141|NCT00002529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6304142|NCT00002529|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6304143|NCT00002529|Hormone Antagonists|hormone antagonists|mesh-ancestor
6304144|NCT00002529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6304145|NCT00002529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6304146|NCT00002529|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6304147|NCT00002529|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6304148|NCT00002529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6304149|NCT00002531|Leucovorin|leucovorin|mesh-list
6304150|NCT00002531|Cytarabine|cytarabine|mesh-list
6304151|NCT00002531|Dexamethasone|dexamethasone|mesh-list
6304152|NCT00002531|Prednisolone|prednisolone|mesh-list
6304153|NCT00002531|Cyclophosphamide|cyclophosphamide|mesh-list
6304154|NCT00002531|Ifosfamide|ifosfamide|mesh-list
6304155|NCT00002531|Doxorubicin|doxorubicin|mesh-list
6304156|NCT00002531|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6304157|NCT00002531|Methotrexate|methotrexate|mesh-list
6304158|NCT00002531|Etoposide|etoposide|mesh-list
6304159|NCT00002531|Vincristine|vincristine|mesh-list
6304160|NCT00002531|Daunorubicin|daunorubicin|mesh-list
6304161|NCT00002531|Asparaginase|asparaginase|mesh-list
6304162|NCT00002531|Mercaptopurine|mercaptopurine|mesh-list
6304163|NCT00002531|Mitoxantrone|mitoxantrone|mesh-list
6304164|NCT00002531|Thioguanine|thioguanine|mesh-list
6304165|NCT00002531|Vindesine|vindesine|mesh-list
6304166|NCT00002531|Teniposide|teniposide|mesh-list
6304167|NCT00002531|Levoleucovorin|levoleucovorin|mesh-list
6304168|NCT00002531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6304169|NCT00002531|Immunologic Factors|immunologic factors|mesh-ancestor
6304170|NCT00002531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6304171|NCT00002531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6304172|NCT00002531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6304173|NCT00002531|Alkylating Agents|alkylating agents|mesh-ancestor
6304174|NCT00002531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6304175|NCT00002531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6304176|NCT00002531|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6304177|NCT00002531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6304178|NCT00002531|Antiemetics|antiemetics|mesh-ancestor
6304179|NCT00002531|Autonomic Agents|autonomic agents|mesh-ancestor
6304180|NCT00002531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6304181|NCT00002531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6304182|NCT00002531|Glucocorticoids|glucocorticoids|mesh-ancestor
6304183|NCT00002531|Hormones|hormones|mesh-ancestor
6304184|NCT00002531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6304185|NCT00002531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6304186|NCT00002531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6304187|NCT00002531|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6304188|NCT00002531|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6304189|NCT00002531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6304190|NCT00002531|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6304191|NCT00002531|Abortifacient Agents|abortifacient agents|mesh-ancestor
6304192|NCT00002531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6304193|NCT00002531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6304194|NCT00002531|Antimetabolites|antimetabolites|mesh-ancestor
6304195|NCT00002531|Dermatologic Agents|dermatologic agents|mesh-ancestor
6304196|NCT00002531|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6304197|NCT00002531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6304198|NCT00002531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6304199|NCT00002531|Antiviral Agents|antiviral agents|mesh-ancestor
6015902|NCT00360698|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6304200|NCT00002531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6304201|NCT00002531|Antidotes|antidotes|mesh-ancestor
6304202|NCT00002531|Protective Agents|protective agents|mesh-ancestor
6304203|NCT00002531|Vitamin B Complex|vitamin b complex|mesh-ancestor
6015903|NCT00360698|Metformin|metformin|mesh-list
6015904|NCT00360698|Insulin Glargine|insulin glargine|mesh-list
6015905|NCT00360698|Glimepiride|glimepiride|mesh-list
6015906|NCT00360698|Insulin glulisine|insulin glulisine|mesh-list
6015907|NCT00360698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6304204|NCT00002531|Vitamins|vitamins|mesh-ancestor
6304205|NCT00002531|Micronutrients|micronutrients|mesh-ancestor
6304206|NCT00002531|Tubulin Modulators|tubulin modulators|mesh-ancestor
6304207|NCT00002531|Antimitotic Agents|antimitotic agents|mesh-ancestor
6304208|NCT00002531|Mitosis Modulators|mitosis modulators|mesh-ancestor
6304209|NCT00002531|Analgesics|analgesics|mesh-ancestor
6304210|NCT00002531|Sensory System Agents|sensory system agents|mesh-ancestor
6304211|NCT00002532|Leucovorin|leucovorin|mesh-list
6304212|NCT00002532|Cytarabine|cytarabine|mesh-list
6304213|NCT00002532|Dexamethasone|dexamethasone|mesh-list
6304214|NCT00002532|Prednisolone|prednisolone|mesh-list
6304215|NCT00002532|Methotrexate|methotrexate|mesh-list
6304216|NCT00002532|Etoposide|etoposide|mesh-list
6304217|NCT00002532|Daunorubicin|daunorubicin|mesh-list
6304218|NCT00002532|Asparaginase|asparaginase|mesh-list
6304219|NCT00002532|Ifosfamide|ifosfamide|mesh-list
6304220|NCT00002532|Idarubicin|idarubicin|mesh-list
6304221|NCT00002532|Vindesine|vindesine|mesh-list
6304222|NCT00002532|Levoleucovorin|levoleucovorin|mesh-list
6015908|NCT00360698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6304223|NCT00002532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6304224|NCT00002532|Antiemetics|antiemetics|mesh-ancestor
6304225|NCT00002532|Autonomic Agents|autonomic agents|mesh-ancestor
6304226|NCT00002532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6304227|NCT00002532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6304228|NCT00002532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6304229|NCT00002532|Glucocorticoids|glucocorticoids|mesh-ancestor
6304230|NCT00002532|Hormones|hormones|mesh-ancestor
6304231|NCT00002532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6304232|NCT00002532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6304233|NCT00002532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6304234|NCT00002532|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6304235|NCT00002532|Abortifacient Agents|abortifacient agents|mesh-ancestor
6304236|NCT00002532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6304237|NCT00002532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6304238|NCT00002532|Antimetabolites|antimetabolites|mesh-ancestor
6304239|NCT00002532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6304240|NCT00002532|Dermatologic Agents|dermatologic agents|mesh-ancestor
6304241|NCT00002532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6304242|NCT00002532|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6304243|NCT00002532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6304244|NCT00002532|Immunologic Factors|immunologic factors|mesh-ancestor
6304245|NCT00002532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6304246|NCT00002532|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6304247|NCT00002532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6304248|NCT00002532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6304249|NCT00002532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6304250|NCT00002532|Antiviral Agents|antiviral agents|mesh-ancestor
6304251|NCT00002532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6304252|NCT00002532|Antidotes|antidotes|mesh-ancestor
6304253|NCT00002532|Protective Agents|protective agents|mesh-ancestor
6015909|NCT00360698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6015910|NCT00360698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6015911|NCT00360698|Immunologic Factors|immunologic factors|mesh-ancestor
6304254|NCT00002532|Vitamin B Complex|vitamin b complex|mesh-ancestor
6304255|NCT00002532|Vitamins|vitamins|mesh-ancestor
6304256|NCT00002532|Micronutrients|micronutrients|mesh-ancestor
6304257|NCT00002532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6304258|NCT00002532|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6304259|NCT00002532|Alkylating Agents|alkylating agents|mesh-ancestor
6015912|NCT00360724|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6304260|NCT00002532|Tubulin Modulators|tubulin modulators|mesh-ancestor
6304261|NCT00002532|Antimitotic Agents|antimitotic agents|mesh-ancestor
6304262|NCT00002532|Mitosis Modulators|mitosis modulators|mesh-ancestor
6304263|NCT00002533|Fluconazole|fluconazole|mesh-list
6304264|NCT00002533|Antifungal Agents|antifungal agents|mesh-ancestor
6304265|NCT00002533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6304266|NCT00002533|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6304267|NCT00002533|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6304268|NCT00002533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6304269|NCT00002533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6304270|NCT00002533|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6304271|NCT00002533|Hormone Antagonists|hormone antagonists|mesh-ancestor
6304272|NCT00002533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6304273|NCT00002533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6304274|NCT00002533|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6538070|NCT00825552|Dopamine Agents|dopamine agents|mesh-ancestor
6304275|NCT00002533|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6304276|NCT00002534|Cytarabine|cytarabine|mesh-list
6304277|NCT00002534|Methylprednisolone|methylprednisolone|mesh-list
6304278|NCT00002534|Cyclophosphamide|cyclophosphamide|mesh-list
6304279|NCT00002534|Thiotepa|thiotepa|mesh-list
6304280|NCT00002534|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6304281|NCT00002534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6304282|NCT00002534|Immunologic Factors|immunologic factors|mesh-ancestor
6304283|NCT00002534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6304284|NCT00002534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6304285|NCT00002534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6304286|NCT00002534|Alkylating Agents|alkylating agents|mesh-ancestor
6304287|NCT00002534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6304288|NCT00002534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6304289|NCT00002534|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6304290|NCT00002534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6304291|NCT00002534|Antimetabolites|antimetabolites|mesh-ancestor
6304292|NCT00002534|Antiviral Agents|antiviral agents|mesh-ancestor
6304293|NCT00002534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6304294|NCT00002534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6304295|NCT00002534|Antiemetics|antiemetics|mesh-ancestor
6304296|NCT00002534|Autonomic Agents|autonomic agents|mesh-ancestor
6304297|NCT00002534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6304298|NCT00002534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6304299|NCT00002534|Glucocorticoids|glucocorticoids|mesh-ancestor
6304300|NCT00002534|Hormones|hormones|mesh-ancestor
6304301|NCT00002534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6304302|NCT00002534|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6304303|NCT00002534|Protective Agents|protective agents|mesh-ancestor
6304304|NCT00002535|Aldesleukin|aldesleukin|mesh-list
6304305|NCT00002535|Indomethacin|indomethacin|mesh-list
6304306|NCT00002535|Cyclophosphamide|cyclophosphamide|mesh-list
6304307|NCT00002535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6304308|NCT00002535|Immunologic Factors|immunologic factors|mesh-ancestor
6304309|NCT00002535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6304310|NCT00002535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6304311|NCT00002535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6304312|NCT00002535|Alkylating Agents|alkylating agents|mesh-ancestor
6304313|NCT00002535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6304314|NCT00002535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6304315|NCT00002535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6304316|NCT00002535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6304317|NCT00002535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6304318|NCT00002535|Antiviral Agents|antiviral agents|mesh-ancestor
6304319|NCT00002535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6304320|NCT00002535|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6304321|NCT00002535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6304322|NCT00002535|Analgesics|analgesics|mesh-ancestor
6304323|NCT00002535|Sensory System Agents|sensory system agents|mesh-ancestor
6304324|NCT00002535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6304325|NCT00002535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6304326|NCT00002535|Gout Suppressants|gout suppressants|mesh-ancestor
6304327|NCT00002535|Tocolytic Agents|tocolytic agents|mesh-ancestor
6304328|NCT00002535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6304329|NCT00002535|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6304330|NCT00002535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6304331|NCT00002536|Vincristine|vincristine|mesh-list
6304332|NCT00002536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6304333|NCT00002536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6304334|NCT00002536|Tubulin Modulators|tubulin modulators|mesh-ancestor
6304335|NCT00002536|Antimitotic Agents|antimitotic agents|mesh-ancestor
6304336|NCT00002536|Mitosis Modulators|mitosis modulators|mesh-ancestor
6304337|NCT00002536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6304338|NCT00002537|Topotecan|topotecan|mesh-list
6304339|NCT00002537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6304340|NCT00002537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6304341|NCT00002537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6304342|NCT00002537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6304343|NCT00002537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6304344|NCT00002539|Doxorubicin|doxorubicin|mesh-list
6304345|NCT00002539|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6304346|NCT00002539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6304347|NCT00002539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6304348|NCT00002539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6304349|NCT00002539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6304350|NCT00002539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6304351|NCT00002539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6304352|NCT00002542|Tamoxifen|tamoxifen|mesh-list
6304353|NCT00002542|Cyclophosphamide|cyclophosphamide|mesh-list
6304354|NCT00002542|Doxorubicin|doxorubicin|mesh-list
6304355|NCT00002542|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6304356|NCT00002542|Fluorouracil|fluorouracil|mesh-list
6304357|NCT00002542|Methotrexate|methotrexate|mesh-list
6304358|NCT00002542|Epirubicin|epirubicin|mesh-list
6304359|NCT00002542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6304360|NCT00002542|Immunologic Factors|immunologic factors|mesh-ancestor
6304361|NCT00002542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6304362|NCT00002542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6304363|NCT00002542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6304364|NCT00002542|Alkylating Agents|alkylating agents|mesh-ancestor
6304365|NCT00002542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6304366|NCT00002542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6304367|NCT00002542|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6304368|NCT00002542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6304369|NCT00002542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6304370|NCT00002542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6304371|NCT00002542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6304372|NCT00002542|Antimetabolites|antimetabolites|mesh-ancestor
6304373|NCT00002542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6304374|NCT00002542|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6304375|NCT00002542|Abortifacient Agents|abortifacient agents|mesh-ancestor
6304376|NCT00002542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6304377|NCT00002542|Dermatologic Agents|dermatologic agents|mesh-ancestor
6304378|NCT00002542|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6304379|NCT00002542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6304380|NCT00002542|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6304381|NCT00002542|Hormone Antagonists|hormone antagonists|mesh-ancestor
6304382|NCT00002542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6304383|NCT00002542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6304384|NCT00002542|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6304385|NCT00002542|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6304386|NCT00002542|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6304387|NCT00002543|Gallium nitrate|gallium nitrate|mesh-list
6304388|NCT00002543|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6304389|NCT00002543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6304390|NCT00002543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6304391|NCT00002544|Docetaxel|docetaxel|mesh-list
6304392|NCT00002544|Mitoxantrone|mitoxantrone|mesh-list
6304393|NCT00002544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6304394|NCT00002544|Tubulin Modulators|tubulin modulators|mesh-ancestor
6304395|NCT00002544|Antimitotic Agents|antimitotic agents|mesh-ancestor
6304396|NCT00002544|Mitosis Modulators|mitosis modulators|mesh-ancestor
6304397|NCT00002544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6304398|NCT00002544|Analgesics|analgesics|mesh-ancestor
6304399|NCT00002544|Sensory System Agents|sensory system agents|mesh-ancestor
6304400|NCT00002544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6304401|NCT00002544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6304402|NCT00002544|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6304403|NCT00002544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6304404|NCT00002544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6304405|NCT00002545|Carmustine|carmustine|mesh-list
6304406|NCT00002545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6304407|NCT00002545|Alkylating Agents|alkylating agents|mesh-ancestor
6304408|NCT00002545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6304409|NCT00002545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6304410|NCT00002546|Ifosfamide|ifosfamide|mesh-list
6304411|NCT00002546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6304412|NCT00002546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6304413|NCT00002546|Alkylating Agents|alkylating agents|mesh-ancestor
6304414|NCT00002546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6304415|NCT00002547|Cytarabine|cytarabine|mesh-list
6304416|NCT00002547|Cyclosporine|cyclosporine|mesh-list
6304417|NCT00002547|Cyclophosphamide|cyclophosphamide|mesh-list
6304418|NCT00002547|Busulfan|busulfan|mesh-list
6304419|NCT00002547|Methotrexate|methotrexate|mesh-list
6304420|NCT00002547|Cyclosporins|cyclosporins|mesh-list
6304421|NCT00002547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6304422|NCT00002547|Immunologic Factors|immunologic factors|mesh-ancestor
6304423|NCT00002547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6304424|NCT00002547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6304425|NCT00002547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6304426|NCT00002547|Alkylating Agents|alkylating agents|mesh-ancestor
6304427|NCT00002547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6304428|NCT00002547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6304429|NCT00002547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6304430|NCT00002547|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6304431|NCT00002547|Abortifacient Agents|abortifacient agents|mesh-ancestor
6304432|NCT00002547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6304433|NCT00002547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6304434|NCT00002547|Antimetabolites|antimetabolites|mesh-ancestor
6304435|NCT00002547|Dermatologic Agents|dermatologic agents|mesh-ancestor
6304436|NCT00002547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6304437|NCT00002547|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6304438|NCT00002547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6304439|NCT00002547|Antiviral Agents|antiviral agents|mesh-ancestor
6304440|NCT00002547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6304441|NCT00002547|Antifungal Agents|antifungal agents|mesh-ancestor
6304442|NCT00002547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6304443|NCT00002548|Interferons|interferons|mesh-list
6304444|NCT00002548|Interferon-alpha|interferon-alpha|mesh-list
6304445|NCT00002548|Dexamethasone|dexamethasone|mesh-list
6304446|NCT00002548|Prednisone|prednisone|mesh-list
6304447|NCT00002548|Cyclophosphamide|cyclophosphamide|mesh-list
6304448|NCT00002548|Melphalan|melphalan|mesh-list
6304449|NCT00002548|Carmustine|carmustine|mesh-list
6304450|NCT00002548|Doxorubicin|doxorubicin|mesh-list
6304451|NCT00002548|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6304452|NCT00002548|Vincristine|vincristine|mesh-list
6304453|NCT00002548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6304454|NCT00002548|Immunologic Factors|immunologic factors|mesh-ancestor
6304455|NCT00002548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6304456|NCT00002548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6304457|NCT00002548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6304458|NCT00002548|Alkylating Agents|alkylating agents|mesh-ancestor
6304459|NCT00002548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6304460|NCT00002548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6304461|NCT00002548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6304462|NCT00002548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6304463|NCT00002548|Antiemetics|antiemetics|mesh-ancestor
6304464|NCT00002548|Autonomic Agents|autonomic agents|mesh-ancestor
6304465|NCT00002548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6304466|NCT00002548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6304467|NCT00002548|Glucocorticoids|glucocorticoids|mesh-ancestor
6304468|NCT00002548|Hormones|hormones|mesh-ancestor
6304469|NCT00002548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6304470|NCT00002548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6304471|NCT00002548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6304472|NCT00002548|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6304473|NCT00002548|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6304474|NCT00002548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6304475|NCT00002548|Antiviral Agents|antiviral agents|mesh-ancestor
6304476|NCT00002548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6304477|NCT00002548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6304478|NCT00002548|Tubulin Modulators|tubulin modulators|mesh-ancestor
6304479|NCT00002548|Antimitotic Agents|antimitotic agents|mesh-ancestor
6304480|NCT00002548|Mitosis Modulators|mitosis modulators|mesh-ancestor
6304481|NCT00002549|Cytarabine|cytarabine|mesh-list
6304482|NCT00002549|Cyclophosphamide|cyclophosphamide|mesh-list
6304483|NCT00002549|Busulfan|busulfan|mesh-list
6304484|NCT00002549|Etoposide|etoposide|mesh-list
6304485|NCT00002549|Daunorubicin|daunorubicin|mesh-list
6304486|NCT00002549|Mitoxantrone|mitoxantrone|mesh-list
6304487|NCT00002549|Idarubicin|idarubicin|mesh-list
6304488|NCT00002549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6304489|NCT00002549|Immunologic Factors|immunologic factors|mesh-ancestor
6304490|NCT00002549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6304491|NCT00002549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6304492|NCT00002549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6304493|NCT00002549|Alkylating Agents|alkylating agents|mesh-ancestor
6304494|NCT00002549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6304495|NCT00002549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6304496|NCT00002549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6304497|NCT00002549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6304498|NCT00002549|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6304499|NCT00002549|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6304500|NCT00002549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6304501|NCT00002549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6304502|NCT00002549|Antimetabolites|antimetabolites|mesh-ancestor
6304503|NCT00002549|Antiviral Agents|antiviral agents|mesh-ancestor
6304504|NCT00002549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6304505|NCT00002549|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6304506|NCT00002549|Analgesics|analgesics|mesh-ancestor
6304507|NCT00002549|Sensory System Agents|sensory system agents|mesh-ancestor
6304508|NCT00002549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6304509|NCT00002550|Etoposide|etoposide|mesh-list
6304510|NCT00002550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6304511|NCT00002550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6304512|NCT00002550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6304513|NCT00002550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6304514|NCT00002550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6304515|NCT00002550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6304516|NCT00002551|Leucovorin|leucovorin|mesh-list
6304517|NCT00002551|Levamisole|levamisole|mesh-list
6304518|NCT00002551|Fluorouracil|fluorouracil|mesh-list
6304519|NCT00002551|Calcium|calcium|mesh-list
6304520|NCT00002551|Levoleucovorin|levoleucovorin|mesh-list
6304521|NCT00002551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6304522|NCT00002551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6304523|NCT00002551|Antimetabolites|antimetabolites|mesh-ancestor
6304524|NCT00002551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6304525|NCT00002551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6304526|NCT00002551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6304527|NCT00002551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6304528|NCT00002551|Immunologic Factors|immunologic factors|mesh-ancestor
6304529|NCT00002551|Antidotes|antidotes|mesh-ancestor
6304530|NCT00002551|Protective Agents|protective agents|mesh-ancestor
6304531|NCT00002551|Vitamin B Complex|vitamin b complex|mesh-ancestor
6304532|NCT00002551|Vitamins|vitamins|mesh-ancestor
6304533|NCT00002551|Micronutrients|micronutrients|mesh-ancestor
6304534|NCT00002551|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6304535|NCT00002551|Antinematodal Agents|antinematodal agents|mesh-ancestor
6304536|NCT00002551|Anthelmintics|anthelmintics|mesh-ancestor
6304537|NCT00002551|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6304538|NCT00002551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6304539|NCT00002551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6304540|NCT00002552|Leucovorin|leucovorin|mesh-list
6304541|NCT00002552|Cytarabine|cytarabine|mesh-list
6304542|NCT00002552|Hydrocortisone|hydrocortisone|mesh-list
6304543|NCT00002552|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6304544|NCT00002552|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6304545|NCT00002552|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6304546|NCT00002552|Cyclophosphamide|cyclophosphamide|mesh-list
6304547|NCT00002552|Carmustine|carmustine|mesh-list
6304548|NCT00002552|Methotrexate|methotrexate|mesh-list
6304549|NCT00002552|Etoposide|etoposide|mesh-list
6304550|NCT00002552|Sargramostim|sargramostim|mesh-list
6304551|NCT00002552|Levoleucovorin|levoleucovorin|mesh-list
6304552|NCT00002552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6304553|NCT00002552|Immunologic Factors|immunologic factors|mesh-ancestor
6304554|NCT00002552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6304555|NCT00002552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6304556|NCT00002552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6304557|NCT00002552|Alkylating Agents|alkylating agents|mesh-ancestor
6304558|NCT00002552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6304559|NCT00002552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6304560|NCT00002552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6304561|NCT00002552|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6304562|NCT00002552|Abortifacient Agents|abortifacient agents|mesh-ancestor
6304563|NCT00002552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6304564|NCT00002552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6304565|NCT00002552|Antimetabolites|antimetabolites|mesh-ancestor
6304566|NCT00002552|Dermatologic Agents|dermatologic agents|mesh-ancestor
6304567|NCT00002552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6304568|NCT00002552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6304569|NCT00002552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6304570|NCT00002552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6304571|NCT00002552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6304572|NCT00002552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6304573|NCT00002552|Antiviral Agents|antiviral agents|mesh-ancestor
6304574|NCT00002552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6304575|NCT00002552|Antidotes|antidotes|mesh-ancestor
6304576|NCT00002552|Protective Agents|protective agents|mesh-ancestor
6304577|NCT00002552|Vitamin B Complex|vitamin b complex|mesh-ancestor
6304578|NCT00002552|Vitamins|vitamins|mesh-ancestor
6304579|NCT00002552|Micronutrients|micronutrients|mesh-ancestor
6304580|NCT00002552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6304581|NCT00002553|Cobalt|cobalt|mesh-list
6304582|NCT00002553|Cyclophosphamide|cyclophosphamide|mesh-list
6304583|NCT00002553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6304584|NCT00002553|Immunologic Factors|immunologic factors|mesh-ancestor
6304585|NCT00002553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6304586|NCT00002553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6304587|NCT00002553|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6304588|NCT00002553|Alkylating Agents|alkylating agents|mesh-ancestor
6304589|NCT00002553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6304590|NCT00002553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6304591|NCT00002553|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6304592|NCT00002553|Trace Elements|trace elements|mesh-ancestor
6304593|NCT00002553|Micronutrients|micronutrients|mesh-ancestor
6304594|NCT00002554|Cyclophosphamide|cyclophosphamide|mesh-list
6304595|NCT00002554|Busulfan|busulfan|mesh-list
6304596|NCT00002554|Methotrexate|methotrexate|mesh-list
6304597|NCT00002554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6304598|NCT00002554|Immunologic Factors|immunologic factors|mesh-ancestor
6304599|NCT00002554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6304600|NCT00002554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6304601|NCT00002554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6304602|NCT00002554|Alkylating Agents|alkylating agents|mesh-ancestor
6304603|NCT00002554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6304604|NCT00002554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6304605|NCT00002554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6304606|NCT00002554|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6304607|NCT00002554|Abortifacient Agents|abortifacient agents|mesh-ancestor
6304608|NCT00002554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6304609|NCT00002554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6304610|NCT00002554|Antimetabolites|antimetabolites|mesh-ancestor
6304611|NCT00002554|Dermatologic Agents|dermatologic agents|mesh-ancestor
6304612|NCT00002554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6304613|NCT00002554|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6304614|NCT00002554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6304615|NCT00002555|Cobalt|cobalt|mesh-list
6304616|NCT00002555|Trace Elements|trace elements|mesh-ancestor
6304617|NCT00002555|Micronutrients|micronutrients|mesh-ancestor
6304618|NCT00002555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6304619|NCT00002556|Interferons|interferons|mesh-list
6304620|NCT00002556|Interferon-alpha|interferon-alpha|mesh-list
6304621|NCT00002556|Interferon alpha-2|interferon alpha-2|mesh-list
6304622|NCT00002556|Prednisone|prednisone|mesh-list
6304623|NCT00002556|Cyclophosphamide|cyclophosphamide|mesh-list
6304624|NCT00002556|Melphalan|melphalan|mesh-list
6304625|NCT00002556|Carmustine|carmustine|mesh-list
6304626|NCT00002556|Vincristine|vincristine|mesh-list
6304627|NCT00002556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6304628|NCT00002556|Immunologic Factors|immunologic factors|mesh-ancestor
6304629|NCT00002556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6304630|NCT00002556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6304631|NCT00002556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6304632|NCT00002556|Alkylating Agents|alkylating agents|mesh-ancestor
6304633|NCT00002556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6304634|NCT00002556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6304635|NCT00002556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6304636|NCT00002556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6304637|NCT00002556|Glucocorticoids|glucocorticoids|mesh-ancestor
6304638|NCT00002556|Hormones|hormones|mesh-ancestor
6304639|NCT00002556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6304640|NCT00002556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6304641|NCT00002556|Antiviral Agents|antiviral agents|mesh-ancestor
6304642|NCT00002556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6304643|NCT00002556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6304644|NCT00002556|Tubulin Modulators|tubulin modulators|mesh-ancestor
6304645|NCT00002556|Antimitotic Agents|antimitotic agents|mesh-ancestor
6304646|NCT00002556|Mitosis Modulators|mitosis modulators|mesh-ancestor
6304647|NCT00002557|Leucovorin|leucovorin|mesh-list
6304648|NCT00002557|Doxorubicin|doxorubicin|mesh-list
6304649|NCT00002557|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6304650|NCT00002557|Etoposide|etoposide|mesh-list
6304651|NCT00002557|Methotrexate|methotrexate|mesh-list
6304652|NCT00002557|Calcium|calcium|mesh-list
6304653|NCT00002557|Levoleucovorin|levoleucovorin|mesh-list
6304654|NCT00002557|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6304655|NCT00002557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6304656|NCT00002557|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6304657|NCT00002557|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6304658|NCT00002557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6304659|NCT00002557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6304660|NCT00002557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6304661|NCT00002557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6304662|NCT00002557|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6304663|NCT00002557|Abortifacient Agents|abortifacient agents|mesh-ancestor
6304664|NCT00002557|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6304665|NCT00002557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6304666|NCT00002557|Antimetabolites|antimetabolites|mesh-ancestor
6304667|NCT00002557|Dermatologic Agents|dermatologic agents|mesh-ancestor
6304668|NCT00002557|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6304669|NCT00002557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6304670|NCT00002557|Immunologic Factors|immunologic factors|mesh-ancestor
6304671|NCT00002557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6304672|NCT00002557|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6304673|NCT00002557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6304674|NCT00002557|Antidotes|antidotes|mesh-ancestor
6304675|NCT00002557|Protective Agents|protective agents|mesh-ancestor
6304676|NCT00002557|Vitamin B Complex|vitamin b complex|mesh-ancestor
6304677|NCT00002557|Vitamins|vitamins|mesh-ancestor
6304678|NCT00002557|Micronutrients|micronutrients|mesh-ancestor
6304679|NCT00002559|Paclitaxel|paclitaxel|mesh-list
6304680|NCT00002559|Ifosfamide|ifosfamide|mesh-list
6304681|NCT00002559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6304682|NCT00002559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6304683|NCT00002559|Tubulin Modulators|tubulin modulators|mesh-ancestor
6304684|NCT00002559|Antimitotic Agents|antimitotic agents|mesh-ancestor
6304685|NCT00002559|Mitosis Modulators|mitosis modulators|mesh-ancestor
6304686|NCT00002559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6304687|NCT00002559|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6304688|NCT00002559|Alkylating Agents|alkylating agents|mesh-ancestor
6304689|NCT00002560|Antibodies|antibodies|mesh-list
6304690|NCT00002560|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6304691|NCT00002560|Sargramostim|sargramostim|mesh-list
6304692|NCT00002560|Immunologic Factors|immunologic factors|mesh-ancestor
6304693|NCT00002560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6304694|NCT00002561|Doxorubicin|doxorubicin|mesh-list
6304695|NCT00002561|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6304696|NCT00002561|Bleomycin|bleomycin|mesh-list
6304697|NCT00002561|Dacarbazine|dacarbazine|mesh-list
6304698|NCT00002561|Vinblastine|vinblastine|mesh-list
6304699|NCT00002561|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6304700|NCT00002561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6304701|NCT00002561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6304702|NCT00002561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6304703|NCT00002561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6304704|NCT00002561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6304705|NCT00002561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6304706|NCT00002561|Alkylating Agents|alkylating agents|mesh-ancestor
6304707|NCT00002561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6304708|NCT00002561|Tubulin Modulators|tubulin modulators|mesh-ancestor
6304709|NCT00002561|Antimitotic Agents|antimitotic agents|mesh-ancestor
6304710|NCT00002561|Mitosis Modulators|mitosis modulators|mesh-ancestor
6304711|NCT00002562|Paclitaxel|paclitaxel|mesh-list
6304712|NCT00002562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6304713|NCT00002562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6304714|NCT00002562|Tubulin Modulators|tubulin modulators|mesh-ancestor
6304715|NCT00002562|Antimitotic Agents|antimitotic agents|mesh-ancestor
6304716|NCT00002562|Mitosis Modulators|mitosis modulators|mesh-ancestor
6304717|NCT00002562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6304718|NCT00002565|Cytarabine|cytarabine|mesh-list
6304719|NCT00002565|Prednisone|prednisone|mesh-list
6304720|NCT00002565|Methylprednisolone|methylprednisolone|mesh-list
6304721|NCT00002565|Cyclophosphamide|cyclophosphamide|mesh-list
6304722|NCT00002565|Ifosfamide|ifosfamide|mesh-list
6304723|NCT00002565|Doxorubicin|doxorubicin|mesh-list
6304724|NCT00002565|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6304725|NCT00002565|Etoposide|etoposide|mesh-list
6304726|NCT00002565|Vincristine|vincristine|mesh-list
6304727|NCT00002565|Mitoxantrone|mitoxantrone|mesh-list
6304728|NCT00002565|Idarubicin|idarubicin|mesh-list
6304729|NCT00002565|Bleomycin|bleomycin|mesh-list
6304730|NCT00002565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6304731|NCT00002565|Immunologic Factors|immunologic factors|mesh-ancestor
6304732|NCT00002565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6304733|NCT00002565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6304734|NCT00002565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6304735|NCT00002565|Alkylating Agents|alkylating agents|mesh-ancestor
6304736|NCT00002565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6304737|NCT00002565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6304738|NCT00002565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6304739|NCT00002565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6304740|NCT00002565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6304741|NCT00002565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6304742|NCT00002565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6304743|NCT00002565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6304744|NCT00002565|Glucocorticoids|glucocorticoids|mesh-ancestor
6304745|NCT00002565|Hormones|hormones|mesh-ancestor
6304746|NCT00002565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6304747|NCT00002565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6304748|NCT00002565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6304749|NCT00002565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6304750|NCT00002565|Antimetabolites|antimetabolites|mesh-ancestor
6304751|NCT00002565|Antiviral Agents|antiviral agents|mesh-ancestor
6304752|NCT00002565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6304753|NCT00002565|Tubulin Modulators|tubulin modulators|mesh-ancestor
6304754|NCT00002565|Antimitotic Agents|antimitotic agents|mesh-ancestor
6304755|NCT00002565|Mitosis Modulators|mitosis modulators|mesh-ancestor
6304756|NCT00002565|Antiemetics|antiemetics|mesh-ancestor
6304757|NCT00002565|Autonomic Agents|autonomic agents|mesh-ancestor
6304758|NCT00002565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6304759|NCT00002565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6304760|NCT00002565|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6304761|NCT00002565|Protective Agents|protective agents|mesh-ancestor
6304762|NCT00002565|Analgesics|analgesics|mesh-ancestor
6304763|NCT00002565|Sensory System Agents|sensory system agents|mesh-ancestor
6304764|NCT00002566|Cyclophosphamide|cyclophosphamide|mesh-list
6304765|NCT00002566|Ifosfamide|ifosfamide|mesh-list
6304766|NCT00002566|Carboplatin|carboplatin|mesh-list
6304767|NCT00002566|Etoposide|etoposide|mesh-list
6304768|NCT00002566|Vinblastine|vinblastine|mesh-list
6304769|NCT00002566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6304770|NCT00002566|Immunologic Factors|immunologic factors|mesh-ancestor
6018486|NCT00381095|Sensory System Agents|sensory system agents|mesh-ancestor
6304771|NCT00002566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6304772|NCT00002566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6304773|NCT00002566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6304774|NCT00002566|Alkylating Agents|alkylating agents|mesh-ancestor
6304775|NCT00002566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6304776|NCT00002566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6304777|NCT00002566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6304778|NCT00002566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6304779|NCT00002566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6304780|NCT00002566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6304781|NCT00002566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6304782|NCT00002566|Tubulin Modulators|tubulin modulators|mesh-ancestor
6304783|NCT00002566|Antimitotic Agents|antimitotic agents|mesh-ancestor
6304784|NCT00002566|Mitosis Modulators|mitosis modulators|mesh-ancestor
6304785|NCT00002567|Etoposide|etoposide|mesh-list
6304786|NCT00002567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6304787|NCT00002567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6304788|NCT00002567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6304789|NCT00002567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6304790|NCT00002567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6304791|NCT00002567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6304792|NCT00002568|Paclitaxel|paclitaxel|mesh-list
6304793|NCT00002568|Cisplatin|cisplatin|mesh-list
6304794|NCT00002568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6304795|NCT00002568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6304796|NCT00002568|Tubulin Modulators|tubulin modulators|mesh-ancestor
6304797|NCT00002568|Antimitotic Agents|antimitotic agents|mesh-ancestor
6304798|NCT00002568|Mitosis Modulators|mitosis modulators|mesh-ancestor
6304799|NCT00002568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6304800|NCT00002569|Vincristine|vincristine|mesh-list
6304801|NCT00002569|Lomustine|lomustine|mesh-list
6304802|NCT00002569|Procarbazine|procarbazine|mesh-list
6304803|NCT00002569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6304804|NCT00002569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6304805|NCT00002569|Tubulin Modulators|tubulin modulators|mesh-ancestor
6304806|NCT00002569|Antimitotic Agents|antimitotic agents|mesh-ancestor
6304807|NCT00002569|Mitosis Modulators|mitosis modulators|mesh-ancestor
6304808|NCT00002569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6304809|NCT00002569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6304810|NCT00002569|Alkylating Agents|alkylating agents|mesh-ancestor
6304811|NCT00002570|Leucovorin|leucovorin|mesh-list
6304812|NCT00002570|Fluorouracil|fluorouracil|mesh-list
6304813|NCT00002570|Calcium|calcium|mesh-list
6304814|NCT00002570|Levoleucovorin|levoleucovorin|mesh-list
6304815|NCT00002570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6304816|NCT00002570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6304817|NCT00002570|Antimetabolites|antimetabolites|mesh-ancestor
6304818|NCT00002570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6304819|NCT00002570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6304820|NCT00002570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6304821|NCT00002570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6304822|NCT00002570|Immunologic Factors|immunologic factors|mesh-ancestor
6304823|NCT00002570|Antidotes|antidotes|mesh-ancestor
6304824|NCT00002570|Protective Agents|protective agents|mesh-ancestor
6304825|NCT00002570|Vitamin B Complex|vitamin b complex|mesh-ancestor
6304826|NCT00002570|Vitamins|vitamins|mesh-ancestor
6304827|NCT00002570|Micronutrients|micronutrients|mesh-ancestor
6304828|NCT00002571|Leucovorin|leucovorin|mesh-list
6304829|NCT00002571|Cytarabine|cytarabine|mesh-list
6304830|NCT00002571|Trimethoprim|trimethoprim|mesh-list
6304831|NCT00002571|Sulfamethoxazole|sulfamethoxazole|mesh-list
6304832|NCT00002571|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6304833|NCT00002571|Prednisone|prednisone|mesh-list
6304834|NCT00002571|Cyclophosphamide|cyclophosphamide|mesh-list
6304835|NCT00002571|Doxorubicin|doxorubicin|mesh-list
6304836|NCT00002571|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6304837|NCT00002571|Methotrexate|methotrexate|mesh-list
6304838|NCT00002571|Etoposide|etoposide|mesh-list
6304839|NCT00002571|Vincristine|vincristine|mesh-list
6304840|NCT00002571|Bleomycin|bleomycin|mesh-list
6304841|NCT00002571|Levoleucovorin|levoleucovorin|mesh-list
6304842|NCT00002571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6304843|NCT00002571|Immunologic Factors|immunologic factors|mesh-ancestor
6304844|NCT00002571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6304845|NCT00002571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6304846|NCT00002571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6304847|NCT00002571|Alkylating Agents|alkylating agents|mesh-ancestor
6304848|NCT00002571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6304849|NCT00002571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6304850|NCT00002571|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6304851|NCT00002571|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6304852|NCT00002571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6304853|NCT00002571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6304854|NCT00002571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6304855|NCT00002571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6304856|NCT00002571|Glucocorticoids|glucocorticoids|mesh-ancestor
6304857|NCT00002571|Hormones|hormones|mesh-ancestor
6304858|NCT00002571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6304859|NCT00002571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6304860|NCT00002571|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6304861|NCT00002571|Abortifacient Agents|abortifacient agents|mesh-ancestor
6304862|NCT00002571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6304863|NCT00002571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6304864|NCT00002571|Antimetabolites|antimetabolites|mesh-ancestor
6304865|NCT00002571|Dermatologic Agents|dermatologic agents|mesh-ancestor
6304866|NCT00002571|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6304867|NCT00002571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6304868|NCT00002571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6304869|NCT00002571|Antiviral Agents|antiviral agents|mesh-ancestor
6304870|NCT00002571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6304871|NCT00002571|Antidotes|antidotes|mesh-ancestor
6304872|NCT00002571|Protective Agents|protective agents|mesh-ancestor
6304873|NCT00002571|Vitamin B Complex|vitamin b complex|mesh-ancestor
6304874|NCT00002571|Vitamins|vitamins|mesh-ancestor
6304875|NCT00002571|Micronutrients|micronutrients|mesh-ancestor
6304876|NCT00002571|Tubulin Modulators|tubulin modulators|mesh-ancestor
6304877|NCT00002571|Antimitotic Agents|antimitotic agents|mesh-ancestor
6304878|NCT00002571|Mitosis Modulators|mitosis modulators|mesh-ancestor
6304879|NCT00002571|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6304880|NCT00002571|Renal Agents|renal agents|mesh-ancestor
6304881|NCT00002571|Antimalarials|antimalarials|mesh-ancestor
6304882|NCT00002571|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6304883|NCT00002571|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6304884|NCT00002571|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6304885|NCT00002571|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6304886|NCT00002571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6304887|NCT00002571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6304888|NCT00002572|Aldesleukin|aldesleukin|mesh-list
6304889|NCT00002572|Muromonab-CD3|muromonab-cd3|mesh-list
6304890|NCT00002572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6304891|NCT00002572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6304892|NCT00002572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6304893|NCT00002572|Antiviral Agents|antiviral agents|mesh-ancestor
6304894|NCT00002572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6304895|NCT00002572|Immunologic Factors|immunologic factors|mesh-ancestor
6304896|NCT00002572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6304897|NCT00002572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6392276|NCT00195793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392277|NCT00195793|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6392278|NCT00195793|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6392279|NCT00195793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6392280|NCT00195806|Valproic Acid|valproic acid|mesh-list
6392281|NCT00195806|Anticonvulsants|anticonvulsants|mesh-ancestor
6392282|NCT00195806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6392283|NCT00195806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392284|NCT00195806|GABA Agents|gaba agents|mesh-ancestor
6392285|NCT00195806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6392286|NCT00195806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392287|NCT00195806|Antimanic Agents|antimanic agents|mesh-ancestor
6392288|NCT00195806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6392289|NCT00195806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6392290|NCT00195806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6392291|NCT00195845|Galantamine|galantamine|mesh-list
6392292|NCT00195845|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6392293|NCT00195845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6392294|NCT00195845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392295|NCT00195845|Cholinergic Agents|cholinergic agents|mesh-ancestor
6392296|NCT00195845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6392297|NCT00195845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392298|NCT00195845|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6392299|NCT00195845|Autonomic Agents|autonomic agents|mesh-ancestor
6392300|NCT00195845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6392301|NCT00195845|Nootropic Agents|nootropic agents|mesh-ancestor
6392302|NCT00195871|Cytarabine|cytarabine|mesh-list
6392303|NCT00195871|Prednisone|prednisone|mesh-list
6392304|NCT00195871|Cyclophosphamide|cyclophosphamide|mesh-list
6392305|NCT00195871|Methotrexate|methotrexate|mesh-list
6392306|NCT00195871|Etoposide|etoposide|mesh-list
6392307|NCT00195871|Vincristine|vincristine|mesh-list
6392308|NCT00195871|Daunorubicin|daunorubicin|mesh-list
6392309|NCT00195871|Asparaginase|asparaginase|mesh-list
6392310|NCT00195871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6392311|NCT00195871|Immunologic Factors|immunologic factors|mesh-ancestor
6392312|NCT00195871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392313|NCT00195871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6392314|NCT00195871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6392315|NCT00195871|Alkylating Agents|alkylating agents|mesh-ancestor
6392316|NCT00195871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392317|NCT00195871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6392318|NCT00195871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6392319|NCT00195871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6392320|NCT00195871|Glucocorticoids|glucocorticoids|mesh-ancestor
6392321|NCT00195871|Hormones|hormones|mesh-ancestor
6392322|NCT00195871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6392323|NCT00195871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6392324|NCT00195871|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6392325|NCT00195871|Abortifacient Agents|abortifacient agents|mesh-ancestor
6392326|NCT00195871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6392327|NCT00195871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6392328|NCT00195871|Antimetabolites|antimetabolites|mesh-ancestor
6392329|NCT00195871|Dermatologic Agents|dermatologic agents|mesh-ancestor
6392330|NCT00195871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6392331|NCT00195871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6392332|NCT00195871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6392333|NCT00195871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6392334|NCT00195871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6392335|NCT00195871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6392336|NCT00195871|Tubulin Modulators|tubulin modulators|mesh-ancestor
6392337|NCT00195871|Antimitotic Agents|antimitotic agents|mesh-ancestor
6392338|NCT00195871|Mitosis Modulators|mitosis modulators|mesh-ancestor
6392339|NCT00195871|Antiviral Agents|antiviral agents|mesh-ancestor
6392340|NCT00195871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6304898|NCT00002574|Interferons|interferons|mesh-list
6304899|NCT00002574|Interferon-alpha|interferon-alpha|mesh-list
6304900|NCT00002574|Homoharringtonine|homoharringtonine|mesh-list
6304901|NCT00002574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6304902|NCT00002574|Antiviral Agents|antiviral agents|mesh-ancestor
6304903|NCT00002574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6304904|NCT00002574|Immunologic Factors|immunologic factors|mesh-ancestor
6304905|NCT00002574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6304906|NCT00002574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6304907|NCT00002574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6304908|NCT00002574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6304909|NCT00002574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6304910|NCT00002576|Prednisolone|prednisolone|mesh-list
6304911|NCT00002576|Cyclophosphamide|cyclophosphamide|mesh-list
6304912|NCT00002576|Doxorubicin|doxorubicin|mesh-list
6304913|NCT00002576|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6304914|NCT00002576|Vincristine|vincristine|mesh-list
6304915|NCT00002576|Mitoxantrone|mitoxantrone|mesh-list
6304916|NCT00002576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6304917|NCT00002576|Immunologic Factors|immunologic factors|mesh-ancestor
6304918|NCT00002576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6304919|NCT00002576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6304920|NCT00002576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6304921|NCT00002576|Alkylating Agents|alkylating agents|mesh-ancestor
6304922|NCT00002576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6304923|NCT00002576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6304924|NCT00002576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6304925|NCT00002576|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6304926|NCT00002576|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6304927|NCT00002576|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6304928|NCT00002576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6304929|NCT00002576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6304930|NCT00002576|Tubulin Modulators|tubulin modulators|mesh-ancestor
6304931|NCT00002576|Antimitotic Agents|antimitotic agents|mesh-ancestor
6304932|NCT00002576|Mitosis Modulators|mitosis modulators|mesh-ancestor
6304933|NCT00002576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6304934|NCT00002576|Glucocorticoids|glucocorticoids|mesh-ancestor
6304935|NCT00002576|Hormones|hormones|mesh-ancestor
6304936|NCT00002576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6304937|NCT00002576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6304938|NCT00002576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6304939|NCT00002576|Analgesics|analgesics|mesh-ancestor
6304940|NCT00002576|Sensory System Agents|sensory system agents|mesh-ancestor
6304941|NCT00002578|Leucovorin|leucovorin|mesh-list
6304942|NCT00002578|Cytarabine|cytarabine|mesh-list
6304943|NCT00002578|Methotrexate|methotrexate|mesh-list
6304944|NCT00002578|Gallium nitrate|gallium nitrate|mesh-list
6304945|NCT00002578|Calcium|calcium|mesh-list
6304946|NCT00002578|Levoleucovorin|levoleucovorin|mesh-list
6304947|NCT00002578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6304948|NCT00002578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6304949|NCT00002578|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6304950|NCT00002578|Abortifacient Agents|abortifacient agents|mesh-ancestor
6304951|NCT00002578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6304952|NCT00002578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6304953|NCT00002578|Antimetabolites|antimetabolites|mesh-ancestor
6304954|NCT00002578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6304955|NCT00002578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6304956|NCT00002578|Dermatologic Agents|dermatologic agents|mesh-ancestor
6304957|NCT00002578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6304958|NCT00002578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6304959|NCT00002578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6304960|NCT00002578|Immunologic Factors|immunologic factors|mesh-ancestor
6304961|NCT00002578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6304962|NCT00002578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6304963|NCT00002578|Antiviral Agents|antiviral agents|mesh-ancestor
6304964|NCT00002578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6304965|NCT00002578|Antidotes|antidotes|mesh-ancestor
6304966|NCT00002578|Protective Agents|protective agents|mesh-ancestor
6304967|NCT00002578|Vitamin B Complex|vitamin b complex|mesh-ancestor
6304968|NCT00002578|Vitamins|vitamins|mesh-ancestor
6304969|NCT00002578|Micronutrients|micronutrients|mesh-ancestor
6304970|NCT00002579|Tamoxifen|tamoxifen|mesh-list
6304971|NCT00002579|Cyclophosphamide|cyclophosphamide|mesh-list
6304972|NCT00002579|Fluorouracil|fluorouracil|mesh-list
6304973|NCT00002579|Methotrexate|methotrexate|mesh-list
6304974|NCT00002579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6304975|NCT00002579|Immunologic Factors|immunologic factors|mesh-ancestor
6304976|NCT00002579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6304977|NCT00002579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6304978|NCT00002579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6304979|NCT00002579|Alkylating Agents|alkylating agents|mesh-ancestor
6304980|NCT00002579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6304981|NCT00002579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6304982|NCT00002579|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6304983|NCT00002579|Antimetabolites|antimetabolites|mesh-ancestor
6304984|NCT00002579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6304985|NCT00002579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6304986|NCT00002579|Abortifacient Agents|abortifacient agents|mesh-ancestor
6304987|NCT00002579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6304988|NCT00002579|Dermatologic Agents|dermatologic agents|mesh-ancestor
6304989|NCT00002579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6304990|NCT00002579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6304991|NCT00002579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6304992|NCT00002579|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6304993|NCT00002579|Hormone Antagonists|hormone antagonists|mesh-ancestor
6304994|NCT00002579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6304995|NCT00002579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6304996|NCT00002579|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6304997|NCT00002579|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6304998|NCT00002579|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6304999|NCT00002580|Tamoxifen|tamoxifen|mesh-list
6305000|NCT00002580|Cyclophosphamide|cyclophosphamide|mesh-list
6305001|NCT00002580|Fluorouracil|fluorouracil|mesh-list
6305002|NCT00002580|Methotrexate|methotrexate|mesh-list
6305003|NCT00002580|Leuprolide|leuprolide|mesh-list
6305004|NCT00002580|Goserelin|goserelin|mesh-list
6305005|NCT00002580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6305006|NCT00002580|Immunologic Factors|immunologic factors|mesh-ancestor
6305007|NCT00002580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6305008|NCT00002580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6305009|NCT00002580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6305010|NCT00002580|Alkylating Agents|alkylating agents|mesh-ancestor
6305011|NCT00002580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6305012|NCT00002580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6305013|NCT00002580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6305014|NCT00002580|Antimetabolites|antimetabolites|mesh-ancestor
6305015|NCT00002580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6305016|NCT00002580|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6305017|NCT00002580|Abortifacient Agents|abortifacient agents|mesh-ancestor
6305018|NCT00002580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6305019|NCT00002580|Dermatologic Agents|dermatologic agents|mesh-ancestor
6305020|NCT00002580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6305021|NCT00002580|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6305022|NCT00002580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6305023|NCT00002580|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6305024|NCT00002580|Hormone Antagonists|hormone antagonists|mesh-ancestor
6305025|NCT00002580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6305026|NCT00002580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6305027|NCT00002580|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6305028|NCT00002580|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6305029|NCT00002580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6305030|NCT00002580|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6305031|NCT00002580|Fertility Agents|fertility agents|mesh-ancestor
6305032|NCT00002581|Tamoxifen|tamoxifen|mesh-list
6305033|NCT00002581|Cyclophosphamide|cyclophosphamide|mesh-list
6305034|NCT00002581|Fluorouracil|fluorouracil|mesh-list
6305035|NCT00002581|Methotrexate|methotrexate|mesh-list
6305036|NCT00002581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6305037|NCT00002581|Immunologic Factors|immunologic factors|mesh-ancestor
6305038|NCT00002581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6305039|NCT00002581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6305040|NCT00002581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6305041|NCT00002581|Alkylating Agents|alkylating agents|mesh-ancestor
6305042|NCT00002581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6305043|NCT00002581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6305044|NCT00002581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6305045|NCT00002581|Antimetabolites|antimetabolites|mesh-ancestor
6305046|NCT00002581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6305047|NCT00002581|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6305048|NCT00002581|Abortifacient Agents|abortifacient agents|mesh-ancestor
6305049|NCT00002581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6305050|NCT00002581|Dermatologic Agents|dermatologic agents|mesh-ancestor
6305051|NCT00002581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6305052|NCT00002581|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6305053|NCT00002581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6305054|NCT00002581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6305055|NCT00002581|Hormone Antagonists|hormone antagonists|mesh-ancestor
6305056|NCT00002581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6305057|NCT00002581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6305058|NCT00002581|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6305059|NCT00002581|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6305060|NCT00002581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6305061|NCT00002582|Tamoxifen|tamoxifen|mesh-list
6305062|NCT00002582|Cyclophosphamide|cyclophosphamide|mesh-list
6305063|NCT00002582|Doxorubicin|doxorubicin|mesh-list
6305064|NCT00002582|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6305065|NCT00002582|Fluorouracil|fluorouracil|mesh-list
6305066|NCT00002582|Methotrexate|methotrexate|mesh-list
6305067|NCT00002582|Leuprolide|leuprolide|mesh-list
6305068|NCT00002582|Goserelin|goserelin|mesh-list
6305069|NCT00002582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6305070|NCT00002582|Immunologic Factors|immunologic factors|mesh-ancestor
6305071|NCT00002582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6305072|NCT00002582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6305073|NCT00002582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6305074|NCT00002582|Alkylating Agents|alkylating agents|mesh-ancestor
6305075|NCT00002582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6305076|NCT00002582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6305077|NCT00002582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6305078|NCT00002582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6305079|NCT00002582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6305080|NCT00002582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6305081|NCT00002582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6305082|NCT00002582|Antimetabolites|antimetabolites|mesh-ancestor
6305083|NCT00002582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6305084|NCT00002582|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6305085|NCT00002582|Abortifacient Agents|abortifacient agents|mesh-ancestor
6305086|NCT00002582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6305087|NCT00002582|Dermatologic Agents|dermatologic agents|mesh-ancestor
6305088|NCT00002582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6305089|NCT00002582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6305090|NCT00002582|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6305091|NCT00002582|Hormone Antagonists|hormone antagonists|mesh-ancestor
6305092|NCT00002582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6305093|NCT00002582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6305094|NCT00002582|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6305095|NCT00002582|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6305096|NCT00002582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6305097|NCT00002582|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6305098|NCT00002582|Fertility Agents|fertility agents|mesh-ancestor
6305099|NCT00002583|Vinorelbine|vinorelbine|mesh-list
6305100|NCT00002583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6305101|NCT00002583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6305102|NCT00002583|Tubulin Modulators|tubulin modulators|mesh-ancestor
6305103|NCT00002583|Antimitotic Agents|antimitotic agents|mesh-ancestor
6305104|NCT00002583|Mitosis Modulators|mitosis modulators|mesh-ancestor
6015913|NCT00360724|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6015914|NCT00360724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6015915|NCT00360724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6015916|NCT00360724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015917|NCT00360724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6015918|NCT00360724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015919|NCT00360724|Analgesics|analgesics|mesh-ancestor
6015920|NCT00360724|Sensory System Agents|sensory system agents|mesh-ancestor
6305105|NCT00002583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6305106|NCT00002585|NSC 366140|nsc 366140|mesh-list
6305107|NCT00002585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6305108|NCT00002586|Vitamin E|vitamin e|mesh-list
6305109|NCT00002586|Tocopherols|tocopherols|mesh-list
6305110|NCT00002586|Tocotrienols|tocotrienols|mesh-list
6305111|NCT00002586|alpha-Tocopherol|alpha-tocopherol|mesh-list
6305112|NCT00002586|Tretinoin|tretinoin|mesh-list
6305113|NCT00002586|Isotretinoin|isotretinoin|mesh-list
6305114|NCT00002586|Vitamins|vitamins|mesh-ancestor
6305115|NCT00002586|Micronutrients|micronutrients|mesh-ancestor
6305116|NCT00002586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6305117|NCT00002586|Antioxidants|antioxidants|mesh-ancestor
6305118|NCT00002586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6305119|NCT00002586|Protective Agents|protective agents|mesh-ancestor
6305120|NCT00002586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6305121|NCT00002586|Keratolytic Agents|keratolytic agents|mesh-ancestor
6305122|NCT00002586|Dermatologic Agents|dermatologic agents|mesh-ancestor
6305123|NCT00002587|Paclitaxel|paclitaxel|mesh-list
6305124|NCT00002587|Topotecan|topotecan|mesh-list
6305125|NCT00002587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6305126|NCT00002587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6305127|NCT00002587|Tubulin Modulators|tubulin modulators|mesh-ancestor
6305128|NCT00002587|Antimitotic Agents|antimitotic agents|mesh-ancestor
6305129|NCT00002587|Mitosis Modulators|mitosis modulators|mesh-ancestor
6305130|NCT00002587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6305131|NCT00002587|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6305132|NCT00002587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6305133|NCT00002587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6305134|NCT00002588|Etoposide|etoposide|mesh-list
6305135|NCT00002588|Topotecan|topotecan|mesh-list
6305136|NCT00002588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6305137|NCT00002588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6305138|NCT00002588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6305139|NCT00002588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6305140|NCT00002588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6305141|NCT00002588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6305142|NCT00002588|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6305143|NCT00002589|Aldesleukin|aldesleukin|mesh-list
6305144|NCT00002589|Muromonab-CD3|muromonab-cd3|mesh-list
6305145|NCT00002589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6305146|NCT00002589|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6305147|NCT00002589|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6305148|NCT00002589|Antiviral Agents|antiviral agents|mesh-ancestor
6305149|NCT00002589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6305150|NCT00002589|Immunologic Factors|immunologic factors|mesh-ancestor
6305151|NCT00002589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6305152|NCT00002589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6305153|NCT00002590|Leucovorin|leucovorin|mesh-list
6305154|NCT00002590|Cytarabine|cytarabine|mesh-list
6305155|NCT00002590|Prednisone|prednisone|mesh-list
6305156|NCT00002590|Cyclophosphamide|cyclophosphamide|mesh-list
6305157|NCT00002590|Doxorubicin|doxorubicin|mesh-list
6305158|NCT00002590|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6305159|NCT00002590|Methotrexate|methotrexate|mesh-list
6305160|NCT00002590|Etoposide|etoposide|mesh-list
6305161|NCT00002590|Vincristine|vincristine|mesh-list
6305162|NCT00002590|Daunorubicin|daunorubicin|mesh-list
6305163|NCT00002590|Asparaginase|asparaginase|mesh-list
6305164|NCT00002590|Pegaspargase|pegaspargase|mesh-list
6305165|NCT00002590|Thioguanine|thioguanine|mesh-list
6305166|NCT00002590|Levoleucovorin|levoleucovorin|mesh-list
6305167|NCT00002590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6305168|NCT00002590|Immunologic Factors|immunologic factors|mesh-ancestor
6305169|NCT00002590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6305170|NCT00002590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6305171|NCT00002590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6305172|NCT00002590|Alkylating Agents|alkylating agents|mesh-ancestor
6305173|NCT00002590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6305174|NCT00002590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6305175|NCT00002590|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6305176|NCT00002590|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6305177|NCT00002590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6305178|NCT00002590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6305179|NCT00002590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6305180|NCT00002590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6305181|NCT00002590|Glucocorticoids|glucocorticoids|mesh-ancestor
6305182|NCT00002590|Hormones|hormones|mesh-ancestor
6305183|NCT00002590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6305184|NCT00002590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6305185|NCT00002590|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6305186|NCT00002590|Abortifacient Agents|abortifacient agents|mesh-ancestor
6305187|NCT00002590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6305188|NCT00002590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6305189|NCT00002590|Antimetabolites|antimetabolites|mesh-ancestor
6305190|NCT00002590|Dermatologic Agents|dermatologic agents|mesh-ancestor
6305191|NCT00002590|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6015921|NCT00360724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6305192|NCT00002590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6305193|NCT00002590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6305194|NCT00002590|Antiviral Agents|antiviral agents|mesh-ancestor
6305195|NCT00002590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6305196|NCT00002590|Antidotes|antidotes|mesh-ancestor
6305197|NCT00002590|Protective Agents|protective agents|mesh-ancestor
6305198|NCT00002590|Vitamin B Complex|vitamin b complex|mesh-ancestor
6305199|NCT00002590|Vitamins|vitamins|mesh-ancestor
6305200|NCT00002590|Micronutrients|micronutrients|mesh-ancestor
6305201|NCT00002590|Tubulin Modulators|tubulin modulators|mesh-ancestor
6305202|NCT00002590|Antimitotic Agents|antimitotic agents|mesh-ancestor
6305203|NCT00002590|Mitosis Modulators|mitosis modulators|mesh-ancestor
6305204|NCT00002592|Cyclophosphamide|cyclophosphamide|mesh-list
6305205|NCT00002592|Busulfan|busulfan|mesh-list
6305206|NCT00002592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6305207|NCT00002592|Immunologic Factors|immunologic factors|mesh-ancestor
6305208|NCT00002592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6305209|NCT00002592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6305210|NCT00002592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6305211|NCT00002592|Alkylating Agents|alkylating agents|mesh-ancestor
6305212|NCT00002592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6305213|NCT00002592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6305214|NCT00002592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6305215|NCT00002593|Leucovorin|leucovorin|mesh-list
6305216|NCT00002593|Levamisole|levamisole|mesh-list
6305217|NCT00002593|Fluorouracil|fluorouracil|mesh-list
6305218|NCT00002593|Calcium|calcium|mesh-list
6305219|NCT00002593|Levoleucovorin|levoleucovorin|mesh-list
6305220|NCT00002593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6305221|NCT00002593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6305222|NCT00002593|Antimetabolites|antimetabolites|mesh-ancestor
6305223|NCT00002593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6305224|NCT00002593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6305225|NCT00002593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6305226|NCT00002593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6305227|NCT00002593|Immunologic Factors|immunologic factors|mesh-ancestor
6305228|NCT00002593|Antidotes|antidotes|mesh-ancestor
6305229|NCT00002593|Protective Agents|protective agents|mesh-ancestor
6305230|NCT00002593|Vitamin B Complex|vitamin b complex|mesh-ancestor
6305231|NCT00002593|Vitamins|vitamins|mesh-ancestor
6305232|NCT00002593|Micronutrients|micronutrients|mesh-ancestor
6305233|NCT00002593|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6305234|NCT00002593|Antinematodal Agents|antinematodal agents|mesh-ancestor
6305235|NCT00002593|Anthelmintics|anthelmintics|mesh-ancestor
6305236|NCT00002593|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6305237|NCT00002593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6305238|NCT00002593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6305239|NCT00002594|Cyclophosphamide|cyclophosphamide|mesh-list
6305240|NCT00002594|Melphalan|melphalan|mesh-list
6305241|NCT00002594|Molgramostim|molgramostim|mesh-list
6305242|NCT00002594|Sargramostim|sargramostim|mesh-list
6305243|NCT00002594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6305244|NCT00002594|Immunologic Factors|immunologic factors|mesh-ancestor
6305245|NCT00002594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6305246|NCT00002594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6305247|NCT00002594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6305248|NCT00002594|Alkylating Agents|alkylating agents|mesh-ancestor
6305249|NCT00002594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6305250|NCT00002594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6305251|NCT00002594|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6305252|NCT00002595|Toremifene|toremifene|mesh-list
6305253|NCT00002595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6305254|NCT00002595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6305255|NCT00002595|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6305256|NCT00002595|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6305257|NCT00002595|Hormone Antagonists|hormone antagonists|mesh-ancestor
6305258|NCT00002595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6305259|NCT00002595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6305260|NCT00002595|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6305261|NCT00002596|Cyclophosphamide|cyclophosphamide|mesh-list
6305262|NCT00002596|Carboplatin|carboplatin|mesh-list
6305263|NCT00002596|Etoposide|etoposide|mesh-list
6305264|NCT00002596|Bleomycin|bleomycin|mesh-list
6305265|NCT00002596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6305266|NCT00002596|Immunologic Factors|immunologic factors|mesh-ancestor
6305267|NCT00002596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6305268|NCT00002596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6305269|NCT00002596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6305270|NCT00002596|Alkylating Agents|alkylating agents|mesh-ancestor
6305271|NCT00002596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6305272|NCT00002596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6305273|NCT00002596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6305274|NCT00002596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6305275|NCT00002596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6305276|NCT00002596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6305277|NCT00002596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6305278|NCT00002596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6305279|NCT00002598|Interferons|interferons|mesh-list
6305280|NCT00002598|Cytarabine|cytarabine|mesh-list
6305281|NCT00002598|Interferon-alpha|interferon-alpha|mesh-list
6305282|NCT00002598|Cyclophosphamide|cyclophosphamide|mesh-list
6305283|NCT00002598|Methotrexate|methotrexate|mesh-list
6305284|NCT00002598|Etoposide|etoposide|mesh-list
6305285|NCT00002598|Mitoxantrone|mitoxantrone|mesh-list
6305286|NCT00002598|Sargramostim|sargramostim|mesh-list
6305287|NCT00002598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6305288|NCT00002598|Immunologic Factors|immunologic factors|mesh-ancestor
6305289|NCT00002598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6305290|NCT00002598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6305291|NCT00002598|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6305292|NCT00002598|Alkylating Agents|alkylating agents|mesh-ancestor
6305293|NCT00002598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6305294|NCT00002598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6305295|NCT00002598|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6305296|NCT00002598|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6305297|NCT00002598|Abortifacient Agents|abortifacient agents|mesh-ancestor
6305298|NCT00002598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6305299|NCT00002598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6305300|NCT00002598|Antimetabolites|antimetabolites|mesh-ancestor
6305301|NCT00002598|Dermatologic Agents|dermatologic agents|mesh-ancestor
6305302|NCT00002598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6305303|NCT00002598|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6305304|NCT00002598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6305305|NCT00002598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6305306|NCT00002598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6305307|NCT00002598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6305308|NCT00002598|Antiviral Agents|antiviral agents|mesh-ancestor
6305309|NCT00002598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6305310|NCT00002598|Analgesics|analgesics|mesh-ancestor
6305311|NCT00002598|Sensory System Agents|sensory system agents|mesh-ancestor
6305312|NCT00002598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6305313|NCT00002599|Cobalt|cobalt|mesh-list
6305314|NCT00002599|Interferons|interferons|mesh-list
6305315|NCT00002599|Interferon-alpha|interferon-alpha|mesh-list
6305316|NCT00002599|Prednisone|prednisone|mesh-list
6305317|NCT00002599|Methylprednisolone|methylprednisolone|mesh-list
6305318|NCT00002599|Cyclophosphamide|cyclophosphamide|mesh-list
6305319|NCT00002599|Melphalan|melphalan|mesh-list
6305320|NCT00002599|Carmustine|carmustine|mesh-list
6305321|NCT00002599|Doxorubicin|doxorubicin|mesh-list
6305322|NCT00002599|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6305323|NCT00002599|Vincristine|vincristine|mesh-list
6305324|NCT00002599|Sargramostim|sargramostim|mesh-list
6305325|NCT00002599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6305326|NCT00002599|Immunologic Factors|immunologic factors|mesh-ancestor
6305327|NCT00002599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6305328|NCT00002599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6305329|NCT00002599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6305330|NCT00002599|Alkylating Agents|alkylating agents|mesh-ancestor
6305331|NCT00002599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6305332|NCT00002599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6305333|NCT00002599|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6305334|NCT00002599|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6305335|NCT00002599|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6305336|NCT00002599|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6305337|NCT00002599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6305338|NCT00002599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6305339|NCT00002599|Glucocorticoids|glucocorticoids|mesh-ancestor
6305340|NCT00002599|Hormones|hormones|mesh-ancestor
6305341|NCT00002599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6305342|NCT00002599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6305343|NCT00002599|Antiviral Agents|antiviral agents|mesh-ancestor
6305344|NCT00002599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6305345|NCT00002599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6305346|NCT00002599|Tubulin Modulators|tubulin modulators|mesh-ancestor
6305347|NCT00002599|Antimitotic Agents|antimitotic agents|mesh-ancestor
6305348|NCT00002599|Mitosis Modulators|mitosis modulators|mesh-ancestor
6305349|NCT00002599|Antiemetics|antiemetics|mesh-ancestor
6305350|NCT00002599|Autonomic Agents|autonomic agents|mesh-ancestor
6305351|NCT00002599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6305352|NCT00002599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6305353|NCT00002599|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6305354|NCT00002599|Protective Agents|protective agents|mesh-ancestor
6305355|NCT00002599|Trace Elements|trace elements|mesh-ancestor
6305356|NCT00002599|Micronutrients|micronutrients|mesh-ancestor
6305357|NCT00002600|Cyclophosphamide|cyclophosphamide|mesh-list
6305358|NCT00002600|Carboplatin|carboplatin|mesh-list
6305359|NCT00002600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6305360|NCT00002600|Immunologic Factors|immunologic factors|mesh-ancestor
6305361|NCT00002600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6305362|NCT00002600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6305363|NCT00002600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6305364|NCT00002600|Alkylating Agents|alkylating agents|mesh-ancestor
6305365|NCT00002600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6305366|NCT00002600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6305367|NCT00002600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6305368|NCT00002604|Carmustine|carmustine|mesh-list
6305369|NCT00002604|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
6305370|NCT00002604|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6305371|NCT00002604|Alkylating Agents|alkylating agents|mesh-ancestor
6305372|NCT00002604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6305373|NCT00002604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6305374|NCT00002604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6305375|NCT00002608|Tamoxifen|tamoxifen|mesh-list
6305376|NCT00002608|Doxorubicin|doxorubicin|mesh-list
6305377|NCT00002608|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6305378|NCT00002608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6305379|NCT00002608|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6305380|NCT00002608|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6305381|NCT00002608|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6305382|NCT00002608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6305383|NCT00002608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6305384|NCT00002608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6305385|NCT00002608|Hormone Antagonists|hormone antagonists|mesh-ancestor
6305386|NCT00002608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6305387|NCT00002608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6305388|NCT00002608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6305389|NCT00002608|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6305390|NCT00002608|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6305391|NCT00002608|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6305392|NCT00002609|Cytarabine|cytarabine|mesh-list
6305393|NCT00002609|Idarubicin|idarubicin|mesh-list
6305394|NCT00002609|Lintuzumab|lintuzumab|mesh-list
6305395|NCT00002609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6305396|NCT00002609|Antimetabolites|antimetabolites|mesh-ancestor
6305397|NCT00002609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6305398|NCT00002609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6305399|NCT00002609|Antiviral Agents|antiviral agents|mesh-ancestor
6305400|NCT00002609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6305401|NCT00002609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6305402|NCT00002609|Immunologic Factors|immunologic factors|mesh-ancestor
6305403|NCT00002609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6305404|NCT00002609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6305405|NCT00002609|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6305406|NCT00002609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6305407|NCT00002609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6305408|NCT00002609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6305409|NCT00002610|Dactinomycin|dactinomycin|mesh-list
6305410|NCT00002610|Cyclophosphamide|cyclophosphamide|mesh-list
6305411|NCT00002610|Carboplatin|carboplatin|mesh-list
6305412|NCT00002610|Doxorubicin|doxorubicin|mesh-list
6305413|NCT00002610|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6305414|NCT00002610|Etoposide|etoposide|mesh-list
6305415|NCT00002610|Vincristine|vincristine|mesh-list
6305416|NCT00002610|Lenograstim|lenograstim|mesh-list
6305417|NCT00002610|Sargramostim|sargramostim|mesh-list
6305418|NCT00002610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6305419|NCT00002610|Immunologic Factors|immunologic factors|mesh-ancestor
6305420|NCT00002610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6305421|NCT00002610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6305422|NCT00002610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6305423|NCT00002610|Alkylating Agents|alkylating agents|mesh-ancestor
6305424|NCT00002610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6305425|NCT00002610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6305426|NCT00002610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6015922|NCT00360724|Antidepressive Agents|antidepressive agents|mesh-ancestor
6015923|NCT00360724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6015924|NCT00360724|Dopamine Agents|dopamine agents|mesh-ancestor
6015925|NCT00360828|Irinotecan|irinotecan|mesh-list
6305427|NCT00002610|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6305428|NCT00002610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6305429|NCT00002610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6305430|NCT00002610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6305431|NCT00002610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6305432|NCT00002610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6305433|NCT00002610|Tubulin Modulators|tubulin modulators|mesh-ancestor
6305434|NCT00002610|Antimitotic Agents|antimitotic agents|mesh-ancestor
6305435|NCT00002610|Mitosis Modulators|mitosis modulators|mesh-ancestor
6015926|NCT00360828|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6305436|NCT00002610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6305437|NCT00002610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6305438|NCT00002610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6305439|NCT00002610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6305440|NCT00002611|Dactinomycin|dactinomycin|mesh-list
6305441|NCT00002611|Cyclophosphamide|cyclophosphamide|mesh-list
6305442|NCT00002611|Doxorubicin|doxorubicin|mesh-list
6305443|NCT00002611|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6305444|NCT00002611|Etoposide|etoposide|mesh-list
6305445|NCT00002611|Vincristine|vincristine|mesh-list
6305446|NCT00002611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6305447|NCT00002611|Immunologic Factors|immunologic factors|mesh-ancestor
6305448|NCT00002611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6305449|NCT00002611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6305450|NCT00002611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6305451|NCT00002611|Alkylating Agents|alkylating agents|mesh-ancestor
6305452|NCT00002611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6305453|NCT00002611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6305454|NCT00002611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6305455|NCT00002611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6305456|NCT00002611|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6305457|NCT00002611|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6305458|NCT00002611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6305459|NCT00002611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6305460|NCT00002611|Tubulin Modulators|tubulin modulators|mesh-ancestor
6305461|NCT00002611|Antimitotic Agents|antimitotic agents|mesh-ancestor
6305462|NCT00002611|Mitosis Modulators|mitosis modulators|mesh-ancestor
6305463|NCT00002611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6305464|NCT00002611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6305465|NCT00002611|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6305466|NCT00002611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6305467|NCT00002615|Fluorouracil|fluorouracil|mesh-list
6305468|NCT00002615|Epirubicin|epirubicin|mesh-list
6305469|NCT00002615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6305470|NCT00002615|Antimetabolites|antimetabolites|mesh-ancestor
6305471|NCT00002615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6305472|NCT00002615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6305473|NCT00002615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6305474|NCT00002615|Immunologic Factors|immunologic factors|mesh-ancestor
6305475|NCT00002615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6305476|NCT00002615|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6305477|NCT00002615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6305478|NCT00002615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6305479|NCT00002615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6305480|NCT00002616|Aldesleukin|aldesleukin|mesh-list
6305481|NCT00002616|Cyclophosphamide|cyclophosphamide|mesh-list
6305482|NCT00002616|Thiotepa|thiotepa|mesh-list
6305483|NCT00002616|Carboplatin|carboplatin|mesh-list
6305484|NCT00002616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6305485|NCT00002616|Immunologic Factors|immunologic factors|mesh-ancestor
6305486|NCT00002616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6305487|NCT00002616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6305488|NCT00002616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6305489|NCT00002616|Alkylating Agents|alkylating agents|mesh-ancestor
6305490|NCT00002616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6305491|NCT00002616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6305492|NCT00002616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6305493|NCT00002616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6305494|NCT00002616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6305495|NCT00002616|Antiviral Agents|antiviral agents|mesh-ancestor
6305496|NCT00002616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6305497|NCT00002618|Leucovorin|leucovorin|mesh-list
6305498|NCT00002618|Cobalt|cobalt|mesh-list
6305499|NCT00002618|Cytarabine|cytarabine|mesh-list
6305500|NCT00002618|Prednisone|prednisone|mesh-list
6305501|NCT00002618|Doxorubicin|doxorubicin|mesh-list
6305502|NCT00002618|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6305503|NCT00002618|Methotrexate|methotrexate|mesh-list
6305504|NCT00002618|Vincristine|vincristine|mesh-list
6305505|NCT00002618|Mercaptopurine|mercaptopurine|mesh-list
6305506|NCT00002618|Levoleucovorin|levoleucovorin|mesh-list
6305507|NCT00002618|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6305508|NCT00002618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6305509|NCT00002618|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6305510|NCT00002618|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6305511|NCT00002618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6305512|NCT00002618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6305513|NCT00002618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6305514|NCT00002618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6305515|NCT00002618|Glucocorticoids|glucocorticoids|mesh-ancestor
6305516|NCT00002618|Hormones|hormones|mesh-ancestor
6305517|NCT00002618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6305518|NCT00002618|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6305519|NCT00002618|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6305520|NCT00002618|Abortifacient Agents|abortifacient agents|mesh-ancestor
6305521|NCT00002618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6305522|NCT00002618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6305523|NCT00002618|Antimetabolites|antimetabolites|mesh-ancestor
6305524|NCT00002618|Dermatologic Agents|dermatologic agents|mesh-ancestor
6305525|NCT00002618|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6305526|NCT00002618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6305527|NCT00002618|Immunologic Factors|immunologic factors|mesh-ancestor
6305528|NCT00002618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6305529|NCT00002618|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6305530|NCT00002618|Antiviral Agents|antiviral agents|mesh-ancestor
6305531|NCT00002618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6305532|NCT00002618|Antidotes|antidotes|mesh-ancestor
6305533|NCT00002618|Protective Agents|protective agents|mesh-ancestor
6305534|NCT00002618|Vitamin B Complex|vitamin b complex|mesh-ancestor
6305535|NCT00002618|Vitamins|vitamins|mesh-ancestor
6305536|NCT00002618|Micronutrients|micronutrients|mesh-ancestor
6305537|NCT00002618|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6305538|NCT00002618|Tubulin Modulators|tubulin modulators|mesh-ancestor
6305539|NCT00002618|Antimitotic Agents|antimitotic agents|mesh-ancestor
6305540|NCT00002618|Mitosis Modulators|mitosis modulators|mesh-ancestor
6305541|NCT00002618|Trace Elements|trace elements|mesh-ancestor
6305542|NCT00002619|Carboplatin|carboplatin|mesh-list
6305543|NCT00002619|Thiotepa|thiotepa|mesh-list
6305544|NCT00002619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6305545|NCT00002619|Immunologic Factors|immunologic factors|mesh-ancestor
6305546|NCT00002619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6305547|NCT00002619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6305548|NCT00002619|Alkylating Agents|alkylating agents|mesh-ancestor
6305549|NCT00002619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6305550|NCT00002619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6305551|NCT00002619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6305552|NCT00002620|Cobalt|cobalt|mesh-list
6305553|NCT00002620|Carmustine|carmustine|mesh-list
6305554|NCT00002620|Mitolactol|mitolactol|mesh-list
6305555|NCT00002620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6305556|NCT00002620|Alkylating Agents|alkylating agents|mesh-ancestor
6305557|NCT00002620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6305558|NCT00002620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6305559|NCT00002620|Trace Elements|trace elements|mesh-ancestor
6305560|NCT00002620|Micronutrients|micronutrients|mesh-ancestor
6305561|NCT00002620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6305562|NCT00002621|Interferons|interferons|mesh-list
6305563|NCT00002621|Interferon-alpha|interferon-alpha|mesh-list
6305564|NCT00002621|Interferon alpha-2|interferon alpha-2|mesh-list
6305565|NCT00002621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6305566|NCT00002621|Antiviral Agents|antiviral agents|mesh-ancestor
6305567|NCT00002621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6305568|NCT00002621|Immunologic Factors|immunologic factors|mesh-ancestor
6305569|NCT00002621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6305570|NCT00002623|Carboplatin|carboplatin|mesh-list
6305571|NCT00002623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6305572|NCT00002625|Topotecan|topotecan|mesh-list
6305573|NCT00002625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6305574|NCT00002625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6305575|NCT00002625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6305576|NCT00002625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6305577|NCT00002625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6305578|NCT00002627|Paclitaxel|paclitaxel|mesh-list
6305579|NCT00002627|Cyclophosphamide|cyclophosphamide|mesh-list
6305580|NCT00002627|Carboplatin|carboplatin|mesh-list
6305581|NCT00002627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6305582|NCT00002627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6305583|NCT00002627|Tubulin Modulators|tubulin modulators|mesh-ancestor
6305584|NCT00002627|Antimitotic Agents|antimitotic agents|mesh-ancestor
6305585|NCT00002627|Mitosis Modulators|mitosis modulators|mesh-ancestor
6305586|NCT00002627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6305587|NCT00002627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6305588|NCT00002627|Immunologic Factors|immunologic factors|mesh-ancestor
6305589|NCT00002627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6305590|NCT00002627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6305591|NCT00002627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6305592|NCT00002627|Alkylating Agents|alkylating agents|mesh-ancestor
6305593|NCT00002627|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6305594|NCT00002628|Paclitaxel|paclitaxel|mesh-list
6305595|NCT00002628|Cyclophosphamide|cyclophosphamide|mesh-list
6015927|NCT00360828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6015928|NCT00360828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6015929|NCT00360828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015930|NCT00360828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6015931|NCT00360971|Cisplatin|cisplatin|mesh-list
6305596|NCT00002628|Carboplatin|carboplatin|mesh-list
6305597|NCT00002628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6305598|NCT00002628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6305599|NCT00002628|Tubulin Modulators|tubulin modulators|mesh-ancestor
6015932|NCT00360971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6015933|NCT00361140|Vidarabine|vidarabine|mesh-list
6015934|NCT00361140|Fludarabine|fludarabine|mesh-list
6015935|NCT00361140|Fludarabine phosphate|fludarabine phosphate|mesh-list
6015936|NCT00361140|Busulfan|busulfan|mesh-list
6015937|NCT00361140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6015938|NCT00361140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6015939|NCT00361140|Antimetabolites|antimetabolites|mesh-ancestor
6015940|NCT00361140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015941|NCT00361140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6015942|NCT00361140|Immunologic Factors|immunologic factors|mesh-ancestor
6305600|NCT00002628|Antimitotic Agents|antimitotic agents|mesh-ancestor
6305601|NCT00002628|Mitosis Modulators|mitosis modulators|mesh-ancestor
6305602|NCT00002628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6305603|NCT00002628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6305604|NCT00002628|Immunologic Factors|immunologic factors|mesh-ancestor
6305605|NCT00002628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6305606|NCT00002628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6305607|NCT00002628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6305608|NCT00002628|Alkylating Agents|alkylating agents|mesh-ancestor
6305609|NCT00002628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6305610|NCT00002630|Cobalt|cobalt|mesh-list
6305611|NCT00002630|Cyclophosphamide|cyclophosphamide|mesh-list
6305612|NCT00002630|Melphalan|melphalan|mesh-list
6305613|NCT00002630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6305614|NCT00002630|Immunologic Factors|immunologic factors|mesh-ancestor
6305615|NCT00002630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6305616|NCT00002630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6305617|NCT00002630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6305618|NCT00002630|Alkylating Agents|alkylating agents|mesh-ancestor
6305619|NCT00002630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6305620|NCT00002630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6305621|NCT00002630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6305622|NCT00002630|Trace Elements|trace elements|mesh-ancestor
6305623|NCT00002630|Micronutrients|micronutrients|mesh-ancestor
6305624|NCT00002631|Fluorouracil|fluorouracil|mesh-list
6305625|NCT00002631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6305626|NCT00002631|Antimetabolites|antimetabolites|mesh-ancestor
6305627|NCT00002631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6305628|NCT00002631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6305629|NCT00002631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6305630|NCT00002631|Immunologic Factors|immunologic factors|mesh-ancestor
6305631|NCT00002631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6305632|NCT00002632|Paclitaxel|paclitaxel|mesh-list
6305633|NCT00002632|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6305634|NCT00002632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6305635|NCT00002632|Tubulin Modulators|tubulin modulators|mesh-ancestor
6305636|NCT00002632|Antimitotic Agents|antimitotic agents|mesh-ancestor
6305637|NCT00002632|Mitosis Modulators|mitosis modulators|mesh-ancestor
6305638|NCT00002632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6305639|NCT00002633|Leuprolide|leuprolide|mesh-list
6305640|NCT00002633|Goserelin|goserelin|mesh-list
6305641|NCT00002633|Flutamide|flutamide|mesh-list
6305642|NCT00002633|Bicalutamide|bicalutamide|mesh-list
6305643|NCT00002633|Nilutamide|nilutamide|mesh-list
6305644|NCT00002633|Buserelin|buserelin|mesh-list
6305645|NCT00002633|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6305646|NCT00002633|Fertility Agents|fertility agents|mesh-ancestor
6305647|NCT00002633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6305648|NCT00002633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6305649|NCT00002633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6305650|NCT00002633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6305651|NCT00002633|Androgen Antagonists|androgen antagonists|mesh-ancestor
6305652|NCT00002633|Hormone Antagonists|hormone antagonists|mesh-ancestor
6015943|NCT00361140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6305653|NCT00002633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6305654|NCT00002634|Cobalt|cobalt|mesh-list
6305655|NCT00002634|Cyclophosphamide|cyclophosphamide|mesh-list
6305656|NCT00002634|Doxorubicin|doxorubicin|mesh-list
6305657|NCT00002634|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6305658|NCT00002634|Etoposide|etoposide|mesh-list
6305659|NCT00002634|Vincristine|vincristine|mesh-list
6305660|NCT00002634|Antibodies|antibodies|mesh-list
6305661|NCT00002634|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6305662|NCT00002634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6305663|NCT00002634|Immunologic Factors|immunologic factors|mesh-ancestor
6305664|NCT00002634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6305665|NCT00002634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6305666|NCT00002634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6305667|NCT00002634|Alkylating Agents|alkylating agents|mesh-ancestor
6305668|NCT00002634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6305669|NCT00002634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6305670|NCT00002634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6305671|NCT00002634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6305672|NCT00002634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6305673|NCT00002634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6305674|NCT00002634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6305675|NCT00002634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6305676|NCT00002634|Tubulin Modulators|tubulin modulators|mesh-ancestor
6305677|NCT00002634|Antimitotic Agents|antimitotic agents|mesh-ancestor
6015944|NCT00361140|Antiviral Agents|antiviral agents|mesh-ancestor
6015945|NCT00361140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6015946|NCT00361140|Alkylating Agents|alkylating agents|mesh-ancestor
6305678|NCT00002634|Mitosis Modulators|mitosis modulators|mesh-ancestor
6305679|NCT00002634|Trace Elements|trace elements|mesh-ancestor
6305680|NCT00002634|Micronutrients|micronutrients|mesh-ancestor
6305681|NCT00002635|Lenograstim|lenograstim|mesh-list
6305682|NCT00002635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6305683|NCT00002635|Immunologic Factors|immunologic factors|mesh-ancestor
6305684|NCT00002635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6305685|NCT00002637|Interferons|interferons|mesh-list
6305686|NCT00002637|Aldesleukin|aldesleukin|mesh-list
6305687|NCT00002637|Interferon-gamma|interferon-gamma|mesh-list
6305688|NCT00002637|Vaccines|vaccines|mesh-list
6305689|NCT00002637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6305690|NCT00002637|Antiviral Agents|antiviral agents|mesh-ancestor
6305691|NCT00002637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6305692|NCT00002637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6305693|NCT00002637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6305694|NCT00002637|Immunologic Factors|immunologic factors|mesh-ancestor
6305695|NCT00002637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6305696|NCT00002638|Cytarabine|cytarabine|mesh-list
6305697|NCT00002638|Cyclophosphamide|cyclophosphamide|mesh-list
6305698|NCT00002638|Carmustine|carmustine|mesh-list
6305699|NCT00002638|Etoposide|etoposide|mesh-list
6305700|NCT00002638|Sargramostim|sargramostim|mesh-list
6305701|NCT00002638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6305702|NCT00002638|Immunologic Factors|immunologic factors|mesh-ancestor
6305703|NCT00002638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6305704|NCT00002638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6305705|NCT00002638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6305706|NCT00002638|Alkylating Agents|alkylating agents|mesh-ancestor
6305707|NCT00002638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6305708|NCT00002638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6305709|NCT00002638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6305710|NCT00002638|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6305711|NCT00002638|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6305712|NCT00002638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6305713|NCT00002638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6305714|NCT00002638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6305715|NCT00002638|Antimetabolites|antimetabolites|mesh-ancestor
6305716|NCT00002638|Antiviral Agents|antiviral agents|mesh-ancestor
6305717|NCT00002638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6305718|NCT00002639|Suramin|suramin|mesh-list
6305719|NCT00002639|Antinematodal Agents|antinematodal agents|mesh-ancestor
6305720|NCT00002639|Anthelmintics|anthelmintics|mesh-ancestor
6305721|NCT00002639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6305722|NCT00002639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6305723|NCT00002639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6305724|NCT00002639|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6305725|NCT00002639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6305726|NCT00002641|Doxorubicin|doxorubicin|mesh-list
6305727|NCT00002641|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6305728|NCT00002641|Ifosfamide|ifosfamide|mesh-list
6305729|NCT00002641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6305730|NCT00002641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6305731|NCT00002641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6305732|NCT00002641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6305733|NCT00002641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6305734|NCT00002641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6305735|NCT00002641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6305736|NCT00002641|Alkylating Agents|alkylating agents|mesh-ancestor
6305737|NCT00002642|Cobalt|cobalt|mesh-list
6305738|NCT00002642|Etoposide|etoposide|mesh-list
6305739|NCT00002642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6305740|NCT00002642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6305741|NCT00002642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6305742|NCT00002642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6305743|NCT00002642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6305744|NCT00002642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6305745|NCT00002642|Trace Elements|trace elements|mesh-ancestor
6305746|NCT00002642|Micronutrients|micronutrients|mesh-ancestor
6305747|NCT00002642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6305748|NCT00002643|Cobalt|cobalt|mesh-list
6305749|NCT00002643|Cyclophosphamide|cyclophosphamide|mesh-list
6305750|NCT00002643|Ifosfamide|ifosfamide|mesh-list
6305751|NCT00002643|Doxorubicin|doxorubicin|mesh-list
6305752|NCT00002643|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6305753|NCT00002643|Etoposide|etoposide|mesh-list
6305754|NCT00002643|Vincristine|vincristine|mesh-list
6305755|NCT00002643|Topotecan|topotecan|mesh-list
6305756|NCT00002643|Amifostine|amifostine|mesh-list
6305757|NCT00002643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6305758|NCT00002643|Immunologic Factors|immunologic factors|mesh-ancestor
6305759|NCT00002643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6305760|NCT00002643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6305761|NCT00002643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6305762|NCT00002643|Alkylating Agents|alkylating agents|mesh-ancestor
6305763|NCT00002643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6305764|NCT00002643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6305765|NCT00002643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6305766|NCT00002643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6305767|NCT00002643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6305768|NCT00002643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6305769|NCT00002643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6305770|NCT00002643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6305771|NCT00002643|Tubulin Modulators|tubulin modulators|mesh-ancestor
6305772|NCT00002643|Antimitotic Agents|antimitotic agents|mesh-ancestor
6305773|NCT00002643|Mitosis Modulators|mitosis modulators|mesh-ancestor
6305774|NCT00002643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6305775|NCT00002643|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6305776|NCT00002643|Protective Agents|protective agents|mesh-ancestor
6305777|NCT00002643|Trace Elements|trace elements|mesh-ancestor
6305778|NCT00002643|Micronutrients|micronutrients|mesh-ancestor
6305779|NCT00002644|Tamoxifen|tamoxifen|mesh-list
6305780|NCT00002644|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6305781|NCT00002644|Hormone Antagonists|hormone antagonists|mesh-ancestor
6305782|NCT00002644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6305783|NCT00002644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6305784|NCT00002644|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6305785|NCT00002644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6305786|NCT00002644|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6305787|NCT00002644|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6305788|NCT00002644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6305789|NCT00002646|Tamoxifen|tamoxifen|mesh-list
6305790|NCT00002646|Fenretinide|fenretinide|mesh-list
6305791|NCT00002646|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6305792|NCT00002646|Hormone Antagonists|hormone antagonists|mesh-ancestor
6305793|NCT00002646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6305794|NCT00002646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6305795|NCT00002646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6305796|NCT00002646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6305797|NCT00002646|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6305798|NCT00002646|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6305799|NCT00002646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6305800|NCT00002646|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6305801|NCT00002646|Protective Agents|protective agents|mesh-ancestor
6305802|NCT00002647|Verteporfin|verteporfin|mesh-list
6305803|NCT00002647|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6305804|NCT00002647|Dermatologic Agents|dermatologic agents|mesh-ancestor
6305805|NCT00002649|Aldesleukin|aldesleukin|mesh-list
6305806|NCT00002649|Cyclophosphamide|cyclophosphamide|mesh-list
6305807|NCT00002649|Etoposide|etoposide|mesh-list
6305808|NCT00002649|Etoposide phosphate|etoposide phosphate|mesh-list
6305809|NCT00002649|Interleukin-2|interleukin-2|mesh-list
6305810|NCT00002649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6305811|NCT00002649|Immunologic Factors|immunologic factors|mesh-ancestor
6305812|NCT00002649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6305813|NCT00002649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6305814|NCT00002649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6305815|NCT00002649|Alkylating Agents|alkylating agents|mesh-ancestor
6305816|NCT00002649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6305817|NCT00002649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6305818|NCT00002649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6305819|NCT00002649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6305820|NCT00002649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6305821|NCT00002649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6305822|NCT00002649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6305823|NCT00002649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6305824|NCT00002649|Analgesics|analgesics|mesh-ancestor
6305825|NCT00002649|Sensory System Agents|sensory system agents|mesh-ancestor
6305826|NCT00002649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6305827|NCT00002649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6305828|NCT00002649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6305829|NCT00002649|Antiviral Agents|antiviral agents|mesh-ancestor
6305830|NCT00002649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6305831|NCT00002650|Folic Acid|folic acid|mesh-list
6305832|NCT00002650|Hematinics|hematinics|mesh-ancestor
6305833|NCT00002650|Vitamin B Complex|vitamin b complex|mesh-ancestor
6305834|NCT00002650|Vitamins|vitamins|mesh-ancestor
6305835|NCT00002650|Micronutrients|micronutrients|mesh-ancestor
6305836|NCT00002650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6305837|NCT00002652|Suramin|suramin|mesh-list
6305838|NCT00002652|Antinematodal Agents|antinematodal agents|mesh-ancestor
6305839|NCT00002652|Anthelmintics|anthelmintics|mesh-ancestor
6305840|NCT00002652|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6305841|NCT00002652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6305842|NCT00002652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6305843|NCT00002652|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6305844|NCT00002652|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6305845|NCT00002653|Prednisone|prednisone|mesh-list
6305846|NCT00002653|Cyclophosphamide|cyclophosphamide|mesh-list
6305847|NCT00002653|Melphalan|melphalan|mesh-list
6305848|NCT00002653|Carmustine|carmustine|mesh-list
6305849|NCT00002653|Doxorubicin|doxorubicin|mesh-list
6305850|NCT00002653|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6305851|NCT00002653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6305852|NCT00002653|Immunologic Factors|immunologic factors|mesh-ancestor
6305853|NCT00002653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6305854|NCT00002653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6305855|NCT00002653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6305856|NCT00002653|Alkylating Agents|alkylating agents|mesh-ancestor
6305857|NCT00002653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6305858|NCT00002653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6305859|NCT00002653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6305860|NCT00002653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6305861|NCT00002653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6015947|NCT00361140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6015948|NCT00361140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6015949|NCT00361218|Citalopram|citalopram|mesh-list
6015950|NCT00361218|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
6015951|NCT00361218|Serotonin|serotonin|mesh-list
6015952|NCT00361218|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6015953|NCT00361218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6015954|NCT00361218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015955|NCT00361218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6015956|NCT00361218|Serotonin Agents|serotonin agents|mesh-ancestor
6015957|NCT00361218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015958|NCT00361218|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6305862|NCT00002653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6305863|NCT00002653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6305864|NCT00002653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6305865|NCT00002653|Glucocorticoids|glucocorticoids|mesh-ancestor
6305866|NCT00002653|Hormones|hormones|mesh-ancestor
6305867|NCT00002653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6305868|NCT00002653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6305869|NCT00002654|Cobalt|cobalt|mesh-list
6305870|NCT00002654|Trace Elements|trace elements|mesh-ancestor
6305871|NCT00002654|Micronutrients|micronutrients|mesh-ancestor
6305872|NCT00002654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6305873|NCT00002656|NSC 366140|nsc 366140|mesh-list
6305874|NCT00002656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6305875|NCT00002657|Interferons|interferons|mesh-list
6305876|NCT00002657|Cytarabine|cytarabine|mesh-list
6305877|NCT00002657|Interferon-alpha|interferon-alpha|mesh-list
6305878|NCT00002657|Prednisone|prednisone|mesh-list
6305879|NCT00002657|Cyclophosphamide|cyclophosphamide|mesh-list
6305880|NCT00002657|Doxorubicin|doxorubicin|mesh-list
6305881|NCT00002657|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6305882|NCT00002657|Methotrexate|methotrexate|mesh-list
6305883|NCT00002657|Etoposide|etoposide|mesh-list
6305884|NCT00002657|Vincristine|vincristine|mesh-list
6305885|NCT00002657|Bleomycin|bleomycin|mesh-list
6305886|NCT00002657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6305887|NCT00002657|Immunologic Factors|immunologic factors|mesh-ancestor
6305888|NCT00002657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6305889|NCT00002657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6305890|NCT00002657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6305891|NCT00002657|Alkylating Agents|alkylating agents|mesh-ancestor
6305892|NCT00002657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6305893|NCT00002657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6305894|NCT00002657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6305895|NCT00002657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6305896|NCT00002657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6305897|NCT00002657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6305898|NCT00002657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6305899|NCT00002657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6305900|NCT00002657|Glucocorticoids|glucocorticoids|mesh-ancestor
6305901|NCT00002657|Hormones|hormones|mesh-ancestor
6305902|NCT00002657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6305903|NCT00002657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6305904|NCT00002657|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6305905|NCT00002657|Abortifacient Agents|abortifacient agents|mesh-ancestor
6305906|NCT00002657|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6305907|NCT00002657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6305908|NCT00002657|Antimetabolites|antimetabolites|mesh-ancestor
6305909|NCT00002657|Dermatologic Agents|dermatologic agents|mesh-ancestor
6305910|NCT00002657|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6305911|NCT00002657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6305912|NCT00002657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6305913|NCT00002657|Antiviral Agents|antiviral agents|mesh-ancestor
6305914|NCT00002657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6305915|NCT00002657|Tubulin Modulators|tubulin modulators|mesh-ancestor
6305916|NCT00002657|Antimitotic Agents|antimitotic agents|mesh-ancestor
6305917|NCT00002657|Mitosis Modulators|mitosis modulators|mesh-ancestor
6305918|NCT00002658|Cytarabine|cytarabine|mesh-list
6305919|NCT00002658|Cyclophosphamide|cyclophosphamide|mesh-list
6305920|NCT00002658|Etoposide|etoposide|mesh-list
6305921|NCT00002658|Daunorubicin|daunorubicin|mesh-list
6015959|NCT00361218|Antidepressive Agents|antidepressive agents|mesh-ancestor
6015960|NCT00361218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6305922|NCT00002658|Mitoxantrone|mitoxantrone|mesh-list
6305923|NCT00002658|Idarubicin|idarubicin|mesh-list
6305924|NCT00002658|Tretinoin|tretinoin|mesh-list
6305925|NCT00002658|Thioguanine|thioguanine|mesh-list
6305926|NCT00002658|Amsacrine|amsacrine|mesh-list
6305927|NCT00002658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6305928|NCT00002658|Immunologic Factors|immunologic factors|mesh-ancestor
6305929|NCT00002658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6305930|NCT00002658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6305931|NCT00002658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6305932|NCT00002658|Alkylating Agents|alkylating agents|mesh-ancestor
6305933|NCT00002658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6305934|NCT00002658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6305935|NCT00002658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6305936|NCT00002658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6305937|NCT00002658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6305938|NCT00002658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6305939|NCT00002658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6305940|NCT00002658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6305941|NCT00002658|Antimetabolites|antimetabolites|mesh-ancestor
6305942|NCT00002658|Antiviral Agents|antiviral agents|mesh-ancestor
6305943|NCT00002658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6305944|NCT00002658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6305945|NCT00002658|Analgesics|analgesics|mesh-ancestor
6305946|NCT00002658|Sensory System Agents|sensory system agents|mesh-ancestor
6305947|NCT00002658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6305948|NCT00002658|Keratolytic Agents|keratolytic agents|mesh-ancestor
6305949|NCT00002658|Dermatologic Agents|dermatologic agents|mesh-ancestor
6305950|NCT00002659|Cisplatin|cisplatin|mesh-list
6305951|NCT00002659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6305952|NCT00002662|Paclitaxel|paclitaxel|mesh-list
6305953|NCT00002662|Docetaxel|docetaxel|mesh-list
6305954|NCT00002662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6305955|NCT00002662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6305956|NCT00002662|Tubulin Modulators|tubulin modulators|mesh-ancestor
6305957|NCT00002662|Antimitotic Agents|antimitotic agents|mesh-ancestor
6305958|NCT00002662|Mitosis Modulators|mitosis modulators|mesh-ancestor
6305959|NCT00002662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6305960|NCT00002664|Sargramostim|sargramostim|mesh-list
6305961|NCT00002664|Edrecolomab|edrecolomab|mesh-list
6305962|NCT00002664|Immunologic Factors|immunologic factors|mesh-ancestor
6305963|NCT00002664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6305964|NCT00002664|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6305965|NCT00002665|Leucovorin|leucovorin|mesh-list
6305966|NCT00002665|Cytarabine|cytarabine|mesh-list
6305967|NCT00002665|Dexamethasone|dexamethasone|mesh-list
6305968|NCT00002665|Prednisone|prednisone|mesh-list
6305969|NCT00002665|Cyclophosphamide|cyclophosphamide|mesh-list
6305970|NCT00002665|Doxorubicin|doxorubicin|mesh-list
6305971|NCT00002665|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6305972|NCT00002665|Methotrexate|methotrexate|mesh-list
6305973|NCT00002665|Etoposide|etoposide|mesh-list
6305974|NCT00002665|Vincristine|vincristine|mesh-list
6305975|NCT00002665|Daunorubicin|daunorubicin|mesh-list
6305976|NCT00002665|Asparaginase|asparaginase|mesh-list
6305977|NCT00002665|Mercaptopurine|mercaptopurine|mesh-list
6305978|NCT00002665|Thioguanine|thioguanine|mesh-list
6305979|NCT00002665|Levoleucovorin|levoleucovorin|mesh-list
6305980|NCT00002665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6305981|NCT00002665|Immunologic Factors|immunologic factors|mesh-ancestor
6305982|NCT00002665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6305983|NCT00002665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6305984|NCT00002665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6305985|NCT00002665|Alkylating Agents|alkylating agents|mesh-ancestor
6305986|NCT00002665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6305987|NCT00002665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6305988|NCT00002665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6305989|NCT00002665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6305990|NCT00002665|Antiemetics|antiemetics|mesh-ancestor
6305991|NCT00002665|Autonomic Agents|autonomic agents|mesh-ancestor
6305992|NCT00002665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6305993|NCT00002665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6305994|NCT00002665|Glucocorticoids|glucocorticoids|mesh-ancestor
6305995|NCT00002665|Hormones|hormones|mesh-ancestor
6305996|NCT00002665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6305997|NCT00002665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6305998|NCT00002665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6305999|NCT00002665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6306000|NCT00002665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6306001|NCT00002665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6306002|NCT00002665|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6306003|NCT00002665|Abortifacient Agents|abortifacient agents|mesh-ancestor
6306004|NCT00002665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6306005|NCT00002665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6306006|NCT00002665|Antimetabolites|antimetabolites|mesh-ancestor
6306007|NCT00002665|Dermatologic Agents|dermatologic agents|mesh-ancestor
6306008|NCT00002665|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6306009|NCT00002665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6306010|NCT00002665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6306011|NCT00002665|Antiviral Agents|antiviral agents|mesh-ancestor
6306012|NCT00002665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6306013|NCT00002665|Antidotes|antidotes|mesh-ancestor
6306014|NCT00002665|Protective Agents|protective agents|mesh-ancestor
6306015|NCT00002665|Vitamin B Complex|vitamin b complex|mesh-ancestor
6306016|NCT00002665|Vitamins|vitamins|mesh-ancestor
6306017|NCT00002665|Micronutrients|micronutrients|mesh-ancestor
6306018|NCT00002665|Tubulin Modulators|tubulin modulators|mesh-ancestor
6306019|NCT00002665|Antimitotic Agents|antimitotic agents|mesh-ancestor
6306020|NCT00002665|Mitosis Modulators|mitosis modulators|mesh-ancestor
6306021|NCT00002669|Interferons|interferons|mesh-list
6306022|NCT00002669|Interferon-alpha|interferon-alpha|mesh-list
6306023|NCT00002669|Aldesleukin|aldesleukin|mesh-list
6306024|NCT00002669|Dacarbazine|dacarbazine|mesh-list
6306025|NCT00002669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6306026|NCT00002669|Antiviral Agents|antiviral agents|mesh-ancestor
6306027|NCT00002669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6306028|NCT00002669|Immunologic Factors|immunologic factors|mesh-ancestor
6306029|NCT00002669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6306030|NCT00002669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6306031|NCT00002669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6306032|NCT00002669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6306033|NCT00002669|Alkylating Agents|alkylating agents|mesh-ancestor
6306034|NCT00002669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6306035|NCT00002670|Cobalt|cobalt|mesh-list
6306036|NCT00002670|Trace Elements|trace elements|mesh-ancestor
6306037|NCT00002670|Micronutrients|micronutrients|mesh-ancestor
6306038|NCT00002670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6306039|NCT00002674|Cytarabine|cytarabine|mesh-list
6306040|NCT00002674|Etoposide|etoposide|mesh-list
6306041|NCT00002674|Mitoxantrone|mitoxantrone|mesh-list
6306042|NCT00002674|Hydroxyurea|hydroxyurea|mesh-list
6306043|NCT00002674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6306044|NCT00002674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6306045|NCT00002674|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6306046|NCT00002674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6306047|NCT00002674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6306048|NCT00002674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6306049|NCT00002674|Immunologic Factors|immunologic factors|mesh-ancestor
6306050|NCT00002674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6306051|NCT00002674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6306052|NCT00002674|Antimetabolites|antimetabolites|mesh-ancestor
6306053|NCT00002674|Antiviral Agents|antiviral agents|mesh-ancestor
6306054|NCT00002674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6306055|NCT00002674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6306056|NCT00002674|Analgesics|analgesics|mesh-ancestor
6306057|NCT00002674|Sensory System Agents|sensory system agents|mesh-ancestor
6306058|NCT00002674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6306059|NCT00002674|Antisickling Agents|antisickling agents|mesh-ancestor
6306060|NCT00002674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6306061|NCT00002675|Cyclophosphamide|cyclophosphamide|mesh-list
6306062|NCT00002675|Carboplatin|carboplatin|mesh-list
6306063|NCT00002675|Etoposide|etoposide|mesh-list
6306064|NCT00002675|Vincristine|vincristine|mesh-list
6306065|NCT00002675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6306066|NCT00002675|Immunologic Factors|immunologic factors|mesh-ancestor
6306067|NCT00002675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6306068|NCT00002675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6306069|NCT00002675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6306070|NCT00002675|Alkylating Agents|alkylating agents|mesh-ancestor
6306071|NCT00002675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6306072|NCT00002675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6306073|NCT00002675|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6306074|NCT00002675|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6306075|NCT00002675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6306076|NCT00002675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6306077|NCT00002675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6306078|NCT00002675|Tubulin Modulators|tubulin modulators|mesh-ancestor
6306079|NCT00002675|Antimitotic Agents|antimitotic agents|mesh-ancestor
6306080|NCT00002675|Mitosis Modulators|mitosis modulators|mesh-ancestor
6306081|NCT00002676|Cobalt|cobalt|mesh-list
6306082|NCT00002676|Cytarabine|cytarabine|mesh-list
6306083|NCT00002676|Dexamethasone|dexamethasone|mesh-list
6306084|NCT00002676|Cyclophosphamide|cyclophosphamide|mesh-list
6306085|NCT00002676|Carmustine|carmustine|mesh-list
6306086|NCT00002676|Doxorubicin|doxorubicin|mesh-list
6306087|NCT00002676|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6306088|NCT00002676|Methotrexate|methotrexate|mesh-list
6306089|NCT00002676|Vincristine|vincristine|mesh-list
6306090|NCT00002676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6306091|NCT00002676|Immunologic Factors|immunologic factors|mesh-ancestor
6306092|NCT00002676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6306093|NCT00002676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6306094|NCT00002676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6306095|NCT00002676|Alkylating Agents|alkylating agents|mesh-ancestor
6306096|NCT00002676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538071|NCT00825591|Melatonin|melatonin|mesh-list
6306097|NCT00002676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6306098|NCT00002676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6306099|NCT00002676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6306100|NCT00002676|Antiemetics|antiemetics|mesh-ancestor
6306101|NCT00002676|Autonomic Agents|autonomic agents|mesh-ancestor
6306102|NCT00002676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6306103|NCT00002676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6306104|NCT00002676|Glucocorticoids|glucocorticoids|mesh-ancestor
6306105|NCT00002676|Hormones|hormones|mesh-ancestor
6306106|NCT00002676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6306107|NCT00002676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6306108|NCT00002676|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6306109|NCT00002676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6306110|NCT00002676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6306111|NCT00002676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6306112|NCT00002676|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6306113|NCT00002676|Abortifacient Agents|abortifacient agents|mesh-ancestor
6306114|NCT00002676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6306115|NCT00002676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6306116|NCT00002676|Antimetabolites|antimetabolites|mesh-ancestor
6306117|NCT00002676|Dermatologic Agents|dermatologic agents|mesh-ancestor
6306118|NCT00002676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6306119|NCT00002676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6306120|NCT00002676|Antiviral Agents|antiviral agents|mesh-ancestor
6306121|NCT00002676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6306122|NCT00002676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6306123|NCT00002676|Tubulin Modulators|tubulin modulators|mesh-ancestor
6306124|NCT00002676|Antimitotic Agents|antimitotic agents|mesh-ancestor
6306125|NCT00002676|Mitosis Modulators|mitosis modulators|mesh-ancestor
6306126|NCT00002676|Trace Elements|trace elements|mesh-ancestor
6306127|NCT00002676|Micronutrients|micronutrients|mesh-ancestor
6306128|NCT00002678|Dexamethasone|dexamethasone|mesh-list
6306129|NCT00002678|Prednisone|prednisone|mesh-list
6306130|NCT00002678|Melphalan|melphalan|mesh-list
6306131|NCT00002678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6306132|NCT00002678|Antiemetics|antiemetics|mesh-ancestor
6306133|NCT00002678|Autonomic Agents|autonomic agents|mesh-ancestor
6306134|NCT00002678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6306135|NCT00002678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6306136|NCT00002678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6306137|NCT00002678|Glucocorticoids|glucocorticoids|mesh-ancestor
6306138|NCT00002678|Hormones|hormones|mesh-ancestor
6306139|NCT00002678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6306140|NCT00002678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6306141|NCT00002678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6306142|NCT00002678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6306143|NCT00002678|Alkylating Agents|alkylating agents|mesh-ancestor
6306144|NCT00002678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6306145|NCT00002678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6306146|NCT00002678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6306147|NCT00002678|Immunologic Factors|immunologic factors|mesh-ancestor
6306148|NCT00002679|Tamoxifen|tamoxifen|mesh-list
6306149|NCT00002679|Paclitaxel|paclitaxel|mesh-list
6306150|NCT00002679|Cyclophosphamide|cyclophosphamide|mesh-list
6306151|NCT00002679|Doxorubicin|doxorubicin|mesh-list
6306152|NCT00002679|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6306153|NCT00002679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6306154|NCT00002679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6306155|NCT00002679|Tubulin Modulators|tubulin modulators|mesh-ancestor
6306156|NCT00002679|Antimitotic Agents|antimitotic agents|mesh-ancestor
6306157|NCT00002679|Mitosis Modulators|mitosis modulators|mesh-ancestor
6306158|NCT00002679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6306159|NCT00002679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6306160|NCT00002679|Immunologic Factors|immunologic factors|mesh-ancestor
6306161|NCT00002679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6306162|NCT00002679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6306163|NCT00002679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6306164|NCT00002679|Alkylating Agents|alkylating agents|mesh-ancestor
6306165|NCT00002679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6306166|NCT00002679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6306167|NCT00002679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6306168|NCT00002679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6306169|NCT00002679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6306170|NCT00002679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6306171|NCT00002679|Hormone Antagonists|hormone antagonists|mesh-ancestor
6306172|NCT00002679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6306173|NCT00002679|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6306174|NCT00002679|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6306175|NCT00002679|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6306176|NCT00002679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6306177|NCT00002680|Tamoxifen|tamoxifen|mesh-list
6306178|NCT00002680|Cyclophosphamide|cyclophosphamide|mesh-list
6306179|NCT00002680|Melphalan|melphalan|mesh-list
6306180|NCT00002680|Thiotepa|thiotepa|mesh-list
6306181|NCT00002680|Megestrol|megestrol|mesh-list
6306182|NCT00002680|Megestrol Acetate|megestrol acetate|mesh-list
6306183|NCT00002680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6306184|NCT00002680|Immunologic Factors|immunologic factors|mesh-ancestor
6306185|NCT00002680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6306186|NCT00002680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6306187|NCT00002680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6306188|NCT00002680|Alkylating Agents|alkylating agents|mesh-ancestor
6306189|NCT00002680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6306190|NCT00002680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6306191|NCT00002680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6306192|NCT00002680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6306193|NCT00002680|Hormone Antagonists|hormone antagonists|mesh-ancestor
6306194|NCT00002680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6306195|NCT00002680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6306196|NCT00002680|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6306197|NCT00002680|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6306198|NCT00002680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6306199|NCT00002680|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6306200|NCT00002680|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6306201|NCT00002680|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6306202|NCT00002680|Contraceptive Agents|contraceptive agents|mesh-ancestor
6306203|NCT00002680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6306204|NCT00002680|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6306205|NCT00002680|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6306206|NCT00002680|Appetite Stimulants|appetite stimulants|mesh-ancestor
6306207|NCT00002680|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6306208|NCT00002681|Aldesleukin|aldesleukin|mesh-list
6306209|NCT00002681|Daclizumab|daclizumab|mesh-list
6306210|NCT00002681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6306211|NCT00002681|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6306212|NCT00002681|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6306213|NCT00002681|Antiviral Agents|antiviral agents|mesh-ancestor
6306214|NCT00002681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6306215|NCT00002681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6306216|NCT00002681|Immunologic Factors|immunologic factors|mesh-ancestor
6306217|NCT00002681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6306218|NCT00002682|Amoxicillin|amoxicillin|mesh-list
6306219|NCT00002682|Metronidazole|metronidazole|mesh-list
6306220|NCT00002682|Clarithromycin|clarithromycin|mesh-list
6306221|NCT00002682|Tetracycline|tetracycline|mesh-list
6306222|NCT00002682|Omeprazole|omeprazole|mesh-list
6306223|NCT00002682|Bismuth|bismuth|mesh-list
6306224|NCT00002682|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
6306225|NCT00002682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6306226|NCT00002682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6306227|NCT00002682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6306228|NCT00002682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6306229|NCT00002682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6306230|NCT00002682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6306231|NCT00002682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6306232|NCT00002682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6306233|NCT00002682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6306234|NCT00002682|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6306235|NCT00002682|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6306236|NCT00002682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6306237|NCT00002682|Antacids|antacids|mesh-ancestor
6306238|NCT00002682|Antidiarrheals|antidiarrheals|mesh-ancestor
6306239|NCT00002684|Paclitaxel|paclitaxel|mesh-list
6306240|NCT00002684|Ifosfamide|ifosfamide|mesh-list
6306241|NCT00002684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6306242|NCT00002684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6306243|NCT00002684|Tubulin Modulators|tubulin modulators|mesh-ancestor
6306244|NCT00002684|Antimitotic Agents|antimitotic agents|mesh-ancestor
6306245|NCT00002684|Mitosis Modulators|mitosis modulators|mesh-ancestor
6306246|NCT00002684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6306247|NCT00002684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6306248|NCT00002684|Alkylating Agents|alkylating agents|mesh-ancestor
6306249|NCT00002687|Aldesleukin|aldesleukin|mesh-list
6306250|NCT00002687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6306251|NCT00002687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6306252|NCT00002687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6306253|NCT00002687|Antiviral Agents|antiviral agents|mesh-ancestor
6306254|NCT00002687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6306255|NCT00002688|Cyclosporine|cyclosporine|mesh-list
6306256|NCT00002688|Etoposide|etoposide|mesh-list
6306257|NCT00002688|Mitoxantrone|mitoxantrone|mesh-list
6306258|NCT00002688|Cyclosporins|cyclosporins|mesh-list
6306259|NCT00002688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6306260|NCT00002688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6306261|NCT00002688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6306262|NCT00002688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6306263|NCT00002688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6306264|NCT00002688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6306265|NCT00002688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6306266|NCT00002688|Immunologic Factors|immunologic factors|mesh-ancestor
6306267|NCT00002688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6306268|NCT00002688|Antifungal Agents|antifungal agents|mesh-ancestor
6306269|NCT00002688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6306270|NCT00002688|Dermatologic Agents|dermatologic agents|mesh-ancestor
6306271|NCT00002688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6306272|NCT00002688|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6306273|NCT00002688|Analgesics|analgesics|mesh-ancestor
6306274|NCT00002688|Sensory System Agents|sensory system agents|mesh-ancestor
6306275|NCT00002688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6306276|NCT00002689|Dexamethasone|dexamethasone|mesh-list
6306277|NCT00002689|Fluorouracil|fluorouracil|mesh-list
6306278|NCT00002689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6306279|NCT00002689|Antiemetics|antiemetics|mesh-ancestor
6306280|NCT00002689|Autonomic Agents|autonomic agents|mesh-ancestor
6306281|NCT00002689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6306282|NCT00002689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6306283|NCT00002689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6306284|NCT00002689|Glucocorticoids|glucocorticoids|mesh-ancestor
6306285|NCT00002689|Hormones|hormones|mesh-ancestor
6306286|NCT00002689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6306287|NCT00002689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6306288|NCT00002689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6306289|NCT00002689|Antimetabolites|antimetabolites|mesh-ancestor
6306290|NCT00002689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6306291|NCT00002689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6306292|NCT00002689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6306293|NCT00002689|Immunologic Factors|immunologic factors|mesh-ancestor
6306294|NCT00002691|Leucovorin|leucovorin|mesh-list
6306295|NCT00002691|Cytarabine|cytarabine|mesh-list
6306296|NCT00002691|Dexamethasone|dexamethasone|mesh-list
6306297|NCT00002691|Cyclophosphamide|cyclophosphamide|mesh-list
6306298|NCT00002691|Methotrexate|methotrexate|mesh-list
6306299|NCT00002691|Etoposide|etoposide|mesh-list
6306300|NCT00002691|Vincristine|vincristine|mesh-list
6306301|NCT00002691|Daunorubicin|daunorubicin|mesh-list
6306302|NCT00002691|Asparaginase|asparaginase|mesh-list
6306303|NCT00002691|Levoleucovorin|levoleucovorin|mesh-list
6306304|NCT00002691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6306305|NCT00002691|Immunologic Factors|immunologic factors|mesh-ancestor
6306306|NCT00002691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6306307|NCT00002691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6306308|NCT00002691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6306309|NCT00002691|Alkylating Agents|alkylating agents|mesh-ancestor
6306310|NCT00002691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6306311|NCT00002691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6306312|NCT00002691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6306313|NCT00002691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6306314|NCT00002691|Antiemetics|antiemetics|mesh-ancestor
6306315|NCT00002691|Autonomic Agents|autonomic agents|mesh-ancestor
6306316|NCT00002691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6306317|NCT00002691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6306318|NCT00002691|Glucocorticoids|glucocorticoids|mesh-ancestor
6306319|NCT00002691|Hormones|hormones|mesh-ancestor
6306320|NCT00002691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6306321|NCT00002691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6306322|NCT00002691|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6306323|NCT00002691|Abortifacient Agents|abortifacient agents|mesh-ancestor
6306324|NCT00002691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6306325|NCT00002691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6306326|NCT00002691|Antimetabolites|antimetabolites|mesh-ancestor
6306327|NCT00002691|Dermatologic Agents|dermatologic agents|mesh-ancestor
6306328|NCT00002691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6306329|NCT00002691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6306330|NCT00002691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6306331|NCT00002691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6306332|NCT00002691|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6306333|NCT00002691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6306334|NCT00002691|Antiviral Agents|antiviral agents|mesh-ancestor
6306335|NCT00002691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6306336|NCT00002691|Antidotes|antidotes|mesh-ancestor
6306337|NCT00002691|Protective Agents|protective agents|mesh-ancestor
6306338|NCT00002691|Vitamin B Complex|vitamin b complex|mesh-ancestor
6306339|NCT00002691|Vitamins|vitamins|mesh-ancestor
6306340|NCT00002691|Micronutrients|micronutrients|mesh-ancestor
6306341|NCT00002691|Tubulin Modulators|tubulin modulators|mesh-ancestor
6306342|NCT00002691|Antimitotic Agents|antimitotic agents|mesh-ancestor
6306343|NCT00002691|Mitosis Modulators|mitosis modulators|mesh-ancestor
6306344|NCT00002691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6306345|NCT00002692|Leucovorin|leucovorin|mesh-list
6306346|NCT00002692|Fluorouracil|fluorouracil|mesh-list
6306347|NCT00002692|Calcium|calcium|mesh-list
6306348|NCT00002692|Levoleucovorin|levoleucovorin|mesh-list
6306349|NCT00002692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6306350|NCT00002692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6306351|NCT00002692|Antimetabolites|antimetabolites|mesh-ancestor
6306352|NCT00002692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6306353|NCT00002692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6306354|NCT00002692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6306355|NCT00002692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6306356|NCT00002692|Immunologic Factors|immunologic factors|mesh-ancestor
6306357|NCT00002692|Antidotes|antidotes|mesh-ancestor
6306358|NCT00002692|Protective Agents|protective agents|mesh-ancestor
6306359|NCT00002692|Vitamin B Complex|vitamin b complex|mesh-ancestor
6306360|NCT00002692|Vitamins|vitamins|mesh-ancestor
6306361|NCT00002692|Micronutrients|micronutrients|mesh-ancestor
6306362|NCT00002693|Carboplatin|carboplatin|mesh-list
6306363|NCT00002693|Topotecan|topotecan|mesh-list
6306364|NCT00002693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6306365|NCT00002693|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6306366|NCT00002693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6306367|NCT00002693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6306368|NCT00002693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6306369|NCT00002696|Cyclophosphamide|cyclophosphamide|mesh-list
6306370|NCT00002696|Doxorubicin|doxorubicin|mesh-list
6306371|NCT00002696|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6306372|NCT00002696|Fluorouracil|fluorouracil|mesh-list
6306373|NCT00002696|Methotrexate|methotrexate|mesh-list
6306374|NCT00002696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6306375|NCT00002696|Immunologic Factors|immunologic factors|mesh-ancestor
6306376|NCT00002696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6306377|NCT00002696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6306378|NCT00002696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6306379|NCT00002696|Alkylating Agents|alkylating agents|mesh-ancestor
6392341|NCT00195871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6306380|NCT00002696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6306381|NCT00002696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6306382|NCT00002696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6306383|NCT00002696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6306384|NCT00002696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6306385|NCT00002696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6306386|NCT00002696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6306387|NCT00002696|Antimetabolites|antimetabolites|mesh-ancestor
6306388|NCT00002696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6306389|NCT00002696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6306390|NCT00002696|Abortifacient Agents|abortifacient agents|mesh-ancestor
6306391|NCT00002696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6306392|NCT00002696|Dermatologic Agents|dermatologic agents|mesh-ancestor
6306393|NCT00002696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6306394|NCT00002696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6306395|NCT00002697|Carboplatin|carboplatin|mesh-list
6306396|NCT00002697|Etoposide|etoposide|mesh-list
6306397|NCT00002697|Ifosfamide|ifosfamide|mesh-list
6306398|NCT00002697|Sargramostim|sargramostim|mesh-list
6306399|NCT00002697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6306400|NCT00002697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6306401|NCT00002697|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6306402|NCT00002697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6306403|NCT00002697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6306404|NCT00002697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6306405|NCT00002697|Immunologic Factors|immunologic factors|mesh-ancestor
6306406|NCT00002697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6306407|NCT00002697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6306408|NCT00002697|Alkylating Agents|alkylating agents|mesh-ancestor
6306409|NCT00002700|Leucovorin|leucovorin|mesh-list
6306410|NCT00002700|Cytarabine|cytarabine|mesh-list
6306411|NCT00002700|Dexamethasone|dexamethasone|mesh-list
6306412|NCT00002700|Prednisone|prednisone|mesh-list
6306413|NCT00002700|Prednisolone|prednisolone|mesh-list
6306414|NCT00002700|Hydrocortisone|hydrocortisone|mesh-list
6306415|NCT00002700|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6306416|NCT00002700|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6306417|NCT00002700|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6306418|NCT00002700|Cyclophosphamide|cyclophosphamide|mesh-list
6306419|NCT00002700|Doxorubicin|doxorubicin|mesh-list
6306420|NCT00002700|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6306421|NCT00002700|Methotrexate|methotrexate|mesh-list
6306422|NCT00002700|Vincristine|vincristine|mesh-list
6306423|NCT00002700|Daunorubicin|daunorubicin|mesh-list
6306424|NCT00002700|Asparaginase|asparaginase|mesh-list
6306425|NCT00002700|Mercaptopurine|mercaptopurine|mesh-list
6306426|NCT00002700|Mitoxantrone|mitoxantrone|mesh-list
6306427|NCT00002700|Levoleucovorin|levoleucovorin|mesh-list
6306428|NCT00002700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6306429|NCT00002700|Immunologic Factors|immunologic factors|mesh-ancestor
6306430|NCT00002700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6306431|NCT00002700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6306432|NCT00002700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6306433|NCT00002700|Alkylating Agents|alkylating agents|mesh-ancestor
6306434|NCT00002700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6306435|NCT00002700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6306436|NCT00002700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6306437|NCT00002700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6306438|NCT00002700|Antiemetics|antiemetics|mesh-ancestor
6306439|NCT00002700|Autonomic Agents|autonomic agents|mesh-ancestor
6306440|NCT00002700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6306441|NCT00002700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6306442|NCT00002700|Glucocorticoids|glucocorticoids|mesh-ancestor
6306443|NCT00002700|Hormones|hormones|mesh-ancestor
6306444|NCT00002700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6306445|NCT00002700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6306446|NCT00002700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6306447|NCT00002700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6306448|NCT00002700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6306449|NCT00002700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6306450|NCT00002700|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6306451|NCT00002700|Abortifacient Agents|abortifacient agents|mesh-ancestor
6306452|NCT00002700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6392342|NCT00195910|Morphine|morphine|mesh-list
6306453|NCT00002700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6306454|NCT00002700|Antimetabolites|antimetabolites|mesh-ancestor
6306455|NCT00002700|Dermatologic Agents|dermatologic agents|mesh-ancestor
6306456|NCT00002700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6306457|NCT00002700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6306458|NCT00002700|Antiviral Agents|antiviral agents|mesh-ancestor
6306459|NCT00002700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6306460|NCT00002700|Antidotes|antidotes|mesh-ancestor
6306461|NCT00002700|Protective Agents|protective agents|mesh-ancestor
6306462|NCT00002700|Vitamin B Complex|vitamin b complex|mesh-ancestor
6306463|NCT00002700|Vitamins|vitamins|mesh-ancestor
6306464|NCT00002700|Micronutrients|micronutrients|mesh-ancestor
6306465|NCT00002700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6306466|NCT00002700|Tubulin Modulators|tubulin modulators|mesh-ancestor
6306467|NCT00002700|Antimitotic Agents|antimitotic agents|mesh-ancestor
6306468|NCT00002700|Mitosis Modulators|mitosis modulators|mesh-ancestor
6306469|NCT00002700|Analgesics|analgesics|mesh-ancestor
6306470|NCT00002700|Sensory System Agents|sensory system agents|mesh-ancestor
6306471|NCT00002701|Cytarabine|cytarabine|mesh-list
6306472|NCT00002701|Cyclophosphamide|cyclophosphamide|mesh-list
6306473|NCT00002701|Busulfan|busulfan|mesh-list
6306474|NCT00002701|Methotrexate|methotrexate|mesh-list
6306475|NCT00002701|Etoposide|etoposide|mesh-list
6306476|NCT00002701|Mercaptopurine|mercaptopurine|mesh-list
6306477|NCT00002701|Mitoxantrone|mitoxantrone|mesh-list
6306478|NCT00002701|Idarubicin|idarubicin|mesh-list
6306479|NCT00002701|Tretinoin|tretinoin|mesh-list
6306480|NCT00002701|Thioguanine|thioguanine|mesh-list
6306481|NCT00002701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6306482|NCT00002701|Immunologic Factors|immunologic factors|mesh-ancestor
6306483|NCT00002701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6306484|NCT00002701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6306485|NCT00002701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6306486|NCT00002701|Alkylating Agents|alkylating agents|mesh-ancestor
6306487|NCT00002701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6306488|NCT00002701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6306489|NCT00002701|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6306490|NCT00002701|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6306491|NCT00002701|Abortifacient Agents|abortifacient agents|mesh-ancestor
6306492|NCT00002701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6306493|NCT00002701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6306494|NCT00002701|Antimetabolites|antimetabolites|mesh-ancestor
6306495|NCT00002701|Dermatologic Agents|dermatologic agents|mesh-ancestor
6306496|NCT00002701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6306497|NCT00002701|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6306498|NCT00002701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6306499|NCT00002701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6306500|NCT00002701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6306501|NCT00002701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6306502|NCT00002701|Antiviral Agents|antiviral agents|mesh-ancestor
6306503|NCT00002701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6306504|NCT00002701|Analgesics|analgesics|mesh-ancestor
6306505|NCT00002701|Sensory System Agents|sensory system agents|mesh-ancestor
6306506|NCT00002701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6306507|NCT00002701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6306508|NCT00002701|Keratolytic Agents|keratolytic agents|mesh-ancestor
6306509|NCT00002702|Aldesleukin|aldesleukin|mesh-list
6306510|NCT00002702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6306511|NCT00002702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6306512|NCT00002702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6306513|NCT00002702|Antiviral Agents|antiviral agents|mesh-ancestor
6306514|NCT00002702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6306515|NCT00002704|Leucovorin|leucovorin|mesh-list
6306516|NCT00002704|Cytarabine|cytarabine|mesh-list
6306517|NCT00002704|Dexamethasone|dexamethasone|mesh-list
6306518|NCT00002704|Hydrocortisone|hydrocortisone|mesh-list
6306519|NCT00002704|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6306520|NCT00002704|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6306521|NCT00002704|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6306522|NCT00002704|Cyclophosphamide|cyclophosphamide|mesh-list
6306523|NCT00002704|Thiotepa|thiotepa|mesh-list
6306524|NCT00002704|Methotrexate|methotrexate|mesh-list
6306525|NCT00002704|Etoposide|etoposide|mesh-list
6306526|NCT00002704|Vincristine|vincristine|mesh-list
6306527|NCT00002704|Daunorubicin|daunorubicin|mesh-list
6306528|NCT00002704|Asparaginase|asparaginase|mesh-list
6306529|NCT00002704|Mercaptopurine|mercaptopurine|mesh-list
6306530|NCT00002704|Levoleucovorin|levoleucovorin|mesh-list
6306531|NCT00002704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6306532|NCT00002704|Immunologic Factors|immunologic factors|mesh-ancestor
6306533|NCT00002704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6306534|NCT00002704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6306535|NCT00002704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6306536|NCT00002704|Alkylating Agents|alkylating agents|mesh-ancestor
6306537|NCT00002704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6306538|NCT00002704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6306539|NCT00002704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6306540|NCT00002704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6306541|NCT00002704|Antiemetics|antiemetics|mesh-ancestor
6306542|NCT00002704|Autonomic Agents|autonomic agents|mesh-ancestor
6306543|NCT00002704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6306544|NCT00002704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6306545|NCT00002704|Glucocorticoids|glucocorticoids|mesh-ancestor
6306546|NCT00002704|Hormones|hormones|mesh-ancestor
6306547|NCT00002704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6306548|NCT00002704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6306549|NCT00002704|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6306550|NCT00002704|Abortifacient Agents|abortifacient agents|mesh-ancestor
6306551|NCT00002704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6306552|NCT00002704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6306553|NCT00002704|Antimetabolites|antimetabolites|mesh-ancestor
6306554|NCT00002704|Dermatologic Agents|dermatologic agents|mesh-ancestor
6306555|NCT00002704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6306556|NCT00002704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6306557|NCT00002704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6306558|NCT00002704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6306559|NCT00002704|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6306560|NCT00002704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6306561|NCT00002704|Antiviral Agents|antiviral agents|mesh-ancestor
6306562|NCT00002704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6306563|NCT00002704|Antidotes|antidotes|mesh-ancestor
6306564|NCT00002704|Protective Agents|protective agents|mesh-ancestor
6306565|NCT00002704|Vitamin B Complex|vitamin b complex|mesh-ancestor
6306566|NCT00002704|Vitamins|vitamins|mesh-ancestor
6306567|NCT00002704|Micronutrients|micronutrients|mesh-ancestor
6306568|NCT00002704|Tubulin Modulators|tubulin modulators|mesh-ancestor
6306569|NCT00002704|Antimitotic Agents|antimitotic agents|mesh-ancestor
6306570|NCT00002704|Mitosis Modulators|mitosis modulators|mesh-ancestor
6306571|NCT00002704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6392343|NCT00195910|Hydromorphone|hydromorphone|mesh-list
6392344|NCT00195910|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6392345|NCT00195910|Narcotics|narcotics|mesh-ancestor
6392346|NCT00195910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6392347|NCT00195910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392348|NCT00195910|Analgesics|analgesics|mesh-ancestor
6392349|NCT00195910|Sensory System Agents|sensory system agents|mesh-ancestor
6392350|NCT00195910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6392351|NCT00195923|Clindamycin|clindamycin|mesh-list
6392352|NCT00195923|Clindamycin palmitate|clindamycin palmitate|mesh-list
6392353|NCT00195923|Clindamycin phosphate|clindamycin phosphate|mesh-list
6392354|NCT00195923|Gentamicins|gentamicins|mesh-list
6392355|NCT00195923|Ceftazidime|ceftazidime|mesh-list
6392356|NCT00195923|Ampicillin|ampicillin|mesh-list
6392357|NCT00195923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6392358|NCT00195923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6392359|NCT00195923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6392360|NCT00195923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6392361|NCT00195923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392362|NCT00195936|Cinacalcet|cinacalcet|mesh-list
6392363|NCT00195936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6392364|NCT00195936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392365|NCT00195936|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6392366|NCT00195936|Hormone Antagonists|hormone antagonists|mesh-ancestor
6392367|NCT00195936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6392368|NCT00195988|Mycophenolic Acid|mycophenolic acid|mesh-list
6392369|NCT00195988|Tacrolimus|tacrolimus|mesh-list
6392370|NCT00195988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6306572|NCT00002705|Topotecan|topotecan|mesh-list
6306573|NCT00002705|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6306574|NCT00002705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6306575|NCT00002705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6306576|NCT00002705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6306577|NCT00002705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6306578|NCT00002707|Tamoxifen|tamoxifen|mesh-list
6306579|NCT00002707|Cyclophosphamide|cyclophosphamide|mesh-list
6306580|NCT00002707|Docetaxel|docetaxel|mesh-list
6306581|NCT00002707|Doxorubicin|doxorubicin|mesh-list
6306582|NCT00002707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6306583|NCT00002707|Immunologic Factors|immunologic factors|mesh-ancestor
6306584|NCT00002707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6306585|NCT00002707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6306586|NCT00002707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6306587|NCT00002707|Alkylating Agents|alkylating agents|mesh-ancestor
6306588|NCT00002707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6306589|NCT00002707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6306590|NCT00002707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6306591|NCT00002707|Tubulin Modulators|tubulin modulators|mesh-ancestor
6306592|NCT00002707|Antimitotic Agents|antimitotic agents|mesh-ancestor
6306593|NCT00002707|Mitosis Modulators|mitosis modulators|mesh-ancestor
6306594|NCT00002707|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6306595|NCT00002707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6306596|NCT00002707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6306597|NCT00002707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6306598|NCT00002707|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6306599|NCT00002707|Hormone Antagonists|hormone antagonists|mesh-ancestor
6306600|NCT00002707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6306601|NCT00002707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6306602|NCT00002707|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6306603|NCT00002707|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6306604|NCT00002707|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6306605|NCT00002711|Paclitaxel|paclitaxel|mesh-list
6306606|NCT00002711|Cisplatin|cisplatin|mesh-list
6306607|NCT00002711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6306608|NCT00002711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6306609|NCT00002711|Tubulin Modulators|tubulin modulators|mesh-ancestor
6306610|NCT00002711|Antimitotic Agents|antimitotic agents|mesh-ancestor
6306611|NCT00002711|Mitosis Modulators|mitosis modulators|mesh-ancestor
6306612|NCT00002711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6306613|NCT00002714|Prednisone|prednisone|mesh-list
6306614|NCT00002714|Doxorubicin|doxorubicin|mesh-list
6306615|NCT00002714|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6306616|NCT00002714|Bleomycin|bleomycin|mesh-list
6306617|NCT00002714|Etoposide|etoposide|mesh-list
6306618|NCT00002714|Vincristine|vincristine|mesh-list
6306619|NCT00002714|Vinblastine|vinblastine|mesh-list
6306620|NCT00002714|Mechlorethamine|mechlorethamine|mesh-list
6306621|NCT00002714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6306622|NCT00002714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6306623|NCT00002714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6306624|NCT00002714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6306625|NCT00002714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6306626|NCT00002714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6306627|NCT00002714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6306628|NCT00002714|Glucocorticoids|glucocorticoids|mesh-ancestor
6306629|NCT00002714|Hormones|hormones|mesh-ancestor
6306630|NCT00002714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6306631|NCT00002714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6306632|NCT00002714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6306633|NCT00002714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6306634|NCT00002714|Tubulin Modulators|tubulin modulators|mesh-ancestor
6306635|NCT00002714|Antimitotic Agents|antimitotic agents|mesh-ancestor
6306636|NCT00002714|Mitosis Modulators|mitosis modulators|mesh-ancestor
6306637|NCT00002714|Alkylating Agents|alkylating agents|mesh-ancestor
6306638|NCT00002714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6306639|NCT00002715|Prednisone|prednisone|mesh-list
6306640|NCT00002715|Doxorubicin|doxorubicin|mesh-list
6306641|NCT00002715|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6306642|NCT00002715|Bleomycin|bleomycin|mesh-list
6306643|NCT00002715|Etoposide|etoposide|mesh-list
6306644|NCT00002715|Vincristine|vincristine|mesh-list
6306645|NCT00002715|Vinblastine|vinblastine|mesh-list
6306646|NCT00002715|Mechlorethamine|mechlorethamine|mesh-list
6306647|NCT00002715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6306648|NCT00002715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6306649|NCT00002715|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6306650|NCT00002715|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6306651|NCT00002715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6306652|NCT00002715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6306653|NCT00002715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6306654|NCT00002715|Glucocorticoids|glucocorticoids|mesh-ancestor
6306655|NCT00002715|Hormones|hormones|mesh-ancestor
6306656|NCT00002715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6306657|NCT00002715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6306658|NCT00002715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6306659|NCT00002715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6306660|NCT00002715|Tubulin Modulators|tubulin modulators|mesh-ancestor
6306661|NCT00002715|Antimitotic Agents|antimitotic agents|mesh-ancestor
6306662|NCT00002715|Mitosis Modulators|mitosis modulators|mesh-ancestor
6306663|NCT00002715|Alkylating Agents|alkylating agents|mesh-ancestor
6306664|NCT00002715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6306665|NCT00002716|Leucovorin|leucovorin|mesh-list
6306666|NCT00002716|Dexamethasone|dexamethasone|mesh-list
6306667|NCT00002716|Fluorouracil|fluorouracil|mesh-list
6306668|NCT00002716|Floxuridine|floxuridine|mesh-list
6306669|NCT00002716|Calcium|calcium|mesh-list
6306670|NCT00002716|Levoleucovorin|levoleucovorin|mesh-list
6306671|NCT00002716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6306672|NCT00002716|Antiemetics|antiemetics|mesh-ancestor
6306673|NCT00002716|Autonomic Agents|autonomic agents|mesh-ancestor
6306674|NCT00002716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6306675|NCT00002716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6306676|NCT00002716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6306677|NCT00002716|Glucocorticoids|glucocorticoids|mesh-ancestor
6306678|NCT00002716|Hormones|hormones|mesh-ancestor
6306679|NCT00002716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6306680|NCT00002716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6306681|NCT00002716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6306682|NCT00002716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6306683|NCT00002716|Antimetabolites|antimetabolites|mesh-ancestor
6306684|NCT00002716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6306685|NCT00002716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6306686|NCT00002716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6306687|NCT00002716|Immunologic Factors|immunologic factors|mesh-ancestor
6306688|NCT00002716|Antidotes|antidotes|mesh-ancestor
6306689|NCT00002716|Protective Agents|protective agents|mesh-ancestor
6306690|NCT00002716|Vitamin B Complex|vitamin b complex|mesh-ancestor
6306691|NCT00002716|Vitamins|vitamins|mesh-ancestor
6306692|NCT00002716|Micronutrients|micronutrients|mesh-ancestor
6306693|NCT00002717|Paclitaxel|paclitaxel|mesh-list
6306694|NCT00002717|Cisplatin|cisplatin|mesh-list
6306695|NCT00002717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6306696|NCT00002717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6306697|NCT00002717|Tubulin Modulators|tubulin modulators|mesh-ancestor
6306698|NCT00002717|Antimitotic Agents|antimitotic agents|mesh-ancestor
6306699|NCT00002717|Mitosis Modulators|mitosis modulators|mesh-ancestor
6306700|NCT00002717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6306701|NCT00002718|Cytarabine|cytarabine|mesh-list
6306702|NCT00002718|Methylprednisolone|methylprednisolone|mesh-list
6306703|NCT00002718|Cyclophosphamide|cyclophosphamide|mesh-list
6306704|NCT00002718|Thiotepa|thiotepa|mesh-list
6306705|NCT00002718|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6306706|NCT00002718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6306707|NCT00002718|Immunologic Factors|immunologic factors|mesh-ancestor
6306708|NCT00002718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6306709|NCT00002718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6306710|NCT00002718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6306711|NCT00002718|Alkylating Agents|alkylating agents|mesh-ancestor
6306712|NCT00002718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6306713|NCT00002718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6306714|NCT00002718|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6306715|NCT00002718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6306716|NCT00002718|Antimetabolites|antimetabolites|mesh-ancestor
6306717|NCT00002718|Antiviral Agents|antiviral agents|mesh-ancestor
6306718|NCT00002718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6306719|NCT00002718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6306720|NCT00002718|Antiemetics|antiemetics|mesh-ancestor
6306721|NCT00002718|Autonomic Agents|autonomic agents|mesh-ancestor
6306722|NCT00002718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6306723|NCT00002718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6306724|NCT00002718|Glucocorticoids|glucocorticoids|mesh-ancestor
6306725|NCT00002718|Hormones|hormones|mesh-ancestor
6306726|NCT00002718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6306727|NCT00002718|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6306728|NCT00002718|Protective Agents|protective agents|mesh-ancestor
6306729|NCT00002719|Cytarabine|cytarabine|mesh-list
6306730|NCT00002719|Etoposide|etoposide|mesh-list
6306731|NCT00002719|Mitoxantrone|mitoxantrone|mesh-list
6306732|NCT00002719|Idarubicin|idarubicin|mesh-list
6306733|NCT00002719|Carmustine|carmustine|mesh-list
6306734|NCT00002719|Amsacrine|amsacrine|mesh-list
6306735|NCT00002719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6306736|NCT00002719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6306737|NCT00002719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6306738|NCT00002719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6306739|NCT00002719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6306740|NCT00002719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6306741|NCT00002719|Immunologic Factors|immunologic factors|mesh-ancestor
6306742|NCT00002719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6306743|NCT00002719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6306744|NCT00002719|Antimetabolites|antimetabolites|mesh-ancestor
6306745|NCT00002719|Antiviral Agents|antiviral agents|mesh-ancestor
6306746|NCT00002719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6306747|NCT00002719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6306748|NCT00002719|Analgesics|analgesics|mesh-ancestor
6306749|NCT00002719|Sensory System Agents|sensory system agents|mesh-ancestor
6306750|NCT00002719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6306751|NCT00002719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6306752|NCT00002719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6306753|NCT00002719|Alkylating Agents|alkylating agents|mesh-ancestor
6306754|NCT00002720|Tamoxifen|tamoxifen|mesh-list
6306755|NCT00002720|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6306756|NCT00002720|Hormone Antagonists|hormone antagonists|mesh-ancestor
6306757|NCT00002720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6306758|NCT00002720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6306759|NCT00002720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6306760|NCT00002720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6015961|NCT00361218|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6015962|NCT00361231|Gemcitabine|gemcitabine|mesh-list
6015963|NCT00361231|Bevacizumab|bevacizumab|mesh-list
6015964|NCT00361231|Oxaliplatin|oxaliplatin|mesh-list
6015965|NCT00361231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6015966|NCT00361231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6306761|NCT00002720|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6306762|NCT00002720|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6306763|NCT00002720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6306764|NCT00002721|Doxorubicin|doxorubicin|mesh-list
6306765|NCT00002721|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6015967|NCT00361231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6306766|NCT00002721|Estramustine|estramustine|mesh-list
6015968|NCT00361231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6015969|NCT00361231|Growth Substances|growth substances|mesh-ancestor
6306767|NCT00002721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6306768|NCT00002721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6306769|NCT00002721|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6306770|NCT00002721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6306771|NCT00002721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6306772|NCT00002721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6306773|NCT00002721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6306774|NCT00002721|Alkylating Agents|alkylating agents|mesh-ancestor
6306775|NCT00002721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6306776|NCT00002722|Leucovorin|leucovorin|mesh-list
6306777|NCT00002722|Fluorouracil|fluorouracil|mesh-list
6306778|NCT00002722|Calcium|calcium|mesh-list
6306779|NCT00002722|Levoleucovorin|levoleucovorin|mesh-list
6306780|NCT00002722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6306781|NCT00002722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6306782|NCT00002722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6306783|NCT00002722|Antimetabolites|antimetabolites|mesh-ancestor
6306784|NCT00002722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6306785|NCT00002722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6306786|NCT00002722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6306787|NCT00002722|Immunologic Factors|immunologic factors|mesh-ancestor
6306788|NCT00002722|Antidotes|antidotes|mesh-ancestor
6306789|NCT00002722|Protective Agents|protective agents|mesh-ancestor
6306790|NCT00002722|Vitamin B Complex|vitamin b complex|mesh-ancestor
6306791|NCT00002722|Vitamins|vitamins|mesh-ancestor
6306792|NCT00002722|Micronutrients|micronutrients|mesh-ancestor
6306793|NCT00002723|Suramin|suramin|mesh-list
6306794|NCT00002723|Antinematodal Agents|antinematodal agents|mesh-ancestor
6306795|NCT00002723|Anthelmintics|anthelmintics|mesh-ancestor
6306796|NCT00002723|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6306797|NCT00002723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6306798|NCT00002723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6306799|NCT00002723|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6306800|NCT00002723|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6306801|NCT00002725|Bryostatin 1|bryostatin 1|mesh-list
6306802|NCT00002725|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6306803|NCT00002725|Immunologic Factors|immunologic factors|mesh-ancestor
6306804|NCT00002725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6306805|NCT00002725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6306806|NCT00002730|Melphalan|melphalan|mesh-list
6306807|NCT00002730|Buthionine Sulfoximine|buthionine sulfoximine|mesh-list
6306808|NCT00002730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6306809|NCT00002730|Alkylating Agents|alkylating agents|mesh-ancestor
6306810|NCT00002730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6306811|NCT00002730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6306812|NCT00002730|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6306813|NCT00002730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6306814|NCT00002730|Immunologic Factors|immunologic factors|mesh-ancestor
6306815|NCT00002730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6306816|NCT00002730|Antimetabolites|antimetabolites|mesh-ancestor
6306817|NCT00002730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6306818|NCT00002730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6392371|NCT00195988|Immunologic Factors|immunologic factors|mesh-ancestor
6306819|NCT00002730|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6306820|NCT00002730|Protective Agents|protective agents|mesh-ancestor
6306821|NCT00002733|Interferons|interferons|mesh-list
6306822|NCT00002733|Interferon-alpha|interferon-alpha|mesh-list
6306823|NCT00002733|Aldesleukin|aldesleukin|mesh-list
6306824|NCT00002733|Cimetidine|cimetidine|mesh-list
6306825|NCT00002733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6306826|NCT00002733|Antiviral Agents|antiviral agents|mesh-ancestor
6306827|NCT00002733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6306828|NCT00002733|Immunologic Factors|immunologic factors|mesh-ancestor
6306829|NCT00002733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6306830|NCT00002733|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6306831|NCT00002733|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6306832|NCT00002733|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6306833|NCT00002733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6306834|NCT00002733|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6306835|NCT00002733|Histamine Antagonists|histamine antagonists|mesh-ancestor
6306836|NCT00002733|Histamine Agents|histamine agents|mesh-ancestor
6306837|NCT00002733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6306838|NCT00002733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6306839|NCT00002733|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6306840|NCT00002733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6306841|NCT00002733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6306842|NCT00002734|Interferons|interferons|mesh-list
6306843|NCT00002734|Interferon-alpha|interferon-alpha|mesh-list
6306844|NCT00002734|Paclitaxel|paclitaxel|mesh-list
6306845|NCT00002734|Topotecan|topotecan|mesh-list
6306846|NCT00002734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6306847|NCT00002734|Antibodies|antibodies|mesh-list
6306848|NCT00002734|Immunoglobulins|immunoglobulins|mesh-list
6306849|NCT00002734|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6306850|NCT00002734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6306851|NCT00002734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6306852|NCT00002734|Tubulin Modulators|tubulin modulators|mesh-ancestor
6306853|NCT00002734|Antimitotic Agents|antimitotic agents|mesh-ancestor
6306854|NCT00002734|Mitosis Modulators|mitosis modulators|mesh-ancestor
6306855|NCT00002734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6306856|NCT00002734|Immunologic Factors|immunologic factors|mesh-ancestor
6306857|NCT00002734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6306858|NCT00002734|Antiviral Agents|antiviral agents|mesh-ancestor
6306859|NCT00002734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6306860|NCT00002734|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6306861|NCT00002734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6306862|NCT00002734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6306863|NCT00002735|Cobalt|cobalt|mesh-list
6306864|NCT00002735|Cisplatin|cisplatin|mesh-list
6306865|NCT00002735|Fluorouracil|fluorouracil|mesh-list
6306866|NCT00002735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6306867|NCT00002735|Antimetabolites|antimetabolites|mesh-ancestor
6306868|NCT00002735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6306869|NCT00002735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6306870|NCT00002735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6306871|NCT00002735|Immunologic Factors|immunologic factors|mesh-ancestor
6306872|NCT00002735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6306873|NCT00002735|Trace Elements|trace elements|mesh-ancestor
6306874|NCT00002735|Micronutrients|micronutrients|mesh-ancestor
6306875|NCT00002737|Interferons|interferons|mesh-list
6306876|NCT00002737|Interferon-alpha|interferon-alpha|mesh-list
6306877|NCT00002737|Isotretinoin|isotretinoin|mesh-list
6306878|NCT00002737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6306879|NCT00002737|Antiviral Agents|antiviral agents|mesh-ancestor
6306880|NCT00002737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6306881|NCT00002737|Immunologic Factors|immunologic factors|mesh-ancestor
6306882|NCT00002737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6306883|NCT00002737|Dermatologic Agents|dermatologic agents|mesh-ancestor
6306884|NCT00002738|Leucovorin|leucovorin|mesh-list
6306885|NCT00002738|Trimetrexate|trimetrexate|mesh-list
6306886|NCT00002738|Calcium|calcium|mesh-list
6306887|NCT00002738|Levoleucovorin|levoleucovorin|mesh-list
6538072|NCT00825591|Antioxidants|antioxidants|mesh-ancestor
6306888|NCT00002738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6306889|NCT00002738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6306890|NCT00002738|Antidotes|antidotes|mesh-ancestor
6306891|NCT00002738|Protective Agents|protective agents|mesh-ancestor
6306892|NCT00002738|Vitamin B Complex|vitamin b complex|mesh-ancestor
6306893|NCT00002738|Vitamins|vitamins|mesh-ancestor
6306894|NCT00002738|Micronutrients|micronutrients|mesh-ancestor
6306895|NCT00002738|Antifungal Agents|antifungal agents|mesh-ancestor
6306896|NCT00002738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6306897|NCT00002738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6306898|NCT00002738|Antimetabolites|antimetabolites|mesh-ancestor
6306899|NCT00002738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6306900|NCT00002738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6306901|NCT00002738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6306902|NCT00002738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6306903|NCT00002740|Cobalt|cobalt|mesh-list
6306904|NCT00002740|Cyclophosphamide|cyclophosphamide|mesh-list
6306905|NCT00002740|Carboplatin|carboplatin|mesh-list
6306906|NCT00002740|Doxorubicin|doxorubicin|mesh-list
6306907|NCT00002740|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6306908|NCT00002740|Etoposide|etoposide|mesh-list
6306909|NCT00002740|Vincristine|vincristine|mesh-list
6306910|NCT00002740|Lenograstim|lenograstim|mesh-list
6306911|NCT00002740|Mesna|mesna|mesh-list
6306912|NCT00002740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6306913|NCT00002740|Immunologic Factors|immunologic factors|mesh-ancestor
6306914|NCT00002740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6306915|NCT00002740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6306916|NCT00002740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6306917|NCT00002740|Alkylating Agents|alkylating agents|mesh-ancestor
6306918|NCT00002740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6306919|NCT00002740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6306920|NCT00002740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6306921|NCT00002740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6306922|NCT00002740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6306923|NCT00002740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6306924|NCT00002740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6306925|NCT00002740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6306926|NCT00002740|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6306927|NCT00002740|Tubulin Modulators|tubulin modulators|mesh-ancestor
6306928|NCT00002740|Antimitotic Agents|antimitotic agents|mesh-ancestor
6306929|NCT00002740|Mitosis Modulators|mitosis modulators|mesh-ancestor
6306930|NCT00002740|Protective Agents|protective agents|mesh-ancestor
6306931|NCT00002740|Trace Elements|trace elements|mesh-ancestor
6306932|NCT00002740|Micronutrients|micronutrients|mesh-ancestor
6306933|NCT00002742|Amphotericin B|amphotericin b|mesh-list
6306934|NCT00002742|Nystatin|nystatin|mesh-list
6306935|NCT00002742|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6306936|NCT00002742|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
6306937|NCT00002742|Deoxycholic Acid|deoxycholic acid|mesh-list
6306938|NCT00002742|Amebicides|amebicides|mesh-ancestor
6306939|NCT00002742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6306940|NCT00002742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6306941|NCT00002742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6306942|NCT00002742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6306943|NCT00002742|Antifungal Agents|antifungal agents|mesh-ancestor
6306944|NCT00002742|Ionophores|ionophores|mesh-ancestor
6306945|NCT00002742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6306946|NCT00002742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6306947|NCT00002742|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6306948|NCT00002742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6306949|NCT00002744|Cobalt|cobalt|mesh-list
6306950|NCT00002744|Cytarabine|cytarabine|mesh-list
6306951|NCT00002744|Dexamethasone|dexamethasone|mesh-list
6306952|NCT00002744|Prednisone|prednisone|mesh-list
6306953|NCT00002744|Hydrocortisone|hydrocortisone|mesh-list
6306954|NCT00002744|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6306955|NCT00002744|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6306956|NCT00002744|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6306957|NCT00002744|Cyclophosphamide|cyclophosphamide|mesh-list
6306958|NCT00002744|Doxorubicin|doxorubicin|mesh-list
6306959|NCT00002744|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6306960|NCT00002744|Methotrexate|methotrexate|mesh-list
6306961|NCT00002744|Vincristine|vincristine|mesh-list
6306962|NCT00002744|Daunorubicin|daunorubicin|mesh-list
6306963|NCT00002744|Asparaginase|asparaginase|mesh-list
6306964|NCT00002744|Mercaptopurine|mercaptopurine|mesh-list
6306965|NCT00002744|Pegaspargase|pegaspargase|mesh-list
6306966|NCT00002744|Thioguanine|thioguanine|mesh-list
6306967|NCT00002744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6306968|NCT00002744|Immunologic Factors|immunologic factors|mesh-ancestor
6306969|NCT00002744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6306970|NCT00002744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6306971|NCT00002744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6306972|NCT00002744|Alkylating Agents|alkylating agents|mesh-ancestor
6306973|NCT00002744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6306974|NCT00002744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6306975|NCT00002744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6306976|NCT00002744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6306977|NCT00002744|Antiemetics|antiemetics|mesh-ancestor
6306978|NCT00002744|Autonomic Agents|autonomic agents|mesh-ancestor
6306979|NCT00002744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6306980|NCT00002744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6306981|NCT00002744|Glucocorticoids|glucocorticoids|mesh-ancestor
6306982|NCT00002744|Hormones|hormones|mesh-ancestor
6306983|NCT00002744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6306984|NCT00002744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6306985|NCT00002744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6306986|NCT00002744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6306987|NCT00002744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6306988|NCT00002744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6306989|NCT00002744|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6306990|NCT00002744|Abortifacient Agents|abortifacient agents|mesh-ancestor
6306991|NCT00002744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6306992|NCT00002744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6306993|NCT00002744|Antimetabolites|antimetabolites|mesh-ancestor
6306994|NCT00002744|Dermatologic Agents|dermatologic agents|mesh-ancestor
6306995|NCT00002744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6306996|NCT00002744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6306997|NCT00002744|Antiviral Agents|antiviral agents|mesh-ancestor
6306998|NCT00002744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6306999|NCT00002744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6307000|NCT00002744|Tubulin Modulators|tubulin modulators|mesh-ancestor
6307001|NCT00002744|Antimitotic Agents|antimitotic agents|mesh-ancestor
6307002|NCT00002744|Mitosis Modulators|mitosis modulators|mesh-ancestor
6307003|NCT00002744|Trace Elements|trace elements|mesh-ancestor
6307004|NCT00002744|Micronutrients|micronutrients|mesh-ancestor
6307005|NCT00002746|Aldesleukin|aldesleukin|mesh-list
6307006|NCT00002746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6307007|NCT00002746|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6307008|NCT00002746|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6307009|NCT00002746|Antiviral Agents|antiviral agents|mesh-ancestor
6307010|NCT00002746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6307011|NCT00002747|Cobalt|cobalt|mesh-list
6307012|NCT00002747|Fluorouracil|fluorouracil|mesh-list
6307013|NCT00002747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6307014|NCT00002747|Antimetabolites|antimetabolites|mesh-ancestor
6307015|NCT00002747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6307016|NCT00002747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6307017|NCT00002747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6307018|NCT00002747|Immunologic Factors|immunologic factors|mesh-ancestor
6307019|NCT00002747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6307020|NCT00002747|Trace Elements|trace elements|mesh-ancestor
6307021|NCT00002747|Micronutrients|micronutrients|mesh-ancestor
6307022|NCT00002748|Interleukin-2|interleukin-2|mesh-list
6307023|NCT00002748|Vaccines|vaccines|mesh-list
6307024|NCT00002748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6307025|NCT00002748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6307026|NCT00002748|Analgesics|analgesics|mesh-ancestor
6307027|NCT00002748|Sensory System Agents|sensory system agents|mesh-ancestor
6307028|NCT00002748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6307029|NCT00002748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6307030|NCT00002748|Immunologic Factors|immunologic factors|mesh-ancestor
6307031|NCT00002749|Carboplatin|carboplatin|mesh-list
6307032|NCT00002749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6307033|NCT00002750|Melphalan|melphalan|mesh-list
6307034|NCT00002750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6307035|NCT00002750|Alkylating Agents|alkylating agents|mesh-ancestor
6307036|NCT00002750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6307037|NCT00002750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6307038|NCT00002750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6307039|NCT00002750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6307040|NCT00002750|Immunologic Factors|immunologic factors|mesh-ancestor
6307041|NCT00002750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6307042|NCT00002751|Antibodies|antibodies|mesh-list
6307043|NCT00002751|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6307044|NCT00002751|Immunologic Factors|immunologic factors|mesh-ancestor
6307045|NCT00002751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6307046|NCT00002752|Antibodies|antibodies|mesh-list
6307047|NCT00002752|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6307048|NCT00002752|Immunologic Factors|immunologic factors|mesh-ancestor
6307049|NCT00002752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6307050|NCT00002753|Antibodies|antibodies|mesh-list
6307051|NCT00002753|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6307052|NCT00002753|Immunologic Factors|immunologic factors|mesh-ancestor
6307053|NCT00002753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6307054|NCT00002754|Antibodies|antibodies|mesh-list
6307055|NCT00002754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6307056|NCT00002754|Immunologic Factors|immunologic factors|mesh-ancestor
6307057|NCT00002754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6307058|NCT00002755|Tamoxifen|tamoxifen|mesh-list
6307059|NCT00002755|Cobalt|cobalt|mesh-list
6307060|NCT00002755|Cyclophosphamide|cyclophosphamide|mesh-list
6307061|NCT00002755|Thiotepa|thiotepa|mesh-list
6307062|NCT00002755|Doxorubicin|doxorubicin|mesh-list
6307063|NCT00002755|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6307064|NCT00002755|Fluorouracil|fluorouracil|mesh-list
6307065|NCT00002755|Methotrexate|methotrexate|mesh-list
6307066|NCT00002755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6307067|NCT00002755|Immunologic Factors|immunologic factors|mesh-ancestor
6307068|NCT00002755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6307069|NCT00002755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6307070|NCT00002755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6307071|NCT00002755|Alkylating Agents|alkylating agents|mesh-ancestor
6307072|NCT00002755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6307073|NCT00002755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6307074|NCT00002755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6307075|NCT00002755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6307076|NCT00002755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6307077|NCT00002755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6307078|NCT00002755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6307079|NCT00002755|Antimetabolites|antimetabolites|mesh-ancestor
6307080|NCT00002755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6307081|NCT00002755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6307082|NCT00002755|Abortifacient Agents|abortifacient agents|mesh-ancestor
6307083|NCT00002755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6307084|NCT00002755|Dermatologic Agents|dermatologic agents|mesh-ancestor
6307085|NCT00002755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6307086|NCT00002755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6307087|NCT00002755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6307088|NCT00002755|Hormone Antagonists|hormone antagonists|mesh-ancestor
6307089|NCT00002755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6307090|NCT00002755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6307091|NCT00002755|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6307092|NCT00002755|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6307093|NCT00002755|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6307094|NCT00002755|Trace Elements|trace elements|mesh-ancestor
6307095|NCT00002755|Micronutrients|micronutrients|mesh-ancestor
6307096|NCT00002756|Leucovorin|leucovorin|mesh-list
6307097|NCT00002756|Cytarabine|cytarabine|mesh-list
6307098|NCT00002756|Prednisone|prednisone|mesh-list
6307099|NCT00002756|Hydrocortisone|hydrocortisone|mesh-list
6307100|NCT00002756|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6307101|NCT00002756|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6307102|NCT00002756|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6307103|NCT00002756|Cyclophosphamide|cyclophosphamide|mesh-list
6307104|NCT00002756|Methotrexate|methotrexate|mesh-list
6307105|NCT00002756|Etoposide|etoposide|mesh-list
6307106|NCT00002756|Vincristine|vincristine|mesh-list
6307107|NCT00002756|Daunorubicin|daunorubicin|mesh-list
6307108|NCT00002756|Asparaginase|asparaginase|mesh-list
6307109|NCT00002756|Mercaptopurine|mercaptopurine|mesh-list
6307110|NCT00002756|Levoleucovorin|levoleucovorin|mesh-list
6307111|NCT00002756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6307112|NCT00002756|Immunologic Factors|immunologic factors|mesh-ancestor
6307113|NCT00002756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6307114|NCT00002756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6307115|NCT00002756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6307116|NCT00002756|Alkylating Agents|alkylating agents|mesh-ancestor
6307117|NCT00002756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6307118|NCT00002756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6307119|NCT00002756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6307120|NCT00002756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6307121|NCT00002756|Glucocorticoids|glucocorticoids|mesh-ancestor
6307122|NCT00002756|Hormones|hormones|mesh-ancestor
6307123|NCT00002756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6307124|NCT00002756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6307125|NCT00002756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6307126|NCT00002756|Abortifacient Agents|abortifacient agents|mesh-ancestor
6307127|NCT00002756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6307128|NCT00002756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6307129|NCT00002756|Antimetabolites|antimetabolites|mesh-ancestor
6307130|NCT00002756|Dermatologic Agents|dermatologic agents|mesh-ancestor
6307131|NCT00002756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6307132|NCT00002756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6307133|NCT00002756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6307134|NCT00002756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6307135|NCT00002756|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6307136|NCT00002756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6307137|NCT00002756|Antiviral Agents|antiviral agents|mesh-ancestor
6307138|NCT00002756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6307139|NCT00002756|Antidotes|antidotes|mesh-ancestor
6307140|NCT00002756|Protective Agents|protective agents|mesh-ancestor
6307141|NCT00002756|Vitamin B Complex|vitamin b complex|mesh-ancestor
6307142|NCT00002756|Vitamins|vitamins|mesh-ancestor
6307143|NCT00002756|Micronutrients|micronutrients|mesh-ancestor
6307144|NCT00002756|Tubulin Modulators|tubulin modulators|mesh-ancestor
6307145|NCT00002756|Antimitotic Agents|antimitotic agents|mesh-ancestor
6307146|NCT00002756|Mitosis Modulators|mitosis modulators|mesh-ancestor
6307147|NCT00002756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6307148|NCT00002757|Cytarabine|cytarabine|mesh-list
6307149|NCT00002757|Prednisone|prednisone|mesh-list
6307150|NCT00002757|Prednisolone|prednisolone|mesh-list
6307151|NCT00002757|Hydrocortisone|hydrocortisone|mesh-list
6307152|NCT00002757|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6307153|NCT00002757|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6307154|NCT00002757|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6307155|NCT00002757|Cyclophosphamide|cyclophosphamide|mesh-list
6307156|NCT00002757|Doxorubicin|doxorubicin|mesh-list
6307157|NCT00002757|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6307158|NCT00002757|Methotrexate|methotrexate|mesh-list
6307159|NCT00002757|Etoposide|etoposide|mesh-list
6307160|NCT00002757|Vincristine|vincristine|mesh-list
6307161|NCT00002757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6307162|NCT00002757|Immunologic Factors|immunologic factors|mesh-ancestor
6307163|NCT00002757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6307164|NCT00002757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6307165|NCT00002757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6307166|NCT00002757|Alkylating Agents|alkylating agents|mesh-ancestor
6307167|NCT00002757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6307168|NCT00002757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6307169|NCT00002757|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6307170|NCT00002757|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6307171|NCT00002757|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6307172|NCT00002757|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6307173|NCT00002757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6307174|NCT00002757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6307175|NCT00002757|Glucocorticoids|glucocorticoids|mesh-ancestor
6307176|NCT00002757|Hormones|hormones|mesh-ancestor
6307177|NCT00002757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6307178|NCT00002757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6307179|NCT00002757|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6307180|NCT00002757|Abortifacient Agents|abortifacient agents|mesh-ancestor
6307181|NCT00002757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6307182|NCT00002757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6307183|NCT00002757|Antimetabolites|antimetabolites|mesh-ancestor
6307184|NCT00002757|Dermatologic Agents|dermatologic agents|mesh-ancestor
6307185|NCT00002757|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6307186|NCT00002757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6307187|NCT00002757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6307188|NCT00002757|Antiviral Agents|antiviral agents|mesh-ancestor
6307189|NCT00002757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6307190|NCT00002757|Tubulin Modulators|tubulin modulators|mesh-ancestor
6307191|NCT00002757|Antimitotic Agents|antimitotic agents|mesh-ancestor
6307192|NCT00002757|Mitosis Modulators|mitosis modulators|mesh-ancestor
6307193|NCT00002759|Cyclosporine|cyclosporine|mesh-list
6307194|NCT00002759|Irinotecan|irinotecan|mesh-list
6307195|NCT00002759|Phenobarbital|phenobarbital|mesh-list
6307196|NCT00002759|Cyclosporins|cyclosporins|mesh-list
6307197|NCT00002759|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6307198|NCT00002759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6307199|NCT00002759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6307200|NCT00002759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6307201|NCT00002759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6307202|NCT00002759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6307203|NCT00002759|Immunologic Factors|immunologic factors|mesh-ancestor
6307204|NCT00002759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6307205|NCT00002759|Antifungal Agents|antifungal agents|mesh-ancestor
6307206|NCT00002759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6307207|NCT00002759|Dermatologic Agents|dermatologic agents|mesh-ancestor
6307208|NCT00002759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6307209|NCT00002759|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6307210|NCT00002759|Anticonvulsants|anticonvulsants|mesh-ancestor
6307211|NCT00002759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6307212|NCT00002759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6307213|NCT00002759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6307214|NCT00002759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6307215|NCT00002759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6307216|NCT00002759|GABA Modulators|gaba modulators|mesh-ancestor
6307217|NCT00002759|GABA Agents|gaba agents|mesh-ancestor
6307218|NCT00002759|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6307219|NCT00002759|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6307220|NCT00002759|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6307221|NCT00002760|Ketoconazole|ketoconazole|mesh-list
6307222|NCT00002760|Hydrocortisone|hydrocortisone|mesh-list
6307223|NCT00002760|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6307224|NCT00002760|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6307225|NCT00002760|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6307226|NCT00002760|Androgen Antagonists|androgen antagonists|mesh-list
6307227|NCT00002760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6307228|NCT00002760|Antifungal Agents|antifungal agents|mesh-ancestor
6307229|NCT00002760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6307230|NCT00002760|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6307231|NCT00002760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6307232|NCT00002760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6307233|NCT00002760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6307234|NCT00002760|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6307235|NCT00002760|Hormone Antagonists|hormone antagonists|mesh-ancestor
6307236|NCT00002760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6307237|NCT00002760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6307238|NCT00002760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6307239|NCT00002761|Interferons|interferons|mesh-list
6307240|NCT00002761|Cytarabine|cytarabine|mesh-list
6307241|NCT00002761|Interferon-gamma|interferon-gamma|mesh-list
6307242|NCT00002761|Cyclosporine|cyclosporine|mesh-list
6307243|NCT00002761|Cyclophosphamide|cyclophosphamide|mesh-list
6307244|NCT00002761|Busulfan|busulfan|mesh-list
6307245|NCT00002761|Idarubicin|idarubicin|mesh-list
6307246|NCT00002761|Cyclosporins|cyclosporins|mesh-list
6307247|NCT00002761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6307248|NCT00002761|Immunologic Factors|immunologic factors|mesh-ancestor
6307249|NCT00002761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6307250|NCT00002761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6307251|NCT00002761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6307252|NCT00002761|Alkylating Agents|alkylating agents|mesh-ancestor
6307253|NCT00002761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6307254|NCT00002761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6307255|NCT00002761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6307256|NCT00002761|Antiviral Agents|antiviral agents|mesh-ancestor
6307257|NCT00002761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6307258|NCT00002761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6307259|NCT00002761|Antimetabolites|antimetabolites|mesh-ancestor
6307260|NCT00002761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6307261|NCT00002761|Antifungal Agents|antifungal agents|mesh-ancestor
6307262|NCT00002761|Dermatologic Agents|dermatologic agents|mesh-ancestor
6307263|NCT00002761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6307264|NCT00002761|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6307265|NCT00002761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6307266|NCT00002761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6307267|NCT00002763|Interferons|interferons|mesh-list
6307268|NCT00002763|Interferon-alpha|interferon-alpha|mesh-list
6307269|NCT00002763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6307270|NCT00002763|Antiviral Agents|antiviral agents|mesh-ancestor
6307271|NCT00002763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6015970|NCT00361231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6015971|NCT00361231|Growth Inhibitors|growth inhibitors|mesh-ancestor
6015972|NCT00361231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6015973|NCT00361231|Antimetabolites|antimetabolites|mesh-ancestor
6015974|NCT00361231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015975|NCT00361231|Antiviral Agents|antiviral agents|mesh-ancestor
6015976|NCT00361231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6307272|NCT00002763|Immunologic Factors|immunologic factors|mesh-ancestor
6307273|NCT00002763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6307274|NCT00002764|Doxorubicin|doxorubicin|mesh-list
6307275|NCT00002764|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6307276|NCT00002764|Ifosfamide|ifosfamide|mesh-list
6307277|NCT00002764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6307278|NCT00002764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6307279|NCT00002764|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6307280|NCT00002764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6307281|NCT00002764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6307282|NCT00002764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6307283|NCT00002764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6307284|NCT00002764|Alkylating Agents|alkylating agents|mesh-ancestor
6307285|NCT00002765|Immunotoxins|immunotoxins|mesh-list
6307286|NCT00002765|Immunologic Factors|immunologic factors|mesh-ancestor
6307287|NCT00002765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6307288|NCT00002767|Interferons|interferons|mesh-list
6307289|NCT00002767|Interferon-alpha|interferon-alpha|mesh-list
6307290|NCT00002767|Detox adjuvant|detox adjuvant|mesh-list
6307291|NCT00002767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6307292|NCT00002767|Antiviral Agents|antiviral agents|mesh-ancestor
6307293|NCT00002767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6307294|NCT00002767|Immunologic Factors|immunologic factors|mesh-ancestor
6307295|NCT00002767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6307296|NCT00002767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6307297|NCT00002768|Cytarabine|cytarabine|mesh-list
6307298|NCT00002768|Methotrexate|methotrexate|mesh-list
6307299|NCT00002768|Etoposide|etoposide|mesh-list
6307300|NCT00002768|Busulfan|busulfan|mesh-list
6307301|NCT00002768|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6307302|NCT00002768|Abortifacient Agents|abortifacient agents|mesh-ancestor
6307303|NCT00002768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6015977|NCT00361231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6307304|NCT00002768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6307305|NCT00002768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6307306|NCT00002768|Antimetabolites|antimetabolites|mesh-ancestor
6307307|NCT00002768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6307308|NCT00002768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6307309|NCT00002768|Dermatologic Agents|dermatologic agents|mesh-ancestor
6307310|NCT00002768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6307311|NCT00002768|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6307312|NCT00002768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6307313|NCT00002768|Immunologic Factors|immunologic factors|mesh-ancestor
6307314|NCT00002768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6307315|NCT00002768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6307316|NCT00002768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6307317|NCT00002768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6307318|NCT00002768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6307319|NCT00002768|Antiviral Agents|antiviral agents|mesh-ancestor
6307320|NCT00002768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6307321|NCT00002768|Alkylating Agents|alkylating agents|mesh-ancestor
6307322|NCT00002768|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6307323|NCT00002768|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6307324|NCT00002771|Interferons|interferons|mesh-list
6307325|NCT00002771|Cytarabine|cytarabine|mesh-list
6307326|NCT00002771|Interferon-alpha|interferon-alpha|mesh-list
6307327|NCT00002771|Busulfan|busulfan|mesh-list
6307328|NCT00002771|Idarubicin|idarubicin|mesh-list
6307329|NCT00002771|Hydroxyurea|hydroxyurea|mesh-list
6307330|NCT00002771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6307331|NCT00002771|Antiviral Agents|antiviral agents|mesh-ancestor
6307332|NCT00002771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6307333|NCT00002771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6307334|NCT00002771|Antimetabolites|antimetabolites|mesh-ancestor
6015978|NCT00361231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6015979|NCT00361231|Immunologic Factors|immunologic factors|mesh-ancestor
6307335|NCT00002771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6307336|NCT00002771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6307337|NCT00002771|Immunologic Factors|immunologic factors|mesh-ancestor
6307338|NCT00002771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6307339|NCT00002771|Alkylating Agents|alkylating agents|mesh-ancestor
6307340|NCT00002771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6307341|NCT00002771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6307342|NCT00002771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6307343|NCT00002771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6307344|NCT00002771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6307345|NCT00002771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6307346|NCT00002771|Antisickling Agents|antisickling agents|mesh-ancestor
6307347|NCT00002771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6307348|NCT00002772|Tamoxifen|tamoxifen|mesh-list
6307349|NCT00002772|Paclitaxel|paclitaxel|mesh-list
6307350|NCT00002772|Cyclophosphamide|cyclophosphamide|mesh-list
6307351|NCT00002772|Carboplatin|carboplatin|mesh-list
6307352|NCT00002772|Doxorubicin|doxorubicin|mesh-list
6307353|NCT00002772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6307354|NCT00002772|Thiotepa|thiotepa|mesh-list
6307355|NCT00002772|Carmustine|carmustine|mesh-list
6307356|NCT00002772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6307357|NCT00002772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6307358|NCT00002772|Tubulin Modulators|tubulin modulators|mesh-ancestor
6307359|NCT00002772|Antimitotic Agents|antimitotic agents|mesh-ancestor
6307360|NCT00002772|Mitosis Modulators|mitosis modulators|mesh-ancestor
6307361|NCT00002772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6307362|NCT00002772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6307363|NCT00002772|Immunologic Factors|immunologic factors|mesh-ancestor
6307364|NCT00002772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6307365|NCT00002772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6307366|NCT00002772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6307367|NCT00002772|Alkylating Agents|alkylating agents|mesh-ancestor
6307368|NCT00002772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6307369|NCT00002772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6307370|NCT00002772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6307371|NCT00002772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6307372|NCT00002772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6307373|NCT00002772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6307374|NCT00002772|Hormone Antagonists|hormone antagonists|mesh-ancestor
6307375|NCT00002772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6307376|NCT00002772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6307377|NCT00002772|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6015980|NCT00361257|Minocycline|minocycline|mesh-list
6307378|NCT00002772|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6307379|NCT00002772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6307380|NCT00002773|Interferons|interferons|mesh-list
6307381|NCT00002773|Interferon-alpha|interferon-alpha|mesh-list
6307382|NCT00002773|Cyclophosphamide|cyclophosphamide|mesh-list
6307383|NCT00002773|Sargramostim|sargramostim|mesh-list
6307384|NCT00002773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6307385|NCT00002773|Immunologic Factors|immunologic factors|mesh-ancestor
6307386|NCT00002773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6307387|NCT00002773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6307388|NCT00002773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6307389|NCT00002773|Alkylating Agents|alkylating agents|mesh-ancestor
6307390|NCT00002773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6307391|NCT00002773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6307392|NCT00002773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6307393|NCT00002773|Antiviral Agents|antiviral agents|mesh-ancestor
6307394|NCT00002773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6307395|NCT00002774|Cisplatin|cisplatin|mesh-list
6307396|NCT00002774|Fluorouracil|fluorouracil|mesh-list
6307397|NCT00002774|Tirapazamine|tirapazamine|mesh-list
6307398|NCT00002774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6307399|NCT00002774|Antimetabolites|antimetabolites|mesh-ancestor
6307400|NCT00002774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6307401|NCT00002774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6307402|NCT00002774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6307403|NCT00002774|Immunologic Factors|immunologic factors|mesh-ancestor
6307404|NCT00002774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6307405|NCT00002775|Docetaxel|docetaxel|mesh-list
6307406|NCT00002775|Estramustine|estramustine|mesh-list
6307407|NCT00002775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6307408|NCT00002775|Tubulin Modulators|tubulin modulators|mesh-ancestor
6307409|NCT00002775|Antimitotic Agents|antimitotic agents|mesh-ancestor
6307410|NCT00002775|Mitosis Modulators|mitosis modulators|mesh-ancestor
6307411|NCT00002775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6307412|NCT00002775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6307413|NCT00002775|Alkylating Agents|alkylating agents|mesh-ancestor
6307414|NCT00002775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6307415|NCT00002777|Tamoxifen|tamoxifen|mesh-list
6307416|NCT00002777|Exemestane|exemestane|mesh-list
6307417|NCT00002777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6307418|NCT00002777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6307419|NCT00002777|Hormone Antagonists|hormone antagonists|mesh-ancestor
6307420|NCT00002777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6307421|NCT00002777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6307422|NCT00002777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6307423|NCT00002777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6307424|NCT00002777|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6307425|NCT00002777|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6307426|NCT00002777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6307427|NCT00002777|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6307428|NCT00002777|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6307429|NCT00002777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6307430|NCT00002778|Sargramostim|sargramostim|mesh-list
6307431|NCT00002778|Immunologic Factors|immunologic factors|mesh-ancestor
6307432|NCT00002778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6307433|NCT00002779|Fludarabine|fludarabine|mesh-list
6307434|NCT00002779|Fludarabine phosphate|fludarabine phosphate|mesh-list
6307435|NCT00002779|Octreotide|octreotide|mesh-list
6307436|NCT00002779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6307437|NCT00002779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6307438|NCT00002779|Antimetabolites|antimetabolites|mesh-ancestor
6307439|NCT00002779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015981|NCT00361257|Tetracycline|tetracycline|mesh-list
6015982|NCT00361257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6015983|NCT00361257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6015984|NCT00361257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6015985|NCT00361257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6015986|NCT00361257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6307440|NCT00002779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6307441|NCT00002779|Immunologic Factors|immunologic factors|mesh-ancestor
6307442|NCT00002779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6307443|NCT00002779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6307444|NCT00002779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6307445|NCT00002780|Aldesleukin|aldesleukin|mesh-list
6307446|NCT00002780|Cyclophosphamide|cyclophosphamide|mesh-list
6307447|NCT00002780|Thiotepa|thiotepa|mesh-list
6307448|NCT00002780|Carboplatin|carboplatin|mesh-list
6307449|NCT00002780|Sargramostim|sargramostim|mesh-list
6307450|NCT00002780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6307451|NCT00002780|Immunologic Factors|immunologic factors|mesh-ancestor
6307452|NCT00002780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6307453|NCT00002780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6307454|NCT00002780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6307455|NCT00002780|Alkylating Agents|alkylating agents|mesh-ancestor
6307456|NCT00002780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6307457|NCT00002780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6307458|NCT00002780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6307459|NCT00002780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6307460|NCT00002780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6307461|NCT00002780|Antiviral Agents|antiviral agents|mesh-ancestor
6307462|NCT00002780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6307463|NCT00002783|Leucovorin|leucovorin|mesh-list
6307464|NCT00002783|Fluorouracil|fluorouracil|mesh-list
6307465|NCT00002783|Floxuridine|floxuridine|mesh-list
6307466|NCT00002783|Calcium|calcium|mesh-list
6307467|NCT00002783|Levoleucovorin|levoleucovorin|mesh-list
6307468|NCT00002783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6307469|NCT00002783|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6307470|NCT00002783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6307471|NCT00002783|Antimetabolites|antimetabolites|mesh-ancestor
6307472|NCT00002783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6307473|NCT00002783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6307474|NCT00002783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6307475|NCT00002783|Immunologic Factors|immunologic factors|mesh-ancestor
6307476|NCT00002783|Antidotes|antidotes|mesh-ancestor
6307477|NCT00002783|Protective Agents|protective agents|mesh-ancestor
6307478|NCT00002783|Vitamin B Complex|vitamin b complex|mesh-ancestor
6307479|NCT00002783|Vitamins|vitamins|mesh-ancestor
6307480|NCT00002783|Micronutrients|micronutrients|mesh-ancestor
6307481|NCT00002784|Tamoxifen|tamoxifen|mesh-list
6307482|NCT00002784|Cyclophosphamide|cyclophosphamide|mesh-list
6307483|NCT00002784|Doxorubicin|doxorubicin|mesh-list
6307484|NCT00002784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6307485|NCT00002784|Fluorouracil|fluorouracil|mesh-list
6307486|NCT00002784|Methotrexate|methotrexate|mesh-list
6307487|NCT00002784|Epirubicin|epirubicin|mesh-list
6307488|NCT00002784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6307489|NCT00002784|Immunologic Factors|immunologic factors|mesh-ancestor
6307490|NCT00002784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6307491|NCT00002784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6307492|NCT00002784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6307493|NCT00002784|Alkylating Agents|alkylating agents|mesh-ancestor
6307494|NCT00002784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6307495|NCT00002784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6307496|NCT00002784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6307497|NCT00002784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6307498|NCT00002784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6307499|NCT00002784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6307500|NCT00002784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6307501|NCT00002784|Antimetabolites|antimetabolites|mesh-ancestor
6307502|NCT00002784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6307503|NCT00002784|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6307504|NCT00002784|Abortifacient Agents|abortifacient agents|mesh-ancestor
6307505|NCT00002784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6307506|NCT00002784|Dermatologic Agents|dermatologic agents|mesh-ancestor
6307507|NCT00002784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6307508|NCT00002784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6307509|NCT00002784|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6307510|NCT00002784|Hormone Antagonists|hormone antagonists|mesh-ancestor
6307511|NCT00002784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6307512|NCT00002784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6307513|NCT00002784|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6307514|NCT00002784|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6307515|NCT00002784|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6307516|NCT00002785|Leucovorin|leucovorin|mesh-list
6307517|NCT00002785|Cobalt|cobalt|mesh-list
6307518|NCT00002785|Cytarabine|cytarabine|mesh-list
6307519|NCT00002785|Cyclosporine|cyclosporine|mesh-list
6307520|NCT00002785|Dexamethasone|dexamethasone|mesh-list
6307521|NCT00002785|Prednisone|prednisone|mesh-list
6307522|NCT00002785|Methylprednisolone|methylprednisolone|mesh-list
6307523|NCT00002785|Hydrocortisone|hydrocortisone|mesh-list
6307524|NCT00002785|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6307525|NCT00002785|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6307526|NCT00002785|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6307527|NCT00002785|Cyclophosphamide|cyclophosphamide|mesh-list
6307528|NCT00002785|Methotrexate|methotrexate|mesh-list
6307529|NCT00002785|Etoposide|etoposide|mesh-list
6307530|NCT00002785|Vincristine|vincristine|mesh-list
6307531|NCT00002785|Daunorubicin|daunorubicin|mesh-list
6307532|NCT00002785|Asparaginase|asparaginase|mesh-list
6307533|NCT00002785|Mercaptopurine|mercaptopurine|mesh-list
6307534|NCT00002785|Pegaspargase|pegaspargase|mesh-list
6307535|NCT00002785|Cyclosporins|cyclosporins|mesh-list
6307536|NCT00002785|Levoleucovorin|levoleucovorin|mesh-list
6307537|NCT00002785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6307538|NCT00002785|Immunologic Factors|immunologic factors|mesh-ancestor
6307539|NCT00002785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6307540|NCT00002785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6307541|NCT00002785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6307542|NCT00002785|Alkylating Agents|alkylating agents|mesh-ancestor
6307543|NCT00002785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6307544|NCT00002785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6307545|NCT00002785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6307546|NCT00002785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6307547|NCT00002785|Antiemetics|antiemetics|mesh-ancestor
6307548|NCT00002785|Autonomic Agents|autonomic agents|mesh-ancestor
6307549|NCT00002785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6307550|NCT00002785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6307551|NCT00002785|Glucocorticoids|glucocorticoids|mesh-ancestor
6307552|NCT00002785|Hormones|hormones|mesh-ancestor
6307553|NCT00002785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6307554|NCT00002785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6307555|NCT00002785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6307556|NCT00002785|Abortifacient Agents|abortifacient agents|mesh-ancestor
6307557|NCT00002785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6307558|NCT00002785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6307559|NCT00002785|Antimetabolites|antimetabolites|mesh-ancestor
6307560|NCT00002785|Dermatologic Agents|dermatologic agents|mesh-ancestor
6307561|NCT00002785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6307562|NCT00002785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6307563|NCT00002785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6307564|NCT00002785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6307565|NCT00002785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6307566|NCT00002785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6307567|NCT00002785|Antiviral Agents|antiviral agents|mesh-ancestor
6307568|NCT00002785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6307569|NCT00002785|Antidotes|antidotes|mesh-ancestor
6307570|NCT00002785|Protective Agents|protective agents|mesh-ancestor
6307571|NCT00002785|Vitamin B Complex|vitamin b complex|mesh-ancestor
6307572|NCT00002785|Vitamins|vitamins|mesh-ancestor
6307573|NCT00002785|Micronutrients|micronutrients|mesh-ancestor
6307574|NCT00002785|Tubulin Modulators|tubulin modulators|mesh-ancestor
6307575|NCT00002785|Antimitotic Agents|antimitotic agents|mesh-ancestor
6307576|NCT00002785|Mitosis Modulators|mitosis modulators|mesh-ancestor
6307577|NCT00002785|Antifungal Agents|antifungal agents|mesh-ancestor
6307578|NCT00002785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6307579|NCT00002785|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6307580|NCT00002785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6307581|NCT00002785|Trace Elements|trace elements|mesh-ancestor
6307582|NCT00002786|Aldesleukin|aldesleukin|mesh-list
6307583|NCT00002786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6307584|NCT00002786|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6307585|NCT00002786|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6307586|NCT00002786|Antiviral Agents|antiviral agents|mesh-ancestor
6307587|NCT00002786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6307588|NCT00002787|Aldesleukin|aldesleukin|mesh-list
6015987|NCT00361270|Complement Factor H|complement factor h|mesh-list
6015988|NCT00361270|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6307589|NCT00002787|Interleukin-2|interleukin-2|mesh-list
6307590|NCT00002787|Vaccines|vaccines|mesh-list
6307591|NCT00002787|Immunoglobulins|immunoglobulins|mesh-list
6015989|NCT00361270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6015990|NCT00361270|Immunologic Factors|immunologic factors|mesh-ancestor
6015991|NCT00361270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6307592|NCT00002787|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6307593|NCT00002787|Antibodies|antibodies|mesh-list
6307594|NCT00002787|Sargramostim|sargramostim|mesh-list
6307595|NCT00002787|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
6307596|NCT00002787|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
6307597|NCT00002787|Immunologic Factors|immunologic factors|mesh-ancestor
6307598|NCT00002787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6307599|NCT00002787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6307600|NCT00002787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6307601|NCT00002787|Analgesics|analgesics|mesh-ancestor
6307602|NCT00002787|Sensory System Agents|sensory system agents|mesh-ancestor
6307603|NCT00002787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6307604|NCT00002787|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6307605|NCT00002787|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6307606|NCT00002787|Antiviral Agents|antiviral agents|mesh-ancestor
6307607|NCT00002787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6307608|NCT00002787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6307609|NCT00002788|Dexamethasone|dexamethasone|mesh-list
6307610|NCT00002788|Cyclophosphamide|cyclophosphamide|mesh-list
6307611|NCT00002788|Etoposide|etoposide|mesh-list
6307612|NCT00002788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6307613|NCT00002788|Immunologic Factors|immunologic factors|mesh-ancestor
6307614|NCT00002788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6307615|NCT00002788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6307616|NCT00002788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6307617|NCT00002788|Alkylating Agents|alkylating agents|mesh-ancestor
6307618|NCT00002788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6307619|NCT00002788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6307620|NCT00002788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6307621|NCT00002788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6307622|NCT00002788|Antiemetics|antiemetics|mesh-ancestor
6307623|NCT00002788|Autonomic Agents|autonomic agents|mesh-ancestor
6307624|NCT00002788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6307625|NCT00002788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6307626|NCT00002788|Glucocorticoids|glucocorticoids|mesh-ancestor
6307627|NCT00002788|Hormones|hormones|mesh-ancestor
6307628|NCT00002788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6307629|NCT00002788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6307630|NCT00002788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6307631|NCT00002788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6307632|NCT00002788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6307633|NCT00002788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6307634|NCT00002789|Cyclosporine|cyclosporine|mesh-list
6307635|NCT00002789|Cyclophosphamide|cyclophosphamide|mesh-list
6307636|NCT00002789|Busulfan|busulfan|mesh-list
6307637|NCT00002789|Methotrexate|methotrexate|mesh-list
6307638|NCT00002789|Cyclosporins|cyclosporins|mesh-list
6307639|NCT00002789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6307640|NCT00002789|Immunologic Factors|immunologic factors|mesh-ancestor
6307641|NCT00002789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6307642|NCT00002789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6307643|NCT00002789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6307644|NCT00002789|Alkylating Agents|alkylating agents|mesh-ancestor
6307645|NCT00002789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6307646|NCT00002789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6307647|NCT00002789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6307648|NCT00002789|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6307649|NCT00002789|Abortifacient Agents|abortifacient agents|mesh-ancestor
6307650|NCT00002789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6307651|NCT00002789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6307652|NCT00002789|Antimetabolites|antimetabolites|mesh-ancestor
6307653|NCT00002789|Dermatologic Agents|dermatologic agents|mesh-ancestor
6307654|NCT00002789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6307655|NCT00002789|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6307656|NCT00002789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6307657|NCT00002789|Antifungal Agents|antifungal agents|mesh-ancestor
6307658|NCT00002789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6307659|NCT00002789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6307660|NCT00002790|Cyclosporine|cyclosporine|mesh-list
6307661|NCT00002790|Sirolimus|sirolimus|mesh-list
6307662|NCT00002790|Methotrexate|methotrexate|mesh-list
6307663|NCT00002790|Cyclosporins|cyclosporins|mesh-list
6307664|NCT00002790|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6307665|NCT00002790|Abortifacient Agents|abortifacient agents|mesh-ancestor
6307666|NCT00002790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6307667|NCT00002790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6307668|NCT00002790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6307669|NCT00002790|Antimetabolites|antimetabolites|mesh-ancestor
6307670|NCT00002790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6307671|NCT00002790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6307672|NCT00002790|Dermatologic Agents|dermatologic agents|mesh-ancestor
6307673|NCT00002790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6307674|NCT00002790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6307675|NCT00002790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6307676|NCT00002790|Immunologic Factors|immunologic factors|mesh-ancestor
6307677|NCT00002790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6307678|NCT00002790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6307679|NCT00002790|Antifungal Agents|antifungal agents|mesh-ancestor
6307680|NCT00002790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6307681|NCT00002790|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6307682|NCT00002790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6307683|NCT00002790|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6307684|NCT00002791|Doxorubicin|doxorubicin|mesh-list
6307685|NCT00002791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6307686|NCT00002791|Ifosfamide|ifosfamide|mesh-list
6307687|NCT00002791|Dacarbazine|dacarbazine|mesh-list
6307688|NCT00002791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6307689|NCT00002791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6307690|NCT00002791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6307691|NCT00002791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6307692|NCT00002791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6307693|NCT00002791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6307694|NCT00002791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6307695|NCT00002791|Alkylating Agents|alkylating agents|mesh-ancestor
6307696|NCT00002792|Cyclosporine|cyclosporine|mesh-list
6307697|NCT00002792|Cyclophosphamide|cyclophosphamide|mesh-list
6307698|NCT00002792|Busulfan|busulfan|mesh-list
6307699|NCT00002792|Methotrexate|methotrexate|mesh-list
6307700|NCT00002792|Tacrolimus|tacrolimus|mesh-list
6307701|NCT00002792|Cyclosporins|cyclosporins|mesh-list
6307702|NCT00002792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6307703|NCT00002792|Immunologic Factors|immunologic factors|mesh-ancestor
6307704|NCT00002792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6307705|NCT00002792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6307706|NCT00002792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6307707|NCT00002792|Alkylating Agents|alkylating agents|mesh-ancestor
6307708|NCT00002792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6307709|NCT00002792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6307710|NCT00002792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6307711|NCT00002792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6307712|NCT00002792|Abortifacient Agents|abortifacient agents|mesh-ancestor
6307713|NCT00002792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6307714|NCT00002792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6307715|NCT00002792|Antimetabolites|antimetabolites|mesh-ancestor
6307716|NCT00002792|Dermatologic Agents|dermatologic agents|mesh-ancestor
6307717|NCT00002792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6307718|NCT00002792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6307719|NCT00002792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6307720|NCT00002792|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6307721|NCT00002792|Antifungal Agents|antifungal agents|mesh-ancestor
6307722|NCT00002792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6307723|NCT00002793|Leucovorin|leucovorin|mesh-list
6307724|NCT00002793|Fluorouracil|fluorouracil|mesh-list
6307725|NCT00002793|Calcium|calcium|mesh-list
6307726|NCT00002793|Levoleucovorin|levoleucovorin|mesh-list
6307727|NCT00002793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6307728|NCT00002793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6307729|NCT00002793|Antimetabolites|antimetabolites|mesh-ancestor
6307730|NCT00002793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6307731|NCT00002793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6307732|NCT00002793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6307733|NCT00002793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6307734|NCT00002793|Immunologic Factors|immunologic factors|mesh-ancestor
6307735|NCT00002793|Antidotes|antidotes|mesh-ancestor
6307736|NCT00002793|Protective Agents|protective agents|mesh-ancestor
6307737|NCT00002793|Vitamin B Complex|vitamin b complex|mesh-ancestor
6307738|NCT00002793|Vitamins|vitamins|mesh-ancestor
6307739|NCT00002793|Micronutrients|micronutrients|mesh-ancestor
6307740|NCT00002794|Carboplatin|carboplatin|mesh-list
6307741|NCT00002794|Vincristine|vincristine|mesh-list
6307742|NCT00002794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6307743|NCT00002794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6307744|NCT00002794|Tubulin Modulators|tubulin modulators|mesh-ancestor
6307745|NCT00002794|Antimitotic Agents|antimitotic agents|mesh-ancestor
6307746|NCT00002794|Mitosis Modulators|mitosis modulators|mesh-ancestor
6307747|NCT00002794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6307748|NCT00002796|Interferons|interferons|mesh-list
6307749|NCT00002796|Interferon-gamma|interferon-gamma|mesh-list
6307750|NCT00002796|Indomethacin|indomethacin|mesh-list
6307751|NCT00002796|Fluorouracil|fluorouracil|mesh-list
6307752|NCT00002796|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
6307753|NCT00002796|Antimetabolites|antimetabolites|mesh-ancestor
6307754|NCT00002796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6307755|NCT00002796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6307756|NCT00002796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6307757|NCT00002796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6307758|NCT00002796|Immunologic Factors|immunologic factors|mesh-ancestor
6307759|NCT00002796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6307760|NCT00002796|Antiviral Agents|antiviral agents|mesh-ancestor
6307761|NCT00002796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6307762|NCT00002796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6307763|NCT00002796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6307764|NCT00002796|Analgesics|analgesics|mesh-ancestor
6307765|NCT00002796|Sensory System Agents|sensory system agents|mesh-ancestor
6307766|NCT00002796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6307767|NCT00002796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6307768|NCT00002796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6307769|NCT00002796|Gout Suppressants|gout suppressants|mesh-ancestor
6307770|NCT00002796|Tocolytic Agents|tocolytic agents|mesh-ancestor
6307771|NCT00002796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6307772|NCT00002796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6307773|NCT00002796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6307774|NCT00002798|Cytarabine|cytarabine|mesh-list
6307775|NCT00002798|Aldesleukin|aldesleukin|mesh-list
6307776|NCT00002798|Dexamethasone|dexamethasone|mesh-list
6307777|NCT00002798|Hydrocortisone|hydrocortisone|mesh-list
6307778|NCT00002798|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6307779|NCT00002798|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6307780|NCT00002798|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6307781|NCT00002798|Cyclophosphamide|cyclophosphamide|mesh-list
6307782|NCT00002798|Busulfan|busulfan|mesh-list
6307783|NCT00002798|Methotrexate|methotrexate|mesh-list
6307784|NCT00002798|Fludarabine|fludarabine|mesh-list
6307785|NCT00002798|Fludarabine phosphate|fludarabine phosphate|mesh-list
6307786|NCT00002798|Etoposide|etoposide|mesh-list
6307787|NCT00002798|Etoposide phosphate|etoposide phosphate|mesh-list
6307788|NCT00002798|Daunorubicin|daunorubicin|mesh-list
6307789|NCT00002798|Interleukin-2|interleukin-2|mesh-list
6307790|NCT00002798|Asparaginase|asparaginase|mesh-list
6307791|NCT00002798|Idarubicin|idarubicin|mesh-list
6307792|NCT00002798|Thioguanine|thioguanine|mesh-list
6307793|NCT00002798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6307794|NCT00002798|Immunologic Factors|immunologic factors|mesh-ancestor
6307795|NCT00002798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6307796|NCT00002798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6307797|NCT00002798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6307798|NCT00002798|Alkylating Agents|alkylating agents|mesh-ancestor
6307799|NCT00002798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6307800|NCT00002798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6307801|NCT00002798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6307802|NCT00002798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6307803|NCT00002798|Antiemetics|antiemetics|mesh-ancestor
6307804|NCT00002798|Autonomic Agents|autonomic agents|mesh-ancestor
6307805|NCT00002798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6307806|NCT00002798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6307807|NCT00002798|Glucocorticoids|glucocorticoids|mesh-ancestor
6307808|NCT00002798|Hormones|hormones|mesh-ancestor
6307809|NCT00002798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6307810|NCT00002798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6307811|NCT00002798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6307812|NCT00002798|Abortifacient Agents|abortifacient agents|mesh-ancestor
6307813|NCT00002798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6307814|NCT00002798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6307815|NCT00002798|Antimetabolites|antimetabolites|mesh-ancestor
6307816|NCT00002798|Dermatologic Agents|dermatologic agents|mesh-ancestor
6307817|NCT00002798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6307818|NCT00002798|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6307819|NCT00002798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6307820|NCT00002798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6307821|NCT00002798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6307822|NCT00002798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6307823|NCT00002798|Antiviral Agents|antiviral agents|mesh-ancestor
6307824|NCT00002798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6307825|NCT00002798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6307826|NCT00002798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6307827|NCT00002798|Analgesics|analgesics|mesh-ancestor
6307828|NCT00002798|Sensory System Agents|sensory system agents|mesh-ancestor
6307829|NCT00002798|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6307830|NCT00002798|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6307831|NCT00002800|Cytarabine|cytarabine|mesh-list
6307832|NCT00002800|Etoposide|etoposide|mesh-list
6307833|NCT00002800|Idarubicin|idarubicin|mesh-list
6307834|NCT00002800|Lintuzumab|lintuzumab|mesh-list
6307835|NCT00002800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6307836|NCT00002800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6307837|NCT00002800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6307838|NCT00002800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6307839|NCT00002800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6307840|NCT00002800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6307841|NCT00002800|Immunologic Factors|immunologic factors|mesh-ancestor
6307842|NCT00002800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6307843|NCT00002800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6307844|NCT00002800|Antimetabolites|antimetabolites|mesh-ancestor
6307845|NCT00002800|Antiviral Agents|antiviral agents|mesh-ancestor
6307846|NCT00002800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6307847|NCT00002800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6307848|NCT00002800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6307849|NCT00002800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6307850|NCT00002801|Leucovorin|leucovorin|mesh-list
6307851|NCT00002801|Tegafur|tegafur|mesh-list
6307852|NCT00002801|Calcium|calcium|mesh-list
6307853|NCT00002801|Levoleucovorin|levoleucovorin|mesh-list
6307854|NCT00002801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6307855|NCT00002801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6307856|NCT00002801|Antidotes|antidotes|mesh-ancestor
6307857|NCT00002801|Protective Agents|protective agents|mesh-ancestor
6307858|NCT00002801|Vitamin B Complex|vitamin b complex|mesh-ancestor
6307859|NCT00002801|Vitamins|vitamins|mesh-ancestor
6307860|NCT00002801|Micronutrients|micronutrients|mesh-ancestor
6307861|NCT00002801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6307862|NCT00002801|Antimetabolites|antimetabolites|mesh-ancestor
6307863|NCT00002801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6307864|NCT00002801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6307865|NCT00002802|Cobalt|cobalt|mesh-list
6307866|NCT00002802|Cyclophosphamide|cyclophosphamide|mesh-list
6307867|NCT00002802|Melphalan|melphalan|mesh-list
6307868|NCT00002802|Ifosfamide|ifosfamide|mesh-list
6307869|NCT00002802|Dacarbazine|dacarbazine|mesh-list
6307870|NCT00002802|Carboplatin|carboplatin|mesh-list
6307871|NCT00002802|Doxorubicin|doxorubicin|mesh-list
6307872|NCT00002802|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6307873|NCT00002802|Etoposide|etoposide|mesh-list
6307874|NCT00002802|Vincristine|vincristine|mesh-list
6307875|NCT00002802|Vindesine|vindesine|mesh-list
6307876|NCT00002802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6307877|NCT00002802|Immunologic Factors|immunologic factors|mesh-ancestor
6307878|NCT00002802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6307879|NCT00002802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6307880|NCT00002802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6307881|NCT00002802|Alkylating Agents|alkylating agents|mesh-ancestor
6307882|NCT00002802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6307883|NCT00002802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6307884|NCT00002802|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6307885|NCT00002802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6307886|NCT00002802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6307887|NCT00002802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6307888|NCT00002802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6307889|NCT00002802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6307890|NCT00002802|Tubulin Modulators|tubulin modulators|mesh-ancestor
6307891|NCT00002802|Antimitotic Agents|antimitotic agents|mesh-ancestor
6307892|NCT00002802|Mitosis Modulators|mitosis modulators|mesh-ancestor
6307893|NCT00002802|Trace Elements|trace elements|mesh-ancestor
6307894|NCT00002802|Micronutrients|micronutrients|mesh-ancestor
6307895|NCT00002803|Cyclophosphamide|cyclophosphamide|mesh-list
6307896|NCT00002803|Doxorubicin|doxorubicin|mesh-list
6307897|NCT00002803|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6307898|NCT00002803|Vincristine|vincristine|mesh-list
6307899|NCT00002803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6307900|NCT00002803|Immunologic Factors|immunologic factors|mesh-ancestor
6307901|NCT00002803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6307902|NCT00002803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6307903|NCT00002803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6307904|NCT00002803|Alkylating Agents|alkylating agents|mesh-ancestor
6307905|NCT00002803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6307906|NCT00002803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6307907|NCT00002803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6307908|NCT00002803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6307909|NCT00002803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6307910|NCT00002803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6307911|NCT00002803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6307912|NCT00002803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6307913|NCT00002803|Tubulin Modulators|tubulin modulators|mesh-ancestor
6307914|NCT00002803|Antimitotic Agents|antimitotic agents|mesh-ancestor
6307915|NCT00002803|Mitosis Modulators|mitosis modulators|mesh-ancestor
6307916|NCT00002804|Cobalt|cobalt|mesh-list
6307917|NCT00002804|Doxorubicin|doxorubicin|mesh-list
6307918|NCT00002804|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6307919|NCT00002804|Vincristine|vincristine|mesh-list
6307920|NCT00002804|Ifosfamide|ifosfamide|mesh-list
6307921|NCT00002804|Lenograstim|lenograstim|mesh-list
6307922|NCT00002804|Sargramostim|sargramostim|mesh-list
6307923|NCT00002804|Mesna|mesna|mesh-list
6307924|NCT00002804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6307925|NCT00002804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6307926|NCT00002804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6307927|NCT00002804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6307928|NCT00002804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6307929|NCT00002804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6307930|NCT00002804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6307931|NCT00002804|Immunologic Factors|immunologic factors|mesh-ancestor
6307932|NCT00002804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6307933|NCT00002804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6307934|NCT00002804|Tubulin Modulators|tubulin modulators|mesh-ancestor
6307935|NCT00002804|Antimitotic Agents|antimitotic agents|mesh-ancestor
6307936|NCT00002804|Mitosis Modulators|mitosis modulators|mesh-ancestor
6307937|NCT00002804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6307938|NCT00002804|Alkylating Agents|alkylating agents|mesh-ancestor
6307939|NCT00002804|Protective Agents|protective agents|mesh-ancestor
6307940|NCT00002804|Trace Elements|trace elements|mesh-ancestor
6307941|NCT00002804|Micronutrients|micronutrients|mesh-ancestor
6307942|NCT00002805|Cobalt|cobalt|mesh-list
6307943|NCT00002805|Cytarabine|cytarabine|mesh-list
6307944|NCT00002805|Hydrocortisone|hydrocortisone|mesh-list
6307945|NCT00002805|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6307946|NCT00002805|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6307947|NCT00002805|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6307948|NCT00002805|Methotrexate|methotrexate|mesh-list
6307949|NCT00002805|Etoposide|etoposide|mesh-list
6307950|NCT00002805|Mitoxantrone|mitoxantrone|mesh-list
6307951|NCT00002805|Cladribine|cladribine|mesh-list
6307952|NCT00002805|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6307953|NCT00002805|Abortifacient Agents|abortifacient agents|mesh-ancestor
6307954|NCT00002805|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6307955|NCT00002805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6307956|NCT00002805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6307957|NCT00002805|Antimetabolites|antimetabolites|mesh-ancestor
6307958|NCT00002805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6307959|NCT00002805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6307960|NCT00002805|Dermatologic Agents|dermatologic agents|mesh-ancestor
6307961|NCT00002805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6307962|NCT00002805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6307963|NCT00002805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6307964|NCT00002805|Immunologic Factors|immunologic factors|mesh-ancestor
6015992|NCT00361283|Atorvastatin|atorvastatin|mesh-list
6015993|NCT00361283|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6015994|NCT00361283|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6307965|NCT00002805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6307966|NCT00002805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6307967|NCT00002805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6307968|NCT00002805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6307969|NCT00002805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6015995|NCT00361283|Antimetabolites|antimetabolites|mesh-ancestor
6015996|NCT00361283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6015997|NCT00361283|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6018487|NCT00381095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6307970|NCT00002805|Antiviral Agents|antiviral agents|mesh-ancestor
6307971|NCT00002805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6307972|NCT00002805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6307973|NCT00002805|Analgesics|analgesics|mesh-ancestor
6307974|NCT00002805|Sensory System Agents|sensory system agents|mesh-ancestor
6307975|NCT00002805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6307976|NCT00002805|Trace Elements|trace elements|mesh-ancestor
6307977|NCT00002805|Micronutrients|micronutrients|mesh-ancestor
6307978|NCT00002806|Vincristine|vincristine|mesh-list
6307979|NCT00002806|Lomustine|lomustine|mesh-list
6307980|NCT00002806|Procarbazine|procarbazine|mesh-list
6307981|NCT00002806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6307982|NCT00002806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6307983|NCT00002806|Tubulin Modulators|tubulin modulators|mesh-ancestor
6307984|NCT00002806|Antimitotic Agents|antimitotic agents|mesh-ancestor
6307985|NCT00002806|Mitosis Modulators|mitosis modulators|mesh-ancestor
6307986|NCT00002806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6307987|NCT00002806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6307988|NCT00002806|Alkylating Agents|alkylating agents|mesh-ancestor
6307989|NCT00002809|Cyclophosphamide|cyclophosphamide|mesh-list
6307990|NCT00002809|Methotrexate|methotrexate|mesh-list
6307991|NCT00002809|Tacrolimus|tacrolimus|mesh-list
6307992|NCT00002809|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6307993|NCT00002809|Sargramostim|sargramostim|mesh-list
6307994|NCT00002809|Immunoglobulins|immunoglobulins|mesh-list
6307995|NCT00002809|Antibodies|antibodies|mesh-list
6307996|NCT00002809|gamma-Globulins|gamma-globulins|mesh-list
6307997|NCT00002809|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6307998|NCT00002809|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6307999|NCT00002809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6308000|NCT00002809|Immunologic Factors|immunologic factors|mesh-ancestor
6308001|NCT00002809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6308002|NCT00002809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6308003|NCT00002809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6308004|NCT00002809|Alkylating Agents|alkylating agents|mesh-ancestor
6308005|NCT00002809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6308006|NCT00002809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6308007|NCT00002809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6308008|NCT00002809|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6308009|NCT00002809|Abortifacient Agents|abortifacient agents|mesh-ancestor
6308010|NCT00002809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6308011|NCT00002809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6308012|NCT00002809|Antimetabolites|antimetabolites|mesh-ancestor
6308013|NCT00002809|Dermatologic Agents|dermatologic agents|mesh-ancestor
6308014|NCT00002809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6308015|NCT00002809|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6308016|NCT00002809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6308017|NCT00002809|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6308018|NCT00002810|Melphalan|melphalan|mesh-list
6308019|NCT00002810|Immunologic Factors|immunologic factors|mesh-ancestor
6308020|NCT00002810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6308021|NCT00002810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6308022|NCT00002810|Alkylating Agents|alkylating agents|mesh-ancestor
6308023|NCT00002810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6308024|NCT00002810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6308025|NCT00002810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6308026|NCT00002810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6308027|NCT00002812|Cytarabine|cytarabine|mesh-list
6308028|NCT00002812|Dexamethasone|dexamethasone|mesh-list
6308029|NCT00002812|Prednisone|prednisone|mesh-list
6308030|NCT00002812|Cyclophosphamide|cyclophosphamide|mesh-list
6308031|NCT00002812|Doxorubicin|doxorubicin|mesh-list
6308032|NCT00002812|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6308033|NCT00002812|Methotrexate|methotrexate|mesh-list
6308034|NCT00002812|Vincristine|vincristine|mesh-list
6308035|NCT00002812|Daunorubicin|daunorubicin|mesh-list
6308036|NCT00002812|Asparaginase|asparaginase|mesh-list
6308037|NCT00002812|Mercaptopurine|mercaptopurine|mesh-list
6308038|NCT00002812|Idarubicin|idarubicin|mesh-list
6308039|NCT00002812|Pegaspargase|pegaspargase|mesh-list
6308040|NCT00002812|Thioguanine|thioguanine|mesh-list
6308041|NCT00002812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6308042|NCT00002812|Immunologic Factors|immunologic factors|mesh-ancestor
6308043|NCT00002812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6308044|NCT00002812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6308045|NCT00002812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6308046|NCT00002812|Alkylating Agents|alkylating agents|mesh-ancestor
6308047|NCT00002812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6308048|NCT00002812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6308049|NCT00002812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6308050|NCT00002812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6308051|NCT00002812|Antiemetics|antiemetics|mesh-ancestor
6308052|NCT00002812|Autonomic Agents|autonomic agents|mesh-ancestor
6308053|NCT00002812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6308054|NCT00002812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6308055|NCT00002812|Glucocorticoids|glucocorticoids|mesh-ancestor
6308056|NCT00002812|Hormones|hormones|mesh-ancestor
6308057|NCT00002812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6308058|NCT00002812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6308059|NCT00002812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6308060|NCT00002812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6308061|NCT00002812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6308062|NCT00002812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6308063|NCT00002812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6308064|NCT00002812|Abortifacient Agents|abortifacient agents|mesh-ancestor
6308065|NCT00002812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6308066|NCT00002812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6308067|NCT00002812|Antimetabolites|antimetabolites|mesh-ancestor
6308068|NCT00002812|Dermatologic Agents|dermatologic agents|mesh-ancestor
6308069|NCT00002812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6308070|NCT00002812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6308071|NCT00002812|Antiviral Agents|antiviral agents|mesh-ancestor
6308072|NCT00002812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6308073|NCT00002812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6308074|NCT00002812|Tubulin Modulators|tubulin modulators|mesh-ancestor
6308075|NCT00002812|Antimitotic Agents|antimitotic agents|mesh-ancestor
6308076|NCT00002812|Mitosis Modulators|mitosis modulators|mesh-ancestor
6308077|NCT00002813|Vinorelbine|vinorelbine|mesh-list
6308078|NCT00002813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6308079|NCT00002813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6308080|NCT00002813|Tubulin Modulators|tubulin modulators|mesh-ancestor
6308081|NCT00002813|Antimitotic Agents|antimitotic agents|mesh-ancestor
6308082|NCT00002813|Mitosis Modulators|mitosis modulators|mesh-ancestor
6308083|NCT00002813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6308084|NCT00002814|Paclitaxel|paclitaxel|mesh-list
6308085|NCT00002814|Topotecan|topotecan|mesh-list
6308086|NCT00002814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6308087|NCT00002814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6308088|NCT00002814|Tubulin Modulators|tubulin modulators|mesh-ancestor
6308089|NCT00002814|Antimitotic Agents|antimitotic agents|mesh-ancestor
6308090|NCT00002814|Mitosis Modulators|mitosis modulators|mesh-ancestor
6308091|NCT00002814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6308092|NCT00002814|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6308093|NCT00002814|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6308094|NCT00002814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6308095|NCT00002816|Leucovorin|leucovorin|mesh-list
6308096|NCT00002816|Cobalt|cobalt|mesh-list
6308097|NCT00002816|Cytarabine|cytarabine|mesh-list
6308098|NCT00002816|Dexamethasone|dexamethasone|mesh-list
6308099|NCT00002816|Hydrocortisone|hydrocortisone|mesh-list
6308100|NCT00002816|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6308101|NCT00002816|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6308102|NCT00002816|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6308103|NCT00002816|Methotrexate|methotrexate|mesh-list
6308104|NCT00002816|Etoposide|etoposide|mesh-list
6308105|NCT00002816|Vincristine|vincristine|mesh-list
6308106|NCT00002816|Asparaginase|asparaginase|mesh-list
6308107|NCT00002816|Ifosfamide|ifosfamide|mesh-list
6308108|NCT00002816|Idarubicin|idarubicin|mesh-list
6308109|NCT00002816|Pegaspargase|pegaspargase|mesh-list
6308110|NCT00002816|Thioguanine|thioguanine|mesh-list
6308111|NCT00002816|Levoleucovorin|levoleucovorin|mesh-list
6308112|NCT00002816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6308113|NCT00002816|Antiemetics|antiemetics|mesh-ancestor
6308114|NCT00002816|Autonomic Agents|autonomic agents|mesh-ancestor
6308115|NCT00002816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6308116|NCT00002816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6308117|NCT00002816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6308118|NCT00002816|Glucocorticoids|glucocorticoids|mesh-ancestor
6308119|NCT00002816|Hormones|hormones|mesh-ancestor
6308120|NCT00002816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6308121|NCT00002816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6308122|NCT00002816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6308123|NCT00002816|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6308124|NCT00002816|Abortifacient Agents|abortifacient agents|mesh-ancestor
6308125|NCT00002816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6308126|NCT00002816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6308127|NCT00002816|Antimetabolites|antimetabolites|mesh-ancestor
6308128|NCT00002816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6308129|NCT00002816|Dermatologic Agents|dermatologic agents|mesh-ancestor
6308130|NCT00002816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6308131|NCT00002816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6308132|NCT00002816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6308133|NCT00002816|Immunologic Factors|immunologic factors|mesh-ancestor
6308134|NCT00002816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6308135|NCT00002816|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6308136|NCT00002816|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6308137|NCT00002816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6308138|NCT00002816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6308139|NCT00002816|Antiviral Agents|antiviral agents|mesh-ancestor
6308140|NCT00002816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6308141|NCT00002816|Antidotes|antidotes|mesh-ancestor
6308142|NCT00002816|Protective Agents|protective agents|mesh-ancestor
6308143|NCT00002816|Vitamin B Complex|vitamin b complex|mesh-ancestor
6308144|NCT00002816|Vitamins|vitamins|mesh-ancestor
6308145|NCT00002816|Micronutrients|micronutrients|mesh-ancestor
6308146|NCT00002816|Tubulin Modulators|tubulin modulators|mesh-ancestor
6308147|NCT00002816|Antimitotic Agents|antimitotic agents|mesh-ancestor
6308148|NCT00002816|Mitosis Modulators|mitosis modulators|mesh-ancestor
6308149|NCT00002816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6308150|NCT00002816|Alkylating Agents|alkylating agents|mesh-ancestor
6308151|NCT00002816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6308152|NCT00002816|Trace Elements|trace elements|mesh-ancestor
6308153|NCT00002817|Sargramostim|sargramostim|mesh-list
6308154|NCT00002817|Immunologic Factors|immunologic factors|mesh-ancestor
6308155|NCT00002817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6308156|NCT00002818|Cytarabine|cytarabine|mesh-list
6308157|NCT00002818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6308158|NCT00002818|Antimetabolites|antimetabolites|mesh-ancestor
6308159|NCT00002818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6308160|NCT00002818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6308161|NCT00002818|Antiviral Agents|antiviral agents|mesh-ancestor
6308162|NCT00002818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6308163|NCT00002818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6308164|NCT00002818|Immunologic Factors|immunologic factors|mesh-ancestor
6308165|NCT00002818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6308166|NCT00002819|Paclitaxel|paclitaxel|mesh-list
6308167|NCT00002819|Cyclophosphamide|cyclophosphamide|mesh-list
6308168|NCT00002819|Carboplatin|carboplatin|mesh-list
6308169|NCT00002819|Mitoxantrone|mitoxantrone|mesh-list
6308170|NCT00002819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6308171|NCT00002819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6308172|NCT00002819|Tubulin Modulators|tubulin modulators|mesh-ancestor
6308173|NCT00002819|Antimitotic Agents|antimitotic agents|mesh-ancestor
6308174|NCT00002819|Mitosis Modulators|mitosis modulators|mesh-ancestor
5724315|NCT03188068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6308175|NCT00002819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6308176|NCT00002819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6308177|NCT00002819|Immunologic Factors|immunologic factors|mesh-ancestor
6308178|NCT00002819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6308179|NCT00002819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6308180|NCT00002819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6308181|NCT00002819|Alkylating Agents|alkylating agents|mesh-ancestor
6308182|NCT00002819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6308183|NCT00002819|Analgesics|analgesics|mesh-ancestor
6308184|NCT00002819|Sensory System Agents|sensory system agents|mesh-ancestor
6308185|NCT00002819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6308186|NCT00002819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6308187|NCT00002819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6308188|NCT00002819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6308189|NCT00002822|Cyclophosphamide|cyclophosphamide|mesh-list
6308190|NCT00002822|Ifosfamide|ifosfamide|mesh-list
6308191|NCT00002822|Carboplatin|carboplatin|mesh-list
6308192|NCT00002822|Doxorubicin|doxorubicin|mesh-list
6308193|NCT00002822|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6308194|NCT00002822|Etoposide|etoposide|mesh-list
6308195|NCT00002822|Vincristine|vincristine|mesh-list
6308196|NCT00002822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6308197|NCT00002822|Immunologic Factors|immunologic factors|mesh-ancestor
6308198|NCT00002822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6308199|NCT00002822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6308200|NCT00002822|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6308201|NCT00002822|Alkylating Agents|alkylating agents|mesh-ancestor
6308202|NCT00002822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6308203|NCT00002822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6308204|NCT00002822|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6308205|NCT00002822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6308206|NCT00002822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6308207|NCT00002822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6308208|NCT00002822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6308209|NCT00002822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6308210|NCT00002822|Tubulin Modulators|tubulin modulators|mesh-ancestor
6308211|NCT00002822|Antimitotic Agents|antimitotic agents|mesh-ancestor
6308212|NCT00002822|Mitosis Modulators|mitosis modulators|mesh-ancestor
6308213|NCT00002823|Etoposide|etoposide|mesh-list
6308214|NCT00002823|Vinorelbine|vinorelbine|mesh-list
6308215|NCT00002823|Vinblastine|vinblastine|mesh-list
6308216|NCT00002823|Vindesine|vindesine|mesh-list
6308217|NCT00002823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6308218|NCT00002823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6308219|NCT00002823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6308220|NCT00002823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6308221|NCT00002823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6308222|NCT00002823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6308223|NCT00002823|Tubulin Modulators|tubulin modulators|mesh-ancestor
6308224|NCT00002823|Antimitotic Agents|antimitotic agents|mesh-ancestor
6308225|NCT00002823|Mitosis Modulators|mitosis modulators|mesh-ancestor
6308226|NCT00002824|Ganciclovir|ganciclovir|mesh-list
6308227|NCT00002824|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6308228|NCT00002824|Antiviral Agents|antiviral agents|mesh-ancestor
6308229|NCT00002824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6308230|NCT00002824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6308231|NCT00002824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6308232|NCT00002824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6308233|NCT00002825|Docetaxel|docetaxel|mesh-list
6308234|NCT00002825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6308235|NCT00002825|Tubulin Modulators|tubulin modulators|mesh-ancestor
6308236|NCT00002825|Antimitotic Agents|antimitotic agents|mesh-ancestor
6308237|NCT00002825|Mitosis Modulators|mitosis modulators|mesh-ancestor
6308238|NCT00002825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6308239|NCT00002826|Paclitaxel|paclitaxel|mesh-list
6308240|NCT00002826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6308241|NCT00002826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6308242|NCT00002826|Tubulin Modulators|tubulin modulators|mesh-ancestor
6308243|NCT00002826|Antimitotic Agents|antimitotic agents|mesh-ancestor
6308244|NCT00002826|Mitosis Modulators|mitosis modulators|mesh-ancestor
6308245|NCT00002826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6308246|NCT00002827|Cobalt|cobalt|mesh-list
6308247|NCT00002827|Doxorubicin|doxorubicin|mesh-list
6308248|NCT00002827|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6308249|NCT00002827|Bleomycin|bleomycin|mesh-list
6308250|NCT00002827|Etoposide|etoposide|mesh-list
6308251|NCT00002827|Dexrazoxane|dexrazoxane|mesh-list
6308252|NCT00002827|Vincristine|vincristine|mesh-list
6308253|NCT00002827|Razoxane|razoxane|mesh-list
6308254|NCT00002827|Lenograstim|lenograstim|mesh-list
6308255|NCT00002827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6308256|NCT00002827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6308257|NCT00002827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6308258|NCT00002827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6308259|NCT00002827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6308260|NCT00002827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6308261|NCT00002827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6308262|NCT00002827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6308263|NCT00002827|Immunologic Factors|immunologic factors|mesh-ancestor
6308264|NCT00002827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6308265|NCT00002827|Tubulin Modulators|tubulin modulators|mesh-ancestor
6308266|NCT00002827|Antimitotic Agents|antimitotic agents|mesh-ancestor
6308267|NCT00002827|Mitosis Modulators|mitosis modulators|mesh-ancestor
6308268|NCT00002827|Trace Elements|trace elements|mesh-ancestor
6308269|NCT00002827|Micronutrients|micronutrients|mesh-ancestor
6308270|NCT00002827|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6308271|NCT00002827|Protective Agents|protective agents|mesh-ancestor
6308272|NCT00002828|Fluorouracil|fluorouracil|mesh-list
6308273|NCT00002828|Raltitrexed|raltitrexed|mesh-list
6308274|NCT00002828|Antimetabolites|antimetabolites|mesh-ancestor
6308275|NCT00002828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6308276|NCT00002828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6308277|NCT00002828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6308278|NCT00002828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6308279|NCT00002828|Immunologic Factors|immunologic factors|mesh-ancestor
6308280|NCT00002828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6308281|NCT00002828|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6308282|NCT00002828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6308283|NCT00002829|Interferons|interferons|mesh-list
6308284|NCT00002829|Interferon-alpha|interferon-alpha|mesh-list
6308285|NCT00002829|Cyclophosphamide|cyclophosphamide|mesh-list
6308286|NCT00002829|Etoposide|etoposide|mesh-list
6308287|NCT00002829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6308288|NCT00002829|Immunologic Factors|immunologic factors|mesh-ancestor
6308289|NCT00002829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6308290|NCT00002829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6308291|NCT00002829|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6308292|NCT00002829|Alkylating Agents|alkylating agents|mesh-ancestor
6308293|NCT00002829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6308294|NCT00002829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6308295|NCT00002829|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6308296|NCT00002829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6308297|NCT00002829|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6308298|NCT00002829|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6308299|NCT00002829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6308300|NCT00002829|Antiviral Agents|antiviral agents|mesh-ancestor
6308301|NCT00002829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6308302|NCT00002831|Cyclosporine|cyclosporine|mesh-list
6308303|NCT00002831|Methylprednisolone|methylprednisolone|mesh-list
6308304|NCT00002831|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6308305|NCT00002831|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6308306|NCT00002831|Prednisolone|prednisolone|mesh-list
6308307|NCT00002831|Prednisolone acetate|prednisolone acetate|mesh-list
6308308|NCT00002831|Cyclophosphamide|cyclophosphamide|mesh-list
6308309|NCT00002831|Busulfan|busulfan|mesh-list
6308310|NCT00002831|Methotrexate|methotrexate|mesh-list
6308311|NCT00002831|Decitabine|decitabine|mesh-list
6308312|NCT00002831|Tacrolimus|tacrolimus|mesh-list
6308313|NCT00002831|Cyclosporins|cyclosporins|mesh-list
6308314|NCT00002831|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6308315|NCT00002831|Prednisolone phosphate|prednisolone phosphate|mesh-list
6308316|NCT00002831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6308317|NCT00002831|Immunologic Factors|immunologic factors|mesh-ancestor
6308318|NCT00002831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6308319|NCT00002831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6308320|NCT00002831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6308321|NCT00002831|Alkylating Agents|alkylating agents|mesh-ancestor
6308322|NCT00002831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6308323|NCT00002831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6308324|NCT00002831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6308325|NCT00002831|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6308326|NCT00002831|Abortifacient Agents|abortifacient agents|mesh-ancestor
6308327|NCT00002831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6308328|NCT00002831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6308329|NCT00002831|Antimetabolites|antimetabolites|mesh-ancestor
6308330|NCT00002831|Dermatologic Agents|dermatologic agents|mesh-ancestor
6308331|NCT00002831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6308332|NCT00002831|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6308333|NCT00002831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6308334|NCT00002831|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6308335|NCT00002831|Antifungal Agents|antifungal agents|mesh-ancestor
6308336|NCT00002831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6308337|NCT00002831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6308338|NCT00002831|Antiemetics|antiemetics|mesh-ancestor
6308339|NCT00002831|Autonomic Agents|autonomic agents|mesh-ancestor
6308340|NCT00002831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6308341|NCT00002831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6308342|NCT00002831|Glucocorticoids|glucocorticoids|mesh-ancestor
6308343|NCT00002831|Hormones|hormones|mesh-ancestor
6308344|NCT00002831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6308345|NCT00002831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6308346|NCT00002831|Protective Agents|protective agents|mesh-ancestor
6308347|NCT00002831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6308348|NCT00002832|Cyclosporine|cyclosporine|mesh-list
6308349|NCT00002832|Decitabine|decitabine|mesh-list
6308350|NCT00002832|Cyclosporins|cyclosporins|mesh-list
6308351|NCT00002832|Immunologic Factors|immunologic factors|mesh-ancestor
6308352|NCT00002832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6308353|NCT00002832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6308354|NCT00002832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6308355|NCT00002832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6308356|NCT00002832|Antifungal Agents|antifungal agents|mesh-ancestor
6308357|NCT00002832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6308358|NCT00002832|Dermatologic Agents|dermatologic agents|mesh-ancestor
6308359|NCT00002832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6308360|NCT00002832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6308361|NCT00002832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6308362|NCT00002832|Antimetabolites|antimetabolites|mesh-ancestor
6308363|NCT00002832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6392372|NCT00195988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392373|NCT00195988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6392374|NCT00195988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6392375|NCT00195988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392376|NCT00195988|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6392377|NCT00195988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6392378|NCT00195988|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6392379|NCT00195988|Antitubercular Agents|antitubercular agents|mesh-ancestor
6392380|NCT00195988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6392381|NCT00195988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6396885|NCT00209833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396886|NCT00209833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6396887|NCT00209833|Immunologic Factors|immunologic factors|mesh-ancestor
6396888|NCT00209833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396889|NCT00209833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6396890|NCT00209833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6396891|NCT00209833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6396892|NCT00209833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6396893|NCT00209833|Antiviral Agents|antiviral agents|mesh-ancestor
6396894|NCT00209833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6396895|NCT00209833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6396896|NCT00209846|Gaboxadol|gaboxadol|mesh-list
6396897|NCT00209846|Analgesics|analgesics|mesh-ancestor
6396898|NCT00209846|Sensory System Agents|sensory system agents|mesh-ancestor
6396899|NCT00209846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6396900|NCT00209846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396901|NCT00209846|Anticonvulsants|anticonvulsants|mesh-ancestor
6396902|NCT00209846|GABA Agonists|gaba agonists|mesh-ancestor
6396903|NCT00209846|GABA Agents|gaba agents|mesh-ancestor
6396904|NCT00209846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6396905|NCT00209846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396906|NCT00209859|Cyclosporine|cyclosporine|mesh-list
6396907|NCT00209859|Betamethasone|betamethasone|mesh-list
6396908|NCT00209859|Methotrexate|methotrexate|mesh-list
6396909|NCT00209859|Cyclosporins|cyclosporins|mesh-list
6396910|NCT00209859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6396911|NCT00209859|Abortifacient Agents|abortifacient agents|mesh-ancestor
6396912|NCT00209859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6396913|NCT00209859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396914|NCT00209859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6396915|NCT00209859|Antimetabolites|antimetabolites|mesh-ancestor
6396916|NCT00209859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396917|NCT00209859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6396918|NCT00209859|Dermatologic Agents|dermatologic agents|mesh-ancestor
6396919|NCT00209859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6396920|NCT00209859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6396921|NCT00209859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6396922|NCT00209859|Immunologic Factors|immunologic factors|mesh-ancestor
6308364|NCT00002833|Cytarabine|cytarabine|mesh-list
6308365|NCT00002833|Cyclosporine|cyclosporine|mesh-list
6308366|NCT00002833|Methylprednisolone|methylprednisolone|mesh-list
6308367|NCT00002833|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6308368|NCT00002833|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6308369|NCT00002833|Prednisolone|prednisolone|mesh-list
6308370|NCT00002833|Prednisolone acetate|prednisolone acetate|mesh-list
6308371|NCT00002833|Fludarabine|fludarabine|mesh-list
6308372|NCT00002833|Fludarabine phosphate|fludarabine phosphate|mesh-list
6308373|NCT00002833|Idarubicin|idarubicin|mesh-list
6308374|NCT00002833|Cladribine|cladribine|mesh-list
6308375|NCT00002833|Cyclosporins|cyclosporins|mesh-list
6308376|NCT00002833|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6308377|NCT00002833|Prednisolone phosphate|prednisolone phosphate|mesh-list
6308378|NCT00002833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6308379|NCT00002833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6308380|NCT00002833|Antimetabolites|antimetabolites|mesh-ancestor
6308381|NCT00002833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6308382|NCT00002833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6308383|NCT00002833|Immunologic Factors|immunologic factors|mesh-ancestor
6308384|NCT00002833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6308385|NCT00002833|Antiviral Agents|antiviral agents|mesh-ancestor
6308386|NCT00002833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6308387|NCT00002833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6308388|NCT00002833|Antifungal Agents|antifungal agents|mesh-ancestor
6015998|NCT00361283|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6308389|NCT00002833|Dermatologic Agents|dermatologic agents|mesh-ancestor
6308390|NCT00002833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6308391|NCT00002833|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6308392|NCT00002833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6308393|NCT00002833|Antiemetics|antiemetics|mesh-ancestor
6308394|NCT00002833|Autonomic Agents|autonomic agents|mesh-ancestor
6308395|NCT00002833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6308396|NCT00002833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6308397|NCT00002833|Glucocorticoids|glucocorticoids|mesh-ancestor
6308398|NCT00002833|Hormones|hormones|mesh-ancestor
6308399|NCT00002833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6308400|NCT00002833|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6308401|NCT00002833|Protective Agents|protective agents|mesh-ancestor
6308402|NCT00002833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6308403|NCT00002833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6308404|NCT00002833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6308405|NCT00002833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6308406|NCT00002835|Leucovorin|leucovorin|mesh-list
6308407|NCT00002835|Interferons|interferons|mesh-list
6308408|NCT00002835|Cytarabine|cytarabine|mesh-list
6308409|NCT00002835|Interferon-alpha|interferon-alpha|mesh-list
6308410|NCT00002835|Methylprednisolone|methylprednisolone|mesh-list
6308411|NCT00002835|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6308412|NCT00002835|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6308413|NCT00002835|Prednisolone|prednisolone|mesh-list
6308414|NCT00002835|Prednisolone acetate|prednisolone acetate|mesh-list
6308415|NCT00002835|Cyclophosphamide|cyclophosphamide|mesh-list
6308416|NCT00002835|Melphalan|melphalan|mesh-list
6308417|NCT00002835|Ifosfamide|ifosfamide|mesh-list
6308418|NCT00002835|Carmustine|carmustine|mesh-list
6308419|NCT00002835|Cisplatin|cisplatin|mesh-list
6308420|NCT00002835|Methotrexate|methotrexate|mesh-list
6308421|NCT00002835|Etoposide|etoposide|mesh-list
6308422|NCT00002835|Vincristine|vincristine|mesh-list
6308423|NCT00002835|Mitoxantrone|mitoxantrone|mesh-list
6308424|NCT00002835|Idarubicin|idarubicin|mesh-list
6308425|NCT00002835|Bleomycin|bleomycin|mesh-list
6308426|NCT00002835|Levoleucovorin|levoleucovorin|mesh-list
6308427|NCT00002835|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6308428|NCT00002835|Prednisolone phosphate|prednisolone phosphate|mesh-list
6308429|NCT00002835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6308430|NCT00002835|Immunologic Factors|immunologic factors|mesh-ancestor
6308431|NCT00002835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6308432|NCT00002835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6308433|NCT00002835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6308434|NCT00002835|Alkylating Agents|alkylating agents|mesh-ancestor
6308435|NCT00002835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6308436|NCT00002835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6308437|NCT00002835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6308438|NCT00002835|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6308439|NCT00002835|Abortifacient Agents|abortifacient agents|mesh-ancestor
6308440|NCT00002835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6308441|NCT00002835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6308442|NCT00002835|Antimetabolites|antimetabolites|mesh-ancestor
6308443|NCT00002835|Dermatologic Agents|dermatologic agents|mesh-ancestor
6308444|NCT00002835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6308445|NCT00002835|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6308446|NCT00002835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6308447|NCT00002835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6308448|NCT00002835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6308449|NCT00002835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6308450|NCT00002835|Antiviral Agents|antiviral agents|mesh-ancestor
6308451|NCT00002835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6308452|NCT00002835|Antidotes|antidotes|mesh-ancestor
6308453|NCT00002835|Protective Agents|protective agents|mesh-ancestor
6308454|NCT00002835|Vitamin B Complex|vitamin b complex|mesh-ancestor
6308455|NCT00002835|Vitamins|vitamins|mesh-ancestor
6308456|NCT00002835|Micronutrients|micronutrients|mesh-ancestor
6308457|NCT00002835|Tubulin Modulators|tubulin modulators|mesh-ancestor
6308458|NCT00002835|Antimitotic Agents|antimitotic agents|mesh-ancestor
6308459|NCT00002835|Mitosis Modulators|mitosis modulators|mesh-ancestor
6308460|NCT00002835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6308461|NCT00002835|Antiemetics|antiemetics|mesh-ancestor
6308462|NCT00002835|Autonomic Agents|autonomic agents|mesh-ancestor
6308463|NCT00002835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6308464|NCT00002835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6308465|NCT00002835|Glucocorticoids|glucocorticoids|mesh-ancestor
6308466|NCT00002835|Hormones|hormones|mesh-ancestor
6308467|NCT00002835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6308468|NCT00002835|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6308469|NCT00002835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6308470|NCT00002835|Analgesics|analgesics|mesh-ancestor
6308471|NCT00002835|Sensory System Agents|sensory system agents|mesh-ancestor
6308472|NCT00002835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6308473|NCT00002836|Cyclophosphamide|cyclophosphamide|mesh-list
6308474|NCT00002836|Thiotepa|thiotepa|mesh-list
6308475|NCT00002836|Carmustine|carmustine|mesh-list
6308476|NCT00002836|Cisplatin|cisplatin|mesh-list
6308477|NCT00002836|Etoposide|etoposide|mesh-list
6308478|NCT00002836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6308479|NCT00002836|Immunologic Factors|immunologic factors|mesh-ancestor
6308480|NCT00002836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6308481|NCT00002836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6308482|NCT00002836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6308483|NCT00002836|Alkylating Agents|alkylating agents|mesh-ancestor
6308484|NCT00002836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6308485|NCT00002836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6308486|NCT00002836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6308487|NCT00002836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6308488|NCT00002836|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6308489|NCT00002836|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6308490|NCT00002836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6308491|NCT00002837|Paclitaxel|paclitaxel|mesh-list
6308492|NCT00002837|Cyclophosphamide|cyclophosphamide|mesh-list
6308493|NCT00002837|Doxorubicin|doxorubicin|mesh-list
6308494|NCT00002837|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6308495|NCT00002837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6308496|NCT00002837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6308497|NCT00002837|Tubulin Modulators|tubulin modulators|mesh-ancestor
6308498|NCT00002837|Antimitotic Agents|antimitotic agents|mesh-ancestor
6308499|NCT00002837|Mitosis Modulators|mitosis modulators|mesh-ancestor
6308500|NCT00002837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6308501|NCT00002837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6308502|NCT00002837|Immunologic Factors|immunologic factors|mesh-ancestor
6308503|NCT00002837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6308504|NCT00002837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6308505|NCT00002837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6308506|NCT00002837|Alkylating Agents|alkylating agents|mesh-ancestor
6308507|NCT00002837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6308508|NCT00002837|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6308509|NCT00002837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6308510|NCT00002837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6308511|NCT00002837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6308512|NCT00002838|Cyclophosphamide|cyclophosphamide|mesh-list
6308513|NCT00002838|Fludarabine|fludarabine|mesh-list
6308514|NCT00002838|Fludarabine phosphate|fludarabine phosphate|mesh-list
6308515|NCT00002838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6308516|NCT00002838|Immunologic Factors|immunologic factors|mesh-ancestor
6308517|NCT00002838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6308518|NCT00002838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6308519|NCT00002838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6308520|NCT00002838|Alkylating Agents|alkylating agents|mesh-ancestor
6308521|NCT00002838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6308522|NCT00002838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6308523|NCT00002838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6308524|NCT00002838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6308525|NCT00002838|Antimetabolites|antimetabolites|mesh-ancestor
6308526|NCT00002839|Fluorouracil|fluorouracil|mesh-list
6308527|NCT00002839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6308528|NCT00002839|Antimetabolites|antimetabolites|mesh-ancestor
6308529|NCT00002839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6308530|NCT00002839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6308531|NCT00002839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6308532|NCT00002839|Immunologic Factors|immunologic factors|mesh-ancestor
6308533|NCT00002839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6308534|NCT00002840|Vincristine|vincristine|mesh-list
6308535|NCT00002840|Lomustine|lomustine|mesh-list
6308536|NCT00002840|Procarbazine|procarbazine|mesh-list
6308537|NCT00002840|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6308538|NCT00002840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6308539|NCT00002840|Tubulin Modulators|tubulin modulators|mesh-ancestor
6308540|NCT00002840|Antimitotic Agents|antimitotic agents|mesh-ancestor
6308541|NCT00002840|Mitosis Modulators|mitosis modulators|mesh-ancestor
6308542|NCT00002840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6308543|NCT00002840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6308544|NCT00002840|Alkylating Agents|alkylating agents|mesh-ancestor
6308545|NCT00002844|Cyclophosphamide|cyclophosphamide|mesh-list
6308546|NCT00002844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6308547|NCT00002844|Immunologic Factors|immunologic factors|mesh-ancestor
6392382|NCT00196131|Morphine|morphine|mesh-list
6308548|NCT00002844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6308549|NCT00002844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6308550|NCT00002844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6308551|NCT00002844|Alkylating Agents|alkylating agents|mesh-ancestor
6308552|NCT00002844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6308553|NCT00002844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6308554|NCT00002844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6308555|NCT00002845|Aldesleukin|aldesleukin|mesh-list
6308556|NCT00002845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6308557|NCT00002845|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6308558|NCT00002845|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6308559|NCT00002845|Antiviral Agents|antiviral agents|mesh-ancestor
6308560|NCT00002845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6308561|NCT00002846|Aldesleukin|aldesleukin|mesh-list
6308562|NCT00002846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6308563|NCT00002846|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6308564|NCT00002846|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6308565|NCT00002846|Antiviral Agents|antiviral agents|mesh-ancestor
6308566|NCT00002846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6308567|NCT00002847|Interferons|interferons|mesh-list
6308568|NCT00002847|Interferon-alpha|interferon-alpha|mesh-list
6308569|NCT00002847|Aldesleukin|aldesleukin|mesh-list
6308570|NCT00002847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6308571|NCT00002847|Antiviral Agents|antiviral agents|mesh-ancestor
6308572|NCT00002847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6308573|NCT00002847|Immunologic Factors|immunologic factors|mesh-ancestor
6308574|NCT00002847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6308575|NCT00002847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6308576|NCT00002847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6308577|NCT00002849|Interferons|interferons|mesh-list
6308578|NCT00002849|Interferon-alpha|interferon-alpha|mesh-list
6308579|NCT00002849|Dexamethasone|dexamethasone|mesh-list
6308580|NCT00002849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6308581|NCT00002849|Antiemetics|antiemetics|mesh-ancestor
6308582|NCT00002849|Autonomic Agents|autonomic agents|mesh-ancestor
6308583|NCT00002849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6308584|NCT00002849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6308585|NCT00002849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6308586|NCT00002849|Glucocorticoids|glucocorticoids|mesh-ancestor
6308587|NCT00002849|Hormones|hormones|mesh-ancestor
6308588|NCT00002849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6308589|NCT00002849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6308590|NCT00002849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6308591|NCT00002849|Antiviral Agents|antiviral agents|mesh-ancestor
6308592|NCT00002849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6308593|NCT00002849|Immunologic Factors|immunologic factors|mesh-ancestor
6308594|NCT00002852|Paclitaxel|paclitaxel|mesh-list
6308595|NCT00002852|Carboplatin|carboplatin|mesh-list
6308596|NCT00002852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6308597|NCT00002852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6308598|NCT00002852|Tubulin Modulators|tubulin modulators|mesh-ancestor
6308599|NCT00002852|Antimitotic Agents|antimitotic agents|mesh-ancestor
6308600|NCT00002852|Mitosis Modulators|mitosis modulators|mesh-ancestor
6308601|NCT00002852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6308602|NCT00002854|Paclitaxel|paclitaxel|mesh-list
6308603|NCT00002854|Etoposide|etoposide|mesh-list
6308604|NCT00002854|Cyclophosphamide|cyclophosphamide|mesh-list
6308605|NCT00002854|Carboplatin|carboplatin|mesh-list
6308606|NCT00002854|Ifosfamide|ifosfamide|mesh-list
6308607|NCT00002854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6308608|NCT00002854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6308609|NCT00002854|Tubulin Modulators|tubulin modulators|mesh-ancestor
6308610|NCT00002854|Antimitotic Agents|antimitotic agents|mesh-ancestor
6308611|NCT00002854|Mitosis Modulators|mitosis modulators|mesh-ancestor
6308612|NCT00002854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6308613|NCT00002854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6308614|NCT00002854|Immunologic Factors|immunologic factors|mesh-ancestor
6308615|NCT00002854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6308616|NCT00002854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6308617|NCT00002854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6308618|NCT00002854|Alkylating Agents|alkylating agents|mesh-ancestor
6308619|NCT00002854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6308620|NCT00002854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6308621|NCT00002854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6308622|NCT00002854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6308623|NCT00002855|Ketoconazole|ketoconazole|mesh-list
6308624|NCT00002855|Hydrocortisone|hydrocortisone|mesh-list
6308625|NCT00002855|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6308626|NCT00002855|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6308627|NCT00002855|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6308628|NCT00002855|Doxorubicin|doxorubicin|mesh-list
6308629|NCT00002855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6308630|NCT00002855|Bicalutamide|bicalutamide|mesh-list
6308631|NCT00002855|Vinblastine|vinblastine|mesh-list
6308632|NCT00002855|Flutamide|flutamide|mesh-list
6308633|NCT00002855|Estramustine|estramustine|mesh-list
6308634|NCT00002855|Nilutamide|nilutamide|mesh-list
6308635|NCT00002855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6308636|NCT00002855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6308637|NCT00002855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6308638|NCT00002855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6308639|NCT00002855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6308640|NCT00002855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6308641|NCT00002855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6308642|NCT00002855|Antifungal Agents|antifungal agents|mesh-ancestor
6308643|NCT00002855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6308644|NCT00002855|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6308645|NCT00002855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6308646|NCT00002855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6308647|NCT00002855|Hormone Antagonists|hormone antagonists|mesh-ancestor
6308648|NCT00002855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6308649|NCT00002855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6308650|NCT00002855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6308651|NCT00002855|Androgen Antagonists|androgen antagonists|mesh-ancestor
6308652|NCT00002855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6308653|NCT00002855|Tubulin Modulators|tubulin modulators|mesh-ancestor
6308654|NCT00002855|Antimitotic Agents|antimitotic agents|mesh-ancestor
6308655|NCT00002855|Mitosis Modulators|mitosis modulators|mesh-ancestor
6308656|NCT00002855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6308657|NCT00002855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6308658|NCT00002855|Alkylating Agents|alkylating agents|mesh-ancestor
6308659|NCT00002858|Cyclophosphamide|cyclophosphamide|mesh-list
6308660|NCT00002858|Doxorubicin|doxorubicin|mesh-list
6308661|NCT00002858|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6308662|NCT00002858|Etoposide|etoposide|mesh-list
6308663|NCT00002858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6308664|NCT00002858|Immunologic Factors|immunologic factors|mesh-ancestor
6308665|NCT00002858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6308666|NCT00002858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6308667|NCT00002858|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6308668|NCT00002858|Alkylating Agents|alkylating agents|mesh-ancestor
6308669|NCT00002858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6308670|NCT00002858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6308671|NCT00002858|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6308672|NCT00002858|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6308673|NCT00002858|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6308674|NCT00002858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6308675|NCT00002858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6308676|NCT00002858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6015999|NCT00361283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6308677|NCT00002862|Perillyl alcohol|perillyl alcohol|mesh-list
6308678|NCT00002862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6308679|NCT00002862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6308680|NCT00002862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6308681|NCT00002864|Tamoxifen|tamoxifen|mesh-list
6308682|NCT00002864|Octreotide|octreotide|mesh-list
6308683|NCT00002864|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6308684|NCT00002864|Hormone Antagonists|hormone antagonists|mesh-ancestor
6308685|NCT00002864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6308686|NCT00002864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6308687|NCT00002864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6308688|NCT00002864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6308689|NCT00002864|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6308690|NCT00002864|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6308691|NCT00002864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6308692|NCT00002864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6308693|NCT00002865|Leucovorin|leucovorin|mesh-list
6308694|NCT00002865|Cobalt|cobalt|mesh-list
6016000|NCT00361335|Golimumab|golimumab|mesh-list
6016001|NCT00361335|Methotrexate|methotrexate|mesh-list
6016002|NCT00361335|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6016003|NCT00361335|Abortifacient Agents|abortifacient agents|mesh-ancestor
6016004|NCT00361335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6016005|NCT00361335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016006|NCT00361335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6016007|NCT00361335|Antimetabolites|antimetabolites|mesh-ancestor
6016008|NCT00361335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6308695|NCT00002865|Cytarabine|cytarabine|mesh-list
6308696|NCT00002865|Dexamethasone|dexamethasone|mesh-list
6308697|NCT00002865|Hydrocortisone|hydrocortisone|mesh-list
6308698|NCT00002865|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6308699|NCT00002865|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6308700|NCT00002865|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6308701|NCT00002865|Cyclophosphamide|cyclophosphamide|mesh-list
6308702|NCT00002865|Ifosfamide|ifosfamide|mesh-list
6308703|NCT00002865|Doxorubicin|doxorubicin|mesh-list
6308704|NCT00002865|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6308705|NCT00002865|Methotrexate|methotrexate|mesh-list
6308706|NCT00002865|Etoposide|etoposide|mesh-list
6308707|NCT00002865|Vincristine|vincristine|mesh-list
6308708|NCT00002865|Levoleucovorin|levoleucovorin|mesh-list
6308709|NCT00002865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6308710|NCT00002865|Immunologic Factors|immunologic factors|mesh-ancestor
6308711|NCT00002865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6308712|NCT00002865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6308713|NCT00002865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6308714|NCT00002865|Alkylating Agents|alkylating agents|mesh-ancestor
6308715|NCT00002865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6308716|NCT00002865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6308717|NCT00002865|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6308718|NCT00002865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6308719|NCT00002865|Antiemetics|antiemetics|mesh-ancestor
6308720|NCT00002865|Autonomic Agents|autonomic agents|mesh-ancestor
6308721|NCT00002865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6308722|NCT00002865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6308723|NCT00002865|Glucocorticoids|glucocorticoids|mesh-ancestor
6308724|NCT00002865|Hormones|hormones|mesh-ancestor
6308725|NCT00002865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6308726|NCT00002865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6308727|NCT00002865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6308728|NCT00002865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6308729|NCT00002865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6308730|NCT00002865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6308731|NCT00002865|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6308732|NCT00002865|Abortifacient Agents|abortifacient agents|mesh-ancestor
6308733|NCT00002865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6308734|NCT00002865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6308735|NCT00002865|Antimetabolites|antimetabolites|mesh-ancestor
6308736|NCT00002865|Dermatologic Agents|dermatologic agents|mesh-ancestor
6308737|NCT00002865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6308738|NCT00002865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6308739|NCT00002865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6308740|NCT00002865|Antiviral Agents|antiviral agents|mesh-ancestor
6308741|NCT00002865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6308742|NCT00002865|Antidotes|antidotes|mesh-ancestor
6308743|NCT00002865|Protective Agents|protective agents|mesh-ancestor
6308744|NCT00002865|Vitamin B Complex|vitamin b complex|mesh-ancestor
6308745|NCT00002865|Vitamins|vitamins|mesh-ancestor
6308746|NCT00002865|Micronutrients|micronutrients|mesh-ancestor
6308747|NCT00002865|Tubulin Modulators|tubulin modulators|mesh-ancestor
6308748|NCT00002865|Antimitotic Agents|antimitotic agents|mesh-ancestor
6308749|NCT00002865|Mitosis Modulators|mitosis modulators|mesh-ancestor
6308750|NCT00002865|Trace Elements|trace elements|mesh-ancestor
6308751|NCT00002866|Docetaxel|docetaxel|mesh-list
6308752|NCT00002866|Epirubicin|epirubicin|mesh-list
6308753|NCT00002866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6308754|NCT00002866|Tubulin Modulators|tubulin modulators|mesh-ancestor
6308755|NCT00002866|Antimitotic Agents|antimitotic agents|mesh-ancestor
6308756|NCT00002866|Mitosis Modulators|mitosis modulators|mesh-ancestor
6308757|NCT00002866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6308758|NCT00002866|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6308759|NCT00002866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6308760|NCT00002866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6308761|NCT00002866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6308762|NCT00002868|Interferons|interferons|mesh-list
6308763|NCT00002868|Cytarabine|cytarabine|mesh-list
6308764|NCT00002868|Interferon-alpha|interferon-alpha|mesh-list
6308765|NCT00002868|Etoposide|etoposide|mesh-list
6308766|NCT00002868|Idarubicin|idarubicin|mesh-list
6308767|NCT00002868|Busulfan|busulfan|mesh-list
6308768|NCT00002868|Hydroxyurea|hydroxyurea|mesh-list
6308769|NCT00002868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6308770|NCT00002868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6308771|NCT00002868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6308772|NCT00002868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6308773|NCT00002868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6308774|NCT00002868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6308775|NCT00002868|Antiviral Agents|antiviral agents|mesh-ancestor
6308776|NCT00002868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6308777|NCT00002868|Immunologic Factors|immunologic factors|mesh-ancestor
6308778|NCT00002868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6308779|NCT00002868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5724316|NCT03188068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5724317|NCT03188068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5724318|NCT03188068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5724319|NCT03188068|Antifungal Agents|antifungal agents|mesh-ancestor
5724320|NCT03188068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5724321|NCT03188068|Immunologic Factors|immunologic factors|mesh-ancestor
5724322|NCT03188068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724323|NCT03188068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5724324|NCT03188068|Glucocorticoids|glucocorticoids|mesh-ancestor
5724325|NCT03188068|Hormones|hormones|mesh-ancestor
6308780|NCT00002868|Antimetabolites|antimetabolites|mesh-ancestor
6308781|NCT00002868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6308782|NCT00002868|Alkylating Agents|alkylating agents|mesh-ancestor
6308783|NCT00002868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5724326|NCT03188068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5724327|NCT03188068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6308784|NCT00002868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6308785|NCT00002868|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6308786|NCT00002868|Antisickling Agents|antisickling agents|mesh-ancestor
6308787|NCT00002868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6308788|NCT00002869|Interferons|interferons|mesh-list
6308789|NCT00002869|Cytarabine|cytarabine|mesh-list
6308790|NCT00002869|Interferon-alpha|interferon-alpha|mesh-list
6308791|NCT00002869|Hydroxyurea|hydroxyurea|mesh-list
6308792|NCT00002869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6308793|NCT00002869|Antiviral Agents|antiviral agents|mesh-ancestor
6308794|NCT00002869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6308795|NCT00002869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6308796|NCT00002869|Antimetabolites|antimetabolites|mesh-ancestor
6308797|NCT00002869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6308798|NCT00002869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6308799|NCT00002869|Immunologic Factors|immunologic factors|mesh-ancestor
6308800|NCT00002869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6308801|NCT00002869|Antisickling Agents|antisickling agents|mesh-ancestor
6308802|NCT00002869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6308803|NCT00002869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6308804|NCT00002870|Cyclophosphamide|cyclophosphamide|mesh-list
6308805|NCT00002870|Thiotepa|thiotepa|mesh-list
6308806|NCT00002870|Fluorouracil|fluorouracil|mesh-list
6308807|NCT00002870|Epirubicin|epirubicin|mesh-list
6308808|NCT00002870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6308809|NCT00002870|Immunologic Factors|immunologic factors|mesh-ancestor
6308810|NCT00002870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6308811|NCT00002870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6308812|NCT00002870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6308813|NCT00002870|Alkylating Agents|alkylating agents|mesh-ancestor
6308814|NCT00002870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6308815|NCT00002870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6308816|NCT00002870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6308817|NCT00002870|Antimetabolites|antimetabolites|mesh-ancestor
6308818|NCT00002870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6308819|NCT00002870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6308820|NCT00002870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6308821|NCT00002870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6308822|NCT00002870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6308823|NCT00002872|Doxycycline|doxycycline|mesh-list
6308824|NCT00002872|Bleomycin|bleomycin|mesh-list
6308825|NCT00002872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6308826|NCT00002872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6308827|NCT00002872|Antimalarials|antimalarials|mesh-ancestor
6308828|NCT00002872|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6308829|NCT00002872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6308830|NCT00002872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6308831|NCT00002872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6308832|NCT00002875|Cyclophosphamide|cyclophosphamide|mesh-list
6308833|NCT00002875|Lomustine|lomustine|mesh-list
6308834|NCT00002875|Cisplatin|cisplatin|mesh-list
6308835|NCT00002875|Vincristine|vincristine|mesh-list
6308836|NCT00002875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6308837|NCT00002875|Immunologic Factors|immunologic factors|mesh-ancestor
6308838|NCT00002875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6308839|NCT00002875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6308840|NCT00002875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6308841|NCT00002875|Alkylating Agents|alkylating agents|mesh-ancestor
6308842|NCT00002875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6308843|NCT00002875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6308844|NCT00002875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6308845|NCT00002875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6308846|NCT00002875|Tubulin Modulators|tubulin modulators|mesh-ancestor
6308847|NCT00002875|Antimitotic Agents|antimitotic agents|mesh-ancestor
6308848|NCT00002875|Mitosis Modulators|mitosis modulators|mesh-ancestor
6308849|NCT00002876|Etoposide|etoposide|mesh-list
6308850|NCT00002876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6308851|NCT00002876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6308852|NCT00002876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6308853|NCT00002876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6308854|NCT00002876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6308855|NCT00002876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6308856|NCT00002878|Dexamethasone|dexamethasone|mesh-list
6308857|NCT00002878|Doxorubicin|doxorubicin|mesh-list
6308858|NCT00002878|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6308859|NCT00002878|Vincristine|vincristine|mesh-list
6308860|NCT00002878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6308861|NCT00002878|Antiemetics|antiemetics|mesh-ancestor
6308862|NCT00002878|Autonomic Agents|autonomic agents|mesh-ancestor
6308863|NCT00002878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6308864|NCT00002878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6308865|NCT00002878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6308866|NCT00002878|Glucocorticoids|glucocorticoids|mesh-ancestor
6308867|NCT00002878|Hormones|hormones|mesh-ancestor
6308868|NCT00002878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6308869|NCT00002878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6308870|NCT00002878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6308871|NCT00002878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6308872|NCT00002878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6308873|NCT00002878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6308874|NCT00002878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6308875|NCT00002878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6308876|NCT00002878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6308877|NCT00002878|Tubulin Modulators|tubulin modulators|mesh-ancestor
6308878|NCT00002878|Antimitotic Agents|antimitotic agents|mesh-ancestor
6308879|NCT00002878|Mitosis Modulators|mitosis modulators|mesh-ancestor
6308880|NCT00002879|Cladribine|cladribine|mesh-list
6308881|NCT00002879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6308882|NCT00002879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6308883|NCT00002879|Immunologic Factors|immunologic factors|mesh-ancestor
6308884|NCT00002879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6308885|NCT00002880|Etoposide|etoposide|mesh-list
6308886|NCT00002880|Etoposide phosphate|etoposide phosphate|mesh-list
6308887|NCT00002880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6308888|NCT00002880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6308889|NCT00002880|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6308890|NCT00002880|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6308891|NCT00002880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6308892|NCT00002880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6308893|NCT00002881|Suramin|suramin|mesh-list
6308894|NCT00002881|Hydrocortisone|hydrocortisone|mesh-list
6308895|NCT00002881|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6308896|NCT00002881|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6308897|NCT00002881|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6308898|NCT00002881|Leuprolide|leuprolide|mesh-list
6308899|NCT00002881|Goserelin|goserelin|mesh-list
6308900|NCT00002881|Flutamide|flutamide|mesh-list
6308901|NCT00002881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6308902|NCT00002881|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6308903|NCT00002881|Fertility Agents|fertility agents|mesh-ancestor
6308904|NCT00002881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6308905|NCT00002881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6308906|NCT00002881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6308907|NCT00002881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6308908|NCT00002881|Androgen Antagonists|androgen antagonists|mesh-ancestor
6308909|NCT00002881|Hormone Antagonists|hormone antagonists|mesh-ancestor
6308910|NCT00002881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6308911|NCT00002881|Antinematodal Agents|antinematodal agents|mesh-ancestor
6308912|NCT00002881|Anthelmintics|anthelmintics|mesh-ancestor
5724328|NCT03187899|Ropivacaine|ropivacaine|mesh-list
5724329|NCT03187899|Anesthetics, Local|anesthetics, local|mesh-ancestor
5724330|NCT03187899|Anesthetics|anesthetics|mesh-ancestor
5724331|NCT03187899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5724332|NCT03187899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6308913|NCT00002881|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6308914|NCT00002881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6308915|NCT00002881|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6308916|NCT00002881|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6308917|NCT00002882|Interferons|interferons|mesh-list
6308918|NCT00002882|Interferon-alpha|interferon-alpha|mesh-list
6308919|NCT00002882|Interferon alpha-2|interferon alpha-2|mesh-list
6308920|NCT00002882|Aldesleukin|aldesleukin|mesh-list
6308921|NCT00002882|Cisplatin|cisplatin|mesh-list
6308922|NCT00002882|Interleukin-2|interleukin-2|mesh-list
6308923|NCT00002882|Dacarbazine|dacarbazine|mesh-list
5724333|NCT03187899|Sensory System Agents|sensory system agents|mesh-ancestor
6308924|NCT00002882|Vinblastine|vinblastine|mesh-list
6308925|NCT00002882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6308926|NCT00002882|Antiviral Agents|antiviral agents|mesh-ancestor
6308927|NCT00002882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6308928|NCT00002882|Immunologic Factors|immunologic factors|mesh-ancestor
6308929|NCT00002882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6308930|NCT00002882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6308931|NCT00002882|Analgesics|analgesics|mesh-ancestor
6308932|NCT00002882|Sensory System Agents|sensory system agents|mesh-ancestor
6308933|NCT00002882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6308934|NCT00002882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6308935|NCT00002882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6308936|NCT00002882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6308937|NCT00002882|Alkylating Agents|alkylating agents|mesh-ancestor
6308938|NCT00002882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6308939|NCT00002882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6308940|NCT00002882|Tubulin Modulators|tubulin modulators|mesh-ancestor
6308941|NCT00002882|Antimitotic Agents|antimitotic agents|mesh-ancestor
6308942|NCT00002882|Mitosis Modulators|mitosis modulators|mesh-ancestor
6308943|NCT00002883|Fluorouracil|fluorouracil|mesh-list
6308944|NCT00002883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6308945|NCT00002883|Antimetabolites|antimetabolites|mesh-ancestor
6308946|NCT00002883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6308947|NCT00002883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6308948|NCT00002883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6308949|NCT00002883|Immunologic Factors|immunologic factors|mesh-ancestor
6308950|NCT00002883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6308951|NCT00002884|Fluorouracil|fluorouracil|mesh-list
6308952|NCT00002884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6308953|NCT00002884|Antimetabolites|antimetabolites|mesh-ancestor
6308954|NCT00002884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6308955|NCT00002884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6308956|NCT00002884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6308957|NCT00002884|Immunologic Factors|immunologic factors|mesh-ancestor
6308958|NCT00002884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6308959|NCT00002887|Etoposide|etoposide|mesh-list
6308960|NCT00002887|Vinorelbine|vinorelbine|mesh-list
6308961|NCT00002887|Hydroxyurea|hydroxyurea|mesh-list
6308962|NCT00002887|Vinblastine|vinblastine|mesh-list
6308963|NCT00002887|Vindesine|vindesine|mesh-list
6308964|NCT00002887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6308965|NCT00002887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6308966|NCT00002887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6308967|NCT00002887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6308968|NCT00002887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6308969|NCT00002887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6308970|NCT00002887|Tubulin Modulators|tubulin modulators|mesh-ancestor
6308971|NCT00002887|Antimitotic Agents|antimitotic agents|mesh-ancestor
6308972|NCT00002887|Mitosis Modulators|mitosis modulators|mesh-ancestor
6308973|NCT00002887|Antisickling Agents|antisickling agents|mesh-ancestor
6308974|NCT00002887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6308975|NCT00002888|Paclitaxel|paclitaxel|mesh-list
6308976|NCT00002888|Fluorouracil|fluorouracil|mesh-list
6308977|NCT00002888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6308978|NCT00002888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6308979|NCT00002888|Tubulin Modulators|tubulin modulators|mesh-ancestor
6308980|NCT00002888|Antimitotic Agents|antimitotic agents|mesh-ancestor
6308981|NCT00002888|Mitosis Modulators|mitosis modulators|mesh-ancestor
6308982|NCT00002888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6308983|NCT00002888|Antimetabolites|antimetabolites|mesh-ancestor
6308984|NCT00002888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6308985|NCT00002888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6308986|NCT00002888|Immunologic Factors|immunologic factors|mesh-ancestor
6308987|NCT00002888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6308988|NCT00002889|Leuprolide|leuprolide|mesh-list
6308989|NCT00002889|Goserelin|goserelin|mesh-list
6308990|NCT00002889|Flutamide|flutamide|mesh-list
6308991|NCT00002889|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6308992|NCT00002889|Fertility Agents|fertility agents|mesh-ancestor
6308993|NCT00002889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6308994|NCT00002889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6308995|NCT00002889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6308996|NCT00002889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6308997|NCT00002889|Androgen Antagonists|androgen antagonists|mesh-ancestor
6308998|NCT00002889|Hormone Antagonists|hormone antagonists|mesh-ancestor
6308999|NCT00002889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6309000|NCT00002890|Lintuzumab|lintuzumab|mesh-list
6309001|NCT00002890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6309002|NCT00002890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309003|NCT00002892|Interferons|interferons|mesh-list
6309004|NCT00002892|Interferon-alpha|interferon-alpha|mesh-list
6309005|NCT00002892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309006|NCT00002892|Antiviral Agents|antiviral agents|mesh-ancestor
6309007|NCT00002892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6309008|NCT00002892|Immunologic Factors|immunologic factors|mesh-ancestor
6309009|NCT00002892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6309010|NCT00002893|Leucovorin|leucovorin|mesh-list
6309011|NCT00002893|Fluorouracil|fluorouracil|mesh-list
6309012|NCT00002893|Raltitrexed|raltitrexed|mesh-list
6309013|NCT00002893|Calcium|calcium|mesh-list
6309014|NCT00002893|Levoleucovorin|levoleucovorin|mesh-list
6309015|NCT00002893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6309016|NCT00002893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6309017|NCT00002893|Antimetabolites|antimetabolites|mesh-ancestor
6309018|NCT00002893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309019|NCT00002893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6309020|NCT00002893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309021|NCT00002893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6309022|NCT00002893|Immunologic Factors|immunologic factors|mesh-ancestor
6309023|NCT00002893|Antidotes|antidotes|mesh-ancestor
6309024|NCT00002893|Protective Agents|protective agents|mesh-ancestor
6309025|NCT00002893|Vitamin B Complex|vitamin b complex|mesh-ancestor
6309026|NCT00002893|Vitamins|vitamins|mesh-ancestor
6309027|NCT00002893|Micronutrients|micronutrients|mesh-ancestor
5724334|NCT03187899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5724671|NCT03185611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5724672|NCT03185611|Antimetabolites|antimetabolites|mesh-ancestor
5724673|NCT03185611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724674|NCT03185611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6309028|NCT00002893|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5724675|NCT03185611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5724676|NCT03185611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6309029|NCT00002893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6309030|NCT00002894|Paclitaxel|paclitaxel|mesh-list
6309031|NCT00002894|Carboplatin|carboplatin|mesh-list
6309032|NCT00002894|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6309033|NCT00002894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309034|NCT00002894|Tubulin Modulators|tubulin modulators|mesh-ancestor
6309035|NCT00002894|Antimitotic Agents|antimitotic agents|mesh-ancestor
6309036|NCT00002894|Mitosis Modulators|mitosis modulators|mesh-ancestor
6309037|NCT00002894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309038|NCT00002896|Leucovorin|leucovorin|mesh-list
6309039|NCT00002896|Cobalt|cobalt|mesh-list
6309040|NCT00002896|Fluorouracil|fluorouracil|mesh-list
6309041|NCT00002896|Calcium|calcium|mesh-list
6309042|NCT00002896|Levoleucovorin|levoleucovorin|mesh-list
6309043|NCT00002896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6309044|NCT00002896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6309045|NCT00002896|Antimetabolites|antimetabolites|mesh-ancestor
6309046|NCT00002896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309047|NCT00002896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6309048|NCT00002896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309049|NCT00002896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6309050|NCT00002896|Immunologic Factors|immunologic factors|mesh-ancestor
6309051|NCT00002896|Antidotes|antidotes|mesh-ancestor
6309052|NCT00002896|Protective Agents|protective agents|mesh-ancestor
6309053|NCT00002896|Vitamin B Complex|vitamin b complex|mesh-ancestor
6309054|NCT00002896|Vitamins|vitamins|mesh-ancestor
6309055|NCT00002896|Micronutrients|micronutrients|mesh-ancestor
6309056|NCT00002896|Trace Elements|trace elements|mesh-ancestor
6309057|NCT00002897|Fluorouracil|fluorouracil|mesh-list
6309058|NCT00002897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309059|NCT00002897|Antimetabolites|antimetabolites|mesh-ancestor
6309060|NCT00002897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309061|NCT00002897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6309062|NCT00002897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6309063|NCT00002897|Immunologic Factors|immunologic factors|mesh-ancestor
6309064|NCT00002897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6309065|NCT00002898|Dactinomycin|dactinomycin|mesh-list
6309066|NCT00002898|Cyclophosphamide|cyclophosphamide|mesh-list
6309067|NCT00002898|Ifosfamide|ifosfamide|mesh-list
6309068|NCT00002898|Carboplatin|carboplatin|mesh-list
6309069|NCT00002898|Etoposide|etoposide|mesh-list
6309070|NCT00002898|Vincristine|vincristine|mesh-list
6309071|NCT00002898|Epirubicin|epirubicin|mesh-list
6309072|NCT00002898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6309073|NCT00002898|Immunologic Factors|immunologic factors|mesh-ancestor
6309074|NCT00002898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6309075|NCT00002898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6309076|NCT00002898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6309077|NCT00002898|Alkylating Agents|alkylating agents|mesh-ancestor
6309078|NCT00002898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309079|NCT00002898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309080|NCT00002898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6309081|NCT00002898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6309082|NCT00002898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6309083|NCT00002898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6309084|NCT00002898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6309085|NCT00002898|Tubulin Modulators|tubulin modulators|mesh-ancestor
6309086|NCT00002898|Antimitotic Agents|antimitotic agents|mesh-ancestor
6309087|NCT00002898|Mitosis Modulators|mitosis modulators|mesh-ancestor
6309088|NCT00002898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6309089|NCT00002898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6309090|NCT00002898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6309091|NCT00002898|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6309092|NCT00002898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6309093|NCT00002901|Docetaxel|docetaxel|mesh-list
6309094|NCT00002901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309095|NCT00002901|Tubulin Modulators|tubulin modulators|mesh-ancestor
6309096|NCT00002901|Antimitotic Agents|antimitotic agents|mesh-ancestor
6309097|NCT00002901|Mitosis Modulators|mitosis modulators|mesh-ancestor
6309098|NCT00002901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309099|NCT00002902|Irinotecan|irinotecan|mesh-list
6309100|NCT00002902|Raltitrexed|raltitrexed|mesh-list
6309101|NCT00002902|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6309102|NCT00002902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6309103|NCT00002902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6309104|NCT00002902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309105|NCT00002902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309106|NCT00002902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6309107|NCT00002902|Antimetabolites|antimetabolites|mesh-ancestor
6309108|NCT00002902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6309109|NCT00002903|Docetaxel|docetaxel|mesh-list
6309110|NCT00002903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309111|NCT00002903|Tubulin Modulators|tubulin modulators|mesh-ancestor
6309112|NCT00002903|Antimitotic Agents|antimitotic agents|mesh-ancestor
6309113|NCT00002903|Mitosis Modulators|mitosis modulators|mesh-ancestor
6309114|NCT00002903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309115|NCT00002904|Trabectedin|trabectedin|mesh-list
6309116|NCT00002904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6309117|NCT00002904|Alkylating Agents|alkylating agents|mesh-ancestor
6309118|NCT00002904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309119|NCT00002904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309120|NCT00002905|Zidovudine|zidovudine|mesh-list
6016009|NCT00361335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6016010|NCT00361335|Dermatologic Agents|dermatologic agents|mesh-ancestor
6016011|NCT00361335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6016012|NCT00361335|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6016013|NCT00361335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6016014|NCT00361335|Immunologic Factors|immunologic factors|mesh-ancestor
6016015|NCT00361335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6016016|NCT00361335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6016017|NCT00361335|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6016018|NCT00361335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6309121|NCT00002905|Didanosine|didanosine|mesh-list
6309122|NCT00002905|Cyclophosphamide|cyclophosphamide|mesh-list
6309123|NCT00002905|Prednimustine|prednimustine|mesh-list
6309124|NCT00002905|Doxorubicin|doxorubicin|mesh-list
6309125|NCT00002905|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6309126|NCT00002905|Etoposide|etoposide|mesh-list
6309127|NCT00002905|Mitoxantrone|mitoxantrone|mesh-list
6309128|NCT00002905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6309129|NCT00002905|Immunologic Factors|immunologic factors|mesh-ancestor
6309130|NCT00002905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6309131|NCT00002905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6309132|NCT00002905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6309133|NCT00002905|Alkylating Agents|alkylating agents|mesh-ancestor
6309134|NCT00002905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309135|NCT00002905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309136|NCT00002905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6309137|NCT00002905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6309138|NCT00002905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6309139|NCT00002905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6309140|NCT00002905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5724335|NCT03187795|Mirabegron|mirabegron|mesh-list
5724336|NCT03187795|Oxybutynin|oxybutynin|mesh-list
5724337|NCT03187795|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6309141|NCT00002905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6309142|NCT00002905|Antimetabolites|antimetabolites|mesh-ancestor
6309143|NCT00002905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6309144|NCT00002905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6309145|NCT00002905|Antiviral Agents|antiviral agents|mesh-ancestor
6309146|NCT00002905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6309147|NCT00002905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6309148|NCT00002905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6309149|NCT00002905|Analgesics|analgesics|mesh-ancestor
5724338|NCT03187795|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6309150|NCT00002905|Sensory System Agents|sensory system agents|mesh-ancestor
6309151|NCT00002905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6309152|NCT00002907|Bryostatin 1|bryostatin 1|mesh-list
6309153|NCT00002907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6309154|NCT00002907|Immunologic Factors|immunologic factors|mesh-ancestor
6309155|NCT00002907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6309156|NCT00002907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309157|NCT00002908|Vincristine|vincristine|mesh-list
6309158|NCT00002908|Bryostatin 1|bryostatin 1|mesh-list
6309159|NCT00002908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6309160|NCT00002908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309161|NCT00002908|Tubulin Modulators|tubulin modulators|mesh-ancestor
6309162|NCT00002908|Antimitotic Agents|antimitotic agents|mesh-ancestor
6309163|NCT00002908|Mitosis Modulators|mitosis modulators|mesh-ancestor
6309164|NCT00002908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309165|NCT00002908|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6309166|NCT00002908|Immunologic Factors|immunologic factors|mesh-ancestor
6309167|NCT00002908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6309168|NCT00002909|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
6309169|NCT00002909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309170|NCT00002911|Marimastat|marimastat|mesh-list
6309171|NCT00002911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6309172|NCT00002911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309173|NCT00002912|Etoposide|etoposide|mesh-list
6309174|NCT00002912|Mitoxantrone|mitoxantrone|mesh-list
5724339|NCT03187795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5724340|NCT03187795|Adrenergic Agents|adrenergic agents|mesh-ancestor
5724341|NCT03187795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5724342|NCT03187795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724343|NCT03187795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724344|NCT03187795|Urological Agents|urological agents|mesh-ancestor
5724345|NCT03187795|Parasympatholytics|parasympatholytics|mesh-ancestor
6309175|NCT00002912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6309176|NCT00002912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309177|NCT00002912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6309178|NCT00002912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6309179|NCT00002912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6309180|NCT00002912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309181|NCT00002912|Analgesics|analgesics|mesh-ancestor
6309182|NCT00002912|Sensory System Agents|sensory system agents|mesh-ancestor
6309183|NCT00002912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6309184|NCT00002912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6309185|NCT00002913|Paclitaxel|paclitaxel|mesh-list
6309186|NCT00002913|Topotecan|topotecan|mesh-list
6309187|NCT00002913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6309188|NCT00002913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309189|NCT00002913|Tubulin Modulators|tubulin modulators|mesh-ancestor
6309190|NCT00002913|Antimitotic Agents|antimitotic agents|mesh-ancestor
6309191|NCT00002913|Mitosis Modulators|mitosis modulators|mesh-ancestor
6309192|NCT00002913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309193|NCT00002913|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6309194|NCT00002913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6309195|NCT00002913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6309196|NCT00002914|Piritrexim|piritrexim|mesh-list
6309197|NCT00002914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309198|NCT00002914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6309199|NCT00002914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6309200|NCT00002914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309201|NCT00002915|Penclomedine|penclomedine|mesh-list
6309202|NCT00002915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309203|NCT00002917|Paclitaxel|paclitaxel|mesh-list
6309204|NCT00002917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6309205|NCT00002917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309206|NCT00002917|Tubulin Modulators|tubulin modulators|mesh-ancestor
6309207|NCT00002917|Antimitotic Agents|antimitotic agents|mesh-ancestor
6309208|NCT00002917|Mitosis Modulators|mitosis modulators|mesh-ancestor
6309209|NCT00002917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309210|NCT00002919|Doxorubicin|doxorubicin|mesh-list
6309211|NCT00002919|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6309212|NCT00002919|Methotrexate|methotrexate|mesh-list
6309213|NCT00002919|Vinblastine|vinblastine|mesh-list
6309214|NCT00002919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309215|NCT00002919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6309216|NCT00002919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6309217|NCT00002919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6309218|NCT00002919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6309219|NCT00002919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309220|NCT00002919|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6309221|NCT00002919|Abortifacient Agents|abortifacient agents|mesh-ancestor
6309222|NCT00002919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6309223|NCT00002919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6309224|NCT00002919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6309225|NCT00002919|Antimetabolites|antimetabolites|mesh-ancestor
6309226|NCT00002919|Dermatologic Agents|dermatologic agents|mesh-ancestor
6309227|NCT00002919|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6309228|NCT00002919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6309229|NCT00002919|Immunologic Factors|immunologic factors|mesh-ancestor
6309230|NCT00002919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6309231|NCT00002919|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6309232|NCT00002919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6309233|NCT00002919|Tubulin Modulators|tubulin modulators|mesh-ancestor
6309234|NCT00002919|Antimitotic Agents|antimitotic agents|mesh-ancestor
6309235|NCT00002919|Mitosis Modulators|mitosis modulators|mesh-ancestor
6309236|NCT00002920|Tamoxifen|tamoxifen|mesh-list
6309237|NCT00002920|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6309238|NCT00002920|Medroxyprogesterone|medroxyprogesterone|mesh-list
6309239|NCT00002920|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6309240|NCT00002920|Hormone Antagonists|hormone antagonists|mesh-ancestor
6309241|NCT00002920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6309242|NCT00002920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6309243|NCT00002920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6309244|NCT00002920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309245|NCT00002920|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6309246|NCT00002920|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6309247|NCT00002920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6309248|NCT00002920|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6309249|NCT00002920|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5724346|NCT03187795|Autonomic Agents|autonomic agents|mesh-ancestor
6309250|NCT00002920|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6309251|NCT00002920|Contraceptive Agents|contraceptive agents|mesh-ancestor
6309252|NCT00002920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6309253|NCT00002920|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6309254|NCT00002920|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6309255|NCT00002920|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6309256|NCT00002921|Suramin|suramin|mesh-list
6309257|NCT00002921|Hydrocortisone|hydrocortisone|mesh-list
6309258|NCT00002921|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6309259|NCT00002921|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6309260|NCT00002921|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6309261|NCT00002921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6309262|NCT00002921|Antinematodal Agents|antinematodal agents|mesh-ancestor
6309263|NCT00002921|Anthelmintics|anthelmintics|mesh-ancestor
6309264|NCT00002921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6309265|NCT00002921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6309266|NCT00002921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309267|NCT00002921|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6309268|NCT00002921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6309269|NCT00002922|Paclitaxel|paclitaxel|mesh-list
6309270|NCT00002922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6309271|NCT00002922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309272|NCT00002922|Tubulin Modulators|tubulin modulators|mesh-ancestor
6309273|NCT00002922|Antimitotic Agents|antimitotic agents|mesh-ancestor
6309274|NCT00002922|Mitosis Modulators|mitosis modulators|mesh-ancestor
6309275|NCT00002922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309276|NCT00002923|KRN 5500|krn 5500|mesh-list
5724347|NCT03187795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5724348|NCT03187795|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5724349|NCT03187795|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5724350|NCT03187795|Cholinergic Agents|cholinergic agents|mesh-ancestor
5724351|NCT03187691|Amphotericin B|amphotericin b|mesh-list
5724352|NCT03187691|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6309277|NCT00002923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309278|NCT00002923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6309279|NCT00002923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6309280|NCT00002923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309281|NCT00002925|Aldesleukin|aldesleukin|mesh-list
6309282|NCT00002925|Etoposide|etoposide|mesh-list
6309283|NCT00002925|Daunorubicin|daunorubicin|mesh-list
6309284|NCT00002925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6309285|NCT00002925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309286|NCT00002925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6309287|NCT00002925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6309288|NCT00002925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6309289|NCT00002925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309290|NCT00002925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6309291|NCT00002925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6309292|NCT00002925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6309293|NCT00002925|Antiviral Agents|antiviral agents|mesh-ancestor
6309294|NCT00002925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6309295|NCT00002926|Cytarabine|cytarabine|mesh-list
6309296|NCT00002926|Etoposide|etoposide|mesh-list
6309297|NCT00002926|Idarubicin|idarubicin|mesh-list
6309298|NCT00002926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6309299|NCT00002926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309300|NCT00002926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6309301|NCT00002926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6309302|NCT00002926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6309303|NCT00002926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309304|NCT00002926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6309305|NCT00002926|Antimetabolites|antimetabolites|mesh-ancestor
6309306|NCT00002926|Antiviral Agents|antiviral agents|mesh-ancestor
6309307|NCT00002926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6309308|NCT00002926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6309309|NCT00002926|Immunologic Factors|immunologic factors|mesh-ancestor
6309310|NCT00002926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6309311|NCT00002926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6309312|NCT00002928|Paclitaxel|paclitaxel|mesh-list
5724353|NCT03187691|Amebicides|amebicides|mesh-ancestor
6309313|NCT00002928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6309314|NCT00002928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309315|NCT00002928|Tubulin Modulators|tubulin modulators|mesh-ancestor
6309316|NCT00002928|Antimitotic Agents|antimitotic agents|mesh-ancestor
6309317|NCT00002928|Mitosis Modulators|mitosis modulators|mesh-ancestor
6309318|NCT00002928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309319|NCT00002930|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6309320|NCT00002930|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6309321|NCT00002930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309322|NCT00002932|Cisplatin|cisplatin|mesh-list
6309323|NCT00002932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309324|NCT00002933|Irinotecan|irinotecan|mesh-list
6309325|NCT00002933|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6309326|NCT00002933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6309327|NCT00002933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6309328|NCT00002933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309329|NCT00002933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309330|NCT00002935|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
6309331|NCT00002935|Trioxsalen|trioxsalen|mesh-list
6309332|NCT00002935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309333|NCT00002935|Dermatologic Agents|dermatologic agents|mesh-ancestor
6309334|NCT00002935|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6309335|NCT00002936|Etoposide|etoposide|mesh-list
6309336|NCT00002936|Altretamine|altretamine|mesh-list
6309337|NCT00002936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6309338|NCT00002936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309339|NCT00002936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6309340|NCT00002936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6309341|NCT00002936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6309342|NCT00002936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309343|NCT00002936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6309344|NCT00002936|Alkylating Agents|alkylating agents|mesh-ancestor
6309345|NCT00002937|Paclitaxel|paclitaxel|mesh-list
6309346|NCT00002937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6309347|NCT00002937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309348|NCT00002937|Tubulin Modulators|tubulin modulators|mesh-ancestor
6309349|NCT00002937|Antimitotic Agents|antimitotic agents|mesh-ancestor
6309350|NCT00002937|Mitosis Modulators|mitosis modulators|mesh-ancestor
6309351|NCT00002937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309352|NCT00002939|Paclitaxel|paclitaxel|mesh-list
6309353|NCT00002939|Irinotecan|irinotecan|mesh-list
6309354|NCT00002939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6309355|NCT00002939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309356|NCT00002939|Tubulin Modulators|tubulin modulators|mesh-ancestor
6309357|NCT00002939|Antimitotic Agents|antimitotic agents|mesh-ancestor
6309358|NCT00002939|Mitosis Modulators|mitosis modulators|mesh-ancestor
6309359|NCT00002939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309360|NCT00002939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6309361|NCT00002939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6309362|NCT00002939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6309363|NCT00002940|Hydroxyurea|hydroxyurea|mesh-list
6309364|NCT00002940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309365|NCT00002940|Antisickling Agents|antisickling agents|mesh-ancestor
6309366|NCT00002940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6309367|NCT00002940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309368|NCT00002940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6309369|NCT00002941|Cyclophosphamide|cyclophosphamide|mesh-list
6309370|NCT00002941|Carmustine|carmustine|mesh-list
6309371|NCT00002941|Etoposide|etoposide|mesh-list
6309372|NCT00002941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6309373|NCT00002941|Immunologic Factors|immunologic factors|mesh-ancestor
6309374|NCT00002941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6309375|NCT00002941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6309376|NCT00002941|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6309377|NCT00002941|Alkylating Agents|alkylating agents|mesh-ancestor
6309378|NCT00002941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309379|NCT00002941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309380|NCT00002941|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6309381|NCT00002941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6309382|NCT00002941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6309383|NCT00002941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6309384|NCT00002941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5724354|NCT03187691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6309385|NCT00002943|Cyclophosphamide|cyclophosphamide|mesh-list
6309386|NCT00002943|Carboplatin|carboplatin|mesh-list
6309387|NCT00002943|Etoposide|etoposide|mesh-list
6309388|NCT00002943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6309389|NCT00002943|Immunologic Factors|immunologic factors|mesh-ancestor
6309390|NCT00002943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6309391|NCT00002943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6309392|NCT00002943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6309393|NCT00002943|Alkylating Agents|alkylating agents|mesh-ancestor
6309394|NCT00002943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309395|NCT00002943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309396|NCT00002943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6309397|NCT00002943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6309398|NCT00002943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6309399|NCT00002943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6309400|NCT00002943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6309401|NCT00002944|Carboplatin|carboplatin|mesh-list
6309402|NCT00002944|Vincristine|vincristine|mesh-list
6309403|NCT00002944|Thioguanine|thioguanine|mesh-list
6309404|NCT00002944|Lomustine|lomustine|mesh-list
6309405|NCT00002944|Procarbazine|procarbazine|mesh-list
6309406|NCT00002944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309407|NCT00002944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6309408|NCT00002944|Tubulin Modulators|tubulin modulators|mesh-ancestor
6309409|NCT00002944|Antimitotic Agents|antimitotic agents|mesh-ancestor
6309410|NCT00002944|Mitosis Modulators|mitosis modulators|mesh-ancestor
6309411|NCT00002944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309412|NCT00002944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6309413|NCT00002944|Antimetabolites|antimetabolites|mesh-ancestor
6309414|NCT00002944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6309415|NCT00002944|Alkylating Agents|alkylating agents|mesh-ancestor
6309416|NCT00002945|Cytarabine|cytarabine|mesh-list
6309417|NCT00002945|Aldesleukin|aldesleukin|mesh-list
6309418|NCT00002945|Cyclophosphamide|cyclophosphamide|mesh-list
6309419|NCT00002945|Melphalan|melphalan|mesh-list
6309420|NCT00002945|Etoposide|etoposide|mesh-list
6309421|NCT00002945|Idarubicin|idarubicin|mesh-list
6309422|NCT00002945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6309423|NCT00002945|Immunologic Factors|immunologic factors|mesh-ancestor
6309424|NCT00002945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6309425|NCT00002945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6309426|NCT00002945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6309427|NCT00002945|Alkylating Agents|alkylating agents|mesh-ancestor
6309428|NCT00002945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309429|NCT00002945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309430|NCT00002945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6309431|NCT00002945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6309432|NCT00002945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6309433|NCT00002945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6309434|NCT00002945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6309435|NCT00002945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6309436|NCT00002945|Antimetabolites|antimetabolites|mesh-ancestor
6309437|NCT00002945|Antiviral Agents|antiviral agents|mesh-ancestor
6309438|NCT00002945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6309439|NCT00002945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6309440|NCT00002945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6309441|NCT00002945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6309442|NCT00002946|Penclomedine|penclomedine|mesh-list
6309443|NCT00002946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309444|NCT00002948|Topotecan|topotecan|mesh-list
6309445|NCT00002948|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6309446|NCT00002948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6309447|NCT00002948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6309448|NCT00002948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309449|NCT00002948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309450|NCT00002949|Paclitaxel|paclitaxel|mesh-list
6309451|NCT00002949|Vinorelbine|vinorelbine|mesh-list
6309452|NCT00002949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6309453|NCT00002949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309454|NCT00002949|Tubulin Modulators|tubulin modulators|mesh-ancestor
6309455|NCT00002949|Antimitotic Agents|antimitotic agents|mesh-ancestor
6309456|NCT00002949|Mitosis Modulators|mitosis modulators|mesh-ancestor
6309457|NCT00002949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309458|NCT00002950|Topotecan|topotecan|mesh-list
6309459|NCT00002950|Sargramostim|sargramostim|mesh-list
6309460|NCT00002950|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6309461|NCT00002950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6309462|NCT00002950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6309463|NCT00002950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309464|NCT00002950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309465|NCT00002950|Immunologic Factors|immunologic factors|mesh-ancestor
6309466|NCT00002950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6309467|NCT00002951|Fluorouracil|fluorouracil|mesh-list
6309468|NCT00002951|Hydroxyurea|hydroxyurea|mesh-list
6309469|NCT00002951|Antimetabolites|antimetabolites|mesh-ancestor
6309470|NCT00002951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309471|NCT00002951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6309472|NCT00002951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309473|NCT00002951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6309474|NCT00002951|Immunologic Factors|immunologic factors|mesh-ancestor
6309475|NCT00002951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6309476|NCT00002951|Antisickling Agents|antisickling agents|mesh-ancestor
6309477|NCT00002951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6309478|NCT00002951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6309479|NCT00002952|Interleukin-12|interleukin-12|mesh-list
6309480|NCT00002952|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6309481|NCT00002952|Immunologic Factors|immunologic factors|mesh-ancestor
6309482|NCT00002952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6309483|NCT00002952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6309484|NCT00002952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6309485|NCT00002952|Growth Substances|growth substances|mesh-ancestor
6309486|NCT00002952|Growth Inhibitors|growth inhibitors|mesh-ancestor
6309487|NCT00002952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309488|NCT00002953|Paclitaxel|paclitaxel|mesh-list
6309489|NCT00002953|Cyclophosphamide|cyclophosphamide|mesh-list
6309490|NCT00002953|Epirubicin|epirubicin|mesh-list
6309491|NCT00002953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6309492|NCT00002953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309493|NCT00002953|Tubulin Modulators|tubulin modulators|mesh-ancestor
6309494|NCT00002953|Antimitotic Agents|antimitotic agents|mesh-ancestor
6309495|NCT00002953|Mitosis Modulators|mitosis modulators|mesh-ancestor
6309496|NCT00002953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309497|NCT00002953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6309498|NCT00002953|Immunologic Factors|immunologic factors|mesh-ancestor
6309499|NCT00002953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6309500|NCT00002953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6309501|NCT00002953|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6309502|NCT00002953|Alkylating Agents|alkylating agents|mesh-ancestor
6309503|NCT00002953|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6309504|NCT00002953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6309505|NCT00002953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6309506|NCT00002953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6309507|NCT00002953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6309508|NCT00002955|Leucovorin|leucovorin|mesh-list
6309509|NCT00002955|Trimetrexate|trimetrexate|mesh-list
5724355|NCT03187691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6309510|NCT00002955|Fluorouracil|fluorouracil|mesh-list
6309511|NCT00002955|Calcium|calcium|mesh-list
6309512|NCT00002955|Levoleucovorin|levoleucovorin|mesh-list
6309513|NCT00002955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6309514|NCT00002955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6309515|NCT00002955|Antimetabolites|antimetabolites|mesh-ancestor
6309516|NCT00002955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309517|NCT00002955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6309518|NCT00002955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309519|NCT00002955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6309520|NCT00002955|Immunologic Factors|immunologic factors|mesh-ancestor
6309521|NCT00002955|Antidotes|antidotes|mesh-ancestor
6309522|NCT00002955|Protective Agents|protective agents|mesh-ancestor
6309523|NCT00002955|Vitamin B Complex|vitamin b complex|mesh-ancestor
6309524|NCT00002955|Vitamins|vitamins|mesh-ancestor
6309525|NCT00002955|Micronutrients|micronutrients|mesh-ancestor
6309526|NCT00002955|Antifungal Agents|antifungal agents|mesh-ancestor
6309527|NCT00002955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6309528|NCT00002955|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6309529|NCT00002955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6392383|NCT00196131|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6392384|NCT00196131|Narcotics|narcotics|mesh-ancestor
6392385|NCT00196131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6392386|NCT00196131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392387|NCT00196131|Analgesics|analgesics|mesh-ancestor
6392388|NCT00196131|Sensory System Agents|sensory system agents|mesh-ancestor
6392389|NCT00196131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6392390|NCT00196352|Levonorgestrel|levonorgestrel|mesh-list
6392391|NCT00196352|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6392392|NCT00196352|Contraceptive Agents|contraceptive agents|mesh-ancestor
6392393|NCT00196352|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6392394|NCT00196352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392395|NCT00196352|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6392396|NCT00196352|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6392397|NCT00196352|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6392398|NCT00196365|Levonorgestrel|levonorgestrel|mesh-list
6392399|NCT00196365|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6392400|NCT00196365|Contraceptive Agents|contraceptive agents|mesh-ancestor
6392401|NCT00196365|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6392402|NCT00196365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392403|NCT00196365|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6392404|NCT00196365|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6392405|NCT00196365|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6392406|NCT00196378|Estrogens|estrogens|mesh-list
6392407|NCT00196378|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6392408|NCT00196378|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
6392409|NCT00196378|Estrogens, conjugated synthetic B|estrogens, conjugated synthetic b|mesh-list
6392410|NCT00196378|Hormones|hormones|mesh-ancestor
6392411|NCT00196378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6392412|NCT00196378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392413|NCT00196391|Progesterone|progesterone|mesh-list
6392414|NCT00196391|Progestins|progestins|mesh-ancestor
6392415|NCT00196391|Hormones|hormones|mesh-ancestor
6392416|NCT00196391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6392417|NCT00196391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392418|NCT00196417|Heparin|heparin|mesh-list
6392419|NCT00196417|Certoparin|certoparin|mesh-list
6309530|NCT00002961|Cyclosporine|cyclosporine|mesh-list
6309531|NCT00002961|Cyclophosphamide|cyclophosphamide|mesh-list
6309532|NCT00002961|Busulfan|busulfan|mesh-list
6309533|NCT00002961|Methotrexate|methotrexate|mesh-list
6309534|NCT00002961|Etoposide|etoposide|mesh-list
6309535|NCT00002961|Etoposide phosphate|etoposide phosphate|mesh-list
6309536|NCT00002961|Cyclosporins|cyclosporins|mesh-list
6309537|NCT00002961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6309538|NCT00002961|Immunologic Factors|immunologic factors|mesh-ancestor
6309539|NCT00002961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6309540|NCT00002961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6309541|NCT00002961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6309542|NCT00002961|Alkylating Agents|alkylating agents|mesh-ancestor
6309543|NCT00002961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309544|NCT00002961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309545|NCT00002961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6309546|NCT00002961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6309547|NCT00002961|Abortifacient Agents|abortifacient agents|mesh-ancestor
6309548|NCT00002961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6309549|NCT00002961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6309550|NCT00002961|Antimetabolites|antimetabolites|mesh-ancestor
6309551|NCT00002961|Dermatologic Agents|dermatologic agents|mesh-ancestor
6309552|NCT00002961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6309553|NCT00002961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6309554|NCT00002961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6309555|NCT00002961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6309556|NCT00002961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6309557|NCT00002961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6309558|NCT00002961|Antifungal Agents|antifungal agents|mesh-ancestor
6309559|NCT00002961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6309560|NCT00002961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6309561|NCT00002963|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6309562|NCT00002963|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6309563|NCT00002963|Dermatologic Agents|dermatologic agents|mesh-ancestor
6309564|NCT00002964|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
6309565|NCT00002964|Trioxsalen|trioxsalen|mesh-list
6309566|NCT00002964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309567|NCT00002964|Dermatologic Agents|dermatologic agents|mesh-ancestor
6309568|NCT00002964|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6309569|NCT00002965|Interferons|interferons|mesh-list
6309570|NCT00002965|Interferon-alpha|interferon-alpha|mesh-list
6309571|NCT00002965|Interferon alpha-2|interferon alpha-2|mesh-list
6309572|NCT00002965|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
6309573|NCT00002965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309574|NCT00002965|Antiviral Agents|antiviral agents|mesh-ancestor
6309575|NCT00002965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6309576|NCT00002965|Immunologic Factors|immunologic factors|mesh-ancestor
6309577|NCT00002965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6309578|NCT00002967|Tamoxifen|tamoxifen|mesh-list
6309579|NCT00002967|Cyclophosphamide|cyclophosphamide|mesh-list
6309580|NCT00002967|Doxorubicin|doxorubicin|mesh-list
6309581|NCT00002967|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6309582|NCT00002967|Octreotide|octreotide|mesh-list
6309583|NCT00002967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6309584|NCT00002967|Immunologic Factors|immunologic factors|mesh-ancestor
6309585|NCT00002967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6309586|NCT00002967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6309587|NCT00002967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6309588|NCT00002967|Alkylating Agents|alkylating agents|mesh-ancestor
6309589|NCT00002967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309590|NCT00002967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309591|NCT00002967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6309592|NCT00002967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6309593|NCT00002967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6309594|NCT00002967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6309595|NCT00002967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6309596|NCT00002967|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6309597|NCT00002967|Hormone Antagonists|hormone antagonists|mesh-ancestor
6309598|NCT00002967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6309599|NCT00002967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6309600|NCT00002967|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6309601|NCT00002967|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6309602|NCT00002967|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6309603|NCT00002967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6309604|NCT00002968|Edrecolomab|edrecolomab|mesh-list
6309605|NCT00002968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6309606|NCT00002968|Immunologic Factors|immunologic factors|mesh-ancestor
6309607|NCT00002968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6309608|NCT00002969|Paclitaxel|paclitaxel|mesh-list
6309609|NCT00002969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6309610|NCT00002969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309611|NCT00002969|Tubulin Modulators|tubulin modulators|mesh-ancestor
6309612|NCT00002969|Antimitotic Agents|antimitotic agents|mesh-ancestor
6309613|NCT00002969|Mitosis Modulators|mitosis modulators|mesh-ancestor
6309614|NCT00002969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309615|NCT00002970|Cytarabine|cytarabine|mesh-list
6309616|NCT00002970|Hydrocortisone|hydrocortisone|mesh-list
6309617|NCT00002970|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6309618|NCT00002970|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6309619|NCT00002970|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6309620|NCT00002970|Methotrexate|methotrexate|mesh-list
6309621|NCT00002970|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6309622|NCT00002970|Abortifacient Agents|abortifacient agents|mesh-ancestor
6309623|NCT00002970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6309624|NCT00002970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6309625|NCT00002970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6309626|NCT00002970|Antimetabolites|antimetabolites|mesh-ancestor
6309627|NCT00002970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309628|NCT00002970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309629|NCT00002970|Dermatologic Agents|dermatologic agents|mesh-ancestor
6309630|NCT00002970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6309631|NCT00002970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6309632|NCT00002970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6309633|NCT00002970|Immunologic Factors|immunologic factors|mesh-ancestor
6309634|NCT00002970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6309635|NCT00002970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6309636|NCT00002970|Antiviral Agents|antiviral agents|mesh-ancestor
6309637|NCT00002970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6309638|NCT00002970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6309639|NCT00002971|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
6309640|NCT00002971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309641|NCT00002971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6309642|NCT00002971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309643|NCT00002972|Paclitaxel|paclitaxel|mesh-list
6309644|NCT00002972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6309645|NCT00002972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309646|NCT00002972|Tubulin Modulators|tubulin modulators|mesh-ancestor
6309647|NCT00002972|Antimitotic Agents|antimitotic agents|mesh-ancestor
6309648|NCT00002972|Mitosis Modulators|mitosis modulators|mesh-ancestor
6309649|NCT00002972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309650|NCT00002973|Melphalan|melphalan|mesh-list
6309651|NCT00002973|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6309652|NCT00002973|Alkylating Agents|alkylating agents|mesh-ancestor
6309653|NCT00002973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309654|NCT00002973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309655|NCT00002973|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6309656|NCT00002973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6309657|NCT00002973|Immunologic Factors|immunologic factors|mesh-ancestor
6309658|NCT00002973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6309659|NCT00002974|Carboplatin|carboplatin|mesh-list
6309660|NCT00002974|Etoposide|etoposide|mesh-list
6309661|NCT00002974|Ifosfamide|ifosfamide|mesh-list
6309662|NCT00002974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309663|NCT00002974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6309664|NCT00002974|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6309665|NCT00002974|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6309666|NCT00002974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6309667|NCT00002974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309668|NCT00002974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6309669|NCT00002974|Alkylating Agents|alkylating agents|mesh-ancestor
6309670|NCT00002976|Estrogens|estrogens|mesh-list
6309671|NCT00002976|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6309672|NCT00002976|Hormones|hormones|mesh-ancestor
6309673|NCT00002976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6309674|NCT00002976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6309675|NCT00002977|Melphalan|melphalan|mesh-list
6309676|NCT00002977|Thiotepa|thiotepa|mesh-list
6309677|NCT00002977|Immunologic Factors|immunologic factors|mesh-ancestor
6309678|NCT00002977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6309679|NCT00002977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6309680|NCT00002977|Alkylating Agents|alkylating agents|mesh-ancestor
6309681|NCT00002977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309682|NCT00002977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309683|NCT00002977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6309684|NCT00002977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6309685|NCT00002980|Decitabine|decitabine|mesh-list
6309686|NCT00002980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6309687|NCT00002980|Antimetabolites|antimetabolites|mesh-ancestor
6309688|NCT00002980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309689|NCT00002980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309690|NCT00002980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6309691|NCT00002981|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6309692|NCT00002981|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6309693|NCT00002981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309694|NCT00002982|Cytarabine|cytarabine|mesh-list
6309695|NCT00002982|Carboplatin|carboplatin|mesh-list
6309696|NCT00002982|Etoposide|etoposide|mesh-list
6309697|NCT00002982|Melphalan|melphalan|mesh-list
6309698|NCT00002982|Ifosfamide|ifosfamide|mesh-list
6309699|NCT00002982|Carmustine|carmustine|mesh-list
6309700|NCT00002982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309701|NCT00002982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6309702|NCT00002982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6309703|NCT00002982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6309704|NCT00002982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6309705|NCT00002982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309706|NCT00002982|Immunologic Factors|immunologic factors|mesh-ancestor
6309707|NCT00002982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6309708|NCT00002982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6309709|NCT00002982|Antimetabolites|antimetabolites|mesh-ancestor
6309710|NCT00002982|Antiviral Agents|antiviral agents|mesh-ancestor
6309711|NCT00002982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6309712|NCT00002982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6309713|NCT00002982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6309714|NCT00002982|Alkylating Agents|alkylating agents|mesh-ancestor
6309715|NCT00002982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6309716|NCT00002984|Paclitaxel|paclitaxel|mesh-list
6309717|NCT00002984|Fluorouracil|fluorouracil|mesh-list
6309718|NCT00002984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6309719|NCT00002984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309720|NCT00002984|Tubulin Modulators|tubulin modulators|mesh-ancestor
6309721|NCT00002984|Antimitotic Agents|antimitotic agents|mesh-ancestor
6309722|NCT00002984|Mitosis Modulators|mitosis modulators|mesh-ancestor
6309723|NCT00002984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309724|NCT00002984|Antimetabolites|antimetabolites|mesh-ancestor
6309725|NCT00002984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6309726|NCT00002984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6309727|NCT00002984|Immunologic Factors|immunologic factors|mesh-ancestor
6309728|NCT00002984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6309729|NCT00002985|Doxorubicin|doxorubicin|mesh-list
6309730|NCT00002985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6309731|NCT00002985|Daunorubicin|daunorubicin|mesh-list
6309732|NCT00002985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6309733|NCT00002985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309734|NCT00002985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6309735|NCT00002985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6309736|NCT00002985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6309737|NCT00002985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309738|NCT00002986|Topotecan|topotecan|mesh-list
6309739|NCT00002986|Carmustine|carmustine|mesh-list
6309740|NCT00002986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6309741|NCT00002986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6309742|NCT00002986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6309743|NCT00002986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309744|NCT00002986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309745|NCT00002986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6309746|NCT00002986|Alkylating Agents|alkylating agents|mesh-ancestor
6309747|NCT00002987|Prednisolone|prednisolone|mesh-list
6309748|NCT00002987|Cyclophosphamide|cyclophosphamide|mesh-list
6309749|NCT00002987|Doxorubicin|doxorubicin|mesh-list
6309750|NCT00002987|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6309751|NCT00002987|Etoposide|etoposide|mesh-list
6309752|NCT00002987|Vincristine|vincristine|mesh-list
6309753|NCT00002987|Bleomycin|bleomycin|mesh-list
6309754|NCT00002987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6309755|NCT00002987|Immunologic Factors|immunologic factors|mesh-ancestor
6309756|NCT00002987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6309757|NCT00002987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6309758|NCT00002987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6309759|NCT00002987|Alkylating Agents|alkylating agents|mesh-ancestor
6309760|NCT00002987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309761|NCT00002987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309762|NCT00002987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6309763|NCT00002987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6309764|NCT00002987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6309765|NCT00002987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6309766|NCT00002987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6309767|NCT00002987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6309768|NCT00002987|Tubulin Modulators|tubulin modulators|mesh-ancestor
6309769|NCT00002987|Antimitotic Agents|antimitotic agents|mesh-ancestor
6309770|NCT00002987|Mitosis Modulators|mitosis modulators|mesh-ancestor
6309771|NCT00002987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6309772|NCT00002987|Glucocorticoids|glucocorticoids|mesh-ancestor
6309773|NCT00002987|Hormones|hormones|mesh-ancestor
6309774|NCT00002987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6309775|NCT00002987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6309776|NCT00002988|Irinotecan|irinotecan|mesh-list
6309777|NCT00002988|Carmustine|carmustine|mesh-list
6309778|NCT00002988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6309779|NCT00002988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6309780|NCT00002988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6309781|NCT00002988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309782|NCT00002988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309783|NCT00002988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6309784|NCT00002988|Alkylating Agents|alkylating agents|mesh-ancestor
6309785|NCT00002989|Cyclophosphamide|cyclophosphamide|mesh-list
6309786|NCT00002989|Melphalan|melphalan|mesh-list
6309787|NCT00002989|Busulfan|busulfan|mesh-list
6309788|NCT00002989|Idarubicin|idarubicin|mesh-list
6309789|NCT00002989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6309790|NCT00002989|Immunologic Factors|immunologic factors|mesh-ancestor
6309791|NCT00002989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6309792|NCT00002989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6309793|NCT00002989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6309794|NCT00002989|Alkylating Agents|alkylating agents|mesh-ancestor
6309795|NCT00002989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309796|NCT00002989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309797|NCT00002989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6309798|NCT00002989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6309799|NCT00002989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6309800|NCT00002989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6309801|NCT00002989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6309802|NCT00002990|BCG Vaccine|bcg vaccine|mesh-list
6309803|NCT00002990|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6309804|NCT00002990|Immunologic Factors|immunologic factors|mesh-ancestor
6309805|NCT00002990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6309806|NCT00002993|Doxorubicin|doxorubicin|mesh-list
6309807|NCT00002993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6309808|NCT00002993|Mitomycins|mitomycins|mesh-list
6309809|NCT00002993|Mitomycin|mitomycin|mesh-list
6309810|NCT00002993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309811|NCT00002993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6309812|NCT00002993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6309813|NCT00002993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6309814|NCT00002993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6309815|NCT00002993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309816|NCT00002993|Alkylating Agents|alkylating agents|mesh-ancestor
6309817|NCT00002993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6309818|NCT00002994|Interleukin-2|interleukin-2|mesh-list
6309819|NCT00002994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309820|NCT00002994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6309821|NCT00002994|Analgesics|analgesics|mesh-ancestor
6309822|NCT00002994|Sensory System Agents|sensory system agents|mesh-ancestor
6309823|NCT00002994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6309824|NCT00002994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6309825|NCT00002995|Dactinomycin|dactinomycin|mesh-list
6309826|NCT00002995|Cyclophosphamide|cyclophosphamide|mesh-list
6309827|NCT00002995|Vincristine|vincristine|mesh-list
6309828|NCT00002995|Sargramostim|sargramostim|mesh-list
6309829|NCT00002995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6309830|NCT00002995|Immunologic Factors|immunologic factors|mesh-ancestor
6309831|NCT00002995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6309832|NCT00002995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6309833|NCT00002995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6309834|NCT00002995|Alkylating Agents|alkylating agents|mesh-ancestor
6309835|NCT00002995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309836|NCT00002995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309837|NCT00002995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6309838|NCT00002995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6309839|NCT00002995|Tubulin Modulators|tubulin modulators|mesh-ancestor
6309840|NCT00002995|Antimitotic Agents|antimitotic agents|mesh-ancestor
6309841|NCT00002995|Mitosis Modulators|mitosis modulators|mesh-ancestor
6309842|NCT00002995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6309843|NCT00002995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6309844|NCT00002995|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6309845|NCT00002995|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6309846|NCT00002995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6309847|NCT00002995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6309848|NCT00002996|Flecainide|flecainide|mesh-list
6309849|NCT00002996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6309850|NCT00002996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6309851|NCT00002996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6309852|NCT00002996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6309853|NCT00002996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309854|NCT00002998|Gemcitabine|gemcitabine|mesh-list
6309855|NCT00002998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309856|NCT00002998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6309857|NCT00002998|Antimetabolites|antimetabolites|mesh-ancestor
6309858|NCT00002998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309859|NCT00002998|Antiviral Agents|antiviral agents|mesh-ancestor
6309860|NCT00002998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6309861|NCT00002998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6309862|NCT00002998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6309863|NCT00002998|Immunologic Factors|immunologic factors|mesh-ancestor
6309864|NCT00002998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6309865|NCT00002999|Fluorouracil|fluorouracil|mesh-list
6309866|NCT00002999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309867|NCT00002999|Antimetabolites|antimetabolites|mesh-ancestor
6309868|NCT00002999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309869|NCT00002999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6309870|NCT00002999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6309871|NCT00002999|Immunologic Factors|immunologic factors|mesh-ancestor
6309872|NCT00002999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6309873|NCT00003000|Fentanyl|fentanyl|mesh-list
6309874|NCT00003000|Morphine|morphine|mesh-list
6309875|NCT00003000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6309876|NCT00003000|Narcotics|narcotics|mesh-ancestor
6309877|NCT00003000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6309878|NCT00003000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6309879|NCT00003000|Analgesics|analgesics|mesh-ancestor
6309880|NCT00003000|Sensory System Agents|sensory system agents|mesh-ancestor
6309881|NCT00003000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6309882|NCT00003000|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6309883|NCT00003000|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6309884|NCT00003000|Anesthetics, General|anesthetics, general|mesh-ancestor
6309885|NCT00003000|Anesthetics|anesthetics|mesh-ancestor
6309886|NCT00003001|Leucovorin|leucovorin|mesh-list
6309887|NCT00003001|Gemcitabine|gemcitabine|mesh-list
6309888|NCT00003001|Fluorouracil|fluorouracil|mesh-list
6309889|NCT00003001|Calcium|calcium|mesh-list
6309890|NCT00003001|Levoleucovorin|levoleucovorin|mesh-list
6309891|NCT00003001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6309892|NCT00003001|Antimetabolites|antimetabolites|mesh-ancestor
6309893|NCT00003001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309894|NCT00003001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5724356|NCT03187691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5724357|NCT03187691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5724358|NCT03187691|Antifungal Agents|antifungal agents|mesh-ancestor
5724359|NCT03187626|Botulinum Toxins|botulinum toxins|mesh-list
6309895|NCT00003001|Antiviral Agents|antiviral agents|mesh-ancestor
6309896|NCT00003001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6309897|NCT00003001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6309898|NCT00003001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6309899|NCT00003001|Immunologic Factors|immunologic factors|mesh-ancestor
6309900|NCT00003001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6309901|NCT00003001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6309902|NCT00003001|Antidotes|antidotes|mesh-ancestor
6309903|NCT00003001|Protective Agents|protective agents|mesh-ancestor
6309904|NCT00003001|Vitamin B Complex|vitamin b complex|mesh-ancestor
6309905|NCT00003001|Vitamins|vitamins|mesh-ancestor
6309906|NCT00003001|Micronutrients|micronutrients|mesh-ancestor
6309907|NCT00003002|Sargramostim|sargramostim|mesh-list
6309908|NCT00003002|Immunologic Factors|immunologic factors|mesh-ancestor
6309909|NCT00003002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6309910|NCT00003003|Mitoxantrone|mitoxantrone|mesh-list
6309911|NCT00003003|Mitomycins|mitomycins|mesh-list
6309912|NCT00003003|Mitomycin|mitomycin|mesh-list
6309913|NCT00003003|Sargramostim|sargramostim|mesh-list
6309914|NCT00003003|Immunologic Factors|immunologic factors|mesh-ancestor
6309915|NCT00003003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6309916|NCT00003003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309917|NCT00003003|Analgesics|analgesics|mesh-ancestor
6309918|NCT00003003|Sensory System Agents|sensory system agents|mesh-ancestor
6309919|NCT00003003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6309920|NCT00003003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6309921|NCT00003003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6309922|NCT00003003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6309923|NCT00003003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309924|NCT00003003|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6309925|NCT00003003|Alkylating Agents|alkylating agents|mesh-ancestor
6309926|NCT00003003|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6309927|NCT00003004|Paclitaxel|paclitaxel|mesh-list
6309928|NCT00003004|Alvocidib|alvocidib|mesh-list
6309929|NCT00003004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6309930|NCT00003004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309931|NCT00003004|Tubulin Modulators|tubulin modulators|mesh-ancestor
6309932|NCT00003004|Antimitotic Agents|antimitotic agents|mesh-ancestor
6309933|NCT00003004|Mitosis Modulators|mitosis modulators|mesh-ancestor
6309934|NCT00003004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016019|NCT00361439|Mometasone Furoate|mometasone furoate|mesh-list
6016020|NCT00361439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6016021|NCT00361439|Dermatologic Agents|dermatologic agents|mesh-ancestor
6016022|NCT00361439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6016023|NCT00361504|Oxycodone|oxycodone|mesh-list
6016024|NCT00361504|Tapentadol|tapentadol|mesh-list
6016025|NCT00361504|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6309935|NCT00003004|Growth Inhibitors|growth inhibitors|mesh-ancestor
6309936|NCT00003004|Growth Substances|growth substances|mesh-ancestor
6309937|NCT00003004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6309938|NCT00003004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6309939|NCT00003004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6309940|NCT00003005|Cordycepin|cordycepin|mesh-list
6309941|NCT00003005|Pentostatin|pentostatin|mesh-list
6309942|NCT00003005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309943|NCT00003005|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
6309944|NCT00003005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6309945|NCT00003005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309946|NCT00003005|Antifungal Agents|antifungal agents|mesh-ancestor
6016026|NCT00361504|Narcotics|narcotics|mesh-ancestor
6309947|NCT00003005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6309948|NCT00003007|Interferons|interferons|mesh-list
6309949|NCT00003007|Interferon-alpha|interferon-alpha|mesh-list
6309950|NCT00003007|Dexamethasone|dexamethasone|mesh-list
6309951|NCT00003007|Cyclophosphamide|cyclophosphamide|mesh-list
6309952|NCT00003007|Melphalan|melphalan|mesh-list
6309953|NCT00003007|Sargramostim|sargramostim|mesh-list
6309954|NCT00003007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6309955|NCT00003007|Immunologic Factors|immunologic factors|mesh-ancestor
6309956|NCT00003007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6309957|NCT00003007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6309958|NCT00003007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6309959|NCT00003007|Alkylating Agents|alkylating agents|mesh-ancestor
6309960|NCT00003007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309961|NCT00003007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309962|NCT00003007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6309963|NCT00003007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6309964|NCT00003007|Antiemetics|antiemetics|mesh-ancestor
6309965|NCT00003007|Autonomic Agents|autonomic agents|mesh-ancestor
6309966|NCT00003007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6309967|NCT00003007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6309968|NCT00003007|Glucocorticoids|glucocorticoids|mesh-ancestor
6309969|NCT00003007|Hormones|hormones|mesh-ancestor
6309970|NCT00003007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6309971|NCT00003007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6309972|NCT00003007|Antiviral Agents|antiviral agents|mesh-ancestor
6309973|NCT00003007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6309974|NCT00003008|Ritonavir|ritonavir|mesh-list
6309975|NCT00003008|Nelfinavir|nelfinavir|mesh-list
6309976|NCT00003008|Indinavir|indinavir|mesh-list
6309977|NCT00003008|Saquinavir|saquinavir|mesh-list
6309978|NCT00003008|Paclitaxel|paclitaxel|mesh-list
6309979|NCT00003008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6309980|NCT00003008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309981|NCT00003008|Tubulin Modulators|tubulin modulators|mesh-ancestor
6309982|NCT00003008|Antimitotic Agents|antimitotic agents|mesh-ancestor
6309983|NCT00003008|Mitosis Modulators|mitosis modulators|mesh-ancestor
6309984|NCT00003008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6309985|NCT00003008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6309986|NCT00003008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6309987|NCT00003008|Protease Inhibitors|protease inhibitors|mesh-ancestor
6309988|NCT00003008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6309989|NCT00003008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6309990|NCT00003008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6309991|NCT00003008|Antiviral Agents|antiviral agents|mesh-ancestor
6309992|NCT00003008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6309993|NCT00003008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6309994|NCT00003008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6309995|NCT00003009|Aldesleukin|aldesleukin|mesh-list
6309996|NCT00003009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6309997|NCT00003009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6309998|NCT00003009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6309999|NCT00003009|Antiviral Agents|antiviral agents|mesh-ancestor
6310000|NCT00003009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6310001|NCT00003010|Marimastat|marimastat|mesh-list
6310002|NCT00003010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6310003|NCT00003010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6310004|NCT00003011|Marimastat|marimastat|mesh-list
6310005|NCT00003011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6310006|NCT00003011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6310007|NCT00003012|Cyclophosphamide|cyclophosphamide|mesh-list
6310008|NCT00003012|Fluorouracil|fluorouracil|mesh-list
6310009|NCT00003012|Methotrexate|methotrexate|mesh-list
6310010|NCT00003012|Epirubicin|epirubicin|mesh-list
6310011|NCT00003012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6310012|NCT00003012|Immunologic Factors|immunologic factors|mesh-ancestor
6310013|NCT00003012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6310014|NCT00003012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6310015|NCT00003012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6310016|NCT00003012|Alkylating Agents|alkylating agents|mesh-ancestor
6310017|NCT00003012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6310018|NCT00003012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6392420|NCT00196417|Anticoagulants|anticoagulants|mesh-ancestor
6310019|NCT00003012|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6310020|NCT00003012|Antimetabolites|antimetabolites|mesh-ancestor
6310021|NCT00003012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6310022|NCT00003012|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6310023|NCT00003012|Abortifacient Agents|abortifacient agents|mesh-ancestor
6310024|NCT00003012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6310025|NCT00003012|Dermatologic Agents|dermatologic agents|mesh-ancestor
6310026|NCT00003012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5724360|NCT03187626|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5724361|NCT03187626|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5724362|NCT03187626|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5724363|NCT03187626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5724364|NCT03187626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6310027|NCT00003012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6310028|NCT00003012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6310029|NCT00003012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6310030|NCT00003012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6310031|NCT00003012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6310032|NCT00003013|Tamoxifen|tamoxifen|mesh-list
6310033|NCT00003013|Paclitaxel|paclitaxel|mesh-list
6310034|NCT00003013|Cyclophosphamide|cyclophosphamide|mesh-list
6310035|NCT00003013|Doxorubicin|doxorubicin|mesh-list
6310036|NCT00003013|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6310037|NCT00003013|Fluorouracil|fluorouracil|mesh-list
6310038|NCT00003013|Methotrexate|methotrexate|mesh-list
6310039|NCT00003013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6310040|NCT00003013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310041|NCT00003013|Tubulin Modulators|tubulin modulators|mesh-ancestor
6310042|NCT00003013|Antimitotic Agents|antimitotic agents|mesh-ancestor
6310043|NCT00003013|Mitosis Modulators|mitosis modulators|mesh-ancestor
6310044|NCT00003013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6310045|NCT00003013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6310046|NCT00003013|Immunologic Factors|immunologic factors|mesh-ancestor
6310047|NCT00003013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6310048|NCT00003013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6310049|NCT00003013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6310050|NCT00003013|Alkylating Agents|alkylating agents|mesh-ancestor
6310051|NCT00003013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6310052|NCT00003013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6310053|NCT00003013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6310054|NCT00003013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6310055|NCT00003013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5724365|NCT03187626|Cholinergic Agents|cholinergic agents|mesh-ancestor
5724366|NCT03187626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5724367|NCT03187626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724368|NCT03187626|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5724369|NCT03187626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5724370|NCT03187548|Calcium|calcium|mesh-list
5724371|NCT03187548|Caseins|caseins|mesh-list
5724372|NCT03187548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5724373|NCT03187548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724374|NCT03187548|Chelating Agents|chelating agents|mesh-ancestor
5724375|NCT03187548|Sequestering Agents|sequestering agents|mesh-ancestor
6310056|NCT00003013|Antimetabolites|antimetabolites|mesh-ancestor
6310057|NCT00003013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5724677|NCT03185611|Immunologic Factors|immunologic factors|mesh-ancestor
6310058|NCT00003013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6310059|NCT00003013|Abortifacient Agents|abortifacient agents|mesh-ancestor
6310060|NCT00003013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6310061|NCT00003013|Dermatologic Agents|dermatologic agents|mesh-ancestor
6310062|NCT00003013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6310063|NCT00003013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6310064|NCT00003013|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6310065|NCT00003013|Hormone Antagonists|hormone antagonists|mesh-ancestor
6310066|NCT00003013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6310067|NCT00003013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5724376|NCT03187548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724377|NCT03187405|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5724378|NCT03187405|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6016027|NCT00361504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6310068|NCT00003013|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6310069|NCT00003013|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6310070|NCT00003013|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6310071|NCT00003014|Carboplatin|carboplatin|mesh-list
6310072|NCT00003014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310073|NCT00003015|Carboplatin|carboplatin|mesh-list
6310074|NCT00003015|Vincristine|vincristine|mesh-list
6310075|NCT00003015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310076|NCT00003015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6310077|NCT00003015|Tubulin Modulators|tubulin modulators|mesh-ancestor
6310078|NCT00003015|Antimitotic Agents|antimitotic agents|mesh-ancestor
6310079|NCT00003015|Mitosis Modulators|mitosis modulators|mesh-ancestor
6310080|NCT00003015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6310081|NCT00003016|Tamoxifen|tamoxifen|mesh-list
6310082|NCT00003016|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6310083|NCT00003016|Hormone Antagonists|hormone antagonists|mesh-ancestor
6310084|NCT00003016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6310085|NCT00003016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6310086|NCT00003016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6310087|NCT00003016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310088|NCT00003016|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6310089|NCT00003016|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6310090|NCT00003016|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6310091|NCT00003017|Interleukin-12|interleukin-12|mesh-list
6310092|NCT00003017|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6310093|NCT00003017|Immunologic Factors|immunologic factors|mesh-ancestor
6310094|NCT00003017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6310095|NCT00003017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6310096|NCT00003017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6016028|NCT00361504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016029|NCT00361504|Analgesics|analgesics|mesh-ancestor
6016030|NCT00361504|Sensory System Agents|sensory system agents|mesh-ancestor
6016031|NCT00361504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6016032|NCT00361504|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6016033|NCT00361504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6310097|NCT00003017|Growth Substances|growth substances|mesh-ancestor
6310098|NCT00003017|Growth Inhibitors|growth inhibitors|mesh-ancestor
6310099|NCT00003017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310100|NCT00003018|Leucovorin|leucovorin|mesh-list
6310101|NCT00003018|Fluorouracil|fluorouracil|mesh-list
6310102|NCT00003018|Mitomycins|mitomycins|mesh-list
6310103|NCT00003018|Mitomycin|mitomycin|mesh-list
6310104|NCT00003018|Dipyridamole|dipyridamole|mesh-list
6310105|NCT00003018|Calcium|calcium|mesh-list
6310106|NCT00003018|Levoleucovorin|levoleucovorin|mesh-list
6310107|NCT00003018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6310108|NCT00003018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6310109|NCT00003018|Antimetabolites|antimetabolites|mesh-ancestor
6310110|NCT00003018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6310111|NCT00003018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6310112|NCT00003018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310113|NCT00003018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6310114|NCT00003018|Immunologic Factors|immunologic factors|mesh-ancestor
6310115|NCT00003018|Antidotes|antidotes|mesh-ancestor
6310116|NCT00003018|Protective Agents|protective agents|mesh-ancestor
6310117|NCT00003018|Vitamin B Complex|vitamin b complex|mesh-ancestor
6310118|NCT00003018|Vitamins|vitamins|mesh-ancestor
6310119|NCT00003018|Micronutrients|micronutrients|mesh-ancestor
6310120|NCT00003018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6310121|NCT00003018|Alkylating Agents|alkylating agents|mesh-ancestor
6310122|NCT00003018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6310123|NCT00003018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6310124|NCT00003018|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6310125|NCT00003018|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6310126|NCT00003018|Vasodilator Agents|vasodilator agents|mesh-ancestor
6310127|NCT00003019|Methotrexate|methotrexate|mesh-list
6310128|NCT00003019|Vinblastine|vinblastine|mesh-list
6310129|NCT00003019|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6310130|NCT00003019|Abortifacient Agents|abortifacient agents|mesh-ancestor
6310131|NCT00003019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6310132|NCT00003019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6310133|NCT00003019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6310134|NCT00003019|Antimetabolites|antimetabolites|mesh-ancestor
6016034|NCT00361504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6016035|NCT00361504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016036|NCT00361504|Adrenergic Agents|adrenergic agents|mesh-ancestor
6310135|NCT00003019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6310136|NCT00003019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310137|NCT00003019|Dermatologic Agents|dermatologic agents|mesh-ancestor
6310138|NCT00003019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6310139|NCT00003019|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6310140|NCT00003019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6310141|NCT00003019|Immunologic Factors|immunologic factors|mesh-ancestor
6310142|NCT00003019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6310143|NCT00003019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6310144|NCT00003019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6310145|NCT00003019|Tubulin Modulators|tubulin modulators|mesh-ancestor
6310146|NCT00003019|Antimitotic Agents|antimitotic agents|mesh-ancestor
6310147|NCT00003019|Mitosis Modulators|mitosis modulators|mesh-ancestor
6310148|NCT00003020|Immunotoxins|immunotoxins|mesh-list
6310149|NCT00003020|Immunologic Factors|immunologic factors|mesh-ancestor
6310150|NCT00003020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6310151|NCT00003021|Bizelesin|bizelesin|mesh-list
6310152|NCT00003021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6310153|NCT00003021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310154|NCT00003021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6310155|NCT00003021|Alkylating Agents|alkylating agents|mesh-ancestor
6310156|NCT00003021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6310157|NCT00003022|Antibodies|antibodies|mesh-list
6310158|NCT00003022|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6310159|NCT00003022|Immunologic Factors|immunologic factors|mesh-ancestor
6310160|NCT00003022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6310161|NCT00003023|Vaccines|vaccines|mesh-list
6310162|NCT00003023|Antibodies|antibodies|mesh-list
6310163|NCT00003023|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6310164|NCT00003023|BCG Vaccine|bcg vaccine|mesh-list
6310165|NCT00003023|Immunologic Factors|immunologic factors|mesh-ancestor
6310166|NCT00003023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6310167|NCT00003023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6310168|NCT00003026|Bicalutamide|bicalutamide|mesh-list
6310169|NCT00003026|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6310170|NCT00003026|Flutamide|flutamide|mesh-list
6310171|NCT00003026|Androgen Antagonists|androgen antagonists|mesh-ancestor
6310172|NCT00003026|Hormone Antagonists|hormone antagonists|mesh-ancestor
6310173|NCT00003026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6310174|NCT00003026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6310175|NCT00003026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310176|NCT00003026|Luteolytic Agents|luteolytic agents|mesh-ancestor
6310177|NCT00003026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6310178|NCT00003026|Contraceptive Agents|contraceptive agents|mesh-ancestor
6310179|NCT00003026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6310180|NCT00003026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6310181|NCT00003026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6310182|NCT00003027|Interferons|interferons|mesh-list
6310183|NCT00003027|Interferon-alpha|interferon-alpha|mesh-list
6310184|NCT00003027|Aldesleukin|aldesleukin|mesh-list
6310185|NCT00003027|Dacarbazine|dacarbazine|mesh-list
6310186|NCT00003027|Vinblastine|vinblastine|mesh-list
6310187|NCT00003027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310188|NCT00003027|Antiviral Agents|antiviral agents|mesh-ancestor
6310189|NCT00003027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6310190|NCT00003027|Immunologic Factors|immunologic factors|mesh-ancestor
6310191|NCT00003027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6310192|NCT00003027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6310193|NCT00003027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6310194|NCT00003027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6310195|NCT00003027|Alkylating Agents|alkylating agents|mesh-ancestor
6310196|NCT00003027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6310197|NCT00003027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6310198|NCT00003027|Tubulin Modulators|tubulin modulators|mesh-ancestor
6310199|NCT00003027|Antimitotic Agents|antimitotic agents|mesh-ancestor
6310200|NCT00003027|Mitosis Modulators|mitosis modulators|mesh-ancestor
6310201|NCT00003029|Fluorouracil|fluorouracil|mesh-list
6310202|NCT00003029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310203|NCT00003029|Antimetabolites|antimetabolites|mesh-ancestor
6310204|NCT00003029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016037|NCT00361504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6016038|NCT00361569|Estrogens|estrogens|mesh-list
6310205|NCT00003029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6310206|NCT00003029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6310207|NCT00003029|Immunologic Factors|immunologic factors|mesh-ancestor
6310208|NCT00003029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6310209|NCT00003031|Voriconazole|voriconazole|mesh-list
6310210|NCT00003031|Amphotericin B|amphotericin b|mesh-list
6310211|NCT00003031|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6310212|NCT00003031|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
6310213|NCT00003031|Deoxycholic Acid|deoxycholic acid|mesh-list
6310214|NCT00003031|Antifungal Agents|antifungal agents|mesh-ancestor
6310215|NCT00003031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6310216|NCT00003031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6310217|NCT00003031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6310218|NCT00003031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6310219|NCT00003031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6310220|NCT00003031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6310221|NCT00003031|Hormone Antagonists|hormone antagonists|mesh-ancestor
6310222|NCT00003031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6310223|NCT00003031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6310224|NCT00003031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6310225|NCT00003031|Amebicides|amebicides|mesh-ancestor
6310226|NCT00003031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6310227|NCT00003031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6310228|NCT00003031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6310229|NCT00003031|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6310230|NCT00003031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6310231|NCT00003032|Tamoxifen|tamoxifen|mesh-list
6310232|NCT00003032|Cyclophosphamide|cyclophosphamide|mesh-list
6310233|NCT00003032|Mitoxantrone|mitoxantrone|mesh-list
6310234|NCT00003032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6310235|NCT00003032|Immunologic Factors|immunologic factors|mesh-ancestor
6310236|NCT00003032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6310237|NCT00003032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6310238|NCT00003032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6310239|NCT00003032|Alkylating Agents|alkylating agents|mesh-ancestor
6310240|NCT00003032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6310241|NCT00003032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310242|NCT00003032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6310243|NCT00003032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6310244|NCT00003032|Hormone Antagonists|hormone antagonists|mesh-ancestor
6310245|NCT00003032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6310246|NCT00003032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6310247|NCT00003032|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6310248|NCT00003032|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6310249|NCT00003032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6310250|NCT00003032|Analgesics|analgesics|mesh-ancestor
6310251|NCT00003032|Sensory System Agents|sensory system agents|mesh-ancestor
6310252|NCT00003032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6310253|NCT00003032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6310254|NCT00003032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6310255|NCT00003032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6310256|NCT00003034|Doxorubicin|doxorubicin|mesh-list
6310257|NCT00003034|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6310258|NCT00003034|Ranpirnase|ranpirnase|mesh-list
6310259|NCT00003034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6310260|NCT00003034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310261|NCT00003034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6310262|NCT00003034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6310263|NCT00003034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6310264|NCT00003034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6310265|NCT00003034|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6310266|NCT00003035|Tamoxifen|tamoxifen|mesh-list
6310267|NCT00003035|Paclitaxel|paclitaxel|mesh-list
6310268|NCT00003035|Doxorubicin|doxorubicin|mesh-list
6310269|NCT00003035|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6310270|NCT00003035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6310271|NCT00003035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310272|NCT00003035|Tubulin Modulators|tubulin modulators|mesh-ancestor
6310273|NCT00003035|Antimitotic Agents|antimitotic agents|mesh-ancestor
6310274|NCT00003035|Mitosis Modulators|mitosis modulators|mesh-ancestor
6310275|NCT00003035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6310276|NCT00003035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6310277|NCT00003035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6310278|NCT00003035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6310279|NCT00003035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6310280|NCT00003035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6310281|NCT00003035|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6310282|NCT00003035|Hormone Antagonists|hormone antagonists|mesh-ancestor
6310283|NCT00003035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6310284|NCT00003035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6310285|NCT00003035|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6310286|NCT00003035|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6310287|NCT00003035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6310288|NCT00003037|Gemcitabine|gemcitabine|mesh-list
6310289|NCT00003037|Docetaxel|docetaxel|mesh-list
6016039|NCT00361569|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6016040|NCT00361569|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
6310290|NCT00003037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6016041|NCT00361569|Hormones|hormones|mesh-ancestor
5724379|NCT03187405|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5724380|NCT03187405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724381|NCT03187509|Torsemide|torsemide|mesh-list
5724382|NCT03187509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5724383|NCT03187509|Diuretics|diuretics|mesh-ancestor
5724384|NCT03187509|Natriuretic Agents|natriuretic agents|mesh-ancestor
5724385|NCT03187509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724386|NCT03187509|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5724387|NCT03187509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5724388|NCT03187509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724389|NCT03187457|Metronidazole|metronidazole|mesh-list
5724390|NCT03187457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5724391|NCT03187457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5724392|NCT03187457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5724393|NCT03187457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5724394|NCT03187093|Vortioxetine|vortioxetine|mesh-list
6310291|NCT00003037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6310292|NCT00003037|Antimetabolites|antimetabolites|mesh-ancestor
6310293|NCT00003037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6310294|NCT00003037|Antiviral Agents|antiviral agents|mesh-ancestor
6310295|NCT00003037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6310296|NCT00003037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6310297|NCT00003037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6310298|NCT00003037|Immunologic Factors|immunologic factors|mesh-ancestor
6310299|NCT00003037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6310300|NCT00003037|Tubulin Modulators|tubulin modulators|mesh-ancestor
6310301|NCT00003037|Antimitotic Agents|antimitotic agents|mesh-ancestor
6310302|NCT00003037|Mitosis Modulators|mitosis modulators|mesh-ancestor
6310303|NCT00003038|Suramin|suramin|mesh-list
6310304|NCT00003038|Doxorubicin|doxorubicin|mesh-list
6310305|NCT00003038|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6310306|NCT00003038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6310307|NCT00003038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310308|NCT00003038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6310309|NCT00003038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6310310|NCT00003038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6310311|NCT00003038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6310312|NCT00003038|Antinematodal Agents|antinematodal agents|mesh-ancestor
6310313|NCT00003038|Anthelmintics|anthelmintics|mesh-ancestor
6310314|NCT00003038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6310315|NCT00003038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6310316|NCT00003038|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6310317|NCT00003038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6310318|NCT00003039|Alvocidib|alvocidib|mesh-list
6310319|NCT00003039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310320|NCT00003039|Growth Inhibitors|growth inhibitors|mesh-ancestor
6310321|NCT00003039|Growth Substances|growth substances|mesh-ancestor
6310322|NCT00003039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6310323|NCT00003039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6310324|NCT00003039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6310325|NCT00003039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6310326|NCT00003041|NSC 366140|nsc 366140|mesh-list
6310327|NCT00003041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310328|NCT00003044|Cisplatin|cisplatin|mesh-list
6310329|NCT00003044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310330|NCT00003046|Interleukin-12|interleukin-12|mesh-list
6310331|NCT00003046|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6310332|NCT00003046|Immunologic Factors|immunologic factors|mesh-ancestor
6310333|NCT00003046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6310334|NCT00003046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6310335|NCT00003046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6310336|NCT00003046|Growth Substances|growth substances|mesh-ancestor
6310337|NCT00003046|Growth Inhibitors|growth inhibitors|mesh-ancestor
6310338|NCT00003046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310339|NCT00003048|Amifostine|amifostine|mesh-list
6310340|NCT00003048|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6310341|NCT00003048|Protective Agents|protective agents|mesh-ancestor
6310342|NCT00003048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6310343|NCT00003049|Leucovorin|leucovorin|mesh-list
6310344|NCT00003049|Fluorouracil|fluorouracil|mesh-list
6310345|NCT00003049|Calcium|calcium|mesh-list
6310346|NCT00003049|Levoleucovorin|levoleucovorin|mesh-list
6310347|NCT00003049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6310348|NCT00003049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6310349|NCT00003049|Antimetabolites|antimetabolites|mesh-ancestor
6310350|NCT00003049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6310351|NCT00003049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6310352|NCT00003049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310353|NCT00003049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6310354|NCT00003049|Immunologic Factors|immunologic factors|mesh-ancestor
6310355|NCT00003049|Antidotes|antidotes|mesh-ancestor
6310356|NCT00003049|Protective Agents|protective agents|mesh-ancestor
6310357|NCT00003049|Vitamin B Complex|vitamin b complex|mesh-ancestor
6310358|NCT00003049|Vitamins|vitamins|mesh-ancestor
6310359|NCT00003049|Micronutrients|micronutrients|mesh-ancestor
6310360|NCT00003050|Tamoxifen|tamoxifen|mesh-list
6310361|NCT00003050|Paclitaxel|paclitaxel|mesh-list
6310362|NCT00003050|Cyclophosphamide|cyclophosphamide|mesh-list
6310363|NCT00003050|Doxorubicin|doxorubicin|mesh-list
6310364|NCT00003050|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6310365|NCT00003050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6310366|NCT00003050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310367|NCT00003050|Tubulin Modulators|tubulin modulators|mesh-ancestor
6310368|NCT00003050|Antimitotic Agents|antimitotic agents|mesh-ancestor
6310369|NCT00003050|Mitosis Modulators|mitosis modulators|mesh-ancestor
6310370|NCT00003050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6310371|NCT00003050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6310372|NCT00003050|Immunologic Factors|immunologic factors|mesh-ancestor
6310373|NCT00003050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6310374|NCT00003050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6310375|NCT00003050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6310376|NCT00003050|Alkylating Agents|alkylating agents|mesh-ancestor
6310377|NCT00003050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6310378|NCT00003050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6310379|NCT00003050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6310380|NCT00003050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6310381|NCT00003050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6310382|NCT00003050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6310383|NCT00003050|Hormone Antagonists|hormone antagonists|mesh-ancestor
6310384|NCT00003050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6310385|NCT00003050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6310386|NCT00003050|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6310387|NCT00003050|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6310388|NCT00003050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6310389|NCT00003052|Doxorubicin|doxorubicin|mesh-list
6310390|NCT00003052|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6310391|NCT00003052|Etoposide|etoposide|mesh-list
6310392|NCT00003052|Ifosfamide|ifosfamide|mesh-list
6310393|NCT00003052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6310394|NCT00003052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310395|NCT00003052|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6310396|NCT00003052|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6310397|NCT00003052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6310398|NCT00003052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6310399|NCT00003052|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6310400|NCT00003052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6310401|NCT00003052|Alkylating Agents|alkylating agents|mesh-ancestor
6310402|NCT00003053|Etoposide|etoposide|mesh-list
6310403|NCT00003053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310404|NCT00003053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6310405|NCT00003053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6310406|NCT00003053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6310407|NCT00003053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6310408|NCT00003053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6310409|NCT00003054|Paclitaxel|paclitaxel|mesh-list
6310410|NCT00003054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6310411|NCT00003054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310412|NCT00003054|Tubulin Modulators|tubulin modulators|mesh-ancestor
6310413|NCT00003054|Antimitotic Agents|antimitotic agents|mesh-ancestor
6310414|NCT00003054|Mitosis Modulators|mitosis modulators|mesh-ancestor
6310415|NCT00003054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6310416|NCT00003055|Irinotecan|irinotecan|mesh-list
5724395|NCT03187093|Citalopram|citalopram|mesh-list
5724396|NCT03187093|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5724397|NCT03187093|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5724398|NCT03187093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6310417|NCT00003055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310418|NCT00003055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6310419|NCT00003055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6310420|NCT00003055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6310421|NCT00003055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6310422|NCT00003056|Cyclosporine|cyclosporine|mesh-list
6310423|NCT00003056|Methotrexate|methotrexate|mesh-list
6310424|NCT00003056|Cyclosporins|cyclosporins|mesh-list
6310425|NCT00003056|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6310426|NCT00003056|Abortifacient Agents|abortifacient agents|mesh-ancestor
6310427|NCT00003056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6310428|NCT00003056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6310429|NCT00003056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6310430|NCT00003056|Antimetabolites|antimetabolites|mesh-ancestor
6310431|NCT00003056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6310432|NCT00003056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310433|NCT00003056|Dermatologic Agents|dermatologic agents|mesh-ancestor
6310434|NCT00003056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6310435|NCT00003056|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6310436|NCT00003056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6310437|NCT00003056|Immunologic Factors|immunologic factors|mesh-ancestor
6310438|NCT00003056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6310439|NCT00003056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6310440|NCT00003056|Antifungal Agents|antifungal agents|mesh-ancestor
6310441|NCT00003056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6310442|NCT00003056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6310443|NCT00003057|Octreotide|octreotide|mesh-list
6310444|NCT00003057|Loperamide|loperamide|mesh-list
6310445|NCT00003057|Antidiarrheals|antidiarrheals|mesh-list
6310446|NCT00003057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6310447|NCT00003057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6016042|NCT00361569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6016043|NCT00361569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016044|NCT00361595|Zoledronic Acid|zoledronic acid|mesh-list
6016045|NCT00361595|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6016046|NCT00361595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016047|NCT00361634|Etanercept|etanercept|mesh-list
6310448|NCT00003057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310449|NCT00003058|Troglitazone|troglitazone|mesh-list
6310450|NCT00003058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6310451|NCT00003058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6310452|NCT00003060|Cyclosporine|cyclosporine|mesh-list
6310453|NCT00003060|Cyclophosphamide|cyclophosphamide|mesh-list
6310454|NCT00003060|Busulfan|busulfan|mesh-list
6310455|NCT00003060|Methotrexate|methotrexate|mesh-list
6310456|NCT00003060|Cyclosporins|cyclosporins|mesh-list
6310457|NCT00003060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6310458|NCT00003060|Immunologic Factors|immunologic factors|mesh-ancestor
6310459|NCT00003060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6310460|NCT00003060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6310461|NCT00003060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6310462|NCT00003060|Alkylating Agents|alkylating agents|mesh-ancestor
6310463|NCT00003060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6310464|NCT00003060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310465|NCT00003060|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6310466|NCT00003060|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6310467|NCT00003060|Abortifacient Agents|abortifacient agents|mesh-ancestor
6310468|NCT00003060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6310469|NCT00003060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6310470|NCT00003060|Antimetabolites|antimetabolites|mesh-ancestor
6310471|NCT00003060|Dermatologic Agents|dermatologic agents|mesh-ancestor
6310472|NCT00003060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6310473|NCT00003060|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6310474|NCT00003060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6310475|NCT00003060|Antifungal Agents|antifungal agents|mesh-ancestor
6310476|NCT00003060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6310477|NCT00003060|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6310478|NCT00003061|Cytarabine|cytarabine|mesh-list
6310479|NCT00003061|Methotrexate|methotrexate|mesh-list
6310480|NCT00003061|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6310481|NCT00003061|Abortifacient Agents|abortifacient agents|mesh-ancestor
6310482|NCT00003061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6310483|NCT00003061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6310484|NCT00003061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6310485|NCT00003061|Antimetabolites|antimetabolites|mesh-ancestor
6310486|NCT00003061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6310487|NCT00003061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310488|NCT00003061|Dermatologic Agents|dermatologic agents|mesh-ancestor
6310489|NCT00003061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6310490|NCT00003061|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6310491|NCT00003061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6310492|NCT00003061|Immunologic Factors|immunologic factors|mesh-ancestor
6310493|NCT00003061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6310494|NCT00003061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6310495|NCT00003061|Antiviral Agents|antiviral agents|mesh-ancestor
6310496|NCT00003061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6310497|NCT00003062|Temozolomide|temozolomide|mesh-list
6310498|NCT00003062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6310499|NCT00003062|Alkylating Agents|alkylating agents|mesh-ancestor
6310500|NCT00003062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6310501|NCT00003062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310502|NCT00003063|Leucovorin|leucovorin|mesh-list
6310503|NCT00003063|Interferons|interferons|mesh-list
6310504|NCT00003063|Interferon-alpha|interferon-alpha|mesh-list
6310505|NCT00003063|Levamisole|levamisole|mesh-list
6310506|NCT00003063|Fluorouracil|fluorouracil|mesh-list
6310507|NCT00003063|Calcium|calcium|mesh-list
6310508|NCT00003063|Levoleucovorin|levoleucovorin|mesh-list
6310509|NCT00003063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6310510|NCT00003063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6310511|NCT00003063|Antimetabolites|antimetabolites|mesh-ancestor
6310512|NCT00003063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6310513|NCT00003063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6310514|NCT00003063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310515|NCT00003063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6310516|NCT00003063|Immunologic Factors|immunologic factors|mesh-ancestor
6310517|NCT00003063|Antiviral Agents|antiviral agents|mesh-ancestor
6310518|NCT00003063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6310519|NCT00003063|Antidotes|antidotes|mesh-ancestor
6310520|NCT00003063|Protective Agents|protective agents|mesh-ancestor
6310521|NCT00003063|Vitamin B Complex|vitamin b complex|mesh-ancestor
6310522|NCT00003063|Vitamins|vitamins|mesh-ancestor
6310523|NCT00003063|Micronutrients|micronutrients|mesh-ancestor
6310524|NCT00003063|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6310525|NCT00003063|Antinematodal Agents|antinematodal agents|mesh-ancestor
6310526|NCT00003063|Anthelmintics|anthelmintics|mesh-ancestor
6310527|NCT00003063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6310528|NCT00003063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6310529|NCT00003064|Paclitaxel|paclitaxel|mesh-list
6310530|NCT00003064|Etoposide|etoposide|mesh-list
6310531|NCT00003064|Carboplatin|carboplatin|mesh-list
6310532|NCT00003064|Topotecan|topotecan|mesh-list
6310533|NCT00003064|Thiotepa|thiotepa|mesh-list
6310534|NCT00003064|Etoposide phosphate|etoposide phosphate|mesh-list
6310535|NCT00003064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6310536|NCT00003064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310537|NCT00003064|Tubulin Modulators|tubulin modulators|mesh-ancestor
6310538|NCT00003064|Antimitotic Agents|antimitotic agents|mesh-ancestor
6310539|NCT00003064|Mitosis Modulators|mitosis modulators|mesh-ancestor
6310540|NCT00003064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6310541|NCT00003064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6310542|NCT00003064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6310543|NCT00003064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6310544|NCT00003064|Immunologic Factors|immunologic factors|mesh-ancestor
6310545|NCT00003064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6310546|NCT00003064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6310547|NCT00003064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6310548|NCT00003064|Alkylating Agents|alkylating agents|mesh-ancestor
6310549|NCT00003064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6310550|NCT00003064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6310551|NCT00003065|Paclitaxel|paclitaxel|mesh-list
6310552|NCT00003065|Topotecan|topotecan|mesh-list
6310553|NCT00003065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6310554|NCT00003065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310555|NCT00003065|Tubulin Modulators|tubulin modulators|mesh-ancestor
6310556|NCT00003065|Antimitotic Agents|antimitotic agents|mesh-ancestor
6310557|NCT00003065|Mitosis Modulators|mitosis modulators|mesh-ancestor
6310558|NCT00003065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6310559|NCT00003065|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6310560|NCT00003065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6310561|NCT00003065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6310562|NCT00003066|Docetaxel|docetaxel|mesh-list
6310563|NCT00003066|Estramustine|estramustine|mesh-list
6310564|NCT00003066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310565|NCT00003066|Tubulin Modulators|tubulin modulators|mesh-ancestor
6310566|NCT00003066|Antimitotic Agents|antimitotic agents|mesh-ancestor
6310567|NCT00003066|Mitosis Modulators|mitosis modulators|mesh-ancestor
6310568|NCT00003066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6310569|NCT00003066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6310570|NCT00003066|Alkylating Agents|alkylating agents|mesh-ancestor
6310571|NCT00003066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6310572|NCT00003067|Aldesleukin|aldesleukin|mesh-list
6310573|NCT00003067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310574|NCT00003067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6310575|NCT00003067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6310576|NCT00003067|Antiviral Agents|antiviral agents|mesh-ancestor
6310577|NCT00003067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6310578|NCT00003068|Cyclophosphamide|cyclophosphamide|mesh-list
6310579|NCT00003068|Thiotepa|thiotepa|mesh-list
6310580|NCT00003068|Mitoxantrone|mitoxantrone|mesh-list
6310581|NCT00003068|Amifostine|amifostine|mesh-list
6310582|NCT00003068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6310583|NCT00003068|Immunologic Factors|immunologic factors|mesh-ancestor
6310584|NCT00003068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6310585|NCT00003068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6310586|NCT00003068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6310587|NCT00003068|Alkylating Agents|alkylating agents|mesh-ancestor
6310588|NCT00003068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6310589|NCT00003068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310590|NCT00003068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6310591|NCT00003068|Analgesics|analgesics|mesh-ancestor
6310592|NCT00003068|Sensory System Agents|sensory system agents|mesh-ancestor
6310593|NCT00003068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6310594|NCT00003068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6310595|NCT00003068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6310596|NCT00003068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6310597|NCT00003068|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6310598|NCT00003068|Protective Agents|protective agents|mesh-ancestor
6310599|NCT00003070|Enalapril|enalapril|mesh-list
6310600|NCT00003070|Enalaprilat|enalaprilat|mesh-list
6310601|NCT00003070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6310602|NCT00003070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6310603|NCT00003070|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6310604|NCT00003070|Protease Inhibitors|protease inhibitors|mesh-ancestor
6310605|NCT00003070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6310606|NCT00003072|Paclitaxel|paclitaxel|mesh-list
6016048|NCT00361634|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6016049|NCT00361634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6016050|NCT00361634|Analgesics|analgesics|mesh-ancestor
6016051|NCT00361634|Sensory System Agents|sensory system agents|mesh-ancestor
6016052|NCT00361634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6016053|NCT00361634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016054|NCT00361634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6016055|NCT00361634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6016056|NCT00361634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6016057|NCT00361634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6016058|NCT00361634|Immunologic Factors|immunologic factors|mesh-ancestor
6016059|NCT00361842|Irinotecan|irinotecan|mesh-list
6016060|NCT00361842|Floxuridine|floxuridine|mesh-list
6016061|NCT00361842|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6310607|NCT00003072|Carboplatin|carboplatin|mesh-list
6310608|NCT00003072|Amifostine|amifostine|mesh-list
6310609|NCT00003072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6310610|NCT00003072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310611|NCT00003072|Tubulin Modulators|tubulin modulators|mesh-ancestor
6310612|NCT00003072|Antimitotic Agents|antimitotic agents|mesh-ancestor
6310613|NCT00003072|Mitosis Modulators|mitosis modulators|mesh-ancestor
6310614|NCT00003072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6310615|NCT00003072|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6310616|NCT00003072|Protective Agents|protective agents|mesh-ancestor
6310617|NCT00003072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6310618|NCT00003073|Cytarabine|cytarabine|mesh-list
6310619|NCT00003073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6310620|NCT00003073|Antimetabolites|antimetabolites|mesh-ancestor
6310621|NCT00003073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6310622|NCT00003073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310623|NCT00003073|Antiviral Agents|antiviral agents|mesh-ancestor
6310624|NCT00003073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6310625|NCT00003073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6310626|NCT00003073|Immunologic Factors|immunologic factors|mesh-ancestor
6310627|NCT00003073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6310628|NCT00003075|Fenretinide|fenretinide|mesh-list
6310629|NCT00003075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310630|NCT00003075|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6310631|NCT00003075|Protective Agents|protective agents|mesh-ancestor
6310632|NCT00003075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6310633|NCT00003076|Eflornithine|eflornithine|mesh-list
6310634|NCT00003076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310635|NCT00003076|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6310636|NCT00003076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6310637|NCT00003076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6310638|NCT00003076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6310639|NCT00003076|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
6310640|NCT00003076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6310641|NCT00003076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6310642|NCT00003078|Fluorouracil|fluorouracil|mesh-list
6310643|NCT00003078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310644|NCT00003078|Antimetabolites|antimetabolites|mesh-ancestor
6310645|NCT00003078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6310646|NCT00003078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6310647|NCT00003078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6310648|NCT00003078|Immunologic Factors|immunologic factors|mesh-ancestor
6310649|NCT00003078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6310650|NCT00003079|Cytarabine|cytarabine|mesh-list
6310651|NCT00003079|Bryostatin 1|bryostatin 1|mesh-list
6310652|NCT00003079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6310653|NCT00003079|Antimetabolites|antimetabolites|mesh-ancestor
6310654|NCT00003079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6310655|NCT00003079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310656|NCT00003079|Antiviral Agents|antiviral agents|mesh-ancestor
6310657|NCT00003079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6310658|NCT00003079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6310659|NCT00003079|Immunologic Factors|immunologic factors|mesh-ancestor
6310660|NCT00003079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6310661|NCT00003079|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6392421|NCT00196417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6392422|NCT00196417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6392423|NCT00196417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392424|NCT00196469|Heparin|heparin|mesh-list
6392425|NCT00196469|Anticoagulants|anticoagulants|mesh-ancestor
6392426|NCT00196469|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6392427|NCT00196469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6392428|NCT00196469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392429|NCT00196534|Thrombin|thrombin|mesh-list
6392430|NCT00196534|Hemostatics|hemostatics|mesh-ancestor
6392431|NCT00196534|Coagulants|coagulants|mesh-ancestor
6392432|NCT00196547|Montelukast|montelukast|mesh-list
6392433|NCT00196547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6392434|NCT00196547|Respiratory System Agents|respiratory system agents|mesh-ancestor
6392435|NCT00196547|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6392436|NCT00196547|Hormone Antagonists|hormone antagonists|mesh-ancestor
6392437|NCT00196547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6392438|NCT00196547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392439|NCT00196547|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6392440|NCT00196547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6392441|NCT00196547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392442|NCT00196586|Interferons|interferons|mesh-list
6392443|NCT00196586|Ribavirin|ribavirin|mesh-list
6392444|NCT00196586|Interferon-alpha|interferon-alpha|mesh-list
6392445|NCT00196586|Interferon alpha-2|interferon alpha-2|mesh-list
6392446|NCT00196586|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6392447|NCT00196586|Interleukin-2|interleukin-2|mesh-list
6392448|NCT00196586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6392449|NCT00196586|Antiviral Agents|antiviral agents|mesh-ancestor
6392450|NCT00196586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6392451|NCT00196586|Antimetabolites|antimetabolites|mesh-ancestor
6392452|NCT00196586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392453|NCT00196586|Immunologic Factors|immunologic factors|mesh-ancestor
6392454|NCT00196586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392455|NCT00196586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6392456|NCT00196586|Analgesics|analgesics|mesh-ancestor
6392457|NCT00196586|Sensory System Agents|sensory system agents|mesh-ancestor
6392458|NCT00196586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6392459|NCT00196599|Emtricitabine|emtricitabine|mesh-list
6392460|NCT00196599|Efavirenz|efavirenz|mesh-list
6392461|NCT00196599|Didanosine|didanosine|mesh-list
6392462|NCT00196599|Antiviral Agents|antiviral agents|mesh-ancestor
6392463|NCT00196599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6392464|NCT00196599|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6310662|NCT00003080|Tamoxifen|tamoxifen|mesh-list
6310663|NCT00003080|Melphalan|melphalan|mesh-list
6310664|NCT00003080|Thiotepa|thiotepa|mesh-list
6310665|NCT00003080|Mitoxantrone|mitoxantrone|mesh-list
6310666|NCT00003080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6310667|NCT00003080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6310668|NCT00003080|Alkylating Agents|alkylating agents|mesh-ancestor
6310669|NCT00003080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310670|NCT00003080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6310671|NCT00003080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6310672|NCT00003080|Immunologic Factors|immunologic factors|mesh-ancestor
6310673|NCT00003080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6310674|NCT00003080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6310675|NCT00003080|Hormone Antagonists|hormone antagonists|mesh-ancestor
6310676|NCT00003080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6310677|NCT00003080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6310678|NCT00003080|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6310679|NCT00003080|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6310680|NCT00003080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6310681|NCT00003080|Analgesics|analgesics|mesh-ancestor
6310682|NCT00003080|Sensory System Agents|sensory system agents|mesh-ancestor
6310683|NCT00003080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6310684|NCT00003080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6310685|NCT00003080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6310686|NCT00003080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6310687|NCT00003081|Melphalan|melphalan|mesh-list
6310688|NCT00003081|Busulfan|busulfan|mesh-list
6310689|NCT00003081|Thiotepa|thiotepa|mesh-list
6310690|NCT00003081|Immunologic Factors|immunologic factors|mesh-ancestor
6310691|NCT00003081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6310692|NCT00003081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6310693|NCT00003081|Alkylating Agents|alkylating agents|mesh-ancestor
6310694|NCT00003081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6310695|NCT00003081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310696|NCT00003081|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6310697|NCT00003081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6310698|NCT00003082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6310699|NCT00003082|Antibodies|antibodies|mesh-list
6310700|NCT00003082|Immunoglobulins|immunoglobulins|mesh-list
6310701|NCT00003082|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6310702|NCT00003082|Immunologic Factors|immunologic factors|mesh-ancestor
6310703|NCT00003082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6310704|NCT00003082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310705|NCT00003084|Ketoconazole|ketoconazole|mesh-list
6310706|NCT00003084|Paclitaxel|paclitaxel|mesh-list
6310707|NCT00003084|Etoposide|etoposide|mesh-list
6310708|NCT00003084|Vinblastine|vinblastine|mesh-list
6310709|NCT00003084|Doxorubicin|doxorubicin|mesh-list
6310710|NCT00003084|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6310711|NCT00003084|Estramustine|estramustine|mesh-list
6310712|NCT00003084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6310713|NCT00003084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310714|NCT00003084|Tubulin Modulators|tubulin modulators|mesh-ancestor
6310715|NCT00003084|Antimitotic Agents|antimitotic agents|mesh-ancestor
6310716|NCT00003084|Mitosis Modulators|mitosis modulators|mesh-ancestor
6310717|NCT00003084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6310718|NCT00003084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6310719|NCT00003084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6310720|NCT00003084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6310721|NCT00003084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6310722|NCT00003084|Antifungal Agents|antifungal agents|mesh-ancestor
6310723|NCT00003084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6310724|NCT00003084|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6310725|NCT00003084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6310726|NCT00003084|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6310727|NCT00003084|Hormone Antagonists|hormone antagonists|mesh-ancestor
6310728|NCT00003084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6310729|NCT00003084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6310730|NCT00003084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6310731|NCT00003084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6310732|NCT00003084|Alkylating Agents|alkylating agents|mesh-ancestor
6310733|NCT00003084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6310734|NCT00003086|Cyclophosphamide|cyclophosphamide|mesh-list
6310735|NCT00003086|Carboplatin|carboplatin|mesh-list
6310736|NCT00003086|Doxorubicin|doxorubicin|mesh-list
6310737|NCT00003086|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6310738|NCT00003086|Fluorouracil|fluorouracil|mesh-list
6310739|NCT00003086|Melphalan|melphalan|mesh-list
6310740|NCT00003086|Ifosfamide|ifosfamide|mesh-list
6310741|NCT00003086|Thiotepa|thiotepa|mesh-list
6310742|NCT00003086|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
6310743|NCT00003086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310744|NCT00003086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6310745|NCT00003086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6310746|NCT00003086|Immunologic Factors|immunologic factors|mesh-ancestor
6310747|NCT00003086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6310748|NCT00003086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6310749|NCT00003086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6310750|NCT00003086|Alkylating Agents|alkylating agents|mesh-ancestor
6310751|NCT00003086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6310752|NCT00003086|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6310753|NCT00003086|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6310754|NCT00003086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6310755|NCT00003086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6310756|NCT00003086|Antimetabolites|antimetabolites|mesh-ancestor
6310757|NCT00003086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6310758|NCT00003086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6310759|NCT00003086|Analgesics|analgesics|mesh-ancestor
6310760|NCT00003086|Sensory System Agents|sensory system agents|mesh-ancestor
6310761|NCT00003086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6310762|NCT00003087|Paclitaxel|paclitaxel|mesh-list
6310763|NCT00003087|Cisplatin|cisplatin|mesh-list
6310764|NCT00003087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5724399|NCT03187093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724400|NCT03187093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5724401|NCT03187093|Serotonin Agents|serotonin agents|mesh-ancestor
6310765|NCT00003087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310766|NCT00003087|Tubulin Modulators|tubulin modulators|mesh-ancestor
6310767|NCT00003087|Antimitotic Agents|antimitotic agents|mesh-ancestor
6310768|NCT00003087|Mitosis Modulators|mitosis modulators|mesh-ancestor
6310769|NCT00003087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6310770|NCT00003088|Paclitaxel|paclitaxel|mesh-list
6310771|NCT00003088|Cyclophosphamide|cyclophosphamide|mesh-list
6310772|NCT00003088|Doxorubicin|doxorubicin|mesh-list
6016062|NCT00361842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6016063|NCT00361842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6016064|NCT00361842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016065|NCT00361842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6016066|NCT00361842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6016067|NCT00361842|Antimetabolites|antimetabolites|mesh-ancestor
6310773|NCT00003088|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6310774|NCT00003088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6310775|NCT00003088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310776|NCT00003088|Tubulin Modulators|tubulin modulators|mesh-ancestor
6310777|NCT00003088|Antimitotic Agents|antimitotic agents|mesh-ancestor
6310778|NCT00003088|Mitosis Modulators|mitosis modulators|mesh-ancestor
6310779|NCT00003088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6310780|NCT00003088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6310781|NCT00003088|Immunologic Factors|immunologic factors|mesh-ancestor
6310782|NCT00003088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6310783|NCT00003088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6310784|NCT00003088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6310785|NCT00003088|Alkylating Agents|alkylating agents|mesh-ancestor
6310786|NCT00003088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6310787|NCT00003088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6310788|NCT00003088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6310789|NCT00003088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6310790|NCT00003088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6310791|NCT00003089|Paclitaxel|paclitaxel|mesh-list
6310792|NCT00003089|Carboplatin|carboplatin|mesh-list
6310793|NCT00003089|Amifostine|amifostine|mesh-list
6310794|NCT00003089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6310795|NCT00003089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310796|NCT00003089|Tubulin Modulators|tubulin modulators|mesh-ancestor
6310797|NCT00003089|Antimitotic Agents|antimitotic agents|mesh-ancestor
6310798|NCT00003089|Mitosis Modulators|mitosis modulators|mesh-ancestor
6310799|NCT00003089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6310800|NCT00003089|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6310801|NCT00003089|Protective Agents|protective agents|mesh-ancestor
6310802|NCT00003089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6310803|NCT00003090|Aldesleukin|aldesleukin|mesh-list
6310804|NCT00003090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310805|NCT00003090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6310806|NCT00003090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6310807|NCT00003090|Antiviral Agents|antiviral agents|mesh-ancestor
6310808|NCT00003090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6310809|NCT00003091|Interferons|interferons|mesh-list
6310810|NCT00003091|Interferon-alpha|interferon-alpha|mesh-list
6310811|NCT00003091|Aldesleukin|aldesleukin|mesh-list
6310812|NCT00003091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310813|NCT00003091|Antiviral Agents|antiviral agents|mesh-ancestor
6310814|NCT00003091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6310815|NCT00003091|Immunologic Factors|immunologic factors|mesh-ancestor
6310816|NCT00003091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6310817|NCT00003091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6310818|NCT00003091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6310819|NCT00003092|Paclitaxel|paclitaxel|mesh-list
6310820|NCT00003092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6310821|NCT00003092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310822|NCT00003092|Tubulin Modulators|tubulin modulators|mesh-ancestor
6310823|NCT00003092|Antimitotic Agents|antimitotic agents|mesh-ancestor
6310824|NCT00003092|Mitosis Modulators|mitosis modulators|mesh-ancestor
6310825|NCT00003092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6310826|NCT00003093|Cyclophosphamide|cyclophosphamide|mesh-list
6310827|NCT00003093|Carboplatin|carboplatin|mesh-list
6310828|NCT00003093|Doxorubicin|doxorubicin|mesh-list
6310829|NCT00003093|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6310830|NCT00003093|Etoposide|etoposide|mesh-list
6310831|NCT00003093|Molgramostim|molgramostim|mesh-list
6310832|NCT00003093|Lenograstim|lenograstim|mesh-list
6310833|NCT00003093|Sargramostim|sargramostim|mesh-list
6310834|NCT00003093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6310835|NCT00003093|Immunologic Factors|immunologic factors|mesh-ancestor
6310836|NCT00003093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6310837|NCT00003093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6310838|NCT00003093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6310839|NCT00003093|Alkylating Agents|alkylating agents|mesh-ancestor
6310840|NCT00003093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6310841|NCT00003093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310842|NCT00003093|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6310843|NCT00003093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6310844|NCT00003093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6310845|NCT00003093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6310846|NCT00003093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6310847|NCT00003093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6310848|NCT00003093|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6310849|NCT00003099|Tamoxifen|tamoxifen|mesh-list
6310850|NCT00003099|Fenretinide|fenretinide|mesh-list
6310851|NCT00003099|Retinamide|retinamide|mesh-list
6310852|NCT00003099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6310853|NCT00003099|Hormone Antagonists|hormone antagonists|mesh-ancestor
6310854|NCT00003099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6310855|NCT00003099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6310856|NCT00003099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6310857|NCT00003099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310858|NCT00003099|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6310859|NCT00003099|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6310860|NCT00003099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6310861|NCT00003099|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6310862|NCT00003099|Protective Agents|protective agents|mesh-ancestor
6310863|NCT00003101|Vincristine|vincristine|mesh-list
6310864|NCT00003101|Busulfan|busulfan|mesh-list
6310865|NCT00003101|Thiotepa|thiotepa|mesh-list
6310866|NCT00003101|Lomustine|lomustine|mesh-list
6310867|NCT00003101|Procarbazine|procarbazine|mesh-list
6310868|NCT00003101|Immunologic Factors|immunologic factors|mesh-ancestor
6310869|NCT00003101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6310870|NCT00003101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6310871|NCT00003101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310872|NCT00003101|Tubulin Modulators|tubulin modulators|mesh-ancestor
6310873|NCT00003101|Antimitotic Agents|antimitotic agents|mesh-ancestor
6310874|NCT00003101|Mitosis Modulators|mitosis modulators|mesh-ancestor
6310875|NCT00003101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6310876|NCT00003101|Alkylating Agents|alkylating agents|mesh-ancestor
6310877|NCT00003101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6310878|NCT00003101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6310879|NCT00003101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6310880|NCT00003103|Docetaxel|docetaxel|mesh-list
6310881|NCT00003103|Oblimersen|oblimersen|mesh-list
6310882|NCT00003103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310883|NCT00003103|Tubulin Modulators|tubulin modulators|mesh-ancestor
6310884|NCT00003103|Antimitotic Agents|antimitotic agents|mesh-ancestor
6310885|NCT00003103|Mitosis Modulators|mitosis modulators|mesh-ancestor
6310886|NCT00003103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6310887|NCT00003105|Gemcitabine|gemcitabine|mesh-list
6310888|NCT00003105|Paclitaxel|paclitaxel|mesh-list
6310889|NCT00003105|Doxorubicin|doxorubicin|mesh-list
6310890|NCT00003105|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6310891|NCT00003105|Ifosfamide|ifosfamide|mesh-list
6310892|NCT00003105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6310893|NCT00003105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310894|NCT00003105|Tubulin Modulators|tubulin modulators|mesh-ancestor
6310895|NCT00003105|Antimitotic Agents|antimitotic agents|mesh-ancestor
6310896|NCT00003105|Mitosis Modulators|mitosis modulators|mesh-ancestor
6310897|NCT00003105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6310898|NCT00003105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6310899|NCT00003105|Antimetabolites|antimetabolites|mesh-ancestor
6310900|NCT00003105|Antiviral Agents|antiviral agents|mesh-ancestor
6310901|NCT00003105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6310902|NCT00003105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6310903|NCT00003105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6310904|NCT00003105|Immunologic Factors|immunologic factors|mesh-ancestor
6310905|NCT00003105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6310906|NCT00003105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6310907|NCT00003105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6310908|NCT00003105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6310909|NCT00003105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6310910|NCT00003105|Alkylating Agents|alkylating agents|mesh-ancestor
6310911|NCT00003107|Interleukin-12|interleukin-12|mesh-list
6310912|NCT00003107|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6310913|NCT00003107|Immunologic Factors|immunologic factors|mesh-ancestor
6310914|NCT00003107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6310915|NCT00003107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6310916|NCT00003107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6310917|NCT00003107|Growth Substances|growth substances|mesh-ancestor
6310918|NCT00003107|Growth Inhibitors|growth inhibitors|mesh-ancestor
6310919|NCT00003107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310920|NCT00003108|Bryostatin 1|bryostatin 1|mesh-list
6310921|NCT00003108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310922|NCT00003108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6310923|NCT00003108|Immunologic Factors|immunologic factors|mesh-ancestor
6310924|NCT00003108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6310925|NCT00003109|Irinotecan|irinotecan|mesh-list
6310926|NCT00003109|Raltitrexed|raltitrexed|mesh-list
6310927|NCT00003109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6310928|NCT00003109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6310929|NCT00003109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6310930|NCT00003109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6310931|NCT00003109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310932|NCT00003109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6310933|NCT00003109|Antimetabolites|antimetabolites|mesh-ancestor
6310934|NCT00003109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6310935|NCT00003110|Bleomycin|bleomycin|mesh-list
6310936|NCT00003110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6310937|NCT00003110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310938|NCT00003111|Paclitaxel|paclitaxel|mesh-list
6310939|NCT00003111|Carboplatin|carboplatin|mesh-list
6310940|NCT00003111|Irinotecan|irinotecan|mesh-list
6310941|NCT00003111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6310942|NCT00003111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310943|NCT00003111|Tubulin Modulators|tubulin modulators|mesh-ancestor
6310944|NCT00003111|Antimitotic Agents|antimitotic agents|mesh-ancestor
6310945|NCT00003111|Mitosis Modulators|mitosis modulators|mesh-ancestor
6310946|NCT00003111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6310947|NCT00003111|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6310948|NCT00003111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6310949|NCT00003111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6310950|NCT00003113|Cyclophosphamide|cyclophosphamide|mesh-list
6310951|NCT00003113|Lomustine|lomustine|mesh-list
6310952|NCT00003113|Etoposide|etoposide|mesh-list
6310953|NCT00003113|Procarbazine|procarbazine|mesh-list
6310954|NCT00003113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6310955|NCT00003113|Immunologic Factors|immunologic factors|mesh-ancestor
6310956|NCT00003113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6310957|NCT00003113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6310958|NCT00003113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6310959|NCT00003113|Alkylating Agents|alkylating agents|mesh-ancestor
6310960|NCT00003113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6310961|NCT00003113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310962|NCT00003113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6310963|NCT00003113|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6310964|NCT00003113|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6310965|NCT00003113|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6310966|NCT00003113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6310967|NCT00003114|Cyclophosphamide|cyclophosphamide|mesh-list
6310968|NCT00003114|Lomustine|lomustine|mesh-list
6310969|NCT00003114|Etoposide|etoposide|mesh-list
6310970|NCT00003114|Procarbazine|procarbazine|mesh-list
6310971|NCT00003114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6310972|NCT00003114|Immunologic Factors|immunologic factors|mesh-ancestor
6310973|NCT00003114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6310974|NCT00003114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6310975|NCT00003114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6310976|NCT00003114|Alkylating Agents|alkylating agents|mesh-ancestor
6310977|NCT00003114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6310978|NCT00003114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6310979|NCT00003114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6310980|NCT00003114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6310981|NCT00003114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6310982|NCT00003114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6310983|NCT00003114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6310984|NCT00003115|Hydromorphone|hydromorphone|mesh-list
6310985|NCT00003115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6310986|NCT00003115|Narcotics|narcotics|mesh-ancestor
6310987|NCT00003115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6310988|NCT00003115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6310989|NCT00003115|Analgesics|analgesics|mesh-ancestor
6310990|NCT00003115|Sensory System Agents|sensory system agents|mesh-ancestor
6310991|NCT00003115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6310992|NCT00003116|Cyclosporine|cyclosporine|mesh-list
6310993|NCT00003116|Cyclophosphamide|cyclophosphamide|mesh-list
6310994|NCT00003116|Busulfan|busulfan|mesh-list
6310995|NCT00003116|Cyclosporins|cyclosporins|mesh-list
6310996|NCT00003116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6310997|NCT00003116|Immunologic Factors|immunologic factors|mesh-ancestor
6310998|NCT00003116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6310999|NCT00003116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6311000|NCT00003116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6311001|NCT00003116|Alkylating Agents|alkylating agents|mesh-ancestor
6311002|NCT00003116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311003|NCT00003116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311004|NCT00003116|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6311005|NCT00003116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6311006|NCT00003116|Antifungal Agents|antifungal agents|mesh-ancestor
6311007|NCT00003116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6311008|NCT00003116|Dermatologic Agents|dermatologic agents|mesh-ancestor
6311009|NCT00003116|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6311010|NCT00003117|Paclitaxel|paclitaxel|mesh-list
6311011|NCT00003117|Carboplatin|carboplatin|mesh-list
6311012|NCT00003117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6311013|NCT00003117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311014|NCT00003117|Tubulin Modulators|tubulin modulators|mesh-ancestor
6311015|NCT00003117|Antimitotic Agents|antimitotic agents|mesh-ancestor
6311016|NCT00003117|Mitosis Modulators|mitosis modulators|mesh-ancestor
6311017|NCT00003117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311018|NCT00003118|Fluorouracil|fluorouracil|mesh-list
6311019|NCT00003118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311020|NCT00003118|Antimetabolites|antimetabolites|mesh-ancestor
6311021|NCT00003118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311022|NCT00003118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6311023|NCT00003118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6311024|NCT00003118|Immunologic Factors|immunologic factors|mesh-ancestor
6311025|NCT00003118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6311026|NCT00003119|Cyclophosphamide|cyclophosphamide|mesh-list
6311027|NCT00003119|Carboplatin|carboplatin|mesh-list
6311028|NCT00003119|Doxorubicin|doxorubicin|mesh-list
6311029|NCT00003119|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6311030|NCT00003119|Etoposide|etoposide|mesh-list
6311031|NCT00003119|Sargramostim|sargramostim|mesh-list
6311032|NCT00003119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6311033|NCT00003119|Immunologic Factors|immunologic factors|mesh-ancestor
6311034|NCT00003119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6311035|NCT00003119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6311036|NCT00003119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6311037|NCT00003119|Alkylating Agents|alkylating agents|mesh-ancestor
6311038|NCT00003119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311039|NCT00003119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311040|NCT00003119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6311041|NCT00003119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6311042|NCT00003119|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6311043|NCT00003119|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6311044|NCT00003119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6311045|NCT00003119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6311046|NCT00003120|Paclitaxel|paclitaxel|mesh-list
6311047|NCT00003120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6311048|NCT00003120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311049|NCT00003120|Tubulin Modulators|tubulin modulators|mesh-ancestor
6311050|NCT00003120|Antimitotic Agents|antimitotic agents|mesh-ancestor
6311051|NCT00003120|Mitosis Modulators|mitosis modulators|mesh-ancestor
6311052|NCT00003120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311053|NCT00003123|Amifostine|amifostine|mesh-list
6311054|NCT00003123|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6311055|NCT00003123|Protective Agents|protective agents|mesh-ancestor
6311056|NCT00003123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6311057|NCT00003124|Leuprolide|leuprolide|mesh-list
6311058|NCT00003124|Flutamide|flutamide|mesh-list
6311059|NCT00003124|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6311060|NCT00003124|Fertility Agents|fertility agents|mesh-ancestor
6311061|NCT00003124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6311062|NCT00003124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6311063|NCT00003124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6311064|NCT00003124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311065|NCT00003124|Androgen Antagonists|androgen antagonists|mesh-ancestor
6311066|NCT00003124|Hormone Antagonists|hormone antagonists|mesh-ancestor
6311067|NCT00003124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6311068|NCT00003125|Aldesleukin|aldesleukin|mesh-list
6311069|NCT00003125|Vaccines|vaccines|mesh-list
6311070|NCT00003125|Sargramostim|sargramostim|mesh-list
6311071|NCT00003125|Immunologic Factors|immunologic factors|mesh-ancestor
6311072|NCT00003125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6311073|NCT00003125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311074|NCT00003125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6311075|NCT00003125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6311076|NCT00003125|Antiviral Agents|antiviral agents|mesh-ancestor
6311077|NCT00003125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6311078|NCT00003126|Aldesleukin|aldesleukin|mesh-list
6311079|NCT00003126|Interleukin-2|interleukin-2|mesh-list
6311080|NCT00003126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311081|NCT00003126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6311082|NCT00003126|Analgesics|analgesics|mesh-ancestor
6311083|NCT00003126|Sensory System Agents|sensory system agents|mesh-ancestor
6311084|NCT00003126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6311085|NCT00003126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6311086|NCT00003126|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6311087|NCT00003126|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6311088|NCT00003126|Antiviral Agents|antiviral agents|mesh-ancestor
6311089|NCT00003126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6311090|NCT00003127|Paclitaxel|paclitaxel|mesh-list
6311091|NCT00003127|Carboplatin|carboplatin|mesh-list
6311092|NCT00003127|Amifostine|amifostine|mesh-list
6311093|NCT00003127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6311094|NCT00003127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311095|NCT00003127|Tubulin Modulators|tubulin modulators|mesh-ancestor
6311096|NCT00003127|Antimitotic Agents|antimitotic agents|mesh-ancestor
6311097|NCT00003127|Mitosis Modulators|mitosis modulators|mesh-ancestor
6311098|NCT00003127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311099|NCT00003127|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6311100|NCT00003127|Protective Agents|protective agents|mesh-ancestor
6311101|NCT00003127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6311102|NCT00003128|Paclitaxel|paclitaxel|mesh-list
6311103|NCT00003128|Ifosfamide|ifosfamide|mesh-list
6311104|NCT00003128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6311105|NCT00003128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311106|NCT00003128|Tubulin Modulators|tubulin modulators|mesh-ancestor
6311107|NCT00003128|Antimitotic Agents|antimitotic agents|mesh-ancestor
6311108|NCT00003128|Mitosis Modulators|mitosis modulators|mesh-ancestor
6311109|NCT00003128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311110|NCT00003128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6311111|NCT00003128|Alkylating Agents|alkylating agents|mesh-ancestor
6311112|NCT00003129|Valrubicin|valrubicin|mesh-list
6311113|NCT00003129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311114|NCT00003129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6311115|NCT00003129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6311116|NCT00003129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6311117|NCT00003129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311118|NCT00003130|Paclitaxel|paclitaxel|mesh-list
6311119|NCT00003130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6311120|NCT00003130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311121|NCT00003130|Tubulin Modulators|tubulin modulators|mesh-ancestor
6311122|NCT00003130|Antimitotic Agents|antimitotic agents|mesh-ancestor
6311123|NCT00003130|Mitosis Modulators|mitosis modulators|mesh-ancestor
6311124|NCT00003130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311125|NCT00003131|Gemtuzumab|gemtuzumab|mesh-list
6311126|NCT00003131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6311127|NCT00003131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311128|NCT00003132|Bryostatin 1|bryostatin 1|mesh-list
6311129|NCT00003132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311130|NCT00003132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5724402|NCT03187093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724403|NCT03187093|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5724404|NCT03187093|Antidepressive Agents|antidepressive agents|mesh-ancestor
5724405|NCT03187093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5724406|NCT03187093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5724407|NCT03187093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5724408|NCT03187093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5724409|NCT03187093|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5724410|NCT03187093|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6311131|NCT00003132|Immunologic Factors|immunologic factors|mesh-ancestor
6311132|NCT00003132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6311133|NCT00003133|Gemcitabine|gemcitabine|mesh-list
6311134|NCT00003133|Paclitaxel|paclitaxel|mesh-list
6311135|NCT00003133|Doxorubicin|doxorubicin|mesh-list
6311136|NCT00003133|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6311137|NCT00003133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6311138|NCT00003133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311139|NCT00003133|Tubulin Modulators|tubulin modulators|mesh-ancestor
6311140|NCT00003133|Antimitotic Agents|antimitotic agents|mesh-ancestor
6311141|NCT00003133|Mitosis Modulators|mitosis modulators|mesh-ancestor
6311142|NCT00003133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311143|NCT00003133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6311144|NCT00003133|Antimetabolites|antimetabolites|mesh-ancestor
6311145|NCT00003133|Antiviral Agents|antiviral agents|mesh-ancestor
6311146|NCT00003133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6311147|NCT00003133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6311148|NCT00003133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6311149|NCT00003133|Immunologic Factors|immunologic factors|mesh-ancestor
6311150|NCT00003133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6311151|NCT00003133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6311152|NCT00003133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6311153|NCT00003133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6311154|NCT00003134|Irinotecan|irinotecan|mesh-list
6311155|NCT00003134|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6311156|NCT00003134|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6311157|NCT00003134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6311158|NCT00003134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311159|NCT00003134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311160|NCT00003135|Doxorubicin|doxorubicin|mesh-list
6311161|NCT00003135|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6311162|NCT00003135|Fluorouracil|fluorouracil|mesh-list
6311163|NCT00003135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6311164|NCT00003135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311165|NCT00003135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6311166|NCT00003135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6311167|NCT00003135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6311168|NCT00003135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311169|NCT00003135|Antimetabolites|antimetabolites|mesh-ancestor
6311170|NCT00003135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6311171|NCT00003135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6311172|NCT00003135|Immunologic Factors|immunologic factors|mesh-ancestor
6311173|NCT00003135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6311174|NCT00003136|Cyclophosphamide|cyclophosphamide|mesh-list
6311175|NCT00003136|Carboplatin|carboplatin|mesh-list
6311176|NCT00003136|Amifostine|amifostine|mesh-list
6311177|NCT00003136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6311178|NCT00003136|Immunologic Factors|immunologic factors|mesh-ancestor
6311179|NCT00003136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6311180|NCT00003136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6311181|NCT00003136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6311182|NCT00003136|Alkylating Agents|alkylating agents|mesh-ancestor
6311183|NCT00003136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311184|NCT00003136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311185|NCT00003136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6311186|NCT00003136|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6311187|NCT00003136|Protective Agents|protective agents|mesh-ancestor
6311188|NCT00003137|Irinotecan|irinotecan|mesh-list
6311189|NCT00003137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6311190|NCT00003137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6311191|NCT00003137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6311192|NCT00003137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311193|NCT00003137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311194|NCT00003139|Pilocarpine|pilocarpine|mesh-list
6311195|NCT00003139|Miotics|miotics|mesh-ancestor
6311196|NCT00003139|Autonomic Agents|autonomic agents|mesh-ancestor
6311197|NCT00003139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6311198|NCT00003139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6311199|NCT00003139|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6311200|NCT00003139|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6311201|NCT00003139|Cholinergic Agents|cholinergic agents|mesh-ancestor
6311202|NCT00003139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6311203|NCT00003139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311204|NCT00003140|Letrozole|letrozole|mesh-list
6311205|NCT00003140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311206|NCT00003140|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6311207|NCT00003140|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6311208|NCT00003140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6311209|NCT00003140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311210|NCT00003140|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6311211|NCT00003140|Hormone Antagonists|hormone antagonists|mesh-ancestor
6311212|NCT00003140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6311213|NCT00003140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6311214|NCT00003141|Cyclophosphamide|cyclophosphamide|mesh-list
6311215|NCT00003141|Thiotepa|thiotepa|mesh-list
6311216|NCT00003141|Cisplatin|cisplatin|mesh-list
6311217|NCT00003141|Carboplatin|carboplatin|mesh-list
6311218|NCT00003141|Etoposide|etoposide|mesh-list
6311219|NCT00003141|Vincristine|vincristine|mesh-list
6311220|NCT00003141|Lenograstim|lenograstim|mesh-list
6311221|NCT00003141|Sargramostim|sargramostim|mesh-list
6311222|NCT00003141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6311223|NCT00003141|Immunologic Factors|immunologic factors|mesh-ancestor
6311224|NCT00003141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6311225|NCT00003141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6311226|NCT00003141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6311227|NCT00003141|Alkylating Agents|alkylating agents|mesh-ancestor
6311228|NCT00003141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311229|NCT00003141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311230|NCT00003141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6311231|NCT00003141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6311232|NCT00003141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6311233|NCT00003141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6311234|NCT00003141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6311235|NCT00003141|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6311236|NCT00003141|Tubulin Modulators|tubulin modulators|mesh-ancestor
6311237|NCT00003141|Antimitotic Agents|antimitotic agents|mesh-ancestor
6311238|NCT00003141|Mitosis Modulators|mitosis modulators|mesh-ancestor
6311239|NCT00003143|Amifostine|amifostine|mesh-list
6311240|NCT00003143|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5724411|NCT03187093|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6311241|NCT00003143|Protective Agents|protective agents|mesh-ancestor
6311242|NCT00003143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6311243|NCT00003144|Gemcitabine|gemcitabine|mesh-list
6311244|NCT00003144|Amifostine|amifostine|mesh-list
6311245|NCT00003144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311246|NCT00003144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6311247|NCT00003144|Antimetabolites|antimetabolites|mesh-ancestor
6311248|NCT00003144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311249|NCT00003144|Antiviral Agents|antiviral agents|mesh-ancestor
6311250|NCT00003144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6311251|NCT00003144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6311252|NCT00003144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6311253|NCT00003144|Immunologic Factors|immunologic factors|mesh-ancestor
6311254|NCT00003144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6311255|NCT00003144|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6311256|NCT00003144|Protective Agents|protective agents|mesh-ancestor
6311257|NCT00003145|Cyclosporine|cyclosporine|mesh-list
6311258|NCT00003145|Mycophenolic Acid|mycophenolic acid|mesh-list
6311259|NCT00003145|Fludarabine|fludarabine|mesh-list
6311260|NCT00003145|Fludarabine phosphate|fludarabine phosphate|mesh-list
6311261|NCT00003145|Cyclosporins|cyclosporins|mesh-list
6311262|NCT00003145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311263|NCT00003145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6311264|NCT00003145|Antimetabolites|antimetabolites|mesh-ancestor
6311265|NCT00003145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311266|NCT00003145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6311267|NCT00003145|Immunologic Factors|immunologic factors|mesh-ancestor
6311268|NCT00003145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6311269|NCT00003145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5724412|NCT03187093|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6311270|NCT00003145|Antifungal Agents|antifungal agents|mesh-ancestor
6311271|NCT00003145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6311272|NCT00003145|Dermatologic Agents|dermatologic agents|mesh-ancestor
6311273|NCT00003145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6311274|NCT00003145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6311275|NCT00003145|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6311276|NCT00003145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6311277|NCT00003145|Antitubercular Agents|antitubercular agents|mesh-ancestor
6311278|NCT00003145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6311279|NCT00003146|Melphalan|melphalan|mesh-list
6311280|NCT00003146|Busulfan|busulfan|mesh-list
6311281|NCT00003146|Thiotepa|thiotepa|mesh-list
6311282|NCT00003146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6311283|NCT00003146|Alkylating Agents|alkylating agents|mesh-ancestor
6311284|NCT00003146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311285|NCT00003146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311286|NCT00003146|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6311287|NCT00003146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6311288|NCT00003146|Immunologic Factors|immunologic factors|mesh-ancestor
6311289|NCT00003146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6311290|NCT00003148|Aldesleukin|aldesleukin|mesh-list
6311291|NCT00003148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311292|NCT00003148|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6311293|NCT00003148|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6311294|NCT00003148|Antiviral Agents|antiviral agents|mesh-ancestor
6311295|NCT00003148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6311296|NCT00003149|Interleukin-12|interleukin-12|mesh-list
6311297|NCT00003149|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6311298|NCT00003149|Immunologic Factors|immunologic factors|mesh-ancestor
6311299|NCT00003149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6311300|NCT00003149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6311301|NCT00003149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6311302|NCT00003149|Growth Substances|growth substances|mesh-ancestor
6311303|NCT00003149|Growth Inhibitors|growth inhibitors|mesh-ancestor
6311304|NCT00003149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311305|NCT00003150|Prednisone|prednisone|mesh-list
6311306|NCT00003150|Cyclophosphamide|cyclophosphamide|mesh-list
6311307|NCT00003150|Rituximab|rituximab|mesh-list
6311308|NCT00003150|Doxorubicin|doxorubicin|mesh-list
6311309|NCT00003150|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6311310|NCT00003150|Vincristine|vincristine|mesh-list
6311311|NCT00003150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6311312|NCT00003150|Immunologic Factors|immunologic factors|mesh-ancestor
6311313|NCT00003150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6311314|NCT00003150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6311315|NCT00003150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6311316|NCT00003150|Alkylating Agents|alkylating agents|mesh-ancestor
6311317|NCT00003150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311318|NCT00003150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311319|NCT00003150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6311320|NCT00003150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6311321|NCT00003150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6311322|NCT00003150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6311323|NCT00003150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6311324|NCT00003150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6311325|NCT00003150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6311326|NCT00003150|Glucocorticoids|glucocorticoids|mesh-ancestor
6311327|NCT00003150|Hormones|hormones|mesh-ancestor
6311328|NCT00003150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6311329|NCT00003150|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6311330|NCT00003150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6311331|NCT00003150|Tubulin Modulators|tubulin modulators|mesh-ancestor
6311332|NCT00003150|Antimitotic Agents|antimitotic agents|mesh-ancestor
6311333|NCT00003150|Mitosis Modulators|mitosis modulators|mesh-ancestor
6311334|NCT00003151|Amoxicillin|amoxicillin|mesh-list
6311335|NCT00003151|Metronidazole|metronidazole|mesh-list
5724413|NCT03187223|Melphalan|melphalan|mesh-list
5724414|NCT03187223|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5724415|NCT03187223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6311336|NCT00003151|Clarithromycin|clarithromycin|mesh-list
6311337|NCT00003151|Tetracycline|tetracycline|mesh-list
6311338|NCT00003151|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
6311339|NCT00003151|Omeprazole|omeprazole|mesh-list
6311340|NCT00003151|Bismuth|bismuth|mesh-list
6311341|NCT00003151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6311342|NCT00003151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6311343|NCT00003151|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6311344|NCT00003151|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6311345|NCT00003151|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6311346|NCT00003151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6311347|NCT00003151|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6311348|NCT00003151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6311349|NCT00003151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311350|NCT00003151|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6311351|NCT00003151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6311352|NCT00003151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6311353|NCT00003151|Antacids|antacids|mesh-ancestor
6311354|NCT00003152|Interferons|interferons|mesh-list
6311355|NCT00003152|Interferon-alpha|interferon-alpha|mesh-list
5724416|NCT03187223|Alkylating Agents|alkylating agents|mesh-ancestor
5724417|NCT03187223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724418|NCT03187223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5724419|NCT03187223|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5724420|NCT03187223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5724421|NCT03187223|Immunologic Factors|immunologic factors|mesh-ancestor
5724422|NCT03187223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6311356|NCT00003152|Prednisone|prednisone|mesh-list
6311357|NCT00003152|Cyclophosphamide|cyclophosphamide|mesh-list
6311358|NCT00003152|Vincristine|vincristine|mesh-list
6311359|NCT00003152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6311360|NCT00003152|Immunologic Factors|immunologic factors|mesh-ancestor
6311361|NCT00003152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6311362|NCT00003152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6311363|NCT00003152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6311364|NCT00003152|Alkylating Agents|alkylating agents|mesh-ancestor
6311365|NCT00003152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311366|NCT00003152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311367|NCT00003152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6311368|NCT00003152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6311369|NCT00003152|Glucocorticoids|glucocorticoids|mesh-ancestor
6311370|NCT00003152|Hormones|hormones|mesh-ancestor
6311371|NCT00003152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6311372|NCT00003152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6311373|NCT00003152|Antiviral Agents|antiviral agents|mesh-ancestor
6311374|NCT00003152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6311375|NCT00003152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6311376|NCT00003152|Tubulin Modulators|tubulin modulators|mesh-ancestor
6311377|NCT00003152|Antimitotic Agents|antimitotic agents|mesh-ancestor
6311378|NCT00003152|Mitosis Modulators|mitosis modulators|mesh-ancestor
6311379|NCT00003156|Topotecan|topotecan|mesh-list
6311380|NCT00003156|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5724423|NCT03187392|Lidocaine|lidocaine|mesh-list
5724424|NCT03187392|Anesthetics, Local|anesthetics, local|mesh-ancestor
6311381|NCT00003156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6311382|NCT00003156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6311383|NCT00003156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311384|NCT00003156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311385|NCT00003157|Gemcitabine|gemcitabine|mesh-list
6311386|NCT00003157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311387|NCT00003157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6311388|NCT00003157|Antimetabolites|antimetabolites|mesh-ancestor
6311389|NCT00003157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311390|NCT00003157|Antiviral Agents|antiviral agents|mesh-ancestor
6311391|NCT00003157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6311392|NCT00003157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6311393|NCT00003157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6311394|NCT00003157|Immunologic Factors|immunologic factors|mesh-ancestor
6311395|NCT00003157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6311396|NCT00003158|Paclitaxel|paclitaxel|mesh-list
6311397|NCT00003158|Etoposide|etoposide|mesh-list
6311398|NCT00003158|Carboplatin|carboplatin|mesh-list
6311399|NCT00003158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6311400|NCT00003158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311401|NCT00003158|Tubulin Modulators|tubulin modulators|mesh-ancestor
6311402|NCT00003158|Antimitotic Agents|antimitotic agents|mesh-ancestor
6311403|NCT00003158|Mitosis Modulators|mitosis modulators|mesh-ancestor
6311404|NCT00003158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311405|NCT00003158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6311406|NCT00003158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6311407|NCT00003158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6311408|NCT00003159|Gemcitabine|gemcitabine|mesh-list
6311409|NCT00003159|Paclitaxel|paclitaxel|mesh-list
6311410|NCT00003159|Vinorelbine|vinorelbine|mesh-list
6311411|NCT00003159|Vinblastine|vinblastine|mesh-list
6311412|NCT00003159|Docetaxel|docetaxel|mesh-list
6311413|NCT00003159|Carboplatin|carboplatin|mesh-list
6311414|NCT00003159|Ifosfamide|ifosfamide|mesh-list
6311415|NCT00003159|Mitomycins|mitomycins|mesh-list
6311416|NCT00003159|Mitomycin|mitomycin|mesh-list
6311417|NCT00003159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6311418|NCT00003159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311419|NCT00003159|Tubulin Modulators|tubulin modulators|mesh-ancestor
6311420|NCT00003159|Antimitotic Agents|antimitotic agents|mesh-ancestor
6311421|NCT00003159|Mitosis Modulators|mitosis modulators|mesh-ancestor
6311422|NCT00003159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311423|NCT00003159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6311424|NCT00003159|Antimetabolites|antimetabolites|mesh-ancestor
6311425|NCT00003159|Antiviral Agents|antiviral agents|mesh-ancestor
6311426|NCT00003159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6311427|NCT00003159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6311428|NCT00003159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6311429|NCT00003159|Immunologic Factors|immunologic factors|mesh-ancestor
6311430|NCT00003159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6311431|NCT00003159|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6311432|NCT00003159|Alkylating Agents|alkylating agents|mesh-ancestor
6311433|NCT00003159|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6311434|NCT00003159|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6311435|NCT00003160|Paclitaxel|paclitaxel|mesh-list
6311436|NCT00003160|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6311437|NCT00003160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311438|NCT00003160|Tubulin Modulators|tubulin modulators|mesh-ancestor
6311439|NCT00003160|Antimitotic Agents|antimitotic agents|mesh-ancestor
6311440|NCT00003160|Mitosis Modulators|mitosis modulators|mesh-ancestor
6311441|NCT00003160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311442|NCT00003163|Cyclophosphamide|cyclophosphamide|mesh-list
6311443|NCT00003163|Melphalan|melphalan|mesh-list
6311444|NCT00003163|Sargramostim|sargramostim|mesh-list
6311445|NCT00003163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5724425|NCT03187392|Anesthetics|anesthetics|mesh-ancestor
5724426|NCT03187392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5724427|NCT03187392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724428|NCT03187392|Sensory System Agents|sensory system agents|mesh-ancestor
5724429|NCT03187392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5724430|NCT03187392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6016068|NCT00361972|Lansoprazole|lansoprazole|mesh-list
6311446|NCT00003163|Immunologic Factors|immunologic factors|mesh-ancestor
6311447|NCT00003163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6311448|NCT00003163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6311449|NCT00003163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6311450|NCT00003163|Alkylating Agents|alkylating agents|mesh-ancestor
6311451|NCT00003163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311452|NCT00003163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311453|NCT00003163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6311454|NCT00003165|Doxorubicin|doxorubicin|mesh-list
6311455|NCT00003165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6311456|NCT00003165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311457|NCT00003165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6311458|NCT00003165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6311459|NCT00003165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6311460|NCT00003165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311461|NCT00003166|Vincristine|vincristine|mesh-list
6311462|NCT00003166|Bryostatin 1|bryostatin 1|mesh-list
6311463|NCT00003166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6311464|NCT00003166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311465|NCT00003166|Tubulin Modulators|tubulin modulators|mesh-ancestor
6311466|NCT00003166|Antimitotic Agents|antimitotic agents|mesh-ancestor
6311467|NCT00003166|Mitosis Modulators|mitosis modulators|mesh-ancestor
6311468|NCT00003166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311469|NCT00003166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6311470|NCT00003166|Immunologic Factors|immunologic factors|mesh-ancestor
6311471|NCT00003166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6311472|NCT00003171|Bryostatin 1|bryostatin 1|mesh-list
6311473|NCT00003171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6311474|NCT00003171|Immunologic Factors|immunologic factors|mesh-ancestor
6311475|NCT00003171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6311476|NCT00003171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311477|NCT00003172|Interferons|interferons|mesh-list
6311478|NCT00003172|Interferon-alpha|interferon-alpha|mesh-list
6311479|NCT00003172|Docetaxel|docetaxel|mesh-list
6311480|NCT00003172|Doxorubicin|doxorubicin|mesh-list
6311481|NCT00003172|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6311482|NCT00003172|Fluorouracil|fluorouracil|mesh-list
6311483|NCT00003172|Hydroxyurea|hydroxyurea|mesh-list
6311484|NCT00003172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311485|NCT00003172|Tubulin Modulators|tubulin modulators|mesh-ancestor
6311486|NCT00003172|Antimitotic Agents|antimitotic agents|mesh-ancestor
6311487|NCT00003172|Mitosis Modulators|mitosis modulators|mesh-ancestor
6311488|NCT00003172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311489|NCT00003172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6311490|NCT00003172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6311491|NCT00003172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6311492|NCT00003172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6311493|NCT00003172|Antimetabolites|antimetabolites|mesh-ancestor
6311494|NCT00003172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6311495|NCT00003172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6311496|NCT00003172|Immunologic Factors|immunologic factors|mesh-ancestor
6311497|NCT00003172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6311498|NCT00003172|Antiviral Agents|antiviral agents|mesh-ancestor
6311499|NCT00003172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6311500|NCT00003172|Antisickling Agents|antisickling agents|mesh-ancestor
6311501|NCT00003172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6311502|NCT00003173|Thiotepa|thiotepa|mesh-list
6311503|NCT00003173|Immunologic Factors|immunologic factors|mesh-ancestor
6311504|NCT00003173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6311505|NCT00003173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6311506|NCT00003173|Alkylating Agents|alkylating agents|mesh-ancestor
6311507|NCT00003173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311508|NCT00003173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311509|NCT00003173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6311510|NCT00003173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6311511|NCT00003174|Cladribine|cladribine|mesh-list
6311512|NCT00003174|Bryostatin 1|bryostatin 1|mesh-list
6311513|NCT00003174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311514|NCT00003174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5724431|NCT03187392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5724432|NCT03187392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6311515|NCT00003174|Immunologic Factors|immunologic factors|mesh-ancestor
6311516|NCT00003174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6311517|NCT00003174|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6311518|NCT00003175|Fluorouracil|fluorouracil|mesh-list
6311519|NCT00003175|Antimetabolites|antimetabolites|mesh-ancestor
6311520|NCT00003175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311521|NCT00003175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6311522|NCT00003175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311523|NCT00003175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6311524|NCT00003175|Immunologic Factors|immunologic factors|mesh-ancestor
6311525|NCT00003175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6311526|NCT00003176|Temozolomide|temozolomide|mesh-list
6311527|NCT00003176|Carmustine|carmustine|mesh-list
6311528|NCT00003176|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6311529|NCT00003176|Alkylating Agents|alkylating agents|mesh-ancestor
6311530|NCT00003176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311531|NCT00003176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311532|NCT00003178|Idarubicin|idarubicin|mesh-list
6311533|NCT00003178|Cladribine|cladribine|mesh-list
6311534|NCT00003178|Lenograstim|lenograstim|mesh-list
6311535|NCT00003178|Sargramostim|sargramostim|mesh-list
6311536|NCT00003178|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6311537|NCT00003178|Immunologic Factors|immunologic factors|mesh-ancestor
6311538|NCT00003178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6311539|NCT00003178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6311540|NCT00003178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311541|NCT00003178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6311542|NCT00003178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6311543|NCT00003178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6311544|NCT00003178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311545|NCT00003178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6311546|NCT00003179|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6311547|NCT00003179|Medroxyprogesterone|medroxyprogesterone|mesh-list
6311548|NCT00003179|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6311549|NCT00003179|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6311550|NCT00003179|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6311551|NCT00003179|Contraceptive Agents|contraceptive agents|mesh-ancestor
6311552|NCT00003179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6311553|NCT00003179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6311554|NCT00003179|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6311555|NCT00003179|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6311556|NCT00003179|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6311557|NCT00003179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6311558|NCT00003179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311559|NCT00003181|Aldesleukin|aldesleukin|mesh-list
6311560|NCT00003181|Vinblastine|vinblastine|mesh-list
6311561|NCT00003181|Sargramostim|sargramostim|mesh-list
6311562|NCT00003181|Immunologic Factors|immunologic factors|mesh-ancestor
6311563|NCT00003181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6311564|NCT00003181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311565|NCT00003181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6311566|NCT00003181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6311567|NCT00003181|Antiviral Agents|antiviral agents|mesh-ancestor
6311568|NCT00003181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6311569|NCT00003181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6311570|NCT00003181|Tubulin Modulators|tubulin modulators|mesh-ancestor
6311571|NCT00003181|Antimitotic Agents|antimitotic agents|mesh-ancestor
6311572|NCT00003181|Mitosis Modulators|mitosis modulators|mesh-ancestor
6311573|NCT00003181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311574|NCT00003182|Gemcitabine|gemcitabine|mesh-list
6311575|NCT00003182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311576|NCT00003182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6311577|NCT00003182|Antimetabolites|antimetabolites|mesh-ancestor
6311578|NCT00003182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311579|NCT00003182|Antiviral Agents|antiviral agents|mesh-ancestor
6311580|NCT00003182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6311581|NCT00003182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6311582|NCT00003182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6311583|NCT00003182|Immunologic Factors|immunologic factors|mesh-ancestor
6311584|NCT00003182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6311585|NCT00003183|Mitoxantrone|mitoxantrone|mesh-list
6311586|NCT00003183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6311587|NCT00003183|Analgesics|analgesics|mesh-ancestor
6311588|NCT00003183|Sensory System Agents|sensory system agents|mesh-ancestor
6311589|NCT00003183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6311590|NCT00003183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311591|NCT00003183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6311592|NCT00003183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6311593|NCT00003183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6311594|NCT00003183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311595|NCT00003184|Vaccines|vaccines|mesh-list
6311596|NCT00003184|Sargramostim|sargramostim|mesh-list
6311597|NCT00003184|BCG Vaccine|bcg vaccine|mesh-list
6016069|NCT00361972|Dexlansoprazole|dexlansoprazole|mesh-list
6311598|NCT00003184|Immunologic Factors|immunologic factors|mesh-ancestor
6311599|NCT00003184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6311600|NCT00003184|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6311601|NCT00003185|Cyclophosphamide|cyclophosphamide|mesh-list
6311602|NCT00003185|Sargramostim|sargramostim|mesh-list
6311603|NCT00003185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6311604|NCT00003185|Immunologic Factors|immunologic factors|mesh-ancestor
6311605|NCT00003185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6311606|NCT00003185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6311607|NCT00003185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6311608|NCT00003185|Alkylating Agents|alkylating agents|mesh-ancestor
6311609|NCT00003185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311610|NCT00003185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311611|NCT00003185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6311612|NCT00003187|Cytarabine|cytarabine|mesh-list
6311613|NCT00003187|Cyclosporine|cyclosporine|mesh-list
6311614|NCT00003187|Methylprednisolone|methylprednisolone|mesh-list
6311615|NCT00003187|Cyclophosphamide|cyclophosphamide|mesh-list
6311616|NCT00003187|Methotrexate|methotrexate|mesh-list
6311617|NCT00003187|Cyclosporins|cyclosporins|mesh-list
6311618|NCT00003187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6311619|NCT00003187|Immunologic Factors|immunologic factors|mesh-ancestor
6311620|NCT00003187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6311621|NCT00003187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6311622|NCT00003187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6311623|NCT00003187|Alkylating Agents|alkylating agents|mesh-ancestor
6311624|NCT00003187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311625|NCT00003187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311626|NCT00003187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6311627|NCT00003187|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6311628|NCT00003187|Abortifacient Agents|abortifacient agents|mesh-ancestor
6311629|NCT00003187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6311630|NCT00003187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6311631|NCT00003187|Antimetabolites|antimetabolites|mesh-ancestor
6311632|NCT00003187|Dermatologic Agents|dermatologic agents|mesh-ancestor
6311633|NCT00003187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6311634|NCT00003187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6311635|NCT00003187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6311636|NCT00003187|Antiviral Agents|antiviral agents|mesh-ancestor
6311637|NCT00003187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6311638|NCT00003187|Antifungal Agents|antifungal agents|mesh-ancestor
6311639|NCT00003187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6311640|NCT00003187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6311641|NCT00003187|Antiemetics|antiemetics|mesh-ancestor
6311642|NCT00003187|Autonomic Agents|autonomic agents|mesh-ancestor
6311643|NCT00003187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6311644|NCT00003187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6311645|NCT00003187|Glucocorticoids|glucocorticoids|mesh-ancestor
6311646|NCT00003187|Hormones|hormones|mesh-ancestor
6311647|NCT00003187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6311648|NCT00003187|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6311649|NCT00003187|Protective Agents|protective agents|mesh-ancestor
6311650|NCT00003190|Cytarabine|cytarabine|mesh-list
6311651|NCT00003190|Etoposide|etoposide|mesh-list
6311652|NCT00003190|Daunorubicin|daunorubicin|mesh-list
6311653|NCT00003190|Etoposide phosphate|etoposide phosphate|mesh-list
6311654|NCT00003190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5724433|NCT03187392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6311655|NCT00003190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311656|NCT00003190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6311657|NCT00003190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6311658|NCT00003190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6311659|NCT00003190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311660|NCT00003190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6311661|NCT00003190|Antimetabolites|antimetabolites|mesh-ancestor
6311662|NCT00003190|Antiviral Agents|antiviral agents|mesh-ancestor
6311663|NCT00003190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6311664|NCT00003190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6311665|NCT00003190|Immunologic Factors|immunologic factors|mesh-ancestor
6311666|NCT00003190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6311667|NCT00003190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6311668|NCT00003191|Fenretinide|fenretinide|mesh-list
6311669|NCT00003191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311670|NCT00003191|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6311671|NCT00003191|Protective Agents|protective agents|mesh-ancestor
6311672|NCT00003191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6311673|NCT00003193|Paclitaxel|paclitaxel|mesh-list
6311674|NCT00003193|Amifostine|amifostine|mesh-list
6311675|NCT00003193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6311676|NCT00003193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311677|NCT00003193|Tubulin Modulators|tubulin modulators|mesh-ancestor
6311678|NCT00003193|Antimitotic Agents|antimitotic agents|mesh-ancestor
6311679|NCT00003193|Mitosis Modulators|mitosis modulators|mesh-ancestor
6311680|NCT00003193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311681|NCT00003193|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6311682|NCT00003193|Protective Agents|protective agents|mesh-ancestor
6311683|NCT00003193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6311684|NCT00003194|Cyclophosphamide|cyclophosphamide|mesh-list
6311685|NCT00003194|Thiotepa|thiotepa|mesh-list
6311686|NCT00003194|Carboplatin|carboplatin|mesh-list
6311687|NCT00003194|Etoposide|etoposide|mesh-list
6311688|NCT00003194|Topotecan|topotecan|mesh-list
6311689|NCT00003194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6311690|NCT00003194|Immunologic Factors|immunologic factors|mesh-ancestor
5724434|NCT03187392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724435|NCT03187106|Metronidazole|metronidazole|mesh-list
5724436|NCT03187106|Cephalexin|cephalexin|mesh-list
5724437|NCT03187106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5724438|NCT03187106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5724439|NCT03187106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6311691|NCT00003194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6311692|NCT00003194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6311693|NCT00003194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6311694|NCT00003194|Alkylating Agents|alkylating agents|mesh-ancestor
6311695|NCT00003194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311696|NCT00003194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311697|NCT00003194|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6311698|NCT00003194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6311699|NCT00003194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6311700|NCT00003194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6311701|NCT00003194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6311702|NCT00003194|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6311703|NCT00003195|Interferons|interferons|mesh-list
6311704|NCT00003195|Interferon-alpha|interferon-alpha|mesh-list
6311705|NCT00003195|Busulfan|busulfan|mesh-list
6311706|NCT00003195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311707|NCT00003195|Antiviral Agents|antiviral agents|mesh-ancestor
6311708|NCT00003195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6311709|NCT00003195|Immunologic Factors|immunologic factors|mesh-ancestor
6311710|NCT00003195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724440|NCT03187106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5724441|NCT03187496|Midazolam|midazolam|mesh-list
5724442|NCT03187496|Caffeine|caffeine|mesh-list
6311711|NCT00003195|Alkylating Agents|alkylating agents|mesh-ancestor
6396923|NCT00209859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6311712|NCT00003195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311713|NCT00003195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6311714|NCT00003195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6311715|NCT00003195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6392465|NCT00196599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6392466|NCT00196599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6392467|NCT00196599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392468|NCT00196599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6392469|NCT00196599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6392470|NCT00196599|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6392471|NCT00196599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6392472|NCT00196599|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6392473|NCT00196599|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6392474|NCT00196599|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6392475|NCT00196599|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6392476|NCT00196599|Antimetabolites|antimetabolites|mesh-ancestor
6392477|NCT00196612|Emtricitabine|emtricitabine|mesh-list
6392478|NCT00196612|Efavirenz|efavirenz|mesh-list
6392479|NCT00196612|Didanosine|didanosine|mesh-list
6392480|NCT00196612|Antiviral Agents|antiviral agents|mesh-ancestor
6392481|NCT00196612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6392482|NCT00196612|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5724443|NCT03187496|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5724444|NCT03187496|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5724445|NCT03187496|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5724446|NCT03187496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5724447|NCT03187496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724448|NCT03187496|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5724449|NCT03187496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5724450|NCT03187496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5724451|NCT03187496|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5724452|NCT03187496|Anesthetics, General|anesthetics, general|mesh-ancestor
5724453|NCT03187496|Anesthetics|anesthetics|mesh-ancestor
6392483|NCT00196612|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6392484|NCT00196612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6392485|NCT00196612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392486|NCT00196612|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6392487|NCT00196612|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6392488|NCT00196612|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6392489|NCT00196612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6392490|NCT00196612|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6392491|NCT00196612|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6392492|NCT00196612|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6392493|NCT00196612|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6392494|NCT00196612|Antimetabolites|antimetabolites|mesh-ancestor
6392495|NCT00196625|Ritonavir|ritonavir|mesh-list
6392496|NCT00196625|Amprenavir|amprenavir|mesh-list
6392497|NCT00196625|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6392498|NCT00196625|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6392499|NCT00196625|Protease Inhibitors|protease inhibitors|mesh-ancestor
6392500|NCT00196625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6392501|NCT00196625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392502|NCT00196625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6392503|NCT00196625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6392504|NCT00196625|Antiviral Agents|antiviral agents|mesh-ancestor
6392505|NCT00196625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6392506|NCT00196625|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6392507|NCT00196625|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6392508|NCT00196625|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6392509|NCT00196625|Antitubercular Agents|antitubercular agents|mesh-ancestor
6392510|NCT00196625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6392511|NCT00196638|Interferons|interferons|mesh-list
6392512|NCT00196638|Interferon-alpha|interferon-alpha|mesh-list
6392513|NCT00196638|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6392514|NCT00196638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6392515|NCT00196638|Antiviral Agents|antiviral agents|mesh-ancestor
6392516|NCT00196638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6392517|NCT00196638|Immunologic Factors|immunologic factors|mesh-ancestor
6392518|NCT00196638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392519|NCT00196664|Paroxetine|paroxetine|mesh-list
6392520|NCT00196664|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6392521|NCT00196664|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5724454|NCT03187496|GABA Modulators|gaba modulators|mesh-ancestor
6311716|NCT00003196|Cyclosporine|cyclosporine|mesh-list
6311717|NCT00003196|Mycophenolic Acid|mycophenolic acid|mesh-list
6311718|NCT00003196|Cyclosporins|cyclosporins|mesh-list
6311719|NCT00003196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6311720|NCT00003196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311721|NCT00003196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6311722|NCT00003196|Immunologic Factors|immunologic factors|mesh-ancestor
6311723|NCT00003196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6311724|NCT00003196|Antifungal Agents|antifungal agents|mesh-ancestor
6311725|NCT00003196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6311726|NCT00003196|Dermatologic Agents|dermatologic agents|mesh-ancestor
6311727|NCT00003196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6311728|NCT00003196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6311729|NCT00003196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6311730|NCT00003196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311731|NCT00003196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6311732|NCT00003196|Antitubercular Agents|antitubercular agents|mesh-ancestor
6311733|NCT00003196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6311734|NCT00003198|Topotecan|topotecan|mesh-list
5724455|NCT03187496|GABA Agents|gaba agents|mesh-ancestor
6311735|NCT00003198|Ifosfamide|ifosfamide|mesh-list
6311736|NCT00003198|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6311737|NCT00003198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6311738|NCT00003198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6311739|NCT00003198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311740|NCT00003198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311741|NCT00003198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6311742|NCT00003198|Alkylating Agents|alkylating agents|mesh-ancestor
6311743|NCT00003200|Docetaxel|docetaxel|mesh-list
6311744|NCT00003200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311745|NCT00003200|Tubulin Modulators|tubulin modulators|mesh-ancestor
6311746|NCT00003200|Antimitotic Agents|antimitotic agents|mesh-ancestor
6311747|NCT00003200|Mitosis Modulators|mitosis modulators|mesh-ancestor
6311748|NCT00003200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311749|NCT00003202|Gemcitabine|gemcitabine|mesh-list
6311750|NCT00003202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311751|NCT00003202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6311752|NCT00003202|Antimetabolites|antimetabolites|mesh-ancestor
5724456|NCT03187496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6311753|NCT00003202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311754|NCT00003202|Antiviral Agents|antiviral agents|mesh-ancestor
6311755|NCT00003202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6311756|NCT00003202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6311757|NCT00003202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6311758|NCT00003202|Immunologic Factors|immunologic factors|mesh-ancestor
6311759|NCT00003202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6311760|NCT00003203|Cyclophosphamide|cyclophosphamide|mesh-list
5724457|NCT03187496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724458|NCT03187496|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6311761|NCT00003203|Cisplatin|cisplatin|mesh-list
6311762|NCT00003203|Carboplatin|carboplatin|mesh-list
6311763|NCT00003203|Vincristine|vincristine|mesh-list
6311764|NCT00003203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6311765|NCT00003203|Immunologic Factors|immunologic factors|mesh-ancestor
6311766|NCT00003203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6311767|NCT00003203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6311768|NCT00003203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6311769|NCT00003203|Alkylating Agents|alkylating agents|mesh-ancestor
6311770|NCT00003203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311771|NCT00003203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311772|NCT00003203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6311773|NCT00003203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6311774|NCT00003203|Tubulin Modulators|tubulin modulators|mesh-ancestor
6311775|NCT00003203|Antimitotic Agents|antimitotic agents|mesh-ancestor
6311776|NCT00003203|Mitosis Modulators|mitosis modulators|mesh-ancestor
6311777|NCT00003204|Prednisone|prednisone|mesh-list
6311778|NCT00003204|Cyclophosphamide|cyclophosphamide|mesh-list
6311779|NCT00003204|Rituximab|rituximab|mesh-list
6311780|NCT00003204|Fludarabine|fludarabine|mesh-list
6311781|NCT00003204|Fludarabine phosphate|fludarabine phosphate|mesh-list
6311782|NCT00003204|Vincristine|vincristine|mesh-list
6311783|NCT00003204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6311784|NCT00003204|Immunologic Factors|immunologic factors|mesh-ancestor
6311785|NCT00003204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6311786|NCT00003204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6311787|NCT00003204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6311788|NCT00003204|Alkylating Agents|alkylating agents|mesh-ancestor
6311789|NCT00003204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311790|NCT00003204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311791|NCT00003204|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6311792|NCT00003204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6311793|NCT00003204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6311794|NCT00003204|Glucocorticoids|glucocorticoids|mesh-ancestor
6311795|NCT00003204|Hormones|hormones|mesh-ancestor
6311796|NCT00003204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6311797|NCT00003204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6311798|NCT00003204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6311799|NCT00003204|Antimetabolites|antimetabolites|mesh-ancestor
6311800|NCT00003204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6311801|NCT00003204|Tubulin Modulators|tubulin modulators|mesh-ancestor
6311802|NCT00003204|Antimitotic Agents|antimitotic agents|mesh-ancestor
6311803|NCT00003204|Mitosis Modulators|mitosis modulators|mesh-ancestor
6311804|NCT00003205|Bryostatin 1|bryostatin 1|mesh-list
6311805|NCT00003205|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6311806|NCT00003205|Immunologic Factors|immunologic factors|mesh-ancestor
6311807|NCT00003205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6311808|NCT00003205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311809|NCT00003206|Paclitaxel|paclitaxel|mesh-list
6311810|NCT00003206|Carboplatin|carboplatin|mesh-list
6311811|NCT00003206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6311812|NCT00003206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311813|NCT00003206|Tubulin Modulators|tubulin modulators|mesh-ancestor
6311814|NCT00003206|Antimitotic Agents|antimitotic agents|mesh-ancestor
6311815|NCT00003206|Mitosis Modulators|mitosis modulators|mesh-ancestor
6311816|NCT00003206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311817|NCT00003207|Doxorubicin|doxorubicin|mesh-list
6311818|NCT00003207|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6311819|NCT00003207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6311820|NCT00003207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311821|NCT00003207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6311822|NCT00003207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6311823|NCT00003207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6311824|NCT00003207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311825|NCT00003209|Fluorouracil|fluorouracil|mesh-list
6311826|NCT00003209|Methotrexate|methotrexate|mesh-list
6311827|NCT00003209|Ifosfamide|ifosfamide|mesh-list
6311828|NCT00003209|Mitomycins|mitomycins|mesh-list
6311829|NCT00003209|Mitomycin|mitomycin|mesh-list
6311830|NCT00003209|Bleomycin|bleomycin|mesh-list
6311831|NCT00003209|Vinblastine|vinblastine|mesh-list
6311832|NCT00003209|Vindesine|vindesine|mesh-list
6311833|NCT00003209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311834|NCT00003209|Antimetabolites|antimetabolites|mesh-ancestor
6311835|NCT00003209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311836|NCT00003209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6311837|NCT00003209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5724459|NCT03187496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5724460|NCT03187496|Antimetabolites|antimetabolites|mesh-ancestor
5724461|NCT03187496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5724462|NCT03187496|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5724463|NCT03187496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5724464|NCT03187496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6016070|NCT00361972|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6311838|NCT00003209|Immunologic Factors|immunologic factors|mesh-ancestor
6311839|NCT00003209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6311840|NCT00003209|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6311841|NCT00003209|Abortifacient Agents|abortifacient agents|mesh-ancestor
6311842|NCT00003209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6311843|NCT00003209|Dermatologic Agents|dermatologic agents|mesh-ancestor
6311844|NCT00003209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6311845|NCT00003209|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6311846|NCT00003209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6311847|NCT00003209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6311848|NCT00003209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6311849|NCT00003209|Alkylating Agents|alkylating agents|mesh-ancestor
6311850|NCT00003209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6311851|NCT00003209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6311852|NCT00003209|Tubulin Modulators|tubulin modulators|mesh-ancestor
6311853|NCT00003209|Antimitotic Agents|antimitotic agents|mesh-ancestor
6311854|NCT00003209|Mitosis Modulators|mitosis modulators|mesh-ancestor
6311855|NCT00003210|Interleukin-12|interleukin-12|mesh-list
6311856|NCT00003210|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6311857|NCT00003210|Immunologic Factors|immunologic factors|mesh-ancestor
6311858|NCT00003210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6311859|NCT00003210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6311860|NCT00003210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6311861|NCT00003210|Growth Substances|growth substances|mesh-ancestor
6311862|NCT00003210|Growth Inhibitors|growth inhibitors|mesh-ancestor
6311863|NCT00003210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311864|NCT00003211|Cyclophosphamide|cyclophosphamide|mesh-list
6311865|NCT00003211|Vincristine|vincristine|mesh-list
6311866|NCT00003211|Amifostine|amifostine|mesh-list
6311867|NCT00003211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6311868|NCT00003211|Immunologic Factors|immunologic factors|mesh-ancestor
6311869|NCT00003211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6311870|NCT00003211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6311871|NCT00003211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6311872|NCT00003211|Alkylating Agents|alkylating agents|mesh-ancestor
6311873|NCT00003211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311874|NCT00003211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311875|NCT00003211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6311876|NCT00003211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6311877|NCT00003211|Tubulin Modulators|tubulin modulators|mesh-ancestor
6311878|NCT00003211|Antimitotic Agents|antimitotic agents|mesh-ancestor
6311879|NCT00003211|Mitosis Modulators|mitosis modulators|mesh-ancestor
6311880|NCT00003211|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6311881|NCT00003211|Protective Agents|protective agents|mesh-ancestor
6311882|NCT00003212|Doxorubicin|doxorubicin|mesh-list
6311883|NCT00003212|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6311884|NCT00003212|Ifosfamide|ifosfamide|mesh-list
6311885|NCT00003212|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6311886|NCT00003212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311887|NCT00003212|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6311888|NCT00003212|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6311889|NCT00003212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6311890|NCT00003212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311891|NCT00003212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6311892|NCT00003212|Alkylating Agents|alkylating agents|mesh-ancestor
6311893|NCT00003213|Dexamethasone|dexamethasone|mesh-list
6311894|NCT00003213|Dexamethasone acetate|dexamethasone acetate|mesh-list
6311895|NCT00003213|Metoclopramide|metoclopramide|mesh-list
6311896|NCT00003213|Granisetron|granisetron|mesh-list
6311897|NCT00003213|BB 1101|bb 1101|mesh-list
6311898|NCT00003213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6311899|NCT00003213|Antiemetics|antiemetics|mesh-ancestor
6311900|NCT00003213|Autonomic Agents|autonomic agents|mesh-ancestor
6311901|NCT00003213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6311902|NCT00003213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6311903|NCT00003213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6311904|NCT00003213|Glucocorticoids|glucocorticoids|mesh-ancestor
6311905|NCT00003213|Hormones|hormones|mesh-ancestor
6311906|NCT00003213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6311907|NCT00003213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6311908|NCT00003213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311909|NCT00003213|Protease Inhibitors|protease inhibitors|mesh-ancestor
6311910|NCT00003213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6311911|NCT00003213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311912|NCT00003213|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6311913|NCT00003213|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6311914|NCT00003213|Dopamine Agents|dopamine agents|mesh-ancestor
6311915|NCT00003213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6311916|NCT00003213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6311917|NCT00003213|Serotonin Agents|serotonin agents|mesh-ancestor
6311918|NCT00003214|Paclitaxel|paclitaxel|mesh-list
6311919|NCT00003214|Cyclophosphamide|cyclophosphamide|mesh-list
6311920|NCT00003214|Carboplatin|carboplatin|mesh-list
6311921|NCT00003214|Doxorubicin|doxorubicin|mesh-list
6311922|NCT00003214|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6311923|NCT00003214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6311924|NCT00003214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311925|NCT00003214|Tubulin Modulators|tubulin modulators|mesh-ancestor
6311926|NCT00003214|Antimitotic Agents|antimitotic agents|mesh-ancestor
6311927|NCT00003214|Mitosis Modulators|mitosis modulators|mesh-ancestor
6311928|NCT00003214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311929|NCT00003214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6311930|NCT00003214|Immunologic Factors|immunologic factors|mesh-ancestor
6311931|NCT00003214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6311932|NCT00003214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6311933|NCT00003214|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6311934|NCT00003214|Alkylating Agents|alkylating agents|mesh-ancestor
6311935|NCT00003214|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6311936|NCT00003214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6311937|NCT00003214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6311938|NCT00003214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6311939|NCT00003214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6311940|NCT00003215|Leucovorin|leucovorin|mesh-list
6311941|NCT00003215|Cytarabine|cytarabine|mesh-list
6311942|NCT00003215|Prednisone|prednisone|mesh-list
6311943|NCT00003215|Methylprednisolone|methylprednisolone|mesh-list
6311944|NCT00003215|Hydrocortisone|hydrocortisone|mesh-list
6311945|NCT00003215|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6311946|NCT00003215|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6311947|NCT00003215|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6311948|NCT00003215|Cyclophosphamide|cyclophosphamide|mesh-list
6311949|NCT00003215|Melphalan|melphalan|mesh-list
6311950|NCT00003215|Doxorubicin|doxorubicin|mesh-list
6311951|NCT00003215|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6311952|NCT00003215|Methotrexate|methotrexate|mesh-list
6311953|NCT00003215|Etoposide|etoposide|mesh-list
6311954|NCT00003215|Vincristine|vincristine|mesh-list
6311955|NCT00003215|Mitoxantrone|mitoxantrone|mesh-list
6311956|NCT00003215|Levoleucovorin|levoleucovorin|mesh-list
6311957|NCT00003215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6311958|NCT00003215|Immunologic Factors|immunologic factors|mesh-ancestor
6311959|NCT00003215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6311960|NCT00003215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6311961|NCT00003215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6311962|NCT00003215|Alkylating Agents|alkylating agents|mesh-ancestor
6311963|NCT00003215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6311964|NCT00003215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6311965|NCT00003215|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6311966|NCT00003215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6311967|NCT00003215|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6311968|NCT00003215|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6311969|NCT00003215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6311970|NCT00003215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6311971|NCT00003215|Glucocorticoids|glucocorticoids|mesh-ancestor
6311972|NCT00003215|Hormones|hormones|mesh-ancestor
6311973|NCT00003215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6311974|NCT00003215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6311975|NCT00003215|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6311976|NCT00003215|Abortifacient Agents|abortifacient agents|mesh-ancestor
6311977|NCT00003215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6311978|NCT00003215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6311979|NCT00003215|Antimetabolites|antimetabolites|mesh-ancestor
6311980|NCT00003215|Dermatologic Agents|dermatologic agents|mesh-ancestor
6311981|NCT00003215|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6311982|NCT00003215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6311983|NCT00003215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6311984|NCT00003215|Antiviral Agents|antiviral agents|mesh-ancestor
6311985|NCT00003215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6311986|NCT00003215|Antidotes|antidotes|mesh-ancestor
6311987|NCT00003215|Protective Agents|protective agents|mesh-ancestor
6311988|NCT00003215|Vitamin B Complex|vitamin b complex|mesh-ancestor
6311989|NCT00003215|Vitamins|vitamins|mesh-ancestor
6311990|NCT00003215|Micronutrients|micronutrients|mesh-ancestor
6311991|NCT00003215|Tubulin Modulators|tubulin modulators|mesh-ancestor
6311992|NCT00003215|Antimitotic Agents|antimitotic agents|mesh-ancestor
6311993|NCT00003215|Mitosis Modulators|mitosis modulators|mesh-ancestor
6311994|NCT00003215|Antiemetics|antiemetics|mesh-ancestor
6311995|NCT00003215|Autonomic Agents|autonomic agents|mesh-ancestor
6311996|NCT00003215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6311997|NCT00003215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6311998|NCT00003215|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6311999|NCT00003215|Analgesics|analgesics|mesh-ancestor
6312000|NCT00003215|Sensory System Agents|sensory system agents|mesh-ancestor
6312001|NCT00003216|Gemcitabine|gemcitabine|mesh-list
6312002|NCT00003216|Fluorouracil|fluorouracil|mesh-list
6312003|NCT00003216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6312004|NCT00003216|Antimetabolites|antimetabolites|mesh-ancestor
6312005|NCT00003216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312006|NCT00003216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312007|NCT00003216|Antiviral Agents|antiviral agents|mesh-ancestor
6312008|NCT00003216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6312009|NCT00003216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6312010|NCT00003216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6312011|NCT00003216|Immunologic Factors|immunologic factors|mesh-ancestor
6312012|NCT00003216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6312013|NCT00003217|Cytarabine|cytarabine|mesh-list
6312014|NCT00003217|Dexamethasone|dexamethasone|mesh-list
6312015|NCT00003217|Cyclophosphamide|cyclophosphamide|mesh-list
6312016|NCT00003217|Doxorubicin|doxorubicin|mesh-list
6312017|NCT00003217|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6312018|NCT00003217|Methotrexate|methotrexate|mesh-list
6312019|NCT00003217|Vincristine|vincristine|mesh-list
6312020|NCT00003217|Lenograstim|lenograstim|mesh-list
6312021|NCT00003217|Sargramostim|sargramostim|mesh-list
6312022|NCT00003217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6312023|NCT00003217|Immunologic Factors|immunologic factors|mesh-ancestor
6312024|NCT00003217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6312025|NCT00003217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6312026|NCT00003217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6016071|NCT00361972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6016072|NCT00361972|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6016073|NCT00361972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6016074|NCT00361972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312027|NCT00003217|Alkylating Agents|alkylating agents|mesh-ancestor
6312028|NCT00003217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312029|NCT00003217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312030|NCT00003217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6312031|NCT00003217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6312032|NCT00003217|Antiemetics|antiemetics|mesh-ancestor
6312033|NCT00003217|Autonomic Agents|autonomic agents|mesh-ancestor
6312034|NCT00003217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6312035|NCT00003217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6312036|NCT00003217|Glucocorticoids|glucocorticoids|mesh-ancestor
6312037|NCT00003217|Hormones|hormones|mesh-ancestor
6312038|NCT00003217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6312039|NCT00003217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6312040|NCT00003217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6312041|NCT00003217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6312042|NCT00003217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6312043|NCT00003217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6312044|NCT00003217|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6312045|NCT00003217|Abortifacient Agents|abortifacient agents|mesh-ancestor
6312046|NCT00003217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6312047|NCT00003217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6312048|NCT00003217|Antimetabolites|antimetabolites|mesh-ancestor
6312049|NCT00003217|Dermatologic Agents|dermatologic agents|mesh-ancestor
6312050|NCT00003217|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6312051|NCT00003217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6312052|NCT00003217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6312053|NCT00003217|Antiviral Agents|antiviral agents|mesh-ancestor
6312054|NCT00003217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6312055|NCT00003217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6312056|NCT00003217|Tubulin Modulators|tubulin modulators|mesh-ancestor
6312057|NCT00003217|Antimitotic Agents|antimitotic agents|mesh-ancestor
6312058|NCT00003217|Mitosis Modulators|mitosis modulators|mesh-ancestor
6312059|NCT00003219|Perillyl alcohol|perillyl alcohol|mesh-list
6312060|NCT00003219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312061|NCT00003219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6312062|NCT00003219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312063|NCT00003220|Bryostatin 1|bryostatin 1|mesh-list
6312064|NCT00003220|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6312065|NCT00003220|Immunologic Factors|immunologic factors|mesh-ancestor
6312066|NCT00003220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6312067|NCT00003220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312068|NCT00003223|Fenretinide|fenretinide|mesh-list
6312069|NCT00003223|Retinamide|retinamide|mesh-list
6312070|NCT00003223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312071|NCT00003223|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6312072|NCT00003223|Protective Agents|protective agents|mesh-ancestor
6312073|NCT00003223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6312074|NCT00003225|Irinotecan|irinotecan|mesh-list
6312075|NCT00003225|Amifostine|amifostine|mesh-list
6312076|NCT00003225|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6312077|NCT00003225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6312078|NCT00003225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6312079|NCT00003225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312080|NCT00003225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312081|NCT00003225|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6312082|NCT00003225|Protective Agents|protective agents|mesh-ancestor
6312083|NCT00003225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6312084|NCT00003229|Aldesleukin|aldesleukin|mesh-list
6312085|NCT00003229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312086|NCT00003229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6312087|NCT00003229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6312088|NCT00003229|Antiviral Agents|antiviral agents|mesh-ancestor
6312089|NCT00003229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6312090|NCT00003230|Paclitaxel|paclitaxel|mesh-list
6312091|NCT00003230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6312092|NCT00003230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312093|NCT00003230|Tubulin Modulators|tubulin modulators|mesh-ancestor
6312094|NCT00003230|Antimitotic Agents|antimitotic agents|mesh-ancestor
6312095|NCT00003230|Mitosis Modulators|mitosis modulators|mesh-ancestor
6312096|NCT00003230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312097|NCT00003231|Docetaxel|docetaxel|mesh-list
6312098|NCT00003231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312099|NCT00003231|Tubulin Modulators|tubulin modulators|mesh-ancestor
6312100|NCT00003231|Antimitotic Agents|antimitotic agents|mesh-ancestor
6312101|NCT00003231|Mitosis Modulators|mitosis modulators|mesh-ancestor
6312102|NCT00003231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312103|NCT00003232|Clodronic Acid|clodronic acid|mesh-list
6312104|NCT00003232|Prednisone|prednisone|mesh-list
6312105|NCT00003232|Mitoxantrone|mitoxantrone|mesh-list
6312106|NCT00003232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6312107|NCT00003232|Glucocorticoids|glucocorticoids|mesh-ancestor
6312108|NCT00003232|Hormones|hormones|mesh-ancestor
6312109|NCT00003232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6312110|NCT00003232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6312111|NCT00003232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6312112|NCT00003232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312113|NCT00003232|Analgesics|analgesics|mesh-ancestor
6312114|NCT00003232|Sensory System Agents|sensory system agents|mesh-ancestor
6312115|NCT00003232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6312116|NCT00003232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6312117|NCT00003232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6312118|NCT00003232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6312119|NCT00003232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312120|NCT00003232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6312121|NCT00003234|Vinorelbine|vinorelbine|mesh-list
6312122|NCT00003234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6312123|NCT00003234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312124|NCT00003234|Tubulin Modulators|tubulin modulators|mesh-ancestor
6312125|NCT00003234|Antimitotic Agents|antimitotic agents|mesh-ancestor
6312126|NCT00003234|Mitosis Modulators|mitosis modulators|mesh-ancestor
6312127|NCT00003234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312128|NCT00003235|Paclitaxel|paclitaxel|mesh-list
6312129|NCT00003235|Carboplatin|carboplatin|mesh-list
6312130|NCT00003235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6312131|NCT00003235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312132|NCT00003235|Tubulin Modulators|tubulin modulators|mesh-ancestor
6312133|NCT00003235|Antimitotic Agents|antimitotic agents|mesh-ancestor
6312134|NCT00003235|Mitosis Modulators|mitosis modulators|mesh-ancestor
6312135|NCT00003235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312136|NCT00003236|ISIS 5132|isis 5132|mesh-list
6312137|NCT00003236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312138|NCT00003236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6312139|NCT00003236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312140|NCT00003237|Paclitaxel|paclitaxel|mesh-list
6312141|NCT00003237|Cisplatin|cisplatin|mesh-list
6312142|NCT00003237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6312143|NCT00003237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312144|NCT00003237|Tubulin Modulators|tubulin modulators|mesh-ancestor
6312145|NCT00003237|Antimitotic Agents|antimitotic agents|mesh-ancestor
6312146|NCT00003237|Mitosis Modulators|mitosis modulators|mesh-ancestor
6312147|NCT00003237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312148|NCT00003238|Perillyl alcohol|perillyl alcohol|mesh-list
6312149|NCT00003238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312150|NCT00003238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6312151|NCT00003238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312152|NCT00003239|Interferons|interferons|mesh-list
6312153|NCT00003239|Cytarabine|cytarabine|mesh-list
6312154|NCT00003239|Interferon-alpha|interferon-alpha|mesh-list
6312155|NCT00003239|Interferon alpha-2|interferon alpha-2|mesh-list
6312156|NCT00003239|Homoharringtonine|homoharringtonine|mesh-list
6312157|NCT00003239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312158|NCT00003239|Antiviral Agents|antiviral agents|mesh-ancestor
6312159|NCT00003239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6312160|NCT00003239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6312161|NCT00003239|Antimetabolites|antimetabolites|mesh-ancestor
6312162|NCT00003239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312163|NCT00003239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6312164|NCT00003239|Immunologic Factors|immunologic factors|mesh-ancestor
6312165|NCT00003239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6312166|NCT00003239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6312167|NCT00003239|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6312168|NCT00003239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6312169|NCT00003240|Vinorelbine|vinorelbine|mesh-list
6312170|NCT00003240|Ifosfamide|ifosfamide|mesh-list
6312171|NCT00003240|Mitomycins|mitomycins|mesh-list
6312172|NCT00003240|Mitomycin|mitomycin|mesh-list
6312173|NCT00003240|Vinblastine|vinblastine|mesh-list
6312174|NCT00003240|Vindesine|vindesine|mesh-list
6312175|NCT00003240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312176|NCT00003240|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6312177|NCT00003240|Tubulin Modulators|tubulin modulators|mesh-ancestor
6312178|NCT00003240|Antimitotic Agents|antimitotic agents|mesh-ancestor
6312179|NCT00003240|Mitosis Modulators|mitosis modulators|mesh-ancestor
6312180|NCT00003240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312181|NCT00003240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6312182|NCT00003240|Alkylating Agents|alkylating agents|mesh-ancestor
6312183|NCT00003240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6312184|NCT00003240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6312185|NCT00003240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6312186|NCT00003241|Phenylacetic acid|phenylacetic acid|mesh-list
6312187|NCT00003241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6312188|NCT00003241|Antimetabolites|antimetabolites|mesh-ancestor
6312189|NCT00003241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312190|NCT00003241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312191|NCT00003242|Paclitaxel|paclitaxel|mesh-list
6312192|NCT00003242|Bryostatin 1|bryostatin 1|mesh-list
6312193|NCT00003242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6312194|NCT00003242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312195|NCT00003242|Tubulin Modulators|tubulin modulators|mesh-ancestor
6312196|NCT00003242|Antimitotic Agents|antimitotic agents|mesh-ancestor
6312197|NCT00003242|Mitosis Modulators|mitosis modulators|mesh-ancestor
6312198|NCT00003242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312199|NCT00003242|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6312200|NCT00003242|Immunologic Factors|immunologic factors|mesh-ancestor
6312201|NCT00003242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6312202|NCT00003243|Aldesleukin|aldesleukin|mesh-list
6312203|NCT00003243|Cyclophosphamide|cyclophosphamide|mesh-list
6312204|NCT00003243|Doxorubicin|doxorubicin|mesh-list
6312205|NCT00003243|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6312206|NCT00003243|Etoposide|etoposide|mesh-list
6312207|NCT00003243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6312208|NCT00003243|Immunologic Factors|immunologic factors|mesh-ancestor
6312209|NCT00003243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6312210|NCT00003243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6312211|NCT00003243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6312212|NCT00003243|Alkylating Agents|alkylating agents|mesh-ancestor
6312213|NCT00003243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312214|NCT00003243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312215|NCT00003243|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6312216|NCT00003243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6312217|NCT00003243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6312218|NCT00003243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6312219|NCT00003243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6312220|NCT00003243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6312221|NCT00003243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6312222|NCT00003243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6312223|NCT00003243|Antiviral Agents|antiviral agents|mesh-ancestor
6312224|NCT00003243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6312225|NCT00003245|Irinotecan|irinotecan|mesh-list
6312226|NCT00003245|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6312227|NCT00003245|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6312228|NCT00003245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6312229|NCT00003245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312230|NCT00003245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312231|NCT00003248|Rituximab|rituximab|mesh-list
6312232|NCT00003248|Fludarabine|fludarabine|mesh-list
6312233|NCT00003248|Fludarabine phosphate|fludarabine phosphate|mesh-list
6312234|NCT00003248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6312235|NCT00003248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312236|NCT00003248|Immunologic Factors|immunologic factors|mesh-ancestor
6312237|NCT00003248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6312238|NCT00003248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6312239|NCT00003248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6312240|NCT00003248|Antimetabolites|antimetabolites|mesh-ancestor
6312241|NCT00003248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312242|NCT00003248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6312243|NCT00003249|Ketoconazole|ketoconazole|mesh-list
6312244|NCT00003249|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
6312245|NCT00003249|Antifungal Agents|antifungal agents|mesh-ancestor
6312246|NCT00003249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6312247|NCT00003249|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6312248|NCT00003249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6312249|NCT00003249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6312250|NCT00003249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312251|NCT00003249|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6312252|NCT00003249|Hormone Antagonists|hormone antagonists|mesh-ancestor
6312253|NCT00003249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6312254|NCT00003249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6312255|NCT00003249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6312256|NCT00003249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312257|NCT00003249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6312258|NCT00003249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6312259|NCT00003249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6312260|NCT00003250|Fenretinide|fenretinide|mesh-list
6312261|NCT00003250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312262|NCT00003250|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6312263|NCT00003250|Protective Agents|protective agents|mesh-ancestor
6312264|NCT00003250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016075|NCT00362115|Olmesartan|olmesartan|mesh-list
6016076|NCT00362115|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
6016077|NCT00362115|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6312265|NCT00003251|Paclitaxel|paclitaxel|mesh-list
6312266|NCT00003251|Amifostine|amifostine|mesh-list
6312267|NCT00003251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6312268|NCT00003251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312269|NCT00003251|Tubulin Modulators|tubulin modulators|mesh-ancestor
6312270|NCT00003251|Antimitotic Agents|antimitotic agents|mesh-ancestor
6312271|NCT00003251|Mitosis Modulators|mitosis modulators|mesh-ancestor
6312272|NCT00003251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312273|NCT00003251|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6312274|NCT00003251|Protective Agents|protective agents|mesh-ancestor
6312275|NCT00003251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6312276|NCT00003252|Amifostine|amifostine|mesh-list
6312277|NCT00003252|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6312278|NCT00003252|Protective Agents|protective agents|mesh-ancestor
6312279|NCT00003252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6312280|NCT00003253|Paclitaxel|paclitaxel|mesh-list
6312281|NCT00003253|Antineoplastic Agents|antineoplastic agents|mesh-list
6312282|NCT00003253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6312283|NCT00003253|Tubulin Modulators|tubulin modulators|mesh-ancestor
6312284|NCT00003253|Antimitotic Agents|antimitotic agents|mesh-ancestor
6312285|NCT00003253|Mitosis Modulators|mitosis modulators|mesh-ancestor
6312286|NCT00003253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312287|NCT00003254|Fluorouracil|fluorouracil|mesh-list
6312288|NCT00003254|Eniluracil|eniluracil|mesh-list
6016078|NCT00362115|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6312289|NCT00003254|Antimetabolites|antimetabolites|mesh-ancestor
6312290|NCT00003254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312291|NCT00003254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6312292|NCT00003254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312293|NCT00003254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6312294|NCT00003254|Immunologic Factors|immunologic factors|mesh-ancestor
6312295|NCT00003254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6312296|NCT00003254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6312297|NCT00003255|Carboplatin|carboplatin|mesh-list
6312298|NCT00003255|Topotecan|topotecan|mesh-list
6312299|NCT00003255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6016079|NCT00362115|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6016080|NCT00362115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016081|NCT00362180|Mipomersen|mipomersen|mesh-list
6016082|NCT00362180|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6016083|NCT00362180|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6016084|NCT00362180|Antimetabolites|antimetabolites|mesh-ancestor
6016085|NCT00362180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016086|NCT00362180|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6016087|NCT00362232|Enoxaparin|enoxaparin|mesh-list
6016088|NCT00362232|Rivaroxaban|rivaroxaban|mesh-list
6016089|NCT00362232|Enoxaparin sodium|enoxaparin sodium|mesh-list
6016090|NCT00362232|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6016091|NCT00362232|Antithrombins|antithrombins|mesh-ancestor
6016092|NCT00362232|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6016093|NCT00362232|Protease Inhibitors|protease inhibitors|mesh-ancestor
6016094|NCT00362232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6016095|NCT00362232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016096|NCT00362232|Anticoagulants|anticoagulants|mesh-ancestor
6016097|NCT00362232|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6016098|NCT00362232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6016099|NCT00362297|Valacyclovir|valacyclovir|mesh-list
6312300|NCT00003255|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6312301|NCT00003255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6312302|NCT00003255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6312303|NCT00003255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312304|NCT00003256|Alvocidib|alvocidib|mesh-list
6312305|NCT00003256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312306|NCT00003256|Growth Inhibitors|growth inhibitors|mesh-ancestor
6312307|NCT00003256|Growth Substances|growth substances|mesh-ancestor
6312308|NCT00003256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6312309|NCT00003256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6312310|NCT00003256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6312311|NCT00003256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312312|NCT00003259|Vinorelbine|vinorelbine|mesh-list
6312313|NCT00003259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6312314|NCT00003259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312315|NCT00003259|Tubulin Modulators|tubulin modulators|mesh-ancestor
6312316|NCT00003259|Antimitotic Agents|antimitotic agents|mesh-ancestor
6312317|NCT00003259|Mitosis Modulators|mitosis modulators|mesh-ancestor
6312318|NCT00003259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312319|NCT00003260|Leucovorin|leucovorin|mesh-list
6312320|NCT00003260|Fluorouracil|fluorouracil|mesh-list
6312321|NCT00003260|Oxaliplatin|oxaliplatin|mesh-list
6312322|NCT00003260|Irinotecan|irinotecan|mesh-list
6312323|NCT00003260|Calcium|calcium|mesh-list
6312324|NCT00003260|Levoleucovorin|levoleucovorin|mesh-list
6312325|NCT00003260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6312326|NCT00003260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6312327|NCT00003260|Antimetabolites|antimetabolites|mesh-ancestor
6312328|NCT00003260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312329|NCT00003260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6016100|NCT00362297|Acyclovir|acyclovir|mesh-list
6016101|NCT00362297|Antiviral Agents|antiviral agents|mesh-ancestor
6312330|NCT00003260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312331|NCT00003260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6312332|NCT00003260|Immunologic Factors|immunologic factors|mesh-ancestor
6312333|NCT00003260|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6312334|NCT00003260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6312335|NCT00003260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6312336|NCT00003260|Antidotes|antidotes|mesh-ancestor
6312337|NCT00003260|Protective Agents|protective agents|mesh-ancestor
6312338|NCT00003260|Vitamin B Complex|vitamin b complex|mesh-ancestor
6312339|NCT00003260|Vitamins|vitamins|mesh-ancestor
6312340|NCT00003260|Micronutrients|micronutrients|mesh-ancestor
6312341|NCT00003261|Zidovudine|zidovudine|mesh-list
6312342|NCT00003261|Methotrexate|methotrexate|mesh-list
6312343|NCT00003261|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6312344|NCT00003261|Abortifacient Agents|abortifacient agents|mesh-ancestor
6312345|NCT00003261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6312346|NCT00003261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6312347|NCT00003261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6312348|NCT00003261|Antimetabolites|antimetabolites|mesh-ancestor
6312349|NCT00003261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312350|NCT00003261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312351|NCT00003261|Dermatologic Agents|dermatologic agents|mesh-ancestor
6312352|NCT00003261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6312353|NCT00003261|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6312354|NCT00003261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6312355|NCT00003261|Immunologic Factors|immunologic factors|mesh-ancestor
6312356|NCT00003261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6312357|NCT00003261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6312358|NCT00003261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6312359|NCT00003261|Antiviral Agents|antiviral agents|mesh-ancestor
6312360|NCT00003261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6312361|NCT00003261|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6312362|NCT00003261|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6312363|NCT00003262|Prednisone|prednisone|mesh-list
6312364|NCT00003262|Doxorubicin|doxorubicin|mesh-list
6312365|NCT00003262|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6312366|NCT00003262|Epirubicin|epirubicin|mesh-list
6312367|NCT00003262|Bleomycin|bleomycin|mesh-list
6312368|NCT00003262|Etoposide|etoposide|mesh-list
6312369|NCT00003262|Vincristine|vincristine|mesh-list
6312370|NCT00003262|Vinblastine|vinblastine|mesh-list
6312371|NCT00003262|Mechlorethamine|mechlorethamine|mesh-list
6312372|NCT00003262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6312373|NCT00003262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312374|NCT00003262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6312375|NCT00003262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6312376|NCT00003262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5724465|NCT03187496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5724466|NCT03187496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5724467|NCT03187496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5724468|NCT03187496|Purinergic Agents|purinergic agents|mesh-ancestor
5724469|NCT03187015|Entinostat|entinostat|mesh-list
5724470|NCT03187015|Midazolam|midazolam|mesh-list
5724471|NCT03187015|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5724472|NCT03187015|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5724473|NCT03187015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5724474|NCT03187015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724475|NCT03187015|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5724476|NCT03187015|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5724477|NCT03187015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5724478|NCT03187015|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5724479|NCT03187015|Anesthetics, General|anesthetics, general|mesh-ancestor
5724480|NCT03187015|Anesthetics|anesthetics|mesh-ancestor
5724481|NCT03187015|GABA Modulators|gaba modulators|mesh-ancestor
5724482|NCT03187015|GABA Agents|gaba agents|mesh-ancestor
6312377|NCT00003262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312378|NCT00003262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6312379|NCT00003262|Glucocorticoids|glucocorticoids|mesh-ancestor
6312380|NCT00003262|Hormones|hormones|mesh-ancestor
6312381|NCT00003262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5724483|NCT03187015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5724678|NCT03185611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6312382|NCT00003262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6312383|NCT00003262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6312384|NCT00003262|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6312385|NCT00003262|Tubulin Modulators|tubulin modulators|mesh-ancestor
5724484|NCT03187015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724485|NCT03187015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5724486|NCT03187015|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5724487|NCT03187015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5724488|NCT03187080|Bupivacaine|bupivacaine|mesh-list
6312386|NCT00003262|Antimitotic Agents|antimitotic agents|mesh-ancestor
6312387|NCT00003262|Mitosis Modulators|mitosis modulators|mesh-ancestor
6312388|NCT00003262|Alkylating Agents|alkylating agents|mesh-ancestor
5724489|NCT03187080|Anesthetics, Local|anesthetics, local|mesh-list
5724490|NCT03187080|Anesthetics|anesthetics|mesh-list
5724491|NCT03187080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5724492|NCT03187080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724493|NCT03187080|Sensory System Agents|sensory system agents|mesh-ancestor
5724494|NCT03187080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5724495|NCT03186729|Fibrinolytic Agents|fibrinolytic agents|mesh-list
5724496|NCT03186729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5724497|NCT03186729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724498|NCT03186755|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
5724499|NCT03186755|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5724500|NCT03186755|Hyaluronic Acid|hyaluronic acid|mesh-list
5724501|NCT03186755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5724502|NCT03186755|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6312389|NCT00003262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6312390|NCT00003263|Interferons|interferons|mesh-list
6312391|NCT00003263|Interferon-alpha|interferon-alpha|mesh-list
6312392|NCT00003263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312393|NCT00003263|Antiviral Agents|antiviral agents|mesh-ancestor
6312394|NCT00003263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6312395|NCT00003263|Immunologic Factors|immunologic factors|mesh-ancestor
6312396|NCT00003263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6312397|NCT00003264|Gemcitabine|gemcitabine|mesh-list
6312398|NCT00003264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312399|NCT00003264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6312400|NCT00003264|Antimetabolites|antimetabolites|mesh-ancestor
6312401|NCT00003264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312402|NCT00003264|Antiviral Agents|antiviral agents|mesh-ancestor
6312403|NCT00003264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6312404|NCT00003264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6312405|NCT00003264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6312406|NCT00003264|Immunologic Factors|immunologic factors|mesh-ancestor
6312407|NCT00003264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6312408|NCT00003266|Methylphenidate|methylphenidate|mesh-list
6312409|NCT00003266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6312410|NCT00003266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6312411|NCT00003266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6312412|NCT00003266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5724503|NCT03186755|Immunologic Factors|immunologic factors|mesh-ancestor
5724504|NCT03186755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724505|NCT03186755|Viscosupplements|viscosupplements|mesh-ancestor
5724506|NCT03186755|Protective Agents|protective agents|mesh-ancestor
5724507|NCT03186755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5724508|NCT03186755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5724509|NCT03186755|Analgesics|analgesics|mesh-ancestor
5724510|NCT03186755|Sensory System Agents|sensory system agents|mesh-ancestor
6312413|NCT00003266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6312414|NCT00003266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312415|NCT00003266|Dopamine Agents|dopamine agents|mesh-ancestor
6312416|NCT00003266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6312417|NCT00003268|Cytarabine|cytarabine|mesh-list
6312418|NCT00003268|Idarubicin|idarubicin|mesh-list
6312419|NCT00003268|Amifostine|amifostine|mesh-list
6312420|NCT00003268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6312421|NCT00003268|Antimetabolites|antimetabolites|mesh-ancestor
6312422|NCT00003268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312423|NCT00003268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312424|NCT00003268|Antiviral Agents|antiviral agents|mesh-ancestor
6312425|NCT00003268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6312426|NCT00003268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6312427|NCT00003268|Immunologic Factors|immunologic factors|mesh-ancestor
6312428|NCT00003268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6312429|NCT00003268|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6312430|NCT00003268|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6312431|NCT00003268|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6312432|NCT00003268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6312433|NCT00003268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6312434|NCT00003268|Protective Agents|protective agents|mesh-ancestor
6312435|NCT00003269|Cyclophosphamide|cyclophosphamide|mesh-list
6312436|NCT00003269|Etoposide|etoposide|mesh-list
6312437|NCT00003269|Sargramostim|sargramostim|mesh-list
6312438|NCT00003269|Amifostine|amifostine|mesh-list
6312439|NCT00003269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6312440|NCT00003269|Immunologic Factors|immunologic factors|mesh-ancestor
6312441|NCT00003269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6312442|NCT00003269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6312443|NCT00003269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6312444|NCT00003269|Alkylating Agents|alkylating agents|mesh-ancestor
6312445|NCT00003269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312446|NCT00003269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312447|NCT00003269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6312448|NCT00003269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6312449|NCT00003269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6312450|NCT00003269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6312451|NCT00003269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6312452|NCT00003269|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6312453|NCT00003269|Protective Agents|protective agents|mesh-ancestor
6312454|NCT00003273|Leucovorin|leucovorin|mesh-list
6312455|NCT00003273|Cyclophosphamide|cyclophosphamide|mesh-list
6312456|NCT00003273|Temozolomide|temozolomide|mesh-list
6312457|NCT00003273|Thiotepa|thiotepa|mesh-list
6312458|NCT00003273|Carboplatin|carboplatin|mesh-list
6312459|NCT00003273|Methotrexate|methotrexate|mesh-list
6312460|NCT00003273|Etoposide|etoposide|mesh-list
6312461|NCT00003273|Vincristine|vincristine|mesh-list
6312462|NCT00003273|Levoleucovorin|levoleucovorin|mesh-list
6312463|NCT00003273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6312464|NCT00003273|Immunologic Factors|immunologic factors|mesh-ancestor
6312465|NCT00003273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6312466|NCT00003273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6312467|NCT00003273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6312468|NCT00003273|Alkylating Agents|alkylating agents|mesh-ancestor
6312469|NCT00003273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312470|NCT00003273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312471|NCT00003273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6312472|NCT00003273|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6312473|NCT00003273|Abortifacient Agents|abortifacient agents|mesh-ancestor
6312474|NCT00003273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6312475|NCT00003273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6312476|NCT00003273|Antimetabolites|antimetabolites|mesh-ancestor
6312477|NCT00003273|Dermatologic Agents|dermatologic agents|mesh-ancestor
6312478|NCT00003273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6312479|NCT00003273|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6312480|NCT00003273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6312481|NCT00003273|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6312482|NCT00003273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6312483|NCT00003273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6312484|NCT00003273|Antidotes|antidotes|mesh-ancestor
6312485|NCT00003273|Protective Agents|protective agents|mesh-ancestor
6312486|NCT00003273|Vitamin B Complex|vitamin b complex|mesh-ancestor
6312487|NCT00003273|Vitamins|vitamins|mesh-ancestor
6312488|NCT00003273|Micronutrients|micronutrients|mesh-ancestor
6312489|NCT00003273|Tubulin Modulators|tubulin modulators|mesh-ancestor
6312490|NCT00003273|Antimitotic Agents|antimitotic agents|mesh-ancestor
6312491|NCT00003273|Mitosis Modulators|mitosis modulators|mesh-ancestor
6312492|NCT00003274|Sargramostim|sargramostim|mesh-list
6312493|NCT00003274|Freund's Adjuvant|freund's adjuvant|mesh-list
6312494|NCT00003274|Immunologic Factors|immunologic factors|mesh-ancestor
6312495|NCT00003274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6312496|NCT00003274|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6312497|NCT00003276|Irinotecan|irinotecan|mesh-list
6312498|NCT00003276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6312499|NCT00003276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6312500|NCT00003276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6312501|NCT00003276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312502|NCT00003276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312503|NCT00003278|Dexamethasone|dexamethasone|mesh-list
6312504|NCT00003278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6312505|NCT00003278|Antiemetics|antiemetics|mesh-ancestor
6312506|NCT00003278|Autonomic Agents|autonomic agents|mesh-ancestor
6312507|NCT00003278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6312508|NCT00003278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6312509|NCT00003278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6312510|NCT00003278|Glucocorticoids|glucocorticoids|mesh-ancestor
6312511|NCT00003278|Hormones|hormones|mesh-ancestor
6312512|NCT00003278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6312513|NCT00003278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6312514|NCT00003278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312515|NCT00003279|Antibodies|antibodies|mesh-list
6312516|NCT00003279|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6312517|NCT00003279|BCG Vaccine|bcg vaccine|mesh-list
6312518|NCT00003279|Immunologic Factors|immunologic factors|mesh-ancestor
6312519|NCT00003279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6312520|NCT00003279|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6312521|NCT00003280|Rituximab|rituximab|mesh-list
6312522|NCT00003280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6312523|NCT00003280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312524|NCT00003280|Immunologic Factors|immunologic factors|mesh-ancestor
6312525|NCT00003280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6312526|NCT00003280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6312527|NCT00003281|Paclitaxel|paclitaxel|mesh-list
6312528|NCT00003281|Topotecan|topotecan|mesh-list
6312529|NCT00003281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6312530|NCT00003281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312531|NCT00003281|Tubulin Modulators|tubulin modulators|mesh-ancestor
6312532|NCT00003281|Antimitotic Agents|antimitotic agents|mesh-ancestor
6312533|NCT00003281|Mitosis Modulators|mitosis modulators|mesh-ancestor
6312534|NCT00003281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312535|NCT00003281|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6312536|NCT00003281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6312537|NCT00003281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6312538|NCT00003283|Prednisone|prednisone|mesh-list
6312539|NCT00003283|Octreotide|octreotide|mesh-list
6312540|NCT00003283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6312541|NCT00003283|Glucocorticoids|glucocorticoids|mesh-ancestor
6312542|NCT00003283|Hormones|hormones|mesh-ancestor
6312543|NCT00003283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6312544|NCT00003283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6312545|NCT00003283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6312546|NCT00003283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312547|NCT00003283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6312548|NCT00003284|Paclitaxel|paclitaxel|mesh-list
6312549|NCT00003284|Etoposide|etoposide|mesh-list
6312550|NCT00003284|Carboplatin|carboplatin|mesh-list
6312551|NCT00003284|Ifosfamide|ifosfamide|mesh-list
6312552|NCT00003284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6312553|NCT00003284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312554|NCT00003284|Tubulin Modulators|tubulin modulators|mesh-ancestor
6312555|NCT00003284|Antimitotic Agents|antimitotic agents|mesh-ancestor
6312556|NCT00003284|Mitosis Modulators|mitosis modulators|mesh-ancestor
6312557|NCT00003284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312558|NCT00003284|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6312559|NCT00003284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6312560|NCT00003284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6312561|NCT00003284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6312562|NCT00003284|Alkylating Agents|alkylating agents|mesh-ancestor
6312563|NCT00003287|Leucovorin|leucovorin|mesh-list
6312564|NCT00003287|Fluorouracil|fluorouracil|mesh-list
6312565|NCT00003287|Oxaliplatin|oxaliplatin|mesh-list
6312566|NCT00003287|Calcium|calcium|mesh-list
6312567|NCT00003287|Levoleucovorin|levoleucovorin|mesh-list
6312568|NCT00003287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6312569|NCT00003287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6312570|NCT00003287|Antimetabolites|antimetabolites|mesh-ancestor
6312571|NCT00003287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312572|NCT00003287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6312573|NCT00003287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312574|NCT00003287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6312575|NCT00003287|Immunologic Factors|immunologic factors|mesh-ancestor
6312576|NCT00003287|Antidotes|antidotes|mesh-ancestor
6312577|NCT00003287|Protective Agents|protective agents|mesh-ancestor
6312578|NCT00003287|Vitamin B Complex|vitamin b complex|mesh-ancestor
6312579|NCT00003287|Vitamins|vitamins|mesh-ancestor
6312580|NCT00003287|Micronutrients|micronutrients|mesh-ancestor
6312581|NCT00003288|Cyclophosphamide|cyclophosphamide|mesh-list
6312582|NCT00003288|Tirapazamine|tirapazamine|mesh-list
6312583|NCT00003288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6312584|NCT00003288|Immunologic Factors|immunologic factors|mesh-ancestor
6312585|NCT00003288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6312586|NCT00003288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6312587|NCT00003288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6312588|NCT00003288|Alkylating Agents|alkylating agents|mesh-ancestor
6312589|NCT00003288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312590|NCT00003288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312591|NCT00003288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6312592|NCT00003289|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
6312593|NCT00003289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312594|NCT00003289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6312595|NCT00003289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6312596|NCT00003289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312597|NCT00003290|Hormones|hormones|mesh-list
6312598|NCT00003290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6312599|NCT00003290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6312600|NCT00003292|Ifosfamide|ifosfamide|mesh-list
6312601|NCT00003292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6312602|NCT00003292|Alkylating Agents|alkylating agents|mesh-ancestor
6312603|NCT00003292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312604|NCT00003292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312605|NCT00003293|Procarbazine|procarbazine|mesh-list
6312606|NCT00003293|Leflunomide|leflunomide|mesh-list
6312607|NCT00003293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6312608|NCT00003293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312609|NCT00003293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6312610|NCT00003293|Immunologic Factors|immunologic factors|mesh-ancestor
6312611|NCT00003293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6312612|NCT00003293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312613|NCT00003294|Paclitaxel|paclitaxel|mesh-list
6312614|NCT00003294|Carboplatin|carboplatin|mesh-list
6312615|NCT00003294|Amifostine|amifostine|mesh-list
6312616|NCT00003294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6312617|NCT00003294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312618|NCT00003294|Tubulin Modulators|tubulin modulators|mesh-ancestor
6312619|NCT00003294|Antimitotic Agents|antimitotic agents|mesh-ancestor
6312620|NCT00003294|Mitosis Modulators|mitosis modulators|mesh-ancestor
6312621|NCT00003294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312622|NCT00003294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6312623|NCT00003294|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6312624|NCT00003294|Protective Agents|protective agents|mesh-ancestor
6312625|NCT00003296|Doxorubicin|doxorubicin|mesh-list
6312626|NCT00003296|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6312627|NCT00003296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6312628|NCT00003296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312629|NCT00003296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6312630|NCT00003296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6312631|NCT00003296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6312632|NCT00003296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312633|NCT00003297|Topotecan|topotecan|mesh-list
6312634|NCT00003297|Mitoxantrone|mitoxantrone|mesh-list
6312635|NCT00003297|Thiotepa|thiotepa|mesh-list
6312636|NCT00003297|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6312637|NCT00003297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6312638|NCT00003297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6312639|NCT00003297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312640|NCT00003297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312641|NCT00003297|Analgesics|analgesics|mesh-ancestor
6312642|NCT00003297|Sensory System Agents|sensory system agents|mesh-ancestor
6312643|NCT00003297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6312644|NCT00003297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6312645|NCT00003297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6312646|NCT00003297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6312647|NCT00003297|Alkylating Agents|alkylating agents|mesh-ancestor
6312648|NCT00003297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6312649|NCT00003297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6312650|NCT00003297|Immunologic Factors|immunologic factors|mesh-ancestor
6312651|NCT00003299|Paclitaxel|paclitaxel|mesh-list
6312652|NCT00003299|Etoposide|etoposide|mesh-list
6312653|NCT00003299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6312654|NCT00003299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312655|NCT00003299|Tubulin Modulators|tubulin modulators|mesh-ancestor
6312656|NCT00003299|Antimitotic Agents|antimitotic agents|mesh-ancestor
6312657|NCT00003299|Mitosis Modulators|mitosis modulators|mesh-ancestor
6312658|NCT00003299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312659|NCT00003299|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6312660|NCT00003299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6312661|NCT00003299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6312662|NCT00003301|Irinotecan|irinotecan|mesh-list
6312663|NCT00003301|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6312664|NCT00003301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6312665|NCT00003301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6312666|NCT00003301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312667|NCT00003301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312668|NCT00003304|Temozolomide|temozolomide|mesh-list
6312669|NCT00003304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6312670|NCT00003304|Alkylating Agents|alkylating agents|mesh-ancestor
6312671|NCT00003304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312672|NCT00003304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312673|NCT00003305|Leucovorin|leucovorin|mesh-list
6312674|NCT00003305|Calcium|calcium|mesh-list
6312675|NCT00003305|Levoleucovorin|levoleucovorin|mesh-list
6312676|NCT00003305|Aminopterin|aminopterin|mesh-list
6312677|NCT00003305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6312678|NCT00003305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6312679|NCT00003305|Antidotes|antidotes|mesh-ancestor
6312680|NCT00003305|Protective Agents|protective agents|mesh-ancestor
6312681|NCT00003305|Vitamin B Complex|vitamin b complex|mesh-ancestor
6312682|NCT00003305|Vitamins|vitamins|mesh-ancestor
6312683|NCT00003305|Micronutrients|micronutrients|mesh-ancestor
6312684|NCT00003305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6312685|NCT00003305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6312686|NCT00003305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312687|NCT00003307|Amifostine|amifostine|mesh-list
6312688|NCT00003307|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6312689|NCT00003307|Protective Agents|protective agents|mesh-ancestor
6312690|NCT00003307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6312691|NCT00003309|Cyclophosphamide|cyclophosphamide|mesh-list
6312692|NCT00003309|Etoposide|etoposide|mesh-list
6312693|NCT00003309|Vincristine|vincristine|mesh-list
6312694|NCT00003309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6312695|NCT00003309|Immunologic Factors|immunologic factors|mesh-ancestor
6312696|NCT00003309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6312697|NCT00003309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6312698|NCT00003309|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6312699|NCT00003309|Alkylating Agents|alkylating agents|mesh-ancestor
6312700|NCT00003309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312701|NCT00003309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312702|NCT00003309|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6312703|NCT00003309|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6312704|NCT00003309|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6312705|NCT00003309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6312706|NCT00003309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6312707|NCT00003309|Tubulin Modulators|tubulin modulators|mesh-ancestor
6312708|NCT00003309|Antimitotic Agents|antimitotic agents|mesh-ancestor
6312709|NCT00003309|Mitosis Modulators|mitosis modulators|mesh-ancestor
6312710|NCT00003311|Cytarabine|cytarabine|mesh-list
6312711|NCT00003311|Dexamethasone|dexamethasone|mesh-list
6312712|NCT00003311|Cyclophosphamide|cyclophosphamide|mesh-list
6312713|NCT00003311|Doxorubicin|doxorubicin|mesh-list
6312714|NCT00003311|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6312715|NCT00003311|Methotrexate|methotrexate|mesh-list
6312716|NCT00003311|Vincristine|vincristine|mesh-list
6312717|NCT00003311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6312718|NCT00003311|Immunologic Factors|immunologic factors|mesh-ancestor
6312719|NCT00003311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6312720|NCT00003311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6312721|NCT00003311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6312722|NCT00003311|Alkylating Agents|alkylating agents|mesh-ancestor
6312723|NCT00003311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312724|NCT00003311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312725|NCT00003311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6312726|NCT00003311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6312727|NCT00003311|Antiemetics|antiemetics|mesh-ancestor
6312728|NCT00003311|Autonomic Agents|autonomic agents|mesh-ancestor
6312729|NCT00003311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6312730|NCT00003311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6312731|NCT00003311|Glucocorticoids|glucocorticoids|mesh-ancestor
6312732|NCT00003311|Hormones|hormones|mesh-ancestor
6312733|NCT00003311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6312734|NCT00003311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6312735|NCT00003311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6312736|NCT00003311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6312737|NCT00003311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6312738|NCT00003311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6312739|NCT00003311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6312740|NCT00003311|Abortifacient Agents|abortifacient agents|mesh-ancestor
6312741|NCT00003311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6312742|NCT00003311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6312743|NCT00003311|Antimetabolites|antimetabolites|mesh-ancestor
6312744|NCT00003311|Dermatologic Agents|dermatologic agents|mesh-ancestor
6312745|NCT00003311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6312746|NCT00003311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6016102|NCT00362297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6018488|NCT00381095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018489|NCT00381095|Anticonvulsants|anticonvulsants|mesh-ancestor
6018490|NCT00381095|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6018491|NCT00381095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6018492|NCT00381095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312747|NCT00003311|Antiviral Agents|antiviral agents|mesh-ancestor
6312748|NCT00003311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6312749|NCT00003311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6312750|NCT00003311|Tubulin Modulators|tubulin modulators|mesh-ancestor
6312751|NCT00003311|Antimitotic Agents|antimitotic agents|mesh-ancestor
6312752|NCT00003311|Mitosis Modulators|mitosis modulators|mesh-ancestor
6312753|NCT00003313|Paclitaxel|paclitaxel|mesh-list
6312754|NCT00003313|Carboplatin|carboplatin|mesh-list
6312755|NCT00003313|Amifostine|amifostine|mesh-list
6312756|NCT00003313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6312757|NCT00003313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312758|NCT00003313|Tubulin Modulators|tubulin modulators|mesh-ancestor
6312759|NCT00003313|Antimitotic Agents|antimitotic agents|mesh-ancestor
6312760|NCT00003313|Mitosis Modulators|mitosis modulators|mesh-ancestor
6018493|NCT00381095|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6312761|NCT00003313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312762|NCT00003313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6312763|NCT00003313|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6312764|NCT00003313|Protective Agents|protective agents|mesh-ancestor
6312765|NCT00003315|Amphotericin B|amphotericin b|mesh-list
6312766|NCT00003315|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6312767|NCT00003315|Sargramostim|sargramostim|mesh-list
6312768|NCT00003315|Immunologic Factors|immunologic factors|mesh-ancestor
6312769|NCT00003315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6312770|NCT00003315|Amebicides|amebicides|mesh-ancestor
6312771|NCT00003315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6312772|NCT00003315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6312773|NCT00003315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6312774|NCT00003315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6312775|NCT00003315|Antifungal Agents|antifungal agents|mesh-ancestor
6312776|NCT00003316|Gemcitabine|gemcitabine|mesh-list
6312777|NCT00003316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6312778|NCT00003316|Antimetabolites|antimetabolites|mesh-ancestor
6312779|NCT00003316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312780|NCT00003316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312781|NCT00003316|Antiviral Agents|antiviral agents|mesh-ancestor
6312782|NCT00003316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6312783|NCT00003316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6312784|NCT00003316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6312785|NCT00003316|Immunologic Factors|immunologic factors|mesh-ancestor
6312786|NCT00003316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6312787|NCT00003317|Paclitaxel|paclitaxel|mesh-list
6312788|NCT00003317|Carboplatin|carboplatin|mesh-list
6312789|NCT00003317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6312790|NCT00003317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312791|NCT00003317|Tubulin Modulators|tubulin modulators|mesh-ancestor
6312792|NCT00003317|Antimitotic Agents|antimitotic agents|mesh-ancestor
6312793|NCT00003317|Mitosis Modulators|mitosis modulators|mesh-ancestor
6312794|NCT00003317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312795|NCT00003322|Paclitaxel|paclitaxel|mesh-list
6312796|NCT00003322|Cisplatin|cisplatin|mesh-list
6312797|NCT00003322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6312798|NCT00003322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312799|NCT00003322|Tubulin Modulators|tubulin modulators|mesh-ancestor
6312800|NCT00003322|Antimitotic Agents|antimitotic agents|mesh-ancestor
6312801|NCT00003322|Mitosis Modulators|mitosis modulators|mesh-ancestor
6312802|NCT00003322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312803|NCT00003323|Flutamide|flutamide|mesh-list
6312804|NCT00003323|Finasteride|finasteride|mesh-list
6312805|NCT00003323|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6312806|NCT00003323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6312807|NCT00003323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6312808|NCT00003323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312809|NCT00003323|Hormone Antagonists|hormone antagonists|mesh-ancestor
6312810|NCT00003323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6312811|NCT00003323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6312812|NCT00003323|Urological Agents|urological agents|mesh-ancestor
6312813|NCT00003323|Androgen Antagonists|androgen antagonists|mesh-ancestor
6312814|NCT00003323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6312815|NCT00003323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312816|NCT00003326|Paclitaxel|paclitaxel|mesh-list
6312817|NCT00003326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6312818|NCT00003326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312819|NCT00003326|Tubulin Modulators|tubulin modulators|mesh-ancestor
6312820|NCT00003326|Antimitotic Agents|antimitotic agents|mesh-ancestor
6312821|NCT00003326|Mitosis Modulators|mitosis modulators|mesh-ancestor
6312822|NCT00003326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312823|NCT00003327|Paclitaxel|paclitaxel|mesh-list
6312824|NCT00003327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6312825|NCT00003327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312826|NCT00003327|Tubulin Modulators|tubulin modulators|mesh-ancestor
6312827|NCT00003327|Antimitotic Agents|antimitotic agents|mesh-ancestor
6312828|NCT00003327|Mitosis Modulators|mitosis modulators|mesh-ancestor
6312829|NCT00003327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392522|NCT00196664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6392523|NCT00196664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392524|NCT00196664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6392525|NCT00196664|Serotonin Agents|serotonin agents|mesh-ancestor
6392526|NCT00196664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392527|NCT00196664|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6392528|NCT00196664|Antidepressive Agents|antidepressive agents|mesh-ancestor
6392529|NCT00196664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6392530|NCT00196664|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6392531|NCT00196664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6392532|NCT00196664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6392533|NCT00196677|Vitamins|vitamins|mesh-list
6392534|NCT00196677|Micronutrients|micronutrients|mesh-ancestor
6392535|NCT00196677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392536|NCT00196690|Donepezil|donepezil|mesh-list
6392537|NCT00196690|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6392538|NCT00196690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6392539|NCT00196690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392540|NCT00196690|Cholinergic Agents|cholinergic agents|mesh-ancestor
6392541|NCT00196690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6392542|NCT00196690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392543|NCT00196690|Nootropic Agents|nootropic agents|mesh-ancestor
6392544|NCT00196703|Memantine|memantine|mesh-list
6392545|NCT00196703|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6392546|NCT00196703|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6392547|NCT00196703|Dopamine Agents|dopamine agents|mesh-ancestor
6392548|NCT00196703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6392549|NCT00196703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392550|NCT00196703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016103|NCT00362414|Mitogens|mitogens|mesh-list
6016104|NCT00362414|Mitosis Modulators|mitosis modulators|mesh-ancestor
6016105|NCT00362414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016106|NCT00362440|Metformin|metformin|mesh-list
6016107|NCT00362440|Pioglitazone|pioglitazone|mesh-list
6016108|NCT00362440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6016109|NCT00362440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016110|NCT00362466|Imatinib Mesylate|imatinib mesylate|mesh-list
6392551|NCT00196703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6392552|NCT00196703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6016111|NCT00362466|Dasatinib|dasatinib|mesh-list
6016112|NCT00362466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6016113|NCT00362466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6016114|NCT00362466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6016115|NCT00362466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016116|NCT00362609|Pantoprazole|pantoprazole|mesh-list
6312830|NCT00003328|Porfiromycin|porfiromycin|mesh-list
6312831|NCT00003328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6312832|NCT00003328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312833|NCT00003330|Interleukin-12|interleukin-12|mesh-list
6312834|NCT00003330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6312835|NCT00003330|Immunologic Factors|immunologic factors|mesh-ancestor
6312836|NCT00003330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6312837|NCT00003330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6312838|NCT00003330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6312839|NCT00003330|Growth Substances|growth substances|mesh-ancestor
6312840|NCT00003330|Growth Inhibitors|growth inhibitors|mesh-ancestor
6312841|NCT00003330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312842|NCT00003331|Leucovorin|leucovorin|mesh-list
6312843|NCT00003331|Fluorouracil|fluorouracil|mesh-list
6312844|NCT00003331|Topotecan|topotecan|mesh-list
6312845|NCT00003331|Calcium|calcium|mesh-list
6312846|NCT00003331|Levoleucovorin|levoleucovorin|mesh-list
6312847|NCT00003331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6312848|NCT00003331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6312849|NCT00003331|Antimetabolites|antimetabolites|mesh-ancestor
6312850|NCT00003331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312851|NCT00003331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6312852|NCT00003331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312853|NCT00003331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6312854|NCT00003331|Immunologic Factors|immunologic factors|mesh-ancestor
6312855|NCT00003331|Antidotes|antidotes|mesh-ancestor
6312856|NCT00003331|Protective Agents|protective agents|mesh-ancestor
6312857|NCT00003331|Vitamin B Complex|vitamin b complex|mesh-ancestor
6312858|NCT00003331|Vitamins|vitamins|mesh-ancestor
6312859|NCT00003331|Micronutrients|micronutrients|mesh-ancestor
6312860|NCT00003331|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6312861|NCT00003331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6312862|NCT00003331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6312863|NCT00003332|Gemcitabine|gemcitabine|mesh-list
6312864|NCT00003332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312865|NCT00003332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6312866|NCT00003332|Antimetabolites|antimetabolites|mesh-ancestor
6312867|NCT00003332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312868|NCT00003332|Antiviral Agents|antiviral agents|mesh-ancestor
6312869|NCT00003332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6312870|NCT00003332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6312871|NCT00003332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6312872|NCT00003332|Immunologic Factors|immunologic factors|mesh-ancestor
6312873|NCT00003332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6312874|NCT00003334|Paclitaxel|paclitaxel|mesh-list
6312875|NCT00003334|Doxorubicin|doxorubicin|mesh-list
6312876|NCT00003334|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6312877|NCT00003334|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6312878|NCT00003334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312879|NCT00003334|Tubulin Modulators|tubulin modulators|mesh-ancestor
6312880|NCT00003334|Antimitotic Agents|antimitotic agents|mesh-ancestor
6312881|NCT00003334|Mitosis Modulators|mitosis modulators|mesh-ancestor
6312882|NCT00003334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312883|NCT00003334|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6312884|NCT00003334|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6312885|NCT00003334|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6312886|NCT00003334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6312887|NCT00003335|Cyclosporine|cyclosporine|mesh-list
6312888|NCT00003335|Methylprednisolone|methylprednisolone|mesh-list
6312889|NCT00003335|Melphalan|melphalan|mesh-list
6312890|NCT00003335|Busulfan|busulfan|mesh-list
6312891|NCT00003335|Cyclosporins|cyclosporins|mesh-list
6312892|NCT00003335|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6312893|NCT00003335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6312894|NCT00003335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312895|NCT00003335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6312896|NCT00003335|Immunologic Factors|immunologic factors|mesh-ancestor
6312897|NCT00003335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6312898|NCT00003335|Antifungal Agents|antifungal agents|mesh-ancestor
6312899|NCT00003335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6312900|NCT00003335|Dermatologic Agents|dermatologic agents|mesh-ancestor
6312901|NCT00003335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6312902|NCT00003335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6312903|NCT00003335|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6312904|NCT00003335|Alkylating Agents|alkylating agents|mesh-ancestor
6312905|NCT00003335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312906|NCT00003335|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6312907|NCT00003335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6312908|NCT00003335|Antiemetics|antiemetics|mesh-ancestor
6312909|NCT00003335|Autonomic Agents|autonomic agents|mesh-ancestor
6312910|NCT00003335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6312911|NCT00003335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6312912|NCT00003335|Glucocorticoids|glucocorticoids|mesh-ancestor
6312913|NCT00003335|Hormones|hormones|mesh-ancestor
6312914|NCT00003335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6312915|NCT00003335|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6312916|NCT00003335|Protective Agents|protective agents|mesh-ancestor
6312917|NCT00003336|Methylprednisolone|methylprednisolone|mesh-list
6312918|NCT00003336|Cyclophosphamide|cyclophosphamide|mesh-list
6312919|NCT00003336|Melphalan|melphalan|mesh-list
6312920|NCT00003336|Busulfan|busulfan|mesh-list
6312921|NCT00003336|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6312922|NCT00003336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6312923|NCT00003336|Immunologic Factors|immunologic factors|mesh-ancestor
6312924|NCT00003336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016117|NCT00362609|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6016118|NCT00362609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6312925|NCT00003336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6312926|NCT00003336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6312927|NCT00003336|Alkylating Agents|alkylating agents|mesh-ancestor
6312928|NCT00003336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312929|NCT00003336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312930|NCT00003336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6312931|NCT00003336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6312932|NCT00003336|Antiemetics|antiemetics|mesh-ancestor
6312933|NCT00003336|Autonomic Agents|autonomic agents|mesh-ancestor
6312934|NCT00003336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6312935|NCT00003336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6312936|NCT00003336|Glucocorticoids|glucocorticoids|mesh-ancestor
6312937|NCT00003336|Hormones|hormones|mesh-ancestor
6312938|NCT00003336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6312939|NCT00003336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6312940|NCT00003336|Protective Agents|protective agents|mesh-ancestor
6312941|NCT00003337|Epratuzumab|epratuzumab|mesh-list
6312942|NCT00003337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6312943|NCT00003337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312944|NCT00003338|Epratuzumab|epratuzumab|mesh-list
6312945|NCT00003338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6312946|NCT00003338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312947|NCT00003339|Interleukin-12|interleukin-12|mesh-list
6312948|NCT00003339|Freund's Adjuvant|freund's adjuvant|mesh-list
6312949|NCT00003339|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6312950|NCT00003339|Immunologic Factors|immunologic factors|mesh-ancestor
6312951|NCT00003339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6312952|NCT00003339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6312953|NCT00003339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6312954|NCT00003339|Growth Substances|growth substances|mesh-ancestor
6312955|NCT00003339|Growth Inhibitors|growth inhibitors|mesh-ancestor
6312956|NCT00003339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312957|NCT00003340|Cyclophosphamide|cyclophosphamide|mesh-list
6312958|NCT00003340|Topotecan|topotecan|mesh-list
6312959|NCT00003340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6312960|NCT00003340|Immunologic Factors|immunologic factors|mesh-ancestor
6312961|NCT00003340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6312962|NCT00003340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6312963|NCT00003340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6312964|NCT00003340|Alkylating Agents|alkylating agents|mesh-ancestor
6312965|NCT00003340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312966|NCT00003340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312967|NCT00003340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6312968|NCT00003340|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6016119|NCT00362609|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6016120|NCT00362609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6016121|NCT00362609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016122|NCT00362817|Carboplatin|carboplatin|mesh-list
6016123|NCT00362817|Temozolomide|temozolomide|mesh-list
6016124|NCT00362817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312969|NCT00003340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6312970|NCT00003340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6312971|NCT00003341|Epoetin Alfa|epoetin alfa|mesh-list
6312972|NCT00003341|Hematinics|hematinics|mesh-ancestor
6312973|NCT00003342|Gemcitabine|gemcitabine|mesh-list
6312974|NCT00003342|Paclitaxel|paclitaxel|mesh-list
6312975|NCT00003342|Carboplatin|carboplatin|mesh-list
6312976|NCT00003342|Doxorubicin|doxorubicin|mesh-list
6312977|NCT00003342|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6312978|NCT00003342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6312979|NCT00003342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6312980|NCT00003342|Tubulin Modulators|tubulin modulators|mesh-ancestor
6312981|NCT00003342|Antimitotic Agents|antimitotic agents|mesh-ancestor
6312982|NCT00003342|Mitosis Modulators|mitosis modulators|mesh-ancestor
6312983|NCT00003342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6312984|NCT00003342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6312985|NCT00003342|Antimetabolites|antimetabolites|mesh-ancestor
6016125|NCT00362817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6016126|NCT00362817|Alkylating Agents|alkylating agents|mesh-ancestor
6018494|NCT00381095|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6312986|NCT00003342|Antiviral Agents|antiviral agents|mesh-ancestor
6312987|NCT00003342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6312988|NCT00003342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6312989|NCT00003342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6312990|NCT00003342|Immunologic Factors|immunologic factors|mesh-ancestor
6312991|NCT00003342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6312992|NCT00003342|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6312993|NCT00003342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6312994|NCT00003342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6312995|NCT00003343|Prednisone|prednisone|mesh-list
6312996|NCT00003343|Mitoxantrone|mitoxantrone|mesh-list
6312997|NCT00003343|Prinomastat|prinomastat|mesh-list
6312998|NCT00003343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6312999|NCT00003343|Glucocorticoids|glucocorticoids|mesh-ancestor
6313000|NCT00003343|Hormones|hormones|mesh-ancestor
6313001|NCT00003343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6313002|NCT00003343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724511|NCT03186755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6313003|NCT00003343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6313004|NCT00003343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313005|NCT00003343|Analgesics|analgesics|mesh-ancestor
6313006|NCT00003343|Sensory System Agents|sensory system agents|mesh-ancestor
6313007|NCT00003343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6313008|NCT00003343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6313009|NCT00003343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6313010|NCT00003343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6313011|NCT00003343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313012|NCT00003343|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
6313013|NCT00003343|Protease Inhibitors|protease inhibitors|mesh-ancestor
6313014|NCT00003344|Irinotecan|irinotecan|mesh-list
6313015|NCT00003344|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6313016|NCT00003344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6313017|NCT00003344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6313018|NCT00003344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313019|NCT00003344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313020|NCT00003345|Irinotecan|irinotecan|mesh-list
6313021|NCT00003345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313022|NCT00003345|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6313023|NCT00003345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6313024|NCT00003345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6313025|NCT00003345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313026|NCT00003346|Acetaminophen|acetaminophen|mesh-list
6313027|NCT00003346|Acetylcysteine|acetylcysteine|mesh-list
6313028|NCT00003346|Carmustine|carmustine|mesh-list
6313029|NCT00003346|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6313030|NCT00003346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6313031|NCT00003346|Analgesics|analgesics|mesh-ancestor
6313032|NCT00003346|Sensory System Agents|sensory system agents|mesh-ancestor
6313033|NCT00003346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6313034|NCT00003346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6313035|NCT00003346|Antipyretics|antipyretics|mesh-ancestor
6313036|NCT00003346|Antiviral Agents|antiviral agents|mesh-ancestor
6313037|NCT00003346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6313038|NCT00003346|Expectorants|expectorants|mesh-ancestor
6313039|NCT00003346|Respiratory System Agents|respiratory system agents|mesh-ancestor
6313040|NCT00003346|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6313041|NCT00003346|Antioxidants|antioxidants|mesh-ancestor
6313042|NCT00003346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313043|NCT00003346|Protective Agents|protective agents|mesh-ancestor
6313044|NCT00003346|Antidotes|antidotes|mesh-ancestor
6313045|NCT00003346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6313046|NCT00003346|Alkylating Agents|alkylating agents|mesh-ancestor
6313047|NCT00003346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313048|NCT00003348|Carmustine|carmustine|mesh-list
5724679|NCT03185611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6313049|NCT00003348|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
6313050|NCT00003348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6313051|NCT00003348|Alkylating Agents|alkylating agents|mesh-ancestor
6313052|NCT00003348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313053|NCT00003348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313054|NCT00003348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6313055|NCT00003350|Paclitaxel|paclitaxel|mesh-list
6313056|NCT00003350|Doxorubicin|doxorubicin|mesh-list
6313057|NCT00003350|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6313058|NCT00003350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6313059|NCT00003350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313060|NCT00003350|Tubulin Modulators|tubulin modulators|mesh-ancestor
6313061|NCT00003350|Antimitotic Agents|antimitotic agents|mesh-ancestor
6313062|NCT00003350|Mitosis Modulators|mitosis modulators|mesh-ancestor
6313063|NCT00003350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313064|NCT00003350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6313065|NCT00003350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6313066|NCT00003350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6313067|NCT00003350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6313068|NCT00003351|Irinotecan|irinotecan|mesh-list
6313069|NCT00003351|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6313070|NCT00003351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6313071|NCT00003351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6313072|NCT00003351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313073|NCT00003351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313074|NCT00003352|Cyclophosphamide|cyclophosphamide|mesh-list
6313075|NCT00003352|Docetaxel|docetaxel|mesh-list
6313076|NCT00003352|Doxorubicin|doxorubicin|mesh-list
6313077|NCT00003352|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6313078|NCT00003352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6313079|NCT00003352|Immunologic Factors|immunologic factors|mesh-ancestor
6313080|NCT00003352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6313081|NCT00003352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6313082|NCT00003352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6313083|NCT00003352|Alkylating Agents|alkylating agents|mesh-ancestor
6313084|NCT00003352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313085|NCT00003352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313086|NCT00003352|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6313087|NCT00003352|Tubulin Modulators|tubulin modulators|mesh-ancestor
6313088|NCT00003352|Antimitotic Agents|antimitotic agents|mesh-ancestor
6313089|NCT00003352|Mitosis Modulators|mitosis modulators|mesh-ancestor
6313090|NCT00003352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6313091|NCT00003352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6313092|NCT00003352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6313093|NCT00003352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6313094|NCT00003353|Melphalan|melphalan|mesh-list
6313095|NCT00003353|Immunologic Factors|immunologic factors|mesh-ancestor
6313096|NCT00003353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6313097|NCT00003353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6313098|NCT00003353|Alkylating Agents|alkylating agents|mesh-ancestor
6313099|NCT00003353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313100|NCT00003353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313101|NCT00003353|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6313102|NCT00003353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6313103|NCT00003356|Aldesleukin|aldesleukin|mesh-list
6313104|NCT00003356|Rituximab|rituximab|mesh-list
6313105|NCT00003356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6313106|NCT00003356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313107|NCT00003356|Immunologic Factors|immunologic factors|mesh-ancestor
6313108|NCT00003356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6313109|NCT00003356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6016127|NCT00362817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016128|NCT00362882|Docetaxel|docetaxel|mesh-list
6016129|NCT00362882|Bortezomib|bortezomib|mesh-list
6016130|NCT00362882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6016131|NCT00362882|Tubulin Modulators|tubulin modulators|mesh-ancestor
6016132|NCT00362882|Antimitotic Agents|antimitotic agents|mesh-ancestor
6016133|NCT00362882|Mitosis Modulators|mitosis modulators|mesh-ancestor
6016134|NCT00362882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016135|NCT00363051|Everolimus|everolimus|mesh-list
6016136|NCT00363051|Octreotide|octreotide|mesh-list
6016137|NCT00363051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6016138|NCT00363051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6016139|NCT00363051|Immunologic Factors|immunologic factors|mesh-ancestor
6016140|NCT00363051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016141|NCT00363051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6016142|NCT00363051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6016143|NCT00363077|Vaccines|vaccines|mesh-list
5724512|NCT03186755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5724513|NCT03186755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5724514|NCT03186755|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5724515|NCT03186755|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5724516|NCT03186755|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5724517|NCT03186755|Histamine Antagonists|histamine antagonists|mesh-ancestor
5724518|NCT03186755|Histamine Agents|histamine agents|mesh-ancestor
5724519|NCT03186755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5724520|NCT03186755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724521|NCT03186742|Eplerenone|eplerenone|mesh-list
5724522|NCT03186742|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5724523|NCT03186742|Hormone Antagonists|hormone antagonists|mesh-ancestor
5724524|NCT03186742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6313110|NCT00003356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6313111|NCT00003356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6313112|NCT00003356|Antiviral Agents|antiviral agents|mesh-ancestor
6313113|NCT00003356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6313114|NCT00003358|Gemcitabine|gemcitabine|mesh-list
6313115|NCT00003358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313116|NCT00003358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6313117|NCT00003358|Antimetabolites|antimetabolites|mesh-ancestor
6313118|NCT00003358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313119|NCT00003358|Antiviral Agents|antiviral agents|mesh-ancestor
6016144|NCT00363077|Immunologic Factors|immunologic factors|mesh-ancestor
6018495|NCT00381095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6313120|NCT00003358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6313121|NCT00003358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6313122|NCT00003358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6313123|NCT00003358|Immunologic Factors|immunologic factors|mesh-ancestor
6313124|NCT00003358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6313125|NCT00003360|Antibodies|antibodies|mesh-list
6313126|NCT00003360|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6313127|NCT00003360|Immunologic Factors|immunologic factors|mesh-ancestor
6313128|NCT00003360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6313129|NCT00003361|Decitabine|decitabine|mesh-list
6313130|NCT00003361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6313131|NCT00003361|Antimetabolites|antimetabolites|mesh-ancestor
6313132|NCT00003361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313133|NCT00003361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313134|NCT00003361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6313135|NCT00003362|Sargramostim|sargramostim|mesh-list
6313136|NCT00003362|Freund's Adjuvant|freund's adjuvant|mesh-list
6313137|NCT00003362|Immunologic Factors|immunologic factors|mesh-ancestor
6313138|NCT00003362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6313139|NCT00003362|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6313140|NCT00003364|Cyclophosphamide|cyclophosphamide|mesh-list
6313141|NCT00003364|Doxorubicin|doxorubicin|mesh-list
6313142|NCT00003364|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6313143|NCT00003364|Etoposide|etoposide|mesh-list
6313144|NCT00003364|Vincristine|vincristine|mesh-list
6313145|NCT00003364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6313146|NCT00003364|Immunologic Factors|immunologic factors|mesh-ancestor
6313147|NCT00003364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6313148|NCT00003364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6313149|NCT00003364|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6313150|NCT00003364|Alkylating Agents|alkylating agents|mesh-ancestor
6313151|NCT00003364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313152|NCT00003364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313153|NCT00003364|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6313154|NCT00003364|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6313155|NCT00003364|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6313156|NCT00003364|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6313157|NCT00003364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6313158|NCT00003364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6313159|NCT00003364|Tubulin Modulators|tubulin modulators|mesh-ancestor
6313160|NCT00003364|Antimitotic Agents|antimitotic agents|mesh-ancestor
6313161|NCT00003364|Mitosis Modulators|mitosis modulators|mesh-ancestor
6313162|NCT00003365|Curcumin|curcumin|mesh-list
6313163|NCT00003365|Sulindac|sulindac|mesh-list
6313164|NCT00003365|Quercetin|quercetin|mesh-list
6313165|NCT00003365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6313166|NCT00003365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6313167|NCT00003365|Analgesics|analgesics|mesh-ancestor
6313168|NCT00003365|Sensory System Agents|sensory system agents|mesh-ancestor
6313169|NCT00003365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6313170|NCT00003365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6313171|NCT00003365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6313172|NCT00003365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6313173|NCT00003365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313174|NCT00003365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6313175|NCT00003365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313176|NCT00003365|Antioxidants|antioxidants|mesh-ancestor
6313177|NCT00003365|Protective Agents|protective agents|mesh-ancestor
6313178|NCT00003365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6313179|NCT00003367|Vitamin E|vitamin e|mesh-list
6313180|NCT00003367|Vitamins|vitamins|mesh-ancestor
6313181|NCT00003367|Micronutrients|micronutrients|mesh-ancestor
6313182|NCT00003367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6313183|NCT00003367|Antioxidants|antioxidants|mesh-ancestor
6313184|NCT00003367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313185|NCT00003367|Protective Agents|protective agents|mesh-ancestor
6313186|NCT00003368|Irinotecan|irinotecan|mesh-list
6313187|NCT00003368|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6313188|NCT00003368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6313189|NCT00003368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6313190|NCT00003368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313191|NCT00003368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313192|NCT00003369|Tirapazamine|tirapazamine|mesh-list
6313193|NCT00003369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313194|NCT00003370|Irofulven|irofulven|mesh-list
6313195|NCT00003370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6313196|NCT00003370|Alkylating Agents|alkylating agents|mesh-ancestor
6313197|NCT00003370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313198|NCT00003370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313199|NCT00003372|Topotecan|topotecan|mesh-list
6313200|NCT00003372|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6313201|NCT00003372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6313202|NCT00003372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6313203|NCT00003372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313204|NCT00003372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313205|NCT00003375|Vincristine|vincristine|mesh-list
6313206|NCT00003375|Lomustine|lomustine|mesh-list
6313207|NCT00003375|Procarbazine|procarbazine|mesh-list
6313208|NCT00003375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6313209|NCT00003375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313210|NCT00003375|Tubulin Modulators|tubulin modulators|mesh-ancestor
6313211|NCT00003375|Antimitotic Agents|antimitotic agents|mesh-ancestor
6313212|NCT00003375|Mitosis Modulators|mitosis modulators|mesh-ancestor
6313213|NCT00003375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313214|NCT00003375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6313215|NCT00003375|Alkylating Agents|alkylating agents|mesh-ancestor
6313216|NCT00003376|Paclitaxel|paclitaxel|mesh-list
6313217|NCT00003376|Vinblastine|vinblastine|mesh-list
6313218|NCT00003376|Carboplatin|carboplatin|mesh-list
6313219|NCT00003376|Doxorubicin|doxorubicin|mesh-list
6313220|NCT00003376|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6313221|NCT00003376|Methotrexate|methotrexate|mesh-list
6313222|NCT00003376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6313223|NCT00003376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313224|NCT00003376|Tubulin Modulators|tubulin modulators|mesh-ancestor
6313225|NCT00003376|Antimitotic Agents|antimitotic agents|mesh-ancestor
6313226|NCT00003376|Mitosis Modulators|mitosis modulators|mesh-ancestor
6313227|NCT00003376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313228|NCT00003376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6313229|NCT00003376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6313230|NCT00003376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6313231|NCT00003376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6313232|NCT00003376|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6313233|NCT00003376|Abortifacient Agents|abortifacient agents|mesh-ancestor
6313234|NCT00003376|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6313235|NCT00003376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6313236|NCT00003376|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6313237|NCT00003376|Antimetabolites|antimetabolites|mesh-ancestor
6313238|NCT00003376|Dermatologic Agents|dermatologic agents|mesh-ancestor
6313239|NCT00003376|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6313240|NCT00003376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6313241|NCT00003376|Immunologic Factors|immunologic factors|mesh-ancestor
6313242|NCT00003376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6313243|NCT00003376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6313244|NCT00003378|Gemcitabine|gemcitabine|mesh-list
6313245|NCT00003378|Paclitaxel|paclitaxel|mesh-list
6313246|NCT00003378|Carboplatin|carboplatin|mesh-list
6313247|NCT00003378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6313248|NCT00003378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313249|NCT00003378|Tubulin Modulators|tubulin modulators|mesh-ancestor
6313250|NCT00003378|Antimitotic Agents|antimitotic agents|mesh-ancestor
6313251|NCT00003378|Mitosis Modulators|mitosis modulators|mesh-ancestor
6313252|NCT00003378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313253|NCT00003378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6313254|NCT00003378|Antimetabolites|antimetabolites|mesh-ancestor
6313255|NCT00003378|Antiviral Agents|antiviral agents|mesh-ancestor
6313256|NCT00003378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6313257|NCT00003378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6313258|NCT00003378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6313259|NCT00003378|Immunologic Factors|immunologic factors|mesh-ancestor
6313260|NCT00003378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6313261|NCT00003379|Paclitaxel|paclitaxel|mesh-list
6313262|NCT00003379|Cisplatin|cisplatin|mesh-list
6313263|NCT00003379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6313264|NCT00003379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313265|NCT00003379|Tubulin Modulators|tubulin modulators|mesh-ancestor
6313266|NCT00003379|Antimitotic Agents|antimitotic agents|mesh-ancestor
6313267|NCT00003379|Mitosis Modulators|mitosis modulators|mesh-ancestor
6313268|NCT00003379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313269|NCT00003380|Doxorubicin|doxorubicin|mesh-list
6313270|NCT00003380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6313271|NCT00003380|Etoposide|etoposide|mesh-list
6313272|NCT00003380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6313273|NCT00003380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313274|NCT00003380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6313275|NCT00003380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6313276|NCT00003380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6313277|NCT00003380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313278|NCT00003380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6313279|NCT00003382|Gemcitabine|gemcitabine|mesh-list
6313280|NCT00003382|Topotecan|topotecan|mesh-list
6313281|NCT00003382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6313282|NCT00003382|Antimetabolites|antimetabolites|mesh-ancestor
6313283|NCT00003382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313284|NCT00003382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313285|NCT00003382|Antiviral Agents|antiviral agents|mesh-ancestor
6313286|NCT00003382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6313287|NCT00003382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6313288|NCT00003382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6313289|NCT00003382|Immunologic Factors|immunologic factors|mesh-ancestor
6313290|NCT00003382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6313291|NCT00003382|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6313292|NCT00003382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6313293|NCT00003385|Paclitaxel|paclitaxel|mesh-list
6313294|NCT00003385|Carboplatin|carboplatin|mesh-list
6313295|NCT00003385|Doxorubicin|doxorubicin|mesh-list
6016145|NCT00363077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016146|NCT00363129|Vitamin E|vitamin e|mesh-list
6313296|NCT00003385|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6313297|NCT00003385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6313298|NCT00003385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313299|NCT00003385|Tubulin Modulators|tubulin modulators|mesh-ancestor
6313300|NCT00003385|Antimitotic Agents|antimitotic agents|mesh-ancestor
6313301|NCT00003385|Mitosis Modulators|mitosis modulators|mesh-ancestor
6313302|NCT00003385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313303|NCT00003385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6313304|NCT00003385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6313305|NCT00003385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6313306|NCT00003385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6313307|NCT00003386|Paclitaxel|paclitaxel|mesh-list
6313308|NCT00003386|Cyclophosphamide|cyclophosphamide|mesh-list
6313309|NCT00003386|Carboplatin|carboplatin|mesh-list
6313310|NCT00003386|Vaccines|vaccines|mesh-list
6313311|NCT00003386|BCG Vaccine|bcg vaccine|mesh-list
6313312|NCT00003386|Immunologic Factors|immunologic factors|mesh-ancestor
6313313|NCT00003386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6313314|NCT00003386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6313315|NCT00003386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5724525|NCT03186742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724526|NCT03186742|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5724527|NCT03186742|Diuretics|diuretics|mesh-ancestor
5724528|NCT03186742|Natriuretic Agents|natriuretic agents|mesh-ancestor
5724529|NCT03186742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6313316|NCT00003386|Tubulin Modulators|tubulin modulators|mesh-ancestor
6313317|NCT00003386|Antimitotic Agents|antimitotic agents|mesh-ancestor
6313318|NCT00003386|Mitosis Modulators|mitosis modulators|mesh-ancestor
6313319|NCT00003386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313320|NCT00003386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6313321|NCT00003386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6313322|NCT00003386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6313323|NCT00003386|Alkylating Agents|alkylating agents|mesh-ancestor
6313324|NCT00003386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6313325|NCT00003386|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6313326|NCT00003387|Paclitaxel|paclitaxel|mesh-list
6313327|NCT00003387|Carboplatin|carboplatin|mesh-list
6313328|NCT00003387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6313329|NCT00003387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313330|NCT00003387|Tubulin Modulators|tubulin modulators|mesh-ancestor
6313331|NCT00003387|Antimitotic Agents|antimitotic agents|mesh-ancestor
6313332|NCT00003387|Mitosis Modulators|mitosis modulators|mesh-ancestor
6313333|NCT00003387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313334|NCT00003388|Cytarabine|cytarabine|mesh-list
6313335|NCT00003388|Prednisone|prednisone|mesh-list
6313336|NCT00003388|Cyclophosphamide|cyclophosphamide|mesh-list
6313337|NCT00003388|Doxorubicin|doxorubicin|mesh-list
6313338|NCT00003388|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6313339|NCT00003388|Methotrexate|methotrexate|mesh-list
6313340|NCT00003388|Vincristine|vincristine|mesh-list
6313341|NCT00003388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6313342|NCT00003388|Immunologic Factors|immunologic factors|mesh-ancestor
6313343|NCT00003388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6313344|NCT00003388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6313345|NCT00003388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6313346|NCT00003388|Alkylating Agents|alkylating agents|mesh-ancestor
6313347|NCT00003388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313348|NCT00003388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313349|NCT00003388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6313350|NCT00003388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6313351|NCT00003388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6313352|NCT00003388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6313353|NCT00003388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6313354|NCT00003388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6313355|NCT00003388|Glucocorticoids|glucocorticoids|mesh-ancestor
6313356|NCT00003388|Hormones|hormones|mesh-ancestor
6313357|NCT00003388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6313358|NCT00003388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6313359|NCT00003388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6313360|NCT00003388|Abortifacient Agents|abortifacient agents|mesh-ancestor
6313361|NCT00003388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6313362|NCT00003388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6313363|NCT00003388|Antimetabolites|antimetabolites|mesh-ancestor
6313364|NCT00003388|Dermatologic Agents|dermatologic agents|mesh-ancestor
6313365|NCT00003388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6313366|NCT00003388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6313367|NCT00003388|Antiviral Agents|antiviral agents|mesh-ancestor
6313368|NCT00003388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6313369|NCT00003388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6313370|NCT00003388|Tubulin Modulators|tubulin modulators|mesh-ancestor
6313371|NCT00003388|Antimitotic Agents|antimitotic agents|mesh-ancestor
6313372|NCT00003388|Mitosis Modulators|mitosis modulators|mesh-ancestor
6313373|NCT00003390|Irofulven|irofulven|mesh-list
6313374|NCT00003390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6313375|NCT00003390|Alkylating Agents|alkylating agents|mesh-ancestor
6313376|NCT00003390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313377|NCT00003390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313378|NCT00003391|Antibodies|antibodies|mesh-list
6313379|NCT00003391|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6313380|NCT00003391|Immunologic Factors|immunologic factors|mesh-ancestor
6313381|NCT00003391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6313382|NCT00003392|Paclitaxel|paclitaxel|mesh-list
6313383|NCT00003392|Cyclophosphamide|cyclophosphamide|mesh-list
6313384|NCT00003392|Carboplatin|carboplatin|mesh-list
6016147|NCT00363129|Vitamins|vitamins|mesh-ancestor
6313385|NCT00003392|Melphalan|melphalan|mesh-list
6313386|NCT00003392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6313387|NCT00003392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313388|NCT00003392|Tubulin Modulators|tubulin modulators|mesh-ancestor
6016148|NCT00363129|Micronutrients|micronutrients|mesh-ancestor
6016149|NCT00363129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016150|NCT00363129|Antioxidants|antioxidants|mesh-ancestor
6313389|NCT00003392|Antimitotic Agents|antimitotic agents|mesh-ancestor
6313390|NCT00003392|Mitosis Modulators|mitosis modulators|mesh-ancestor
6313391|NCT00003392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313392|NCT00003392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6313393|NCT00003392|Immunologic Factors|immunologic factors|mesh-ancestor
6313394|NCT00003392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6313395|NCT00003392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6313396|NCT00003392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6313397|NCT00003392|Alkylating Agents|alkylating agents|mesh-ancestor
6313398|NCT00003392|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6313399|NCT00003394|Paclitaxel|paclitaxel|mesh-list
6313400|NCT00003394|Carboplatin|carboplatin|mesh-list
6313401|NCT00003394|Leuprolide|leuprolide|mesh-list
6313402|NCT00003394|Goserelin|goserelin|mesh-list
6313403|NCT00003394|Estramustine|estramustine|mesh-list
6313404|NCT00003394|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6313405|NCT00003394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313406|NCT00003394|Tubulin Modulators|tubulin modulators|mesh-ancestor
6313407|NCT00003394|Antimitotic Agents|antimitotic agents|mesh-ancestor
6313408|NCT00003394|Mitosis Modulators|mitosis modulators|mesh-ancestor
6313409|NCT00003394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313410|NCT00003394|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6313411|NCT00003394|Fertility Agents|fertility agents|mesh-ancestor
6313412|NCT00003394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6313413|NCT00003394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6313414|NCT00003394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6313415|NCT00003394|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6313416|NCT00003394|Alkylating Agents|alkylating agents|mesh-ancestor
6313417|NCT00003395|Arsenic Trioxide|arsenic trioxide|mesh-list
6313418|NCT00003395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313419|NCT00003396|Cyclophosphamide|cyclophosphamide|mesh-list
6313420|NCT00003396|Melphalan|melphalan|mesh-list
6313421|NCT00003396|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6313422|NCT00003396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6313423|NCT00003396|Immunologic Factors|immunologic factors|mesh-ancestor
6313424|NCT00003396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6313425|NCT00003396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6313426|NCT00003396|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6313427|NCT00003396|Alkylating Agents|alkylating agents|mesh-ancestor
6313428|NCT00003396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313429|NCT00003396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313430|NCT00003396|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6313431|NCT00003397|Gemcitabine|gemcitabine|mesh-list
6313432|NCT00003397|Dexamethasone|dexamethasone|mesh-list
6313433|NCT00003397|Paclitaxel|paclitaxel|mesh-list
6313434|NCT00003397|Etoposide|etoposide|mesh-list
6313435|NCT00003397|Cyclophosphamide|cyclophosphamide|mesh-list
6313436|NCT00003397|Rituximab|rituximab|mesh-list
6313437|NCT00003397|Melphalan|melphalan|mesh-list
6313438|NCT00003397|Carmustine|carmustine|mesh-list
6313439|NCT00003397|Sargramostim|sargramostim|mesh-list
6313440|NCT00003397|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6313441|NCT00003397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313442|NCT00003397|Tubulin Modulators|tubulin modulators|mesh-ancestor
6016151|NCT00363129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313443|NCT00003397|Antimitotic Agents|antimitotic agents|mesh-ancestor
6313444|NCT00003397|Mitosis Modulators|mitosis modulators|mesh-ancestor
6313445|NCT00003397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313446|NCT00003397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6313447|NCT00003397|Immunologic Factors|immunologic factors|mesh-ancestor
6313448|NCT00003397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6313449|NCT00003397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6313450|NCT00003397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6313451|NCT00003397|Alkylating Agents|alkylating agents|mesh-ancestor
6313452|NCT00003397|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6313453|NCT00003397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6313454|NCT00003397|Antiemetics|antiemetics|mesh-ancestor
6313455|NCT00003397|Autonomic Agents|autonomic agents|mesh-ancestor
6313456|NCT00003397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6313457|NCT00003397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6313458|NCT00003397|Glucocorticoids|glucocorticoids|mesh-ancestor
6313459|NCT00003397|Hormones|hormones|mesh-ancestor
6313460|NCT00003397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6313461|NCT00003397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6313462|NCT00003397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6313463|NCT00003397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6313464|NCT00003397|Antimetabolites|antimetabolites|mesh-ancestor
6313465|NCT00003397|Antiviral Agents|antiviral agents|mesh-ancestor
6313466|NCT00003397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6313467|NCT00003397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6313468|NCT00003397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6313469|NCT00003397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6313470|NCT00003398|Cyclophosphamide|cyclophosphamide|mesh-list
6313471|NCT00003398|Thiotepa|thiotepa|mesh-list
6313472|NCT00003398|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6313473|NCT00003398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6313474|NCT00003398|Immunologic Factors|immunologic factors|mesh-ancestor
6313475|NCT00003398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6313476|NCT00003398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6313477|NCT00003398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6313478|NCT00003398|Alkylating Agents|alkylating agents|mesh-ancestor
6313479|NCT00003398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313480|NCT00003398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313481|NCT00003398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6313482|NCT00003399|Dexamethasone|dexamethasone|mesh-list
6313483|NCT00003399|Paclitaxel|paclitaxel|mesh-list
6313484|NCT00003399|Etoposide|etoposide|mesh-list
6313485|NCT00003399|Cyclophosphamide|cyclophosphamide|mesh-list
6313486|NCT00003399|Melphalan|melphalan|mesh-list
6313487|NCT00003399|Carmustine|carmustine|mesh-list
6313488|NCT00003399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6313489|NCT00003399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313490|NCT00003399|Tubulin Modulators|tubulin modulators|mesh-ancestor
6313491|NCT00003399|Antimitotic Agents|antimitotic agents|mesh-ancestor
6313492|NCT00003399|Mitosis Modulators|mitosis modulators|mesh-ancestor
6313493|NCT00003399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313494|NCT00003399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6313495|NCT00003399|Immunologic Factors|immunologic factors|mesh-ancestor
6313496|NCT00003399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6313497|NCT00003399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6313498|NCT00003399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6313499|NCT00003399|Alkylating Agents|alkylating agents|mesh-ancestor
6313500|NCT00003399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6313501|NCT00003399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6313502|NCT00003399|Antiemetics|antiemetics|mesh-ancestor
6313503|NCT00003399|Autonomic Agents|autonomic agents|mesh-ancestor
6313504|NCT00003399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6313505|NCT00003399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6313506|NCT00003399|Glucocorticoids|glucocorticoids|mesh-ancestor
6313507|NCT00003399|Hormones|hormones|mesh-ancestor
6313508|NCT00003399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6313509|NCT00003399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6313510|NCT00003399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6313511|NCT00003399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6313512|NCT00003399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6313513|NCT00003400|Melphalan|melphalan|mesh-list
6313514|NCT00003400|Vinorelbine|vinorelbine|mesh-list
6313515|NCT00003400|Carmustine|carmustine|mesh-list
6016152|NCT00363129|Protective Agents|protective agents|mesh-ancestor
6016153|NCT00363142|Ritonavir|ritonavir|mesh-list
6016154|NCT00363142|Fosamprenavir|fosamprenavir|mesh-list
6016155|NCT00363142|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6016156|NCT00363142|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6016157|NCT00363142|Protease Inhibitors|protease inhibitors|mesh-ancestor
6016158|NCT00363142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6016159|NCT00363142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313516|NCT00003400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313517|NCT00003400|Immunologic Factors|immunologic factors|mesh-ancestor
6313518|NCT00003400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6313519|NCT00003400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6313520|NCT00003400|Alkylating Agents|alkylating agents|mesh-ancestor
6313521|NCT00003400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313522|NCT00003400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6313523|NCT00003400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6313524|NCT00003400|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6313525|NCT00003400|Tubulin Modulators|tubulin modulators|mesh-ancestor
6313526|NCT00003400|Antimitotic Agents|antimitotic agents|mesh-ancestor
6313527|NCT00003400|Mitosis Modulators|mitosis modulators|mesh-ancestor
6313528|NCT00003401|Gemcitabine|gemcitabine|mesh-list
6313529|NCT00003401|Dexamethasone|dexamethasone|mesh-list
6313530|NCT00003401|Paclitaxel|paclitaxel|mesh-list
6313531|NCT00003401|Etoposide|etoposide|mesh-list
6313532|NCT00003401|Cyclophosphamide|cyclophosphamide|mesh-list
6313533|NCT00003401|Melphalan|melphalan|mesh-list
6313534|NCT00003401|Carmustine|carmustine|mesh-list
6313535|NCT00003401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6313536|NCT00003401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313537|NCT00003401|Tubulin Modulators|tubulin modulators|mesh-ancestor
6313538|NCT00003401|Antimitotic Agents|antimitotic agents|mesh-ancestor
6313539|NCT00003401|Mitosis Modulators|mitosis modulators|mesh-ancestor
6313540|NCT00003401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313541|NCT00003401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6313542|NCT00003401|Immunologic Factors|immunologic factors|mesh-ancestor
6313543|NCT00003401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6313544|NCT00003401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6313545|NCT00003401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6016160|NCT00363142|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6016161|NCT00363142|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6016162|NCT00363142|Antiviral Agents|antiviral agents|mesh-ancestor
6016163|NCT00363142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6313546|NCT00003401|Alkylating Agents|alkylating agents|mesh-ancestor
6313547|NCT00003401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6313548|NCT00003401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6313549|NCT00003401|Antiemetics|antiemetics|mesh-ancestor
6313550|NCT00003401|Autonomic Agents|autonomic agents|mesh-ancestor
6016164|NCT00363142|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6313551|NCT00003401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6313552|NCT00003401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6313553|NCT00003401|Glucocorticoids|glucocorticoids|mesh-ancestor
6313554|NCT00003401|Hormones|hormones|mesh-ancestor
6313555|NCT00003401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6313556|NCT00003401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6313557|NCT00003401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6313558|NCT00003401|Antimetabolites|antimetabolites|mesh-ancestor
6313559|NCT00003401|Antiviral Agents|antiviral agents|mesh-ancestor
6313560|NCT00003401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6313561|NCT00003401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6313562|NCT00003401|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6313563|NCT00003401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6313564|NCT00003402|Dexamethasone|dexamethasone|mesh-list
6313565|NCT00003402|Paclitaxel|paclitaxel|mesh-list
6313566|NCT00003402|Etoposide|etoposide|mesh-list
6313567|NCT00003402|Cyclophosphamide|cyclophosphamide|mesh-list
6313568|NCT00003402|Melphalan|melphalan|mesh-list
6313569|NCT00003402|Carmustine|carmustine|mesh-list
6313570|NCT00003402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6313571|NCT00003402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313572|NCT00003402|Tubulin Modulators|tubulin modulators|mesh-ancestor
6313573|NCT00003402|Antimitotic Agents|antimitotic agents|mesh-ancestor
6313574|NCT00003402|Mitosis Modulators|mitosis modulators|mesh-ancestor
6313575|NCT00003402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313576|NCT00003402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6313577|NCT00003402|Immunologic Factors|immunologic factors|mesh-ancestor
6313578|NCT00003402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6313579|NCT00003402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6313580|NCT00003402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6313581|NCT00003402|Alkylating Agents|alkylating agents|mesh-ancestor
6313582|NCT00003402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6313583|NCT00003402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6313584|NCT00003402|Antiemetics|antiemetics|mesh-ancestor
6313585|NCT00003402|Autonomic Agents|autonomic agents|mesh-ancestor
6313586|NCT00003402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6313587|NCT00003402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6313588|NCT00003402|Glucocorticoids|glucocorticoids|mesh-ancestor
6313589|NCT00003402|Hormones|hormones|mesh-ancestor
6313590|NCT00003402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6313591|NCT00003402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6313592|NCT00003402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6313593|NCT00003402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6313594|NCT00003402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6313595|NCT00003405|Interferons|interferons|mesh-list
6313596|NCT00003405|Cytarabine|cytarabine|mesh-list
6313597|NCT00003405|Interferon-alpha|interferon-alpha|mesh-list
6313598|NCT00003405|Bromodeoxyuridine|bromodeoxyuridine|mesh-list
6313599|NCT00003405|5-bromouridine|5-bromouridine|mesh-list
6313600|NCT00003405|Idoxuridine|idoxuridine|mesh-list
6313601|NCT00003405|Mitoxantrone|mitoxantrone|mesh-list
6313602|NCT00003405|Idarubicin|idarubicin|mesh-list
6313603|NCT00003405|Isotretinoin|isotretinoin|mesh-list
6313604|NCT00003405|Amifostine|amifostine|mesh-list
6313605|NCT00003405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313606|NCT00003405|Antiviral Agents|antiviral agents|mesh-ancestor
6313607|NCT00003405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6313608|NCT00003405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6313609|NCT00003405|Antimetabolites|antimetabolites|mesh-ancestor
6313610|NCT00003405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313611|NCT00003405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6313612|NCT00003405|Immunologic Factors|immunologic factors|mesh-ancestor
6313613|NCT00003405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6313614|NCT00003405|Analgesics|analgesics|mesh-ancestor
6313615|NCT00003405|Sensory System Agents|sensory system agents|mesh-ancestor
6313616|NCT00003405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6313617|NCT00003405|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6313618|NCT00003405|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6313619|NCT00003405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6313620|NCT00003405|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6313621|NCT00003405|Dermatologic Agents|dermatologic agents|mesh-ancestor
6313622|NCT00003405|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6313623|NCT00003405|Protective Agents|protective agents|mesh-ancestor
6313624|NCT00003405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6313625|NCT00003406|Carboplatin|carboplatin|mesh-list
6313626|NCT00003406|Docetaxel|docetaxel|mesh-list
6313627|NCT00003406|Ifosfamide|ifosfamide|mesh-list
6313628|NCT00003406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313629|NCT00003406|Tubulin Modulators|tubulin modulators|mesh-ancestor
6313630|NCT00003406|Antimitotic Agents|antimitotic agents|mesh-ancestor
6313631|NCT00003406|Mitosis Modulators|mitosis modulators|mesh-ancestor
6313632|NCT00003406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313633|NCT00003406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6313634|NCT00003406|Alkylating Agents|alkylating agents|mesh-ancestor
6313635|NCT00003407|Cytarabine|cytarabine|mesh-list
6313636|NCT00003407|Mitoxantrone|mitoxantrone|mesh-list
6313637|NCT00003407|Amifostine|amifostine|mesh-list
6313638|NCT00003407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6313639|NCT00003407|Antimetabolites|antimetabolites|mesh-ancestor
6016165|NCT00363142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6016166|NCT00363168|Ranibizumab|ranibizumab|mesh-list
6016167|NCT00363168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6016168|NCT00363168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6016169|NCT00363168|Growth Substances|growth substances|mesh-ancestor
6313640|NCT00003407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313641|NCT00003407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313642|NCT00003407|Antiviral Agents|antiviral agents|mesh-ancestor
6313643|NCT00003407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6313644|NCT00003407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6313645|NCT00003407|Immunologic Factors|immunologic factors|mesh-ancestor
6313646|NCT00003407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6313647|NCT00003407|Analgesics|analgesics|mesh-ancestor
6313648|NCT00003407|Sensory System Agents|sensory system agents|mesh-ancestor
6313649|NCT00003407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6313650|NCT00003407|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6313651|NCT00003407|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6313652|NCT00003407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6313653|NCT00003407|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6313654|NCT00003407|Protective Agents|protective agents|mesh-ancestor
6313655|NCT00003408|Interferons|interferons|mesh-list
6313656|NCT00003408|Interferon-alpha|interferon-alpha|mesh-list
6313657|NCT00003408|Aldesleukin|aldesleukin|mesh-list
6313658|NCT00003408|Sargramostim|sargramostim|mesh-list
6313659|NCT00003408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313660|NCT00003408|Antiviral Agents|antiviral agents|mesh-ancestor
6313661|NCT00003408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6313662|NCT00003408|Immunologic Factors|immunologic factors|mesh-ancestor
6313663|NCT00003408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6313664|NCT00003408|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6313665|NCT00003408|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6313666|NCT00003409|Motexafin gadolinium|motexafin gadolinium|mesh-list
6313667|NCT00003409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313668|NCT00003409|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6313669|NCT00003409|Dermatologic Agents|dermatologic agents|mesh-ancestor
6313670|NCT00003410|Motexafin gadolinium|motexafin gadolinium|mesh-list
6313671|NCT00003410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313672|NCT00003410|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6313673|NCT00003410|Dermatologic Agents|dermatologic agents|mesh-ancestor
6313674|NCT00003411|Motexafin gadolinium|motexafin gadolinium|mesh-list
6313675|NCT00003411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313676|NCT00003411|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6313677|NCT00003411|Dermatologic Agents|dermatologic agents|mesh-ancestor
6313678|NCT00003412|Interleukin-12|interleukin-12|mesh-list
6313679|NCT00003412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6313680|NCT00003412|Immunologic Factors|immunologic factors|mesh-ancestor
6313681|NCT00003412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6313682|NCT00003412|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6313683|NCT00003412|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6313684|NCT00003412|Growth Substances|growth substances|mesh-ancestor
6313685|NCT00003412|Growth Inhibitors|growth inhibitors|mesh-ancestor
6313686|NCT00003412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313687|NCT00003413|Paclitaxel|paclitaxel|mesh-list
6313688|NCT00003413|Melphalan|melphalan|mesh-list
6313689|NCT00003413|Carmustine|carmustine|mesh-list
6313690|NCT00003413|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6313691|NCT00003413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313692|NCT00003413|Tubulin Modulators|tubulin modulators|mesh-ancestor
6313693|NCT00003413|Antimitotic Agents|antimitotic agents|mesh-ancestor
6313694|NCT00003413|Mitosis Modulators|mitosis modulators|mesh-ancestor
6313695|NCT00003413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313696|NCT00003413|Immunologic Factors|immunologic factors|mesh-ancestor
6313697|NCT00003413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6313698|NCT00003413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6313699|NCT00003413|Alkylating Agents|alkylating agents|mesh-ancestor
6313700|NCT00003413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6313701|NCT00003413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6313702|NCT00003414|Interferons|interferons|mesh-list
6313703|NCT00003414|Aldesleukin|aldesleukin|mesh-list
6313704|NCT00003414|Interferon-gamma|interferon-gamma|mesh-list
6313705|NCT00003414|Cyclosporine|cyclosporine|mesh-list
6313706|NCT00003414|Cyclophosphamide|cyclophosphamide|mesh-list
6313707|NCT00003414|Busulfan|busulfan|mesh-list
6313708|NCT00003414|Cyclosporins|cyclosporins|mesh-list
6313709|NCT00003414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6313710|NCT00003414|Immunologic Factors|immunologic factors|mesh-ancestor
6313711|NCT00003414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6313712|NCT00003414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6313713|NCT00003414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6313714|NCT00003414|Alkylating Agents|alkylating agents|mesh-ancestor
6313715|NCT00003414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313716|NCT00003414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313717|NCT00003414|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6313718|NCT00003414|Antiviral Agents|antiviral agents|mesh-ancestor
6313719|NCT00003414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6313720|NCT00003414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6313721|NCT00003414|Antifungal Agents|antifungal agents|mesh-ancestor
6313722|NCT00003414|Dermatologic Agents|dermatologic agents|mesh-ancestor
6313723|NCT00003414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6313724|NCT00003414|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6313725|NCT00003414|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6313726|NCT00003415|Topotecan|topotecan|mesh-list
6313727|NCT00003415|Amifostine|amifostine|mesh-list
6313728|NCT00003415|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6313729|NCT00003415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6313730|NCT00003415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6313731|NCT00003415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313732|NCT00003415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313733|NCT00003415|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6313734|NCT00003415|Protective Agents|protective agents|mesh-ancestor
6313735|NCT00003415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6313736|NCT00003416|Interferons|interferons|mesh-list
6313737|NCT00003416|Interferon-alpha|interferon-alpha|mesh-list
6313738|NCT00003416|Dexamethasone|dexamethasone|mesh-list
6313739|NCT00003416|Melphalan|melphalan|mesh-list
6313740|NCT00003416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6313741|NCT00003416|Antiemetics|antiemetics|mesh-ancestor
6313742|NCT00003416|Autonomic Agents|autonomic agents|mesh-ancestor
6313743|NCT00003416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6313744|NCT00003416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6313745|NCT00003416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6313746|NCT00003416|Glucocorticoids|glucocorticoids|mesh-ancestor
6313747|NCT00003416|Hormones|hormones|mesh-ancestor
6313748|NCT00003416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6313749|NCT00003416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6313750|NCT00003416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313751|NCT00003416|Antiviral Agents|antiviral agents|mesh-ancestor
6313752|NCT00003416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6313753|NCT00003416|Immunologic Factors|immunologic factors|mesh-ancestor
6313754|NCT00003416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6313755|NCT00003416|Alkylating Agents|alkylating agents|mesh-ancestor
6313756|NCT00003416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313757|NCT00003416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6313758|NCT00003416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6313759|NCT00003417|Carmustine|carmustine|mesh-list
6313760|NCT00003417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6313761|NCT00003417|Alkylating Agents|alkylating agents|mesh-ancestor
6313762|NCT00003417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313763|NCT00003417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313764|NCT00003418|Tamoxifen|tamoxifen|mesh-list
6313765|NCT00003418|Exemestane|exemestane|mesh-list
6313766|NCT00003418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313767|NCT00003418|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6313768|NCT00003418|Hormone Antagonists|hormone antagonists|mesh-ancestor
6313769|NCT00003418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6313770|NCT00003418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6313771|NCT00003418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6313772|NCT00003418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313773|NCT00003418|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6313774|NCT00003418|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6313775|NCT00003418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6313776|NCT00003418|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6313777|NCT00003418|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6313778|NCT00003418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5724530|NCT03186664|Nabiximols|nabiximols|mesh-list
5724531|NCT03186664|Analgesics|analgesics|mesh-ancestor
5724532|NCT03186664|Sensory System Agents|sensory system agents|mesh-ancestor
6313779|NCT00003419|Antiviral Agents|antiviral agents|mesh-list
6313780|NCT00003419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6313781|NCT00003421|Prednisolone|prednisolone|mesh-list
6313782|NCT00003421|Doxorubicin|doxorubicin|mesh-list
6313783|NCT00003421|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6313784|NCT00003421|Bleomycin|bleomycin|mesh-list
6313785|NCT00003421|Etoposide|etoposide|mesh-list
6313786|NCT00003421|Vincristine|vincristine|mesh-list
6313787|NCT00003421|Dacarbazine|dacarbazine|mesh-list
6313788|NCT00003421|Vinblastine|vinblastine|mesh-list
6313789|NCT00003421|Procarbazine|procarbazine|mesh-list
6313790|NCT00003421|Chlorambucil|chlorambucil|mesh-list
6313791|NCT00003421|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6313792|NCT00003421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313793|NCT00003421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6313794|NCT00003421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6313795|NCT00003421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6313796|NCT00003421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313797|NCT00003421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6313798|NCT00003421|Tubulin Modulators|tubulin modulators|mesh-ancestor
6313799|NCT00003421|Antimitotic Agents|antimitotic agents|mesh-ancestor
6313800|NCT00003421|Mitosis Modulators|mitosis modulators|mesh-ancestor
6313801|NCT00003421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6313802|NCT00003421|Glucocorticoids|glucocorticoids|mesh-ancestor
6313803|NCT00003421|Hormones|hormones|mesh-ancestor
6313804|NCT00003421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6313805|NCT00003421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6313806|NCT00003421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6313807|NCT00003421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6313808|NCT00003421|Alkylating Agents|alkylating agents|mesh-ancestor
6313809|NCT00003422|Leucovorin|leucovorin|mesh-list
6313810|NCT00003422|Fluorouracil|fluorouracil|mesh-list
6313811|NCT00003422|Calcium|calcium|mesh-list
6313812|NCT00003422|Levoleucovorin|levoleucovorin|mesh-list
6313813|NCT00003422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6313814|NCT00003422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6313815|NCT00003422|Antimetabolites|antimetabolites|mesh-ancestor
6313816|NCT00003422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313817|NCT00003422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6313818|NCT00003422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5724533|NCT03186664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5724534|NCT03186664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6313819|NCT00003422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6313820|NCT00003422|Immunologic Factors|immunologic factors|mesh-ancestor
6313821|NCT00003422|Antidotes|antidotes|mesh-ancestor
6313822|NCT00003422|Protective Agents|protective agents|mesh-ancestor
6313823|NCT00003422|Vitamin B Complex|vitamin b complex|mesh-ancestor
6313824|NCT00003422|Vitamins|vitamins|mesh-ancestor
6313825|NCT00003422|Micronutrients|micronutrients|mesh-ancestor
6313826|NCT00003423|Cytarabine|cytarabine|mesh-list
6313827|NCT00003423|Dexamethasone|dexamethasone|mesh-list
6313828|NCT00003423|Prednisolone|prednisolone|mesh-list
6313829|NCT00003423|Cyclophosphamide|cyclophosphamide|mesh-list
6313830|NCT00003423|Methotrexate|methotrexate|mesh-list
6313831|NCT00003423|Etoposide|etoposide|mesh-list
6313832|NCT00003423|Vincristine|vincristine|mesh-list
6313833|NCT00003423|Daunorubicin|daunorubicin|mesh-list
6313834|NCT00003423|Asparaginase|asparaginase|mesh-list
6313835|NCT00003423|Mercaptopurine|mercaptopurine|mesh-list
6313836|NCT00003423|Thioguanine|thioguanine|mesh-list
6313837|NCT00003423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6313838|NCT00003423|Immunologic Factors|immunologic factors|mesh-ancestor
6313839|NCT00003423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6313840|NCT00003423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6313841|NCT00003423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6313842|NCT00003423|Alkylating Agents|alkylating agents|mesh-ancestor
6313843|NCT00003423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313844|NCT00003423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313845|NCT00003423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6313846|NCT00003423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6313847|NCT00003423|Antiemetics|antiemetics|mesh-ancestor
6313848|NCT00003423|Autonomic Agents|autonomic agents|mesh-ancestor
6313849|NCT00003423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6313850|NCT00003423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6313851|NCT00003423|Glucocorticoids|glucocorticoids|mesh-ancestor
6313852|NCT00003423|Hormones|hormones|mesh-ancestor
6313853|NCT00003423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6313854|NCT00003423|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6313855|NCT00003423|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6313856|NCT00003423|Abortifacient Agents|abortifacient agents|mesh-ancestor
6313857|NCT00003423|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6313858|NCT00003423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6313859|NCT00003423|Antimetabolites|antimetabolites|mesh-ancestor
6313860|NCT00003423|Dermatologic Agents|dermatologic agents|mesh-ancestor
6313861|NCT00003423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6313862|NCT00003423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6313863|NCT00003423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6313864|NCT00003423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5724535|NCT03186586|Ulipristal acetate|ulipristal acetate|mesh-list
5724536|NCT03186586|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5724537|NCT03186586|Contraceptive Agents|contraceptive agents|mesh-ancestor
6313865|NCT00003423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6313866|NCT00003423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6313867|NCT00003423|Antiviral Agents|antiviral agents|mesh-ancestor
6313868|NCT00003423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6313869|NCT00003423|Tubulin Modulators|tubulin modulators|mesh-ancestor
6313870|NCT00003423|Antimitotic Agents|antimitotic agents|mesh-ancestor
6313871|NCT00003423|Mitosis Modulators|mitosis modulators|mesh-ancestor
6313872|NCT00003423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6313873|NCT00003424|Tamoxifen|tamoxifen|mesh-list
6313874|NCT00003424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6313875|NCT00003424|Hormone Antagonists|hormone antagonists|mesh-ancestor
6313876|NCT00003424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6313877|NCT00003424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6313878|NCT00003424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6313879|NCT00003424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313880|NCT00003424|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6313881|NCT00003424|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6313882|NCT00003424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6313883|NCT00003425|Cyclophosphamide|cyclophosphamide|mesh-list
6313884|NCT00003425|Melphalan|melphalan|mesh-list
6313885|NCT00003425|Amifostine|amifostine|mesh-list
6313886|NCT00003425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6313887|NCT00003425|Immunologic Factors|immunologic factors|mesh-ancestor
6313888|NCT00003425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6313889|NCT00003425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6313890|NCT00003425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6313891|NCT00003425|Alkylating Agents|alkylating agents|mesh-ancestor
6313892|NCT00003425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313893|NCT00003425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313894|NCT00003425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6313895|NCT00003425|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6313896|NCT00003425|Protective Agents|protective agents|mesh-ancestor
6313897|NCT00003426|Gemcitabine|gemcitabine|mesh-list
6313898|NCT00003426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6313899|NCT00003426|Antimetabolites|antimetabolites|mesh-ancestor
6313900|NCT00003426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313901|NCT00003426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313902|NCT00003426|Antiviral Agents|antiviral agents|mesh-ancestor
6313903|NCT00003426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6313904|NCT00003426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6313905|NCT00003426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6313906|NCT00003426|Immunologic Factors|immunologic factors|mesh-ancestor
6313907|NCT00003426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6313908|NCT00003427|Oxaliplatin|oxaliplatin|mesh-list
6313909|NCT00003427|Irinotecan|irinotecan|mesh-list
6313910|NCT00003427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313911|NCT00003427|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6313912|NCT00003427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6313913|NCT00003427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6313914|NCT00003427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313915|NCT00003429|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6313916|NCT00003429|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6313917|NCT00003429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313918|NCT00003431|Flt3 ligand protein|flt3 ligand protein|mesh-list
6313919|NCT00003431|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6313920|NCT00003431|Immunologic Factors|immunologic factors|mesh-ancestor
6313921|NCT00003431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6313922|NCT00003431|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6313923|NCT00003431|Protective Agents|protective agents|mesh-ancestor
6313924|NCT00003435|Antiviral Agents|antiviral agents|mesh-list
6313925|NCT00003435|Melphalan|melphalan|mesh-list
6313926|NCT00003435|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6313927|NCT00003435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6313928|NCT00003435|Alkylating Agents|alkylating agents|mesh-ancestor
6313929|NCT00003435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313930|NCT00003435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313931|NCT00003435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6313932|NCT00003435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6313933|NCT00003435|Immunologic Factors|immunologic factors|mesh-ancestor
6313934|NCT00003435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6313935|NCT00003435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6313936|NCT00003436|Cytarabine|cytarabine|mesh-list
6313937|NCT00003436|Hydrocortisone|hydrocortisone|mesh-list
6313938|NCT00003436|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6313939|NCT00003436|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6313940|NCT00003436|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6313941|NCT00003436|Methotrexate|methotrexate|mesh-list
6313942|NCT00003436|Etoposide|etoposide|mesh-list
6313943|NCT00003436|Daunorubicin|daunorubicin|mesh-list
6313944|NCT00003436|Asparaginase|asparaginase|mesh-list
6313945|NCT00003436|Mitoxantrone|mitoxantrone|mesh-list
6313946|NCT00003436|Amsacrine|amsacrine|mesh-list
6313947|NCT00003436|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6313948|NCT00003436|Abortifacient Agents|abortifacient agents|mesh-ancestor
6313949|NCT00003436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6313950|NCT00003436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6313951|NCT00003436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6313952|NCT00003436|Antimetabolites|antimetabolites|mesh-ancestor
6313953|NCT00003436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313954|NCT00003436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313955|NCT00003436|Dermatologic Agents|dermatologic agents|mesh-ancestor
6313956|NCT00003436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6313957|NCT00003436|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6313958|NCT00003436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6313959|NCT00003436|Immunologic Factors|immunologic factors|mesh-ancestor
6313960|NCT00003436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6313961|NCT00003436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6313962|NCT00003436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6313963|NCT00003436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6313964|NCT00003436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6313965|NCT00003436|Antiviral Agents|antiviral agents|mesh-ancestor
6313966|NCT00003436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6313967|NCT00003436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6313968|NCT00003436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6016170|NCT00363168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016171|NCT00363168|Growth Inhibitors|growth inhibitors|mesh-ancestor
6016172|NCT00363168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6016173|NCT00363298|Caffeine|caffeine|mesh-list
6016174|NCT00363298|Amphetamine|amphetamine|mesh-list
6016175|NCT00363298|Dextroamphetamine|dextroamphetamine|mesh-list
6016176|NCT00363298|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6016177|NCT00363298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016178|NCT00363298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6016179|NCT00363298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6016180|NCT00363298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313969|NCT00003436|Analgesics|analgesics|mesh-ancestor
6313970|NCT00003436|Sensory System Agents|sensory system agents|mesh-ancestor
6313971|NCT00003436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6313972|NCT00003437|Cytarabine|cytarabine|mesh-list
6313973|NCT00003437|Dexamethasone|dexamethasone|mesh-list
6313974|NCT00003437|Prednisolone|prednisolone|mesh-list
6313975|NCT00003437|Cyclophosphamide|cyclophosphamide|mesh-list
6313976|NCT00003437|Doxorubicin|doxorubicin|mesh-list
6313977|NCT00003437|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6313978|NCT00003437|Methotrexate|methotrexate|mesh-list
6313979|NCT00003437|Vincristine|vincristine|mesh-list
6313980|NCT00003437|Daunorubicin|daunorubicin|mesh-list
6313981|NCT00003437|Asparaginase|asparaginase|mesh-list
6313982|NCT00003437|Mercaptopurine|mercaptopurine|mesh-list
6313983|NCT00003437|Pegaspargase|pegaspargase|mesh-list
6313984|NCT00003437|Thioguanine|thioguanine|mesh-list
6313985|NCT00003437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6313986|NCT00003437|Immunologic Factors|immunologic factors|mesh-ancestor
6313987|NCT00003437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6313988|NCT00003437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6313989|NCT00003437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6313990|NCT00003437|Alkylating Agents|alkylating agents|mesh-ancestor
6313991|NCT00003437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6313992|NCT00003437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6313993|NCT00003437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6313994|NCT00003437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6313995|NCT00003437|Antiemetics|antiemetics|mesh-ancestor
6313996|NCT00003437|Autonomic Agents|autonomic agents|mesh-ancestor
6313997|NCT00003437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6313998|NCT00003437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6313999|NCT00003437|Glucocorticoids|glucocorticoids|mesh-ancestor
6314000|NCT00003437|Hormones|hormones|mesh-ancestor
6314001|NCT00003437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6314002|NCT00003437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6314003|NCT00003437|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6314004|NCT00003437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6314005|NCT00003437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6314006|NCT00003437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6314007|NCT00003437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6314008|NCT00003437|Abortifacient Agents|abortifacient agents|mesh-ancestor
6314009|NCT00003437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6314010|NCT00003437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6314011|NCT00003437|Antimetabolites|antimetabolites|mesh-ancestor
6314012|NCT00003437|Dermatologic Agents|dermatologic agents|mesh-ancestor
6314013|NCT00003437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6314014|NCT00003437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6314015|NCT00003437|Antiviral Agents|antiviral agents|mesh-ancestor
6314016|NCT00003437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6314017|NCT00003437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6314018|NCT00003437|Tubulin Modulators|tubulin modulators|mesh-ancestor
6314019|NCT00003437|Antimitotic Agents|antimitotic agents|mesh-ancestor
6314020|NCT00003437|Mitosis Modulators|mitosis modulators|mesh-ancestor
6314021|NCT00003439|Interleukin-12|interleukin-12|mesh-list
6314022|NCT00003439|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6314023|NCT00003439|Immunologic Factors|immunologic factors|mesh-ancestor
6314024|NCT00003439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6314025|NCT00003439|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6314026|NCT00003439|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6314027|NCT00003439|Growth Substances|growth substances|mesh-ancestor
6314028|NCT00003439|Growth Inhibitors|growth inhibitors|mesh-ancestor
6314029|NCT00003439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314030|NCT00003440|Paclitaxel|paclitaxel|mesh-list
6314031|NCT00003440|Trastuzumab|trastuzumab|mesh-list
6314032|NCT00003440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6314033|NCT00003440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314034|NCT00003440|Tubulin Modulators|tubulin modulators|mesh-ancestor
6314035|NCT00003440|Antimitotic Agents|antimitotic agents|mesh-ancestor
6314036|NCT00003440|Mitosis Modulators|mitosis modulators|mesh-ancestor
6314037|NCT00003440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314038|NCT00003440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6314039|NCT00003441|Irofulven|irofulven|mesh-list
6314040|NCT00003441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6314041|NCT00003441|Alkylating Agents|alkylating agents|mesh-ancestor
6314042|NCT00003441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314043|NCT00003441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314044|NCT00003443|Bryostatin 1|bryostatin 1|mesh-list
6314045|NCT00003443|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6314046|NCT00003443|Immunologic Factors|immunologic factors|mesh-ancestor
6314047|NCT00003443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6314048|NCT00003443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6392553|NCT00196755|Calcium|calcium|mesh-list
6392554|NCT00196755|Sevelamer|sevelamer|mesh-list
6314049|NCT00003444|Interferons|interferons|mesh-list
6314050|NCT00003444|Interferon-alpha|interferon-alpha|mesh-list
6314051|NCT00003444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314052|NCT00003444|Antiviral Agents|antiviral agents|mesh-ancestor
6314053|NCT00003444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6314054|NCT00003444|Immunologic Factors|immunologic factors|mesh-ancestor
6314055|NCT00003444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6314056|NCT00003445|Docetaxel|docetaxel|mesh-list
6314057|NCT00003445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314058|NCT00003445|Tubulin Modulators|tubulin modulators|mesh-ancestor
6314059|NCT00003445|Antimitotic Agents|antimitotic agents|mesh-ancestor
6314060|NCT00003445|Mitosis Modulators|mitosis modulators|mesh-ancestor
6314061|NCT00003445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314062|NCT00003446|Leucovorin|leucovorin|mesh-list
6314063|NCT00003446|Trimetrexate|trimetrexate|mesh-list
6314064|NCT00003446|Fluorouracil|fluorouracil|mesh-list
6314065|NCT00003446|Calcium|calcium|mesh-list
6314066|NCT00003446|Levoleucovorin|levoleucovorin|mesh-list
6314067|NCT00003446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6314068|NCT00003446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6314069|NCT00003446|Antimetabolites|antimetabolites|mesh-ancestor
6314070|NCT00003446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314071|NCT00003446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6314072|NCT00003446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314073|NCT00003446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6314074|NCT00003446|Immunologic Factors|immunologic factors|mesh-ancestor
6314075|NCT00003446|Antidotes|antidotes|mesh-ancestor
6314076|NCT00003446|Protective Agents|protective agents|mesh-ancestor
6314077|NCT00003446|Vitamin B Complex|vitamin b complex|mesh-ancestor
6314078|NCT00003446|Vitamins|vitamins|mesh-ancestor
6314079|NCT00003446|Micronutrients|micronutrients|mesh-ancestor
6314080|NCT00003446|Antifungal Agents|antifungal agents|mesh-ancestor
6314081|NCT00003446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6314082|NCT00003446|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6314083|NCT00003446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6314084|NCT00003447|Gemcitabine|gemcitabine|mesh-list
6314085|NCT00003447|Vinorelbine|vinorelbine|mesh-list
6314086|NCT00003447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6314087|NCT00003447|Antimetabolites|antimetabolites|mesh-ancestor
6314088|NCT00003447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314089|NCT00003447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314090|NCT00003447|Antiviral Agents|antiviral agents|mesh-ancestor
6314091|NCT00003447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6314092|NCT00003447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6314093|NCT00003447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6314094|NCT00003447|Immunologic Factors|immunologic factors|mesh-ancestor
6314095|NCT00003447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6314096|NCT00003447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6314097|NCT00003447|Tubulin Modulators|tubulin modulators|mesh-ancestor
6314098|NCT00003447|Antimitotic Agents|antimitotic agents|mesh-ancestor
6314099|NCT00003447|Mitosis Modulators|mitosis modulators|mesh-ancestor
6314100|NCT00003449|Gemcitabine|gemcitabine|mesh-list
6314101|NCT00003449|Dexamethasone|dexamethasone|mesh-list
6314102|NCT00003449|Paclitaxel|paclitaxel|mesh-list
6314103|NCT00003449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6314104|NCT00003449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314105|NCT00003449|Tubulin Modulators|tubulin modulators|mesh-ancestor
6314106|NCT00003449|Antimitotic Agents|antimitotic agents|mesh-ancestor
6314107|NCT00003449|Mitosis Modulators|mitosis modulators|mesh-ancestor
6016181|NCT00363298|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6016182|NCT00363298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6016183|NCT00363298|Purinergic Agents|purinergic agents|mesh-ancestor
6016184|NCT00363298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6016185|NCT00363298|Sympathomimetics|sympathomimetics|mesh-ancestor
6016186|NCT00363298|Autonomic Agents|autonomic agents|mesh-ancestor
6314108|NCT00003449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314109|NCT00003449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6314110|NCT00003449|Antiemetics|antiemetics|mesh-ancestor
6314111|NCT00003449|Autonomic Agents|autonomic agents|mesh-ancestor
6016187|NCT00363298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6016188|NCT00363298|Dopamine Agents|dopamine agents|mesh-ancestor
6016189|NCT00363298|Adrenergic Agents|adrenergic agents|mesh-ancestor
6016190|NCT00363298|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6016191|NCT00363298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6314112|NCT00003449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6314113|NCT00003449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6314114|NCT00003449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6314115|NCT00003449|Glucocorticoids|glucocorticoids|mesh-ancestor
6314116|NCT00003449|Hormones|hormones|mesh-ancestor
6314117|NCT00003449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6314118|NCT00003449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6314119|NCT00003449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6314120|NCT00003449|Antimetabolites|antimetabolites|mesh-ancestor
6314121|NCT00003449|Antiviral Agents|antiviral agents|mesh-ancestor
6314122|NCT00003449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6314123|NCT00003449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6314124|NCT00003449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6314125|NCT00003449|Immunologic Factors|immunologic factors|mesh-ancestor
6314126|NCT00003451|Interferons|interferons|mesh-list
6314127|NCT00003451|Interferon-alpha|interferon-alpha|mesh-list
6314128|NCT00003451|Interleukin-12|interleukin-12|mesh-list
6314129|NCT00003451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314130|NCT00003451|Antiviral Agents|antiviral agents|mesh-ancestor
6314131|NCT00003451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6314132|NCT00003451|Immunologic Factors|immunologic factors|mesh-ancestor
6314133|NCT00003451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6314134|NCT00003451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6314135|NCT00003451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6314136|NCT00003451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6314137|NCT00003451|Growth Substances|growth substances|mesh-ancestor
6314138|NCT00003451|Growth Inhibitors|growth inhibitors|mesh-ancestor
6314139|NCT00003461|Antibodies|antibodies|mesh-list
6314140|NCT00003461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6314141|NCT00003461|Immunologic Factors|immunologic factors|mesh-ancestor
6314142|NCT00003461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6314143|NCT00003462|Busulfan|busulfan|mesh-list
6314144|NCT00003462|Alkylating Agents|alkylating agents|mesh-ancestor
6314145|NCT00003462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314146|NCT00003462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6314147|NCT00003462|Immunologic Factors|immunologic factors|mesh-ancestor
6314148|NCT00003462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6314149|NCT00003462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6314150|NCT00003462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314151|NCT00003462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6314152|NCT00003463|Irinotecan|irinotecan|mesh-list
6314153|NCT00003463|Carmustine|carmustine|mesh-list
6314154|NCT00003463|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6314155|NCT00003463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6314156|NCT00003463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6314157|NCT00003463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314158|NCT00003463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314159|NCT00003463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6314160|NCT00003463|Alkylating Agents|alkylating agents|mesh-ancestor
6314161|NCT00003464|Temozolomide|temozolomide|mesh-list
6314162|NCT00003464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6314163|NCT00003464|Alkylating Agents|alkylating agents|mesh-ancestor
6314164|NCT00003464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314165|NCT00003464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314166|NCT00003465|Temozolomide|temozolomide|mesh-list
6314167|NCT00003465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6314168|NCT00003465|Alkylating Agents|alkylating agents|mesh-ancestor
6314169|NCT00003465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314170|NCT00003465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314171|NCT00003466|Temozolomide|temozolomide|mesh-list
6016192|NCT00363298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6016193|NCT00363298|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6016194|NCT00363311|Dutasteride|dutasteride|mesh-list
6016195|NCT00363311|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6016196|NCT00363311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6016197|NCT00363311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6314172|NCT00003466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6314173|NCT00003466|Alkylating Agents|alkylating agents|mesh-ancestor
6314174|NCT00003466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314175|NCT00003466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6016198|NCT00363311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016199|NCT00363311|Hormone Antagonists|hormone antagonists|mesh-ancestor
6016200|NCT00363311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6314176|NCT00003467|Carmustine|carmustine|mesh-list
6314177|NCT00003467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6314178|NCT00003467|Alkylating Agents|alkylating agents|mesh-ancestor
6314179|NCT00003467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314180|NCT00003467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314181|NCT00003478|Antibodies|antibodies|mesh-list
6314182|NCT00003478|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6314183|NCT00003478|Immunologic Factors|immunologic factors|mesh-ancestor
6314184|NCT00003478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6314185|NCT00003484|Irinotecan|irinotecan|mesh-list
6314186|NCT00003484|Carmustine|carmustine|mesh-list
6314187|NCT00003484|Antibodies|antibodies|mesh-list
6314188|NCT00003484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6314189|NCT00003484|Immunologic Factors|immunologic factors|mesh-ancestor
6314190|NCT00003484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6314191|NCT00003484|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6016201|NCT00363311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016202|NCT00363415|Carboplatin|carboplatin|mesh-list
6016203|NCT00363415|Etoposide|etoposide|mesh-list
6016204|NCT00363415|Pemetrexed|pemetrexed|mesh-list
6016205|NCT00363415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6016206|NCT00363415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6016207|NCT00363415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6016208|NCT00363415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6016209|NCT00363415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6016210|NCT00363415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314192|NCT00003484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6314193|NCT00003484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6314194|NCT00003484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314195|NCT00003484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314196|NCT00003484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6314197|NCT00003484|Alkylating Agents|alkylating agents|mesh-ancestor
6314198|NCT00003490|Prednisone|prednisone|mesh-list
6314199|NCT00003490|Cyclophosphamide|cyclophosphamide|mesh-list
6314200|NCT00003490|Vincristine|vincristine|mesh-list
6314201|NCT00003490|Sargramostim|sargramostim|mesh-list
6314202|NCT00003490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6314203|NCT00003490|Immunologic Factors|immunologic factors|mesh-ancestor
6314204|NCT00003490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6314205|NCT00003490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6314206|NCT00003490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6314207|NCT00003490|Alkylating Agents|alkylating agents|mesh-ancestor
6314208|NCT00003490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314209|NCT00003490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314210|NCT00003490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6314211|NCT00003490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6314212|NCT00003490|Glucocorticoids|glucocorticoids|mesh-ancestor
6016211|NCT00363415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6016212|NCT00363415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6016213|NCT00363467|Busulfan|busulfan|mesh-list
6016214|NCT00363467|Immunologic Factors|immunologic factors|mesh-ancestor
6016215|NCT00363467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016216|NCT00363467|Alkylating Agents|alkylating agents|mesh-ancestor
6016217|NCT00363467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016218|NCT00363467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6016219|NCT00363467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6016220|NCT00363467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314213|NCT00003490|Hormones|hormones|mesh-ancestor
6314214|NCT00003490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6314215|NCT00003490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6016221|NCT00363467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6016222|NCT00363480|Fluticasone|fluticasone|mesh-list
6016223|NCT00363480|Albuterol|albuterol|mesh-list
6016224|NCT00363480|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6016225|NCT00363480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6016226|NCT00363480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6016227|NCT00363480|Autonomic Agents|autonomic agents|mesh-ancestor
6016228|NCT00363480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6016229|NCT00363480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016230|NCT00363480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6016231|NCT00363480|Respiratory System Agents|respiratory system agents|mesh-ancestor
6016232|NCT00363480|Dermatologic Agents|dermatologic agents|mesh-ancestor
6016233|NCT00363480|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6016234|NCT00363480|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6016235|NCT00363480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6016236|NCT00363480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6016237|NCT00363480|Adrenergic Agents|adrenergic agents|mesh-ancestor
6016238|NCT00363480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6016239|NCT00363480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016240|NCT00363480|Tocolytic Agents|tocolytic agents|mesh-ancestor
6016241|NCT00363480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6016242|NCT00363545|Vaccines|vaccines|mesh-list
6016243|NCT00363545|Immunologic Factors|immunologic factors|mesh-ancestor
6016244|NCT00363545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016245|NCT00363649|Interferons|interferons|mesh-list
6016246|NCT00363649|Interferon-alpha|interferon-alpha|mesh-list
6016247|NCT00363649|Sargramostim|sargramostim|mesh-list
6016248|NCT00363649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314216|NCT00003490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6314217|NCT00003490|Tubulin Modulators|tubulin modulators|mesh-ancestor
6314218|NCT00003490|Antimitotic Agents|antimitotic agents|mesh-ancestor
6314219|NCT00003490|Mitosis Modulators|mitosis modulators|mesh-ancestor
6314220|NCT00003493|Dexamethasone|dexamethasone|mesh-list
6314221|NCT00003493|Doxorubicin|doxorubicin|mesh-list
6314222|NCT00003493|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6314223|NCT00003493|Vincristine|vincristine|mesh-list
6314224|NCT00003493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6314225|NCT00003493|Antiemetics|antiemetics|mesh-ancestor
6314226|NCT00003493|Autonomic Agents|autonomic agents|mesh-ancestor
6314227|NCT00003493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6314228|NCT00003493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6314229|NCT00003493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6314230|NCT00003493|Glucocorticoids|glucocorticoids|mesh-ancestor
6314231|NCT00003493|Hormones|hormones|mesh-ancestor
6314232|NCT00003493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6314233|NCT00003493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6314234|NCT00003493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314235|NCT00003493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6314236|NCT00003493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6314237|NCT00003493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6314238|NCT00003493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6314239|NCT00003493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314240|NCT00003493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6314241|NCT00003493|Tubulin Modulators|tubulin modulators|mesh-ancestor
6314242|NCT00003493|Antimitotic Agents|antimitotic agents|mesh-ancestor
6314243|NCT00003493|Mitosis Modulators|mitosis modulators|mesh-ancestor
6314244|NCT00003517|Leuprolide|leuprolide|mesh-list
6314245|NCT00003517|Flutamide|flutamide|mesh-list
6314246|NCT00003517|Bicalutamide|bicalutamide|mesh-list
6314247|NCT00003517|Hormones|hormones|mesh-list
6314248|NCT00003517|Androgen Antagonists|androgen antagonists|mesh-list
6314249|NCT00003517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6314250|NCT00003517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016249|NCT00363649|Antiviral Agents|antiviral agents|mesh-ancestor
6314251|NCT00003517|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6016250|NCT00363649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6314252|NCT00003517|Fertility Agents|fertility agents|mesh-ancestor
6314253|NCT00003517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6314254|NCT00003517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6314255|NCT00003517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314256|NCT00003517|Hormone Antagonists|hormone antagonists|mesh-ancestor
6314257|NCT00003518|Gemcitabine|gemcitabine|mesh-list
6314258|NCT00003518|Paclitaxel|paclitaxel|mesh-list
6314259|NCT00003518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6314260|NCT00003518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314261|NCT00003518|Tubulin Modulators|tubulin modulators|mesh-ancestor
6314262|NCT00003518|Antimitotic Agents|antimitotic agents|mesh-ancestor
6314263|NCT00003518|Mitosis Modulators|mitosis modulators|mesh-ancestor
6314264|NCT00003518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314265|NCT00003518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6314266|NCT00003518|Antimetabolites|antimetabolites|mesh-ancestor
6314267|NCT00003518|Antiviral Agents|antiviral agents|mesh-ancestor
6314268|NCT00003518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6314269|NCT00003518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6314270|NCT00003518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6314271|NCT00003518|Immunologic Factors|immunologic factors|mesh-ancestor
6314272|NCT00003518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6314273|NCT00003519|Cyclophosphamide|cyclophosphamide|mesh-list
6314274|NCT00003519|Docetaxel|docetaxel|mesh-list
6314275|NCT00003519|Doxorubicin|doxorubicin|mesh-list
6314276|NCT00003519|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6314277|NCT00003519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6314278|NCT00003519|Immunologic Factors|immunologic factors|mesh-ancestor
6314279|NCT00003519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6314280|NCT00003519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6314281|NCT00003519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6314282|NCT00003519|Alkylating Agents|alkylating agents|mesh-ancestor
6314283|NCT00003519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314284|NCT00003519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314285|NCT00003519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6314286|NCT00003519|Tubulin Modulators|tubulin modulators|mesh-ancestor
6314287|NCT00003519|Antimitotic Agents|antimitotic agents|mesh-ancestor
6314288|NCT00003519|Mitosis Modulators|mitosis modulators|mesh-ancestor
6314289|NCT00003519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6314290|NCT00003519|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6314291|NCT00003519|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6314292|NCT00003519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6314293|NCT00003528|Raltitrexed|raltitrexed|mesh-list
6314294|NCT00003528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6314295|NCT00003528|Antimetabolites|antimetabolites|mesh-ancestor
6314296|NCT00003528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314297|NCT00003528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314298|NCT00003528|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6314299|NCT00003528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6314300|NCT00003536|Methotrexate|methotrexate|mesh-list
6314301|NCT00003536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6016251|NCT00363649|Immunologic Factors|immunologic factors|mesh-ancestor
6016252|NCT00363649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016253|NCT00363779|Cyclosporine|cyclosporine|mesh-list
6016254|NCT00363779|Cyclosporins|cyclosporins|mesh-list
6016255|NCT00363779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6016256|NCT00363779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016257|NCT00363779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6314302|NCT00003536|Abortifacient Agents|abortifacient agents|mesh-ancestor
6314303|NCT00003536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6314304|NCT00003536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6314305|NCT00003536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6314306|NCT00003536|Antimetabolites|antimetabolites|mesh-ancestor
6314307|NCT00003536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314308|NCT00003536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314309|NCT00003536|Dermatologic Agents|dermatologic agents|mesh-ancestor
6314310|NCT00003536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6314311|NCT00003536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6314312|NCT00003536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6314313|NCT00003536|Immunologic Factors|immunologic factors|mesh-ancestor
6314314|NCT00003536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6314315|NCT00003536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6314316|NCT00003539|Paclitaxel|paclitaxel|mesh-list
6314317|NCT00003539|Trastuzumab|trastuzumab|mesh-list
6314318|NCT00003539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6314319|NCT00003539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314320|NCT00003539|Tubulin Modulators|tubulin modulators|mesh-ancestor
6314321|NCT00003539|Antimitotic Agents|antimitotic agents|mesh-ancestor
6314322|NCT00003539|Mitosis Modulators|mitosis modulators|mesh-ancestor
6314323|NCT00003539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314324|NCT00003539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6314325|NCT00003540|Gemcitabine|gemcitabine|mesh-list
6314326|NCT00003540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6314327|NCT00003540|Antimetabolites|antimetabolites|mesh-ancestor
6314328|NCT00003540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314329|NCT00003540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314330|NCT00003540|Antiviral Agents|antiviral agents|mesh-ancestor
6314331|NCT00003540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6314332|NCT00003540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6314333|NCT00003540|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6314334|NCT00003540|Immunologic Factors|immunologic factors|mesh-ancestor
6314335|NCT00003540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6314336|NCT00003541|Prednisone|prednisone|mesh-list
6314337|NCT00003541|Cyclophosphamide|cyclophosphamide|mesh-list
6314338|NCT00003541|Ifosfamide|ifosfamide|mesh-list
6314339|NCT00003541|Carboplatin|carboplatin|mesh-list
6016258|NCT00363779|Immunologic Factors|immunologic factors|mesh-ancestor
6016259|NCT00363779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6314340|NCT00003541|Doxorubicin|doxorubicin|mesh-list
6314341|NCT00003541|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6314342|NCT00003541|Etoposide|etoposide|mesh-list
6314343|NCT00003541|Vincristine|vincristine|mesh-list
6314344|NCT00003541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6314345|NCT00003541|Immunologic Factors|immunologic factors|mesh-ancestor
6314346|NCT00003541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6314347|NCT00003541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6314348|NCT00003541|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6314349|NCT00003541|Alkylating Agents|alkylating agents|mesh-ancestor
6314350|NCT00003541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314351|NCT00003541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314352|NCT00003541|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6314353|NCT00003541|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6314354|NCT00003541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6314355|NCT00003541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6314356|NCT00003541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6314357|NCT00003541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6314358|NCT00003541|Glucocorticoids|glucocorticoids|mesh-ancestor
6314359|NCT00003541|Hormones|hormones|mesh-ancestor
6314360|NCT00003541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6314361|NCT00003541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6314362|NCT00003541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6314363|NCT00003541|Tubulin Modulators|tubulin modulators|mesh-ancestor
6314364|NCT00003541|Antimitotic Agents|antimitotic agents|mesh-ancestor
6314365|NCT00003541|Mitosis Modulators|mitosis modulators|mesh-ancestor
6314366|NCT00003542|Interferons|interferons|mesh-list
6314367|NCT00003542|Interferon-alpha|interferon-alpha|mesh-list
6314368|NCT00003542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314369|NCT00003542|Antiviral Agents|antiviral agents|mesh-ancestor
6314370|NCT00003542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6314371|NCT00003542|Immunologic Factors|immunologic factors|mesh-ancestor
6314372|NCT00003542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6314373|NCT00003543|Fluorouracil|fluorouracil|mesh-list
6314374|NCT00003543|Vincristine|vincristine|mesh-list
6314375|NCT00003543|Carmustine|carmustine|mesh-list
6314376|NCT00003543|Streptozocin|streptozocin|mesh-list
6314377|NCT00003543|Antibodies|antibodies|mesh-list
6314378|NCT00003543|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6314379|NCT00003543|Immunologic Factors|immunologic factors|mesh-ancestor
6314380|NCT00003543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6314381|NCT00003543|Antimetabolites|antimetabolites|mesh-ancestor
6314382|NCT00003543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314383|NCT00003543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6314384|NCT00003543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5724538|NCT03186586|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5724539|NCT03186586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724540|NCT03186586|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5724541|NCT03186547|Botulinum Toxins|botulinum toxins|mesh-list
5724542|NCT03186547|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5724543|NCT03186547|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5724544|NCT03186547|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5724545|NCT03186547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5724546|NCT03186547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724547|NCT03186547|Cholinergic Agents|cholinergic agents|mesh-ancestor
5724548|NCT03186547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5724549|NCT03186547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724550|NCT03186547|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5724551|NCT03186547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5724552|NCT03186482|Rifampin|rifampin|mesh-list
5724553|NCT03186482|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
5724554|NCT03186482|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5724555|NCT03186482|Antitubercular Agents|antitubercular agents|mesh-ancestor
6314385|NCT00003543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6314386|NCT00003543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6314387|NCT00003543|Tubulin Modulators|tubulin modulators|mesh-ancestor
6314388|NCT00003543|Antimitotic Agents|antimitotic agents|mesh-ancestor
6314389|NCT00003543|Mitosis Modulators|mitosis modulators|mesh-ancestor
6314390|NCT00003543|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6314391|NCT00003543|Alkylating Agents|alkylating agents|mesh-ancestor
6314392|NCT00003543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6314393|NCT00003544|Irinotecan|irinotecan|mesh-list
6314394|NCT00003544|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6314395|NCT00003544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6314396|NCT00003544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6314397|NCT00003544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314398|NCT00003544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314399|NCT00003546|Gemcitabine|gemcitabine|mesh-list
6314400|NCT00003546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6314401|NCT00003546|Antimetabolites|antimetabolites|mesh-ancestor
6314402|NCT00003546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314403|NCT00003546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314404|NCT00003546|Antiviral Agents|antiviral agents|mesh-ancestor
6314405|NCT00003546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6314406|NCT00003546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6314407|NCT00003546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6314408|NCT00003546|Immunologic Factors|immunologic factors|mesh-ancestor
6314409|NCT00003546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6314410|NCT00003549|Cyclophosphamide|cyclophosphamide|mesh-list
6314411|NCT00003549|Fluorouracil|fluorouracil|mesh-list
6314412|NCT00003549|Methotrexate|methotrexate|mesh-list
6314413|NCT00003549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6016260|NCT00363779|Antifungal Agents|antifungal agents|mesh-ancestor
6016261|NCT00363779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6016262|NCT00363779|Dermatologic Agents|dermatologic agents|mesh-ancestor
6016263|NCT00363779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6016264|NCT00363779|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6016265|NCT00363883|Vorinostat|vorinostat|mesh-list
6016266|NCT00363883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6016267|NCT00363883|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6016268|NCT00363883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6016269|NCT00363883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016270|NCT00363896|Bromides|bromides|mesh-list
6016271|NCT00363896|Anticonvulsants|anticonvulsants|mesh-ancestor
6016272|NCT00364013|Panitumumab|panitumumab|mesh-list
6016273|NCT00364013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6016274|NCT00364013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6016275|NCT00364156|Nicotine|nicotine|mesh-list
6016276|NCT00364156|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6016277|NCT00364156|Autonomic Agents|autonomic agents|mesh-ancestor
6016278|NCT00364156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6016279|NCT00364156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016280|NCT00364156|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6016281|NCT00364156|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6016282|NCT00364156|Cholinergic Agents|cholinergic agents|mesh-ancestor
5724556|NCT03186482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5724557|NCT03186482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5724558|NCT03186482|Leprostatic Agents|leprostatic agents|mesh-ancestor
5724559|NCT03186482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5724560|NCT03186482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5724561|NCT03186482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016283|NCT00364156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6314414|NCT00003549|Immunologic Factors|immunologic factors|mesh-ancestor
6314415|NCT00003549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6314416|NCT00003549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5724562|NCT03186482|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5724563|NCT03186482|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5724564|NCT03186482|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5724565|NCT03186482|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5724566|NCT03186482|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5724567|NCT03186482|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5724568|NCT03186482|Antiviral Agents|antiviral agents|mesh-ancestor
5724569|NCT03186482|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5724570|NCT03186482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5724571|NCT03186482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5724572|NCT03186313|Ribavirin|ribavirin|mesh-list
5724573|NCT03186313|Sofosbuvir|sofosbuvir|mesh-list
5724574|NCT03186313|Antimetabolites|antimetabolites|mesh-ancestor
5724575|NCT03186313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314417|NCT00003549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6314418|NCT00003549|Alkylating Agents|alkylating agents|mesh-ancestor
6314419|NCT00003549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314420|NCT00003549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314421|NCT00003549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6314422|NCT00003549|Antimetabolites|antimetabolites|mesh-ancestor
6314423|NCT00003549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6314424|NCT00003549|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6314425|NCT00003549|Abortifacient Agents|abortifacient agents|mesh-ancestor
6314426|NCT00003549|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6314427|NCT00003549|Dermatologic Agents|dermatologic agents|mesh-ancestor
6314428|NCT00003549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6314429|NCT00003549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6314430|NCT00003549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6314431|NCT00003552|Cyclophosphamide|cyclophosphamide|mesh-list
6314432|NCT00003552|Fludarabine|fludarabine|mesh-list
6314433|NCT00003552|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6314434|NCT00003552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6314435|NCT00003552|Immunologic Factors|immunologic factors|mesh-ancestor
6314436|NCT00003552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6314437|NCT00003552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6314438|NCT00003552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6314439|NCT00003552|Alkylating Agents|alkylating agents|mesh-ancestor
6314440|NCT00003552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314441|NCT00003552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314442|NCT00003552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6314443|NCT00003554|Prednisone|prednisone|mesh-list
6314444|NCT00003554|Rituximab|rituximab|mesh-list
6314445|NCT00003554|Melphalan|melphalan|mesh-list
6314446|NCT00003554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6314447|NCT00003554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314448|NCT00003554|Immunologic Factors|immunologic factors|mesh-ancestor
6314449|NCT00003554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6314450|NCT00003554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6314451|NCT00003554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6314452|NCT00003554|Glucocorticoids|glucocorticoids|mesh-ancestor
6314453|NCT00003554|Hormones|hormones|mesh-ancestor
6314454|NCT00003554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6314455|NCT00003554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6314456|NCT00003554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6314457|NCT00003554|Alkylating Agents|alkylating agents|mesh-ancestor
6314458|NCT00003554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314459|NCT00003554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6314460|NCT00003554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6314461|NCT00003555|Paclitaxel|paclitaxel|mesh-list
6314462|NCT00003555|Amifostine|amifostine|mesh-list
6314463|NCT00003555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6314464|NCT00003555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314465|NCT00003555|Tubulin Modulators|tubulin modulators|mesh-ancestor
6314466|NCT00003555|Antimitotic Agents|antimitotic agents|mesh-ancestor
6314467|NCT00003555|Mitosis Modulators|mitosis modulators|mesh-ancestor
6314468|NCT00003555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314469|NCT00003555|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6314470|NCT00003555|Protective Agents|protective agents|mesh-ancestor
6314471|NCT00003555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6314472|NCT00003557|Dolastatin 10|dolastatin 10|mesh-list
6314473|NCT00003557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314474|NCT00003557|Tubulin Modulators|tubulin modulators|mesh-ancestor
6314475|NCT00003557|Antimitotic Agents|antimitotic agents|mesh-ancestor
6314476|NCT00003557|Mitosis Modulators|mitosis modulators|mesh-ancestor
6314477|NCT00003557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314478|NCT00003558|Leucovorin|leucovorin|mesh-list
6314479|NCT00003558|Paclitaxel|paclitaxel|mesh-list
6314480|NCT00003558|Etoposide|etoposide|mesh-list
6314481|NCT00003558|Carboplatin|carboplatin|mesh-list
6314482|NCT00003558|Fluorouracil|fluorouracil|mesh-list
6314483|NCT00003558|Calcium|calcium|mesh-list
6314484|NCT00003558|Levoleucovorin|levoleucovorin|mesh-list
6314485|NCT00003558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6314486|NCT00003558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314487|NCT00003558|Tubulin Modulators|tubulin modulators|mesh-ancestor
6314488|NCT00003558|Antimitotic Agents|antimitotic agents|mesh-ancestor
6016284|NCT00364156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016285|NCT00364286|Dasatinib|dasatinib|mesh-list
6016286|NCT00364286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6016287|NCT00364286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6016288|NCT00364286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6016289|NCT00364286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016290|NCT00364351|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6016291|NCT00364351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6016292|NCT00364351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6016293|NCT00364351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6016294|NCT00364351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016295|NCT00364377|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6314489|NCT00003558|Mitosis Modulators|mitosis modulators|mesh-ancestor
6314490|NCT00003558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392555|NCT00196755|Calcium acetate|calcium acetate|mesh-list
6314491|NCT00003558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6314492|NCT00003558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6314493|NCT00003558|Antimetabolites|antimetabolites|mesh-ancestor
6314494|NCT00003558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6314495|NCT00003558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6314496|NCT00003558|Immunologic Factors|immunologic factors|mesh-ancestor
6314497|NCT00003558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6314498|NCT00003558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6314499|NCT00003558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6314500|NCT00003558|Antidotes|antidotes|mesh-ancestor
6314501|NCT00003558|Protective Agents|protective agents|mesh-ancestor
6314502|NCT00003558|Vitamin B Complex|vitamin b complex|mesh-ancestor
6314503|NCT00003558|Vitamins|vitamins|mesh-ancestor
6314504|NCT00003558|Micronutrients|micronutrients|mesh-ancestor
6314505|NCT00003560|Carboplatin|carboplatin|mesh-list
6314506|NCT00003560|Docetaxel|docetaxel|mesh-list
6314507|NCT00003560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314508|NCT00003560|Tubulin Modulators|tubulin modulators|mesh-ancestor
6314509|NCT00003560|Antimitotic Agents|antimitotic agents|mesh-ancestor
6314510|NCT00003560|Mitosis Modulators|mitosis modulators|mesh-ancestor
6314511|NCT00003560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314512|NCT00003561|Interferons|interferons|mesh-list
6314513|NCT00003561|Interferon-alpha|interferon-alpha|mesh-list
6314514|NCT00003561|Sargramostim|sargramostim|mesh-list
6314515|NCT00003561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314516|NCT00003561|Antiviral Agents|antiviral agents|mesh-ancestor
6314517|NCT00003561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6314518|NCT00003561|Immunologic Factors|immunologic factors|mesh-ancestor
6314519|NCT00003561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6314520|NCT00003562|Carboplatin|carboplatin|mesh-list
6314521|NCT00003562|Docetaxel|docetaxel|mesh-list
6314522|NCT00003562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314523|NCT00003562|Tubulin Modulators|tubulin modulators|mesh-ancestor
6314524|NCT00003562|Antimitotic Agents|antimitotic agents|mesh-ancestor
6314525|NCT00003562|Mitosis Modulators|mitosis modulators|mesh-ancestor
6314526|NCT00003562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314527|NCT00003564|Procarbazine|procarbazine|mesh-list
6314528|NCT00003564|Isotretinoin|isotretinoin|mesh-list
6314529|NCT00003564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314530|NCT00003564|Dermatologic Agents|dermatologic agents|mesh-ancestor
6314531|NCT00003565|Docetaxel|docetaxel|mesh-list
6314532|NCT00003565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314533|NCT00003565|Tubulin Modulators|tubulin modulators|mesh-ancestor
6314534|NCT00003565|Antimitotic Agents|antimitotic agents|mesh-ancestor
6314535|NCT00003565|Mitosis Modulators|mitosis modulators|mesh-ancestor
6314536|NCT00003565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314537|NCT00003567|Temozolomide|temozolomide|mesh-list
6314538|NCT00003567|Carmustine|carmustine|mesh-list
6314539|NCT00003567|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
6314540|NCT00003567|Sargramostim|sargramostim|mesh-list
6314541|NCT00003567|Immunologic Factors|immunologic factors|mesh-ancestor
6314542|NCT00003567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6314543|NCT00003567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6314544|NCT00003567|Alkylating Agents|alkylating agents|mesh-ancestor
6314545|NCT00003567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314546|NCT00003567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314547|NCT00003567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6314548|NCT00003568|Aldesleukin|aldesleukin|mesh-list
6314549|NCT00003568|Freund's Adjuvant|freund's adjuvant|mesh-list
6314550|NCT00003568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314551|NCT00003568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6314552|NCT00003568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5724576|NCT03186313|Antiviral Agents|antiviral agents|mesh-ancestor
5724577|NCT03186313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5724680|NCT03185624|Rifaximin|rifaximin|mesh-list
5724681|NCT03185624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5724682|NCT03185624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5724683|NCT03185624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5724684|NCT03185429|Cyclophosphamide|cyclophosphamide|mesh-list
5724685|NCT03185429|Immunologic Factors|immunologic factors|mesh-ancestor
5724686|NCT03185429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724687|NCT03185429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5724688|NCT03185429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5724689|NCT03185429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5724690|NCT03185429|Alkylating Agents|alkylating agents|mesh-ancestor
5724691|NCT03185429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724692|NCT03185429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5724693|NCT03185429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5724694|NCT03185364|Sildenafil Citrate|sildenafil citrate|mesh-list
5724695|NCT03185364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016296|NCT00364377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6314553|NCT00003568|Antiviral Agents|antiviral agents|mesh-ancestor
6314554|NCT00003568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6314555|NCT00003568|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6314556|NCT00003568|Immunologic Factors|immunologic factors|mesh-ancestor
6314557|NCT00003568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6314558|NCT00003569|Paclitaxel|paclitaxel|mesh-list
6314559|NCT00003569|Cisplatin|cisplatin|mesh-list
6314560|NCT00003569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6314561|NCT00003569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314562|NCT00003569|Tubulin Modulators|tubulin modulators|mesh-ancestor
6314563|NCT00003569|Antimitotic Agents|antimitotic agents|mesh-ancestor
6314564|NCT00003569|Mitosis Modulators|mitosis modulators|mesh-ancestor
6314565|NCT00003569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314566|NCT00003572|Mycophenolic Acid|mycophenolic acid|mesh-list
6314567|NCT00003572|Tacrolimus|tacrolimus|mesh-list
6314568|NCT00003572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6314569|NCT00003572|Immunologic Factors|immunologic factors|mesh-ancestor
6314570|NCT00003572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6314571|NCT00003572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6314572|NCT00003572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6314573|NCT00003572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314574|NCT00003572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6314575|NCT00003572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6016297|NCT00364377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016298|NCT00364377|Incretins|incretins|mesh-ancestor
6016299|NCT00364377|Hormones|hormones|mesh-ancestor
6016300|NCT00364377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6016301|NCT00364377|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6016302|NCT00364377|Protease Inhibitors|protease inhibitors|mesh-ancestor
6016303|NCT00364377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6016304|NCT00364377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314576|NCT00003572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6314577|NCT00003572|Antitubercular Agents|antitubercular agents|mesh-ancestor
6314578|NCT00003572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6314579|NCT00003572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6314580|NCT00003573|Cyclophosphamide|cyclophosphamide|mesh-list
6314581|NCT00003573|Cisplatin|cisplatin|mesh-list
6314582|NCT00003573|Etoposide|etoposide|mesh-list
6016305|NCT00364533|Oxycodone|oxycodone|mesh-list
6016306|NCT00364533|Tapentadol|tapentadol|mesh-list
6016307|NCT00364533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6016308|NCT00364533|Narcotics|narcotics|mesh-ancestor
6016309|NCT00364533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6016310|NCT00364533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016311|NCT00364533|Analgesics|analgesics|mesh-ancestor
6016312|NCT00364533|Sensory System Agents|sensory system agents|mesh-ancestor
6016313|NCT00364533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6016314|NCT00364533|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6016315|NCT00364533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6016316|NCT00364533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6016317|NCT00364533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016318|NCT00364533|Adrenergic Agents|adrenergic agents|mesh-ancestor
6016319|NCT00364533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6016320|NCT00364611|Bevacizumab|bevacizumab|mesh-list
6016321|NCT00364611|Trastuzumab|trastuzumab|mesh-list
6016322|NCT00364611|Docetaxel|docetaxel|mesh-list
6016323|NCT00364611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6016324|NCT00364611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6016325|NCT00364611|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6016326|NCT00364611|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6314583|NCT00003573|Vincristine|vincristine|mesh-list
6314584|NCT00003573|Lenograstim|lenograstim|mesh-list
6314585|NCT00003573|Sargramostim|sargramostim|mesh-list
6314586|NCT00003573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6314587|NCT00003573|Immunologic Factors|immunologic factors|mesh-ancestor
6314588|NCT00003573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6314589|NCT00003573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6314590|NCT00003573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6314591|NCT00003573|Alkylating Agents|alkylating agents|mesh-ancestor
6314592|NCT00003573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314593|NCT00003573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314594|NCT00003573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6314595|NCT00003573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6314596|NCT00003573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6314597|NCT00003573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6314598|NCT00003573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6314599|NCT00003573|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6314600|NCT00003573|Tubulin Modulators|tubulin modulators|mesh-ancestor
6314601|NCT00003573|Antimitotic Agents|antimitotic agents|mesh-ancestor
6314602|NCT00003573|Mitosis Modulators|mitosis modulators|mesh-ancestor
6314603|NCT00003575|Etoposide|etoposide|mesh-list
6314604|NCT00003575|Ifosfamide|ifosfamide|mesh-list
6314605|NCT00003575|Interleukin-12|interleukin-12|mesh-list
6314606|NCT00003575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6314607|NCT00003575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314608|NCT00003575|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6016327|NCT00364611|Growth Substances|growth substances|mesh-ancestor
6016328|NCT00364611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016329|NCT00364611|Growth Inhibitors|growth inhibitors|mesh-ancestor
6016330|NCT00364611|Tubulin Modulators|tubulin modulators|mesh-ancestor
6016331|NCT00364611|Antimitotic Agents|antimitotic agents|mesh-ancestor
6016332|NCT00364611|Mitosis Modulators|mitosis modulators|mesh-ancestor
6016333|NCT00364611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016334|NCT00364793|Emtricitabine|emtricitabine|mesh-list
6016335|NCT00364793|Efavirenz|efavirenz|mesh-list
6016336|NCT00364793|Didanosine|didanosine|mesh-list
6016337|NCT00364793|Antiviral Agents|antiviral agents|mesh-ancestor
6016338|NCT00364793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6314609|NCT00003575|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6314610|NCT00003575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6314611|NCT00003575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314612|NCT00003575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6314613|NCT00003575|Immunologic Factors|immunologic factors|mesh-ancestor
6314614|NCT00003575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6314615|NCT00003575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6314616|NCT00003575|Alkylating Agents|alkylating agents|mesh-ancestor
6314617|NCT00003575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6314618|NCT00003575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6314619|NCT00003575|Growth Substances|growth substances|mesh-ancestor
6314620|NCT00003575|Growth Inhibitors|growth inhibitors|mesh-ancestor
6314621|NCT00003576|Fluorouracil|fluorouracil|mesh-list
6314622|NCT00003576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314623|NCT00003576|Antimetabolites|antimetabolites|mesh-ancestor
6314624|NCT00003576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314625|NCT00003576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6314626|NCT00003576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6314627|NCT00003576|Immunologic Factors|immunologic factors|mesh-ancestor
6314628|NCT00003576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6314629|NCT00003577|Cyclophosphamide|cyclophosphamide|mesh-list
6314630|NCT00003577|Fluorouracil|fluorouracil|mesh-list
6314631|NCT00003577|Methotrexate|methotrexate|mesh-list
6314632|NCT00003577|Epirubicin|epirubicin|mesh-list
6314633|NCT00003577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6314634|NCT00003577|Immunologic Factors|immunologic factors|mesh-ancestor
6314635|NCT00003577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6314636|NCT00003577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6314637|NCT00003577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6314638|NCT00003577|Alkylating Agents|alkylating agents|mesh-ancestor
6314639|NCT00003577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314640|NCT00003577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314641|NCT00003577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6314642|NCT00003577|Antimetabolites|antimetabolites|mesh-ancestor
6314643|NCT00003577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6314644|NCT00003577|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6314645|NCT00003577|Abortifacient Agents|abortifacient agents|mesh-ancestor
6314646|NCT00003577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6314647|NCT00003577|Dermatologic Agents|dermatologic agents|mesh-ancestor
6314648|NCT00003577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6314649|NCT00003577|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6314650|NCT00003577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6314651|NCT00003577|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6314652|NCT00003577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6314653|NCT00003577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6314654|NCT00003578|Cytarabine|cytarabine|mesh-list
6314655|NCT00003578|Prednisone|prednisone|mesh-list
6314656|NCT00003578|Cyclophosphamide|cyclophosphamide|mesh-list
6314657|NCT00003578|Melphalan|melphalan|mesh-list
6314658|NCT00003578|Carmustine|carmustine|mesh-list
6314659|NCT00003578|Doxorubicin|doxorubicin|mesh-list
6314660|NCT00003578|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6314661|NCT00003578|Etoposide|etoposide|mesh-list
6314662|NCT00003578|Vincristine|vincristine|mesh-list
6314663|NCT00003578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6314664|NCT00003578|Immunologic Factors|immunologic factors|mesh-ancestor
6314665|NCT00003578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6314666|NCT00003578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6314667|NCT00003578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6314668|NCT00003578|Alkylating Agents|alkylating agents|mesh-ancestor
6314669|NCT00003578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314670|NCT00003578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6016339|NCT00364793|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6016340|NCT00364793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6016341|NCT00364793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6016342|NCT00364793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016343|NCT00364793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6016344|NCT00364793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6016345|NCT00364793|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6016346|NCT00364793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6016347|NCT00364793|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6016348|NCT00364793|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6016349|NCT00364793|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6314671|NCT00003578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6314672|NCT00003578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6314673|NCT00003578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6314674|NCT00003578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6314675|NCT00003578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6314676|NCT00003578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6314677|NCT00003578|Glucocorticoids|glucocorticoids|mesh-ancestor
6314678|NCT00003578|Hormones|hormones|mesh-ancestor
6314679|NCT00003578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6314680|NCT00003578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6016350|NCT00364793|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6016351|NCT00364793|Antimetabolites|antimetabolites|mesh-ancestor
6016352|NCT00364819|Rituximab|rituximab|mesh-list
6016353|NCT00364819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6016354|NCT00364819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6016355|NCT00364819|Immunologic Factors|immunologic factors|mesh-ancestor
6016356|NCT00364819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016357|NCT00364819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6016358|NCT00364832|Epoetin Alfa|epoetin alfa|mesh-list
6016359|NCT00364832|Hematinics|hematinics|mesh-ancestor
6016360|NCT00364845|Darbepoetin alfa|darbepoetin alfa|mesh-list
6016361|NCT00364845|Hematinics|hematinics|mesh-ancestor
6016362|NCT00364923|10-deazaaminopterin|10-deazaaminopterin|mesh-list
6016363|NCT00364923|Aminopterin|aminopterin|mesh-list
6016364|NCT00364923|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6016365|NCT00364923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6016366|NCT00364923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016367|NCT00364923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6016368|NCT00365053|Belinostat|belinostat|mesh-list
6016369|NCT00365053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6016370|NCT00365053|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6016371|NCT00365053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6016372|NCT00365053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016373|NCT00365105|Vitamin D|vitamin d|mesh-list
6016374|NCT00365105|Zoledronic Acid|zoledronic acid|mesh-list
6016375|NCT00365105|Calcium|calcium|mesh-list
6016376|NCT00365105|Vitamins|vitamins|mesh-ancestor
6016377|NCT00365105|Micronutrients|micronutrients|mesh-ancestor
6016378|NCT00365105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016379|NCT00365105|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6016380|NCT00365105|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6016381|NCT00365144|Bevacizumab|bevacizumab|mesh-list
6016382|NCT00365144|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6016383|NCT00365144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6016384|NCT00365144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6016385|NCT00365144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6016386|NCT00365144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6016387|NCT00365144|Growth Substances|growth substances|mesh-ancestor
6016388|NCT00365144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016389|NCT00365144|Growth Inhibitors|growth inhibitors|mesh-ancestor
6016390|NCT00365144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6016391|NCT00365144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6314681|NCT00003578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6314682|NCT00003578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6314683|NCT00003578|Antimetabolites|antimetabolites|mesh-ancestor
6314684|NCT00003578|Antiviral Agents|antiviral agents|mesh-ancestor
6314685|NCT00003578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6314686|NCT00003578|Tubulin Modulators|tubulin modulators|mesh-ancestor
6314687|NCT00003578|Antimitotic Agents|antimitotic agents|mesh-ancestor
6314688|NCT00003578|Mitosis Modulators|mitosis modulators|mesh-ancestor
6314689|NCT00003580|Amifostine|amifostine|mesh-list
6314690|NCT00003580|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6314691|NCT00003580|Protective Agents|protective agents|mesh-ancestor
6314692|NCT00003580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6314693|NCT00003582|Paclitaxel|paclitaxel|mesh-list
6314694|NCT00003582|Fluorouracil|fluorouracil|mesh-list
6314695|NCT00003582|Amifostine|amifostine|mesh-list
6314696|NCT00003582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6314697|NCT00003582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314698|NCT00003582|Tubulin Modulators|tubulin modulators|mesh-ancestor
6314699|NCT00003582|Antimitotic Agents|antimitotic agents|mesh-ancestor
6314700|NCT00003582|Mitosis Modulators|mitosis modulators|mesh-ancestor
6314701|NCT00003582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314702|NCT00003582|Antimetabolites|antimetabolites|mesh-ancestor
6314703|NCT00003582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6314704|NCT00003582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6314705|NCT00003582|Immunologic Factors|immunologic factors|mesh-ancestor
6314706|NCT00003582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6314707|NCT00003582|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6314708|NCT00003582|Protective Agents|protective agents|mesh-ancestor
6314709|NCT00003583|Etoposide|etoposide|mesh-list
6314710|NCT00003583|Amifostine|amifostine|mesh-list
6314711|NCT00003583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314712|NCT00003583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6314713|NCT00003583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6314714|NCT00003583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6314715|NCT00003583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6314716|NCT00003583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314717|NCT00003583|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6314718|NCT00003583|Protective Agents|protective agents|mesh-ancestor
6314719|NCT00003583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6314720|NCT00003584|Prednisone|prednisone|mesh-list
6314721|NCT00003584|Estramustine|estramustine|mesh-list
6314722|NCT00003584|Vinorelbine|vinorelbine|mesh-list
6314723|NCT00003584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6314724|NCT00003584|Glucocorticoids|glucocorticoids|mesh-ancestor
6314725|NCT00003584|Hormones|hormones|mesh-ancestor
6314726|NCT00003584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6314727|NCT00003584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6314728|NCT00003584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6314729|NCT00003584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314730|NCT00003584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6314731|NCT00003584|Tubulin Modulators|tubulin modulators|mesh-ancestor
6314732|NCT00003584|Antimitotic Agents|antimitotic agents|mesh-ancestor
6314733|NCT00003584|Mitosis Modulators|mitosis modulators|mesh-ancestor
6314734|NCT00003584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314735|NCT00003584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6314736|NCT00003584|Alkylating Agents|alkylating agents|mesh-ancestor
6314737|NCT00003585|Interferons|interferons|mesh-list
6314738|NCT00003585|Interferon-alpha|interferon-alpha|mesh-list
6016392|NCT00365144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016393|NCT00365209|Curcumin|curcumin|mesh-list
6016394|NCT00365209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6016395|NCT00365209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6016396|NCT00365209|Analgesics|analgesics|mesh-ancestor
6016397|NCT00365209|Sensory System Agents|sensory system agents|mesh-ancestor
6016398|NCT00365209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6314739|NCT00003585|Aldesleukin|aldesleukin|mesh-list
6314740|NCT00003585|Fluorouracil|fluorouracil|mesh-list
6314741|NCT00003585|Isotretinoin|isotretinoin|mesh-list
6314742|NCT00003585|Antimetabolites|antimetabolites|mesh-ancestor
6314743|NCT00003585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314744|NCT00003585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6314745|NCT00003585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314746|NCT00003585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6314747|NCT00003585|Immunologic Factors|immunologic factors|mesh-ancestor
6314748|NCT00003585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6314749|NCT00003585|Antiviral Agents|antiviral agents|mesh-ancestor
6314750|NCT00003585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6314751|NCT00003585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6314752|NCT00003585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6314753|NCT00003585|Dermatologic Agents|dermatologic agents|mesh-ancestor
6314754|NCT00003587|Gemcitabine|gemcitabine|mesh-list
6314755|NCT00003587|Paclitaxel|paclitaxel|mesh-list
6314756|NCT00003587|Vinorelbine|vinorelbine|mesh-list
6314757|NCT00003587|Docetaxel|docetaxel|mesh-list
6314758|NCT00003587|Carboplatin|carboplatin|mesh-list
6314759|NCT00003587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6314760|NCT00003587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314761|NCT00003587|Tubulin Modulators|tubulin modulators|mesh-ancestor
6314762|NCT00003587|Antimitotic Agents|antimitotic agents|mesh-ancestor
6314763|NCT00003587|Mitosis Modulators|mitosis modulators|mesh-ancestor
6314764|NCT00003587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314765|NCT00003587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6314766|NCT00003587|Antimetabolites|antimetabolites|mesh-ancestor
6314767|NCT00003587|Antiviral Agents|antiviral agents|mesh-ancestor
6314768|NCT00003587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6314769|NCT00003587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6314770|NCT00003587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6314771|NCT00003587|Immunologic Factors|immunologic factors|mesh-ancestor
6314772|NCT00003587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6314773|NCT00003589|Gemcitabine|gemcitabine|mesh-list
6314774|NCT00003589|Paclitaxel|paclitaxel|mesh-list
6314775|NCT00003589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6314776|NCT00003589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314777|NCT00003589|Tubulin Modulators|tubulin modulators|mesh-ancestor
6314778|NCT00003589|Antimitotic Agents|antimitotic agents|mesh-ancestor
6314779|NCT00003589|Mitosis Modulators|mitosis modulators|mesh-ancestor
6314780|NCT00003589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314781|NCT00003589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6314782|NCT00003589|Antimetabolites|antimetabolites|mesh-ancestor
6314783|NCT00003589|Antiviral Agents|antiviral agents|mesh-ancestor
6314784|NCT00003589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6314785|NCT00003589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6314786|NCT00003589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6314787|NCT00003589|Immunologic Factors|immunologic factors|mesh-ancestor
6314788|NCT00003589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6314789|NCT00003591|Paclitaxel|paclitaxel|mesh-list
6314790|NCT00003591|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6016399|NCT00365209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016400|NCT00365209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6016401|NCT00365209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6016402|NCT00365209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314791|NCT00003591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314792|NCT00003591|Tubulin Modulators|tubulin modulators|mesh-ancestor
6314793|NCT00003591|Antimitotic Agents|antimitotic agents|mesh-ancestor
6314794|NCT00003591|Mitosis Modulators|mitosis modulators|mesh-ancestor
6314795|NCT00003591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314796|NCT00003592|Paclitaxel|paclitaxel|mesh-list
6314797|NCT00003592|Methotrexate|methotrexate|mesh-list
6314798|NCT00003592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6314799|NCT00003592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314800|NCT00003592|Tubulin Modulators|tubulin modulators|mesh-ancestor
6314801|NCT00003592|Antimitotic Agents|antimitotic agents|mesh-ancestor
6314802|NCT00003592|Mitosis Modulators|mitosis modulators|mesh-ancestor
6314803|NCT00003592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314804|NCT00003592|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6314805|NCT00003592|Abortifacient Agents|abortifacient agents|mesh-ancestor
6314806|NCT00003592|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6314807|NCT00003592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6314808|NCT00003592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6314809|NCT00003592|Antimetabolites|antimetabolites|mesh-ancestor
6314810|NCT00003592|Dermatologic Agents|dermatologic agents|mesh-ancestor
6314811|NCT00003592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6314812|NCT00003592|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6314813|NCT00003592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6314814|NCT00003592|Immunologic Factors|immunologic factors|mesh-ancestor
6314815|NCT00003592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6314816|NCT00003592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6392556|NCT00196755|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6392557|NCT00196755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392558|NCT00196755|Chelating Agents|chelating agents|mesh-ancestor
6392559|NCT00196755|Sequestering Agents|sequestering agents|mesh-ancestor
6392560|NCT00196755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392561|NCT00196768|Arsenic Trioxide|arsenic trioxide|mesh-list
6392562|NCT00196768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6392563|NCT00196820|Capecitabine|capecitabine|mesh-list
6392564|NCT00196820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6392565|NCT00196820|Antimetabolites|antimetabolites|mesh-ancestor
6392566|NCT00196820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392567|NCT00196820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6392568|NCT00196846|Goserelin|goserelin|mesh-list
6392569|NCT00196846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6392570|NCT00196846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6392571|NCT00196859|Ibandronic Acid|ibandronic acid|mesh-list
6392572|NCT00196859|Capecitabine|capecitabine|mesh-list
6392573|NCT00196859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6392574|NCT00196859|Antimetabolites|antimetabolites|mesh-ancestor
6392575|NCT00196859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392576|NCT00196859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6392577|NCT00196859|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6392578|NCT00196859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392579|NCT00196872|Cyclophosphamide|cyclophosphamide|mesh-list
6392580|NCT00196872|Epirubicin|epirubicin|mesh-list
6392581|NCT00196872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6392582|NCT00196872|Immunologic Factors|immunologic factors|mesh-ancestor
6392583|NCT00196872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392584|NCT00196872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6392585|NCT00196872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6392586|NCT00196872|Alkylating Agents|alkylating agents|mesh-ancestor
6392587|NCT00196872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392588|NCT00196872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6392589|NCT00196872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6392590|NCT00196872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6392591|NCT00196872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6392592|NCT00196872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6392593|NCT00196872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6392594|NCT00196885|Acetylcysteine|acetylcysteine|mesh-list
6392595|NCT00196885|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6392596|NCT00196885|Antiviral Agents|antiviral agents|mesh-ancestor
6392597|NCT00196885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6392598|NCT00196885|Expectorants|expectorants|mesh-ancestor
6392599|NCT00196885|Respiratory System Agents|respiratory system agents|mesh-ancestor
6314817|NCT00003593|Cytarabine|cytarabine|mesh-list
6314818|NCT00003593|Hydrocortisone|hydrocortisone|mesh-list
6314819|NCT00003593|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6314820|NCT00003593|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6314821|NCT00003593|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6314822|NCT00003593|Methotrexate|methotrexate|mesh-list
6314823|NCT00003593|Thioguanine|thioguanine|mesh-list
6314824|NCT00003593|Daunorubicin|daunorubicin|mesh-list
6314825|NCT00003593|Asparaginase|asparaginase|mesh-list
6314826|NCT00003593|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6314827|NCT00003593|Abortifacient Agents|abortifacient agents|mesh-ancestor
6314828|NCT00003593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6314829|NCT00003593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6314830|NCT00003593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6314831|NCT00003593|Antimetabolites|antimetabolites|mesh-ancestor
6314832|NCT00003593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314833|NCT00003593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314834|NCT00003593|Dermatologic Agents|dermatologic agents|mesh-ancestor
6314835|NCT00003593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6314836|NCT00003593|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6314837|NCT00003593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6314838|NCT00003593|Immunologic Factors|immunologic factors|mesh-ancestor
6314839|NCT00003593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6314840|NCT00003593|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6314841|NCT00003593|Antiviral Agents|antiviral agents|mesh-ancestor
6314842|NCT00003593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6314843|NCT00003593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6314844|NCT00003593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6314845|NCT00003593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6314846|NCT00003593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6314847|NCT00003594|Leucovorin|leucovorin|mesh-list
6314848|NCT00003594|Fluorouracil|fluorouracil|mesh-list
6314849|NCT00003594|Oxaliplatin|oxaliplatin|mesh-list
6314850|NCT00003594|Irinotecan|irinotecan|mesh-list
6314851|NCT00003594|Calcium|calcium|mesh-list
6314852|NCT00003594|Levoleucovorin|levoleucovorin|mesh-list
6314853|NCT00003594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6016403|NCT00365209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6016404|NCT00365209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016405|NCT00365261|Eszopiclone|eszopiclone|mesh-list
6016406|NCT00365261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6314854|NCT00003594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6314855|NCT00003594|Antimetabolites|antimetabolites|mesh-ancestor
6314856|NCT00003594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314857|NCT00003594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6314858|NCT00003594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314859|NCT00003594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6314860|NCT00003594|Immunologic Factors|immunologic factors|mesh-ancestor
6314861|NCT00003594|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6314862|NCT00003594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6314863|NCT00003594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6314864|NCT00003594|Antidotes|antidotes|mesh-ancestor
6314865|NCT00003594|Protective Agents|protective agents|mesh-ancestor
6314866|NCT00003594|Vitamin B Complex|vitamin b complex|mesh-ancestor
6314867|NCT00003594|Vitamins|vitamins|mesh-ancestor
6314868|NCT00003594|Micronutrients|micronutrients|mesh-ancestor
6314869|NCT00003595|Prednisone|prednisone|mesh-list
6314870|NCT00003595|Cyclophosphamide|cyclophosphamide|mesh-list
6314871|NCT00003595|Rituximab|rituximab|mesh-list
6314872|NCT00003595|Doxorubicin|doxorubicin|mesh-list
6314873|NCT00003595|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6314874|NCT00003595|Vincristine|vincristine|mesh-list
6314875|NCT00003595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6314876|NCT00003595|Immunologic Factors|immunologic factors|mesh-ancestor
6314877|NCT00003595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6314878|NCT00003595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6314879|NCT00003595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6314880|NCT00003595|Alkylating Agents|alkylating agents|mesh-ancestor
6314881|NCT00003595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314882|NCT00003595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314883|NCT00003595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6314884|NCT00003595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6314885|NCT00003595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6314886|NCT00003595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6314887|NCT00003595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6314888|NCT00003595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6314889|NCT00003595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6314890|NCT00003595|Glucocorticoids|glucocorticoids|mesh-ancestor
6314891|NCT00003595|Hormones|hormones|mesh-ancestor
6314892|NCT00003595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6314893|NCT00003595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6314894|NCT00003595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6314895|NCT00003595|Tubulin Modulators|tubulin modulators|mesh-ancestor
6314896|NCT00003595|Antimitotic Agents|antimitotic agents|mesh-ancestor
6314897|NCT00003595|Mitosis Modulators|mitosis modulators|mesh-ancestor
6314898|NCT00003596|Fluorouracil|fluorouracil|mesh-list
6314899|NCT00003596|Mitomycins|mitomycins|mesh-list
6314900|NCT00003596|Mitomycin|mitomycin|mesh-list
6314901|NCT00003596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314902|NCT00003596|Antimetabolites|antimetabolites|mesh-ancestor
6314903|NCT00003596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314904|NCT00003596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6314905|NCT00003596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6314906|NCT00003596|Immunologic Factors|immunologic factors|mesh-ancestor
6314907|NCT00003596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6314908|NCT00003596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6314909|NCT00003596|Alkylating Agents|alkylating agents|mesh-ancestor
6314910|NCT00003596|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6314911|NCT00003596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6314912|NCT00003597|Carboplatin|carboplatin|mesh-list
6314913|NCT00003597|Etoposide|etoposide|mesh-list
6314914|NCT00003597|Ifosfamide|ifosfamide|mesh-list
6314915|NCT00003597|Lenograstim|lenograstim|mesh-list
6314916|NCT00003597|Sargramostim|sargramostim|mesh-list
6314917|NCT00003597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314918|NCT00003597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6314919|NCT00003597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6314920|NCT00003597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6314921|NCT00003597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6314922|NCT00003597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314923|NCT00003597|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6314924|NCT00003597|Immunologic Factors|immunologic factors|mesh-ancestor
6314925|NCT00003597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6314926|NCT00003597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6314927|NCT00003597|Alkylating Agents|alkylating agents|mesh-ancestor
6314928|NCT00003598|Tretinoin|tretinoin|mesh-list
6314929|NCT00003598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314930|NCT00003598|Keratolytic Agents|keratolytic agents|mesh-ancestor
6314931|NCT00003598|Dermatologic Agents|dermatologic agents|mesh-ancestor
6314932|NCT00003599|Vitamin E|vitamin e|mesh-list
6314933|NCT00003599|Tocopherols|tocopherols|mesh-list
6314934|NCT00003599|alpha-Tocopherol|alpha-tocopherol|mesh-list
6314935|NCT00003599|Isotretinoin|isotretinoin|mesh-list
6314936|NCT00003599|Vitamins|vitamins|mesh-ancestor
6314937|NCT00003599|Micronutrients|micronutrients|mesh-ancestor
6314938|NCT00003599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6314939|NCT00003599|Antioxidants|antioxidants|mesh-ancestor
6314940|NCT00003599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314941|NCT00003599|Protective Agents|protective agents|mesh-ancestor
6314942|NCT00003599|Dermatologic Agents|dermatologic agents|mesh-ancestor
6314943|NCT00003600|Epoetin Alfa|epoetin alfa|mesh-list
6314944|NCT00003600|Hematinics|hematinics|mesh-ancestor
6314945|NCT00003601|Tretinoin|tretinoin|mesh-list
6314946|NCT00003601|Fenretinide|fenretinide|mesh-list
6314947|NCT00003601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314948|NCT00003601|Keratolytic Agents|keratolytic agents|mesh-ancestor
6314949|NCT00003601|Dermatologic Agents|dermatologic agents|mesh-ancestor
6314950|NCT00003601|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6314951|NCT00003601|Protective Agents|protective agents|mesh-ancestor
6314952|NCT00003601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6314953|NCT00003602|Cytarabine|cytarabine|mesh-list
6314954|NCT00003602|Etoposide|etoposide|mesh-list
6314955|NCT00003602|Mitoxantrone|mitoxantrone|mesh-list
6314956|NCT00003602|Idarubicin|idarubicin|mesh-list
6314957|NCT00003602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6314958|NCT00003602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314959|NCT00003602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6314960|NCT00003602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6314961|NCT00003602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6314962|NCT00003602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314963|NCT00003602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6314964|NCT00003602|Antimetabolites|antimetabolites|mesh-ancestor
6314965|NCT00003602|Antiviral Agents|antiviral agents|mesh-ancestor
6314966|NCT00003602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6314967|NCT00003602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6314968|NCT00003602|Immunologic Factors|immunologic factors|mesh-ancestor
6314969|NCT00003602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6314970|NCT00003602|Analgesics|analgesics|mesh-ancestor
6314971|NCT00003602|Sensory System Agents|sensory system agents|mesh-ancestor
6314972|NCT00003602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6314973|NCT00003602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6314974|NCT00003603|Dexamethasone|dexamethasone|mesh-list
6314975|NCT00003603|Prednisolone|prednisolone|mesh-list
6314976|NCT00003603|Cyclophosphamide|cyclophosphamide|mesh-list
6314977|NCT00003603|Melphalan|melphalan|mesh-list
6314978|NCT00003603|Lomustine|lomustine|mesh-list
6314979|NCT00003603|Idarubicin|idarubicin|mesh-list
6314980|NCT00003603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6314981|NCT00003603|Immunologic Factors|immunologic factors|mesh-ancestor
6314982|NCT00003603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6314983|NCT00003603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6314984|NCT00003603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6314985|NCT00003603|Alkylating Agents|alkylating agents|mesh-ancestor
6314986|NCT00003603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6314987|NCT00003603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6314988|NCT00003603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6314989|NCT00003603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6314990|NCT00003603|Antiemetics|antiemetics|mesh-ancestor
6314991|NCT00003603|Autonomic Agents|autonomic agents|mesh-ancestor
6314992|NCT00003603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6314993|NCT00003603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6314994|NCT00003603|Glucocorticoids|glucocorticoids|mesh-ancestor
6314995|NCT00003603|Hormones|hormones|mesh-ancestor
6314996|NCT00003603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6314997|NCT00003603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6314998|NCT00003603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6314999|NCT00003603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6315000|NCT00003603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6315001|NCT00003603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6315002|NCT00003604|Aldesleukin|aldesleukin|mesh-list
6315003|NCT00003604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315004|NCT00003604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6315005|NCT00003604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6315006|NCT00003604|Antiviral Agents|antiviral agents|mesh-ancestor
6315007|NCT00003604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6315008|NCT00003605|Cyclophosphamide|cyclophosphamide|mesh-list
6315009|NCT00003605|Rituximab|rituximab|mesh-list
6315010|NCT00003605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6315011|NCT00003605|Immunologic Factors|immunologic factors|mesh-ancestor
6315012|NCT00003605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6315013|NCT00003605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6315014|NCT00003605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6315015|NCT00003605|Alkylating Agents|alkylating agents|mesh-ancestor
6315016|NCT00003605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6315017|NCT00003605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315018|NCT00003605|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6315019|NCT00003605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6315020|NCT00003606|Cyclophosphamide|cyclophosphamide|mesh-list
6315021|NCT00003606|Etoposide|etoposide|mesh-list
6315022|NCT00003606|Epirubicin|epirubicin|mesh-list
6315023|NCT00003606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6315024|NCT00003606|Immunologic Factors|immunologic factors|mesh-ancestor
6315025|NCT00003606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6315026|NCT00003606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6315027|NCT00003606|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6315028|NCT00003606|Alkylating Agents|alkylating agents|mesh-ancestor
6315029|NCT00003606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6315030|NCT00003606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315031|NCT00003606|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6315032|NCT00003606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6315033|NCT00003606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6315034|NCT00003606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6315035|NCT00003606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6315036|NCT00003606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6315037|NCT00003610|Capsaicin|capsaicin|mesh-list
6315038|NCT00003610|Antipruritics|antipruritics|mesh-ancestor
6315039|NCT00003610|Dermatologic Agents|dermatologic agents|mesh-ancestor
6315040|NCT00003610|Sensory System Agents|sensory system agents|mesh-ancestor
6315041|NCT00003610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6315042|NCT00003610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6315043|NCT00003611|Acitretin|acitretin|mesh-list
6315044|NCT00003611|Keratolytic Agents|keratolytic agents|mesh-ancestor
6315045|NCT00003611|Dermatologic Agents|dermatologic agents|mesh-ancestor
6315046|NCT00003612|Paclitaxel|paclitaxel|mesh-list
6315047|NCT00003612|Carboplatin|carboplatin|mesh-list
6315048|NCT00003612|Trastuzumab|trastuzumab|mesh-list
6315049|NCT00003612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6315050|NCT00003612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315051|NCT00003612|Tubulin Modulators|tubulin modulators|mesh-ancestor
6315052|NCT00003612|Antimitotic Agents|antimitotic agents|mesh-ancestor
6315053|NCT00003612|Mitosis Modulators|mitosis modulators|mesh-ancestor
6315054|NCT00003612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6315055|NCT00003612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6315056|NCT00003613|Carmustine|carmustine|mesh-list
6315057|NCT00003613|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
6315058|NCT00003613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6315059|NCT00003613|Alkylating Agents|alkylating agents|mesh-ancestor
6315060|NCT00003613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016407|NCT00365261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6016408|NCT00365261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016409|NCT00365274|Prednisone|prednisone|mesh-list
6016410|NCT00365274|Cyclophosphamide|cyclophosphamide|mesh-list
6016411|NCT00365274|Doxorubicin|doxorubicin|mesh-list
6315061|NCT00003613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315062|NCT00003613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6315063|NCT00003614|Paclitaxel|paclitaxel|mesh-list
6315064|NCT00003614|Estramustine|estramustine|mesh-list
6315065|NCT00003614|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6315066|NCT00003614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315067|NCT00003614|Tubulin Modulators|tubulin modulators|mesh-ancestor
6315068|NCT00003614|Antimitotic Agents|antimitotic agents|mesh-ancestor
6315069|NCT00003614|Mitosis Modulators|mitosis modulators|mesh-ancestor
6315070|NCT00003614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6315071|NCT00003614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6315072|NCT00003614|Alkylating Agents|alkylating agents|mesh-ancestor
6315073|NCT00003614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6315074|NCT00003615|Denileukin diftitox|denileukin diftitox|mesh-list
6315075|NCT00003615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315076|NCT00003616|Irinotecan|irinotecan|mesh-list
6315077|NCT00003616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6315078|NCT00003616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6315079|NCT00003616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6315080|NCT00003616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6315081|NCT00003616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315082|NCT00003617|Clarithromycin|clarithromycin|mesh-list
6315083|NCT00003617|Tinidazole|tinidazole|mesh-list
6315084|NCT00003617|Chlorambucil|chlorambucil|mesh-list
6315085|NCT00003617|Omeprazole|omeprazole|mesh-list
6315086|NCT00003617|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6315087|NCT00003617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6315088|NCT00003617|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6315089|NCT00003617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6315090|NCT00003617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6315091|NCT00003617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6315092|NCT00003617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6315093|NCT00003617|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6315094|NCT00003617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6315095|NCT00003617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6315096|NCT00003617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6315097|NCT00003617|Alkylating Agents|alkylating agents|mesh-ancestor
6315098|NCT00003617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315099|NCT00003617|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
6315100|NCT00003617|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6315101|NCT00003617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6315102|NCT00003619|Vitamin E|vitamin e|mesh-list
6315103|NCT00003619|Cytarabine|cytarabine|mesh-list
6315104|NCT00003619|Fludarabine|fludarabine|mesh-list
6315105|NCT00003619|Fludarabine phosphate|fludarabine phosphate|mesh-list
6315106|NCT00003619|Etoposide|etoposide|mesh-list
6315107|NCT00003619|Busulfan|busulfan|mesh-list
6315108|NCT00003619|Topotecan|topotecan|mesh-list
6315109|NCT00003619|Isotretinoin|isotretinoin|mesh-list
6315110|NCT00003619|Vitamins|vitamins|mesh-ancestor
6016412|NCT00365274|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6315111|NCT00003619|Micronutrients|micronutrients|mesh-ancestor
6315112|NCT00003619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6315113|NCT00003619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315114|NCT00003619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6315115|NCT00003619|Antimetabolites|antimetabolites|mesh-ancestor
6315116|NCT00003619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6315117|NCT00003619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6315118|NCT00003619|Immunologic Factors|immunologic factors|mesh-ancestor
6315119|NCT00003619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6315120|NCT00003619|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6315121|NCT00003619|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6315122|NCT00003619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6315123|NCT00003619|Antiviral Agents|antiviral agents|mesh-ancestor
6315124|NCT00003619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6315125|NCT00003619|Alkylating Agents|alkylating agents|mesh-ancestor
6315126|NCT00003619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6315127|NCT00003619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6315128|NCT00003619|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6315129|NCT00003619|Antioxidants|antioxidants|mesh-ancestor
6315130|NCT00003619|Protective Agents|protective agents|mesh-ancestor
6315131|NCT00003619|Dermatologic Agents|dermatologic agents|mesh-ancestor
6315132|NCT00003620|Alvocidib|alvocidib|mesh-list
6315133|NCT00003620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315134|NCT00003620|Growth Inhibitors|growth inhibitors|mesh-ancestor
6315135|NCT00003620|Growth Substances|growth substances|mesh-ancestor
6315136|NCT00003620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6315137|NCT00003620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6315138|NCT00003620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6315139|NCT00003620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6315140|NCT00003621|Etoposide|etoposide|mesh-list
6315141|NCT00003621|Carmustine|carmustine|mesh-list
6315142|NCT00003621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315143|NCT00003621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6315144|NCT00003621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6315145|NCT00003621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6315146|NCT00003621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6315147|NCT00003621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6315148|NCT00003621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6315149|NCT00003621|Alkylating Agents|alkylating agents|mesh-ancestor
6315150|NCT00003622|Paclitaxel|paclitaxel|mesh-list
6315151|NCT00003622|Vinorelbine|vinorelbine|mesh-list
6315152|NCT00003622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6315153|NCT00003622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315154|NCT00003622|Tubulin Modulators|tubulin modulators|mesh-ancestor
6315155|NCT00003622|Antimitotic Agents|antimitotic agents|mesh-ancestor
6315156|NCT00003622|Mitosis Modulators|mitosis modulators|mesh-ancestor
6315157|NCT00003622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6315158|NCT00003624|Paclitaxel|paclitaxel|mesh-list
6315159|NCT00003624|Amifostine|amifostine|mesh-list
6315160|NCT00003624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6315161|NCT00003624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315162|NCT00003624|Tubulin Modulators|tubulin modulators|mesh-ancestor
6315163|NCT00003624|Antimitotic Agents|antimitotic agents|mesh-ancestor
6315164|NCT00003624|Mitosis Modulators|mitosis modulators|mesh-ancestor
6315165|NCT00003624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6315166|NCT00003624|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6315167|NCT00003624|Protective Agents|protective agents|mesh-ancestor
6315168|NCT00003624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6315169|NCT00003625|Cyclosporine|cyclosporine|mesh-list
6315170|NCT00003625|Etoposide|etoposide|mesh-list
6315171|NCT00003625|Vincristine|vincristine|mesh-list
6315172|NCT00003625|Cyclosporins|cyclosporins|mesh-list
6315173|NCT00003625|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6315174|NCT00003625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315175|NCT00003625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6315176|NCT00003625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6315177|NCT00003625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6315178|NCT00003625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6315179|NCT00003625|Tubulin Modulators|tubulin modulators|mesh-ancestor
6315180|NCT00003625|Antimitotic Agents|antimitotic agents|mesh-ancestor
6315181|NCT00003625|Mitosis Modulators|mitosis modulators|mesh-ancestor
6315182|NCT00003625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6315183|NCT00003625|Immunologic Factors|immunologic factors|mesh-ancestor
6315184|NCT00003625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6315185|NCT00003625|Antifungal Agents|antifungal agents|mesh-ancestor
6315186|NCT00003625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6315187|NCT00003625|Dermatologic Agents|dermatologic agents|mesh-ancestor
6315188|NCT00003625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6315189|NCT00003625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6315190|NCT00003626|Dolastatin 10|dolastatin 10|mesh-list
6315191|NCT00003626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315192|NCT00003626|Tubulin Modulators|tubulin modulators|mesh-ancestor
6315193|NCT00003626|Antimitotic Agents|antimitotic agents|mesh-ancestor
6315194|NCT00003626|Mitosis Modulators|mitosis modulators|mesh-ancestor
6315195|NCT00003626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6315196|NCT00003627|Fluorouracil|fluorouracil|mesh-list
6315197|NCT00003627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315198|NCT00003627|Antimetabolites|antimetabolites|mesh-ancestor
6315199|NCT00003627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6315200|NCT00003627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6315201|NCT00003627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6315202|NCT00003627|Immunologic Factors|immunologic factors|mesh-ancestor
6315203|NCT00003627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6315204|NCT00003630|Arsenic Trioxide|arsenic trioxide|mesh-list
6315205|NCT00003630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315206|NCT00003632|Cytarabine|cytarabine|mesh-list
6315207|NCT00003632|Methotrexate|methotrexate|mesh-list
6315208|NCT00003632|Etoposide|etoposide|mesh-list
6315209|NCT00003632|Melphalan|melphalan|mesh-list
6315210|NCT00003632|Carmustine|carmustine|mesh-list
6315211|NCT00003632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6315212|NCT00003632|Abortifacient Agents|abortifacient agents|mesh-ancestor
6315213|NCT00003632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6315214|NCT00003632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6315215|NCT00003632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6315216|NCT00003632|Antimetabolites|antimetabolites|mesh-ancestor
6315217|NCT00003632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6315218|NCT00003632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315219|NCT00003632|Dermatologic Agents|dermatologic agents|mesh-ancestor
6315220|NCT00003632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6315221|NCT00003632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6315222|NCT00003632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6315223|NCT00003632|Immunologic Factors|immunologic factors|mesh-ancestor
6315224|NCT00003632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6315225|NCT00003632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6315226|NCT00003632|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6315227|NCT00003632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6315228|NCT00003632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6315229|NCT00003632|Antiviral Agents|antiviral agents|mesh-ancestor
6315230|NCT00003632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6315231|NCT00003632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6315232|NCT00003632|Alkylating Agents|alkylating agents|mesh-ancestor
6315233|NCT00003632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6315234|NCT00003633|Prednisone|prednisone|mesh-list
6315235|NCT00003633|Docetaxel|docetaxel|mesh-list
6315236|NCT00003633|Mitoxantrone|mitoxantrone|mesh-list
6315237|NCT00003633|Estramustine|estramustine|mesh-list
6315238|NCT00003633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315239|NCT00003633|Tubulin Modulators|tubulin modulators|mesh-ancestor
6315240|NCT00003633|Antimitotic Agents|antimitotic agents|mesh-ancestor
6315241|NCT00003633|Mitosis Modulators|mitosis modulators|mesh-ancestor
6315242|NCT00003633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6315243|NCT00003633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6315244|NCT00003633|Glucocorticoids|glucocorticoids|mesh-ancestor
6315245|NCT00003633|Hormones|hormones|mesh-ancestor
6315246|NCT00003633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6315247|NCT00003633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6315248|NCT00003633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6315249|NCT00003633|Analgesics|analgesics|mesh-ancestor
6315250|NCT00003633|Sensory System Agents|sensory system agents|mesh-ancestor
6315251|NCT00003633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6315252|NCT00003633|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6315253|NCT00003633|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6315254|NCT00003633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6315255|NCT00003633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6315256|NCT00003633|Alkylating Agents|alkylating agents|mesh-ancestor
6315257|NCT00003634|Oregovomab|oregovomab|mesh-list
6315258|NCT00003634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6315259|NCT00003634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315260|NCT00003636|Carboplatin|carboplatin|mesh-list
6315261|NCT00003636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315262|NCT00003637|Fluorouracil|fluorouracil|mesh-list
6315263|NCT00003637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315264|NCT00003637|Antimetabolites|antimetabolites|mesh-ancestor
6315265|NCT00003637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6315266|NCT00003637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6315267|NCT00003637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6315268|NCT00003637|Immunologic Factors|immunologic factors|mesh-ancestor
6315269|NCT00003637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6315270|NCT00003638|Cyclophosphamide|cyclophosphamide|mesh-list
6315271|NCT00003638|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
6315272|NCT00003638|Detox adjuvant|detox adjuvant|mesh-list
6315273|NCT00003638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6315274|NCT00003638|Immunologic Factors|immunologic factors|mesh-ancestor
6315275|NCT00003638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6315276|NCT00003638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6315277|NCT00003638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6315278|NCT00003638|Alkylating Agents|alkylating agents|mesh-ancestor
6315279|NCT00003638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6315280|NCT00003638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315281|NCT00003638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6315282|NCT00003638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6315283|NCT00003639|Interferons|interferons|mesh-list
6315284|NCT00003639|Interferon-alpha|interferon-alpha|mesh-list
6315285|NCT00003639|Dexamethasone|dexamethasone|mesh-list
6315286|NCT00003639|Idarubicin|idarubicin|mesh-list
6315287|NCT00003639|Chlorambucil|chlorambucil|mesh-list
6315288|NCT00003639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6315289|NCT00003639|Antiemetics|antiemetics|mesh-ancestor
6315290|NCT00003639|Autonomic Agents|autonomic agents|mesh-ancestor
6315291|NCT00003639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6315292|NCT00003639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6315293|NCT00003639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6315294|NCT00003639|Glucocorticoids|glucocorticoids|mesh-ancestor
6315295|NCT00003639|Hormones|hormones|mesh-ancestor
6315296|NCT00003639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6315297|NCT00003639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6315298|NCT00003639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315299|NCT00003639|Antiviral Agents|antiviral agents|mesh-ancestor
6315300|NCT00003639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6315301|NCT00003639|Immunologic Factors|immunologic factors|mesh-ancestor
6315302|NCT00003639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6315303|NCT00003639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6315304|NCT00003639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6315305|NCT00003639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6315306|NCT00003639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6315307|NCT00003639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6315308|NCT00003639|Alkylating Agents|alkylating agents|mesh-ancestor
6315309|NCT00003640|Doxorubicin|doxorubicin|mesh-list
6315310|NCT00003640|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6315311|NCT00003640|Methotrexate|methotrexate|mesh-list
6315312|NCT00003640|Vinblastine|vinblastine|mesh-list
6315313|NCT00003640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315314|NCT00003640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6315315|NCT00003640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6315316|NCT00003640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6315317|NCT00003640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6315318|NCT00003640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6315319|NCT00003640|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6315320|NCT00003640|Abortifacient Agents|abortifacient agents|mesh-ancestor
6315321|NCT00003640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6315322|NCT00003640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6315323|NCT00003640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6315324|NCT00003640|Antimetabolites|antimetabolites|mesh-ancestor
6315325|NCT00003640|Dermatologic Agents|dermatologic agents|mesh-ancestor
6315326|NCT00003640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6315327|NCT00003640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6315328|NCT00003640|Immunologic Factors|immunologic factors|mesh-ancestor
6315329|NCT00003640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6315330|NCT00003640|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6315331|NCT00003640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6315332|NCT00003640|Tubulin Modulators|tubulin modulators|mesh-ancestor
6315333|NCT00003640|Antimitotic Agents|antimitotic agents|mesh-ancestor
6315334|NCT00003640|Mitosis Modulators|mitosis modulators|mesh-ancestor
6315335|NCT00003642|Fluorouracil|fluorouracil|mesh-list
6315336|NCT00003642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315337|NCT00003642|Antimetabolites|antimetabolites|mesh-ancestor
6315338|NCT00003642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6315339|NCT00003642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6315340|NCT00003642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6315341|NCT00003642|Immunologic Factors|immunologic factors|mesh-ancestor
6315342|NCT00003642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6315343|NCT00003643|Paclitaxel|paclitaxel|mesh-list
6315344|NCT00003643|Etoposide|etoposide|mesh-list
6315345|NCT00003643|Bleomycin|bleomycin|mesh-list
6315346|NCT00003643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6315347|NCT00003643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315348|NCT00003643|Tubulin Modulators|tubulin modulators|mesh-ancestor
6315349|NCT00003643|Antimitotic Agents|antimitotic agents|mesh-ancestor
6315350|NCT00003643|Mitosis Modulators|mitosis modulators|mesh-ancestor
6315351|NCT00003643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6315352|NCT00003643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6315353|NCT00003643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6315354|NCT00003643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6315355|NCT00003643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6315356|NCT00003647|Dacarbazine|dacarbazine|mesh-list
6315357|NCT00003647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6315358|NCT00003647|Alkylating Agents|alkylating agents|mesh-ancestor
6315359|NCT00003647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6315360|NCT00003647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315361|NCT00003650|Cytarabine|cytarabine|mesh-list
6315362|NCT00003650|Dexamethasone|dexamethasone|mesh-list
6315363|NCT00003650|Prednisone|prednisone|mesh-list
6315364|NCT00003650|Methylprednisolone|methylprednisolone|mesh-list
6315365|NCT00003650|Cyclophosphamide|cyclophosphamide|mesh-list
6315366|NCT00003650|Methotrexate|methotrexate|mesh-list
6315367|NCT00003650|Etoposide|etoposide|mesh-list
6315368|NCT00003650|Vincristine|vincristine|mesh-list
6315369|NCT00003650|Daunorubicin|daunorubicin|mesh-list
6315370|NCT00003650|Asparaginase|asparaginase|mesh-list
6315371|NCT00003650|Mercaptopurine|mercaptopurine|mesh-list
6315372|NCT00003650|Mitoxantrone|mitoxantrone|mesh-list
6315373|NCT00003650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6315374|NCT00003650|Immunologic Factors|immunologic factors|mesh-ancestor
6315375|NCT00003650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6315376|NCT00003650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6315377|NCT00003650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6315378|NCT00003650|Alkylating Agents|alkylating agents|mesh-ancestor
6315379|NCT00003650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6315380|NCT00003650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315381|NCT00003650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6315382|NCT00003650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6315383|NCT00003650|Antiemetics|antiemetics|mesh-ancestor
6315384|NCT00003650|Autonomic Agents|autonomic agents|mesh-ancestor
6315385|NCT00003650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6315386|NCT00003650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6315387|NCT00003650|Glucocorticoids|glucocorticoids|mesh-ancestor
6315388|NCT00003650|Hormones|hormones|mesh-ancestor
6315389|NCT00003650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6315390|NCT00003650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6315391|NCT00003650|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6315392|NCT00003650|Abortifacient Agents|abortifacient agents|mesh-ancestor
6315393|NCT00003650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6315394|NCT00003650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6315395|NCT00003650|Antimetabolites|antimetabolites|mesh-ancestor
6315396|NCT00003650|Dermatologic Agents|dermatologic agents|mesh-ancestor
6315397|NCT00003650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6315398|NCT00003650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6315399|NCT00003650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6315400|NCT00003650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6315401|NCT00003650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6315402|NCT00003650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6315403|NCT00003650|Antiviral Agents|antiviral agents|mesh-ancestor
6315404|NCT00003650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6315405|NCT00003650|Tubulin Modulators|tubulin modulators|mesh-ancestor
6315406|NCT00003650|Antimitotic Agents|antimitotic agents|mesh-ancestor
6315407|NCT00003650|Mitosis Modulators|mitosis modulators|mesh-ancestor
6315408|NCT00003650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6315409|NCT00003650|Protective Agents|protective agents|mesh-ancestor
6315410|NCT00003650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6315411|NCT00003650|Analgesics|analgesics|mesh-ancestor
6315412|NCT00003650|Sensory System Agents|sensory system agents|mesh-ancestor
6315413|NCT00003652|Fluorouracil|fluorouracil|mesh-list
6315414|NCT00003652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315415|NCT00003652|Antimetabolites|antimetabolites|mesh-ancestor
6315416|NCT00003652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6315417|NCT00003652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6315418|NCT00003652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6315419|NCT00003652|Immunologic Factors|immunologic factors|mesh-ancestor
6315420|NCT00003652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6315421|NCT00003653|Leuprolide|leuprolide|mesh-list
6315422|NCT00003653|Goserelin|goserelin|mesh-list
6315423|NCT00003653|Flutamide|flutamide|mesh-list
6315424|NCT00003653|Bicalutamide|bicalutamide|mesh-list
6315425|NCT00003653|Cyproterone Acetate|cyproterone acetate|mesh-list
6315426|NCT00003653|Nilutamide|nilutamide|mesh-list
6315427|NCT00003653|Buserelin|buserelin|mesh-list
6315428|NCT00003653|Cyproterone|cyproterone|mesh-list
6315429|NCT00003653|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6315430|NCT00003653|Fertility Agents|fertility agents|mesh-ancestor
6315431|NCT00003653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6315432|NCT00003653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6315433|NCT00003653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6315434|NCT00003653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315435|NCT00003653|Androgen Antagonists|androgen antagonists|mesh-ancestor
6315436|NCT00003653|Hormone Antagonists|hormone antagonists|mesh-ancestor
6315437|NCT00003653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6315438|NCT00003653|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6315439|NCT00003653|Contraceptive Agents|contraceptive agents|mesh-ancestor
6315440|NCT00003654|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
6315441|NCT00003654|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6315442|NCT00003654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6315443|NCT00003656|Interferons|interferons|mesh-list
6315444|NCT00003656|Interferon-alpha|interferon-alpha|mesh-list
6315445|NCT00003656|Tretinoin|tretinoin|mesh-list
6315446|NCT00003656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315447|NCT00003656|Antiviral Agents|antiviral agents|mesh-ancestor
6315448|NCT00003656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6315449|NCT00003656|Immunologic Factors|immunologic factors|mesh-ancestor
6315450|NCT00003656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6315451|NCT00003656|Keratolytic Agents|keratolytic agents|mesh-ancestor
6315452|NCT00003656|Dermatologic Agents|dermatologic agents|mesh-ancestor
6315453|NCT00003657|Carboplatin|carboplatin|mesh-list
6315454|NCT00003657|Etoposide|etoposide|mesh-list
6315455|NCT00003657|Ifosfamide|ifosfamide|mesh-list
6315456|NCT00003657|Amifostine|amifostine|mesh-list
6315457|NCT00003657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315458|NCT00003657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6315459|NCT00003657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6315460|NCT00003657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6315461|NCT00003657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6315462|NCT00003657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6315463|NCT00003657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6315464|NCT00003657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6315465|NCT00003657|Alkylating Agents|alkylating agents|mesh-ancestor
6315466|NCT00003657|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6315467|NCT00003657|Protective Agents|protective agents|mesh-ancestor
6315468|NCT00003658|Cyclophosphamide|cyclophosphamide|mesh-list
6315469|NCT00003658|Rituximab|rituximab|mesh-list
6315470|NCT00003658|Pentostatin|pentostatin|mesh-list
6315471|NCT00003658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6315472|NCT00003658|Immunologic Factors|immunologic factors|mesh-ancestor
6315473|NCT00003658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6315474|NCT00003658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6315475|NCT00003658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6315476|NCT00003658|Alkylating Agents|alkylating agents|mesh-ancestor
6315477|NCT00003658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6315478|NCT00003658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315479|NCT00003658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6315480|NCT00003658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6315481|NCT00003658|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
6315482|NCT00003658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6315483|NCT00003661|Cyclosporine|cyclosporine|mesh-list
6315484|NCT00003661|Methylprednisolone|methylprednisolone|mesh-list
6315485|NCT00003661|Melphalan|melphalan|mesh-list
6315486|NCT00003661|Busulfan|busulfan|mesh-list
6315487|NCT00003661|Cyclosporins|cyclosporins|mesh-list
6315488|NCT00003661|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6315489|NCT00003661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6315490|NCT00003661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6315491|NCT00003661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6315492|NCT00003661|Immunologic Factors|immunologic factors|mesh-ancestor
6315493|NCT00003661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6315494|NCT00003661|Antifungal Agents|antifungal agents|mesh-ancestor
6315495|NCT00003661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6315496|NCT00003661|Dermatologic Agents|dermatologic agents|mesh-ancestor
6315497|NCT00003661|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6315498|NCT00003661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6315499|NCT00003661|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6315500|NCT00003661|Alkylating Agents|alkylating agents|mesh-ancestor
6315501|NCT00003661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315502|NCT00003661|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6315503|NCT00003661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6315504|NCT00003661|Antiemetics|antiemetics|mesh-ancestor
6315505|NCT00003661|Autonomic Agents|autonomic agents|mesh-ancestor
6315506|NCT00003661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6315507|NCT00003661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6315508|NCT00003661|Glucocorticoids|glucocorticoids|mesh-ancestor
6315509|NCT00003661|Hormones|hormones|mesh-ancestor
6315510|NCT00003661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6315511|NCT00003661|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6315512|NCT00003661|Protective Agents|protective agents|mesh-ancestor
6315513|NCT00003662|Cyclosporine|cyclosporine|mesh-list
6315514|NCT00003662|Methylprednisolone|methylprednisolone|mesh-list
6315515|NCT00003662|Cyclophosphamide|cyclophosphamide|mesh-list
6315516|NCT00003662|Melphalan|melphalan|mesh-list
6315517|NCT00003662|Busulfan|busulfan|mesh-list
6315518|NCT00003662|Cyclosporins|cyclosporins|mesh-list
6315519|NCT00003662|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6315520|NCT00003662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6315521|NCT00003662|Immunologic Factors|immunologic factors|mesh-ancestor
6315522|NCT00003662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6315523|NCT00003662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6315524|NCT00003662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6315525|NCT00003662|Alkylating Agents|alkylating agents|mesh-ancestor
6315526|NCT00003662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6315527|NCT00003662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315528|NCT00003662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6315529|NCT00003662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6315530|NCT00003662|Antifungal Agents|antifungal agents|mesh-ancestor
6315531|NCT00003662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6315532|NCT00003662|Dermatologic Agents|dermatologic agents|mesh-ancestor
6315533|NCT00003662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6315534|NCT00003662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6315535|NCT00003662|Antiemetics|antiemetics|mesh-ancestor
6315536|NCT00003662|Autonomic Agents|autonomic agents|mesh-ancestor
6315537|NCT00003662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6315538|NCT00003662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6315539|NCT00003662|Glucocorticoids|glucocorticoids|mesh-ancestor
6315540|NCT00003662|Hormones|hormones|mesh-ancestor
6315541|NCT00003662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6315542|NCT00003662|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6315543|NCT00003662|Protective Agents|protective agents|mesh-ancestor
6315544|NCT00003663|Dexamethasone|dexamethasone|mesh-list
6315545|NCT00003663|Rituximab|rituximab|mesh-list
6315546|NCT00003663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6315547|NCT00003663|Antiemetics|antiemetics|mesh-ancestor
6315548|NCT00003663|Autonomic Agents|autonomic agents|mesh-ancestor
6315549|NCT00003663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6315550|NCT00003663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6315551|NCT00003663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6315552|NCT00003663|Glucocorticoids|glucocorticoids|mesh-ancestor
6315553|NCT00003663|Hormones|hormones|mesh-ancestor
6315554|NCT00003663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6315555|NCT00003663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6315556|NCT00003663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315557|NCT00003663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6315558|NCT00003663|Immunologic Factors|immunologic factors|mesh-ancestor
6315559|NCT00003663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6315560|NCT00003664|Gemcitabine|gemcitabine|mesh-list
6315561|NCT00003664|Interferons|interferons|mesh-list
6315562|NCT00003664|Interferon-alpha|interferon-alpha|mesh-list
6315563|NCT00003664|Aldesleukin|aldesleukin|mesh-list
6315564|NCT00003664|Fluorouracil|fluorouracil|mesh-list
6315565|NCT00003664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6315566|NCT00003664|Antimetabolites|antimetabolites|mesh-ancestor
6315567|NCT00003664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6315568|NCT00003664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315569|NCT00003664|Antiviral Agents|antiviral agents|mesh-ancestor
6315570|NCT00003664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6315571|NCT00003664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6315572|NCT00003664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6315573|NCT00003664|Immunologic Factors|immunologic factors|mesh-ancestor
6315574|NCT00003664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6315575|NCT00003664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6315576|NCT00003664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6315577|NCT00003666|Irofulven|irofulven|mesh-list
6315578|NCT00003666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6315579|NCT00003666|Alkylating Agents|alkylating agents|mesh-ancestor
6315580|NCT00003666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6315581|NCT00003666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315582|NCT00003667|Cyclophosphamide|cyclophosphamide|mesh-list
6315583|NCT00003667|Doxorubicin|doxorubicin|mesh-list
6315584|NCT00003667|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6315585|NCT00003667|Vincristine|vincristine|mesh-list
6315586|NCT00003667|Dexrazoxane|dexrazoxane|mesh-list
6315587|NCT00003667|Razoxane|razoxane|mesh-list
6315588|NCT00003667|Glycerol|glycerol|mesh-list
6315589|NCT00003667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6315590|NCT00003667|Immunologic Factors|immunologic factors|mesh-ancestor
6315591|NCT00003667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6315592|NCT00003667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6315593|NCT00003667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6315594|NCT00003667|Alkylating Agents|alkylating agents|mesh-ancestor
6315595|NCT00003667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6315596|NCT00003667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315597|NCT00003667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6315598|NCT00003667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6315599|NCT00003667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6315600|NCT00003667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6315601|NCT00003667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6315602|NCT00003667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6315603|NCT00003667|Tubulin Modulators|tubulin modulators|mesh-ancestor
6315604|NCT00003667|Antimitotic Agents|antimitotic agents|mesh-ancestor
6315605|NCT00003667|Mitosis Modulators|mitosis modulators|mesh-ancestor
6315606|NCT00003667|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6315607|NCT00003667|Protective Agents|protective agents|mesh-ancestor
6315608|NCT00003667|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6315609|NCT00003671|Leucovorin|leucovorin|mesh-list
6315610|NCT00003671|Cytarabine|cytarabine|mesh-list
6315611|NCT00003671|Dexamethasone|dexamethasone|mesh-list
6315612|NCT00003671|Cyclophosphamide|cyclophosphamide|mesh-list
6315613|NCT00003671|Methotrexate|methotrexate|mesh-list
6315614|NCT00003671|Vincristine|vincristine|mesh-list
6315615|NCT00003671|Daunorubicin|daunorubicin|mesh-list
6315616|NCT00003671|Asparaginase|asparaginase|mesh-list
6315617|NCT00003671|Mercaptopurine|mercaptopurine|mesh-list
6315618|NCT00003671|Thioguanine|thioguanine|mesh-list
6315619|NCT00003671|Levoleucovorin|levoleucovorin|mesh-list
6315620|NCT00003671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6315621|NCT00003671|Immunologic Factors|immunologic factors|mesh-ancestor
6315622|NCT00003671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6315623|NCT00003671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6315624|NCT00003671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6315625|NCT00003671|Alkylating Agents|alkylating agents|mesh-ancestor
6315626|NCT00003671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6315627|NCT00003671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315628|NCT00003671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6315629|NCT00003671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6315630|NCT00003671|Antiemetics|antiemetics|mesh-ancestor
6315631|NCT00003671|Autonomic Agents|autonomic agents|mesh-ancestor
6315632|NCT00003671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6315633|NCT00003671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6315634|NCT00003671|Glucocorticoids|glucocorticoids|mesh-ancestor
6315635|NCT00003671|Hormones|hormones|mesh-ancestor
6315636|NCT00003671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6315637|NCT00003671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6315638|NCT00003671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6315639|NCT00003671|Abortifacient Agents|abortifacient agents|mesh-ancestor
6016413|NCT00365274|Vincristine|vincristine|mesh-list
6016414|NCT00365274|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6016415|NCT00365274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6016416|NCT00365274|Immunologic Factors|immunologic factors|mesh-ancestor
6315640|NCT00003671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6315641|NCT00003671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6315642|NCT00003671|Antimetabolites|antimetabolites|mesh-ancestor
6315643|NCT00003671|Dermatologic Agents|dermatologic agents|mesh-ancestor
5724578|NCT03186053|Phosphocreatine|phosphocreatine|mesh-list
6315644|NCT00003671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6315645|NCT00003671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6315646|NCT00003671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6315647|NCT00003671|Antiviral Agents|antiviral agents|mesh-ancestor
6315648|NCT00003671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6315649|NCT00003671|Antidotes|antidotes|mesh-ancestor
6315650|NCT00003671|Protective Agents|protective agents|mesh-ancestor
6315651|NCT00003671|Vitamin B Complex|vitamin b complex|mesh-ancestor
6315652|NCT00003671|Vitamins|vitamins|mesh-ancestor
6315653|NCT00003671|Micronutrients|micronutrients|mesh-ancestor
6315654|NCT00003671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6315655|NCT00003671|Tubulin Modulators|tubulin modulators|mesh-ancestor
6315656|NCT00003671|Antimitotic Agents|antimitotic agents|mesh-ancestor
6315657|NCT00003671|Mitosis Modulators|mitosis modulators|mesh-ancestor
6315658|NCT00003671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6315659|NCT00003671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6315660|NCT00003671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6315661|NCT00003673|Gemtuzumab|gemtuzumab|mesh-list
6315662|NCT00003673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6315663|NCT00003673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315664|NCT00003674|Dalteparin|dalteparin|mesh-list
6315665|NCT00003674|Tinzaparin|tinzaparin|mesh-list
6315666|NCT00003674|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6315667|NCT00003674|Anticoagulants|anticoagulants|mesh-ancestor
6315668|NCT00003674|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6315669|NCT00003674|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6315670|NCT00003674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6315671|NCT00003675|Topotecan|topotecan|mesh-list
6315672|NCT00003675|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6315673|NCT00003675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6315674|NCT00003675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6315675|NCT00003675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6315676|NCT00003675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315677|NCT00003677|Dolastatin 10|dolastatin 10|mesh-list
6315678|NCT00003677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315679|NCT00003677|Tubulin Modulators|tubulin modulators|mesh-ancestor
6315680|NCT00003677|Antimitotic Agents|antimitotic agents|mesh-ancestor
6315681|NCT00003677|Mitosis Modulators|mitosis modulators|mesh-ancestor
6315682|NCT00003677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6315683|NCT00003678|Tamoxifen|tamoxifen|mesh-list
6315684|NCT00003678|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6315685|NCT00003678|Hormone Antagonists|hormone antagonists|mesh-ancestor
6315686|NCT00003678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6315687|NCT00003678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6315688|NCT00003678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6315689|NCT00003678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315690|NCT00003678|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6315691|NCT00003678|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6315692|NCT00003678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6315693|NCT00003679|Tamoxifen|tamoxifen|mesh-list
6315694|NCT00003679|Cyclophosphamide|cyclophosphamide|mesh-list
6315695|NCT00003679|Docetaxel|docetaxel|mesh-list
6315696|NCT00003679|Doxorubicin|doxorubicin|mesh-list
6315697|NCT00003679|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6315698|NCT00003679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6315699|NCT00003679|Immunologic Factors|immunologic factors|mesh-ancestor
6315700|NCT00003679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6315701|NCT00003679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6315702|NCT00003679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6315703|NCT00003679|Alkylating Agents|alkylating agents|mesh-ancestor
6315704|NCT00003679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6315705|NCT00003679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315706|NCT00003679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6315707|NCT00003679|Tubulin Modulators|tubulin modulators|mesh-ancestor
6315708|NCT00003679|Antimitotic Agents|antimitotic agents|mesh-ancestor
6315709|NCT00003679|Mitosis Modulators|mitosis modulators|mesh-ancestor
6315710|NCT00003679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6315711|NCT00003679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6315712|NCT00003679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6315713|NCT00003679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6315714|NCT00003679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6315715|NCT00003679|Hormone Antagonists|hormone antagonists|mesh-ancestor
6315716|NCT00003679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6315717|NCT00003679|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6315718|NCT00003679|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6315719|NCT00003679|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6315720|NCT00003679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6315721|NCT00003680|Tamoxifen|tamoxifen|mesh-list
6315722|NCT00003680|Cyclophosphamide|cyclophosphamide|mesh-list
6315723|NCT00003680|Thiotepa|thiotepa|mesh-list
6315724|NCT00003680|Fluorouracil|fluorouracil|mesh-list
6315725|NCT00003680|Methotrexate|methotrexate|mesh-list
6315726|NCT00003680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6315727|NCT00003680|Immunologic Factors|immunologic factors|mesh-ancestor
6315728|NCT00003680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6315729|NCT00003680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6315730|NCT00003680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6315731|NCT00003680|Alkylating Agents|alkylating agents|mesh-ancestor
6315732|NCT00003680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6315733|NCT00003680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315734|NCT00003680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6315735|NCT00003680|Antimetabolites|antimetabolites|mesh-ancestor
6315736|NCT00003680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6315737|NCT00003680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6315738|NCT00003680|Abortifacient Agents|abortifacient agents|mesh-ancestor
6315739|NCT00003680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6315740|NCT00003680|Dermatologic Agents|dermatologic agents|mesh-ancestor
6315741|NCT00003680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6315742|NCT00003680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6315743|NCT00003680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6315744|NCT00003680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6315745|NCT00003680|Hormone Antagonists|hormone antagonists|mesh-ancestor
6315746|NCT00003680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6315747|NCT00003680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6315748|NCT00003680|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6315749|NCT00003680|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6315750|NCT00003680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6315751|NCT00003681|Epoetin Alfa|epoetin alfa|mesh-list
6315752|NCT00003681|Amifostine|amifostine|mesh-list
6315753|NCT00003681|Hematinics|hematinics|mesh-ancestor
6315754|NCT00003681|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6315755|NCT00003681|Protective Agents|protective agents|mesh-ancestor
6315756|NCT00003681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6315757|NCT00003682|Methylprednisolone|methylprednisolone|mesh-list
6315758|NCT00003682|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6315759|NCT00003682|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6315760|NCT00003682|Prednisolone|prednisolone|mesh-list
6315761|NCT00003682|Prednisolone acetate|prednisolone acetate|mesh-list
6315762|NCT00003682|Doxorubicin|doxorubicin|mesh-list
6315763|NCT00003682|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6315764|NCT00003682|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6315765|NCT00003682|Prednisolone phosphate|prednisolone phosphate|mesh-list
6315766|NCT00003682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6315767|NCT00003682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315768|NCT00003682|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6315769|NCT00003682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6315770|NCT00003682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6315771|NCT00003682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6315772|NCT00003682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6315773|NCT00003682|Antiemetics|antiemetics|mesh-ancestor
6315774|NCT00003682|Autonomic Agents|autonomic agents|mesh-ancestor
6315775|NCT00003682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6315776|NCT00003682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6315777|NCT00003682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6315778|NCT00003682|Glucocorticoids|glucocorticoids|mesh-ancestor
6315779|NCT00003682|Hormones|hormones|mesh-ancestor
6315780|NCT00003682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6315781|NCT00003682|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6315782|NCT00003682|Protective Agents|protective agents|mesh-ancestor
6315783|NCT00003682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6315784|NCT00003683|Doxorubicin|doxorubicin|mesh-list
6315785|NCT00003683|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6315786|NCT00003683|Ifosfamide|ifosfamide|mesh-list
6315787|NCT00003683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5724579|NCT03186053|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6315788|NCT00003683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315789|NCT00003683|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6315790|NCT00003683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6315791|NCT00003683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6315792|NCT00003683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6315793|NCT00003683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6315794|NCT00003683|Alkylating Agents|alkylating agents|mesh-ancestor
6315795|NCT00003684|Theophylline|theophylline|mesh-list
6315796|NCT00003684|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6315797|NCT00003684|Autonomic Agents|autonomic agents|mesh-ancestor
6315798|NCT00003684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6315799|NCT00003684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6315800|NCT00003684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6315801|NCT00003684|Respiratory System Agents|respiratory system agents|mesh-ancestor
6315802|NCT00003684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6315803|NCT00003684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6315804|NCT00003684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6315805|NCT00003684|Vasodilator Agents|vasodilator agents|mesh-ancestor
6315806|NCT00003684|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6315807|NCT00003684|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6315808|NCT00003684|Purinergic Agents|purinergic agents|mesh-ancestor
6315809|NCT00003684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6315810|NCT00003686|Pilocarpine|pilocarpine|mesh-list
6315811|NCT00003686|Miotics|miotics|mesh-ancestor
6315812|NCT00003686|Autonomic Agents|autonomic agents|mesh-ancestor
6315813|NCT00003686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6315814|NCT00003686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6315815|NCT00003686|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6315816|NCT00003686|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6315817|NCT00003686|Cholinergic Agents|cholinergic agents|mesh-ancestor
6315818|NCT00003686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6315819|NCT00003686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6315820|NCT00003687|Morphine|morphine|mesh-list
6315821|NCT00003687|Dextromethorphan|dextromethorphan|mesh-list
6315822|NCT00003687|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6315823|NCT00003687|Narcotics|narcotics|mesh-ancestor
6315824|NCT00003687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6315825|NCT00003687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6315826|NCT00003687|Analgesics|analgesics|mesh-ancestor
6315827|NCT00003687|Sensory System Agents|sensory system agents|mesh-ancestor
6315828|NCT00003687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6315829|NCT00003687|Antitussive Agents|antitussive agents|mesh-ancestor
6315830|NCT00003687|Respiratory System Agents|respiratory system agents|mesh-ancestor
6315831|NCT00003687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6315832|NCT00003687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6315833|NCT00003687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6315834|NCT00003687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6315835|NCT00003688|Dactinomycin|dactinomycin|mesh-list
6315836|NCT00003688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6315837|NCT00003688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6315838|NCT00003688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6315839|NCT00003688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315840|NCT00003688|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6315841|NCT00003688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6315842|NCT00003688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6315843|NCT00003688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6315844|NCT00003690|Carboplatin|carboplatin|mesh-list
6315845|NCT00003690|Alvocidib|alvocidib|mesh-list
6315846|NCT00003690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315847|NCT00003690|Growth Inhibitors|growth inhibitors|mesh-ancestor
6315848|NCT00003690|Growth Substances|growth substances|mesh-ancestor
6315849|NCT00003690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6315850|NCT00003690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6315851|NCT00003690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6315852|NCT00003690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6315853|NCT00003691|Paclitaxel|paclitaxel|mesh-list
6315854|NCT00003691|Doxorubicin|doxorubicin|mesh-list
6315855|NCT00003691|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6315856|NCT00003691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6315857|NCT00003691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315858|NCT00003691|Tubulin Modulators|tubulin modulators|mesh-ancestor
6315859|NCT00003691|Antimitotic Agents|antimitotic agents|mesh-ancestor
6315860|NCT00003691|Mitosis Modulators|mitosis modulators|mesh-ancestor
6315861|NCT00003691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6315862|NCT00003691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6315863|NCT00003691|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6315864|NCT00003691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6315865|NCT00003691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6315866|NCT00003693|Dolastatin 10|dolastatin 10|mesh-list
6315867|NCT00003693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315868|NCT00003693|Tubulin Modulators|tubulin modulators|mesh-ancestor
6315869|NCT00003693|Antimitotic Agents|antimitotic agents|mesh-ancestor
6315870|NCT00003693|Mitosis Modulators|mitosis modulators|mesh-ancestor
6315871|NCT00003693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6315872|NCT00003694|Cytarabine|cytarabine|mesh-list
6315873|NCT00003694|Homoharringtonine|homoharringtonine|mesh-list
6315874|NCT00003694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6315875|NCT00003694|Antimetabolites|antimetabolites|mesh-ancestor
6315876|NCT00003694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6315877|NCT00003694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315878|NCT00003694|Antiviral Agents|antiviral agents|mesh-ancestor
6315879|NCT00003694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6315880|NCT00003694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6315881|NCT00003694|Immunologic Factors|immunologic factors|mesh-ancestor
6315882|NCT00003694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6315883|NCT00003694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6315884|NCT00003694|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6315885|NCT00003694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6315886|NCT00003696|Paclitaxel|paclitaxel|mesh-list
6315887|NCT00003696|Etoposide|etoposide|mesh-list
6315888|NCT00003696|Cyclophosphamide|cyclophosphamide|mesh-list
6315889|NCT00003696|Carboplatin|carboplatin|mesh-list
6315890|NCT00003696|Doxorubicin|doxorubicin|mesh-list
6315891|NCT00003696|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6315892|NCT00003696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6315893|NCT00003696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315894|NCT00003696|Tubulin Modulators|tubulin modulators|mesh-ancestor
6315895|NCT00003696|Antimitotic Agents|antimitotic agents|mesh-ancestor
6315896|NCT00003696|Mitosis Modulators|mitosis modulators|mesh-ancestor
6315897|NCT00003696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6315898|NCT00003696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6315899|NCT00003696|Immunologic Factors|immunologic factors|mesh-ancestor
6315900|NCT00003696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6315901|NCT00003696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6315902|NCT00003696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6315903|NCT00003696|Alkylating Agents|alkylating agents|mesh-ancestor
6315904|NCT00003696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6315905|NCT00003696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6315906|NCT00003696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6315907|NCT00003696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6315908|NCT00003696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6315909|NCT00003697|Vadimezan|vadimezan|mesh-list
6315910|NCT00003697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315911|NCT00003698|Fosbretabulin|fosbretabulin|mesh-list
6315912|NCT00003698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6315913|NCT00003698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315914|NCT00003700|Leucovorin|leucovorin|mesh-list
6315915|NCT00003700|Cytarabine|cytarabine|mesh-list
6315916|NCT00003700|Prednisone|prednisone|mesh-list
6315917|NCT00003700|Cyclophosphamide|cyclophosphamide|mesh-list
6315918|NCT00003700|Methotrexate|methotrexate|mesh-list
6315919|NCT00003700|Vincristine|vincristine|mesh-list
6315920|NCT00003700|Daunorubicin|daunorubicin|mesh-list
6315921|NCT00003700|Asparaginase|asparaginase|mesh-list
6315922|NCT00003700|Mercaptopurine|mercaptopurine|mesh-list
6315923|NCT00003700|Allopurinol|allopurinol|mesh-list
6315924|NCT00003700|Levoleucovorin|levoleucovorin|mesh-list
6315925|NCT00003700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6315926|NCT00003700|Immunologic Factors|immunologic factors|mesh-ancestor
6315927|NCT00003700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6315928|NCT00003700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6315929|NCT00003700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6315930|NCT00003700|Alkylating Agents|alkylating agents|mesh-ancestor
6315931|NCT00003700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6315932|NCT00003700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315933|NCT00003700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6315934|NCT00003700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6315935|NCT00003700|Glucocorticoids|glucocorticoids|mesh-ancestor
6315936|NCT00003700|Hormones|hormones|mesh-ancestor
6315937|NCT00003700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6315938|NCT00003700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6315939|NCT00003700|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6315940|NCT00003700|Abortifacient Agents|abortifacient agents|mesh-ancestor
6315941|NCT00003700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6315942|NCT00003700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6315943|NCT00003700|Antimetabolites|antimetabolites|mesh-ancestor
6315944|NCT00003700|Dermatologic Agents|dermatologic agents|mesh-ancestor
6315945|NCT00003700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6315946|NCT00003700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6315947|NCT00003700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6315948|NCT00003700|Antiviral Agents|antiviral agents|mesh-ancestor
6315949|NCT00003700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6315950|NCT00003700|Antidotes|antidotes|mesh-ancestor
6315951|NCT00003700|Protective Agents|protective agents|mesh-ancestor
6315952|NCT00003700|Vitamin B Complex|vitamin b complex|mesh-ancestor
6315953|NCT00003700|Vitamins|vitamins|mesh-ancestor
6315954|NCT00003700|Micronutrients|micronutrients|mesh-ancestor
6315955|NCT00003700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6315956|NCT00003700|Tubulin Modulators|tubulin modulators|mesh-ancestor
6315957|NCT00003700|Antimitotic Agents|antimitotic agents|mesh-ancestor
6315958|NCT00003700|Mitosis Modulators|mitosis modulators|mesh-ancestor
6315959|NCT00003700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6315960|NCT00003700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6315961|NCT00003700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6315962|NCT00003700|Gout Suppressants|gout suppressants|mesh-ancestor
6315963|NCT00003700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6315964|NCT00003700|Antioxidants|antioxidants|mesh-ancestor
6315965|NCT00003701|Paclitaxel|paclitaxel|mesh-list
6315966|NCT00003701|Vinblastine|vinblastine|mesh-list
6315967|NCT00003701|Carboplatin|carboplatin|mesh-list
6315968|NCT00003701|Doxorubicin|doxorubicin|mesh-list
6315969|NCT00003701|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6315970|NCT00003701|Methotrexate|methotrexate|mesh-list
6315971|NCT00003701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6315972|NCT00003701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315973|NCT00003701|Tubulin Modulators|tubulin modulators|mesh-ancestor
6315974|NCT00003701|Antimitotic Agents|antimitotic agents|mesh-ancestor
6315975|NCT00003701|Mitosis Modulators|mitosis modulators|mesh-ancestor
6315976|NCT00003701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6315977|NCT00003701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6315978|NCT00003701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6315979|NCT00003701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6315980|NCT00003701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6315981|NCT00003701|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6315982|NCT00003701|Abortifacient Agents|abortifacient agents|mesh-ancestor
6315983|NCT00003701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6315984|NCT00003701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6315985|NCT00003701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6315986|NCT00003701|Antimetabolites|antimetabolites|mesh-ancestor
6315987|NCT00003701|Dermatologic Agents|dermatologic agents|mesh-ancestor
6315988|NCT00003701|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6315989|NCT00003701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6315990|NCT00003701|Immunologic Factors|immunologic factors|mesh-ancestor
6315991|NCT00003701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6315992|NCT00003701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6315993|NCT00003704|Capecitabine|capecitabine|mesh-list
6315994|NCT00003704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6315995|NCT00003704|Antimetabolites|antimetabolites|mesh-ancestor
6315996|NCT00003704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6315997|NCT00003704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6315998|NCT00003706|Pemetrexed|pemetrexed|mesh-list
6315999|NCT00003706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316000|NCT00003706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6316001|NCT00003706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316002|NCT00003706|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6316003|NCT00003706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6316004|NCT00003707|Gemcitabine|gemcitabine|mesh-list
6316005|NCT00003707|Tipifarnib|tipifarnib|mesh-list
6316006|NCT00003707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6316007|NCT00003707|Antimetabolites|antimetabolites|mesh-ancestor
6316008|NCT00003707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316009|NCT00003707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316010|NCT00003707|Antiviral Agents|antiviral agents|mesh-ancestor
6316011|NCT00003707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6316012|NCT00003707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6316013|NCT00003707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6316014|NCT00003707|Immunologic Factors|immunologic factors|mesh-ancestor
6316015|NCT00003707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6316016|NCT00003708|Temozolomide|temozolomide|mesh-list
6316017|NCT00003708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6316018|NCT00003708|Alkylating Agents|alkylating agents|mesh-ancestor
6316019|NCT00003708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316020|NCT00003708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316021|NCT00003709|Carbendazim|carbendazim|mesh-list
6316022|NCT00003709|Antinematodal Agents|antinematodal agents|mesh-ancestor
6316023|NCT00003709|Anthelmintics|anthelmintics|mesh-ancestor
6316024|NCT00003709|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6316025|NCT00003709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6316026|NCT00003710|Irinotecan|irinotecan|mesh-list
6316027|NCT00003710|Mitomycins|mitomycins|mesh-list
6316028|NCT00003710|Mitomycin|mitomycin|mesh-list
6316029|NCT00003710|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6316030|NCT00003710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6316031|NCT00003710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6316032|NCT00003710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316033|NCT00003710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316034|NCT00003710|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6316035|NCT00003710|Alkylating Agents|alkylating agents|mesh-ancestor
6316036|NCT00003710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6316037|NCT00003711|Irinotecan|irinotecan|mesh-list
6316038|NCT00003711|Pemetrexed|pemetrexed|mesh-list
6316039|NCT00003711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6316040|NCT00003711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6316041|NCT00003711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6316042|NCT00003711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316043|NCT00003711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316044|NCT00003711|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6316045|NCT00003711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6392600|NCT00196885|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6392601|NCT00196885|Antioxidants|antioxidants|mesh-ancestor
6392602|NCT00196885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392603|NCT00196885|Protective Agents|protective agents|mesh-ancestor
6392604|NCT00196885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016417|NCT00365274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016418|NCT00365274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6016419|NCT00365274|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6016420|NCT00365274|Alkylating Agents|alkylating agents|mesh-ancestor
6016421|NCT00365274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392605|NCT00196885|Antidotes|antidotes|mesh-ancestor
6392606|NCT00196989|Pioglitazone|pioglitazone|mesh-list
6392607|NCT00196989|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6392608|NCT00196989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392609|NCT00197080|Ropinirole|ropinirole|mesh-list
6392610|NCT00197080|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6392611|NCT00197080|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6392612|NCT00197080|Dopamine Agonists|dopamine agonists|mesh-ancestor
6392613|NCT00197080|Dopamine Agents|dopamine agents|mesh-ancestor
6016422|NCT00365274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6016423|NCT00365274|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6016424|NCT00365274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6016425|NCT00365274|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6016426|NCT00365274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6016427|NCT00365274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6016428|NCT00365274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6016429|NCT00365274|Glucocorticoids|glucocorticoids|mesh-ancestor
6392614|NCT00197080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6392615|NCT00197080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392616|NCT00197080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392617|NCT00197132|Rosiglitazone|rosiglitazone|mesh-list
6392618|NCT00197132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6392619|NCT00197132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392620|NCT00197197|Aplaviroc|aplaviroc|mesh-list
6392621|NCT00197197|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6392622|NCT00197197|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6392623|NCT00197197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392624|NCT00197197|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6392625|NCT00197197|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6392626|NCT00197197|Antiviral Agents|antiviral agents|mesh-ancestor
6392627|NCT00197197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6392628|NCT00197249|Vaccines|vaccines|mesh-list
6392629|NCT00197249|Immunologic Factors|immunologic factors|mesh-ancestor
6392630|NCT00197249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392631|NCT00197301|Vaccines|vaccines|mesh-list
6392632|NCT00197301|Immunologic Factors|immunologic factors|mesh-ancestor
6392633|NCT00197301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392634|NCT00197327|Bupivacaine|bupivacaine|mesh-list
6392635|NCT00197327|Anesthetics, Local|anesthetics, local|mesh-ancestor
6392636|NCT00197327|Anesthetics|anesthetics|mesh-ancestor
6392637|NCT00197327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6392638|NCT00197327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392639|NCT00197327|Sensory System Agents|sensory system agents|mesh-ancestor
6316046|NCT00003712|Sirolimus|sirolimus|mesh-list
6316047|NCT00003712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6316048|NCT00003712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6316049|NCT00003712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6316050|NCT00003712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316051|NCT00003712|Antifungal Agents|antifungal agents|mesh-ancestor
6316052|NCT00003712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6316053|NCT00003712|Immunologic Factors|immunologic factors|mesh-ancestor
6316054|NCT00003712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6316055|NCT00003714|NSC 366140|nsc 366140|mesh-list
6316056|NCT00003714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316057|NCT00003715|Interferons|interferons|mesh-list
6316058|NCT00003715|Interferon-alpha|interferon-alpha|mesh-list
6316059|NCT00003715|Cyclophosphamide|cyclophosphamide|mesh-list
6316060|NCT00003715|Vaccines|vaccines|mesh-list
6316061|NCT00003715|BCG Vaccine|bcg vaccine|mesh-list
6316062|NCT00003715|Immunologic Factors|immunologic factors|mesh-ancestor
6316063|NCT00003715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6316064|NCT00003715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6316065|NCT00003715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6316066|NCT00003715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6316067|NCT00003715|Alkylating Agents|alkylating agents|mesh-ancestor
6316068|NCT00003715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316069|NCT00003715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316070|NCT00003715|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6316071|NCT00003715|Antiviral Agents|antiviral agents|mesh-ancestor
6316072|NCT00003715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6316073|NCT00003715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6316074|NCT00003716|Rituximab|rituximab|mesh-list
6316075|NCT00003716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6316076|NCT00003716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316077|NCT00003716|Immunologic Factors|immunologic factors|mesh-ancestor
6316078|NCT00003716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6316079|NCT00003716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6316080|NCT00003717|Paclitaxel|paclitaxel|mesh-list
6316081|NCT00003717|Estramustine|estramustine|mesh-list
6316082|NCT00003717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6316083|NCT00003717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316084|NCT00003717|Tubulin Modulators|tubulin modulators|mesh-ancestor
6316085|NCT00003717|Antimitotic Agents|antimitotic agents|mesh-ancestor
6316086|NCT00003717|Mitosis Modulators|mitosis modulators|mesh-ancestor
6316087|NCT00003717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316088|NCT00003717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6316089|NCT00003717|Alkylating Agents|alkylating agents|mesh-ancestor
6316090|NCT00003717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6316091|NCT00003718|Temozolomide|temozolomide|mesh-list
6316092|NCT00003718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6316093|NCT00003718|Alkylating Agents|alkylating agents|mesh-ancestor
6316094|NCT00003718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316095|NCT00003718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316096|NCT00003719|Irinotecan|irinotecan|mesh-list
6316097|NCT00003719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6316098|NCT00003719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6316099|NCT00003719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6316100|NCT00003719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316101|NCT00003719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316102|NCT00003720|Semaxinib|semaxinib|mesh-list
6316103|NCT00003720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6316104|NCT00003720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6316105|NCT00003720|Growth Substances|growth substances|mesh-ancestor
6316106|NCT00003720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6316107|NCT00003720|Growth Inhibitors|growth inhibitors|mesh-ancestor
6316108|NCT00003720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316109|NCT00003720|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6316110|NCT00003720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6316111|NCT00003720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316112|NCT00003723|Gemcitabine|gemcitabine|mesh-list
6316113|NCT00003723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6316114|NCT00003723|Antimetabolites|antimetabolites|mesh-ancestor
6316115|NCT00003723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316116|NCT00003723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316117|NCT00003723|Antiviral Agents|antiviral agents|mesh-ancestor
6316118|NCT00003723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6316119|NCT00003723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6316120|NCT00003723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6316121|NCT00003723|Immunologic Factors|immunologic factors|mesh-ancestor
6316122|NCT00003723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6316123|NCT00003725|Valrubicin|valrubicin|mesh-list
6316124|NCT00003725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316125|NCT00003725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6316126|NCT00003725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6316127|NCT00003725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6316128|NCT00003725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316129|NCT00003727|Gemcitabine|gemcitabine|mesh-list
6316130|NCT00003727|Interferons|interferons|mesh-list
6316131|NCT00003727|Interferon-alpha|interferon-alpha|mesh-list
6316132|NCT00003727|Cyclophosphamide|cyclophosphamide|mesh-list
6316133|NCT00003727|Melphalan|melphalan|mesh-list
6316134|NCT00003727|Carmustine|carmustine|mesh-list
6316135|NCT00003727|Etoposide|etoposide|mesh-list
6316136|NCT00003727|Sargramostim|sargramostim|mesh-list
6316137|NCT00003727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6316138|NCT00003727|Immunologic Factors|immunologic factors|mesh-ancestor
6316139|NCT00003727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6316140|NCT00003727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6316141|NCT00003727|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6316142|NCT00003727|Alkylating Agents|alkylating agents|mesh-ancestor
6316143|NCT00003727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316144|NCT00003727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316145|NCT00003727|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6316146|NCT00003727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6316147|NCT00003727|Antimetabolites|antimetabolites|mesh-ancestor
6316148|NCT00003727|Antiviral Agents|antiviral agents|mesh-ancestor
6316149|NCT00003727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6316150|NCT00003727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6316151|NCT00003727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6316152|NCT00003727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6316153|NCT00003727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6316154|NCT00003728|Leucovorin|leucovorin|mesh-list
6316155|NCT00003728|Cytarabine|cytarabine|mesh-list
6316156|NCT00003728|Dexamethasone|dexamethasone|mesh-list
6316157|NCT00003728|Methylprednisolone|methylprednisolone|mesh-list
6316158|NCT00003728|Prednisolone|prednisolone|mesh-list
6316159|NCT00003728|Hydrocortisone|hydrocortisone|mesh-list
6316160|NCT00003728|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6316161|NCT00003728|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6316162|NCT00003728|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6316163|NCT00003728|Cyclophosphamide|cyclophosphamide|mesh-list
6316164|NCT00003728|Doxorubicin|doxorubicin|mesh-list
6316165|NCT00003728|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6316166|NCT00003728|Methotrexate|methotrexate|mesh-list
6316167|NCT00003728|Etoposide|etoposide|mesh-list
6316168|NCT00003728|Vincristine|vincristine|mesh-list
6316169|NCT00003728|Daunorubicin|daunorubicin|mesh-list
6316170|NCT00003728|Asparaginase|asparaginase|mesh-list
6316171|NCT00003728|Mercaptopurine|mercaptopurine|mesh-list
6316172|NCT00003728|Mitoxantrone|mitoxantrone|mesh-list
6316173|NCT00003728|Thioguanine|thioguanine|mesh-list
6316174|NCT00003728|Vindesine|vindesine|mesh-list
6316175|NCT00003728|Levoleucovorin|levoleucovorin|mesh-list
6316176|NCT00003728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6316177|NCT00003728|Immunologic Factors|immunologic factors|mesh-ancestor
6316178|NCT00003728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6316179|NCT00003728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6316180|NCT00003728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6316181|NCT00003728|Alkylating Agents|alkylating agents|mesh-ancestor
6316182|NCT00003728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316183|NCT00003728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316184|NCT00003728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6316185|NCT00003728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6316186|NCT00003728|Antiemetics|antiemetics|mesh-ancestor
6316187|NCT00003728|Autonomic Agents|autonomic agents|mesh-ancestor
6316188|NCT00003728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6316189|NCT00003728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6316190|NCT00003728|Glucocorticoids|glucocorticoids|mesh-ancestor
6316191|NCT00003728|Hormones|hormones|mesh-ancestor
6316192|NCT00003728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6316193|NCT00003728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6316194|NCT00003728|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6316195|NCT00003728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6316196|NCT00003728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6316197|NCT00003728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6316198|NCT00003728|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6316199|NCT00003728|Abortifacient Agents|abortifacient agents|mesh-ancestor
6316200|NCT00003728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6316201|NCT00003728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6316202|NCT00003728|Antimetabolites|antimetabolites|mesh-ancestor
6316203|NCT00003728|Dermatologic Agents|dermatologic agents|mesh-ancestor
6316204|NCT00003728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6316205|NCT00003728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6316206|NCT00003728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6316207|NCT00003728|Antiviral Agents|antiviral agents|mesh-ancestor
6316208|NCT00003728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6316209|NCT00003728|Antidotes|antidotes|mesh-ancestor
6316210|NCT00003728|Protective Agents|protective agents|mesh-ancestor
6316211|NCT00003728|Vitamin B Complex|vitamin b complex|mesh-ancestor
6316212|NCT00003728|Vitamins|vitamins|mesh-ancestor
6316213|NCT00003728|Micronutrients|micronutrients|mesh-ancestor
6316214|NCT00003728|Tubulin Modulators|tubulin modulators|mesh-ancestor
6316215|NCT00003728|Antimitotic Agents|antimitotic agents|mesh-ancestor
6316216|NCT00003728|Mitosis Modulators|mitosis modulators|mesh-ancestor
6316217|NCT00003728|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6316218|NCT00003728|Analgesics|analgesics|mesh-ancestor
6316219|NCT00003728|Sensory System Agents|sensory system agents|mesh-ancestor
6316220|NCT00003729|Cytarabine|cytarabine|mesh-list
6316221|NCT00003729|Fludarabine|fludarabine|mesh-list
6316222|NCT00003729|Fludarabine phosphate|fludarabine phosphate|mesh-list
6316223|NCT00003729|Idarubicin|idarubicin|mesh-list
6316224|NCT00003729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316225|NCT00003729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6316226|NCT00003729|Antimetabolites|antimetabolites|mesh-ancestor
6316227|NCT00003729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316228|NCT00003729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6316229|NCT00003729|Immunologic Factors|immunologic factors|mesh-ancestor
6316230|NCT00003729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6316231|NCT00003729|Antiviral Agents|antiviral agents|mesh-ancestor
6316232|NCT00003729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6316233|NCT00003729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6316234|NCT00003729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6316235|NCT00003729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6316236|NCT00003729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6316237|NCT00003730|Fluorouracil|fluorouracil|mesh-list
6316238|NCT00003730|Vinorelbine|vinorelbine|mesh-list
6316239|NCT00003730|Antimetabolites|antimetabolites|mesh-ancestor
6316240|NCT00003730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316241|NCT00003730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6316242|NCT00003730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316243|NCT00003730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6316244|NCT00003730|Immunologic Factors|immunologic factors|mesh-ancestor
6316245|NCT00003730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6316246|NCT00003730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6316247|NCT00003730|Tubulin Modulators|tubulin modulators|mesh-ancestor
6316248|NCT00003730|Antimitotic Agents|antimitotic agents|mesh-ancestor
6316249|NCT00003730|Mitosis Modulators|mitosis modulators|mesh-ancestor
6316250|NCT00003731|Temozolomide|temozolomide|mesh-list
6316251|NCT00003731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6316252|NCT00003731|Alkylating Agents|alkylating agents|mesh-ancestor
6316253|NCT00003731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316254|NCT00003731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316255|NCT00003732|Paclitaxel|paclitaxel|mesh-list
6316256|NCT00003732|Carboplatin|carboplatin|mesh-list
6316257|NCT00003732|Topotecan|topotecan|mesh-list
6316258|NCT00003732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6316259|NCT00003732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316260|NCT00003732|Tubulin Modulators|tubulin modulators|mesh-ancestor
6316261|NCT00003732|Antimitotic Agents|antimitotic agents|mesh-ancestor
6316262|NCT00003732|Mitosis Modulators|mitosis modulators|mesh-ancestor
6316263|NCT00003732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316264|NCT00003732|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6316265|NCT00003732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6316266|NCT00003732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6316267|NCT00003733|Paclitaxel|paclitaxel|mesh-list
6316268|NCT00003733|Carboplatin|carboplatin|mesh-list
6316269|NCT00003733|Topotecan|topotecan|mesh-list
6316270|NCT00003733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6316271|NCT00003733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316272|NCT00003733|Tubulin Modulators|tubulin modulators|mesh-ancestor
6316273|NCT00003733|Antimitotic Agents|antimitotic agents|mesh-ancestor
6316274|NCT00003733|Mitosis Modulators|mitosis modulators|mesh-ancestor
6316275|NCT00003733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316276|NCT00003733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6316277|NCT00003733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6316278|NCT00003733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6316279|NCT00003734|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6316280|NCT00003734|Flutamide|flutamide|mesh-list
6316281|NCT00003734|Luteolytic Agents|luteolytic agents|mesh-ancestor
6316282|NCT00003734|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6316283|NCT00003734|Contraceptive Agents|contraceptive agents|mesh-ancestor
6316284|NCT00003734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6316285|NCT00003734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6316286|NCT00003734|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6316287|NCT00003734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6316288|NCT00003734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316289|NCT00003734|Androgen Antagonists|androgen antagonists|mesh-ancestor
6316290|NCT00003734|Hormone Antagonists|hormone antagonists|mesh-ancestor
6316291|NCT00003734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6316292|NCT00003735|Topotecan|topotecan|mesh-list
6316293|NCT00003735|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
6316294|NCT00003735|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6316295|NCT00003735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6316296|NCT00003735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6316297|NCT00003735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316298|NCT00003735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316299|NCT00003735|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6316300|NCT00003736|Motexafin gadolinium|motexafin gadolinium|mesh-list
6316301|NCT00003736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316302|NCT00003736|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6316303|NCT00003736|Dermatologic Agents|dermatologic agents|mesh-ancestor
6316304|NCT00003739|Lenograstim|lenograstim|mesh-list
6316305|NCT00003739|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6316306|NCT00003739|Immunologic Factors|immunologic factors|mesh-ancestor
6316307|NCT00003739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6316308|NCT00003740|Trastuzumab|trastuzumab|mesh-list
6316309|NCT00003740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6316310|NCT00003740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316311|NCT00003741|Antibodies|antibodies|mesh-list
6316312|NCT00003741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6316313|NCT00003741|Immunologic Factors|immunologic factors|mesh-ancestor
6316314|NCT00003741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6316315|NCT00003742|Paclitaxel|paclitaxel|mesh-list
6316316|NCT00003742|Irinotecan|irinotecan|mesh-list
6316317|NCT00003742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6316318|NCT00003742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316319|NCT00003742|Tubulin Modulators|tubulin modulators|mesh-ancestor
6316320|NCT00003742|Antimitotic Agents|antimitotic agents|mesh-ancestor
6316321|NCT00003742|Mitosis Modulators|mitosis modulators|mesh-ancestor
6316322|NCT00003742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316323|NCT00003742|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6316324|NCT00003742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6316325|NCT00003742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6316326|NCT00003743|Aldesleukin|aldesleukin|mesh-list
6316327|NCT00003743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316328|NCT00003743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6316329|NCT00003743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6316330|NCT00003743|Antiviral Agents|antiviral agents|mesh-ancestor
6316331|NCT00003743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6316332|NCT00003744|Gemcitabine|gemcitabine|mesh-list
6316333|NCT00003744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6316334|NCT00003744|Antimetabolites|antimetabolites|mesh-ancestor
6316335|NCT00003744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316336|NCT00003744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316337|NCT00003744|Antiviral Agents|antiviral agents|mesh-ancestor
6316338|NCT00003744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6316339|NCT00003744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6316340|NCT00003744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6316341|NCT00003744|Immunologic Factors|immunologic factors|mesh-ancestor
6316342|NCT00003744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6316343|NCT00003745|Topotecan|topotecan|mesh-list
6316344|NCT00003745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6316345|NCT00003745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6316346|NCT00003745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6392640|NCT00197327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6316347|NCT00003745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316348|NCT00003745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316349|NCT00003746|Cladribine|cladribine|mesh-list
6316350|NCT00003746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316351|NCT00003746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6316352|NCT00003746|Immunologic Factors|immunologic factors|mesh-ancestor
6316353|NCT00003746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6316354|NCT00003747|Carboplatin|carboplatin|mesh-list
6316355|NCT00003747|Temozolomide|temozolomide|mesh-list
6316356|NCT00003747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316357|NCT00003747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6316358|NCT00003747|Alkylating Agents|alkylating agents|mesh-ancestor
6316359|NCT00003747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316360|NCT00003748|Irinotecan|irinotecan|mesh-list
6316361|NCT00003748|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6316362|NCT00003748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6316363|NCT00003748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6316364|NCT00003748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316365|NCT00003748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316366|NCT00003751|Penicillamine|penicillamine|mesh-list
6316367|NCT00003751|Antidotes|antidotes|mesh-ancestor
6316368|NCT00003751|Protective Agents|protective agents|mesh-ancestor
6316369|NCT00003751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6316370|NCT00003751|Chelating Agents|chelating agents|mesh-ancestor
6316371|NCT00003751|Sequestering Agents|sequestering agents|mesh-ancestor
6316372|NCT00003751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316373|NCT00003751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6316374|NCT00003752|Bexarotene|bexarotene|mesh-list
6316375|NCT00003752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316376|NCT00003753|Dexamethasone|dexamethasone|mesh-list
6316377|NCT00003753|Irinotecan|irinotecan|mesh-list
6316378|NCT00003753|Floxuridine|floxuridine|mesh-list
6316379|NCT00003753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6316380|NCT00003753|Antiemetics|antiemetics|mesh-ancestor
6316381|NCT00003753|Autonomic Agents|autonomic agents|mesh-ancestor
6316382|NCT00003753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6316383|NCT00003753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6316384|NCT00003753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6316385|NCT00003753|Glucocorticoids|glucocorticoids|mesh-ancestor
6316386|NCT00003753|Hormones|hormones|mesh-ancestor
6316387|NCT00003753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6316388|NCT00003753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6316389|NCT00003753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316390|NCT00003753|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6316391|NCT00003753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6316392|NCT00003753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6316393|NCT00003753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316394|NCT00003753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6316395|NCT00003753|Antimetabolites|antimetabolites|mesh-ancestor
6316396|NCT00003754|Thalidomide|thalidomide|mesh-list
6316397|NCT00003754|Cyclophosphamide|cyclophosphamide|mesh-list
6316398|NCT00003754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6316399|NCT00003754|Immunologic Factors|immunologic factors|mesh-ancestor
6316400|NCT00003754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6316401|NCT00003754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6316402|NCT00003754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6316403|NCT00003754|Alkylating Agents|alkylating agents|mesh-ancestor
6316404|NCT00003754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316405|NCT00003754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316406|NCT00003754|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6316407|NCT00003754|Leprostatic Agents|leprostatic agents|mesh-ancestor
6316408|NCT00003754|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6316409|NCT00003754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6316410|NCT00003754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6316411|NCT00003754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6016430|NCT00365274|Hormones|hormones|mesh-ancestor
6316412|NCT00003754|Growth Substances|growth substances|mesh-ancestor
6316413|NCT00003754|Growth Inhibitors|growth inhibitors|mesh-ancestor
6316414|NCT00003757|Rituximab|rituximab|mesh-list
6316415|NCT00003757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6316416|NCT00003757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6016431|NCT00365274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6016432|NCT00365274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6016433|NCT00365274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6016434|NCT00365274|Tubulin Modulators|tubulin modulators|mesh-ancestor
6316417|NCT00003757|Immunologic Factors|immunologic factors|mesh-ancestor
6316418|NCT00003757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6316419|NCT00003757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6316420|NCT00003758|Cytarabine|cytarabine|mesh-list
6316421|NCT00003758|Idarubicin|idarubicin|mesh-list
6316422|NCT00003758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6316423|NCT00003758|Antimetabolites|antimetabolites|mesh-ancestor
6316424|NCT00003758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316425|NCT00003758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316426|NCT00003758|Antiviral Agents|antiviral agents|mesh-ancestor
6316427|NCT00003758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6316428|NCT00003758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6316429|NCT00003758|Immunologic Factors|immunologic factors|mesh-ancestor
6316430|NCT00003758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6316431|NCT00003758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6316432|NCT00003758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6316433|NCT00003758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6316434|NCT00003758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6316435|NCT00003759|Valrubicin|valrubicin|mesh-list
6316436|NCT00003759|BCG Vaccine|bcg vaccine|mesh-list
6316437|NCT00003759|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6316438|NCT00003759|Immunologic Factors|immunologic factors|mesh-ancestor
6316439|NCT00003759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6316440|NCT00003759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316441|NCT00003759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6316442|NCT00003759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6316443|NCT00003759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6316444|NCT00003759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316445|NCT00003760|Irofulven|irofulven|mesh-list
6316446|NCT00003760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6316447|NCT00003760|Alkylating Agents|alkylating agents|mesh-ancestor
6316448|NCT00003760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316449|NCT00003760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316450|NCT00003762|Gemcitabine|gemcitabine|mesh-list
6316451|NCT00003762|Docetaxel|docetaxel|mesh-list
6316452|NCT00003762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6316453|NCT00003762|Antimetabolites|antimetabolites|mesh-ancestor
6316454|NCT00003762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316455|NCT00003762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316456|NCT00003762|Antiviral Agents|antiviral agents|mesh-ancestor
6316457|NCT00003762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6316458|NCT00003762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6316459|NCT00003762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6316460|NCT00003762|Immunologic Factors|immunologic factors|mesh-ancestor
6316461|NCT00003762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6316462|NCT00003762|Tubulin Modulators|tubulin modulators|mesh-ancestor
6316463|NCT00003762|Antimitotic Agents|antimitotic agents|mesh-ancestor
6316464|NCT00003762|Mitosis Modulators|mitosis modulators|mesh-ancestor
6316465|NCT00003763|Folic Acid|folic acid|mesh-list
6316466|NCT00003763|Hematinics|hematinics|mesh-ancestor
6316467|NCT00003763|Vitamin B Complex|vitamin b complex|mesh-ancestor
6316468|NCT00003763|Vitamins|vitamins|mesh-ancestor
6316469|NCT00003763|Micronutrients|micronutrients|mesh-ancestor
6316470|NCT00003763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6316471|NCT00003764|Cyclophosphamide|cyclophosphamide|mesh-list
6316472|NCT00003764|Fludarabine|fludarabine|mesh-list
6316473|NCT00003764|Fludarabine phosphate|fludarabine phosphate|mesh-list
6316474|NCT00003764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6316475|NCT00003764|Immunologic Factors|immunologic factors|mesh-ancestor
6316476|NCT00003764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6316477|NCT00003764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6316478|NCT00003764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6316479|NCT00003764|Alkylating Agents|alkylating agents|mesh-ancestor
6316480|NCT00003764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316481|NCT00003764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316482|NCT00003764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6316483|NCT00003764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6316484|NCT00003764|Antimetabolites|antimetabolites|mesh-ancestor
6316485|NCT00003765|Carmustine|carmustine|mesh-list
6316486|NCT00003765|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
6316487|NCT00003765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6316488|NCT00003765|Alkylating Agents|alkylating agents|mesh-ancestor
6316489|NCT00003765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316490|NCT00003765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316491|NCT00003765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6316492|NCT00003766|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
6316493|NCT00003766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316494|NCT00003766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6316495|NCT00003766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316496|NCT00003768|Fosbretabulin|fosbretabulin|mesh-list
6016435|NCT00365274|Antimitotic Agents|antimitotic agents|mesh-ancestor
6016436|NCT00365274|Mitosis Modulators|mitosis modulators|mesh-ancestor
6016437|NCT00365274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6016438|NCT00365300|Pantoprazole|pantoprazole|mesh-list
6016439|NCT00365300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6016440|NCT00365300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6016441|NCT00365300|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6016442|NCT00365300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6016443|NCT00365300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016444|NCT00365352|Gabapentin|gabapentin|mesh-list
6016445|NCT00365352|Analgesics|analgesics|mesh-ancestor
6016446|NCT00365352|Sensory System Agents|sensory system agents|mesh-ancestor
6016447|NCT00365352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6016448|NCT00365352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016449|NCT00365352|Anticonvulsants|anticonvulsants|mesh-ancestor
6016450|NCT00365352|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6316497|NCT00003768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6316498|NCT00003768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316499|NCT00003769|Perillyl alcohol|perillyl alcohol|mesh-list
6316500|NCT00003769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316501|NCT00003769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6316502|NCT00003769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316503|NCT00003771|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6316504|NCT00003771|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6316505|NCT00003771|Norethindrone|norethindrone|mesh-list
6016451|NCT00365352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6316506|NCT00003771|Norethindrone Acetate|norethindrone acetate|mesh-list
6316507|NCT00003771|Estradiol|estradiol|mesh-list
6316508|NCT00003771|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6316509|NCT00003771|Estrogens|estrogens|mesh-ancestor
6316510|NCT00003771|Hormones|hormones|mesh-ancestor
6316511|NCT00003771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6316512|NCT00003771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6316513|NCT00003771|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6316514|NCT00003771|Contraceptive Agents|contraceptive agents|mesh-ancestor
6316515|NCT00003771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6316516|NCT00003771|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6316517|NCT00003771|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6316518|NCT00003771|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6316519|NCT00003771|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6316520|NCT00003775|Leflunomide|leflunomide|mesh-list
6316521|NCT00003775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6316522|NCT00003775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316523|NCT00003775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6316524|NCT00003775|Immunologic Factors|immunologic factors|mesh-ancestor
6316525|NCT00003775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6316526|NCT00003776|Leucovorin|leucovorin|mesh-list
6316527|NCT00003776|Trimetrexate|trimetrexate|mesh-list
6316528|NCT00003776|Doxorubicin|doxorubicin|mesh-list
6316529|NCT00003776|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6316530|NCT00003776|Methotrexate|methotrexate|mesh-list
6316531|NCT00003776|Ifosfamide|ifosfamide|mesh-list
6316532|NCT00003776|Calcium|calcium|mesh-list
6316533|NCT00003776|Levoleucovorin|levoleucovorin|mesh-list
6316534|NCT00003776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316535|NCT00003776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6316536|NCT00003776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6316537|NCT00003776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6316538|NCT00003776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6316539|NCT00003776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316540|NCT00003776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6316541|NCT00003776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6316542|NCT00003776|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6316543|NCT00003776|Abortifacient Agents|abortifacient agents|mesh-ancestor
6316544|NCT00003776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6316545|NCT00003776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6316546|NCT00003776|Antimetabolites|antimetabolites|mesh-ancestor
6316547|NCT00003776|Dermatologic Agents|dermatologic agents|mesh-ancestor
6316548|NCT00003776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6316549|NCT00003776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6316550|NCT00003776|Immunologic Factors|immunologic factors|mesh-ancestor
6316551|NCT00003776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6316552|NCT00003776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6316553|NCT00003776|Antidotes|antidotes|mesh-ancestor
6316554|NCT00003776|Protective Agents|protective agents|mesh-ancestor
6316555|NCT00003776|Vitamin B Complex|vitamin b complex|mesh-ancestor
6316556|NCT00003776|Vitamins|vitamins|mesh-ancestor
6316557|NCT00003776|Micronutrients|micronutrients|mesh-ancestor
6316558|NCT00003776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6316559|NCT00003776|Alkylating Agents|alkylating agents|mesh-ancestor
6316560|NCT00003776|Antifungal Agents|antifungal agents|mesh-ancestor
6316561|NCT00003776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6316562|NCT00003778|Dolastatin 10|dolastatin 10|mesh-list
6316563|NCT00003778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316564|NCT00003778|Tubulin Modulators|tubulin modulators|mesh-ancestor
6316565|NCT00003778|Antimitotic Agents|antimitotic agents|mesh-ancestor
6316566|NCT00003778|Mitosis Modulators|mitosis modulators|mesh-ancestor
6316567|NCT00003778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316568|NCT00003780|Gemcitabine|gemcitabine|mesh-list
6316569|NCT00003780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6316570|NCT00003780|Antimetabolites|antimetabolites|mesh-ancestor
6316571|NCT00003780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316572|NCT00003780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316573|NCT00003780|Antiviral Agents|antiviral agents|mesh-ancestor
6316574|NCT00003780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6316575|NCT00003780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6316576|NCT00003780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6316577|NCT00003780|Immunologic Factors|immunologic factors|mesh-ancestor
6316578|NCT00003780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6316579|NCT00003781|Docetaxel|docetaxel|mesh-list
6316580|NCT00003781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316581|NCT00003781|Tubulin Modulators|tubulin modulators|mesh-ancestor
6316582|NCT00003781|Antimitotic Agents|antimitotic agents|mesh-ancestor
6316583|NCT00003781|Mitosis Modulators|mitosis modulators|mesh-ancestor
6316584|NCT00003781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316585|NCT00003783|Leucovorin|leucovorin|mesh-list
6316586|NCT00003783|Cytarabine|cytarabine|mesh-list
6316587|NCT00003783|Dexamethasone|dexamethasone|mesh-list
6316588|NCT00003783|Prednisone|prednisone|mesh-list
6316589|NCT00003783|Cyclophosphamide|cyclophosphamide|mesh-list
6316590|NCT00003783|Methotrexate|methotrexate|mesh-list
6316591|NCT00003783|Etoposide|etoposide|mesh-list
6316592|NCT00003783|Vincristine|vincristine|mesh-list
6316593|NCT00003783|Daunorubicin|daunorubicin|mesh-list
6316594|NCT00003783|Asparaginase|asparaginase|mesh-list
6316595|NCT00003783|Mercaptopurine|mercaptopurine|mesh-list
6316596|NCT00003783|Idarubicin|idarubicin|mesh-list
6316597|NCT00003783|Levoleucovorin|levoleucovorin|mesh-list
6316598|NCT00003783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6316599|NCT00003783|Immunologic Factors|immunologic factors|mesh-ancestor
6316600|NCT00003783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6316601|NCT00003783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6316602|NCT00003783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6316603|NCT00003783|Alkylating Agents|alkylating agents|mesh-ancestor
6316604|NCT00003783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316605|NCT00003783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316606|NCT00003783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6316607|NCT00003783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6316608|NCT00003783|Antiemetics|antiemetics|mesh-ancestor
6316609|NCT00003783|Autonomic Agents|autonomic agents|mesh-ancestor
6316610|NCT00003783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6316611|NCT00003783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6316612|NCT00003783|Glucocorticoids|glucocorticoids|mesh-ancestor
6316613|NCT00003783|Hormones|hormones|mesh-ancestor
6316614|NCT00003783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6316615|NCT00003783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6316616|NCT00003783|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6316617|NCT00003783|Abortifacient Agents|abortifacient agents|mesh-ancestor
6316618|NCT00003783|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6316619|NCT00003783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6316620|NCT00003783|Antimetabolites|antimetabolites|mesh-ancestor
6316621|NCT00003783|Dermatologic Agents|dermatologic agents|mesh-ancestor
6316622|NCT00003783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6316623|NCT00003783|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6316624|NCT00003783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6316625|NCT00003783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6316626|NCT00003783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6316627|NCT00003783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6316628|NCT00003783|Antiviral Agents|antiviral agents|mesh-ancestor
6316629|NCT00003783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6316630|NCT00003783|Antidotes|antidotes|mesh-ancestor
6316631|NCT00003783|Protective Agents|protective agents|mesh-ancestor
6316632|NCT00003783|Vitamin B Complex|vitamin b complex|mesh-ancestor
6316633|NCT00003783|Vitamins|vitamins|mesh-ancestor
6316634|NCT00003783|Micronutrients|micronutrients|mesh-ancestor
6316635|NCT00003783|Tubulin Modulators|tubulin modulators|mesh-ancestor
6316636|NCT00003783|Antimitotic Agents|antimitotic agents|mesh-ancestor
6316637|NCT00003783|Mitosis Modulators|mitosis modulators|mesh-ancestor
6316638|NCT00003783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6316639|NCT00003784|Prednisone|prednisone|mesh-list
6316640|NCT00003784|Cyclophosphamide|cyclophosphamide|mesh-list
6316641|NCT00003784|Doxorubicin|doxorubicin|mesh-list
6316642|NCT00003784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6316643|NCT00003784|Vincristine|vincristine|mesh-list
6316644|NCT00003784|Tositumomab I-131|tositumomab i-131|mesh-list
6316645|NCT00003784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6316646|NCT00003784|Immunologic Factors|immunologic factors|mesh-ancestor
6316647|NCT00003784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6316648|NCT00003784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6316649|NCT00003784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6316650|NCT00003784|Alkylating Agents|alkylating agents|mesh-ancestor
6316651|NCT00003784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316652|NCT00003784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316653|NCT00003784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6316654|NCT00003784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6316655|NCT00003784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6316656|NCT00003784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6316657|NCT00003784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6316658|NCT00003784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6316659|NCT00003784|Glucocorticoids|glucocorticoids|mesh-ancestor
6316660|NCT00003784|Hormones|hormones|mesh-ancestor
6316661|NCT00003784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6316662|NCT00003784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6016452|NCT00365352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6316663|NCT00003784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6316664|NCT00003784|Tubulin Modulators|tubulin modulators|mesh-ancestor
6316665|NCT00003784|Antimitotic Agents|antimitotic agents|mesh-ancestor
6316666|NCT00003784|Mitosis Modulators|mitosis modulators|mesh-ancestor
6316667|NCT00003786|Irofulven|irofulven|mesh-list
6316668|NCT00003786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6316669|NCT00003786|Alkylating Agents|alkylating agents|mesh-ancestor
6316670|NCT00003786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316671|NCT00003786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316672|NCT00003788|Carmustine|carmustine|mesh-list
6316673|NCT00003788|Lomustine|lomustine|mesh-list
6316674|NCT00003788|Procarbazine|procarbazine|mesh-list
6316675|NCT00003788|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
6316676|NCT00003788|Trioxsalen|trioxsalen|mesh-list
6316677|NCT00003788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6316678|NCT00003788|Alkylating Agents|alkylating agents|mesh-ancestor
6316679|NCT00003788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316680|NCT00003788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316681|NCT00003788|Dermatologic Agents|dermatologic agents|mesh-ancestor
6316682|NCT00003788|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6316683|NCT00003789|Melphalan|melphalan|mesh-list
6316684|NCT00003789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6316685|NCT00003789|Alkylating Agents|alkylating agents|mesh-ancestor
6316686|NCT00003789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316687|NCT00003789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316688|NCT00003789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6316689|NCT00003789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6316690|NCT00003789|Immunologic Factors|immunologic factors|mesh-ancestor
6316691|NCT00003789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6316692|NCT00003792|Lenograstim|lenograstim|mesh-list
6316693|NCT00003792|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6316694|NCT00003792|Immunologic Factors|immunologic factors|mesh-ancestor
6316695|NCT00003792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6316696|NCT00003796|Irofulven|irofulven|mesh-list
6316697|NCT00003796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6316698|NCT00003796|Alkylating Agents|alkylating agents|mesh-ancestor
6316699|NCT00003796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316700|NCT00003796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316701|NCT00003797|Gemcitabine|gemcitabine|mesh-list
6316702|NCT00003797|Trastuzumab|trastuzumab|mesh-list
6316703|NCT00003797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6316704|NCT00003797|Antimetabolites|antimetabolites|mesh-ancestor
6316705|NCT00003797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316706|NCT00003797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316707|NCT00003797|Antiviral Agents|antiviral agents|mesh-ancestor
6316708|NCT00003797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6316709|NCT00003797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6316710|NCT00003797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6316711|NCT00003797|Immunologic Factors|immunologic factors|mesh-ancestor
6316712|NCT00003797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6316713|NCT00003797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6316714|NCT00003798|Motexafin gadolinium|motexafin gadolinium|mesh-list
6316715|NCT00003798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316716|NCT00003798|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6316717|NCT00003798|Dermatologic Agents|dermatologic agents|mesh-ancestor
6316718|NCT00003799|Leucovorin|leucovorin|mesh-list
6316719|NCT00003799|Fluorouracil|fluorouracil|mesh-list
6316720|NCT00003799|Oxaliplatin|oxaliplatin|mesh-list
6316721|NCT00003799|Calcium|calcium|mesh-list
6316722|NCT00003799|Levoleucovorin|levoleucovorin|mesh-list
6316723|NCT00003799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6316724|NCT00003799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6316725|NCT00003799|Antimetabolites|antimetabolites|mesh-ancestor
6316726|NCT00003799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316727|NCT00003799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6316728|NCT00003799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6392641|NCT00197340|Ropivacaine|ropivacaine|mesh-list
6316729|NCT00003799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6316730|NCT00003799|Immunologic Factors|immunologic factors|mesh-ancestor
6316731|NCT00003799|Antidotes|antidotes|mesh-ancestor
6316732|NCT00003799|Protective Agents|protective agents|mesh-ancestor
6316733|NCT00003799|Vitamin B Complex|vitamin b complex|mesh-ancestor
6316734|NCT00003799|Vitamins|vitamins|mesh-ancestor
6316735|NCT00003799|Micronutrients|micronutrients|mesh-ancestor
6316736|NCT00003802|NSC 366140|nsc 366140|mesh-list
6316737|NCT00003802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316738|NCT00003803|Gemcitabine|gemcitabine|mesh-list
6316739|NCT00003803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316740|NCT00003803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6316741|NCT00003803|Antimetabolites|antimetabolites|mesh-ancestor
6316742|NCT00003803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316743|NCT00003803|Antiviral Agents|antiviral agents|mesh-ancestor
6316744|NCT00003803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6316745|NCT00003803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6316746|NCT00003803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6316747|NCT00003803|Immunologic Factors|immunologic factors|mesh-ancestor
6316748|NCT00003803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6316749|NCT00003804|Dactinomycin|dactinomycin|mesh-list
6316750|NCT00003804|Vincristine|vincristine|mesh-list
6316751|NCT00003804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6316752|NCT00003804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316753|NCT00003804|Tubulin Modulators|tubulin modulators|mesh-ancestor
6316754|NCT00003804|Antimitotic Agents|antimitotic agents|mesh-ancestor
6316755|NCT00003804|Mitosis Modulators|mitosis modulators|mesh-ancestor
6316756|NCT00003804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316757|NCT00003804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6316758|NCT00003804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6316759|NCT00003804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6316760|NCT00003804|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6316761|NCT00003804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6316762|NCT00003804|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6316763|NCT00003805|Vancomycin|vancomycin|mesh-list
6316764|NCT00003805|Tazobactam|tazobactam|mesh-list
6316765|NCT00003805|Piperacillin|piperacillin|mesh-list
6316766|NCT00003805|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
6316767|NCT00003805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6316768|NCT00003805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6316769|NCT00003805|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6316770|NCT00003805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6316771|NCT00003805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316772|NCT00003808|Theophylline|theophylline|mesh-list
6316773|NCT00003808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6316774|NCT00003808|Autonomic Agents|autonomic agents|mesh-ancestor
6316775|NCT00003808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6316776|NCT00003808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6316777|NCT00003808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6316778|NCT00003808|Respiratory System Agents|respiratory system agents|mesh-ancestor
6316779|NCT00003808|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6316780|NCT00003808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6316781|NCT00003808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316782|NCT00003808|Vasodilator Agents|vasodilator agents|mesh-ancestor
6316783|NCT00003808|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6016453|NCT00365352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6316784|NCT00003808|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6316785|NCT00003808|Purinergic Agents|purinergic agents|mesh-ancestor
6316786|NCT00003808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6316787|NCT00003809|Cetuximab|cetuximab|mesh-list
6316788|NCT00003809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316789|NCT00003809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6316790|NCT00003810|Gemcitabine|gemcitabine|mesh-list
6316791|NCT00003810|Docetaxel|docetaxel|mesh-list
6316792|NCT00003810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6316793|NCT00003810|Antimetabolites|antimetabolites|mesh-ancestor
6316794|NCT00003810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316795|NCT00003810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316796|NCT00003810|Antiviral Agents|antiviral agents|mesh-ancestor
6316797|NCT00003810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6316798|NCT00003810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6316799|NCT00003810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6316800|NCT00003810|Immunologic Factors|immunologic factors|mesh-ancestor
6316801|NCT00003810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6316802|NCT00003810|Tubulin Modulators|tubulin modulators|mesh-ancestor
6016454|NCT00365352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6316803|NCT00003810|Antimitotic Agents|antimitotic agents|mesh-ancestor
6316804|NCT00003810|Mitosis Modulators|mitosis modulators|mesh-ancestor
6316805|NCT00003811|Etoposide|etoposide|mesh-list
6316806|NCT00003811|Bleomycin|bleomycin|mesh-list
6316807|NCT00003811|Amifostine|amifostine|mesh-list
6316808|NCT00003811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316809|NCT00003811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6316810|NCT00003811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6316811|NCT00003811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6316812|NCT00003811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6316813|NCT00003811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316814|NCT00003811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6316815|NCT00003811|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6316816|NCT00003811|Protective Agents|protective agents|mesh-ancestor
6316817|NCT00003811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6316818|NCT00003812|Paclitaxel|paclitaxel|mesh-list
6316819|NCT00003812|Etoposide|etoposide|mesh-list
6316820|NCT00003812|Carboplatin|carboplatin|mesh-list
6316821|NCT00003812|Topotecan|topotecan|mesh-list
6316822|NCT00003812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6316823|NCT00003812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316824|NCT00003812|Tubulin Modulators|tubulin modulators|mesh-ancestor
6316825|NCT00003812|Antimitotic Agents|antimitotic agents|mesh-ancestor
6316826|NCT00003812|Mitosis Modulators|mitosis modulators|mesh-ancestor
6316827|NCT00003812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316828|NCT00003812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6316829|NCT00003812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6316830|NCT00003812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6316831|NCT00003812|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6316832|NCT00003814|Eflornithine|eflornithine|mesh-list
6316833|NCT00003814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316834|NCT00003814|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6316835|NCT00003814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6316836|NCT00003814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6316837|NCT00003814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6316838|NCT00003814|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
6316839|NCT00003814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6316840|NCT00003814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316841|NCT00003815|Cytarabine|cytarabine|mesh-list
6316842|NCT00003815|Prednisolone|prednisolone|mesh-list
6316843|NCT00003815|Cyclophosphamide|cyclophosphamide|mesh-list
6316844|NCT00003815|Melphalan|melphalan|mesh-list
6316845|NCT00003815|Carmustine|carmustine|mesh-list
6316846|NCT00003815|Doxorubicin|doxorubicin|mesh-list
6316847|NCT00003815|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6316848|NCT00003815|Etoposide|etoposide|mesh-list
6316849|NCT00003815|Vincristine|vincristine|mesh-list
6316850|NCT00003815|Bleomycin|bleomycin|mesh-list
6316851|NCT00003815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6316852|NCT00003815|Immunologic Factors|immunologic factors|mesh-ancestor
6316853|NCT00003815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6316854|NCT00003815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6316855|NCT00003815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6316856|NCT00003815|Alkylating Agents|alkylating agents|mesh-ancestor
6316857|NCT00003815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316858|NCT00003815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316859|NCT00003815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6316860|NCT00003815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6316861|NCT00003815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6316862|NCT00003815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6316863|NCT00003815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6316864|NCT00003815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6316865|NCT00003815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6316866|NCT00003815|Antimetabolites|antimetabolites|mesh-ancestor
6316867|NCT00003815|Antiviral Agents|antiviral agents|mesh-ancestor
6316868|NCT00003815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6316869|NCT00003815|Tubulin Modulators|tubulin modulators|mesh-ancestor
6316870|NCT00003815|Antimitotic Agents|antimitotic agents|mesh-ancestor
6316871|NCT00003815|Mitosis Modulators|mitosis modulators|mesh-ancestor
6316872|NCT00003815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6316873|NCT00003815|Glucocorticoids|glucocorticoids|mesh-ancestor
6316874|NCT00003815|Hormones|hormones|mesh-ancestor
6316875|NCT00003815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6316876|NCT00003815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6316877|NCT00003817|Ondansetron|ondansetron|mesh-list
6316878|NCT00003817|Granisetron|granisetron|mesh-list
6316879|NCT00003817|Tropisetron|tropisetron|mesh-list
6316880|NCT00003817|Dolasetron|dolasetron|mesh-list
6316881|NCT00003817|Antiemetics|antiemetics|mesh-ancestor
6316882|NCT00003817|Autonomic Agents|autonomic agents|mesh-ancestor
6316883|NCT00003817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6316884|NCT00003817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6316885|NCT00003817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6316886|NCT00003817|Antipruritics|antipruritics|mesh-ancestor
6316887|NCT00003817|Dermatologic Agents|dermatologic agents|mesh-ancestor
6316888|NCT00003817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6316889|NCT00003817|Serotonin Agents|serotonin agents|mesh-ancestor
6316890|NCT00003817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6316891|NCT00003817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316892|NCT00003817|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6316893|NCT00003817|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6316894|NCT00003817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6316895|NCT00003817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6316896|NCT00003817|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6316897|NCT00003817|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6316898|NCT00003819|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
6316899|NCT00003819|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6316900|NCT00003819|Immunologic Factors|immunologic factors|mesh-ancestor
6316901|NCT00003819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6316902|NCT00003821|Aminopterin|aminopterin|mesh-list
6316903|NCT00003821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6316904|NCT00003821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6316905|NCT00003821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316906|NCT00003824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6316907|NCT00003824|Ciprofloxacin|ciprofloxacin|mesh-list
6316908|NCT00003824|Cephalexin|cephalexin|mesh-list
6316909|NCT00003824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6316910|NCT00003824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6316911|NCT00003824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6316912|NCT00003824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6316913|NCT00003824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316914|NCT00003824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316915|NCT00003824|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6316916|NCT00003824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6316917|NCT00003825|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
6316918|NCT00003825|Anticoagulants|anticoagulants|mesh-ancestor
6316919|NCT00003827|Cytarabine|cytarabine|mesh-list
6316920|NCT00003827|Topotecan|topotecan|mesh-list
6316921|NCT00003827|Amifostine|amifostine|mesh-list
6316922|NCT00003827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6316923|NCT00003827|Antimetabolites|antimetabolites|mesh-ancestor
6316924|NCT00003827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316925|NCT00003827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316926|NCT00003827|Antiviral Agents|antiviral agents|mesh-ancestor
6316927|NCT00003827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6316928|NCT00003827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6316929|NCT00003827|Immunologic Factors|immunologic factors|mesh-ancestor
6316930|NCT00003827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6316931|NCT00003827|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6316932|NCT00003827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6316933|NCT00003827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6316934|NCT00003827|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6316935|NCT00003827|Protective Agents|protective agents|mesh-ancestor
6316936|NCT00003828|Vinorelbine|vinorelbine|mesh-list
6316937|NCT00003828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6316938|NCT00003828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316939|NCT00003828|Tubulin Modulators|tubulin modulators|mesh-ancestor
6316940|NCT00003828|Antimitotic Agents|antimitotic agents|mesh-ancestor
6316941|NCT00003828|Mitosis Modulators|mitosis modulators|mesh-ancestor
6316942|NCT00003828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016455|NCT00365352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6016456|NCT00365352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6016457|NCT00365352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016458|NCT00365352|Antimanic Agents|antimanic agents|mesh-ancestor
6016459|NCT00365365|Cyclophosphamide|cyclophosphamide|mesh-list
6016460|NCT00365365|Bevacizumab|bevacizumab|mesh-list
6016461|NCT00365365|Carboplatin|carboplatin|mesh-list
6316943|NCT00003829|Cyclophosphamide|cyclophosphamide|mesh-list
6316944|NCT00003829|Fludarabine|fludarabine|mesh-list
6316945|NCT00003829|Fludarabine phosphate|fludarabine phosphate|mesh-list
6316946|NCT00003829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6316947|NCT00003829|Immunologic Factors|immunologic factors|mesh-ancestor
6316948|NCT00003829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6316949|NCT00003829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6316950|NCT00003829|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6316951|NCT00003829|Alkylating Agents|alkylating agents|mesh-ancestor
6316952|NCT00003829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316953|NCT00003829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316954|NCT00003829|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6316955|NCT00003829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6316956|NCT00003829|Antimetabolites|antimetabolites|mesh-ancestor
6392642|NCT00197340|Anesthetics, Local|anesthetics, local|mesh-ancestor
6392643|NCT00197340|Anesthetics|anesthetics|mesh-ancestor
6392644|NCT00197340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6392645|NCT00197340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392646|NCT00197340|Sensory System Agents|sensory system agents|mesh-ancestor
6392647|NCT00197340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6392648|NCT00197353|Bupivacaine|bupivacaine|mesh-list
6392649|NCT00197353|Anesthetics, Local|anesthetics, local|mesh-ancestor
6392650|NCT00197353|Anesthetics|anesthetics|mesh-ancestor
6392651|NCT00197353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6392652|NCT00197353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392653|NCT00197353|Sensory System Agents|sensory system agents|mesh-ancestor
6392654|NCT00197353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6392655|NCT00197379|Roxithromycin|roxithromycin|mesh-list
6392656|NCT00197379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6392657|NCT00197379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6392658|NCT00197418|Amoxicillin|amoxicillin|mesh-list
6392659|NCT00197418|Metronidazole|metronidazole|mesh-list
6392660|NCT00197418|Clarithromycin|clarithromycin|mesh-list
6392661|NCT00197418|Rabeprazole|rabeprazole|mesh-list
6392662|NCT00197418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6392663|NCT00197418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6392664|NCT00197418|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6392665|NCT00197418|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6392666|NCT00197418|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6392667|NCT00197418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6392668|NCT00197418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392669|NCT00197418|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6392670|NCT00197418|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6392671|NCT00197418|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6392672|NCT00197418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6392673|NCT00197418|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6392674|NCT00197444|Nedaplatin|nedaplatin|mesh-list
6392675|NCT00197444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6392676|NCT00197483|Pergolide|pergolide|mesh-list
6392677|NCT00197483|Dopamine Agonists|dopamine agonists|mesh-ancestor
6392678|NCT00197483|Dopamine Agents|dopamine agents|mesh-ancestor
6016462|NCT00365365|Docetaxel|docetaxel|mesh-list
6016463|NCT00365365|Doxorubicin|doxorubicin|mesh-list
6392679|NCT00197483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6392680|NCT00197483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316957|NCT00003832|Bromodeoxyuridine|bromodeoxyuridine|mesh-list
6316958|NCT00003832|5-bromouridine|5-bromouridine|mesh-list
6316959|NCT00003832|Antimetabolites|antimetabolites|mesh-ancestor
6316960|NCT00003832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316961|NCT00003832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6316962|NCT00003832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316963|NCT00003832|Antiviral Agents|antiviral agents|mesh-ancestor
6316964|NCT00003832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6316965|NCT00003834|Leucovorin|leucovorin|mesh-list
6316966|NCT00003834|Fluorouracil|fluorouracil|mesh-list
6316967|NCT00003834|Oxaliplatin|oxaliplatin|mesh-list
6316968|NCT00003834|Calcium|calcium|mesh-list
6316969|NCT00003834|Levoleucovorin|levoleucovorin|mesh-list
6316970|NCT00003834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6316971|NCT00003834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6316972|NCT00003834|Antimetabolites|antimetabolites|mesh-ancestor
6316973|NCT00003834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316974|NCT00003834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6316975|NCT00003834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316976|NCT00003834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6316977|NCT00003834|Immunologic Factors|immunologic factors|mesh-ancestor
6316978|NCT00003834|Antidotes|antidotes|mesh-ancestor
6316979|NCT00003834|Protective Agents|protective agents|mesh-ancestor
6316980|NCT00003834|Vitamin B Complex|vitamin b complex|mesh-ancestor
6316981|NCT00003834|Vitamins|vitamins|mesh-ancestor
6316982|NCT00003834|Micronutrients|micronutrients|mesh-ancestor
6316983|NCT00003835|Leucovorin|leucovorin|mesh-list
6316984|NCT00003835|Fluorouracil|fluorouracil|mesh-list
6316985|NCT00003835|Irinotecan|irinotecan|mesh-list
6316986|NCT00003835|Calcium|calcium|mesh-list
6316987|NCT00003835|Levoleucovorin|levoleucovorin|mesh-list
6316988|NCT00003835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6316989|NCT00003835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6316990|NCT00003835|Antimetabolites|antimetabolites|mesh-ancestor
6316991|NCT00003835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6316992|NCT00003835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6316993|NCT00003835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6316994|NCT00003835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6316995|NCT00003835|Immunologic Factors|immunologic factors|mesh-ancestor
6316996|NCT00003835|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6316997|NCT00003835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6316998|NCT00003835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6316999|NCT00003835|Antidotes|antidotes|mesh-ancestor
6317000|NCT00003835|Protective Agents|protective agents|mesh-ancestor
6317001|NCT00003835|Vitamin B Complex|vitamin b complex|mesh-ancestor
6317002|NCT00003835|Vitamins|vitamins|mesh-ancestor
6317003|NCT00003835|Micronutrients|micronutrients|mesh-ancestor
6317004|NCT00003842|Interleukin-4|interleukin-4|mesh-list
6317005|NCT00003842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6317006|NCT00003842|Immunologic Factors|immunologic factors|mesh-ancestor
6317007|NCT00003842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6317008|NCT00003842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317009|NCT00003842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6317010|NCT00003843|Irinotecan|irinotecan|mesh-list
6317011|NCT00003843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6317012|NCT00003843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6317013|NCT00003843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6317014|NCT00003843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317015|NCT00003843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317016|NCT00003846|Cyclophosphamide|cyclophosphamide|mesh-list
6317017|NCT00003846|Thiotepa|thiotepa|mesh-list
6317018|NCT00003846|Carboplatin|carboplatin|mesh-list
6317019|NCT00003846|Vincristine|vincristine|mesh-list
6317020|NCT00003846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6317021|NCT00003846|Immunologic Factors|immunologic factors|mesh-ancestor
6317022|NCT00003846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6317023|NCT00003846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6317024|NCT00003846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6317025|NCT00003846|Alkylating Agents|alkylating agents|mesh-ancestor
6317026|NCT00003846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317027|NCT00003846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317028|NCT00003846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6317029|NCT00003846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6317030|NCT00003846|Tubulin Modulators|tubulin modulators|mesh-ancestor
6317031|NCT00003846|Antimitotic Agents|antimitotic agents|mesh-ancestor
6317032|NCT00003846|Mitosis Modulators|mitosis modulators|mesh-ancestor
6317033|NCT00003847|Doxorubicin|doxorubicin|mesh-list
6317034|NCT00003847|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6317035|NCT00003847|Vincristine|vincristine|mesh-list
6317036|NCT00003847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6317037|NCT00003847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317038|NCT00003847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6317039|NCT00003847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6317040|NCT00003847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6317041|NCT00003847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317042|NCT00003847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6317043|NCT00003847|Tubulin Modulators|tubulin modulators|mesh-ancestor
6317044|NCT00003847|Antimitotic Agents|antimitotic agents|mesh-ancestor
6317045|NCT00003847|Mitosis Modulators|mitosis modulators|mesh-ancestor
6317046|NCT00003849|Rituximab|rituximab|mesh-list
6317047|NCT00003849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6317048|NCT00003849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317049|NCT00003849|Immunologic Factors|immunologic factors|mesh-ancestor
6317050|NCT00003849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6317051|NCT00003849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6317052|NCT00003850|Thalidomide|thalidomide|mesh-list
6317053|NCT00003850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6317054|NCT00003850|Immunologic Factors|immunologic factors|mesh-ancestor
6317055|NCT00003850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6317056|NCT00003850|Leprostatic Agents|leprostatic agents|mesh-ancestor
6317057|NCT00003850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6317058|NCT00003850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6317059|NCT00003850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6317060|NCT00003850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6317061|NCT00003850|Growth Substances|growth substances|mesh-ancestor
6317062|NCT00003850|Growth Inhibitors|growth inhibitors|mesh-ancestor
6317063|NCT00003850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317064|NCT00003851|Gemcitabine|gemcitabine|mesh-list
6317065|NCT00003851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6317066|NCT00003851|Antimetabolites|antimetabolites|mesh-ancestor
6317067|NCT00003851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317068|NCT00003851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317069|NCT00003851|Antiviral Agents|antiviral agents|mesh-ancestor
6317070|NCT00003851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6317071|NCT00003851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6317072|NCT00003851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6317073|NCT00003851|Immunologic Factors|immunologic factors|mesh-ancestor
6317074|NCT00003851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6317075|NCT00003852|Paclitaxel|paclitaxel|mesh-list
6317076|NCT00003852|Etoposide|etoposide|mesh-list
6317077|NCT00003852|Cyclophosphamide|cyclophosphamide|mesh-list
6317078|NCT00003852|Carboplatin|carboplatin|mesh-list
6317079|NCT00003852|Epirubicin|epirubicin|mesh-list
6317080|NCT00003852|Ifosfamide|ifosfamide|mesh-list
6317081|NCT00003852|Thiotepa|thiotepa|mesh-list
6317082|NCT00003852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6317083|NCT00003852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317084|NCT00003852|Tubulin Modulators|tubulin modulators|mesh-ancestor
6317085|NCT00003852|Antimitotic Agents|antimitotic agents|mesh-ancestor
6317086|NCT00003852|Mitosis Modulators|mitosis modulators|mesh-ancestor
6317087|NCT00003852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317088|NCT00003852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6317089|NCT00003852|Immunologic Factors|immunologic factors|mesh-ancestor
6317090|NCT00003852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6317091|NCT00003852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6317092|NCT00003852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6317093|NCT00003852|Alkylating Agents|alkylating agents|mesh-ancestor
6317094|NCT00003852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6317095|NCT00003852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6317096|NCT00003852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6317097|NCT00003852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6317098|NCT00003852|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6317099|NCT00003853|Esorubicin|esorubicin|mesh-list
6317100|NCT00003853|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6317101|NCT00003853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317102|NCT00003856|Temoporfin|temoporfin|mesh-list
6317103|NCT00003856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317104|NCT00003856|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6317105|NCT00003856|Dermatologic Agents|dermatologic agents|mesh-ancestor
6317106|NCT00003857|Tamoxifen|tamoxifen|mesh-list
6317107|NCT00003857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6317108|NCT00003857|Hormone Antagonists|hormone antagonists|mesh-ancestor
6317109|NCT00003857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6317110|NCT00003857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6317111|NCT00003857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6317112|NCT00003857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317113|NCT00003857|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6317114|NCT00003857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6317115|NCT00003857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6317116|NCT00003858|Mitoxantrone|mitoxantrone|mesh-list
6016464|NCT00365365|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6016465|NCT00365365|Trastuzumab|trastuzumab|mesh-list
6016466|NCT00365365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6016467|NCT00365365|Immunologic Factors|immunologic factors|mesh-ancestor
6016468|NCT00365365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016469|NCT00365365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6016470|NCT00365365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6016471|NCT00365365|Alkylating Agents|alkylating agents|mesh-ancestor
6016472|NCT00365365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016473|NCT00365365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6016474|NCT00365365|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6016475|NCT00365365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6317117|NCT00003858|Analgesics|analgesics|mesh-ancestor
6317118|NCT00003858|Sensory System Agents|sensory system agents|mesh-ancestor
6317119|NCT00003858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6317120|NCT00003858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6317121|NCT00003858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317122|NCT00003858|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6317123|NCT00003858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6317124|NCT00003858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6317125|NCT00003858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317126|NCT00003859|Cyclophosphamide|cyclophosphamide|mesh-list
6317127|NCT00003859|Carboplatin|carboplatin|mesh-list
6317128|NCT00003859|Etoposide|etoposide|mesh-list
6317129|NCT00003859|Vincristine|vincristine|mesh-list
6317130|NCT00003859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6317131|NCT00003859|Immunologic Factors|immunologic factors|mesh-ancestor
6317132|NCT00003859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6317133|NCT00003859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6317134|NCT00003859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6317135|NCT00003859|Alkylating Agents|alkylating agents|mesh-ancestor
6317136|NCT00003859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317137|NCT00003859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317138|NCT00003859|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6317139|NCT00003859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6317140|NCT00003859|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6317141|NCT00003859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6317142|NCT00003859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6317143|NCT00003859|Tubulin Modulators|tubulin modulators|mesh-ancestor
6317144|NCT00003859|Antimitotic Agents|antimitotic agents|mesh-ancestor
6317145|NCT00003859|Mitosis Modulators|mitosis modulators|mesh-ancestor
6317146|NCT00003860|Carboplatin|carboplatin|mesh-list
6317147|NCT00003860|Etoposide|etoposide|mesh-list
6317148|NCT00003860|Ifosfamide|ifosfamide|mesh-list
6317149|NCT00003860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317150|NCT00003860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6317151|NCT00003860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6317152|NCT00003860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6317153|NCT00003860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6317154|NCT00003860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317155|NCT00003860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6317156|NCT00003860|Alkylating Agents|alkylating agents|mesh-ancestor
6317157|NCT00003862|Leucovorin|leucovorin|mesh-list
6317158|NCT00003862|Paclitaxel|paclitaxel|mesh-list
6317159|NCT00003862|Fluorouracil|fluorouracil|mesh-list
6317160|NCT00003862|Calcium|calcium|mesh-list
6317161|NCT00003862|Levoleucovorin|levoleucovorin|mesh-list
6317162|NCT00003862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6317163|NCT00003862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317164|NCT00003862|Tubulin Modulators|tubulin modulators|mesh-ancestor
6317165|NCT00003862|Antimitotic Agents|antimitotic agents|mesh-ancestor
6317166|NCT00003862|Mitosis Modulators|mitosis modulators|mesh-ancestor
6317167|NCT00003862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317168|NCT00003862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6317169|NCT00003862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6317170|NCT00003862|Antimetabolites|antimetabolites|mesh-ancestor
6317171|NCT00003862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6317172|NCT00003862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6317173|NCT00003862|Immunologic Factors|immunologic factors|mesh-ancestor
6317174|NCT00003862|Antidotes|antidotes|mesh-ancestor
6317175|NCT00003862|Protective Agents|protective agents|mesh-ancestor
6317176|NCT00003862|Vitamin B Complex|vitamin b complex|mesh-ancestor
6317177|NCT00003862|Vitamins|vitamins|mesh-ancestor
6317178|NCT00003862|Micronutrients|micronutrients|mesh-ancestor
6317179|NCT00003864|Carboplatin|carboplatin|mesh-list
6317180|NCT00003864|Docetaxel|docetaxel|mesh-list
6317181|NCT00003864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317182|NCT00003864|Tubulin Modulators|tubulin modulators|mesh-ancestor
6317183|NCT00003864|Antimitotic Agents|antimitotic agents|mesh-ancestor
6317184|NCT00003864|Mitosis Modulators|mitosis modulators|mesh-ancestor
6317185|NCT00003864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317186|NCT00003865|Toremifene|toremifene|mesh-list
6317187|NCT00003865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6317188|NCT00003865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317189|NCT00003865|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6317190|NCT00003865|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6317191|NCT00003865|Hormone Antagonists|hormone antagonists|mesh-ancestor
6317192|NCT00003865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6317193|NCT00003865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6317194|NCT00003865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6317195|NCT00003867|Capecitabine|capecitabine|mesh-list
6317196|NCT00003867|Irinotecan|irinotecan|mesh-list
6317197|NCT00003867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6317198|NCT00003867|Antimetabolites|antimetabolites|mesh-ancestor
6317199|NCT00003867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317200|NCT00003867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317201|NCT00003867|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6317202|NCT00003867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6317203|NCT00003867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6317204|NCT00003868|Cyclophosphamide|cyclophosphamide|mesh-list
6317205|NCT00003868|Methotrexate|methotrexate|mesh-list
6317206|NCT00003868|Antibodies|antibodies|mesh-list
6317207|NCT00003868|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6317208|NCT00003868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6317209|NCT00003868|Immunologic Factors|immunologic factors|mesh-ancestor
6317210|NCT00003868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6317211|NCT00003868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6317212|NCT00003868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6317213|NCT00003868|Alkylating Agents|alkylating agents|mesh-ancestor
6317214|NCT00003868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317215|NCT00003868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317216|NCT00003868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6317217|NCT00003868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6317218|NCT00003868|Abortifacient Agents|abortifacient agents|mesh-ancestor
6317219|NCT00003868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6317220|NCT00003868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6317221|NCT00003868|Antimetabolites|antimetabolites|mesh-ancestor
6317222|NCT00003868|Dermatologic Agents|dermatologic agents|mesh-ancestor
6317223|NCT00003868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6317224|NCT00003868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6317225|NCT00003868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6317226|NCT00003870|Cyclophosphamide|cyclophosphamide|mesh-list
6317227|NCT00003870|Methotrexate|methotrexate|mesh-list
6317228|NCT00003870|Antibodies|antibodies|mesh-list
6317229|NCT00003870|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6317230|NCT00003870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6317231|NCT00003870|Immunologic Factors|immunologic factors|mesh-ancestor
6317232|NCT00003870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6317233|NCT00003870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6317234|NCT00003870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6317235|NCT00003870|Alkylating Agents|alkylating agents|mesh-ancestor
6317236|NCT00003870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317237|NCT00003870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317238|NCT00003870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6317239|NCT00003870|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6317240|NCT00003870|Abortifacient Agents|abortifacient agents|mesh-ancestor
6317241|NCT00003870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6317242|NCT00003870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6317243|NCT00003870|Antimetabolites|antimetabolites|mesh-ancestor
6317244|NCT00003870|Dermatologic Agents|dermatologic agents|mesh-ancestor
6317245|NCT00003870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6317246|NCT00003870|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6317247|NCT00003870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6317248|NCT00003871|Vaccines|vaccines|mesh-list
6317249|NCT00003871|Immunologic Factors|immunologic factors|mesh-ancestor
6317250|NCT00003871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6317251|NCT00003873|Fluorouracil|fluorouracil|mesh-list
6317252|NCT00003873|Eniluracil|eniluracil|mesh-list
6317253|NCT00003873|Antimetabolites|antimetabolites|mesh-ancestor
6317254|NCT00003873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317255|NCT00003873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6317256|NCT00003873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317257|NCT00003873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6317258|NCT00003873|Immunologic Factors|immunologic factors|mesh-ancestor
6317259|NCT00003873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6317260|NCT00003873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6317261|NCT00003874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6317262|NCT00003874|Antibodies|antibodies|mesh-list
6317263|NCT00003874|Immunoglobulins|immunoglobulins|mesh-list
6317264|NCT00003874|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6317265|NCT00003874|Immunologic Factors|immunologic factors|mesh-ancestor
6317266|NCT00003874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6317267|NCT00003874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317268|NCT00003876|Carmustine|carmustine|mesh-list
6317269|NCT00003876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6317270|NCT00003876|Alkylating Agents|alkylating agents|mesh-ancestor
6317271|NCT00003876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317272|NCT00003876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317273|NCT00003877|Paclitaxel|paclitaxel|mesh-list
6317274|NCT00003877|Cyclophosphamide|cyclophosphamide|mesh-list
6317275|NCT00003877|Carboplatin|carboplatin|mesh-list
6317276|NCT00003877|Thiotepa|thiotepa|mesh-list
6317277|NCT00003877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6317278|NCT00003877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317279|NCT00003877|Tubulin Modulators|tubulin modulators|mesh-ancestor
6317280|NCT00003877|Antimitotic Agents|antimitotic agents|mesh-ancestor
6317281|NCT00003877|Mitosis Modulators|mitosis modulators|mesh-ancestor
6317282|NCT00003877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317283|NCT00003877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6317284|NCT00003877|Immunologic Factors|immunologic factors|mesh-ancestor
6317285|NCT00003877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6317286|NCT00003877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6317287|NCT00003877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6317288|NCT00003877|Alkylating Agents|alkylating agents|mesh-ancestor
6317289|NCT00003877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6317290|NCT00003878|Carmustine|carmustine|mesh-list
6317291|NCT00003878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6317292|NCT00003878|Alkylating Agents|alkylating agents|mesh-ancestor
6317293|NCT00003878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317294|NCT00003878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317295|NCT00003880|Paclitaxel|paclitaxel|mesh-list
6317296|NCT00003880|Carboplatin|carboplatin|mesh-list
6317297|NCT00003880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6317298|NCT00003880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317299|NCT00003880|Tubulin Modulators|tubulin modulators|mesh-ancestor
6317300|NCT00003880|Antimitotic Agents|antimitotic agents|mesh-ancestor
6317301|NCT00003880|Mitosis Modulators|mitosis modulators|mesh-ancestor
6317302|NCT00003880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317303|NCT00003881|Paclitaxel|paclitaxel|mesh-list
6317304|NCT00003881|Carboplatin|carboplatin|mesh-list
6317305|NCT00003881|Trastuzumab|trastuzumab|mesh-list
6317306|NCT00003881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6317307|NCT00003881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317308|NCT00003881|Tubulin Modulators|tubulin modulators|mesh-ancestor
6317309|NCT00003881|Antimitotic Agents|antimitotic agents|mesh-ancestor
6317310|NCT00003881|Mitosis Modulators|mitosis modulators|mesh-ancestor
6317311|NCT00003881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317312|NCT00003881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6317313|NCT00003883|Itraconazole|itraconazole|mesh-list
6317314|NCT00003883|Fluconazole|fluconazole|mesh-list
6317315|NCT00003883|Antifungal Agents|antifungal agents|mesh-ancestor
6317316|NCT00003883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6317317|NCT00003883|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6317318|NCT00003883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6016476|NCT00365365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6016477|NCT00365365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6016478|NCT00365365|Growth Substances|growth substances|mesh-ancestor
6016479|NCT00365365|Growth Inhibitors|growth inhibitors|mesh-ancestor
6016480|NCT00365365|Tubulin Modulators|tubulin modulators|mesh-ancestor
6016481|NCT00365365|Antimitotic Agents|antimitotic agents|mesh-ancestor
6016482|NCT00365365|Mitosis Modulators|mitosis modulators|mesh-ancestor
6016483|NCT00365365|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6016484|NCT00365365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6016485|NCT00365365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6317319|NCT00003883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6317320|NCT00003883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317321|NCT00003883|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6317322|NCT00003883|Hormone Antagonists|hormone antagonists|mesh-ancestor
6317323|NCT00003883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6317324|NCT00003883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6317325|NCT00003883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6317326|NCT00003883|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6317327|NCT00003883|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6317328|NCT00003884|Zoledronic Acid|zoledronic acid|mesh-list
6317329|NCT00003884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6317330|NCT00003884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6317331|NCT00003885|Arsenic Trioxide|arsenic trioxide|mesh-list
6317332|NCT00003885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317333|NCT00003888|Docetaxel|docetaxel|mesh-list
6317334|NCT00003888|Fluorouracil|fluorouracil|mesh-list
6317335|NCT00003888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317336|NCT00003888|Tubulin Modulators|tubulin modulators|mesh-ancestor
6317337|NCT00003888|Antimitotic Agents|antimitotic agents|mesh-ancestor
6317338|NCT00003888|Mitosis Modulators|mitosis modulators|mesh-ancestor
6317339|NCT00003888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317340|NCT00003888|Antimetabolites|antimetabolites|mesh-ancestor
6317341|NCT00003888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6317342|NCT00003888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6317343|NCT00003888|Immunologic Factors|immunologic factors|mesh-ancestor
6317344|NCT00003888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6317345|NCT00003891|Lurtotecan|lurtotecan|mesh-list
6317346|NCT00003891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317347|NCT00003892|ISIS 5132|isis 5132|mesh-list
6317348|NCT00003892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317349|NCT00003892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6317350|NCT00003892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317351|NCT00003893|Cyclophosphamide|cyclophosphamide|mesh-list
6317352|NCT00003893|Doxorubicin|doxorubicin|mesh-list
6317353|NCT00003893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6016486|NCT00365365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6317354|NCT00003893|Fluorouracil|fluorouracil|mesh-list
6317355|NCT00003893|Methotrexate|methotrexate|mesh-list
6317356|NCT00003893|Epirubicin|epirubicin|mesh-list
6317357|NCT00003893|Mitoxantrone|mitoxantrone|mesh-list
6317358|NCT00003893|Mitomycins|mitomycins|mesh-list
6317359|NCT00003893|Mitomycin|mitomycin|mesh-list
6317360|NCT00003893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6317361|NCT00003893|Immunologic Factors|immunologic factors|mesh-ancestor
6317362|NCT00003893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6317363|NCT00003893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6317364|NCT00003893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6317365|NCT00003893|Alkylating Agents|alkylating agents|mesh-ancestor
6317366|NCT00003893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317367|NCT00003893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317368|NCT00003893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6317369|NCT00003893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6317370|NCT00003893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6317371|NCT00003893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6317372|NCT00003893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6317373|NCT00003893|Antimetabolites|antimetabolites|mesh-ancestor
6317374|NCT00003893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6317375|NCT00003893|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6317376|NCT00003893|Abortifacient Agents|abortifacient agents|mesh-ancestor
6317377|NCT00003893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6317378|NCT00003893|Dermatologic Agents|dermatologic agents|mesh-ancestor
6317379|NCT00003893|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6317380|NCT00003893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6317381|NCT00003893|Analgesics|analgesics|mesh-ancestor
5724580|NCT03186053|Protective Agents|protective agents|mesh-ancestor
6317382|NCT00003893|Sensory System Agents|sensory system agents|mesh-ancestor
6317383|NCT00003893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6317384|NCT00003894|Thalidomide|thalidomide|mesh-list
6317385|NCT00003894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6317386|NCT00003894|Immunologic Factors|immunologic factors|mesh-ancestor
6317387|NCT00003894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6317388|NCT00003894|Leprostatic Agents|leprostatic agents|mesh-ancestor
6317389|NCT00003894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6317390|NCT00003894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6317391|NCT00003894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6317392|NCT00003894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6317393|NCT00003894|Growth Substances|growth substances|mesh-ancestor
6317394|NCT00003894|Growth Inhibitors|growth inhibitors|mesh-ancestor
6317395|NCT00003894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317396|NCT00003897|Sargramostim|sargramostim|mesh-list
6317397|NCT00003897|Immunologic Factors|immunologic factors|mesh-ancestor
6317398|NCT00003897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6317399|NCT00003899|Paclitaxel|paclitaxel|mesh-list
6317400|NCT00003899|Cyclophosphamide|cyclophosphamide|mesh-list
6317401|NCT00003899|Melphalan|melphalan|mesh-list
6317402|NCT00003899|Thiotepa|thiotepa|mesh-list
6317403|NCT00003899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6317404|NCT00003899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317405|NCT00003899|Tubulin Modulators|tubulin modulators|mesh-ancestor
6317406|NCT00003899|Antimitotic Agents|antimitotic agents|mesh-ancestor
6317407|NCT00003899|Mitosis Modulators|mitosis modulators|mesh-ancestor
6317408|NCT00003899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317409|NCT00003899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6317410|NCT00003899|Immunologic Factors|immunologic factors|mesh-ancestor
6317411|NCT00003899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6317412|NCT00003899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6317413|NCT00003899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6317414|NCT00003899|Alkylating Agents|alkylating agents|mesh-ancestor
6317415|NCT00003899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6317416|NCT00003900|Docetaxel|docetaxel|mesh-list
6317417|NCT00003900|Irinotecan|irinotecan|mesh-list
6317418|NCT00003900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317419|NCT00003900|Tubulin Modulators|tubulin modulators|mesh-ancestor
6317420|NCT00003900|Antimitotic Agents|antimitotic agents|mesh-ancestor
6317421|NCT00003900|Mitosis Modulators|mitosis modulators|mesh-ancestor
6317422|NCT00003900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317423|NCT00003900|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6317424|NCT00003900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6317425|NCT00003900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6317426|NCT00003902|Capecitabine|capecitabine|mesh-list
6317427|NCT00003902|Vinorelbine|vinorelbine|mesh-list
6317428|NCT00003902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6317429|NCT00003902|Antimetabolites|antimetabolites|mesh-ancestor
6317430|NCT00003902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317431|NCT00003902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317432|NCT00003902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6317433|NCT00003902|Tubulin Modulators|tubulin modulators|mesh-ancestor
6317434|NCT00003902|Antimitotic Agents|antimitotic agents|mesh-ancestor
6317435|NCT00003902|Mitosis Modulators|mitosis modulators|mesh-ancestor
6317436|NCT00003906|Tamoxifen|tamoxifen|mesh-list
6317437|NCT00003906|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
6317438|NCT00003906|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6317439|NCT00003906|Hormone Antagonists|hormone antagonists|mesh-ancestor
6317440|NCT00003906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6317441|NCT00003906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6317442|NCT00003906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6317443|NCT00003906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317444|NCT00003906|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6317445|NCT00003906|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6317446|NCT00003906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6317447|NCT00003908|Carboplatin|carboplatin|mesh-list
6317448|NCT00003908|Docetaxel|docetaxel|mesh-list
6317449|NCT00003908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317450|NCT00003908|Tubulin Modulators|tubulin modulators|mesh-ancestor
6317451|NCT00003908|Antimitotic Agents|antimitotic agents|mesh-ancestor
6317452|NCT00003908|Mitosis Modulators|mitosis modulators|mesh-ancestor
6317453|NCT00003908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317454|NCT00003909|Motexafin gadolinium|motexafin gadolinium|mesh-list
6317455|NCT00003909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317456|NCT00003909|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6317457|NCT00003909|Dermatologic Agents|dermatologic agents|mesh-ancestor
6317458|NCT00003912|Carboplatin|carboplatin|mesh-list
6317459|NCT00003912|Doxorubicin|doxorubicin|mesh-list
6317460|NCT00003912|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6317461|NCT00003912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317462|NCT00003912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6317463|NCT00003912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6317464|NCT00003912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6317465|NCT00003912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6317466|NCT00003912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317467|NCT00003913|Methylprednisolone|methylprednisolone|mesh-list
6317468|NCT00003913|Cyclophosphamide|cyclophosphamide|mesh-list
6317469|NCT00003913|Busulfan|busulfan|mesh-list
6317470|NCT00003913|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6317471|NCT00003913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6317472|NCT00003913|Immunologic Factors|immunologic factors|mesh-ancestor
6317473|NCT00003913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6317474|NCT00003913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6317475|NCT00003913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6317476|NCT00003913|Alkylating Agents|alkylating agents|mesh-ancestor
6317477|NCT00003913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317478|NCT00003913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317479|NCT00003913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6317480|NCT00003913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6317481|NCT00003913|Antiemetics|antiemetics|mesh-ancestor
6317482|NCT00003913|Autonomic Agents|autonomic agents|mesh-ancestor
6317483|NCT00003913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6317484|NCT00003913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6317485|NCT00003913|Glucocorticoids|glucocorticoids|mesh-ancestor
6317486|NCT00003913|Hormones|hormones|mesh-ancestor
6317487|NCT00003913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6317488|NCT00003913|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6317489|NCT00003913|Protective Agents|protective agents|mesh-ancestor
6317490|NCT00003914|Dolastatin 10|dolastatin 10|mesh-list
6317491|NCT00003914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317492|NCT00003914|Tubulin Modulators|tubulin modulators|mesh-ancestor
6317493|NCT00003914|Antimitotic Agents|antimitotic agents|mesh-ancestor
6317494|NCT00003914|Mitosis Modulators|mitosis modulators|mesh-ancestor
6317495|NCT00003914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317496|NCT00003917|Topotecan|topotecan|mesh-list
6317497|NCT00003917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6317498|NCT00003917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6317499|NCT00003917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6317500|NCT00003917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317501|NCT00003917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317502|NCT00003920|Cyclosporine|cyclosporine|mesh-list
6317503|NCT00003920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6317504|NCT00003920|Antibodies|antibodies|mesh-list
6317505|NCT00003920|Immunoglobulins|immunoglobulins|mesh-list
6317506|NCT00003920|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6317507|NCT00003920|Cyclosporins|cyclosporins|mesh-list
6317508|NCT00003920|Immunologic Factors|immunologic factors|mesh-ancestor
6317509|NCT00003920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6317510|NCT00003920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317511|NCT00003920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6317512|NCT00003920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317513|NCT00003920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6317514|NCT00003920|Antifungal Agents|antifungal agents|mesh-ancestor
6317515|NCT00003920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6317516|NCT00003920|Dermatologic Agents|dermatologic agents|mesh-ancestor
6317517|NCT00003920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6317518|NCT00003920|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6317519|NCT00003923|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
6317520|NCT00003923|Trioxsalen|trioxsalen|mesh-list
6317521|NCT00003923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317522|NCT00003923|Dermatologic Agents|dermatologic agents|mesh-ancestor
6317523|NCT00003923|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6317524|NCT00003924|Interferons|interferons|mesh-list
6317525|NCT00003924|Interferon-alpha|interferon-alpha|mesh-list
6317526|NCT00003924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317527|NCT00003924|Antiviral Agents|antiviral agents|mesh-ancestor
6317528|NCT00003924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6317529|NCT00003924|Immunologic Factors|immunologic factors|mesh-ancestor
6317530|NCT00003924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6317531|NCT00003925|Leucovorin|leucovorin|mesh-list
6317532|NCT00003925|Gemcitabine|gemcitabine|mesh-list
6317533|NCT00003925|Tegafur|tegafur|mesh-list
6317534|NCT00003925|Calcium|calcium|mesh-list
6317535|NCT00003925|Levoleucovorin|levoleucovorin|mesh-list
6317536|NCT00003925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6317537|NCT00003925|Antimetabolites|antimetabolites|mesh-ancestor
6317538|NCT00003925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317539|NCT00003925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317540|NCT00003925|Antiviral Agents|antiviral agents|mesh-ancestor
6317541|NCT00003925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6317542|NCT00003925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6317543|NCT00003925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6317544|NCT00003925|Immunologic Factors|immunologic factors|mesh-ancestor
6317545|NCT00003925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6317546|NCT00003925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6317547|NCT00003925|Antidotes|antidotes|mesh-ancestor
6317548|NCT00003925|Protective Agents|protective agents|mesh-ancestor
6317549|NCT00003925|Vitamin B Complex|vitamin b complex|mesh-ancestor
6317550|NCT00003925|Vitamins|vitamins|mesh-ancestor
6317551|NCT00003925|Micronutrients|micronutrients|mesh-ancestor
6317552|NCT00003926|Melphalan|melphalan|mesh-list
6317553|NCT00003926|Busulfan|busulfan|mesh-list
6317554|NCT00003926|Thiotepa|thiotepa|mesh-list
6317555|NCT00003926|Lenograstim|lenograstim|mesh-list
6317556|NCT00003926|Sargramostim|sargramostim|mesh-list
6317557|NCT00003926|Amifostine|amifostine|mesh-list
6317558|NCT00003926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6317559|NCT00003926|Immunologic Factors|immunologic factors|mesh-ancestor
6317560|NCT00003926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6317561|NCT00003926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6317562|NCT00003926|Alkylating Agents|alkylating agents|mesh-ancestor
6317563|NCT00003926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317564|NCT00003926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317565|NCT00003926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6317566|NCT00003926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6317567|NCT00003926|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6317568|NCT00003926|Protective Agents|protective agents|mesh-ancestor
6317569|NCT00003928|Gemcitabine|gemcitabine|mesh-list
6317570|NCT00003928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317571|NCT00003928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6317572|NCT00003928|Antimetabolites|antimetabolites|mesh-ancestor
6317573|NCT00003928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317574|NCT00003928|Antiviral Agents|antiviral agents|mesh-ancestor
6317575|NCT00003928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6317576|NCT00003928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6317577|NCT00003928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6317578|NCT00003928|Immunologic Factors|immunologic factors|mesh-ancestor
6317579|NCT00003928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6317580|NCT00003929|Lomustine|lomustine|mesh-list
6317581|NCT00003929|Procarbazine|procarbazine|mesh-list
6317582|NCT00003929|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6317583|NCT00003929|Alkylating Agents|alkylating agents|mesh-ancestor
6317584|NCT00003929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317585|NCT00003929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317586|NCT00003930|Gemcitabine|gemcitabine|mesh-list
6317587|NCT00003930|Paclitaxel|paclitaxel|mesh-list
6317588|NCT00003930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6317589|NCT00003930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317590|NCT00003930|Tubulin Modulators|tubulin modulators|mesh-ancestor
6317591|NCT00003930|Antimitotic Agents|antimitotic agents|mesh-ancestor
6317592|NCT00003930|Mitosis Modulators|mitosis modulators|mesh-ancestor
6317593|NCT00003930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317594|NCT00003930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6317595|NCT00003930|Antimetabolites|antimetabolites|mesh-ancestor
6317596|NCT00003930|Antiviral Agents|antiviral agents|mesh-ancestor
6317597|NCT00003930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6317598|NCT00003930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6317599|NCT00003930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6317600|NCT00003930|Immunologic Factors|immunologic factors|mesh-ancestor
6317601|NCT00003930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6317602|NCT00003934|Cytarabine|cytarabine|mesh-list
6317603|NCT00003934|Methotrexate|methotrexate|mesh-list
6317604|NCT00003934|Mercaptopurine|mercaptopurine|mesh-list
6317605|NCT00003934|Daunorubicin|daunorubicin|mesh-list
6317606|NCT00003934|Arsenic Trioxide|arsenic trioxide|mesh-list
6317607|NCT00003934|Tretinoin|tretinoin|mesh-list
6317608|NCT00003934|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6317609|NCT00003934|Abortifacient Agents|abortifacient agents|mesh-ancestor
6317610|NCT00003934|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6317611|NCT00003934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6317612|NCT00003934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6317613|NCT00003934|Antimetabolites|antimetabolites|mesh-ancestor
6317614|NCT00003934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317615|NCT00003934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317616|NCT00003934|Dermatologic Agents|dermatologic agents|mesh-ancestor
6317617|NCT00003934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6317618|NCT00003934|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6317619|NCT00003934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6317620|NCT00003934|Immunologic Factors|immunologic factors|mesh-ancestor
6317621|NCT00003934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6317622|NCT00003934|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6317623|NCT00003934|Antiviral Agents|antiviral agents|mesh-ancestor
6317624|NCT00003934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6317625|NCT00003934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6317626|NCT00003934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6317627|NCT00003934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6317628|NCT00003934|Keratolytic Agents|keratolytic agents|mesh-ancestor
6317629|NCT00003935|Etoposide|etoposide|mesh-list
6317630|NCT00003935|Vincristine|vincristine|mesh-list
6317631|NCT00003935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6317632|NCT00003935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317633|NCT00003935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6317634|NCT00003935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6317635|NCT00003935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6317636|NCT00003935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317637|NCT00003935|Tubulin Modulators|tubulin modulators|mesh-ancestor
6317638|NCT00003935|Antimitotic Agents|antimitotic agents|mesh-ancestor
6317639|NCT00003935|Mitosis Modulators|mitosis modulators|mesh-ancestor
6317640|NCT00003936|Bryostatin 1|bryostatin 1|mesh-list
6317641|NCT00003936|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6317642|NCT00003936|Immunologic Factors|immunologic factors|mesh-ancestor
6317643|NCT00003936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6317644|NCT00003936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317645|NCT00003937|Cisplatin|cisplatin|mesh-list
6317646|NCT00003937|Doxorubicin|doxorubicin|mesh-list
6317647|NCT00003937|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6317648|NCT00003937|Methotrexate|methotrexate|mesh-list
6317649|NCT00003937|Etoposide|etoposide|mesh-list
6317650|NCT00003937|Ifosfamide|ifosfamide|mesh-list
6317651|NCT00003937|Dexrazoxane|dexrazoxane|mesh-list
6317652|NCT00003937|Razoxane|razoxane|mesh-list
6317653|NCT00003937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317654|NCT00003937|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5724696|NCT03185364|Vasodilator Agents|vasodilator agents|mesh-ancestor
6317655|NCT00003937|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6317656|NCT00003937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6317657|NCT00003937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6317658|NCT00003937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317659|NCT00003937|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6317660|NCT00003937|Abortifacient Agents|abortifacient agents|mesh-ancestor
6317661|NCT00003937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6317662|NCT00003937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6317663|NCT00003937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6317664|NCT00003937|Antimetabolites|antimetabolites|mesh-ancestor
6317665|NCT00003937|Dermatologic Agents|dermatologic agents|mesh-ancestor
6317666|NCT00003937|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6317667|NCT00003937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6317668|NCT00003937|Immunologic Factors|immunologic factors|mesh-ancestor
6317669|NCT00003937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6317670|NCT00003937|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6317671|NCT00003937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6317672|NCT00003937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6317673|NCT00003937|Alkylating Agents|alkylating agents|mesh-ancestor
6317674|NCT00003937|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6317675|NCT00003937|Protective Agents|protective agents|mesh-ancestor
6317676|NCT00003937|Antimitotic Agents|antimitotic agents|mesh-ancestor
6317677|NCT00003937|Mitosis Modulators|mitosis modulators|mesh-ancestor
6317678|NCT00003938|Amphotericin B|amphotericin b|mesh-list
6317679|NCT00003938|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6317680|NCT00003938|Amebicides|amebicides|mesh-ancestor
6317681|NCT00003938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6317682|NCT00003938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6317683|NCT00003938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6317684|NCT00003938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6317685|NCT00003938|Antifungal Agents|antifungal agents|mesh-ancestor
6317686|NCT00003939|Trabectedin|trabectedin|mesh-list
6317687|NCT00003939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6317688|NCT00003939|Alkylating Agents|alkylating agents|mesh-ancestor
6317689|NCT00003939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317690|NCT00003939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317691|NCT00003941|Etoposide|etoposide|mesh-list
6317692|NCT00003941|Ifosfamide|ifosfamide|mesh-list
6317693|NCT00003941|Bleomycin|bleomycin|mesh-list
6317694|NCT00003941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317695|NCT00003941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6317696|NCT00003941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6317697|NCT00003941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6317698|NCT00003941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6317699|NCT00003941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317700|NCT00003941|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6317701|NCT00003941|Alkylating Agents|alkylating agents|mesh-ancestor
6317702|NCT00003941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6317703|NCT00003943|Paclitaxel|paclitaxel|mesh-list
6317704|NCT00003943|Cyclophosphamide|cyclophosphamide|mesh-list
6317705|NCT00003943|Carboplatin|carboplatin|mesh-list
6317706|NCT00003943|Topotecan|topotecan|mesh-list
6317707|NCT00003943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6317708|NCT00003943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317709|NCT00003943|Tubulin Modulators|tubulin modulators|mesh-ancestor
6317710|NCT00003943|Antimitotic Agents|antimitotic agents|mesh-ancestor
6317711|NCT00003943|Mitosis Modulators|mitosis modulators|mesh-ancestor
6317712|NCT00003943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317713|NCT00003943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6317714|NCT00003943|Immunologic Factors|immunologic factors|mesh-ancestor
6317715|NCT00003943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6317716|NCT00003943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6317717|NCT00003943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6317718|NCT00003943|Alkylating Agents|alkylating agents|mesh-ancestor
6317719|NCT00003943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6317720|NCT00003943|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6317721|NCT00003943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6317722|NCT00003943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6317723|NCT00003944|Paclitaxel|paclitaxel|mesh-list
6317724|NCT00003944|Cyclophosphamide|cyclophosphamide|mesh-list
6317725|NCT00003944|Carboplatin|carboplatin|mesh-list
6317726|NCT00003944|Topotecan|topotecan|mesh-list
6317727|NCT00003944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6317728|NCT00003944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317729|NCT00003944|Tubulin Modulators|tubulin modulators|mesh-ancestor
6317730|NCT00003944|Antimitotic Agents|antimitotic agents|mesh-ancestor
6317731|NCT00003944|Mitosis Modulators|mitosis modulators|mesh-ancestor
6317732|NCT00003944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317733|NCT00003944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6317734|NCT00003944|Immunologic Factors|immunologic factors|mesh-ancestor
6317735|NCT00003944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6317736|NCT00003944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6317737|NCT00003944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6317738|NCT00003944|Alkylating Agents|alkylating agents|mesh-ancestor
6317739|NCT00003944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6317740|NCT00003944|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6317741|NCT00003944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6317742|NCT00003944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6317743|NCT00003945|Topotecan|topotecan|mesh-list
6317744|NCT00003945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317745|NCT00003945|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6317746|NCT00003945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6317747|NCT00003945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6317748|NCT00003945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317749|NCT00003946|Danazol|danazol|mesh-list
6317750|NCT00003946|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6317751|NCT00003946|Hormone Antagonists|hormone antagonists|mesh-ancestor
6317752|NCT00003946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6317753|NCT00003946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6317754|NCT00003950|Cyclosporine|cyclosporine|mesh-list
6317755|NCT00003950|Irinotecan|irinotecan|mesh-list
6317756|NCT00003950|Cyclosporins|cyclosporins|mesh-list
6317757|NCT00003950|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6317758|NCT00003950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6317759|NCT00003950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6317760|NCT00003950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317761|NCT00003950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317762|NCT00003950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6317763|NCT00003950|Immunologic Factors|immunologic factors|mesh-ancestor
6317764|NCT00003950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6317765|NCT00003950|Antifungal Agents|antifungal agents|mesh-ancestor
6317766|NCT00003950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6317767|NCT00003950|Dermatologic Agents|dermatologic agents|mesh-ancestor
6317768|NCT00003950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6317769|NCT00003950|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6317770|NCT00003951|Exatecan|exatecan|mesh-list
6317771|NCT00003951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6317772|NCT00003951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6317773|NCT00003951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6317774|NCT00003951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317775|NCT00003951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317776|NCT00003953|Tamoxifen|tamoxifen|mesh-list
6317777|NCT00003953|Cyclophosphamide|cyclophosphamide|mesh-list
6317778|NCT00003953|Docetaxel|docetaxel|mesh-list
6317779|NCT00003953|Doxorubicin|doxorubicin|mesh-list
6317780|NCT00003953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6317781|NCT00003953|Fluorouracil|fluorouracil|mesh-list
6317782|NCT00003953|Methotrexate|methotrexate|mesh-list
6317783|NCT00003953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6317784|NCT00003953|Immunologic Factors|immunologic factors|mesh-ancestor
6317785|NCT00003953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6317786|NCT00003953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6317787|NCT00003953|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6317788|NCT00003953|Alkylating Agents|alkylating agents|mesh-ancestor
6317789|NCT00003953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317790|NCT00003953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317791|NCT00003953|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6317792|NCT00003953|Tubulin Modulators|tubulin modulators|mesh-ancestor
6317793|NCT00003953|Antimitotic Agents|antimitotic agents|mesh-ancestor
6317794|NCT00003953|Mitosis Modulators|mitosis modulators|mesh-ancestor
6317795|NCT00003953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6317796|NCT00003953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6317797|NCT00003953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6317798|NCT00003953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6317799|NCT00003953|Antimetabolites|antimetabolites|mesh-ancestor
6317800|NCT00003953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6317801|NCT00003953|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6317802|NCT00003953|Abortifacient Agents|abortifacient agents|mesh-ancestor
6317803|NCT00003953|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6317804|NCT00003953|Dermatologic Agents|dermatologic agents|mesh-ancestor
6317805|NCT00003953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6317806|NCT00003953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6317807|NCT00003953|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6317808|NCT00003953|Hormone Antagonists|hormone antagonists|mesh-ancestor
6317809|NCT00003953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6317810|NCT00003953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6317811|NCT00003953|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6317812|NCT00003953|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6317813|NCT00003953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6317814|NCT00003954|Cyclosporine|cyclosporine|mesh-list
6317815|NCT00003954|Mycophenolic Acid|mycophenolic acid|mesh-list
6317816|NCT00003954|Melphalan|melphalan|mesh-list
6317817|NCT00003954|Cyclosporins|cyclosporins|mesh-list
6317818|NCT00003954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6317819|NCT00003954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317820|NCT00003954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6317821|NCT00003954|Immunologic Factors|immunologic factors|mesh-ancestor
6317822|NCT00003954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6317823|NCT00003954|Antifungal Agents|antifungal agents|mesh-ancestor
6317824|NCT00003954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6317825|NCT00003954|Dermatologic Agents|dermatologic agents|mesh-ancestor
6317826|NCT00003954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6317827|NCT00003954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6317828|NCT00003954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6317829|NCT00003954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317830|NCT00003954|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6317831|NCT00003954|Antitubercular Agents|antitubercular agents|mesh-ancestor
6317832|NCT00003954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6317833|NCT00003954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6317834|NCT00003954|Alkylating Agents|alkylating agents|mesh-ancestor
6317835|NCT00003954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6317836|NCT00003955|Dactinomycin|dactinomycin|mesh-list
6317837|NCT00003955|Cyclophosphamide|cyclophosphamide|mesh-list
6317838|NCT00003955|Irinotecan|irinotecan|mesh-list
6317839|NCT00003955|Vincristine|vincristine|mesh-list
6317840|NCT00003955|Sargramostim|sargramostim|mesh-list
6317841|NCT00003955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6317842|NCT00003955|Immunologic Factors|immunologic factors|mesh-ancestor
6317843|NCT00003955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6317844|NCT00003955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6317845|NCT00003955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6317846|NCT00003955|Alkylating Agents|alkylating agents|mesh-ancestor
6317847|NCT00003955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317848|NCT00003955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317849|NCT00003955|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6317850|NCT00003955|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6317851|NCT00003955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6317852|NCT00003955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6317853|NCT00003955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6317854|NCT00003955|Tubulin Modulators|tubulin modulators|mesh-ancestor
6317855|NCT00003955|Antimitotic Agents|antimitotic agents|mesh-ancestor
6317856|NCT00003955|Mitosis Modulators|mitosis modulators|mesh-ancestor
6317857|NCT00003955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6317858|NCT00003955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6317859|NCT00003955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6317860|NCT00003955|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6317861|NCT00003955|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6317862|NCT00003956|Leucovorin|leucovorin|mesh-list
6317863|NCT00003956|Fluorouracil|fluorouracil|mesh-list
6317864|NCT00003956|Calcium|calcium|mesh-list
6317865|NCT00003956|Levoleucovorin|levoleucovorin|mesh-list
6317866|NCT00003956|Lonafarnib|lonafarnib|mesh-list
6317867|NCT00003956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6317868|NCT00003956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6317869|NCT00003956|Antimetabolites|antimetabolites|mesh-ancestor
6317870|NCT00003956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317871|NCT00003956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6317872|NCT00003956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317873|NCT00003956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6317874|NCT00003956|Immunologic Factors|immunologic factors|mesh-ancestor
6317875|NCT00003956|Antidotes|antidotes|mesh-ancestor
6317876|NCT00003956|Protective Agents|protective agents|mesh-ancestor
6317877|NCT00003956|Vitamin B Complex|vitamin b complex|mesh-ancestor
6317878|NCT00003956|Vitamins|vitamins|mesh-ancestor
6317879|NCT00003956|Micronutrients|micronutrients|mesh-ancestor
6317880|NCT00003956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6317881|NCT00003957|Cytarabine|cytarabine|mesh-list
6317882|NCT00003957|Paclitaxel|paclitaxel|mesh-list
6317883|NCT00003957|Etoposide|etoposide|mesh-list
6317884|NCT00003957|Cyclophosphamide|cyclophosphamide|mesh-list
6317885|NCT00003957|Melphalan|melphalan|mesh-list
6317886|NCT00003957|Mitoxantrone|mitoxantrone|mesh-list
6317887|NCT00003957|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6317888|NCT00003957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317889|NCT00003957|Tubulin Modulators|tubulin modulators|mesh-ancestor
6317890|NCT00003957|Antimitotic Agents|antimitotic agents|mesh-ancestor
6317891|NCT00003957|Mitosis Modulators|mitosis modulators|mesh-ancestor
6317892|NCT00003957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317893|NCT00003957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6317894|NCT00003957|Immunologic Factors|immunologic factors|mesh-ancestor
6317895|NCT00003957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6317896|NCT00003957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6317897|NCT00003957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6317898|NCT00003957|Alkylating Agents|alkylating agents|mesh-ancestor
6317899|NCT00003957|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6317900|NCT00003957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6317901|NCT00003957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6317902|NCT00003957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6317903|NCT00003957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6317904|NCT00003957|Antimetabolites|antimetabolites|mesh-ancestor
6317905|NCT00003957|Antiviral Agents|antiviral agents|mesh-ancestor
6317906|NCT00003957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6317907|NCT00003957|Analgesics|analgesics|mesh-ancestor
6317908|NCT00003957|Sensory System Agents|sensory system agents|mesh-ancestor
6317909|NCT00003957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6317910|NCT00003958|Dactinomycin|dactinomycin|mesh-list
6317911|NCT00003958|Cactinomycin|cactinomycin|mesh-list
6317912|NCT00003958|Cyclophosphamide|cyclophosphamide|mesh-list
6317913|NCT00003958|Vincristine|vincristine|mesh-list
6317914|NCT00003958|Topotecan|topotecan|mesh-list
6317915|NCT00003958|Sargramostim|sargramostim|mesh-list
6317916|NCT00003958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6317917|NCT00003958|Immunologic Factors|immunologic factors|mesh-ancestor
6317918|NCT00003958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6317919|NCT00003958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6317920|NCT00003958|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6317921|NCT00003958|Alkylating Agents|alkylating agents|mesh-ancestor
6317922|NCT00003958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317923|NCT00003958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317924|NCT00003958|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6317925|NCT00003958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6317926|NCT00003958|Tubulin Modulators|tubulin modulators|mesh-ancestor
6317927|NCT00003958|Antimitotic Agents|antimitotic agents|mesh-ancestor
6317928|NCT00003958|Mitosis Modulators|mitosis modulators|mesh-ancestor
6317929|NCT00003958|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6317930|NCT00003958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6317931|NCT00003958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6317932|NCT00003958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6317933|NCT00003958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6317934|NCT00003958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6317935|NCT00003958|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6317936|NCT00003958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6317937|NCT00003959|Sargramostim|sargramostim|mesh-list
6317938|NCT00003959|Immunologic Factors|immunologic factors|mesh-ancestor
6317939|NCT00003959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6317940|NCT00003960|Methylprednisolone|methylprednisolone|mesh-list
6317941|NCT00003960|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6016487|NCT00365391|Bevacizumab|bevacizumab|mesh-list
6317942|NCT00003960|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6317943|NCT00003960|Prednisolone|prednisolone|mesh-list
6317944|NCT00003960|Prednisolone acetate|prednisolone acetate|mesh-list
6317945|NCT00003960|Cyclophosphamide|cyclophosphamide|mesh-list
6317946|NCT00003960|Busulfan|busulfan|mesh-list
6317947|NCT00003960|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6317948|NCT00003960|Prednisolone phosphate|prednisolone phosphate|mesh-list
6317949|NCT00003960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6317950|NCT00003960|Immunologic Factors|immunologic factors|mesh-ancestor
6317951|NCT00003960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6317952|NCT00003960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6317953|NCT00003960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6317954|NCT00003960|Alkylating Agents|alkylating agents|mesh-ancestor
6317955|NCT00003960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317956|NCT00003960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317957|NCT00003960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6317958|NCT00003960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6317959|NCT00003960|Antiemetics|antiemetics|mesh-ancestor
6317960|NCT00003960|Autonomic Agents|autonomic agents|mesh-ancestor
6317961|NCT00003960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6317962|NCT00003960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6317963|NCT00003960|Glucocorticoids|glucocorticoids|mesh-ancestor
6317964|NCT00003960|Hormones|hormones|mesh-ancestor
6317965|NCT00003960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6317966|NCT00003960|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6317967|NCT00003960|Protective Agents|protective agents|mesh-ancestor
6317968|NCT00003960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6317969|NCT00003961|Sargramostim|sargramostim|mesh-list
6317970|NCT00003961|Immunologic Factors|immunologic factors|mesh-ancestor
6016488|NCT00365391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6016489|NCT00365391|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6317971|NCT00003961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6317972|NCT00003962|Aldesleukin|aldesleukin|mesh-list
6317973|NCT00003962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317974|NCT00003962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6317975|NCT00003962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6317976|NCT00003962|Antiviral Agents|antiviral agents|mesh-ancestor
6317977|NCT00003962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6317978|NCT00003963|Rituximab|rituximab|mesh-list
6317979|NCT00003963|Vinorelbine|vinorelbine|mesh-list
6317980|NCT00003963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6317981|NCT00003963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317982|NCT00003963|Immunologic Factors|immunologic factors|mesh-ancestor
6317983|NCT00003963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6317984|NCT00003963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6317985|NCT00003963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6317986|NCT00003963|Tubulin Modulators|tubulin modulators|mesh-ancestor
6317987|NCT00003963|Antimitotic Agents|antimitotic agents|mesh-ancestor
6317988|NCT00003963|Mitosis Modulators|mitosis modulators|mesh-ancestor
6317989|NCT00003963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317990|NCT00003966|Defibrotide|defibrotide|mesh-list
6317991|NCT00003966|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6317992|NCT00003966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6317993|NCT00003966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6317994|NCT00003966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6392681|NCT00197483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392682|NCT00197548|Folic Acid|folic acid|mesh-list
6392683|NCT00197548|Vitamin B Complex|vitamin b complex|mesh-list
6392684|NCT00197548|Vitamins|vitamins|mesh-ancestor
6392685|NCT00197548|Micronutrients|micronutrients|mesh-ancestor
6392686|NCT00197548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392687|NCT00197548|Hematinics|hematinics|mesh-ancestor
6392688|NCT00197561|Selenium|selenium|mesh-list
6392689|NCT00197561|Antioxidants|antioxidants|mesh-ancestor
6392690|NCT00197561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392691|NCT00197561|Protective Agents|protective agents|mesh-ancestor
6392692|NCT00197561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392693|NCT00197561|Trace Elements|trace elements|mesh-ancestor
6392694|NCT00197561|Micronutrients|micronutrients|mesh-ancestor
6392695|NCT00197587|Nevirapine|nevirapine|mesh-list
6392696|NCT00197587|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6392697|NCT00197587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6392698|NCT00197587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6392699|NCT00197587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392700|NCT00197587|Antiviral Agents|antiviral agents|mesh-ancestor
6392701|NCT00197587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6392702|NCT00197587|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6392703|NCT00197587|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6392704|NCT00197587|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6392705|NCT00197587|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6392706|NCT00197613|Lamivudine|lamivudine|mesh-list
6392707|NCT00197613|Zidovudine|zidovudine|mesh-list
6392708|NCT00197613|Efavirenz|efavirenz|mesh-list
6392709|NCT00197613|Nevirapine|nevirapine|mesh-list
6392710|NCT00197613|Stavudine|stavudine|mesh-list
6392711|NCT00197613|Didanosine|didanosine|mesh-list
6392712|NCT00197613|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6392713|NCT00197613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6392714|NCT00197613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6392715|NCT00197613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392716|NCT00197613|Antiviral Agents|antiviral agents|mesh-ancestor
6392717|NCT00197613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6392718|NCT00197613|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6392719|NCT00197613|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6392720|NCT00197613|Antimetabolites|antimetabolites|mesh-ancestor
6392721|NCT00197613|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6392722|NCT00197613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6392723|NCT00197613|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6392724|NCT00197613|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6392725|NCT00197613|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6392726|NCT00197613|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6392727|NCT00197639|Ritonavir|ritonavir|mesh-list
6392728|NCT00197639|Indinavir|indinavir|mesh-list
6392729|NCT00197639|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6392730|NCT00197639|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6392731|NCT00197639|Protease Inhibitors|protease inhibitors|mesh-ancestor
6392732|NCT00197639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6392733|NCT00197639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392734|NCT00197639|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6392735|NCT00197639|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6392736|NCT00197639|Antiviral Agents|antiviral agents|mesh-ancestor
6392737|NCT00197639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6392738|NCT00197639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6392739|NCT00197639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6392740|NCT00197730|Folic Acid|folic acid|mesh-list
6392741|NCT00197730|Vitamin B Complex|vitamin b complex|mesh-list
6392742|NCT00197730|Vitamins|vitamins|mesh-ancestor
6392743|NCT00197730|Micronutrients|micronutrients|mesh-ancestor
6392744|NCT00197730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392745|NCT00197730|Hematinics|hematinics|mesh-ancestor
6392746|NCT00197743|Vitamin A|vitamin a|mesh-list
6392747|NCT00197743|Beta Carotene|beta carotene|mesh-list
6392748|NCT00197743|Carotenoids|carotenoids|mesh-list
6392749|NCT00197743|Vitamins|vitamins|mesh-ancestor
6392750|NCT00197743|Micronutrients|micronutrients|mesh-ancestor
6392751|NCT00197743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392752|NCT00197743|Antioxidants|antioxidants|mesh-ancestor
6317995|NCT00003967|Etoposide|etoposide|mesh-list
6317996|NCT00003967|Topotecan|topotecan|mesh-list
6317997|NCT00003967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6317998|NCT00003967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6317999|NCT00003967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6318000|NCT00003967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6318001|NCT00003967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6318002|NCT00003967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318003|NCT00003967|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6318004|NCT00003968|Bryostatin 1|bryostatin 1|mesh-list
6318005|NCT00003968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6318006|NCT00003968|Immunologic Factors|immunologic factors|mesh-ancestor
6318007|NCT00003968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6318008|NCT00003968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318009|NCT00003970|Irinotecan|irinotecan|mesh-list
6318010|NCT00003970|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6318011|NCT00003970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6318012|NCT00003970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6318013|NCT00003970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318014|NCT00003970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318015|NCT00003972|Tamoxifen|tamoxifen|mesh-list
6318016|NCT00003972|Paclitaxel|paclitaxel|mesh-list
6318017|NCT00003972|Cyclophosphamide|cyclophosphamide|mesh-list
6318018|NCT00003972|Carboplatin|carboplatin|mesh-list
6318019|NCT00003972|Melphalan|melphalan|mesh-list
6318020|NCT00003972|Busulfan|busulfan|mesh-list
6318021|NCT00003972|Thiotepa|thiotepa|mesh-list
6318022|NCT00003972|Sargramostim|sargramostim|mesh-list
6318023|NCT00003972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6318024|NCT00003972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318025|NCT00003972|Tubulin Modulators|tubulin modulators|mesh-ancestor
6318026|NCT00003972|Antimitotic Agents|antimitotic agents|mesh-ancestor
6318027|NCT00003972|Mitosis Modulators|mitosis modulators|mesh-ancestor
6318028|NCT00003972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318029|NCT00003972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6318030|NCT00003972|Immunologic Factors|immunologic factors|mesh-ancestor
6318031|NCT00003972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6318032|NCT00003972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6318033|NCT00003972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6318034|NCT00003972|Alkylating Agents|alkylating agents|mesh-ancestor
6318035|NCT00003972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6318036|NCT00003972|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6318037|NCT00003972|Hormone Antagonists|hormone antagonists|mesh-ancestor
6318038|NCT00003972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6318039|NCT00003972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6318040|NCT00003972|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6318041|NCT00003972|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6318042|NCT00003972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6318043|NCT00003974|Cyclophosphamide|cyclophosphamide|mesh-list
6318044|NCT00003974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6318045|NCT00003974|Immunologic Factors|immunologic factors|mesh-ancestor
6318046|NCT00003974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6318047|NCT00003974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6318048|NCT00003974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6318049|NCT00003974|Alkylating Agents|alkylating agents|mesh-ancestor
6318050|NCT00003974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318051|NCT00003974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318052|NCT00003974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6318053|NCT00003976|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
6318054|NCT00003976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318055|NCT00003976|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6318056|NCT00003976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6318057|NCT00003976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318058|NCT00003981|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
6318059|NCT00003981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318060|NCT00003981|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6318061|NCT00003981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6318062|NCT00003981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318063|NCT00003984|Lintuzumab|lintuzumab|mesh-list
6318064|NCT00003984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6318065|NCT00003984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318066|NCT00003985|KRN 7000|krn 7000|mesh-list
6318067|NCT00003985|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6318068|NCT00003985|Immunologic Factors|immunologic factors|mesh-ancestor
6318069|NCT00003985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6318070|NCT00003985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318071|NCT00003991|Aldesleukin|aldesleukin|mesh-list
6318072|NCT00003991|Histamine|histamine|mesh-list
6318073|NCT00003991|Histamine phosphate|histamine phosphate|mesh-list
6318074|NCT00003991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318075|NCT00003991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6318076|NCT00003991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6318077|NCT00003991|Antiviral Agents|antiviral agents|mesh-ancestor
6318078|NCT00003991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6318079|NCT00003991|Histamine Agonists|histamine agonists|mesh-ancestor
6318080|NCT00003991|Histamine Agents|histamine agents|mesh-ancestor
6318081|NCT00003991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6318082|NCT00003991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318083|NCT00003991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6318084|NCT00003992|Tamoxifen|tamoxifen|mesh-list
6318085|NCT00003992|Paclitaxel|paclitaxel|mesh-list
6318086|NCT00003992|Cyclophosphamide|cyclophosphamide|mesh-list
6318087|NCT00003992|Doxorubicin|doxorubicin|mesh-list
6318088|NCT00003992|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6318089|NCT00003992|Trastuzumab|trastuzumab|mesh-list
6318090|NCT00003992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6318091|NCT00003992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318092|NCT00003992|Tubulin Modulators|tubulin modulators|mesh-ancestor
6318093|NCT00003992|Antimitotic Agents|antimitotic agents|mesh-ancestor
6318094|NCT00003992|Mitosis Modulators|mitosis modulators|mesh-ancestor
6318095|NCT00003992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318096|NCT00003992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6318097|NCT00003992|Immunologic Factors|immunologic factors|mesh-ancestor
6318098|NCT00003992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6318099|NCT00003992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6318100|NCT00003992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6318101|NCT00003992|Alkylating Agents|alkylating agents|mesh-ancestor
6318102|NCT00003992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6318103|NCT00003992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6318104|NCT00003992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6318105|NCT00003992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6318106|NCT00003992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6318107|NCT00003992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6318108|NCT00003992|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6318109|NCT00003992|Hormone Antagonists|hormone antagonists|mesh-ancestor
6318110|NCT00003992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6318111|NCT00003992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6318112|NCT00003992|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6318113|NCT00003992|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6318114|NCT00003992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6318115|NCT00003993|Aldesleukin|aldesleukin|mesh-list
6318116|NCT00003993|Bryostatin 1|bryostatin 1|mesh-list
6318117|NCT00003993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318118|NCT00003993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6318119|NCT00003993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6318120|NCT00003993|Antiviral Agents|antiviral agents|mesh-ancestor
6318121|NCT00003993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6318122|NCT00003993|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6318123|NCT00003993|Immunologic Factors|immunologic factors|mesh-ancestor
6318124|NCT00003993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6318125|NCT00003994|Carboplatin|carboplatin|mesh-list
6318126|NCT00003994|Fluorouracil|fluorouracil|mesh-list
6318127|NCT00003994|Vincristine|vincristine|mesh-list
6318128|NCT00003994|Amifostine|amifostine|mesh-list
6318129|NCT00003994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318130|NCT00003994|Antimetabolites|antimetabolites|mesh-ancestor
6318131|NCT00003994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318132|NCT00003994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6318133|NCT00003994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6318134|NCT00003994|Immunologic Factors|immunologic factors|mesh-ancestor
6318135|NCT00003994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6318136|NCT00003994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6318137|NCT00003994|Tubulin Modulators|tubulin modulators|mesh-ancestor
6318138|NCT00003994|Antimitotic Agents|antimitotic agents|mesh-ancestor
6318139|NCT00003994|Mitosis Modulators|mitosis modulators|mesh-ancestor
6318140|NCT00003994|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6318141|NCT00003994|Protective Agents|protective agents|mesh-ancestor
6318142|NCT00003995|Trastuzumab|trastuzumab|mesh-list
6318143|NCT00003995|Irinotecan|irinotecan|mesh-list
6318144|NCT00003995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6318145|NCT00003995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318146|NCT00003995|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6318147|NCT00003995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6318148|NCT00003995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6318149|NCT00003995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318150|NCT00003996|Etoposide|etoposide|mesh-list
6318151|NCT00003996|Carmustine|carmustine|mesh-list
6318152|NCT00003996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318153|NCT00003996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6318154|NCT00003996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6318155|NCT00003996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6318156|NCT00003996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6318157|NCT00003996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318158|NCT00003996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6318159|NCT00003996|Alkylating Agents|alkylating agents|mesh-ancestor
6318160|NCT00003997|Irofulven|irofulven|mesh-list
6318161|NCT00003997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6318162|NCT00003997|Alkylating Agents|alkylating agents|mesh-ancestor
6318163|NCT00003997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318164|NCT00003997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318165|NCT00003998|Paclitaxel|paclitaxel|mesh-list
6318166|NCT00003998|Docetaxel|docetaxel|mesh-list
6318167|NCT00003998|Carboplatin|carboplatin|mesh-list
6318168|NCT00003998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6318169|NCT00003998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318170|NCT00003998|Tubulin Modulators|tubulin modulators|mesh-ancestor
6318171|NCT00003998|Antimitotic Agents|antimitotic agents|mesh-ancestor
6318172|NCT00003998|Mitosis Modulators|mitosis modulators|mesh-ancestor
6318173|NCT00003998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318174|NCT00004001|Prednisone|prednisone|mesh-list
6318175|NCT00004001|Docetaxel|docetaxel|mesh-list
6318176|NCT00004001|Mitoxantrone|mitoxantrone|mesh-list
6318177|NCT00004001|Estramustine|estramustine|mesh-list
6318178|NCT00004001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318179|NCT00004001|Tubulin Modulators|tubulin modulators|mesh-ancestor
6318180|NCT00004001|Antimitotic Agents|antimitotic agents|mesh-ancestor
6318181|NCT00004001|Mitosis Modulators|mitosis modulators|mesh-ancestor
6318182|NCT00004001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318183|NCT00004001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6318184|NCT00004001|Glucocorticoids|glucocorticoids|mesh-ancestor
6318185|NCT00004001|Hormones|hormones|mesh-ancestor
6318186|NCT00004001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6318187|NCT00004001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6318188|NCT00004001|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6318189|NCT00004001|Analgesics|analgesics|mesh-ancestor
6318190|NCT00004001|Sensory System Agents|sensory system agents|mesh-ancestor
6318191|NCT00004001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6318192|NCT00004001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6318193|NCT00004001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6318194|NCT00004001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6318195|NCT00004001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6318196|NCT00004001|Alkylating Agents|alkylating agents|mesh-ancestor
6318197|NCT00004002|Bortezomib|bortezomib|mesh-list
6318198|NCT00004002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318199|NCT00004003|Gemcitabine|gemcitabine|mesh-list
6318200|NCT00004003|Fluorouracil|fluorouracil|mesh-list
6318201|NCT00004003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318202|NCT00004003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6318203|NCT00004003|Antimetabolites|antimetabolites|mesh-ancestor
6318204|NCT00004003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318205|NCT00004003|Antiviral Agents|antiviral agents|mesh-ancestor
6318206|NCT00004003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6318207|NCT00004003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6318208|NCT00004003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6318209|NCT00004003|Immunologic Factors|immunologic factors|mesh-ancestor
6318210|NCT00004003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6318211|NCT00004004|Procarbazine|procarbazine|mesh-list
6318212|NCT00004004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318213|NCT00004005|Leucovorin|leucovorin|mesh-list
6318214|NCT00004005|Fluorouracil|fluorouracil|mesh-list
6318215|NCT00004005|Irinotecan|irinotecan|mesh-list
6318216|NCT00004005|Calcium|calcium|mesh-list
6318217|NCT00004005|Levoleucovorin|levoleucovorin|mesh-list
6318218|NCT00004005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6318219|NCT00004005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6318220|NCT00004005|Antimetabolites|antimetabolites|mesh-ancestor
6318221|NCT00004005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318222|NCT00004005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6318223|NCT00004005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318224|NCT00004005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6318225|NCT00004005|Immunologic Factors|immunologic factors|mesh-ancestor
6318226|NCT00004005|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6318227|NCT00004005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6318228|NCT00004005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6318229|NCT00004005|Antidotes|antidotes|mesh-ancestor
6318230|NCT00004005|Protective Agents|protective agents|mesh-ancestor
6318231|NCT00004005|Vitamin B Complex|vitamin b complex|mesh-ancestor
6318232|NCT00004005|Vitamins|vitamins|mesh-ancestor
6318233|NCT00004005|Micronutrients|micronutrients|mesh-ancestor
6318234|NCT00004006|Cyclophosphamide|cyclophosphamide|mesh-list
6318235|NCT00004006|Carboplatin|carboplatin|mesh-list
6318236|NCT00004006|Doxorubicin|doxorubicin|mesh-list
6318237|NCT00004006|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6318238|NCT00004006|Etoposide|etoposide|mesh-list
6318239|NCT00004006|Topotecan|topotecan|mesh-list
6318240|NCT00004006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6318241|NCT00004006|Immunologic Factors|immunologic factors|mesh-ancestor
6318242|NCT00004006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6318243|NCT00004006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6318244|NCT00004006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6318245|NCT00004006|Alkylating Agents|alkylating agents|mesh-ancestor
6318246|NCT00004006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318247|NCT00004006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318248|NCT00004006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6318249|NCT00004006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6318250|NCT00004006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6318251|NCT00004006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6318252|NCT00004006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6318253|NCT00004006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6318254|NCT00004006|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6318255|NCT00004008|Bryostatin 1|bryostatin 1|mesh-list
6318256|NCT00004008|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6318257|NCT00004008|Immunologic Factors|immunologic factors|mesh-ancestor
6318258|NCT00004008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6318259|NCT00004008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318260|NCT00004009|Tipifarnib|tipifarnib|mesh-list
6318261|NCT00004009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318262|NCT00004010|Prednisone|prednisone|mesh-list
6318263|NCT00004010|Cyclophosphamide|cyclophosphamide|mesh-list
6318264|NCT00004010|Dacarbazine|dacarbazine|mesh-list
6318265|NCT00004010|Doxorubicin|doxorubicin|mesh-list
6318266|NCT00004010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6318267|NCT00004010|Etoposide|etoposide|mesh-list
6318268|NCT00004010|Vincristine|vincristine|mesh-list
6318269|NCT00004010|Bleomycin|bleomycin|mesh-list
6318270|NCT00004010|Vinblastine|vinblastine|mesh-list
6318271|NCT00004010|Procarbazine|procarbazine|mesh-list
6318272|NCT00004010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6016490|NCT00365391|Antibodies|antibodies|mesh-list
6016491|NCT00365391|Immunoglobulins|immunoglobulins|mesh-list
6016492|NCT00365391|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6016493|NCT00365391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6016494|NCT00365391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6016495|NCT00365391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6318273|NCT00004010|Immunologic Factors|immunologic factors|mesh-ancestor
6318274|NCT00004010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6318275|NCT00004010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6318276|NCT00004010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6318277|NCT00004010|Alkylating Agents|alkylating agents|mesh-ancestor
6318278|NCT00004010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318279|NCT00004010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318280|NCT00004010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6318281|NCT00004010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6318282|NCT00004010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6318283|NCT00004010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6318284|NCT00004010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6318285|NCT00004010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6318286|NCT00004010|Glucocorticoids|glucocorticoids|mesh-ancestor
6318287|NCT00004010|Hormones|hormones|mesh-ancestor
6318288|NCT00004010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6318289|NCT00004010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6318290|NCT00004010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6318291|NCT00004010|Tubulin Modulators|tubulin modulators|mesh-ancestor
6318292|NCT00004010|Antimitotic Agents|antimitotic agents|mesh-ancestor
6318293|NCT00004010|Mitosis Modulators|mitosis modulators|mesh-ancestor
6318294|NCT00004011|Paclitaxel|paclitaxel|mesh-list
6318295|NCT00004011|Carboplatin|carboplatin|mesh-list
6318296|NCT00004011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6318297|NCT00004011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318298|NCT00004011|Tubulin Modulators|tubulin modulators|mesh-ancestor
6318299|NCT00004011|Antimitotic Agents|antimitotic agents|mesh-ancestor
6318300|NCT00004011|Mitosis Modulators|mitosis modulators|mesh-ancestor
6318301|NCT00004011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318302|NCT00004012|Capecitabine|capecitabine|mesh-list
6318303|NCT00004012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6318304|NCT00004012|Antimetabolites|antimetabolites|mesh-ancestor
6318305|NCT00004012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318306|NCT00004012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318307|NCT00004013|Paclitaxel|paclitaxel|mesh-list
6318308|NCT00004013|Trastuzumab|trastuzumab|mesh-list
6318309|NCT00004013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6318310|NCT00004013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318311|NCT00004013|Tubulin Modulators|tubulin modulators|mesh-ancestor
6318312|NCT00004013|Antimitotic Agents|antimitotic agents|mesh-ancestor
6318313|NCT00004013|Mitosis Modulators|mitosis modulators|mesh-ancestor
6318314|NCT00004013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318315|NCT00004013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6318316|NCT00004014|Doxorubicin|doxorubicin|mesh-list
6318317|NCT00004014|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6318318|NCT00004014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6318319|NCT00004014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318320|NCT00004014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6318321|NCT00004014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6318322|NCT00004014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6318323|NCT00004014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318324|NCT00004016|Interferons|interferons|mesh-list
6318325|NCT00004016|Interferon-gamma|interferon-gamma|mesh-list
6318326|NCT00004016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318327|NCT00004016|Antiviral Agents|antiviral agents|mesh-ancestor
6318328|NCT00004016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6318329|NCT00004017|Antibodies|antibodies|mesh-list
6318330|NCT00004017|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6318331|NCT00004017|Immunologic Factors|immunologic factors|mesh-ancestor
6318332|NCT00004017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6318333|NCT00004022|Aldesleukin|aldesleukin|mesh-list
6318334|NCT00004022|Muromonab-CD3|muromonab-cd3|mesh-list
6318335|NCT00004022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318336|NCT00004022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6318337|NCT00004022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6318338|NCT00004022|Antiviral Agents|antiviral agents|mesh-ancestor
6318339|NCT00004022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6318340|NCT00004022|Immunologic Factors|immunologic factors|mesh-ancestor
6318341|NCT00004022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6318342|NCT00004022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6318343|NCT00004024|Aldesleukin|aldesleukin|mesh-list
6318344|NCT00004024|Sargramostim|sargramostim|mesh-list
6318345|NCT00004024|Muromonab-CD3|muromonab-cd3|mesh-list
6318346|NCT00004024|Immunologic Factors|immunologic factors|mesh-ancestor
6318347|NCT00004024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6318348|NCT00004024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318349|NCT00004024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6318350|NCT00004024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6318351|NCT00004024|Antiviral Agents|antiviral agents|mesh-ancestor
6318352|NCT00004024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6318353|NCT00004024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6318354|NCT00004025|Aldesleukin|aldesleukin|mesh-list
6318355|NCT00004025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318356|NCT00004025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6318357|NCT00004025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6318358|NCT00004025|Antiviral Agents|antiviral agents|mesh-ancestor
6318359|NCT00004025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6318360|NCT00004028|Carmustine|carmustine|mesh-list
6318361|NCT00004028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6318362|NCT00004028|Alkylating Agents|alkylating agents|mesh-ancestor
6318363|NCT00004028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318364|NCT00004028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318365|NCT00004029|Sargramostim|sargramostim|mesh-list
6318366|NCT00004029|Vaccines|vaccines|mesh-list
6318367|NCT00004029|Immunologic Factors|immunologic factors|mesh-ancestor
6318368|NCT00004029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6318369|NCT00004030|Doxorubicin|doxorubicin|mesh-list
6318370|NCT00004030|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6318371|NCT00004030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6318372|NCT00004030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318373|NCT00004030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6318374|NCT00004030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6318375|NCT00004030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6318376|NCT00004030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318377|NCT00004032|Interferons|interferons|mesh-list
6318378|NCT00004032|Interferon-gamma|interferon-gamma|mesh-list
6318379|NCT00004032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318380|NCT00004032|Antiviral Agents|antiviral agents|mesh-ancestor
6318381|NCT00004032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6318382|NCT00004036|Cyclophosphamide|cyclophosphamide|mesh-list
6318383|NCT00004036|Carboplatin|carboplatin|mesh-list
6318384|NCT00004036|Sargramostim|sargramostim|mesh-list
6318385|NCT00004036|Amifostine|amifostine|mesh-list
6318386|NCT00004036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6318387|NCT00004036|Immunologic Factors|immunologic factors|mesh-ancestor
6318388|NCT00004036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6318389|NCT00004036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6318390|NCT00004036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6318391|NCT00004036|Alkylating Agents|alkylating agents|mesh-ancestor
6318392|NCT00004036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318393|NCT00004036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318394|NCT00004036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6318395|NCT00004036|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6318396|NCT00004036|Protective Agents|protective agents|mesh-ancestor
6318397|NCT00004037|Docetaxel|docetaxel|mesh-list
6318398|NCT00004037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318399|NCT00004037|Tubulin Modulators|tubulin modulators|mesh-ancestor
6318400|NCT00004037|Antimitotic Agents|antimitotic agents|mesh-ancestor
6318401|NCT00004037|Mitosis Modulators|mitosis modulators|mesh-ancestor
6318402|NCT00004037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318403|NCT00004039|Interferons|interferons|mesh-list
6318404|NCT00004039|Interferon-alpha|interferon-alpha|mesh-list
6318405|NCT00004039|Prednisone|prednisone|mesh-list
6318406|NCT00004039|Cyclophosphamide|cyclophosphamide|mesh-list
6318407|NCT00004039|Rituximab|rituximab|mesh-list
6318408|NCT00004039|Doxorubicin|doxorubicin|mesh-list
6318409|NCT00004039|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6318410|NCT00004039|Vincristine|vincristine|mesh-list
6318411|NCT00004039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6318412|NCT00004039|Immunologic Factors|immunologic factors|mesh-ancestor
6318413|NCT00004039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6318414|NCT00004039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6318415|NCT00004039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6318416|NCT00004039|Alkylating Agents|alkylating agents|mesh-ancestor
6318417|NCT00004039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318418|NCT00004039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318419|NCT00004039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6318420|NCT00004039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6318421|NCT00004039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6318422|NCT00004039|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6318423|NCT00004039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6318424|NCT00004039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6318425|NCT00004039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6318426|NCT00004039|Glucocorticoids|glucocorticoids|mesh-ancestor
6318427|NCT00004039|Hormones|hormones|mesh-ancestor
6318428|NCT00004039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6318429|NCT00004039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6318430|NCT00004039|Antiviral Agents|antiviral agents|mesh-ancestor
6318431|NCT00004039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6318432|NCT00004039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6318433|NCT00004039|Tubulin Modulators|tubulin modulators|mesh-ancestor
6318434|NCT00004039|Antimitotic Agents|antimitotic agents|mesh-ancestor
6318435|NCT00004039|Mitosis Modulators|mitosis modulators|mesh-ancestor
6318436|NCT00004040|Interferons|interferons|mesh-list
6318437|NCT00004040|Interferon-alpha|interferon-alpha|mesh-list
6318438|NCT00004040|Rituximab|rituximab|mesh-list
6318439|NCT00004040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6318440|NCT00004040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318441|NCT00004040|Immunologic Factors|immunologic factors|mesh-ancestor
6318442|NCT00004040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6318443|NCT00004040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6318444|NCT00004040|Antiviral Agents|antiviral agents|mesh-ancestor
6318445|NCT00004040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6318446|NCT00004042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6318447|NCT00004042|Antibodies|antibodies|mesh-list
6318448|NCT00004042|Immunoglobulins|immunoglobulins|mesh-list
6318449|NCT00004042|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6318450|NCT00004042|Immunologic Factors|immunologic factors|mesh-ancestor
6318451|NCT00004042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6318452|NCT00004042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318453|NCT00004043|Calcitriol|calcitriol|mesh-list
6318454|NCT00004043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6318455|NCT00004043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6318456|NCT00004043|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6318457|NCT00004043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6318458|NCT00004043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318459|NCT00004043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6318460|NCT00004043|Vitamins|vitamins|mesh-ancestor
6318461|NCT00004043|Micronutrients|micronutrients|mesh-ancestor
6318462|NCT00004043|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6318463|NCT00004045|Exatecan|exatecan|mesh-list
6318464|NCT00004045|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6318465|NCT00004045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6318466|NCT00004045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6318467|NCT00004045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318468|NCT00004045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318469|NCT00004046|Exatecan|exatecan|mesh-list
6318470|NCT00004046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6318471|NCT00004046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6318472|NCT00004046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6318473|NCT00004046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318474|NCT00004046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318475|NCT00004047|Exatecan|exatecan|mesh-list
6318476|NCT00004047|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6318477|NCT00004047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6318478|NCT00004047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6318479|NCT00004047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318480|NCT00004047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318481|NCT00004048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6318482|NCT00004048|Doxorubicin|doxorubicin|mesh-list
6318483|NCT00004048|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6318484|NCT00004048|Antibodies|antibodies|mesh-list
6318485|NCT00004048|Immunoglobulins|immunoglobulins|mesh-list
6318486|NCT00004048|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6318487|NCT00004048|Immunologic Factors|immunologic factors|mesh-ancestor
6318488|NCT00004048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6318489|NCT00004048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318490|NCT00004048|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6318491|NCT00004048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6318492|NCT00004048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6318493|NCT00004048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6318494|NCT00004048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318495|NCT00004050|Interleukin-2|interleukin-2|mesh-list
6318496|NCT00004050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318497|NCT00004050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6318498|NCT00004050|Analgesics|analgesics|mesh-ancestor
6318499|NCT00004050|Sensory System Agents|sensory system agents|mesh-ancestor
6318500|NCT00004050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6318501|NCT00004050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6318502|NCT00004051|Irinotecan|irinotecan|mesh-list
6318503|NCT00004051|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6318504|NCT00004051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6318505|NCT00004051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6318506|NCT00004051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318507|NCT00004051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318508|NCT00004055|Paclitaxel|paclitaxel|mesh-list
6318509|NCT00004055|Topotecan|topotecan|mesh-list
6318510|NCT00004055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6318511|NCT00004055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318512|NCT00004055|Tubulin Modulators|tubulin modulators|mesh-ancestor
6318513|NCT00004055|Antimitotic Agents|antimitotic agents|mesh-ancestor
6318514|NCT00004055|Mitosis Modulators|mitosis modulators|mesh-ancestor
6318515|NCT00004055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318516|NCT00004055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6318517|NCT00004055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6318518|NCT00004055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6318519|NCT00004056|Cytarabine|cytarabine|mesh-list
6318520|NCT00004056|Thioguanine|thioguanine|mesh-list
6318521|NCT00004056|Melphalan|melphalan|mesh-list
6318522|NCT00004056|Daunorubicin|daunorubicin|mesh-list
6318523|NCT00004056|Asparaginase|asparaginase|mesh-list
6318524|NCT00004056|Lenograstim|lenograstim|mesh-list
6318525|NCT00004056|Sargramostim|sargramostim|mesh-list
6318526|NCT00004056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6318527|NCT00004056|Immunologic Factors|immunologic factors|mesh-ancestor
6318528|NCT00004056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6318529|NCT00004056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6318530|NCT00004056|Antimetabolites|antimetabolites|mesh-ancestor
6318531|NCT00004056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318532|NCT00004056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318533|NCT00004056|Antiviral Agents|antiviral agents|mesh-ancestor
6318534|NCT00004056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6318535|NCT00004056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6318536|NCT00004056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6318537|NCT00004056|Alkylating Agents|alkylating agents|mesh-ancestor
6318538|NCT00004056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6318539|NCT00004056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6318540|NCT00004056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6318541|NCT00004056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6318542|NCT00004056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6318543|NCT00004057|Paclitaxel|paclitaxel|mesh-list
6318544|NCT00004057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6318545|NCT00004057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318546|NCT00004057|Tubulin Modulators|tubulin modulators|mesh-ancestor
6318547|NCT00004057|Antimitotic Agents|antimitotic agents|mesh-ancestor
6318548|NCT00004057|Mitosis Modulators|mitosis modulators|mesh-ancestor
6318549|NCT00004057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318550|NCT00004059|Fluorouracil|fluorouracil|mesh-list
6318551|NCT00004059|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
6318552|NCT00004059|Antimetabolites|antimetabolites|mesh-ancestor
6318553|NCT00004059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318554|NCT00004059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6318555|NCT00004059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318556|NCT00004059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6318557|NCT00004059|Immunologic Factors|immunologic factors|mesh-ancestor
6318558|NCT00004059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6318559|NCT00004059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6318560|NCT00004059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6318561|NCT00004060|Exatecan|exatecan|mesh-list
6318562|NCT00004060|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6318563|NCT00004060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6318564|NCT00004060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6318565|NCT00004060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318566|NCT00004060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318567|NCT00004061|Cyclophosphamide|cyclophosphamide|mesh-list
6318568|NCT00004061|Ifosfamide|ifosfamide|mesh-list
6318569|NCT00004061|Etoposide|etoposide|mesh-list
6318570|NCT00004061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6318571|NCT00004061|Immunologic Factors|immunologic factors|mesh-ancestor
6318572|NCT00004061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6318573|NCT00004061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6318574|NCT00004061|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6318575|NCT00004061|Alkylating Agents|alkylating agents|mesh-ancestor
6318576|NCT00004061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318577|NCT00004061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318578|NCT00004061|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6318579|NCT00004061|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6318580|NCT00004061|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6318581|NCT00004061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6318582|NCT00004061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6318583|NCT00004062|Azacitidine|azacitidine|mesh-list
6318584|NCT00004062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6318585|NCT00004062|Antimetabolites|antimetabolites|mesh-ancestor
6318586|NCT00004062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318587|NCT00004062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318588|NCT00004062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6318589|NCT00004063|Gemcitabine|gemcitabine|mesh-list
6318590|NCT00004063|Interferons|interferons|mesh-list
6318591|NCT00004063|Interferon-alpha|interferon-alpha|mesh-list
6318592|NCT00004063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318593|NCT00004063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6318594|NCT00004063|Antimetabolites|antimetabolites|mesh-ancestor
6318595|NCT00004063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318596|NCT00004063|Antiviral Agents|antiviral agents|mesh-ancestor
6318597|NCT00004063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6318598|NCT00004063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6318599|NCT00004063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6318600|NCT00004063|Immunologic Factors|immunologic factors|mesh-ancestor
6318601|NCT00004063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6318602|NCT00004064|Oregovomab|oregovomab|mesh-list
6318603|NCT00004064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6318604|NCT00004064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318605|NCT00004066|Gemcitabine|gemcitabine|mesh-list
6318606|NCT00004066|Docetaxel|docetaxel|mesh-list
6318607|NCT00004066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6318608|NCT00004066|Antimetabolites|antimetabolites|mesh-ancestor
6318609|NCT00004066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318610|NCT00004066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318611|NCT00004066|Antiviral Agents|antiviral agents|mesh-ancestor
6318612|NCT00004066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6318613|NCT00004066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6318614|NCT00004066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6318615|NCT00004066|Immunologic Factors|immunologic factors|mesh-ancestor
6318616|NCT00004066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6318617|NCT00004066|Tubulin Modulators|tubulin modulators|mesh-ancestor
6318618|NCT00004066|Antimitotic Agents|antimitotic agents|mesh-ancestor
6318619|NCT00004066|Mitosis Modulators|mitosis modulators|mesh-ancestor
6318620|NCT00004067|Paclitaxel|paclitaxel|mesh-list
6318621|NCT00004067|Cyclophosphamide|cyclophosphamide|mesh-list
6318622|NCT00004067|Doxorubicin|doxorubicin|mesh-list
6318623|NCT00004067|Trastuzumab|trastuzumab|mesh-list
6318624|NCT00004067|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6318625|NCT00004067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6318626|NCT00004067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318627|NCT00004067|Tubulin Modulators|tubulin modulators|mesh-ancestor
6318628|NCT00004067|Antimitotic Agents|antimitotic agents|mesh-ancestor
6318629|NCT00004067|Mitosis Modulators|mitosis modulators|mesh-ancestor
6318630|NCT00004067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318631|NCT00004067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6318632|NCT00004067|Immunologic Factors|immunologic factors|mesh-ancestor
6318633|NCT00004067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6318634|NCT00004067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6318635|NCT00004067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6318636|NCT00004067|Alkylating Agents|alkylating agents|mesh-ancestor
6318637|NCT00004067|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6318638|NCT00004067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6318639|NCT00004067|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6318640|NCT00004067|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6318641|NCT00004067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6318642|NCT00004067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6318643|NCT00004068|Irinotecan|irinotecan|mesh-list
6318644|NCT00004068|Temozolomide|temozolomide|mesh-list
6318645|NCT00004068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6318646|NCT00004068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6318647|NCT00004068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6318648|NCT00004068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318649|NCT00004068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318650|NCT00004068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6318651|NCT00004068|Alkylating Agents|alkylating agents|mesh-ancestor
6318652|NCT00004070|Interleukin-12|interleukin-12|mesh-list
6318653|NCT00004070|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6318654|NCT00004070|Immunologic Factors|immunologic factors|mesh-ancestor
6318655|NCT00004070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6318656|NCT00004070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6318657|NCT00004070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6318658|NCT00004070|Growth Substances|growth substances|mesh-ancestor
6318659|NCT00004070|Growth Inhibitors|growth inhibitors|mesh-ancestor
6318660|NCT00004070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318661|NCT00004071|Prednisone|prednisone|mesh-list
6318662|NCT00004071|Mitoxantrone|mitoxantrone|mesh-list
6318663|NCT00004071|Leflunomide|leflunomide|mesh-list
6318664|NCT00004071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6318665|NCT00004071|Glucocorticoids|glucocorticoids|mesh-ancestor
6318666|NCT00004071|Hormones|hormones|mesh-ancestor
6318667|NCT00004071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6318668|NCT00004071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6318669|NCT00004071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6318670|NCT00004071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318671|NCT00004071|Analgesics|analgesics|mesh-ancestor
6318672|NCT00004071|Sensory System Agents|sensory system agents|mesh-ancestor
6318673|NCT00004071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6318674|NCT00004071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6318675|NCT00004071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6318676|NCT00004071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6318677|NCT00004071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318678|NCT00004071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6318679|NCT00004071|Immunologic Factors|immunologic factors|mesh-ancestor
6318680|NCT00004072|Carmustine|carmustine|mesh-list
6318681|NCT00004072|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
6318682|NCT00004072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6318683|NCT00004072|Alkylating Agents|alkylating agents|mesh-ancestor
6318684|NCT00004072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318685|NCT00004072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318686|NCT00004072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6318687|NCT00004073|Suramin|suramin|mesh-list
6318688|NCT00004073|Antinematodal Agents|antinematodal agents|mesh-ancestor
6318689|NCT00004073|Anthelmintics|anthelmintics|mesh-ancestor
6318690|NCT00004073|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6318691|NCT00004073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6318692|NCT00004073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318693|NCT00004073|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6318694|NCT00004073|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6318695|NCT00004074|Carboplatin|carboplatin|mesh-list
6318696|NCT00004074|Trastuzumab|trastuzumab|mesh-list
6318697|NCT00004074|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6318698|NCT00004074|Interleukin-12|interleukin-12|mesh-list
6318699|NCT00004074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318700|NCT00004074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6318701|NCT00004074|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6318702|NCT00004074|Immunologic Factors|immunologic factors|mesh-ancestor
6318703|NCT00004074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6318704|NCT00004074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6318705|NCT00004074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6318706|NCT00004074|Growth Substances|growth substances|mesh-ancestor
6318707|NCT00004074|Growth Inhibitors|growth inhibitors|mesh-ancestor
6318708|NCT00004077|Paclitaxel|paclitaxel|mesh-list
6318709|NCT00004077|Ifosfamide|ifosfamide|mesh-list
6318710|NCT00004077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6318711|NCT00004077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318712|NCT00004077|Tubulin Modulators|tubulin modulators|mesh-ancestor
6318713|NCT00004077|Antimitotic Agents|antimitotic agents|mesh-ancestor
6318714|NCT00004077|Mitosis Modulators|mitosis modulators|mesh-ancestor
6318715|NCT00004077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318716|NCT00004077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6318717|NCT00004077|Alkylating Agents|alkylating agents|mesh-ancestor
6318718|NCT00004078|Irinotecan|irinotecan|mesh-list
6318719|NCT00004078|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6318720|NCT00004078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6318721|NCT00004078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6318722|NCT00004078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318723|NCT00004078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318724|NCT00004081|Docetaxel|docetaxel|mesh-list
6318725|NCT00004081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318726|NCT00004081|Tubulin Modulators|tubulin modulators|mesh-ancestor
6318727|NCT00004081|Antimitotic Agents|antimitotic agents|mesh-ancestor
6318728|NCT00004081|Mitosis Modulators|mitosis modulators|mesh-ancestor
6318729|NCT00004081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318730|NCT00004082|Gemcitabine|gemcitabine|mesh-list
6318731|NCT00004082|Carboplatin|carboplatin|mesh-list
6318732|NCT00004082|Docetaxel|docetaxel|mesh-list
6318733|NCT00004082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318734|NCT00004082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6318735|NCT00004082|Antimetabolites|antimetabolites|mesh-ancestor
6318736|NCT00004082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318737|NCT00004082|Antiviral Agents|antiviral agents|mesh-ancestor
6318738|NCT00004082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6318739|NCT00004082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6318740|NCT00004082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6318741|NCT00004082|Immunologic Factors|immunologic factors|mesh-ancestor
6318742|NCT00004082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6318743|NCT00004082|Tubulin Modulators|tubulin modulators|mesh-ancestor
6318744|NCT00004082|Antimitotic Agents|antimitotic agents|mesh-ancestor
6318745|NCT00004082|Mitosis Modulators|mitosis modulators|mesh-ancestor
6318746|NCT00004083|Cisplatin|cisplatin|mesh-list
6318747|NCT00004083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318748|NCT00004084|Epratuzumab|epratuzumab|mesh-list
6318749|NCT00004084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6318750|NCT00004084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318751|NCT00004085|Antibodies|antibodies|mesh-list
6318752|NCT00004085|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6318753|NCT00004085|Immunologic Factors|immunologic factors|mesh-ancestor
6318754|NCT00004085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6318755|NCT00004086|Cytarabine|cytarabine|mesh-list
6318756|NCT00004086|Etoposide|etoposide|mesh-list
6318757|NCT00004086|Ifosfamide|ifosfamide|mesh-list
6318758|NCT00004086|Epratuzumab|epratuzumab|mesh-list
6318759|NCT00004086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318760|NCT00004086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6318761|NCT00004086|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6318762|NCT00004086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6318763|NCT00004086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6318764|NCT00004086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318765|NCT00004086|Immunologic Factors|immunologic factors|mesh-ancestor
6318766|NCT00004086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6318767|NCT00004086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6318768|NCT00004086|Antimetabolites|antimetabolites|mesh-ancestor
6318769|NCT00004086|Antiviral Agents|antiviral agents|mesh-ancestor
6318770|NCT00004086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6318771|NCT00004086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6318772|NCT00004086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6318773|NCT00004086|Alkylating Agents|alkylating agents|mesh-ancestor
6318774|NCT00004086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6318775|NCT00004087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6318776|NCT00004087|Antibodies|antibodies|mesh-list
6318777|NCT00004087|Immunoglobulins|immunoglobulins|mesh-list
6318778|NCT00004087|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6318779|NCT00004087|Immunologic Factors|immunologic factors|mesh-ancestor
6318780|NCT00004087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6318781|NCT00004087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318782|NCT00004089|Paclitaxel|paclitaxel|mesh-list
6318783|NCT00004089|Fluorouracil|fluorouracil|mesh-list
6318784|NCT00004089|Hydroxyurea|hydroxyurea|mesh-list
6318785|NCT00004089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6318786|NCT00004089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318787|NCT00004089|Tubulin Modulators|tubulin modulators|mesh-ancestor
6318788|NCT00004089|Antimitotic Agents|antimitotic agents|mesh-ancestor
6318789|NCT00004089|Mitosis Modulators|mitosis modulators|mesh-ancestor
6318790|NCT00004089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318791|NCT00004089|Antimetabolites|antimetabolites|mesh-ancestor
6318792|NCT00004089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6318793|NCT00004089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6318794|NCT00004089|Immunologic Factors|immunologic factors|mesh-ancestor
6318795|NCT00004089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6318796|NCT00004089|Antisickling Agents|antisickling agents|mesh-ancestor
6318797|NCT00004089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6318798|NCT00004089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6318799|NCT00004090|Gemcitabine|gemcitabine|mesh-list
6318800|NCT00004090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318801|NCT00004090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6318802|NCT00004090|Antimetabolites|antimetabolites|mesh-ancestor
6318803|NCT00004090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318804|NCT00004090|Antiviral Agents|antiviral agents|mesh-ancestor
6318805|NCT00004090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6318806|NCT00004090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6318807|NCT00004090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6318808|NCT00004090|Immunologic Factors|immunologic factors|mesh-ancestor
6318809|NCT00004090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6318810|NCT00004091|Antibodies|antibodies|mesh-list
6318811|NCT00004091|Immunologic Factors|immunologic factors|mesh-ancestor
6318812|NCT00004091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6318813|NCT00004094|Paclitaxel|paclitaxel|mesh-list
6318814|NCT00004094|Carboplatin|carboplatin|mesh-list
6318815|NCT00004094|Fluorouracil|fluorouracil|mesh-list
6318816|NCT00004094|Hydroxyurea|hydroxyurea|mesh-list
6318817|NCT00004094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6318818|NCT00004094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318819|NCT00004094|Tubulin Modulators|tubulin modulators|mesh-ancestor
6318820|NCT00004094|Antimitotic Agents|antimitotic agents|mesh-ancestor
6318821|NCT00004094|Mitosis Modulators|mitosis modulators|mesh-ancestor
6318822|NCT00004094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318823|NCT00004094|Antimetabolites|antimetabolites|mesh-ancestor
6318824|NCT00004094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6318825|NCT00004094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6318826|NCT00004094|Immunologic Factors|immunologic factors|mesh-ancestor
6318827|NCT00004094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6318828|NCT00004094|Antisickling Agents|antisickling agents|mesh-ancestor
6318829|NCT00004094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6318830|NCT00004094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6392753|NCT00197743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392754|NCT00197743|Protective Agents|protective agents|mesh-ancestor
6392755|NCT00197743|Provitamins|provitamins|mesh-ancestor
6392756|NCT00197756|Vitamins|vitamins|mesh-list
6392757|NCT00197756|Vitamin A|vitamin a|mesh-list
6392758|NCT00197756|Retinol palmitate|retinol palmitate|mesh-list
6392759|NCT00197756|Micronutrients|micronutrients|mesh-ancestor
6392760|NCT00197756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392761|NCT00197756|Antioxidants|antioxidants|mesh-ancestor
6392762|NCT00197756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318831|NCT00004095|Gemcitabine|gemcitabine|mesh-list
6318832|NCT00004095|Irinotecan|irinotecan|mesh-list
6318833|NCT00004095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6318834|NCT00004095|Antimetabolites|antimetabolites|mesh-ancestor
6318835|NCT00004095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318836|NCT00004095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318837|NCT00004095|Antiviral Agents|antiviral agents|mesh-ancestor
6318838|NCT00004095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6318839|NCT00004095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6318840|NCT00004095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6318841|NCT00004095|Immunologic Factors|immunologic factors|mesh-ancestor
6318842|NCT00004095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6318843|NCT00004095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6318844|NCT00004095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6318845|NCT00004097|Gemcitabine|gemcitabine|mesh-list
6318846|NCT00004097|Paclitaxel|paclitaxel|mesh-list
6318847|NCT00004097|Fluorouracil|fluorouracil|mesh-list
6318848|NCT00004097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6318849|NCT00004097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318850|NCT00004097|Tubulin Modulators|tubulin modulators|mesh-ancestor
6318851|NCT00004097|Antimitotic Agents|antimitotic agents|mesh-ancestor
6318852|NCT00004097|Mitosis Modulators|mitosis modulators|mesh-ancestor
6318853|NCT00004097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318854|NCT00004097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6318855|NCT00004097|Antimetabolites|antimetabolites|mesh-ancestor
6318856|NCT00004097|Antiviral Agents|antiviral agents|mesh-ancestor
6318857|NCT00004097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6318858|NCT00004097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6318859|NCT00004097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6318860|NCT00004097|Immunologic Factors|immunologic factors|mesh-ancestor
6318861|NCT00004097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6318862|NCT00004099|Leucovorin|leucovorin|mesh-list
6318863|NCT00004099|Fluorouracil|fluorouracil|mesh-list
6318864|NCT00004099|Calcium|calcium|mesh-list
6318865|NCT00004099|Levoleucovorin|levoleucovorin|mesh-list
6318866|NCT00004099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318867|NCT00004099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6318868|NCT00004099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6318869|NCT00004099|Antimetabolites|antimetabolites|mesh-ancestor
6318870|NCT00004099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318871|NCT00004099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6318872|NCT00004099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6318873|NCT00004099|Immunologic Factors|immunologic factors|mesh-ancestor
6318874|NCT00004099|Antidotes|antidotes|mesh-ancestor
6318875|NCT00004099|Protective Agents|protective agents|mesh-ancestor
6318876|NCT00004099|Vitamin B Complex|vitamin b complex|mesh-ancestor
6318877|NCT00004099|Vitamins|vitamins|mesh-ancestor
6318878|NCT00004099|Micronutrients|micronutrients|mesh-ancestor
6318879|NCT00004100|Gemcitabine|gemcitabine|mesh-list
6318880|NCT00004100|Vinorelbine|vinorelbine|mesh-list
6318881|NCT00004100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318882|NCT00004100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6318883|NCT00004100|Antimetabolites|antimetabolites|mesh-ancestor
6318884|NCT00004100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318885|NCT00004100|Antiviral Agents|antiviral agents|mesh-ancestor
6318886|NCT00004100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6318887|NCT00004100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6318888|NCT00004100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6318889|NCT00004100|Immunologic Factors|immunologic factors|mesh-ancestor
6318890|NCT00004100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6318891|NCT00004100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6318892|NCT00004100|Tubulin Modulators|tubulin modulators|mesh-ancestor
6318893|NCT00004100|Antimitotic Agents|antimitotic agents|mesh-ancestor
6318894|NCT00004100|Mitosis Modulators|mitosis modulators|mesh-ancestor
6318895|NCT00004102|Leucovorin|leucovorin|mesh-list
6318896|NCT00004102|Fluorouracil|fluorouracil|mesh-list
6318897|NCT00004102|Oxaliplatin|oxaliplatin|mesh-list
6318898|NCT00004102|Calcium|calcium|mesh-list
6318899|NCT00004102|Levoleucovorin|levoleucovorin|mesh-list
6318900|NCT00004102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6318901|NCT00004102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6318902|NCT00004102|Antimetabolites|antimetabolites|mesh-ancestor
6318903|NCT00004102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318904|NCT00004102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6318905|NCT00004102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318906|NCT00004102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6318907|NCT00004102|Immunologic Factors|immunologic factors|mesh-ancestor
6318908|NCT00004102|Antidotes|antidotes|mesh-ancestor
6318909|NCT00004102|Protective Agents|protective agents|mesh-ancestor
6318910|NCT00004102|Vitamin B Complex|vitamin b complex|mesh-ancestor
6318911|NCT00004102|Vitamins|vitamins|mesh-ancestor
6318912|NCT00004102|Micronutrients|micronutrients|mesh-ancestor
6318913|NCT00004103|Irinotecan|irinotecan|mesh-list
6318914|NCT00004103|Floxuridine|floxuridine|mesh-list
6318915|NCT00004103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318916|NCT00004103|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6318917|NCT00004103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6318918|NCT00004103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6318919|NCT00004103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318920|NCT00004103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6318921|NCT00004103|Antimetabolites|antimetabolites|mesh-ancestor
6318922|NCT00004104|Interferons|interferons|mesh-list
6318923|NCT00004104|Interferon-alpha|interferon-alpha|mesh-list
6318924|NCT00004104|Interleukin-2|interleukin-2|mesh-list
6318925|NCT00004104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318926|NCT00004104|Antiviral Agents|antiviral agents|mesh-ancestor
6318927|NCT00004104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6318928|NCT00004104|Immunologic Factors|immunologic factors|mesh-ancestor
6318929|NCT00004104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6318930|NCT00004104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6318931|NCT00004104|Analgesics|analgesics|mesh-ancestor
6318932|NCT00004104|Sensory System Agents|sensory system agents|mesh-ancestor
6318933|NCT00004104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6318934|NCT00004105|Paclitaxel|paclitaxel|mesh-list
6318935|NCT00004105|Vinorelbine|vinorelbine|mesh-list
6318936|NCT00004105|Estramustine|estramustine|mesh-list
6318937|NCT00004105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6318938|NCT00004105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318939|NCT00004105|Tubulin Modulators|tubulin modulators|mesh-ancestor
6318940|NCT00004105|Antimitotic Agents|antimitotic agents|mesh-ancestor
6318941|NCT00004105|Mitosis Modulators|mitosis modulators|mesh-ancestor
6318942|NCT00004105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318943|NCT00004105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6318944|NCT00004105|Alkylating Agents|alkylating agents|mesh-ancestor
6318945|NCT00004105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6318946|NCT00004107|Epratuzumab|epratuzumab|mesh-list
6318947|NCT00004107|Antibodies|antibodies|mesh-list
6318948|NCT00004107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6318949|NCT00004107|Immunologic Factors|immunologic factors|mesh-ancestor
6318950|NCT00004107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6318951|NCT00004107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6318952|NCT00004107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318953|NCT00004108|Exatecan|exatecan|mesh-list
6318954|NCT00004108|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6318955|NCT00004108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6318956|NCT00004108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6318957|NCT00004108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318958|NCT00004108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318959|NCT00004109|Doxorubicin|doxorubicin|mesh-list
6318960|NCT00004109|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6318961|NCT00004109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6318962|NCT00004109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318963|NCT00004109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6318964|NCT00004109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6318965|NCT00004109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6318966|NCT00004109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318967|NCT00004110|Etoposide|etoposide|mesh-list
6318968|NCT00004110|Isotretinoin|isotretinoin|mesh-list
6318969|NCT00004110|Antibodies|antibodies|mesh-list
6318970|NCT00004110|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6318971|NCT00004110|Immunologic Factors|immunologic factors|mesh-ancestor
6318972|NCT00004110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6318973|NCT00004110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6318974|NCT00004110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318975|NCT00004110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6318976|NCT00004110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6318977|NCT00004110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6318978|NCT00004110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318979|NCT00004110|Dermatologic Agents|dermatologic agents|mesh-ancestor
6318980|NCT00004112|Prednisone|prednisone|mesh-list
6318981|NCT00004112|Cyclophosphamide|cyclophosphamide|mesh-list
6318982|NCT00004112|Rituximab|rituximab|mesh-list
6318983|NCT00004112|Doxorubicin|doxorubicin|mesh-list
6318984|NCT00004112|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6318985|NCT00004112|Vincristine|vincristine|mesh-list
6318986|NCT00004112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6318987|NCT00004112|Immunologic Factors|immunologic factors|mesh-ancestor
6318988|NCT00004112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6318989|NCT00004112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6318990|NCT00004112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6318991|NCT00004112|Alkylating Agents|alkylating agents|mesh-ancestor
6318992|NCT00004112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6318993|NCT00004112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6318994|NCT00004112|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6318995|NCT00004112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6318996|NCT00004112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6318997|NCT00004112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6318998|NCT00004112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6318999|NCT00004112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6319000|NCT00004112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6319001|NCT00004112|Glucocorticoids|glucocorticoids|mesh-ancestor
6319002|NCT00004112|Hormones|hormones|mesh-ancestor
6319003|NCT00004112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6319004|NCT00004112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6319005|NCT00004112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6319006|NCT00004112|Tubulin Modulators|tubulin modulators|mesh-ancestor
6319007|NCT00004112|Antimitotic Agents|antimitotic agents|mesh-ancestor
6319008|NCT00004112|Mitosis Modulators|mitosis modulators|mesh-ancestor
6319009|NCT00004113|Temozolomide|temozolomide|mesh-list
6319010|NCT00004113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6319011|NCT00004113|Alkylating Agents|alkylating agents|mesh-ancestor
6319012|NCT00004113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319013|NCT00004113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319014|NCT00004114|Cytarabine|cytarabine|mesh-list
6319015|NCT00004114|Cyclophosphamide|cyclophosphamide|mesh-list
6319016|NCT00004114|Fludarabine|fludarabine|mesh-list
6319017|NCT00004114|Fludarabine phosphate|fludarabine phosphate|mesh-list
6319018|NCT00004114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6319019|NCT00004114|Immunologic Factors|immunologic factors|mesh-ancestor
6319020|NCT00004114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6319021|NCT00004114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6319022|NCT00004114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6319023|NCT00004114|Alkylating Agents|alkylating agents|mesh-ancestor
6319024|NCT00004114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319025|NCT00004114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319026|NCT00004114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6319027|NCT00004114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6319028|NCT00004114|Antimetabolites|antimetabolites|mesh-ancestor
6319029|NCT00004114|Antiviral Agents|antiviral agents|mesh-ancestor
6319030|NCT00004114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6319031|NCT00004115|Antibodies|antibodies|mesh-list
6319032|NCT00004115|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6319033|NCT00004115|Immunologic Factors|immunologic factors|mesh-ancestor
6319034|NCT00004115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6319035|NCT00004122|Interferons|interferons|mesh-list
6319036|NCT00004122|Interferon-alpha|interferon-alpha|mesh-list
6319037|NCT00004122|BCG Vaccine|bcg vaccine|mesh-list
6319038|NCT00004122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319039|NCT00004122|Antiviral Agents|antiviral agents|mesh-ancestor
6319040|NCT00004122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6319041|NCT00004122|Immunologic Factors|immunologic factors|mesh-ancestor
6319042|NCT00004122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6319043|NCT00004122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6319044|NCT00004123|Doxorubicin|doxorubicin|mesh-list
6319045|NCT00004123|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6319046|NCT00004123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6319047|NCT00004123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319048|NCT00004123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6319049|NCT00004123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6319050|NCT00004123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6319051|NCT00004123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319052|NCT00004125|Tamoxifen|tamoxifen|mesh-list
6319053|NCT00004125|Paclitaxel|paclitaxel|mesh-list
6319054|NCT00004125|Docetaxel|docetaxel|mesh-list
6319055|NCT00004125|Cyclophosphamide|cyclophosphamide|mesh-list
6319056|NCT00004125|Doxorubicin|doxorubicin|mesh-list
6319057|NCT00004125|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6319058|NCT00004125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6319059|NCT00004125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319060|NCT00004125|Tubulin Modulators|tubulin modulators|mesh-ancestor
6319061|NCT00004125|Antimitotic Agents|antimitotic agents|mesh-ancestor
6319062|NCT00004125|Mitosis Modulators|mitosis modulators|mesh-ancestor
6319063|NCT00004125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319064|NCT00004125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6319065|NCT00004125|Immunologic Factors|immunologic factors|mesh-ancestor
6319066|NCT00004125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6319067|NCT00004125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6319068|NCT00004125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6319069|NCT00004125|Alkylating Agents|alkylating agents|mesh-ancestor
6319070|NCT00004125|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6319071|NCT00004125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6319072|NCT00004125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6319073|NCT00004125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6319074|NCT00004125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6319075|NCT00004125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6319076|NCT00004125|Hormone Antagonists|hormone antagonists|mesh-ancestor
6319077|NCT00004125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6319078|NCT00004125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6319079|NCT00004125|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6319080|NCT00004125|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6319081|NCT00004125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6319082|NCT00004126|Paclitaxel|paclitaxel|mesh-list
6319083|NCT00004126|Oxaliplatin|oxaliplatin|mesh-list
6319084|NCT00004126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6319085|NCT00004126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319086|NCT00004126|Tubulin Modulators|tubulin modulators|mesh-ancestor
6319087|NCT00004126|Antimitotic Agents|antimitotic agents|mesh-ancestor
6319088|NCT00004126|Mitosis Modulators|mitosis modulators|mesh-ancestor
6319089|NCT00004126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319090|NCT00004127|Leucovorin|leucovorin|mesh-list
6319091|NCT00004127|Fluorouracil|fluorouracil|mesh-list
6319092|NCT00004127|Oxaliplatin|oxaliplatin|mesh-list
6319093|NCT00004127|Calcium|calcium|mesh-list
6319094|NCT00004127|Levoleucovorin|levoleucovorin|mesh-list
6319095|NCT00004127|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6319096|NCT00004127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6319097|NCT00004127|Antimetabolites|antimetabolites|mesh-ancestor
6319098|NCT00004127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319099|NCT00004127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6319100|NCT00004127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319101|NCT00004127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6319102|NCT00004127|Immunologic Factors|immunologic factors|mesh-ancestor
6319103|NCT00004127|Antidotes|antidotes|mesh-ancestor
6319104|NCT00004127|Protective Agents|protective agents|mesh-ancestor
6319105|NCT00004127|Vitamin B Complex|vitamin b complex|mesh-ancestor
6319106|NCT00004127|Vitamins|vitamins|mesh-ancestor
6319107|NCT00004127|Micronutrients|micronutrients|mesh-ancestor
6016496|NCT00365391|Growth Substances|growth substances|mesh-ancestor
6016497|NCT00365391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016498|NCT00365391|Growth Inhibitors|growth inhibitors|mesh-ancestor
6319108|NCT00004128|Cytarabine|cytarabine|mesh-list
6319109|NCT00004128|Aldesleukin|aldesleukin|mesh-list
6319110|NCT00004128|Cyclophosphamide|cyclophosphamide|mesh-list
6319111|NCT00004128|Busulfan|busulfan|mesh-list
6319112|NCT00004128|Etoposide|etoposide|mesh-list
6319113|NCT00004128|Daunorubicin|daunorubicin|mesh-list
6319114|NCT00004128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6319115|NCT00004128|Immunologic Factors|immunologic factors|mesh-ancestor
6319116|NCT00004128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6319117|NCT00004128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6319118|NCT00004128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6319119|NCT00004128|Alkylating Agents|alkylating agents|mesh-ancestor
6319120|NCT00004128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319121|NCT00004128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319122|NCT00004128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6319123|NCT00004128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6319124|NCT00004128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6319125|NCT00004128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6319126|NCT00004128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6319127|NCT00004128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6319128|NCT00004128|Antimetabolites|antimetabolites|mesh-ancestor
6319129|NCT00004128|Antiviral Agents|antiviral agents|mesh-ancestor
6319130|NCT00004128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6319131|NCT00004128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6319132|NCT00004128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6319133|NCT00004128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6319134|NCT00004132|Cyclophosphamide|cyclophosphamide|mesh-list
6319135|NCT00004132|Ifosfamide|ifosfamide|mesh-list
6319136|NCT00004132|Etoposide|etoposide|mesh-list
6319137|NCT00004132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6319138|NCT00004132|Immunologic Factors|immunologic factors|mesh-ancestor
6319139|NCT00004132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6319140|NCT00004132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6319141|NCT00004132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6319142|NCT00004132|Alkylating Agents|alkylating agents|mesh-ancestor
6319143|NCT00004132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319144|NCT00004132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319145|NCT00004132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6319146|NCT00004132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6319147|NCT00004132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6319148|NCT00004132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6319149|NCT00004132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6319150|NCT00004135|Cyclophosphamide|cyclophosphamide|mesh-list
6319151|NCT00004135|Fludarabine|fludarabine|mesh-list
6319152|NCT00004135|Fludarabine phosphate|fludarabine phosphate|mesh-list
6319153|NCT00004135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6319154|NCT00004135|Immunologic Factors|immunologic factors|mesh-ancestor
6319155|NCT00004135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6319156|NCT00004135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6319157|NCT00004135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6319158|NCT00004135|Alkylating Agents|alkylating agents|mesh-ancestor
6319159|NCT00004135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319160|NCT00004135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319161|NCT00004135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6319162|NCT00004135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6319163|NCT00004135|Antimetabolites|antimetabolites|mesh-ancestor
6319164|NCT00004137|Paclitaxel|paclitaxel|mesh-list
6319165|NCT00004137|Carboplatin|carboplatin|mesh-list
6319166|NCT00004137|Topotecan|topotecan|mesh-list
6319167|NCT00004137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6319168|NCT00004137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319169|NCT00004137|Tubulin Modulators|tubulin modulators|mesh-ancestor
6319170|NCT00004137|Antimitotic Agents|antimitotic agents|mesh-ancestor
6319171|NCT00004137|Mitosis Modulators|mitosis modulators|mesh-ancestor
6319172|NCT00004137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319173|NCT00004137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6319174|NCT00004137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6319175|NCT00004137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6319176|NCT00004138|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6319177|NCT00004138|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6319178|NCT00004138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319179|NCT00004139|Gemcitabine|gemcitabine|mesh-list
6319180|NCT00004139|Docetaxel|docetaxel|mesh-list
6319181|NCT00004139|Irinotecan|irinotecan|mesh-list
6319182|NCT00004139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6319183|NCT00004139|Antimetabolites|antimetabolites|mesh-ancestor
6319184|NCT00004139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319185|NCT00004139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319186|NCT00004139|Antiviral Agents|antiviral agents|mesh-ancestor
6319187|NCT00004139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6319188|NCT00004139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6319189|NCT00004139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6319190|NCT00004139|Immunologic Factors|immunologic factors|mesh-ancestor
6319191|NCT00004139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6319192|NCT00004139|Tubulin Modulators|tubulin modulators|mesh-ancestor
6319193|NCT00004139|Antimitotic Agents|antimitotic agents|mesh-ancestor
6319194|NCT00004139|Mitosis Modulators|mitosis modulators|mesh-ancestor
6319195|NCT00004139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6319196|NCT00004139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6319197|NCT00004141|Dacarbazine|dacarbazine|mesh-list
6319198|NCT00004141|Molgramostim|molgramostim|mesh-list
6319199|NCT00004141|Sargramostim|sargramostim|mesh-list
6319200|NCT00004141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319201|NCT00004141|Immunologic Factors|immunologic factors|mesh-ancestor
6319202|NCT00004141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6319203|NCT00004141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6319204|NCT00004141|Alkylating Agents|alkylating agents|mesh-ancestor
6319205|NCT00004141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319206|NCT00004142|Fluorouracil|fluorouracil|mesh-list
6319207|NCT00004142|Floxuridine|floxuridine|mesh-list
6319208|NCT00004142|Antimetabolites|antimetabolites|mesh-ancestor
6319209|NCT00004142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319210|NCT00004142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6319211|NCT00004142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319212|NCT00004142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6319213|NCT00004142|Immunologic Factors|immunologic factors|mesh-ancestor
6319214|NCT00004142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6319215|NCT00004144|Gemcitabine|gemcitabine|mesh-list
6319216|NCT00004144|Bryostatin 1|bryostatin 1|mesh-list
6319217|NCT00004144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6319218|NCT00004144|Antimetabolites|antimetabolites|mesh-ancestor
6319219|NCT00004144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319220|NCT00004144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319221|NCT00004144|Antiviral Agents|antiviral agents|mesh-ancestor
6319222|NCT00004144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6319223|NCT00004144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6319224|NCT00004144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6319225|NCT00004144|Immunologic Factors|immunologic factors|mesh-ancestor
6319226|NCT00004144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6319227|NCT00004144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6319228|NCT00004145|Cyclophosphamide|cyclophosphamide|mesh-list
6319229|NCT00004145|Fludarabine|fludarabine|mesh-list
6319230|NCT00004145|Fludarabine phosphate|fludarabine phosphate|mesh-list
6319231|NCT00004145|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6319232|NCT00004145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6319233|NCT00004145|Immunologic Factors|immunologic factors|mesh-ancestor
6319234|NCT00004145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6319235|NCT00004145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6319236|NCT00004145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6319237|NCT00004145|Alkylating Agents|alkylating agents|mesh-ancestor
6319238|NCT00004145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319239|NCT00004145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319240|NCT00004145|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6319241|NCT00004145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6319242|NCT00004145|Antimetabolites|antimetabolites|mesh-ancestor
6319243|NCT00004149|Arsenic Trioxide|arsenic trioxide|mesh-list
6319244|NCT00004149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319245|NCT00004150|Leucovorin|leucovorin|mesh-list
6319246|NCT00004150|Fluorouracil|fluorouracil|mesh-list
6319247|NCT00004150|Calcium|calcium|mesh-list
6319248|NCT00004150|Levoleucovorin|levoleucovorin|mesh-list
6319249|NCT00004150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6319250|NCT00004150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6319251|NCT00004150|Antimetabolites|antimetabolites|mesh-ancestor
6319252|NCT00004150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319253|NCT00004150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6319254|NCT00004150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319255|NCT00004150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6319256|NCT00004150|Immunologic Factors|immunologic factors|mesh-ancestor
6319257|NCT00004150|Antidotes|antidotes|mesh-ancestor
6319258|NCT00004150|Protective Agents|protective agents|mesh-ancestor
6319259|NCT00004150|Vitamin B Complex|vitamin b complex|mesh-ancestor
6319260|NCT00004150|Vitamins|vitamins|mesh-ancestor
6319261|NCT00004150|Micronutrients|micronutrients|mesh-ancestor
6319262|NCT00004152|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6319263|NCT00004152|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6319264|NCT00004152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319265|NCT00004154|Fenretinide|fenretinide|mesh-list
6319266|NCT00004154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319267|NCT00004154|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6319268|NCT00004154|Protective Agents|protective agents|mesh-ancestor
6319269|NCT00004154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6319270|NCT00004157|Oprelvekin|oprelvekin|mesh-list
6319271|NCT00004157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319272|NCT00004158|Melphalan|melphalan|mesh-list
6319273|NCT00004158|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6319274|NCT00004158|Alkylating Agents|alkylating agents|mesh-ancestor
6319275|NCT00004158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319276|NCT00004158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319277|NCT00004158|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6319278|NCT00004158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6319279|NCT00004158|Immunologic Factors|immunologic factors|mesh-ancestor
6319280|NCT00004158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6319281|NCT00004159|Gemcitabine|gemcitabine|mesh-list
6319282|NCT00004159|Paclitaxel|paclitaxel|mesh-list
6319283|NCT00004159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6319284|NCT00004159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319285|NCT00004159|Tubulin Modulators|tubulin modulators|mesh-ancestor
6319286|NCT00004159|Antimitotic Agents|antimitotic agents|mesh-ancestor
6319287|NCT00004159|Mitosis Modulators|mitosis modulators|mesh-ancestor
6319288|NCT00004159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319289|NCT00004159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6319290|NCT00004159|Antimetabolites|antimetabolites|mesh-ancestor
6319291|NCT00004159|Antiviral Agents|antiviral agents|mesh-ancestor
6319292|NCT00004159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6319293|NCT00004159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6319294|NCT00004159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6319295|NCT00004159|Immunologic Factors|immunologic factors|mesh-ancestor
6319296|NCT00004159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6319297|NCT00004160|Gemcitabine|gemcitabine|mesh-list
6319298|NCT00004160|Paclitaxel|paclitaxel|mesh-list
6319299|NCT00004160|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6319300|NCT00004160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319301|NCT00004160|Tubulin Modulators|tubulin modulators|mesh-ancestor
6319302|NCT00004160|Antimitotic Agents|antimitotic agents|mesh-ancestor
6319303|NCT00004160|Mitosis Modulators|mitosis modulators|mesh-ancestor
6319304|NCT00004160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319305|NCT00004160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6319306|NCT00004160|Antimetabolites|antimetabolites|mesh-ancestor
6319307|NCT00004160|Antiviral Agents|antiviral agents|mesh-ancestor
6319308|NCT00004160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6319309|NCT00004160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6319310|NCT00004160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6319311|NCT00004160|Immunologic Factors|immunologic factors|mesh-ancestor
6319312|NCT00004160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6319313|NCT00004161|Fenretinide|fenretinide|mesh-list
6319314|NCT00004161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319315|NCT00004161|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6319316|NCT00004161|Protective Agents|protective agents|mesh-ancestor
6319317|NCT00004161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6319318|NCT00004162|Doxorubicin|doxorubicin|mesh-list
6319319|NCT00004162|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6319320|NCT00004162|Methotrexate|methotrexate|mesh-list
6319321|NCT00004162|Vincristine|vincristine|mesh-list
6319322|NCT00004162|Sargramostim|sargramostim|mesh-list
6319323|NCT00004162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6319324|NCT00004162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319325|NCT00004162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6319326|NCT00004162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6319327|NCT00004162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6319328|NCT00004162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319329|NCT00004162|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6319330|NCT00004162|Abortifacient Agents|abortifacient agents|mesh-ancestor
6319331|NCT00004162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6319332|NCT00004162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6319333|NCT00004162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6319334|NCT00004162|Antimetabolites|antimetabolites|mesh-ancestor
6319335|NCT00004162|Dermatologic Agents|dermatologic agents|mesh-ancestor
6319336|NCT00004162|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6319337|NCT00004162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6319338|NCT00004162|Immunologic Factors|immunologic factors|mesh-ancestor
6319339|NCT00004162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6319340|NCT00004162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6319341|NCT00004162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6319342|NCT00004162|Tubulin Modulators|tubulin modulators|mesh-ancestor
6319343|NCT00004162|Antimitotic Agents|antimitotic agents|mesh-ancestor
6319344|NCT00004162|Mitosis Modulators|mitosis modulators|mesh-ancestor
6319345|NCT00004163|Trastuzumab|trastuzumab|mesh-list
6319346|NCT00004163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6319347|NCT00004163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319348|NCT00004164|Leucovorin|leucovorin|mesh-list
6319349|NCT00004164|Docetaxel|docetaxel|mesh-list
6319350|NCT00004164|Fluorouracil|fluorouracil|mesh-list
6319351|NCT00004164|Calcium|calcium|mesh-list
6319352|NCT00004164|Levoleucovorin|levoleucovorin|mesh-list
6319353|NCT00004164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319354|NCT00004164|Tubulin Modulators|tubulin modulators|mesh-ancestor
6319355|NCT00004164|Antimitotic Agents|antimitotic agents|mesh-ancestor
6319356|NCT00004164|Mitosis Modulators|mitosis modulators|mesh-ancestor
6319357|NCT00004164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319358|NCT00004164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6319359|NCT00004164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6319360|NCT00004164|Antimetabolites|antimetabolites|mesh-ancestor
6319361|NCT00004164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6319362|NCT00004164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6319363|NCT00004164|Immunologic Factors|immunologic factors|mesh-ancestor
6319364|NCT00004164|Antidotes|antidotes|mesh-ancestor
6319365|NCT00004164|Protective Agents|protective agents|mesh-ancestor
6319366|NCT00004164|Vitamin B Complex|vitamin b complex|mesh-ancestor
6319367|NCT00004164|Vitamins|vitamins|mesh-ancestor
6319368|NCT00004164|Micronutrients|micronutrients|mesh-ancestor
6319369|NCT00004173|Paclitaxel|paclitaxel|mesh-list
6319370|NCT00004173|Oxaliplatin|oxaliplatin|mesh-list
6319371|NCT00004173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6319372|NCT00004173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319373|NCT00004173|Tubulin Modulators|tubulin modulators|mesh-ancestor
6319374|NCT00004173|Antimitotic Agents|antimitotic agents|mesh-ancestor
6319375|NCT00004173|Mitosis Modulators|mitosis modulators|mesh-ancestor
6319376|NCT00004173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319377|NCT00004174|Paclitaxel|paclitaxel|mesh-list
6319378|NCT00004174|Cyclophosphamide|cyclophosphamide|mesh-list
6319379|NCT00004174|Thiotepa|thiotepa|mesh-list
6319380|NCT00004174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6319381|NCT00004174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319382|NCT00004174|Tubulin Modulators|tubulin modulators|mesh-ancestor
6319383|NCT00004174|Antimitotic Agents|antimitotic agents|mesh-ancestor
6319384|NCT00004174|Mitosis Modulators|mitosis modulators|mesh-ancestor
6319385|NCT00004174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319386|NCT00004174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6319387|NCT00004174|Immunologic Factors|immunologic factors|mesh-ancestor
6319388|NCT00004174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6319389|NCT00004174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6319390|NCT00004174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6319391|NCT00004174|Alkylating Agents|alkylating agents|mesh-ancestor
6319392|NCT00004174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6319393|NCT00004176|Etoposide|etoposide|mesh-list
6319394|NCT00004176|Amifostine|amifostine|mesh-list
6319395|NCT00004176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319396|NCT00004176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6319397|NCT00004176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6319398|NCT00004176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6319399|NCT00004176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6319400|NCT00004176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319401|NCT00004176|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6319402|NCT00004176|Protective Agents|protective agents|mesh-ancestor
6319403|NCT00004176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6319404|NCT00004177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6319405|NCT00004177|Antibodies|antibodies|mesh-list
6319406|NCT00004177|Immunoglobulins|immunoglobulins|mesh-list
6319407|NCT00004177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6319408|NCT00004177|Immunologic Factors|immunologic factors|mesh-ancestor
6319409|NCT00004177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6319410|NCT00004177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319411|NCT00004179|Prednisone|prednisone|mesh-list
6319412|NCT00004179|Cyclophosphamide|cyclophosphamide|mesh-list
6319413|NCT00004179|Rituximab|rituximab|mesh-list
6319414|NCT00004179|Doxorubicin|doxorubicin|mesh-list
6319415|NCT00004179|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6319416|NCT00004179|Vincristine|vincristine|mesh-list
6319417|NCT00004179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6319418|NCT00004179|Immunologic Factors|immunologic factors|mesh-ancestor
6319419|NCT00004179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6319420|NCT00004179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6319421|NCT00004179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6319422|NCT00004179|Alkylating Agents|alkylating agents|mesh-ancestor
6319423|NCT00004179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319424|NCT00004179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319425|NCT00004179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6319426|NCT00004179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6319427|NCT00004179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6319428|NCT00004179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6319429|NCT00004179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6319430|NCT00004179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6319431|NCT00004179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6319432|NCT00004179|Glucocorticoids|glucocorticoids|mesh-ancestor
6319433|NCT00004179|Hormones|hormones|mesh-ancestor
6319434|NCT00004179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6319435|NCT00004179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6319436|NCT00004179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6319437|NCT00004179|Tubulin Modulators|tubulin modulators|mesh-ancestor
6319438|NCT00004179|Antimitotic Agents|antimitotic agents|mesh-ancestor
6319439|NCT00004179|Mitosis Modulators|mitosis modulators|mesh-ancestor
6319440|NCT00004180|Rosiglitazone|rosiglitazone|mesh-list
6319441|NCT00004180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6319442|NCT00004180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6319443|NCT00004183|Capecitabine|capecitabine|mesh-list
6319444|NCT00004183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6319445|NCT00004183|Antimetabolites|antimetabolites|mesh-ancestor
6319446|NCT00004183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319447|NCT00004183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319448|NCT00004184|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6319449|NCT00004184|Antibodies|antibodies|mesh-list
6319450|NCT00004184|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6319451|NCT00004184|Sargramostim|sargramostim|mesh-list
6319452|NCT00004184|Aluminum sulfate|aluminum sulfate|mesh-list
6319453|NCT00004184|Immunologic Factors|immunologic factors|mesh-ancestor
6319454|NCT00004184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6319455|NCT00004184|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6319456|NCT00004184|Antacids|antacids|mesh-ancestor
6319457|NCT00004184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319458|NCT00004184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6319459|NCT00004186|Carboplatin|carboplatin|mesh-list
6319460|NCT00004186|Etoposide|etoposide|mesh-list
6319461|NCT00004186|Topotecan|topotecan|mesh-list
6319462|NCT00004186|Ifosfamide|ifosfamide|mesh-list
6319463|NCT00004186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319464|NCT00004186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6319465|NCT00004186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6319466|NCT00004186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6319467|NCT00004186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6319468|NCT00004186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319469|NCT00004186|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6319470|NCT00004186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6319471|NCT00004186|Alkylating Agents|alkylating agents|mesh-ancestor
6319472|NCT00004187|Capecitabine|capecitabine|mesh-list
6319473|NCT00004187|Oxaliplatin|oxaliplatin|mesh-list
6319474|NCT00004187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6319475|NCT00004187|Antimetabolites|antimetabolites|mesh-ancestor
6319476|NCT00004187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319477|NCT00004187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319478|NCT00004188|Cyclophosphamide|cyclophosphamide|mesh-list
6319479|NCT00004188|Melphalan|melphalan|mesh-list
6319480|NCT00004188|Mechlorethamine|mechlorethamine|mesh-list
6319481|NCT00004188|Cisplatin|cisplatin|mesh-list
6319482|NCT00004188|Carboplatin|carboplatin|mesh-list
6319483|NCT00004188|Doxorubicin|doxorubicin|mesh-list
6319484|NCT00004188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6319485|NCT00004188|Etoposide|etoposide|mesh-list
6319486|NCT00004188|Vincristine|vincristine|mesh-list
6319487|NCT00004188|Topotecan|topotecan|mesh-list
6319488|NCT00004188|Isotretinoin|isotretinoin|mesh-list
6319489|NCT00004188|Lenograstim|lenograstim|mesh-list
6319490|NCT00004188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6319491|NCT00004188|Immunologic Factors|immunologic factors|mesh-ancestor
6319492|NCT00004188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6319493|NCT00004188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6319494|NCT00004188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6319495|NCT00004188|Alkylating Agents|alkylating agents|mesh-ancestor
6319496|NCT00004188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319497|NCT00004188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319498|NCT00004188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6319499|NCT00004188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6319500|NCT00004188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6319501|NCT00004188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6319502|NCT00004188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6319503|NCT00004188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6319504|NCT00004188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6319505|NCT00004188|Tubulin Modulators|tubulin modulators|mesh-ancestor
6319506|NCT00004188|Antimitotic Agents|antimitotic agents|mesh-ancestor
6319507|NCT00004188|Mitosis Modulators|mitosis modulators|mesh-ancestor
6319508|NCT00004188|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6319509|NCT00004188|Dermatologic Agents|dermatologic agents|mesh-ancestor
6319510|NCT00004189|Cisplatin|cisplatin|mesh-list
6319511|NCT00004189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319512|NCT00004190|Gemcitabine|gemcitabine|mesh-list
6319513|NCT00004190|Oxaliplatin|oxaliplatin|mesh-list
6319514|NCT00004190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6319515|NCT00004190|Antimetabolites|antimetabolites|mesh-ancestor
6319516|NCT00004190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319517|NCT00004190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319518|NCT00004190|Antiviral Agents|antiviral agents|mesh-ancestor
6319519|NCT00004190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6319520|NCT00004190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6319521|NCT00004190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6319522|NCT00004190|Immunologic Factors|immunologic factors|mesh-ancestor
6319523|NCT00004190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6319524|NCT00004192|Cytarabine|cytarabine|mesh-list
6319525|NCT00004192|Methylprednisolone|methylprednisolone|mesh-list
6319526|NCT00004192|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6319527|NCT00004192|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6319528|NCT00004192|Prednisolone|prednisolone|mesh-list
6319529|NCT00004192|Prednisolone acetate|prednisolone acetate|mesh-list
6319530|NCT00004192|Etoposide|etoposide|mesh-list
6319531|NCT00004192|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6319532|NCT00004192|Prednisolone phosphate|prednisolone phosphate|mesh-list
6319533|NCT00004192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319534|NCT00004192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6319535|NCT00004192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6319536|NCT00004192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6319537|NCT00004192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6319538|NCT00004192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319539|NCT00004192|Immunologic Factors|immunologic factors|mesh-ancestor
6319540|NCT00004192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6319541|NCT00004192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6319542|NCT00004192|Antimetabolites|antimetabolites|mesh-ancestor
6319543|NCT00004192|Antiviral Agents|antiviral agents|mesh-ancestor
6319544|NCT00004192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6319545|NCT00004192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6319546|NCT00004192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6319547|NCT00004192|Antiemetics|antiemetics|mesh-ancestor
6319548|NCT00004192|Autonomic Agents|autonomic agents|mesh-ancestor
6319549|NCT00004192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6319550|NCT00004192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6319551|NCT00004192|Glucocorticoids|glucocorticoids|mesh-ancestor
6319552|NCT00004192|Hormones|hormones|mesh-ancestor
6319553|NCT00004192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6319554|NCT00004192|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6319555|NCT00004192|Protective Agents|protective agents|mesh-ancestor
6319556|NCT00004192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6319557|NCT00004194|Fludarabine|fludarabine|mesh-list
6319558|NCT00004194|Fludarabine phosphate|fludarabine phosphate|mesh-list
6319559|NCT00004194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319560|NCT00004194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6319561|NCT00004194|Antimetabolites|antimetabolites|mesh-ancestor
6319562|NCT00004194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319563|NCT00004194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6319564|NCT00004194|Immunologic Factors|immunologic factors|mesh-ancestor
6319565|NCT00004194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6319566|NCT00004195|Eniluracil|eniluracil|mesh-list
6319567|NCT00004195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319568|NCT00004195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6319569|NCT00004196|Interferons|interferons|mesh-list
6319570|NCT00004196|Interferon-alpha|interferon-alpha|mesh-list
6319571|NCT00004196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319572|NCT00004196|Antiviral Agents|antiviral agents|mesh-ancestor
6319573|NCT00004196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6319574|NCT00004196|Immunologic Factors|immunologic factors|mesh-ancestor
6319575|NCT00004196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6319576|NCT00004197|Prednisone|prednisone|mesh-list
6319577|NCT00004197|Cyclophosphamide|cyclophosphamide|mesh-list
6319578|NCT00004197|Doxorubicin|doxorubicin|mesh-list
6319579|NCT00004197|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6319580|NCT00004197|Vincristine|vincristine|mesh-list
6319581|NCT00004197|Mitoxantrone|mitoxantrone|mesh-list
6319582|NCT00004197|Sargramostim|sargramostim|mesh-list
6319583|NCT00004197|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
6319584|NCT00004197|Vaccines|vaccines|mesh-list
6319585|NCT00004197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6319586|NCT00004197|Immunologic Factors|immunologic factors|mesh-ancestor
6319587|NCT00004197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6319588|NCT00004197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6319589|NCT00004197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6319590|NCT00004197|Alkylating Agents|alkylating agents|mesh-ancestor
6319591|NCT00004197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319592|NCT00004197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319593|NCT00004197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6319594|NCT00004197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6319595|NCT00004197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6319596|NCT00004197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6319597|NCT00004197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6319598|NCT00004197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6319599|NCT00004197|Glucocorticoids|glucocorticoids|mesh-ancestor
6319600|NCT00004197|Hormones|hormones|mesh-ancestor
6319601|NCT00004197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6319602|NCT00004197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6319603|NCT00004197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6319604|NCT00004197|Tubulin Modulators|tubulin modulators|mesh-ancestor
6319605|NCT00004197|Antimitotic Agents|antimitotic agents|mesh-ancestor
6319606|NCT00004197|Mitosis Modulators|mitosis modulators|mesh-ancestor
6319607|NCT00004197|Analgesics|analgesics|mesh-ancestor
6319608|NCT00004197|Sensory System Agents|sensory system agents|mesh-ancestor
6319609|NCT00004197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6319610|NCT00004197|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6319611|NCT00004198|Sargramostim|sargramostim|mesh-list
6319612|NCT00004198|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
6319613|NCT00004198|Vaccines|vaccines|mesh-list
6319614|NCT00004198|Immunologic Factors|immunologic factors|mesh-ancestor
6319615|NCT00004198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6319616|NCT00004198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6319617|NCT00004199|Gemcitabine|gemcitabine|mesh-list
6319618|NCT00004199|Prinomastat|prinomastat|mesh-list
6319619|NCT00004199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319620|NCT00004199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6319621|NCT00004199|Antimetabolites|antimetabolites|mesh-ancestor
6319622|NCT00004199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319623|NCT00004199|Antiviral Agents|antiviral agents|mesh-ancestor
6319624|NCT00004199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6319625|NCT00004199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6319626|NCT00004199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6319627|NCT00004199|Immunologic Factors|immunologic factors|mesh-ancestor
6319628|NCT00004199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6319629|NCT00004199|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
6319630|NCT00004199|Protease Inhibitors|protease inhibitors|mesh-ancestor
6319631|NCT00004200|Temozolomide|temozolomide|mesh-list
6319632|NCT00004200|Prinomastat|prinomastat|mesh-list
6319633|NCT00004200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6319634|NCT00004200|Alkylating Agents|alkylating agents|mesh-ancestor
6319635|NCT00004200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319636|NCT00004200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319637|NCT00004200|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
6319638|NCT00004200|Protease Inhibitors|protease inhibitors|mesh-ancestor
6319639|NCT00004200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6319640|NCT00004201|Gemcitabine|gemcitabine|mesh-list
6319641|NCT00004201|Carboplatin|carboplatin|mesh-list
6319642|NCT00004201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319643|NCT00004201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6319644|NCT00004201|Antimetabolites|antimetabolites|mesh-ancestor
6319645|NCT00004201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319646|NCT00004201|Antiviral Agents|antiviral agents|mesh-ancestor
6319647|NCT00004201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6319648|NCT00004201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6319649|NCT00004201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6319650|NCT00004201|Immunologic Factors|immunologic factors|mesh-ancestor
6319651|NCT00004201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6319652|NCT00004202|Paclitaxel|paclitaxel|mesh-list
6319653|NCT00004202|Carboplatin|carboplatin|mesh-list
6319654|NCT00004202|Efaproxiral|efaproxiral|mesh-list
6319655|NCT00004202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6319656|NCT00004202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319657|NCT00004202|Tubulin Modulators|tubulin modulators|mesh-ancestor
6319658|NCT00004202|Antimitotic Agents|antimitotic agents|mesh-ancestor
6319659|NCT00004202|Mitosis Modulators|mitosis modulators|mesh-ancestor
6319660|NCT00004202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319661|NCT00004202|Antisickling Agents|antisickling agents|mesh-ancestor
6319662|NCT00004203|Oxaliplatin|oxaliplatin|mesh-list
6319663|NCT00004203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319664|NCT00004204|Temozolomide|temozolomide|mesh-list
6319665|NCT00004204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6319666|NCT00004204|Alkylating Agents|alkylating agents|mesh-ancestor
6319667|NCT00004204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319668|NCT00004204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319669|NCT00004205|Tamoxifen|tamoxifen|mesh-list
6319670|NCT00004205|Letrozole|letrozole|mesh-list
6319671|NCT00004205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319672|NCT00004205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319673|NCT00004205|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6319674|NCT00004205|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6319675|NCT00004205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6319676|NCT00004205|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6319677|NCT00004205|Hormone Antagonists|hormone antagonists|mesh-ancestor
6319678|NCT00004205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6319679|NCT00004205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6319680|NCT00004205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6319681|NCT00004205|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6319682|NCT00004205|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6319683|NCT00004205|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6319684|NCT00004206|Leucovorin|leucovorin|mesh-list
6319685|NCT00004206|Fluorouracil|fluorouracil|mesh-list
6319686|NCT00004206|Oxaliplatin|oxaliplatin|mesh-list
6319687|NCT00004206|Calcium|calcium|mesh-list
6319688|NCT00004206|Levoleucovorin|levoleucovorin|mesh-list
6319689|NCT00004206|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6319690|NCT00004206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6319691|NCT00004206|Antimetabolites|antimetabolites|mesh-ancestor
6319692|NCT00004206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319693|NCT00004206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6319694|NCT00004206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319695|NCT00004206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6319696|NCT00004206|Immunologic Factors|immunologic factors|mesh-ancestor
6319697|NCT00004206|Antidotes|antidotes|mesh-ancestor
6319698|NCT00004206|Protective Agents|protective agents|mesh-ancestor
6319699|NCT00004206|Vitamin B Complex|vitamin b complex|mesh-ancestor
6319700|NCT00004206|Vitamins|vitamins|mesh-ancestor
6319701|NCT00004206|Micronutrients|micronutrients|mesh-ancestor
6319702|NCT00004207|Daunorubicin|daunorubicin|mesh-list
6319703|NCT00004207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319704|NCT00004207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6319705|NCT00004207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319706|NCT00004207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6319707|NCT00004207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6319708|NCT00004207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6319709|NCT00004209|Mitomycins|mitomycins|mesh-list
6319710|NCT00004209|Mitomycin|mitomycin|mesh-list
6319711|NCT00004209|Vinblastine|vinblastine|mesh-list
6319712|NCT00004209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319713|NCT00004209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6319714|NCT00004209|Alkylating Agents|alkylating agents|mesh-ancestor
6319715|NCT00004209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319716|NCT00004209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6319717|NCT00004209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6319718|NCT00004209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6319719|NCT00004209|Tubulin Modulators|tubulin modulators|mesh-ancestor
6319720|NCT00004209|Antimitotic Agents|antimitotic agents|mesh-ancestor
6319721|NCT00004209|Mitosis Modulators|mitosis modulators|mesh-ancestor
6319722|NCT00004212|Exatecan|exatecan|mesh-list
6319723|NCT00004212|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6319724|NCT00004212|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6319725|NCT00004212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6319726|NCT00004212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319727|NCT00004212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319728|NCT00004215|Cytarabine|cytarabine|mesh-list
6319729|NCT00004215|Daunorubicin|daunorubicin|mesh-list
6319730|NCT00004215|Immunologic Factors|immunologic factors|mesh-ancestor
6319731|NCT00004215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6319732|NCT00004215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6319733|NCT00004215|Antimetabolites|antimetabolites|mesh-ancestor
6319734|NCT00004215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319735|NCT00004215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319736|NCT00004215|Antiviral Agents|antiviral agents|mesh-ancestor
6319737|NCT00004215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6319738|NCT00004215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6319739|NCT00004215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6319740|NCT00004215|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6319741|NCT00004215|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6319742|NCT00004215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6319743|NCT00004216|Ciprofloxacin|ciprofloxacin|mesh-list
6319744|NCT00004216|Ceftriaxone|ceftriaxone|mesh-list
6319745|NCT00004216|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6319746|NCT00004216|Cefixime|cefixime|mesh-list
6319747|NCT00004216|Trimethoprim|trimethoprim|mesh-list
6319748|NCT00004216|Sulfamethoxazole|sulfamethoxazole|mesh-list
6319749|NCT00004216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6319750|NCT00004216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6319751|NCT00004216|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6319752|NCT00004216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6319753|NCT00004216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6319754|NCT00004216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319755|NCT00004216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319756|NCT00004216|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6319757|NCT00004216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6319758|NCT00004216|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6319759|NCT00004216|Renal Agents|renal agents|mesh-ancestor
6319760|NCT00004216|Antimalarials|antimalarials|mesh-ancestor
6319761|NCT00004216|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6319762|NCT00004216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6319763|NCT00004216|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6319764|NCT00004216|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6319765|NCT00004216|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6319766|NCT00004217|Cytarabine|cytarabine|mesh-list
6319767|NCT00004217|Daunorubicin|daunorubicin|mesh-list
6319768|NCT00004217|Sargramostim|sargramostim|mesh-list
6319769|NCT00004217|Immunologic Factors|immunologic factors|mesh-ancestor
6319770|NCT00004217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6319771|NCT00004217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6319772|NCT00004217|Antimetabolites|antimetabolites|mesh-ancestor
6319773|NCT00004217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319774|NCT00004217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319775|NCT00004217|Antiviral Agents|antiviral agents|mesh-ancestor
6319776|NCT00004217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6319777|NCT00004217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6319778|NCT00004217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6319779|NCT00004217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6319780|NCT00004217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6319781|NCT00004217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6319782|NCT00004218|Prednisolone|prednisolone|mesh-list
6319783|NCT00004218|Cyclophosphamide|cyclophosphamide|mesh-list
6319784|NCT00004218|Chlorambucil|chlorambucil|mesh-list
6319785|NCT00004218|Doxorubicin|doxorubicin|mesh-list
6319786|NCT00004218|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6319787|NCT00004218|Fludarabine|fludarabine|mesh-list
6319788|NCT00004218|Fludarabine phosphate|fludarabine phosphate|mesh-list
6319789|NCT00004218|Vincristine|vincristine|mesh-list
6319790|NCT00004218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6319791|NCT00004218|Immunologic Factors|immunologic factors|mesh-ancestor
6319792|NCT00004218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6319793|NCT00004218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6319794|NCT00004218|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6319795|NCT00004218|Alkylating Agents|alkylating agents|mesh-ancestor
6319796|NCT00004218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319797|NCT00004218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319798|NCT00004218|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6319799|NCT00004218|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6319800|NCT00004218|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6319801|NCT00004218|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6319802|NCT00004218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6319803|NCT00004218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6319804|NCT00004218|Antimetabolites|antimetabolites|mesh-ancestor
6319805|NCT00004218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6319806|NCT00004218|Tubulin Modulators|tubulin modulators|mesh-ancestor
6319807|NCT00004218|Antimitotic Agents|antimitotic agents|mesh-ancestor
6319808|NCT00004218|Mitosis Modulators|mitosis modulators|mesh-ancestor
6319809|NCT00004218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6319810|NCT00004218|Glucocorticoids|glucocorticoids|mesh-ancestor
6319811|NCT00004218|Hormones|hormones|mesh-ancestor
6319812|NCT00004218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6319813|NCT00004218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6319814|NCT00004219|Granisetron|granisetron|mesh-list
6319815|NCT00004219|Antiemetics|antiemetics|mesh-ancestor
6319816|NCT00004219|Autonomic Agents|autonomic agents|mesh-ancestor
6319817|NCT00004219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6319818|NCT00004219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6319819|NCT00004219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6319820|NCT00004219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6319821|NCT00004219|Serotonin Agents|serotonin agents|mesh-ancestor
6319822|NCT00004219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6319823|NCT00004219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319824|NCT00004220|Gemcitabine|gemcitabine|mesh-list
6319825|NCT00004220|Oxaliplatin|oxaliplatin|mesh-list
6319826|NCT00004220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6319827|NCT00004220|Antimetabolites|antimetabolites|mesh-ancestor
6319828|NCT00004220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319829|NCT00004220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319830|NCT00004220|Antiviral Agents|antiviral agents|mesh-ancestor
6319831|NCT00004220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6319832|NCT00004220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6319833|NCT00004220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6319834|NCT00004220|Immunologic Factors|immunologic factors|mesh-ancestor
6319835|NCT00004220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6319836|NCT00004221|Paclitaxel|paclitaxel|mesh-list
6319837|NCT00004221|Cyclophosphamide|cyclophosphamide|mesh-list
6319838|NCT00004221|Carboplatin|carboplatin|mesh-list
6319839|NCT00004221|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6319840|NCT00004221|Topotecan|topotecan|mesh-list
6319841|NCT00004221|Lenograstim|lenograstim|mesh-list
6319842|NCT00004221|Sargramostim|sargramostim|mesh-list
6319843|NCT00004221|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6319844|NCT00004221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319845|NCT00004221|Tubulin Modulators|tubulin modulators|mesh-ancestor
6319846|NCT00004221|Antimitotic Agents|antimitotic agents|mesh-ancestor
6319847|NCT00004221|Mitosis Modulators|mitosis modulators|mesh-ancestor
6319848|NCT00004221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319849|NCT00004221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6319850|NCT00004221|Immunologic Factors|immunologic factors|mesh-ancestor
6319851|NCT00004221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6319852|NCT00004221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6319853|NCT00004221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6319854|NCT00004221|Alkylating Agents|alkylating agents|mesh-ancestor
6319855|NCT00004221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6319856|NCT00004221|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6319857|NCT00004221|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6319858|NCT00004221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6319859|NCT00004221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6319860|NCT00004223|Gemcitabine|gemcitabine|mesh-list
6319861|NCT00004223|Docetaxel|docetaxel|mesh-list
6319862|NCT00004223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6319863|NCT00004223|Antimetabolites|antimetabolites|mesh-ancestor
6319864|NCT00004223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319865|NCT00004223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319866|NCT00004223|Antiviral Agents|antiviral agents|mesh-ancestor
6319867|NCT00004223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6319868|NCT00004223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6319869|NCT00004223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6319870|NCT00004223|Immunologic Factors|immunologic factors|mesh-ancestor
6319871|NCT00004223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6319872|NCT00004223|Tubulin Modulators|tubulin modulators|mesh-ancestor
6319873|NCT00004223|Antimitotic Agents|antimitotic agents|mesh-ancestor
6319874|NCT00004223|Mitosis Modulators|mitosis modulators|mesh-ancestor
6319875|NCT00004224|Cyclophosphamide|cyclophosphamide|mesh-list
6319876|NCT00004224|Etoposide|etoposide|mesh-list
6319877|NCT00004224|Vincristine|vincristine|mesh-list
6319878|NCT00004224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6319879|NCT00004224|Immunologic Factors|immunologic factors|mesh-ancestor
6319880|NCT00004224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6319881|NCT00004224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6319882|NCT00004224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6319883|NCT00004224|Alkylating Agents|alkylating agents|mesh-ancestor
6319884|NCT00004224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319885|NCT00004224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319886|NCT00004224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6319887|NCT00004224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6319888|NCT00004224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6319889|NCT00004224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6319890|NCT00004224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6319891|NCT00004224|Tubulin Modulators|tubulin modulators|mesh-ancestor
6319892|NCT00004224|Antimitotic Agents|antimitotic agents|mesh-ancestor
6319893|NCT00004224|Mitosis Modulators|mitosis modulators|mesh-ancestor
6319894|NCT00004227|Cetuximab|cetuximab|mesh-list
6319895|NCT00004227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6319896|NCT00004227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319897|NCT00004229|Endostatins|endostatins|mesh-list
6319898|NCT00004229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319899|NCT00004229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6319900|NCT00004229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6319901|NCT00004229|Growth Substances|growth substances|mesh-ancestor
6319902|NCT00004229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6319903|NCT00004229|Growth Inhibitors|growth inhibitors|mesh-ancestor
6392763|NCT00197756|Protective Agents|protective agents|mesh-ancestor
6392764|NCT00197756|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6392765|NCT00197756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6396924|NCT00209859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6396925|NCT00209859|Antifungal Agents|antifungal agents|mesh-ancestor
6396926|NCT00209859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6396927|NCT00209859|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6396928|NCT00209859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6396929|NCT00209859|Glucocorticoids|glucocorticoids|mesh-ancestor
6396930|NCT00209859|Hormones|hormones|mesh-ancestor
6396931|NCT00209859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6396932|NCT00209859|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6319904|NCT00004232|Cyclosporine|cyclosporine|mesh-list
6319905|NCT00004232|Prednisone|prednisone|mesh-list
6319906|NCT00004232|Methylprednisolone|methylprednisolone|mesh-list
6319907|NCT00004232|Cyclosporins|cyclosporins|mesh-list
6319908|NCT00004232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6319909|NCT00004232|Glucocorticoids|glucocorticoids|mesh-ancestor
6319910|NCT00004232|Hormones|hormones|mesh-ancestor
6319911|NCT00004232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6319912|NCT00004232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6319913|NCT00004232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6319914|NCT00004232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319915|NCT00004232|Immunologic Factors|immunologic factors|mesh-ancestor
6319916|NCT00004232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6319917|NCT00004232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319918|NCT00004232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6319919|NCT00004232|Antifungal Agents|antifungal agents|mesh-ancestor
6319920|NCT00004232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6319921|NCT00004232|Dermatologic Agents|dermatologic agents|mesh-ancestor
6319922|NCT00004232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6319923|NCT00004232|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6319924|NCT00004232|Antiemetics|antiemetics|mesh-ancestor
6319925|NCT00004232|Autonomic Agents|autonomic agents|mesh-ancestor
6319926|NCT00004232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6319927|NCT00004232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6319928|NCT00004232|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6319929|NCT00004232|Protective Agents|protective agents|mesh-ancestor
6319930|NCT00004233|Leucovorin|leucovorin|mesh-list
6319931|NCT00004233|Fluorouracil|fluorouracil|mesh-list
6319932|NCT00004233|Calcium|calcium|mesh-list
6319933|NCT00004233|Levoleucovorin|levoleucovorin|mesh-list
6319934|NCT00004233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6319935|NCT00004233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6319936|NCT00004233|Antimetabolites|antimetabolites|mesh-ancestor
6319937|NCT00004233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319938|NCT00004233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6319939|NCT00004233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319940|NCT00004233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6319941|NCT00004233|Immunologic Factors|immunologic factors|mesh-ancestor
6319942|NCT00004233|Antidotes|antidotes|mesh-ancestor
6319943|NCT00004233|Protective Agents|protective agents|mesh-ancestor
6319944|NCT00004233|Vitamin B Complex|vitamin b complex|mesh-ancestor
6319945|NCT00004233|Vitamins|vitamins|mesh-ancestor
6319946|NCT00004233|Micronutrients|micronutrients|mesh-ancestor
6319947|NCT00004235|Docetaxel|docetaxel|mesh-list
6319948|NCT00004235|Irinotecan|irinotecan|mesh-list
6319949|NCT00004235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319950|NCT00004235|Tubulin Modulators|tubulin modulators|mesh-ancestor
6319951|NCT00004235|Antimitotic Agents|antimitotic agents|mesh-ancestor
6319952|NCT00004235|Mitosis Modulators|mitosis modulators|mesh-ancestor
6319953|NCT00004235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319954|NCT00004235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6319955|NCT00004235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6319956|NCT00004235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6319957|NCT00004236|Doxorubicin|doxorubicin|mesh-list
6319958|NCT00004236|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6319959|NCT00004236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6319960|NCT00004236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319961|NCT00004236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6319962|NCT00004236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6319963|NCT00004236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6319964|NCT00004236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319965|NCT00004237|Cyclophosphamide|cyclophosphamide|mesh-list
6319966|NCT00004237|Doxorubicin|doxorubicin|mesh-list
6319967|NCT00004237|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6319968|NCT00004237|Vinorelbine|vinorelbine|mesh-list
6319969|NCT00004237|Epirubicin|epirubicin|mesh-list
6319970|NCT00004237|Mitoxantrone|mitoxantrone|mesh-list
6319971|NCT00004237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6319972|NCT00004237|Immunologic Factors|immunologic factors|mesh-ancestor
6319973|NCT00004237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6319974|NCT00004237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6319975|NCT00004237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6319976|NCT00004237|Alkylating Agents|alkylating agents|mesh-ancestor
6319977|NCT00004237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319978|NCT00004237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319979|NCT00004237|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6319980|NCT00004237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6319981|NCT00004237|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6319982|NCT00004237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6319983|NCT00004237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6319984|NCT00004237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6319985|NCT00004237|Tubulin Modulators|tubulin modulators|mesh-ancestor
6319986|NCT00004237|Antimitotic Agents|antimitotic agents|mesh-ancestor
6319987|NCT00004237|Mitosis Modulators|mitosis modulators|mesh-ancestor
6319988|NCT00004237|Analgesics|analgesics|mesh-ancestor
6319989|NCT00004237|Sensory System Agents|sensory system agents|mesh-ancestor
6319990|NCT00004237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6319991|NCT00004242|Gemcitabine|gemcitabine|mesh-list
6319992|NCT00004242|Fluorouracil|fluorouracil|mesh-list
6319993|NCT00004242|Oxaliplatin|oxaliplatin|mesh-list
6319994|NCT00004242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6319995|NCT00004242|Antimetabolites|antimetabolites|mesh-ancestor
6319996|NCT00004242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6319997|NCT00004242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6319998|NCT00004242|Antiviral Agents|antiviral agents|mesh-ancestor
6319999|NCT00004242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6320000|NCT00004242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6320001|NCT00004242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6320002|NCT00004242|Immunologic Factors|immunologic factors|mesh-ancestor
6320003|NCT00004242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320004|NCT00004243|Docetaxel|docetaxel|mesh-list
6320005|NCT00004243|Oxaliplatin|oxaliplatin|mesh-list
6320006|NCT00004243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6320007|NCT00004243|Tubulin Modulators|tubulin modulators|mesh-ancestor
6320008|NCT00004243|Antimitotic Agents|antimitotic agents|mesh-ancestor
6320009|NCT00004243|Mitosis Modulators|mitosis modulators|mesh-ancestor
6320010|NCT00004243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6320011|NCT00004244|Interferons|interferons|mesh-list
6320012|NCT00004244|Interferon-alpha|interferon-alpha|mesh-list
6320013|NCT00004244|Interleukin-12|interleukin-12|mesh-list
6320014|NCT00004244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6320015|NCT00004244|Antiviral Agents|antiviral agents|mesh-ancestor
6320016|NCT00004244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6320017|NCT00004244|Immunologic Factors|immunologic factors|mesh-ancestor
6320018|NCT00004244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320019|NCT00004244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6016499|NCT00365391|Immunologic Factors|immunologic factors|mesh-ancestor
6320020|NCT00004244|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6320021|NCT00004244|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6320022|NCT00004244|Growth Substances|growth substances|mesh-ancestor
6320023|NCT00004244|Growth Inhibitors|growth inhibitors|mesh-ancestor
6320024|NCT00004245|Salicylates|salicylates|mesh-list
6320025|NCT00004245|Sodium Salicylate|sodium salicylate|mesh-list
6320026|NCT00004245|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
6320027|NCT00004245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6320028|NCT00004245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6320029|NCT00004245|Analgesics|analgesics|mesh-ancestor
6320030|NCT00004245|Sensory System Agents|sensory system agents|mesh-ancestor
6320031|NCT00004245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6320032|NCT00004245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320033|NCT00004245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6320034|NCT00004245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6320035|NCT00004245|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6320036|NCT00004245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6320037|NCT00004245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6320038|NCT00004246|Vidarabine|vidarabine|mesh-list
6320039|NCT00004246|Fludarabine|fludarabine|mesh-list
6320040|NCT00004246|Fludarabine phosphate|fludarabine phosphate|mesh-list
6320041|NCT00004246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6320042|NCT00004246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6320043|NCT00004246|Antimetabolites|antimetabolites|mesh-ancestor
6320044|NCT00004246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6320045|NCT00004246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6320046|NCT00004246|Immunologic Factors|immunologic factors|mesh-ancestor
6320047|NCT00004246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320048|NCT00004246|Antiviral Agents|antiviral agents|mesh-ancestor
6320049|NCT00004246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6320050|NCT00004248|Aldesleukin|aldesleukin|mesh-list
6320051|NCT00004248|Doxorubicin|doxorubicin|mesh-list
6320052|NCT00004248|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6320053|NCT00004248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6320054|NCT00004248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6320055|NCT00004248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6320056|NCT00004248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6320057|NCT00004248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6320058|NCT00004248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6320059|NCT00004248|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6320060|NCT00004248|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6320061|NCT00004248|Antiviral Agents|antiviral agents|mesh-ancestor
6320062|NCT00004248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6320063|NCT00004249|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
6320064|NCT00004249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6320065|NCT00004249|Immunologic Factors|immunologic factors|mesh-ancestor
6320066|NCT00004249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320067|NCT00004250|Dactinomycin|dactinomycin|mesh-list
6320068|NCT00004250|Melphalan|melphalan|mesh-list
6320069|NCT00004250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6320070|NCT00004250|Alkylating Agents|alkylating agents|mesh-ancestor
6320071|NCT00004250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6320072|NCT00004250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6320073|NCT00004250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6320074|NCT00004250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6320075|NCT00004250|Immunologic Factors|immunologic factors|mesh-ancestor
6320076|NCT00004250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320077|NCT00004250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6320078|NCT00004250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6320079|NCT00004250|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6320080|NCT00004250|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6320081|NCT00004250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6320082|NCT00004250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6320083|NCT00004251|Letrozole|letrozole|mesh-list
6320084|NCT00004251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6320085|NCT00004251|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6320086|NCT00004251|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6320087|NCT00004251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6320088|NCT00004251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6320089|NCT00004251|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6320090|NCT00004251|Hormone Antagonists|hormone antagonists|mesh-ancestor
6320091|NCT00004251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6320092|NCT00004251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320093|NCT00004252|Leucovorin|leucovorin|mesh-list
6320094|NCT00004252|Fluorouracil|fluorouracil|mesh-list
6320095|NCT00004252|Calcium|calcium|mesh-list
6320096|NCT00004252|Levoleucovorin|levoleucovorin|mesh-list
6320097|NCT00004252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6320098|NCT00004252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320099|NCT00004252|Antimetabolites|antimetabolites|mesh-ancestor
6320100|NCT00004252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6320101|NCT00004252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6320102|NCT00004252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6320103|NCT00004252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6320104|NCT00004252|Immunologic Factors|immunologic factors|mesh-ancestor
6320105|NCT00004252|Antidotes|antidotes|mesh-ancestor
6320106|NCT00004252|Protective Agents|protective agents|mesh-ancestor
6320107|NCT00004252|Vitamin B Complex|vitamin b complex|mesh-ancestor
6320108|NCT00004252|Vitamins|vitamins|mesh-ancestor
6320109|NCT00004252|Micronutrients|micronutrients|mesh-ancestor
6320110|NCT00004253|Paclitaxel|paclitaxel|mesh-list
6320111|NCT00004253|Carboplatin|carboplatin|mesh-list
6320112|NCT00004253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6320113|NCT00004253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6320114|NCT00004253|Tubulin Modulators|tubulin modulators|mesh-ancestor
6320115|NCT00004253|Antimitotic Agents|antimitotic agents|mesh-ancestor
6320116|NCT00004253|Mitosis Modulators|mitosis modulators|mesh-ancestor
6320117|NCT00004253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6320118|NCT00004254|Raltitrexed|raltitrexed|mesh-list
6320119|NCT00004254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6320120|NCT00004254|Antimetabolites|antimetabolites|mesh-ancestor
6320121|NCT00004254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6320122|NCT00004254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6320123|NCT00004254|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6320124|NCT00004254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6320125|NCT00004255|Methylprednisolone|methylprednisolone|mesh-list
6320126|NCT00004255|Cyclophosphamide|cyclophosphamide|mesh-list
6320127|NCT00004255|Fludarabine|fludarabine|mesh-list
6320128|NCT00004255|Fludarabine phosphate|fludarabine phosphate|mesh-list
6320129|NCT00004255|Tacrolimus|tacrolimus|mesh-list
6320130|NCT00004255|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6320131|NCT00004255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6320132|NCT00004255|Immunologic Factors|immunologic factors|mesh-ancestor
6320133|NCT00004255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320134|NCT00004255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6320135|NCT00004255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6320136|NCT00004255|Alkylating Agents|alkylating agents|mesh-ancestor
6320137|NCT00004255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6320138|NCT00004255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6320139|NCT00004255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6320140|NCT00004255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6320141|NCT00004255|Antimetabolites|antimetabolites|mesh-ancestor
6320142|NCT00004255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6320143|NCT00004255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6320144|NCT00004255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6320145|NCT00004255|Antiemetics|antiemetics|mesh-ancestor
6320146|NCT00004255|Autonomic Agents|autonomic agents|mesh-ancestor
6320147|NCT00004255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6320148|NCT00004255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6320149|NCT00004255|Glucocorticoids|glucocorticoids|mesh-ancestor
6320150|NCT00004255|Hormones|hormones|mesh-ancestor
6320151|NCT00004255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6320152|NCT00004255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6320153|NCT00004255|Protective Agents|protective agents|mesh-ancestor
6320154|NCT00004256|Sargramostim|sargramostim|mesh-list
6320155|NCT00004256|Immunologic Factors|immunologic factors|mesh-ancestor
6320156|NCT00004256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320157|NCT00004257|Fluorouracil|fluorouracil|mesh-list
6320158|NCT00004257|Oxaliplatin|oxaliplatin|mesh-list
6320159|NCT00004257|Antimetabolites|antimetabolites|mesh-ancestor
6320160|NCT00004257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6320161|NCT00004257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6320162|NCT00004257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6320163|NCT00004257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6320164|NCT00004257|Immunologic Factors|immunologic factors|mesh-ancestor
6320165|NCT00004257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320166|NCT00004260|Rituximab|rituximab|mesh-list
6320167|NCT00004260|Interleukin-12|interleukin-12|mesh-list
6320168|NCT00004260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6320169|NCT00004260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6320170|NCT00004260|Immunologic Factors|immunologic factors|mesh-ancestor
6320171|NCT00004260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320172|NCT00004260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6320173|NCT00004260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6320174|NCT00004260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6320175|NCT00004260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6320176|NCT00004260|Growth Substances|growth substances|mesh-ancestor
6320177|NCT00004260|Growth Inhibitors|growth inhibitors|mesh-ancestor
6320178|NCT00004261|Antibodies|antibodies|mesh-list
6320179|NCT00004261|Immunologic Factors|immunologic factors|mesh-ancestor
6320180|NCT00004261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320181|NCT00004262|Motexafin gadolinium|motexafin gadolinium|mesh-list
6320182|NCT00004262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6320183|NCT00004262|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6320184|NCT00004262|Dermatologic Agents|dermatologic agents|mesh-ancestor
6320185|NCT00004263|Cytarabine|cytarabine|mesh-list
6320186|NCT00004263|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
6320187|NCT00004263|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6320188|NCT00004263|Antimetabolites|antimetabolites|mesh-ancestor
6320189|NCT00004263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6320190|NCT00004263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6320191|NCT00004263|Antiviral Agents|antiviral agents|mesh-ancestor
6320192|NCT00004263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6320193|NCT00004263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6320194|NCT00004263|Immunologic Factors|immunologic factors|mesh-ancestor
6320195|NCT00004263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320196|NCT00004263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6320197|NCT00004263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6320198|NCT00004264|Docetaxel|docetaxel|mesh-list
6320199|NCT00004264|Amifostine|amifostine|mesh-list
6320200|NCT00004264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6320201|NCT00004264|Tubulin Modulators|tubulin modulators|mesh-ancestor
6320202|NCT00004264|Antimitotic Agents|antimitotic agents|mesh-ancestor
6320203|NCT00004264|Mitosis Modulators|mitosis modulators|mesh-ancestor
6320204|NCT00004264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6320205|NCT00004264|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6320206|NCT00004264|Protective Agents|protective agents|mesh-ancestor
6320207|NCT00004264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320208|NCT00004265|Paclitaxel|paclitaxel|mesh-list
6320209|NCT00004265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6320210|NCT00004265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6320211|NCT00004265|Tubulin Modulators|tubulin modulators|mesh-ancestor
6320212|NCT00004265|Antimitotic Agents|antimitotic agents|mesh-ancestor
6320213|NCT00004265|Mitosis Modulators|mitosis modulators|mesh-ancestor
6320214|NCT00004265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6320215|NCT00004266|Lisinopril|lisinopril|mesh-list
6320216|NCT00004266|Nifedipine|nifedipine|mesh-list
6320217|NCT00004266|Simvastatin|simvastatin|mesh-list
6320218|NCT00004266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6320219|NCT00004266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6320220|NCT00004266|Antimetabolites|antimetabolites|mesh-ancestor
6320221|NCT00004266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6320222|NCT00004266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6320223|NCT00004266|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6320224|NCT00004266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6320225|NCT00004266|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6320226|NCT00004266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6320227|NCT00004266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6320228|NCT00004266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320229|NCT00004266|Vasodilator Agents|vasodilator agents|mesh-ancestor
6320230|NCT00004266|Tocolytic Agents|tocolytic agents|mesh-ancestor
6320231|NCT00004266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6320232|NCT00004266|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6320233|NCT00004266|Protease Inhibitors|protease inhibitors|mesh-ancestor
6320234|NCT00004266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6320235|NCT00004266|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6320236|NCT00004266|Protective Agents|protective agents|mesh-ancestor
6320237|NCT00004268|Midodrine|midodrine|mesh-list
6320238|NCT00004268|Sympathomimetics|sympathomimetics|mesh-ancestor
6320239|NCT00004268|Autonomic Agents|autonomic agents|mesh-ancestor
6320240|NCT00004268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6320241|NCT00004268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320242|NCT00004268|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6320243|NCT00004268|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6320244|NCT00004268|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6320245|NCT00004268|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6320246|NCT00004268|Adrenergic Agents|adrenergic agents|mesh-ancestor
6320247|NCT00004268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6320248|NCT00004268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6320249|NCT00004274|Estrogens|estrogens|mesh-list
6320250|NCT00004274|Hormones|hormones|mesh-ancestor
6320251|NCT00004274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6320252|NCT00004274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320253|NCT00004275|Hormones|hormones|mesh-list
6320254|NCT00004275|Oxandrolone|oxandrolone|mesh-list
6320255|NCT00004275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6320256|NCT00004275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320257|NCT00004275|Androgens|androgens|mesh-ancestor
6320258|NCT00004275|Anabolic Agents|anabolic agents|mesh-ancestor
6320259|NCT00004276|Thalidomide|thalidomide|mesh-list
6320260|NCT00004276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6320261|NCT00004276|Immunologic Factors|immunologic factors|mesh-ancestor
6320262|NCT00004276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320263|NCT00004276|Leprostatic Agents|leprostatic agents|mesh-ancestor
6320264|NCT00004276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6320265|NCT00004276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6320266|NCT00004276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6320267|NCT00004276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6320268|NCT00004276|Growth Substances|growth substances|mesh-ancestor
6320269|NCT00004276|Growth Inhibitors|growth inhibitors|mesh-ancestor
6320270|NCT00004276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6320271|NCT00004278|Ganciclovir|ganciclovir|mesh-list
6320272|NCT00004278|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6320273|NCT00004278|Antiviral Agents|antiviral agents|mesh-ancestor
6320274|NCT00004278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6320275|NCT00004278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6320276|NCT00004278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6320277|NCT00004278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6320278|NCT00004284|Potassium Citrate|potassium citrate|mesh-list
6320279|NCT00004284|Potassium phosphate|potassium phosphate|mesh-list
6320280|NCT00004284|Diuretics|diuretics|mesh-ancestor
6320281|NCT00004284|Natriuretic Agents|natriuretic agents|mesh-ancestor
6320282|NCT00004284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320283|NCT00004284|Expectorants|expectorants|mesh-ancestor
6320284|NCT00004284|Respiratory System Agents|respiratory system agents|mesh-ancestor
6320285|NCT00004284|Cariostatic Agents|cariostatic agents|mesh-ancestor
6320286|NCT00004284|Protective Agents|protective agents|mesh-ancestor
6320287|NCT00004286|Immunoglobulins|immunoglobulins|mesh-list
6320288|NCT00004286|Antibodies|antibodies|mesh-list
6320289|NCT00004286|gamma-Globulins|gamma-globulins|mesh-list
6320290|NCT00004286|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6320291|NCT00004286|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6320292|NCT00004286|Immunologic Factors|immunologic factors|mesh-ancestor
6320293|NCT00004286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320294|NCT00004288|Olsalazine|olsalazine|mesh-list
6320295|NCT00004288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6320296|NCT00004288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6320297|NCT00004288|Analgesics|analgesics|mesh-ancestor
6320298|NCT00004288|Sensory System Agents|sensory system agents|mesh-ancestor
6320299|NCT00004288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6320300|NCT00004288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320301|NCT00004288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6320302|NCT00004288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6320303|NCT00004288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6320304|NCT00004297|Diazepam|diazepam|mesh-list
6320305|NCT00004297|Lorazepam|lorazepam|mesh-list
6320306|NCT00004297|Anticonvulsants|anticonvulsants|mesh-ancestor
6320307|NCT00004297|Antiemetics|antiemetics|mesh-ancestor
6320308|NCT00004297|Autonomic Agents|autonomic agents|mesh-ancestor
6320309|NCT00004297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6320310|NCT00004297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320311|NCT00004297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6320312|NCT00004297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6320313|NCT00004297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6320314|NCT00004297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6320315|NCT00004297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6320316|NCT00004297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6320317|NCT00004297|GABA Modulators|gaba modulators|mesh-ancestor
6320318|NCT00004297|GABA Agents|gaba agents|mesh-ancestor
6320319|NCT00004297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6320320|NCT00004297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6320321|NCT00004297|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6320322|NCT00004297|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6320323|NCT00004297|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6320324|NCT00004297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6320325|NCT00004297|Anesthetics, General|anesthetics, general|mesh-ancestor
6320326|NCT00004297|Anesthetics|anesthetics|mesh-ancestor
6320327|NCT00004300|Bromocriptine|bromocriptine|mesh-list
6320328|NCT00004300|Sertraline|sertraline|mesh-list
6320329|NCT00004300|Antidepressive Agents|antidepressive agents|mesh-ancestor
6320330|NCT00004300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6320331|NCT00004300|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6320332|NCT00004300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6320333|NCT00004300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6320334|NCT00004300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6320335|NCT00004300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6320336|NCT00004300|Serotonin Agents|serotonin agents|mesh-ancestor
6320337|NCT00004300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320338|NCT00004300|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6320339|NCT00004300|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6320340|NCT00004300|Hormone Antagonists|hormone antagonists|mesh-ancestor
6320341|NCT00004300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6320342|NCT00004300|Dopamine Agonists|dopamine agonists|mesh-ancestor
6320343|NCT00004300|Dopamine Agents|dopamine agents|mesh-ancestor
6320344|NCT00004310|Clomipramine|clomipramine|mesh-list
6320345|NCT00004310|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6320346|NCT00004310|Antidepressive Agents|antidepressive agents|mesh-ancestor
6320347|NCT00004310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6320348|NCT00004310|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6320349|NCT00004310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6320350|NCT00004310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6320351|NCT00004310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6320352|NCT00004310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6320353|NCT00004310|Serotonin Agents|serotonin agents|mesh-ancestor
6320354|NCT00004310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320355|NCT00004311|Leuprolide|leuprolide|mesh-list
6320356|NCT00004311|Spironolactone|spironolactone|mesh-list
6320357|NCT00004311|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6320358|NCT00004311|Fertility Agents|fertility agents|mesh-ancestor
6320359|NCT00004311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6320360|NCT00004311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320361|NCT00004311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6320362|NCT00004311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6320363|NCT00004311|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6320364|NCT00004311|Hormone Antagonists|hormone antagonists|mesh-ancestor
6320365|NCT00004311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6320366|NCT00004311|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6320367|NCT00004311|Diuretics|diuretics|mesh-ancestor
6320368|NCT00004311|Natriuretic Agents|natriuretic agents|mesh-ancestor
6320369|NCT00004313|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
6320370|NCT00004313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6320371|NCT00004313|Immunologic Factors|immunologic factors|mesh-ancestor
6320372|NCT00004313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320373|NCT00004315|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
6320374|NCT00004315|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6320375|NCT00004315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6320376|NCT00004316|Capsaicin|capsaicin|mesh-list
6320377|NCT00004316|Antipruritics|antipruritics|mesh-ancestor
6320378|NCT00004316|Dermatologic Agents|dermatologic agents|mesh-ancestor
6320379|NCT00004316|Sensory System Agents|sensory system agents|mesh-ancestor
6320380|NCT00004316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6320381|NCT00004316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320382|NCT00004317|Leucovorin|leucovorin|mesh-list
6320383|NCT00004317|Pyrimethamine|pyrimethamine|mesh-list
6320384|NCT00004317|Sulfadiazine|sulfadiazine|mesh-list
6320385|NCT00004317|Spiramycin|spiramycin|mesh-list
6320386|NCT00004317|Calcium|calcium|mesh-list
6320387|NCT00004317|Levoleucovorin|levoleucovorin|mesh-list
6320388|NCT00004317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6320389|NCT00004317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320390|NCT00004317|Antidotes|antidotes|mesh-ancestor
6320391|NCT00004317|Protective Agents|protective agents|mesh-ancestor
6320392|NCT00004317|Vitamin B Complex|vitamin b complex|mesh-ancestor
6320393|NCT00004317|Vitamins|vitamins|mesh-ancestor
6320394|NCT00004317|Micronutrients|micronutrients|mesh-ancestor
6320395|NCT00004317|Antimalarials|antimalarials|mesh-ancestor
6320396|NCT00004317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6320397|NCT00004317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6320398|NCT00004317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6320399|NCT00004317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6320400|NCT00004317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6320401|NCT00004317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6320402|NCT00004317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6320403|NCT00004317|Coccidiostats|coccidiostats|mesh-ancestor
6320404|NCT00004323|Cyclosporine|cyclosporine|mesh-list
6320405|NCT00004323|Methylprednisolone|methylprednisolone|mesh-list
6320406|NCT00004323|Cyclophosphamide|cyclophosphamide|mesh-list
6320407|NCT00004323|Methotrexate|methotrexate|mesh-list
6320408|NCT00004323|Cyclosporins|cyclosporins|mesh-list
6320409|NCT00004323|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6320410|NCT00004323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6320411|NCT00004323|Immunologic Factors|immunologic factors|mesh-ancestor
6320412|NCT00004323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320413|NCT00004323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6320414|NCT00004323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6320415|NCT00004323|Alkylating Agents|alkylating agents|mesh-ancestor
6320416|NCT00004323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6320417|NCT00004323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6320418|NCT00004323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6320419|NCT00004323|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6320420|NCT00004323|Abortifacient Agents|abortifacient agents|mesh-ancestor
6320421|NCT00004323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6320422|NCT00004323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6320423|NCT00004323|Antimetabolites|antimetabolites|mesh-ancestor
6320424|NCT00004323|Dermatologic Agents|dermatologic agents|mesh-ancestor
6320425|NCT00004323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6320426|NCT00004323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6320427|NCT00004323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6320428|NCT00004323|Antifungal Agents|antifungal agents|mesh-ancestor
6320429|NCT00004323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6320430|NCT00004323|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6320431|NCT00004323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6320432|NCT00004323|Antiemetics|antiemetics|mesh-ancestor
6320433|NCT00004323|Autonomic Agents|autonomic agents|mesh-ancestor
6320434|NCT00004323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6320435|NCT00004323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6320436|NCT00004323|Glucocorticoids|glucocorticoids|mesh-ancestor
6320437|NCT00004323|Hormones|hormones|mesh-ancestor
6320438|NCT00004323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6320439|NCT00004323|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6320440|NCT00004323|Protective Agents|protective agents|mesh-ancestor
6320441|NCT00004327|Octreotide|octreotide|mesh-list
6320442|NCT00004327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6320443|NCT00004327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6320444|NCT00004327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6320445|NCT00004328|Enalapril|enalapril|mesh-list
6320446|NCT00004328|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
6320447|NCT00004328|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6320448|NCT00004328|Protease Inhibitors|protease inhibitors|mesh-ancestor
6320449|NCT00004328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6320450|NCT00004328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6320451|NCT00004328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6320452|NCT00004328|Chelating Agents|chelating agents|mesh-ancestor
6320453|NCT00004328|Sequestering Agents|sequestering agents|mesh-ancestor
6320454|NCT00004330|Hormones|hormones|mesh-list
6320455|NCT00004330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6320456|NCT00004330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320457|NCT00004339|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
6320458|NCT00004339|Trientine|trientine|mesh-list
6320459|NCT00004339|Chelating Agents|chelating agents|mesh-ancestor
6320460|NCT00004339|Sequestering Agents|sequestering agents|mesh-ancestor
6320461|NCT00004339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6320462|NCT00004339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6320463|NCT00004339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6320464|NCT00004339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6320465|NCT00004339|Growth Substances|growth substances|mesh-ancestor
6320466|NCT00004339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320467|NCT00004339|Growth Inhibitors|growth inhibitors|mesh-ancestor
6320468|NCT00004339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6320469|NCT00004340|Calcitriol|calcitriol|mesh-list
6320470|NCT00004340|Hormones|hormones|mesh-list
6320471|NCT00004340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6320472|NCT00004340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320473|NCT00004340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6320474|NCT00004340|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6320475|NCT00004340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6320476|NCT00004340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6320477|NCT00004340|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6320478|NCT00004340|Vitamins|vitamins|mesh-ancestor
6320479|NCT00004340|Micronutrients|micronutrients|mesh-ancestor
6016500|NCT00365391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6016501|NCT00365391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6016502|NCT00365391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016503|NCT00365417|Cyclophosphamide|cyclophosphamide|mesh-list
6016504|NCT00365417|Bevacizumab|bevacizumab|mesh-list
6016505|NCT00365417|Docetaxel|docetaxel|mesh-list
6016506|NCT00365417|Doxorubicin|doxorubicin|mesh-list
6016507|NCT00365417|Capecitabine|capecitabine|mesh-list
6320480|NCT00004340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6320481|NCT00004344|Leuprolide|leuprolide|mesh-list
6320482|NCT00004344|Testosterone|testosterone|mesh-list
6320483|NCT00004344|Androgens|androgens|mesh-ancestor
6320484|NCT00004344|Hormones|hormones|mesh-ancestor
6320485|NCT00004344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6320486|NCT00004344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320487|NCT00004344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6320488|NCT00004344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6320489|NCT00004344|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6320490|NCT00004344|Fertility Agents|fertility agents|mesh-ancestor
6320491|NCT00004344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6320492|NCT00004346|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
6320493|NCT00004346|Lovastatin|lovastatin|mesh-list
6320494|NCT00004346|L 647318|l 647318|mesh-list
6320495|NCT00004346|Dihydromevinolin|dihydromevinolin|mesh-list
6320496|NCT00004346|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6320497|NCT00004346|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6320498|NCT00004346|Antimetabolites|antimetabolites|mesh-ancestor
6320499|NCT00004346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6320500|NCT00004346|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6320501|NCT00004346|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6320502|NCT00004346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6320503|NCT00004346|Cathartics|cathartics|mesh-ancestor
6320504|NCT00004346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6320505|NCT00004357|Methylprednisolone|methylprednisolone|mesh-list
6320506|NCT00004357|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6320507|NCT00004357|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6320508|NCT00004357|Prednisolone|prednisolone|mesh-list
6320509|NCT00004357|Prednisolone acetate|prednisolone acetate|mesh-list
6320510|NCT00004357|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6320511|NCT00004357|Prednisolone phosphate|prednisolone phosphate|mesh-list
6320512|NCT00004357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6320513|NCT00004357|Antiemetics|antiemetics|mesh-ancestor
6320514|NCT00004357|Autonomic Agents|autonomic agents|mesh-ancestor
6016508|NCT00365417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6320515|NCT00004357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6320516|NCT00004357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320517|NCT00004357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6320518|NCT00004357|Glucocorticoids|glucocorticoids|mesh-ancestor
6320519|NCT00004357|Hormones|hormones|mesh-ancestor
6320520|NCT00004357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6320521|NCT00004357|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6320522|NCT00004357|Protective Agents|protective agents|mesh-ancestor
6320523|NCT00004357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6320524|NCT00004357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6320525|NCT00004358|Calcitonin|calcitonin|mesh-list
6320526|NCT00004358|Salmon calcitonin|salmon calcitonin|mesh-list
6320527|NCT00004358|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
6320528|NCT00004358|Katacalcin|katacalcin|mesh-list
6320529|NCT00004358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6320530|NCT00004358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320531|NCT00004358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6320532|NCT00004358|Vasodilator Agents|vasodilator agents|mesh-ancestor
6320533|NCT00004359|Methoxsalen|methoxsalen|mesh-list
6320534|NCT00004359|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6320535|NCT00004359|Dermatologic Agents|dermatologic agents|mesh-ancestor
6320536|NCT00004360|Chlorothiazide|chlorothiazide|mesh-list
6320537|NCT00004360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6320538|NCT00004360|Diuretics|diuretics|mesh-ancestor
6320539|NCT00004360|Natriuretic Agents|natriuretic agents|mesh-ancestor
6320540|NCT00004360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320541|NCT00004360|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6320542|NCT00004360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6320543|NCT00004360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6320544|NCT00004361|Citric Acid|citric acid|mesh-list
6320545|NCT00004361|Sodium Citrate|sodium citrate|mesh-list
6320546|NCT00004361|Calcium|calcium|mesh-list
6320547|NCT00004361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6320548|NCT00004361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320549|NCT00004361|Anticoagulants|anticoagulants|mesh-ancestor
6320550|NCT00004361|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6320551|NCT00004361|Chelating Agents|chelating agents|mesh-ancestor
6320552|NCT00004361|Sequestering Agents|sequestering agents|mesh-ancestor
6320553|NCT00004361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6320554|NCT00004363|Chlorpropamide|chlorpropamide|mesh-list
6320555|NCT00004363|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
6016509|NCT00365417|Immunologic Factors|immunologic factors|mesh-ancestor
6016510|NCT00365417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320556|NCT00004363|Hemostatics|hemostatics|mesh-ancestor
6320557|NCT00004363|Coagulants|coagulants|mesh-ancestor
6320558|NCT00004363|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6320559|NCT00004363|Natriuretic Agents|natriuretic agents|mesh-ancestor
6320560|NCT00004363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320561|NCT00004363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6320562|NCT00004364|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
6320563|NCT00004364|Hemostatics|hemostatics|mesh-ancestor
6320564|NCT00004364|Coagulants|coagulants|mesh-ancestor
6320565|NCT00004364|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6016511|NCT00365417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6320566|NCT00004364|Natriuretic Agents|natriuretic agents|mesh-ancestor
6320567|NCT00004364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320568|NCT00004368|Colchicine|colchicine|mesh-list
6320569|NCT00004368|Gout Suppressants|gout suppressants|mesh-ancestor
6320570|NCT00004368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6320571|NCT00004368|Tubulin Modulators|tubulin modulators|mesh-ancestor
6320572|NCT00004368|Antimitotic Agents|antimitotic agents|mesh-ancestor
6320573|NCT00004368|Mitosis Modulators|mitosis modulators|mesh-ancestor
6320574|NCT00004368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6320575|NCT00004368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6320576|NCT00004373|Alprazolam|alprazolam|mesh-list
6320577|NCT00004373|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6320578|NCT00004373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6320579|NCT00004373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320580|NCT00004373|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6320581|NCT00004373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6320582|NCT00004373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6320583|NCT00004373|GABA Modulators|gaba modulators|mesh-ancestor
6320584|NCT00004373|GABA Agents|gaba agents|mesh-ancestor
6320585|NCT00004373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6320586|NCT00004373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392766|NCT00197821|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6392767|NCT00197821|Immunologic Factors|immunologic factors|mesh-ancestor
6392768|NCT00197821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392769|NCT00197834|Valproic Acid|valproic acid|mesh-list
6392770|NCT00197834|Anticonvulsants|anticonvulsants|mesh-ancestor
6392771|NCT00197834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6392772|NCT00197834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392773|NCT00197834|GABA Agents|gaba agents|mesh-ancestor
6392774|NCT00197834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6392775|NCT00197834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392776|NCT00197834|Antimanic Agents|antimanic agents|mesh-ancestor
6392777|NCT00197834|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6392778|NCT00197834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6392779|NCT00197834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6392780|NCT00197886|Norepinephrine|norepinephrine|mesh-list
6392781|NCT00197886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6392782|NCT00197886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6392783|NCT00197886|Adrenergic Agents|adrenergic agents|mesh-ancestor
6392784|NCT00197886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6392785|NCT00197886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392786|NCT00197886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392787|NCT00197886|Sympathomimetics|sympathomimetics|mesh-ancestor
6392788|NCT00197886|Autonomic Agents|autonomic agents|mesh-ancestor
6392789|NCT00197886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6392790|NCT00197886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6392791|NCT00197912|Celecoxib|celecoxib|mesh-list
6392792|NCT00197912|Cyclophosphamide|cyclophosphamide|mesh-list
6392793|NCT00197912|Interleukin-2|interleukin-2|mesh-list
6392794|NCT00197912|Immunologic Factors|immunologic factors|mesh-ancestor
6392795|NCT00197912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392796|NCT00197912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6392797|NCT00197912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6392798|NCT00197912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6392799|NCT00197912|Alkylating Agents|alkylating agents|mesh-ancestor
6392800|NCT00197912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392801|NCT00197912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6392802|NCT00197912|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6392803|NCT00197912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6392804|NCT00197912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6392805|NCT00197912|Analgesics|analgesics|mesh-ancestor
6392806|NCT00197912|Sensory System Agents|sensory system agents|mesh-ancestor
6392807|NCT00197912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6392808|NCT00197912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6392809|NCT00197912|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6392810|NCT00197912|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6392811|NCT00197912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6392812|NCT00198055|Aripiprazole|aripiprazole|mesh-list
6392813|NCT00198055|Antidepressive Agents|antidepressive agents|mesh-ancestor
6392814|NCT00198055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6392815|NCT00198055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6392816|NCT00198055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6392817|NCT00198055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6392818|NCT00198055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392819|NCT00198055|Dopamine Agonists|dopamine agonists|mesh-ancestor
6392820|NCT00198055|Dopamine Agents|dopamine agents|mesh-ancestor
6392821|NCT00198055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6320587|NCT00004376|Guanfacine|guanfacine|mesh-list
6320588|NCT00004376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6320589|NCT00004376|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6320590|NCT00004376|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6320591|NCT00004376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6320592|NCT00004376|Adrenergic Agents|adrenergic agents|mesh-ancestor
6320593|NCT00004376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6320594|NCT00004376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6320595|NCT00004376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320596|NCT00004380|Methocarbamol|methocarbamol|mesh-list
6320597|NCT00004380|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6320598|NCT00004380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320599|NCT00004380|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6320600|NCT00004380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6320601|NCT00004381|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
6320602|NCT00004381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6320603|NCT00004381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6320604|NCT00004382|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
6320605|NCT00004382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6320606|NCT00004382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6320607|NCT00004390|Morphine|morphine|mesh-list
6320608|NCT00004390|Methadone|methadone|mesh-list
6320609|NCT00004390|Nortriptyline|nortriptyline|mesh-list
6320610|NCT00004390|Desipramine|desipramine|mesh-list
6320611|NCT00004390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6320612|NCT00004390|Narcotics|narcotics|mesh-ancestor
6320613|NCT00004390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6320614|NCT00004390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320615|NCT00004390|Analgesics|analgesics|mesh-ancestor
6320616|NCT00004390|Sensory System Agents|sensory system agents|mesh-ancestor
6320617|NCT00004390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6320618|NCT00004390|Antitussive Agents|antitussive agents|mesh-ancestor
6320619|NCT00004390|Respiratory System Agents|respiratory system agents|mesh-ancestor
6320620|NCT00004390|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6320621|NCT00004390|Antidepressive Agents|antidepressive agents|mesh-ancestor
6320622|NCT00004390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6320623|NCT00004390|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6320624|NCT00004390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6320625|NCT00004390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6320626|NCT00004390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6320627|NCT00004390|Adrenergic Agents|adrenergic agents|mesh-ancestor
6320628|NCT00004390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6320629|NCT00004390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6320630|NCT00004393|Risperidone|risperidone|mesh-list
6320631|NCT00004393|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6320632|NCT00004393|Serotonin Agents|serotonin agents|mesh-ancestor
6320633|NCT00004393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6320634|NCT00004393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6320635|NCT00004393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320636|NCT00004393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6320637|NCT00004393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6320638|NCT00004393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6320639|NCT00004393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6320640|NCT00004393|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6320641|NCT00004393|Dopamine Agents|dopamine agents|mesh-ancestor
6320642|NCT00004396|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
6320643|NCT00004396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6320644|NCT00004396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6320645|NCT00004397|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
6320646|NCT00004397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6320647|NCT00004397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6320648|NCT00004398|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
6320649|NCT00004398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6320650|NCT00004398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6320651|NCT00004399|Magnesium Sulfate|magnesium sulfate|mesh-list
6320652|NCT00004399|Nimodipine|nimodipine|mesh-list
6320653|NCT00004399|Analgesics|analgesics|mesh-ancestor
6320654|NCT00004399|Sensory System Agents|sensory system agents|mesh-ancestor
6320655|NCT00004399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6320656|NCT00004399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320657|NCT00004399|Anesthetics|anesthetics|mesh-ancestor
6320658|NCT00004399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6320659|NCT00004399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6320660|NCT00004399|Anticonvulsants|anticonvulsants|mesh-ancestor
6320661|NCT00004399|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6320662|NCT00004399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6320663|NCT00004399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6320664|NCT00004399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6320665|NCT00004399|Tocolytic Agents|tocolytic agents|mesh-ancestor
6320666|NCT00004399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6320667|NCT00004399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6320668|NCT00004399|Vasodilator Agents|vasodilator agents|mesh-ancestor
6320669|NCT00004400|Testosterone|testosterone|mesh-list
6320670|NCT00004400|Androgens|androgens|mesh-ancestor
6320671|NCT00004400|Hormones|hormones|mesh-ancestor
6320672|NCT00004400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6320673|NCT00004400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320674|NCT00004401|Immunoglobulins|immunoglobulins|mesh-list
6320675|NCT00004401|Antibodies|antibodies|mesh-list
6320676|NCT00004401|gamma-Globulins|gamma-globulins|mesh-list
6320677|NCT00004401|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6320678|NCT00004401|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6320679|NCT00004401|Immunologic Factors|immunologic factors|mesh-ancestor
6320680|NCT00004401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320681|NCT00004402|Calcitriol|calcitriol|mesh-list
6320682|NCT00004402|Interferons|interferons|mesh-list
6320683|NCT00004402|Interferon-gamma|interferon-gamma|mesh-list
6320684|NCT00004402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6320685|NCT00004402|Antiviral Agents|antiviral agents|mesh-ancestor
6320686|NCT00004402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6320687|NCT00004402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6320688|NCT00004402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320689|NCT00004402|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6320690|NCT00004402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6320691|NCT00004402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6320692|NCT00004402|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6320693|NCT00004402|Vitamins|vitamins|mesh-ancestor
6320694|NCT00004402|Micronutrients|micronutrients|mesh-ancestor
6320695|NCT00004402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6320696|NCT00004403|Albendazole|albendazole|mesh-list
6320697|NCT00004403|Dexamethasone|dexamethasone|mesh-list
6320698|NCT00004403|Phenytoin|phenytoin|mesh-list
6320699|NCT00004403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6320700|NCT00004403|Antiemetics|antiemetics|mesh-ancestor
6320701|NCT00004403|Autonomic Agents|autonomic agents|mesh-ancestor
6320702|NCT00004403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6320703|NCT00004403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320704|NCT00004403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6320705|NCT00004403|Glucocorticoids|glucocorticoids|mesh-ancestor
6320706|NCT00004403|Hormones|hormones|mesh-ancestor
6320707|NCT00004403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6320708|NCT00004403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6320709|NCT00004403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6320710|NCT00004403|Anthelmintics|anthelmintics|mesh-ancestor
6320711|NCT00004403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6320712|NCT00004403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6320713|NCT00004403|Anticestodal Agents|anticestodal agents|mesh-ancestor
6320714|NCT00004403|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6320715|NCT00004403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6320716|NCT00004403|Tubulin Modulators|tubulin modulators|mesh-ancestor
6320717|NCT00004403|Antimitotic Agents|antimitotic agents|mesh-ancestor
6320718|NCT00004403|Mitosis Modulators|mitosis modulators|mesh-ancestor
6320719|NCT00004403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6320720|NCT00004403|Anticonvulsants|anticonvulsants|mesh-ancestor
6320721|NCT00004403|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6320722|NCT00004403|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6320723|NCT00004403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6320724|NCT00004403|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6320725|NCT00004403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6320726|NCT00004404|Clotrimazole|clotrimazole|mesh-list
6320727|NCT00004404|Miconazole|miconazole|mesh-list
6320728|NCT00004404|Hydroxyurea|hydroxyurea|mesh-list
6320729|NCT00004404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6320730|NCT00004404|Antisickling Agents|antisickling agents|mesh-ancestor
6320731|NCT00004404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6320732|NCT00004404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6320733|NCT00004404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6320734|NCT00004404|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6320735|NCT00004404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6320736|NCT00004404|Antifungal Agents|antifungal agents|mesh-ancestor
6320737|NCT00004404|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6320738|NCT00004404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6320739|NCT00004404|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6320740|NCT00004404|Hormone Antagonists|hormone antagonists|mesh-ancestor
6320741|NCT00004404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6320742|NCT00004404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320743|NCT00004404|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6320744|NCT00004404|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6320745|NCT00004406|Hormones|hormones|mesh-list
6320746|NCT00004406|Parathyroid Hormone|parathyroid hormone|mesh-list
6320747|NCT00004406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6320748|NCT00004406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320749|NCT00004406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6320750|NCT00004407|Immunoglobulins|immunoglobulins|mesh-list
6320751|NCT00004407|Antibodies|antibodies|mesh-list
6320752|NCT00004407|gamma-Globulins|gamma-globulins|mesh-list
6320753|NCT00004407|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6320754|NCT00004407|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6320755|NCT00004407|Immunologic Factors|immunologic factors|mesh-ancestor
6320756|NCT00004407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320757|NCT00004410|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
6320758|NCT00004410|Antiviral Agents|antiviral agents|mesh-ancestor
6320759|NCT00004410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6320760|NCT00004410|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6320761|NCT00004410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6320762|NCT00004416|Botulinum Toxins|botulinum toxins|mesh-list
6320763|NCT00004416|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6320764|NCT00004416|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6320765|NCT00004416|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6320766|NCT00004416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6320767|NCT00004416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6320768|NCT00004416|Cholinergic Agents|cholinergic agents|mesh-ancestor
6320769|NCT00004416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6320770|NCT00004416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320771|NCT00004416|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6320772|NCT00004416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6320773|NCT00004419|Mitogens|mitogens|mesh-list
6320774|NCT00004419|Mitosis Modulators|mitosis modulators|mesh-ancestor
6320775|NCT00004419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6320776|NCT00004420|Evening primrose oil|evening primrose oil|mesh-list
6320777|NCT00004420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6320778|NCT00004420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6320779|NCT00004420|Analgesics|analgesics|mesh-ancestor
6320780|NCT00004420|Sensory System Agents|sensory system agents|mesh-ancestor
6320781|NCT00004420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6320782|NCT00004420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320783|NCT00004420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6320784|NCT00004420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6320785|NCT00004420|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6320786|NCT00004420|Antimetabolites|antimetabolites|mesh-ancestor
6320787|NCT00004420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6320788|NCT00004420|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6320789|NCT00004420|Dermatologic Agents|dermatologic agents|mesh-ancestor
6320790|NCT00004422|Immunoglobulins|immunoglobulins|mesh-list
6320791|NCT00004422|Antibodies|antibodies|mesh-list
6320792|NCT00004422|gamma-Globulins|gamma-globulins|mesh-list
6320793|NCT00004422|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6320794|NCT00004422|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6320795|NCT00004422|Immunologic Factors|immunologic factors|mesh-ancestor
6320796|NCT00004422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320797|NCT00004423|Aminosalicylic Acid|aminosalicylic acid|mesh-list
6320798|NCT00004423|Antitubercular Agents|antitubercular agents|mesh-ancestor
6320799|NCT00004423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6320800|NCT00004423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6320801|NCT00004424|Fentanyl|fentanyl|mesh-list
6320802|NCT00004424|Midazolam|midazolam|mesh-list
6320803|NCT00004424|Propofol|propofol|mesh-list
6320804|NCT00004424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6320805|NCT00004424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6320806|NCT00004424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320807|NCT00004424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6320808|NCT00004424|Anesthetics, General|anesthetics, general|mesh-ancestor
6320809|NCT00004424|Anesthetics|anesthetics|mesh-ancestor
6320810|NCT00004424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6320811|NCT00004424|Narcotics|narcotics|mesh-ancestor
6320812|NCT00004424|Analgesics|analgesics|mesh-ancestor
6320813|NCT00004424|Sensory System Agents|sensory system agents|mesh-ancestor
6320814|NCT00004424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6320815|NCT00004424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6320816|NCT00004424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6320817|NCT00004424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6320818|NCT00004424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6320819|NCT00004424|GABA Modulators|gaba modulators|mesh-ancestor
6320820|NCT00004424|GABA Agents|gaba agents|mesh-ancestor
6320821|NCT00004424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6320822|NCT00004424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6320823|NCT00004426|Leuprolide|leuprolide|mesh-list
6320824|NCT00004426|Hormones|hormones|mesh-list
6320825|NCT00004426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6320826|NCT00004426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320827|NCT00004426|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6320828|NCT00004426|Fertility Agents|fertility agents|mesh-ancestor
6320829|NCT00004426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6320830|NCT00004426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6320831|NCT00004426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6320832|NCT00004429|Hormones|hormones|mesh-list
6320833|NCT00004429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6320834|NCT00004429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320835|NCT00004430|Prednisolone|prednisolone|mesh-list
6320836|NCT00004430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6320837|NCT00004430|Glucocorticoids|glucocorticoids|mesh-ancestor
6320838|NCT00004430|Hormones|hormones|mesh-ancestor
6320839|NCT00004430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6320840|NCT00004430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320841|NCT00004430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6320842|NCT00004430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6320843|NCT00004431|Baclofen|baclofen|mesh-list
6320844|NCT00004431|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6320845|NCT00004431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320846|NCT00004431|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6320847|NCT00004431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6320848|NCT00004431|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6320849|NCT00004431|GABA Agonists|gaba agonists|mesh-ancestor
6320850|NCT00004431|GABA Agents|gaba agents|mesh-ancestor
6320851|NCT00004431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6320852|NCT00004431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6320853|NCT00004433|Pergolide|pergolide|mesh-list
6320854|NCT00004433|Dopamine Agonists|dopamine agonists|mesh-ancestor
6320855|NCT00004433|Dopamine Agents|dopamine agents|mesh-ancestor
6320856|NCT00004433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6320857|NCT00004433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6320858|NCT00004433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320859|NCT00004436|Prednisone|prednisone|mesh-list
6320860|NCT00004436|Leuprolide|leuprolide|mesh-list
6320861|NCT00004436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6320862|NCT00004436|Glucocorticoids|glucocorticoids|mesh-ancestor
6320863|NCT00004436|Hormones|hormones|mesh-ancestor
6320864|NCT00004436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6320865|NCT00004436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320866|NCT00004436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6320867|NCT00004436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6320868|NCT00004436|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6320869|NCT00004436|Fertility Agents|fertility agents|mesh-ancestor
6320870|NCT00004436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6320871|NCT00004438|Leuprolide|leuprolide|mesh-list
6320872|NCT00004438|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6320873|NCT00004438|Fertility Agents|fertility agents|mesh-ancestor
6320874|NCT00004438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6320875|NCT00004438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320876|NCT00004438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6320877|NCT00004438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6320878|NCT00004440|Ibuprofen|ibuprofen|mesh-list
6320879|NCT00004440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6320880|NCT00004440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6320881|NCT00004440|Analgesics|analgesics|mesh-ancestor
6320882|NCT00004440|Sensory System Agents|sensory system agents|mesh-ancestor
6320883|NCT00004440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6320884|NCT00004440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320885|NCT00004440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6320886|NCT00004440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6320887|NCT00004440|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6320888|NCT00004440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6320889|NCT00004440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6320890|NCT00004441|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
6320891|NCT00004441|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
6320892|NCT00004441|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6320893|NCT00004441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6320894|NCT00004441|Antiviral Agents|antiviral agents|mesh-ancestor
6320895|NCT00004441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6320896|NCT00004442|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
6320897|NCT00004442|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
6320898|NCT00004442|Cholic Acids|cholic acids|mesh-list
6320899|NCT00004442|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6320900|NCT00004442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6320901|NCT00004442|Cathartics|cathartics|mesh-ancestor
6320902|NCT00004444|Paromomycin|paromomycin|mesh-list
6320903|NCT00004444|Streptomycin|streptomycin|mesh-list
6320904|NCT00004444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6320905|NCT00004444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6320906|NCT00004444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6320907|NCT00004444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6320908|NCT00004444|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6320909|NCT00004444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6320910|NCT00004444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6320911|NCT00004446|Fluoxetine|fluoxetine|mesh-list
6320912|NCT00004446|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6320913|NCT00004446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6320914|NCT00004446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6320915|NCT00004446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6320916|NCT00004446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6320917|NCT00004446|Serotonin Agents|serotonin agents|mesh-ancestor
6320918|NCT00004446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320919|NCT00004446|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6320920|NCT00004446|Antidepressive Agents|antidepressive agents|mesh-ancestor
6320921|NCT00004446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6320922|NCT00004446|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6320923|NCT00004446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6320924|NCT00004446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6320925|NCT00004448|Prednisone|prednisone|mesh-list
6320926|NCT00004448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6320927|NCT00004448|Glucocorticoids|glucocorticoids|mesh-ancestor
6320928|NCT00004448|Hormones|hormones|mesh-ancestor
6320929|NCT00004448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6320930|NCT00004448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320931|NCT00004448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6320932|NCT00004448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6320933|NCT00004450|Interferons|interferons|mesh-list
6320934|NCT00004450|Interferon-beta|interferon-beta|mesh-list
6320935|NCT00004450|Thalidomide|thalidomide|mesh-list
6320936|NCT00004450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6320937|NCT00004450|Antiviral Agents|antiviral agents|mesh-ancestor
6320938|NCT00004450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6320939|NCT00004450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6320940|NCT00004450|Immunologic Factors|immunologic factors|mesh-ancestor
6320941|NCT00004450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320942|NCT00004450|Leprostatic Agents|leprostatic agents|mesh-ancestor
6320943|NCT00004450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6320944|NCT00004450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6320945|NCT00004450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6320946|NCT00004450|Growth Substances|growth substances|mesh-ancestor
6320947|NCT00004450|Growth Inhibitors|growth inhibitors|mesh-ancestor
6320948|NCT00004464|Cyclophosphamide|cyclophosphamide|mesh-list
6320949|NCT00004464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6320950|NCT00004464|Immunologic Factors|immunologic factors|mesh-ancestor
6320951|NCT00004464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320952|NCT00004464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6320953|NCT00004464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6320954|NCT00004464|Alkylating Agents|alkylating agents|mesh-ancestor
6320955|NCT00004464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6320956|NCT00004464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6320957|NCT00004464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6320958|NCT00004465|Shiga Toxins|shiga toxins|mesh-list
6320959|NCT00004465|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6320960|NCT00004465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6320961|NCT00004465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6320962|NCT00004466|Atorvastatin|atorvastatin|mesh-list
6320963|NCT00004466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6320964|NCT00004466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6320965|NCT00004466|Antimetabolites|antimetabolites|mesh-ancestor
6320966|NCT00004466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6320967|NCT00004466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6320968|NCT00004466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6320969|NCT00004466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6320970|NCT00004467|Acetylcysteine|acetylcysteine|mesh-list
6320971|NCT00004467|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6320972|NCT00004467|Antiviral Agents|antiviral agents|mesh-ancestor
6320973|NCT00004467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6320974|NCT00004467|Expectorants|expectorants|mesh-ancestor
6320975|NCT00004467|Respiratory System Agents|respiratory system agents|mesh-ancestor
6320976|NCT00004467|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6320977|NCT00004467|Antioxidants|antioxidants|mesh-ancestor
6320978|NCT00004467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6320979|NCT00004467|Protective Agents|protective agents|mesh-ancestor
6320980|NCT00004467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320981|NCT00004467|Antidotes|antidotes|mesh-ancestor
6320982|NCT00004468|Calcitriol|calcitriol|mesh-list
6320983|NCT00004468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6320984|NCT00004468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320985|NCT00004468|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6320986|NCT00004468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6320987|NCT00004468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6320988|NCT00004468|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6320989|NCT00004468|Vitamins|vitamins|mesh-ancestor
6320990|NCT00004468|Micronutrients|micronutrients|mesh-ancestor
6320991|NCT00004468|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6320992|NCT00004474|Cyclophosphamide|cyclophosphamide|mesh-list
6320993|NCT00004474|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6320994|NCT00004474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6320995|NCT00004474|Immunologic Factors|immunologic factors|mesh-ancestor
6320996|NCT00004474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6320997|NCT00004474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6320998|NCT00004474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6320999|NCT00004474|Alkylating Agents|alkylating agents|mesh-ancestor
6321000|NCT00004474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6321001|NCT00004474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6321002|NCT00004474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6321003|NCT00004478|Droxidopa|droxidopa|mesh-list
6321004|NCT00004478|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6321005|NCT00004478|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6321006|NCT00004479|Midodrine|midodrine|mesh-list
6321007|NCT00004479|Sympathomimetics|sympathomimetics|mesh-ancestor
6321008|NCT00004479|Autonomic Agents|autonomic agents|mesh-ancestor
6321009|NCT00004479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6321010|NCT00004479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321011|NCT00004479|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6321012|NCT00004479|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6321013|NCT00004479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6321014|NCT00004479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6321015|NCT00004479|Adrenergic Agents|adrenergic agents|mesh-ancestor
6321016|NCT00004479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6321017|NCT00004479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6321018|NCT00004480|Botulinum Toxins|botulinum toxins|mesh-list
6321019|NCT00004480|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6321020|NCT00004480|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6321021|NCT00004480|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6321022|NCT00004480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6321023|NCT00004480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6321024|NCT00004480|Cholinergic Agents|cholinergic agents|mesh-ancestor
6321025|NCT00004480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6321026|NCT00004480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321027|NCT00004480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6321028|NCT00004480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6321029|NCT00004482|Cyclosporine|cyclosporine|mesh-list
6321030|NCT00004482|Prednisone|prednisone|mesh-list
6321031|NCT00004482|Methylprednisolone|methylprednisolone|mesh-list
6321032|NCT00004482|Cyclosporins|cyclosporins|mesh-list
6321033|NCT00004482|Muromonab-CD3|muromonab-cd3|mesh-list
6321034|NCT00004482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6321035|NCT00004482|Glucocorticoids|glucocorticoids|mesh-ancestor
6321036|NCT00004482|Hormones|hormones|mesh-ancestor
6321037|NCT00004482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6321038|NCT00004482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321039|NCT00004482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6321040|NCT00004482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6321041|NCT00004482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6321042|NCT00004482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6321043|NCT00004482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6321044|NCT00004482|Immunologic Factors|immunologic factors|mesh-ancestor
6321045|NCT00004482|Antifungal Agents|antifungal agents|mesh-ancestor
6321046|NCT00004482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6321047|NCT00004482|Dermatologic Agents|dermatologic agents|mesh-ancestor
6321048|NCT00004482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6321049|NCT00004482|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6321050|NCT00004482|Antiemetics|antiemetics|mesh-ancestor
6321051|NCT00004482|Autonomic Agents|autonomic agents|mesh-ancestor
6321052|NCT00004482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6321053|NCT00004482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6321054|NCT00004482|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6321055|NCT00004482|Protective Agents|protective agents|mesh-ancestor
6321056|NCT00004485|Cyclosporine|cyclosporine|mesh-list
6321057|NCT00004485|Mycophenolic Acid|mycophenolic acid|mesh-list
6321058|NCT00004485|Fludarabine|fludarabine|mesh-list
6321059|NCT00004485|Cyclosporins|cyclosporins|mesh-list
6321060|NCT00004485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6321061|NCT00004485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6321062|NCT00004485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6321063|NCT00004485|Immunologic Factors|immunologic factors|mesh-ancestor
6321064|NCT00004485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321065|NCT00004485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6321066|NCT00004485|Antifungal Agents|antifungal agents|mesh-ancestor
6321067|NCT00004485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6321068|NCT00004485|Dermatologic Agents|dermatologic agents|mesh-ancestor
6321069|NCT00004485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6321070|NCT00004485|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6321071|NCT00004485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6321072|NCT00004485|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6321073|NCT00004485|Antitubercular Agents|antitubercular agents|mesh-ancestor
6321074|NCT00004485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6321075|NCT00004486|Fluoxetine|fluoxetine|mesh-list
6321076|NCT00004486|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6321077|NCT00004486|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6321078|NCT00004486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6321079|NCT00004486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6321080|NCT00004486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6321081|NCT00004486|Serotonin Agents|serotonin agents|mesh-ancestor
6321082|NCT00004486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321083|NCT00004486|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6321084|NCT00004486|Antidepressive Agents|antidepressive agents|mesh-ancestor
6321085|NCT00004486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6321086|NCT00004486|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6321087|NCT00004486|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6321088|NCT00004486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6321089|NCT00004488|Cholecalciferol|cholecalciferol|mesh-list
6321090|NCT00004488|Alendronate|alendronate|mesh-list
6321091|NCT00004488|Calcium Carbonate|calcium carbonate|mesh-list
6321092|NCT00004488|Calcium|calcium|mesh-list
6321093|NCT00004488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6321094|NCT00004488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321095|NCT00004488|Vitamins|vitamins|mesh-ancestor
6321096|NCT00004488|Micronutrients|micronutrients|mesh-ancestor
6321097|NCT00004488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6321098|NCT00004488|Antacids|antacids|mesh-ancestor
6321099|NCT00004488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6321100|NCT00004488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6321101|NCT00004489|Cholecalciferol|cholecalciferol|mesh-list
6321102|NCT00004489|Alendronate|alendronate|mesh-list
6321103|NCT00004489|Calcium Carbonate|calcium carbonate|mesh-list
6321104|NCT00004489|Calcium|calcium|mesh-list
6321105|NCT00004489|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6321106|NCT00004489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321107|NCT00004489|Vitamins|vitamins|mesh-ancestor
6321108|NCT00004489|Micronutrients|micronutrients|mesh-ancestor
6321109|NCT00004489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6321110|NCT00004489|Antacids|antacids|mesh-ancestor
6321111|NCT00004489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6321112|NCT00004489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6321113|NCT00004492|Clotrimazole|clotrimazole|mesh-list
6321114|NCT00004492|Miconazole|miconazole|mesh-list
6321115|NCT00004492|Hydroxyurea|hydroxyurea|mesh-list
6321116|NCT00004492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6321117|NCT00004492|Antisickling Agents|antisickling agents|mesh-ancestor
6321118|NCT00004492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6321119|NCT00004492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6321120|NCT00004492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6321121|NCT00004492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6321122|NCT00004492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6321123|NCT00004492|Antifungal Agents|antifungal agents|mesh-ancestor
6321124|NCT00004492|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6321125|NCT00004492|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6321126|NCT00004492|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6321127|NCT00004492|Hormone Antagonists|hormone antagonists|mesh-ancestor
6321128|NCT00004492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6321129|NCT00004492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321130|NCT00004492|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6321131|NCT00004492|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6321132|NCT00004494|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
6321133|NCT00004494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6321134|NCT00004494|Vasodilator Agents|vasodilator agents|mesh-ancestor
6321135|NCT00004494|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6321136|NCT00004494|Protective Agents|protective agents|mesh-ancestor
6321137|NCT00004494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321138|NCT00004495|Folic Acid|folic acid|mesh-list
6321139|NCT00004495|Pyridoxine|pyridoxine|mesh-list
6321140|NCT00004495|Vitamin B 12|vitamin b 12|mesh-list
6321141|NCT00004495|Hydroxocobalamin|hydroxocobalamin|mesh-list
6321142|NCT00004495|Hematinics|hematinics|mesh-ancestor
6321143|NCT00004495|Vitamin B Complex|vitamin b complex|mesh-ancestor
6321144|NCT00004495|Vitamins|vitamins|mesh-ancestor
6321145|NCT00004495|Micronutrients|micronutrients|mesh-ancestor
6321146|NCT00004495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321147|NCT00004496|Hormones|hormones|mesh-list
6321148|NCT00004496|alpha-MSH|alpha-msh|mesh-list
6321149|NCT00004496|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6321150|NCT00004496|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
6321151|NCT00004496|beta-Endorphin|beta-endorphin|mesh-list
6321152|NCT00004496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6321153|NCT00004496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321154|NCT00004496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6321155|NCT00004496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6321156|NCT00004551|Nicotine|nicotine|mesh-list
6321157|NCT00004551|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6321158|NCT00004551|Autonomic Agents|autonomic agents|mesh-ancestor
6321159|NCT00004551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6321160|NCT00004551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321161|NCT00004551|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6321162|NCT00004551|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6321163|NCT00004551|Cholinergic Agents|cholinergic agents|mesh-ancestor
6321164|NCT00004551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6321165|NCT00004551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6321166|NCT00004552|Acamprosate|acamprosate|mesh-list
6321167|NCT00004552|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6321168|NCT00004554|Naltrexone|naltrexone|mesh-list
6321169|NCT00004554|Sertraline|sertraline|mesh-list
6321170|NCT00004554|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6321171|NCT00004554|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6321172|NCT00004554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321173|NCT00004554|Sensory System Agents|sensory system agents|mesh-ancestor
6321174|NCT00004554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6321175|NCT00004554|Antidepressive Agents|antidepressive agents|mesh-ancestor
6321176|NCT00004554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6321177|NCT00004554|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6321178|NCT00004554|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6321179|NCT00004554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6321180|NCT00004554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6321181|NCT00004554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6321182|NCT00004554|Serotonin Agents|serotonin agents|mesh-ancestor
6321183|NCT00004564|Clopidogrel|clopidogrel|mesh-list
6321184|NCT00004564|Atorvastatin|atorvastatin|mesh-list
6321185|NCT00004564|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6321186|NCT00004564|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6321187|NCT00004564|Antimetabolites|antimetabolites|mesh-ancestor
6321188|NCT00004564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6321189|NCT00004564|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6321190|NCT00004564|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6321191|NCT00004564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6321192|NCT00004564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6321193|NCT00004564|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6321194|NCT00004564|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6321195|NCT00004564|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6321196|NCT00004564|Purinergic Agents|purinergic agents|mesh-ancestor
6321197|NCT00004564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6321198|NCT00004564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392822|NCT00198055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392823|NCT00198055|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6392824|NCT00198055|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6392825|NCT00198055|Serotonin Agents|serotonin agents|mesh-ancestor
6392826|NCT00198055|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6392827|NCT00198055|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6392828|NCT00198055|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6392829|NCT00198055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6392830|NCT00198094|Alprazolam|alprazolam|mesh-list
6392831|NCT00198094|Sertraline|sertraline|mesh-list
6392832|NCT00198094|Antidepressive Agents|antidepressive agents|mesh-ancestor
6392833|NCT00198094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6392834|NCT00198094|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6392835|NCT00198094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6392836|NCT00198094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6392837|NCT00198094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392838|NCT00198094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6392839|NCT00198094|Serotonin Agents|serotonin agents|mesh-ancestor
6392840|NCT00198094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392841|NCT00198094|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6392842|NCT00198094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6392843|NCT00198094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6392844|NCT00198094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6392845|NCT00198094|GABA Modulators|gaba modulators|mesh-ancestor
6392846|NCT00198094|GABA Agents|gaba agents|mesh-ancestor
6392847|NCT00198120|Cycloserine|cycloserine|mesh-list
6392848|NCT00198120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6392849|NCT00198120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6392850|NCT00198120|Renal Agents|renal agents|mesh-ancestor
6392851|NCT00198120|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6392852|NCT00198120|Antitubercular Agents|antitubercular agents|mesh-ancestor
6392853|NCT00198120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6392854|NCT00198120|Antimetabolites|antimetabolites|mesh-ancestor
6392855|NCT00198120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392856|NCT00198146|Daclizumab|daclizumab|mesh-list
6392857|NCT00198146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6392858|NCT00198146|Immunologic Factors|immunologic factors|mesh-ancestor
6392859|NCT00198146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392860|NCT00198159|Gefitinib|gefitinib|mesh-list
6392861|NCT00198159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6392862|NCT00198159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6392863|NCT00198159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6392864|NCT00198159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392865|NCT00198172|Epirubicin|epirubicin|mesh-list
6321199|NCT00004567|Mycophenolic Acid|mycophenolic acid|mesh-list
6321200|NCT00004567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6321201|NCT00004567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6321202|NCT00004567|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6321203|NCT00004567|Antitubercular Agents|antitubercular agents|mesh-ancestor
6321204|NCT00004567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6321205|NCT00004567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6321206|NCT00004567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6321207|NCT00004567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6321208|NCT00004573|Ganciclovir|ganciclovir|mesh-list
6321209|NCT00004573|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6321210|NCT00004573|Antiviral Agents|antiviral agents|mesh-ancestor
6321211|NCT00004573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6321212|NCT00004573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6321213|NCT00004573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6321214|NCT00004573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6321215|NCT00004575|Miconazole|miconazole|mesh-list
6321216|NCT00004575|Bradykinin|bradykinin|mesh-list
6321217|NCT00004575|Kininogens|kininogens|mesh-list
6321218|NCT00004575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6321219|NCT00004575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6321220|NCT00004575|Antifungal Agents|antifungal agents|mesh-ancestor
6321221|NCT00004575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6321222|NCT00004575|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6321223|NCT00004575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6321224|NCT00004575|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6321225|NCT00004575|Hormone Antagonists|hormone antagonists|mesh-ancestor
6321226|NCT00004575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6321227|NCT00004575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321228|NCT00004575|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6321229|NCT00004575|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6321230|NCT00004575|Vasodilator Agents|vasodilator agents|mesh-ancestor
6321231|NCT00004575|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
6321232|NCT00004575|Protease Inhibitors|protease inhibitors|mesh-ancestor
6321233|NCT00004578|Ritonavir|ritonavir|mesh-list
6321234|NCT00004578|Lopinavir|lopinavir|mesh-list
6321235|NCT00004578|Lamivudine|lamivudine|mesh-list
6321236|NCT00004578|Stavudine|stavudine|mesh-list
6321237|NCT00004578|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6321238|NCT00004578|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6321239|NCT00004578|Protease Inhibitors|protease inhibitors|mesh-ancestor
6321240|NCT00004578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6321241|NCT00004578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6321242|NCT00004578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6321243|NCT00004578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6321244|NCT00004578|Antiviral Agents|antiviral agents|mesh-ancestor
6321245|NCT00004578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6321246|NCT00004578|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6321247|NCT00004578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6321248|NCT00004578|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6321249|NCT00004578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6321250|NCT00004578|Antimetabolites|antimetabolites|mesh-ancestor
6321251|NCT00004580|Ritonavir|ritonavir|mesh-list
6321252|NCT00004580|Lopinavir|lopinavir|mesh-list
6321253|NCT00004580|Nevirapine|nevirapine|mesh-list
6321254|NCT00004580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6321255|NCT00004580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6321256|NCT00004580|Protease Inhibitors|protease inhibitors|mesh-ancestor
6321257|NCT00004580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6321258|NCT00004580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6321259|NCT00004580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6321260|NCT00004580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6321261|NCT00004580|Antiviral Agents|antiviral agents|mesh-ancestor
6321262|NCT00004580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6321263|NCT00004580|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6321264|NCT00004580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6321265|NCT00004580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6321266|NCT00004580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6321267|NCT00004580|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6321268|NCT00004580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6321269|NCT00004581|Ritonavir|ritonavir|mesh-list
6321270|NCT00004581|Lopinavir|lopinavir|mesh-list
6321271|NCT00004581|Nevirapine|nevirapine|mesh-list
6321272|NCT00004581|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6321273|NCT00004581|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6321274|NCT00004581|Protease Inhibitors|protease inhibitors|mesh-ancestor
6321275|NCT00004581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6321276|NCT00004581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6321277|NCT00004581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6321278|NCT00004581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6321279|NCT00004581|Antiviral Agents|antiviral agents|mesh-ancestor
6321280|NCT00004581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6321281|NCT00004581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6321282|NCT00004581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6321283|NCT00004581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6321284|NCT00004581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6321285|NCT00004581|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6321286|NCT00004581|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6321287|NCT00004582|Ritonavir|ritonavir|mesh-list
6321288|NCT00004582|Lopinavir|lopinavir|mesh-list
6321289|NCT00004582|Efavirenz|efavirenz|mesh-list
6321290|NCT00004582|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6321291|NCT00004582|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6321292|NCT00004582|Protease Inhibitors|protease inhibitors|mesh-ancestor
6321293|NCT00004582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6321294|NCT00004582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6321295|NCT00004582|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6321296|NCT00004582|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6321297|NCT00004582|Antiviral Agents|antiviral agents|mesh-ancestor
6321298|NCT00004582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6321299|NCT00004582|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6321300|NCT00004582|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6321301|NCT00004582|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6321302|NCT00004582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6321303|NCT00004582|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6321304|NCT00004582|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6321305|NCT00004582|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6321306|NCT00004582|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6321307|NCT00004582|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6321308|NCT00004583|Ritonavir|ritonavir|mesh-list
6321309|NCT00004583|Lopinavir|lopinavir|mesh-list
6321310|NCT00004583|Nelfinavir|nelfinavir|mesh-list
6321311|NCT00004583|Lamivudine|lamivudine|mesh-list
6321312|NCT00004583|Stavudine|stavudine|mesh-list
6321313|NCT00004583|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6321314|NCT00004583|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6321315|NCT00004583|Protease Inhibitors|protease inhibitors|mesh-ancestor
6321316|NCT00004583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6321317|NCT00004583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6321318|NCT00004583|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6321319|NCT00004583|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6321320|NCT00004583|Antiviral Agents|antiviral agents|mesh-ancestor
6321321|NCT00004583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6321322|NCT00004583|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6321323|NCT00004583|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6321324|NCT00004583|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6321325|NCT00004583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6321326|NCT00004583|Antimetabolites|antimetabolites|mesh-ancestor
6321327|NCT00004585|Lamivudine|lamivudine|mesh-list
6321328|NCT00004585|Zidovudine|zidovudine|mesh-list
6321329|NCT00004585|Efavirenz|efavirenz|mesh-list
6321330|NCT00004585|Abacavir|abacavir|mesh-list
6321331|NCT00004585|Dideoxynucleosides|dideoxynucleosides|mesh-list
6321332|NCT00004585|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6321333|NCT00004585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6321334|NCT00004585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6321335|NCT00004585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6321336|NCT00004585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6321337|NCT00004585|Antiviral Agents|antiviral agents|mesh-ancestor
6321338|NCT00004585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6321339|NCT00004585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6321340|NCT00004585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6321341|NCT00004585|Antimetabolites|antimetabolites|mesh-ancestor
6321342|NCT00004585|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6321343|NCT00004585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6321344|NCT00004585|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6321345|NCT00004585|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6321346|NCT00004585|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6321347|NCT00004585|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6321348|NCT00004637|Vitamin E|vitamin e|mesh-list
6321349|NCT00004637|Vitamins|vitamins|mesh-ancestor
6321350|NCT00004637|Micronutrients|micronutrients|mesh-ancestor
6321351|NCT00004637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321352|NCT00004637|Antioxidants|antioxidants|mesh-ancestor
6321353|NCT00004637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6321354|NCT00004637|Protective Agents|protective agents|mesh-ancestor
6321355|NCT00004640|Chlorhexidine|chlorhexidine|mesh-list
6321356|NCT00004640|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6321357|NCT00004640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6321358|NCT00004640|Disinfectants|disinfectants|mesh-ancestor
6321359|NCT00004643|Cytarabine|cytarabine|mesh-list
6321360|NCT00004643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6321361|NCT00004643|Antimetabolites|antimetabolites|mesh-ancestor
6321362|NCT00004643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6321363|NCT00004643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6321364|NCT00004643|Antiviral Agents|antiviral agents|mesh-ancestor
6321365|NCT00004643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6321366|NCT00004643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6321367|NCT00004643|Immunologic Factors|immunologic factors|mesh-ancestor
6321368|NCT00004643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321369|NCT00004644|Acyclovir|acyclovir|mesh-list
6321370|NCT00004644|Antiviral Agents|antiviral agents|mesh-ancestor
6321371|NCT00004644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6321372|NCT00004646|Prednisone|prednisone|mesh-list
6321373|NCT00004646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6321374|NCT00004646|Glucocorticoids|glucocorticoids|mesh-ancestor
6321375|NCT00004646|Hormones|hormones|mesh-ancestor
6321376|NCT00004646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6321377|NCT00004646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321378|NCT00004646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6321379|NCT00004646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6321380|NCT00004647|Mexiletine|mexiletine|mesh-list
6321381|NCT00004647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6321382|NCT00004647|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6321383|NCT00004647|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6321384|NCT00004647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6321385|NCT00004647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6321386|NCT00004650|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6321387|NCT00004650|Medroxyprogesterone|medroxyprogesterone|mesh-list
6321388|NCT00004650|Estrogens|estrogens|mesh-list
6321389|NCT00004650|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6321390|NCT00004650|Hormones|hormones|mesh-ancestor
6321391|NCT00004650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6321392|NCT00004650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321393|NCT00004650|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6321394|NCT00004650|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6321395|NCT00004650|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6321396|NCT00004650|Contraceptive Agents|contraceptive agents|mesh-ancestor
6321397|NCT00004650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6321398|NCT00004650|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6321399|NCT00004650|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6321400|NCT00004650|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6321401|NCT00004650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6321402|NCT00004650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6321403|NCT00004652|Pimozide|pimozide|mesh-list
6321404|NCT00004652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6321405|NCT00004652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6321406|NCT00004652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6321407|NCT00004652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321408|NCT00004652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6321409|NCT00004652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6321410|NCT00004652|Dopamine Agents|dopamine agents|mesh-ancestor
6321411|NCT00004652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6321412|NCT00004652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6321413|NCT00004652|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6321414|NCT00004662|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
6321415|NCT00004662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6321416|NCT00004662|Immunologic Factors|immunologic factors|mesh-ancestor
6321417|NCT00004662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321418|NCT00004664|Megestrol|megestrol|mesh-list
6321419|NCT00004664|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6321420|NCT00004664|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6321421|NCT00004664|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6321422|NCT00004664|Contraceptive Agents|contraceptive agents|mesh-ancestor
6321423|NCT00004664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6321424|NCT00004664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321425|NCT00004664|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6321426|NCT00004664|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6321427|NCT00004664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6321428|NCT00004664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6321429|NCT00004665|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
6321430|NCT00004665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6321431|NCT00004665|Immunologic Factors|immunologic factors|mesh-ancestor
6321432|NCT00004665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321433|NCT00004669|Hydrocortisone|hydrocortisone|mesh-list
6321434|NCT00004669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6321435|NCT00004682|Immunoglobulins|immunoglobulins|mesh-list
6321436|NCT00004682|Antibodies|antibodies|mesh-list
6321437|NCT00004682|gamma-Globulins|gamma-globulins|mesh-list
6321438|NCT00004682|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6321439|NCT00004682|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6321440|NCT00004682|Immunologic Factors|immunologic factors|mesh-ancestor
6321441|NCT00004682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321442|NCT00004685|Albuterol|albuterol|mesh-list
6321443|NCT00004685|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6321444|NCT00004685|Autonomic Agents|autonomic agents|mesh-ancestor
6321445|NCT00004685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6321446|NCT00004685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321447|NCT00004685|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6321448|NCT00004685|Respiratory System Agents|respiratory system agents|mesh-ancestor
6321449|NCT00004685|Tocolytic Agents|tocolytic agents|mesh-ancestor
6321450|NCT00004685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6321451|NCT00004685|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6321452|NCT00004685|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6321453|NCT00004685|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6321454|NCT00004685|Adrenergic Agents|adrenergic agents|mesh-ancestor
6321455|NCT00004685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6321456|NCT00004685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6321457|NCT00004686|Prednisone|prednisone|mesh-list
6321458|NCT00004686|Methotrexate|methotrexate|mesh-list
6321459|NCT00004686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6321460|NCT00004686|Glucocorticoids|glucocorticoids|mesh-ancestor
6321461|NCT00004686|Hormones|hormones|mesh-ancestor
6321462|NCT00004686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6321463|NCT00004686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321464|NCT00004686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6321465|NCT00004686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6321466|NCT00004686|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6321467|NCT00004686|Abortifacient Agents|abortifacient agents|mesh-ancestor
6321468|NCT00004686|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6321469|NCT00004686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6321470|NCT00004686|Antimetabolites|antimetabolites|mesh-ancestor
6321471|NCT00004686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6321472|NCT00004686|Dermatologic Agents|dermatologic agents|mesh-ancestor
6321473|NCT00004686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6321474|NCT00004686|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6321475|NCT00004686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6321476|NCT00004686|Immunologic Factors|immunologic factors|mesh-ancestor
6321477|NCT00004686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6321478|NCT00004686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6321479|NCT00004688|Mercaptopurine|mercaptopurine|mesh-list
6321480|NCT00004688|Carmustine|carmustine|mesh-list
6321481|NCT00004688|Streptozocin|streptozocin|mesh-list
6321482|NCT00004688|Antimetabolites|antimetabolites|mesh-ancestor
6321483|NCT00004688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6321484|NCT00004688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6321485|NCT00004688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6321486|NCT00004688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6321487|NCT00004688|Immunologic Factors|immunologic factors|mesh-ancestor
6321488|NCT00004688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321489|NCT00004688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6321490|NCT00004688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6321491|NCT00004688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6321492|NCT00004688|Alkylating Agents|alkylating agents|mesh-ancestor
6321493|NCT00004688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6321494|NCT00004689|Clarithromycin|clarithromycin|mesh-list
6321495|NCT00004689|Rifampin|rifampin|mesh-list
6321496|NCT00004689|Ethambutol|ethambutol|mesh-list
6321497|NCT00004689|Streptomycin|streptomycin|mesh-list
6321498|NCT00004689|Thioacetazone|thioacetazone|mesh-list
6321499|NCT00004689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6321500|NCT00004689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6321501|NCT00004689|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6321502|NCT00004689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6321503|NCT00004689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6321504|NCT00004689|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6321505|NCT00004689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6321506|NCT00004689|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6321507|NCT00004689|Antitubercular Agents|antitubercular agents|mesh-ancestor
6321508|NCT00004689|Leprostatic Agents|leprostatic agents|mesh-ancestor
6321509|NCT00004689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6321510|NCT00004689|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6321511|NCT00004689|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6321512|NCT00004689|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6321513|NCT00004689|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6321514|NCT00004689|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6321515|NCT00004689|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6321516|NCT00004690|Monolaurin|monolaurin|mesh-list
6321517|NCT00004690|Cariostatic Agents|cariostatic agents|mesh-ancestor
6321518|NCT00004690|Protective Agents|protective agents|mesh-ancestor
6321519|NCT00004690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321520|NCT00004694|Heparin|heparin|mesh-list
6321521|NCT00004694|Anticoagulants|anticoagulants|mesh-ancestor
6321522|NCT00004694|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6321523|NCT00004694|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6321524|NCT00004694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6321525|NCT00004695|Interleukin-2|interleukin-2|mesh-list
6321526|NCT00004695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6321527|NCT00004695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6321528|NCT00004695|Analgesics|analgesics|mesh-ancestor
6321529|NCT00004695|Sensory System Agents|sensory system agents|mesh-ancestor
6321530|NCT00004695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6321531|NCT00004695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321532|NCT00004696|Morphine|morphine|mesh-list
6321533|NCT00004696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6321534|NCT00004696|Narcotics|narcotics|mesh-ancestor
6321535|NCT00004696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6321536|NCT00004696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321537|NCT00004696|Analgesics|analgesics|mesh-ancestor
6321538|NCT00004696|Sensory System Agents|sensory system agents|mesh-ancestor
6321539|NCT00004696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6321540|NCT00004697|Choline|choline|mesh-list
6321541|NCT00004697|Lipotropic Agents|lipotropic agents|mesh-ancestor
6321542|NCT00004697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6321543|NCT00004697|Antimetabolites|antimetabolites|mesh-ancestor
6321544|NCT00004697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6321545|NCT00004697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6321546|NCT00004697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6321547|NCT00004697|Nootropic Agents|nootropic agents|mesh-ancestor
6321548|NCT00004699|Mitogens|mitogens|mesh-list
6321549|NCT00004699|Mitosis Modulators|mitosis modulators|mesh-ancestor
6321550|NCT00004699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6321551|NCT00004700|Mitogens|mitogens|mesh-list
6321552|NCT00004700|Mitosis Modulators|mitosis modulators|mesh-ancestor
6321553|NCT00004700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6321554|NCT00004705|Amiloride|amiloride|mesh-list
6321555|NCT00004705|Diuretics|diuretics|mesh-ancestor
6321556|NCT00004705|Natriuretic Agents|natriuretic agents|mesh-ancestor
6321557|NCT00004705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321558|NCT00004705|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
6321559|NCT00004705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6321560|NCT00004705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6321561|NCT00004705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6321562|NCT00004705|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
6321563|NCT00004705|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6321564|NCT00004727|Aspirin|aspirin|mesh-list
6321565|NCT00004727|Ticlopidine|ticlopidine|mesh-list
6321566|NCT00004727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6321567|NCT00004727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6321568|NCT00004727|Analgesics|analgesics|mesh-ancestor
6321569|NCT00004727|Sensory System Agents|sensory system agents|mesh-ancestor
6321570|NCT00004727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6321571|NCT00004727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321572|NCT00004727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6321573|NCT00004727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6321574|NCT00004727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6321575|NCT00004727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6321576|NCT00004727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6321577|NCT00004727|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6321578|NCT00004727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6321579|NCT00004727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6321580|NCT00004727|Antipyretics|antipyretics|mesh-ancestor
6321581|NCT00004727|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6321582|NCT00004727|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6321583|NCT00004727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6321584|NCT00004727|Purinergic Agents|purinergic agents|mesh-ancestor
6321585|NCT00004727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6321586|NCT00004727|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6321587|NCT00004727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6321588|NCT00004728|Aspirin|aspirin|mesh-list
6321589|NCT00004728|Warfarin|warfarin|mesh-list
6321590|NCT00004728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6321591|NCT00004728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6321592|NCT00004728|Analgesics|analgesics|mesh-ancestor
6321593|NCT00004728|Sensory System Agents|sensory system agents|mesh-ancestor
6321594|NCT00004728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6321595|NCT00004728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321596|NCT00004728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6321597|NCT00004728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6321598|NCT00004728|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6321599|NCT00004728|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6321600|NCT00004728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6321601|NCT00004728|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6321602|NCT00004728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6321603|NCT00004728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6321604|NCT00004728|Antipyretics|antipyretics|mesh-ancestor
6321605|NCT00004728|Anticoagulants|anticoagulants|mesh-ancestor
6321606|NCT00004730|Magnesium Sulfate|magnesium sulfate|mesh-list
6321607|NCT00004730|Analgesics|analgesics|mesh-ancestor
6321608|NCT00004730|Sensory System Agents|sensory system agents|mesh-ancestor
6321609|NCT00004730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6321610|NCT00004730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321611|NCT00004730|Anesthetics|anesthetics|mesh-ancestor
6321612|NCT00004730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6321613|NCT00004730|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6321614|NCT00004730|Anticonvulsants|anticonvulsants|mesh-ancestor
6321615|NCT00004730|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6321616|NCT00004730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6321617|NCT00004730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6321618|NCT00004730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6321619|NCT00004730|Tocolytic Agents|tocolytic agents|mesh-ancestor
6321620|NCT00004730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6321621|NCT00004731|Ubiquinone|ubiquinone|mesh-list
6321622|NCT00004731|Coenzyme Q10|coenzyme q10|mesh-list
6321623|NCT00004731|Micronutrients|micronutrients|mesh-ancestor
6321624|NCT00004731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321625|NCT00004731|Vitamins|vitamins|mesh-ancestor
6321626|NCT00004733|Levodopa|levodopa|mesh-list
6321627|NCT00004733|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6321628|NCT00004733|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6321629|NCT00004733|Dopamine Agents|dopamine agents|mesh-ancestor
6321630|NCT00004733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6321631|NCT00004733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6321632|NCT00004733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321633|NCT00004734|Folic Acid|folic acid|mesh-list
6321634|NCT00004734|Pyridoxine|pyridoxine|mesh-list
6321635|NCT00004734|Vitamin B 12|vitamin b 12|mesh-list
6321636|NCT00004734|Hydroxocobalamin|hydroxocobalamin|mesh-list
6321637|NCT00004734|Hematinics|hematinics|mesh-ancestor
6321638|NCT00004734|Vitamin B Complex|vitamin b complex|mesh-ancestor
6321639|NCT00004734|Vitamins|vitamins|mesh-ancestor
6321640|NCT00004734|Micronutrients|micronutrients|mesh-ancestor
6321641|NCT00004734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321642|NCT00004736|Lamivudine|lamivudine|mesh-list
6321643|NCT00004736|Zidovudine|zidovudine|mesh-list
6321644|NCT00004736|Stavudine|stavudine|mesh-list
6321645|NCT00004736|Nelfinavir|nelfinavir|mesh-list
6321646|NCT00004736|Isoniazid|isoniazid|mesh-list
6321647|NCT00004736|Pyrazinamide|pyrazinamide|mesh-list
6321648|NCT00004736|Ethambutol|ethambutol|mesh-list
6321649|NCT00004736|Rifabutin|rifabutin|mesh-list
6321650|NCT00004736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6321651|NCT00004736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6321652|NCT00004736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6321653|NCT00004736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6321654|NCT00004736|Antiviral Agents|antiviral agents|mesh-ancestor
6321655|NCT00004736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6321656|NCT00004736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6321657|NCT00004736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6321658|NCT00004736|Antimetabolites|antimetabolites|mesh-ancestor
6321659|NCT00004736|Antitubercular Agents|antitubercular agents|mesh-ancestor
6321660|NCT00004736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6321661|NCT00004736|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6321662|NCT00004736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6321663|NCT00004736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6321664|NCT00004736|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6321665|NCT00004736|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6321666|NCT00004736|Protease Inhibitors|protease inhibitors|mesh-ancestor
6321667|NCT00004736|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6321668|NCT00004739|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6321669|NCT00004739|Antiviral Agents|antiviral agents|mesh-ancestor
6321670|NCT00004739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6321671|NCT00004740|Isoniazid|isoniazid|mesh-list
6321672|NCT00004740|Antitubercular Agents|antitubercular agents|mesh-ancestor
6321673|NCT00004740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6321674|NCT00004740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6321675|NCT00004740|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6321676|NCT00004740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6321677|NCT00004740|Antimetabolites|antimetabolites|mesh-ancestor
6321678|NCT00004740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6321679|NCT00004740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6321680|NCT00004744|Immunoglobulins|immunoglobulins|mesh-list
6321681|NCT00004744|Antibodies|antibodies|mesh-list
6321682|NCT00004744|gamma-Globulins|gamma-globulins|mesh-list
6321683|NCT00004744|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6321684|NCT00004744|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6321685|NCT00004744|Immunologic Factors|immunologic factors|mesh-ancestor
6321686|NCT00004744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321687|NCT00004747|Immunoglobulins|immunoglobulins|mesh-list
6321688|NCT00004747|Antibodies|antibodies|mesh-list
6321689|NCT00004747|gamma-Globulins|gamma-globulins|mesh-list
6321690|NCT00004747|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6321691|NCT00004747|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6321692|NCT00004747|Immunologic Factors|immunologic factors|mesh-ancestor
6321693|NCT00004747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321694|NCT00004748|Methotrexate|methotrexate|mesh-list
6321695|NCT00004748|Colchicine|colchicine|mesh-list
6321696|NCT00004748|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
6321697|NCT00004748|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6321698|NCT00004748|Abortifacient Agents|abortifacient agents|mesh-ancestor
6321699|NCT00004748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6321700|NCT00004748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321701|NCT00004748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6321702|NCT00004748|Antimetabolites|antimetabolites|mesh-ancestor
6321703|NCT00004748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6321704|NCT00004748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6321705|NCT00004748|Dermatologic Agents|dermatologic agents|mesh-ancestor
6321706|NCT00004748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6321707|NCT00004748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6321708|NCT00004748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6321709|NCT00004748|Immunologic Factors|immunologic factors|mesh-ancestor
6321710|NCT00004748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6321711|NCT00004748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6321712|NCT00004748|Gout Suppressants|gout suppressants|mesh-ancestor
6321713|NCT00004748|Tubulin Modulators|tubulin modulators|mesh-ancestor
6321714|NCT00004748|Antimitotic Agents|antimitotic agents|mesh-ancestor
6321715|NCT00004748|Mitosis Modulators|mitosis modulators|mesh-ancestor
6321716|NCT00004748|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6321717|NCT00004748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6321718|NCT00004754|Epoprostenol|epoprostenol|mesh-list
6321719|NCT00004754|Tezosentan|tezosentan|mesh-list
6321720|NCT00004754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6321721|NCT00004754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6321722|NCT00004754|Vasodilator Agents|vasodilator agents|mesh-ancestor
6321723|NCT00004755|Meglumine Antimoniate|meglumine antimoniate|mesh-list
6321724|NCT00004755|Allopurinol|allopurinol|mesh-list
6321725|NCT00004755|Antimetabolites|antimetabolites|mesh-ancestor
6321726|NCT00004755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6321727|NCT00004755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6321728|NCT00004755|Gout Suppressants|gout suppressants|mesh-ancestor
6321729|NCT00004755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6321730|NCT00004755|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6321731|NCT00004755|Antioxidants|antioxidants|mesh-ancestor
6321732|NCT00004755|Protective Agents|protective agents|mesh-ancestor
6321733|NCT00004755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321734|NCT00004755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6321735|NCT00004755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6321736|NCT00004755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6321737|NCT00004757|Acyclovir|acyclovir|mesh-list
6321738|NCT00004757|Antiviral Agents|antiviral agents|mesh-ancestor
6321739|NCT00004757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6321740|NCT00004758|Pyridoxine|pyridoxine|mesh-list
6321741|NCT00004758|Carbamazepine|carbamazepine|mesh-list
6321742|NCT00004758|Valproic Acid|valproic acid|mesh-list
6321743|NCT00004758|Nitrazepam|nitrazepam|mesh-list
6321744|NCT00004758|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6321745|NCT00004758|Anticonvulsants|anticonvulsants|mesh-ancestor
6321746|NCT00004758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6321747|NCT00004758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6321748|NCT00004758|GABA Agents|gaba agents|mesh-ancestor
6321749|NCT00004758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6321750|NCT00004758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321751|NCT00004758|Antimanic Agents|antimanic agents|mesh-ancestor
6321752|NCT00004758|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6321753|NCT00004758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6321754|NCT00004758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6321755|NCT00004758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6321756|NCT00004758|Analgesics|analgesics|mesh-ancestor
6321757|NCT00004758|Sensory System Agents|sensory system agents|mesh-ancestor
6321758|NCT00004758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6321759|NCT00004758|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6321760|NCT00004758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6321761|NCT00004758|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6321762|NCT00004758|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6321763|NCT00004758|Vitamin B Complex|vitamin b complex|mesh-ancestor
6321764|NCT00004758|Vitamins|vitamins|mesh-ancestor
6321765|NCT00004758|Micronutrients|micronutrients|mesh-ancestor
6321766|NCT00004758|Hormones|hormones|mesh-ancestor
6321767|NCT00004758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6321768|NCT00004758|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6321769|NCT00004758|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6321770|NCT00004758|GABA Modulators|gaba modulators|mesh-ancestor
6321771|NCT00004759|Methylprednisolone|methylprednisolone|mesh-list
6321772|NCT00004759|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6321773|NCT00004759|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6321774|NCT00004759|Prednisolone|prednisolone|mesh-list
6321775|NCT00004759|Prednisolone acetate|prednisolone acetate|mesh-list
6321776|NCT00004759|Tirilazad|tirilazad|mesh-list
6321777|NCT00004759|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6321778|NCT00004759|Prednisolone phosphate|prednisolone phosphate|mesh-list
6016512|NCT00365417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6016513|NCT00365417|Alkylating Agents|alkylating agents|mesh-ancestor
6321779|NCT00004759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6321780|NCT00004759|Antiemetics|antiemetics|mesh-ancestor
6016514|NCT00365417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6321781|NCT00004759|Autonomic Agents|autonomic agents|mesh-ancestor
6321782|NCT00004759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6321783|NCT00004759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321784|NCT00004759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6321785|NCT00004759|Glucocorticoids|glucocorticoids|mesh-ancestor
6321786|NCT00004759|Hormones|hormones|mesh-ancestor
6321787|NCT00004759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6321788|NCT00004759|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6321789|NCT00004759|Protective Agents|protective agents|mesh-ancestor
6321790|NCT00004759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6321791|NCT00004759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6321792|NCT00004759|Antioxidants|antioxidants|mesh-ancestor
6321793|NCT00004759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6321794|NCT00004762|Cladribine|cladribine|mesh-list
6321795|NCT00004762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6321796|NCT00004762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6321797|NCT00004762|Immunologic Factors|immunologic factors|mesh-ancestor
6321798|NCT00004762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321799|NCT00004763|Leuprolide|leuprolide|mesh-list
6321800|NCT00004763|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6321801|NCT00004763|Norethindrone|norethindrone|mesh-list
6321802|NCT00004763|Norethindrone Acetate|norethindrone acetate|mesh-list
6321803|NCT00004763|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
6321804|NCT00004763|Norinyl|norinyl|mesh-list
6321805|NCT00004763|Estradiol|estradiol|mesh-list
6321806|NCT00004763|Estrogens|estrogens|mesh-ancestor
6321807|NCT00004763|Hormones|hormones|mesh-ancestor
6321808|NCT00004763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6321809|NCT00004763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321810|NCT00004763|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6321811|NCT00004763|Contraceptive Agents|contraceptive agents|mesh-ancestor
6321812|NCT00004763|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6321813|NCT00004763|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6321814|NCT00004763|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6321815|NCT00004763|Fertility Agents|fertility agents|mesh-ancestor
6321816|NCT00004763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6321817|NCT00004763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6321818|NCT00004763|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6321819|NCT00004763|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6321820|NCT00004763|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6321821|NCT00004763|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6321822|NCT00004763|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
6321823|NCT00004767|Sodium Benzoate|sodium benzoate|mesh-list
6321824|NCT00004767|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
6321825|NCT00004767|Phenylacetic acid|phenylacetic acid|mesh-list
6321826|NCT00004767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6321827|NCT00004767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6321828|NCT00004767|Antimetabolites|antimetabolites|mesh-ancestor
6321829|NCT00004767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6321830|NCT00004767|Antifungal Agents|antifungal agents|mesh-ancestor
6321831|NCT00004767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6321832|NCT00004770|Thioctic Acid|thioctic acid|mesh-list
6321833|NCT00004770|Antioxidants|antioxidants|mesh-ancestor
6321834|NCT00004770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6321835|NCT00004770|Protective Agents|protective agents|mesh-ancestor
6321836|NCT00004770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321837|NCT00004770|Vitamin B Complex|vitamin b complex|mesh-ancestor
6321838|NCT00004770|Vitamins|vitamins|mesh-ancestor
6321839|NCT00004770|Micronutrients|micronutrients|mesh-ancestor
6321840|NCT00004771|Leuprolide|leuprolide|mesh-list
6321841|NCT00004771|Testosterone|testosterone|mesh-list
6321842|NCT00004771|Androgens|androgens|mesh-ancestor
6321843|NCT00004771|Hormones|hormones|mesh-ancestor
6321844|NCT00004771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6321845|NCT00004771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321846|NCT00004771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6321847|NCT00004771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6321848|NCT00004771|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6321849|NCT00004771|Fertility Agents|fertility agents|mesh-ancestor
6321850|NCT00004771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6321851|NCT00004772|Immunoglobulins|immunoglobulins|mesh-list
6321852|NCT00004772|Antibodies|antibodies|mesh-list
6321853|NCT00004772|gamma-Globulins|gamma-globulins|mesh-list
6321854|NCT00004772|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6321855|NCT00004772|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6321856|NCT00004772|Immunologic Factors|immunologic factors|mesh-ancestor
6321857|NCT00004772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321858|NCT00004776|Topiramate|topiramate|mesh-list
6321859|NCT00004776|Anticonvulsants|anticonvulsants|mesh-ancestor
6321860|NCT00004776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6321861|NCT00004776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321862|NCT00004778|Dexamethasone|dexamethasone|mesh-list
6321863|NCT00004778|Betamethasone|betamethasone|mesh-list
6321864|NCT00004778|Hormones|hormones|mesh-list
6321865|NCT00004778|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
6321866|NCT00004778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6321867|NCT00004778|Antiemetics|antiemetics|mesh-ancestor
6321868|NCT00004778|Autonomic Agents|autonomic agents|mesh-ancestor
6321869|NCT00004778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6321870|NCT00004778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321871|NCT00004778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6321872|NCT00004778|Glucocorticoids|glucocorticoids|mesh-ancestor
6321873|NCT00004778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6321874|NCT00004778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6321875|NCT00004778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6321876|NCT00004778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6321877|NCT00004778|Respiratory System Agents|respiratory system agents|mesh-ancestor
6321878|NCT00004784|Methotrexate|methotrexate|mesh-list
6321879|NCT00004784|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
6321880|NCT00004784|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6321881|NCT00004784|Abortifacient Agents|abortifacient agents|mesh-ancestor
6321882|NCT00004784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6321883|NCT00004784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321884|NCT00004784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6321885|NCT00004784|Antimetabolites|antimetabolites|mesh-ancestor
6321886|NCT00004784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6321887|NCT00004784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6321888|NCT00004784|Dermatologic Agents|dermatologic agents|mesh-ancestor
6321889|NCT00004784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6321890|NCT00004784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6321891|NCT00004784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6321892|NCT00004784|Immunologic Factors|immunologic factors|mesh-ancestor
6321893|NCT00004784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6321894|NCT00004784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6321895|NCT00004784|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6321896|NCT00004784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6321897|NCT00004785|Dexamethasone|dexamethasone|mesh-list
6321898|NCT00004785|Methylprednisolone|methylprednisolone|mesh-list
6321899|NCT00004785|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6321900|NCT00004785|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6321901|NCT00004785|Prednisolone|prednisolone|mesh-list
6321902|NCT00004785|Prednisolone acetate|prednisolone acetate|mesh-list
6321903|NCT00004785|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6321904|NCT00004785|Prednisolone phosphate|prednisolone phosphate|mesh-list
6321905|NCT00004785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6321906|NCT00004785|Antiemetics|antiemetics|mesh-ancestor
6321907|NCT00004785|Autonomic Agents|autonomic agents|mesh-ancestor
6321908|NCT00004785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6321909|NCT00004785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321910|NCT00004785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6321911|NCT00004785|Glucocorticoids|glucocorticoids|mesh-ancestor
6321912|NCT00004785|Hormones|hormones|mesh-ancestor
6321913|NCT00004785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6321914|NCT00004785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6321915|NCT00004785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6321916|NCT00004785|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6321917|NCT00004785|Protective Agents|protective agents|mesh-ancestor
6321918|NCT00004786|Iloprost|iloprost|mesh-list
6321919|NCT00004786|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6321920|NCT00004786|Vasodilator Agents|vasodilator agents|mesh-ancestor
6321921|NCT00004787|Lenograstim|lenograstim|mesh-list
6321922|NCT00004787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6321923|NCT00004787|Immunologic Factors|immunologic factors|mesh-ancestor
6321924|NCT00004787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321925|NCT00004789|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
6321926|NCT00004789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6321927|NCT00004789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392866|NCT00198172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6392867|NCT00198172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6392868|NCT00198172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6392869|NCT00198172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6392870|NCT00198172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6392871|NCT00198172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392872|NCT00198198|Aripiprazole|aripiprazole|mesh-list
6392873|NCT00198198|Antidepressive Agents|antidepressive agents|mesh-ancestor
6392874|NCT00198198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6392875|NCT00198198|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6392876|NCT00198198|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6392877|NCT00198198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6392878|NCT00198198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392879|NCT00198198|Dopamine Agonists|dopamine agonists|mesh-ancestor
6392880|NCT00198198|Dopamine Agents|dopamine agents|mesh-ancestor
6392881|NCT00198198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6392882|NCT00198198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392883|NCT00198198|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6392884|NCT00198198|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6392885|NCT00198198|Serotonin Agents|serotonin agents|mesh-ancestor
6392886|NCT00198198|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6392887|NCT00198198|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6392888|NCT00198198|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6392889|NCT00198198|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6392890|NCT00198237|Docetaxel|docetaxel|mesh-list
6392891|NCT00198237|Capecitabine|capecitabine|mesh-list
6392892|NCT00198237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6392893|NCT00198237|Tubulin Modulators|tubulin modulators|mesh-ancestor
6392894|NCT00198237|Antimitotic Agents|antimitotic agents|mesh-ancestor
6392895|NCT00198237|Mitosis Modulators|mitosis modulators|mesh-ancestor
6392896|NCT00198237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392897|NCT00198237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6392898|NCT00198237|Antimetabolites|antimetabolites|mesh-ancestor
6392899|NCT00198250|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6392900|NCT00198250|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6392901|NCT00198250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6392902|NCT00198250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6392903|NCT00198250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392904|NCT00198250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6392905|NCT00198250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392906|NCT00198250|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6392907|NCT00198250|Antidepressive Agents|antidepressive agents|mesh-ancestor
6392908|NCT00198250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6392909|NCT00198315|Bleomycin|bleomycin|mesh-list
6392910|NCT00198315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6392911|NCT00198315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6392912|NCT00198328|Bleomycin|bleomycin|mesh-list
6392913|NCT00198328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6392914|NCT00198328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6392915|NCT00198354|Gemcitabine|gemcitabine|mesh-list
6392916|NCT00198354|Paclitaxel|paclitaxel|mesh-list
6392917|NCT00198354|Carboplatin|carboplatin|mesh-list
6392918|NCT00198354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6392919|NCT00198354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6392920|NCT00198354|Tubulin Modulators|tubulin modulators|mesh-ancestor
6392921|NCT00198354|Antimitotic Agents|antimitotic agents|mesh-ancestor
6392922|NCT00198354|Mitosis Modulators|mitosis modulators|mesh-ancestor
6392923|NCT00198354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392924|NCT00198354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6392925|NCT00198354|Antimetabolites|antimetabolites|mesh-ancestor
6392926|NCT00198354|Antiviral Agents|antiviral agents|mesh-ancestor
6392927|NCT00198354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6392928|NCT00198354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6321928|NCT00004794|Cidofovir|cidofovir|mesh-list
6321929|NCT00004794|Antiviral Agents|antiviral agents|mesh-ancestor
6321930|NCT00004794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6321931|NCT00004794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6321932|NCT00004794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6321933|NCT00004795|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
6321934|NCT00004795|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6321935|NCT00004795|Immunologic Factors|immunologic factors|mesh-ancestor
6321936|NCT00004795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321937|NCT00004796|Lactulose|lactulose|mesh-list
6321938|NCT00004796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6321939|NCT00004799|Vaccines|vaccines|mesh-list
6321940|NCT00004799|Immunologic Factors|immunologic factors|mesh-ancestor
6321941|NCT00004799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321942|NCT00004800|Vaccines|vaccines|mesh-list
6321943|NCT00004800|Immunologic Factors|immunologic factors|mesh-ancestor
6321944|NCT00004800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321945|NCT00004802|Dichlorphenamide|dichlorphenamide|mesh-list
6321946|NCT00004802|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6321947|NCT00004802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6321948|NCT00004802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6321949|NCT00004804|Interferons|interferons|mesh-list
6321950|NCT00004804|Interferon-alpha|interferon-alpha|mesh-list
6321951|NCT00004804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6321952|NCT00004804|Antiviral Agents|antiviral agents|mesh-ancestor
6321953|NCT00004804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6321954|NCT00004804|Immunologic Factors|immunologic factors|mesh-ancestor
6321955|NCT00004804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321956|NCT00004807|Topiramate|topiramate|mesh-list
6321957|NCT00004807|Dextromethorphan|dextromethorphan|mesh-list
6321958|NCT00004807|Donepezil|donepezil|mesh-list
6321959|NCT00004807|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6321960|NCT00004807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6321961|NCT00004807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6321962|NCT00004807|Cholinergic Agents|cholinergic agents|mesh-ancestor
6321963|NCT00004807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6321964|NCT00004807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321965|NCT00004807|Nootropic Agents|nootropic agents|mesh-ancestor
6321966|NCT00004807|Anticonvulsants|anticonvulsants|mesh-ancestor
6321967|NCT00004807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6321968|NCT00004807|Antitussive Agents|antitussive agents|mesh-ancestor
6321969|NCT00004807|Respiratory System Agents|respiratory system agents|mesh-ancestor
6321970|NCT00004807|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6321971|NCT00004807|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6321972|NCT00004808|Fluconazole|fluconazole|mesh-list
6321973|NCT00004808|Antifungal Agents|antifungal agents|mesh-ancestor
6321974|NCT00004808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6321975|NCT00004808|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6321976|NCT00004808|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6321977|NCT00004808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6321978|NCT00004808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6321979|NCT00004808|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6321980|NCT00004808|Hormone Antagonists|hormone antagonists|mesh-ancestor
6321981|NCT00004808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6321982|NCT00004808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6321983|NCT00004808|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6321984|NCT00004808|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6321985|NCT00004810|Aminosalicylic Acid|aminosalicylic acid|mesh-list
6321986|NCT00004810|Antitubercular Agents|antitubercular agents|mesh-ancestor
6321987|NCT00004810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6321988|NCT00004810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6321989|NCT00004811|Itraconazole|itraconazole|mesh-list
6321990|NCT00004811|Antifungal Agents|antifungal agents|mesh-ancestor
6321991|NCT00004811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6321992|NCT00004811|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6321993|NCT00004811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6321994|NCT00004811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6321995|NCT00004811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6321996|NCT00004811|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6321997|NCT00004811|Hormone Antagonists|hormone antagonists|mesh-ancestor
6321998|NCT00004811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6321999|NCT00004811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322000|NCT00004811|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6322001|NCT00004814|Glatiramer Acetate|glatiramer acetate|mesh-list
6322002|NCT00004814|(T,G)-A-L|(t,g)-a-l|mesh-list
6322003|NCT00004814|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6322004|NCT00004814|Immunologic Factors|immunologic factors|mesh-ancestor
6322005|NCT00004814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322006|NCT00004814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6322007|NCT00004814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6322008|NCT00004815|Hormones|hormones|mesh-list
6322009|NCT00004815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6322010|NCT00004815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322011|NCT00004816|Antibodies|antibodies|mesh-list
6322012|NCT00004816|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6322013|NCT00004816|Immunologic Factors|immunologic factors|mesh-ancestor
6322014|NCT00004816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322015|NCT00004817|Phenytoin|phenytoin|mesh-list
6322016|NCT00004817|Valproic Acid|valproic acid|mesh-list
6322017|NCT00004817|Anticonvulsants|anticonvulsants|mesh-ancestor
6322018|NCT00004817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6322019|NCT00004817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322020|NCT00004817|GABA Agents|gaba agents|mesh-ancestor
6322021|NCT00004817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6322022|NCT00004817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322023|NCT00004817|Antimanic Agents|antimanic agents|mesh-ancestor
6322024|NCT00004817|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6322025|NCT00004817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6322026|NCT00004817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6322027|NCT00004817|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6322028|NCT00004817|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6322029|NCT00004817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6322030|NCT00004817|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6322031|NCT00004817|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6322032|NCT00004825|Insulin|insulin|mesh-list
6322033|NCT00004825|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6322034|NCT00004825|Mitogens|mitogens|mesh-list
6322035|NCT00004825|Mecasermin|mecasermin|mesh-list
6322036|NCT00004825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6322037|NCT00004825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322038|NCT00004825|Mitosis Modulators|mitosis modulators|mesh-ancestor
6322039|NCT00004825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322040|NCT00004825|Growth Substances|growth substances|mesh-ancestor
6322041|NCT00004826|Clozapine|clozapine|mesh-list
6322042|NCT00004826|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6322043|NCT00004826|Serotonin Agents|serotonin agents|mesh-ancestor
6322044|NCT00004826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6322045|NCT00004826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322046|NCT00004826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322047|NCT00004826|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6322048|NCT00004826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6322049|NCT00004826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6322050|NCT00004826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6322051|NCT00004826|GABA Antagonists|gaba antagonists|mesh-ancestor
6322052|NCT00004826|GABA Agents|gaba agents|mesh-ancestor
6322053|NCT00004829|Tobramycin|tobramycin|mesh-list
6322054|NCT00004829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6322055|NCT00004829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6322056|NCT00004832|Amifampridine|amifampridine|mesh-list
6322057|NCT00004832|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6322058|NCT00004832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6322059|NCT00004832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322060|NCT00004832|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6322061|NCT00004832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6322062|NCT00004832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322063|NCT00004833|Immunoglobulins|immunoglobulins|mesh-list
6322064|NCT00004833|Antibodies|antibodies|mesh-list
6322065|NCT00004833|gamma-Globulins|gamma-globulins|mesh-list
6322066|NCT00004833|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6322067|NCT00004833|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6322068|NCT00004833|Immunologic Factors|immunologic factors|mesh-ancestor
6322069|NCT00004833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322070|NCT00004834|Imipramine|imipramine|mesh-list
6322071|NCT00004834|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6322072|NCT00004834|Antidepressive Agents|antidepressive agents|mesh-ancestor
6322073|NCT00004834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6322074|NCT00004834|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6322075|NCT00004834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6322076|NCT00004834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6322077|NCT00004834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322078|NCT00004834|Adrenergic Agents|adrenergic agents|mesh-ancestor
6322079|NCT00004834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6322080|NCT00004834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322081|NCT00004838|Succimer|succimer|mesh-list
6322082|NCT00004838|Antidotes|antidotes|mesh-ancestor
6322083|NCT00004838|Protective Agents|protective agents|mesh-ancestor
6322084|NCT00004838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322085|NCT00004838|Chelating Agents|chelating agents|mesh-ancestor
6322086|NCT00004838|Sequestering Agents|sequestering agents|mesh-ancestor
6322087|NCT00004838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322088|NCT00004840|Hormones|hormones|mesh-list
6322089|NCT00004840|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
6322090|NCT00004840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6322091|NCT00004840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322092|NCT00004842|Budesonide|budesonide|mesh-list
6322093|NCT00004842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6322094|NCT00004842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6322095|NCT00004842|Autonomic Agents|autonomic agents|mesh-ancestor
6322096|NCT00004842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6322097|NCT00004842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322098|NCT00004842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6322099|NCT00004842|Respiratory System Agents|respiratory system agents|mesh-ancestor
6322100|NCT00004842|Glucocorticoids|glucocorticoids|mesh-ancestor
6322101|NCT00004842|Hormones|hormones|mesh-ancestor
6322102|NCT00004842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6322103|NCT00004845|Naproxen|naproxen|mesh-list
6322104|NCT00004845|Rofecoxib|rofecoxib|mesh-list
6322105|NCT00004845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6322106|NCT00004845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6322107|NCT00004845|Analgesics|analgesics|mesh-ancestor
6322108|NCT00004845|Sensory System Agents|sensory system agents|mesh-ancestor
6322109|NCT00004845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6322110|NCT00004845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322111|NCT00004845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6322112|NCT00004845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6322113|NCT00004845|Gout Suppressants|gout suppressants|mesh-ancestor
6322114|NCT00004845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6322115|NCT00004845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6322116|NCT00004845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322117|NCT00004845|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6322118|NCT00004852|Lamivudine|lamivudine|mesh-list
6322119|NCT00004852|Zidovudine|zidovudine|mesh-list
6322120|NCT00004852|Efavirenz|efavirenz|mesh-list
6322121|NCT00004852|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6322122|NCT00004852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6322123|NCT00004852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6322124|NCT00004852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322125|NCT00004852|Antiviral Agents|antiviral agents|mesh-ancestor
6322126|NCT00004852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6322127|NCT00004852|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6322128|NCT00004852|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6322129|NCT00004852|Antimetabolites|antimetabolites|mesh-ancestor
6322130|NCT00004852|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6322131|NCT00004852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6322132|NCT00004852|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6322133|NCT00004852|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6322134|NCT00004852|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6322135|NCT00004852|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6322136|NCT00004853|Lenograstim|lenograstim|mesh-list
6322137|NCT00004853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6322138|NCT00004853|Immunologic Factors|immunologic factors|mesh-ancestor
6322139|NCT00004853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322140|NCT00004854|Carvedilol|carvedilol|mesh-list
6322141|NCT00004854|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6322142|NCT00004854|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6322143|NCT00004854|Adrenergic Agents|adrenergic agents|mesh-ancestor
6322144|NCT00004854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6322145|NCT00004854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322146|NCT00004854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322147|NCT00004854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6322148|NCT00004854|Antioxidants|antioxidants|mesh-ancestor
6322149|NCT00004854|Protective Agents|protective agents|mesh-ancestor
6322150|NCT00004854|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6322151|NCT00004854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6322152|NCT00004854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6322153|NCT00004854|Vasodilator Agents|vasodilator agents|mesh-ancestor
6322154|NCT00004854|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6322155|NCT00004854|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6322156|NCT00004855|Ritonavir|ritonavir|mesh-list
6322157|NCT00004855|Lopinavir|lopinavir|mesh-list
6322158|NCT00004855|Lamivudine|lamivudine|mesh-list
6322159|NCT00004855|Nevirapine|nevirapine|mesh-list
6322160|NCT00004855|Abacavir|abacavir|mesh-list
6322161|NCT00004855|Stavudine|stavudine|mesh-list
6322162|NCT00004855|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6322163|NCT00004855|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6322164|NCT00004855|Protease Inhibitors|protease inhibitors|mesh-ancestor
6322165|NCT00004855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6322166|NCT00004855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322167|NCT00004855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6322168|NCT00004855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6322169|NCT00004855|Antiviral Agents|antiviral agents|mesh-ancestor
6322170|NCT00004855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6322171|NCT00004855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6322172|NCT00004855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6322173|NCT00004855|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6322174|NCT00004855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6322175|NCT00004855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6322176|NCT00004855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6322177|NCT00004855|Antimetabolites|antimetabolites|mesh-ancestor
6322178|NCT00004856|Trastuzumab|trastuzumab|mesh-list
6322179|NCT00004856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6322180|NCT00004856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6322181|NCT00004857|Fludarabine|fludarabine|mesh-list
6322182|NCT00004857|Fludarabine phosphate|fludarabine phosphate|mesh-list
6322183|NCT00004857|Alemtuzumab|alemtuzumab|mesh-list
6322184|NCT00004857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6322185|NCT00004857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6322186|NCT00004857|Antimetabolites|antimetabolites|mesh-ancestor
6322187|NCT00004857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322188|NCT00004857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6322189|NCT00004857|Immunologic Factors|immunologic factors|mesh-ancestor
6322190|NCT00004857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322191|NCT00004857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6322192|NCT00004858|Genistein|genistein|mesh-list
6322193|NCT00004858|Immunoconjugates|immunoconjugates|mesh-list
6322194|NCT00004858|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6322195|NCT00004858|Protective Agents|protective agents|mesh-ancestor
6322196|NCT00004858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322197|NCT00004858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6322198|NCT00004858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6322199|NCT00004858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6322200|NCT00004858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322201|NCT00004858|Phytoestrogens|phytoestrogens|mesh-ancestor
6322202|NCT00004858|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6322203|NCT00004858|Estrogens|estrogens|mesh-ancestor
6322204|NCT00004858|Hormones|hormones|mesh-ancestor
6322205|NCT00004858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6322206|NCT00004858|Immunologic Factors|immunologic factors|mesh-ancestor
6322207|NCT00004860|Leucovorin|leucovorin|mesh-list
6322208|NCT00004860|Tegafur|tegafur|mesh-list
6322209|NCT00004860|Calcium|calcium|mesh-list
6322210|NCT00004860|Levoleucovorin|levoleucovorin|mesh-list
6322211|NCT00004860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6322212|NCT00004860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322213|NCT00004860|Antidotes|antidotes|mesh-ancestor
6322214|NCT00004860|Protective Agents|protective agents|mesh-ancestor
6322215|NCT00004860|Vitamin B Complex|vitamin b complex|mesh-ancestor
6322216|NCT00004860|Vitamins|vitamins|mesh-ancestor
6322217|NCT00004860|Micronutrients|micronutrients|mesh-ancestor
6322218|NCT00004860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6322219|NCT00004860|Antimetabolites|antimetabolites|mesh-ancestor
6322220|NCT00004860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322221|NCT00004860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6322222|NCT00004861|Gemcitabine|gemcitabine|mesh-list
6322223|NCT00004861|Tacedinaline|tacedinaline|mesh-list
6322224|NCT00004861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6322225|NCT00004861|Antimetabolites|antimetabolites|mesh-ancestor
6322226|NCT00004861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322227|NCT00004861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6322228|NCT00004861|Antiviral Agents|antiviral agents|mesh-ancestor
6322229|NCT00004861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6322230|NCT00004861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6322231|NCT00004861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6322232|NCT00004861|Immunologic Factors|immunologic factors|mesh-ancestor
6322233|NCT00004861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322234|NCT00004861|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6322235|NCT00004862|Cytarabine|cytarabine|mesh-list
6322236|NCT00004862|Fludarabine|fludarabine|mesh-list
6322237|NCT00004862|Fludarabine phosphate|fludarabine phosphate|mesh-list
6322238|NCT00004862|Oblimersen|oblimersen|mesh-list
6322239|NCT00004862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6322240|NCT00004862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6322241|NCT00004862|Antimetabolites|antimetabolites|mesh-ancestor
6322242|NCT00004862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322243|NCT00004862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6322244|NCT00004862|Immunologic Factors|immunologic factors|mesh-ancestor
6322245|NCT00004862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322246|NCT00004862|Antiviral Agents|antiviral agents|mesh-ancestor
6322247|NCT00004862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6322248|NCT00004863|Paclitaxel|paclitaxel|mesh-list
6322249|NCT00004863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6322250|NCT00004863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6322251|NCT00004863|Tubulin Modulators|tubulin modulators|mesh-ancestor
6322252|NCT00004863|Antimitotic Agents|antimitotic agents|mesh-ancestor
6322253|NCT00004863|Mitosis Modulators|mitosis modulators|mesh-ancestor
6322254|NCT00004863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322255|NCT00004864|Docetaxel|docetaxel|mesh-list
6322256|NCT00004864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6322257|NCT00004864|Tubulin Modulators|tubulin modulators|mesh-ancestor
6322258|NCT00004864|Antimitotic Agents|antimitotic agents|mesh-ancestor
6322259|NCT00004864|Mitosis Modulators|mitosis modulators|mesh-ancestor
6322260|NCT00004864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322261|NCT00004865|Paclitaxel|paclitaxel|mesh-list
6322262|NCT00004865|Fluorouracil|fluorouracil|mesh-list
6322263|NCT00004865|Cetuximab|cetuximab|mesh-list
6322264|NCT00004865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6322265|NCT00004865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6322266|NCT00004865|Tubulin Modulators|tubulin modulators|mesh-ancestor
6322267|NCT00004865|Antimitotic Agents|antimitotic agents|mesh-ancestor
6322268|NCT00004865|Mitosis Modulators|mitosis modulators|mesh-ancestor
6322269|NCT00004865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322270|NCT00004865|Antimetabolites|antimetabolites|mesh-ancestor
6322271|NCT00004865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6322272|NCT00004865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6322273|NCT00004865|Immunologic Factors|immunologic factors|mesh-ancestor
6322274|NCT00004865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322275|NCT00004865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6322276|NCT00004866|Exatecan|exatecan|mesh-list
6322277|NCT00004866|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6322278|NCT00004866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6322279|NCT00004866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6322280|NCT00004866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322281|NCT00004866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6322282|NCT00004867|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6322283|NCT00004867|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6322284|NCT00004867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322285|NCT00004868|Semaxinib|semaxinib|mesh-list
6322286|NCT00004868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6322287|NCT00004868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6322288|NCT00004868|Growth Substances|growth substances|mesh-ancestor
6322289|NCT00004868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322290|NCT00004868|Growth Inhibitors|growth inhibitors|mesh-ancestor
6322291|NCT00004868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6322292|NCT00004868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6322293|NCT00004868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6322294|NCT00004868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322295|NCT00004870|Irinotecan|irinotecan|mesh-list
6322296|NCT00004870|Oblimersen|oblimersen|mesh-list
6322297|NCT00004870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6322298|NCT00004870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6322299|NCT00004870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6322300|NCT00004870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322301|NCT00004870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6322302|NCT00004871|Azacitidine|azacitidine|mesh-list
6322303|NCT00004871|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
6322304|NCT00004871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6322305|NCT00004871|Antimetabolites|antimetabolites|mesh-ancestor
6322306|NCT00004871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322307|NCT00004871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6322308|NCT00004871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6322309|NCT00004872|Endostatins|endostatins|mesh-list
6322310|NCT00004872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6322311|NCT00004872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6322312|NCT00004872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6322313|NCT00004872|Growth Substances|growth substances|mesh-ancestor
6322314|NCT00004872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322315|NCT00004872|Growth Inhibitors|growth inhibitors|mesh-ancestor
6322316|NCT00004873|Docetaxel|docetaxel|mesh-list
6322317|NCT00004873|Fluorouracil|fluorouracil|mesh-list
6322318|NCT00004873|Epirubicin|epirubicin|mesh-list
6322319|NCT00004873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6322320|NCT00004873|Tubulin Modulators|tubulin modulators|mesh-ancestor
6322321|NCT00004873|Antimitotic Agents|antimitotic agents|mesh-ancestor
6322322|NCT00004873|Mitosis Modulators|mitosis modulators|mesh-ancestor
6322323|NCT00004873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322324|NCT00004873|Antimetabolites|antimetabolites|mesh-ancestor
6322325|NCT00004873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6322326|NCT00004873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6322327|NCT00004873|Immunologic Factors|immunologic factors|mesh-ancestor
6322328|NCT00004873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322329|NCT00004873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6322330|NCT00004873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6322331|NCT00004873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6322332|NCT00004873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6322333|NCT00004874|Iodine|iodine|mesh-list
6322334|NCT00004874|Tositumomab I-131|tositumomab i-131|mesh-list
6322335|NCT00004874|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6322336|NCT00004874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6322337|NCT00004874|Trace Elements|trace elements|mesh-ancestor
6322338|NCT00004874|Micronutrients|micronutrients|mesh-ancestor
6322339|NCT00004874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322340|NCT00004874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6322341|NCT00004875|Heparin|heparin|mesh-list
6322342|NCT00004875|Enoxaparin|enoxaparin|mesh-list
6322343|NCT00004875|Anticoagulants|anticoagulants|mesh-ancestor
6322344|NCT00004875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6322345|NCT00004875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6322346|NCT00004875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322347|NCT00004876|Thalidomide|thalidomide|mesh-list
6322348|NCT00004876|Carboplatin|carboplatin|mesh-list
6322349|NCT00004876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6322350|NCT00004876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6322351|NCT00004876|Immunologic Factors|immunologic factors|mesh-ancestor
6322352|NCT00004876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322353|NCT00004876|Leprostatic Agents|leprostatic agents|mesh-ancestor
6322354|NCT00004876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6322355|NCT00004876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6322356|NCT00004876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6322357|NCT00004876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6322358|NCT00004876|Growth Substances|growth substances|mesh-ancestor
6322359|NCT00004876|Growth Inhibitors|growth inhibitors|mesh-ancestor
6322360|NCT00004878|Cytarabine|cytarabine|mesh-list
6322361|NCT00004878|Methotrexate|methotrexate|mesh-list
6322362|NCT00004878|Fludarabine phosphate|fludarabine phosphate|mesh-list
6322363|NCT00004878|Fludarabine|fludarabine|mesh-list
6322364|NCT00004878|Idarubicin|idarubicin|mesh-list
6322365|NCT00004878|Tacrolimus|tacrolimus|mesh-list
6322366|NCT00004878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6322367|NCT00004878|Abortifacient Agents|abortifacient agents|mesh-ancestor
6322368|NCT00004878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6322369|NCT00004878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322370|NCT00004878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6322371|NCT00004878|Antimetabolites|antimetabolites|mesh-ancestor
6322372|NCT00004878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322373|NCT00004878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6322374|NCT00004878|Dermatologic Agents|dermatologic agents|mesh-ancestor
6322375|NCT00004878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6322376|NCT00004878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6322377|NCT00004878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6322378|NCT00004878|Immunologic Factors|immunologic factors|mesh-ancestor
6322379|NCT00004878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6322380|NCT00004878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6322381|NCT00004878|Antiviral Agents|antiviral agents|mesh-ancestor
6322382|NCT00004878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6322383|NCT00004878|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6322384|NCT00004878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6322385|NCT00004878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6322386|NCT00004878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6322387|NCT00004879|Panitumumab|panitumumab|mesh-list
6322388|NCT00004879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6322389|NCT00004879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6322390|NCT00004880|Vaccines|vaccines|mesh-list
6322391|NCT00004880|Immunologic Factors|immunologic factors|mesh-ancestor
6322392|NCT00004880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322393|NCT00004883|Trastuzumab|trastuzumab|mesh-list
6322394|NCT00004883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6322395|NCT00004883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6322396|NCT00004884|Gemcitabine|gemcitabine|mesh-list
6322397|NCT00004884|Docetaxel|docetaxel|mesh-list
6322398|NCT00004884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6322399|NCT00004884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6322400|NCT00004884|Antimetabolites|antimetabolites|mesh-ancestor
6322401|NCT00004884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322402|NCT00004884|Antiviral Agents|antiviral agents|mesh-ancestor
6322403|NCT00004884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6322404|NCT00004884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6322405|NCT00004884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6322406|NCT00004884|Immunologic Factors|immunologic factors|mesh-ancestor
6322407|NCT00004884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322408|NCT00004884|Tubulin Modulators|tubulin modulators|mesh-ancestor
6322409|NCT00004884|Antimitotic Agents|antimitotic agents|mesh-ancestor
6322410|NCT00004884|Mitosis Modulators|mitosis modulators|mesh-ancestor
6322411|NCT00004885|Leucovorin|leucovorin|mesh-list
6322412|NCT00004885|Fluorouracil|fluorouracil|mesh-list
6322413|NCT00004885|Irinotecan|irinotecan|mesh-list
6322414|NCT00004885|Calcium|calcium|mesh-list
6322415|NCT00004885|Levoleucovorin|levoleucovorin|mesh-list
6322416|NCT00004885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6322417|NCT00004885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322418|NCT00004885|Antimetabolites|antimetabolites|mesh-ancestor
6322419|NCT00004885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322420|NCT00004885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6322421|NCT00004885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6322422|NCT00004885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6322423|NCT00004885|Immunologic Factors|immunologic factors|mesh-ancestor
6322424|NCT00004885|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6322425|NCT00004885|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6322426|NCT00004885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6322427|NCT00004885|Antidotes|antidotes|mesh-ancestor
6322428|NCT00004885|Protective Agents|protective agents|mesh-ancestor
6322429|NCT00004885|Vitamin B Complex|vitamin b complex|mesh-ancestor
6322430|NCT00004885|Vitamins|vitamins|mesh-ancestor
6322431|NCT00004885|Micronutrients|micronutrients|mesh-ancestor
6322432|NCT00004886|Docetaxel|docetaxel|mesh-list
6322433|NCT00004886|Dofequidar|dofequidar|mesh-list
6322434|NCT00004886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6322435|NCT00004886|Tubulin Modulators|tubulin modulators|mesh-ancestor
6322436|NCT00004886|Antimitotic Agents|antimitotic agents|mesh-ancestor
6322437|NCT00004886|Mitosis Modulators|mitosis modulators|mesh-ancestor
6322438|NCT00004886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322439|NCT00004887|Paclitaxel|paclitaxel|mesh-list
6322440|NCT00004887|Vinblastine|vinblastine|mesh-list
6322441|NCT00004887|Carboplatin|carboplatin|mesh-list
6322442|NCT00004887|Ifosfamide|ifosfamide|mesh-list
6322443|NCT00004887|Mitomycins|mitomycins|mesh-list
6322444|NCT00004887|Mitomycin|mitomycin|mesh-list
6322445|NCT00004887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6322446|NCT00004887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6322447|NCT00004887|Tubulin Modulators|tubulin modulators|mesh-ancestor
6322448|NCT00004887|Antimitotic Agents|antimitotic agents|mesh-ancestor
6322449|NCT00004887|Mitosis Modulators|mitosis modulators|mesh-ancestor
6322450|NCT00004887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322451|NCT00004887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6322452|NCT00004887|Alkylating Agents|alkylating agents|mesh-ancestor
6322453|NCT00004887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6322454|NCT00004887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6322455|NCT00004887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6322456|NCT00004889|Rituximab|rituximab|mesh-list
6322457|NCT00004889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6322458|NCT00004889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6322459|NCT00004889|Immunologic Factors|immunologic factors|mesh-ancestor
6322460|NCT00004889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322461|NCT00004889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6322462|NCT00004890|Aldesleukin|aldesleukin|mesh-list
6322463|NCT00004890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6322464|NCT00004890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6322465|NCT00004890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6322466|NCT00004890|Antiviral Agents|antiviral agents|mesh-ancestor
6322467|NCT00004890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6322468|NCT00004891|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6322469|NCT00004891|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6322470|NCT00004891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322471|NCT00004892|Carmustine|carmustine|mesh-list
6322472|NCT00004892|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
6322473|NCT00004892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6322474|NCT00004892|Alkylating Agents|alkylating agents|mesh-ancestor
6322475|NCT00004892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322476|NCT00004892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6322477|NCT00004892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6322478|NCT00004893|Interleukin-12|interleukin-12|mesh-list
6322479|NCT00004893|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6322480|NCT00004893|Immunologic Factors|immunologic factors|mesh-ancestor
6322481|NCT00004893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322482|NCT00004893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6322483|NCT00004893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6322484|NCT00004893|Growth Substances|growth substances|mesh-ancestor
6322485|NCT00004893|Growth Inhibitors|growth inhibitors|mesh-ancestor
6322486|NCT00004893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6322487|NCT00004900|Cyclophosphamide|cyclophosphamide|mesh-list
6322488|NCT00004900|Thiotepa|thiotepa|mesh-list
6322489|NCT00004900|Carboplatin|carboplatin|mesh-list
6322490|NCT00004900|Etoposide|etoposide|mesh-list
6322491|NCT00004900|Anastrozole|anastrozole|mesh-list
6322492|NCT00004900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6322493|NCT00004900|Immunologic Factors|immunologic factors|mesh-ancestor
6322494|NCT00004900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322495|NCT00004900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6322496|NCT00004900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6322497|NCT00004900|Alkylating Agents|alkylating agents|mesh-ancestor
6322498|NCT00004900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322499|NCT00004900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6322500|NCT00004900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6322501|NCT00004900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6322502|NCT00004900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6322503|NCT00004900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6322504|NCT00004900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6322505|NCT00004900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6322506|NCT00004900|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6322507|NCT00004900|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6322508|NCT00004900|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6322509|NCT00004900|Hormone Antagonists|hormone antagonists|mesh-ancestor
6322510|NCT00004900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6322511|NCT00004901|Fluorouracil|fluorouracil|mesh-list
6322512|NCT00004901|Hydroxyurea|hydroxyurea|mesh-list
6322513|NCT00004901|Eniluracil|eniluracil|mesh-list
6322514|NCT00004901|Antimetabolites|antimetabolites|mesh-ancestor
6322515|NCT00004901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322516|NCT00004901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6322517|NCT00004901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6322518|NCT00004901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6322519|NCT00004901|Immunologic Factors|immunologic factors|mesh-ancestor
6322520|NCT00004901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322521|NCT00004901|Antisickling Agents|antisickling agents|mesh-ancestor
6322522|NCT00004901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6322523|NCT00004901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6016515|NCT00365417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6322524|NCT00004903|Interferons|interferons|mesh-list
6322525|NCT00004903|Cytarabine|cytarabine|mesh-list
6322526|NCT00004903|Interferon-alpha|interferon-alpha|mesh-list
6322527|NCT00004903|Cyclophosphamide|cyclophosphamide|mesh-list
6322528|NCT00004903|Melphalan|melphalan|mesh-list
6322529|NCT00004903|Etoposide|etoposide|mesh-list
6322530|NCT00004903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6322531|NCT00004903|Immunologic Factors|immunologic factors|mesh-ancestor
6322532|NCT00004903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322533|NCT00004903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6322534|NCT00004903|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6322535|NCT00004903|Alkylating Agents|alkylating agents|mesh-ancestor
6322536|NCT00004903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322537|NCT00004903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6322538|NCT00004903|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6322539|NCT00004903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6322540|NCT00004903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6016516|NCT00365417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6322541|NCT00004903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6322542|NCT00004903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6322543|NCT00004903|Antiviral Agents|antiviral agents|mesh-ancestor
6322544|NCT00004903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6322545|NCT00004903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6322546|NCT00004903|Antimetabolites|antimetabolites|mesh-ancestor
6322547|NCT00004904|Methylprednisolone|methylprednisolone|mesh-list
6322548|NCT00004904|Cyclophosphamide|cyclophosphamide|mesh-list
6322549|NCT00004904|Etoposide|etoposide|mesh-list
6322550|NCT00004904|Cladribine|cladribine|mesh-list
6322551|NCT00004904|Tacrolimus|tacrolimus|mesh-list
6322552|NCT00004904|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6322553|NCT00004904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6322554|NCT00004904|Immunologic Factors|immunologic factors|mesh-ancestor
6322555|NCT00004904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322556|NCT00004904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6322557|NCT00004904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6322558|NCT00004904|Alkylating Agents|alkylating agents|mesh-ancestor
6322559|NCT00004904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322560|NCT00004904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6322561|NCT00004904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6322562|NCT00004904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6322563|NCT00004904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6322564|NCT00004904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6322565|NCT00004904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6322566|NCT00004904|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6322567|NCT00004904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6322568|NCT00004904|Antiemetics|antiemetics|mesh-ancestor
6322569|NCT00004904|Autonomic Agents|autonomic agents|mesh-ancestor
6322570|NCT00004904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6322571|NCT00004904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6322572|NCT00004904|Glucocorticoids|glucocorticoids|mesh-ancestor
6322573|NCT00004904|Hormones|hormones|mesh-ancestor
6392929|NCT00198354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6322574|NCT00004904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6322575|NCT00004904|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6322576|NCT00004904|Protective Agents|protective agents|mesh-ancestor
6322577|NCT00004905|Interferons|interferons|mesh-list
6322578|NCT00004905|Cytarabine|cytarabine|mesh-list
6322579|NCT00004905|Interferon-alpha|interferon-alpha|mesh-list
6322580|NCT00004905|Cyclophosphamide|cyclophosphamide|mesh-list
6322581|NCT00004905|Etoposide|etoposide|mesh-list
6322582|NCT00004905|Idarubicin|idarubicin|mesh-list
6322583|NCT00004905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6322584|NCT00004905|Immunologic Factors|immunologic factors|mesh-ancestor
6322585|NCT00004905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322586|NCT00004905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6322587|NCT00004905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6322588|NCT00004905|Alkylating Agents|alkylating agents|mesh-ancestor
6322589|NCT00004905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322590|NCT00004905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6322591|NCT00004905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6322592|NCT00004905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6322593|NCT00004905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6322594|NCT00004905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6322595|NCT00004905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6322596|NCT00004905|Antiviral Agents|antiviral agents|mesh-ancestor
6322597|NCT00004905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6322598|NCT00004905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6322599|NCT00004905|Antimetabolites|antimetabolites|mesh-ancestor
6322600|NCT00004905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6322601|NCT00004906|Pamidronate|pamidronate|mesh-list
6322602|NCT00004906|Cyclophosphamide|cyclophosphamide|mesh-list
6322603|NCT00004906|Thiotepa|thiotepa|mesh-list
6322604|NCT00004906|Carboplatin|carboplatin|mesh-list
6322605|NCT00004906|Docetaxel|docetaxel|mesh-list
6322606|NCT00004906|Doxorubicin|doxorubicin|mesh-list
6322607|NCT00004906|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6322608|NCT00004906|Etoposide|etoposide|mesh-list
6322609|NCT00004906|Anastrozole|anastrozole|mesh-list
6322610|NCT00004906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6322611|NCT00004906|Immunologic Factors|immunologic factors|mesh-ancestor
6322612|NCT00004906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322613|NCT00004906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6322614|NCT00004906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6322615|NCT00004906|Alkylating Agents|alkylating agents|mesh-ancestor
6322616|NCT00004906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322617|NCT00004906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6322618|NCT00004906|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6322619|NCT00004906|Tubulin Modulators|tubulin modulators|mesh-ancestor
6322620|NCT00004906|Antimitotic Agents|antimitotic agents|mesh-ancestor
6322621|NCT00004906|Mitosis Modulators|mitosis modulators|mesh-ancestor
6322622|NCT00004906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6322623|NCT00004906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6322624|NCT00004906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6322625|NCT00004906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6322626|NCT00004906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6322627|NCT00004906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6322628|NCT00004906|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6322629|NCT00004906|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6322630|NCT00004906|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6322631|NCT00004906|Hormone Antagonists|hormone antagonists|mesh-ancestor
6322632|NCT00004906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6322633|NCT00004906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6322634|NCT00004913|Leucovorin|leucovorin|mesh-list
6322635|NCT00004913|Docetaxel|docetaxel|mesh-list
6322636|NCT00004913|Fluorouracil|fluorouracil|mesh-list
6322637|NCT00004913|Calcium|calcium|mesh-list
6322638|NCT00004913|Levoleucovorin|levoleucovorin|mesh-list
6322639|NCT00004913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6322640|NCT00004913|Tubulin Modulators|tubulin modulators|mesh-ancestor
6322641|NCT00004913|Antimitotic Agents|antimitotic agents|mesh-ancestor
6322642|NCT00004913|Mitosis Modulators|mitosis modulators|mesh-ancestor
6322643|NCT00004913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322644|NCT00004913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6322645|NCT00004913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322646|NCT00004913|Antimetabolites|antimetabolites|mesh-ancestor
6322647|NCT00004913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6322648|NCT00004913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6322649|NCT00004913|Immunologic Factors|immunologic factors|mesh-ancestor
6322650|NCT00004913|Antidotes|antidotes|mesh-ancestor
6322651|NCT00004913|Protective Agents|protective agents|mesh-ancestor
6322652|NCT00004913|Vitamin B Complex|vitamin b complex|mesh-ancestor
6322653|NCT00004913|Vitamins|vitamins|mesh-ancestor
6322654|NCT00004913|Micronutrients|micronutrients|mesh-ancestor
6322655|NCT00004917|Epoetin Alfa|epoetin alfa|mesh-list
6322656|NCT00004917|Hematinics|hematinics|mesh-ancestor
6322657|NCT00004918|Sargramostim|sargramostim|mesh-list
6322658|NCT00004918|Immunologic Factors|immunologic factors|mesh-ancestor
6322659|NCT00004918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322660|NCT00004919|Irinotecan|irinotecan|mesh-list
6322661|NCT00004919|Amifostine|amifostine|mesh-list
6322662|NCT00004919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6322663|NCT00004919|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6322664|NCT00004919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6322665|NCT00004919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6322666|NCT00004919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322667|NCT00004919|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6322668|NCT00004919|Protective Agents|protective agents|mesh-ancestor
6322669|NCT00004919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322670|NCT00004920|Raltitrexed|raltitrexed|mesh-list
6322671|NCT00004920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6322672|NCT00004920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6322673|NCT00004920|Antimetabolites|antimetabolites|mesh-ancestor
6322674|NCT00004920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322675|NCT00004920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6322676|NCT00004920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6322677|NCT00004921|Paclitaxel|paclitaxel|mesh-list
6322678|NCT00004921|Cyclophosphamide|cyclophosphamide|mesh-list
6322679|NCT00004921|Carboplatin|carboplatin|mesh-list
6322680|NCT00004921|Melphalan|melphalan|mesh-list
6322681|NCT00004921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6322682|NCT00004921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6322683|NCT00004921|Tubulin Modulators|tubulin modulators|mesh-ancestor
6322684|NCT00004921|Antimitotic Agents|antimitotic agents|mesh-ancestor
6322685|NCT00004921|Mitosis Modulators|mitosis modulators|mesh-ancestor
6322686|NCT00004921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322687|NCT00004921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6322688|NCT00004921|Immunologic Factors|immunologic factors|mesh-ancestor
6322689|NCT00004921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322690|NCT00004921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6322691|NCT00004921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6322692|NCT00004921|Alkylating Agents|alkylating agents|mesh-ancestor
6322693|NCT00004921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6322694|NCT00004922|Irinotecan|irinotecan|mesh-list
6322695|NCT00004922|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6322696|NCT00004922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6322697|NCT00004922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6322698|NCT00004922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322699|NCT00004922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6322700|NCT00004923|Docetaxel|docetaxel|mesh-list
6322701|NCT00004923|Irinotecan|irinotecan|mesh-list
6322702|NCT00004923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6322703|NCT00004923|Tubulin Modulators|tubulin modulators|mesh-ancestor
6322704|NCT00004923|Antimitotic Agents|antimitotic agents|mesh-ancestor
6322705|NCT00004923|Mitosis Modulators|mitosis modulators|mesh-ancestor
6322706|NCT00004923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322707|NCT00004923|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6322708|NCT00004923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6322709|NCT00004923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6322710|NCT00004924|Paclitaxel|paclitaxel|mesh-list
6322711|NCT00004924|Irinotecan|irinotecan|mesh-list
6322712|NCT00004924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6322713|NCT00004924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6322714|NCT00004924|Tubulin Modulators|tubulin modulators|mesh-ancestor
6322715|NCT00004924|Antimitotic Agents|antimitotic agents|mesh-ancestor
6322716|NCT00004924|Mitosis Modulators|mitosis modulators|mesh-ancestor
6322717|NCT00004924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322718|NCT00004924|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6322719|NCT00004924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6322720|NCT00004924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6322721|NCT00004925|Doxorubicin|doxorubicin|mesh-list
6322722|NCT00004925|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6322723|NCT00004925|Trastuzumab|trastuzumab|mesh-list
6322724|NCT00004925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6322725|NCT00004925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6322726|NCT00004925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6322727|NCT00004925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6322728|NCT00004925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6322729|NCT00004925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322730|NCT00004925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6322731|NCT00004926|Vitamin D|vitamin d|mesh-list
6322732|NCT00004926|Cholecalciferol|cholecalciferol|mesh-list
6322733|NCT00004926|Ro 23-7553|ro 23-7553|mesh-list
6322734|NCT00004926|Vitamins|vitamins|mesh-ancestor
6322735|NCT00004926|Micronutrients|micronutrients|mesh-ancestor
6322736|NCT00004926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322737|NCT00004926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6322738|NCT00004926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6322739|NCT00004926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6322740|NCT00004928|Zoledronic Acid|zoledronic acid|mesh-list
6322741|NCT00004928|Calcitriol|calcitriol|mesh-list
6322742|NCT00004928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6322743|NCT00004928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322744|NCT00004928|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6322745|NCT00004928|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6322746|NCT00004928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6322747|NCT00004928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322748|NCT00004928|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6322749|NCT00004928|Vitamins|vitamins|mesh-ancestor
6322750|NCT00004928|Micronutrients|micronutrients|mesh-ancestor
6322751|NCT00004930|Doxorubicin|doxorubicin|mesh-list
6322752|NCT00004930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6322753|NCT00004930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6322754|NCT00004930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6322755|NCT00004930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6322756|NCT00004930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6322757|NCT00004930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6322758|NCT00004930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322759|NCT00004931|Leucovorin|leucovorin|mesh-list
6322760|NCT00004931|Fluorouracil|fluorouracil|mesh-list
6322761|NCT00004931|Oxaliplatin|oxaliplatin|mesh-list
6322762|NCT00004931|Calcium|calcium|mesh-list
6322763|NCT00004931|Levoleucovorin|levoleucovorin|mesh-list
6322764|NCT00004931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6322765|NCT00004931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322766|NCT00004931|Antimetabolites|antimetabolites|mesh-ancestor
6322767|NCT00004931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322768|NCT00004931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6322769|NCT00004931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6322770|NCT00004931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6322771|NCT00004931|Immunologic Factors|immunologic factors|mesh-ancestor
6322772|NCT00004931|Antidotes|antidotes|mesh-ancestor
6322773|NCT00004931|Protective Agents|protective agents|mesh-ancestor
6322774|NCT00004931|Vitamin B Complex|vitamin b complex|mesh-ancestor
6322775|NCT00004931|Vitamins|vitamins|mesh-ancestor
6322776|NCT00004931|Micronutrients|micronutrients|mesh-ancestor
6392930|NCT00198354|Immunologic Factors|immunologic factors|mesh-ancestor
6392931|NCT00198354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392932|NCT00198367|Cisplatin|cisplatin|mesh-list
6392933|NCT00198367|Carboplatin|carboplatin|mesh-list
6392934|NCT00198367|Vinorelbine|vinorelbine|mesh-list
6392935|NCT00198367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6392936|NCT00198367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392937|NCT00198367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6392938|NCT00198367|Tubulin Modulators|tubulin modulators|mesh-ancestor
6392939|NCT00198367|Antimitotic Agents|antimitotic agents|mesh-ancestor
6392940|NCT00198367|Mitosis Modulators|mitosis modulators|mesh-ancestor
6392941|NCT00198380|Gefitinib|gefitinib|mesh-list
6392942|NCT00198380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6392943|NCT00198380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6392944|NCT00198380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6392945|NCT00198380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392946|NCT00198393|Gemcitabine|gemcitabine|mesh-list
6392947|NCT00198393|Docetaxel|docetaxel|mesh-list
6392948|NCT00198393|Gefitinib|gefitinib|mesh-list
6392949|NCT00198393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6392950|NCT00198393|Antimetabolites|antimetabolites|mesh-ancestor
6392951|NCT00198393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392952|NCT00198393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6392953|NCT00198393|Antiviral Agents|antiviral agents|mesh-ancestor
6392954|NCT00198393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6392955|NCT00198393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6392956|NCT00198393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6392957|NCT00198393|Immunologic Factors|immunologic factors|mesh-ancestor
6392958|NCT00198393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392959|NCT00198393|Tubulin Modulators|tubulin modulators|mesh-ancestor
6392960|NCT00198393|Antimitotic Agents|antimitotic agents|mesh-ancestor
6392961|NCT00198393|Mitosis Modulators|mitosis modulators|mesh-ancestor
6392962|NCT00198393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6392963|NCT00198432|Paclitaxel|paclitaxel|mesh-list
6392964|NCT00198432|Vinorelbine|vinorelbine|mesh-list
6392965|NCT00198432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6392966|NCT00198432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6392967|NCT00198432|Tubulin Modulators|tubulin modulators|mesh-ancestor
6392968|NCT00198432|Antimitotic Agents|antimitotic agents|mesh-ancestor
6392969|NCT00198432|Mitosis Modulators|mitosis modulators|mesh-ancestor
6392970|NCT00198432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392971|NCT00198445|Bromfenac|bromfenac|mesh-list
6322777|NCT00004932|Imatinib Mesylate|imatinib mesylate|mesh-list
6322778|NCT00004932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6322779|NCT00004932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6322780|NCT00004932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6322781|NCT00004932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322782|NCT00004933|Hydroxyurea|hydroxyurea|mesh-list
6322783|NCT00004933|Homoharringtonine|homoharringtonine|mesh-list
6322784|NCT00004933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6322785|NCT00004933|Antisickling Agents|antisickling agents|mesh-ancestor
6322786|NCT00004933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6322787|NCT00004933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322788|NCT00004933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6322789|NCT00004933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6322790|NCT00004933|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6322791|NCT00004934|Paclitaxel|paclitaxel|mesh-list
6322792|NCT00004934|Carboplatin|carboplatin|mesh-list
6322793|NCT00004934|Epirubicin|epirubicin|mesh-list
6322794|NCT00004934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6322795|NCT00004934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6322796|NCT00004934|Tubulin Modulators|tubulin modulators|mesh-ancestor
6322797|NCT00004934|Antimitotic Agents|antimitotic agents|mesh-ancestor
6322798|NCT00004934|Mitosis Modulators|mitosis modulators|mesh-ancestor
6322799|NCT00004934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322800|NCT00004934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6322801|NCT00004934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6322802|NCT00004934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6322803|NCT00004934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6322804|NCT00004935|Trastuzumab|trastuzumab|mesh-list
6322805|NCT00004935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6322806|NCT00004935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6322807|NCT00004938|Fluconazole|fluconazole|mesh-list
6322808|NCT00004938|Antifungal Agents|antifungal agents|mesh-ancestor
6322809|NCT00004938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6322810|NCT00004938|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6322811|NCT00004938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6322812|NCT00004938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6322813|NCT00004938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322814|NCT00004938|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6322815|NCT00004938|Hormone Antagonists|hormone antagonists|mesh-ancestor
6322816|NCT00004938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6322817|NCT00004938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322818|NCT00004938|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6322819|NCT00004938|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6322820|NCT00004941|Infliximab|infliximab|mesh-list
6322821|NCT00004941|Antibodies|antibodies|mesh-list
6322822|NCT00004941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6322823|NCT00004941|Immunologic Factors|immunologic factors|mesh-ancestor
6322824|NCT00004941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322825|NCT00004941|Dermatologic Agents|dermatologic agents|mesh-ancestor
6322826|NCT00004941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6322827|NCT00004941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6322828|NCT00004979|Paclitaxel|paclitaxel|mesh-list
6322829|NCT00004979|Topotecan|topotecan|mesh-list
6322830|NCT00004979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6322831|NCT00004979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6322832|NCT00004979|Tubulin Modulators|tubulin modulators|mesh-ancestor
6322833|NCT00004979|Antimitotic Agents|antimitotic agents|mesh-ancestor
6322834|NCT00004979|Mitosis Modulators|mitosis modulators|mesh-ancestor
6322835|NCT00004979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322836|NCT00004979|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6322837|NCT00004979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6322838|NCT00004979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6322839|NCT00004981|Lamivudine|lamivudine|mesh-list
6322840|NCT00004981|Zidovudine|zidovudine|mesh-list
6322841|NCT00004981|Abacavir|abacavir|mesh-list
6322842|NCT00004981|Dideoxynucleosides|dideoxynucleosides|mesh-list
6322843|NCT00004981|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6322844|NCT00004981|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6322845|NCT00004981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6322846|NCT00004981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6322847|NCT00004981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322848|NCT00004981|Antiviral Agents|antiviral agents|mesh-ancestor
6322849|NCT00004981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6322850|NCT00004981|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6322851|NCT00004981|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6322852|NCT00004981|Antimetabolites|antimetabolites|mesh-ancestor
6322853|NCT00004984|Insulin|insulin|mesh-list
6322854|NCT00004984|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6322855|NCT00004984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6322856|NCT00004984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322857|NCT00004985|Nelfinavir|nelfinavir|mesh-list
6322858|NCT00004985|Capravirine|capravirine|mesh-list
6322859|NCT00004985|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6322860|NCT00004985|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6322861|NCT00004985|Protease Inhibitors|protease inhibitors|mesh-ancestor
6322862|NCT00004985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6322863|NCT00004985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322864|NCT00004985|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6322865|NCT00004985|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6322866|NCT00004985|Antiviral Agents|antiviral agents|mesh-ancestor
6322867|NCT00004985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6322868|NCT00004985|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6322869|NCT00004985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6322870|NCT00004986|Nitazoxanide|nitazoxanide|mesh-list
6322871|NCT00004986|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6322872|NCT00004986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6322873|NCT00004990|Dexamethasone|dexamethasone|mesh-list
6322874|NCT00004990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6322875|NCT00004990|Antiemetics|antiemetics|mesh-ancestor
6322876|NCT00004990|Autonomic Agents|autonomic agents|mesh-ancestor
6322877|NCT00004990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6322878|NCT00004990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322879|NCT00004990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6322880|NCT00004990|Glucocorticoids|glucocorticoids|mesh-ancestor
6322881|NCT00004990|Hormones|hormones|mesh-ancestor
6322882|NCT00004990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6322883|NCT00004990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6322884|NCT00004990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6322885|NCT00004992|Metformin|metformin|mesh-list
6322886|NCT00004992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6322887|NCT00004992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322888|NCT00004993|Hormones|hormones|mesh-list
6322889|NCT00004993|Parathyroid Hormone|parathyroid hormone|mesh-list
6322890|NCT00004993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6322891|NCT00004993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322892|NCT00004993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6322893|NCT00004997|Leucovorin|leucovorin|mesh-list
6322894|NCT00004997|Antidotes|antidotes|mesh-ancestor
6322895|NCT00004997|Protective Agents|protective agents|mesh-ancestor
6322896|NCT00004997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322897|NCT00004997|Vitamin B Complex|vitamin b complex|mesh-ancestor
6322898|NCT00004997|Vitamins|vitamins|mesh-ancestor
6322899|NCT00004997|Micronutrients|micronutrients|mesh-ancestor
6322900|NCT00004998|Lamivudine|lamivudine|mesh-list
6322901|NCT00004998|Zidovudine|zidovudine|mesh-list
6322902|NCT00004998|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6322903|NCT00004998|Capravirine|capravirine|mesh-list
6322904|NCT00004998|Nelfinavir|nelfinavir|mesh-list
6322905|NCT00004998|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6322906|NCT00004998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6322907|NCT00004998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6322908|NCT00004998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322909|NCT00004998|Antiviral Agents|antiviral agents|mesh-ancestor
6322910|NCT00004998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6322911|NCT00004998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6322912|NCT00004998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6322913|NCT00004998|Antimetabolites|antimetabolites|mesh-ancestor
6322914|NCT00004998|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6322915|NCT00004998|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6322916|NCT00004998|Protease Inhibitors|protease inhibitors|mesh-ancestor
6322917|NCT00004999|Lamivudine|lamivudine|mesh-list
6322918|NCT00004999|Zidovudine|zidovudine|mesh-list
6322919|NCT00004999|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6322920|NCT00004999|Capravirine|capravirine|mesh-list
6322921|NCT00004999|Nelfinavir|nelfinavir|mesh-list
6322922|NCT00004999|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6322923|NCT00004999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6322924|NCT00004999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6322925|NCT00004999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322926|NCT00004999|Antiviral Agents|antiviral agents|mesh-ancestor
6322927|NCT00004999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6322928|NCT00004999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6322929|NCT00004999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6322930|NCT00004999|Antimetabolites|antimetabolites|mesh-ancestor
6322931|NCT00004999|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6322932|NCT00004999|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6322933|NCT00004999|Protease Inhibitors|protease inhibitors|mesh-ancestor
6322934|NCT00005000|Lamivudine|lamivudine|mesh-list
6322935|NCT00005000|Zidovudine|zidovudine|mesh-list
6322936|NCT00005000|Efavirenz|efavirenz|mesh-list
6322937|NCT00005000|Stavudine|stavudine|mesh-list
6322938|NCT00005000|Didanosine|didanosine|mesh-list
6322939|NCT00005000|Nelfinavir|nelfinavir|mesh-list
6016517|NCT00365417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6016518|NCT00365417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6016519|NCT00365417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6016520|NCT00365417|Growth Substances|growth substances|mesh-ancestor
6016521|NCT00365417|Growth Inhibitors|growth inhibitors|mesh-ancestor
6016522|NCT00365417|Tubulin Modulators|tubulin modulators|mesh-ancestor
6016523|NCT00365417|Antimitotic Agents|antimitotic agents|mesh-ancestor
6016524|NCT00365417|Mitosis Modulators|mitosis modulators|mesh-ancestor
6016525|NCT00365417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6016526|NCT00365417|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6016527|NCT00365417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6016528|NCT00365417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6016529|NCT00365417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6016530|NCT00365417|Antimetabolites|antimetabolites|mesh-ancestor
6322940|NCT00005000|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
6322941|NCT00005000|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6322942|NCT00005000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6322943|NCT00005000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6322944|NCT00005000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322945|NCT00005000|Antiviral Agents|antiviral agents|mesh-ancestor
6322946|NCT00005000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6322947|NCT00005000|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6322948|NCT00005000|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6322949|NCT00005000|Antimetabolites|antimetabolites|mesh-ancestor
6322950|NCT00005000|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6322951|NCT00005000|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6322952|NCT00005000|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6322953|NCT00005000|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6322954|NCT00005000|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6322955|NCT00005000|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6322956|NCT00005000|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6322957|NCT00005000|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6322958|NCT00005000|Protease Inhibitors|protease inhibitors|mesh-ancestor
6322959|NCT00005000|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6322960|NCT00005000|Immunologic Factors|immunologic factors|mesh-ancestor
6322961|NCT00005000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322962|NCT00005002|Lamivudine|lamivudine|mesh-list
6322963|NCT00005002|Zidovudine|zidovudine|mesh-list
6322964|NCT00005002|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6322965|NCT00005002|Nelfinavir|nelfinavir|mesh-list
6322966|NCT00005002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6322967|NCT00005002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6322968|NCT00005002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6322969|NCT00005002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6322970|NCT00005002|Antiviral Agents|antiviral agents|mesh-ancestor
6322971|NCT00005002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6322972|NCT00005002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6322973|NCT00005002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6322974|NCT00005002|Antimetabolites|antimetabolites|mesh-ancestor
6322975|NCT00005002|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6322976|NCT00005002|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6322977|NCT00005002|Protease Inhibitors|protease inhibitors|mesh-ancestor
6322978|NCT00005005|Alendronate|alendronate|mesh-list
6322979|NCT00005005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6322980|NCT00005005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322981|NCT00005006|Alendronate|alendronate|mesh-list
6322982|NCT00005006|Teriparatide|teriparatide|mesh-list
6322983|NCT00005006|Hormones|hormones|mesh-list
6322984|NCT00005006|Parathyroid Hormone|parathyroid hormone|mesh-list
6322985|NCT00005006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6322986|NCT00005006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322987|NCT00005006|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6322988|NCT00005006|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6322989|NCT00005007|Etanercept|etanercept|mesh-list
6322990|NCT00005007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6322991|NCT00005007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6322992|NCT00005007|Analgesics|analgesics|mesh-ancestor
6322993|NCT00005007|Sensory System Agents|sensory system agents|mesh-ancestor
6322994|NCT00005007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6322995|NCT00005007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6322996|NCT00005007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6322997|NCT00005007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6322998|NCT00005007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6322999|NCT00005007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6323000|NCT00005007|Immunologic Factors|immunologic factors|mesh-ancestor
6323001|NCT00005009|Vaccines|vaccines|mesh-list
6323002|NCT00005009|Immunologic Factors|immunologic factors|mesh-ancestor
6323003|NCT00005009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6323004|NCT00005010|Irbesartan|irbesartan|mesh-list
6323005|NCT00005010|Pravastatin|pravastatin|mesh-list
6323006|NCT00005010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6323007|NCT00005010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6323008|NCT00005010|Antimetabolites|antimetabolites|mesh-ancestor
6323009|NCT00005010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323010|NCT00005010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6323011|NCT00005010|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6323012|NCT00005010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6323013|NCT00005010|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6323014|NCT00005010|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6323015|NCT00005010|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6323016|NCT00005012|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6323017|NCT00005012|Antiviral Agents|antiviral agents|mesh-ancestor
6323018|NCT00005012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6323019|NCT00005013|Sertraline|sertraline|mesh-list
6323020|NCT00005013|Antidepressive Agents|antidepressive agents|mesh-ancestor
6323021|NCT00005013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6323022|NCT00005013|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6323023|NCT00005013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6323024|NCT00005013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6323025|NCT00005013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323026|NCT00005013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6323027|NCT00005013|Serotonin Agents|serotonin agents|mesh-ancestor
6323028|NCT00005013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6323029|NCT00005014|Risperidone|risperidone|mesh-list
6323030|NCT00005014|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6323031|NCT00005014|Serotonin Agents|serotonin agents|mesh-ancestor
6323032|NCT00005014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6323033|NCT00005014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323034|NCT00005014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6323035|NCT00005014|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6323036|NCT00005014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6323037|NCT00005014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6323038|NCT00005014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6323039|NCT00005014|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6323040|NCT00005014|Dopamine Agents|dopamine agents|mesh-ancestor
6323041|NCT00005015|Fluoxetine|fluoxetine|mesh-list
6323042|NCT00005015|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6323043|NCT00005015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6323044|NCT00005015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6323045|NCT00005015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323046|NCT00005015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6323047|NCT00005015|Serotonin Agents|serotonin agents|mesh-ancestor
6323048|NCT00005015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6323049|NCT00005015|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6323050|NCT00005015|Antidepressive Agents|antidepressive agents|mesh-ancestor
6323051|NCT00005015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6323052|NCT00005015|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6323053|NCT00005015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6323054|NCT00005015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6323055|NCT00005017|Ritonavir|ritonavir|mesh-list
6323056|NCT00005017|Amprenavir|amprenavir|mesh-list
6323057|NCT00005017|Lamivudine|lamivudine|mesh-list
6323058|NCT00005017|Abacavir|abacavir|mesh-list
6323059|NCT00005017|Stavudine|stavudine|mesh-list
6323060|NCT00005017|Efavirenz|efavirenz|mesh-list
6323061|NCT00005017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6323062|NCT00005017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6323063|NCT00005017|Protease Inhibitors|protease inhibitors|mesh-ancestor
6323064|NCT00005017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6323065|NCT00005017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323066|NCT00005017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6323067|NCT00005017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6323068|NCT00005017|Antiviral Agents|antiviral agents|mesh-ancestor
6323069|NCT00005017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6323070|NCT00005017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6323071|NCT00005017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6323072|NCT00005017|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6323073|NCT00005017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6323074|NCT00005017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6323075|NCT00005017|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6323076|NCT00005017|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6323077|NCT00005017|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6323078|NCT00005017|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6323079|NCT00005017|Antimetabolites|antimetabolites|mesh-ancestor
6323080|NCT00005017|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6323081|NCT00005017|Antitubercular Agents|antitubercular agents|mesh-ancestor
6323082|NCT00005017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6323083|NCT00005018|Efavirenz|efavirenz|mesh-list
6323084|NCT00005018|Abacavir|abacavir|mesh-list
6323085|NCT00005018|Didanosine|didanosine|mesh-list
6323086|NCT00005018|Hydroxyurea|hydroxyurea|mesh-list
6323087|NCT00005018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6323088|NCT00005018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6323089|NCT00005018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6323090|NCT00005018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323091|NCT00005018|Antiviral Agents|antiviral agents|mesh-ancestor
6323092|NCT00005018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6323093|NCT00005018|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6323094|NCT00005018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6323095|NCT00005018|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6323096|NCT00005018|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6323097|NCT00005018|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6323098|NCT00005018|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6016531|NCT00365456|Risedronic Acid|risedronic acid|mesh-list
6016532|NCT00365456|Hormones|hormones|mesh-list
6016533|NCT00365456|Parathyroid Hormone|parathyroid hormone|mesh-list
6016534|NCT00365456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6323099|NCT00005018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6323100|NCT00005018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6323101|NCT00005018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323102|NCT00005018|Antisickling Agents|antisickling agents|mesh-ancestor
6323103|NCT00005018|Antimetabolites|antimetabolites|mesh-ancestor
6323104|NCT00005021|Paclitaxel|paclitaxel|mesh-list
6323105|NCT00005021|Carboplatin|carboplatin|mesh-list
6323106|NCT00005021|Topotecan|topotecan|mesh-list
6323107|NCT00005021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6323108|NCT00005021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323109|NCT00005021|Tubulin Modulators|tubulin modulators|mesh-ancestor
6323110|NCT00005021|Antimitotic Agents|antimitotic agents|mesh-ancestor
6323111|NCT00005021|Mitosis Modulators|mitosis modulators|mesh-ancestor
6323112|NCT00005021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323113|NCT00005021|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6323114|NCT00005021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6323115|NCT00005021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6323116|NCT00005022|Etoposide|etoposide|mesh-list
6323117|NCT00005022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323118|NCT00005022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6323119|NCT00005022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6323120|NCT00005022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6323121|NCT00005022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6323122|NCT00005022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323123|NCT00005023|Sargramostim|sargramostim|mesh-list
6323124|NCT00005023|Immunologic Factors|immunologic factors|mesh-ancestor
6323125|NCT00005023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6323126|NCT00005024|Cyclophosphamide|cyclophosphamide|mesh-list
6323127|NCT00005024|Carboplatin|carboplatin|mesh-list
6323128|NCT00005024|Doxorubicin|doxorubicin|mesh-list
6323129|NCT00005024|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6323130|NCT00005024|Granisetron|granisetron|mesh-list
6323131|NCT00005024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6323132|NCT00005024|Immunologic Factors|immunologic factors|mesh-ancestor
6323133|NCT00005024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6323134|NCT00005024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6323135|NCT00005024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6323136|NCT00005024|Alkylating Agents|alkylating agents|mesh-ancestor
6323137|NCT00005024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323138|NCT00005024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323139|NCT00005024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6323140|NCT00005024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6323141|NCT00005024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6323142|NCT00005024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6323143|NCT00005024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6323144|NCT00005024|Antiemetics|antiemetics|mesh-ancestor
6323145|NCT00005024|Autonomic Agents|autonomic agents|mesh-ancestor
6323146|NCT00005024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6323147|NCT00005024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6323148|NCT00005024|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6323149|NCT00005024|Serotonin Agents|serotonin agents|mesh-ancestor
6323150|NCT00005024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6323151|NCT00005025|Ganciclovir|ganciclovir|mesh-list
6323152|NCT00005025|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6323153|NCT00005025|Antiviral Agents|antiviral agents|mesh-ancestor
6323154|NCT00005025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6323155|NCT00005025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6323156|NCT00005025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6323157|NCT00005025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323158|NCT00005026|Paclitaxel|paclitaxel|mesh-list
6323159|NCT00005026|Carboplatin|carboplatin|mesh-list
6323160|NCT00005026|Topotecan|topotecan|mesh-list
6323161|NCT00005026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6323162|NCT00005026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323163|NCT00005026|Tubulin Modulators|tubulin modulators|mesh-ancestor
6323164|NCT00005026|Antimitotic Agents|antimitotic agents|mesh-ancestor
6323165|NCT00005026|Mitosis Modulators|mitosis modulators|mesh-ancestor
6323166|NCT00005026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323167|NCT00005026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6323168|NCT00005026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6323169|NCT00005026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6323170|NCT00005028|Paclitaxel|paclitaxel|mesh-list
6323171|NCT00005028|Bryostatin 1|bryostatin 1|mesh-list
6323172|NCT00005028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6323173|NCT00005028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323174|NCT00005028|Tubulin Modulators|tubulin modulators|mesh-ancestor
6323175|NCT00005028|Antimitotic Agents|antimitotic agents|mesh-ancestor
6323176|NCT00005028|Mitosis Modulators|mitosis modulators|mesh-ancestor
6323177|NCT00005028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323178|NCT00005028|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6323179|NCT00005028|Immunologic Factors|immunologic factors|mesh-ancestor
6323180|NCT00005028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6323181|NCT00005029|Topotecan|topotecan|mesh-list
6323182|NCT00005029|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6323183|NCT00005029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6323184|NCT00005029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6323185|NCT00005029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323186|NCT00005029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323187|NCT00005030|Lonafarnib|lonafarnib|mesh-list
6323188|NCT00005030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6323189|NCT00005030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323190|NCT00005031|Irofulven|irofulven|mesh-list
6323191|NCT00005031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6323192|NCT00005031|Alkylating Agents|alkylating agents|mesh-ancestor
6323193|NCT00005031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323194|NCT00005031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323195|NCT00005032|Paclitaxel|paclitaxel|mesh-list
6323196|NCT00005032|Oblimersen|oblimersen|mesh-list
6323197|NCT00005032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6323198|NCT00005032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323199|NCT00005032|Tubulin Modulators|tubulin modulators|mesh-ancestor
6323200|NCT00005032|Antimitotic Agents|antimitotic agents|mesh-ancestor
6323201|NCT00005032|Mitosis Modulators|mitosis modulators|mesh-ancestor
6323202|NCT00005032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323203|NCT00005033|Trastuzumab|trastuzumab|mesh-list
6323204|NCT00005033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6323205|NCT00005033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323206|NCT00005035|Oxaliplatin|oxaliplatin|mesh-list
6323207|NCT00005035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323208|NCT00005036|Leucovorin|leucovorin|mesh-list
6323209|NCT00005036|Fluorouracil|fluorouracil|mesh-list
6323210|NCT00005036|Oxaliplatin|oxaliplatin|mesh-list
6323211|NCT00005036|Irinotecan|irinotecan|mesh-list
6323212|NCT00005036|Calcium|calcium|mesh-list
6323213|NCT00005036|Levoleucovorin|levoleucovorin|mesh-list
6323214|NCT00005036|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6323215|NCT00005036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6323216|NCT00005036|Antimetabolites|antimetabolites|mesh-ancestor
6323217|NCT00005036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323218|NCT00005036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6323219|NCT00005036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323220|NCT00005036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6323221|NCT00005036|Immunologic Factors|immunologic factors|mesh-ancestor
6323222|NCT00005036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6323223|NCT00005036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6323224|NCT00005036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6323225|NCT00005036|Antidotes|antidotes|mesh-ancestor
6323226|NCT00005036|Protective Agents|protective agents|mesh-ancestor
6323227|NCT00005036|Vitamin B Complex|vitamin b complex|mesh-ancestor
6323228|NCT00005036|Vitamins|vitamins|mesh-ancestor
6323229|NCT00005036|Micronutrients|micronutrients|mesh-ancestor
6323230|NCT00005037|Temozolomide|temozolomide|mesh-list
6323231|NCT00005037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6323232|NCT00005037|Alkylating Agents|alkylating agents|mesh-ancestor
6323233|NCT00005037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323234|NCT00005037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323235|NCT00005038|Aldesleukin|aldesleukin|mesh-list
6323236|NCT00005038|Histamine|histamine|mesh-list
6323237|NCT00005038|Histamine phosphate|histamine phosphate|mesh-list
6323238|NCT00005038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323239|NCT00005038|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6323240|NCT00005038|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6323241|NCT00005038|Antiviral Agents|antiviral agents|mesh-ancestor
6323242|NCT00005038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6323243|NCT00005038|Histamine Agonists|histamine agonists|mesh-ancestor
6323244|NCT00005038|Histamine Agents|histamine agents|mesh-ancestor
6323245|NCT00005038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6323246|NCT00005038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323247|NCT00005038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6323248|NCT00005039|Vaccines|vaccines|mesh-list
6323249|NCT00005039|Immunologic Factors|immunologic factors|mesh-ancestor
6323250|NCT00005039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6323251|NCT00005040|Arsenic Trioxide|arsenic trioxide|mesh-list
6323252|NCT00005040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323253|NCT00005041|Tipifarnib|tipifarnib|mesh-list
6323254|NCT00005041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323255|NCT00005042|Semaxinib|semaxinib|mesh-list
6323256|NCT00005042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6323257|NCT00005042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6323258|NCT00005042|Growth Substances|growth substances|mesh-ancestor
6323259|NCT00005042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6323260|NCT00005042|Growth Inhibitors|growth inhibitors|mesh-ancestor
6323261|NCT00005042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323262|NCT00005042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6323263|NCT00005042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6323264|NCT00005042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323265|NCT00005045|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
6323266|NCT00005045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323267|NCT00005045|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6323268|NCT00005045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6323269|NCT00005045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323270|NCT00005045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6323271|NCT00005045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6323272|NCT00005046|Paclitaxel|paclitaxel|mesh-list
6323273|NCT00005046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6323274|NCT00005046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323275|NCT00005046|Tubulin Modulators|tubulin modulators|mesh-ancestor
6323276|NCT00005046|Antimitotic Agents|antimitotic agents|mesh-ancestor
6323277|NCT00005046|Mitosis Modulators|mitosis modulators|mesh-ancestor
6323278|NCT00005046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323279|NCT00005048|Paclitaxel|paclitaxel|mesh-list
6323280|NCT00005048|Estramustine|estramustine|mesh-list
6323281|NCT00005048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6323282|NCT00005048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323283|NCT00005048|Tubulin Modulators|tubulin modulators|mesh-ancestor
6323284|NCT00005048|Antimitotic Agents|antimitotic agents|mesh-ancestor
6323285|NCT00005048|Mitosis Modulators|mitosis modulators|mesh-ancestor
6323286|NCT00005048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323287|NCT00005048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6323288|NCT00005048|Alkylating Agents|alkylating agents|mesh-ancestor
6323289|NCT00005048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6323290|NCT00005049|Carboplatin|carboplatin|mesh-list
6323291|NCT00005049|Floxuridine|floxuridine|mesh-list
6323292|NCT00005049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323293|NCT00005049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6323294|NCT00005049|Antimetabolites|antimetabolites|mesh-ancestor
6323295|NCT00005049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323296|NCT00005050|Fluorouracil|fluorouracil|mesh-list
6323297|NCT00005050|Oxaliplatin|oxaliplatin|mesh-list
6323298|NCT00005050|Eniluracil|eniluracil|mesh-list
6323299|NCT00005050|Antimetabolites|antimetabolites|mesh-ancestor
6323300|NCT00005050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323301|NCT00005050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6323302|NCT00005050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323303|NCT00005050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6323304|NCT00005050|Immunologic Factors|immunologic factors|mesh-ancestor
6323305|NCT00005050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6323306|NCT00005050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6323307|NCT00005051|Paclitaxel|paclitaxel|mesh-list
6323308|NCT00005051|Carboplatin|carboplatin|mesh-list
6323309|NCT00005051|Topotecan|topotecan|mesh-list
6323310|NCT00005051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6323311|NCT00005051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323312|NCT00005051|Tubulin Modulators|tubulin modulators|mesh-ancestor
6323313|NCT00005051|Antimitotic Agents|antimitotic agents|mesh-ancestor
6323314|NCT00005051|Mitosis Modulators|mitosis modulators|mesh-ancestor
6323315|NCT00005051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323316|NCT00005051|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6323317|NCT00005051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6323318|NCT00005051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6323319|NCT00005054|Temozolomide|temozolomide|mesh-list
6323320|NCT00005054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6323321|NCT00005054|Alkylating Agents|alkylating agents|mesh-ancestor
6323322|NCT00005054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323323|NCT00005054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323324|NCT00005056|Bryostatin 1|bryostatin 1|mesh-list
6323325|NCT00005056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6323326|NCT00005056|Immunologic Factors|immunologic factors|mesh-ancestor
6323327|NCT00005056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6323328|NCT00005056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323329|NCT00005057|Ganciclovir|ganciclovir|mesh-list
6323330|NCT00005057|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6323331|NCT00005057|Antiviral Agents|antiviral agents|mesh-ancestor
6323332|NCT00005057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6323333|NCT00005057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6323334|NCT00005057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6323335|NCT00005057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323336|NCT00005059|Paclitaxel|paclitaxel|mesh-list
6323337|NCT00005059|Carboplatin|carboplatin|mesh-list
6323338|NCT00005059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6323339|NCT00005059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323340|NCT00005059|Tubulin Modulators|tubulin modulators|mesh-ancestor
6323341|NCT00005059|Antimitotic Agents|antimitotic agents|mesh-ancestor
6323342|NCT00005059|Mitosis Modulators|mitosis modulators|mesh-ancestor
6323343|NCT00005059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323344|NCT00005060|Docetaxel|docetaxel|mesh-list
6323345|NCT00005060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323346|NCT00005060|Tubulin Modulators|tubulin modulators|mesh-ancestor
6323347|NCT00005060|Antimitotic Agents|antimitotic agents|mesh-ancestor
6323348|NCT00005060|Mitosis Modulators|mitosis modulators|mesh-ancestor
6323349|NCT00005060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323350|NCT00005061|Bevacizumab|bevacizumab|mesh-list
6323351|NCT00005061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6323352|NCT00005061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323353|NCT00005061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6323354|NCT00005061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6323355|NCT00005061|Growth Substances|growth substances|mesh-ancestor
6323356|NCT00005061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6323357|NCT00005061|Growth Inhibitors|growth inhibitors|mesh-ancestor
6323358|NCT00005064|Bortezomib|bortezomib|mesh-list
6323359|NCT00005064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323360|NCT00005065|Paclitaxel|paclitaxel|mesh-list
6323361|NCT00005065|Carboplatin|carboplatin|mesh-list
6323362|NCT00005065|Motexafin gadolinium|motexafin gadolinium|mesh-list
6323363|NCT00005065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6323364|NCT00005065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323365|NCT00005065|Tubulin Modulators|tubulin modulators|mesh-ancestor
6323366|NCT00005065|Antimitotic Agents|antimitotic agents|mesh-ancestor
6323367|NCT00005065|Mitosis Modulators|mitosis modulators|mesh-ancestor
6323368|NCT00005065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323369|NCT00005065|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6323370|NCT00005065|Dermatologic Agents|dermatologic agents|mesh-ancestor
6323371|NCT00005066|Carmustine|carmustine|mesh-list
6323372|NCT00005066|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
6323373|NCT00005066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6323374|NCT00005066|Alkylating Agents|alkylating agents|mesh-ancestor
6323375|NCT00005066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323376|NCT00005066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323377|NCT00005066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6323378|NCT00005067|Motexafin lutetium|motexafin lutetium|mesh-list
6323379|NCT00005067|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6323380|NCT00005067|Dermatologic Agents|dermatologic agents|mesh-ancestor
6323381|NCT00005068|Leucovorin|leucovorin|mesh-list
6323382|NCT00005068|Fluorouracil|fluorouracil|mesh-list
6323383|NCT00005068|Oxaliplatin|oxaliplatin|mesh-list
6323384|NCT00005068|Irinotecan|irinotecan|mesh-list
6323385|NCT00005068|Calcium|calcium|mesh-list
6323386|NCT00005068|Levoleucovorin|levoleucovorin|mesh-list
6323387|NCT00005068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6323388|NCT00005068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6323389|NCT00005068|Antimetabolites|antimetabolites|mesh-ancestor
6323390|NCT00005068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323391|NCT00005068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6323392|NCT00005068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323393|NCT00005068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6323394|NCT00005068|Immunologic Factors|immunologic factors|mesh-ancestor
6323395|NCT00005068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6323396|NCT00005068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6323397|NCT00005068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6323398|NCT00005068|Antidotes|antidotes|mesh-ancestor
6323399|NCT00005068|Protective Agents|protective agents|mesh-ancestor
6323400|NCT00005068|Vitamin B Complex|vitamin b complex|mesh-ancestor
6323401|NCT00005068|Vitamins|vitamins|mesh-ancestor
6323402|NCT00005068|Micronutrients|micronutrients|mesh-ancestor
6323403|NCT00005069|Arsenic Trioxide|arsenic trioxide|mesh-list
6323404|NCT00005069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323405|NCT00005070|Irofulven|irofulven|mesh-list
6323406|NCT00005070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6323407|NCT00005070|Alkylating Agents|alkylating agents|mesh-ancestor
6323408|NCT00005070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323409|NCT00005070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323410|NCT00005072|Interleukin-2|interleukin-2|mesh-list
6323411|NCT00005072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323412|NCT00005072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6323413|NCT00005072|Analgesics|analgesics|mesh-ancestor
6323414|NCT00005072|Sensory System Agents|sensory system agents|mesh-ancestor
6323415|NCT00005072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6323416|NCT00005072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6323417|NCT00005073|Zoledronic Acid|zoledronic acid|mesh-list
6323418|NCT00005073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6323419|NCT00005073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6323420|NCT00005074|Alvocidib|alvocidib|mesh-list
6323421|NCT00005074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323422|NCT00005074|Growth Inhibitors|growth inhibitors|mesh-ancestor
6323423|NCT00005074|Growth Substances|growth substances|mesh-ancestor
6323424|NCT00005074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6323425|NCT00005074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6323426|NCT00005074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6323427|NCT00005074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323428|NCT00005076|Irinotecan|irinotecan|mesh-list
6323429|NCT00005076|Cetuximab|cetuximab|mesh-list
6323430|NCT00005076|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6323431|NCT00005076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6323432|NCT00005076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6323433|NCT00005076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323434|NCT00005076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323435|NCT00005076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6323436|NCT00005077|Oxaliplatin|oxaliplatin|mesh-list
6323437|NCT00005077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323438|NCT00005078|Paclitaxel|paclitaxel|mesh-list
6323439|NCT00005078|Carboplatin|carboplatin|mesh-list
6323440|NCT00005078|Tirapazamine|tirapazamine|mesh-list
6323441|NCT00005078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6323442|NCT00005078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323443|NCT00005078|Tubulin Modulators|tubulin modulators|mesh-ancestor
6323444|NCT00005078|Antimitotic Agents|antimitotic agents|mesh-ancestor
6323445|NCT00005078|Mitosis Modulators|mitosis modulators|mesh-ancestor
6323446|NCT00005078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6392972|NCT00198445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6392973|NCT00198445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6392974|NCT00198445|Analgesics|analgesics|mesh-ancestor
6392975|NCT00198445|Sensory System Agents|sensory system agents|mesh-ancestor
6392976|NCT00198445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6392977|NCT00198445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392978|NCT00198445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6392979|NCT00198445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6392980|NCT00198523|Tobramycin|tobramycin|mesh-list
6392981|NCT00198523|Prednisolone|prednisolone|mesh-list
6392982|NCT00198523|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6392983|NCT00198523|Methylprednisolone|methylprednisolone|mesh-list
6392984|NCT00198523|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6392985|NCT00198523|Prednisolone acetate|prednisolone acetate|mesh-list
6392986|NCT00198523|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6392987|NCT00198523|Prednisolone phosphate|prednisolone phosphate|mesh-list
6392988|NCT00198523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6392989|NCT00198523|Glucocorticoids|glucocorticoids|mesh-ancestor
6392990|NCT00198523|Hormones|hormones|mesh-ancestor
6392991|NCT00198523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6392992|NCT00198523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6392993|NCT00198523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6392994|NCT00198523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323447|NCT00005081|Carmustine|carmustine|mesh-list
6323448|NCT00005081|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
6323449|NCT00005081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6323450|NCT00005081|Alkylating Agents|alkylating agents|mesh-ancestor
6323451|NCT00005081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323452|NCT00005081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323453|NCT00005081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6323454|NCT00005086|Gemcitabine|gemcitabine|mesh-list
6323455|NCT00005086|Docetaxel|docetaxel|mesh-list
6323456|NCT00005086|Methotrexate|methotrexate|mesh-list
6323457|NCT00005086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323458|NCT00005086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6323459|NCT00005086|Antimetabolites|antimetabolites|mesh-ancestor
6323460|NCT00005086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323461|NCT00005086|Antiviral Agents|antiviral agents|mesh-ancestor
6323462|NCT00005086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6323463|NCT00005086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6323464|NCT00005086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6323465|NCT00005086|Immunologic Factors|immunologic factors|mesh-ancestor
6323466|NCT00005086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6323467|NCT00005086|Tubulin Modulators|tubulin modulators|mesh-ancestor
6323468|NCT00005086|Antimitotic Agents|antimitotic agents|mesh-ancestor
6323469|NCT00005086|Mitosis Modulators|mitosis modulators|mesh-ancestor
6323470|NCT00005086|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6323471|NCT00005086|Abortifacient Agents|abortifacient agents|mesh-ancestor
6323472|NCT00005086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6323473|NCT00005086|Dermatologic Agents|dermatologic agents|mesh-ancestor
6323474|NCT00005086|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6323475|NCT00005086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6323476|NCT00005086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6323477|NCT00005087|Paclitaxel|paclitaxel|mesh-list
6323478|NCT00005087|Cisplatin|cisplatin|mesh-list
6323479|NCT00005087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6323480|NCT00005087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323481|NCT00005087|Tubulin Modulators|tubulin modulators|mesh-ancestor
6323482|NCT00005087|Antimitotic Agents|antimitotic agents|mesh-ancestor
6323483|NCT00005087|Mitosis Modulators|mitosis modulators|mesh-ancestor
6323484|NCT00005087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323485|NCT00005088|Cisplatin|cisplatin|mesh-list
6323486|NCT00005088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323487|NCT00005089|Prednisone|prednisone|mesh-list
6323488|NCT00005089|Cyclophosphamide|cyclophosphamide|mesh-list
6323489|NCT00005089|Rituximab|rituximab|mesh-list
6323490|NCT00005089|Doxorubicin|doxorubicin|mesh-list
6323491|NCT00005089|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6323492|NCT00005089|Vincristine|vincristine|mesh-list
6323493|NCT00005089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6323494|NCT00005089|Immunologic Factors|immunologic factors|mesh-ancestor
6323495|NCT00005089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6323496|NCT00005089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6323497|NCT00005089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6323498|NCT00005089|Alkylating Agents|alkylating agents|mesh-ancestor
6323499|NCT00005089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323500|NCT00005089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323501|NCT00005089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6323502|NCT00005089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6323503|NCT00005089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6323504|NCT00005089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6323505|NCT00005089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6323506|NCT00005089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6323507|NCT00005089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6323508|NCT00005089|Glucocorticoids|glucocorticoids|mesh-ancestor
6323509|NCT00005089|Hormones|hormones|mesh-ancestor
6323510|NCT00005089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6323511|NCT00005089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6323512|NCT00005089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6323513|NCT00005089|Tubulin Modulators|tubulin modulators|mesh-ancestor
6323514|NCT00005089|Antimitotic Agents|antimitotic agents|mesh-ancestor
6323515|NCT00005089|Mitosis Modulators|mitosis modulators|mesh-ancestor
6323516|NCT00005090|Cyclophosphamide|cyclophosphamide|mesh-list
6323517|NCT00005090|Dacarbazine|dacarbazine|mesh-list
6323518|NCT00005090|Carmustine|carmustine|mesh-list
6323519|NCT00005090|Doxorubicin|doxorubicin|mesh-list
6323520|NCT00005090|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6323521|NCT00005090|Etoposide|etoposide|mesh-list
6323522|NCT00005090|Bleomycin|bleomycin|mesh-list
6323523|NCT00005090|Vinblastine|vinblastine|mesh-list
6323524|NCT00005090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6323525|NCT00005090|Immunologic Factors|immunologic factors|mesh-ancestor
6323526|NCT00005090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6323527|NCT00005090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6323528|NCT00005090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6323529|NCT00005090|Alkylating Agents|alkylating agents|mesh-ancestor
6323530|NCT00005090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323531|NCT00005090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323532|NCT00005090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6323533|NCT00005090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6323534|NCT00005090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6323535|NCT00005090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6323536|NCT00005090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6323537|NCT00005090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6323538|NCT00005090|Tubulin Modulators|tubulin modulators|mesh-ancestor
6323539|NCT00005090|Antimitotic Agents|antimitotic agents|mesh-ancestor
6323540|NCT00005090|Mitosis Modulators|mitosis modulators|mesh-ancestor
6323541|NCT00005091|Exatecan|exatecan|mesh-list
6323542|NCT00005091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6323543|NCT00005091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6323544|NCT00005091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6323545|NCT00005091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323546|NCT00005091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323547|NCT00005092|Cyclophosphamide|cyclophosphamide|mesh-list
6323548|NCT00005092|Thiotepa|thiotepa|mesh-list
6323549|NCT00005092|Methoxsalen|methoxsalen|mesh-list
6323550|NCT00005092|Furocoumarins|furocoumarins|mesh-list
6323551|NCT00005092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6323552|NCT00005092|Immunologic Factors|immunologic factors|mesh-ancestor
6323553|NCT00005092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6323554|NCT00005092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6323555|NCT00005092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6323556|NCT00005092|Alkylating Agents|alkylating agents|mesh-ancestor
6323557|NCT00005092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323558|NCT00005092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323559|NCT00005092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6323560|NCT00005092|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6323561|NCT00005092|Dermatologic Agents|dermatologic agents|mesh-ancestor
6323562|NCT00005093|Gemcitabine|gemcitabine|mesh-list
6323563|NCT00005093|Tacedinaline|tacedinaline|mesh-list
6323564|NCT00005093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6323565|NCT00005093|Antimetabolites|antimetabolites|mesh-ancestor
6323566|NCT00005093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323567|NCT00005093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323568|NCT00005093|Antiviral Agents|antiviral agents|mesh-ancestor
6323569|NCT00005093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6323570|NCT00005093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6323571|NCT00005093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6323572|NCT00005093|Immunologic Factors|immunologic factors|mesh-ancestor
6323573|NCT00005093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6323574|NCT00005093|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6323575|NCT00005094|Celecoxib|celecoxib|mesh-list
6323576|NCT00005094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6323577|NCT00005094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6323578|NCT00005094|Analgesics|analgesics|mesh-ancestor
6323579|NCT00005094|Sensory System Agents|sensory system agents|mesh-ancestor
6323580|NCT00005094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6323581|NCT00005094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6323582|NCT00005094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6323583|NCT00005094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6323584|NCT00005094|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6323585|NCT00005094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6323586|NCT00005094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6323587|NCT00005094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323588|NCT00005096|Docetaxel|docetaxel|mesh-list
6323589|NCT00005096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323590|NCT00005096|Tubulin Modulators|tubulin modulators|mesh-ancestor
6323591|NCT00005096|Antimitotic Agents|antimitotic agents|mesh-ancestor
6323592|NCT00005096|Mitosis Modulators|mitosis modulators|mesh-ancestor
6323593|NCT00005096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323594|NCT00005104|Metformin|metformin|mesh-list
6323595|NCT00005104|Clomiphene|clomiphene|mesh-list
6323596|NCT00005104|Enclomiphene|enclomiphene|mesh-list
6323597|NCT00005104|Zuclomiphene|zuclomiphene|mesh-list
6323598|NCT00005104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6323599|NCT00005104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6323600|NCT00005104|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6323601|NCT00005104|Hormone Antagonists|hormone antagonists|mesh-ancestor
6323602|NCT00005104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6323603|NCT00005104|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6323604|NCT00005104|Fertility Agents|fertility agents|mesh-ancestor
6323605|NCT00005104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6323606|NCT00005104|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6323607|NCT00005104|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6323608|NCT00005106|Lamivudine|lamivudine|mesh-list
6323609|NCT00005106|Zidovudine|zidovudine|mesh-list
6323610|NCT00005106|Abacavir|abacavir|mesh-list
6323611|NCT00005106|Stavudine|stavudine|mesh-list
6323612|NCT00005106|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6323613|NCT00005106|Nelfinavir|nelfinavir|mesh-list
6323614|NCT00005106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6323615|NCT00005106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6323616|NCT00005106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6323617|NCT00005106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323618|NCT00005106|Antiviral Agents|antiviral agents|mesh-ancestor
6323619|NCT00005106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6323620|NCT00005106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6323621|NCT00005106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6323622|NCT00005106|Antimetabolites|antimetabolites|mesh-ancestor
6323623|NCT00005106|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6323624|NCT00005106|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6323625|NCT00005106|Protease Inhibitors|protease inhibitors|mesh-ancestor
6323626|NCT00005107|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
6323627|NCT00005107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6323628|NCT00005107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323629|NCT00005108|Estradiol|estradiol|mesh-list
6323630|NCT00005108|Progesterone|progesterone|mesh-list
6323631|NCT00005108|Estrogens|estrogens|mesh-ancestor
6323632|NCT00005108|Hormones|hormones|mesh-ancestor
6323633|NCT00005108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6323634|NCT00005108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6323635|NCT00005108|Progestins|progestins|mesh-ancestor
6323636|NCT00005110|Albuterol|albuterol|mesh-list
6323637|NCT00005110|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6323638|NCT00005110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6323639|NCT00005110|Autonomic Agents|autonomic agents|mesh-ancestor
6323640|NCT00005110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6323641|NCT00005110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6323642|NCT00005110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6323643|NCT00005110|Respiratory System Agents|respiratory system agents|mesh-ancestor
6323644|NCT00005110|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6323645|NCT00005110|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6323646|NCT00005110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6323647|NCT00005110|Adrenergic Agents|adrenergic agents|mesh-ancestor
6323648|NCT00005110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6323649|NCT00005110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323650|NCT00005110|Tocolytic Agents|tocolytic agents|mesh-ancestor
6323651|NCT00005110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6323652|NCT00005112|Hormones|hormones|mesh-list
6323653|NCT00005112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6323654|NCT00005112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6323655|NCT00005113|Cyclosporine|cyclosporine|mesh-list
6323656|NCT00005113|Sirolimus|sirolimus|mesh-list
6323657|NCT00005113|Tacrolimus|tacrolimus|mesh-list
6323658|NCT00005113|Cyclosporins|cyclosporins|mesh-list
6323659|NCT00005113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6323660|NCT00005113|Immunologic Factors|immunologic factors|mesh-ancestor
6323661|NCT00005113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6323662|NCT00005113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6323663|NCT00005113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6323664|NCT00005113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323665|NCT00005113|Antifungal Agents|antifungal agents|mesh-ancestor
6323666|NCT00005113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6323667|NCT00005113|Dermatologic Agents|dermatologic agents|mesh-ancestor
6323668|NCT00005113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6323669|NCT00005113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6323670|NCT00005113|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6323671|NCT00005113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323672|NCT00005117|Pravastatin|pravastatin|mesh-list
6323673|NCT00005117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6323674|NCT00005117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6323675|NCT00005117|Antimetabolites|antimetabolites|mesh-ancestor
6323676|NCT00005117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323677|NCT00005117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6323678|NCT00005117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6323679|NCT00005117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6323680|NCT00005118|Ritonavir|ritonavir|mesh-list
6323681|NCT00005118|Indinavir|indinavir|mesh-list
6323682|NCT00005118|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6323683|NCT00005118|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6323684|NCT00005118|Protease Inhibitors|protease inhibitors|mesh-ancestor
6323685|NCT00005118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6323686|NCT00005118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323687|NCT00005118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6323688|NCT00005118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6323689|NCT00005118|Antiviral Agents|antiviral agents|mesh-ancestor
6323690|NCT00005118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6323691|NCT00005118|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6323692|NCT00005118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6323693|NCT00005119|Calcium|calcium|mesh-list
6323694|NCT00005119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6323695|NCT00005119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6323696|NCT00005120|Calanolide A|calanolide a|mesh-list
6323697|NCT00005120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6323698|NCT00005120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6323699|NCT00005120|Antiviral Agents|antiviral agents|mesh-ancestor
6323700|NCT00005120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6323701|NCT00005520|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6323702|NCT00005520|Candesartan|candesartan|mesh-list
6323703|NCT00005520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6323704|NCT00005520|Diuretics|diuretics|mesh-ancestor
6323705|NCT00005520|Natriuretic Agents|natriuretic agents|mesh-ancestor
6323706|NCT00005520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6323707|NCT00005520|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6323708|NCT00005520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6323709|NCT00005520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323710|NCT00005520|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6323711|NCT00005520|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6323712|NCT00005569|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
6323713|NCT00005569|Protease Inhibitors|protease inhibitors|mesh-list
6323714|NCT00005569|Secretory Leukocyte Peptidase Inhibitor|secretory leukocyte peptidase inhibitor|mesh-list
6323715|NCT00005569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6323716|NCT00005569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323717|NCT00005569|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6323718|NCT00005569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6323719|NCT00005569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6323720|NCT00005569|Antiviral Agents|antiviral agents|mesh-ancestor
6323721|NCT00005569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6323722|NCT00005569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6323723|NCT00005571|Eculizumab|eculizumab|mesh-list
6323724|NCT00005571|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6323725|NCT00005571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6323726|NCT00005571|Immunologic Factors|immunologic factors|mesh-ancestor
6323727|NCT00005571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6323728|NCT00005574|Gentamicins|gentamicins|mesh-list
6323729|NCT00005574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6323730|NCT00005574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6323731|NCT00005574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6323732|NCT00005574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6323733|NCT00005574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323734|NCT00005575|Imipramine|imipramine|mesh-list
6323735|NCT00005575|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6323736|NCT00005575|Antidepressive Agents|antidepressive agents|mesh-ancestor
6323737|NCT00005575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6323738|NCT00005575|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6323739|NCT00005575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6323740|NCT00005575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6323741|NCT00005575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323742|NCT00005575|Adrenergic Agents|adrenergic agents|mesh-ancestor
6323743|NCT00005575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6323744|NCT00005575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6323745|NCT00005576|Aldesleukin|aldesleukin|mesh-list
6323746|NCT00005576|Interleukin-2|interleukin-2|mesh-list
6323747|NCT00005576|Dinutuximab|dinutuximab|mesh-list
6323748|NCT00005576|Isotretinoin|isotretinoin|mesh-list
6323749|NCT00005576|Antibodies|antibodies|mesh-list
6323750|NCT00005576|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6323751|NCT00005576|Sargramostim|sargramostim|mesh-list
6323752|NCT00005576|Immunologic Factors|immunologic factors|mesh-ancestor
6323753|NCT00005576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6323754|NCT00005576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323755|NCT00005576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6323756|NCT00005576|Analgesics|analgesics|mesh-ancestor
6323757|NCT00005576|Sensory System Agents|sensory system agents|mesh-ancestor
6323758|NCT00005576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6323759|NCT00005576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6323760|NCT00005576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6323761|NCT00005576|Antiviral Agents|antiviral agents|mesh-ancestor
6323762|NCT00005576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6323763|NCT00005576|Dermatologic Agents|dermatologic agents|mesh-ancestor
6323764|NCT00005577|Gemcitabine|gemcitabine|mesh-list
6323765|NCT00005577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6323766|NCT00005577|Antimetabolites|antimetabolites|mesh-ancestor
6323767|NCT00005577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323768|NCT00005577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323769|NCT00005577|Antiviral Agents|antiviral agents|mesh-ancestor
6323770|NCT00005577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6323771|NCT00005577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6323772|NCT00005577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6323773|NCT00005577|Immunologic Factors|immunologic factors|mesh-ancestor
6323774|NCT00005577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6323775|NCT00005578|Prednisone|prednisone|mesh-list
6323776|NCT00005578|Cyclophosphamide|cyclophosphamide|mesh-list
6323777|NCT00005578|Doxorubicin|doxorubicin|mesh-list
6323778|NCT00005578|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6323779|NCT00005578|Etoposide|etoposide|mesh-list
6323780|NCT00005578|Vincristine|vincristine|mesh-list
6323781|NCT00005578|Bleomycin|bleomycin|mesh-list
6323782|NCT00005578|Dexrazoxane|dexrazoxane|mesh-list
6323783|NCT00005578|Razoxane|razoxane|mesh-list
6323784|NCT00005578|Lenograstim|lenograstim|mesh-list
6323785|NCT00005578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6323786|NCT00005578|Immunologic Factors|immunologic factors|mesh-ancestor
6323787|NCT00005578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6323788|NCT00005578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6323789|NCT00005578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6323790|NCT00005578|Alkylating Agents|alkylating agents|mesh-ancestor
6323791|NCT00005578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323792|NCT00005578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323793|NCT00005578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6323794|NCT00005578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6323795|NCT00005578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6323796|NCT00005578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6323797|NCT00005578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6323798|NCT00005578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6323799|NCT00005578|Glucocorticoids|glucocorticoids|mesh-ancestor
6323800|NCT00005578|Hormones|hormones|mesh-ancestor
6323801|NCT00005578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6323802|NCT00005578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6323803|NCT00005578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6323804|NCT00005578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6323805|NCT00005578|Tubulin Modulators|tubulin modulators|mesh-ancestor
6323806|NCT00005578|Antimitotic Agents|antimitotic agents|mesh-ancestor
6323807|NCT00005578|Mitosis Modulators|mitosis modulators|mesh-ancestor
6323808|NCT00005578|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6323809|NCT00005578|Protective Agents|protective agents|mesh-ancestor
6323810|NCT00005579|Dolastatin 10|dolastatin 10|mesh-list
6323811|NCT00005579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323812|NCT00005579|Tubulin Modulators|tubulin modulators|mesh-ancestor
6323813|NCT00005579|Antimitotic Agents|antimitotic agents|mesh-ancestor
6323814|NCT00005579|Mitosis Modulators|mitosis modulators|mesh-ancestor
6323815|NCT00005579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323816|NCT00005580|Fludarabine|fludarabine|mesh-list
6323817|NCT00005580|Fludarabine phosphate|fludarabine phosphate|mesh-list
6323818|NCT00005580|Bryostatin 1|bryostatin 1|mesh-list
6323819|NCT00005580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323820|NCT00005580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6323821|NCT00005580|Antimetabolites|antimetabolites|mesh-ancestor
6323822|NCT00005580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323823|NCT00005580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6323824|NCT00005580|Immunologic Factors|immunologic factors|mesh-ancestor
6323825|NCT00005580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6323826|NCT00005580|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6323827|NCT00005581|Paclitaxel|paclitaxel|mesh-list
6323828|NCT00005581|Cyclophosphamide|cyclophosphamide|mesh-list
6323829|NCT00005581|Fluorouracil|fluorouracil|mesh-list
6323830|NCT00005581|Epirubicin|epirubicin|mesh-list
6323831|NCT00005581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6323832|NCT00005581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323833|NCT00005581|Tubulin Modulators|tubulin modulators|mesh-ancestor
6323834|NCT00005581|Antimitotic Agents|antimitotic agents|mesh-ancestor
6323835|NCT00005581|Mitosis Modulators|mitosis modulators|mesh-ancestor
6323836|NCT00005581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323837|NCT00005581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6323838|NCT00005581|Immunologic Factors|immunologic factors|mesh-ancestor
6323839|NCT00005581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6323840|NCT00005581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6323841|NCT00005581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6323842|NCT00005581|Alkylating Agents|alkylating agents|mesh-ancestor
6323843|NCT00005581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6323844|NCT00005581|Antimetabolites|antimetabolites|mesh-ancestor
6323845|NCT00005581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6323846|NCT00005581|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6323847|NCT00005581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6323848|NCT00005581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6323849|NCT00005581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6323850|NCT00005583|Doxorubicin|doxorubicin|mesh-list
6323851|NCT00005583|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6323852|NCT00005583|Epirubicin|epirubicin|mesh-list
6323853|NCT00005583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323854|NCT00005583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6323855|NCT00005583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6323856|NCT00005583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6323857|NCT00005583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6323858|NCT00005583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323859|NCT00005584|Prednisone|prednisone|mesh-list
6323860|NCT00005584|Epirubicin|epirubicin|mesh-list
6323861|NCT00005584|Bleomycin|bleomycin|mesh-list
6323862|NCT00005584|Vinblastine|vinblastine|mesh-list
6323863|NCT00005584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6323864|NCT00005584|Glucocorticoids|glucocorticoids|mesh-ancestor
6323865|NCT00005584|Hormones|hormones|mesh-ancestor
6323866|NCT00005584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6323867|NCT00005584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6323868|NCT00005584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6323869|NCT00005584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323870|NCT00005584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6323871|NCT00005584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6323872|NCT00005584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6323873|NCT00005584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6323874|NCT00005584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323875|NCT00005584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6323876|NCT00005584|Tubulin Modulators|tubulin modulators|mesh-ancestor
6323877|NCT00005584|Antimitotic Agents|antimitotic agents|mesh-ancestor
6323878|NCT00005584|Mitosis Modulators|mitosis modulators|mesh-ancestor
6323879|NCT00005585|Leucovorin|leucovorin|mesh-list
6323880|NCT00005585|Cytarabine|cytarabine|mesh-list
6323881|NCT00005585|Dexamethasone|dexamethasone|mesh-list
6323882|NCT00005585|Cyclophosphamide|cyclophosphamide|mesh-list
6323883|NCT00005585|Methotrexate|methotrexate|mesh-list
6323884|NCT00005585|Vincristine|vincristine|mesh-list
6323885|NCT00005585|Daunorubicin|daunorubicin|mesh-list
6323886|NCT00005585|Asparaginase|asparaginase|mesh-list
6323887|NCT00005585|Mercaptopurine|mercaptopurine|mesh-list
6323888|NCT00005585|Pegaspargase|pegaspargase|mesh-list
6323889|NCT00005585|Thioguanine|thioguanine|mesh-list
6323890|NCT00005585|Levoleucovorin|levoleucovorin|mesh-list
6323891|NCT00005585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6323892|NCT00005585|Immunologic Factors|immunologic factors|mesh-ancestor
6323893|NCT00005585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6323894|NCT00005585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6323895|NCT00005585|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6323896|NCT00005585|Alkylating Agents|alkylating agents|mesh-ancestor
6323897|NCT00005585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323898|NCT00005585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323899|NCT00005585|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6323900|NCT00005585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6323901|NCT00005585|Antiemetics|antiemetics|mesh-ancestor
6323902|NCT00005585|Autonomic Agents|autonomic agents|mesh-ancestor
6323903|NCT00005585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6323904|NCT00005585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6323905|NCT00005585|Glucocorticoids|glucocorticoids|mesh-ancestor
6323906|NCT00005585|Hormones|hormones|mesh-ancestor
6323907|NCT00005585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6323908|NCT00005585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6323909|NCT00005585|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6323910|NCT00005585|Abortifacient Agents|abortifacient agents|mesh-ancestor
6323911|NCT00005585|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6323912|NCT00005585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6323913|NCT00005585|Antimetabolites|antimetabolites|mesh-ancestor
6323914|NCT00005585|Dermatologic Agents|dermatologic agents|mesh-ancestor
6323915|NCT00005585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6323916|NCT00005585|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6323917|NCT00005585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6323918|NCT00005585|Antiviral Agents|antiviral agents|mesh-ancestor
6323919|NCT00005585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6323920|NCT00005585|Antidotes|antidotes|mesh-ancestor
6323921|NCT00005585|Protective Agents|protective agents|mesh-ancestor
6323922|NCT00005585|Vitamin B Complex|vitamin b complex|mesh-ancestor
6323923|NCT00005585|Vitamins|vitamins|mesh-ancestor
6323924|NCT00005585|Micronutrients|micronutrients|mesh-ancestor
6323925|NCT00005585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6323926|NCT00005585|Tubulin Modulators|tubulin modulators|mesh-ancestor
6323927|NCT00005585|Antimitotic Agents|antimitotic agents|mesh-ancestor
6323928|NCT00005585|Mitosis Modulators|mitosis modulators|mesh-ancestor
6323929|NCT00005585|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6323930|NCT00005585|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6323931|NCT00005585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6323932|NCT00005586|Leucovorin|leucovorin|mesh-list
6323933|NCT00005586|Fluorouracil|fluorouracil|mesh-list
6323934|NCT00005586|Levoleucovorin|levoleucovorin|mesh-list
6323935|NCT00005586|Antimetabolites|antimetabolites|mesh-ancestor
6323936|NCT00005586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323937|NCT00005586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6323938|NCT00005586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323939|NCT00005586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6323940|NCT00005586|Immunologic Factors|immunologic factors|mesh-ancestor
6323941|NCT00005586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6323942|NCT00005586|Antidotes|antidotes|mesh-ancestor
6323943|NCT00005586|Protective Agents|protective agents|mesh-ancestor
6323944|NCT00005586|Vitamin B Complex|vitamin b complex|mesh-ancestor
6323945|NCT00005586|Vitamins|vitamins|mesh-ancestor
6323946|NCT00005586|Micronutrients|micronutrients|mesh-ancestor
6323947|NCT00005589|Cytarabine|cytarabine|mesh-list
6323948|NCT00005589|Cyclophosphamide|cyclophosphamide|mesh-list
6323949|NCT00005589|Melphalan|melphalan|mesh-list
6323950|NCT00005589|Carmustine|carmustine|mesh-list
6323951|NCT00005589|Rituximab|rituximab|mesh-list
6323952|NCT00005589|Etoposide|etoposide|mesh-list
6323953|NCT00005589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6323954|NCT00005589|Immunologic Factors|immunologic factors|mesh-ancestor
6323955|NCT00005589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6323956|NCT00005589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6323957|NCT00005589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6323958|NCT00005589|Alkylating Agents|alkylating agents|mesh-ancestor
6323959|NCT00005589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323960|NCT00005589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323961|NCT00005589|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6323962|NCT00005589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6323963|NCT00005589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6323964|NCT00005589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6323965|NCT00005589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6323966|NCT00005589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6323967|NCT00005589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6323968|NCT00005589|Antimetabolites|antimetabolites|mesh-ancestor
6323969|NCT00005589|Antiviral Agents|antiviral agents|mesh-ancestor
6323970|NCT00005589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6323971|NCT00005590|Levofloxacin|levofloxacin|mesh-list
6323972|NCT00005590|Ofloxacin|ofloxacin|mesh-list
6323973|NCT00005590|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6323974|NCT00005590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6323975|NCT00005590|Renal Agents|renal agents|mesh-ancestor
6323976|NCT00005590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6323977|NCT00005590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6323978|NCT00005590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6323979|NCT00005590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6323980|NCT00005590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323981|NCT00005590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323982|NCT00005590|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6323983|NCT00005590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6323984|NCT00005591|Gemcitabine|gemcitabine|mesh-list
6323985|NCT00005591|Cetuximab|cetuximab|mesh-list
6323986|NCT00005591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6323987|NCT00005591|Antimetabolites|antimetabolites|mesh-ancestor
6323988|NCT00005591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6323989|NCT00005591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6323990|NCT00005591|Antiviral Agents|antiviral agents|mesh-ancestor
6323991|NCT00005591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6323992|NCT00005591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6323993|NCT00005591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6323994|NCT00005591|Immunologic Factors|immunologic factors|mesh-ancestor
6323995|NCT00005591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6323996|NCT00005591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6323997|NCT00005592|Rituximab|rituximab|mesh-list
6323998|NCT00005592|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6323999|NCT00005592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6324000|NCT00005592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324001|NCT00005592|Immunologic Factors|immunologic factors|mesh-ancestor
6324002|NCT00005592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6324003|NCT00005592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6324004|NCT00005593|Carboplatin|carboplatin|mesh-list
6324005|NCT00005593|Fludarabine|fludarabine|mesh-list
6324006|NCT00005593|Fludarabine phosphate|fludarabine phosphate|mesh-list
6324007|NCT00005593|Topotecan|topotecan|mesh-list
6324008|NCT00005593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324009|NCT00005593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6324010|NCT00005593|Antimetabolites|antimetabolites|mesh-ancestor
6324011|NCT00005593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324012|NCT00005593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6324013|NCT00005593|Immunologic Factors|immunologic factors|mesh-ancestor
6324014|NCT00005593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6324015|NCT00005593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6324016|NCT00005593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6324017|NCT00005593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6324018|NCT00005596|Leucovorin|leucovorin|mesh-list
6324019|NCT00005596|Cytarabine|cytarabine|mesh-list
6324020|NCT00005596|Dexamethasone|dexamethasone|mesh-list
6324021|NCT00005596|Cyclophosphamide|cyclophosphamide|mesh-list
6324022|NCT00005596|Methotrexate|methotrexate|mesh-list
6324023|NCT00005596|Vincristine|vincristine|mesh-list
6324024|NCT00005596|Daunorubicin|daunorubicin|mesh-list
6324025|NCT00005596|Mercaptopurine|mercaptopurine|mesh-list
6324026|NCT00005596|Pegaspargase|pegaspargase|mesh-list
6324027|NCT00005596|Thioguanine|thioguanine|mesh-list
6324028|NCT00005596|Levoleucovorin|levoleucovorin|mesh-list
6324029|NCT00005596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6324030|NCT00005596|Immunologic Factors|immunologic factors|mesh-ancestor
6324031|NCT00005596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6324032|NCT00005596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6324033|NCT00005596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6324034|NCT00005596|Alkylating Agents|alkylating agents|mesh-ancestor
6324035|NCT00005596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324036|NCT00005596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324037|NCT00005596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6324038|NCT00005596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6324039|NCT00005596|Antiemetics|antiemetics|mesh-ancestor
6324040|NCT00005596|Autonomic Agents|autonomic agents|mesh-ancestor
6324041|NCT00005596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6324042|NCT00005596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6324043|NCT00005596|Glucocorticoids|glucocorticoids|mesh-ancestor
6324044|NCT00005596|Hormones|hormones|mesh-ancestor
6324045|NCT00005596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6324046|NCT00005596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6324047|NCT00005596|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6324048|NCT00005596|Abortifacient Agents|abortifacient agents|mesh-ancestor
6324049|NCT00005596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6324050|NCT00005596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6324051|NCT00005596|Antimetabolites|antimetabolites|mesh-ancestor
6324052|NCT00005596|Dermatologic Agents|dermatologic agents|mesh-ancestor
6016535|NCT00365456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016536|NCT00365456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6016537|NCT00365456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6016538|NCT00365456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016539|NCT00365456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6016540|NCT00365456|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6016541|NCT00365508|Nicotine|nicotine|mesh-list
6016542|NCT00365508|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6324053|NCT00005596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6324054|NCT00005596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6324055|NCT00005596|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6324056|NCT00005596|Antiviral Agents|antiviral agents|mesh-ancestor
6324057|NCT00005596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6324058|NCT00005596|Antidotes|antidotes|mesh-ancestor
6324059|NCT00005596|Protective Agents|protective agents|mesh-ancestor
6324060|NCT00005596|Vitamin B Complex|vitamin b complex|mesh-ancestor
6324061|NCT00005596|Vitamins|vitamins|mesh-ancestor
6324062|NCT00005596|Micronutrients|micronutrients|mesh-ancestor
6324063|NCT00005596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6324064|NCT00005596|Tubulin Modulators|tubulin modulators|mesh-ancestor
6324065|NCT00005596|Antimitotic Agents|antimitotic agents|mesh-ancestor
6324066|NCT00005596|Mitosis Modulators|mitosis modulators|mesh-ancestor
6324067|NCT00005596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6324068|NCT00005596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6324069|NCT00005596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6324070|NCT00005597|Temozolomide|temozolomide|mesh-list
6324071|NCT00005597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6324072|NCT00005597|Alkylating Agents|alkylating agents|mesh-ancestor
6324073|NCT00005597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324074|NCT00005597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6392995|NCT00198523|Antiemetics|antiemetics|mesh-ancestor
6392996|NCT00198523|Autonomic Agents|autonomic agents|mesh-ancestor
6392997|NCT00198523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6392998|NCT00198523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6392999|NCT00198523|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6393000|NCT00198523|Protective Agents|protective agents|mesh-ancestor
6393001|NCT00198523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6393002|NCT00198523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6393003|NCT00198536|Ecabet|ecabet|mesh-list
6393004|NCT00198536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6393005|NCT00198536|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6393006|NCT00198536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6393007|NCT00198536|Protease Inhibitors|protease inhibitors|mesh-ancestor
6393008|NCT00198536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6393009|NCT00198536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393010|NCT00198536|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6393011|NCT00198536|Protective Agents|protective agents|mesh-ancestor
6393012|NCT00198536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6393013|NCT00198536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6393014|NCT00198562|Losartan|losartan|mesh-list
6393015|NCT00198562|Amlodipine|amlodipine|mesh-list
6393016|NCT00198562|Antihypertensive Agents|antihypertensive agents|mesh-list
6324075|NCT00005598|Azacitidine|azacitidine|mesh-list
6324076|NCT00005598|Amifostine|amifostine|mesh-list
6324077|NCT00005598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6324078|NCT00005598|Antimetabolites|antimetabolites|mesh-ancestor
6324079|NCT00005598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324080|NCT00005598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324081|NCT00005598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6324082|NCT00005598|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6324083|NCT00005598|Protective Agents|protective agents|mesh-ancestor
6324084|NCT00005598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6324085|NCT00005599|Paclitaxel|paclitaxel|mesh-list
6324086|NCT00005599|Bryostatin 1|bryostatin 1|mesh-list
6324087|NCT00005599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6324088|NCT00005599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324089|NCT00005599|Tubulin Modulators|tubulin modulators|mesh-ancestor
6324090|NCT00005599|Antimitotic Agents|antimitotic agents|mesh-ancestor
6324091|NCT00005599|Mitosis Modulators|mitosis modulators|mesh-ancestor
6324092|NCT00005599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324093|NCT00005599|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6324094|NCT00005599|Immunologic Factors|immunologic factors|mesh-ancestor
6324095|NCT00005599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6324096|NCT00005601|Cytarabine|cytarabine|mesh-list
6324097|NCT00005601|Dexamethasone|dexamethasone|mesh-list
6324098|NCT00005601|Rituximab|rituximab|mesh-list
6324099|NCT00005601|Sargramostim|sargramostim|mesh-list
6324100|NCT00005601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324101|NCT00005601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6324102|NCT00005601|Antiemetics|antiemetics|mesh-ancestor
6324103|NCT00005601|Autonomic Agents|autonomic agents|mesh-ancestor
6324104|NCT00005601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6324105|NCT00005601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6324106|NCT00005601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6324107|NCT00005601|Glucocorticoids|glucocorticoids|mesh-ancestor
6324108|NCT00005601|Hormones|hormones|mesh-ancestor
6324109|NCT00005601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6324110|NCT00005601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6324111|NCT00005601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6324112|NCT00005601|Immunologic Factors|immunologic factors|mesh-ancestor
6324113|NCT00005601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6324114|NCT00005601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6324115|NCT00005601|Antimetabolites|antimetabolites|mesh-ancestor
6324116|NCT00005601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324117|NCT00005601|Antiviral Agents|antiviral agents|mesh-ancestor
6324118|NCT00005601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6324119|NCT00005601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6324120|NCT00005602|Carboplatin|carboplatin|mesh-list
6324121|NCT00005602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324122|NCT00005603|Cytarabine|cytarabine|mesh-list
6324123|NCT00005603|Dexamethasone|dexamethasone|mesh-list
6324124|NCT00005603|Prednisone|prednisone|mesh-list
6324125|NCT00005603|Cyclophosphamide|cyclophosphamide|mesh-list
6324126|NCT00005603|Doxorubicin|doxorubicin|mesh-list
6324127|NCT00005603|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6324128|NCT00005603|Methotrexate|methotrexate|mesh-list
6324129|NCT00005603|Vincristine|vincristine|mesh-list
6324130|NCT00005603|Daunorubicin|daunorubicin|mesh-list
6324131|NCT00005603|Asparaginase|asparaginase|mesh-list
6324132|NCT00005603|Mercaptopurine|mercaptopurine|mesh-list
6324133|NCT00005603|Thioguanine|thioguanine|mesh-list
6324134|NCT00005603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6324135|NCT00005603|Immunologic Factors|immunologic factors|mesh-ancestor
6324136|NCT00005603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6324137|NCT00005603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6324138|NCT00005603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6324139|NCT00005603|Alkylating Agents|alkylating agents|mesh-ancestor
6324140|NCT00005603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324141|NCT00005603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324142|NCT00005603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6324143|NCT00005603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6324144|NCT00005603|Antiemetics|antiemetics|mesh-ancestor
6324145|NCT00005603|Autonomic Agents|autonomic agents|mesh-ancestor
6324146|NCT00005603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6324147|NCT00005603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6324148|NCT00005603|Glucocorticoids|glucocorticoids|mesh-ancestor
6324149|NCT00005603|Hormones|hormones|mesh-ancestor
6324150|NCT00005603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6324151|NCT00005603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6324152|NCT00005603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6324153|NCT00005603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6324154|NCT00005603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6324155|NCT00005603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6324156|NCT00005603|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6324157|NCT00005603|Abortifacient Agents|abortifacient agents|mesh-ancestor
6324158|NCT00005603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6324159|NCT00005603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6324160|NCT00005603|Antimetabolites|antimetabolites|mesh-ancestor
6324161|NCT00005603|Dermatologic Agents|dermatologic agents|mesh-ancestor
6324162|NCT00005603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6324163|NCT00005603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6324164|NCT00005603|Antiviral Agents|antiviral agents|mesh-ancestor
6324165|NCT00005603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6324166|NCT00005603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6324167|NCT00005603|Tubulin Modulators|tubulin modulators|mesh-ancestor
6324168|NCT00005603|Antimitotic Agents|antimitotic agents|mesh-ancestor
6324169|NCT00005603|Mitosis Modulators|mitosis modulators|mesh-ancestor
6324170|NCT00005604|Aldesleukin|aldesleukin|mesh-list
6324171|NCT00005604|Interleukin-2|interleukin-2|mesh-list
6324172|NCT00005604|Interleukin-12|interleukin-12|mesh-list
6324173|NCT00005604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324174|NCT00005604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6324175|NCT00005604|Analgesics|analgesics|mesh-ancestor
6324176|NCT00005604|Sensory System Agents|sensory system agents|mesh-ancestor
6324177|NCT00005604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6324178|NCT00005604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6324179|NCT00005604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6324180|NCT00005604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6324181|NCT00005604|Antiviral Agents|antiviral agents|mesh-ancestor
6324182|NCT00005604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6324183|NCT00005604|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6324184|NCT00005604|Immunologic Factors|immunologic factors|mesh-ancestor
6324185|NCT00005604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6324186|NCT00005604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6324187|NCT00005604|Growth Substances|growth substances|mesh-ancestor
6324188|NCT00005604|Growth Inhibitors|growth inhibitors|mesh-ancestor
6324189|NCT00005607|Leucovorin|leucovorin|mesh-list
6324190|NCT00005607|Fluorouracil|fluorouracil|mesh-list
6324191|NCT00005607|Irinotecan|irinotecan|mesh-list
6324192|NCT00005607|Calcium|calcium|mesh-list
6324193|NCT00005607|Levoleucovorin|levoleucovorin|mesh-list
6324194|NCT00005607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6324195|NCT00005607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6324196|NCT00005607|Antimetabolites|antimetabolites|mesh-ancestor
6324197|NCT00005607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324198|NCT00005607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6324199|NCT00005607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324200|NCT00005607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6324201|NCT00005607|Immunologic Factors|immunologic factors|mesh-ancestor
6324202|NCT00005607|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6324203|NCT00005607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6324204|NCT00005607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6324205|NCT00005607|Antidotes|antidotes|mesh-ancestor
6324206|NCT00005607|Protective Agents|protective agents|mesh-ancestor
6324207|NCT00005607|Vitamin B Complex|vitamin b complex|mesh-ancestor
6324208|NCT00005607|Vitamins|vitamins|mesh-ancestor
6324209|NCT00005607|Micronutrients|micronutrients|mesh-ancestor
6324210|NCT00005609|Rituximab|rituximab|mesh-list
6324211|NCT00005609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6324212|NCT00005609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324213|NCT00005609|Immunologic Factors|immunologic factors|mesh-ancestor
6324214|NCT00005609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6324215|NCT00005609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6324216|NCT00005610|Sargramostim|sargramostim|mesh-list
6324217|NCT00005610|Immunologic Factors|immunologic factors|mesh-ancestor
6324218|NCT00005610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6324219|NCT00005612|Paclitaxel|paclitaxel|mesh-list
6324220|NCT00005612|Etoposide|etoposide|mesh-list
6324221|NCT00005612|Cyclophosphamide|cyclophosphamide|mesh-list
6324222|NCT00005612|Carboplatin|carboplatin|mesh-list
6324223|NCT00005612|Topotecan|topotecan|mesh-list
6324224|NCT00005612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6324225|NCT00005612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324226|NCT00005612|Tubulin Modulators|tubulin modulators|mesh-ancestor
6324227|NCT00005612|Antimitotic Agents|antimitotic agents|mesh-ancestor
6324228|NCT00005612|Mitosis Modulators|mitosis modulators|mesh-ancestor
6324229|NCT00005612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324230|NCT00005612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6324231|NCT00005612|Immunologic Factors|immunologic factors|mesh-ancestor
6324232|NCT00005612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6324233|NCT00005612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6324234|NCT00005612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6324235|NCT00005612|Alkylating Agents|alkylating agents|mesh-ancestor
6324236|NCT00005612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6324237|NCT00005612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6324238|NCT00005612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6324239|NCT00005612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6324240|NCT00005612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6324241|NCT00005613|Cyclophosphamide|cyclophosphamide|mesh-list
6324242|NCT00005613|Carmustine|carmustine|mesh-list
6324243|NCT00005613|Etoposide|etoposide|mesh-list
6324244|NCT00005613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6324245|NCT00005613|Immunologic Factors|immunologic factors|mesh-ancestor
6324246|NCT00005613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6324247|NCT00005613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6324248|NCT00005613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6324249|NCT00005613|Alkylating Agents|alkylating agents|mesh-ancestor
6324250|NCT00005613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324251|NCT00005613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324252|NCT00005613|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6324253|NCT00005613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6324254|NCT00005613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6324255|NCT00005613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6324256|NCT00005613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6324257|NCT00005614|Gemcitabine|gemcitabine|mesh-list
6324258|NCT00005614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6324259|NCT00005614|Antimetabolites|antimetabolites|mesh-ancestor
6324260|NCT00005614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324261|NCT00005614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324262|NCT00005614|Antiviral Agents|antiviral agents|mesh-ancestor
6324263|NCT00005614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6324264|NCT00005614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6324265|NCT00005614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6324266|NCT00005614|Immunologic Factors|immunologic factors|mesh-ancestor
6324267|NCT00005614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6324268|NCT00005615|Interferons|interferons|mesh-list
6324269|NCT00005615|Interferon-alpha|interferon-alpha|mesh-list
6324270|NCT00005615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324271|NCT00005615|Antiviral Agents|antiviral agents|mesh-ancestor
6324272|NCT00005615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6324273|NCT00005615|Immunologic Factors|immunologic factors|mesh-ancestor
6324274|NCT00005615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6324275|NCT00005616|Antibodies|antibodies|mesh-list
6324276|NCT00005616|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6324277|NCT00005616|Immunologic Factors|immunologic factors|mesh-ancestor
6324278|NCT00005616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6324279|NCT00005618|Arsenic Trioxide|arsenic trioxide|mesh-list
6324280|NCT00005618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324281|NCT00005622|Cyclophosphamide|cyclophosphamide|mesh-list
6324282|NCT00005622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6324283|NCT00005622|Immunologic Factors|immunologic factors|mesh-ancestor
6324284|NCT00005622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6324285|NCT00005622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6324286|NCT00005622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6324287|NCT00005622|Alkylating Agents|alkylating agents|mesh-ancestor
6324288|NCT00005622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324289|NCT00005622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324290|NCT00005622|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6324291|NCT00005623|Cyproterone Acetate|cyproterone acetate|mesh-list
6324292|NCT00005623|Cyproterone|cyproterone|mesh-list
6324293|NCT00005623|Androgen Antagonists|androgen antagonists|mesh-ancestor
6324294|NCT00005623|Hormone Antagonists|hormone antagonists|mesh-ancestor
6324295|NCT00005623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6324296|NCT00005623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6324297|NCT00005623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324298|NCT00005623|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6324299|NCT00005623|Contraceptive Agents|contraceptive agents|mesh-ancestor
6324300|NCT00005623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6324301|NCT00005624|Tacedinaline|tacedinaline|mesh-list
6324302|NCT00005624|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
6324303|NCT00005624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6324304|NCT00005624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324305|NCT00005624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324306|NCT00005625|Trabectedin|trabectedin|mesh-list
6324307|NCT00005625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6324308|NCT00005625|Alkylating Agents|alkylating agents|mesh-ancestor
6324309|NCT00005625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324310|NCT00005625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324311|NCT00005626|Irinotecan|irinotecan|mesh-list
6324312|NCT00005626|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6324313|NCT00005626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6324314|NCT00005626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6324315|NCT00005626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324316|NCT00005626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324317|NCT00005627|Carboplatin|carboplatin|mesh-list
6324318|NCT00005627|Docetaxel|docetaxel|mesh-list
6324319|NCT00005627|Estramustine|estramustine|mesh-list
6324320|NCT00005627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324321|NCT00005627|Tubulin Modulators|tubulin modulators|mesh-ancestor
6324322|NCT00005627|Antimitotic Agents|antimitotic agents|mesh-ancestor
6324323|NCT00005627|Mitosis Modulators|mitosis modulators|mesh-ancestor
6324324|NCT00005627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324325|NCT00005627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6324326|NCT00005627|Alkylating Agents|alkylating agents|mesh-ancestor
6324327|NCT00005627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6324328|NCT00005630|Sargramostim|sargramostim|mesh-list
6324329|NCT00005630|Immunologic Factors|immunologic factors|mesh-ancestor
6324330|NCT00005630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6324331|NCT00005631|Rituximab|rituximab|mesh-list
6324332|NCT00005631|Carboplatin|carboplatin|mesh-list
6324333|NCT00005631|Etoposide|etoposide|mesh-list
6324334|NCT00005631|Ifosfamide|ifosfamide|mesh-list
6324335|NCT00005631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6324336|NCT00005631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324337|NCT00005631|Immunologic Factors|immunologic factors|mesh-ancestor
6324338|NCT00005631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6324339|NCT00005631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6324340|NCT00005631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6324341|NCT00005631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6324342|NCT00005631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6324343|NCT00005631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6324344|NCT00005631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324345|NCT00005631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6324346|NCT00005631|Alkylating Agents|alkylating agents|mesh-ancestor
6324347|NCT00005634|Vorinostat|vorinostat|mesh-list
6324348|NCT00005634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324349|NCT00005634|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6016543|NCT00365508|Autonomic Agents|autonomic agents|mesh-ancestor
6324350|NCT00005634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6324351|NCT00005634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324352|NCT00005635|Paclitaxel|paclitaxel|mesh-list
6324353|NCT00005635|Trastuzumab|trastuzumab|mesh-list
6324354|NCT00005635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6324355|NCT00005635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324356|NCT00005635|Tubulin Modulators|tubulin modulators|mesh-ancestor
6324357|NCT00005635|Antimitotic Agents|antimitotic agents|mesh-ancestor
6324358|NCT00005635|Mitosis Modulators|mitosis modulators|mesh-ancestor
6324359|NCT00005635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324360|NCT00005635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6324361|NCT00005636|Pemetrexed|pemetrexed|mesh-list
6324362|NCT00005636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324363|NCT00005636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6324364|NCT00005636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324365|NCT00005636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6324366|NCT00005636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6324367|NCT00005637|Temozolomide|temozolomide|mesh-list
6324368|NCT00005637|Carmustine|carmustine|mesh-list
6324369|NCT00005637|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6324370|NCT00005637|Alkylating Agents|alkylating agents|mesh-ancestor
6324371|NCT00005637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324372|NCT00005637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324373|NCT00005638|Irinotecan|irinotecan|mesh-list
6324374|NCT00005638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324375|NCT00005638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6324376|NCT00005638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6324377|NCT00005638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6324378|NCT00005638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324379|NCT00005639|Azacitidine|azacitidine|mesh-list
6324380|NCT00005639|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
6324381|NCT00005639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6324382|NCT00005639|Antimetabolites|antimetabolites|mesh-ancestor
6324383|NCT00005639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324384|NCT00005639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324385|NCT00005639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6324386|NCT00005640|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
6324387|NCT00005640|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6324388|NCT00005640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324389|NCT00005641|Leucovorin|leucovorin|mesh-list
6324390|NCT00005641|Cyclosporine|cyclosporine|mesh-list
6324391|NCT00005641|Methylprednisolone|methylprednisolone|mesh-list
6324392|NCT00005641|Cyclophosphamide|cyclophosphamide|mesh-list
6324393|NCT00005641|Busulfan|busulfan|mesh-list
6324394|NCT00005641|Methotrexate|methotrexate|mesh-list
6324395|NCT00005641|Cyclosporins|cyclosporins|mesh-list
6324396|NCT00005641|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6324397|NCT00005641|Levoleucovorin|levoleucovorin|mesh-list
6324398|NCT00005641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6324399|NCT00005641|Immunologic Factors|immunologic factors|mesh-ancestor
6324400|NCT00005641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6324401|NCT00005641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6324402|NCT00005641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6324403|NCT00005641|Alkylating Agents|alkylating agents|mesh-ancestor
6324404|NCT00005641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324405|NCT00005641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324406|NCT00005641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6324407|NCT00005641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6324408|NCT00005641|Abortifacient Agents|abortifacient agents|mesh-ancestor
6324409|NCT00005641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6324410|NCT00005641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6324411|NCT00005641|Antimetabolites|antimetabolites|mesh-ancestor
6324412|NCT00005641|Dermatologic Agents|dermatologic agents|mesh-ancestor
6324413|NCT00005641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6324414|NCT00005641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6324415|NCT00005641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6324416|NCT00005641|Antidotes|antidotes|mesh-ancestor
6324417|NCT00005641|Protective Agents|protective agents|mesh-ancestor
6324418|NCT00005641|Vitamin B Complex|vitamin b complex|mesh-ancestor
6324419|NCT00005641|Vitamins|vitamins|mesh-ancestor
6324420|NCT00005641|Micronutrients|micronutrients|mesh-ancestor
6324421|NCT00005641|Antifungal Agents|antifungal agents|mesh-ancestor
6324422|NCT00005641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6324423|NCT00005641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6324424|NCT00005641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6324425|NCT00005641|Antiemetics|antiemetics|mesh-ancestor
6324426|NCT00005641|Autonomic Agents|autonomic agents|mesh-ancestor
6324427|NCT00005641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6324428|NCT00005641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6324429|NCT00005641|Glucocorticoids|glucocorticoids|mesh-ancestor
6324430|NCT00005641|Hormones|hormones|mesh-ancestor
6324431|NCT00005641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6324432|NCT00005641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6324433|NCT00005642|Semaxinib|semaxinib|mesh-list
6324434|NCT00005642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6324435|NCT00005642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6324436|NCT00005642|Growth Substances|growth substances|mesh-ancestor
6324437|NCT00005642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6324438|NCT00005642|Growth Inhibitors|growth inhibitors|mesh-ancestor
6324439|NCT00005642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324440|NCT00005642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6324441|NCT00005642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6324442|NCT00005642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324443|NCT00005643|Doxorubicin|doxorubicin|mesh-list
6324444|NCT00005643|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6324445|NCT00005643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6324446|NCT00005643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324447|NCT00005643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6324448|NCT00005643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6324449|NCT00005643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6324450|NCT00005643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324451|NCT00005644|Gemcitabine|gemcitabine|mesh-list
6324452|NCT00005644|Paclitaxel|paclitaxel|mesh-list
6324453|NCT00005644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6324454|NCT00005644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324455|NCT00005644|Tubulin Modulators|tubulin modulators|mesh-ancestor
6324456|NCT00005644|Antimitotic Agents|antimitotic agents|mesh-ancestor
6324457|NCT00005644|Mitosis Modulators|mitosis modulators|mesh-ancestor
6324458|NCT00005644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324459|NCT00005644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6324460|NCT00005644|Antimetabolites|antimetabolites|mesh-ancestor
6324461|NCT00005644|Antiviral Agents|antiviral agents|mesh-ancestor
6324462|NCT00005644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6324463|NCT00005644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6324464|NCT00005644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6324465|NCT00005644|Immunologic Factors|immunologic factors|mesh-ancestor
6324466|NCT00005644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6324467|NCT00005646|Paclitaxel|paclitaxel|mesh-list
6324468|NCT00005646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6324469|NCT00005646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324470|NCT00005646|Tubulin Modulators|tubulin modulators|mesh-ancestor
6324471|NCT00005646|Antimitotic Agents|antimitotic agents|mesh-ancestor
6324472|NCT00005646|Mitosis Modulators|mitosis modulators|mesh-ancestor
6324473|NCT00005646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324474|NCT00005647|Paclitaxel|paclitaxel|mesh-list
6324475|NCT00005647|Semaxinib|semaxinib|mesh-list
6324476|NCT00005647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6324477|NCT00005647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324478|NCT00005647|Tubulin Modulators|tubulin modulators|mesh-ancestor
6324479|NCT00005647|Antimitotic Agents|antimitotic agents|mesh-ancestor
6324480|NCT00005647|Mitosis Modulators|mitosis modulators|mesh-ancestor
6324481|NCT00005647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324482|NCT00005647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6324483|NCT00005647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6324484|NCT00005647|Growth Substances|growth substances|mesh-ancestor
6324485|NCT00005647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6324486|NCT00005647|Growth Inhibitors|growth inhibitors|mesh-ancestor
6324487|NCT00005647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6324488|NCT00005647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6324489|NCT00005648|Gemcitabine|gemcitabine|mesh-list
6324490|NCT00005648|Tipifarnib|tipifarnib|mesh-list
6324491|NCT00005648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6324492|NCT00005648|Antimetabolites|antimetabolites|mesh-ancestor
6324493|NCT00005648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324494|NCT00005648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324495|NCT00005648|Antiviral Agents|antiviral agents|mesh-ancestor
6324496|NCT00005648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6324497|NCT00005648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6324498|NCT00005648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6324499|NCT00005648|Immunologic Factors|immunologic factors|mesh-ancestor
6324500|NCT00005648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6324501|NCT00005649|Paclitaxel|paclitaxel|mesh-list
6324502|NCT00005649|Capecitabine|capecitabine|mesh-list
6324503|NCT00005649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6324504|NCT00005649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324505|NCT00005649|Tubulin Modulators|tubulin modulators|mesh-ancestor
6324506|NCT00005649|Antimitotic Agents|antimitotic agents|mesh-ancestor
6324507|NCT00005649|Mitosis Modulators|mitosis modulators|mesh-ancestor
6324508|NCT00005649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324509|NCT00005649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6324510|NCT00005649|Antimetabolites|antimetabolites|mesh-ancestor
6324511|NCT00005652|Rituximab|rituximab|mesh-list
6324512|NCT00005652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6324513|NCT00005652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324514|NCT00005652|Immunologic Factors|immunologic factors|mesh-ancestor
6324515|NCT00005652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6324516|NCT00005652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6324517|NCT00005654|Metformin|metformin|mesh-list
6324518|NCT00005654|Clomiphene|clomiphene|mesh-list
6324519|NCT00005654|Enclomiphene|enclomiphene|mesh-list
6324520|NCT00005654|Zuclomiphene|zuclomiphene|mesh-list
6324521|NCT00005654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6324522|NCT00005654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6324523|NCT00005654|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6324524|NCT00005654|Hormone Antagonists|hormone antagonists|mesh-ancestor
6324525|NCT00005654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6324526|NCT00005654|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6324527|NCT00005654|Fertility Agents|fertility agents|mesh-ancestor
6324528|NCT00005654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6324529|NCT00005654|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6324530|NCT00005654|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6324531|NCT00005658|Glycine|glycine|mesh-list
6324532|NCT00005658|Glycine Agents|glycine agents|mesh-ancestor
6324533|NCT00005658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6324534|NCT00005658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324535|NCT00005658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6324536|NCT00005663|Valacyclovir|valacyclovir|mesh-list
6324537|NCT00005663|Antiviral Agents|antiviral agents|mesh-ancestor
6324538|NCT00005663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6324539|NCT00005665|Interferons|interferons|mesh-list
6324540|NCT00005665|Interferon-alpha|interferon-alpha|mesh-list
6324541|NCT00005665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324542|NCT00005665|Antiviral Agents|antiviral agents|mesh-ancestor
6324543|NCT00005665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6324544|NCT00005665|Immunologic Factors|immunologic factors|mesh-ancestor
6324545|NCT00005665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6324546|NCT00005668|Itraconazole|itraconazole|mesh-list
6324547|NCT00005668|Antifungal Agents|antifungal agents|mesh-ancestor
6324548|NCT00005668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6324549|NCT00005668|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6324550|NCT00005668|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6324551|NCT00005668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6324552|NCT00005668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324553|NCT00005668|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6324554|NCT00005668|Hormone Antagonists|hormone antagonists|mesh-ancestor
6324555|NCT00005668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6324556|NCT00005668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6324557|NCT00005668|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6324558|NCT00005673|Capravirine|capravirine|mesh-list
6324559|NCT00005673|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6324560|NCT00005673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6324561|NCT00005673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6324562|NCT00005673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324563|NCT00005673|Antiviral Agents|antiviral agents|mesh-ancestor
6324564|NCT00005673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6324565|NCT00005673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6324566|NCT00005673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6324567|NCT00005684|Heparin|heparin|mesh-list
6324568|NCT00005684|Warfarin|warfarin|mesh-list
6324569|NCT00005684|Anticoagulants|anticoagulants|mesh-ancestor
6324570|NCT00005684|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6324571|NCT00005684|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6324572|NCT00005684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393017|NCT00198562|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6393018|NCT00198562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6393019|NCT00198562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393020|NCT00198562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6393021|NCT00198562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6393022|NCT00198562|Vasodilator Agents|vasodilator agents|mesh-ancestor
6324573|NCT00005762|Ritonavir|ritonavir|mesh-list
6324574|NCT00005762|Nelfinavir|nelfinavir|mesh-list
6324575|NCT00005762|Indinavir|indinavir|mesh-list
6324576|NCT00005762|Saquinavir|saquinavir|mesh-list
6016544|NCT00365508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6016545|NCT00365508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016546|NCT00365508|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6016547|NCT00365508|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6324577|NCT00005762|Amprenavir|amprenavir|mesh-list
6324578|NCT00005762|Efavirenz|efavirenz|mesh-list
6324579|NCT00005762|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6324580|NCT00005762|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6324581|NCT00005762|Protease Inhibitors|protease inhibitors|mesh-ancestor
6324582|NCT00005762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6324583|NCT00005762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324584|NCT00005762|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6324585|NCT00005762|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6324586|NCT00005762|Antiviral Agents|antiviral agents|mesh-ancestor
6324587|NCT00005762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6324588|NCT00005762|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6324589|NCT00005762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6324590|NCT00005762|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6324591|NCT00005762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6324592|NCT00005762|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6324593|NCT00005762|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6324594|NCT00005762|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6324595|NCT00005762|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6324596|NCT00005762|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6324597|NCT00005762|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6324598|NCT00005762|Antitubercular Agents|antitubercular agents|mesh-ancestor
6324599|NCT00005762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6324600|NCT00005764|Lamivudine|lamivudine|mesh-list
6324601|NCT00005764|Zidovudine|zidovudine|mesh-list
6324602|NCT00005764|Abacavir|abacavir|mesh-list
6324603|NCT00005764|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6324604|NCT00005764|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6324605|NCT00005764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6324606|NCT00005764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6324607|NCT00005764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324608|NCT00005764|Antiviral Agents|antiviral agents|mesh-ancestor
6324609|NCT00005764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6324610|NCT00005764|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6324611|NCT00005764|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6324612|NCT00005764|Antimetabolites|antimetabolites|mesh-ancestor
6324613|NCT00005765|Nicotine|nicotine|mesh-list
6324614|NCT00005765|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6324615|NCT00005765|Autonomic Agents|autonomic agents|mesh-ancestor
6324616|NCT00005765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6324617|NCT00005765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6324618|NCT00005765|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6324619|NCT00005765|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6324620|NCT00005765|Cholinergic Agents|cholinergic agents|mesh-ancestor
6324621|NCT00005765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6324622|NCT00005765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324623|NCT00005768|Estrogens|estrogens|mesh-list
6324624|NCT00005768|Hormones|hormones|mesh-ancestor
6324625|NCT00005768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6324626|NCT00005768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6324627|NCT00005769|Hormones|hormones|mesh-list
6324628|NCT00005769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6324629|NCT00005769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6324630|NCT00005773|Nitric Oxide|nitric oxide|mesh-list
6324631|NCT00005773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6324632|NCT00005773|Autonomic Agents|autonomic agents|mesh-ancestor
6324633|NCT00005773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6324634|NCT00005773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6324635|NCT00005773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6324636|NCT00005773|Respiratory System Agents|respiratory system agents|mesh-ancestor
6324637|NCT00005773|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6324638|NCT00005773|Antioxidants|antioxidants|mesh-ancestor
6324639|NCT00005773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324640|NCT00005773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6324641|NCT00005773|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6324642|NCT00005773|Vasodilator Agents|vasodilator agents|mesh-ancestor
6324643|NCT00005773|Gasotransmitters|gasotransmitters|mesh-ancestor
6324644|NCT00005773|Protective Agents|protective agents|mesh-ancestor
6324645|NCT00005774|Pulmonary Surfactants|pulmonary surfactants|mesh-list
6324646|NCT00005774|Respiratory System Agents|respiratory system agents|mesh-ancestor
6324647|NCT00005775|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
6324648|NCT00005775|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6324649|NCT00005775|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6324650|NCT00005776|Nitric Oxide|nitric oxide|mesh-list
6324651|NCT00005776|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6324652|NCT00005776|Autonomic Agents|autonomic agents|mesh-ancestor
6324653|NCT00005776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6324654|NCT00005776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6324655|NCT00005776|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6324656|NCT00005776|Respiratory System Agents|respiratory system agents|mesh-ancestor
6324657|NCT00005776|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6324658|NCT00005776|Antioxidants|antioxidants|mesh-ancestor
6324659|NCT00005776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324660|NCT00005776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6324661|NCT00005776|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6324662|NCT00005776|Vasodilator Agents|vasodilator agents|mesh-ancestor
6324663|NCT00005776|Gasotransmitters|gasotransmitters|mesh-ancestor
6324664|NCT00005776|Protective Agents|protective agents|mesh-ancestor
6324665|NCT00005777|Dexamethasone|dexamethasone|mesh-list
6324666|NCT00005777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6324667|NCT00005777|Antiemetics|antiemetics|mesh-ancestor
6324668|NCT00005777|Autonomic Agents|autonomic agents|mesh-ancestor
6324669|NCT00005777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6324670|NCT00005777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6324671|NCT00005777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6324672|NCT00005777|Glucocorticoids|glucocorticoids|mesh-ancestor
6324673|NCT00005777|Hormones|hormones|mesh-ancestor
6324674|NCT00005777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6324675|NCT00005777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6324676|NCT00005777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324677|NCT00005779|Interleukin-12|interleukin-12|mesh-list
6324678|NCT00005779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6324679|NCT00005779|Immunologic Factors|immunologic factors|mesh-ancestor
6324680|NCT00005779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6324681|NCT00005779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6324682|NCT00005779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6324683|NCT00005779|Growth Substances|growth substances|mesh-ancestor
6324684|NCT00005779|Growth Inhibitors|growth inhibitors|mesh-ancestor
6324685|NCT00005779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324686|NCT00005782|Sargramostim|sargramostim|mesh-list
6324687|NCT00005782|Lenograstim|lenograstim|mesh-list
6324688|NCT00005782|Immunologic Factors|immunologic factors|mesh-ancestor
6324689|NCT00005782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6324690|NCT00005782|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6324691|NCT00005786|Arsenic Trioxide|arsenic trioxide|mesh-list
6324692|NCT00005786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324693|NCT00005787|Epoetin Alfa|epoetin alfa|mesh-list
6324694|NCT00005787|Flt3 ligand protein|flt3 ligand protein|mesh-list
6324695|NCT00005787|Sargramostim|sargramostim|mesh-list
6324696|NCT00005787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6324697|NCT00005787|Immunologic Factors|immunologic factors|mesh-ancestor
6324698|NCT00005787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6324699|NCT00005787|Hematinics|hematinics|mesh-ancestor
6324700|NCT00005787|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6324701|NCT00005787|Protective Agents|protective agents|mesh-ancestor
6324702|NCT00005791|Fluorouracil|fluorouracil|mesh-list
6324703|NCT00005791|Irinotecan|irinotecan|mesh-list
6324704|NCT00005791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324705|NCT00005791|Antimetabolites|antimetabolites|mesh-ancestor
6324706|NCT00005791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324707|NCT00005791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6324708|NCT00005791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6324709|NCT00005791|Immunologic Factors|immunologic factors|mesh-ancestor
6324710|NCT00005791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6324711|NCT00005791|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6324712|NCT00005791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6324713|NCT00005791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6324714|NCT00005792|Etoposide|etoposide|mesh-list
6324715|NCT00005792|Melphalan|melphalan|mesh-list
6324716|NCT00005792|Topotecan|topotecan|mesh-list
6324717|NCT00005792|Etoposide phosphate|etoposide phosphate|mesh-list
6324718|NCT00005792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6324719|NCT00005792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324720|NCT00005792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6324721|NCT00005792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6324722|NCT00005792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6324723|NCT00005792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324724|NCT00005792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6324725|NCT00005792|Alkylating Agents|alkylating agents|mesh-ancestor
6324726|NCT00005792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6324727|NCT00005792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6324728|NCT00005792|Immunologic Factors|immunologic factors|mesh-ancestor
6324729|NCT00005792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6324730|NCT00005792|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6324731|NCT00005793|Cytarabine|cytarabine|mesh-list
6324732|NCT00005793|Etoposide|etoposide|mesh-list
6324733|NCT00005793|Daunorubicin|daunorubicin|mesh-list
6324734|NCT00005793|Topotecan|topotecan|mesh-list
6324735|NCT00005793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6324736|NCT00005793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324737|NCT00005793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6324738|NCT00005793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6324739|NCT00005793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6324740|NCT00005793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324741|NCT00005793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6324742|NCT00005793|Antimetabolites|antimetabolites|mesh-ancestor
6324743|NCT00005793|Antiviral Agents|antiviral agents|mesh-ancestor
6324744|NCT00005793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6324745|NCT00005793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6324746|NCT00005793|Immunologic Factors|immunologic factors|mesh-ancestor
6324747|NCT00005793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6324748|NCT00005793|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6324749|NCT00005793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6324750|NCT00005796|Vincristine|vincristine|mesh-list
6324751|NCT00005796|Lomustine|lomustine|mesh-list
6324752|NCT00005796|Procarbazine|procarbazine|mesh-list
6324753|NCT00005796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6324754|NCT00005796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324755|NCT00005796|Tubulin Modulators|tubulin modulators|mesh-ancestor
6324756|NCT00005796|Antimitotic Agents|antimitotic agents|mesh-ancestor
6324757|NCT00005796|Mitosis Modulators|mitosis modulators|mesh-ancestor
6324758|NCT00005796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324759|NCT00005796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6324760|NCT00005796|Alkylating Agents|alkylating agents|mesh-ancestor
6324761|NCT00005797|Cyclophosphamide|cyclophosphamide|mesh-list
6324762|NCT00005797|Busulfan|busulfan|mesh-list
6324763|NCT00005797|Etoposide|etoposide|mesh-list
6324764|NCT00005797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6324765|NCT00005797|Immunologic Factors|immunologic factors|mesh-ancestor
6324766|NCT00005797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6324767|NCT00005797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6324768|NCT00005797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6324769|NCT00005797|Alkylating Agents|alkylating agents|mesh-ancestor
6324770|NCT00005797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324771|NCT00005797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324772|NCT00005797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6324773|NCT00005797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6324774|NCT00005797|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6324775|NCT00005797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6324776|NCT00005797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6324777|NCT00005798|Cyclophosphamide|cyclophosphamide|mesh-list
6324778|NCT00005798|Thiotepa|thiotepa|mesh-list
6324779|NCT00005798|Carboplatin|carboplatin|mesh-list
6324780|NCT00005798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6324781|NCT00005798|Immunologic Factors|immunologic factors|mesh-ancestor
6324782|NCT00005798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6324783|NCT00005798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6324784|NCT00005798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6324785|NCT00005798|Alkylating Agents|alkylating agents|mesh-ancestor
6324786|NCT00005798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324787|NCT00005798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324788|NCT00005798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6324789|NCT00005799|Cyclosporine|cyclosporine|mesh-list
6324790|NCT00005799|Mycophenolic Acid|mycophenolic acid|mesh-list
6324791|NCT00005799|Fludarabine|fludarabine|mesh-list
6324792|NCT00005799|Fludarabine phosphate|fludarabine phosphate|mesh-list
6324793|NCT00005799|Cyclosporins|cyclosporins|mesh-list
6324794|NCT00005799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324795|NCT00005799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6324796|NCT00005799|Antimetabolites|antimetabolites|mesh-ancestor
6324797|NCT00005799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324798|NCT00005799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6324799|NCT00005799|Immunologic Factors|immunologic factors|mesh-ancestor
6324800|NCT00005799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6324801|NCT00005799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6324802|NCT00005799|Antifungal Agents|antifungal agents|mesh-ancestor
6324803|NCT00005799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6324804|NCT00005799|Dermatologic Agents|dermatologic agents|mesh-ancestor
6324805|NCT00005799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6324806|NCT00005799|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6324807|NCT00005799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6324808|NCT00005799|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6324809|NCT00005799|Antitubercular Agents|antitubercular agents|mesh-ancestor
6324810|NCT00005799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6324811|NCT00005800|Docetaxel|docetaxel|mesh-list
6324812|NCT00005800|Doxorubicin|doxorubicin|mesh-list
6324813|NCT00005800|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6324814|NCT00005800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324815|NCT00005800|Tubulin Modulators|tubulin modulators|mesh-ancestor
6324816|NCT00005800|Antimitotic Agents|antimitotic agents|mesh-ancestor
6324817|NCT00005800|Mitosis Modulators|mitosis modulators|mesh-ancestor
6324818|NCT00005800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324819|NCT00005800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6324820|NCT00005800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6324821|NCT00005800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6324822|NCT00005800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6324823|NCT00005802|Cytarabine|cytarabine|mesh-list
6324824|NCT00005802|Aldesleukin|aldesleukin|mesh-list
6324825|NCT00005802|Hydrocortisone|hydrocortisone|mesh-list
6324826|NCT00005802|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6324827|NCT00005802|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6324828|NCT00005802|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6324829|NCT00005802|Methotrexate|methotrexate|mesh-list
6324830|NCT00005802|Fludarabine phosphate|fludarabine phosphate|mesh-list
6324831|NCT00005802|Fludarabine|fludarabine|mesh-list
6324832|NCT00005802|Etoposide|etoposide|mesh-list
6324833|NCT00005802|Mitoxantrone|mitoxantrone|mesh-list
6324834|NCT00005802|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6324835|NCT00005802|Abortifacient Agents|abortifacient agents|mesh-ancestor
6324836|NCT00005802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6324837|NCT00005802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6324838|NCT00005802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6324839|NCT00005802|Antimetabolites|antimetabolites|mesh-ancestor
6324840|NCT00005802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324841|NCT00005802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324842|NCT00005802|Dermatologic Agents|dermatologic agents|mesh-ancestor
6324843|NCT00005802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6324844|NCT00005802|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6324845|NCT00005802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6324846|NCT00005802|Immunologic Factors|immunologic factors|mesh-ancestor
6324847|NCT00005802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6324848|NCT00005802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6324849|NCT00005802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6324850|NCT00005802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6324851|NCT00005802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6324852|NCT00005802|Antiviral Agents|antiviral agents|mesh-ancestor
6324853|NCT00005802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6324854|NCT00005802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6324855|NCT00005802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6324856|NCT00005802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6324857|NCT00005802|Analgesics|analgesics|mesh-ancestor
6324858|NCT00005802|Sensory System Agents|sensory system agents|mesh-ancestor
6324859|NCT00005802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6324860|NCT00005804|Cyclophosphamide|cyclophosphamide|mesh-list
6324861|NCT00005804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6324862|NCT00005804|Immunologic Factors|immunologic factors|mesh-ancestor
6324863|NCT00005804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6324864|NCT00005804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6324865|NCT00005804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6324866|NCT00005804|Alkylating Agents|alkylating agents|mesh-ancestor
6324867|NCT00005804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324868|NCT00005804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324869|NCT00005804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6324870|NCT00005806|Paclitaxel|paclitaxel|mesh-list
6324871|NCT00005806|Carboplatin|carboplatin|mesh-list
6324872|NCT00005806|Gefitinib|gefitinib|mesh-list
6324873|NCT00005806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6324874|NCT00005806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324875|NCT00005806|Tubulin Modulators|tubulin modulators|mesh-ancestor
6324876|NCT00005806|Antimitotic Agents|antimitotic agents|mesh-ancestor
6324877|NCT00005806|Mitosis Modulators|mitosis modulators|mesh-ancestor
6324878|NCT00005806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324879|NCT00005806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6324880|NCT00005806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6324881|NCT00005807|Epothilones|epothilones|mesh-list
6324882|NCT00005807|Tubulin Modulators|tubulin modulators|mesh-ancestor
6324883|NCT00005807|Antimitotic Agents|antimitotic agents|mesh-ancestor
6324884|NCT00005807|Mitosis Modulators|mitosis modulators|mesh-ancestor
6324885|NCT00005807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324886|NCT00005807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324887|NCT00005808|Motexafin lutetium|motexafin lutetium|mesh-list
6324888|NCT00005808|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6324889|NCT00005808|Dermatologic Agents|dermatologic agents|mesh-ancestor
6324890|NCT00005810|Carboplatin|carboplatin|mesh-list
6016548|NCT00365508|Cholinergic Agents|cholinergic agents|mesh-ancestor
6016549|NCT00365508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6324891|NCT00005810|Docetaxel|docetaxel|mesh-list
6324892|NCT00005810|Estramustine|estramustine|mesh-list
6324893|NCT00005810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324894|NCT00005810|Tubulin Modulators|tubulin modulators|mesh-ancestor
6324895|NCT00005810|Antimitotic Agents|antimitotic agents|mesh-ancestor
6324896|NCT00005810|Mitosis Modulators|mitosis modulators|mesh-ancestor
6324897|NCT00005810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324898|NCT00005810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6324899|NCT00005810|Alkylating Agents|alkylating agents|mesh-ancestor
6324900|NCT00005810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6324901|NCT00005811|Topotecan|topotecan|mesh-list
6324902|NCT00005811|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6324903|NCT00005811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6324904|NCT00005811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6324905|NCT00005811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324906|NCT00005811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324907|NCT00005812|Temozolomide|temozolomide|mesh-list
6324908|NCT00005812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6324909|NCT00005812|Alkylating Agents|alkylating agents|mesh-ancestor
6324910|NCT00005812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324911|NCT00005812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324912|NCT00005813|Antibodies|antibodies|mesh-list
6324913|NCT00005813|Antibodies, Bispecific|antibodies, bispecific|mesh-list
6324914|NCT00005813|Immunologic Factors|immunologic factors|mesh-ancestor
6324915|NCT00005813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6324916|NCT00005814|Cetuximab|cetuximab|mesh-list
6324917|NCT00005814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324918|NCT00005814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6324919|NCT00005815|Thalidomide|thalidomide|mesh-list
6324920|NCT00005815|Temozolomide|temozolomide|mesh-list
6324921|NCT00005815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6324922|NCT00005815|Alkylating Agents|alkylating agents|mesh-ancestor
6324923|NCT00005815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324924|NCT00005815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324925|NCT00005815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6324926|NCT00005815|Immunologic Factors|immunologic factors|mesh-ancestor
6324927|NCT00005815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6324928|NCT00005815|Leprostatic Agents|leprostatic agents|mesh-ancestor
6324929|NCT00005815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6324930|NCT00005815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6324931|NCT00005815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6324932|NCT00005815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6324933|NCT00005815|Growth Substances|growth substances|mesh-ancestor
6324934|NCT00005815|Growth Inhibitors|growth inhibitors|mesh-ancestor
6393023|NCT00198562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6393024|NCT00198562|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6393025|NCT00198562|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6393026|NCT00198588|Argatroban|argatroban|mesh-list
6393027|NCT00198588|Antithrombins|antithrombins|mesh-ancestor
6393028|NCT00198588|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6393029|NCT00198588|Protease Inhibitors|protease inhibitors|mesh-ancestor
6393030|NCT00198588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6393031|NCT00198588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393032|NCT00198588|Anticoagulants|anticoagulants|mesh-ancestor
6393033|NCT00198588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6393034|NCT00198601|Gentamicins|gentamicins|mesh-list
6393035|NCT00198601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6393036|NCT00198601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6393037|NCT00198601|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6393038|NCT00198601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6393039|NCT00198601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393040|NCT00198614|Metoprolol|metoprolol|mesh-list
6324935|NCT00005818|Irinotecan|irinotecan|mesh-list
6324936|NCT00005818|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6324937|NCT00005818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6324938|NCT00005818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6324939|NCT00005818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324940|NCT00005818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324941|NCT00005819|Paclitaxel|paclitaxel|mesh-list
6324942|NCT00005819|Fenretinide|fenretinide|mesh-list
6324943|NCT00005819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6324944|NCT00005819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324945|NCT00005819|Tubulin Modulators|tubulin modulators|mesh-ancestor
6324946|NCT00005819|Antimitotic Agents|antimitotic agents|mesh-ancestor
6324947|NCT00005819|Mitosis Modulators|mitosis modulators|mesh-ancestor
6324948|NCT00005819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324949|NCT00005819|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6324950|NCT00005819|Protective Agents|protective agents|mesh-ancestor
6324951|NCT00005819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6324952|NCT00005822|Tamoxifen|tamoxifen|mesh-list
6324953|NCT00005822|Doxorubicin|doxorubicin|mesh-list
6324954|NCT00005822|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6324955|NCT00005822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6324956|NCT00005822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324957|NCT00005822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6324958|NCT00005822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6324959|NCT00005822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6324960|NCT00005822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324961|NCT00005822|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6324962|NCT00005822|Hormone Antagonists|hormone antagonists|mesh-ancestor
6324963|NCT00005822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6324964|NCT00005822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6324965|NCT00005822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6324966|NCT00005822|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6324967|NCT00005822|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6324968|NCT00005822|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6324969|NCT00005823|Cytarabine|cytarabine|mesh-list
6324970|NCT00005823|Etoposide|etoposide|mesh-list
6324971|NCT00005823|Daunorubicin|daunorubicin|mesh-list
6324972|NCT00005823|Mitoxantrone|mitoxantrone|mesh-list
6324973|NCT00005823|Idarubicin|idarubicin|mesh-list
6324974|NCT00005823|Hydroxyurea|hydroxyurea|mesh-list
6324975|NCT00005823|Tretinoin|tretinoin|mesh-list
6324976|NCT00005823|Thioguanine|thioguanine|mesh-list
6324977|NCT00005823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6324978|NCT00005823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6324979|NCT00005823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6324980|NCT00005823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6324981|NCT00005823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6324982|NCT00005823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6324983|NCT00005823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6324984|NCT00005823|Antimetabolites|antimetabolites|mesh-ancestor
6324985|NCT00005823|Antiviral Agents|antiviral agents|mesh-ancestor
6324986|NCT00005823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6324987|NCT00005823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6324988|NCT00005823|Immunologic Factors|immunologic factors|mesh-ancestor
6324989|NCT00005823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6324990|NCT00005823|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6324991|NCT00005823|Analgesics|analgesics|mesh-ancestor
6324992|NCT00005823|Sensory System Agents|sensory system agents|mesh-ancestor
6324993|NCT00005823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6324994|NCT00005823|Antisickling Agents|antisickling agents|mesh-ancestor
6324995|NCT00005823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6324996|NCT00005823|Keratolytic Agents|keratolytic agents|mesh-ancestor
6324997|NCT00005823|Dermatologic Agents|dermatologic agents|mesh-ancestor
6324998|NCT00005824|Cyclophosphamide|cyclophosphamide|mesh-list
6324999|NCT00005824|Busulfan|busulfan|mesh-list
6325000|NCT00005824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6325001|NCT00005824|Immunologic Factors|immunologic factors|mesh-ancestor
6325002|NCT00005824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6325003|NCT00005824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6325004|NCT00005824|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6325005|NCT00005824|Alkylating Agents|alkylating agents|mesh-ancestor
6325006|NCT00005824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325007|NCT00005824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325008|NCT00005824|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6325009|NCT00005825|Vinorelbine|vinorelbine|mesh-list
6325010|NCT00005825|Mitomycins|mitomycins|mesh-list
6325011|NCT00005825|Mitomycin|mitomycin|mesh-list
6325012|NCT00005825|Tretinoin|tretinoin|mesh-list
6325013|NCT00005825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325014|NCT00005825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6325015|NCT00005825|Tubulin Modulators|tubulin modulators|mesh-ancestor
6325016|NCT00005825|Antimitotic Agents|antimitotic agents|mesh-ancestor
6325017|NCT00005825|Mitosis Modulators|mitosis modulators|mesh-ancestor
6325018|NCT00005825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325019|NCT00005825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6325020|NCT00005825|Alkylating Agents|alkylating agents|mesh-ancestor
6325021|NCT00005825|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6325022|NCT00005825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6325023|NCT00005825|Keratolytic Agents|keratolytic agents|mesh-ancestor
6325024|NCT00005825|Dermatologic Agents|dermatologic agents|mesh-ancestor
6325025|NCT00005826|Rubitecan|rubitecan|mesh-list
6325026|NCT00005826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325027|NCT00005826|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6325028|NCT00005826|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6325029|NCT00005826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6325030|NCT00005826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325031|NCT00005827|Genistein|genistein|mesh-list
6325032|NCT00005827|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6325033|NCT00005827|Protective Agents|protective agents|mesh-ancestor
6325034|NCT00005827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6325035|NCT00005827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325036|NCT00005827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6325037|NCT00005827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6325038|NCT00005827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325039|NCT00005827|Phytoestrogens|phytoestrogens|mesh-ancestor
6325040|NCT00005827|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6325041|NCT00005827|Estrogens|estrogens|mesh-ancestor
6325042|NCT00005827|Hormones|hormones|mesh-ancestor
6325043|NCT00005827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6325044|NCT00005829|Gemcitabine|gemcitabine|mesh-list
6325045|NCT00005829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6325046|NCT00005829|Antimetabolites|antimetabolites|mesh-ancestor
6325047|NCT00005829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325048|NCT00005829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325049|NCT00005829|Antiviral Agents|antiviral agents|mesh-ancestor
6325050|NCT00005829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6325051|NCT00005829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6325052|NCT00005829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6325053|NCT00005829|Immunologic Factors|immunologic factors|mesh-ancestor
6325054|NCT00005829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6325055|NCT00005830|Doxorubicin|doxorubicin|mesh-list
6325056|NCT00005830|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6325057|NCT00005830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325058|NCT00005830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6325059|NCT00005830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6325060|NCT00005830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6325061|NCT00005830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6325062|NCT00005830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325063|NCT00005831|Gemcitabine|gemcitabine|mesh-list
6325064|NCT00005831|Paclitaxel|paclitaxel|mesh-list
6325065|NCT00005831|Carboplatin|carboplatin|mesh-list
6325066|NCT00005831|Trastuzumab|trastuzumab|mesh-list
6325067|NCT00005831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6325068|NCT00005831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325069|NCT00005831|Tubulin Modulators|tubulin modulators|mesh-ancestor
6325070|NCT00005831|Antimitotic Agents|antimitotic agents|mesh-ancestor
6325071|NCT00005831|Mitosis Modulators|mitosis modulators|mesh-ancestor
6325072|NCT00005831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325073|NCT00005831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6325074|NCT00005831|Antimetabolites|antimetabolites|mesh-ancestor
6325075|NCT00005831|Antiviral Agents|antiviral agents|mesh-ancestor
6325076|NCT00005831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6325077|NCT00005831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6325078|NCT00005831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6325079|NCT00005831|Immunologic Factors|immunologic factors|mesh-ancestor
6325080|NCT00005831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6325081|NCT00005831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6325082|NCT00005832|Tipifarnib|tipifarnib|mesh-list
6325083|NCT00005832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325084|NCT00005833|Tipifarnib|tipifarnib|mesh-list
6325085|NCT00005833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325086|NCT00005834|Thalidomide|thalidomide|mesh-list
6325087|NCT00005834|Dexamethasone|dexamethasone|mesh-list
6325088|NCT00005834|Cyclophosphamide|cyclophosphamide|mesh-list
6325089|NCT00005834|Etoposide|etoposide|mesh-list
6325090|NCT00005834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6325091|NCT00005834|Immunologic Factors|immunologic factors|mesh-ancestor
6325092|NCT00005834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6325093|NCT00005834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6325094|NCT00005834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6325095|NCT00005834|Alkylating Agents|alkylating agents|mesh-ancestor
6325096|NCT00005834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325097|NCT00005834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325098|NCT00005834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6325099|NCT00005834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6325100|NCT00005834|Antiemetics|antiemetics|mesh-ancestor
6325101|NCT00005834|Autonomic Agents|autonomic agents|mesh-ancestor
6325102|NCT00005834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6325103|NCT00005834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6325104|NCT00005834|Glucocorticoids|glucocorticoids|mesh-ancestor
6325105|NCT00005834|Hormones|hormones|mesh-ancestor
6325106|NCT00005834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6325107|NCT00005834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6325108|NCT00005834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6325109|NCT00005834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6325110|NCT00005834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6325111|NCT00005834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6325112|NCT00005834|Leprostatic Agents|leprostatic agents|mesh-ancestor
6325113|NCT00005834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6325114|NCT00005834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6325115|NCT00005834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6325116|NCT00005834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6325117|NCT00005834|Growth Substances|growth substances|mesh-ancestor
6325118|NCT00005834|Growth Inhibitors|growth inhibitors|mesh-ancestor
6325119|NCT00005835|Melphalan|melphalan|mesh-list
6325120|NCT00005835|Buthionine Sulfoximine|buthionine sulfoximine|mesh-list
6325121|NCT00005835|Immunologic Factors|immunologic factors|mesh-ancestor
6325122|NCT00005835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6325123|NCT00005835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6325124|NCT00005835|Alkylating Agents|alkylating agents|mesh-ancestor
6325125|NCT00005835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325126|NCT00005835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325127|NCT00005835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6325128|NCT00005835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6325129|NCT00005835|Antimetabolites|antimetabolites|mesh-ancestor
6325130|NCT00005835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6325131|NCT00005835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6325132|NCT00005835|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6325133|NCT00005835|Protective Agents|protective agents|mesh-ancestor
6325134|NCT00005836|Oxaliplatin|oxaliplatin|mesh-list
6325135|NCT00005836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325136|NCT00005837|Oxaliplatin|oxaliplatin|mesh-list
6325137|NCT00005837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325138|NCT00005838|Paclitaxel|paclitaxel|mesh-list
6325139|NCT00005838|Vinorelbine|vinorelbine|mesh-list
6325140|NCT00005838|Carboplatin|carboplatin|mesh-list
6325141|NCT00005838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6325142|NCT00005838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325143|NCT00005838|Tubulin Modulators|tubulin modulators|mesh-ancestor
6325144|NCT00005838|Antimitotic Agents|antimitotic agents|mesh-ancestor
6325145|NCT00005838|Mitosis Modulators|mitosis modulators|mesh-ancestor
6325146|NCT00005838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325147|NCT00005839|Capecitabine|capecitabine|mesh-list
6325148|NCT00005839|Oxaliplatin|oxaliplatin|mesh-list
6325149|NCT00005839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6325150|NCT00005839|Antimetabolites|antimetabolites|mesh-ancestor
6325151|NCT00005839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325152|NCT00005839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325153|NCT00005840|Paclitaxel|paclitaxel|mesh-list
6325154|NCT00005840|Cisplatin|cisplatin|mesh-list
6325155|NCT00005840|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6325156|NCT00005840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325157|NCT00005840|Tubulin Modulators|tubulin modulators|mesh-ancestor
6325158|NCT00005840|Antimitotic Agents|antimitotic agents|mesh-ancestor
6325159|NCT00005840|Mitosis Modulators|mitosis modulators|mesh-ancestor
6325160|NCT00005840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325161|NCT00005841|Freund's Adjuvant|freund's adjuvant|mesh-list
6325162|NCT00005841|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6325163|NCT00005841|Immunologic Factors|immunologic factors|mesh-ancestor
6325164|NCT00005841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6325165|NCT00005842|Trastuzumab|trastuzumab|mesh-list
6325166|NCT00005842|Tipifarnib|tipifarnib|mesh-list
6325167|NCT00005842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6325168|NCT00005842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325169|NCT00005843|Tipifarnib|tipifarnib|mesh-list
6325170|NCT00005843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325171|NCT00005844|Oxaliplatin|oxaliplatin|mesh-list
6325172|NCT00005844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325173|NCT00005845|Tipifarnib|tipifarnib|mesh-list
6325174|NCT00005845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325175|NCT00005847|Interferons|interferons|mesh-list
6325176|NCT00005847|Interferon-alpha|interferon-alpha|mesh-list
6325177|NCT00005847|Paclitaxel|paclitaxel|mesh-list
6325178|NCT00005847|Vinorelbine|vinorelbine|mesh-list
6325179|NCT00005847|Mitoxantrone|mitoxantrone|mesh-list
6325180|NCT00005847|Estramustine|estramustine|mesh-list
6325181|NCT00005847|Isotretinoin|isotretinoin|mesh-list
6325182|NCT00005847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6325183|NCT00005847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325184|NCT00005847|Tubulin Modulators|tubulin modulators|mesh-ancestor
6325185|NCT00005847|Antimitotic Agents|antimitotic agents|mesh-ancestor
6325186|NCT00005847|Mitosis Modulators|mitosis modulators|mesh-ancestor
6325187|NCT00005847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325188|NCT00005847|Antiviral Agents|antiviral agents|mesh-ancestor
6325189|NCT00005847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6325190|NCT00005847|Immunologic Factors|immunologic factors|mesh-ancestor
6325191|NCT00005847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6325192|NCT00005847|Analgesics|analgesics|mesh-ancestor
6325193|NCT00005847|Sensory System Agents|sensory system agents|mesh-ancestor
6325194|NCT00005847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6325195|NCT00005847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6325196|NCT00005847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6325197|NCT00005847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6325198|NCT00005847|Dermatologic Agents|dermatologic agents|mesh-ancestor
6325199|NCT00005847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6325200|NCT00005847|Alkylating Agents|alkylating agents|mesh-ancestor
6325201|NCT00005847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6325202|NCT00005848|Tipifarnib|tipifarnib|mesh-list
6325203|NCT00005848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325204|NCT00005849|Paclitaxel|paclitaxel|mesh-list
6325205|NCT00005849|Bryostatin 1|bryostatin 1|mesh-list
6325206|NCT00005849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6325207|NCT00005849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325208|NCT00005849|Tubulin Modulators|tubulin modulators|mesh-ancestor
6325209|NCT00005849|Antimitotic Agents|antimitotic agents|mesh-ancestor
6325210|NCT00005849|Mitosis Modulators|mitosis modulators|mesh-ancestor
6325211|NCT00005849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325212|NCT00005849|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6325213|NCT00005849|Immunologic Factors|immunologic factors|mesh-ancestor
6325214|NCT00005849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6325215|NCT00005850|Gemcitabine|gemcitabine|mesh-list
6325216|NCT00005850|Fluoxetine|fluoxetine|mesh-list
6325217|NCT00005850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325218|NCT00005850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6325219|NCT00005850|Antimetabolites|antimetabolites|mesh-ancestor
6325220|NCT00005850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325221|NCT00005850|Antiviral Agents|antiviral agents|mesh-ancestor
6325222|NCT00005850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6325223|NCT00005850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6325224|NCT00005850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6325225|NCT00005850|Immunologic Factors|immunologic factors|mesh-ancestor
6325226|NCT00005850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6325227|NCT00005850|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6325228|NCT00005850|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6325229|NCT00005850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6325230|NCT00005850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6325231|NCT00005850|Serotonin Agents|serotonin agents|mesh-ancestor
6325232|NCT00005850|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6325233|NCT00005850|Antidepressive Agents|antidepressive agents|mesh-ancestor
6325234|NCT00005850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6325235|NCT00005850|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6325236|NCT00005850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6325237|NCT00005851|Cyclosporine|cyclosporine|mesh-list
6325238|NCT00005851|Mycophenolic Acid|mycophenolic acid|mesh-list
6325239|NCT00005851|Fludarabine|fludarabine|mesh-list
6325240|NCT00005851|Fludarabine phosphate|fludarabine phosphate|mesh-list
6325241|NCT00005851|Cyclosporins|cyclosporins|mesh-list
6325242|NCT00005851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325243|NCT00005851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6325244|NCT00005851|Antimetabolites|antimetabolites|mesh-ancestor
6325245|NCT00005851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325246|NCT00005851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6325247|NCT00005851|Immunologic Factors|immunologic factors|mesh-ancestor
6325248|NCT00005851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6325249|NCT00005851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6325250|NCT00005851|Antifungal Agents|antifungal agents|mesh-ancestor
6325251|NCT00005851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6325252|NCT00005851|Dermatologic Agents|dermatologic agents|mesh-ancestor
6325253|NCT00005851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6325254|NCT00005851|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6325255|NCT00005851|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6325256|NCT00005851|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6325257|NCT00005851|Antitubercular Agents|antitubercular agents|mesh-ancestor
6325258|NCT00005851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6325259|NCT00005852|Cyclosporine|cyclosporine|mesh-list
6325260|NCT00005852|Methylprednisolone|methylprednisolone|mesh-list
6325261|NCT00005852|Cyclophosphamide|cyclophosphamide|mesh-list
6325262|NCT00005852|Cyclosporins|cyclosporins|mesh-list
6325263|NCT00005852|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6325264|NCT00005852|Muromonab-CD3|muromonab-cd3|mesh-list
6325265|NCT00005852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6325266|NCT00005852|Immunologic Factors|immunologic factors|mesh-ancestor
6325267|NCT00005852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6325268|NCT00005852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6325269|NCT00005852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6325270|NCT00005852|Alkylating Agents|alkylating agents|mesh-ancestor
6325271|NCT00005852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325272|NCT00005852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325273|NCT00005852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6325274|NCT00005852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6325275|NCT00005852|Antifungal Agents|antifungal agents|mesh-ancestor
6325276|NCT00005852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6325277|NCT00005852|Dermatologic Agents|dermatologic agents|mesh-ancestor
6325278|NCT00005852|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6325279|NCT00005852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6325280|NCT00005852|Antiemetics|antiemetics|mesh-ancestor
6325281|NCT00005852|Autonomic Agents|autonomic agents|mesh-ancestor
6325282|NCT00005852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6325283|NCT00005852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6325284|NCT00005852|Glucocorticoids|glucocorticoids|mesh-ancestor
6325285|NCT00005852|Hormones|hormones|mesh-ancestor
6325286|NCT00005852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6325287|NCT00005852|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6325288|NCT00005852|Protective Agents|protective agents|mesh-ancestor
6325289|NCT00005853|Etanercept|etanercept|mesh-list
6325290|NCT00005853|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6325291|NCT00005853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6325292|NCT00005853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6325293|NCT00005853|Analgesics|analgesics|mesh-ancestor
6325294|NCT00005853|Sensory System Agents|sensory system agents|mesh-ancestor
6325295|NCT00005853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6325296|NCT00005853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6325297|NCT00005853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6325298|NCT00005853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6325299|NCT00005853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6325300|NCT00005853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6325301|NCT00005853|Immunologic Factors|immunologic factors|mesh-ancestor
6325302|NCT00005854|Cyclosporine|cyclosporine|mesh-list
6325303|NCT00005854|Cyclophosphamide|cyclophosphamide|mesh-list
6325304|NCT00005854|Methotrexate|methotrexate|mesh-list
6325305|NCT00005854|Cyclosporins|cyclosporins|mesh-list
6325306|NCT00005854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6325307|NCT00005854|Immunologic Factors|immunologic factors|mesh-ancestor
6325308|NCT00005854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6325309|NCT00005854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6325310|NCT00005854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6325311|NCT00005854|Alkylating Agents|alkylating agents|mesh-ancestor
6325312|NCT00005854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325313|NCT00005854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325314|NCT00005854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6325315|NCT00005854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6325316|NCT00005854|Abortifacient Agents|abortifacient agents|mesh-ancestor
6325317|NCT00005854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6325318|NCT00005854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6325319|NCT00005854|Antimetabolites|antimetabolites|mesh-ancestor
6325320|NCT00005854|Dermatologic Agents|dermatologic agents|mesh-ancestor
6325321|NCT00005854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6325322|NCT00005854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6325323|NCT00005854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6325324|NCT00005854|Antifungal Agents|antifungal agents|mesh-ancestor
6325325|NCT00005854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6325326|NCT00005854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6325327|NCT00005855|Carmustine|carmustine|mesh-list
6325328|NCT00005855|Efaproxiral|efaproxiral|mesh-list
6325329|NCT00005855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6325330|NCT00005855|Alkylating Agents|alkylating agents|mesh-ancestor
6325331|NCT00005855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325332|NCT00005855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325333|NCT00005855|Antisickling Agents|antisickling agents|mesh-ancestor
6325334|NCT00005856|Oxaliplatin|oxaliplatin|mesh-list
6325335|NCT00005856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325336|NCT00005857|Docetaxel|docetaxel|mesh-list
6325337|NCT00005857|Trastuzumab|trastuzumab|mesh-list
6325338|NCT00005857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325339|NCT00005857|Tubulin Modulators|tubulin modulators|mesh-ancestor
6325340|NCT00005857|Antimitotic Agents|antimitotic agents|mesh-ancestor
6325341|NCT00005857|Mitosis Modulators|mitosis modulators|mesh-ancestor
6325342|NCT00005857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325343|NCT00005857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6325344|NCT00005858|Immunotoxins|immunotoxins|mesh-list
6325345|NCT00005858|Immunologic Factors|immunologic factors|mesh-ancestor
6325346|NCT00005858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6325347|NCT00005859|Tipifarnib|tipifarnib|mesh-list
6325348|NCT00005859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325349|NCT00005860|Leucovorin|leucovorin|mesh-list
6325350|NCT00005860|Oxaliplatin|oxaliplatin|mesh-list
6325351|NCT00005860|Floxuridine|floxuridine|mesh-list
6325352|NCT00005860|Calcium|calcium|mesh-list
6325353|NCT00005860|Levoleucovorin|levoleucovorin|mesh-list
6325354|NCT00005860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6325355|NCT00005860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6325356|NCT00005860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325357|NCT00005860|Antidotes|antidotes|mesh-ancestor
6325358|NCT00005860|Protective Agents|protective agents|mesh-ancestor
6325359|NCT00005860|Vitamin B Complex|vitamin b complex|mesh-ancestor
6325360|NCT00005860|Vitamins|vitamins|mesh-ancestor
6325361|NCT00005860|Micronutrients|micronutrients|mesh-ancestor
6325362|NCT00005860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6325363|NCT00005860|Antimetabolites|antimetabolites|mesh-ancestor
6325364|NCT00005860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325365|NCT00005861|Doxorubicin|doxorubicin|mesh-list
6325366|NCT00005861|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6325367|NCT00005861|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6325368|NCT00005861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325369|NCT00005861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6325370|NCT00005861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6325371|NCT00005861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6325372|NCT00005861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325373|NCT00005862|Semaxinib|semaxinib|mesh-list
6325374|NCT00005862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6325375|NCT00005862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6325376|NCT00005862|Growth Substances|growth substances|mesh-ancestor
6325377|NCT00005862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6325378|NCT00005862|Growth Inhibitors|growth inhibitors|mesh-ancestor
6325379|NCT00005862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325380|NCT00005862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6325381|NCT00005862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6325382|NCT00005862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325383|NCT00005863|Cytarabine|cytarabine|mesh-list
6325384|NCT00005863|Fludarabine|fludarabine|mesh-list
6325385|NCT00005863|Fludarabine phosphate|fludarabine phosphate|mesh-list
6325386|NCT00005863|Etoposide|etoposide|mesh-list
6325387|NCT00005863|Daunorubicin|daunorubicin|mesh-list
6325388|NCT00005863|Tretinoin|tretinoin|mesh-list
6325389|NCT00005863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325390|NCT00005863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6325391|NCT00005863|Antimetabolites|antimetabolites|mesh-ancestor
6325392|NCT00005863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325393|NCT00005863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6325394|NCT00005863|Immunologic Factors|immunologic factors|mesh-ancestor
6325395|NCT00005863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6325396|NCT00005863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6325397|NCT00005863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6325398|NCT00005863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6325399|NCT00005863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6325400|NCT00005863|Antiviral Agents|antiviral agents|mesh-ancestor
6325401|NCT00005863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6325402|NCT00005863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6325403|NCT00005863|Keratolytic Agents|keratolytic agents|mesh-ancestor
6325404|NCT00005863|Dermatologic Agents|dermatologic agents|mesh-ancestor
6325405|NCT00005864|Sulfanilamides|sulfanilamides|mesh-list
6325406|NCT00005864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6325407|NCT00005865|Vinorelbine|vinorelbine|mesh-list
6325408|NCT00005865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6325409|NCT00005865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325410|NCT00005865|Tubulin Modulators|tubulin modulators|mesh-ancestor
6325411|NCT00005865|Antimitotic Agents|antimitotic agents|mesh-ancestor
6325412|NCT00005865|Mitosis Modulators|mitosis modulators|mesh-ancestor
6325413|NCT00005865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325414|NCT00005866|Cyclosporine|cyclosporine|mesh-list
6325415|NCT00005866|Cyclophosphamide|cyclophosphamide|mesh-list
6325416|NCT00005866|Busulfan|busulfan|mesh-list
6325417|NCT00005866|Methotrexate|methotrexate|mesh-list
6325418|NCT00005866|Cyclosporins|cyclosporins|mesh-list
6325419|NCT00005866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6325420|NCT00005866|Immunologic Factors|immunologic factors|mesh-ancestor
6325421|NCT00005866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6325422|NCT00005866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6325423|NCT00005866|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6325424|NCT00005866|Alkylating Agents|alkylating agents|mesh-ancestor
6325425|NCT00005866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325426|NCT00005866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325427|NCT00005866|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6325428|NCT00005866|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6325429|NCT00005866|Abortifacient Agents|abortifacient agents|mesh-ancestor
6325430|NCT00005866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6325431|NCT00005866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6325432|NCT00005866|Antimetabolites|antimetabolites|mesh-ancestor
6325433|NCT00005866|Dermatologic Agents|dermatologic agents|mesh-ancestor
6325434|NCT00005866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6325435|NCT00005866|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6325436|NCT00005866|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6325437|NCT00005866|Antifungal Agents|antifungal agents|mesh-ancestor
6325438|NCT00005866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6325439|NCT00005866|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6325440|NCT00005867|Prednisolone|prednisolone|mesh-list
6325441|NCT00005867|Cyclophosphamide|cyclophosphamide|mesh-list
6325442|NCT00005867|Doxorubicin|doxorubicin|mesh-list
6325443|NCT00005867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6325444|NCT00005867|Etoposide|etoposide|mesh-list
6325445|NCT00005867|Vincristine|vincristine|mesh-list
6325446|NCT00005867|Mitoxantrone|mitoxantrone|mesh-list
6325447|NCT00005867|Bleomycin|bleomycin|mesh-list
6325448|NCT00005867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6325449|NCT00005867|Immunologic Factors|immunologic factors|mesh-ancestor
6325450|NCT00005867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6325451|NCT00005867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6325452|NCT00005867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6325453|NCT00005867|Alkylating Agents|alkylating agents|mesh-ancestor
6325454|NCT00005867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325455|NCT00005867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325456|NCT00005867|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6325457|NCT00005867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6325458|NCT00005867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6325459|NCT00005867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6325460|NCT00005867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6325461|NCT00005867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6325462|NCT00005867|Tubulin Modulators|tubulin modulators|mesh-ancestor
6325463|NCT00005867|Antimitotic Agents|antimitotic agents|mesh-ancestor
6325464|NCT00005867|Mitosis Modulators|mitosis modulators|mesh-ancestor
6325465|NCT00005867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6325466|NCT00005867|Glucocorticoids|glucocorticoids|mesh-ancestor
6325467|NCT00005867|Hormones|hormones|mesh-ancestor
6325468|NCT00005867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6325469|NCT00005867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6325470|NCT00005867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6325471|NCT00005867|Analgesics|analgesics|mesh-ancestor
6325472|NCT00005867|Sensory System Agents|sensory system agents|mesh-ancestor
6325473|NCT00005868|Docetaxel|docetaxel|mesh-list
6325474|NCT00005868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325475|NCT00005868|Tubulin Modulators|tubulin modulators|mesh-ancestor
6325476|NCT00005868|Antimitotic Agents|antimitotic agents|mesh-ancestor
6325477|NCT00005868|Mitosis Modulators|mitosis modulators|mesh-ancestor
6325478|NCT00005868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325479|NCT00005869|Gemcitabine|gemcitabine|mesh-list
6325480|NCT00005869|Rubitecan|rubitecan|mesh-list
6325481|NCT00005869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6325482|NCT00005869|Antimetabolites|antimetabolites|mesh-ancestor
6325483|NCT00005869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325484|NCT00005869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325485|NCT00005869|Antiviral Agents|antiviral agents|mesh-ancestor
6325486|NCT00005869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6325487|NCT00005869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6325488|NCT00005869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6325489|NCT00005869|Immunologic Factors|immunologic factors|mesh-ancestor
6325490|NCT00005869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6325491|NCT00005869|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6325492|NCT00005869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6325493|NCT00005870|Gemcitabine|gemcitabine|mesh-list
6325494|NCT00005870|Fluorouracil|fluorouracil|mesh-list
6325495|NCT00005870|Mitomycins|mitomycins|mesh-list
6325496|NCT00005870|Mitomycin|mitomycin|mesh-list
6325497|NCT00005870|Rubitecan|rubitecan|mesh-list
6325498|NCT00005870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6325499|NCT00005870|Antimetabolites|antimetabolites|mesh-ancestor
6325500|NCT00005870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325501|NCT00005870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325502|NCT00005870|Antiviral Agents|antiviral agents|mesh-ancestor
6325503|NCT00005870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6325504|NCT00005870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6325505|NCT00005870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6325506|NCT00005870|Immunologic Factors|immunologic factors|mesh-ancestor
6325507|NCT00005870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6325508|NCT00005870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6325509|NCT00005870|Alkylating Agents|alkylating agents|mesh-ancestor
6325510|NCT00005870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6325511|NCT00005870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6325512|NCT00005870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6325513|NCT00005871|Fluorouracil|fluorouracil|mesh-list
6325514|NCT00005871|Rubitecan|rubitecan|mesh-list
6325515|NCT00005871|Antimetabolites|antimetabolites|mesh-ancestor
6325516|NCT00005871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325517|NCT00005871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6325518|NCT00005871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325519|NCT00005871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6325520|NCT00005871|Immunologic Factors|immunologic factors|mesh-ancestor
6325521|NCT00005871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6325522|NCT00005871|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6325523|NCT00005871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6325524|NCT00005871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6325525|NCT00005872|Rubitecan|rubitecan|mesh-list
6325526|NCT00005872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325527|NCT00005872|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6325528|NCT00005872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6325529|NCT00005872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6325530|NCT00005872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325531|NCT00005873|Rubitecan|rubitecan|mesh-list
6325532|NCT00005873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325533|NCT00005873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6325534|NCT00005873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6325535|NCT00005873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6325536|NCT00005873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325537|NCT00005874|Rubitecan|rubitecan|mesh-list
6325538|NCT00005874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325539|NCT00005874|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6325540|NCT00005874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6325541|NCT00005874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6325542|NCT00005874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325543|NCT00005875|Rubitecan|rubitecan|mesh-list
6325544|NCT00005875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325545|NCT00005875|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6325546|NCT00005875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6325547|NCT00005875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6325548|NCT00005875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325549|NCT00005876|Rubitecan|rubitecan|mesh-list
6325550|NCT00005876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325551|NCT00005876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6325552|NCT00005876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6325553|NCT00005876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6325554|NCT00005876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325555|NCT00005877|Rubitecan|rubitecan|mesh-list
6325556|NCT00005877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325557|NCT00005877|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6325558|NCT00005877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6325559|NCT00005877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6325560|NCT00005877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325561|NCT00005878|Celecoxib|celecoxib|mesh-list
6325562|NCT00005878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6325563|NCT00005878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6325564|NCT00005878|Analgesics|analgesics|mesh-ancestor
6325565|NCT00005878|Sensory System Agents|sensory system agents|mesh-ancestor
6325566|NCT00005878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6325567|NCT00005878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6325568|NCT00005878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6325569|NCT00005878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6325570|NCT00005878|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6325571|NCT00005878|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6325572|NCT00005878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6325573|NCT00005878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325574|NCT00005880|Budesonide|budesonide|mesh-list
6325575|NCT00005880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6325576|NCT00005880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6325577|NCT00005880|Autonomic Agents|autonomic agents|mesh-ancestor
6325578|NCT00005880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6325579|NCT00005880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6325580|NCT00005880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6325581|NCT00005880|Respiratory System Agents|respiratory system agents|mesh-ancestor
6325582|NCT00005880|Glucocorticoids|glucocorticoids|mesh-ancestor
6325583|NCT00005880|Hormones|hormones|mesh-ancestor
6325584|NCT00005880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6325585|NCT00005883|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
6325586|NCT00005883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6325587|NCT00005883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325588|NCT00005883|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6325589|NCT00005883|Protective Agents|protective agents|mesh-ancestor
6325590|NCT00005883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6325591|NCT00005883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325592|NCT00005884|Eflornithine|eflornithine|mesh-list
6325593|NCT00005884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325594|NCT00005884|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6325595|NCT00005884|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6325596|NCT00005884|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6325597|NCT00005884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6325598|NCT00005884|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
6325599|NCT00005884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6325600|NCT00005884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325601|NCT00005886|Tamoxifen|tamoxifen|mesh-list
6325602|NCT00005886|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6325603|NCT00005886|Hormone Antagonists|hormone antagonists|mesh-ancestor
6325604|NCT00005886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6325605|NCT00005886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6325606|NCT00005886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6325607|NCT00005886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325608|NCT00005886|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6325609|NCT00005886|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6325610|NCT00005886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6325611|NCT00005887|Efaproxiral|efaproxiral|mesh-list
6325612|NCT00005887|Antisickling Agents|antisickling agents|mesh-ancestor
6325613|NCT00005889|Glucagon|glucagon|mesh-list
6325614|NCT00005889|Glycerol|glycerol|mesh-list
6325615|NCT00005889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6325616|NCT00005889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6325617|NCT00005889|Hormones|hormones|mesh-ancestor
6325618|NCT00005889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6325619|NCT00005889|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6325620|NCT00005889|Protective Agents|protective agents|mesh-ancestor
6325621|NCT00005890|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6325622|NCT00005890|Hormones|hormones|mesh-ancestor
6325623|NCT00005890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6325624|NCT00005890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6325625|NCT00005891|Cyclophosphamide|cyclophosphamide|mesh-list
6325626|NCT00005891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6325627|NCT00005891|Immunologic Factors|immunologic factors|mesh-ancestor
6325628|NCT00005891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6325629|NCT00005891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6325630|NCT00005891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6325631|NCT00005891|Alkylating Agents|alkylating agents|mesh-ancestor
6325632|NCT00005891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325633|NCT00005891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325634|NCT00005891|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6325635|NCT00005892|Cyclophosphamide|cyclophosphamide|mesh-list
6325636|NCT00005892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6325637|NCT00005892|Immunologic Factors|immunologic factors|mesh-ancestor
6325638|NCT00005892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6325639|NCT00005892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6325640|NCT00005892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6325641|NCT00005892|Alkylating Agents|alkylating agents|mesh-ancestor
6325642|NCT00005892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325643|NCT00005892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325644|NCT00005892|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6325645|NCT00005893|Cyclophosphamide|cyclophosphamide|mesh-list
6325646|NCT00005893|Busulfan|busulfan|mesh-list
6325647|NCT00005893|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6325648|NCT00005893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6325649|NCT00005893|Immunologic Factors|immunologic factors|mesh-ancestor
6325650|NCT00005893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6325651|NCT00005893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6325652|NCT00005893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6325653|NCT00005893|Alkylating Agents|alkylating agents|mesh-ancestor
6325654|NCT00005893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325655|NCT00005893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325656|NCT00005893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6325657|NCT00005896|Lenograstim|lenograstim|mesh-list
6325658|NCT00005896|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6325659|NCT00005896|Immunologic Factors|immunologic factors|mesh-ancestor
6325660|NCT00005896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6325661|NCT00005898|Cyclosporine|cyclosporine|mesh-list
6325662|NCT00005898|Methylprednisolone|methylprednisolone|mesh-list
6325663|NCT00005898|Cyclophosphamide|cyclophosphamide|mesh-list
6325664|NCT00005898|Fludarabine|fludarabine|mesh-list
6325665|NCT00005898|Cyclosporins|cyclosporins|mesh-list
6325666|NCT00005898|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6325667|NCT00005898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6325668|NCT00005898|Immunologic Factors|immunologic factors|mesh-ancestor
6325669|NCT00005898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6325670|NCT00005898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6325671|NCT00005898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6325672|NCT00005898|Alkylating Agents|alkylating agents|mesh-ancestor
6325673|NCT00005898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325674|NCT00005898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325675|NCT00005898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6325676|NCT00005898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6325677|NCT00005898|Antifungal Agents|antifungal agents|mesh-ancestor
6325678|NCT00005898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6325679|NCT00005898|Dermatologic Agents|dermatologic agents|mesh-ancestor
6325680|NCT00005898|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6325681|NCT00005898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6325682|NCT00005898|Antiemetics|antiemetics|mesh-ancestor
6325683|NCT00005898|Autonomic Agents|autonomic agents|mesh-ancestor
6325684|NCT00005898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6325685|NCT00005898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6325686|NCT00005898|Glucocorticoids|glucocorticoids|mesh-ancestor
6325687|NCT00005898|Hormones|hormones|mesh-ancestor
6325688|NCT00005898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6325689|NCT00005898|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6325690|NCT00005898|Protective Agents|protective agents|mesh-ancestor
6325691|NCT00005912|Voriconazole|voriconazole|mesh-list
6325692|NCT00005912|Antifungal Agents|antifungal agents|mesh-ancestor
6325693|NCT00005912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6325694|NCT00005912|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6325695|NCT00005912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6325696|NCT00005912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6325697|NCT00005912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325698|NCT00005912|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6325699|NCT00005912|Hormone Antagonists|hormone antagonists|mesh-ancestor
6325700|NCT00005912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6325701|NCT00005912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6325702|NCT00005912|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6325703|NCT00005920|Caspofungin|caspofungin|mesh-list
6325704|NCT00005920|Antifungal Agents|antifungal agents|mesh-ancestor
6393041|NCT00198614|Carvedilol|carvedilol|mesh-list
6325705|NCT00005920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6325706|NCT00005920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6325707|NCT00005920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325708|NCT00005921|Caspofungin|caspofungin|mesh-list
6325709|NCT00005921|Antifungal Agents|antifungal agents|mesh-ancestor
6325710|NCT00005921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6325711|NCT00005921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6325712|NCT00005921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325713|NCT00005922|Triamcinolone|triamcinolone|mesh-list
6325714|NCT00005922|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6325715|NCT00005922|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6325716|NCT00005922|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6325717|NCT00005922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6325718|NCT00005922|Glucocorticoids|glucocorticoids|mesh-ancestor
6325719|NCT00005922|Hormones|hormones|mesh-ancestor
6325720|NCT00005922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6325721|NCT00005922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6325722|NCT00005922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6325723|NCT00005922|Immunologic Factors|immunologic factors|mesh-ancestor
6325724|NCT00005922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6325725|NCT00005922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325726|NCT00005925|Muscimol|muscimol|mesh-list
6325727|NCT00005925|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6325728|NCT00005925|GABA Agonists|gaba agonists|mesh-ancestor
6325729|NCT00005925|GABA Agents|gaba agents|mesh-ancestor
6325730|NCT00005925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6325731|NCT00005925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325732|NCT00005925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6325733|NCT00005926|Gemcitabine|gemcitabine|mesh-list
6325734|NCT00005926|Trastuzumab|trastuzumab|mesh-list
6325735|NCT00005926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6325736|NCT00005926|Antimetabolites|antimetabolites|mesh-ancestor
6325737|NCT00005926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325738|NCT00005926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325739|NCT00005926|Antiviral Agents|antiviral agents|mesh-ancestor
6325740|NCT00005926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6325741|NCT00005926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6325742|NCT00005926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6325743|NCT00005926|Immunologic Factors|immunologic factors|mesh-ancestor
6325744|NCT00005926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6325745|NCT00005926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6325746|NCT00005928|Ramipril|ramipril|mesh-list
6325747|NCT00005928|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6325748|NCT00005928|Protease Inhibitors|protease inhibitors|mesh-ancestor
6325749|NCT00005928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6325750|NCT00005928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325751|NCT00005928|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6325752|NCT00005931|Semaxinib|semaxinib|mesh-list
6325753|NCT00005931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6325754|NCT00005931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6325755|NCT00005931|Growth Substances|growth substances|mesh-ancestor
6325756|NCT00005931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6325757|NCT00005931|Growth Inhibitors|growth inhibitors|mesh-ancestor
6325758|NCT00005931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325759|NCT00005931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6325760|NCT00005931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6325761|NCT00005931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325762|NCT00005934|Azacitidine|azacitidine|mesh-list
6325763|NCT00005934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6325764|NCT00005934|Antimetabolites|antimetabolites|mesh-ancestor
6325765|NCT00005934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325766|NCT00005934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325767|NCT00005934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6325768|NCT00005935|Cyclosporine|cyclosporine|mesh-list
6325769|NCT00005935|Mycophenolic Acid|mycophenolic acid|mesh-list
6325770|NCT00005935|Cyclosporins|cyclosporins|mesh-list
6325771|NCT00005935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6325772|NCT00005935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325773|NCT00005935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6325774|NCT00005935|Immunologic Factors|immunologic factors|mesh-ancestor
6325775|NCT00005935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6325776|NCT00005935|Antifungal Agents|antifungal agents|mesh-ancestor
6325777|NCT00005935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6325778|NCT00005935|Dermatologic Agents|dermatologic agents|mesh-ancestor
6325779|NCT00005935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6325780|NCT00005935|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6325781|NCT00005935|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6325782|NCT00005935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325783|NCT00005935|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6325784|NCT00005935|Antitubercular Agents|antitubercular agents|mesh-ancestor
6325785|NCT00005935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6325786|NCT00005938|Exatecan|exatecan|mesh-list
6325787|NCT00005938|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6325788|NCT00005938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6325789|NCT00005938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6325790|NCT00005938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325791|NCT00005938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6393042|NCT00198614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6393043|NCT00198614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6393044|NCT00198614|Sympatholytics|sympatholytics|mesh-ancestor
6393045|NCT00198614|Autonomic Agents|autonomic agents|mesh-ancestor
6393046|NCT00198614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6393047|NCT00198614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6393048|NCT00198614|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6393049|NCT00198614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6393050|NCT00198614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6393051|NCT00198614|Adrenergic Agents|adrenergic agents|mesh-ancestor
6393052|NCT00198614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6393053|NCT00198614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393054|NCT00198614|Antioxidants|antioxidants|mesh-ancestor
6393055|NCT00198614|Protective Agents|protective agents|mesh-ancestor
6393056|NCT00198614|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6393057|NCT00198614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6393058|NCT00198614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6393059|NCT00198614|Vasodilator Agents|vasodilator agents|mesh-ancestor
6393060|NCT00198614|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6393061|NCT00198614|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6393062|NCT00198627|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6393063|NCT00198627|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6393064|NCT00198627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6393065|NCT00198627|Renal Agents|renal agents|mesh-ancestor
6393066|NCT00198627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6393067|NCT00198627|Antimalarials|antimalarials|mesh-ancestor
6393068|NCT00198627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6393069|NCT00198627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6393070|NCT00198640|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6393071|NCT00198640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6393072|NCT00198679|Chlorhexidine|chlorhexidine|mesh-list
6393073|NCT00198679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6393074|NCT00198679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6393075|NCT00198679|Disinfectants|disinfectants|mesh-ancestor
6393076|NCT00198718|Vitamin A|vitamin a|mesh-list
6393077|NCT00198718|Retinol palmitate|retinol palmitate|mesh-list
6393078|NCT00198718|Vitamins|vitamins|mesh-ancestor
6393079|NCT00198718|Micronutrients|micronutrients|mesh-ancestor
6393080|NCT00198718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6393081|NCT00198718|Antioxidants|antioxidants|mesh-ancestor
6393082|NCT00198718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393083|NCT00198718|Protective Agents|protective agents|mesh-ancestor
6393084|NCT00198718|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6393085|NCT00198718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6393086|NCT00198848|Folic Acid|folic acid|mesh-list
6393087|NCT00198848|Hematinics|hematinics|mesh-ancestor
6393088|NCT00198848|Vitamin B Complex|vitamin b complex|mesh-ancestor
6325792|NCT00005940|Iodine|iodine|mesh-list
6325793|NCT00005940|Cyclosporine|cyclosporine|mesh-list
6325794|NCT00005940|Cyclophosphamide|cyclophosphamide|mesh-list
6325795|NCT00005940|Busulfan|busulfan|mesh-list
6325796|NCT00005940|Methotrexate|methotrexate|mesh-list
6325797|NCT00005940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6325798|NCT00005940|Cyclosporins|cyclosporins|mesh-list
6325799|NCT00005940|Antibodies|antibodies|mesh-list
6325800|NCT00005940|Immunoglobulins|immunoglobulins|mesh-list
6325801|NCT00005940|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6325802|NCT00005940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6325803|NCT00005940|Immunologic Factors|immunologic factors|mesh-ancestor
6325804|NCT00005940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6325805|NCT00005940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6325806|NCT00005940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6325807|NCT00005940|Alkylating Agents|alkylating agents|mesh-ancestor
6325808|NCT00005940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325809|NCT00005940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325810|NCT00005940|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6325811|NCT00005940|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6325812|NCT00005940|Abortifacient Agents|abortifacient agents|mesh-ancestor
6325813|NCT00005940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6325814|NCT00005940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6325815|NCT00005940|Antimetabolites|antimetabolites|mesh-ancestor
6325816|NCT00005940|Dermatologic Agents|dermatologic agents|mesh-ancestor
6325817|NCT00005940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6325818|NCT00005940|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6325819|NCT00005940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6325820|NCT00005940|Antifungal Agents|antifungal agents|mesh-ancestor
6325821|NCT00005940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6325822|NCT00005940|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6325823|NCT00005940|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6325824|NCT00005940|Trace Elements|trace elements|mesh-ancestor
6325825|NCT00005940|Micronutrients|micronutrients|mesh-ancestor
6325826|NCT00005941|Cyclosporine|cyclosporine|mesh-list
6325827|NCT00005941|Mycophenolic Acid|mycophenolic acid|mesh-list
6325828|NCT00005941|Fludarabine|fludarabine|mesh-list
6325829|NCT00005941|Fludarabine phosphate|fludarabine phosphate|mesh-list
6325830|NCT00005941|Cyclosporins|cyclosporins|mesh-list
6325831|NCT00005941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325832|NCT00005941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6325833|NCT00005941|Antimetabolites|antimetabolites|mesh-ancestor
6325834|NCT00005941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325835|NCT00005941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6325836|NCT00005941|Immunologic Factors|immunologic factors|mesh-ancestor
6325837|NCT00005941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6325838|NCT00005941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6325839|NCT00005941|Antifungal Agents|antifungal agents|mesh-ancestor
6325840|NCT00005941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6325841|NCT00005941|Dermatologic Agents|dermatologic agents|mesh-ancestor
6325842|NCT00005941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6325843|NCT00005941|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6325844|NCT00005941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6325845|NCT00005941|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6325846|NCT00005941|Antitubercular Agents|antitubercular agents|mesh-ancestor
6325847|NCT00005941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6325848|NCT00005942|Daunorubicin|daunorubicin|mesh-list
6325849|NCT00005942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325850|NCT00005942|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6325851|NCT00005942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325852|NCT00005942|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6325853|NCT00005942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6325854|NCT00005942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6325855|NCT00005943|Aldesleukin|aldesleukin|mesh-list
6325856|NCT00005943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325857|NCT00005943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6325858|NCT00005943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6325859|NCT00005943|Antiviral Agents|antiviral agents|mesh-ancestor
6325860|NCT00005943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6325861|NCT00005944|Leucovorin|leucovorin|mesh-list
6325862|NCT00005944|Fluorouracil|fluorouracil|mesh-list
6325863|NCT00005944|Mitomycins|mitomycins|mesh-list
6325864|NCT00005944|Mitomycin|mitomycin|mesh-list
6325865|NCT00005944|Calcium|calcium|mesh-list
6325866|NCT00005944|Levoleucovorin|levoleucovorin|mesh-list
6325867|NCT00005944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6325868|NCT00005944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6325869|NCT00005944|Antimetabolites|antimetabolites|mesh-ancestor
6325870|NCT00005944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325871|NCT00005944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6325872|NCT00005944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325873|NCT00005944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6325874|NCT00005944|Immunologic Factors|immunologic factors|mesh-ancestor
6325875|NCT00005944|Antidotes|antidotes|mesh-ancestor
6325876|NCT00005944|Protective Agents|protective agents|mesh-ancestor
6325877|NCT00005944|Vitamin B Complex|vitamin b complex|mesh-ancestor
6325878|NCT00005944|Vitamins|vitamins|mesh-ancestor
6325879|NCT00005944|Micronutrients|micronutrients|mesh-ancestor
6325880|NCT00005944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6325881|NCT00005944|Alkylating Agents|alkylating agents|mesh-ancestor
6325882|NCT00005944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6325883|NCT00005944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6325884|NCT00005945|Cytarabine|cytarabine|mesh-list
6325885|NCT00005945|Dexamethasone|dexamethasone|mesh-list
6325886|NCT00005945|Cyclophosphamide|cyclophosphamide|mesh-list
6325887|NCT00005945|Doxorubicin|doxorubicin|mesh-list
6325888|NCT00005945|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6325889|NCT00005945|Methotrexate|methotrexate|mesh-list
6325890|NCT00005945|Vincristine|vincristine|mesh-list
6325891|NCT00005945|Daunorubicin|daunorubicin|mesh-list
6325892|NCT00005945|Asparaginase|asparaginase|mesh-list
6325893|NCT00005945|Mercaptopurine|mercaptopurine|mesh-list
6325894|NCT00005945|Pegaspargase|pegaspargase|mesh-list
6325895|NCT00005945|Thioguanine|thioguanine|mesh-list
6325896|NCT00005945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6325897|NCT00005945|Immunologic Factors|immunologic factors|mesh-ancestor
6325898|NCT00005945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6325899|NCT00005945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6325900|NCT00005945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6325901|NCT00005945|Alkylating Agents|alkylating agents|mesh-ancestor
6325902|NCT00005945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325903|NCT00005945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325904|NCT00005945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6325905|NCT00005945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6325906|NCT00005945|Antiemetics|antiemetics|mesh-ancestor
6325907|NCT00005945|Autonomic Agents|autonomic agents|mesh-ancestor
6325908|NCT00005945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6325909|NCT00005945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6325910|NCT00005945|Glucocorticoids|glucocorticoids|mesh-ancestor
6325911|NCT00005945|Hormones|hormones|mesh-ancestor
6325912|NCT00005945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6325913|NCT00005945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6325914|NCT00005945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6325915|NCT00005945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6325916|NCT00005945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6325917|NCT00005945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6325918|NCT00005945|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6325919|NCT00005945|Abortifacient Agents|abortifacient agents|mesh-ancestor
6325920|NCT00005945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6325921|NCT00005945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6325922|NCT00005945|Antimetabolites|antimetabolites|mesh-ancestor
6325923|NCT00005945|Dermatologic Agents|dermatologic agents|mesh-ancestor
6325924|NCT00005945|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6325925|NCT00005945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6325926|NCT00005945|Antiviral Agents|antiviral agents|mesh-ancestor
6325927|NCT00005945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6325928|NCT00005945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6325929|NCT00005945|Tubulin Modulators|tubulin modulators|mesh-ancestor
6325930|NCT00005945|Antimitotic Agents|antimitotic agents|mesh-ancestor
6325931|NCT00005945|Mitosis Modulators|mitosis modulators|mesh-ancestor
6325932|NCT00005946|Cyclophosphamide|cyclophosphamide|mesh-list
6325933|NCT00005946|Etoposide|etoposide|mesh-list
6325934|NCT00005946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6325935|NCT00005946|Immunologic Factors|immunologic factors|mesh-ancestor
6325936|NCT00005946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6325937|NCT00005946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6325938|NCT00005946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6325939|NCT00005946|Alkylating Agents|alkylating agents|mesh-ancestor
6325940|NCT00005946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325941|NCT00005946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325942|NCT00005946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6325943|NCT00005946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6325944|NCT00005946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6325945|NCT00005946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6325946|NCT00005946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6325947|NCT00005948|Interferons|interferons|mesh-list
6325948|NCT00005948|Interferon-alpha|interferon-alpha|mesh-list
6325949|NCT00005948|Aldesleukin|aldesleukin|mesh-list
6325950|NCT00005948|Busulfan|busulfan|mesh-list
6325951|NCT00005948|Sargramostim|sargramostim|mesh-list
6325952|NCT00005948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325953|NCT00005948|Antiviral Agents|antiviral agents|mesh-ancestor
6325954|NCT00005948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6325955|NCT00005948|Immunologic Factors|immunologic factors|mesh-ancestor
6325956|NCT00005948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6325957|NCT00005948|Alkylating Agents|alkylating agents|mesh-ancestor
6325958|NCT00005948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325959|NCT00005948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6325960|NCT00005948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6325961|NCT00005948|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6325962|NCT00005948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6325963|NCT00005948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6325964|NCT00005949|Aldesleukin|aldesleukin|mesh-list
6325965|NCT00005949|Interleukin-2|interleukin-2|mesh-list
6325966|NCT00005949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325967|NCT00005949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6325968|NCT00005949|Analgesics|analgesics|mesh-ancestor
6325969|NCT00005949|Sensory System Agents|sensory system agents|mesh-ancestor
6325970|NCT00005949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6325971|NCT00005949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6325972|NCT00005949|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6325973|NCT00005949|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6325974|NCT00005949|Antiviral Agents|antiviral agents|mesh-ancestor
6325975|NCT00005949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6325976|NCT00005951|Irinotecan|irinotecan|mesh-list
6325977|NCT00005951|Temozolomide|temozolomide|mesh-list
6325978|NCT00005951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6325979|NCT00005951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6325980|NCT00005951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6325981|NCT00005951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325982|NCT00005951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325983|NCT00005951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6325984|NCT00005951|Alkylating Agents|alkylating agents|mesh-ancestor
6325985|NCT00005952|Temozolomide|temozolomide|mesh-list
6325986|NCT00005952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6325987|NCT00005952|Alkylating Agents|alkylating agents|mesh-ancestor
6325988|NCT00005952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325989|NCT00005952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325990|NCT00005954|Temozolomide|temozolomide|mesh-list
6325991|NCT00005954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6325992|NCT00005954|Alkylating Agents|alkylating agents|mesh-ancestor
6325993|NCT00005954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325994|NCT00005954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6325995|NCT00005955|Temozolomide|temozolomide|mesh-list
6325996|NCT00005955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6325997|NCT00005955|Alkylating Agents|alkylating agents|mesh-ancestor
6325998|NCT00005955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6325999|NCT00005955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326000|NCT00005958|Gemcitabine|gemcitabine|mesh-list
6326001|NCT00005958|Docetaxel|docetaxel|mesh-list
6326002|NCT00005958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6326003|NCT00005958|Antimetabolites|antimetabolites|mesh-ancestor
6326004|NCT00005958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6326005|NCT00005958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326006|NCT00005958|Antiviral Agents|antiviral agents|mesh-ancestor
6326007|NCT00005958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6326008|NCT00005958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6326009|NCT00005958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6326010|NCT00005958|Immunologic Factors|immunologic factors|mesh-ancestor
6326011|NCT00005958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6326012|NCT00005958|Tubulin Modulators|tubulin modulators|mesh-ancestor
6326013|NCT00005958|Antimitotic Agents|antimitotic agents|mesh-ancestor
6326014|NCT00005958|Mitosis Modulators|mitosis modulators|mesh-ancestor
6326015|NCT00005959|Prednisone|prednisone|mesh-list
6326016|NCT00005959|Cyclophosphamide|cyclophosphamide|mesh-list
6326017|NCT00005959|Rituximab|rituximab|mesh-list
6326018|NCT00005959|Doxorubicin|doxorubicin|mesh-list
6326019|NCT00005959|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6326020|NCT00005959|Vincristine|vincristine|mesh-list
6326021|NCT00005959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6326022|NCT00005959|Immunologic Factors|immunologic factors|mesh-ancestor
6326023|NCT00005959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6326024|NCT00005959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6326025|NCT00005959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6326026|NCT00005959|Alkylating Agents|alkylating agents|mesh-ancestor
6326027|NCT00005959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6326028|NCT00005959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326029|NCT00005959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6326030|NCT00005959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6326031|NCT00005959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6326032|NCT00005959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6326033|NCT00005959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6326034|NCT00005959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6326035|NCT00005959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6326036|NCT00005959|Glucocorticoids|glucocorticoids|mesh-ancestor
6326037|NCT00005959|Hormones|hormones|mesh-ancestor
6393089|NCT00198848|Vitamins|vitamins|mesh-ancestor
6326038|NCT00005959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6326039|NCT00005959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6326040|NCT00005959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6326041|NCT00005959|Tubulin Modulators|tubulin modulators|mesh-ancestor
6326042|NCT00005959|Antimitotic Agents|antimitotic agents|mesh-ancestor
6326043|NCT00005959|Mitosis Modulators|mitosis modulators|mesh-ancestor
6326044|NCT00005960|Cyclophosphamide|cyclophosphamide|mesh-list
6326045|NCT00005960|Docetaxel|docetaxel|mesh-list
6326046|NCT00005960|Doxorubicin|doxorubicin|mesh-list
6326047|NCT00005960|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6326048|NCT00005960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6326049|NCT00005960|Immunologic Factors|immunologic factors|mesh-ancestor
6326050|NCT00005960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6326051|NCT00005960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6326052|NCT00005960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6326053|NCT00005960|Alkylating Agents|alkylating agents|mesh-ancestor
6326054|NCT00005960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6326055|NCT00005960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326056|NCT00005960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6326057|NCT00005960|Tubulin Modulators|tubulin modulators|mesh-ancestor
6326058|NCT00005960|Antimitotic Agents|antimitotic agents|mesh-ancestor
6326059|NCT00005960|Mitosis Modulators|mitosis modulators|mesh-ancestor
6326060|NCT00005960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6326061|NCT00005960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6326062|NCT00005960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6326063|NCT00005960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6326064|NCT00005961|Carmustine|carmustine|mesh-list
6326065|NCT00005961|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
6326066|NCT00005961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6326067|NCT00005961|Alkylating Agents|alkylating agents|mesh-ancestor
6326068|NCT00005961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6326069|NCT00005961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326070|NCT00005961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6326071|NCT00005962|Cytarabine|cytarabine|mesh-list
6326072|NCT00005962|Cyclophosphamide|cyclophosphamide|mesh-list
6326073|NCT00005962|Topotecan|topotecan|mesh-list
6326074|NCT00005962|Daunorubicin|daunorubicin|mesh-list
6326075|NCT00005962|Gemtuzumab|gemtuzumab|mesh-list
6326076|NCT00005962|Sargramostim|sargramostim|mesh-list
6326077|NCT00005962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6326078|NCT00005962|Immunologic Factors|immunologic factors|mesh-ancestor
6326079|NCT00005962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6326080|NCT00005962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6326081|NCT00005962|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6326082|NCT00005962|Alkylating Agents|alkylating agents|mesh-ancestor
6326083|NCT00005962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6326084|NCT00005962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326085|NCT00005962|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6326086|NCT00005962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6326087|NCT00005962|Antimetabolites|antimetabolites|mesh-ancestor
6326088|NCT00005962|Antiviral Agents|antiviral agents|mesh-ancestor
6326089|NCT00005962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6326090|NCT00005962|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6326091|NCT00005962|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6326092|NCT00005962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6326093|NCT00005962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6326094|NCT00005962|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6326095|NCT00005962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6326096|NCT00005963|Carboplatin|carboplatin|mesh-list
6326097|NCT00005963|Docetaxel|docetaxel|mesh-list
6326098|NCT00005963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326099|NCT00005963|Tubulin Modulators|tubulin modulators|mesh-ancestor
6326100|NCT00005963|Antimitotic Agents|antimitotic agents|mesh-ancestor
6326101|NCT00005963|Mitosis Modulators|mitosis modulators|mesh-ancestor
6326102|NCT00005963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6326103|NCT00005964|Prednisone|prednisone|mesh-list
6326104|NCT00005964|Cyclophosphamide|cyclophosphamide|mesh-list
6326105|NCT00005964|Doxorubicin|doxorubicin|mesh-list
6326106|NCT00005964|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6326107|NCT00005964|Etoposide|etoposide|mesh-list
6326108|NCT00005964|Vincristine|vincristine|mesh-list
6326109|NCT00005964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6326110|NCT00005964|Immunologic Factors|immunologic factors|mesh-ancestor
6326111|NCT00005964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6326112|NCT00005964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6326113|NCT00005964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6326114|NCT00005964|Alkylating Agents|alkylating agents|mesh-ancestor
6326115|NCT00005964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6326116|NCT00005964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326117|NCT00005964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6326118|NCT00005964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6326119|NCT00005964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6326120|NCT00005964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6326121|NCT00005964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6326122|NCT00005964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6326123|NCT00005964|Glucocorticoids|glucocorticoids|mesh-ancestor
6326124|NCT00005964|Hormones|hormones|mesh-ancestor
6326125|NCT00005964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6326126|NCT00005964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6326127|NCT00005964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6326128|NCT00005964|Tubulin Modulators|tubulin modulators|mesh-ancestor
6326129|NCT00005964|Antimitotic Agents|antimitotic agents|mesh-ancestor
6326130|NCT00005964|Mitosis Modulators|mitosis modulators|mesh-ancestor
6326131|NCT00005965|Bryostatin 1|bryostatin 1|mesh-list
6393090|NCT00198848|Micronutrients|micronutrients|mesh-ancestor
6326132|NCT00005965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326133|NCT00005965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6326134|NCT00005965|Immunologic Factors|immunologic factors|mesh-ancestor
6326135|NCT00005965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6326136|NCT00005966|Interferons|interferons|mesh-list
6326137|NCT00005966|Interferon-alpha|interferon-alpha|mesh-list
6326138|NCT00005966|Thalidomide|thalidomide|mesh-list
6326139|NCT00005966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326140|NCT00005966|Antiviral Agents|antiviral agents|mesh-ancestor
6326141|NCT00005966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6326142|NCT00005966|Immunologic Factors|immunologic factors|mesh-ancestor
6326143|NCT00005966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6326144|NCT00005966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6326145|NCT00005966|Leprostatic Agents|leprostatic agents|mesh-ancestor
6326146|NCT00005966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6326147|NCT00005966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6326148|NCT00005966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6326149|NCT00005966|Growth Substances|growth substances|mesh-ancestor
6326150|NCT00005966|Growth Inhibitors|growth inhibitors|mesh-ancestor
6326151|NCT00005967|Tipifarnib|tipifarnib|mesh-list
6326152|NCT00005967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326153|NCT00005968|Irofulven|irofulven|mesh-list
6326154|NCT00005968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6326155|NCT00005968|Alkylating Agents|alkylating agents|mesh-ancestor
6326156|NCT00005968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6326157|NCT00005968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326158|NCT00005969|Tretinoin|tretinoin|mesh-list
6326159|NCT00005969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326160|NCT00005969|Keratolytic Agents|keratolytic agents|mesh-ancestor
6326161|NCT00005969|Dermatologic Agents|dermatologic agents|mesh-ancestor
6326162|NCT00005970|Tamoxifen|tamoxifen|mesh-list
6326163|NCT00005970|Paclitaxel|paclitaxel|mesh-list
6326164|NCT00005970|Cyclophosphamide|cyclophosphamide|mesh-list
6326165|NCT00005970|Doxorubicin|doxorubicin|mesh-list
6326166|NCT00005970|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6326167|NCT00005970|Trastuzumab|trastuzumab|mesh-list
6326168|NCT00005970|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6326169|NCT00005970|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
6326170|NCT00005970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6326171|NCT00005970|Antibodies|antibodies|mesh-list
6326172|NCT00005970|Immunoglobulins|immunoglobulins|mesh-list
6326173|NCT00005970|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6326174|NCT00005970|Aromatase Inhibitors|aromatase inhibitors|mesh-list
6326175|NCT00005970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6326176|NCT00005970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326177|NCT00005970|Tubulin Modulators|tubulin modulators|mesh-ancestor
6326178|NCT00005970|Antimitotic Agents|antimitotic agents|mesh-ancestor
6326179|NCT00005970|Mitosis Modulators|mitosis modulators|mesh-ancestor
6326180|NCT00005970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6326181|NCT00005970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6326182|NCT00005970|Immunologic Factors|immunologic factors|mesh-ancestor
6326183|NCT00005970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6326184|NCT00005970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6326185|NCT00005970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6326186|NCT00005970|Alkylating Agents|alkylating agents|mesh-ancestor
6326187|NCT00005970|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6326188|NCT00005970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6326189|NCT00005970|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6326190|NCT00005970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6326191|NCT00005970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6326192|NCT00005970|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6326193|NCT00005970|Hormone Antagonists|hormone antagonists|mesh-ancestor
6326194|NCT00005970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6326195|NCT00005970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6326196|NCT00005970|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6326197|NCT00005970|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6326198|NCT00005970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6326199|NCT00005970|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6326200|NCT00005971|Alvocidib|alvocidib|mesh-list
6326201|NCT00005971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326202|NCT00005971|Growth Inhibitors|growth inhibitors|mesh-ancestor
6326203|NCT00005971|Growth Substances|growth substances|mesh-ancestor
6326204|NCT00005971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6326205|NCT00005971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6326206|NCT00005971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6326207|NCT00005971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6326208|NCT00005972|Gemcitabine|gemcitabine|mesh-list
6326209|NCT00005972|Irinotecan|irinotecan|mesh-list
6326210|NCT00005972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6326211|NCT00005972|Antimetabolites|antimetabolites|mesh-ancestor
6326212|NCT00005972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6326213|NCT00005972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326214|NCT00005972|Antiviral Agents|antiviral agents|mesh-ancestor
6326215|NCT00005972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6326216|NCT00005972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6326217|NCT00005972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6326218|NCT00005972|Immunologic Factors|immunologic factors|mesh-ancestor
6326219|NCT00005972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6326220|NCT00005972|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6326221|NCT00005972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6326222|NCT00005974|Alvocidib|alvocidib|mesh-list
6326223|NCT00005974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326224|NCT00005974|Growth Inhibitors|growth inhibitors|mesh-ancestor
6326225|NCT00005974|Growth Substances|growth substances|mesh-ancestor
6326226|NCT00005974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6326227|NCT00005974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6326228|NCT00005974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6326229|NCT00005974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6326230|NCT00005975|Megestrol|megestrol|mesh-list
6326231|NCT00005975|Megestrol Acetate|megestrol acetate|mesh-list
6326232|NCT00005975|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6326233|NCT00005975|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6326234|NCT00005975|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6326235|NCT00005975|Contraceptive Agents|contraceptive agents|mesh-ancestor
6326236|NCT00005975|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6326237|NCT00005975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6326238|NCT00005975|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6326239|NCT00005975|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6326240|NCT00005975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6326241|NCT00005975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326242|NCT00005975|Appetite Stimulants|appetite stimulants|mesh-ancestor
6326243|NCT00005975|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6326244|NCT00005976|Carboplatin|carboplatin|mesh-list
6326245|NCT00005976|NSC 366140|nsc 366140|mesh-list
6326246|NCT00005976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326247|NCT00005977|Leucovorin|leucovorin|mesh-list
6326248|NCT00005977|Cytarabine|cytarabine|mesh-list
6326249|NCT00005977|Dexamethasone|dexamethasone|mesh-list
6326250|NCT00005977|Cyclophosphamide|cyclophosphamide|mesh-list
6326251|NCT00005977|Ifosfamide|ifosfamide|mesh-list
6326252|NCT00005977|Doxorubicin|doxorubicin|mesh-list
6326253|NCT00005977|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6326254|NCT00005977|Methotrexate|methotrexate|mesh-list
6326255|NCT00005977|Etoposide|etoposide|mesh-list
6326256|NCT00005977|Vincristine|vincristine|mesh-list
6326257|NCT00005977|Lenograstim|lenograstim|mesh-list
6326258|NCT00005977|Levoleucovorin|levoleucovorin|mesh-list
6326259|NCT00005977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6326260|NCT00005977|Immunologic Factors|immunologic factors|mesh-ancestor
6326261|NCT00005977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6326262|NCT00005977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6326263|NCT00005977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6326264|NCT00005977|Alkylating Agents|alkylating agents|mesh-ancestor
6326265|NCT00005977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6326266|NCT00005977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326267|NCT00005977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6326268|NCT00005977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6326269|NCT00005977|Antiemetics|antiemetics|mesh-ancestor
6326270|NCT00005977|Autonomic Agents|autonomic agents|mesh-ancestor
6326271|NCT00005977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6326272|NCT00005977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6326273|NCT00005977|Glucocorticoids|glucocorticoids|mesh-ancestor
6326274|NCT00005977|Hormones|hormones|mesh-ancestor
6326275|NCT00005977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6326276|NCT00005977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6326277|NCT00005977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6326278|NCT00005977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6326279|NCT00005977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6326280|NCT00005977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6326281|NCT00005977|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6326282|NCT00005977|Abortifacient Agents|abortifacient agents|mesh-ancestor
6326283|NCT00005977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6326284|NCT00005977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6326285|NCT00005977|Antimetabolites|antimetabolites|mesh-ancestor
6326286|NCT00005977|Dermatologic Agents|dermatologic agents|mesh-ancestor
6326287|NCT00005977|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6326288|NCT00005977|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6326289|NCT00005977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6326290|NCT00005977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6326291|NCT00005977|Antiviral Agents|antiviral agents|mesh-ancestor
6326292|NCT00005977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6326293|NCT00005977|Antidotes|antidotes|mesh-ancestor
6326294|NCT00005977|Protective Agents|protective agents|mesh-ancestor
6326295|NCT00005977|Vitamin B Complex|vitamin b complex|mesh-ancestor
6326296|NCT00005977|Vitamins|vitamins|mesh-ancestor
6326297|NCT00005977|Micronutrients|micronutrients|mesh-ancestor
6326298|NCT00005977|Tubulin Modulators|tubulin modulators|mesh-ancestor
6326299|NCT00005977|Antimitotic Agents|antimitotic agents|mesh-ancestor
6326300|NCT00005977|Mitosis Modulators|mitosis modulators|mesh-ancestor
6326301|NCT00005978|Carboplatin|carboplatin|mesh-list
6326302|NCT00005978|Etoposide|etoposide|mesh-list
6326303|NCT00005978|Melphalan|melphalan|mesh-list
6326304|NCT00005978|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
6326305|NCT00005978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326306|NCT00005978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6326307|NCT00005978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6326308|NCT00005978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6326309|NCT00005978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6326310|NCT00005978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6326311|NCT00005978|Immunologic Factors|immunologic factors|mesh-ancestor
6326312|NCT00005978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6326313|NCT00005978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6326314|NCT00005978|Alkylating Agents|alkylating agents|mesh-ancestor
6326315|NCT00005978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6326316|NCT00005978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6326317|NCT00005978|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6326318|NCT00005979|Leucovorin|leucovorin|mesh-list
6326319|NCT00005979|Fluorouracil|fluorouracil|mesh-list
6326320|NCT00005979|Irinotecan|irinotecan|mesh-list
6326321|NCT00005979|Calcium|calcium|mesh-list
6326322|NCT00005979|Levoleucovorin|levoleucovorin|mesh-list
6326323|NCT00005979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6326324|NCT00005979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6326325|NCT00005979|Antimetabolites|antimetabolites|mesh-ancestor
6326326|NCT00005979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6326327|NCT00005979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6326328|NCT00005979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326329|NCT00005979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6326330|NCT00005979|Immunologic Factors|immunologic factors|mesh-ancestor
6326331|NCT00005979|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6326332|NCT00005979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6326333|NCT00005979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6326334|NCT00005979|Antidotes|antidotes|mesh-ancestor
6326335|NCT00005979|Protective Agents|protective agents|mesh-ancestor
6326336|NCT00005979|Vitamin B Complex|vitamin b complex|mesh-ancestor
6326337|NCT00005979|Vitamins|vitamins|mesh-ancestor
6326338|NCT00005979|Micronutrients|micronutrients|mesh-ancestor
6326339|NCT00005980|Doxorubicin|doxorubicin|mesh-list
6326340|NCT00005980|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6326341|NCT00005980|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6326342|NCT00005980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326343|NCT00005980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6326344|NCT00005980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6326345|NCT00005980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6326346|NCT00005980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6326347|NCT00005981|Carmustine|carmustine|mesh-list
6326348|NCT00005981|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
6326349|NCT00005981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6326350|NCT00005981|Alkylating Agents|alkylating agents|mesh-ancestor
6326351|NCT00005981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6326352|NCT00005981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326353|NCT00005981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6326354|NCT00005984|Interferons|interferons|mesh-list
6326355|NCT00005984|Interferon-alpha|interferon-alpha|mesh-list
6326356|NCT00005984|Cyclophosphamide|cyclophosphamide|mesh-list
6326357|NCT00005984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6326358|NCT00005984|Immunologic Factors|immunologic factors|mesh-ancestor
6326359|NCT00005984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6326360|NCT00005984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6326361|NCT00005984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6326362|NCT00005984|Alkylating Agents|alkylating agents|mesh-ancestor
6326363|NCT00005984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6326364|NCT00005984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326365|NCT00005984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6326366|NCT00005984|Antiviral Agents|antiviral agents|mesh-ancestor
6326367|NCT00005984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6326368|NCT00005985|Cytarabine|cytarabine|mesh-list
6326369|NCT00005985|Dexamethasone|dexamethasone|mesh-list
6326370|NCT00005985|Cyclophosphamide|cyclophosphamide|mesh-list
6326371|NCT00005985|Carmustine|carmustine|mesh-list
6326372|NCT00005985|Etoposide|etoposide|mesh-list
6326373|NCT00005985|Mitoxantrone|mitoxantrone|mesh-list
6326374|NCT00005985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6326375|NCT00005985|Immunologic Factors|immunologic factors|mesh-ancestor
6326376|NCT00005985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6326377|NCT00005985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6326378|NCT00005985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6326379|NCT00005985|Alkylating Agents|alkylating agents|mesh-ancestor
6326380|NCT00005985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6326381|NCT00005985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326382|NCT00005985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6326383|NCT00005985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6326384|NCT00005985|Antiemetics|antiemetics|mesh-ancestor
6326385|NCT00005985|Autonomic Agents|autonomic agents|mesh-ancestor
6326386|NCT00005985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6326387|NCT00005985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6326388|NCT00005985|Glucocorticoids|glucocorticoids|mesh-ancestor
6326389|NCT00005985|Hormones|hormones|mesh-ancestor
6326390|NCT00005985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6326391|NCT00005985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6326392|NCT00005985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6326393|NCT00005985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6326394|NCT00005985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6326395|NCT00005985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6326396|NCT00005985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6326397|NCT00005985|Antimetabolites|antimetabolites|mesh-ancestor
6326398|NCT00005985|Antiviral Agents|antiviral agents|mesh-ancestor
6326399|NCT00005985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6326400|NCT00005985|Analgesics|analgesics|mesh-ancestor
6326401|NCT00005985|Sensory System Agents|sensory system agents|mesh-ancestor
6326402|NCT00005986|Interferons|interferons|mesh-list
6326403|NCT00005986|Interferon-alpha|interferon-alpha|mesh-list
6326404|NCT00005986|Cyclophosphamide|cyclophosphamide|mesh-list
6326405|NCT00005986|Busulfan|busulfan|mesh-list
6326406|NCT00005986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6326407|NCT00005986|Immunologic Factors|immunologic factors|mesh-ancestor
6326408|NCT00005986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6326409|NCT00005986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6326410|NCT00005986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6326411|NCT00005986|Alkylating Agents|alkylating agents|mesh-ancestor
6326412|NCT00005986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6326413|NCT00005986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326414|NCT00005986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6326415|NCT00005986|Antiviral Agents|antiviral agents|mesh-ancestor
6326416|NCT00005986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6326417|NCT00005987|Interferons|interferons|mesh-list
6326418|NCT00005987|Interferon-alpha|interferon-alpha|mesh-list
6326419|NCT00005987|Dexamethasone|dexamethasone|mesh-list
6326420|NCT00005987|Cyclophosphamide|cyclophosphamide|mesh-list
6326421|NCT00005987|Carmustine|carmustine|mesh-list
6326422|NCT00005987|Etoposide|etoposide|mesh-list
6326423|NCT00005987|Mitoxantrone|mitoxantrone|mesh-list
6326424|NCT00005987|Sargramostim|sargramostim|mesh-list
6326425|NCT00005987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6326426|NCT00005987|Immunologic Factors|immunologic factors|mesh-ancestor
6326427|NCT00005987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6326428|NCT00005987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6326429|NCT00005987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6326430|NCT00005987|Alkylating Agents|alkylating agents|mesh-ancestor
6326431|NCT00005987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6326432|NCT00005987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326433|NCT00005987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6326434|NCT00005987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6326435|NCT00005987|Antiemetics|antiemetics|mesh-ancestor
6326436|NCT00005987|Autonomic Agents|autonomic agents|mesh-ancestor
6326437|NCT00005987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6326438|NCT00005987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6326439|NCT00005987|Glucocorticoids|glucocorticoids|mesh-ancestor
6326440|NCT00005987|Hormones|hormones|mesh-ancestor
6326441|NCT00005987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6326442|NCT00005987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6326443|NCT00005987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6326444|NCT00005987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6326445|NCT00005987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6326446|NCT00005987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6326447|NCT00005987|Antiviral Agents|antiviral agents|mesh-ancestor
6326448|NCT00005987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6326449|NCT00005987|Analgesics|analgesics|mesh-ancestor
6326450|NCT00005987|Sensory System Agents|sensory system agents|mesh-ancestor
6326451|NCT00005988|Leucovorin|leucovorin|mesh-list
6326452|NCT00005988|Cyclosporine|cyclosporine|mesh-list
6326453|NCT00005988|Methylprednisolone|methylprednisolone|mesh-list
6326454|NCT00005988|Cyclophosphamide|cyclophosphamide|mesh-list
6326455|NCT00005988|Methotrexate|methotrexate|mesh-list
6326456|NCT00005988|Cyclosporins|cyclosporins|mesh-list
6326457|NCT00005988|Levoleucovorin|levoleucovorin|mesh-list
6326458|NCT00005988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6326459|NCT00005988|Immunologic Factors|immunologic factors|mesh-ancestor
6326460|NCT00005988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6326461|NCT00005988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6326462|NCT00005988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6326463|NCT00005988|Alkylating Agents|alkylating agents|mesh-ancestor
6326464|NCT00005988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6326465|NCT00005988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326466|NCT00005988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6326467|NCT00005988|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6326468|NCT00005988|Abortifacient Agents|abortifacient agents|mesh-ancestor
6326469|NCT00005988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6326470|NCT00005988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6326471|NCT00005988|Antimetabolites|antimetabolites|mesh-ancestor
6326472|NCT00005988|Dermatologic Agents|dermatologic agents|mesh-ancestor
6326473|NCT00005988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6326474|NCT00005988|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6326475|NCT00005988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6326476|NCT00005988|Antidotes|antidotes|mesh-ancestor
6326477|NCT00005988|Protective Agents|protective agents|mesh-ancestor
6326478|NCT00005988|Vitamin B Complex|vitamin b complex|mesh-ancestor
6326479|NCT00005988|Vitamins|vitamins|mesh-ancestor
6326480|NCT00005988|Micronutrients|micronutrients|mesh-ancestor
6326481|NCT00005988|Antifungal Agents|antifungal agents|mesh-ancestor
6326482|NCT00005988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6326483|NCT00005988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6326484|NCT00005988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6326485|NCT00005988|Antiemetics|antiemetics|mesh-ancestor
6326486|NCT00005988|Autonomic Agents|autonomic agents|mesh-ancestor
6326487|NCT00005988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6326488|NCT00005988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6326489|NCT00005988|Glucocorticoids|glucocorticoids|mesh-ancestor
6326490|NCT00005988|Hormones|hormones|mesh-ancestor
6326491|NCT00005988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6326492|NCT00005988|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6326493|NCT00005989|Tipifarnib|tipifarnib|mesh-list
6326494|NCT00005989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326495|NCT00005990|Topotecan|topotecan|mesh-list
6326496|NCT00005990|Tipifarnib|tipifarnib|mesh-list
6326497|NCT00005990|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6326498|NCT00005990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6326499|NCT00005990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6326500|NCT00005990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6326501|NCT00005990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326502|NCT00005991|Gemcitabine|gemcitabine|mesh-list
6326503|NCT00005991|Doxorubicin|doxorubicin|mesh-list
6326504|NCT00005991|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6326505|NCT00005991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6326506|NCT00005991|Antimetabolites|antimetabolites|mesh-ancestor
6326507|NCT00005991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6326508|NCT00005991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326509|NCT00005991|Antiviral Agents|antiviral agents|mesh-ancestor
6326510|NCT00005991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6326511|NCT00005991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6326512|NCT00005991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6326513|NCT00005991|Immunologic Factors|immunologic factors|mesh-ancestor
6326514|NCT00005991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6326515|NCT00005991|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6326516|NCT00005991|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6326517|NCT00005991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6326518|NCT00005993|Aldesleukin|aldesleukin|mesh-list
6326519|NCT00005993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326520|NCT00005993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6326521|NCT00005993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6326522|NCT00005993|Antiviral Agents|antiviral agents|mesh-ancestor
6326523|NCT00005993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6326524|NCT00005994|Ondansetron|ondansetron|mesh-list
6326525|NCT00005994|Antiemetics|antiemetics|mesh-ancestor
6326526|NCT00005994|Autonomic Agents|autonomic agents|mesh-ancestor
6326527|NCT00005994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6326528|NCT00005994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6326529|NCT00005994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6326530|NCT00005994|Antipruritics|antipruritics|mesh-ancestor
6326531|NCT00005994|Dermatologic Agents|dermatologic agents|mesh-ancestor
6326532|NCT00005994|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6326533|NCT00005994|Serotonin Agents|serotonin agents|mesh-ancestor
6326534|NCT00005994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6326535|NCT00005994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6326536|NCT00005994|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6326537|NCT00005994|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6326538|NCT00005994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6326539|NCT00005994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6326540|NCT00005994|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6326541|NCT00005996|Gemcitabine|gemcitabine|mesh-list
6326542|NCT00005996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326543|NCT00005996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6326544|NCT00005996|Antimetabolites|antimetabolites|mesh-ancestor
6326545|NCT00005996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6326546|NCT00005996|Antiviral Agents|antiviral agents|mesh-ancestor
6326547|NCT00005996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6326548|NCT00005996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6326549|NCT00005996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6326550|NCT00005996|Immunologic Factors|immunologic factors|mesh-ancestor
6326551|NCT00005996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6326552|NCT00005998|Cytarabine|cytarabine|mesh-list
6326553|NCT00005998|Dexamethasone|dexamethasone|mesh-list
6326554|NCT00005998|Cyclophosphamide|cyclophosphamide|mesh-list
6326555|NCT00005998|Carmustine|carmustine|mesh-list
6326556|NCT00005998|Etoposide|etoposide|mesh-list
6326557|NCT00005998|Mitoxantrone|mitoxantrone|mesh-list
6326558|NCT00005998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6326559|NCT00005998|Immunologic Factors|immunologic factors|mesh-ancestor
6326560|NCT00005998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6326561|NCT00005998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6326562|NCT00005998|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6326563|NCT00005998|Alkylating Agents|alkylating agents|mesh-ancestor
6326564|NCT00005998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6326565|NCT00005998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326566|NCT00005998|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6326567|NCT00005998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6326568|NCT00005998|Antiemetics|antiemetics|mesh-ancestor
6326569|NCT00005998|Autonomic Agents|autonomic agents|mesh-ancestor
6326570|NCT00005998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6326571|NCT00005998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6326572|NCT00005998|Glucocorticoids|glucocorticoids|mesh-ancestor
6326573|NCT00005998|Hormones|hormones|mesh-ancestor
6326574|NCT00005998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6326575|NCT00005998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6326576|NCT00005998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6326577|NCT00005998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6326578|NCT00005998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6326579|NCT00005998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6326580|NCT00005998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6326581|NCT00005998|Antimetabolites|antimetabolites|mesh-ancestor
6326582|NCT00005998|Antiviral Agents|antiviral agents|mesh-ancestor
6326583|NCT00005998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6326584|NCT00005998|Analgesics|analgesics|mesh-ancestor
6326585|NCT00005998|Sensory System Agents|sensory system agents|mesh-ancestor
6326586|NCT00005999|Arsenic Trioxide|arsenic trioxide|mesh-list
6326587|NCT00005999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326588|NCT00006000|Irinotecan|irinotecan|mesh-list
6326589|NCT00006000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326590|NCT00006000|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6326591|NCT00006000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6326592|NCT00006000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6326593|NCT00006000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6326594|NCT00006001|Semaxinib|semaxinib|mesh-list
6326595|NCT00006001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6326596|NCT00006001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6326597|NCT00006001|Growth Substances|growth substances|mesh-ancestor
6326598|NCT00006001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6326599|NCT00006001|Growth Inhibitors|growth inhibitors|mesh-ancestor
6326600|NCT00006001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326601|NCT00006001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6326602|NCT00006001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6326603|NCT00006001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6326604|NCT00006002|Dexamethasone|dexamethasone|mesh-list
6326605|NCT00006002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6326606|NCT00006002|Antiemetics|antiemetics|mesh-ancestor
6326607|NCT00006002|Autonomic Agents|autonomic agents|mesh-ancestor
6326608|NCT00006002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6326609|NCT00006002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6326610|NCT00006002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6326611|NCT00006002|Glucocorticoids|glucocorticoids|mesh-ancestor
6326612|NCT00006002|Hormones|hormones|mesh-ancestor
6326613|NCT00006002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6326614|NCT00006002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6326615|NCT00006002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326616|NCT00006003|Semaxinib|semaxinib|mesh-list
6326617|NCT00006003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6326618|NCT00006003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6326619|NCT00006003|Growth Substances|growth substances|mesh-ancestor
6326620|NCT00006003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6326621|NCT00006003|Growth Inhibitors|growth inhibitors|mesh-ancestor
6326622|NCT00006003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326623|NCT00006003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6326624|NCT00006003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6326625|NCT00006003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6326626|NCT00006004|Gemcitabine|gemcitabine|mesh-list
6326627|NCT00006004|Paclitaxel|paclitaxel|mesh-list
6326628|NCT00006004|Carboplatin|carboplatin|mesh-list
6326629|NCT00006004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6326630|NCT00006004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326631|NCT00006004|Tubulin Modulators|tubulin modulators|mesh-ancestor
6326632|NCT00006004|Antimitotic Agents|antimitotic agents|mesh-ancestor
6326633|NCT00006004|Mitosis Modulators|mitosis modulators|mesh-ancestor
6326634|NCT00006004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6326635|NCT00006004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6326636|NCT00006004|Antimetabolites|antimetabolites|mesh-ancestor
6326637|NCT00006004|Antiviral Agents|antiviral agents|mesh-ancestor
6326638|NCT00006004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6326639|NCT00006004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6326640|NCT00006004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6326641|NCT00006004|Immunologic Factors|immunologic factors|mesh-ancestor
6326642|NCT00006004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6326643|NCT00006005|Thalidomide|thalidomide|mesh-list
6326644|NCT00006005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6326645|NCT00006005|Immunologic Factors|immunologic factors|mesh-ancestor
6326646|NCT00006005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6326647|NCT00006005|Leprostatic Agents|leprostatic agents|mesh-ancestor
6326648|NCT00006005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6326649|NCT00006005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6326650|NCT00006005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6326651|NCT00006005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6326652|NCT00006005|Growth Substances|growth substances|mesh-ancestor
6326653|NCT00006005|Growth Inhibitors|growth inhibitors|mesh-ancestor
6326654|NCT00006005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326655|NCT00006006|Interferons|interferons|mesh-list
6326656|NCT00006006|Interferon-alpha|interferon-alpha|mesh-list
6326657|NCT00006006|Thalidomide|thalidomide|mesh-list
6326658|NCT00006006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326659|NCT00006006|Antiviral Agents|antiviral agents|mesh-ancestor
6326660|NCT00006006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6326661|NCT00006006|Immunologic Factors|immunologic factors|mesh-ancestor
6326662|NCT00006006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6326663|NCT00006006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6326664|NCT00006006|Leprostatic Agents|leprostatic agents|mesh-ancestor
6326665|NCT00006006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6326666|NCT00006006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6326667|NCT00006006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6326668|NCT00006006|Growth Substances|growth substances|mesh-ancestor
6326669|NCT00006006|Growth Inhibitors|growth inhibitors|mesh-ancestor
6326670|NCT00006007|Gemcitabine|gemcitabine|mesh-list
6326671|NCT00006007|Pemetrexed|pemetrexed|mesh-list
6326672|NCT00006007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6326673|NCT00006007|Antimetabolites|antimetabolites|mesh-ancestor
6326674|NCT00006007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6326675|NCT00006007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326676|NCT00006007|Antiviral Agents|antiviral agents|mesh-ancestor
6326677|NCT00006007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6326678|NCT00006007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6326679|NCT00006007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6326680|NCT00006007|Immunologic Factors|immunologic factors|mesh-ancestor
6326681|NCT00006007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6326682|NCT00006007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6326683|NCT00006007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6326684|NCT00006008|Arsenic Trioxide|arsenic trioxide|mesh-list
6326685|NCT00006008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326686|NCT00006009|Visilizumab|visilizumab|mesh-list
6326687|NCT00006009|Immunologic Factors|immunologic factors|mesh-ancestor
6326688|NCT00006009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6326689|NCT00006010|Gemcitabine|gemcitabine|mesh-list
6326690|NCT00006010|Docetaxel|docetaxel|mesh-list
6326691|NCT00006010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6326692|NCT00006010|Antimetabolites|antimetabolites|mesh-ancestor
6326693|NCT00006010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6326694|NCT00006010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326695|NCT00006010|Antiviral Agents|antiviral agents|mesh-ancestor
6326696|NCT00006010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6326697|NCT00006010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6326698|NCT00006010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6326699|NCT00006010|Immunologic Factors|immunologic factors|mesh-ancestor
6326700|NCT00006010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6326701|NCT00006010|Tubulin Modulators|tubulin modulators|mesh-ancestor
6326702|NCT00006010|Antimitotic Agents|antimitotic agents|mesh-ancestor
6326703|NCT00006010|Mitosis Modulators|mitosis modulators|mesh-ancestor
6326704|NCT00006012|Paclitaxel|paclitaxel|mesh-list
6326705|NCT00006012|Etoposide|etoposide|mesh-list
6326706|NCT00006012|Topotecan|topotecan|mesh-list
6326707|NCT00006012|Amifostine|amifostine|mesh-list
6326708|NCT00006012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6326709|NCT00006012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326710|NCT00006012|Tubulin Modulators|tubulin modulators|mesh-ancestor
6326711|NCT00006012|Antimitotic Agents|antimitotic agents|mesh-ancestor
6326712|NCT00006012|Mitosis Modulators|mitosis modulators|mesh-ancestor
6326713|NCT00006012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6326714|NCT00006012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6326715|NCT00006012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6326716|NCT00006012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6326717|NCT00006012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6326718|NCT00006012|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6326719|NCT00006012|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6326720|NCT00006012|Protective Agents|protective agents|mesh-ancestor
6326721|NCT00006013|Semaxinib|semaxinib|mesh-list
6326722|NCT00006013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6326723|NCT00006013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6326724|NCT00006013|Growth Substances|growth substances|mesh-ancestor
6326725|NCT00006013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6326726|NCT00006013|Growth Inhibitors|growth inhibitors|mesh-ancestor
6326727|NCT00006013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326728|NCT00006013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6326729|NCT00006013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6326730|NCT00006013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6326731|NCT00006014|Semaxinib|semaxinib|mesh-list
6326732|NCT00006014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6326733|NCT00006014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6326734|NCT00006014|Growth Substances|growth substances|mesh-ancestor
6326735|NCT00006014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6326736|NCT00006014|Growth Inhibitors|growth inhibitors|mesh-ancestor
6326737|NCT00006014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326738|NCT00006014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6326739|NCT00006014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6326740|NCT00006014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6326741|NCT00006015|Leucovorin|leucovorin|mesh-list
6326742|NCT00006015|Fluorouracil|fluorouracil|mesh-list
6326743|NCT00006015|Oxaliplatin|oxaliplatin|mesh-list
6326744|NCT00006015|Trastuzumab|trastuzumab|mesh-list
6326745|NCT00006015|Calcium|calcium|mesh-list
6326746|NCT00006015|Levoleucovorin|levoleucovorin|mesh-list
6326747|NCT00006015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6326748|NCT00006015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6326749|NCT00006015|Antimetabolites|antimetabolites|mesh-ancestor
6326750|NCT00006015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6326751|NCT00006015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6326752|NCT00006015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326753|NCT00006015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6326754|NCT00006015|Immunologic Factors|immunologic factors|mesh-ancestor
6326755|NCT00006015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6326756|NCT00006015|Antidotes|antidotes|mesh-ancestor
6326757|NCT00006015|Protective Agents|protective agents|mesh-ancestor
6326758|NCT00006015|Vitamin B Complex|vitamin b complex|mesh-ancestor
6326759|NCT00006015|Vitamins|vitamins|mesh-ancestor
6326760|NCT00006015|Micronutrients|micronutrients|mesh-ancestor
6326761|NCT00006016|Thalidomide|thalidomide|mesh-list
6326762|NCT00006016|Doxorubicin|doxorubicin|mesh-list
6326763|NCT00006016|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6326764|NCT00006016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6326765|NCT00006016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326766|NCT00006016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6326767|NCT00006016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6326768|NCT00006016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6326769|NCT00006016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6326770|NCT00006016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6326771|NCT00006016|Immunologic Factors|immunologic factors|mesh-ancestor
6326772|NCT00006016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6326773|NCT00006016|Leprostatic Agents|leprostatic agents|mesh-ancestor
6326774|NCT00006016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6326775|NCT00006016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6326776|NCT00006016|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6326777|NCT00006016|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6326778|NCT00006016|Growth Substances|growth substances|mesh-ancestor
6326779|NCT00006016|Growth Inhibitors|growth inhibitors|mesh-ancestor
6326780|NCT00006018|Paclitaxel|paclitaxel|mesh-list
6326781|NCT00006018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6326782|NCT00006018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326783|NCT00006018|Tubulin Modulators|tubulin modulators|mesh-ancestor
6326784|NCT00006018|Antimitotic Agents|antimitotic agents|mesh-ancestor
6326785|NCT00006018|Mitosis Modulators|mitosis modulators|mesh-ancestor
6326786|NCT00006018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6326787|NCT00006019|Azacitidine|azacitidine|mesh-list
6326788|NCT00006019|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
6326789|NCT00006019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6326790|NCT00006019|Antimetabolites|antimetabolites|mesh-ancestor
6326791|NCT00006019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6326792|NCT00006019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326793|NCT00006019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6326794|NCT00006021|Ascorbic Acid|ascorbic acid|mesh-list
6326795|NCT00006021|Arsenic Trioxide|arsenic trioxide|mesh-list
6326796|NCT00006021|Antioxidants|antioxidants|mesh-ancestor
6326797|NCT00006021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6326798|NCT00006021|Protective Agents|protective agents|mesh-ancestor
6326799|NCT00006021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6326800|NCT00006021|Vitamins|vitamins|mesh-ancestor
6326801|NCT00006021|Micronutrients|micronutrients|mesh-ancestor
6326802|NCT00006021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326803|NCT00006022|Aldesleukin|aldesleukin|mesh-list
6326804|NCT00006022|Bryostatin 1|bryostatin 1|mesh-list
6326805|NCT00006022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326806|NCT00006022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6326807|NCT00006022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6326808|NCT00006022|Antiviral Agents|antiviral agents|mesh-ancestor
6326809|NCT00006022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6326810|NCT00006022|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6326811|NCT00006022|Immunologic Factors|immunologic factors|mesh-ancestor
6326812|NCT00006022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6326813|NCT00006023|Capecitabine|capecitabine|mesh-list
6326814|NCT00006023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6326815|NCT00006023|Antimetabolites|antimetabolites|mesh-ancestor
6326816|NCT00006023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6326817|NCT00006023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326818|NCT00006024|Temozolomide|temozolomide|mesh-list
6326819|NCT00006024|Lomustine|lomustine|mesh-list
6326820|NCT00006024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6326821|NCT00006024|Alkylating Agents|alkylating agents|mesh-ancestor
6326822|NCT00006024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6326823|NCT00006024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326824|NCT00006025|Irinotecan|irinotecan|mesh-list
6326825|NCT00006025|Temozolomide|temozolomide|mesh-list
6326826|NCT00006025|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6326827|NCT00006025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6326828|NCT00006025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6326829|NCT00006025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6326830|NCT00006025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326831|NCT00006025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6326832|NCT00006025|Alkylating Agents|alkylating agents|mesh-ancestor
6326833|NCT00006026|Rubitecan|rubitecan|mesh-list
6326834|NCT00006026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326835|NCT00006026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6326836|NCT00006026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6326837|NCT00006026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6326838|NCT00006026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6326839|NCT00006027|Paclitaxel|paclitaxel|mesh-list
6326840|NCT00006027|Cisplatin|cisplatin|mesh-list
6326841|NCT00006027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6326842|NCT00006027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326843|NCT00006027|Tubulin Modulators|tubulin modulators|mesh-ancestor
6326844|NCT00006027|Antimitotic Agents|antimitotic agents|mesh-ancestor
6326845|NCT00006027|Mitosis Modulators|mitosis modulators|mesh-ancestor
6326846|NCT00006027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6326847|NCT00006028|Gemcitabine|gemcitabine|mesh-list
6326848|NCT00006028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326849|NCT00006028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6326850|NCT00006028|Antimetabolites|antimetabolites|mesh-ancestor
6326851|NCT00006028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6326852|NCT00006028|Antiviral Agents|antiviral agents|mesh-ancestor
6326853|NCT00006028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6326854|NCT00006028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6326855|NCT00006028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6326856|NCT00006028|Immunologic Factors|immunologic factors|mesh-ancestor
6326857|NCT00006028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6326858|NCT00006029|Gemcitabine|gemcitabine|mesh-list
6326859|NCT00006029|Doxorubicin|doxorubicin|mesh-list
6326860|NCT00006029|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6326861|NCT00006029|Vinorelbine|vinorelbine|mesh-list
6326862|NCT00006029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6326863|NCT00006029|Antimetabolites|antimetabolites|mesh-ancestor
6326864|NCT00006029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6326865|NCT00006029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326866|NCT00006029|Antiviral Agents|antiviral agents|mesh-ancestor
6326867|NCT00006029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6326868|NCT00006029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6326869|NCT00006029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6326870|NCT00006029|Immunologic Factors|immunologic factors|mesh-ancestor
6326871|NCT00006029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6326872|NCT00006029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6326873|NCT00006029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6326874|NCT00006029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6326875|NCT00006029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6326876|NCT00006029|Tubulin Modulators|tubulin modulators|mesh-ancestor
6326877|NCT00006029|Antimitotic Agents|antimitotic agents|mesh-ancestor
6326878|NCT00006029|Mitosis Modulators|mitosis modulators|mesh-ancestor
6326879|NCT00006030|Tamoxifen|tamoxifen|mesh-list
6326880|NCT00006030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6326881|NCT00006030|Hormone Antagonists|hormone antagonists|mesh-ancestor
6326882|NCT00006030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6326883|NCT00006030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6326884|NCT00006030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6326885|NCT00006030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326886|NCT00006030|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6326887|NCT00006030|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6326888|NCT00006030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6326889|NCT00006032|Etoposide|etoposide|mesh-list
6326890|NCT00006032|Topotecan|topotecan|mesh-list
6326891|NCT00006032|Ifosfamide|ifosfamide|mesh-list
6326892|NCT00006032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6326893|NCT00006032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326894|NCT00006032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6326895|NCT00006032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6326896|NCT00006032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6326897|NCT00006032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6326898|NCT00006032|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6326899|NCT00006032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6326900|NCT00006032|Alkylating Agents|alkylating agents|mesh-ancestor
6326901|NCT00006033|Methotrexate|methotrexate|mesh-list
6326902|NCT00006033|Interleukin-2|interleukin-2|mesh-list
6326903|NCT00006033|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6326904|NCT00006033|Abortifacient Agents|abortifacient agents|mesh-ancestor
6326905|NCT00006033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6326906|NCT00006033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6326907|NCT00006033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6326908|NCT00006033|Antimetabolites|antimetabolites|mesh-ancestor
6326909|NCT00006033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6326910|NCT00006033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326911|NCT00006033|Dermatologic Agents|dermatologic agents|mesh-ancestor
6326912|NCT00006033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6326913|NCT00006033|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6326914|NCT00006033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6326915|NCT00006033|Immunologic Factors|immunologic factors|mesh-ancestor
6326916|NCT00006033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6326917|NCT00006033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6326918|NCT00006033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6326919|NCT00006033|Analgesics|analgesics|mesh-ancestor
6326920|NCT00006033|Sensory System Agents|sensory system agents|mesh-ancestor
6326921|NCT00006033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6326922|NCT00006034|Doxorubicin|doxorubicin|mesh-list
6326923|NCT00006034|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6326924|NCT00006034|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
6326925|NCT00006034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6326926|NCT00006034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326927|NCT00006034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6326928|NCT00006034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6326929|NCT00006034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6326930|NCT00006034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6326931|NCT00006034|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6326932|NCT00006034|Immunologic Factors|immunologic factors|mesh-ancestor
6326933|NCT00006034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6326934|NCT00006035|Bleomycin|bleomycin|mesh-list
6326935|NCT00006035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6326936|NCT00006035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326937|NCT00006036|Lurtotecan|lurtotecan|mesh-list
6326938|NCT00006036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326939|NCT00006037|Fluorouracil|fluorouracil|mesh-list
6326940|NCT00006037|Irinotecan|irinotecan|mesh-list
6326941|NCT00006037|Antimetabolites|antimetabolites|mesh-ancestor
6326942|NCT00006037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6326943|NCT00006037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6326944|NCT00006037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326945|NCT00006037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6326946|NCT00006037|Immunologic Factors|immunologic factors|mesh-ancestor
6326947|NCT00006037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6326948|NCT00006037|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6326949|NCT00006037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6326950|NCT00006037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6326951|NCT00006038|Leucovorin|leucovorin|mesh-list
6326952|NCT00006038|Docetaxel|docetaxel|mesh-list
6326953|NCT00006038|Fluorouracil|fluorouracil|mesh-list
6326954|NCT00006038|Floxuridine|floxuridine|mesh-list
6326955|NCT00006038|Calcium|calcium|mesh-list
6326956|NCT00006038|Levoleucovorin|levoleucovorin|mesh-list
6326957|NCT00006038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326958|NCT00006038|Tubulin Modulators|tubulin modulators|mesh-ancestor
6326959|NCT00006038|Antimitotic Agents|antimitotic agents|mesh-ancestor
6326960|NCT00006038|Mitosis Modulators|mitosis modulators|mesh-ancestor
6326961|NCT00006038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6326962|NCT00006038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6326963|NCT00006038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6326964|NCT00006038|Antimetabolites|antimetabolites|mesh-ancestor
6326965|NCT00006038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6326966|NCT00006038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6326967|NCT00006038|Immunologic Factors|immunologic factors|mesh-ancestor
6326968|NCT00006038|Antidotes|antidotes|mesh-ancestor
6326969|NCT00006038|Protective Agents|protective agents|mesh-ancestor
6326970|NCT00006038|Vitamin B Complex|vitamin b complex|mesh-ancestor
6326971|NCT00006038|Vitamins|vitamins|mesh-ancestor
6326972|NCT00006038|Micronutrients|micronutrients|mesh-ancestor
6326973|NCT00006039|Interferons|interferons|mesh-list
6326974|NCT00006039|Interferon-alpha|interferon-alpha|mesh-list
6326975|NCT00006039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326976|NCT00006039|Antiviral Agents|antiviral agents|mesh-ancestor
6326977|NCT00006039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6326978|NCT00006039|Immunologic Factors|immunologic factors|mesh-ancestor
6326979|NCT00006039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6326980|NCT00006040|Etoposide|etoposide|mesh-list
6326981|NCT00006040|Antibodies|antibodies|mesh-list
6326982|NCT00006040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6326983|NCT00006040|Immunologic Factors|immunologic factors|mesh-ancestor
6326984|NCT00006040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6326985|NCT00006040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6326986|NCT00006040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6326987|NCT00006040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6326988|NCT00006040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6326989|NCT00006040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6326990|NCT00006040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6326991|NCT00006041|Vaccines|vaccines|mesh-list
6326992|NCT00006041|Saponin QA-21V1|saponin qa-21v1|mesh-list
6326993|NCT00006041|Immunologic Factors|immunologic factors|mesh-ancestor
6326994|NCT00006041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6326995|NCT00006041|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6326996|NCT00006042|Mycophenolic Acid|mycophenolic acid|mesh-list
6326997|NCT00006042|Cyclophosphamide|cyclophosphamide|mesh-list
6326998|NCT00006042|Fludarabine|fludarabine|mesh-list
6326999|NCT00006042|Fludarabine phosphate|fludarabine phosphate|mesh-list
6327000|NCT00006042|Tacrolimus|tacrolimus|mesh-list
6327001|NCT00006042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6327002|NCT00006042|Immunologic Factors|immunologic factors|mesh-ancestor
6327003|NCT00006042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6327004|NCT00006042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6327005|NCT00006042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6327006|NCT00006042|Alkylating Agents|alkylating agents|mesh-ancestor
6327007|NCT00006042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327008|NCT00006042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327009|NCT00006042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6327010|NCT00006042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6327011|NCT00006042|Antimetabolites|antimetabolites|mesh-ancestor
6327012|NCT00006042|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6327013|NCT00006042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6327014|NCT00006042|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6327015|NCT00006042|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6327016|NCT00006042|Antitubercular Agents|antitubercular agents|mesh-ancestor
6327017|NCT00006042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6327018|NCT00006042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6327019|NCT00006043|Temozolomide|temozolomide|mesh-list
6327020|NCT00006043|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6327021|NCT00006043|Alkylating Agents|alkylating agents|mesh-ancestor
6327022|NCT00006043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327023|NCT00006043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6393091|NCT00198848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6393092|NCT00198978|Cytarabine|cytarabine|mesh-list
6393093|NCT00198978|Dexamethasone|dexamethasone|mesh-list
6393094|NCT00198978|Prednisolone|prednisolone|mesh-list
6393095|NCT00198978|Cyclophosphamide|cyclophosphamide|mesh-list
6327024|NCT00006044|Testosterone|testosterone|mesh-list
6327025|NCT00006044|Androgens|androgens|mesh-ancestor
6327026|NCT00006044|Hormones|hormones|mesh-ancestor
6327027|NCT00006044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6327028|NCT00006044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6327029|NCT00006045|Cytarabine|cytarabine|mesh-list
6327030|NCT00006045|Etoposide|etoposide|mesh-list
6327031|NCT00006045|Mitoxantrone|mitoxantrone|mesh-list
6327032|NCT00006045|Lintuzumab|lintuzumab|mesh-list
6327033|NCT00006045|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6327034|NCT00006045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327035|NCT00006045|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6327036|NCT00006045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6327037|NCT00006045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6327038|NCT00006045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327039|NCT00006045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6327040|NCT00006045|Antimetabolites|antimetabolites|mesh-ancestor
6327041|NCT00006045|Antiviral Agents|antiviral agents|mesh-ancestor
6327042|NCT00006045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6327043|NCT00006045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6327044|NCT00006045|Immunologic Factors|immunologic factors|mesh-ancestor
6327045|NCT00006045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6327046|NCT00006045|Analgesics|analgesics|mesh-ancestor
6327047|NCT00006045|Sensory System Agents|sensory system agents|mesh-ancestor
6327048|NCT00006045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6327049|NCT00006045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6327050|NCT00006047|Etoposide|etoposide|mesh-list
6327051|NCT00006047|Rubitecan|rubitecan|mesh-list
6327052|NCT00006047|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
6327053|NCT00006047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6327054|NCT00006047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327055|NCT00006047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6327056|NCT00006047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6327057|NCT00006047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6327058|NCT00006047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327059|NCT00006048|Gemcitabine|gemcitabine|mesh-list
6327060|NCT00006048|Gefitinib|gefitinib|mesh-list
6327061|NCT00006048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327062|NCT00006048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6327063|NCT00006048|Antimetabolites|antimetabolites|mesh-ancestor
6327064|NCT00006048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327065|NCT00006048|Antiviral Agents|antiviral agents|mesh-ancestor
6327066|NCT00006048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6327067|NCT00006048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6327068|NCT00006048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6327069|NCT00006048|Immunologic Factors|immunologic factors|mesh-ancestor
6327070|NCT00006048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6327071|NCT00006048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6327072|NCT00006049|Paclitaxel|paclitaxel|mesh-list
6327073|NCT00006049|Carboplatin|carboplatin|mesh-list
6327074|NCT00006049|Gefitinib|gefitinib|mesh-list
6327075|NCT00006049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6327076|NCT00006049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327077|NCT00006049|Tubulin Modulators|tubulin modulators|mesh-ancestor
6327078|NCT00006049|Antimitotic Agents|antimitotic agents|mesh-ancestor
6327079|NCT00006049|Mitosis Modulators|mitosis modulators|mesh-ancestor
6327080|NCT00006049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327081|NCT00006049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6327082|NCT00006049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6327083|NCT00006050|Leucovorin|leucovorin|mesh-list
6327084|NCT00006050|Fluorouracil|fluorouracil|mesh-list
6327085|NCT00006050|Oxaliplatin|oxaliplatin|mesh-list
6327086|NCT00006050|Calcium|calcium|mesh-list
6327087|NCT00006050|Levoleucovorin|levoleucovorin|mesh-list
6327088|NCT00006050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6327089|NCT00006050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6327090|NCT00006050|Antimetabolites|antimetabolites|mesh-ancestor
6327091|NCT00006050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327092|NCT00006050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6327093|NCT00006050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327094|NCT00006050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6327095|NCT00006050|Immunologic Factors|immunologic factors|mesh-ancestor
6327096|NCT00006050|Antidotes|antidotes|mesh-ancestor
6327097|NCT00006050|Protective Agents|protective agents|mesh-ancestor
6327098|NCT00006050|Vitamin B Complex|vitamin b complex|mesh-ancestor
6327099|NCT00006050|Vitamins|vitamins|mesh-ancestor
6327100|NCT00006050|Micronutrients|micronutrients|mesh-ancestor
6327101|NCT00006051|Fluorouracil|fluorouracil|mesh-list
6327102|NCT00006051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327103|NCT00006051|Antimetabolites|antimetabolites|mesh-ancestor
6327104|NCT00006051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327105|NCT00006051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6327106|NCT00006051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6327107|NCT00006051|Immunologic Factors|immunologic factors|mesh-ancestor
6327108|NCT00006051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6327109|NCT00006052|Imatinib Mesylate|imatinib mesylate|mesh-list
6327110|NCT00006052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327111|NCT00006052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6327112|NCT00006052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6327113|NCT00006052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327114|NCT00006053|Imatinib Mesylate|imatinib mesylate|mesh-list
6327115|NCT00006053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327116|NCT00006053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6327117|NCT00006053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6327118|NCT00006053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327119|NCT00006054|Cyclosporine|cyclosporine|mesh-list
6327120|NCT00006054|Prednisone|prednisone|mesh-list
6327121|NCT00006054|Methylprednisolone|methylprednisolone|mesh-list
6327122|NCT00006054|Cyclophosphamide|cyclophosphamide|mesh-list
6327123|NCT00006054|Busulfan|busulfan|mesh-list
6327124|NCT00006054|Methotrexate|methotrexate|mesh-list
6327125|NCT00006054|Etoposide|etoposide|mesh-list
6327126|NCT00006054|Cyclosporins|cyclosporins|mesh-list
6327127|NCT00006054|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6327128|NCT00006054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6327129|NCT00006054|Immunologic Factors|immunologic factors|mesh-ancestor
6327130|NCT00006054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6327131|NCT00006054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6327132|NCT00006054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6327133|NCT00006054|Alkylating Agents|alkylating agents|mesh-ancestor
6327134|NCT00006054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327135|NCT00006054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327136|NCT00006054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6327137|NCT00006054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6327138|NCT00006054|Glucocorticoids|glucocorticoids|mesh-ancestor
6327139|NCT00006054|Hormones|hormones|mesh-ancestor
6327140|NCT00006054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6327141|NCT00006054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6327142|NCT00006054|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6327143|NCT00006054|Abortifacient Agents|abortifacient agents|mesh-ancestor
6327144|NCT00006054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6327145|NCT00006054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6327146|NCT00006054|Antimetabolites|antimetabolites|mesh-ancestor
6327147|NCT00006054|Dermatologic Agents|dermatologic agents|mesh-ancestor
6327148|NCT00006054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6327149|NCT00006054|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6327150|NCT00006054|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6327151|NCT00006054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6327152|NCT00006054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6327153|NCT00006054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6327154|NCT00006054|Antifungal Agents|antifungal agents|mesh-ancestor
6327155|NCT00006054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6327156|NCT00006054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6327157|NCT00006054|Antiemetics|antiemetics|mesh-ancestor
6327158|NCT00006054|Autonomic Agents|autonomic agents|mesh-ancestor
6327159|NCT00006054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6327160|NCT00006054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6327161|NCT00006054|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6327162|NCT00006054|Protective Agents|protective agents|mesh-ancestor
6327163|NCT00006055|Cyclosporine|cyclosporine|mesh-list
6327164|NCT00006055|Prednisone|prednisone|mesh-list
6327165|NCT00006055|Methylprednisolone|methylprednisolone|mesh-list
6327166|NCT00006055|Cyclophosphamide|cyclophosphamide|mesh-list
6327167|NCT00006055|Cyclosporins|cyclosporins|mesh-list
6327168|NCT00006055|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6327169|NCT00006055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6327170|NCT00006055|Immunologic Factors|immunologic factors|mesh-ancestor
6327171|NCT00006055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6327172|NCT00006055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6327173|NCT00006055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6327174|NCT00006055|Alkylating Agents|alkylating agents|mesh-ancestor
6327175|NCT00006055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327176|NCT00006055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327177|NCT00006055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6327178|NCT00006055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6327179|NCT00006055|Glucocorticoids|glucocorticoids|mesh-ancestor
6327180|NCT00006055|Hormones|hormones|mesh-ancestor
6327181|NCT00006055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6327182|NCT00006055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6327183|NCT00006055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6327184|NCT00006055|Antifungal Agents|antifungal agents|mesh-ancestor
6327185|NCT00006055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6327186|NCT00006055|Dermatologic Agents|dermatologic agents|mesh-ancestor
6327187|NCT00006055|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6327188|NCT00006055|Antiemetics|antiemetics|mesh-ancestor
6327189|NCT00006055|Autonomic Agents|autonomic agents|mesh-ancestor
6327190|NCT00006055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6327191|NCT00006055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6327192|NCT00006055|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6327193|NCT00006055|Protective Agents|protective agents|mesh-ancestor
6327194|NCT00006056|Cyclosporine|cyclosporine|mesh-list
6327195|NCT00006056|Cyclophosphamide|cyclophosphamide|mesh-list
6327196|NCT00006056|Busulfan|busulfan|mesh-list
6327197|NCT00006056|Methotrexate|methotrexate|mesh-list
6327198|NCT00006056|Etoposide|etoposide|mesh-list
6327199|NCT00006056|Cyclosporins|cyclosporins|mesh-list
6327200|NCT00006056|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6327201|NCT00006056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6327202|NCT00006056|Immunologic Factors|immunologic factors|mesh-ancestor
6327203|NCT00006056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6327204|NCT00006056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6327205|NCT00006056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6327206|NCT00006056|Alkylating Agents|alkylating agents|mesh-ancestor
6327207|NCT00006056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327208|NCT00006056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327209|NCT00006056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6327210|NCT00006056|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6327211|NCT00006056|Abortifacient Agents|abortifacient agents|mesh-ancestor
6327212|NCT00006056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6327213|NCT00006056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6327214|NCT00006056|Antimetabolites|antimetabolites|mesh-ancestor
6327215|NCT00006056|Dermatologic Agents|dermatologic agents|mesh-ancestor
6327216|NCT00006056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6327217|NCT00006056|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6327218|NCT00006056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6327219|NCT00006056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6327220|NCT00006056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6327221|NCT00006056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6327222|NCT00006056|Antifungal Agents|antifungal agents|mesh-ancestor
6327223|NCT00006056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6327224|NCT00006056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6327225|NCT00006062|Oxaliplatin|oxaliplatin|mesh-list
6327226|NCT00006062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327227|NCT00006063|Pancrelipase|pancrelipase|mesh-list
6327228|NCT00006063|Pancreatin|pancreatin|mesh-list
6327229|NCT00006063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6327230|NCT00006066|Aldesleukin|aldesleukin|mesh-list
6327231|NCT00006066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327232|NCT00006066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6327233|NCT00006066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6327234|NCT00006066|Antiviral Agents|antiviral agents|mesh-ancestor
6327235|NCT00006066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6327236|NCT00006070|Etanercept|etanercept|mesh-list
6327237|NCT00006070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6327238|NCT00006070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6327239|NCT00006070|Analgesics|analgesics|mesh-ancestor
6327240|NCT00006070|Sensory System Agents|sensory system agents|mesh-ancestor
6327241|NCT00006070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6327242|NCT00006070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6327243|NCT00006070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6327244|NCT00006070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6327245|NCT00006070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6327246|NCT00006070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6327247|NCT00006070|Immunologic Factors|immunologic factors|mesh-ancestor
6327248|NCT00006072|Rituximab|rituximab|mesh-list
6327249|NCT00006072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6327250|NCT00006072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327251|NCT00006072|Immunologic Factors|immunologic factors|mesh-ancestor
6327252|NCT00006072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6327253|NCT00006072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6327254|NCT00006075|Chlorhexidine|chlorhexidine|mesh-list
6327255|NCT00006075|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6327256|NCT00006075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6327257|NCT00006075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6327258|NCT00006075|Disinfectants|disinfectants|mesh-ancestor
6327259|NCT00006075|Dermatologic Agents|dermatologic agents|mesh-ancestor
6327260|NCT00006077|Levodopa|levodopa|mesh-list
6327261|NCT00006077|Domperidone|domperidone|mesh-list
6327262|NCT00006077|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6327263|NCT00006077|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6327264|NCT00006077|Dopamine Agents|dopamine agents|mesh-ancestor
6327265|NCT00006077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6327266|NCT00006077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327267|NCT00006077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6327268|NCT00006077|Antiemetics|antiemetics|mesh-ancestor
6327269|NCT00006077|Autonomic Agents|autonomic agents|mesh-ancestor
6327270|NCT00006077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6327271|NCT00006077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6327272|NCT00006077|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6327273|NCT00006078|Lycopene|lycopene|mesh-list
6327274|NCT00006078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6327275|NCT00006078|Antioxidants|antioxidants|mesh-ancestor
6327276|NCT00006078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327277|NCT00006078|Protective Agents|protective agents|mesh-ancestor
6327278|NCT00006078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6327279|NCT00006078|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6327280|NCT00006078|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6327281|NCT00006078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327282|NCT00006079|Eflornithine|eflornithine|mesh-list
6327283|NCT00006079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327284|NCT00006079|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6327285|NCT00006079|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6327286|NCT00006079|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6327287|NCT00006079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6327288|NCT00006079|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
6327289|NCT00006079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6327290|NCT00006079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327291|NCT00006080|Fenretinide|fenretinide|mesh-list
6327292|NCT00006080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327293|NCT00006080|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6327294|NCT00006080|Protective Agents|protective agents|mesh-ancestor
6327295|NCT00006080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6327296|NCT00006081|Paclitaxel|paclitaxel|mesh-list
6327297|NCT00006081|Bryostatin 1|bryostatin 1|mesh-list
6327298|NCT00006081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6327299|NCT00006081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327300|NCT00006081|Tubulin Modulators|tubulin modulators|mesh-ancestor
6327301|NCT00006081|Antimitotic Agents|antimitotic agents|mesh-ancestor
6327302|NCT00006081|Mitosis Modulators|mitosis modulators|mesh-ancestor
6327303|NCT00006081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327304|NCT00006081|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6327305|NCT00006081|Immunologic Factors|immunologic factors|mesh-ancestor
6327306|NCT00006081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6327307|NCT00006082|Rubitecan|rubitecan|mesh-list
6327308|NCT00006082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327309|NCT00006082|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6327310|NCT00006082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6327311|NCT00006082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6327312|NCT00006082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327313|NCT00006083|Dalteparin|dalteparin|mesh-list
6327314|NCT00006083|Anticoagulants|anticoagulants|mesh-ancestor
6327315|NCT00006083|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6327316|NCT00006083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6327317|NCT00006083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327318|NCT00006084|Lintuzumab|lintuzumab|mesh-list
6327319|NCT00006084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6327320|NCT00006084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327321|NCT00006086|Carboplatin|carboplatin|mesh-list
6327322|NCT00006086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327323|NCT00006088|Vinorelbine|vinorelbine|mesh-list
6327324|NCT00006088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6327325|NCT00006088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327326|NCT00006088|Tubulin Modulators|tubulin modulators|mesh-ancestor
6327327|NCT00006088|Antimitotic Agents|antimitotic agents|mesh-ancestor
6327328|NCT00006088|Mitosis Modulators|mitosis modulators|mesh-ancestor
6327329|NCT00006088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327330|NCT00006089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6327331|NCT00006089|Trastuzumab|trastuzumab|mesh-list
6327332|NCT00006089|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
6327333|NCT00006089|Antibodies|antibodies|mesh-list
6327334|NCT00006089|Immunoglobulins|immunoglobulins|mesh-list
6327335|NCT00006089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6327336|NCT00006089|Immunologic Factors|immunologic factors|mesh-ancestor
6327337|NCT00006089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6327338|NCT00006089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327339|NCT00006090|Arsenic Trioxide|arsenic trioxide|mesh-list
6327340|NCT00006090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327341|NCT00006091|Arsenic Trioxide|arsenic trioxide|mesh-list
6327342|NCT00006091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327343|NCT00006092|Arsenic Trioxide|arsenic trioxide|mesh-list
6327344|NCT00006092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327345|NCT00006094|Fluorouracil|fluorouracil|mesh-list
6327346|NCT00006094|Oxaliplatin|oxaliplatin|mesh-list
6327347|NCT00006094|Antimetabolites|antimetabolites|mesh-ancestor
6327348|NCT00006094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327349|NCT00006094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6327350|NCT00006094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327351|NCT00006094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6327352|NCT00006094|Immunologic Factors|immunologic factors|mesh-ancestor
6327353|NCT00006094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6327354|NCT00006095|Irinotecan|irinotecan|mesh-list
6327355|NCT00006095|Vincristine|vincristine|mesh-list
6327356|NCT00006095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6327357|NCT00006095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6327358|NCT00006095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6327359|NCT00006095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327360|NCT00006095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327361|NCT00006095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6327362|NCT00006095|Tubulin Modulators|tubulin modulators|mesh-ancestor
6327363|NCT00006095|Antimitotic Agents|antimitotic agents|mesh-ancestor
6327364|NCT00006095|Mitosis Modulators|mitosis modulators|mesh-ancestor
6327365|NCT00006096|Cisplatin|cisplatin|mesh-list
6327366|NCT00006096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327367|NCT00006098|Bortezomib|bortezomib|mesh-list
6327368|NCT00006098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327369|NCT00006100|Aldesleukin|aldesleukin|mesh-list
6327370|NCT00006100|Fludarabine|fludarabine|mesh-list
6327371|NCT00006100|Fludarabine phosphate|fludarabine phosphate|mesh-list
6327372|NCT00006100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327373|NCT00006100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6327374|NCT00006100|Antimetabolites|antimetabolites|mesh-ancestor
6327375|NCT00006100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327376|NCT00006100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6327377|NCT00006100|Immunologic Factors|immunologic factors|mesh-ancestor
6327378|NCT00006100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6327379|NCT00006100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6327380|NCT00006100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6327381|NCT00006100|Antiviral Agents|antiviral agents|mesh-ancestor
6327382|NCT00006100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6327383|NCT00006103|Leucovorin|leucovorin|mesh-list
6327384|NCT00006103|Fluorouracil|fluorouracil|mesh-list
6327385|NCT00006103|Irinotecan|irinotecan|mesh-list
6327386|NCT00006103|Calcium|calcium|mesh-list
6327387|NCT00006103|Levoleucovorin|levoleucovorin|mesh-list
6327388|NCT00006103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6327389|NCT00006103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6327390|NCT00006103|Antimetabolites|antimetabolites|mesh-ancestor
6327391|NCT00006103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327392|NCT00006103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6327393|NCT00006103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327394|NCT00006103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6327395|NCT00006103|Immunologic Factors|immunologic factors|mesh-ancestor
6327396|NCT00006103|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6327397|NCT00006103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6327398|NCT00006103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6327399|NCT00006103|Antidotes|antidotes|mesh-ancestor
6327400|NCT00006103|Protective Agents|protective agents|mesh-ancestor
6327401|NCT00006103|Vitamin B Complex|vitamin b complex|mesh-ancestor
6327402|NCT00006103|Vitamins|vitamins|mesh-ancestor
6327403|NCT00006103|Micronutrients|micronutrients|mesh-ancestor
6327404|NCT00006104|Docetaxel|docetaxel|mesh-list
6327405|NCT00006104|Trastuzumab|trastuzumab|mesh-list
6327406|NCT00006104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327407|NCT00006104|Tubulin Modulators|tubulin modulators|mesh-ancestor
6327408|NCT00006104|Antimitotic Agents|antimitotic agents|mesh-ancestor
6327409|NCT00006104|Mitosis Modulators|mitosis modulators|mesh-ancestor
6327410|NCT00006104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327411|NCT00006104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6327412|NCT00006105|Gemcitabine|gemcitabine|mesh-list
6327413|NCT00006105|Amifostine|amifostine|mesh-list
6327414|NCT00006105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327415|NCT00006105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6327416|NCT00006105|Antimetabolites|antimetabolites|mesh-ancestor
6327417|NCT00006105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327418|NCT00006105|Antiviral Agents|antiviral agents|mesh-ancestor
6327419|NCT00006105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6327420|NCT00006105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6327421|NCT00006105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6327422|NCT00006105|Immunologic Factors|immunologic factors|mesh-ancestor
6327423|NCT00006105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6327424|NCT00006105|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6327425|NCT00006105|Protective Agents|protective agents|mesh-ancestor
6327426|NCT00006106|Fluorouracil|fluorouracil|mesh-list
6327427|NCT00006106|Dl1520|dl1520|mesh-list
6327428|NCT00006106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327429|NCT00006106|Antimetabolites|antimetabolites|mesh-ancestor
6327430|NCT00006106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327431|NCT00006106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6327432|NCT00006106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6327433|NCT00006106|Immunologic Factors|immunologic factors|mesh-ancestor
6327434|NCT00006106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6327435|NCT00006107|Docetaxel|docetaxel|mesh-list
6327436|NCT00006107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327437|NCT00006107|Tubulin Modulators|tubulin modulators|mesh-ancestor
6327438|NCT00006107|Antimitotic Agents|antimitotic agents|mesh-ancestor
6327439|NCT00006107|Mitosis Modulators|mitosis modulators|mesh-ancestor
6327440|NCT00006107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327441|NCT00006108|Paclitaxel|paclitaxel|mesh-list
6327442|NCT00006108|Capecitabine|capecitabine|mesh-list
6327443|NCT00006108|Trastuzumab|trastuzumab|mesh-list
6327444|NCT00006108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6327445|NCT00006108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327446|NCT00006108|Tubulin Modulators|tubulin modulators|mesh-ancestor
6327447|NCT00006108|Antimitotic Agents|antimitotic agents|mesh-ancestor
6327448|NCT00006108|Mitosis Modulators|mitosis modulators|mesh-ancestor
6327449|NCT00006108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327450|NCT00006108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6327451|NCT00006108|Antimetabolites|antimetabolites|mesh-ancestor
6327452|NCT00006108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6327453|NCT00006111|Fluorouracil|fluorouracil|mesh-list
6327454|NCT00006111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327455|NCT00006111|Antimetabolites|antimetabolites|mesh-ancestor
6327456|NCT00006111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327457|NCT00006111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6327458|NCT00006111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6327459|NCT00006111|Immunologic Factors|immunologic factors|mesh-ancestor
6327460|NCT00006111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6327461|NCT00006112|Leucovorin|leucovorin|mesh-list
6327462|NCT00006112|Fluorouracil|fluorouracil|mesh-list
6327463|NCT00006112|Mitomycins|mitomycins|mesh-list
6327464|NCT00006112|Mitomycin|mitomycin|mesh-list
6327465|NCT00006112|Calcium|calcium|mesh-list
6327466|NCT00006112|Levoleucovorin|levoleucovorin|mesh-list
6327467|NCT00006112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6327468|NCT00006112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6327469|NCT00006112|Antimetabolites|antimetabolites|mesh-ancestor
6327470|NCT00006112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327471|NCT00006112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6327472|NCT00006112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327473|NCT00006112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6327474|NCT00006112|Immunologic Factors|immunologic factors|mesh-ancestor
6327475|NCT00006112|Antidotes|antidotes|mesh-ancestor
6327476|NCT00006112|Protective Agents|protective agents|mesh-ancestor
6327477|NCT00006112|Vitamin B Complex|vitamin b complex|mesh-ancestor
6327478|NCT00006112|Vitamins|vitamins|mesh-ancestor
6327479|NCT00006112|Micronutrients|micronutrients|mesh-ancestor
6327480|NCT00006112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6327481|NCT00006112|Alkylating Agents|alkylating agents|mesh-ancestor
6327482|NCT00006112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6327483|NCT00006112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6327484|NCT00006113|Interferons|interferons|mesh-list
6327485|NCT00006113|Aldesleukin|aldesleukin|mesh-list
6327486|NCT00006113|Interferon-gamma|interferon-gamma|mesh-list
6327487|NCT00006113|Interleukin-4|interleukin-4|mesh-list
6327488|NCT00006113|Sargramostim|sargramostim|mesh-list
6327489|NCT00006113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327490|NCT00006113|Antiviral Agents|antiviral agents|mesh-ancestor
6327491|NCT00006113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6327492|NCT00006113|Immunologic Factors|immunologic factors|mesh-ancestor
6327493|NCT00006113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6327494|NCT00006113|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6327495|NCT00006113|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6327496|NCT00006113|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6327497|NCT00006113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6327498|NCT00006114|Vinorelbine|vinorelbine|mesh-list
6327499|NCT00006114|Mitoxantrone|mitoxantrone|mesh-list
6327500|NCT00006114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6327501|NCT00006114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327502|NCT00006114|Tubulin Modulators|tubulin modulators|mesh-ancestor
6327503|NCT00006114|Antimitotic Agents|antimitotic agents|mesh-ancestor
6327504|NCT00006114|Mitosis Modulators|mitosis modulators|mesh-ancestor
6327505|NCT00006114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327506|NCT00006114|Analgesics|analgesics|mesh-ancestor
6327507|NCT00006114|Sensory System Agents|sensory system agents|mesh-ancestor
6327508|NCT00006114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6327509|NCT00006114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6327510|NCT00006114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6327511|NCT00006114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6327512|NCT00006114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6327513|NCT00006115|Leucovorin|leucovorin|mesh-list
6327514|NCT00006115|Fluorouracil|fluorouracil|mesh-list
6327515|NCT00006115|Oxaliplatin|oxaliplatin|mesh-list
6327516|NCT00006115|Irinotecan|irinotecan|mesh-list
6327517|NCT00006115|Calcium|calcium|mesh-list
6327518|NCT00006115|Levoleucovorin|levoleucovorin|mesh-list
6327519|NCT00006115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6327520|NCT00006115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6327521|NCT00006115|Antimetabolites|antimetabolites|mesh-ancestor
6327522|NCT00006115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327523|NCT00006115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6327524|NCT00006115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327525|NCT00006115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6327526|NCT00006115|Immunologic Factors|immunologic factors|mesh-ancestor
6327527|NCT00006115|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6327528|NCT00006115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6327529|NCT00006115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6327530|NCT00006115|Antidotes|antidotes|mesh-ancestor
6327531|NCT00006115|Protective Agents|protective agents|mesh-ancestor
6327532|NCT00006115|Vitamin B Complex|vitamin b complex|mesh-ancestor
6327533|NCT00006115|Vitamins|vitamins|mesh-ancestor
6327534|NCT00006115|Micronutrients|micronutrients|mesh-ancestor
6327535|NCT00006116|Gemcitabine|gemcitabine|mesh-list
6327536|NCT00006116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327537|NCT00006116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6327538|NCT00006116|Antimetabolites|antimetabolites|mesh-ancestor
6327539|NCT00006116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327540|NCT00006116|Antiviral Agents|antiviral agents|mesh-ancestor
6327541|NCT00006116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6327542|NCT00006116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6327543|NCT00006116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6327544|NCT00006116|Immunologic Factors|immunologic factors|mesh-ancestor
6327545|NCT00006116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6327546|NCT00006117|Gemcitabine|gemcitabine|mesh-list
6327547|NCT00006117|Oxaliplatin|oxaliplatin|mesh-list
6327548|NCT00006117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6327549|NCT00006117|Antimetabolites|antimetabolites|mesh-ancestor
6327550|NCT00006117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327551|NCT00006117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327552|NCT00006117|Antiviral Agents|antiviral agents|mesh-ancestor
6327553|NCT00006117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6327554|NCT00006117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6327555|NCT00006117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6327556|NCT00006117|Immunologic Factors|immunologic factors|mesh-ancestor
6327557|NCT00006117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6327558|NCT00006118|Gemcitabine|gemcitabine|mesh-list
6327559|NCT00006118|Paclitaxel|paclitaxel|mesh-list
6327560|NCT00006118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6327561|NCT00006118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327562|NCT00006118|Tubulin Modulators|tubulin modulators|mesh-ancestor
6327563|NCT00006118|Antimitotic Agents|antimitotic agents|mesh-ancestor
6327564|NCT00006118|Mitosis Modulators|mitosis modulators|mesh-ancestor
6327565|NCT00006118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016550|NCT00365508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016551|NCT00365547|Bevacizumab|bevacizumab|mesh-list
6016552|NCT00365547|Topotecan|topotecan|mesh-list
6016553|NCT00365547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6327566|NCT00006118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6327567|NCT00006118|Antimetabolites|antimetabolites|mesh-ancestor
6327568|NCT00006118|Antiviral Agents|antiviral agents|mesh-ancestor
6327569|NCT00006118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6327570|NCT00006118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6327571|NCT00006118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6327572|NCT00006118|Immunologic Factors|immunologic factors|mesh-ancestor
6327573|NCT00006118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6327574|NCT00006119|Hydroxyurea|hydroxyurea|mesh-list
6327575|NCT00006119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327576|NCT00006119|Antisickling Agents|antisickling agents|mesh-ancestor
6327577|NCT00006119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6327578|NCT00006119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327579|NCT00006119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6327580|NCT00006120|Paclitaxel|paclitaxel|mesh-list
6327581|NCT00006120|Docetaxel|docetaxel|mesh-list
6327582|NCT00006120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6327583|NCT00006120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327584|NCT00006120|Tubulin Modulators|tubulin modulators|mesh-ancestor
6327585|NCT00006120|Antimitotic Agents|antimitotic agents|mesh-ancestor
6327586|NCT00006120|Mitosis Modulators|mitosis modulators|mesh-ancestor
6327587|NCT00006120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327588|NCT00006121|Oxaliplatin|oxaliplatin|mesh-list
6327589|NCT00006121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327590|NCT00006122|Cytarabine|cytarabine|mesh-list
6327591|NCT00006122|Etoposide|etoposide|mesh-list
6327592|NCT00006122|Mitoxantrone|mitoxantrone|mesh-list
6327593|NCT00006122|Idarubicin|idarubicin|mesh-list
6327594|NCT00006122|Gemtuzumab|gemtuzumab|mesh-list
6327595|NCT00006122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6327596|NCT00006122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327597|NCT00006122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6327598|NCT00006122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6327599|NCT00006122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6327600|NCT00006122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327601|NCT00006122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6327602|NCT00006122|Antimetabolites|antimetabolites|mesh-ancestor
6327603|NCT00006122|Antiviral Agents|antiviral agents|mesh-ancestor
6327604|NCT00006122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6327605|NCT00006122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6327606|NCT00006122|Immunologic Factors|immunologic factors|mesh-ancestor
6327607|NCT00006122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6327608|NCT00006122|Analgesics|analgesics|mesh-ancestor
6327609|NCT00006122|Sensory System Agents|sensory system agents|mesh-ancestor
6327610|NCT00006122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6327611|NCT00006122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6327612|NCT00006122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6327613|NCT00006123|Cyclophosphamide|cyclophosphamide|mesh-list
6327614|NCT00006123|Thiotepa|thiotepa|mesh-list
6327615|NCT00006123|Carmustine|carmustine|mesh-list
6327616|NCT00006123|Carboplatin|carboplatin|mesh-list
6327617|NCT00006123|Trastuzumab|trastuzumab|mesh-list
6327618|NCT00006123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6327619|NCT00006123|Immunologic Factors|immunologic factors|mesh-ancestor
6327620|NCT00006123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6327621|NCT00006123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6327622|NCT00006123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6327623|NCT00006123|Alkylating Agents|alkylating agents|mesh-ancestor
6327624|NCT00006123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327625|NCT00006123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327626|NCT00006123|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6327627|NCT00006123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6327628|NCT00006124|Celecoxib|celecoxib|mesh-list
6327629|NCT00006124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6327630|NCT00006124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6327631|NCT00006124|Analgesics|analgesics|mesh-ancestor
6327632|NCT00006124|Sensory System Agents|sensory system agents|mesh-ancestor
6327633|NCT00006124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6327634|NCT00006124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6327635|NCT00006124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6327636|NCT00006124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6327637|NCT00006124|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6327638|NCT00006124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6327639|NCT00006124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6327640|NCT00006124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327641|NCT00006125|Doxorubicin|doxorubicin|mesh-list
6327642|NCT00006125|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6327643|NCT00006125|Topotecan|topotecan|mesh-list
6327644|NCT00006125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6327645|NCT00006125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327646|NCT00006125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6327647|NCT00006125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6327648|NCT00006125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6327649|NCT00006125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327650|NCT00006125|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6327651|NCT00006126|Cyclophosphamide|cyclophosphamide|mesh-list
6327652|NCT00006126|Busulfan|busulfan|mesh-list
6327653|NCT00006126|Fludarabine|fludarabine|mesh-list
6327654|NCT00006126|Fludarabine phosphate|fludarabine phosphate|mesh-list
6327655|NCT00006126|Etoposide|etoposide|mesh-list
6327656|NCT00006126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6327657|NCT00006126|Immunologic Factors|immunologic factors|mesh-ancestor
6327658|NCT00006126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6327659|NCT00006126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6327660|NCT00006126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6327661|NCT00006126|Alkylating Agents|alkylating agents|mesh-ancestor
6327662|NCT00006126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327663|NCT00006126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327664|NCT00006126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6327665|NCT00006126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6327666|NCT00006126|Antimetabolites|antimetabolites|mesh-ancestor
6327667|NCT00006126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6327668|NCT00006126|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6327669|NCT00006126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6327670|NCT00006126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6327671|NCT00006127|Amifostine|amifostine|mesh-list
6327672|NCT00006127|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6327673|NCT00006127|Protective Agents|protective agents|mesh-ancestor
6327674|NCT00006127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6327675|NCT00006129|Testosterone|testosterone|mesh-list
6327676|NCT00006129|Androgens|androgens|mesh-ancestor
6327677|NCT00006129|Hormones|hormones|mesh-ancestor
6327678|NCT00006129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6327679|NCT00006129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6327680|NCT00006131|Valacyclovir|valacyclovir|mesh-list
6327681|NCT00006131|Antiviral Agents|antiviral agents|mesh-ancestor
6327682|NCT00006131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6327683|NCT00006132|Acyclovir|acyclovir|mesh-list
6327684|NCT00006132|Antiviral Agents|antiviral agents|mesh-ancestor
6327685|NCT00006132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6327686|NCT00006133|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6327687|NCT00006133|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6327688|NCT00006133|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6327689|NCT00006133|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6327690|NCT00006133|Medroxyprogesterone|medroxyprogesterone|mesh-list
6327691|NCT00006133|Norethindrone|norethindrone|mesh-list
6327692|NCT00006133|Norethindrone Acetate|norethindrone acetate|mesh-list
6327693|NCT00006133|Estradiol|estradiol|mesh-list
6327694|NCT00006133|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6327695|NCT00006133|Estrogens|estrogens|mesh-ancestor
6327696|NCT00006133|Hormones|hormones|mesh-ancestor
6327697|NCT00006133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6327698|NCT00006133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6327699|NCT00006133|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6327700|NCT00006133|Contraceptive Agents|contraceptive agents|mesh-ancestor
6327701|NCT00006133|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6327702|NCT00006133|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6327703|NCT00006133|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6327704|NCT00006133|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6327705|NCT00006133|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6327706|NCT00006133|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6327707|NCT00006133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6327708|NCT00006133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327709|NCT00006135|Acyclovir|acyclovir|mesh-list
6327710|NCT00006135|Antiviral Agents|antiviral agents|mesh-ancestor
6327711|NCT00006135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6327712|NCT00006136|Arginine butyrate|arginine butyrate|mesh-list
6327713|NCT00006136|Epoetin Alfa|epoetin alfa|mesh-list
6327714|NCT00006136|Hematinics|hematinics|mesh-ancestor
6327715|NCT00006136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327716|NCT00006137|Enalapril|enalapril|mesh-list
6327717|NCT00006137|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6327718|NCT00006137|Protease Inhibitors|protease inhibitors|mesh-ancestor
6327719|NCT00006137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6327720|NCT00006137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327721|NCT00006137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6327722|NCT00006144|Ritonavir|ritonavir|mesh-list
6327723|NCT00006144|Lopinavir|lopinavir|mesh-list
6327724|NCT00006144|Emtricitabine|emtricitabine|mesh-list
6327725|NCT00006144|Stavudine|stavudine|mesh-list
6327726|NCT00006144|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6327727|NCT00006144|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6327728|NCT00006144|Protease Inhibitors|protease inhibitors|mesh-ancestor
6327729|NCT00006144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6327730|NCT00006144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327731|NCT00006144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6327732|NCT00006144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6327733|NCT00006144|Antiviral Agents|antiviral agents|mesh-ancestor
6327734|NCT00006144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6327735|NCT00006144|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6327736|NCT00006144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6327737|NCT00006144|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6327738|NCT00006144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6327739|NCT00006144|Antimetabolites|antimetabolites|mesh-ancestor
6327740|NCT00006145|Valganciclovir|valganciclovir|mesh-list
6327741|NCT00006145|Antiviral Agents|antiviral agents|mesh-ancestor
6327742|NCT00006145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6327743|NCT00006152|Ritonavir|ritonavir|mesh-list
6327744|NCT00006152|Amprenavir|amprenavir|mesh-list
6327745|NCT00006152|Abacavir|abacavir|mesh-list
6327746|NCT00006152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6327747|NCT00006152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6327748|NCT00006152|Protease Inhibitors|protease inhibitors|mesh-ancestor
6327749|NCT00006152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6327750|NCT00006152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327751|NCT00006152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6327752|NCT00006152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6327753|NCT00006152|Antiviral Agents|antiviral agents|mesh-ancestor
6327754|NCT00006152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6327755|NCT00006152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6327756|NCT00006152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6327757|NCT00006152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6327758|NCT00006152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6327759|NCT00006152|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6327760|NCT00006152|Antitubercular Agents|antitubercular agents|mesh-ancestor
6327761|NCT00006152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6327762|NCT00006154|Ritonavir|ritonavir|mesh-list
6327763|NCT00006154|Indinavir|indinavir|mesh-list
6327764|NCT00006154|Aldesleukin|aldesleukin|mesh-list
6327765|NCT00006154|Abacavir|abacavir|mesh-list
6327766|NCT00006154|Stavudine|stavudine|mesh-list
6327767|NCT00006154|Didanosine|didanosine|mesh-list
6327768|NCT00006154|Efavirenz|efavirenz|mesh-list
6327769|NCT00006154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6327770|NCT00006154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6327771|NCT00006154|Protease Inhibitors|protease inhibitors|mesh-ancestor
6327772|NCT00006154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6327773|NCT00006154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327774|NCT00006154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6327775|NCT00006154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6327776|NCT00006154|Antiviral Agents|antiviral agents|mesh-ancestor
6327777|NCT00006154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6327778|NCT00006154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6327779|NCT00006154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6327780|NCT00006154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327781|NCT00006154|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6327782|NCT00006154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6327783|NCT00006154|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6327784|NCT00006154|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6327785|NCT00006154|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6327786|NCT00006154|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6327787|NCT00006154|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6327788|NCT00006154|Antimetabolites|antimetabolites|mesh-ancestor
6327789|NCT00006155|Carboplatin|carboplatin|mesh-list
6327790|NCT00006155|Semaxinib|semaxinib|mesh-list
6327791|NCT00006155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327792|NCT00006155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6327793|NCT00006155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6327794|NCT00006155|Growth Substances|growth substances|mesh-ancestor
6327795|NCT00006155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6327796|NCT00006155|Growth Inhibitors|growth inhibitors|mesh-ancestor
6327797|NCT00006155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6327798|NCT00006155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6327799|NCT00006155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327800|NCT00006157|Desipramine|desipramine|mesh-list
6327801|NCT00006157|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6327802|NCT00006157|Antidepressive Agents|antidepressive agents|mesh-ancestor
6327803|NCT00006157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6327804|NCT00006157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6327805|NCT00006157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327806|NCT00006157|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6327807|NCT00006157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6327808|NCT00006157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6327809|NCT00006157|Adrenergic Agents|adrenergic agents|mesh-ancestor
6327810|NCT00006157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6327811|NCT00006157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6327812|NCT00006158|Testosterone|testosterone|mesh-list
6327813|NCT00006158|Androgens|androgens|mesh-ancestor
6327814|NCT00006158|Hormones|hormones|mesh-ancestor
6327815|NCT00006158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6327816|NCT00006158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6393096|NCT00198978|Rituximab|rituximab|mesh-list
6393097|NCT00198978|Methotrexate|methotrexate|mesh-list
6393098|NCT00198978|Vincristine|vincristine|mesh-list
6393099|NCT00198978|Asparaginase|asparaginase|mesh-list
6393100|NCT00198978|Mercaptopurine|mercaptopurine|mesh-list
6393101|NCT00198978|Idarubicin|idarubicin|mesh-list
6393102|NCT00198978|Sargramostim|sargramostim|mesh-list
6393103|NCT00198978|Lenograstim|lenograstim|mesh-list
6393104|NCT00198978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6393105|NCT00198978|Immunologic Factors|immunologic factors|mesh-ancestor
6393106|NCT00198978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6393107|NCT00198978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6393108|NCT00198978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6393109|NCT00198978|Alkylating Agents|alkylating agents|mesh-ancestor
6393110|NCT00198978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393111|NCT00198978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6393112|NCT00198978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6393113|NCT00198978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6393114|NCT00198978|Antiemetics|antiemetics|mesh-ancestor
6393115|NCT00198978|Autonomic Agents|autonomic agents|mesh-ancestor
6393116|NCT00198978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6393117|NCT00198978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6393118|NCT00198978|Glucocorticoids|glucocorticoids|mesh-ancestor
6393119|NCT00198978|Hormones|hormones|mesh-ancestor
6393120|NCT00198978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6393121|NCT00198978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6393122|NCT00198978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6393123|NCT00198978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6393124|NCT00198978|Abortifacient Agents|abortifacient agents|mesh-ancestor
6393125|NCT00198978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6393126|NCT00198978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6393127|NCT00198978|Antimetabolites|antimetabolites|mesh-ancestor
6393128|NCT00198978|Dermatologic Agents|dermatologic agents|mesh-ancestor
6393129|NCT00198978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6327817|NCT00006167|Oxandrolone|oxandrolone|mesh-list
6016554|NCT00365547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6016555|NCT00365547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6327818|NCT00006167|Androgens|androgens|mesh-ancestor
6327819|NCT00006167|Hormones|hormones|mesh-ancestor
6327820|NCT00006167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6327821|NCT00006167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6327822|NCT00006167|Anabolic Agents|anabolic agents|mesh-ancestor
6327823|NCT00006168|Methotrexate|methotrexate|mesh-list
6327824|NCT00006168|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6327825|NCT00006168|Abortifacient Agents|abortifacient agents|mesh-ancestor
6327826|NCT00006168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6327827|NCT00006168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6327828|NCT00006168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6327829|NCT00006168|Antimetabolites|antimetabolites|mesh-ancestor
6327830|NCT00006168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327831|NCT00006168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327832|NCT00006168|Dermatologic Agents|dermatologic agents|mesh-ancestor
6327833|NCT00006168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6327834|NCT00006168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6327835|NCT00006168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6327836|NCT00006168|Immunologic Factors|immunologic factors|mesh-ancestor
6327837|NCT00006168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6327838|NCT00006168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6327839|NCT00006174|Letrozole|letrozole|mesh-list
6327840|NCT00006174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327841|NCT00006174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6327842|NCT00006174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6327843|NCT00006174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6327844|NCT00006174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327845|NCT00006174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6327846|NCT00006174|Hormone Antagonists|hormone antagonists|mesh-ancestor
6327847|NCT00006174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6327848|NCT00006174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6327849|NCT00006180|Alendronate|alendronate|mesh-list
6327850|NCT00006180|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6327851|NCT00006180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6327852|NCT00006185|Rosiglitazone|rosiglitazone|mesh-list
6327853|NCT00006185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6327854|NCT00006185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6327855|NCT00006190|Lamivudine|lamivudine|mesh-list
6327856|NCT00006190|Efavirenz|efavirenz|mesh-list
6327857|NCT00006190|Stavudine|stavudine|mesh-list
6327858|NCT00006190|Nelfinavir|nelfinavir|mesh-list
6327859|NCT00006190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6327860|NCT00006190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6327861|NCT00006190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6327862|NCT00006190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327863|NCT00006190|Antiviral Agents|antiviral agents|mesh-ancestor
6327864|NCT00006190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6327865|NCT00006190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6327866|NCT00006190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6327867|NCT00006190|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6327868|NCT00006190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6327869|NCT00006190|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6327870|NCT00006190|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6327871|NCT00006190|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6327872|NCT00006190|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6327873|NCT00006190|Antimetabolites|antimetabolites|mesh-ancestor
6327874|NCT00006190|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6327875|NCT00006190|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6327876|NCT00006190|Protease Inhibitors|protease inhibitors|mesh-ancestor
6327877|NCT00006195|Olanzapine|olanzapine|mesh-list
6327878|NCT00006195|Risperidone|risperidone|mesh-list
6327879|NCT00006195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6327880|NCT00006195|Serotonin Agents|serotonin agents|mesh-ancestor
6327881|NCT00006195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6327882|NCT00006195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327883|NCT00006195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6327884|NCT00006195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6327885|NCT00006195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6327886|NCT00006195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6327887|NCT00006195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6327888|NCT00006195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6327889|NCT00006195|Dopamine Agents|dopamine agents|mesh-ancestor
6327890|NCT00006195|Antiemetics|antiemetics|mesh-ancestor
6327891|NCT00006195|Autonomic Agents|autonomic agents|mesh-ancestor
6327892|NCT00006195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6327893|NCT00006195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6327894|NCT00006195|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6327895|NCT00006195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6327896|NCT00006195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6327897|NCT00006196|Vitamin D|vitamin d|mesh-list
6327898|NCT00006196|Vitamins|vitamins|mesh-ancestor
6327899|NCT00006196|Micronutrients|micronutrients|mesh-ancestor
6327900|NCT00006196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6327901|NCT00006196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6327902|NCT00006198|Thalidomide|thalidomide|mesh-list
6327903|NCT00006198|Doxorubicin|doxorubicin|mesh-list
6327904|NCT00006198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6327905|NCT00006198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327906|NCT00006198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6327907|NCT00006198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6327908|NCT00006198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6327909|NCT00006198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327910|NCT00006198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6327911|NCT00006198|Immunologic Factors|immunologic factors|mesh-ancestor
6327912|NCT00006198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6327913|NCT00006198|Leprostatic Agents|leprostatic agents|mesh-ancestor
6327914|NCT00006198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6327915|NCT00006198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6327916|NCT00006198|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6327917|NCT00006198|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6327918|NCT00006198|Growth Substances|growth substances|mesh-ancestor
6327919|NCT00006198|Growth Inhibitors|growth inhibitors|mesh-ancestor
6327920|NCT00006199|Topotecan|topotecan|mesh-list
6327921|NCT00006199|Tipifarnib|tipifarnib|mesh-list
6327922|NCT00006199|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6327923|NCT00006199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6327924|NCT00006199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6327925|NCT00006199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327926|NCT00006199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327927|NCT00006200|Thalidomide|thalidomide|mesh-list
6327928|NCT00006200|Dacarbazine|dacarbazine|mesh-list
6327929|NCT00006200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6327930|NCT00006200|Immunologic Factors|immunologic factors|mesh-ancestor
6327931|NCT00006200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6327932|NCT00006200|Leprostatic Agents|leprostatic agents|mesh-ancestor
6327933|NCT00006200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6327934|NCT00006200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6327935|NCT00006200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6327936|NCT00006200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6327937|NCT00006200|Growth Substances|growth substances|mesh-ancestor
6327938|NCT00006200|Growth Inhibitors|growth inhibitors|mesh-ancestor
6327939|NCT00006200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6327940|NCT00006200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6327941|NCT00006200|Alkylating Agents|alkylating agents|mesh-ancestor
6327942|NCT00006200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327943|NCT00006203|Naltrexone|naltrexone|mesh-list
6327944|NCT00006203|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6327945|NCT00006203|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6327946|NCT00006203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6327947|NCT00006203|Sensory System Agents|sensory system agents|mesh-ancestor
6327948|NCT00006203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6327949|NCT00006204|Naltrexone|naltrexone|mesh-list
6327950|NCT00006204|Fluoxetine|fluoxetine|mesh-list
6327951|NCT00006204|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6327952|NCT00006204|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6327953|NCT00006204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6327954|NCT00006204|Sensory System Agents|sensory system agents|mesh-ancestor
6327955|NCT00006204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6327956|NCT00006204|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6327957|NCT00006204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6327958|NCT00006204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6327959|NCT00006204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327960|NCT00006204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6327961|NCT00006204|Serotonin Agents|serotonin agents|mesh-ancestor
6327962|NCT00006204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6327963|NCT00006204|Antidepressive Agents|antidepressive agents|mesh-ancestor
6327964|NCT00006204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6327965|NCT00006204|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6327966|NCT00006204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6327967|NCT00006204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6327968|NCT00006205|Topiramate|topiramate|mesh-list
6327969|NCT00006205|Ondansetron|ondansetron|mesh-list
6327970|NCT00006205|Antiemetics|antiemetics|mesh-ancestor
6327971|NCT00006205|Autonomic Agents|autonomic agents|mesh-ancestor
6327972|NCT00006205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6327973|NCT00006205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6327974|NCT00006205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6327975|NCT00006205|Antipruritics|antipruritics|mesh-ancestor
6327976|NCT00006205|Dermatologic Agents|dermatologic agents|mesh-ancestor
6327977|NCT00006205|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6327978|NCT00006205|Serotonin Agents|serotonin agents|mesh-ancestor
6327979|NCT00006205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6327980|NCT00006205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6327981|NCT00006205|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6327982|NCT00006205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6327983|NCT00006205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6327984|NCT00006205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6327985|NCT00006205|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6327986|NCT00006205|Anticonvulsants|anticonvulsants|mesh-ancestor
6327987|NCT00006205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6327988|NCT00006206|Naltrexone|naltrexone|mesh-list
6327989|NCT00006206|Acamprosate|acamprosate|mesh-list
6327990|NCT00006206|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6327991|NCT00006206|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6327992|NCT00006206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6327993|NCT00006206|Sensory System Agents|sensory system agents|mesh-ancestor
6327994|NCT00006206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6327995|NCT00006208|Emtricitabine|emtricitabine|mesh-list
6327996|NCT00006208|Efavirenz|efavirenz|mesh-list
6327997|NCT00006208|Stavudine|stavudine|mesh-list
6327998|NCT00006208|Didanosine|didanosine|mesh-list
6327999|NCT00006208|Antiviral Agents|antiviral agents|mesh-ancestor
6328000|NCT00006208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6328001|NCT00006208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6328002|NCT00006208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6328003|NCT00006208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6328004|NCT00006208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328005|NCT00006208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6328006|NCT00006208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6328007|NCT00006208|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6328008|NCT00006208|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6328009|NCT00006208|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6328010|NCT00006208|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6328011|NCT00006208|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6328012|NCT00006208|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6328013|NCT00006208|Antimetabolites|antimetabolites|mesh-ancestor
6328014|NCT00006211|Nelfinavir|nelfinavir|mesh-list
6328015|NCT00006211|Capravirine|capravirine|mesh-list
6328016|NCT00006211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6328017|NCT00006211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6328018|NCT00006211|Protease Inhibitors|protease inhibitors|mesh-ancestor
6328019|NCT00006211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6328020|NCT00006211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328021|NCT00006211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6328022|NCT00006211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6328023|NCT00006211|Antiviral Agents|antiviral agents|mesh-ancestor
6328024|NCT00006211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6328025|NCT00006211|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6328026|NCT00006211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6328027|NCT00006212|Vinblastine|vinblastine|mesh-list
6328028|NCT00006212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328029|NCT00006212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6328030|NCT00006212|Tubulin Modulators|tubulin modulators|mesh-ancestor
6328031|NCT00006212|Antimitotic Agents|antimitotic agents|mesh-ancestor
6328032|NCT00006212|Mitosis Modulators|mitosis modulators|mesh-ancestor
6328033|NCT00006212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328034|NCT00006214|Flutamide|flutamide|mesh-list
6328035|NCT00006214|Androgen Antagonists|androgen antagonists|mesh-ancestor
6328036|NCT00006214|Hormone Antagonists|hormone antagonists|mesh-ancestor
6328037|NCT00006214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6328038|NCT00006214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6328039|NCT00006214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6328040|NCT00006214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328041|NCT00006215|Docetaxel|docetaxel|mesh-list
6328042|NCT00006215|Vinorelbine|vinorelbine|mesh-list
6328043|NCT00006215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328044|NCT00006215|Tubulin Modulators|tubulin modulators|mesh-ancestor
6328045|NCT00006215|Antimitotic Agents|antimitotic agents|mesh-ancestor
6328046|NCT00006215|Mitosis Modulators|mitosis modulators|mesh-ancestor
6328047|NCT00006215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328048|NCT00006215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6328049|NCT00006216|Ganciclovir|ganciclovir|mesh-list
6328050|NCT00006216|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6328051|NCT00006216|Antiviral Agents|antiviral agents|mesh-ancestor
6328052|NCT00006216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6328053|NCT00006216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6328054|NCT00006216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6328055|NCT00006216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328056|NCT00006219|Clarithromycin|clarithromycin|mesh-list
6328057|NCT00006219|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
6328058|NCT00006219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6328059|NCT00006219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6328060|NCT00006219|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6328061|NCT00006219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6328062|NCT00006219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328063|NCT00006219|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6328064|NCT00006219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6328065|NCT00006219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6328066|NCT00006219|Immunologic Factors|immunologic factors|mesh-ancestor
6328067|NCT00006219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6328068|NCT00006220|Arsenic Trioxide|arsenic trioxide|mesh-list
6328069|NCT00006220|Tretinoin|tretinoin|mesh-list
6328070|NCT00006220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328071|NCT00006220|Keratolytic Agents|keratolytic agents|mesh-ancestor
6328072|NCT00006220|Dermatologic Agents|dermatologic agents|mesh-ancestor
6328073|NCT00006223|Flt3 ligand protein|flt3 ligand protein|mesh-list
6328074|NCT00006223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6328075|NCT00006223|Immunologic Factors|immunologic factors|mesh-ancestor
6328076|NCT00006223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6328077|NCT00006223|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6328078|NCT00006223|Protective Agents|protective agents|mesh-ancestor
6328079|NCT00006224|Gemcitabine|gemcitabine|mesh-list
6328080|NCT00006224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6328081|NCT00006224|Antimetabolites|antimetabolites|mesh-ancestor
6328082|NCT00006224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328083|NCT00006224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328084|NCT00006224|Antiviral Agents|antiviral agents|mesh-ancestor
6328085|NCT00006224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6328086|NCT00006224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6328087|NCT00006224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6328088|NCT00006224|Immunologic Factors|immunologic factors|mesh-ancestor
6328089|NCT00006224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6328090|NCT00006226|Thalidomide|thalidomide|mesh-list
6328091|NCT00006226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6328092|NCT00006226|Immunologic Factors|immunologic factors|mesh-ancestor
6328093|NCT00006226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6328094|NCT00006226|Leprostatic Agents|leprostatic agents|mesh-ancestor
6328095|NCT00006226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6328096|NCT00006226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6328097|NCT00006226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6328098|NCT00006226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6328099|NCT00006226|Growth Substances|growth substances|mesh-ancestor
6328100|NCT00006226|Growth Inhibitors|growth inhibitors|mesh-ancestor
6328101|NCT00006226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328102|NCT00006228|Aldesleukin|aldesleukin|mesh-list
6328103|NCT00006228|Trastuzumab|trastuzumab|mesh-list
6328104|NCT00006228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6328105|NCT00006228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328106|NCT00006228|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6328107|NCT00006228|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6328108|NCT00006228|Antiviral Agents|antiviral agents|mesh-ancestor
6328109|NCT00006228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6328110|NCT00006229|Paclitaxel|paclitaxel|mesh-list
6328111|NCT00006229|Carboplatin|carboplatin|mesh-list
6328112|NCT00006229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6328113|NCT00006229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328114|NCT00006229|Tubulin Modulators|tubulin modulators|mesh-ancestor
6328115|NCT00006229|Antimitotic Agents|antimitotic agents|mesh-ancestor
6328116|NCT00006229|Mitosis Modulators|mitosis modulators|mesh-ancestor
6393130|NCT00198978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6328117|NCT00006229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328118|NCT00006230|Rubitecan|rubitecan|mesh-list
6328119|NCT00006230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328120|NCT00006230|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6328121|NCT00006230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6328122|NCT00006230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6328123|NCT00006230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328124|NCT00006232|Dexamethasone|dexamethasone|mesh-list
6328125|NCT00006232|Doxorubicin|doxorubicin|mesh-list
6328126|NCT00006232|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6328127|NCT00006232|Vincristine|vincristine|mesh-list
6328128|NCT00006232|Idarubicin|idarubicin|mesh-list
6328129|NCT00006232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6328130|NCT00006232|Antiemetics|antiemetics|mesh-ancestor
6328131|NCT00006232|Autonomic Agents|autonomic agents|mesh-ancestor
6328132|NCT00006232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6328133|NCT00006232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6328134|NCT00006232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6328135|NCT00006232|Glucocorticoids|glucocorticoids|mesh-ancestor
6328136|NCT00006232|Hormones|hormones|mesh-ancestor
6328137|NCT00006232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6328138|NCT00006232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6328139|NCT00006232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328140|NCT00006232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6328141|NCT00006232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6328142|NCT00006232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6328143|NCT00006232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6328144|NCT00006232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328145|NCT00006232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6328146|NCT00006232|Tubulin Modulators|tubulin modulators|mesh-ancestor
6328147|NCT00006232|Antimitotic Agents|antimitotic agents|mesh-ancestor
6328148|NCT00006232|Mitosis Modulators|mitosis modulators|mesh-ancestor
6328149|NCT00006233|Cyclosporine|cyclosporine|mesh-list
6328150|NCT00006233|Mycophenolic Acid|mycophenolic acid|mesh-list
6328151|NCT00006233|Fludarabine|fludarabine|mesh-list
6328152|NCT00006233|Fludarabine phosphate|fludarabine phosphate|mesh-list
6328153|NCT00006233|Cyclosporins|cyclosporins|mesh-list
6328154|NCT00006233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328155|NCT00006233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6328156|NCT00006233|Antimetabolites|antimetabolites|mesh-ancestor
6328157|NCT00006233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328158|NCT00006233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6328159|NCT00006233|Immunologic Factors|immunologic factors|mesh-ancestor
6328160|NCT00006233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6328161|NCT00006233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6328162|NCT00006233|Antifungal Agents|antifungal agents|mesh-ancestor
6328163|NCT00006233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6328164|NCT00006233|Dermatologic Agents|dermatologic agents|mesh-ancestor
6328165|NCT00006233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6328166|NCT00006233|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6328167|NCT00006233|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6328168|NCT00006233|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6328169|NCT00006233|Antitubercular Agents|antitubercular agents|mesh-ancestor
6328170|NCT00006233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6328171|NCT00006235|Carboplatin|carboplatin|mesh-list
6328172|NCT00006235|Doxorubicin|doxorubicin|mesh-list
6328173|NCT00006235|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6328174|NCT00006235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328175|NCT00006235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6328176|NCT00006235|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6328177|NCT00006235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6328178|NCT00006235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6328179|NCT00006235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328180|NCT00006239|Tretinoin|tretinoin|mesh-list
6328181|NCT00006239|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
6328182|NCT00006239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328183|NCT00006239|Keratolytic Agents|keratolytic agents|mesh-ancestor
6328184|NCT00006239|Dermatologic Agents|dermatologic agents|mesh-ancestor
6328185|NCT00006240|Dexamethasone|dexamethasone|mesh-list
6328186|NCT00006240|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
6328187|NCT00006240|Sargramostim|sargramostim|mesh-list
6328188|NCT00006240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6328189|NCT00006240|Antiemetics|antiemetics|mesh-ancestor
6328190|NCT00006240|Autonomic Agents|autonomic agents|mesh-ancestor
6328191|NCT00006240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6328192|NCT00006240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6328193|NCT00006240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6328194|NCT00006240|Glucocorticoids|glucocorticoids|mesh-ancestor
6328195|NCT00006240|Hormones|hormones|mesh-ancestor
6328196|NCT00006240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6328197|NCT00006240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6328198|NCT00006240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328199|NCT00006240|Immunologic Factors|immunologic factors|mesh-ancestor
6328200|NCT00006241|Lenograstim|lenograstim|mesh-list
6328201|NCT00006241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6328202|NCT00006241|Immunologic Factors|immunologic factors|mesh-ancestor
6328203|NCT00006241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6328204|NCT00006243|Sargramostim|sargramostim|mesh-list
6328205|NCT00006243|Freund's Adjuvant|freund's adjuvant|mesh-list
6328206|NCT00006243|Immunologic Factors|immunologic factors|mesh-ancestor
6328207|NCT00006243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6328208|NCT00006243|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6328209|NCT00006245|Paclitaxel|paclitaxel|mesh-list
6328210|NCT00006245|Alvocidib|alvocidib|mesh-list
6328211|NCT00006245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6328212|NCT00006245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328213|NCT00006245|Tubulin Modulators|tubulin modulators|mesh-ancestor
6328214|NCT00006245|Antimitotic Agents|antimitotic agents|mesh-ancestor
6328215|NCT00006245|Mitosis Modulators|mitosis modulators|mesh-ancestor
6328216|NCT00006245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328217|NCT00006245|Growth Inhibitors|growth inhibitors|mesh-ancestor
6328218|NCT00006245|Growth Substances|growth substances|mesh-ancestor
6328219|NCT00006245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6328220|NCT00006245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6328221|NCT00006245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6328222|NCT00006246|Busulfan|busulfan|mesh-list
6328223|NCT00006246|Alkylating Agents|alkylating agents|mesh-ancestor
6328224|NCT00006246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328225|NCT00006246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6328226|NCT00006246|Immunologic Factors|immunologic factors|mesh-ancestor
6328227|NCT00006246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6328228|NCT00006246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6328229|NCT00006246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328230|NCT00006246|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6328231|NCT00006247|Semaxinib|semaxinib|mesh-list
6328232|NCT00006247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6328233|NCT00006247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6328234|NCT00006247|Growth Substances|growth substances|mesh-ancestor
6328235|NCT00006247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6328236|NCT00006247|Growth Inhibitors|growth inhibitors|mesh-ancestor
6328237|NCT00006247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328238|NCT00006247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6328239|NCT00006247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6328240|NCT00006247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328241|NCT00006248|Paclitaxel|paclitaxel|mesh-list
6328242|NCT00006248|Fluorouracil|fluorouracil|mesh-list
6328243|NCT00006248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6328244|NCT00006248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328245|NCT00006248|Tubulin Modulators|tubulin modulators|mesh-ancestor
6328246|NCT00006248|Antimitotic Agents|antimitotic agents|mesh-ancestor
6328247|NCT00006248|Mitosis Modulators|mitosis modulators|mesh-ancestor
6328248|NCT00006248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328249|NCT00006248|Antimetabolites|antimetabolites|mesh-ancestor
6328250|NCT00006248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6328251|NCT00006248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6328252|NCT00006248|Immunologic Factors|immunologic factors|mesh-ancestor
6328253|NCT00006248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6328254|NCT00006249|Interferons|interferons|mesh-list
6328255|NCT00006249|Interferon-alpha|interferon-alpha|mesh-list
6328256|NCT00006249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328257|NCT00006249|Antiviral Agents|antiviral agents|mesh-ancestor
6328258|NCT00006249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6328259|NCT00006249|Immunologic Factors|immunologic factors|mesh-ancestor
6328260|NCT00006249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6328261|NCT00006250|Dexamethasone|dexamethasone|mesh-list
6328262|NCT00006250|Fludarabine|fludarabine|mesh-list
6328263|NCT00006250|Fludarabine phosphate|fludarabine phosphate|mesh-list
6328264|NCT00006250|Mitoxantrone|mitoxantrone|mesh-list
6328265|NCT00006250|Chlorambucil|chlorambucil|mesh-list
6328266|NCT00006250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6328267|NCT00006250|Antiemetics|antiemetics|mesh-ancestor
6328268|NCT00006250|Autonomic Agents|autonomic agents|mesh-ancestor
6328269|NCT00006250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6328270|NCT00006250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6328271|NCT00006250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6328272|NCT00006250|Glucocorticoids|glucocorticoids|mesh-ancestor
6328273|NCT00006250|Hormones|hormones|mesh-ancestor
6328274|NCT00006250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6328275|NCT00006250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6328276|NCT00006250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328277|NCT00006250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6328278|NCT00006250|Antimetabolites|antimetabolites|mesh-ancestor
6328279|NCT00006250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328280|NCT00006250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6328281|NCT00006250|Immunologic Factors|immunologic factors|mesh-ancestor
6328282|NCT00006250|Analgesics|analgesics|mesh-ancestor
6328283|NCT00006250|Sensory System Agents|sensory system agents|mesh-ancestor
6328284|NCT00006250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6328285|NCT00006250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6328286|NCT00006250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6328287|NCT00006250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6328288|NCT00006250|Alkylating Agents|alkylating agents|mesh-ancestor
6328289|NCT00006251|Cyclosporine|cyclosporine|mesh-list
6328290|NCT00006251|Mycophenolic Acid|mycophenolic acid|mesh-list
6328291|NCT00006251|Fludarabine|fludarabine|mesh-list
6328292|NCT00006251|Fludarabine phosphate|fludarabine phosphate|mesh-list
6328293|NCT00006251|Cyclosporins|cyclosporins|mesh-list
6328294|NCT00006251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328295|NCT00006251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6328296|NCT00006251|Antimetabolites|antimetabolites|mesh-ancestor
6328297|NCT00006251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328298|NCT00006251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6328299|NCT00006251|Immunologic Factors|immunologic factors|mesh-ancestor
6328300|NCT00006251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6328301|NCT00006251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6328302|NCT00006251|Antifungal Agents|antifungal agents|mesh-ancestor
6328303|NCT00006251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6328304|NCT00006251|Dermatologic Agents|dermatologic agents|mesh-ancestor
6328305|NCT00006251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6328306|NCT00006251|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6328307|NCT00006251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6328308|NCT00006251|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6328309|NCT00006251|Antitubercular Agents|antitubercular agents|mesh-ancestor
6328310|NCT00006251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6328311|NCT00006252|Cyclophosphamide|cyclophosphamide|mesh-list
6328312|NCT00006252|Fludarabine|fludarabine|mesh-list
6328313|NCT00006252|Fludarabine phosphate|fludarabine phosphate|mesh-list
6328314|NCT00006252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6328315|NCT00006252|Immunologic Factors|immunologic factors|mesh-ancestor
6328316|NCT00006252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6328317|NCT00006252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6328318|NCT00006252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6328319|NCT00006252|Alkylating Agents|alkylating agents|mesh-ancestor
6328320|NCT00006252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328321|NCT00006252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328322|NCT00006252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6328323|NCT00006252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6328324|NCT00006252|Antimetabolites|antimetabolites|mesh-ancestor
6328325|NCT00006256|Paclitaxel|paclitaxel|mesh-list
6328326|NCT00006256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6328327|NCT00006256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328328|NCT00006256|Tubulin Modulators|tubulin modulators|mesh-ancestor
6328329|NCT00006256|Antimitotic Agents|antimitotic agents|mesh-ancestor
6328330|NCT00006256|Mitosis Modulators|mitosis modulators|mesh-ancestor
6328331|NCT00006256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328332|NCT00006257|Paclitaxel|paclitaxel|mesh-list
6328333|NCT00006257|Semaxinib|semaxinib|mesh-list
6328334|NCT00006257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6328335|NCT00006257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328336|NCT00006257|Tubulin Modulators|tubulin modulators|mesh-ancestor
6328337|NCT00006257|Antimitotic Agents|antimitotic agents|mesh-ancestor
6328338|NCT00006257|Mitosis Modulators|mitosis modulators|mesh-ancestor
6328339|NCT00006257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328340|NCT00006257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6328341|NCT00006257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6328342|NCT00006257|Growth Substances|growth substances|mesh-ancestor
6328343|NCT00006257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6328344|NCT00006257|Growth Inhibitors|growth inhibitors|mesh-ancestor
6328345|NCT00006257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6328346|NCT00006257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6328347|NCT00006258|Cyclophosphamide|cyclophosphamide|mesh-list
6328348|NCT00006258|Methotrexate|methotrexate|mesh-list
6328349|NCT00006258|Etoposide|etoposide|mesh-list
6328350|NCT00006258|Vincristine|vincristine|mesh-list
6328351|NCT00006258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6328352|NCT00006258|Immunologic Factors|immunologic factors|mesh-ancestor
6328353|NCT00006258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6328354|NCT00006258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6328355|NCT00006258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6328356|NCT00006258|Alkylating Agents|alkylating agents|mesh-ancestor
6328357|NCT00006258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328358|NCT00006258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328359|NCT00006258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6328360|NCT00006258|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6328361|NCT00006258|Abortifacient Agents|abortifacient agents|mesh-ancestor
6328362|NCT00006258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6328363|NCT00006258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6328364|NCT00006258|Antimetabolites|antimetabolites|mesh-ancestor
6328365|NCT00006258|Dermatologic Agents|dermatologic agents|mesh-ancestor
6328366|NCT00006258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6328367|NCT00006258|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6328368|NCT00006258|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6328369|NCT00006258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6328370|NCT00006258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6328371|NCT00006258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6328372|NCT00006258|Tubulin Modulators|tubulin modulators|mesh-ancestor
6328373|NCT00006258|Antimitotic Agents|antimitotic agents|mesh-ancestor
6328374|NCT00006258|Mitosis Modulators|mitosis modulators|mesh-ancestor
6328375|NCT00006260|Etoposide|etoposide|mesh-list
6328376|NCT00006260|Ifosfamide|ifosfamide|mesh-list
6328377|NCT00006260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328378|NCT00006260|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6328379|NCT00006260|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6328380|NCT00006260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6328381|NCT00006260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6328382|NCT00006260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328383|NCT00006260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6328384|NCT00006260|Alkylating Agents|alkylating agents|mesh-ancestor
6328385|NCT00006261|Cyclophosphamide|cyclophosphamide|mesh-list
6328386|NCT00006261|Docetaxel|docetaxel|mesh-list
6328387|NCT00006261|Doxorubicin|doxorubicin|mesh-list
6328388|NCT00006261|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6328389|NCT00006261|Fludarabine|fludarabine|mesh-list
6328390|NCT00006261|Fludarabine phosphate|fludarabine phosphate|mesh-list
6328391|NCT00006261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6328392|NCT00006261|Immunologic Factors|immunologic factors|mesh-ancestor
6328393|NCT00006261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6328394|NCT00006261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6328395|NCT00006261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6328396|NCT00006261|Alkylating Agents|alkylating agents|mesh-ancestor
6328397|NCT00006261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328398|NCT00006261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328399|NCT00006261|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6328400|NCT00006261|Tubulin Modulators|tubulin modulators|mesh-ancestor
6328401|NCT00006261|Antimitotic Agents|antimitotic agents|mesh-ancestor
6328402|NCT00006261|Mitosis Modulators|mitosis modulators|mesh-ancestor
6328403|NCT00006261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6328404|NCT00006261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6328405|NCT00006261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6328406|NCT00006261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6328407|NCT00006261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6328408|NCT00006261|Antimetabolites|antimetabolites|mesh-ancestor
6328409|NCT00006263|Carboplatin|carboplatin|mesh-list
6328410|NCT00006263|Temozolomide|temozolomide|mesh-list
6328411|NCT00006263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328412|NCT00006263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6328413|NCT00006263|Alkylating Agents|alkylating agents|mesh-ancestor
6328414|NCT00006263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328415|NCT00006264|Zidovudine|zidovudine|mesh-list
6328416|NCT00006264|Aldesleukin|aldesleukin|mesh-list
6328417|NCT00006264|Ganciclovir|ganciclovir|mesh-list
6328418|NCT00006264|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6328419|NCT00006264|Antimetabolites|antimetabolites|mesh-ancestor
6328420|NCT00006264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328421|NCT00006264|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6328422|NCT00006264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6328423|NCT00006264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6328424|NCT00006264|Antiviral Agents|antiviral agents|mesh-ancestor
6328425|NCT00006264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6328426|NCT00006264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6328427|NCT00006264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6328428|NCT00006264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328429|NCT00006265|Cytarabine|cytarabine|mesh-list
6328430|NCT00006265|Gemtuzumab|gemtuzumab|mesh-list
6328431|NCT00006265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6328432|NCT00006265|Antimetabolites|antimetabolites|mesh-ancestor
6328433|NCT00006265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328434|NCT00006265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328435|NCT00006265|Antiviral Agents|antiviral agents|mesh-ancestor
6328436|NCT00006265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6328437|NCT00006265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6328438|NCT00006265|Immunologic Factors|immunologic factors|mesh-ancestor
6328439|NCT00006265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6328440|NCT00006265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6328441|NCT00006267|Rubitecan|rubitecan|mesh-list
6328442|NCT00006267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328443|NCT00006267|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6328444|NCT00006267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6328445|NCT00006267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6328446|NCT00006267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328447|NCT00006269|Irinotecan|irinotecan|mesh-list
6328448|NCT00006269|Octreotide|octreotide|mesh-list
6328449|NCT00006269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6328450|NCT00006269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6328451|NCT00006269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6328452|NCT00006269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328453|NCT00006269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328454|NCT00006269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6328455|NCT00006269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6328456|NCT00006270|Cosyntropin|cosyntropin|mesh-list
6328457|NCT00006270|Metyrapone|metyrapone|mesh-list
6328458|NCT00006270|Hormones|hormones|mesh-ancestor
6328459|NCT00006270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6328460|NCT00006270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6328461|NCT00006270|Antimetabolites|antimetabolites|mesh-ancestor
6328462|NCT00006270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328463|NCT00006270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6328464|NCT00006275|Calcitriol|calcitriol|mesh-list
6328465|NCT00006275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6328466|NCT00006275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6328467|NCT00006275|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6328468|NCT00006275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6328469|NCT00006275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328470|NCT00006275|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6328471|NCT00006275|Vitamins|vitamins|mesh-ancestor
6328472|NCT00006275|Micronutrients|micronutrients|mesh-ancestor
6328473|NCT00006275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6328474|NCT00006276|Paclitaxel|paclitaxel|mesh-list
6328475|NCT00006276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6328476|NCT00006276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328477|NCT00006276|Tubulin Modulators|tubulin modulators|mesh-ancestor
6328478|NCT00006276|Antimitotic Agents|antimitotic agents|mesh-ancestor
6328479|NCT00006276|Mitosis Modulators|mitosis modulators|mesh-ancestor
6328480|NCT00006276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328481|NCT00006279|Nevirapine|nevirapine|mesh-list
6328482|NCT00006279|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6328483|NCT00006279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6328484|NCT00006279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6328485|NCT00006279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328486|NCT00006279|Antiviral Agents|antiviral agents|mesh-ancestor
6328487|NCT00006279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6328488|NCT00006279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6328489|NCT00006279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6328490|NCT00006279|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6328491|NCT00006279|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6328492|NCT00006280|Tobramycin|tobramycin|mesh-list
6328493|NCT00006280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6328494|NCT00006280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6393131|NCT00198978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6393132|NCT00198978|Antiviral Agents|antiviral agents|mesh-ancestor
6393133|NCT00198978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6393134|NCT00198978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6393135|NCT00198978|Tubulin Modulators|tubulin modulators|mesh-ancestor
6393136|NCT00198978|Antimitotic Agents|antimitotic agents|mesh-ancestor
6393137|NCT00198978|Mitosis Modulators|mitosis modulators|mesh-ancestor
6393138|NCT00198978|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6393139|NCT00198978|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6393140|NCT00198978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6393141|NCT00198978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6393142|NCT00198991|Cytarabine|cytarabine|mesh-list
6393143|NCT00198991|Dexamethasone|dexamethasone|mesh-list
6393144|NCT00198991|Prednisolone|prednisolone|mesh-list
6393145|NCT00198991|Cyclophosphamide|cyclophosphamide|mesh-list
6393146|NCT00198991|Methotrexate|methotrexate|mesh-list
6393147|NCT00198991|Fludarabine|fludarabine|mesh-list
6393148|NCT00198991|Vincristine|vincristine|mesh-list
6393149|NCT00198991|Doxorubicin|doxorubicin|mesh-list
6393150|NCT00198991|Daunorubicin|daunorubicin|mesh-list
6393151|NCT00198991|Asparaginase|asparaginase|mesh-list
6393152|NCT00198991|Mercaptopurine|mercaptopurine|mesh-list
6393153|NCT00198991|Idarubicin|idarubicin|mesh-list
6393154|NCT00198991|Thioguanine|thioguanine|mesh-list
6393155|NCT00198991|Cladribine|cladribine|mesh-list
6393156|NCT00198991|Vindesine|vindesine|mesh-list
6393157|NCT00198991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6393158|NCT00198991|Immunologic Factors|immunologic factors|mesh-ancestor
6393159|NCT00198991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6393160|NCT00198991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6393161|NCT00198991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6393162|NCT00198991|Alkylating Agents|alkylating agents|mesh-ancestor
6393163|NCT00198991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393164|NCT00198991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6393165|NCT00198991|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6393166|NCT00198991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6393167|NCT00198991|Antiemetics|antiemetics|mesh-ancestor
6393168|NCT00198991|Autonomic Agents|autonomic agents|mesh-ancestor
6393169|NCT00198991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6393170|NCT00198991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6393171|NCT00198991|Glucocorticoids|glucocorticoids|mesh-ancestor
6393172|NCT00198991|Hormones|hormones|mesh-ancestor
6393173|NCT00198991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6393174|NCT00198991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6393175|NCT00198991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6393176|NCT00198991|Abortifacient Agents|abortifacient agents|mesh-ancestor
6393177|NCT00198991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6393178|NCT00198991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6393179|NCT00198991|Antimetabolites|antimetabolites|mesh-ancestor
6393180|NCT00198991|Dermatologic Agents|dermatologic agents|mesh-ancestor
6393181|NCT00198991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6393182|NCT00198991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6393183|NCT00198991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6393184|NCT00198991|Antiviral Agents|antiviral agents|mesh-ancestor
6393185|NCT00198991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6393186|NCT00198991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6393187|NCT00198991|Tubulin Modulators|tubulin modulators|mesh-ancestor
6393188|NCT00198991|Antimitotic Agents|antimitotic agents|mesh-ancestor
6393189|NCT00198991|Mitosis Modulators|mitosis modulators|mesh-ancestor
6393190|NCT00198991|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6393191|NCT00198991|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6393192|NCT00198991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6393193|NCT00199004|Cytarabine|cytarabine|mesh-list
6393194|NCT00199004|Dexamethasone|dexamethasone|mesh-list
6393195|NCT00199004|Prednisolone|prednisolone|mesh-list
6393196|NCT00199004|Cyclophosphamide|cyclophosphamide|mesh-list
6393197|NCT00199004|Rituximab|rituximab|mesh-list
6393198|NCT00199004|Methotrexate|methotrexate|mesh-list
6393199|NCT00199004|Vincristine|vincristine|mesh-list
6393200|NCT00199004|Doxorubicin|doxorubicin|mesh-list
6393201|NCT00199004|Daunorubicin|daunorubicin|mesh-list
6393202|NCT00199004|Asparaginase|asparaginase|mesh-list
6393203|NCT00199004|Mercaptopurine|mercaptopurine|mesh-list
6393204|NCT00199004|Thioguanine|thioguanine|mesh-list
6393205|NCT00199004|Vindesine|vindesine|mesh-list
6393206|NCT00199004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6393207|NCT00199004|Immunologic Factors|immunologic factors|mesh-ancestor
6328495|NCT00006286|Fluoxetine|fluoxetine|mesh-list
6328496|NCT00006286|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6328497|NCT00006286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6328498|NCT00006286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6328499|NCT00006286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328500|NCT00006286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6328501|NCT00006286|Serotonin Agents|serotonin agents|mesh-ancestor
6328502|NCT00006286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6328503|NCT00006286|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6328504|NCT00006286|Antidepressive Agents|antidepressive agents|mesh-ancestor
6328505|NCT00006286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6328506|NCT00006286|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6328507|NCT00006286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6328508|NCT00006286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6328509|NCT00006291|Aldesleukin|aldesleukin|mesh-list
6328510|NCT00006291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328511|NCT00006291|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6328512|NCT00006291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6328513|NCT00006291|Antiviral Agents|antiviral agents|mesh-ancestor
6328514|NCT00006291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6328515|NCT00006292|Infliximab|infliximab|mesh-list
6328516|NCT00006292|Dermatologic Agents|dermatologic agents|mesh-ancestor
6328517|NCT00006292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6328518|NCT00006292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6328519|NCT00006294|Amlodipine|amlodipine|mesh-list
6328520|NCT00006294|Lisinopril|lisinopril|mesh-list
6328521|NCT00006294|Chlorthalidone|chlorthalidone|mesh-list
6328522|NCT00006294|Doxazosin|doxazosin|mesh-list
6328523|NCT00006294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6328524|NCT00006294|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6328525|NCT00006294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6328526|NCT00006294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328527|NCT00006294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6328528|NCT00006294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6328529|NCT00006294|Vasodilator Agents|vasodilator agents|mesh-ancestor
6328530|NCT00006294|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6328531|NCT00006294|Protease Inhibitors|protease inhibitors|mesh-ancestor
6328532|NCT00006294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6328533|NCT00006294|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6328534|NCT00006294|Protective Agents|protective agents|mesh-ancestor
6328535|NCT00006294|Diuretics|diuretics|mesh-ancestor
6328536|NCT00006294|Natriuretic Agents|natriuretic agents|mesh-ancestor
6328537|NCT00006294|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6328538|NCT00006294|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6328539|NCT00006294|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6328540|NCT00006294|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6328541|NCT00006294|Adrenergic Agents|adrenergic agents|mesh-ancestor
6328542|NCT00006294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6328543|NCT00006299|Celecoxib|celecoxib|mesh-list
6328544|NCT00006299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6328545|NCT00006299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6328546|NCT00006299|Analgesics|analgesics|mesh-ancestor
6328547|NCT00006299|Sensory System Agents|sensory system agents|mesh-ancestor
6328548|NCT00006299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6328549|NCT00006299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6328550|NCT00006299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6328551|NCT00006299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6328552|NCT00006299|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6328553|NCT00006299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6328554|NCT00006299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6328555|NCT00006299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328556|NCT00006320|Anti-HIV Agents|anti-hiv agents|mesh-list
6328557|NCT00006320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6328558|NCT00006320|Antiviral Agents|antiviral agents|mesh-ancestor
6328559|NCT00006320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6328560|NCT00006324|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6328561|NCT00006324|Levonorgestrel|levonorgestrel|mesh-list
6328562|NCT00006324|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6328563|NCT00006324|Medroxyprogesterone|medroxyprogesterone|mesh-list
6328564|NCT00006324|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
6328565|NCT00006324|Estradiol|estradiol|mesh-list
6328566|NCT00006324|Estrogens|estrogens|mesh-ancestor
6328567|NCT00006324|Hormones|hormones|mesh-ancestor
6328568|NCT00006324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6328569|NCT00006324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6328570|NCT00006324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6328571|NCT00006324|Contraceptive Agents|contraceptive agents|mesh-ancestor
6328572|NCT00006324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6328573|NCT00006324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6328574|NCT00006324|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6328575|NCT00006324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6328576|NCT00006324|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6328577|NCT00006324|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6328578|NCT00006324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6328579|NCT00006324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328580|NCT00006324|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6328581|NCT00006325|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6328582|NCT00006325|Antiviral Agents|antiviral agents|mesh-ancestor
6328583|NCT00006325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6328584|NCT00006326|Ritonavir|ritonavir|mesh-list
6328585|NCT00006326|Indinavir|indinavir|mesh-list
6328586|NCT00006326|Delavirdine|delavirdine|mesh-list
6328587|NCT00006326|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6328588|NCT00006326|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6328589|NCT00006326|Protease Inhibitors|protease inhibitors|mesh-ancestor
6328590|NCT00006326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6328591|NCT00006326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328592|NCT00006326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6328593|NCT00006326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6328594|NCT00006326|Antiviral Agents|antiviral agents|mesh-ancestor
6328595|NCT00006326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6328596|NCT00006326|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6328597|NCT00006326|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6328598|NCT00006326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6328599|NCT00006326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6328600|NCT00006330|Digoxin|digoxin|mesh-list
6328601|NCT00006330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6328602|NCT00006330|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6328603|NCT00006330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6328604|NCT00006330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328605|NCT00006330|Protective Agents|protective agents|mesh-ancestor
6328606|NCT00006330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6328607|NCT00006332|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
6328608|NCT00006332|Chelating Agents|chelating agents|mesh-ancestor
6328609|NCT00006332|Sequestering Agents|sequestering agents|mesh-ancestor
6328610|NCT00006332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328611|NCT00006332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6328612|NCT00006332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6328613|NCT00006332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6328614|NCT00006332|Growth Substances|growth substances|mesh-ancestor
6328615|NCT00006332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6328616|NCT00006332|Growth Inhibitors|growth inhibitors|mesh-ancestor
6328617|NCT00006332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328618|NCT00006337|Levodopa|levodopa|mesh-list
6328619|NCT00006337|Istradefylline|istradefylline|mesh-list
6328620|NCT00006337|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6328621|NCT00006337|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6328622|NCT00006337|Dopamine Agents|dopamine agents|mesh-ancestor
6328623|NCT00006337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6328624|NCT00006337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328625|NCT00006337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6328626|NCT00006337|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
6328627|NCT00006337|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6328628|NCT00006337|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6328629|NCT00006337|Purinergic Agents|purinergic agents|mesh-ancestor
6328630|NCT00006339|Ritonavir|ritonavir|mesh-list
6328631|NCT00006339|Indinavir|indinavir|mesh-list
6328632|NCT00006339|Stavudine|stavudine|mesh-list
6328633|NCT00006339|Didanosine|didanosine|mesh-list
6328634|NCT00006339|Hydroxyurea|hydroxyurea|mesh-list
6328635|NCT00006339|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6328636|NCT00006339|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6328637|NCT00006339|Protease Inhibitors|protease inhibitors|mesh-ancestor
6328638|NCT00006339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6328639|NCT00006339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328640|NCT00006339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6328641|NCT00006339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6328642|NCT00006339|Antiviral Agents|antiviral agents|mesh-ancestor
6328643|NCT00006339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6328644|NCT00006339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6328645|NCT00006339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6328646|NCT00006339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328647|NCT00006339|Antisickling Agents|antisickling agents|mesh-ancestor
6328648|NCT00006339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6328649|NCT00006339|Antimetabolites|antimetabolites|mesh-ancestor
6328650|NCT00006339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6328651|NCT00006340|Ganciclovir|ganciclovir|mesh-list
6328652|NCT00006340|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6328653|NCT00006340|Arginine butyrate|arginine butyrate|mesh-list
6328654|NCT00006340|Antiviral Agents|antiviral agents|mesh-ancestor
6328655|NCT00006340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6328656|NCT00006340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6328657|NCT00006340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6328658|NCT00006340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328659|NCT00006340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328660|NCT00006343|Interferons|interferons|mesh-list
6328661|NCT00006343|Cytarabine|cytarabine|mesh-list
6328662|NCT00006343|Interferon-alpha|interferon-alpha|mesh-list
6328663|NCT00006343|Imatinib Mesylate|imatinib mesylate|mesh-list
6328664|NCT00006343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328665|NCT00006343|Antiviral Agents|antiviral agents|mesh-ancestor
6328666|NCT00006343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6328667|NCT00006343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6328668|NCT00006343|Antimetabolites|antimetabolites|mesh-ancestor
6328669|NCT00006343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328670|NCT00006343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6328671|NCT00006343|Immunologic Factors|immunologic factors|mesh-ancestor
6328672|NCT00006343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6328673|NCT00006343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6328674|NCT00006343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6328675|NCT00006345|Dexamethasone|dexamethasone|mesh-list
6328676|NCT00006345|Denileukin diftitox|denileukin diftitox|mesh-list
6328677|NCT00006345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6328678|NCT00006345|Antiemetics|antiemetics|mesh-ancestor
6328679|NCT00006345|Autonomic Agents|autonomic agents|mesh-ancestor
6328680|NCT00006345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6328681|NCT00006345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6328682|NCT00006345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6328683|NCT00006345|Glucocorticoids|glucocorticoids|mesh-ancestor
6328684|NCT00006345|Hormones|hormones|mesh-ancestor
6328685|NCT00006345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6328686|NCT00006345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6328687|NCT00006345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328688|NCT00006347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6328689|NCT00006347|Antibodies|antibodies|mesh-list
6328690|NCT00006347|Immunoglobulins|immunoglobulins|mesh-list
6328691|NCT00006347|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6328692|NCT00006347|Immunologic Factors|immunologic factors|mesh-ancestor
6328693|NCT00006347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6328694|NCT00006347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328695|NCT00006348|Ondansetron|ondansetron|mesh-list
6328696|NCT00006348|Antiemetics|antiemetics|mesh-ancestor
6328697|NCT00006348|Autonomic Agents|autonomic agents|mesh-ancestor
6328698|NCT00006348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6328699|NCT00006348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6328700|NCT00006348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6328701|NCT00006348|Antipruritics|antipruritics|mesh-ancestor
6328702|NCT00006348|Dermatologic Agents|dermatologic agents|mesh-ancestor
6328703|NCT00006348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6328704|NCT00006348|Serotonin Agents|serotonin agents|mesh-ancestor
6328705|NCT00006348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6328706|NCT00006348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328707|NCT00006348|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6328708|NCT00006348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6328709|NCT00006348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6328710|NCT00006348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6328711|NCT00006348|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6328712|NCT00006349|Vitamin E|vitamin e|mesh-list
6328713|NCT00006349|Donepezil|donepezil|mesh-list
6328714|NCT00006349|Vitamins|vitamins|mesh-ancestor
6328715|NCT00006349|Micronutrients|micronutrients|mesh-ancestor
6328716|NCT00006349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6328717|NCT00006349|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6328718|NCT00006349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6328719|NCT00006349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328720|NCT00006349|Cholinergic Agents|cholinergic agents|mesh-ancestor
6328721|NCT00006349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6328722|NCT00006349|Nootropic Agents|nootropic agents|mesh-ancestor
6328723|NCT00006349|Antioxidants|antioxidants|mesh-ancestor
6328724|NCT00006349|Protective Agents|protective agents|mesh-ancestor
6328725|NCT00006350|Mycophenolic Acid|mycophenolic acid|mesh-list
6328726|NCT00006350|Tacrolimus|tacrolimus|mesh-list
6328727|NCT00006350|Daclizumab|daclizumab|mesh-list
6328728|NCT00006350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6328729|NCT00006350|Immunologic Factors|immunologic factors|mesh-ancestor
6328730|NCT00006350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6328731|NCT00006350|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6328732|NCT00006350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6328733|NCT00006350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328734|NCT00006350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6328735|NCT00006350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328736|NCT00006350|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6328737|NCT00006350|Antitubercular Agents|antitubercular agents|mesh-ancestor
6328738|NCT00006350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6328739|NCT00006350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6328740|NCT00006351|Gemcitabine|gemcitabine|mesh-list
6328741|NCT00006351|Lonafarnib|lonafarnib|mesh-list
6328742|NCT00006351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6328743|NCT00006351|Antimetabolites|antimetabolites|mesh-ancestor
6328744|NCT00006351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328745|NCT00006351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328746|NCT00006351|Antiviral Agents|antiviral agents|mesh-ancestor
6328747|NCT00006351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6328748|NCT00006351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6328749|NCT00006351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6328750|NCT00006351|Immunologic Factors|immunologic factors|mesh-ancestor
6328751|NCT00006351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6328752|NCT00006352|Antibodies|antibodies|mesh-list
6328753|NCT00006352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6328754|NCT00006352|BCG Vaccine|bcg vaccine|mesh-list
6328755|NCT00006352|Immunologic Factors|immunologic factors|mesh-ancestor
6328756|NCT00006352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6328757|NCT00006352|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6328758|NCT00006353|Temozolomide|temozolomide|mesh-list
6328759|NCT00006353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6328760|NCT00006353|Alkylating Agents|alkylating agents|mesh-ancestor
6328761|NCT00006353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328762|NCT00006353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328763|NCT00006355|NSC 366140|nsc 366140|mesh-list
6328764|NCT00006355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328765|NCT00006356|Carboplatin|carboplatin|mesh-list
6328766|NCT00006356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328767|NCT00006357|Imatinib Mesylate|imatinib mesylate|mesh-list
6328768|NCT00006357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328769|NCT00006357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6328770|NCT00006357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6328771|NCT00006357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328772|NCT00006358|Thalidomide|thalidomide|mesh-list
6328773|NCT00006358|Temozolomide|temozolomide|mesh-list
6328774|NCT00006358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6328775|NCT00006358|Alkylating Agents|alkylating agents|mesh-ancestor
6328776|NCT00006358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328777|NCT00006358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328778|NCT00006358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6328779|NCT00006358|Immunologic Factors|immunologic factors|mesh-ancestor
6328780|NCT00006358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6328781|NCT00006358|Leprostatic Agents|leprostatic agents|mesh-ancestor
6328782|NCT00006358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6328783|NCT00006358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6328784|NCT00006358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6328785|NCT00006358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6328786|NCT00006358|Growth Substances|growth substances|mesh-ancestor
6328787|NCT00006358|Growth Inhibitors|growth inhibitors|mesh-ancestor
6328788|NCT00006359|Androgen Antagonists|androgen antagonists|mesh-list
6328789|NCT00006359|Hormone Antagonists|hormone antagonists|mesh-ancestor
6328790|NCT00006359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6328791|NCT00006359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6328792|NCT00006361|Semaxinib|semaxinib|mesh-list
6328793|NCT00006361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6328794|NCT00006361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6328795|NCT00006361|Growth Substances|growth substances|mesh-ancestor
6328796|NCT00006361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6328797|NCT00006361|Growth Inhibitors|growth inhibitors|mesh-ancestor
6328798|NCT00006361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328799|NCT00006361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6328800|NCT00006361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6328801|NCT00006361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328802|NCT00006362|Bortezomib|bortezomib|mesh-list
6328803|NCT00006362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328804|NCT00006363|Cytarabine|cytarabine|mesh-list
6328805|NCT00006363|Aldesleukin|aldesleukin|mesh-list
6328806|NCT00006363|Etoposide|etoposide|mesh-list
6328807|NCT00006363|Daunorubicin|daunorubicin|mesh-list
6328808|NCT00006363|Etoposide phosphate|etoposide phosphate|mesh-list
6328809|NCT00006363|Busulfan|busulfan|mesh-list
6328810|NCT00006363|Interleukin-2|interleukin-2|mesh-list
6328811|NCT00006363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6328812|NCT00006363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328813|NCT00006363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6328814|NCT00006363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6328815|NCT00006363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6328816|NCT00006363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328817|NCT00006363|Immunologic Factors|immunologic factors|mesh-ancestor
6328818|NCT00006363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6328819|NCT00006363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6328820|NCT00006363|Antimetabolites|antimetabolites|mesh-ancestor
6328821|NCT00006363|Antiviral Agents|antiviral agents|mesh-ancestor
6328822|NCT00006363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6328823|NCT00006363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6328824|NCT00006363|Alkylating Agents|alkylating agents|mesh-ancestor
6328825|NCT00006363|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6328826|NCT00006363|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6328827|NCT00006363|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6328828|NCT00006363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6328829|NCT00006363|Analgesics|analgesics|mesh-ancestor
6328830|NCT00006363|Sensory System Agents|sensory system agents|mesh-ancestor
6328831|NCT00006363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6328832|NCT00006363|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6328833|NCT00006363|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6328834|NCT00006364|Homoharringtonine|homoharringtonine|mesh-list
6328835|NCT00006364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6328836|NCT00006364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328837|NCT00006364|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6328838|NCT00006364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6328839|NCT00006364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328840|NCT00006366|Fluorouracil|fluorouracil|mesh-list
6328841|NCT00006366|Irinotecan|irinotecan|mesh-list
6328842|NCT00006366|Antimetabolites|antimetabolites|mesh-ancestor
6328843|NCT00006366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328844|NCT00006366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6328845|NCT00006366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328846|NCT00006366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6328847|NCT00006366|Immunologic Factors|immunologic factors|mesh-ancestor
6328848|NCT00006366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6328849|NCT00006366|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6328850|NCT00006366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6328851|NCT00006366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6328852|NCT00006367|Cytarabine|cytarabine|mesh-list
6328853|NCT00006367|Busulfan|busulfan|mesh-list
6328854|NCT00006367|Idarubicin|idarubicin|mesh-list
6328855|NCT00006367|Immunologic Factors|immunologic factors|mesh-ancestor
6328856|NCT00006367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6328857|NCT00006367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6328858|NCT00006367|Antimetabolites|antimetabolites|mesh-ancestor
6328859|NCT00006367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328860|NCT00006367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328861|NCT00006367|Antiviral Agents|antiviral agents|mesh-ancestor
6328862|NCT00006367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6328863|NCT00006367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6328864|NCT00006367|Alkylating Agents|alkylating agents|mesh-ancestor
6328865|NCT00006367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6328866|NCT00006367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6328867|NCT00006367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6328868|NCT00006367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6328869|NCT00006367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6328870|NCT00006367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6328871|NCT00006368|Edotreotide|edotreotide|mesh-list
6328872|NCT00006368|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6328873|NCT00006368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328874|NCT00006370|Edotreotide|edotreotide|mesh-list
6328875|NCT00006370|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6328876|NCT00006370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328877|NCT00006371|Ketoconazole|ketoconazole|mesh-list
6328878|NCT00006371|Hydrocortisone|hydrocortisone|mesh-list
6328879|NCT00006371|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6328880|NCT00006371|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6328881|NCT00006371|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6328882|NCT00006371|Aminoglutethimide|aminoglutethimide|mesh-list
6328883|NCT00006371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6328884|NCT00006371|Antifungal Agents|antifungal agents|mesh-ancestor
6328885|NCT00006371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6328886|NCT00006371|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6328887|NCT00006371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6328888|NCT00006371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6328889|NCT00006371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328890|NCT00006371|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6328891|NCT00006371|Hormone Antagonists|hormone antagonists|mesh-ancestor
6328892|NCT00006371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6328893|NCT00006371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6328894|NCT00006371|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6328895|NCT00006371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6328896|NCT00006371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328897|NCT00006371|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6328898|NCT00006371|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6328899|NCT00006372|Gemcitabine|gemcitabine|mesh-list
6328900|NCT00006372|Doxorubicin|doxorubicin|mesh-list
6328901|NCT00006372|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6328902|NCT00006372|Vinorelbine|vinorelbine|mesh-list
6328903|NCT00006372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6328904|NCT00006372|Antimetabolites|antimetabolites|mesh-ancestor
6328905|NCT00006372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328906|NCT00006372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328907|NCT00006372|Antiviral Agents|antiviral agents|mesh-ancestor
6328908|NCT00006372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6328909|NCT00006372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6328910|NCT00006372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6328911|NCT00006372|Immunologic Factors|immunologic factors|mesh-ancestor
6328912|NCT00006372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6328913|NCT00006372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6328914|NCT00006372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6328915|NCT00006372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6328916|NCT00006372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6328917|NCT00006372|Tubulin Modulators|tubulin modulators|mesh-ancestor
6328918|NCT00006372|Antimitotic Agents|antimitotic agents|mesh-ancestor
6328919|NCT00006372|Mitosis Modulators|mitosis modulators|mesh-ancestor
6328920|NCT00006373|Etoposide|etoposide|mesh-list
6328921|NCT00006373|Topotecan|topotecan|mesh-list
6328922|NCT00006373|Ifosfamide|ifosfamide|mesh-list
6328923|NCT00006373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6328924|NCT00006373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328925|NCT00006373|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6328926|NCT00006373|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6328927|NCT00006373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6328928|NCT00006373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328929|NCT00006373|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6328930|NCT00006373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6328931|NCT00006373|Alkylating Agents|alkylating agents|mesh-ancestor
6328932|NCT00006374|Paclitaxel|paclitaxel|mesh-list
6328933|NCT00006374|Etoposide|etoposide|mesh-list
6328934|NCT00006374|Topotecan|topotecan|mesh-list
6328935|NCT00006374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6328936|NCT00006374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328937|NCT00006374|Tubulin Modulators|tubulin modulators|mesh-ancestor
6328938|NCT00006374|Antimitotic Agents|antimitotic agents|mesh-ancestor
6328939|NCT00006374|Mitosis Modulators|mitosis modulators|mesh-ancestor
6328940|NCT00006374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328941|NCT00006374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6328942|NCT00006374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6328943|NCT00006374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6328944|NCT00006374|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6328945|NCT00006376|Tipifarnib|tipifarnib|mesh-list
6328946|NCT00006376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328947|NCT00006377|Paclitaxel|paclitaxel|mesh-list
6328948|NCT00006377|Carboplatin|carboplatin|mesh-list
6328949|NCT00006377|Doxorubicin|doxorubicin|mesh-list
6328950|NCT00006377|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6328951|NCT00006377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6328952|NCT00006377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328953|NCT00006377|Tubulin Modulators|tubulin modulators|mesh-ancestor
6328954|NCT00006377|Antimitotic Agents|antimitotic agents|mesh-ancestor
6328955|NCT00006377|Mitosis Modulators|mitosis modulators|mesh-ancestor
6328956|NCT00006377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328957|NCT00006377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6328958|NCT00006377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6328959|NCT00006377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6328960|NCT00006377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6328961|NCT00006378|Paclitaxel|paclitaxel|mesh-list
6328962|NCT00006378|Carboplatin|carboplatin|mesh-list
6328963|NCT00006378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6328964|NCT00006378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328965|NCT00006378|Tubulin Modulators|tubulin modulators|mesh-ancestor
6328966|NCT00006378|Antimitotic Agents|antimitotic agents|mesh-ancestor
6328967|NCT00006378|Mitosis Modulators|mitosis modulators|mesh-ancestor
6328968|NCT00006378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328969|NCT00006379|Cyclophosphamide|cyclophosphamide|mesh-list
6328970|NCT00006379|Fludarabine|fludarabine|mesh-list
6328971|NCT00006379|Fludarabine phosphate|fludarabine phosphate|mesh-list
6328972|NCT00006379|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6328973|NCT00006379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6328974|NCT00006379|Immunologic Factors|immunologic factors|mesh-ancestor
6328975|NCT00006379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6328976|NCT00006379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6328977|NCT00006379|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6328978|NCT00006379|Alkylating Agents|alkylating agents|mesh-ancestor
6328979|NCT00006379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6328980|NCT00006379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328981|NCT00006379|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6328982|NCT00006379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6328983|NCT00006379|Antimetabolites|antimetabolites|mesh-ancestor
6328984|NCT00006380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6328985|NCT00006380|Antibodies|antibodies|mesh-list
6328986|NCT00006380|Immunoglobulins|immunoglobulins|mesh-list
6328987|NCT00006380|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6328988|NCT00006380|Immunologic Factors|immunologic factors|mesh-ancestor
6328989|NCT00006380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6328990|NCT00006380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328991|NCT00006381|Celecoxib|celecoxib|mesh-list
6328992|NCT00006381|Trastuzumab|trastuzumab|mesh-list
6328993|NCT00006381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6328994|NCT00006381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6328995|NCT00006381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6328996|NCT00006381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6328997|NCT00006381|Analgesics|analgesics|mesh-ancestor
6328998|NCT00006381|Sensory System Agents|sensory system agents|mesh-ancestor
6328999|NCT00006381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6329000|NCT00006381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6329001|NCT00006381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6329002|NCT00006381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6329003|NCT00006381|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6329004|NCT00006381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6329005|NCT00006381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6329006|NCT00006381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329007|NCT00006383|Vincristine|vincristine|mesh-list
6329008|NCT00006383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6329009|NCT00006383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329010|NCT00006383|Tubulin Modulators|tubulin modulators|mesh-ancestor
6329011|NCT00006383|Antimitotic Agents|antimitotic agents|mesh-ancestor
6329012|NCT00006383|Mitosis Modulators|mitosis modulators|mesh-ancestor
6329013|NCT00006383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329014|NCT00006384|Interferons|interferons|mesh-list
6329015|NCT00006384|Interferon-alpha|interferon-alpha|mesh-list
6329016|NCT00006384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329017|NCT00006384|Antiviral Agents|antiviral agents|mesh-ancestor
6329018|NCT00006384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6329019|NCT00006384|Immunologic Factors|immunologic factors|mesh-ancestor
6329020|NCT00006384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6329021|NCT00006385|Interferons|interferons|mesh-list
6329022|NCT00006385|Interferon-alpha|interferon-alpha|mesh-list
6329023|NCT00006385|Sargramostim|sargramostim|mesh-list
6329024|NCT00006385|Freund's Adjuvant|freund's adjuvant|mesh-list
6329025|NCT00006385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329026|NCT00006385|Antiviral Agents|antiviral agents|mesh-ancestor
6329027|NCT00006385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6329028|NCT00006385|Immunologic Factors|immunologic factors|mesh-ancestor
6329029|NCT00006385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6329030|NCT00006385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6329031|NCT00006386|Carmustine|carmustine|mesh-list
6329032|NCT00006386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6329033|NCT00006386|Alkylating Agents|alkylating agents|mesh-ancestor
6329034|NCT00006386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329035|NCT00006386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329036|NCT00006388|Tamoxifen|tamoxifen|mesh-list
6329037|NCT00006388|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6329038|NCT00006388|Hormone Antagonists|hormone antagonists|mesh-ancestor
6329039|NCT00006388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6329040|NCT00006388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6329041|NCT00006388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6329042|NCT00006388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329043|NCT00006388|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6329044|NCT00006388|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6329045|NCT00006388|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6329046|NCT00006390|Cyclophosphamide|cyclophosphamide|mesh-list
6329047|NCT00006390|Alemtuzumab|alemtuzumab|mesh-list
6329048|NCT00006390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6329049|NCT00006390|Immunologic Factors|immunologic factors|mesh-ancestor
6329050|NCT00006390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6329051|NCT00006390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6329052|NCT00006390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6329053|NCT00006390|Alkylating Agents|alkylating agents|mesh-ancestor
6329054|NCT00006390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329055|NCT00006390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329056|NCT00006390|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6329057|NCT00006390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6329058|NCT00006391|Oxaliplatin|oxaliplatin|mesh-list
6329059|NCT00006391|Topotecan|topotecan|mesh-list
6329060|NCT00006391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329061|NCT00006391|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6329062|NCT00006391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6329063|NCT00006391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6329064|NCT00006391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329065|NCT00006394|Hormones|hormones|mesh-list
6329066|NCT00006394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6329067|NCT00006394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6329068|NCT00006396|Zidovudine|zidovudine|mesh-list
6329069|NCT00006396|Nevirapine|nevirapine|mesh-list
6329070|NCT00006396|Antimetabolites|antimetabolites|mesh-ancestor
6329071|NCT00006396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329072|NCT00006396|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6329073|NCT00006396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6329074|NCT00006396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6329075|NCT00006396|Antiviral Agents|antiviral agents|mesh-ancestor
6329076|NCT00006396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6329077|NCT00006396|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6329078|NCT00006396|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6329079|NCT00006396|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6329080|NCT00006396|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6393208|NCT00199004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6393209|NCT00199004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6393210|NCT00199004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6393211|NCT00199004|Alkylating Agents|alkylating agents|mesh-ancestor
6393212|NCT00199004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393213|NCT00199004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6393214|NCT00199004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6393215|NCT00199004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6393216|NCT00199004|Antiemetics|antiemetics|mesh-ancestor
6393217|NCT00199004|Autonomic Agents|autonomic agents|mesh-ancestor
6393218|NCT00199004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6393219|NCT00199004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6393220|NCT00199004|Glucocorticoids|glucocorticoids|mesh-ancestor
6393221|NCT00199004|Hormones|hormones|mesh-ancestor
6393222|NCT00199004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6393223|NCT00199004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6393224|NCT00199004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6393225|NCT00199004|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6393226|NCT00199004|Abortifacient Agents|abortifacient agents|mesh-ancestor
6393227|NCT00199004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6393228|NCT00199004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6393229|NCT00199004|Antimetabolites|antimetabolites|mesh-ancestor
6393230|NCT00199004|Dermatologic Agents|dermatologic agents|mesh-ancestor
6393231|NCT00199004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6393232|NCT00199004|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6393233|NCT00199004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6393234|NCT00199004|Antiviral Agents|antiviral agents|mesh-ancestor
6393235|NCT00199004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6393236|NCT00199004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6393237|NCT00199004|Tubulin Modulators|tubulin modulators|mesh-ancestor
6329081|NCT00006397|Ritonavir|ritonavir|mesh-list
6329082|NCT00006397|Indinavir|indinavir|mesh-list
6329083|NCT00006397|Stavudine|stavudine|mesh-list
6329084|NCT00006397|Didanosine|didanosine|mesh-list
6329085|NCT00006397|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6329086|NCT00006397|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6329087|NCT00006397|Protease Inhibitors|protease inhibitors|mesh-ancestor
6329088|NCT00006397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6329089|NCT00006397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329090|NCT00006397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6329091|NCT00006397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6329092|NCT00006397|Antiviral Agents|antiviral agents|mesh-ancestor
6329093|NCT00006397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6329094|NCT00006397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6329095|NCT00006397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6329096|NCT00006397|Antimetabolites|antimetabolites|mesh-ancestor
6329097|NCT00006397|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6329098|NCT00006397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6329099|NCT00006398|Timolol|timolol|mesh-list
6329100|NCT00006398|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6329101|NCT00006398|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6329102|NCT00006398|Adrenergic Agents|adrenergic agents|mesh-ancestor
6329103|NCT00006398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6329104|NCT00006398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329105|NCT00006398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6329106|NCT00006398|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6329107|NCT00006398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6329108|NCT00006399|Donepezil|donepezil|mesh-list
6329109|NCT00006399|Progesterone|progesterone|mesh-list
6329110|NCT00006399|Estrogens|estrogens|mesh-list
6329111|NCT00006399|Progestins|progestins|mesh-ancestor
6329112|NCT00006399|Hormones|hormones|mesh-ancestor
6329113|NCT00006399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6329114|NCT00006399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6329115|NCT00006399|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6329116|NCT00006399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6329117|NCT00006399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329118|NCT00006399|Cholinergic Agents|cholinergic agents|mesh-ancestor
6329119|NCT00006399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6329120|NCT00006399|Nootropic Agents|nootropic agents|mesh-ancestor
6329121|NCT00006401|Nitric Oxide|nitric oxide|mesh-list
6329122|NCT00006401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6329123|NCT00006401|Autonomic Agents|autonomic agents|mesh-ancestor
6329124|NCT00006401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6329125|NCT00006401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6329126|NCT00006401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6329127|NCT00006401|Respiratory System Agents|respiratory system agents|mesh-ancestor
6329128|NCT00006401|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6329129|NCT00006401|Antioxidants|antioxidants|mesh-ancestor
6329130|NCT00006401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329131|NCT00006401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6329132|NCT00006401|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6329133|NCT00006401|Vasodilator Agents|vasodilator agents|mesh-ancestor
6329134|NCT00006401|Gasotransmitters|gasotransmitters|mesh-ancestor
6329135|NCT00006401|Protective Agents|protective agents|mesh-ancestor
6329136|NCT00006412|Fenofibrate|fenofibrate|mesh-list
6329137|NCT00006412|Pravastatin|pravastatin|mesh-list
6329138|NCT00006412|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6329139|NCT00006412|Antimetabolites|antimetabolites|mesh-ancestor
6329140|NCT00006412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329141|NCT00006412|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6393238|NCT00199004|Antimitotic Agents|antimitotic agents|mesh-ancestor
6329142|NCT00006412|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6329143|NCT00006412|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6329144|NCT00006412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6329145|NCT00006427|Amitriptyline|amitriptyline|mesh-list
6329146|NCT00006427|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6329147|NCT00006427|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6329148|NCT00006427|Antidepressive Agents|antidepressive agents|mesh-ancestor
6329149|NCT00006427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6329150|NCT00006427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6329151|NCT00006427|Analgesics|analgesics|mesh-ancestor
6329152|NCT00006427|Sensory System Agents|sensory system agents|mesh-ancestor
6329153|NCT00006427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6329154|NCT00006427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6329155|NCT00006427|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6329156|NCT00006427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6329157|NCT00006427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6329158|NCT00006427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329159|NCT00006427|Adrenergic Agents|adrenergic agents|mesh-ancestor
6329160|NCT00006427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6329161|NCT00006427|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6329162|NCT00006427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6329163|NCT00006427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6329164|NCT00006428|Amitriptyline|amitriptyline|mesh-list
6329165|NCT00006428|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6329166|NCT00006428|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6329167|NCT00006428|Antidepressive Agents|antidepressive agents|mesh-ancestor
6329168|NCT00006428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6329169|NCT00006428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6329170|NCT00006428|Analgesics|analgesics|mesh-ancestor
6329171|NCT00006428|Sensory System Agents|sensory system agents|mesh-ancestor
6329172|NCT00006428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6329173|NCT00006428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6329174|NCT00006428|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6329175|NCT00006428|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6329176|NCT00006428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6329177|NCT00006428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329178|NCT00006428|Adrenergic Agents|adrenergic agents|mesh-ancestor
6329179|NCT00006428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6329180|NCT00006428|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6329181|NCT00006428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6329182|NCT00006428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6329183|NCT00006441|Lamivudine|lamivudine|mesh-list
6329184|NCT00006441|Zidovudine|zidovudine|mesh-list
6329185|NCT00006441|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6329186|NCT00006441|Aldesleukin|aldesleukin|mesh-list
6329187|NCT00006441|Nelfinavir|nelfinavir|mesh-list
6329188|NCT00006441|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6329189|NCT00006441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6329190|NCT00006441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6329191|NCT00006441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329192|NCT00006441|Antiviral Agents|antiviral agents|mesh-ancestor
6329193|NCT00006441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6329194|NCT00006441|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6329195|NCT00006441|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6329196|NCT00006441|Antimetabolites|antimetabolites|mesh-ancestor
6329197|NCT00006441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329198|NCT00006441|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6329199|NCT00006441|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6329200|NCT00006441|Protease Inhibitors|protease inhibitors|mesh-ancestor
6329201|NCT00006443|Lamivudine|lamivudine|mesh-list
6329202|NCT00006443|Stavudine|stavudine|mesh-list
6329203|NCT00006443|Nelfinavir|nelfinavir|mesh-list
6329204|NCT00006443|Indinavir|indinavir|mesh-list
6329205|NCT00006443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6329206|NCT00006443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6329207|NCT00006443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6329208|NCT00006443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329209|NCT00006443|Antiviral Agents|antiviral agents|mesh-ancestor
6329210|NCT00006443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6329211|NCT00006443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6329212|NCT00006443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6329213|NCT00006443|Antimetabolites|antimetabolites|mesh-ancestor
6329214|NCT00006443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6329215|NCT00006443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6329216|NCT00006443|Protease Inhibitors|protease inhibitors|mesh-ancestor
6329217|NCT00006448|Methadone|methadone|mesh-list
6329218|NCT00006448|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6329219|NCT00006448|Narcotics|narcotics|mesh-ancestor
6329220|NCT00006448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6329221|NCT00006448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6329222|NCT00006448|Analgesics|analgesics|mesh-ancestor
6329223|NCT00006448|Sensory System Agents|sensory system agents|mesh-ancestor
6329224|NCT00006448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6329225|NCT00006448|Antitussive Agents|antitussive agents|mesh-ancestor
6329226|NCT00006448|Respiratory System Agents|respiratory system agents|mesh-ancestor
6329227|NCT00006449|Naltrexone|naltrexone|mesh-list
6329228|NCT00006449|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6329229|NCT00006449|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6329230|NCT00006449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6329231|NCT00006449|Sensory System Agents|sensory system agents|mesh-ancestor
6329232|NCT00006449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6329233|NCT00006450|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
6329234|NCT00006450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329235|NCT00006451|Cyclosporine|cyclosporine|mesh-list
6329236|NCT00006451|Methylprednisolone|methylprednisolone|mesh-list
6329237|NCT00006451|Cyclophosphamide|cyclophosphamide|mesh-list
6329238|NCT00006451|Methotrexate|methotrexate|mesh-list
6329239|NCT00006451|Cyclosporins|cyclosporins|mesh-list
6329240|NCT00006451|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6329241|NCT00006451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6329242|NCT00006451|Immunologic Factors|immunologic factors|mesh-ancestor
6329243|NCT00006451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6329244|NCT00006451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6329245|NCT00006451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6329246|NCT00006451|Alkylating Agents|alkylating agents|mesh-ancestor
6329247|NCT00006451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329248|NCT00006451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329249|NCT00006451|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6329250|NCT00006451|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6329251|NCT00006451|Abortifacient Agents|abortifacient agents|mesh-ancestor
6329252|NCT00006451|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6329253|NCT00006451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6329254|NCT00006451|Antimetabolites|antimetabolites|mesh-ancestor
6329255|NCT00006451|Dermatologic Agents|dermatologic agents|mesh-ancestor
6016556|NCT00365547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6016557|NCT00365547|Growth Substances|growth substances|mesh-ancestor
6016558|NCT00365547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016559|NCT00365547|Growth Inhibitors|growth inhibitors|mesh-ancestor
6016560|NCT00365547|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6329256|NCT00006451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6329257|NCT00006451|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6329258|NCT00006451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6329259|NCT00006451|Antifungal Agents|antifungal agents|mesh-ancestor
6329260|NCT00006451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6329261|NCT00006451|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6329262|NCT00006451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6329263|NCT00006451|Antiemetics|antiemetics|mesh-ancestor
6329264|NCT00006451|Autonomic Agents|autonomic agents|mesh-ancestor
6329265|NCT00006451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6329266|NCT00006451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6329267|NCT00006451|Glucocorticoids|glucocorticoids|mesh-ancestor
6329268|NCT00006451|Hormones|hormones|mesh-ancestor
6329269|NCT00006451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6329270|NCT00006451|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6329271|NCT00006451|Protective Agents|protective agents|mesh-ancestor
6329272|NCT00006452|Motexafin gadolinium|motexafin gadolinium|mesh-list
6329273|NCT00006452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329274|NCT00006452|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6329275|NCT00006452|Dermatologic Agents|dermatologic agents|mesh-ancestor
6329276|NCT00006453|Gemcitabine|gemcitabine|mesh-list
6329277|NCT00006453|Carboplatin|carboplatin|mesh-list
6329278|NCT00006453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329279|NCT00006453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6329280|NCT00006453|Antimetabolites|antimetabolites|mesh-ancestor
6329281|NCT00006453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329282|NCT00006453|Antiviral Agents|antiviral agents|mesh-ancestor
6329283|NCT00006453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6329284|NCT00006453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6329285|NCT00006453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6329286|NCT00006453|Immunologic Factors|immunologic factors|mesh-ancestor
6329287|NCT00006453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6329288|NCT00006454|Paclitaxel|paclitaxel|mesh-list
6329289|NCT00006454|Carboplatin|carboplatin|mesh-list
6329290|NCT00006454|Topotecan|topotecan|mesh-list
6329291|NCT00006454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6329292|NCT00006454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329293|NCT00006454|Tubulin Modulators|tubulin modulators|mesh-ancestor
6329294|NCT00006454|Antimitotic Agents|antimitotic agents|mesh-ancestor
6329295|NCT00006454|Mitosis Modulators|mitosis modulators|mesh-ancestor
6329296|NCT00006454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329297|NCT00006454|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6329298|NCT00006454|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6329299|NCT00006454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6329300|NCT00006455|Leucovorin|leucovorin|mesh-list
6329301|NCT00006455|Cytarabine|cytarabine|mesh-list
6329302|NCT00006455|Dexamethasone|dexamethasone|mesh-list
6329303|NCT00006455|Hydrocortisone|hydrocortisone|mesh-list
6329304|NCT00006455|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6329305|NCT00006455|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6329306|NCT00006455|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6329307|NCT00006455|Cyclophosphamide|cyclophosphamide|mesh-list
6329308|NCT00006455|Ifosfamide|ifosfamide|mesh-list
6329309|NCT00006455|Doxorubicin|doxorubicin|mesh-list
6329310|NCT00006455|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6329311|NCT00006455|Methotrexate|methotrexate|mesh-list
6329312|NCT00006455|Etoposide|etoposide|mesh-list
6329313|NCT00006455|Vinblastine|vinblastine|mesh-list
6329314|NCT00006455|Levoleucovorin|levoleucovorin|mesh-list
6329315|NCT00006455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6329316|NCT00006455|Immunologic Factors|immunologic factors|mesh-ancestor
6329317|NCT00006455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6329318|NCT00006455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6329319|NCT00006455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6329320|NCT00006455|Alkylating Agents|alkylating agents|mesh-ancestor
6329321|NCT00006455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329322|NCT00006455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329323|NCT00006455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6329324|NCT00006455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6329325|NCT00006455|Antiemetics|antiemetics|mesh-ancestor
6329326|NCT00006455|Autonomic Agents|autonomic agents|mesh-ancestor
6329327|NCT00006455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6329328|NCT00006455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6329329|NCT00006455|Glucocorticoids|glucocorticoids|mesh-ancestor
6329330|NCT00006455|Hormones|hormones|mesh-ancestor
6329331|NCT00006455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6329332|NCT00006455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6329333|NCT00006455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6329334|NCT00006455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6329335|NCT00006455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6329336|NCT00006455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6329337|NCT00006455|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6329338|NCT00006455|Abortifacient Agents|abortifacient agents|mesh-ancestor
6329339|NCT00006455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6329340|NCT00006455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6329341|NCT00006455|Antimetabolites|antimetabolites|mesh-ancestor
6329342|NCT00006455|Dermatologic Agents|dermatologic agents|mesh-ancestor
6329343|NCT00006455|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6329344|NCT00006455|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6329345|NCT00006455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6329346|NCT00006455|Antiviral Agents|antiviral agents|mesh-ancestor
6329347|NCT00006455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6329348|NCT00006455|Antidotes|antidotes|mesh-ancestor
6329349|NCT00006455|Protective Agents|protective agents|mesh-ancestor
6329350|NCT00006455|Vitamin B Complex|vitamin b complex|mesh-ancestor
6329351|NCT00006455|Vitamins|vitamins|mesh-ancestor
6329352|NCT00006455|Micronutrients|micronutrients|mesh-ancestor
6329353|NCT00006455|Tubulin Modulators|tubulin modulators|mesh-ancestor
6329354|NCT00006455|Antimitotic Agents|antimitotic agents|mesh-ancestor
6329355|NCT00006455|Mitosis Modulators|mitosis modulators|mesh-ancestor
6329356|NCT00006457|Oltipraz|oltipraz|mesh-list
6329357|NCT00006457|Antiviral Agents|antiviral agents|mesh-ancestor
6329358|NCT00006457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6329359|NCT00006457|Schistosomicides|schistosomicides|mesh-ancestor
6329360|NCT00006457|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6329361|NCT00006457|Anthelmintics|anthelmintics|mesh-ancestor
6329362|NCT00006457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6329363|NCT00006457|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6329364|NCT00006457|Protective Agents|protective agents|mesh-ancestor
6329365|NCT00006457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6329366|NCT00006457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329367|NCT00006457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6329368|NCT00006457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6329369|NCT00006457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6329370|NCT00006457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329371|NCT00006458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6329372|NCT00006458|Antibodies|antibodies|mesh-list
6329373|NCT00006458|Immunoglobulins|immunoglobulins|mesh-list
6329374|NCT00006458|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6329375|NCT00006458|Immunologic Factors|immunologic factors|mesh-ancestor
6329376|NCT00006458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6329377|NCT00006458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329378|NCT00006459|Gemcitabine|gemcitabine|mesh-list
6329379|NCT00006459|Paclitaxel|paclitaxel|mesh-list
6329380|NCT00006459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6329381|NCT00006459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329382|NCT00006459|Tubulin Modulators|tubulin modulators|mesh-ancestor
6329383|NCT00006459|Antimitotic Agents|antimitotic agents|mesh-ancestor
6329384|NCT00006459|Mitosis Modulators|mitosis modulators|mesh-ancestor
6329385|NCT00006459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329386|NCT00006459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6329387|NCT00006459|Antimetabolites|antimetabolites|mesh-ancestor
6329388|NCT00006459|Antiviral Agents|antiviral agents|mesh-ancestor
6329389|NCT00006459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6329390|NCT00006459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6329391|NCT00006459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6329392|NCT00006459|Immunologic Factors|immunologic factors|mesh-ancestor
6329393|NCT00006459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6329394|NCT00006461|Cyclophosphamide|cyclophosphamide|mesh-list
6329395|NCT00006461|Etoposide|etoposide|mesh-list
6329396|NCT00006461|Vincristine|vincristine|mesh-list
6329397|NCT00006461|Etoposide phosphate|etoposide phosphate|mesh-list
6329398|NCT00006461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6329399|NCT00006461|Immunologic Factors|immunologic factors|mesh-ancestor
6329400|NCT00006461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6329401|NCT00006461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6329402|NCT00006461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6329403|NCT00006461|Alkylating Agents|alkylating agents|mesh-ancestor
6329404|NCT00006461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329405|NCT00006461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329406|NCT00006461|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6329407|NCT00006461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6329408|NCT00006461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6329409|NCT00006461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6329410|NCT00006461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6329411|NCT00006461|Tubulin Modulators|tubulin modulators|mesh-ancestor
6329412|NCT00006461|Antimitotic Agents|antimitotic agents|mesh-ancestor
6329413|NCT00006461|Mitosis Modulators|mitosis modulators|mesh-ancestor
6329414|NCT00006462|Gemcitabine|gemcitabine|mesh-list
6329415|NCT00006462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6329416|NCT00006462|Antimetabolites|antimetabolites|mesh-ancestor
6329417|NCT00006462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329418|NCT00006462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329419|NCT00006462|Antiviral Agents|antiviral agents|mesh-ancestor
6329420|NCT00006462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6329421|NCT00006462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6329422|NCT00006462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6329423|NCT00006462|Immunologic Factors|immunologic factors|mesh-ancestor
6329424|NCT00006462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6329425|NCT00006463|Trabectedin|trabectedin|mesh-list
6329426|NCT00006463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6329427|NCT00006463|Alkylating Agents|alkylating agents|mesh-ancestor
6329428|NCT00006463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329429|NCT00006463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329430|NCT00006464|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
6329431|NCT00006464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329432|NCT00006464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6329433|NCT00006464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6329434|NCT00006464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329435|NCT00006465|Capecitabine|capecitabine|mesh-list
6329436|NCT00006465|Oxaliplatin|oxaliplatin|mesh-list
6329437|NCT00006465|Irinotecan|irinotecan|mesh-list
6329438|NCT00006465|Camptothecin|camptothecin|mesh-list
6329439|NCT00006465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6016561|NCT00365547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6016562|NCT00365547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6016563|NCT00365547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016564|NCT00365599|Tamoxifen|tamoxifen|mesh-list
6016565|NCT00365599|Vorinostat|vorinostat|mesh-list
6016566|NCT00365599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016567|NCT00365599|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6016568|NCT00365599|Hormone Antagonists|hormone antagonists|mesh-ancestor
6016569|NCT00365599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6016570|NCT00365599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016571|NCT00365599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6016572|NCT00365599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6016573|NCT00365599|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6016574|NCT00365599|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6016575|NCT00365599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6329440|NCT00006465|Antimetabolites|antimetabolites|mesh-ancestor
6329441|NCT00006465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329442|NCT00006465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329443|NCT00006465|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6329444|NCT00006465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6329445|NCT00006465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6329446|NCT00006465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6329447|NCT00006467|Gemcitabine|gemcitabine|mesh-list
6329448|NCT00006467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6329449|NCT00006467|Antimetabolites|antimetabolites|mesh-ancestor
6329450|NCT00006467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329451|NCT00006467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329452|NCT00006467|Antiviral Agents|antiviral agents|mesh-ancestor
6329453|NCT00006467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6329454|NCT00006467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6329455|NCT00006467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6329456|NCT00006467|Immunologic Factors|immunologic factors|mesh-ancestor
6329457|NCT00006467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6329458|NCT00006468|Leucovorin|leucovorin|mesh-list
6329459|NCT00006468|Fluorouracil|fluorouracil|mesh-list
6329460|NCT00006468|Oxaliplatin|oxaliplatin|mesh-list
6329461|NCT00006468|Calcium|calcium|mesh-list
6329462|NCT00006468|Levoleucovorin|levoleucovorin|mesh-list
6329463|NCT00006468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6329464|NCT00006468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6329465|NCT00006468|Antimetabolites|antimetabolites|mesh-ancestor
6329466|NCT00006468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329467|NCT00006468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6329468|NCT00006468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329469|NCT00006468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6329470|NCT00006468|Immunologic Factors|immunologic factors|mesh-ancestor
6329471|NCT00006468|Antidotes|antidotes|mesh-ancestor
6329472|NCT00006468|Protective Agents|protective agents|mesh-ancestor
6329473|NCT00006468|Vitamin B Complex|vitamin b complex|mesh-ancestor
6329474|NCT00006468|Vitamins|vitamins|mesh-ancestor
6329475|NCT00006468|Micronutrients|micronutrients|mesh-ancestor
6329476|NCT00006469|Paclitaxel|paclitaxel|mesh-list
6329477|NCT00006469|Carboplatin|carboplatin|mesh-list
6329478|NCT00006469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6329479|NCT00006469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329480|NCT00006469|Tubulin Modulators|tubulin modulators|mesh-ancestor
6329481|NCT00006469|Antimitotic Agents|antimitotic agents|mesh-ancestor
6329482|NCT00006469|Mitosis Modulators|mitosis modulators|mesh-ancestor
6329483|NCT00006469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329484|NCT00006470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6329485|NCT00006470|Vaccines|vaccines|mesh-list
6329486|NCT00006470|Antibodies|antibodies|mesh-list
6329487|NCT00006470|Immunoglobulins|immunoglobulins|mesh-list
6329488|NCT00006470|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6329489|NCT00006470|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
6329490|NCT00006470|Immunologic Factors|immunologic factors|mesh-ancestor
6329491|NCT00006470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6329492|NCT00006470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329493|NCT00006471|Fenretinide|fenretinide|mesh-list
6329494|NCT00006471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329495|NCT00006471|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6329496|NCT00006471|Protective Agents|protective agents|mesh-ancestor
6329497|NCT00006471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6329498|NCT00006472|Paclitaxel|paclitaxel|mesh-list
6329499|NCT00006472|Carboplatin|carboplatin|mesh-list
6329500|NCT00006472|Fluorouracil|fluorouracil|mesh-list
6329501|NCT00006472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6329502|NCT00006472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329503|NCT00006472|Tubulin Modulators|tubulin modulators|mesh-ancestor
6329504|NCT00006472|Antimitotic Agents|antimitotic agents|mesh-ancestor
6329505|NCT00006472|Mitosis Modulators|mitosis modulators|mesh-ancestor
6329506|NCT00006472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329507|NCT00006472|Antimetabolites|antimetabolites|mesh-ancestor
6329508|NCT00006472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6329509|NCT00006472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6329510|NCT00006472|Immunologic Factors|immunologic factors|mesh-ancestor
6329511|NCT00006472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6329512|NCT00006473|Oxaliplatin|oxaliplatin|mesh-list
6329513|NCT00006473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329514|NCT00006474|Temozolomide|temozolomide|mesh-list
6329515|NCT00006474|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
6329516|NCT00006474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6329517|NCT00006474|Alkylating Agents|alkylating agents|mesh-ancestor
6329518|NCT00006474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329519|NCT00006474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329520|NCT00006474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6329521|NCT00006475|Imatinib Mesylate|imatinib mesylate|mesh-list
6329522|NCT00006475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329523|NCT00006475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6329524|NCT00006475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6329525|NCT00006475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329526|NCT00006476|Suramin|suramin|mesh-list
6329527|NCT00006476|Antinematodal Agents|antinematodal agents|mesh-ancestor
6329528|NCT00006476|Anthelmintics|anthelmintics|mesh-ancestor
6329529|NCT00006476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6329530|NCT00006476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6329531|NCT00006476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329532|NCT00006476|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6329533|NCT00006476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6329534|NCT00006479|Leucovorin|leucovorin|mesh-list
6329535|NCT00006479|Fluorouracil|fluorouracil|mesh-list
6329536|NCT00006479|Oxaliplatin|oxaliplatin|mesh-list
6329537|NCT00006479|Calcium|calcium|mesh-list
6329538|NCT00006479|Levoleucovorin|levoleucovorin|mesh-list
6329539|NCT00006479|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6329540|NCT00006479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6329541|NCT00006479|Antimetabolites|antimetabolites|mesh-ancestor
6329542|NCT00006479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329543|NCT00006479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6329544|NCT00006479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329545|NCT00006479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6329546|NCT00006479|Immunologic Factors|immunologic factors|mesh-ancestor
6329547|NCT00006479|Antidotes|antidotes|mesh-ancestor
6329548|NCT00006479|Protective Agents|protective agents|mesh-ancestor
6329549|NCT00006479|Vitamin B Complex|vitamin b complex|mesh-ancestor
6329550|NCT00006479|Vitamins|vitamins|mesh-ancestor
6329551|NCT00006479|Micronutrients|micronutrients|mesh-ancestor
6329552|NCT00006480|Aldesleukin|aldesleukin|mesh-list
6329553|NCT00006480|Ganciclovir|ganciclovir|mesh-list
6329554|NCT00006480|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6329555|NCT00006480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329556|NCT00006480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6329557|NCT00006480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6329558|NCT00006480|Antiviral Agents|antiviral agents|mesh-ancestor
6329559|NCT00006480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6329560|NCT00006480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6329561|NCT00006480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6329562|NCT00006480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329563|NCT00006482|Gemcitabine|gemcitabine|mesh-list
6329564|NCT00006482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329565|NCT00006482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6329566|NCT00006482|Antimetabolites|antimetabolites|mesh-ancestor
6329567|NCT00006482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329568|NCT00006482|Antiviral Agents|antiviral agents|mesh-ancestor
6329569|NCT00006482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6329570|NCT00006482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6329571|NCT00006482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6329572|NCT00006482|Immunologic Factors|immunologic factors|mesh-ancestor
6329573|NCT00006482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6329574|NCT00006483|Sargramostim|sargramostim|mesh-list
6329575|NCT00006483|Immunologic Factors|immunologic factors|mesh-ancestor
6329576|NCT00006483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6329577|NCT00006484|Paclitaxel|paclitaxel|mesh-list
6329578|NCT00006484|Carboplatin|carboplatin|mesh-list
6329579|NCT00006484|Tirapazamine|tirapazamine|mesh-list
6329580|NCT00006484|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6329581|NCT00006484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329582|NCT00006484|Tubulin Modulators|tubulin modulators|mesh-ancestor
6329583|NCT00006484|Antimitotic Agents|antimitotic agents|mesh-ancestor
6329584|NCT00006484|Mitosis Modulators|mitosis modulators|mesh-ancestor
6329585|NCT00006484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329586|NCT00006485|Irinotecan|irinotecan|mesh-list
6329587|NCT00006485|Alvocidib|alvocidib|mesh-list
6329588|NCT00006485|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6329589|NCT00006485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6329590|NCT00006485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6329591|NCT00006485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329592|NCT00006485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329593|NCT00006485|Growth Inhibitors|growth inhibitors|mesh-ancestor
6329594|NCT00006485|Growth Substances|growth substances|mesh-ancestor
6329595|NCT00006485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6329596|NCT00006485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6329597|NCT00006486|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
6329598|NCT00006486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329599|NCT00006486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6329600|NCT00006486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6329601|NCT00006486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329602|NCT00006486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6329603|NCT00006486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6329604|NCT00006487|Etoposide|etoposide|mesh-list
6329605|NCT00006487|Tirapazamine|tirapazamine|mesh-list
6329606|NCT00006487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329607|NCT00006487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6329608|NCT00006487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6329609|NCT00006487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6329610|NCT00006487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6329611|NCT00006487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329612|NCT00006493|Rosiglitazone|rosiglitazone|mesh-list
6329613|NCT00006493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6329614|NCT00006493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6329615|NCT00006508|Insulin|insulin|mesh-list
6329616|NCT00006508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6329617|NCT00006508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6329618|NCT00006519|Capravirine|capravirine|mesh-list
6329619|NCT00006519|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6329620|NCT00006519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6329621|NCT00006519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6329622|NCT00006519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329623|NCT00006519|Antiviral Agents|antiviral agents|mesh-ancestor
6329624|NCT00006519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6329625|NCT00006519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6329626|NCT00006519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6329627|NCT00006578|Ritonavir|ritonavir|mesh-list
6329628|NCT00006578|Amprenavir|amprenavir|mesh-list
6329629|NCT00006578|Lamivudine|lamivudine|mesh-list
6329630|NCT00006578|Abacavir|abacavir|mesh-list
6329631|NCT00006578|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6329632|NCT00006578|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6329633|NCT00006578|Protease Inhibitors|protease inhibitors|mesh-ancestor
6329634|NCT00006578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6329635|NCT00006578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329636|NCT00006578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6329637|NCT00006578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6329638|NCT00006578|Antiviral Agents|antiviral agents|mesh-ancestor
6329639|NCT00006578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6329640|NCT00006578|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6329641|NCT00006578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6329642|NCT00006578|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6329643|NCT00006578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6329644|NCT00006578|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6329645|NCT00006578|Antitubercular Agents|antitubercular agents|mesh-ancestor
6329646|NCT00006578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6329647|NCT00006591|Ritonavir|ritonavir|mesh-list
6329648|NCT00006591|Amprenavir|amprenavir|mesh-list
6329649|NCT00006591|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6329650|NCT00006591|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6329651|NCT00006591|Protease Inhibitors|protease inhibitors|mesh-ancestor
6329652|NCT00006591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6329653|NCT00006591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329654|NCT00006591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6329655|NCT00006591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6329656|NCT00006591|Antiviral Agents|antiviral agents|mesh-ancestor
6329657|NCT00006591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6329658|NCT00006591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6329659|NCT00006591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6329660|NCT00006591|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6329661|NCT00006591|Antitubercular Agents|antitubercular agents|mesh-ancestor
6329662|NCT00006591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6329663|NCT00006617|Lamivudine|lamivudine|mesh-list
6329664|NCT00006617|Zidovudine|zidovudine|mesh-list
6329665|NCT00006617|Abacavir|abacavir|mesh-list
6329666|NCT00006617|Amprenavir|amprenavir|mesh-list
6329667|NCT00006617|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6329668|NCT00006617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6329669|NCT00006617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6329670|NCT00006617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329671|NCT00006617|Antiviral Agents|antiviral agents|mesh-ancestor
6329672|NCT00006617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6329673|NCT00006617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6329674|NCT00006617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6329675|NCT00006617|Antimetabolites|antimetabolites|mesh-ancestor
6329676|NCT00006617|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6329677|NCT00006617|Antitubercular Agents|antitubercular agents|mesh-ancestor
6329678|NCT00006617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6329679|NCT00006617|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6329680|NCT00006617|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6329681|NCT00006617|Protease Inhibitors|protease inhibitors|mesh-ancestor
6329682|NCT00006630|Immunoglobulins|immunoglobulins|mesh-list
6329683|NCT00006630|Antibodies|antibodies|mesh-list
6329684|NCT00006630|gamma-Globulins|gamma-globulins|mesh-list
6329685|NCT00006630|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6329686|NCT00006630|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6329687|NCT00006630|Immunologic Factors|immunologic factors|mesh-ancestor
6329688|NCT00006630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6329689|NCT00006656|Ethanol|ethanol|mesh-list
6329690|NCT00006656|Carmustine|carmustine|mesh-list
6329691|NCT00006656|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6329692|NCT00006656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6329693|NCT00006656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6329694|NCT00006656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6329695|NCT00006656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6329696|NCT00006656|Alkylating Agents|alkylating agents|mesh-ancestor
6329697|NCT00006656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329698|NCT00006656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329699|NCT00006669|Prednisone|prednisone|mesh-list
6329700|NCT00006669|Cyclophosphamide|cyclophosphamide|mesh-list
6329701|NCT00006669|Rituximab|rituximab|mesh-list
6329702|NCT00006669|Doxorubicin|doxorubicin|mesh-list
6329703|NCT00006669|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6329704|NCT00006669|Etoposide|etoposide|mesh-list
6329705|NCT00006669|Vincristine|vincristine|mesh-list
6329706|NCT00006669|Sargramostim|sargramostim|mesh-list
6329707|NCT00006669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6329708|NCT00006669|Immunologic Factors|immunologic factors|mesh-ancestor
6329709|NCT00006669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6329710|NCT00006669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6016576|NCT00365599|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6016577|NCT00365599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6016578|NCT00365716|Vaccines|vaccines|mesh-list
6016579|NCT00365716|Immunologic Factors|immunologic factors|mesh-ancestor
6016580|NCT00365716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6329711|NCT00006669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6329712|NCT00006669|Alkylating Agents|alkylating agents|mesh-ancestor
6329713|NCT00006669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329714|NCT00006669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329715|NCT00006669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6329716|NCT00006669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6329717|NCT00006669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6329718|NCT00006669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6329719|NCT00006669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6329720|NCT00006669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6329721|NCT00006669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6329722|NCT00006669|Glucocorticoids|glucocorticoids|mesh-ancestor
6329723|NCT00006669|Hormones|hormones|mesh-ancestor
6329724|NCT00006669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6329725|NCT00006669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6329726|NCT00006669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6329727|NCT00006669|Tubulin Modulators|tubulin modulators|mesh-ancestor
6329728|NCT00006669|Antimitotic Agents|antimitotic agents|mesh-ancestor
6329729|NCT00006669|Mitosis Modulators|mitosis modulators|mesh-ancestor
6329730|NCT00006682|Docetaxel|docetaxel|mesh-list
6329731|NCT00006682|Vinorelbine|vinorelbine|mesh-list
6329732|NCT00006682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329733|NCT00006682|Tubulin Modulators|tubulin modulators|mesh-ancestor
6329734|NCT00006682|Antimitotic Agents|antimitotic agents|mesh-ancestor
6329735|NCT00006682|Mitosis Modulators|mitosis modulators|mesh-ancestor
6329736|NCT00006682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329737|NCT00006682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6329738|NCT00006695|Iodine|iodine|mesh-list
6329739|NCT00006695|Cytarabine|cytarabine|mesh-list
6329740|NCT00006695|Etoposide|etoposide|mesh-list
6329741|NCT00006695|Melphalan|melphalan|mesh-list
6329742|NCT00006695|Carmustine|carmustine|mesh-list
6329743|NCT00006695|Tositumomab I-131|tositumomab i-131|mesh-list
6329744|NCT00006695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6329745|NCT00006695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329746|NCT00006695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6329747|NCT00006695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6329748|NCT00006695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6329749|NCT00006695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329750|NCT00006695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6329751|NCT00006695|Antimetabolites|antimetabolites|mesh-ancestor
6329752|NCT00006695|Antiviral Agents|antiviral agents|mesh-ancestor
6329753|NCT00006695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6329754|NCT00006695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6329755|NCT00006695|Immunologic Factors|immunologic factors|mesh-ancestor
6329756|NCT00006695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6329757|NCT00006695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6329758|NCT00006695|Alkylating Agents|alkylating agents|mesh-ancestor
6329759|NCT00006695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6329760|NCT00006695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6329761|NCT00006695|Trace Elements|trace elements|mesh-ancestor
6329762|NCT00006695|Micronutrients|micronutrients|mesh-ancestor
6329763|NCT00006708|Rituximab|rituximab|mesh-list
6329764|NCT00006708|Carboplatin|carboplatin|mesh-list
6329765|NCT00006708|Etoposide|etoposide|mesh-list
6329766|NCT00006708|Ifosfamide|ifosfamide|mesh-list
6329767|NCT00006708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6329768|NCT00006708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329769|NCT00006708|Immunologic Factors|immunologic factors|mesh-ancestor
6329770|NCT00006708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6329771|NCT00006708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6329772|NCT00006708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6329773|NCT00006708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6329774|NCT00006708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6329775|NCT00006708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6329776|NCT00006708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329777|NCT00006708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6329778|NCT00006708|Alkylating Agents|alkylating agents|mesh-ancestor
6329779|NCT00006734|Cyclophosphamide|cyclophosphamide|mesh-list
6329780|NCT00006734|Ifosfamide|ifosfamide|mesh-list
6329781|NCT00006734|Doxorubicin|doxorubicin|mesh-list
6329782|NCT00006734|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6329783|NCT00006734|Etoposide|etoposide|mesh-list
6329784|NCT00006734|Vincristine|vincristine|mesh-list
6329785|NCT00006734|Lenograstim|lenograstim|mesh-list
6329786|NCT00006734|Sargramostim|sargramostim|mesh-list
6329787|NCT00006734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6329788|NCT00006734|Immunologic Factors|immunologic factors|mesh-ancestor
6329789|NCT00006734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6329790|NCT00006734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6329791|NCT00006734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6329792|NCT00006734|Alkylating Agents|alkylating agents|mesh-ancestor
6329793|NCT00006734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329794|NCT00006734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329795|NCT00006734|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6329796|NCT00006734|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6329797|NCT00006734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6329798|NCT00006734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6329799|NCT00006734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6329800|NCT00006734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6329801|NCT00006734|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6329802|NCT00006734|Tubulin Modulators|tubulin modulators|mesh-ancestor
6329803|NCT00006734|Antimitotic Agents|antimitotic agents|mesh-ancestor
6329804|NCT00006734|Mitosis Modulators|mitosis modulators|mesh-ancestor
6329805|NCT00006747|Cytarabine|cytarabine|mesh-list
6329806|NCT00006747|Methotrexate|methotrexate|mesh-list
6329807|NCT00006747|Etoposide|etoposide|mesh-list
6329808|NCT00006747|Melphalan|melphalan|mesh-list
6329809|NCT00006747|Carmustine|carmustine|mesh-list
6329810|NCT00006747|Tacrolimus|tacrolimus|mesh-list
6329811|NCT00006747|Sargramostim|sargramostim|mesh-list
6329812|NCT00006747|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6329813|NCT00006747|Abortifacient Agents|abortifacient agents|mesh-ancestor
6329814|NCT00006747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6329815|NCT00006747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6329816|NCT00006747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6329817|NCT00006747|Antimetabolites|antimetabolites|mesh-ancestor
6329818|NCT00006747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329819|NCT00006747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329820|NCT00006747|Dermatologic Agents|dermatologic agents|mesh-ancestor
6329821|NCT00006747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6329822|NCT00006747|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6329823|NCT00006747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6329824|NCT00006747|Immunologic Factors|immunologic factors|mesh-ancestor
6329825|NCT00006747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6329826|NCT00006747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6329827|NCT00006747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6329828|NCT00006747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6329829|NCT00006747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6329830|NCT00006747|Antiviral Agents|antiviral agents|mesh-ancestor
6329831|NCT00006747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6329832|NCT00006747|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6329833|NCT00006747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6329834|NCT00006747|Alkylating Agents|alkylating agents|mesh-ancestor
6329835|NCT00006747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6329836|NCT00006760|Vinorelbine|vinorelbine|mesh-list
6329837|NCT00006760|Ifosfamide|ifosfamide|mesh-list
6329838|NCT00006760|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6329839|NCT00006760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329840|NCT00006760|Tubulin Modulators|tubulin modulators|mesh-ancestor
6329841|NCT00006760|Antimitotic Agents|antimitotic agents|mesh-ancestor
6329842|NCT00006760|Mitosis Modulators|mitosis modulators|mesh-ancestor
6329843|NCT00006760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329844|NCT00006760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6329845|NCT00006760|Alkylating Agents|alkylating agents|mesh-ancestor
6329846|NCT00006773|Bortezomib|bortezomib|mesh-list
6329847|NCT00006773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329848|NCT00006786|Leucovorin|leucovorin|mesh-list
6329849|NCT00006786|Bevacizumab|bevacizumab|mesh-list
6329850|NCT00006786|Fluorouracil|fluorouracil|mesh-list
6329851|NCT00006786|Irinotecan|irinotecan|mesh-list
6329852|NCT00006786|Calcium|calcium|mesh-list
6329853|NCT00006786|Levoleucovorin|levoleucovorin|mesh-list
6329854|NCT00006786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6329855|NCT00006786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329856|NCT00006786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6329857|NCT00006786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6329858|NCT00006786|Growth Substances|growth substances|mesh-ancestor
6329859|NCT00006786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6329860|NCT00006786|Growth Inhibitors|growth inhibitors|mesh-ancestor
6329861|NCT00006786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6329862|NCT00006786|Antimetabolites|antimetabolites|mesh-ancestor
6329863|NCT00006786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329864|NCT00006786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6329865|NCT00006786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6329866|NCT00006786|Immunologic Factors|immunologic factors|mesh-ancestor
6329867|NCT00006786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6329868|NCT00006786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6329869|NCT00006786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6329870|NCT00006786|Antidotes|antidotes|mesh-ancestor
6329871|NCT00006786|Protective Agents|protective agents|mesh-ancestor
6329872|NCT00006786|Vitamin B Complex|vitamin b complex|mesh-ancestor
6329873|NCT00006786|Vitamins|vitamins|mesh-ancestor
6329874|NCT00006786|Micronutrients|micronutrients|mesh-ancestor
6329875|NCT00006799|Megestrol|megestrol|mesh-list
6329876|NCT00006799|Megestrol Acetate|megestrol acetate|mesh-list
6329877|NCT00006799|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6329878|NCT00006799|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6329879|NCT00006799|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6329880|NCT00006799|Contraceptive Agents|contraceptive agents|mesh-ancestor
6329881|NCT00006799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6329882|NCT00006799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6329883|NCT00006799|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6329884|NCT00006799|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6329885|NCT00006799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6329886|NCT00006799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329887|NCT00006799|Appetite Stimulants|appetite stimulants|mesh-ancestor
6329888|NCT00006799|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6329889|NCT00006812|Capecitabine|capecitabine|mesh-list
6329890|NCT00006812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6329891|NCT00006812|Antimetabolites|antimetabolites|mesh-ancestor
6329892|NCT00006812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329893|NCT00006812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329894|NCT00006825|Doxorubicin|doxorubicin|mesh-list
6329895|NCT00006825|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6329896|NCT00006825|Trastuzumab|trastuzumab|mesh-list
6329897|NCT00006825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6329898|NCT00006825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329899|NCT00006825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6329900|NCT00006825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6329901|NCT00006825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6329902|NCT00006825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329903|NCT00006825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6329904|NCT00006864|Aldesleukin|aldesleukin|mesh-list
6329905|NCT00006864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329906|NCT00006864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6329907|NCT00006864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6329908|NCT00006864|Antiviral Agents|antiviral agents|mesh-ancestor
6329909|NCT00006864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6329910|NCT00006877|Temozolomide|temozolomide|mesh-list
6329911|NCT00006877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6329912|NCT00006877|Alkylating Agents|alkylating agents|mesh-ancestor
6329913|NCT00006877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329914|NCT00006877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329915|NCT00006890|Thalidomide|thalidomide|mesh-list
6329916|NCT00006890|Prednisone|prednisone|mesh-list
6329917|NCT00006890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6329918|NCT00006890|Glucocorticoids|glucocorticoids|mesh-ancestor
6329919|NCT00006890|Hormones|hormones|mesh-ancestor
6329920|NCT00006890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6329921|NCT00006890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6329922|NCT00006890|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6329923|NCT00006890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329924|NCT00006890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6329925|NCT00006890|Immunologic Factors|immunologic factors|mesh-ancestor
6329926|NCT00006890|Leprostatic Agents|leprostatic agents|mesh-ancestor
6329927|NCT00006890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6329928|NCT00006890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6329929|NCT00006890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6329930|NCT00006890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6329931|NCT00006890|Growth Substances|growth substances|mesh-ancestor
6329932|NCT00006890|Growth Inhibitors|growth inhibitors|mesh-ancestor
6329933|NCT00006929|Suramin|suramin|mesh-list
6329934|NCT00006929|Paclitaxel|paclitaxel|mesh-list
6329935|NCT00006929|Carboplatin|carboplatin|mesh-list
6329936|NCT00006929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6329937|NCT00006929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329938|NCT00006929|Tubulin Modulators|tubulin modulators|mesh-ancestor
6329939|NCT00006929|Antimitotic Agents|antimitotic agents|mesh-ancestor
6329940|NCT00006929|Mitosis Modulators|mitosis modulators|mesh-ancestor
6329941|NCT00006929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329942|NCT00006929|Antinematodal Agents|antinematodal agents|mesh-ancestor
6329943|NCT00006929|Anthelmintics|anthelmintics|mesh-ancestor
6329944|NCT00006929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6329945|NCT00006929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6329946|NCT00006929|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6329947|NCT00006929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6329948|NCT00006942|Bryostatin 1|bryostatin 1|mesh-list
6329949|NCT00006942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329950|NCT00006942|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6329951|NCT00006942|Immunologic Factors|immunologic factors|mesh-ancestor
6329952|NCT00006942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6329953|NCT00006968|Cyclosporine|cyclosporine|mesh-list
6329954|NCT00006968|Pentostatin|pentostatin|mesh-list
6329955|NCT00006968|Cyclosporins|cyclosporins|mesh-list
6329956|NCT00006968|Immunologic Factors|immunologic factors|mesh-ancestor
6329957|NCT00006968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6329958|NCT00006968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6329959|NCT00006968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329960|NCT00006968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6329961|NCT00006968|Antifungal Agents|antifungal agents|mesh-ancestor
6329962|NCT00006968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6329963|NCT00006968|Dermatologic Agents|dermatologic agents|mesh-ancestor
6329964|NCT00006968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6329965|NCT00006968|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6329966|NCT00006968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329967|NCT00006968|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
6329968|NCT00006981|Immunotoxins|immunotoxins|mesh-list
6329969|NCT00006981|Immunologic Factors|immunologic factors|mesh-ancestor
6329970|NCT00006981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6329971|NCT00007033|Magnesium Sulfate|magnesium sulfate|mesh-list
6329972|NCT00007033|Analgesics|analgesics|mesh-ancestor
6329973|NCT00007033|Sensory System Agents|sensory system agents|mesh-ancestor
6329974|NCT00007033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6329975|NCT00007033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6329976|NCT00007033|Anesthetics|anesthetics|mesh-ancestor
6329977|NCT00007033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6329978|NCT00007033|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6329979|NCT00007033|Anticonvulsants|anticonvulsants|mesh-ancestor
6329980|NCT00007033|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6329981|NCT00007033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6329982|NCT00007033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329983|NCT00007033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6329984|NCT00007033|Tocolytic Agents|tocolytic agents|mesh-ancestor
6329985|NCT00007033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6329986|NCT00007059|Mycophenolic Acid|mycophenolic acid|mesh-list
6329987|NCT00007059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6329988|NCT00007059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6329989|NCT00007059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6329990|NCT00007059|Antitubercular Agents|antitubercular agents|mesh-ancestor
6329991|NCT00007059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6329992|NCT00007059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6329993|NCT00007059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6329994|NCT00007059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6329995|NCT00007189|Celecoxib|celecoxib|mesh-list
6329996|NCT00007189|Naproxen|naproxen|mesh-list
6329997|NCT00007189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6329998|NCT00007189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6329999|NCT00007189|Analgesics|analgesics|mesh-ancestor
6330000|NCT00007189|Sensory System Agents|sensory system agents|mesh-ancestor
6330001|NCT00007189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6330002|NCT00007189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6330003|NCT00007189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6330004|NCT00007189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6330005|NCT00007189|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6330006|NCT00007189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6330007|NCT00007189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6330008|NCT00007189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6330009|NCT00007189|Gout Suppressants|gout suppressants|mesh-ancestor
6330010|NCT00007202|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6330011|NCT00007202|Stavudine|stavudine|mesh-list
6330012|NCT00007202|Didanosine|didanosine|mesh-list
6330013|NCT00007202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6330014|NCT00007202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6330015|NCT00007202|Protease Inhibitors|protease inhibitors|mesh-ancestor
6330016|NCT00007202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6330017|NCT00007202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6330018|NCT00007202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6330019|NCT00007202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6330020|NCT00007202|Antiviral Agents|antiviral agents|mesh-ancestor
6330021|NCT00007202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6330022|NCT00007202|Antimetabolites|antimetabolites|mesh-ancestor
6330023|NCT00007202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6330024|NCT00007202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6330025|NCT00007306|Hormones|hormones|mesh-list
6330026|NCT00007306|Parathyroid Hormone|parathyroid hormone|mesh-list
6330027|NCT00007306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6330028|NCT00007306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6330029|NCT00007306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6330030|NCT00007358|Dexamethasone|dexamethasone|mesh-list
6330031|NCT00007358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6330032|NCT00007358|Antiemetics|antiemetics|mesh-ancestor
6330033|NCT00007358|Autonomic Agents|autonomic agents|mesh-ancestor
6330034|NCT00007358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6330035|NCT00007358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6330036|NCT00007358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6330037|NCT00007358|Glucocorticoids|glucocorticoids|mesh-ancestor
6330038|NCT00007358|Hormones|hormones|mesh-ancestor
6330039|NCT00007358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6330040|NCT00007358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6330041|NCT00007358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6330042|NCT00007423|polysaccharide-K|polysaccharide-k|mesh-list
6330043|NCT00007423|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6330044|NCT00007423|Immunologic Factors|immunologic factors|mesh-ancestor
6330045|NCT00007423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6330046|NCT00007423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6330047|NCT00007423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6330048|NCT00007423|Antiviral Agents|antiviral agents|mesh-ancestor
6330049|NCT00007423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6330050|NCT00007423|Interferon Inducers|interferon inducers|mesh-ancestor
6330051|NCT00007423|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6330052|NCT00007423|Protective Agents|protective agents|mesh-ancestor
6330053|NCT00007436|Tenofovir|tenofovir|mesh-list
6330054|NCT00007436|Antiviral Agents|antiviral agents|mesh-ancestor
6330055|NCT00007436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6330056|NCT00007436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6330057|NCT00007436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6330058|NCT00007436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6330059|NCT00007436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6330060|NCT00007436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6330061|NCT00007436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6330062|NCT00007527|Buprenorphine|buprenorphine|mesh-list
6330063|NCT00007527|Naloxone|naloxone|mesh-list
6330064|NCT00007527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6330065|NCT00007527|Narcotics|narcotics|mesh-ancestor
6330066|NCT00007527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6330067|NCT00007527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6330068|NCT00007527|Analgesics|analgesics|mesh-ancestor
6330069|NCT00007527|Sensory System Agents|sensory system agents|mesh-ancestor
6330070|NCT00007527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6330071|NCT00007527|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6330072|NCT00007592|Chlorthalidone|chlorthalidone|mesh-list
6330073|NCT00007592|Furosemide|furosemide|mesh-list
6330074|NCT00007592|Diuretics|diuretics|mesh-ancestor
6330075|NCT00007592|Natriuretic Agents|natriuretic agents|mesh-ancestor
6330076|NCT00007592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6330077|NCT00007592|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6330078|NCT00007592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6330079|NCT00007592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6330080|NCT00007592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6330081|NCT00007592|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6330082|NCT00007605|Amiodarone|amiodarone|mesh-list
6330083|NCT00007605|Sotalol|sotalol|mesh-list
6330084|NCT00007605|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6330085|NCT00007605|Vasodilator Agents|vasodilator agents|mesh-ancestor
6330086|NCT00007605|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6330087|NCT00007605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6330088|NCT00007605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6330089|NCT00007605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6330090|NCT00007605|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6330091|NCT00007605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6330092|NCT00007605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6330093|NCT00007605|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6330094|NCT00007605|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6330095|NCT00007605|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6330096|NCT00007605|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6330097|NCT00007605|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6330098|NCT00007605|Adrenergic Agents|adrenergic agents|mesh-ancestor
6330099|NCT00007605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6330100|NCT00007605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6330101|NCT00007605|Sympatholytics|sympatholytics|mesh-ancestor
6330102|NCT00007605|Autonomic Agents|autonomic agents|mesh-ancestor
6330103|NCT00007605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6330104|NCT00007631|Tretinoin|tretinoin|mesh-list
6330105|NCT00007631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6330106|NCT00007631|Keratolytic Agents|keratolytic agents|mesh-ancestor
6330107|NCT00007631|Dermatologic Agents|dermatologic agents|mesh-ancestor
6330108|NCT00007670|Lamotrigine|lamotrigine|mesh-list
6330109|NCT00007670|Carbamazepine|carbamazepine|mesh-list
6330110|NCT00007670|Gabapentin|gabapentin|mesh-list
6330111|NCT00007670|Analgesics|analgesics|mesh-ancestor
6330112|NCT00007670|Sensory System Agents|sensory system agents|mesh-ancestor
6330113|NCT00007670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6330114|NCT00007670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6330115|NCT00007670|Anticonvulsants|anticonvulsants|mesh-ancestor
6330116|NCT00007670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6330117|NCT00007670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6330118|NCT00007670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6330119|NCT00007670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6330120|NCT00007670|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6330121|NCT00007670|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6330122|NCT00007670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6330123|NCT00007670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6330124|NCT00007670|Antimanic Agents|antimanic agents|mesh-ancestor
6330125|NCT00007670|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6330126|NCT00007670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6330127|NCT00007670|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6330128|NCT00007670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6330129|NCT00007670|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6330130|NCT00007670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6330131|NCT00007670|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6330132|NCT00007670|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6330133|NCT00007683|Aspirin|aspirin|mesh-list
6330134|NCT00007683|Warfarin|warfarin|mesh-list
6330135|NCT00007683|Clopidogrel|clopidogrel|mesh-list
6330136|NCT00007683|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6330137|NCT00007683|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6330138|NCT00007683|Analgesics|analgesics|mesh-ancestor
6330139|NCT00007683|Sensory System Agents|sensory system agents|mesh-ancestor
6330140|NCT00007683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6330141|NCT00007683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6330142|NCT00007683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6330143|NCT00007683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6330144|NCT00007683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6330145|NCT00007683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6330146|NCT00007683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6330147|NCT00007683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6330148|NCT00007683|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6330149|NCT00007683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6330150|NCT00007683|Antipyretics|antipyretics|mesh-ancestor
6330151|NCT00007683|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6330152|NCT00007683|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6330153|NCT00007683|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6330154|NCT00007683|Purinergic Agents|purinergic agents|mesh-ancestor
6330155|NCT00007683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6330156|NCT00007683|Anticoagulants|anticoagulants|mesh-ancestor
6330157|NCT00007735|Doxycycline|doxycycline|mesh-list
6330158|NCT00007735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6330159|NCT00007735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6330160|NCT00007735|Antimalarials|antimalarials|mesh-ancestor
6330161|NCT00007735|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6330162|NCT00007735|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6330163|NCT00007774|Haloperidol|haloperidol|mesh-list
6330164|NCT00007774|Olanzapine|olanzapine|mesh-list
6330165|NCT00007774|Haloperidol decanoate|haloperidol decanoate|mesh-list
6330166|NCT00007774|Antiemetics|antiemetics|mesh-ancestor
6330167|NCT00007774|Autonomic Agents|autonomic agents|mesh-ancestor
6330168|NCT00007774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6330169|NCT00007774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6330170|NCT00007774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6330171|NCT00007774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6330172|NCT00007774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6330173|NCT00007774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6330174|NCT00007774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6330175|NCT00007774|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6330176|NCT00007774|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6330177|NCT00007774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6330178|NCT00007774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6330179|NCT00007774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6330180|NCT00007774|Serotonin Agents|serotonin agents|mesh-ancestor
6330181|NCT00007774|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6330182|NCT00007774|Dopamine Agents|dopamine agents|mesh-ancestor
6330183|NCT00007774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6330184|NCT00007787|Cyclosporine|cyclosporine|mesh-list
6330185|NCT00007787|Tacrolimus|tacrolimus|mesh-list
6330186|NCT00007787|Cyclosporins|cyclosporins|mesh-list
6330187|NCT00007787|Thymoglobulin|thymoglobulin|mesh-list
6330188|NCT00007787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6330189|NCT00007787|Immunologic Factors|immunologic factors|mesh-ancestor
6330190|NCT00007787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6330191|NCT00007787|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6330192|NCT00007787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6330193|NCT00007787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6330194|NCT00007787|Antifungal Agents|antifungal agents|mesh-ancestor
6330195|NCT00007787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6016581|NCT00365794|Testosterone|testosterone|mesh-list
6330196|NCT00007787|Dermatologic Agents|dermatologic agents|mesh-ancestor
6330197|NCT00007787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6330198|NCT00007813|Cyclophosphamide|cyclophosphamide|mesh-list
6330199|NCT00007813|Carboplatin|carboplatin|mesh-list
6330200|NCT00007813|Etoposide|etoposide|mesh-list
6330201|NCT00007813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6330202|NCT00007813|Immunologic Factors|immunologic factors|mesh-ancestor
6330203|NCT00007813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6330204|NCT00007813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6330205|NCT00007813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6330206|NCT00007813|Alkylating Agents|alkylating agents|mesh-ancestor
6330207|NCT00007813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6330208|NCT00007813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6330209|NCT00007813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6330210|NCT00007813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6330211|NCT00007813|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6330212|NCT00007813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6330213|NCT00007813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6330214|NCT00007826|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6330215|NCT00007826|Vaccines|vaccines|mesh-list
6330216|NCT00007826|Antibodies|antibodies|mesh-list
6330217|NCT00007826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6330218|NCT00007826|BCG Vaccine|bcg vaccine|mesh-list
6330219|NCT00007826|Aluminum sulfate|aluminum sulfate|mesh-list
6330220|NCT00007826|Immunologic Factors|immunologic factors|mesh-ancestor
6330221|NCT00007826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6330222|NCT00007826|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6330223|NCT00007826|Antacids|antacids|mesh-ancestor
6330224|NCT00007826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6330225|NCT00007826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6330226|NCT00007852|Cytarabine|cytarabine|mesh-list
6330227|NCT00007852|Rituximab|rituximab|mesh-list
6330228|NCT00007852|Etoposide|etoposide|mesh-list
6330229|NCT00007852|Melphalan|melphalan|mesh-list
6330230|NCT00007852|Carmustine|carmustine|mesh-list
6330231|NCT00007852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6330232|NCT00007852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6330233|NCT00007852|Immunologic Factors|immunologic factors|mesh-ancestor
6330234|NCT00007852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6330235|NCT00007852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6330236|NCT00007852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6330237|NCT00007852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6330238|NCT00007852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6330239|NCT00007852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6330240|NCT00007852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6330241|NCT00007852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6330242|NCT00007852|Antimetabolites|antimetabolites|mesh-ancestor
6330243|NCT00007852|Antiviral Agents|antiviral agents|mesh-ancestor
6330244|NCT00007852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6330245|NCT00007852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6330246|NCT00007852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6330247|NCT00007852|Alkylating Agents|alkylating agents|mesh-ancestor
6330248|NCT00007852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6330249|NCT00007865|Rituximab|rituximab|mesh-list
6330250|NCT00007865|Carboplatin|carboplatin|mesh-list
6330251|NCT00007865|Etoposide|etoposide|mesh-list
6016582|NCT00365794|Androgens|androgens|mesh-ancestor
6016583|NCT00365794|Hormones|hormones|mesh-ancestor
6016584|NCT00365794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6330252|NCT00007865|Ifosfamide|ifosfamide|mesh-list
6330253|NCT00007865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6330254|NCT00007865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6330255|NCT00007865|Immunologic Factors|immunologic factors|mesh-ancestor
6330256|NCT00007865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6330257|NCT00007865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6330258|NCT00007865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6330259|NCT00007865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6330260|NCT00007865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6330261|NCT00007865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6393239|NCT00199004|Mitosis Modulators|mitosis modulators|mesh-ancestor
6330262|NCT00007865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6330263|NCT00007865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6330264|NCT00007865|Alkylating Agents|alkylating agents|mesh-ancestor
6330265|NCT00007878|Leucovorin|leucovorin|mesh-list
6330266|NCT00007878|Fluorouracil|fluorouracil|mesh-list
6330267|NCT00007878|Bortezomib|bortezomib|mesh-list
6330268|NCT00007878|Calcium|calcium|mesh-list
6330269|NCT00007878|Levoleucovorin|levoleucovorin|mesh-list
6330270|NCT00007878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6330271|NCT00007878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6330272|NCT00007878|Antimetabolites|antimetabolites|mesh-ancestor
6330273|NCT00007878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6330274|NCT00007878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6330275|NCT00007878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6330276|NCT00007878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6330277|NCT00007878|Immunologic Factors|immunologic factors|mesh-ancestor
6330278|NCT00007878|Antidotes|antidotes|mesh-ancestor
6330279|NCT00007878|Protective Agents|protective agents|mesh-ancestor
6330280|NCT00007878|Vitamin B Complex|vitamin b complex|mesh-ancestor
6330281|NCT00007878|Vitamins|vitamins|mesh-ancestor
6330282|NCT00007878|Micronutrients|micronutrients|mesh-ancestor
6330283|NCT00007891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6330284|NCT00007891|Antibodies|antibodies|mesh-list
6330285|NCT00007891|Immunoglobulins|immunoglobulins|mesh-list
6330286|NCT00007891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6330287|NCT00007891|Immunologic Factors|immunologic factors|mesh-ancestor
6330288|NCT00007891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6330289|NCT00007891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6330290|NCT00007904|Tamoxifen|tamoxifen|mesh-list
6330291|NCT00007904|Paclitaxel|paclitaxel|mesh-list
6330292|NCT00007904|Cyclophosphamide|cyclophosphamide|mesh-list
6330293|NCT00007904|Doxorubicin|doxorubicin|mesh-list
6330294|NCT00007904|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6330295|NCT00007904|Lenograstim|lenograstim|mesh-list
6330296|NCT00007904|Sargramostim|sargramostim|mesh-list
6330297|NCT00007904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6330298|NCT00007904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6330299|NCT00007904|Tubulin Modulators|tubulin modulators|mesh-ancestor
6330300|NCT00007904|Antimitotic Agents|antimitotic agents|mesh-ancestor
6330301|NCT00007904|Mitosis Modulators|mitosis modulators|mesh-ancestor
6330302|NCT00007904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6330303|NCT00007904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6330304|NCT00007904|Immunologic Factors|immunologic factors|mesh-ancestor
6330305|NCT00007904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6330306|NCT00007904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6330307|NCT00007904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6330308|NCT00007904|Alkylating Agents|alkylating agents|mesh-ancestor
6330309|NCT00007904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6330310|NCT00007904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6330311|NCT00007904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6330312|NCT00007904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6330313|NCT00007904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6330314|NCT00007904|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6330315|NCT00007904|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6330316|NCT00007904|Hormone Antagonists|hormone antagonists|mesh-ancestor
6330317|NCT00007904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6330318|NCT00007904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6330319|NCT00007904|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6330320|NCT00007904|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6330321|NCT00007904|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6393240|NCT00199004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6393241|NCT00199004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6393242|NCT00199004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6393243|NCT00199017|Cytarabine|cytarabine|mesh-list
6393244|NCT00199017|Dexamethasone|dexamethasone|mesh-list
6393245|NCT00199017|Prednisolone|prednisolone|mesh-list
6393246|NCT00199017|Cyclophosphamide|cyclophosphamide|mesh-list
6393247|NCT00199017|Methotrexate|methotrexate|mesh-list
6393248|NCT00199017|Vincristine|vincristine|mesh-list
6393249|NCT00199017|Doxorubicin|doxorubicin|mesh-list
6393250|NCT00199017|Daunorubicin|daunorubicin|mesh-list
6393251|NCT00199017|Asparaginase|asparaginase|mesh-list
6393252|NCT00199017|Mercaptopurine|mercaptopurine|mesh-list
6393253|NCT00199017|Thioguanine|thioguanine|mesh-list
6393254|NCT00199017|Cladribine|cladribine|mesh-list
6393255|NCT00199017|Vindesine|vindesine|mesh-list
6393256|NCT00199017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6393257|NCT00199017|Immunologic Factors|immunologic factors|mesh-ancestor
6393258|NCT00199017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6393259|NCT00199017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6393260|NCT00199017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6330322|NCT00007917|Gemcitabine|gemcitabine|mesh-list
6330323|NCT00007917|Alvocidib|alvocidib|mesh-list
6330324|NCT00007917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6330325|NCT00007917|Antimetabolites|antimetabolites|mesh-ancestor
6330326|NCT00007917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6330327|NCT00007917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6330328|NCT00007917|Antiviral Agents|antiviral agents|mesh-ancestor
6330329|NCT00007917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6330330|NCT00007917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6330331|NCT00007917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6330332|NCT00007917|Immunologic Factors|immunologic factors|mesh-ancestor
6330333|NCT00007917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6330334|NCT00007917|Growth Inhibitors|growth inhibitors|mesh-ancestor
6330335|NCT00007917|Growth Substances|growth substances|mesh-ancestor
6330336|NCT00007917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6330337|NCT00007943|Gemcitabine|gemcitabine|mesh-list
6330338|NCT00007943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6330339|NCT00007943|Antimetabolites|antimetabolites|mesh-ancestor
6330340|NCT00007943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6330341|NCT00007943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6330342|NCT00007943|Antiviral Agents|antiviral agents|mesh-ancestor
6330343|NCT00007943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6330344|NCT00007943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6330345|NCT00007943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6330346|NCT00007943|Immunologic Factors|immunologic factors|mesh-ancestor
6330347|NCT00007943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6330348|NCT00007956|Antibodies|antibodies|mesh-list
6330349|NCT00007956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6330350|NCT00007956|Immunologic Factors|immunologic factors|mesh-ancestor
6330351|NCT00007956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6330352|NCT00007969|Verteporfin|verteporfin|mesh-list
6330353|NCT00007969|Detox adjuvant|detox adjuvant|mesh-list
6330354|NCT00007969|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6330355|NCT00007969|Dermatologic Agents|dermatologic agents|mesh-ancestor
6330356|NCT00007969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6330357|NCT00007969|Immunologic Factors|immunologic factors|mesh-ancestor
6393261|NCT00199017|Alkylating Agents|alkylating agents|mesh-ancestor
6330358|NCT00007969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6330359|NCT00007982|Cyclophosphamide|cyclophosphamide|mesh-list
6330360|NCT00007982|Thiotepa|thiotepa|mesh-list
6330361|NCT00007982|Carmustine|carmustine|mesh-list
6330362|NCT00007982|Etoposide|etoposide|mesh-list
6330363|NCT00007982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6330364|NCT00007982|Immunologic Factors|immunologic factors|mesh-ancestor
6330365|NCT00007982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6330366|NCT00007982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6330367|NCT00007982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6330368|NCT00007982|Alkylating Agents|alkylating agents|mesh-ancestor
6330369|NCT00007982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6330370|NCT00007982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6330371|NCT00007982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6330372|NCT00007982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6330373|NCT00007982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6330374|NCT00007982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6330375|NCT00007982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6330376|NCT00007995|Interferons|interferons|mesh-list
6330377|NCT00007995|Interferon-alpha|interferon-alpha|mesh-list
6330378|NCT00007995|Cyclophosphamide|cyclophosphamide|mesh-list
6330379|NCT00007995|Melphalan|melphalan|mesh-list
6330380|NCT00007995|Busulfan|busulfan|mesh-list
6330381|NCT00007995|Sargramostim|sargramostim|mesh-list
6330382|NCT00007995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6330383|NCT00007995|Immunologic Factors|immunologic factors|mesh-ancestor
6330384|NCT00007995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6330385|NCT00007995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6330386|NCT00007995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6330387|NCT00007995|Alkylating Agents|alkylating agents|mesh-ancestor
6330388|NCT00007995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6330389|NCT00007995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6330390|NCT00007995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6330391|NCT00007995|Antiviral Agents|antiviral agents|mesh-ancestor
6330392|NCT00007995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6330393|NCT00008008|Cyclophosphamide|cyclophosphamide|mesh-list
6330394|NCT00008008|Thiotepa|thiotepa|mesh-list
6330395|NCT00008008|Sargramostim|sargramostim|mesh-list
6330396|NCT00008008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6330397|NCT00008008|Immunologic Factors|immunologic factors|mesh-ancestor
6330398|NCT00008008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6330399|NCT00008008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6330400|NCT00008008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6330401|NCT00008008|Alkylating Agents|alkylating agents|mesh-ancestor
6330402|NCT00008008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6330403|NCT00008008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6330404|NCT00008008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6330405|NCT00008021|Cyclosporine|cyclosporine|mesh-list
6330406|NCT00008021|Paclitaxel|paclitaxel|mesh-list
6330407|NCT00008021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6330408|NCT00008021|Antibodies|antibodies|mesh-list
6330409|NCT00008021|Immunoglobulins|immunoglobulins|mesh-list
6330410|NCT00008021|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6330411|NCT00008021|Cyclosporins|cyclosporins|mesh-list
6330412|NCT00008021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6330413|NCT00008021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6330414|NCT00008021|Tubulin Modulators|tubulin modulators|mesh-ancestor
6330415|NCT00008021|Antimitotic Agents|antimitotic agents|mesh-ancestor
6330416|NCT00008021|Mitosis Modulators|mitosis modulators|mesh-ancestor
6330417|NCT00008021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6330418|NCT00008021|Immunologic Factors|immunologic factors|mesh-ancestor
6330419|NCT00008021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6330420|NCT00008021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6330421|NCT00008021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6330422|NCT00008021|Antifungal Agents|antifungal agents|mesh-ancestor
6330423|NCT00008021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6330424|NCT00008021|Dermatologic Agents|dermatologic agents|mesh-ancestor
6330425|NCT00008021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6330426|NCT00008021|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6330427|NCT00008034|Cyclophosphamide|cyclophosphamide|mesh-list
6330428|NCT00008034|Capecitabine|capecitabine|mesh-list
6330429|NCT00008034|Epirubicin|epirubicin|mesh-list
6330430|NCT00008034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6330431|NCT00008034|Immunologic Factors|immunologic factors|mesh-ancestor
6330432|NCT00008034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6330433|NCT00008034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6330434|NCT00008034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6330435|NCT00008034|Alkylating Agents|alkylating agents|mesh-ancestor
6330436|NCT00008034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6330437|NCT00008034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6330438|NCT00008034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6330439|NCT00008034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6330440|NCT00008034|Antimetabolites|antimetabolites|mesh-ancestor
6330441|NCT00008034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6330442|NCT00008034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6330443|NCT00008034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6330444|NCT00008034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6330445|NCT00008047|Paclitaxel|paclitaxel|mesh-list
6330446|NCT00008047|Fluorouracil|fluorouracil|mesh-list
6330447|NCT00008047|Hydroxyurea|hydroxyurea|mesh-list
6330448|NCT00008047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6330449|NCT00008047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6330450|NCT00008047|Tubulin Modulators|tubulin modulators|mesh-ancestor
6330451|NCT00008047|Antimitotic Agents|antimitotic agents|mesh-ancestor
6330452|NCT00008047|Mitosis Modulators|mitosis modulators|mesh-ancestor
6330453|NCT00008047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6330454|NCT00008047|Antimetabolites|antimetabolites|mesh-ancestor
6330455|NCT00008047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6330456|NCT00008047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6330457|NCT00008047|Immunologic Factors|immunologic factors|mesh-ancestor
6330458|NCT00008047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6330459|NCT00008047|Antisickling Agents|antisickling agents|mesh-ancestor
6330460|NCT00008047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6330461|NCT00008047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6330462|NCT00008060|Leucovorin|leucovorin|mesh-list
6330463|NCT00008060|Fluorouracil|fluorouracil|mesh-list
6330464|NCT00008060|Oxaliplatin|oxaliplatin|mesh-list
6330465|NCT00008060|Irinotecan|irinotecan|mesh-list
6330466|NCT00008060|Calcium|calcium|mesh-list
6330467|NCT00008060|Levoleucovorin|levoleucovorin|mesh-list
6330468|NCT00008060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6330469|NCT00008060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6330470|NCT00008060|Antimetabolites|antimetabolites|mesh-ancestor
6330471|NCT00008060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6330472|NCT00008060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6330473|NCT00008060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6330474|NCT00008060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6330475|NCT00008060|Immunologic Factors|immunologic factors|mesh-ancestor
6330476|NCT00008060|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6330477|NCT00008060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6330478|NCT00008060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6330479|NCT00008060|Antidotes|antidotes|mesh-ancestor
6330480|NCT00008060|Protective Agents|protective agents|mesh-ancestor
6330481|NCT00008060|Vitamin B Complex|vitamin b complex|mesh-ancestor
6330482|NCT00008060|Vitamins|vitamins|mesh-ancestor
6330483|NCT00008060|Micronutrients|micronutrients|mesh-ancestor
6330484|NCT00008073|Doxorubicin|doxorubicin|mesh-list
6330485|NCT00008073|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6330486|NCT00008073|Octreotide|octreotide|mesh-list
6330487|NCT00008073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6330488|NCT00008073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6330489|NCT00008073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6330490|NCT00008073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6330491|NCT00008073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6330492|NCT00008073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6330493|NCT00008073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6330494|NCT00008073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6330495|NCT00008086|Calcitriol|calcitriol|mesh-list
6330496|NCT00008086|Carboplatin|carboplatin|mesh-list
6330497|NCT00008086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6330498|NCT00008086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6330499|NCT00008086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6330500|NCT00008086|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6330501|NCT00008086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6330502|NCT00008086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6330503|NCT00008086|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6330504|NCT00008086|Vitamins|vitamins|mesh-ancestor
6330505|NCT00008086|Micronutrients|micronutrients|mesh-ancestor
6330506|NCT00008086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6330507|NCT00008112|Cisplatin|cisplatin|mesh-list
6330508|NCT00008112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6330509|NCT00008125|Gemcitabine|gemcitabine|mesh-list
6330510|NCT00008125|Carboplatin|carboplatin|mesh-list
6330511|NCT00008125|Docetaxel|docetaxel|mesh-list
6330512|NCT00008125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6330513|NCT00008125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6330514|NCT00008125|Antimetabolites|antimetabolites|mesh-ancestor
6330515|NCT00008125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6330516|NCT00008125|Antiviral Agents|antiviral agents|mesh-ancestor
6330517|NCT00008125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6330518|NCT00008125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6330519|NCT00008125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6330520|NCT00008125|Immunologic Factors|immunologic factors|mesh-ancestor
6330521|NCT00008125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6330522|NCT00008125|Tubulin Modulators|tubulin modulators|mesh-ancestor
6330523|NCT00008125|Antimitotic Agents|antimitotic agents|mesh-ancestor
6330524|NCT00008125|Mitosis Modulators|mitosis modulators|mesh-ancestor
6330525|NCT00008151|Cyclosporine|cyclosporine|mesh-list
6330526|NCT00008151|Mycophenolic Acid|mycophenolic acid|mesh-list
6330527|NCT00008151|Methotrexate|methotrexate|mesh-list
6330528|NCT00008151|Fludarabine phosphate|fludarabine phosphate|mesh-list
6330529|NCT00008151|Fludarabine|fludarabine|mesh-list
6330530|NCT00008151|Gemtuzumab|gemtuzumab|mesh-list
6330531|NCT00008151|Cyclosporins|cyclosporins|mesh-list
6330532|NCT00008151|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6330533|NCT00008151|Abortifacient Agents|abortifacient agents|mesh-ancestor
6330534|NCT00008151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6330535|NCT00008151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6330536|NCT00008151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6330537|NCT00008151|Antimetabolites|antimetabolites|mesh-ancestor
6330538|NCT00008151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6330539|NCT00008151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6330540|NCT00008151|Dermatologic Agents|dermatologic agents|mesh-ancestor
6330541|NCT00008151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6330542|NCT00008151|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6330543|NCT00008151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6330544|NCT00008151|Immunologic Factors|immunologic factors|mesh-ancestor
6330545|NCT00008151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6330546|NCT00008151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6330547|NCT00008151|Antifungal Agents|antifungal agents|mesh-ancestor
6330548|NCT00008151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6330549|NCT00008151|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6330550|NCT00008151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6330551|NCT00008151|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6330552|NCT00008151|Antitubercular Agents|antitubercular agents|mesh-ancestor
6330553|NCT00008151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6330554|NCT00008151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6330555|NCT00008177|Iodine|iodine|mesh-list
6330556|NCT00008177|Cyclosporine|cyclosporine|mesh-list
6330557|NCT00008177|Mycophenolic Acid|mycophenolic acid|mesh-list
6330558|NCT00008177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6330559|NCT00008177|Fludarabine|fludarabine|mesh-list
6330560|NCT00008177|Fludarabine phosphate|fludarabine phosphate|mesh-list
6330561|NCT00008177|Antibodies|antibodies|mesh-list
6330562|NCT00008177|Immunoglobulins|immunoglobulins|mesh-list
6330563|NCT00008177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6330564|NCT00008177|Cyclosporins|cyclosporins|mesh-list
6330565|NCT00008177|Immunologic Factors|immunologic factors|mesh-ancestor
6330566|NCT00008177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6330567|NCT00008177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6330568|NCT00008177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6330569|NCT00008177|Antimetabolites|antimetabolites|mesh-ancestor
6330570|NCT00008177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6330571|NCT00008177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6330572|NCT00008177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6330573|NCT00008177|Antifungal Agents|antifungal agents|mesh-ancestor
6330574|NCT00008177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6330575|NCT00008177|Dermatologic Agents|dermatologic agents|mesh-ancestor
6330576|NCT00008177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6330577|NCT00008177|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6330578|NCT00008177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6330579|NCT00008177|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6330580|NCT00008177|Antitubercular Agents|antitubercular agents|mesh-ancestor
6330581|NCT00008177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6330582|NCT00008177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6330583|NCT00008177|Trace Elements|trace elements|mesh-ancestor
6330584|NCT00008177|Micronutrients|micronutrients|mesh-ancestor
6330585|NCT00008190|Aldesleukin|aldesleukin|mesh-list
6330586|NCT00008190|Cyclophosphamide|cyclophosphamide|mesh-list
6330587|NCT00008190|Melphalan|melphalan|mesh-list
6330588|NCT00008190|Busulfan|busulfan|mesh-list
6330589|NCT00008190|Etoposide|etoposide|mesh-list
6330590|NCT00008190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6330591|NCT00008190|Immunologic Factors|immunologic factors|mesh-ancestor
6330592|NCT00008190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6330593|NCT00008190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6330594|NCT00008190|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6330595|NCT00008190|Alkylating Agents|alkylating agents|mesh-ancestor
6330596|NCT00008190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6330597|NCT00008190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6330598|NCT00008190|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6330599|NCT00008190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6330600|NCT00008190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6330601|NCT00008190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6330602|NCT00008190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6330603|NCT00008190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6330604|NCT00008190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6330605|NCT00008190|Antiviral Agents|antiviral agents|mesh-ancestor
6330606|NCT00008190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6330607|NCT00008203|Interferons|interferons|mesh-list
6330608|NCT00008203|Aldesleukin|aldesleukin|mesh-list
6330609|NCT00008203|Interferon-gamma|interferon-gamma|mesh-list
6330610|NCT00008203|Cyclosporine|cyclosporine|mesh-list
6330611|NCT00008203|Cyclophosphamide|cyclophosphamide|mesh-list
6330612|NCT00008203|Thiotepa|thiotepa|mesh-list
6330613|NCT00008203|Carboplatin|carboplatin|mesh-list
6330614|NCT00008203|Cyclosporins|cyclosporins|mesh-list
6330615|NCT00008203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6330616|NCT00008203|Immunologic Factors|immunologic factors|mesh-ancestor
6330617|NCT00008203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6330618|NCT00008203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6330619|NCT00008203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6330620|NCT00008203|Alkylating Agents|alkylating agents|mesh-ancestor
6330621|NCT00008203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6330622|NCT00008203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6330623|NCT00008203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6330624|NCT00008203|Antiviral Agents|antiviral agents|mesh-ancestor
6330625|NCT00008203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6330626|NCT00008203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6330627|NCT00008203|Antifungal Agents|antifungal agents|mesh-ancestor
6330628|NCT00008203|Dermatologic Agents|dermatologic agents|mesh-ancestor
6330629|NCT00008203|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6330630|NCT00008203|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6330631|NCT00008203|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6330632|NCT00008229|Melphalan|melphalan|mesh-list
6330633|NCT00008229|Immunologic Factors|immunologic factors|mesh-ancestor
6330634|NCT00008229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6330635|NCT00008229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6330636|NCT00008229|Alkylating Agents|alkylating agents|mesh-ancestor
6330637|NCT00008229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6330638|NCT00008229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6330639|NCT00008229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6330640|NCT00008229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6330641|NCT00008242|Thalidomide|thalidomide|mesh-list
6330642|NCT00008242|Dexamethasone|dexamethasone|mesh-list
6330643|NCT00008242|Doxorubicin|doxorubicin|mesh-list
6330644|NCT00008242|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6330645|NCT00008242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6330646|NCT00008242|Antiemetics|antiemetics|mesh-ancestor
6330647|NCT00008242|Autonomic Agents|autonomic agents|mesh-ancestor
6330648|NCT00008242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6330649|NCT00008242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6330650|NCT00008242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6016585|NCT00365794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016586|NCT00365846|Alemtuzumab|alemtuzumab|mesh-list
6016587|NCT00365846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6016588|NCT00365846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6016589|NCT00365859|Aripiprazole|aripiprazole|mesh-list
6016590|NCT00365859|Antidepressive Agents|antidepressive agents|mesh-ancestor
6016591|NCT00365859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6016592|NCT00365859|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6016593|NCT00365859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6016594|NCT00365859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6330651|NCT00008242|Glucocorticoids|glucocorticoids|mesh-ancestor
6330652|NCT00008242|Hormones|hormones|mesh-ancestor
6330653|NCT00008242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6330654|NCT00008242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6330655|NCT00008242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6330656|NCT00008242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6330657|NCT00008242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6330658|NCT00008242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6330659|NCT00008242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6330660|NCT00008242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6330661|NCT00008242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6330662|NCT00008242|Immunologic Factors|immunologic factors|mesh-ancestor
6330663|NCT00008242|Leprostatic Agents|leprostatic agents|mesh-ancestor
6330664|NCT00008242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6330665|NCT00008242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6330666|NCT00008242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6330667|NCT00008242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6330668|NCT00008242|Growth Substances|growth substances|mesh-ancestor
6330669|NCT00008242|Growth Inhibitors|growth inhibitors|mesh-ancestor
6330670|NCT00008268|Melphalan|melphalan|mesh-list
6330671|NCT00008268|Immunologic Factors|immunologic factors|mesh-ancestor
6330672|NCT00008268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6330673|NCT00008268|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6330674|NCT00008268|Alkylating Agents|alkylating agents|mesh-ancestor
6330675|NCT00008268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6330676|NCT00008268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6330677|NCT00008268|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6330678|NCT00008268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6016595|NCT00365859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6330679|NCT00008281|Leucovorin|leucovorin|mesh-list
6330680|NCT00008281|Fluorouracil|fluorouracil|mesh-list
6330681|NCT00008281|Oxaliplatin|oxaliplatin|mesh-list
6330682|NCT00008281|Calcium|calcium|mesh-list
6330683|NCT00008281|Levoleucovorin|levoleucovorin|mesh-list
6330684|NCT00008281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6330685|NCT00008281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6330686|NCT00008281|Antimetabolites|antimetabolites|mesh-ancestor
6330687|NCT00008281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6330688|NCT00008281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6330689|NCT00008281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6330690|NCT00008281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6330691|NCT00008281|Immunologic Factors|immunologic factors|mesh-ancestor
6330692|NCT00008281|Antidotes|antidotes|mesh-ancestor
6330693|NCT00008281|Protective Agents|protective agents|mesh-ancestor
6330694|NCT00008281|Vitamin B Complex|vitamin b complex|mesh-ancestor
6330695|NCT00008281|Vitamins|vitamins|mesh-ancestor
6330696|NCT00008281|Micronutrients|micronutrients|mesh-ancestor
6330697|NCT00008294|Leucovorin|leucovorin|mesh-list
6330698|NCT00008294|Dexamethasone|dexamethasone|mesh-list
6330699|NCT00008294|Fluorouracil|fluorouracil|mesh-list
6330700|NCT00008294|Oxaliplatin|oxaliplatin|mesh-list
6330701|NCT00008294|Floxuridine|floxuridine|mesh-list
6330702|NCT00008294|Calcium|calcium|mesh-list
6330703|NCT00008294|Levoleucovorin|levoleucovorin|mesh-list
6330704|NCT00008294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6330705|NCT00008294|Antiemetics|antiemetics|mesh-ancestor
6330706|NCT00008294|Autonomic Agents|autonomic agents|mesh-ancestor
6330707|NCT00008294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6330708|NCT00008294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6330709|NCT00008294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6330710|NCT00008294|Glucocorticoids|glucocorticoids|mesh-ancestor
6330711|NCT00008294|Hormones|hormones|mesh-ancestor
6330712|NCT00008294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6330713|NCT00008294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6330714|NCT00008294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6330715|NCT00008294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6330716|NCT00008294|Antimetabolites|antimetabolites|mesh-ancestor
6330717|NCT00008294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6330718|NCT00008294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6330719|NCT00008294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6330720|NCT00008294|Immunologic Factors|immunologic factors|mesh-ancestor
6330721|NCT00008294|Antidotes|antidotes|mesh-ancestor
6330722|NCT00008294|Protective Agents|protective agents|mesh-ancestor
6330723|NCT00008294|Vitamin B Complex|vitamin b complex|mesh-ancestor
6330724|NCT00008294|Vitamins|vitamins|mesh-ancestor
6330725|NCT00008294|Micronutrients|micronutrients|mesh-ancestor
6330726|NCT00008307|Cyclosporine|cyclosporine|mesh-list
6330727|NCT00008307|Mycophenolic Acid|mycophenolic acid|mesh-list
6330728|NCT00008307|Methylprednisolone|methylprednisolone|mesh-list
6330729|NCT00008307|Fludarabine|fludarabine|mesh-list
6330730|NCT00008307|Fludarabine phosphate|fludarabine phosphate|mesh-list
6330731|NCT00008307|Melphalan|melphalan|mesh-list
6330732|NCT00008307|Cyclosporins|cyclosporins|mesh-list
6330733|NCT00008307|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6330734|NCT00008307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6330735|NCT00008307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6330736|NCT00008307|Antimetabolites|antimetabolites|mesh-ancestor
6330737|NCT00008307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6330738|NCT00008307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6330739|NCT00008307|Immunologic Factors|immunologic factors|mesh-ancestor
6330740|NCT00008307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6330741|NCT00008307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6330742|NCT00008307|Antifungal Agents|antifungal agents|mesh-ancestor
6330743|NCT00008307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6330744|NCT00008307|Dermatologic Agents|dermatologic agents|mesh-ancestor
6330745|NCT00008307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6330746|NCT00008307|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6330747|NCT00008307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6330748|NCT00008307|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6330749|NCT00008307|Antitubercular Agents|antitubercular agents|mesh-ancestor
6330750|NCT00008307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6330751|NCT00008307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6330752|NCT00008307|Alkylating Agents|alkylating agents|mesh-ancestor
6330753|NCT00008307|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6330754|NCT00008307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6330755|NCT00008307|Antiemetics|antiemetics|mesh-ancestor
6330756|NCT00008307|Autonomic Agents|autonomic agents|mesh-ancestor
6330757|NCT00008307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6330758|NCT00008307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6330759|NCT00008307|Glucocorticoids|glucocorticoids|mesh-ancestor
6330760|NCT00008307|Hormones|hormones|mesh-ancestor
6330761|NCT00008307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6330762|NCT00008307|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6330763|NCT00008307|Protective Agents|protective agents|mesh-ancestor
6330764|NCT00008333|Vinorelbine|vinorelbine|mesh-list
6330765|NCT00008333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6330766|NCT00008333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6330767|NCT00008333|Tubulin Modulators|tubulin modulators|mesh-ancestor
6330768|NCT00008333|Antimitotic Agents|antimitotic agents|mesh-ancestor
6330769|NCT00008333|Mitosis Modulators|mitosis modulators|mesh-ancestor
6330770|NCT00008333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6330771|NCT00008359|Amphotericin B|amphotericin b|mesh-list
6330772|NCT00008359|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6330773|NCT00008359|Caspofungin|caspofungin|mesh-list
6330774|NCT00008359|Amebicides|amebicides|mesh-ancestor
6330775|NCT00008359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6330776|NCT00008359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6330777|NCT00008359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6330778|NCT00008359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6330779|NCT00008359|Antifungal Agents|antifungal agents|mesh-ancestor
6330780|NCT00008359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6330781|NCT00008359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6330782|NCT00008372|Sulfanilamides|sulfanilamides|mesh-list
6330783|NCT00008372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6330784|NCT00008398|Sargramostim|sargramostim|mesh-list
6330785|NCT00008398|Immunologic Factors|immunologic factors|mesh-ancestor
6330786|NCT00008398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6330787|NCT00008411|Docetaxel|docetaxel|mesh-list
6330788|NCT00008411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6330789|NCT00008411|Tubulin Modulators|tubulin modulators|mesh-ancestor
6330790|NCT00008411|Antimitotic Agents|antimitotic agents|mesh-ancestor
6330791|NCT00008411|Mitosis Modulators|mitosis modulators|mesh-ancestor
6330792|NCT00008411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6330793|NCT00008424|Irinotecan|irinotecan|mesh-list
6330794|NCT00008424|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6330795|NCT00008424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6330796|NCT00008424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6330797|NCT00008424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6330798|NCT00008424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6330799|NCT00008450|Cyclosporine|cyclosporine|mesh-list
6330800|NCT00008450|Mycophenolic Acid|mycophenolic acid|mesh-list
6330801|NCT00008450|Cyclosporins|cyclosporins|mesh-list
6330802|NCT00008450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6330803|NCT00008450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6330804|NCT00008450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6330805|NCT00008450|Immunologic Factors|immunologic factors|mesh-ancestor
6330806|NCT00008450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6330807|NCT00008450|Antifungal Agents|antifungal agents|mesh-ancestor
6330808|NCT00008450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6330809|NCT00008450|Dermatologic Agents|dermatologic agents|mesh-ancestor
6330810|NCT00008450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6330811|NCT00008450|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6330812|NCT00008450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6330813|NCT00008450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6330814|NCT00008450|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6330815|NCT00008450|Antitubercular Agents|antitubercular agents|mesh-ancestor
6330816|NCT00008450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6330817|NCT00008463|Interferons|interferons|mesh-list
6330818|NCT00008463|Ribavirin|ribavirin|mesh-list
6330819|NCT00008463|Interferon-alpha|interferon-alpha|mesh-list
6330820|NCT00008463|Interferon alpha-2|interferon alpha-2|mesh-list
6330821|NCT00008463|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6330822|NCT00008463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6330823|NCT00008463|Antiviral Agents|antiviral agents|mesh-ancestor
6330824|NCT00008463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6330825|NCT00008463|Antimetabolites|antimetabolites|mesh-ancestor
6330826|NCT00008463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6330827|NCT00008463|Immunologic Factors|immunologic factors|mesh-ancestor
6330828|NCT00008463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6330829|NCT00008476|Capsaicin|capsaicin|mesh-list
6330830|NCT00008476|Antipruritics|antipruritics|mesh-ancestor
6330831|NCT00008476|Dermatologic Agents|dermatologic agents|mesh-ancestor
6330832|NCT00008476|Sensory System Agents|sensory system agents|mesh-ancestor
6330833|NCT00008476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6330834|NCT00008476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6330835|NCT00008489|Didanosine|didanosine|mesh-list
6330836|NCT00008489|Antimetabolites|antimetabolites|mesh-ancestor
6330837|NCT00008489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6330838|NCT00008489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6330839|NCT00008489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6330840|NCT00008489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6330841|NCT00008489|Antiviral Agents|antiviral agents|mesh-ancestor
6330842|NCT00008489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6330843|NCT00008489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6330844|NCT00008489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6330845|NCT00008515|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
6330846|NCT00008515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6330847|NCT00008515|Glucocorticoids|glucocorticoids|mesh-ancestor
6330848|NCT00008515|Hormones|hormones|mesh-ancestor
6330849|NCT00008515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6330850|NCT00008515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6330851|NCT00008528|Enfuvirtide|enfuvirtide|mesh-list
6330852|NCT00008528|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6330853|NCT00008528|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6330854|NCT00008528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6330855|NCT00008528|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6330856|NCT00008528|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6330857|NCT00008528|Antiviral Agents|antiviral agents|mesh-ancestor
6330858|NCT00008528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6330859|NCT00008554|Lamivudine|lamivudine|mesh-list
6330860|NCT00008554|Abacavir|abacavir|mesh-list
6330861|NCT00008554|Nelfinavir|nelfinavir|mesh-list
6330862|NCT00008554|Fosamprenavir|fosamprenavir|mesh-list
6330863|NCT00008554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6330864|NCT00008554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6330865|NCT00008554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6330866|NCT00008554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6330867|NCT00008554|Antiviral Agents|antiviral agents|mesh-ancestor
6330868|NCT00008554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6330869|NCT00008554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6330870|NCT00008554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6330871|NCT00008554|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6330872|NCT00008554|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6330873|NCT00008554|Protease Inhibitors|protease inhibitors|mesh-ancestor
6330874|NCT00008697|Arsenic Trioxide|arsenic trioxide|mesh-list
6330875|NCT00008697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6330876|NCT00008736|Metoclopramide|metoclopramide|mesh-list
6330877|NCT00008736|Antiemetics|antiemetics|mesh-ancestor
6330878|NCT00008736|Autonomic Agents|autonomic agents|mesh-ancestor
6330879|NCT00008736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6330880|NCT00008736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6330881|NCT00008736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6330882|NCT00008736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6330883|NCT00008736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6330884|NCT00008736|Dopamine Agents|dopamine agents|mesh-ancestor
6330885|NCT00008736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6330886|NCT00008736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6330887|NCT00008866|Didanosine|didanosine|mesh-list
6330888|NCT00008866|Hydroxyurea|hydroxyurea|mesh-list
6330889|NCT00008866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6330890|NCT00008866|Antisickling Agents|antisickling agents|mesh-ancestor
6330891|NCT00008866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6330892|NCT00008866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6330893|NCT00008866|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6330894|NCT00008866|Antimetabolites|antimetabolites|mesh-ancestor
6330895|NCT00008866|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6330896|NCT00008866|Antiviral Agents|antiviral agents|mesh-ancestor
6330897|NCT00008866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6330898|NCT00008866|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6330899|NCT00008866|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6330900|NCT00009009|Immunosuppressive Agents|immunosuppressive agents|mesh-list
6330901|NCT00009009|Complement System Proteins|complement system proteins|mesh-list
6330902|NCT00009009|Immunologic Factors|immunologic factors|mesh-ancestor
6330903|NCT00009009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6330904|NCT00009048|Levodopa|levodopa|mesh-list
6330905|NCT00009048|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6330906|NCT00009048|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6330907|NCT00009048|Dopamine Agents|dopamine agents|mesh-ancestor
6330908|NCT00009048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6396933|NCT00209859|Respiratory System Agents|respiratory system agents|mesh-ancestor
6330909|NCT00009048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6330910|NCT00009048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6330911|NCT00009061|Ritonavir|ritonavir|mesh-list
6330912|NCT00009061|Nelfinavir|nelfinavir|mesh-list
6330913|NCT00009061|Fosamprenavir|fosamprenavir|mesh-list
6330914|NCT00009061|Lamivudine|lamivudine|mesh-list
6330915|NCT00009061|Abacavir|abacavir|mesh-list
6330916|NCT00009061|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6330917|NCT00009061|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6330918|NCT00009061|Protease Inhibitors|protease inhibitors|mesh-ancestor
6330919|NCT00009061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6330920|NCT00009061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6330921|NCT00009061|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6330922|NCT00009061|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6330923|NCT00009061|Antiviral Agents|antiviral agents|mesh-ancestor
6330924|NCT00009061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6330925|NCT00009061|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6330926|NCT00009061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6330927|NCT00009061|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6330928|NCT00009061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6330929|NCT00009178|Fluoxetine|fluoxetine|mesh-list
6330930|NCT00009178|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6330931|NCT00009178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6330932|NCT00009178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6330933|NCT00009178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6330934|NCT00009178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6330935|NCT00009178|Serotonin Agents|serotonin agents|mesh-ancestor
6330936|NCT00009178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6330937|NCT00009178|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6330938|NCT00009178|Antidepressive Agents|antidepressive agents|mesh-ancestor
6330939|NCT00009178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6330940|NCT00009178|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6330941|NCT00009178|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6330942|NCT00009178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6330943|NCT00009191|Sertraline|sertraline|mesh-list
6330944|NCT00009191|Antidepressive Agents|antidepressive agents|mesh-ancestor
6330945|NCT00009191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6330946|NCT00009191|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6330947|NCT00009191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6330948|NCT00009191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6330949|NCT00009191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6330950|NCT00009191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6330951|NCT00009191|Serotonin Agents|serotonin agents|mesh-ancestor
6330952|NCT00009191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6330953|NCT00009204|Perphenazine|perphenazine|mesh-list
6330954|NCT00009204|Citalopram|citalopram|mesh-list
6330955|NCT00009204|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6330956|NCT00009204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6330957|NCT00009204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6330958|NCT00009204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6330959|NCT00009204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6330960|NCT00009204|Serotonin Agents|serotonin agents|mesh-ancestor
6330961|NCT00009204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6330962|NCT00009204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6330963|NCT00009204|Antidepressive Agents|antidepressive agents|mesh-ancestor
6330964|NCT00009204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6330965|NCT00009204|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6330966|NCT00009204|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6330967|NCT00009204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6330968|NCT00009204|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6330969|NCT00009204|Dopamine Agents|dopamine agents|mesh-ancestor
6330970|NCT00009217|Haloperidol|haloperidol|mesh-list
6330971|NCT00009217|Haloperidol decanoate|haloperidol decanoate|mesh-list
6330972|NCT00009217|Antiemetics|antiemetics|mesh-ancestor
6330973|NCT00009217|Autonomic Agents|autonomic agents|mesh-ancestor
6330974|NCT00009217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6330975|NCT00009217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6330976|NCT00009217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6330977|NCT00009217|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6330978|NCT00009217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6330979|NCT00009217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6330980|NCT00009217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6330981|NCT00009217|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6330982|NCT00009217|Dopamine Agents|dopamine agents|mesh-ancestor
6330983|NCT00009217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6330984|NCT00009217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6330985|NCT00009217|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6330986|NCT00009230|Celecoxib|celecoxib|mesh-list
6330987|NCT00009230|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6330988|NCT00009230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6330989|NCT00009230|Analgesics|analgesics|mesh-ancestor
6330990|NCT00009230|Sensory System Agents|sensory system agents|mesh-ancestor
6330991|NCT00009230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6330992|NCT00009230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6330993|NCT00009230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6330994|NCT00009230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6330995|NCT00009230|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6330996|NCT00009230|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6330997|NCT00009230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6330998|NCT00009230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6330999|NCT00009555|Testosterone|testosterone|mesh-list
6331000|NCT00009555|Androgens|androgens|mesh-ancestor
6331001|NCT00009555|Hormones|hormones|mesh-ancestor
6331002|NCT00009555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6331003|NCT00009555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331004|NCT00009581|Acetylcholine|acetylcholine|mesh-list
6331005|NCT00009581|Vasodilator Agents|vasodilator agents|mesh-ancestor
6331006|NCT00009581|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6331007|NCT00009581|Cholinergic Agents|cholinergic agents|mesh-ancestor
6331008|NCT00009581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6331009|NCT00009581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331010|NCT00009581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331011|NCT00009620|Phenobarbital|phenobarbital|mesh-list
6331012|NCT00009620|Anticonvulsants|anticonvulsants|mesh-ancestor
6331013|NCT00009620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6331014|NCT00009620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6331015|NCT00009620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331016|NCT00009620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6331017|NCT00009620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6331018|NCT00009620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6331019|NCT00009620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331020|NCT00009620|GABA Modulators|gaba modulators|mesh-ancestor
6331021|NCT00009620|GABA Agents|gaba agents|mesh-ancestor
6331022|NCT00009620|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6331023|NCT00009620|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6331024|NCT00009620|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6331025|NCT00009646|Indomethacin|indomethacin|mesh-list
6331026|NCT00009646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6331027|NCT00009646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6331028|NCT00009646|Analgesics|analgesics|mesh-ancestor
6331029|NCT00009646|Sensory System Agents|sensory system agents|mesh-ancestor
6331030|NCT00009646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6331031|NCT00009646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331032|NCT00009646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6331033|NCT00009646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6331034|NCT00009646|Gout Suppressants|gout suppressants|mesh-ancestor
6331035|NCT00009646|Tocolytic Agents|tocolytic agents|mesh-ancestor
6331036|NCT00009646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6331037|NCT00009646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6331038|NCT00009646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6331039|NCT00009646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331040|NCT00009659|Ulipristal acetate|ulipristal acetate|mesh-list
6331041|NCT00009659|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6331042|NCT00009659|Contraceptive Agents|contraceptive agents|mesh-ancestor
6331043|NCT00009659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6331044|NCT00009659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331045|NCT00009659|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6331046|NCT00009672|Morphine|morphine|mesh-list
6331047|NCT00009672|Nortriptyline|nortriptyline|mesh-list
6331048|NCT00009672|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6331049|NCT00009672|Narcotics|narcotics|mesh-ancestor
6331050|NCT00009672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6331051|NCT00009672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331052|NCT00009672|Analgesics|analgesics|mesh-ancestor
6331053|NCT00009672|Sensory System Agents|sensory system agents|mesh-ancestor
6331054|NCT00009672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6331055|NCT00009672|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6331056|NCT00009672|Antidepressive Agents|antidepressive agents|mesh-ancestor
6331057|NCT00009672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6331058|NCT00009672|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6331059|NCT00009672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6331060|NCT00009672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6331061|NCT00009672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331062|NCT00009672|Adrenergic Agents|adrenergic agents|mesh-ancestor
6331063|NCT00009672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6331064|NCT00009698|Aldesleukin|aldesleukin|mesh-list
6331065|NCT00009698|Interleukin-2|interleukin-2|mesh-list
6331066|NCT00009698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331067|NCT00009698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6331068|NCT00009698|Analgesics|analgesics|mesh-ancestor
6331069|NCT00009698|Sensory System Agents|sensory system agents|mesh-ancestor
6331070|NCT00009698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6331071|NCT00009698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331072|NCT00009698|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6331073|NCT00009698|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6331074|NCT00009698|Antiviral Agents|antiviral agents|mesh-ancestor
6331075|NCT00009698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6331076|NCT00009750|Cyclosporine|cyclosporine|mesh-list
6331077|NCT00009750|Paclitaxel|paclitaxel|mesh-list
6331078|NCT00009750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6331079|NCT00009750|Antibodies|antibodies|mesh-list
6331080|NCT00009750|Immunoglobulins|immunoglobulins|mesh-list
6331081|NCT00009750|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6331082|NCT00009750|Cyclosporins|cyclosporins|mesh-list
6331083|NCT00009750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6331084|NCT00009750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331085|NCT00009750|Tubulin Modulators|tubulin modulators|mesh-ancestor
6331086|NCT00009750|Antimitotic Agents|antimitotic agents|mesh-ancestor
6331087|NCT00009750|Mitosis Modulators|mitosis modulators|mesh-ancestor
6331088|NCT00009750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331089|NCT00009750|Immunologic Factors|immunologic factors|mesh-ancestor
6331090|NCT00009750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331091|NCT00009750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6331092|NCT00009750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6331093|NCT00009750|Antifungal Agents|antifungal agents|mesh-ancestor
6331094|NCT00009750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6331095|NCT00009750|Dermatologic Agents|dermatologic agents|mesh-ancestor
6331096|NCT00009750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6331097|NCT00009750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6331098|NCT00009763|Cyclosporine|cyclosporine|mesh-list
6331099|NCT00009763|Paclitaxel|paclitaxel|mesh-list
6331100|NCT00009763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6331101|NCT00009763|Antibodies|antibodies|mesh-list
6331102|NCT00009763|Immunoglobulins|immunoglobulins|mesh-list
6331103|NCT00009763|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6331104|NCT00009763|Cyclosporins|cyclosporins|mesh-list
6331105|NCT00009763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6331106|NCT00009763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331107|NCT00009763|Tubulin Modulators|tubulin modulators|mesh-ancestor
6331108|NCT00009763|Antimitotic Agents|antimitotic agents|mesh-ancestor
6331109|NCT00009763|Mitosis Modulators|mitosis modulators|mesh-ancestor
6331110|NCT00009763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331111|NCT00009763|Immunologic Factors|immunologic factors|mesh-ancestor
6331112|NCT00009763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331113|NCT00009763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6331114|NCT00009763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6331115|NCT00009763|Antifungal Agents|antifungal agents|mesh-ancestor
6331116|NCT00009763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6331117|NCT00009763|Dermatologic Agents|dermatologic agents|mesh-ancestor
6331118|NCT00009763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6331119|NCT00009763|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6331120|NCT00009776|Cyclosporine|cyclosporine|mesh-list
6331121|NCT00009776|Paclitaxel|paclitaxel|mesh-list
6331122|NCT00009776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6331123|NCT00009776|Antibodies|antibodies|mesh-list
6331124|NCT00009776|Immunoglobulins|immunoglobulins|mesh-list
6331125|NCT00009776|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6331126|NCT00009776|Cyclosporins|cyclosporins|mesh-list
6331127|NCT00009776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6331128|NCT00009776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331129|NCT00009776|Tubulin Modulators|tubulin modulators|mesh-ancestor
6331130|NCT00009776|Antimitotic Agents|antimitotic agents|mesh-ancestor
6331131|NCT00009776|Mitosis Modulators|mitosis modulators|mesh-ancestor
6331132|NCT00009776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331133|NCT00009776|Immunologic Factors|immunologic factors|mesh-ancestor
6331134|NCT00009776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331135|NCT00009776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6331136|NCT00009776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6331137|NCT00009776|Antifungal Agents|antifungal agents|mesh-ancestor
6331138|NCT00009776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6331139|NCT00009776|Dermatologic Agents|dermatologic agents|mesh-ancestor
6331140|NCT00009776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6331141|NCT00009776|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6331142|NCT00009802|Calcitriol|calcitriol|mesh-list
6331143|NCT00009802|Paclitaxel|paclitaxel|mesh-list
6331144|NCT00009802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6331145|NCT00009802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331146|NCT00009802|Tubulin Modulators|tubulin modulators|mesh-ancestor
6331147|NCT00009802|Antimitotic Agents|antimitotic agents|mesh-ancestor
6331148|NCT00009802|Mitosis Modulators|mitosis modulators|mesh-ancestor
6331149|NCT00009802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331150|NCT00009802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6331151|NCT00009802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331152|NCT00009802|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6331153|NCT00009802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6331154|NCT00009802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6331155|NCT00009802|Vitamins|vitamins|mesh-ancestor
6331156|NCT00009802|Micronutrients|micronutrients|mesh-ancestor
6331157|NCT00009802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6331158|NCT00009815|Leucovorin|leucovorin|mesh-list
6331159|NCT00009815|Etoposide|etoposide|mesh-list
6331160|NCT00009815|Tegafur|tegafur|mesh-list
6331161|NCT00009815|Calcium|calcium|mesh-list
6331162|NCT00009815|Levoleucovorin|levoleucovorin|mesh-list
6016596|NCT00365859|Dopamine Agonists|dopamine agonists|mesh-ancestor
6016597|NCT00365859|Dopamine Agents|dopamine agents|mesh-ancestor
6016598|NCT00365859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6331163|NCT00009815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6331164|NCT00009815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331165|NCT00009815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6331166|NCT00009815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331167|NCT00009815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6331168|NCT00009815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6331169|NCT00009815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6331170|NCT00009815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331171|NCT00009815|Antidotes|antidotes|mesh-ancestor
6331172|NCT00009815|Protective Agents|protective agents|mesh-ancestor
6331173|NCT00009815|Vitamin B Complex|vitamin b complex|mesh-ancestor
6331174|NCT00009815|Vitamins|vitamins|mesh-ancestor
6331175|NCT00009815|Micronutrients|micronutrients|mesh-ancestor
6331176|NCT00009815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6331177|NCT00009815|Antimetabolites|antimetabolites|mesh-ancestor
6331178|NCT00009828|Leucovorin|leucovorin|mesh-list
6331179|NCT00009828|Paclitaxel|paclitaxel|mesh-list
6331180|NCT00009828|Tegafur|tegafur|mesh-list
6331181|NCT00009828|Calcium|calcium|mesh-list
6331182|NCT00009828|Levoleucovorin|levoleucovorin|mesh-list
6331183|NCT00009828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6331184|NCT00009828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331185|NCT00009828|Tubulin Modulators|tubulin modulators|mesh-ancestor
6331186|NCT00009828|Antimitotic Agents|antimitotic agents|mesh-ancestor
6331187|NCT00009828|Mitosis Modulators|mitosis modulators|mesh-ancestor
6331188|NCT00009828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331189|NCT00009828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6331190|NCT00009828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331191|NCT00009828|Antidotes|antidotes|mesh-ancestor
6331192|NCT00009828|Protective Agents|protective agents|mesh-ancestor
6331193|NCT00009828|Vitamin B Complex|vitamin b complex|mesh-ancestor
6331194|NCT00009828|Vitamins|vitamins|mesh-ancestor
6331195|NCT00009828|Micronutrients|micronutrients|mesh-ancestor
6331196|NCT00009828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6331197|NCT00009828|Antimetabolites|antimetabolites|mesh-ancestor
6331198|NCT00009841|Mitogens|mitogens|mesh-list
6331199|NCT00009841|Mitosis Modulators|mitosis modulators|mesh-ancestor
6331200|NCT00009841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331201|NCT00009854|Ethanol|ethanol|mesh-list
6331202|NCT00009854|Carmustine|carmustine|mesh-list
6331203|NCT00009854|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6331204|NCT00009854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6331205|NCT00009854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6331206|NCT00009854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331207|NCT00009854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6331208|NCT00009854|Alkylating Agents|alkylating agents|mesh-ancestor
6331209|NCT00009854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331210|NCT00009854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331211|NCT00009867|Arsenic Trioxide|arsenic trioxide|mesh-list
6331212|NCT00009867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331213|NCT00009880|Paclitaxel|paclitaxel|mesh-list
6331214|NCT00009880|Fluorouracil|fluorouracil|mesh-list
6331215|NCT00009880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6331216|NCT00009880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331217|NCT00009880|Tubulin Modulators|tubulin modulators|mesh-ancestor
6331218|NCT00009880|Antimitotic Agents|antimitotic agents|mesh-ancestor
6331219|NCT00009880|Mitosis Modulators|mitosis modulators|mesh-ancestor
6331220|NCT00009880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331221|NCT00009880|Antimetabolites|antimetabolites|mesh-ancestor
6331222|NCT00009880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6331223|NCT00009880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6331224|NCT00009880|Immunologic Factors|immunologic factors|mesh-ancestor
6331225|NCT00009880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331226|NCT00009893|Leucovorin|leucovorin|mesh-list
6331227|NCT00009893|Gemcitabine|gemcitabine|mesh-list
6331228|NCT00009893|Fluorouracil|fluorouracil|mesh-list
6331229|NCT00009893|Calcium|calcium|mesh-list
6331230|NCT00009893|Levoleucovorin|levoleucovorin|mesh-list
6331231|NCT00009893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6331232|NCT00009893|Antimetabolites|antimetabolites|mesh-ancestor
6331233|NCT00009893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331234|NCT00009893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331235|NCT00009893|Antiviral Agents|antiviral agents|mesh-ancestor
6331236|NCT00009893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6331237|NCT00009893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6331238|NCT00009893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6331239|NCT00009893|Immunologic Factors|immunologic factors|mesh-ancestor
6331240|NCT00009893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331241|NCT00009893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6331242|NCT00009893|Antidotes|antidotes|mesh-ancestor
6331243|NCT00009893|Protective Agents|protective agents|mesh-ancestor
6331244|NCT00009893|Vitamin B Complex|vitamin b complex|mesh-ancestor
6331245|NCT00009893|Vitamins|vitamins|mesh-ancestor
6331246|NCT00009893|Micronutrients|micronutrients|mesh-ancestor
6331247|NCT00009906|Imatinib Mesylate|imatinib mesylate|mesh-list
6331248|NCT00009906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331249|NCT00009906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6331250|NCT00009906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6331251|NCT00009906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331252|NCT00009919|Semaxinib|semaxinib|mesh-list
6331253|NCT00009919|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6331254|NCT00009919|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6331255|NCT00009919|Growth Substances|growth substances|mesh-ancestor
6331256|NCT00009919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331257|NCT00009919|Growth Inhibitors|growth inhibitors|mesh-ancestor
6331258|NCT00009919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331259|NCT00009919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6331260|NCT00009919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6331261|NCT00009919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331262|NCT00009932|Paclitaxel|paclitaxel|mesh-list
6331263|NCT00009932|Fenretinide|fenretinide|mesh-list
6331264|NCT00009932|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6331265|NCT00009932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331266|NCT00009932|Tubulin Modulators|tubulin modulators|mesh-ancestor
6331267|NCT00009932|Antimitotic Agents|antimitotic agents|mesh-ancestor
6331268|NCT00009932|Mitosis Modulators|mitosis modulators|mesh-ancestor
6331269|NCT00009932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331270|NCT00009932|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6331271|NCT00009932|Protective Agents|protective agents|mesh-ancestor
6331272|NCT00009932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6393262|NCT00199017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393263|NCT00199017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6393264|NCT00199017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6393265|NCT00199017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6393266|NCT00199017|Antiemetics|antiemetics|mesh-ancestor
6393267|NCT00199017|Autonomic Agents|autonomic agents|mesh-ancestor
6393268|NCT00199017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6393269|NCT00199017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6393270|NCT00199017|Glucocorticoids|glucocorticoids|mesh-ancestor
6393271|NCT00199017|Hormones|hormones|mesh-ancestor
6393272|NCT00199017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6393273|NCT00199017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6393274|NCT00199017|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6393275|NCT00199017|Abortifacient Agents|abortifacient agents|mesh-ancestor
6393276|NCT00199017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6393277|NCT00199017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6393278|NCT00199017|Antimetabolites|antimetabolites|mesh-ancestor
6393279|NCT00199017|Dermatologic Agents|dermatologic agents|mesh-ancestor
6393280|NCT00199017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6393281|NCT00199017|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6393282|NCT00199017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6393283|NCT00199017|Antiviral Agents|antiviral agents|mesh-ancestor
6393284|NCT00199017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6393285|NCT00199017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6393286|NCT00199017|Tubulin Modulators|tubulin modulators|mesh-ancestor
6393287|NCT00199017|Antimitotic Agents|antimitotic agents|mesh-ancestor
6393288|NCT00199017|Mitosis Modulators|mitosis modulators|mesh-ancestor
6393289|NCT00199017|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6393290|NCT00199017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6393291|NCT00199017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6393292|NCT00199030|Alemtuzumab|alemtuzumab|mesh-list
6393293|NCT00199030|Cladribine|cladribine|mesh-list
6393294|NCT00199030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6393295|NCT00199030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6393296|NCT00199030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6393297|NCT00199030|Immunologic Factors|immunologic factors|mesh-ancestor
6393298|NCT00199030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6393299|NCT00199043|Allopurinol|allopurinol|mesh-list
6393300|NCT00199043|Rasburicase|rasburicase|mesh-list
6393301|NCT00199043|Antimetabolites|antimetabolites|mesh-ancestor
6393302|NCT00199043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393303|NCT00199043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6393304|NCT00199043|Gout Suppressants|gout suppressants|mesh-ancestor
6393305|NCT00199043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6393306|NCT00199043|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6393307|NCT00199043|Antioxidants|antioxidants|mesh-ancestor
6393308|NCT00199043|Protective Agents|protective agents|mesh-ancestor
6393309|NCT00199043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6393310|NCT00199056|Cytarabine|cytarabine|mesh-list
6393311|NCT00199056|Dexamethasone|dexamethasone|mesh-list
6393312|NCT00199056|Prednisolone|prednisolone|mesh-list
6393313|NCT00199056|Cyclophosphamide|cyclophosphamide|mesh-list
6393314|NCT00199056|Ifosfamide|ifosfamide|mesh-list
6393315|NCT00199056|Methotrexate|methotrexate|mesh-list
6393316|NCT00199056|Fludarabine|fludarabine|mesh-list
6393317|NCT00199056|Vincristine|vincristine|mesh-list
6393318|NCT00199056|Doxorubicin|doxorubicin|mesh-list
6393319|NCT00199056|Daunorubicin|daunorubicin|mesh-list
6393320|NCT00199056|Asparaginase|asparaginase|mesh-list
6393321|NCT00199056|Mercaptopurine|mercaptopurine|mesh-list
6393322|NCT00199056|Idarubicin|idarubicin|mesh-list
6393323|NCT00199056|Thioguanine|thioguanine|mesh-list
6393324|NCT00199056|Vindesine|vindesine|mesh-list
6393325|NCT00199056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6393326|NCT00199056|Immunologic Factors|immunologic factors|mesh-ancestor
6393327|NCT00199056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331273|NCT00009958|Metronidazole|metronidazole|mesh-list
6331274|NCT00009958|Vaccines|vaccines|mesh-list
6331275|NCT00009958|Sargramostim|sargramostim|mesh-list
6331276|NCT00009958|Immunologic Factors|immunologic factors|mesh-ancestor
6331277|NCT00009958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331278|NCT00009958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6331279|NCT00009958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6331280|NCT00009958|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6331281|NCT00009958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6331282|NCT00009971|Fenretinide|fenretinide|mesh-list
6331283|NCT00009971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331284|NCT00009971|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6331285|NCT00009971|Protective Agents|protective agents|mesh-ancestor
6331286|NCT00009971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331287|NCT00009984|Thalidomide|thalidomide|mesh-list
6331288|NCT00009984|Fludarabine|fludarabine|mesh-list
6331289|NCT00009984|Fludarabine phosphate|fludarabine phosphate|mesh-list
6331290|NCT00009984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331291|NCT00009984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6331292|NCT00009984|Antimetabolites|antimetabolites|mesh-ancestor
6331293|NCT00009984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331294|NCT00009984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6331295|NCT00009984|Immunologic Factors|immunologic factors|mesh-ancestor
6331296|NCT00009984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331297|NCT00009984|Leprostatic Agents|leprostatic agents|mesh-ancestor
6331298|NCT00009984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6331299|NCT00009984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6331300|NCT00009984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6331301|NCT00009984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6331302|NCT00009984|Growth Substances|growth substances|mesh-ancestor
6331303|NCT00009984|Growth Inhibitors|growth inhibitors|mesh-ancestor
6331304|NCT00009997|Tamoxifen|tamoxifen|mesh-list
6331305|NCT00009997|Paclitaxel|paclitaxel|mesh-list
6331306|NCT00009997|Cyclophosphamide|cyclophosphamide|mesh-list
6331307|NCT00009997|Doxorubicin|doxorubicin|mesh-list
6331308|NCT00009997|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6331309|NCT00009997|Trastuzumab|trastuzumab|mesh-list
6331310|NCT00009997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6331311|NCT00009997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331312|NCT00009997|Tubulin Modulators|tubulin modulators|mesh-ancestor
6331313|NCT00009997|Antimitotic Agents|antimitotic agents|mesh-ancestor
6331314|NCT00009997|Mitosis Modulators|mitosis modulators|mesh-ancestor
6331315|NCT00009997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331316|NCT00009997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6331317|NCT00009997|Immunologic Factors|immunologic factors|mesh-ancestor
6331318|NCT00009997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331319|NCT00009997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6331320|NCT00009997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6331321|NCT00009997|Alkylating Agents|alkylating agents|mesh-ancestor
6331322|NCT00009997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6331323|NCT00009997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6331324|NCT00009997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6331325|NCT00009997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6331326|NCT00009997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6331327|NCT00009997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6331328|NCT00009997|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6331329|NCT00009997|Hormone Antagonists|hormone antagonists|mesh-ancestor
6331330|NCT00009997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6331331|NCT00009997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6331332|NCT00009997|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6331333|NCT00009997|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6331334|NCT00009997|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6331335|NCT00010010|Exemestane|exemestane|mesh-list
6331336|NCT00010010|Goserelin|goserelin|mesh-list
6331337|NCT00010010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331338|NCT00010010|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6331339|NCT00010010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6331340|NCT00010010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6331341|NCT00010010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331342|NCT00010010|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6331343|NCT00010010|Hormone Antagonists|hormone antagonists|mesh-ancestor
6331344|NCT00010010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6331345|NCT00010010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331346|NCT00010010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6331347|NCT00010023|Capecitabine|capecitabine|mesh-list
6331348|NCT00010023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331349|NCT00010023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6331350|NCT00010023|Antimetabolites|antimetabolites|mesh-ancestor
6331351|NCT00010023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331352|NCT00010036|Carboplatin|carboplatin|mesh-list
6331353|NCT00010036|Irinotecan|irinotecan|mesh-list
6331354|NCT00010036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331355|NCT00010036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6331356|NCT00010036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6331357|NCT00010036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6331358|NCT00010036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331359|NCT00010049|Imatinib Mesylate|imatinib mesylate|mesh-list
6331360|NCT00010049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331361|NCT00010049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6331362|NCT00010049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6331363|NCT00010049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331364|NCT00010062|Fluorouracil|fluorouracil|mesh-list
6331365|NCT00010062|Antimetabolites|antimetabolites|mesh-ancestor
6331366|NCT00010062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331367|NCT00010062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6331368|NCT00010062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331369|NCT00010062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6331370|NCT00010062|Immunologic Factors|immunologic factors|mesh-ancestor
6331371|NCT00010062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331372|NCT00010075|Leucovorin|leucovorin|mesh-list
6331373|NCT00010075|Fluorouracil|fluorouracil|mesh-list
6331374|NCT00010075|Mitoxantrone|mitoxantrone|mesh-list
6331375|NCT00010075|Calcium|calcium|mesh-list
6331376|NCT00010075|Levoleucovorin|levoleucovorin|mesh-list
6331377|NCT00010075|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6331378|NCT00010075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331379|NCT00010075|Antimetabolites|antimetabolites|mesh-ancestor
6331380|NCT00010075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331381|NCT00010075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6331382|NCT00010075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331383|NCT00010075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6331384|NCT00010075|Immunologic Factors|immunologic factors|mesh-ancestor
6331385|NCT00010075|Antidotes|antidotes|mesh-ancestor
6331386|NCT00010075|Protective Agents|protective agents|mesh-ancestor
6331387|NCT00010075|Vitamin B Complex|vitamin b complex|mesh-ancestor
6331388|NCT00010075|Vitamins|vitamins|mesh-ancestor
6331389|NCT00010075|Micronutrients|micronutrients|mesh-ancestor
6331390|NCT00010075|Analgesics|analgesics|mesh-ancestor
6331391|NCT00010075|Sensory System Agents|sensory system agents|mesh-ancestor
6331392|NCT00010075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6331393|NCT00010075|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6331394|NCT00010075|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6331395|NCT00010075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6331396|NCT00010088|Leucovorin|leucovorin|mesh-list
6331397|NCT00010088|Gemcitabine|gemcitabine|mesh-list
6331398|NCT00010088|Fluorouracil|fluorouracil|mesh-list
6331399|NCT00010088|Calcium|calcium|mesh-list
6331400|NCT00010088|Levoleucovorin|levoleucovorin|mesh-list
6331401|NCT00010088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6331402|NCT00010088|Antimetabolites|antimetabolites|mesh-ancestor
6331403|NCT00010088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331404|NCT00010088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331405|NCT00010088|Antiviral Agents|antiviral agents|mesh-ancestor
6331406|NCT00010088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6331407|NCT00010088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6331408|NCT00010088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6331409|NCT00010088|Immunologic Factors|immunologic factors|mesh-ancestor
6331410|NCT00010088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331411|NCT00010088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6331412|NCT00010088|Antidotes|antidotes|mesh-ancestor
6331413|NCT00010088|Protective Agents|protective agents|mesh-ancestor
6331414|NCT00010088|Vitamin B Complex|vitamin b complex|mesh-ancestor
6331415|NCT00010088|Vitamins|vitamins|mesh-ancestor
6331416|NCT00010088|Micronutrients|micronutrients|mesh-ancestor
6331417|NCT00010140|Tamoxifen|tamoxifen|mesh-list
6331418|NCT00010140|Docetaxel|docetaxel|mesh-list
6331419|NCT00010140|Epirubicin|epirubicin|mesh-list
6331420|NCT00010140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331421|NCT00010140|Tubulin Modulators|tubulin modulators|mesh-ancestor
6331422|NCT00010140|Antimitotic Agents|antimitotic agents|mesh-ancestor
6331423|NCT00010140|Mitosis Modulators|mitosis modulators|mesh-ancestor
6331424|NCT00010140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331425|NCT00010140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6331426|NCT00010140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6331427|NCT00010140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6331428|NCT00010140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6331429|NCT00010140|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6331430|NCT00010140|Hormone Antagonists|hormone antagonists|mesh-ancestor
6331431|NCT00010140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6331432|NCT00010140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331433|NCT00010140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6331434|NCT00010140|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6331435|NCT00010140|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6331436|NCT00010140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6331437|NCT00010153|Fulvestrant|fulvestrant|mesh-list
6331438|NCT00010153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6331439|NCT00010153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331440|NCT00010153|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6331441|NCT00010153|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6331442|NCT00010153|Hormone Antagonists|hormone antagonists|mesh-ancestor
6331443|NCT00010153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6331444|NCT00010153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331445|NCT00010166|Gemcitabine|gemcitabine|mesh-list
6331446|NCT00010166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6331447|NCT00010166|Antimetabolites|antimetabolites|mesh-ancestor
6331448|NCT00010166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331449|NCT00010166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331450|NCT00010166|Antiviral Agents|antiviral agents|mesh-ancestor
6331451|NCT00010166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6331452|NCT00010166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6331453|NCT00010166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6331454|NCT00010166|Immunologic Factors|immunologic factors|mesh-ancestor
6331455|NCT00010166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331456|NCT00010179|Lurtotecan|lurtotecan|mesh-list
6331457|NCT00010179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331458|NCT00010192|Aldesleukin|aldesleukin|mesh-list
6331459|NCT00010192|Rituximab|rituximab|mesh-list
6331460|NCT00010192|Interleukin-2|interleukin-2|mesh-list
6331461|NCT00010192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6331462|NCT00010192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331463|NCT00010192|Immunologic Factors|immunologic factors|mesh-ancestor
6331464|NCT00010192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331465|NCT00010192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6331466|NCT00010192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6331467|NCT00010192|Analgesics|analgesics|mesh-ancestor
6331468|NCT00010192|Sensory System Agents|sensory system agents|mesh-ancestor
6331469|NCT00010192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6331470|NCT00010192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6331471|NCT00010192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6331472|NCT00010192|Antiviral Agents|antiviral agents|mesh-ancestor
6331473|NCT00010192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6331474|NCT00010231|Calcitriol|calcitriol|mesh-list
6331475|NCT00010231|Dexamethasone|dexamethasone|mesh-list
6331476|NCT00010231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6331477|NCT00010231|Antiemetics|antiemetics|mesh-ancestor
6331478|NCT00010231|Autonomic Agents|autonomic agents|mesh-ancestor
6331479|NCT00010231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6331480|NCT00010231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331481|NCT00010231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6331482|NCT00010231|Glucocorticoids|glucocorticoids|mesh-ancestor
6331483|NCT00010231|Hormones|hormones|mesh-ancestor
6331484|NCT00010231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6331485|NCT00010231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6331486|NCT00010231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331487|NCT00010231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6331488|NCT00010231|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6016599|NCT00365859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016600|NCT00365859|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6016601|NCT00365859|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6016602|NCT00365859|Serotonin Agents|serotonin agents|mesh-ancestor
6016603|NCT00365859|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6331489|NCT00010231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6393328|NCT00199056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6331490|NCT00010231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331491|NCT00010231|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6331492|NCT00010231|Vitamins|vitamins|mesh-ancestor
6331493|NCT00010231|Micronutrients|micronutrients|mesh-ancestor
6331494|NCT00010231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6331495|NCT00010270|Immunotoxins|immunotoxins|mesh-list
6331496|NCT00010270|Immunologic Factors|immunologic factors|mesh-ancestor
6331497|NCT00010270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331498|NCT00010283|Beclomethasone|beclomethasone|mesh-list
6331499|NCT00010283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6331500|NCT00010283|Glucocorticoids|glucocorticoids|mesh-ancestor
6331501|NCT00010283|Hormones|hormones|mesh-ancestor
6331502|NCT00010283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6331503|NCT00010283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331504|NCT00010283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6331505|NCT00010283|Respiratory System Agents|respiratory system agents|mesh-ancestor
6331506|NCT00010322|Toremifene|toremifene|mesh-list
6331507|NCT00010322|Atamestane|atamestane|mesh-list
6331508|NCT00010322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6331509|NCT00010322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331510|NCT00010322|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6331511|NCT00010322|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6331512|NCT00010322|Hormone Antagonists|hormone antagonists|mesh-ancestor
6331513|NCT00010322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6331514|NCT00010322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331515|NCT00010322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6331516|NCT00010322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6331517|NCT00010322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331518|NCT00010361|Cyclosporine|cyclosporine|mesh-list
6331519|NCT00010361|Mycophenolic Acid|mycophenolic acid|mesh-list
6331520|NCT00010361|Fludarabine|fludarabine|mesh-list
6016604|NCT00365859|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6016605|NCT00365859|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6331521|NCT00010361|Cyclosporins|cyclosporins|mesh-list
6331522|NCT00010361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331523|NCT00010361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331524|NCT00010361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6331525|NCT00010361|Immunologic Factors|immunologic factors|mesh-ancestor
6331526|NCT00010361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331527|NCT00010361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6331528|NCT00010361|Antifungal Agents|antifungal agents|mesh-ancestor
6331529|NCT00010361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6331530|NCT00010361|Dermatologic Agents|dermatologic agents|mesh-ancestor
6331531|NCT00010361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6331532|NCT00010361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6331533|NCT00010361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6331534|NCT00010361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6331535|NCT00010361|Antitubercular Agents|antitubercular agents|mesh-ancestor
6331536|NCT00010361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6331537|NCT00010387|Cyclophosphamide|cyclophosphamide|mesh-list
6331538|NCT00010387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6331539|NCT00010387|Immunologic Factors|immunologic factors|mesh-ancestor
6331540|NCT00010387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331541|NCT00010387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6331542|NCT00010387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6331543|NCT00010387|Alkylating Agents|alkylating agents|mesh-ancestor
6331544|NCT00010387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331545|NCT00010387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331546|NCT00010387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6331547|NCT00010400|Cyclophosphamide|cyclophosphamide|mesh-list
6331548|NCT00010400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6331549|NCT00010400|Immunologic Factors|immunologic factors|mesh-ancestor
6331550|NCT00010400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331551|NCT00010400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6331552|NCT00010400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6331553|NCT00010400|Alkylating Agents|alkylating agents|mesh-ancestor
6331554|NCT00010400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331555|NCT00010400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331556|NCT00010400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6331557|NCT00010413|Cyclophosphamide|cyclophosphamide|mesh-list
6331558|NCT00010413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6331559|NCT00010413|Immunologic Factors|immunologic factors|mesh-ancestor
6331560|NCT00010413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331561|NCT00010413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6331562|NCT00010413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6331563|NCT00010413|Alkylating Agents|alkylating agents|mesh-ancestor
6331564|NCT00010413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331565|NCT00010413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331566|NCT00010413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6331567|NCT00010426|Cysteamine|cysteamine|mesh-list
6331568|NCT00010426|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
6331569|NCT00010426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331570|NCT00010452|Picibanil|picibanil|mesh-list
6331571|NCT00010452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331572|NCT00010686|Phytoestrogens|phytoestrogens|mesh-list
6331573|NCT00010686|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6331574|NCT00010686|Estrogens|estrogens|mesh-ancestor
6331575|NCT00010686|Hormones|hormones|mesh-ancestor
6331576|NCT00010686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6331577|NCT00010686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331578|NCT00010699|Vitamin E|vitamin e|mesh-list
6331579|NCT00010699|Vitamins|vitamins|mesh-ancestor
6331580|NCT00010699|Micronutrients|micronutrients|mesh-ancestor
6331581|NCT00010699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331582|NCT00010699|Antioxidants|antioxidants|mesh-ancestor
6331583|NCT00010699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331584|NCT00010699|Protective Agents|protective agents|mesh-ancestor
6331585|NCT00010725|Vitamins|vitamins|mesh-list
6331586|NCT00010725|Micronutrients|micronutrients|mesh-ancestor
6331587|NCT00010725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331588|NCT00010842|Vitamin E|vitamin e|mesh-list
6331589|NCT00010842|Thioctic Acid|thioctic acid|mesh-list
6331590|NCT00010842|Selenium|selenium|mesh-list
6331591|NCT00010842|Vitamins|vitamins|mesh-ancestor
6331592|NCT00010842|Micronutrients|micronutrients|mesh-ancestor
6331593|NCT00010842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331594|NCT00010842|Antioxidants|antioxidants|mesh-ancestor
6331595|NCT00010842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331596|NCT00010842|Protective Agents|protective agents|mesh-ancestor
6331597|NCT00010842|Trace Elements|trace elements|mesh-ancestor
6331598|NCT00010842|Vitamin B Complex|vitamin b complex|mesh-ancestor
6331599|NCT00010855|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
6331600|NCT00010855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6331601|NCT00010855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331602|NCT00010881|Antioxidants|antioxidants|mesh-list
6331603|NCT00010881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331604|NCT00010881|Protective Agents|protective agents|mesh-ancestor
6331605|NCT00010881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331606|NCT00011076|Pirfenidone|pirfenidone|mesh-list
6331607|NCT00011076|Analgesics|analgesics|mesh-ancestor
6331608|NCT00011076|Sensory System Agents|sensory system agents|mesh-ancestor
6331609|NCT00011076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6331610|NCT00011076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331611|NCT00011076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6331612|NCT00011076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6331613|NCT00011076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6331614|NCT00011076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6331615|NCT00011076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331616|NCT00011089|Tenofovir|tenofovir|mesh-list
6331617|NCT00011089|Antiviral Agents|antiviral agents|mesh-ancestor
6331618|NCT00011089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6331619|NCT00011089|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6331620|NCT00011089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6331621|NCT00011089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6331622|NCT00011089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331623|NCT00011089|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6331624|NCT00011089|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6331625|NCT00011128|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6331626|NCT00011128|Antiviral Agents|antiviral agents|mesh-ancestor
6331627|NCT00011128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6331628|NCT00011297|Gabapentin|gabapentin|mesh-list
6331629|NCT00011297|Lorazepam|lorazepam|mesh-list
6331630|NCT00011297|Analgesics|analgesics|mesh-ancestor
6331631|NCT00011297|Sensory System Agents|sensory system agents|mesh-ancestor
6331632|NCT00011297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6331633|NCT00011297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331634|NCT00011297|Anticonvulsants|anticonvulsants|mesh-ancestor
6331635|NCT00011297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6331636|NCT00011297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6331637|NCT00011297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6331638|NCT00011297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6331639|NCT00011297|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6331640|NCT00011297|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6331641|NCT00011297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6331642|NCT00011297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331643|NCT00011297|Antimanic Agents|antimanic agents|mesh-ancestor
6331644|NCT00011297|Antiemetics|antiemetics|mesh-ancestor
6331645|NCT00011297|Autonomic Agents|autonomic agents|mesh-ancestor
6331646|NCT00011297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6331647|NCT00011297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6331648|NCT00011297|GABA Modulators|gaba modulators|mesh-ancestor
6331649|NCT00011297|GABA Agents|gaba agents|mesh-ancestor
6331650|NCT00011362|Dexamethasone|dexamethasone|mesh-list
6331651|NCT00011362|Dexamethasone acetate|dexamethasone acetate|mesh-list
6331652|NCT00011362|BB 1101|bb 1101|mesh-list
6331653|NCT00011362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6331654|NCT00011362|Antiemetics|antiemetics|mesh-ancestor
6331655|NCT00011362|Autonomic Agents|autonomic agents|mesh-ancestor
6331656|NCT00011362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6331657|NCT00011362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331658|NCT00011362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6331659|NCT00011362|Glucocorticoids|glucocorticoids|mesh-ancestor
6331660|NCT00011362|Hormones|hormones|mesh-ancestor
6331661|NCT00011362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6331662|NCT00011362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6331663|NCT00011362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331664|NCT00011362|Protease Inhibitors|protease inhibitors|mesh-ancestor
6331665|NCT00011362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6331666|NCT00011362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331667|NCT00011375|Rolipram|rolipram|mesh-list
6331668|NCT00011375|Antidepressive Agents|antidepressive agents|mesh-ancestor
6331669|NCT00011375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6331670|NCT00011375|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6331671|NCT00011375|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6016606|NCT00365859|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6016607|NCT00365976|Eszopiclone|eszopiclone|mesh-list
6016608|NCT00365976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6016609|NCT00365976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6016610|NCT00365976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016611|NCT00366106|Dexamethasone|dexamethasone|mesh-list
6016612|NCT00366106|Doxorubicin|doxorubicin|mesh-list
6016613|NCT00366106|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6016614|NCT00366106|Bortezomib|bortezomib|mesh-list
6016615|NCT00366106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6016616|NCT00366106|Antiemetics|antiemetics|mesh-ancestor
6016617|NCT00366106|Autonomic Agents|autonomic agents|mesh-ancestor
6016618|NCT00366106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6016619|NCT00366106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016620|NCT00366106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6016621|NCT00366106|Glucocorticoids|glucocorticoids|mesh-ancestor
6016622|NCT00366106|Hormones|hormones|mesh-ancestor
6016623|NCT00366106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6331672|NCT00011375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6331673|NCT00011375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331674|NCT00011479|Abacavir|abacavir|mesh-list
6331675|NCT00011479|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6331676|NCT00011479|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6331677|NCT00011479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6016624|NCT00366106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6016625|NCT00366106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6016626|NCT00366106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6331678|NCT00011479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331679|NCT00011479|Antiviral Agents|antiviral agents|mesh-ancestor
6331680|NCT00011479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6331681|NCT00011479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6331682|NCT00011479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6393329|NCT00199056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6393330|NCT00199056|Alkylating Agents|alkylating agents|mesh-ancestor
6393331|NCT00199056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393332|NCT00199056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6393333|NCT00199056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6393334|NCT00199056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6393335|NCT00199056|Antiemetics|antiemetics|mesh-ancestor
6393336|NCT00199056|Autonomic Agents|autonomic agents|mesh-ancestor
6393337|NCT00199056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6393338|NCT00199056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6393339|NCT00199056|Glucocorticoids|glucocorticoids|mesh-ancestor
6393340|NCT00199056|Hormones|hormones|mesh-ancestor
6393341|NCT00199056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6393342|NCT00199056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6393343|NCT00199056|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6393344|NCT00199056|Abortifacient Agents|abortifacient agents|mesh-ancestor
6393345|NCT00199056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6393346|NCT00199056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6393347|NCT00199056|Antimetabolites|antimetabolites|mesh-ancestor
6393348|NCT00199056|Dermatologic Agents|dermatologic agents|mesh-ancestor
6393349|NCT00199056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6393350|NCT00199056|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6393351|NCT00199056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6393352|NCT00199056|Antiviral Agents|antiviral agents|mesh-ancestor
6393353|NCT00199056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6393354|NCT00199056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6393355|NCT00199056|Tubulin Modulators|tubulin modulators|mesh-ancestor
6393356|NCT00199056|Antimitotic Agents|antimitotic agents|mesh-ancestor
6393357|NCT00199056|Mitosis Modulators|mitosis modulators|mesh-ancestor
6393358|NCT00199056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6393359|NCT00199056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6393360|NCT00199056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6393361|NCT00199069|Cytarabine|cytarabine|mesh-list
6393362|NCT00199069|Dexamethasone|dexamethasone|mesh-list
6393363|NCT00199069|Prednisolone|prednisolone|mesh-list
6393364|NCT00199069|Cyclophosphamide|cyclophosphamide|mesh-list
6393365|NCT00199069|Ifosfamide|ifosfamide|mesh-list
6393366|NCT00199069|Methotrexate|methotrexate|mesh-list
6393367|NCT00199069|Vincristine|vincristine|mesh-list
6393368|NCT00199069|Doxorubicin|doxorubicin|mesh-list
6393369|NCT00199069|Daunorubicin|daunorubicin|mesh-list
6393370|NCT00199069|Asparaginase|asparaginase|mesh-list
6393371|NCT00199069|Mercaptopurine|mercaptopurine|mesh-list
6393372|NCT00199069|Mitoxantrone|mitoxantrone|mesh-list
6393373|NCT00199069|Thioguanine|thioguanine|mesh-list
6331683|NCT00011635|Silymarin|silymarin|mesh-list
6331684|NCT00011635|Antioxidants|antioxidants|mesh-ancestor
6331685|NCT00011635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331686|NCT00011635|Protective Agents|protective agents|mesh-ancestor
6331687|NCT00011635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331688|NCT00011765|Fluoxetine|fluoxetine|mesh-list
6331689|NCT00011765|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6331690|NCT00011765|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6331691|NCT00011765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6331692|NCT00011765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331693|NCT00011765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6331694|NCT00011765|Serotonin Agents|serotonin agents|mesh-ancestor
6331695|NCT00011765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331696|NCT00011765|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6331697|NCT00011765|Antidepressive Agents|antidepressive agents|mesh-ancestor
6331698|NCT00011765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6331699|NCT00011765|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6331700|NCT00011765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6331701|NCT00011765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6331702|NCT00011778|Bortezomib|bortezomib|mesh-list
6331703|NCT00011778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331704|NCT00011804|Topiramate|topiramate|mesh-list
6331705|NCT00011804|Anticonvulsants|anticonvulsants|mesh-ancestor
6331706|NCT00011804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6016627|NCT00366106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6331707|NCT00011804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331708|NCT00011895|Lamivudine|lamivudine|mesh-list
6331709|NCT00011895|Zidovudine|zidovudine|mesh-list
6331710|NCT00011895|Efavirenz|efavirenz|mesh-list
6331711|NCT00011895|Abacavir|abacavir|mesh-list
6331712|NCT00011895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6331713|NCT00011895|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6331714|NCT00011895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6331715|NCT00011895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331716|NCT00011895|Antiviral Agents|antiviral agents|mesh-ancestor
6331717|NCT00011895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6331718|NCT00011895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6331719|NCT00011895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6331720|NCT00011895|Antimetabolites|antimetabolites|mesh-ancestor
6331721|NCT00011895|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6331722|NCT00011895|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6331723|NCT00011895|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6331724|NCT00011895|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6331725|NCT00011895|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6331726|NCT00011895|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6331727|NCT00011908|Epratuzumab|epratuzumab|mesh-list
6331728|NCT00011908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6331729|NCT00011908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331730|NCT00011921|Paclitaxel|paclitaxel|mesh-list
6331731|NCT00011921|Etoposide|etoposide|mesh-list
6331732|NCT00011921|Carboplatin|carboplatin|mesh-list
6331733|NCT00011921|Etoposide phosphate|etoposide phosphate|mesh-list
6331734|NCT00011921|Epirubicin|epirubicin|mesh-list
6331735|NCT00011921|Ifosfamide|ifosfamide|mesh-list
6331736|NCT00011921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6331737|NCT00011921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331738|NCT00011921|Tubulin Modulators|tubulin modulators|mesh-ancestor
6331739|NCT00011921|Antimitotic Agents|antimitotic agents|mesh-ancestor
6331740|NCT00011921|Mitosis Modulators|mitosis modulators|mesh-ancestor
6331741|NCT00011921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331742|NCT00011921|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6331743|NCT00011921|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6331744|NCT00011921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6331745|NCT00011921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6331746|NCT00011921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6331747|NCT00011921|Alkylating Agents|alkylating agents|mesh-ancestor
6016628|NCT00366106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6016629|NCT00366106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6016630|NCT00366106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331748|NCT00011934|Interferons|interferons|mesh-list
6331749|NCT00011934|Interferon-alpha|interferon-alpha|mesh-list
6331750|NCT00011934|Sargramostim|sargramostim|mesh-list
6331751|NCT00011934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331752|NCT00011934|Antiviral Agents|antiviral agents|mesh-ancestor
6331753|NCT00011934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6331754|NCT00011934|Immunologic Factors|immunologic factors|mesh-ancestor
6331755|NCT00011934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331756|NCT00011960|Paclitaxel|paclitaxel|mesh-list
6331757|NCT00011960|Cisplatin|cisplatin|mesh-list
6331758|NCT00011960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6331759|NCT00011960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331760|NCT00011960|Tubulin Modulators|tubulin modulators|mesh-ancestor
6331761|NCT00011960|Antimitotic Agents|antimitotic agents|mesh-ancestor
6331762|NCT00011960|Mitosis Modulators|mitosis modulators|mesh-ancestor
6331763|NCT00011960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331764|NCT00011973|Fenretinide|fenretinide|mesh-list
6331765|NCT00011973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331766|NCT00011973|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6331767|NCT00011973|Protective Agents|protective agents|mesh-ancestor
6331768|NCT00011973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331769|NCT00011999|Paclitaxel|paclitaxel|mesh-list
6331770|NCT00011999|Cisplatin|cisplatin|mesh-list
6331771|NCT00011999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6331772|NCT00011999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331773|NCT00011999|Tubulin Modulators|tubulin modulators|mesh-ancestor
6331774|NCT00011999|Antimitotic Agents|antimitotic agents|mesh-ancestor
6331775|NCT00011999|Mitosis Modulators|mitosis modulators|mesh-ancestor
6331776|NCT00011999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331777|NCT00012025|Fulvestrant|fulvestrant|mesh-list
6331778|NCT00012025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6331779|NCT00012025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331780|NCT00012025|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6331781|NCT00012025|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6331782|NCT00012025|Hormone Antagonists|hormone antagonists|mesh-ancestor
6331783|NCT00012025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6331784|NCT00012025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331785|NCT00012038|Irofulven|irofulven|mesh-list
6331786|NCT00012038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6331787|NCT00012038|Alkylating Agents|alkylating agents|mesh-ancestor
6331788|NCT00012038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331789|NCT00012038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331790|NCT00012051|Cytarabine|cytarabine|mesh-list
6331791|NCT00012051|Dexamethasone|dexamethasone|mesh-list
6331792|NCT00012051|Rituximab|rituximab|mesh-list
6331793|NCT00012051|Methotrexate|methotrexate|mesh-list
6331794|NCT00012051|Etoposide|etoposide|mesh-list
6331795|NCT00012051|Melphalan|melphalan|mesh-list
6331796|NCT00012051|Ifosfamide|ifosfamide|mesh-list
6331797|NCT00012051|Carmustine|carmustine|mesh-list
6331798|NCT00012051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331799|NCT00012051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6331800|NCT00012051|Antiemetics|antiemetics|mesh-ancestor
6331801|NCT00012051|Autonomic Agents|autonomic agents|mesh-ancestor
6331802|NCT00012051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6331803|NCT00012051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331804|NCT00012051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6331805|NCT00012051|Glucocorticoids|glucocorticoids|mesh-ancestor
6331806|NCT00012051|Hormones|hormones|mesh-ancestor
6331807|NCT00012051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6331808|NCT00012051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6331809|NCT00012051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6331810|NCT00012051|Immunologic Factors|immunologic factors|mesh-ancestor
6331811|NCT00012051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6331812|NCT00012051|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6331813|NCT00012051|Abortifacient Agents|abortifacient agents|mesh-ancestor
6331814|NCT00012051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6331815|NCT00012051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6331816|NCT00012051|Antimetabolites|antimetabolites|mesh-ancestor
6331817|NCT00012051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331818|NCT00012051|Dermatologic Agents|dermatologic agents|mesh-ancestor
6331819|NCT00012051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6331820|NCT00012051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6331821|NCT00012051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6331822|NCT00012051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6331823|NCT00012051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6331824|NCT00012051|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6331825|NCT00012051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6331826|NCT00012051|Antiviral Agents|antiviral agents|mesh-ancestor
6331827|NCT00012051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6331828|NCT00012051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6331829|NCT00012051|Alkylating Agents|alkylating agents|mesh-ancestor
6331830|NCT00012051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6331831|NCT00012090|Goserelin|goserelin|mesh-list
6331832|NCT00012090|Bicalutamide|bicalutamide|mesh-list
6331833|NCT00012090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6331834|NCT00012090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331835|NCT00012090|Androgen Antagonists|androgen antagonists|mesh-ancestor
6331836|NCT00012090|Hormone Antagonists|hormone antagonists|mesh-ancestor
6331837|NCT00012090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6331838|NCT00012090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331839|NCT00012116|Temozolomide|temozolomide|mesh-list
6331840|NCT00012116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6331841|NCT00012116|Alkylating Agents|alkylating agents|mesh-ancestor
6331842|NCT00012116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331843|NCT00012116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331844|NCT00012129|Annamycin|annamycin|mesh-list
6331845|NCT00012129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6331846|NCT00012129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331847|NCT00012142|Sirolimus|sirolimus|mesh-list
6331848|NCT00012142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6331849|NCT00012142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6331850|NCT00012142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6331851|NCT00012142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331852|NCT00012142|Antifungal Agents|antifungal agents|mesh-ancestor
6331853|NCT00012142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6331854|NCT00012142|Immunologic Factors|immunologic factors|mesh-ancestor
6331855|NCT00012142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331856|NCT00012168|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
6331857|NCT00012168|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6331858|NCT00012168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331859|NCT00012181|Alvocidib|alvocidib|mesh-list
6331860|NCT00012181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331861|NCT00012181|Growth Inhibitors|growth inhibitors|mesh-ancestor
6331862|NCT00012181|Growth Substances|growth substances|mesh-ancestor
6331863|NCT00012181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331864|NCT00012181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6331865|NCT00012181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6331866|NCT00012181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331867|NCT00012194|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
6331868|NCT00012194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331869|NCT00012194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6331870|NCT00012194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6331871|NCT00012194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331872|NCT00012207|Aldesleukin|aldesleukin|mesh-list
6331873|NCT00012207|Prednisone|prednisone|mesh-list
6331874|NCT00012207|Cyclophosphamide|cyclophosphamide|mesh-list
6331875|NCT00012207|Vincristine|vincristine|mesh-list
6331876|NCT00012207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6331877|NCT00012207|Immunologic Factors|immunologic factors|mesh-ancestor
6331878|NCT00012207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331879|NCT00012207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6331880|NCT00012207|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6331881|NCT00012207|Alkylating Agents|alkylating agents|mesh-ancestor
6331882|NCT00012207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331883|NCT00012207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331884|NCT00012207|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6331885|NCT00012207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6331886|NCT00012207|Glucocorticoids|glucocorticoids|mesh-ancestor
6331887|NCT00012207|Hormones|hormones|mesh-ancestor
6331888|NCT00012207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6331889|NCT00012207|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6331890|NCT00012207|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6331891|NCT00012207|Tubulin Modulators|tubulin modulators|mesh-ancestor
6331892|NCT00012207|Antimitotic Agents|antimitotic agents|mesh-ancestor
6331893|NCT00012207|Mitosis Modulators|mitosis modulators|mesh-ancestor
6331894|NCT00012207|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6331895|NCT00012207|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6331896|NCT00012207|Antiviral Agents|antiviral agents|mesh-ancestor
6331897|NCT00012207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6331898|NCT00012220|Gemcitabine|gemcitabine|mesh-list
6331899|NCT00012220|Docetaxel|docetaxel|mesh-list
6331900|NCT00012220|Irinotecan|irinotecan|mesh-list
6331901|NCT00012220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331902|NCT00012220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6331903|NCT00012220|Antimetabolites|antimetabolites|mesh-ancestor
6331904|NCT00012220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331905|NCT00012220|Antiviral Agents|antiviral agents|mesh-ancestor
6331906|NCT00012220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6331907|NCT00012220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6331908|NCT00012220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6331909|NCT00012220|Immunologic Factors|immunologic factors|mesh-ancestor
6331910|NCT00012220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331911|NCT00012220|Tubulin Modulators|tubulin modulators|mesh-ancestor
6331912|NCT00012220|Antimitotic Agents|antimitotic agents|mesh-ancestor
6331913|NCT00012220|Mitosis Modulators|mitosis modulators|mesh-ancestor
6331914|NCT00012220|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6331915|NCT00012220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6331916|NCT00012246|Sargramostim|sargramostim|mesh-list
6331917|NCT00012246|Freund's Adjuvant|freund's adjuvant|mesh-list
6331918|NCT00012246|Immunologic Factors|immunologic factors|mesh-ancestor
6331919|NCT00012246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331920|NCT00012246|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6331921|NCT00012259|Troxacitabine|troxacitabine|mesh-list
6331922|NCT00012259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331923|NCT00012259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6331924|NCT00012259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6331925|NCT00012259|Antiviral Agents|antiviral agents|mesh-ancestor
6331926|NCT00012259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6331927|NCT00012311|Cyclophosphamide|cyclophosphamide|mesh-list
6331928|NCT00012311|Ifosfamide|ifosfamide|mesh-list
6331929|NCT00012311|Thiotepa|thiotepa|mesh-list
6331930|NCT00012311|Carboplatin|carboplatin|mesh-list
6331931|NCT00012311|Docetaxel|docetaxel|mesh-list
6331932|NCT00012311|Doxorubicin|doxorubicin|mesh-list
6331933|NCT00012311|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6331934|NCT00012311|Fluorouracil|fluorouracil|mesh-list
6331935|NCT00012311|Methotrexate|methotrexate|mesh-list
6331936|NCT00012311|Etoposide|etoposide|mesh-list
6331937|NCT00012311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6331938|NCT00012311|Immunologic Factors|immunologic factors|mesh-ancestor
6331939|NCT00012311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331940|NCT00012311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6331941|NCT00012311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6331942|NCT00012311|Alkylating Agents|alkylating agents|mesh-ancestor
6331943|NCT00012311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331944|NCT00012311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331945|NCT00012311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6331946|NCT00012311|Tubulin Modulators|tubulin modulators|mesh-ancestor
6331947|NCT00012311|Antimitotic Agents|antimitotic agents|mesh-ancestor
6331948|NCT00012311|Mitosis Modulators|mitosis modulators|mesh-ancestor
6331949|NCT00012311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6331950|NCT00012311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6331951|NCT00012311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6331952|NCT00012311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6331953|NCT00012311|Antimetabolites|antimetabolites|mesh-ancestor
6331954|NCT00012311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6331955|NCT00012311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6331956|NCT00012311|Abortifacient Agents|abortifacient agents|mesh-ancestor
6331957|NCT00012311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6331958|NCT00012311|Dermatologic Agents|dermatologic agents|mesh-ancestor
6331959|NCT00012311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6331960|NCT00012311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6331961|NCT00012311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6331962|NCT00012324|Doxorubicin|doxorubicin|mesh-list
6331963|NCT00012324|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6331964|NCT00012324|Nolatrexed|nolatrexed|mesh-list
6331965|NCT00012324|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6331966|NCT00012324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331967|NCT00012324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6331968|NCT00012324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6331969|NCT00012324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6331970|NCT00012324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331971|NCT00012324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6331972|NCT00012324|Antimetabolites|antimetabolites|mesh-ancestor
6331973|NCT00012324|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6331974|NCT00012337|Gefitinib|gefitinib|mesh-list
6331975|NCT00012337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331976|NCT00012337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6331977|NCT00012337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6331978|NCT00012337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331979|NCT00012350|Tipifarnib|tipifarnib|mesh-list
6331980|NCT00012350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331981|NCT00012363|Gemcitabine|gemcitabine|mesh-list
6331982|NCT00012363|Irinotecan|irinotecan|mesh-list
6331983|NCT00012363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6331984|NCT00012363|Antimetabolites|antimetabolites|mesh-ancestor
6331985|NCT00012363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6331986|NCT00012363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6331987|NCT00012363|Antiviral Agents|antiviral agents|mesh-ancestor
6331988|NCT00012363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6331989|NCT00012363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6331990|NCT00012363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6331991|NCT00012363|Immunologic Factors|immunologic factors|mesh-ancestor
6331992|NCT00012363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331993|NCT00012363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6331994|NCT00012363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6331995|NCT00012376|Bryostatin 1|bryostatin 1|mesh-list
6331996|NCT00012376|Sargramostim|sargramostim|mesh-list
6331997|NCT00012376|Immunologic Factors|immunologic factors|mesh-ancestor
6331998|NCT00012376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6331999|NCT00012376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6332000|NCT00012376|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6332001|NCT00012389|Oxaliplatin|oxaliplatin|mesh-list
6332002|NCT00012389|Irinotecan|irinotecan|mesh-list
6332003|NCT00012389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6332004|NCT00012389|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6332005|NCT00012389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6332006|NCT00012389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6332007|NCT00012389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332008|NCT00012467|Interferons|interferons|mesh-list
6332009|NCT00012467|Interferon-gamma|interferon-gamma|mesh-list
6332010|NCT00012467|Itraconazole|itraconazole|mesh-list
6332011|NCT00012467|Fluconazole|fluconazole|mesh-list
6332012|NCT00012467|Amphotericin B|amphotericin b|mesh-list
6332013|NCT00012467|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6332014|NCT00012467|Flucytosine|flucytosine|mesh-list
6332015|NCT00012467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6332016|NCT00012467|Antiviral Agents|antiviral agents|mesh-ancestor
6332017|NCT00012467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6332018|NCT00012467|Antifungal Agents|antifungal agents|mesh-ancestor
6332019|NCT00012467|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6332020|NCT00012467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6332021|NCT00012467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6332022|NCT00012467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332023|NCT00012467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6332024|NCT00012467|Hormone Antagonists|hormone antagonists|mesh-ancestor
6332025|NCT00012467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6332026|NCT00012467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332027|NCT00012467|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6332028|NCT00012467|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6332029|NCT00012467|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6332030|NCT00012467|Amebicides|amebicides|mesh-ancestor
6332031|NCT00012467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6332032|NCT00012467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6332033|NCT00012467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6332034|NCT00012467|Antimetabolites|antimetabolites|mesh-ancestor
6332035|NCT00012506|Etanercept|etanercept|mesh-list
6332036|NCT00012506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6332037|NCT00012506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6332038|NCT00012506|Analgesics|analgesics|mesh-ancestor
6332039|NCT00012506|Sensory System Agents|sensory system agents|mesh-ancestor
6332040|NCT00012506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6332041|NCT00012506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332042|NCT00012506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6332043|NCT00012506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6332044|NCT00012506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6332045|NCT00012506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6332046|NCT00012506|Immunologic Factors|immunologic factors|mesh-ancestor
6332047|NCT00012519|Ritonavir|ritonavir|mesh-list
6332048|NCT00012519|Indinavir|indinavir|mesh-list
6332049|NCT00012519|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6332050|NCT00012519|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6332051|NCT00012519|Protease Inhibitors|protease inhibitors|mesh-ancestor
6332052|NCT00012519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6332053|NCT00012519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332054|NCT00012519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6332055|NCT00012519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6332056|NCT00012519|Antiviral Agents|antiviral agents|mesh-ancestor
6332057|NCT00012519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6332058|NCT00012519|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6332059|NCT00012519|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6332060|NCT00012558|Inositol|inositol|mesh-list
6332061|NCT00012558|Lamotrigine|lamotrigine|mesh-list
6332062|NCT00012558|Valproic Acid|valproic acid|mesh-list
6332063|NCT00012558|Risperidone|risperidone|mesh-list
6332064|NCT00012558|Tranylcypromine|tranylcypromine|mesh-list
6332065|NCT00012558|Bupropion|bupropion|mesh-list
6332066|NCT00012558|Paroxetine|paroxetine|mesh-list
6332067|NCT00012558|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6332068|NCT00012558|Serotonin Agents|serotonin agents|mesh-ancestor
6332069|NCT00012558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6332070|NCT00012558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332071|NCT00012558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332072|NCT00012558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6332073|NCT00012558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6332074|NCT00012558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6332075|NCT00012558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6332076|NCT00012558|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6332077|NCT00012558|Dopamine Agents|dopamine agents|mesh-ancestor
6332078|NCT00012558|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6332079|NCT00012558|Antidepressive Agents|antidepressive agents|mesh-ancestor
6332080|NCT00012558|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6332081|NCT00012558|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6332082|NCT00012558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6332083|NCT00012558|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6332084|NCT00012558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6332085|NCT00012558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6332086|NCT00012558|Antimanic Agents|antimanic agents|mesh-ancestor
6332087|NCT00012558|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6332088|NCT00012558|Anticonvulsants|anticonvulsants|mesh-ancestor
6332089|NCT00012558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6332090|NCT00012558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6332091|NCT00012558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6332092|NCT00012558|GABA Agents|gaba agents|mesh-ancestor
6332093|NCT00012558|Vitamin B Complex|vitamin b complex|mesh-ancestor
6332094|NCT00012558|Vitamins|vitamins|mesh-ancestor
6332095|NCT00012558|Micronutrients|micronutrients|mesh-ancestor
6332096|NCT00012558|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6332097|NCT00012558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6332098|NCT00012584|Fluvoxamine|fluvoxamine|mesh-list
6332099|NCT00012584|Methylphenidate|methylphenidate|mesh-list
6332100|NCT00012584|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6332101|NCT00012584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332102|NCT00012584|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6332103|NCT00012584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6332104|NCT00012584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6332105|NCT00012584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332106|NCT00012584|Dopamine Agents|dopamine agents|mesh-ancestor
6332107|NCT00012584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6332108|NCT00012584|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6332109|NCT00012584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6332110|NCT00012584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6332111|NCT00012584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6332112|NCT00012584|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6332113|NCT00012584|Serotonin Agents|serotonin agents|mesh-ancestor
6332114|NCT00012584|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6332115|NCT00012584|Antidepressive Agents|antidepressive agents|mesh-ancestor
6332116|NCT00012584|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6332117|NCT00012584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6332118|NCT00012584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6332119|NCT00012584|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6332120|NCT00012688|Chlorhexidine|chlorhexidine|mesh-list
6332121|NCT00012688|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6332122|NCT00012688|Doxycycline|doxycycline|mesh-list
6332123|NCT00012688|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6332124|NCT00012688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6332125|NCT00012688|Disinfectants|disinfectants|mesh-ancestor
6332126|NCT00012688|Dermatologic Agents|dermatologic agents|mesh-ancestor
6332127|NCT00012688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6332128|NCT00012688|Antimalarials|antimalarials|mesh-ancestor
6332129|NCT00012688|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6332130|NCT00012688|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6332131|NCT00012857|Acetaminophen|acetaminophen|mesh-list
6332132|NCT00012857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6332133|NCT00012857|Analgesics|analgesics|mesh-ancestor
6332134|NCT00012857|Sensory System Agents|sensory system agents|mesh-ancestor
6332135|NCT00012857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6332136|NCT00012857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332137|NCT00012857|Antipyretics|antipyretics|mesh-ancestor
6332138|NCT00012909|Hormones|hormones|mesh-list
6332139|NCT00012909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6332140|NCT00012909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6393374|NCT00199069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6393375|NCT00199069|Immunologic Factors|immunologic factors|mesh-ancestor
6393376|NCT00199069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6393377|NCT00199069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6393378|NCT00199069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6393379|NCT00199069|Alkylating Agents|alkylating agents|mesh-ancestor
6393380|NCT00199069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393381|NCT00199069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6393382|NCT00199069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6393383|NCT00199069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6393384|NCT00199069|Antiemetics|antiemetics|mesh-ancestor
6393385|NCT00199069|Autonomic Agents|autonomic agents|mesh-ancestor
6393386|NCT00199069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6393387|NCT00199069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6393388|NCT00199069|Glucocorticoids|glucocorticoids|mesh-ancestor
6393389|NCT00199069|Hormones|hormones|mesh-ancestor
6393390|NCT00199069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6393391|NCT00199069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6393392|NCT00199069|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6393393|NCT00199069|Abortifacient Agents|abortifacient agents|mesh-ancestor
6393394|NCT00199069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6393395|NCT00199069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6393396|NCT00199069|Antimetabolites|antimetabolites|mesh-ancestor
6393397|NCT00199069|Dermatologic Agents|dermatologic agents|mesh-ancestor
6393398|NCT00199069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6393399|NCT00199069|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6393400|NCT00199069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6393401|NCT00199069|Antiviral Agents|antiviral agents|mesh-ancestor
6393402|NCT00199069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6393403|NCT00199069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6393404|NCT00199069|Tubulin Modulators|tubulin modulators|mesh-ancestor
6393405|NCT00199069|Antimitotic Agents|antimitotic agents|mesh-ancestor
6393406|NCT00199069|Mitosis Modulators|mitosis modulators|mesh-ancestor
6393407|NCT00199069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6393408|NCT00199069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6393409|NCT00199069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6393410|NCT00199069|Analgesics|analgesics|mesh-ancestor
6332141|NCT00013520|Lamivudine|lamivudine|mesh-list
6332142|NCT00013520|Zidovudine|zidovudine|mesh-list
6332143|NCT00013520|Efavirenz|efavirenz|mesh-list
6332144|NCT00013520|Nevirapine|nevirapine|mesh-list
6332145|NCT00013520|Abacavir|abacavir|mesh-list
6332146|NCT00013520|Dideoxynucleosides|dideoxynucleosides|mesh-list
6332147|NCT00013520|Stavudine|stavudine|mesh-list
6332148|NCT00013520|Didanosine|didanosine|mesh-list
6332149|NCT00013520|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6332150|NCT00013520|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6332151|NCT00013520|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6332152|NCT00013520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6332153|NCT00013520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6332154|NCT00013520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332155|NCT00013520|Antiviral Agents|antiviral agents|mesh-ancestor
6332156|NCT00013520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6332157|NCT00013520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6332158|NCT00013520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6332159|NCT00013520|Antimetabolites|antimetabolites|mesh-ancestor
6332160|NCT00013520|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6332161|NCT00013520|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6332162|NCT00013520|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6332163|NCT00013520|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6332164|NCT00013520|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6332165|NCT00013520|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6332166|NCT00013520|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6332167|NCT00013520|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6332168|NCT00013520|Protease Inhibitors|protease inhibitors|mesh-ancestor
6332169|NCT00013585|Selegiline|selegiline|mesh-list
6332170|NCT00013585|Antidepressive Agents|antidepressive agents|mesh-ancestor
6332171|NCT00013585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6332172|NCT00013585|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6332173|NCT00013585|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6332174|NCT00013585|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6332175|NCT00013585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6332176|NCT00013585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332177|NCT00013585|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6332178|NCT00013585|Protective Agents|protective agents|mesh-ancestor
6332179|NCT00013585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332180|NCT00013598|Pioglitazone|pioglitazone|mesh-list
6332181|NCT00013598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6332182|NCT00013598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332183|NCT00013624|Levodopa|levodopa|mesh-list
6332184|NCT00013624|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6332185|NCT00013624|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6332186|NCT00013624|Dopamine Agents|dopamine agents|mesh-ancestor
6332187|NCT00013624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6332188|NCT00013624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332189|NCT00013624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332190|NCT00013663|Aldesleukin|aldesleukin|mesh-list
6332191|NCT00013663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6332192|NCT00013663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6332193|NCT00013663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6332194|NCT00013663|Antiviral Agents|antiviral agents|mesh-ancestor
6332195|NCT00013663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6332196|NCT00013689|Pyrimethamine|pyrimethamine|mesh-list
6332197|NCT00013689|Sulfadoxine|sulfadoxine|mesh-list
6332198|NCT00013689|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6332199|NCT00013689|Antimalarials|antimalarials|mesh-ancestor
6332200|NCT00013689|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6332201|NCT00013689|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6332202|NCT00013689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6332203|NCT00013689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6332204|NCT00013689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6332205|NCT00013689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332206|NCT00013689|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6332207|NCT00013689|Renal Agents|renal agents|mesh-ancestor
6332208|NCT00013702|Adefovir|adefovir|mesh-list
6332209|NCT00013702|Antiviral Agents|antiviral agents|mesh-ancestor
6332210|NCT00013702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6332211|NCT00013702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6332212|NCT00013702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6332213|NCT00013702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6332214|NCT00013702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332215|NCT00013871|Vaccines|vaccines|mesh-list
6332216|NCT00013871|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6332217|NCT00013871|Immunologic Factors|immunologic factors|mesh-ancestor
6332218|NCT00013871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332219|NCT00013962|Vitamin D|vitamin d|mesh-list
6332220|NCT00013962|Vitamins|vitamins|mesh-ancestor
6332221|NCT00013962|Micronutrients|micronutrients|mesh-ancestor
6332222|NCT00013962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332223|NCT00013962|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6332224|NCT00014001|Olanzapine|olanzapine|mesh-list
6332225|NCT00014001|Risperidone|risperidone|mesh-list
6332226|NCT00014001|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6332227|NCT00014001|Ziprasidone|ziprasidone|mesh-list
6332228|NCT00014001|Clozapine|clozapine|mesh-list
6332229|NCT00014001|Perphenazine|perphenazine|mesh-list
6332230|NCT00014001|Fluphenazine|fluphenazine|mesh-list
6332231|NCT00014001|Fluphenazine depot|fluphenazine depot|mesh-list
6332232|NCT00014001|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
6332233|NCT00014001|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6332234|NCT00014001|Serotonin Agents|serotonin agents|mesh-ancestor
6332235|NCT00014001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6332236|NCT00014001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332237|NCT00014001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332238|NCT00014001|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6332239|NCT00014001|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6332240|NCT00014001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6332241|NCT00014001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6332242|NCT00014001|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6332243|NCT00014001|Dopamine Agents|dopamine agents|mesh-ancestor
6332244|NCT00014001|Antiemetics|antiemetics|mesh-ancestor
6332245|NCT00014001|Autonomic Agents|autonomic agents|mesh-ancestor
6332246|NCT00014001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6332247|NCT00014001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6332248|NCT00014001|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6332249|NCT00014001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6332250|NCT00014001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6332251|NCT00014001|Antidepressive Agents|antidepressive agents|mesh-ancestor
6332252|NCT00014001|GABA Antagonists|gaba antagonists|mesh-ancestor
6332253|NCT00014001|GABA Agents|gaba agents|mesh-ancestor
6332254|NCT00014014|Lamivudine|lamivudine|mesh-list
6332255|NCT00014014|Zidovudine|zidovudine|mesh-list
6332256|NCT00014014|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6332257|NCT00014014|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6332258|NCT00014014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6332259|NCT00014014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6332260|NCT00014014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332261|NCT00014014|Antiviral Agents|antiviral agents|mesh-ancestor
6332262|NCT00014014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6332263|NCT00014014|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6332264|NCT00014014|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6332265|NCT00014014|Antimetabolites|antimetabolites|mesh-ancestor
6332266|NCT00014040|Nitric Oxide|nitric oxide|mesh-list
6332267|NCT00014040|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6332268|NCT00014040|Autonomic Agents|autonomic agents|mesh-ancestor
6332269|NCT00014040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6332270|NCT00014040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332271|NCT00014040|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6332272|NCT00014040|Respiratory System Agents|respiratory system agents|mesh-ancestor
6332273|NCT00014040|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6332274|NCT00014040|Antioxidants|antioxidants|mesh-ancestor
6332275|NCT00014040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332276|NCT00014040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6332277|NCT00014040|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6332278|NCT00014040|Vasodilator Agents|vasodilator agents|mesh-ancestor
6332279|NCT00014040|Gasotransmitters|gasotransmitters|mesh-ancestor
6332280|NCT00014040|Protective Agents|protective agents|mesh-ancestor
6332281|NCT00014066|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
6332282|NCT00014066|Hematoporphyrins|hematoporphyrins|mesh-list
6332283|NCT00014066|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6332284|NCT00014066|Dermatologic Agents|dermatologic agents|mesh-ancestor
6332285|NCT00014066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6332286|NCT00014092|Interferons|interferons|mesh-list
6332287|NCT00014092|Interferon-alpha|interferon-alpha|mesh-list
6332288|NCT00014092|Aldesleukin|aldesleukin|mesh-list
6332289|NCT00014092|Temozolomide|temozolomide|mesh-list
6332290|NCT00014092|Sargramostim|sargramostim|mesh-list
6332291|NCT00014092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6332292|NCT00014092|Antiviral Agents|antiviral agents|mesh-ancestor
6332293|NCT00014092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6332294|NCT00014092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6332295|NCT00014092|Alkylating Agents|alkylating agents|mesh-ancestor
6332296|NCT00014092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332297|NCT00014092|Immunologic Factors|immunologic factors|mesh-ancestor
6332298|NCT00014092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332299|NCT00014092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6332300|NCT00014092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6332301|NCT00014105|Carboplatin|carboplatin|mesh-list
6332302|NCT00014105|Temozolomide|temozolomide|mesh-list
6332303|NCT00014105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6332304|NCT00014105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6332305|NCT00014105|Alkylating Agents|alkylating agents|mesh-ancestor
6332306|NCT00014105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332307|NCT00014118|Paclitaxel|paclitaxel|mesh-list
6332308|NCT00014118|Carboplatin|carboplatin|mesh-list
6332309|NCT00014118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6332310|NCT00014118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6332311|NCT00014118|Tubulin Modulators|tubulin modulators|mesh-ancestor
6332312|NCT00014118|Antimitotic Agents|antimitotic agents|mesh-ancestor
6332313|NCT00014118|Mitosis Modulators|mitosis modulators|mesh-ancestor
6332314|NCT00014118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332315|NCT00014144|Gefitinib|gefitinib|mesh-list
6332316|NCT00014144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6332317|NCT00014144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6332318|NCT00014144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6332319|NCT00014144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332320|NCT00014170|Gefitinib|gefitinib|mesh-list
6332321|NCT00014170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6332322|NCT00014170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6332323|NCT00014170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6332324|NCT00014170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332325|NCT00014183|Gefitinib|gefitinib|mesh-list
6332326|NCT00014183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6332327|NCT00014183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6332328|NCT00014183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6332329|NCT00014183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332330|NCT00014196|Docetaxel|docetaxel|mesh-list
6332331|NCT00014196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6332332|NCT00014196|Tubulin Modulators|tubulin modulators|mesh-ancestor
6332333|NCT00014196|Antimitotic Agents|antimitotic agents|mesh-ancestor
6332334|NCT00014196|Mitosis Modulators|mitosis modulators|mesh-ancestor
6332335|NCT00014196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332336|NCT00014209|Gemcitabine|gemcitabine|mesh-list
6332337|NCT00014209|Dexamethasone|dexamethasone|mesh-list
6332338|NCT00014209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6332339|NCT00014209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6332340|NCT00014209|Antiemetics|antiemetics|mesh-ancestor
6332341|NCT00014209|Autonomic Agents|autonomic agents|mesh-ancestor
6332342|NCT00014209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6332343|NCT00014209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332344|NCT00014209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6332345|NCT00014209|Glucocorticoids|glucocorticoids|mesh-ancestor
6332346|NCT00014209|Hormones|hormones|mesh-ancestor
6332347|NCT00014209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6332348|NCT00014209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6332349|NCT00014209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6332350|NCT00014209|Antimetabolites|antimetabolites|mesh-ancestor
6332351|NCT00014209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332352|NCT00014209|Antiviral Agents|antiviral agents|mesh-ancestor
6332353|NCT00014209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6332354|NCT00014209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6332355|NCT00014209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6332356|NCT00014209|Immunologic Factors|immunologic factors|mesh-ancestor
6332357|NCT00014235|Cyclosporine|cyclosporine|mesh-list
6332358|NCT00014235|Mycophenolic Acid|mycophenolic acid|mesh-list
6332359|NCT00014235|Fludarabine|fludarabine|mesh-list
6332360|NCT00014235|Fludarabine phosphate|fludarabine phosphate|mesh-list
6332361|NCT00014235|Cyclosporins|cyclosporins|mesh-list
6332362|NCT00014235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6332363|NCT00014235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6332364|NCT00014235|Antimetabolites|antimetabolites|mesh-ancestor
6332365|NCT00014235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332366|NCT00014235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6332367|NCT00014235|Immunologic Factors|immunologic factors|mesh-ancestor
6332368|NCT00014235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332369|NCT00014235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6332370|NCT00014235|Antifungal Agents|antifungal agents|mesh-ancestor
6332371|NCT00014235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6332372|NCT00014235|Dermatologic Agents|dermatologic agents|mesh-ancestor
6332373|NCT00014235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6332374|NCT00014235|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6332375|NCT00014235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6332376|NCT00014235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6332377|NCT00014235|Antitubercular Agents|antitubercular agents|mesh-ancestor
6332378|NCT00014235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6332379|NCT00014248|Adenosine|adenosine|mesh-list
6332380|NCT00014248|Analgesics|analgesics|mesh-ancestor
6332381|NCT00014248|Sensory System Agents|sensory system agents|mesh-ancestor
6332382|NCT00014248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6332383|NCT00014248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332384|NCT00014248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6332385|NCT00014248|Vasodilator Agents|vasodilator agents|mesh-ancestor
6332386|NCT00014248|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6332387|NCT00014248|Purinergic Agonists|purinergic agonists|mesh-ancestor
6332388|NCT00014248|Purinergic Agents|purinergic agents|mesh-ancestor
6332389|NCT00014248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6332390|NCT00014248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332391|NCT00014261|Interferons|interferons|mesh-list
6332392|NCT00014261|Interferon-alpha|interferon-alpha|mesh-list
6332393|NCT00014261|Interferon alpha-2|interferon alpha-2|mesh-list
6332394|NCT00014261|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6332395|NCT00014261|Temozolomide|temozolomide|mesh-list
6332396|NCT00014261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6332397|NCT00014261|Antiviral Agents|antiviral agents|mesh-ancestor
6332398|NCT00014261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6332399|NCT00014261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6332400|NCT00014261|Alkylating Agents|alkylating agents|mesh-ancestor
6332401|NCT00014261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332402|NCT00014261|Immunologic Factors|immunologic factors|mesh-ancestor
6332403|NCT00014261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332404|NCT00014274|Gemcitabine|gemcitabine|mesh-list
6332405|NCT00014274|Carboplatin|carboplatin|mesh-list
6332406|NCT00014274|Methotrexate|methotrexate|mesh-list
6332407|NCT00014274|Vinblastine|vinblastine|mesh-list
6332408|NCT00014274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6332409|NCT00014274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6332410|NCT00014274|Antimetabolites|antimetabolites|mesh-ancestor
6332411|NCT00014274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332412|NCT00014274|Antiviral Agents|antiviral agents|mesh-ancestor
6332413|NCT00014274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6332414|NCT00014274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6332415|NCT00014274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6332416|NCT00014274|Immunologic Factors|immunologic factors|mesh-ancestor
6332417|NCT00014274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332418|NCT00014274|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6332419|NCT00014274|Abortifacient Agents|abortifacient agents|mesh-ancestor
6332420|NCT00014274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6332421|NCT00014274|Dermatologic Agents|dermatologic agents|mesh-ancestor
6332422|NCT00014274|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6332423|NCT00014274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6332424|NCT00014274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6332425|NCT00014274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6332426|NCT00014274|Tubulin Modulators|tubulin modulators|mesh-ancestor
6332427|NCT00014274|Antimitotic Agents|antimitotic agents|mesh-ancestor
6332428|NCT00014274|Mitosis Modulators|mitosis modulators|mesh-ancestor
6332429|NCT00014287|Gemcitabine|gemcitabine|mesh-list
6332430|NCT00014287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6332431|NCT00014287|Antimetabolites|antimetabolites|mesh-ancestor
6332432|NCT00014287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332433|NCT00014287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6332434|NCT00014287|Antiviral Agents|antiviral agents|mesh-ancestor
6332435|NCT00014287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6332436|NCT00014287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6332437|NCT00014287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6332438|NCT00014287|Immunologic Factors|immunologic factors|mesh-ancestor
6332439|NCT00014287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332440|NCT00014313|Etoposide|etoposide|mesh-list
6332441|NCT00014313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6332442|NCT00014313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6332443|NCT00014313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6332444|NCT00014313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6332445|NCT00014313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6332446|NCT00014313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332447|NCT00014339|Prednisone|prednisone|mesh-list
6332448|NCT00014339|Melphalan|melphalan|mesh-list
6332449|NCT00014339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6332450|NCT00014339|Glucocorticoids|glucocorticoids|mesh-ancestor
6332451|NCT00014339|Hormones|hormones|mesh-ancestor
6332452|NCT00014339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6332453|NCT00014339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332454|NCT00014339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6332455|NCT00014339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6332456|NCT00014339|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6332457|NCT00014339|Alkylating Agents|alkylating agents|mesh-ancestor
6332458|NCT00014339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332459|NCT00014339|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6332460|NCT00014339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6332461|NCT00014339|Immunologic Factors|immunologic factors|mesh-ancestor
6332462|NCT00014352|Ketoconazole|ketoconazole|mesh-list
6332463|NCT00014352|Docetaxel|docetaxel|mesh-list
6332464|NCT00014352|Doxorubicin|doxorubicin|mesh-list
6332465|NCT00014352|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6332466|NCT00014352|Estramustine|estramustine|mesh-list
6332467|NCT00014352|Warfarin|warfarin|mesh-list
6332468|NCT00014352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6332469|NCT00014352|Tubulin Modulators|tubulin modulators|mesh-ancestor
6332470|NCT00014352|Antimitotic Agents|antimitotic agents|mesh-ancestor
6332471|NCT00014352|Mitosis Modulators|mitosis modulators|mesh-ancestor
6332472|NCT00014352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332473|NCT00014352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6332474|NCT00014352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6332475|NCT00014352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6332476|NCT00014352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6332477|NCT00014352|Anticoagulants|anticoagulants|mesh-ancestor
6332478|NCT00014352|Antifungal Agents|antifungal agents|mesh-ancestor
6332479|NCT00014352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6332480|NCT00014352|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6332481|NCT00014352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6332482|NCT00014352|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6332483|NCT00014352|Hormone Antagonists|hormone antagonists|mesh-ancestor
6332484|NCT00014352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6332485|NCT00014352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332486|NCT00014352|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6332487|NCT00014352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6332488|NCT00014352|Alkylating Agents|alkylating agents|mesh-ancestor
6332489|NCT00014352|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6332490|NCT00014391|Ribavirin|ribavirin|mesh-list
6332491|NCT00014391|Palivizumab|palivizumab|mesh-list
6332492|NCT00014391|Antimetabolites|antimetabolites|mesh-ancestor
6332493|NCT00014391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332494|NCT00014391|Antiviral Agents|antiviral agents|mesh-ancestor
6332495|NCT00014391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6332496|NCT00014404|Celecoxib|celecoxib|mesh-list
6332497|NCT00014404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6332498|NCT00014404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6332499|NCT00014404|Analgesics|analgesics|mesh-ancestor
6332500|NCT00014404|Sensory System Agents|sensory system agents|mesh-ancestor
6332501|NCT00014404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6332502|NCT00014404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332503|NCT00014404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6332504|NCT00014404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6332505|NCT00014404|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6332506|NCT00014404|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6332507|NCT00014404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6332508|NCT00014404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393411|NCT00199069|Sensory System Agents|sensory system agents|mesh-ancestor
6393412|NCT00199082|Cytarabine|cytarabine|mesh-list
6393413|NCT00199082|Dexamethasone|dexamethasone|mesh-list
6393414|NCT00199082|Prednisolone|prednisolone|mesh-list
6393415|NCT00199082|Cyclophosphamide|cyclophosphamide|mesh-list
6393416|NCT00199082|Ifosfamide|ifosfamide|mesh-list
6393417|NCT00199082|Rituximab|rituximab|mesh-list
6393418|NCT00199082|Methotrexate|methotrexate|mesh-list
6393419|NCT00199082|Vincristine|vincristine|mesh-list
6393420|NCT00199082|Doxorubicin|doxorubicin|mesh-list
6393421|NCT00199082|Vindesine|vindesine|mesh-list
6393422|NCT00199082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6393423|NCT00199082|Immunologic Factors|immunologic factors|mesh-ancestor
6393424|NCT00199082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6393425|NCT00199082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6393426|NCT00199082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6393427|NCT00199082|Alkylating Agents|alkylating agents|mesh-ancestor
6393428|NCT00199082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393429|NCT00199082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6393430|NCT00199082|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6393431|NCT00199082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6393432|NCT00199082|Antiemetics|antiemetics|mesh-ancestor
6393433|NCT00199082|Autonomic Agents|autonomic agents|mesh-ancestor
6393434|NCT00199082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6393435|NCT00199082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6393436|NCT00199082|Glucocorticoids|glucocorticoids|mesh-ancestor
6393437|NCT00199082|Hormones|hormones|mesh-ancestor
6393438|NCT00199082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6393439|NCT00199082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6393440|NCT00199082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6393441|NCT00199082|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6393442|NCT00199082|Abortifacient Agents|abortifacient agents|mesh-ancestor
6393443|NCT00199082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6393444|NCT00199082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6393445|NCT00199082|Antimetabolites|antimetabolites|mesh-ancestor
6393446|NCT00199082|Dermatologic Agents|dermatologic agents|mesh-ancestor
6393447|NCT00199082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6393448|NCT00199082|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6393449|NCT00199082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6393450|NCT00199082|Antiviral Agents|antiviral agents|mesh-ancestor
6393451|NCT00199082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6016631|NCT00366249|Ertapenem|ertapenem|mesh-list
6393452|NCT00199082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6393453|NCT00199082|Tubulin Modulators|tubulin modulators|mesh-ancestor
6332509|NCT00014430|Trastuzumab|trastuzumab|mesh-list
6332510|NCT00014430|Vinorelbine|vinorelbine|mesh-list
6332511|NCT00014430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6332512|NCT00014430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6332513|NCT00014430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6332514|NCT00014430|Tubulin Modulators|tubulin modulators|mesh-ancestor
6332515|NCT00014430|Antimitotic Agents|antimitotic agents|mesh-ancestor
6332516|NCT00014430|Mitosis Modulators|mitosis modulators|mesh-ancestor
6332517|NCT00014430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332518|NCT00014443|Thalidomide|thalidomide|mesh-list
6332519|NCT00014443|Topotecan|topotecan|mesh-list
6332520|NCT00014443|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6332521|NCT00014443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6332522|NCT00014443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6332523|NCT00014443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332524|NCT00014443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6332525|NCT00014443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6332526|NCT00014443|Immunologic Factors|immunologic factors|mesh-ancestor
6332527|NCT00014443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332528|NCT00014443|Leprostatic Agents|leprostatic agents|mesh-ancestor
6332529|NCT00014443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6332530|NCT00014443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6332531|NCT00014443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6332532|NCT00014443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6332533|NCT00014443|Growth Substances|growth substances|mesh-ancestor
6332534|NCT00014443|Growth Inhibitors|growth inhibitors|mesh-ancestor
6332535|NCT00014456|Gemcitabine|gemcitabine|mesh-list
6332536|NCT00014456|Docetaxel|docetaxel|mesh-list
6332537|NCT00014456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6332538|NCT00014456|Antimetabolites|antimetabolites|mesh-ancestor
6332539|NCT00014456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332540|NCT00014456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6332541|NCT00014456|Antiviral Agents|antiviral agents|mesh-ancestor
6332542|NCT00014456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6332543|NCT00014456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6332544|NCT00014456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6332545|NCT00014456|Immunologic Factors|immunologic factors|mesh-ancestor
6332546|NCT00014456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332547|NCT00014456|Tubulin Modulators|tubulin modulators|mesh-ancestor
6332548|NCT00014456|Antimitotic Agents|antimitotic agents|mesh-ancestor
6332549|NCT00014456|Mitosis Modulators|mitosis modulators|mesh-ancestor
6332550|NCT00014469|Methotrexate|methotrexate|mesh-list
6332551|NCT00014469|Melphalan|melphalan|mesh-list
6332552|NCT00014469|Busulfan|busulfan|mesh-list
6332553|NCT00014469|Tacrolimus|tacrolimus|mesh-list
6332554|NCT00014469|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6332555|NCT00014469|Abortifacient Agents|abortifacient agents|mesh-ancestor
6332556|NCT00014469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6332557|NCT00014469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332558|NCT00014469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6332559|NCT00014469|Antimetabolites|antimetabolites|mesh-ancestor
6332560|NCT00014469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332561|NCT00014469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6332562|NCT00014469|Dermatologic Agents|dermatologic agents|mesh-ancestor
6332563|NCT00014469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6016632|NCT00366249|Tigecycline|tigecycline|mesh-list
6332564|NCT00014469|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6332565|NCT00014469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6332566|NCT00014469|Immunologic Factors|immunologic factors|mesh-ancestor
6332567|NCT00014469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6332568|NCT00014469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6332569|NCT00014469|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6332570|NCT00014469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6332571|NCT00014469|Alkylating Agents|alkylating agents|mesh-ancestor
6332572|NCT00014469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6332573|NCT00014508|Cyclosporine|cyclosporine|mesh-list
6332574|NCT00014508|Cyclophosphamide|cyclophosphamide|mesh-list
6332575|NCT00014508|Melphalan|melphalan|mesh-list
6332576|NCT00014508|Fludarabine|fludarabine|mesh-list
6332577|NCT00014508|Fludarabine phosphate|fludarabine phosphate|mesh-list
6332578|NCT00014508|Cyclosporins|cyclosporins|mesh-list
6332579|NCT00014508|Sargramostim|sargramostim|mesh-list
6332580|NCT00014508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6332581|NCT00014508|Immunologic Factors|immunologic factors|mesh-ancestor
6332582|NCT00014508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332583|NCT00014508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6332584|NCT00014508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6332585|NCT00014508|Alkylating Agents|alkylating agents|mesh-ancestor
6332586|NCT00014508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332587|NCT00014508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6332588|NCT00014508|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6332589|NCT00014508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6332590|NCT00014508|Antimetabolites|antimetabolites|mesh-ancestor
6332591|NCT00014508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6332592|NCT00014508|Antifungal Agents|antifungal agents|mesh-ancestor
6332593|NCT00014508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6332594|NCT00014508|Dermatologic Agents|dermatologic agents|mesh-ancestor
6332595|NCT00014508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6332596|NCT00014534|Gemcitabine|gemcitabine|mesh-list
6332597|NCT00014534|Doxorubicin|doxorubicin|mesh-list
6332598|NCT00014534|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6332599|NCT00014534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6332600|NCT00014534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6332601|NCT00014534|Antimetabolites|antimetabolites|mesh-ancestor
6332602|NCT00014534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332603|NCT00014534|Antiviral Agents|antiviral agents|mesh-ancestor
6332604|NCT00014534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6332605|NCT00014534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6332606|NCT00014534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6332607|NCT00014534|Immunologic Factors|immunologic factors|mesh-ancestor
6332608|NCT00014534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332609|NCT00014534|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6332610|NCT00014534|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6332611|NCT00014534|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6332612|NCT00014547|BBR 3464|bbr 3464|mesh-list
6332613|NCT00014547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6332614|NCT00014573|Aldesleukin|aldesleukin|mesh-list
6332615|NCT00014573|Paclitaxel|paclitaxel|mesh-list
6332616|NCT00014573|Cyclophosphamide|cyclophosphamide|mesh-list
6332617|NCT00014573|Carmustine|carmustine|mesh-list
6332618|NCT00014573|Sargramostim|sargramostim|mesh-list
6332619|NCT00014573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6332620|NCT00014573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6332621|NCT00014573|Tubulin Modulators|tubulin modulators|mesh-ancestor
6332622|NCT00014573|Antimitotic Agents|antimitotic agents|mesh-ancestor
6332623|NCT00014573|Mitosis Modulators|mitosis modulators|mesh-ancestor
6332624|NCT00014573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332625|NCT00014573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6332626|NCT00014573|Immunologic Factors|immunologic factors|mesh-ancestor
6332627|NCT00014573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332628|NCT00014573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6332629|NCT00014573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6332630|NCT00014573|Alkylating Agents|alkylating agents|mesh-ancestor
6332631|NCT00014573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6332632|NCT00014573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6332633|NCT00014573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6332634|NCT00014573|Antiviral Agents|antiviral agents|mesh-ancestor
6332635|NCT00014573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6332636|NCT00014586|Goserelin|goserelin|mesh-list
6332637|NCT00014586|Bicalutamide|bicalutamide|mesh-list
6332638|NCT00014586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6332639|NCT00014586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6332640|NCT00014586|Androgen Antagonists|androgen antagonists|mesh-ancestor
6332641|NCT00014586|Hormone Antagonists|hormone antagonists|mesh-ancestor
6332642|NCT00014586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6332643|NCT00014586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016633|NCT00366249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6016634|NCT00366249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6016635|NCT00366249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6016636|NCT00366249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6016637|NCT00366249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016638|NCT00366301|Metformin|metformin|mesh-list
6016639|NCT00366301|Insulin Glargine|insulin glargine|mesh-list
6016640|NCT00366301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6016641|NCT00366301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016642|NCT00366340|Vaccines|vaccines|mesh-list
6016643|NCT00366340|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6016644|NCT00366340|Immunologic Factors|immunologic factors|mesh-ancestor
6016645|NCT00366340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016646|NCT00366444|Diclofenac|diclofenac|mesh-list
6016647|NCT00366444|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6016648|NCT00366444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6016649|NCT00366444|Analgesics|analgesics|mesh-ancestor
6016650|NCT00366444|Sensory System Agents|sensory system agents|mesh-ancestor
6016651|NCT00366444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6016652|NCT00366444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016653|NCT00366444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6016654|NCT00366444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6332644|NCT00014599|Paclitaxel|paclitaxel|mesh-list
6332645|NCT00014599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6332646|NCT00014599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6332647|NCT00014599|Tubulin Modulators|tubulin modulators|mesh-ancestor
6332648|NCT00014599|Antimitotic Agents|antimitotic agents|mesh-ancestor
6332649|NCT00014599|Mitosis Modulators|mitosis modulators|mesh-ancestor
6332650|NCT00014599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332651|NCT00014625|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
6332652|NCT00014625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6332653|NCT00014625|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6332654|NCT00014625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6332655|NCT00014625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332656|NCT00014638|Letrozole|letrozole|mesh-list
6332657|NCT00014638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6332658|NCT00014638|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6332659|NCT00014638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6332660|NCT00014638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6332661|NCT00014638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332662|NCT00014638|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6332663|NCT00014638|Hormone Antagonists|hormone antagonists|mesh-ancestor
6332664|NCT00014638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6332665|NCT00014638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332666|NCT00014651|Vapreotide|vapreotide|mesh-list
6332667|NCT00014651|Analgesics|analgesics|mesh-ancestor
6332668|NCT00014651|Sensory System Agents|sensory system agents|mesh-ancestor
6332669|NCT00014651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6332670|NCT00014651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332671|NCT00014651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6332672|NCT00014677|Interleukin-4|interleukin-4|mesh-list
6332673|NCT00014677|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6332674|NCT00014677|Immunologic Factors|immunologic factors|mesh-ancestor
6332675|NCT00014677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332676|NCT00014677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6332677|NCT00014677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6332678|NCT00014690|Topotecan|topotecan|mesh-list
6332679|NCT00014690|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6332680|NCT00014690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6332681|NCT00014690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6332682|NCT00014690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332683|NCT00014690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6332684|NCT00014729|Isotretinoin|isotretinoin|mesh-list
6332685|NCT00014729|Dermatologic Agents|dermatologic agents|mesh-ancestor
6332686|NCT00014755|Prednisone|prednisone|mesh-list
6332687|NCT00014755|Cyclophosphamide|cyclophosphamide|mesh-list
6332688|NCT00014755|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6332689|NCT00014755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6332690|NCT00014755|Immunologic Factors|immunologic factors|mesh-ancestor
6332691|NCT00014755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332692|NCT00014755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6332693|NCT00014755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6332694|NCT00014755|Alkylating Agents|alkylating agents|mesh-ancestor
6332695|NCT00014755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332696|NCT00014755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6332697|NCT00014755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6332698|NCT00014755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6332699|NCT00014755|Glucocorticoids|glucocorticoids|mesh-ancestor
6332700|NCT00014755|Hormones|hormones|mesh-ancestor
6332701|NCT00014755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6332702|NCT00014755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6332703|NCT00014937|Ritonavir|ritonavir|mesh-list
6332704|NCT00014937|Lopinavir|lopinavir|mesh-list
6332705|NCT00014937|Lamivudine|lamivudine|mesh-list
6332706|NCT00014937|Zidovudine|zidovudine|mesh-list
6332707|NCT00014937|Stavudine|stavudine|mesh-list
6332708|NCT00014937|Didanosine|didanosine|mesh-list
6332709|NCT00014937|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6332710|NCT00014937|Efavirenz|efavirenz|mesh-list
6332711|NCT00014937|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6332712|NCT00014937|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6332713|NCT00014937|Protease Inhibitors|protease inhibitors|mesh-ancestor
6332714|NCT00014937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6332715|NCT00014937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332716|NCT00014937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6332717|NCT00014937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6332718|NCT00014937|Antiviral Agents|antiviral agents|mesh-ancestor
6332719|NCT00014937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6332720|NCT00014937|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6332721|NCT00014937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6332722|NCT00014937|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6332723|NCT00014937|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6332724|NCT00014937|Antimetabolites|antimetabolites|mesh-ancestor
6332725|NCT00014937|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6332726|NCT00014937|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6332727|NCT00014937|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6332728|NCT00014937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6332729|NCT00014937|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6332730|NCT00014989|Magnesium Sulfate|magnesium sulfate|mesh-list
6332731|NCT00014989|Analgesics|analgesics|mesh-ancestor
6332732|NCT00014989|Sensory System Agents|sensory system agents|mesh-ancestor
6332733|NCT00014989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6332734|NCT00014989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332735|NCT00014989|Anesthetics|anesthetics|mesh-ancestor
6332736|NCT00014989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6332737|NCT00014989|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6332738|NCT00014989|Anticonvulsants|anticonvulsants|mesh-ancestor
6332739|NCT00014989|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6332740|NCT00014989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6332741|NCT00014989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332742|NCT00014989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6332743|NCT00014989|Tocolytic Agents|tocolytic agents|mesh-ancestor
6332744|NCT00014989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6332745|NCT00015002|Betamethasone|betamethasone|mesh-list
6332746|NCT00015002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6332747|NCT00015002|Glucocorticoids|glucocorticoids|mesh-ancestor
6332748|NCT00015002|Hormones|hormones|mesh-ancestor
6332749|NCT00015002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6332750|NCT00015002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332751|NCT00015002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6332752|NCT00015002|Respiratory System Agents|respiratory system agents|mesh-ancestor
6332753|NCT00015028|Buprenorphine|buprenorphine|mesh-list
6332754|NCT00015028|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6332755|NCT00015028|Naloxone|naloxone|mesh-list
6332756|NCT00015028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6332757|NCT00015028|Narcotics|narcotics|mesh-ancestor
6332758|NCT00015028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6332759|NCT00015028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332760|NCT00015028|Analgesics|analgesics|mesh-ancestor
6332761|NCT00015028|Sensory System Agents|sensory system agents|mesh-ancestor
6332762|NCT00015028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6332763|NCT00015028|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6332764|NCT00015041|Buprenorphine|buprenorphine|mesh-list
6332765|NCT00015041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6332766|NCT00015041|Narcotics|narcotics|mesh-ancestor
6332767|NCT00015041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6332768|NCT00015041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332769|NCT00015041|Analgesics|analgesics|mesh-ancestor
6332770|NCT00015041|Sensory System Agents|sensory system agents|mesh-ancestor
6332771|NCT00015041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6332772|NCT00015041|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6332773|NCT00015054|Methylphenidate|methylphenidate|mesh-list
6332774|NCT00015054|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6332775|NCT00015054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332776|NCT00015054|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6332777|NCT00015054|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6332778|NCT00015054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6332779|NCT00015054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332780|NCT00015054|Dopamine Agents|dopamine agents|mesh-ancestor
6332781|NCT00015054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6332782|NCT00015067|Methylphenidate|methylphenidate|mesh-list
6332783|NCT00015067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6332784|NCT00015067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332785|NCT00015067|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6332786|NCT00015067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6332787|NCT00015067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6332788|NCT00015067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332789|NCT00015067|Dopamine Agents|dopamine agents|mesh-ancestor
6332790|NCT00015067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6332791|NCT00015080|Naltrexone|naltrexone|mesh-list
6332792|NCT00015080|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6332793|NCT00015080|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6332794|NCT00015080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332795|NCT00015080|Sensory System Agents|sensory system agents|mesh-ancestor
6332796|NCT00015080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6332797|NCT00015106|Lamotrigine|lamotrigine|mesh-list
6332798|NCT00015106|Anticonvulsants|anticonvulsants|mesh-ancestor
6332799|NCT00015106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6332800|NCT00015106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6332801|NCT00015106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332802|NCT00015106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6332803|NCT00015106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332804|NCT00015106|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6332805|NCT00015106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6332806|NCT00015106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6332807|NCT00015106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6332808|NCT00015106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6332809|NCT00015132|Sertraline|sertraline|mesh-list
6332810|NCT00015132|Antidepressive Agents|antidepressive agents|mesh-ancestor
6332811|NCT00015132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6332812|NCT00015132|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6332813|NCT00015132|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6332814|NCT00015132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6332815|NCT00015132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332816|NCT00015132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6332817|NCT00015132|Serotonin Agents|serotonin agents|mesh-ancestor
6332818|NCT00015132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332819|NCT00015171|Buprenorphine|buprenorphine|mesh-list
6332820|NCT00015171|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6332821|NCT00015171|Naloxone|naloxone|mesh-list
6332822|NCT00015171|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6332823|NCT00015171|Narcotics|narcotics|mesh-ancestor
6332824|NCT00015171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6332825|NCT00015171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332826|NCT00015171|Analgesics|analgesics|mesh-ancestor
6332827|NCT00015171|Sensory System Agents|sensory system agents|mesh-ancestor
6332828|NCT00015171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6332829|NCT00015171|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6332830|NCT00015210|Nefazodone|nefazodone|mesh-list
6332831|NCT00015210|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6332832|NCT00015210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6332833|NCT00015210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6332834|NCT00015210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332835|NCT00015210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6332836|NCT00015210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332837|NCT00015210|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6332838|NCT00015210|Antidepressive Agents|antidepressive agents|mesh-ancestor
6332839|NCT00015210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6332840|NCT00015210|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6332841|NCT00015210|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6332842|NCT00015210|Serotonin Agents|serotonin agents|mesh-ancestor
6332843|NCT00015223|Methylphenidate|methylphenidate|mesh-list
6332844|NCT00015223|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6332845|NCT00015223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332846|NCT00015223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6332847|NCT00015223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6332848|NCT00015223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6332849|NCT00015223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332850|NCT00015223|Dopamine Agents|dopamine agents|mesh-ancestor
6332851|NCT00015223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6332852|NCT00015236|Amantadine|amantadine|mesh-list
6332853|NCT00015236|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6332854|NCT00015236|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6332855|NCT00015236|Antiviral Agents|antiviral agents|mesh-ancestor
6332856|NCT00015236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6332857|NCT00015236|Dopamine Agents|dopamine agents|mesh-ancestor
6332858|NCT00015236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6332859|NCT00015236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332860|NCT00015236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332861|NCT00015236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6332862|NCT00015236|Analgesics|analgesics|mesh-ancestor
6332863|NCT00015236|Sensory System Agents|sensory system agents|mesh-ancestor
6332864|NCT00015236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6332865|NCT00015249|Amantadine|amantadine|mesh-list
6332866|NCT00015249|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6332867|NCT00015249|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6332868|NCT00015249|Antiviral Agents|antiviral agents|mesh-ancestor
6332869|NCT00015249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6332870|NCT00015249|Dopamine Agents|dopamine agents|mesh-ancestor
6332871|NCT00015249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6332872|NCT00015249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332873|NCT00015249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332874|NCT00015249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6332875|NCT00015249|Analgesics|analgesics|mesh-ancestor
6332876|NCT00015249|Sensory System Agents|sensory system agents|mesh-ancestor
6332877|NCT00015249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6332878|NCT00015275|Cocaine|cocaine|mesh-list
6332879|NCT00015275|Anesthetics, Local|anesthetics, local|mesh-ancestor
6332880|NCT00015275|Anesthetics|anesthetics|mesh-ancestor
6332881|NCT00015275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6332882|NCT00015275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332883|NCT00015275|Sensory System Agents|sensory system agents|mesh-ancestor
6332884|NCT00015275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6332885|NCT00015275|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6332886|NCT00015275|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6332887|NCT00015275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6332888|NCT00015275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6332889|NCT00015275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332890|NCT00015275|Dopamine Agents|dopamine agents|mesh-ancestor
6332891|NCT00015275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6332892|NCT00015288|Buprenorphine|buprenorphine|mesh-list
6332893|NCT00015288|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6332894|NCT00015288|Naloxone|naloxone|mesh-list
6332895|NCT00015288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6332896|NCT00015288|Narcotics|narcotics|mesh-ancestor
6332897|NCT00015288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6332898|NCT00015288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332899|NCT00015288|Analgesics|analgesics|mesh-ancestor
6332900|NCT00015288|Sensory System Agents|sensory system agents|mesh-ancestor
6332901|NCT00015288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6332902|NCT00015288|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6332903|NCT00015301|Methylphenidate|methylphenidate|mesh-list
6332904|NCT00015301|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6332905|NCT00015301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332906|NCT00015301|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6332907|NCT00015301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6332908|NCT00015301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6332909|NCT00015301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332910|NCT00015301|Dopamine Agents|dopamine agents|mesh-ancestor
6332911|NCT00015301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6332912|NCT00015340|Buprenorphine|buprenorphine|mesh-list
6332913|NCT00015340|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6332914|NCT00015340|Naloxone|naloxone|mesh-list
6332915|NCT00015340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6332916|NCT00015340|Narcotics|narcotics|mesh-ancestor
6332917|NCT00015340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6332918|NCT00015340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332919|NCT00015340|Analgesics|analgesics|mesh-ancestor
6332920|NCT00015340|Sensory System Agents|sensory system agents|mesh-ancestor
6332921|NCT00015340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6332922|NCT00015340|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6332923|NCT00015548|Olanzapine|olanzapine|mesh-list
6332924|NCT00015548|Risperidone|risperidone|mesh-list
6332925|NCT00015548|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6332926|NCT00015548|Citalopram|citalopram|mesh-list
6332927|NCT00015548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6332928|NCT00015548|Serotonin Agents|serotonin agents|mesh-ancestor
6332929|NCT00015548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6332930|NCT00015548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332931|NCT00015548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332932|NCT00015548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6332933|NCT00015548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6332934|NCT00015548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6332935|NCT00015548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6332936|NCT00015548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6332937|NCT00015548|Dopamine Agents|dopamine agents|mesh-ancestor
6332938|NCT00015548|Antiemetics|antiemetics|mesh-ancestor
6332939|NCT00015548|Autonomic Agents|autonomic agents|mesh-ancestor
6332940|NCT00015548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6332941|NCT00015548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6332942|NCT00015548|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6332943|NCT00015548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6332944|NCT00015548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6332945|NCT00015548|Antidepressive Agents|antidepressive agents|mesh-ancestor
6332946|NCT00015548|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6332947|NCT00015626|Metformin|metformin|mesh-list
6332948|NCT00015626|Pioglitazone|pioglitazone|mesh-list
6332949|NCT00015626|Rosiglitazone|rosiglitazone|mesh-list
6332950|NCT00015626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6332951|NCT00015626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332952|NCT00015652|Ribavirin|ribavirin|mesh-list
6332953|NCT00015652|Aldesleukin|aldesleukin|mesh-list
6332954|NCT00015652|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6332955|NCT00015652|Antimetabolites|antimetabolites|mesh-ancestor
6332956|NCT00015652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332957|NCT00015652|Antiviral Agents|antiviral agents|mesh-ancestor
6332958|NCT00015652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6332959|NCT00015652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6332960|NCT00015652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6332961|NCT00015652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6332962|NCT00015665|Voriconazole|voriconazole|mesh-list
6332963|NCT00015665|Antifungal Agents|antifungal agents|mesh-ancestor
6332964|NCT00015665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6332965|NCT00015665|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6332966|NCT00015665|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6332967|NCT00015665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6332968|NCT00015665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332969|NCT00015665|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6332970|NCT00015665|Hormone Antagonists|hormone antagonists|mesh-ancestor
6332971|NCT00015665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6332972|NCT00015665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332973|NCT00015665|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6332974|NCT00015691|Metformin|metformin|mesh-list
6332975|NCT00015691|Rosiglitazone|rosiglitazone|mesh-list
6332976|NCT00015691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6332977|NCT00015691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332978|NCT00015704|Aldesleukin|aldesleukin|mesh-list
6332979|NCT00015704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6332980|NCT00015704|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6332981|NCT00015704|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6332982|NCT00015704|Antiviral Agents|antiviral agents|mesh-ancestor
6332983|NCT00015704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6332984|NCT00015769|Levetiracetam|levetiracetam|mesh-list
6332985|NCT00015769|Anticonvulsants|anticonvulsants|mesh-ancestor
6332986|NCT00015769|Nootropic Agents|nootropic agents|mesh-ancestor
6332987|NCT00015808|Idebenone|idebenone|mesh-list
6332988|NCT00015808|Antioxidants|antioxidants|mesh-ancestor
6332989|NCT00015808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6332990|NCT00015808|Protective Agents|protective agents|mesh-ancestor
6332991|NCT00015808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332992|NCT00015821|Thalidomide|thalidomide|mesh-list
6332993|NCT00015821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6332994|NCT00015821|Immunologic Factors|immunologic factors|mesh-ancestor
6332995|NCT00015821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6332996|NCT00015821|Leprostatic Agents|leprostatic agents|mesh-ancestor
6332997|NCT00015821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6332998|NCT00015821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6332999|NCT00015821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6333000|NCT00015821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6333001|NCT00015821|Growth Substances|growth substances|mesh-ancestor
6333002|NCT00015821|Growth Inhibitors|growth inhibitors|mesh-ancestor
6333003|NCT00015821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333004|NCT00015834|Cytarabine|cytarabine|mesh-list
6333005|NCT00015834|Imatinib Mesylate|imatinib mesylate|mesh-list
6333006|NCT00015834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6333007|NCT00015834|Antimetabolites|antimetabolites|mesh-ancestor
6333008|NCT00015834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333009|NCT00015834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333010|NCT00015834|Antiviral Agents|antiviral agents|mesh-ancestor
6333011|NCT00015834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6333012|NCT00015834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6333013|NCT00015834|Immunologic Factors|immunologic factors|mesh-ancestor
6333014|NCT00015834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6333015|NCT00015834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6333016|NCT00015834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6333017|NCT00015860|Prednisone|prednisone|mesh-list
6333018|NCT00015860|Vincristine|vincristine|mesh-list
6333019|NCT00015860|Imatinib Mesylate|imatinib mesylate|mesh-list
6333020|NCT00015860|Daunorubicin|daunorubicin|mesh-list
6333021|NCT00015860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6333022|NCT00015860|Glucocorticoids|glucocorticoids|mesh-ancestor
6333023|NCT00015860|Hormones|hormones|mesh-ancestor
6333024|NCT00015860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6333025|NCT00015860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6333026|NCT00015860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6333027|NCT00015860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333028|NCT00015860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6333029|NCT00015860|Tubulin Modulators|tubulin modulators|mesh-ancestor
6333030|NCT00015860|Antimitotic Agents|antimitotic agents|mesh-ancestor
6333031|NCT00015860|Mitosis Modulators|mitosis modulators|mesh-ancestor
6333032|NCT00015860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333033|NCT00015860|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6333034|NCT00015860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6333035|NCT00015860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6333036|NCT00015860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6333037|NCT00015860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6333038|NCT00015873|Cytarabine|cytarabine|mesh-list
6333039|NCT00015873|Prednisolone|prednisolone|mesh-list
6333040|NCT00015873|Methotrexate|methotrexate|mesh-list
6333041|NCT00015873|Mercaptopurine|mercaptopurine|mesh-list
6333042|NCT00015873|Vincristine|vincristine|mesh-list
6333043|NCT00015873|Asparaginase|asparaginase|mesh-list
6333044|NCT00015873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6333045|NCT00015873|Abortifacient Agents|abortifacient agents|mesh-ancestor
6333046|NCT00015873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6333047|NCT00015873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6333048|NCT00015873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6333049|NCT00015873|Antimetabolites|antimetabolites|mesh-ancestor
6333050|NCT00015873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333051|NCT00015873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333052|NCT00015873|Dermatologic Agents|dermatologic agents|mesh-ancestor
6333053|NCT00015873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6333054|NCT00015873|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6333055|NCT00015873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6333056|NCT00015873|Immunologic Factors|immunologic factors|mesh-ancestor
6333057|NCT00015873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6333058|NCT00015873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6333059|NCT00015873|Antiviral Agents|antiviral agents|mesh-ancestor
6333060|NCT00015873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6333061|NCT00015873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6333062|NCT00015873|Tubulin Modulators|tubulin modulators|mesh-ancestor
6333063|NCT00015873|Antimitotic Agents|antimitotic agents|mesh-ancestor
6333064|NCT00015873|Mitosis Modulators|mitosis modulators|mesh-ancestor
6333065|NCT00015873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6333066|NCT00015873|Glucocorticoids|glucocorticoids|mesh-ancestor
6333067|NCT00015873|Hormones|hormones|mesh-ancestor
6333068|NCT00015873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6333069|NCT00015873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6333070|NCT00015886|Docetaxel|docetaxel|mesh-list
6333071|NCT00015886|Fluorouracil|fluorouracil|mesh-list
6333072|NCT00015886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333073|NCT00015886|Tubulin Modulators|tubulin modulators|mesh-ancestor
6333074|NCT00015886|Antimitotic Agents|antimitotic agents|mesh-ancestor
6333075|NCT00015886|Mitosis Modulators|mitosis modulators|mesh-ancestor
6333076|NCT00015886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333077|NCT00015886|Antimetabolites|antimetabolites|mesh-ancestor
6333078|NCT00015886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6333079|NCT00015886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6333080|NCT00015886|Immunologic Factors|immunologic factors|mesh-ancestor
6333081|NCT00015886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6333082|NCT00015899|Lonafarnib|lonafarnib|mesh-list
6333083|NCT00015899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6333084|NCT00015899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333085|NCT00015912|Interferons|interferons|mesh-list
6333086|NCT00015912|Interferon-alpha|interferon-alpha|mesh-list
6333087|NCT00015912|Interferon alpha-2|interferon alpha-2|mesh-list
6333088|NCT00015912|Thalidomide|thalidomide|mesh-list
6333089|NCT00015912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333090|NCT00015912|Antiviral Agents|antiviral agents|mesh-ancestor
6333091|NCT00015912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6333092|NCT00015912|Immunologic Factors|immunologic factors|mesh-ancestor
6333093|NCT00015912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6333094|NCT00015912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6333095|NCT00015912|Leprostatic Agents|leprostatic agents|mesh-ancestor
6333096|NCT00015912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6333097|NCT00015912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6333098|NCT00015912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6333099|NCT00015912|Growth Substances|growth substances|mesh-ancestor
6333100|NCT00015912|Growth Inhibitors|growth inhibitors|mesh-ancestor
6333101|NCT00015925|Entinostat|entinostat|mesh-list
6333102|NCT00015925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333103|NCT00015925|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6333104|NCT00015925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6333105|NCT00015925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333106|NCT00015938|Docetaxel|docetaxel|mesh-list
6333107|NCT00015938|Vinorelbine|vinorelbine|mesh-list
6333108|NCT00015938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333109|NCT00015938|Tubulin Modulators|tubulin modulators|mesh-ancestor
6333110|NCT00015938|Antimitotic Agents|antimitotic agents|mesh-ancestor
6333111|NCT00015938|Mitosis Modulators|mitosis modulators|mesh-ancestor
6333112|NCT00015938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333113|NCT00015938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6333114|NCT00015951|Cytarabine|cytarabine|mesh-list
6333115|NCT00015951|Bevacizumab|bevacizumab|mesh-list
6333116|NCT00015951|Mitoxantrone|mitoxantrone|mesh-list
6333117|NCT00015951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6333118|NCT00015951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333119|NCT00015951|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6333120|NCT00015951|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6333121|NCT00015951|Growth Substances|growth substances|mesh-ancestor
6333122|NCT00015951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6333123|NCT00015951|Growth Inhibitors|growth inhibitors|mesh-ancestor
6333124|NCT00015951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6333125|NCT00015951|Antimetabolites|antimetabolites|mesh-ancestor
6333126|NCT00015951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333127|NCT00015951|Antiviral Agents|antiviral agents|mesh-ancestor
6333128|NCT00015951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6333129|NCT00015951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6333130|NCT00015951|Immunologic Factors|immunologic factors|mesh-ancestor
6333131|NCT00015951|Analgesics|analgesics|mesh-ancestor
6333132|NCT00015951|Sensory System Agents|sensory system agents|mesh-ancestor
6333133|NCT00015951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6333134|NCT00015951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6333135|NCT00015951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6333136|NCT00015951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6333137|NCT00015964|Gefitinib|gefitinib|mesh-list
6333138|NCT00015964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333139|NCT00015964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6333140|NCT00015964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6333141|NCT00015964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333142|NCT00015977|Interleukin-12|interleukin-12|mesh-list
6333143|NCT00015977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6333144|NCT00015977|Immunologic Factors|immunologic factors|mesh-ancestor
6333145|NCT00015977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6333146|NCT00015977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6333147|NCT00015977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6333148|NCT00015977|Growth Substances|growth substances|mesh-ancestor
6333149|NCT00015977|Growth Inhibitors|growth inhibitors|mesh-ancestor
6333150|NCT00015977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333151|NCT00015990|Thalidomide|thalidomide|mesh-list
6333152|NCT00015990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6333153|NCT00015990|Immunologic Factors|immunologic factors|mesh-ancestor
6333154|NCT00015990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6333155|NCT00015990|Leprostatic Agents|leprostatic agents|mesh-ancestor
6333156|NCT00015990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6333157|NCT00015990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6333158|NCT00015990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6333159|NCT00015990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6333160|NCT00015990|Growth Substances|growth substances|mesh-ancestor
6333161|NCT00015990|Growth Inhibitors|growth inhibitors|mesh-ancestor
6333162|NCT00015990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333163|NCT00016016|Cytarabine|cytarabine|mesh-list
6333164|NCT00016016|Mitoxantrone|mitoxantrone|mesh-list
6333165|NCT00016016|Alvocidib|alvocidib|mesh-list
6333166|NCT00016016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6333167|NCT00016016|Antimetabolites|antimetabolites|mesh-ancestor
6333168|NCT00016016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333169|NCT00016016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333170|NCT00016016|Antiviral Agents|antiviral agents|mesh-ancestor
6333171|NCT00016016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6333172|NCT00016016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6333173|NCT00016016|Immunologic Factors|immunologic factors|mesh-ancestor
6333174|NCT00016016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6333175|NCT00016016|Analgesics|analgesics|mesh-ancestor
6333176|NCT00016016|Sensory System Agents|sensory system agents|mesh-ancestor
6333177|NCT00016016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6333178|NCT00016016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6333179|NCT00016016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6333180|NCT00016016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6333181|NCT00016016|Growth Inhibitors|growth inhibitors|mesh-ancestor
6333182|NCT00016016|Growth Substances|growth substances|mesh-ancestor
6333183|NCT00016016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6333184|NCT00016042|Interferons|interferons|mesh-list
6333185|NCT00016042|Interferon-alpha|interferon-alpha|mesh-list
6333186|NCT00016042|Fluorouracil|fluorouracil|mesh-list
6333187|NCT00016042|Sargramostim|sargramostim|mesh-list
6333188|NCT00016042|Antimetabolites|antimetabolites|mesh-ancestor
6333189|NCT00016042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333190|NCT00016042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6333191|NCT00016042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333192|NCT00016042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6333193|NCT00016042|Immunologic Factors|immunologic factors|mesh-ancestor
6333194|NCT00016042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6333195|NCT00016042|Antiviral Agents|antiviral agents|mesh-ancestor
6333196|NCT00016042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6333197|NCT00016055|Temozolomide|temozolomide|mesh-list
6333198|NCT00016055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6333199|NCT00016055|Alkylating Agents|alkylating agents|mesh-ancestor
6333200|NCT00016055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333201|NCT00016055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333202|NCT00016068|Valganciclovir|valganciclovir|mesh-list
6333203|NCT00016068|Ganciclovir|ganciclovir|mesh-list
6333204|NCT00016068|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6333205|NCT00016068|Antiviral Agents|antiviral agents|mesh-ancestor
6333206|NCT00016068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6333207|NCT00016068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6333208|NCT00016068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6333209|NCT00016068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333210|NCT00016081|Ribavirin|ribavirin|mesh-list
6333211|NCT00016081|Antimetabolites|antimetabolites|mesh-ancestor
6333212|NCT00016081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333213|NCT00016081|Antiviral Agents|antiviral agents|mesh-ancestor
6333214|NCT00016081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6333215|NCT00016094|Bevacizumab|bevacizumab|mesh-list
6333216|NCT00016094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6333217|NCT00016094|Antibodies|antibodies|mesh-list
6333218|NCT00016094|Immunoglobulins|immunoglobulins|mesh-list
6333219|NCT00016094|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6333220|NCT00016094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333221|NCT00016094|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6333222|NCT00016094|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6333223|NCT00016094|Growth Substances|growth substances|mesh-ancestor
6333224|NCT00016094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6333225|NCT00016094|Growth Inhibitors|growth inhibitors|mesh-ancestor
6333226|NCT00016094|Immunologic Factors|immunologic factors|mesh-ancestor
6333227|NCT00016107|Bevacizumab|bevacizumab|mesh-list
6333228|NCT00016107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6333229|NCT00016107|Docetaxel|docetaxel|mesh-list
6333230|NCT00016107|Estramustine|estramustine|mesh-list
6333231|NCT00016107|Antibodies|antibodies|mesh-list
6333232|NCT00016107|Immunoglobulins|immunoglobulins|mesh-list
6333233|NCT00016107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6333234|NCT00016107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333235|NCT00016107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6333236|NCT00016107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6333237|NCT00016107|Growth Substances|growth substances|mesh-ancestor
6333238|NCT00016107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6333239|NCT00016107|Growth Inhibitors|growth inhibitors|mesh-ancestor
6333240|NCT00016107|Immunologic Factors|immunologic factors|mesh-ancestor
6333241|NCT00016107|Tubulin Modulators|tubulin modulators|mesh-ancestor
6333242|NCT00016107|Antimitotic Agents|antimitotic agents|mesh-ancestor
6333243|NCT00016107|Mitosis Modulators|mitosis modulators|mesh-ancestor
6333244|NCT00016107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333245|NCT00016107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6333246|NCT00016107|Alkylating Agents|alkylating agents|mesh-ancestor
6333247|NCT00016107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6333248|NCT00016133|Leucovorin|leucovorin|mesh-list
6333249|NCT00016133|Fluorouracil|fluorouracil|mesh-list
6333250|NCT00016133|Vaccines|vaccines|mesh-list
6333251|NCT00016133|BCG Vaccine|bcg vaccine|mesh-list
6333252|NCT00016133|Calcium|calcium|mesh-list
6333253|NCT00016133|Levoleucovorin|levoleucovorin|mesh-list
6333254|NCT00016133|Immunologic Factors|immunologic factors|mesh-ancestor
6333255|NCT00016133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6333256|NCT00016133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6333257|NCT00016133|Antimetabolites|antimetabolites|mesh-ancestor
6333258|NCT00016133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333259|NCT00016133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6333260|NCT00016133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333261|NCT00016133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6333262|NCT00016133|Antidotes|antidotes|mesh-ancestor
6333263|NCT00016133|Protective Agents|protective agents|mesh-ancestor
6333264|NCT00016133|Vitamin B Complex|vitamin b complex|mesh-ancestor
6333265|NCT00016133|Vitamins|vitamins|mesh-ancestor
6333266|NCT00016133|Micronutrients|micronutrients|mesh-ancestor
6333267|NCT00016133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6393454|NCT00199082|Antimitotic Agents|antimitotic agents|mesh-ancestor
6393455|NCT00199082|Mitosis Modulators|mitosis modulators|mesh-ancestor
6393456|NCT00199082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6393457|NCT00199082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6393458|NCT00199082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6393459|NCT00199095|Cytarabine|cytarabine|mesh-list
6393460|NCT00199095|Dexamethasone|dexamethasone|mesh-list
6393461|NCT00199095|Cyclophosphamide|cyclophosphamide|mesh-list
6393462|NCT00199095|Ifosfamide|ifosfamide|mesh-list
6393463|NCT00199095|Methotrexate|methotrexate|mesh-list
6393464|NCT00199095|Vincristine|vincristine|mesh-list
6393465|NCT00199095|Doxorubicin|doxorubicin|mesh-list
6393466|NCT00199095|Mercaptopurine|mercaptopurine|mesh-list
6393467|NCT00199095|Idarubicin|idarubicin|mesh-list
6393468|NCT00199095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6393469|NCT00199095|Immunologic Factors|immunologic factors|mesh-ancestor
6393470|NCT00199095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6393471|NCT00199095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6393472|NCT00199095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6393473|NCT00199095|Alkylating Agents|alkylating agents|mesh-ancestor
6393474|NCT00199095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393475|NCT00199095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6393476|NCT00199095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6393477|NCT00199095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6393478|NCT00199095|Antiemetics|antiemetics|mesh-ancestor
6393479|NCT00199095|Autonomic Agents|autonomic agents|mesh-ancestor
6393480|NCT00199095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6393481|NCT00199095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6393482|NCT00199095|Glucocorticoids|glucocorticoids|mesh-ancestor
6393483|NCT00199095|Hormones|hormones|mesh-ancestor
6393484|NCT00199095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6393485|NCT00199095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6393486|NCT00199095|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6393487|NCT00199095|Abortifacient Agents|abortifacient agents|mesh-ancestor
6393488|NCT00199095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6393489|NCT00199095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6393490|NCT00199095|Antimetabolites|antimetabolites|mesh-ancestor
6393491|NCT00199095|Dermatologic Agents|dermatologic agents|mesh-ancestor
6393492|NCT00199095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6393493|NCT00199095|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6393494|NCT00199095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6393495|NCT00199095|Antiviral Agents|antiviral agents|mesh-ancestor
6393496|NCT00199095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6393497|NCT00199095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6393498|NCT00199095|Tubulin Modulators|tubulin modulators|mesh-ancestor
6393499|NCT00199095|Antimitotic Agents|antimitotic agents|mesh-ancestor
6393500|NCT00199095|Mitosis Modulators|mitosis modulators|mesh-ancestor
6393501|NCT00199095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6393502|NCT00199095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6393503|NCT00199095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6393504|NCT00199108|Dexamethasone|dexamethasone|mesh-list
6393505|NCT00199108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6393506|NCT00199108|Antiemetics|antiemetics|mesh-ancestor
6393507|NCT00199108|Autonomic Agents|autonomic agents|mesh-ancestor
6393508|NCT00199108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6393509|NCT00199108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6393510|NCT00199108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6393511|NCT00199108|Glucocorticoids|glucocorticoids|mesh-ancestor
6333268|NCT00016159|Idarubicin|idarubicin|mesh-list
6333269|NCT00016159|Arsenic Trioxide|arsenic trioxide|mesh-list
6333270|NCT00016159|Tretinoin|tretinoin|mesh-list
6333271|NCT00016159|Lintuzumab|lintuzumab|mesh-list
6333272|NCT00016159|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6333273|NCT00016159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333274|NCT00016159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6333275|NCT00016159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6333276|NCT00016159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6333277|NCT00016159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333278|NCT00016159|Keratolytic Agents|keratolytic agents|mesh-ancestor
6333279|NCT00016159|Dermatologic Agents|dermatologic agents|mesh-ancestor
6333280|NCT00016159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6333281|NCT00016172|Doxorubicin|doxorubicin|mesh-list
6333282|NCT00016172|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6333283|NCT00016172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6333284|NCT00016172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333285|NCT00016172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6333286|NCT00016172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6333287|NCT00016172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6333288|NCT00016172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333289|NCT00016185|Docetaxel|docetaxel|mesh-list
6333290|NCT00016185|Alvocidib|alvocidib|mesh-list
6333291|NCT00016185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333292|NCT00016185|Tubulin Modulators|tubulin modulators|mesh-ancestor
6333293|NCT00016185|Antimitotic Agents|antimitotic agents|mesh-ancestor
6333294|NCT00016185|Mitosis Modulators|mitosis modulators|mesh-ancestor
6333295|NCT00016185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333296|NCT00016185|Growth Inhibitors|growth inhibitors|mesh-ancestor
6333297|NCT00016185|Growth Substances|growth substances|mesh-ancestor
6333298|NCT00016185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6333299|NCT00016185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6333300|NCT00016185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6333301|NCT00016198|Leucovorin|leucovorin|mesh-list
6333302|NCT00016198|Fluorouracil|fluorouracil|mesh-list
6333303|NCT00016198|Oxaliplatin|oxaliplatin|mesh-list
6333304|NCT00016198|Calcium|calcium|mesh-list
6333305|NCT00016198|Levoleucovorin|levoleucovorin|mesh-list
6333306|NCT00016198|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6333307|NCT00016198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6333308|NCT00016198|Antimetabolites|antimetabolites|mesh-ancestor
6333309|NCT00016198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333310|NCT00016198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6333311|NCT00016198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333312|NCT00016198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6333313|NCT00016198|Immunologic Factors|immunologic factors|mesh-ancestor
6333314|NCT00016198|Antidotes|antidotes|mesh-ancestor
6333315|NCT00016198|Protective Agents|protective agents|mesh-ancestor
6333316|NCT00016198|Vitamin B Complex|vitamin b complex|mesh-ancestor
6333317|NCT00016198|Vitamins|vitamins|mesh-ancestor
6333318|NCT00016198|Micronutrients|micronutrients|mesh-ancestor
6333319|NCT00016224|Thalidomide|thalidomide|mesh-list
6333320|NCT00016224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6333321|NCT00016224|Immunologic Factors|immunologic factors|mesh-ancestor
6333322|NCT00016224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6333323|NCT00016224|Leprostatic Agents|leprostatic agents|mesh-ancestor
6333324|NCT00016224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6333325|NCT00016224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6333326|NCT00016224|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6333327|NCT00016224|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6333328|NCT00016224|Growth Substances|growth substances|mesh-ancestor
6333329|NCT00016224|Growth Inhibitors|growth inhibitors|mesh-ancestor
6333330|NCT00016224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333331|NCT00016263|Dacarbazine|dacarbazine|mesh-list
6333332|NCT00016263|Oblimersen|oblimersen|mesh-list
6333333|NCT00016263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6333334|NCT00016263|Alkylating Agents|alkylating agents|mesh-ancestor
6333335|NCT00016263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333336|NCT00016263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333337|NCT00016276|Tamoxifen|tamoxifen|mesh-list
6333338|NCT00016276|Paclitaxel|paclitaxel|mesh-list
6333339|NCT00016276|Razoxane|razoxane|mesh-list
6333340|NCT00016276|Cyclophosphamide|cyclophosphamide|mesh-list
6333341|NCT00016276|Doxorubicin|doxorubicin|mesh-list
6333342|NCT00016276|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6333343|NCT00016276|Trastuzumab|trastuzumab|mesh-list
6333344|NCT00016276|Dexrazoxane|dexrazoxane|mesh-list
6333345|NCT00016276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6333346|NCT00016276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333347|NCT00016276|Tubulin Modulators|tubulin modulators|mesh-ancestor
6333348|NCT00016276|Antimitotic Agents|antimitotic agents|mesh-ancestor
6333349|NCT00016276|Mitosis Modulators|mitosis modulators|mesh-ancestor
6333350|NCT00016276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333351|NCT00016276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6333352|NCT00016276|Immunologic Factors|immunologic factors|mesh-ancestor
6333353|NCT00016276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6333354|NCT00016276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6333355|NCT00016276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6333356|NCT00016276|Alkylating Agents|alkylating agents|mesh-ancestor
6333357|NCT00016276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6333358|NCT00016276|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6333359|NCT00016276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6333360|NCT00016276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6333361|NCT00016276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6333362|NCT00016276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6333363|NCT00016276|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6333364|NCT00016276|Hormone Antagonists|hormone antagonists|mesh-ancestor
6333365|NCT00016276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6333366|NCT00016276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6333367|NCT00016276|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6333368|NCT00016276|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6333369|NCT00016276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6333370|NCT00016276|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6333371|NCT00016276|Protective Agents|protective agents|mesh-ancestor
6333372|NCT00016289|Interleukin-12|interleukin-12|mesh-list
6333373|NCT00016289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6333374|NCT00016289|Immunologic Factors|immunologic factors|mesh-ancestor
6333375|NCT00016289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6333376|NCT00016289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6333377|NCT00016289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6333378|NCT00016289|Growth Substances|growth substances|mesh-ancestor
6333379|NCT00016289|Growth Inhibitors|growth inhibitors|mesh-ancestor
6333380|NCT00016289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333381|NCT00016302|Leucovorin|leucovorin|mesh-list
6333382|NCT00016302|Cytarabine|cytarabine|mesh-list
6333383|NCT00016302|Dexamethasone|dexamethasone|mesh-list
6333384|NCT00016302|Prednisone|prednisone|mesh-list
6333385|NCT00016302|Cyclophosphamide|cyclophosphamide|mesh-list
6333386|NCT00016302|Doxorubicin|doxorubicin|mesh-list
6333387|NCT00016302|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6333388|NCT00016302|Methotrexate|methotrexate|mesh-list
6333389|NCT00016302|Vincristine|vincristine|mesh-list
6333390|NCT00016302|Daunorubicin|daunorubicin|mesh-list
6333391|NCT00016302|Asparaginase|asparaginase|mesh-list
6333392|NCT00016302|Mercaptopurine|mercaptopurine|mesh-list
6333393|NCT00016302|Pegaspargase|pegaspargase|mesh-list
6333394|NCT00016302|Thioguanine|thioguanine|mesh-list
6333395|NCT00016302|Levoleucovorin|levoleucovorin|mesh-list
6333396|NCT00016302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6333397|NCT00016302|Immunologic Factors|immunologic factors|mesh-ancestor
6333398|NCT00016302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6333399|NCT00016302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6333400|NCT00016302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6333401|NCT00016302|Alkylating Agents|alkylating agents|mesh-ancestor
6333402|NCT00016302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333403|NCT00016302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333404|NCT00016302|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6333405|NCT00016302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6333406|NCT00016302|Antiemetics|antiemetics|mesh-ancestor
6333407|NCT00016302|Autonomic Agents|autonomic agents|mesh-ancestor
6333408|NCT00016302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6333409|NCT00016302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6333410|NCT00016302|Glucocorticoids|glucocorticoids|mesh-ancestor
6333411|NCT00016302|Hormones|hormones|mesh-ancestor
6393512|NCT00199108|Hormones|hormones|mesh-ancestor
6333412|NCT00016302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6333413|NCT00016302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6333414|NCT00016302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6333415|NCT00016302|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6333416|NCT00016302|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6333417|NCT00016302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6333418|NCT00016302|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6333419|NCT00016302|Abortifacient Agents|abortifacient agents|mesh-ancestor
6333420|NCT00016302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6333421|NCT00016302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6333422|NCT00016302|Antimetabolites|antimetabolites|mesh-ancestor
6333423|NCT00016302|Dermatologic Agents|dermatologic agents|mesh-ancestor
6333424|NCT00016302|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6333425|NCT00016302|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6333426|NCT00016302|Antiviral Agents|antiviral agents|mesh-ancestor
6333427|NCT00016302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6333428|NCT00016302|Antidotes|antidotes|mesh-ancestor
6333429|NCT00016302|Protective Agents|protective agents|mesh-ancestor
6333430|NCT00016302|Vitamin B Complex|vitamin b complex|mesh-ancestor
6333431|NCT00016302|Vitamins|vitamins|mesh-ancestor
6333432|NCT00016302|Micronutrients|micronutrients|mesh-ancestor
6333433|NCT00016302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6333434|NCT00016302|Tubulin Modulators|tubulin modulators|mesh-ancestor
6333435|NCT00016302|Antimitotic Agents|antimitotic agents|mesh-ancestor
6333436|NCT00016302|Mitosis Modulators|mitosis modulators|mesh-ancestor
6333437|NCT00016315|Gemcitabine|gemcitabine|mesh-list
6333438|NCT00016315|Paclitaxel|paclitaxel|mesh-list
6333439|NCT00016315|Carboplatin|carboplatin|mesh-list
6333440|NCT00016315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6333441|NCT00016315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333442|NCT00016315|Tubulin Modulators|tubulin modulators|mesh-ancestor
6333443|NCT00016315|Antimitotic Agents|antimitotic agents|mesh-ancestor
6333444|NCT00016315|Mitosis Modulators|mitosis modulators|mesh-ancestor
6333445|NCT00016315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333446|NCT00016315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6333447|NCT00016315|Antimetabolites|antimetabolites|mesh-ancestor
6333448|NCT00016315|Antiviral Agents|antiviral agents|mesh-ancestor
6333449|NCT00016315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6333450|NCT00016315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6333451|NCT00016315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6333452|NCT00016315|Immunologic Factors|immunologic factors|mesh-ancestor
6333453|NCT00016315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6333454|NCT00016328|Sirolimus|sirolimus|mesh-list
6333455|NCT00016328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6333456|NCT00016328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6333457|NCT00016328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6333458|NCT00016328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333459|NCT00016328|Antifungal Agents|antifungal agents|mesh-ancestor
6333460|NCT00016328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6333461|NCT00016328|Immunologic Factors|immunologic factors|mesh-ancestor
6333462|NCT00016328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6333463|NCT00016341|Tamoxifen|tamoxifen|mesh-list
6333464|NCT00016341|Paclitaxel|paclitaxel|mesh-list
6333465|NCT00016341|Doxorubicin|doxorubicin|mesh-list
6333466|NCT00016341|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6333467|NCT00016341|Megestrol|megestrol|mesh-list
6333468|NCT00016341|Megestrol Acetate|megestrol acetate|mesh-list
6333469|NCT00016341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6333470|NCT00016341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333471|NCT00016341|Tubulin Modulators|tubulin modulators|mesh-ancestor
6333472|NCT00016341|Antimitotic Agents|antimitotic agents|mesh-ancestor
6333473|NCT00016341|Mitosis Modulators|mitosis modulators|mesh-ancestor
6333474|NCT00016341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333475|NCT00016341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6333476|NCT00016341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6333477|NCT00016341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6333478|NCT00016341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6333479|NCT00016341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6333480|NCT00016341|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6333481|NCT00016341|Hormone Antagonists|hormone antagonists|mesh-ancestor
6333482|NCT00016341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6333483|NCT00016341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6333484|NCT00016341|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6333485|NCT00016341|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6333486|NCT00016341|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6333487|NCT00016341|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6333488|NCT00016341|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6333489|NCT00016341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6333490|NCT00016341|Contraceptive Agents|contraceptive agents|mesh-ancestor
6333491|NCT00016341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6333492|NCT00016341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6333493|NCT00016341|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6333494|NCT00016341|Appetite Stimulants|appetite stimulants|mesh-ancestor
6333495|NCT00016341|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6333496|NCT00016367|Gemcitabine|gemcitabine|mesh-list
6333497|NCT00016367|Cisplatin|cisplatin|mesh-list
6333498|NCT00016367|Trastuzumab|trastuzumab|mesh-list
6333499|NCT00016367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333500|NCT00016367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6333501|NCT00016367|Antimetabolites|antimetabolites|mesh-ancestor
6333502|NCT00016367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333503|NCT00016367|Antiviral Agents|antiviral agents|mesh-ancestor
6333504|NCT00016367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6333505|NCT00016367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6333506|NCT00016367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6333507|NCT00016367|Immunologic Factors|immunologic factors|mesh-ancestor
6333508|NCT00016367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6333509|NCT00016367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6333510|NCT00016380|Dexamethasone|dexamethasone|mesh-list
6333511|NCT00016380|Ondansetron|ondansetron|mesh-list
6333512|NCT00016380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6333513|NCT00016380|Antiemetics|antiemetics|mesh-ancestor
6333514|NCT00016380|Autonomic Agents|autonomic agents|mesh-ancestor
6333515|NCT00016380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6333516|NCT00016380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6333517|NCT00016380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6333518|NCT00016380|Glucocorticoids|glucocorticoids|mesh-ancestor
6333519|NCT00016380|Hormones|hormones|mesh-ancestor
6333520|NCT00016380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6333521|NCT00016380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6333522|NCT00016380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333523|NCT00016380|Antipruritics|antipruritics|mesh-ancestor
6333524|NCT00016380|Dermatologic Agents|dermatologic agents|mesh-ancestor
6333525|NCT00016380|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6333526|NCT00016380|Serotonin Agents|serotonin agents|mesh-ancestor
6333527|NCT00016380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6333528|NCT00016380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333529|NCT00016380|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6333530|NCT00016380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6333531|NCT00016380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6333532|NCT00016380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6333533|NCT00016380|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6333534|NCT00016406|Paclitaxel|paclitaxel|mesh-list
6333535|NCT00016406|Cyclophosphamide|cyclophosphamide|mesh-list
6333536|NCT00016406|Doxorubicin|doxorubicin|mesh-list
6333537|NCT00016406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6333538|NCT00016406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333539|NCT00016406|Tubulin Modulators|tubulin modulators|mesh-ancestor
6333540|NCT00016406|Antimitotic Agents|antimitotic agents|mesh-ancestor
6333541|NCT00016406|Mitosis Modulators|mitosis modulators|mesh-ancestor
6333542|NCT00016406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333543|NCT00016406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6333544|NCT00016406|Immunologic Factors|immunologic factors|mesh-ancestor
6333545|NCT00016406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6333546|NCT00016406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6333547|NCT00016406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6333548|NCT00016406|Alkylating Agents|alkylating agents|mesh-ancestor
6333549|NCT00016406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6333550|NCT00016406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6333551|NCT00016406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6333552|NCT00016406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6333553|NCT00016406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6333554|NCT00016419|Cyclosporine|cyclosporine|mesh-list
6333555|NCT00016419|Cyclosporins|cyclosporins|mesh-list
6333556|NCT00016419|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6333557|NCT00016419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6333558|NCT00016419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333559|NCT00016419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6333560|NCT00016419|Immunologic Factors|immunologic factors|mesh-ancestor
6333561|NCT00016419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6333562|NCT00016419|Antifungal Agents|antifungal agents|mesh-ancestor
6333563|NCT00016419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6333564|NCT00016419|Dermatologic Agents|dermatologic agents|mesh-ancestor
6333565|NCT00016419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6333566|NCT00016419|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6333567|NCT00016432|Exemestane|exemestane|mesh-list
6333568|NCT00016432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333569|NCT00016432|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6333570|NCT00016432|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6333571|NCT00016432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6333572|NCT00016432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333573|NCT00016432|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6333574|NCT00016432|Hormone Antagonists|hormone antagonists|mesh-ancestor
6333575|NCT00016432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6333576|NCT00016432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6333577|NCT00016445|Hormones|hormones|mesh-list
6333578|NCT00016445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6333579|NCT00016445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6333580|NCT00016458|Cyclophosphamide|cyclophosphamide|mesh-list
6333581|NCT00016458|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6333582|NCT00016458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6333583|NCT00016458|Immunologic Factors|immunologic factors|mesh-ancestor
6333584|NCT00016458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6333585|NCT00016458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6333586|NCT00016458|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6333587|NCT00016458|Alkylating Agents|alkylating agents|mesh-ancestor
6333588|NCT00016458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333589|NCT00016458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333590|NCT00016458|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6333591|NCT00016523|Nitric Oxide|nitric oxide|mesh-list
6333592|NCT00016523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6333593|NCT00016523|Autonomic Agents|autonomic agents|mesh-ancestor
6333594|NCT00016523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6333595|NCT00016523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6333596|NCT00016523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6333597|NCT00016523|Respiratory System Agents|respiratory system agents|mesh-ancestor
6333598|NCT00016523|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6333599|NCT00016523|Antioxidants|antioxidants|mesh-ancestor
6333600|NCT00016523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333601|NCT00016523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6333602|NCT00016523|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6333603|NCT00016523|Vasodilator Agents|vasodilator agents|mesh-ancestor
6333604|NCT00016523|Gasotransmitters|gasotransmitters|mesh-ancestor
6333605|NCT00016523|Protective Agents|protective agents|mesh-ancestor
6333606|NCT00016549|Bevacizumab|bevacizumab|mesh-list
6333607|NCT00016549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6333608|NCT00016549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333609|NCT00016549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6333610|NCT00016549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6333611|NCT00016549|Growth Substances|growth substances|mesh-ancestor
6333612|NCT00016549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6333613|NCT00016549|Growth Inhibitors|growth inhibitors|mesh-ancestor
6333614|NCT00016588|Tenofovir|tenofovir|mesh-list
6333615|NCT00016588|Antiviral Agents|antiviral agents|mesh-ancestor
6333616|NCT00016588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6333617|NCT00016588|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6333618|NCT00016588|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6333619|NCT00016588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6333620|NCT00016588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333621|NCT00016588|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6333622|NCT00016588|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6333623|NCT00016601|Ritonavir|ritonavir|mesh-list
6333624|NCT00016601|Nelfinavir|nelfinavir|mesh-list
6333625|NCT00016601|Indinavir|indinavir|mesh-list
6333626|NCT00016601|Nevirapine|nevirapine|mesh-list
6333627|NCT00016601|Efavirenz|efavirenz|mesh-list
6333628|NCT00016601|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6333629|NCT00016601|Medroxyprogesterone|medroxyprogesterone|mesh-list
6333630|NCT00016601|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6333631|NCT00016601|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6333632|NCT00016601|Protease Inhibitors|protease inhibitors|mesh-ancestor
6333633|NCT00016601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6333634|NCT00016601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333635|NCT00016601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6333636|NCT00016601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6333637|NCT00016601|Antiviral Agents|antiviral agents|mesh-ancestor
6333638|NCT00016601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6333639|NCT00016601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6333640|NCT00016601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6333641|NCT00016601|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6333642|NCT00016601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6333643|NCT00016601|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6333644|NCT00016601|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6333645|NCT00016601|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6333646|NCT00016601|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6333647|NCT00016601|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6333648|NCT00016601|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6333649|NCT00016601|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6333650|NCT00016601|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6333651|NCT00016601|Contraceptive Agents|contraceptive agents|mesh-ancestor
6333652|NCT00016601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6333653|NCT00016601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6333654|NCT00016601|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6333655|NCT00016601|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6333656|NCT00016601|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6333657|NCT00016601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6333658|NCT00016601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333659|NCT00016666|Propranolol|propranolol|mesh-list
6333660|NCT00016666|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6333661|NCT00016666|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6333662|NCT00016666|Adrenergic Agents|adrenergic agents|mesh-ancestor
6333663|NCT00016666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6333664|NCT00016666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333665|NCT00016666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6333666|NCT00016666|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6333667|NCT00016666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6333668|NCT00016666|Vasodilator Agents|vasodilator agents|mesh-ancestor
6333669|NCT00016744|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
6333670|NCT00016744|Genistein|genistein|mesh-list
6333671|NCT00016744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333672|NCT00016744|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6333673|NCT00016744|Protective Agents|protective agents|mesh-ancestor
6333674|NCT00016744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6333675|NCT00016744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6333676|NCT00016744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6333677|NCT00016744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333678|NCT00016744|Phytoestrogens|phytoestrogens|mesh-ancestor
6333679|NCT00016744|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6333680|NCT00016744|Estrogens|estrogens|mesh-ancestor
6333681|NCT00016744|Hormones|hormones|mesh-ancestor
6333682|NCT00016744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6333683|NCT00016835|Metronidazole|metronidazole|mesh-list
6333684|NCT00016835|Doxycycline|doxycycline|mesh-list
6333685|NCT00016835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6333686|NCT00016835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6333687|NCT00016835|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6333688|NCT00016835|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6333689|NCT00016835|Antimalarials|antimalarials|mesh-ancestor
6333690|NCT00016861|Irinotecan|irinotecan|mesh-list
6333691|NCT00016861|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6333692|NCT00016861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6333693|NCT00016861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6333694|NCT00016861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333695|NCT00016861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333696|NCT00016874|Paclitaxel|paclitaxel|mesh-list
6333697|NCT00016874|Cisplatin|cisplatin|mesh-list
6333698|NCT00016874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6333699|NCT00016874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333700|NCT00016874|Tubulin Modulators|tubulin modulators|mesh-ancestor
6333701|NCT00016874|Antimitotic Agents|antimitotic agents|mesh-ancestor
6333702|NCT00016874|Mitosis Modulators|mitosis modulators|mesh-ancestor
6333703|NCT00016874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333704|NCT00016887|Interferons|interferons|mesh-list
6333705|NCT00016887|Cytarabine|cytarabine|mesh-list
6333706|NCT00016887|Interferon-alpha|interferon-alpha|mesh-list
6333707|NCT00016887|Dexamethasone|dexamethasone|mesh-list
6333708|NCT00016887|Cyclophosphamide|cyclophosphamide|mesh-list
6333709|NCT00016887|Melphalan|melphalan|mesh-list
6333710|NCT00016887|Carmustine|carmustine|mesh-list
6333711|NCT00016887|Etoposide|etoposide|mesh-list
6333712|NCT00016887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6333713|NCT00016887|Immunologic Factors|immunologic factors|mesh-ancestor
6333714|NCT00016887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6333715|NCT00016887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6333716|NCT00016887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6333717|NCT00016887|Alkylating Agents|alkylating agents|mesh-ancestor
6333718|NCT00016887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333719|NCT00016887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333720|NCT00016887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6333721|NCT00016887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6333722|NCT00016887|Antiemetics|antiemetics|mesh-ancestor
6333723|NCT00016887|Autonomic Agents|autonomic agents|mesh-ancestor
6333724|NCT00016887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6333725|NCT00016887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6333726|NCT00016887|Glucocorticoids|glucocorticoids|mesh-ancestor
6333727|NCT00016887|Hormones|hormones|mesh-ancestor
6333728|NCT00016887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6333729|NCT00016887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6333730|NCT00016887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6333731|NCT00016887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6333732|NCT00016887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6333733|NCT00016887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6333734|NCT00016887|Antiviral Agents|antiviral agents|mesh-ancestor
6333735|NCT00016887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6333736|NCT00016887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6333737|NCT00016887|Antimetabolites|antimetabolites|mesh-ancestor
6333738|NCT00016900|Paclitaxel|paclitaxel|mesh-list
6333739|NCT00016900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6333740|NCT00016900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333741|NCT00016900|Tubulin Modulators|tubulin modulators|mesh-ancestor
6333742|NCT00016900|Antimitotic Agents|antimitotic agents|mesh-ancestor
6333743|NCT00016900|Mitosis Modulators|mitosis modulators|mesh-ancestor
6333744|NCT00016900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333745|NCT00016926|Capecitabine|capecitabine|mesh-list
6333746|NCT00016926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6333747|NCT00016926|Antimetabolites|antimetabolites|mesh-ancestor
6333748|NCT00016926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333749|NCT00016926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333750|NCT00016939|Alvocidib|alvocidib|mesh-list
6333751|NCT00016939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333752|NCT00016939|Growth Inhibitors|growth inhibitors|mesh-ancestor
6333753|NCT00016939|Growth Substances|growth substances|mesh-ancestor
6333754|NCT00016939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6333755|NCT00016939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6333756|NCT00016939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6333757|NCT00016939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333758|NCT00016952|Leucovorin|leucovorin|mesh-list
6333759|NCT00016952|Fluorouracil|fluorouracil|mesh-list
6333760|NCT00016952|Irinotecan|irinotecan|mesh-list
6016655|NCT00366444|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6016656|NCT00366444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6333761|NCT00016952|Calcium|calcium|mesh-list
6333762|NCT00016952|Levoleucovorin|levoleucovorin|mesh-list
6333763|NCT00016952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6333764|NCT00016952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6333765|NCT00016952|Antimetabolites|antimetabolites|mesh-ancestor
6333766|NCT00016952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333767|NCT00016952|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6333768|NCT00016952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333769|NCT00016952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6333770|NCT00016952|Immunologic Factors|immunologic factors|mesh-ancestor
6333771|NCT00016952|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6333772|NCT00016952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6333773|NCT00016952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6333774|NCT00016952|Antidotes|antidotes|mesh-ancestor
6333775|NCT00016952|Protective Agents|protective agents|mesh-ancestor
6333776|NCT00016952|Vitamin B Complex|vitamin b complex|mesh-ancestor
6333777|NCT00016952|Vitamins|vitamins|mesh-ancestor
6333778|NCT00016952|Micronutrients|micronutrients|mesh-ancestor
6333779|NCT00016978|Leucovorin|leucovorin|mesh-list
6333780|NCT00016978|Fluorouracil|fluorouracil|mesh-list
6333781|NCT00016978|Oxaliplatin|oxaliplatin|mesh-list
6333782|NCT00016978|Calcium|calcium|mesh-list
6333783|NCT00016978|Levoleucovorin|levoleucovorin|mesh-list
6333784|NCT00016978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6333785|NCT00016978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6333786|NCT00016978|Antimetabolites|antimetabolites|mesh-ancestor
6333787|NCT00016978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333788|NCT00016978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6333789|NCT00016978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333790|NCT00016978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6333791|NCT00016978|Immunologic Factors|immunologic factors|mesh-ancestor
6333792|NCT00016978|Antidotes|antidotes|mesh-ancestor
6333793|NCT00016978|Protective Agents|protective agents|mesh-ancestor
6333794|NCT00016978|Vitamin B Complex|vitamin b complex|mesh-ancestor
6333795|NCT00016978|Vitamins|vitamins|mesh-ancestor
6333796|NCT00016978|Micronutrients|micronutrients|mesh-ancestor
6333797|NCT00016991|Gefitinib|gefitinib|mesh-list
6333798|NCT00016991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333799|NCT00016991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6333800|NCT00016991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6333801|NCT00016991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016657|NCT00366444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333802|NCT00017004|Epoetin Alfa|epoetin alfa|mesh-list
6333803|NCT00017004|Hematinics|hematinics|mesh-ancestor
6333804|NCT00017017|Paclitaxel|paclitaxel|mesh-list
6333805|NCT00017017|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
6333806|NCT00017017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6333807|NCT00017017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333808|NCT00017017|Tubulin Modulators|tubulin modulators|mesh-ancestor
6333809|NCT00017017|Antimitotic Agents|antimitotic agents|mesh-ancestor
6333810|NCT00017017|Mitosis Modulators|mitosis modulators|mesh-ancestor
6333811|NCT00017017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333812|NCT00017030|Trabectedin|trabectedin|mesh-list
6333813|NCT00017030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6333814|NCT00017030|Alkylating Agents|alkylating agents|mesh-ancestor
6333815|NCT00017030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333816|NCT00017030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333817|NCT00017069|Dexamethasone|dexamethasone|mesh-list
6333818|NCT00017069|Arsenic Trioxide|arsenic trioxide|mesh-list
6333819|NCT00017069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6333820|NCT00017069|Antiemetics|antiemetics|mesh-ancestor
6333821|NCT00017069|Autonomic Agents|autonomic agents|mesh-ancestor
6333822|NCT00017069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6333823|NCT00017069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6333824|NCT00017069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6333825|NCT00017069|Glucocorticoids|glucocorticoids|mesh-ancestor
6333826|NCT00017069|Hormones|hormones|mesh-ancestor
6333827|NCT00017069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6333828|NCT00017069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6333829|NCT00017069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333830|NCT00017082|Oxaliplatin|oxaliplatin|mesh-list
6333831|NCT00017082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333832|NCT00017095|Cyclophosphamide|cyclophosphamide|mesh-list
6333833|NCT00017095|Docetaxel|docetaxel|mesh-list
6333834|NCT00017095|Fluorouracil|fluorouracil|mesh-list
6333835|NCT00017095|Epirubicin|epirubicin|mesh-list
6333836|NCT00017095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6333837|NCT00017095|Immunologic Factors|immunologic factors|mesh-ancestor
6333838|NCT00017095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6333839|NCT00017095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6333840|NCT00017095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6333841|NCT00017095|Alkylating Agents|alkylating agents|mesh-ancestor
6333842|NCT00017095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333843|NCT00017095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333844|NCT00017095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6333845|NCT00017095|Tubulin Modulators|tubulin modulators|mesh-ancestor
6333846|NCT00017095|Antimitotic Agents|antimitotic agents|mesh-ancestor
6333847|NCT00017095|Mitosis Modulators|mitosis modulators|mesh-ancestor
6333848|NCT00017095|Antimetabolites|antimetabolites|mesh-ancestor
6333849|NCT00017095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6333850|NCT00017095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6333851|NCT00017095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6333852|NCT00017095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6333853|NCT00017095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6333854|NCT00017108|Cyclophosphamide|cyclophosphamide|mesh-list
6333855|NCT00017108|Chlorambucil|chlorambucil|mesh-list
6333856|NCT00017108|Fludarabine|fludarabine|mesh-list
6333857|NCT00017108|Fludarabine phosphate|fludarabine phosphate|mesh-list
6333858|NCT00017108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6333859|NCT00017108|Immunologic Factors|immunologic factors|mesh-ancestor
6333860|NCT00017108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6333861|NCT00017108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6333862|NCT00017108|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6333863|NCT00017108|Alkylating Agents|alkylating agents|mesh-ancestor
6333864|NCT00017108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333865|NCT00017108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333866|NCT00017108|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6333867|NCT00017108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6333868|NCT00017108|Antimetabolites|antimetabolites|mesh-ancestor
6333869|NCT00017121|Sargramostim|sargramostim|mesh-list
6333870|NCT00017121|Immunologic Factors|immunologic factors|mesh-ancestor
6333871|NCT00017121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6333872|NCT00017134|Fenretinide|fenretinide|mesh-list
6333873|NCT00017134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333874|NCT00017134|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6333875|NCT00017134|Protective Agents|protective agents|mesh-ancestor
6333876|NCT00017134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6333877|NCT00017147|Carmustine|carmustine|mesh-list
6333878|NCT00017147|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
6333879|NCT00017147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6333880|NCT00017147|Alkylating Agents|alkylating agents|mesh-ancestor
6333881|NCT00017147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333882|NCT00017147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333883|NCT00017147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6333884|NCT00017160|Doxorubicin|doxorubicin|mesh-list
6333885|NCT00017160|Ifosfamide|ifosfamide|mesh-list
6333886|NCT00017160|Sargramostim|sargramostim|mesh-list
6333887|NCT00017160|Immunologic Factors|immunologic factors|mesh-list
6333888|NCT00017160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6333889|NCT00017160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333890|NCT00017160|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6333891|NCT00017160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6333892|NCT00017160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6333893|NCT00017160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333894|NCT00017160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6333895|NCT00017160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6333896|NCT00017160|Alkylating Agents|alkylating agents|mesh-ancestor
6333897|NCT00017173|Cisplatin|cisplatin|mesh-list
6333898|NCT00017173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333899|NCT00017186|Gemcitabine|gemcitabine|mesh-list
6333900|NCT00017186|Epirubicin|epirubicin|mesh-list
6333901|NCT00017186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6333902|NCT00017186|Antimetabolites|antimetabolites|mesh-ancestor
6333903|NCT00017186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333904|NCT00017186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333905|NCT00017186|Antiviral Agents|antiviral agents|mesh-ancestor
6333906|NCT00017186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6333907|NCT00017186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6333908|NCT00017186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6333909|NCT00017186|Immunologic Factors|immunologic factors|mesh-ancestor
6333910|NCT00017186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6333911|NCT00017186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6333912|NCT00017186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6333913|NCT00017186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6333914|NCT00017199|Bortezomib|bortezomib|mesh-list
6333915|NCT00017199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333916|NCT00017212|Exatecan|exatecan|mesh-list
6333917|NCT00017212|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6333918|NCT00017212|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6333919|NCT00017212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6333920|NCT00017212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333921|NCT00017212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333922|NCT00017225|Cyclophosphamide|cyclophosphamide|mesh-list
6333923|NCT00017225|Melphalan|melphalan|mesh-list
6333924|NCT00017225|Ifosfamide|ifosfamide|mesh-list
6333925|NCT00017225|Dacarbazine|dacarbazine|mesh-list
6333926|NCT00017225|Carboplatin|carboplatin|mesh-list
6333927|NCT00017225|Doxorubicin|doxorubicin|mesh-list
6333928|NCT00017225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6333929|NCT00017225|Etoposide|etoposide|mesh-list
6333930|NCT00017225|Vincristine|vincristine|mesh-list
6333931|NCT00017225|Tretinoin|tretinoin|mesh-list
6333932|NCT00017225|Vindesine|vindesine|mesh-list
6333933|NCT00017225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6333934|NCT00017225|Immunologic Factors|immunologic factors|mesh-ancestor
6333935|NCT00017225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6333936|NCT00017225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6333937|NCT00017225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6333938|NCT00017225|Alkylating Agents|alkylating agents|mesh-ancestor
6333939|NCT00017225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333940|NCT00017225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333941|NCT00017225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6333942|NCT00017225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6333943|NCT00017225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6333944|NCT00017225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6333945|NCT00017225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6333946|NCT00017225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6333947|NCT00017225|Tubulin Modulators|tubulin modulators|mesh-ancestor
6333948|NCT00017225|Antimitotic Agents|antimitotic agents|mesh-ancestor
6333949|NCT00017225|Mitosis Modulators|mitosis modulators|mesh-ancestor
6333950|NCT00017225|Keratolytic Agents|keratolytic agents|mesh-ancestor
6333951|NCT00017225|Dermatologic Agents|dermatologic agents|mesh-ancestor
6333952|NCT00017238|KRN 5500|krn 5500|mesh-list
6333953|NCT00017238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333954|NCT00017238|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6333955|NCT00017238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6333956|NCT00017238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333957|NCT00017251|Carboplatin|carboplatin|mesh-list
6333958|NCT00017251|Etoposide|etoposide|mesh-list
6333959|NCT00017251|Etoposide phosphate|etoposide phosphate|mesh-list
6333960|NCT00017251|Oblimersen|oblimersen|mesh-list
6333961|NCT00017251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333962|NCT00017251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6333963|NCT00017251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6333964|NCT00017251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6333965|NCT00017251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6333966|NCT00017251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333967|NCT00017264|Atrasentan|atrasentan|mesh-list
6333968|NCT00017264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333969|NCT00017264|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
6333970|NCT00017264|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6333971|NCT00017264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333972|NCT00017277|Epoetin Alfa|epoetin alfa|mesh-list
6333973|NCT00017277|Hematinics|hematinics|mesh-ancestor
6333974|NCT00017290|Prednisone|prednisone|mesh-list
6333975|NCT00017290|Cyclophosphamide|cyclophosphamide|mesh-list
6333976|NCT00017290|Vincristine|vincristine|mesh-list
6333977|NCT00017290|Immunoglobulins|immunoglobulins|mesh-list
6333978|NCT00017290|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6333979|NCT00017290|Antibodies|antibodies|mesh-list
6333980|NCT00017290|Sargramostim|sargramostim|mesh-list
6333981|NCT00017290|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
6333982|NCT00017290|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
6333983|NCT00017290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6333984|NCT00017290|Immunologic Factors|immunologic factors|mesh-ancestor
6333985|NCT00017290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6333986|NCT00017290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6333987|NCT00017290|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6333988|NCT00017290|Alkylating Agents|alkylating agents|mesh-ancestor
6333989|NCT00017290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6333990|NCT00017290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6333991|NCT00017290|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6333992|NCT00017290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6333993|NCT00017290|Glucocorticoids|glucocorticoids|mesh-ancestor
6333994|NCT00017290|Hormones|hormones|mesh-ancestor
6333995|NCT00017290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6333996|NCT00017290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6333997|NCT00017290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6333998|NCT00017290|Tubulin Modulators|tubulin modulators|mesh-ancestor
6333999|NCT00017290|Antimitotic Agents|antimitotic agents|mesh-ancestor
6334000|NCT00017290|Mitosis Modulators|mitosis modulators|mesh-ancestor
6334001|NCT00017290|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6334002|NCT00017303|Paclitaxel|paclitaxel|mesh-list
6334003|NCT00017303|Carboplatin|carboplatin|mesh-list
6334004|NCT00017303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6334005|NCT00017303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6334006|NCT00017303|Tubulin Modulators|tubulin modulators|mesh-ancestor
6334007|NCT00017303|Antimitotic Agents|antimitotic agents|mesh-ancestor
6334008|NCT00017303|Mitosis Modulators|mitosis modulators|mesh-ancestor
6334009|NCT00017303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6334010|NCT00017316|Thalidomide|thalidomide|mesh-list
6334011|NCT00017316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6016658|NCT00366457|Gemcitabine|gemcitabine|mesh-list
6334012|NCT00017316|Immunologic Factors|immunologic factors|mesh-ancestor
6396934|NCT00209872|Lidocaine|lidocaine|mesh-list
6334013|NCT00017316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334014|NCT00017316|Leprostatic Agents|leprostatic agents|mesh-ancestor
6334015|NCT00017316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6334016|NCT00017316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6334017|NCT00017316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6334018|NCT00017316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6334019|NCT00017316|Growth Substances|growth substances|mesh-ancestor
6334020|NCT00017316|Growth Inhibitors|growth inhibitors|mesh-ancestor
6334021|NCT00017316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6334022|NCT00017329|Bortezomib|bortezomib|mesh-list
6334023|NCT00017329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6334024|NCT00017342|Cytarabine|cytarabine|mesh-list
6334025|NCT00017342|Bryostatin 1|bryostatin 1|mesh-list
6334026|NCT00017342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6334027|NCT00017342|Antimetabolites|antimetabolites|mesh-ancestor
6334028|NCT00017342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6334029|NCT00017342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6334030|NCT00017342|Antiviral Agents|antiviral agents|mesh-ancestor
6334031|NCT00017342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6334032|NCT00017342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6334033|NCT00017342|Immunologic Factors|immunologic factors|mesh-ancestor
6334034|NCT00017342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334035|NCT00017342|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6334036|NCT00017355|Lenograstim|lenograstim|mesh-list
6334037|NCT00017355|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6334038|NCT00017355|Immunologic Factors|immunologic factors|mesh-ancestor
6334039|NCT00017355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334040|NCT00017368|Cyclophosphamide|cyclophosphamide|mesh-list
6334041|NCT00017368|Melphalan|melphalan|mesh-list
6334042|NCT00017368|Ifosfamide|ifosfamide|mesh-list
6334043|NCT00017368|Thiotepa|thiotepa|mesh-list
6334044|NCT00017368|Carboplatin|carboplatin|mesh-list
6334045|NCT00017368|Doxorubicin|doxorubicin|mesh-list
6334046|NCT00017368|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6334047|NCT00017368|Etoposide|etoposide|mesh-list
6334048|NCT00017368|Etoposide phosphate|etoposide phosphate|mesh-list
6334049|NCT00017368|Vincristine|vincristine|mesh-list
6334050|NCT00017368|Isotretinoin|isotretinoin|mesh-list
6334051|NCT00017368|Sargramostim|sargramostim|mesh-list
6334052|NCT00017368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6334053|NCT00017368|Immunologic Factors|immunologic factors|mesh-ancestor
6334054|NCT00017368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334055|NCT00017368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6334056|NCT00017368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6334057|NCT00017368|Alkylating Agents|alkylating agents|mesh-ancestor
6334058|NCT00017368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6334059|NCT00017368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6334060|NCT00017368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6334061|NCT00017368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6334062|NCT00017368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6334063|NCT00017368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6334064|NCT00017368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6334065|NCT00017368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6334066|NCT00017368|Tubulin Modulators|tubulin modulators|mesh-ancestor
6334067|NCT00017368|Antimitotic Agents|antimitotic agents|mesh-ancestor
6334068|NCT00017368|Mitosis Modulators|mitosis modulators|mesh-ancestor
6334069|NCT00017368|Dermatologic Agents|dermatologic agents|mesh-ancestor
6334070|NCT00017381|Cyclophosphamide|cyclophosphamide|mesh-list
6334071|NCT00017381|Rituximab|rituximab|mesh-list
6334072|NCT00017381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6334073|NCT00017381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6334074|NCT00017381|Immunologic Factors|immunologic factors|mesh-ancestor
6334075|NCT00017381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334076|NCT00017381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6334077|NCT00017381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6334078|NCT00017381|Alkylating Agents|alkylating agents|mesh-ancestor
6334079|NCT00017381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6334080|NCT00017381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6334081|NCT00017381|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6334082|NCT00017381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6334083|NCT00017394|Bevacizumab|bevacizumab|mesh-list
6334084|NCT00017394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6334085|NCT00017394|Vinorelbine|vinorelbine|mesh-list
6334086|NCT00017394|Antibodies|antibodies|mesh-list
6334087|NCT00017394|Immunoglobulins|immunoglobulins|mesh-list
6334088|NCT00017394|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6334089|NCT00017394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6334090|NCT00017394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6334091|NCT00017394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6334092|NCT00017394|Growth Substances|growth substances|mesh-ancestor
6334093|NCT00017394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334094|NCT00017394|Growth Inhibitors|growth inhibitors|mesh-ancestor
6334095|NCT00017394|Immunologic Factors|immunologic factors|mesh-ancestor
6334096|NCT00017394|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6334097|NCT00017394|Tubulin Modulators|tubulin modulators|mesh-ancestor
6334098|NCT00017394|Antimitotic Agents|antimitotic agents|mesh-ancestor
6334099|NCT00017394|Mitosis Modulators|mitosis modulators|mesh-ancestor
6334100|NCT00017394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6334101|NCT00017407|Paclitaxel|paclitaxel|mesh-list
6334102|NCT00017407|Carboplatin|carboplatin|mesh-list
6334103|NCT00017407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6334104|NCT00017407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6334105|NCT00017407|Tubulin Modulators|tubulin modulators|mesh-ancestor
6334106|NCT00017407|Antimitotic Agents|antimitotic agents|mesh-ancestor
6334107|NCT00017407|Mitosis Modulators|mitosis modulators|mesh-ancestor
6334108|NCT00017407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6334109|NCT00017433|Arsenic Trioxide|arsenic trioxide|mesh-list
6334110|NCT00017433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6334111|NCT00017459|Vinorelbine|vinorelbine|mesh-list
6334112|NCT00017459|Tirapazamine|tirapazamine|mesh-list
6334113|NCT00017459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6334114|NCT00017459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6334115|NCT00017459|Tubulin Modulators|tubulin modulators|mesh-ancestor
6334116|NCT00017459|Antimitotic Agents|antimitotic agents|mesh-ancestor
6334117|NCT00017459|Mitosis Modulators|mitosis modulators|mesh-ancestor
6334118|NCT00017459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6334119|NCT00017472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6334120|NCT00017472|Antibodies|antibodies|mesh-list
6334121|NCT00017472|Immunoglobulins|immunoglobulins|mesh-list
6334122|NCT00017472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6334123|NCT00017472|Immunologic Factors|immunologic factors|mesh-ancestor
6334124|NCT00017472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334125|NCT00017472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6334126|NCT00017498|Gemcitabine|gemcitabine|mesh-list
6334127|NCT00017498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6334128|NCT00017498|Antimetabolites|antimetabolites|mesh-ancestor
6334129|NCT00017498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6334130|NCT00017498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6334131|NCT00017498|Antiviral Agents|antiviral agents|mesh-ancestor
6334132|NCT00017498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6334133|NCT00017498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6334134|NCT00017498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6334135|NCT00017498|Immunologic Factors|immunologic factors|mesh-ancestor
6334136|NCT00017498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334137|NCT00017511|Cevimeline|cevimeline|mesh-list
6334138|NCT00017511|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6334139|NCT00017511|Autonomic Agents|autonomic agents|mesh-ancestor
6334140|NCT00017511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6334141|NCT00017511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334142|NCT00017511|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6334143|NCT00017511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6334144|NCT00017511|Cholinergic Agents|cholinergic agents|mesh-ancestor
6334145|NCT00017511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6334146|NCT00017511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6334147|NCT00017550|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6334148|NCT00017550|Immunologic Factors|immunologic factors|mesh-ancestor
6334149|NCT00017550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334150|NCT00017550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6334151|NCT00017576|Calcitriol|calcitriol|mesh-list
6334152|NCT00017576|Carboplatin|carboplatin|mesh-list
6334153|NCT00017576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6334154|NCT00017576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6334155|NCT00017576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334156|NCT00017576|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6334157|NCT00017576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6334158|NCT00017576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6334159|NCT00017576|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6334160|NCT00017576|Vitamins|vitamins|mesh-ancestor
6334161|NCT00017576|Micronutrients|micronutrients|mesh-ancestor
6334162|NCT00017576|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6334163|NCT00017589|Gemtuzumab|gemtuzumab|mesh-list
6334164|NCT00017589|Oblimersen|oblimersen|mesh-list
6334165|NCT00017589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6334166|NCT00017589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6334167|NCT00017602|Dexamethasone|dexamethasone|mesh-list
6334168|NCT00017602|Oblimersen|oblimersen|mesh-list
6334169|NCT00017602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6334170|NCT00017602|Antiemetics|antiemetics|mesh-ancestor
6334171|NCT00017602|Autonomic Agents|autonomic agents|mesh-ancestor
6334172|NCT00017602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6334173|NCT00017602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334174|NCT00017602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6334175|NCT00017602|Glucocorticoids|glucocorticoids|mesh-ancestor
6334176|NCT00017602|Hormones|hormones|mesh-ancestor
6334177|NCT00017602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6334178|NCT00017602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6334179|NCT00017602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6334180|NCT00017628|Methylprednisolone|methylprednisolone|mesh-list
6334181|NCT00017628|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6334182|NCT00017628|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6334183|NCT00017628|Prednisolone|prednisolone|mesh-list
6334184|NCT00017628|Prednisolone acetate|prednisolone acetate|mesh-list
6334185|NCT00017628|Cyclophosphamide|cyclophosphamide|mesh-list
6334186|NCT00017628|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6334187|NCT00017628|Prednisolone phosphate|prednisolone phosphate|mesh-list
6334188|NCT00017628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6334189|NCT00017628|Immunologic Factors|immunologic factors|mesh-ancestor
6334190|NCT00017628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334191|NCT00017628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6334192|NCT00017628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6334193|NCT00017628|Alkylating Agents|alkylating agents|mesh-ancestor
6334194|NCT00017628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6334195|NCT00017628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6334196|NCT00017628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6334197|NCT00017628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6334198|NCT00017628|Antiemetics|antiemetics|mesh-ancestor
6334199|NCT00017628|Autonomic Agents|autonomic agents|mesh-ancestor
6334200|NCT00017628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6334201|NCT00017628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6334202|NCT00017628|Glucocorticoids|glucocorticoids|mesh-ancestor
6334203|NCT00017628|Hormones|hormones|mesh-ancestor
6334204|NCT00017628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6334205|NCT00017628|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6334206|NCT00017628|Protective Agents|protective agents|mesh-ancestor
6334207|NCT00017628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6393513|NCT00199108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6393514|NCT00199108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6393515|NCT00199108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6393516|NCT00199121|Zidovudine|zidovudine|mesh-list
6393517|NCT00199121|Antimetabolites|antimetabolites|mesh-ancestor
6393518|NCT00199121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393519|NCT00199121|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6393520|NCT00199121|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6393521|NCT00199121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6393522|NCT00199121|Antiviral Agents|antiviral agents|mesh-ancestor
6393523|NCT00199121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6393524|NCT00199121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6393525|NCT00199121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6393526|NCT00199134|Letrozole|letrozole|mesh-list
6393527|NCT00199134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6393528|NCT00199134|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6393529|NCT00199134|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6393530|NCT00199134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6334208|NCT00017641|Cyclophosphamide|cyclophosphamide|mesh-list
6334209|NCT00017641|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6334210|NCT00017641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6334211|NCT00017641|Immunologic Factors|immunologic factors|mesh-ancestor
6334212|NCT00017641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334213|NCT00017641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6334214|NCT00017641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6334215|NCT00017641|Alkylating Agents|alkylating agents|mesh-ancestor
6334216|NCT00017641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6334217|NCT00017641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6334218|NCT00017641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6334219|NCT00017654|Cyclosporine|cyclosporine|mesh-list
6334220|NCT00017654|Methylprednisolone|methylprednisolone|mesh-list
6334221|NCT00017654|Cyclophosphamide|cyclophosphamide|mesh-list
6334222|NCT00017654|Cyclosporins|cyclosporins|mesh-list
6334223|NCT00017654|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6334224|NCT00017654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6334225|NCT00017654|Immunologic Factors|immunologic factors|mesh-ancestor
6334226|NCT00017654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334227|NCT00017654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6334228|NCT00017654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6334229|NCT00017654|Alkylating Agents|alkylating agents|mesh-ancestor
6334230|NCT00017654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6334231|NCT00017654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6334232|NCT00017654|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6334233|NCT00017654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6334234|NCT00017654|Antifungal Agents|antifungal agents|mesh-ancestor
6334235|NCT00017654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6334236|NCT00017654|Dermatologic Agents|dermatologic agents|mesh-ancestor
6334237|NCT00017654|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6334238|NCT00017654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6334239|NCT00017654|Antiemetics|antiemetics|mesh-ancestor
6334240|NCT00017654|Autonomic Agents|autonomic agents|mesh-ancestor
6334241|NCT00017654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6334242|NCT00017654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6334243|NCT00017654|Glucocorticoids|glucocorticoids|mesh-ancestor
6334244|NCT00017654|Hormones|hormones|mesh-ancestor
6334245|NCT00017654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6334246|NCT00017654|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6334247|NCT00017654|Protective Agents|protective agents|mesh-ancestor
6334248|NCT00017680|Melphalan|melphalan|mesh-list
6334249|NCT00017680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6334250|NCT00017680|Alkylating Agents|alkylating agents|mesh-ancestor
6334251|NCT00017680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6334252|NCT00017680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6334253|NCT00017680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6334254|NCT00017680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6334255|NCT00017680|Immunologic Factors|immunologic factors|mesh-ancestor
6334256|NCT00017680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334257|NCT00017693|Interleukin-4|interleukin-4|mesh-list
6334258|NCT00017693|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6334259|NCT00017693|Immunologic Factors|immunologic factors|mesh-ancestor
6334260|NCT00017693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334261|NCT00017693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6334262|NCT00017693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6334263|NCT00017719|Lamivudine|lamivudine|mesh-list
6334264|NCT00017719|Zidovudine|zidovudine|mesh-list
6334265|NCT00017719|Nevirapine|nevirapine|mesh-list
6334266|NCT00017719|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6334267|NCT00017719|Nelfinavir|nelfinavir|mesh-list
6334268|NCT00017719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6334269|NCT00017719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6334270|NCT00017719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6334271|NCT00017719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6334272|NCT00017719|Antiviral Agents|antiviral agents|mesh-ancestor
6334273|NCT00017719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6334274|NCT00017719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6334275|NCT00017719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6334276|NCT00017719|Antimetabolites|antimetabolites|mesh-ancestor
6334277|NCT00017719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6334278|NCT00017719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6334279|NCT00017719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6334280|NCT00017719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6334281|NCT00017719|Protease Inhibitors|protease inhibitors|mesh-ancestor
6334282|NCT00017758|Efavirenz|efavirenz|mesh-list
6334283|NCT00017758|Nelfinavir|nelfinavir|mesh-list
6334284|NCT00017758|Atorvastatin|atorvastatin|mesh-list
6334285|NCT00017758|Simvastatin|simvastatin|mesh-list
6334286|NCT00017758|Pravastatin|pravastatin|mesh-list
6334287|NCT00017758|Calcium|calcium|mesh-list
6334288|NCT00017758|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6334289|NCT00017758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334290|NCT00017758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6334291|NCT00017758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6334292|NCT00017758|Antimetabolites|antimetabolites|mesh-ancestor
6334293|NCT00017758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6334294|NCT00017758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6334295|NCT00017758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6334296|NCT00017758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6334297|NCT00017758|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6334298|NCT00017758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6334299|NCT00017758|Antiviral Agents|antiviral agents|mesh-ancestor
6334300|NCT00017758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6334301|NCT00017758|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6334302|NCT00017758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6334303|NCT00017758|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6334304|NCT00017758|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6334305|NCT00017758|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6334306|NCT00017758|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6334307|NCT00017758|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6334308|NCT00017758|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6334309|NCT00017758|Protease Inhibitors|protease inhibitors|mesh-ancestor
6334310|NCT00017758|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6334311|NCT00017758|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6334312|NCT00017784|Valganciclovir|valganciclovir|mesh-list
6334313|NCT00017784|Antiviral Agents|antiviral agents|mesh-ancestor
6334314|NCT00017784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6334315|NCT00017862|Reslizumab|reslizumab|mesh-list
6334316|NCT00017862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6334317|NCT00017862|Respiratory System Agents|respiratory system agents|mesh-ancestor
6334318|NCT00017940|Mitogens|mitogens|mesh-list
6334319|NCT00017940|Mitosis Modulators|mitosis modulators|mesh-ancestor
6334320|NCT00017940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6334321|NCT00017992|Ritonavir|ritonavir|mesh-list
6334322|NCT00017992|Lopinavir|lopinavir|mesh-list
6334323|NCT00017992|Emtricitabine|emtricitabine|mesh-list
6334324|NCT00017992|Stavudine|stavudine|mesh-list
6334325|NCT00017992|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6334326|NCT00017992|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6334327|NCT00017992|Protease Inhibitors|protease inhibitors|mesh-ancestor
6334328|NCT00017992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6334329|NCT00017992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6334330|NCT00017992|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6334331|NCT00017992|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6334332|NCT00017992|Antiviral Agents|antiviral agents|mesh-ancestor
6334333|NCT00017992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6334334|NCT00017992|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6334335|NCT00017992|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6334336|NCT00017992|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6334337|NCT00017992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6334338|NCT00017992|Antimetabolites|antimetabolites|mesh-ancestor
6334339|NCT00018018|Zidovudine|zidovudine|mesh-list
6334340|NCT00018018|Antimetabolites|antimetabolites|mesh-ancestor
6334341|NCT00018018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6334342|NCT00018018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6334343|NCT00018018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6334344|NCT00018018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6334345|NCT00018018|Antiviral Agents|antiviral agents|mesh-ancestor
6334346|NCT00018018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6334347|NCT00018018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6334348|NCT00018018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6334349|NCT00018083|Efavirenz|efavirenz|mesh-list
6334350|NCT00018083|Isoniazid|isoniazid|mesh-list
6334351|NCT00018083|Rifabutin|rifabutin|mesh-list
6334352|NCT00018083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6334353|NCT00018083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6334354|NCT00018083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6334355|NCT00018083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6334356|NCT00018083|Antiviral Agents|antiviral agents|mesh-ancestor
6334357|NCT00018083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6334358|NCT00018083|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6334359|NCT00018083|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6334360|NCT00018083|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6334361|NCT00018083|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6334362|NCT00018083|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6334363|NCT00018083|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6334364|NCT00018083|Antitubercular Agents|antitubercular agents|mesh-ancestor
6334365|NCT00018083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6334366|NCT00018083|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6334367|NCT00018083|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6334368|NCT00018083|Antimetabolites|antimetabolites|mesh-ancestor
6334369|NCT00018083|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6334370|NCT00018083|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6334371|NCT00018135|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6334372|NCT00018135|Calcium|calcium|mesh-list
6334373|NCT00018135|Sevelamer|sevelamer|mesh-list
6334374|NCT00018135|Calcium acetate|calcium acetate|mesh-list
6334375|NCT00018135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6334376|NCT00018135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334377|NCT00018135|Chelating Agents|chelating agents|mesh-ancestor
6334378|NCT00018135|Sequestering Agents|sequestering agents|mesh-ancestor
6334379|NCT00018135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6334380|NCT00018135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6334381|NCT00018135|Immunologic Factors|immunologic factors|mesh-ancestor
6334382|NCT00018135|Antacids|antacids|mesh-ancestor
6334383|NCT00018135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6334384|NCT00018148|Nortriptyline|nortriptyline|mesh-list
6334385|NCT00018148|Nicotine|nicotine|mesh-list
6334386|NCT00018148|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6334387|NCT00018148|Autonomic Agents|autonomic agents|mesh-ancestor
6334388|NCT00018148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6334389|NCT00018148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334390|NCT00018148|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6334391|NCT00018148|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6334392|NCT00018148|Cholinergic Agents|cholinergic agents|mesh-ancestor
6334393|NCT00018148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6334394|NCT00018148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6334395|NCT00018148|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6334396|NCT00018148|Antidepressive Agents|antidepressive agents|mesh-ancestor
6334397|NCT00018148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6334398|NCT00018148|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6334399|NCT00018148|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6334400|NCT00018148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6334401|NCT00018148|Adrenergic Agents|adrenergic agents|mesh-ancestor
6334402|NCT00018161|Mecamylamine|mecamylamine|mesh-list
6334403|NCT00018161|Nicotine|nicotine|mesh-list
6334404|NCT00018161|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6334405|NCT00018161|Autonomic Agents|autonomic agents|mesh-ancestor
6334406|NCT00018161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6334407|NCT00018161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334408|NCT00018161|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6334409|NCT00018161|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6334410|NCT00018161|Cholinergic Agents|cholinergic agents|mesh-ancestor
6334411|NCT00018161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6334412|NCT00018161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6334413|NCT00018161|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6334414|NCT00018161|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
6334415|NCT00018161|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
6334416|NCT00018161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6334417|NCT00018174|Fluoxetine|fluoxetine|mesh-list
6334418|NCT00018174|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6334419|NCT00018174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6334420|NCT00018174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6334421|NCT00018174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6334422|NCT00018174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6334423|NCT00018174|Serotonin Agents|serotonin agents|mesh-ancestor
6334424|NCT00018174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334425|NCT00018174|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6334426|NCT00018174|Antidepressive Agents|antidepressive agents|mesh-ancestor
6334427|NCT00018174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6334428|NCT00018174|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6334429|NCT00018174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6334430|NCT00018174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6334431|NCT00018187|Mecamylamine|mecamylamine|mesh-list
6334432|NCT00018187|Bupropion|bupropion|mesh-list
6334433|NCT00018187|Nicotine|nicotine|mesh-list
6334434|NCT00018187|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6334435|NCT00018187|Autonomic Agents|autonomic agents|mesh-ancestor
6334436|NCT00018187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6334437|NCT00018187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334438|NCT00018187|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6334439|NCT00018187|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6334440|NCT00018187|Cholinergic Agents|cholinergic agents|mesh-ancestor
6334441|NCT00018187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6334442|NCT00018187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6334443|NCT00018187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6334444|NCT00018187|Antidepressive Agents|antidepressive agents|mesh-ancestor
6334445|NCT00018187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6334446|NCT00018187|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6334447|NCT00018187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6334448|NCT00018187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6334449|NCT00018187|Dopamine Agents|dopamine agents|mesh-ancestor
6334450|NCT00018187|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6334451|NCT00018187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6334452|NCT00018187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6334453|NCT00018187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6334454|NCT00018187|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
6334455|NCT00018187|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
6334456|NCT00018187|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6334457|NCT00018200|Benztropine|benztropine|mesh-list
6334458|NCT00018200|Fluoxetine|fluoxetine|mesh-list
6334459|NCT00018200|Desipramine|desipramine|mesh-list
6334460|NCT00018200|Clomipramine|clomipramine|mesh-list
6334461|NCT00018200|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6334462|NCT00018200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6334463|NCT00018200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6334464|NCT00018200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6334465|NCT00018200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6334466|NCT00018200|Serotonin Agents|serotonin agents|mesh-ancestor
6334467|NCT00018200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334468|NCT00018200|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6334469|NCT00018200|Antidepressive Agents|antidepressive agents|mesh-ancestor
6334470|NCT00018200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6334471|NCT00018200|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6334472|NCT00018200|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6334473|NCT00018200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6334474|NCT00018200|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6334475|NCT00018200|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6334476|NCT00018200|Adrenergic Agents|adrenergic agents|mesh-ancestor
6334477|NCT00018200|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6334478|NCT00018200|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6334479|NCT00018200|Parasympatholytics|parasympatholytics|mesh-ancestor
6334480|NCT00018200|Autonomic Agents|autonomic agents|mesh-ancestor
6334481|NCT00018200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6334482|NCT00018200|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6334483|NCT00018200|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6334484|NCT00018200|Cholinergic Agents|cholinergic agents|mesh-ancestor
6334485|NCT00018200|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6334486|NCT00018200|Dopamine Agents|dopamine agents|mesh-ancestor
6334487|NCT00018213|Naltrexone|naltrexone|mesh-list
6334488|NCT00018213|Nicotine|nicotine|mesh-list
6334489|NCT00018213|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6334490|NCT00018213|Autonomic Agents|autonomic agents|mesh-ancestor
6334491|NCT00018213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6334492|NCT00018213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334493|NCT00018213|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6334494|NCT00018213|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6334495|NCT00018213|Cholinergic Agents|cholinergic agents|mesh-ancestor
6334496|NCT00018213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6334497|NCT00018213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6334498|NCT00018213|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6334499|NCT00018213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6334500|NCT00018213|Sensory System Agents|sensory system agents|mesh-ancestor
6334501|NCT00018278|Donepezil|donepezil|mesh-list
6334502|NCT00018278|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6334503|NCT00018278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6334504|NCT00018278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6334505|NCT00018278|Cholinergic Agents|cholinergic agents|mesh-ancestor
6334506|NCT00018278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6334507|NCT00018278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334508|NCT00018278|Nootropic Agents|nootropic agents|mesh-ancestor
6334509|NCT00018291|Gabapentin|gabapentin|mesh-list
6334510|NCT00018291|Risperidone|risperidone|mesh-list
6334511|NCT00018291|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6334512|NCT00018291|Serotonin Agents|serotonin agents|mesh-ancestor
6334513|NCT00018291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6334514|NCT00018291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6334515|NCT00018291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334516|NCT00018291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6334517|NCT00018291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6334518|NCT00018291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6334519|NCT00018291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6334520|NCT00018291|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6334521|NCT00018291|Dopamine Agents|dopamine agents|mesh-ancestor
6334522|NCT00018291|Analgesics|analgesics|mesh-ancestor
6334523|NCT00018291|Sensory System Agents|sensory system agents|mesh-ancestor
6334524|NCT00018291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6334525|NCT00018291|Anticonvulsants|anticonvulsants|mesh-ancestor
6334526|NCT00018291|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6334527|NCT00018291|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6334528|NCT00018291|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6334529|NCT00018291|Antimanic Agents|antimanic agents|mesh-ancestor
6334530|NCT00018343|Estrogens|estrogens|mesh-list
6334531|NCT00018343|Hormones|hormones|mesh-ancestor
6334532|NCT00018343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6334533|NCT00018343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334534|NCT00018356|Testosterone|testosterone|mesh-list
6334535|NCT00018356|Androgens|androgens|mesh-ancestor
6334536|NCT00018356|Hormones|hormones|mesh-ancestor
6334537|NCT00018356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6334538|NCT00018356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334539|NCT00018382|Rosiglitazone|rosiglitazone|mesh-list
6334540|NCT00018382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6334541|NCT00018382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334542|NCT00018447|Fluorides|fluorides|mesh-list
6334543|NCT00018447|Cariostatic Agents|cariostatic agents|mesh-ancestor
6334544|NCT00018447|Protective Agents|protective agents|mesh-ancestor
6334545|NCT00018447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334546|NCT00018460|Vitamins|vitamins|mesh-list
6334547|NCT00018460|Vitamin B Complex|vitamin b complex|mesh-list
6334548|NCT00018460|Micronutrients|micronutrients|mesh-ancestor
6334549|NCT00018460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334550|NCT00018551|Folic Acid|folic acid|mesh-list
6334551|NCT00018551|Hematinics|hematinics|mesh-ancestor
6334552|NCT00018551|Vitamin B Complex|vitamin b complex|mesh-ancestor
6334553|NCT00018551|Vitamins|vitamins|mesh-ancestor
6334554|NCT00018551|Micronutrients|micronutrients|mesh-ancestor
6334555|NCT00018551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334556|NCT00018603|Guanfacine|guanfacine|mesh-list
6334557|NCT00018603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6334558|NCT00018603|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6334559|NCT00018603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6334560|NCT00018603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6334561|NCT00018603|Adrenergic Agents|adrenergic agents|mesh-ancestor
6334562|NCT00018603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6334563|NCT00018603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6334564|NCT00018603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334565|NCT00018642|Haloperidol|haloperidol|mesh-list
6334566|NCT00018642|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6334567|NCT00018642|Haloperidol decanoate|haloperidol decanoate|mesh-list
6334568|NCT00018642|Antidepressive Agents|antidepressive agents|mesh-ancestor
6334569|NCT00018642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6334570|NCT00018642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6334571|NCT00018642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6334572|NCT00018642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6334573|NCT00018642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334574|NCT00018642|Antiemetics|antiemetics|mesh-ancestor
6334575|NCT00018642|Autonomic Agents|autonomic agents|mesh-ancestor
6334576|NCT00018642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6334577|NCT00018642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6334578|NCT00018642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6334579|NCT00018642|Dopamine Agents|dopamine agents|mesh-ancestor
6334580|NCT00018642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6334581|NCT00018642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6334582|NCT00018642|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6334583|NCT00018668|Olanzapine|olanzapine|mesh-list
6334584|NCT00018668|Risperidone|risperidone|mesh-list
6334585|NCT00018668|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6334586|NCT00018668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6334587|NCT00018668|Serotonin Agents|serotonin agents|mesh-ancestor
6334588|NCT00018668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6334589|NCT00018668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6334590|NCT00018668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334591|NCT00018668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6334592|NCT00018668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6334593|NCT00018668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6334594|NCT00018668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6334595|NCT00018668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6334596|NCT00018668|Dopamine Agents|dopamine agents|mesh-ancestor
6334597|NCT00018668|Antiemetics|antiemetics|mesh-ancestor
6334598|NCT00018668|Autonomic Agents|autonomic agents|mesh-ancestor
6334599|NCT00018668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6334600|NCT00018668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6334601|NCT00018668|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6334602|NCT00018668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6334603|NCT00018668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6334604|NCT00018668|Antidepressive Agents|antidepressive agents|mesh-ancestor
6334605|NCT00018694|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
6334606|NCT00018694|Cathartics|cathartics|mesh-ancestor
6334607|NCT00018694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6334608|NCT00018733|Paroxetine|paroxetine|mesh-list
6334609|NCT00018733|Desipramine|desipramine|mesh-list
6334610|NCT00018733|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6334611|NCT00018733|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6334612|NCT00018733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6334613|NCT00018733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6334614|NCT00018733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6334615|NCT00018733|Serotonin Agents|serotonin agents|mesh-ancestor
6334616|NCT00018733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334617|NCT00018733|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6334618|NCT00018733|Antidepressive Agents|antidepressive agents|mesh-ancestor
6334619|NCT00018733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6334620|NCT00018733|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6334621|NCT00018733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6334622|NCT00018733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6334623|NCT00018733|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6334624|NCT00018733|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6334625|NCT00018733|Adrenergic Agents|adrenergic agents|mesh-ancestor
6334626|NCT00018759|Paroxetine|paroxetine|mesh-list
6334627|NCT00018759|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6334628|NCT00018759|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6334629|NCT00018759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6334630|NCT00018759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6334631|NCT00018759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6334632|NCT00018759|Serotonin Agents|serotonin agents|mesh-ancestor
6334633|NCT00018759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334634|NCT00018759|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6334635|NCT00018759|Antidepressive Agents|antidepressive agents|mesh-ancestor
6334636|NCT00018759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6334637|NCT00018759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6334638|NCT00018759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6334639|NCT00018759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6334640|NCT00018824|Naltrexone|naltrexone|mesh-list
6334641|NCT00018824|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6334642|NCT00018824|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6334643|NCT00018824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334644|NCT00018824|Sensory System Agents|sensory system agents|mesh-ancestor
6334645|NCT00018824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6334646|NCT00018850|Haloperidol|haloperidol|mesh-list
6334647|NCT00018850|Ondansetron|ondansetron|mesh-list
6334648|NCT00018850|Haloperidol decanoate|haloperidol decanoate|mesh-list
6334649|NCT00018850|Nicotine|nicotine|mesh-list
6334650|NCT00018850|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6334651|NCT00018850|Autonomic Agents|autonomic agents|mesh-ancestor
6334652|NCT00018850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6334653|NCT00018850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334654|NCT00018850|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6334655|NCT00018850|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6334656|NCT00018850|Cholinergic Agents|cholinergic agents|mesh-ancestor
6334657|NCT00018850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6334658|NCT00018850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6334659|NCT00018850|Antiemetics|antiemetics|mesh-ancestor
6334660|NCT00018850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6334661|NCT00018850|Antipruritics|antipruritics|mesh-ancestor
6334662|NCT00018850|Dermatologic Agents|dermatologic agents|mesh-ancestor
6334663|NCT00018850|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6334664|NCT00018850|Serotonin Agents|serotonin agents|mesh-ancestor
6334665|NCT00018850|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6334666|NCT00018850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6334667|NCT00018850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6334668|NCT00018850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6334669|NCT00018850|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6334670|NCT00018850|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6334671|NCT00018850|Dopamine Agents|dopamine agents|mesh-ancestor
6334672|NCT00018850|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6334673|NCT00018863|Methylphenidate|methylphenidate|mesh-list
6334674|NCT00018863|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6334675|NCT00018863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334676|NCT00018863|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6334677|NCT00018863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6334678|NCT00018863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6334679|NCT00018863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6334680|NCT00018863|Dopamine Agents|dopamine agents|mesh-ancestor
6334681|NCT00018863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6334682|NCT00018902|Fluoxetine|fluoxetine|mesh-list
6334683|NCT00018902|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6334684|NCT00018902|Citalopram|citalopram|mesh-list
6334685|NCT00018902|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6334686|NCT00018902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6334687|NCT00018902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6334688|NCT00018902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6334689|NCT00018902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6334690|NCT00018902|Serotonin Agents|serotonin agents|mesh-ancestor
6334691|NCT00018902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334692|NCT00018902|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6334693|NCT00018902|Antidepressive Agents|antidepressive agents|mesh-ancestor
6334694|NCT00018902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6334695|NCT00018902|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6334696|NCT00018902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6334697|NCT00018902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6334698|NCT00018902|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6334699|NCT00018941|Aldesleukin|aldesleukin|mesh-list
6334700|NCT00018941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6334701|NCT00018941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6334702|NCT00018941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6334703|NCT00018941|Antiviral Agents|antiviral agents|mesh-ancestor
6334704|NCT00018941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6334705|NCT00018954|Cytarabine|cytarabine|mesh-list
6334706|NCT00018954|Prednisone|prednisone|mesh-list
6334707|NCT00018954|Cyclophosphamide|cyclophosphamide|mesh-list
6334708|NCT00018954|Ifosfamide|ifosfamide|mesh-list
6334709|NCT00018954|Doxorubicin|doxorubicin|mesh-list
6334710|NCT00018954|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6334711|NCT00018954|Methotrexate|methotrexate|mesh-list
6334712|NCT00018954|Etoposide|etoposide|mesh-list
6334713|NCT00018954|Vincristine|vincristine|mesh-list
6334714|NCT00018954|Daunorubicin|daunorubicin|mesh-list
6334715|NCT00018954|Asparaginase|asparaginase|mesh-list
6334716|NCT00018954|Mercaptopurine|mercaptopurine|mesh-list
6334717|NCT00018954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6334718|NCT00018954|Immunologic Factors|immunologic factors|mesh-ancestor
6334719|NCT00018954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334720|NCT00018954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6334721|NCT00018954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6334722|NCT00018954|Alkylating Agents|alkylating agents|mesh-ancestor
6334723|NCT00018954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6334724|NCT00018954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6334725|NCT00018954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6334726|NCT00018954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6334727|NCT00018954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6334728|NCT00018954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6334729|NCT00018954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6334730|NCT00018954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6334731|NCT00018954|Glucocorticoids|glucocorticoids|mesh-ancestor
6334732|NCT00018954|Hormones|hormones|mesh-ancestor
6334733|NCT00018954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6334734|NCT00018954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6334735|NCT00018954|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6334736|NCT00018954|Abortifacient Agents|abortifacient agents|mesh-ancestor
6334737|NCT00018954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6334738|NCT00018954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6334739|NCT00018954|Antimetabolites|antimetabolites|mesh-ancestor
6334740|NCT00018954|Dermatologic Agents|dermatologic agents|mesh-ancestor
6334741|NCT00018954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6334742|NCT00018954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6334743|NCT00018954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6334744|NCT00018954|Antiviral Agents|antiviral agents|mesh-ancestor
6334745|NCT00018954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6334746|NCT00018954|Tubulin Modulators|tubulin modulators|mesh-ancestor
6334747|NCT00018954|Antimitotic Agents|antimitotic agents|mesh-ancestor
6334748|NCT00018954|Mitosis Modulators|mitosis modulators|mesh-ancestor
6334749|NCT00019006|Detox adjuvant|detox adjuvant|mesh-list
6334750|NCT00019006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6334751|NCT00019006|Immunologic Factors|immunologic factors|mesh-ancestor
6334752|NCT00019006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334753|NCT00019019|Paclitaxel|paclitaxel|mesh-list
6334754|NCT00019019|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
6334755|NCT00019019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6334756|NCT00019019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6334757|NCT00019019|Tubulin Modulators|tubulin modulators|mesh-ancestor
6334758|NCT00019019|Antimitotic Agents|antimitotic agents|mesh-ancestor
6334759|NCT00019019|Mitosis Modulators|mitosis modulators|mesh-ancestor
6334760|NCT00019019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6334761|NCT00019019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6334762|NCT00019019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6334763|NCT00019019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6334764|NCT00019019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334765|NCT00019032|Antibodies|antibodies|mesh-list
6334766|NCT00019032|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6334767|NCT00019032|Immunologic Factors|immunologic factors|mesh-ancestor
6334768|NCT00019032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334769|NCT00019058|Hydroxyurea|hydroxyurea|mesh-list
6334770|NCT00019058|Pentoxifylline|pentoxifylline|mesh-list
6334771|NCT00019058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6334772|NCT00019058|Antisickling Agents|antisickling agents|mesh-ancestor
6334773|NCT00019058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6334774|NCT00019058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6334775|NCT00019058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6334776|NCT00019058|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6334777|NCT00019058|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6334778|NCT00019058|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6334779|NCT00019058|Protective Agents|protective agents|mesh-ancestor
6334780|NCT00019058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334781|NCT00019058|Vasodilator Agents|vasodilator agents|mesh-ancestor
6334782|NCT00019058|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6334783|NCT00019058|Antioxidants|antioxidants|mesh-ancestor
6016659|NCT00366457|Bevacizumab|bevacizumab|mesh-list
6334784|NCT00019071|Cladribine|cladribine|mesh-list
6334785|NCT00019071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6334786|NCT00019071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6334787|NCT00019071|Immunologic Factors|immunologic factors|mesh-ancestor
6334788|NCT00019071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334789|NCT00019084|Aldesleukin|aldesleukin|mesh-list
6334790|NCT00019084|Vaccines|vaccines|mesh-list
6334791|NCT00019084|Sargramostim|sargramostim|mesh-list
6334792|NCT00019084|Immunologic Factors|immunologic factors|mesh-ancestor
6334793|NCT00019084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334794|NCT00019084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6334795|NCT00019084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6334796|NCT00019084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6334797|NCT00019084|Antiviral Agents|antiviral agents|mesh-ancestor
6334798|NCT00019084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6334799|NCT00019097|Melphalan|melphalan|mesh-list
6334800|NCT00019097|Sargramostim|sargramostim|mesh-list
6334801|NCT00019097|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
6334802|NCT00019097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6334803|NCT00019097|Alkylating Agents|alkylating agents|mesh-ancestor
6334804|NCT00019097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6334805|NCT00019097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6334806|NCT00019097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6334807|NCT00019097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6334808|NCT00019097|Immunologic Factors|immunologic factors|mesh-ancestor
6334809|NCT00019097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334810|NCT00019097|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6334811|NCT00019123|Thalidomide|thalidomide|mesh-list
6334812|NCT00019123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6334813|NCT00019123|Immunologic Factors|immunologic factors|mesh-ancestor
6334814|NCT00019123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334815|NCT00019123|Leprostatic Agents|leprostatic agents|mesh-ancestor
6334816|NCT00019123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6334817|NCT00019123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6334818|NCT00019123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6334819|NCT00019123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6334820|NCT00019123|Growth Substances|growth substances|mesh-ancestor
6334821|NCT00019123|Growth Inhibitors|growth inhibitors|mesh-ancestor
6334822|NCT00019123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6393531|NCT00199134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393532|NCT00199134|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6393533|NCT00199134|Hormone Antagonists|hormone antagonists|mesh-ancestor
6393534|NCT00199134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6393535|NCT00199134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6393536|NCT00199147|Cytarabine|cytarabine|mesh-list
6393537|NCT00199147|Fludarabine|fludarabine|mesh-list
6393538|NCT00199147|Etoposide|etoposide|mesh-list
6393539|NCT00199147|Idarubicin|idarubicin|mesh-list
6393540|NCT00199147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6393541|NCT00199147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6393542|NCT00199147|Antimetabolites|antimetabolites|mesh-ancestor
6393543|NCT00199147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393544|NCT00199147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6393545|NCT00199147|Immunologic Factors|immunologic factors|mesh-ancestor
6393546|NCT00199147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6393547|NCT00199147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6393548|NCT00199147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6393549|NCT00199147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6393550|NCT00199147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6393551|NCT00199147|Antiviral Agents|antiviral agents|mesh-ancestor
6393552|NCT00199147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6393553|NCT00199147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6393554|NCT00199160|Sorafenib|sorafenib|mesh-list
6393555|NCT00199160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6393556|NCT00199160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6393557|NCT00199160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6393558|NCT00199160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393559|NCT00199186|Cytarabine|cytarabine|mesh-list
6393560|NCT00199186|Dexamethasone|dexamethasone|mesh-list
6393561|NCT00199186|Dexamethasone acetate|dexamethasone acetate|mesh-list
6334823|NCT00019136|Aldesleukin|aldesleukin|mesh-list
6334824|NCT00019136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6334825|NCT00019136|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6334826|NCT00019136|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6334827|NCT00019136|Antiviral Agents|antiviral agents|mesh-ancestor
6334828|NCT00019136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6334829|NCT00019175|Aldesleukin|aldesleukin|mesh-list
6334830|NCT00019175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6334831|NCT00019175|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6334832|NCT00019175|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6334833|NCT00019175|Antiviral Agents|antiviral agents|mesh-ancestor
6334834|NCT00019175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6334835|NCT00019188|Interleukin-12|interleukin-12|mesh-list
6334836|NCT00019188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6334837|NCT00019188|Immunologic Factors|immunologic factors|mesh-ancestor
6334838|NCT00019188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334839|NCT00019188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6334840|NCT00019188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6334841|NCT00019188|Growth Substances|growth substances|mesh-ancestor
6334842|NCT00019188|Growth Inhibitors|growth inhibitors|mesh-ancestor
6334843|NCT00019188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6334844|NCT00019214|Aldesleukin|aldesleukin|mesh-list
6334845|NCT00019214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6334846|NCT00019214|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6334847|NCT00019214|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6334848|NCT00019214|Antiviral Agents|antiviral agents|mesh-ancestor
6334849|NCT00019214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6334850|NCT00019227|Calcium|calcium|mesh-list
6334851|NCT00019227|Daclizumab|daclizumab|mesh-list
6334852|NCT00019227|Pentetic Acid|pentetic acid|mesh-list
6334853|NCT00019227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6334854|NCT00019227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334855|NCT00019227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6334856|NCT00019227|Immunologic Factors|immunologic factors|mesh-ancestor
6334857|NCT00019227|Antidotes|antidotes|mesh-ancestor
6334858|NCT00019227|Protective Agents|protective agents|mesh-ancestor
6334859|NCT00019227|Chelating Agents|chelating agents|mesh-ancestor
6334860|NCT00019227|Sequestering Agents|sequestering agents|mesh-ancestor
6334861|NCT00019227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6334862|NCT00019227|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6334863|NCT00019240|Cidofovir|cidofovir|mesh-list
6334864|NCT00019240|Antiviral Agents|antiviral agents|mesh-ancestor
6334865|NCT00019240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6334866|NCT00019240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6334867|NCT00019240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6334868|NCT00019318|Romidepsin|romidepsin|mesh-list
6334869|NCT00019318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6334870|NCT00019318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6334871|NCT00019331|Aldesleukin|aldesleukin|mesh-list
6334872|NCT00019331|Sargramostim|sargramostim|mesh-list
6334873|NCT00019331|Immunologic Factors|immunologic factors|mesh-ancestor
6334874|NCT00019331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334875|NCT00019331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6334876|NCT00019331|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6334877|NCT00019331|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6334878|NCT00019331|Antiviral Agents|antiviral agents|mesh-ancestor
6334879|NCT00019331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6334880|NCT00019344|Alvocidib|alvocidib|mesh-list
6334881|NCT00019344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6334882|NCT00019344|Growth Inhibitors|growth inhibitors|mesh-ancestor
6334883|NCT00019344|Growth Substances|growth substances|mesh-ancestor
6334884|NCT00019344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334885|NCT00019344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6334886|NCT00019344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6334887|NCT00019344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6334888|NCT00019357|Aldesleukin|aldesleukin|mesh-list
6334889|NCT00019357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6334890|NCT00019357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6334891|NCT00019357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6334892|NCT00019357|Antiviral Agents|antiviral agents|mesh-ancestor
6334893|NCT00019357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6334894|NCT00019383|Aldesleukin|aldesleukin|mesh-list
6334895|NCT00019383|Sargramostim|sargramostim|mesh-list
6334896|NCT00019383|Freund's Adjuvant|freund's adjuvant|mesh-list
6334897|NCT00019383|Immunologic Factors|immunologic factors|mesh-ancestor
6334898|NCT00019383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334899|NCT00019383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6334900|NCT00019383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6334901|NCT00019383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6334902|NCT00019383|Antiviral Agents|antiviral agents|mesh-ancestor
6334903|NCT00019383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6334904|NCT00019383|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6334905|NCT00019396|Flt3 ligand protein|flt3 ligand protein|mesh-list
6334906|NCT00019396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6334907|NCT00019396|Immunologic Factors|immunologic factors|mesh-ancestor
6334908|NCT00019396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334909|NCT00019396|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6334910|NCT00019396|Protective Agents|protective agents|mesh-ancestor
6334911|NCT00019409|Cytarabine|cytarabine|mesh-list
6334912|NCT00019409|Prednisone|prednisone|mesh-list
6334913|NCT00019409|Hydrocortisone|hydrocortisone|mesh-list
6334914|NCT00019409|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6334915|NCT00019409|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6334916|NCT00019409|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6334917|NCT00019409|Cyclophosphamide|cyclophosphamide|mesh-list
6334918|NCT00019409|Methotrexate|methotrexate|mesh-list
6334919|NCT00019409|Vincristine|vincristine|mesh-list
6334920|NCT00019409|Daunorubicin|daunorubicin|mesh-list
6334921|NCT00019409|Asparaginase|asparaginase|mesh-list
6334922|NCT00019409|Mercaptopurine|mercaptopurine|mesh-list
6334923|NCT00019409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6334924|NCT00019409|Immunologic Factors|immunologic factors|mesh-ancestor
6334925|NCT00019409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334926|NCT00019409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6334927|NCT00019409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6334928|NCT00019409|Alkylating Agents|alkylating agents|mesh-ancestor
6334929|NCT00019409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6334930|NCT00019409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6334931|NCT00019409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6334932|NCT00019409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6334933|NCT00019409|Glucocorticoids|glucocorticoids|mesh-ancestor
6334934|NCT00019409|Hormones|hormones|mesh-ancestor
6334935|NCT00019409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6334936|NCT00019409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6334937|NCT00019409|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6334938|NCT00019409|Abortifacient Agents|abortifacient agents|mesh-ancestor
6334939|NCT00019409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6334940|NCT00019409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6334941|NCT00019409|Antimetabolites|antimetabolites|mesh-ancestor
6334942|NCT00019409|Dermatologic Agents|dermatologic agents|mesh-ancestor
6334943|NCT00019409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6334944|NCT00019409|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6334945|NCT00019409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6334946|NCT00019409|Antiviral Agents|antiviral agents|mesh-ancestor
6334947|NCT00019409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6334948|NCT00019409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6334949|NCT00019409|Tubulin Modulators|tubulin modulators|mesh-ancestor
6334950|NCT00019409|Antimitotic Agents|antimitotic agents|mesh-ancestor
6334951|NCT00019409|Mitosis Modulators|mitosis modulators|mesh-ancestor
6334952|NCT00019409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6334953|NCT00019409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6334954|NCT00019409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6334955|NCT00019422|Carboplatin|carboplatin|mesh-list
6334956|NCT00019422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6334957|NCT00019435|Immunotoxins|immunotoxins|mesh-list
6334958|NCT00019435|Immunologic Factors|immunologic factors|mesh-ancestor
6334959|NCT00019435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334960|NCT00019448|Interleukin-2|interleukin-2|mesh-list
6334961|NCT00019448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6334962|NCT00019448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6334963|NCT00019448|Analgesics|analgesics|mesh-ancestor
6334964|NCT00019448|Sensory System Agents|sensory system agents|mesh-ancestor
6334965|NCT00019448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6334966|NCT00019448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334967|NCT00019461|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
6334968|NCT00019461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6334969|NCT00019461|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6334970|NCT00019461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6334971|NCT00019461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6334972|NCT00019461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6334973|NCT00019461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334974|NCT00019474|Interferons|interferons|mesh-list
6334975|NCT00019474|Interferon-alpha|interferon-alpha|mesh-list
6334976|NCT00019474|Fluorouracil|fluorouracil|mesh-list
6334977|NCT00019474|Hydroxyurea|hydroxyurea|mesh-list
6334978|NCT00019474|Antimetabolites|antimetabolites|mesh-ancestor
6334979|NCT00019474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6334980|NCT00019474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6334981|NCT00019474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6334982|NCT00019474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6334983|NCT00019474|Immunologic Factors|immunologic factors|mesh-ancestor
6334984|NCT00019474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6334985|NCT00019474|Antiviral Agents|antiviral agents|mesh-ancestor
6334986|NCT00019474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6334987|NCT00019474|Antisickling Agents|antisickling agents|mesh-ancestor
6334988|NCT00019474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6334989|NCT00019474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6334990|NCT00019487|Aldesleukin|aldesleukin|mesh-list
6334991|NCT00019487|Freund's Adjuvant|freund's adjuvant|mesh-list
6334992|NCT00019487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6334993|NCT00019487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6334994|NCT00019487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6334995|NCT00019487|Antiviral Agents|antiviral agents|mesh-ancestor
6334996|NCT00019487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6334997|NCT00019487|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6334998|NCT00019487|Immunologic Factors|immunologic factors|mesh-ancestor
6334999|NCT00019487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6335000|NCT00019500|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
6335001|NCT00019500|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6335002|NCT00019500|Hormone Antagonists|hormone antagonists|mesh-ancestor
6335003|NCT00019500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6335004|NCT00019500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6335005|NCT00019500|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6335006|NCT00019500|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6335007|NCT00019500|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6335008|NCT00019513|Leucovorin|leucovorin|mesh-list
6335009|NCT00019513|Gemcitabine|gemcitabine|mesh-list
6335010|NCT00019513|Fluorouracil|fluorouracil|mesh-list
6335011|NCT00019513|Calcium|calcium|mesh-list
6335012|NCT00019513|Levoleucovorin|levoleucovorin|mesh-list
6335013|NCT00019513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6335014|NCT00019513|Antimetabolites|antimetabolites|mesh-ancestor
6335015|NCT00019513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6335016|NCT00019513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335017|NCT00019513|Antiviral Agents|antiviral agents|mesh-ancestor
6335018|NCT00019513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6335019|NCT00019513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6335020|NCT00019513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6335021|NCT00019513|Immunologic Factors|immunologic factors|mesh-ancestor
6335022|NCT00019513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6335023|NCT00019513|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6335024|NCT00019513|Antidotes|antidotes|mesh-ancestor
6335025|NCT00019513|Protective Agents|protective agents|mesh-ancestor
6335026|NCT00019513|Vitamin B Complex|vitamin b complex|mesh-ancestor
6335027|NCT00019513|Vitamins|vitamins|mesh-ancestor
6335028|NCT00019513|Micronutrients|micronutrients|mesh-ancestor
6335029|NCT00019539|Thalidomide|thalidomide|mesh-list
6335030|NCT00019539|Bevacizumab|bevacizumab|mesh-list
6335031|NCT00019539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6335032|NCT00019539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335033|NCT00019539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6335034|NCT00019539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6335035|NCT00019539|Growth Substances|growth substances|mesh-ancestor
6335036|NCT00019539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6335037|NCT00019539|Growth Inhibitors|growth inhibitors|mesh-ancestor
6335038|NCT00019539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6335039|NCT00019539|Immunologic Factors|immunologic factors|mesh-ancestor
6335040|NCT00019539|Leprostatic Agents|leprostatic agents|mesh-ancestor
6335041|NCT00019539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6335042|NCT00019539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6335043|NCT00019552|Irofulven|irofulven|mesh-list
6335044|NCT00019552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6335045|NCT00019552|Alkylating Agents|alkylating agents|mesh-ancestor
6335046|NCT00019552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6335047|NCT00019552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335048|NCT00019565|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6335049|NCT00019565|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6335050|NCT00019565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6335051|NCT00019591|Aldesleukin|aldesleukin|mesh-list
6335052|NCT00019591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335053|NCT00019591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6335054|NCT00019591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6335055|NCT00019591|Antiviral Agents|antiviral agents|mesh-ancestor
6335056|NCT00019591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6335057|NCT00019630|Doxorubicin|doxorubicin|mesh-list
6335058|NCT00019630|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6335059|NCT00019630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6335060|NCT00019630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335061|NCT00019630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6335062|NCT00019630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6335063|NCT00019630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6335064|NCT00019630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6335065|NCT00019669|Aldesleukin|aldesleukin|mesh-list
6335066|NCT00019669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335067|NCT00019669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6335068|NCT00019669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6335069|NCT00019669|Antiviral Agents|antiviral agents|mesh-ancestor
6335070|NCT00019669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6335071|NCT00019695|Alendronate|alendronate|mesh-list
6335072|NCT00019695|Ketoconazole|ketoconazole|mesh-list
6335073|NCT00019695|Antifungal Agents|antifungal agents|mesh-ancestor
6335074|NCT00019695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6335075|NCT00019695|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6335076|NCT00019695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6335077|NCT00019695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6335078|NCT00019695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6335079|NCT00019695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6335080|NCT00019695|Hormone Antagonists|hormone antagonists|mesh-ancestor
6335081|NCT00019695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6335082|NCT00019695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6335083|NCT00019695|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6335084|NCT00019695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6335085|NCT00019721|Aldesleukin|aldesleukin|mesh-list
6335086|NCT00019721|Freund's Adjuvant|freund's adjuvant|mesh-list
6335087|NCT00019721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335088|NCT00019721|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6335089|NCT00019721|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6335090|NCT00019721|Antiviral Agents|antiviral agents|mesh-ancestor
6335091|NCT00019721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6335092|NCT00019721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6335093|NCT00019721|Immunologic Factors|immunologic factors|mesh-ancestor
6335094|NCT00019721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6335095|NCT00019734|Aldesleukin|aldesleukin|mesh-list
6335096|NCT00019734|Vaccines|vaccines|mesh-list
6335097|NCT00019734|Immunologic Factors|immunologic factors|mesh-ancestor
6335098|NCT00019734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6335099|NCT00019734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335100|NCT00019734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6335101|NCT00019734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6335102|NCT00019734|Antiviral Agents|antiviral agents|mesh-ancestor
6335103|NCT00019734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6335104|NCT00019760|Leucovorin|leucovorin|mesh-list
6335105|NCT00019760|Melphalan|melphalan|mesh-list
6335106|NCT00019760|Floxuridine|floxuridine|mesh-list
6335107|NCT00019760|Calcium|calcium|mesh-list
6335108|NCT00019760|Levoleucovorin|levoleucovorin|mesh-list
6335109|NCT00019760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6335110|NCT00019760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6335111|NCT00019760|Antidotes|antidotes|mesh-ancestor
6335112|NCT00019760|Protective Agents|protective agents|mesh-ancestor
6335113|NCT00019760|Vitamin B Complex|vitamin b complex|mesh-ancestor
6335114|NCT00019760|Vitamins|vitamins|mesh-ancestor
6335115|NCT00019760|Micronutrients|micronutrients|mesh-ancestor
6335116|NCT00019760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6335117|NCT00019760|Alkylating Agents|alkylating agents|mesh-ancestor
6335118|NCT00019760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6335119|NCT00019760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335120|NCT00019760|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6335121|NCT00019760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6335122|NCT00019760|Immunologic Factors|immunologic factors|mesh-ancestor
6335123|NCT00019760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6335124|NCT00019760|Antimetabolites|antimetabolites|mesh-ancestor
6335125|NCT00019773|Capecitabine|capecitabine|mesh-list
6335126|NCT00019773|Oxaliplatin|oxaliplatin|mesh-list
6335127|NCT00019773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6335128|NCT00019773|Antimetabolites|antimetabolites|mesh-ancestor
6335129|NCT00019773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6335130|NCT00019773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335131|NCT00019786|Melphalan|melphalan|mesh-list
6335132|NCT00019786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6335133|NCT00019786|Alkylating Agents|alkylating agents|mesh-ancestor
6335134|NCT00019786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6335135|NCT00019786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335136|NCT00019786|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6335137|NCT00019786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6335138|NCT00019786|Immunologic Factors|immunologic factors|mesh-ancestor
6335139|NCT00019786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6335140|NCT00019812|Paclitaxel|paclitaxel|mesh-list
6335141|NCT00019812|Trastuzumab|trastuzumab|mesh-list
6335142|NCT00019812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6335143|NCT00019812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335144|NCT00019812|Tubulin Modulators|tubulin modulators|mesh-ancestor
6335145|NCT00019812|Antimitotic Agents|antimitotic agents|mesh-ancestor
6335146|NCT00019812|Mitosis Modulators|mitosis modulators|mesh-ancestor
6335147|NCT00019812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6335148|NCT00019812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6335149|NCT00019825|Decitabine|decitabine|mesh-list
6335150|NCT00019825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6016660|NCT00366457|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6016661|NCT00366457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6335151|NCT00019825|Antimetabolites|antimetabolites|mesh-ancestor
6335152|NCT00019825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6335153|NCT00019825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335154|NCT00019825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6335155|NCT00019838|Fludarabine|fludarabine|mesh-list
6335156|NCT00019838|Fludarabine phosphate|fludarabine phosphate|mesh-list
6335157|NCT00019838|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
6335158|NCT00019838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335159|NCT00019838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6335160|NCT00019838|Antimetabolites|antimetabolites|mesh-ancestor
6335161|NCT00019838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6335162|NCT00019838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6335163|NCT00019838|Immunologic Factors|immunologic factors|mesh-ancestor
6335164|NCT00019838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6335165|NCT00019838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6335166|NCT00019838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6335167|NCT00019864|Leucovorin|leucovorin|mesh-list
6335168|NCT00019864|Doxorubicin|doxorubicin|mesh-list
6335169|NCT00019864|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6335170|NCT00019864|Methotrexate|methotrexate|mesh-list
6335171|NCT00019864|Dexrazoxane|dexrazoxane|mesh-list
6335172|NCT00019864|Razoxane|razoxane|mesh-list
6335173|NCT00019864|Calcium|calcium|mesh-list
6335174|NCT00019864|Levoleucovorin|levoleucovorin|mesh-list
6335175|NCT00019864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335176|NCT00019864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6335177|NCT00019864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6335178|NCT00019864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6335179|NCT00019864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6335180|NCT00019864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6335181|NCT00019864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6335182|NCT00019864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6335183|NCT00019864|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6335184|NCT00019864|Abortifacient Agents|abortifacient agents|mesh-ancestor
6335185|NCT00019864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6335186|NCT00019864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6335187|NCT00019864|Antimetabolites|antimetabolites|mesh-ancestor
6335188|NCT00019864|Dermatologic Agents|dermatologic agents|mesh-ancestor
6335189|NCT00019864|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6335190|NCT00019864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6335191|NCT00019864|Immunologic Factors|immunologic factors|mesh-ancestor
6335192|NCT00019864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6335193|NCT00019864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6335194|NCT00019864|Antidotes|antidotes|mesh-ancestor
6335195|NCT00019864|Protective Agents|protective agents|mesh-ancestor
6335196|NCT00019864|Vitamin B Complex|vitamin b complex|mesh-ancestor
6335197|NCT00019864|Vitamins|vitamins|mesh-ancestor
6335198|NCT00019864|Micronutrients|micronutrients|mesh-ancestor
6335199|NCT00019864|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6335200|NCT00019864|Antimitotic Agents|antimitotic agents|mesh-ancestor
6335201|NCT00019864|Mitosis Modulators|mitosis modulators|mesh-ancestor
6335202|NCT00019890|Sargramostim|sargramostim|mesh-list
6335203|NCT00019890|Immunologic Factors|immunologic factors|mesh-ancestor
6335204|NCT00019890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6335205|NCT00019916|Aldesleukin|aldesleukin|mesh-list
6335206|NCT00019916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335207|NCT00019916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6335208|NCT00019916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6335209|NCT00019916|Antiviral Agents|antiviral agents|mesh-ancestor
6335210|NCT00019916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6335211|NCT00019968|Melphalan|melphalan|mesh-list
6335212|NCT00019968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6335213|NCT00019968|Alkylating Agents|alkylating agents|mesh-ancestor
6335214|NCT00019968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6335215|NCT00019968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335216|NCT00019968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6335217|NCT00019968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6335218|NCT00019968|Immunologic Factors|immunologic factors|mesh-ancestor
6335219|NCT00019968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6335220|NCT00019994|Aldesleukin|aldesleukin|mesh-list
6335221|NCT00019994|Freund's Adjuvant|freund's adjuvant|mesh-list
6335222|NCT00019994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335223|NCT00019994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6335224|NCT00019994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6335225|NCT00019994|Antiviral Agents|antiviral agents|mesh-ancestor
6335226|NCT00019994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6335227|NCT00019994|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6335228|NCT00019994|Immunologic Factors|immunologic factors|mesh-ancestor
6335229|NCT00019994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6335230|NCT00020007|Paclitaxel|paclitaxel|mesh-list
6335231|NCT00020007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6335232|NCT00020007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335233|NCT00020007|Tubulin Modulators|tubulin modulators|mesh-ancestor
6335234|NCT00020007|Antimitotic Agents|antimitotic agents|mesh-ancestor
6335235|NCT00020007|Mitosis Modulators|mitosis modulators|mesh-ancestor
6335236|NCT00020007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6335237|NCT00020046|Thalidomide|thalidomide|mesh-list
6335238|NCT00020046|Docetaxel|docetaxel|mesh-list
6335239|NCT00020046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335240|NCT00020046|Tubulin Modulators|tubulin modulators|mesh-ancestor
6335241|NCT00020046|Antimitotic Agents|antimitotic agents|mesh-ancestor
6335242|NCT00020046|Mitosis Modulators|mitosis modulators|mesh-ancestor
6335243|NCT00020046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6335244|NCT00020046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6335245|NCT00020046|Immunologic Factors|immunologic factors|mesh-ancestor
6335246|NCT00020046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6335247|NCT00020046|Leprostatic Agents|leprostatic agents|mesh-ancestor
6335248|NCT00020046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6335249|NCT00020046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6335250|NCT00020046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6335251|NCT00020046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6335252|NCT00020046|Growth Substances|growth substances|mesh-ancestor
6335253|NCT00020046|Growth Inhibitors|growth inhibitors|mesh-ancestor
6335254|NCT00020111|Arsenic Trioxide|arsenic trioxide|mesh-list
6335255|NCT00020111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335256|NCT00020124|Doxorubicin|doxorubicin|mesh-list
6335257|NCT00020124|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6335258|NCT00020124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6335259|NCT00020124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335260|NCT00020124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6335261|NCT00020124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6335262|NCT00020124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6335263|NCT00020124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6335264|NCT00020150|Temozolomide|temozolomide|mesh-list
6335265|NCT00020150|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
6335266|NCT00020150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6335267|NCT00020150|Alkylating Agents|alkylating agents|mesh-ancestor
6335268|NCT00020150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6335269|NCT00020150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335270|NCT00020150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6335271|NCT00020176|Cyclosporine|cyclosporine|mesh-list
6335272|NCT00020176|Cyclophosphamide|cyclophosphamide|mesh-list
6335273|NCT00020176|Fludarabine|fludarabine|mesh-list
6335274|NCT00020176|Fludarabine phosphate|fludarabine phosphate|mesh-list
6335275|NCT00020176|Cyclosporins|cyclosporins|mesh-list
6335276|NCT00020176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6335277|NCT00020176|Immunologic Factors|immunologic factors|mesh-ancestor
6335278|NCT00020176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6335279|NCT00020176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6335280|NCT00020176|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6335281|NCT00020176|Alkylating Agents|alkylating agents|mesh-ancestor
6335282|NCT00020176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6335283|NCT00020176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335284|NCT00020176|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6335285|NCT00020176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6335286|NCT00020176|Antimetabolites|antimetabolites|mesh-ancestor
6335287|NCT00020176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6335288|NCT00020176|Antifungal Agents|antifungal agents|mesh-ancestor
6335289|NCT00020176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6335290|NCT00020176|Dermatologic Agents|dermatologic agents|mesh-ancestor
6335291|NCT00020176|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6335292|NCT00020189|Aspirin|aspirin|mesh-list
6335293|NCT00020189|Alvocidib|alvocidib|mesh-list
6335294|NCT00020189|Clopidogrel|clopidogrel|mesh-list
6335295|NCT00020189|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6335296|NCT00020189|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6335297|NCT00020189|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6335298|NCT00020189|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6335299|NCT00020189|Purinergic Agents|purinergic agents|mesh-ancestor
6335300|NCT00020189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6335301|NCT00020189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6335302|NCT00020189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6335303|NCT00020189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6335304|NCT00020189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6335305|NCT00020189|Analgesics|analgesics|mesh-ancestor
6335306|NCT00020189|Sensory System Agents|sensory system agents|mesh-ancestor
6335307|NCT00020189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6335308|NCT00020189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6335309|NCT00020189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6335310|NCT00020189|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6335311|NCT00020189|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6335312|NCT00020189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6335313|NCT00020189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6335314|NCT00020189|Antipyretics|antipyretics|mesh-ancestor
6335315|NCT00020189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335316|NCT00020189|Growth Inhibitors|growth inhibitors|mesh-ancestor
6335317|NCT00020189|Growth Substances|growth substances|mesh-ancestor
6335318|NCT00020189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6335319|NCT00020202|Romidepsin|romidepsin|mesh-list
6335320|NCT00020202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6335321|NCT00020202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335322|NCT00020254|Aldesleukin|aldesleukin|mesh-list
6335323|NCT00020254|Nilutamide|nilutamide|mesh-list
6335324|NCT00020254|Vaccines|vaccines|mesh-list
6335325|NCT00020254|Sargramostim|sargramostim|mesh-list
6335326|NCT00020254|Immunologic Factors|immunologic factors|mesh-ancestor
6335327|NCT00020254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6335328|NCT00020254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335329|NCT00020254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6335330|NCT00020254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6335331|NCT00020254|Antiviral Agents|antiviral agents|mesh-ancestor
6335332|NCT00020254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6335333|NCT00020254|Androgen Antagonists|androgen antagonists|mesh-ancestor
6335334|NCT00020254|Hormone Antagonists|hormone antagonists|mesh-ancestor
6335335|NCT00020254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6335336|NCT00020267|Interleukin-2|interleukin-2|mesh-list
6335337|NCT00020267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335338|NCT00020267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6335339|NCT00020267|Analgesics|analgesics|mesh-ancestor
6335340|NCT00020267|Sensory System Agents|sensory system agents|mesh-ancestor
6335341|NCT00020267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6335342|NCT00020267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6335343|NCT00020332|Docetaxel|docetaxel|mesh-list
6335344|NCT00020332|Alvocidib|alvocidib|mesh-list
6335345|NCT00020332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335346|NCT00020332|Tubulin Modulators|tubulin modulators|mesh-ancestor
6335347|NCT00020332|Antimitotic Agents|antimitotic agents|mesh-ancestor
6335348|NCT00020332|Mitosis Modulators|mitosis modulators|mesh-ancestor
6335349|NCT00020332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6335350|NCT00020332|Growth Inhibitors|growth inhibitors|mesh-ancestor
6335351|NCT00020332|Growth Substances|growth substances|mesh-ancestor
6335352|NCT00020332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6335353|NCT00020332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6335354|NCT00020332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6335355|NCT00020345|Gemcitabine|gemcitabine|mesh-list
6335356|NCT00020345|Fluorouracil|fluorouracil|mesh-list
6335357|NCT00020345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6335358|NCT00020345|Antimetabolites|antimetabolites|mesh-ancestor
6335359|NCT00020345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6335360|NCT00020345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335361|NCT00020345|Antiviral Agents|antiviral agents|mesh-ancestor
6335362|NCT00020345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6335363|NCT00020345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6335364|NCT00020345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6335365|NCT00020345|Immunologic Factors|immunologic factors|mesh-ancestor
6335366|NCT00020345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6335367|NCT00020358|Aldesleukin|aldesleukin|mesh-list
6335368|NCT00020358|Freund's Adjuvant|freund's adjuvant|mesh-list
6335369|NCT00020358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335370|NCT00020358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6335371|NCT00020358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6335372|NCT00020358|Antiviral Agents|antiviral agents|mesh-ancestor
6335373|NCT00020358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6335374|NCT00020358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6335375|NCT00020358|Immunologic Factors|immunologic factors|mesh-ancestor
6335376|NCT00020358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6335377|NCT00020371|Lenograstim|lenograstim|mesh-list
6335378|NCT00020371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6335379|NCT00020371|Immunologic Factors|immunologic factors|mesh-ancestor
6335380|NCT00020371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6335381|NCT00020397|Aldesleukin|aldesleukin|mesh-list
6335382|NCT00020397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335383|NCT00020397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6335384|NCT00020397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6335385|NCT00020397|Antiviral Agents|antiviral agents|mesh-ancestor
6335386|NCT00020397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6335387|NCT00020410|Antibodies|antibodies|mesh-list
6335388|NCT00020410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6335389|NCT00020410|Immunologic Factors|immunologic factors|mesh-ancestor
6335390|NCT00020410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6335391|NCT00020449|Paclitaxel|paclitaxel|mesh-list
6335392|NCT00020449|Doxorubicin|doxorubicin|mesh-list
6335393|NCT00020449|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6335394|NCT00020449|Interleukin-12|interleukin-12|mesh-list
6335395|NCT00020449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6335396|NCT00020449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335397|NCT00020449|Tubulin Modulators|tubulin modulators|mesh-ancestor
6335398|NCT00020449|Antimitotic Agents|antimitotic agents|mesh-ancestor
6335399|NCT00020449|Mitosis Modulators|mitosis modulators|mesh-ancestor
6335400|NCT00020449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6335401|NCT00020449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6335402|NCT00020449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6335403|NCT00020449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6335404|NCT00020449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6335405|NCT00020449|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6335406|NCT00020449|Immunologic Factors|immunologic factors|mesh-ancestor
6335407|NCT00020449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6335408|NCT00020449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6335409|NCT00020449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6335410|NCT00020449|Growth Substances|growth substances|mesh-ancestor
6335411|NCT00020449|Growth Inhibitors|growth inhibitors|mesh-ancestor
6335412|NCT00020462|Aldesleukin|aldesleukin|mesh-list
6335413|NCT00020462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335414|NCT00020462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6335415|NCT00020462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6335416|NCT00020462|Antiviral Agents|antiviral agents|mesh-ancestor
6335417|NCT00020462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6335418|NCT00020475|Interleukin-2|interleukin-2|mesh-list
6335419|NCT00020475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335420|NCT00020475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6335421|NCT00020475|Analgesics|analgesics|mesh-ancestor
6335422|NCT00020475|Sensory System Agents|sensory system agents|mesh-ancestor
6335423|NCT00020475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6335424|NCT00020475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6335425|NCT00020488|Leucovorin|leucovorin|mesh-list
6335426|NCT00020488|Fluorouracil|fluorouracil|mesh-list
6335427|NCT00020488|Irinotecan|irinotecan|mesh-list
6335428|NCT00020488|Calcium|calcium|mesh-list
6335429|NCT00020488|Levoleucovorin|levoleucovorin|mesh-list
6335430|NCT00020488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6335431|NCT00020488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6335432|NCT00020488|Antimetabolites|antimetabolites|mesh-ancestor
6335433|NCT00020488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6335434|NCT00020488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6335435|NCT00020488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335436|NCT00020488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6335437|NCT00020488|Immunologic Factors|immunologic factors|mesh-ancestor
6335438|NCT00020488|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6335439|NCT00020488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6335440|NCT00020488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6335441|NCT00020488|Antidotes|antidotes|mesh-ancestor
6335442|NCT00020488|Protective Agents|protective agents|mesh-ancestor
6335443|NCT00020488|Vitamin B Complex|vitamin b complex|mesh-ancestor
6335444|NCT00020488|Vitamins|vitamins|mesh-ancestor
6335445|NCT00020488|Micronutrients|micronutrients|mesh-ancestor
6335446|NCT00020501|Leucovorin|leucovorin|mesh-list
6335447|NCT00020501|Fluorouracil|fluorouracil|mesh-list
6335448|NCT00020501|Floxuridine|floxuridine|mesh-list
6335449|NCT00020501|Irinotecan|irinotecan|mesh-list
6335450|NCT00020501|Melphalan|melphalan|mesh-list
6335451|NCT00020501|Calcium|calcium|mesh-list
6335452|NCT00020501|Levoleucovorin|levoleucovorin|mesh-list
6335453|NCT00020501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6335454|NCT00020501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6335455|NCT00020501|Antimetabolites|antimetabolites|mesh-ancestor
6335456|NCT00020501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6335457|NCT00020501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6335458|NCT00020501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335459|NCT00020501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6335460|NCT00020501|Immunologic Factors|immunologic factors|mesh-ancestor
6335461|NCT00020501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6335462|NCT00020501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6335463|NCT00020501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6335464|NCT00020501|Antidotes|antidotes|mesh-ancestor
6335465|NCT00020501|Protective Agents|protective agents|mesh-ancestor
6335466|NCT00020501|Vitamin B Complex|vitamin b complex|mesh-ancestor
6335467|NCT00020501|Vitamins|vitamins|mesh-ancestor
6335468|NCT00020501|Micronutrients|micronutrients|mesh-ancestor
6335469|NCT00020501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6335470|NCT00020501|Alkylating Agents|alkylating agents|mesh-ancestor
6335471|NCT00020501|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6335472|NCT00020527|Caspofungin|caspofungin|mesh-list
6335473|NCT00020527|Antifungal Agents|antifungal agents|mesh-ancestor
6335474|NCT00020527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6335475|NCT00020527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6335476|NCT00020527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6335477|NCT00020540|Flt3 ligand protein|flt3 ligand protein|mesh-list
6335478|NCT00020540|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6335479|NCT00020540|Immunologic Factors|immunologic factors|mesh-ancestor
6335480|NCT00020540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6335481|NCT00020540|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6335482|NCT00020540|Protective Agents|protective agents|mesh-ancestor
6335483|NCT00020566|Dactinomycin|dactinomycin|mesh-list
6335484|NCT00020566|Doxorubicin|doxorubicin|mesh-list
6335485|NCT00020566|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6335486|NCT00020566|Etoposide|etoposide|mesh-list
6335487|NCT00020566|Vincristine|vincristine|mesh-list
6335488|NCT00020566|Melphalan|melphalan|mesh-list
6335489|NCT00020566|Busulfan|busulfan|mesh-list
6335490|NCT00020566|Ifosfamide|ifosfamide|mesh-list
6335491|NCT00020566|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6335492|NCT00020566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335493|NCT00020566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6335494|NCT00020566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6335495|NCT00020566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6335496|NCT00020566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6335497|NCT00020566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6335498|NCT00020566|Tubulin Modulators|tubulin modulators|mesh-ancestor
6335499|NCT00020566|Antimitotic Agents|antimitotic agents|mesh-ancestor
6335500|NCT00020566|Mitosis Modulators|mitosis modulators|mesh-ancestor
6335501|NCT00020566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6335502|NCT00020566|Alkylating Agents|alkylating agents|mesh-ancestor
6335503|NCT00020566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6335504|NCT00020566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6335505|NCT00020566|Immunologic Factors|immunologic factors|mesh-ancestor
6335506|NCT00020566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6335507|NCT00020566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6335508|NCT00020566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6335509|NCT00020566|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6335510|NCT00020566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6335511|NCT00020579|Entinostat|entinostat|mesh-list
6335512|NCT00020579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335513|NCT00020579|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6335514|NCT00020579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6335515|NCT00020579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6335516|NCT00020605|Naloxone|naloxone|mesh-list
6335517|NCT00020605|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6335518|NCT00020605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6335519|NCT00020605|Sensory System Agents|sensory system agents|mesh-ancestor
6335520|NCT00020605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6335521|NCT00020618|Morphine|morphine|mesh-list
6335522|NCT00020618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6335523|NCT00020618|Narcotics|narcotics|mesh-ancestor
6335524|NCT00020618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6335525|NCT00020618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6335526|NCT00020618|Analgesics|analgesics|mesh-ancestor
6335527|NCT00020618|Sensory System Agents|sensory system agents|mesh-ancestor
6335528|NCT00020618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6335529|NCT00020631|Pirfenidone|pirfenidone|mesh-list
6335530|NCT00020631|Analgesics|analgesics|mesh-ancestor
6335531|NCT00020631|Sensory System Agents|sensory system agents|mesh-ancestor
6335532|NCT00020631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6335533|NCT00020631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6335534|NCT00020631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6335535|NCT00020631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6335536|NCT00020631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6335537|NCT00020631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6335538|NCT00020631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335539|NCT00020644|Gemcitabine|gemcitabine|mesh-list
6335540|NCT00020644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6335541|NCT00020644|Antimetabolites|antimetabolites|mesh-ancestor
6335542|NCT00020644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6335543|NCT00020644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335544|NCT00020644|Antiviral Agents|antiviral agents|mesh-ancestor
6335545|NCT00020644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6335546|NCT00020644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6335547|NCT00020644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6335548|NCT00020644|Immunologic Factors|immunologic factors|mesh-ancestor
6335549|NCT00020644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6335550|NCT00020657|Ondansetron|ondansetron|mesh-list
6335551|NCT00020657|Granisetron|granisetron|mesh-list
6335552|NCT00020657|Prochlorperazine|prochlorperazine|mesh-list
6335553|NCT00020657|Dolasetron|dolasetron|mesh-list
6335554|NCT00020657|Antiemetics|antiemetics|mesh-ancestor
6335555|NCT00020657|Autonomic Agents|autonomic agents|mesh-ancestor
6335556|NCT00020657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6335557|NCT00020657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6335558|NCT00020657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6335559|NCT00020657|Antipruritics|antipruritics|mesh-ancestor
6335560|NCT00020657|Dermatologic Agents|dermatologic agents|mesh-ancestor
6335561|NCT00020657|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6335562|NCT00020657|Serotonin Agents|serotonin agents|mesh-ancestor
6335563|NCT00020657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6335564|NCT00020657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6335565|NCT00020657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6335566|NCT00020657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6335567|NCT00020657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6335568|NCT00020657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6335569|NCT00020657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6335570|NCT00020657|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6335571|NCT00020657|Dopamine Agents|dopamine agents|mesh-ancestor
6335572|NCT00020670|Vaccines|vaccines|mesh-list
6335573|NCT00020670|Immunologic Factors|immunologic factors|mesh-ancestor
6335574|NCT00020670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6335575|NCT00020696|Tirapazamine|tirapazamine|mesh-list
6335576|NCT00020696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335577|NCT00020709|Docetaxel|docetaxel|mesh-list
6335578|NCT00020709|Etoposide|etoposide|mesh-list
6335579|NCT00020709|Etoposide phosphate|etoposide phosphate|mesh-list
6335580|NCT00020709|Gefitinib|gefitinib|mesh-list
6335581|NCT00020709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335582|NCT00020709|Tubulin Modulators|tubulin modulators|mesh-ancestor
6335583|NCT00020709|Antimitotic Agents|antimitotic agents|mesh-ancestor
6335584|NCT00020709|Mitosis Modulators|mitosis modulators|mesh-ancestor
6335585|NCT00020709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6335586|NCT00020709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6335587|NCT00020709|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6335588|NCT00020709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6335589|NCT00020709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6335590|NCT00020709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6335591|NCT00020735|Toremifene|toremifene|mesh-list
6335592|NCT00020735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6335593|NCT00020735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335594|NCT00020735|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6335595|NCT00020735|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6335596|NCT00020735|Hormone Antagonists|hormone antagonists|mesh-ancestor
6335597|NCT00020735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6335598|NCT00020735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6335599|NCT00020735|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6335600|NCT00020748|Irinotecan|irinotecan|mesh-list
6335601|NCT00020748|Epirubicin|epirubicin|mesh-list
6335602|NCT00020748|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6335603|NCT00020748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6335604|NCT00020748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6335605|NCT00020748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6335606|NCT00020748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335607|NCT00020748|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6335608|NCT00020748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6335609|NCT00020761|Paclitaxel|paclitaxel|mesh-list
6335610|NCT00020761|Irinotecan|irinotecan|mesh-list
6335611|NCT00020761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6335612|NCT00020761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335613|NCT00020761|Tubulin Modulators|tubulin modulators|mesh-ancestor
6335614|NCT00020761|Antimitotic Agents|antimitotic agents|mesh-ancestor
6335615|NCT00020761|Mitosis Modulators|mitosis modulators|mesh-ancestor
6335616|NCT00020761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6335617|NCT00020761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6335618|NCT00020761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6335619|NCT00020761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6335620|NCT00020774|Gemcitabine|gemcitabine|mesh-list
6335621|NCT00020774|Lonafarnib|lonafarnib|mesh-list
6335622|NCT00020774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6335623|NCT00020774|Antimetabolites|antimetabolites|mesh-ancestor
6335624|NCT00020774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6335625|NCT00020774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335626|NCT00020774|Antiviral Agents|antiviral agents|mesh-ancestor
6335627|NCT00020774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6335628|NCT00020774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6335629|NCT00020774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6335630|NCT00020774|Immunologic Factors|immunologic factors|mesh-ancestor
6335631|NCT00020774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6335632|NCT00020787|Cisplatin|cisplatin|mesh-list
6335633|NCT00020787|Fluorouracil|fluorouracil|mesh-list
6335634|NCT00020787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335635|NCT00020787|Antimetabolites|antimetabolites|mesh-ancestor
6335636|NCT00020787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6335637|NCT00020787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6335638|NCT00020787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6335639|NCT00020787|Immunologic Factors|immunologic factors|mesh-ancestor
6335640|NCT00020787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6335641|NCT00020800|Rituximab|rituximab|mesh-list
6335642|NCT00020800|Fludarabine|fludarabine|mesh-list
6335643|NCT00020800|Fludarabine phosphate|fludarabine phosphate|mesh-list
6335644|NCT00020800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6335645|NCT00020800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335646|NCT00020800|Immunologic Factors|immunologic factors|mesh-ancestor
6335647|NCT00020800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6335648|NCT00020800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6335649|NCT00020800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6335650|NCT00020800|Antimetabolites|antimetabolites|mesh-ancestor
6335651|NCT00020800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6335652|NCT00020800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6335653|NCT00020839|Temozolomide|temozolomide|mesh-list
6335654|NCT00020839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6335655|NCT00020839|Alkylating Agents|alkylating agents|mesh-ancestor
6335656|NCT00020839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6335657|NCT00020839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335658|NCT00020865|Levofloxacin|levofloxacin|mesh-list
6335659|NCT00020865|Ofloxacin|ofloxacin|mesh-list
6335660|NCT00020865|Cefepime|cefepime|mesh-list
6335661|NCT00020865|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6335662|NCT00020865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6335663|NCT00020865|Renal Agents|renal agents|mesh-ancestor
6335664|NCT00020865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6335665|NCT00020865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6335666|NCT00020865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6335667|NCT00020865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6335668|NCT00020865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6335669|NCT00020865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335670|NCT00020865|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6335671|NCT00020865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6335672|NCT00020878|Celecoxib|celecoxib|mesh-list
6335673|NCT00020878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6335674|NCT00020878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6335675|NCT00020878|Analgesics|analgesics|mesh-ancestor
6335676|NCT00020878|Sensory System Agents|sensory system agents|mesh-ancestor
6335677|NCT00020878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6335678|NCT00020878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6335679|NCT00020878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6335680|NCT00020878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6335681|NCT00020878|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6335682|NCT00020878|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6335683|NCT00020878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6335684|NCT00020878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6335685|NCT00020917|Leucovorin|leucovorin|mesh-list
6335686|NCT00020917|Fluorouracil|fluorouracil|mesh-list
6335687|NCT00020917|Irinotecan|irinotecan|mesh-list
6335688|NCT00020917|Cetuximab|cetuximab|mesh-list
6335689|NCT00020917|Calcium|calcium|mesh-list
6335690|NCT00020917|Levoleucovorin|levoleucovorin|mesh-list
6335691|NCT00020917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6335692|NCT00020917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6335693|NCT00020917|Antimetabolites|antimetabolites|mesh-ancestor
6335694|NCT00020917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6335695|NCT00020917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6335696|NCT00020917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335697|NCT00020917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6335698|NCT00020917|Immunologic Factors|immunologic factors|mesh-ancestor
6335699|NCT00020917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6335700|NCT00020917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6335701|NCT00020917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6335702|NCT00020917|Antidotes|antidotes|mesh-ancestor
6335703|NCT00020917|Protective Agents|protective agents|mesh-ancestor
6335704|NCT00020917|Vitamin B Complex|vitamin b complex|mesh-ancestor
6335705|NCT00020917|Vitamins|vitamins|mesh-ancestor
6335706|NCT00020917|Micronutrients|micronutrients|mesh-ancestor
6335707|NCT00020917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6335708|NCT00020930|Cetuximab|cetuximab|mesh-list
6335709|NCT00020930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6335710|NCT00020930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6393562|NCT00199186|Cyclophosphamide|cyclophosphamide|mesh-list
6393563|NCT00199186|Methotrexate|methotrexate|mesh-list
6393564|NCT00199186|Vincristine|vincristine|mesh-list
6393565|NCT00199186|Imatinib Mesylate|imatinib mesylate|mesh-list
6393566|NCT00199186|Idarubicin|idarubicin|mesh-list
6393567|NCT00199186|BB 1101|bb 1101|mesh-list
6393568|NCT00199186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6393569|NCT00199186|Immunologic Factors|immunologic factors|mesh-ancestor
6393570|NCT00199186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6393571|NCT00199186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6393572|NCT00199186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6393573|NCT00199186|Alkylating Agents|alkylating agents|mesh-ancestor
6393574|NCT00199186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393575|NCT00199186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6393576|NCT00199186|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6393577|NCT00199186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6393578|NCT00199186|Antiemetics|antiemetics|mesh-ancestor
6393579|NCT00199186|Autonomic Agents|autonomic agents|mesh-ancestor
6393580|NCT00199186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6393581|NCT00199186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6393582|NCT00199186|Glucocorticoids|glucocorticoids|mesh-ancestor
6393583|NCT00199186|Hormones|hormones|mesh-ancestor
6393584|NCT00199186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6393585|NCT00199186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6393586|NCT00199186|Protease Inhibitors|protease inhibitors|mesh-ancestor
6393587|NCT00199186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6393588|NCT00199186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6393589|NCT00199186|Abortifacient Agents|abortifacient agents|mesh-ancestor
6393590|NCT00199186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6393591|NCT00199186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6393592|NCT00199186|Antimetabolites|antimetabolites|mesh-ancestor
6335711|NCT00020943|Leucovorin|leucovorin|mesh-list
6335712|NCT00020943|Cytarabine|cytarabine|mesh-list
6335713|NCT00020943|Prednisone|prednisone|mesh-list
6335714|NCT00020943|Cyclophosphamide|cyclophosphamide|mesh-list
6335715|NCT00020943|Carmustine|carmustine|mesh-list
6335716|NCT00020943|Rituximab|rituximab|mesh-list
6335717|NCT00020943|Doxorubicin|doxorubicin|mesh-list
6335718|NCT00020943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6335719|NCT00020943|Methotrexate|methotrexate|mesh-list
6335720|NCT00020943|Etoposide|etoposide|mesh-list
6335721|NCT00020943|Vincristine|vincristine|mesh-list
6335722|NCT00020943|Levoleucovorin|levoleucovorin|mesh-list
6335723|NCT00020943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6335724|NCT00020943|Immunologic Factors|immunologic factors|mesh-ancestor
6335725|NCT00020943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6335726|NCT00020943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6335727|NCT00020943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6335728|NCT00020943|Alkylating Agents|alkylating agents|mesh-ancestor
6335729|NCT00020943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6335730|NCT00020943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335731|NCT00020943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6335732|NCT00020943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6335733|NCT00020943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6335734|NCT00020943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6335735|NCT00020943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6335736|NCT00020943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6335737|NCT00020943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6335738|NCT00020943|Glucocorticoids|glucocorticoids|mesh-ancestor
6335739|NCT00020943|Hormones|hormones|mesh-ancestor
6335740|NCT00020943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6335741|NCT00020943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6335742|NCT00020943|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6335743|NCT00020943|Abortifacient Agents|abortifacient agents|mesh-ancestor
6335744|NCT00020943|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6335745|NCT00020943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6335746|NCT00020943|Antimetabolites|antimetabolites|mesh-ancestor
6335747|NCT00020943|Dermatologic Agents|dermatologic agents|mesh-ancestor
6335748|NCT00020943|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6335749|NCT00020943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6335750|NCT00020943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6335751|NCT00020943|Antiviral Agents|antiviral agents|mesh-ancestor
6335752|NCT00020943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6335753|NCT00020943|Antidotes|antidotes|mesh-ancestor
6335754|NCT00020943|Protective Agents|protective agents|mesh-ancestor
6335755|NCT00020943|Vitamin B Complex|vitamin b complex|mesh-ancestor
6335756|NCT00020943|Vitamins|vitamins|mesh-ancestor
6335757|NCT00020943|Micronutrients|micronutrients|mesh-ancestor
6335758|NCT00020943|Tubulin Modulators|tubulin modulators|mesh-ancestor
6335759|NCT00020943|Antimitotic Agents|antimitotic agents|mesh-ancestor
6335760|NCT00020943|Mitosis Modulators|mitosis modulators|mesh-ancestor
6335761|NCT00020969|Arsenic Trioxide|arsenic trioxide|mesh-list
6335762|NCT00020969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335763|NCT00021034|Taurolidine|taurolidine|mesh-list
6335764|NCT00021034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6335765|NCT00021034|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6335766|NCT00021034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335767|NCT00021047|Carboplatin|carboplatin|mesh-list
6335768|NCT00021047|Capecitabine|capecitabine|mesh-list
6335769|NCT00021047|Epirubicin|epirubicin|mesh-list
6335770|NCT00021047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335771|NCT00021047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6335772|NCT00021047|Antimetabolites|antimetabolites|mesh-ancestor
6335773|NCT00021047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6335774|NCT00021047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6335775|NCT00021047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6335776|NCT00021047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6335777|NCT00021047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6335778|NCT00021060|Paclitaxel|paclitaxel|mesh-list
6335779|NCT00021060|Bevacizumab|bevacizumab|mesh-list
6335780|NCT00021060|Carboplatin|carboplatin|mesh-list
6335781|NCT00021060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6335782|NCT00021060|Antibodies|antibodies|mesh-list
6335783|NCT00021060|Immunoglobulins|immunoglobulins|mesh-list
6335784|NCT00021060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6335785|NCT00021060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6335786|NCT00021060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335787|NCT00021060|Tubulin Modulators|tubulin modulators|mesh-ancestor
6335788|NCT00021060|Antimitotic Agents|antimitotic agents|mesh-ancestor
6335789|NCT00021060|Mitosis Modulators|mitosis modulators|mesh-ancestor
6335790|NCT00021060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6335791|NCT00021060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6335792|NCT00021060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6335793|NCT00021060|Growth Substances|growth substances|mesh-ancestor
6335794|NCT00021060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6335795|NCT00021060|Growth Inhibitors|growth inhibitors|mesh-ancestor
6335796|NCT00021060|Immunologic Factors|immunologic factors|mesh-ancestor
6335797|NCT00021073|Leucovorin|leucovorin|mesh-list
6335798|NCT00021073|Fluorouracil|fluorouracil|mesh-list
6335799|NCT00021073|Irinotecan|irinotecan|mesh-list
6335800|NCT00021073|Alvocidib|alvocidib|mesh-list
6335801|NCT00021073|Calcium|calcium|mesh-list
6335802|NCT00021073|Levoleucovorin|levoleucovorin|mesh-list
6335803|NCT00021073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6335804|NCT00021073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6335805|NCT00021073|Antimetabolites|antimetabolites|mesh-ancestor
6335806|NCT00021073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6335807|NCT00021073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6335808|NCT00021073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335809|NCT00021073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6335810|NCT00021073|Immunologic Factors|immunologic factors|mesh-ancestor
6335811|NCT00021073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6335812|NCT00021073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6335813|NCT00021073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6335814|NCT00021073|Antidotes|antidotes|mesh-ancestor
6335815|NCT00021073|Protective Agents|protective agents|mesh-ancestor
6335816|NCT00021073|Vitamin B Complex|vitamin b complex|mesh-ancestor
6335817|NCT00021073|Vitamins|vitamins|mesh-ancestor
6335818|NCT00021073|Micronutrients|micronutrients|mesh-ancestor
6335819|NCT00021073|Growth Inhibitors|growth inhibitors|mesh-ancestor
6335820|NCT00021073|Growth Substances|growth substances|mesh-ancestor
6335821|NCT00021073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6335822|NCT00021099|Epothilones|epothilones|mesh-list
6335823|NCT00021099|Epothilone B|epothilone b|mesh-list
6335824|NCT00021099|Tubulin Modulators|tubulin modulators|mesh-ancestor
6335825|NCT00021099|Antimitotic Agents|antimitotic agents|mesh-ancestor
6335826|NCT00021099|Mitosis Modulators|mitosis modulators|mesh-ancestor
6335827|NCT00021099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6335828|NCT00021099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335829|NCT00021112|Etoposide|etoposide|mesh-list
6335830|NCT00021112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335831|NCT00021112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6335832|NCT00021112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6335833|NCT00021112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6335834|NCT00021112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6335835|NCT00021112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6335836|NCT00021138|Nicotine|nicotine|mesh-list
6335837|NCT00021138|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6335838|NCT00021138|Autonomic Agents|autonomic agents|mesh-ancestor
6335839|NCT00021138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6335840|NCT00021138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6335841|NCT00021138|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6335842|NCT00021138|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6335843|NCT00021138|Cholinergic Agents|cholinergic agents|mesh-ancestor
6335844|NCT00021138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6335845|NCT00021138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6335846|NCT00021151|Alemtuzumab|alemtuzumab|mesh-list
6335847|NCT00021151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6335848|NCT00021151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335849|NCT00021164|Aldesleukin|aldesleukin|mesh-list
6335850|NCT00021164|Freund's Adjuvant|freund's adjuvant|mesh-list
6335851|NCT00021164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335852|NCT00021164|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6335853|NCT00021164|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6335854|NCT00021164|Antiviral Agents|antiviral agents|mesh-ancestor
6335855|NCT00021164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6335856|NCT00021164|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6335857|NCT00021164|Immunologic Factors|immunologic factors|mesh-ancestor
6335858|NCT00021164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6335859|NCT00021216|Bortezomib|bortezomib|mesh-list
6335860|NCT00021216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335861|NCT00021242|Docetaxel|docetaxel|mesh-list
6335862|NCT00021242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335863|NCT00021242|Tubulin Modulators|tubulin modulators|mesh-ancestor
6335864|NCT00021242|Antimitotic Agents|antimitotic agents|mesh-ancestor
6335865|NCT00021242|Mitosis Modulators|mitosis modulators|mesh-ancestor
6335866|NCT00021242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6335867|NCT00021268|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
6335868|NCT00021268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335869|NCT00021268|Immunologic Factors|immunologic factors|mesh-ancestor
6335870|NCT00021268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6335871|NCT00021281|Leucovorin|leucovorin|mesh-list
6335872|NCT00021281|Fluorouracil|fluorouracil|mesh-list
6335873|NCT00021281|Irinotecan|irinotecan|mesh-list
6335874|NCT00021281|Calcium|calcium|mesh-list
6335875|NCT00021281|Levoleucovorin|levoleucovorin|mesh-list
6335876|NCT00021281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6335877|NCT00021281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6335878|NCT00021281|Antimetabolites|antimetabolites|mesh-ancestor
6335879|NCT00021281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6335880|NCT00021281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6335881|NCT00021281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335882|NCT00021281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6335883|NCT00021281|Immunologic Factors|immunologic factors|mesh-ancestor
6335884|NCT00021281|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6335885|NCT00021281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6335886|NCT00021281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6335887|NCT00021281|Antidotes|antidotes|mesh-ancestor
6335888|NCT00021281|Protective Agents|protective agents|mesh-ancestor
6335889|NCT00021281|Vitamin B Complex|vitamin b complex|mesh-ancestor
6335890|NCT00021281|Vitamins|vitamins|mesh-ancestor
6335891|NCT00021281|Micronutrients|micronutrients|mesh-ancestor
6335892|NCT00021294|Eflornithine|eflornithine|mesh-list
6335893|NCT00021294|Triamcinolone|triamcinolone|mesh-list
6335894|NCT00021294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6335895|NCT00021294|Glucocorticoids|glucocorticoids|mesh-ancestor
6335896|NCT00021294|Hormones|hormones|mesh-ancestor
6335897|NCT00021294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6335898|NCT00021294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6335899|NCT00021294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6335900|NCT00021294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6335901|NCT00021294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335902|NCT00021294|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6335903|NCT00021294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6335904|NCT00021294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6335905|NCT00021294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6335906|NCT00021294|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
6335907|NCT00021307|Carboplatin|carboplatin|mesh-list
6335908|NCT00021307|Temozolomide|temozolomide|mesh-list
6335909|NCT00021307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335910|NCT00021307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6335911|NCT00021307|Alkylating Agents|alkylating agents|mesh-ancestor
6335912|NCT00021307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6335913|NCT00021320|Paclitaxel|paclitaxel|mesh-list
6335914|NCT00021320|Fluorouracil|fluorouracil|mesh-list
6335915|NCT00021320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6335916|NCT00021320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335917|NCT00021320|Tubulin Modulators|tubulin modulators|mesh-ancestor
6335918|NCT00021320|Antimitotic Agents|antimitotic agents|mesh-ancestor
6335919|NCT00021320|Mitosis Modulators|mitosis modulators|mesh-ancestor
6335920|NCT00021320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6335921|NCT00021320|Antimetabolites|antimetabolites|mesh-ancestor
6335922|NCT00021320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6335923|NCT00021320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6335924|NCT00021320|Immunologic Factors|immunologic factors|mesh-ancestor
6335925|NCT00021320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6335926|NCT00021333|Paclitaxel|paclitaxel|mesh-list
6335927|NCT00021333|Cisplatin|cisplatin|mesh-list
6335928|NCT00021333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6335929|NCT00021333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335930|NCT00021333|Tubulin Modulators|tubulin modulators|mesh-ancestor
6335931|NCT00021333|Antimitotic Agents|antimitotic agents|mesh-ancestor
6335932|NCT00021333|Mitosis Modulators|mitosis modulators|mesh-ancestor
6016662|NCT00366457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335933|NCT00021333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6335934|NCT00021346|Gemcitabine|gemcitabine|mesh-list
6335935|NCT00021346|Carboplatin|carboplatin|mesh-list
6335936|NCT00021346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335937|NCT00021346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6335938|NCT00021346|Antimetabolites|antimetabolites|mesh-ancestor
6335939|NCT00021346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6335940|NCT00021346|Antiviral Agents|antiviral agents|mesh-ancestor
6335941|NCT00021346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6335942|NCT00021346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6335943|NCT00021346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6335944|NCT00021346|Immunologic Factors|immunologic factors|mesh-ancestor
6335945|NCT00021346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6335946|NCT00021359|Dexamethasone|dexamethasone|mesh-list
6335947|NCT00021359|Isotretinoin|isotretinoin|mesh-list
6016663|NCT00366457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6335948|NCT00021359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6335949|NCT00021359|Antiemetics|antiemetics|mesh-ancestor
6335950|NCT00021359|Autonomic Agents|autonomic agents|mesh-ancestor
6335951|NCT00021359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6335952|NCT00021359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6335953|NCT00021359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6335954|NCT00021359|Glucocorticoids|glucocorticoids|mesh-ancestor
6335955|NCT00021359|Hormones|hormones|mesh-ancestor
6335956|NCT00021359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6335957|NCT00021359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6335958|NCT00021359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335959|NCT00021359|Dermatologic Agents|dermatologic agents|mesh-ancestor
6335960|NCT00021372|Paclitaxel|paclitaxel|mesh-list
6335961|NCT00021372|Estramustine|estramustine|mesh-list
6335962|NCT00021372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6335963|NCT00021372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335964|NCT00021372|Tubulin Modulators|tubulin modulators|mesh-ancestor
6335965|NCT00021372|Antimitotic Agents|antimitotic agents|mesh-ancestor
6335966|NCT00021372|Mitosis Modulators|mitosis modulators|mesh-ancestor
6335967|NCT00021372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6335968|NCT00021372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6335969|NCT00021372|Alkylating Agents|alkylating agents|mesh-ancestor
6335970|NCT00021372|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6335971|NCT00021385|Squalamine|squalamine|mesh-list
6335972|NCT00021385|Carboplatin|carboplatin|mesh-list
6335973|NCT00021385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335974|NCT00021385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6335975|NCT00021385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6335976|NCT00021385|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6335977|NCT00021385|Protective Agents|protective agents|mesh-ancestor
6335978|NCT00021385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6335979|NCT00021385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6335980|NCT00021385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6335981|NCT00021385|Growth Substances|growth substances|mesh-ancestor
6335982|NCT00021385|Growth Inhibitors|growth inhibitors|mesh-ancestor
6335983|NCT00021398|Leucovorin|leucovorin|mesh-list
6335984|NCT00021398|Fluorouracil|fluorouracil|mesh-list
6335985|NCT00021398|Calcium|calcium|mesh-list
6335986|NCT00021398|Levoleucovorin|levoleucovorin|mesh-list
6335987|NCT00021398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6335988|NCT00021398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6335989|NCT00021398|Antimetabolites|antimetabolites|mesh-ancestor
6335990|NCT00021398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6335991|NCT00021398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6335992|NCT00021398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6335993|NCT00021398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6335994|NCT00021398|Immunologic Factors|immunologic factors|mesh-ancestor
6335995|NCT00021398|Antidotes|antidotes|mesh-ancestor
6335996|NCT00021398|Protective Agents|protective agents|mesh-ancestor
6335997|NCT00021398|Vitamin B Complex|vitamin b complex|mesh-ancestor
6335998|NCT00021398|Vitamins|vitamins|mesh-ancestor
6335999|NCT00021398|Micronutrients|micronutrients|mesh-ancestor
6336000|NCT00021450|Goserelin|goserelin|mesh-list
6336001|NCT00021450|Bicalutamide|bicalutamide|mesh-list
6336002|NCT00021450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6336003|NCT00021450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6336004|NCT00021450|Androgen Antagonists|androgen antagonists|mesh-ancestor
6336005|NCT00021450|Hormone Antagonists|hormone antagonists|mesh-ancestor
6336006|NCT00021450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6336007|NCT00021450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6336008|NCT00021463|Lamivudine|lamivudine|mesh-list
6336009|NCT00021463|Zidovudine|zidovudine|mesh-list
6336010|NCT00021463|Efavirenz|efavirenz|mesh-list
6336011|NCT00021463|Nevirapine|nevirapine|mesh-list
6336012|NCT00021463|Abacavir|abacavir|mesh-list
6336013|NCT00021463|Dideoxynucleosides|dideoxynucleosides|mesh-list
6336014|NCT00021463|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6336015|NCT00021463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6336016|NCT00021463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6336017|NCT00021463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6336018|NCT00021463|Antiviral Agents|antiviral agents|mesh-ancestor
6336019|NCT00021463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6336020|NCT00021463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6336021|NCT00021463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6336022|NCT00021463|Antimetabolites|antimetabolites|mesh-ancestor
6336023|NCT00021463|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6336024|NCT00021463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6336025|NCT00021463|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6336026|NCT00021463|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6336027|NCT00021463|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6336028|NCT00021463|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6336029|NCT00021489|Mycophenolic Acid|mycophenolic acid|mesh-list
6336030|NCT00021489|Abacavir|abacavir|mesh-list
6336031|NCT00021489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6336032|NCT00021489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6336033|NCT00021489|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6336034|NCT00021489|Antitubercular Agents|antitubercular agents|mesh-ancestor
6336035|NCT00021489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6336036|NCT00021489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6336037|NCT00021489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6336038|NCT00021489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6336039|NCT00021489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6336040|NCT00021489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6336041|NCT00021489|Antiviral Agents|antiviral agents|mesh-ancestor
6336042|NCT00021489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6336043|NCT00021489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6336044|NCT00021528|Mirtazapine|mirtazapine|mesh-list
6336045|NCT00021528|Buspirone|buspirone|mesh-list
6336046|NCT00021528|Tranylcypromine|tranylcypromine|mesh-list
6336047|NCT00021528|Sertraline|sertraline|mesh-list
6336048|NCT00021528|Citalopram|citalopram|mesh-list
6336049|NCT00021528|Nortriptyline|nortriptyline|mesh-list
6336050|NCT00021528|Antidepressive Agents|antidepressive agents|mesh-ancestor
6336051|NCT00021528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6336052|NCT00021528|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6336053|NCT00021528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6336054|NCT00021528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6336055|NCT00021528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6336056|NCT00021528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6336057|NCT00021528|Serotonin Agents|serotonin agents|mesh-ancestor
6336058|NCT00021528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6336059|NCT00021528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6336060|NCT00021528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6336061|NCT00021528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6336062|NCT00021528|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6336063|NCT00021528|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6336064|NCT00021528|Histamine Antagonists|histamine antagonists|mesh-ancestor
6336065|NCT00021528|Histamine Agents|histamine agents|mesh-ancestor
6336066|NCT00021528|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6336067|NCT00021528|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6336068|NCT00021528|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6336069|NCT00021528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6336070|NCT00021528|Adrenergic Agents|adrenergic agents|mesh-ancestor
6336071|NCT00021528|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6336072|NCT00021528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6336073|NCT00021528|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6336074|NCT00021528|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6336075|NCT00021528|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6336076|NCT00021528|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6336077|NCT00021528|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6336078|NCT00021554|Enfuvirtide|enfuvirtide|mesh-list
6336079|NCT00021554|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6336080|NCT00021554|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6336081|NCT00021554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6336082|NCT00021554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6336083|NCT00021554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6336084|NCT00021554|Antiviral Agents|antiviral agents|mesh-ancestor
6336085|NCT00021554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6336086|NCT00021567|Interferons|interferons|mesh-list
6336087|NCT00021567|Interferon-gamma|interferon-gamma|mesh-list
6336088|NCT00021567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6336089|NCT00021567|Antiviral Agents|antiviral agents|mesh-ancestor
6336090|NCT00021567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6336091|NCT00021645|Vitamin E|vitamin e|mesh-list
6336092|NCT00021645|Vitamins|vitamins|mesh-ancestor
6336093|NCT00021645|Micronutrients|micronutrients|mesh-ancestor
6336094|NCT00021645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6336095|NCT00021645|Antioxidants|antioxidants|mesh-ancestor
6336096|NCT00021645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6336097|NCT00021645|Protective Agents|protective agents|mesh-ancestor
6336098|NCT00021671|Metronidazole|metronidazole|mesh-list
6336099|NCT00021671|Nevirapine|nevirapine|mesh-list
6016664|NCT00366457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6016665|NCT00366457|Growth Substances|growth substances|mesh-ancestor
6336100|NCT00021671|Erythromycin|erythromycin|mesh-list
6536997|NCT00819845|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6536998|NCT00819845|Protease Inhibitors|protease inhibitors|mesh-ancestor
6536999|NCT00819845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6537000|NCT00819962|Bupivacaine|bupivacaine|mesh-list
6537001|NCT00819962|Anesthetics, Local|anesthetics, local|mesh-ancestor
6537002|NCT00819962|Anesthetics|anesthetics|mesh-ancestor
6537003|NCT00819962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6537004|NCT00819962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537005|NCT00819962|Sensory System Agents|sensory system agents|mesh-ancestor
6537006|NCT00819962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6537007|NCT00819975|Caseins|caseins|mesh-list
6537008|NCT00819975|Chelating Agents|chelating agents|mesh-ancestor
6537009|NCT00819975|Sequestering Agents|sequestering agents|mesh-ancestor
6537010|NCT00819975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537011|NCT00819988|Pregabalin|pregabalin|mesh-list
6336101|NCT00021671|Erythromycin Estolate|erythromycin estolate|mesh-list
6336102|NCT00021671|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
6336103|NCT00021671|Erythromycin stearate|erythromycin stearate|mesh-list
6336104|NCT00021671|Ampicillin|ampicillin|mesh-list
6336105|NCT00021671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6336106|NCT00021671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6336107|NCT00021671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6336108|NCT00021671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6336109|NCT00021671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6336110|NCT00021671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6336111|NCT00021671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6336112|NCT00021671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6336113|NCT00021671|Antiviral Agents|antiviral agents|mesh-ancestor
6336114|NCT00021671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6336115|NCT00021671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6336116|NCT00021671|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6336117|NCT00021671|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6336118|NCT00021671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6336119|NCT00021671|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6336120|NCT00021736|Bevacizumab|bevacizumab|mesh-list
6336121|NCT00021736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6336122|NCT00021736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6336123|NCT00021736|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6336124|NCT00021736|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6336125|NCT00021736|Growth Substances|growth substances|mesh-ancestor
6336126|NCT00021736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6336127|NCT00021736|Growth Inhibitors|growth inhibitors|mesh-ancestor
6336128|NCT00021814|Doxazosin|doxazosin|mesh-list
6336129|NCT00021814|Finasteride|finasteride|mesh-list
6336130|NCT00021814|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6336131|NCT00021814|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6336132|NCT00021814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6336133|NCT00021814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6336134|NCT00021814|Hormone Antagonists|hormone antagonists|mesh-ancestor
6336135|NCT00021814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6537012|NCT00819988|Analgesics|analgesics|mesh-ancestor
6537013|NCT00819988|Sensory System Agents|sensory system agents|mesh-ancestor
6336136|NCT00021814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6336137|NCT00021814|Urological Agents|urological agents|mesh-ancestor
6336138|NCT00021814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6336139|NCT00021814|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6336140|NCT00021814|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6336141|NCT00021814|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6336142|NCT00021814|Adrenergic Agents|adrenergic agents|mesh-ancestor
6336143|NCT00021814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6336144|NCT00021827|Hormones|hormones|mesh-list
6336145|NCT00021827|Parathyroid Hormone|parathyroid hormone|mesh-list
6336146|NCT00021827|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
6336147|NCT00021827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6336148|NCT00021827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6336149|NCT00021827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6336150|NCT00021983|Immunotoxins|immunotoxins|mesh-list
6336151|NCT00021983|Immunologic Factors|immunologic factors|mesh-ancestor
6336152|NCT00021983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6336153|NCT00021996|Valdecoxib|valdecoxib|mesh-list
6336154|NCT00021996|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6336155|NCT00021996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6336156|NCT00021996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6336157|NCT00021996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6336158|NCT00021996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6336159|NCT00021996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6336160|NCT00021996|Analgesics|analgesics|mesh-ancestor
6336161|NCT00021996|Sensory System Agents|sensory system agents|mesh-ancestor
6336162|NCT00021996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6336163|NCT00021996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6336164|NCT00021996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6336165|NCT00021996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6336166|NCT00022009|Gemcitabine|gemcitabine|mesh-list
6336167|NCT00022009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6336168|NCT00022009|Antimetabolites|antimetabolites|mesh-ancestor
6336169|NCT00022009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6336170|NCT00022009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6336171|NCT00022009|Antiviral Agents|antiviral agents|mesh-ancestor
6336172|NCT00022009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6336173|NCT00022009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6336174|NCT00022009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6336175|NCT00022009|Immunologic Factors|immunologic factors|mesh-ancestor
6336176|NCT00022009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537014|NCT00819988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6336177|NCT00022022|Docetaxel|docetaxel|mesh-list
6336178|NCT00022022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6336179|NCT00022022|Tubulin Modulators|tubulin modulators|mesh-ancestor
6336180|NCT00022022|Antimitotic Agents|antimitotic agents|mesh-ancestor
6336181|NCT00022022|Mitosis Modulators|mitosis modulators|mesh-ancestor
6336182|NCT00022022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6336183|NCT00022048|Bevacizumab|bevacizumab|mesh-list
6336184|NCT00022048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6336185|NCT00022048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6336186|NCT00022048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6336187|NCT00022048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6336188|NCT00022048|Growth Substances|growth substances|mesh-ancestor
6336189|NCT00022048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6336190|NCT00022048|Growth Inhibitors|growth inhibitors|mesh-ancestor
6336191|NCT00022074|Gabapentin|gabapentin|mesh-list
6336192|NCT00022074|Analgesics|analgesics|mesh-ancestor
6336193|NCT00022074|Sensory System Agents|sensory system agents|mesh-ancestor
6336194|NCT00022074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6336195|NCT00022074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6336196|NCT00022074|Anticonvulsants|anticonvulsants|mesh-ancestor
6336197|NCT00022074|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6336198|NCT00022074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6336199|NCT00022074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6336200|NCT00022074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6336201|NCT00022074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6336202|NCT00022074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6336203|NCT00022074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6336204|NCT00022074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6336205|NCT00022074|Antimanic Agents|antimanic agents|mesh-ancestor
6336206|NCT00022087|Vitamin D|vitamin d|mesh-list
6336207|NCT00022087|Cholecalciferol|cholecalciferol|mesh-list
6336208|NCT00022087|Zoledronic Acid|zoledronic acid|mesh-list
6336209|NCT00022087|Calcium|calcium|mesh-list
6336210|NCT00022087|Vitamins|vitamins|mesh-ancestor
6336211|NCT00022087|Micronutrients|micronutrients|mesh-ancestor
6336212|NCT00022087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6336213|NCT00022087|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6336214|NCT00022087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6336215|NCT00022126|Cytarabine|cytarabine|mesh-list
6336216|NCT00022126|Cyclosporine|cyclosporine|mesh-list
6336217|NCT00022126|Dexamethasone|dexamethasone|mesh-list
6336218|NCT00022126|Methylprednisolone|methylprednisolone|mesh-list
6336219|NCT00022126|Cyclophosphamide|cyclophosphamide|mesh-list
6336220|NCT00022126|Doxorubicin|doxorubicin|mesh-list
6336221|NCT00022126|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6016666|NCT00366457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016667|NCT00366457|Growth Inhibitors|growth inhibitors|mesh-ancestor
6016668|NCT00366457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6016669|NCT00366457|Antimetabolites|antimetabolites|mesh-ancestor
6016670|NCT00366457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016671|NCT00366457|Antiviral Agents|antiviral agents|mesh-ancestor
6016672|NCT00366457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6016673|NCT00366457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6016674|NCT00366457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6016675|NCT00366457|Immunologic Factors|immunologic factors|mesh-ancestor
6016676|NCT00366457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6016677|NCT00366535|Neurotropin|neurotropin|mesh-list
6016678|NCT00366535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6016679|NCT00366535|Immunologic Factors|immunologic factors|mesh-ancestor
6016680|NCT00366535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016681|NCT00366535|Analgesics|analgesics|mesh-ancestor
6016682|NCT00366535|Sensory System Agents|sensory system agents|mesh-ancestor
6016683|NCT00366535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6016684|NCT00366535|Anticonvulsants|anticonvulsants|mesh-ancestor
6016685|NCT00366548|Vaccines|vaccines|mesh-list
6016686|NCT00366548|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6016687|NCT00366548|Immunologic Factors|immunologic factors|mesh-ancestor
6016688|NCT00366548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016689|NCT00366626|Naltrexone|naltrexone|mesh-list
6016690|NCT00366626|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6336222|NCT00022126|Methotrexate|methotrexate|mesh-list
6336223|NCT00022126|Vincristine|vincristine|mesh-list
6336224|NCT00022126|Daunorubicin|daunorubicin|mesh-list
6336225|NCT00022126|Asparaginase|asparaginase|mesh-list
6336226|NCT00022126|Mercaptopurine|mercaptopurine|mesh-list
6336227|NCT00022126|Pegaspargase|pegaspargase|mesh-list
6336228|NCT00022126|Thioguanine|thioguanine|mesh-list
6336229|NCT00022126|Cyclosporins|cyclosporins|mesh-list
6336230|NCT00022126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6336231|NCT00022126|Immunologic Factors|immunologic factors|mesh-ancestor
6336232|NCT00022126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6336233|NCT00022126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6336234|NCT00022126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6336235|NCT00022126|Alkylating Agents|alkylating agents|mesh-ancestor
6336236|NCT00022126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6336237|NCT00022126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6336238|NCT00022126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6336239|NCT00022126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6336240|NCT00022126|Antiemetics|antiemetics|mesh-ancestor
6336241|NCT00022126|Autonomic Agents|autonomic agents|mesh-ancestor
6336242|NCT00022126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6336243|NCT00022126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6336244|NCT00022126|Glucocorticoids|glucocorticoids|mesh-ancestor
6336245|NCT00022126|Hormones|hormones|mesh-ancestor
6336246|NCT00022126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6336247|NCT00022126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6336248|NCT00022126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6336249|NCT00022126|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6336250|NCT00022126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6336251|NCT00022126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6336252|NCT00022126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6336253|NCT00022126|Abortifacient Agents|abortifacient agents|mesh-ancestor
6336254|NCT00022126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6336255|NCT00022126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6336256|NCT00022126|Antimetabolites|antimetabolites|mesh-ancestor
6016691|NCT00366626|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6016692|NCT00366626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016693|NCT00366626|Sensory System Agents|sensory system agents|mesh-ancestor
6016694|NCT00366626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6016695|NCT00366678|Vaccines|vaccines|mesh-list
6016696|NCT00366678|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6336257|NCT00022126|Dermatologic Agents|dermatologic agents|mesh-ancestor
6336258|NCT00022126|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6336259|NCT00022126|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6336260|NCT00022126|Antiviral Agents|antiviral agents|mesh-ancestor
6336261|NCT00022126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6336262|NCT00022126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6336263|NCT00022126|Tubulin Modulators|tubulin modulators|mesh-ancestor
6336264|NCT00022126|Antimitotic Agents|antimitotic agents|mesh-ancestor
6336265|NCT00022126|Mitosis Modulators|mitosis modulators|mesh-ancestor
6336266|NCT00022126|Antifungal Agents|antifungal agents|mesh-ancestor
6336267|NCT00022126|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6336268|NCT00022126|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6336269|NCT00022126|Protective Agents|protective agents|mesh-ancestor
6336270|NCT00022139|Paclitaxel|paclitaxel|mesh-list
6336271|NCT00022139|Carboplatin|carboplatin|mesh-list
6336272|NCT00022139|Fluorouracil|fluorouracil|mesh-list
6336273|NCT00022139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6336274|NCT00022139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6336275|NCT00022139|Tubulin Modulators|tubulin modulators|mesh-ancestor
6336276|NCT00022139|Antimitotic Agents|antimitotic agents|mesh-ancestor
6336277|NCT00022139|Mitosis Modulators|mitosis modulators|mesh-ancestor
6336278|NCT00022139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6336279|NCT00022139|Antimetabolites|antimetabolites|mesh-ancestor
6336280|NCT00022139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6336281|NCT00022139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6336282|NCT00022139|Immunologic Factors|immunologic factors|mesh-ancestor
6336283|NCT00022139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016697|NCT00366678|Immunologic Factors|immunologic factors|mesh-ancestor
6016698|NCT00366678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016699|NCT00366899|Vaccines|vaccines|mesh-list
6016700|NCT00366899|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6016701|NCT00366899|Immunologic Factors|immunologic factors|mesh-ancestor
6016702|NCT00366899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016703|NCT00367016|Omalizumab|omalizumab|mesh-list
6016704|NCT00367016|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6016705|NCT00367016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5724581|NCT03186053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724582|NCT03186352|Anti-Infective Agents|anti-infective agents|mesh-list
6336284|NCT00022152|Vinorelbine|vinorelbine|mesh-list
6336285|NCT00022152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6336286|NCT00022152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6336287|NCT00022152|Tubulin Modulators|tubulin modulators|mesh-ancestor
6336288|NCT00022152|Antimitotic Agents|antimitotic agents|mesh-ancestor
6336289|NCT00022152|Mitosis Modulators|mitosis modulators|mesh-ancestor
6336290|NCT00022152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6336291|NCT00022165|Selenium|selenium|mesh-list
6336292|NCT00022165|Antioxidants|antioxidants|mesh-ancestor
6336293|NCT00022165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6336294|NCT00022165|Protective Agents|protective agents|mesh-ancestor
6336295|NCT00022165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6336296|NCT00022165|Trace Elements|trace elements|mesh-ancestor
6336297|NCT00022165|Micronutrients|micronutrients|mesh-ancestor
6336298|NCT00022178|Cyclophosphamide|cyclophosphamide|mesh-list
6336299|NCT00022178|Doxorubicin|doxorubicin|mesh-list
6336300|NCT00022178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6336301|NCT00022178|Fluorouracil|fluorouracil|mesh-list
6336302|NCT00022178|Vincristine|vincristine|mesh-list
6336303|NCT00022178|Epirubicin|epirubicin|mesh-list
6336304|NCT00022178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6336305|NCT00022178|Immunologic Factors|immunologic factors|mesh-ancestor
6336306|NCT00022178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6336307|NCT00022178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6336308|NCT00022178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6336309|NCT00022178|Alkylating Agents|alkylating agents|mesh-ancestor
6336310|NCT00022178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6336311|NCT00022178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6336312|NCT00022178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6336313|NCT00022178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6336314|NCT00022178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6336315|NCT00022178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6537015|NCT00819988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537016|NCT00819988|Anticonvulsants|anticonvulsants|mesh-ancestor
6537017|NCT00819988|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6537018|NCT00819988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6537019|NCT00819988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537020|NCT00819988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6537021|NCT00819988|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6537022|NCT00819988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6537023|NCT00819988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6537024|NCT00819988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6537025|NCT00820053|Epirubicin|epirubicin|mesh-list
6537026|NCT00820053|Ethiodized Oil|ethiodized oil|mesh-list
6537027|NCT00820053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6537028|NCT00820053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6537029|NCT00820053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6336316|NCT00022178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6336317|NCT00022178|Antimetabolites|antimetabolites|mesh-ancestor
6336318|NCT00022178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6336319|NCT00022178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6336320|NCT00022178|Tubulin Modulators|tubulin modulators|mesh-ancestor
6336321|NCT00022178|Antimitotic Agents|antimitotic agents|mesh-ancestor
6336322|NCT00022178|Mitosis Modulators|mitosis modulators|mesh-ancestor
6336323|NCT00022191|Gemcitabine|gemcitabine|mesh-list
6336324|NCT00022191|Paclitaxel|paclitaxel|mesh-list
6336325|NCT00022191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6537030|NCT00820053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6537031|NCT00820053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6537032|NCT00820053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537033|NCT00820092|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
6537034|NCT00820092|Hormones|hormones|mesh-ancestor
6537035|NCT00820092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6336326|NCT00022191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6336327|NCT00022191|Tubulin Modulators|tubulin modulators|mesh-ancestor
6336328|NCT00022191|Antimitotic Agents|antimitotic agents|mesh-ancestor
6336329|NCT00022191|Mitosis Modulators|mitosis modulators|mesh-ancestor
6336330|NCT00022191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537036|NCT00820092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537037|NCT00820118|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6537038|NCT00820118|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6537039|NCT00820118|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6537040|NCT00820118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6537041|NCT00820118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6537042|NCT00820118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537043|NCT00820118|Antiviral Agents|antiviral agents|mesh-ancestor
6537044|NCT00820118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6537045|NCT00820118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6537046|NCT00820118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6537047|NCT00820118|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6537048|NCT00820118|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6537049|NCT00820118|Protease Inhibitors|protease inhibitors|mesh-ancestor
6336331|NCT00022191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6336332|NCT00022191|Antimetabolites|antimetabolites|mesh-ancestor
6336333|NCT00022191|Antiviral Agents|antiviral agents|mesh-ancestor
6336334|NCT00022191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6336335|NCT00022191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6336336|NCT00022191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6336337|NCT00022191|Immunologic Factors|immunologic factors|mesh-ancestor
6336338|NCT00022191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6336339|NCT00022204|Vitamin E|vitamin e|mesh-list
6336340|NCT00022204|Pentoxifylline|pentoxifylline|mesh-list
6336341|NCT00022204|Vitamins|vitamins|mesh-ancestor
6336342|NCT00022204|Micronutrients|micronutrients|mesh-ancestor
6336343|NCT00022204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6336344|NCT00022204|Antioxidants|antioxidants|mesh-ancestor
6336345|NCT00022204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6336346|NCT00022204|Protective Agents|protective agents|mesh-ancestor
6336347|NCT00022204|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6336348|NCT00022204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6336349|NCT00022204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6336350|NCT00022204|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6336351|NCT00022204|Vasodilator Agents|vasodilator agents|mesh-ancestor
6336352|NCT00022204|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6336353|NCT00022217|Paclitaxel|paclitaxel|mesh-list
6336354|NCT00022217|Carboplatin|carboplatin|mesh-list
6537050|NCT00820326|Dolasetron|dolasetron|mesh-list
6537051|NCT00820326|Antiemetics|antiemetics|mesh-ancestor
6537052|NCT00820326|Autonomic Agents|autonomic agents|mesh-ancestor
6537053|NCT00820326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6537054|NCT00820326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537055|NCT00820326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6537056|NCT00820326|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6537057|NCT00820326|Serotonin Agents|serotonin agents|mesh-ancestor
6537058|NCT00820326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6537059|NCT00820326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537060|NCT00820352|Bosentan|bosentan|mesh-list
6537061|NCT00820352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6537062|NCT00820352|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6537063|NCT00820352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537064|NCT00820404|BLI-489|bli-489|mesh-list
6537065|NCT00820404|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6537066|NCT00820404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6336355|NCT00022217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6336356|NCT00022217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6336357|NCT00022217|Tubulin Modulators|tubulin modulators|mesh-ancestor
6336358|NCT00022217|Antimitotic Agents|antimitotic agents|mesh-ancestor
6336359|NCT00022217|Mitosis Modulators|mitosis modulators|mesh-ancestor
6336360|NCT00022217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6336361|NCT00022230|Aldesleukin|aldesleukin|mesh-list
6336362|NCT00022230|Paclitaxel|paclitaxel|mesh-list
6336363|NCT00022230|Cyclophosphamide|cyclophosphamide|mesh-list
6336364|NCT00022230|Doxorubicin|doxorubicin|mesh-list
6336365|NCT00022230|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6336366|NCT00022230|Sargramostim|sargramostim|mesh-list
6336367|NCT00022230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6336368|NCT00022230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6336369|NCT00022230|Tubulin Modulators|tubulin modulators|mesh-ancestor
6336370|NCT00022230|Antimitotic Agents|antimitotic agents|mesh-ancestor
6336371|NCT00022230|Mitosis Modulators|mitosis modulators|mesh-ancestor
6336372|NCT00022230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6336373|NCT00022230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6336374|NCT00022230|Immunologic Factors|immunologic factors|mesh-ancestor
6336375|NCT00022230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6336376|NCT00022230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6336377|NCT00022230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6336378|NCT00022230|Alkylating Agents|alkylating agents|mesh-ancestor
6336379|NCT00022230|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6336380|NCT00022230|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6336381|NCT00022230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6336382|NCT00022230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6336383|NCT00022230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6336384|NCT00022230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6336385|NCT00022230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6336386|NCT00022230|Antiviral Agents|antiviral agents|mesh-ancestor
6336387|NCT00022230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6336388|NCT00022256|Motexafin gadolinium|motexafin gadolinium|mesh-list
6336389|NCT00022256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6336390|NCT00022256|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6336391|NCT00022256|Dermatologic Agents|dermatologic agents|mesh-ancestor
6336392|NCT00022308|Irinotecan|irinotecan|mesh-list
6336393|NCT00022308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6336394|NCT00022308|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6336395|NCT00022308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6336396|NCT00022308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6016706|NCT00367016|Respiratory System Agents|respiratory system agents|mesh-ancestor
6016707|NCT00367055|Metformin|metformin|mesh-list
6016708|NCT00367055|Rosiglitazone|rosiglitazone|mesh-list
6336397|NCT00022308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6336398|NCT00022321|Gemtuzumab|gemtuzumab|mesh-list
6336399|NCT00022321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6336400|NCT00022321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6336401|NCT00022360|Taurolidine|taurolidine|mesh-list
6336402|NCT00022360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6336403|NCT00022360|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6336404|NCT00022360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6336405|NCT00022386|Epoetin Alfa|epoetin alfa|mesh-list
6336406|NCT00022386|Hematinics|hematinics|mesh-ancestor
6336407|NCT00022399|Celecoxib|celecoxib|mesh-list
6336408|NCT00022399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6336409|NCT00022399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6336410|NCT00022399|Analgesics|analgesics|mesh-ancestor
6336411|NCT00022399|Sensory System Agents|sensory system agents|mesh-ancestor
6336412|NCT00022399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6336413|NCT00022399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6336414|NCT00022399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6336415|NCT00022399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6336416|NCT00022399|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6336417|NCT00022399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6336418|NCT00022399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6336419|NCT00022399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6336420|NCT00022412|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
6336421|NCT00022412|Vitamins|vitamins|mesh-ancestor
6336422|NCT00022412|Micronutrients|micronutrients|mesh-ancestor
6336423|NCT00022412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6336424|NCT00022412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6336425|NCT00022425|Perillyl alcohol|perillyl alcohol|mesh-list
6016709|NCT00367055|Gliclazide|gliclazide|mesh-list
6336426|NCT00022425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6336427|NCT00022425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6336428|NCT00022425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6336429|NCT00022438|Aldesleukin|aldesleukin|mesh-list
6336430|NCT00022438|Freund's Adjuvant|freund's adjuvant|mesh-list
6336431|NCT00022438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6336432|NCT00022438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6336433|NCT00022438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6336434|NCT00022438|Antiviral Agents|antiviral agents|mesh-ancestor
6336435|NCT00022438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6336436|NCT00022438|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6336437|NCT00022438|Immunologic Factors|immunologic factors|mesh-ancestor
6336438|NCT00022438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6336439|NCT00022451|Tipifarnib|tipifarnib|mesh-list
6336440|NCT00022451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6336441|NCT00022464|Sirolimus|sirolimus|mesh-list
6336442|NCT00022464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6336443|NCT00022464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6336444|NCT00022464|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6336445|NCT00022464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6336446|NCT00022464|Antifungal Agents|antifungal agents|mesh-ancestor
6336447|NCT00022464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6336448|NCT00022464|Immunologic Factors|immunologic factors|mesh-ancestor
6336449|NCT00022464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6393593|NCT00199186|Dermatologic Agents|dermatologic agents|mesh-ancestor
6393594|NCT00199186|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6393595|NCT00199186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6393596|NCT00199186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6393597|NCT00199186|Tubulin Modulators|tubulin modulators|mesh-ancestor
6393598|NCT00199186|Antimitotic Agents|antimitotic agents|mesh-ancestor
6393599|NCT00199186|Mitosis Modulators|mitosis modulators|mesh-ancestor
6393600|NCT00199186|Antiviral Agents|antiviral agents|mesh-ancestor
6393601|NCT00199186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6393602|NCT00199186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6393603|NCT00199186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6393604|NCT00199186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6393605|NCT00199186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6396935|NCT00209872|Ketamine|ketamine|mesh-list
6396936|NCT00209872|Gabapentin|gabapentin|mesh-list
6396937|NCT00209872|Esketamine|esketamine|mesh-list
6396938|NCT00209872|Anesthetics, Local|anesthetics, local|mesh-ancestor
6396939|NCT00209872|Anesthetics|anesthetics|mesh-ancestor
6396940|NCT00209872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6396941|NCT00209872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396942|NCT00209872|Sensory System Agents|sensory system agents|mesh-ancestor
6396943|NCT00209872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6396944|NCT00209872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6396945|NCT00209872|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6396946|NCT00209872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6396947|NCT00209872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6396948|NCT00209872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396949|NCT00209872|Analgesics|analgesics|mesh-ancestor
6396950|NCT00209872|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6396951|NCT00209872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6396952|NCT00209872|Anesthetics, General|anesthetics, general|mesh-ancestor
6396953|NCT00209872|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6396954|NCT00209872|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6396955|NCT00209872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6396956|NCT00209872|Anticonvulsants|anticonvulsants|mesh-ancestor
6396957|NCT00209872|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6396958|NCT00209872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6396959|NCT00209872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6396960|NCT00209872|Antimanic Agents|antimanic agents|mesh-ancestor
6336450|NCT00022529|Trastuzumab|trastuzumab|mesh-list
6336451|NCT00022529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6336452|NCT00022529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6336453|NCT00022542|Epothilones|epothilones|mesh-list
6336454|NCT00022542|Epothilone B|epothilone b|mesh-list
6336455|NCT00022542|Tubulin Modulators|tubulin modulators|mesh-ancestor
6336456|NCT00022542|Antimitotic Agents|antimitotic agents|mesh-ancestor
6336457|NCT00022542|Mitosis Modulators|mitosis modulators|mesh-ancestor
6336458|NCT00022542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6336459|NCT00022542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6336460|NCT00022555|Vincristine|vincristine|mesh-list
6336461|NCT00022555|Bryostatin 1|bryostatin 1|mesh-list
6336462|NCT00022555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6336463|NCT00022555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6336464|NCT00022555|Tubulin Modulators|tubulin modulators|mesh-ancestor
6336465|NCT00022555|Antimitotic Agents|antimitotic agents|mesh-ancestor
6336466|NCT00022555|Mitosis Modulators|mitosis modulators|mesh-ancestor
6336467|NCT00022555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6336468|NCT00022555|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6336469|NCT00022555|Immunologic Factors|immunologic factors|mesh-ancestor
6336470|NCT00022555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6336471|NCT00022581|Thalidomide|thalidomide|mesh-list
6336472|NCT00022581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6336473|NCT00022581|Immunologic Factors|immunologic factors|mesh-ancestor
6336474|NCT00022581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6336475|NCT00022581|Leprostatic Agents|leprostatic agents|mesh-ancestor
6336476|NCT00022581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6336477|NCT00022581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6336478|NCT00022581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6336479|NCT00022581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6336480|NCT00022581|Growth Substances|growth substances|mesh-ancestor
6336481|NCT00022581|Growth Inhibitors|growth inhibitors|mesh-ancestor
6336482|NCT00022581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6336483|NCT00022594|Lurtotecan|lurtotecan|mesh-list
6336484|NCT00022594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6336485|NCT00022607|Thalidomide|thalidomide|mesh-list
6336486|NCT00022607|Bevacizumab|bevacizumab|mesh-list
6336487|NCT00022607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6336488|NCT00022607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6537067|NCT00820404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537068|NCT00820404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6537069|NCT00820404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6537070|NCT00820417|Cetuximab|cetuximab|mesh-list
6537071|NCT00820417|Gefitinib|gefitinib|mesh-list
6537072|NCT00820417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6537073|NCT00820417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6336489|NCT00022607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6336490|NCT00022607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6336491|NCT00022607|Growth Substances|growth substances|mesh-ancestor
6336492|NCT00022607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6336493|NCT00022607|Growth Inhibitors|growth inhibitors|mesh-ancestor
6336494|NCT00022607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6336495|NCT00022607|Immunologic Factors|immunologic factors|mesh-ancestor
6336496|NCT00022607|Leprostatic Agents|leprostatic agents|mesh-ancestor
6336497|NCT00022607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6336498|NCT00022607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6336499|NCT00022620|Paclitaxel|paclitaxel|mesh-list
6336500|NCT00022620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6336501|NCT00022620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6336502|NCT00022620|Tubulin Modulators|tubulin modulators|mesh-ancestor
6336503|NCT00022620|Antimitotic Agents|antimitotic agents|mesh-ancestor
6336504|NCT00022620|Mitosis Modulators|mitosis modulators|mesh-ancestor
6336505|NCT00022620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6336506|NCT00022646|Gemcitabine|gemcitabine|mesh-list
6336507|NCT00022646|Pemetrexed|pemetrexed|mesh-list
6336508|NCT00022646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6336509|NCT00022646|Antimetabolites|antimetabolites|mesh-ancestor
6336510|NCT00022646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6336511|NCT00022646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6336512|NCT00022646|Antiviral Agents|antiviral agents|mesh-ancestor
6336513|NCT00022646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6336514|NCT00022646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6336515|NCT00022646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6336516|NCT00022646|Immunologic Factors|immunologic factors|mesh-ancestor
6336517|NCT00022646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6336518|NCT00022646|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6336519|NCT00022646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6336520|NCT00022685|Epratuzumab|epratuzumab|mesh-list
6336521|NCT00022685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6336522|NCT00022685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6336523|NCT00022711|Temozolomide|temozolomide|mesh-list
6336524|NCT00022711|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6336525|NCT00022711|Alkylating Agents|alkylating agents|mesh-ancestor
6336526|NCT00022711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6336527|NCT00022711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6336528|NCT00022724|Sirolimus|sirolimus|mesh-list
6336529|NCT00022724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6336530|NCT00022724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6336531|NCT00022724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6336532|NCT00022724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6336533|NCT00022724|Antifungal Agents|antifungal agents|mesh-ancestor
6336534|NCT00022724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6336535|NCT00022724|Immunologic Factors|immunologic factors|mesh-ancestor
6336536|NCT00022724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6336537|NCT00022737|Leucovorin|leucovorin|mesh-list
6336538|NCT00022737|Cytarabine|cytarabine|mesh-list
6336539|NCT00022737|Cyclosporine|cyclosporine|mesh-list
6336540|NCT00022737|Dexamethasone|dexamethasone|mesh-list
6336541|NCT00022737|Cyclophosphamide|cyclophosphamide|mesh-list
6336542|NCT00022737|Ifosfamide|ifosfamide|mesh-list
6336543|NCT00022737|Methotrexate|methotrexate|mesh-list
6336544|NCT00022737|Etoposide|etoposide|mesh-list
6336545|NCT00022737|Vincristine|vincristine|mesh-list
6336546|NCT00022737|Etoposide phosphate|etoposide phosphate|mesh-list
6336547|NCT00022737|Imatinib Mesylate|imatinib mesylate|mesh-list
6336548|NCT00022737|Daunorubicin|daunorubicin|mesh-list
6336549|NCT00022737|Asparaginase|asparaginase|mesh-list
6336550|NCT00022737|Mercaptopurine|mercaptopurine|mesh-list
6336551|NCT00022737|Pegaspargase|pegaspargase|mesh-list
6336552|NCT00022737|Cyclosporins|cyclosporins|mesh-list
6336553|NCT00022737|Levoleucovorin|levoleucovorin|mesh-list
6336554|NCT00022737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6336555|NCT00022737|Immunologic Factors|immunologic factors|mesh-ancestor
6336556|NCT00022737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6336557|NCT00022737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6336558|NCT00022737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6336559|NCT00022737|Alkylating Agents|alkylating agents|mesh-ancestor
6336560|NCT00022737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6336561|NCT00022737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6336562|NCT00022737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6336563|NCT00022737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6336564|NCT00022737|Antiemetics|antiemetics|mesh-ancestor
6336565|NCT00022737|Autonomic Agents|autonomic agents|mesh-ancestor
6336566|NCT00022737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6336567|NCT00022737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6336568|NCT00022737|Glucocorticoids|glucocorticoids|mesh-ancestor
6336569|NCT00022737|Hormones|hormones|mesh-ancestor
6336570|NCT00022737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6336571|NCT00022737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6336572|NCT00022737|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6336573|NCT00022737|Abortifacient Agents|abortifacient agents|mesh-ancestor
6336574|NCT00022737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6336575|NCT00022737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6336576|NCT00022737|Antimetabolites|antimetabolites|mesh-ancestor
6336577|NCT00022737|Dermatologic Agents|dermatologic agents|mesh-ancestor
6336578|NCT00022737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6336579|NCT00022737|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6336580|NCT00022737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6336581|NCT00022737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6336582|NCT00022737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6336583|NCT00022737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6336584|NCT00022737|Antiviral Agents|antiviral agents|mesh-ancestor
6336585|NCT00022737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6336586|NCT00022737|Antidotes|antidotes|mesh-ancestor
6336587|NCT00022737|Protective Agents|protective agents|mesh-ancestor
6336588|NCT00022737|Vitamin B Complex|vitamin b complex|mesh-ancestor
6336589|NCT00022737|Vitamins|vitamins|mesh-ancestor
6336590|NCT00022737|Micronutrients|micronutrients|mesh-ancestor
6336591|NCT00022737|Tubulin Modulators|tubulin modulators|mesh-ancestor
6537074|NCT00820417|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6537075|NCT00820417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6537076|NCT00820417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537077|NCT00820469|Rituximab|rituximab|mesh-list
6537078|NCT00820469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6537079|NCT00820469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6537080|NCT00820469|Immunologic Factors|immunologic factors|mesh-ancestor
6537081|NCT00820469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537082|NCT00820469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6537083|NCT00820482|Menotropins|menotropins|mesh-list
6537084|NCT00820482|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6336592|NCT00022737|Antimitotic Agents|antimitotic agents|mesh-ancestor
6336593|NCT00022737|Mitosis Modulators|mitosis modulators|mesh-ancestor
6336594|NCT00022737|Antifungal Agents|antifungal agents|mesh-ancestor
6336595|NCT00022737|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6336596|NCT00022737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6336597|NCT00022737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6336598|NCT00022841|Pamidronate|pamidronate|mesh-list
6336599|NCT00022841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6336600|NCT00022841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6336601|NCT00022880|Tositumomab I-131|tositumomab i-131|mesh-list
6336602|NCT00022880|Antibodies|antibodies|mesh-list
6336603|NCT00022880|Immunologic Factors|immunologic factors|mesh-ancestor
6336604|NCT00022880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6336605|NCT00022880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6336606|NCT00022893|Tositumomab I-131|tositumomab i-131|mesh-list
6336607|NCT00022893|Antibodies|antibodies|mesh-list
6336608|NCT00022893|Immunologic Factors|immunologic factors|mesh-ancestor
6336609|NCT00022893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6336610|NCT00022893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6336611|NCT00022906|Tositumomab I-131|tositumomab i-131|mesh-list
6336612|NCT00022906|Antibodies|antibodies|mesh-list
6336613|NCT00022906|Immunologic Factors|immunologic factors|mesh-ancestor
6336614|NCT00022906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6336615|NCT00022906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6336616|NCT00022932|Tositumomab I-131|tositumomab i-131|mesh-list
6336617|NCT00022932|Antibodies|antibodies|mesh-list
6336618|NCT00022932|Immunologic Factors|immunologic factors|mesh-ancestor
6336619|NCT00022932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6336620|NCT00022932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6336621|NCT00022945|Prednisone|prednisone|mesh-list
6336622|NCT00022945|Cyclophosphamide|cyclophosphamide|mesh-list
6336623|NCT00022945|Doxorubicin|doxorubicin|mesh-list
6336624|NCT00022945|Vincristine|vincristine|mesh-list
6336625|NCT00022945|Tositumomab I-131|tositumomab i-131|mesh-list
6336626|NCT00022945|Antibodies|antibodies|mesh-list
6336627|NCT00022945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6336628|NCT00022945|Immunologic Factors|immunologic factors|mesh-ancestor
6336629|NCT00022945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6336630|NCT00022945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6336631|NCT00022945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6336632|NCT00022945|Alkylating Agents|alkylating agents|mesh-ancestor
6336633|NCT00022945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6336634|NCT00022945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6336635|NCT00022945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6336636|NCT00022945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6336637|NCT00022945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6336638|NCT00022945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6336639|NCT00022945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6336640|NCT00022945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6336641|NCT00022945|Glucocorticoids|glucocorticoids|mesh-ancestor
6336642|NCT00022945|Hormones|hormones|mesh-ancestor
6336643|NCT00022945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6336644|NCT00022945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6336645|NCT00022945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6336646|NCT00022945|Tubulin Modulators|tubulin modulators|mesh-ancestor
6336647|NCT00022945|Antimitotic Agents|antimitotic agents|mesh-ancestor
6336648|NCT00022945|Mitosis Modulators|mitosis modulators|mesh-ancestor
6336649|NCT00022958|Tositumomab I-131|tositumomab i-131|mesh-list
6336650|NCT00022958|Antibodies|antibodies|mesh-list
6336651|NCT00022958|Immunologic Factors|immunologic factors|mesh-ancestor
6336652|NCT00022958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6336653|NCT00022958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6336654|NCT00022971|Rituximab|rituximab|mesh-list
6336655|NCT00022971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6336656|NCT00022971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6336657|NCT00022971|Immunologic Factors|immunologic factors|mesh-ancestor
6336658|NCT00022971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6336659|NCT00022971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6336660|NCT00023153|Adefovir|adefovir|mesh-list
6336661|NCT00023153|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6336662|NCT00023153|Antiviral Agents|antiviral agents|mesh-ancestor
6336663|NCT00023153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6336664|NCT00023153|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6336665|NCT00023153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6336666|NCT00023153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6336667|NCT00023153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6336668|NCT00023166|Paclitaxel|paclitaxel|mesh-list
6336669|NCT00023166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6336670|NCT00023166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6336671|NCT00023166|Tubulin Modulators|tubulin modulators|mesh-ancestor
6336672|NCT00023166|Antimitotic Agents|antimitotic agents|mesh-ancestor
6336673|NCT00023166|Mitosis Modulators|mitosis modulators|mesh-ancestor
6336674|NCT00023166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6336675|NCT00023218|Ritonavir|ritonavir|mesh-list
6336676|NCT00023218|Lopinavir|lopinavir|mesh-list
6336677|NCT00023218|Efavirenz|efavirenz|mesh-list
6336678|NCT00023218|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6336679|NCT00023218|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6336680|NCT00023218|Protease Inhibitors|protease inhibitors|mesh-ancestor
6336681|NCT00023218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6393606|NCT00199212|Trastuzumab|trastuzumab|mesh-list
6336682|NCT00023218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6336683|NCT00023218|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6336684|NCT00023218|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6336685|NCT00023218|Antiviral Agents|antiviral agents|mesh-ancestor
6336686|NCT00023218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6336687|NCT00023218|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6336688|NCT00023218|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6336689|NCT00023218|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6336690|NCT00023218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6336691|NCT00023218|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6336692|NCT00023218|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6336693|NCT00023218|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6336694|NCT00023218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6336695|NCT00023218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6336696|NCT00023231|Mycophenolic Acid|mycophenolic acid|mesh-list
6336697|NCT00023231|Sirolimus|sirolimus|mesh-list
6336698|NCT00023231|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6336699|NCT00023231|Ganciclovir|ganciclovir|mesh-list
6336700|NCT00023231|Prednisone|prednisone|mesh-list
6336701|NCT00023231|Methylprednisolone|methylprednisolone|mesh-list
6336702|NCT00023231|Atorvastatin|atorvastatin|mesh-list
6336703|NCT00023231|Daclizumab|daclizumab|mesh-list
6336704|NCT00023231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6336705|NCT00023231|Glucocorticoids|glucocorticoids|mesh-ancestor
6336706|NCT00023231|Hormones|hormones|mesh-ancestor
6336707|NCT00023231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6336708|NCT00023231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6336709|NCT00023231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6336710|NCT00023231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6336711|NCT00023231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6336712|NCT00023231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6336713|NCT00023231|Antitubercular Agents|antitubercular agents|mesh-ancestor
6336714|NCT00023231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6336715|NCT00023231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6336716|NCT00023231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6336717|NCT00023231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6336718|NCT00023231|Antifungal Agents|antifungal agents|mesh-ancestor
6336719|NCT00023231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6336720|NCT00023231|Immunologic Factors|immunologic factors|mesh-ancestor
6336721|NCT00023231|Antiemetics|antiemetics|mesh-ancestor
6336722|NCT00023231|Autonomic Agents|autonomic agents|mesh-ancestor
6336723|NCT00023231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6336724|NCT00023231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6336725|NCT00023231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6336726|NCT00023231|Protective Agents|protective agents|mesh-ancestor
6336727|NCT00023231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6336728|NCT00023231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6336729|NCT00023231|Antimetabolites|antimetabolites|mesh-ancestor
6336730|NCT00023231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6336731|NCT00023231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6336732|NCT00023231|Antiviral Agents|antiviral agents|mesh-ancestor
6336733|NCT00023231|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6336734|NCT00023231|Renal Agents|renal agents|mesh-ancestor
6336735|NCT00023231|Antimalarials|antimalarials|mesh-ancestor
6336736|NCT00023231|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6336737|NCT00023231|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6336738|NCT00023244|Cyclosporine|cyclosporine|mesh-list
6336739|NCT00023244|Sirolimus|sirolimus|mesh-list
6336740|NCT00023244|Trimethoprim|trimethoprim|mesh-list
6336741|NCT00023244|Sulfamethoxazole|sulfamethoxazole|mesh-list
6336742|NCT00023244|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6336743|NCT00023244|Prednisone|prednisone|mesh-list
6336744|NCT00023244|Methylprednisolone|methylprednisolone|mesh-list
6336745|NCT00023244|Tacrolimus|tacrolimus|mesh-list
6336746|NCT00023244|Cyclosporins|cyclosporins|mesh-list
6336747|NCT00023244|Basiliximab|basiliximab|mesh-list
6336748|NCT00023244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6336749|NCT00023244|Glucocorticoids|glucocorticoids|mesh-ancestor
6336750|NCT00023244|Hormones|hormones|mesh-ancestor
6336751|NCT00023244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6336752|NCT00023244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6336753|NCT00023244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6336754|NCT00023244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6336755|NCT00023244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6336756|NCT00023244|Immunologic Factors|immunologic factors|mesh-ancestor
6336757|NCT00023244|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6336758|NCT00023244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6336759|NCT00023244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6336760|NCT00023244|Antifungal Agents|antifungal agents|mesh-ancestor
6336761|NCT00023244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6336762|NCT00023244|Dermatologic Agents|dermatologic agents|mesh-ancestor
6336763|NCT00023244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6336764|NCT00023244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6336765|NCT00023244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6336766|NCT00023244|Antiemetics|antiemetics|mesh-ancestor
6336767|NCT00023244|Autonomic Agents|autonomic agents|mesh-ancestor
6336768|NCT00023244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6336769|NCT00023244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6336770|NCT00023244|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6336771|NCT00023244|Protective Agents|protective agents|mesh-ancestor
6336772|NCT00023244|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6336773|NCT00023244|Renal Agents|renal agents|mesh-ancestor
6336774|NCT00023244|Antimalarials|antimalarials|mesh-ancestor
6336775|NCT00023244|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6336776|NCT00023244|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6336777|NCT00023244|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6336778|NCT00023244|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6336779|NCT00023244|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6336780|NCT00023244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6336781|NCT00023283|Buprenorphine|buprenorphine|mesh-list
6336782|NCT00023283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6336783|NCT00023283|Narcotics|narcotics|mesh-ancestor
6336784|NCT00023283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6336785|NCT00023283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6336786|NCT00023283|Analgesics|analgesics|mesh-ancestor
6336787|NCT00023283|Sensory System Agents|sensory system agents|mesh-ancestor
6336788|NCT00023283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6336789|NCT00023283|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6336790|NCT00023296|Nitric Oxide|nitric oxide|mesh-list
6336791|NCT00023296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6336792|NCT00023296|Autonomic Agents|autonomic agents|mesh-ancestor
6336793|NCT00023296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6336794|NCT00023296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6336795|NCT00023296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6336796|NCT00023296|Respiratory System Agents|respiratory system agents|mesh-ancestor
6336797|NCT00023296|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6336798|NCT00023296|Antioxidants|antioxidants|mesh-ancestor
6336799|NCT00023296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6336800|NCT00023296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6336801|NCT00023296|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6336802|NCT00023296|Vasodilator Agents|vasodilator agents|mesh-ancestor
6336803|NCT00023296|Gasotransmitters|gasotransmitters|mesh-ancestor
6336804|NCT00023296|Protective Agents|protective agents|mesh-ancestor
6336805|NCT00023335|Isoniazid|isoniazid|mesh-list
6336806|NCT00023335|Rifapentine|rifapentine|mesh-list
6336807|NCT00023335|Antitubercular Agents|antitubercular agents|mesh-ancestor
6336808|NCT00023335|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6336809|NCT00023335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6336810|NCT00023335|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6336811|NCT00023335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6336812|NCT00023335|Antimetabolites|antimetabolites|mesh-ancestor
6336813|NCT00023335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6336814|NCT00023335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6336815|NCT00023335|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6336816|NCT00023335|Leprostatic Agents|leprostatic agents|mesh-ancestor
6336817|NCT00023348|Isoniazid|isoniazid|mesh-list
6336818|NCT00023348|Rifabutin|rifabutin|mesh-list
6336819|NCT00023348|Antitubercular Agents|antitubercular agents|mesh-ancestor
6336820|NCT00023348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6336821|NCT00023348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6336822|NCT00023348|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6336823|NCT00023348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6336824|NCT00023348|Antimetabolites|antimetabolites|mesh-ancestor
6336825|NCT00023348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6336826|NCT00023348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6336827|NCT00023348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6336828|NCT00023361|Rifabutin|rifabutin|mesh-list
6336829|NCT00023361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6336830|NCT00023361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6336831|NCT00023361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6336832|NCT00023361|Antitubercular Agents|antitubercular agents|mesh-ancestor
6336833|NCT00023374|Rifampin|rifampin|mesh-list
6336834|NCT00023374|Pyrazinamide|pyrazinamide|mesh-list
6336835|NCT00023374|Ethambutol|ethambutol|mesh-list
6336836|NCT00023374|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6336837|NCT00023374|Antitubercular Agents|antitubercular agents|mesh-ancestor
6336838|NCT00023374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6336839|NCT00023374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6336840|NCT00023374|Leprostatic Agents|leprostatic agents|mesh-ancestor
6336841|NCT00023374|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6336842|NCT00023374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6336843|NCT00023374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6336844|NCT00023374|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6336845|NCT00023374|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6336846|NCT00023374|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6336847|NCT00023374|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6336848|NCT00023374|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6336849|NCT00023374|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6336850|NCT00023387|Isoniazid|isoniazid|mesh-list
6336851|NCT00023387|Rifapentine|rifapentine|mesh-list
6336852|NCT00023387|Rifampin|rifampin|mesh-list
6336853|NCT00023387|Antitubercular Agents|antitubercular agents|mesh-ancestor
6336854|NCT00023387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6336855|NCT00023387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6393607|NCT00199212|Bortezomib|bortezomib|mesh-list
6336856|NCT00023387|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6336857|NCT00023387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6336858|NCT00023387|Antimetabolites|antimetabolites|mesh-ancestor
6336859|NCT00023387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6336860|NCT00023387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6336861|NCT00023387|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6336862|NCT00023387|Leprostatic Agents|leprostatic agents|mesh-ancestor
6336863|NCT00023387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6336864|NCT00023387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6336865|NCT00023387|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6336866|NCT00023387|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6336867|NCT00023387|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6336868|NCT00023387|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6336869|NCT00023387|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6336870|NCT00023387|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6336871|NCT00023400|Nelfinavir|nelfinavir|mesh-list
6336872|NCT00023400|Rifabutin|rifabutin|mesh-list
6336873|NCT00023400|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6336874|NCT00023400|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6336875|NCT00023400|Protease Inhibitors|protease inhibitors|mesh-ancestor
6336876|NCT00023400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6336877|NCT00023400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6336878|NCT00023400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6336879|NCT00023400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6336880|NCT00023400|Antiviral Agents|antiviral agents|mesh-ancestor
6336881|NCT00023400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6336882|NCT00023400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6336883|NCT00023400|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6336884|NCT00023400|Antitubercular Agents|antitubercular agents|mesh-ancestor
6336885|NCT00023413|Efavirenz|efavirenz|mesh-list
6336886|NCT00023413|Rifabutin|rifabutin|mesh-list
6336887|NCT00023413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6336888|NCT00023413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6336889|NCT00023413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6336890|NCT00023413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6336891|NCT00023413|Antiviral Agents|antiviral agents|mesh-ancestor
6336892|NCT00023413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6336893|NCT00023413|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6336894|NCT00023413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6336895|NCT00023413|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6336896|NCT00023413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6336897|NCT00023413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6336898|NCT00023413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6336899|NCT00023413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6336900|NCT00023413|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6336901|NCT00023413|Antitubercular Agents|antitubercular agents|mesh-ancestor
6336902|NCT00023426|Rifapentine|rifapentine|mesh-list
6336903|NCT00023426|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6336904|NCT00023426|Antitubercular Agents|antitubercular agents|mesh-ancestor
6336905|NCT00023426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6336906|NCT00023426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6336907|NCT00023426|Leprostatic Agents|leprostatic agents|mesh-ancestor
6336908|NCT00023504|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6336909|NCT00023504|Immunologic Factors|immunologic factors|mesh-ancestor
6336910|NCT00023504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6336911|NCT00023530|Thalidomide|thalidomide|mesh-list
6336912|NCT00023530|Fluconazole|fluconazole|mesh-list
6336913|NCT00023530|Voriconazole|voriconazole|mesh-list
6336914|NCT00023530|Dexamethasone|dexamethasone|mesh-list
6336915|NCT00023530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6336916|NCT00023530|Antiemetics|antiemetics|mesh-ancestor
6336917|NCT00023530|Autonomic Agents|autonomic agents|mesh-ancestor
6336918|NCT00023530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6336919|NCT00023530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6336920|NCT00023530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6336921|NCT00023530|Glucocorticoids|glucocorticoids|mesh-ancestor
6336922|NCT00023530|Hormones|hormones|mesh-ancestor
6336923|NCT00023530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6336924|NCT00023530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6336925|NCT00023530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6336926|NCT00023530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6336927|NCT00023530|Immunologic Factors|immunologic factors|mesh-ancestor
6336928|NCT00023530|Leprostatic Agents|leprostatic agents|mesh-ancestor
6336929|NCT00023530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6336930|NCT00023530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6336931|NCT00023530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6336932|NCT00023530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6336933|NCT00023530|Growth Substances|growth substances|mesh-ancestor
6336934|NCT00023530|Growth Inhibitors|growth inhibitors|mesh-ancestor
6336935|NCT00023530|Antifungal Agents|antifungal agents|mesh-ancestor
6336936|NCT00023530|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6336937|NCT00023530|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6336938|NCT00023530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6336939|NCT00023530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6336940|NCT00023530|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6336941|NCT00023530|Hormone Antagonists|hormone antagonists|mesh-ancestor
6336942|NCT00023530|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6336943|NCT00023530|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6336944|NCT00023530|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6336945|NCT00023621|Celecoxib|celecoxib|mesh-list
6336946|NCT00023621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6336947|NCT00023621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6336948|NCT00023621|Analgesics|analgesics|mesh-ancestor
6336949|NCT00023621|Sensory System Agents|sensory system agents|mesh-ancestor
6336950|NCT00023621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6336951|NCT00023621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6336952|NCT00023621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6336953|NCT00023621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6336954|NCT00023621|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6336955|NCT00023621|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6336956|NCT00023621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6336957|NCT00023621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6336958|NCT00023634|Sargramostim|sargramostim|mesh-list
6336959|NCT00023634|Immunologic Factors|immunologic factors|mesh-ancestor
6336960|NCT00023634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6336961|NCT00023660|Celecoxib|celecoxib|mesh-list
6336962|NCT00023660|Fluorouracil|fluorouracil|mesh-list
6336963|NCT00023660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6336964|NCT00023660|Antimetabolites|antimetabolites|mesh-ancestor
6336965|NCT00023660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6336966|NCT00023660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6336967|NCT00023660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6336968|NCT00023660|Immunologic Factors|immunologic factors|mesh-ancestor
6336969|NCT00023660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6336970|NCT00023660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6336971|NCT00023660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6336972|NCT00023660|Analgesics|analgesics|mesh-ancestor
6336973|NCT00023660|Sensory System Agents|sensory system agents|mesh-ancestor
6336974|NCT00023660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6336975|NCT00023660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6336976|NCT00023660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6336977|NCT00023660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6336978|NCT00023660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6336979|NCT00023660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6336980|NCT00023699|Gefitinib|gefitinib|mesh-list
6336981|NCT00023699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6336982|NCT00023699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6336983|NCT00023699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6336984|NCT00023699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6336985|NCT00023725|Semaxinib|semaxinib|mesh-list
6336986|NCT00023725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6336987|NCT00023725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6336988|NCT00023725|Growth Substances|growth substances|mesh-ancestor
6336989|NCT00023725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6336990|NCT00023725|Growth Inhibitors|growth inhibitors|mesh-ancestor
6336991|NCT00023725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6336992|NCT00023725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6336993|NCT00023725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6336994|NCT00023725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393608|NCT00199212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6393609|NCT00199212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6393610|NCT00199225|Moxifloxacin|moxifloxacin|mesh-list
6393611|NCT00199225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6393612|NCT00199225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6393613|NCT00199225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6393614|NCT00199225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6393615|NCT00199225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6393616|NCT00199225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393617|NCT00199225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6393618|NCT00199264|Albaconazole|albaconazole|mesh-list
6393619|NCT00199264|Antifungal Agents|antifungal agents|mesh-ancestor
6393620|NCT00199264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6393621|NCT00199277|Iron|iron|mesh-list
6393622|NCT00199277|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6393623|NCT00199277|Trace Elements|trace elements|mesh-ancestor
6393624|NCT00199277|Micronutrients|micronutrients|mesh-ancestor
6393625|NCT00199277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6393626|NCT00199277|Hematinics|hematinics|mesh-ancestor
6393627|NCT00199316|Morphine|morphine|mesh-list
6393628|NCT00199316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6393629|NCT00199316|Narcotics|narcotics|mesh-ancestor
6393630|NCT00199316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6393631|NCT00199316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6393632|NCT00199316|Analgesics|analgesics|mesh-ancestor
6393633|NCT00199316|Sensory System Agents|sensory system agents|mesh-ancestor
6393634|NCT00199316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6393635|NCT00199329|Ondansetron|ondansetron|mesh-list
6393636|NCT00199329|Antiemetics|antiemetics|mesh-ancestor
6393637|NCT00199329|Autonomic Agents|autonomic agents|mesh-ancestor
6393638|NCT00199329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6393639|NCT00199329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6393640|NCT00199329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6393641|NCT00199329|Antipruritics|antipruritics|mesh-ancestor
6336995|NCT00023738|Doxorubicin|doxorubicin|mesh-list
6336996|NCT00023738|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6336997|NCT00023738|Ifosfamide|ifosfamide|mesh-list
6336998|NCT00023738|Dacarbazine|dacarbazine|mesh-list
6336999|NCT00023738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6337000|NCT00023738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337001|NCT00023738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6337002|NCT00023738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6337003|NCT00023738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6337004|NCT00023738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337005|NCT00023738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6337006|NCT00023738|Alkylating Agents|alkylating agents|mesh-ancestor
6337007|NCT00023751|Leucovorin|leucovorin|mesh-list
6337008|NCT00023751|Fluorouracil|fluorouracil|mesh-list
6337009|NCT00023751|Calcium|calcium|mesh-list
6337010|NCT00023751|Levoleucovorin|levoleucovorin|mesh-list
6337011|NCT00023751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6337012|NCT00023751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6337013|NCT00023751|Antimetabolites|antimetabolites|mesh-ancestor
6337014|NCT00023751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337015|NCT00023751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6337016|NCT00023751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337017|NCT00023751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6337018|NCT00023751|Immunologic Factors|immunologic factors|mesh-ancestor
6337019|NCT00023751|Antidotes|antidotes|mesh-ancestor
6337020|NCT00023751|Protective Agents|protective agents|mesh-ancestor
6337021|NCT00023751|Vitamin B Complex|vitamin b complex|mesh-ancestor
6337022|NCT00023751|Vitamins|vitamins|mesh-ancestor
6337023|NCT00023751|Micronutrients|micronutrients|mesh-ancestor
6337024|NCT00023777|Cytarabine|cytarabine|mesh-list
6337025|NCT00023777|Daunorubicin|daunorubicin|mesh-list
6337026|NCT00023777|Sargramostim|sargramostim|mesh-list
6337027|NCT00023777|Immunologic Factors|immunologic factors|mesh-ancestor
6337028|NCT00023777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6337029|NCT00023777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6337030|NCT00023777|Antimetabolites|antimetabolites|mesh-ancestor
6337031|NCT00023777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337032|NCT00023777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337033|NCT00023777|Antiviral Agents|antiviral agents|mesh-ancestor
6337034|NCT00023777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6337035|NCT00023777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6337036|NCT00023777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6337037|NCT00023777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6337038|NCT00023777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6337039|NCT00023777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6337040|NCT00023790|Silicon|silicon|mesh-list
6337041|NCT00023790|Silicon phthalocyanine|silicon phthalocyanine|mesh-list
6337042|NCT00023790|Trace Elements|trace elements|mesh-ancestor
6337043|NCT00023790|Micronutrients|micronutrients|mesh-ancestor
6337044|NCT00023790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6337045|NCT00023790|Antimalarials|antimalarials|mesh-ancestor
6016710|NCT00367055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6016711|NCT00367055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016712|NCT00367133|Triamcinolone|triamcinolone|mesh-list
6016713|NCT00367133|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6016714|NCT00367133|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6016715|NCT00367133|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6016716|NCT00367133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6016717|NCT00367133|Glucocorticoids|glucocorticoids|mesh-ancestor
6016718|NCT00367133|Hormones|hormones|mesh-ancestor
6016719|NCT00367133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6016720|NCT00367133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016721|NCT00367133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6016722|NCT00367133|Immunologic Factors|immunologic factors|mesh-ancestor
6016723|NCT00367133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6016724|NCT00367133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016725|NCT00367237|Methotrexate|methotrexate|mesh-list
6016726|NCT00367237|Infliximab|infliximab|mesh-list
6016727|NCT00367237|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6016728|NCT00367237|Abortifacient Agents|abortifacient agents|mesh-ancestor
6016729|NCT00367237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6016730|NCT00367237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016731|NCT00367237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6016732|NCT00367237|Antimetabolites|antimetabolites|mesh-ancestor
6337046|NCT00023790|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6337047|NCT00023790|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6337048|NCT00023790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6337049|NCT00023790|Antiviral Agents|antiviral agents|mesh-ancestor
6337050|NCT00023790|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6337051|NCT00023790|Dermatologic Agents|dermatologic agents|mesh-ancestor
6337052|NCT00023816|Carbendazim|carbendazim|mesh-list
6337053|NCT00023816|Antinematodal Agents|antinematodal agents|mesh-ancestor
6337054|NCT00023816|Anthelmintics|anthelmintics|mesh-ancestor
6337055|NCT00023816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6337056|NCT00023816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6337057|NCT00023829|Bicalutamide|bicalutamide|mesh-list
6337058|NCT00023829|Flutamide|flutamide|mesh-list
6337059|NCT00023829|Hormones|hormones|mesh-list
6337060|NCT00023829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6337061|NCT00023829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6337062|NCT00023829|Androgen Antagonists|androgen antagonists|mesh-ancestor
6337063|NCT00023829|Hormone Antagonists|hormone antagonists|mesh-ancestor
6337064|NCT00023829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337065|NCT00023829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6337066|NCT00023842|Mitomycins|mitomycins|mesh-list
6337067|NCT00023842|Mitomycin|mitomycin|mesh-list
6337068|NCT00023842|BCG Vaccine|bcg vaccine|mesh-list
6337069|NCT00023842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6337070|NCT00023842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337071|NCT00023842|Alkylating Agents|alkylating agents|mesh-ancestor
6337072|NCT00023842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337073|NCT00023842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6337074|NCT00023842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6337075|NCT00023842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6337076|NCT00023842|Immunologic Factors|immunologic factors|mesh-ancestor
6337077|NCT00023842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6337078|NCT00023855|Doxorubicin|doxorubicin|mesh-list
6337079|NCT00023855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6337080|NCT00023855|Bortezomib|bortezomib|mesh-list
6337081|NCT00023855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6337082|NCT00023855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337083|NCT00023855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6337084|NCT00023855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6337085|NCT00023855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6337086|NCT00023855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337087|NCT00023868|Leucovorin|leucovorin|mesh-list
6337088|NCT00023868|Doxorubicin|doxorubicin|mesh-list
6337089|NCT00023868|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6337090|NCT00023868|Fluorouracil|fluorouracil|mesh-list
6337091|NCT00023868|Irinotecan|irinotecan|mesh-list
6337092|NCT00023868|Mitomycins|mitomycins|mesh-list
6337093|NCT00023868|Mitomycin|mitomycin|mesh-list
6337094|NCT00023868|Levoleucovorin|levoleucovorin|mesh-list
6337095|NCT00023868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337096|NCT00023868|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6337097|NCT00023868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6337098|NCT00023868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6337099|NCT00023868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6337100|NCT00023868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337101|NCT00023868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6337102|NCT00023868|Antimetabolites|antimetabolites|mesh-ancestor
6337103|NCT00023868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6337104|NCT00023868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6337105|NCT00023868|Immunologic Factors|immunologic factors|mesh-ancestor
6337106|NCT00023868|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6337107|NCT00023868|Antidotes|antidotes|mesh-ancestor
6337108|NCT00023868|Protective Agents|protective agents|mesh-ancestor
6337109|NCT00023868|Vitamin B Complex|vitamin b complex|mesh-ancestor
6337110|NCT00023868|Vitamins|vitamins|mesh-ancestor
6337111|NCT00023868|Micronutrients|micronutrients|mesh-ancestor
6537085|NCT00820482|Fertility Agents|fertility agents|mesh-ancestor
6537086|NCT00820482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6537087|NCT00820482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538073|NCT00825591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538074|NCT00825591|Protective Agents|protective agents|mesh-ancestor
6538075|NCT00825591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724583|NCT03186352|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6538076|NCT00825591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6538100|NCT00825851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538101|NCT00825864|Dexamethasone|dexamethasone|mesh-list
6538102|NCT00825864|Diclofenac|diclofenac|mesh-list
6538103|NCT00825864|Dexamethasone acetate|dexamethasone acetate|mesh-list
6538104|NCT00825864|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6538105|NCT00825864|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
6538106|NCT00825864|BB 1101|bb 1101|mesh-list
6538107|NCT00825864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6538108|NCT00825864|Antiemetics|antiemetics|mesh-ancestor
6538109|NCT00825864|Autonomic Agents|autonomic agents|mesh-ancestor
6538110|NCT00825864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6538111|NCT00825864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6337112|NCT00023868|Alkylating Agents|alkylating agents|mesh-ancestor
6337113|NCT00023868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6337114|NCT00023881|Bortezomib|bortezomib|mesh-list
6337115|NCT00023881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337116|NCT00023894|Alvocidib|alvocidib|mesh-list
6337117|NCT00023894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337118|NCT00023894|Growth Inhibitors|growth inhibitors|mesh-ancestor
6337119|NCT00023894|Growth Substances|growth substances|mesh-ancestor
6337120|NCT00023894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6337121|NCT00023894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6337122|NCT00023894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6337123|NCT00023894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337124|NCT00023907|Paclitaxel|paclitaxel|mesh-list
6337125|NCT00023907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6337126|NCT00023907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337127|NCT00023907|Tubulin Modulators|tubulin modulators|mesh-ancestor
6337128|NCT00023907|Antimitotic Agents|antimitotic agents|mesh-ancestor
6337129|NCT00023907|Mitosis Modulators|mitosis modulators|mesh-ancestor
6337130|NCT00023907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337131|NCT00023920|Cytarabine|cytarabine|mesh-list
6538112|NCT00825864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6538113|NCT00825864|Glucocorticoids|glucocorticoids|mesh-ancestor
6537088|NCT00820547|Cyclophosphamide|cyclophosphamide|mesh-list
6537089|NCT00820547|Bevacizumab|bevacizumab|mesh-list
6537090|NCT00820547|Docetaxel|docetaxel|mesh-list
6537091|NCT00820547|Fluorouracil|fluorouracil|mesh-list
6537092|NCT00820547|Epirubicin|epirubicin|mesh-list
6537093|NCT00820547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6537094|NCT00820547|Immunologic Factors|immunologic factors|mesh-ancestor
6537095|NCT00820547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537096|NCT00820547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6537097|NCT00820547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6537098|NCT00820547|Alkylating Agents|alkylating agents|mesh-ancestor
6537099|NCT00820547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537100|NCT00820547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6537101|NCT00820547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6537102|NCT00820547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6537103|NCT00820547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6537104|NCT00820547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6337132|NCT00023920|Bevacizumab|bevacizumab|mesh-list
6337133|NCT00023920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6337134|NCT00023920|Idarubicin|idarubicin|mesh-list
6337135|NCT00023920|Antibodies|antibodies|mesh-list
6337136|NCT00023920|Immunoglobulins|immunoglobulins|mesh-list
6337137|NCT00023920|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6337138|NCT00023920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337139|NCT00023920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6337140|NCT00023920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6337141|NCT00023920|Growth Substances|growth substances|mesh-ancestor
6337142|NCT00023920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6337143|NCT00023920|Growth Inhibitors|growth inhibitors|mesh-ancestor
6337144|NCT00023920|Immunologic Factors|immunologic factors|mesh-ancestor
6537105|NCT00820547|Growth Substances|growth substances|mesh-ancestor
6537106|NCT00820547|Growth Inhibitors|growth inhibitors|mesh-ancestor
6537107|NCT00820547|Tubulin Modulators|tubulin modulators|mesh-ancestor
6537108|NCT00820547|Antimitotic Agents|antimitotic agents|mesh-ancestor
6537109|NCT00820547|Mitosis Modulators|mitosis modulators|mesh-ancestor
6537110|NCT00820547|Antimetabolites|antimetabolites|mesh-ancestor
6537111|NCT00820547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6537112|NCT00820547|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6537113|NCT00820547|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6537114|NCT00820547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6537115|NCT00820547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6537116|NCT00820690|Paclitaxel|paclitaxel|mesh-list
6337145|NCT00023920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6337146|NCT00023920|Antimetabolites|antimetabolites|mesh-ancestor
6337147|NCT00023920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337148|NCT00023920|Antiviral Agents|antiviral agents|mesh-ancestor
6337149|NCT00023920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6337150|NCT00023920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6337151|NCT00023920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6337152|NCT00023920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6337153|NCT00023920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6337154|NCT00023920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6337155|NCT00023933|Antibodies|antibodies|mesh-list
6337156|NCT00023933|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6337157|NCT00023933|Immunologic Factors|immunologic factors|mesh-ancestor
6337158|NCT00023933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6337159|NCT00023946|Epothilones|epothilones|mesh-list
6337160|NCT00023946|Epothilone B|epothilone b|mesh-list
6337161|NCT00023946|Tubulin Modulators|tubulin modulators|mesh-ancestor
6337162|NCT00023946|Antimitotic Agents|antimitotic agents|mesh-ancestor
6337163|NCT00023946|Mitosis Modulators|mitosis modulators|mesh-ancestor
6337164|NCT00023946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337165|NCT00023946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337166|NCT00023959|Bevacizumab|bevacizumab|mesh-list
6337167|NCT00023959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6337168|NCT00023959|Fluorouracil|fluorouracil|mesh-list
6337169|NCT00023959|Hydroxyurea|hydroxyurea|mesh-list
6337170|NCT00023959|Antibodies|antibodies|mesh-list
6337171|NCT00023959|Immunoglobulins|immunoglobulins|mesh-list
6337172|NCT00023959|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6337173|NCT00023959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337174|NCT00023959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6337175|NCT00023959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6337176|NCT00023959|Growth Substances|growth substances|mesh-ancestor
6337177|NCT00023959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6337178|NCT00023959|Growth Inhibitors|growth inhibitors|mesh-ancestor
6337179|NCT00023959|Immunologic Factors|immunologic factors|mesh-ancestor
6337180|NCT00023959|Antimetabolites|antimetabolites|mesh-ancestor
6337181|NCT00023959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337182|NCT00023959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6337183|NCT00023959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6337184|NCT00023959|Antisickling Agents|antisickling agents|mesh-ancestor
6337185|NCT00023959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6337186|NCT00023959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6337187|NCT00023972|Gemcitabine|gemcitabine|mesh-list
6337188|NCT00023972|Exatecan|exatecan|mesh-list
6337189|NCT00023972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6337190|NCT00023972|Antimetabolites|antimetabolites|mesh-ancestor
6337191|NCT00023972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337192|NCT00023972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337193|NCT00023972|Antiviral Agents|antiviral agents|mesh-ancestor
6337194|NCT00023972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6337195|NCT00023972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6337196|NCT00023972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6337197|NCT00023972|Immunologic Factors|immunologic factors|mesh-ancestor
6337198|NCT00023972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6337199|NCT00023972|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6337200|NCT00023972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6337201|NCT00023998|Leucovorin|leucovorin|mesh-list
6337202|NCT00023998|Doxorubicin|doxorubicin|mesh-list
6337203|NCT00023998|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6337204|NCT00023998|Methotrexate|methotrexate|mesh-list
6337205|NCT00023998|Trastuzumab|trastuzumab|mesh-list
6337206|NCT00023998|Etoposide|etoposide|mesh-list
6337207|NCT00023998|Etoposide phosphate|etoposide phosphate|mesh-list
6337208|NCT00023998|Ifosfamide|ifosfamide|mesh-list
6337209|NCT00023998|Levoleucovorin|levoleucovorin|mesh-list
6337210|NCT00023998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337211|NCT00023998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6337212|NCT00023998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6337213|NCT00023998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6337214|NCT00023998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6337215|NCT00023998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337216|NCT00023998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6337217|NCT00023998|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6337218|NCT00023998|Abortifacient Agents|abortifacient agents|mesh-ancestor
6337219|NCT00023998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6016733|NCT00367237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016734|NCT00367237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6016735|NCT00367237|Dermatologic Agents|dermatologic agents|mesh-ancestor
6016736|NCT00367237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6016737|NCT00367237|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6016738|NCT00367237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6016739|NCT00367237|Immunologic Factors|immunologic factors|mesh-ancestor
6016740|NCT00367237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6016741|NCT00367237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6016742|NCT00367237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6016743|NCT00367341|Citalopram|citalopram|mesh-list
6337220|NCT00023998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6337221|NCT00023998|Antimetabolites|antimetabolites|mesh-ancestor
6337222|NCT00023998|Dermatologic Agents|dermatologic agents|mesh-ancestor
6337223|NCT00023998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6337224|NCT00023998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6337225|NCT00023998|Immunologic Factors|immunologic factors|mesh-ancestor
6337226|NCT00023998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6337227|NCT00023998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6337228|NCT00023998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6337229|NCT00023998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6337230|NCT00023998|Antidotes|antidotes|mesh-ancestor
6337231|NCT00023998|Protective Agents|protective agents|mesh-ancestor
6337232|NCT00023998|Vitamin B Complex|vitamin b complex|mesh-ancestor
6337233|NCT00023998|Vitamins|vitamins|mesh-ancestor
6337234|NCT00023998|Micronutrients|micronutrients|mesh-ancestor
6337235|NCT00023998|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6337236|NCT00023998|Alkylating Agents|alkylating agents|mesh-ancestor
6337237|NCT00024011|Bortezomib|bortezomib|mesh-list
6337238|NCT00024011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337239|NCT00024050|Cyclosporine|cyclosporine|mesh-list
6337240|NCT00024050|Cyclophosphamide|cyclophosphamide|mesh-list
6337241|NCT00024050|Busulfan|busulfan|mesh-list
6337242|NCT00024050|Methotrexate|methotrexate|mesh-list
6337243|NCT00024050|Cyclosporins|cyclosporins|mesh-list
6337244|NCT00024050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6337245|NCT00024050|Immunologic Factors|immunologic factors|mesh-ancestor
6337246|NCT00024050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6337247|NCT00024050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6337248|NCT00024050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6337249|NCT00024050|Alkylating Agents|alkylating agents|mesh-ancestor
6337250|NCT00024050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337251|NCT00024050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337252|NCT00024050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6337253|NCT00024050|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6337254|NCT00024050|Abortifacient Agents|abortifacient agents|mesh-ancestor
6337255|NCT00024050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6337256|NCT00024050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6337257|NCT00024050|Antimetabolites|antimetabolites|mesh-ancestor
6337258|NCT00024050|Dermatologic Agents|dermatologic agents|mesh-ancestor
6337259|NCT00024050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6337260|NCT00024050|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6337261|NCT00024050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6337262|NCT00024050|Antifungal Agents|antifungal agents|mesh-ancestor
6337263|NCT00024050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6337264|NCT00024050|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6337265|NCT00024063|Orantinib|orantinib|mesh-list
6337266|NCT00024063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6337267|NCT00024063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6337268|NCT00024063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337269|NCT00024089|Gefitinib|gefitinib|mesh-list
6337270|NCT00024089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337271|NCT00024089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6337272|NCT00024089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6337273|NCT00024089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393642|NCT00199329|Dermatologic Agents|dermatologic agents|mesh-ancestor
6393643|NCT00199329|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6393644|NCT00199329|Serotonin Agents|serotonin agents|mesh-ancestor
6393645|NCT00199329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6393646|NCT00199329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393647|NCT00199329|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6393648|NCT00199329|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6393649|NCT00199329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6393650|NCT00199329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6393651|NCT00199329|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6393652|NCT00199342|Ecromeximab|ecromeximab|mesh-list
6393653|NCT00199342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6393654|NCT00199342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6393655|NCT00199355|Istradefylline|istradefylline|mesh-list
6537117|NCT00820690|Cyclophosphamide|cyclophosphamide|mesh-list
6537118|NCT00820690|Doxorubicin|doxorubicin|mesh-list
6537119|NCT00820690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6537120|NCT00820690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6537121|NCT00820690|Tubulin Modulators|tubulin modulators|mesh-ancestor
6537122|NCT00820690|Antimitotic Agents|antimitotic agents|mesh-ancestor
6537123|NCT00820690|Mitosis Modulators|mitosis modulators|mesh-ancestor
6537124|NCT00820690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337274|NCT00024115|Antibodies|antibodies|mesh-list
6337275|NCT00024115|Immunotoxins|immunotoxins|mesh-list
6337276|NCT00024115|Immunologic Factors|immunologic factors|mesh-list
6337277|NCT00024115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6337278|NCT00024128|Cyclosporine|cyclosporine|mesh-list
6337279|NCT00024128|Cyclophosphamide|cyclophosphamide|mesh-list
6337280|NCT00024128|Cyclosporins|cyclosporins|mesh-list
6337281|NCT00024128|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6337282|NCT00024128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6337283|NCT00024128|Immunologic Factors|immunologic factors|mesh-ancestor
6337284|NCT00024128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6337285|NCT00024128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6337286|NCT00024128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6337287|NCT00024128|Alkylating Agents|alkylating agents|mesh-ancestor
6337288|NCT00024128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337289|NCT00024128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337290|NCT00024128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6337291|NCT00024128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6337292|NCT00024128|Antifungal Agents|antifungal agents|mesh-ancestor
6537125|NCT00820690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6537126|NCT00820690|Immunologic Factors|immunologic factors|mesh-ancestor
6537127|NCT00820690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537128|NCT00820690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6537129|NCT00820690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6537130|NCT00820690|Alkylating Agents|alkylating agents|mesh-ancestor
6537131|NCT00820690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6537132|NCT00820690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6537133|NCT00820690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6537134|NCT00820690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6537135|NCT00820690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6537136|NCT00820768|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5724584|NCT03186326|Bevacizumab|bevacizumab|mesh-list
6537137|NCT00820768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6537138|NCT00820794|Lithium Carbonate|lithium carbonate|mesh-list
6537139|NCT00820794|Antidepressive Agents|antidepressive agents|mesh-ancestor
6337293|NCT00024128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6337294|NCT00024128|Dermatologic Agents|dermatologic agents|mesh-ancestor
6337295|NCT00024128|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6337296|NCT00024141|Fluorouracil|fluorouracil|mesh-list
6337297|NCT00024141|Irinotecan|irinotecan|mesh-list
6337298|NCT00024141|Antimetabolites|antimetabolites|mesh-ancestor
6337299|NCT00024141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337300|NCT00024141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6337301|NCT00024141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337302|NCT00024141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6337303|NCT00024141|Immunologic Factors|immunologic factors|mesh-ancestor
6337304|NCT00024141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6337305|NCT00024141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6337306|NCT00024141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6337307|NCT00024141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6337308|NCT00024154|Trastuzumab|trastuzumab|mesh-list
6337309|NCT00024154|Gefitinib|gefitinib|mesh-list
6337310|NCT00024154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6337311|NCT00024154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337312|NCT00024154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6337313|NCT00024154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6337314|NCT00024154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337315|NCT00024180|Romidepsin|romidepsin|mesh-list
6337316|NCT00024180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6337317|NCT00024180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337318|NCT00024193|Cyclophosphamide|cyclophosphamide|mesh-list
6337319|NCT00024193|Melphalan|melphalan|mesh-list
6337320|NCT00024193|Busulfan|busulfan|mesh-list
6337321|NCT00024193|Doxorubicin|doxorubicin|mesh-list
6337322|NCT00024193|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6337323|NCT00024193|Etoposide|etoposide|mesh-list
6337324|NCT00024193|Vincristine|vincristine|mesh-list
6337325|NCT00024193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6337326|NCT00024193|Immunologic Factors|immunologic factors|mesh-ancestor
6337327|NCT00024193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6337328|NCT00024193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6337329|NCT00024193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6337330|NCT00024193|Alkylating Agents|alkylating agents|mesh-ancestor
6337331|NCT00024193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337332|NCT00024193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337333|NCT00024193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6337334|NCT00024193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6337335|NCT00024193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6337336|NCT00024193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6337337|NCT00024193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6337338|NCT00024193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6337339|NCT00024193|Tubulin Modulators|tubulin modulators|mesh-ancestor
6337340|NCT00024193|Antimitotic Agents|antimitotic agents|mesh-ancestor
6337341|NCT00024193|Mitosis Modulators|mitosis modulators|mesh-ancestor
6337342|NCT00024206|Orantinib|orantinib|mesh-list
6337343|NCT00024206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6337344|NCT00024206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6337345|NCT00024206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337346|NCT00024232|Antibodies|antibodies|mesh-list
6337347|NCT00024232|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6337348|NCT00024232|Immunologic Factors|immunologic factors|mesh-ancestor
6337349|NCT00024232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6337350|NCT00024245|Probenecid|probenecid|mesh-list
6337351|NCT00024245|Uricosuric Agents|uricosuric agents|mesh-ancestor
6337352|NCT00024245|Gout Suppressants|gout suppressants|mesh-ancestor
6337353|NCT00024245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6337354|NCT00024245|Renal Agents|renal agents|mesh-ancestor
6337355|NCT00024271|Gemcitabine|gemcitabine|mesh-list
6337356|NCT00024271|Interferons|interferons|mesh-list
6337357|NCT00024271|Interferon-gamma|interferon-gamma|mesh-list
6337358|NCT00024271|Doxorubicin|doxorubicin|mesh-list
6337359|NCT00024271|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6337360|NCT00024271|Mitomycins|mitomycins|mesh-list
6337361|NCT00024271|Mitomycin|mitomycin|mesh-list
6337362|NCT00024271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337363|NCT00024271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6337364|NCT00024271|Antimetabolites|antimetabolites|mesh-ancestor
6337365|NCT00024271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337366|NCT00024271|Antiviral Agents|antiviral agents|mesh-ancestor
6337367|NCT00024271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6337368|NCT00024271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6337369|NCT00024271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6337370|NCT00024271|Immunologic Factors|immunologic factors|mesh-ancestor
6337371|NCT00024271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6337372|NCT00024271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6337373|NCT00024271|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6337374|NCT00024271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6337375|NCT00024271|Alkylating Agents|alkylating agents|mesh-ancestor
6337376|NCT00024271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6337377|NCT00024284|Carboplatin|carboplatin|mesh-list
6337378|NCT00024284|Irinotecan|irinotecan|mesh-list
6337379|NCT00024284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337380|NCT00024284|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6337381|NCT00024284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6337382|NCT00024284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6337383|NCT00024284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337384|NCT00024297|Warfarin|warfarin|mesh-list
6337385|NCT00024297|Anticoagulants|anticoagulants|mesh-ancestor
6337386|NCT00024310|Folic Acid|folic acid|mesh-list
6337387|NCT00024310|Paclitaxel|paclitaxel|mesh-list
6337388|NCT00024310|Lometrexol|lometrexol|mesh-list
6337389|NCT00024310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6337390|NCT00024310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337391|NCT00024310|Tubulin Modulators|tubulin modulators|mesh-ancestor
6337392|NCT00024310|Antimitotic Agents|antimitotic agents|mesh-ancestor
6337393|NCT00024310|Mitosis Modulators|mitosis modulators|mesh-ancestor
6337394|NCT00024310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337395|NCT00024310|Hematinics|hematinics|mesh-ancestor
6337396|NCT00024310|Vitamin B Complex|vitamin b complex|mesh-ancestor
6337397|NCT00024310|Vitamins|vitamins|mesh-ancestor
6337398|NCT00024310|Micronutrients|micronutrients|mesh-ancestor
6337399|NCT00024310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6337400|NCT00024310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6337401|NCT00024310|Antimetabolites|antimetabolites|mesh-ancestor
6337402|NCT00024310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6337403|NCT00024310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6337404|NCT00024323|Cisplatin|cisplatin|mesh-list
6337405|NCT00024323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337406|NCT00024336|Tamoxifen|tamoxifen|mesh-list
6337407|NCT00024336|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6337408|NCT00024336|Hormone Antagonists|hormone antagonists|mesh-ancestor
6337409|NCT00024336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6337410|NCT00024336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6337411|NCT00024336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6337412|NCT00024336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337413|NCT00024336|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6337414|NCT00024336|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6337415|NCT00024336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6337416|NCT00024349|Fluorouracil|fluorouracil|mesh-list
6337417|NCT00024349|Mitomycins|mitomycins|mesh-list
6016744|NCT00367341|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6016745|NCT00367341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6337418|NCT00024349|Mitomycin|mitomycin|mesh-list
6337419|NCT00024349|Antimetabolites|antimetabolites|mesh-ancestor
6337420|NCT00024349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337421|NCT00024349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6337422|NCT00024349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337423|NCT00024349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6337424|NCT00024349|Immunologic Factors|immunologic factors|mesh-ancestor
6337425|NCT00024349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6337426|NCT00024349|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6337427|NCT00024349|Alkylating Agents|alkylating agents|mesh-ancestor
6337428|NCT00024349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6337429|NCT00024349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6337430|NCT00024362|BBR 3464|bbr 3464|mesh-list
6337431|NCT00024362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337432|NCT00024375|Paclitaxel|paclitaxel|mesh-list
6337433|NCT00024375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6337434|NCT00024375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337435|NCT00024375|Tubulin Modulators|tubulin modulators|mesh-ancestor
6337436|NCT00024375|Antimitotic Agents|antimitotic agents|mesh-ancestor
6337437|NCT00024375|Mitosis Modulators|mitosis modulators|mesh-ancestor
6393656|NCT00199355|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
6337438|NCT00024375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337439|NCT00024388|Paclitaxel|paclitaxel|mesh-list
6337440|NCT00024388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6337441|NCT00024388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337442|NCT00024388|Tubulin Modulators|tubulin modulators|mesh-ancestor
6337443|NCT00024388|Antimitotic Agents|antimitotic agents|mesh-ancestor
6337444|NCT00024388|Mitosis Modulators|mitosis modulators|mesh-ancestor
6016746|NCT00367341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6016747|NCT00367341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016748|NCT00367341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6016749|NCT00367341|Serotonin Agents|serotonin agents|mesh-ancestor
6337445|NCT00024388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337446|NCT00024401|Paclitaxel|paclitaxel|mesh-list
6337447|NCT00024401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6337448|NCT00024401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337449|NCT00024401|Tubulin Modulators|tubulin modulators|mesh-ancestor
6337450|NCT00024401|Antimitotic Agents|antimitotic agents|mesh-ancestor
6337451|NCT00024401|Mitosis Modulators|mitosis modulators|mesh-ancestor
6337452|NCT00024401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337453|NCT00024414|Paclitaxel|paclitaxel|mesh-list
6337454|NCT00024414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6337455|NCT00024414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337456|NCT00024414|Tubulin Modulators|tubulin modulators|mesh-ancestor
6337457|NCT00024414|Antimitotic Agents|antimitotic agents|mesh-ancestor
6337458|NCT00024414|Mitosis Modulators|mitosis modulators|mesh-ancestor
6016750|NCT00367341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016751|NCT00367341|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6016752|NCT00367341|Antidepressive Agents|antidepressive agents|mesh-ancestor
6016753|NCT00367341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6016754|NCT00367432|Levetiracetam|levetiracetam|mesh-list
6016755|NCT00367432|Anticonvulsants|anticonvulsants|mesh-ancestor
6016756|NCT00367432|Nootropic Agents|nootropic agents|mesh-ancestor
6016757|NCT00367458|Atorvastatin|atorvastatin|mesh-list
6016758|NCT00367458|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6337459|NCT00024414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337460|NCT00024427|Gemcitabine|gemcitabine|mesh-list
6337461|NCT00024427|Fluorouracil|fluorouracil|mesh-list
6337462|NCT00024427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6337463|NCT00024427|Antimetabolites|antimetabolites|mesh-ancestor
6337464|NCT00024427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337465|NCT00024427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337466|NCT00024427|Antiviral Agents|antiviral agents|mesh-ancestor
6337467|NCT00024427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6337468|NCT00024427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6337469|NCT00024427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6337470|NCT00024427|Immunologic Factors|immunologic factors|mesh-ancestor
6337471|NCT00024427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6337472|NCT00024440|Cyclophosphamide|cyclophosphamide|mesh-list
6337473|NCT00024440|Fludarabine|fludarabine|mesh-list
6337474|NCT00024440|Fludarabine phosphate|fludarabine phosphate|mesh-list
6337475|NCT00024440|Oblimersen|oblimersen|mesh-list
6337476|NCT00024440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6337477|NCT00024440|Immunologic Factors|immunologic factors|mesh-ancestor
6337478|NCT00024440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6337479|NCT00024440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6337480|NCT00024440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6337481|NCT00024440|Alkylating Agents|alkylating agents|mesh-ancestor
6337482|NCT00024440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337483|NCT00024440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337484|NCT00024440|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6337485|NCT00024440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6337486|NCT00024440|Antimetabolites|antimetabolites|mesh-ancestor
6337487|NCT00024453|Teicoplanin|teicoplanin|mesh-list
6337488|NCT00024453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6337489|NCT00024453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6337490|NCT00024466|Vaccines|vaccines|mesh-list
6337491|NCT00024466|Immunologic Factors|immunologic factors|mesh-ancestor
6337492|NCT00024466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537140|NCT00820794|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6537141|NCT00820794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6537142|NCT00820794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537143|NCT00820794|Antimanic Agents|antimanic agents|mesh-ancestor
6337493|NCT00024492|Mitoxantrone|mitoxantrone|mesh-list
6537144|NCT00820794|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6537145|NCT00820794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6537146|NCT00820794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537147|NCT00820885|Teduglutide|teduglutide|mesh-list
6537148|NCT00820885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6537149|NCT00820885|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6537150|NCT00820885|Protective Agents|protective agents|mesh-ancestor
6537151|NCT00820885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537152|NCT00820911|Cyclosporine|cyclosporine|mesh-list
6537153|NCT00820911|Everolimus|everolimus|mesh-list
6537154|NCT00820911|Cyclosporins|cyclosporins|mesh-list
6537155|NCT00820911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6537156|NCT00820911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537157|NCT00820911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6537158|NCT00820911|Immunologic Factors|immunologic factors|mesh-ancestor
6537159|NCT00820911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537160|NCT00820911|Antifungal Agents|antifungal agents|mesh-ancestor
6537161|NCT00820911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6537162|NCT00820911|Dermatologic Agents|dermatologic agents|mesh-ancestor
6537163|NCT00820911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6537164|NCT00820911|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6537165|NCT00820911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6537166|NCT00820963|Temozolomide|temozolomide|mesh-list
6537167|NCT00820963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6537168|NCT00820963|Alkylating Agents|alkylating agents|mesh-ancestor
6537169|NCT00820963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537170|NCT00820963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6537171|NCT00821028|Paclitaxel|paclitaxel|mesh-list
6537172|NCT00821028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6537173|NCT00821028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6537174|NCT00821028|Tubulin Modulators|tubulin modulators|mesh-ancestor
6337494|NCT00024492|Analgesics|analgesics|mesh-ancestor
6337495|NCT00024492|Sensory System Agents|sensory system agents|mesh-ancestor
6337496|NCT00024492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6337497|NCT00024492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6337498|NCT00024492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337499|NCT00024492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6337500|NCT00024492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6537175|NCT00821028|Antimitotic Agents|antimitotic agents|mesh-ancestor
6537176|NCT00821028|Mitosis Modulators|mitosis modulators|mesh-ancestor
6537177|NCT00821028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337501|NCT00024492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6337502|NCT00024492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337503|NCT00024518|Interferons|interferons|mesh-list
6337504|NCT00024518|Interferon-alpha|interferon-alpha|mesh-list
6337505|NCT00024518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337506|NCT00024518|Antiviral Agents|antiviral agents|mesh-ancestor
6337507|NCT00024518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6337508|NCT00024518|Immunologic Factors|immunologic factors|mesh-ancestor
6337509|NCT00024518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6337510|NCT00024531|Atorvastatin|atorvastatin|mesh-list
6337511|NCT00024531|Calcium|calcium|mesh-list
6337512|NCT00024531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6337513|NCT00024531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6337514|NCT00024531|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6337515|NCT00024531|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6337516|NCT00024531|Antimetabolites|antimetabolites|mesh-ancestor
6337517|NCT00024531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337518|NCT00024531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6337519|NCT00024531|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6337520|NCT00024531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6337521|NCT00024544|Antibodies|antibodies|mesh-list
6337522|NCT00024544|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6337523|NCT00024544|Immunologic Factors|immunologic factors|mesh-ancestor
6337524|NCT00024544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6337525|NCT00024687|Immunotoxins|immunotoxins|mesh-list
6337526|NCT00024687|Immunologic Factors|immunologic factors|mesh-ancestor
6337527|NCT00024687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6337528|NCT00024986|Tenofovir|tenofovir|mesh-list
6337529|NCT00024986|Antiviral Agents|antiviral agents|mesh-ancestor
6337530|NCT00024986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6337531|NCT00024986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6337532|NCT00024986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6337533|NCT00024986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6337534|NCT00024986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337535|NCT00024986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6337536|NCT00024986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6337537|NCT00025012|Isotretinoin|isotretinoin|mesh-list
6337538|NCT00025012|Dermatologic Agents|dermatologic agents|mesh-ancestor
6337539|NCT00025038|Cytarabine|cytarabine|mesh-list
6337540|NCT00025038|Cyclophosphamide|cyclophosphamide|mesh-list
6337541|NCT00025038|Fludarabine|fludarabine|mesh-list
6337542|NCT00025038|Fludarabine phosphate|fludarabine phosphate|mesh-list
6337543|NCT00025038|Tipifarnib|tipifarnib|mesh-list
6337544|NCT00025038|Isotretinoin|isotretinoin|mesh-list
6337545|NCT00025038|Thymoglobulin|thymoglobulin|mesh-list
6337546|NCT00025038|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6337547|NCT00025038|Immunoglobulins|immunoglobulins|mesh-list
6337548|NCT00025038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6337549|NCT00025038|Immunologic Factors|immunologic factors|mesh-ancestor
6337550|NCT00025038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6337551|NCT00025038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6337552|NCT00025038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6337553|NCT00025038|Alkylating Agents|alkylating agents|mesh-ancestor
6337554|NCT00025038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337555|NCT00025038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337556|NCT00025038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6337557|NCT00025038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6337558|NCT00025038|Antimetabolites|antimetabolites|mesh-ancestor
6337559|NCT00025038|Antiviral Agents|antiviral agents|mesh-ancestor
6337560|NCT00025038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6337561|NCT00025038|Dermatologic Agents|dermatologic agents|mesh-ancestor
6337562|NCT00025051|Celecoxib|celecoxib|mesh-list
6337563|NCT00025051|Mitogens|mitogens|mesh-list
6337564|NCT00025051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6337565|NCT00025051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6337566|NCT00025051|Analgesics|analgesics|mesh-ancestor
6337567|NCT00025051|Sensory System Agents|sensory system agents|mesh-ancestor
6337568|NCT00025051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6337569|NCT00025051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6337570|NCT00025051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6337571|NCT00025051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6337572|NCT00025051|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5724585|NCT03186326|Cetuximab|cetuximab|mesh-list
6337573|NCT00025051|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6337574|NCT00025051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6337575|NCT00025051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337576|NCT00025051|Mitosis Modulators|mitosis modulators|mesh-ancestor
6337577|NCT00025064|Prednisolone|prednisolone|mesh-list
6337578|NCT00025064|Doxorubicin|doxorubicin|mesh-list
6337579|NCT00025064|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6337580|NCT00025064|Etoposide|etoposide|mesh-list
6337581|NCT00025064|Vincristine|vincristine|mesh-list
6337582|NCT00025064|Melphalan|melphalan|mesh-list
6337583|NCT00025064|Ifosfamide|ifosfamide|mesh-list
6337584|NCT00025064|Dacarbazine|dacarbazine|mesh-list
6337585|NCT00025064|Bleomycin|bleomycin|mesh-list
6337586|NCT00025064|Vinblastine|vinblastine|mesh-list
6337587|NCT00025064|Procarbazine|procarbazine|mesh-list
6337588|NCT00025064|Chlorambucil|chlorambucil|mesh-list
6337589|NCT00025064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337590|NCT00025064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6337591|NCT00025064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6337592|NCT00025064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6337593|NCT00025064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6337594|NCT00025064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337595|NCT00025064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6337596|NCT00025064|Tubulin Modulators|tubulin modulators|mesh-ancestor
6337597|NCT00025064|Antimitotic Agents|antimitotic agents|mesh-ancestor
6337598|NCT00025064|Mitosis Modulators|mitosis modulators|mesh-ancestor
6337599|NCT00025064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6337600|NCT00025064|Alkylating Agents|alkylating agents|mesh-ancestor
6337601|NCT00025064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6337602|NCT00025064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6337603|NCT00025064|Immunologic Factors|immunologic factors|mesh-ancestor
6337604|NCT00025064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6337605|NCT00025064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6337606|NCT00025064|Glucocorticoids|glucocorticoids|mesh-ancestor
6337607|NCT00025064|Hormones|hormones|mesh-ancestor
6337608|NCT00025064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6337609|NCT00025064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6337610|NCT00025077|Cyclophosphamide|cyclophosphamide|mesh-list
6337611|NCT00025077|Thiotepa|thiotepa|mesh-list
6337612|NCT00025077|Carboplatin|carboplatin|mesh-list
6337613|NCT00025077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6337614|NCT00025077|Immunologic Factors|immunologic factors|mesh-ancestor
6337615|NCT00025077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6337616|NCT00025077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6337617|NCT00025077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6337618|NCT00025077|Alkylating Agents|alkylating agents|mesh-ancestor
6337619|NCT00025077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337620|NCT00025077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337621|NCT00025077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6337622|NCT00025090|Fluorouracil|fluorouracil|mesh-list
6337623|NCT00025090|Mitomycins|mitomycins|mesh-list
6337624|NCT00025090|Mitomycin|mitomycin|mesh-list
6337625|NCT00025090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337626|NCT00025090|Antimetabolites|antimetabolites|mesh-ancestor
6337627|NCT00025090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337628|NCT00025090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6337629|NCT00025090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6337630|NCT00025090|Immunologic Factors|immunologic factors|mesh-ancestor
6337631|NCT00025090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6337632|NCT00025090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6337633|NCT00025090|Alkylating Agents|alkylating agents|mesh-ancestor
6337634|NCT00025090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6337635|NCT00025090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6337636|NCT00025103|Dactinomycin|dactinomycin|mesh-list
6337637|NCT00025103|Cyclophosphamide|cyclophosphamide|mesh-list
6337638|NCT00025103|Melphalan|melphalan|mesh-list
6337639|NCT00025103|Carboplatin|carboplatin|mesh-list
6337640|NCT00025103|Doxorubicin|doxorubicin|mesh-list
6337641|NCT00025103|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6337642|NCT00025103|Etoposide|etoposide|mesh-list
6337643|NCT00025103|Vincristine|vincristine|mesh-list
6337644|NCT00025103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6337645|NCT00025103|Immunologic Factors|immunologic factors|mesh-ancestor
6337646|NCT00025103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6337647|NCT00025103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6337648|NCT00025103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6337649|NCT00025103|Alkylating Agents|alkylating agents|mesh-ancestor
6337650|NCT00025103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337651|NCT00025103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337652|NCT00025103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6337653|NCT00025103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6337654|NCT00025103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6337655|NCT00025103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6337656|NCT00025103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6337657|NCT00025103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6337658|NCT00025103|Tubulin Modulators|tubulin modulators|mesh-ancestor
6337659|NCT00025103|Antimitotic Agents|antimitotic agents|mesh-ancestor
6016759|NCT00367458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6016760|NCT00367458|Antimetabolites|antimetabolites|mesh-ancestor
6337660|NCT00025103|Mitosis Modulators|mitosis modulators|mesh-ancestor
6337661|NCT00025103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6337662|NCT00025103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6337663|NCT00025103|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6337664|NCT00025103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6337665|NCT00025116|Gefitinib|gefitinib|mesh-list
6337666|NCT00025116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337667|NCT00025116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6337668|NCT00025116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6337669|NCT00025116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337670|NCT00025142|Leucovorin|leucovorin|mesh-list
6337671|NCT00025142|Fluorouracil|fluorouracil|mesh-list
6337672|NCT00025142|Oxaliplatin|oxaliplatin|mesh-list
6337673|NCT00025142|Gefitinib|gefitinib|mesh-list
6337674|NCT00025142|Calcium|calcium|mesh-list
6337675|NCT00025142|Levoleucovorin|levoleucovorin|mesh-list
6337676|NCT00025142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6337677|NCT00025142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6337678|NCT00025142|Antimetabolites|antimetabolites|mesh-ancestor
6337679|NCT00025142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337680|NCT00025142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6337681|NCT00025142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337682|NCT00025142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6337683|NCT00025142|Immunologic Factors|immunologic factors|mesh-ancestor
6337684|NCT00025142|Antidotes|antidotes|mesh-ancestor
6337685|NCT00025142|Protective Agents|protective agents|mesh-ancestor
6337686|NCT00025142|Vitamin B Complex|vitamin b complex|mesh-ancestor
6337687|NCT00025142|Vitamins|vitamins|mesh-ancestor
6337688|NCT00025142|Micronutrients|micronutrients|mesh-ancestor
6337689|NCT00025142|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6337690|NCT00025142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6337691|NCT00025168|Gemcitabine|gemcitabine|mesh-list
6337692|NCT00025168|Irinotecan|irinotecan|mesh-list
6337693|NCT00025168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6337694|NCT00025168|Antimetabolites|antimetabolites|mesh-ancestor
6337695|NCT00025168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337696|NCT00025168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337697|NCT00025168|Antiviral Agents|antiviral agents|mesh-ancestor
6337698|NCT00025168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6337699|NCT00025168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6337700|NCT00025168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6337701|NCT00025168|Immunologic Factors|immunologic factors|mesh-ancestor
6337702|NCT00025168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6337703|NCT00025168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6337704|NCT00025168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6337705|NCT00025181|Ipilimumab|ipilimumab|mesh-list
6337706|NCT00025181|Freund's Adjuvant|freund's adjuvant|mesh-list
6337707|NCT00025181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6337708|NCT00025181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337709|NCT00025181|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6337710|NCT00025181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337711|NCT00025181|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6337712|NCT00025181|Immunologic Factors|immunologic factors|mesh-ancestor
6337713|NCT00025181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6337714|NCT00025194|Estramustine|estramustine|mesh-list
6337715|NCT00025194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6337716|NCT00025194|Alkylating Agents|alkylating agents|mesh-ancestor
6337717|NCT00025194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337718|NCT00025194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337719|NCT00025194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6337720|NCT00025207|Gefitinib|gefitinib|mesh-list
6337721|NCT00025207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337722|NCT00025207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6337723|NCT00025207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6337724|NCT00025207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337725|NCT00025220|Thalidomide|thalidomide|mesh-list
6337726|NCT00025220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6337727|NCT00025220|Immunologic Factors|immunologic factors|mesh-ancestor
6337728|NCT00025220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6337729|NCT00025220|Leprostatic Agents|leprostatic agents|mesh-ancestor
6337730|NCT00025220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6337731|NCT00025220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6337732|NCT00025220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6337733|NCT00025220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6337734|NCT00025220|Growth Substances|growth substances|mesh-ancestor
6337735|NCT00025220|Growth Inhibitors|growth inhibitors|mesh-ancestor
6337736|NCT00025220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337737|NCT00025246|Imatinib Mesylate|imatinib mesylate|mesh-list
6337738|NCT00025246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337739|NCT00025246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6337740|NCT00025246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6337741|NCT00025246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337742|NCT00025272|Carboplatin|carboplatin|mesh-list
6337743|NCT00025272|Etoposide|etoposide|mesh-list
6337744|NCT00025272|Topotecan|topotecan|mesh-list
6337745|NCT00025272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337746|NCT00025272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6337747|NCT00025272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6337748|NCT00025272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6337749|NCT00025272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6337750|NCT00025272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337751|NCT00025272|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6337752|NCT00025285|Thalidomide|thalidomide|mesh-list
6337753|NCT00025285|Carboplatin|carboplatin|mesh-list
6337754|NCT00025285|Irinotecan|irinotecan|mesh-list
6337755|NCT00025285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337756|NCT00025285|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6337757|NCT00025285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6337758|NCT00025285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6337759|NCT00025285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337760|NCT00025285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6337761|NCT00025285|Immunologic Factors|immunologic factors|mesh-ancestor
6337762|NCT00025285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6337763|NCT00025285|Leprostatic Agents|leprostatic agents|mesh-ancestor
6337764|NCT00025285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6337765|NCT00025285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6337766|NCT00025285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6337767|NCT00025285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6337768|NCT00025285|Growth Substances|growth substances|mesh-ancestor
6337769|NCT00025285|Growth Inhibitors|growth inhibitors|mesh-ancestor
6337770|NCT00025298|Paclitaxel|paclitaxel|mesh-list
6337771|NCT00025298|Carboplatin|carboplatin|mesh-list
6337772|NCT00025298|Amifostine|amifostine|mesh-list
6337773|NCT00025298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6337774|NCT00025298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337775|NCT00025298|Tubulin Modulators|tubulin modulators|mesh-ancestor
6337776|NCT00025298|Antimitotic Agents|antimitotic agents|mesh-ancestor
6337777|NCT00025298|Mitosis Modulators|mitosis modulators|mesh-ancestor
6337778|NCT00025298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337779|NCT00025298|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6337780|NCT00025298|Protective Agents|protective agents|mesh-ancestor
6337781|NCT00025298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6337782|NCT00025311|Topotecan|topotecan|mesh-list
6337783|NCT00025311|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6337784|NCT00025311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6537178|NCT00821054|Lapatinib|lapatinib|mesh-list
6537179|NCT00821054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337785|NCT00025311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6337786|NCT00025311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337787|NCT00025311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337788|NCT00025324|Cyclophosphamide|cyclophosphamide|mesh-list
6337789|NCT00025324|Thiotepa|thiotepa|mesh-list
6337790|NCT00025324|Carboplatin|carboplatin|mesh-list
6337791|NCT00025324|Etoposide|etoposide|mesh-list
6337792|NCT00025324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6337793|NCT00025324|Immunologic Factors|immunologic factors|mesh-ancestor
6337794|NCT00025324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6337795|NCT00025324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5724586|NCT03186326|Avelumab|avelumab|mesh-list
5724587|NCT03186326|Panitumumab|panitumumab|mesh-list
6337796|NCT00025324|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6337797|NCT00025324|Alkylating Agents|alkylating agents|mesh-ancestor
6337798|NCT00025324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337799|NCT00025324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337800|NCT00025324|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6337801|NCT00025324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6337802|NCT00025324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6337803|NCT00025324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6337804|NCT00025324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6337805|NCT00025337|Leucovorin|leucovorin|mesh-list
6337806|NCT00025337|Bevacizumab|bevacizumab|mesh-list
6337807|NCT00025337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6337808|NCT00025337|Fluorouracil|fluorouracil|mesh-list
6337809|NCT00025337|Oxaliplatin|oxaliplatin|mesh-list
6337810|NCT00025337|Antibodies|antibodies|mesh-list
6337811|NCT00025337|Immunoglobulins|immunoglobulins|mesh-list
6337812|NCT00025337|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6337813|NCT00025337|Levoleucovorin|levoleucovorin|mesh-list
6337814|NCT00025337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337815|NCT00025337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6337816|NCT00025337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6337817|NCT00025337|Growth Substances|growth substances|mesh-ancestor
6337818|NCT00025337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6337819|NCT00025337|Growth Inhibitors|growth inhibitors|mesh-ancestor
6337820|NCT00025337|Immunologic Factors|immunologic factors|mesh-ancestor
6337821|NCT00025337|Antimetabolites|antimetabolites|mesh-ancestor
6337822|NCT00025337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337823|NCT00025337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6337824|NCT00025337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6016761|NCT00367458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016762|NCT00367458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6016763|NCT00367458|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6016764|NCT00367458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6337825|NCT00025337|Antidotes|antidotes|mesh-ancestor
6337826|NCT00025337|Protective Agents|protective agents|mesh-ancestor
6337827|NCT00025337|Vitamin B Complex|vitamin b complex|mesh-ancestor
6337828|NCT00025337|Vitamins|vitamins|mesh-ancestor
6337829|NCT00025337|Micronutrients|micronutrients|mesh-ancestor
6337830|NCT00025350|Gefitinib|gefitinib|mesh-list
6337831|NCT00025350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337832|NCT00025350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6337833|NCT00025350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6337834|NCT00025350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337835|NCT00025363|Cyclophosphamide|cyclophosphamide|mesh-list
6337836|NCT00025363|Ifosfamide|ifosfamide|mesh-list
6337837|NCT00025363|Doxorubicin|doxorubicin|mesh-list
6337838|NCT00025363|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6337839|NCT00025363|Irinotecan|irinotecan|mesh-list
6337840|NCT00025363|Etoposide|etoposide|mesh-list
6337841|NCT00025363|Vincristine|vincristine|mesh-list
6337842|NCT00025363|Etoposide phosphate|etoposide phosphate|mesh-list
6337843|NCT00025363|Tirapazamine|tirapazamine|mesh-list
6337844|NCT00025363|Sargramostim|sargramostim|mesh-list
6337845|NCT00025363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6337846|NCT00025363|Immunologic Factors|immunologic factors|mesh-ancestor
6337847|NCT00025363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6337848|NCT00025363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6337849|NCT00025363|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6337850|NCT00025363|Alkylating Agents|alkylating agents|mesh-ancestor
6337851|NCT00025363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337852|NCT00025363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337853|NCT00025363|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6337854|NCT00025363|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6337855|NCT00025363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6337856|NCT00025363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6337857|NCT00025363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6337858|NCT00025363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6337859|NCT00025363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6337860|NCT00025363|Tubulin Modulators|tubulin modulators|mesh-ancestor
6337861|NCT00025363|Antimitotic Agents|antimitotic agents|mesh-ancestor
6337862|NCT00025363|Mitosis Modulators|mitosis modulators|mesh-ancestor
6337863|NCT00025376|Bortezomib|bortezomib|mesh-list
6337864|NCT00025376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337865|NCT00025389|Paclitaxel|paclitaxel|mesh-list
6337866|NCT00025389|Bevacizumab|bevacizumab|mesh-list
6337867|NCT00025389|Carboplatin|carboplatin|mesh-list
6337868|NCT00025389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6337869|NCT00025389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337870|NCT00025389|Tubulin Modulators|tubulin modulators|mesh-ancestor
6337871|NCT00025389|Antimitotic Agents|antimitotic agents|mesh-ancestor
6337872|NCT00025389|Mitosis Modulators|mitosis modulators|mesh-ancestor
6337873|NCT00025389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337874|NCT00025389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6337875|NCT00025389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6337876|NCT00025389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6337877|NCT00025389|Growth Substances|growth substances|mesh-ancestor
6337878|NCT00025389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6337879|NCT00025389|Growth Inhibitors|growth inhibitors|mesh-ancestor
6337880|NCT00025402|Interferons|interferons|mesh-list
6337881|NCT00025402|Cytarabine|cytarabine|mesh-list
6337882|NCT00025402|Interferon-alpha|interferon-alpha|mesh-list
6337883|NCT00025402|Cyclophosphamide|cyclophosphamide|mesh-list
6337884|NCT00025402|Busulfan|busulfan|mesh-list
6337885|NCT00025402|Etoposide|etoposide|mesh-list
6337886|NCT00025402|Idarubicin|idarubicin|mesh-list
6337887|NCT00025402|Hydroxyurea|hydroxyurea|mesh-list
6337888|NCT00025402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6337889|NCT00025402|Immunologic Factors|immunologic factors|mesh-ancestor
6337890|NCT00025402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6337891|NCT00025402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6337892|NCT00025402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6337893|NCT00025402|Alkylating Agents|alkylating agents|mesh-ancestor
6337894|NCT00025402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337895|NCT00025402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337896|NCT00025402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6337897|NCT00025402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6337898|NCT00025402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6337899|NCT00025402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6337900|NCT00025402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6337901|NCT00025402|Antiviral Agents|antiviral agents|mesh-ancestor
6337902|NCT00025402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6337903|NCT00025402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6337904|NCT00025402|Antimetabolites|antimetabolites|mesh-ancestor
6337905|NCT00025402|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6337906|NCT00025402|Antisickling Agents|antisickling agents|mesh-ancestor
6337907|NCT00025402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6337908|NCT00025415|Imatinib Mesylate|imatinib mesylate|mesh-list
6337909|NCT00025415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337910|NCT00025415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6337911|NCT00025415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6337912|NCT00025415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337913|NCT00025428|Cyclophosphamide|cyclophosphamide|mesh-list
6337914|NCT00025428|Carboplatin|carboplatin|mesh-list
6337915|NCT00025428|Doxorubicin|doxorubicin|mesh-list
6337916|NCT00025428|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6337917|NCT00025428|Etoposide|etoposide|mesh-list
6337918|NCT00025428|Vincristine|vincristine|mesh-list
6337919|NCT00025428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6337920|NCT00025428|Immunologic Factors|immunologic factors|mesh-ancestor
6337921|NCT00025428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6337922|NCT00025428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6337923|NCT00025428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6337924|NCT00025428|Alkylating Agents|alkylating agents|mesh-ancestor
6337925|NCT00025428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337926|NCT00025428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337927|NCT00025428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6337928|NCT00025428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6337929|NCT00025428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6337930|NCT00025428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6337931|NCT00025428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6337932|NCT00025428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6337933|NCT00025428|Tubulin Modulators|tubulin modulators|mesh-ancestor
6337934|NCT00025428|Antimitotic Agents|antimitotic agents|mesh-ancestor
6337935|NCT00025428|Mitosis Modulators|mitosis modulators|mesh-ancestor
6337936|NCT00025441|Dactinomycin|dactinomycin|mesh-list
6337937|NCT00025441|Cyclophosphamide|cyclophosphamide|mesh-list
6337938|NCT00025441|Ifosfamide|ifosfamide|mesh-list
6337939|NCT00025441|Carboplatin|carboplatin|mesh-list
6337940|NCT00025441|Doxorubicin|doxorubicin|mesh-list
6337941|NCT00025441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6337942|NCT00025441|Etoposide|etoposide|mesh-list
6337943|NCT00025441|Vincristine|vincristine|mesh-list
6337944|NCT00025441|Epirubicin|epirubicin|mesh-list
6337945|NCT00025441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6337946|NCT00025441|Immunologic Factors|immunologic factors|mesh-ancestor
6337947|NCT00025441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6337948|NCT00025441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6337949|NCT00025441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6337950|NCT00025441|Alkylating Agents|alkylating agents|mesh-ancestor
6337951|NCT00025441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337952|NCT00025441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337953|NCT00025441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6337954|NCT00025441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6337955|NCT00025441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6337956|NCT00025441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6337957|NCT00025441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6337958|NCT00025441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6337959|NCT00025441|Tubulin Modulators|tubulin modulators|mesh-ancestor
6337960|NCT00025441|Antimitotic Agents|antimitotic agents|mesh-ancestor
6337961|NCT00025441|Mitosis Modulators|mitosis modulators|mesh-ancestor
6337962|NCT00025441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6337963|NCT00025441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6337964|NCT00025441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6337965|NCT00025441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6337966|NCT00025454|Tipifarnib|tipifarnib|mesh-list
6337967|NCT00025454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337968|NCT00025467|Thalidomide|thalidomide|mesh-list
6337969|NCT00025467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6337970|NCT00025467|Immunologic Factors|immunologic factors|mesh-ancestor
6337971|NCT00025467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6337972|NCT00025467|Leprostatic Agents|leprostatic agents|mesh-ancestor
6337973|NCT00025467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6337974|NCT00025467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6337975|NCT00025467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6337976|NCT00025467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6337977|NCT00025467|Growth Substances|growth substances|mesh-ancestor
6337978|NCT00025467|Growth Inhibitors|growth inhibitors|mesh-ancestor
6337979|NCT00025467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337980|NCT00025480|Paclitaxel|paclitaxel|mesh-list
6337981|NCT00025480|Carboplatin|carboplatin|mesh-list
6337982|NCT00025480|Tipifarnib|tipifarnib|mesh-list
6337983|NCT00025480|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6337984|NCT00025480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337985|NCT00025480|Tubulin Modulators|tubulin modulators|mesh-ancestor
6337986|NCT00025480|Antimitotic Agents|antimitotic agents|mesh-ancestor
6337987|NCT00025480|Mitosis Modulators|mitosis modulators|mesh-ancestor
6337988|NCT00025480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337989|NCT00025493|Docetaxel|docetaxel|mesh-list
6337990|NCT00025493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6337991|NCT00025493|Tubulin Modulators|tubulin modulators|mesh-ancestor
6337992|NCT00025493|Antimitotic Agents|antimitotic agents|mesh-ancestor
6337993|NCT00025493|Mitosis Modulators|mitosis modulators|mesh-ancestor
6337994|NCT00025493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6337995|NCT00025519|Mycophenolic Acid|mycophenolic acid|mesh-list
6337996|NCT00025519|Thalidomide|thalidomide|mesh-list
6337997|NCT00025519|Fludarabine|fludarabine|mesh-list
6337998|NCT00025519|Fludarabine phosphate|fludarabine phosphate|mesh-list
6016765|NCT00367484|Interferons|interferons|mesh-list
6016766|NCT00367484|Interferon-beta|interferon-beta|mesh-list
6016767|NCT00367484|Interferon beta-1a|interferon beta-1a|mesh-list
6016768|NCT00367484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6016769|NCT00367484|Antiviral Agents|antiviral agents|mesh-ancestor
6016770|NCT00367484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6337999|NCT00025519|Tacrolimus|tacrolimus|mesh-list
6338000|NCT00025519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6338001|NCT00025519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6338002|NCT00025519|Antimetabolites|antimetabolites|mesh-ancestor
6338003|NCT00025519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6338004|NCT00025519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6338005|NCT00025519|Immunologic Factors|immunologic factors|mesh-ancestor
6338006|NCT00025519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338007|NCT00025519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6338008|NCT00025519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6338009|NCT00025519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6338010|NCT00025519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6338011|NCT00025519|Antitubercular Agents|antitubercular agents|mesh-ancestor
6338012|NCT00025519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6338013|NCT00025519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6338014|NCT00025519|Leprostatic Agents|leprostatic agents|mesh-ancestor
6338015|NCT00025519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6338016|NCT00025519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6338017|NCT00025519|Growth Substances|growth substances|mesh-ancestor
6338018|NCT00025519|Growth Inhibitors|growth inhibitors|mesh-ancestor
6338019|NCT00025532|Antibodies|antibodies|mesh-list
6338020|NCT00025532|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6338021|NCT00025532|Immunologic Factors|immunologic factors|mesh-ancestor
6016771|NCT00367484|Immunologic Factors|immunologic factors|mesh-ancestor
6016772|NCT00367484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016773|NCT00367484|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6016774|NCT00367601|Bevacizumab|bevacizumab|mesh-list
6016775|NCT00367601|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6016776|NCT00367601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6338022|NCT00025532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338023|NCT00025545|Cyclophosphamide|cyclophosphamide|mesh-list
6338024|NCT00025545|Methotrexate|methotrexate|mesh-list
6338025|NCT00025545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6338026|NCT00025545|Immunologic Factors|immunologic factors|mesh-ancestor
6338027|NCT00025545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338028|NCT00025545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6338029|NCT00025545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6338030|NCT00025545|Alkylating Agents|alkylating agents|mesh-ancestor
6338031|NCT00025545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6338032|NCT00025545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6338033|NCT00025545|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6338034|NCT00025545|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6338035|NCT00025545|Abortifacient Agents|abortifacient agents|mesh-ancestor
6338036|NCT00025545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6338037|NCT00025545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6338038|NCT00025545|Antimetabolites|antimetabolites|mesh-ancestor
6338039|NCT00025545|Dermatologic Agents|dermatologic agents|mesh-ancestor
6338040|NCT00025545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6338041|NCT00025545|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6338042|NCT00025545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6338043|NCT00025558|Carboplatin|carboplatin|mesh-list
6338044|NCT00025558|Temozolomide|temozolomide|mesh-list
6338045|NCT00025558|Thiotepa|thiotepa|mesh-list
6338046|NCT00025558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6016777|NCT00367601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6016778|NCT00367601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6016779|NCT00367601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6016780|NCT00367601|Growth Substances|growth substances|mesh-ancestor
6338047|NCT00025558|Immunologic Factors|immunologic factors|mesh-ancestor
6338048|NCT00025558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338049|NCT00025558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6338050|NCT00025558|Alkylating Agents|alkylating agents|mesh-ancestor
6338051|NCT00025558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6338052|NCT00025558|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6338053|NCT00025558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6338054|NCT00025584|Bortezomib|bortezomib|mesh-list
6338055|NCT00025584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6338056|NCT00025597|Cyclophosphamide|cyclophosphamide|mesh-list
6016781|NCT00367601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016782|NCT00367601|Growth Inhibitors|growth inhibitors|mesh-ancestor
6016783|NCT00367601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6016784|NCT00367601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6016785|NCT00367601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016786|NCT00367640|Immunologic Factors|immunologic factors|mesh-list
6016787|NCT00367640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016788|NCT00367744|Rosiglitazone|rosiglitazone|mesh-list
6338057|NCT00025597|Carboplatin|carboplatin|mesh-list
6338058|NCT00025597|Doxorubicin|doxorubicin|mesh-list
6338059|NCT00025597|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6338060|NCT00025597|Etoposide|etoposide|mesh-list
6338061|NCT00025597|Vincristine|vincristine|mesh-list
6338062|NCT00025597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6338063|NCT00025597|Immunologic Factors|immunologic factors|mesh-ancestor
6338064|NCT00025597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338065|NCT00025597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6338066|NCT00025597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6338067|NCT00025597|Alkylating Agents|alkylating agents|mesh-ancestor
6338068|NCT00025597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6338069|NCT00025597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6338070|NCT00025597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6338071|NCT00025597|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6338072|NCT00025597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6338073|NCT00025597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6338074|NCT00025597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6338075|NCT00025597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6338076|NCT00025597|Tubulin Modulators|tubulin modulators|mesh-ancestor
6338077|NCT00025597|Antimitotic Agents|antimitotic agents|mesh-ancestor
6338078|NCT00025597|Mitosis Modulators|mitosis modulators|mesh-ancestor
6338079|NCT00025610|Cyclophosphamide|cyclophosphamide|mesh-list
6338080|NCT00025610|Carboplatin|carboplatin|mesh-list
6338081|NCT00025610|Doxorubicin|doxorubicin|mesh-list
6338082|NCT00025610|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6338083|NCT00025610|Etoposide|etoposide|mesh-list
6338084|NCT00025610|Vincristine|vincristine|mesh-list
6338085|NCT00025610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6338086|NCT00025610|Immunologic Factors|immunologic factors|mesh-ancestor
6338087|NCT00025610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338088|NCT00025610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6338089|NCT00025610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6338090|NCT00025610|Alkylating Agents|alkylating agents|mesh-ancestor
6338091|NCT00025610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6338092|NCT00025610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6338093|NCT00025610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6338094|NCT00025610|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6338095|NCT00025610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6338096|NCT00025610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6338097|NCT00025610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6338098|NCT00025610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6338099|NCT00025610|Tubulin Modulators|tubulin modulators|mesh-ancestor
6338100|NCT00025610|Antimitotic Agents|antimitotic agents|mesh-ancestor
6338101|NCT00025610|Mitosis Modulators|mitosis modulators|mesh-ancestor
6338102|NCT00025623|Cyclophosphamide|cyclophosphamide|mesh-list
6338103|NCT00025623|Carboplatin|carboplatin|mesh-list
6338104|NCT00025623|Doxorubicin|doxorubicin|mesh-list
6338105|NCT00025623|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6338106|NCT00025623|Etoposide|etoposide|mesh-list
6338107|NCT00025623|Vincristine|vincristine|mesh-list
6338108|NCT00025623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6338109|NCT00025623|Immunologic Factors|immunologic factors|mesh-ancestor
6338110|NCT00025623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338111|NCT00025623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6338112|NCT00025623|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6338113|NCT00025623|Alkylating Agents|alkylating agents|mesh-ancestor
6338114|NCT00025623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6338115|NCT00025623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6338116|NCT00025623|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6338117|NCT00025623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6338118|NCT00025623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6338119|NCT00025623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6338120|NCT00025623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6338121|NCT00025623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6338122|NCT00025623|Tubulin Modulators|tubulin modulators|mesh-ancestor
6338123|NCT00025623|Antimitotic Agents|antimitotic agents|mesh-ancestor
6338124|NCT00025623|Mitosis Modulators|mitosis modulators|mesh-ancestor
6338125|NCT00025636|Cytarabine|cytarabine|mesh-list
6338126|NCT00025636|Dexamethasone|dexamethasone|mesh-list
6338127|NCT00025636|Cyclophosphamide|cyclophosphamide|mesh-list
6338128|NCT00025636|Melphalan|melphalan|mesh-list
6338129|NCT00025636|Carmustine|carmustine|mesh-list
6338130|NCT00025636|Methotrexate|methotrexate|mesh-list
6338131|NCT00025636|Etoposide|etoposide|mesh-list
6338132|NCT00025636|Vincristine|vincristine|mesh-list
6338133|NCT00025636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6338134|NCT00025636|Immunologic Factors|immunologic factors|mesh-ancestor
6338135|NCT00025636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338136|NCT00025636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6338137|NCT00025636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6338138|NCT00025636|Alkylating Agents|alkylating agents|mesh-ancestor
6338139|NCT00025636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6338140|NCT00025636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6338141|NCT00025636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6338142|NCT00025636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6338143|NCT00025636|Antiemetics|antiemetics|mesh-ancestor
6338144|NCT00025636|Autonomic Agents|autonomic agents|mesh-ancestor
6338145|NCT00025636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6338146|NCT00025636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6338147|NCT00025636|Glucocorticoids|glucocorticoids|mesh-ancestor
6338148|NCT00025636|Hormones|hormones|mesh-ancestor
6338149|NCT00025636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6338150|NCT00025636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6338151|NCT00025636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6338152|NCT00025636|Abortifacient Agents|abortifacient agents|mesh-ancestor
6338153|NCT00025636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6338154|NCT00025636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6338155|NCT00025636|Antimetabolites|antimetabolites|mesh-ancestor
6338156|NCT00025636|Dermatologic Agents|dermatologic agents|mesh-ancestor
6338157|NCT00025636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6338158|NCT00025636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6338159|NCT00025636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6338160|NCT00025636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6338161|NCT00025636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5724588|NCT03186326|Aflibercept|aflibercept|mesh-list
6338162|NCT00025636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6338163|NCT00025636|Antiviral Agents|antiviral agents|mesh-ancestor
6338164|NCT00025636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6338165|NCT00025636|Tubulin Modulators|tubulin modulators|mesh-ancestor
6338166|NCT00025636|Antimitotic Agents|antimitotic agents|mesh-ancestor
6338167|NCT00025636|Mitosis Modulators|mitosis modulators|mesh-ancestor
6338168|NCT00025649|Cyclophosphamide|cyclophosphamide|mesh-list
6338169|NCT00025649|Melphalan|melphalan|mesh-list
6338170|NCT00025649|Busulfan|busulfan|mesh-list
6338171|NCT00025649|Carboplatin|carboplatin|mesh-list
6338172|NCT00025649|Doxorubicin|doxorubicin|mesh-list
6338173|NCT00025649|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6338174|NCT00025649|Etoposide|etoposide|mesh-list
6338175|NCT00025649|Vincristine|vincristine|mesh-list
6338176|NCT00025649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6338177|NCT00025649|Immunologic Factors|immunologic factors|mesh-ancestor
6338178|NCT00025649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338179|NCT00025649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6338180|NCT00025649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6338181|NCT00025649|Alkylating Agents|alkylating agents|mesh-ancestor
6338182|NCT00025649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6338183|NCT00025649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6338184|NCT00025649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6338185|NCT00025649|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6338186|NCT00025649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6338187|NCT00025649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6338188|NCT00025649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6338189|NCT00025649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6338190|NCT00025649|Tubulin Modulators|tubulin modulators|mesh-ancestor
6338191|NCT00025649|Antimitotic Agents|antimitotic agents|mesh-ancestor
6338192|NCT00025649|Mitosis Modulators|mitosis modulators|mesh-ancestor
6338193|NCT00025675|Gefitinib|gefitinib|mesh-list
6338194|NCT00025675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6338195|NCT00025675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6338196|NCT00025675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6338197|NCT00025675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6338198|NCT00025688|Paclitaxel|paclitaxel|mesh-list
6338199|NCT00025688|Carboplatin|carboplatin|mesh-list
6338200|NCT00025688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6537180|NCT00821054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6537181|NCT00821054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6537182|NCT00821054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537183|NCT00821080|Sirolimus|sirolimus|mesh-list
6537184|NCT00821080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6537185|NCT00821080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6537186|NCT00821080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6537187|NCT00821080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6537188|NCT00821080|Antifungal Agents|antifungal agents|mesh-ancestor
6537189|NCT00821080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6537190|NCT00821080|Immunologic Factors|immunologic factors|mesh-ancestor
6338201|NCT00025688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6338202|NCT00025688|Tubulin Modulators|tubulin modulators|mesh-ancestor
6338203|NCT00025688|Antimitotic Agents|antimitotic agents|mesh-ancestor
6338204|NCT00025688|Mitosis Modulators|mitosis modulators|mesh-ancestor
6338205|NCT00025688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6338206|NCT00025727|Ritonavir|ritonavir|mesh-list
6338207|NCT00025727|Lopinavir|lopinavir|mesh-list
6338208|NCT00025727|Fosamprenavir|fosamprenavir|mesh-list
6338209|NCT00025727|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6338210|NCT00025727|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6338211|NCT00025727|Protease Inhibitors|protease inhibitors|mesh-ancestor
6338212|NCT00025727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6338213|NCT00025727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6338214|NCT00025727|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6338215|NCT00025727|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6338216|NCT00025727|Antiviral Agents|antiviral agents|mesh-ancestor
6338217|NCT00025727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6338218|NCT00025727|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6537191|NCT00821080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338219|NCT00025727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6338220|NCT00025740|Clonazepam|clonazepam|mesh-list
6338221|NCT00025740|Paroxetine|paroxetine|mesh-list
6338222|NCT00025740|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6338223|NCT00025740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6338224|NCT00025740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6338225|NCT00025740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6338226|NCT00025740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6338227|NCT00025740|Serotonin Agents|serotonin agents|mesh-ancestor
6338228|NCT00025740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338229|NCT00025740|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6338230|NCT00025740|Antidepressive Agents|antidepressive agents|mesh-ancestor
6338231|NCT00025740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6338232|NCT00025740|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6338233|NCT00025740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6338234|NCT00025740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6338235|NCT00025740|Anticonvulsants|anticonvulsants|mesh-ancestor
6338236|NCT00025740|GABA Modulators|gaba modulators|mesh-ancestor
6338237|NCT00025740|GABA Agents|gaba agents|mesh-ancestor
6393657|NCT00199355|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6393658|NCT00199355|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6393659|NCT00199355|Purinergic Agents|purinergic agents|mesh-ancestor
6393660|NCT00199355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6393661|NCT00199355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393662|NCT00199355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6393663|NCT00199368|Istradefylline|istradefylline|mesh-list
6393664|NCT00199368|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
6393665|NCT00199368|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6393666|NCT00199368|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6393667|NCT00199368|Purinergic Agents|purinergic agents|mesh-ancestor
6393668|NCT00199368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6393669|NCT00199368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393670|NCT00199368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6393671|NCT00199394|Istradefylline|istradefylline|mesh-list
6393672|NCT00199394|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
6393673|NCT00199394|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6393674|NCT00199394|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6393675|NCT00199394|Purinergic Agents|purinergic agents|mesh-ancestor
6393676|NCT00199394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6393677|NCT00199394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393678|NCT00199394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6393679|NCT00199407|Istradefylline|istradefylline|mesh-list
6393680|NCT00199407|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
6393681|NCT00199407|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6393682|NCT00199407|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6393683|NCT00199407|Purinergic Agents|purinergic agents|mesh-ancestor
6393684|NCT00199407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6393685|NCT00199407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393686|NCT00199407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6393687|NCT00199420|Istradefylline|istradefylline|mesh-list
6393688|NCT00199420|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
6393689|NCT00199420|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6393690|NCT00199420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6393691|NCT00199420|Purinergic Agents|purinergic agents|mesh-ancestor
6393692|NCT00199420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6393693|NCT00199420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393694|NCT00199420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6393695|NCT00199433|Istradefylline|istradefylline|mesh-list
6393696|NCT00199433|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
6393697|NCT00199433|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6393698|NCT00199433|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6393699|NCT00199433|Purinergic Agents|purinergic agents|mesh-ancestor
6393700|NCT00199433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6393701|NCT00199433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393702|NCT00199433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016789|NCT00367744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6338238|NCT00025753|Rosiglitazone|rosiglitazone|mesh-list
6338239|NCT00025753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6338240|NCT00025753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338241|NCT00025779|Guanfacine|guanfacine|mesh-list
6338242|NCT00025779|Methylphenidate|methylphenidate|mesh-list
6338243|NCT00025779|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6338244|NCT00025779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338245|NCT00025779|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6338246|NCT00025779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6338247|NCT00025779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6338248|NCT00025779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6338249|NCT00025779|Dopamine Agents|dopamine agents|mesh-ancestor
6338250|NCT00025779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6338251|NCT00025779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6338252|NCT00025779|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6338253|NCT00025779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6338254|NCT00025779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6338255|NCT00025779|Adrenergic Agents|adrenergic agents|mesh-ancestor
6338256|NCT00025792|Pramipexole|pramipexole|mesh-list
6338257|NCT00025792|Antioxidants|antioxidants|mesh-ancestor
6338258|NCT00025792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6338259|NCT00025792|Protective Agents|protective agents|mesh-ancestor
6338260|NCT00025792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338261|NCT00025792|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6338262|NCT00025792|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6338263|NCT00025792|Dopamine Agonists|dopamine agonists|mesh-ancestor
6338264|NCT00025792|Dopamine Agents|dopamine agents|mesh-ancestor
6338265|NCT00025792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6338266|NCT00026039|Estrogens|estrogens|mesh-list
6338267|NCT00026039|Hormones|hormones|mesh-ancestor
6338268|NCT00026039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6338269|NCT00026039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338270|NCT00026052|Riluzole|riluzole|mesh-list
6338271|NCT00026052|Anticonvulsants|anticonvulsants|mesh-ancestor
6338272|NCT00026052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6338273|NCT00026052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6338274|NCT00026052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6338275|NCT00026052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6338276|NCT00026052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338277|NCT00026052|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6338278|NCT00026052|Protective Agents|protective agents|mesh-ancestor
6338279|NCT00026078|Docetaxel|docetaxel|mesh-list
6338280|NCT00026078|Ifosfamide|ifosfamide|mesh-list
6338281|NCT00026078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6338282|NCT00026078|Tubulin Modulators|tubulin modulators|mesh-ancestor
6338283|NCT00026078|Antimitotic Agents|antimitotic agents|mesh-ancestor
6338284|NCT00026078|Mitosis Modulators|mitosis modulators|mesh-ancestor
6338285|NCT00026078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6338286|NCT00026078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6338287|NCT00026078|Alkylating Agents|alkylating agents|mesh-ancestor
6338288|NCT00026091|Fenretinide|fenretinide|mesh-list
6338289|NCT00026091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6338290|NCT00026091|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6338291|NCT00026091|Protective Agents|protective agents|mesh-ancestor
6338292|NCT00026091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338293|NCT00026104|Gemcitabine|gemcitabine|mesh-list
6338294|NCT00026104|Paclitaxel|paclitaxel|mesh-list
6338295|NCT00026104|Tipifarnib|tipifarnib|mesh-list
6338296|NCT00026104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6338297|NCT00026104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6338298|NCT00026104|Tubulin Modulators|tubulin modulators|mesh-ancestor
6338299|NCT00026104|Antimitotic Agents|antimitotic agents|mesh-ancestor
6338300|NCT00026104|Mitosis Modulators|mitosis modulators|mesh-ancestor
6338301|NCT00026104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6338302|NCT00026104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6338303|NCT00026104|Antimetabolites|antimetabolites|mesh-ancestor
6338304|NCT00026104|Antiviral Agents|antiviral agents|mesh-ancestor
6338305|NCT00026104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6338306|NCT00026104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6338307|NCT00026104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6338308|NCT00026104|Immunologic Factors|immunologic factors|mesh-ancestor
6338309|NCT00026104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338310|NCT00026130|Gemcitabine|gemcitabine|mesh-list
6338311|NCT00026130|Fluorouracil|fluorouracil|mesh-list
6338312|NCT00026130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6338313|NCT00026130|Antimetabolites|antimetabolites|mesh-ancestor
6338314|NCT00026130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6338315|NCT00026130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6338316|NCT00026130|Antiviral Agents|antiviral agents|mesh-ancestor
6338317|NCT00026130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6338318|NCT00026130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6338319|NCT00026130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6338320|NCT00026130|Immunologic Factors|immunologic factors|mesh-ancestor
6338321|NCT00026130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338322|NCT00026143|Interferons|interferons|mesh-list
6338323|NCT00026143|Interferon-alpha|interferon-alpha|mesh-list
6338324|NCT00026143|Interferon alpha-2|interferon alpha-2|mesh-list
6338325|NCT00026143|Interleukin-12|interleukin-12|mesh-list
6338326|NCT00026143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6338327|NCT00026143|Antiviral Agents|antiviral agents|mesh-ancestor
6338328|NCT00026143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6338329|NCT00026143|Immunologic Factors|immunologic factors|mesh-ancestor
6338330|NCT00026143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338331|NCT00026143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6338332|NCT00026143|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6338333|NCT00026143|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6338334|NCT00026143|Growth Substances|growth substances|mesh-ancestor
6338335|NCT00026143|Growth Inhibitors|growth inhibitors|mesh-ancestor
6338336|NCT00026156|Docetaxel|docetaxel|mesh-list
6338337|NCT00026156|Vinorelbine|vinorelbine|mesh-list
6338338|NCT00026156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6338339|NCT00026156|Tubulin Modulators|tubulin modulators|mesh-ancestor
6338340|NCT00026156|Antimitotic Agents|antimitotic agents|mesh-ancestor
6338341|NCT00026156|Mitosis Modulators|mitosis modulators|mesh-ancestor
6338342|NCT00026156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6338343|NCT00026156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6338344|NCT00026169|Imatinib Mesylate|imatinib mesylate|mesh-list
6338345|NCT00026169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6338346|NCT00026169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6338347|NCT00026169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6338348|NCT00026169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6338349|NCT00026182|Rituximab|rituximab|mesh-list
6338350|NCT00026182|Interleukin-12|interleukin-12|mesh-list
6338351|NCT00026182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6338352|NCT00026182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6338353|NCT00026182|Immunologic Factors|immunologic factors|mesh-ancestor
6338354|NCT00026182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338355|NCT00026182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6338356|NCT00026182|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6338357|NCT00026182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6338358|NCT00026182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6338359|NCT00026182|Growth Substances|growth substances|mesh-ancestor
6338360|NCT00026182|Growth Inhibitors|growth inhibitors|mesh-ancestor
6338361|NCT00026195|Irinotecan|irinotecan|mesh-list
6338362|NCT00026195|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6338363|NCT00026195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6338364|NCT00026195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6338365|NCT00026195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6338366|NCT00026195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6338367|NCT00026234|Dexamethasone|dexamethasone|mesh-list
6338368|NCT00026234|Capecitabine|capecitabine|mesh-list
6338369|NCT00026234|Oxaliplatin|oxaliplatin|mesh-list
6338370|NCT00026234|Floxuridine|floxuridine|mesh-list
6338371|NCT00026234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6338372|NCT00026234|Antiemetics|antiemetics|mesh-ancestor
6338373|NCT00026234|Autonomic Agents|autonomic agents|mesh-ancestor
6338374|NCT00026234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6338375|NCT00026234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338376|NCT00026234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6338377|NCT00026234|Glucocorticoids|glucocorticoids|mesh-ancestor
6338378|NCT00026234|Hormones|hormones|mesh-ancestor
6338379|NCT00026234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6338380|NCT00026234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6338381|NCT00026234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6338382|NCT00026234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6338383|NCT00026234|Antimetabolites|antimetabolites|mesh-ancestor
6338384|NCT00026234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6338385|NCT00026260|Semaxinib|semaxinib|mesh-list
6338386|NCT00026260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6338387|NCT00026260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6338388|NCT00026260|Growth Substances|growth substances|mesh-ancestor
6338389|NCT00026260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338390|NCT00026260|Growth Inhibitors|growth inhibitors|mesh-ancestor
6338391|NCT00026260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6338392|NCT00026260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6338393|NCT00026260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6338394|NCT00026260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6338395|NCT00026273|Leucovorin|leucovorin|mesh-list
6338396|NCT00026273|Fluorouracil|fluorouracil|mesh-list
6338397|NCT00026273|Irinotecan|irinotecan|mesh-list
6338398|NCT00026273|Calcium|calcium|mesh-list
6338399|NCT00026273|Levoleucovorin|levoleucovorin|mesh-list
6338400|NCT00026273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6338401|NCT00026273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338402|NCT00026273|Antimetabolites|antimetabolites|mesh-ancestor
6338403|NCT00026273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6338404|NCT00026273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6338405|NCT00026273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6338406|NCT00026273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6338407|NCT00026273|Immunologic Factors|immunologic factors|mesh-ancestor
6338408|NCT00026273|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6338409|NCT00026273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6338410|NCT00026273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6338411|NCT00026273|Antidotes|antidotes|mesh-ancestor
6338412|NCT00026273|Protective Agents|protective agents|mesh-ancestor
6338413|NCT00026273|Vitamin B Complex|vitamin b complex|mesh-ancestor
6338414|NCT00026273|Vitamins|vitamins|mesh-ancestor
6338415|NCT00026273|Micronutrients|micronutrients|mesh-ancestor
6338416|NCT00026286|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6338417|NCT00026286|Medroxyprogesterone|medroxyprogesterone|mesh-list
6338418|NCT00026286|Estrogens|estrogens|mesh-list
6338419|NCT00026286|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6338420|NCT00026286|Hormones|hormones|mesh-ancestor
6338421|NCT00026286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6338422|NCT00026286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338423|NCT00026286|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6338424|NCT00026286|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6338425|NCT00026286|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6338426|NCT00026286|Contraceptive Agents|contraceptive agents|mesh-ancestor
6338427|NCT00026286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6338428|NCT00026286|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6338429|NCT00026286|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6338430|NCT00026286|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6338431|NCT00026286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6338432|NCT00026286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6338433|NCT00026299|Oxaliplatin|oxaliplatin|mesh-list
6338434|NCT00026299|Gefitinib|gefitinib|mesh-list
6338435|NCT00026299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6338436|NCT00026299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6338437|NCT00026299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6338438|NCT00026299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6338439|NCT00026338|Gemcitabine|gemcitabine|mesh-list
6338440|NCT00026338|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6338441|NCT00026338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6338442|NCT00026338|Antimetabolites|antimetabolites|mesh-ancestor
6338443|NCT00026338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6338444|NCT00026338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6338445|NCT00026338|Antiviral Agents|antiviral agents|mesh-ancestor
6338446|NCT00026338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6338447|NCT00026338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6338448|NCT00026338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6338449|NCT00026338|Immunologic Factors|immunologic factors|mesh-ancestor
6338450|NCT00026338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338451|NCT00026338|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6338452|NCT00026351|Rituximab|rituximab|mesh-list
6338453|NCT00026351|Pentostatin|pentostatin|mesh-list
6338454|NCT00026351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6338455|NCT00026351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6338456|NCT00026351|Immunologic Factors|immunologic factors|mesh-ancestor
6338457|NCT00026351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338458|NCT00026351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6338459|NCT00026351|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
6338460|NCT00026351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6338461|NCT00026351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6338462|NCT00026364|Leucovorin|leucovorin|mesh-list
6338463|NCT00026364|Fluorouracil|fluorouracil|mesh-list
6338464|NCT00026364|Irinotecan|irinotecan|mesh-list
6338465|NCT00026364|Gefitinib|gefitinib|mesh-list
6338466|NCT00026364|Calcium|calcium|mesh-list
6338467|NCT00026364|Levoleucovorin|levoleucovorin|mesh-list
6338468|NCT00026364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6338469|NCT00026364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338470|NCT00026364|Antimetabolites|antimetabolites|mesh-ancestor
6338471|NCT00026364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6338472|NCT00026364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6338473|NCT00026364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6338474|NCT00026364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6338475|NCT00026364|Immunologic Factors|immunologic factors|mesh-ancestor
6338476|NCT00026364|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6338477|NCT00026364|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6338478|NCT00026364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6338479|NCT00026364|Antidotes|antidotes|mesh-ancestor
6338480|NCT00026364|Protective Agents|protective agents|mesh-ancestor
6338481|NCT00026364|Vitamin B Complex|vitamin b complex|mesh-ancestor
6338482|NCT00026364|Vitamins|vitamins|mesh-ancestor
6338483|NCT00026364|Micronutrients|micronutrients|mesh-ancestor
6338484|NCT00026364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6338485|NCT00026377|Leuprolide|leuprolide|mesh-list
6338486|NCT00026377|Goserelin|goserelin|mesh-list
6338487|NCT00026377|Flutamide|flutamide|mesh-list
6338488|NCT00026377|Bicalutamide|bicalutamide|mesh-list
6338489|NCT00026377|Semaxinib|semaxinib|mesh-list
6338490|NCT00026377|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6338491|NCT00026377|Fertility Agents|fertility agents|mesh-ancestor
6338492|NCT00026377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6338493|NCT00026377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338494|NCT00026377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6338495|NCT00026377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6338496|NCT00026377|Androgen Antagonists|androgen antagonists|mesh-ancestor
6338497|NCT00026377|Hormone Antagonists|hormone antagonists|mesh-ancestor
6338498|NCT00026377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6338499|NCT00026377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6338500|NCT00026377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6338501|NCT00026377|Growth Substances|growth substances|mesh-ancestor
6338502|NCT00026377|Growth Inhibitors|growth inhibitors|mesh-ancestor
6393703|NCT00199446|Istradefylline|istradefylline|mesh-list
6338503|NCT00026377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6338504|NCT00026377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6338505|NCT00026377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6338506|NCT00026403|Gemcitabine|gemcitabine|mesh-list
6338507|NCT00026403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6338508|NCT00026403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6338509|NCT00026403|Antimetabolites|antimetabolites|mesh-ancestor
6338510|NCT00026403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6338511|NCT00026403|Antiviral Agents|antiviral agents|mesh-ancestor
6338512|NCT00026403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6338513|NCT00026403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6338514|NCT00026403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6338515|NCT00026403|Immunologic Factors|immunologic factors|mesh-ancestor
6338516|NCT00026403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338517|NCT00026416|Interferons|interferons|mesh-list
6338518|NCT00026416|Interferon-alpha|interferon-alpha|mesh-list
6338519|NCT00026416|Thalidomide|thalidomide|mesh-list
6338520|NCT00026416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6338521|NCT00026416|Antiviral Agents|antiviral agents|mesh-ancestor
6338522|NCT00026416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6338523|NCT00026416|Immunologic Factors|immunologic factors|mesh-ancestor
6338524|NCT00026416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338525|NCT00026416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6338526|NCT00026416|Leprostatic Agents|leprostatic agents|mesh-ancestor
6338527|NCT00026416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6338528|NCT00026416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6338529|NCT00026416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6338530|NCT00026416|Growth Substances|growth substances|mesh-ancestor
6338531|NCT00026416|Growth Inhibitors|growth inhibitors|mesh-ancestor
6338532|NCT00026429|Denileukin diftitox|denileukin diftitox|mesh-list
6338533|NCT00026429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6338534|NCT00026442|Capecitabine|capecitabine|mesh-list
6338535|NCT00026442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6338536|NCT00026442|Antimetabolites|antimetabolites|mesh-ancestor
6338537|NCT00026442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6338538|NCT00026442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6338539|NCT00026468|Sulindac sulfone|sulindac sulfone|mesh-list
6338540|NCT00026468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6338541|NCT00026468|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6338542|NCT00026468|Protective Agents|protective agents|mesh-ancestor
6338543|NCT00026468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338544|NCT00026468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6338545|NCT00026468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6338546|NCT00026468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6338547|NCT00026468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6338548|NCT00026468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6338549|NCT00026468|Analgesics|analgesics|mesh-ancestor
6338550|NCT00026468|Sensory System Agents|sensory system agents|mesh-ancestor
6338551|NCT00026468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6338552|NCT00026468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6338553|NCT00026468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6338554|NCT00026520|Interferons|interferons|mesh-list
6338555|NCT00026520|Interferon-alpha|interferon-alpha|mesh-list
6338556|NCT00026520|Thalidomide|thalidomide|mesh-list
6338557|NCT00026520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6338558|NCT00026520|Antiviral Agents|antiviral agents|mesh-ancestor
6338559|NCT00026520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6338560|NCT00026520|Immunologic Factors|immunologic factors|mesh-ancestor
6338561|NCT00026520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338562|NCT00026520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6338563|NCT00026520|Leprostatic Agents|leprostatic agents|mesh-ancestor
6338564|NCT00026520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6338565|NCT00026520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6338566|NCT00026520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6338567|NCT00026520|Growth Substances|growth substances|mesh-ancestor
6338568|NCT00026520|Growth Inhibitors|growth inhibitors|mesh-ancestor
6338569|NCT00026533|Thalidomide|thalidomide|mesh-list
6338570|NCT00026533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6338571|NCT00026533|Immunologic Factors|immunologic factors|mesh-ancestor
6338572|NCT00026533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338573|NCT00026533|Leprostatic Agents|leprostatic agents|mesh-ancestor
6338574|NCT00026533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6338575|NCT00026533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6338576|NCT00026533|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6338577|NCT00026533|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6338578|NCT00026533|Growth Substances|growth substances|mesh-ancestor
6338579|NCT00026533|Growth Inhibitors|growth inhibitors|mesh-ancestor
6338580|NCT00026533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6338581|NCT00026585|Tamoxifen|tamoxifen|mesh-list
6338582|NCT00026585|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6338583|NCT00026585|Hormone Antagonists|hormone antagonists|mesh-ancestor
6338584|NCT00026585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6338585|NCT00026585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338586|NCT00026585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6338587|NCT00026585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6338588|NCT00026585|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6338589|NCT00026585|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6338590|NCT00026585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6338591|NCT00026624|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
6338592|NCT00026624|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6338593|NCT00026624|Immunologic Factors|immunologic factors|mesh-ancestor
6338594|NCT00026624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338595|NCT00026637|Sertraline|sertraline|mesh-list
6338596|NCT00026637|Antidepressive Agents|antidepressive agents|mesh-ancestor
6338597|NCT00026637|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6338598|NCT00026637|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6338599|NCT00026637|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6338600|NCT00026637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6338601|NCT00026637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6338602|NCT00026637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6338603|NCT00026637|Serotonin Agents|serotonin agents|mesh-ancestor
6338604|NCT00026637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338605|NCT00026819|Rofecoxib|rofecoxib|mesh-list
6338606|NCT00026819|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6338607|NCT00026819|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6338608|NCT00026819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6338609|NCT00026819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6338610|NCT00026819|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6338611|NCT00026819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6338612|NCT00026819|Analgesics|analgesics|mesh-ancestor
6338613|NCT00026819|Sensory System Agents|sensory system agents|mesh-ancestor
6338614|NCT00026819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6338615|NCT00026819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338616|NCT00026819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6338617|NCT00026819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6338618|NCT00026962|Estradiol|estradiol|mesh-list
6338619|NCT00026962|Progesterone|progesterone|mesh-list
6338620|NCT00026962|Estrogens|estrogens|mesh-ancestor
6338621|NCT00026962|Hormones|hormones|mesh-ancestor
6338622|NCT00026962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6338623|NCT00026962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338624|NCT00026962|Progestins|progestins|mesh-ancestor
6338625|NCT00027014|Fentanyl|fentanyl|mesh-list
6338626|NCT00027014|Oxycodone|oxycodone|mesh-list
6338627|NCT00027014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6338628|NCT00027014|Narcotics|narcotics|mesh-ancestor
6338629|NCT00027014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6338630|NCT00027014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338631|NCT00027014|Analgesics|analgesics|mesh-ancestor
6338632|NCT00027014|Sensory System Agents|sensory system agents|mesh-ancestor
6338633|NCT00027014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6338634|NCT00027014|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6338635|NCT00027014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6338636|NCT00027014|Anesthetics, General|anesthetics, general|mesh-ancestor
6338637|NCT00027014|Anesthetics|anesthetics|mesh-ancestor
6338638|NCT00027040|Selegiline|selegiline|mesh-list
6338639|NCT00027040|Antidepressive Agents|antidepressive agents|mesh-ancestor
6338640|NCT00027040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6338641|NCT00027040|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6338642|NCT00027040|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6338643|NCT00027040|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6338644|NCT00027040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6338645|NCT00027040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6338646|NCT00027040|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6338647|NCT00027040|Protective Agents|protective agents|mesh-ancestor
6338648|NCT00027040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338649|NCT00027053|Trazodone|trazodone|mesh-list
6338650|NCT00027053|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6338651|NCT00027053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6338652|NCT00027053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6338653|NCT00027053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338654|NCT00027053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6338655|NCT00027053|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6338656|NCT00027053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6338657|NCT00027053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6338658|NCT00027053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6338659|NCT00027053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6338660|NCT00027053|Serotonin Agents|serotonin agents|mesh-ancestor
6338661|NCT00027053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6338662|NCT00027053|Antidepressive Agents|antidepressive agents|mesh-ancestor
6338663|NCT00027066|Aspirin|aspirin|mesh-list
6338664|NCT00027066|Warfarin|warfarin|mesh-list
6338665|NCT00027066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6338666|NCT00027066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6338667|NCT00027066|Analgesics|analgesics|mesh-ancestor
6338668|NCT00027066|Sensory System Agents|sensory system agents|mesh-ancestor
6338669|NCT00027066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6338670|NCT00027066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338671|NCT00027066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6338672|NCT00027066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6338673|NCT00027066|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6338674|NCT00027066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6338675|NCT00027066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6338676|NCT00027066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6338677|NCT00027066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6338678|NCT00027066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6338679|NCT00027066|Antipyretics|antipyretics|mesh-ancestor
6338680|NCT00027066|Anticoagulants|anticoagulants|mesh-ancestor
6338681|NCT00027079|Naltrexone|naltrexone|mesh-list
6338682|NCT00027079|Ondansetron|ondansetron|mesh-list
6338683|NCT00027079|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6338684|NCT00027079|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6338685|NCT00027079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338686|NCT00027079|Sensory System Agents|sensory system agents|mesh-ancestor
6338687|NCT00027079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6338688|NCT00027079|Antiemetics|antiemetics|mesh-ancestor
6338689|NCT00027079|Autonomic Agents|autonomic agents|mesh-ancestor
6338690|NCT00027079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6338691|NCT00027079|Antipruritics|antipruritics|mesh-ancestor
6338692|NCT00027079|Dermatologic Agents|dermatologic agents|mesh-ancestor
6338693|NCT00027079|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6338694|NCT00027079|Serotonin Agents|serotonin agents|mesh-ancestor
6338695|NCT00027079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6338696|NCT00027079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6338697|NCT00027079|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6338698|NCT00027079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6338699|NCT00027079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6338700|NCT00027079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6338701|NCT00027079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6338702|NCT00027248|Omiganan pentahydrochloride|omiganan pentahydrochloride|mesh-list
6338703|NCT00027248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6338704|NCT00027287|Vitamin E|vitamin e|mesh-list
6016790|NCT00367744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338705|NCT00027287|Vitamins|vitamins|mesh-ancestor
6338706|NCT00027287|Micronutrients|micronutrients|mesh-ancestor
6338707|NCT00027287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338708|NCT00027287|Antioxidants|antioxidants|mesh-ancestor
6338709|NCT00027287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6338710|NCT00027287|Protective Agents|protective agents|mesh-ancestor
6338711|NCT00027300|Natalizumab|natalizumab|mesh-list
6338712|NCT00027300|Immunologic Factors|immunologic factors|mesh-ancestor
6338713|NCT00027300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338714|NCT00027339|Ritonavir|ritonavir|mesh-list
6338715|NCT00027339|Lopinavir|lopinavir|mesh-list
6338716|NCT00027339|Indinavir|indinavir|mesh-list
6338717|NCT00027339|Fosamprenavir|fosamprenavir|mesh-list
6338718|NCT00027339|Tenofovir|tenofovir|mesh-list
6338719|NCT00027339|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6338720|NCT00027339|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6338721|NCT00027339|Protease Inhibitors|protease inhibitors|mesh-ancestor
6338722|NCT00027339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6338723|NCT00027339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6338724|NCT00027339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6338725|NCT00027339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6338726|NCT00027339|Antiviral Agents|antiviral agents|mesh-ancestor
6338727|NCT00027339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6338728|NCT00027339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6338729|NCT00027339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6338730|NCT00027339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6338731|NCT00027339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6338732|NCT00027391|Albuterol|albuterol|mesh-list
6338733|NCT00027391|Oxandrolone|oxandrolone|mesh-list
6338734|NCT00027391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6338735|NCT00027391|Autonomic Agents|autonomic agents|mesh-ancestor
6338736|NCT00027391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6338737|NCT00027391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338738|NCT00027391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6338739|NCT00027391|Respiratory System Agents|respiratory system agents|mesh-ancestor
6338740|NCT00027391|Tocolytic Agents|tocolytic agents|mesh-ancestor
6338741|NCT00027391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6338742|NCT00027391|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6338743|NCT00027391|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6338744|NCT00027391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6338745|NCT00027391|Adrenergic Agents|adrenergic agents|mesh-ancestor
6338746|NCT00027391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6338747|NCT00027391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6338748|NCT00027391|Androgens|androgens|mesh-ancestor
6338749|NCT00027391|Hormones|hormones|mesh-ancestor
6338750|NCT00027391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6338751|NCT00027391|Anabolic Agents|anabolic agents|mesh-ancestor
6393704|NCT00199446|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
6393705|NCT00199446|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6393706|NCT00199446|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6393707|NCT00199446|Purinergic Agents|purinergic agents|mesh-ancestor
6393708|NCT00199446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6393709|NCT00199446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393710|NCT00199446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6393711|NCT00199472|Diuretics|diuretics|mesh-list
6393712|NCT00199472|Natriuretic Agents|natriuretic agents|mesh-ancestor
6393713|NCT00199472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6393714|NCT00199511|Mannitol|mannitol|mesh-list
6393715|NCT00199511|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6393716|NCT00199511|Diuretics|diuretics|mesh-ancestor
6393717|NCT00199511|Natriuretic Agents|natriuretic agents|mesh-ancestor
6393718|NCT00199511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6393719|NCT00199563|Sildenafil Citrate|sildenafil citrate|mesh-list
6393720|NCT00199563|Vasodilator Agents|vasodilator agents|mesh-ancestor
6393721|NCT00199563|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6393722|NCT00199563|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6393723|NCT00199563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6393724|NCT00199563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393725|NCT00199563|Urological Agents|urological agents|mesh-ancestor
6393726|NCT00199576|Methylprednisolone|methylprednisolone|mesh-list
6393727|NCT00199576|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6393728|NCT00199576|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6338752|NCT00027404|Fluoxetine|fluoxetine|mesh-list
6338753|NCT00027404|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6338754|NCT00027404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6338755|NCT00027404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6338756|NCT00027404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6338757|NCT00027404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6338758|NCT00027404|Serotonin Agents|serotonin agents|mesh-ancestor
6338759|NCT00027404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338760|NCT00027404|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6338761|NCT00027404|Antidepressive Agents|antidepressive agents|mesh-ancestor
6338762|NCT00027404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6338763|NCT00027404|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6338764|NCT00027404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6338765|NCT00027404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6338766|NCT00027443|Cyclosporine|cyclosporine|mesh-list
6338767|NCT00027443|Cyclosporins|cyclosporins|mesh-list
6338768|NCT00027443|Muromonab-CD3|muromonab-cd3|mesh-list
6338769|NCT00027443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6338770|NCT00027443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6338771|NCT00027443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6338772|NCT00027443|Immunologic Factors|immunologic factors|mesh-ancestor
6338773|NCT00027443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338774|NCT00027443|Antifungal Agents|antifungal agents|mesh-ancestor
6338775|NCT00027443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6338776|NCT00027443|Dermatologic Agents|dermatologic agents|mesh-ancestor
6338777|NCT00027443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6338778|NCT00027443|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6338779|NCT00027495|Curcumin|curcumin|mesh-list
6016791|NCT00367770|Bosentan|bosentan|mesh-list
6016792|NCT00367770|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6016793|NCT00367770|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6016794|NCT00367770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016795|NCT00367835|Guanfacine|guanfacine|mesh-list
6016796|NCT00367835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6338780|NCT00027495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6338781|NCT00027495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6338782|NCT00027495|Analgesics|analgesics|mesh-ancestor
6016797|NCT00367835|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6016798|NCT00367835|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6016799|NCT00367835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6016800|NCT00367835|Adrenergic Agents|adrenergic agents|mesh-ancestor
6016801|NCT00367835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6016802|NCT00367835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016803|NCT00367835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338783|NCT00027495|Sensory System Agents|sensory system agents|mesh-ancestor
6338784|NCT00027495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6338785|NCT00027495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338786|NCT00027495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6338787|NCT00027495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6338788|NCT00027495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6338789|NCT00027495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6338790|NCT00027495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6338791|NCT00027508|Trabectedin|trabectedin|mesh-list
6338792|NCT00027508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6338793|NCT00027508|Alkylating Agents|alkylating agents|mesh-ancestor
6338794|NCT00027508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6338795|NCT00027508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6338796|NCT00027521|Bleomycin|bleomycin|mesh-list
6338797|NCT00027521|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6338798|NCT00027521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6016804|NCT00367991|Epoetin Alfa|epoetin alfa|mesh-list
6016805|NCT00367991|Hematinics|hematinics|mesh-ancestor
6016806|NCT00368069|Levetiracetam|levetiracetam|mesh-list
6016807|NCT00368069|Anticonvulsants|anticonvulsants|mesh-ancestor
6016808|NCT00368069|Nootropic Agents|nootropic agents|mesh-ancestor
6016809|NCT00368251|Brivaracetam|brivaracetam|mesh-list
6338799|NCT00027534|Metronidazole|metronidazole|mesh-list
6338800|NCT00027534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6338801|NCT00027534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6338802|NCT00027534|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6338803|NCT00027534|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6338804|NCT00027547|Cytarabine|cytarabine|mesh-list
6338805|NCT00027547|Cyclosporine|cyclosporine|mesh-list
6338806|NCT00027547|Mycophenolic Acid|mycophenolic acid|mesh-list
6338807|NCT00027547|Methotrexate|methotrexate|mesh-list
6016810|NCT00368251|Anticonvulsants|anticonvulsants|mesh-ancestor
6338808|NCT00027547|Fludarabine phosphate|fludarabine phosphate|mesh-list
6338809|NCT00027547|Fludarabine|fludarabine|mesh-list
6338810|NCT00027547|Cyclosporins|cyclosporins|mesh-list
6338811|NCT00027547|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6338812|NCT00027547|Abortifacient Agents|abortifacient agents|mesh-ancestor
6338813|NCT00027547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6338814|NCT00027547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338815|NCT00027547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6338816|NCT00027547|Antimetabolites|antimetabolites|mesh-ancestor
6338817|NCT00027547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6338818|NCT00027547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6338819|NCT00027547|Dermatologic Agents|dermatologic agents|mesh-ancestor
6338820|NCT00027547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6338821|NCT00027547|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6338822|NCT00027547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6338823|NCT00027547|Immunologic Factors|immunologic factors|mesh-ancestor
6338824|NCT00027547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6338825|NCT00027547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6338826|NCT00027547|Antiviral Agents|antiviral agents|mesh-ancestor
6338827|NCT00027547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6338828|NCT00027547|Antifungal Agents|antifungal agents|mesh-ancestor
6338829|NCT00027547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6338830|NCT00027547|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6338831|NCT00027547|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6338832|NCT00027547|Antitubercular Agents|antitubercular agents|mesh-ancestor
6338833|NCT00027547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6338834|NCT00027573|Cyclophosphamide|cyclophosphamide|mesh-list
6338835|NCT00027573|Methotrexate|methotrexate|mesh-list
6338836|NCT00027573|Fludarabine|fludarabine|mesh-list
6338837|NCT00027573|Fludarabine phosphate|fludarabine phosphate|mesh-list
6338838|NCT00027573|Tacrolimus|tacrolimus|mesh-list
6338839|NCT00027573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6338840|NCT00027573|Immunologic Factors|immunologic factors|mesh-ancestor
6338841|NCT00027573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338842|NCT00027573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6338843|NCT00027573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6338844|NCT00027573|Alkylating Agents|alkylating agents|mesh-ancestor
6338845|NCT00027573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6338846|NCT00027573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6338847|NCT00027573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6338848|NCT00027573|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6338849|NCT00027573|Abortifacient Agents|abortifacient agents|mesh-ancestor
6338850|NCT00027573|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6338851|NCT00027573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6338852|NCT00027573|Antimetabolites|antimetabolites|mesh-ancestor
6338853|NCT00027573|Dermatologic Agents|dermatologic agents|mesh-ancestor
6338854|NCT00027573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6338855|NCT00027573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6338856|NCT00027573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6338857|NCT00027573|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6338858|NCT00027586|Imatinib Mesylate|imatinib mesylate|mesh-list
6338859|NCT00027586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6338860|NCT00027586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6338861|NCT00027586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6338862|NCT00027586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6338863|NCT00027599|Bevacizumab|bevacizumab|mesh-list
6338864|NCT00027599|Sargramostim|sargramostim|mesh-list
6338865|NCT00027599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6338866|NCT00027599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6338867|NCT00027599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6338868|NCT00027599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6338869|NCT00027599|Growth Substances|growth substances|mesh-ancestor
6338870|NCT00027599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338871|NCT00027599|Growth Inhibitors|growth inhibitors|mesh-ancestor
6338872|NCT00027599|Immunologic Factors|immunologic factors|mesh-ancestor
6338873|NCT00027612|Irinotecan|irinotecan|mesh-list
6338874|NCT00027612|Carmustine|carmustine|mesh-list
6338875|NCT00027612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6338876|NCT00027612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6338877|NCT00027612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6338878|NCT00027612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6338879|NCT00027612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6338880|NCT00027612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6338881|NCT00027612|Alkylating Agents|alkylating agents|mesh-ancestor
6338882|NCT00027625|Temozolomide|temozolomide|mesh-list
6338883|NCT00027625|Gefitinib|gefitinib|mesh-list
6338884|NCT00027625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6338885|NCT00027625|Alkylating Agents|alkylating agents|mesh-ancestor
6338886|NCT00027625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6338887|NCT00027625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6338888|NCT00027625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6338889|NCT00027625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6338890|NCT00027638|Thalidomide|thalidomide|mesh-list
6338891|NCT00027638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6338892|NCT00027638|Immunologic Factors|immunologic factors|mesh-ancestor
6338893|NCT00027638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338894|NCT00027638|Leprostatic Agents|leprostatic agents|mesh-ancestor
6338895|NCT00027638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6338896|NCT00027638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6338897|NCT00027638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6338898|NCT00027638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6338899|NCT00027638|Growth Substances|growth substances|mesh-ancestor
6338900|NCT00027638|Growth Inhibitors|growth inhibitors|mesh-ancestor
6338901|NCT00027638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6338902|NCT00027664|Interferons|interferons|mesh-list
6338903|NCT00027664|Interferon-alpha|interferon-alpha|mesh-list
6338904|NCT00027664|Thalidomide|thalidomide|mesh-list
6338905|NCT00027664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6338906|NCT00027664|Antiviral Agents|antiviral agents|mesh-ancestor
6338907|NCT00027664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6338908|NCT00027664|Immunologic Factors|immunologic factors|mesh-ancestor
6338909|NCT00027664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338910|NCT00027664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6338911|NCT00027664|Leprostatic Agents|leprostatic agents|mesh-ancestor
6338912|NCT00027664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6338913|NCT00027664|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6338914|NCT00027664|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6338915|NCT00027664|Growth Substances|growth substances|mesh-ancestor
6338916|NCT00027664|Growth Inhibitors|growth inhibitors|mesh-ancestor
6338917|NCT00027677|Halofuginone|halofuginone|mesh-list
6338918|NCT00027677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6338919|NCT00027677|Coccidiostats|coccidiostats|mesh-ancestor
6338920|NCT00027677|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6338921|NCT00027677|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6338922|NCT00027677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6338923|NCT00027677|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6338924|NCT00027677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6338925|NCT00027677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6338926|NCT00027677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6338927|NCT00027677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6338928|NCT00027677|Growth Substances|growth substances|mesh-ancestor
6338929|NCT00027677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338930|NCT00027677|Growth Inhibitors|growth inhibitors|mesh-ancestor
6338931|NCT00027690|Gefitinib|gefitinib|mesh-list
6338932|NCT00027690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6338933|NCT00027690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6338934|NCT00027690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6338935|NCT00027690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6338936|NCT00027703|Gemcitabine|gemcitabine|mesh-list
6338937|NCT00027703|Bevacizumab|bevacizumab|mesh-list
6338938|NCT00027703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6338939|NCT00027703|Antibodies|antibodies|mesh-list
6338940|NCT00027703|Immunoglobulins|immunoglobulins|mesh-list
6338941|NCT00027703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6338942|NCT00027703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6338943|NCT00027703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6338944|NCT00027703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6338945|NCT00027703|Growth Substances|growth substances|mesh-ancestor
6338946|NCT00027703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338947|NCT00027703|Growth Inhibitors|growth inhibitors|mesh-ancestor
6338948|NCT00027703|Immunologic Factors|immunologic factors|mesh-ancestor
6338949|NCT00027703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6338950|NCT00027703|Antimetabolites|antimetabolites|mesh-ancestor
6338951|NCT00027703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6338952|NCT00027703|Antiviral Agents|antiviral agents|mesh-ancestor
6338953|NCT00027703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6338954|NCT00027703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6338955|NCT00027703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6338956|NCT00027716|Bortezomib|bortezomib|mesh-list
6338957|NCT00027716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6338958|NCT00027742|Interferons|interferons|mesh-list
6338959|NCT00027742|Interferon-alpha|interferon-alpha|mesh-list
6338960|NCT00027742|Temozolomide|temozolomide|mesh-list
6338961|NCT00027742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6338962|NCT00027742|Antiviral Agents|antiviral agents|mesh-ancestor
6338963|NCT00027742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6338964|NCT00027742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6338965|NCT00027742|Alkylating Agents|alkylating agents|mesh-ancestor
6338966|NCT00027742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6338967|NCT00027742|Immunologic Factors|immunologic factors|mesh-ancestor
6338968|NCT00027742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338969|NCT00027768|Ethiodized Oil|ethiodized oil|mesh-list
6338970|NCT00027768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6338971|NCT00027807|Aldesleukin|aldesleukin|mesh-list
6338972|NCT00027807|Molgramostim|molgramostim|mesh-list
6338973|NCT00027807|Sargramostim|sargramostim|mesh-list
6338974|NCT00027807|Immunologic Factors|immunologic factors|mesh-ancestor
6338975|NCT00027807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338976|NCT00027807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6338977|NCT00027807|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6338978|NCT00027807|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6338979|NCT00027807|Antiviral Agents|antiviral agents|mesh-ancestor
6338980|NCT00027807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6338981|NCT00027820|Cyclosporine|cyclosporine|mesh-list
6338982|NCT00027820|Mycophenolic Acid|mycophenolic acid|mesh-list
6338983|NCT00027820|Fludarabine|fludarabine|mesh-list
6338984|NCT00027820|Fludarabine phosphate|fludarabine phosphate|mesh-list
6338985|NCT00027820|Cyclosporins|cyclosporins|mesh-list
6338986|NCT00027820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6338987|NCT00027820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6338988|NCT00027820|Antimetabolites|antimetabolites|mesh-ancestor
6338989|NCT00027820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6338990|NCT00027820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6338991|NCT00027820|Immunologic Factors|immunologic factors|mesh-ancestor
6338992|NCT00027820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6338993|NCT00027820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6338994|NCT00027820|Antifungal Agents|antifungal agents|mesh-ancestor
6338995|NCT00027820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6338996|NCT00027820|Dermatologic Agents|dermatologic agents|mesh-ancestor
6338997|NCT00027820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6338998|NCT00027820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6338999|NCT00027820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6339000|NCT00027820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6339001|NCT00027820|Antitubercular Agents|antitubercular agents|mesh-ancestor
6339002|NCT00027820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6339003|NCT00027833|Leucovorin|leucovorin|mesh-list
6339004|NCT00027833|Fluorouracil|fluorouracil|mesh-list
6339005|NCT00027833|Irinotecan|irinotecan|mesh-list
6339006|NCT00027833|Calcium|calcium|mesh-list
6339007|NCT00027833|Levoleucovorin|levoleucovorin|mesh-list
6339008|NCT00027833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6339009|NCT00027833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6339010|NCT00027833|Antimetabolites|antimetabolites|mesh-ancestor
6339011|NCT00027833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339012|NCT00027833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6339013|NCT00027833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6339014|NCT00027833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6339015|NCT00027833|Immunologic Factors|immunologic factors|mesh-ancestor
6339016|NCT00027833|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6339017|NCT00027833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6339018|NCT00027833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6339019|NCT00027833|Antidotes|antidotes|mesh-ancestor
6339020|NCT00027833|Protective Agents|protective agents|mesh-ancestor
6339021|NCT00027833|Vitamin B Complex|vitamin b complex|mesh-ancestor
6339022|NCT00027833|Vitamins|vitamins|mesh-ancestor
6339023|NCT00027833|Micronutrients|micronutrients|mesh-ancestor
6339024|NCT00027859|Ketoconazole|ketoconazole|mesh-list
6339025|NCT00027859|Hydrocortisone|hydrocortisone|mesh-list
6339026|NCT00027859|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6339027|NCT00027859|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6339028|NCT00027859|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6339029|NCT00027859|Docetaxel|docetaxel|mesh-list
6339030|NCT00027859|Estramustine|estramustine|mesh-list
6339031|NCT00027859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6339032|NCT00027859|Tubulin Modulators|tubulin modulators|mesh-ancestor
6339033|NCT00027859|Antimitotic Agents|antimitotic agents|mesh-ancestor
6339034|NCT00027859|Mitosis Modulators|mitosis modulators|mesh-ancestor
6339035|NCT00027859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339036|NCT00027859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6339037|NCT00027859|Antifungal Agents|antifungal agents|mesh-ancestor
6339038|NCT00027859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6339039|NCT00027859|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6339040|NCT00027859|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6339041|NCT00027859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6339042|NCT00027859|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6339043|NCT00027859|Hormone Antagonists|hormone antagonists|mesh-ancestor
6339044|NCT00027859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6339045|NCT00027859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6339046|NCT00027859|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6339047|NCT00027859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6339048|NCT00027859|Alkylating Agents|alkylating agents|mesh-ancestor
6339049|NCT00027859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6339050|NCT00027872|Tipifarnib|tipifarnib|mesh-list
6339051|NCT00027872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6339052|NCT00027885|Cyclophosphamide|cyclophosphamide|mesh-list
6339053|NCT00027885|Bevacizumab|bevacizumab|mesh-list
6339054|NCT00027885|Docetaxel|docetaxel|mesh-list
6339055|NCT00027885|Doxorubicin|doxorubicin|mesh-list
6339056|NCT00027885|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6339057|NCT00027885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6339058|NCT00027885|Immunologic Factors|immunologic factors|mesh-ancestor
6339059|NCT00027885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6339060|NCT00027885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6339061|NCT00027885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6339062|NCT00027885|Alkylating Agents|alkylating agents|mesh-ancestor
6339063|NCT00027885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339064|NCT00027885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6339065|NCT00027885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6339066|NCT00027885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6339067|NCT00027885|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6339068|NCT00027885|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6339069|NCT00027885|Growth Substances|growth substances|mesh-ancestor
6339070|NCT00027885|Growth Inhibitors|growth inhibitors|mesh-ancestor
6339071|NCT00027885|Tubulin Modulators|tubulin modulators|mesh-ancestor
6339072|NCT00027885|Antimitotic Agents|antimitotic agents|mesh-ancestor
6339073|NCT00027885|Mitosis Modulators|mitosis modulators|mesh-ancestor
6339074|NCT00027885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6339075|NCT00027885|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6339076|NCT00027885|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6339077|NCT00027885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6339078|NCT00027898|Carboplatin|carboplatin|mesh-list
6339079|NCT00027898|Etoposide|etoposide|mesh-list
6339080|NCT00027898|Bortezomib|bortezomib|mesh-list
6339081|NCT00027898|Etoposide phosphate|etoposide phosphate|mesh-list
6339082|NCT00027898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6339083|NCT00027898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6339084|NCT00027898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6339085|NCT00027898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6339086|NCT00027898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6339087|NCT00027898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339088|NCT00027911|Sargramostim|sargramostim|mesh-list
6339089|NCT00027911|Immunologic Factors|immunologic factors|mesh-ancestor
6339090|NCT00027911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6339091|NCT00027924|Cyclosporine|cyclosporine|mesh-list
6339092|NCT00027924|Methotrexate|methotrexate|mesh-list
6339093|NCT00027924|Fludarabine phosphate|fludarabine phosphate|mesh-list
6339094|NCT00027924|Fludarabine|fludarabine|mesh-list
6339095|NCT00027924|Busulfan|busulfan|mesh-list
6339096|NCT00027924|Cyclosporins|cyclosporins|mesh-list
6339097|NCT00027924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6339098|NCT00027924|Abortifacient Agents|abortifacient agents|mesh-ancestor
6339099|NCT00027924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6339100|NCT00027924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6339101|NCT00027924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6339102|NCT00027924|Antimetabolites|antimetabolites|mesh-ancestor
6339103|NCT00027924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339104|NCT00027924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6339105|NCT00027924|Dermatologic Agents|dermatologic agents|mesh-ancestor
6016811|NCT00368277|Amlodipine|amlodipine|mesh-list
6339106|NCT00027924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6339107|NCT00027924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6339108|NCT00027924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6339109|NCT00027924|Immunologic Factors|immunologic factors|mesh-ancestor
6339110|NCT00027924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6339111|NCT00027924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6339112|NCT00027924|Antifungal Agents|antifungal agents|mesh-ancestor
6339113|NCT00027924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6339114|NCT00027924|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6339115|NCT00027924|Alkylating Agents|alkylating agents|mesh-ancestor
6339116|NCT00027924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6339117|NCT00027924|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6339118|NCT00027937|Aldesleukin|aldesleukin|mesh-list
6339119|NCT00027937|Paclitaxel|paclitaxel|mesh-list
6339120|NCT00027937|Cyclophosphamide|cyclophosphamide|mesh-list
6339121|NCT00027937|Melphalan|melphalan|mesh-list
6339122|NCT00027937|Busulfan|busulfan|mesh-list
6339123|NCT00027937|Thiotepa|thiotepa|mesh-list
6339124|NCT00027937|Sargramostim|sargramostim|mesh-list
6339125|NCT00027937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6339126|NCT00027937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6339127|NCT00027937|Tubulin Modulators|tubulin modulators|mesh-ancestor
6339128|NCT00027937|Antimitotic Agents|antimitotic agents|mesh-ancestor
6339129|NCT00027937|Mitosis Modulators|mitosis modulators|mesh-ancestor
6339130|NCT00027937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339131|NCT00027937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6339132|NCT00027937|Immunologic Factors|immunologic factors|mesh-ancestor
6339133|NCT00027937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6339134|NCT00027937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6339135|NCT00027937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6339136|NCT00027937|Alkylating Agents|alkylating agents|mesh-ancestor
6339137|NCT00027937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6339138|NCT00027937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6339139|NCT00027937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6339140|NCT00027937|Antiviral Agents|antiviral agents|mesh-ancestor
6339141|NCT00027937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6339142|NCT00027963|Gabapentin|gabapentin|mesh-list
6339143|NCT00027963|Analgesics|analgesics|mesh-ancestor
6339144|NCT00027963|Sensory System Agents|sensory system agents|mesh-ancestor
6339145|NCT00027963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6339146|NCT00027963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6339147|NCT00027963|Anticonvulsants|anticonvulsants|mesh-ancestor
6339148|NCT00027963|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6339149|NCT00027963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6339150|NCT00027963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6339151|NCT00027963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6339152|NCT00027963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6339153|NCT00027963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6339154|NCT00027963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6339155|NCT00027963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339156|NCT00027963|Antimanic Agents|antimanic agents|mesh-ancestor
6339157|NCT00027976|Celecoxib|celecoxib|mesh-list
6339158|NCT00027976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6339159|NCT00027976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6339160|NCT00027976|Analgesics|analgesics|mesh-ancestor
6339161|NCT00027976|Sensory System Agents|sensory system agents|mesh-ancestor
6339162|NCT00027976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6339163|NCT00027976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6339164|NCT00027976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6339165|NCT00027976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6339166|NCT00027976|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6339167|NCT00027976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6339168|NCT00027976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6339169|NCT00027976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339170|NCT00027989|Gemcitabine|gemcitabine|mesh-list
6339171|NCT00027989|Doxorubicin|doxorubicin|mesh-list
6339172|NCT00027989|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6339173|NCT00027989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6339174|NCT00027989|Antimetabolites|antimetabolites|mesh-ancestor
6339175|NCT00027989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339176|NCT00027989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6339177|NCT00027989|Antiviral Agents|antiviral agents|mesh-ancestor
6339178|NCT00027989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6339179|NCT00027989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6339180|NCT00027989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6339181|NCT00027989|Immunologic Factors|immunologic factors|mesh-ancestor
6339182|NCT00027989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6339183|NCT00027989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6339184|NCT00027989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6339185|NCT00027989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6339186|NCT00028028|Sirolimus|sirolimus|mesh-list
6339187|NCT00028028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6339188|NCT00028028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6339189|NCT00028028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6339190|NCT00028028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6339191|NCT00028028|Antifungal Agents|antifungal agents|mesh-ancestor
6339192|NCT00028028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6339193|NCT00028028|Immunologic Factors|immunologic factors|mesh-ancestor
6339194|NCT00028028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6339195|NCT00028106|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
6339196|NCT00028106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6339197|NCT00028106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6339198|NCT00028106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339199|NCT00028106|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6339200|NCT00028132|Tenofovir|tenofovir|mesh-list
6339201|NCT00028132|Antiviral Agents|antiviral agents|mesh-ancestor
6339202|NCT00028132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6339203|NCT00028132|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6339204|NCT00028132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6339205|NCT00028132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6339206|NCT00028132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339207|NCT00028132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6339208|NCT00028132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6339209|NCT00028171|Tacrolimus|tacrolimus|mesh-list
6339210|NCT00028171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6339211|NCT00028171|Immunologic Factors|immunologic factors|mesh-ancestor
6339212|NCT00028171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6339213|NCT00028171|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6339214|NCT00028171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6339215|NCT00028171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339216|NCT00028275|Interferons|interferons|mesh-list
6339217|NCT00028275|Interferon-gamma|interferon-gamma|mesh-list
6339218|NCT00028275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6339219|NCT00028275|Antiviral Agents|antiviral agents|mesh-ancestor
6339220|NCT00028275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6339221|NCT00028288|Daclizumab|daclizumab|mesh-list
6339222|NCT00028288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6339223|NCT00028288|Immunologic Factors|immunologic factors|mesh-ancestor
6339224|NCT00028288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6339225|NCT00028314|Ritonavir|ritonavir|mesh-list
6339226|NCT00028314|Lopinavir|lopinavir|mesh-list
6339227|NCT00028314|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6339228|NCT00028314|Nevirapine|nevirapine|mesh-list
6339229|NCT00028314|Abacavir|abacavir|mesh-list
6339230|NCT00028314|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6339231|NCT00028314|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6339232|NCT00028314|Protease Inhibitors|protease inhibitors|mesh-ancestor
6339233|NCT00028314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6339234|NCT00028314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339235|NCT00028314|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6339236|NCT00028314|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6339237|NCT00028314|Antiviral Agents|antiviral agents|mesh-ancestor
6339238|NCT00028314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6339239|NCT00028314|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6339240|NCT00028314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6339241|NCT00028314|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6339242|NCT00028314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6339243|NCT00028314|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6339244|NCT00028314|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6339245|NCT00028327|Lamivudine|lamivudine|mesh-list
6339246|NCT00028327|Zidovudine|zidovudine|mesh-list
6339247|NCT00028327|Efavirenz|efavirenz|mesh-list
6339248|NCT00028327|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6339249|NCT00028327|Nelfinavir|nelfinavir|mesh-list
6339250|NCT00028327|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6339251|NCT00028327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6339252|NCT00028327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6339253|NCT00028327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339254|NCT00028327|Antiviral Agents|antiviral agents|mesh-ancestor
6339255|NCT00028327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6339256|NCT00028327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6339257|NCT00028327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6339258|NCT00028327|Antimetabolites|antimetabolites|mesh-ancestor
6339259|NCT00028327|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6339260|NCT00028327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6339261|NCT00028327|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6339262|NCT00028327|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6339263|NCT00028327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6339264|NCT00028327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6339265|NCT00028327|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6339266|NCT00028327|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6339267|NCT00028327|Protease Inhibitors|protease inhibitors|mesh-ancestor
6339268|NCT00028353|Toremifene|toremifene|mesh-list
6339269|NCT00028353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6339270|NCT00028353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6339271|NCT00028353|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6339272|NCT00028353|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6339273|NCT00028353|Hormone Antagonists|hormone antagonists|mesh-ancestor
6339274|NCT00028353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6339275|NCT00028353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6339276|NCT00028353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6339277|NCT00028366|Ritonavir|ritonavir|mesh-list
6339278|NCT00028366|Lopinavir|lopinavir|mesh-list
6339279|NCT00028366|Fosamprenavir|fosamprenavir|mesh-list
6339280|NCT00028366|Tenofovir|tenofovir|mesh-list
6339281|NCT00028366|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6339282|NCT00028366|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6339283|NCT00028366|Protease Inhibitors|protease inhibitors|mesh-ancestor
6339284|NCT00028366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6339285|NCT00028366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339286|NCT00028366|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6339287|NCT00028366|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6339288|NCT00028366|Antiviral Agents|antiviral agents|mesh-ancestor
6339289|NCT00028366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6339290|NCT00028366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6339291|NCT00028366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6339292|NCT00028366|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6339293|NCT00028366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6339294|NCT00028405|Talaporfin|talaporfin|mesh-list
6339295|NCT00028405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6339296|NCT00028405|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6339297|NCT00028405|Dermatologic Agents|dermatologic agents|mesh-ancestor
6339298|NCT00028418|Clofarabine|clofarabine|mesh-list
6339299|NCT00028418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6339300|NCT00028418|Antimetabolites|antimetabolites|mesh-ancestor
6339301|NCT00028418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339302|NCT00028418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6339303|NCT00028431|Ipilimumab|ipilimumab|mesh-list
6339304|NCT00028431|Antibodies|antibodies|mesh-list
6339305|NCT00028431|Immunologic Factors|immunologic factors|mesh-ancestor
6339306|NCT00028431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6339307|NCT00028431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6339308|NCT00028431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6339309|NCT00028431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6339310|NCT00028431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339311|NCT00028483|Docetaxel|docetaxel|mesh-list
6339312|NCT00028483|Doxorubicin|doxorubicin|mesh-list
6339313|NCT00028483|Immunoconjugates|immunoconjugates|mesh-list
6339314|NCT00028483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6339315|NCT00028483|Tubulin Modulators|tubulin modulators|mesh-ancestor
6339316|NCT00028483|Antimitotic Agents|antimitotic agents|mesh-ancestor
6339317|NCT00028483|Mitosis Modulators|mitosis modulators|mesh-ancestor
6339318|NCT00028483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339319|NCT00028483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6339320|NCT00028483|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6339321|NCT00028483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6339322|NCT00028483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6339323|NCT00028483|Immunologic Factors|immunologic factors|mesh-ancestor
6339324|NCT00028483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6339325|NCT00028496|Metronidazole|metronidazole|mesh-list
6339326|NCT00028496|Molgramostim|molgramostim|mesh-list
6339327|NCT00028496|Vaccines|vaccines|mesh-list
6339328|NCT00028496|Sargramostim|sargramostim|mesh-list
6339329|NCT00028496|Immunologic Factors|immunologic factors|mesh-ancestor
6339330|NCT00028496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6339331|NCT00028496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6339332|NCT00028496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6339333|NCT00028496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6339334|NCT00028496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6339335|NCT00028496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6339336|NCT00028535|Paclitaxel|paclitaxel|mesh-list
6339337|NCT00028535|Trastuzumab|trastuzumab|mesh-list
6339338|NCT00028535|Interleukin-12|interleukin-12|mesh-list
6339339|NCT00028535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6339340|NCT00028535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6339341|NCT00028535|Tubulin Modulators|tubulin modulators|mesh-ancestor
6339342|NCT00028535|Antimitotic Agents|antimitotic agents|mesh-ancestor
6339343|NCT00028535|Mitosis Modulators|mitosis modulators|mesh-ancestor
6339344|NCT00028535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339345|NCT00028535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6339346|NCT00028535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6339347|NCT00028535|Immunologic Factors|immunologic factors|mesh-ancestor
6339348|NCT00028535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6339349|NCT00028535|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6339350|NCT00028535|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6339351|NCT00028535|Growth Substances|growth substances|mesh-ancestor
6339352|NCT00028535|Growth Inhibitors|growth inhibitors|mesh-ancestor
6339353|NCT00028561|Carboplatin|carboplatin|mesh-list
6339354|NCT00028561|Epothilone B|epothilone b|mesh-list
6339355|NCT00028561|Epothilones|epothilones|mesh-list
6339356|NCT00028561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6339357|NCT00028561|Tubulin Modulators|tubulin modulators|mesh-ancestor
6339358|NCT00028561|Antimitotic Agents|antimitotic agents|mesh-ancestor
6339359|NCT00028561|Mitosis Modulators|mitosis modulators|mesh-ancestor
6339360|NCT00028561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339361|NCT00028574|Gabapentin|gabapentin|mesh-list
6339362|NCT00028574|Analgesics|analgesics|mesh-ancestor
6339363|NCT00028574|Sensory System Agents|sensory system agents|mesh-ancestor
6339364|NCT00028574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6339365|NCT00028574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6339366|NCT00028574|Anticonvulsants|anticonvulsants|mesh-ancestor
6339367|NCT00028574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6339368|NCT00028574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6339369|NCT00028574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6339370|NCT00028574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6339371|NCT00028574|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6339372|NCT00028574|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6339373|NCT00028574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6339374|NCT00028574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339375|NCT00028574|Antimanic Agents|antimanic agents|mesh-ancestor
6339376|NCT00028587|Paclitaxel|paclitaxel|mesh-list
6339377|NCT00028587|Carboplatin|carboplatin|mesh-list
6339378|NCT00028587|Bortezomib|bortezomib|mesh-list
6339379|NCT00028587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6339380|NCT00028587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6339381|NCT00028587|Tubulin Modulators|tubulin modulators|mesh-ancestor
6339382|NCT00028587|Antimitotic Agents|antimitotic agents|mesh-ancestor
6339383|NCT00028587|Mitosis Modulators|mitosis modulators|mesh-ancestor
6339384|NCT00028587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339385|NCT00028600|Cyclophosphamide|cyclophosphamide|mesh-list
6339386|NCT00028600|Melphalan|melphalan|mesh-list
6339387|NCT00028600|Methotrexate|methotrexate|mesh-list
6339388|NCT00028600|Fludarabine|fludarabine|mesh-list
6339389|NCT00028600|Fludarabine phosphate|fludarabine phosphate|mesh-list
6339390|NCT00028600|Tacrolimus|tacrolimus|mesh-list
6339391|NCT00028600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6339392|NCT00028600|Immunologic Factors|immunologic factors|mesh-ancestor
6339393|NCT00028600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6339394|NCT00028600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6339395|NCT00028600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6339396|NCT00028600|Alkylating Agents|alkylating agents|mesh-ancestor
6339397|NCT00028600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339398|NCT00028600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6339399|NCT00028600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6339400|NCT00028600|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6339401|NCT00028600|Abortifacient Agents|abortifacient agents|mesh-ancestor
6339402|NCT00028600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6339403|NCT00028600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6339404|NCT00028600|Antimetabolites|antimetabolites|mesh-ancestor
6339405|NCT00028600|Dermatologic Agents|dermatologic agents|mesh-ancestor
6339406|NCT00028600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6339407|NCT00028600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6339408|NCT00028600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6339409|NCT00028600|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6339410|NCT00028613|Antibodies|antibodies|mesh-list
6339411|NCT00028613|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6339412|NCT00028613|Immunologic Factors|immunologic factors|mesh-ancestor
6339413|NCT00028613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6339414|NCT00028652|Interleukin-12|interleukin-12|mesh-list
6339415|NCT00028652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6339416|NCT00028652|Immunologic Factors|immunologic factors|mesh-ancestor
6339417|NCT00028652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6339418|NCT00028652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6339419|NCT00028652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6339420|NCT00028652|Growth Substances|growth substances|mesh-ancestor
6339421|NCT00028652|Growth Inhibitors|growth inhibitors|mesh-ancestor
6339422|NCT00028652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6339423|NCT00028665|Cyclophosphamide|cyclophosphamide|mesh-list
6339424|NCT00028665|Carmustine|carmustine|mesh-list
6339425|NCT00028665|Rituximab|rituximab|mesh-list
6339426|NCT00028665|Etoposide|etoposide|mesh-list
6339427|NCT00028665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6339428|NCT00028665|Immunologic Factors|immunologic factors|mesh-ancestor
6339429|NCT00028665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6339430|NCT00028665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6339431|NCT00028665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6339432|NCT00028665|Alkylating Agents|alkylating agents|mesh-ancestor
6339433|NCT00028665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339434|NCT00028665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6339435|NCT00028665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6339436|NCT00028665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6339437|NCT00028665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6339438|NCT00028665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6339439|NCT00028665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6339440|NCT00028665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6339441|NCT00028678|Dalteparin|dalteparin|mesh-list
6339442|NCT00028678|Tinzaparin|tinzaparin|mesh-list
6339443|NCT00028678|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6339444|NCT00028678|Anticoagulants|anticoagulants|mesh-ancestor
6339445|NCT00028678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6339446|NCT00028678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6339447|NCT00028678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339448|NCT00028691|Chlorambucil|chlorambucil|mesh-list
6339449|NCT00028691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6339450|NCT00028691|Alkylating Agents|alkylating agents|mesh-ancestor
6339451|NCT00028691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339452|NCT00028691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6339453|NCT00028717|Prednisone|prednisone|mesh-list
6339454|NCT00028717|Cyclophosphamide|cyclophosphamide|mesh-list
6339455|NCT00028717|Rituximab|rituximab|mesh-list
6339456|NCT00028717|Doxorubicin|doxorubicin|mesh-list
6339457|NCT00028717|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6339458|NCT00028717|Vincristine|vincristine|mesh-list
6339459|NCT00028717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6339460|NCT00028717|Immunologic Factors|immunologic factors|mesh-ancestor
6339461|NCT00028717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6339462|NCT00028717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6339463|NCT00028717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6339464|NCT00028717|Alkylating Agents|alkylating agents|mesh-ancestor
6339465|NCT00028717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339466|NCT00028717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6339467|NCT00028717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6339468|NCT00028717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6339469|NCT00028717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6339470|NCT00028717|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6339471|NCT00028717|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6339472|NCT00028717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6339473|NCT00028717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6339474|NCT00028717|Glucocorticoids|glucocorticoids|mesh-ancestor
6339475|NCT00028717|Hormones|hormones|mesh-ancestor
6339476|NCT00028717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6339477|NCT00028717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6339478|NCT00028717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6339479|NCT00028717|Tubulin Modulators|tubulin modulators|mesh-ancestor
6339480|NCT00028717|Antimitotic Agents|antimitotic agents|mesh-ancestor
6339481|NCT00028717|Mitosis Modulators|mitosis modulators|mesh-ancestor
6339482|NCT00028730|Cyclophosphamide|cyclophosphamide|mesh-list
6339483|NCT00028730|Thiotepa|thiotepa|mesh-list
6339484|NCT00028730|Fludarabine|fludarabine|mesh-list
6339485|NCT00028730|Fludarabine phosphate|fludarabine phosphate|mesh-list
6339486|NCT00028730|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6339487|NCT00028730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6339488|NCT00028730|Immunologic Factors|immunologic factors|mesh-ancestor
6339489|NCT00028730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6339490|NCT00028730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6339491|NCT00028730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6339492|NCT00028730|Alkylating Agents|alkylating agents|mesh-ancestor
6339493|NCT00028730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339494|NCT00028730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6339495|NCT00028730|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6339496|NCT00028730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6339497|NCT00028730|Antimetabolites|antimetabolites|mesh-ancestor
6339498|NCT00028743|Paclitaxel|paclitaxel|mesh-list
6339499|NCT00028743|Carboplatin|carboplatin|mesh-list
6339500|NCT00028743|Topotecan|topotecan|mesh-list
6339501|NCT00028743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6339502|NCT00028743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6339503|NCT00028743|Tubulin Modulators|tubulin modulators|mesh-ancestor
6339504|NCT00028743|Antimitotic Agents|antimitotic agents|mesh-ancestor
6339505|NCT00028743|Mitosis Modulators|mitosis modulators|mesh-ancestor
6339506|NCT00028743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339507|NCT00028743|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6339508|NCT00028743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6339509|NCT00028743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6339510|NCT00028756|Gemcitabine|gemcitabine|mesh-list
6339511|NCT00028756|Doxorubicin|doxorubicin|mesh-list
6339512|NCT00028756|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6339513|NCT00028756|Methotrexate|methotrexate|mesh-list
6339514|NCT00028756|Vinblastine|vinblastine|mesh-list
6339515|NCT00028756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6339516|NCT00028756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6339517|NCT00028756|Antimetabolites|antimetabolites|mesh-ancestor
6339518|NCT00028756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339519|NCT00028756|Antiviral Agents|antiviral agents|mesh-ancestor
6339520|NCT00028756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6339521|NCT00028756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6339522|NCT00028756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6339523|NCT00028756|Immunologic Factors|immunologic factors|mesh-ancestor
6339524|NCT00028756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6339525|NCT00028756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6339526|NCT00028756|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6339527|NCT00028756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6339528|NCT00028756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6339529|NCT00028756|Abortifacient Agents|abortifacient agents|mesh-ancestor
6339530|NCT00028756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6339531|NCT00028756|Dermatologic Agents|dermatologic agents|mesh-ancestor
6339532|NCT00028756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6339533|NCT00028756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6339534|NCT00028756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6339535|NCT00028756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6339536|NCT00028756|Tubulin Modulators|tubulin modulators|mesh-ancestor
6339537|NCT00028756|Antimitotic Agents|antimitotic agents|mesh-ancestor
6339538|NCT00028756|Mitosis Modulators|mitosis modulators|mesh-ancestor
6339539|NCT00028782|Etanidazole|etanidazole|mesh-list
6339540|NCT00028782|Imidazole|imidazole|mesh-list
6339541|NCT00028782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6339542|NCT00028782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339543|NCT00028782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6339544|NCT00028795|Temozolomide|temozolomide|mesh-list
6339545|NCT00028795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6339546|NCT00028795|Alkylating Agents|alkylating agents|mesh-ancestor
6339547|NCT00028795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339548|NCT00028795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6339549|NCT00028821|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
6339550|NCT00028821|Estradiol|estradiol|mesh-list
6339551|NCT00028821|Estrogens|estrogens|mesh-ancestor
6339552|NCT00028821|Hormones|hormones|mesh-ancestor
6339553|NCT00028821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6339554|NCT00028821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6339555|NCT00028821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6339556|NCT00028821|Tubulin Modulators|tubulin modulators|mesh-ancestor
6339557|NCT00028821|Antimitotic Agents|antimitotic agents|mesh-ancestor
6339558|NCT00028821|Mitosis Modulators|mitosis modulators|mesh-ancestor
6339559|NCT00028821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339560|NCT00028834|Gemcitabine|gemcitabine|mesh-list
6339561|NCT00028834|Bevacizumab|bevacizumab|mesh-list
6339562|NCT00028834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6339563|NCT00028834|Antibodies|antibodies|mesh-list
6339564|NCT00028834|Immunoglobulins|immunoglobulins|mesh-list
6339565|NCT00028834|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6339566|NCT00028834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6339567|NCT00028834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6339568|NCT00028834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6339569|NCT00028834|Growth Substances|growth substances|mesh-ancestor
6339570|NCT00028834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6339571|NCT00028834|Growth Inhibitors|growth inhibitors|mesh-ancestor
6339572|NCT00028834|Immunologic Factors|immunologic factors|mesh-ancestor
6339573|NCT00028834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6339574|NCT00028834|Antimetabolites|antimetabolites|mesh-ancestor
6339575|NCT00028834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339576|NCT00028834|Antiviral Agents|antiviral agents|mesh-ancestor
6339577|NCT00028834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6339578|NCT00028834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6339579|NCT00028834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6339580|NCT00028847|Cytarabine|cytarabine|mesh-list
6339581|NCT00028847|Imatinib Mesylate|imatinib mesylate|mesh-list
6339582|NCT00028847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6339583|NCT00028847|Antimetabolites|antimetabolites|mesh-ancestor
6339584|NCT00028847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339585|NCT00028847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6339586|NCT00028847|Antiviral Agents|antiviral agents|mesh-ancestor
6339587|NCT00028847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6339588|NCT00028847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6339589|NCT00028847|Immunologic Factors|immunologic factors|mesh-ancestor
6339590|NCT00028847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6339591|NCT00028847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6339592|NCT00028847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6339593|NCT00028860|Gemcitabine|gemcitabine|mesh-list
6339594|NCT00028860|Paclitaxel|paclitaxel|mesh-list
6339595|NCT00028860|Carboplatin|carboplatin|mesh-list
6339596|NCT00028860|Ifosfamide|ifosfamide|mesh-list
6339597|NCT00028860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6339598|NCT00028860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6339599|NCT00028860|Tubulin Modulators|tubulin modulators|mesh-ancestor
6339600|NCT00028860|Antimitotic Agents|antimitotic agents|mesh-ancestor
6339601|NCT00028860|Mitosis Modulators|mitosis modulators|mesh-ancestor
6339602|NCT00028860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339603|NCT00028860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6339604|NCT00028860|Antimetabolites|antimetabolites|mesh-ancestor
6339605|NCT00028860|Antiviral Agents|antiviral agents|mesh-ancestor
6339606|NCT00028860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6339607|NCT00028860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6339608|NCT00028860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6339609|NCT00028860|Immunologic Factors|immunologic factors|mesh-ancestor
6339610|NCT00028860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6339611|NCT00028860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6339612|NCT00028860|Alkylating Agents|alkylating agents|mesh-ancestor
6339613|NCT00028873|Paclitaxel|paclitaxel|mesh-list
6339614|NCT00028873|Docetaxel|docetaxel|mesh-list
6339615|NCT00028873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6339616|NCT00028873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6339617|NCT00028873|Tubulin Modulators|tubulin modulators|mesh-ancestor
6339618|NCT00028873|Antimitotic Agents|antimitotic agents|mesh-ancestor
6339619|NCT00028873|Mitosis Modulators|mitosis modulators|mesh-ancestor
6339620|NCT00028873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339621|NCT00028886|Interferons|interferons|mesh-list
6339622|NCT00028886|Interferon-alpha|interferon-alpha|mesh-list
6339623|NCT00028886|Thalidomide|thalidomide|mesh-list
6339624|NCT00028886|Dexamethasone|dexamethasone|mesh-list
6339625|NCT00028886|Cyclophosphamide|cyclophosphamide|mesh-list
6339626|NCT00028886|Melphalan|melphalan|mesh-list
6339627|NCT00028886|Doxorubicin|doxorubicin|mesh-list
6339628|NCT00028886|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6339629|NCT00028886|Vincristine|vincristine|mesh-list
6339630|NCT00028886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6339631|NCT00028886|Immunologic Factors|immunologic factors|mesh-ancestor
6339632|NCT00028886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6339633|NCT00028886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6339634|NCT00028886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6339635|NCT00028886|Alkylating Agents|alkylating agents|mesh-ancestor
6339636|NCT00028886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339637|NCT00028886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6339638|NCT00028886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6339639|NCT00028886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6339640|NCT00028886|Antiemetics|antiemetics|mesh-ancestor
6339641|NCT00028886|Autonomic Agents|autonomic agents|mesh-ancestor
6339642|NCT00028886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6339643|NCT00028886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6339644|NCT00028886|Glucocorticoids|glucocorticoids|mesh-ancestor
6339645|NCT00028886|Hormones|hormones|mesh-ancestor
6339646|NCT00028886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6339647|NCT00028886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6339648|NCT00028886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6339649|NCT00028886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6339650|NCT00028886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6339651|NCT00028886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6339652|NCT00028886|Antiviral Agents|antiviral agents|mesh-ancestor
6339653|NCT00028886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6339654|NCT00028886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6339655|NCT00028886|Tubulin Modulators|tubulin modulators|mesh-ancestor
6339656|NCT00028886|Antimitotic Agents|antimitotic agents|mesh-ancestor
6339657|NCT00028886|Mitosis Modulators|mitosis modulators|mesh-ancestor
6339658|NCT00028886|Leprostatic Agents|leprostatic agents|mesh-ancestor
6339659|NCT00028886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6339660|NCT00028886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6339661|NCT00028886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6339662|NCT00028886|Growth Substances|growth substances|mesh-ancestor
6339663|NCT00028886|Growth Inhibitors|growth inhibitors|mesh-ancestor
6339664|NCT00028899|Cytarabine|cytarabine|mesh-list
6339665|NCT00028899|Asparaginase|asparaginase|mesh-list
6339666|NCT00028899|Mitoxantrone|mitoxantrone|mesh-list
6339667|NCT00028899|Gemtuzumab|gemtuzumab|mesh-list
6339668|NCT00028899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6339669|NCT00028899|Antimetabolites|antimetabolites|mesh-ancestor
6339670|NCT00028899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339671|NCT00028899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6339672|NCT00028899|Antiviral Agents|antiviral agents|mesh-ancestor
6339673|NCT00028899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6339674|NCT00028899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6339675|NCT00028899|Immunologic Factors|immunologic factors|mesh-ancestor
6339676|NCT00028899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6339677|NCT00028899|Analgesics|analgesics|mesh-ancestor
6339678|NCT00028899|Sensory System Agents|sensory system agents|mesh-ancestor
6339679|NCT00028899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6339680|NCT00028899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6339681|NCT00028899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6339682|NCT00028899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6339683|NCT00028899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6339684|NCT00028912|Carboplatin|carboplatin|mesh-list
6339685|NCT00028912|Bortezomib|bortezomib|mesh-list
6339686|NCT00028912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6339687|NCT00028925|Carboplatin|carboplatin|mesh-list
6339688|NCT00028925|Topotecan|topotecan|mesh-list
6339689|NCT00028925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6339690|NCT00028925|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6339691|NCT00028925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6339692|NCT00028925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6339693|NCT00028925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339694|NCT00028938|Paclitaxel|paclitaxel|mesh-list
6339695|NCT00028938|Carboplatin|carboplatin|mesh-list
6339696|NCT00028938|Epoetin Alfa|epoetin alfa|mesh-list
6339697|NCT00028938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6339698|NCT00028938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6339699|NCT00028938|Tubulin Modulators|tubulin modulators|mesh-ancestor
6339700|NCT00028938|Antimitotic Agents|antimitotic agents|mesh-ancestor
6339701|NCT00028938|Mitosis Modulators|mitosis modulators|mesh-ancestor
6339702|NCT00028938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339703|NCT00028938|Hematinics|hematinics|mesh-ancestor
6339704|NCT00028951|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6339705|NCT00028951|Hemostatics|hemostatics|mesh-ancestor
6339706|NCT00028951|Coagulants|coagulants|mesh-ancestor
6339707|NCT00028964|Cyclophosphamide|cyclophosphamide|mesh-list
6339708|NCT00028964|Doxorubicin|doxorubicin|mesh-list
6339709|NCT00028964|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6339710|NCT00028964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6339711|NCT00028964|Immunologic Factors|immunologic factors|mesh-ancestor
6339712|NCT00028964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6339713|NCT00028964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6339714|NCT00028964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6339715|NCT00028964|Alkylating Agents|alkylating agents|mesh-ancestor
6339716|NCT00028964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339717|NCT00028964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6339718|NCT00028964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6339719|NCT00028964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6339720|NCT00028964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6339721|NCT00028964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6339722|NCT00028964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6393729|NCT00199576|Prednisolone|prednisolone|mesh-list
6016812|NCT00368277|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6393730|NCT00199576|Prednisolone acetate|prednisolone acetate|mesh-list
6339723|NCT00028990|Paclitaxel|paclitaxel|mesh-list
6339724|NCT00028990|Bevacizumab|bevacizumab|mesh-list
6339725|NCT00028990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6339726|NCT00028990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6339727|NCT00028990|Tubulin Modulators|tubulin modulators|mesh-ancestor
6339728|NCT00028990|Antimitotic Agents|antimitotic agents|mesh-ancestor
6339729|NCT00028990|Mitosis Modulators|mitosis modulators|mesh-ancestor
6339730|NCT00028990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339731|NCT00028990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6339732|NCT00028990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6339733|NCT00028990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6339734|NCT00028990|Growth Substances|growth substances|mesh-ancestor
6339735|NCT00028990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6339736|NCT00028990|Growth Inhibitors|growth inhibitors|mesh-ancestor
6339737|NCT00029003|Gefitinib|gefitinib|mesh-list
6339738|NCT00029003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6339739|NCT00029003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6339740|NCT00029003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6339741|NCT00029003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339742|NCT00029042|Infliximab|infliximab|mesh-list
6339743|NCT00029042|Dermatologic Agents|dermatologic agents|mesh-ancestor
6339744|NCT00029042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6339745|NCT00029042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6339746|NCT00029159|Estrogens|estrogens|mesh-list
6339747|NCT00029159|Androgens|androgens|mesh-list
6339748|NCT00029159|Hormones|hormones|mesh-ancestor
6339749|NCT00029159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6339750|NCT00029159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6339751|NCT00029224|Zoledronic Acid|zoledronic acid|mesh-list
6339752|NCT00029224|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6339753|NCT00029224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6339754|NCT00029250|Allicin|allicin|mesh-list
6339755|NCT00029250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6339756|NCT00029250|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6339757|NCT00029250|Antimetabolites|antimetabolites|mesh-ancestor
6339758|NCT00029250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339759|NCT00029250|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6339760|NCT00029250|Antioxidants|antioxidants|mesh-ancestor
6339761|NCT00029250|Protective Agents|protective agents|mesh-ancestor
6339762|NCT00029250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6339763|NCT00029250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6339764|NCT00029250|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6339765|NCT00029315|Plasminogen|plasminogen|mesh-list
6339766|NCT00029315|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6339767|NCT00029315|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6339768|NCT00029315|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6339769|NCT00029315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339770|NCT00029328|Etanercept|etanercept|mesh-list
6339771|NCT00029328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6339772|NCT00029328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6339773|NCT00029328|Analgesics|analgesics|mesh-ancestor
6339774|NCT00029328|Sensory System Agents|sensory system agents|mesh-ancestor
6339775|NCT00029328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6339776|NCT00029328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6339777|NCT00029328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6339778|NCT00029328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6339779|NCT00029328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6339780|NCT00029328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6339781|NCT00029328|Immunologic Factors|immunologic factors|mesh-ancestor
6339782|NCT00029380|Cyclosporine|cyclosporine|mesh-list
6339783|NCT00029380|Mycophenolic Acid|mycophenolic acid|mesh-list
6339784|NCT00029380|Cyclophosphamide|cyclophosphamide|mesh-list
6339785|NCT00029380|Busulfan|busulfan|mesh-list
6339786|NCT00029380|Cyclosporins|cyclosporins|mesh-list
6339787|NCT00029380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6339788|NCT00029380|Immunologic Factors|immunologic factors|mesh-ancestor
6339789|NCT00029380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6339790|NCT00029380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6339791|NCT00029380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6339792|NCT00029380|Alkylating Agents|alkylating agents|mesh-ancestor
6339793|NCT00029380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339794|NCT00029380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6339795|NCT00029380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6339796|NCT00029380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6339797|NCT00029380|Antifungal Agents|antifungal agents|mesh-ancestor
6339798|NCT00029380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6339799|NCT00029380|Dermatologic Agents|dermatologic agents|mesh-ancestor
6339800|NCT00029380|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6339801|NCT00029380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6339802|NCT00029380|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6339803|NCT00029380|Antitubercular Agents|antitubercular agents|mesh-ancestor
6339804|NCT00029380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6339805|NCT00029458|Clozapine|clozapine|mesh-list
6339806|NCT00029458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6339807|NCT00029458|Serotonin Agents|serotonin agents|mesh-ancestor
6339808|NCT00029458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6339809|NCT00029458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339810|NCT00029458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6339811|NCT00029458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6339812|NCT00029458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6339813|NCT00029458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6339814|NCT00029458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6339815|NCT00029458|GABA Antagonists|gaba antagonists|mesh-ancestor
6339816|NCT00029458|GABA Agents|gaba agents|mesh-ancestor
6339817|NCT00029497|Amitriptyline|amitriptyline|mesh-list
6339818|NCT00029497|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6339819|NCT00029497|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6339820|NCT00029497|Antidepressive Agents|antidepressive agents|mesh-ancestor
6339821|NCT00029497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6339822|NCT00029497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6339823|NCT00029497|Analgesics|analgesics|mesh-ancestor
6339824|NCT00029497|Sensory System Agents|sensory system agents|mesh-ancestor
6339825|NCT00029497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6339826|NCT00029497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6339827|NCT00029497|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6339828|NCT00029497|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6339829|NCT00029497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6339830|NCT00029497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339831|NCT00029497|Adrenergic Agents|adrenergic agents|mesh-ancestor
6339832|NCT00029497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6339833|NCT00029497|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6339834|NCT00029497|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6339835|NCT00029497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6339836|NCT00029523|Cytarabine|cytarabine|mesh-list
6339837|NCT00029523|Methotrexate|methotrexate|mesh-list
6339838|NCT00029523|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6339839|NCT00029523|Abortifacient Agents|abortifacient agents|mesh-ancestor
6339840|NCT00029523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6339841|NCT00029523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6339842|NCT00029523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6339843|NCT00029523|Antimetabolites|antimetabolites|mesh-ancestor
6339844|NCT00029523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339845|NCT00029523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6339846|NCT00029523|Dermatologic Agents|dermatologic agents|mesh-ancestor
6339847|NCT00029523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6339848|NCT00029523|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6339849|NCT00029523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6339850|NCT00029523|Immunologic Factors|immunologic factors|mesh-ancestor
6339851|NCT00029523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6339852|NCT00029523|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6339853|NCT00029523|Antiviral Agents|antiviral agents|mesh-ancestor
6339854|NCT00029523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6339855|NCT00029614|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6339856|NCT00029614|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6339857|NCT00029614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6339858|NCT00029614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6339859|NCT00029614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339860|NCT00029614|Adrenergic Agents|adrenergic agents|mesh-ancestor
6339861|NCT00029614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6339862|NCT00029614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6339863|NCT00029627|Yohimbine|yohimbine|mesh-list
6339864|NCT00029627|Mydriatics|mydriatics|mesh-ancestor
6339865|NCT00029627|Autonomic Agents|autonomic agents|mesh-ancestor
6339866|NCT00029627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6339867|NCT00029627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6339868|NCT00029627|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6339869|NCT00029627|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6339870|NCT00029627|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6339871|NCT00029627|Adrenergic Agents|adrenergic agents|mesh-ancestor
6339872|NCT00029627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6339873|NCT00029627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339874|NCT00029627|Urological Agents|urological agents|mesh-ancestor
6339875|NCT00029679|Borage oil|borage oil|mesh-list
6339876|NCT00029679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6339877|NCT00029757|Estrogens|estrogens|mesh-list
6339878|NCT00029757|Hormones|hormones|mesh-ancestor
6339879|NCT00029757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6339880|NCT00029757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6339881|NCT00029770|Acetaminophen|acetaminophen|mesh-list
6339882|NCT00029770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
6339883|NCT00029770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
6339884|NCT00029770|Codeine|codeine|mesh-list
6339885|NCT00029770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6339886|NCT00029770|Analgesics|analgesics|mesh-ancestor
6339887|NCT00029770|Sensory System Agents|sensory system agents|mesh-ancestor
6339888|NCT00029770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6339889|NCT00029770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6339890|NCT00029770|Antipyretics|antipyretics|mesh-ancestor
6339891|NCT00029770|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6339892|NCT00029770|Narcotics|narcotics|mesh-ancestor
6339893|NCT00029770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6339894|NCT00029770|Antitussive Agents|antitussive agents|mesh-ancestor
6339895|NCT00029770|Respiratory System Agents|respiratory system agents|mesh-ancestor
6339896|NCT00029770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6339897|NCT00029822|Alfuzosin|alfuzosin|mesh-list
6339898|NCT00029822|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6339899|NCT00029822|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6339900|NCT00029822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6339901|NCT00029822|Adrenergic Agents|adrenergic agents|mesh-ancestor
6339902|NCT00029822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6339903|NCT00029822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339904|NCT00029822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6339905|NCT00029822|Urological Agents|urological agents|mesh-ancestor
6339906|NCT00029835|Rimonabant|rimonabant|mesh-list
6339907|NCT00029835|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6339908|NCT00029835|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
6339909|NCT00029835|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6339910|NCT00029835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6339911|NCT00029835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339912|NCT00029835|Hormones|hormones|mesh-ancestor
6339913|NCT00029835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6339914|NCT00029835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6339915|NCT00029848|Rimonabant|rimonabant|mesh-list
6339916|NCT00029848|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6339917|NCT00029848|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
6339918|NCT00029848|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6339919|NCT00029848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6339920|NCT00029848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339921|NCT00029848|Hormones|hormones|mesh-ancestor
6339922|NCT00029848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6339923|NCT00029848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6339924|NCT00029861|Rimonabant|rimonabant|mesh-list
6339925|NCT00029861|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6339926|NCT00029861|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
6339927|NCT00029861|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6339928|NCT00029861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6339929|NCT00029861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339930|NCT00029861|Hormones|hormones|mesh-ancestor
6339931|NCT00029861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6339932|NCT00029861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6339933|NCT00029874|Minocycline|minocycline|mesh-list
6016813|NCT00368277|Ramipril|ramipril|mesh-list
6339934|NCT00029874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6339935|NCT00029874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6016814|NCT00368277|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6016815|NCT00368277|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6016816|NCT00368277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6339936|NCT00030004|Midazolam|midazolam|mesh-list
6339937|NCT00030004|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6339938|NCT00030004|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6339939|NCT00030004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6339940|NCT00030004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6339941|NCT00030004|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6339942|NCT00030004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6339943|NCT00030004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6339944|NCT00030004|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6339945|NCT00030004|Anesthetics, General|anesthetics, general|mesh-ancestor
6339946|NCT00030004|Anesthetics|anesthetics|mesh-ancestor
6339947|NCT00030004|GABA Modulators|gaba modulators|mesh-ancestor
6339948|NCT00030004|GABA Agents|gaba agents|mesh-ancestor
6339949|NCT00030004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6339950|NCT00030004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339951|NCT00030030|Silymarin|silymarin|mesh-list
6339952|NCT00030030|Antioxidants|antioxidants|mesh-ancestor
6339953|NCT00030030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339954|NCT00030030|Protective Agents|protective agents|mesh-ancestor
6339955|NCT00030030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6339956|NCT00030056|Molgramostim|molgramostim|mesh-list
6339957|NCT00030056|Sargramostim|sargramostim|mesh-list
6339958|NCT00030056|Immunologic Factors|immunologic factors|mesh-ancestor
6339959|NCT00030056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6339960|NCT00030056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6339961|NCT00030069|Calcitriol|calcitriol|mesh-list
6339962|NCT00030069|Dexamethasone|dexamethasone|mesh-list
6339963|NCT00030069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6339964|NCT00030069|Antiemetics|antiemetics|mesh-ancestor
6339965|NCT00030069|Autonomic Agents|autonomic agents|mesh-ancestor
6339966|NCT00030069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6339967|NCT00030069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6339968|NCT00030069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6339969|NCT00030069|Glucocorticoids|glucocorticoids|mesh-ancestor
6339970|NCT00030069|Hormones|hormones|mesh-ancestor
6339971|NCT00030069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6339972|NCT00030069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6339973|NCT00030069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6339974|NCT00030069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6339975|NCT00030069|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6339976|NCT00030069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6339977|NCT00030069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339978|NCT00030069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6339979|NCT00030069|Vitamins|vitamins|mesh-ancestor
6339980|NCT00030069|Micronutrients|micronutrients|mesh-ancestor
6339981|NCT00030069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6339982|NCT00030082|Melphalan|melphalan|mesh-list
6339983|NCT00030082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6339984|NCT00030082|Alkylating Agents|alkylating agents|mesh-ancestor
6538077|NCT00825617|Hormones|hormones|mesh-list
6016817|NCT00368277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339985|NCT00030082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339986|NCT00030082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6339987|NCT00030082|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6339988|NCT00030082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6339989|NCT00030082|Immunologic Factors|immunologic factors|mesh-ancestor
6339990|NCT00030082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6339991|NCT00030095|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
6339992|NCT00030095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6339993|NCT00030095|Tubulin Modulators|tubulin modulators|mesh-ancestor
6339994|NCT00030095|Antimitotic Agents|antimitotic agents|mesh-ancestor
6339995|NCT00030095|Mitosis Modulators|mitosis modulators|mesh-ancestor
6339996|NCT00030095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6339997|NCT00030121|Cardiodilatin|cardiodilatin|mesh-list
6339998|NCT00030121|Vasodilator Agents|vasodilator agents|mesh-ancestor
6339999|NCT00030173|Epothilones|epothilones|mesh-list
6340000|NCT00030173|Desoxyepothilone B|desoxyepothilone b|mesh-list
6340001|NCT00030173|Tubulin Modulators|tubulin modulators|mesh-ancestor
6340002|NCT00030173|Antimitotic Agents|antimitotic agents|mesh-ancestor
6340003|NCT00030173|Mitosis Modulators|mitosis modulators|mesh-ancestor
6340004|NCT00030173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340005|NCT00030173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340006|NCT00030238|Calcium|calcium|mesh-list
6340007|NCT00030238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6340008|NCT00030238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6340009|NCT00030342|Interferons|interferons|mesh-list
6340010|NCT00030342|Interferon-alpha|interferon-alpha|mesh-list
6340011|NCT00030342|Fluorouracil|fluorouracil|mesh-list
6340012|NCT00030342|Sargramostim|sargramostim|mesh-list
6340013|NCT00030342|Antimetabolites|antimetabolites|mesh-ancestor
6340014|NCT00030342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340015|NCT00030342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6340016|NCT00030342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340017|NCT00030342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6340018|NCT00030342|Immunologic Factors|immunologic factors|mesh-ancestor
6340019|NCT00030342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6340020|NCT00030342|Antiviral Agents|antiviral agents|mesh-ancestor
6340021|NCT00030342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6340022|NCT00030355|Homoharringtonine|homoharringtonine|mesh-list
6340023|NCT00030355|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6340024|NCT00030355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340025|NCT00030355|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6340026|NCT00030355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6340027|NCT00030355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340028|NCT00030368|Paclitaxel|paclitaxel|mesh-list
6340029|NCT00030368|Bortezomib|bortezomib|mesh-list
6340030|NCT00030368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6340031|NCT00030368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340032|NCT00030368|Tubulin Modulators|tubulin modulators|mesh-ancestor
6340033|NCT00030368|Antimitotic Agents|antimitotic agents|mesh-ancestor
6340034|NCT00030368|Mitosis Modulators|mitosis modulators|mesh-ancestor
6340035|NCT00030368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340036|NCT00030381|Esorubicin|esorubicin|mesh-list
6340037|NCT00030381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6340038|NCT00030381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340039|NCT00030394|Imatinib Mesylate|imatinib mesylate|mesh-list
6340040|NCT00030394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340041|NCT00030394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6340042|NCT00030394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6340043|NCT00030394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340044|NCT00030407|Celecoxib|celecoxib|mesh-list
6340045|NCT00030407|Docetaxel|docetaxel|mesh-list
6340046|NCT00030407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340047|NCT00030407|Tubulin Modulators|tubulin modulators|mesh-ancestor
6340048|NCT00030407|Antimitotic Agents|antimitotic agents|mesh-ancestor
6340049|NCT00030407|Mitosis Modulators|mitosis modulators|mesh-ancestor
6340050|NCT00030407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340051|NCT00030407|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6340052|NCT00030407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6340053|NCT00030407|Analgesics|analgesics|mesh-ancestor
6340054|NCT00030407|Sensory System Agents|sensory system agents|mesh-ancestor
6340055|NCT00030407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6340056|NCT00030407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6340057|NCT00030407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6340058|NCT00030407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6340059|NCT00030407|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6340060|NCT00030407|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6340061|NCT00030407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6340062|NCT00030420|Celecoxib|celecoxib|mesh-list
6340063|NCT00030420|Docetaxel|docetaxel|mesh-list
6340064|NCT00030420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340065|NCT00030420|Tubulin Modulators|tubulin modulators|mesh-ancestor
6340066|NCT00030420|Antimitotic Agents|antimitotic agents|mesh-ancestor
6340067|NCT00030420|Mitosis Modulators|mitosis modulators|mesh-ancestor
6340068|NCT00030420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340069|NCT00030420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6340070|NCT00030420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6340071|NCT00030420|Analgesics|analgesics|mesh-ancestor
6340072|NCT00030420|Sensory System Agents|sensory system agents|mesh-ancestor
6340073|NCT00030420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6340074|NCT00030420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6340075|NCT00030420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6340076|NCT00030420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6340077|NCT00030420|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6340078|NCT00030420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6340079|NCT00030420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6340080|NCT00030433|Gemcitabine|gemcitabine|mesh-list
6340081|NCT00030433|Irinotecan|irinotecan|mesh-list
6340082|NCT00030433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6340083|NCT00030433|Antimetabolites|antimetabolites|mesh-ancestor
6340084|NCT00030433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340085|NCT00030433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340086|NCT00030433|Antiviral Agents|antiviral agents|mesh-ancestor
6340087|NCT00030433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6340088|NCT00030433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6340089|NCT00030433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6340090|NCT00030433|Immunologic Factors|immunologic factors|mesh-ancestor
6340091|NCT00030433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6340092|NCT00030433|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6340093|NCT00030433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6340094|NCT00030446|Carboplatin|carboplatin|mesh-list
6340095|NCT00030446|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6340096|NCT00030446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340097|NCT00030446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6340098|NCT00030446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6340099|NCT00030446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340100|NCT00030459|Vinorelbine|vinorelbine|mesh-list
6340101|NCT00030459|Mitomycins|mitomycins|mesh-list
6340102|NCT00030459|Mitomycin|mitomycin|mesh-list
6340103|NCT00030459|Vinblastine|vinblastine|mesh-list
6340104|NCT00030459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340105|NCT00030459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6340106|NCT00030459|Tubulin Modulators|tubulin modulators|mesh-ancestor
6340107|NCT00030459|Antimitotic Agents|antimitotic agents|mesh-ancestor
6340108|NCT00030459|Mitosis Modulators|mitosis modulators|mesh-ancestor
6340109|NCT00030459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340110|NCT00030459|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6340111|NCT00030459|Alkylating Agents|alkylating agents|mesh-ancestor
6340112|NCT00030459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6340113|NCT00030459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6340114|NCT00030472|Doxorubicin|doxorubicin|mesh-list
6340115|NCT00030472|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6340116|NCT00030472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6340117|NCT00030472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340118|NCT00030472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6340119|NCT00030472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6340120|NCT00030472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6340121|NCT00030472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340122|NCT00030485|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6340123|NCT00030485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340124|NCT00030485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6340125|NCT00030485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6340126|NCT00030485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340127|NCT00030498|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6340128|NCT00030498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340129|NCT00030498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6340130|NCT00030498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6340131|NCT00030498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340132|NCT00030511|Fluorouracil|fluorouracil|mesh-list
6340133|NCT00030511|Antimetabolites|antimetabolites|mesh-ancestor
6340134|NCT00030511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340135|NCT00030511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6340136|NCT00030511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340137|NCT00030511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6340138|NCT00030511|Immunologic Factors|immunologic factors|mesh-ancestor
6340139|NCT00030511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6340140|NCT00030524|Gefitinib|gefitinib|mesh-list
6340141|NCT00030524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340142|NCT00030524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6340143|NCT00030524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6340144|NCT00030524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340145|NCT00030537|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6340146|NCT00030537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340147|NCT00030537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6340148|NCT00030537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6340149|NCT00030537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340150|NCT00030550|Thalidomide|thalidomide|mesh-list
6340151|NCT00030550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6340152|NCT00030550|Immunologic Factors|immunologic factors|mesh-ancestor
6340153|NCT00030550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6340154|NCT00030550|Leprostatic Agents|leprostatic agents|mesh-ancestor
6340155|NCT00030550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6340156|NCT00030550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6340157|NCT00030550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6340158|NCT00030550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6340159|NCT00030550|Growth Substances|growth substances|mesh-ancestor
6340160|NCT00030550|Growth Inhibitors|growth inhibitors|mesh-ancestor
6340161|NCT00030550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340162|NCT00030563|Irinotecan|irinotecan|mesh-list
6340163|NCT00030563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6340164|NCT00030563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6340165|NCT00030563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6340166|NCT00030563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340167|NCT00030563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340168|NCT00030576|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6340169|NCT00030576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340170|NCT00030576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6340171|NCT00030576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6340172|NCT00030576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340173|NCT00030589|Bexarotene|bexarotene|mesh-list
6340174|NCT00030589|Methoxsalen|methoxsalen|mesh-list
6340175|NCT00030589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340176|NCT00030589|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6340177|NCT00030589|Dermatologic Agents|dermatologic agents|mesh-ancestor
6340178|NCT00030602|Freund's Adjuvant|freund's adjuvant|mesh-list
6340179|NCT00030602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6340180|NCT00030602|Immunologic Factors|immunologic factors|mesh-ancestor
6340181|NCT00030602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6340182|NCT00030615|Decitabine|decitabine|mesh-list
6340183|NCT00030615|Azacitidine|azacitidine|mesh-list
6340184|NCT00030615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6340185|NCT00030615|Antimetabolites|antimetabolites|mesh-ancestor
6340186|NCT00030615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340187|NCT00030615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340188|NCT00030615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6393731|NCT00199576|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6393732|NCT00199576|Prednisolone phosphate|prednisolone phosphate|mesh-list
6393733|NCT00199576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6393734|NCT00199576|Antiemetics|antiemetics|mesh-ancestor
6393735|NCT00199576|Autonomic Agents|autonomic agents|mesh-ancestor
6393736|NCT00199576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6393737|NCT00199576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6393738|NCT00199576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6393739|NCT00199576|Glucocorticoids|glucocorticoids|mesh-ancestor
6393740|NCT00199576|Hormones|hormones|mesh-ancestor
6340189|NCT00030641|Docetaxel|docetaxel|mesh-list
6340190|NCT00030641|Oblimersen|oblimersen|mesh-list
6340191|NCT00030641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340192|NCT00030641|Tubulin Modulators|tubulin modulators|mesh-ancestor
6340193|NCT00030641|Antimitotic Agents|antimitotic agents|mesh-ancestor
6340194|NCT00030641|Mitosis Modulators|mitosis modulators|mesh-ancestor
6340195|NCT00030641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340196|NCT00030654|Ketoconazole|ketoconazole|mesh-list
6340197|NCT00030654|Vinblastine|vinblastine|mesh-list
6340198|NCT00030654|Docetaxel|docetaxel|mesh-list
6340199|NCT00030654|Doxorubicin|doxorubicin|mesh-list
6340200|NCT00030654|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6340201|NCT00030654|Bicalutamide|bicalutamide|mesh-list
6340202|NCT00030654|Flutamide|flutamide|mesh-list
6340203|NCT00030654|Estramustine|estramustine|mesh-list
6340204|NCT00030654|Hormones|hormones|mesh-list
6340205|NCT00030654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6340206|NCT00030654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340207|NCT00030654|Tubulin Modulators|tubulin modulators|mesh-ancestor
6340208|NCT00030654|Antimitotic Agents|antimitotic agents|mesh-ancestor
6340209|NCT00030654|Mitosis Modulators|mitosis modulators|mesh-ancestor
6340210|NCT00030654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340211|NCT00030654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6340212|NCT00030654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6340213|NCT00030654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6340214|NCT00030654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6340215|NCT00030654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6340216|NCT00030654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6340217|NCT00030654|Antifungal Agents|antifungal agents|mesh-ancestor
6340218|NCT00030654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6340219|NCT00030654|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6340220|NCT00030654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6340221|NCT00030654|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6340222|NCT00030654|Hormone Antagonists|hormone antagonists|mesh-ancestor
6340223|NCT00030654|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6340224|NCT00030654|Androgen Antagonists|androgen antagonists|mesh-ancestor
6340225|NCT00030654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6340226|NCT00030654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6340227|NCT00030654|Alkylating Agents|alkylating agents|mesh-ancestor
6340228|NCT00030667|Imatinib Mesylate|imatinib mesylate|mesh-list
6340229|NCT00030667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340230|NCT00030667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6340231|NCT00030667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6340232|NCT00030667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340233|NCT00030693|Metronidazole|metronidazole|mesh-list
6340234|NCT00030693|Vaccines|vaccines|mesh-list
6340235|NCT00030693|Immunologic Factors|immunologic factors|mesh-ancestor
6340236|NCT00030693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6340237|NCT00030693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6340238|NCT00030693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6340239|NCT00030693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6340240|NCT00030693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6340241|NCT00030719|Cyclophosphamide|cyclophosphamide|mesh-list
6340242|NCT00030719|Melphalan|melphalan|mesh-list
6340243|NCT00030719|Busulfan|busulfan|mesh-list
6340244|NCT00030719|Carboplatin|carboplatin|mesh-list
6340245|NCT00030719|Etoposide|etoposide|mesh-list
6340246|NCT00030719|Vincristine|vincristine|mesh-list
6340247|NCT00030719|Dinutuximab|dinutuximab|mesh-list
6340248|NCT00030719|Isotretinoin|isotretinoin|mesh-list
6340249|NCT00030719|Antibodies|antibodies|mesh-list
6340250|NCT00030719|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6340251|NCT00030719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6340252|NCT00030719|Immunologic Factors|immunologic factors|mesh-ancestor
6340253|NCT00030719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6340254|NCT00030719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6340255|NCT00030719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6340256|NCT00030719|Alkylating Agents|alkylating agents|mesh-ancestor
6340257|NCT00030719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340258|NCT00030719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340259|NCT00030719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6340260|NCT00030719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6340261|NCT00030719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6340262|NCT00030719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6340263|NCT00030719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6340264|NCT00030719|Tubulin Modulators|tubulin modulators|mesh-ancestor
6340265|NCT00030719|Antimitotic Agents|antimitotic agents|mesh-ancestor
6340266|NCT00030719|Mitosis Modulators|mitosis modulators|mesh-ancestor
6340267|NCT00030719|Dermatologic Agents|dermatologic agents|mesh-ancestor
6340268|NCT00030732|Gemcitabine|gemcitabine|mesh-list
6340269|NCT00030732|Capecitabine|capecitabine|mesh-list
6340270|NCT00030732|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6340271|NCT00030732|Antimetabolites|antimetabolites|mesh-ancestor
6340272|NCT00030732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340273|NCT00030732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340274|NCT00030732|Antiviral Agents|antiviral agents|mesh-ancestor
6340275|NCT00030732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6340276|NCT00030732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6340277|NCT00030732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6340278|NCT00030732|Immunologic Factors|immunologic factors|mesh-ancestor
6340279|NCT00030732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6340280|NCT00030745|Gemcitabine|gemcitabine|mesh-list
6340281|NCT00030745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340282|NCT00030745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6340283|NCT00030745|Antimetabolites|antimetabolites|mesh-ancestor
6340284|NCT00030745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340285|NCT00030745|Antiviral Agents|antiviral agents|mesh-ancestor
6340286|NCT00030745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6340287|NCT00030745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6340288|NCT00030745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6340289|NCT00030745|Immunologic Factors|immunologic factors|mesh-ancestor
6340290|NCT00030745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6340291|NCT00030758|Lenograstim|lenograstim|mesh-list
6340292|NCT00030758|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6340293|NCT00030758|Immunologic Factors|immunologic factors|mesh-ancestor
6340294|NCT00030758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6340295|NCT00030784|Doxorubicin|doxorubicin|mesh-list
6340296|NCT00030784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6340297|NCT00030784|Ifosfamide|ifosfamide|mesh-list
6340298|NCT00030784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6340299|NCT00030784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340300|NCT00030784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6340301|NCT00030784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6340302|NCT00030784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6340303|NCT00030784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340304|NCT00030784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6340305|NCT00030784|Alkylating Agents|alkylating agents|mesh-ancestor
6340306|NCT00030797|Irinotecan|irinotecan|mesh-list
6340307|NCT00030797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6340308|NCT00030797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6340309|NCT00030797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6340310|NCT00030797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340311|NCT00030797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340312|NCT00030810|Docetaxel|docetaxel|mesh-list
6340313|NCT00030810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340314|NCT00030810|Tubulin Modulators|tubulin modulators|mesh-ancestor
6340315|NCT00030810|Antimitotic Agents|antimitotic agents|mesh-ancestor
6340316|NCT00030810|Mitosis Modulators|mitosis modulators|mesh-ancestor
6340317|NCT00030810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340318|NCT00030849|Interferons|interferons|mesh-list
6340319|NCT00030849|Interferon-alpha|interferon-alpha|mesh-list
6340320|NCT00030849|Bexarotene|bexarotene|mesh-list
6340321|NCT00030849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340322|NCT00030849|Antiviral Agents|antiviral agents|mesh-ancestor
6340323|NCT00030849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6340324|NCT00030849|Immunologic Factors|immunologic factors|mesh-ancestor
6340325|NCT00030849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6340326|NCT00030862|Irinotecan|irinotecan|mesh-list
6340327|NCT00030862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340328|NCT00030862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6340329|NCT00030862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6340330|NCT00030862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6340331|NCT00030862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340332|NCT00030875|Bortezomib|bortezomib|mesh-list
6340333|NCT00030875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340334|NCT00030888|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
6340335|NCT00030888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340336|NCT00030888|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6340337|NCT00030888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6340338|NCT00030888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340339|NCT00030914|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6340340|NCT00030914|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6340341|NCT00030914|Medroxyprogesterone|medroxyprogesterone|mesh-list
6340342|NCT00030914|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6340343|NCT00030914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6340344|NCT00030914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6340345|NCT00030914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340346|NCT00030914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6340347|NCT00030914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6340348|NCT00030914|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6340349|NCT00030914|Antidepressive Agents|antidepressive agents|mesh-ancestor
6340350|NCT00030914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6340351|NCT00030914|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6340352|NCT00030914|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6340353|NCT00030914|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6340354|NCT00030914|Contraceptive Agents|contraceptive agents|mesh-ancestor
6340355|NCT00030914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6340356|NCT00030914|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6340357|NCT00030914|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6340358|NCT00030914|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6340359|NCT00030914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6340360|NCT00030914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340361|NCT00030966|Natalizumab|natalizumab|mesh-list
6340362|NCT00030966|Immunologic Factors|immunologic factors|mesh-ancestor
6340363|NCT00030966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6340364|NCT00030979|Donepezil|donepezil|mesh-list
6340365|NCT00030979|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6340366|NCT00030979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6340367|NCT00030979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340368|NCT00030979|Cholinergic Agents|cholinergic agents|mesh-ancestor
6340369|NCT00030979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6340370|NCT00030979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6340371|NCT00030979|Nootropic Agents|nootropic agents|mesh-ancestor
6340372|NCT00031018|Interferon alpha-2|interferon alpha-2|mesh-list
6340373|NCT00031018|Donepezil|donepezil|mesh-list
6340374|NCT00031018|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6340375|NCT00031018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6340376|NCT00031018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340377|NCT00031018|Cholinergic Agents|cholinergic agents|mesh-ancestor
6340378|NCT00031018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6340379|NCT00031018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6340380|NCT00031018|Nootropic Agents|nootropic agents|mesh-ancestor
6340381|NCT00031018|Antiviral Agents|antiviral agents|mesh-ancestor
6340382|NCT00031018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6340383|NCT00031018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340384|NCT00031044|Enfuvirtide|enfuvirtide|mesh-list
6340385|NCT00031044|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6340386|NCT00031044|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6340387|NCT00031044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340388|NCT00031044|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6340389|NCT00031044|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6340390|NCT00031044|Antiviral Agents|antiviral agents|mesh-ancestor
6340391|NCT00031044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6340392|NCT00031057|Riboflavin|riboflavin|mesh-list
6340393|NCT00031057|Thiamine|thiamine|mesh-list
6340394|NCT00031057|Vitamin B Complex|vitamin b complex|mesh-ancestor
6340395|NCT00031057|Vitamins|vitamins|mesh-ancestor
6340396|NCT00031057|Micronutrients|micronutrients|mesh-ancestor
6340397|NCT00031057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6340398|NCT00031057|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6340399|NCT00031057|Dermatologic Agents|dermatologic agents|mesh-ancestor
6340400|NCT00031070|Cyclosporine|cyclosporine|mesh-list
6340401|NCT00031070|Lamivudine|lamivudine|mesh-list
6340402|NCT00031070|Zidovudine|zidovudine|mesh-list
6340403|NCT00031070|Efavirenz|efavirenz|mesh-list
6340404|NCT00031070|Abacavir|abacavir|mesh-list
6340405|NCT00031070|Vaccines|vaccines|mesh-list
6340406|NCT00031070|Cyclosporins|cyclosporins|mesh-list
6340407|NCT00031070|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6340408|NCT00031070|Immunologic Factors|immunologic factors|mesh-ancestor
6340409|NCT00031070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6340410|NCT00031070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6340411|NCT00031070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340412|NCT00031070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6340413|NCT00031070|Antifungal Agents|antifungal agents|mesh-ancestor
6340414|NCT00031070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6340415|NCT00031070|Dermatologic Agents|dermatologic agents|mesh-ancestor
6340416|NCT00031070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6340417|NCT00031070|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6340418|NCT00031070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6340419|NCT00031070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6340420|NCT00031070|Antiviral Agents|antiviral agents|mesh-ancestor
6340421|NCT00031070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6340422|NCT00031070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6340423|NCT00031070|Antimetabolites|antimetabolites|mesh-ancestor
6340424|NCT00031070|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6340425|NCT00031070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6340426|NCT00031070|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6340427|NCT00031070|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6340428|NCT00031070|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6340429|NCT00031070|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6340430|NCT00031083|Interferons|interferons|mesh-list
6340431|NCT00031083|Interferon-beta|interferon-beta|mesh-list
6340432|NCT00031083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340433|NCT00031083|Antiviral Agents|antiviral agents|mesh-ancestor
6340434|NCT00031083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6340435|NCT00031083|Immunologic Factors|immunologic factors|mesh-ancestor
6340436|NCT00031083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6340437|NCT00031096|Azelaic acid|azelaic acid|mesh-list
6340438|NCT00031096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340439|NCT00031096|Dermatologic Agents|dermatologic agents|mesh-ancestor
6340440|NCT00031109|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6340441|NCT00031109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6340442|NCT00031109|Immunologic Factors|immunologic factors|mesh-ancestor
6340443|NCT00031109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6340444|NCT00031109|Antacids|antacids|mesh-ancestor
6340445|NCT00031109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340446|NCT00031109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6340447|NCT00031135|Choline|choline|mesh-list
6340448|NCT00031135|Lipotropic Agents|lipotropic agents|mesh-ancestor
6340449|NCT00031135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6340450|NCT00031135|Antimetabolites|antimetabolites|mesh-ancestor
6340451|NCT00031135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340452|NCT00031135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6340453|NCT00031135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6340454|NCT00031135|Nootropic Agents|nootropic agents|mesh-ancestor
6340455|NCT00031148|Mitogens|mitogens|mesh-list
6340456|NCT00031148|Mitosis Modulators|mitosis modulators|mesh-ancestor
6340457|NCT00031148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340458|NCT00031161|Nitisinone|nitisinone|mesh-list
6340459|NCT00031161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6340460|NCT00031161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340461|NCT00031187|Docetaxel|docetaxel|mesh-list
6340462|NCT00031187|Doxorubicin|doxorubicin|mesh-list
6340463|NCT00031187|Immunoconjugates|immunoconjugates|mesh-list
6340464|NCT00031187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340465|NCT00031187|Tubulin Modulators|tubulin modulators|mesh-ancestor
6340466|NCT00031187|Antimitotic Agents|antimitotic agents|mesh-ancestor
6340467|NCT00031187|Mitosis Modulators|mitosis modulators|mesh-ancestor
6340468|NCT00031187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340469|NCT00031187|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6340470|NCT00031187|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6340471|NCT00031187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6340472|NCT00031187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6340473|NCT00031187|Immunologic Factors|immunologic factors|mesh-ancestor
6340474|NCT00031187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6340475|NCT00031278|Trastuzumab|trastuzumab|mesh-list
6340476|NCT00031278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6340477|NCT00031278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340478|NCT00031291|Immunoglobulins|immunoglobulins|mesh-list
6340479|NCT00031291|Antibodies|antibodies|mesh-list
6340480|NCT00031291|gamma-Globulins|gamma-globulins|mesh-list
6340481|NCT00031291|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6340482|NCT00031291|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6340483|NCT00031291|Immunologic Factors|immunologic factors|mesh-ancestor
6340484|NCT00031291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6340485|NCT00031317|Clozapine|clozapine|mesh-list
6340486|NCT00031317|Paroxetine|paroxetine|mesh-list
6340487|NCT00031317|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6340488|NCT00031317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6340489|NCT00031317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6340490|NCT00031317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340491|NCT00031317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6340492|NCT00031317|Serotonin Agents|serotonin agents|mesh-ancestor
6340493|NCT00031317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6340494|NCT00031317|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6340495|NCT00031317|Antidepressive Agents|antidepressive agents|mesh-ancestor
6340496|NCT00031317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6340497|NCT00031317|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6340498|NCT00031317|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6340499|NCT00031317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6340500|NCT00031317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6340501|NCT00031317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6340502|NCT00031317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6340503|NCT00031317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6340504|NCT00031317|GABA Antagonists|gaba antagonists|mesh-ancestor
6340505|NCT00031317|GABA Agents|gaba agents|mesh-ancestor
6340506|NCT00031343|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6340507|NCT00031343|Antiviral Agents|antiviral agents|mesh-ancestor
6340508|NCT00031343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6340509|NCT00031395|Clonidine|clonidine|mesh-list
6340510|NCT00031395|Methylphenidate|methylphenidate|mesh-list
6340511|NCT00031395|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6340512|NCT00031395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6340513|NCT00031395|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6340514|NCT00031395|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6340515|NCT00031395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6340516|NCT00031395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340517|NCT00031395|Dopamine Agents|dopamine agents|mesh-ancestor
6340518|NCT00031395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6016818|NCT00368277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6340519|NCT00031395|Analgesics|analgesics|mesh-ancestor
6340520|NCT00031395|Sensory System Agents|sensory system agents|mesh-ancestor
6016819|NCT00368277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016820|NCT00368277|Vasodilator Agents|vasodilator agents|mesh-ancestor
6016821|NCT00368277|Diuretics|diuretics|mesh-ancestor
6016822|NCT00368277|Natriuretic Agents|natriuretic agents|mesh-ancestor
6016823|NCT00368277|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6016824|NCT00368277|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6016825|NCT00368277|Protease Inhibitors|protease inhibitors|mesh-ancestor
6016826|NCT00368277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6016827|NCT00368290|Modafinil|modafinil|mesh-list
6016828|NCT00368290|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6016829|NCT00368290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016830|NCT00368290|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6016831|NCT00368290|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6016832|NCT00368290|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6016833|NCT00368290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016834|NCT00368355|Cytarabine|cytarabine|mesh-list
6016835|NCT00368355|Cyclophosphamide|cyclophosphamide|mesh-list
6016836|NCT00368355|Alemtuzumab|alemtuzumab|mesh-list
6340521|NCT00031395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6340522|NCT00031395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6340523|NCT00031395|Sympatholytics|sympatholytics|mesh-ancestor
6340524|NCT00031395|Autonomic Agents|autonomic agents|mesh-ancestor
6340525|NCT00031395|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6340526|NCT00031395|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6340527|NCT00031395|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6340528|NCT00031395|Adrenergic Agents|adrenergic agents|mesh-ancestor
6340529|NCT00031434|Valganciclovir|valganciclovir|mesh-list
6340530|NCT00031434|Ganciclovir|ganciclovir|mesh-list
6340531|NCT00031434|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6340532|NCT00031434|Antiviral Agents|antiviral agents|mesh-ancestor
6340533|NCT00031434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6340534|NCT00031434|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6340535|NCT00031434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6340536|NCT00031434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340537|NCT00031473|Ribavirin|ribavirin|mesh-list
6340538|NCT00031473|Antimetabolites|antimetabolites|mesh-ancestor
6340539|NCT00031473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340540|NCT00031473|Antiviral Agents|antiviral agents|mesh-ancestor
6340541|NCT00031473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6340542|NCT00031499|Azithromycin|azithromycin|mesh-list
6340543|NCT00031499|Doxycycline|doxycycline|mesh-list
6340544|NCT00031499|Penicillins|penicillins|mesh-list
6340545|NCT00031499|Penicillin G Benzathine|penicillin g benzathine|mesh-list
6340546|NCT00031499|Penicillin G|penicillin g|mesh-list
6340547|NCT00031499|Penicillin G Procaine|penicillin g procaine|mesh-list
6340548|NCT00031499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6340549|NCT00031499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6340550|NCT00031499|Antimalarials|antimalarials|mesh-ancestor
6340551|NCT00031499|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6340552|NCT00031499|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6016837|NCT00368355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6016838|NCT00368355|Immunologic Factors|immunologic factors|mesh-ancestor
6340553|NCT00031564|Aldesleukin|aldesleukin|mesh-list
6340554|NCT00031564|Interleukin-2|interleukin-2|mesh-list
6340555|NCT00031564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6340556|NCT00031564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340557|NCT00031564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6340558|NCT00031564|Analgesics|analgesics|mesh-ancestor
6340559|NCT00031564|Sensory System Agents|sensory system agents|mesh-ancestor
6340560|NCT00031564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6340561|NCT00031564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6340562|NCT00031564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6340563|NCT00031564|Antiviral Agents|antiviral agents|mesh-ancestor
6340564|NCT00031564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6340565|NCT00031577|Paclitaxel|paclitaxel|mesh-list
6340566|NCT00031577|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6340567|NCT00031577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340568|NCT00031577|Tubulin Modulators|tubulin modulators|mesh-ancestor
6340569|NCT00031577|Antimitotic Agents|antimitotic agents|mesh-ancestor
6340570|NCT00031577|Mitosis Modulators|mitosis modulators|mesh-ancestor
6340571|NCT00031577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340572|NCT00031616|Brivudine|brivudine|mesh-list
6340573|NCT00031616|Phosphoramidic acid|phosphoramidic acid|mesh-list
6340574|NCT00031616|Antiviral Agents|antiviral agents|mesh-ancestor
6340575|NCT00031616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6340576|NCT00031616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6340577|NCT00031616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340578|NCT00031629|Gemcitabine|gemcitabine|mesh-list
6340579|NCT00031629|Docetaxel|docetaxel|mesh-list
6340580|NCT00031629|Lenograstim|lenograstim|mesh-list
6340581|NCT00031629|Sargramostim|sargramostim|mesh-list
6340582|NCT00031629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6340583|NCT00031629|Antimetabolites|antimetabolites|mesh-ancestor
6340584|NCT00031629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340585|NCT00031629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340586|NCT00031629|Antiviral Agents|antiviral agents|mesh-ancestor
6340587|NCT00031629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6340588|NCT00031629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6340589|NCT00031629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6340590|NCT00031629|Immunologic Factors|immunologic factors|mesh-ancestor
6340591|NCT00031629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6340592|NCT00031629|Tubulin Modulators|tubulin modulators|mesh-ancestor
6340593|NCT00031629|Antimitotic Agents|antimitotic agents|mesh-ancestor
6340594|NCT00031629|Mitosis Modulators|mitosis modulators|mesh-ancestor
6340595|NCT00031629|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6340596|NCT00031642|Rituximab|rituximab|mesh-list
6340597|NCT00031642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6340598|NCT00031642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340599|NCT00031642|Immunologic Factors|immunologic factors|mesh-ancestor
6340600|NCT00031642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6340601|NCT00031642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6340602|NCT00031655|Cyclosporine|cyclosporine|mesh-list
6340603|NCT00031655|Mycophenolic Acid|mycophenolic acid|mesh-list
6340604|NCT00031655|Fludarabine|fludarabine|mesh-list
6340605|NCT00031655|Fludarabine phosphate|fludarabine phosphate|mesh-list
6340606|NCT00031655|Cyclosporins|cyclosporins|mesh-list
6340607|NCT00031655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340608|NCT00031655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6340609|NCT00031655|Antimetabolites|antimetabolites|mesh-ancestor
6340610|NCT00031655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340611|NCT00031655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6340612|NCT00031655|Immunologic Factors|immunologic factors|mesh-ancestor
6340613|NCT00031655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6340614|NCT00031655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6340615|NCT00031655|Antifungal Agents|antifungal agents|mesh-ancestor
6340616|NCT00031655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6340617|NCT00031655|Dermatologic Agents|dermatologic agents|mesh-ancestor
6340618|NCT00031655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6340619|NCT00031655|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6340620|NCT00031655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6340621|NCT00031655|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6340622|NCT00031655|Antitubercular Agents|antitubercular agents|mesh-ancestor
6340623|NCT00031655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6340624|NCT00031681|Irinotecan|irinotecan|mesh-list
6340625|NCT00031681|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
6340626|NCT00031681|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6340627|NCT00031681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6340628|NCT00031681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6340629|NCT00031681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340630|NCT00031681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340631|NCT00031681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6340632|NCT00031707|Megestrol|megestrol|mesh-list
6340633|NCT00031707|Megestrol Acetate|megestrol acetate|mesh-list
6340634|NCT00031707|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6340635|NCT00031707|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6340636|NCT00031707|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6340637|NCT00031707|Contraceptive Agents|contraceptive agents|mesh-ancestor
6340638|NCT00031707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6340639|NCT00031707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6340640|NCT00031707|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6340641|NCT00031707|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6340642|NCT00031707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6340643|NCT00031707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340644|NCT00031707|Appetite Stimulants|appetite stimulants|mesh-ancestor
6340645|NCT00031707|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6340646|NCT00031720|Tamoxifen|tamoxifen|mesh-list
6340647|NCT00031720|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6340648|NCT00031720|Hormone Antagonists|hormone antagonists|mesh-ancestor
6340649|NCT00031720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6340650|NCT00031720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6340651|NCT00031720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6340652|NCT00031720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340653|NCT00031720|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6340654|NCT00031720|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6340655|NCT00031720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6340656|NCT00031733|Interleukin-12|interleukin-12|mesh-list
6340657|NCT00031733|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6340658|NCT00031733|Sargramostim|sargramostim|mesh-list
6340659|NCT00031733|Freund's Adjuvant|freund's adjuvant|mesh-list
6340660|NCT00031733|Aluminum sulfate|aluminum sulfate|mesh-list
6340661|NCT00031733|Immunologic Factors|immunologic factors|mesh-ancestor
6340662|NCT00031733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6340663|NCT00031733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340664|NCT00031733|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6340665|NCT00031733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6340666|NCT00031733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6340667|NCT00031733|Growth Substances|growth substances|mesh-ancestor
6340668|NCT00031733|Growth Inhibitors|growth inhibitors|mesh-ancestor
6340669|NCT00031733|Antacids|antacids|mesh-ancestor
6340670|NCT00031733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340671|NCT00031733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6340672|NCT00031746|Caseins|caseins|mesh-list
6340673|NCT00031746|Chelating Agents|chelating agents|mesh-ancestor
6340674|NCT00031746|Sequestering Agents|sequestering agents|mesh-ancestor
6340675|NCT00031746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340676|NCT00031759|Imiquimod|imiquimod|mesh-list
6340677|NCT00031759|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6340678|NCT00031759|Immunologic Factors|immunologic factors|mesh-ancestor
6340679|NCT00031759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6340680|NCT00031759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340681|NCT00031759|Interferon Inducers|interferon inducers|mesh-ancestor
6340682|NCT00031785|Megestrol|megestrol|mesh-list
6340683|NCT00031785|Megestrol Acetate|megestrol acetate|mesh-list
6340684|NCT00031785|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6340685|NCT00031785|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6340686|NCT00031785|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6340687|NCT00031785|Contraceptive Agents|contraceptive agents|mesh-ancestor
6340688|NCT00031785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6016839|NCT00368355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016840|NCT00368355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6016841|NCT00368355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6016842|NCT00368355|Alkylating Agents|alkylating agents|mesh-ancestor
6016843|NCT00368355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016844|NCT00368355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6016845|NCT00368355|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6016846|NCT00368355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6340689|NCT00031785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6340690|NCT00031785|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6340691|NCT00031785|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6340692|NCT00031785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6340693|NCT00031785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340694|NCT00031785|Appetite Stimulants|appetite stimulants|mesh-ancestor
6340695|NCT00031785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6340696|NCT00031798|Methylphenidate|methylphenidate|mesh-list
6340697|NCT00031798|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6340698|NCT00031798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6340699|NCT00031798|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6340700|NCT00031798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6340701|NCT00031798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6396961|NCT00209872|Antidepressive Agents|antidepressive agents|mesh-ancestor
6340702|NCT00031798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340703|NCT00031798|Dopamine Agents|dopamine agents|mesh-ancestor
6340704|NCT00031798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6340705|NCT00031811|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
6340706|NCT00031811|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6340707|NCT00031811|Hormone Antagonists|hormone antagonists|mesh-ancestor
6340708|NCT00031811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6340709|NCT00031811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6340710|NCT00031811|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6340711|NCT00031811|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6340712|NCT00031811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6340713|NCT00031824|Cyclosporine|cyclosporine|mesh-list
6340714|NCT00031824|Hydroxychloroquine|hydroxychloroquine|mesh-list
6340715|NCT00031824|Prednisone|prednisone|mesh-list
6340716|NCT00031824|Tacrolimus|tacrolimus|mesh-list
6340717|NCT00031824|Cyclosporins|cyclosporins|mesh-list
6340718|NCT00031824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6340719|NCT00031824|Glucocorticoids|glucocorticoids|mesh-ancestor
6340720|NCT00031824|Hormones|hormones|mesh-ancestor
6340721|NCT00031824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6340722|NCT00031824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6340723|NCT00031824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6340724|NCT00031824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340725|NCT00031824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6340726|NCT00031824|Immunologic Factors|immunologic factors|mesh-ancestor
6340727|NCT00031824|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6340728|NCT00031824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6340729|NCT00031824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340730|NCT00031824|Antifungal Agents|antifungal agents|mesh-ancestor
6340731|NCT00031824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6340732|NCT00031824|Dermatologic Agents|dermatologic agents|mesh-ancestor
6340733|NCT00031824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6340734|NCT00031824|Antimalarials|antimalarials|mesh-ancestor
6340735|NCT00031824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6340736|NCT00031824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6340737|NCT00031837|Gemcitabine|gemcitabine|mesh-list
6340738|NCT00031837|Dalteparin|dalteparin|mesh-list
6340739|NCT00031837|Tinzaparin|tinzaparin|mesh-list
6340740|NCT00031837|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6340741|NCT00031837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6340742|NCT00031837|Antimetabolites|antimetabolites|mesh-ancestor
6340743|NCT00031837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340744|NCT00031837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340745|NCT00031837|Antiviral Agents|antiviral agents|mesh-ancestor
6340746|NCT00031837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6340747|NCT00031837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6340748|NCT00031837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6340749|NCT00031837|Immunologic Factors|immunologic factors|mesh-ancestor
6340750|NCT00031837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6340751|NCT00031837|Anticoagulants|anticoagulants|mesh-ancestor
6340752|NCT00031837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6340753|NCT00031837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6340754|NCT00031850|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
6340755|NCT00031850|Goserelin|goserelin|mesh-list
6340756|NCT00031850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6340757|NCT00031850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340758|NCT00031850|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6340759|NCT00031850|Hormone Antagonists|hormone antagonists|mesh-ancestor
6340760|NCT00031850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6340761|NCT00031850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6340762|NCT00031850|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6340763|NCT00031850|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6340764|NCT00031850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6340765|NCT00031863|Rofecoxib|rofecoxib|mesh-list
6340766|NCT00031863|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6340767|NCT00031863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6340768|NCT00031863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6340769|NCT00031863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340770|NCT00031863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6340771|NCT00031863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6340772|NCT00031863|Analgesics|analgesics|mesh-ancestor
6340773|NCT00031863|Sensory System Agents|sensory system agents|mesh-ancestor
6340774|NCT00031863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6340775|NCT00031863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396962|NCT00209885|Lidocaine|lidocaine|mesh-list
6340776|NCT00031863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6340777|NCT00031863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6340778|NCT00031876|Paclitaxel|paclitaxel|mesh-list
6340779|NCT00031876|Capecitabine|capecitabine|mesh-list
6340780|NCT00031876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6340781|NCT00031876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340782|NCT00031876|Tubulin Modulators|tubulin modulators|mesh-ancestor
6340783|NCT00031876|Antimitotic Agents|antimitotic agents|mesh-ancestor
6340784|NCT00031876|Mitosis Modulators|mitosis modulators|mesh-ancestor
6340785|NCT00031876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340786|NCT00031876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6340787|NCT00031876|Antimetabolites|antimetabolites|mesh-ancestor
6340788|NCT00031889|Exemestane|exemestane|mesh-list
6340789|NCT00031889|Bicalutamide|bicalutamide|mesh-list
6340790|NCT00031889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340791|NCT00031889|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6340792|NCT00031889|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6340793|NCT00031889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6340794|NCT00031889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340795|NCT00031889|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6340796|NCT00031889|Hormone Antagonists|hormone antagonists|mesh-ancestor
6340797|NCT00031889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6340798|NCT00031889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6340799|NCT00031889|Androgen Antagonists|androgen antagonists|mesh-ancestor
6340800|NCT00031902|Prednisolone|prednisolone|mesh-list
6340801|NCT00031902|Rituximab|rituximab|mesh-list
6340802|NCT00031902|Vincristine|vincristine|mesh-list
6340803|NCT00031902|Bleomycin|bleomycin|mesh-list
6340804|NCT00031902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6340805|NCT00031902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340806|NCT00031902|Immunologic Factors|immunologic factors|mesh-ancestor
6340807|NCT00031902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6340808|NCT00031902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6340809|NCT00031902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6340810|NCT00031902|Tubulin Modulators|tubulin modulators|mesh-ancestor
6340811|NCT00031902|Antimitotic Agents|antimitotic agents|mesh-ancestor
6340812|NCT00031902|Mitosis Modulators|mitosis modulators|mesh-ancestor
6340813|NCT00031902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340814|NCT00031902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6340815|NCT00031902|Glucocorticoids|glucocorticoids|mesh-ancestor
6340816|NCT00031902|Hormones|hormones|mesh-ancestor
6340817|NCT00031902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6340818|NCT00031902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6340819|NCT00031902|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6340820|NCT00031915|Imatinib Mesylate|imatinib mesylate|mesh-list
6340821|NCT00031915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340822|NCT00031915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6340823|NCT00031915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6340824|NCT00031915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340825|NCT00031928|Mafosfamide|mafosfamide|mesh-list
6340826|NCT00031928|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6340827|NCT00031928|Immunologic Factors|immunologic factors|mesh-ancestor
6340828|NCT00031928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6340829|NCT00031928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340830|NCT00031941|Lenalidomide|lenalidomide|mesh-list
6340831|NCT00031941|Immunologic Factors|immunologic factors|mesh-ancestor
6340832|NCT00031941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6340833|NCT00031941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6396963|NCT00209885|Droperidol|droperidol|mesh-list
6340834|NCT00031941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6340835|NCT00031941|Growth Substances|growth substances|mesh-ancestor
6340836|NCT00031941|Growth Inhibitors|growth inhibitors|mesh-ancestor
6340837|NCT00031941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340838|NCT00031954|Gemcitabine|gemcitabine|mesh-list
6340839|NCT00031954|Paclitaxel|paclitaxel|mesh-list
6340840|NCT00031954|Carboplatin|carboplatin|mesh-list
6340841|NCT00031954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6340842|NCT00031954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340843|NCT00031954|Tubulin Modulators|tubulin modulators|mesh-ancestor
6340844|NCT00031954|Antimitotic Agents|antimitotic agents|mesh-ancestor
6340845|NCT00031954|Mitosis Modulators|mitosis modulators|mesh-ancestor
6340846|NCT00031954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340847|NCT00031954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6340848|NCT00031954|Antimetabolites|antimetabolites|mesh-ancestor
6340849|NCT00031954|Antiviral Agents|antiviral agents|mesh-ancestor
6340850|NCT00031954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6340851|NCT00031954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6340852|NCT00031954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6340853|NCT00031954|Immunologic Factors|immunologic factors|mesh-ancestor
6340854|NCT00031954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6340855|NCT00031967|Melatonin|melatonin|mesh-list
6340856|NCT00031967|Antioxidants|antioxidants|mesh-ancestor
6340857|NCT00031967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340858|NCT00031967|Protective Agents|protective agents|mesh-ancestor
6340859|NCT00031967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6340860|NCT00031967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6340861|NCT00031980|Cyclosporine|cyclosporine|mesh-list
6340862|NCT00031980|Cyclosporins|cyclosporins|mesh-list
6340863|NCT00031980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6340864|NCT00031980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340865|NCT00031980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6340866|NCT00031980|Immunologic Factors|immunologic factors|mesh-ancestor
6340867|NCT00031980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6340868|NCT00031980|Antifungal Agents|antifungal agents|mesh-ancestor
6340869|NCT00031980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6340870|NCT00031980|Dermatologic Agents|dermatologic agents|mesh-ancestor
6340871|NCT00031980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6340872|NCT00031980|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6340873|NCT00031993|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6340874|NCT00031993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340875|NCT00031993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6340876|NCT00031993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6340877|NCT00031993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340878|NCT00032019|Prednisone|prednisone|mesh-list
6340879|NCT00032019|Cyclophosphamide|cyclophosphamide|mesh-list
6340880|NCT00032019|Rituximab|rituximab|mesh-list
6340881|NCT00032019|Doxorubicin|doxorubicin|mesh-list
6340882|NCT00032019|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6340883|NCT00032019|Etoposide|etoposide|mesh-list
6340884|NCT00032019|Vincristine|vincristine|mesh-list
6340885|NCT00032019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6340886|NCT00032019|Immunologic Factors|immunologic factors|mesh-ancestor
6340887|NCT00032019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6340888|NCT00032019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6340889|NCT00032019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6340890|NCT00032019|Alkylating Agents|alkylating agents|mesh-ancestor
6340891|NCT00032019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340892|NCT00032019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340893|NCT00032019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6340894|NCT00032019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6340895|NCT00032019|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6340896|NCT00032019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6340897|NCT00032019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6340898|NCT00032019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6340899|NCT00032019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6340900|NCT00032019|Glucocorticoids|glucocorticoids|mesh-ancestor
6016847|NCT00368355|Antimetabolites|antimetabolites|mesh-ancestor
6016848|NCT00368355|Antiviral Agents|antiviral agents|mesh-ancestor
6016849|NCT00368355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6340901|NCT00032019|Hormones|hormones|mesh-ancestor
6340902|NCT00032019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6340903|NCT00032019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6340904|NCT00032019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6340905|NCT00032019|Tubulin Modulators|tubulin modulators|mesh-ancestor
6340906|NCT00032019|Antimitotic Agents|antimitotic agents|mesh-ancestor
6340907|NCT00032019|Mitosis Modulators|mitosis modulators|mesh-ancestor
6340908|NCT00032032|Paclitaxel|paclitaxel|mesh-list
6340909|NCT00032032|Carboplatin|carboplatin|mesh-list
6396964|NCT00209885|Ketamine|ketamine|mesh-list
6340910|NCT00032032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6340911|NCT00032032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340912|NCT00032032|Tubulin Modulators|tubulin modulators|mesh-ancestor
6340913|NCT00032032|Antimitotic Agents|antimitotic agents|mesh-ancestor
6340914|NCT00032032|Mitosis Modulators|mitosis modulators|mesh-ancestor
6340915|NCT00032032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340916|NCT00032045|Ipilimumab|ipilimumab|mesh-list
6340917|NCT00032045|Freund's Adjuvant|freund's adjuvant|mesh-list
6340918|NCT00032045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6340919|NCT00032045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340920|NCT00032045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6340921|NCT00032045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340922|NCT00032045|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6340923|NCT00032045|Immunologic Factors|immunologic factors|mesh-ancestor
6340924|NCT00032045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6340925|NCT00032084|Bupropion|bupropion|mesh-list
6340926|NCT00032084|Nicotine|nicotine|mesh-list
6340927|NCT00032084|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6340928|NCT00032084|Autonomic Agents|autonomic agents|mesh-ancestor
6340929|NCT00032084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6340930|NCT00032084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6340931|NCT00032084|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6340932|NCT00032084|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6340933|NCT00032084|Cholinergic Agents|cholinergic agents|mesh-ancestor
6340934|NCT00032084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6340935|NCT00032084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340936|NCT00032084|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6340937|NCT00032084|Antidepressive Agents|antidepressive agents|mesh-ancestor
6340938|NCT00032084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6340939|NCT00032084|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6340940|NCT00032084|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6340941|NCT00032084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6340942|NCT00032084|Dopamine Agents|dopamine agents|mesh-ancestor
6340943|NCT00032084|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6340944|NCT00032084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6340945|NCT00032084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6340946|NCT00032097|Motexafin gadolinium|motexafin gadolinium|mesh-list
6340947|NCT00032097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6016850|NCT00368355|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6016851|NCT00368459|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
6016852|NCT00368459|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6016853|NCT00368459|Hormone Antagonists|hormone antagonists|mesh-ancestor
6340948|NCT00032097|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6340949|NCT00032097|Dermatologic Agents|dermatologic agents|mesh-ancestor
6340950|NCT00032110|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6340951|NCT00032110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340952|NCT00032110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6340953|NCT00032110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6340954|NCT00032110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340955|NCT00032123|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6340956|NCT00032123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340957|NCT00032123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6340958|NCT00032123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6340959|NCT00032123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340960|NCT00032136|Tamoxifen|tamoxifen|mesh-list
6340961|NCT00032136|Exemestane|exemestane|mesh-list
6340962|NCT00032136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340963|NCT00032136|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6340964|NCT00032136|Hormone Antagonists|hormone antagonists|mesh-ancestor
6340965|NCT00032136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6340966|NCT00032136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6340967|NCT00032136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6340968|NCT00032136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340969|NCT00032136|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6340970|NCT00032136|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6340971|NCT00032136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6340972|NCT00032136|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6340973|NCT00032136|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6340974|NCT00032136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6393741|NCT00199576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6340975|NCT00032149|Prednisolone|prednisolone|mesh-list
6340976|NCT00032149|Cyclophosphamide|cyclophosphamide|mesh-list
6340977|NCT00032149|Etoposide|etoposide|mesh-list
6340978|NCT00032149|Vincristine|vincristine|mesh-list
6340979|NCT00032149|Mitoxantrone|mitoxantrone|mesh-list
6340980|NCT00032149|Bleomycin|bleomycin|mesh-list
6340981|NCT00032149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6340982|NCT00032149|Immunologic Factors|immunologic factors|mesh-ancestor
6340983|NCT00032149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6340984|NCT00032149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6340985|NCT00032149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6340986|NCT00032149|Alkylating Agents|alkylating agents|mesh-ancestor
6340987|NCT00032149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6340988|NCT00032149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6340989|NCT00032149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6340990|NCT00032149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6340991|NCT00032149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6340992|NCT00032149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6340993|NCT00032149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6340994|NCT00032149|Tubulin Modulators|tubulin modulators|mesh-ancestor
6340995|NCT00032149|Antimitotic Agents|antimitotic agents|mesh-ancestor
6340996|NCT00032149|Mitosis Modulators|mitosis modulators|mesh-ancestor
6340997|NCT00032149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6340998|NCT00032149|Glucocorticoids|glucocorticoids|mesh-ancestor
6340999|NCT00032149|Hormones|hormones|mesh-ancestor
6341000|NCT00032149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6341001|NCT00032149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6341002|NCT00032149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6341003|NCT00032149|Analgesics|analgesics|mesh-ancestor
6341004|NCT00032149|Sensory System Agents|sensory system agents|mesh-ancestor
6341005|NCT00032149|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6341006|NCT00032162|Carboplatin|carboplatin|mesh-list
6341007|NCT00032162|Doxorubicin|doxorubicin|mesh-list
6341008|NCT00032162|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6341009|NCT00032162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6341010|NCT00032162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6341011|NCT00032162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6341012|NCT00032162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6341013|NCT00032162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6341014|NCT00032162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341015|NCT00032175|Gemcitabine|gemcitabine|mesh-list
6341016|NCT00032175|Capecitabine|capecitabine|mesh-list
6341017|NCT00032175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6341018|NCT00032175|Antimetabolites|antimetabolites|mesh-ancestor
6341019|NCT00032175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341020|NCT00032175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6341021|NCT00032175|Antiviral Agents|antiviral agents|mesh-ancestor
6341022|NCT00032175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6341023|NCT00032175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6341024|NCT00032175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6341025|NCT00032175|Immunologic Factors|immunologic factors|mesh-ancestor
6341026|NCT00032175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341027|NCT00032188|Aldesleukin|aldesleukin|mesh-list
6341028|NCT00032188|Interleukin-2|interleukin-2|mesh-list
6341029|NCT00032188|Bryostatin 1|bryostatin 1|mesh-list
6341030|NCT00032188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6341031|NCT00032188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6341032|NCT00032188|Analgesics|analgesics|mesh-ancestor
6341033|NCT00032188|Sensory System Agents|sensory system agents|mesh-ancestor
6341034|NCT00032188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6341035|NCT00032188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341036|NCT00032188|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6341037|NCT00032188|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6341038|NCT00032188|Antiviral Agents|antiviral agents|mesh-ancestor
6341039|NCT00032188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6341040|NCT00032188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6341041|NCT00032188|Immunologic Factors|immunologic factors|mesh-ancestor
6341042|NCT00032279|Visilizumab|visilizumab|mesh-list
6341043|NCT00032279|Immunologic Factors|immunologic factors|mesh-ancestor
6341044|NCT00032279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341045|NCT00032292|Visilizumab|visilizumab|mesh-list
6341046|NCT00032292|Immunologic Factors|immunologic factors|mesh-ancestor
6341047|NCT00032292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341048|NCT00032305|Visilizumab|visilizumab|mesh-list
6341049|NCT00032305|Immunologic Factors|immunologic factors|mesh-ancestor
6341050|NCT00032305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341051|NCT00032396|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
6341052|NCT00032396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6341053|NCT00032396|Glucocorticoids|glucocorticoids|mesh-ancestor
6341054|NCT00032396|Hormones|hormones|mesh-ancestor
6341055|NCT00032396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6341056|NCT00032396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341057|NCT00032734|Satavaptan|satavaptan|mesh-list
6341058|NCT00032734|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6341059|NCT00032734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341060|NCT00032734|Natriuretic Agents|natriuretic agents|mesh-ancestor
6341061|NCT00032734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341062|NCT00032747|Vasopressins|vasopressins|mesh-list
6341063|NCT00032747|Arginine Vasopressin|arginine vasopressin|mesh-list
6341064|NCT00032747|Hemostatics|hemostatics|mesh-ancestor
6341065|NCT00032747|Coagulants|coagulants|mesh-ancestor
6341066|NCT00032747|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6341067|NCT00032747|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6341068|NCT00032747|Natriuretic Agents|natriuretic agents|mesh-ancestor
6341069|NCT00032747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341070|NCT00032773|Pentostatin|pentostatin|mesh-list
6341071|NCT00032773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6341072|NCT00032773|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
6341073|NCT00032773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6341074|NCT00032773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341075|NCT00032786|Natalizumab|natalizumab|mesh-list
6016854|NCT00368459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6341076|NCT00032786|Immunologic Factors|immunologic factors|mesh-ancestor
6341077|NCT00032786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341078|NCT00032799|Natalizumab|natalizumab|mesh-list
6341079|NCT00032799|Immunologic Factors|immunologic factors|mesh-ancestor
6341080|NCT00032799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341081|NCT00032812|Raclopride|raclopride|mesh-list
6341082|NCT00032812|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6341083|NCT00032812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6341084|NCT00032812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6341085|NCT00032812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341086|NCT00032812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6341087|NCT00032812|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6341088|NCT00032812|Dopamine Agents|dopamine agents|mesh-ancestor
6341089|NCT00032812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6341090|NCT00032812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341091|NCT00032825|Ketoconazole|ketoconazole|mesh-list
6341092|NCT00032825|Docetaxel|docetaxel|mesh-list
6341093|NCT00032825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6341094|NCT00032825|Tubulin Modulators|tubulin modulators|mesh-ancestor
6341095|NCT00032825|Antimitotic Agents|antimitotic agents|mesh-ancestor
6341096|NCT00032825|Mitosis Modulators|mitosis modulators|mesh-ancestor
6341097|NCT00032825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341098|NCT00032825|Antifungal Agents|antifungal agents|mesh-ancestor
6341099|NCT00032825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6341100|NCT00032825|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6341101|NCT00032825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6341102|NCT00032825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6341103|NCT00032825|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6341104|NCT00032825|Hormone Antagonists|hormone antagonists|mesh-ancestor
6341105|NCT00032825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6341106|NCT00032825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341107|NCT00032825|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6341108|NCT00032838|Yohimbine|yohimbine|mesh-list
6341109|NCT00032838|Mydriatics|mydriatics|mesh-ancestor
6341110|NCT00032838|Autonomic Agents|autonomic agents|mesh-ancestor
6341111|NCT00032838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6341112|NCT00032838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341113|NCT00032838|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6341114|NCT00032838|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6341115|NCT00032838|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6341116|NCT00032838|Adrenergic Agents|adrenergic agents|mesh-ancestor
6341117|NCT00032838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6341118|NCT00032838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341119|NCT00032838|Urological Agents|urological agents|mesh-ancestor
6341120|NCT00032890|Celecoxib|celecoxib|mesh-list
6341121|NCT00032890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6341122|NCT00032890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6341123|NCT00032890|Analgesics|analgesics|mesh-ancestor
6341124|NCT00032890|Sensory System Agents|sensory system agents|mesh-ancestor
6341125|NCT00032890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6341126|NCT00032890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341127|NCT00032890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6341128|NCT00032890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6341129|NCT00032890|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6341130|NCT00032890|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6341131|NCT00032890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6341132|NCT00032890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341133|NCT00032929|Selegiline|selegiline|mesh-list
6341134|NCT00032929|Antidepressive Agents|antidepressive agents|mesh-ancestor
6341135|NCT00032929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6341136|NCT00032929|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6341137|NCT00032929|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6341138|NCT00032929|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6341139|NCT00032929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6341140|NCT00032929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341141|NCT00032929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6341142|NCT00032929|Protective Agents|protective agents|mesh-ancestor
6341143|NCT00032929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341144|NCT00032942|Lofexidine|lofexidine|mesh-list
6341145|NCT00032942|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6341146|NCT00032942|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6341147|NCT00032942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341148|NCT00032942|Sensory System Agents|sensory system agents|mesh-ancestor
6341149|NCT00032942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6341150|NCT00032942|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6341151|NCT00032942|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6341152|NCT00032942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6341153|NCT00032942|Adrenergic Agents|adrenergic agents|mesh-ancestor
6341154|NCT00032942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6341155|NCT00032942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341156|NCT00032955|Buprenorphine|buprenorphine|mesh-list
6341157|NCT00032955|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6341158|NCT00032955|Naloxone|naloxone|mesh-list
6341159|NCT00032955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6341160|NCT00032955|Narcotics|narcotics|mesh-ancestor
6341161|NCT00032955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6341162|NCT00032955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341163|NCT00032955|Analgesics|analgesics|mesh-ancestor
6341164|NCT00032955|Sensory System Agents|sensory system agents|mesh-ancestor
6341165|NCT00032955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6341166|NCT00032955|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6341167|NCT00032968|Buprenorphine|buprenorphine|mesh-list
6341168|NCT00032968|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6341169|NCT00032968|Naloxone|naloxone|mesh-list
6341170|NCT00032968|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6341171|NCT00032968|Narcotics|narcotics|mesh-ancestor
6341172|NCT00032968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6341173|NCT00032968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341174|NCT00032968|Analgesics|analgesics|mesh-ancestor
6341175|NCT00032968|Sensory System Agents|sensory system agents|mesh-ancestor
6341176|NCT00032968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6341177|NCT00032968|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6341178|NCT00033033|Reserpine|reserpine|mesh-list
6341179|NCT00033033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6341180|NCT00033033|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6341181|NCT00033033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6341182|NCT00033033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6341183|NCT00033033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341184|NCT00033033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6341185|NCT00033033|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6341186|NCT00033033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6341187|NCT00033033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6341188|NCT00033033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341189|NCT00033033|Adrenergic Agents|adrenergic agents|mesh-ancestor
6341190|NCT00033033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6341191|NCT00033046|Modafinil|modafinil|mesh-list
6341192|NCT00033046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6341193|NCT00033046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341194|NCT00033046|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6341195|NCT00033046|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6341196|NCT00033046|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6341197|NCT00033046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341198|NCT00033059|Tolcapone|tolcapone|mesh-list
6341199|NCT00033059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6341200|NCT00033059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6341201|NCT00033059|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6341202|NCT00033059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6341203|NCT00033059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341204|NCT00033072|Selegiline|selegiline|mesh-list
6341205|NCT00033072|Antidepressive Agents|antidepressive agents|mesh-ancestor
6341206|NCT00033072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6341207|NCT00033072|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6341208|NCT00033072|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6341209|NCT00033072|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6341210|NCT00033072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6341211|NCT00033072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341212|NCT00033072|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6341213|NCT00033072|Protective Agents|protective agents|mesh-ancestor
6341214|NCT00033072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341215|NCT00033085|Ondansetron|ondansetron|mesh-list
6341216|NCT00033085|Antiemetics|antiemetics|mesh-ancestor
6341217|NCT00033085|Autonomic Agents|autonomic agents|mesh-ancestor
6341218|NCT00033085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6341219|NCT00033085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341220|NCT00033085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6341221|NCT00033085|Antipruritics|antipruritics|mesh-ancestor
6341222|NCT00033085|Dermatologic Agents|dermatologic agents|mesh-ancestor
6341223|NCT00033085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6341224|NCT00033085|Serotonin Agents|serotonin agents|mesh-ancestor
6341225|NCT00033085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6341226|NCT00033085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341227|NCT00033085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6341228|NCT00033085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6341229|NCT00033085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6341230|NCT00033085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6341231|NCT00033085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6341232|NCT00033098|Metyrapone|metyrapone|mesh-list
6341233|NCT00033098|Antimetabolites|antimetabolites|mesh-ancestor
6341234|NCT00033098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341235|NCT00033098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6341236|NCT00033111|Cabergoline|cabergoline|mesh-list
6341237|NCT00033111|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6341238|NCT00033111|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6341239|NCT00033111|Dopamine Agonists|dopamine agonists|mesh-ancestor
6341240|NCT00033111|Dopamine Agents|dopamine agents|mesh-ancestor
6341241|NCT00033111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6341242|NCT00033111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341243|NCT00033111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341244|NCT00033163|Tenofovir|tenofovir|mesh-list
6341245|NCT00033163|Adefovir|adefovir|mesh-list
6341246|NCT00033163|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6341247|NCT00033163|Antiviral Agents|antiviral agents|mesh-ancestor
6341248|NCT00033163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6341249|NCT00033163|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6341250|NCT00033163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6341251|NCT00033163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6341252|NCT00033163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341253|NCT00033163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6341254|NCT00033163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6341255|NCT00033176|Thioctic Acid|thioctic acid|mesh-list
6341256|NCT00033176|Antioxidants|antioxidants|mesh-ancestor
6341257|NCT00033176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341258|NCT00033176|Protective Agents|protective agents|mesh-ancestor
6341259|NCT00033176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341260|NCT00033176|Vitamin B Complex|vitamin b complex|mesh-ancestor
6341261|NCT00033176|Vitamins|vitamins|mesh-ancestor
6341262|NCT00033176|Micronutrients|micronutrients|mesh-ancestor
6341263|NCT00033189|Ubiquinone|ubiquinone|mesh-list
6341264|NCT00033189|Coenzyme Q10|coenzyme q10|mesh-list
6341265|NCT00033189|Micronutrients|micronutrients|mesh-ancestor
6341266|NCT00033189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341267|NCT00033189|Vitamins|vitamins|mesh-ancestor
6341268|NCT00033215|S 3304|s 3304|mesh-list
6341269|NCT00033215|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
6341270|NCT00033215|Protease Inhibitors|protease inhibitors|mesh-ancestor
6341271|NCT00033215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6341272|NCT00033215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341273|NCT00033241|Gemcitabine|gemcitabine|mesh-list
6341274|NCT00033241|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6341275|NCT00033241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6341276|NCT00033241|Antimetabolites|antimetabolites|mesh-ancestor
6341277|NCT00033241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341278|NCT00033241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6341279|NCT00033241|Antiviral Agents|antiviral agents|mesh-ancestor
6341280|NCT00033241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6341281|NCT00033241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6341282|NCT00033241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6341283|NCT00033241|Immunologic Factors|immunologic factors|mesh-ancestor
6341284|NCT00033241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341285|NCT00033241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6341286|NCT00033254|Thalidomide|thalidomide|mesh-list
6341287|NCT00033254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6341288|NCT00033254|Immunologic Factors|immunologic factors|mesh-ancestor
6341289|NCT00033254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341290|NCT00033254|Leprostatic Agents|leprostatic agents|mesh-ancestor
6341291|NCT00033254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6341292|NCT00033254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6341293|NCT00033254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6341294|NCT00033254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6341295|NCT00033254|Growth Substances|growth substances|mesh-ancestor
6341296|NCT00033254|Growth Inhibitors|growth inhibitors|mesh-ancestor
6341297|NCT00033254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6341298|NCT00033267|Sirolimus|sirolimus|mesh-list
6341299|NCT00033267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6341300|NCT00033267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6341301|NCT00033267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6341302|NCT00033267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6341303|NCT00033267|Antifungal Agents|antifungal agents|mesh-ancestor
6341304|NCT00033267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6341305|NCT00033267|Immunologic Factors|immunologic factors|mesh-ancestor
6341306|NCT00033267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341307|NCT00033280|Temozolomide|temozolomide|mesh-list
6341308|NCT00033280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6341309|NCT00033280|Alkylating Agents|alkylating agents|mesh-ancestor
6341310|NCT00033280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341311|NCT00033280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6341312|NCT00033306|Irinotecan|irinotecan|mesh-list
6341313|NCT00033306|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6341314|NCT00033306|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6341315|NCT00033306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6341316|NCT00033306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341317|NCT00033306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6341318|NCT00033319|Aspirin|aspirin|mesh-list
6341319|NCT00033319|Folic Acid|folic acid|mesh-list
6341320|NCT00033319|Hematinics|hematinics|mesh-ancestor
6341321|NCT00033319|Vitamin B Complex|vitamin b complex|mesh-ancestor
6341322|NCT00033319|Vitamins|vitamins|mesh-ancestor
6341323|NCT00033319|Micronutrients|micronutrients|mesh-ancestor
6341324|NCT00033319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341325|NCT00033319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6341326|NCT00033319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6341327|NCT00033319|Analgesics|analgesics|mesh-ancestor
6341328|NCT00033319|Sensory System Agents|sensory system agents|mesh-ancestor
6341329|NCT00033319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6341330|NCT00033319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6341331|NCT00033319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6341332|NCT00033319|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6341333|NCT00033319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6341334|NCT00033319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341335|NCT00033319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6396965|NCT00209885|Gabapentin|gabapentin|mesh-list
6341336|NCT00033319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6341337|NCT00033319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6341338|NCT00033319|Antipyretics|antipyretics|mesh-ancestor
6341339|NCT00033332|Zoledronic Acid|zoledronic acid|mesh-list
6341340|NCT00033332|Pamidronate|pamidronate|mesh-list
6341341|NCT00033332|Thalidomide|thalidomide|mesh-list
6341342|NCT00033332|Dexamethasone|dexamethasone|mesh-list
6341343|NCT00033332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6341344|NCT00033332|Antiemetics|antiemetics|mesh-ancestor
6341345|NCT00033332|Autonomic Agents|autonomic agents|mesh-ancestor
6341346|NCT00033332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6341347|NCT00033332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341348|NCT00033332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6341349|NCT00033332|Glucocorticoids|glucocorticoids|mesh-ancestor
6341350|NCT00033332|Hormones|hormones|mesh-ancestor
6341351|NCT00033332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6341352|NCT00033332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6341353|NCT00033332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6341354|NCT00033332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6341355|NCT00033332|Immunologic Factors|immunologic factors|mesh-ancestor
6341356|NCT00033332|Leprostatic Agents|leprostatic agents|mesh-ancestor
6341357|NCT00033332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6341358|NCT00033332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6341359|NCT00033332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6341360|NCT00033332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6341361|NCT00033332|Growth Substances|growth substances|mesh-ancestor
6341362|NCT00033332|Growth Inhibitors|growth inhibitors|mesh-ancestor
6341363|NCT00033332|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6341364|NCT00033345|Indole-3-carbinol|indole-3-carbinol|mesh-list
6341365|NCT00033345|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6341366|NCT00033345|Protective Agents|protective agents|mesh-ancestor
6341367|NCT00033345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341368|NCT00033345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6341369|NCT00033358|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6341370|NCT00033358|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6341371|NCT00033358|Medroxyprogesterone|medroxyprogesterone|mesh-list
6341372|NCT00033358|Norgestrel|norgestrel|mesh-list
6341373|NCT00033358|Estradiol|estradiol|mesh-list
6341374|NCT00033358|Estrogens|estrogens|mesh-ancestor
6341375|NCT00033358|Hormones|hormones|mesh-ancestor
6341376|NCT00033358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6341377|NCT00033358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341378|NCT00033358|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6341379|NCT00033358|Contraceptive Agents|contraceptive agents|mesh-ancestor
6341380|NCT00033358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6341381|NCT00033358|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6341382|NCT00033358|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6341383|NCT00033358|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6341384|NCT00033358|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6341385|NCT00033358|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6341386|NCT00033358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6341387|NCT00033358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6341388|NCT00033410|Paclitaxel|paclitaxel|mesh-list
6341389|NCT00033410|Carboplatin|carboplatin|mesh-list
6341390|NCT00033410|Tirapazamine|tirapazamine|mesh-list
6341391|NCT00033410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6341392|NCT00033410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6341393|NCT00033410|Tubulin Modulators|tubulin modulators|mesh-ancestor
6341394|NCT00033410|Antimitotic Agents|antimitotic agents|mesh-ancestor
6341395|NCT00033410|Mitosis Modulators|mitosis modulators|mesh-ancestor
6341396|NCT00033410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341397|NCT00033423|Rituximab|rituximab|mesh-list
6341398|NCT00033423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6341399|NCT00033423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6341400|NCT00033423|Immunologic Factors|immunologic factors|mesh-ancestor
6396966|NCT00209885|Esketamine|esketamine|mesh-list
6341401|NCT00033423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341402|NCT00033423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6341403|NCT00033436|Niacinamide|niacinamide|mesh-list
6341404|NCT00033436|Niacin|niacin|mesh-list
6341405|NCT00033436|Nicotinic Acids|nicotinic acids|mesh-list
6341406|NCT00033436|Vitamin B Complex|vitamin b complex|mesh-ancestor
6341407|NCT00033436|Vitamins|vitamins|mesh-ancestor
6341408|NCT00033436|Micronutrients|micronutrients|mesh-ancestor
6341409|NCT00033436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341410|NCT00033436|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6341411|NCT00033436|Antimetabolites|antimetabolites|mesh-ancestor
6341412|NCT00033436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341413|NCT00033436|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6341414|NCT00033436|Vasodilator Agents|vasodilator agents|mesh-ancestor
6341415|NCT00033449|Gefitinib|gefitinib|mesh-list
6341416|NCT00033449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6341417|NCT00033449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6341418|NCT00033449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6341419|NCT00033449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341420|NCT00033462|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6341421|NCT00033462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6341422|NCT00033462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6341423|NCT00033462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6341424|NCT00033462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341425|NCT00033553|Gemcitabine|gemcitabine|mesh-list
6341426|NCT00033553|Paclitaxel|paclitaxel|mesh-list
6341427|NCT00033553|Carboplatin|carboplatin|mesh-list
6341428|NCT00033553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6341429|NCT00033553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6341430|NCT00033553|Tubulin Modulators|tubulin modulators|mesh-ancestor
6341431|NCT00033553|Antimitotic Agents|antimitotic agents|mesh-ancestor
6341432|NCT00033553|Mitosis Modulators|mitosis modulators|mesh-ancestor
6341433|NCT00033553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341434|NCT00033553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6341435|NCT00033553|Antimetabolites|antimetabolites|mesh-ancestor
6341436|NCT00033553|Antiviral Agents|antiviral agents|mesh-ancestor
6341437|NCT00033553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6341438|NCT00033553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6341439|NCT00033553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6341440|NCT00033553|Immunologic Factors|immunologic factors|mesh-ancestor
6341441|NCT00033553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341442|NCT00033566|S 3304|s 3304|mesh-list
6341443|NCT00033566|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
6341444|NCT00033566|Protease Inhibitors|protease inhibitors|mesh-ancestor
6341445|NCT00033566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6341446|NCT00033566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341447|NCT00033592|Bupropion|bupropion|mesh-list
6341448|NCT00033592|Nicotine|nicotine|mesh-list
6341449|NCT00033592|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6341450|NCT00033592|Autonomic Agents|autonomic agents|mesh-ancestor
6341451|NCT00033592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6341452|NCT00033592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341453|NCT00033592|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6341454|NCT00033592|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6341455|NCT00033592|Cholinergic Agents|cholinergic agents|mesh-ancestor
6341456|NCT00033592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6341457|NCT00033592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341458|NCT00033592|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6341459|NCT00033592|Antidepressive Agents|antidepressive agents|mesh-ancestor
6341460|NCT00033592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6341461|NCT00033592|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6341462|NCT00033592|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6341463|NCT00033592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6341464|NCT00033592|Dopamine Agents|dopamine agents|mesh-ancestor
6341465|NCT00033592|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6341466|NCT00033592|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6341467|NCT00033592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6341468|NCT00033605|Octreotide|octreotide|mesh-list
6341469|NCT00033605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6341470|NCT00033605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6341471|NCT00033605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6341472|NCT00033618|Epothilones|epothilones|mesh-list
6341473|NCT00033618|Epothilone B|epothilone b|mesh-list
6341474|NCT00033618|Tubulin Modulators|tubulin modulators|mesh-ancestor
6341475|NCT00033618|Antimitotic Agents|antimitotic agents|mesh-ancestor
6341476|NCT00033618|Mitosis Modulators|mitosis modulators|mesh-ancestor
6341477|NCT00033618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341478|NCT00033618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6341479|NCT00033644|Doxorubicin|doxorubicin|mesh-list
6341480|NCT00033644|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6341481|NCT00033644|Mitomycins|mitomycins|mesh-list
6341482|NCT00033644|Mitomycin|mitomycin|mesh-list
6341483|NCT00033644|Dacarbazine|dacarbazine|mesh-list
6341484|NCT00033644|Sargramostim|sargramostim|mesh-list
6341485|NCT00033644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6341486|NCT00033644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6341487|NCT00033644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6341488|NCT00033644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6341489|NCT00033644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6341490|NCT00033644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341491|NCT00033644|Immunologic Factors|immunologic factors|mesh-ancestor
6341492|NCT00033644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341493|NCT00033644|Alkylating Agents|alkylating agents|mesh-ancestor
6341494|NCT00033644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6341495|NCT00033644|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6341496|NCT00033683|Tamoxifen|tamoxifen|mesh-list
6341497|NCT00033683|Cyclophosphamide|cyclophosphamide|mesh-list
6341498|NCT00033683|Docetaxel|docetaxel|mesh-list
6341499|NCT00033683|Fluorouracil|fluorouracil|mesh-list
6341500|NCT00033683|Methotrexate|methotrexate|mesh-list
6341501|NCT00033683|Epirubicin|epirubicin|mesh-list
6341502|NCT00033683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6341503|NCT00033683|Immunologic Factors|immunologic factors|mesh-ancestor
6341504|NCT00033683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341505|NCT00033683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6341506|NCT00033683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6341507|NCT00033683|Alkylating Agents|alkylating agents|mesh-ancestor
6341508|NCT00033683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341509|NCT00033683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6341510|NCT00033683|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6341511|NCT00033683|Tubulin Modulators|tubulin modulators|mesh-ancestor
6341512|NCT00033683|Antimitotic Agents|antimitotic agents|mesh-ancestor
6341513|NCT00033683|Mitosis Modulators|mitosis modulators|mesh-ancestor
6341514|NCT00033683|Antimetabolites|antimetabolites|mesh-ancestor
6341515|NCT00033683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6341516|NCT00033683|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6341517|NCT00033683|Abortifacient Agents|abortifacient agents|mesh-ancestor
6341518|NCT00033683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6341519|NCT00033683|Dermatologic Agents|dermatologic agents|mesh-ancestor
6341520|NCT00033683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6341521|NCT00033683|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6341522|NCT00033683|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6341523|NCT00033683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6341524|NCT00033683|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6341525|NCT00033683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6341526|NCT00033683|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6341527|NCT00033683|Hormone Antagonists|hormone antagonists|mesh-ancestor
6341528|NCT00033683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6341529|NCT00033683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6341530|NCT00033683|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6341531|NCT00033683|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6341532|NCT00033683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6341533|NCT00033696|Paclitaxel|paclitaxel|mesh-list
6341534|NCT00033696|Etoposide|etoposide|mesh-list
6341535|NCT00033696|Carboplatin|carboplatin|mesh-list
6341536|NCT00033696|Topotecan|topotecan|mesh-list
6341537|NCT00033696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6341538|NCT00033696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6341539|NCT00033696|Tubulin Modulators|tubulin modulators|mesh-ancestor
6341540|NCT00033696|Antimitotic Agents|antimitotic agents|mesh-ancestor
6341541|NCT00033696|Mitosis Modulators|mitosis modulators|mesh-ancestor
6341542|NCT00033696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341543|NCT00033696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6341544|NCT00033696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6341545|NCT00033696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6341546|NCT00033696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6393742|NCT00199576|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6393743|NCT00199576|Protective Agents|protective agents|mesh-ancestor
6393744|NCT00199576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6393745|NCT00199576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6393746|NCT00199602|Heparin|heparin|mesh-list
6393747|NCT00199602|Anticoagulants|anticoagulants|mesh-ancestor
6341547|NCT00033709|Thalidomide|thalidomide|mesh-list
6341548|NCT00033709|Temozolomide|temozolomide|mesh-list
6341549|NCT00033709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6341550|NCT00033709|Alkylating Agents|alkylating agents|mesh-ancestor
6341551|NCT00033709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341552|NCT00033709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6341553|NCT00033709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6341554|NCT00033709|Immunologic Factors|immunologic factors|mesh-ancestor
6341555|NCT00033709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341556|NCT00033709|Leprostatic Agents|leprostatic agents|mesh-ancestor
6341557|NCT00033709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6341558|NCT00033709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6341559|NCT00033709|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6341560|NCT00033709|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6341561|NCT00033709|Growth Substances|growth substances|mesh-ancestor
6341562|NCT00033709|Growth Inhibitors|growth inhibitors|mesh-ancestor
6341563|NCT00033722|Folic Acid|folic acid|mesh-list
6341564|NCT00033722|Lometrexol|lometrexol|mesh-list
6341565|NCT00033722|Hematinics|hematinics|mesh-ancestor
6341566|NCT00033722|Vitamin B Complex|vitamin b complex|mesh-ancestor
6341567|NCT00033722|Vitamins|vitamins|mesh-ancestor
6341568|NCT00033722|Micronutrients|micronutrients|mesh-ancestor
6341569|NCT00033722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341570|NCT00033722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6341571|NCT00033722|Antimetabolites|antimetabolites|mesh-ancestor
6341572|NCT00033722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341573|NCT00033722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6341574|NCT00033722|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6341575|NCT00033722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6341576|NCT00033735|Fluorouracil|fluorouracil|mesh-list
6341577|NCT00033735|Irofulven|irofulven|mesh-list
6341578|NCT00033735|Antimetabolites|antimetabolites|mesh-ancestor
6341579|NCT00033735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341580|NCT00033735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6341581|NCT00033735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6341582|NCT00033735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6341583|NCT00033735|Immunologic Factors|immunologic factors|mesh-ancestor
6341584|NCT00033735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341585|NCT00033735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6341586|NCT00033735|Alkylating Agents|alkylating agents|mesh-ancestor
6341587|NCT00033748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6341588|NCT00033748|Antibodies|antibodies|mesh-list
6341589|NCT00033748|Immunoglobulins|immunoglobulins|mesh-list
6341590|NCT00033748|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6341591|NCT00033748|Immunologic Factors|immunologic factors|mesh-ancestor
6341592|NCT00033748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341593|NCT00033748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6341594|NCT00033813|Oxatomide|oxatomide|mesh-list
6341595|NCT00033813|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6341596|NCT00033813|Histamine Antagonists|histamine antagonists|mesh-ancestor
6341597|NCT00033813|Histamine Agents|histamine agents|mesh-ancestor
6341598|NCT00033813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6341599|NCT00033813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341600|NCT00033813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341601|NCT00033813|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6341602|NCT00033813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6341603|NCT00033813|Respiratory System Agents|respiratory system agents|mesh-ancestor
6341604|NCT00033891|Infliximab|infliximab|mesh-list
6341605|NCT00033891|Dermatologic Agents|dermatologic agents|mesh-ancestor
6341606|NCT00033891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6341607|NCT00033891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6341608|NCT00033982|Posaconazole|posaconazole|mesh-list
6341609|NCT00033982|Antifungal Agents|antifungal agents|mesh-ancestor
6341610|NCT00033982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6341611|NCT00033982|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6341612|NCT00033982|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6341613|NCT00033982|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6341614|NCT00033982|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6341615|NCT00033982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6341616|NCT00033982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6341617|NCT00033982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341618|NCT00033982|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6341619|NCT00033982|Hormone Antagonists|hormone antagonists|mesh-ancestor
6341620|NCT00033982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6341621|NCT00033982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341622|NCT00034047|Nafarelin|nafarelin|mesh-list
6341623|NCT00034047|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6341624|NCT00034047|Fertility Agents|fertility agents|mesh-ancestor
6341625|NCT00034047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6341626|NCT00034047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341627|NCT00034060|Etanercept|etanercept|mesh-list
6341628|NCT00034060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6341629|NCT00034060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6341630|NCT00034060|Analgesics|analgesics|mesh-ancestor
6341631|NCT00034060|Sensory System Agents|sensory system agents|mesh-ancestor
6341632|NCT00034060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6341633|NCT00034060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341634|NCT00034060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6341635|NCT00034060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6341636|NCT00034060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6341637|NCT00034060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6341638|NCT00034060|Immunologic Factors|immunologic factors|mesh-ancestor
6341639|NCT00034086|Ritonavir|ritonavir|mesh-list
6341640|NCT00034086|Lopinavir|lopinavir|mesh-list
6341641|NCT00034086|Tenofovir|tenofovir|mesh-list
6341642|NCT00034086|Lamivudine|lamivudine|mesh-list
6341643|NCT00034086|Zidovudine|zidovudine|mesh-list
6341644|NCT00034086|Stavudine|stavudine|mesh-list
6341645|NCT00034086|Didanosine|didanosine|mesh-list
6341646|NCT00034086|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6341647|NCT00034086|Vaccines|vaccines|mesh-list
6341648|NCT00034086|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6341649|NCT00034086|Immunologic Factors|immunologic factors|mesh-ancestor
6341650|NCT00034086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341651|NCT00034086|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6341652|NCT00034086|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6341653|NCT00034086|Protease Inhibitors|protease inhibitors|mesh-ancestor
6341654|NCT00034086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6341655|NCT00034086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016855|NCT00368459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341656|NCT00034086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6341657|NCT00034086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6341658|NCT00034086|Antiviral Agents|antiviral agents|mesh-ancestor
6341659|NCT00034086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6341660|NCT00034086|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6341661|NCT00034086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6341662|NCT00034086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6341663|NCT00034086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6341664|NCT00034086|Antimetabolites|antimetabolites|mesh-ancestor
6341665|NCT00034125|Tamoxifen|tamoxifen|mesh-list
6341666|NCT00034125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6341667|NCT00034125|Hormone Antagonists|hormone antagonists|mesh-ancestor
6341668|NCT00034125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6341669|NCT00034125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341670|NCT00034125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6341671|NCT00034125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6341672|NCT00034125|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6341673|NCT00034125|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6341674|NCT00034125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6341675|NCT00034138|Oregovomab|oregovomab|mesh-list
6341676|NCT00034138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6341677|NCT00034138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6341678|NCT00034151|Paclitaxel|paclitaxel|mesh-list
6341679|NCT00034151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6341680|NCT00034151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6341681|NCT00034151|Tubulin Modulators|tubulin modulators|mesh-ancestor
6341682|NCT00034151|Antimitotic Agents|antimitotic agents|mesh-ancestor
6341683|NCT00034151|Mitosis Modulators|mitosis modulators|mesh-ancestor
6341684|NCT00034151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341685|NCT00034164|Paclitaxel|paclitaxel|mesh-list
6341686|NCT00034164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6341687|NCT00034164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6341688|NCT00034164|Tubulin Modulators|tubulin modulators|mesh-ancestor
6341689|NCT00034164|Antimitotic Agents|antimitotic agents|mesh-ancestor
6341690|NCT00034164|Mitosis Modulators|mitosis modulators|mesh-ancestor
6393748|NCT00199602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6341691|NCT00034164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341692|NCT00034177|Paclitaxel|paclitaxel|mesh-list
6341693|NCT00034177|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6341694|NCT00034177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6341695|NCT00034177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6341696|NCT00034177|Tubulin Modulators|tubulin modulators|mesh-ancestor
6341697|NCT00034177|Antimitotic Agents|antimitotic agents|mesh-ancestor
6341698|NCT00034177|Mitosis Modulators|mitosis modulators|mesh-ancestor
6341699|NCT00034177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341700|NCT00034190|Paclitaxel|paclitaxel|mesh-list
6341701|NCT00034190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6341702|NCT00034190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6341703|NCT00034190|Tubulin Modulators|tubulin modulators|mesh-ancestor
6341704|NCT00034190|Antimitotic Agents|antimitotic agents|mesh-ancestor
6341705|NCT00034190|Mitosis Modulators|mitosis modulators|mesh-ancestor
6341706|NCT00034190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341707|NCT00034229|Felbamate|felbamate|mesh-list
6341708|NCT00034229|Anticonvulsants|anticonvulsants|mesh-ancestor
6341709|NCT00034229|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6341710|NCT00034229|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6341711|NCT00034229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6341712|NCT00034229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341713|NCT00034229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341714|NCT00034242|Immunoglobulins|immunoglobulins|mesh-list
6341715|NCT00034242|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6341716|NCT00034242|Antibodies|antibodies|mesh-list
6341717|NCT00034242|gamma-Globulins|gamma-globulins|mesh-list
6341718|NCT00034242|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6341719|NCT00034242|Immunologic Factors|immunologic factors|mesh-ancestor
6341720|NCT00034242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341721|NCT00034307|Sitaxsentan|sitaxsentan|mesh-list
6341722|NCT00034307|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6341723|NCT00034307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341724|NCT00034346|Paclitaxel|paclitaxel|mesh-list
6341725|NCT00034346|Carboplatin|carboplatin|mesh-list
6341726|NCT00034346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6341727|NCT00034346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6341728|NCT00034346|Tubulin Modulators|tubulin modulators|mesh-ancestor
6341729|NCT00034346|Antimitotic Agents|antimitotic agents|mesh-ancestor
6341730|NCT00034346|Mitosis Modulators|mitosis modulators|mesh-ancestor
6341731|NCT00034346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341732|NCT00034359|Lamivudine|lamivudine|mesh-list
6341733|NCT00034359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6341734|NCT00034359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6341735|NCT00034359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6341736|NCT00034359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341737|NCT00034359|Antiviral Agents|antiviral agents|mesh-ancestor
6341738|NCT00034359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6341739|NCT00034359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6341740|NCT00034359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6341741|NCT00034372|Oregovomab|oregovomab|mesh-list
6341742|NCT00034372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6341743|NCT00034372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6341744|NCT00034385|Valganciclovir|valganciclovir|mesh-list
6341745|NCT00034385|Antiviral Agents|antiviral agents|mesh-ancestor
6341746|NCT00034385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6341747|NCT00034463|Folic Acid|folic acid|mesh-list
6341748|NCT00034463|Vitamins|vitamins|mesh-ancestor
6341749|NCT00034463|Micronutrients|micronutrients|mesh-ancestor
6341750|NCT00034463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341751|NCT00034463|Hematinics|hematinics|mesh-ancestor
6341752|NCT00034463|Vitamin B Complex|vitamin b complex|mesh-ancestor
6341753|NCT00034489|Gemcitabine|gemcitabine|mesh-list
6341754|NCT00034489|Pemetrexed|pemetrexed|mesh-list
6341755|NCT00034489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6341756|NCT00034489|Antimetabolites|antimetabolites|mesh-ancestor
6341757|NCT00034489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341758|NCT00034489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6341759|NCT00034489|Antiviral Agents|antiviral agents|mesh-ancestor
6341760|NCT00034489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6341761|NCT00034489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6341762|NCT00034489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6341763|NCT00034489|Immunologic Factors|immunologic factors|mesh-ancestor
6341764|NCT00034489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341765|NCT00034489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6341766|NCT00034489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6341767|NCT00034502|Irinotecan|irinotecan|mesh-list
6341768|NCT00034502|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6341769|NCT00034502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6341770|NCT00034502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6341771|NCT00034502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341772|NCT00034502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6341773|NCT00034528|Prednisone|prednisone|mesh-list
6341774|NCT00034528|Fludarabine|fludarabine|mesh-list
6341775|NCT00034528|Busulfan|busulfan|mesh-list
6341776|NCT00034528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6341777|NCT00034528|Glucocorticoids|glucocorticoids|mesh-ancestor
6341778|NCT00034528|Hormones|hormones|mesh-ancestor
6341779|NCT00034528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6341780|NCT00034528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341781|NCT00034528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6341782|NCT00034528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6341783|NCT00034528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341784|NCT00034528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6341785|NCT00034528|Immunologic Factors|immunologic factors|mesh-ancestor
6341786|NCT00034528|Alkylating Agents|alkylating agents|mesh-ancestor
6341787|NCT00034528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6341788|NCT00034528|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6341789|NCT00034541|Paclitaxel|paclitaxel|mesh-list
6341790|NCT00034541|Carboplatin|carboplatin|mesh-list
6341791|NCT00034541|Cetuximab|cetuximab|mesh-list
6341792|NCT00034541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6341793|NCT00034541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6341794|NCT00034541|Tubulin Modulators|tubulin modulators|mesh-ancestor
6341795|NCT00034541|Antimitotic Agents|antimitotic agents|mesh-ancestor
6341796|NCT00034541|Mitosis Modulators|mitosis modulators|mesh-ancestor
6341797|NCT00034541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341798|NCT00034541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6341799|NCT00034580|Olanzapine|olanzapine|mesh-list
6341800|NCT00034580|Risperidone|risperidone|mesh-list
6341801|NCT00034580|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6341802|NCT00034580|Serotonin Agents|serotonin agents|mesh-ancestor
6341803|NCT00034580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6341804|NCT00034580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341805|NCT00034580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341806|NCT00034580|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6341807|NCT00034580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6341808|NCT00034580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6341809|NCT00034580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6341810|NCT00034580|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6341811|NCT00034580|Dopamine Agents|dopamine agents|mesh-ancestor
6341812|NCT00034580|Antiemetics|antiemetics|mesh-ancestor
6341813|NCT00034580|Autonomic Agents|autonomic agents|mesh-ancestor
6341814|NCT00034580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6341815|NCT00034580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6341816|NCT00034580|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6341817|NCT00034580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6341818|NCT00034580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6341819|NCT00034593|Gemcitabine|gemcitabine|mesh-list
6341820|NCT00034593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6341821|NCT00034593|Antimetabolites|antimetabolites|mesh-ancestor
6341822|NCT00034593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341823|NCT00034593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6341824|NCT00034593|Antiviral Agents|antiviral agents|mesh-ancestor
6341825|NCT00034593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6341826|NCT00034593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6341827|NCT00034593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6341828|NCT00034593|Immunologic Factors|immunologic factors|mesh-ancestor
6341829|NCT00034593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341830|NCT00034606|Gemcitabine|gemcitabine|mesh-list
6341831|NCT00034606|Pemetrexed|pemetrexed|mesh-list
6341832|NCT00034606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6341833|NCT00034606|Antimetabolites|antimetabolites|mesh-ancestor
6341834|NCT00034606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341835|NCT00034606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6341836|NCT00034606|Antiviral Agents|antiviral agents|mesh-ancestor
6341837|NCT00034606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6341838|NCT00034606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6341839|NCT00034606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6341840|NCT00034606|Immunologic Factors|immunologic factors|mesh-ancestor
6341841|NCT00034606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341842|NCT00034606|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6341843|NCT00034606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6341844|NCT00034619|Oxaliplatin|oxaliplatin|mesh-list
6341845|NCT00034619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6341846|NCT00034632|Posaconazole|posaconazole|mesh-list
6341847|NCT00034632|Antifungal Agents|antifungal agents|mesh-ancestor
6341848|NCT00034632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6341849|NCT00034632|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6341850|NCT00034632|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6341851|NCT00034632|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6341852|NCT00034632|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6341853|NCT00034632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6341854|NCT00034632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6341855|NCT00034632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341856|NCT00034632|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6341857|NCT00034632|Hormone Antagonists|hormone antagonists|mesh-ancestor
6341858|NCT00034632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6341859|NCT00034632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341860|NCT00034645|Posaconazole|posaconazole|mesh-list
6341861|NCT00034645|Antifungal Agents|antifungal agents|mesh-ancestor
6341862|NCT00034645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6341863|NCT00034645|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6341864|NCT00034645|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6341865|NCT00034645|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6341866|NCT00034645|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6341867|NCT00034645|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6341868|NCT00034645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6341869|NCT00034645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341870|NCT00034645|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6341871|NCT00034645|Hormone Antagonists|hormone antagonists|mesh-ancestor
6341872|NCT00034645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6341873|NCT00034645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341874|NCT00034658|Posaconazole|posaconazole|mesh-list
6341875|NCT00034658|Antifungal Agents|antifungal agents|mesh-ancestor
6341876|NCT00034658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6341877|NCT00034658|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6341878|NCT00034658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6341879|NCT00034658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6341880|NCT00034658|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6341881|NCT00034658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6341882|NCT00034658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6341883|NCT00034658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341884|NCT00034658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6341885|NCT00034658|Hormone Antagonists|hormone antagonists|mesh-ancestor
6341886|NCT00034658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6341887|NCT00034658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341888|NCT00034671|Posaconazole|posaconazole|mesh-list
6341889|NCT00034671|Antifungal Agents|antifungal agents|mesh-ancestor
6341890|NCT00034671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6341891|NCT00034671|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6341892|NCT00034671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6341893|NCT00034671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6341894|NCT00034671|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6341895|NCT00034671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6341896|NCT00034671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6341897|NCT00034671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341898|NCT00034671|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6341899|NCT00034671|Hormone Antagonists|hormone antagonists|mesh-ancestor
6341900|NCT00034671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6341901|NCT00034671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341902|NCT00034697|Temozolomide|temozolomide|mesh-list
6341903|NCT00034697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6341904|NCT00034697|Alkylating Agents|alkylating agents|mesh-ancestor
6341905|NCT00034697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341906|NCT00034697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6341907|NCT00034710|Capsaicin|capsaicin|mesh-list
6341908|NCT00034710|Antipruritics|antipruritics|mesh-ancestor
6341909|NCT00034710|Dermatologic Agents|dermatologic agents|mesh-ancestor
6341910|NCT00034710|Sensory System Agents|sensory system agents|mesh-ancestor
6341911|NCT00034710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6341912|NCT00034710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341913|NCT00034736|Levofloxacin|levofloxacin|mesh-list
6341914|NCT00034736|Ofloxacin|ofloxacin|mesh-list
6341915|NCT00034736|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6341916|NCT00034736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6341917|NCT00034736|Renal Agents|renal agents|mesh-ancestor
6341918|NCT00034736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6341919|NCT00034736|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6341920|NCT00034736|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6341921|NCT00034736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6341922|NCT00034736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341923|NCT00034736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6341924|NCT00034736|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6341925|NCT00034736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6341926|NCT00034749|Risperidone|risperidone|mesh-list
6341927|NCT00034749|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6341928|NCT00034749|Serotonin Agents|serotonin agents|mesh-ancestor
6341929|NCT00034749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6341930|NCT00034749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341931|NCT00034749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341932|NCT00034749|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6341933|NCT00034749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6341934|NCT00034749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6341935|NCT00034749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6341936|NCT00034749|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6341937|NCT00034749|Dopamine Agents|dopamine agents|mesh-ancestor
6341938|NCT00034762|Risperidone|risperidone|mesh-list
6341939|NCT00034762|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6341940|NCT00034762|Serotonin Agents|serotonin agents|mesh-ancestor
6341941|NCT00034762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6341942|NCT00034762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341943|NCT00034762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341944|NCT00034762|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6341945|NCT00034762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6341946|NCT00034762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6341947|NCT00034762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6341948|NCT00034762|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6341949|NCT00034762|Dopamine Agents|dopamine agents|mesh-ancestor
6341950|NCT00034775|Risperidone|risperidone|mesh-list
6341951|NCT00034775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6341952|NCT00034775|Serotonin Agents|serotonin agents|mesh-ancestor
6341953|NCT00034775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6341954|NCT00034775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341955|NCT00034775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341956|NCT00034775|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6341957|NCT00034775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6341958|NCT00034775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6341959|NCT00034775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6341960|NCT00034775|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6341961|NCT00034775|Dopamine Agents|dopamine agents|mesh-ancestor
6341962|NCT00034788|Becaplermin|becaplermin|mesh-list
6341963|NCT00034788|Anticoagulants|anticoagulants|mesh-ancestor
6341964|NCT00034788|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
6341965|NCT00034788|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6341966|NCT00034788|Growth Substances|growth substances|mesh-ancestor
6341967|NCT00034788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341968|NCT00034801|Olanzapine|olanzapine|mesh-list
6341969|NCT00034801|Ziprasidone|ziprasidone|mesh-list
6341970|NCT00034801|Antiemetics|antiemetics|mesh-ancestor
6341971|NCT00034801|Autonomic Agents|autonomic agents|mesh-ancestor
6341972|NCT00034801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6341973|NCT00034801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6341974|NCT00034801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6341975|NCT00034801|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6341976|NCT00034801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6341977|NCT00034801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6341978|NCT00034801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6341979|NCT00034801|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6341980|NCT00034801|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6341981|NCT00034801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6341982|NCT00034801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341983|NCT00034801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6341984|NCT00034801|Serotonin Agents|serotonin agents|mesh-ancestor
6341985|NCT00034801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6341986|NCT00034801|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6341987|NCT00034801|Dopamine Agents|dopamine agents|mesh-ancestor
6341988|NCT00034840|Valsartan|valsartan|mesh-list
6341989|NCT00034840|Telmisartan|telmisartan|mesh-list
6341990|NCT00034840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6341991|NCT00034840|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6341992|NCT00034840|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6341993|NCT00034840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6341994|NCT00034853|Naproxen|naproxen|mesh-list
6341995|NCT00034853|Meloxicam|meloxicam|mesh-list
6341996|NCT00034853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6341997|NCT00034853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6341998|NCT00034853|Analgesics|analgesics|mesh-ancestor
6341999|NCT00034853|Sensory System Agents|sensory system agents|mesh-ancestor
6342000|NCT00034853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6342001|NCT00034853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342002|NCT00034853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6342003|NCT00034853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6342004|NCT00034853|Gout Suppressants|gout suppressants|mesh-ancestor
6342005|NCT00034853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6342006|NCT00034853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6342007|NCT00034853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342008|NCT00034853|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6342009|NCT00034866|Tipranavir|tipranavir|mesh-list
6342010|NCT00034866|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
6342011|NCT00034866|Protease Inhibitors|protease inhibitors|mesh-list
6342012|NCT00034866|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6342013|NCT00034866|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6342014|NCT00034866|Antiviral Agents|antiviral agents|mesh-ancestor
6342015|NCT00034866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6342016|NCT00034866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6342017|NCT00034866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342018|NCT00034866|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6342019|NCT00034879|Gefitinib|gefitinib|mesh-list
6342020|NCT00034879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6342021|NCT00034879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6342022|NCT00034879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6342023|NCT00034879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342024|NCT00034892|Olanzapine|olanzapine|mesh-list
6342025|NCT00034892|Risperidone|risperidone|mesh-list
6342026|NCT00034892|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6342027|NCT00034892|Serotonin Agents|serotonin agents|mesh-ancestor
6342028|NCT00034892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6342029|NCT00034892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342030|NCT00034892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342031|NCT00034892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6342032|NCT00034892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6342033|NCT00034892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6342034|NCT00034892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6342035|NCT00034892|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6342036|NCT00034892|Dopamine Agents|dopamine agents|mesh-ancestor
6342037|NCT00034892|Antiemetics|antiemetics|mesh-ancestor
6342038|NCT00034892|Autonomic Agents|autonomic agents|mesh-ancestor
6342039|NCT00034892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6342040|NCT00034892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6342041|NCT00034892|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6342042|NCT00034892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6342043|NCT00034892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6342044|NCT00034905|Risperidone|risperidone|mesh-list
6342045|NCT00034905|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6342046|NCT00034905|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6342047|NCT00034905|Serotonin Agents|serotonin agents|mesh-ancestor
6342048|NCT00034905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6342049|NCT00034905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342050|NCT00034905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342051|NCT00034905|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6342052|NCT00034905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6342053|NCT00034905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6342054|NCT00034905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6342055|NCT00034905|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6342056|NCT00034905|Dopamine Agents|dopamine agents|mesh-ancestor
6342057|NCT00034905|Antidepressive Agents|antidepressive agents|mesh-ancestor
6342058|NCT00034944|Aprepitant|aprepitant|mesh-list
6342059|NCT00034944|Antiemetics|antiemetics|mesh-ancestor
6342060|NCT00034944|Autonomic Agents|autonomic agents|mesh-ancestor
6342061|NCT00034944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6342062|NCT00034944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342063|NCT00034944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6342064|NCT00034944|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6342065|NCT00034944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6342066|NCT00034944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342067|NCT00034983|Aprepitant|aprepitant|mesh-list
6342068|NCT00034983|Paroxetine|paroxetine|mesh-list
6342069|NCT00034983|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6342070|NCT00034983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6342071|NCT00034983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6342072|NCT00034983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342073|NCT00034983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6342074|NCT00034983|Serotonin Agents|serotonin agents|mesh-ancestor
6342075|NCT00034983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342076|NCT00034983|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6342077|NCT00034983|Antidepressive Agents|antidepressive agents|mesh-ancestor
6342078|NCT00034983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6342079|NCT00034983|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6342080|NCT00034983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6342081|NCT00034983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6342082|NCT00034983|Antiemetics|antiemetics|mesh-ancestor
6342083|NCT00034983|Autonomic Agents|autonomic agents|mesh-ancestor
6342084|NCT00034983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6342085|NCT00034983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6342086|NCT00034983|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6342087|NCT00035009|Aprepitant|aprepitant|mesh-list
6342088|NCT00035009|Paroxetine|paroxetine|mesh-list
6342089|NCT00035009|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6342090|NCT00035009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6342091|NCT00035009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6342092|NCT00035009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342093|NCT00035009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6342094|NCT00035009|Serotonin Agents|serotonin agents|mesh-ancestor
6342095|NCT00035009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342096|NCT00035009|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6342097|NCT00035009|Antidepressive Agents|antidepressive agents|mesh-ancestor
6342098|NCT00035009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6342099|NCT00035009|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6342100|NCT00035009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6342101|NCT00035009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6342102|NCT00035009|Antiemetics|antiemetics|mesh-ancestor
6342103|NCT00035009|Autonomic Agents|autonomic agents|mesh-ancestor
6342104|NCT00035009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6342105|NCT00035009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6342106|NCT00035009|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6342107|NCT00035035|Gemcitabine|gemcitabine|mesh-list
6342108|NCT00035035|Pemetrexed|pemetrexed|mesh-list
6342109|NCT00035035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6342110|NCT00035035|Antimetabolites|antimetabolites|mesh-ancestor
6342111|NCT00035035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342112|NCT00035035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6342113|NCT00035035|Antiviral Agents|antiviral agents|mesh-ancestor
6342114|NCT00035035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6342115|NCT00035035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6342116|NCT00035035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6342117|NCT00035035|Immunologic Factors|immunologic factors|mesh-ancestor
6342118|NCT00035035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342119|NCT00035035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6342120|NCT00035035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6342121|NCT00035048|Aprepitant|aprepitant|mesh-list
6342122|NCT00035048|Antiemetics|antiemetics|mesh-ancestor
6342123|NCT00035048|Autonomic Agents|autonomic agents|mesh-ancestor
6342124|NCT00035048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6342125|NCT00035048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342126|NCT00035048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6342127|NCT00035048|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6342128|NCT00035048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6342129|NCT00035048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342130|NCT00035061|Pemetrexed|pemetrexed|mesh-list
6342131|NCT00035061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6342132|NCT00035061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6342133|NCT00035061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342134|NCT00035061|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6342135|NCT00035061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6342136|NCT00035074|Methotrexate|methotrexate|mesh-list
6342137|NCT00035074|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6342138|NCT00035074|Abortifacient Agents|abortifacient agents|mesh-ancestor
6342139|NCT00035074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6342140|NCT00035074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342141|NCT00035074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6342142|NCT00035074|Antimetabolites|antimetabolites|mesh-ancestor
6342143|NCT00035074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342144|NCT00035074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6342145|NCT00035074|Dermatologic Agents|dermatologic agents|mesh-ancestor
6342146|NCT00035074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6342147|NCT00035074|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6342148|NCT00035074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6342149|NCT00035074|Immunologic Factors|immunologic factors|mesh-ancestor
6342150|NCT00035074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6342151|NCT00035074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6342152|NCT00035087|Epothilones|epothilones|mesh-list
6342153|NCT00035087|Epothilone B|epothilone b|mesh-list
6342154|NCT00035087|Tubulin Modulators|tubulin modulators|mesh-ancestor
6342155|NCT00035087|Antimitotic Agents|antimitotic agents|mesh-ancestor
6342156|NCT00035087|Mitosis Modulators|mitosis modulators|mesh-ancestor
6342157|NCT00035087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342158|NCT00035087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6342159|NCT00035100|Epothilones|epothilones|mesh-list
6342160|NCT00035100|Epothilone B|epothilone b|mesh-list
6342161|NCT00035100|Tubulin Modulators|tubulin modulators|mesh-ancestor
6342162|NCT00035100|Antimitotic Agents|antimitotic agents|mesh-ancestor
6342163|NCT00035100|Mitosis Modulators|mitosis modulators|mesh-ancestor
6342164|NCT00035100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342165|NCT00035100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6342166|NCT00035113|Epothilones|epothilones|mesh-list
6342167|NCT00035113|Epothilone B|epothilone b|mesh-list
6342168|NCT00035113|Tubulin Modulators|tubulin modulators|mesh-ancestor
6342169|NCT00035113|Antimitotic Agents|antimitotic agents|mesh-ancestor
6342170|NCT00035113|Mitosis Modulators|mitosis modulators|mesh-ancestor
6342171|NCT00035113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342172|NCT00035113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6342173|NCT00035126|Epothilones|epothilones|mesh-list
6342174|NCT00035126|Epothilone B|epothilone b|mesh-list
6342175|NCT00035126|Tubulin Modulators|tubulin modulators|mesh-ancestor
6342176|NCT00035126|Antimitotic Agents|antimitotic agents|mesh-ancestor
6342177|NCT00035126|Mitosis Modulators|mitosis modulators|mesh-ancestor
6342178|NCT00035126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342179|NCT00035126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6342180|NCT00035139|Methylphenidate|methylphenidate|mesh-list
6342181|NCT00035139|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6342182|NCT00035139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342183|NCT00035139|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6342184|NCT00035139|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6342185|NCT00035139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6342186|NCT00035139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342187|NCT00035139|Dopamine Agents|dopamine agents|mesh-ancestor
6342188|NCT00035139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6342189|NCT00035152|Paclitaxel|paclitaxel|mesh-list
6342190|NCT00035152|Carboplatin|carboplatin|mesh-list
6342191|NCT00035152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6342192|NCT00035152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6342193|NCT00035152|Tubulin Modulators|tubulin modulators|mesh-ancestor
6342194|NCT00035152|Antimitotic Agents|antimitotic agents|mesh-ancestor
6342195|NCT00035152|Mitosis Modulators|mitosis modulators|mesh-ancestor
6342196|NCT00035152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393749|NCT00199602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6393750|NCT00199602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393751|NCT00199667|Mycophenolic Acid|mycophenolic acid|mesh-list
6393752|NCT00199667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6393753|NCT00199667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6393754|NCT00199667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6393755|NCT00199667|Antitubercular Agents|antitubercular agents|mesh-ancestor
6393756|NCT00199667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6393757|NCT00199667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6393758|NCT00199667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6393759|NCT00199667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393760|NCT00199719|Ribavirin|ribavirin|mesh-list
6393761|NCT00199719|Antimetabolites|antimetabolites|mesh-ancestor
6393762|NCT00199719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393763|NCT00199719|Antiviral Agents|antiviral agents|mesh-ancestor
6393764|NCT00199719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6393765|NCT00199745|Atorvastatin|atorvastatin|mesh-list
6393766|NCT00199745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6393767|NCT00199745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6393768|NCT00199745|Antimetabolites|antimetabolites|mesh-ancestor
6393769|NCT00199745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393770|NCT00199745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6393771|NCT00199745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6393772|NCT00199745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6393773|NCT00199758|Gemcitabine|gemcitabine|mesh-list
6393774|NCT00199758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6393775|NCT00199758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6393776|NCT00199758|Antimetabolites|antimetabolites|mesh-ancestor
6393777|NCT00199758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393778|NCT00199758|Antiviral Agents|antiviral agents|mesh-ancestor
6393779|NCT00199758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6393780|NCT00199758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6393781|NCT00199758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6393782|NCT00199758|Immunologic Factors|immunologic factors|mesh-ancestor
6393783|NCT00199758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6393784|NCT00199771|Dextrans|dextrans|mesh-list
6393785|NCT00199771|Anticoagulants|anticoagulants|mesh-ancestor
6393786|NCT00199771|Plasma Substitutes|plasma substitutes|mesh-ancestor
6342197|NCT00035165|Epothilones|epothilones|mesh-list
6342198|NCT00035165|Epothilone B|epothilone b|mesh-list
6342199|NCT00035165|Tubulin Modulators|tubulin modulators|mesh-ancestor
6342200|NCT00035165|Antimitotic Agents|antimitotic agents|mesh-ancestor
6342201|NCT00035165|Mitosis Modulators|mitosis modulators|mesh-ancestor
6342202|NCT00035165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342203|NCT00035165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6342204|NCT00035178|Argatroban|argatroban|mesh-list
6342205|NCT00035178|Antithrombins|antithrombins|mesh-ancestor
6342206|NCT00035178|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6342207|NCT00035178|Protease Inhibitors|protease inhibitors|mesh-ancestor
6342208|NCT00035178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6342209|NCT00035178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342210|NCT00035178|Anticoagulants|anticoagulants|mesh-ancestor
6342211|NCT00035178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6342212|NCT00035191|Galantamine|galantamine|mesh-list
6342213|NCT00035191|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6342214|NCT00035191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6342215|NCT00035191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342216|NCT00035191|Cholinergic Agents|cholinergic agents|mesh-ancestor
6342217|NCT00035191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6342218|NCT00035191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342219|NCT00035191|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6342220|NCT00035191|Autonomic Agents|autonomic agents|mesh-ancestor
6342221|NCT00035191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6342222|NCT00035191|Nootropic Agents|nootropic agents|mesh-ancestor
6342223|NCT00035204|Galantamine|galantamine|mesh-list
6342224|NCT00035204|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6342225|NCT00035204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6342226|NCT00035204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342227|NCT00035204|Cholinergic Agents|cholinergic agents|mesh-ancestor
6342228|NCT00035204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6342229|NCT00035204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342230|NCT00035204|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6342231|NCT00035204|Autonomic Agents|autonomic agents|mesh-ancestor
6342232|NCT00035204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6342233|NCT00035204|Nootropic Agents|nootropic agents|mesh-ancestor
6342234|NCT00035230|Topiramate|topiramate|mesh-list
6342235|NCT00035230|Anticonvulsants|anticonvulsants|mesh-ancestor
6342236|NCT00035230|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6342237|NCT00035230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342238|NCT00035243|Epothilones|epothilones|mesh-list
6342239|NCT00035243|Epothilone B|epothilone b|mesh-list
6342240|NCT00035243|Tubulin Modulators|tubulin modulators|mesh-ancestor
6342241|NCT00035243|Antimitotic Agents|antimitotic agents|mesh-ancestor
6342242|NCT00035243|Mitosis Modulators|mitosis modulators|mesh-ancestor
6342243|NCT00035243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342244|NCT00035243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6342245|NCT00035256|Teriparatide|teriparatide|mesh-list
6342246|NCT00035256|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
6342247|NCT00035256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6342248|NCT00035256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342249|NCT00035256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6342250|NCT00035256|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6342251|NCT00035256|Hormone Antagonists|hormone antagonists|mesh-ancestor
6342252|NCT00035256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6342253|NCT00035256|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6342254|NCT00035256|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6342255|NCT00035269|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6342256|NCT00035269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6342257|NCT00035282|Aprepitant|aprepitant|mesh-list
6342258|NCT00035282|Antiemetics|antiemetics|mesh-ancestor
6342259|NCT00035282|Autonomic Agents|autonomic agents|mesh-ancestor
6342260|NCT00035282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6342261|NCT00035282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342262|NCT00035282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6342263|NCT00035282|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6342264|NCT00035282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6342265|NCT00035282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342266|NCT00035295|Aprepitant|aprepitant|mesh-list
6342267|NCT00035295|Antiemetics|antiemetics|mesh-ancestor
6342268|NCT00035295|Autonomic Agents|autonomic agents|mesh-ancestor
6342269|NCT00035295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6342270|NCT00035295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342271|NCT00035295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6342272|NCT00035295|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6342273|NCT00035295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6342274|NCT00035295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342275|NCT00035308|Abetimus|abetimus|mesh-list
6342276|NCT00035308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6342277|NCT00035308|Immunologic Factors|immunologic factors|mesh-ancestor
6342278|NCT00035308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342279|NCT00035321|Olanzapine|olanzapine|mesh-list
6342280|NCT00035321|Fluoxetine|fluoxetine|mesh-list
6342281|NCT00035321|Antiemetics|antiemetics|mesh-ancestor
6342282|NCT00035321|Autonomic Agents|autonomic agents|mesh-ancestor
6342283|NCT00035321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6342284|NCT00035321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342285|NCT00035321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6342286|NCT00035321|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6342287|NCT00035321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6342288|NCT00035321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6342289|NCT00035321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6342290|NCT00035321|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6342291|NCT00035321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6342292|NCT00035321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6342293|NCT00035321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342294|NCT00035321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6342295|NCT00035321|Serotonin Agents|serotonin agents|mesh-ancestor
6342296|NCT00035321|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6342297|NCT00035321|Antidepressive Agents|antidepressive agents|mesh-ancestor
6342298|NCT00035321|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6342299|NCT00035321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6342300|NCT00035321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6342301|NCT00035347|Azithromycin|azithromycin|mesh-list
6342302|NCT00035347|Levofloxacin|levofloxacin|mesh-list
6342303|NCT00035347|Ofloxacin|ofloxacin|mesh-list
6342304|NCT00035347|Ceftriaxone|ceftriaxone|mesh-list
6342305|NCT00035347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6342306|NCT00035347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6342307|NCT00035347|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6342308|NCT00035347|Renal Agents|renal agents|mesh-ancestor
6342309|NCT00035347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6342310|NCT00035347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6342311|NCT00035347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6342312|NCT00035347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342313|NCT00035347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6342314|NCT00035347|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6342315|NCT00035347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6342316|NCT00035360|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6342317|NCT00035360|Antiviral Agents|antiviral agents|mesh-ancestor
6342318|NCT00035360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6342319|NCT00035425|Vancomycin|vancomycin|mesh-list
6342320|NCT00035425|Linezolid|linezolid|mesh-list
6342321|NCT00035425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6342322|NCT00035425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6342323|NCT00035425|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6342324|NCT00035425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6342325|NCT00035425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342326|NCT00035451|Sotalol|sotalol|mesh-list
6342327|NCT00035451|Azimilide|azimilide|mesh-list
6342328|NCT00035451|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6342329|NCT00035451|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6342330|NCT00035451|Adrenergic Agents|adrenergic agents|mesh-ancestor
6342331|NCT00035451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6342332|NCT00035451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342333|NCT00035451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342334|NCT00035451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6342335|NCT00035451|Sympatholytics|sympatholytics|mesh-ancestor
6342336|NCT00035451|Autonomic Agents|autonomic agents|mesh-ancestor
6342337|NCT00035451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6342338|NCT00035451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6342339|NCT00035451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6342340|NCT00035451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6342341|NCT00035464|Azimilide|azimilide|mesh-list
6342342|NCT00035464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6342343|NCT00035464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6342344|NCT00035464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6342345|NCT00035464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342346|NCT00035464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6342347|NCT00035464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342348|NCT00035477|Azimilide|azimilide|mesh-list
6342349|NCT00035477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6342350|NCT00035477|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6342351|NCT00035477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6342352|NCT00035477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342353|NCT00035477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6342354|NCT00035477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342355|NCT00035490|Azimilide|azimilide|mesh-list
6342356|NCT00035490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6342357|NCT00035490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6342358|NCT00035490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6342359|NCT00035490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342360|NCT00035490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6342361|NCT00035490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342362|NCT00035516|Epothilones|epothilones|mesh-list
6342363|NCT00035516|Tubulin Modulators|tubulin modulators|mesh-ancestor
6342364|NCT00035516|Antimitotic Agents|antimitotic agents|mesh-ancestor
6342365|NCT00035516|Mitosis Modulators|mitosis modulators|mesh-ancestor
6342366|NCT00035516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342367|NCT00035516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6342368|NCT00035581|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
6342369|NCT00035581|Poly I-C|poly i-c|mesh-list
6342370|NCT00035581|Antiviral Agents|antiviral agents|mesh-ancestor
6342371|NCT00035581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6342372|NCT00035581|Interferon Inducers|interferon inducers|mesh-ancestor
6342373|NCT00035581|Immunologic Factors|immunologic factors|mesh-ancestor
6342374|NCT00035581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342375|NCT00035607|Darbepoetin alfa|darbepoetin alfa|mesh-list
6342376|NCT00035607|Hematinics|hematinics|mesh-ancestor
6342377|NCT00035620|Lenograstim|lenograstim|mesh-list
6342378|NCT00035620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6342379|NCT00035620|Immunologic Factors|immunologic factors|mesh-ancestor
6342380|NCT00035620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342381|NCT00035802|Topiramate|topiramate|mesh-list
6342382|NCT00035802|Anticonvulsants|anticonvulsants|mesh-ancestor
6342383|NCT00035802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6342384|NCT00035802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342385|NCT00035854|Linezolid|linezolid|mesh-list
6342386|NCT00035854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6342387|NCT00035854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6342388|NCT00035854|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6342389|NCT00035854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6342390|NCT00035854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342391|NCT00035893|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
6342392|NCT00035893|Poly I-C|poly i-c|mesh-list
6342393|NCT00035893|Antiviral Agents|antiviral agents|mesh-ancestor
6342394|NCT00035893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6342395|NCT00035893|Interferon Inducers|interferon inducers|mesh-ancestor
6342396|NCT00035893|Immunologic Factors|immunologic factors|mesh-ancestor
6342397|NCT00035893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342398|NCT00035958|Prednisone|prednisone|mesh-list
6342399|NCT00035958|Etanercept|etanercept|mesh-list
6342400|NCT00035958|Methotrexate|methotrexate|mesh-list
6342401|NCT00035958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6342402|NCT00035958|Glucocorticoids|glucocorticoids|mesh-ancestor
6342403|NCT00035958|Hormones|hormones|mesh-ancestor
6342404|NCT00035958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6342405|NCT00035958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342406|NCT00035958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6342407|NCT00035958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6342408|NCT00035958|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6342409|NCT00035958|Abortifacient Agents|abortifacient agents|mesh-ancestor
6342410|NCT00035958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6342411|NCT00035958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6342412|NCT00035958|Antimetabolites|antimetabolites|mesh-ancestor
6342413|NCT00035958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342414|NCT00035958|Dermatologic Agents|dermatologic agents|mesh-ancestor
6342415|NCT00035958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6342416|NCT00035958|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6342417|NCT00035958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6342418|NCT00035958|Immunologic Factors|immunologic factors|mesh-ancestor
6342419|NCT00035958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6342420|NCT00035958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6342421|NCT00035958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6342422|NCT00035958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6342423|NCT00035958|Analgesics|analgesics|mesh-ancestor
6342424|NCT00035958|Sensory System Agents|sensory system agents|mesh-ancestor
6342425|NCT00035958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6342426|NCT00035958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6342427|NCT00035971|Alendronate|alendronate|mesh-list
6342428|NCT00035971|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
6342429|NCT00035971|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6342430|NCT00035971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342431|NCT00035971|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6342432|NCT00035971|Hormone Antagonists|hormone antagonists|mesh-ancestor
6342433|NCT00035971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6342434|NCT00035971|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6342435|NCT00035971|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6342436|NCT00035984|Exenatide|exenatide|mesh-list
6342437|NCT00035984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6342438|NCT00035984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342439|NCT00035984|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6342440|NCT00035984|Incretins|incretins|mesh-ancestor
6342441|NCT00035984|Hormones|hormones|mesh-ancestor
6342442|NCT00035984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6342443|NCT00035997|Zoledronic Acid|zoledronic acid|mesh-list
6342444|NCT00035997|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6342445|NCT00035997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342446|NCT00036023|Darbepoetin alfa|darbepoetin alfa|mesh-list
6342447|NCT00036023|Hematinics|hematinics|mesh-ancestor
6342448|NCT00036062|Sivelestat|sivelestat|mesh-list
6342449|NCT00036062|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6342450|NCT00036062|Protease Inhibitors|protease inhibitors|mesh-ancestor
6342451|NCT00036062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6342452|NCT00036062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342453|NCT00036088|Olanzapine|olanzapine|mesh-list
6342454|NCT00036088|Antiemetics|antiemetics|mesh-ancestor
6342455|NCT00036088|Autonomic Agents|autonomic agents|mesh-ancestor
6342456|NCT00036088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6342457|NCT00036088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342458|NCT00036088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6342459|NCT00036088|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6342460|NCT00036088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6342461|NCT00036088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6342462|NCT00036088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6342463|NCT00036088|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6342464|NCT00036088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6342465|NCT00036088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6342466|NCT00036088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342467|NCT00036088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6342468|NCT00036088|Serotonin Agents|serotonin agents|mesh-ancestor
6342469|NCT00036101|Aripiprazole|aripiprazole|mesh-list
6342470|NCT00036101|Antidepressive Agents|antidepressive agents|mesh-ancestor
6342471|NCT00036101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6342472|NCT00036101|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6342473|NCT00036101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6342474|NCT00036101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6342475|NCT00036101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342476|NCT00036101|Dopamine Agonists|dopamine agonists|mesh-ancestor
6342477|NCT00036101|Dopamine Agents|dopamine agents|mesh-ancestor
6342478|NCT00036101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6342479|NCT00036101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342480|NCT00036101|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6342481|NCT00036101|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6342482|NCT00036101|Serotonin Agents|serotonin agents|mesh-ancestor
6342483|NCT00036101|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6342484|NCT00036101|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6342485|NCT00036101|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6342486|NCT00036101|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6342487|NCT00036114|Aripiprazole|aripiprazole|mesh-list
6342488|NCT00036114|Antidepressive Agents|antidepressive agents|mesh-ancestor
6342489|NCT00036114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6342490|NCT00036114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6342491|NCT00036114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6342492|NCT00036114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6342493|NCT00036114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342494|NCT00036114|Dopamine Agonists|dopamine agonists|mesh-ancestor
6342495|NCT00036114|Dopamine Agents|dopamine agents|mesh-ancestor
6342496|NCT00036114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6342497|NCT00036114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342498|NCT00036114|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6342499|NCT00036114|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6342500|NCT00036114|Serotonin Agents|serotonin agents|mesh-ancestor
6342501|NCT00036114|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6342502|NCT00036114|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6342503|NCT00036114|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6342504|NCT00036114|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6342505|NCT00036127|Aripiprazole|aripiprazole|mesh-list
6342506|NCT00036127|Antidepressive Agents|antidepressive agents|mesh-ancestor
6342507|NCT00036127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6342508|NCT00036127|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6342509|NCT00036127|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6342510|NCT00036127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6342511|NCT00036127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342512|NCT00036127|Dopamine Agonists|dopamine agonists|mesh-ancestor
6342513|NCT00036127|Dopamine Agents|dopamine agents|mesh-ancestor
6342514|NCT00036127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6342515|NCT00036127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342516|NCT00036127|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6342517|NCT00036127|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6342518|NCT00036127|Serotonin Agents|serotonin agents|mesh-ancestor
6342519|NCT00036127|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6342520|NCT00036127|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6342521|NCT00036127|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6342522|NCT00036127|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6342523|NCT00036153|Methotrexate|methotrexate|mesh-list
6342524|NCT00036153|Tacrolimus|tacrolimus|mesh-list
6342525|NCT00036153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6342526|NCT00036153|Abortifacient Agents|abortifacient agents|mesh-ancestor
6342527|NCT00036153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6342528|NCT00036153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6393787|NCT00199771|Blood Substitutes|blood substitutes|mesh-ancestor
6342529|NCT00036153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6342530|NCT00036153|Antimetabolites|antimetabolites|mesh-ancestor
6342531|NCT00036153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342532|NCT00036153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6342533|NCT00036153|Dermatologic Agents|dermatologic agents|mesh-ancestor
6342534|NCT00036153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6342535|NCT00036153|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6342536|NCT00036153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6342537|NCT00036153|Immunologic Factors|immunologic factors|mesh-ancestor
6342538|NCT00036153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6342539|NCT00036153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6342540|NCT00036153|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6342541|NCT00036166|Micafungin|micafungin|mesh-list
6342542|NCT00036166|Antifungal Agents|antifungal agents|mesh-ancestor
6342543|NCT00036166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6342544|NCT00036179|Micafungin|micafungin|mesh-list
6342545|NCT00036179|Antifungal Agents|antifungal agents|mesh-ancestor
6342546|NCT00036179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6342547|NCT00036218|Ropinirole|ropinirole|mesh-list
6342548|NCT00036218|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6342549|NCT00036218|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6342550|NCT00036218|Dopamine Agonists|dopamine agonists|mesh-ancestor
6342551|NCT00036218|Dopamine Agents|dopamine agents|mesh-ancestor
6342552|NCT00036218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6342553|NCT00036218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342554|NCT00036218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342555|NCT00036231|Secretin|secretin|mesh-list
6342556|NCT00036231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6342557|NCT00036231|Hormones|hormones|mesh-ancestor
6342558|NCT00036231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6342559|NCT00036231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342560|NCT00036244|Secretin|secretin|mesh-list
6342561|NCT00036244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6342562|NCT00036244|Hormones|hormones|mesh-ancestor
6342563|NCT00036244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6342564|NCT00036244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342565|NCT00036283|Celecoxib|celecoxib|mesh-list
6342566|NCT00036283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6342567|NCT00036283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6342568|NCT00036283|Analgesics|analgesics|mesh-ancestor
6342569|NCT00036283|Sensory System Agents|sensory system agents|mesh-ancestor
6342570|NCT00036283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6342571|NCT00036283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342572|NCT00036283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6342573|NCT00036283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6342574|NCT00036283|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6342575|NCT00036283|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6342576|NCT00036283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6342577|NCT00036283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342578|NCT00036309|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6342579|NCT00036309|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6342580|NCT00036309|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6342581|NCT00036309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6342582|NCT00036309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342583|NCT00036309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6342584|NCT00036309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342585|NCT00036309|Analgesics|analgesics|mesh-ancestor
6342586|NCT00036309|Sensory System Agents|sensory system agents|mesh-ancestor
6342587|NCT00036309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6342588|NCT00036309|Antidepressive Agents|antidepressive agents|mesh-ancestor
6342589|NCT00036309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6342590|NCT00036309|Dopamine Agents|dopamine agents|mesh-ancestor
6342591|NCT00036335|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6342592|NCT00036335|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6342593|NCT00036335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6342594|NCT00036335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6342595|NCT00036335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342596|NCT00036335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6342597|NCT00036335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342598|NCT00036335|Analgesics|analgesics|mesh-ancestor
6342599|NCT00036335|Sensory System Agents|sensory system agents|mesh-ancestor
6342600|NCT00036335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6342601|NCT00036335|Antidepressive Agents|antidepressive agents|mesh-ancestor
6342602|NCT00036335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6342603|NCT00036335|Dopamine Agents|dopamine agents|mesh-ancestor
6342604|NCT00036348|Aripiprazole|aripiprazole|mesh-list
6342605|NCT00036348|Antidepressive Agents|antidepressive agents|mesh-ancestor
6342606|NCT00036348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6342607|NCT00036348|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6342608|NCT00036348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6342609|NCT00036348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6342610|NCT00036348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342611|NCT00036348|Dopamine Agonists|dopamine agonists|mesh-ancestor
6342612|NCT00036348|Dopamine Agents|dopamine agents|mesh-ancestor
6342613|NCT00036348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6342614|NCT00036348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342615|NCT00036348|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6342616|NCT00036348|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6342617|NCT00036348|Serotonin Agents|serotonin agents|mesh-ancestor
6342618|NCT00036348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6342619|NCT00036348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6342620|NCT00036348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6342621|NCT00036348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6342622|NCT00036361|Aripiprazole|aripiprazole|mesh-list
6342623|NCT00036361|Antidepressive Agents|antidepressive agents|mesh-ancestor
6342624|NCT00036361|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6342625|NCT00036361|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6342626|NCT00036361|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6342627|NCT00036361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6342628|NCT00036361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342629|NCT00036361|Dopamine Agonists|dopamine agonists|mesh-ancestor
6342630|NCT00036361|Dopamine Agents|dopamine agents|mesh-ancestor
6342631|NCT00036361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6342632|NCT00036361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342633|NCT00036361|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6342634|NCT00036361|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6342635|NCT00036361|Serotonin Agents|serotonin agents|mesh-ancestor
6342636|NCT00036361|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6342637|NCT00036361|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6342638|NCT00036361|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6342639|NCT00036361|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6342640|NCT00036374|Infliximab|infliximab|mesh-list
6342641|NCT00036374|Dermatologic Agents|dermatologic agents|mesh-ancestor
6342642|NCT00036374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6342643|NCT00036374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6342644|NCT00036387|Infliximab|infliximab|mesh-list
6342645|NCT00036387|Dermatologic Agents|dermatologic agents|mesh-ancestor
6342646|NCT00036387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6342647|NCT00036387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6342648|NCT00036400|Epoetin Alfa|epoetin alfa|mesh-list
6342649|NCT00036400|Hematinics|hematinics|mesh-ancestor
6342650|NCT00036439|Infliximab|infliximab|mesh-list
6342651|NCT00036439|Dermatologic Agents|dermatologic agents|mesh-ancestor
6342652|NCT00036439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6342653|NCT00036439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6342654|NCT00036452|Ritonavir|ritonavir|mesh-list
6342655|NCT00036452|Lopinavir|lopinavir|mesh-list
6342656|NCT00036452|Tenofovir|tenofovir|mesh-list
6342657|NCT00036452|Emtricitabine|emtricitabine|mesh-list
6342658|NCT00036452|Stavudine|stavudine|mesh-list
6342659|NCT00036452|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6342660|NCT00036452|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6342661|NCT00036452|Protease Inhibitors|protease inhibitors|mesh-ancestor
6342662|NCT00036452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6342663|NCT00036452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342664|NCT00036452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6342665|NCT00036452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6342666|NCT00036452|Antiviral Agents|antiviral agents|mesh-ancestor
6342667|NCT00036452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6342668|NCT00036452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6342669|NCT00036452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6342670|NCT00036452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6342671|NCT00036452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6342672|NCT00036452|Antimetabolites|antimetabolites|mesh-ancestor
6342673|NCT00036491|Rituximab|rituximab|mesh-list
6342674|NCT00036491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6342675|NCT00036491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6342676|NCT00036491|Immunologic Factors|immunologic factors|mesh-ancestor
6342677|NCT00036491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342678|NCT00036491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6342679|NCT00036504|Insulin Lispro|insulin lispro|mesh-list
6342680|NCT00036504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6342681|NCT00036504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342682|NCT00036543|Atrasentan|atrasentan|mesh-list
6342683|NCT00036543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6342684|NCT00036543|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
6342685|NCT00036543|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6342686|NCT00036543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342687|NCT00036556|Atrasentan|atrasentan|mesh-list
6342688|NCT00036556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6342689|NCT00036556|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
6342690|NCT00036556|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6342691|NCT00036556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342692|NCT00036582|Clozapine|clozapine|mesh-list
6342693|NCT00036582|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6342694|NCT00036582|Serotonin Agents|serotonin agents|mesh-ancestor
6342695|NCT00036582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6342696|NCT00036582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342697|NCT00036582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342698|NCT00036582|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6342699|NCT00036582|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6342700|NCT00036582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6342701|NCT00036582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6342702|NCT00036582|GABA Antagonists|gaba antagonists|mesh-ancestor
6342703|NCT00036582|GABA Agents|gaba agents|mesh-ancestor
6342704|NCT00036634|Tenofovir|tenofovir|mesh-list
6342705|NCT00036634|Antiviral Agents|antiviral agents|mesh-ancestor
6342706|NCT00036634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6342707|NCT00036634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6342708|NCT00036634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6342709|NCT00036634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6342710|NCT00036634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342711|NCT00036634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6342712|NCT00036634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6342713|NCT00036647|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6342714|NCT00036647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6342715|NCT00036647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6342716|NCT00036647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6342717|NCT00036647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393788|NCT00199784|Phenylephrine|phenylephrine|mesh-list
6393789|NCT00199784|Oxymetazoline|oxymetazoline|mesh-list
6393790|NCT00199784|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6393791|NCT00199784|Mydriatics|mydriatics|mesh-ancestor
6393792|NCT00199784|Autonomic Agents|autonomic agents|mesh-ancestor
6393793|NCT00199784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6393794|NCT00199784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6393795|NCT00199784|Sympathomimetics|sympathomimetics|mesh-ancestor
6393796|NCT00199784|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6393797|NCT00199784|Nasal Decongestants|nasal decongestants|mesh-ancestor
6393798|NCT00199784|Respiratory System Agents|respiratory system agents|mesh-ancestor
6393799|NCT00199784|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6393800|NCT00199784|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6393801|NCT00199784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6393802|NCT00199784|Adrenergic Agents|adrenergic agents|mesh-ancestor
6393803|NCT00199784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6393804|NCT00199784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393805|NCT00199784|Protective Agents|protective agents|mesh-ancestor
6393806|NCT00199862|Antibodies|antibodies|mesh-list
6393807|NCT00199862|Immunologic Factors|immunologic factors|mesh-ancestor
6393808|NCT00199862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6393809|NCT00199940|Ziprasidone|ziprasidone|mesh-list
6393810|NCT00199940|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6393811|NCT00199940|Serotonin Agents|serotonin agents|mesh-ancestor
6393812|NCT00199940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6393813|NCT00199940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393814|NCT00199940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6393815|NCT00199940|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6393816|NCT00199940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6393817|NCT00199940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6393818|NCT00199940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6393819|NCT00199940|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6393820|NCT00199940|Dopamine Agents|dopamine agents|mesh-ancestor
6393821|NCT00199953|Rabeprazole|rabeprazole|mesh-list
6393822|NCT00199953|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6393823|NCT00199953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6393824|NCT00199953|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6393825|NCT00199953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6393826|NCT00199953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393827|NCT00199966|Valproic Acid|valproic acid|mesh-list
6393828|NCT00199966|Anticonvulsants|anticonvulsants|mesh-ancestor
6393829|NCT00199966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6393830|NCT00199966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393831|NCT00199966|GABA Agents|gaba agents|mesh-ancestor
6393832|NCT00199966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6393833|NCT00199966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6393834|NCT00199966|Antimanic Agents|antimanic agents|mesh-ancestor
6393835|NCT00199966|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6342718|NCT00036751|Imatinib Mesylate|imatinib mesylate|mesh-list
6342719|NCT00036751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6342720|NCT00036751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6342721|NCT00036751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6342722|NCT00036751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342723|NCT00036764|Epothilones|epothilones|mesh-list
6342724|NCT00036764|Epothilone B|epothilone b|mesh-list
6342725|NCT00036764|Tubulin Modulators|tubulin modulators|mesh-ancestor
6342726|NCT00036764|Antimitotic Agents|antimitotic agents|mesh-ancestor
6342727|NCT00036764|Mitosis Modulators|mitosis modulators|mesh-ancestor
6342728|NCT00036764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342729|NCT00036764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6342730|NCT00036777|Carboplatin|carboplatin|mesh-list
6342731|NCT00036777|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
6342732|NCT00036777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6342733|NCT00036777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6342734|NCT00036777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6342735|NCT00036777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342736|NCT00036790|Doxorubicin|doxorubicin|mesh-list
6342737|NCT00036790|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6342738|NCT00036790|Motexafin gadolinium|motexafin gadolinium|mesh-list
6342739|NCT00036790|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6342740|NCT00036790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6342741|NCT00036790|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6342742|NCT00036790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6342743|NCT00036790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6342744|NCT00036790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342745|NCT00036790|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6342746|NCT00036790|Dermatologic Agents|dermatologic agents|mesh-ancestor
6342747|NCT00036842|Arsenic Trioxide|arsenic trioxide|mesh-list
6342748|NCT00036842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6342749|NCT00036855|Rituximab|rituximab|mesh-list
6342750|NCT00036855|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6342751|NCT00036855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6342752|NCT00036855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6342753|NCT00036855|Immunologic Factors|immunologic factors|mesh-ancestor
6342754|NCT00036855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342755|NCT00036855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6342756|NCT00036868|Cyclophosphamide|cyclophosphamide|mesh-list
6342757|NCT00036868|Fluorouracil|fluorouracil|mesh-list
6342758|NCT00036868|Methotrexate|methotrexate|mesh-list
6342759|NCT00036868|Trastuzumab|trastuzumab|mesh-list
6342760|NCT00036868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6342761|NCT00036868|Immunologic Factors|immunologic factors|mesh-ancestor
6342762|NCT00036868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342763|NCT00036868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6342764|NCT00036868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6342765|NCT00036868|Alkylating Agents|alkylating agents|mesh-ancestor
6342766|NCT00036868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342767|NCT00036868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6342768|NCT00036868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6342769|NCT00036868|Antimetabolites|antimetabolites|mesh-ancestor
6342770|NCT00036868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6342771|NCT00036868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6342772|NCT00036868|Abortifacient Agents|abortifacient agents|mesh-ancestor
6342773|NCT00036868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6342774|NCT00036868|Dermatologic Agents|dermatologic agents|mesh-ancestor
6342775|NCT00036868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6342776|NCT00036868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6342777|NCT00036868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6342778|NCT00036868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6342779|NCT00036881|Zinc Sulfate|zinc sulfate|mesh-list
6342780|NCT00036881|Astringents|astringents|mesh-ancestor
6342781|NCT00036881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342782|NCT00036881|Dermatologic Agents|dermatologic agents|mesh-ancestor
6342783|NCT00036894|Lenalidomide|lenalidomide|mesh-list
6342784|NCT00036894|Immunologic Factors|immunologic factors|mesh-ancestor
6342785|NCT00036894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342786|NCT00036894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6342787|NCT00036894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6342788|NCT00036894|Growth Substances|growth substances|mesh-ancestor
6342789|NCT00036894|Growth Inhibitors|growth inhibitors|mesh-ancestor
6342790|NCT00036894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6342791|NCT00036946|Aflibercept|aflibercept|mesh-list
6342792|NCT00036946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6396967|NCT00209885|Anesthetics, Local|anesthetics, local|mesh-ancestor
6342793|NCT00036946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6342794|NCT00036946|Growth Substances|growth substances|mesh-ancestor
6342795|NCT00036946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342796|NCT00036946|Growth Inhibitors|growth inhibitors|mesh-ancestor
6342797|NCT00036946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6342798|NCT00036985|Cyclophosphamide|cyclophosphamide|mesh-list
6342799|NCT00036985|Doxorubicin|doxorubicin|mesh-list
6342800|NCT00036985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6342801|NCT00036985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6342802|NCT00036985|Immunologic Factors|immunologic factors|mesh-ancestor
6342803|NCT00036985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342804|NCT00036985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6342805|NCT00036985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6342806|NCT00036985|Alkylating Agents|alkylating agents|mesh-ancestor
6342807|NCT00036985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342808|NCT00036985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6342809|NCT00036985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6342810|NCT00036985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6342811|NCT00036985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6342812|NCT00036985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6342813|NCT00036985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6342814|NCT00037011|Antibodies|antibodies|mesh-list
6342815|NCT00037011|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6342816|NCT00037011|Immunologic Factors|immunologic factors|mesh-ancestor
6342817|NCT00037011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342818|NCT00037037|Sargramostim|sargramostim|mesh-list
6342819|NCT00037037|Immunologic Factors|immunologic factors|mesh-ancestor
6342820|NCT00037037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342821|NCT00037050|Vancomycin|vancomycin|mesh-list
6342822|NCT00037050|Linezolid|linezolid|mesh-list
6342823|NCT00037050|Oxacillin|oxacillin|mesh-list
6342824|NCT00037050|Dicloxacillin|dicloxacillin|mesh-list
6342825|NCT00037050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6342826|NCT00037050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6342827|NCT00037050|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6342828|NCT00037050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6342829|NCT00037050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342830|NCT00037063|Ascorbic Acid|ascorbic acid|mesh-list
6342831|NCT00037063|Vitamin E|vitamin e|mesh-list
6342832|NCT00037063|Riboflavin|riboflavin|mesh-list
6342833|NCT00037063|Thiamine|thiamine|mesh-list
6342834|NCT00037063|Vitamins|vitamins|mesh-ancestor
6342835|NCT00037063|Micronutrients|micronutrients|mesh-ancestor
6342836|NCT00037063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342837|NCT00037063|Antioxidants|antioxidants|mesh-ancestor
6342838|NCT00037063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342839|NCT00037063|Protective Agents|protective agents|mesh-ancestor
6342840|NCT00037063|Vitamin B Complex|vitamin b complex|mesh-ancestor
6342841|NCT00037063|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6342842|NCT00037063|Dermatologic Agents|dermatologic agents|mesh-ancestor
6342843|NCT00037089|Tegafur|tegafur|mesh-list
6342844|NCT00037089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6342845|NCT00037089|Antimetabolites|antimetabolites|mesh-ancestor
6342846|NCT00037089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342847|NCT00037089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6342848|NCT00037102|Interferons|interferons|mesh-list
6342849|NCT00037102|Interferon-beta|interferon-beta|mesh-list
6342850|NCT00037102|Interferon beta-1a|interferon beta-1a|mesh-list
6342851|NCT00037102|Methotrexate|methotrexate|mesh-list
6342852|NCT00037102|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6342853|NCT00037102|Abortifacient Agents|abortifacient agents|mesh-ancestor
6342854|NCT00037102|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6342855|NCT00037102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342856|NCT00037102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6342857|NCT00037102|Antimetabolites|antimetabolites|mesh-ancestor
6342858|NCT00037102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342859|NCT00037102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6342860|NCT00037102|Dermatologic Agents|dermatologic agents|mesh-ancestor
6342861|NCT00037102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6342862|NCT00037102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6342863|NCT00037102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6342864|NCT00037102|Immunologic Factors|immunologic factors|mesh-ancestor
6342865|NCT00037102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6342866|NCT00037102|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6342867|NCT00037102|Antiviral Agents|antiviral agents|mesh-ancestor
6342868|NCT00037102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6342869|NCT00037102|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6342870|NCT00037115|Interferons|interferons|mesh-list
6342871|NCT00037115|Interferon-beta|interferon-beta|mesh-list
6342872|NCT00037115|Interferon beta-1a|interferon beta-1a|mesh-list
6342873|NCT00037115|Methylprednisolone|methylprednisolone|mesh-list
6342874|NCT00037115|Methotrexate|methotrexate|mesh-list
6342875|NCT00037115|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6342876|NCT00037115|Abortifacient Agents|abortifacient agents|mesh-ancestor
6342877|NCT00037115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6342878|NCT00037115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342879|NCT00037115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6342880|NCT00037115|Antimetabolites|antimetabolites|mesh-ancestor
6342881|NCT00037115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342882|NCT00037115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6342883|NCT00037115|Dermatologic Agents|dermatologic agents|mesh-ancestor
6342884|NCT00037115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6342885|NCT00037115|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6342886|NCT00037115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6342887|NCT00037115|Immunologic Factors|immunologic factors|mesh-ancestor
6342888|NCT00037115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6342889|NCT00037115|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6342890|NCT00037115|Antiviral Agents|antiviral agents|mesh-ancestor
6342891|NCT00037115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6342892|NCT00037115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6342893|NCT00037115|Antiemetics|antiemetics|mesh-ancestor
6342894|NCT00037115|Autonomic Agents|autonomic agents|mesh-ancestor
6342895|NCT00037115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6342896|NCT00037115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6342897|NCT00037115|Glucocorticoids|glucocorticoids|mesh-ancestor
6342898|NCT00037115|Hormones|hormones|mesh-ancestor
6342899|NCT00037115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6342900|NCT00037115|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6342901|NCT00037115|Protective Agents|protective agents|mesh-ancestor
6342902|NCT00037115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6342903|NCT00037154|Saw palmetto extract|saw palmetto extract|mesh-list
6342904|NCT00037154|Urological Agents|urological agents|mesh-ancestor
6342905|NCT00037180|Leucovorin|leucovorin|mesh-list
6342906|NCT00037180|Celecoxib|celecoxib|mesh-list
6342907|NCT00037180|Fluorouracil|fluorouracil|mesh-list
6342908|NCT00037180|Irinotecan|irinotecan|mesh-list
6342909|NCT00037180|Antimetabolites|antimetabolites|mesh-ancestor
6342910|NCT00037180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342911|NCT00037180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6342912|NCT00037180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6342913|NCT00037180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6342914|NCT00037180|Immunologic Factors|immunologic factors|mesh-ancestor
6342915|NCT00037180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342916|NCT00037180|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6342917|NCT00037180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6342918|NCT00037180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6342919|NCT00037180|Antidotes|antidotes|mesh-ancestor
6342920|NCT00037180|Protective Agents|protective agents|mesh-ancestor
6342921|NCT00037180|Vitamin B Complex|vitamin b complex|mesh-ancestor
6342922|NCT00037180|Vitamins|vitamins|mesh-ancestor
6342923|NCT00037180|Micronutrients|micronutrients|mesh-ancestor
6342924|NCT00037180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6342925|NCT00037180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6342926|NCT00037180|Analgesics|analgesics|mesh-ancestor
6342927|NCT00037180|Sensory System Agents|sensory system agents|mesh-ancestor
6342928|NCT00037180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6342929|NCT00037180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6342930|NCT00037180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6342931|NCT00037180|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6342932|NCT00037180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6342933|NCT00037206|Anidulafungin|anidulafungin|mesh-list
6342934|NCT00037206|Antifungal Agents|antifungal agents|mesh-ancestor
6342935|NCT00037206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6342936|NCT00037219|Anidulafungin|anidulafungin|mesh-list
6342937|NCT00037219|Antifungal Agents|antifungal agents|mesh-ancestor
6342938|NCT00037219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6342939|NCT00037479|Ceftriaxone|ceftriaxone|mesh-list
6342940|NCT00037479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6342941|NCT00037479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6342942|NCT00037518|Cinacalcet|cinacalcet|mesh-list
6342943|NCT00037518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6342944|NCT00037518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342945|NCT00037518|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6342946|NCT00037518|Hormone Antagonists|hormone antagonists|mesh-ancestor
6342947|NCT00037518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6342948|NCT00037531|Sirolimus|sirolimus|mesh-list
6342949|NCT00037531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6342950|NCT00037531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6342951|NCT00037531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6342952|NCT00037531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6342953|NCT00037531|Antifungal Agents|antifungal agents|mesh-ancestor
6342954|NCT00037531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6342955|NCT00037531|Immunologic Factors|immunologic factors|mesh-ancestor
6342956|NCT00037531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342957|NCT00037544|Factor VIII|factor viii|mesh-list
6342958|NCT00037544|Coagulants|coagulants|mesh-ancestor
6342959|NCT00037570|Pantoprazole|pantoprazole|mesh-list
6342960|NCT00037570|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6342961|NCT00037570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6342962|NCT00037570|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6342963|NCT00037570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6342964|NCT00037570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342965|NCT00037583|Gemtuzumab|gemtuzumab|mesh-list
6342966|NCT00037583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6342967|NCT00037583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6342968|NCT00037596|Cytarabine|cytarabine|mesh-list
6342969|NCT00037596|Gemtuzumab|gemtuzumab|mesh-list
6342970|NCT00037596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6342971|NCT00037596|Antimetabolites|antimetabolites|mesh-ancestor
6342972|NCT00037596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342973|NCT00037596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6342974|NCT00037596|Antiviral Agents|antiviral agents|mesh-ancestor
6342975|NCT00037596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6342976|NCT00037596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6342977|NCT00037596|Immunologic Factors|immunologic factors|mesh-ancestor
6342978|NCT00037596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342979|NCT00037596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6342980|NCT00037609|Sulindac sulfone|sulindac sulfone|mesh-list
6342981|NCT00037609|Capecitabine|capecitabine|mesh-list
6342982|NCT00037609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6342983|NCT00037609|Antimetabolites|antimetabolites|mesh-ancestor
6342984|NCT00037609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6342985|NCT00037609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6342986|NCT00037609|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6342987|NCT00037609|Protective Agents|protective agents|mesh-ancestor
6342988|NCT00037609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6342989|NCT00037609|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6342990|NCT00037609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6342991|NCT00037609|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6342992|NCT00037609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6342993|NCT00037609|Analgesics|analgesics|mesh-ancestor
6342994|NCT00037609|Sensory System Agents|sensory system agents|mesh-ancestor
6342995|NCT00037609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6342996|NCT00037609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6342997|NCT00037609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6342998|NCT00037622|Dexelvucitabine|dexelvucitabine|mesh-list
6342999|NCT00037622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6343000|NCT00037622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6343001|NCT00037622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6343002|NCT00037622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343003|NCT00037622|Antiviral Agents|antiviral agents|mesh-ancestor
6343004|NCT00037622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6343005|NCT00037622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6343006|NCT00037622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6343007|NCT00037635|Cinacalcet|cinacalcet|mesh-list
6343008|NCT00037635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6343009|NCT00037635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6343010|NCT00037635|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6343011|NCT00037635|Hormone Antagonists|hormone antagonists|mesh-ancestor
6343012|NCT00037635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6343013|NCT00037648|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6343014|NCT00037648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6343015|NCT00037661|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6343016|NCT00037661|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6343017|NCT00037674|Topiramate|topiramate|mesh-list
6343018|NCT00037674|Anticonvulsants|anticonvulsants|mesh-ancestor
6343019|NCT00037674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6343020|NCT00037674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6343021|NCT00037700|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6343022|NCT00037700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6343023|NCT00037752|Sibutramine|sibutramine|mesh-list
6343024|NCT00037752|Antidepressive Agents|antidepressive agents|mesh-ancestor
6343025|NCT00037752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6343026|NCT00037752|Appetite Depressants|appetite depressants|mesh-ancestor
6343027|NCT00037752|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6343028|NCT00037804|Irinotecan|irinotecan|mesh-list
6343029|NCT00037804|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6343030|NCT00037804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6343031|NCT00037804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6343032|NCT00037804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343033|NCT00037804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343034|NCT00037817|Celecoxib|celecoxib|mesh-list
6343035|NCT00037817|Decitabine|decitabine|mesh-list
6343036|NCT00037817|Romidepsin|romidepsin|mesh-list
6343037|NCT00037817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6343038|NCT00037817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6343039|NCT00037817|Analgesics|analgesics|mesh-ancestor
6343040|NCT00037817|Sensory System Agents|sensory system agents|mesh-ancestor
6343041|NCT00037817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6343042|NCT00037817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6343043|NCT00037817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6343044|NCT00037817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6343045|NCT00037817|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6343046|NCT00037817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6343047|NCT00037817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6343048|NCT00037817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343049|NCT00037817|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6343050|NCT00037817|Antimetabolites|antimetabolites|mesh-ancestor
6343051|NCT00037817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343052|NCT00037817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6343053|NCT00037869|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
6343054|NCT00037869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343055|NCT00037869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6343056|NCT00037869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343057|NCT00037869|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6343058|NCT00037882|Interferons|interferons|mesh-list
6343059|NCT00037882|Interferon-alpha|interferon-alpha|mesh-list
6343060|NCT00037882|Interferon alpha-2|interferon alpha-2|mesh-list
6343061|NCT00037882|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6343062|NCT00037882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343063|NCT00037882|Antiviral Agents|antiviral agents|mesh-ancestor
6343064|NCT00037882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6343065|NCT00037882|Immunologic Factors|immunologic factors|mesh-ancestor
6343066|NCT00037882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6343067|NCT00037999|Testosterone|testosterone|mesh-list
6343068|NCT00037999|Androgens|androgens|mesh-ancestor
6343069|NCT00037999|Hormones|hormones|mesh-ancestor
6343070|NCT00037999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6343071|NCT00037999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6343072|NCT00038012|Carboplatin|carboplatin|mesh-list
6343073|NCT00038012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343074|NCT00038025|Pentostatin|pentostatin|mesh-list
6343075|NCT00038025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343076|NCT00038025|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
6343077|NCT00038025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6343078|NCT00038025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343079|NCT00038051|Lintuzumab|lintuzumab|mesh-list
6343080|NCT00038051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6343081|NCT00038051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343082|NCT00038064|Darbepoetin alfa|darbepoetin alfa|mesh-list
6343083|NCT00038064|Hematinics|hematinics|mesh-ancestor
6343084|NCT00038077|Metoprolol|metoprolol|mesh-list
6343085|NCT00038077|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6343086|NCT00038077|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6343087|NCT00038077|Sympatholytics|sympatholytics|mesh-ancestor
6343088|NCT00038077|Autonomic Agents|autonomic agents|mesh-ancestor
6343089|NCT00038077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6343090|NCT00038077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6343091|NCT00038077|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6343092|NCT00038077|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6343093|NCT00038077|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6343094|NCT00038077|Adrenergic Agents|adrenergic agents|mesh-ancestor
6343095|NCT00038077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6343096|NCT00038077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343097|NCT00038090|Thalidomide|thalidomide|mesh-list
6343098|NCT00038090|Dexamethasone|dexamethasone|mesh-list
6343099|NCT00038090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6343100|NCT00038090|Antiemetics|antiemetics|mesh-ancestor
6343101|NCT00038090|Autonomic Agents|autonomic agents|mesh-ancestor
6343102|NCT00038090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6343103|NCT00038090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6343104|NCT00038090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6343105|NCT00038090|Glucocorticoids|glucocorticoids|mesh-ancestor
6343106|NCT00038090|Hormones|hormones|mesh-ancestor
6343107|NCT00038090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6343108|NCT00038090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6343109|NCT00038090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343110|NCT00038090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6343111|NCT00038090|Immunologic Factors|immunologic factors|mesh-ancestor
6343112|NCT00038090|Leprostatic Agents|leprostatic agents|mesh-ancestor
6343113|NCT00038090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6343114|NCT00038090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6343115|NCT00038090|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6343116|NCT00038090|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6343117|NCT00038090|Growth Substances|growth substances|mesh-ancestor
6343118|NCT00038090|Growth Inhibitors|growth inhibitors|mesh-ancestor
6393836|NCT00199966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6393837|NCT00199966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6393838|NCT00199979|Nevirapine|nevirapine|mesh-list
6393839|NCT00199979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6393840|NCT00199979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6393841|NCT00199979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6393842|NCT00199979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393843|NCT00199979|Antiviral Agents|antiviral agents|mesh-ancestor
6393844|NCT00199979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6393845|NCT00199979|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6393846|NCT00199979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6393847|NCT00199979|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6393848|NCT00199979|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6393849|NCT00200174|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
6393850|NCT00200174|Exemestane|exemestane|mesh-list
6393851|NCT00200174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6393852|NCT00200174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6393853|NCT00200174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6393854|NCT00200174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6393855|NCT00200174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393856|NCT00200174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6393857|NCT00200174|Hormone Antagonists|hormone antagonists|mesh-ancestor
6393858|NCT00200174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6393859|NCT00200174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6393860|NCT00200174|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6393861|NCT00200174|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6393862|NCT00200174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6393863|NCT00200187|Anesthetics|anesthetics|mesh-list
6393864|NCT00200187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6393865|NCT00200187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6393866|NCT00200200|Bevacizumab|bevacizumab|mesh-list
6393867|NCT00200200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6393868|NCT00200200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6393869|NCT00200200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6393870|NCT00200200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6393871|NCT00200200|Growth Substances|growth substances|mesh-ancestor
6393872|NCT00200200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6393873|NCT00200200|Growth Inhibitors|growth inhibitors|mesh-ancestor
6393874|NCT00200226|Vitamin B 6|vitamin b 6|mesh-list
6393875|NCT00200226|Pyridoxal|pyridoxal|mesh-list
6393876|NCT00200226|Pyridoxine|pyridoxine|mesh-list
6393877|NCT00200226|Misoprostol|misoprostol|mesh-list
6393878|NCT00200226|Vitamins|vitamins|mesh-ancestor
6343119|NCT00038116|Dopamine|dopamine|mesh-list
6343120|NCT00038116|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6343121|NCT00038116|Sympathomimetics|sympathomimetics|mesh-ancestor
6343122|NCT00038116|Autonomic Agents|autonomic agents|mesh-ancestor
6343123|NCT00038116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6343124|NCT00038116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6343125|NCT00038116|Dopamine Agents|dopamine agents|mesh-ancestor
6343126|NCT00038116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6343127|NCT00038116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343128|NCT00038116|Protective Agents|protective agents|mesh-ancestor
6343129|NCT00038168|Paclitaxel|paclitaxel|mesh-list
6343130|NCT00038168|Estramustine|estramustine|mesh-list
6343131|NCT00038168|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6343132|NCT00038168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343133|NCT00038168|Tubulin Modulators|tubulin modulators|mesh-ancestor
6343134|NCT00038168|Antimitotic Agents|antimitotic agents|mesh-ancestor
6343135|NCT00038168|Mitosis Modulators|mitosis modulators|mesh-ancestor
6343136|NCT00038168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343137|NCT00038168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6343138|NCT00038168|Alkylating Agents|alkylating agents|mesh-ancestor
6343139|NCT00038168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6343140|NCT00038181|Thalidomide|thalidomide|mesh-list
6343141|NCT00038181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6343142|NCT00038181|Immunologic Factors|immunologic factors|mesh-ancestor
6343143|NCT00038181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6343144|NCT00038181|Leprostatic Agents|leprostatic agents|mesh-ancestor
6343145|NCT00038181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6343146|NCT00038181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6343147|NCT00038181|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6343148|NCT00038181|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6343149|NCT00038181|Growth Substances|growth substances|mesh-ancestor
6343150|NCT00038181|Growth Inhibitors|growth inhibitors|mesh-ancestor
6343151|NCT00038181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343152|NCT00038194|Docetaxel|docetaxel|mesh-list
6343153|NCT00038194|Imatinib Mesylate|imatinib mesylate|mesh-list
6343154|NCT00038194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343155|NCT00038194|Tubulin Modulators|tubulin modulators|mesh-ancestor
6343156|NCT00038194|Antimitotic Agents|antimitotic agents|mesh-ancestor
6343157|NCT00038194|Mitosis Modulators|mitosis modulators|mesh-ancestor
6343158|NCT00038194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343159|NCT00038194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6343160|NCT00038194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6343161|NCT00038207|Vincristine|vincristine|mesh-list
6343162|NCT00038207|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6343163|NCT00038207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343164|NCT00038207|Tubulin Modulators|tubulin modulators|mesh-ancestor
6343165|NCT00038207|Antimitotic Agents|antimitotic agents|mesh-ancestor
6343166|NCT00038207|Mitosis Modulators|mitosis modulators|mesh-ancestor
6343167|NCT00038207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343168|NCT00038220|Ritonavir|ritonavir|mesh-list
6343169|NCT00038220|Lopinavir|lopinavir|mesh-list
6343170|NCT00038220|Tenofovir|tenofovir|mesh-list
6343171|NCT00038220|Lamivudine|lamivudine|mesh-list
6343172|NCT00038220|Efavirenz|efavirenz|mesh-list
6343173|NCT00038220|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6343174|NCT00038220|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6343175|NCT00038220|Protease Inhibitors|protease inhibitors|mesh-ancestor
6343176|NCT00038220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6343177|NCT00038220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343178|NCT00038220|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6343179|NCT00038220|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6343180|NCT00038220|Antiviral Agents|antiviral agents|mesh-ancestor
6343181|NCT00038220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6343182|NCT00038220|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6343183|NCT00038220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6343184|NCT00038220|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6343185|NCT00038220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6343186|NCT00038220|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6343187|NCT00038220|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6343188|NCT00038220|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6343189|NCT00038220|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6343190|NCT00038220|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6343191|NCT00038233|Thalidomide|thalidomide|mesh-list
6343192|NCT00038233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6343193|NCT00038233|Immunologic Factors|immunologic factors|mesh-ancestor
6343194|NCT00038233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6343195|NCT00038233|Leprostatic Agents|leprostatic agents|mesh-ancestor
6343196|NCT00038233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6343197|NCT00038233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6343198|NCT00038233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6343199|NCT00038233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6343200|NCT00038233|Growth Substances|growth substances|mesh-ancestor
6343201|NCT00038233|Growth Inhibitors|growth inhibitors|mesh-ancestor
6343202|NCT00038233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343203|NCT00038246|Thalidomide|thalidomide|mesh-list
6343204|NCT00038246|Paclitaxel|paclitaxel|mesh-list
6343205|NCT00038246|Estramustine|estramustine|mesh-list
6343206|NCT00038246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6343207|NCT00038246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343208|NCT00038246|Tubulin Modulators|tubulin modulators|mesh-ancestor
6343209|NCT00038246|Antimitotic Agents|antimitotic agents|mesh-ancestor
6343210|NCT00038246|Mitosis Modulators|mitosis modulators|mesh-ancestor
6343211|NCT00038246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343212|NCT00038246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6343213|NCT00038246|Immunologic Factors|immunologic factors|mesh-ancestor
6343214|NCT00038246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6343215|NCT00038246|Leprostatic Agents|leprostatic agents|mesh-ancestor
6343216|NCT00038246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6343217|NCT00038246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6343218|NCT00038246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6343219|NCT00038246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6343220|NCT00038246|Growth Substances|growth substances|mesh-ancestor
6343221|NCT00038246|Growth Inhibitors|growth inhibitors|mesh-ancestor
6343222|NCT00038246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6343223|NCT00038246|Alkylating Agents|alkylating agents|mesh-ancestor
6343224|NCT00038246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6343225|NCT00038259|Aldesleukin|aldesleukin|mesh-list
6343226|NCT00038259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343227|NCT00038259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6343228|NCT00038259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6343229|NCT00038259|Antiviral Agents|antiviral agents|mesh-ancestor
6343230|NCT00038259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6343231|NCT00038272|Mycophenolic Acid|mycophenolic acid|mesh-list
6343232|NCT00038272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6343233|NCT00038272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343234|NCT00038272|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6343235|NCT00038272|Antitubercular Agents|antitubercular agents|mesh-ancestor
6343236|NCT00038272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6343237|NCT00038272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6343238|NCT00038272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6343239|NCT00038272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343240|NCT00038376|Interferons|interferons|mesh-list
6343241|NCT00038376|Interferon-alpha|interferon-alpha|mesh-list
6343242|NCT00038376|Interferon alpha-2|interferon alpha-2|mesh-list
6343243|NCT00038376|Isotretinoin|isotretinoin|mesh-list
6343244|NCT00038376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343245|NCT00038376|Antiviral Agents|antiviral agents|mesh-ancestor
6343246|NCT00038376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6343247|NCT00038376|Immunologic Factors|immunologic factors|mesh-ancestor
6343248|NCT00038376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6343249|NCT00038376|Dermatologic Agents|dermatologic agents|mesh-ancestor
6343250|NCT00038389|Rofecoxib|rofecoxib|mesh-list
6343251|NCT00038389|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6343252|NCT00038389|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6343253|NCT00038389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6343254|NCT00038389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343255|NCT00038389|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6343256|NCT00038389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6343257|NCT00038389|Analgesics|analgesics|mesh-ancestor
6343258|NCT00038389|Sensory System Agents|sensory system agents|mesh-ancestor
6343259|NCT00038389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6343260|NCT00038389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6343261|NCT00038389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6343262|NCT00038389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6343263|NCT00038402|Paclitaxel|paclitaxel|mesh-list
6343264|NCT00038402|Cyclophosphamide|cyclophosphamide|mesh-list
6343265|NCT00038402|Fluorouracil|fluorouracil|mesh-list
6343266|NCT00038402|Trastuzumab|trastuzumab|mesh-list
6343267|NCT00038402|Epirubicin|epirubicin|mesh-list
6343268|NCT00038402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6343269|NCT00038402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343270|NCT00038402|Tubulin Modulators|tubulin modulators|mesh-ancestor
6343271|NCT00038402|Antimitotic Agents|antimitotic agents|mesh-ancestor
6343272|NCT00038402|Mitosis Modulators|mitosis modulators|mesh-ancestor
6343273|NCT00038402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343274|NCT00038402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6343275|NCT00038402|Immunologic Factors|immunologic factors|mesh-ancestor
6343276|NCT00038402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6343277|NCT00038402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6343278|NCT00038402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6343279|NCT00038402|Alkylating Agents|alkylating agents|mesh-ancestor
6343280|NCT00038402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6343281|NCT00038402|Antimetabolites|antimetabolites|mesh-ancestor
6343282|NCT00038402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6343283|NCT00038402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6343284|NCT00038402|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6343285|NCT00038402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6343286|NCT00038402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6343287|NCT00038402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6343288|NCT00038480|Ritonavir|ritonavir|mesh-list
6343289|NCT00038480|Lopinavir|lopinavir|mesh-list
6343290|NCT00038480|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6343291|NCT00038480|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6343292|NCT00038480|Protease Inhibitors|protease inhibitors|mesh-ancestor
6343293|NCT00038480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6343294|NCT00038480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343295|NCT00038480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6343296|NCT00038480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6343297|NCT00038480|Antiviral Agents|antiviral agents|mesh-ancestor
6343298|NCT00038480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6343299|NCT00038480|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6343300|NCT00038480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6343301|NCT00038493|Temozolomide|temozolomide|mesh-list
6343302|NCT00038493|Lonafarnib|lonafarnib|mesh-list
6343303|NCT00038493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6343304|NCT00038493|Alkylating Agents|alkylating agents|mesh-ancestor
6343305|NCT00038493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343306|NCT00038493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343307|NCT00038493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6343308|NCT00038506|Tenofovir|tenofovir|mesh-list
6343309|NCT00038506|Lamivudine|lamivudine|mesh-list
6343310|NCT00038506|Zidovudine|zidovudine|mesh-list
6343311|NCT00038506|Abacavir|abacavir|mesh-list
6343312|NCT00038506|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6343313|NCT00038506|Antiviral Agents|antiviral agents|mesh-ancestor
6343314|NCT00038506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6343315|NCT00038506|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6343316|NCT00038506|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6343317|NCT00038506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6343318|NCT00038506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343319|NCT00038506|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6343320|NCT00038506|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6343321|NCT00038506|Antimetabolites|antimetabolites|mesh-ancestor
6343322|NCT00038519|Ritonavir|ritonavir|mesh-list
6343323|NCT00038519|Saquinavir|saquinavir|mesh-list
6343324|NCT00038519|Amprenavir|amprenavir|mesh-list
6343325|NCT00038519|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6343326|NCT00038519|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6343327|NCT00038519|Protease Inhibitors|protease inhibitors|mesh-ancestor
6343328|NCT00038519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6343329|NCT00038519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343330|NCT00038519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6343331|NCT00038519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6343332|NCT00038519|Antiviral Agents|antiviral agents|mesh-ancestor
6343333|NCT00038519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6343334|NCT00038519|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6343335|NCT00038519|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6343336|NCT00038519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6343337|NCT00038519|Antitubercular Agents|antitubercular agents|mesh-ancestor
6343338|NCT00038519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6343339|NCT00038532|Ritonavir|ritonavir|mesh-list
6343340|NCT00038532|Saquinavir|saquinavir|mesh-list
6343341|NCT00038532|Amprenavir|amprenavir|mesh-list
6343342|NCT00038532|Efavirenz|efavirenz|mesh-list
6343343|NCT00038532|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6343344|NCT00038532|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6343345|NCT00038532|Protease Inhibitors|protease inhibitors|mesh-ancestor
6343346|NCT00038532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6393879|NCT00200226|Micronutrients|micronutrients|mesh-ancestor
6343347|NCT00038532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343348|NCT00038532|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6343349|NCT00038532|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6343350|NCT00038532|Antiviral Agents|antiviral agents|mesh-ancestor
6343351|NCT00038532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6343352|NCT00038532|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6343353|NCT00038532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6343354|NCT00038532|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6343355|NCT00038532|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6343356|NCT00038532|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6343357|NCT00038532|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6343358|NCT00038532|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6343359|NCT00038532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6343360|NCT00038532|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6343361|NCT00038532|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6343362|NCT00038532|Antitubercular Agents|antitubercular agents|mesh-ancestor
6343363|NCT00038532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6343364|NCT00038545|Paclitaxel|paclitaxel|mesh-list
6343365|NCT00038545|Topotecan|topotecan|mesh-list
6343366|NCT00038545|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6343367|NCT00038545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343368|NCT00038545|Tubulin Modulators|tubulin modulators|mesh-ancestor
6343369|NCT00038545|Antimitotic Agents|antimitotic agents|mesh-ancestor
6343370|NCT00038545|Mitosis Modulators|mitosis modulators|mesh-ancestor
6343371|NCT00038545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343372|NCT00038545|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6343373|NCT00038545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6343374|NCT00038545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6343375|NCT00038558|Doxorubicin|doxorubicin|mesh-list
6343376|NCT00038558|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6343377|NCT00038558|Bleomycin|bleomycin|mesh-list
6343378|NCT00038558|Dacarbazine|dacarbazine|mesh-list
6343379|NCT00038558|Vinblastine|vinblastine|mesh-list
6343380|NCT00038558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6343381|NCT00038558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343382|NCT00038558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6343383|NCT00038558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6343384|NCT00038558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6343385|NCT00038558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343386|NCT00038558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6343387|NCT00038558|Alkylating Agents|alkylating agents|mesh-ancestor
6343388|NCT00038558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6343389|NCT00038558|Tubulin Modulators|tubulin modulators|mesh-ancestor
6343390|NCT00038558|Antimitotic Agents|antimitotic agents|mesh-ancestor
6343391|NCT00038558|Mitosis Modulators|mitosis modulators|mesh-ancestor
6343392|NCT00038571|Bortezomib|bortezomib|mesh-list
6343393|NCT00038571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343394|NCT00038584|Lonafarnib|lonafarnib|mesh-list
6343395|NCT00038584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6343396|NCT00038584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343397|NCT00038597|Lonafarnib|lonafarnib|mesh-list
6343398|NCT00038597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6343399|NCT00038597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016856|NCT00368459|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6343400|NCT00038623|Rituximab|rituximab|mesh-list
6343401|NCT00038623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6343402|NCT00038623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343403|NCT00038623|Immunologic Factors|immunologic factors|mesh-ancestor
6343404|NCT00038623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6343405|NCT00038623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6343406|NCT00038636|Ritonavir|ritonavir|mesh-list
6343407|NCT00038636|Lopinavir|lopinavir|mesh-list
6343408|NCT00038636|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6343409|NCT00038636|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6343410|NCT00038636|Protease Inhibitors|protease inhibitors|mesh-ancestor
6343411|NCT00038636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6343412|NCT00038636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343413|NCT00038636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6343414|NCT00038636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6343415|NCT00038636|Antiviral Agents|antiviral agents|mesh-ancestor
6343416|NCT00038636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6343417|NCT00038636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6343418|NCT00038636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6343419|NCT00038662|Atrasentan|atrasentan|mesh-list
6343420|NCT00038662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343421|NCT00038662|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
6343422|NCT00038662|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6343423|NCT00038662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343424|NCT00038701|O-(Chloroacetylcarbamoyl)fumagillol|o-(chloroacetylcarbamoyl)fumagillol|mesh-list
6343425|NCT00038701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6343426|NCT00038701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343427|NCT00038701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6343428|NCT00038701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6343429|NCT00038701|Growth Substances|growth substances|mesh-ancestor
6343430|NCT00038701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6343431|NCT00038701|Growth Inhibitors|growth inhibitors|mesh-ancestor
6343432|NCT00038766|Semapimod|semapimod|mesh-list
6343433|NCT00038766|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6343434|NCT00038766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6343435|NCT00038766|Analgesics|analgesics|mesh-ancestor
6343436|NCT00038766|Sensory System Agents|sensory system agents|mesh-ancestor
6343437|NCT00038766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6343438|NCT00038766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6343439|NCT00038766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6343440|NCT00038766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6343441|NCT00038766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6343442|NCT00038766|Immunologic Factors|immunologic factors|mesh-ancestor
6343443|NCT00038792|Mitogens|mitogens|mesh-list
6343444|NCT00038792|Mitosis Modulators|mitosis modulators|mesh-ancestor
6343445|NCT00038792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343446|NCT00038805|Gemtuzumab|gemtuzumab|mesh-list
6343447|NCT00038805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6343448|NCT00038805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343449|NCT00038831|Vidarabine|vidarabine|mesh-list
6343450|NCT00038831|Fludarabine|fludarabine|mesh-list
6343451|NCT00038831|Fludarabine phosphate|fludarabine phosphate|mesh-list
6343452|NCT00038831|Melphalan|melphalan|mesh-list
6343453|NCT00038831|Gemtuzumab|gemtuzumab|mesh-list
6343454|NCT00038831|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6343455|NCT00038831|Thymoglobulin|thymoglobulin|mesh-list
6343456|NCT00038831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343457|NCT00038831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6343458|NCT00038831|Antimetabolites|antimetabolites|mesh-ancestor
6343459|NCT00038831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343460|NCT00038831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6343461|NCT00038831|Immunologic Factors|immunologic factors|mesh-ancestor
6343462|NCT00038831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6343463|NCT00038831|Antiviral Agents|antiviral agents|mesh-ancestor
6343464|NCT00038831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6343465|NCT00038831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6343466|NCT00038831|Alkylating Agents|alkylating agents|mesh-ancestor
6343467|NCT00038831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6343468|NCT00038831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6343469|NCT00038844|Vidarabine|vidarabine|mesh-list
6343470|NCT00038844|Cyclophosphamide|cyclophosphamide|mesh-list
6343471|NCT00038844|Rituximab|rituximab|mesh-list
6343472|NCT00038844|Fludarabine|fludarabine|mesh-list
6343473|NCT00038844|Fludarabine phosphate|fludarabine phosphate|mesh-list
6343474|NCT00038844|Alemtuzumab|alemtuzumab|mesh-list
6343475|NCT00038844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6343476|NCT00038844|Immunologic Factors|immunologic factors|mesh-ancestor
6343477|NCT00038844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6343478|NCT00038844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6343479|NCT00038844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6343480|NCT00038844|Alkylating Agents|alkylating agents|mesh-ancestor
6343481|NCT00038844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343482|NCT00038844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343483|NCT00038844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6343484|NCT00038844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6343485|NCT00038844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6343486|NCT00038844|Antimetabolites|antimetabolites|mesh-ancestor
6343487|NCT00038844|Antiviral Agents|antiviral agents|mesh-ancestor
6343488|NCT00038844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6343489|NCT00038883|Alemtuzumab|alemtuzumab|mesh-list
6343490|NCT00038883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6343491|NCT00038883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343492|NCT00038896|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6343493|NCT00038896|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6343494|NCT00038896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6343495|NCT00038896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6343496|NCT00038896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343497|NCT00038896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6343498|NCT00038896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6343499|NCT00038896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6343500|NCT00038896|Antidepressive Agents|antidepressive agents|mesh-ancestor
6343501|NCT00038896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6343502|NCT00038922|Oprelvekin|oprelvekin|mesh-list
6343503|NCT00038922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343504|NCT00038935|Factor VIII|factor viii|mesh-list
6016857|NCT00368459|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6016858|NCT00368459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6016859|NCT00368537|Ampicillin|ampicillin|mesh-list
6016860|NCT00368537|Tigecycline|tigecycline|mesh-list
6016861|NCT00368537|Sulbactam|sulbactam|mesh-list
6016862|NCT00368537|Sultamicillin|sultamicillin|mesh-list
6016863|NCT00368537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6016864|NCT00368537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6016865|NCT00368537|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6016866|NCT00368537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6016867|NCT00368537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016868|NCT00368537|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6016869|NCT00368550|Sertraline|sertraline|mesh-list
6016870|NCT00368550|Antidepressive Agents|antidepressive agents|mesh-ancestor
6016871|NCT00368550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6016872|NCT00368550|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6016873|NCT00368550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6016874|NCT00368550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6016875|NCT00368550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343505|NCT00038935|Coagulants|coagulants|mesh-ancestor
6343506|NCT00038961|PENTA|penta|mesh-list
6343507|NCT00038961|Fondaparinux|fondaparinux|mesh-list
6343508|NCT00038961|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6343509|NCT00038961|Antithrombins|antithrombins|mesh-ancestor
6343510|NCT00038961|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6343511|NCT00038961|Protease Inhibitors|protease inhibitors|mesh-ancestor
6343512|NCT00038961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6343513|NCT00038961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343514|NCT00038961|Anticoagulants|anticoagulants|mesh-ancestor
6343515|NCT00038961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6343516|NCT00038961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6343517|NCT00038974|Ribavirin|ribavirin|mesh-list
6343518|NCT00038974|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6343519|NCT00038974|Antimetabolites|antimetabolites|mesh-ancestor
6343520|NCT00038974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343521|NCT00038974|Antiviral Agents|antiviral agents|mesh-ancestor
6343522|NCT00038974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6343523|NCT00039013|Exenatide|exenatide|mesh-list
6343524|NCT00039013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6343525|NCT00039013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6343526|NCT00039013|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6343527|NCT00039013|Incretins|incretins|mesh-ancestor
6343528|NCT00039013|Hormones|hormones|mesh-ancestor
6343529|NCT00039013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6343530|NCT00039026|Exenatide|exenatide|mesh-list
6343531|NCT00039026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6343532|NCT00039026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6343533|NCT00039026|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6343534|NCT00039026|Incretins|incretins|mesh-ancestor
6343535|NCT00039026|Hormones|hormones|mesh-ancestor
6343536|NCT00039026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6343537|NCT00039039|Paclitaxel|paclitaxel|mesh-list
6343538|NCT00039039|Carboplatin|carboplatin|mesh-list
6343539|NCT00039039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6343540|NCT00039039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343541|NCT00039039|Tubulin Modulators|tubulin modulators|mesh-ancestor
6343542|NCT00039039|Antimitotic Agents|antimitotic agents|mesh-ancestor
6343543|NCT00039039|Mitosis Modulators|mitosis modulators|mesh-ancestor
6343544|NCT00039039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343545|NCT00039052|Interleukin-4|interleukin-4|mesh-list
6343546|NCT00039052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6343547|NCT00039052|Immunologic Factors|immunologic factors|mesh-ancestor
6343548|NCT00039052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6343549|NCT00039052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343550|NCT00039052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6343551|NCT00039091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6343552|NCT00039091|Ipilimumab|ipilimumab|mesh-list
6343553|NCT00039091|Antibodies|antibodies|mesh-list
6343554|NCT00039091|Immunoglobulins|immunoglobulins|mesh-list
6343555|NCT00039091|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6343556|NCT00039091|Immunologic Factors|immunologic factors|mesh-ancestor
6343557|NCT00039091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6343558|NCT00039091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343559|NCT00039091|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6343560|NCT00039091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343561|NCT00039104|Zoledronic Acid|zoledronic acid|mesh-list
6343562|NCT00039104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6343563|NCT00039104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6343564|NCT00039117|Cytarabine|cytarabine|mesh-list
6343565|NCT00039117|Daunorubicin|daunorubicin|mesh-list
6343566|NCT00039117|Oblimersen|oblimersen|mesh-list
6343567|NCT00039117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6343568|NCT00039117|Antimetabolites|antimetabolites|mesh-ancestor
6343569|NCT00039117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343570|NCT00039117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343571|NCT00039117|Antiviral Agents|antiviral agents|mesh-ancestor
6343572|NCT00039117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6343573|NCT00039117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6343574|NCT00039117|Immunologic Factors|immunologic factors|mesh-ancestor
6343575|NCT00039117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6343576|NCT00039117|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6343577|NCT00039117|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6343578|NCT00039117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6343579|NCT00039117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6343580|NCT00039156|IDN 5109|idn 5109|mesh-list
6343581|NCT00039156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343582|NCT00039169|IDN 5109|idn 5109|mesh-list
6343583|NCT00039169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343584|NCT00039182|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6343585|NCT00039182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343586|NCT00039182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6343587|NCT00039182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6343588|NCT00039182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343589|NCT00039208|Leucovorin|leucovorin|mesh-list
6343590|NCT00039208|Fluorouracil|fluorouracil|mesh-list
6343591|NCT00039208|Oxaliplatin|oxaliplatin|mesh-list
6343592|NCT00039208|Irinotecan|irinotecan|mesh-list
6343593|NCT00039208|Calcium|calcium|mesh-list
6343594|NCT00039208|Levoleucovorin|levoleucovorin|mesh-list
6343595|NCT00039208|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6343596|NCT00039208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6343597|NCT00039208|Antimetabolites|antimetabolites|mesh-ancestor
6343598|NCT00039208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343599|NCT00039208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6343600|NCT00039208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343601|NCT00039208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6343602|NCT00039208|Immunologic Factors|immunologic factors|mesh-ancestor
6343603|NCT00039208|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6343604|NCT00039208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6343605|NCT00039208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6343606|NCT00039208|Antidotes|antidotes|mesh-ancestor
6343607|NCT00039208|Protective Agents|protective agents|mesh-ancestor
6343608|NCT00039208|Vitamin B Complex|vitamin b complex|mesh-ancestor
6343609|NCT00039208|Vitamins|vitamins|mesh-ancestor
6343610|NCT00039208|Micronutrients|micronutrients|mesh-ancestor
6343611|NCT00039234|Aldesleukin|aldesleukin|mesh-list
6343612|NCT00039234|Histamine|histamine|mesh-list
6343613|NCT00039234|Histamine phosphate|histamine phosphate|mesh-list
6343614|NCT00039234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343615|NCT00039234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6343616|NCT00039234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6343617|NCT00039234|Antiviral Agents|antiviral agents|mesh-ancestor
6343618|NCT00039234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6343619|NCT00039234|Histamine Agonists|histamine agonists|mesh-ancestor
6343620|NCT00039234|Histamine Agents|histamine agents|mesh-ancestor
6343621|NCT00039234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6343622|NCT00039234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343623|NCT00039234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6343624|NCT00039273|Panitumumab|panitumumab|mesh-list
6343625|NCT00039273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6343626|NCT00039273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343627|NCT00039286|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6343628|NCT00039286|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6343629|NCT00039286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343630|NCT00039338|Cisplatin|cisplatin|mesh-list
6343631|NCT00039338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343632|NCT00039351|Prednisone|prednisone|mesh-list
6343633|NCT00039351|Cyclophosphamide|cyclophosphamide|mesh-list
6343634|NCT00039351|Vincristine|vincristine|mesh-list
6343635|NCT00039351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6343636|NCT00039351|Immunologic Factors|immunologic factors|mesh-ancestor
6343637|NCT00039351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6343638|NCT00039351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6343639|NCT00039351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6343640|NCT00039351|Alkylating Agents|alkylating agents|mesh-ancestor
6343641|NCT00039351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343642|NCT00039351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343643|NCT00039351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6343644|NCT00039351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6343645|NCT00039351|Glucocorticoids|glucocorticoids|mesh-ancestor
6343646|NCT00039351|Hormones|hormones|mesh-ancestor
6343647|NCT00039351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6343648|NCT00039351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6343649|NCT00039351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6343650|NCT00039351|Tubulin Modulators|tubulin modulators|mesh-ancestor
6343651|NCT00039351|Antimitotic Agents|antimitotic agents|mesh-ancestor
6343652|NCT00039351|Mitosis Modulators|mitosis modulators|mesh-ancestor
6343653|NCT00039364|Imatinib Mesylate|imatinib mesylate|mesh-list
6343654|NCT00039364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343655|NCT00039364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6343656|NCT00039364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6343657|NCT00039364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343658|NCT00039390|Capecitabine|capecitabine|mesh-list
6343659|NCT00039390|Gefitinib|gefitinib|mesh-list
6343660|NCT00039390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6343661|NCT00039390|Antimetabolites|antimetabolites|mesh-ancestor
6343662|NCT00039390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343663|NCT00039390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343664|NCT00039390|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6343665|NCT00039390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6343666|NCT00039403|Gemcitabine|gemcitabine|mesh-list
6343667|NCT00039403|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
6343668|NCT00039403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6343669|NCT00039403|Antimetabolites|antimetabolites|mesh-ancestor
6343670|NCT00039403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343671|NCT00039403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343672|NCT00039403|Antiviral Agents|antiviral agents|mesh-ancestor
6343673|NCT00039403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6343674|NCT00039403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6343675|NCT00039403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6343676|NCT00039403|Immunologic Factors|immunologic factors|mesh-ancestor
6343677|NCT00039403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6343678|NCT00039403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6343679|NCT00039416|Imatinib Mesylate|imatinib mesylate|mesh-list
6343680|NCT00039416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343681|NCT00039416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6343682|NCT00039416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6396968|NCT00209885|Anesthetics|anesthetics|mesh-ancestor
6343683|NCT00039416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343684|NCT00039429|Atrasentan|atrasentan|mesh-list
6343685|NCT00039429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343686|NCT00039429|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
6343687|NCT00039429|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6343688|NCT00039429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343689|NCT00039442|Capecitabine|capecitabine|mesh-list
6343690|NCT00039442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6343691|NCT00039442|Antimetabolites|antimetabolites|mesh-ancestor
6343692|NCT00039442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343693|NCT00039442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343694|NCT00039455|Trastuzumab|trastuzumab|mesh-list
6343695|NCT00039455|Alvocidib|alvocidib|mesh-list
6343696|NCT00039455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6343697|NCT00039455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343698|NCT00039455|Growth Inhibitors|growth inhibitors|mesh-ancestor
6343699|NCT00039455|Growth Substances|growth substances|mesh-ancestor
6343700|NCT00039455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6343701|NCT00039455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6343702|NCT00039455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6343703|NCT00039455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343704|NCT00039468|Thalidomide|thalidomide|mesh-list
6343705|NCT00039468|Irinotecan|irinotecan|mesh-list
6343706|NCT00039468|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6343707|NCT00039468|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6343708|NCT00039468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6343709|NCT00039468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343710|NCT00039468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343711|NCT00039468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6343712|NCT00039468|Immunologic Factors|immunologic factors|mesh-ancestor
6343713|NCT00039468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6343714|NCT00039468|Leprostatic Agents|leprostatic agents|mesh-ancestor
6343715|NCT00039468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6343716|NCT00039468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6343717|NCT00039468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6343718|NCT00039468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6343719|NCT00039468|Growth Substances|growth substances|mesh-ancestor
6343720|NCT00039468|Growth Inhibitors|growth inhibitors|mesh-ancestor
6343721|NCT00039481|Cyclophosphamide|cyclophosphamide|mesh-list
6343722|NCT00039481|Doxorubicin|doxorubicin|mesh-list
6343723|NCT00039481|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6343724|NCT00039481|Dexrazoxane|dexrazoxane|mesh-list
6343725|NCT00039481|Razoxane|razoxane|mesh-list
6343726|NCT00039481|Oblimersen|oblimersen|mesh-list
6343727|NCT00039481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6343728|NCT00039481|Immunologic Factors|immunologic factors|mesh-ancestor
6343729|NCT00039481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6343730|NCT00039481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6343731|NCT00039481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6343732|NCT00039481|Alkylating Agents|alkylating agents|mesh-ancestor
6343733|NCT00039481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343734|NCT00039481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343735|NCT00039481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6343736|NCT00039481|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6343737|NCT00039481|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6343738|NCT00039481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6343739|NCT00039481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6343740|NCT00039481|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6343741|NCT00039481|Protective Agents|protective agents|mesh-ancestor
6343742|NCT00039481|Antimitotic Agents|antimitotic agents|mesh-ancestor
6343743|NCT00039481|Mitosis Modulators|mitosis modulators|mesh-ancestor
6343744|NCT00039494|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6343745|NCT00039494|Temozolomide|temozolomide|mesh-list
6343746|NCT00039494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343747|NCT00039494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6343748|NCT00039494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6343749|NCT00039494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343750|NCT00039494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6343751|NCT00039494|Alkylating Agents|alkylating agents|mesh-ancestor
6343752|NCT00039520|Sulindac|sulindac|mesh-list
6343753|NCT00039520|Docetaxel|docetaxel|mesh-list
6343754|NCT00039520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343755|NCT00039520|Tubulin Modulators|tubulin modulators|mesh-ancestor
6343756|NCT00039520|Antimitotic Agents|antimitotic agents|mesh-ancestor
6343757|NCT00039520|Mitosis Modulators|mitosis modulators|mesh-ancestor
6343758|NCT00039520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343759|NCT00039520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6343760|NCT00039520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6343761|NCT00039520|Analgesics|analgesics|mesh-ancestor
6343762|NCT00039520|Sensory System Agents|sensory system agents|mesh-ancestor
6343763|NCT00039520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6343764|NCT00039520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6343765|NCT00039520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6343766|NCT00039520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6343767|NCT00039520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6343768|NCT00039520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6343769|NCT00039546|Gemcitabine|gemcitabine|mesh-list
6343770|NCT00039546|Paclitaxel|paclitaxel|mesh-list
6343771|NCT00039546|Cyclophosphamide|cyclophosphamide|mesh-list
6343772|NCT00039546|Epirubicin|epirubicin|mesh-list
6343773|NCT00039546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6343774|NCT00039546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343775|NCT00039546|Tubulin Modulators|tubulin modulators|mesh-ancestor
6343776|NCT00039546|Antimitotic Agents|antimitotic agents|mesh-ancestor
6343777|NCT00039546|Mitosis Modulators|mitosis modulators|mesh-ancestor
6343778|NCT00039546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343779|NCT00039546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6343780|NCT00039546|Immunologic Factors|immunologic factors|mesh-ancestor
6343781|NCT00039546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6343782|NCT00039546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6343783|NCT00039546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6343784|NCT00039546|Alkylating Agents|alkylating agents|mesh-ancestor
6343785|NCT00039546|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6343786|NCT00039546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6343787|NCT00039546|Antimetabolites|antimetabolites|mesh-ancestor
6343788|NCT00039546|Antiviral Agents|antiviral agents|mesh-ancestor
6343789|NCT00039546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6343790|NCT00039546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6343791|NCT00039546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6343792|NCT00039546|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6343793|NCT00039546|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6343794|NCT00039585|Imatinib Mesylate|imatinib mesylate|mesh-list
6343795|NCT00039585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343796|NCT00039585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6343797|NCT00039585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6343798|NCT00039585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343799|NCT00039611|Leucovorin|leucovorin|mesh-list
6343800|NCT00039611|Fluorouracil|fluorouracil|mesh-list
6343801|NCT00039611|Oxaliplatin|oxaliplatin|mesh-list
6343802|NCT00039611|Calcium|calcium|mesh-list
6343803|NCT00039611|Levoleucovorin|levoleucovorin|mesh-list
6343804|NCT00039611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6343805|NCT00039611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6343806|NCT00039611|Antimetabolites|antimetabolites|mesh-ancestor
6343807|NCT00039611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343808|NCT00039611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6343809|NCT00039611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343810|NCT00039611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6343811|NCT00039611|Immunologic Factors|immunologic factors|mesh-ancestor
6343812|NCT00039611|Antidotes|antidotes|mesh-ancestor
6343813|NCT00039611|Protective Agents|protective agents|mesh-ancestor
6343814|NCT00039611|Vitamin B Complex|vitamin b complex|mesh-ancestor
6343815|NCT00039611|Vitamins|vitamins|mesh-ancestor
6343816|NCT00039611|Micronutrients|micronutrients|mesh-ancestor
6343817|NCT00039663|Rosiglitazone|rosiglitazone|mesh-list
6343818|NCT00039663|Pravastatin|pravastatin|mesh-list
6343819|NCT00039663|Gemfibrozil|gemfibrozil|mesh-list
6343820|NCT00039663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6343821|NCT00039663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6343822|NCT00039663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6343823|NCT00039663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6343824|NCT00039663|Antimetabolites|antimetabolites|mesh-ancestor
6343825|NCT00039663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343826|NCT00039663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6343827|NCT00039663|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6343828|NCT00039663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6343829|NCT00039663|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6343830|NCT00039663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6393880|NCT00200226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6393881|NCT00200226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6393882|NCT00200226|Abortifacient Agents|abortifacient agents|mesh-ancestor
6393883|NCT00200226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6393884|NCT00200226|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6393885|NCT00200226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6393886|NCT00200226|Oxytocics|oxytocics|mesh-ancestor
6393887|NCT00200226|Vitamin B Complex|vitamin b complex|mesh-ancestor
6393888|NCT00200252|Oxytocin|oxytocin|mesh-list
6393889|NCT00200252|Oxytocics|oxytocics|mesh-ancestor
6393890|NCT00200252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6393891|NCT00200252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6393892|NCT00200382|Bortezomib|bortezomib|mesh-list
6393893|NCT00200382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6393894|NCT00200395|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6393895|NCT00200395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6393896|NCT00200395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6393897|NCT00200395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6393898|NCT00200395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393899|NCT00200421|Atenolol|atenolol|mesh-list
6393900|NCT00200421|Nebivolol|nebivolol|mesh-list
6393901|NCT00200421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6393902|NCT00200421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6393903|NCT00200421|Sympatholytics|sympatholytics|mesh-ancestor
6393904|NCT00200421|Autonomic Agents|autonomic agents|mesh-ancestor
6393905|NCT00200421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6393906|NCT00200421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6393907|NCT00200421|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6393908|NCT00200421|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6393909|NCT00200421|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6393910|NCT00200421|Adrenergic Agents|adrenergic agents|mesh-ancestor
6393911|NCT00200421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6393912|NCT00200421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393913|NCT00200421|Vasodilator Agents|vasodilator agents|mesh-ancestor
6393914|NCT00200421|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6393915|NCT00200421|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6393916|NCT00200421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6393917|NCT00200434|Nebivolol|nebivolol|mesh-list
6393918|NCT00200434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6393919|NCT00200434|Vasodilator Agents|vasodilator agents|mesh-ancestor
6393920|NCT00200434|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6393921|NCT00200434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6393922|NCT00200434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6393923|NCT00200434|Adrenergic Agents|adrenergic agents|mesh-ancestor
6393924|NCT00200434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6393925|NCT00200434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343831|NCT00039767|Lepirudin|lepirudin|mesh-list
6343832|NCT00039767|Antithrombins|antithrombins|mesh-ancestor
6343833|NCT00039767|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6343834|NCT00039767|Protease Inhibitors|protease inhibitors|mesh-ancestor
6343835|NCT00039767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6343836|NCT00039767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343837|NCT00039767|Anticoagulants|anticoagulants|mesh-ancestor
6343838|NCT00039767|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6343839|NCT00039767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6343840|NCT00039780|2,2'-dithiodiethanesulfonic acid|2,2'-dithiodiethanesulfonic acid|mesh-list
6343841|NCT00039780|Protective Agents|protective agents|mesh-ancestor
6343842|NCT00039780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6343843|NCT00039832|Reteplase|reteplase|mesh-list
6343844|NCT00039832|Abciximab|abciximab|mesh-list
6343845|NCT00039832|Anticoagulants|anticoagulants|mesh-ancestor
6343846|NCT00039832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6343847|NCT00039832|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6343848|NCT00039832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6343849|NCT00039832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343850|NCT00039858|Argatroban|argatroban|mesh-list
6343851|NCT00039858|Antithrombins|antithrombins|mesh-ancestor
6343852|NCT00039858|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6343853|NCT00039858|Protease Inhibitors|protease inhibitors|mesh-ancestor
6343854|NCT00039858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6343855|NCT00039858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343856|NCT00039858|Anticoagulants|anticoagulants|mesh-ancestor
6343857|NCT00039858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6343858|NCT00039884|Darbepoetin alfa|darbepoetin alfa|mesh-list
6343859|NCT00039884|Hematinics|hematinics|mesh-ancestor
6343860|NCT00039962|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6343861|NCT00039962|Thymalfasin|thymalfasin|mesh-list
6343862|NCT00039962|Antiviral Agents|antiviral agents|mesh-ancestor
6343863|NCT00039962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6343864|NCT00039962|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6343865|NCT00039962|Immunologic Factors|immunologic factors|mesh-ancestor
6343866|NCT00039962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6343867|NCT00039975|Ritonavir|ritonavir|mesh-list
6343868|NCT00039975|Indinavir|indinavir|mesh-list
6343869|NCT00039975|Amlodipine|amlodipine|mesh-list
6343870|NCT00039975|Diltiazem|diltiazem|mesh-list
6343871|NCT00039975|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6343872|NCT00039975|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6343873|NCT00039975|Protease Inhibitors|protease inhibitors|mesh-ancestor
6343874|NCT00039975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6343875|NCT00039975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343876|NCT00039975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6343877|NCT00039975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6343878|NCT00039975|Antiviral Agents|antiviral agents|mesh-ancestor
6343879|NCT00039975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6343880|NCT00039975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6343881|NCT00039975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6343882|NCT00039975|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6343883|NCT00039975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6343884|NCT00039975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6343885|NCT00039975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6343886|NCT00039975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6343887|NCT00039975|Vasodilator Agents|vasodilator agents|mesh-ancestor
6343888|NCT00039988|Glatiramer Acetate|glatiramer acetate|mesh-list
6343889|NCT00039988|Albuterol|albuterol|mesh-list
6343890|NCT00039988|(T,G)-A-L|(t,g)-a-l|mesh-list
6343891|NCT00039988|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6343892|NCT00039988|Autonomic Agents|autonomic agents|mesh-ancestor
6343893|NCT00039988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6343894|NCT00039988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6343895|NCT00039988|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6343896|NCT00039988|Respiratory System Agents|respiratory system agents|mesh-ancestor
6343897|NCT00039988|Tocolytic Agents|tocolytic agents|mesh-ancestor
6343898|NCT00039988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6343899|NCT00039988|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6343900|NCT00039988|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6343901|NCT00039988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6343902|NCT00039988|Adrenergic Agents|adrenergic agents|mesh-ancestor
6343903|NCT00039988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6343904|NCT00039988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343905|NCT00039988|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6343906|NCT00039988|Immunologic Factors|immunologic factors|mesh-ancestor
6343907|NCT00039988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6343908|NCT00039988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6343909|NCT00040014|Exemestane|exemestane|mesh-list
6343910|NCT00040014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343911|NCT00040014|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6343912|NCT00040014|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6343913|NCT00040014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6343914|NCT00040014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343915|NCT00040014|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6343916|NCT00040014|Hormone Antagonists|hormone antagonists|mesh-ancestor
6343917|NCT00040014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6343918|NCT00040014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6343919|NCT00040027|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6343920|NCT00040027|Interferon-alpha|interferon-alpha|mesh-list
6343921|NCT00040027|Thymalfasin|thymalfasin|mesh-list
6343922|NCT00040027|Antiviral Agents|antiviral agents|mesh-ancestor
6343923|NCT00040027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6343924|NCT00040027|Immunologic Factors|immunologic factors|mesh-ancestor
6343925|NCT00040027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6343926|NCT00040027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6343927|NCT00040040|Bupropion|bupropion|mesh-list
6343928|NCT00040040|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6343929|NCT00040040|Antidepressive Agents|antidepressive agents|mesh-ancestor
6343930|NCT00040040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6343931|NCT00040040|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6343932|NCT00040040|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6343933|NCT00040040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6343934|NCT00040040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343935|NCT00040040|Dopamine Agents|dopamine agents|mesh-ancestor
6343936|NCT00040040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6343937|NCT00040040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6343938|NCT00040040|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6343939|NCT00040040|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6343940|NCT00040040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6343941|NCT00040053|Ondansetron|ondansetron|mesh-list
6343942|NCT00040053|Antiemetics|antiemetics|mesh-ancestor
6343943|NCT00040053|Autonomic Agents|autonomic agents|mesh-ancestor
6343944|NCT00040053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6343945|NCT00040053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6343946|NCT00040053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6343947|NCT00040053|Antipruritics|antipruritics|mesh-ancestor
6343948|NCT00040053|Dermatologic Agents|dermatologic agents|mesh-ancestor
6343949|NCT00040053|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6343950|NCT00040053|Serotonin Agents|serotonin agents|mesh-ancestor
6343951|NCT00040053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6343952|NCT00040053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343953|NCT00040053|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6343954|NCT00040053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6343955|NCT00040053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6343956|NCT00040053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6343957|NCT00040053|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6343958|NCT00040066|Cocaine|cocaine|mesh-list
6343959|NCT00040066|Anesthetics, Local|anesthetics, local|mesh-ancestor
6343960|NCT00040066|Anesthetics|anesthetics|mesh-ancestor
6343961|NCT00040066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6343962|NCT00040066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6343963|NCT00040066|Sensory System Agents|sensory system agents|mesh-ancestor
6343964|NCT00040066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6343965|NCT00040066|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6343966|NCT00040066|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6343967|NCT00040066|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6343968|NCT00040066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6343969|NCT00040066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343970|NCT00040066|Dopamine Agents|dopamine agents|mesh-ancestor
6343971|NCT00040066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6343972|NCT00040105|Imatinib Mesylate|imatinib mesylate|mesh-list
6343973|NCT00040105|Tipifarnib|tipifarnib|mesh-list
6343974|NCT00040105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343975|NCT00040105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6343976|NCT00040105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6343977|NCT00040105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343978|NCT00040144|Dexelvucitabine|dexelvucitabine|mesh-list
6343979|NCT00040144|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6343980|NCT00040144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6343981|NCT00040144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6343982|NCT00040144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343983|NCT00040144|Antiviral Agents|antiviral agents|mesh-ancestor
6343984|NCT00040144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6343985|NCT00040144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6343986|NCT00040144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6343987|NCT00040157|Dexelvucitabine|dexelvucitabine|mesh-list
6343988|NCT00040157|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6343989|NCT00040157|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6343990|NCT00040157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6343991|NCT00040157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6343992|NCT00040157|Antiviral Agents|antiviral agents|mesh-ancestor
6343993|NCT00040157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6343994|NCT00040157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6343995|NCT00040157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6343996|NCT00040183|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6343997|NCT00040183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6343998|NCT00040183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6343999|NCT00040183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6344000|NCT00040183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344001|NCT00040209|Levodopa|levodopa|mesh-list
6344002|NCT00040209|Apomorphine|apomorphine|mesh-list
6344003|NCT00040209|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6344004|NCT00040209|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6344005|NCT00040209|Dopamine Agents|dopamine agents|mesh-ancestor
6344006|NCT00040209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6344007|NCT00040209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344008|NCT00040209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6344009|NCT00040209|Emetics|emetics|mesh-ancestor
6344010|NCT00040209|Autonomic Agents|autonomic agents|mesh-ancestor
6344011|NCT00040209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6344012|NCT00040209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6344013|NCT00040209|Dopamine Agonists|dopamine agonists|mesh-ancestor
6344014|NCT00040248|Daclizumab|daclizumab|mesh-list
6344015|NCT00040248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6344016|NCT00040248|Immunologic Factors|immunologic factors|mesh-ancestor
6344017|NCT00040248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6344018|NCT00040261|Memantine|memantine|mesh-list
6344019|NCT00040261|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6344020|NCT00040261|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6344021|NCT00040261|Dopamine Agents|dopamine agents|mesh-ancestor
6344022|NCT00040261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6344023|NCT00040261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344024|NCT00040261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6344025|NCT00040261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6344026|NCT00040261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6344027|NCT00040274|Dexelvucitabine|dexelvucitabine|mesh-list
6344028|NCT00040274|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6344029|NCT00040274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6344030|NCT00040274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6344031|NCT00040274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344032|NCT00040274|Antiviral Agents|antiviral agents|mesh-ancestor
6344033|NCT00040274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6344034|NCT00040274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6344035|NCT00040274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6344036|NCT00040300|Racivir|racivir|mesh-list
6344037|NCT00040300|Antiviral Agents|antiviral agents|mesh-ancestor
6344038|NCT00040300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6344039|NCT00040326|Anticonvulsants|anticonvulsants|mesh-list
6344040|NCT00040378|Vitamins|vitamins|mesh-list
6344041|NCT00040378|Vitamin E|vitamin e|mesh-list
6344042|NCT00040378|Tocopherols|tocopherols|mesh-list
6344043|NCT00040378|Tocotrienols|tocotrienols|mesh-list
6344044|NCT00040378|alpha-Tocopherol|alpha-tocopherol|mesh-list
6344045|NCT00040378|Selenium|selenium|mesh-list
6344046|NCT00040378|Micronutrients|micronutrients|mesh-ancestor
6344047|NCT00040378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6344048|NCT00040378|Antioxidants|antioxidants|mesh-ancestor
6344049|NCT00040378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344050|NCT00040378|Protective Agents|protective agents|mesh-ancestor
6344051|NCT00040378|Trace Elements|trace elements|mesh-ancestor
6344052|NCT00040391|Leucovorin|leucovorin|mesh-list
6344053|NCT00040391|Fluorouracil|fluorouracil|mesh-list
6344054|NCT00040391|Irinotecan|irinotecan|mesh-list
6344055|NCT00040391|Antimetabolites|antimetabolites|mesh-ancestor
6344056|NCT00040391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344057|NCT00040391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6344058|NCT00040391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344059|NCT00040391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6344060|NCT00040391|Immunologic Factors|immunologic factors|mesh-ancestor
6344061|NCT00040391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6344062|NCT00040391|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6344063|NCT00040391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6344064|NCT00040391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6344065|NCT00040391|Antidotes|antidotes|mesh-ancestor
6344066|NCT00040391|Protective Agents|protective agents|mesh-ancestor
6344067|NCT00040391|Vitamin B Complex|vitamin b complex|mesh-ancestor
6344068|NCT00040391|Vitamins|vitamins|mesh-ancestor
6344069|NCT00040391|Micronutrients|micronutrients|mesh-ancestor
6344070|NCT00040417|Fludarabine|fludarabine|mesh-list
6344071|NCT00040417|Alemtuzumab|alemtuzumab|mesh-list
6344072|NCT00040417|Sargramostim|sargramostim|mesh-list
6344073|NCT00040417|Lenograstim|lenograstim|mesh-list
6344074|NCT00040417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344075|NCT00040417|Immunologic Factors|immunologic factors|mesh-ancestor
6344076|NCT00040417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6344077|NCT00040417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6344078|NCT00040417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6344079|NCT00040469|Cyclophosphamide|cyclophosphamide|mesh-list
6016876|NCT00368550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6344080|NCT00040469|Busulfan|busulfan|mesh-list
6344081|NCT00040469|Alemtuzumab|alemtuzumab|mesh-list
6344082|NCT00040469|Phenytoin|phenytoin|mesh-list
6344083|NCT00040469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6344084|NCT00040469|Immunologic Factors|immunologic factors|mesh-ancestor
6344085|NCT00040469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6344086|NCT00040469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6344087|NCT00040469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6344088|NCT00040469|Alkylating Agents|alkylating agents|mesh-ancestor
6016877|NCT00368550|Serotonin Agents|serotonin agents|mesh-ancestor
6016878|NCT00368550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6344089|NCT00040469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344090|NCT00040469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344091|NCT00040469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6344092|NCT00040469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6344093|NCT00040469|Anticonvulsants|anticonvulsants|mesh-ancestor
6344094|NCT00040469|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6344095|NCT00040469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6344096|NCT00040469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6344097|NCT00040469|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6344098|NCT00040469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6344099|NCT00040482|Cyclophosphamide|cyclophosphamide|mesh-list
6344100|NCT00040482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6344101|NCT00040482|Immunologic Factors|immunologic factors|mesh-ancestor
6344102|NCT00040482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6344103|NCT00040482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6344104|NCT00040482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6344105|NCT00040482|Alkylating Agents|alkylating agents|mesh-ancestor
6344106|NCT00040482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344107|NCT00040482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344108|NCT00040482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6344109|NCT00040495|Pantoprazole|pantoprazole|mesh-list
6344110|NCT00040495|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6344111|NCT00040495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6344112|NCT00040495|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6344113|NCT00040495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6344114|NCT00040495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344115|NCT00040508|Sirolimus|sirolimus|mesh-list
6344116|NCT00040508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6344117|NCT00040508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6344118|NCT00040508|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6344119|NCT00040508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344120|NCT00040508|Antifungal Agents|antifungal agents|mesh-ancestor
6344121|NCT00040508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6344122|NCT00040508|Immunologic Factors|immunologic factors|mesh-ancestor
6344123|NCT00040508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6344124|NCT00040521|Oprelvekin|oprelvekin|mesh-list
6344125|NCT00040521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344126|NCT00040586|Interleukin-2|interleukin-2|mesh-list
6344127|NCT00040586|Antibodies|antibodies|mesh-list
6016879|NCT00368641|Icodextrin|icodextrin|mesh-list
6344128|NCT00040586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6344129|NCT00040586|Immunologic Factors|immunologic factors|mesh-ancestor
6344130|NCT00040586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6344131|NCT00040586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344132|NCT00040586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6344133|NCT00040586|Analgesics|analgesics|mesh-ancestor
6344134|NCT00040586|Sensory System Agents|sensory system agents|mesh-ancestor
6344135|NCT00040586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6344136|NCT00040599|Labetuzumab|labetuzumab|mesh-list
6344137|NCT00040599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6344138|NCT00040599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344139|NCT00040625|Pemetrexed|pemetrexed|mesh-list
6344140|NCT00040625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344141|NCT00040625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6344142|NCT00040625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344143|NCT00040625|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6344144|NCT00040625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6344145|NCT00040651|Cyclophosphamide|cyclophosphamide|mesh-list
6344146|NCT00040651|Fludarabine|fludarabine|mesh-list
6344147|NCT00040651|Thymoglobulin|thymoglobulin|mesh-list
6344148|NCT00040651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6344149|NCT00040651|Immunologic Factors|immunologic factors|mesh-ancestor
6344150|NCT00040651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6344151|NCT00040651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6344152|NCT00040651|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6344153|NCT00040651|Alkylating Agents|alkylating agents|mesh-ancestor
6344154|NCT00040651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344155|NCT00040651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344156|NCT00040651|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6344157|NCT00040690|Leucovorin|leucovorin|mesh-list
6344158|NCT00040690|Cytarabine|cytarabine|mesh-list
6344159|NCT00040690|Cyclophosphamide|cyclophosphamide|mesh-list
6344160|NCT00040690|Ifosfamide|ifosfamide|mesh-list
6344161|NCT00040690|Doxorubicin|doxorubicin|mesh-list
6344162|NCT00040690|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6344163|NCT00040690|Methotrexate|methotrexate|mesh-list
6344164|NCT00040690|Etoposide|etoposide|mesh-list
6344165|NCT00040690|Vincristine|vincristine|mesh-list
6344166|NCT00040690|Levoleucovorin|levoleucovorin|mesh-list
6344167|NCT00040690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6344168|NCT00040690|Immunologic Factors|immunologic factors|mesh-ancestor
6344169|NCT00040690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6344170|NCT00040690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6344171|NCT00040690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6344172|NCT00040690|Alkylating Agents|alkylating agents|mesh-ancestor
6344173|NCT00040690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344174|NCT00040690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344175|NCT00040690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6344176|NCT00040690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6344177|NCT00040690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6344178|NCT00040690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6344179|NCT00040690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6344180|NCT00040690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6344181|NCT00040690|Abortifacient Agents|abortifacient agents|mesh-ancestor
6344182|NCT00040690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6344183|NCT00040690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6344184|NCT00040690|Antimetabolites|antimetabolites|mesh-ancestor
6344185|NCT00040690|Dermatologic Agents|dermatologic agents|mesh-ancestor
6344186|NCT00040690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6344187|NCT00040690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6344188|NCT00040690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6344189|NCT00040690|Antiviral Agents|antiviral agents|mesh-ancestor
6344190|NCT00040690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6344191|NCT00040690|Antidotes|antidotes|mesh-ancestor
6344192|NCT00040690|Protective Agents|protective agents|mesh-ancestor
6344193|NCT00040690|Vitamin B Complex|vitamin b complex|mesh-ancestor
6344194|NCT00040690|Vitamins|vitamins|mesh-ancestor
6344195|NCT00040690|Micronutrients|micronutrients|mesh-ancestor
6344196|NCT00040690|Tubulin Modulators|tubulin modulators|mesh-ancestor
6344197|NCT00040690|Antimitotic Agents|antimitotic agents|mesh-ancestor
6344198|NCT00040690|Mitosis Modulators|mitosis modulators|mesh-ancestor
6344199|NCT00040768|Bortezomib|bortezomib|mesh-list
6344200|NCT00040768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344201|NCT00040781|Gefitinib|gefitinib|mesh-list
6344202|NCT00040781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344203|NCT00040781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6344204|NCT00040781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6344205|NCT00040781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344206|NCT00040794|Paclitaxel|paclitaxel|mesh-list
6344207|NCT00040794|Carboplatin|carboplatin|mesh-list
6344208|NCT00040794|Gefitinib|gefitinib|mesh-list
6344209|NCT00040794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6344210|NCT00040794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344211|NCT00040794|Tubulin Modulators|tubulin modulators|mesh-ancestor
6344212|NCT00040794|Antimitotic Agents|antimitotic agents|mesh-ancestor
6344213|NCT00040794|Mitosis Modulators|mitosis modulators|mesh-ancestor
6344214|NCT00040794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344215|NCT00040794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6344216|NCT00040794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6344217|NCT00040807|Docetaxel|docetaxel|mesh-list
6344218|NCT00040807|Irinotecan|irinotecan|mesh-list
6344219|NCT00040807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344220|NCT00040807|Tubulin Modulators|tubulin modulators|mesh-ancestor
6344221|NCT00040807|Antimitotic Agents|antimitotic agents|mesh-ancestor
6344222|NCT00040807|Mitosis Modulators|mitosis modulators|mesh-ancestor
6344223|NCT00040807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344224|NCT00040807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6344225|NCT00040807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6344226|NCT00040807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6344227|NCT00040820|Oxaliplatin|oxaliplatin|mesh-list
6344228|NCT00040820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344229|NCT00040859|Capecitabine|capecitabine|mesh-list
6344230|NCT00040859|Oxaliplatin|oxaliplatin|mesh-list
6344231|NCT00040859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6344232|NCT00040859|Antimetabolites|antimetabolites|mesh-ancestor
6344233|NCT00040859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344234|NCT00040859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344235|NCT00040872|Cyclophosphamide|cyclophosphamide|mesh-list
6344236|NCT00040872|Thiotepa|thiotepa|mesh-list
6344237|NCT00040872|Carboplatin|carboplatin|mesh-list
6344238|NCT00040872|Doxorubicin|doxorubicin|mesh-list
6344239|NCT00040872|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6344240|NCT00040872|Etoposide|etoposide|mesh-list
6344241|NCT00040872|Vincristine|vincristine|mesh-list
6344242|NCT00040872|Topotecan|topotecan|mesh-list
6344243|NCT00040872|Isotretinoin|isotretinoin|mesh-list
6344244|NCT00040872|Antibodies|antibodies|mesh-list
6344245|NCT00040872|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6344246|NCT00040872|Sargramostim|sargramostim|mesh-list
6344247|NCT00040872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6344248|NCT00040872|Immunologic Factors|immunologic factors|mesh-ancestor
6344249|NCT00040872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6344250|NCT00040872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6344251|NCT00040872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6344252|NCT00040872|Alkylating Agents|alkylating agents|mesh-ancestor
6344253|NCT00040872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344254|NCT00040872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344255|NCT00040872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6344256|NCT00040872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6344257|NCT00040872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6344258|NCT00040872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6344259|NCT00040872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6344260|NCT00040872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6344261|NCT00040872|Tubulin Modulators|tubulin modulators|mesh-ancestor
6344262|NCT00040872|Antimitotic Agents|antimitotic agents|mesh-ancestor
6344263|NCT00040872|Mitosis Modulators|mitosis modulators|mesh-ancestor
6344264|NCT00040872|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6344265|NCT00040872|Dermatologic Agents|dermatologic agents|mesh-ancestor
6344266|NCT00040885|Docetaxel|docetaxel|mesh-list
6344267|NCT00040885|Infliximab|infliximab|mesh-list
6344268|NCT00040885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344269|NCT00040885|Tubulin Modulators|tubulin modulators|mesh-ancestor
6344270|NCT00040885|Antimitotic Agents|antimitotic agents|mesh-ancestor
6344271|NCT00040885|Mitosis Modulators|mitosis modulators|mesh-ancestor
6344272|NCT00040885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344273|NCT00040885|Dermatologic Agents|dermatologic agents|mesh-ancestor
6344274|NCT00040885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6344275|NCT00040885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6344276|NCT00040950|Rituximab|rituximab|mesh-list
6344277|NCT00040950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6344278|NCT00040950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344279|NCT00040950|Immunologic Factors|immunologic factors|mesh-ancestor
6344280|NCT00040950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6344281|NCT00040950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6344282|NCT00040989|Enzyme Inhibitors|enzyme inhibitors|mesh-list
6344283|NCT00040989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344284|NCT00041015|Etoposide|etoposide|mesh-list
6344285|NCT00041015|Topotecan|topotecan|mesh-list
6344286|NCT00041015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344287|NCT00041015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6344288|NCT00041015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6344289|NCT00041015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6344290|NCT00041015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6344291|NCT00041015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344292|NCT00041015|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6344293|NCT00041041|Imatinib Mesylate|imatinib mesylate|mesh-list
6344294|NCT00041041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344295|NCT00041041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6344296|NCT00041041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6344297|NCT00041041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344298|NCT00041054|Sulindac sulfone|sulindac sulfone|mesh-list
6344299|NCT00041054|Carboplatin|carboplatin|mesh-list
6344300|NCT00041054|Etoposide|etoposide|mesh-list
6344301|NCT00041054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344302|NCT00041054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6344303|NCT00041054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6344304|NCT00041054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6344305|NCT00041054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6344306|NCT00041054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344307|NCT00041054|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6344308|NCT00041054|Protective Agents|protective agents|mesh-ancestor
6344309|NCT00041054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6344310|NCT00041054|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6344311|NCT00041054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6344312|NCT00041054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6344313|NCT00041054|Analgesics|analgesics|mesh-ancestor
6344314|NCT00041054|Sensory System Agents|sensory system agents|mesh-ancestor
6344315|NCT00041054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6344316|NCT00041054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6344317|NCT00041054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6344318|NCT00041093|Docetaxel|docetaxel|mesh-list
6344319|NCT00041093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344320|NCT00041093|Tubulin Modulators|tubulin modulators|mesh-ancestor
6344321|NCT00041093|Antimitotic Agents|antimitotic agents|mesh-ancestor
6344322|NCT00041093|Mitosis Modulators|mitosis modulators|mesh-ancestor
6344323|NCT00041093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344324|NCT00041106|Gemcitabine|gemcitabine|mesh-list
6344325|NCT00041106|Gefitinib|gefitinib|mesh-list
6344326|NCT00041106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344327|NCT00041106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6344328|NCT00041106|Antimetabolites|antimetabolites|mesh-ancestor
6344329|NCT00041106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344330|NCT00041106|Antiviral Agents|antiviral agents|mesh-ancestor
6344331|NCT00041106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6344332|NCT00041106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6344333|NCT00041106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6344334|NCT00041106|Immunologic Factors|immunologic factors|mesh-ancestor
6344335|NCT00041106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6344336|NCT00041106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6344337|NCT00041171|Docetaxel|docetaxel|mesh-list
6344338|NCT00041171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344339|NCT00041171|Tubulin Modulators|tubulin modulators|mesh-ancestor
6344340|NCT00041171|Antimitotic Agents|antimitotic agents|mesh-ancestor
6344341|NCT00041171|Mitosis Modulators|mitosis modulators|mesh-ancestor
6344342|NCT00041171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344343|NCT00041197|Imatinib Mesylate|imatinib mesylate|mesh-list
6344344|NCT00041197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344345|NCT00041197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6344346|NCT00041197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6344347|NCT00041197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344348|NCT00041210|Prednisone|prednisone|mesh-list
6344349|NCT00041210|Doxorubicin|doxorubicin|mesh-list
6344350|NCT00041210|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6344351|NCT00041210|Bleomycin|bleomycin|mesh-list
6344352|NCT00041210|Etoposide|etoposide|mesh-list
6344353|NCT00041210|Vincristine|vincristine|mesh-list
6344354|NCT00041210|Dacarbazine|dacarbazine|mesh-list
6344355|NCT00041210|Vinblastine|vinblastine|mesh-list
6344356|NCT00041210|Mechlorethamine|mechlorethamine|mesh-list
6344357|NCT00041210|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6344358|NCT00041210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344359|NCT00041210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6344360|NCT00041210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6344361|NCT00041210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6344362|NCT00041210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344363|NCT00041210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6344364|NCT00041210|Glucocorticoids|glucocorticoids|mesh-ancestor
6344365|NCT00041210|Hormones|hormones|mesh-ancestor
6344366|NCT00041210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6344367|NCT00041210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6344368|NCT00041210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6344369|NCT00041210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6344370|NCT00041210|Tubulin Modulators|tubulin modulators|mesh-ancestor
6344371|NCT00041210|Antimitotic Agents|antimitotic agents|mesh-ancestor
6344372|NCT00041210|Mitosis Modulators|mitosis modulators|mesh-ancestor
6344373|NCT00041210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6344374|NCT00041210|Alkylating Agents|alkylating agents|mesh-ancestor
6344375|NCT00041223|Proanthocyanidin|proanthocyanidin|mesh-list
6344376|NCT00041223|Procyanidin|procyanidin|mesh-list
6344377|NCT00041223|Antioxidants|antioxidants|mesh-ancestor
6344378|NCT00041223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344379|NCT00041223|Protective Agents|protective agents|mesh-ancestor
6344380|NCT00041223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6344381|NCT00041223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6344382|NCT00041223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6344383|NCT00041223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6344384|NCT00041236|Exatecan|exatecan|mesh-list
6344385|NCT00041236|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6344386|NCT00041236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6344387|NCT00041236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6344388|NCT00041236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344389|NCT00041236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344390|NCT00041262|Fluorouracil|fluorouracil|mesh-list
6344391|NCT00041262|Epirubicin|epirubicin|mesh-list
6344392|NCT00041262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344393|NCT00041262|Antimetabolites|antimetabolites|mesh-ancestor
6344394|NCT00041262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344395|NCT00041262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6344396|NCT00041262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6344397|NCT00041262|Immunologic Factors|immunologic factors|mesh-ancestor
6344398|NCT00041262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6344399|NCT00041262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6344400|NCT00041262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6344401|NCT00041262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6344402|NCT00041262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6344403|NCT00041275|Megestrol|megestrol|mesh-list
6344404|NCT00041275|Megestrol Acetate|megestrol acetate|mesh-list
6344405|NCT00041275|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6344406|NCT00041275|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6344407|NCT00041275|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6344408|NCT00041275|Contraceptive Agents|contraceptive agents|mesh-ancestor
6344409|NCT00041275|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6344410|NCT00041275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6344411|NCT00041275|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6344412|NCT00041275|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6344413|NCT00041275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6344414|NCT00041275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344415|NCT00041275|Appetite Stimulants|appetite stimulants|mesh-ancestor
6344416|NCT00041275|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6344417|NCT00041288|Cyclosporine|cyclosporine|mesh-list
6344418|NCT00041288|Mycophenolic Acid|mycophenolic acid|mesh-list
6344419|NCT00041288|Cyclophosphamide|cyclophosphamide|mesh-list
6344420|NCT00041288|Methotrexate|methotrexate|mesh-list
6344421|NCT00041288|Fludarabine|fludarabine|mesh-list
6344422|NCT00041288|Fludarabine phosphate|fludarabine phosphate|mesh-list
6344423|NCT00041288|Tacrolimus|tacrolimus|mesh-list
6344424|NCT00041288|Cyclosporins|cyclosporins|mesh-list
6344425|NCT00041288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6344426|NCT00041288|Immunologic Factors|immunologic factors|mesh-ancestor
6344427|NCT00041288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6344428|NCT00041288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6344429|NCT00041288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6344430|NCT00041288|Alkylating Agents|alkylating agents|mesh-ancestor
6344431|NCT00041288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344432|NCT00041288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344433|NCT00041288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6344434|NCT00041288|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6344435|NCT00041288|Abortifacient Agents|abortifacient agents|mesh-ancestor
6344436|NCT00041288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6344437|NCT00041288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6344438|NCT00041288|Antimetabolites|antimetabolites|mesh-ancestor
6344439|NCT00041288|Dermatologic Agents|dermatologic agents|mesh-ancestor
6344440|NCT00041288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6344441|NCT00041288|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6344442|NCT00041288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6344443|NCT00041288|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6344444|NCT00041288|Antifungal Agents|antifungal agents|mesh-ancestor
6344445|NCT00041288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6344446|NCT00041288|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6344447|NCT00041288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6344448|NCT00041288|Antitubercular Agents|antitubercular agents|mesh-ancestor
6344449|NCT00041288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6344450|NCT00041314|Gemcitabine|gemcitabine|mesh-list
6344451|NCT00041314|Sulindac sulfone|sulindac sulfone|mesh-list
6344452|NCT00041314|Carboplatin|carboplatin|mesh-list
6344453|NCT00041314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344454|NCT00041314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6344455|NCT00041314|Antimetabolites|antimetabolites|mesh-ancestor
6344456|NCT00041314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344457|NCT00041314|Antiviral Agents|antiviral agents|mesh-ancestor
6344458|NCT00041314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6344459|NCT00041314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6344460|NCT00041314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6344461|NCT00041314|Immunologic Factors|immunologic factors|mesh-ancestor
6344462|NCT00041314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6344463|NCT00041314|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6344464|NCT00041314|Protective Agents|protective agents|mesh-ancestor
6344465|NCT00041314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6344466|NCT00041314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6344467|NCT00041314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6344468|NCT00041314|Analgesics|analgesics|mesh-ancestor
6344469|NCT00041314|Sensory System Agents|sensory system agents|mesh-ancestor
6344470|NCT00041314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6344471|NCT00041314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6344472|NCT00041314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6344473|NCT00041327|Interferons|interferons|mesh-list
6344474|NCT00041327|Interferon-alpha|interferon-alpha|mesh-list
6344475|NCT00041327|Lamivudine|lamivudine|mesh-list
6344476|NCT00041327|Zidovudine|zidovudine|mesh-list
6344477|NCT00041327|Prednisone|prednisone|mesh-list
6344478|NCT00041327|Cyclophosphamide|cyclophosphamide|mesh-list
6344479|NCT00041327|Doxorubicin|doxorubicin|mesh-list
6344480|NCT00041327|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6344481|NCT00041327|Etoposide|etoposide|mesh-list
6344482|NCT00041327|Vincristine|vincristine|mesh-list
6344483|NCT00041327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6344484|NCT00041327|Immunologic Factors|immunologic factors|mesh-ancestor
6344485|NCT00041327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6344486|NCT00041327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6344487|NCT00041327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6344488|NCT00041327|Alkylating Agents|alkylating agents|mesh-ancestor
6344489|NCT00041327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344490|NCT00041327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344491|NCT00041327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6344492|NCT00041327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6344493|NCT00041327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6344494|NCT00041327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6344495|NCT00041327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6344496|NCT00041327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6344497|NCT00041327|Glucocorticoids|glucocorticoids|mesh-ancestor
6344498|NCT00041327|Hormones|hormones|mesh-ancestor
6344499|NCT00041327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6344500|NCT00041327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6344501|NCT00041327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6344502|NCT00041327|Antiviral Agents|antiviral agents|mesh-ancestor
6344503|NCT00041327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6344504|NCT00041327|Tubulin Modulators|tubulin modulators|mesh-ancestor
6344505|NCT00041327|Antimitotic Agents|antimitotic agents|mesh-ancestor
6344506|NCT00041327|Mitosis Modulators|mitosis modulators|mesh-ancestor
6344507|NCT00041327|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6344508|NCT00041327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6344509|NCT00041327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6344510|NCT00041327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6344511|NCT00041327|Antimetabolites|antimetabolites|mesh-ancestor
6344512|NCT00041340|Imatinib Mesylate|imatinib mesylate|mesh-list
6344513|NCT00041340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344514|NCT00041340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6344515|NCT00041340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6344516|NCT00041340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344517|NCT00041431|Hormones|hormones|mesh-list
6344518|NCT00041431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6344519|NCT00041431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6393926|NCT00200434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6393927|NCT00200447|Carbidopa|carbidopa|mesh-list
6393928|NCT00200447|Levodopa|levodopa|mesh-list
6393929|NCT00200447|Entacapone|entacapone|mesh-list
6393930|NCT00200447|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
6393931|NCT00200447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6393932|NCT00200447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6393933|NCT00200447|Dopamine Agents|dopamine agents|mesh-ancestor
6393934|NCT00200447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6393935|NCT00200447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393936|NCT00200447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6393937|NCT00200447|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6393938|NCT00200447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6393939|NCT00200447|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6393940|NCT00200460|Nebivolol|nebivolol|mesh-list
6393941|NCT00200460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6393942|NCT00200460|Vasodilator Agents|vasodilator agents|mesh-ancestor
6393943|NCT00200460|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6393944|NCT00200460|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6393945|NCT00200460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6393946|NCT00200460|Adrenergic Agents|adrenergic agents|mesh-ancestor
6393947|NCT00200460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6393948|NCT00200460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393949|NCT00200460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6393950|NCT00200473|Nebivolol|nebivolol|mesh-list
6393951|NCT00200473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6393952|NCT00200473|Vasodilator Agents|vasodilator agents|mesh-ancestor
6393953|NCT00200473|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6393954|NCT00200473|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6393955|NCT00200473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6393956|NCT00200473|Adrenergic Agents|adrenergic agents|mesh-ancestor
6393957|NCT00200473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6393958|NCT00200473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393959|NCT00200473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6393960|NCT00200499|Nebivolol|nebivolol|mesh-list
6393961|NCT00200499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6393962|NCT00200499|Vasodilator Agents|vasodilator agents|mesh-ancestor
6393963|NCT00200499|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6393964|NCT00200499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6393965|NCT00200499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6393966|NCT00200499|Adrenergic Agents|adrenergic agents|mesh-ancestor
6393967|NCT00200499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6393968|NCT00200499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393969|NCT00200499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6393970|NCT00200512|Apomorphine|apomorphine|mesh-list
6393971|NCT00200512|Emetics|emetics|mesh-ancestor
6393972|NCT00200512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6393973|NCT00200512|Autonomic Agents|autonomic agents|mesh-ancestor
6393974|NCT00200512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6393975|NCT00200512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6393976|NCT00200512|Dopamine Agonists|dopamine agonists|mesh-ancestor
6393977|NCT00200512|Dopamine Agents|dopamine agents|mesh-ancestor
6393978|NCT00200512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6393979|NCT00200512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393980|NCT00200525|Apomorphine|apomorphine|mesh-list
6393981|NCT00200525|Emetics|emetics|mesh-ancestor
6393982|NCT00200525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6393983|NCT00200525|Autonomic Agents|autonomic agents|mesh-ancestor
6344520|NCT00041483|Anecortave|anecortave|mesh-list
6344521|NCT00041483|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6344522|NCT00041483|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6344523|NCT00041483|Growth Substances|growth substances|mesh-ancestor
6344524|NCT00041483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6344525|NCT00041483|Growth Inhibitors|growth inhibitors|mesh-ancestor
6344526|NCT00041483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344527|NCT00041535|Miglustat|miglustat|mesh-list
6344528|NCT00041535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6344529|NCT00041535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344530|NCT00041535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6344531|NCT00041535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6344532|NCT00041535|Antiviral Agents|antiviral agents|mesh-ancestor
6344533|NCT00041535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6344534|NCT00041535|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6344535|NCT00041535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6344536|NCT00041535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6344537|NCT00041548|Nitric Oxide|nitric oxide|mesh-list
6344538|NCT00041548|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6344539|NCT00041548|Autonomic Agents|autonomic agents|mesh-ancestor
6344540|NCT00041548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6344541|NCT00041548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6344542|NCT00041548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6344543|NCT00041548|Respiratory System Agents|respiratory system agents|mesh-ancestor
6344544|NCT00041548|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6344545|NCT00041548|Antioxidants|antioxidants|mesh-ancestor
6344546|NCT00041548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344547|NCT00041548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6344548|NCT00041548|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6344549|NCT00041548|Vasodilator Agents|vasodilator agents|mesh-ancestor
6344550|NCT00041548|Gasotransmitters|gasotransmitters|mesh-ancestor
6344551|NCT00041548|Protective Agents|protective agents|mesh-ancestor
6344552|NCT00041561|Nitric Oxide|nitric oxide|mesh-list
6344553|NCT00041561|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6344554|NCT00041561|Autonomic Agents|autonomic agents|mesh-ancestor
6344555|NCT00041561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6344556|NCT00041561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6344557|NCT00041561|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6344558|NCT00041561|Respiratory System Agents|respiratory system agents|mesh-ancestor
6344559|NCT00041561|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6344560|NCT00041561|Antioxidants|antioxidants|mesh-ancestor
6344561|NCT00041561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344562|NCT00041561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6344563|NCT00041561|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6344564|NCT00041561|Vasodilator Agents|vasodilator agents|mesh-ancestor
6344565|NCT00041561|Gasotransmitters|gasotransmitters|mesh-ancestor
6344566|NCT00041561|Protective Agents|protective agents|mesh-ancestor
6344567|NCT00041574|Nitric Oxide|nitric oxide|mesh-list
6344568|NCT00041574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6344569|NCT00041574|Autonomic Agents|autonomic agents|mesh-ancestor
6344570|NCT00041574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6344571|NCT00041574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6344572|NCT00041574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6344573|NCT00041574|Respiratory System Agents|respiratory system agents|mesh-ancestor
6344574|NCT00041574|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6344575|NCT00041574|Antioxidants|antioxidants|mesh-ancestor
6016880|NCT00368641|Dialysis Solutions|dialysis solutions|mesh-ancestor
6016881|NCT00368641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6016882|NCT00368745|Pregabalin|pregabalin|mesh-list
6016883|NCT00368745|Analgesics|analgesics|mesh-ancestor
6016884|NCT00368745|Sensory System Agents|sensory system agents|mesh-ancestor
6016885|NCT00368745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6016886|NCT00368745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016887|NCT00368745|Anticonvulsants|anticonvulsants|mesh-ancestor
6016888|NCT00368745|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6016889|NCT00368745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6344576|NCT00041574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344577|NCT00041574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6344578|NCT00041574|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6344579|NCT00041574|Vasodilator Agents|vasodilator agents|mesh-ancestor
6344580|NCT00041574|Gasotransmitters|gasotransmitters|mesh-ancestor
6344581|NCT00041574|Protective Agents|protective agents|mesh-ancestor
6344582|NCT00041639|Labetuzumab|labetuzumab|mesh-list
6344583|NCT00041639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6344584|NCT00041639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344585|NCT00041652|Labetuzumab|labetuzumab|mesh-list
6344586|NCT00041652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6344587|NCT00041652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344588|NCT00041665|Mitogens|mitogens|mesh-list
6344589|NCT00041665|Mitosis Modulators|mitosis modulators|mesh-ancestor
6344590|NCT00041665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344591|NCT00041678|Aripiprazole|aripiprazole|mesh-list
6344592|NCT00041678|Antidepressive Agents|antidepressive agents|mesh-ancestor
6344593|NCT00041678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6344594|NCT00041678|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6344595|NCT00041678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6344596|NCT00041678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6344597|NCT00041678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6344598|NCT00041678|Dopamine Agonists|dopamine agonists|mesh-ancestor
6344599|NCT00041678|Dopamine Agents|dopamine agents|mesh-ancestor
6344600|NCT00041678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6344601|NCT00041678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344602|NCT00041678|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6344603|NCT00041678|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6344604|NCT00041678|Serotonin Agents|serotonin agents|mesh-ancestor
6344605|NCT00041678|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6344606|NCT00041678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6344607|NCT00041678|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6344608|NCT00041678|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6016890|NCT00368745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344609|NCT00041691|Labetuzumab|labetuzumab|mesh-list
6344610|NCT00041691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6344611|NCT00041691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344612|NCT00041704|Anidulafungin|anidulafungin|mesh-list
6344613|NCT00041704|Antifungal Agents|antifungal agents|mesh-ancestor
6344614|NCT00041704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6016891|NCT00368745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6016892|NCT00368745|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6016893|NCT00368745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6016894|NCT00368745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6016895|NCT00368745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6016896|NCT00368849|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6016897|NCT00368849|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6016898|NCT00368849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6016899|NCT00368849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6344615|NCT00041782|Dalteparin|dalteparin|mesh-list
6344616|NCT00041782|Tinzaparin|tinzaparin|mesh-list
6344617|NCT00041782|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6344618|NCT00041782|Anticoagulants|anticoagulants|mesh-ancestor
6344619|NCT00041782|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6344620|NCT00041782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6393984|NCT00200525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6344621|NCT00041782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344622|NCT00041899|Ulipristal acetate|ulipristal acetate|mesh-list
6344623|NCT00041899|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6344624|NCT00041899|Contraceptive Agents|contraceptive agents|mesh-ancestor
6344625|NCT00041899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6344626|NCT00041899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6344627|NCT00041899|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6344628|NCT00041977|Doxycycline|doxycycline|mesh-list
6344629|NCT00041977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6344630|NCT00041977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6344631|NCT00041977|Antimalarials|antimalarials|mesh-ancestor
6344632|NCT00041977|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6344633|NCT00041977|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6344634|NCT00041990|Decitabine|decitabine|mesh-list
6344635|NCT00041990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6344636|NCT00041990|Antimetabolites|antimetabolites|mesh-ancestor
6344637|NCT00041990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344638|NCT00041990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344639|NCT00041990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6344640|NCT00042003|Decitabine|decitabine|mesh-list
6344641|NCT00042003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6344642|NCT00042003|Antimetabolites|antimetabolites|mesh-ancestor
6344643|NCT00042003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344644|NCT00042003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344645|NCT00042003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6344646|NCT00042016|Decitabine|decitabine|mesh-list
6344647|NCT00042016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6344648|NCT00042016|Antimetabolites|antimetabolites|mesh-ancestor
6344649|NCT00042016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344650|NCT00042016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344651|NCT00042016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6344652|NCT00042029|Aprepitant|aprepitant|mesh-list
6344653|NCT00042029|Antiemetics|antiemetics|mesh-ancestor
6344654|NCT00042029|Autonomic Agents|autonomic agents|mesh-ancestor
6344655|NCT00042029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6344656|NCT00042029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6344657|NCT00042029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6344658|NCT00042029|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6344659|NCT00042029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6344660|NCT00042029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344661|NCT00042068|Meloxicam|meloxicam|mesh-list
6344662|NCT00042068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6344663|NCT00042068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6344664|NCT00042068|Analgesics|analgesics|mesh-ancestor
6344665|NCT00042068|Sensory System Agents|sensory system agents|mesh-ancestor
6344666|NCT00042068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6344667|NCT00042068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6344668|NCT00042068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6344669|NCT00042068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6344670|NCT00042068|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6344671|NCT00042068|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6344672|NCT00042068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6344673|NCT00042068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344674|NCT00042146|Zolpidem|zolpidem|mesh-list
6344675|NCT00042146|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6344676|NCT00042146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6344677|NCT00042146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6344678|NCT00042146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6344679|NCT00042146|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6344680|NCT00042146|GABA Agonists|gaba agonists|mesh-ancestor
6344681|NCT00042146|GABA Agents|gaba agents|mesh-ancestor
6344682|NCT00042146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6344683|NCT00042146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344684|NCT00042172|Donepezil|donepezil|mesh-list
6344685|NCT00042172|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6344686|NCT00042172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6344687|NCT00042172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344688|NCT00042172|Cholinergic Agents|cholinergic agents|mesh-ancestor
6344689|NCT00042172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6344690|NCT00042172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6344691|NCT00042172|Nootropic Agents|nootropic agents|mesh-ancestor
6344692|NCT00042289|Ritonavir|ritonavir|mesh-list
6344693|NCT00042289|Lopinavir|lopinavir|mesh-list
6344694|NCT00042289|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6344695|NCT00042289|Darunavir|darunavir|mesh-list
6344696|NCT00042289|Tenofovir|tenofovir|mesh-list
6344697|NCT00042289|Nevirapine|nevirapine|mesh-list
6344698|NCT00042289|Dolutegravir|dolutegravir|mesh-list
6344699|NCT00042289|Cobicistat|cobicistat|mesh-list
6344700|NCT00042289|Elvitegravir|elvitegravir|mesh-list
6344701|NCT00042289|Moxifloxacin|moxifloxacin|mesh-list
6344702|NCT00042289|Efavirenz|efavirenz|mesh-list
6344703|NCT00042289|Levofloxacin|levofloxacin|mesh-list
6344704|NCT00042289|Ofloxacin|ofloxacin|mesh-list
6344705|NCT00042289|Rifampin|rifampin|mesh-list
6344706|NCT00042289|Isoniazid|isoniazid|mesh-list
6344707|NCT00042289|Cycloserine|cycloserine|mesh-list
6344708|NCT00042289|Linezolid|linezolid|mesh-list
6344709|NCT00042289|Amikacin|amikacin|mesh-list
6344710|NCT00042289|Pyrazinamide|pyrazinamide|mesh-list
6344711|NCT00042289|Ethambutol|ethambutol|mesh-list
6344712|NCT00042289|Bedaquiline|bedaquiline|mesh-list
6344713|NCT00042289|Etravirine|etravirine|mesh-list
6344714|NCT00042289|Clofazimine|clofazimine|mesh-list
6344715|NCT00042289|Aminosalicylic Acid|aminosalicylic acid|mesh-list
6344716|NCT00042289|Kanamycin|kanamycin|mesh-list
6344717|NCT00042289|Ethionamide|ethionamide|mesh-list
6344718|NCT00042289|Capreomycin|capreomycin|mesh-list
6344719|NCT00042289|Prothionamide|prothionamide|mesh-list
6344720|NCT00042289|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6344721|NCT00042289|Etonogestrel|etonogestrel|mesh-list
6344722|NCT00042289|Contraceptive Agents|contraceptive agents|mesh-list
6344723|NCT00042289|Contraceptives, Oral|contraceptives, oral|mesh-list
6344724|NCT00042289|Estradiol|estradiol|mesh-list
6344725|NCT00042289|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6344726|NCT00042289|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6344727|NCT00042289|Protease Inhibitors|protease inhibitors|mesh-ancestor
6344728|NCT00042289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6344729|NCT00042289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344730|NCT00042289|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6344731|NCT00042289|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6344732|NCT00042289|Antiviral Agents|antiviral agents|mesh-ancestor
6344733|NCT00042289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6344734|NCT00042289|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6344735|NCT00042289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6344736|NCT00042289|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6344737|NCT00042289|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6344738|NCT00042289|Estrogens|estrogens|mesh-ancestor
6344739|NCT00042289|Hormones|hormones|mesh-ancestor
6344740|NCT00042289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6344741|NCT00042289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6344742|NCT00042289|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6344743|NCT00042289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6344744|NCT00042289|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6344745|NCT00042289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6344746|NCT00042289|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6344747|NCT00042289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6344748|NCT00042289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344749|NCT00042289|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6344750|NCT00042289|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6344751|NCT00042289|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6344752|NCT00042289|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6344753|NCT00042289|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6344754|NCT00042289|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6344755|NCT00042289|Renal Agents|renal agents|mesh-ancestor
6344756|NCT00042289|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6344757|NCT00042289|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6344758|NCT00042289|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6344759|NCT00042289|Antitubercular Agents|antitubercular agents|mesh-ancestor
6344760|NCT00042289|Leprostatic Agents|leprostatic agents|mesh-ancestor
6344761|NCT00042289|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6344762|NCT00042289|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6344763|NCT00042289|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6538114|NCT00825864|Hormones|hormones|mesh-ancestor
6344764|NCT00042289|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6344765|NCT00042289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6344766|NCT00042289|Antimetabolites|antimetabolites|mesh-ancestor
6344767|NCT00042289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6344768|NCT00042289|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6344769|NCT00042289|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6344770|NCT00042289|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6344771|NCT00042289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6344772|NCT00042302|Paclitaxel|paclitaxel|mesh-list
6344773|NCT00042302|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6344774|NCT00042302|Carboplatin|carboplatin|mesh-list
6344775|NCT00042302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6344776|NCT00042302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344777|NCT00042302|Tubulin Modulators|tubulin modulators|mesh-ancestor
6344778|NCT00042302|Antimitotic Agents|antimitotic agents|mesh-ancestor
6344779|NCT00042302|Mitosis Modulators|mitosis modulators|mesh-ancestor
6344780|NCT00042302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344781|NCT00042315|Vinorelbine|vinorelbine|mesh-list
6344782|NCT00042315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6344783|NCT00042315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344784|NCT00042315|Tubulin Modulators|tubulin modulators|mesh-ancestor
6344785|NCT00042315|Antimitotic Agents|antimitotic agents|mesh-ancestor
6344786|NCT00042315|Mitosis Modulators|mitosis modulators|mesh-ancestor
6344787|NCT00042315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344788|NCT00042328|Valacyclovir|valacyclovir|mesh-list
6344789|NCT00042328|Antiviral Agents|antiviral agents|mesh-ancestor
6344790|NCT00042328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6344791|NCT00042341|Clofarabine|clofarabine|mesh-list
6344792|NCT00042341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6344793|NCT00042341|Antimetabolites|antimetabolites|mesh-ancestor
6344794|NCT00042341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344795|NCT00042341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344796|NCT00042354|Clofarabine|clofarabine|mesh-list
6344797|NCT00042354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6344798|NCT00042354|Antimetabolites|antimetabolites|mesh-ancestor
6344799|NCT00042354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344800|NCT00042354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344801|NCT00042367|Mafosfamide|mafosfamide|mesh-list
6344802|NCT00042367|Cyclophosphamide|cyclophosphamide|mesh-list
6344803|NCT00042367|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6344804|NCT00042367|Immunologic Factors|immunologic factors|mesh-ancestor
6344805|NCT00042367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6344806|NCT00042367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344807|NCT00042367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6344808|NCT00042367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6344809|NCT00042367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6344810|NCT00042367|Alkylating Agents|alkylating agents|mesh-ancestor
6344811|NCT00042367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344812|NCT00042367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6344813|NCT00042393|Adefovir|adefovir|mesh-list
6344814|NCT00042393|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6344815|NCT00042393|Antiviral Agents|antiviral agents|mesh-ancestor
6344816|NCT00042393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6344817|NCT00042393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6344818|NCT00042393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6344819|NCT00042393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6344820|NCT00042393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344821|NCT00042406|Zanolimumab|zanolimumab|mesh-list
6344822|NCT00042406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6344823|NCT00042406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344824|NCT00042458|Pramlintide|pramlintide|mesh-list
6344825|NCT00042458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6344826|NCT00042458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6344827|NCT00042471|Pramlintide|pramlintide|mesh-list
6344828|NCT00042471|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
6344829|NCT00042471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6344830|NCT00042471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6344831|NCT00042471|Appetite Depressants|appetite depressants|mesh-ancestor
6344832|NCT00042471|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6344833|NCT00042471|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
6344834|NCT00042471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344835|NCT00042536|Naltrexone|naltrexone|mesh-list
6344836|NCT00042536|Yohimbine|yohimbine|mesh-list
6344837|NCT00042536|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6344838|NCT00042536|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6344839|NCT00042536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6344840|NCT00042536|Sensory System Agents|sensory system agents|mesh-ancestor
6344841|NCT00042536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6344842|NCT00042536|Mydriatics|mydriatics|mesh-ancestor
6344843|NCT00042536|Autonomic Agents|autonomic agents|mesh-ancestor
6344844|NCT00042536|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6344845|NCT00042536|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6344846|NCT00042536|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6344847|NCT00042536|Adrenergic Agents|adrenergic agents|mesh-ancestor
6344848|NCT00042536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6344849|NCT00042536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344850|NCT00042536|Urological Agents|urological agents|mesh-ancestor
6344851|NCT00042549|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
6344852|NCT00042549|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6344853|NCT00042549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6344854|NCT00042562|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6344855|NCT00042562|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6344856|NCT00042562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6344857|NCT00042562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6344858|NCT00042562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344859|NCT00042562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6344860|NCT00042562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6344861|NCT00042562|Analgesics|analgesics|mesh-ancestor
6344862|NCT00042562|Sensory System Agents|sensory system agents|mesh-ancestor
6344863|NCT00042562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6344864|NCT00042562|Antidepressive Agents|antidepressive agents|mesh-ancestor
6344865|NCT00042562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6344866|NCT00042562|Dopamine Agents|dopamine agents|mesh-ancestor
6344867|NCT00042575|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6344868|NCT00042575|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6344869|NCT00042575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6344870|NCT00042575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6344871|NCT00042575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344872|NCT00042575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6344873|NCT00042575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6344874|NCT00042575|Analgesics|analgesics|mesh-ancestor
6344875|NCT00042575|Sensory System Agents|sensory system agents|mesh-ancestor
6344876|NCT00042575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6344877|NCT00042575|Antidepressive Agents|antidepressive agents|mesh-ancestor
6344878|NCT00042575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6344879|NCT00042575|Dopamine Agents|dopamine agents|mesh-ancestor
6344880|NCT00042588|Antibodies|antibodies|mesh-list
6344881|NCT00042588|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6344882|NCT00042588|Immunologic Factors|immunologic factors|mesh-ancestor
6344883|NCT00042588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6344884|NCT00042601|Pramlintide|pramlintide|mesh-list
6344885|NCT00042601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6344886|NCT00042601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6344887|NCT00042653|Cinacalcet|cinacalcet|mesh-list
6344888|NCT00042653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6344889|NCT00042653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6344890|NCT00042653|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6344891|NCT00042653|Hormone Antagonists|hormone antagonists|mesh-ancestor
6344892|NCT00042653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6344893|NCT00042679|Gemcitabine|gemcitabine|mesh-list
6344894|NCT00042679|Carboplatin|carboplatin|mesh-list
6344895|NCT00042679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344896|NCT00042679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6344897|NCT00042679|Antimetabolites|antimetabolites|mesh-ancestor
6344898|NCT00042679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344899|NCT00042679|Antiviral Agents|antiviral agents|mesh-ancestor
6344900|NCT00042679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6344901|NCT00042679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6344902|NCT00042679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6344903|NCT00042679|Immunologic Factors|immunologic factors|mesh-ancestor
6344904|NCT00042679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6344905|NCT00042718|Amoxicillin|amoxicillin|mesh-list
6344906|NCT00042718|Azithromycin|azithromycin|mesh-list
6344907|NCT00042718|Levofloxacin|levofloxacin|mesh-list
6344908|NCT00042718|Ofloxacin|ofloxacin|mesh-list
6344909|NCT00042718|Clavulanic Acid|clavulanic acid|mesh-list
6344910|NCT00042718|Clavulanic Acids|clavulanic acids|mesh-list
6344911|NCT00042718|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6344912|NCT00042718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6344913|NCT00042718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6344914|NCT00042718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6344915|NCT00042718|Renal Agents|renal agents|mesh-ancestor
6344916|NCT00042718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6344917|NCT00042718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6344918|NCT00042718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6344919|NCT00042718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344920|NCT00042718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344921|NCT00042718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6344922|NCT00042718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6344923|NCT00042718|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6344924|NCT00042731|Lycopene|lycopene|mesh-list
6344925|NCT00042731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6344926|NCT00042731|Antioxidants|antioxidants|mesh-ancestor
6344927|NCT00042731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344928|NCT00042731|Protective Agents|protective agents|mesh-ancestor
6344929|NCT00042731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6344930|NCT00042731|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6344931|NCT00042731|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6344932|NCT00042731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344933|NCT00042796|Decitabine|decitabine|mesh-list
6344934|NCT00042796|Azacitidine|azacitidine|mesh-list
6344935|NCT00042796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6344936|NCT00042796|Antimetabolites|antimetabolites|mesh-ancestor
6344937|NCT00042796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344938|NCT00042796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344939|NCT00042796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6344940|NCT00042809|Paclitaxel|paclitaxel|mesh-list
6344941|NCT00042809|Trastuzumab|trastuzumab|mesh-list
6344942|NCT00042809|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6344943|NCT00042809|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6344944|NCT00042809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344945|NCT00042809|Tubulin Modulators|tubulin modulators|mesh-ancestor
6344946|NCT00042809|Antimitotic Agents|antimitotic agents|mesh-ancestor
6344947|NCT00042809|Mitosis Modulators|mitosis modulators|mesh-ancestor
6344948|NCT00042809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344949|NCT00042809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6344950|NCT00042809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6344951|NCT00042809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6344952|NCT00042822|Romidepsin|romidepsin|mesh-list
6344953|NCT00042822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6344954|NCT00042822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344955|NCT00042835|Paclitaxel|paclitaxel|mesh-list
6344956|NCT00042835|Etoposide|etoposide|mesh-list
6344957|NCT00042835|Docetaxel|docetaxel|mesh-list
6344958|NCT00042835|Carboplatin|carboplatin|mesh-list
6344959|NCT00042835|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6016900|NCT00368849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016901|NCT00368849|Adrenergic Agents|adrenergic agents|mesh-ancestor
6016902|NCT00368849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6016903|NCT00368849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016904|NCT00368875|Paclitaxel|paclitaxel|mesh-list
6344960|NCT00042835|Etoposide phosphate|etoposide phosphate|mesh-list
6344961|NCT00042835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6344962|NCT00042835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344963|NCT00042835|Tubulin Modulators|tubulin modulators|mesh-ancestor
6344964|NCT00042835|Antimitotic Agents|antimitotic agents|mesh-ancestor
6344965|NCT00042835|Mitosis Modulators|mitosis modulators|mesh-ancestor
6344966|NCT00042835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344967|NCT00042835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6344968|NCT00042835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6344969|NCT00042835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6344970|NCT00042835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6344971|NCT00042848|Modafinil|modafinil|mesh-list
6344972|NCT00042848|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6344973|NCT00042848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6344974|NCT00042848|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6344975|NCT00042848|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6344976|NCT00042848|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6344977|NCT00042848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344978|NCT00042861|Leucovorin|leucovorin|mesh-list
6344979|NCT00042861|Fluorouracil|fluorouracil|mesh-list
6344980|NCT00042861|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
6344981|NCT00042861|Calcium|calcium|mesh-list
6344982|NCT00042861|Levoleucovorin|levoleucovorin|mesh-list
6344983|NCT00042861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6344984|NCT00042861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6344985|NCT00042861|Antimetabolites|antimetabolites|mesh-ancestor
6344986|NCT00042861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6344987|NCT00042861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6344988|NCT00042861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6344989|NCT00042861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6344990|NCT00042861|Immunologic Factors|immunologic factors|mesh-ancestor
6344991|NCT00042861|Antidotes|antidotes|mesh-ancestor
6344992|NCT00042861|Protective Agents|protective agents|mesh-ancestor
6344993|NCT00042861|Vitamin B Complex|vitamin b complex|mesh-ancestor
6344994|NCT00042861|Vitamins|vitamins|mesh-ancestor
6344995|NCT00042861|Micronutrients|micronutrients|mesh-ancestor
6344996|NCT00042861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6344997|NCT00042861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6344998|NCT00042874|Leucovorin|leucovorin|mesh-list
6344999|NCT00042874|Fluorouracil|fluorouracil|mesh-list
6345000|NCT00042874|Irinotecan|irinotecan|mesh-list
6016905|NCT00368875|Bevacizumab|bevacizumab|mesh-list
6016906|NCT00368875|Vorinostat|vorinostat|mesh-list
6345001|NCT00042874|Alvocidib|alvocidib|mesh-list
6345002|NCT00042874|Calcium|calcium|mesh-list
6345003|NCT00042874|Levoleucovorin|levoleucovorin|mesh-list
6345004|NCT00042874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6345005|NCT00042874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6345006|NCT00042874|Antimetabolites|antimetabolites|mesh-ancestor
6345007|NCT00042874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345008|NCT00042874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6345009|NCT00042874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6345010|NCT00042874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6345011|NCT00042874|Immunologic Factors|immunologic factors|mesh-ancestor
6345012|NCT00042874|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6345013|NCT00042874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6345014|NCT00042874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6345015|NCT00042874|Antidotes|antidotes|mesh-ancestor
6345016|NCT00042874|Protective Agents|protective agents|mesh-ancestor
6345017|NCT00042874|Vitamin B Complex|vitamin b complex|mesh-ancestor
6345018|NCT00042874|Vitamins|vitamins|mesh-ancestor
6345019|NCT00042874|Micronutrients|micronutrients|mesh-ancestor
6345020|NCT00042874|Growth Inhibitors|growth inhibitors|mesh-ancestor
6345021|NCT00042874|Growth Substances|growth substances|mesh-ancestor
6345022|NCT00042874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6345023|NCT00042887|Mitomycins|mitomycins|mesh-list
6345024|NCT00042887|Mitomycin|mitomycin|mesh-list
6345025|NCT00042887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6345026|NCT00042887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6345027|NCT00042887|Alkylating Agents|alkylating agents|mesh-ancestor
6345028|NCT00042887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345029|NCT00042887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6345030|NCT00042887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6345031|NCT00042913|Epratuzumab|epratuzumab|mesh-list
6345032|NCT00042913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6345033|NCT00042913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6345034|NCT00042926|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
6345035|NCT00042926|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6345036|NCT00042926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393985|NCT00200525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6393986|NCT00200525|Dopamine Agonists|dopamine agonists|mesh-ancestor
6393987|NCT00200525|Dopamine Agents|dopamine agents|mesh-ancestor
6393988|NCT00200525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6393989|NCT00200525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393990|NCT00200538|Memantine|memantine|mesh-list
6393991|NCT00200538|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6393992|NCT00200538|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6393993|NCT00200538|Dopamine Agents|dopamine agents|mesh-ancestor
6393994|NCT00200538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6393995|NCT00200538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6393996|NCT00200538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6393997|NCT00200538|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6393998|NCT00200538|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6393999|NCT00200551|Cyclosporine|cyclosporine|mesh-list
6394000|NCT00200551|Mycophenolic Acid|mycophenolic acid|mesh-list
6394001|NCT00200551|Cyclosporins|cyclosporins|mesh-list
6394002|NCT00200551|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6394003|NCT00200551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6394004|NCT00200551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394005|NCT00200551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6394006|NCT00200551|Immunologic Factors|immunologic factors|mesh-ancestor
6394007|NCT00200551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394008|NCT00200551|Antifungal Agents|antifungal agents|mesh-ancestor
6394009|NCT00200551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6394010|NCT00200551|Dermatologic Agents|dermatologic agents|mesh-ancestor
6394011|NCT00200551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6394012|NCT00200551|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6394013|NCT00200551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6394014|NCT00200551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6394015|NCT00200551|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6394016|NCT00200551|Antitubercular Agents|antitubercular agents|mesh-ancestor
6394017|NCT00200551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6394018|NCT00200564|Ketamine|ketamine|mesh-list
6394019|NCT00200564|Analgesics|analgesics|mesh-ancestor
6394020|NCT00200564|Sensory System Agents|sensory system agents|mesh-ancestor
6394021|NCT00200564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6394022|NCT00200564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394023|NCT00200564|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6345037|NCT00042952|Imatinib Mesylate|imatinib mesylate|mesh-list
6345038|NCT00042952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6345039|NCT00042952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6345040|NCT00042952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6345041|NCT00042952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345042|NCT00042965|Gemcitabine|gemcitabine|mesh-list
6345043|NCT00042965|Capecitabine|capecitabine|mesh-list
6345044|NCT00042965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6345045|NCT00042965|Antimetabolites|antimetabolites|mesh-ancestor
6345046|NCT00042965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345047|NCT00042965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6345048|NCT00042965|Antiviral Agents|antiviral agents|mesh-ancestor
6345049|NCT00042965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6345050|NCT00042965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6345051|NCT00042965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6345052|NCT00042965|Immunologic Factors|immunologic factors|mesh-ancestor
6345053|NCT00042965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6345054|NCT00042978|Carboplatin|carboplatin|mesh-list
6345055|NCT00042978|Etoposide|etoposide|mesh-list
6345056|NCT00042978|Etoposide phosphate|etoposide phosphate|mesh-list
6345057|NCT00042978|Oblimersen|oblimersen|mesh-list
6345058|NCT00042978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6345059|NCT00042978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6345060|NCT00042978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6345061|NCT00042978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6345062|NCT00042978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6345063|NCT00042978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345064|NCT00043004|Leucovorin|leucovorin|mesh-list
6345065|NCT00043004|Bevacizumab|bevacizumab|mesh-list
6345066|NCT00043004|Fluorouracil|fluorouracil|mesh-list
6345067|NCT00043004|Oxaliplatin|oxaliplatin|mesh-list
6345068|NCT00043004|Calcium|calcium|mesh-list
6345069|NCT00043004|Levoleucovorin|levoleucovorin|mesh-list
6345070|NCT00043004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6345071|NCT00043004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6345072|NCT00043004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6345073|NCT00043004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6345074|NCT00043004|Growth Substances|growth substances|mesh-ancestor
6345075|NCT00043004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6345076|NCT00043004|Growth Inhibitors|growth inhibitors|mesh-ancestor
6345077|NCT00043004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6345078|NCT00043004|Antimetabolites|antimetabolites|mesh-ancestor
6345079|NCT00043004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345080|NCT00043004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6345081|NCT00043004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6345082|NCT00043004|Immunologic Factors|immunologic factors|mesh-ancestor
6345083|NCT00043004|Antidotes|antidotes|mesh-ancestor
6345084|NCT00043004|Protective Agents|protective agents|mesh-ancestor
6345085|NCT00043004|Vitamin B Complex|vitamin b complex|mesh-ancestor
6345086|NCT00043004|Vitamins|vitamins|mesh-ancestor
6345087|NCT00043004|Micronutrients|micronutrients|mesh-ancestor
6345088|NCT00043043|Celecoxib|celecoxib|mesh-list
6345089|NCT00043043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6345090|NCT00043043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6345091|NCT00043043|Analgesics|analgesics|mesh-ancestor
6345092|NCT00043043|Sensory System Agents|sensory system agents|mesh-ancestor
6345093|NCT00043043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6345094|NCT00043043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6345095|NCT00043043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6345096|NCT00043043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6345097|NCT00043043|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6345098|NCT00043043|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6345099|NCT00043043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6345100|NCT00043043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345101|NCT00043069|Cholecalciferol|cholecalciferol|mesh-list
6345102|NCT00043069|Risedronic Acid|risedronic acid|mesh-list
6345103|NCT00043069|Calcium Carbonate|calcium carbonate|mesh-list
6345104|NCT00043069|Estrogens|estrogens|mesh-list
6345105|NCT00043069|Estrogen Antagonists|estrogen antagonists|mesh-list
6345106|NCT00043069|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-list
6345107|NCT00043069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6345108|NCT00043069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6345109|NCT00043069|Vitamins|vitamins|mesh-ancestor
6345110|NCT00043069|Micronutrients|micronutrients|mesh-ancestor
6345111|NCT00043069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6345112|NCT00043069|Hormones|hormones|mesh-ancestor
6345113|NCT00043069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6345114|NCT00043069|Antacids|antacids|mesh-ancestor
6345115|NCT00043069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345116|NCT00043069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6345117|NCT00043069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6345118|NCT00043069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6345119|NCT00043069|Hormone Antagonists|hormone antagonists|mesh-ancestor
6345120|NCT00043082|Carboplatin|carboplatin|mesh-list
6345121|NCT00043082|Doxorubicin|doxorubicin|mesh-list
6345122|NCT00043082|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6345123|NCT00043082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6345124|NCT00043082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6345125|NCT00043082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6345126|NCT00043082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6345127|NCT00043082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6345128|NCT00043082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345129|NCT00043095|Gemcitabine|gemcitabine|mesh-list
6345130|NCT00043095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6345131|NCT00043095|Antimetabolites|antimetabolites|mesh-ancestor
6345132|NCT00043095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345133|NCT00043095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6345134|NCT00043095|Antiviral Agents|antiviral agents|mesh-ancestor
6345135|NCT00043095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6345136|NCT00043095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6345137|NCT00043095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6345138|NCT00043095|Immunologic Factors|immunologic factors|mesh-ancestor
6345139|NCT00043095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6345140|NCT00043121|Leucovorin|leucovorin|mesh-list
6345141|NCT00043121|Fluorouracil|fluorouracil|mesh-list
6345142|NCT00043121|Capecitabine|capecitabine|mesh-list
6345143|NCT00043121|Oxaliplatin|oxaliplatin|mesh-list
6345144|NCT00043121|Calcium|calcium|mesh-list
6345145|NCT00043121|Levoleucovorin|levoleucovorin|mesh-list
6345146|NCT00043121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6345147|NCT00043121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6345148|NCT00043121|Antimetabolites|antimetabolites|mesh-ancestor
6345149|NCT00043121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345150|NCT00043121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6345151|NCT00043121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6345152|NCT00043121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6345153|NCT00043121|Immunologic Factors|immunologic factors|mesh-ancestor
6345154|NCT00043121|Antidotes|antidotes|mesh-ancestor
6345155|NCT00043121|Protective Agents|protective agents|mesh-ancestor
6345156|NCT00043121|Vitamin B Complex|vitamin b complex|mesh-ancestor
6345157|NCT00043121|Vitamins|vitamins|mesh-ancestor
6345158|NCT00043121|Micronutrients|micronutrients|mesh-ancestor
6345159|NCT00043134|Decitabine|decitabine|mesh-list
6345160|NCT00043134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6345161|NCT00043134|Antimetabolites|antimetabolites|mesh-ancestor
6345162|NCT00043134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345163|NCT00043134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6345164|NCT00043134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6345165|NCT00043147|Prednisone|prednisone|mesh-list
6345166|NCT00043147|Methylprednisolone|methylprednisolone|mesh-list
6345167|NCT00043147|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6345168|NCT00043147|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6345169|NCT00043147|Prednisolone|prednisolone|mesh-list
6345170|NCT00043147|Prednisolone acetate|prednisolone acetate|mesh-list
6345171|NCT00043147|Beclomethasone|beclomethasone|mesh-list
6345172|NCT00043147|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6345173|NCT00043147|Prednisolone phosphate|prednisolone phosphate|mesh-list
6345174|NCT00043147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6345175|NCT00043147|Glucocorticoids|glucocorticoids|mesh-ancestor
6345176|NCT00043147|Hormones|hormones|mesh-ancestor
6345177|NCT00043147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6345178|NCT00043147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6345179|NCT00043147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6345180|NCT00043147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6345181|NCT00043147|Antiemetics|antiemetics|mesh-ancestor
6345182|NCT00043147|Autonomic Agents|autonomic agents|mesh-ancestor
6345183|NCT00043147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6345184|NCT00043147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6345185|NCT00043147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6345186|NCT00043147|Protective Agents|protective agents|mesh-ancestor
6345187|NCT00043147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6345188|NCT00043147|Respiratory System Agents|respiratory system agents|mesh-ancestor
6345189|NCT00043199|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II)|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii)|mesh-list
6345190|NCT00043199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6345191|NCT00043264|Azithromycin|azithromycin|mesh-list
6345192|NCT00043264|Rifampin|rifampin|mesh-list
6345193|NCT00043264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6345194|NCT00043264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6345195|NCT00043264|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6345196|NCT00043264|Antitubercular Agents|antitubercular agents|mesh-ancestor
6345197|NCT00043264|Leprostatic Agents|leprostatic agents|mesh-ancestor
6345198|NCT00043264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6345199|NCT00043264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6345200|NCT00043264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345201|NCT00043264|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6345202|NCT00043264|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6345203|NCT00043264|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6345204|NCT00043264|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6345205|NCT00043264|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6345206|NCT00043264|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6345207|NCT00043277|Bivalirudin|bivalirudin|mesh-list
6345208|NCT00043277|Antithrombins|antithrombins|mesh-ancestor
6345209|NCT00043277|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6345210|NCT00043277|Protease Inhibitors|protease inhibitors|mesh-ancestor
6345211|NCT00043277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6345212|NCT00043277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345213|NCT00043277|Anticoagulants|anticoagulants|mesh-ancestor
6345214|NCT00043303|Interferons|interferons|mesh-list
6345215|NCT00043303|Interferon-gamma|interferon-gamma|mesh-list
6345216|NCT00043303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6345217|NCT00043303|Antiviral Agents|antiviral agents|mesh-ancestor
6345218|NCT00043303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6345219|NCT00043316|Interferons|interferons|mesh-list
6345220|NCT00043316|Interferon-gamma|interferon-gamma|mesh-list
6345221|NCT00043316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6345222|NCT00043316|Antiviral Agents|antiviral agents|mesh-ancestor
6345223|NCT00043316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6345224|NCT00043329|Interferon-gamma|interferon-gamma|mesh-list
6345225|NCT00043329|Antiviral Agents|antiviral agents|mesh-ancestor
6345226|NCT00043329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6345227|NCT00043342|Interferons|interferons|mesh-list
6345228|NCT00043342|Interferon-gamma|interferon-gamma|mesh-list
6345229|NCT00043342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6345230|NCT00043342|Antiviral Agents|antiviral agents|mesh-ancestor
6345231|NCT00043342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6345232|NCT00043355|Interferons|interferons|mesh-list
6345233|NCT00043355|Interferon-gamma|interferon-gamma|mesh-list
6345234|NCT00043355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6345235|NCT00043355|Antiviral Agents|antiviral agents|mesh-ancestor
6345236|NCT00043355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6345237|NCT00043381|Decitabine|decitabine|mesh-list
6345238|NCT00043381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6345239|NCT00043381|Antimetabolites|antimetabolites|mesh-ancestor
6345240|NCT00043381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345241|NCT00043381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6345242|NCT00043381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6345243|NCT00043394|Trastuzumab|trastuzumab|mesh-list
6345244|NCT00043394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6345245|NCT00043394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6345246|NCT00043537|Fluoxetine|fluoxetine|mesh-list
6345247|NCT00043537|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6345248|NCT00043537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6345249|NCT00043537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6345250|NCT00043537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345251|NCT00043537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6345252|NCT00043537|Serotonin Agents|serotonin agents|mesh-ancestor
6345253|NCT00043537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6345254|NCT00043537|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6345255|NCT00043537|Antidepressive Agents|antidepressive agents|mesh-ancestor
6345256|NCT00043537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6345257|NCT00043537|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6345258|NCT00043537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6345259|NCT00043537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6345260|NCT00043576|Calcitriol|calcitriol|mesh-list
6345261|NCT00043576|Docetaxel|docetaxel|mesh-list
6345262|NCT00043576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6345263|NCT00043576|Tubulin Modulators|tubulin modulators|mesh-ancestor
6345264|NCT00043576|Antimitotic Agents|antimitotic agents|mesh-ancestor
6345265|NCT00043576|Mitosis Modulators|mitosis modulators|mesh-ancestor
6345266|NCT00043576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345267|NCT00043576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6345268|NCT00043576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6345269|NCT00043576|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6345270|NCT00043576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6345271|NCT00043576|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6345272|NCT00043576|Vitamins|vitamins|mesh-ancestor
6345273|NCT00043576|Micronutrients|micronutrients|mesh-ancestor
6345274|NCT00043576|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6345275|NCT00043589|Donepezil|donepezil|mesh-list
6345276|NCT00043589|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6345277|NCT00043589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6345278|NCT00043589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345279|NCT00043589|Cholinergic Agents|cholinergic agents|mesh-ancestor
6345280|NCT00043589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6345281|NCT00043589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6345282|NCT00043589|Nootropic Agents|nootropic agents|mesh-ancestor
6345283|NCT00043654|Mifepristone|mifepristone|mesh-list
6345284|NCT00043654|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6345285|NCT00043654|Abortifacient Agents|abortifacient agents|mesh-ancestor
6345286|NCT00043654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6345287|NCT00043654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6345288|NCT00043654|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6345289|NCT00043654|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6345290|NCT00043654|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6345291|NCT00043654|Contraceptive Agents|contraceptive agents|mesh-ancestor
6345292|NCT00043654|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6345293|NCT00043654|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6345294|NCT00043654|Hormone Antagonists|hormone antagonists|mesh-ancestor
6394024|NCT00200564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6345295|NCT00043654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6345296|NCT00043654|Luteolytic Agents|luteolytic agents|mesh-ancestor
6345297|NCT00043654|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6345298|NCT00043654|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6345299|NCT00043667|Daclizumab|daclizumab|mesh-list
6345300|NCT00043667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6345301|NCT00043667|Immunologic Factors|immunologic factors|mesh-ancestor
6345302|NCT00043667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6345303|NCT00043680|Celecoxib|celecoxib|mesh-list
6345304|NCT00043680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6345305|NCT00043680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6345306|NCT00043680|Analgesics|analgesics|mesh-ancestor
6345307|NCT00043680|Sensory System Agents|sensory system agents|mesh-ancestor
6345308|NCT00043680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6345309|NCT00043680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6345310|NCT00043680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6345311|NCT00043680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6345312|NCT00043680|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6345313|NCT00043680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6345314|NCT00043680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6345315|NCT00043680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345316|NCT00043706|Antibodies|antibodies|mesh-list
6345317|NCT00043706|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6345318|NCT00043706|Mitogens|mitogens|mesh-list
6345319|NCT00043706|Immunologic Factors|immunologic factors|mesh-ancestor
6345320|NCT00043706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6345321|NCT00043706|Mitosis Modulators|mitosis modulators|mesh-ancestor
6345322|NCT00043706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345323|NCT00043719|Vitamin D|vitamin d|mesh-list
6345324|NCT00043719|Nitroglycerin|nitroglycerin|mesh-list
6345325|NCT00043719|Calcium|calcium|mesh-list
6345326|NCT00043719|Vitamins|vitamins|mesh-ancestor
6345327|NCT00043719|Micronutrients|micronutrients|mesh-ancestor
6345328|NCT00043719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6345329|NCT00043719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6345330|NCT00043719|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6345331|NCT00043719|Vasodilator Agents|vasodilator agents|mesh-ancestor
6345332|NCT00043758|Tolvaptan|tolvaptan|mesh-list
6345333|NCT00043758|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6345334|NCT00043758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345335|NCT00043758|Natriuretic Agents|natriuretic agents|mesh-ancestor
6345336|NCT00043758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6345337|NCT00043771|Tolvaptan|tolvaptan|mesh-list
6345338|NCT00043771|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6345339|NCT00043771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345340|NCT00043771|Natriuretic Agents|natriuretic agents|mesh-ancestor
6345341|NCT00043771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6345342|NCT00043784|Enoxaparin|enoxaparin|mesh-list
6345343|NCT00043784|Anticoagulants|anticoagulants|mesh-ancestor
6345344|NCT00043784|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6345345|NCT00043784|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6345346|NCT00043784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345347|NCT00043810|Vidarabine|vidarabine|mesh-list
6345348|NCT00043810|Fludarabine|fludarabine|mesh-list
6345349|NCT00043810|Fludarabine phosphate|fludarabine phosphate|mesh-list
6345350|NCT00043810|Busulfan|busulfan|mesh-list
6345351|NCT00043810|GEL protein, Gelonium multiflorum|gel protein, gelonium multiflorum|mesh-list
6345352|NCT00043810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6345353|NCT00043810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6345354|NCT00043810|Antimetabolites|antimetabolites|mesh-ancestor
6345355|NCT00043810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345356|NCT00043810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6345357|NCT00043810|Immunologic Factors|immunologic factors|mesh-ancestor
6345358|NCT00043810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6345359|NCT00043810|Antiviral Agents|antiviral agents|mesh-ancestor
6345360|NCT00043810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6345361|NCT00043810|Alkylating Agents|alkylating agents|mesh-ancestor
6345362|NCT00043810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6345363|NCT00043810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6345364|NCT00043810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6345365|NCT00043810|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6345366|NCT00043810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6345367|NCT00043823|Bevacizumab|bevacizumab|mesh-list
6345368|NCT00043823|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6345369|NCT00043823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6345370|NCT00043823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6345371|NCT00043823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6345372|NCT00043823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6345373|NCT00043823|Growth Substances|growth substances|mesh-ancestor
6345374|NCT00043823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6345375|NCT00043823|Growth Inhibitors|growth inhibitors|mesh-ancestor
6345376|NCT00043823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6345377|NCT00043823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6345378|NCT00043823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345379|NCT00043849|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6345380|NCT00043849|Antidepressive Agents|antidepressive agents|mesh-ancestor
6345381|NCT00043849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6345382|NCT00043849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6345383|NCT00043849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6345384|NCT00043849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6345385|NCT00043849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6345386|NCT00043862|Topotecan|topotecan|mesh-list
6345387|NCT00043862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6345388|NCT00043862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6345389|NCT00043862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6345390|NCT00043862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345391|NCT00043862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6345392|NCT00043875|Lamotrigine|lamotrigine|mesh-list
6345393|NCT00043875|Anticonvulsants|anticonvulsants|mesh-ancestor
6345394|NCT00043875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6345395|NCT00043875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6345396|NCT00043875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345397|NCT00043875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6345398|NCT00043875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6345399|NCT00043875|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6345400|NCT00043875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6345401|NCT00043875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6345402|NCT00043875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6345403|NCT00043875|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6345404|NCT00043888|Ritonavir|ritonavir|mesh-list
6345405|NCT00043888|Fosamprenavir|fosamprenavir|mesh-list
6345406|NCT00043888|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6345407|NCT00043888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6345408|NCT00043888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6345409|NCT00043888|Protease Inhibitors|protease inhibitors|mesh-ancestor
6345410|NCT00043888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6394025|NCT00200564|Anesthetics, General|anesthetics, general|mesh-ancestor
6345411|NCT00043888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345412|NCT00043888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6345413|NCT00043888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6345414|NCT00043888|Antiviral Agents|antiviral agents|mesh-ancestor
6345415|NCT00043888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6345416|NCT00043888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6345417|NCT00043888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6345418|NCT00043888|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6345419|NCT00043888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6345420|NCT00043901|Lamotrigine|lamotrigine|mesh-list
6345421|NCT00043901|Anticonvulsants|anticonvulsants|mesh-ancestor
6345422|NCT00043901|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6345423|NCT00043901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6345424|NCT00043901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345425|NCT00043901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6345426|NCT00043901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6345427|NCT00043901|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6345428|NCT00043901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6345429|NCT00043901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6345430|NCT00043901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6345431|NCT00043901|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6345432|NCT00043914|Lamotrigine|lamotrigine|mesh-list
6345433|NCT00043914|Anticonvulsants|anticonvulsants|mesh-ancestor
6345434|NCT00043914|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6345435|NCT00043914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6345436|NCT00043914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345437|NCT00043914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6345438|NCT00043914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6345439|NCT00043914|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6345440|NCT00043914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6345441|NCT00043914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6345442|NCT00043914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6345443|NCT00043914|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6345444|NCT00043927|Cisplatin|cisplatin|mesh-list
6345445|NCT00043927|Etoposide|etoposide|mesh-list
6345446|NCT00043927|Topotecan|topotecan|mesh-list
6345447|NCT00043927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6345448|NCT00043927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6345449|NCT00043927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6345450|NCT00043927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6345451|NCT00043927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6345452|NCT00043927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345453|NCT00043927|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6345454|NCT00043940|Bivalirudin|bivalirudin|mesh-list
6345455|NCT00043940|Antithrombins|antithrombins|mesh-ancestor
6345456|NCT00043940|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6345457|NCT00043940|Protease Inhibitors|protease inhibitors|mesh-ancestor
6345458|NCT00043940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6345459|NCT00043940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345460|NCT00043940|Anticoagulants|anticoagulants|mesh-ancestor
6345461|NCT00043953|Ritonavir|ritonavir|mesh-list
6345462|NCT00043953|Lopinavir|lopinavir|mesh-list
6345463|NCT00043953|Saquinavir|saquinavir|mesh-list
6345464|NCT00043953|Lamivudine|lamivudine|mesh-list
6345465|NCT00043953|Zidovudine|zidovudine|mesh-list
6345466|NCT00043953|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6345467|NCT00043953|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6345468|NCT00043953|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6345469|NCT00043953|Protease Inhibitors|protease inhibitors|mesh-ancestor
6345470|NCT00043953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6345471|NCT00043953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345472|NCT00043953|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6345473|NCT00043953|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6345474|NCT00043953|Antiviral Agents|antiviral agents|mesh-ancestor
6345475|NCT00043953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6345476|NCT00043953|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6345477|NCT00043953|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6345478|NCT00043953|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6345479|NCT00043953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6345480|NCT00043953|Antimetabolites|antimetabolites|mesh-ancestor
6345481|NCT00043966|Ritonavir|ritonavir|mesh-list
6345482|NCT00043966|Lopinavir|lopinavir|mesh-list
6345483|NCT00043966|Tenofovir|tenofovir|mesh-list
6345484|NCT00043966|Emtricitabine|emtricitabine|mesh-list
6345485|NCT00043966|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6345486|NCT00043966|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6345487|NCT00043966|Protease Inhibitors|protease inhibitors|mesh-ancestor
6345488|NCT00043966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6345489|NCT00043966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345490|NCT00043966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6345491|NCT00043966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6345492|NCT00043966|Antiviral Agents|antiviral agents|mesh-ancestor
6345493|NCT00043966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6345494|NCT00043966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6345495|NCT00043966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6345496|NCT00043966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6345497|NCT00043966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6345498|NCT00044057|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6345499|NCT00044057|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6345500|NCT00044057|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6345501|NCT00044057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345502|NCT00044135|Clevudine|clevudine|mesh-list
6345503|NCT00044135|Antiviral Agents|antiviral agents|mesh-ancestor
6345504|NCT00044135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6345505|NCT00044148|Ruboxistaurin|ruboxistaurin|mesh-list
6345506|NCT00044148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6345507|NCT00044148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345508|NCT00044187|Sibutramine|sibutramine|mesh-list
6345509|NCT00044187|Antidepressive Agents|antidepressive agents|mesh-ancestor
6345510|NCT00044187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6345511|NCT00044187|Appetite Depressants|appetite depressants|mesh-ancestor
6345512|NCT00044187|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6345513|NCT00044265|Ramipril|ramipril|mesh-list
6345514|NCT00044265|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6345515|NCT00044265|Protease Inhibitors|protease inhibitors|mesh-ancestor
6345516|NCT00044265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6345517|NCT00044265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345518|NCT00044265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6345519|NCT00044278|Lamotrigine|lamotrigine|mesh-list
6345520|NCT00044278|Anticonvulsants|anticonvulsants|mesh-ancestor
6345521|NCT00044278|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6345522|NCT00044278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6345523|NCT00044278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345524|NCT00044278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6345525|NCT00044278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6345526|NCT00044278|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6345527|NCT00044278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6345528|NCT00044278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6345529|NCT00044278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6345530|NCT00044278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6345531|NCT00044291|Toremifene|toremifene|mesh-list
6345532|NCT00044291|Letrozole|letrozole|mesh-list
6345533|NCT00044291|Hormones|hormones|mesh-list
6345534|NCT00044291|Atamestane|atamestane|mesh-list
6345535|NCT00044291|Estrogen Antagonists|estrogen antagonists|mesh-list
6345536|NCT00044291|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-list
6345537|NCT00044291|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-list
6345538|NCT00044291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6345539|NCT00044291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6345540|NCT00044291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6345541|NCT00044291|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6345542|NCT00044291|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6345543|NCT00044291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6345544|NCT00044291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345545|NCT00044291|Hormone Antagonists|hormone antagonists|mesh-ancestor
6345546|NCT00044291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6345547|NCT00044291|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6345548|NCT00044291|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6345549|NCT00044343|Lapatinib|lapatinib|mesh-list
6345550|NCT00044343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6345551|NCT00044343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6345552|NCT00044343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6345553|NCT00044343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345554|NCT00044382|Lenalidomide|lenalidomide|mesh-list
6345555|NCT00044382|Immunologic Factors|immunologic factors|mesh-ancestor
6345556|NCT00044382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6345557|NCT00044382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6345558|NCT00044382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6345559|NCT00044382|Growth Substances|growth substances|mesh-ancestor
6345560|NCT00044382|Growth Inhibitors|growth inhibitors|mesh-ancestor
6345561|NCT00044382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6345562|NCT00044395|Ruboxistaurin|ruboxistaurin|mesh-list
6345563|NCT00044395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6345564|NCT00044395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345565|NCT00044408|Ruboxistaurin|ruboxistaurin|mesh-list
6345566|NCT00044408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6345567|NCT00044408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345568|NCT00044421|Ruboxistaurin|ruboxistaurin|mesh-list
6345569|NCT00044421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6345570|NCT00044421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345571|NCT00044434|Bupropion|bupropion|mesh-list
6345572|NCT00044434|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6345573|NCT00044434|Antidepressive Agents|antidepressive agents|mesh-ancestor
6345574|NCT00044434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6345575|NCT00044434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6345576|NCT00044434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6345577|NCT00044434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6345578|NCT00044434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345579|NCT00044434|Dopamine Agents|dopamine agents|mesh-ancestor
6345580|NCT00044434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6345581|NCT00044434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6345582|NCT00044434|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6345583|NCT00044434|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6345584|NCT00044434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6345585|NCT00044447|Glimepiride|glimepiride|mesh-list
6345586|NCT00044447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6345587|NCT00044447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6345588|NCT00044447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6345589|NCT00044447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6345590|NCT00044447|Immunologic Factors|immunologic factors|mesh-ancestor
6345591|NCT00044460|Rosiglitazone|rosiglitazone|mesh-list
6345592|NCT00044460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6345593|NCT00044460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6345594|NCT00044473|Levofloxacin|levofloxacin|mesh-list
6345595|NCT00044473|Ofloxacin|ofloxacin|mesh-list
6345596|NCT00044473|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6345597|NCT00044473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6345598|NCT00044473|Renal Agents|renal agents|mesh-ancestor
6345599|NCT00044473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6345600|NCT00044473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6345601|NCT00044473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6345602|NCT00044473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6345603|NCT00044473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345604|NCT00044473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6345605|NCT00044473|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6345606|NCT00044473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6345607|NCT00044486|Posaconazole|posaconazole|mesh-list
6345608|NCT00044486|Antifungal Agents|antifungal agents|mesh-ancestor
6345609|NCT00044486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6345610|NCT00044486|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6345611|NCT00044486|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6345612|NCT00044486|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6345613|NCT00044486|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6345614|NCT00044486|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6345615|NCT00044486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6345616|NCT00044486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345617|NCT00044486|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6345618|NCT00044486|Hormone Antagonists|hormone antagonists|mesh-ancestor
6345619|NCT00044486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6345620|NCT00044486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6345621|NCT00044525|Taxane|taxane|mesh-list
6345622|NCT00044525|IDN 5109|idn 5109|mesh-list
6345623|NCT00044525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6345624|NCT00044538|Taxane|taxane|mesh-list
6345625|NCT00044538|IDN 5109|idn 5109|mesh-list
6345626|NCT00044538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6394026|NCT00200564|Anesthetics|anesthetics|mesh-ancestor
6394027|NCT00200564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6394028|NCT00200564|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6394029|NCT00200564|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6394030|NCT00200564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6394031|NCT00200564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394032|NCT00200590|Acetaminophen|acetaminophen|mesh-list
6394033|NCT00200590|Morphine|morphine|mesh-list
6394034|NCT00200590|Nalbuphine|nalbuphine|mesh-list
6394035|NCT00200590|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6394036|NCT00200590|Narcotics|narcotics|mesh-ancestor
6394037|NCT00200590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6394038|NCT00200590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394039|NCT00200590|Analgesics|analgesics|mesh-ancestor
6394040|NCT00200590|Sensory System Agents|sensory system agents|mesh-ancestor
6394041|NCT00200590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6394042|NCT00200590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6394043|NCT00200590|Antipyretics|antipyretics|mesh-ancestor
6394044|NCT00200603|Calcium|calcium|mesh-list
6394045|NCT00200603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6394046|NCT00200603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394047|NCT00200616|Anti-Infective Agents|anti-infective agents|mesh-list
6394048|NCT00200616|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6394049|NCT00200629|Adenosine|adenosine|mesh-list
6394050|NCT00200629|Analgesics|analgesics|mesh-ancestor
6394051|NCT00200629|Sensory System Agents|sensory system agents|mesh-ancestor
6394052|NCT00200629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6394053|NCT00200629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394054|NCT00200629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6394055|NCT00200629|Vasodilator Agents|vasodilator agents|mesh-ancestor
6394056|NCT00200629|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6394057|NCT00200629|Purinergic Agonists|purinergic agonists|mesh-ancestor
6394058|NCT00200629|Purinergic Agents|purinergic agents|mesh-ancestor
6394059|NCT00200629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6394060|NCT00200629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394061|NCT00200655|Pravastatin|pravastatin|mesh-list
6394062|NCT00200655|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6394063|NCT00200655|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6394064|NCT00200655|Antimetabolites|antimetabolites|mesh-ancestor
6394065|NCT00200655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394066|NCT00200655|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6394067|NCT00200655|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6345627|NCT00044551|Taxane|taxane|mesh-list
6345628|NCT00044551|IDN 5109|idn 5109|mesh-list
6345629|NCT00044551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6345630|NCT00044564|IDN 5109|idn 5109|mesh-list
6345631|NCT00044564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6345632|NCT00044577|Tenofovir|tenofovir|mesh-list
6345633|NCT00044577|Lamivudine|lamivudine|mesh-list
6345634|NCT00044577|Abacavir|abacavir|mesh-list
6345635|NCT00044577|Dideoxynucleosides|dideoxynucleosides|mesh-list
6345636|NCT00044577|Antiviral Agents|antiviral agents|mesh-ancestor
6345637|NCT00044577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6345638|NCT00044577|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6345639|NCT00044577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6345640|NCT00044577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6345641|NCT00044577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345642|NCT00044577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6345643|NCT00044577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6345644|NCT00044577|Antimetabolites|antimetabolites|mesh-ancestor
6345645|NCT00044616|Fluoxetine|fluoxetine|mesh-list
6345646|NCT00044616|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6345647|NCT00044616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6345648|NCT00044616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6345649|NCT00044616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345650|NCT00044616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6345651|NCT00044616|Serotonin Agents|serotonin agents|mesh-ancestor
6345652|NCT00044616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6345653|NCT00044616|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6345654|NCT00044616|Antidepressive Agents|antidepressive agents|mesh-ancestor
6345655|NCT00044616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6345656|NCT00044616|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6345657|NCT00044616|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6345658|NCT00044616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6345659|NCT00044629|Zolpidem|zolpidem|mesh-list
6345660|NCT00044629|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6345661|NCT00044629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6345662|NCT00044629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6345663|NCT00044629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6345664|NCT00044629|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6345665|NCT00044629|GABA Agonists|gaba agonists|mesh-ancestor
6345666|NCT00044629|GABA Agents|gaba agents|mesh-ancestor
6345667|NCT00044629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6345668|NCT00044629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345669|NCT00044642|Lorazepam|lorazepam|mesh-list
6345670|NCT00044642|Anticonvulsants|anticonvulsants|mesh-ancestor
6345671|NCT00044642|Antiemetics|antiemetics|mesh-ancestor
6345672|NCT00044642|Autonomic Agents|autonomic agents|mesh-ancestor
6394068|NCT00200655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6345673|NCT00044642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6345674|NCT00044642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6345675|NCT00044642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6345676|NCT00044642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6345677|NCT00044642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6345678|NCT00044642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6345679|NCT00044642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6345680|NCT00044642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6345681|NCT00044642|GABA Modulators|gaba modulators|mesh-ancestor
6345682|NCT00044642|GABA Agents|gaba agents|mesh-ancestor
6345683|NCT00044642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6345684|NCT00044642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345685|NCT00044668|Exenatide|exenatide|mesh-list
6345686|NCT00044668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6345687|NCT00044668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6345688|NCT00044668|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6345689|NCT00044668|Incretins|incretins|mesh-ancestor
6345690|NCT00044668|Hormones|hormones|mesh-ancestor
6345691|NCT00044668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6345692|NCT00044681|Risperidone|risperidone|mesh-list
6345693|NCT00044681|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6345694|NCT00044681|Serotonin Agents|serotonin agents|mesh-ancestor
6345695|NCT00044681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6345696|NCT00044681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345697|NCT00044681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6345698|NCT00044681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6345699|NCT00044681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6345700|NCT00044681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6345701|NCT00044681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6345702|NCT00044681|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6345703|NCT00044681|Dopamine Agents|dopamine agents|mesh-ancestor
6345704|NCT00044694|Exenatide|exenatide|mesh-list
6345705|NCT00044694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6345706|NCT00044694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6345707|NCT00044694|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6345708|NCT00044694|Incretins|incretins|mesh-ancestor
6345709|NCT00044694|Hormones|hormones|mesh-ancestor
6345710|NCT00044694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6345711|NCT00044707|Pramlintide|pramlintide|mesh-list
6345712|NCT00044707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6345713|NCT00044707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6345714|NCT00044720|Sirolimus|sirolimus|mesh-list
6345715|NCT00044720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6345716|NCT00044720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6345717|NCT00044720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6345718|NCT00044720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6345719|NCT00044720|Antifungal Agents|antifungal agents|mesh-ancestor
6345720|NCT00044720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6345721|NCT00044720|Immunologic Factors|immunologic factors|mesh-ancestor
6345722|NCT00044720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6345723|NCT00044733|Gemtuzumab|gemtuzumab|mesh-list
6345724|NCT00044733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6345725|NCT00044733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6345726|NCT00044746|Tazobactam|tazobactam|mesh-list
6345727|NCT00044746|Piperacillin|piperacillin|mesh-list
6345728|NCT00044746|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
6345729|NCT00044746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6345730|NCT00044746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6345731|NCT00044746|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6345732|NCT00044746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6345733|NCT00044746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345734|NCT00044759|Tazobactam|tazobactam|mesh-list
6345735|NCT00044759|Piperacillin|piperacillin|mesh-list
6345736|NCT00044759|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
6345737|NCT00044759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6345738|NCT00044759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6345739|NCT00044759|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6345740|NCT00044759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6345741|NCT00044759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345742|NCT00044772|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6345743|NCT00044772|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6345744|NCT00044772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6345745|NCT00044772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6345746|NCT00044772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345747|NCT00044772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6345748|NCT00044772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6345749|NCT00044772|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6345750|NCT00044772|Antidepressive Agents|antidepressive agents|mesh-ancestor
6345751|NCT00044772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6345752|NCT00044785|Leucovorin|leucovorin|mesh-list
6345753|NCT00044785|Fluorouracil|fluorouracil|mesh-list
6345754|NCT00044785|Irinotecan|irinotecan|mesh-list
6345755|NCT00044785|Antimetabolites|antimetabolites|mesh-ancestor
6345756|NCT00044785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345757|NCT00044785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6345758|NCT00044785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6345759|NCT00044785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6345760|NCT00044785|Immunologic Factors|immunologic factors|mesh-ancestor
6345761|NCT00044785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6345762|NCT00044785|Antidotes|antidotes|mesh-ancestor
6345763|NCT00044785|Protective Agents|protective agents|mesh-ancestor
6345764|NCT00044785|Vitamin B Complex|vitamin b complex|mesh-ancestor
6345765|NCT00044785|Vitamins|vitamins|mesh-ancestor
6345766|NCT00044785|Micronutrients|micronutrients|mesh-ancestor
6345767|NCT00044785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6345768|NCT00044785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6345769|NCT00044785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6016907|NCT00368875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6016908|NCT00368875|Antibodies|antibodies|mesh-list
6016909|NCT00368875|Immunoglobulins|immunoglobulins|mesh-list
6016910|NCT00368875|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6016911|NCT00368875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6016912|NCT00368875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6016913|NCT00368875|Tubulin Modulators|tubulin modulators|mesh-ancestor
6016914|NCT00368875|Antimitotic Agents|antimitotic agents|mesh-ancestor
6016915|NCT00368875|Mitosis Modulators|mitosis modulators|mesh-ancestor
6016916|NCT00368875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016917|NCT00368875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6345770|NCT00044798|Citalopram|citalopram|mesh-list
6345771|NCT00044798|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6345772|NCT00044798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6345773|NCT00044798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6345774|NCT00044798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345775|NCT00044798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6345776|NCT00044798|Serotonin Agents|serotonin agents|mesh-ancestor
6345777|NCT00044798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6345778|NCT00044798|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6345779|NCT00044798|Antidepressive Agents|antidepressive agents|mesh-ancestor
6345780|NCT00044798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6345781|NCT00044811|Fexofenadine|fexofenadine|mesh-list
6345782|NCT00044811|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6345783|NCT00044811|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6345784|NCT00044811|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6345785|NCT00044811|Histamine Antagonists|histamine antagonists|mesh-ancestor
6345786|NCT00044811|Histamine Agents|histamine agents|mesh-ancestor
6345787|NCT00044811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6345788|NCT00044811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345789|NCT00044811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6345790|NCT00044824|Fexofenadine|fexofenadine|mesh-list
6345791|NCT00044824|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6345792|NCT00044824|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6345793|NCT00044824|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6345794|NCT00044824|Histamine Antagonists|histamine antagonists|mesh-ancestor
6345795|NCT00044824|Histamine Agents|histamine agents|mesh-ancestor
6345796|NCT00044824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6345797|NCT00044824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345798|NCT00044824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6345799|NCT00044837|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6345800|NCT00044837|Medroxyprogesterone|medroxyprogesterone|mesh-list
6345801|NCT00044837|Estradiol|estradiol|mesh-list
6345802|NCT00044837|Estrogens|estrogens|mesh-ancestor
6345803|NCT00044837|Hormones|hormones|mesh-ancestor
6345804|NCT00044837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6345805|NCT00044837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6345806|NCT00044837|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6345807|NCT00044837|Contraceptive Agents|contraceptive agents|mesh-ancestor
6345808|NCT00044837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6345809|NCT00044837|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6345810|NCT00044837|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6345811|NCT00044837|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6345812|NCT00044837|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6345813|NCT00044837|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6345814|NCT00044837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6345815|NCT00044837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6345816|NCT00044863|Cetuximab|cetuximab|mesh-list
6345817|NCT00044863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6345818|NCT00044863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6345819|NCT00044876|Ulipristal acetate|ulipristal acetate|mesh-list
6345820|NCT00044876|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6345821|NCT00044876|Contraceptive Agents|contraceptive agents|mesh-ancestor
6345822|NCT00044876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6345823|NCT00044876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6345824|NCT00044876|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6345825|NCT00044889|Clofarabine|clofarabine|mesh-list
6345826|NCT00044889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6345827|NCT00044889|Antimetabolites|antimetabolites|mesh-ancestor
5724589|NCT03186326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6345828|NCT00044889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345829|NCT00044889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6345830|NCT00044902|Epratuzumab|epratuzumab|mesh-list
6345831|NCT00044902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6345832|NCT00044902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6345833|NCT00044915|Repinotan hydrochloride|repinotan hydrochloride|mesh-list
6345834|NCT00044915|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6345835|NCT00044915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6345836|NCT00044915|Serotonin Agents|serotonin agents|mesh-ancestor
6345837|NCT00044915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6345838|NCT00044915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345839|NCT00044915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6345840|NCT00044928|Tazobactam|tazobactam|mesh-list
6345841|NCT00044928|Piperacillin|piperacillin|mesh-list
6345842|NCT00044928|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
6345843|NCT00044928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6345844|NCT00044928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6345845|NCT00044928|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6345846|NCT00044928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6345847|NCT00044928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345848|NCT00044954|Cyclosporine|cyclosporine|mesh-list
6345849|NCT00044954|Mycophenolic Acid|mycophenolic acid|mesh-list
6345850|NCT00044954|Fludarabine|fludarabine|mesh-list
6345851|NCT00044954|Fludarabine phosphate|fludarabine phosphate|mesh-list
6345852|NCT00044954|Cyclosporins|cyclosporins|mesh-list
6345853|NCT00044954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6345854|NCT00044954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6345855|NCT00044954|Antimetabolites|antimetabolites|mesh-ancestor
6345856|NCT00044954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345857|NCT00044954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6345858|NCT00044954|Immunologic Factors|immunologic factors|mesh-ancestor
6345859|NCT00044954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6345860|NCT00044954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6345861|NCT00044954|Antifungal Agents|antifungal agents|mesh-ancestor
6345862|NCT00044954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6345863|NCT00044954|Dermatologic Agents|dermatologic agents|mesh-ancestor
6345864|NCT00044954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6345865|NCT00044954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6345866|NCT00044954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6345867|NCT00044954|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6345868|NCT00044954|Antitubercular Agents|antitubercular agents|mesh-ancestor
6345869|NCT00044954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6345870|NCT00044993|Docetaxel|docetaxel|mesh-list
6345871|NCT00044993|Doxorubicin|doxorubicin|mesh-list
6345872|NCT00044993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6345873|NCT00044993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6345874|NCT00044993|Tubulin Modulators|tubulin modulators|mesh-ancestor
6345875|NCT00044993|Antimitotic Agents|antimitotic agents|mesh-ancestor
6345876|NCT00044993|Mitosis Modulators|mitosis modulators|mesh-ancestor
6345877|NCT00044993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345878|NCT00044993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6345879|NCT00044993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6345880|NCT00044993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6345881|NCT00044993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6345882|NCT00045006|Vorinostat|vorinostat|mesh-list
6345883|NCT00045006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6345884|NCT00045006|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6345885|NCT00045006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6345886|NCT00045006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345887|NCT00045045|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6345888|NCT00045045|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6345889|NCT00045045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345890|NCT00045136|Melphalan|melphalan|mesh-list
6345891|NCT00045136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6345892|NCT00045136|Alkylating Agents|alkylating agents|mesh-ancestor
6345893|NCT00045136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345894|NCT00045136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6345895|NCT00045136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6345896|NCT00045136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6345897|NCT00045136|Immunologic Factors|immunologic factors|mesh-ancestor
6345898|NCT00045136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6345899|NCT00045149|Aldesleukin|aldesleukin|mesh-list
6345900|NCT00045149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6345901|NCT00045149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6345902|NCT00045149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6345903|NCT00045149|Antiviral Agents|antiviral agents|mesh-ancestor
6345904|NCT00045149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6345905|NCT00045175|Topotecan|topotecan|mesh-list
6345906|NCT00045175|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
6345907|NCT00045175|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6345908|NCT00045175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6345909|NCT00045175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6345910|NCT00045175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345911|NCT00045175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6345912|NCT00045175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6345913|NCT00045188|Imatinib Mesylate|imatinib mesylate|mesh-list
6345914|NCT00045188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6345915|NCT00045188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6345916|NCT00045188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6345917|NCT00045188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345918|NCT00045227|Docetaxel|docetaxel|mesh-list
6345919|NCT00045227|Vaccines|vaccines|mesh-list
6345920|NCT00045227|Sargramostim|sargramostim|mesh-list
6345921|NCT00045227|Immunologic Factors|immunologic factors|mesh-ancestor
6345922|NCT00045227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6345923|NCT00045227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6345924|NCT00045227|Tubulin Modulators|tubulin modulators|mesh-ancestor
6345925|NCT00045227|Antimitotic Agents|antimitotic agents|mesh-ancestor
6345926|NCT00045227|Mitosis Modulators|mitosis modulators|mesh-ancestor
6345927|NCT00045227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345928|NCT00045266|Aflibercept|aflibercept|mesh-list
6345929|NCT00045266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6345930|NCT00045266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6345931|NCT00045266|Growth Substances|growth substances|mesh-ancestor
6345932|NCT00045266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6345933|NCT00045266|Growth Inhibitors|growth inhibitors|mesh-ancestor
6345934|NCT00045266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6345935|NCT00045279|Interferons|interferons|mesh-list
6345936|NCT00045279|Interferon-alpha|interferon-alpha|mesh-list
6345937|NCT00045279|Interferon alpha-2|interferon alpha-2|mesh-list
6345938|NCT00045279|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6345939|NCT00045279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6345940|NCT00045279|Antiviral Agents|antiviral agents|mesh-ancestor
6345941|NCT00045279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6345942|NCT00045279|Immunologic Factors|immunologic factors|mesh-ancestor
6345943|NCT00045279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6345944|NCT00045292|Valacyclovir|valacyclovir|mesh-list
6345945|NCT00045292|Acyclovir|acyclovir|mesh-list
6345946|NCT00045292|Antiviral Agents|antiviral agents|mesh-ancestor
6345947|NCT00045292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6345948|NCT00045318|Exatecan|exatecan|mesh-list
6345949|NCT00045318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6345950|NCT00045318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6345951|NCT00045318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6345952|NCT00045318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345953|NCT00045318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6345954|NCT00045370|Interferons|interferons|mesh-list
6345955|NCT00045370|Interferon-alpha|interferon-alpha|mesh-list
6345956|NCT00045370|Sirolimus|sirolimus|mesh-list
6345957|NCT00045370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6345958|NCT00045370|Antiviral Agents|antiviral agents|mesh-ancestor
6345959|NCT00045370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6345960|NCT00045370|Immunologic Factors|immunologic factors|mesh-ancestor
6345961|NCT00045370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6345962|NCT00045370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6345963|NCT00045370|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6345964|NCT00045370|Antifungal Agents|antifungal agents|mesh-ancestor
6345965|NCT00045370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6345966|NCT00045396|Tipifarnib|tipifarnib|mesh-list
6345967|NCT00045396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6345968|NCT00045422|Interferons|interferons|mesh-list
6345969|NCT00045422|Interferon-alpha|interferon-alpha|mesh-list
6345970|NCT00045422|Imatinib Mesylate|imatinib mesylate|mesh-list
6345971|NCT00045422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6345972|NCT00045422|Antiviral Agents|antiviral agents|mesh-ancestor
6345973|NCT00045422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6345974|NCT00045422|Immunologic Factors|immunologic factors|mesh-ancestor
6345975|NCT00045422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6345976|NCT00045422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6345977|NCT00045422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6345978|NCT00045422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345979|NCT00045448|Docetaxel|docetaxel|mesh-list
6345980|NCT00045448|Alvocidib|alvocidib|mesh-list
6345981|NCT00045448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6345982|NCT00045448|Tubulin Modulators|tubulin modulators|mesh-ancestor
6345983|NCT00045448|Antimitotic Agents|antimitotic agents|mesh-ancestor
6345984|NCT00045448|Mitosis Modulators|mitosis modulators|mesh-ancestor
6345985|NCT00045448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345986|NCT00045448|Growth Inhibitors|growth inhibitors|mesh-ancestor
6345987|NCT00045448|Growth Substances|growth substances|mesh-ancestor
6345988|NCT00045448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6345989|NCT00045448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6345990|NCT00045448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6345991|NCT00045461|Carboplatin|carboplatin|mesh-list
6345992|NCT00045461|Ifosfamide|ifosfamide|mesh-list
6345993|NCT00045461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6345994|NCT00045461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6345995|NCT00045461|Alkylating Agents|alkylating agents|mesh-ancestor
6345996|NCT00045461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6345997|NCT00045500|Prednisone|prednisone|mesh-list
6345998|NCT00045500|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
6345999|NCT00045500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6346000|NCT00045500|Glucocorticoids|glucocorticoids|mesh-ancestor
6346001|NCT00045500|Hormones|hormones|mesh-ancestor
6346002|NCT00045500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6346003|NCT00045500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6346004|NCT00045500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6346005|NCT00045500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346006|NCT00045500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6346007|NCT00045500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6346008|NCT00045500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346009|NCT00045513|Fludarabine|fludarabine|mesh-list
6346010|NCT00045513|Fludarabine phosphate|fludarabine phosphate|mesh-list
6346011|NCT00045513|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
6346012|NCT00045513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346013|NCT00045513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6346014|NCT00045513|Antimetabolites|antimetabolites|mesh-ancestor
6346015|NCT00045513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346016|NCT00045513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6346017|NCT00045513|Immunologic Factors|immunologic factors|mesh-ancestor
6346018|NCT00045513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6346019|NCT00045513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6346020|NCT00045513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6346021|NCT00045526|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6346022|NCT00045526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346023|NCT00045526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6346024|NCT00045526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6346025|NCT00045526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346026|NCT00045539|Leucovorin|leucovorin|mesh-list
6346027|NCT00045539|Methotrexate|methotrexate|mesh-list
6346028|NCT00045539|Thiotepa|thiotepa|mesh-list
6346029|NCT00045539|Calcium|calcium|mesh-list
6346030|NCT00045539|Levoleucovorin|levoleucovorin|mesh-list
6346031|NCT00045539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6346032|NCT00045539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6346033|NCT00045539|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6346034|NCT00045539|Abortifacient Agents|abortifacient agents|mesh-ancestor
6346035|NCT00045539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6346036|NCT00045539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6346037|NCT00045539|Antimetabolites|antimetabolites|mesh-ancestor
6346038|NCT00045539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346039|NCT00045539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346040|NCT00045539|Dermatologic Agents|dermatologic agents|mesh-ancestor
6346041|NCT00045539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6346042|NCT00045539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6346043|NCT00045539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6346044|NCT00045539|Immunologic Factors|immunologic factors|mesh-ancestor
6346045|NCT00045539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6346046|NCT00045539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6346047|NCT00045539|Antidotes|antidotes|mesh-ancestor
6346048|NCT00045539|Protective Agents|protective agents|mesh-ancestor
6346049|NCT00045539|Vitamin B Complex|vitamin b complex|mesh-ancestor
6346050|NCT00045539|Vitamins|vitamins|mesh-ancestor
6346051|NCT00045539|Micronutrients|micronutrients|mesh-ancestor
6346052|NCT00045539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6346053|NCT00045539|Alkylating Agents|alkylating agents|mesh-ancestor
6346054|NCT00045539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6346055|NCT00045565|Arsenic Trioxide|arsenic trioxide|mesh-list
6346056|NCT00045565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346057|NCT00045591|Celecoxib|celecoxib|mesh-list
6346058|NCT00045591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6346059|NCT00045591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6346060|NCT00045591|Analgesics|analgesics|mesh-ancestor
6346061|NCT00045591|Sensory System Agents|sensory system agents|mesh-ancestor
6346062|NCT00045591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6346063|NCT00045591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6346064|NCT00045591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6346065|NCT00045591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6346066|NCT00045591|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6346067|NCT00045591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6346068|NCT00045591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6346069|NCT00045591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346070|NCT00045604|Irinotecan|irinotecan|mesh-list
6346071|NCT00045604|Imatinib Mesylate|imatinib mesylate|mesh-list
6346072|NCT00045604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346073|NCT00045604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6346074|NCT00045604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6346075|NCT00045604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6346076|NCT00045604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346077|NCT00045604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6346078|NCT00045617|Etoposide|etoposide|mesh-list
6346079|NCT00045617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6346080|NCT00045617|Vaccines|vaccines|mesh-list
6346081|NCT00045617|Antibodies|antibodies|mesh-list
6346082|NCT00045617|Immunoglobulins|immunoglobulins|mesh-list
6346083|NCT00045617|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6346084|NCT00045617|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
6346085|NCT00045617|Immunologic Factors|immunologic factors|mesh-ancestor
6346086|NCT00045617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6346087|NCT00045617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346088|NCT00045617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6346089|NCT00045617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6346090|NCT00045617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6346091|NCT00045617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6346092|NCT00045617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346093|NCT00045669|Imatinib Mesylate|imatinib mesylate|mesh-list
6346094|NCT00045669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346095|NCT00045669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6346096|NCT00045669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6346097|NCT00045669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346098|NCT00045682|Paclitaxel|paclitaxel|mesh-list
6346099|NCT00045682|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6346100|NCT00045682|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
6346101|NCT00045682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6346102|NCT00045682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346103|NCT00045682|Tubulin Modulators|tubulin modulators|mesh-ancestor
6346104|NCT00045682|Antimitotic Agents|antimitotic agents|mesh-ancestor
6346105|NCT00045682|Mitosis Modulators|mitosis modulators|mesh-ancestor
6346106|NCT00045682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346107|NCT00045695|Bortezomib|bortezomib|mesh-list
6346108|NCT00045695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346109|NCT00045721|Carmustine|carmustine|mesh-list
6346110|NCT00045721|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
6346111|NCT00045721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6346112|NCT00045721|Alkylating Agents|alkylating agents|mesh-ancestor
6346113|NCT00045721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346114|NCT00045721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346115|NCT00045721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6346116|NCT00045747|Fluorouracil|fluorouracil|mesh-list
6346117|NCT00045747|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
6346118|NCT00045747|Antimetabolites|antimetabolites|mesh-ancestor
6394069|NCT00200668|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6346119|NCT00045747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346120|NCT00045747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6346121|NCT00045747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346122|NCT00045747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6346123|NCT00045747|Immunologic Factors|immunologic factors|mesh-ancestor
6346124|NCT00045747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6346125|NCT00045747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6346126|NCT00045747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6346127|NCT00045760|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
6346128|NCT00045760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6346129|NCT00045773|Sertraline|sertraline|mesh-list
6346130|NCT00045773|Antidepressive Agents|antidepressive agents|mesh-ancestor
6346131|NCT00045773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6346132|NCT00045773|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6346133|NCT00045773|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6346134|NCT00045773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6346135|NCT00045773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346136|NCT00045773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6346137|NCT00045773|Serotonin Agents|serotonin agents|mesh-ancestor
6346138|NCT00045773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6346139|NCT00045799|Omeprazole|omeprazole|mesh-list
6346140|NCT00045799|Cimetidine|cimetidine|mesh-list
6346141|NCT00045799|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6346142|NCT00045799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6346143|NCT00045799|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6346144|NCT00045799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6346145|NCT00045799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346146|NCT00045799|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6346147|NCT00045799|Histamine Antagonists|histamine antagonists|mesh-ancestor
6346148|NCT00045799|Histamine Agents|histamine agents|mesh-ancestor
6346149|NCT00045799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6346150|NCT00045799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6346151|NCT00045799|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6346152|NCT00045799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6346153|NCT00045812|Ezetimibe|ezetimibe|mesh-list
6346154|NCT00045812|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6346155|NCT00045812|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6346156|NCT00045812|Antimetabolites|antimetabolites|mesh-ancestor
6346157|NCT00045812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346158|NCT00045812|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6346159|NCT00045864|Aldesleukin|aldesleukin|mesh-list
6346160|NCT00045864|Rituximab|rituximab|mesh-list
6346161|NCT00045864|Interleukin-2|interleukin-2|mesh-list
6346162|NCT00045864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6346163|NCT00045864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346164|NCT00045864|Immunologic Factors|immunologic factors|mesh-ancestor
6346165|NCT00045864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6346166|NCT00045864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6346167|NCT00045864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6346168|NCT00045864|Analgesics|analgesics|mesh-ancestor
6346169|NCT00045864|Sensory System Agents|sensory system agents|mesh-ancestor
6346170|NCT00045864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6346171|NCT00045864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6346172|NCT00045864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6346173|NCT00045864|Antiviral Agents|antiviral agents|mesh-ancestor
6346174|NCT00045864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6346175|NCT00045877|Aldesleukin|aldesleukin|mesh-list
6346176|NCT00045877|Rituximab|rituximab|mesh-list
6346177|NCT00045877|Interleukin-2|interleukin-2|mesh-list
6346178|NCT00045877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6346179|NCT00045877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346180|NCT00045877|Immunologic Factors|immunologic factors|mesh-ancestor
6346181|NCT00045877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6346182|NCT00045877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6346183|NCT00045877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6346184|NCT00045877|Analgesics|analgesics|mesh-ancestor
6346185|NCT00045877|Sensory System Agents|sensory system agents|mesh-ancestor
6346186|NCT00045877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6346187|NCT00045877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6346188|NCT00045877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6346189|NCT00045877|Antiviral Agents|antiviral agents|mesh-ancestor
6346190|NCT00045877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6346191|NCT00045916|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6346192|NCT00045916|Nortriptyline|nortriptyline|mesh-list
6346193|NCT00045916|Antidepressive Agents|antidepressive agents|mesh-ancestor
6346194|NCT00045916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6346195|NCT00045916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346196|NCT00045916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6346197|NCT00045916|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6346198|NCT00045916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6346199|NCT00045916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6346200|NCT00045916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6346201|NCT00045916|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6346202|NCT00045916|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6346203|NCT00045916|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6346204|NCT00045916|Adrenergic Agents|adrenergic agents|mesh-ancestor
6346205|NCT00045955|Fexofenadine|fexofenadine|mesh-list
6346206|NCT00045955|Montelukast|montelukast|mesh-list
6346207|NCT00045955|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6346208|NCT00045955|Respiratory System Agents|respiratory system agents|mesh-ancestor
6346209|NCT00045955|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6346210|NCT00045955|Hormone Antagonists|hormone antagonists|mesh-ancestor
6346211|NCT00045955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6346212|NCT00045955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6346213|NCT00045955|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6346214|NCT00045955|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6346215|NCT00045955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346216|NCT00045955|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6346217|NCT00045955|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6346218|NCT00045955|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6346219|NCT00045955|Histamine Antagonists|histamine antagonists|mesh-ancestor
6346220|NCT00045955|Histamine Agents|histamine agents|mesh-ancestor
6346221|NCT00045955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6346222|NCT00046020|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6346223|NCT00046020|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6346224|NCT00046020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6346225|NCT00046020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6346226|NCT00046020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346227|NCT00046020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6346228|NCT00046020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6346229|NCT00046020|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6346230|NCT00046020|Antidepressive Agents|antidepressive agents|mesh-ancestor
6346231|NCT00046020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6346232|NCT00046033|Ritonavir|ritonavir|mesh-list
6346233|NCT00046033|Lopinavir|lopinavir|mesh-list
6346234|NCT00046033|Saquinavir|saquinavir|mesh-list
6346235|NCT00046033|Amprenavir|amprenavir|mesh-list
6346236|NCT00046033|Tenofovir|tenofovir|mesh-list
6346237|NCT00046033|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6346238|NCT00046033|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6346239|NCT00046033|Protease Inhibitors|protease inhibitors|mesh-ancestor
6346240|NCT00046033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6346241|NCT00046033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346242|NCT00046033|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6346243|NCT00046033|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6346244|NCT00046033|Antiviral Agents|antiviral agents|mesh-ancestor
6346245|NCT00046033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6346246|NCT00046033|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6346247|NCT00046033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6346248|NCT00046033|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6346249|NCT00046033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6346250|NCT00046033|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6346251|NCT00046033|Antitubercular Agents|antitubercular agents|mesh-ancestor
6346252|NCT00046033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6346253|NCT00046111|Topotecan|topotecan|mesh-list
6346254|NCT00046111|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6346255|NCT00046111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6346256|NCT00046111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6346257|NCT00046111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346258|NCT00046111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346259|NCT00046137|Teriparatide|teriparatide|mesh-list
6346260|NCT00046137|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
6346261|NCT00046137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6346262|NCT00046137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6346263|NCT00046137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6346264|NCT00046137|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6346265|NCT00046137|Hormone Antagonists|hormone antagonists|mesh-ancestor
6346266|NCT00046137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6346267|NCT00046137|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6346268|NCT00046137|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6346269|NCT00046150|Insulin glulisine|insulin glulisine|mesh-list
6346270|NCT00046150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6346271|NCT00046150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6346272|NCT00046163|Midodrine|midodrine|mesh-list
6346273|NCT00046163|Sympathomimetics|sympathomimetics|mesh-ancestor
6346274|NCT00046163|Autonomic Agents|autonomic agents|mesh-ancestor
6346275|NCT00046163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6346276|NCT00046163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6346277|NCT00046163|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6346278|NCT00046163|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6346279|NCT00046163|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6346280|NCT00046163|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6346281|NCT00046163|Adrenergic Agents|adrenergic agents|mesh-ancestor
6346282|NCT00046163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6346283|NCT00046163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346284|NCT00046176|Lamivudine|lamivudine|mesh-list
6346285|NCT00046176|Abacavir|abacavir|mesh-list
6346286|NCT00046176|Dideoxynucleosides|dideoxynucleosides|mesh-list
6346287|NCT00046176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6346288|NCT00046176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6346289|NCT00046176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6346290|NCT00046176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346291|NCT00046176|Antiviral Agents|antiviral agents|mesh-ancestor
6346292|NCT00046176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6346293|NCT00046176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6346294|NCT00046176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6346295|NCT00046176|Antimetabolites|antimetabolites|mesh-ancestor
6346296|NCT00046241|Bupropion|bupropion|mesh-list
6346297|NCT00046241|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6346298|NCT00046241|Antidepressive Agents|antidepressive agents|mesh-ancestor
6346299|NCT00046241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6346300|NCT00046241|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6346301|NCT00046241|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6346302|NCT00046241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6346303|NCT00046241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346304|NCT00046241|Dopamine Agents|dopamine agents|mesh-ancestor
6346305|NCT00046241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6346306|NCT00046241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6346307|NCT00046241|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6346308|NCT00046241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6346309|NCT00046241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6346310|NCT00046254|Zoledronic Acid|zoledronic acid|mesh-list
6346311|NCT00046254|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6346312|NCT00046254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6346313|NCT00046267|Niacin|niacin|mesh-list
6346314|NCT00046267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6346315|NCT00046267|Antimetabolites|antimetabolites|mesh-ancestor
6346316|NCT00046267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346317|NCT00046267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6346318|NCT00046267|Vasodilator Agents|vasodilator agents|mesh-ancestor
6346319|NCT00046267|Vitamin B Complex|vitamin b complex|mesh-ancestor
6346320|NCT00046267|Vitamins|vitamins|mesh-ancestor
6346321|NCT00046267|Micronutrients|micronutrients|mesh-ancestor
6346322|NCT00046267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6346323|NCT00046293|Abciximab|abciximab|mesh-list
6346324|NCT00046293|Anticoagulants|anticoagulants|mesh-ancestor
6346325|NCT00046293|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6346326|NCT00046306|Antioxidants|antioxidants|mesh-list
6346327|NCT00046306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346328|NCT00046306|Protective Agents|protective agents|mesh-ancestor
6346329|NCT00046306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6346330|NCT00046319|Ambrisentan|ambrisentan|mesh-list
6346331|NCT00046319|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6394070|NCT00200668|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6394071|NCT00200668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394072|NCT00200681|Bortezomib|bortezomib|mesh-list
6394073|NCT00200681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6396969|NCT00209885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6396970|NCT00209885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396971|NCT00209885|Sensory System Agents|sensory system agents|mesh-ancestor
6396972|NCT00209885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6396973|NCT00209885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6396974|NCT00209885|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6396975|NCT00209885|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6396976|NCT00209885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6396977|NCT00209885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396978|NCT00209885|Analgesics|analgesics|mesh-ancestor
6396979|NCT00209885|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6396980|NCT00209885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6396981|NCT00209885|Anesthetics, General|anesthetics, general|mesh-ancestor
6396982|NCT00209885|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6396983|NCT00209885|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6396984|NCT00209885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6396985|NCT00209885|Anticonvulsants|anticonvulsants|mesh-ancestor
6396986|NCT00209885|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6396987|NCT00209885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6396988|NCT00209885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6346332|NCT00046345|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6346333|NCT00046345|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6346334|NCT00046345|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6346335|NCT00046345|Protease Inhibitors|protease inhibitors|mesh-ancestor
6346336|NCT00046345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6346337|NCT00046345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346338|NCT00046345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6346339|NCT00046345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6346340|NCT00046345|Antiviral Agents|antiviral agents|mesh-ancestor
6346341|NCT00046345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6346342|NCT00046358|Ibuprofen|ibuprofen|mesh-list
6346343|NCT00046358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6346344|NCT00046358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6346345|NCT00046358|Analgesics|analgesics|mesh-ancestor
6346346|NCT00046358|Sensory System Agents|sensory system agents|mesh-ancestor
6346347|NCT00046358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6346348|NCT00046358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6346349|NCT00046358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6346350|NCT00046358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6346351|NCT00046358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6346352|NCT00046358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6346353|NCT00046358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346354|NCT00046384|Aripiprazole|aripiprazole|mesh-list
6346355|NCT00046384|Antidepressive Agents|antidepressive agents|mesh-ancestor
6346356|NCT00046384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6346357|NCT00046384|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6346358|NCT00046384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6346359|NCT00046384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6346360|NCT00046384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6346361|NCT00046384|Dopamine Agonists|dopamine agonists|mesh-ancestor
6346362|NCT00046384|Dopamine Agents|dopamine agents|mesh-ancestor
6346363|NCT00046384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6346364|NCT00046384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346365|NCT00046384|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6346366|NCT00046384|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6346367|NCT00046384|Serotonin Agents|serotonin agents|mesh-ancestor
6346368|NCT00046384|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6346369|NCT00046384|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6346370|NCT00046384|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6346371|NCT00046384|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6346372|NCT00046423|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6346373|NCT00046423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346374|NCT00046462|Metformin|metformin|mesh-list
6346375|NCT00046462|Insulin Glargine|insulin glargine|mesh-list
6346376|NCT00046462|Glyburide|glyburide|mesh-list
6346377|NCT00046462|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
6346378|NCT00046462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6346379|NCT00046462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6346380|NCT00046501|Insulin|insulin|mesh-list
6346381|NCT00046501|Insulin Glargine|insulin glargine|mesh-list
6346382|NCT00046501|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6346383|NCT00046501|Insulin, Isophane|insulin, isophane|mesh-list
6346384|NCT00046501|Isophane Insulin, Human|isophane insulin, human|mesh-list
6346385|NCT00046501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6346386|NCT00046501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6346387|NCT00046514|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6346388|NCT00046514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346389|NCT00046527|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6346390|NCT00046527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346391|NCT00046553|Mifepristone|mifepristone|mesh-list
6346392|NCT00046553|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6346393|NCT00046553|Abortifacient Agents|abortifacient agents|mesh-ancestor
6346394|NCT00046553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6346395|NCT00046553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6346396|NCT00046553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6346397|NCT00046553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6346398|NCT00046553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6346399|NCT00046553|Contraceptive Agents|contraceptive agents|mesh-ancestor
6346400|NCT00046553|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6346401|NCT00046553|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6346402|NCT00046553|Hormone Antagonists|hormone antagonists|mesh-ancestor
6346403|NCT00046553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6346404|NCT00046553|Luteolytic Agents|luteolytic agents|mesh-ancestor
6346405|NCT00046553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6346406|NCT00046553|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6346407|NCT00046683|Alemtuzumab|alemtuzumab|mesh-list
6346408|NCT00046683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6346409|NCT00046683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346410|NCT00046735|Lenalidomide|lenalidomide|mesh-list
6346411|NCT00046735|Immunologic Factors|immunologic factors|mesh-ancestor
6346412|NCT00046735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6346413|NCT00046735|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6346414|NCT00046735|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6346415|NCT00046735|Growth Substances|growth substances|mesh-ancestor
6346416|NCT00046735|Growth Inhibitors|growth inhibitors|mesh-ancestor
6346417|NCT00046735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346418|NCT00046748|Omalizumab|omalizumab|mesh-list
6346419|NCT00046748|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6346420|NCT00046748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6346421|NCT00046748|Respiratory System Agents|respiratory system agents|mesh-ancestor
6346422|NCT00046787|Lurtotecan|lurtotecan|mesh-list
6346423|NCT00046787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346424|NCT00046800|Lurtotecan|lurtotecan|mesh-list
6346425|NCT00046800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346426|NCT00046813|Nicotine|nicotine|mesh-list
6346427|NCT00046813|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6346428|NCT00046813|Autonomic Agents|autonomic agents|mesh-ancestor
6346429|NCT00046813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6346430|NCT00046813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6346431|NCT00046813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6346432|NCT00046813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6346433|NCT00046813|Cholinergic Agents|cholinergic agents|mesh-ancestor
6346434|NCT00046813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6346435|NCT00046813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346436|NCT00046826|Thalidomide|thalidomide|mesh-list
6346437|NCT00046826|Docetaxel|docetaxel|mesh-list
6346438|NCT00046826|Estramustine|estramustine|mesh-list
6346439|NCT00046826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346440|NCT00046826|Tubulin Modulators|tubulin modulators|mesh-ancestor
6346441|NCT00046826|Antimitotic Agents|antimitotic agents|mesh-ancestor
6346442|NCT00046826|Mitosis Modulators|mitosis modulators|mesh-ancestor
6346443|NCT00046826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346444|NCT00046826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6346445|NCT00046826|Immunologic Factors|immunologic factors|mesh-ancestor
6346446|NCT00046826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6346447|NCT00046826|Leprostatic Agents|leprostatic agents|mesh-ancestor
6346448|NCT00046826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6346449|NCT00046826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6346450|NCT00046826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6346451|NCT00046826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6346452|NCT00046826|Growth Substances|growth substances|mesh-ancestor
6346453|NCT00046826|Growth Inhibitors|growth inhibitors|mesh-ancestor
6346454|NCT00046826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6346455|NCT00046826|Alkylating Agents|alkylating agents|mesh-ancestor
6346456|NCT00046826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6346457|NCT00046852|Cyclophosphamide|cyclophosphamide|mesh-list
6346458|NCT00046852|Melphalan|melphalan|mesh-list
6346459|NCT00046852|Carmustine|carmustine|mesh-list
6346460|NCT00046852|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6346461|NCT00046852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6346462|NCT00046852|Immunologic Factors|immunologic factors|mesh-ancestor
6346463|NCT00046852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6346464|NCT00046852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6346465|NCT00046852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6346466|NCT00046852|Alkylating Agents|alkylating agents|mesh-ancestor
6346467|NCT00046852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346468|NCT00046852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346469|NCT00046852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6346470|NCT00046878|Carmustine|carmustine|mesh-list
6346471|NCT00046878|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
6346472|NCT00046878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6346473|NCT00046878|Alkylating Agents|alkylating agents|mesh-ancestor
6346474|NCT00046878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346475|NCT00046878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346476|NCT00046878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6346477|NCT00046904|Etanercept|etanercept|mesh-list
6346478|NCT00046904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6346479|NCT00046904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6346480|NCT00046904|Analgesics|analgesics|mesh-ancestor
6346481|NCT00046904|Sensory System Agents|sensory system agents|mesh-ancestor
6346482|NCT00046904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6346483|NCT00046904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6346484|NCT00046904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6346485|NCT00046904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6346486|NCT00046904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6346487|NCT00046904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6346488|NCT00046904|Immunologic Factors|immunologic factors|mesh-ancestor
6346489|NCT00046917|Irinotecan|irinotecan|mesh-list
6346490|NCT00046917|Alvocidib|alvocidib|mesh-list
6346491|NCT00046917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346492|NCT00046917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6346493|NCT00046917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6346494|NCT00046917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6346495|NCT00046917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346496|NCT00046917|Growth Inhibitors|growth inhibitors|mesh-ancestor
6346497|NCT00046917|Growth Substances|growth substances|mesh-ancestor
6346498|NCT00046917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6346499|NCT00046917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6346500|NCT00046943|Atrasentan|atrasentan|mesh-list
6346501|NCT00046943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346502|NCT00046943|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
6346503|NCT00046943|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6346504|NCT00046943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346505|NCT00046969|Cisplatin|cisplatin|mesh-list
6346506|NCT00046969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346507|NCT00046995|Leucovorin|leucovorin|mesh-list
6346508|NCT00046995|Carboplatin|carboplatin|mesh-list
6346509|NCT00046995|Fluorouracil|fluorouracil|mesh-list
6346510|NCT00046995|Calcium|calcium|mesh-list
6346511|NCT00046995|Levoleucovorin|levoleucovorin|mesh-list
6346512|NCT00046995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6016918|NCT00368875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6016919|NCT00368875|Growth Substances|growth substances|mesh-ancestor
6016920|NCT00368875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016921|NCT00368875|Growth Inhibitors|growth inhibitors|mesh-ancestor
6016922|NCT00368875|Immunologic Factors|immunologic factors|mesh-ancestor
6016923|NCT00368875|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6016924|NCT00368875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6016925|NCT00368927|Sulindac|sulindac|mesh-list
6016926|NCT00368927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6346513|NCT00046995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6346514|NCT00046995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6346515|NCT00046995|Antimetabolites|antimetabolites|mesh-ancestor
6346516|NCT00046995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346517|NCT00046995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6346518|NCT00046995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6346519|NCT00046995|Immunologic Factors|immunologic factors|mesh-ancestor
6346520|NCT00046995|Antidotes|antidotes|mesh-ancestor
6346521|NCT00046995|Protective Agents|protective agents|mesh-ancestor
6346522|NCT00046995|Vitamin B Complex|vitamin b complex|mesh-ancestor
6346523|NCT00046995|Vitamins|vitamins|mesh-ancestor
6346524|NCT00046995|Micronutrients|micronutrients|mesh-ancestor
6346525|NCT00047021|Cytarabine|cytarabine|mesh-list
6346526|NCT00047021|Mitoxantrone|mitoxantrone|mesh-list
6346527|NCT00047021|Sargramostim|sargramostim|mesh-list
6346528|NCT00047021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6346529|NCT00047021|Antimetabolites|antimetabolites|mesh-ancestor
6346530|NCT00047021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346531|NCT00047021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346532|NCT00047021|Antiviral Agents|antiviral agents|mesh-ancestor
6346533|NCT00047021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6346534|NCT00047021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6346535|NCT00047021|Immunologic Factors|immunologic factors|mesh-ancestor
6346536|NCT00047021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6346537|NCT00047021|Analgesics|analgesics|mesh-ancestor
6346538|NCT00047021|Sensory System Agents|sensory system agents|mesh-ancestor
6346539|NCT00047021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6346540|NCT00047021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6346541|NCT00047021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6346542|NCT00047021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6346543|NCT00047047|Gemcitabine|gemcitabine|mesh-list
6346544|NCT00047047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346545|NCT00047047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6346546|NCT00047047|Antimetabolites|antimetabolites|mesh-ancestor
6346547|NCT00047047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346548|NCT00047047|Antiviral Agents|antiviral agents|mesh-ancestor
6346549|NCT00047047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6346550|NCT00047047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6346551|NCT00047047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6346552|NCT00047047|Immunologic Factors|immunologic factors|mesh-ancestor
6346553|NCT00047047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6346554|NCT00047073|Sirolimus|sirolimus|mesh-list
6346555|NCT00047073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6346556|NCT00047073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6346557|NCT00047073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6346558|NCT00047073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346559|NCT00047073|Antifungal Agents|antifungal agents|mesh-ancestor
6346560|NCT00047073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6346561|NCT00047073|Immunologic Factors|immunologic factors|mesh-ancestor
6346562|NCT00047073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6346563|NCT00047099|Tamoxifen|tamoxifen|mesh-list
6346564|NCT00047099|Cyclophosphamide|cyclophosphamide|mesh-list
6346565|NCT00047099|Docetaxel|docetaxel|mesh-list
6346566|NCT00047099|Fluorouracil|fluorouracil|mesh-list
6346567|NCT00047099|Epirubicin|epirubicin|mesh-list
6346568|NCT00047099|Goserelin|goserelin|mesh-list
6346569|NCT00047099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6346570|NCT00047099|Immunologic Factors|immunologic factors|mesh-ancestor
6346571|NCT00047099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6346572|NCT00047099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6346573|NCT00047099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6346574|NCT00047099|Alkylating Agents|alkylating agents|mesh-ancestor
6346575|NCT00047099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346576|NCT00047099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346577|NCT00047099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6346578|NCT00047099|Tubulin Modulators|tubulin modulators|mesh-ancestor
6346579|NCT00047099|Antimitotic Agents|antimitotic agents|mesh-ancestor
6346580|NCT00047099|Mitosis Modulators|mitosis modulators|mesh-ancestor
6346581|NCT00047099|Antimetabolites|antimetabolites|mesh-ancestor
6346582|NCT00047099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6346583|NCT00047099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6346584|NCT00047099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6346585|NCT00047099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6346586|NCT00047099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6346587|NCT00047099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6346588|NCT00047099|Hormone Antagonists|hormone antagonists|mesh-ancestor
6346589|NCT00047099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6346590|NCT00047099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6346591|NCT00047099|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6346592|NCT00047099|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6346593|NCT00047099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6346594|NCT00047112|Fluorouracil|fluorouracil|mesh-list
6346595|NCT00047112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346596|NCT00047112|Antimetabolites|antimetabolites|mesh-ancestor
6346597|NCT00047112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346598|NCT00047112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6346599|NCT00047112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6346600|NCT00047112|Immunologic Factors|immunologic factors|mesh-ancestor
6346601|NCT00047112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6346602|NCT00047138|Dactinomycin|dactinomycin|mesh-list
6346603|NCT00047138|Cyclophosphamide|cyclophosphamide|mesh-list
6346604|NCT00047138|Carboplatin|carboplatin|mesh-list
6346605|NCT00047138|Doxorubicin|doxorubicin|mesh-list
6346606|NCT00047138|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6346607|NCT00047138|Etoposide|etoposide|mesh-list
6346608|NCT00047138|Vincristine|vincristine|mesh-list
6346609|NCT00047138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6346610|NCT00047138|Immunologic Factors|immunologic factors|mesh-ancestor
6346611|NCT00047138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6346612|NCT00047138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6346613|NCT00047138|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6346614|NCT00047138|Alkylating Agents|alkylating agents|mesh-ancestor
6346615|NCT00047138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346616|NCT00047138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346617|NCT00047138|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6346618|NCT00047138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6346619|NCT00047138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6346620|NCT00047138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6346621|NCT00047138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6346622|NCT00047138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6346623|NCT00047138|Tubulin Modulators|tubulin modulators|mesh-ancestor
6346624|NCT00047138|Antimitotic Agents|antimitotic agents|mesh-ancestor
6346625|NCT00047138|Mitosis Modulators|mitosis modulators|mesh-ancestor
6346626|NCT00047138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6346627|NCT00047138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6346628|NCT00047138|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6346629|NCT00047138|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6346630|NCT00047164|Ipilimumab|ipilimumab|mesh-list
6346631|NCT00047164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6346632|NCT00047164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346633|NCT00047164|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6346634|NCT00047164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346635|NCT00047177|Oxaliplatin|oxaliplatin|mesh-list
6346636|NCT00047177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346637|NCT00047190|Tipifarnib|tipifarnib|mesh-list
6346638|NCT00047190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346639|NCT00047203|Alvocidib|alvocidib|mesh-list
6346640|NCT00047203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346641|NCT00047203|Growth Inhibitors|growth inhibitors|mesh-ancestor
6346642|NCT00047203|Growth Substances|growth substances|mesh-ancestor
6346643|NCT00047203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6346644|NCT00047203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6346645|NCT00047203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6346646|NCT00047203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346647|NCT00047216|Tipifarnib|tipifarnib|mesh-list
6346648|NCT00047216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346649|NCT00047229|Doxorubicin|doxorubicin|mesh-list
6346650|NCT00047229|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6346651|NCT00047229|Oblimersen|oblimersen|mesh-list
6346652|NCT00047229|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6346653|NCT00047229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346654|NCT00047229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6346655|NCT00047229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6346656|NCT00047229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6346657|NCT00047229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346658|NCT00047242|Irinotecan|irinotecan|mesh-list
6346659|NCT00047242|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
6346660|NCT00047242|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6346661|NCT00047242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6346662|NCT00047242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6346663|NCT00047242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346664|NCT00047242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346665|NCT00047242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6346666|NCT00047255|Carboplatin|carboplatin|mesh-list
6346667|NCT00047255|Docetaxel|docetaxel|mesh-list
6346668|NCT00047255|Trastuzumab|trastuzumab|mesh-list
6346669|NCT00047255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346670|NCT00047255|Tubulin Modulators|tubulin modulators|mesh-ancestor
6346671|NCT00047255|Antimitotic Agents|antimitotic agents|mesh-ancestor
6346672|NCT00047255|Mitosis Modulators|mitosis modulators|mesh-ancestor
6346673|NCT00047255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346674|NCT00047255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6346675|NCT00047268|Cytarabine|cytarabine|mesh-list
6346676|NCT00047268|Mercaptopurine|mercaptopurine|mesh-list
6346677|NCT00047268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6346678|NCT00047268|Antimetabolites|antimetabolites|mesh-ancestor
6346679|NCT00047268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346680|NCT00047268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346681|NCT00047268|Antiviral Agents|antiviral agents|mesh-ancestor
6346682|NCT00047268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6346683|NCT00047268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6346684|NCT00047268|Immunologic Factors|immunologic factors|mesh-ancestor
6346685|NCT00047268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6346686|NCT00047268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6346687|NCT00047268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6346688|NCT00047281|Thalidomide|thalidomide|mesh-list
6346689|NCT00047281|Celecoxib|celecoxib|mesh-list
6346690|NCT00047281|Cyclophosphamide|cyclophosphamide|mesh-list
6346691|NCT00047281|Etoposide|etoposide|mesh-list
6346692|NCT00047281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6346693|NCT00047281|Immunologic Factors|immunologic factors|mesh-ancestor
6346694|NCT00047281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6346695|NCT00047281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6346696|NCT00047281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6346697|NCT00047281|Alkylating Agents|alkylating agents|mesh-ancestor
6346698|NCT00047281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346699|NCT00047281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346700|NCT00047281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6346701|NCT00047281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6346702|NCT00047281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6346703|NCT00047281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6346704|NCT00047281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6346705|NCT00047281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6346706|NCT00047281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6346707|NCT00047281|Analgesics|analgesics|mesh-ancestor
6346708|NCT00047281|Sensory System Agents|sensory system agents|mesh-ancestor
6346709|NCT00047281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6346710|NCT00047281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6346711|NCT00047281|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6346712|NCT00047281|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6346713|NCT00047281|Leprostatic Agents|leprostatic agents|mesh-ancestor
6346714|NCT00047281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6346715|NCT00047281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6346716|NCT00047281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6346717|NCT00047281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6346718|NCT00047281|Growth Substances|growth substances|mesh-ancestor
6346719|NCT00047281|Growth Inhibitors|growth inhibitors|mesh-ancestor
6346720|NCT00047294|Thalidomide|thalidomide|mesh-list
6346721|NCT00047294|Celecoxib|celecoxib|mesh-list
6346722|NCT00047294|Temozolomide|temozolomide|mesh-list
6346723|NCT00047294|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6346724|NCT00047294|Alkylating Agents|alkylating agents|mesh-ancestor
6346725|NCT00047294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346726|NCT00047294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346727|NCT00047294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6346728|NCT00047294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6346729|NCT00047294|Analgesics|analgesics|mesh-ancestor
6346730|NCT00047294|Sensory System Agents|sensory system agents|mesh-ancestor
6346731|NCT00047294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6346732|NCT00047294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6346733|NCT00047294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6346734|NCT00047294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6346735|NCT00047294|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6346736|NCT00047294|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6346737|NCT00047294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6346738|NCT00047294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6346739|NCT00047294|Immunologic Factors|immunologic factors|mesh-ancestor
6346740|NCT00047294|Leprostatic Agents|leprostatic agents|mesh-ancestor
6346741|NCT00047294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6346742|NCT00047294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6346743|NCT00047294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6346744|NCT00047294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6346745|NCT00047294|Growth Substances|growth substances|mesh-ancestor
6346746|NCT00047294|Growth Inhibitors|growth inhibitors|mesh-ancestor
6346747|NCT00047307|Gemcitabine|gemcitabine|mesh-list
6346748|NCT00047307|Alvocidib|alvocidib|mesh-list
6346749|NCT00047307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6346750|NCT00047307|Antimetabolites|antimetabolites|mesh-ancestor
6346751|NCT00047307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346752|NCT00047307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346753|NCT00047307|Antiviral Agents|antiviral agents|mesh-ancestor
6346754|NCT00047307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6346755|NCT00047307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6346756|NCT00047307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6346757|NCT00047307|Immunologic Factors|immunologic factors|mesh-ancestor
6346758|NCT00047307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6346759|NCT00047307|Growth Inhibitors|growth inhibitors|mesh-ancestor
6346760|NCT00047307|Growth Substances|growth substances|mesh-ancestor
6346761|NCT00047307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6346762|NCT00047333|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6346763|NCT00047333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346764|NCT00047333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6346765|NCT00047333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6346766|NCT00047333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346767|NCT00047346|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6346768|NCT00047346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346769|NCT00047346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6346770|NCT00047346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6346771|NCT00047346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346772|NCT00047450|Citalopram|citalopram|mesh-list
6346773|NCT00047450|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6346774|NCT00047450|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6346775|NCT00047450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6346776|NCT00047450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346777|NCT00047450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6346778|NCT00047450|Serotonin Agents|serotonin agents|mesh-ancestor
6346779|NCT00047450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6346780|NCT00047450|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6346781|NCT00047450|Antidepressive Agents|antidepressive agents|mesh-ancestor
6346782|NCT00047450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6346783|NCT00047476|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
6346784|NCT00047476|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6346785|NCT00047476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6346786|NCT00047476|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6346787|NCT00047476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6346788|NCT00047476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6346789|NCT00047476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346790|NCT00047476|Dopamine Agents|dopamine agents|mesh-ancestor
6346791|NCT00047476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6346792|NCT00047502|Imatinib Mesylate|imatinib mesylate|mesh-list
6346793|NCT00047502|Lonafarnib|lonafarnib|mesh-list
6346794|NCT00047502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346795|NCT00047502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6346796|NCT00047502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6346797|NCT00047502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346798|NCT00047554|Travoprost|travoprost|mesh-list
6346799|NCT00047554|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6346800|NCT00047554|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6346801|NCT00047554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6346802|NCT00047567|Zonisamide|zonisamide|mesh-list
6346803|NCT00047567|Anticonvulsants|anticonvulsants|mesh-ancestor
6346804|NCT00047567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6346805|NCT00047567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6346806|NCT00047567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346807|NCT00047567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6346808|NCT00047567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6346809|NCT00047580|Tizanidine|tizanidine|mesh-list
6346810|NCT00047580|Analgesics|analgesics|mesh-ancestor
6346811|NCT00047580|Sensory System Agents|sensory system agents|mesh-ancestor
6346812|NCT00047580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6346813|NCT00047580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6346814|NCT00047580|Anticonvulsants|anticonvulsants|mesh-ancestor
6346815|NCT00047580|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6346816|NCT00047580|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6346817|NCT00047580|Parasympatholytics|parasympatholytics|mesh-ancestor
6346818|NCT00047580|Autonomic Agents|autonomic agents|mesh-ancestor
6346819|NCT00047580|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6346820|NCT00047580|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6346821|NCT00047580|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6346822|NCT00047580|Adrenergic Agents|adrenergic agents|mesh-ancestor
6346823|NCT00047580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6346824|NCT00047580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346825|NCT00047632|Interferons|interferons|mesh-list
6346826|NCT00047632|Interferon-gamma|interferon-gamma|mesh-list
6346827|NCT00047632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346828|NCT00047632|Antiviral Agents|antiviral agents|mesh-ancestor
6346829|NCT00047632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6346830|NCT00047645|Interferons|interferons|mesh-list
6346831|NCT00047645|Interferon-gamma|interferon-gamma|mesh-list
6346832|NCT00047645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346833|NCT00047645|Antiviral Agents|antiviral agents|mesh-ancestor
6346834|NCT00047645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6346835|NCT00047658|Interferons|interferons|mesh-list
6346836|NCT00047658|Interferon-gamma|interferon-gamma|mesh-list
6346837|NCT00047658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346838|NCT00047658|Antiviral Agents|antiviral agents|mesh-ancestor
6346839|NCT00047658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6346840|NCT00047671|Citalopram|citalopram|mesh-list
6346841|NCT00047671|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6346842|NCT00047671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6346843|NCT00047671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6346844|NCT00047671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346845|NCT00047671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6346846|NCT00047671|Serotonin Agents|serotonin agents|mesh-ancestor
6346847|NCT00047671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6346848|NCT00047671|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6346849|NCT00047671|Antidepressive Agents|antidepressive agents|mesh-ancestor
6346850|NCT00047671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6346851|NCT00047710|Bevacizumab|bevacizumab|mesh-list
6346852|NCT00047710|Capecitabine|capecitabine|mesh-list
6346853|NCT00047710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6346854|NCT00047710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346855|NCT00047710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6346856|NCT00047710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6346857|NCT00047710|Growth Substances|growth substances|mesh-ancestor
6346858|NCT00047710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6346859|NCT00047710|Growth Inhibitors|growth inhibitors|mesh-ancestor
6346860|NCT00047710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6346861|NCT00047710|Antimetabolites|antimetabolites|mesh-ancestor
6346862|NCT00047710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346863|NCT00047723|Minocycline|minocycline|mesh-list
6346864|NCT00047723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6346865|NCT00047723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6346866|NCT00047736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6346867|NCT00047736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346868|NCT00047736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6346869|NCT00047736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6346870|NCT00047736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346871|NCT00047749|Ziconotide|ziconotide|mesh-list
6346872|NCT00047749|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6346873|NCT00047749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6346874|NCT00047749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346875|NCT00047749|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6346876|NCT00047749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6346877|NCT00047749|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6346878|NCT00047749|Protective Agents|protective agents|mesh-ancestor
6346879|NCT00047749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6346880|NCT00047749|Analgesics|analgesics|mesh-ancestor
6346881|NCT00047749|Sensory System Agents|sensory system agents|mesh-ancestor
6346882|NCT00047749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6346883|NCT00047762|Bevacizumab|bevacizumab|mesh-list
6346884|NCT00047762|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6346885|NCT00047762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6346886|NCT00047762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346887|NCT00047762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6346888|NCT00047762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6346889|NCT00047762|Growth Substances|growth substances|mesh-ancestor
6346890|NCT00047762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6346891|NCT00047762|Growth Inhibitors|growth inhibitors|mesh-ancestor
6346892|NCT00047762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6346893|NCT00047762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6346894|NCT00047762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346895|NCT00047801|Docetaxel|docetaxel|mesh-list
6346896|NCT00047801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346897|NCT00047801|Tubulin Modulators|tubulin modulators|mesh-ancestor
6346898|NCT00047801|Antimitotic Agents|antimitotic agents|mesh-ancestor
6346899|NCT00047801|Mitosis Modulators|mitosis modulators|mesh-ancestor
6346900|NCT00047801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346901|NCT00047827|Amphotericin B|amphotericin b|mesh-list
6346902|NCT00047827|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6346903|NCT00047827|Micafungin|micafungin|mesh-list
6346904|NCT00047827|Amebicides|amebicides|mesh-ancestor
6346905|NCT00047827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6346906|NCT00047827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6346907|NCT00047827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6346908|NCT00047827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6346909|NCT00047827|Antifungal Agents|antifungal agents|mesh-ancestor
6346910|NCT00047840|Docetaxel|docetaxel|mesh-list
6346911|NCT00047840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346912|NCT00047840|Tubulin Modulators|tubulin modulators|mesh-ancestor
6346913|NCT00047840|Antimitotic Agents|antimitotic agents|mesh-ancestor
6346914|NCT00047840|Mitosis Modulators|mitosis modulators|mesh-ancestor
6346915|NCT00047840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394074|NCT00200694|Valsartan|valsartan|mesh-list
6394075|NCT00200694|Ramipril|ramipril|mesh-list
6394076|NCT00200694|Furosemide|furosemide|mesh-list
6394077|NCT00200694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6394078|NCT00200694|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6394079|NCT00200694|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6394080|NCT00200694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394081|NCT00200694|Diuretics|diuretics|mesh-ancestor
6394082|NCT00200694|Natriuretic Agents|natriuretic agents|mesh-ancestor
6394083|NCT00200694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394084|NCT00200694|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6394085|NCT00200694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6394086|NCT00200694|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6394087|NCT00200694|Protease Inhibitors|protease inhibitors|mesh-ancestor
6346916|NCT00048087|Docetaxel|docetaxel|mesh-list
6346917|NCT00048087|Gefitinib|gefitinib|mesh-list
6346918|NCT00048087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346919|NCT00048087|Tubulin Modulators|tubulin modulators|mesh-ancestor
6346920|NCT00048087|Antimitotic Agents|antimitotic agents|mesh-ancestor
6346921|NCT00048087|Mitosis Modulators|mitosis modulators|mesh-ancestor
6346922|NCT00048087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346923|NCT00048087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6346924|NCT00048087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6346925|NCT00048113|Alicaforsen|alicaforsen|mesh-list
6346926|NCT00048113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6346927|NCT00048113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6346928|NCT00048113|Immunologic Factors|immunologic factors|mesh-ancestor
6346929|NCT00048113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6346930|NCT00048126|Capecitabine|capecitabine|mesh-list
6346931|NCT00048126|Irinotecan|irinotecan|mesh-list
6346932|NCT00048126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6346933|NCT00048126|Antimetabolites|antimetabolites|mesh-ancestor
6346934|NCT00048126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346935|NCT00048126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346936|NCT00048126|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6346937|NCT00048126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6346938|NCT00048126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6346939|NCT00048139|Capecitabine|capecitabine|mesh-list
6346940|NCT00048139|Irinotecan|irinotecan|mesh-list
6346941|NCT00048139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6346942|NCT00048139|Antimetabolites|antimetabolites|mesh-ancestor
6346943|NCT00048139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346944|NCT00048139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346945|NCT00048139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6346946|NCT00048139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6346947|NCT00048139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6346948|NCT00048152|Mycophenolic Acid|mycophenolic acid|mesh-list
6346949|NCT00048152|Cyclosporine|cyclosporine|mesh-list
6346950|NCT00048152|Cyclosporins|cyclosporins|mesh-list
6346951|NCT00048152|Daclizumab|daclizumab|mesh-list
6346952|NCT00048152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6346953|NCT00048152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346954|NCT00048152|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6346955|NCT00048152|Antitubercular Agents|antitubercular agents|mesh-ancestor
6346956|NCT00048152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6346957|NCT00048152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6346958|NCT00048152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6346959|NCT00048152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346960|NCT00048152|Antifungal Agents|antifungal agents|mesh-ancestor
6346961|NCT00048152|Dermatologic Agents|dermatologic agents|mesh-ancestor
6346962|NCT00048152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6346963|NCT00048152|Immunologic Factors|immunologic factors|mesh-ancestor
6346964|NCT00048152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6346965|NCT00048152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6346966|NCT00048152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6346967|NCT00048204|Paroxetine|paroxetine|mesh-list
6346968|NCT00048204|Vestipitant|vestipitant|mesh-list
6346969|NCT00048204|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6346970|NCT00048204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6346971|NCT00048204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6346972|NCT00048204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6346973|NCT00048204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6346974|NCT00048204|Serotonin Agents|serotonin agents|mesh-ancestor
6346975|NCT00048204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6346976|NCT00048204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6346977|NCT00048204|Antidepressive Agents|antidepressive agents|mesh-ancestor
6346978|NCT00048204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6346979|NCT00048204|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6346980|NCT00048204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6346981|NCT00048204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6346982|NCT00048204|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6346983|NCT00048230|Bortezomib|bortezomib|mesh-list
6346984|NCT00048230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346985|NCT00048295|Alicaforsen|alicaforsen|mesh-list
6346986|NCT00048295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6346987|NCT00048295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6346988|NCT00048295|Immunologic Factors|immunologic factors|mesh-ancestor
6346989|NCT00048295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6346990|NCT00048334|Romidepsin|romidepsin|mesh-list
6346991|NCT00048334|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6346992|NCT00048334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6346993|NCT00048360|Bupropion|bupropion|mesh-list
6346994|NCT00048360|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6346995|NCT00048360|Antidepressive Agents|antidepressive agents|mesh-ancestor
6346996|NCT00048360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6346997|NCT00048360|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6346998|NCT00048360|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6346999|NCT00048360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6347000|NCT00048360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347001|NCT00048360|Dopamine Agents|dopamine agents|mesh-ancestor
6347002|NCT00048360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6347003|NCT00048360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347004|NCT00048360|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6347005|NCT00048360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6347006|NCT00048360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6347007|NCT00048373|Etanercept|etanercept|mesh-list
6347008|NCT00048373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6347009|NCT00048373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6016927|NCT00368927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6016928|NCT00368927|Analgesics|analgesics|mesh-ancestor
6016929|NCT00368927|Sensory System Agents|sensory system agents|mesh-ancestor
6016930|NCT00368927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6016931|NCT00368927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016932|NCT00368927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6016933|NCT00368927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6016934|NCT00368927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6016935|NCT00368927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6016936|NCT00368927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6347010|NCT00048373|Analgesics|analgesics|mesh-ancestor
6347011|NCT00048373|Sensory System Agents|sensory system agents|mesh-ancestor
6347012|NCT00048373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6347013|NCT00048373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347014|NCT00048373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6347015|NCT00048373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6347016|NCT00048373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6347017|NCT00048373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6347018|NCT00048373|Immunologic Factors|immunologic factors|mesh-ancestor
6347019|NCT00048399|Fludarabine|fludarabine|mesh-list
6347020|NCT00048399|Alemtuzumab|alemtuzumab|mesh-list
6347021|NCT00048399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6347022|NCT00048399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6347023|NCT00048412|Fludarabine|fludarabine|mesh-list
6347024|NCT00048412|Alemtuzumab|alemtuzumab|mesh-list
6016937|NCT00368927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016938|NCT00368966|Vaccines|vaccines|mesh-list
6016939|NCT00368966|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6016940|NCT00368966|Immunologic Factors|immunologic factors|mesh-ancestor
6016941|NCT00368966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347025|NCT00048412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6347026|NCT00048412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6347027|NCT00048425|Simendan|simendan|mesh-list
6347028|NCT00048425|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6347029|NCT00048425|Vasodilator Agents|vasodilator agents|mesh-ancestor
6347030|NCT00048425|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6347031|NCT00048425|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6347032|NCT00048425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6347033|NCT00048425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347034|NCT00048425|Protective Agents|protective agents|mesh-ancestor
6347035|NCT00048425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347036|NCT00048477|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
6347037|NCT00048477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6347038|NCT00048477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347039|NCT00048503|Tipifarnib|tipifarnib|mesh-list
6347040|NCT00048503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6347041|NCT00048555|Galiximab|galiximab|mesh-list
6347042|NCT00048555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6347043|NCT00048555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6347044|NCT00048594|Aprepitant|aprepitant|mesh-list
6347045|NCT00048594|Antiemetics|antiemetics|mesh-ancestor
6347046|NCT00048594|Autonomic Agents|autonomic agents|mesh-ancestor
6347047|NCT00048594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6347048|NCT00048594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347049|NCT00048594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6347050|NCT00048594|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6347051|NCT00048594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6347052|NCT00048594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347053|NCT00048607|Aprepitant|aprepitant|mesh-list
6347054|NCT00048607|Paroxetine|paroxetine|mesh-list
6347055|NCT00048607|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6347056|NCT00048607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6347057|NCT00048607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6347058|NCT00048607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347059|NCT00048607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6347060|NCT00048607|Serotonin Agents|serotonin agents|mesh-ancestor
6347061|NCT00048607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347062|NCT00048607|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6347063|NCT00048607|Antidepressive Agents|antidepressive agents|mesh-ancestor
6347064|NCT00048607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6347065|NCT00048607|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6347066|NCT00048607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6347067|NCT00048607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6347068|NCT00048607|Antiemetics|antiemetics|mesh-ancestor
6347069|NCT00048607|Autonomic Agents|autonomic agents|mesh-ancestor
6347070|NCT00048607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6347071|NCT00048607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6347072|NCT00048607|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6347073|NCT00048646|Progesterone|progesterone|mesh-list
6347074|NCT00048646|Progestins|progestins|mesh-ancestor
6347075|NCT00048646|Hormones|hormones|mesh-ancestor
6347076|NCT00048646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6347077|NCT00048646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347078|NCT00048659|N-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|n-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|mesh-list
6347079|NCT00048659|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6347080|NCT00048659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347081|NCT00048672|Imatinib Mesylate|imatinib mesylate|mesh-list
6347082|NCT00048672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6347083|NCT00048672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6347084|NCT00048672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6347085|NCT00048672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347086|NCT00048750|Micafungin|micafungin|mesh-list
6347087|NCT00048750|Antifungal Agents|antifungal agents|mesh-ancestor
6347088|NCT00048750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6347089|NCT00048763|Cilostazol|cilostazol|mesh-list
6347090|NCT00048763|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6347091|NCT00048763|Autonomic Agents|autonomic agents|mesh-ancestor
6347092|NCT00048763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6347093|NCT00048763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347094|NCT00048763|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6347095|NCT00048763|Respiratory System Agents|respiratory system agents|mesh-ancestor
6347096|NCT00048763|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6347097|NCT00048763|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6347098|NCT00048763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347099|NCT00048763|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6347100|NCT00048763|Vasodilator Agents|vasodilator agents|mesh-ancestor
6347101|NCT00048763|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6347102|NCT00048763|Protective Agents|protective agents|mesh-ancestor
6394088|NCT00200694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6347103|NCT00048763|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6347104|NCT00048763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6347105|NCT00048763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6347106|NCT00048776|Cilostazol|cilostazol|mesh-list
6347107|NCT00048776|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6347108|NCT00048776|Autonomic Agents|autonomic agents|mesh-ancestor
6347109|NCT00048776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6347110|NCT00048776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347111|NCT00048776|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6347112|NCT00048776|Respiratory System Agents|respiratory system agents|mesh-ancestor
6347113|NCT00048776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6347114|NCT00048776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6347115|NCT00048776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347116|NCT00048776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6347117|NCT00048776|Vasodilator Agents|vasodilator agents|mesh-ancestor
6347118|NCT00048776|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6347119|NCT00048776|Protective Agents|protective agents|mesh-ancestor
6347120|NCT00048776|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6347121|NCT00048776|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6347122|NCT00048776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6347123|NCT00048802|Valproic Acid|valproic acid|mesh-list
6347124|NCT00048802|Olanzapine|olanzapine|mesh-list
6347125|NCT00048802|Risperidone|risperidone|mesh-list
6347126|NCT00048802|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6347127|NCT00048802|Ziprasidone|ziprasidone|mesh-list
6347128|NCT00048802|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6347129|NCT00048802|Serotonin Agents|serotonin agents|mesh-ancestor
6347130|NCT00048802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6347131|NCT00048802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347132|NCT00048802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347133|NCT00048802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6347134|NCT00048802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6347135|NCT00048802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6347136|NCT00048802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6347137|NCT00048802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6347138|NCT00048802|Dopamine Agents|dopamine agents|mesh-ancestor
6347139|NCT00048802|Antiemetics|antiemetics|mesh-ancestor
6347140|NCT00048802|Autonomic Agents|autonomic agents|mesh-ancestor
6347141|NCT00048802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6347142|NCT00048802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6347143|NCT00048802|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6347144|NCT00048802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6347145|NCT00048802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6347146|NCT00048802|Antidepressive Agents|antidepressive agents|mesh-ancestor
6347147|NCT00048802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6347148|NCT00048802|Antimanic Agents|antimanic agents|mesh-ancestor
6347149|NCT00048802|Anticonvulsants|anticonvulsants|mesh-ancestor
6347150|NCT00048802|GABA Agents|gaba agents|mesh-ancestor
6347151|NCT00048828|Olanzapine|olanzapine|mesh-list
6347152|NCT00048828|Clozapine|clozapine|mesh-list
6347153|NCT00048828|Antiemetics|antiemetics|mesh-ancestor
6347154|NCT00048828|Autonomic Agents|autonomic agents|mesh-ancestor
6347155|NCT00048828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6347156|NCT00048828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347157|NCT00048828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6347158|NCT00048828|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6347159|NCT00048828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6347160|NCT00048828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6347161|NCT00048828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6347162|NCT00048828|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6347163|NCT00048828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6347164|NCT00048828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6347165|NCT00048828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347166|NCT00048828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6347167|NCT00048828|Serotonin Agents|serotonin agents|mesh-ancestor
6347168|NCT00048828|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6347169|NCT00048828|GABA Antagonists|gaba antagonists|mesh-ancestor
6347170|NCT00048828|GABA Agents|gaba agents|mesh-ancestor
6347171|NCT00048841|Alendronate|alendronate|mesh-list
6347172|NCT00048841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6347173|NCT00048841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347174|NCT00048854|Sertraline|sertraline|mesh-list
6347175|NCT00048854|Antidepressive Agents|antidepressive agents|mesh-ancestor
6347176|NCT00048854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6347177|NCT00048854|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6347178|NCT00048854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6347179|NCT00048854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6347180|NCT00048854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347181|NCT00048854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6347182|NCT00048854|Serotonin Agents|serotonin agents|mesh-ancestor
6347183|NCT00048854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347184|NCT00048880|Antibodies|antibodies|mesh-list
6347185|NCT00048880|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6347186|NCT00048880|Immunologic Factors|immunologic factors|mesh-ancestor
6347187|NCT00048880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347188|NCT00048945|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6347189|NCT00048945|Antiviral Agents|antiviral agents|mesh-ancestor
6347190|NCT00048945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6347191|NCT00049023|Octreotide|octreotide|mesh-list
6347192|NCT00049023|Edotreotide|edotreotide|mesh-list
6347193|NCT00049023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6347194|NCT00049023|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6347195|NCT00049023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6347196|NCT00049023|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6347197|NCT00049023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347198|NCT00049062|Gefitinib|gefitinib|mesh-list
6347199|NCT00049062|Anastrozole|anastrozole|mesh-list
6347200|NCT00049062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6347201|NCT00049062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6347202|NCT00049062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6347203|NCT00049062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347204|NCT00049062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6347205|NCT00049062|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6347206|NCT00049062|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6347207|NCT00049062|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6347208|NCT00049062|Hormone Antagonists|hormone antagonists|mesh-ancestor
6347209|NCT00049062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6347210|NCT00049062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347211|NCT00049075|Fludarabine|fludarabine|mesh-list
6347212|NCT00049075|Fludarabine phosphate|fludarabine phosphate|mesh-list
6347213|NCT00049075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6347214|NCT00049075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6347215|NCT00049075|Antimetabolites|antimetabolites|mesh-ancestor
6347216|NCT00049075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347217|NCT00049075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6347218|NCT00049075|Immunologic Factors|immunologic factors|mesh-ancestor
6347219|NCT00049075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347220|NCT00049088|Bevacizumab|bevacizumab|mesh-list
6347221|NCT00049088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6347222|NCT00049088|Docetaxel|docetaxel|mesh-list
6347223|NCT00049088|Antibodies|antibodies|mesh-list
6347224|NCT00049088|Immunoglobulins|immunoglobulins|mesh-list
6347225|NCT00049088|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6347226|NCT00049088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6347227|NCT00049088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6347228|NCT00049088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6347229|NCT00049088|Growth Substances|growth substances|mesh-ancestor
6347230|NCT00049088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347231|NCT00049088|Growth Inhibitors|growth inhibitors|mesh-ancestor
6347232|NCT00049088|Immunologic Factors|immunologic factors|mesh-ancestor
6347233|NCT00049088|Tubulin Modulators|tubulin modulators|mesh-ancestor
6347234|NCT00049088|Antimitotic Agents|antimitotic agents|mesh-ancestor
6347235|NCT00049088|Mitosis Modulators|mitosis modulators|mesh-ancestor
6347236|NCT00049088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347237|NCT00049101|Leucovorin|leucovorin|mesh-list
6347238|NCT00049101|Fluorouracil|fluorouracil|mesh-list
6347239|NCT00049101|Oxaliplatin|oxaliplatin|mesh-list
6347240|NCT00049101|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6347241|NCT00049101|Calcium|calcium|mesh-list
6347242|NCT00049101|Levoleucovorin|levoleucovorin|mesh-list
6347243|NCT00049101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6347244|NCT00049101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347245|NCT00049101|Antimetabolites|antimetabolites|mesh-ancestor
6347246|NCT00049101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347247|NCT00049101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6347248|NCT00049101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6347249|NCT00049101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6347250|NCT00049101|Immunologic Factors|immunologic factors|mesh-ancestor
6347251|NCT00049101|Antidotes|antidotes|mesh-ancestor
6347252|NCT00049101|Protective Agents|protective agents|mesh-ancestor
6347253|NCT00049101|Vitamin B Complex|vitamin b complex|mesh-ancestor
6347254|NCT00049101|Vitamins|vitamins|mesh-ancestor
6347255|NCT00049101|Micronutrients|micronutrients|mesh-ancestor
6347256|NCT00049101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6347257|NCT00049101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6347258|NCT00049114|Cyclophosphamide|cyclophosphamide|mesh-list
6347259|NCT00049114|Doxorubicin|doxorubicin|mesh-list
6347260|NCT00049114|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6347261|NCT00049114|Tipifarnib|tipifarnib|mesh-list
6347262|NCT00049114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6347263|NCT00049114|Immunologic Factors|immunologic factors|mesh-ancestor
6347264|NCT00049114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347265|NCT00049114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6347266|NCT00049114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6347267|NCT00049114|Alkylating Agents|alkylating agents|mesh-ancestor
6347268|NCT00049114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347269|NCT00049114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6347270|NCT00049114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6347271|NCT00049114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6347272|NCT00049114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6347273|NCT00049114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6347274|NCT00049114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6347275|NCT00049166|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6347276|NCT00049166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6347277|NCT00049166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6347278|NCT00049166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6347279|NCT00049166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347280|NCT00049179|Cytarabine|cytarabine|mesh-list
6347281|NCT00049179|Gemtuzumab|gemtuzumab|mesh-list
6347282|NCT00049179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6347283|NCT00049179|Antimetabolites|antimetabolites|mesh-ancestor
6347284|NCT00049179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347285|NCT00049179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6347286|NCT00049179|Antiviral Agents|antiviral agents|mesh-ancestor
6347287|NCT00049179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6347288|NCT00049179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6347289|NCT00049179|Immunologic Factors|immunologic factors|mesh-ancestor
6347290|NCT00049179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347291|NCT00049179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6347292|NCT00049192|Imatinib Mesylate|imatinib mesylate|mesh-list
6347293|NCT00049192|Oblimersen|oblimersen|mesh-list
6347294|NCT00049192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6347295|NCT00049192|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6347296|NCT00049192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6347297|NCT00049192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347298|NCT00049218|Carboplatin|carboplatin|mesh-list
6347299|NCT00049218|Etoposide|etoposide|mesh-list
6347300|NCT00049218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6347301|NCT00049218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6347302|NCT00049218|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6347303|NCT00049218|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6347304|NCT00049218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6347305|NCT00049218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347306|NCT00049244|Capecitabine|capecitabine|mesh-list
6347307|NCT00049244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6347308|NCT00049244|Antimetabolites|antimetabolites|mesh-ancestor
6347309|NCT00049244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347310|NCT00049244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6347311|NCT00049283|Docetaxel|docetaxel|mesh-list
6347312|NCT00049283|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6347313|NCT00049283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6347314|NCT00049283|Tubulin Modulators|tubulin modulators|mesh-ancestor
6347315|NCT00049283|Antimitotic Agents|antimitotic agents|mesh-ancestor
6347316|NCT00049283|Mitosis Modulators|mitosis modulators|mesh-ancestor
6347317|NCT00049283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347318|NCT00049283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6347319|NCT00049283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6347320|NCT00049296|Thalidomide|thalidomide|mesh-list
6347321|NCT00049296|Docetaxel|docetaxel|mesh-list
6347322|NCT00049296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6347323|NCT00049296|Tubulin Modulators|tubulin modulators|mesh-ancestor
6347324|NCT00049296|Antimitotic Agents|antimitotic agents|mesh-ancestor
6347325|NCT00049296|Mitosis Modulators|mitosis modulators|mesh-ancestor
6347326|NCT00049296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347327|NCT00049296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6347328|NCT00049296|Immunologic Factors|immunologic factors|mesh-ancestor
6347329|NCT00049296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347330|NCT00049296|Leprostatic Agents|leprostatic agents|mesh-ancestor
6347331|NCT00049296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6347332|NCT00049296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6347333|NCT00049296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6347334|NCT00049296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6347335|NCT00049296|Growth Substances|growth substances|mesh-ancestor
6347336|NCT00049296|Growth Inhibitors|growth inhibitors|mesh-ancestor
6347337|NCT00049335|Capecitabine|capecitabine|mesh-list
6347338|NCT00049335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6347339|NCT00049335|Antimetabolites|antimetabolites|mesh-ancestor
6347340|NCT00049335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347341|NCT00049335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6347342|NCT00049348|Gemcitabine|gemcitabine|mesh-list
6347343|NCT00049348|Fluorouracil|fluorouracil|mesh-list
6347344|NCT00049348|Epoetin Alfa|epoetin alfa|mesh-list
6347345|NCT00049348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6347346|NCT00049348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6347347|NCT00049348|Antimetabolites|antimetabolites|mesh-ancestor
6347348|NCT00049348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347349|NCT00049348|Antiviral Agents|antiviral agents|mesh-ancestor
6347350|NCT00049348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6347351|NCT00049348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6347352|NCT00049348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6347353|NCT00049348|Immunologic Factors|immunologic factors|mesh-ancestor
6347354|NCT00049348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347355|NCT00049348|Hematinics|hematinics|mesh-ancestor
6347356|NCT00049361|Thalidomide|thalidomide|mesh-list
6347357|NCT00049361|Temozolomide|temozolomide|mesh-list
6347358|NCT00049361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6347359|NCT00049361|Alkylating Agents|alkylating agents|mesh-ancestor
6347360|NCT00049361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347361|NCT00049361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6347362|NCT00049361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6347363|NCT00049361|Immunologic Factors|immunologic factors|mesh-ancestor
6347364|NCT00049361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347365|NCT00049361|Leprostatic Agents|leprostatic agents|mesh-ancestor
6347366|NCT00049361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6347367|NCT00049361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6347368|NCT00049361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6347369|NCT00049361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6347370|NCT00049361|Growth Substances|growth substances|mesh-ancestor
6347371|NCT00049361|Growth Inhibitors|growth inhibitors|mesh-ancestor
6347372|NCT00049374|Thalidomide|thalidomide|mesh-list
6347373|NCT00049374|Dexamethasone|dexamethasone|mesh-list
6347374|NCT00049374|Oblimersen|oblimersen|mesh-list
6347375|NCT00049374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6347376|NCT00049374|Antiemetics|antiemetics|mesh-ancestor
6347377|NCT00049374|Autonomic Agents|autonomic agents|mesh-ancestor
6347378|NCT00049374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6347379|NCT00049374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347380|NCT00049374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6347381|NCT00049374|Glucocorticoids|glucocorticoids|mesh-ancestor
6347382|NCT00049374|Hormones|hormones|mesh-ancestor
6347383|NCT00049374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6347384|NCT00049374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6347385|NCT00049374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6347386|NCT00049374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6347387|NCT00049374|Immunologic Factors|immunologic factors|mesh-ancestor
6347388|NCT00049374|Leprostatic Agents|leprostatic agents|mesh-ancestor
6347389|NCT00049374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6347390|NCT00049374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6347391|NCT00049374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6347392|NCT00049374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6347393|NCT00049374|Growth Substances|growth substances|mesh-ancestor
6347394|NCT00049374|Growth Inhibitors|growth inhibitors|mesh-ancestor
6347395|NCT00049387|Temozolomide|temozolomide|mesh-list
6347396|NCT00049387|Tipifarnib|tipifarnib|mesh-list
6347397|NCT00049387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6347398|NCT00049387|Alkylating Agents|alkylating agents|mesh-ancestor
6347399|NCT00049387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347400|NCT00049387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6347401|NCT00049413|Cyclophosphamide|cyclophosphamide|mesh-list
6347402|NCT00049413|Rituximab|rituximab|mesh-list
6347403|NCT00049413|Pentostatin|pentostatin|mesh-list
6347404|NCT00049413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6347405|NCT00049413|Immunologic Factors|immunologic factors|mesh-ancestor
6347406|NCT00049413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347407|NCT00049413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6347408|NCT00049413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6347409|NCT00049413|Alkylating Agents|alkylating agents|mesh-ancestor
6347410|NCT00049413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347411|NCT00049413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6347412|NCT00049413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6347413|NCT00049413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6347414|NCT00049413|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
6347415|NCT00049413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6347416|NCT00049439|Cyclophosphamide|cyclophosphamide|mesh-list
6347417|NCT00049439|Lomustine|lomustine|mesh-list
6347418|NCT00049439|Etoposide|etoposide|mesh-list
6347419|NCT00049439|Procarbazine|procarbazine|mesh-list
6347420|NCT00049439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6347421|NCT00049439|Immunologic Factors|immunologic factors|mesh-ancestor
6347422|NCT00049439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347423|NCT00049439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6347424|NCT00049439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6347425|NCT00049439|Alkylating Agents|alkylating agents|mesh-ancestor
6347426|NCT00049439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347427|NCT00049439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6347428|NCT00049439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6347429|NCT00049439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6347430|NCT00049439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6347431|NCT00049439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6347432|NCT00049439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6347433|NCT00049452|Zoledronic Acid|zoledronic acid|mesh-list
6347434|NCT00049452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6347435|NCT00049452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347436|NCT00049556|Gefitinib|gefitinib|mesh-list
6347437|NCT00049556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6347438|NCT00049556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6347439|NCT00049556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6347440|NCT00049556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347441|NCT00049569|Leucovorin|leucovorin|mesh-list
6347442|NCT00049569|Cytarabine|cytarabine|mesh-list
6347443|NCT00049569|Prednisone|prednisone|mesh-list
6347444|NCT00049569|Hydrocortisone|hydrocortisone|mesh-list
6347445|NCT00049569|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6347446|NCT00049569|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6347447|NCT00049569|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6347448|NCT00049569|Cyclophosphamide|cyclophosphamide|mesh-list
6347449|NCT00049569|Doxorubicin|doxorubicin|mesh-list
6347450|NCT00049569|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6347451|NCT00049569|Methotrexate|methotrexate|mesh-list
6347452|NCT00049569|Etoposide|etoposide|mesh-list
6347453|NCT00049569|Vincristine|vincristine|mesh-list
6347454|NCT00049569|Imatinib Mesylate|imatinib mesylate|mesh-list
6347455|NCT00049569|Asparaginase|asparaginase|mesh-list
6347456|NCT00049569|Pegaspargase|pegaspargase|mesh-list
6347457|NCT00049569|Levoleucovorin|levoleucovorin|mesh-list
6347458|NCT00049569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6347459|NCT00049569|Immunologic Factors|immunologic factors|mesh-ancestor
6347460|NCT00049569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347461|NCT00049569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6347462|NCT00049569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6347463|NCT00049569|Alkylating Agents|alkylating agents|mesh-ancestor
6347464|NCT00049569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347465|NCT00049569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6347466|NCT00049569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6347467|NCT00049569|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6347468|NCT00049569|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6347469|NCT00049569|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6347470|NCT00049569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6347471|NCT00049569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6347472|NCT00049569|Glucocorticoids|glucocorticoids|mesh-ancestor
6347473|NCT00049569|Hormones|hormones|mesh-ancestor
6347474|NCT00049569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6347475|NCT00049569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6347476|NCT00049569|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6347477|NCT00049569|Abortifacient Agents|abortifacient agents|mesh-ancestor
6347478|NCT00049569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6347479|NCT00049569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6347480|NCT00049569|Antimetabolites|antimetabolites|mesh-ancestor
6347481|NCT00049569|Dermatologic Agents|dermatologic agents|mesh-ancestor
6347482|NCT00049569|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6347483|NCT00049569|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6394089|NCT00200941|Topiramate|topiramate|mesh-list
6347484|NCT00049569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6347485|NCT00049569|Antiviral Agents|antiviral agents|mesh-ancestor
6347486|NCT00049569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6347487|NCT00049569|Antidotes|antidotes|mesh-ancestor
6347488|NCT00049569|Protective Agents|protective agents|mesh-ancestor
6347489|NCT00049569|Vitamin B Complex|vitamin b complex|mesh-ancestor
6347490|NCT00049569|Vitamins|vitamins|mesh-ancestor
6347491|NCT00049569|Micronutrients|micronutrients|mesh-ancestor
6347492|NCT00049569|Tubulin Modulators|tubulin modulators|mesh-ancestor
6347493|NCT00049569|Antimitotic Agents|antimitotic agents|mesh-ancestor
6347494|NCT00049569|Mitosis Modulators|mitosis modulators|mesh-ancestor
6347495|NCT00049569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6347496|NCT00049582|Decitabine|decitabine|mesh-list
6347497|NCT00049582|Azacitidine|azacitidine|mesh-list
6347498|NCT00049582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6347499|NCT00049582|Antimetabolites|antimetabolites|mesh-ancestor
6347500|NCT00049582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347501|NCT00049582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6347502|NCT00049582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6347503|NCT00049595|Prednisone|prednisone|mesh-list
6347504|NCT00049595|Cyclophosphamide|cyclophosphamide|mesh-list
6347505|NCT00049595|Dacarbazine|dacarbazine|mesh-list
6347506|NCT00049595|Doxorubicin|doxorubicin|mesh-list
6347507|NCT00049595|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6347508|NCT00049595|Etoposide|etoposide|mesh-list
6347509|NCT00049595|Vincristine|vincristine|mesh-list
6347510|NCT00049595|Bleomycin|bleomycin|mesh-list
6347511|NCT00049595|Vinblastine|vinblastine|mesh-list
6347512|NCT00049595|Procarbazine|procarbazine|mesh-list
6347513|NCT00049595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6347514|NCT00049595|Immunologic Factors|immunologic factors|mesh-ancestor
6347515|NCT00049595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347516|NCT00049595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6347517|NCT00049595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6347518|NCT00049595|Alkylating Agents|alkylating agents|mesh-ancestor
6347519|NCT00049595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347520|NCT00049595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6347521|NCT00049595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6347522|NCT00049595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6347523|NCT00049595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6347524|NCT00049595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6347525|NCT00049595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6347526|NCT00049595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6347527|NCT00049595|Glucocorticoids|glucocorticoids|mesh-ancestor
6347528|NCT00049595|Hormones|hormones|mesh-ancestor
6347529|NCT00049595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6347530|NCT00049595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6347531|NCT00049595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6347532|NCT00049595|Tubulin Modulators|tubulin modulators|mesh-ancestor
6347533|NCT00049595|Antimitotic Agents|antimitotic agents|mesh-ancestor
6347534|NCT00049595|Mitosis Modulators|mitosis modulators|mesh-ancestor
6347535|NCT00049608|Gemcitabine|gemcitabine|mesh-list
6347536|NCT00049608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6347537|NCT00049608|Antimetabolites|antimetabolites|mesh-ancestor
6347538|NCT00049608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347539|NCT00049608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6347540|NCT00049608|Antiviral Agents|antiviral agents|mesh-ancestor
6347541|NCT00049608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6347542|NCT00049608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6347543|NCT00049608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6347544|NCT00049608|Immunologic Factors|immunologic factors|mesh-ancestor
6347545|NCT00049608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347546|NCT00049634|Cyclosporine|cyclosporine|mesh-list
6347547|NCT00049634|Cyclophosphamide|cyclophosphamide|mesh-list
6347548|NCT00049634|Busulfan|busulfan|mesh-list
6347549|NCT00049634|Methotrexate|methotrexate|mesh-list
6347550|NCT00049634|Cyclosporins|cyclosporins|mesh-list
6347551|NCT00049634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6347552|NCT00049634|Immunologic Factors|immunologic factors|mesh-ancestor
6347553|NCT00049634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347554|NCT00049634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6347555|NCT00049634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6347556|NCT00049634|Alkylating Agents|alkylating agents|mesh-ancestor
6347557|NCT00049634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347558|NCT00049634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6347559|NCT00049634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6347560|NCT00049634|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6347561|NCT00049634|Abortifacient Agents|abortifacient agents|mesh-ancestor
6347562|NCT00049634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6347563|NCT00049634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6347564|NCT00049634|Antimetabolites|antimetabolites|mesh-ancestor
6347565|NCT00049634|Dermatologic Agents|dermatologic agents|mesh-ancestor
6347566|NCT00049634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6347567|NCT00049634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6347568|NCT00049634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6347569|NCT00049634|Antifungal Agents|antifungal agents|mesh-ancestor
6347570|NCT00049634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6347571|NCT00049634|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6347572|NCT00049660|Capecitabine|capecitabine|mesh-list
6347573|NCT00049660|Vinorelbine|vinorelbine|mesh-list
6347574|NCT00049660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6347575|NCT00049660|Antimetabolites|antimetabolites|mesh-ancestor
6347576|NCT00049660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347577|NCT00049660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6347578|NCT00049660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6347579|NCT00049660|Tubulin Modulators|tubulin modulators|mesh-ancestor
6347580|NCT00049660|Antimitotic Agents|antimitotic agents|mesh-ancestor
6347581|NCT00049660|Mitosis Modulators|mitosis modulators|mesh-ancestor
6347582|NCT00049725|Daclizumab|daclizumab|mesh-list
6347583|NCT00049725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6347584|NCT00049725|Immunologic Factors|immunologic factors|mesh-ancestor
6347585|NCT00049725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347586|NCT00049751|Adalimumab|adalimumab|mesh-list
6347587|NCT00049751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6347588|NCT00049751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6394090|NCT00200941|Anticonvulsants|anticonvulsants|mesh-ancestor
6394091|NCT00200941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6394092|NCT00200941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394093|NCT00201305|Leucovorin|leucovorin|mesh-list
6394094|NCT00201305|Gemcitabine|gemcitabine|mesh-list
6394095|NCT00201305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6394096|NCT00201305|Antimetabolites|antimetabolites|mesh-ancestor
6394097|NCT00201305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394098|NCT00201305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6394099|NCT00201305|Antiviral Agents|antiviral agents|mesh-ancestor
6394100|NCT00201305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6394101|NCT00201305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6394102|NCT00201305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6394103|NCT00201305|Immunologic Factors|immunologic factors|mesh-ancestor
6394104|NCT00201305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394105|NCT00201305|Antidotes|antidotes|mesh-ancestor
6394106|NCT00201305|Protective Agents|protective agents|mesh-ancestor
6394107|NCT00201305|Vitamin B Complex|vitamin b complex|mesh-ancestor
6394108|NCT00201305|Vitamins|vitamins|mesh-ancestor
6394109|NCT00201305|Micronutrients|micronutrients|mesh-ancestor
6394110|NCT00201318|Lamivudine|lamivudine|mesh-list
6394111|NCT00201318|Cyclophosphamide|cyclophosphamide|mesh-list
6394112|NCT00201318|Doxorubicin|doxorubicin|mesh-list
6394113|NCT00201318|Vincristine|vincristine|mesh-list
6394114|NCT00201318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6394115|NCT00201318|Immunologic Factors|immunologic factors|mesh-ancestor
6394116|NCT00201318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394117|NCT00201318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6394118|NCT00201318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6394119|NCT00201318|Alkylating Agents|alkylating agents|mesh-ancestor
6394120|NCT00201318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394121|NCT00201318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6394122|NCT00201318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6394123|NCT00201318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6394124|NCT00201318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6394125|NCT00201318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6394126|NCT00201318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6394127|NCT00201318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6394128|NCT00201318|Tubulin Modulators|tubulin modulators|mesh-ancestor
6394129|NCT00201318|Antimitotic Agents|antimitotic agents|mesh-ancestor
6394130|NCT00201318|Mitosis Modulators|mitosis modulators|mesh-ancestor
6394131|NCT00201318|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6394132|NCT00201318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6394133|NCT00201318|Antiviral Agents|antiviral agents|mesh-ancestor
6394134|NCT00201318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6394135|NCT00201318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6394136|NCT00201318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6394137|NCT00201331|Leucovorin|leucovorin|mesh-list
6394138|NCT00201331|Antidotes|antidotes|mesh-ancestor
6394139|NCT00201331|Protective Agents|protective agents|mesh-ancestor
6396989|NCT00209885|Antimanic Agents|antimanic agents|mesh-ancestor
6347589|NCT00049764|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
6347590|NCT00049764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6347591|NCT00049777|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
6347592|NCT00049777|Heparin|heparin|mesh-list
6347593|NCT00049777|Calcium heparin|calcium heparin|mesh-list
6347594|NCT00049777|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6347595|NCT00049777|Tinzaparin|tinzaparin|mesh-list
6347596|NCT00049777|Dalteparin|dalteparin|mesh-list
6347597|NCT00049777|Anticoagulants|anticoagulants|mesh-ancestor
6347598|NCT00049777|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6347599|NCT00049777|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6347600|NCT00049777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347601|NCT00049777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6347602|NCT00049790|Paclitaxel|paclitaxel|mesh-list
6347603|NCT00049790|Carboplatin|carboplatin|mesh-list
6347604|NCT00049790|Angiostatins|angiostatins|mesh-list
6347605|NCT00049790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6347606|NCT00049790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6347607|NCT00049790|Tubulin Modulators|tubulin modulators|mesh-ancestor
6347608|NCT00049790|Antimitotic Agents|antimitotic agents|mesh-ancestor
6347609|NCT00049790|Mitosis Modulators|mitosis modulators|mesh-ancestor
6347610|NCT00049790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347611|NCT00049790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6347612|NCT00049790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6347613|NCT00049790|Growth Substances|growth substances|mesh-ancestor
6347614|NCT00049790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347615|NCT00049790|Growth Inhibitors|growth inhibitors|mesh-ancestor
6347616|NCT00049803|Sodium Oxybate|sodium oxybate|mesh-list
6347617|NCT00049803|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6347618|NCT00049803|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6347619|NCT00049803|Anesthetics, General|anesthetics, general|mesh-ancestor
6347620|NCT00049803|Anesthetics|anesthetics|mesh-ancestor
6347621|NCT00049803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6347622|NCT00049803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347623|NCT00049829|Zoledronic Acid|zoledronic acid|mesh-list
6347624|NCT00049829|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6347625|NCT00049829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347626|NCT00049946|Risperidone|risperidone|mesh-list
6347627|NCT00049946|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6016942|NCT00368979|Dutasteride|dutasteride|mesh-list
6016943|NCT00368979|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6016944|NCT00368979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6016945|NCT00368979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6016946|NCT00368979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016947|NCT00368979|Hormone Antagonists|hormone antagonists|mesh-ancestor
6347628|NCT00049946|Serotonin Agents|serotonin agents|mesh-ancestor
6347629|NCT00049946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6347630|NCT00049946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347631|NCT00049946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347632|NCT00049946|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6347633|NCT00049946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6347634|NCT00049946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6347635|NCT00049946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6347636|NCT00049946|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6347637|NCT00049946|Dopamine Agents|dopamine agents|mesh-ancestor
6347638|NCT00049972|Paroxetine|paroxetine|mesh-list
6347639|NCT00049972|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6347640|NCT00049972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6347641|NCT00049972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6347642|NCT00049972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347643|NCT00049972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6347644|NCT00049972|Serotonin Agents|serotonin agents|mesh-ancestor
6347645|NCT00049972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347646|NCT00049972|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6347647|NCT00049972|Antidepressive Agents|antidepressive agents|mesh-ancestor
6347648|NCT00049972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6347649|NCT00049972|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6347650|NCT00049972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6347651|NCT00049972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6347652|NCT00049985|Darbepoetin alfa|darbepoetin alfa|mesh-list
6347653|NCT00049985|Hematinics|hematinics|mesh-ancestor
6347654|NCT00049998|Topotecan|topotecan|mesh-list
6347655|NCT00049998|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6347656|NCT00049998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6347657|NCT00049998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6347658|NCT00049998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347659|NCT00049998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6347660|NCT00050063|Vaccines|vaccines|mesh-list
6347661|NCT00050063|Immunologic Factors|immunologic factors|mesh-ancestor
6347662|NCT00050063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347663|NCT00050141|Tipifarnib|tipifarnib|mesh-list
6347664|NCT00050141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6347665|NCT00050154|Tipifarnib|tipifarnib|mesh-list
6347666|NCT00050154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6347667|NCT00050180|Indinavir|indinavir|mesh-list
6347668|NCT00050180|Saquinavir|saquinavir|mesh-list
6347669|NCT00050180|Midazolam|midazolam|mesh-list
6347670|NCT00050180|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6347671|NCT00050180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6347672|NCT00050180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6347673|NCT00050180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347674|NCT00050180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6347675|NCT00050180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6347676|NCT00050180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6347677|NCT00050180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6347678|NCT00050180|Anesthetics, General|anesthetics, general|mesh-ancestor
6347679|NCT00050180|Anesthetics|anesthetics|mesh-ancestor
6347680|NCT00050180|GABA Modulators|gaba modulators|mesh-ancestor
6347681|NCT00050180|GABA Agents|gaba agents|mesh-ancestor
6347682|NCT00050180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6347683|NCT00050180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347684|NCT00050180|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6347685|NCT00050180|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6347686|NCT00050180|Protease Inhibitors|protease inhibitors|mesh-ancestor
6347687|NCT00050180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6347688|NCT00050180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6347689|NCT00050180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6347690|NCT00050180|Antiviral Agents|antiviral agents|mesh-ancestor
6347691|NCT00050180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6347692|NCT00050180|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6347693|NCT00050180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6347694|NCT00050206|Olanzapine|olanzapine|mesh-list
6347695|NCT00050206|Antiemetics|antiemetics|mesh-ancestor
6347696|NCT00050206|Autonomic Agents|autonomic agents|mesh-ancestor
6347697|NCT00050206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6347698|NCT00050206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347699|NCT00050206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6347700|NCT00050206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6347701|NCT00050206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6347702|NCT00050206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6347703|NCT00050206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6347704|NCT00050206|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6347705|NCT00050206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6347706|NCT00050206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6347707|NCT00050206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347708|NCT00050206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6347709|NCT00050206|Serotonin Agents|serotonin agents|mesh-ancestor
6347710|NCT00050245|Rituximab|rituximab|mesh-list
6347711|NCT00050245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6347712|NCT00050245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6347713|NCT00050245|Immunologic Factors|immunologic factors|mesh-ancestor
6347714|NCT00050245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347715|NCT00050245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6347716|NCT00050271|Acetylcarnitine|acetylcarnitine|mesh-list
6347717|NCT00050271|Vitamin B Complex|vitamin b complex|mesh-ancestor
6347718|NCT00050271|Vitamins|vitamins|mesh-ancestor
6347719|NCT00050271|Micronutrients|micronutrients|mesh-ancestor
6347720|NCT00050271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347721|NCT00050271|Nootropic Agents|nootropic agents|mesh-ancestor
6347722|NCT00050297|N-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|n-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|mesh-list
6347723|NCT00050297|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6347724|NCT00050297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347725|NCT00050336|Lonafarnib|lonafarnib|mesh-list
6347726|NCT00050336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6347727|NCT00050336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347728|NCT00050349|Epothilones|epothilones|mesh-list
6347729|NCT00050349|Epothilone B|epothilone b|mesh-list
6347730|NCT00050349|Tubulin Modulators|tubulin modulators|mesh-ancestor
6347731|NCT00050349|Antimitotic Agents|antimitotic agents|mesh-ancestor
6347732|NCT00050349|Mitosis Modulators|mitosis modulators|mesh-ancestor
6347733|NCT00050349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347734|NCT00050349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6347735|NCT00050362|Rofecoxib|rofecoxib|mesh-list
6347736|NCT00050362|Bupivacaine|bupivacaine|mesh-list
6347737|NCT00050362|Anesthetics, Local|anesthetics, local|mesh-ancestor
6347738|NCT00050362|Anesthetics|anesthetics|mesh-ancestor
6347739|NCT00050362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6347740|NCT00050362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347741|NCT00050362|Sensory System Agents|sensory system agents|mesh-ancestor
6347742|NCT00050362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6347743|NCT00050362|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6347744|NCT00050362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6347745|NCT00050362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6347746|NCT00050362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347747|NCT00050362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6347748|NCT00050362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6347749|NCT00050362|Analgesics|analgesics|mesh-ancestor
6347750|NCT00050362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6347751|NCT00050362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6347752|NCT00050375|Oregovomab|oregovomab|mesh-list
6347753|NCT00050375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6347754|NCT00050375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6347755|NCT00050401|Vancomycin|vancomycin|mesh-list
6347756|NCT00050401|Tobramycin|tobramycin|mesh-list
6347757|NCT00050401|Meropenem|meropenem|mesh-list
6347758|NCT00050401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6347759|NCT00050401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6347760|NCT00050414|Dexamethasone|dexamethasone|mesh-list
6347761|NCT00050414|Trabectedin|trabectedin|mesh-list
6347762|NCT00050414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6347763|NCT00050414|Antiemetics|antiemetics|mesh-ancestor
6347764|NCT00050414|Autonomic Agents|autonomic agents|mesh-ancestor
6347765|NCT00050414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6347766|NCT00050414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347767|NCT00050414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6347768|NCT00050414|Glucocorticoids|glucocorticoids|mesh-ancestor
6347769|NCT00050414|Hormones|hormones|mesh-ancestor
6347770|NCT00050414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6347771|NCT00050414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6347772|NCT00050414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6347773|NCT00050414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6347774|NCT00050414|Alkylating Agents|alkylating agents|mesh-ancestor
6347775|NCT00050414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347776|NCT00050427|Trabectedin|trabectedin|mesh-list
6347777|NCT00050427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6347778|NCT00050427|Alkylating Agents|alkylating agents|mesh-ancestor
6347779|NCT00050427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347780|NCT00050427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6347781|NCT00050440|Dexamethasone|dexamethasone|mesh-list
6347782|NCT00050440|Trabectedin|trabectedin|mesh-list
6347783|NCT00050440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6347784|NCT00050440|Antiemetics|antiemetics|mesh-ancestor
6347785|NCT00050440|Autonomic Agents|autonomic agents|mesh-ancestor
6347786|NCT00050440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6347787|NCT00050440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347788|NCT00050440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6347789|NCT00050440|Glucocorticoids|glucocorticoids|mesh-ancestor
6347790|NCT00050440|Hormones|hormones|mesh-ancestor
6347791|NCT00050440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6347792|NCT00050440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6347793|NCT00050440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6347794|NCT00050440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6347795|NCT00050440|Alkylating Agents|alkylating agents|mesh-ancestor
6347796|NCT00050440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347797|NCT00050479|Celecoxib|celecoxib|mesh-list
6347798|NCT00050479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6347799|NCT00050479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6347800|NCT00050479|Analgesics|analgesics|mesh-ancestor
6347801|NCT00050479|Sensory System Agents|sensory system agents|mesh-ancestor
6347802|NCT00050479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6347803|NCT00050479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347804|NCT00050479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6347805|NCT00050479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6347806|NCT00050479|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6347807|NCT00050479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6347808|NCT00050479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6347809|NCT00050479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347810|NCT00050505|Vaccines|vaccines|mesh-list
6347811|NCT00050505|Immunologic Factors|immunologic factors|mesh-ancestor
6347812|NCT00050505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347813|NCT00050531|Interferons|interferons|mesh-list
6347814|NCT00050531|Interferon-alpha|interferon-alpha|mesh-list
6347815|NCT00050531|Interferon alpha-2|interferon alpha-2|mesh-list
6347816|NCT00050531|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6347817|NCT00050531|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
6347818|NCT00050531|Imatinib Mesylate|imatinib mesylate|mesh-list
6347819|NCT00050531|Molgramostim|molgramostim|mesh-list
6347820|NCT00050531|Sargramostim|sargramostim|mesh-list
6347821|NCT00050531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6347822|NCT00050531|Antiviral Agents|antiviral agents|mesh-ancestor
6347823|NCT00050531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6347824|NCT00050531|Immunologic Factors|immunologic factors|mesh-ancestor
6347825|NCT00050531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347826|NCT00050531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6347827|NCT00050531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6347828|NCT00050531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347829|NCT00050596|Docetaxel|docetaxel|mesh-list
6347830|NCT00050596|Ipilimumab|ipilimumab|mesh-list
6347831|NCT00050596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6347832|NCT00050596|Tubulin Modulators|tubulin modulators|mesh-ancestor
6347833|NCT00050596|Antimitotic Agents|antimitotic agents|mesh-ancestor
6347834|NCT00050596|Mitosis Modulators|mitosis modulators|mesh-ancestor
6347835|NCT00050596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347836|NCT00050596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6347837|NCT00050596|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6347838|NCT00050609|Tadalafil|tadalafil|mesh-list
6347839|NCT00050609|Vasodilator Agents|vasodilator agents|mesh-ancestor
6347840|NCT00050609|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6347841|NCT00050609|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6347842|NCT00050609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6347843|NCT00050609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347844|NCT00050609|Urological Agents|urological agents|mesh-ancestor
6347845|NCT00050635|Octreotide|octreotide|mesh-list
6347846|NCT00050635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6347847|NCT00050635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6347848|NCT00050635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6347849|NCT00050648|Cyclosporine|cyclosporine|mesh-list
6347850|NCT00050648|Cyclosporins|cyclosporins|mesh-list
6347851|NCT00050648|Daclizumab|daclizumab|mesh-list
6347852|NCT00050648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6347853|NCT00050648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347854|NCT00050648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6347855|NCT00050648|Immunologic Factors|immunologic factors|mesh-ancestor
6347856|NCT00050648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347857|NCT00050648|Antifungal Agents|antifungal agents|mesh-ancestor
6347858|NCT00050648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6347859|NCT00050648|Dermatologic Agents|dermatologic agents|mesh-ancestor
6347860|NCT00050648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6347861|NCT00050648|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6347862|NCT00050661|Daclizumab|daclizumab|mesh-list
6347863|NCT00050661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6347864|NCT00050661|Immunologic Factors|immunologic factors|mesh-ancestor
6347865|NCT00050661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347866|NCT00050674|Lenograstim|lenograstim|mesh-list
6347867|NCT00050674|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6347868|NCT00050674|Immunologic Factors|immunologic factors|mesh-ancestor
6347869|NCT00050674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347870|NCT00050713|Sirolimus|sirolimus|mesh-list
6347871|NCT00050713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6347872|NCT00050713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6347873|NCT00050713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6347874|NCT00050713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6347875|NCT00050713|Antifungal Agents|antifungal agents|mesh-ancestor
6347876|NCT00050713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6347877|NCT00050713|Immunologic Factors|immunologic factors|mesh-ancestor
6347878|NCT00050713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347879|NCT00050726|Interleukin-2|interleukin-2|mesh-list
6347880|NCT00050726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6347881|NCT00050726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6347882|NCT00050726|Analgesics|analgesics|mesh-ancestor
6347883|NCT00050726|Sensory System Agents|sensory system agents|mesh-ancestor
6347884|NCT00050726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6347885|NCT00050726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347886|NCT00050804|Sertraline|sertraline|mesh-list
6347887|NCT00050804|Antidepressive Agents|antidepressive agents|mesh-ancestor
6347888|NCT00050804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6347889|NCT00050804|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6347890|NCT00050804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6347891|NCT00050804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6347892|NCT00050804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347893|NCT00050804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6347894|NCT00050804|Serotonin Agents|serotonin agents|mesh-ancestor
6347895|NCT00050804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347896|NCT00050817|Clopidogrel|clopidogrel|mesh-list
6347897|NCT00050817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6347898|NCT00050817|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6347899|NCT00050817|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6347900|NCT00050817|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6347901|NCT00050817|Purinergic Agents|purinergic agents|mesh-ancestor
6347902|NCT00050817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6347903|NCT00050817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347904|NCT00050817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347905|NCT00050830|Canertinib dihydrochloride|canertinib dihydrochloride|mesh-list
6347906|NCT00050830|Anesthetics, Local|anesthetics, local|mesh-ancestor
6347907|NCT00050830|Anesthetics|anesthetics|mesh-ancestor
6347908|NCT00050830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6347909|NCT00050830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347910|NCT00050830|Sensory System Agents|sensory system agents|mesh-ancestor
6347911|NCT00050830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6347912|NCT00050830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6347913|NCT00050830|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6347914|NCT00050830|Protective Agents|protective agents|mesh-ancestor
6347915|NCT00050843|Thalidomide|thalidomide|mesh-list
6347916|NCT00050843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6347917|NCT00050843|Immunologic Factors|immunologic factors|mesh-ancestor
6347918|NCT00050843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347919|NCT00050843|Leprostatic Agents|leprostatic agents|mesh-ancestor
6347920|NCT00050843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6347921|NCT00050843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6347922|NCT00050843|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6347923|NCT00050843|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6347924|NCT00050843|Growth Substances|growth substances|mesh-ancestor
6347925|NCT00050843|Growth Inhibitors|growth inhibitors|mesh-ancestor
6347926|NCT00050843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6347927|NCT00050856|Enfuvirtide|enfuvirtide|mesh-list
6347928|NCT00050856|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6347929|NCT00050856|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6347930|NCT00050856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347931|NCT00050856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6347932|NCT00050856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6347933|NCT00050856|Antiviral Agents|antiviral agents|mesh-ancestor
6347934|NCT00050856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6347935|NCT00050895|Ritonavir|ritonavir|mesh-list
6347936|NCT00050895|Lopinavir|lopinavir|mesh-list
6347937|NCT00050895|Tenofovir|tenofovir|mesh-list
6347938|NCT00050895|Lamivudine|lamivudine|mesh-list
6347939|NCT00050895|Zidovudine|zidovudine|mesh-list
6347940|NCT00050895|Stavudine|stavudine|mesh-list
6347941|NCT00050895|Efavirenz|efavirenz|mesh-list
6347942|NCT00050895|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6347943|NCT00050895|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6347944|NCT00050895|Protease Inhibitors|protease inhibitors|mesh-ancestor
6347945|NCT00050895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6347946|NCT00050895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347947|NCT00050895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6347948|NCT00050895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6347949|NCT00050895|Antiviral Agents|antiviral agents|mesh-ancestor
6347950|NCT00050895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6347951|NCT00050895|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6347952|NCT00050895|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6347953|NCT00050895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6347954|NCT00050895|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6347955|NCT00050895|Antimetabolites|antimetabolites|mesh-ancestor
6347956|NCT00050895|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6347957|NCT00050895|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6347958|NCT00050895|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6347959|NCT00050895|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6347960|NCT00050895|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6347961|NCT00050921|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
6347962|NCT00050921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6347963|NCT00050921|Immunologic Factors|immunologic factors|mesh-ancestor
6347964|NCT00050921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347965|NCT00050934|Oxcarbazepine|oxcarbazepine|mesh-list
6347966|NCT00050934|Anticonvulsants|anticonvulsants|mesh-ancestor
6347967|NCT00050934|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6347968|NCT00050934|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6347969|NCT00050934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6347970|NCT00050934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347971|NCT00050934|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6347972|NCT00050934|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6347973|NCT00050947|Oxcarbazepine|oxcarbazepine|mesh-list
6347974|NCT00050947|Anticonvulsants|anticonvulsants|mesh-ancestor
6347975|NCT00050947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6347976|NCT00050947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6347977|NCT00050947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6347978|NCT00050947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347979|NCT00050947|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6347980|NCT00050947|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6347981|NCT00050973|Bexarotene|bexarotene|mesh-list
6347982|NCT00050973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6347983|NCT00051051|Canertinib dihydrochloride|canertinib dihydrochloride|mesh-list
6347984|NCT00051051|Anesthetics, Local|anesthetics, local|mesh-ancestor
6347985|NCT00051051|Anesthetics|anesthetics|mesh-ancestor
6347986|NCT00051051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6347987|NCT00051051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6347988|NCT00051051|Sensory System Agents|sensory system agents|mesh-ancestor
6347989|NCT00051051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6347990|NCT00051051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6347991|NCT00051051|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6347992|NCT00051051|Protective Agents|protective agents|mesh-ancestor
6347993|NCT00051077|Ribavirin|ribavirin|mesh-list
6347994|NCT00051077|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6347995|NCT00051077|Adefovir|adefovir|mesh-list
6347996|NCT00051077|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6347997|NCT00051077|Antimetabolites|antimetabolites|mesh-ancestor
6347998|NCT00051077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6347999|NCT00051077|Antiviral Agents|antiviral agents|mesh-ancestor
6348000|NCT00051077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6348001|NCT00051077|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6348002|NCT00051077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6348003|NCT00051077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6348004|NCT00051090|Lamivudine|lamivudine|mesh-list
6348005|NCT00051090|Efavirenz|efavirenz|mesh-list
6348006|NCT00051090|Abacavir|abacavir|mesh-list
6348007|NCT00051090|Didanosine|didanosine|mesh-list
6348008|NCT00051090|Telbivudine|telbivudine|mesh-list
6348009|NCT00051090|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6348010|NCT00051090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6348011|NCT00051090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6348012|NCT00051090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348013|NCT00051090|Antiviral Agents|antiviral agents|mesh-ancestor
6348014|NCT00051090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6348015|NCT00051090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6348016|NCT00051090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6348017|NCT00051090|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6348018|NCT00051090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6348019|NCT00051090|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6348020|NCT00051090|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6348021|NCT00051090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6348022|NCT00051090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6348023|NCT00051090|Antimetabolites|antimetabolites|mesh-ancestor
6348024|NCT00051103|Antineoplastic Agents|antineoplastic agents|mesh-list
6348025|NCT00051116|Lenalidomide|lenalidomide|mesh-list
6348026|NCT00051116|Immunologic Factors|immunologic factors|mesh-ancestor
6348027|NCT00051116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6348028|NCT00051116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6348029|NCT00051116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6348030|NCT00051116|Growth Substances|growth substances|mesh-ancestor
6348031|NCT00051116|Growth Inhibitors|growth inhibitors|mesh-ancestor
6348032|NCT00051116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348033|NCT00051142|Travoprost|travoprost|mesh-list
6348034|NCT00051142|Latanoprost|latanoprost|mesh-list
6348035|NCT00051142|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6348036|NCT00051142|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6348037|NCT00051142|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6348038|NCT00051155|Timolol|timolol|mesh-list
6348039|NCT00051155|Travoprost|travoprost|mesh-list
6348040|NCT00051155|Latanoprost|latanoprost|mesh-list
6348041|NCT00051155|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6348042|NCT00051155|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6348043|NCT00051155|Adrenergic Agents|adrenergic agents|mesh-ancestor
6348044|NCT00051155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6348045|NCT00051155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348046|NCT00051155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6348047|NCT00051155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6348048|NCT00051155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6348049|NCT00051155|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6348050|NCT00051155|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6348051|NCT00051181|Travoprost|travoprost|mesh-list
6348052|NCT00051181|Latanoprost|latanoprost|mesh-list
6348053|NCT00051181|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6348054|NCT00051181|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6348055|NCT00051181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6348056|NCT00051259|Bupropion|bupropion|mesh-list
6348057|NCT00051259|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6348058|NCT00051259|Antidepressive Agents|antidepressive agents|mesh-ancestor
6348059|NCT00051259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6348060|NCT00051259|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6348061|NCT00051259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6348062|NCT00051259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6348063|NCT00051259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348064|NCT00051259|Dopamine Agents|dopamine agents|mesh-ancestor
6348065|NCT00051259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6348066|NCT00051259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6348067|NCT00051259|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6348068|NCT00051259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6348069|NCT00051259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6348070|NCT00051272|Bupropion|bupropion|mesh-list
6348071|NCT00051272|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6348072|NCT00051272|Antidepressive Agents|antidepressive agents|mesh-ancestor
6348073|NCT00051272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6348074|NCT00051272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6348075|NCT00051272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6348076|NCT00051272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6348077|NCT00051272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348078|NCT00051272|Dopamine Agents|dopamine agents|mesh-ancestor
6348079|NCT00051272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6348080|NCT00051272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6348081|NCT00051272|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6348082|NCT00051272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6348083|NCT00051272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6348084|NCT00051285|Enoximone|enoximone|mesh-list
6348085|NCT00051285|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6348086|NCT00051285|Vasodilator Agents|vasodilator agents|mesh-ancestor
6348087|NCT00051285|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6348088|NCT00051285|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6348089|NCT00051285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6348090|NCT00051285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348091|NCT00051285|Protective Agents|protective agents|mesh-ancestor
6348092|NCT00051285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6348093|NCT00051298|Olanzapine|olanzapine|mesh-list
6348094|NCT00051298|Antiemetics|antiemetics|mesh-ancestor
6348095|NCT00051298|Autonomic Agents|autonomic agents|mesh-ancestor
6348096|NCT00051298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6348097|NCT00051298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6348098|NCT00051298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6348099|NCT00051298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6348100|NCT00051298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6348101|NCT00051298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6348102|NCT00051298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6348103|NCT00051298|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6348104|NCT00051298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6348105|NCT00051298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6348106|NCT00051298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348107|NCT00051298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6348108|NCT00051298|Serotonin Agents|serotonin agents|mesh-ancestor
6394140|NCT00201331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394141|NCT00201331|Vitamin B Complex|vitamin b complex|mesh-ancestor
6394142|NCT00201331|Vitamins|vitamins|mesh-ancestor
6394143|NCT00201331|Micronutrients|micronutrients|mesh-ancestor
6394144|NCT00201344|Leucovorin|leucovorin|mesh-list
6394145|NCT00201344|Antidotes|antidotes|mesh-ancestor
6394146|NCT00201344|Protective Agents|protective agents|mesh-ancestor
6394147|NCT00201344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394148|NCT00201344|Vitamin B Complex|vitamin b complex|mesh-ancestor
6394149|NCT00201344|Vitamins|vitamins|mesh-ancestor
6394150|NCT00201344|Micronutrients|micronutrients|mesh-ancestor
6394151|NCT00201357|Thalidomide|thalidomide|mesh-list
6394152|NCT00201357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6394153|NCT00201357|Immunologic Factors|immunologic factors|mesh-ancestor
6394154|NCT00201357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394155|NCT00201357|Leprostatic Agents|leprostatic agents|mesh-ancestor
6394156|NCT00201357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6394157|NCT00201357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6394158|NCT00201357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6394159|NCT00201357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6394160|NCT00201357|Growth Substances|growth substances|mesh-ancestor
6394161|NCT00201357|Growth Inhibitors|growth inhibitors|mesh-ancestor
6394162|NCT00201357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6394163|NCT00201383|Cisplatin|cisplatin|mesh-list
6394164|NCT00201383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6394165|NCT00201396|Leucovorin|leucovorin|mesh-list
6394166|NCT00201396|Fluorouracil|fluorouracil|mesh-list
6394167|NCT00201396|Epirubicin|epirubicin|mesh-list
6394168|NCT00201396|Mitomycins|mitomycins|mesh-list
6394169|NCT00201396|Mitomycin|mitomycin|mesh-list
6394170|NCT00201396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6394171|NCT00201396|Antimetabolites|antimetabolites|mesh-ancestor
6394172|NCT00201396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394173|NCT00201396|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6394174|NCT00201396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6394175|NCT00201396|Immunologic Factors|immunologic factors|mesh-ancestor
6394176|NCT00201396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394177|NCT00201396|Antidotes|antidotes|mesh-ancestor
6394178|NCT00201396|Protective Agents|protective agents|mesh-ancestor
6394179|NCT00201396|Vitamin B Complex|vitamin b complex|mesh-ancestor
6394180|NCT00201396|Vitamins|vitamins|mesh-ancestor
6394181|NCT00201396|Micronutrients|micronutrients|mesh-ancestor
6394182|NCT00201396|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6394183|NCT00201396|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6394184|NCT00201396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6394185|NCT00201396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6394186|NCT00201396|Alkylating Agents|alkylating agents|mesh-ancestor
6348109|NCT00051389|Fosinopril|fosinopril|mesh-list
6348110|NCT00051389|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6348111|NCT00051389|Protease Inhibitors|protease inhibitors|mesh-ancestor
6348112|NCT00051389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6348113|NCT00051389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348114|NCT00051389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6348115|NCT00051441|Benzydamine|benzydamine|mesh-list
6348116|NCT00051441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6348117|NCT00051493|Carboplatin|carboplatin|mesh-list
6348118|NCT00051493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348119|NCT00051506|Carboplatin|carboplatin|mesh-list
6348120|NCT00051506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348121|NCT00051532|Seocalcitol|seocalcitol|mesh-list
6348122|NCT00051532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348123|NCT00051532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6348124|NCT00051532|Immunologic Factors|immunologic factors|mesh-ancestor
6348125|NCT00051532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6348126|NCT00051545|Seocalcitol|seocalcitol|mesh-list
6016948|NCT00368979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6016949|NCT00368979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016950|NCT00368992|Paclitaxel|paclitaxel|mesh-list
6016951|NCT00368992|Bevacizumab|bevacizumab|mesh-list
6348127|NCT00051545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348128|NCT00051545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6348129|NCT00051545|Immunologic Factors|immunologic factors|mesh-ancestor
6348130|NCT00051545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6348131|NCT00051571|Docetaxel|docetaxel|mesh-list
6348132|NCT00051571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348133|NCT00051571|Tubulin Modulators|tubulin modulators|mesh-ancestor
6348134|NCT00051571|Antimitotic Agents|antimitotic agents|mesh-ancestor
6348135|NCT00051571|Mitosis Modulators|mitosis modulators|mesh-ancestor
6348136|NCT00051571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348137|NCT00051584|Gemcitabine|gemcitabine|mesh-list
6348138|NCT00051584|Doxorubicin|doxorubicin|mesh-list
6348139|NCT00051584|Immunoconjugates|immunoconjugates|mesh-list
6348140|NCT00051584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6348141|NCT00051584|Antimetabolites|antimetabolites|mesh-ancestor
6348142|NCT00051584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348143|NCT00051584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348144|NCT00051584|Antiviral Agents|antiviral agents|mesh-ancestor
6348145|NCT00051584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6348146|NCT00051584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6348147|NCT00051584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6348148|NCT00051584|Immunologic Factors|immunologic factors|mesh-ancestor
6348149|NCT00051584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6348150|NCT00051584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6348151|NCT00051584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6348152|NCT00051584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6348153|NCT00051597|Antibodies|antibodies|mesh-list
6348154|NCT00051597|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6348155|NCT00051597|Immunologic Factors|immunologic factors|mesh-ancestor
6348156|NCT00051597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6348157|NCT00051623|Infliximab|infliximab|mesh-list
6348158|NCT00051623|Dermatologic Agents|dermatologic agents|mesh-ancestor
6348159|NCT00051623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6348160|NCT00051623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6348161|NCT00051688|Oxaliplatin|oxaliplatin|mesh-list
6348162|NCT00051688|Tezacitabine|tezacitabine|mesh-list
6348163|NCT00051688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348164|NCT00051688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6348165|NCT00051688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348166|NCT00051701|Alemtuzumab|alemtuzumab|mesh-list
6348167|NCT00051701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6348168|NCT00051701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348169|NCT00051753|Amoxicillin|amoxicillin|mesh-list
6348170|NCT00051753|Levofloxacin|levofloxacin|mesh-list
6348171|NCT00051753|Ofloxacin|ofloxacin|mesh-list
6348172|NCT00051753|Clavulanic Acid|clavulanic acid|mesh-list
6348173|NCT00051753|Clavulanic Acids|clavulanic acids|mesh-list
6348174|NCT00051753|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6348175|NCT00051753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6348176|NCT00051753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6348177|NCT00051753|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6348178|NCT00051753|Renal Agents|renal agents|mesh-ancestor
6348179|NCT00051753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6348180|NCT00051753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6348181|NCT00051753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6348182|NCT00051753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348183|NCT00051753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348184|NCT00051753|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6348185|NCT00051753|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6348186|NCT00051753|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6348187|NCT00051831|Ritonavir|ritonavir|mesh-list
6348188|NCT00051831|Saquinavir|saquinavir|mesh-list
6348189|NCT00051831|Tenofovir|tenofovir|mesh-list
6348190|NCT00051831|Emtricitabine|emtricitabine|mesh-list
6348191|NCT00051831|Enfuvirtide|enfuvirtide|mesh-list
6348192|NCT00051831|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6348193|NCT00051831|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6348194|NCT00051831|Protease Inhibitors|protease inhibitors|mesh-ancestor
6348195|NCT00051831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6348196|NCT00051831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348197|NCT00051831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6348198|NCT00051831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6348199|NCT00051831|Antiviral Agents|antiviral agents|mesh-ancestor
6348200|NCT00051831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6348201|NCT00051831|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6348202|NCT00051831|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6348203|NCT00051831|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6348204|NCT00051831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6348205|NCT00051831|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6348206|NCT00051831|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6348207|NCT00051844|Capravirine|capravirine|mesh-list
6348208|NCT00051844|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6348209|NCT00051844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6348210|NCT00051844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6348211|NCT00051844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348212|NCT00051844|Antiviral Agents|antiviral agents|mesh-ancestor
6348213|NCT00051844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6348214|NCT00051844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6348215|NCT00051844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6348216|NCT00051896|Vanoxerine|vanoxerine|mesh-list
6348217|NCT00051896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6348218|NCT00051896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6348219|NCT00051896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6348220|NCT00051896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348221|NCT00051896|Dopamine Agents|dopamine agents|mesh-ancestor
6348222|NCT00051896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6348223|NCT00051896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6348224|NCT00051974|Bortezomib|bortezomib|mesh-list
6348225|NCT00051974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348226|NCT00051987|Bortezomib|bortezomib|mesh-list
6348227|NCT00051987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348228|NCT00052000|Antibodies|antibodies|mesh-list
6348229|NCT00052000|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6348230|NCT00052000|Immunologic Factors|immunologic factors|mesh-ancestor
6348231|NCT00052000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6348232|NCT00052013|Vatalanib|vatalanib|mesh-list
6348233|NCT00052013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6348234|NCT00052013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6348235|NCT00052013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348236|NCT00052026|Carvedilol|carvedilol|mesh-list
6348237|NCT00052026|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6348238|NCT00052026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6348239|NCT00052026|Adrenergic Agents|adrenergic agents|mesh-ancestor
6348240|NCT00052026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6348241|NCT00052026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348242|NCT00052026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6348243|NCT00052026|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6348244|NCT00052026|Antioxidants|antioxidants|mesh-ancestor
6348245|NCT00052026|Protective Agents|protective agents|mesh-ancestor
6348246|NCT00052026|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6348247|NCT00052026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6348248|NCT00052026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6348249|NCT00052026|Vasodilator Agents|vasodilator agents|mesh-ancestor
6348250|NCT00052026|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6348251|NCT00052026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6348252|NCT00052039|Interferons|interferons|mesh-list
6348253|NCT00052039|Interferon-gamma|interferon-gamma|mesh-list
6348254|NCT00052039|Azathioprine|azathioprine|mesh-list
6348255|NCT00052039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348256|NCT00052039|Antiviral Agents|antiviral agents|mesh-ancestor
6348257|NCT00052039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6348258|NCT00052039|Antimetabolites|antimetabolites|mesh-ancestor
6348259|NCT00052039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348260|NCT00052039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6348261|NCT00052039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6348262|NCT00052039|Immunologic Factors|immunologic factors|mesh-ancestor
6348263|NCT00052039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6348264|NCT00052039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6348265|NCT00052052|Interferons|interferons|mesh-list
6348266|NCT00052052|Interferon-gamma|interferon-gamma|mesh-list
6348267|NCT00052052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348268|NCT00052052|Antiviral Agents|antiviral agents|mesh-ancestor
6348269|NCT00052052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6348270|NCT00052117|Capravirine|capravirine|mesh-list
6348271|NCT00052117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6348272|NCT00052117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348273|NCT00052117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6348274|NCT00052117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6348275|NCT00052117|Antiviral Agents|antiviral agents|mesh-ancestor
6348276|NCT00052117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6348277|NCT00052117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6348278|NCT00052117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6348279|NCT00052169|Docetaxel|docetaxel|mesh-list
6348280|NCT00052169|Gefitinib|gefitinib|mesh-list
6348281|NCT00052169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348282|NCT00052169|Tubulin Modulators|tubulin modulators|mesh-ancestor
6348283|NCT00052169|Antimitotic Agents|antimitotic agents|mesh-ancestor
6348284|NCT00052169|Mitosis Modulators|mitosis modulators|mesh-ancestor
6348285|NCT00052169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348286|NCT00052169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6348287|NCT00052169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6348288|NCT00052208|Gefitinib|gefitinib|mesh-list
6348289|NCT00052208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348290|NCT00052208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6348291|NCT00052208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6348292|NCT00052208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348293|NCT00052221|Epoetin Alfa|epoetin alfa|mesh-list
6348294|NCT00052221|Hematinics|hematinics|mesh-ancestor
6348295|NCT00052273|Capecitabine|capecitabine|mesh-list
6348296|NCT00052273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6348297|NCT00052273|Antimetabolites|antimetabolites|mesh-ancestor
6348298|NCT00052273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348299|NCT00052273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348300|NCT00052286|Modafinil|modafinil|mesh-list
6348301|NCT00052286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6348302|NCT00052286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6348303|NCT00052286|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6348304|NCT00052286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6348305|NCT00052286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6348306|NCT00052286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348307|NCT00052299|Cytarabine|cytarabine|mesh-list
6348308|NCT00052299|Etoposide|etoposide|mesh-list
6348309|NCT00052299|Mitoxantrone|mitoxantrone|mesh-list
6348310|NCT00052299|Idarubicin|idarubicin|mesh-list
6348311|NCT00052299|Gemtuzumab|gemtuzumab|mesh-list
6348312|NCT00052299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6348313|NCT00052299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348314|NCT00052299|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6348315|NCT00052299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6348316|NCT00052299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6348317|NCT00052299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348318|NCT00052299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6348319|NCT00052299|Antimetabolites|antimetabolites|mesh-ancestor
6348320|NCT00052299|Antiviral Agents|antiviral agents|mesh-ancestor
6348321|NCT00052299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6348322|NCT00052299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6348323|NCT00052299|Immunologic Factors|immunologic factors|mesh-ancestor
6348324|NCT00052299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6348325|NCT00052299|Analgesics|analgesics|mesh-ancestor
6348326|NCT00052299|Sensory System Agents|sensory system agents|mesh-ancestor
6348327|NCT00052299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6348328|NCT00052299|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6348329|NCT00052299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6348330|NCT00052312|Paclitaxel|paclitaxel|mesh-list
6348331|NCT00052312|Doxorubicin|doxorubicin|mesh-list
6348332|NCT00052312|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6348333|NCT00052312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6348334|NCT00052312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348335|NCT00052312|Tubulin Modulators|tubulin modulators|mesh-ancestor
6348336|NCT00052312|Antimitotic Agents|antimitotic agents|mesh-ancestor
6348337|NCT00052312|Mitosis Modulators|mitosis modulators|mesh-ancestor
6348338|NCT00052312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348339|NCT00052312|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6348340|NCT00052312|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6348341|NCT00052312|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6348342|NCT00052312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6348343|NCT00052338|Gemcitabine|gemcitabine|mesh-list
6348344|NCT00052338|Carboplatin|carboplatin|mesh-list
6348345|NCT00052338|Bortezomib|bortezomib|mesh-list
6348346|NCT00052338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348347|NCT00052338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6348348|NCT00052338|Antimetabolites|antimetabolites|mesh-ancestor
6348349|NCT00052338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348350|NCT00052338|Antiviral Agents|antiviral agents|mesh-ancestor
6348351|NCT00052338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6348352|NCT00052338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6348353|NCT00052338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6348354|NCT00052338|Immunologic Factors|immunologic factors|mesh-ancestor
6348355|NCT00052338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6348356|NCT00052351|Metronidazole|metronidazole|mesh-list
6348357|NCT00052351|Paclitaxel|paclitaxel|mesh-list
6348358|NCT00052351|Cyclophosphamide|cyclophosphamide|mesh-list
6348359|NCT00052351|Doxorubicin|doxorubicin|mesh-list
6348360|NCT00052351|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6348361|NCT00052351|Vaccines|vaccines|mesh-list
6348362|NCT00052351|Sargramostim|sargramostim|mesh-list
6348363|NCT00052351|Immunologic Factors|immunologic factors|mesh-ancestor
6348364|NCT00052351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6348365|NCT00052351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6348366|NCT00052351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348367|NCT00052351|Tubulin Modulators|tubulin modulators|mesh-ancestor
6348368|NCT00052351|Antimitotic Agents|antimitotic agents|mesh-ancestor
6348369|NCT00052351|Mitosis Modulators|mitosis modulators|mesh-ancestor
6348370|NCT00052351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348371|NCT00052351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6348372|NCT00052351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6348373|NCT00052351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6348374|NCT00052351|Alkylating Agents|alkylating agents|mesh-ancestor
6348375|NCT00052351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6348376|NCT00052351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6348377|NCT00052351|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6348378|NCT00052351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6348379|NCT00052351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6348380|NCT00052351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6348381|NCT00052351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6348382|NCT00052351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6348383|NCT00052351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6348384|NCT00052364|Oxaliplatin|oxaliplatin|mesh-list
6348385|NCT00052364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348386|NCT00052377|Aldesleukin|aldesleukin|mesh-list
6348387|NCT00052377|Interleukin-2|interleukin-2|mesh-list
6348388|NCT00052377|Interleukin-12|interleukin-12|mesh-list
6348389|NCT00052377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348390|NCT00052377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6348391|NCT00052377|Analgesics|analgesics|mesh-ancestor
6348392|NCT00052377|Sensory System Agents|sensory system agents|mesh-ancestor
6348393|NCT00052377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6348394|NCT00052377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6348395|NCT00052377|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6348396|NCT00052377|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6348397|NCT00052377|Antiviral Agents|antiviral agents|mesh-ancestor
6348398|NCT00052377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6348399|NCT00052377|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6348400|NCT00052377|Immunologic Factors|immunologic factors|mesh-ancestor
6348401|NCT00052377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6348402|NCT00052377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6348403|NCT00052377|Growth Substances|growth substances|mesh-ancestor
6348404|NCT00052377|Growth Inhibitors|growth inhibitors|mesh-ancestor
6348405|NCT00052390|Bevacizumab|bevacizumab|mesh-list
6348406|NCT00052390|Doxorubicin|doxorubicin|mesh-list
6348407|NCT00052390|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6348408|NCT00052390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6348409|NCT00052390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348410|NCT00052390|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6348411|NCT00052390|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6348412|NCT00052390|Growth Substances|growth substances|mesh-ancestor
6348413|NCT00052390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6348414|NCT00052390|Growth Inhibitors|growth inhibitors|mesh-ancestor
6348415|NCT00052390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6348416|NCT00052390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6348417|NCT00052390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6348418|NCT00052390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6348419|NCT00052390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348420|NCT00052403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6348421|NCT00052403|Antibodies|antibodies|mesh-list
6348422|NCT00052403|Immunoglobulins|immunoglobulins|mesh-list
6348423|NCT00052403|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6348424|NCT00052403|Antibodies, Anti-Idiotypic|antibodies, anti-idiotypic|mesh-list
6348425|NCT00052403|Immunologic Factors|immunologic factors|mesh-list
6348426|NCT00052403|Mitogens|mitogens|mesh-list
6348427|NCT00052403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6348428|NCT00052403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348429|NCT00052403|Mitosis Modulators|mitosis modulators|mesh-ancestor
6348430|NCT00052403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348431|NCT00052416|Thalidomide|thalidomide|mesh-list
6348432|NCT00052416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6348433|NCT00052416|Immunologic Factors|immunologic factors|mesh-ancestor
6348434|NCT00052416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6348435|NCT00052416|Leprostatic Agents|leprostatic agents|mesh-ancestor
6348436|NCT00052416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6348437|NCT00052416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6348438|NCT00052416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6348439|NCT00052416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6348440|NCT00052416|Growth Substances|growth substances|mesh-ancestor
6348441|NCT00052416|Growth Inhibitors|growth inhibitors|mesh-ancestor
6348442|NCT00052416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348443|NCT00052455|Vincristine|vincristine|mesh-list
6348444|NCT00052455|Temozolomide|temozolomide|mesh-list
6348445|NCT00052455|Lomustine|lomustine|mesh-list
6348446|NCT00052455|Procarbazine|procarbazine|mesh-list
6348447|NCT00052455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6348448|NCT00052455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348449|NCT00052455|Tubulin Modulators|tubulin modulators|mesh-ancestor
6348450|NCT00052455|Antimitotic Agents|antimitotic agents|mesh-ancestor
6348451|NCT00052455|Mitosis Modulators|mitosis modulators|mesh-ancestor
6348452|NCT00052455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348453|NCT00052455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6348454|NCT00052455|Alkylating Agents|alkylating agents|mesh-ancestor
6348455|NCT00052468|Gemcitabine|gemcitabine|mesh-list
6348456|NCT00052468|Paclitaxel|paclitaxel|mesh-list
6348457|NCT00052468|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6348458|NCT00052468|Carboplatin|carboplatin|mesh-list
6348459|NCT00052468|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6348460|NCT00052468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348461|NCT00052468|Tubulin Modulators|tubulin modulators|mesh-ancestor
6348462|NCT00052468|Antimitotic Agents|antimitotic agents|mesh-ancestor
6348463|NCT00052468|Mitosis Modulators|mitosis modulators|mesh-ancestor
6348464|NCT00052468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348465|NCT00052468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6348466|NCT00052468|Antimetabolites|antimetabolites|mesh-ancestor
6348467|NCT00052468|Antiviral Agents|antiviral agents|mesh-ancestor
6348468|NCT00052468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6348469|NCT00052468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6348470|NCT00052468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6348471|NCT00052468|Immunologic Factors|immunologic factors|mesh-ancestor
6348472|NCT00052468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6348473|NCT00052494|Irinotecan|irinotecan|mesh-list
6348474|NCT00052494|Imatinib Mesylate|imatinib mesylate|mesh-list
6348475|NCT00052494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348476|NCT00052494|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6348477|NCT00052494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6348478|NCT00052494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6348479|NCT00052494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348480|NCT00052494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6348481|NCT00052507|Bortezomib|bortezomib|mesh-list
6348482|NCT00052507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348483|NCT00052559|Bevacizumab|bevacizumab|mesh-list
6348484|NCT00052559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6348485|NCT00052559|Fluorouracil|fluorouracil|mesh-list
6348486|NCT00052559|Antibodies|antibodies|mesh-list
6348487|NCT00052559|Immunoglobulins|immunoglobulins|mesh-list
6348488|NCT00052559|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6348489|NCT00052559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348490|NCT00052559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6348491|NCT00052559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6348492|NCT00052559|Growth Substances|growth substances|mesh-ancestor
6348493|NCT00052559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6348494|NCT00052559|Growth Inhibitors|growth inhibitors|mesh-ancestor
6348495|NCT00052559|Immunologic Factors|immunologic factors|mesh-ancestor
6348496|NCT00052559|Antimetabolites|antimetabolites|mesh-ancestor
6348497|NCT00052559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348498|NCT00052559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6348499|NCT00052559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6348500|NCT00052585|Leucovorin|leucovorin|mesh-list
6348501|NCT00052585|Fluorouracil|fluorouracil|mesh-list
6348502|NCT00052585|Irinotecan|irinotecan|mesh-list
6348503|NCT00052585|Gefitinib|gefitinib|mesh-list
6348504|NCT00052585|Calcium|calcium|mesh-list
6348505|NCT00052585|Levoleucovorin|levoleucovorin|mesh-list
6348506|NCT00052585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6348507|NCT00052585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6348508|NCT00052585|Antimetabolites|antimetabolites|mesh-ancestor
6348509|NCT00052585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348510|NCT00052585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6348511|NCT00052585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348512|NCT00052585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6348513|NCT00052585|Immunologic Factors|immunologic factors|mesh-ancestor
6348514|NCT00052585|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6348515|NCT00052585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6348516|NCT00052585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6348517|NCT00052585|Antidotes|antidotes|mesh-ancestor
6348518|NCT00052585|Protective Agents|protective agents|mesh-ancestor
6348519|NCT00052585|Vitamin B Complex|vitamin b complex|mesh-ancestor
6348520|NCT00052585|Vitamins|vitamins|mesh-ancestor
6348521|NCT00052585|Micronutrients|micronutrients|mesh-ancestor
6348522|NCT00052585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6348523|NCT00052611|Celecoxib|celecoxib|mesh-list
6348524|NCT00052611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6348525|NCT00052611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6348526|NCT00052611|Analgesics|analgesics|mesh-ancestor
6348527|NCT00052611|Sensory System Agents|sensory system agents|mesh-ancestor
6348528|NCT00052611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6348529|NCT00052611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6348530|NCT00052611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6348531|NCT00052611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6348532|NCT00052611|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6348533|NCT00052611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6348534|NCT00052611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6348535|NCT00052611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348536|NCT00052676|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
6348537|NCT00052676|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6348538|NCT00052676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348539|NCT00052689|Gemcitabine|gemcitabine|mesh-list
6348540|NCT00052689|Bortezomib|bortezomib|mesh-list
6348541|NCT00052689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6348542|NCT00052689|Antimetabolites|antimetabolites|mesh-ancestor
6348543|NCT00052689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348544|NCT00052689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348545|NCT00052689|Antiviral Agents|antiviral agents|mesh-ancestor
6348546|NCT00052689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6348547|NCT00052689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6348548|NCT00052689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6348549|NCT00052689|Immunologic Factors|immunologic factors|mesh-ancestor
6348550|NCT00052689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6348551|NCT00052728|Tamoxifen|tamoxifen|mesh-list
6348552|NCT00052728|Tipifarnib|tipifarnib|mesh-list
6348553|NCT00052728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6348554|NCT00052728|Hormone Antagonists|hormone antagonists|mesh-ancestor
6348555|NCT00052728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6348556|NCT00052728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6348557|NCT00052728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6348558|NCT00052728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348559|NCT00052728|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6348560|NCT00052728|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6348561|NCT00052728|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6348562|NCT00052754|Gefitinib|gefitinib|mesh-list
6348563|NCT00052754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348564|NCT00052754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6348565|NCT00052754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6348566|NCT00052754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348567|NCT00052780|Temozolomide|temozolomide|mesh-list
6348568|NCT00052780|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
6348569|NCT00052780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6348570|NCT00052780|Alkylating Agents|alkylating agents|mesh-ancestor
6348571|NCT00052780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348572|NCT00052780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348573|NCT00052780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6348574|NCT00052832|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
6348575|NCT00052832|Vitamins|vitamins|mesh-ancestor
6348576|NCT00052832|Micronutrients|micronutrients|mesh-ancestor
6348577|NCT00052832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6348578|NCT00052832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6348579|NCT00052845|Sulindac sulfone|sulindac sulfone|mesh-list
6348580|NCT00052845|Docetaxel|docetaxel|mesh-list
6348581|NCT00052845|Estramustine|estramustine|mesh-list
6348582|NCT00052845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348583|NCT00052845|Tubulin Modulators|tubulin modulators|mesh-ancestor
6348584|NCT00052845|Antimitotic Agents|antimitotic agents|mesh-ancestor
6348585|NCT00052845|Mitosis Modulators|mitosis modulators|mesh-ancestor
6348586|NCT00052845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348587|NCT00052845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6348588|NCT00052845|Alkylating Agents|alkylating agents|mesh-ancestor
6348589|NCT00052845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6348590|NCT00052845|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6348591|NCT00052845|Protective Agents|protective agents|mesh-ancestor
6348592|NCT00052845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6348593|NCT00052845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6348594|NCT00052845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6348595|NCT00052845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6348596|NCT00052845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6348597|NCT00052845|Analgesics|analgesics|mesh-ancestor
6348598|NCT00052845|Sensory System Agents|sensory system agents|mesh-ancestor
6348599|NCT00052845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6348600|NCT00052845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6348601|NCT00052845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6348602|NCT00052884|Melphalan|melphalan|mesh-list
6348603|NCT00052884|Amifostine|amifostine|mesh-list
6348604|NCT00052884|Immunologic Factors|immunologic factors|mesh-ancestor
6348605|NCT00052884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6348606|NCT00052884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6348607|NCT00052884|Alkylating Agents|alkylating agents|mesh-ancestor
6348608|NCT00052884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348609|NCT00052884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348610|NCT00052884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6348611|NCT00052884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6348612|NCT00052884|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6348613|NCT00052884|Protective Agents|protective agents|mesh-ancestor
6348614|NCT00052923|Cyclophosphamide|cyclophosphamide|mesh-list
6348615|NCT00052923|Carmustine|carmustine|mesh-list
6348616|NCT00052923|Rituximab|rituximab|mesh-list
6348617|NCT00052923|Etoposide|etoposide|mesh-list
6348618|NCT00052923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6348619|NCT00052923|Immunologic Factors|immunologic factors|mesh-ancestor
6348620|NCT00052923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6348621|NCT00052923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6348622|NCT00052923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6348623|NCT00052923|Alkylating Agents|alkylating agents|mesh-ancestor
6348624|NCT00052923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348625|NCT00052923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348626|NCT00052923|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6348627|NCT00052923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6348628|NCT00052923|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6348629|NCT00052923|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6348630|NCT00052923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6348631|NCT00052923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6348632|NCT00052936|Prednisone|prednisone|mesh-list
6348633|NCT00052936|Cyclophosphamide|cyclophosphamide|mesh-list
6348634|NCT00052936|Rituximab|rituximab|mesh-list
6348635|NCT00052936|Doxorubicin|doxorubicin|mesh-list
6348636|NCT00052936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6348637|NCT00052936|Vincristine|vincristine|mesh-list
6348638|NCT00052936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6348639|NCT00052936|Immunologic Factors|immunologic factors|mesh-ancestor
6348640|NCT00052936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6348641|NCT00052936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6348642|NCT00052936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6348643|NCT00052936|Alkylating Agents|alkylating agents|mesh-ancestor
6348644|NCT00052936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348645|NCT00052936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348646|NCT00052936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6348647|NCT00052936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6348648|NCT00052936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6348649|NCT00052936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6348650|NCT00052936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6348651|NCT00052936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6348652|NCT00052936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6348653|NCT00052936|Glucocorticoids|glucocorticoids|mesh-ancestor
6348654|NCT00052936|Hormones|hormones|mesh-ancestor
6348655|NCT00052936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6348656|NCT00052936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6348657|NCT00052936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6348658|NCT00052936|Tubulin Modulators|tubulin modulators|mesh-ancestor
6348659|NCT00052936|Antimitotic Agents|antimitotic agents|mesh-ancestor
6348660|NCT00052936|Mitosis Modulators|mitosis modulators|mesh-ancestor
6348661|NCT00052949|Imatinib Mesylate|imatinib mesylate|mesh-list
6348662|NCT00052949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348663|NCT00052949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6348664|NCT00052949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6348665|NCT00052949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348666|NCT00053001|Thalidomide|thalidomide|mesh-list
6348667|NCT00053001|Epoetin Alfa|epoetin alfa|mesh-list
6348668|NCT00053001|Hematinics|hematinics|mesh-ancestor
6348669|NCT00053001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6348670|NCT00053001|Immunologic Factors|immunologic factors|mesh-ancestor
6348671|NCT00053001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6348672|NCT00053001|Leprostatic Agents|leprostatic agents|mesh-ancestor
6348673|NCT00053001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6348674|NCT00053001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6348675|NCT00053001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6348676|NCT00053001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6348677|NCT00053001|Growth Substances|growth substances|mesh-ancestor
6348678|NCT00053001|Growth Inhibitors|growth inhibitors|mesh-ancestor
6348679|NCT00053001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348680|NCT00053027|Rituximab|rituximab|mesh-list
6348681|NCT00053027|Cladribine|cladribine|mesh-list
6348682|NCT00053027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6348683|NCT00053027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348684|NCT00053027|Immunologic Factors|immunologic factors|mesh-ancestor
6348685|NCT00053027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6348686|NCT00053027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6348687|NCT00053027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6348688|NCT00053092|Cyclophosphamide|cyclophosphamide|mesh-list
6348689|NCT00053092|Rituximab|rituximab|mesh-list
6348690|NCT00053092|Fludarabine|fludarabine|mesh-list
6348691|NCT00053092|Fludarabine phosphate|fludarabine phosphate|mesh-list
6348692|NCT00053092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6348693|NCT00053092|Immunologic Factors|immunologic factors|mesh-ancestor
6348694|NCT00053092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6348695|NCT00053092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6348696|NCT00053092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6348697|NCT00053092|Alkylating Agents|alkylating agents|mesh-ancestor
6348698|NCT00053092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348699|NCT00053092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348700|NCT00053092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6348701|NCT00053092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6348702|NCT00053092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6348703|NCT00053092|Antimetabolites|antimetabolites|mesh-ancestor
6394187|NCT00201396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6394188|NCT00201422|Amoxicillin|amoxicillin|mesh-list
6394189|NCT00201422|Clarithromycin|clarithromycin|mesh-list
6016952|NCT00368992|Cetuximab|cetuximab|mesh-list
6016953|NCT00368992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6016954|NCT00368992|Antibodies|antibodies|mesh-list
6016955|NCT00368992|Immunoglobulins|immunoglobulins|mesh-list
6016956|NCT00368992|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6016957|NCT00368992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6016958|NCT00368992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6016959|NCT00368992|Tubulin Modulators|tubulin modulators|mesh-ancestor
6016960|NCT00368992|Antimitotic Agents|antimitotic agents|mesh-ancestor
6016961|NCT00368992|Mitosis Modulators|mitosis modulators|mesh-ancestor
6348704|NCT00053105|Cytarabine|cytarabine|mesh-list
6348705|NCT00053105|Methylprednisolone|methylprednisolone|mesh-list
6348706|NCT00053105|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6348707|NCT00053105|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6348708|NCT00053105|Prednisolone|prednisolone|mesh-list
6348709|NCT00053105|Prednisolone acetate|prednisolone acetate|mesh-list
6348710|NCT00053105|Pixantrone|pixantrone|mesh-list
6348711|NCT00053105|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6348712|NCT00053105|Prednisolone phosphate|prednisolone phosphate|mesh-list
6348713|NCT00053105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348714|NCT00053105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6348715|NCT00053105|Antimetabolites|antimetabolites|mesh-ancestor
6348716|NCT00053105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348717|NCT00053105|Antiviral Agents|antiviral agents|mesh-ancestor
6348718|NCT00053105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6348719|NCT00053105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6348720|NCT00053105|Immunologic Factors|immunologic factors|mesh-ancestor
6348721|NCT00053105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6348722|NCT00053105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6348723|NCT00053105|Antiemetics|antiemetics|mesh-ancestor
6348724|NCT00053105|Autonomic Agents|autonomic agents|mesh-ancestor
6348725|NCT00053105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6348726|NCT00053105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6348727|NCT00053105|Glucocorticoids|glucocorticoids|mesh-ancestor
6348728|NCT00053105|Hormones|hormones|mesh-ancestor
6348729|NCT00053105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6348730|NCT00053105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6348731|NCT00053105|Protective Agents|protective agents|mesh-ancestor
6348732|NCT00053105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6348733|NCT00053105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6348734|NCT00053105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6348735|NCT00053105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6348736|NCT00053118|Carboplatin|carboplatin|mesh-list
6348737|NCT00053118|Etoposide|etoposide|mesh-list
6348738|NCT00053118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348739|NCT00053118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6348740|NCT00053118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6348741|NCT00053118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6348742|NCT00053118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6348743|NCT00053118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348744|NCT00053131|Cytarabine|cytarabine|mesh-list
6348745|NCT00053131|Mitoxantrone|mitoxantrone|mesh-list
6348746|NCT00053131|Sargramostim|sargramostim|mesh-list
6348747|NCT00053131|Immunologic Factors|immunologic factors|mesh-ancestor
6348748|NCT00053131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6348749|NCT00053131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6348750|NCT00053131|Antimetabolites|antimetabolites|mesh-ancestor
6348751|NCT00053131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348752|NCT00053131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348753|NCT00053131|Antiviral Agents|antiviral agents|mesh-ancestor
6348754|NCT00053131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6348755|NCT00053131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6348756|NCT00053131|Analgesics|analgesics|mesh-ancestor
6348757|NCT00053131|Sensory System Agents|sensory system agents|mesh-ancestor
6348758|NCT00053131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6348759|NCT00053131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6348760|NCT00053131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6348761|NCT00053131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6348762|NCT00053144|Cytarabine|cytarabine|mesh-list
6348763|NCT00053144|Irinotecan|irinotecan|mesh-list
6348764|NCT00053144|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6348765|NCT00053144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6348766|NCT00053144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6348767|NCT00053144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348768|NCT00053144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348769|NCT00053144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6348770|NCT00053144|Antimetabolites|antimetabolites|mesh-ancestor
6348771|NCT00053144|Antiviral Agents|antiviral agents|mesh-ancestor
6348772|NCT00053144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6348773|NCT00053144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6348774|NCT00053144|Immunologic Factors|immunologic factors|mesh-ancestor
6348775|NCT00053144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6348776|NCT00053157|Sargramostim|sargramostim|mesh-list
6348777|NCT00053157|Immunologic Factors|immunologic factors|mesh-ancestor
6348778|NCT00053157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6348779|NCT00053196|Mycophenolic Acid|mycophenolic acid|mesh-list
6348780|NCT00053196|Methotrexate|methotrexate|mesh-list
6348781|NCT00053196|Fludarabine phosphate|fludarabine phosphate|mesh-list
6348782|NCT00053196|Fludarabine|fludarabine|mesh-list
6348783|NCT00053196|Busulfan|busulfan|mesh-list
6348784|NCT00053196|Allopurinol|allopurinol|mesh-list
6348785|NCT00053196|Tacrolimus|tacrolimus|mesh-list
6348786|NCT00053196|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6348787|NCT00053196|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6348788|NCT00053196|Abortifacient Agents|abortifacient agents|mesh-ancestor
6348789|NCT00053196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6348790|NCT00053196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6348791|NCT00053196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6348792|NCT00053196|Antimetabolites|antimetabolites|mesh-ancestor
6348793|NCT00053196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348794|NCT00053196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348795|NCT00053196|Dermatologic Agents|dermatologic agents|mesh-ancestor
6348796|NCT00053196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6348797|NCT00053196|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6348798|NCT00053196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6348799|NCT00053196|Immunologic Factors|immunologic factors|mesh-ancestor
6348800|NCT00053196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6348801|NCT00053196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6348802|NCT00053196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6348803|NCT00053196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6348804|NCT00053196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6348805|NCT00053196|Antitubercular Agents|antitubercular agents|mesh-ancestor
6348806|NCT00053196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6348807|NCT00053196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6348808|NCT00053196|Alkylating Agents|alkylating agents|mesh-ancestor
6348809|NCT00053196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6348810|NCT00053196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6348811|NCT00053196|Gout Suppressants|gout suppressants|mesh-ancestor
6348812|NCT00053196|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6348813|NCT00053196|Antioxidants|antioxidants|mesh-ancestor
6348814|NCT00053196|Protective Agents|protective agents|mesh-ancestor
6348815|NCT00053209|Gemcitabine|gemcitabine|mesh-list
6348816|NCT00053209|Pemetrexed|pemetrexed|mesh-list
6348817|NCT00053209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6348818|NCT00053209|Antimetabolites|antimetabolites|mesh-ancestor
6348819|NCT00053209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348820|NCT00053209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348821|NCT00053209|Antiviral Agents|antiviral agents|mesh-ancestor
6348822|NCT00053209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6348823|NCT00053209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6348824|NCT00053209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6348825|NCT00053209|Immunologic Factors|immunologic factors|mesh-ancestor
6348826|NCT00053209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6348827|NCT00053209|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6348828|NCT00053209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6348829|NCT00053222|Arsenic Trioxide|arsenic trioxide|mesh-list
6348830|NCT00053222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348831|NCT00053248|Imatinib Mesylate|imatinib mesylate|mesh-list
6348832|NCT00053248|Arsenic Trioxide|arsenic trioxide|mesh-list
6348833|NCT00053248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348834|NCT00053248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6348835|NCT00053248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6348836|NCT00053248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348837|NCT00053287|Thalidomide|thalidomide|mesh-list
6348838|NCT00053287|Carboplatin|carboplatin|mesh-list
6348839|NCT00053287|Fludarabine|fludarabine|mesh-list
6348840|NCT00053287|Fludarabine phosphate|fludarabine phosphate|mesh-list
6348841|NCT00053287|Topotecan|topotecan|mesh-list
6348842|NCT00053287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348843|NCT00053287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6348844|NCT00053287|Antimetabolites|antimetabolites|mesh-ancestor
6348845|NCT00053287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348846|NCT00053287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6348847|NCT00053287|Immunologic Factors|immunologic factors|mesh-ancestor
6348848|NCT00053287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6348849|NCT00053287|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6348850|NCT00053287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6348851|NCT00053287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6348852|NCT00053287|Leprostatic Agents|leprostatic agents|mesh-ancestor
6348853|NCT00053287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6348854|NCT00053287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6348855|NCT00053287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6348856|NCT00053287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6348857|NCT00053287|Growth Substances|growth substances|mesh-ancestor
6348858|NCT00053287|Growth Inhibitors|growth inhibitors|mesh-ancestor
6348859|NCT00053300|Thalidomide|thalidomide|mesh-list
6348860|NCT00053300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6348861|NCT00053300|Immunologic Factors|immunologic factors|mesh-ancestor
6348862|NCT00053300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6348863|NCT00053300|Leprostatic Agents|leprostatic agents|mesh-ancestor
6348864|NCT00053300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6348865|NCT00053300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6348866|NCT00053300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6348867|NCT00053300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6348868|NCT00053300|Growth Substances|growth substances|mesh-ancestor
6348869|NCT00053300|Growth Inhibitors|growth inhibitors|mesh-ancestor
6348870|NCT00053300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348871|NCT00053326|Fenretinide|fenretinide|mesh-list
6348872|NCT00053326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348873|NCT00053326|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6348874|NCT00053326|Protective Agents|protective agents|mesh-ancestor
6348875|NCT00053326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6348876|NCT00053339|Tamoxifen|tamoxifen|mesh-list
6348877|NCT00053339|Trastuzumab|trastuzumab|mesh-list
6348878|NCT00053339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6348879|NCT00053339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348880|NCT00053339|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6348881|NCT00053339|Hormone Antagonists|hormone antagonists|mesh-ancestor
6348882|NCT00053339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6348883|NCT00053339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6348884|NCT00053339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6348885|NCT00053339|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6348886|NCT00053339|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6348887|NCT00053339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6348888|NCT00053378|Calcium|calcium|mesh-list
6348889|NCT00053378|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6348890|NCT00053378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6348891|NCT00053430|Thalidomide|thalidomide|mesh-list
6348892|NCT00053430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6348893|NCT00053430|Immunologic Factors|immunologic factors|mesh-ancestor
6348894|NCT00053430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6348895|NCT00053430|Leprostatic Agents|leprostatic agents|mesh-ancestor
6348896|NCT00053430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6348897|NCT00053430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6348898|NCT00053430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6348899|NCT00053430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6348900|NCT00053430|Growth Substances|growth substances|mesh-ancestor
6348901|NCT00053430|Growth Inhibitors|growth inhibitors|mesh-ancestor
6348902|NCT00053430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348903|NCT00053560|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
6348904|NCT00053560|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6348905|NCT00053560|Immunologic Factors|immunologic factors|mesh-ancestor
6348906|NCT00053560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6348907|NCT00053599|Simvastatin|simvastatin|mesh-list
6348908|NCT00053599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6348909|NCT00053599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6348910|NCT00053599|Antimetabolites|antimetabolites|mesh-ancestor
6348911|NCT00053599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348912|NCT00053599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6348913|NCT00053599|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6348914|NCT00053599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6348915|NCT00053612|Vitamin A|vitamin a|mesh-list
6348916|NCT00053612|Vitamins|vitamins|mesh-ancestor
6348917|NCT00053612|Micronutrients|micronutrients|mesh-ancestor
6348918|NCT00053612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6348919|NCT00053638|Tenofovir|tenofovir|mesh-list
6348920|NCT00053638|Lamivudine|lamivudine|mesh-list
6348921|NCT00053638|Efavirenz|efavirenz|mesh-list
6348922|NCT00053638|Abacavir|abacavir|mesh-list
6348923|NCT00053638|Antiviral Agents|antiviral agents|mesh-ancestor
6348924|NCT00053638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6348925|NCT00053638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6348926|NCT00053638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6348927|NCT00053638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6348928|NCT00053638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348929|NCT00053638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6348930|NCT00053638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6348931|NCT00053638|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6348932|NCT00053638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6348933|NCT00053638|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6348934|NCT00053638|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6348935|NCT00053638|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6348936|NCT00053638|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6348937|NCT00053716|Alprostadil|alprostadil|mesh-list
6348938|NCT00053716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6348939|NCT00053716|Vasodilator Agents|vasodilator agents|mesh-ancestor
6348940|NCT00053716|Urological Agents|urological agents|mesh-ancestor
6348941|NCT00053768|Prednisone|prednisone|mesh-list
6348942|NCT00053768|Cyclophosphamide|cyclophosphamide|mesh-list
6348943|NCT00053768|Doxorubicin|doxorubicin|mesh-list
6348944|NCT00053768|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6348945|NCT00053768|Etoposide|etoposide|mesh-list
6348946|NCT00053768|Vincristine|vincristine|mesh-list
6348947|NCT00053768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6348948|NCT00053768|Immunologic Factors|immunologic factors|mesh-ancestor
6348949|NCT00053768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6348950|NCT00053768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6348951|NCT00053768|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6348952|NCT00053768|Alkylating Agents|alkylating agents|mesh-ancestor
6348953|NCT00053768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348954|NCT00053768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348955|NCT00053768|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6348956|NCT00053768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6016962|NCT00368992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016963|NCT00368992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6348957|NCT00053768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6348958|NCT00053768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6348959|NCT00053768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6348960|NCT00053768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6348961|NCT00053768|Glucocorticoids|glucocorticoids|mesh-ancestor
6348962|NCT00053768|Hormones|hormones|mesh-ancestor
6348963|NCT00053768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6348964|NCT00053768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6348965|NCT00053768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6348966|NCT00053768|Tubulin Modulators|tubulin modulators|mesh-ancestor
6348967|NCT00053768|Antimitotic Agents|antimitotic agents|mesh-ancestor
6348968|NCT00053768|Mitosis Modulators|mitosis modulators|mesh-ancestor
6348969|NCT00053807|Interferons|interferons|mesh-list
6348970|NCT00053807|Interferon-alpha|interferon-alpha|mesh-list
6348971|NCT00053807|Aldesleukin|aldesleukin|mesh-list
6348972|NCT00053807|Fluorouracil|fluorouracil|mesh-list
6348973|NCT00053807|Antimetabolites|antimetabolites|mesh-ancestor
6348974|NCT00053807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348975|NCT00053807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6348976|NCT00053807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348977|NCT00053807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6348978|NCT00053807|Immunologic Factors|immunologic factors|mesh-ancestor
6348979|NCT00053807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6348980|NCT00053807|Antiviral Agents|antiviral agents|mesh-ancestor
6348981|NCT00053807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6348982|NCT00053807|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6348983|NCT00053807|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6348984|NCT00053820|Interferons|interferons|mesh-list
6348985|NCT00053820|Interferon-alpha|interferon-alpha|mesh-list
6348986|NCT00053820|Aldesleukin|aldesleukin|mesh-list
6348987|NCT00053820|Fluorouracil|fluorouracil|mesh-list
6348988|NCT00053820|Antimetabolites|antimetabolites|mesh-ancestor
6348989|NCT00053820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6348990|NCT00053820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6348991|NCT00053820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6348992|NCT00053820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6348993|NCT00053820|Immunologic Factors|immunologic factors|mesh-ancestor
6348994|NCT00053820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6348995|NCT00053820|Antiviral Agents|antiviral agents|mesh-ancestor
6348996|NCT00053820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6348997|NCT00053820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6348998|NCT00053820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6348999|NCT00053833|Irinotecan|irinotecan|mesh-list
6349000|NCT00053833|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6349001|NCT00053833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6349002|NCT00053833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6349003|NCT00053833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349004|NCT00053833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349005|NCT00053872|Vincristine|vincristine|mesh-list
6349006|NCT00053872|Lomustine|lomustine|mesh-list
6349007|NCT00053872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349008|NCT00053872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6349009|NCT00053872|Tubulin Modulators|tubulin modulators|mesh-ancestor
6349010|NCT00053872|Antimitotic Agents|antimitotic agents|mesh-ancestor
6349011|NCT00053872|Mitosis Modulators|mitosis modulators|mesh-ancestor
6349012|NCT00053872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349013|NCT00053872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6349014|NCT00053872|Alkylating Agents|alkylating agents|mesh-ancestor
6349015|NCT00053885|Vatalanib|vatalanib|mesh-list
6349016|NCT00053885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6349017|NCT00053885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6349018|NCT00053885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349019|NCT00053911|Tamoxifen|tamoxifen|mesh-list
6349020|NCT00053911|Cyclophosphamide|cyclophosphamide|mesh-list
6349021|NCT00053911|Docetaxel|docetaxel|mesh-list
6349022|NCT00053911|Fluorouracil|fluorouracil|mesh-list
6349023|NCT00053911|Epirubicin|epirubicin|mesh-list
6349024|NCT00053911|Anastrozole|anastrozole|mesh-list
6349025|NCT00053911|Goserelin|goserelin|mesh-list
6349026|NCT00053911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6349027|NCT00053911|Immunologic Factors|immunologic factors|mesh-ancestor
6349028|NCT00053911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6349029|NCT00053911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6349030|NCT00053911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6349031|NCT00053911|Alkylating Agents|alkylating agents|mesh-ancestor
6349032|NCT00053911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349033|NCT00053911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349034|NCT00053911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6349035|NCT00053911|Tubulin Modulators|tubulin modulators|mesh-ancestor
6349036|NCT00053911|Antimitotic Agents|antimitotic agents|mesh-ancestor
6349037|NCT00053911|Mitosis Modulators|mitosis modulators|mesh-ancestor
6349038|NCT00053911|Antimetabolites|antimetabolites|mesh-ancestor
6349039|NCT00053911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6349040|NCT00053911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6349041|NCT00053911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6349042|NCT00053911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6349043|NCT00053911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6349044|NCT00053911|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6349045|NCT00053911|Hormone Antagonists|hormone antagonists|mesh-ancestor
6349046|NCT00053911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6349047|NCT00053911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6349048|NCT00053911|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6349049|NCT00053911|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6349050|NCT00053911|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6349051|NCT00053911|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6349052|NCT00053911|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6349053|NCT00053937|Pirfenidone|pirfenidone|mesh-list
6349054|NCT00053937|Analgesics|analgesics|mesh-ancestor
6349055|NCT00053937|Sensory System Agents|sensory system agents|mesh-ancestor
6349056|NCT00053937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6349057|NCT00053937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6349058|NCT00053937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6349059|NCT00053937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6349060|NCT00053937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6349061|NCT00053937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6349062|NCT00053937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349063|NCT00053950|NSC 366140|nsc 366140|mesh-list
6349064|NCT00053950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349065|NCT00053963|Romidepsin|romidepsin|mesh-list
6349066|NCT00053963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6349067|NCT00053963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349068|NCT00053976|Methylprednisolone|methylprednisolone|mesh-list
6349069|NCT00053976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6349070|NCT00053976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6349071|NCT00053976|Prednisolone|prednisolone|mesh-list
6349072|NCT00053976|Prednisolone acetate|prednisolone acetate|mesh-list
6349073|NCT00053976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6349074|NCT00053976|Prednisolone phosphate|prednisolone phosphate|mesh-list
6349075|NCT00053976|Daclizumab|daclizumab|mesh-list
6349076|NCT00053976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6349077|NCT00053976|Antiemetics|antiemetics|mesh-ancestor
6349078|NCT00053976|Autonomic Agents|autonomic agents|mesh-ancestor
6349079|NCT00053976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6349080|NCT00053976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6349081|NCT00053976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6349082|NCT00053976|Glucocorticoids|glucocorticoids|mesh-ancestor
6349083|NCT00053976|Hormones|hormones|mesh-ancestor
6349084|NCT00053976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6349085|NCT00053976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6349086|NCT00053976|Protective Agents|protective agents|mesh-ancestor
6349087|NCT00053976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6349088|NCT00053976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349089|NCT00053976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6349090|NCT00053976|Immunologic Factors|immunologic factors|mesh-ancestor
6349091|NCT00054002|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
6349092|NCT00054002|Trioxsalen|trioxsalen|mesh-list
6349093|NCT00054002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349094|NCT00054002|Dermatologic Agents|dermatologic agents|mesh-ancestor
6349095|NCT00054002|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6349096|NCT00054041|Vaccines|vaccines|mesh-list
6349097|NCT00054041|Immunologic Factors|immunologic factors|mesh-ancestor
6349098|NCT00054041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6349099|NCT00054054|Docetaxel|docetaxel|mesh-list
6349100|NCT00054054|Fluorouracil|fluorouracil|mesh-list
6349101|NCT00054054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349102|NCT00054054|Tubulin Modulators|tubulin modulators|mesh-ancestor
6349103|NCT00054054|Antimitotic Agents|antimitotic agents|mesh-ancestor
6349104|NCT00054054|Mitosis Modulators|mitosis modulators|mesh-ancestor
6349105|NCT00054054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349106|NCT00054054|Antimetabolites|antimetabolites|mesh-ancestor
6349107|NCT00054054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6349108|NCT00054054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6349109|NCT00054054|Immunologic Factors|immunologic factors|mesh-ancestor
6349110|NCT00054054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6349111|NCT00054067|Cisplatin|cisplatin|mesh-list
6349112|NCT00054067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349113|NCT00054106|Flutamide|flutamide|mesh-list
6349114|NCT00054106|Buserelin|buserelin|mesh-list
6349115|NCT00054106|Androgen Antagonists|androgen antagonists|mesh-ancestor
6349116|NCT00054106|Hormone Antagonists|hormone antagonists|mesh-ancestor
6349117|NCT00054106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6349118|NCT00054106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6349119|NCT00054106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6349120|NCT00054106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349121|NCT00054106|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6349122|NCT00054106|Fertility Agents|fertility agents|mesh-ancestor
6349123|NCT00054106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6349124|NCT00054158|Thalidomide|thalidomide|mesh-list
6349125|NCT00054158|Dexamethasone|dexamethasone|mesh-list
6349126|NCT00054158|Doxorubicin|doxorubicin|mesh-list
6349127|NCT00054158|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6349128|NCT00054158|Vincristine|vincristine|mesh-list
6349129|NCT00054158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6349130|NCT00054158|Antiemetics|antiemetics|mesh-ancestor
6349131|NCT00054158|Autonomic Agents|autonomic agents|mesh-ancestor
6349132|NCT00054158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6349133|NCT00054158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6349134|NCT00054158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6349135|NCT00054158|Glucocorticoids|glucocorticoids|mesh-ancestor
6349136|NCT00054158|Hormones|hormones|mesh-ancestor
6349137|NCT00054158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6349138|NCT00054158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6349139|NCT00054158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349140|NCT00054158|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6349141|NCT00054158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6349142|NCT00054158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6349143|NCT00054158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6349144|NCT00054158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349145|NCT00054158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6349146|NCT00054158|Tubulin Modulators|tubulin modulators|mesh-ancestor
6349147|NCT00054158|Antimitotic Agents|antimitotic agents|mesh-ancestor
6349148|NCT00054158|Mitosis Modulators|mitosis modulators|mesh-ancestor
6349149|NCT00054158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6349150|NCT00054158|Immunologic Factors|immunologic factors|mesh-ancestor
6349151|NCT00054158|Leprostatic Agents|leprostatic agents|mesh-ancestor
6349152|NCT00054158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6349153|NCT00054158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6349154|NCT00054158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6349155|NCT00054158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6349156|NCT00054158|Growth Substances|growth substances|mesh-ancestor
6349157|NCT00054158|Growth Inhibitors|growth inhibitors|mesh-ancestor
6349158|NCT00054171|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6349159|NCT00054171|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6349160|NCT00054171|Dermatologic Agents|dermatologic agents|mesh-ancestor
6349161|NCT00054184|Paclitaxel|paclitaxel|mesh-list
6349162|NCT00054184|Docetaxel|docetaxel|mesh-list
6349163|NCT00054184|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
6349164|NCT00054184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6349165|NCT00054184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349166|NCT00054184|Tubulin Modulators|tubulin modulators|mesh-ancestor
6349167|NCT00054184|Antimitotic Agents|antimitotic agents|mesh-ancestor
6349168|NCT00054184|Mitosis Modulators|mitosis modulators|mesh-ancestor
6349169|NCT00054184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349170|NCT00054197|Gemcitabine|gemcitabine|mesh-list
6349171|NCT00054197|Paclitaxel|paclitaxel|mesh-list
6349172|NCT00054197|Vinorelbine|vinorelbine|mesh-list
6349173|NCT00054197|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
6349174|NCT00054197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6349175|NCT00054197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349176|NCT00054197|Tubulin Modulators|tubulin modulators|mesh-ancestor
6349177|NCT00054197|Antimitotic Agents|antimitotic agents|mesh-ancestor
6349178|NCT00054197|Mitosis Modulators|mitosis modulators|mesh-ancestor
6349179|NCT00054197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349180|NCT00054197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6349181|NCT00054197|Antimetabolites|antimetabolites|mesh-ancestor
6349182|NCT00054197|Antiviral Agents|antiviral agents|mesh-ancestor
6349183|NCT00054197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6349184|NCT00054197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6349185|NCT00054197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6349186|NCT00054197|Immunologic Factors|immunologic factors|mesh-ancestor
6349187|NCT00054197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6349188|NCT00054210|Paclitaxel|paclitaxel|mesh-list
6349189|NCT00054210|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6349190|NCT00054210|Carboplatin|carboplatin|mesh-list
6349191|NCT00054210|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
6349192|NCT00054210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6349193|NCT00054210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349194|NCT00054210|Tubulin Modulators|tubulin modulators|mesh-ancestor
6349195|NCT00054210|Antimitotic Agents|antimitotic agents|mesh-ancestor
6349196|NCT00054210|Mitosis Modulators|mitosis modulators|mesh-ancestor
6349197|NCT00054210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349198|NCT00054236|Methylprednisolone|methylprednisolone|mesh-list
6349199|NCT00054236|Cyclophosphamide|cyclophosphamide|mesh-list
6349200|NCT00054236|Fludarabine|fludarabine|mesh-list
6349201|NCT00054236|Fludarabine phosphate|fludarabine phosphate|mesh-list
6349202|NCT00054236|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6349203|NCT00054236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6349204|NCT00054236|Immunologic Factors|immunologic factors|mesh-ancestor
6349205|NCT00054236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6349206|NCT00054236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6349207|NCT00054236|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6349208|NCT00054236|Alkylating Agents|alkylating agents|mesh-ancestor
6349209|NCT00054236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349210|NCT00054236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349211|NCT00054236|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6349212|NCT00054236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6349213|NCT00054236|Antimetabolites|antimetabolites|mesh-ancestor
6349214|NCT00054236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6349215|NCT00054236|Antiemetics|antiemetics|mesh-ancestor
6349216|NCT00054236|Autonomic Agents|autonomic agents|mesh-ancestor
6349217|NCT00054236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6349218|NCT00054236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6349219|NCT00054236|Glucocorticoids|glucocorticoids|mesh-ancestor
6349220|NCT00054236|Hormones|hormones|mesh-ancestor
6349221|NCT00054236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6349222|NCT00054236|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6349223|NCT00054236|Protective Agents|protective agents|mesh-ancestor
6349224|NCT00054288|Gemcitabine|gemcitabine|mesh-list
6349225|NCT00054288|Irinotecan|irinotecan|mesh-list
6349226|NCT00054288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6349227|NCT00054288|Antimetabolites|antimetabolites|mesh-ancestor
6349228|NCT00054288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349229|NCT00054288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349230|NCT00054288|Antiviral Agents|antiviral agents|mesh-ancestor
6349231|NCT00054288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6349232|NCT00054288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6349233|NCT00054288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6349234|NCT00054288|Immunologic Factors|immunologic factors|mesh-ancestor
6349235|NCT00054288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6349236|NCT00054288|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6349237|NCT00054288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6349238|NCT00054314|IDN 5109|idn 5109|mesh-list
6349239|NCT00054314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349240|NCT00054340|Cyclosporine|cyclosporine|mesh-list
6349241|NCT00054340|Cyclophosphamide|cyclophosphamide|mesh-list
6349242|NCT00054340|Busulfan|busulfan|mesh-list
6349243|NCT00054340|Methotrexate|methotrexate|mesh-list
6349244|NCT00054340|Cyclosporins|cyclosporins|mesh-list
6349245|NCT00054340|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6349246|NCT00054340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6349247|NCT00054340|Immunologic Factors|immunologic factors|mesh-ancestor
6349248|NCT00054340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6349249|NCT00054340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6349250|NCT00054340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6349251|NCT00054340|Alkylating Agents|alkylating agents|mesh-ancestor
6349252|NCT00054340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349253|NCT00054340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349254|NCT00054340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6349255|NCT00054340|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6349256|NCT00054340|Abortifacient Agents|abortifacient agents|mesh-ancestor
6349257|NCT00054340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6349258|NCT00054340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6349259|NCT00054340|Antimetabolites|antimetabolites|mesh-ancestor
6349260|NCT00054340|Dermatologic Agents|dermatologic agents|mesh-ancestor
6349261|NCT00054340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6349262|NCT00054340|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6349263|NCT00054340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6349264|NCT00054340|Antifungal Agents|antifungal agents|mesh-ancestor
6349265|NCT00054340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6349266|NCT00054340|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6349267|NCT00054392|Gemcitabine|gemcitabine|mesh-list
6349268|NCT00054392|Paclitaxel|paclitaxel|mesh-list
6349269|NCT00054392|Carboplatin|carboplatin|mesh-list
6349270|NCT00054392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6349271|NCT00054392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349272|NCT00054392|Tubulin Modulators|tubulin modulators|mesh-ancestor
6349273|NCT00054392|Antimitotic Agents|antimitotic agents|mesh-ancestor
6349274|NCT00054392|Mitosis Modulators|mitosis modulators|mesh-ancestor
6349275|NCT00054392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349276|NCT00054392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6349277|NCT00054392|Antimetabolites|antimetabolites|mesh-ancestor
6349278|NCT00054392|Antiviral Agents|antiviral agents|mesh-ancestor
6349279|NCT00054392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6349280|NCT00054392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6349281|NCT00054392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6349282|NCT00054392|Immunologic Factors|immunologic factors|mesh-ancestor
6349283|NCT00054392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6349284|NCT00054405|Aldesleukin|aldesleukin|mesh-list
6349285|NCT00054405|Interleukin-2|interleukin-2|mesh-list
6349286|NCT00054405|Interleukin-12|interleukin-12|mesh-list
6349287|NCT00054405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349288|NCT00054405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6349289|NCT00054405|Analgesics|analgesics|mesh-ancestor
6349290|NCT00054405|Sensory System Agents|sensory system agents|mesh-ancestor
6349291|NCT00054405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6349292|NCT00054405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6349293|NCT00054405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6349294|NCT00054405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6349295|NCT00054405|Antiviral Agents|antiviral agents|mesh-ancestor
6349296|NCT00054405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6349297|NCT00054405|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6349298|NCT00054405|Immunologic Factors|immunologic factors|mesh-ancestor
6349299|NCT00054405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6349300|NCT00054405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6349301|NCT00054405|Growth Substances|growth substances|mesh-ancestor
6349302|NCT00054405|Growth Inhibitors|growth inhibitors|mesh-ancestor
6349303|NCT00054418|Vitamin D|vitamin d|mesh-list
6349304|NCT00054418|Risedronic Acid|risedronic acid|mesh-list
6349305|NCT00054418|Calcium Carbonate|calcium carbonate|mesh-list
6349306|NCT00054418|Calcium|calcium|mesh-list
6349307|NCT00054418|Vitamins|vitamins|mesh-ancestor
6349308|NCT00054418|Micronutrients|micronutrients|mesh-ancestor
6349309|NCT00054418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6349310|NCT00054418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6349311|NCT00054418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6349312|NCT00054418|Antacids|antacids|mesh-ancestor
6349313|NCT00054418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349314|NCT00054418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6349315|NCT00054418|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6349316|NCT00054418|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6349317|NCT00054431|Imatinib Mesylate|imatinib mesylate|mesh-list
6349318|NCT00054431|Decitabine|decitabine|mesh-list
6349319|NCT00054431|Azacitidine|azacitidine|mesh-list
6349320|NCT00054431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349321|NCT00054431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6349322|NCT00054431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6349323|NCT00054431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349324|NCT00054431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6349325|NCT00054431|Antimetabolites|antimetabolites|mesh-ancestor
6349326|NCT00054444|Topotecan|topotecan|mesh-list
6349327|NCT00054444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349328|NCT00054444|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6349329|NCT00054444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6349330|NCT00054444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6349331|NCT00054444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349332|NCT00054457|Docetaxel|docetaxel|mesh-list
5724590|NCT03186326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349333|NCT00054457|Capecitabine|capecitabine|mesh-list
6349334|NCT00054457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349335|NCT00054457|Tubulin Modulators|tubulin modulators|mesh-ancestor
6349336|NCT00054457|Antimitotic Agents|antimitotic agents|mesh-ancestor
6349337|NCT00054457|Mitosis Modulators|mitosis modulators|mesh-ancestor
6349338|NCT00054457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349339|NCT00054457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6349340|NCT00054457|Antimetabolites|antimetabolites|mesh-ancestor
6349341|NCT00054470|Trastuzumab|trastuzumab|mesh-list
6349342|NCT00054470|Tipifarnib|tipifarnib|mesh-list
6349343|NCT00054470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6349344|NCT00054470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349345|NCT00054483|Bortezomib|bortezomib|mesh-list
6349346|NCT00054483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349347|NCT00054496|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6349348|NCT00054496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349349|NCT00054496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6349350|NCT00054496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6349351|NCT00054496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349352|NCT00054522|Calcitriol|calcitriol|mesh-list
6349353|NCT00054522|Dexamethasone|dexamethasone|mesh-list
6349354|NCT00054522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6349355|NCT00054522|Antiemetics|antiemetics|mesh-ancestor
6349356|NCT00054522|Autonomic Agents|autonomic agents|mesh-ancestor
6349357|NCT00054522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6349358|NCT00054522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6349359|NCT00054522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6349360|NCT00054522|Glucocorticoids|glucocorticoids|mesh-ancestor
6349361|NCT00054522|Hormones|hormones|mesh-ancestor
6349362|NCT00054522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6349363|NCT00054522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6349364|NCT00054522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349365|NCT00054522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6349366|NCT00054522|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6349367|NCT00054522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6349368|NCT00054522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349369|NCT00054522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6349370|NCT00054522|Vitamins|vitamins|mesh-ancestor
6349371|NCT00054522|Micronutrients|micronutrients|mesh-ancestor
6349372|NCT00054522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6349373|NCT00054535|Aldesleukin|aldesleukin|mesh-list
6349374|NCT00054535|Vaccines|vaccines|mesh-list
6349375|NCT00054535|Immunologic Factors|immunologic factors|mesh-ancestor
6349376|NCT00054535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6349377|NCT00054535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349378|NCT00054535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6349379|NCT00054535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6349380|NCT00054535|Antiviral Agents|antiviral agents|mesh-ancestor
6349381|NCT00054535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6349382|NCT00054548|Paclitaxel|paclitaxel|mesh-list
6349383|NCT00054548|Oblimersen|oblimersen|mesh-list
6349384|NCT00054548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6349385|NCT00054548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349386|NCT00054548|Tubulin Modulators|tubulin modulators|mesh-ancestor
6349387|NCT00054548|Antimitotic Agents|antimitotic agents|mesh-ancestor
6349388|NCT00054548|Mitosis Modulators|mitosis modulators|mesh-ancestor
6349389|NCT00054548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349390|NCT00054561|Vitamin E|vitamin e|mesh-list
6349391|NCT00054561|Interferons|interferons|mesh-list
6349392|NCT00054561|Interferon-alpha|interferon-alpha|mesh-list
6349393|NCT00054561|Isotretinoin|isotretinoin|mesh-list
6349394|NCT00054561|Vitamins|vitamins|mesh-ancestor
6349395|NCT00054561|Micronutrients|micronutrients|mesh-ancestor
6349396|NCT00054561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6349397|NCT00054561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349398|NCT00054561|Antiviral Agents|antiviral agents|mesh-ancestor
6349399|NCT00054561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6349400|NCT00054561|Immunologic Factors|immunologic factors|mesh-ancestor
6349401|NCT00054561|Antioxidants|antioxidants|mesh-ancestor
6349402|NCT00054561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349403|NCT00054561|Protective Agents|protective agents|mesh-ancestor
6349404|NCT00054561|Dermatologic Agents|dermatologic agents|mesh-ancestor
6349405|NCT00054574|Panitumumab|panitumumab|mesh-list
6349406|NCT00054574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6349407|NCT00054574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349408|NCT00054587|Cyclophosphamide|cyclophosphamide|mesh-list
6349409|NCT00054587|Docetaxel|docetaxel|mesh-list
6349410|NCT00054587|Fluorouracil|fluorouracil|mesh-list
6349411|NCT00054587|Trastuzumab|trastuzumab|mesh-list
6349412|NCT00054587|Epirubicin|epirubicin|mesh-list
6349413|NCT00054587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6349414|NCT00054587|Immunologic Factors|immunologic factors|mesh-ancestor
6349415|NCT00054587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6349416|NCT00054587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6349417|NCT00054587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6349418|NCT00054587|Alkylating Agents|alkylating agents|mesh-ancestor
6349419|NCT00054587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349420|NCT00054587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349421|NCT00054587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6349422|NCT00054587|Tubulin Modulators|tubulin modulators|mesh-ancestor
6349423|NCT00054587|Antimitotic Agents|antimitotic agents|mesh-ancestor
6349424|NCT00054587|Mitosis Modulators|mitosis modulators|mesh-ancestor
6349425|NCT00054587|Antimetabolites|antimetabolites|mesh-ancestor
6349426|NCT00054587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6349427|NCT00054587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6349428|NCT00054587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6349429|NCT00054587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6349430|NCT00054587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6349431|NCT00054587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6349432|NCT00054600|Methoxsalen|methoxsalen|mesh-list
6349433|NCT00054600|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6349434|NCT00054600|Dermatologic Agents|dermatologic agents|mesh-ancestor
6349435|NCT00054613|Methoxsalen|methoxsalen|mesh-list
6349436|NCT00054613|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6349437|NCT00054613|Dermatologic Agents|dermatologic agents|mesh-ancestor
6349438|NCT00054626|Gemcitabine|gemcitabine|mesh-list
6349439|NCT00054626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349440|NCT00054626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6349441|NCT00054626|Antimetabolites|antimetabolites|mesh-ancestor
6349442|NCT00054626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349443|NCT00054626|Antiviral Agents|antiviral agents|mesh-ancestor
6349444|NCT00054626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6349445|NCT00054626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6349446|NCT00054626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6349447|NCT00054626|Immunologic Factors|immunologic factors|mesh-ancestor
6349448|NCT00054626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6349449|NCT00054795|Motexafin gadolinium|motexafin gadolinium|mesh-list
6349450|NCT00054795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349451|NCT00054795|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6349452|NCT00054795|Dermatologic Agents|dermatologic agents|mesh-ancestor
6349453|NCT00054808|Gallium nitrate|gallium nitrate|mesh-list
6349454|NCT00054808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6349455|NCT00054808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6349456|NCT00054808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349457|NCT00054834|Epratuzumab|epratuzumab|mesh-list
6349458|NCT00054834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6349459|NCT00054834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6394190|NCT00201422|Omeprazole|omeprazole|mesh-list
6394191|NCT00201422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6394192|NCT00201422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6394193|NCT00201422|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6394194|NCT00201422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6394195|NCT00201422|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6394196|NCT00201422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6394197|NCT00201422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394198|NCT00201422|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6394199|NCT00201422|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6394200|NCT00201422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6394201|NCT00201435|Paclitaxel|paclitaxel|mesh-list
6394202|NCT00201435|Docetaxel|docetaxel|mesh-list
6394203|NCT00201435|Capecitabine|capecitabine|mesh-list
6394204|NCT00201435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6394205|NCT00201435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6394206|NCT00201435|Tubulin Modulators|tubulin modulators|mesh-ancestor
6394207|NCT00201435|Antimitotic Agents|antimitotic agents|mesh-ancestor
6394208|NCT00201435|Mitosis Modulators|mitosis modulators|mesh-ancestor
6394209|NCT00201435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394210|NCT00201435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6394211|NCT00201435|Antimetabolites|antimetabolites|mesh-ancestor
6394212|NCT00201539|Morphine|morphine|mesh-list
6537192|NCT00821158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
6537193|NCT00821158|Antioxidants|antioxidants|mesh-list
6537194|NCT00821158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537195|NCT00821158|Protective Agents|protective agents|mesh-ancestor
6394213|NCT00201539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6394214|NCT00201539|Narcotics|narcotics|mesh-ancestor
6394215|NCT00201539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6349460|NCT00054873|Fluorouracil|fluorouracil|mesh-list
6349461|NCT00054873|Tezacitabine|tezacitabine|mesh-list
6349462|NCT00054873|Antimetabolites|antimetabolites|mesh-ancestor
6349463|NCT00054873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349464|NCT00054873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6349465|NCT00054873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349466|NCT00054873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6349467|NCT00054873|Immunologic Factors|immunologic factors|mesh-ancestor
6349468|NCT00054873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6349469|NCT00054873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6349470|NCT00054886|Sunitinib|sunitinib|mesh-list
6349471|NCT00054886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349472|NCT00054886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6349473|NCT00054886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6349474|NCT00054886|Growth Substances|growth substances|mesh-ancestor
6349475|NCT00054886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6349476|NCT00054886|Growth Inhibitors|growth inhibitors|mesh-ancestor
6349477|NCT00054886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6349478|NCT00054886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6349479|NCT00054886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349480|NCT00054938|Aspirin|aspirin|mesh-list
6349481|NCT00054938|Ramipril|ramipril|mesh-list
6349482|NCT00054938|Pravastatin|pravastatin|mesh-list
6349483|NCT00054938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6349484|NCT00054938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6349485|NCT00054938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6349486|NCT00054938|Analgesics|analgesics|mesh-ancestor
6349487|NCT00054938|Sensory System Agents|sensory system agents|mesh-ancestor
6349488|NCT00054938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6349489|NCT00054938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6349490|NCT00054938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6349491|NCT00054938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6349492|NCT00054938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6349493|NCT00054938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349494|NCT00054938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6349495|NCT00054938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6349496|NCT00054938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6349497|NCT00054938|Antipyretics|antipyretics|mesh-ancestor
6349498|NCT00054938|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6349499|NCT00054938|Protease Inhibitors|protease inhibitors|mesh-ancestor
6349500|NCT00054938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6349501|NCT00054938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6349502|NCT00054938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6349503|NCT00054938|Antimetabolites|antimetabolites|mesh-ancestor
6349504|NCT00054938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6349505|NCT00054938|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6349506|NCT00054977|Fluorouracil|fluorouracil|mesh-list
6349507|NCT00054977|Antimetabolites|antimetabolites|mesh-ancestor
6349508|NCT00054977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349509|NCT00054977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6349510|NCT00054977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349511|NCT00054977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6349512|NCT00054977|Immunologic Factors|immunologic factors|mesh-ancestor
6349513|NCT00054977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6349514|NCT00055042|Vitamin E|vitamin e|mesh-list
6349515|NCT00055042|Vitamins|vitamins|mesh-ancestor
6349516|NCT00055042|Micronutrients|micronutrients|mesh-ancestor
6349517|NCT00055042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6349518|NCT00055042|Antioxidants|antioxidants|mesh-ancestor
6349519|NCT00055042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349520|NCT00055042|Protective Agents|protective agents|mesh-ancestor
6349521|NCT00055107|Nitazoxanide|nitazoxanide|mesh-list
6349522|NCT00055107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6349523|NCT00055107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6349524|NCT00055120|Ritonavir|ritonavir|mesh-list
6349525|NCT00055120|Lopinavir|lopinavir|mesh-list
6349526|NCT00055120|Tenofovir|tenofovir|mesh-list
6349527|NCT00055120|Emtricitabine|emtricitabine|mesh-list
6349528|NCT00055120|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6349529|NCT00055120|Stavudine|stavudine|mesh-list
6349530|NCT00055120|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6349531|NCT00055120|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6349532|NCT00055120|Protease Inhibitors|protease inhibitors|mesh-ancestor
6349533|NCT00055120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6349534|NCT00055120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349535|NCT00055120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6349536|NCT00055120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6349537|NCT00055120|Antiviral Agents|antiviral agents|mesh-ancestor
6349538|NCT00055120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6349539|NCT00055120|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6349540|NCT00055120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6349541|NCT00055120|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6349542|NCT00055120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6349543|NCT00055120|Antimetabolites|antimetabolites|mesh-ancestor
6349544|NCT00055133|Paclitaxel|paclitaxel|mesh-list
6349545|NCT00055133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6349546|NCT00055133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349547|NCT00055133|Tubulin Modulators|tubulin modulators|mesh-ancestor
6349548|NCT00055133|Antimitotic Agents|antimitotic agents|mesh-ancestor
6349549|NCT00055133|Mitosis Modulators|mitosis modulators|mesh-ancestor
6537196|NCT00821158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537197|NCT00821262|Propofol|propofol|mesh-list
6537198|NCT00821262|Sevoflurane|sevoflurane|mesh-list
6537199|NCT00821262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6537200|NCT00821262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6349550|NCT00055133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349551|NCT00055159|Plasminogen|plasminogen|mesh-list
6349552|NCT00055159|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6349553|NCT00055159|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6349554|NCT00055159|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6349555|NCT00055159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349556|NCT00055185|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
6349557|NCT00055185|Immunologic Factors|immunologic factors|mesh-ancestor
6349558|NCT00055185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6349559|NCT00055198|Daptomycin|daptomycin|mesh-list
6349560|NCT00055198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6349561|NCT00055198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6016964|NCT00368992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6016965|NCT00368992|Growth Substances|growth substances|mesh-ancestor
6016966|NCT00368992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016967|NCT00368992|Growth Inhibitors|growth inhibitors|mesh-ancestor
6016968|NCT00368992|Immunologic Factors|immunologic factors|mesh-ancestor
6016969|NCT00369122|Bevacizumab|bevacizumab|mesh-list
6016970|NCT00369122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6016971|NCT00369122|Cisplatin|cisplatin|mesh-list
6016972|NCT00369122|Endothelial Growth Factors|endothelial growth factors|mesh-list
6349562|NCT00055250|Gemcitabine|gemcitabine|mesh-list
6349563|NCT00055250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6349564|NCT00055250|Antimetabolites|antimetabolites|mesh-ancestor
6349565|NCT00055250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349566|NCT00055250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349567|NCT00055250|Antiviral Agents|antiviral agents|mesh-ancestor
6016973|NCT00369122|Antibodies|antibodies|mesh-list
6349568|NCT00055250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6349569|NCT00055250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6349570|NCT00055250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6349571|NCT00055250|Immunologic Factors|immunologic factors|mesh-ancestor
6349572|NCT00055250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6349573|NCT00055302|Anastrozole|anastrozole|mesh-list
6349574|NCT00055302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6349575|NCT00055302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6537201|NCT00821262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537202|NCT00821262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6016974|NCT00369122|Immunoglobulins|immunoglobulins|mesh-list
6349576|NCT00055302|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6349577|NCT00055302|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6349578|NCT00055302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6349579|NCT00055302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349580|NCT00055302|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6349581|NCT00055302|Hormone Antagonists|hormone antagonists|mesh-ancestor
6349582|NCT00055302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6349583|NCT00055302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6349584|NCT00055341|Ribavirin|ribavirin|mesh-list
6349585|NCT00055341|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6349586|NCT00055341|Antimetabolites|antimetabolites|mesh-ancestor
6016975|NCT00369122|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6016976|NCT00369122|Immunoglobulin G|immunoglobulin g|mesh-list
6349587|NCT00055341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349588|NCT00055341|Antiviral Agents|antiviral agents|mesh-ancestor
6349589|NCT00055341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6349590|NCT00055367|Natalizumab|natalizumab|mesh-list
6349591|NCT00055367|Immunologic Factors|immunologic factors|mesh-ancestor
6349592|NCT00055367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6349593|NCT00055393|Bupropion|bupropion|mesh-list
6349594|NCT00055393|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6349595|NCT00055393|Antidepressive Agents|antidepressive agents|mesh-ancestor
6349596|NCT00055393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6349597|NCT00055393|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6349598|NCT00055393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6349599|NCT00055393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6349600|NCT00055393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349601|NCT00055393|Dopamine Agents|dopamine agents|mesh-ancestor
6349602|NCT00055393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6349603|NCT00055393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6349604|NCT00055393|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6349605|NCT00055393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6349606|NCT00055393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6349607|NCT00055419|Cetuximab|cetuximab|mesh-list
6349608|NCT00055419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6349609|NCT00055419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349610|NCT00055432|Gemcitabine|gemcitabine|mesh-list
6349611|NCT00055432|Pemetrexed|pemetrexed|mesh-list
6349612|NCT00055432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6349613|NCT00055432|Antimetabolites|antimetabolites|mesh-ancestor
6349614|NCT00055432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349615|NCT00055432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6016977|NCT00369122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349616|NCT00055432|Antiviral Agents|antiviral agents|mesh-ancestor
6349617|NCT00055432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6349618|NCT00055432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6349619|NCT00055432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6349620|NCT00055432|Immunologic Factors|immunologic factors|mesh-ancestor
6349621|NCT00055432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6349622|NCT00055432|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6349623|NCT00055432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6349624|NCT00055484|Zonisamide|zonisamide|mesh-list
6349625|NCT00055484|Anticonvulsants|anticonvulsants|mesh-ancestor
6349626|NCT00055484|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6349627|NCT00055484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6349628|NCT00055484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349629|NCT00055484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6349630|NCT00055484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6349631|NCT00055523|Adalimumab|adalimumab|mesh-list
6349632|NCT00055523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6349633|NCT00055523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6349634|NCT00055536|Natalizumab|natalizumab|mesh-list
6349635|NCT00055536|Immunologic Factors|immunologic factors|mesh-ancestor
6349636|NCT00055536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6349637|NCT00055549|Lorazepam|lorazepam|mesh-list
6349638|NCT00055549|Dextromethorphan|dextromethorphan|mesh-list
6349639|NCT00055549|Antitussive Agents|antitussive agents|mesh-ancestor
6349640|NCT00055549|Respiratory System Agents|respiratory system agents|mesh-ancestor
6349641|NCT00055549|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6349642|NCT00055549|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6349643|NCT00055549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6349644|NCT00055549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349645|NCT00055549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6349646|NCT00055549|Anticonvulsants|anticonvulsants|mesh-ancestor
6349647|NCT00055549|Antiemetics|antiemetics|mesh-ancestor
6349648|NCT00055549|Autonomic Agents|autonomic agents|mesh-ancestor
6349649|NCT00055549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6349650|NCT00055549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6349651|NCT00055549|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6349652|NCT00055549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6349653|NCT00055549|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6349654|NCT00055549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6349655|NCT00055549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6349656|NCT00055549|GABA Modulators|gaba modulators|mesh-ancestor
6349657|NCT00055549|GABA Agents|gaba agents|mesh-ancestor
6349658|NCT00055562|Lenalidomide|lenalidomide|mesh-list
6349659|NCT00055562|Immunologic Factors|immunologic factors|mesh-ancestor
6349660|NCT00055562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6349661|NCT00055562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6349662|NCT00055562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6349663|NCT00055562|Growth Substances|growth substances|mesh-ancestor
6349664|NCT00055562|Growth Inhibitors|growth inhibitors|mesh-ancestor
6349665|NCT00055562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349666|NCT00055614|Topotecan|topotecan|mesh-list
6349667|NCT00055614|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6349668|NCT00055614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6349669|NCT00055614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6349670|NCT00055614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349671|NCT00055614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349672|NCT00055640|Prednisone|prednisone|mesh-list
6349673|NCT00055640|Cyclophosphamide|cyclophosphamide|mesh-list
6349674|NCT00055640|Rituximab|rituximab|mesh-list
6349675|NCT00055640|Doxorubicin|doxorubicin|mesh-list
6349676|NCT00055640|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6349677|NCT00055640|Vincristine|vincristine|mesh-list
6349678|NCT00055640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6349679|NCT00055640|Immunologic Factors|immunologic factors|mesh-ancestor
6349680|NCT00055640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6349681|NCT00055640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6349682|NCT00055640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6349683|NCT00055640|Alkylating Agents|alkylating agents|mesh-ancestor
6349684|NCT00055640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349685|NCT00055640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349686|NCT00055640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6349687|NCT00055640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6349688|NCT00055640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6349689|NCT00055640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6349690|NCT00055640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6349691|NCT00055640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6349692|NCT00055640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6349693|NCT00055640|Glucocorticoids|glucocorticoids|mesh-ancestor
6349694|NCT00055640|Hormones|hormones|mesh-ancestor
6349695|NCT00055640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6349696|NCT00055640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6349697|NCT00055640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6349698|NCT00055640|Tubulin Modulators|tubulin modulators|mesh-ancestor
6349699|NCT00055640|Antimitotic Agents|antimitotic agents|mesh-ancestor
6349700|NCT00055640|Mitosis Modulators|mitosis modulators|mesh-ancestor
6349701|NCT00055653|Cyclosporine|cyclosporine|mesh-list
6349702|NCT00055653|Methylprednisolone|methylprednisolone|mesh-list
6349703|NCT00055653|Cyclophosphamide|cyclophosphamide|mesh-list
6349704|NCT00055653|Melphalan|melphalan|mesh-list
6349705|NCT00055653|Busulfan|busulfan|mesh-list
6349706|NCT00055653|Fludarabine|fludarabine|mesh-list
6349707|NCT00055653|Fludarabine phosphate|fludarabine phosphate|mesh-list
6349708|NCT00055653|Cyclosporins|cyclosporins|mesh-list
6349709|NCT00055653|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6349710|NCT00055653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6349711|NCT00055653|Immunologic Factors|immunologic factors|mesh-ancestor
6349712|NCT00055653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6349713|NCT00055653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6349714|NCT00055653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6349715|NCT00055653|Alkylating Agents|alkylating agents|mesh-ancestor
6349716|NCT00055653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349717|NCT00055653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349718|NCT00055653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6349719|NCT00055653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6349720|NCT00055653|Antimetabolites|antimetabolites|mesh-ancestor
6349721|NCT00055653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6349722|NCT00055653|Antifungal Agents|antifungal agents|mesh-ancestor
6349723|NCT00055653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6349724|NCT00055653|Dermatologic Agents|dermatologic agents|mesh-ancestor
6349725|NCT00055653|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6349726|NCT00055653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6349727|NCT00055653|Antiemetics|antiemetics|mesh-ancestor
6349728|NCT00055653|Autonomic Agents|autonomic agents|mesh-ancestor
6349729|NCT00055653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6349730|NCT00055653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6349731|NCT00055653|Glucocorticoids|glucocorticoids|mesh-ancestor
6349732|NCT00055653|Hormones|hormones|mesh-ancestor
6349733|NCT00055653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6349734|NCT00055653|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6349735|NCT00055653|Protective Agents|protective agents|mesh-ancestor
6349736|NCT00055666|Beclomethasone|beclomethasone|mesh-list
6349737|NCT00055666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6349738|NCT00055666|Glucocorticoids|glucocorticoids|mesh-ancestor
6349739|NCT00055666|Hormones|hormones|mesh-ancestor
6349740|NCT00055666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6349741|NCT00055666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6349742|NCT00055666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6349743|NCT00055666|Respiratory System Agents|respiratory system agents|mesh-ancestor
6349744|NCT00055679|Cyclophosphamide|cyclophosphamide|mesh-list
6349745|NCT00055679|Fluorouracil|fluorouracil|mesh-list
6016978|NCT00369122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6016979|NCT00369122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6016980|NCT00369122|Growth Substances|growth substances|mesh-ancestor
6016981|NCT00369122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016982|NCT00369122|Growth Inhibitors|growth inhibitors|mesh-ancestor
6016983|NCT00369122|Immunologic Factors|immunologic factors|mesh-ancestor
6016984|NCT00369161|Everolimus|everolimus|mesh-list
6016985|NCT00369161|Tacrolimus|tacrolimus|mesh-list
6016986|NCT00369161|Basiliximab|basiliximab|mesh-list
6016987|NCT00369161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6016988|NCT00369161|Immunologic Factors|immunologic factors|mesh-ancestor
6016989|NCT00369161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6016990|NCT00369161|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6016991|NCT00369161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6016992|NCT00369161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016993|NCT00369161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349746|NCT00055679|Epirubicin|epirubicin|mesh-list
6349747|NCT00055679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6349748|NCT00055679|Immunologic Factors|immunologic factors|mesh-ancestor
6349749|NCT00055679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6349750|NCT00055679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6349751|NCT00055679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6349752|NCT00055679|Alkylating Agents|alkylating agents|mesh-ancestor
6349753|NCT00055679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349754|NCT00055679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349755|NCT00055679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6349756|NCT00055679|Antimetabolites|antimetabolites|mesh-ancestor
6349757|NCT00055679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6349758|NCT00055679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6349759|NCT00055679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6349760|NCT00055679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6349761|NCT00055679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6349762|NCT00055718|Silymarin|silymarin|mesh-list
6349763|NCT00055718|Antioxidants|antioxidants|mesh-ancestor
6349764|NCT00055718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349765|NCT00055718|Protective Agents|protective agents|mesh-ancestor
6349766|NCT00055718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6349767|NCT00055731|Aspirin|aspirin|mesh-list
6349768|NCT00055731|Docetaxel|docetaxel|mesh-list
6349769|NCT00055731|Goserelin|goserelin|mesh-list
6349770|NCT00055731|Bicalutamide|bicalutamide|mesh-list
6349771|NCT00055731|Estramustine|estramustine|mesh-list
6349772|NCT00055731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349773|NCT00055731|Tubulin Modulators|tubulin modulators|mesh-ancestor
6349774|NCT00055731|Antimitotic Agents|antimitotic agents|mesh-ancestor
6349775|NCT00055731|Mitosis Modulators|mitosis modulators|mesh-ancestor
6349776|NCT00055731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349777|NCT00055731|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6349778|NCT00055731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6349779|NCT00055731|Analgesics|analgesics|mesh-ancestor
6349780|NCT00055731|Sensory System Agents|sensory system agents|mesh-ancestor
6349781|NCT00055731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6349782|NCT00055731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6349783|NCT00055731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6349784|NCT00055731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6349785|NCT00055731|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6016994|NCT00369226|Methotrexate|methotrexate|mesh-list
6016995|NCT00369226|Bortezomib|bortezomib|mesh-list
6349786|NCT00055731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6349787|NCT00055731|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6349788|NCT00055731|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6349789|NCT00055731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6349790|NCT00055731|Antipyretics|antipyretics|mesh-ancestor
6349791|NCT00055731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6349792|NCT00055731|Androgen Antagonists|androgen antagonists|mesh-ancestor
6349793|NCT00055731|Hormone Antagonists|hormone antagonists|mesh-ancestor
6349794|NCT00055731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6349795|NCT00055731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6349796|NCT00055731|Alkylating Agents|alkylating agents|mesh-ancestor
6349797|NCT00055757|Gemcitabine|gemcitabine|mesh-list
6349798|NCT00055757|Tipifarnib|tipifarnib|mesh-list
6349799|NCT00055757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349800|NCT00055757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6349801|NCT00055757|Antimetabolites|antimetabolites|mesh-ancestor
6349802|NCT00055757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349803|NCT00055757|Antiviral Agents|antiviral agents|mesh-ancestor
6349804|NCT00055757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6349805|NCT00055757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6349806|NCT00055757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6349807|NCT00055757|Immunologic Factors|immunologic factors|mesh-ancestor
6349808|NCT00055757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6349809|NCT00055770|Docetaxel|docetaxel|mesh-list
6349810|NCT00055770|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6349811|NCT00055770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349812|NCT00055770|Tubulin Modulators|tubulin modulators|mesh-ancestor
6349813|NCT00055770|Antimitotic Agents|antimitotic agents|mesh-ancestor
6349814|NCT00055770|Mitosis Modulators|mitosis modulators|mesh-ancestor
6349815|NCT00055770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349816|NCT00055770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6349817|NCT00055770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6349818|NCT00055809|Interferons|interferons|mesh-list
6349819|NCT00055809|Interferon-alpha|interferon-alpha|mesh-list
6349820|NCT00055809|Interferon alpha-2|interferon alpha-2|mesh-list
6349821|NCT00055809|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6349822|NCT00055809|Bevacizumab|bevacizumab|mesh-list
6349823|NCT00055809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6349824|NCT00055809|Antibodies|antibodies|mesh-list
6349825|NCT00055809|Immunoglobulins|immunoglobulins|mesh-list
6349826|NCT00055809|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6349827|NCT00055809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349828|NCT00055809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6349829|NCT00055809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6537203|NCT00821262|Anesthetics, General|anesthetics, general|mesh-ancestor
6349830|NCT00055809|Growth Substances|growth substances|mesh-ancestor
6349831|NCT00055809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6349832|NCT00055809|Growth Inhibitors|growth inhibitors|mesh-ancestor
6349833|NCT00055809|Immunologic Factors|immunologic factors|mesh-ancestor
6349834|NCT00055809|Antiviral Agents|antiviral agents|mesh-ancestor
6349835|NCT00055809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6349836|NCT00055822|Leucovorin|leucovorin|mesh-list
6349837|NCT00055822|Fluorouracil|fluorouracil|mesh-list
6349838|NCT00055822|Oxaliplatin|oxaliplatin|mesh-list
6349839|NCT00055822|Oblimersen|oblimersen|mesh-list
6349840|NCT00055822|Calcium|calcium|mesh-list
6349841|NCT00055822|Levoleucovorin|levoleucovorin|mesh-list
6349842|NCT00055822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6349843|NCT00055822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6349844|NCT00055822|Antimetabolites|antimetabolites|mesh-ancestor
6349845|NCT00055822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349846|NCT00055822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6349847|NCT00055822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349848|NCT00055822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6349849|NCT00055822|Immunologic Factors|immunologic factors|mesh-ancestor
6349850|NCT00055822|Antidotes|antidotes|mesh-ancestor
6349851|NCT00055822|Protective Agents|protective agents|mesh-ancestor
6349852|NCT00055822|Vitamin B Complex|vitamin b complex|mesh-ancestor
6349853|NCT00055822|Vitamins|vitamins|mesh-ancestor
6349854|NCT00055822|Micronutrients|micronutrients|mesh-ancestor
6349855|NCT00055835|Gemcitabine|gemcitabine|mesh-list
6349856|NCT00055835|Paclitaxel|paclitaxel|mesh-list
6349857|NCT00055835|Carboplatin|carboplatin|mesh-list
6349858|NCT00055835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6349859|NCT00055835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349860|NCT00055835|Tubulin Modulators|tubulin modulators|mesh-ancestor
6349861|NCT00055835|Antimitotic Agents|antimitotic agents|mesh-ancestor
6349862|NCT00055835|Mitosis Modulators|mitosis modulators|mesh-ancestor
6349863|NCT00055835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349864|NCT00055835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6349865|NCT00055835|Antimetabolites|antimetabolites|mesh-ancestor
6349866|NCT00055835|Antiviral Agents|antiviral agents|mesh-ancestor
6349867|NCT00055835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6349868|NCT00055835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6349869|NCT00055835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6349870|NCT00055835|Immunologic Factors|immunologic factors|mesh-ancestor
6349871|NCT00055835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6349872|NCT00055861|Bevacizumab|bevacizumab|mesh-list
6349873|NCT00055861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6349874|NCT00055861|Docetaxel|docetaxel|mesh-list
6349875|NCT00055861|Antibodies|antibodies|mesh-list
6349876|NCT00055861|Immunoglobulins|immunoglobulins|mesh-list
6349877|NCT00055861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6349878|NCT00055861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349879|NCT00055861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6349880|NCT00055861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6349881|NCT00055861|Growth Substances|growth substances|mesh-ancestor
6349882|NCT00055861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6349883|NCT00055861|Growth Inhibitors|growth inhibitors|mesh-ancestor
6349884|NCT00055861|Immunologic Factors|immunologic factors|mesh-ancestor
6349885|NCT00055861|Tubulin Modulators|tubulin modulators|mesh-ancestor
6349886|NCT00055861|Antimitotic Agents|antimitotic agents|mesh-ancestor
6349887|NCT00055861|Mitosis Modulators|mitosis modulators|mesh-ancestor
6349888|NCT00055861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349889|NCT00055874|Interferons|interferons|mesh-list
6349890|NCT00055874|Cytarabine|cytarabine|mesh-list
6349891|NCT00055874|Interferon-alpha|interferon-alpha|mesh-list
6349892|NCT00055874|Imatinib Mesylate|imatinib mesylate|mesh-list
6349893|NCT00055874|Hydroxyurea|hydroxyurea|mesh-list
6349894|NCT00055874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349895|NCT00055874|Antiviral Agents|antiviral agents|mesh-ancestor
6349896|NCT00055874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6349897|NCT00055874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6349898|NCT00055874|Antimetabolites|antimetabolites|mesh-ancestor
6349899|NCT00055874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349900|NCT00055874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6349901|NCT00055874|Immunologic Factors|immunologic factors|mesh-ancestor
6349902|NCT00055874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6349903|NCT00055874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6349904|NCT00055874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6349905|NCT00055874|Antisickling Agents|antisickling agents|mesh-ancestor
6349906|NCT00055874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6349907|NCT00055887|Gemcitabine|gemcitabine|mesh-list
6349908|NCT00055887|Paclitaxel|paclitaxel|mesh-list
6349909|NCT00055887|Vinorelbine|vinorelbine|mesh-list
6349910|NCT00055887|Carboplatin|carboplatin|mesh-list
6349911|NCT00055887|Efaproxiral|efaproxiral|mesh-list
6349912|NCT00055887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6349913|NCT00055887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349914|NCT00055887|Tubulin Modulators|tubulin modulators|mesh-ancestor
6349915|NCT00055887|Antimitotic Agents|antimitotic agents|mesh-ancestor
6349916|NCT00055887|Mitosis Modulators|mitosis modulators|mesh-ancestor
6349917|NCT00055887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349918|NCT00055887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6349919|NCT00055887|Antimetabolites|antimetabolites|mesh-ancestor
6349920|NCT00055887|Antiviral Agents|antiviral agents|mesh-ancestor
6349921|NCT00055887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6349922|NCT00055887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6349923|NCT00055887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6349924|NCT00055887|Immunologic Factors|immunologic factors|mesh-ancestor
6349925|NCT00055887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6349926|NCT00055887|Antisickling Agents|antisickling agents|mesh-ancestor
6349927|NCT00055913|Bevacizumab|bevacizumab|mesh-list
6349928|NCT00055913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6349929|NCT00055913|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6349930|NCT00055913|Antibodies|antibodies|mesh-list
6349931|NCT00055913|Immunoglobulins|immunoglobulins|mesh-list
6349932|NCT00055913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6349933|NCT00055913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349934|NCT00055913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6349935|NCT00055913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6349936|NCT00055913|Growth Substances|growth substances|mesh-ancestor
6349937|NCT00055913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6349938|NCT00055913|Growth Inhibitors|growth inhibitors|mesh-ancestor
6349939|NCT00055913|Immunologic Factors|immunologic factors|mesh-ancestor
6349940|NCT00055913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6349941|NCT00055913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6349942|NCT00055913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349943|NCT00055939|Exatecan|exatecan|mesh-list
6349944|NCT00055939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6349945|NCT00055939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6349946|NCT00055939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6349947|NCT00055939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349948|NCT00055939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349949|NCT00055952|Exatecan|exatecan|mesh-list
6349950|NCT00055952|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6349951|NCT00055952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6349952|NCT00055952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6349953|NCT00055952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349954|NCT00055952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349955|NCT00055965|Gemcitabine|gemcitabine|mesh-list
6349956|NCT00055965|Carboplatin|carboplatin|mesh-list
6349957|NCT00055965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349958|NCT00055965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6349959|NCT00055965|Antimetabolites|antimetabolites|mesh-ancestor
6349960|NCT00055965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349961|NCT00055965|Antiviral Agents|antiviral agents|mesh-ancestor
6349962|NCT00055965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6349963|NCT00055965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6349964|NCT00055965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6349965|NCT00055965|Immunologic Factors|immunologic factors|mesh-ancestor
6349966|NCT00055965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6349967|NCT00055978|Celecoxib|celecoxib|mesh-list
6349968|NCT00055978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6349969|NCT00055978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6349970|NCT00055978|Analgesics|analgesics|mesh-ancestor
6349971|NCT00055978|Sensory System Agents|sensory system agents|mesh-ancestor
6349972|NCT00055978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6349973|NCT00055978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6349974|NCT00055978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6349975|NCT00055978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6349976|NCT00055978|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6349977|NCT00055978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6349978|NCT00055978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6349979|NCT00055978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349980|NCT00055991|Bexarotene|bexarotene|mesh-list
6537204|NCT00821262|Anesthetics|anesthetics|mesh-ancestor
6349981|NCT00055991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6349982|NCT00056004|Zileuton|zileuton|mesh-list
6349983|NCT00056004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6349984|NCT00056004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6349985|NCT00056004|Analgesics|analgesics|mesh-ancestor
6349986|NCT00056004|Sensory System Agents|sensory system agents|mesh-ancestor
6349987|NCT00056004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6349988|NCT00056004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6349989|NCT00056004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6349990|NCT00056004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6349991|NCT00056004|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6349992|NCT00056004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6349993|NCT00056004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6349994|NCT00056004|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6349995|NCT00056004|Hormone Antagonists|hormone antagonists|mesh-ancestor
6349996|NCT00056004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6349997|NCT00056030|Leucovorin|leucovorin|mesh-list
6349998|NCT00056030|Fluorouracil|fluorouracil|mesh-list
6349999|NCT00056030|Oxaliplatin|oxaliplatin|mesh-list
6350000|NCT00056030|Cetuximab|cetuximab|mesh-list
6350001|NCT00056030|Calcium|calcium|mesh-list
6350002|NCT00056030|Levoleucovorin|levoleucovorin|mesh-list
6350003|NCT00056030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6350004|NCT00056030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350005|NCT00056030|Antimetabolites|antimetabolites|mesh-ancestor
6350006|NCT00056030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350007|NCT00056030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6350008|NCT00056030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350009|NCT00056030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6350010|NCT00056030|Immunologic Factors|immunologic factors|mesh-ancestor
6350011|NCT00056030|Antidotes|antidotes|mesh-ancestor
6350012|NCT00056030|Protective Agents|protective agents|mesh-ancestor
6350013|NCT00056030|Vitamin B Complex|vitamin b complex|mesh-ancestor
6350014|NCT00056030|Vitamins|vitamins|mesh-ancestor
6350015|NCT00056030|Micronutrients|micronutrients|mesh-ancestor
6350016|NCT00056030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6350017|NCT00056056|Bexarotene|bexarotene|mesh-list
6350018|NCT00056056|Methoxsalen|methoxsalen|mesh-list
6350019|NCT00056056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6016996|NCT00369226|Tacrolimus|tacrolimus|mesh-list
6350020|NCT00056056|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6350021|NCT00056056|Dermatologic Agents|dermatologic agents|mesh-ancestor
6350022|NCT00056082|Celecoxib|celecoxib|mesh-list
6350023|NCT00056082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6350024|NCT00056082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6350025|NCT00056082|Analgesics|analgesics|mesh-ancestor
6350026|NCT00056082|Sensory System Agents|sensory system agents|mesh-ancestor
6350027|NCT00056082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6350028|NCT00056082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350029|NCT00056082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6350030|NCT00056082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6350031|NCT00056082|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6350032|NCT00056082|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6350033|NCT00056082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6350034|NCT00056082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350035|NCT00056095|Cyclosporine|cyclosporine|mesh-list
6350036|NCT00056095|Cyclophosphamide|cyclophosphamide|mesh-list
6350037|NCT00056095|Fludarabine|fludarabine|mesh-list
6350038|NCT00056095|Fludarabine phosphate|fludarabine phosphate|mesh-list
6350039|NCT00056095|Cyclosporins|cyclosporins|mesh-list
6350040|NCT00056095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6350041|NCT00056095|Immunologic Factors|immunologic factors|mesh-ancestor
6350042|NCT00056095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350043|NCT00056095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6350044|NCT00056095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6350045|NCT00056095|Alkylating Agents|alkylating agents|mesh-ancestor
6350046|NCT00056095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350047|NCT00056095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350048|NCT00056095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6350049|NCT00056095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6350050|NCT00056095|Antimetabolites|antimetabolites|mesh-ancestor
6350051|NCT00056095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6350052|NCT00056095|Antifungal Agents|antifungal agents|mesh-ancestor
6350053|NCT00056095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6350054|NCT00056095|Dermatologic Agents|dermatologic agents|mesh-ancestor
6350055|NCT00056095|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6350056|NCT00056225|Vitamins|vitamins|mesh-list
6350057|NCT00056225|Vitamin B 12|vitamin b 12|mesh-list
6350058|NCT00056225|Hydroxocobalamin|hydroxocobalamin|mesh-list
6350059|NCT00056225|Vitamin B 6|vitamin b 6|mesh-list
6350060|NCT00056225|Pyridoxal|pyridoxal|mesh-list
6350061|NCT00056225|Pyridoxine|pyridoxine|mesh-list
6350062|NCT00056225|Vitamin B Complex|vitamin b complex|mesh-list
6350063|NCT00056225|Micronutrients|micronutrients|mesh-ancestor
6350064|NCT00056225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350065|NCT00056225|Hematinics|hematinics|mesh-ancestor
6350066|NCT00056264|Infliximab|infliximab|mesh-list
6350067|NCT00056264|Dermatologic Agents|dermatologic agents|mesh-ancestor
6350068|NCT00056264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6350069|NCT00056264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6350070|NCT00056277|Lamotrigine|lamotrigine|mesh-list
6350071|NCT00056277|Anticonvulsants|anticonvulsants|mesh-ancestor
6350072|NCT00056277|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6350073|NCT00056277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6350074|NCT00056277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350075|NCT00056277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6350076|NCT00056277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350077|NCT00056277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6350078|NCT00056277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6350079|NCT00056277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6350080|NCT00056277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6350081|NCT00056277|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6350082|NCT00056329|Vitamin E|vitamin e|mesh-list
6350083|NCT00056329|Tocopherols|tocopherols|mesh-list
6350084|NCT00056329|Vitamins|vitamins|mesh-ancestor
6350085|NCT00056329|Micronutrients|micronutrients|mesh-ancestor
6350086|NCT00056329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350087|NCT00056329|Antioxidants|antioxidants|mesh-ancestor
6350088|NCT00056329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350089|NCT00056329|Protective Agents|protective agents|mesh-ancestor
6350090|NCT00056368|Fluconazole|fluconazole|mesh-list
6350091|NCT00056368|Anidulafungin|anidulafungin|mesh-list
6350092|NCT00056368|Antifungal Agents|antifungal agents|mesh-ancestor
6350093|NCT00056368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6350094|NCT00056368|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6350095|NCT00056368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6350096|NCT00056368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6350097|NCT00056368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350098|NCT00056368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6350099|NCT00056368|Hormone Antagonists|hormone antagonists|mesh-ancestor
6350100|NCT00056368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6350101|NCT00056368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350102|NCT00056368|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6350103|NCT00056368|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6350104|NCT00056381|Anidulafungin|anidulafungin|mesh-list
6350105|NCT00056381|Antifungal Agents|antifungal agents|mesh-ancestor
6350106|NCT00056381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6350107|NCT00056433|Hydroxyurea|hydroxyurea|mesh-list
6350108|NCT00056433|Sildenafil Citrate|sildenafil citrate|mesh-list
6350109|NCT00056433|Vasodilator Agents|vasodilator agents|mesh-ancestor
6350110|NCT00056433|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6350111|NCT00056433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6350112|NCT00056433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6350113|NCT00056433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350114|NCT00056433|Urological Agents|urological agents|mesh-ancestor
6350115|NCT00056433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350116|NCT00056433|Antisickling Agents|antisickling agents|mesh-ancestor
6350117|NCT00056433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6350118|NCT00056446|Vatalanib|vatalanib|mesh-list
6350119|NCT00056446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6350120|NCT00056446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6350121|NCT00056446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350122|NCT00056459|Vatalanib|vatalanib|mesh-list
6350123|NCT00056459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6350124|NCT00056459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6350125|NCT00056459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394216|NCT00201539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394217|NCT00201539|Analgesics|analgesics|mesh-ancestor
6394218|NCT00201539|Sensory System Agents|sensory system agents|mesh-ancestor
6394219|NCT00201539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6394220|NCT00201630|Alfuzosin|alfuzosin|mesh-list
6394221|NCT00201630|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6394222|NCT00201630|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6394223|NCT00201630|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6394224|NCT00201630|Adrenergic Agents|adrenergic agents|mesh-ancestor
6394225|NCT00201630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6394226|NCT00201630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394227|NCT00201630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394228|NCT00201630|Urological Agents|urological agents|mesh-ancestor
6394229|NCT00201669|Clofarabine|clofarabine|mesh-list
6394230|NCT00201669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6394231|NCT00201669|Antimetabolites|antimetabolites|mesh-ancestor
6394232|NCT00201669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394233|NCT00201669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6394234|NCT00201682|Etanercept|etanercept|mesh-list
6394235|NCT00201682|Rituximab|rituximab|mesh-list
6394236|NCT00201682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6394237|NCT00201682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6394238|NCT00201682|Immunologic Factors|immunologic factors|mesh-ancestor
6394239|NCT00201682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394240|NCT00201682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6394241|NCT00201682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6394242|NCT00201682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6394243|NCT00201682|Analgesics|analgesics|mesh-ancestor
6394244|NCT00201682|Sensory System Agents|sensory system agents|mesh-ancestor
6394245|NCT00201682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6394246|NCT00201682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6394247|NCT00201682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6350126|NCT00056576|Zonisamide|zonisamide|mesh-list
6350127|NCT00056576|Anticonvulsants|anticonvulsants|mesh-ancestor
6350128|NCT00056576|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6350129|NCT00056576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6350130|NCT00056576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350131|NCT00056576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6350132|NCT00056576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350133|NCT00056641|Ritonavir|ritonavir|mesh-list
6350134|NCT00056641|Lopinavir|lopinavir|mesh-list
6350135|NCT00056641|Saquinavir|saquinavir|mesh-list
6350136|NCT00056641|Amprenavir|amprenavir|mesh-list
6350137|NCT00056641|Tipranavir|tipranavir|mesh-list
6350138|NCT00056641|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6350139|NCT00056641|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6350140|NCT00056641|Protease Inhibitors|protease inhibitors|mesh-ancestor
6350141|NCT00056641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6350142|NCT00056641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350143|NCT00056641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6350144|NCT00056641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6350145|NCT00056641|Antiviral Agents|antiviral agents|mesh-ancestor
6350146|NCT00056641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6350147|NCT00056641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6350148|NCT00056641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6350149|NCT00056641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6350150|NCT00056641|Antitubercular Agents|antitubercular agents|mesh-ancestor
6350151|NCT00056641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6350152|NCT00056654|Leuprolide|leuprolide|mesh-list
6350153|NCT00056654|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6350154|NCT00056654|Fertility Agents|fertility agents|mesh-ancestor
6350155|NCT00056654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6350156|NCT00056654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350157|NCT00056654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6350158|NCT00056654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350159|NCT00056693|Sunitinib|sunitinib|mesh-list
6350160|NCT00056693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350161|NCT00056693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6350162|NCT00056693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6350163|NCT00056693|Growth Substances|growth substances|mesh-ancestor
6350164|NCT00056693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350165|NCT00056693|Growth Inhibitors|growth inhibitors|mesh-ancestor
6350166|NCT00056693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6350167|NCT00056693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6350168|NCT00056693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350169|NCT00056758|Vaccines|vaccines|mesh-list
6350170|NCT00056758|Immunologic Factors|immunologic factors|mesh-ancestor
6350171|NCT00056758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350172|NCT00056797|Interleukin-2|interleukin-2|mesh-list
6350173|NCT00056797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350174|NCT00056797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6350175|NCT00056797|Analgesics|analgesics|mesh-ancestor
6350176|NCT00056797|Sensory System Agents|sensory system agents|mesh-ancestor
6350177|NCT00056797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6350178|NCT00056797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350179|NCT00056810|4-Aminopyridine|4-aminopyridine|mesh-list
6350180|NCT00056810|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6350181|NCT00056810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6350182|NCT00056810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350183|NCT00056823|Ranibizumab|ranibizumab|mesh-list
6350184|NCT00056823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6350185|NCT00056823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6350186|NCT00056823|Growth Substances|growth substances|mesh-ancestor
6350187|NCT00056823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350188|NCT00056823|Growth Inhibitors|growth inhibitors|mesh-ancestor
6350189|NCT00056823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350190|NCT00056836|Ranibizumab|ranibizumab|mesh-list
6350191|NCT00056836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6350192|NCT00056836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6350193|NCT00056836|Growth Substances|growth substances|mesh-ancestor
6350194|NCT00056836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350195|NCT00056836|Growth Inhibitors|growth inhibitors|mesh-ancestor
6350196|NCT00056836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350197|NCT00056875|Mitogens|mitogens|mesh-list
6350198|NCT00056875|Mitosis Modulators|mitosis modulators|mesh-ancestor
6350199|NCT00056875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350200|NCT00056966|Fludarabine|fludarabine|mesh-list
6350201|NCT00056966|Alemtuzumab|alemtuzumab|mesh-list
6350202|NCT00056966|Tacrolimus|tacrolimus|mesh-list
6350203|NCT00056966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350204|NCT00056966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350205|NCT00056966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6350206|NCT00056966|Immunologic Factors|immunologic factors|mesh-ancestor
6350207|NCT00056966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350208|NCT00056966|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6350209|NCT00056966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6350210|NCT00056966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6350211|NCT00056979|Fludarabine|fludarabine|mesh-list
6350212|NCT00056979|Alemtuzumab|alemtuzumab|mesh-list
6350213|NCT00056979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350214|NCT00056979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6350215|NCT00057005|Cyclophosphamide|cyclophosphamide|mesh-list
6350216|NCT00057005|Alemtuzumab|alemtuzumab|mesh-list
6350217|NCT00057005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6350218|NCT00057005|Immunologic Factors|immunologic factors|mesh-ancestor
6350219|NCT00057005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350220|NCT00057005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6350221|NCT00057005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6350222|NCT00057005|Alkylating Agents|alkylating agents|mesh-ancestor
6350223|NCT00057005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350224|NCT00057005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350225|NCT00057005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6350226|NCT00057005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6350227|NCT00057031|Calcitriol|calcitriol|mesh-list
6350228|NCT00057031|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6350229|NCT00057031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350230|NCT00057031|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6350231|NCT00057031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6350232|NCT00057031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350233|NCT00057031|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6350234|NCT00057031|Vitamins|vitamins|mesh-ancestor
6350235|NCT00057031|Micronutrients|micronutrients|mesh-ancestor
6350236|NCT00057031|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6350237|NCT00057122|Rifampin|rifampin|mesh-list
6350238|NCT00057122|Rifapentine|rifapentine|mesh-list
6350239|NCT00057122|Isoniazid|isoniazid|mesh-list
6350240|NCT00057122|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6350241|NCT00057122|Antitubercular Agents|antitubercular agents|mesh-ancestor
6350242|NCT00057122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6350243|NCT00057122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6350244|NCT00057122|Leprostatic Agents|leprostatic agents|mesh-ancestor
6350245|NCT00057122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6350246|NCT00057122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6350247|NCT00057122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350248|NCT00057122|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6350249|NCT00057122|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6350250|NCT00057122|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6350251|NCT00057122|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6350252|NCT00057122|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6350253|NCT00057122|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6350254|NCT00057122|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6350255|NCT00057122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6350256|NCT00057122|Antimetabolites|antimetabolites|mesh-ancestor
6350257|NCT00057122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6350258|NCT00057265|Lamivudine|lamivudine|mesh-list
6350259|NCT00057265|Telbivudine|telbivudine|mesh-list
6350260|NCT00057265|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6350261|NCT00057265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6350262|NCT00057265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6350263|NCT00057265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350264|NCT00057265|Antiviral Agents|antiviral agents|mesh-ancestor
6350265|NCT00057265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6350266|NCT00057265|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6350267|NCT00057265|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6350268|NCT00057278|Gabapentin|gabapentin|mesh-list
6350269|NCT00057278|Analgesics|analgesics|mesh-ancestor
6350270|NCT00057278|Sensory System Agents|sensory system agents|mesh-ancestor
6350271|NCT00057278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6350272|NCT00057278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350273|NCT00057278|Anticonvulsants|anticonvulsants|mesh-ancestor
6350274|NCT00057278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6350275|NCT00057278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6350276|NCT00057278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6350277|NCT00057278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6350278|NCT00057278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6350279|NCT00057278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6350280|NCT00057278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6350281|NCT00057278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350282|NCT00057278|Antimanic Agents|antimanic agents|mesh-ancestor
6350283|NCT00057304|Insulin|insulin|mesh-list
6350284|NCT00057304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6350285|NCT00057304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350286|NCT00057343|Rituximab|rituximab|mesh-list
6350287|NCT00057343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6350288|NCT00057343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350289|NCT00057343|Immunologic Factors|immunologic factors|mesh-ancestor
6350290|NCT00057343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350291|NCT00057343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6350292|NCT00057356|Conivaptan|conivaptan|mesh-list
6350293|NCT00057356|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6350294|NCT00057356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350295|NCT00057356|Natriuretic Agents|natriuretic agents|mesh-ancestor
6350296|NCT00057356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350297|NCT00057369|Dalbavancin|dalbavancin|mesh-list
6350298|NCT00057369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6350299|NCT00057369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6350300|NCT00057382|Doxorubicin|doxorubicin|mesh-list
6350301|NCT00057382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6350302|NCT00057382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350303|NCT00057382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6350304|NCT00057382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6350305|NCT00057382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6350306|NCT00057382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350307|NCT00057395|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II)|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii)|mesh-list
6350308|NCT00057395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350309|NCT00057408|Olanzapine|olanzapine|mesh-list
6350310|NCT00057408|Antipsychotic Agents|antipsychotic agents|mesh-list
6350311|NCT00057408|Antiemetics|antiemetics|mesh-ancestor
6350312|NCT00057408|Autonomic Agents|autonomic agents|mesh-ancestor
6350313|NCT00057408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6350314|NCT00057408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350315|NCT00057408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6350316|NCT00057408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6350317|NCT00057408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6350318|NCT00057408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6350319|NCT00057408|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6350320|NCT00057408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6350321|NCT00057408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6350322|NCT00057408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350323|NCT00057408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6350324|NCT00057408|Serotonin Agents|serotonin agents|mesh-ancestor
6350325|NCT00057421|Prednisolone|prednisolone|mesh-list
6350326|NCT00057421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6350327|NCT00057421|Glucocorticoids|glucocorticoids|mesh-ancestor
6350328|NCT00057421|Hormones|hormones|mesh-ancestor
6350329|NCT00057421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6350330|NCT00057421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350331|NCT00057421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6350332|NCT00057421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350333|NCT00057447|Interferons|interferons|mesh-list
6350334|NCT00057447|Interferon-gamma|interferon-gamma|mesh-list
6350335|NCT00057447|Rituximab|rituximab|mesh-list
6350336|NCT00057447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6350337|NCT00057447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350338|NCT00057447|Immunologic Factors|immunologic factors|mesh-ancestor
6350339|NCT00057447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350340|NCT00057447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6350341|NCT00057447|Antiviral Agents|antiviral agents|mesh-ancestor
6350342|NCT00057447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6350343|NCT00057512|Masoprocol|masoprocol|mesh-list
6350344|NCT00057512|Antioxidants|antioxidants|mesh-ancestor
6350345|NCT00057512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350346|NCT00057512|Protective Agents|protective agents|mesh-ancestor
6350347|NCT00057512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350348|NCT00057512|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6350349|NCT00057512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6350350|NCT00057512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6350351|NCT00057512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6350352|NCT00057512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6350353|NCT00057512|Analgesics|analgesics|mesh-ancestor
6350354|NCT00057512|Sensory System Agents|sensory system agents|mesh-ancestor
6350355|NCT00057512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6350356|NCT00057512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6350357|NCT00057512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6350358|NCT00057564|Thalidomide|thalidomide|mesh-list
6350359|NCT00057564|Dexamethasone|dexamethasone|mesh-list
6350360|NCT00057564|Dexamethasone acetate|dexamethasone acetate|mesh-list
6350361|NCT00057564|BB 1101|bb 1101|mesh-list
6350362|NCT00057564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6350363|NCT00057564|Antiemetics|antiemetics|mesh-ancestor
6350364|NCT00057564|Autonomic Agents|autonomic agents|mesh-ancestor
6350365|NCT00057564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6350366|NCT00057564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350367|NCT00057564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6350368|NCT00057564|Glucocorticoids|glucocorticoids|mesh-ancestor
6350369|NCT00057564|Hormones|hormones|mesh-ancestor
6350370|NCT00057564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6350371|NCT00057564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6350372|NCT00057564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350373|NCT00057564|Protease Inhibitors|protease inhibitors|mesh-ancestor
6350374|NCT00057564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6350375|NCT00057564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350376|NCT00057564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6350377|NCT00057564|Immunologic Factors|immunologic factors|mesh-ancestor
6350378|NCT00057564|Leprostatic Agents|leprostatic agents|mesh-ancestor
6350379|NCT00057564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6350380|NCT00057564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6350381|NCT00057564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6350382|NCT00057564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6350383|NCT00057564|Growth Substances|growth substances|mesh-ancestor
6350384|NCT00057564|Growth Inhibitors|growth inhibitors|mesh-ancestor
6350385|NCT00057616|Lenalidomide|lenalidomide|mesh-list
6350386|NCT00057616|Immunologic Factors|immunologic factors|mesh-ancestor
6350387|NCT00057616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350388|NCT00057616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6350389|NCT00057616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6350390|NCT00057616|Growth Substances|growth substances|mesh-ancestor
6350391|NCT00057616|Growth Inhibitors|growth inhibitors|mesh-ancestor
6350392|NCT00057616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350393|NCT00057642|Sertraline|sertraline|mesh-list
6350394|NCT00057642|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6350395|NCT00057642|Antidepressive Agents|antidepressive agents|mesh-ancestor
6350396|NCT00057642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6350397|NCT00057642|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6350398|NCT00057642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6350399|NCT00057642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6350400|NCT00057642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350401|NCT00057642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6350402|NCT00057642|Serotonin Agents|serotonin agents|mesh-ancestor
6350403|NCT00057642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350404|NCT00057642|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6350405|NCT00057642|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6350406|NCT00057707|Modafinil|modafinil|mesh-list
6350407|NCT00057707|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6350408|NCT00057707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350409|NCT00057707|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6350410|NCT00057707|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6350411|NCT00057707|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6350412|NCT00057707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350413|NCT00057720|Doxorubicin|doxorubicin|mesh-list
6350414|NCT00057720|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6350415|NCT00057720|Topotecan|topotecan|mesh-list
6350416|NCT00057720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6350417|NCT00057720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350418|NCT00057720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6350419|NCT00057720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6350420|NCT00057720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6350421|NCT00057720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350422|NCT00057720|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6350423|NCT00057759|Sildenafil Citrate|sildenafil citrate|mesh-list
6350424|NCT00057759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350425|NCT00057759|Vasodilator Agents|vasodilator agents|mesh-ancestor
6350426|NCT00057759|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6350427|NCT00057759|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6350428|NCT00057759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6350429|NCT00057759|Urological Agents|urological agents|mesh-ancestor
6350430|NCT00057798|Gemcitabine|gemcitabine|mesh-list
6350431|NCT00057798|Vinorelbine|vinorelbine|mesh-list
6350432|NCT00057798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6350433|NCT00057798|Antimetabolites|antimetabolites|mesh-ancestor
6350434|NCT00057798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350435|NCT00057798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350436|NCT00057798|Antiviral Agents|antiviral agents|mesh-ancestor
6350437|NCT00057798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6350438|NCT00057798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6350439|NCT00057798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6350440|NCT00057798|Immunologic Factors|immunologic factors|mesh-ancestor
6350441|NCT00057798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350442|NCT00057798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6350443|NCT00057798|Tubulin Modulators|tubulin modulators|mesh-ancestor
6350444|NCT00057798|Antimitotic Agents|antimitotic agents|mesh-ancestor
6350445|NCT00057798|Mitosis Modulators|mitosis modulators|mesh-ancestor
6350446|NCT00057850|Cisplatin|cisplatin|mesh-list
6350447|NCT00057850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350448|NCT00057889|Ipilimumab|ipilimumab|mesh-list
6350449|NCT00057889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6350450|NCT00057889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350451|NCT00057889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6350452|NCT00057889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350453|NCT00057928|Gemcitabine|gemcitabine|mesh-list
6350454|NCT00057928|Paclitaxel|paclitaxel|mesh-list
6350455|NCT00057928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6350456|NCT00057928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350457|NCT00057928|Tubulin Modulators|tubulin modulators|mesh-ancestor
6350458|NCT00057928|Antimitotic Agents|antimitotic agents|mesh-ancestor
6350459|NCT00057928|Mitosis Modulators|mitosis modulators|mesh-ancestor
6350460|NCT00057928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350461|NCT00057928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6350462|NCT00057928|Antimetabolites|antimetabolites|mesh-ancestor
6350463|NCT00057928|Antiviral Agents|antiviral agents|mesh-ancestor
6350464|NCT00057928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6350465|NCT00057928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6350466|NCT00057928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6350467|NCT00057928|Immunologic Factors|immunologic factors|mesh-ancestor
6350468|NCT00057928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350469|NCT00057967|Alemtuzumab|alemtuzumab|mesh-list
6350470|NCT00057967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6350471|NCT00057967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350472|NCT00058006|Celecoxib|celecoxib|mesh-list
6350473|NCT00058006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6350474|NCT00058006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6350475|NCT00058006|Analgesics|analgesics|mesh-ancestor
6350476|NCT00058006|Sensory System Agents|sensory system agents|mesh-ancestor
6350477|NCT00058006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6350478|NCT00058006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350479|NCT00058006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6350480|NCT00058006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6350481|NCT00058006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6350482|NCT00058006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6350483|NCT00058006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6350484|NCT00058006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350485|NCT00058045|Aldesleukin|aldesleukin|mesh-list
6350486|NCT00058045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350487|NCT00058045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6350488|NCT00058045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6350489|NCT00058045|Antiviral Agents|antiviral agents|mesh-ancestor
6350490|NCT00058045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6350491|NCT00058071|Amifostine|amifostine|mesh-list
6350492|NCT00058071|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6350493|NCT00058071|Protective Agents|protective agents|mesh-ancestor
6350494|NCT00058071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350495|NCT00058084|Prednisone|prednisone|mesh-list
6350496|NCT00058084|Mitoxantrone|mitoxantrone|mesh-list
6350497|NCT00058084|Epothilone B|epothilone b|mesh-list
6350498|NCT00058084|Epothilones|epothilones|mesh-list
6350499|NCT00058084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6350500|NCT00058084|Glucocorticoids|glucocorticoids|mesh-ancestor
6350501|NCT00058084|Hormones|hormones|mesh-ancestor
6350502|NCT00058084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6350503|NCT00058084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350504|NCT00058084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6350505|NCT00058084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350506|NCT00058084|Analgesics|analgesics|mesh-ancestor
6350507|NCT00058084|Sensory System Agents|sensory system agents|mesh-ancestor
6350508|NCT00058084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6350509|NCT00058084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6350510|NCT00058084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6350511|NCT00058084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6350512|NCT00058084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350513|NCT00058084|Tubulin Modulators|tubulin modulators|mesh-ancestor
6350514|NCT00058084|Antimitotic Agents|antimitotic agents|mesh-ancestor
6350515|NCT00058084|Mitosis Modulators|mitosis modulators|mesh-ancestor
6350516|NCT00058097|Tipifarnib|tipifarnib|mesh-list
6350517|NCT00058097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350518|NCT00058149|Gemcitabine|gemcitabine|mesh-list
6350519|NCT00058149|Oxaliplatin|oxaliplatin|mesh-list
6350520|NCT00058149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6350521|NCT00058149|Antimetabolites|antimetabolites|mesh-ancestor
6350522|NCT00058149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350523|NCT00058149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350524|NCT00058149|Antiviral Agents|antiviral agents|mesh-ancestor
6350525|NCT00058149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6350526|NCT00058149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6350527|NCT00058149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6350528|NCT00058149|Immunologic Factors|immunologic factors|mesh-ancestor
6350529|NCT00058149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350530|NCT00058201|Leucovorin|leucovorin|mesh-list
6350531|NCT00058201|Gemcitabine|gemcitabine|mesh-list
6350532|NCT00058201|Fluorouracil|fluorouracil|mesh-list
6350533|NCT00058201|Calcium|calcium|mesh-list
6350534|NCT00058201|Levoleucovorin|levoleucovorin|mesh-list
6350535|NCT00058201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6350536|NCT00058201|Antimetabolites|antimetabolites|mesh-ancestor
6350537|NCT00058201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6016997|NCT00369226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6016998|NCT00369226|Abortifacient Agents|abortifacient agents|mesh-ancestor
6016999|NCT00369226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6350538|NCT00058201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350539|NCT00058201|Antiviral Agents|antiviral agents|mesh-ancestor
6350540|NCT00058201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6350541|NCT00058201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6350542|NCT00058201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6350543|NCT00058201|Immunologic Factors|immunologic factors|mesh-ancestor
6350544|NCT00058201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350545|NCT00058201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6350546|NCT00058201|Antidotes|antidotes|mesh-ancestor
6350547|NCT00058201|Protective Agents|protective agents|mesh-ancestor
6350548|NCT00058201|Vitamin B Complex|vitamin b complex|mesh-ancestor
6350549|NCT00058201|Vitamins|vitamins|mesh-ancestor
6350550|NCT00058201|Micronutrients|micronutrients|mesh-ancestor
6350551|NCT00058227|Rituximab|rituximab|mesh-list
6350552|NCT00058227|Fludarabine|fludarabine|mesh-list
6350553|NCT00058227|Fludarabine phosphate|fludarabine phosphate|mesh-list
6350554|NCT00058227|Alvocidib|alvocidib|mesh-list
6350555|NCT00058227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6350556|NCT00058227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350557|NCT00058227|Immunologic Factors|immunologic factors|mesh-ancestor
6350558|NCT00058227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350559|NCT00058227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6350560|NCT00058227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6350561|NCT00058227|Antimetabolites|antimetabolites|mesh-ancestor
6350562|NCT00058227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350563|NCT00058227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6350564|NCT00058227|Growth Inhibitors|growth inhibitors|mesh-ancestor
6350565|NCT00058227|Growth Substances|growth substances|mesh-ancestor
6350566|NCT00058227|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6350567|NCT00058227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6350568|NCT00058253|Docetaxel|docetaxel|mesh-list
6350569|NCT00058253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350570|NCT00058253|Tubulin Modulators|tubulin modulators|mesh-ancestor
6350571|NCT00058253|Antimitotic Agents|antimitotic agents|mesh-ancestor
6350572|NCT00058253|Mitosis Modulators|mitosis modulators|mesh-ancestor
6350573|NCT00058253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350574|NCT00058279|Aldesleukin|aldesleukin|mesh-list
6350575|NCT00058279|Ipilimumab|ipilimumab|mesh-list
6350576|NCT00058279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6350577|NCT00058279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350578|NCT00058279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6350579|NCT00058279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350580|NCT00058279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6350581|NCT00058279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6350582|NCT00058279|Antiviral Agents|antiviral agents|mesh-ancestor
6350583|NCT00058279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6350584|NCT00058292|Cytarabine|cytarabine|mesh-list
6350585|NCT00058292|Rituximab|rituximab|mesh-list
6350586|NCT00058292|Etoposide|etoposide|mesh-list
6350587|NCT00058292|Etoposide phosphate|etoposide phosphate|mesh-list
6350588|NCT00058292|Melphalan|melphalan|mesh-list
6350589|NCT00058292|Carmustine|carmustine|mesh-list
6350590|NCT00058292|Lenograstim|lenograstim|mesh-list
6350591|NCT00058292|Sargramostim|sargramostim|mesh-list
6350592|NCT00058292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6350593|NCT00058292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350594|NCT00058292|Immunologic Factors|immunologic factors|mesh-ancestor
6350595|NCT00058292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350596|NCT00058292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6350597|NCT00058292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6350598|NCT00058292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6350599|NCT00058292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6350600|NCT00058292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6350601|NCT00058292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350602|NCT00058292|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6350603|NCT00058292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6350604|NCT00058292|Antimetabolites|antimetabolites|mesh-ancestor
6350605|NCT00058292|Antiviral Agents|antiviral agents|mesh-ancestor
6350606|NCT00058292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6350607|NCT00058292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6350608|NCT00058292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6350609|NCT00058292|Alkylating Agents|alkylating agents|mesh-ancestor
6350610|NCT00058292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6394248|NCT00201682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6394249|NCT00201695|Dexamethasone|dexamethasone|mesh-list
6394250|NCT00201695|Doxorubicin|doxorubicin|mesh-list
6394251|NCT00201695|Vincristine|vincristine|mesh-list
6394252|NCT00201695|Arsenic Trioxide|arsenic trioxide|mesh-list
6394253|NCT00201695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6394254|NCT00201695|Antiemetics|antiemetics|mesh-ancestor
6394255|NCT00201695|Autonomic Agents|autonomic agents|mesh-ancestor
6394256|NCT00201695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6394257|NCT00201695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394258|NCT00201695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6394259|NCT00201695|Glucocorticoids|glucocorticoids|mesh-ancestor
6394260|NCT00201695|Hormones|hormones|mesh-ancestor
6394261|NCT00201695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6394262|NCT00201695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6394263|NCT00201695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6394264|NCT00201695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6394265|NCT00201695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6394266|NCT00201695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6394267|NCT00201695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6394268|NCT00201695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394269|NCT00201695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6394270|NCT00201695|Tubulin Modulators|tubulin modulators|mesh-ancestor
6394271|NCT00201695|Antimitotic Agents|antimitotic agents|mesh-ancestor
6394272|NCT00201695|Mitosis Modulators|mitosis modulators|mesh-ancestor
6394273|NCT00201708|Cyclophosphamide|cyclophosphamide|mesh-list
6394274|NCT00201708|Docetaxel|docetaxel|mesh-list
6394275|NCT00201708|Doxorubicin|doxorubicin|mesh-list
6394276|NCT00201708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6394277|NCT00201708|Immunologic Factors|immunologic factors|mesh-ancestor
6394278|NCT00201708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394279|NCT00201708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6394280|NCT00201708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6394281|NCT00201708|Alkylating Agents|alkylating agents|mesh-ancestor
6394282|NCT00201708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394283|NCT00201708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6394284|NCT00201708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6394285|NCT00201708|Tubulin Modulators|tubulin modulators|mesh-ancestor
6394286|NCT00201708|Antimitotic Agents|antimitotic agents|mesh-ancestor
6394287|NCT00201708|Mitosis Modulators|mitosis modulators|mesh-ancestor
6394288|NCT00201708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6394289|NCT00201708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6394290|NCT00201708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6394291|NCT00201708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6394292|NCT00201721|Cyclophosphamide|cyclophosphamide|mesh-list
6394293|NCT00201721|Rituximab|rituximab|mesh-list
6394294|NCT00201721|Pentostatin|pentostatin|mesh-list
6394295|NCT00201721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6394296|NCT00201721|Immunologic Factors|immunologic factors|mesh-ancestor
6394297|NCT00201721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394298|NCT00201721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6394299|NCT00201721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6394300|NCT00201721|Alkylating Agents|alkylating agents|mesh-ancestor
6394301|NCT00201721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394302|NCT00201721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6394303|NCT00201721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6394304|NCT00201721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6394305|NCT00201721|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
6394306|NCT00201721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6394307|NCT00201747|Mitomycins|mitomycins|mesh-list
6394308|NCT00201747|Mitomycin|mitomycin|mesh-list
6394309|NCT00201747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6394310|NCT00201747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6394311|NCT00201747|Alkylating Agents|alkylating agents|mesh-ancestor
6394312|NCT00201747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394313|NCT00201747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6394314|NCT00201747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6394315|NCT00201786|Pentostatin|pentostatin|mesh-list
6394316|NCT00201786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350611|NCT00058305|Vincristine|vincristine|mesh-list
6350612|NCT00058305|Bryostatin 1|bryostatin 1|mesh-list
6350613|NCT00058305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6350614|NCT00058305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350615|NCT00058305|Tubulin Modulators|tubulin modulators|mesh-ancestor
6350616|NCT00058305|Antimitotic Agents|antimitotic agents|mesh-ancestor
6350617|NCT00058305|Mitosis Modulators|mitosis modulators|mesh-ancestor
6350618|NCT00058305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350619|NCT00058305|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6350620|NCT00058305|Immunologic Factors|immunologic factors|mesh-ancestor
6350621|NCT00058305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350622|NCT00058318|Gemcitabine|gemcitabine|mesh-list
6350623|NCT00058318|Capecitabine|capecitabine|mesh-list
6350624|NCT00058318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6350625|NCT00058318|Antimetabolites|antimetabolites|mesh-ancestor
6350626|NCT00058318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350627|NCT00058318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350628|NCT00058318|Antiviral Agents|antiviral agents|mesh-ancestor
6350629|NCT00058318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6350630|NCT00058318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6350631|NCT00058318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6350632|NCT00058318|Immunologic Factors|immunologic factors|mesh-ancestor
6350633|NCT00058318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350634|NCT00058331|Epoetin Alfa|epoetin alfa|mesh-list
6350635|NCT00058331|Hematinics|hematinics|mesh-ancestor
6350636|NCT00058357|Lidocaine|lidocaine|mesh-list
6350637|NCT00058357|Anesthetics, Local|anesthetics, local|mesh-ancestor
6350638|NCT00058357|Anesthetics|anesthetics|mesh-ancestor
6350639|NCT00058357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6350640|NCT00058357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350641|NCT00058357|Sensory System Agents|sensory system agents|mesh-ancestor
6350642|NCT00058357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6350643|NCT00058357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6350644|NCT00058357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6350645|NCT00058357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6350646|NCT00058357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6350647|NCT00058357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350648|NCT00058435|Abagovomab|abagovomab|mesh-list
6350649|NCT00058435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6350650|NCT00058435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350651|NCT00058448|Docetaxel|docetaxel|mesh-list
6350652|NCT00058448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350653|NCT00058448|Tubulin Modulators|tubulin modulators|mesh-ancestor
6350654|NCT00058448|Antimitotic Agents|antimitotic agents|mesh-ancestor
6350655|NCT00058448|Mitosis Modulators|mitosis modulators|mesh-ancestor
6350656|NCT00058448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350657|NCT00058461|Cytarabine|cytarabine|mesh-list
6350658|NCT00058461|Rituximab|rituximab|mesh-list
6350659|NCT00058461|Carboplatin|carboplatin|mesh-list
6350660|NCT00058461|Methotrexate|methotrexate|mesh-list
6350661|NCT00058461|Etoposide|etoposide|mesh-list
6350662|NCT00058461|Ifosfamide|ifosfamide|mesh-list
6350663|NCT00058461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6350664|NCT00058461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350665|NCT00058461|Immunologic Factors|immunologic factors|mesh-ancestor
6350666|NCT00058461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350667|NCT00058461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6350668|NCT00058461|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6350669|NCT00058461|Abortifacient Agents|abortifacient agents|mesh-ancestor
6350670|NCT00058461|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6350671|NCT00058461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6350672|NCT00058461|Antimetabolites|antimetabolites|mesh-ancestor
6350673|NCT00058461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350674|NCT00058461|Dermatologic Agents|dermatologic agents|mesh-ancestor
6350675|NCT00058461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6350676|NCT00058461|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6350677|NCT00058461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6350678|NCT00058461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6350679|NCT00058461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6350680|NCT00058461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6350681|NCT00058461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6350682|NCT00058461|Antiviral Agents|antiviral agents|mesh-ancestor
6350683|NCT00058461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6350684|NCT00058461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6350685|NCT00058461|Alkylating Agents|alkylating agents|mesh-ancestor
6350686|NCT00058474|Fluorouracil|fluorouracil|mesh-list
6350687|NCT00058474|Capecitabine|capecitabine|mesh-list
6350688|NCT00058474|Oxaliplatin|oxaliplatin|mesh-list
6350689|NCT00058474|Antimetabolites|antimetabolites|mesh-ancestor
6350690|NCT00058474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350691|NCT00058474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6350692|NCT00058474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350693|NCT00058474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6350694|NCT00058474|Immunologic Factors|immunologic factors|mesh-ancestor
6350695|NCT00058474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350696|NCT00058487|Thalidomide|thalidomide|mesh-list
6350697|NCT00058487|Epirubicin|epirubicin|mesh-list
6350698|NCT00058487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6350699|NCT00058487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350700|NCT00058487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6350701|NCT00058487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6350702|NCT00058487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6350703|NCT00058487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350704|NCT00058487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6350705|NCT00058487|Immunologic Factors|immunologic factors|mesh-ancestor
6350706|NCT00058487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350707|NCT00058487|Leprostatic Agents|leprostatic agents|mesh-ancestor
6350708|NCT00058487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6350709|NCT00058487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6350710|NCT00058487|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6350711|NCT00058487|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6350712|NCT00058487|Growth Substances|growth substances|mesh-ancestor
6350713|NCT00058487|Growth Inhibitors|growth inhibitors|mesh-ancestor
6350714|NCT00058578|Cyclophosphamide|cyclophosphamide|mesh-list
6350715|NCT00058578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6350716|NCT00058578|Immunologic Factors|immunologic factors|mesh-ancestor
6350717|NCT00058578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350718|NCT00058578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6350719|NCT00058578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6350720|NCT00058578|Alkylating Agents|alkylating agents|mesh-ancestor
6350721|NCT00058578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350722|NCT00058578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350723|NCT00058578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6350724|NCT00058682|Anidulafungin|anidulafungin|mesh-list
6350725|NCT00058682|Antifungal Agents|antifungal agents|mesh-ancestor
6350726|NCT00058682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6350727|NCT00058747|Imatinib Mesylate|imatinib mesylate|mesh-list
6350728|NCT00058747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350729|NCT00058747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6350730|NCT00058747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6350731|NCT00058747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350732|NCT00058890|Gabapentin|gabapentin|mesh-list
6350733|NCT00058890|Analgesics|analgesics|mesh-ancestor
6350734|NCT00058890|Sensory System Agents|sensory system agents|mesh-ancestor
6350735|NCT00058890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6350736|NCT00058890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350737|NCT00058890|Anticonvulsants|anticonvulsants|mesh-ancestor
6350738|NCT00058890|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6350739|NCT00058890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6350740|NCT00058890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6350741|NCT00058890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6350742|NCT00058890|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6350743|NCT00058890|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6350744|NCT00058890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6350745|NCT00058890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350746|NCT00058890|Antimanic Agents|antimanic agents|mesh-ancestor
6350747|NCT00058903|Sertraline|sertraline|mesh-list
6350748|NCT00058903|Antidepressive Agents|antidepressive agents|mesh-ancestor
6350749|NCT00058903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6350750|NCT00058903|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6350751|NCT00058903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6350752|NCT00058903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6350753|NCT00058903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350754|NCT00058903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6350755|NCT00058903|Serotonin Agents|serotonin agents|mesh-ancestor
6350756|NCT00058903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350757|NCT00058929|Treprostinil|treprostinil|mesh-list
6350758|NCT00058929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6350759|NCT00058955|Sodium Oxybate|sodium oxybate|mesh-list
6350760|NCT00058955|Triazolam|triazolam|mesh-list
6350761|NCT00058955|Pentobarbital|pentobarbital|mesh-list
6350762|NCT00058955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6350763|NCT00058955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6350764|NCT00058955|Anesthetics, General|anesthetics, general|mesh-ancestor
6350765|NCT00058955|Anesthetics|anesthetics|mesh-ancestor
6350766|NCT00058955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6350767|NCT00058955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350768|NCT00058955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6350769|NCT00058955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6350770|NCT00058955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6350771|NCT00058955|GABA Modulators|gaba modulators|mesh-ancestor
6350772|NCT00058955|GABA Agents|gaba agents|mesh-ancestor
6350773|NCT00058955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6350774|NCT00058955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350775|NCT00058955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6350776|NCT00058968|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6350777|NCT00058968|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6350778|NCT00058968|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6350779|NCT00058968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6350780|NCT00058968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350781|NCT00058968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6350782|NCT00058968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350783|NCT00058968|Analgesics|analgesics|mesh-ancestor
6350784|NCT00058968|Sensory System Agents|sensory system agents|mesh-ancestor
6350785|NCT00058968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6350786|NCT00058968|Antidepressive Agents|antidepressive agents|mesh-ancestor
6350787|NCT00058968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6350788|NCT00058968|Dopamine Agents|dopamine agents|mesh-ancestor
6350789|NCT00058994|Anecortave|anecortave|mesh-list
6350790|NCT00058994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6350791|NCT00058994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6350792|NCT00058994|Growth Substances|growth substances|mesh-ancestor
6350793|NCT00058994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350794|NCT00058994|Growth Inhibitors|growth inhibitors|mesh-ancestor
6350795|NCT00058994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350796|NCT00059254|Palmitic Acid|palmitic acid|mesh-list
6350797|NCT00059254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6350798|NCT00059254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350799|NCT00059267|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6350800|NCT00059267|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6350801|NCT00059267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6350802|NCT00059267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6350803|NCT00059267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350804|NCT00059267|Antiviral Agents|antiviral agents|mesh-ancestor
6350805|NCT00059267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6350806|NCT00059306|Aspirin|aspirin|mesh-list
6350807|NCT00059306|Clopidogrel|clopidogrel|mesh-list
6350808|NCT00059306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6350809|NCT00059306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6350810|NCT00059306|Analgesics|analgesics|mesh-ancestor
6350811|NCT00059306|Sensory System Agents|sensory system agents|mesh-ancestor
6350812|NCT00059306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6350813|NCT00059306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350814|NCT00059306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6350815|NCT00059306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6350816|NCT00059306|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6350817|NCT00059306|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6350818|NCT00059306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350819|NCT00059306|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6350820|NCT00059306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6350821|NCT00059306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6350822|NCT00059306|Antipyretics|antipyretics|mesh-ancestor
6350823|NCT00059306|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6350824|NCT00059306|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6350825|NCT00059306|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6350826|NCT00059306|Purinergic Agents|purinergic agents|mesh-ancestor
6350827|NCT00059306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6350828|NCT00059358|Interferons|interferons|mesh-list
6350829|NCT00059358|Ribavirin|ribavirin|mesh-list
6350830|NCT00059358|Interferon-alpha|interferon-alpha|mesh-list
6350831|NCT00059358|Interferon alpha-2|interferon alpha-2|mesh-list
6350832|NCT00059358|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6350833|NCT00059358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350834|NCT00059358|Antiviral Agents|antiviral agents|mesh-ancestor
6350835|NCT00059358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6350836|NCT00059358|Antimetabolites|antimetabolites|mesh-ancestor
6350837|NCT00059358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350838|NCT00059358|Immunologic Factors|immunologic factors|mesh-ancestor
6350839|NCT00059358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350840|NCT00059462|Interleukin-2|interleukin-2|mesh-list
6350841|NCT00059462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350842|NCT00059462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6350843|NCT00059462|Analgesics|analgesics|mesh-ancestor
6350844|NCT00059462|Sensory System Agents|sensory system agents|mesh-ancestor
6350845|NCT00059462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6350846|NCT00059462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350847|NCT00059592|Valacyclovir|valacyclovir|mesh-list
6350848|NCT00059592|Antiviral Agents|antiviral agents|mesh-ancestor
6350849|NCT00059592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6350850|NCT00059618|Carboplatin|carboplatin|mesh-list
6350851|NCT00059618|Bortezomib|bortezomib|mesh-list
6350852|NCT00059618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350853|NCT00059631|Bortezomib|bortezomib|mesh-list
6350854|NCT00059631|Mitoxantrone|mitoxantrone|mesh-list
6350855|NCT00059631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350856|NCT00059631|Analgesics|analgesics|mesh-ancestor
6350857|NCT00059631|Sensory System Agents|sensory system agents|mesh-ancestor
6350858|NCT00059631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6350859|NCT00059631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350860|NCT00059631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6350861|NCT00059631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6350862|NCT00059631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6350863|NCT00059631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350864|NCT00059722|Gefitinib|gefitinib|mesh-list
6350865|NCT00059722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350866|NCT00059722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6350867|NCT00059722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6350868|NCT00059722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350869|NCT00059735|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
6350870|NCT00059735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350871|NCT00059735|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6350872|NCT00059735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6350873|NCT00059735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350874|NCT00059761|Irinotecan|irinotecan|mesh-list
6350875|NCT00059761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350876|NCT00059761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6350877|NCT00059761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6350878|NCT00059761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6350879|NCT00059761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350880|NCT00059800|Boron|boron|mesh-list
6350881|NCT00059800|Trace Elements|trace elements|mesh-ancestor
6350882|NCT00059800|Micronutrients|micronutrients|mesh-ancestor
6350883|NCT00059800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350884|NCT00059813|Interferons|interferons|mesh-list
6350885|NCT00059813|Interferon-alpha|interferon-alpha|mesh-list
6350886|NCT00059813|Interferon alpha-2|interferon alpha-2|mesh-list
6350887|NCT00059813|Oblimersen|oblimersen|mesh-list
6350888|NCT00059813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350889|NCT00059813|Antiviral Agents|antiviral agents|mesh-ancestor
6350890|NCT00059813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6350891|NCT00059813|Immunologic Factors|immunologic factors|mesh-ancestor
6350892|NCT00059813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350893|NCT00059826|Interferons|interferons|mesh-list
6350894|NCT00059826|Interferon-alpha|interferon-alpha|mesh-list
6350895|NCT00059826|Interferon alpha-2|interferon alpha-2|mesh-list
6350896|NCT00059826|Fluorouracil|fluorouracil|mesh-list
6350897|NCT00059826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350898|NCT00059826|Antimetabolites|antimetabolites|mesh-ancestor
6350899|NCT00059826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350900|NCT00059826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6350901|NCT00059826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6350902|NCT00059826|Immunologic Factors|immunologic factors|mesh-ancestor
6350903|NCT00059826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350904|NCT00059826|Antiviral Agents|antiviral agents|mesh-ancestor
6350905|NCT00059826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6350906|NCT00059852|Gemcitabine|gemcitabine|mesh-list
6350907|NCT00059852|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6350908|NCT00059852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6350909|NCT00059852|Antimetabolites|antimetabolites|mesh-ancestor
6350910|NCT00059852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350911|NCT00059852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350912|NCT00059852|Antiviral Agents|antiviral agents|mesh-ancestor
6350913|NCT00059852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6350914|NCT00059852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6350915|NCT00059852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6350916|NCT00059852|Immunologic Factors|immunologic factors|mesh-ancestor
6350917|NCT00059852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350918|NCT00059852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6350919|NCT00059865|Gemcitabine|gemcitabine|mesh-list
6350920|NCT00059865|Pemetrexed|pemetrexed|mesh-list
6350921|NCT00059865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6350922|NCT00059865|Antimetabolites|antimetabolites|mesh-ancestor
6350923|NCT00059865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350924|NCT00059865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350925|NCT00059865|Antiviral Agents|antiviral agents|mesh-ancestor
6350926|NCT00059865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6350927|NCT00059865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6350928|NCT00059865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6350929|NCT00059865|Immunologic Factors|immunologic factors|mesh-ancestor
6350930|NCT00059865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350931|NCT00059865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6350932|NCT00059865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6350933|NCT00059878|Interferons|interferons|mesh-list
6350934|NCT00059878|Interferon-gamma|interferon-gamma|mesh-list
6350935|NCT00059878|Voriconazole|voriconazole|mesh-list
6350936|NCT00059878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350937|NCT00059878|Antiviral Agents|antiviral agents|mesh-ancestor
6350938|NCT00059878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6350939|NCT00059878|Antifungal Agents|antifungal agents|mesh-ancestor
6350940|NCT00059878|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6350941|NCT00059878|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6350942|NCT00059878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6350943|NCT00059878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350944|NCT00059878|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6350945|NCT00059878|Hormone Antagonists|hormone antagonists|mesh-ancestor
6350946|NCT00059878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6350947|NCT00059878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350948|NCT00059878|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6350949|NCT00059904|Aldesleukin|aldesleukin|mesh-list
6350950|NCT00059904|Rituximab|rituximab|mesh-list
6350951|NCT00059904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6350952|NCT00059904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350953|NCT00059904|Immunologic Factors|immunologic factors|mesh-ancestor
6350954|NCT00059904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350955|NCT00059904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6350956|NCT00059904|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6350957|NCT00059904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6350958|NCT00059904|Antiviral Agents|antiviral agents|mesh-ancestor
6350959|NCT00059904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6350960|NCT00059917|Camptothecin|camptothecin|mesh-list
6350961|NCT00059917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6350962|NCT00059917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350963|NCT00059917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6350964|NCT00059917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6350965|NCT00059917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6350966|NCT00059917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350967|NCT00059930|Leucovorin|leucovorin|mesh-list
6350968|NCT00059930|Dexamethasone|dexamethasone|mesh-list
6350969|NCT00059930|Fluorouracil|fluorouracil|mesh-list
6350970|NCT00059930|Oxaliplatin|oxaliplatin|mesh-list
6350971|NCT00059930|Floxuridine|floxuridine|mesh-list
6350972|NCT00059930|Calcium|calcium|mesh-list
6350973|NCT00059930|Levoleucovorin|levoleucovorin|mesh-list
6350974|NCT00059930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6350975|NCT00059930|Antiemetics|antiemetics|mesh-ancestor
6350976|NCT00059930|Autonomic Agents|autonomic agents|mesh-ancestor
6350977|NCT00059930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6350978|NCT00059930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6350979|NCT00059930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6350980|NCT00059930|Glucocorticoids|glucocorticoids|mesh-ancestor
6350981|NCT00059930|Hormones|hormones|mesh-ancestor
6350982|NCT00059930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6350983|NCT00059930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6350984|NCT00059930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350985|NCT00059930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6350986|NCT00059930|Antimetabolites|antimetabolites|mesh-ancestor
6350987|NCT00059930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6350988|NCT00059930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6350989|NCT00059930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6350990|NCT00059930|Immunologic Factors|immunologic factors|mesh-ancestor
6350991|NCT00059930|Antidotes|antidotes|mesh-ancestor
6350992|NCT00059930|Protective Agents|protective agents|mesh-ancestor
6350993|NCT00059930|Vitamin B Complex|vitamin b complex|mesh-ancestor
6350994|NCT00059930|Vitamins|vitamins|mesh-ancestor
6350995|NCT00059930|Micronutrients|micronutrients|mesh-ancestor
6350996|NCT00059943|Docetaxel|docetaxel|mesh-list
6350997|NCT00059943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6350998|NCT00059943|Tubulin Modulators|tubulin modulators|mesh-ancestor
6350999|NCT00059943|Antimitotic Agents|antimitotic agents|mesh-ancestor
6351000|NCT00059943|Mitosis Modulators|mitosis modulators|mesh-ancestor
6351001|NCT00059943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351002|NCT00060112|Gemcitabine|gemcitabine|mesh-list
6351003|NCT00060112|Oblimersen|oblimersen|mesh-list
6351004|NCT00060112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6351005|NCT00060112|Antimetabolites|antimetabolites|mesh-ancestor
6351006|NCT00060112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351007|NCT00060112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6351008|NCT00060112|Antiviral Agents|antiviral agents|mesh-ancestor
6351009|NCT00060112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6351010|NCT00060112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6351011|NCT00060112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6351012|NCT00060112|Immunologic Factors|immunologic factors|mesh-ancestor
6351013|NCT00060112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351014|NCT00060125|Tipifarnib|tipifarnib|mesh-list
6351015|NCT00060125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6394317|NCT00201786|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
6394318|NCT00201786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6394319|NCT00201786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394320|NCT00201799|Infliximab|infliximab|mesh-list
6394321|NCT00201799|Dermatologic Agents|dermatologic agents|mesh-ancestor
6394322|NCT00201799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6394323|NCT00201799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6394324|NCT00201812|Dexamethasone|dexamethasone|mesh-list
6394325|NCT00201812|Etanercept|etanercept|mesh-list
6394326|NCT00201812|Docetaxel|docetaxel|mesh-list
6394327|NCT00201812|Glucocorticoids|glucocorticoids|mesh-list
6394328|NCT00201812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6394329|NCT00201812|Antiemetics|antiemetics|mesh-ancestor
6394330|NCT00201812|Autonomic Agents|autonomic agents|mesh-ancestor
6394331|NCT00201812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6394332|NCT00201812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394333|NCT00201812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6394334|NCT00201812|Hormones|hormones|mesh-ancestor
6394335|NCT00201812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6394336|NCT00201812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6394337|NCT00201812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6394338|NCT00201812|Tubulin Modulators|tubulin modulators|mesh-ancestor
6394339|NCT00201812|Antimitotic Agents|antimitotic agents|mesh-ancestor
6394340|NCT00201812|Mitosis Modulators|mitosis modulators|mesh-ancestor
6394341|NCT00201812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394342|NCT00201812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6394343|NCT00201812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6394344|NCT00201812|Analgesics|analgesics|mesh-ancestor
6394345|NCT00201812|Sensory System Agents|sensory system agents|mesh-ancestor
6394346|NCT00201812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6394347|NCT00201812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6394348|NCT00201812|Immunologic Factors|immunologic factors|mesh-ancestor
6394349|NCT00201955|Rebamipide|rebamipide|mesh-list
6351016|NCT00060138|Zoledronic Acid|zoledronic acid|mesh-list
6351017|NCT00060138|Antibodies|antibodies|mesh-list
6351018|NCT00060138|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6351019|NCT00060138|Immunologic Factors|immunologic factors|mesh-ancestor
6351020|NCT00060138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351021|NCT00060138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6351022|NCT00060242|Fosbretabulin|fosbretabulin|mesh-list
6351023|NCT00060242|Combretastatin|combretastatin|mesh-list
6351024|NCT00060242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6351025|NCT00060242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6351026|NCT00060242|Tubulin Modulators|tubulin modulators|mesh-ancestor
6351027|NCT00060242|Antimitotic Agents|antimitotic agents|mesh-ancestor
6351028|NCT00060242|Mitosis Modulators|mitosis modulators|mesh-ancestor
6351029|NCT00060242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351030|NCT00060255|Cyclophosphamide|cyclophosphamide|mesh-list
6351031|NCT00060255|Melphalan|melphalan|mesh-list
6351032|NCT00060255|Busulfan|busulfan|mesh-list
6351033|NCT00060255|Thiotepa|thiotepa|mesh-list
6351034|NCT00060255|Carmustine|carmustine|mesh-list
6351035|NCT00060255|Carboplatin|carboplatin|mesh-list
6351036|NCT00060255|Etoposide|etoposide|mesh-list
6351037|NCT00060255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6351038|NCT00060255|Immunologic Factors|immunologic factors|mesh-ancestor
6351039|NCT00060255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351040|NCT00060255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6351041|NCT00060255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6351042|NCT00060255|Alkylating Agents|alkylating agents|mesh-ancestor
6351043|NCT00060255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351044|NCT00060255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6351045|NCT00060255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6351046|NCT00060255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6351047|NCT00060255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6351048|NCT00060255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6351049|NCT00060255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6351050|NCT00060294|Rituximab|rituximab|mesh-list
6351051|NCT00060294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6351052|NCT00060294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6351053|NCT00060294|Immunologic Factors|immunologic factors|mesh-ancestor
6351054|NCT00060294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351055|NCT00060294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6351056|NCT00060307|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6351057|NCT00060307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6351058|NCT00060307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6351059|NCT00060307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6351060|NCT00060307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351061|NCT00060359|Paclitaxel|paclitaxel|mesh-list
6351062|NCT00060359|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6351063|NCT00060359|Carboplatin|carboplatin|mesh-list
6351064|NCT00060359|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
6351065|NCT00060359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6351066|NCT00060359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6351067|NCT00060359|Tubulin Modulators|tubulin modulators|mesh-ancestor
6351068|NCT00060359|Antimitotic Agents|antimitotic agents|mesh-ancestor
6351069|NCT00060359|Mitosis Modulators|mitosis modulators|mesh-ancestor
6351070|NCT00060359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351071|NCT00060372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6351072|NCT00060372|Ipilimumab|ipilimumab|mesh-list
6351073|NCT00060372|Antibodies|antibodies|mesh-list
6351074|NCT00060372|Immunoglobulins|immunoglobulins|mesh-list
6351075|NCT00060372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6351076|NCT00060372|Immunologic Factors|immunologic factors|mesh-ancestor
6351077|NCT00060372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351078|NCT00060372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6351079|NCT00060372|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6351080|NCT00060372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351081|NCT00060385|Prednisone|prednisone|mesh-list
6351082|NCT00060385|Cyclophosphamide|cyclophosphamide|mesh-list
6351083|NCT00060385|Doxorubicin|doxorubicin|mesh-list
6351084|NCT00060385|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6351085|NCT00060385|Etoposide|etoposide|mesh-list
6351086|NCT00060385|Vincristine|vincristine|mesh-list
6351087|NCT00060385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6351088|NCT00060385|Immunologic Factors|immunologic factors|mesh-ancestor
6351089|NCT00060385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351090|NCT00060385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6351091|NCT00060385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6351092|NCT00060385|Alkylating Agents|alkylating agents|mesh-ancestor
6351093|NCT00060385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351094|NCT00060385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6351095|NCT00060385|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6351096|NCT00060385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6351097|NCT00060385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6351098|NCT00060385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6351099|NCT00060385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6351100|NCT00060385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6351101|NCT00060385|Glucocorticoids|glucocorticoids|mesh-ancestor
6351102|NCT00060385|Hormones|hormones|mesh-ancestor
6351103|NCT00060385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6351104|NCT00060385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6351105|NCT00060385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6351106|NCT00060385|Tubulin Modulators|tubulin modulators|mesh-ancestor
6351107|NCT00060385|Antimitotic Agents|antimitotic agents|mesh-ancestor
6351108|NCT00060385|Mitosis Modulators|mitosis modulators|mesh-ancestor
6351109|NCT00060398|Dexamethasone|dexamethasone|mesh-list
6351110|NCT00060398|Epoetin Alfa|epoetin alfa|mesh-list
6351111|NCT00060398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6351112|NCT00060398|Antiemetics|antiemetics|mesh-ancestor
6351113|NCT00060398|Autonomic Agents|autonomic agents|mesh-ancestor
6351114|NCT00060398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6351115|NCT00060398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351116|NCT00060398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6351117|NCT00060398|Glucocorticoids|glucocorticoids|mesh-ancestor
6351118|NCT00060398|Hormones|hormones|mesh-ancestor
6351119|NCT00060398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6351120|NCT00060398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6351121|NCT00060398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6351122|NCT00060398|Hematinics|hematinics|mesh-ancestor
6351123|NCT00060411|Leucovorin|leucovorin|mesh-list
6351124|NCT00060411|Bevacizumab|bevacizumab|mesh-list
6351125|NCT00060411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6351126|NCT00060411|Fluorouracil|fluorouracil|mesh-list
6351127|NCT00060411|Oxaliplatin|oxaliplatin|mesh-list
6351128|NCT00060411|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6351129|NCT00060411|Antibodies|antibodies|mesh-list
6351130|NCT00060411|Immunoglobulins|immunoglobulins|mesh-list
6351131|NCT00060411|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6351132|NCT00060411|Levoleucovorin|levoleucovorin|mesh-list
6351133|NCT00060411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6351134|NCT00060411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6351135|NCT00060411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6351136|NCT00060411|Growth Substances|growth substances|mesh-ancestor
6351137|NCT00060411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351138|NCT00060411|Growth Inhibitors|growth inhibitors|mesh-ancestor
6351139|NCT00060411|Immunologic Factors|immunologic factors|mesh-ancestor
6351140|NCT00060411|Antimetabolites|antimetabolites|mesh-ancestor
6351141|NCT00060411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351142|NCT00060411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6351143|NCT00060411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6351144|NCT00060411|Antidotes|antidotes|mesh-ancestor
6351145|NCT00060411|Protective Agents|protective agents|mesh-ancestor
6351146|NCT00060411|Vitamin B Complex|vitamin b complex|mesh-ancestor
6351147|NCT00060411|Vitamins|vitamins|mesh-ancestor
6351148|NCT00060411|Micronutrients|micronutrients|mesh-ancestor
6351149|NCT00060411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6351150|NCT00060411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6351151|NCT00060450|Nitric Oxide|nitric oxide|mesh-list
6351152|NCT00060450|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6351153|NCT00060450|Autonomic Agents|autonomic agents|mesh-ancestor
6351154|NCT00060450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6351155|NCT00060450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351156|NCT00060450|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6351157|NCT00060450|Respiratory System Agents|respiratory system agents|mesh-ancestor
6351158|NCT00060450|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6351159|NCT00060450|Antioxidants|antioxidants|mesh-ancestor
6351160|NCT00060450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351161|NCT00060450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6351162|NCT00060450|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6351163|NCT00060450|Vasodilator Agents|vasodilator agents|mesh-ancestor
6351164|NCT00060450|Gasotransmitters|gasotransmitters|mesh-ancestor
6351165|NCT00060450|Protective Agents|protective agents|mesh-ancestor
6351166|NCT00060463|Contraceptive Agents|contraceptive agents|mesh-list
6351167|NCT00060463|Contraceptives, Postcoital|contraceptives, postcoital|mesh-list
6351168|NCT00060463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6351169|NCT00060463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351170|NCT00060463|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6351171|NCT00060476|Rofecoxib|rofecoxib|mesh-list
6351172|NCT00060476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6351173|NCT00060476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6351174|NCT00060476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6351175|NCT00060476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351176|NCT00060476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6351177|NCT00060476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6351178|NCT00060476|Analgesics|analgesics|mesh-ancestor
6351179|NCT00060476|Sensory System Agents|sensory system agents|mesh-ancestor
6351180|NCT00060476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6351181|NCT00060476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351182|NCT00060476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6351183|NCT00060476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6351184|NCT00060489|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6351185|NCT00060489|Antidepressive Agents|antidepressive agents|mesh-ancestor
6351186|NCT00060489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6351187|NCT00060489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6351188|NCT00060489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6351189|NCT00060489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6351190|NCT00060489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351191|NCT00060502|Gemcitabine|gemcitabine|mesh-list
6351192|NCT00060502|Infliximab|infliximab|mesh-list
6351193|NCT00060502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6351194|NCT00060502|Antimetabolites|antimetabolites|mesh-ancestor
6351195|NCT00060502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351196|NCT00060502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6351197|NCT00060502|Antiviral Agents|antiviral agents|mesh-ancestor
6351198|NCT00060502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6351199|NCT00060502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6351200|NCT00060502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6351201|NCT00060502|Immunologic Factors|immunologic factors|mesh-ancestor
6351202|NCT00060502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351203|NCT00060502|Dermatologic Agents|dermatologic agents|mesh-ancestor
6351204|NCT00060502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6351205|NCT00060502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6351206|NCT00060554|Heparin|heparin|mesh-list
6351207|NCT00060554|PENTA|penta|mesh-list
6351208|NCT00060554|Fondaparinux|fondaparinux|mesh-list
6351209|NCT00060554|Anticoagulants|anticoagulants|mesh-ancestor
6351210|NCT00060554|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6351211|NCT00060554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6351212|NCT00060554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351213|NCT00060554|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6351214|NCT00060554|Antithrombins|antithrombins|mesh-ancestor
6351215|NCT00060554|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6351216|NCT00060554|Protease Inhibitors|protease inhibitors|mesh-ancestor
6351217|NCT00060554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6351218|NCT00060567|Irinotecan|irinotecan|mesh-list
6351219|NCT00060567|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
6351220|NCT00060567|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6351221|NCT00060567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6351222|NCT00060567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6351223|NCT00060567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351224|NCT00060567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6351225|NCT00060567|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6351226|NCT00060632|Sirolimus|sirolimus|mesh-list
6351227|NCT00060632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6351228|NCT00060632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6351229|NCT00060632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6351230|NCT00060632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6351231|NCT00060632|Antifungal Agents|antifungal agents|mesh-ancestor
6351232|NCT00060632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6351233|NCT00060632|Immunologic Factors|immunologic factors|mesh-ancestor
6351234|NCT00060632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351235|NCT00060645|Sirolimus|sirolimus|mesh-list
6351236|NCT00060645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6351237|NCT00060645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6351238|NCT00060645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6351239|NCT00060645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6351240|NCT00060645|Antifungal Agents|antifungal agents|mesh-ancestor
6351241|NCT00060645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6351242|NCT00060645|Immunologic Factors|immunologic factors|mesh-ancestor
6351243|NCT00060645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351244|NCT00060671|Rituximab|rituximab|mesh-list
6351245|NCT00060671|Pixantrone|pixantrone|mesh-list
6351246|NCT00060671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6351247|NCT00060671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6351248|NCT00060671|Immunologic Factors|immunologic factors|mesh-ancestor
6351249|NCT00060671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351250|NCT00060671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6351251|NCT00060671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6351252|NCT00060671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6351253|NCT00060671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6351254|NCT00060671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351255|NCT00060684|Dexamethasone|dexamethasone|mesh-list
6351256|NCT00060684|Rituximab|rituximab|mesh-list
6351257|NCT00060684|Fludarabine|fludarabine|mesh-list
6351258|NCT00060684|Pixantrone|pixantrone|mesh-list
6351259|NCT00060684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6351260|NCT00060684|Antiemetics|antiemetics|mesh-ancestor
6351261|NCT00060684|Autonomic Agents|autonomic agents|mesh-ancestor
6351262|NCT00060684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6351263|NCT00060684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351264|NCT00060684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6351265|NCT00060684|Glucocorticoids|glucocorticoids|mesh-ancestor
6351266|NCT00060684|Hormones|hormones|mesh-ancestor
6351267|NCT00060684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6351268|NCT00060684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6351269|NCT00060684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6351270|NCT00060684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6351271|NCT00060684|Immunologic Factors|immunologic factors|mesh-ancestor
6351272|NCT00060684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6351273|NCT00060684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351274|NCT00060684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5724591|NCT03186326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6351275|NCT00060684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6351276|NCT00060684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6351277|NCT00060866|Propranolol|propranolol|mesh-list
6351278|NCT00060866|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6351279|NCT00060866|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6351280|NCT00060866|Adrenergic Agents|adrenergic agents|mesh-ancestor
6351281|NCT00060866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6351282|NCT00060866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351283|NCT00060866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351284|NCT00060866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6351285|NCT00060866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6351286|NCT00060866|Vasodilator Agents|vasodilator agents|mesh-ancestor
6351287|NCT00060905|Valproic Acid|valproic acid|mesh-list
6351288|NCT00060905|Anticonvulsants|anticonvulsants|mesh-ancestor
6351289|NCT00060905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6351290|NCT00060905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351291|NCT00060905|GABA Agents|gaba agents|mesh-ancestor
6351292|NCT00060905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6351293|NCT00060905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351294|NCT00060905|Antimanic Agents|antimanic agents|mesh-ancestor
6351295|NCT00060905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6351296|NCT00060905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6351297|NCT00060905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6351298|NCT00060918|Metoprolol|metoprolol|mesh-list
6351299|NCT00060918|Carvedilol|carvedilol|mesh-list
6351300|NCT00060918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6351301|NCT00060918|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6351302|NCT00060918|Sympatholytics|sympatholytics|mesh-ancestor
6351303|NCT00060918|Autonomic Agents|autonomic agents|mesh-ancestor
6351304|NCT00060918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6351305|NCT00060918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351306|NCT00060918|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6351307|NCT00060918|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6351308|NCT00060918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6351309|NCT00060918|Adrenergic Agents|adrenergic agents|mesh-ancestor
6351310|NCT00060918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6351311|NCT00060918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351312|NCT00060918|Antioxidants|antioxidants|mesh-ancestor
6351313|NCT00060918|Protective Agents|protective agents|mesh-ancestor
6351314|NCT00060918|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6351315|NCT00060918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6351316|NCT00060918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6351317|NCT00060918|Vasodilator Agents|vasodilator agents|mesh-ancestor
6351318|NCT00060918|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6351319|NCT00060918|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6351320|NCT00060931|Metoprolol|metoprolol|mesh-list
6351321|NCT00060931|Carvedilol|carvedilol|mesh-list
6351322|NCT00060931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6351323|NCT00060931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6351324|NCT00060931|Sympatholytics|sympatholytics|mesh-ancestor
6351325|NCT00060931|Autonomic Agents|autonomic agents|mesh-ancestor
6351326|NCT00060931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6351327|NCT00060931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351328|NCT00060931|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6351329|NCT00060931|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6351330|NCT00060931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6351331|NCT00060931|Adrenergic Agents|adrenergic agents|mesh-ancestor
6351332|NCT00060931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6351333|NCT00060931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351334|NCT00060931|Antioxidants|antioxidants|mesh-ancestor
6351335|NCT00060931|Protective Agents|protective agents|mesh-ancestor
6351336|NCT00060931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6351337|NCT00060931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6351338|NCT00060931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6351339|NCT00060931|Vasodilator Agents|vasodilator agents|mesh-ancestor
6351340|NCT00060931|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6351341|NCT00060931|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6351342|NCT00060957|Botulinum Toxins|botulinum toxins|mesh-list
6351343|NCT00060957|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6351344|NCT00060957|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6351345|NCT00060957|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6351346|NCT00060957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6351347|NCT00060957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351348|NCT00060957|Cholinergic Agents|cholinergic agents|mesh-ancestor
6351349|NCT00060957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6351350|NCT00060957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351351|NCT00060957|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6351352|NCT00060957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6351353|NCT00060996|Treprostinil|treprostinil|mesh-list
6351354|NCT00060996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6351355|NCT00061022|Disufenton sodium|disufenton sodium|mesh-list
6351356|NCT00061022|Antioxidants|antioxidants|mesh-ancestor
6351357|NCT00061022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351358|NCT00061022|Protective Agents|protective agents|mesh-ancestor
6351359|NCT00061022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351360|NCT00061035|Vaccines|vaccines|mesh-list
6351361|NCT00061035|Immunologic Factors|immunologic factors|mesh-ancestor
6351362|NCT00061035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351363|NCT00061074|Nicotine|nicotine|mesh-list
6351364|NCT00061074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6351365|NCT00061074|Autonomic Agents|autonomic agents|mesh-ancestor
6351366|NCT00061074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6351367|NCT00061074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351368|NCT00061074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6351369|NCT00061074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6351370|NCT00061074|Cholinergic Agents|cholinergic agents|mesh-ancestor
6351371|NCT00061074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6351372|NCT00061074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351373|NCT00061087|Methylphenidate|methylphenidate|mesh-list
6351374|NCT00061087|Bupropion|bupropion|mesh-list
6351375|NCT00061087|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6351376|NCT00061087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351377|NCT00061087|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6351378|NCT00061087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6351379|NCT00061087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6351380|NCT00061087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351381|NCT00061087|Dopamine Agents|dopamine agents|mesh-ancestor
6351382|NCT00061087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6351383|NCT00061087|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6351384|NCT00061087|Antidepressive Agents|antidepressive agents|mesh-ancestor
6351385|NCT00061087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6351386|NCT00061087|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6351387|NCT00061087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6351388|NCT00061087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6351389|NCT00061113|Fluoxetine|fluoxetine|mesh-list
6351390|NCT00061113|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6351391|NCT00061113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6351392|NCT00061113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6351393|NCT00061113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351394|NCT00061113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6351395|NCT00061113|Serotonin Agents|serotonin agents|mesh-ancestor
6394350|NCT00201955|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6351396|NCT00061113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351397|NCT00061113|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6351398|NCT00061113|Antidepressive Agents|antidepressive agents|mesh-ancestor
6351399|NCT00061113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6351400|NCT00061113|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6351401|NCT00061113|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6351402|NCT00061113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6351403|NCT00061126|Panitumumab|panitumumab|mesh-list
6351404|NCT00061126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6351405|NCT00061126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6351406|NCT00061152|Capsaicin|capsaicin|mesh-list
6351407|NCT00061152|Antipruritics|antipruritics|mesh-ancestor
6351408|NCT00061152|Dermatologic Agents|dermatologic agents|mesh-ancestor
6351409|NCT00061152|Sensory System Agents|sensory system agents|mesh-ancestor
6351410|NCT00061152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6351411|NCT00061152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351412|NCT00061178|Bevacizumab|bevacizumab|mesh-list
6351413|NCT00061178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6351414|NCT00061178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6351415|NCT00061178|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6351416|NCT00061178|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6351417|NCT00061178|Growth Substances|growth substances|mesh-ancestor
6351418|NCT00061178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351419|NCT00061178|Growth Inhibitors|growth inhibitors|mesh-ancestor
6351420|NCT00061243|Vaccines|vaccines|mesh-list
6351421|NCT00061243|Immunologic Factors|immunologic factors|mesh-ancestor
6351422|NCT00061243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351423|NCT00061256|Vitamin D|vitamin d|mesh-list
6351424|NCT00061256|Alendronate|alendronate|mesh-list
6351425|NCT00061256|Calcium Carbonate|calcium carbonate|mesh-list
6351426|NCT00061256|Calcium|calcium|mesh-list
6351427|NCT00061256|Vitamins|vitamins|mesh-ancestor
6351428|NCT00061256|Micronutrients|micronutrients|mesh-ancestor
6351429|NCT00061256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351430|NCT00061256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6351431|NCT00061256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6351432|NCT00061256|Antacids|antacids|mesh-ancestor
6351433|NCT00061256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351434|NCT00061256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6351435|NCT00061282|Clotrimazole|clotrimazole|mesh-list
6351436|NCT00061282|Miconazole|miconazole|mesh-list
6351437|NCT00061282|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6351438|NCT00061282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6351439|NCT00061282|Antifungal Agents|antifungal agents|mesh-ancestor
6351440|NCT00061282|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6351441|NCT00061282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6351442|NCT00061282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6351443|NCT00061282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351444|NCT00061282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6351445|NCT00061282|Hormone Antagonists|hormone antagonists|mesh-ancestor
6351446|NCT00061282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6351447|NCT00061282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351448|NCT00061282|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6351449|NCT00061282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6351450|NCT00061308|Gemcitabine|gemcitabine|mesh-list
6351451|NCT00061308|Topotecan|topotecan|mesh-list
6351452|NCT00061308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6351453|NCT00061308|Antimetabolites|antimetabolites|mesh-ancestor
6351454|NCT00061308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351455|NCT00061308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6351456|NCT00061308|Antiviral Agents|antiviral agents|mesh-ancestor
6351457|NCT00061308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6351458|NCT00061308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6351459|NCT00061308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6351460|NCT00061308|Immunologic Factors|immunologic factors|mesh-ancestor
6351461|NCT00061308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351462|NCT00061308|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6351463|NCT00061308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6351464|NCT00061321|Nevirapine|nevirapine|mesh-list
6351465|NCT00061321|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6351466|NCT00061321|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6351467|NCT00061321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6351468|NCT00061321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351469|NCT00061321|Antiviral Agents|antiviral agents|mesh-ancestor
6351470|NCT00061321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6351471|NCT00061321|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6351472|NCT00061321|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6351473|NCT00061321|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6351474|NCT00061321|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6351475|NCT00061360|Cyclosporine|cyclosporine|mesh-list
6351476|NCT00061360|Sirolimus|sirolimus|mesh-list
6351477|NCT00061360|Cyclosporins|cyclosporins|mesh-list
6351478|NCT00061360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6351479|NCT00061360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351480|NCT00061360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6351481|NCT00061360|Immunologic Factors|immunologic factors|mesh-ancestor
6351482|NCT00061360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351483|NCT00061360|Antifungal Agents|antifungal agents|mesh-ancestor
6351484|NCT00061360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6351485|NCT00061360|Dermatologic Agents|dermatologic agents|mesh-ancestor
6351486|NCT00061360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6351487|NCT00061360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6351488|NCT00061360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6351489|NCT00061360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6351490|NCT00061360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6351491|NCT00061425|Epratuzumab|epratuzumab|mesh-list
6351492|NCT00061425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6351493|NCT00061425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6351494|NCT00061438|Meropenem|meropenem|mesh-list
6351495|NCT00061438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6351496|NCT00061438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6351497|NCT00061451|Gemcitabine|gemcitabine|mesh-list
6351498|NCT00061451|Pemetrexed|pemetrexed|mesh-list
6351499|NCT00061451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6351500|NCT00061451|Antimetabolites|antimetabolites|mesh-ancestor
6351501|NCT00061451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351502|NCT00061451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6351503|NCT00061451|Antiviral Agents|antiviral agents|mesh-ancestor
6351504|NCT00061451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6351505|NCT00061451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6351506|NCT00061451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6351507|NCT00061451|Immunologic Factors|immunologic factors|mesh-ancestor
6351508|NCT00061451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351509|NCT00061451|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6351510|NCT00061451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6351511|NCT00061464|Gemcitabine|gemcitabine|mesh-list
6351512|NCT00061464|Pemetrexed|pemetrexed|mesh-list
6351513|NCT00061464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6351514|NCT00061464|Antimetabolites|antimetabolites|mesh-ancestor
6351515|NCT00061464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351516|NCT00061464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6351517|NCT00061464|Antiviral Agents|antiviral agents|mesh-ancestor
6351518|NCT00061464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6351519|NCT00061464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6351520|NCT00061464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6351521|NCT00061464|Immunologic Factors|immunologic factors|mesh-ancestor
6351522|NCT00061464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351523|NCT00061464|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6351524|NCT00061464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6351525|NCT00061477|Gemcitabine|gemcitabine|mesh-list
6351526|NCT00061477|Pemetrexed|pemetrexed|mesh-list
6351527|NCT00061477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6351528|NCT00061477|Antimetabolites|antimetabolites|mesh-ancestor
6351529|NCT00061477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351530|NCT00061477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6351531|NCT00061477|Antiviral Agents|antiviral agents|mesh-ancestor
6351532|NCT00061477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6351533|NCT00061477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6351534|NCT00061477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6351535|NCT00061477|Immunologic Factors|immunologic factors|mesh-ancestor
6351536|NCT00061477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351537|NCT00061477|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6351538|NCT00061477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6351539|NCT00061503|Travoprost|travoprost|mesh-list
6351540|NCT00061503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6351541|NCT00061516|Brinzolamide|brinzolamide|mesh-list
6351542|NCT00061516|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6351543|NCT00061516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6351544|NCT00061516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351545|NCT00061529|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6351546|NCT00061529|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6351547|NCT00061529|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6351548|NCT00061529|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6351549|NCT00061529|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6351550|NCT00061529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6351551|NCT00061529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6351552|NCT00061529|Adrenergic Agents|adrenergic agents|mesh-ancestor
6351553|NCT00061529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6351554|NCT00061529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351555|NCT00061529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351556|NCT00061542|Timolol|timolol|mesh-list
6351557|NCT00061542|Betaxolol|betaxolol|mesh-list
6351558|NCT00061542|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6351559|NCT00061542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6351560|NCT00061542|Adrenergic Agents|adrenergic agents|mesh-ancestor
6351561|NCT00061542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6351562|NCT00061542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351563|NCT00061542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351564|NCT00061542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6351565|NCT00061542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6351566|NCT00061542|Sympatholytics|sympatholytics|mesh-ancestor
6351567|NCT00061542|Autonomic Agents|autonomic agents|mesh-ancestor
6351568|NCT00061542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6351569|NCT00061542|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6351570|NCT00061594|Ranibizumab|ranibizumab|mesh-list
6351571|NCT00061594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6351572|NCT00061594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6351573|NCT00061594|Growth Substances|growth substances|mesh-ancestor
6351574|NCT00061594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351575|NCT00061594|Growth Inhibitors|growth inhibitors|mesh-ancestor
6351576|NCT00061594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6351577|NCT00061620|Tezacitabine|tezacitabine|mesh-list
6351578|NCT00061620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6351579|NCT00061620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6351580|NCT00061620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351581|NCT00061646|Carboplatin|carboplatin|mesh-list
6351582|NCT00061646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6351583|NCT00061711|Hormones|hormones|mesh-list
6351584|NCT00061711|Phytoestrogens|phytoestrogens|mesh-list
6351585|NCT00061711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6351586|NCT00061711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351587|NCT00061711|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6351588|NCT00061711|Estrogens|estrogens|mesh-ancestor
6394351|NCT00201955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6394352|NCT00201955|Antioxidants|antioxidants|mesh-ancestor
6394353|NCT00201955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394354|NCT00201955|Protective Agents|protective agents|mesh-ancestor
6394355|NCT00201955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394356|NCT00201955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6394357|NCT00201981|Rebamipide|rebamipide|mesh-list
6394358|NCT00201981|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6394359|NCT00201981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6394360|NCT00201981|Antioxidants|antioxidants|mesh-ancestor
6394361|NCT00201981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394362|NCT00201981|Protective Agents|protective agents|mesh-ancestor
6394363|NCT00201981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394364|NCT00201981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6394365|NCT00201994|Tolvaptan|tolvaptan|mesh-list
6394366|NCT00201994|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6394367|NCT00201994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394368|NCT00201994|Natriuretic Agents|natriuretic agents|mesh-ancestor
6394369|NCT00201994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394370|NCT00202007|Risperidone|risperidone|mesh-list
6394371|NCT00202007|Aripiprazole|aripiprazole|mesh-list
6394372|NCT00202007|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6351589|NCT00061750|Deferasirox|deferasirox|mesh-list
6351590|NCT00061750|Deferoxamine|deferoxamine|mesh-list
6351591|NCT00061750|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6351592|NCT00061750|Chelating Agents|chelating agents|mesh-ancestor
6351593|NCT00061750|Sequestering Agents|sequestering agents|mesh-ancestor
6351594|NCT00061750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351595|NCT00061750|Siderophores|siderophores|mesh-ancestor
6351596|NCT00061763|Deferasirox|deferasirox|mesh-list
6351597|NCT00061763|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6351598|NCT00061763|Chelating Agents|chelating agents|mesh-ancestor
6351599|NCT00061763|Sequestering Agents|sequestering agents|mesh-ancestor
6351600|NCT00061763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351601|NCT00061776|Capsaicin|capsaicin|mesh-list
6351602|NCT00061776|Antipruritics|antipruritics|mesh-ancestor
6351603|NCT00061776|Dermatologic Agents|dermatologic agents|mesh-ancestor
6351604|NCT00061776|Sensory System Agents|sensory system agents|mesh-ancestor
6351605|NCT00061776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6351606|NCT00061776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351607|NCT00061789|Acetylcholine|acetylcholine|mesh-list
6351608|NCT00061789|Vasodilator Agents|vasodilator agents|mesh-ancestor
6351609|NCT00061789|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6351610|NCT00061789|Cholinergic Agents|cholinergic agents|mesh-ancestor
6351611|NCT00061789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6351612|NCT00061789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351613|NCT00061789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351614|NCT00061802|Risperidone|risperidone|mesh-list
6351615|NCT00061802|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6351616|NCT00061802|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6351617|NCT00061802|Serotonin Agents|serotonin agents|mesh-ancestor
6351618|NCT00061802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6351619|NCT00061802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351620|NCT00061802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351621|NCT00061802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6351622|NCT00061802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6351623|NCT00061802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6351624|NCT00061802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6351625|NCT00061802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6351626|NCT00061802|Dopamine Agents|dopamine agents|mesh-ancestor
6351627|NCT00061802|Antidepressive Agents|antidepressive agents|mesh-ancestor
6351628|NCT00061815|Leucovorin|leucovorin|mesh-list
6351629|NCT00061815|Fluorouracil|fluorouracil|mesh-list
6351630|NCT00061815|Oxaliplatin|oxaliplatin|mesh-list
6351631|NCT00061815|Cetuximab|cetuximab|mesh-list
6351632|NCT00061815|Antimetabolites|antimetabolites|mesh-ancestor
6351633|NCT00061815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351634|NCT00061815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6351635|NCT00061815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6351636|NCT00061815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6351637|NCT00061815|Immunologic Factors|immunologic factors|mesh-ancestor
6351638|NCT00061815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351639|NCT00061815|Antidotes|antidotes|mesh-ancestor
6351640|NCT00061815|Protective Agents|protective agents|mesh-ancestor
6351641|NCT00061815|Vitamin B Complex|vitamin b complex|mesh-ancestor
6351642|NCT00061815|Vitamins|vitamins|mesh-ancestor
6351643|NCT00061815|Micronutrients|micronutrients|mesh-ancestor
6351644|NCT00061815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6351645|NCT00061854|Soblidotin|soblidotin|mesh-list
6351646|NCT00061854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6351647|NCT00061867|Doxorubicin|doxorubicin|mesh-list
6351648|NCT00061867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6351649|NCT00061867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6351650|NCT00061867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6351651|NCT00061867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6351652|NCT00061867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6351653|NCT00061867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6351654|NCT00061867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351655|NCT00061906|Celecoxib|celecoxib|mesh-list
6351656|NCT00061906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6351657|NCT00061906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6351658|NCT00061906|Analgesics|analgesics|mesh-ancestor
6351659|NCT00061906|Sensory System Agents|sensory system agents|mesh-ancestor
6351660|NCT00061906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6351661|NCT00061906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351662|NCT00061906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6351663|NCT00061906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6351664|NCT00061906|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6351665|NCT00061906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6351666|NCT00061906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6351667|NCT00061906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351668|NCT00061919|Thalidomide|thalidomide|mesh-list
6351669|NCT00061919|Carboplatin|carboplatin|mesh-list
6351670|NCT00061919|Etoposide|etoposide|mesh-list
6351671|NCT00061919|Etoposide phosphate|etoposide phosphate|mesh-list
6351672|NCT00061919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6351673|NCT00061919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6351674|NCT00061919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6017000|NCT00369226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017001|NCT00369226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6017002|NCT00369226|Antimetabolites|antimetabolites|mesh-ancestor
6351675|NCT00061919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6351676|NCT00061919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6351677|NCT00061919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351678|NCT00061919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6351679|NCT00061919|Immunologic Factors|immunologic factors|mesh-ancestor
6351680|NCT00061919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351681|NCT00061919|Leprostatic Agents|leprostatic agents|mesh-ancestor
6351682|NCT00061919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6351683|NCT00061919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6351684|NCT00061919|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6351685|NCT00061919|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6351686|NCT00061919|Growth Substances|growth substances|mesh-ancestor
6351687|NCT00061919|Growth Inhibitors|growth inhibitors|mesh-ancestor
6351688|NCT00061958|Arsenic Trioxide|arsenic trioxide|mesh-list
6351689|NCT00061958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6351690|NCT00061984|Doxorubicin|doxorubicin|mesh-list
6351691|NCT00061984|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6351692|NCT00061984|Ifosfamide|ifosfamide|mesh-list
6351693|NCT00061984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6351694|NCT00061984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6351695|NCT00061984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6351696|NCT00061984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6351697|NCT00061984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6351698|NCT00061984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351699|NCT00061984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6351700|NCT00061984|Alkylating Agents|alkylating agents|mesh-ancestor
6351701|NCT00061997|Inositol|inositol|mesh-list
6351702|NCT00061997|Vitamin B Complex|vitamin b complex|mesh-ancestor
6351703|NCT00061997|Vitamins|vitamins|mesh-ancestor
6351704|NCT00061997|Micronutrients|micronutrients|mesh-ancestor
6351705|NCT00061997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351706|NCT00062023|Aspirin|aspirin|mesh-list
6351707|NCT00062023|Sulindac|sulindac|mesh-list
6351708|NCT00062023|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
6351709|NCT00062023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6351710|NCT00062023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6351711|NCT00062023|Analgesics|analgesics|mesh-ancestor
6351712|NCT00062023|Sensory System Agents|sensory system agents|mesh-ancestor
6351713|NCT00062023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6351714|NCT00062023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351715|NCT00062023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6351716|NCT00062023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6351717|NCT00062023|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6351718|NCT00062023|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6351719|NCT00062023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351720|NCT00062023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6351721|NCT00062023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6351722|NCT00062023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6351723|NCT00062023|Antipyretics|antipyretics|mesh-ancestor
6351724|NCT00062023|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6351725|NCT00062023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6351726|NCT00062023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6351727|NCT00062036|Aldesleukin|aldesleukin|mesh-list
6351728|NCT00062036|Cyclophosphamide|cyclophosphamide|mesh-list
6351729|NCT00062036|Fludarabine|fludarabine|mesh-list
6351730|NCT00062036|Fludarabine phosphate|fludarabine phosphate|mesh-list
6351731|NCT00062036|Interleukin-2|interleukin-2|mesh-list
6351732|NCT00062036|Freund's Adjuvant|freund's adjuvant|mesh-list
6351733|NCT00062036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6351734|NCT00062036|Immunologic Factors|immunologic factors|mesh-ancestor
6351735|NCT00062036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351736|NCT00062036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6351737|NCT00062036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6351738|NCT00062036|Alkylating Agents|alkylating agents|mesh-ancestor
6351739|NCT00062036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351740|NCT00062036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6351741|NCT00062036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6351742|NCT00062036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6351743|NCT00062036|Antimetabolites|antimetabolites|mesh-ancestor
6351744|NCT00062036|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6351745|NCT00062036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6351746|NCT00062036|Analgesics|analgesics|mesh-ancestor
6351747|NCT00062036|Sensory System Agents|sensory system agents|mesh-ancestor
6351748|NCT00062036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6351749|NCT00062036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6351750|NCT00062036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6351751|NCT00062036|Antiviral Agents|antiviral agents|mesh-ancestor
6351752|NCT00062036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6351753|NCT00062062|Paclitaxel|paclitaxel|mesh-list
6351754|NCT00062062|Carboplatin|carboplatin|mesh-list
6351755|NCT00062062|Gefitinib|gefitinib|mesh-list
6351756|NCT00062062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6351757|NCT00062062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6351758|NCT00062062|Tubulin Modulators|tubulin modulators|mesh-ancestor
6351759|NCT00062062|Antimitotic Agents|antimitotic agents|mesh-ancestor
6351760|NCT00062062|Mitosis Modulators|mitosis modulators|mesh-ancestor
6351761|NCT00062062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351762|NCT00062062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6351763|NCT00062062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6351764|NCT00062075|Romidepsin|romidepsin|mesh-list
6351765|NCT00062075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6351766|NCT00062075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6351767|NCT00062101|Celecoxib|celecoxib|mesh-list
6351768|NCT00062101|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6351769|NCT00062101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6351770|NCT00062101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6351771|NCT00062101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6351772|NCT00062101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351773|NCT00062101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6351774|NCT00062101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6351775|NCT00062101|Analgesics|analgesics|mesh-ancestor
6351776|NCT00062101|Sensory System Agents|sensory system agents|mesh-ancestor
6351777|NCT00062101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6351778|NCT00062101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351779|NCT00062101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6351780|NCT00062101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6351781|NCT00062101|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6351782|NCT00062101|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6351783|NCT00062114|Rituximab|rituximab|mesh-list
6394373|NCT00202007|Serotonin Agents|serotonin agents|mesh-ancestor
6351784|NCT00062114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6351785|NCT00062114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6351786|NCT00062114|Immunologic Factors|immunologic factors|mesh-ancestor
6351787|NCT00062114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351788|NCT00062114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6351789|NCT00062127|Thalidomide|thalidomide|mesh-list
6351790|NCT00062127|Irinotecan|irinotecan|mesh-list
6351791|NCT00062127|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6351792|NCT00062127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6351793|NCT00062127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6351794|NCT00062127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351795|NCT00062127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6351796|NCT00062127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6351797|NCT00062127|Immunologic Factors|immunologic factors|mesh-ancestor
6351798|NCT00062127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351799|NCT00062127|Leprostatic Agents|leprostatic agents|mesh-ancestor
6351800|NCT00062127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6351801|NCT00062127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6351802|NCT00062127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6351803|NCT00062127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6351804|NCT00062127|Growth Substances|growth substances|mesh-ancestor
6351805|NCT00062127|Growth Inhibitors|growth inhibitors|mesh-ancestor
6351806|NCT00062140|Cyclophosphamide|cyclophosphamide|mesh-list
6351807|NCT00062140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6351808|NCT00062140|Immunologic Factors|immunologic factors|mesh-ancestor
6351809|NCT00062140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351810|NCT00062140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6351811|NCT00062140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6351812|NCT00062140|Alkylating Agents|alkylating agents|mesh-ancestor
6351813|NCT00062140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351814|NCT00062140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6351815|NCT00062140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6351816|NCT00062179|Celecoxib|celecoxib|mesh-list
6351817|NCT00062179|Paclitaxel|paclitaxel|mesh-list
6351818|NCT00062179|Carboplatin|carboplatin|mesh-list
6351819|NCT00062179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6351820|NCT00062179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6351821|NCT00062179|Tubulin Modulators|tubulin modulators|mesh-ancestor
6351822|NCT00062179|Antimitotic Agents|antimitotic agents|mesh-ancestor
6351823|NCT00062179|Mitosis Modulators|mitosis modulators|mesh-ancestor
6351824|NCT00062179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351825|NCT00062179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6351826|NCT00062179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6351827|NCT00062179|Analgesics|analgesics|mesh-ancestor
6351828|NCT00062179|Sensory System Agents|sensory system agents|mesh-ancestor
6351829|NCT00062179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6351830|NCT00062179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351831|NCT00062179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6351832|NCT00062179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6351833|NCT00062179|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6351834|NCT00062179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6351835|NCT00062179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6351836|NCT00062205|Imatinib Mesylate|imatinib mesylate|mesh-list
6351837|NCT00062205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6351838|NCT00062205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6351839|NCT00062205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6351840|NCT00062205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351841|NCT00062231|Amoxicillin|amoxicillin|mesh-list
6351842|NCT00062231|Moxifloxacin|moxifloxacin|mesh-list
6351843|NCT00062231|Ciprofloxacin|ciprofloxacin|mesh-list
6351844|NCT00062231|Clavulanic Acid|clavulanic acid|mesh-list
6351845|NCT00062231|Clavulanic Acids|clavulanic acids|mesh-list
6351846|NCT00062231|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6351847|NCT00062231|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6351848|NCT00062231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6351849|NCT00062231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6351850|NCT00062231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6351851|NCT00062231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6351852|NCT00062231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6351853|NCT00062231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351854|NCT00062231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6351855|NCT00062231|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6351856|NCT00062231|Contraceptive Agents|contraceptive agents|mesh-ancestor
6351857|NCT00062231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6351858|NCT00062231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351859|NCT00062231|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6351860|NCT00062231|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6351861|NCT00062231|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6351862|NCT00062231|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6351863|NCT00062231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6351864|NCT00062231|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6351865|NCT00062244|Oblimersen|oblimersen|mesh-list
6351866|NCT00062244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6351867|NCT00062257|Irofulven|irofulven|mesh-list
6351868|NCT00062257|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6351869|NCT00062257|Alkylating Agents|alkylating agents|mesh-ancestor
6351870|NCT00062257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351871|NCT00062257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6351872|NCT00062270|Gemcitabine|gemcitabine|mesh-list
6351873|NCT00062270|Docetaxel|docetaxel|mesh-list
6351874|NCT00062270|Gefitinib|gefitinib|mesh-list
6351875|NCT00062270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6351876|NCT00062270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6351877|NCT00062270|Antimetabolites|antimetabolites|mesh-ancestor
6351878|NCT00062270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351879|NCT00062270|Antiviral Agents|antiviral agents|mesh-ancestor
6351880|NCT00062270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6351881|NCT00062270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6351882|NCT00062270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6351883|NCT00062270|Immunologic Factors|immunologic factors|mesh-ancestor
6351884|NCT00062270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351885|NCT00062270|Tubulin Modulators|tubulin modulators|mesh-ancestor
6351886|NCT00062270|Antimitotic Agents|antimitotic agents|mesh-ancestor
6351887|NCT00062270|Mitosis Modulators|mitosis modulators|mesh-ancestor
6351888|NCT00062270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6351889|NCT00062283|Alanosine|alanosine|mesh-list
6351890|NCT00062283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6351891|NCT00062283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6351892|NCT00062283|Chelating Agents|chelating agents|mesh-ancestor
6351893|NCT00062283|Sequestering Agents|sequestering agents|mesh-ancestor
6351894|NCT00062283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351895|NCT00062296|Rituximab|rituximab|mesh-list
6351896|NCT00062296|Epirubicin|epirubicin|mesh-list
6351897|NCT00062296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6351898|NCT00062296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6351899|NCT00062296|Immunologic Factors|immunologic factors|mesh-ancestor
6351900|NCT00062296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351901|NCT00062296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6351902|NCT00062296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6351903|NCT00062296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6351904|NCT00062296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6351905|NCT00062296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6351906|NCT00062296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351907|NCT00062322|Irinotecan|irinotecan|mesh-list
6351908|NCT00062322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6351909|NCT00062322|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6351910|NCT00062322|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6351911|NCT00062322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6351912|NCT00062322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351913|NCT00062426|Leucovorin|leucovorin|mesh-list
6351914|NCT00062426|Bevacizumab|bevacizumab|mesh-list
6351915|NCT00062426|Fluorouracil|fluorouracil|mesh-list
6351916|NCT00062426|Capecitabine|capecitabine|mesh-list
6351917|NCT00062426|Oxaliplatin|oxaliplatin|mesh-list
6351918|NCT00062426|Calcium|calcium|mesh-list
6351919|NCT00062426|Levoleucovorin|levoleucovorin|mesh-list
6351920|NCT00062426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6351921|NCT00062426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6351922|NCT00062426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6351923|NCT00062426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6351924|NCT00062426|Growth Substances|growth substances|mesh-ancestor
6351925|NCT00062426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351926|NCT00062426|Growth Inhibitors|growth inhibitors|mesh-ancestor
6351927|NCT00062426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6351928|NCT00062426|Antimetabolites|antimetabolites|mesh-ancestor
6351929|NCT00062426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351930|NCT00062426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6351931|NCT00062426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6351932|NCT00062426|Immunologic Factors|immunologic factors|mesh-ancestor
6351933|NCT00062426|Antidotes|antidotes|mesh-ancestor
6351934|NCT00062426|Protective Agents|protective agents|mesh-ancestor
6351935|NCT00062426|Vitamin B Complex|vitamin b complex|mesh-ancestor
6351936|NCT00062426|Vitamins|vitamins|mesh-ancestor
6351937|NCT00062426|Micronutrients|micronutrients|mesh-ancestor
6351938|NCT00062478|Camptothecin|camptothecin|mesh-list
6351939|NCT00062478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6351940|NCT00062478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6351941|NCT00062478|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6351942|NCT00062478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6351943|NCT00062478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6017003|NCT00369226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351944|NCT00062478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351945|NCT00062556|Niacin|niacin|mesh-list
6351946|NCT00062556|Lovastatin|lovastatin|mesh-list
6351947|NCT00062556|L 647318|l 647318|mesh-list
6351948|NCT00062556|Dihydromevinolin|dihydromevinolin|mesh-list
6351949|NCT00062556|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6351950|NCT00062556|Antimetabolites|antimetabolites|mesh-ancestor
6351951|NCT00062556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351952|NCT00062556|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6351953|NCT00062556|Vasodilator Agents|vasodilator agents|mesh-ancestor
6351954|NCT00062556|Vitamin B Complex|vitamin b complex|mesh-ancestor
6351955|NCT00062556|Vitamins|vitamins|mesh-ancestor
6351956|NCT00062556|Micronutrients|micronutrients|mesh-ancestor
6351957|NCT00062556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351958|NCT00062556|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6351959|NCT00062556|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6017004|NCT00369226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6017005|NCT00369226|Dermatologic Agents|dermatologic agents|mesh-ancestor
6017006|NCT00369226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6017007|NCT00369226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6351960|NCT00062556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6351961|NCT00062595|Vitamin K 1|vitamin k 1|mesh-list
6351962|NCT00062595|Vitamin K|vitamin k|mesh-list
6351963|NCT00062595|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6351964|NCT00062595|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6351965|NCT00062595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017008|NCT00369226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6351966|NCT00062595|Hemostatics|hemostatics|mesh-ancestor
6351967|NCT00062595|Coagulants|coagulants|mesh-ancestor
6351968|NCT00062595|Vitamins|vitamins|mesh-ancestor
6351969|NCT00062595|Micronutrients|micronutrients|mesh-ancestor
6351970|NCT00062595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351971|NCT00062660|Tipranavir|tipranavir|mesh-list
6351972|NCT00062660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6351973|NCT00062660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6351974|NCT00062660|Antiviral Agents|antiviral agents|mesh-ancestor
6351975|NCT00062660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6351976|NCT00062673|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6351977|NCT00062673|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6351978|NCT00062673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6351979|NCT00062673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6351980|NCT00062673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351981|NCT00062673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6351982|NCT00062673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351983|NCT00062673|Analgesics|analgesics|mesh-ancestor
6351984|NCT00062673|Sensory System Agents|sensory system agents|mesh-ancestor
6351985|NCT00062673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6351986|NCT00062673|Antidepressive Agents|antidepressive agents|mesh-ancestor
6351987|NCT00062673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6351988|NCT00062673|Dopamine Agents|dopamine agents|mesh-ancestor
6351989|NCT00062686|Lapatinib|lapatinib|mesh-list
6351990|NCT00062686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6351991|NCT00062686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6351992|NCT00062686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6351993|NCT00062686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6351994|NCT00062699|Calcitriol|calcitriol|mesh-list
6351995|NCT00062699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6351996|NCT00062699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6351997|NCT00062699|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6351998|NCT00062699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6351999|NCT00062699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352000|NCT00062699|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6352001|NCT00062699|Vitamins|vitamins|mesh-ancestor
6352002|NCT00062699|Micronutrients|micronutrients|mesh-ancestor
6352003|NCT00062699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6352004|NCT00062712|Sirolimus|sirolimus|mesh-list
6352005|NCT00062712|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6352006|NCT00062712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6352007|NCT00062712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6352008|NCT00062712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6352009|NCT00062712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6352010|NCT00062712|Antifungal Agents|antifungal agents|mesh-ancestor
6352011|NCT00062712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6352012|NCT00062712|Immunologic Factors|immunologic factors|mesh-ancestor
6352013|NCT00062712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352014|NCT00062790|Dutasteride|dutasteride|mesh-list
6352015|NCT00062790|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6352016|NCT00062790|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6352017|NCT00062790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6352018|NCT00062790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352019|NCT00062790|Hormone Antagonists|hormone antagonists|mesh-ancestor
6352020|NCT00062790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6352021|NCT00062790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352022|NCT00062803|Heparin|heparin|mesh-list
6352023|NCT00062803|Warfarin|warfarin|mesh-list
6352024|NCT00062803|Acenocoumarol|acenocoumarol|mesh-list
6352025|NCT00062803|Anticoagulants|anticoagulants|mesh-ancestor
6352026|NCT00062803|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6352027|NCT00062803|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6352028|NCT00062803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352029|NCT00062816|Ribavirin|ribavirin|mesh-list
6352030|NCT00062816|Antimetabolites|antimetabolites|mesh-ancestor
6352031|NCT00062816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352032|NCT00062816|Antiviral Agents|antiviral agents|mesh-ancestor
6352033|NCT00062816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6352034|NCT00062842|Irinotecan|irinotecan|mesh-list
6352035|NCT00062842|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6352036|NCT00062842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6352037|NCT00062842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6352038|NCT00062842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352039|NCT00062842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6352040|NCT00062881|Mafosfamide|mafosfamide|mesh-list
6352041|NCT00062881|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6352042|NCT00062881|Immunologic Factors|immunologic factors|mesh-ancestor
6352043|NCT00062881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352044|NCT00062881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6352045|NCT00062894|Tositumomab I-131|tositumomab i-131|mesh-list
6352046|NCT00062894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6352047|NCT00062946|Fallypride|fallypride|mesh-list
6352048|NCT00062946|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6352049|NCT00062946|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6352050|NCT00062946|Dopamine Agents|dopamine agents|mesh-ancestor
6352051|NCT00062946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6352052|NCT00062946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352053|NCT00062946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352054|NCT00062972|Donepezil|donepezil|mesh-list
6352055|NCT00062972|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6352056|NCT00062972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6352057|NCT00062972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352058|NCT00062972|Cholinergic Agents|cholinergic agents|mesh-ancestor
6352059|NCT00062972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6352060|NCT00062972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352061|NCT00062972|Nootropic Agents|nootropic agents|mesh-ancestor
6352062|NCT00063011|Calcium|calcium|mesh-list
6352063|NCT00063011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6352064|NCT00063011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352065|NCT00063024|Calcium|calcium|mesh-list
6352066|NCT00063024|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6352067|NCT00063024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352068|NCT00063076|Bexarotene|bexarotene|mesh-list
6352069|NCT00063076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6352070|NCT00063089|Immunoglobulins|immunoglobulins|mesh-list
6352071|NCT00063089|Antibodies|antibodies|mesh-list
6352072|NCT00063089|gamma-Globulins|gamma-globulins|mesh-list
6352073|NCT00063089|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6352074|NCT00063089|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6352075|NCT00063089|Immunologic Factors|immunologic factors|mesh-ancestor
6352076|NCT00063089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352077|NCT00063128|Insulin|insulin|mesh-list
6352078|NCT00063128|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6352079|NCT00063128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6352080|NCT00063128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352081|NCT00063141|Irinotecan|irinotecan|mesh-list
6352082|NCT00063141|Cetuximab|cetuximab|mesh-list
6352083|NCT00063141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6352084|NCT00063141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6352085|NCT00063141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6352086|NCT00063141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352087|NCT00063141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6352088|NCT00063141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6352089|NCT00063193|Minocycline|minocycline|mesh-list
6352090|NCT00063193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6352091|NCT00063193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6352092|NCT00063310|Leuprolide|leuprolide|mesh-list
6352093|NCT00063310|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6352094|NCT00063310|Fertility Agents|fertility agents|mesh-ancestor
6352095|NCT00063310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6352096|NCT00063310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352097|NCT00063310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6352098|NCT00063310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6352099|NCT00063323|Bupropion|bupropion|mesh-list
6352100|NCT00063323|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6352101|NCT00063323|Antidepressive Agents|antidepressive agents|mesh-ancestor
6352102|NCT00063323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6352103|NCT00063323|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6352104|NCT00063323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6352105|NCT00063323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6352106|NCT00063323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352107|NCT00063323|Dopamine Agents|dopamine agents|mesh-ancestor
6352108|NCT00063323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6352109|NCT00063323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352110|NCT00063323|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6352111|NCT00063323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6352112|NCT00063323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6352113|NCT00063388|Cetuximab|cetuximab|mesh-list
6352114|NCT00063388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6352115|NCT00063388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6394374|NCT00202007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6394375|NCT00202007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394376|NCT00202007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394377|NCT00202007|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6394378|NCT00202007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6394379|NCT00202007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6394380|NCT00202007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6394381|NCT00202007|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6394382|NCT00202007|Dopamine Agents|dopamine agents|mesh-ancestor
6394383|NCT00202007|Antidepressive Agents|antidepressive agents|mesh-ancestor
6394384|NCT00202007|Dopamine Agonists|dopamine agonists|mesh-ancestor
6394385|NCT00202007|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6394386|NCT00202007|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6352116|NCT00063401|Paclitaxel|paclitaxel|mesh-list
6352117|NCT00063401|Carboplatin|carboplatin|mesh-list
6352118|NCT00063401|Cetuximab|cetuximab|mesh-list
6352119|NCT00063401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6352120|NCT00063401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6352121|NCT00063401|Tubulin Modulators|tubulin modulators|mesh-ancestor
6352122|NCT00063401|Antimitotic Agents|antimitotic agents|mesh-ancestor
6352123|NCT00063401|Mitosis Modulators|mitosis modulators|mesh-ancestor
6352124|NCT00063401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352125|NCT00063401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6352126|NCT00063414|Alicaforsen|alicaforsen|mesh-list
6352127|NCT00063414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6352128|NCT00063414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6352129|NCT00063414|Immunologic Factors|immunologic factors|mesh-ancestor
6352130|NCT00063414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352131|NCT00063453|Vitamins|vitamins|mesh-list
6352132|NCT00063453|Vitamin E|vitamin e|mesh-list
6352133|NCT00063453|Tocopherols|tocopherols|mesh-list
6352134|NCT00063453|Tocotrienols|tocotrienols|mesh-list
6352135|NCT00063453|alpha-Tocopherol|alpha-tocopherol|mesh-list
6352136|NCT00063453|Selenium|selenium|mesh-list
6352137|NCT00063453|Micronutrients|micronutrients|mesh-ancestor
6352138|NCT00063453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352139|NCT00063453|Antioxidants|antioxidants|mesh-ancestor
6352140|NCT00063453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352141|NCT00063453|Protective Agents|protective agents|mesh-ancestor
6352142|NCT00063453|Trace Elements|trace elements|mesh-ancestor
6352143|NCT00063479|Zoledronic Acid|zoledronic acid|mesh-list
6352144|NCT00063479|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6352145|NCT00063479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352146|NCT00063583|Pirfenidone|pirfenidone|mesh-list
6352147|NCT00063583|Analgesics|analgesics|mesh-ancestor
6352148|NCT00063583|Sensory System Agents|sensory system agents|mesh-ancestor
6352149|NCT00063583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6352150|NCT00063583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352151|NCT00063583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6352152|NCT00063583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6352153|NCT00063583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6352154|NCT00063583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6352155|NCT00063583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6352156|NCT00063596|Vitamin A|vitamin a|mesh-list
6352157|NCT00063596|Vitamins|vitamins|mesh-ancestor
6352158|NCT00063596|Micronutrients|micronutrients|mesh-ancestor
6352159|NCT00063596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352160|NCT00063609|Zoledronic Acid|zoledronic acid|mesh-list
6352161|NCT00063609|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6352162|NCT00063609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352163|NCT00063687|Oxypurinol|oxypurinol|mesh-list
6352164|NCT00063687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6352165|NCT00063687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352166|NCT00063713|Bortezomib|bortezomib|mesh-list
6352167|NCT00063713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6352168|NCT00063726|Bortezomib|bortezomib|mesh-list
6352169|NCT00063726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6352170|NCT00063791|Bortezomib|bortezomib|mesh-list
6352171|NCT00063791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6352172|NCT00063804|Ritonavir|ritonavir|mesh-list
6352173|NCT00063804|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6352174|NCT00063804|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6352175|NCT00063804|Protease Inhibitors|protease inhibitors|mesh-ancestor
6352176|NCT00063804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6352177|NCT00063804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352178|NCT00063804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6352179|NCT00063804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6352180|NCT00063804|Antiviral Agents|antiviral agents|mesh-ancestor
6352181|NCT00063804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6017009|NCT00369226|Immunologic Factors|immunologic factors|mesh-ancestor
6352182|NCT00063804|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6352183|NCT00063804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6352184|NCT00063830|Alicaforsen|alicaforsen|mesh-list
6352185|NCT00063830|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6352186|NCT00063830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6352187|NCT00063830|Immunologic Factors|immunologic factors|mesh-ancestor
6352188|NCT00063830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352189|NCT00063869|Etanercept|etanercept|mesh-list
6352190|NCT00063869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6352191|NCT00063869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6352192|NCT00063869|Analgesics|analgesics|mesh-ancestor
6352193|NCT00063869|Sensory System Agents|sensory system agents|mesh-ancestor
6352194|NCT00063869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6352195|NCT00063869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352196|NCT00063869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6352197|NCT00063869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6352198|NCT00063869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6352199|NCT00063869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6352200|NCT00063869|Immunologic Factors|immunologic factors|mesh-ancestor
6352201|NCT00063895|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6352202|NCT00063895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6352203|NCT00063895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6352204|NCT00063895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6352205|NCT00063895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352206|NCT00063947|Gemcitabine|gemcitabine|mesh-list
6352207|NCT00063947|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6352208|NCT00063947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6352209|NCT00063947|Antimetabolites|antimetabolites|mesh-ancestor
6352210|NCT00063947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352211|NCT00063947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6352212|NCT00063947|Antiviral Agents|antiviral agents|mesh-ancestor
6352213|NCT00063947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6352214|NCT00063947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6352215|NCT00063947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6352216|NCT00063947|Immunologic Factors|immunologic factors|mesh-ancestor
6352217|NCT00063947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352218|NCT00063947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6352219|NCT00063960|Irinotecan|irinotecan|mesh-list
6352220|NCT00063960|Floxuridine|floxuridine|mesh-list
6352221|NCT00063960|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6352222|NCT00063960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6352223|NCT00063960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6352224|NCT00063960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352225|NCT00063960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6352226|NCT00063960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6017010|NCT00369226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6352227|NCT00063960|Antimetabolites|antimetabolites|mesh-ancestor
6352228|NCT00064012|Docetaxel|docetaxel|mesh-list
6352229|NCT00064012|Bortezomib|bortezomib|mesh-list
6352230|NCT00064012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6352231|NCT00064012|Tubulin Modulators|tubulin modulators|mesh-ancestor
6352232|NCT00064012|Antimitotic Agents|antimitotic agents|mesh-ancestor
6352233|NCT00064012|Mitosis Modulators|mitosis modulators|mesh-ancestor
6352234|NCT00064012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352235|NCT00064051|Gemcitabine|gemcitabine|mesh-list
6352236|NCT00064051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6352237|NCT00064051|Antimetabolites|antimetabolites|mesh-ancestor
6352238|NCT00064051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352239|NCT00064051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6352240|NCT00064051|Antiviral Agents|antiviral agents|mesh-ancestor
6352241|NCT00064051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6352242|NCT00064051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6352243|NCT00064051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6352244|NCT00064051|Immunologic Factors|immunologic factors|mesh-ancestor
6352245|NCT00064051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352246|NCT00064064|Gemcitabine|gemcitabine|mesh-list
6352247|NCT00064064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6352248|NCT00064064|Antimetabolites|antimetabolites|mesh-ancestor
6352249|NCT00064064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352250|NCT00064064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6352251|NCT00064064|Antiviral Agents|antiviral agents|mesh-ancestor
6352252|NCT00064064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6352253|NCT00064064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6352254|NCT00064064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6352255|NCT00064064|Immunologic Factors|immunologic factors|mesh-ancestor
6352256|NCT00064064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352257|NCT00064090|Cytarabine|cytarabine|mesh-list
6352258|NCT00064090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6352259|NCT00064090|Antimetabolites|antimetabolites|mesh-ancestor
6352260|NCT00064090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352261|NCT00064090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6352262|NCT00064090|Antiviral Agents|antiviral agents|mesh-ancestor
6352263|NCT00064090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6352264|NCT00064090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6352265|NCT00064090|Immunologic Factors|immunologic factors|mesh-ancestor
6352266|NCT00064090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352267|NCT00064116|Rituximab|rituximab|mesh-list
6352268|NCT00064116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6352269|NCT00064116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6352270|NCT00064116|Immunologic Factors|immunologic factors|mesh-ancestor
6352271|NCT00064116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352272|NCT00064116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6352273|NCT00064129|Ipilimumab|ipilimumab|mesh-list
6352274|NCT00064129|Sargramostim|sargramostim|mesh-list
6352275|NCT00064129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6017011|NCT00369226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6017012|NCT00369226|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6017013|NCT00369278|Mycophenolic Acid|mycophenolic acid|mesh-list
6017014|NCT00369278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6017015|NCT00369278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6017016|NCT00369278|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6017017|NCT00369278|Antitubercular Agents|antitubercular agents|mesh-ancestor
6017018|NCT00369278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6017019|NCT00369278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6017020|NCT00369278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6017021|NCT00369278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017022|NCT00369343|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6017023|NCT00369343|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6017024|NCT00369343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6017025|NCT00369343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6017026|NCT00369343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017027|NCT00369343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6017028|NCT00369343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017029|NCT00369343|Antidepressive Agents|antidepressive agents|mesh-ancestor
6017030|NCT00369343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6352276|NCT00064129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6352277|NCT00064129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6352278|NCT00064129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352279|NCT00064129|Immunologic Factors|immunologic factors|mesh-ancestor
6352280|NCT00064129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352281|NCT00064142|Halofuginone|halofuginone|mesh-list
6352282|NCT00064142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6352283|NCT00064142|Coccidiostats|coccidiostats|mesh-ancestor
6352284|NCT00064142|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6352285|NCT00064142|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6352286|NCT00064142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6352287|NCT00064142|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6352288|NCT00064142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6352289|NCT00064142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352290|NCT00064142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6352291|NCT00064142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6352292|NCT00064142|Growth Substances|growth substances|mesh-ancestor
6352293|NCT00064142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352294|NCT00064142|Growth Inhibitors|growth inhibitors|mesh-ancestor
6352295|NCT00064181|Leucovorin|leucovorin|mesh-list
6352296|NCT00064181|Celecoxib|celecoxib|mesh-list
6352297|NCT00064181|Fluorouracil|fluorouracil|mesh-list
6352298|NCT00064181|Capecitabine|capecitabine|mesh-list
6352299|NCT00064181|Irinotecan|irinotecan|mesh-list
6352300|NCT00064181|Calcium|calcium|mesh-list
6352301|NCT00064181|Levoleucovorin|levoleucovorin|mesh-list
6352302|NCT00064181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6352303|NCT00064181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352304|NCT00064181|Antimetabolites|antimetabolites|mesh-ancestor
6352305|NCT00064181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352306|NCT00064181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6352307|NCT00064181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6352308|NCT00064181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6352309|NCT00064181|Immunologic Factors|immunologic factors|mesh-ancestor
6352310|NCT00064181|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6352311|NCT00064181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6352312|NCT00064181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6352313|NCT00064181|Antidotes|antidotes|mesh-ancestor
6352314|NCT00064181|Protective Agents|protective agents|mesh-ancestor
6352315|NCT00064181|Vitamin B Complex|vitamin b complex|mesh-ancestor
6352316|NCT00064181|Vitamins|vitamins|mesh-ancestor
6352317|NCT00064181|Micronutrients|micronutrients|mesh-ancestor
6352318|NCT00064181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6537205|NCT00821262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6537206|NCT00821262|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6352319|NCT00064181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6352320|NCT00064181|Analgesics|analgesics|mesh-ancestor
6352321|NCT00064181|Sensory System Agents|sensory system agents|mesh-ancestor
6352322|NCT00064181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6537207|NCT00821301|Fluphenazine|fluphenazine|mesh-list
6352323|NCT00064181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6352324|NCT00064181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6352325|NCT00064181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6352326|NCT00064181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6352327|NCT00064194|Vitamin E|vitamin e|mesh-list
6352328|NCT00064194|Selenium|selenium|mesh-list
6352329|NCT00064194|Vitamins|vitamins|mesh-ancestor
6352330|NCT00064194|Micronutrients|micronutrients|mesh-ancestor
6352331|NCT00064194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352332|NCT00064194|Antioxidants|antioxidants|mesh-ancestor
6352333|NCT00064194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352334|NCT00064194|Protective Agents|protective agents|mesh-ancestor
6352335|NCT00064194|Trace Elements|trace elements|mesh-ancestor
6352336|NCT00064207|Gemcitabine|gemcitabine|mesh-list
6352337|NCT00064207|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6352338|NCT00064207|Antimetabolites|antimetabolites|mesh-ancestor
6352339|NCT00064207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352340|NCT00064207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6352341|NCT00064207|Antiviral Agents|antiviral agents|mesh-ancestor
6352342|NCT00064207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6352343|NCT00064207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6352344|NCT00064207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6352345|NCT00064207|Immunologic Factors|immunologic factors|mesh-ancestor
6352346|NCT00064207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352347|NCT00064220|Soblidotin|soblidotin|mesh-list
6352348|NCT00064220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6352349|NCT00064233|Dasatinib|dasatinib|mesh-list
6352350|NCT00064233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6352351|NCT00064233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6352352|NCT00064233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6352353|NCT00064233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352354|NCT00064246|Rituximab|rituximab|mesh-list
6352355|NCT00064246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6352356|NCT00064246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6352357|NCT00064246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6352358|NCT00064246|Immunologic Factors|immunologic factors|mesh-ancestor
6352359|NCT00064246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352360|NCT00064246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6352361|NCT00064285|Imatinib Mesylate|imatinib mesylate|mesh-list
6352362|NCT00064285|Alvocidib|alvocidib|mesh-list
6352363|NCT00064285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6352364|NCT00064285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6352365|NCT00064285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6352366|NCT00064285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352367|NCT00064285|Growth Inhibitors|growth inhibitors|mesh-ancestor
6352368|NCT00064285|Growth Substances|growth substances|mesh-ancestor
6352369|NCT00064285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352370|NCT00064389|Albuterol|albuterol|mesh-list
6352371|NCT00064389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6352372|NCT00064389|Autonomic Agents|autonomic agents|mesh-ancestor
6352373|NCT00064389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6352374|NCT00064389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352375|NCT00064389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6352376|NCT00064389|Respiratory System Agents|respiratory system agents|mesh-ancestor
6352377|NCT00064389|Tocolytic Agents|tocolytic agents|mesh-ancestor
6352378|NCT00064389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6352379|NCT00064389|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6352380|NCT00064389|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6352381|NCT00064389|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6352382|NCT00064389|Adrenergic Agents|adrenergic agents|mesh-ancestor
6352383|NCT00064389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6352384|NCT00064389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352385|NCT00064402|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6352386|NCT00064402|Formoterol Fumarate|formoterol fumarate|mesh-list
6352387|NCT00064402|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6352388|NCT00064402|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6352389|NCT00064402|Autonomic Agents|autonomic agents|mesh-ancestor
6352390|NCT00064402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6352391|NCT00064402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352392|NCT00064402|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6352393|NCT00064402|Respiratory System Agents|respiratory system agents|mesh-ancestor
6352394|NCT00064402|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6352395|NCT00064402|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6352396|NCT00064402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6352397|NCT00064402|Adrenergic Agents|adrenergic agents|mesh-ancestor
6352398|NCT00064402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6352399|NCT00064402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352400|NCT00064415|Formoterol Fumarate|formoterol fumarate|mesh-list
6352401|NCT00064415|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6352402|NCT00064415|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6352403|NCT00064415|Autonomic Agents|autonomic agents|mesh-ancestor
6352404|NCT00064415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6352405|NCT00064415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352406|NCT00064415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6352407|NCT00064415|Respiratory System Agents|respiratory system agents|mesh-ancestor
6352408|NCT00064415|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6352409|NCT00064415|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6352410|NCT00064415|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6352411|NCT00064415|Adrenergic Agents|adrenergic agents|mesh-ancestor
6352412|NCT00064415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6352413|NCT00064415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352414|NCT00064428|PENTA|penta|mesh-list
6352415|NCT00064428|Fondaparinux|fondaparinux|mesh-list
6352416|NCT00064428|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6352417|NCT00064428|Antithrombins|antithrombins|mesh-ancestor
6352418|NCT00064428|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6352419|NCT00064428|Protease Inhibitors|protease inhibitors|mesh-ancestor
6352420|NCT00064428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6352421|NCT00064428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352422|NCT00064428|Anticoagulants|anticoagulants|mesh-ancestor
6352423|NCT00064428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6352424|NCT00064428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6352425|NCT00064467|Bupropion|bupropion|mesh-list
6352426|NCT00064467|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6352427|NCT00064467|Antidepressive Agents|antidepressive agents|mesh-ancestor
6352428|NCT00064467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6352429|NCT00064467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6352430|NCT00064467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6352431|NCT00064467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6352432|NCT00064467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352433|NCT00064467|Dopamine Agents|dopamine agents|mesh-ancestor
6352434|NCT00064467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6352435|NCT00064467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352436|NCT00064467|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6352437|NCT00064467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6352438|NCT00064467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6352439|NCT00064610|Bortezomib|bortezomib|mesh-list
6352440|NCT00064610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6352441|NCT00064623|Capsaicin|capsaicin|mesh-list
6352442|NCT00064623|Antipruritics|antipruritics|mesh-ancestor
6352443|NCT00064623|Dermatologic Agents|dermatologic agents|mesh-ancestor
6537208|NCT00821301|Fluphenazine depot|fluphenazine depot|mesh-list
6352444|NCT00064623|Sensory System Agents|sensory system agents|mesh-ancestor
6352445|NCT00064623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6352446|NCT00064623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352447|NCT00064636|Bortezomib|bortezomib|mesh-list
6352448|NCT00064636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6352449|NCT00064649|Finasteride|finasteride|mesh-list
6352450|NCT00064649|Alfuzosin|alfuzosin|mesh-list
6352451|NCT00064649|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6352452|NCT00064649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6352453|NCT00064649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6352454|NCT00064649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352455|NCT00064649|Hormone Antagonists|hormone antagonists|mesh-ancestor
6352456|NCT00064649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6352457|NCT00064649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352458|NCT00064649|Urological Agents|urological agents|mesh-ancestor
6352459|NCT00064649|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6352460|NCT00064649|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6352461|NCT00064649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6352462|NCT00064649|Adrenergic Agents|adrenergic agents|mesh-ancestor
6352463|NCT00064649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6352464|NCT00064727|Rosiglitazone|rosiglitazone|mesh-list
6352465|NCT00064727|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6352466|NCT00064727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352467|NCT00064766|Doxycycline|doxycycline|mesh-list
6352468|NCT00064766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6352469|NCT00064766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6352470|NCT00064766|Antimalarials|antimalarials|mesh-ancestor
6352471|NCT00064766|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6352472|NCT00064766|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6352473|NCT00064857|Pycnogenols|pycnogenols|mesh-list
6352474|NCT00064857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6352475|NCT00064857|Immunologic Factors|immunologic factors|mesh-ancestor
6352476|NCT00064857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352477|NCT00064857|Antioxidants|antioxidants|mesh-ancestor
6352478|NCT00064857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352479|NCT00064857|Protective Agents|protective agents|mesh-ancestor
6352480|NCT00064857|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6352481|NCT00064974|Lenalidomide|lenalidomide|mesh-list
6352482|NCT00064974|Immunologic Factors|immunologic factors|mesh-ancestor
6352483|NCT00064974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352484|NCT00064974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6352485|NCT00064974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6352486|NCT00064974|Growth Substances|growth substances|mesh-ancestor
6352487|NCT00064974|Growth Inhibitors|growth inhibitors|mesh-ancestor
6352488|NCT00064974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6017031|NCT00369382|Cyclosporine|cyclosporine|mesh-list
6017032|NCT00369382|Sirolimus|sirolimus|mesh-list
6017033|NCT00369382|Tacrolimus|tacrolimus|mesh-list
6017034|NCT00369382|Cyclosporins|cyclosporins|mesh-list
6017035|NCT00369382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6017036|NCT00369382|Immunologic Factors|immunologic factors|mesh-ancestor
6017037|NCT00369382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017038|NCT00369382|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6017039|NCT00369382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6394387|NCT00202007|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6394388|NCT00202007|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6394389|NCT00202020|Aspirin|aspirin|mesh-list
6394390|NCT00202020|Cilostazol|cilostazol|mesh-list
6394391|NCT00202020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6394392|NCT00202020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6394393|NCT00202020|Analgesics|analgesics|mesh-ancestor
6394394|NCT00202020|Sensory System Agents|sensory system agents|mesh-ancestor
6394395|NCT00202020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6394396|NCT00202020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394397|NCT00202020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6394398|NCT00202020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6394399|NCT00202020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6394400|NCT00202020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6394401|NCT00202020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352489|NCT00065117|Leucovorin|leucovorin|mesh-list
6352490|NCT00065117|Fluorouracil|fluorouracil|mesh-list
6352491|NCT00065117|Oxaliplatin|oxaliplatin|mesh-list
6352492|NCT00065117|Antimetabolites|antimetabolites|mesh-ancestor
6352493|NCT00065117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352494|NCT00065117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6352495|NCT00065117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6352496|NCT00065117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6352497|NCT00065117|Immunologic Factors|immunologic factors|mesh-ancestor
6352498|NCT00065117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352499|NCT00065117|Antidotes|antidotes|mesh-ancestor
6352500|NCT00065117|Protective Agents|protective agents|mesh-ancestor
6352501|NCT00065117|Vitamin B Complex|vitamin b complex|mesh-ancestor
6352502|NCT00065117|Vitamins|vitamins|mesh-ancestor
6352503|NCT00065117|Micronutrients|micronutrients|mesh-ancestor
6352504|NCT00065130|Insulin|insulin|mesh-list
6352505|NCT00065130|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6352506|NCT00065130|Insulin Aspart|insulin aspart|mesh-list
6352507|NCT00065130|Isophane Insulin, Human|isophane insulin, human|mesh-list
6352508|NCT00065130|Insulin, Isophane|insulin, isophane|mesh-list
6352509|NCT00065130|Isophane insulin, beef|isophane insulin, beef|mesh-list
6352510|NCT00065130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6352511|NCT00065130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352512|NCT00065143|Clofarabine|clofarabine|mesh-list
6352513|NCT00065143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6352514|NCT00065143|Antimetabolites|antimetabolites|mesh-ancestor
6352515|NCT00065143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352516|NCT00065143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6017040|NCT00369382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017041|NCT00369382|Antifungal Agents|antifungal agents|mesh-ancestor
6017042|NCT00369382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6017043|NCT00369382|Dermatologic Agents|dermatologic agents|mesh-ancestor
6017044|NCT00369382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6017045|NCT00369382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6017046|NCT00369382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6017047|NCT00369382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6017048|NCT00369486|Triamcinolone|triamcinolone|mesh-list
6017049|NCT00369486|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6017050|NCT00369486|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6017051|NCT00369486|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6352517|NCT00065169|Celecoxib|celecoxib|mesh-list
6352518|NCT00065169|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6352519|NCT00065169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6352520|NCT00065169|Analgesics|analgesics|mesh-ancestor
6352521|NCT00065169|Sensory System Agents|sensory system agents|mesh-ancestor
6352522|NCT00065169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6352523|NCT00065169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352524|NCT00065169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6352525|NCT00065169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6352526|NCT00065169|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6352527|NCT00065169|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6352528|NCT00065169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6352529|NCT00065169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352530|NCT00065273|Olanzapine|olanzapine|mesh-list
6352531|NCT00065273|Risperidone|risperidone|mesh-list
6352532|NCT00065273|Clozapine|clozapine|mesh-list
6352533|NCT00065273|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6352534|NCT00065273|Serotonin Agents|serotonin agents|mesh-ancestor
6352535|NCT00065273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6352536|NCT00065273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352537|NCT00065273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352538|NCT00065273|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6352539|NCT00065273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6352540|NCT00065273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6352541|NCT00065273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6352542|NCT00065273|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6352543|NCT00065273|Dopamine Agents|dopamine agents|mesh-ancestor
6352544|NCT00065273|Antiemetics|antiemetics|mesh-ancestor
6352545|NCT00065273|Autonomic Agents|autonomic agents|mesh-ancestor
6352546|NCT00065273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6352547|NCT00065273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6352548|NCT00065273|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6352549|NCT00065273|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6352550|NCT00065273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6352551|NCT00065273|GABA Antagonists|gaba antagonists|mesh-ancestor
6352552|NCT00065273|GABA Agents|gaba agents|mesh-ancestor
6352553|NCT00065325|Fulvestrant|fulvestrant|mesh-list
6352554|NCT00065325|Exemestane|exemestane|mesh-list
6352555|NCT00065325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6352556|NCT00065325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6352557|NCT00065325|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6352558|NCT00065325|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6352559|NCT00065325|Hormone Antagonists|hormone antagonists|mesh-ancestor
6352560|NCT00065325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6352561|NCT00065325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352562|NCT00065325|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6352563|NCT00065325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6352564|NCT00065325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6352565|NCT00065325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352566|NCT00065351|Lenalidomide|lenalidomide|mesh-list
6352567|NCT00065351|Immunologic Factors|immunologic factors|mesh-ancestor
6352568|NCT00065351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352569|NCT00065351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6352570|NCT00065351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6352571|NCT00065351|Growth Substances|growth substances|mesh-ancestor
6352572|NCT00065351|Growth Inhibitors|growth inhibitors|mesh-ancestor
6352573|NCT00065351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6352574|NCT00065390|Pyrimethamine|pyrimethamine|mesh-list
6352575|NCT00065390|Antimalarials|antimalarials|mesh-ancestor
6352576|NCT00065390|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6352577|NCT00065390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6352578|NCT00065390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6352579|NCT00065390|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6352580|NCT00065390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6352581|NCT00065390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352582|NCT00065455|Vitamin A|vitamin a|mesh-list
6352583|NCT00065455|Vitamins|vitamins|mesh-ancestor
6352584|NCT00065455|Micronutrients|micronutrients|mesh-ancestor
6352585|NCT00065455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352586|NCT00065533|Pemetrexed|pemetrexed|mesh-list
6352587|NCT00065533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6352588|NCT00065533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6352589|NCT00065533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352590|NCT00065533|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6352591|NCT00065533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6352592|NCT00065546|Choline|choline|mesh-list
6352593|NCT00065546|Estrogens|estrogens|mesh-list
6352594|NCT00065546|Hormones|hormones|mesh-ancestor
6352595|NCT00065546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6352596|NCT00065546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352597|NCT00065546|Lipotropic Agents|lipotropic agents|mesh-ancestor
6352598|NCT00065546|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6352599|NCT00065546|Antimetabolites|antimetabolites|mesh-ancestor
6352600|NCT00065546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352601|NCT00065546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6537209|NCT00821301|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
6537210|NCT00821301|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6537211|NCT00821301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6537212|NCT00821301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6017052|NCT00369486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6352602|NCT00065546|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6017053|NCT00369486|Glucocorticoids|glucocorticoids|mesh-ancestor
6352603|NCT00065546|Nootropic Agents|nootropic agents|mesh-ancestor
6537213|NCT00821301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352604|NCT00065559|Celecoxib|celecoxib|mesh-list
6352605|NCT00065559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6352606|NCT00065559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6352607|NCT00065559|Analgesics|analgesics|mesh-ancestor
6352608|NCT00065559|Sensory System Agents|sensory system agents|mesh-ancestor
6352609|NCT00065559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6352610|NCT00065559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352611|NCT00065559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6352612|NCT00065559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6352613|NCT00065559|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6352614|NCT00065559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6352615|NCT00065559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6352616|NCT00065559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352617|NCT00065624|Thioctic Acid|thioctic acid|mesh-list
6352618|NCT00065624|Antioxidants|antioxidants|mesh-ancestor
6352619|NCT00065624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352620|NCT00065624|Protective Agents|protective agents|mesh-ancestor
6352621|NCT00065624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352622|NCT00065624|Vitamin B Complex|vitamin b complex|mesh-ancestor
6352623|NCT00065624|Vitamins|vitamins|mesh-ancestor
6352624|NCT00065624|Micronutrients|micronutrients|mesh-ancestor
6352625|NCT00065637|Teriparatide|teriparatide|mesh-list
6352626|NCT00065637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6352627|NCT00065637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352628|NCT00065637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6352629|NCT00065741|Silymarin|silymarin|mesh-list
6352630|NCT00065741|Antioxidants|antioxidants|mesh-ancestor
6352631|NCT00065741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352632|NCT00065741|Protective Agents|protective agents|mesh-ancestor
6352633|NCT00065741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352634|NCT00065767|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
6352635|NCT00065767|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6352636|NCT00065767|Hormone Antagonists|hormone antagonists|mesh-ancestor
6352637|NCT00065767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6352638|NCT00065767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352639|NCT00065767|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6352640|NCT00065767|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6537214|NCT00821301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6537215|NCT00821301|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6537216|NCT00821301|Dopamine Agents|dopamine agents|mesh-ancestor
6352641|NCT00065767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6352642|NCT00065871|Contraceptive Agents|contraceptive agents|mesh-list
6352643|NCT00065871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6352644|NCT00065871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352645|NCT00065884|Valproic Acid|valproic acid|mesh-list
6352646|NCT00065884|Anticonvulsants|anticonvulsants|mesh-ancestor
6352647|NCT00065884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6352648|NCT00065884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352649|NCT00065884|GABA Agents|gaba agents|mesh-ancestor
6352650|NCT00065884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6352651|NCT00065884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352652|NCT00065884|Antimanic Agents|antimanic agents|mesh-ancestor
6537217|NCT00821301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6537218|NCT00821301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537219|NCT00821353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
6537220|NCT00821392|Febuxostat|febuxostat|mesh-list
6352653|NCT00065884|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6352654|NCT00065884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6352655|NCT00065884|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6352656|NCT00065923|Topiramate|topiramate|mesh-list
6352657|NCT00065923|Anticonvulsants|anticonvulsants|mesh-ancestor
6352658|NCT00065923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6352659|NCT00065923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352660|NCT00065936|Naltrexone|naltrexone|mesh-list
6352661|NCT00065936|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6352662|NCT00065936|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6352663|NCT00065936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352664|NCT00065936|Sensory System Agents|sensory system agents|mesh-ancestor
6352665|NCT00065936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6352666|NCT00065949|Magnesium Sulfate|magnesium sulfate|mesh-list
6352667|NCT00065949|Analgesics|analgesics|mesh-ancestor
6352668|NCT00065949|Sensory System Agents|sensory system agents|mesh-ancestor
6352669|NCT00065949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6352670|NCT00065949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352671|NCT00065949|Anesthetics|anesthetics|mesh-ancestor
6352672|NCT00065949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6352673|NCT00065949|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6352674|NCT00065949|Anticonvulsants|anticonvulsants|mesh-ancestor
6352675|NCT00065949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6352676|NCT00065949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6352677|NCT00065949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352678|NCT00065949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6352679|NCT00065949|Tocolytic Agents|tocolytic agents|mesh-ancestor
6352680|NCT00065949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6352681|NCT00065962|Secretin|secretin|mesh-list
6352682|NCT00065962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6352683|NCT00065962|Hormones|hormones|mesh-ancestor
6352684|NCT00065962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6352685|NCT00065962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352686|NCT00066001|Metronidazole|metronidazole|mesh-list
6352687|NCT00066001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6352688|NCT00066001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6352689|NCT00066001|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6352690|NCT00066001|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6352691|NCT00066027|Doxycycline|doxycycline|mesh-list
6352692|NCT00066027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6352693|NCT00066027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6352694|NCT00066027|Antimalarials|antimalarials|mesh-ancestor
6352695|NCT00066027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6352696|NCT00066027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6352697|NCT00066040|Chlorhexidine|chlorhexidine|mesh-list
6352698|NCT00066040|Chlorhexidine, thymol drug combination|chlorhexidine, thymol drug combination|mesh-list
6352699|NCT00066040|Fluorides|fluorides|mesh-list
6352700|NCT00066040|Fluorides, Topical|fluorides, topical|mesh-list
6352701|NCT00066040|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
6352702|NCT00066040|Cariostatic Agents|cariostatic agents|mesh-ancestor
6352703|NCT00066040|Protective Agents|protective agents|mesh-ancestor
6352704|NCT00066040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352705|NCT00066040|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6352706|NCT00066040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6352707|NCT00066040|Disinfectants|disinfectants|mesh-ancestor
6352708|NCT00066092|Lenograstim|lenograstim|mesh-list
6352709|NCT00066092|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6352710|NCT00066092|Immunologic Factors|immunologic factors|mesh-ancestor
6352711|NCT00066092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352712|NCT00066157|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6352713|NCT00066157|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6352714|NCT00066157|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6352715|NCT00066157|Medroxyprogesterone|medroxyprogesterone|mesh-list
6352716|NCT00066157|Estradiol|estradiol|mesh-list
6352717|NCT00066157|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6352718|NCT00066157|Estrogens|estrogens|mesh-list
6352719|NCT00066157|Progesterone|progesterone|mesh-list
6352720|NCT00066157|Hormones|hormones|mesh-ancestor
6352721|NCT00066157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6352722|NCT00066157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352723|NCT00066157|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6352724|NCT00066157|Contraceptive Agents|contraceptive agents|mesh-ancestor
6352725|NCT00066157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6352726|NCT00066157|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6352727|NCT00066157|Progestins|progestins|mesh-ancestor
6352728|NCT00066157|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6352729|NCT00066157|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6352730|NCT00066157|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6352731|NCT00066157|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6352732|NCT00066157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6352733|NCT00066157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6352734|NCT00066196|Dacarbazine|dacarbazine|mesh-list
6352735|NCT00066196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6352736|NCT00066196|Alkylating Agents|alkylating agents|mesh-ancestor
6352737|NCT00066196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352738|NCT00066196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6352739|NCT00066248|Cyproheptadine|cyproheptadine|mesh-list
6352740|NCT00066248|Megestrol|megestrol|mesh-list
6352741|NCT00066248|Megestrol Acetate|megestrol acetate|mesh-list
6352742|NCT00066248|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6352743|NCT00066248|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6352744|NCT00066248|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6352745|NCT00066248|Contraceptive Agents|contraceptive agents|mesh-ancestor
6352746|NCT00066248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6352747|NCT00066248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352748|NCT00066248|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6352749|NCT00066248|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6352750|NCT00066248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6352751|NCT00066248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6352752|NCT00066248|Appetite Stimulants|appetite stimulants|mesh-ancestor
6352753|NCT00066248|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6352754|NCT00066248|Antipruritics|antipruritics|mesh-ancestor
6352755|NCT00066248|Dermatologic Agents|dermatologic agents|mesh-ancestor
6352756|NCT00066248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6352757|NCT00066248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6352758|NCT00066248|Histamine Antagonists|histamine antagonists|mesh-ancestor
6352759|NCT00066248|Histamine Agents|histamine agents|mesh-ancestor
6352760|NCT00066248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6352761|NCT00066248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352762|NCT00066248|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6352763|NCT00066248|Serotonin Agents|serotonin agents|mesh-ancestor
6352764|NCT00066248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6352765|NCT00066274|Leucovorin|leucovorin|mesh-list
6352766|NCT00066274|Fluorouracil|fluorouracil|mesh-list
6352767|NCT00066274|Oxaliplatin|oxaliplatin|mesh-list
6352768|NCT00066274|Irinotecan|irinotecan|mesh-list
6352769|NCT00066274|Calcium|calcium|mesh-list
6352770|NCT00066274|Levoleucovorin|levoleucovorin|mesh-list
6352771|NCT00066274|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6352772|NCT00066274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352773|NCT00066274|Antimetabolites|antimetabolites|mesh-ancestor
6352774|NCT00066274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352775|NCT00066274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6352776|NCT00066274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6352777|NCT00066274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6352778|NCT00066274|Immunologic Factors|immunologic factors|mesh-ancestor
6352779|NCT00066274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6352780|NCT00066274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6352781|NCT00066274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6352782|NCT00066274|Antidotes|antidotes|mesh-ancestor
6352783|NCT00066274|Protective Agents|protective agents|mesh-ancestor
6352784|NCT00066274|Vitamin B Complex|vitamin b complex|mesh-ancestor
6352785|NCT00066274|Vitamins|vitamins|mesh-ancestor
6352786|NCT00066274|Micronutrients|micronutrients|mesh-ancestor
6352787|NCT00066326|Imatinib Mesylate|imatinib mesylate|mesh-list
6352788|NCT00066326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6352789|NCT00066326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6352790|NCT00066326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6352791|NCT00066326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352792|NCT00066339|Gefitinib|gefitinib|mesh-list
6352793|NCT00066339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6352794|NCT00066339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6352795|NCT00066339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6352796|NCT00066339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352797|NCT00066352|Bortezomib|bortezomib|mesh-list
6352798|NCT00066352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6352799|NCT00066378|Gefitinib|gefitinib|mesh-list
6352800|NCT00066378|Anastrozole|anastrozole|mesh-list
6352801|NCT00066378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6352802|NCT00066378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6352803|NCT00066378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6352804|NCT00066378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352805|NCT00066378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6352806|NCT00066378|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6352807|NCT00066378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6352808|NCT00066378|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6352809|NCT00066378|Hormone Antagonists|hormone antagonists|mesh-ancestor
6352810|NCT00066378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6352811|NCT00066378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352812|NCT00066391|Irinotecan|irinotecan|mesh-list
6352813|NCT00066391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6352814|NCT00066391|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6352815|NCT00066391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6352816|NCT00066391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6352817|NCT00066391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352818|NCT00066417|Cyclosporine|cyclosporine|mesh-list
6352819|NCT00066417|Methylprednisolone|methylprednisolone|mesh-list
6352820|NCT00066417|Cyclophosphamide|cyclophosphamide|mesh-list
6352821|NCT00066417|Thiotepa|thiotepa|mesh-list
6352822|NCT00066417|Fludarabine|fludarabine|mesh-list
6352823|NCT00066417|Fludarabine phosphate|fludarabine phosphate|mesh-list
6352824|NCT00066417|Cyclosporins|cyclosporins|mesh-list
6352825|NCT00066417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6352826|NCT00066417|Immunologic Factors|immunologic factors|mesh-ancestor
6352827|NCT00066417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352828|NCT00066417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6352829|NCT00066417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6352830|NCT00066417|Alkylating Agents|alkylating agents|mesh-ancestor
6352831|NCT00066417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352832|NCT00066417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6352833|NCT00066417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6352834|NCT00066417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6352835|NCT00066417|Antimetabolites|antimetabolites|mesh-ancestor
6352836|NCT00066417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6352837|NCT00066417|Antifungal Agents|antifungal agents|mesh-ancestor
6352838|NCT00066417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6352839|NCT00066417|Dermatologic Agents|dermatologic agents|mesh-ancestor
6352840|NCT00066417|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6352841|NCT00066417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6352842|NCT00066417|Antiemetics|antiemetics|mesh-ancestor
6352843|NCT00066417|Autonomic Agents|autonomic agents|mesh-ancestor
6352844|NCT00066417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6352845|NCT00066417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6352846|NCT00066417|Glucocorticoids|glucocorticoids|mesh-ancestor
6352847|NCT00066417|Hormones|hormones|mesh-ancestor
6352848|NCT00066417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6352849|NCT00066417|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6352850|NCT00066417|Protective Agents|protective agents|mesh-ancestor
6352851|NCT00066443|Docetaxel|docetaxel|mesh-list
6352852|NCT00066443|Epirubicin|epirubicin|mesh-list
6352853|NCT00066443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6352854|NCT00066443|Tubulin Modulators|tubulin modulators|mesh-ancestor
6352855|NCT00066443|Antimitotic Agents|antimitotic agents|mesh-ancestor
6352856|NCT00066443|Mitosis Modulators|mitosis modulators|mesh-ancestor
6352857|NCT00066443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352858|NCT00066443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6352859|NCT00066443|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6352860|NCT00066443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6352861|NCT00066443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6352862|NCT00066456|Docetaxel|docetaxel|mesh-list
6352863|NCT00066456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6352864|NCT00066456|Tubulin Modulators|tubulin modulators|mesh-ancestor
6352865|NCT00066456|Antimitotic Agents|antimitotic agents|mesh-ancestor
6352866|NCT00066456|Mitosis Modulators|mitosis modulators|mesh-ancestor
6352867|NCT00066456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352868|NCT00066482|Cyclophosphamide|cyclophosphamide|mesh-list
6352869|NCT00066482|Cisplatin|cisplatin|mesh-list
6352870|NCT00066482|Etoposide|etoposide|mesh-list
6352871|NCT00066482|Bleomycin|bleomycin|mesh-list
6352872|NCT00066482|Lenograstim|lenograstim|mesh-list
6352873|NCT00066482|Sargramostim|sargramostim|mesh-list
6352874|NCT00066482|Mesna|mesna|mesh-list
6352875|NCT00066482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6352876|NCT00066482|Immunologic Factors|immunologic factors|mesh-ancestor
6352877|NCT00066482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352878|NCT00066482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6352879|NCT00066482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6352880|NCT00066482|Alkylating Agents|alkylating agents|mesh-ancestor
6352881|NCT00066482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352882|NCT00066482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6352883|NCT00066482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6352884|NCT00066482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6352885|NCT00066482|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6352886|NCT00066482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6352887|NCT00066482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6352888|NCT00066482|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6352889|NCT00066482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6352890|NCT00066482|Protective Agents|protective agents|mesh-ancestor
6352891|NCT00066508|Bortezomib|bortezomib|mesh-list
6352892|NCT00066508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6352893|NCT00066547|Antibodies|antibodies|mesh-list
6352894|NCT00066547|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6352895|NCT00066547|Immunologic Factors|immunologic factors|mesh-ancestor
6352896|NCT00066547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352897|NCT00066586|Exemestane|exemestane|mesh-list
6352898|NCT00066586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6352899|NCT00066586|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6352900|NCT00066586|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6352901|NCT00066586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6352902|NCT00066586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352903|NCT00066586|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6352904|NCT00066586|Hormone Antagonists|hormone antagonists|mesh-ancestor
6352905|NCT00066586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6352906|NCT00066586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352907|NCT00066599|Voriconazole|voriconazole|mesh-list
6352908|NCT00066599|Antifungal Agents|antifungal agents|mesh-ancestor
6352909|NCT00066599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6352910|NCT00066599|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6352911|NCT00066599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6352912|NCT00066599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6352913|NCT00066599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352914|NCT00066599|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6352915|NCT00066599|Hormone Antagonists|hormone antagonists|mesh-ancestor
6352916|NCT00066599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6352917|NCT00066599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352918|NCT00066599|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6352919|NCT00066612|Irinotecan|irinotecan|mesh-list
6352920|NCT00066612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6352921|NCT00066612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6352922|NCT00066612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6352923|NCT00066612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352924|NCT00066612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6352925|NCT00066625|Oxaliplatin|oxaliplatin|mesh-list
6352926|NCT00066625|Bortezomib|bortezomib|mesh-list
6352927|NCT00066625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6352928|NCT00066638|Romidepsin|romidepsin|mesh-list
6352929|NCT00066638|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6352930|NCT00066638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6352931|NCT00066651|Immunotoxins|immunotoxins|mesh-list
6352932|NCT00066651|Immunologic Factors|immunologic factors|mesh-ancestor
6352933|NCT00066651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352934|NCT00066716|Celecoxib|celecoxib|mesh-list
6352935|NCT00066716|Paclitaxel|paclitaxel|mesh-list
6352936|NCT00066716|Carboplatin|carboplatin|mesh-list
6352937|NCT00066716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6352938|NCT00066716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6352939|NCT00066716|Tubulin Modulators|tubulin modulators|mesh-ancestor
6352940|NCT00066716|Antimitotic Agents|antimitotic agents|mesh-ancestor
6352941|NCT00066716|Mitosis Modulators|mitosis modulators|mesh-ancestor
6352942|NCT00066716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352943|NCT00066716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6352944|NCT00066716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6352945|NCT00066716|Analgesics|analgesics|mesh-ancestor
6352946|NCT00066716|Sensory System Agents|sensory system agents|mesh-ancestor
6352947|NCT00066716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6352948|NCT00066716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352949|NCT00066716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6352950|NCT00066716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6352951|NCT00066716|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6352952|NCT00066716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6352953|NCT00066716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6352954|NCT00066768|Gemcitabine|gemcitabine|mesh-list
6352955|NCT00066768|Suramin|suramin|mesh-list
6352956|NCT00066768|Docetaxel|docetaxel|mesh-list
6352957|NCT00066768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6352958|NCT00066768|Antimetabolites|antimetabolites|mesh-ancestor
6352959|NCT00066768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352960|NCT00066768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6352961|NCT00066768|Antiviral Agents|antiviral agents|mesh-ancestor
6352962|NCT00066768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6352963|NCT00066768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6352964|NCT00066768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6352965|NCT00066768|Immunologic Factors|immunologic factors|mesh-ancestor
6352966|NCT00066768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352967|NCT00066768|Tubulin Modulators|tubulin modulators|mesh-ancestor
6352968|NCT00066768|Antimitotic Agents|antimitotic agents|mesh-ancestor
6352969|NCT00066768|Mitosis Modulators|mitosis modulators|mesh-ancestor
6352970|NCT00066768|Antinematodal Agents|antinematodal agents|mesh-ancestor
6352971|NCT00066768|Anthelmintics|anthelmintics|mesh-ancestor
6352972|NCT00066768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6352973|NCT00066768|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6352974|NCT00066768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6352975|NCT00066794|Cytarabine|cytarabine|mesh-list
6352976|NCT00066794|Cyclosporine|cyclosporine|mesh-list
6352977|NCT00066794|Daunorubicin|daunorubicin|mesh-list
6352978|NCT00066794|Cyclosporins|cyclosporins|mesh-list
6352979|NCT00066794|Sargramostim|sargramostim|mesh-list
6352980|NCT00066794|Immunologic Factors|immunologic factors|mesh-ancestor
6017054|NCT00369486|Hormones|hormones|mesh-ancestor
6017055|NCT00369486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6017056|NCT00369486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017057|NCT00369486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6017058|NCT00369486|Immunologic Factors|immunologic factors|mesh-ancestor
6017059|NCT00369486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6017060|NCT00369486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017061|NCT00369512|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6017062|NCT00369512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6017063|NCT00369512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6017064|NCT00369512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6352981|NCT00066794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6352982|NCT00066794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6352983|NCT00066794|Antimetabolites|antimetabolites|mesh-ancestor
6352984|NCT00066794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6352985|NCT00066794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6352986|NCT00066794|Antiviral Agents|antiviral agents|mesh-ancestor
6352987|NCT00066794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6352988|NCT00066794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6352989|NCT00066794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6352990|NCT00066794|Antifungal Agents|antifungal agents|mesh-ancestor
6352991|NCT00066794|Dermatologic Agents|dermatologic agents|mesh-ancestor
6352992|NCT00066794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6352993|NCT00066794|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6352994|NCT00066794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6352995|NCT00066794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6352996|NCT00066794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6352997|NCT00066846|Leucovorin|leucovorin|mesh-list
6352998|NCT00066846|Bevacizumab|bevacizumab|mesh-list
6352999|NCT00066846|Fluorouracil|fluorouracil|mesh-list
6353000|NCT00066846|Calcium|calcium|mesh-list
6353001|NCT00066846|Levoleucovorin|levoleucovorin|mesh-list
6353002|NCT00066846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6353003|NCT00066846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6353004|NCT00066846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6353005|NCT00066846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6353006|NCT00066846|Growth Substances|growth substances|mesh-ancestor
6353007|NCT00066846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353008|NCT00066846|Growth Inhibitors|growth inhibitors|mesh-ancestor
6353009|NCT00066846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6353010|NCT00066846|Antimetabolites|antimetabolites|mesh-ancestor
6353011|NCT00066846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353012|NCT00066846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6353013|NCT00066846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6353014|NCT00066846|Immunologic Factors|immunologic factors|mesh-ancestor
6353015|NCT00066846|Antidotes|antidotes|mesh-ancestor
6353016|NCT00066846|Protective Agents|protective agents|mesh-ancestor
6353017|NCT00066846|Vitamin B Complex|vitamin b complex|mesh-ancestor
6353018|NCT00066846|Vitamins|vitamins|mesh-ancestor
6353019|NCT00066846|Micronutrients|micronutrients|mesh-ancestor
6353020|NCT00066859|Sertraline|sertraline|mesh-list
6353021|NCT00066859|Antidepressive Agents|antidepressive agents|mesh-ancestor
6353022|NCT00066859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6353023|NCT00066859|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6353024|NCT00066859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6353025|NCT00066859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6353026|NCT00066859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353027|NCT00066859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6353028|NCT00066859|Serotonin Agents|serotonin agents|mesh-ancestor
6353029|NCT00066859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353030|NCT00066872|Imiquimod|imiquimod|mesh-list
6353031|NCT00066872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6353032|NCT00066872|Immunologic Factors|immunologic factors|mesh-ancestor
6353033|NCT00066872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353034|NCT00066872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6353035|NCT00066872|Interferon Inducers|interferon inducers|mesh-ancestor
6353036|NCT00066885|Calcitriol|calcitriol|mesh-list
6353037|NCT00066885|Docetaxel|docetaxel|mesh-list
6353038|NCT00066885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6353039|NCT00066885|Tubulin Modulators|tubulin modulators|mesh-ancestor
6353040|NCT00066885|Antimitotic Agents|antimitotic agents|mesh-ancestor
6353041|NCT00066885|Mitosis Modulators|mitosis modulators|mesh-ancestor
6353042|NCT00066885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353043|NCT00066885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6353044|NCT00066885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353045|NCT00066885|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6353046|NCT00066885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6353047|NCT00066885|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6353048|NCT00066885|Vitamins|vitamins|mesh-ancestor
6353049|NCT00066885|Micronutrients|micronutrients|mesh-ancestor
6353050|NCT00066885|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6394402|NCT00202020|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6394403|NCT00202020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6394404|NCT00202020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6394405|NCT00202020|Antipyretics|antipyretics|mesh-ancestor
6394406|NCT00202020|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6394407|NCT00202020|Autonomic Agents|autonomic agents|mesh-ancestor
6394408|NCT00202020|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6394409|NCT00202020|Respiratory System Agents|respiratory system agents|mesh-ancestor
6394410|NCT00202020|Vasodilator Agents|vasodilator agents|mesh-ancestor
6394411|NCT00202020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6394412|NCT00202020|Protective Agents|protective agents|mesh-ancestor
6394413|NCT00202020|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6394414|NCT00202020|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6394415|NCT00202059|Zoledronic Acid|zoledronic acid|mesh-list
6394416|NCT00202059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6394417|NCT00202059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394418|NCT00202124|Tryptophan|tryptophan|mesh-list
6394419|NCT00202124|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6394420|NCT00202124|Antidepressive Agents|antidepressive agents|mesh-ancestor
6394421|NCT00202124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6394422|NCT00202163|Testosterone|testosterone|mesh-list
6394423|NCT00202163|Androgens|androgens|mesh-ancestor
6394424|NCT00202163|Hormones|hormones|mesh-ancestor
6394425|NCT00202163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6394426|NCT00202163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394427|NCT00202176|Bromides|bromides|mesh-list
6394428|NCT00202176|Ipratropium|ipratropium|mesh-list
6394429|NCT00202176|Anticonvulsants|anticonvulsants|mesh-ancestor
6394430|NCT00202176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6394431|NCT00202176|Autonomic Agents|autonomic agents|mesh-ancestor
6394432|NCT00202176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6394433|NCT00202176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394434|NCT00202176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6394435|NCT00202176|Respiratory System Agents|respiratory system agents|mesh-ancestor
6394436|NCT00202176|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6394437|NCT00202176|Cholinergic Agents|cholinergic agents|mesh-ancestor
6394438|NCT00202176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6394439|NCT00202176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394440|NCT00202189|Budesonide|budesonide|mesh-list
6394441|NCT00202189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6394442|NCT00202189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6394443|NCT00202189|Autonomic Agents|autonomic agents|mesh-ancestor
6537221|NCT00821392|Gout Suppressants|gout suppressants|mesh-ancestor
6353051|NCT00066950|Chlorhexidine|chlorhexidine|mesh-list
6353052|NCT00066950|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6353053|NCT00066950|Fluorides|fluorides|mesh-list
6353054|NCT00066950|Fluorides, Topical|fluorides, topical|mesh-list
6353055|NCT00066950|Cariostatic Agents|cariostatic agents|mesh-ancestor
6353056|NCT00066950|Protective Agents|protective agents|mesh-ancestor
6353057|NCT00066950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353058|NCT00066950|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6353059|NCT00066950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6353060|NCT00066950|Disinfectants|disinfectants|mesh-ancestor
6353061|NCT00066950|Dermatologic Agents|dermatologic agents|mesh-ancestor
6353062|NCT00066989|Immunoglobulins|immunoglobulins|mesh-list
6353063|NCT00066989|Antibodies|antibodies|mesh-list
6353064|NCT00066989|gamma-Globulins|gamma-globulins|mesh-list
6353065|NCT00066989|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6353066|NCT00066989|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6353067|NCT00066989|Immunologic Factors|immunologic factors|mesh-ancestor
6353068|NCT00066989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353069|NCT00067015|Goserelin|goserelin|mesh-list
6353070|NCT00067015|Bicalutamide|bicalutamide|mesh-list
6353071|NCT00067015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6353072|NCT00067015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6353073|NCT00067015|Androgen Antagonists|androgen antagonists|mesh-ancestor
6353074|NCT00067015|Hormone Antagonists|hormone antagonists|mesh-ancestor
6353075|NCT00067015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6353076|NCT00067015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353077|NCT00067041|Treprostinil|treprostinil|mesh-list
6353078|NCT00067041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6353079|NCT00067080|Deferasirox|deferasirox|mesh-list
6353080|NCT00067080|Deferoxamine|deferoxamine|mesh-list
6353081|NCT00067080|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6353082|NCT00067080|Chelating Agents|chelating agents|mesh-ancestor
6353083|NCT00067080|Sequestering Agents|sequestering agents|mesh-ancestor
6353084|NCT00067080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353085|NCT00067080|Siderophores|siderophores|mesh-ancestor
6353086|NCT00067093|Vitamin K|vitamin k|mesh-list
6353087|NCT00067093|Heparin|heparin|mesh-list
6353088|NCT00067093|Calcium heparin|calcium heparin|mesh-list
6353089|NCT00067093|Idraparinux|idraparinux|mesh-list
6353090|NCT00067093|Vitamins|vitamins|mesh-ancestor
6353091|NCT00067093|Micronutrients|micronutrients|mesh-ancestor
6353092|NCT00067093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353093|NCT00067093|Anticoagulants|anticoagulants|mesh-ancestor
6353094|NCT00067093|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6353095|NCT00067093|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6353096|NCT00067093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353097|NCT00067093|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6353098|NCT00067093|Hemostatics|hemostatics|mesh-ancestor
6353099|NCT00067093|Coagulants|coagulants|mesh-ancestor
6353100|NCT00067093|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6353101|NCT00067093|Antithrombins|antithrombins|mesh-ancestor
6353102|NCT00067093|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6353103|NCT00067093|Protease Inhibitors|protease inhibitors|mesh-ancestor
6353104|NCT00067093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6353105|NCT00067119|Aspirin|aspirin|mesh-list
6353106|NCT00067119|Dipyridamole|dipyridamole|mesh-list
6353107|NCT00067119|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
6353108|NCT00067119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6353109|NCT00067119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6353110|NCT00067119|Analgesics|analgesics|mesh-ancestor
6353111|NCT00067119|Sensory System Agents|sensory system agents|mesh-ancestor
6353112|NCT00067119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6353113|NCT00067119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353114|NCT00067119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6353115|NCT00067119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6353116|NCT00067119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6353117|NCT00067119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6353118|NCT00067119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353119|NCT00067119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6353120|NCT00067119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6353121|NCT00067119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6353122|NCT00067119|Antipyretics|antipyretics|mesh-ancestor
6353123|NCT00067119|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6353124|NCT00067119|Vasodilator Agents|vasodilator agents|mesh-ancestor
6353125|NCT00067158|Nicotine|nicotine|mesh-list
6353126|NCT00067158|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6353127|NCT00067158|Autonomic Agents|autonomic agents|mesh-ancestor
6353128|NCT00067158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6353129|NCT00067158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353130|NCT00067158|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6353131|NCT00067158|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6353132|NCT00067158|Cholinergic Agents|cholinergic agents|mesh-ancestor
6353133|NCT00067158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6353134|NCT00067158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353135|NCT00067262|Valproic Acid|valproic acid|mesh-list
6353136|NCT00067262|Anticonvulsants|anticonvulsants|mesh-ancestor
6353137|NCT00067262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6353138|NCT00067262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353139|NCT00067262|GABA Agents|gaba agents|mesh-ancestor
6353140|NCT00067262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6353141|NCT00067262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353142|NCT00067262|Antimanic Agents|antimanic agents|mesh-ancestor
6353143|NCT00067262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6353144|NCT00067262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6353145|NCT00067262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6353146|NCT00067301|Citalopram|citalopram|mesh-list
6353147|NCT00067301|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6353148|NCT00067301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6353149|NCT00067301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6353150|NCT00067301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353151|NCT00067301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6353152|NCT00067301|Serotonin Agents|serotonin agents|mesh-ancestor
6353153|NCT00067301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353154|NCT00067301|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6353155|NCT00067301|Antidepressive Agents|antidepressive agents|mesh-ancestor
6353156|NCT00067301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6353157|NCT00067340|Chlorhexidine|chlorhexidine|mesh-list
6353158|NCT00067340|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6353159|NCT00067340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6353160|NCT00067340|Disinfectants|disinfectants|mesh-ancestor
6353161|NCT00067353|Fluorides|fluorides|mesh-list
6353162|NCT00067353|Fluorides, Topical|fluorides, topical|mesh-list
6353163|NCT00067353|Cariostatic Agents|cariostatic agents|mesh-ancestor
6353164|NCT00067353|Protective Agents|protective agents|mesh-ancestor
6353165|NCT00067353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353166|NCT00067405|Micronutrients|micronutrients|mesh-list
6353167|NCT00067405|Trace Elements|trace elements|mesh-list
6353168|NCT00067405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353169|NCT00067431|Valproic Acid|valproic acid|mesh-list
6017065|NCT00369512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017066|NCT00369577|Loxapine|loxapine|mesh-list
6017067|NCT00369577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6017068|NCT00369577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6353170|NCT00067431|Anticonvulsants|anticonvulsants|mesh-ancestor
6353171|NCT00067431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6353172|NCT00067431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353173|NCT00067431|GABA Agents|gaba agents|mesh-ancestor
6353174|NCT00067431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6353175|NCT00067431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353176|NCT00067431|Antimanic Agents|antimanic agents|mesh-ancestor
6353177|NCT00067431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6353178|NCT00067431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6353179|NCT00067431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6353180|NCT00067444|Paroxetine|paroxetine|mesh-list
6353181|NCT00067444|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6537222|NCT00821392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6537223|NCT00821444|Ziprasidone|ziprasidone|mesh-list
6537224|NCT00821444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6353182|NCT00067444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6353183|NCT00067444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6353184|NCT00067444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353185|NCT00067444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6353186|NCT00067444|Serotonin Agents|serotonin agents|mesh-ancestor
6353187|NCT00067444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353188|NCT00067444|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6353189|NCT00067444|Antidepressive Agents|antidepressive agents|mesh-ancestor
6353190|NCT00067444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6353191|NCT00067444|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6353192|NCT00067444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6353193|NCT00067444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6353194|NCT00067457|Alosetron|alosetron|mesh-list
6353195|NCT00067457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6353196|NCT00067457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6353197|NCT00067457|Serotonin Agents|serotonin agents|mesh-ancestor
6353198|NCT00067457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6353199|NCT00067457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353200|NCT00067457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353201|NCT00067496|Modafinil|modafinil|mesh-list
6353202|NCT00067496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6353203|NCT00067496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353204|NCT00067496|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6353205|NCT00067496|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6353206|NCT00067496|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6353207|NCT00067496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353208|NCT00067509|Progesterone|progesterone|mesh-list
6353209|NCT00067509|Estrogens|estrogens|mesh-list
6353210|NCT00067509|Progestins|progestins|mesh-ancestor
6353211|NCT00067509|Hormones|hormones|mesh-ancestor
6353212|NCT00067509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6353213|NCT00067509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353214|NCT00067535|Cocaine|cocaine|mesh-list
6353215|NCT00067535|Anesthetics, Local|anesthetics, local|mesh-ancestor
6353216|NCT00067535|Anesthetics|anesthetics|mesh-ancestor
6353217|NCT00067535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6353218|NCT00067535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353219|NCT00067535|Sensory System Agents|sensory system agents|mesh-ancestor
6353220|NCT00067535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6353221|NCT00067535|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6353222|NCT00067535|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6353223|NCT00067535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6353224|NCT00067535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6537225|NCT00821444|Serotonin Agents|serotonin agents|mesh-ancestor
6353225|NCT00067535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353226|NCT00067535|Dopamine Agents|dopamine agents|mesh-ancestor
6353227|NCT00067535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6353228|NCT00067548|EKB 569|ekb 569|mesh-list
6353229|NCT00067548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6353230|NCT00067548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6353231|NCT00067548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6353232|NCT00067548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353233|NCT00067561|Alosetron|alosetron|mesh-list
6353234|NCT00067561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6353235|NCT00067561|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6353236|NCT00067561|Serotonin Agents|serotonin agents|mesh-ancestor
6353237|NCT00067561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6353238|NCT00067561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353239|NCT00067561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353240|NCT00067600|Calcium|calcium|mesh-list
6353241|NCT00067600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6353242|NCT00067600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353243|NCT00067626|Chromium|chromium|mesh-list
6353244|NCT00067626|Trace Elements|trace elements|mesh-ancestor
6353245|NCT00067626|Micronutrients|micronutrients|mesh-ancestor
6353246|NCT00067626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353247|NCT00067730|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
6353248|NCT00067730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6353249|NCT00067743|Lenalidomide|lenalidomide|mesh-list
6353250|NCT00067743|Immunologic Factors|immunologic factors|mesh-ancestor
6353251|NCT00067743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353252|NCT00067743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6353253|NCT00067743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6353254|NCT00067743|Growth Substances|growth substances|mesh-ancestor
6353255|NCT00067743|Growth Inhibitors|growth inhibitors|mesh-ancestor
6353256|NCT00067743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6353257|NCT00067756|Butyric Acid|butyric acid|mesh-list
6353258|NCT00067756|Histamine Antagonists|histamine antagonists|mesh-ancestor
6353259|NCT00067756|Histamine Agents|histamine agents|mesh-ancestor
6353260|NCT00067756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6353261|NCT00067756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353262|NCT00067756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353263|NCT00067860|Hormones|hormones|mesh-list
6353264|NCT00067860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6353265|NCT00067860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353266|NCT00067899|Vitamins|vitamins|mesh-list
6353267|NCT00067899|Ascorbic Acid|ascorbic acid|mesh-list
6353268|NCT00067899|Vitamin E|vitamin e|mesh-list
6353269|NCT00067899|Micronutrients|micronutrients|mesh-ancestor
6353270|NCT00067899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353271|NCT00067899|Antioxidants|antioxidants|mesh-ancestor
6353272|NCT00067899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353273|NCT00067899|Protective Agents|protective agents|mesh-ancestor
6353274|NCT00067912|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6353275|NCT00067912|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6353276|NCT00067912|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6353277|NCT00067912|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6353278|NCT00067912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6353279|NCT00067912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353280|NCT00067912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6353281|NCT00067912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353282|NCT00067912|Analgesics|analgesics|mesh-ancestor
6353283|NCT00067912|Sensory System Agents|sensory system agents|mesh-ancestor
6353284|NCT00067912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6353285|NCT00067912|Antidepressive Agents|antidepressive agents|mesh-ancestor
6353286|NCT00067912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6353287|NCT00067912|Dopamine Agents|dopamine agents|mesh-ancestor
6353288|NCT00067912|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6353289|NCT00067925|Calcium|calcium|mesh-list
6353290|NCT00067925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6353291|NCT00067925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353292|NCT00067938|Lamotrigine|lamotrigine|mesh-list
6353293|NCT00067938|Anticonvulsants|anticonvulsants|mesh-ancestor
6353294|NCT00067938|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6353295|NCT00067938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6353296|NCT00067938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353297|NCT00067938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6353298|NCT00067938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353299|NCT00067938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6353300|NCT00067938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6353301|NCT00067938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6353302|NCT00067938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6353303|NCT00067938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6353304|NCT00067951|Metformin|metformin|mesh-list
6353305|NCT00067951|Rosiglitazone|rosiglitazone|mesh-list
6353306|NCT00067951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6353307|NCT00067951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353308|NCT00068029|Octreotide|octreotide|mesh-list
6353309|NCT00068029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6353310|NCT00068029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6353311|NCT00068029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6353312|NCT00068042|Octreotide|octreotide|mesh-list
6353313|NCT00068042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6353314|NCT00068042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6353315|NCT00068042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6017069|NCT00369577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6017070|NCT00369577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353316|NCT00068055|gamma-Globulins|gamma-globulins|mesh-list
6353317|NCT00068055|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6353318|NCT00068055|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6353319|NCT00068055|Immunologic Factors|immunologic factors|mesh-ancestor
6353320|NCT00068055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353321|NCT00068068|Talaporfin|talaporfin|mesh-list
6353322|NCT00068068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6353323|NCT00068068|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6353324|NCT00068068|Dermatologic Agents|dermatologic agents|mesh-ancestor
6353325|NCT00068081|Capsaicin|capsaicin|mesh-list
6353326|NCT00068081|Antipruritics|antipruritics|mesh-ancestor
6353327|NCT00068081|Dermatologic Agents|dermatologic agents|mesh-ancestor
6353328|NCT00068081|Sensory System Agents|sensory system agents|mesh-ancestor
6353329|NCT00068081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6353330|NCT00068081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353331|NCT00068276|Cholecalciferol|cholecalciferol|mesh-list
6353332|NCT00068276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6353333|NCT00068276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353334|NCT00068276|Vitamins|vitamins|mesh-ancestor
6353335|NCT00068276|Micronutrients|micronutrients|mesh-ancestor
6353336|NCT00068276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6353337|NCT00068289|Bortezomib|bortezomib|mesh-list
6353338|NCT00068289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6353339|NCT00068302|Sirolimus|sirolimus|mesh-list
6353340|NCT00068302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6353341|NCT00068302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6353342|NCT00068302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6353343|NCT00068302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6353344|NCT00068302|Antifungal Agents|antifungal agents|mesh-ancestor
6353345|NCT00068302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6353346|NCT00068302|Immunologic Factors|immunologic factors|mesh-ancestor
6353347|NCT00068302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353348|NCT00068315|Rituximab|rituximab|mesh-list
6353349|NCT00068315|Fludarabine|fludarabine|mesh-list
6353350|NCT00068315|Fludarabine phosphate|fludarabine phosphate|mesh-list
6353351|NCT00068315|Bortezomib|bortezomib|mesh-list
6353352|NCT00068315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6353353|NCT00068315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6353354|NCT00068315|Immunologic Factors|immunologic factors|mesh-ancestor
6353355|NCT00068315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353356|NCT00068315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6353357|NCT00068315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6353358|NCT00068315|Antimetabolites|antimetabolites|mesh-ancestor
6353359|NCT00068315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017071|NCT00369577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6353360|NCT00068315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6353361|NCT00068432|Gemcitabine|gemcitabine|mesh-list
6353362|NCT00068432|Celecoxib|celecoxib|mesh-list
6353363|NCT00068432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6353364|NCT00068432|Antimetabolites|antimetabolites|mesh-ancestor
6353365|NCT00068432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353366|NCT00068432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6353367|NCT00068432|Antiviral Agents|antiviral agents|mesh-ancestor
6353368|NCT00068432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6353369|NCT00068432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6353370|NCT00068432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6353371|NCT00068432|Immunologic Factors|immunologic factors|mesh-ancestor
6353372|NCT00068432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353373|NCT00068432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6353374|NCT00068432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6353375|NCT00068432|Analgesics|analgesics|mesh-ancestor
6353376|NCT00068432|Sensory System Agents|sensory system agents|mesh-ancestor
6353377|NCT00068432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6353378|NCT00068432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6353379|NCT00068432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6353380|NCT00068432|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6353381|NCT00068432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6353382|NCT00068458|Calcium, Dietary|calcium, dietary|mesh-list
6353383|NCT00068458|Calcium|calcium|mesh-list
6353384|NCT00068458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6353385|NCT00068458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353386|NCT00068458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6353387|NCT00068471|Anidulafungin|anidulafungin|mesh-list
6353388|NCT00068471|Antifungal Agents|antifungal agents|mesh-ancestor
6353389|NCT00068471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6353390|NCT00068484|Bortezomib|bortezomib|mesh-list
6353391|NCT00068484|Topotecan|topotecan|mesh-list
6353392|NCT00068484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6353393|NCT00068484|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6353394|NCT00068484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6353395|NCT00068484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6353396|NCT00068484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353397|NCT00068497|Gefitinib|gefitinib|mesh-list
6353398|NCT00068497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6353399|NCT00068497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6353400|NCT00068497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6353401|NCT00068497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353402|NCT00068523|Cyclosporine|cyclosporine|mesh-list
6353403|NCT00068523|Methylprednisolone|methylprednisolone|mesh-list
6353404|NCT00068523|Cyclophosphamide|cyclophosphamide|mesh-list
6353405|NCT00068523|Fludarabine|fludarabine|mesh-list
6353406|NCT00068523|Fludarabine phosphate|fludarabine phosphate|mesh-list
6353407|NCT00068523|Cyclosporins|cyclosporins|mesh-list
6353408|NCT00068523|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6353409|NCT00068523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6353410|NCT00068523|Immunologic Factors|immunologic factors|mesh-ancestor
6353411|NCT00068523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353412|NCT00068523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6353413|NCT00068523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6353414|NCT00068523|Alkylating Agents|alkylating agents|mesh-ancestor
6353415|NCT00068523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353416|NCT00068523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6353417|NCT00068523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6353418|NCT00068523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6353419|NCT00068523|Antimetabolites|antimetabolites|mesh-ancestor
6353420|NCT00068523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6353421|NCT00068523|Antifungal Agents|antifungal agents|mesh-ancestor
6353422|NCT00068523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6353423|NCT00068523|Dermatologic Agents|dermatologic agents|mesh-ancestor
6353424|NCT00068523|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6353425|NCT00068523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6353426|NCT00068523|Antiemetics|antiemetics|mesh-ancestor
6353427|NCT00068523|Autonomic Agents|autonomic agents|mesh-ancestor
6353428|NCT00068523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6353429|NCT00068523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6353430|NCT00068523|Glucocorticoids|glucocorticoids|mesh-ancestor
6353431|NCT00068523|Hormones|hormones|mesh-ancestor
6353432|NCT00068523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6353433|NCT00068523|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6353434|NCT00068523|Protective Agents|protective agents|mesh-ancestor
6353435|NCT00068549|Gemcitabine|gemcitabine|mesh-list
6353436|NCT00068549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6353437|NCT00068549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6353438|NCT00068549|Antimetabolites|antimetabolites|mesh-ancestor
6353439|NCT00068549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353440|NCT00068549|Antiviral Agents|antiviral agents|mesh-ancestor
6353441|NCT00068549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6353442|NCT00068549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6353443|NCT00068549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6353444|NCT00068549|Immunologic Factors|immunologic factors|mesh-ancestor
6353445|NCT00068549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394444|NCT00202189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6394445|NCT00202189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394446|NCT00202189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6394447|NCT00202189|Respiratory System Agents|respiratory system agents|mesh-ancestor
6394448|NCT00202189|Glucocorticoids|glucocorticoids|mesh-ancestor
6394449|NCT00202189|Hormones|hormones|mesh-ancestor
6394450|NCT00202189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6394451|NCT00202228|Riboflavin|riboflavin|mesh-list
6394452|NCT00202228|Thiamine|thiamine|mesh-list
6394453|NCT00202228|Vitamin B Complex|vitamin b complex|mesh-ancestor
6394454|NCT00202228|Vitamins|vitamins|mesh-ancestor
6394455|NCT00202228|Micronutrients|micronutrients|mesh-ancestor
6394456|NCT00202228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394457|NCT00202228|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6394458|NCT00202228|Dermatologic Agents|dermatologic agents|mesh-ancestor
6394459|NCT00202241|Testosterone|testosterone|mesh-list
6394460|NCT00202241|Androgens|androgens|mesh-ancestor
6394461|NCT00202241|Hormones|hormones|mesh-ancestor
6394462|NCT00202241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6394463|NCT00202241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394464|NCT00202280|Folic Acid|folic acid|mesh-list
6394465|NCT00202280|Vitamin B 12|vitamin b 12|mesh-list
6394466|NCT00202280|Hydroxocobalamin|hydroxocobalamin|mesh-list
6394467|NCT00202280|Vitamins|vitamins|mesh-ancestor
6394468|NCT00202280|Micronutrients|micronutrients|mesh-ancestor
6394469|NCT00202280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394470|NCT00202280|Hematinics|hematinics|mesh-ancestor
6394471|NCT00202280|Vitamin B Complex|vitamin b complex|mesh-ancestor
6394472|NCT00202293|Olanzapine|olanzapine|mesh-list
6394473|NCT00202293|Chlorpromazine|chlorpromazine|mesh-list
6394474|NCT00202293|Antiemetics|antiemetics|mesh-ancestor
6394475|NCT00202293|Autonomic Agents|autonomic agents|mesh-ancestor
6394476|NCT00202293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6394477|NCT00202293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394478|NCT00202293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6394479|NCT00202293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6394480|NCT00202293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6394481|NCT00202293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6394482|NCT00202293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6394483|NCT00202293|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6394484|NCT00202293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6394485|NCT00202293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6394486|NCT00202293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394487|NCT00202293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6394488|NCT00202293|Serotonin Agents|serotonin agents|mesh-ancestor
6394489|NCT00202293|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6394490|NCT00202293|Dopamine Agents|dopamine agents|mesh-ancestor
6394491|NCT00202306|Lithium Carbonate|lithium carbonate|mesh-list
6394492|NCT00202306|Antidepressive Agents|antidepressive agents|mesh-ancestor
6394493|NCT00202306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6394494|NCT00202306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6394495|NCT00202306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394496|NCT00202306|Antimanic Agents|antimanic agents|mesh-ancestor
6394497|NCT00202306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6394498|NCT00202306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6394499|NCT00202306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396990|NCT00209885|Antidepressive Agents|antidepressive agents|mesh-ancestor
6353446|NCT00068653|Celecoxib|celecoxib|mesh-list
6353447|NCT00068653|Gefitinib|gefitinib|mesh-list
6353448|NCT00068653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6353449|NCT00068653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6353450|NCT00068653|Analgesics|analgesics|mesh-ancestor
6353451|NCT00068653|Sensory System Agents|sensory system agents|mesh-ancestor
6353452|NCT00068653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6353453|NCT00068653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353454|NCT00068653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6353455|NCT00068653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6353456|NCT00068653|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6353457|NCT00068653|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6353458|NCT00068653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6353459|NCT00068653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353460|NCT00068653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6353461|NCT00068653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6353462|NCT00068666|Temozolomide|temozolomide|mesh-list
6353463|NCT00068666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6353464|NCT00068666|Alkylating Agents|alkylating agents|mesh-ancestor
6353465|NCT00068666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353466|NCT00068666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6353467|NCT00068731|Lycopene|lycopene|mesh-list
6353468|NCT00068731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6353469|NCT00068731|Antioxidants|antioxidants|mesh-ancestor
6353470|NCT00068731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353471|NCT00068731|Protective Agents|protective agents|mesh-ancestor
6353472|NCT00068731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353473|NCT00068731|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6353474|NCT00068731|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6353475|NCT00068731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6353476|NCT00068744|Fluorouracil|fluorouracil|mesh-list
6353477|NCT00068744|Mitomycins|mitomycins|mesh-list
6353478|NCT00068744|Mitomycin|mitomycin|mesh-list
6353479|NCT00068744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6353480|NCT00068744|Antimetabolites|antimetabolites|mesh-ancestor
6353481|NCT00068744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353482|NCT00068744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6353483|NCT00068744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6353484|NCT00068744|Immunologic Factors|immunologic factors|mesh-ancestor
6353485|NCT00068744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353486|NCT00068744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6353487|NCT00068744|Alkylating Agents|alkylating agents|mesh-ancestor
6353488|NCT00068744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6353489|NCT00068744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6353490|NCT00068757|Paclitaxel|paclitaxel|mesh-list
6353491|NCT00068757|Trastuzumab|trastuzumab|mesh-list
6353492|NCT00068757|Lonafarnib|lonafarnib|mesh-list
6353493|NCT00068757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6353494|NCT00068757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6353495|NCT00068757|Tubulin Modulators|tubulin modulators|mesh-ancestor
6353496|NCT00068757|Antimitotic Agents|antimitotic agents|mesh-ancestor
6353497|NCT00068757|Mitosis Modulators|mitosis modulators|mesh-ancestor
6353498|NCT00068757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353499|NCT00068757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6353500|NCT00068757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6353501|NCT00068783|Imatinib Mesylate|imatinib mesylate|mesh-list
6353502|NCT00068783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6353503|NCT00068783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6353504|NCT00068783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6353505|NCT00068783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353506|NCT00068809|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6353507|NCT00068809|Antiviral Agents|antiviral agents|mesh-ancestor
6353508|NCT00068809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6353509|NCT00068848|Contraceptive Agents|contraceptive agents|mesh-list
6353510|NCT00068848|Contraceptives, Oral|contraceptives, oral|mesh-list
6353511|NCT00068848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6353512|NCT00068848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353513|NCT00068848|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6353514|NCT00068861|Metformin|metformin|mesh-list
6353515|NCT00068861|Clomiphene|clomiphene|mesh-list
6353516|NCT00068861|Enclomiphene|enclomiphene|mesh-list
6353517|NCT00068861|Zuclomiphene|zuclomiphene|mesh-list
6353518|NCT00068861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6353519|NCT00068861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353520|NCT00068861|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6353521|NCT00068861|Hormone Antagonists|hormone antagonists|mesh-ancestor
6353522|NCT00068861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6353523|NCT00068861|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6353524|NCT00068861|Fertility Agents|fertility agents|mesh-ancestor
6353525|NCT00068861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6353526|NCT00068861|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6353527|NCT00068861|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6353528|NCT00068952|Temozolomide|temozolomide|mesh-list
6353529|NCT00068952|Carmustine|carmustine|mesh-list
6353530|NCT00068952|Lomustine|lomustine|mesh-list
6353531|NCT00068952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6353532|NCT00068952|Alkylating Agents|alkylating agents|mesh-ancestor
6353533|NCT00068952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353534|NCT00068952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5724592|NCT03186326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6353535|NCT00069251|Bupropion|bupropion|mesh-list
6353536|NCT00069251|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6353537|NCT00069251|Antidepressive Agents|antidepressive agents|mesh-ancestor
6353538|NCT00069251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6353539|NCT00069251|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6353540|NCT00069251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6353541|NCT00069251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6353542|NCT00069251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353543|NCT00069251|Dopamine Agents|dopamine agents|mesh-ancestor
6353544|NCT00069251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6353545|NCT00069251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353546|NCT00069251|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6353547|NCT00069251|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6353548|NCT00069251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6353549|NCT00069355|Propranolol|propranolol|mesh-list
6353550|NCT00069355|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6353551|NCT00069355|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6353552|NCT00069355|Adrenergic Agents|adrenergic agents|mesh-ancestor
6353553|NCT00069355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6353554|NCT00069355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353555|NCT00069355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353556|NCT00069355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6353557|NCT00069355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6353558|NCT00069355|Vasodilator Agents|vasodilator agents|mesh-ancestor
6353559|NCT00069446|Bevacizumab|bevacizumab|mesh-list
6353560|NCT00069446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6353561|NCT00069446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6353562|NCT00069446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6353563|NCT00069446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6353564|NCT00069446|Growth Substances|growth substances|mesh-ancestor
6353565|NCT00069446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353566|NCT00069446|Growth Inhibitors|growth inhibitors|mesh-ancestor
6353567|NCT00069459|Bupropion|bupropion|mesh-list
6353568|NCT00069459|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6353569|NCT00069459|Antidepressive Agents|antidepressive agents|mesh-ancestor
6353570|NCT00069459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6353571|NCT00069459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6353572|NCT00069459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6353573|NCT00069459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6353574|NCT00069459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353575|NCT00069459|Dopamine Agents|dopamine agents|mesh-ancestor
6353576|NCT00069459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6353577|NCT00069459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353578|NCT00069459|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6353579|NCT00069459|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6353580|NCT00069459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6353581|NCT00069498|Aminosalicylic Acid|aminosalicylic acid|mesh-list
6353582|NCT00069498|Mesalamine|mesalamine|mesh-list
6353583|NCT00069498|Antitubercular Agents|antitubercular agents|mesh-ancestor
6353584|NCT00069498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6353585|NCT00069498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6353586|NCT00069498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6353587|NCT00069498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6353588|NCT00069498|Analgesics|analgesics|mesh-ancestor
6353589|NCT00069498|Sensory System Agents|sensory system agents|mesh-ancestor
6353590|NCT00069498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6353591|NCT00069498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353592|NCT00069498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6353593|NCT00069498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6353594|NCT00069550|Dextromethorphan|dextromethorphan|mesh-list
6353595|NCT00069550|Donepezil|donepezil|mesh-list
6353596|NCT00069550|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6353597|NCT00069550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6353598|NCT00069550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353599|NCT00069550|Cholinergic Agents|cholinergic agents|mesh-ancestor
6353600|NCT00069550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6353601|NCT00069550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017072|NCT00369577|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6017073|NCT00369577|Dopamine Agents|dopamine agents|mesh-ancestor
6017074|NCT00369577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6017075|NCT00369577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353602|NCT00069550|Nootropic Agents|nootropic agents|mesh-ancestor
6353603|NCT00069550|Antitussive Agents|antitussive agents|mesh-ancestor
6353604|NCT00069550|Respiratory System Agents|respiratory system agents|mesh-ancestor
6353605|NCT00069550|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6353606|NCT00069550|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6353607|NCT00069706|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6353608|NCT00069706|Latanoprost|latanoprost|mesh-list
6353609|NCT00069706|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6353610|NCT00069836|Metformin|metformin|mesh-list
6353611|NCT00069836|Rosiglitazone|rosiglitazone|mesh-list
6353612|NCT00069836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6353613|NCT00069836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353614|NCT00069875|Gemcitabine|gemcitabine|mesh-list
6353615|NCT00069875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6353616|NCT00069875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6353617|NCT00069875|Antimetabolites|antimetabolites|mesh-ancestor
6353618|NCT00069875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353619|NCT00069875|Antiviral Agents|antiviral agents|mesh-ancestor
6353620|NCT00069875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6353621|NCT00069875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6353622|NCT00069875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6353623|NCT00069875|Immunologic Factors|immunologic factors|mesh-ancestor
6353624|NCT00069875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353625|NCT00069888|Docetaxel|docetaxel|mesh-list
6353626|NCT00069888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6353627|NCT00069888|Tubulin Modulators|tubulin modulators|mesh-ancestor
6353628|NCT00069888|Antimitotic Agents|antimitotic agents|mesh-ancestor
6353629|NCT00069888|Mitosis Modulators|mitosis modulators|mesh-ancestor
6353630|NCT00069888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353631|NCT00069901|Paclitaxel|paclitaxel|mesh-list
6353632|NCT00069901|Carboplatin|carboplatin|mesh-list
6353633|NCT00069901|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
6353634|NCT00069901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6353635|NCT00069901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6353636|NCT00069901|Tubulin Modulators|tubulin modulators|mesh-ancestor
6353637|NCT00069901|Antimitotic Agents|antimitotic agents|mesh-ancestor
6353638|NCT00069901|Mitosis Modulators|mitosis modulators|mesh-ancestor
6353639|NCT00069901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353640|NCT00069927|Methylphenidate|methylphenidate|mesh-list
6353641|NCT00069927|Amphetamine|amphetamine|mesh-list
6353642|NCT00069927|Adderall|adderall|mesh-list
6353643|NCT00069927|Dextroamphetamine|dextroamphetamine|mesh-list
6353644|NCT00069927|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6353645|NCT00069927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353646|NCT00069927|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6353647|NCT00069927|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6353648|NCT00069927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6353649|NCT00069927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353650|NCT00069927|Dopamine Agents|dopamine agents|mesh-ancestor
6353651|NCT00069927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6353652|NCT00069927|Sympathomimetics|sympathomimetics|mesh-ancestor
6353653|NCT00069927|Autonomic Agents|autonomic agents|mesh-ancestor
6353654|NCT00069927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6353655|NCT00069927|Adrenergic Agents|adrenergic agents|mesh-ancestor
6353656|NCT00069927|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6353657|NCT00069940|Sargramostim|sargramostim|mesh-list
6353658|NCT00069940|Immunologic Factors|immunologic factors|mesh-ancestor
6353659|NCT00069940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353660|NCT00069966|Cytarabine|cytarabine|mesh-list
6353661|NCT00069966|Methylprednisolone|methylprednisolone|mesh-list
6353662|NCT00069966|Rituximab|rituximab|mesh-list
6353663|NCT00069966|Pixantrone|pixantrone|mesh-list
6353664|NCT00069966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6353665|NCT00069966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6353666|NCT00069966|Immunologic Factors|immunologic factors|mesh-ancestor
6353667|NCT00069966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353668|NCT00069966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6353669|NCT00069966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6353670|NCT00069966|Antimetabolites|antimetabolites|mesh-ancestor
6353671|NCT00069966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353672|NCT00069966|Antiviral Agents|antiviral agents|mesh-ancestor
6353673|NCT00069966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6353674|NCT00069966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6353675|NCT00069966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6353676|NCT00069966|Antiemetics|antiemetics|mesh-ancestor
6353677|NCT00069966|Autonomic Agents|autonomic agents|mesh-ancestor
6353678|NCT00069966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6353679|NCT00069966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6353680|NCT00069966|Glucocorticoids|glucocorticoids|mesh-ancestor
6353681|NCT00069966|Hormones|hormones|mesh-ancestor
6353682|NCT00069966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6353683|NCT00069966|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6353684|NCT00069966|Protective Agents|protective agents|mesh-ancestor
6353685|NCT00069966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6353686|NCT00069966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6353687|NCT00069966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6353688|NCT00069992|Fludarabine|fludarabine|mesh-list
6353689|NCT00069992|Alemtuzumab|alemtuzumab|mesh-list
6353690|NCT00069992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6353691|NCT00069992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6353692|NCT00070057|Celecoxib|celecoxib|mesh-list
6353693|NCT00070057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6353694|NCT00070057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6353695|NCT00070057|Analgesics|analgesics|mesh-ancestor
6353696|NCT00070057|Sensory System Agents|sensory system agents|mesh-ancestor
6353697|NCT00070057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6353698|NCT00070057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353699|NCT00070057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6353700|NCT00070057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6353701|NCT00070057|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6353702|NCT00070057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6353703|NCT00070057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5724593|NCT03186326|Growth Substances|growth substances|mesh-ancestor
6353704|NCT00070057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353705|NCT00070083|Prednisone|prednisone|mesh-list
6353706|NCT00070083|Cyclophosphamide|cyclophosphamide|mesh-list
6353707|NCT00070083|Rituximab|rituximab|mesh-list
6353708|NCT00070083|Doxorubicin|doxorubicin|mesh-list
6353709|NCT00070083|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6353710|NCT00070083|Vincristine|vincristine|mesh-list
6353711|NCT00070083|Oblimersen|oblimersen|mesh-list
6353712|NCT00070083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6353713|NCT00070083|Immunologic Factors|immunologic factors|mesh-ancestor
6353714|NCT00070083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353715|NCT00070083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6353716|NCT00070083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6353717|NCT00070083|Alkylating Agents|alkylating agents|mesh-ancestor
6353718|NCT00070083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353719|NCT00070083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6353720|NCT00070083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6353721|NCT00070083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6353722|NCT00070083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6353723|NCT00070083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6353724|NCT00070083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6353725|NCT00070083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6353726|NCT00070083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6353727|NCT00070083|Glucocorticoids|glucocorticoids|mesh-ancestor
6353728|NCT00070083|Hormones|hormones|mesh-ancestor
6353729|NCT00070083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6353730|NCT00070083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6353731|NCT00070083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6353732|NCT00070083|Tubulin Modulators|tubulin modulators|mesh-ancestor
6353733|NCT00070083|Antimitotic Agents|antimitotic agents|mesh-ancestor
6353734|NCT00070083|Mitosis Modulators|mitosis modulators|mesh-ancestor
6353735|NCT00070122|Leucovorin|leucovorin|mesh-list
6353736|NCT00070122|Bevacizumab|bevacizumab|mesh-list
6353737|NCT00070122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6353738|NCT00070122|Fluorouracil|fluorouracil|mesh-list
6353739|NCT00070122|Capecitabine|capecitabine|mesh-list
6353740|NCT00070122|Oxaliplatin|oxaliplatin|mesh-list
6353741|NCT00070122|Antibodies|antibodies|mesh-list
6353742|NCT00070122|Immunoglobulins|immunoglobulins|mesh-list
6353743|NCT00070122|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6353744|NCT00070122|Levoleucovorin|levoleucovorin|mesh-list
6353745|NCT00070122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6353746|NCT00070122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6353747|NCT00070122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6353748|NCT00070122|Growth Substances|growth substances|mesh-ancestor
6353749|NCT00070122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353750|NCT00070122|Growth Inhibitors|growth inhibitors|mesh-ancestor
6353751|NCT00070122|Immunologic Factors|immunologic factors|mesh-ancestor
6353752|NCT00070122|Antimetabolites|antimetabolites|mesh-ancestor
6353753|NCT00070122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353754|NCT00070122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6353755|NCT00070122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6353756|NCT00070122|Antidotes|antidotes|mesh-ancestor
6353757|NCT00070122|Protective Agents|protective agents|mesh-ancestor
6353758|NCT00070122|Vitamin B Complex|vitamin b complex|mesh-ancestor
6353759|NCT00070122|Vitamins|vitamins|mesh-ancestor
6353760|NCT00070122|Micronutrients|micronutrients|mesh-ancestor
6353761|NCT00070148|Megestrol|megestrol|mesh-list
6353762|NCT00070148|Megestrol Acetate|megestrol acetate|mesh-list
6353763|NCT00070148|Oxandrolone|oxandrolone|mesh-list
6353764|NCT00070148|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6353765|NCT00070148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6353766|NCT00070148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6353767|NCT00070148|Contraceptive Agents|contraceptive agents|mesh-ancestor
6353768|NCT00070148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6353769|NCT00070148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353770|NCT00070148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6353771|NCT00070148|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6353772|NCT00070148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6353773|NCT00070148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6353774|NCT00070148|Appetite Stimulants|appetite stimulants|mesh-ancestor
6353775|NCT00070148|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6353776|NCT00070148|Androgens|androgens|mesh-ancestor
6353777|NCT00070148|Hormones|hormones|mesh-ancestor
6353778|NCT00070148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6353779|NCT00070148|Anabolic Agents|anabolic agents|mesh-ancestor
6353780|NCT00070161|Donepezil|donepezil|mesh-list
6353781|NCT00070161|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6353782|NCT00070161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6353783|NCT00070161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353784|NCT00070161|Cholinergic Agents|cholinergic agents|mesh-ancestor
6353785|NCT00070161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6353786|NCT00070161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353787|NCT00070161|Nootropic Agents|nootropic agents|mesh-ancestor
6353788|NCT00070174|Cytarabine|cytarabine|mesh-list
6353789|NCT00070174|Cyclosporine|cyclosporine|mesh-list
6353790|NCT00070174|Cyclophosphamide|cyclophosphamide|mesh-list
6353791|NCT00070174|Busulfan|busulfan|mesh-list
6353792|NCT00070174|Methotrexate|methotrexate|mesh-list
6353793|NCT00070174|Etoposide|etoposide|mesh-list
6353794|NCT00070174|Daunorubicin|daunorubicin|mesh-list
6353795|NCT00070174|Asparaginase|asparaginase|mesh-list
6353796|NCT00070174|Mitoxantrone|mitoxantrone|mesh-list
6353797|NCT00070174|Gemtuzumab|gemtuzumab|mesh-list
6353798|NCT00070174|Cyclosporins|cyclosporins|mesh-list
6353799|NCT00070174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6353800|NCT00070174|Immunologic Factors|immunologic factors|mesh-ancestor
6353801|NCT00070174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353802|NCT00070174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6353803|NCT00070174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6353804|NCT00070174|Alkylating Agents|alkylating agents|mesh-ancestor
6353805|NCT00070174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353806|NCT00070174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6353807|NCT00070174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6353808|NCT00070174|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6353809|NCT00070174|Abortifacient Agents|abortifacient agents|mesh-ancestor
6353810|NCT00070174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6353811|NCT00070174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6353812|NCT00070174|Antimetabolites|antimetabolites|mesh-ancestor
6353813|NCT00070174|Dermatologic Agents|dermatologic agents|mesh-ancestor
6353814|NCT00070174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6353815|NCT00070174|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6353816|NCT00070174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6353817|NCT00070174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6353818|NCT00070174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6353819|NCT00070174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6353820|NCT00070174|Antiviral Agents|antiviral agents|mesh-ancestor
6353821|NCT00070174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6353822|NCT00070174|Antifungal Agents|antifungal agents|mesh-ancestor
6353823|NCT00070174|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6353824|NCT00070174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6353825|NCT00070174|Analgesics|analgesics|mesh-ancestor
6353826|NCT00070174|Sensory System Agents|sensory system agents|mesh-ancestor
6353827|NCT00070174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6353828|NCT00070174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6353829|NCT00070187|Interferons|interferons|mesh-list
6353830|NCT00070187|Cytarabine|cytarabine|mesh-list
6353831|NCT00070187|Aldesleukin|aldesleukin|mesh-list
6353832|NCT00070187|Interferon-gamma|interferon-gamma|mesh-list
6353833|NCT00070187|Cyclosporine|cyclosporine|mesh-list
6353834|NCT00070187|Etoposide|etoposide|mesh-list
6353835|NCT00070187|Melphalan|melphalan|mesh-list
6353836|NCT00070187|Interleukin-2|interleukin-2|mesh-list
6353837|NCT00070187|Carmustine|carmustine|mesh-list
6353838|NCT00070187|Cyclosporins|cyclosporins|mesh-list
6353839|NCT00070187|Lenograstim|lenograstim|mesh-list
6353840|NCT00070187|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6353841|NCT00070187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6353842|NCT00070187|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6353843|NCT00070187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6353844|NCT00070187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6353845|NCT00070187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353846|NCT00070187|Antiviral Agents|antiviral agents|mesh-ancestor
6353847|NCT00070187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6353848|NCT00070187|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6353849|NCT00070187|Immunologic Factors|immunologic factors|mesh-ancestor
6353850|NCT00070187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353851|NCT00070187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6353852|NCT00070187|Antimetabolites|antimetabolites|mesh-ancestor
6353853|NCT00070187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6353854|NCT00070187|Antifungal Agents|antifungal agents|mesh-ancestor
6353855|NCT00070187|Dermatologic Agents|dermatologic agents|mesh-ancestor
6353856|NCT00070187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6353857|NCT00070187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6353858|NCT00070187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6353859|NCT00070187|Alkylating Agents|alkylating agents|mesh-ancestor
6353860|NCT00070187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6353861|NCT00070187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6353862|NCT00070187|Analgesics|analgesics|mesh-ancestor
6353863|NCT00070187|Sensory System Agents|sensory system agents|mesh-ancestor
6353864|NCT00070187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6353865|NCT00070187|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6353866|NCT00070187|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6353867|NCT00070200|Cyclophosphamide|cyclophosphamide|mesh-list
6353868|NCT00070200|Melphalan|melphalan|mesh-list
6353869|NCT00070200|Doxorubicin|doxorubicin|mesh-list
6353870|NCT00070200|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6353871|NCT00070200|Etoposide|etoposide|mesh-list
6353872|NCT00070200|Vincristine|vincristine|mesh-list
6353873|NCT00070200|Topotecan|topotecan|mesh-list
6353874|NCT00070200|Isotretinoin|isotretinoin|mesh-list
6353875|NCT00070200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6353876|NCT00070200|Immunologic Factors|immunologic factors|mesh-ancestor
6353877|NCT00070200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353878|NCT00070200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6353879|NCT00070200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6353880|NCT00070200|Alkylating Agents|alkylating agents|mesh-ancestor
6353881|NCT00070200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353882|NCT00070200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6353883|NCT00070200|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6353884|NCT00070200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6353885|NCT00070200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6353886|NCT00070200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6353887|NCT00070200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6353888|NCT00070200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6353889|NCT00070200|Tubulin Modulators|tubulin modulators|mesh-ancestor
6353890|NCT00070200|Antimitotic Agents|antimitotic agents|mesh-ancestor
6353891|NCT00070200|Mitosis Modulators|mitosis modulators|mesh-ancestor
6353892|NCT00070200|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6353893|NCT00070200|Dermatologic Agents|dermatologic agents|mesh-ancestor
6353894|NCT00070213|Leucovorin|leucovorin|mesh-list
6353895|NCT00070213|Fluorouracil|fluorouracil|mesh-list
6353896|NCT00070213|Capecitabine|capecitabine|mesh-list
6017076|NCT00369590|Aflibercept|aflibercept|mesh-list
6017077|NCT00369590|Endothelial Growth Factors|endothelial growth factors|mesh-list
6017078|NCT00369590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6353897|NCT00070213|Oxaliplatin|oxaliplatin|mesh-list
6353898|NCT00070213|Calcium|calcium|mesh-list
6353899|NCT00070213|Levoleucovorin|levoleucovorin|mesh-list
6353900|NCT00070213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6353901|NCT00070213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353902|NCT00070213|Antimetabolites|antimetabolites|mesh-ancestor
6353903|NCT00070213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353904|NCT00070213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6353905|NCT00070213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6353906|NCT00070213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6353907|NCT00070213|Immunologic Factors|immunologic factors|mesh-ancestor
6353908|NCT00070213|Antidotes|antidotes|mesh-ancestor
6353909|NCT00070213|Protective Agents|protective agents|mesh-ancestor
6353910|NCT00070213|Vitamin B Complex|vitamin b complex|mesh-ancestor
6353911|NCT00070213|Vitamins|vitamins|mesh-ancestor
6353912|NCT00070213|Micronutrients|micronutrients|mesh-ancestor
6353913|NCT00070239|Alvocidib|alvocidib|mesh-list
6353914|NCT00070239|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6353915|NCT00070239|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6353916|NCT00070239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353917|NCT00070239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353918|NCT00070239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6353919|NCT00070239|Growth Inhibitors|growth inhibitors|mesh-ancestor
6353920|NCT00070239|Growth Substances|growth substances|mesh-ancestor
6353921|NCT00070239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6353922|NCT00070239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6353923|NCT00070252|Docetaxel|docetaxel|mesh-list
6353924|NCT00070252|Capecitabine|capecitabine|mesh-list
6353925|NCT00070252|Tipifarnib|tipifarnib|mesh-list
6353926|NCT00070252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6353927|NCT00070252|Tubulin Modulators|tubulin modulators|mesh-ancestor
6353928|NCT00070252|Antimitotic Agents|antimitotic agents|mesh-ancestor
6353929|NCT00070252|Mitosis Modulators|mitosis modulators|mesh-ancestor
6353930|NCT00070252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353931|NCT00070252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6353932|NCT00070252|Antimetabolites|antimetabolites|mesh-ancestor
6353933|NCT00070265|Capecitabine|capecitabine|mesh-list
6353934|NCT00070265|Oxaliplatin|oxaliplatin|mesh-list
6353935|NCT00070265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6353936|NCT00070265|Antimetabolites|antimetabolites|mesh-ancestor
6353937|NCT00070265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353938|NCT00070265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6353939|NCT00070278|Gemcitabine|gemcitabine|mesh-list
6353940|NCT00070278|Paclitaxel|paclitaxel|mesh-list
6353941|NCT00070278|Cyclophosphamide|cyclophosphamide|mesh-list
6353942|NCT00070278|Epirubicin|epirubicin|mesh-list
6353943|NCT00070278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6353944|NCT00070278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6353945|NCT00070278|Tubulin Modulators|tubulin modulators|mesh-ancestor
6353946|NCT00070278|Antimitotic Agents|antimitotic agents|mesh-ancestor
6353947|NCT00070278|Mitosis Modulators|mitosis modulators|mesh-ancestor
6353948|NCT00070278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353949|NCT00070278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6353950|NCT00070278|Immunologic Factors|immunologic factors|mesh-ancestor
6353951|NCT00070278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353952|NCT00070278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6353953|NCT00070278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6353954|NCT00070278|Alkylating Agents|alkylating agents|mesh-ancestor
6353955|NCT00070278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6353956|NCT00070278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6353957|NCT00070278|Antimetabolites|antimetabolites|mesh-ancestor
6353958|NCT00070278|Antiviral Agents|antiviral agents|mesh-ancestor
6353959|NCT00070278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6353960|NCT00070278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6353961|NCT00070278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6353962|NCT00070278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6353963|NCT00070278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6353964|NCT00070304|Gemcitabine|gemcitabine|mesh-list
6353965|NCT00070304|Vinorelbine|vinorelbine|mesh-list
6353966|NCT00070304|Lenograstim|lenograstim|mesh-list
6353967|NCT00070304|Sargramostim|sargramostim|mesh-list
6353968|NCT00070304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6353969|NCT00070304|Antimetabolites|antimetabolites|mesh-ancestor
6353970|NCT00070304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353971|NCT00070304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6353972|NCT00070304|Antiviral Agents|antiviral agents|mesh-ancestor
6353973|NCT00070304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6353974|NCT00070304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6353975|NCT00070304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6353976|NCT00070304|Immunologic Factors|immunologic factors|mesh-ancestor
6353977|NCT00070304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6353978|NCT00070304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6353979|NCT00070304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6353980|NCT00070304|Tubulin Modulators|tubulin modulators|mesh-ancestor
6353981|NCT00070304|Antimitotic Agents|antimitotic agents|mesh-ancestor
6353982|NCT00070304|Mitosis Modulators|mitosis modulators|mesh-ancestor
6353983|NCT00070343|Dacarbazine|dacarbazine|mesh-list
6353984|NCT00070343|Oblimersen|oblimersen|mesh-list
6353985|NCT00070343|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6353986|NCT00070343|Alkylating Agents|alkylating agents|mesh-ancestor
6353987|NCT00070343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6353988|NCT00070343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6353989|NCT00070382|Epoetin Alfa|epoetin alfa|mesh-list
6353990|NCT00070382|Darbepoetin alfa|darbepoetin alfa|mesh-list
6353991|NCT00070382|Hematinics|hematinics|mesh-ancestor
6353992|NCT00070434|Leucovorin|leucovorin|mesh-list
6353993|NCT00070434|Pyridoxine|pyridoxine|mesh-list
6353994|NCT00070434|Fluorouracil|fluorouracil|mesh-list
6353995|NCT00070434|Capecitabine|capecitabine|mesh-list
6353996|NCT00070434|Oxaliplatin|oxaliplatin|mesh-list
6353997|NCT00070434|Irinotecan|irinotecan|mesh-list
6353998|NCT00070434|Levoleucovorin|levoleucovorin|mesh-list
6353999|NCT00070434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354000|NCT00070434|Antimetabolites|antimetabolites|mesh-ancestor
6354001|NCT00070434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354002|NCT00070434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6354003|NCT00070434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6354004|NCT00070434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6354005|NCT00070434|Immunologic Factors|immunologic factors|mesh-ancestor
6354006|NCT00070434|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6354007|NCT00070434|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6354008|NCT00070434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6354009|NCT00070434|Antidotes|antidotes|mesh-ancestor
6354010|NCT00070434|Protective Agents|protective agents|mesh-ancestor
6354011|NCT00070434|Vitamin B Complex|vitamin b complex|mesh-ancestor
6354012|NCT00070434|Vitamins|vitamins|mesh-ancestor
6354013|NCT00070434|Micronutrients|micronutrients|mesh-ancestor
6354014|NCT00070447|Prednisone|prednisone|mesh-list
6354015|NCT00070447|Cyclophosphamide|cyclophosphamide|mesh-list
6354016|NCT00070447|Rituximab|rituximab|mesh-list
6354017|NCT00070447|Doxorubicin|doxorubicin|mesh-list
6354018|NCT00070447|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6354019|NCT00070447|Vincristine|vincristine|mesh-list
6354020|NCT00070447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6354021|NCT00070447|Immunologic Factors|immunologic factors|mesh-ancestor
6017079|NCT00369590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6017080|NCT00369590|Growth Substances|growth substances|mesh-ancestor
6017081|NCT00369590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017082|NCT00369590|Growth Inhibitors|growth inhibitors|mesh-ancestor
6017083|NCT00369590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6017084|NCT00369629|Gemcitabine|gemcitabine|mesh-list
6017085|NCT00369629|Pemetrexed|pemetrexed|mesh-list
6017086|NCT00369629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6354022|NCT00070447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354023|NCT00070447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6354024|NCT00070447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6354025|NCT00070447|Alkylating Agents|alkylating agents|mesh-ancestor
6354026|NCT00070447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354027|NCT00070447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6354028|NCT00070447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6354029|NCT00070447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6354030|NCT00070447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6354031|NCT00070447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6017087|NCT00369629|Antimetabolites|antimetabolites|mesh-ancestor
6354032|NCT00070447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6354033|NCT00070447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6354034|NCT00070447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6354035|NCT00070447|Glucocorticoids|glucocorticoids|mesh-ancestor
6354036|NCT00070447|Hormones|hormones|mesh-ancestor
6354037|NCT00070447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6354038|NCT00070447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6354039|NCT00070447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6354040|NCT00070447|Tubulin Modulators|tubulin modulators|mesh-ancestor
6354041|NCT00070447|Antimitotic Agents|antimitotic agents|mesh-ancestor
6354042|NCT00070447|Mitosis Modulators|mitosis modulators|mesh-ancestor
6354043|NCT00070473|Pemetrexed|pemetrexed|mesh-list
6354044|NCT00070473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6354045|NCT00070473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6354046|NCT00070473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354047|NCT00070473|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6354048|NCT00070473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6354049|NCT00070486|Gemcitabine|gemcitabine|mesh-list
6354050|NCT00070486|Celecoxib|celecoxib|mesh-list
6354051|NCT00070486|Zileuton|zileuton|mesh-list
6354052|NCT00070486|Carboplatin|carboplatin|mesh-list
6354053|NCT00070486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6354054|NCT00070486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6354055|NCT00070486|Antimetabolites|antimetabolites|mesh-ancestor
6354056|NCT00070486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354057|NCT00070486|Antiviral Agents|antiviral agents|mesh-ancestor
6354058|NCT00070486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6354059|NCT00070486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6354060|NCT00070486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6354061|NCT00070486|Immunologic Factors|immunologic factors|mesh-ancestor
6354062|NCT00070486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354063|NCT00070486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6354064|NCT00070486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6354065|NCT00070486|Analgesics|analgesics|mesh-ancestor
6354066|NCT00070486|Sensory System Agents|sensory system agents|mesh-ancestor
6354067|NCT00070486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6354068|NCT00070486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6354069|NCT00070486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6354070|NCT00070486|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6354071|NCT00070486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6354072|NCT00070486|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6354073|NCT00070486|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6354074|NCT00070486|Hormone Antagonists|hormone antagonists|mesh-ancestor
6354075|NCT00070486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6354076|NCT00070525|Tipifarnib|tipifarnib|mesh-list
6354077|NCT00070525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6394500|NCT00202345|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6394501|NCT00202345|Hematinics|hematinics|mesh-ancestor
6394502|NCT00202358|Atenolol|atenolol|mesh-list
6394503|NCT00202358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6394504|NCT00202358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6394505|NCT00202358|Sympatholytics|sympatholytics|mesh-ancestor
6394506|NCT00202358|Autonomic Agents|autonomic agents|mesh-ancestor
6394507|NCT00202358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6394508|NCT00202358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394509|NCT00202358|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6394510|NCT00202358|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6394511|NCT00202358|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6394512|NCT00202358|Adrenergic Agents|adrenergic agents|mesh-ancestor
6394513|NCT00202358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6394514|NCT00202358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354078|NCT00070538|Cytarabine|cytarabine|mesh-list
6354079|NCT00070538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6354080|NCT00070538|Antimetabolites|antimetabolites|mesh-ancestor
6354081|NCT00070538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354082|NCT00070538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6354083|NCT00070538|Antiviral Agents|antiviral agents|mesh-ancestor
6354084|NCT00070538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6354085|NCT00070538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6354086|NCT00070538|Immunologic Factors|immunologic factors|mesh-ancestor
6354087|NCT00070538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354088|NCT00070551|Cytarabine|cytarabine|mesh-list
6354089|NCT00070551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6354090|NCT00070551|Antimetabolites|antimetabolites|mesh-ancestor
6354091|NCT00070551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354092|NCT00070551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6354093|NCT00070551|Antiviral Agents|antiviral agents|mesh-ancestor
6354094|NCT00070551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6354095|NCT00070551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6354096|NCT00070551|Immunologic Factors|immunologic factors|mesh-ancestor
6354097|NCT00070551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354098|NCT00070629|Paclitaxel|paclitaxel|mesh-list
6354099|NCT00070629|Docetaxel|docetaxel|mesh-list
6017088|NCT00369629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017089|NCT00369629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6017090|NCT00369629|Antiviral Agents|antiviral agents|mesh-ancestor
6017091|NCT00369629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6017092|NCT00369629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6017093|NCT00369629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6017094|NCT00369629|Immunologic Factors|immunologic factors|mesh-ancestor
6017095|NCT00369629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354100|NCT00070629|Cisplatin|cisplatin|mesh-list
6354101|NCT00070629|Carboplatin|carboplatin|mesh-list
6354102|NCT00070629|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6354103|NCT00070629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6354104|NCT00070629|Tubulin Modulators|tubulin modulators|mesh-ancestor
6354105|NCT00070629|Antimitotic Agents|antimitotic agents|mesh-ancestor
6354106|NCT00070629|Mitosis Modulators|mitosis modulators|mesh-ancestor
6354107|NCT00070629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354108|NCT00070642|Dacarbazine|dacarbazine|mesh-list
6354109|NCT00070642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6354110|NCT00070642|Alkylating Agents|alkylating agents|mesh-ancestor
6354111|NCT00070642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354112|NCT00070642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6354113|NCT00070655|Vitamin K|vitamin k|mesh-list
6354114|NCT00070655|Warfarin|warfarin|mesh-list
6354115|NCT00070655|Acenocoumarol|acenocoumarol|mesh-list
6354116|NCT00070655|Idraparinux|idraparinux|mesh-list
6354117|NCT00070655|Vitamins|vitamins|mesh-ancestor
6354118|NCT00070655|Micronutrients|micronutrients|mesh-ancestor
6354119|NCT00070655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354120|NCT00070655|Anticoagulants|anticoagulants|mesh-ancestor
6354121|NCT00070655|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6354122|NCT00070655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6354123|NCT00070655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354124|NCT00070655|Hemostatics|hemostatics|mesh-ancestor
6017096|NCT00369629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6354125|NCT00070655|Coagulants|coagulants|mesh-ancestor
6354126|NCT00070655|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6354127|NCT00070655|Antithrombins|antithrombins|mesh-ancestor
6354128|NCT00070655|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6354129|NCT00070655|Protease Inhibitors|protease inhibitors|mesh-ancestor
6354130|NCT00070655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6354131|NCT00070733|Methyltestosterone|methyltestosterone|mesh-list
6354132|NCT00070733|Testosterone|testosterone|mesh-list
6354133|NCT00070733|Testosterone undecanoate|testosterone undecanoate|mesh-list
6354134|NCT00070733|Testosterone enanthate|testosterone enanthate|mesh-list
6354135|NCT00070733|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6354136|NCT00070733|Androgens|androgens|mesh-ancestor
6354137|NCT00070733|Hormones|hormones|mesh-ancestor
6354138|NCT00070733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6354139|NCT00070733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354140|NCT00070733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6354141|NCT00070733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6354142|NCT00070733|Anabolic Agents|anabolic agents|mesh-ancestor
6354143|NCT00070759|Daclizumab|daclizumab|mesh-list
6354144|NCT00070759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6354145|NCT00070759|Immunologic Factors|immunologic factors|mesh-ancestor
6354146|NCT00070759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354147|NCT00070837|Antibodies|antibodies|mesh-list
6354148|NCT00070837|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6354149|NCT00070837|Immunologic Factors|immunologic factors|mesh-ancestor
6354150|NCT00070837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354151|NCT00071071|Zanolimumab|zanolimumab|mesh-list
6354152|NCT00071071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6354153|NCT00071071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6354154|NCT00071084|Zanolimumab|zanolimumab|mesh-list
6354155|NCT00071084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6354156|NCT00071084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6354157|NCT00071097|Darunavir|darunavir|mesh-list
6354158|NCT00071097|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6354159|NCT00071097|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6354160|NCT00071097|Protease Inhibitors|protease inhibitors|mesh-ancestor
6354161|NCT00071097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6354162|NCT00071097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354163|NCT00071097|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6354164|NCT00071097|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6354165|NCT00071097|Antiviral Agents|antiviral agents|mesh-ancestor
6354166|NCT00071097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6354167|NCT00071136|Gemcitabine|gemcitabine|mesh-list
6354168|NCT00071136|Pemetrexed|pemetrexed|mesh-list
6354169|NCT00071136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6354170|NCT00071136|Antimetabolites|antimetabolites|mesh-ancestor
6354171|NCT00071136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354172|NCT00071136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6354173|NCT00071136|Antiviral Agents|antiviral agents|mesh-ancestor
6354174|NCT00071136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6354175|NCT00071136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6354176|NCT00071136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6354177|NCT00071136|Immunologic Factors|immunologic factors|mesh-ancestor
6354178|NCT00071136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354179|NCT00071136|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6354180|NCT00071136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6354181|NCT00071188|Paclitaxel|paclitaxel|mesh-list
6354182|NCT00071188|Carboplatin|carboplatin|mesh-list
6354183|NCT00071188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6354184|NCT00071188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6354185|NCT00071188|Tubulin Modulators|tubulin modulators|mesh-ancestor
6354186|NCT00071188|Antimitotic Agents|antimitotic agents|mesh-ancestor
6354187|NCT00071188|Mitosis Modulators|mitosis modulators|mesh-ancestor
6354188|NCT00071188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354189|NCT00071201|Adefovir|adefovir|mesh-list
6354190|NCT00071201|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6354191|NCT00071201|Antiviral Agents|antiviral agents|mesh-ancestor
6354192|NCT00071201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6354193|NCT00071201|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6354194|NCT00071201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6354195|NCT00071201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6354196|NCT00071201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354197|NCT00071227|Triamcinolone|triamcinolone|mesh-list
6354198|NCT00071227|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6354199|NCT00071227|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6354200|NCT00071227|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6354201|NCT00071227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6354202|NCT00071227|Glucocorticoids|glucocorticoids|mesh-ancestor
6354203|NCT00071227|Hormones|hormones|mesh-ancestor
6354204|NCT00071227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6354205|NCT00071227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354206|NCT00071227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6354207|NCT00071227|Immunologic Factors|immunologic factors|mesh-ancestor
6354208|NCT00071227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6354209|NCT00071227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354210|NCT00071240|Hormones|hormones|mesh-list
6354211|NCT00071240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6354212|NCT00071240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354213|NCT00071253|Valproic Acid|valproic acid|mesh-list
6354214|NCT00071253|Olanzapine|olanzapine|mesh-list
6354215|NCT00071253|Antiemetics|antiemetics|mesh-ancestor
6354216|NCT00071253|Autonomic Agents|autonomic agents|mesh-ancestor
6354217|NCT00071253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6354218|NCT00071253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354219|NCT00071253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6354220|NCT00071253|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6354221|NCT00071253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6354222|NCT00071253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6354223|NCT00071253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6354224|NCT00071253|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6354225|NCT00071253|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6354226|NCT00071253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6354227|NCT00071253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354228|NCT00071253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6354229|NCT00071253|Serotonin Agents|serotonin agents|mesh-ancestor
6354230|NCT00071253|Anticonvulsants|anticonvulsants|mesh-ancestor
6354231|NCT00071253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6354232|NCT00071253|GABA Agents|gaba agents|mesh-ancestor
6354233|NCT00071253|Antimanic Agents|antimanic agents|mesh-ancestor
6354234|NCT00071266|Niacin|niacin|mesh-list
6354235|NCT00071266|Lovastatin|lovastatin|mesh-list
6354236|NCT00071266|L 647318|l 647318|mesh-list
6354237|NCT00071266|Dihydromevinolin|dihydromevinolin|mesh-list
6354238|NCT00071266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6354239|NCT00071266|Antimetabolites|antimetabolites|mesh-ancestor
6354240|NCT00071266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354241|NCT00071266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6354242|NCT00071266|Vasodilator Agents|vasodilator agents|mesh-ancestor
6354243|NCT00071266|Vitamin B Complex|vitamin b complex|mesh-ancestor
6354244|NCT00071266|Vitamins|vitamins|mesh-ancestor
6354245|NCT00071266|Micronutrients|micronutrients|mesh-ancestor
6354246|NCT00071266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354247|NCT00071266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6354248|NCT00071266|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6354249|NCT00071266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6354250|NCT00071279|Idraparinux|idraparinux|mesh-list
6354251|NCT00071279|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6354252|NCT00071279|Antithrombins|antithrombins|mesh-ancestor
6354253|NCT00071279|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6354254|NCT00071279|Protease Inhibitors|protease inhibitors|mesh-ancestor
6354255|NCT00071279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6354256|NCT00071279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354257|NCT00071279|Anticoagulants|anticoagulants|mesh-ancestor
6354258|NCT00071331|Tolvaptan|tolvaptan|mesh-list
6354259|NCT00071331|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6354260|NCT00071331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354261|NCT00071331|Natriuretic Agents|natriuretic agents|mesh-ancestor
6354262|NCT00071331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354263|NCT00071448|Insulin|insulin|mesh-list
6354264|NCT00071448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6354265|NCT00071448|Insulin Aspart|insulin aspart|mesh-list
6354266|NCT00071448|Insulin Lispro|insulin lispro|mesh-list
6354267|NCT00071448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6394515|NCT00202397|Riluzole|riluzole|mesh-list
6354268|NCT00071448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354269|NCT00071539|Immunotoxins|immunotoxins|mesh-list
6354270|NCT00071539|Immunologic Factors|immunologic factors|mesh-ancestor
6354271|NCT00071539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354272|NCT00071643|Citalopram|citalopram|mesh-list
6354273|NCT00071643|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6354274|NCT00071643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6354275|NCT00071643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6354276|NCT00071643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354277|NCT00071643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6354278|NCT00071643|Serotonin Agents|serotonin agents|mesh-ancestor
6354279|NCT00071643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354280|NCT00071643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6354281|NCT00071643|Antidepressive Agents|antidepressive agents|mesh-ancestor
6354282|NCT00071643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6354283|NCT00071695|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6354284|NCT00071695|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6354285|NCT00071695|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6354286|NCT00071695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6354287|NCT00071695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6354288|NCT00071695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354289|NCT00071695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6354290|NCT00071695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354291|NCT00071695|Analgesics|analgesics|mesh-ancestor
6354292|NCT00071695|Sensory System Agents|sensory system agents|mesh-ancestor
6354293|NCT00071695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6354294|NCT00071695|Antidepressive Agents|antidepressive agents|mesh-ancestor
6354295|NCT00071695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6354296|NCT00071695|Dopamine Agents|dopamine agents|mesh-ancestor
6354297|NCT00071695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6354298|NCT00071747|Lamotrigine|lamotrigine|mesh-list
6354299|NCT00071747|Anticonvulsants|anticonvulsants|mesh-ancestor
6354300|NCT00071747|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6354301|NCT00071747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6354302|NCT00071747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354303|NCT00071747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6354304|NCT00071747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354305|NCT00071747|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6354306|NCT00071747|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6354307|NCT00071747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6354308|NCT00071747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6354309|NCT00071747|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6354310|NCT00071838|Daclizumab|daclizumab|mesh-list
6354311|NCT00071838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6354312|NCT00071838|Immunologic Factors|immunologic factors|mesh-ancestor
6354313|NCT00071838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354314|NCT00071929|Oxaliplatin|oxaliplatin|mesh-list
6354315|NCT00071929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6354316|NCT00071942|Metronidazole|metronidazole|mesh-list
6354317|NCT00071942|Vaccines|vaccines|mesh-list
6354318|NCT00071942|Immunologic Factors|immunologic factors|mesh-ancestor
6354319|NCT00071942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354320|NCT00071942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6354321|NCT00071942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6354322|NCT00071942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6354323|NCT00071942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6354324|NCT00071955|Immunoglobulins|immunoglobulins|mesh-list
6354325|NCT00071955|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6354326|NCT00071955|Antibodies|antibodies|mesh-list
6354327|NCT00071955|Sargramostim|sargramostim|mesh-list
6354328|NCT00071955|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
6354329|NCT00071955|Immunologic Factors|immunologic factors|mesh-ancestor
6354330|NCT00071955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354331|NCT00071968|Sirolimus|sirolimus|mesh-list
6354332|NCT00071968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6354333|NCT00071968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6354334|NCT00071968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6354335|NCT00071968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6354336|NCT00071968|Antifungal Agents|antifungal agents|mesh-ancestor
6354337|NCT00071968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6354338|NCT00071968|Immunologic Factors|immunologic factors|mesh-ancestor
6354339|NCT00071968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354340|NCT00071994|Gefitinib|gefitinib|mesh-list
6354341|NCT00071994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6354342|NCT00071994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6354343|NCT00071994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6354344|NCT00071994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354345|NCT00072007|Prednisone|prednisone|mesh-list
6354346|NCT00072007|Cyclophosphamide|cyclophosphamide|mesh-list
6354347|NCT00072007|Rituximab|rituximab|mesh-list
6354348|NCT00072007|Doxorubicin|doxorubicin|mesh-list
6354349|NCT00072007|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6354350|NCT00072007|Vincristine|vincristine|mesh-list
6354351|NCT00072007|Cladribine|cladribine|mesh-list
6354352|NCT00072007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6354353|NCT00072007|Immunologic Factors|immunologic factors|mesh-ancestor
6354354|NCT00072007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354355|NCT00072007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6354356|NCT00072007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6354357|NCT00072007|Alkylating Agents|alkylating agents|mesh-ancestor
6354358|NCT00072007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354359|NCT00072007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6354360|NCT00072007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6354361|NCT00072007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6354362|NCT00072007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6354363|NCT00072007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6354364|NCT00072007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6354365|NCT00072007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6354366|NCT00072007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6354367|NCT00072007|Glucocorticoids|glucocorticoids|mesh-ancestor
6354368|NCT00072007|Hormones|hormones|mesh-ancestor
6354369|NCT00072007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6354370|NCT00072007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6354371|NCT00072007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6354372|NCT00072007|Tubulin Modulators|tubulin modulators|mesh-ancestor
6354373|NCT00072007|Antimitotic Agents|antimitotic agents|mesh-ancestor
6354374|NCT00072007|Mitosis Modulators|mitosis modulators|mesh-ancestor
6354375|NCT00072020|Zoledronic Acid|zoledronic acid|mesh-list
6354376|NCT00072020|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6354377|NCT00072020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354378|NCT00072033|Docetaxel|docetaxel|mesh-list
6354379|NCT00072033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6354380|NCT00072033|Tubulin Modulators|tubulin modulators|mesh-ancestor
6354381|NCT00072033|Antimitotic Agents|antimitotic agents|mesh-ancestor
6354382|NCT00072033|Mitosis Modulators|mitosis modulators|mesh-ancestor
6354383|NCT00072033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354384|NCT00072046|Interferons|interferons|mesh-list
6354385|NCT00072046|Interferon-alpha|interferon-alpha|mesh-list
6354386|NCT00072046|Bevacizumab|bevacizumab|mesh-list
6354387|NCT00072046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6354388|NCT00072046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6354389|NCT00072046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6354390|NCT00072046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6354391|NCT00072046|Growth Substances|growth substances|mesh-ancestor
6354392|NCT00072046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354393|NCT00072046|Growth Inhibitors|growth inhibitors|mesh-ancestor
6354394|NCT00072046|Antiviral Agents|antiviral agents|mesh-ancestor
6354395|NCT00072046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6354396|NCT00072046|Immunologic Factors|immunologic factors|mesh-ancestor
6354397|NCT00072059|Epoetin Alfa|epoetin alfa|mesh-list
6354398|NCT00072059|Hematinics|hematinics|mesh-ancestor
6354399|NCT00072072|Celecoxib|celecoxib|mesh-list
6354400|NCT00072072|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6354401|NCT00072072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6354402|NCT00072072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6354403|NCT00072072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6354404|NCT00072072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354405|NCT00072072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6354406|NCT00072072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6354407|NCT00072072|Analgesics|analgesics|mesh-ancestor
6354408|NCT00072072|Sensory System Agents|sensory system agents|mesh-ancestor
6354409|NCT00072072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6354410|NCT00072072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354411|NCT00072072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6354412|NCT00072072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6354413|NCT00072072|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6354414|NCT00072072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6354415|NCT00072085|Aldesleukin|aldesleukin|mesh-list
6354416|NCT00072085|Freund's Adjuvant|freund's adjuvant|mesh-list
6354417|NCT00072085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6354418|NCT00072085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6354419|NCT00072085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6354420|NCT00072085|Antiviral Agents|antiviral agents|mesh-ancestor
6354421|NCT00072085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6354422|NCT00072085|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6354423|NCT00072085|Immunologic Factors|immunologic factors|mesh-ancestor
6354424|NCT00072085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354425|NCT00072098|Interleukin-12|interleukin-12|mesh-list
6354426|NCT00072098|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6354427|NCT00072098|Immunologic Factors|immunologic factors|mesh-ancestor
6354428|NCT00072098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354429|NCT00072098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6354430|NCT00072098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6354431|NCT00072098|Growth Substances|growth substances|mesh-ancestor
6354432|NCT00072098|Growth Inhibitors|growth inhibitors|mesh-ancestor
6354433|NCT00072098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6354434|NCT00072111|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6354435|NCT00072111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6354436|NCT00072124|Dacarbazine|dacarbazine|mesh-list
6354437|NCT00072124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6354438|NCT00072124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6354439|NCT00072124|Alkylating Agents|alkylating agents|mesh-ancestor
6354440|NCT00072124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354441|NCT00072137|Metronidazole|metronidazole|mesh-list
6354442|NCT00072137|Molgramostim|molgramostim|mesh-list
6354443|NCT00072137|Vaccines|vaccines|mesh-list
6354444|NCT00072137|Sargramostim|sargramostim|mesh-list
6354445|NCT00072137|Immunologic Factors|immunologic factors|mesh-ancestor
6354446|NCT00072137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354447|NCT00072137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6354448|NCT00072137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6354449|NCT00072137|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6354450|NCT00072137|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6354451|NCT00072137|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6354452|NCT00072150|Bortezomib|bortezomib|mesh-list
6354453|NCT00072150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6354454|NCT00072163|Thalidomide|thalidomide|mesh-list
6354455|NCT00072163|Temozolomide|temozolomide|mesh-list
6354456|NCT00072163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6354457|NCT00072163|Alkylating Agents|alkylating agents|mesh-ancestor
6354458|NCT00072163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354459|NCT00072163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6354460|NCT00072163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6354461|NCT00072163|Immunologic Factors|immunologic factors|mesh-ancestor
6354462|NCT00072163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354463|NCT00072163|Leprostatic Agents|leprostatic agents|mesh-ancestor
6354464|NCT00072163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6354465|NCT00072163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6354466|NCT00072163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6354467|NCT00072163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6354468|NCT00072163|Growth Substances|growth substances|mesh-ancestor
6354469|NCT00072163|Growth Inhibitors|growth inhibitors|mesh-ancestor
6354470|NCT00072215|Paclitaxel|paclitaxel|mesh-list
6354471|NCT00072215|Vinblastine|vinblastine|mesh-list
6354472|NCT00072215|Ifosfamide|ifosfamide|mesh-list
6354473|NCT00072215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6354474|NCT00072215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6354475|NCT00072215|Tubulin Modulators|tubulin modulators|mesh-ancestor
6354476|NCT00072215|Antimitotic Agents|antimitotic agents|mesh-ancestor
6354477|NCT00072215|Mitosis Modulators|mitosis modulators|mesh-ancestor
6354478|NCT00072215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354479|NCT00072215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6354480|NCT00072215|Alkylating Agents|alkylating agents|mesh-ancestor
6354481|NCT00072228|Gemcitabine|gemcitabine|mesh-list
6354482|NCT00072228|Soblidotin|soblidotin|mesh-list
6354483|NCT00072228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6354484|NCT00072228|Antimetabolites|antimetabolites|mesh-ancestor
6354485|NCT00072228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354486|NCT00072228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6354487|NCT00072228|Antiviral Agents|antiviral agents|mesh-ancestor
6354488|NCT00072228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6354489|NCT00072228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6354490|NCT00072228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6354491|NCT00072228|Immunologic Factors|immunologic factors|mesh-ancestor
6354492|NCT00072228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354493|NCT00072267|Topotecan|topotecan|mesh-list
6354494|NCT00072267|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
6354495|NCT00072267|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6354496|NCT00072267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6354497|NCT00072267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6354498|NCT00072267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354499|NCT00072267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6354500|NCT00072267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6394516|NCT00202397|Anticonvulsants|anticonvulsants|mesh-ancestor
6394517|NCT00202397|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6394518|NCT00202397|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6394519|NCT00202397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6394520|NCT00202397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394521|NCT00202397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394522|NCT00202397|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6394523|NCT00202397|Protective Agents|protective agents|mesh-ancestor
6394524|NCT00202423|Nabiximols|nabiximols|mesh-list
6394525|NCT00202423|Analgesics|analgesics|mesh-ancestor
6394526|NCT00202423|Sensory System Agents|sensory system agents|mesh-ancestor
6394527|NCT00202423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6394528|NCT00202423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394529|NCT00202462|Testosterone|testosterone|mesh-list
6394530|NCT00202462|Androgens|androgens|mesh-ancestor
6394531|NCT00202462|Hormones|hormones|mesh-ancestor
6394532|NCT00202462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6394533|NCT00202462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394534|NCT00202514|Valproic Acid|valproic acid|mesh-list
6394535|NCT00202514|Anticonvulsants|anticonvulsants|mesh-ancestor
6394536|NCT00202514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6394537|NCT00202514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394538|NCT00202514|GABA Agents|gaba agents|mesh-ancestor
6394539|NCT00202514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6394540|NCT00202514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394541|NCT00202514|Antimanic Agents|antimanic agents|mesh-ancestor
6394542|NCT00202514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6394543|NCT00202514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6394544|NCT00202514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6394545|NCT00202553|Perindopril|perindopril|mesh-list
6394546|NCT00202553|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6394547|NCT00202553|Protease Inhibitors|protease inhibitors|mesh-ancestor
6394548|NCT00202553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6394549|NCT00202553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394550|NCT00202553|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6394551|NCT00202592|Perindopril|perindopril|mesh-list
6394552|NCT00202592|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6394553|NCT00202592|Protease Inhibitors|protease inhibitors|mesh-ancestor
6394554|NCT00202592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6394555|NCT00202592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394556|NCT00202592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6394557|NCT00202605|Amphetamine|amphetamine|mesh-list
6394558|NCT00202605|Dextroamphetamine|dextroamphetamine|mesh-list
6394559|NCT00202605|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6394560|NCT00202605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394561|NCT00202605|Sympathomimetics|sympathomimetics|mesh-ancestor
6394562|NCT00202605|Autonomic Agents|autonomic agents|mesh-ancestor
6394563|NCT00202605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6394564|NCT00202605|Dopamine Agents|dopamine agents|mesh-ancestor
6394565|NCT00202605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6394566|NCT00202605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394567|NCT00202605|Adrenergic Agents|adrenergic agents|mesh-ancestor
6354501|NCT00072319|Paclitaxel|paclitaxel|mesh-list
6354502|NCT00072319|Cyclophosphamide|cyclophosphamide|mesh-list
6354503|NCT00072319|Epirubicin|epirubicin|mesh-list
6354504|NCT00072319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6354505|NCT00072319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6354506|NCT00072319|Tubulin Modulators|tubulin modulators|mesh-ancestor
6354507|NCT00072319|Antimitotic Agents|antimitotic agents|mesh-ancestor
6354508|NCT00072319|Mitosis Modulators|mitosis modulators|mesh-ancestor
6354509|NCT00072319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354510|NCT00072319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6354511|NCT00072319|Immunologic Factors|immunologic factors|mesh-ancestor
6354512|NCT00072319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354513|NCT00072319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6354514|NCT00072319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6354515|NCT00072319|Alkylating Agents|alkylating agents|mesh-ancestor
6354516|NCT00072319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6354517|NCT00072319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6354518|NCT00072319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6354519|NCT00072319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6354520|NCT00072319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6354521|NCT00072332|Cisplatin|cisplatin|mesh-list
6354522|NCT00072332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6354523|NCT00072345|Thalidomide|thalidomide|mesh-list
6354524|NCT00072345|Temozolomide|temozolomide|mesh-list
6354525|NCT00072345|Lomustine|lomustine|mesh-list
6354526|NCT00072345|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6354527|NCT00072345|Alkylating Agents|alkylating agents|mesh-ancestor
6354528|NCT00072345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354529|NCT00072345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6354530|NCT00072345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6354531|NCT00072345|Immunologic Factors|immunologic factors|mesh-ancestor
6354532|NCT00072345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354533|NCT00072345|Leprostatic Agents|leprostatic agents|mesh-ancestor
6354534|NCT00072345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6354535|NCT00072345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6354536|NCT00072345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6354537|NCT00072345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6354538|NCT00072345|Growth Substances|growth substances|mesh-ancestor
6354539|NCT00072345|Growth Inhibitors|growth inhibitors|mesh-ancestor
6354540|NCT00072358|Carbamide Peroxide|carbamide peroxide|mesh-list
6354541|NCT00072358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6354542|NCT00072358|Irinotecan|irinotecan|mesh-list
6354543|NCT00072358|Temozolomide|temozolomide|mesh-list
6354544|NCT00072358|Molgramostim|molgramostim|mesh-list
6354545|NCT00072358|Isotretinoin|isotretinoin|mesh-list
6354546|NCT00072358|Antibodies|antibodies|mesh-list
6354547|NCT00072358|Immunoglobulins|immunoglobulins|mesh-list
6354548|NCT00072358|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6354549|NCT00072358|Sargramostim|sargramostim|mesh-list
6354550|NCT00072358|Immunoglobulin G|immunoglobulin g|mesh-list
6354551|NCT00072358|Immunologic Factors|immunologic factors|mesh-ancestor
6354552|NCT00072358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354553|NCT00072358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6354554|NCT00072358|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6354555|NCT00072358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6354556|NCT00072358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6354557|NCT00072358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354558|NCT00072358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6354559|NCT00072358|Alkylating Agents|alkylating agents|mesh-ancestor
6354560|NCT00072358|Dermatologic Agents|dermatologic agents|mesh-ancestor
6354561|NCT00072358|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6354562|NCT00072358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6354563|NCT00072436|Gemcitabine|gemcitabine|mesh-list
6354564|NCT00072436|Alvocidib|alvocidib|mesh-list
6354565|NCT00072436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6354566|NCT00072436|Antimetabolites|antimetabolites|mesh-ancestor
6354567|NCT00072436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354568|NCT00072436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6354569|NCT00072436|Antiviral Agents|antiviral agents|mesh-ancestor
6354570|NCT00072436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6354571|NCT00072436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6354572|NCT00072436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6354573|NCT00072436|Immunologic Factors|immunologic factors|mesh-ancestor
6354574|NCT00072436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354575|NCT00072436|Growth Inhibitors|growth inhibitors|mesh-ancestor
6354576|NCT00072436|Growth Substances|growth substances|mesh-ancestor
6354577|NCT00072436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6354578|NCT00072462|Tamoxifen|tamoxifen|mesh-list
6354579|NCT00072462|Anastrozole|anastrozole|mesh-list
6354580|NCT00072462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354581|NCT00072462|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6354582|NCT00072462|Hormone Antagonists|hormone antagonists|mesh-ancestor
6354583|NCT00072462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6354584|NCT00072462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354585|NCT00072462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6354586|NCT00072462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6354587|NCT00072462|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6354588|NCT00072462|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6354589|NCT00072462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6354590|NCT00072462|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6354591|NCT00072462|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6354592|NCT00072462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6354593|NCT00072527|Carboplatin|carboplatin|mesh-list
6354594|NCT00072527|Irinotecan|irinotecan|mesh-list
6354595|NCT00072527|Etoposide|etoposide|mesh-list
6354596|NCT00072527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6354597|NCT00072527|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6354598|NCT00072527|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6354599|NCT00072527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6354600|NCT00072527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354601|NCT00072527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6354602|NCT00072527|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6354603|NCT00072540|Celecoxib|celecoxib|mesh-list
6354604|NCT00072540|Enzyme Inhibitors|enzyme inhibitors|mesh-list
6354605|NCT00072540|Mitogens|mitogens|mesh-list
6354606|NCT00072540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6354607|NCT00072540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6354608|NCT00072540|Analgesics|analgesics|mesh-ancestor
6354609|NCT00072540|Sensory System Agents|sensory system agents|mesh-ancestor
6354610|NCT00072540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6354611|NCT00072540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354612|NCT00072540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6354613|NCT00072540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6354614|NCT00072540|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6354615|NCT00072540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6354616|NCT00072540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354617|NCT00072540|Mitosis Modulators|mitosis modulators|mesh-ancestor
6354618|NCT00072553|Leucovorin|leucovorin|mesh-list
6354619|NCT00072553|Celecoxib|celecoxib|mesh-list
6354620|NCT00072553|Fluorouracil|fluorouracil|mesh-list
6354621|NCT00072553|Oxaliplatin|oxaliplatin|mesh-list
6354622|NCT00072553|Calcium|calcium|mesh-list
6354623|NCT00072553|Levoleucovorin|levoleucovorin|mesh-list
6354624|NCT00072553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6354625|NCT00072553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354626|NCT00072553|Antimetabolites|antimetabolites|mesh-ancestor
6354627|NCT00072553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354628|NCT00072553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6354629|NCT00072553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6354630|NCT00072553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6354631|NCT00072553|Immunologic Factors|immunologic factors|mesh-ancestor
6354632|NCT00072553|Antidotes|antidotes|mesh-ancestor
6354633|NCT00072553|Protective Agents|protective agents|mesh-ancestor
6354634|NCT00072553|Vitamin B Complex|vitamin b complex|mesh-ancestor
6354635|NCT00072553|Vitamins|vitamins|mesh-ancestor
6354636|NCT00072553|Micronutrients|micronutrients|mesh-ancestor
6354637|NCT00072553|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6354638|NCT00072553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6354639|NCT00072553|Analgesics|analgesics|mesh-ancestor
6354640|NCT00072553|Sensory System Agents|sensory system agents|mesh-ancestor
6354641|NCT00072553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6354642|NCT00072553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6354643|NCT00072553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6354644|NCT00072553|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6354645|NCT00072553|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6354646|NCT00072553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6354647|NCT00072579|Sargramostim|sargramostim|mesh-list
6354648|NCT00072579|Immunologic Factors|immunologic factors|mesh-ancestor
6354649|NCT00072579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354650|NCT00072592|Rituximab|rituximab|mesh-list
6354651|NCT00072592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6354652|NCT00072592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6354653|NCT00072592|Immunologic Factors|immunologic factors|mesh-ancestor
6354654|NCT00072592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354655|NCT00072592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6354656|NCT00072618|Sulindac sulfone|sulindac sulfone|mesh-list
6354657|NCT00072618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6354658|NCT00072618|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6354659|NCT00072618|Protective Agents|protective agents|mesh-ancestor
6354660|NCT00072618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354661|NCT00072618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6354662|NCT00072618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6354663|NCT00072618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354664|NCT00072618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6354665|NCT00072618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6354666|NCT00072618|Analgesics|analgesics|mesh-ancestor
6354667|NCT00072618|Sensory System Agents|sensory system agents|mesh-ancestor
6354668|NCT00072618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6354669|NCT00072618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6354670|NCT00072618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6354671|NCT00072631|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6354672|NCT00072631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6354673|NCT00072631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6354674|NCT00072631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6354675|NCT00072631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354676|NCT00072670|Trabectedin|trabectedin|mesh-list
6354677|NCT00072670|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6354678|NCT00072670|Alkylating Agents|alkylating agents|mesh-ancestor
6354679|NCT00072670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354680|NCT00072670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6354681|NCT00072683|Tolvaptan|tolvaptan|mesh-list
6354682|NCT00072683|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6354683|NCT00072683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354684|NCT00072683|Natriuretic Agents|natriuretic agents|mesh-ancestor
6354685|NCT00072683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354686|NCT00072722|Pomalidomide|pomalidomide|mesh-list
6354687|NCT00072722|Immunologic Factors|immunologic factors|mesh-ancestor
6354688|NCT00072722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354689|NCT00072722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6354690|NCT00072722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6354691|NCT00072722|Growth Substances|growth substances|mesh-ancestor
6354692|NCT00072722|Growth Inhibitors|growth inhibitors|mesh-ancestor
6354693|NCT00072722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6354694|NCT00072748|EKB 569|ekb 569|mesh-list
6354695|NCT00072748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6354696|NCT00072748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6354697|NCT00072748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6354698|NCT00072748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354699|NCT00072787|Cisplatin|cisplatin|mesh-list
6354700|NCT00072787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6354701|NCT00072826|Acetylcholine|acetylcholine|mesh-list
6354702|NCT00072826|Oxypurinol|oxypurinol|mesh-list
6354703|NCT00072826|Vasodilator Agents|vasodilator agents|mesh-ancestor
6354704|NCT00072826|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6354705|NCT00072826|Cholinergic Agents|cholinergic agents|mesh-ancestor
6354706|NCT00072826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6354707|NCT00072826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354708|NCT00072826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354709|NCT00072826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6354710|NCT00072839|Teduglutide|teduglutide|mesh-list
6354711|NCT00072839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6354712|NCT00072839|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6354713|NCT00072839|Protective Agents|protective agents|mesh-ancestor
6354714|NCT00072839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354715|NCT00072852|Irinotecan|irinotecan|mesh-list
6354716|NCT00072852|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6354717|NCT00072852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6354718|NCT00072852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6354719|NCT00072852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354720|NCT00072852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6354721|NCT00072865|Carboplatin|carboplatin|mesh-list
6354722|NCT00072865|Pemetrexed|pemetrexed|mesh-list
6354723|NCT00072865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6354724|NCT00072865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6354725|NCT00072865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354726|NCT00072865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6354727|NCT00072865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6354728|NCT00072904|Repaglinide|repaglinide|mesh-list
6354729|NCT00072904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6354730|NCT00072904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354731|NCT00072930|Zoledronic Acid|zoledronic acid|mesh-list
6354732|NCT00072930|Prednisone|prednisone|mesh-list
6354733|NCT00072930|Docetaxel|docetaxel|mesh-list
6354734|NCT00072930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6354735|NCT00072930|Tubulin Modulators|tubulin modulators|mesh-ancestor
6354736|NCT00072930|Antimitotic Agents|antimitotic agents|mesh-ancestor
6354737|NCT00072930|Mitosis Modulators|mitosis modulators|mesh-ancestor
6354738|NCT00072930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354739|NCT00072930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6354740|NCT00072930|Glucocorticoids|glucocorticoids|mesh-ancestor
6354741|NCT00072930|Hormones|hormones|mesh-ancestor
6354742|NCT00072930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6354743|NCT00072930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354744|NCT00072930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6354745|NCT00072930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6354746|NCT00072943|Interferons|interferons|mesh-list
6354747|NCT00072943|Interferon-gamma|interferon-gamma|mesh-list
6354748|NCT00072943|Antibodies|antibodies|mesh-list
6354749|NCT00072943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6354750|NCT00072943|Immunologic Factors|immunologic factors|mesh-ancestor
6354751|NCT00072943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354752|NCT00072943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6354753|NCT00072943|Antiviral Agents|antiviral agents|mesh-ancestor
6354754|NCT00072943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6354755|NCT00072969|Daclizumab|daclizumab|mesh-list
6354756|NCT00072969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6354757|NCT00072969|Immunologic Factors|immunologic factors|mesh-ancestor
6354758|NCT00072969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354759|NCT00072982|Borage oil|borage oil|mesh-list
6354760|NCT00072982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6354761|NCT00073047|Daclizumab|daclizumab|mesh-list
6354762|NCT00073047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6354763|NCT00073047|Immunologic Factors|immunologic factors|mesh-ancestor
6354764|NCT00073047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354765|NCT00073164|Valproic Acid|valproic acid|mesh-list
6354766|NCT00073164|Olanzapine|olanzapine|mesh-list
6354767|NCT00073164|Risperidone|risperidone|mesh-list
6354768|NCT00073164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6354769|NCT00073164|Serotonin Agents|serotonin agents|mesh-ancestor
6354770|NCT00073164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6354771|NCT00073164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354772|NCT00073164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354773|NCT00073164|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6354774|NCT00073164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6354775|NCT00073164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6354776|NCT00073164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6354777|NCT00073164|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6354778|NCT00073164|Dopamine Agents|dopamine agents|mesh-ancestor
6354779|NCT00073164|Antiemetics|antiemetics|mesh-ancestor
6354780|NCT00073164|Autonomic Agents|autonomic agents|mesh-ancestor
6354781|NCT00073164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6354782|NCT00073164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6354783|NCT00073164|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6354784|NCT00073164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6354785|NCT00073164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6354786|NCT00073164|Anticonvulsants|anticonvulsants|mesh-ancestor
6354787|NCT00073164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6354788|NCT00073164|GABA Agents|gaba agents|mesh-ancestor
6354789|NCT00073164|Antimanic Agents|antimanic agents|mesh-ancestor
6354790|NCT00073203|Paroxetine|paroxetine|mesh-list
6354791|NCT00073203|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6354792|NCT00073203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6354793|NCT00073203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6354794|NCT00073203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354795|NCT00073203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6354796|NCT00073203|Serotonin Agents|serotonin agents|mesh-ancestor
6354797|NCT00073203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354798|NCT00073203|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6354799|NCT00073203|Antidepressive Agents|antidepressive agents|mesh-ancestor
6354800|NCT00073203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6354801|NCT00073203|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6354802|NCT00073203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6354803|NCT00073203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6354804|NCT00073320|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6354805|NCT00073320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6354806|NCT00073320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6354807|NCT00073320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6354808|NCT00073320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354809|NCT00073320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6354810|NCT00073320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6354811|NCT00073320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6354812|NCT00073320|Serotonin Agents|serotonin agents|mesh-ancestor
6354813|NCT00073320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6354814|NCT00073320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354815|NCT00073320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6354816|NCT00073320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6354817|NCT00073320|Dopamine Agents|dopamine agents|mesh-ancestor
6354818|NCT00073372|Abciximab|abciximab|mesh-list
6354819|NCT00073372|Anticoagulants|anticoagulants|mesh-ancestor
6354820|NCT00073372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6354821|NCT00073385|Docetaxel|docetaxel|mesh-list
6354822|NCT00073385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6354823|NCT00073385|Tubulin Modulators|tubulin modulators|mesh-ancestor
6354824|NCT00073385|Antimitotic Agents|antimitotic agents|mesh-ancestor
6354825|NCT00073385|Mitosis Modulators|mitosis modulators|mesh-ancestor
6354826|NCT00073385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354827|NCT00073411|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6354828|NCT00073411|Citalopram|citalopram|mesh-list
6354829|NCT00073411|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6354830|NCT00073411|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6354831|NCT00073411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6354832|NCT00073411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354833|NCT00073411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6354834|NCT00073411|Serotonin Agents|serotonin agents|mesh-ancestor
6354835|NCT00073411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354836|NCT00073411|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6354837|NCT00073411|Antidepressive Agents|antidepressive agents|mesh-ancestor
6354838|NCT00073411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6354839|NCT00073411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6354840|NCT00073411|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6354841|NCT00073411|Analgesics|analgesics|mesh-ancestor
6354842|NCT00073411|Sensory System Agents|sensory system agents|mesh-ancestor
6354843|NCT00073411|Dopamine Agents|dopamine agents|mesh-ancestor
6354844|NCT00073437|Infliximab|infliximab|mesh-list
6354845|NCT00073437|Dermatologic Agents|dermatologic agents|mesh-ancestor
6354846|NCT00073437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6354847|NCT00073437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6354848|NCT00073580|Hirudins|hirudins|mesh-list
6354849|NCT00073580|Anticoagulants|anticoagulants|mesh-list
6354850|NCT00073580|Bivalirudin|bivalirudin|mesh-list
6354851|NCT00073580|Antithrombins|antithrombins|mesh-ancestor
6354852|NCT00073580|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6354853|NCT00073580|Protease Inhibitors|protease inhibitors|mesh-ancestor
6354854|NCT00073580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6354855|NCT00073580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354856|NCT00073580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6354857|NCT00073580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6354858|NCT00073593|Heparin|heparin|mesh-list
6354859|NCT00073593|Bivalirudin|bivalirudin|mesh-list
6354860|NCT00073593|Protamines|protamines|mesh-list
6354861|NCT00073593|Anticoagulants|anticoagulants|mesh-ancestor
6354862|NCT00073593|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6354863|NCT00073593|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6354864|NCT00073593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354865|NCT00073593|Antithrombins|antithrombins|mesh-ancestor
6354866|NCT00073593|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6354867|NCT00073593|Protease Inhibitors|protease inhibitors|mesh-ancestor
6354868|NCT00073593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6354869|NCT00073593|Heparin Antagonists|heparin antagonists|mesh-ancestor
6354870|NCT00073593|Coagulants|coagulants|mesh-ancestor
6354871|NCT00073658|Risperidone|risperidone|mesh-list
6354872|NCT00073658|Citalopram|citalopram|mesh-list
6354873|NCT00073658|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6354874|NCT00073658|Serotonin Agents|serotonin agents|mesh-ancestor
6354875|NCT00073658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6354876|NCT00073658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354877|NCT00073658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354878|NCT00073658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6354879|NCT00073658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6354880|NCT00073658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6354881|NCT00073658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6354882|NCT00073658|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6354883|NCT00073658|Dopamine Agents|dopamine agents|mesh-ancestor
6354884|NCT00073658|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6354885|NCT00073658|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6354886|NCT00073658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6354887|NCT00073658|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6354888|NCT00073658|Antidepressive Agents|antidepressive agents|mesh-ancestor
6354889|NCT00073697|Dexetimide|dexetimide|mesh-list
6354890|NCT00073697|Citalopram|citalopram|mesh-list
6354891|NCT00073697|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6354892|NCT00073697|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6354893|NCT00073697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6354894|NCT00073697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354895|NCT00073697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6354896|NCT00073697|Serotonin Agents|serotonin agents|mesh-ancestor
6354897|NCT00073697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354898|NCT00073697|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6354899|NCT00073697|Antidepressive Agents|antidepressive agents|mesh-ancestor
6017097|NCT00369629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6354900|NCT00073697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6354901|NCT00073697|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6354902|NCT00073697|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6354903|NCT00073697|Parasympatholytics|parasympatholytics|mesh-ancestor
6354904|NCT00073697|Autonomic Agents|autonomic agents|mesh-ancestor
6354905|NCT00073697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6354906|NCT00073697|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6354907|NCT00073697|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6017098|NCT00369655|Aflibercept|aflibercept|mesh-list
6017099|NCT00369655|Endothelial Growth Factors|endothelial growth factors|mesh-list
6017100|NCT00369655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6017101|NCT00369655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6017102|NCT00369655|Growth Substances|growth substances|mesh-ancestor
6017103|NCT00369655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017104|NCT00369655|Growth Inhibitors|growth inhibitors|mesh-ancestor
6017105|NCT00369655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6017106|NCT00369681|Rituximab|rituximab|mesh-list
6017107|NCT00369681|Doxorubicin|doxorubicin|mesh-list
6017108|NCT00369681|Dacarbazine|dacarbazine|mesh-list
6017109|NCT00369681|Bleomycin|bleomycin|mesh-list
6017110|NCT00369681|Vinblastine|vinblastine|mesh-list
6354908|NCT00073697|Cholinergic Agents|cholinergic agents|mesh-ancestor
6354909|NCT00073710|Calcitriol|calcitriol|mesh-list
6354910|NCT00073710|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6354911|NCT00073710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354912|NCT00073710|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6354913|NCT00073710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6354914|NCT00073710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354915|NCT00073710|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6354916|NCT00073710|Vitamins|vitamins|mesh-ancestor
6017111|NCT00369681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6017112|NCT00369681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6017113|NCT00369681|Immunologic Factors|immunologic factors|mesh-ancestor
6017114|NCT00369681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017115|NCT00369681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6017116|NCT00369681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6017117|NCT00369681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6017118|NCT00369681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6017119|NCT00369681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6017120|NCT00369681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017121|NCT00369681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6017122|NCT00369681|Alkylating Agents|alkylating agents|mesh-ancestor
6017123|NCT00369681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6017124|NCT00369681|Tubulin Modulators|tubulin modulators|mesh-ancestor
6017125|NCT00369681|Antimitotic Agents|antimitotic agents|mesh-ancestor
6017126|NCT00369681|Mitosis Modulators|mitosis modulators|mesh-ancestor
6017127|NCT00369707|Rituximab|rituximab|mesh-list
6017128|NCT00369707|Bortezomib|bortezomib|mesh-list
6017129|NCT00369707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6017130|NCT00369707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6017131|NCT00369707|Immunologic Factors|immunologic factors|mesh-ancestor
6017132|NCT00369707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017133|NCT00369707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6017134|NCT00369746|Citalopram|citalopram|mesh-list
6354917|NCT00073710|Micronutrients|micronutrients|mesh-ancestor
6354918|NCT00073710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6354919|NCT00073723|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6354920|NCT00073723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6354921|NCT00073736|Cytarabine|cytarabine|mesh-list
6354922|NCT00073736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6354923|NCT00073736|Antimetabolites|antimetabolites|mesh-ancestor
6354924|NCT00073736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354925|NCT00073736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6354926|NCT00073736|Antiviral Agents|antiviral agents|mesh-ancestor
6354927|NCT00073736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6354928|NCT00073736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6354929|NCT00073736|Immunologic Factors|immunologic factors|mesh-ancestor
6354930|NCT00073736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354931|NCT00073814|Albuterol|albuterol|mesh-list
6354932|NCT00073814|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6354933|NCT00073814|Autonomic Agents|autonomic agents|mesh-ancestor
6354934|NCT00073814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6354935|NCT00073814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354936|NCT00073814|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6354937|NCT00073814|Respiratory System Agents|respiratory system agents|mesh-ancestor
6354938|NCT00073814|Tocolytic Agents|tocolytic agents|mesh-ancestor
6354939|NCT00073814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6354940|NCT00073814|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6354941|NCT00073814|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6354942|NCT00073814|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6354943|NCT00073814|Adrenergic Agents|adrenergic agents|mesh-ancestor
6354944|NCT00073814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6354945|NCT00073814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354946|NCT00073827|Albuterol|albuterol|mesh-list
6354947|NCT00073827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6354948|NCT00073827|Autonomic Agents|autonomic agents|mesh-ancestor
6354949|NCT00073827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6354950|NCT00073827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354951|NCT00073827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6354952|NCT00073827|Respiratory System Agents|respiratory system agents|mesh-ancestor
6354953|NCT00073827|Tocolytic Agents|tocolytic agents|mesh-ancestor
6354954|NCT00073827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6354955|NCT00073827|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6354956|NCT00073827|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6354957|NCT00073827|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6354958|NCT00073827|Adrenergic Agents|adrenergic agents|mesh-ancestor
6354959|NCT00073827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6354960|NCT00073827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354961|NCT00073840|Albuterol|albuterol|mesh-list
6354962|NCT00073840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6354963|NCT00073840|Autonomic Agents|autonomic agents|mesh-ancestor
6354964|NCT00073840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6354965|NCT00073840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354966|NCT00073840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6354967|NCT00073840|Respiratory System Agents|respiratory system agents|mesh-ancestor
6354968|NCT00073840|Tocolytic Agents|tocolytic agents|mesh-ancestor
6354969|NCT00073840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6354970|NCT00073840|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6354971|NCT00073840|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6354972|NCT00073840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6354973|NCT00073840|Adrenergic Agents|adrenergic agents|mesh-ancestor
6354974|NCT00073840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6354975|NCT00073840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354976|NCT00073879|Cyclophosphamide|cyclophosphamide|mesh-list
6354977|NCT00073879|Fludarabine|fludarabine|mesh-list
6354978|NCT00073879|Fludarabine phosphate|fludarabine phosphate|mesh-list
6354979|NCT00073879|Alemtuzumab|alemtuzumab|mesh-list
6354980|NCT00073879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6354981|NCT00073879|Immunologic Factors|immunologic factors|mesh-ancestor
6354982|NCT00073879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6354983|NCT00073879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6354984|NCT00073879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6354985|NCT00073879|Alkylating Agents|alkylating agents|mesh-ancestor
6354986|NCT00073879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354987|NCT00073879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6354988|NCT00073879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6354989|NCT00073879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6354990|NCT00073879|Antimetabolites|antimetabolites|mesh-ancestor
6354991|NCT00073879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6354992|NCT00073905|Gemcitabine|gemcitabine|mesh-list
6354993|NCT00073905|Capecitabine|capecitabine|mesh-list
6354994|NCT00073905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6354995|NCT00073905|Antimetabolites|antimetabolites|mesh-ancestor
6354996|NCT00073905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6354997|NCT00073905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6354998|NCT00073905|Antiviral Agents|antiviral agents|mesh-ancestor
6354999|NCT00073905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6355000|NCT00073905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6355001|NCT00073905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6355002|NCT00073905|Immunologic Factors|immunologic factors|mesh-ancestor
6355003|NCT00073905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6355004|NCT00073931|Tositumomab I-131|tositumomab i-131|mesh-list
6355005|NCT00073931|Sargramostim|sargramostim|mesh-list
6355006|NCT00073931|Immunologic Factors|immunologic factors|mesh-ancestor
6355007|NCT00073931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6355008|NCT00073931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6394568|NCT00202605|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6394569|NCT00202605|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6394570|NCT00202605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6394571|NCT00202605|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6394572|NCT00202618|Amlodipine|amlodipine|mesh-list
6394573|NCT00202618|Valsartan|valsartan|mesh-list
6394574|NCT00202618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6394575|NCT00202618|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6394576|NCT00202618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6394577|NCT00202618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394578|NCT00202618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6394579|NCT00202618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6355009|NCT00073970|Celecoxib|celecoxib|mesh-list
6355010|NCT00073970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6355011|NCT00073970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6355012|NCT00073970|Analgesics|analgesics|mesh-ancestor
6355013|NCT00073970|Sensory System Agents|sensory system agents|mesh-ancestor
6355014|NCT00073970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6355015|NCT00073970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6355016|NCT00073970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6355017|NCT00073970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6355018|NCT00073970|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6355019|NCT00073970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6355020|NCT00073970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6355021|NCT00073970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355022|NCT00074009|Bortezomib|bortezomib|mesh-list
6355023|NCT00074009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355024|NCT00074022|Docetaxel|docetaxel|mesh-list
6355025|NCT00074022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355026|NCT00074022|Tubulin Modulators|tubulin modulators|mesh-ancestor
6355027|NCT00074022|Antimitotic Agents|antimitotic agents|mesh-ancestor
6355028|NCT00074022|Mitosis Modulators|mitosis modulators|mesh-ancestor
6355029|NCT00074022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355030|NCT00074074|Infliximab|infliximab|mesh-list
6355031|NCT00074074|Dermatologic Agents|dermatologic agents|mesh-ancestor
6355032|NCT00074074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6355033|NCT00074074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6355034|NCT00074087|Doxorubicin|doxorubicin|mesh-list
6355035|NCT00074087|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6355036|NCT00074087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6355037|NCT00074087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355038|NCT00074087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6355039|NCT00074087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6355040|NCT00074087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6355041|NCT00074087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355042|NCT00074100|Amonafide|amonafide|mesh-list
6355043|NCT00074100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355044|NCT00074100|Antiviral Agents|antiviral agents|mesh-ancestor
6355045|NCT00074100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6355046|NCT00074100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6355047|NCT00074100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355048|NCT00074139|Cyclophosphamide|cyclophosphamide|mesh-list
6355049|NCT00074139|Docetaxel|docetaxel|mesh-list
6355050|NCT00074139|Doxorubicin|doxorubicin|mesh-list
6355051|NCT00074139|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6355052|NCT00074139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6355053|NCT00074139|Immunologic Factors|immunologic factors|mesh-ancestor
6355054|NCT00074139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6355055|NCT00074139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6355056|NCT00074139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6355057|NCT00074139|Alkylating Agents|alkylating agents|mesh-ancestor
6355058|NCT00074139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355059|NCT00074139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355060|NCT00074139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6355061|NCT00074139|Tubulin Modulators|tubulin modulators|mesh-ancestor
6355062|NCT00074139|Antimitotic Agents|antimitotic agents|mesh-ancestor
6355063|NCT00074139|Mitosis Modulators|mitosis modulators|mesh-ancestor
6355064|NCT00074139|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6355065|NCT00074139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6355066|NCT00074139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6355067|NCT00074139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6355068|NCT00074178|Cytarabine|cytarabine|mesh-list
6355069|NCT00074178|Dexamethasone|dexamethasone|mesh-list
6355070|NCT00074178|Cyclophosphamide|cyclophosphamide|mesh-list
6355071|NCT00074178|Methotrexate|methotrexate|mesh-list
6355072|NCT00074178|Etoposide|etoposide|mesh-list
6355073|NCT00074178|Etoposide phosphate|etoposide phosphate|mesh-list
6355074|NCT00074178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6355075|NCT00074178|Immunologic Factors|immunologic factors|mesh-ancestor
6355076|NCT00074178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6355077|NCT00074178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6355078|NCT00074178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6355079|NCT00074178|Alkylating Agents|alkylating agents|mesh-ancestor
6355080|NCT00074178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355081|NCT00074178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355082|NCT00074178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6355083|NCT00074178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6355084|NCT00074178|Antiemetics|antiemetics|mesh-ancestor
6355085|NCT00074178|Autonomic Agents|autonomic agents|mesh-ancestor
6355086|NCT00074178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6355087|NCT00074178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6355088|NCT00074178|Glucocorticoids|glucocorticoids|mesh-ancestor
6355089|NCT00074178|Hormones|hormones|mesh-ancestor
6355090|NCT00074178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6355091|NCT00074178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6355092|NCT00074178|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6355093|NCT00074178|Abortifacient Agents|abortifacient agents|mesh-ancestor
6355094|NCT00074178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6355095|NCT00074178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6355096|NCT00074178|Antimetabolites|antimetabolites|mesh-ancestor
6355097|NCT00074178|Dermatologic Agents|dermatologic agents|mesh-ancestor
6355098|NCT00074178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6355099|NCT00074178|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6355100|NCT00074178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6355101|NCT00074178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6355102|NCT00074178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6355103|NCT00074178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6355104|NCT00074178|Antiviral Agents|antiviral agents|mesh-ancestor
6355105|NCT00074178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6355106|NCT00074191|Cytarabine|cytarabine|mesh-list
6355107|NCT00074191|Dexamethasone|dexamethasone|mesh-list
6355108|NCT00074191|Methotrexate|methotrexate|mesh-list
6355109|NCT00074191|Lomustine|lomustine|mesh-list
6355110|NCT00074191|Procarbazine|procarbazine|mesh-list
6355111|NCT00074191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6355112|NCT00074191|Antiemetics|antiemetics|mesh-ancestor
6355113|NCT00074191|Autonomic Agents|autonomic agents|mesh-ancestor
6355114|NCT00074191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6355115|NCT00074191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6355116|NCT00074191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6355117|NCT00074191|Glucocorticoids|glucocorticoids|mesh-ancestor
6355118|NCT00074191|Hormones|hormones|mesh-ancestor
6355119|NCT00074191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6355120|NCT00074191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6355121|NCT00074191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355122|NCT00074191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6355123|NCT00074191|Abortifacient Agents|abortifacient agents|mesh-ancestor
6355124|NCT00074191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6355125|NCT00074191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6355126|NCT00074191|Antimetabolites|antimetabolites|mesh-ancestor
6355127|NCT00074191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355128|NCT00074191|Dermatologic Agents|dermatologic agents|mesh-ancestor
6355129|NCT00074191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6355130|NCT00074191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6355131|NCT00074191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6355132|NCT00074191|Immunologic Factors|immunologic factors|mesh-ancestor
6355133|NCT00074191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6355134|NCT00074191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6355135|NCT00074191|Antiviral Agents|antiviral agents|mesh-ancestor
6394580|NCT00202618|Vasodilator Agents|vasodilator agents|mesh-ancestor
6355136|NCT00074191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6355137|NCT00074191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6355138|NCT00074191|Alkylating Agents|alkylating agents|mesh-ancestor
6355139|NCT00074204|Gemcitabine|gemcitabine|mesh-list
6355140|NCT00074204|Carboplatin|carboplatin|mesh-list
6355141|NCT00074204|Docetaxel|docetaxel|mesh-list
6355142|NCT00074204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355143|NCT00074204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6355144|NCT00074204|Antimetabolites|antimetabolites|mesh-ancestor
6355145|NCT00074204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355146|NCT00074204|Antiviral Agents|antiviral agents|mesh-ancestor
6355147|NCT00074204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6355148|NCT00074204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6355149|NCT00074204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6355150|NCT00074204|Immunologic Factors|immunologic factors|mesh-ancestor
6355151|NCT00074204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6355152|NCT00074204|Tubulin Modulators|tubulin modulators|mesh-ancestor
6355153|NCT00074204|Antimitotic Agents|antimitotic agents|mesh-ancestor
6355154|NCT00074204|Mitosis Modulators|mitosis modulators|mesh-ancestor
6355155|NCT00074230|BIRC5 protein, human|birc5 protein, human|mesh-list
6355156|NCT00074230|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
6355157|NCT00074230|Protease Inhibitors|protease inhibitors|mesh-ancestor
6355158|NCT00074230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6355159|NCT00074230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355160|NCT00074321|Capecitabine|capecitabine|mesh-list
6355161|NCT00074321|Oxaliplatin|oxaliplatin|mesh-list
6355162|NCT00074321|Irinotecan|irinotecan|mesh-list
6355163|NCT00074321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6355164|NCT00074321|Antimetabolites|antimetabolites|mesh-ancestor
6355165|NCT00074321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355166|NCT00074321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355167|NCT00074321|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6355168|NCT00074321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6355169|NCT00074321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6355170|NCT00074334|Immunotoxins|immunotoxins|mesh-list
6355171|NCT00074334|Immunologic Factors|immunologic factors|mesh-ancestor
6355172|NCT00074334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6355173|NCT00074399|Nevirapine|nevirapine|mesh-list
6355174|NCT00074399|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6355175|NCT00074399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6355176|NCT00074399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6355177|NCT00074399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355178|NCT00074399|Antiviral Agents|antiviral agents|mesh-ancestor
6355179|NCT00074399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6355180|NCT00074399|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6355181|NCT00074399|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6355182|NCT00074399|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6355183|NCT00074399|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6355184|NCT00074438|Rituximab|rituximab|mesh-list
6355185|NCT00074438|Methotrexate|methotrexate|mesh-list
6355186|NCT00074438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6355187|NCT00074438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355188|NCT00074438|Immunologic Factors|immunologic factors|mesh-ancestor
6355189|NCT00074438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6355190|NCT00074438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6355191|NCT00074438|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6355192|NCT00074438|Abortifacient Agents|abortifacient agents|mesh-ancestor
6355193|NCT00074438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6355194|NCT00074438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6355195|NCT00074438|Antimetabolites|antimetabolites|mesh-ancestor
6355196|NCT00074438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355197|NCT00074438|Dermatologic Agents|dermatologic agents|mesh-ancestor
6355198|NCT00074438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6355199|NCT00074438|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6355200|NCT00074438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6355201|NCT00074438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6355202|NCT00074607|Gemcitabine|gemcitabine|mesh-list
6355203|NCT00074607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6355204|NCT00074607|Antimetabolites|antimetabolites|mesh-ancestor
6355205|NCT00074607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355206|NCT00074607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355207|NCT00074607|Antiviral Agents|antiviral agents|mesh-ancestor
6355208|NCT00074607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6355209|NCT00074607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6355210|NCT00074607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6355211|NCT00074607|Immunologic Factors|immunologic factors|mesh-ancestor
6355212|NCT00074607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6355213|NCT00074620|Hirudins|hirudins|mesh-list
6355214|NCT00074620|Antithrombins|antithrombins|mesh-ancestor
6355215|NCT00074620|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6355216|NCT00074620|Protease Inhibitors|protease inhibitors|mesh-ancestor
6355217|NCT00074620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6355218|NCT00074620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355219|NCT00074620|Anticoagulants|anticoagulants|mesh-ancestor
6355220|NCT00074620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6355221|NCT00074620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6355222|NCT00074737|Cytarabine|cytarabine|mesh-list
6355223|NCT00074737|Idarubicin|idarubicin|mesh-list
6355224|NCT00074737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6355225|NCT00074737|Antimetabolites|antimetabolites|mesh-ancestor
6355226|NCT00074737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355227|NCT00074737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355228|NCT00074737|Antiviral Agents|antiviral agents|mesh-ancestor
6355229|NCT00074737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6355230|NCT00074737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6355231|NCT00074737|Immunologic Factors|immunologic factors|mesh-ancestor
6355232|NCT00074737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6355233|NCT00074737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6355234|NCT00074737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6355235|NCT00074737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6355236|NCT00074737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6355237|NCT00074750|Molgramostim|molgramostim|mesh-list
6355238|NCT00074750|Sargramostim|sargramostim|mesh-list
6355239|NCT00074750|Immunologic Factors|immunologic factors|mesh-ancestor
6355240|NCT00074750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6355241|NCT00074750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355242|NCT00074776|Lamotrigine|lamotrigine|mesh-list
6355243|NCT00074776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6355244|NCT00074776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355245|NCT00074776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6355246|NCT00074776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6355247|NCT00074776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6355248|NCT00074776|Anticonvulsants|anticonvulsants|mesh-ancestor
6355249|NCT00074776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6355250|NCT00074776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6355251|NCT00074776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6355252|NCT00074776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6355253|NCT00074776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6355254|NCT00074828|Enoxaparin|enoxaparin|mesh-list
6355255|NCT00074828|Anticoagulants|anticoagulants|mesh-ancestor
6355256|NCT00074828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6355257|NCT00074828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6355258|NCT00074828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355259|NCT00074841|Azithromycin|azithromycin|mesh-list
6355260|NCT00074841|Chloroquine|chloroquine|mesh-list
6355261|NCT00074841|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
6355262|NCT00074841|Pyrimethamine|pyrimethamine|mesh-list
6355263|NCT00074841|Sulfadoxine|sulfadoxine|mesh-list
6355264|NCT00074841|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6355265|NCT00074841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6355266|NCT00074841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6355267|NCT00074841|Amebicides|amebicides|mesh-ancestor
6355268|NCT00074841|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6355269|NCT00074841|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6355270|NCT00074841|Antimalarials|antimalarials|mesh-ancestor
6355271|NCT00074841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6355272|NCT00074841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6355273|NCT00074841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6355274|NCT00074841|Analgesics|analgesics|mesh-ancestor
6355275|NCT00074841|Sensory System Agents|sensory system agents|mesh-ancestor
6355276|NCT00074841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6355277|NCT00074841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6355278|NCT00074841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6355279|NCT00074841|Filaricides|filaricides|mesh-ancestor
6355280|NCT00074841|Antinematodal Agents|antinematodal agents|mesh-ancestor
6355281|NCT00074841|Anthelmintics|anthelmintics|mesh-ancestor
6355282|NCT00074841|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6355283|NCT00074841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6355284|NCT00074841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355285|NCT00074841|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6355286|NCT00074841|Renal Agents|renal agents|mesh-ancestor
6355287|NCT00075010|Decitabine|decitabine|mesh-list
6355288|NCT00075010|Valproic Acid|valproic acid|mesh-list
6355289|NCT00075010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6355290|NCT00075010|Antimetabolites|antimetabolites|mesh-ancestor
6355291|NCT00075010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355292|NCT00075010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355293|NCT00075010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6355294|NCT00075010|Anticonvulsants|anticonvulsants|mesh-ancestor
6355295|NCT00075010|GABA Agents|gaba agents|mesh-ancestor
6355296|NCT00075010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6355297|NCT00075010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6355298|NCT00075010|Antimanic Agents|antimanic agents|mesh-ancestor
6355299|NCT00075010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6355300|NCT00075010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6355301|NCT00075010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6355302|NCT00075075|Infliximab|infliximab|mesh-list
6355303|NCT00075075|Dermatologic Agents|dermatologic agents|mesh-ancestor
6355304|NCT00075075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6355305|NCT00075075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6355306|NCT00075101|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
6355307|NCT00075101|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6355308|NCT00075101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6355309|NCT00075101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355310|NCT00075101|Cholinergic Agents|cholinergic agents|mesh-ancestor
6355311|NCT00075101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6355312|NCT00075101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6355313|NCT00075179|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6355314|NCT00075179|Natriuretic Agents|natriuretic agents|mesh-ancestor
6017135|NCT00369746|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6017136|NCT00369746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6355315|NCT00075179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6355316|NCT00075192|Leuprolide|leuprolide|mesh-list
6355317|NCT00075192|Bicalutamide|bicalutamide|mesh-list
6355318|NCT00075192|Tremelimumab|tremelimumab|mesh-list
6355319|NCT00075192|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6355320|NCT00075192|Fertility Agents|fertility agents|mesh-ancestor
6355321|NCT00075192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6355322|NCT00075192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6355323|NCT00075192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6355324|NCT00075192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355325|NCT00075192|Androgen Antagonists|androgen antagonists|mesh-ancestor
6355326|NCT00075192|Hormone Antagonists|hormone antagonists|mesh-ancestor
6355327|NCT00075192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6355328|NCT00075205|Rimonabant|rimonabant|mesh-list
6355329|NCT00075205|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6355330|NCT00075205|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
6355331|NCT00075205|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6355332|NCT00075205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6355333|NCT00075205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355334|NCT00075205|Hormones|hormones|mesh-ancestor
6355335|NCT00075205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6355336|NCT00075205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6355337|NCT00075231|Ritonavir|ritonavir|mesh-list
6355338|NCT00075231|Lopinavir|lopinavir|mesh-list
6355339|NCT00075231|Lamivudine|lamivudine|mesh-list
6355340|NCT00075231|Zidovudine|zidovudine|mesh-list
6355341|NCT00075231|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6355342|NCT00075231|Efavirenz|efavirenz|mesh-list
6355343|NCT00075231|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6355344|NCT00075231|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6355345|NCT00075231|Protease Inhibitors|protease inhibitors|mesh-ancestor
6355346|NCT00075231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6355347|NCT00075231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355348|NCT00075231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6355349|NCT00075231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6355350|NCT00075231|Antiviral Agents|antiviral agents|mesh-ancestor
6355351|NCT00075231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6355352|NCT00075231|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6355353|NCT00075231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6355354|NCT00075231|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6355355|NCT00075231|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6355356|NCT00075231|Antimetabolites|antimetabolites|mesh-ancestor
6355357|NCT00075231|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6355358|NCT00075231|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6355359|NCT00075231|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6355360|NCT00075231|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6355361|NCT00075231|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6355362|NCT00075374|Docetaxel|docetaxel|mesh-list
6355363|NCT00075374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355364|NCT00075374|Tubulin Modulators|tubulin modulators|mesh-ancestor
6355365|NCT00075374|Antimitotic Agents|antimitotic agents|mesh-ancestor
6355366|NCT00075374|Mitosis Modulators|mitosis modulators|mesh-ancestor
6355367|NCT00075374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355368|NCT00075387|Sodium thiosulfate|sodium thiosulfate|mesh-list
6355369|NCT00075387|Cyclophosphamide|cyclophosphamide|mesh-list
6355370|NCT00075387|Carboplatin|carboplatin|mesh-list
6355371|NCT00075387|Etoposide|etoposide|mesh-list
6355372|NCT00075387|Etoposide phosphate|etoposide phosphate|mesh-list
6355373|NCT00075387|Antidotes|antidotes|mesh-list
6355374|NCT00075387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6355375|NCT00075387|Immunologic Factors|immunologic factors|mesh-ancestor
6355376|NCT00075387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6355377|NCT00075387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6355378|NCT00075387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6355379|NCT00075387|Alkylating Agents|alkylating agents|mesh-ancestor
6355380|NCT00075387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355381|NCT00075387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355382|NCT00075387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6355383|NCT00075387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6355384|NCT00075387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6355385|NCT00075387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6355386|NCT00075387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6355387|NCT00075387|Protective Agents|protective agents|mesh-ancestor
6355388|NCT00075387|Antioxidants|antioxidants|mesh-ancestor
6355389|NCT00075387|Antitubercular Agents|antitubercular agents|mesh-ancestor
6355390|NCT00075387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6355391|NCT00075387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6355392|NCT00075387|Chelating Agents|chelating agents|mesh-ancestor
6355393|NCT00075387|Sequestering Agents|sequestering agents|mesh-ancestor
6355394|NCT00075413|Arsenic Trioxide|arsenic trioxide|mesh-list
6355395|NCT00075413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355396|NCT00075426|Arsenic Trioxide|arsenic trioxide|mesh-list
6355397|NCT00075426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355398|NCT00075439|Gefitinib|gefitinib|mesh-list
6355399|NCT00075439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355400|NCT00075439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6355401|NCT00075439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6355402|NCT00075439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355403|NCT00075452|Gemcitabine|gemcitabine|mesh-list
6355404|NCT00075452|Oxaliplatin|oxaliplatin|mesh-list
6355405|NCT00075452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6355406|NCT00075452|Antimetabolites|antimetabolites|mesh-ancestor
6355407|NCT00075452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355408|NCT00075452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355409|NCT00075452|Antiviral Agents|antiviral agents|mesh-ancestor
6355410|NCT00075452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6355411|NCT00075452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6355412|NCT00075452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6355413|NCT00075452|Immunologic Factors|immunologic factors|mesh-ancestor
6355414|NCT00075452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6355415|NCT00075465|Docetaxel|docetaxel|mesh-list
6355416|NCT00075465|Epirubicin|epirubicin|mesh-list
6355417|NCT00075465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355418|NCT00075465|Tubulin Modulators|tubulin modulators|mesh-ancestor
6355419|NCT00075465|Antimitotic Agents|antimitotic agents|mesh-ancestor
6355420|NCT00075465|Mitosis Modulators|mitosis modulators|mesh-ancestor
6355421|NCT00075465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355422|NCT00075465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6355423|NCT00075465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6355424|NCT00075465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6355425|NCT00075465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6355426|NCT00075491|Fenretinide|fenretinide|mesh-list
6355427|NCT00075491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355428|NCT00075491|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6355429|NCT00075491|Protective Agents|protective agents|mesh-ancestor
6355430|NCT00075491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6355431|NCT00075517|Gemcitabine|gemcitabine|mesh-list
6355432|NCT00075517|Docetaxel|docetaxel|mesh-list
6355433|NCT00075517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6355434|NCT00075517|Antimetabolites|antimetabolites|mesh-ancestor
6355435|NCT00075517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355436|NCT00075517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355437|NCT00075517|Antiviral Agents|antiviral agents|mesh-ancestor
6355438|NCT00075517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6355439|NCT00075517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6355440|NCT00075517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6355441|NCT00075517|Immunologic Factors|immunologic factors|mesh-ancestor
6355442|NCT00075517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6355443|NCT00075517|Tubulin Modulators|tubulin modulators|mesh-ancestor
6355444|NCT00075517|Antimitotic Agents|antimitotic agents|mesh-ancestor
6355445|NCT00075517|Mitosis Modulators|mitosis modulators|mesh-ancestor
6355446|NCT00075543|Docetaxel|docetaxel|mesh-list
6355447|NCT00075543|Oxaliplatin|oxaliplatin|mesh-list
6355448|NCT00075543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355449|NCT00075543|Tubulin Modulators|tubulin modulators|mesh-ancestor
6355450|NCT00075543|Antimitotic Agents|antimitotic agents|mesh-ancestor
6355451|NCT00075543|Mitosis Modulators|mitosis modulators|mesh-ancestor
6355452|NCT00075543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355453|NCT00075556|Capecitabine|capecitabine|mesh-list
6355454|NCT00075556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6355455|NCT00075556|Antimetabolites|antimetabolites|mesh-ancestor
6355456|NCT00075556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355457|NCT00075556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355458|NCT00075595|Leucovorin|leucovorin|mesh-list
6355459|NCT00075595|Fluorouracil|fluorouracil|mesh-list
6355460|NCT00075595|Irinotecan|irinotecan|mesh-list
6355461|NCT00075595|Calcium|calcium|mesh-list
6355462|NCT00075595|Levoleucovorin|levoleucovorin|mesh-list
6355463|NCT00075595|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6355464|NCT00075595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6355465|NCT00075595|Antimetabolites|antimetabolites|mesh-ancestor
6355466|NCT00075595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355467|NCT00075595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6355468|NCT00075595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355469|NCT00075595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6355470|NCT00075595|Immunologic Factors|immunologic factors|mesh-ancestor
6355471|NCT00075595|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6355472|NCT00075595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6355473|NCT00075595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6355474|NCT00075595|Antidotes|antidotes|mesh-ancestor
6355475|NCT00075595|Protective Agents|protective agents|mesh-ancestor
6355476|NCT00075595|Vitamin B Complex|vitamin b complex|mesh-ancestor
6355477|NCT00075595|Vitamins|vitamins|mesh-ancestor
6355478|NCT00075595|Micronutrients|micronutrients|mesh-ancestor
6355479|NCT00075621|Melphalan|melphalan|mesh-list
6355480|NCT00075621|Immunologic Factors|immunologic factors|mesh-ancestor
6355481|NCT00075621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6355482|NCT00075621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6355483|NCT00075621|Alkylating Agents|alkylating agents|mesh-ancestor
6355484|NCT00075621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355485|NCT00075621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355486|NCT00075621|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6355487|NCT00075621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6355488|NCT00075634|Cyclophosphamide|cyclophosphamide|mesh-list
6355489|NCT00075634|Doxorubicin|doxorubicin|mesh-list
6355490|NCT00075634|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6355491|NCT00075634|Decitabine|decitabine|mesh-list
6355492|NCT00075634|Azacitidine|azacitidine|mesh-list
6355493|NCT00075634|Lenograstim|lenograstim|mesh-list
6355494|NCT00075634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6355495|NCT00075634|Immunologic Factors|immunologic factors|mesh-ancestor
6355496|NCT00075634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6355497|NCT00075634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6355498|NCT00075634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6355499|NCT00075634|Alkylating Agents|alkylating agents|mesh-ancestor
6355500|NCT00075634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355501|NCT00075634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355502|NCT00075634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6355503|NCT00075634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6355504|NCT00075634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6355505|NCT00075634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6355506|NCT00075634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6355507|NCT00075634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6355508|NCT00075634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6355509|NCT00075634|Antimetabolites|antimetabolites|mesh-ancestor
6355510|NCT00075647|Sirolimus|sirolimus|mesh-list
6355511|NCT00075647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6355512|NCT00075647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6355513|NCT00075647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6355514|NCT00075647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355515|NCT00075647|Antifungal Agents|antifungal agents|mesh-ancestor
6355516|NCT00075647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6355517|NCT00075647|Immunologic Factors|immunologic factors|mesh-ancestor
6355518|NCT00075647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6355519|NCT00075673|Celecoxib|celecoxib|mesh-list
6355520|NCT00075673|Vinorelbine|vinorelbine|mesh-list
6355521|NCT00075673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6355522|NCT00075673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6355523|NCT00075673|Analgesics|analgesics|mesh-ancestor
6355524|NCT00075673|Sensory System Agents|sensory system agents|mesh-ancestor
6355525|NCT00075673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6355526|NCT00075673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6355527|NCT00075673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6355528|NCT00075673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6355529|NCT00075673|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6355530|NCT00075673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6017137|NCT00369746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6017138|NCT00369746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017139|NCT00369746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6017140|NCT00369746|Serotonin Agents|serotonin agents|mesh-ancestor
6017141|NCT00369746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6355531|NCT00075673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6355532|NCT00075673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355533|NCT00075673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6017142|NCT00369746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6355534|NCT00075673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355535|NCT00075673|Tubulin Modulators|tubulin modulators|mesh-ancestor
6017143|NCT00369746|Antidepressive Agents|antidepressive agents|mesh-ancestor
6355536|NCT00075673|Antimitotic Agents|antimitotic agents|mesh-ancestor
6355537|NCT00075673|Mitosis Modulators|mitosis modulators|mesh-ancestor
6355538|NCT00075686|Gemcitabine|gemcitabine|mesh-list
6355539|NCT00075686|Cetuximab|cetuximab|mesh-list
6355540|NCT00075686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6355541|NCT00075686|Antimetabolites|antimetabolites|mesh-ancestor
6355542|NCT00075686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355543|NCT00075686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355544|NCT00075686|Antiviral Agents|antiviral agents|mesh-ancestor
6355545|NCT00075686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6355546|NCT00075686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6355547|NCT00075686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6355548|NCT00075686|Immunologic Factors|immunologic factors|mesh-ancestor
6355549|NCT00075686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6355550|NCT00075686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6355551|NCT00075699|Vincristine|vincristine|mesh-list
6355552|NCT00075699|Vinorelbine|vinorelbine|mesh-list
6355553|NCT00075699|Mitomycins|mitomycins|mesh-list
6355554|NCT00075699|Mitomycin|mitomycin|mesh-list
6355555|NCT00075699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355556|NCT00075699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6355557|NCT00075699|Tubulin Modulators|tubulin modulators|mesh-ancestor
6355558|NCT00075699|Antimitotic Agents|antimitotic agents|mesh-ancestor
6355559|NCT00075699|Mitosis Modulators|mitosis modulators|mesh-ancestor
6355560|NCT00075699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355561|NCT00075699|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6355562|NCT00075699|Alkylating Agents|alkylating agents|mesh-ancestor
6355563|NCT00075699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6355564|NCT00075699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6355565|NCT00075712|Paclitaxel|paclitaxel|mesh-list
6355566|NCT00075712|Carboplatin|carboplatin|mesh-list
6355567|NCT00075712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6355568|NCT00075712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355569|NCT00075712|Tubulin Modulators|tubulin modulators|mesh-ancestor
6355570|NCT00075712|Antimitotic Agents|antimitotic agents|mesh-ancestor
6355571|NCT00075712|Mitosis Modulators|mitosis modulators|mesh-ancestor
6355572|NCT00075712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355573|NCT00075738|Leucovorin|leucovorin|mesh-list
6355574|NCT00075738|Fluorouracil|fluorouracil|mesh-list
6355575|NCT00075738|Irinotecan|irinotecan|mesh-list
6355576|NCT00075738|Calcium|calcium|mesh-list
6355577|NCT00075738|Levoleucovorin|levoleucovorin|mesh-list
6355578|NCT00075738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355579|NCT00075738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6355580|NCT00075738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6355581|NCT00075738|Antimetabolites|antimetabolites|mesh-ancestor
6355582|NCT00075738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355583|NCT00075738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6355584|NCT00075738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6355585|NCT00075738|Immunologic Factors|immunologic factors|mesh-ancestor
6355586|NCT00075738|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6355587|NCT00075738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6355588|NCT00075738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6355589|NCT00075738|Antidotes|antidotes|mesh-ancestor
6355590|NCT00075738|Protective Agents|protective agents|mesh-ancestor
6355591|NCT00075738|Vitamin B Complex|vitamin b complex|mesh-ancestor
6355592|NCT00075738|Vitamins|vitamins|mesh-ancestor
6355593|NCT00075738|Micronutrients|micronutrients|mesh-ancestor
6355594|NCT00075751|Gemcitabine|gemcitabine|mesh-list
6355595|NCT00075751|Carboplatin|carboplatin|mesh-list
6355596|NCT00075751|Bortezomib|bortezomib|mesh-list
6355597|NCT00075751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355598|NCT00075751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6355599|NCT00075751|Antimetabolites|antimetabolites|mesh-ancestor
6355600|NCT00075751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355601|NCT00075751|Antiviral Agents|antiviral agents|mesh-ancestor
6355602|NCT00075751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6355603|NCT00075751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6355604|NCT00075751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6355605|NCT00075751|Immunologic Factors|immunologic factors|mesh-ancestor
6355606|NCT00075751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6355607|NCT00075777|Valproic Acid|valproic acid|mesh-list
6355608|NCT00075777|Anticonvulsants|anticonvulsants|mesh-ancestor
6355609|NCT00075777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6355610|NCT00075777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355611|NCT00075777|GABA Agents|gaba agents|mesh-ancestor
6355612|NCT00075777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6355613|NCT00075777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6355614|NCT00075777|Antimanic Agents|antimanic agents|mesh-ancestor
6355615|NCT00075777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6017144|NCT00369746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6017145|NCT00369785|Donepezil|donepezil|mesh-list
6017146|NCT00369785|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6017147|NCT00369785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6017148|NCT00369785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017149|NCT00369785|Cholinergic Agents|cholinergic agents|mesh-ancestor
6017150|NCT00369785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6017151|NCT00369785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017152|NCT00369785|Nootropic Agents|nootropic agents|mesh-ancestor
6017153|NCT00369915|Scopolamine|scopolamine|mesh-list
6355616|NCT00075777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6355617|NCT00075777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6355618|NCT00075855|Testosterone|testosterone|mesh-list
6355619|NCT00075855|Androgens|androgens|mesh-ancestor
6355620|NCT00075855|Hormones|hormones|mesh-ancestor
6355621|NCT00075855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6355622|NCT00075855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6355623|NCT00075868|Octreotide|octreotide|mesh-list
6355624|NCT00075868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6355625|NCT00075868|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6355626|NCT00075868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355627|NCT00075894|Alanosine|alanosine|mesh-list
6355628|NCT00075894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6355629|NCT00075894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355630|NCT00075894|Chelating Agents|chelating agents|mesh-ancestor
6355631|NCT00075894|Sequestering Agents|sequestering agents|mesh-ancestor
6355632|NCT00075894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394581|NCT00202618|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6394582|NCT00202618|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6394583|NCT00202696|Nalmefene|nalmefene|mesh-list
6394584|NCT00202696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6394585|NCT00202696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394586|NCT00202696|Sensory System Agents|sensory system agents|mesh-ancestor
6394587|NCT00202696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6394588|NCT00202774|Fluorouracil|fluorouracil|mesh-list
6394589|NCT00202774|Capecitabine|capecitabine|mesh-list
6394590|NCT00202774|Oxaliplatin|oxaliplatin|mesh-list
6394591|NCT00202774|Antimetabolites|antimetabolites|mesh-ancestor
6394592|NCT00202774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394593|NCT00202774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6394594|NCT00202774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6394595|NCT00202774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6394596|NCT00202774|Immunologic Factors|immunologic factors|mesh-ancestor
6394597|NCT00202774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394598|NCT00202787|Leucovorin|leucovorin|mesh-list
6394599|NCT00202787|Cetuximab|cetuximab|mesh-list
6394600|NCT00202787|Fluorouracil|fluorouracil|mesh-list
6394601|NCT00202787|Oxaliplatin|oxaliplatin|mesh-list
6394602|NCT00202787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6394603|NCT00202787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6394604|NCT00202787|Antimetabolites|antimetabolites|mesh-ancestor
6394605|NCT00202787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394606|NCT00202787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6394607|NCT00202787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6394608|NCT00202787|Immunologic Factors|immunologic factors|mesh-ancestor
6394609|NCT00202787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394610|NCT00202787|Antidotes|antidotes|mesh-ancestor
6394611|NCT00202787|Protective Agents|protective agents|mesh-ancestor
6394612|NCT00202787|Vitamin B Complex|vitamin b complex|mesh-ancestor
6394613|NCT00202787|Vitamins|vitamins|mesh-ancestor
6394614|NCT00202787|Micronutrients|micronutrients|mesh-ancestor
6394615|NCT00202800|Gemcitabine|gemcitabine|mesh-list
6394616|NCT00202800|Etoposide|etoposide|mesh-list
6394617|NCT00202800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6394618|NCT00202800|Antimetabolites|antimetabolites|mesh-ancestor
6394619|NCT00202800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394620|NCT00202800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6394621|NCT00202800|Antiviral Agents|antiviral agents|mesh-ancestor
6355633|NCT00075907|Ritonavir|ritonavir|mesh-list
6355634|NCT00075907|Lopinavir|lopinavir|mesh-list
6355635|NCT00075907|Efavirenz|efavirenz|mesh-list
6355636|NCT00075907|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6355637|NCT00075907|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6355638|NCT00075907|Protease Inhibitors|protease inhibitors|mesh-ancestor
6355639|NCT00075907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6355640|NCT00075907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355641|NCT00075907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6355642|NCT00075907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6355643|NCT00075907|Antiviral Agents|antiviral agents|mesh-ancestor
6355644|NCT00075907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6355645|NCT00075907|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6355646|NCT00075907|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6355647|NCT00075907|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6355648|NCT00075907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6355649|NCT00075907|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6355650|NCT00075907|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6355651|NCT00075907|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6355652|NCT00075907|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6355653|NCT00075907|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6355654|NCT00075933|Beta-lapachone|beta-lapachone|mesh-list
6355655|NCT00075933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6355656|NCT00075933|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6355657|NCT00075933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6355658|NCT00075933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6355659|NCT00075933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355660|NCT00075933|Antiviral Agents|antiviral agents|mesh-ancestor
6355661|NCT00075959|Disufenton sodium|disufenton sodium|mesh-list
6355662|NCT00075959|Antioxidants|antioxidants|mesh-ancestor
6355663|NCT00075959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355664|NCT00075959|Protective Agents|protective agents|mesh-ancestor
6355665|NCT00075959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6355666|NCT00075972|Nicotine|nicotine|mesh-list
6355667|NCT00075972|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6355668|NCT00075972|Autonomic Agents|autonomic agents|mesh-ancestor
6355669|NCT00075972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6355670|NCT00075972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6355671|NCT00075972|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6355672|NCT00075972|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6355673|NCT00075972|Cholinergic Agents|cholinergic agents|mesh-ancestor
6355674|NCT00075972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6355675|NCT00075972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355676|NCT00075998|Interferons|interferons|mesh-list
6355677|NCT00075998|Interferon-gamma|interferon-gamma|mesh-list
6355678|NCT00075998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355679|NCT00075998|Antiviral Agents|antiviral agents|mesh-ancestor
6355680|NCT00075998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6355681|NCT00076115|Risperidone|risperidone|mesh-list
6355682|NCT00076115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6355683|NCT00076115|Serotonin Agents|serotonin agents|mesh-ancestor
6355684|NCT00076115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6355685|NCT00076115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355686|NCT00076115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6355687|NCT00076115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6355688|NCT00076115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6355689|NCT00076115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6355690|NCT00076115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6355691|NCT00076115|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6355692|NCT00076115|Dopamine Agents|dopamine agents|mesh-ancestor
6355693|NCT00076206|Sirolimus|sirolimus|mesh-list
6355694|NCT00076206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6355695|NCT00076206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6355696|NCT00076206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6355697|NCT00076206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355698|NCT00076206|Antifungal Agents|antifungal agents|mesh-ancestor
6355699|NCT00076206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6355700|NCT00076206|Immunologic Factors|immunologic factors|mesh-ancestor
6355701|NCT00076206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6355702|NCT00076232|Acyclovir|acyclovir|mesh-list
6355703|NCT00076232|Antiviral Agents|antiviral agents|mesh-ancestor
6355704|NCT00076232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6355705|NCT00076284|Aplaviroc|aplaviroc|mesh-list
6355706|NCT00076284|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6355707|NCT00076284|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6355708|NCT00076284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355709|NCT00076284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6355710|NCT00076284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6355711|NCT00076284|Antiviral Agents|antiviral agents|mesh-ancestor
6355712|NCT00076284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6355713|NCT00076310|Cisplatin|cisplatin|mesh-list
6355714|NCT00076310|Docetaxel|docetaxel|mesh-list
6355715|NCT00076310|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6355716|NCT00076310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355717|NCT00076310|Tubulin Modulators|tubulin modulators|mesh-ancestor
6355718|NCT00076310|Antimitotic Agents|antimitotic agents|mesh-ancestor
6355719|NCT00076310|Mitosis Modulators|mitosis modulators|mesh-ancestor
6355720|NCT00076310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355721|NCT00076310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6355722|NCT00076310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6355723|NCT00076323|Primaquine|primaquine|mesh-list
6355724|NCT00076323|Antimalarials|antimalarials|mesh-ancestor
6355725|NCT00076323|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6355726|NCT00076323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6355727|NCT00076323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6355728|NCT00076349|Rituximab|rituximab|mesh-list
6355729|NCT00076349|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6355730|NCT00076349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6355731|NCT00076349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355732|NCT00076349|Immunologic Factors|immunologic factors|mesh-ancestor
6355733|NCT00076349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6355734|NCT00076349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6355735|NCT00076349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6355736|NCT00076349|Alkylating Agents|alkylating agents|mesh-ancestor
6355737|NCT00076349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355738|NCT00076362|Octreotide|octreotide|mesh-list
6355739|NCT00076362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6355740|NCT00076362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6355741|NCT00076362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355742|NCT00076388|Docetaxel|docetaxel|mesh-list
6355743|NCT00076388|Gefitinib|gefitinib|mesh-list
6355744|NCT00076388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355745|NCT00076388|Tubulin Modulators|tubulin modulators|mesh-ancestor
6355746|NCT00076388|Antimitotic Agents|antimitotic agents|mesh-ancestor
6355747|NCT00076388|Mitosis Modulators|mitosis modulators|mesh-ancestor
6355748|NCT00076388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355749|NCT00076388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6355750|NCT00076388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6355751|NCT00076401|Motexafin gadolinium|motexafin gadolinium|mesh-list
6355752|NCT00076401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355753|NCT00076401|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6355754|NCT00076401|Dermatologic Agents|dermatologic agents|mesh-ancestor
6355755|NCT00076414|Acetylcholine|acetylcholine|mesh-list
6355756|NCT00076414|Vasodilator Agents|vasodilator agents|mesh-ancestor
6355757|NCT00076414|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6355758|NCT00076414|Cholinergic Agents|cholinergic agents|mesh-ancestor
6355759|NCT00076414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6355760|NCT00076414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355761|NCT00076414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6355762|NCT00076440|Leuprolide|leuprolide|mesh-list
6355763|NCT00076440|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6355764|NCT00076440|Fertility Agents|fertility agents|mesh-ancestor
6355765|NCT00076440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6355766|NCT00076440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6355767|NCT00076440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6355768|NCT00076440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355769|NCT00076492|Coenzyme Q10|coenzyme q10|mesh-list
6355770|NCT00076492|Vitamins|vitamins|mesh-ancestor
6355771|NCT00076492|Micronutrients|micronutrients|mesh-ancestor
6355772|NCT00076492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6355773|NCT00076518|Fenofibrate|fenofibrate|mesh-list
6355774|NCT00076518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6355775|NCT00076518|Antimetabolites|antimetabolites|mesh-ancestor
6355776|NCT00076518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355777|NCT00076518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6355778|NCT00076531|Leuprolide|leuprolide|mesh-list
6355779|NCT00076531|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6355780|NCT00076531|Fertility Agents|fertility agents|mesh-ancestor
6355781|NCT00076531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6355782|NCT00076531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6355783|NCT00076531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6355784|NCT00076531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355785|NCT00076544|Ziconotide|ziconotide|mesh-list
6355786|NCT00076544|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6355787|NCT00076544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6355788|NCT00076544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355789|NCT00076544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6355790|NCT00076544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6355791|NCT00076544|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6355792|NCT00076544|Protective Agents|protective agents|mesh-ancestor
6355793|NCT00076544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6355794|NCT00076544|Analgesics|analgesics|mesh-ancestor
6355795|NCT00076544|Sensory System Agents|sensory system agents|mesh-ancestor
6355796|NCT00076544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6355797|NCT00076609|Capecitabine|capecitabine|mesh-list
6355798|NCT00076609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6355799|NCT00076609|Antimetabolites|antimetabolites|mesh-ancestor
6355800|NCT00076609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355801|NCT00076609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355802|NCT00076635|Interferons|interferons|mesh-list
6355803|NCT00076635|Interferon-gamma|interferon-gamma|mesh-list
6355804|NCT00076635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355805|NCT00076635|Antiviral Agents|antiviral agents|mesh-ancestor
6355806|NCT00076635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6355807|NCT00076674|Levodopa|levodopa|mesh-list
6355808|NCT00076674|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6355809|NCT00076674|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6355810|NCT00076674|Dopamine Agents|dopamine agents|mesh-ancestor
6355811|NCT00076674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6355812|NCT00076674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355813|NCT00076674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6355814|NCT00076726|Infliximab|infliximab|mesh-list
6355815|NCT00076726|Dermatologic Agents|dermatologic agents|mesh-ancestor
6355816|NCT00076726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6355817|NCT00076726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6355818|NCT00076791|Tenofovir|tenofovir|mesh-list
6355819|NCT00076791|Emtricitabine|emtricitabine|mesh-list
6355820|NCT00076791|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6355821|NCT00076791|Antiviral Agents|antiviral agents|mesh-ancestor
6355822|NCT00076791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6355823|NCT00076791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6355824|NCT00076791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6355825|NCT00076791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6355826|NCT00076791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355827|NCT00076791|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6355828|NCT00076791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6355829|NCT00076856|Temozolomide|temozolomide|mesh-list
6355830|NCT00076856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6355831|NCT00076856|Alkylating Agents|alkylating agents|mesh-ancestor
6355832|NCT00076856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355833|NCT00076856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355834|NCT00076869|Amphotericin B|amphotericin b|mesh-list
6355835|NCT00076869|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6355836|NCT00076869|Caspofungin|caspofungin|mesh-list
6355837|NCT00076869|Amebicides|amebicides|mesh-ancestor
6355838|NCT00076869|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6355839|NCT00076869|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6355840|NCT00076869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6355841|NCT00076869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6355842|NCT00076869|Antifungal Agents|antifungal agents|mesh-ancestor
6355843|NCT00076869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6355844|NCT00076869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355845|NCT00076960|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
6355846|NCT00076960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6355847|NCT00076960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355848|NCT00076986|Carmustine|carmustine|mesh-list
6355849|NCT00076986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6355850|NCT00076986|Alkylating Agents|alkylating agents|mesh-ancestor
6355851|NCT00076986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355852|NCT00076986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355853|NCT00077025|Gefitinib|gefitinib|mesh-list
6355854|NCT00077025|Anastrozole|anastrozole|mesh-list
6355855|NCT00077025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355856|NCT00077025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6355857|NCT00077025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6355858|NCT00077025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355859|NCT00077025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6355860|NCT00077025|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6355861|NCT00077025|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6355862|NCT00077025|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6355863|NCT00077025|Hormone Antagonists|hormone antagonists|mesh-ancestor
6355864|NCT00077025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6355865|NCT00077025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6355866|NCT00077051|Tetrahydrouridine|tetrahydrouridine|mesh-list
6355867|NCT00077051|Antimetabolites|antimetabolites|mesh-ancestor
6355868|NCT00077051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355869|NCT00077077|Capecitabine|capecitabine|mesh-list
6355870|NCT00077077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6355871|NCT00077077|Antimetabolites|antimetabolites|mesh-ancestor
6355872|NCT00077077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355873|NCT00077077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355874|NCT00077103|Doxorubicin|doxorubicin|mesh-list
6355875|NCT00077103|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6355876|NCT00077103|Fosbretabulin|fosbretabulin|mesh-list
6355877|NCT00077103|Combretastatin|combretastatin|mesh-list
6355878|NCT00077103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355879|NCT00077103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6355880|NCT00077103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6355881|NCT00077103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6355882|NCT00077103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6355883|NCT00077103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355884|NCT00077103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6355885|NCT00077103|Tubulin Modulators|tubulin modulators|mesh-ancestor
6355886|NCT00077103|Antimitotic Agents|antimitotic agents|mesh-ancestor
6355887|NCT00077103|Mitosis Modulators|mitosis modulators|mesh-ancestor
6355888|NCT00077116|Cytarabine|cytarabine|mesh-list
6355889|NCT00077116|Cyclophosphamide|cyclophosphamide|mesh-list
6355890|NCT00077116|Busulfan|busulfan|mesh-list
6355891|NCT00077116|Idarubicin|idarubicin|mesh-list
6355892|NCT00077116|Gemtuzumab|gemtuzumab|mesh-list
6355893|NCT00077116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6355894|NCT00077116|Immunologic Factors|immunologic factors|mesh-ancestor
6355895|NCT00077116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6355896|NCT00077116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6355897|NCT00077116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6355898|NCT00077116|Alkylating Agents|alkylating agents|mesh-ancestor
6355899|NCT00077116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355900|NCT00077116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355901|NCT00077116|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6355902|NCT00077116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6355903|NCT00077116|Antimetabolites|antimetabolites|mesh-ancestor
6355904|NCT00077116|Antiviral Agents|antiviral agents|mesh-ancestor
6355905|NCT00077116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6355906|NCT00077116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6355907|NCT00077116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6355908|NCT00077116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6355909|NCT00077116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6355910|NCT00077116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6355911|NCT00077129|Paclitaxel|paclitaxel|mesh-list
6355912|NCT00077129|Carboplatin|carboplatin|mesh-list
6355913|NCT00077129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6355914|NCT00077129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355915|NCT00077129|Tubulin Modulators|tubulin modulators|mesh-ancestor
6355916|NCT00077129|Antimitotic Agents|antimitotic agents|mesh-ancestor
6355917|NCT00077129|Mitosis Modulators|mitosis modulators|mesh-ancestor
6355918|NCT00077129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355919|NCT00077168|Tamoxifen|tamoxifen|mesh-list
6355920|NCT00077168|Anastrozole|anastrozole|mesh-list
6355921|NCT00077168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355922|NCT00077168|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6355923|NCT00077168|Hormone Antagonists|hormone antagonists|mesh-ancestor
6355924|NCT00077168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6355925|NCT00077168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6355926|NCT00077168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6355927|NCT00077168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355928|NCT00077168|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6355929|NCT00077168|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6355930|NCT00077168|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6355931|NCT00077168|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6355932|NCT00077168|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6355933|NCT00077168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6355934|NCT00077181|Cytarabine|cytarabine|mesh-list
6355935|NCT00077181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6355936|NCT00077181|Antimetabolites|antimetabolites|mesh-ancestor
6355937|NCT00077181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355938|NCT00077181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355939|NCT00077181|Antiviral Agents|antiviral agents|mesh-ancestor
6355940|NCT00077181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6355941|NCT00077181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6355942|NCT00077181|Immunologic Factors|immunologic factors|mesh-ancestor
6355943|NCT00077181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6355944|NCT00077194|Romidepsin|romidepsin|mesh-list
6355945|NCT00077194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6355946|NCT00077194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355947|NCT00077220|Paclitaxel|paclitaxel|mesh-list
6355948|NCT00077220|Carboplatin|carboplatin|mesh-list
6355949|NCT00077220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6355950|NCT00077220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355951|NCT00077220|Tubulin Modulators|tubulin modulators|mesh-ancestor
6355952|NCT00077220|Antimitotic Agents|antimitotic agents|mesh-ancestor
6355953|NCT00077220|Mitosis Modulators|mitosis modulators|mesh-ancestor
6355954|NCT00077220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355955|NCT00077233|Leucovorin|leucovorin|mesh-list
6355956|NCT00077233|Fluorouracil|fluorouracil|mesh-list
6355957|NCT00077233|Oxaliplatin|oxaliplatin|mesh-list
6355958|NCT00077233|Irinotecan|irinotecan|mesh-list
6355959|NCT00077233|Cetuximab|cetuximab|mesh-list
6355960|NCT00077233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6355961|NCT00077233|Antimetabolites|antimetabolites|mesh-ancestor
6355962|NCT00077233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355963|NCT00077233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6355964|NCT00077233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355965|NCT00077233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6355966|NCT00077233|Immunologic Factors|immunologic factors|mesh-ancestor
6355967|NCT00077233|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6355968|NCT00077233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6355969|NCT00077233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6355970|NCT00077233|Antidotes|antidotes|mesh-ancestor
6355971|NCT00077233|Protective Agents|protective agents|mesh-ancestor
6355972|NCT00077233|Vitamin B Complex|vitamin b complex|mesh-ancestor
6355973|NCT00077233|Vitamins|vitamins|mesh-ancestor
6355974|NCT00077233|Micronutrients|micronutrients|mesh-ancestor
6355975|NCT00077233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6355976|NCT00077246|Paclitaxel|paclitaxel|mesh-list
6355977|NCT00077246|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6355978|NCT00077246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6355979|NCT00077246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355980|NCT00077246|Tubulin Modulators|tubulin modulators|mesh-ancestor
6355981|NCT00077246|Antimitotic Agents|antimitotic agents|mesh-ancestor
6355982|NCT00077246|Mitosis Modulators|mitosis modulators|mesh-ancestor
6355983|NCT00077246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355984|NCT00077259|Epothilones|epothilones|mesh-list
6355985|NCT00077259|Desoxyepothilone B|desoxyepothilone b|mesh-list
6355986|NCT00077259|Tubulin Modulators|tubulin modulators|mesh-ancestor
6355987|NCT00077259|Antimitotic Agents|antimitotic agents|mesh-ancestor
6355988|NCT00077259|Mitosis Modulators|mitosis modulators|mesh-ancestor
6355989|NCT00077259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6355990|NCT00077259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355991|NCT00077298|Bevacizumab|bevacizumab|mesh-list
6355992|NCT00077298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6355993|NCT00077298|Cetuximab|cetuximab|mesh-list
6355994|NCT00077298|Irinotecan|irinotecan|mesh-list
6355995|NCT00077298|Antibodies|antibodies|mesh-list
6355996|NCT00077298|Immunoglobulins|immunoglobulins|mesh-list
6355997|NCT00077298|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6355998|NCT00077298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6355999|NCT00077298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6356000|NCT00077298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6356001|NCT00077298|Growth Substances|growth substances|mesh-ancestor
6356002|NCT00077298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356003|NCT00077298|Growth Inhibitors|growth inhibitors|mesh-ancestor
6356004|NCT00077298|Immunologic Factors|immunologic factors|mesh-ancestor
6356005|NCT00077298|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6356006|NCT00077298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6356007|NCT00077298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6356008|NCT00077298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356009|NCT00077311|Docetaxel|docetaxel|mesh-list
6356010|NCT00077311|Darbepoetin alfa|darbepoetin alfa|mesh-list
6356011|NCT00077311|2,2'-dithiodiethanesulfonic acid|2,2'-dithiodiethanesulfonic acid|mesh-list
6356012|NCT00077311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356013|NCT00077311|Tubulin Modulators|tubulin modulators|mesh-ancestor
6356014|NCT00077311|Antimitotic Agents|antimitotic agents|mesh-ancestor
6356015|NCT00077311|Mitosis Modulators|mitosis modulators|mesh-ancestor
6356016|NCT00077311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356017|NCT00077311|Hematinics|hematinics|mesh-ancestor
6356018|NCT00077311|Protective Agents|protective agents|mesh-ancestor
6356019|NCT00077311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356020|NCT00077337|Romidepsin|romidepsin|mesh-list
6356021|NCT00077337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6356022|NCT00077337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356023|NCT00077350|Gemcitabine|gemcitabine|mesh-list
6356024|NCT00077350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6356025|NCT00077350|Antimetabolites|antimetabolites|mesh-ancestor
6356026|NCT00077350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356027|NCT00077350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356028|NCT00077350|Antiviral Agents|antiviral agents|mesh-ancestor
6356029|NCT00077350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6356030|NCT00077350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6356031|NCT00077350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6356032|NCT00077350|Immunologic Factors|immunologic factors|mesh-ancestor
6356033|NCT00077350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356034|NCT00077363|Capecitabine|capecitabine|mesh-list
6356035|NCT00077363|Tipifarnib|tipifarnib|mesh-list
6356036|NCT00077363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6356037|NCT00077363|Antimetabolites|antimetabolites|mesh-ancestor
6356038|NCT00077363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356039|NCT00077363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356040|NCT00077389|Carboplatin|carboplatin|mesh-list
6356041|NCT00077389|Doxorubicin|doxorubicin|mesh-list
6356042|NCT00077389|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6356043|NCT00077389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356044|NCT00077389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6356045|NCT00077389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6356046|NCT00077389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6356047|NCT00077389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6356048|NCT00077389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356049|NCT00077402|Fenretinide|fenretinide|mesh-list
6356050|NCT00077402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356051|NCT00077402|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6356052|NCT00077402|Protective Agents|protective agents|mesh-ancestor
6356053|NCT00077402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356054|NCT00077415|Gemcitabine|gemcitabine|mesh-list
6356055|NCT00077415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6356056|NCT00077415|Antimetabolites|antimetabolites|mesh-ancestor
6356057|NCT00077415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356058|NCT00077415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356059|NCT00077415|Antiviral Agents|antiviral agents|mesh-ancestor
6356060|NCT00077415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6356061|NCT00077415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6356062|NCT00077415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6356063|NCT00077415|Immunologic Factors|immunologic factors|mesh-ancestor
6356064|NCT00077415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356065|NCT00077428|Doxorubicin|doxorubicin|mesh-list
6356066|NCT00077428|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6356067|NCT00077428|Bortezomib|bortezomib|mesh-list
6356068|NCT00077428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6356069|NCT00077428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356070|NCT00077428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6356071|NCT00077428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6356072|NCT00077428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6356073|NCT00077428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356074|NCT00077441|Bortezomib|bortezomib|mesh-list
6356075|NCT00077441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356076|NCT00077454|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6356077|NCT00077454|Temozolomide|temozolomide|mesh-list
6356078|NCT00077454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356079|NCT00077454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6356080|NCT00077454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6356081|NCT00077454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356082|NCT00077454|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6356083|NCT00077454|Alkylating Agents|alkylating agents|mesh-ancestor
6356084|NCT00077467|Bortezomib|bortezomib|mesh-list
6356085|NCT00077467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356086|NCT00077493|Antibodies|antibodies|mesh-list
6356087|NCT00077493|Immunoglobulins|immunoglobulins|mesh-list
6356088|NCT00077493|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6356089|NCT00077493|Immunoconjugates|immunoconjugates|mesh-list
6356090|NCT00077493|Immunotoxins|immunotoxins|mesh-list
6356091|NCT00077493|Immunologic Factors|immunologic factors|mesh-ancestor
6356092|NCT00077493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356093|NCT00077519|Tipifarnib|tipifarnib|mesh-list
6356094|NCT00077519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356095|NCT00077532|Ipilimumab|ipilimumab|mesh-list
6356096|NCT00077532|Freund's Adjuvant|freund's adjuvant|mesh-list
6356097|NCT00077532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6356098|NCT00077532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356099|NCT00077532|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6356100|NCT00077532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356101|NCT00077532|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6356102|NCT00077532|Immunologic Factors|immunologic factors|mesh-ancestor
6356103|NCT00077532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356104|NCT00077545|Cisplatin|cisplatin|mesh-list
6356105|NCT00077545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356106|NCT00077558|Fludarabine|fludarabine|mesh-list
6356107|NCT00077558|Fludarabine phosphate|fludarabine phosphate|mesh-list
6356108|NCT00077558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356109|NCT00077558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6356110|NCT00077558|Antimetabolites|antimetabolites|mesh-ancestor
6356111|NCT00077558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356112|NCT00077558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6356113|NCT00077558|Immunologic Factors|immunologic factors|mesh-ancestor
6356114|NCT00077558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356115|NCT00077584|Bosentan|bosentan|mesh-list
6356116|NCT00077584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6356117|NCT00077584|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6356118|NCT00077584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356119|NCT00077597|Epoetin Alfa|epoetin alfa|mesh-list
6356120|NCT00077597|Hematinics|hematinics|mesh-ancestor
6356121|NCT00077688|Paclitaxel|paclitaxel|mesh-list
6356122|NCT00077688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6356123|NCT00077688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356124|NCT00077688|Tubulin Modulators|tubulin modulators|mesh-ancestor
6356125|NCT00077688|Antimitotic Agents|antimitotic agents|mesh-ancestor
6356126|NCT00077688|Mitosis Modulators|mitosis modulators|mesh-ancestor
6356127|NCT00077688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356128|NCT00077714|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6356129|NCT00077714|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6356130|NCT00077714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6356131|NCT00077714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6356132|NCT00077714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356133|NCT00077714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6356134|NCT00077714|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6356135|NCT00077714|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6356136|NCT00077714|Serotonin Agents|serotonin agents|mesh-ancestor
6356137|NCT00077714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6356138|NCT00077714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356139|NCT00077714|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6356140|NCT00077714|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6356141|NCT00077714|Dopamine Agents|dopamine agents|mesh-ancestor
6356142|NCT00077727|Galantamine|galantamine|mesh-list
6356143|NCT00077727|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6356144|NCT00077727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6356145|NCT00077727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356146|NCT00077727|Cholinergic Agents|cholinergic agents|mesh-ancestor
6356147|NCT00077727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6356148|NCT00077727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356149|NCT00077727|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6356150|NCT00077727|Autonomic Agents|autonomic agents|mesh-ancestor
6356151|NCT00077727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6356152|NCT00077727|Nootropic Agents|nootropic agents|mesh-ancestor
6394622|NCT00202800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6394623|NCT00202800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6394624|NCT00202800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6394625|NCT00202800|Immunologic Factors|immunologic factors|mesh-ancestor
6394626|NCT00202800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394627|NCT00202800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6394628|NCT00202800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6394629|NCT00202800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6394630|NCT00202813|Anti-Infective Agents|anti-infective agents|mesh-list
6394631|NCT00202813|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6394632|NCT00202852|Infliximab|infliximab|mesh-list
6394633|NCT00202852|Dermatologic Agents|dermatologic agents|mesh-ancestor
6394634|NCT00202852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6394635|NCT00202852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6394636|NCT00202865|Infliximab|infliximab|mesh-list
6394637|NCT00202865|Dermatologic Agents|dermatologic agents|mesh-ancestor
6394638|NCT00202865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6394639|NCT00202865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6394640|NCT00202891|Sisomicin|sisomicin|mesh-list
6394641|NCT00202891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6394642|NCT00202891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6394643|NCT00202891|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6394644|NCT00202891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6394645|NCT00202891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394646|NCT00202917|Fludarabine|fludarabine|mesh-list
6394647|NCT00202917|Melphalan|melphalan|mesh-list
6394648|NCT00202917|Thiotepa|thiotepa|mesh-list
6394649|NCT00202917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6394650|NCT00202917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394651|NCT00202917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6394652|NCT00202917|Immunologic Factors|immunologic factors|mesh-ancestor
6356153|NCT00077753|Enoxaparin|enoxaparin|mesh-list
6356154|NCT00077753|Enoxaparin sodium|enoxaparin sodium|mesh-list
6356155|NCT00077753|Anticoagulants|anticoagulants|mesh-ancestor
6356156|NCT00077753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6356157|NCT00077753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6356158|NCT00077753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356159|NCT00077779|Adalimumab|adalimumab|mesh-list
6356160|NCT00077779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6356161|NCT00077779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6356162|NCT00077792|Enoxaparin|enoxaparin|mesh-list
6356163|NCT00077792|Enoxaparin sodium|enoxaparin sodium|mesh-list
6356164|NCT00077792|Anticoagulants|anticoagulants|mesh-ancestor
6356165|NCT00077792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6356166|NCT00077792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6356167|NCT00077792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356168|NCT00077805|Enoxaparin|enoxaparin|mesh-list
6356169|NCT00077805|Enoxaparin sodium|enoxaparin sodium|mesh-list
6356170|NCT00077805|Anticoagulants|anticoagulants|mesh-ancestor
6356171|NCT00077805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6356172|NCT00077805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6356173|NCT00077805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356174|NCT00077818|Enoxaparin|enoxaparin|mesh-list
6356175|NCT00077818|Enoxaparin sodium|enoxaparin sodium|mesh-list
6356176|NCT00077818|Anticoagulants|anticoagulants|mesh-ancestor
6356177|NCT00077818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6356178|NCT00077818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6356179|NCT00077818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356180|NCT00077844|Enoxaparin|enoxaparin|mesh-list
6356181|NCT00077844|Enoxaparin sodium|enoxaparin sodium|mesh-list
6356182|NCT00077844|Anticoagulants|anticoagulants|mesh-ancestor
6356183|NCT00077844|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6356184|NCT00077844|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6356185|NCT00077844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356186|NCT00077870|Ocrelizumab|ocrelizumab|mesh-list
6356187|NCT00077870|Immunologic Factors|immunologic factors|mesh-ancestor
6356188|NCT00077870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356189|NCT00077883|Cisplatin|cisplatin|mesh-list
6356190|NCT00077883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356191|NCT00077948|Metoprolol|metoprolol|mesh-list
6356192|NCT00077948|Enoximone|enoximone|mesh-list
6356193|NCT00077948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6356194|NCT00077948|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6356195|NCT00077948|Sympatholytics|sympatholytics|mesh-ancestor
6356196|NCT00077948|Autonomic Agents|autonomic agents|mesh-ancestor
6356197|NCT00077948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6356198|NCT00077948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356199|NCT00077948|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6356200|NCT00077948|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6356201|NCT00077948|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6356202|NCT00077948|Adrenergic Agents|adrenergic agents|mesh-ancestor
6356203|NCT00077948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6356204|NCT00077948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356205|NCT00077948|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6356206|NCT00077948|Vasodilator Agents|vasodilator agents|mesh-ancestor
6356207|NCT00077948|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6356208|NCT00077948|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6356209|NCT00077948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6356210|NCT00077948|Protective Agents|protective agents|mesh-ancestor
6356211|NCT00077961|Alemtuzumab|alemtuzumab|mesh-list
6356212|NCT00077961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6356213|NCT00077961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356214|NCT00077987|Sunitinib|sunitinib|mesh-list
6356215|NCT00077987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356216|NCT00077987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6356217|NCT00077987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6356218|NCT00077987|Growth Substances|growth substances|mesh-ancestor
6356219|NCT00077987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356220|NCT00077987|Growth Inhibitors|growth inhibitors|mesh-ancestor
6356221|NCT00077987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6356222|NCT00077987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6356223|NCT00077987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356224|NCT00078000|Sunitinib|sunitinib|mesh-list
6356225|NCT00078000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356226|NCT00078000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6356227|NCT00078000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6356228|NCT00078000|Growth Substances|growth substances|mesh-ancestor
6356229|NCT00078000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356230|NCT00078000|Growth Inhibitors|growth inhibitors|mesh-ancestor
6356231|NCT00078000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6356232|NCT00078000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6356233|NCT00078000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356234|NCT00078039|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6356235|NCT00078039|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6356236|NCT00078039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6356237|NCT00078039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6356238|NCT00078039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356239|NCT00078039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6356240|NCT00078039|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6356241|NCT00078039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6356242|NCT00078039|Serotonin Agents|serotonin agents|mesh-ancestor
6356243|NCT00078039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6356244|NCT00078039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356245|NCT00078039|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6356246|NCT00078039|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6356247|NCT00078039|Dopamine Agents|dopamine agents|mesh-ancestor
6356248|NCT00078117|Buprenorphine|buprenorphine|mesh-list
6356249|NCT00078117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6356250|NCT00078117|Narcotics|narcotics|mesh-ancestor
6356251|NCT00078117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6356252|NCT00078117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356253|NCT00078117|Analgesics|analgesics|mesh-ancestor
6356254|NCT00078117|Sensory System Agents|sensory system agents|mesh-ancestor
6356255|NCT00078117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6356256|NCT00078117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6356257|NCT00078130|Buprenorphine|buprenorphine|mesh-list
6356258|NCT00078130|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6356259|NCT00078130|Naloxone|naloxone|mesh-list
6356260|NCT00078130|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6356261|NCT00078130|Narcotics|narcotics|mesh-ancestor
6356262|NCT00078130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6356263|NCT00078130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356264|NCT00078130|Analgesics|analgesics|mesh-ancestor
6356265|NCT00078130|Sensory System Agents|sensory system agents|mesh-ancestor
6356266|NCT00078130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6356267|NCT00078130|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6356268|NCT00078182|Tenofovir|tenofovir|mesh-list
6356269|NCT00078182|Antiviral Agents|antiviral agents|mesh-ancestor
6356270|NCT00078182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6356271|NCT00078182|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6356272|NCT00078182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6356273|NCT00078182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6356274|NCT00078182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356275|NCT00078182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6356276|NCT00078182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6356277|NCT00078195|Omalizumab|omalizumab|mesh-list
6356278|NCT00078195|Immunoglobulins|immunoglobulins|mesh-list
6356279|NCT00078195|Immunologic Factors|immunologic factors|mesh-list
6356280|NCT00078195|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6356281|NCT00078195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356282|NCT00078195|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6356283|NCT00078195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6356284|NCT00078195|Respiratory System Agents|respiratory system agents|mesh-ancestor
6356285|NCT00078234|Rituximab|rituximab|mesh-list
6356286|NCT00078234|Fludarabine|fludarabine|mesh-list
6356287|NCT00078234|Oblimersen|oblimersen|mesh-list
6356288|NCT00078234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6356289|NCT00078234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356290|NCT00078234|Immunologic Factors|immunologic factors|mesh-ancestor
6356291|NCT00078234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356292|NCT00078234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6356293|NCT00078247|Lamivudine|lamivudine|mesh-list
6356294|NCT00078247|Zidovudine|zidovudine|mesh-list
6356295|NCT00078247|Abacavir|abacavir|mesh-list
6356296|NCT00078247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6356297|NCT00078247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6356298|NCT00078247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6356299|NCT00078247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356300|NCT00078247|Antiviral Agents|antiviral agents|mesh-ancestor
6356301|NCT00078247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6356302|NCT00078247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6356303|NCT00078247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6356304|NCT00078247|Antimetabolites|antimetabolites|mesh-ancestor
6356305|NCT00078260|Pemetrexed|pemetrexed|mesh-list
6356306|NCT00078260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356307|NCT00078260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6356308|NCT00078260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356309|NCT00078260|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6356310|NCT00078260|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6356311|NCT00078351|Hylan|hylan|mesh-list
6356312|NCT00078351|Viscosupplements|viscosupplements|mesh-ancestor
6356313|NCT00078351|Protective Agents|protective agents|mesh-ancestor
6356314|NCT00078351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356315|NCT00078390|S 3304|s 3304|mesh-list
6356316|NCT00078390|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
6356317|NCT00078390|Protease Inhibitors|protease inhibitors|mesh-ancestor
6356318|NCT00078390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6356319|NCT00078390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356320|NCT00078442|Interferons|interferons|mesh-list
6356321|NCT00078442|Interferon-alpha|interferon-alpha|mesh-list
6356322|NCT00078442|Interferon alpha-2|interferon alpha-2|mesh-list
6356323|NCT00078442|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6356324|NCT00078442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356325|NCT00078442|Antiviral Agents|antiviral agents|mesh-ancestor
6356326|NCT00078442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6356327|NCT00078442|Immunologic Factors|immunologic factors|mesh-ancestor
6356328|NCT00078442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356329|NCT00078481|Idebenone|idebenone|mesh-list
6356330|NCT00078481|Antioxidants|antioxidants|mesh-ancestor
6356331|NCT00078481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356332|NCT00078481|Protective Agents|protective agents|mesh-ancestor
6356333|NCT00078481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356334|NCT00078546|Antibodies|antibodies|mesh-list
6356335|NCT00078546|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6356336|NCT00078546|Immunologic Factors|immunologic factors|mesh-ancestor
6356337|NCT00078546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356338|NCT00078572|Capecitabine|capecitabine|mesh-list
6356339|NCT00078572|Lapatinib|lapatinib|mesh-list
6356340|NCT00078572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6356341|NCT00078572|Antimetabolites|antimetabolites|mesh-ancestor
6356342|NCT00078572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356343|NCT00078572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356344|NCT00078572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6356345|NCT00078572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6356346|NCT00078598|Rituximab|rituximab|mesh-list
6356347|NCT00078598|Tositumomab I-131|tositumomab i-131|mesh-list
6356348|NCT00078598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6356349|NCT00078598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356350|NCT00078598|Immunologic Factors|immunologic factors|mesh-ancestor
6356351|NCT00078598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356352|NCT00078598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6356353|NCT00078611|Natalizumab|natalizumab|mesh-list
6356354|NCT00078611|Immunologic Factors|immunologic factors|mesh-ancestor
6356355|NCT00078611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356356|NCT00078689|Daclizumab|daclizumab|mesh-list
6356357|NCT00078689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6356358|NCT00078689|Immunologic Factors|immunologic factors|mesh-ancestor
6356359|NCT00078689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356360|NCT00078793|Etanercept|etanercept|mesh-list
6356361|NCT00078793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6356362|NCT00078793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6356363|NCT00078793|Analgesics|analgesics|mesh-ancestor
6356364|NCT00078793|Sensory System Agents|sensory system agents|mesh-ancestor
6356365|NCT00078793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6356366|NCT00078793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356367|NCT00078793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6356368|NCT00078793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6356369|NCT00078793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6356370|NCT00078793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6356371|NCT00078793|Immunologic Factors|immunologic factors|mesh-ancestor
6356372|NCT00078806|Etanercept|etanercept|mesh-list
6356373|NCT00078806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6356374|NCT00078806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6356375|NCT00078806|Analgesics|analgesics|mesh-ancestor
6356376|NCT00078806|Sensory System Agents|sensory system agents|mesh-ancestor
6356377|NCT00078806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6356378|NCT00078806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356379|NCT00078806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6356380|NCT00078806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6356381|NCT00078806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6356382|NCT00078806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6356383|NCT00078806|Immunologic Factors|immunologic factors|mesh-ancestor
6356384|NCT00078832|Anastrozole|anastrozole|mesh-list
6356385|NCT00078832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6356386|NCT00078832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356387|NCT00078832|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6356388|NCT00078832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6356389|NCT00078832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6356390|NCT00078832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356391|NCT00078832|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6356392|NCT00078832|Hormone Antagonists|hormone antagonists|mesh-ancestor
6356393|NCT00078832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6356394|NCT00078832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356395|NCT00078845|Amifostine|amifostine|mesh-list
6356396|NCT00078845|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6356397|NCT00078845|Protective Agents|protective agents|mesh-ancestor
6356398|NCT00078845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356399|NCT00078858|Cyclosporine|cyclosporine|mesh-list
6356400|NCT00078858|Mycophenolic Acid|mycophenolic acid|mesh-list
6356401|NCT00078858|Fludarabine|fludarabine|mesh-list
6356402|NCT00078858|Fludarabine phosphate|fludarabine phosphate|mesh-list
6356403|NCT00078858|Cyclosporins|cyclosporins|mesh-list
6356404|NCT00078858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356405|NCT00078858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6356406|NCT00078858|Antimetabolites|antimetabolites|mesh-ancestor
6356407|NCT00078858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356408|NCT00078858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6356409|NCT00078858|Immunologic Factors|immunologic factors|mesh-ancestor
6356410|NCT00078858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356411|NCT00078858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6356412|NCT00078858|Antifungal Agents|antifungal agents|mesh-ancestor
6356413|NCT00078858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6356414|NCT00078858|Dermatologic Agents|dermatologic agents|mesh-ancestor
6356415|NCT00078858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6356416|NCT00078858|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6356417|NCT00078858|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6356418|NCT00078858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6356419|NCT00078858|Antitubercular Agents|antitubercular agents|mesh-ancestor
6356420|NCT00078858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6356421|NCT00078910|Sulindac sulfone|sulindac sulfone|mesh-list
6356422|NCT00078910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356423|NCT00078910|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6356424|NCT00078910|Protective Agents|protective agents|mesh-ancestor
6356425|NCT00078910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356426|NCT00078910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6356427|NCT00078910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6356428|NCT00078910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356429|NCT00078910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6356430|NCT00078910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6356431|NCT00078910|Analgesics|analgesics|mesh-ancestor
6356432|NCT00078910|Sensory System Agents|sensory system agents|mesh-ancestor
6356433|NCT00078910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6356434|NCT00078910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6356435|NCT00078910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6356436|NCT00078962|Gemcitabine|gemcitabine|mesh-list
6356437|NCT00078962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6356438|NCT00078962|Antimetabolites|antimetabolites|mesh-ancestor
6356439|NCT00078962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356440|NCT00078962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356441|NCT00078962|Antiviral Agents|antiviral agents|mesh-ancestor
6356442|NCT00078962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6356443|NCT00078962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6356444|NCT00078962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6356445|NCT00078962|Immunologic Factors|immunologic factors|mesh-ancestor
6356446|NCT00078962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356447|NCT00078975|Gemcitabine|gemcitabine|mesh-list
6356448|NCT00078975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6356449|NCT00078975|Antimetabolites|antimetabolites|mesh-ancestor
6356450|NCT00078975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356451|NCT00078975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356452|NCT00078975|Antiviral Agents|antiviral agents|mesh-ancestor
6356453|NCT00078975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6356454|NCT00078975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6356455|NCT00078975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6356456|NCT00078975|Immunologic Factors|immunologic factors|mesh-ancestor
6356457|NCT00078975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356458|NCT00078988|Carboplatin|carboplatin|mesh-list
6356459|NCT00078988|Etoposide|etoposide|mesh-list
6356460|NCT00078988|Thiotepa|thiotepa|mesh-list
6356461|NCT00078988|Isotretinoin|isotretinoin|mesh-list
6356462|NCT00078988|Lenograstim|lenograstim|mesh-list
6356463|NCT00078988|Sargramostim|sargramostim|mesh-list
6356464|NCT00078988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356465|NCT00078988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6356466|NCT00078988|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6356467|NCT00078988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6356468|NCT00078988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6356469|NCT00078988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356470|NCT00078988|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6356471|NCT00078988|Immunologic Factors|immunologic factors|mesh-ancestor
6356472|NCT00078988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356473|NCT00078988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6356474|NCT00078988|Alkylating Agents|alkylating agents|mesh-ancestor
6356475|NCT00078988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6356476|NCT00078988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6356477|NCT00078988|Dermatologic Agents|dermatologic agents|mesh-ancestor
6356478|NCT00079014|Doxorubicin|doxorubicin|mesh-list
6356479|NCT00079014|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6356480|NCT00079014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6356481|NCT00079014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356482|NCT00079014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6356483|NCT00079014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6356484|NCT00079014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6356485|NCT00079014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356486|NCT00079027|Doxorubicin|doxorubicin|mesh-list
6356487|NCT00079027|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6356488|NCT00079027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6356489|NCT00079027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356490|NCT00079027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6356491|NCT00079027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6356492|NCT00079027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6356493|NCT00079027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356494|NCT00079053|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6356495|NCT00079053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356496|NCT00079053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6356497|NCT00079053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6356498|NCT00079053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356499|NCT00079066|Cetuximab|cetuximab|mesh-list
6356500|NCT00079066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6356501|NCT00079066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356502|NCT00079079|Gemcitabine|gemcitabine|mesh-list
6356503|NCT00079079|Carboplatin|carboplatin|mesh-list
6356504|NCT00079079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356505|NCT00079079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6356506|NCT00079079|Antimetabolites|antimetabolites|mesh-ancestor
6356507|NCT00079079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356508|NCT00079079|Antiviral Agents|antiviral agents|mesh-ancestor
6356509|NCT00079079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6356510|NCT00079079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6356511|NCT00079079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6356512|NCT00079079|Immunologic Factors|immunologic factors|mesh-ancestor
6356513|NCT00079079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356514|NCT00079092|Thalidomide|thalidomide|mesh-list
6356515|NCT00079092|Procarbazine|procarbazine|mesh-list
6356516|NCT00079092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6356517|NCT00079092|Immunologic Factors|immunologic factors|mesh-ancestor
6356518|NCT00079092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356519|NCT00079092|Leprostatic Agents|leprostatic agents|mesh-ancestor
6356520|NCT00079092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6356521|NCT00079092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6356522|NCT00079092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6356523|NCT00079092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6356524|NCT00079092|Growth Substances|growth substances|mesh-ancestor
6356525|NCT00079092|Growth Inhibitors|growth inhibitors|mesh-ancestor
6356526|NCT00079092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356527|NCT00079105|Prednisolone|prednisolone|mesh-list
6356528|NCT00079105|Cyclophosphamide|cyclophosphamide|mesh-list
6356529|NCT00079105|Etoposide|etoposide|mesh-list
6356530|NCT00079105|Vincristine|vincristine|mesh-list
6356531|NCT00079105|Mitoxantrone|mitoxantrone|mesh-list
6356532|NCT00079105|Bleomycin|bleomycin|mesh-list
6356533|NCT00079105|Vinblastine|vinblastine|mesh-list
6356534|NCT00079105|Procarbazine|procarbazine|mesh-list
6356535|NCT00079105|Prednisolone phosphate|prednisolone phosphate|mesh-list
6356536|NCT00079105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6356537|NCT00079105|Immunologic Factors|immunologic factors|mesh-ancestor
6356538|NCT00079105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356539|NCT00079105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6356540|NCT00079105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6356541|NCT00079105|Alkylating Agents|alkylating agents|mesh-ancestor
6356542|NCT00079105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356543|NCT00079105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356544|NCT00079105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6356545|NCT00079105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6356546|NCT00079105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6356547|NCT00079105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6356548|NCT00079105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6356549|NCT00079105|Tubulin Modulators|tubulin modulators|mesh-ancestor
6356550|NCT00079105|Antimitotic Agents|antimitotic agents|mesh-ancestor
6356551|NCT00079105|Mitosis Modulators|mitosis modulators|mesh-ancestor
6356552|NCT00079105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6356553|NCT00079105|Glucocorticoids|glucocorticoids|mesh-ancestor
6356554|NCT00079105|Hormones|hormones|mesh-ancestor
6356555|NCT00079105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6356556|NCT00079105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6356557|NCT00079105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6356558|NCT00079105|Analgesics|analgesics|mesh-ancestor
6356559|NCT00079105|Sensory System Agents|sensory system agents|mesh-ancestor
6356560|NCT00079105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6356561|NCT00079118|Docetaxel|docetaxel|mesh-list
6356562|NCT00079118|Irinotecan|irinotecan|mesh-list
6356563|NCT00079118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356564|NCT00079118|Tubulin Modulators|tubulin modulators|mesh-ancestor
6356565|NCT00079118|Antimitotic Agents|antimitotic agents|mesh-ancestor
6356566|NCT00079118|Mitosis Modulators|mitosis modulators|mesh-ancestor
6356567|NCT00079118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356568|NCT00079118|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6356569|NCT00079118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6356570|NCT00079118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6356571|NCT00079131|Oblimersen|oblimersen|mesh-list
6356572|NCT00079131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356573|NCT00079144|Aldesleukin|aldesleukin|mesh-list
6356574|NCT00079144|Cyclophosphamide|cyclophosphamide|mesh-list
6356575|NCT00079144|Fludarabine|fludarabine|mesh-list
6356576|NCT00079144|Fludarabine phosphate|fludarabine phosphate|mesh-list
6356577|NCT00079144|Freund's Adjuvant|freund's adjuvant|mesh-list
6356578|NCT00079144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6356579|NCT00079144|Immunologic Factors|immunologic factors|mesh-ancestor
6356580|NCT00079144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356581|NCT00079144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6356582|NCT00079144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6356583|NCT00079144|Alkylating Agents|alkylating agents|mesh-ancestor
6356584|NCT00079144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356585|NCT00079144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356586|NCT00079144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6356587|NCT00079144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6356588|NCT00079144|Antimetabolites|antimetabolites|mesh-ancestor
6356589|NCT00079144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6356590|NCT00079144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6356591|NCT00079144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6356592|NCT00079144|Antiviral Agents|antiviral agents|mesh-ancestor
6356593|NCT00079144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6356594|NCT00079157|Sargramostim|sargramostim|mesh-list
6356595|NCT00079157|Freund's Adjuvant|freund's adjuvant|mesh-list
6356596|NCT00079157|Immunologic Factors|immunologic factors|mesh-ancestor
6356597|NCT00079157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356598|NCT00079157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6356599|NCT00079170|Docetaxel|docetaxel|mesh-list
6356600|NCT00079170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356601|NCT00079170|Tubulin Modulators|tubulin modulators|mesh-ancestor
6356602|NCT00079170|Antimitotic Agents|antimitotic agents|mesh-ancestor
6356603|NCT00079170|Mitosis Modulators|mitosis modulators|mesh-ancestor
6356604|NCT00079170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356605|NCT00079222|Itraconazole|itraconazole|mesh-list
6356606|NCT00079222|Voriconazole|voriconazole|mesh-list
6356607|NCT00079222|Antifungal Agents|antifungal agents|mesh-ancestor
6356608|NCT00079222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6356609|NCT00079222|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6356610|NCT00079222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6356611|NCT00079222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6356612|NCT00079222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356613|NCT00079222|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6356614|NCT00079222|Hormone Antagonists|hormone antagonists|mesh-ancestor
6356615|NCT00079222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6356616|NCT00079222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356617|NCT00079222|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6356618|NCT00079235|Sirolimus|sirolimus|mesh-list
6356619|NCT00079235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6356620|NCT00079235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6356621|NCT00079235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6356622|NCT00079235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356623|NCT00079235|Antifungal Agents|antifungal agents|mesh-ancestor
6356624|NCT00079235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6356625|NCT00079235|Immunologic Factors|immunologic factors|mesh-ancestor
6356626|NCT00079235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356627|NCT00079248|Progesterone|progesterone|mesh-list
6356628|NCT00079248|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6356629|NCT00079248|Estrogens|estrogens|mesh-list
6356630|NCT00079248|Progestins|progestins|mesh-ancestor
6356631|NCT00079248|Hormones|hormones|mesh-ancestor
6356632|NCT00079248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6356633|NCT00079248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356634|NCT00079261|Gemcitabine|gemcitabine|mesh-list
6356635|NCT00079261|Prednisone|prednisone|mesh-list
6356636|NCT00079261|Cyclophosphamide|cyclophosphamide|mesh-list
6356637|NCT00079261|Doxorubicin|doxorubicin|mesh-list
6356638|NCT00079261|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6356639|NCT00079261|Vincristine|vincristine|mesh-list
6356640|NCT00079261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6356641|NCT00079261|Immunologic Factors|immunologic factors|mesh-ancestor
6356642|NCT00079261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356643|NCT00079261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6356644|NCT00079261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6356645|NCT00079261|Alkylating Agents|alkylating agents|mesh-ancestor
6356646|NCT00079261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356647|NCT00079261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356648|NCT00079261|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6356649|NCT00079261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6356650|NCT00079261|Antimetabolites|antimetabolites|mesh-ancestor
6356651|NCT00079261|Antiviral Agents|antiviral agents|mesh-ancestor
6356652|NCT00079261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6356653|NCT00079261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6356654|NCT00079261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6356655|NCT00079261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6356656|NCT00079261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6356657|NCT00079261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6356658|NCT00079261|Glucocorticoids|glucocorticoids|mesh-ancestor
6356659|NCT00079261|Hormones|hormones|mesh-ancestor
6356660|NCT00079261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6356661|NCT00079261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6356662|NCT00079261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6356663|NCT00079261|Tubulin Modulators|tubulin modulators|mesh-ancestor
6356664|NCT00079261|Antimitotic Agents|antimitotic agents|mesh-ancestor
6356665|NCT00079261|Mitosis Modulators|mitosis modulators|mesh-ancestor
6356666|NCT00079287|Gemcitabine|gemcitabine|mesh-list
6356667|NCT00079287|Paclitaxel|paclitaxel|mesh-list
6356668|NCT00079287|Vinorelbine|vinorelbine|mesh-list
6356669|NCT00079287|Docetaxel|docetaxel|mesh-list
6356670|NCT00079287|Carboplatin|carboplatin|mesh-list
6356671|NCT00079287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6356672|NCT00079287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356673|NCT00079287|Tubulin Modulators|tubulin modulators|mesh-ancestor
6356674|NCT00079287|Antimitotic Agents|antimitotic agents|mesh-ancestor
6356675|NCT00079287|Mitosis Modulators|mitosis modulators|mesh-ancestor
6356676|NCT00079287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356677|NCT00079287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6356678|NCT00079287|Antimetabolites|antimetabolites|mesh-ancestor
6356679|NCT00079287|Antiviral Agents|antiviral agents|mesh-ancestor
6356680|NCT00079287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6356681|NCT00079287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6356682|NCT00079287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6356683|NCT00079287|Immunologic Factors|immunologic factors|mesh-ancestor
6356684|NCT00079287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356685|NCT00079300|Imiquimod|imiquimod|mesh-list
5724594|NCT03186326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724595|NCT03186326|Growth Inhibitors|growth inhibitors|mesh-ancestor
5724596|NCT03186365|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
6356686|NCT00079300|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6356687|NCT00079300|Immunologic Factors|immunologic factors|mesh-ancestor
6356688|NCT00079300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356689|NCT00079300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356690|NCT00079300|Interferon Inducers|interferon inducers|mesh-ancestor
6356691|NCT00079313|Imatinib Mesylate|imatinib mesylate|mesh-list
6356692|NCT00079313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356693|NCT00079313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6356694|NCT00079313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6356695|NCT00079313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356696|NCT00079352|Gemcitabine|gemcitabine|mesh-list
6356697|NCT00079352|Irinotecan|irinotecan|mesh-list
6356698|NCT00079352|Alvocidib|alvocidib|mesh-list
6356699|NCT00079352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6356700|NCT00079352|Antimetabolites|antimetabolites|mesh-ancestor
6356701|NCT00079352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356702|NCT00079352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356703|NCT00079352|Antiviral Agents|antiviral agents|mesh-ancestor
6356704|NCT00079352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6356705|NCT00079352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6356706|NCT00079352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6356707|NCT00079352|Immunologic Factors|immunologic factors|mesh-ancestor
6356708|NCT00079352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356709|NCT00079352|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6356710|NCT00079352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6356711|NCT00079352|Growth Inhibitors|growth inhibitors|mesh-ancestor
6356712|NCT00079352|Growth Substances|growth substances|mesh-ancestor
6356713|NCT00079352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6356714|NCT00079365|Gemcitabine|gemcitabine|mesh-list
6356715|NCT00079365|Fluorouracil|fluorouracil|mesh-list
6356716|NCT00079365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6356717|NCT00079365|Antimetabolites|antimetabolites|mesh-ancestor
6356718|NCT00079365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356719|NCT00079365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356720|NCT00079365|Antiviral Agents|antiviral agents|mesh-ancestor
6356721|NCT00079365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6356722|NCT00079365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6356723|NCT00079365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6356724|NCT00079365|Immunologic Factors|immunologic factors|mesh-ancestor
6356725|NCT00079365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356726|NCT00079378|Decitabine|decitabine|mesh-list
6356727|NCT00079378|Azacitidine|azacitidine|mesh-list
6356728|NCT00079378|Valproic Acid|valproic acid|mesh-list
6356729|NCT00079378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6356730|NCT00079378|Antimetabolites|antimetabolites|mesh-ancestor
6356731|NCT00079378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356732|NCT00079378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356733|NCT00079378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6356734|NCT00079378|Anticonvulsants|anticonvulsants|mesh-ancestor
6356735|NCT00079378|GABA Agents|gaba agents|mesh-ancestor
6356736|NCT00079378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6356737|NCT00079378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356738|NCT00079378|Antimanic Agents|antimanic agents|mesh-ancestor
6356739|NCT00079378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6356740|NCT00079378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6356741|NCT00079378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6356742|NCT00079430|Paclitaxel|paclitaxel|mesh-list
6356743|NCT00079430|Bevacizumab|bevacizumab|mesh-list
6356744|NCT00079430|Carboplatin|carboplatin|mesh-list
6356745|NCT00079430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6356746|NCT00079430|Antibodies|antibodies|mesh-list
6356747|NCT00079430|Immunoglobulins|immunoglobulins|mesh-list
6356748|NCT00079430|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6356749|NCT00079430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6356750|NCT00079430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356751|NCT00079430|Tubulin Modulators|tubulin modulators|mesh-ancestor
6356752|NCT00079430|Antimitotic Agents|antimitotic agents|mesh-ancestor
6356753|NCT00079430|Mitosis Modulators|mitosis modulators|mesh-ancestor
6356754|NCT00079430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356755|NCT00079430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6356756|NCT00079430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6356757|NCT00079430|Growth Substances|growth substances|mesh-ancestor
6356758|NCT00079430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356759|NCT00079430|Growth Inhibitors|growth inhibitors|mesh-ancestor
6356760|NCT00079430|Immunologic Factors|immunologic factors|mesh-ancestor
6356761|NCT00079443|Rituximab|rituximab|mesh-list
6356762|NCT00079443|Fludarabine|fludarabine|mesh-list
6356763|NCT00079443|Fludarabine phosphate|fludarabine phosphate|mesh-list
6356764|NCT00079443|Romidepsin|romidepsin|mesh-list
6356765|NCT00079443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6356766|NCT00079443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356767|NCT00079443|Immunologic Factors|immunologic factors|mesh-ancestor
6356768|NCT00079443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356769|NCT00079443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6356770|NCT00079443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6356771|NCT00079443|Antimetabolites|antimetabolites|mesh-ancestor
6356772|NCT00079443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356773|NCT00079443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6356774|NCT00079443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6356775|NCT00079456|Sirolimus|sirolimus|mesh-list
6356776|NCT00079456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6356777|NCT00079456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6356778|NCT00079456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6356779|NCT00079456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356780|NCT00079456|Antifungal Agents|antifungal agents|mesh-ancestor
6356781|NCT00079456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6356782|NCT00079456|Immunologic Factors|immunologic factors|mesh-ancestor
6356783|NCT00079456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356784|NCT00079469|Bupropion|bupropion|mesh-list
6356785|NCT00079469|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6356786|NCT00079469|Antidepressive Agents|antidepressive agents|mesh-ancestor
6356787|NCT00079469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6356788|NCT00079469|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6356789|NCT00079469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6356790|NCT00079469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6356791|NCT00079469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356792|NCT00079469|Dopamine Agents|dopamine agents|mesh-ancestor
6356793|NCT00079469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6356794|NCT00079469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356795|NCT00079469|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6356796|NCT00079469|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6356797|NCT00079469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6356798|NCT00079508|Bivalirudin|bivalirudin|mesh-list
6356799|NCT00079508|Antithrombins|antithrombins|mesh-ancestor
6356800|NCT00079508|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6356801|NCT00079508|Protease Inhibitors|protease inhibitors|mesh-ancestor
6356802|NCT00079508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6356803|NCT00079508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356804|NCT00079508|Anticoagulants|anticoagulants|mesh-ancestor
6394653|NCT00202917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394654|NCT00202917|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6394655|NCT00202917|Alkylating Agents|alkylating agents|mesh-ancestor
6394656|NCT00202917|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6394657|NCT00202969|Cisplatin|cisplatin|mesh-list
6394658|NCT00202969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6394659|NCT00202982|Glatiramer Acetate|glatiramer acetate|mesh-list
6394660|NCT00202982|(T,G)-A-L|(t,g)-a-l|mesh-list
6394661|NCT00202982|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6394662|NCT00202982|Immunologic Factors|immunologic factors|mesh-ancestor
6394663|NCT00202982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394664|NCT00202982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6394665|NCT00202982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6394666|NCT00202995|Glatiramer Acetate|glatiramer acetate|mesh-list
6394667|NCT00202995|Interferon beta-1b|interferon beta-1b|mesh-list
6394668|NCT00202995|(T,G)-A-L|(t,g)-a-l|mesh-list
6394669|NCT00202995|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6356805|NCT00079560|Dronabinol|dronabinol|mesh-list
6356806|NCT00079560|Hallucinogens|hallucinogens|mesh-ancestor
6356807|NCT00079560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356808|NCT00079560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6356809|NCT00079560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6356810|NCT00079560|Analgesics|analgesics|mesh-ancestor
6356811|NCT00079560|Sensory System Agents|sensory system agents|mesh-ancestor
6356812|NCT00079560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6356813|NCT00079560|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6356814|NCT00079560|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6356815|NCT00079560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6356816|NCT00079560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356817|NCT00079560|Hormones|hormones|mesh-ancestor
6356818|NCT00079560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6356819|NCT00079586|Heparin|heparin|mesh-list
6356820|NCT00079586|Bivalirudin|bivalirudin|mesh-list
6356821|NCT00079586|Anticoagulants|anticoagulants|mesh-ancestor
6356822|NCT00079586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6356823|NCT00079586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6356824|NCT00079586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356825|NCT00079586|Antithrombins|antithrombins|mesh-ancestor
6356826|NCT00079586|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6356827|NCT00079586|Protease Inhibitors|protease inhibitors|mesh-ancestor
6356828|NCT00079586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6356829|NCT00079612|Sorafenib|sorafenib|mesh-list
6356830|NCT00079612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356831|NCT00079612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6356832|NCT00079612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6356833|NCT00079612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356834|NCT00079638|Niacin|niacin|mesh-list
6356835|NCT00079638|Atorvastatin|atorvastatin|mesh-list
6356836|NCT00079638|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6356837|NCT00079638|Simvastatin|simvastatin|mesh-list
6356838|NCT00079638|Ezetimibe|ezetimibe|mesh-list
6356839|NCT00079638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6356840|NCT00079638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6356841|NCT00079638|Antimetabolites|antimetabolites|mesh-ancestor
6356842|NCT00079638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356843|NCT00079638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6356844|NCT00079638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6356845|NCT00079638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6356846|NCT00079638|Vasodilator Agents|vasodilator agents|mesh-ancestor
6356847|NCT00079638|Vitamin B Complex|vitamin b complex|mesh-ancestor
6356848|NCT00079638|Vitamins|vitamins|mesh-ancestor
6356849|NCT00079638|Micronutrients|micronutrients|mesh-ancestor
6356850|NCT00079638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356851|NCT00079716|Dacetuzumab|dacetuzumab|mesh-list
6356852|NCT00079716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6356853|NCT00079716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356854|NCT00079755|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6356855|NCT00079755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6356856|NCT00079755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356857|NCT00079768|Alemtuzumab|alemtuzumab|mesh-list
6356858|NCT00079768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6356859|NCT00079768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356860|NCT00079807|Thioctic Acid|thioctic acid|mesh-list
6356861|NCT00079807|Antioxidants|antioxidants|mesh-ancestor
6356862|NCT00079807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356863|NCT00079807|Protective Agents|protective agents|mesh-ancestor
6356864|NCT00079807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356865|NCT00079807|Vitamin B Complex|vitamin b complex|mesh-ancestor
6356866|NCT00079807|Vitamins|vitamins|mesh-ancestor
6356867|NCT00079807|Micronutrients|micronutrients|mesh-ancestor
6356868|NCT00079820|Vaccines|vaccines|mesh-list
6356869|NCT00079820|Immunologic Factors|immunologic factors|mesh-ancestor
6356870|NCT00079820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356871|NCT00079833|Esomeprazole|esomeprazole|mesh-list
6356872|NCT00079833|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6356873|NCT00079833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6356874|NCT00079833|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6356875|NCT00079833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6356876|NCT00079833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356877|NCT00079872|Pemetrexed|pemetrexed|mesh-list
6356878|NCT00079872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356879|NCT00079872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6356880|NCT00079872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356881|NCT00079872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6356882|NCT00079872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6356883|NCT00079885|Tigecycline|tigecycline|mesh-list
6356884|NCT00079885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6356885|NCT00079885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6356886|NCT00079885|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6356887|NCT00079885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6356888|NCT00079885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356889|NCT00079911|Valacyclovir|valacyclovir|mesh-list
6356890|NCT00079911|Antiviral Agents|antiviral agents|mesh-ancestor
6356891|NCT00079911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6356892|NCT00079924|Teriparatide|teriparatide|mesh-list
6356893|NCT00079924|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
6356894|NCT00079924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6356895|NCT00079924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356896|NCT00079924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6356897|NCT00079924|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6356898|NCT00079924|Hormone Antagonists|hormone antagonists|mesh-ancestor
6356899|NCT00079924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6356900|NCT00079924|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6356901|NCT00079924|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6356902|NCT00079963|Vitamins|vitamins|mesh-list
6356903|NCT00079963|Ascorbic Acid|ascorbic acid|mesh-list
6356904|NCT00079963|Vitamin E|vitamin e|mesh-list
6356905|NCT00079963|Micronutrients|micronutrients|mesh-ancestor
6356906|NCT00079963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356907|NCT00079963|Antioxidants|antioxidants|mesh-ancestor
6356908|NCT00079963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356909|NCT00079963|Protective Agents|protective agents|mesh-ancestor
6356910|NCT00079976|Tigecycline|tigecycline|mesh-list
6356911|NCT00079976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6356912|NCT00079976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6356913|NCT00079976|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6356914|NCT00079976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6356915|NCT00079976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356916|NCT00079989|Tigecycline|tigecycline|mesh-list
6356917|NCT00079989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6356918|NCT00079989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6356919|NCT00079989|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6356920|NCT00079989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6356921|NCT00079989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356922|NCT00080028|Motexafin gadolinium|motexafin gadolinium|mesh-list
6356923|NCT00080028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356924|NCT00080028|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6356925|NCT00080028|Dermatologic Agents|dermatologic agents|mesh-ancestor
6356926|NCT00080041|Motexafin gadolinium|motexafin gadolinium|mesh-list
6356927|NCT00080041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356928|NCT00080041|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6356929|NCT00080041|Dermatologic Agents|dermatologic agents|mesh-ancestor
6356930|NCT00080054|Motexafin gadolinium|motexafin gadolinium|mesh-list
6356931|NCT00080054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356932|NCT00080054|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6356933|NCT00080054|Dermatologic Agents|dermatologic agents|mesh-ancestor
6356934|NCT00080080|Docetaxel|docetaxel|mesh-list
6356935|NCT00080080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356936|NCT00080080|Tubulin Modulators|tubulin modulators|mesh-ancestor
6356937|NCT00080080|Antimitotic Agents|antimitotic agents|mesh-ancestor
6356938|NCT00080080|Mitosis Modulators|mitosis modulators|mesh-ancestor
6356939|NCT00080080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356940|NCT00080145|Risperidone|risperidone|mesh-list
6356941|NCT00080145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6356942|NCT00080145|Serotonin Agents|serotonin agents|mesh-ancestor
6356943|NCT00080145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6356944|NCT00080145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356945|NCT00080145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356946|NCT00080145|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6356947|NCT00080145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6356948|NCT00080145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6356949|NCT00080145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6356950|NCT00080145|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6356951|NCT00080145|Dopamine Agents|dopamine agents|mesh-ancestor
6356952|NCT00080158|Mirtazapine|mirtazapine|mesh-list
6356953|NCT00080158|Citalopram|citalopram|mesh-list
6356954|NCT00080158|Bupropion|bupropion|mesh-list
6356955|NCT00080158|Fluoxetine|fluoxetine|mesh-list
6356956|NCT00080158|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6356957|NCT00080158|Sertraline|sertraline|mesh-list
6356958|NCT00080158|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6356959|NCT00080158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6356960|NCT00080158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6356961|NCT00080158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356962|NCT00080158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6356963|NCT00080158|Serotonin Agents|serotonin agents|mesh-ancestor
6356964|NCT00080158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6356965|NCT00080158|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6356966|NCT00080158|Antidepressive Agents|antidepressive agents|mesh-ancestor
6356967|NCT00080158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6356968|NCT00080158|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6356969|NCT00080158|Dopamine Agents|dopamine agents|mesh-ancestor
6356970|NCT00080158|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6356971|NCT00080158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6356972|NCT00080158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6356973|NCT00080158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6356974|NCT00080158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6356975|NCT00080158|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6356976|NCT00080158|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6356977|NCT00080158|Histamine Antagonists|histamine antagonists|mesh-ancestor
6356978|NCT00080158|Histamine Agents|histamine agents|mesh-ancestor
6356979|NCT00080158|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6356980|NCT00080158|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6356981|NCT00080158|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6356982|NCT00080158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6356983|NCT00080158|Adrenergic Agents|adrenergic agents|mesh-ancestor
6356984|NCT00080158|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6356985|NCT00080158|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6356986|NCT00080158|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6356987|NCT00080197|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
6356988|NCT00080197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6356989|NCT00080197|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6356990|NCT00080197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6356991|NCT00080197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356992|NCT00080275|Niacin|niacin|mesh-list
6356993|NCT00080275|Simvastatin|simvastatin|mesh-list
6356994|NCT00080275|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6356995|NCT00080275|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6356996|NCT00080275|Antimetabolites|antimetabolites|mesh-ancestor
6356997|NCT00080275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6356998|NCT00080275|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6356999|NCT00080275|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6357000|NCT00080275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6357001|NCT00080275|Vasodilator Agents|vasodilator agents|mesh-ancestor
6357002|NCT00080275|Vitamin B Complex|vitamin b complex|mesh-ancestor
6357003|NCT00080275|Vitamins|vitamins|mesh-ancestor
6357004|NCT00080275|Micronutrients|micronutrients|mesh-ancestor
6357005|NCT00080275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6357006|NCT00080314|Aripiprazole|aripiprazole|mesh-list
6357007|NCT00080314|Antidepressive Agents|antidepressive agents|mesh-ancestor
6357008|NCT00080314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6357009|NCT00080314|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6357010|NCT00080314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6357011|NCT00080314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6357012|NCT00080314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6357013|NCT00080314|Dopamine Agonists|dopamine agonists|mesh-ancestor
6357014|NCT00080314|Dopamine Agents|dopamine agents|mesh-ancestor
6357015|NCT00080314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6357016|NCT00080314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357017|NCT00080314|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6357018|NCT00080314|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6357019|NCT00080314|Serotonin Agents|serotonin agents|mesh-ancestor
6357020|NCT00080314|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6357021|NCT00080314|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6357022|NCT00080314|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6357023|NCT00080314|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6357024|NCT00080327|Aripiprazole|aripiprazole|mesh-list
6357025|NCT00080327|Antidepressive Agents|antidepressive agents|mesh-ancestor
6357026|NCT00080327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6357027|NCT00080327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6357028|NCT00080327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6357029|NCT00080327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6357030|NCT00080327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6357031|NCT00080327|Dopamine Agonists|dopamine agonists|mesh-ancestor
6357032|NCT00080327|Dopamine Agents|dopamine agents|mesh-ancestor
6357033|NCT00080327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6357034|NCT00080327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357035|NCT00080327|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6357036|NCT00080327|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6357037|NCT00080327|Serotonin Agents|serotonin agents|mesh-ancestor
6357038|NCT00080327|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6357039|NCT00080327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6357040|NCT00080327|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6357041|NCT00080327|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6357042|NCT00080340|Gefitinib|gefitinib|mesh-list
6357043|NCT00080340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6357044|NCT00080340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6357045|NCT00080340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6357046|NCT00080340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357047|NCT00080405|Bortezomib|bortezomib|mesh-list
6357048|NCT00080405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6357049|NCT00080418|Paclitaxel|paclitaxel|mesh-list
6357050|NCT00080418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6357051|NCT00080418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6357052|NCT00080418|Tubulin Modulators|tubulin modulators|mesh-ancestor
6357053|NCT00080418|Antimitotic Agents|antimitotic agents|mesh-ancestor
6357054|NCT00080418|Mitosis Modulators|mitosis modulators|mesh-ancestor
6357055|NCT00080418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357056|NCT00080431|Daclizumab|daclizumab|mesh-list
6357057|NCT00080431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6357058|NCT00080431|Immunologic Factors|immunologic factors|mesh-ancestor
6357059|NCT00080431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6357060|NCT00080444|Dexamethasone|dexamethasone|mesh-list
6357061|NCT00080444|Dexamethasone acetate|dexamethasone acetate|mesh-list
6357062|NCT00080444|Ondansetron|ondansetron|mesh-list
6357063|NCT00080444|Aprepitant|aprepitant|mesh-list
6357064|NCT00080444|Fosaprepitant|fosaprepitant|mesh-list
6357065|NCT00080444|BB 1101|bb 1101|mesh-list
6357066|NCT00080444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6357067|NCT00080444|Antiemetics|antiemetics|mesh-ancestor
6357068|NCT00080444|Autonomic Agents|autonomic agents|mesh-ancestor
6357069|NCT00080444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6357070|NCT00080444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6357071|NCT00080444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6357072|NCT00080444|Glucocorticoids|glucocorticoids|mesh-ancestor
6357073|NCT00080444|Hormones|hormones|mesh-ancestor
6357074|NCT00080444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6357075|NCT00080444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6357076|NCT00080444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6357077|NCT00080444|Protease Inhibitors|protease inhibitors|mesh-ancestor
6357078|NCT00080444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6357079|NCT00080444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357080|NCT00080444|Antipruritics|antipruritics|mesh-ancestor
6357081|NCT00080444|Dermatologic Agents|dermatologic agents|mesh-ancestor
6357082|NCT00080444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6357083|NCT00080444|Serotonin Agents|serotonin agents|mesh-ancestor
6357084|NCT00080444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6357085|NCT00080444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6357086|NCT00080444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6357087|NCT00080444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6357088|NCT00080444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6357089|NCT00080444|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6357090|NCT00080444|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6357091|NCT00080457|Sitaxsentan|sitaxsentan|mesh-list
6357092|NCT00080457|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6357093|NCT00080457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357094|NCT00080496|Imipenem|imipenem|mesh-list
6357095|NCT00080496|Tigecycline|tigecycline|mesh-list
6357096|NCT00080496|Cilastatin|cilastatin|mesh-list
6357097|NCT00080496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6357098|NCT00080496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6357099|NCT00080496|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6357100|NCT00080496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6357101|NCT00080496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357102|NCT00080496|Protease Inhibitors|protease inhibitors|mesh-ancestor
6357103|NCT00080509|Desoxyepothilone B|desoxyepothilone b|mesh-list
6357104|NCT00080509|Tubulin Modulators|tubulin modulators|mesh-ancestor
6357105|NCT00080509|Antimitotic Agents|antimitotic agents|mesh-ancestor
6357106|NCT00080509|Mitosis Modulators|mitosis modulators|mesh-ancestor
6357107|NCT00080509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357108|NCT00080509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6357109|NCT00080522|Ritonavir|ritonavir|mesh-list
6357110|NCT00080522|Lopinavir|lopinavir|mesh-list
6357111|NCT00080522|Lamivudine|lamivudine|mesh-list
6357112|NCT00080522|Zidovudine|zidovudine|mesh-list
6357113|NCT00080522|Stavudine|stavudine|mesh-list
6357114|NCT00080522|Didanosine|didanosine|mesh-list
6357115|NCT00080522|Efavirenz|efavirenz|mesh-list
6357116|NCT00080522|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6357117|NCT00080522|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6357118|NCT00080522|Protease Inhibitors|protease inhibitors|mesh-ancestor
6357119|NCT00080522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6357120|NCT00080522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357121|NCT00080522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6357122|NCT00080522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6357123|NCT00080522|Antiviral Agents|antiviral agents|mesh-ancestor
6357124|NCT00080522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6357125|NCT00080522|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6357126|NCT00080522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6357127|NCT00080522|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6357128|NCT00080522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6357129|NCT00080522|Antimetabolites|antimetabolites|mesh-ancestor
6357130|NCT00080522|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6357131|NCT00080522|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6357132|NCT00080522|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6357133|NCT00080522|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6357134|NCT00080522|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6357135|NCT00080613|Exemestane|exemestane|mesh-list
6357136|NCT00080613|Hormones|hormones|mesh-list
6357137|NCT00080613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6357138|NCT00080613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6357139|NCT00080613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6357140|NCT00080613|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6357141|NCT00080613|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6357142|NCT00080613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6357143|NCT00080613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357144|NCT00080613|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6357145|NCT00080613|Hormone Antagonists|hormone antagonists|mesh-ancestor
6357146|NCT00080626|Docetaxel|docetaxel|mesh-list
6357147|NCT00080626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6357148|NCT00080626|Tubulin Modulators|tubulin modulators|mesh-ancestor
6357149|NCT00080626|Antimitotic Agents|antimitotic agents|mesh-ancestor
6357150|NCT00080626|Mitosis Modulators|mitosis modulators|mesh-ancestor
6357151|NCT00080626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357152|NCT00080665|Docetaxel|docetaxel|mesh-list
6357153|NCT00080665|Imatinib Mesylate|imatinib mesylate|mesh-list
6394670|NCT00202995|Immunologic Factors|immunologic factors|mesh-ancestor
6357154|NCT00080665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6357155|NCT00080665|Tubulin Modulators|tubulin modulators|mesh-ancestor
6357156|NCT00080665|Antimitotic Agents|antimitotic agents|mesh-ancestor
6357157|NCT00080665|Mitosis Modulators|mitosis modulators|mesh-ancestor
6357158|NCT00080665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357159|NCT00080665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6357160|NCT00080665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6357161|NCT00080678|Docetaxel|docetaxel|mesh-list
6357162|NCT00080678|Imatinib Mesylate|imatinib mesylate|mesh-list
6357163|NCT00080678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6357164|NCT00080678|Tubulin Modulators|tubulin modulators|mesh-ancestor
6357165|NCT00080678|Antimitotic Agents|antimitotic agents|mesh-ancestor
6357166|NCT00080678|Mitosis Modulators|mitosis modulators|mesh-ancestor
6357167|NCT00080678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357168|NCT00080678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6357169|NCT00080678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6357170|NCT00080743|Tamoxifen|tamoxifen|mesh-list
6357171|NCT00080743|Gefitinib|gefitinib|mesh-list
6357172|NCT00080743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357173|NCT00080743|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6357174|NCT00080743|Hormone Antagonists|hormone antagonists|mesh-ancestor
6357175|NCT00080743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6357176|NCT00080743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6357177|NCT00080743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6357178|NCT00080743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6357179|NCT00080743|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6357180|NCT00080743|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6357181|NCT00080743|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6357182|NCT00080743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6357183|NCT00080743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6357184|NCT00080756|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6357185|NCT00080756|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6357186|NCT00080756|Estradiol|estradiol|mesh-list
6357187|NCT00080756|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6357188|NCT00080756|Testosterone|testosterone|mesh-list
6357189|NCT00080756|Deslorelin|deslorelin|mesh-list
6357190|NCT00080756|Estrogens|estrogens|mesh-ancestor
6357191|NCT00080756|Hormones|hormones|mesh-ancestor
6357192|NCT00080756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6357193|NCT00080756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6357194|NCT00080756|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6357195|NCT00080756|Contraceptive Agents|contraceptive agents|mesh-ancestor
6357196|NCT00080756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6357197|NCT00080756|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6357198|NCT00080756|Androgens|androgens|mesh-ancestor
6357199|NCT00080756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6357200|NCT00080756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357201|NCT00080782|Celecoxib|celecoxib|mesh-list
6357202|NCT00080782|Doxorubicin|doxorubicin|mesh-list
6357203|NCT00080782|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6357204|NCT00080782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6357205|NCT00080782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5724597|NCT03186365|Antiviral Agents|antiviral agents|mesh-ancestor
5724598|NCT03186365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5724599|NCT03186443|Pregabalin|pregabalin|mesh-list
5724600|NCT03186443|Gabapentin|gabapentin|mesh-list
5724601|NCT03186443|Analgesics|analgesics|mesh-ancestor
5724602|NCT03186443|Sensory System Agents|sensory system agents|mesh-ancestor
5724603|NCT03186443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5724604|NCT03186443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724605|NCT03186443|Anticonvulsants|anticonvulsants|mesh-ancestor
5724606|NCT03186443|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5724607|NCT03186443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5724608|NCT03186443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724609|NCT03186443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5724610|NCT03186443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5724611|NCT03186443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5724612|NCT03186443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5724613|NCT03186443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5724614|NCT03186443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5724615|NCT03186443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6357206|NCT00080782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6357207|NCT00080782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6357208|NCT00080782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6357209|NCT00080782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357210|NCT00080782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6357211|NCT00080782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6357212|NCT00080782|Analgesics|analgesics|mesh-ancestor
6357213|NCT00080782|Sensory System Agents|sensory system agents|mesh-ancestor
6357214|NCT00080782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6357215|NCT00080782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6357216|NCT00080782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6357217|NCT00080782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6357218|NCT00080782|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6357219|NCT00080782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6357220|NCT00080795|Gemcitabine|gemcitabine|mesh-list
6357221|NCT00080795|Doxorubicin|doxorubicin|mesh-list
6357222|NCT00080795|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6357223|NCT00080795|Ifosfamide|ifosfamide|mesh-list
6357224|NCT00080795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6357225|NCT00080795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6357226|NCT00080795|Antimetabolites|antimetabolites|mesh-ancestor
6357227|NCT00080795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357228|NCT00080795|Antiviral Agents|antiviral agents|mesh-ancestor
6357229|NCT00080795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6357230|NCT00080795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6357231|NCT00080795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6357232|NCT00080795|Immunologic Factors|immunologic factors|mesh-ancestor
6357233|NCT00080795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6357234|NCT00080795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6357235|NCT00080795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6357236|NCT00080795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6357237|NCT00080795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6357238|NCT00080795|Alkylating Agents|alkylating agents|mesh-ancestor
6357239|NCT00080808|Phentolamine|phentolamine|mesh-list
6357240|NCT00080808|Sildenafil Citrate|sildenafil citrate|mesh-list
6357241|NCT00080808|Alprostadil|alprostadil|mesh-list
6357242|NCT00080808|Papaverine|papaverine|mesh-list
6357243|NCT00080808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357244|NCT00080808|Vasodilator Agents|vasodilator agents|mesh-ancestor
6357245|NCT00080808|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6357246|NCT00080808|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6357247|NCT00080808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6357248|NCT00080808|Urological Agents|urological agents|mesh-ancestor
6357249|NCT00080808|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6357250|NCT00080808|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6357251|NCT00080808|Adrenergic Agents|adrenergic agents|mesh-ancestor
6357252|NCT00080808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6357253|NCT00080808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6357254|NCT00080808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6357255|NCT00080808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6357256|NCT00080847|Prednisone|prednisone|mesh-list
6357257|NCT00080847|Cyclophosphamide|cyclophosphamide|mesh-list
6357258|NCT00080847|Rituximab|rituximab|mesh-list
6357259|NCT00080847|Doxorubicin|doxorubicin|mesh-list
6357260|NCT00080847|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6357261|NCT00080847|Vincristine|vincristine|mesh-list
6357262|NCT00080847|Oblimersen|oblimersen|mesh-list
6357263|NCT00080847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6357264|NCT00080847|Immunologic Factors|immunologic factors|mesh-ancestor
6357265|NCT00080847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6357266|NCT00080847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6357267|NCT00080847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6357268|NCT00080847|Alkylating Agents|alkylating agents|mesh-ancestor
6357269|NCT00080847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357270|NCT00080847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6357271|NCT00080847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6357272|NCT00080847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6357273|NCT00080847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6357274|NCT00080847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6357275|NCT00080847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6357276|NCT00080847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6357277|NCT00080847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6357278|NCT00080847|Glucocorticoids|glucocorticoids|mesh-ancestor
6357279|NCT00080847|Hormones|hormones|mesh-ancestor
6357280|NCT00080847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6357281|NCT00080847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6357282|NCT00080847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6357283|NCT00080847|Tubulin Modulators|tubulin modulators|mesh-ancestor
6357284|NCT00080847|Antimitotic Agents|antimitotic agents|mesh-ancestor
6357285|NCT00080847|Mitosis Modulators|mitosis modulators|mesh-ancestor
6357286|NCT00080860|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
6357287|NCT00080860|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6357288|NCT00080860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357289|NCT00080886|Cytarabine|cytarabine|mesh-list
6357290|NCT00080886|Rituximab|rituximab|mesh-list
6357291|NCT00080886|Etoposide|etoposide|mesh-list
6357292|NCT00080886|Melphalan|melphalan|mesh-list
6357293|NCT00080886|Carmustine|carmustine|mesh-list
6357294|NCT00080886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6357295|NCT00080886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6357296|NCT00080886|Immunologic Factors|immunologic factors|mesh-ancestor
6357297|NCT00080886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6357298|NCT00080886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6357299|NCT00080886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6357300|NCT00080886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6357301|NCT00080886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6357302|NCT00080886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6357303|NCT00080886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357304|NCT00080886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6357305|NCT00080886|Antimetabolites|antimetabolites|mesh-ancestor
6357306|NCT00080886|Antiviral Agents|antiviral agents|mesh-ancestor
6357307|NCT00080886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6357308|NCT00080886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6357309|NCT00080886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6357310|NCT00080886|Alkylating Agents|alkylating agents|mesh-ancestor
6357311|NCT00080886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6357312|NCT00080925|Cytarabine|cytarabine|mesh-list
6357313|NCT00080925|Cyclosporine|cyclosporine|mesh-list
6357314|NCT00080925|Prednisone|prednisone|mesh-list
6357315|NCT00080925|Cyclophosphamide|cyclophosphamide|mesh-list
6357316|NCT00080925|Rituximab|rituximab|mesh-list
6357317|NCT00080925|Doxorubicin|doxorubicin|mesh-list
6357318|NCT00080925|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6357319|NCT00080925|Fludarabine|fludarabine|mesh-list
6357320|NCT00080925|Fludarabine phosphate|fludarabine phosphate|mesh-list
6357321|NCT00080925|Etoposide|etoposide|mesh-list
6357322|NCT00080925|Vincristine|vincristine|mesh-list
6357323|NCT00080925|Cyclosporins|cyclosporins|mesh-list
6357324|NCT00080925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6357325|NCT00080925|Immunologic Factors|immunologic factors|mesh-ancestor
6357326|NCT00080925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6357327|NCT00080925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6357328|NCT00080925|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6357329|NCT00080925|Alkylating Agents|alkylating agents|mesh-ancestor
6357330|NCT00080925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357331|NCT00080925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6357332|NCT00080925|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6017154|NCT00369915|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
6017155|NCT00369915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6357333|NCT00080925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6357334|NCT00080925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6357335|NCT00080925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6357336|NCT00080925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6357337|NCT00080925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6357338|NCT00080925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6357339|NCT00080925|Glucocorticoids|glucocorticoids|mesh-ancestor
6357340|NCT00080925|Hormones|hormones|mesh-ancestor
6357341|NCT00080925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6357342|NCT00080925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6357343|NCT00080925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6357344|NCT00080925|Antimetabolites|antimetabolites|mesh-ancestor
6357345|NCT00080925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6357346|NCT00080925|Antiviral Agents|antiviral agents|mesh-ancestor
6357347|NCT00080925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6357348|NCT00080925|Tubulin Modulators|tubulin modulators|mesh-ancestor
6357349|NCT00080925|Antimitotic Agents|antimitotic agents|mesh-ancestor
6357350|NCT00080925|Mitosis Modulators|mitosis modulators|mesh-ancestor
6357351|NCT00080925|Antifungal Agents|antifungal agents|mesh-ancestor
6357352|NCT00080925|Dermatologic Agents|dermatologic agents|mesh-ancestor
6357353|NCT00080925|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6357354|NCT00080951|Leucovorin|leucovorin|mesh-list
6357355|NCT00080951|Fluorouracil|fluorouracil|mesh-list
6357356|NCT00080951|Oxaliplatin|oxaliplatin|mesh-list
6357357|NCT00080951|Irinotecan|irinotecan|mesh-list
6357358|NCT00080951|Calcium|calcium|mesh-list
6357359|NCT00080951|Levoleucovorin|levoleucovorin|mesh-list
6357360|NCT00080951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6357361|NCT00080951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6357362|NCT00080951|Antimetabolites|antimetabolites|mesh-ancestor
6357363|NCT00080951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357364|NCT00080951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6357365|NCT00080951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6357366|NCT00080951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6357367|NCT00080951|Immunologic Factors|immunologic factors|mesh-ancestor
6357368|NCT00080951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6357369|NCT00080951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6357370|NCT00080951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6357371|NCT00080951|Antidotes|antidotes|mesh-ancestor
6357372|NCT00080951|Protective Agents|protective agents|mesh-ancestor
6357373|NCT00080951|Vitamin B Complex|vitamin b complex|mesh-ancestor
6357374|NCT00080951|Vitamins|vitamins|mesh-ancestor
6357375|NCT00080951|Micronutrients|micronutrients|mesh-ancestor
6357376|NCT00080977|Aldesleukin|aldesleukin|mesh-list
6357377|NCT00080977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6357378|NCT00080977|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6357379|NCT00080977|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6357380|NCT00080977|Antiviral Agents|antiviral agents|mesh-ancestor
6357381|NCT00080977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6357382|NCT00080990|Leucovorin|leucovorin|mesh-list
6357383|NCT00080990|Fluorouracil|fluorouracil|mesh-list
6357384|NCT00080990|Oxaliplatin|oxaliplatin|mesh-list
6357385|NCT00080990|Alvocidib|alvocidib|mesh-list
6357386|NCT00080990|Calcium|calcium|mesh-list
6357387|NCT00080990|Levoleucovorin|levoleucovorin|mesh-list
6357388|NCT00080990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6357389|NCT00080990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6357390|NCT00080990|Antimetabolites|antimetabolites|mesh-ancestor
6357391|NCT00080990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357392|NCT00080990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6357393|NCT00080990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6357394|NCT00080990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6357395|NCT00080990|Immunologic Factors|immunologic factors|mesh-ancestor
6357396|NCT00080990|Antidotes|antidotes|mesh-ancestor
6357397|NCT00080990|Protective Agents|protective agents|mesh-ancestor
6357398|NCT00080990|Vitamin B Complex|vitamin b complex|mesh-ancestor
6357399|NCT00080990|Vitamins|vitamins|mesh-ancestor
6357400|NCT00080990|Micronutrients|micronutrients|mesh-ancestor
6357401|NCT00080990|Growth Inhibitors|growth inhibitors|mesh-ancestor
6357402|NCT00080990|Growth Substances|growth substances|mesh-ancestor
6357403|NCT00080990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6357404|NCT00080990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6357405|NCT00081042|Paclitaxel|paclitaxel|mesh-list
6357406|NCT00081042|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6357407|NCT00081042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6357408|NCT00081042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6357409|NCT00081042|Tubulin Modulators|tubulin modulators|mesh-ancestor
6357410|NCT00081042|Antimitotic Agents|antimitotic agents|mesh-ancestor
6357411|NCT00081042|Mitosis Modulators|mitosis modulators|mesh-ancestor
6357412|NCT00081042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357413|NCT00081055|Cyclosporine|cyclosporine|mesh-list
6357414|NCT00081055|Cyclophosphamide|cyclophosphamide|mesh-list
6357415|NCT00081055|Busulfan|busulfan|mesh-list
6357416|NCT00081055|Methotrexate|methotrexate|mesh-list
6357417|NCT00081055|Cyclosporins|cyclosporins|mesh-list
6357418|NCT00081055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6357419|NCT00081055|Immunologic Factors|immunologic factors|mesh-ancestor
6357420|NCT00081055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6357421|NCT00081055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6357422|NCT00081055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6357423|NCT00081055|Alkylating Agents|alkylating agents|mesh-ancestor
6357424|NCT00081055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357425|NCT00081055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6357426|NCT00081055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6357427|NCT00081055|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6357428|NCT00081055|Abortifacient Agents|abortifacient agents|mesh-ancestor
6357429|NCT00081055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6357430|NCT00081055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6357431|NCT00081055|Antimetabolites|antimetabolites|mesh-ancestor
6357432|NCT00081055|Dermatologic Agents|dermatologic agents|mesh-ancestor
6357433|NCT00081055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6357434|NCT00081055|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6357435|NCT00081055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6357436|NCT00081055|Antifungal Agents|antifungal agents|mesh-ancestor
6357437|NCT00081055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6357438|NCT00081055|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6357439|NCT00081068|Alemtuzumab|alemtuzumab|mesh-list
6357440|NCT00081068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6357441|NCT00081068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6357442|NCT00081094|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6357443|NCT00081094|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6357444|NCT00081094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357445|NCT00081107|Epothilones|epothilones|mesh-list
6357446|NCT00081107|Desoxyepothilone B|desoxyepothilone b|mesh-list
6357447|NCT00081107|Tubulin Modulators|tubulin modulators|mesh-ancestor
6357448|NCT00081107|Antimitotic Agents|antimitotic agents|mesh-ancestor
6357449|NCT00081107|Mitosis Modulators|mitosis modulators|mesh-ancestor
6357450|NCT00081107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357451|NCT00081107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6357452|NCT00081133|Imatinib Mesylate|imatinib mesylate|mesh-list
6357453|NCT00081133|Arsenic Trioxide|arsenic trioxide|mesh-list
6357454|NCT00081133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6357455|NCT00081133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6357456|NCT00081133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6357457|NCT00081133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357458|NCT00081172|Antibodies|antibodies|mesh-list
6357459|NCT00081172|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6357460|NCT00081172|Immunologic Factors|immunologic factors|mesh-ancestor
6357461|NCT00081172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6357462|NCT00081224|Celecoxib|celecoxib|mesh-list
6357463|NCT00081224|Capecitabine|capecitabine|mesh-list
6357464|NCT00081224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6357465|NCT00081224|Antimetabolites|antimetabolites|mesh-ancestor
6357466|NCT00081224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357467|NCT00081224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6357468|NCT00081224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6357469|NCT00081224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6357470|NCT00081224|Analgesics|analgesics|mesh-ancestor
6357471|NCT00081224|Sensory System Agents|sensory system agents|mesh-ancestor
6357472|NCT00081224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6357473|NCT00081224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6357474|NCT00081224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6357475|NCT00081224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6357476|NCT00081224|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6357477|NCT00081224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6357478|NCT00081224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6357479|NCT00081237|Oxaliplatin|oxaliplatin|mesh-list
6357480|NCT00081237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6357481|NCT00081276|Cisplatin|cisplatin|mesh-list
6357482|NCT00081276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6394671|NCT00202995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394672|NCT00202995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6394673|NCT00202995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6394674|NCT00203034|Rasagiline|rasagiline|mesh-list
6394675|NCT00203034|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6394676|NCT00203034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6394677|NCT00203034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394678|NCT00203034|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6357483|NCT00081302|Paclitaxel|paclitaxel|mesh-list
6357484|NCT00081302|Carboplatin|carboplatin|mesh-list
6357485|NCT00081302|Cetuximab|cetuximab|mesh-list
6357486|NCT00081302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6357487|NCT00081302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6357488|NCT00081302|Tubulin Modulators|tubulin modulators|mesh-ancestor
6357489|NCT00081302|Antimitotic Agents|antimitotic agents|mesh-ancestor
6357490|NCT00081302|Mitosis Modulators|mitosis modulators|mesh-ancestor
6357491|NCT00081302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357492|NCT00081302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6357493|NCT00081315|Amifostine|amifostine|mesh-list
6357494|NCT00081315|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6357495|NCT00081315|Protective Agents|protective agents|mesh-ancestor
6357496|NCT00081315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6357497|NCT00081380|Valproic Acid|valproic acid|mesh-list
6357498|NCT00081380|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6357499|NCT00081380|Antipsychotic Agents|antipsychotic agents|mesh-list
6357500|NCT00081380|Antidepressive Agents|antidepressive agents|mesh-ancestor
6357501|NCT00081380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6357502|NCT00081380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6357503|NCT00081380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6357504|NCT00081380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6357505|NCT00081380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6357506|NCT00081380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357507|NCT00081380|Antimanic Agents|antimanic agents|mesh-ancestor
6357508|NCT00081380|Anticonvulsants|anticonvulsants|mesh-ancestor
6357509|NCT00081380|GABA Agents|gaba agents|mesh-ancestor
6357510|NCT00081380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6357511|NCT00081471|Darbepoetin alfa|darbepoetin alfa|mesh-list
6357512|NCT00081471|Hematinics|hematinics|mesh-ancestor
6357513|NCT00081484|Epoetin Alfa|epoetin alfa|mesh-list
6357514|NCT00081484|Hematinics|hematinics|mesh-ancestor
6357515|NCT00081536|Capecitabine|capecitabine|mesh-list
6357516|NCT00081536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6357517|NCT00081536|Antimetabolites|antimetabolites|mesh-ancestor
6357518|NCT00081536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357519|NCT00081536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6357520|NCT00081549|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II)|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii)|mesh-list
6357521|NCT00081549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6357522|NCT00081575|Levofloxacin|levofloxacin|mesh-list
6357523|NCT00081575|Ofloxacin|ofloxacin|mesh-list
6357524|NCT00081575|Tigecycline|tigecycline|mesh-list
6357525|NCT00081575|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6357526|NCT00081575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6357527|NCT00081575|Renal Agents|renal agents|mesh-ancestor
6357528|NCT00081575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6357529|NCT00081575|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6357530|NCT00081575|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6357531|NCT00081575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6357532|NCT00081575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357533|NCT00081575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6357534|NCT00081575|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6357535|NCT00081575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6357536|NCT00081575|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6357537|NCT00081588|Darunavir|darunavir|mesh-list
6357538|NCT00081588|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6357539|NCT00081588|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6357540|NCT00081588|Protease Inhibitors|protease inhibitors|mesh-ancestor
6357541|NCT00081588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6357542|NCT00081588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357543|NCT00081588|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6357544|NCT00081588|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6357545|NCT00081588|Antiviral Agents|antiviral agents|mesh-ancestor
6357546|NCT00081588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6357547|NCT00081614|Bevacizumab|bevacizumab|mesh-list
6357548|NCT00081614|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6357549|NCT00081614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6357550|NCT00081614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6357551|NCT00081614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6357552|NCT00081614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6357553|NCT00081614|Growth Substances|growth substances|mesh-ancestor
6357554|NCT00081614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6357555|NCT00081614|Growth Inhibitors|growth inhibitors|mesh-ancestor
6357556|NCT00081614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6357557|NCT00081614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6357558|NCT00081614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357559|NCT00081744|Tigecycline|tigecycline|mesh-list
6357560|NCT00081744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6357561|NCT00081744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6357562|NCT00081744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6357563|NCT00081744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6357564|NCT00081744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357565|NCT00081757|Thalidomide|thalidomide|mesh-list
6357566|NCT00081757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6357567|NCT00081757|Immunologic Factors|immunologic factors|mesh-ancestor
6357568|NCT00081757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6357569|NCT00081757|Leprostatic Agents|leprostatic agents|mesh-ancestor
6357570|NCT00081757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6357571|NCT00081757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6357572|NCT00081757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6357573|NCT00081757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6357574|NCT00081757|Growth Substances|growth substances|mesh-ancestor
6357575|NCT00081757|Growth Inhibitors|growth inhibitors|mesh-ancestor
6357576|NCT00081757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6357577|NCT00081796|Capecitabine|capecitabine|mesh-list
6357578|NCT00081796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6357579|NCT00081796|Antimetabolites|antimetabolites|mesh-ancestor
6357580|NCT00081796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357581|NCT00081796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6357582|NCT00081822|Cytarabine|cytarabine|mesh-list
6357583|NCT00081822|Clofarabine|clofarabine|mesh-list
6357584|NCT00081822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6357585|NCT00081822|Antimetabolites|antimetabolites|mesh-ancestor
6357586|NCT00081822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357587|NCT00081822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6357588|NCT00081822|Antiviral Agents|antiviral agents|mesh-ancestor
6357589|NCT00081822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6357590|NCT00081822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6357591|NCT00081822|Immunologic Factors|immunologic factors|mesh-ancestor
6357592|NCT00081822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6357593|NCT00081835|Immunoglobulins|immunoglobulins|mesh-list
6357594|NCT00081835|Antibodies|antibodies|mesh-list
6357595|NCT00081835|gamma-Globulins|gamma-globulins|mesh-list
6017156|NCT00369915|Antiemetics|antiemetics|mesh-ancestor
6357596|NCT00081835|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6357597|NCT00081835|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6357598|NCT00081835|Immunologic Factors|immunologic factors|mesh-ancestor
6357599|NCT00081835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6357600|NCT00081848|Metronidazole|metronidazole|mesh-list
6357601|NCT00081848|Celecoxib|celecoxib|mesh-list
6357602|NCT00081848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6357603|NCT00081848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6357604|NCT00081848|Analgesics|analgesics|mesh-ancestor
6357605|NCT00081848|Sensory System Agents|sensory system agents|mesh-ancestor
6357606|NCT00081848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6357607|NCT00081848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6357608|NCT00081848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6357609|NCT00081848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6357610|NCT00081848|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6357611|NCT00081848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6357612|NCT00081848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6357613|NCT00081848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357614|NCT00081848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6357615|NCT00081848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6357616|NCT00081848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6357617|NCT00081848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6357618|NCT00081874|Everolimus|everolimus|mesh-list
6357619|NCT00081874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6357620|NCT00081874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6357621|NCT00081874|Immunologic Factors|immunologic factors|mesh-ancestor
6357622|NCT00081874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6357623|NCT00081887|Clofarabine|clofarabine|mesh-list
6357624|NCT00081887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6357625|NCT00081887|Antimetabolites|antimetabolites|mesh-ancestor
6357626|NCT00081887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357627|NCT00081887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6357628|NCT00081900|N(1),N(11)-diethylnorspermine|n(1),n(11)-diethylnorspermine|mesh-list
6357629|NCT00081900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6357630|NCT00081900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6357631|NCT00081926|Imatinib Mesylate|imatinib mesylate|mesh-list
6357632|NCT00081926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6357633|NCT00081926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6357634|NCT00081926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6357635|NCT00081926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357636|NCT00081978|Etravirine|etravirine|mesh-list
6357637|NCT00081978|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6357638|NCT00081978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6357639|NCT00081978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5724616|NCT03186443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6357640|NCT00081978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357641|NCT00081978|Antiviral Agents|antiviral agents|mesh-ancestor
6357642|NCT00081978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6357643|NCT00082043|Dutasteride|dutasteride|mesh-list
6357644|NCT00082043|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6357645|NCT00082043|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6357646|NCT00082043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6357647|NCT00082043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724617|NCT03186443|Antimanic Agents|antimanic agents|mesh-ancestor
5724618|NCT03186027|Ascorbic Acid|ascorbic acid|mesh-list
5724619|NCT03186027|Coenzyme Q10|coenzyme q10|mesh-list
5724620|NCT03186027|Ubiquinone|ubiquinone|mesh-list
5724621|NCT03186027|Vitamins|vitamins|mesh-ancestor
5724622|NCT03186027|Micronutrients|micronutrients|mesh-ancestor
5724623|NCT03186027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724624|NCT03186027|Antioxidants|antioxidants|mesh-ancestor
5724625|NCT03186027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724626|NCT03186027|Protective Agents|protective agents|mesh-ancestor
5724627|NCT03186131|Vitamin D|vitamin d|mesh-list
5724628|NCT03186131|Ibandronic Acid|ibandronic acid|mesh-list
5724629|NCT03186131|Vitamins|vitamins|mesh-ancestor
5724630|NCT03186131|Micronutrients|micronutrients|mesh-ancestor
5724631|NCT03186131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724632|NCT03186131|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6357648|NCT00082043|Hormone Antagonists|hormone antagonists|mesh-ancestor
6357649|NCT00082043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6357650|NCT00082043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6357651|NCT00082082|Thymalfasin|thymalfasin|mesh-list
6357652|NCT00082082|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6357653|NCT00082082|Immunologic Factors|immunologic factors|mesh-ancestor
6357654|NCT00082082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6357655|NCT00082095|Doxorubicin|doxorubicin|mesh-list
6357656|NCT00082095|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6357657|NCT00082095|Capecitabine|capecitabine|mesh-list
6357658|NCT00082095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6357659|NCT00082095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6357660|NCT00082095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6357661|NCT00082095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6357662|NCT00082095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6357663|NCT00082095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357664|NCT00082095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6357665|NCT00082095|Antimetabolites|antimetabolites|mesh-ancestor
6357666|NCT00082186|Bosentan|bosentan|mesh-list
6357667|NCT00082186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6357668|NCT00082186|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6357669|NCT00082186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357670|NCT00082199|Aripiprazole|aripiprazole|mesh-list
6357671|NCT00082199|Antidepressive Agents|antidepressive agents|mesh-ancestor
6357672|NCT00082199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6357673|NCT00082199|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6357674|NCT00082199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6357675|NCT00082199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6357676|NCT00082199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6357677|NCT00082199|Dopamine Agonists|dopamine agonists|mesh-ancestor
6357678|NCT00082199|Dopamine Agents|dopamine agents|mesh-ancestor
6357679|NCT00082199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6357680|NCT00082199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357681|NCT00082199|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6357682|NCT00082199|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6357683|NCT00082199|Serotonin Agents|serotonin agents|mesh-ancestor
6357684|NCT00082199|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6357685|NCT00082199|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6357686|NCT00082199|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6357687|NCT00082199|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6357688|NCT00082212|Cetuximab|cetuximab|mesh-list
6357689|NCT00082212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6357690|NCT00082212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6357691|NCT00082225|Antibodies|antibodies|mesh-list
6357692|NCT00082225|Immunologic Factors|immunologic factors|mesh-ancestor
6357693|NCT00082225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6357694|NCT00082251|Niacin|niacin|mesh-list
6357695|NCT00082251|Simvastatin|simvastatin|mesh-list
6357696|NCT00082251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6357697|NCT00082251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6357698|NCT00082251|Antimetabolites|antimetabolites|mesh-ancestor
6357699|NCT00082251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357700|NCT00082251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6357701|NCT00082251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6357702|NCT00082251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6357703|NCT00082251|Vasodilator Agents|vasodilator agents|mesh-ancestor
6357704|NCT00082251|Vitamin B Complex|vitamin b complex|mesh-ancestor
6357705|NCT00082251|Vitamins|vitamins|mesh-ancestor
6357706|NCT00082251|Micronutrients|micronutrients|mesh-ancestor
6357707|NCT00082251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6357708|NCT00082277|Risedronic Acid|risedronic acid|mesh-list
6357709|NCT00082277|Anastrozole|anastrozole|mesh-list
6357710|NCT00082277|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6357711|NCT00082277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6357712|NCT00082277|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6357713|NCT00082277|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6357714|NCT00082277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6357715|NCT00082277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357716|NCT00082277|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6357717|NCT00082277|Hormone Antagonists|hormone antagonists|mesh-ancestor
6357718|NCT00082277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6357719|NCT00082277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6357720|NCT00082277|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6394679|NCT00203034|Protective Agents|protective agents|mesh-ancestor
6357721|NCT00082277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6357722|NCT00082277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6357723|NCT00082277|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6357724|NCT00082316|Capsaicin|capsaicin|mesh-list
6357725|NCT00082316|Antipruritics|antipruritics|mesh-ancestor
6357726|NCT00082316|Dermatologic Agents|dermatologic agents|mesh-ancestor
6357727|NCT00082316|Sensory System Agents|sensory system agents|mesh-ancestor
6357728|NCT00082316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6357729|NCT00082316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6357730|NCT00082394|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6357731|NCT00082394|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6357732|NCT00082394|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6357733|NCT00082394|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6357734|NCT00082394|Protease Inhibitors|protease inhibitors|mesh-ancestor
6357735|NCT00082394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6357736|NCT00082394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357737|NCT00082394|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6357738|NCT00082394|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6357739|NCT00082394|Antiviral Agents|antiviral agents|mesh-ancestor
6357740|NCT00082394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6357741|NCT00082394|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6357742|NCT00082394|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6357743|NCT00082446|Vaccines|vaccines|mesh-list
6357744|NCT00082446|Immunologic Factors|immunologic factors|mesh-ancestor
6357745|NCT00082446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6357746|NCT00082472|Docetaxel|docetaxel|mesh-list
6357747|NCT00082472|Doxorubicin|doxorubicin|mesh-list
6357748|NCT00082472|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6357749|NCT00082472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6357750|NCT00082472|Tubulin Modulators|tubulin modulators|mesh-ancestor
6357751|NCT00082472|Antimitotic Agents|antimitotic agents|mesh-ancestor
6357752|NCT00082472|Mitosis Modulators|mitosis modulators|mesh-ancestor
6357753|NCT00082472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357754|NCT00082472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6357755|NCT00082472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6357756|NCT00082472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6357757|NCT00082472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6357758|NCT00082485|Baclofen|baclofen|mesh-list
6357759|NCT00082485|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6357760|NCT00082485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6357761|NCT00082485|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6357762|NCT00082485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6357763|NCT00082485|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6357764|NCT00082485|GABA Agonists|gaba agonists|mesh-ancestor
6357765|NCT00082485|GABA Agents|gaba agents|mesh-ancestor
6357766|NCT00082485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6357767|NCT00082485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357768|NCT00082511|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
6357769|NCT00082511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6357770|NCT00082511|Immunologic Factors|immunologic factors|mesh-ancestor
6357771|NCT00082511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6357772|NCT00082524|Caspofungin|caspofungin|mesh-list
6357773|NCT00082524|Antifungal Agents|antifungal agents|mesh-ancestor
6357774|NCT00082524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6357775|NCT00082524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6357776|NCT00082524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357777|NCT00082537|Caspofungin|caspofungin|mesh-list
6357778|NCT00082537|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6357779|NCT00082537|Antifungal Agents|antifungal agents|mesh-ancestor
6357780|NCT00082537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6357781|NCT00082537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6357782|NCT00082537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357783|NCT00082537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6357784|NCT00082537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6357785|NCT00082563|Azithromycin|azithromycin|mesh-list
6357786|NCT00082563|Chloroquine|chloroquine|mesh-list
6357787|NCT00082563|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
6357788|NCT00082563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6357789|NCT00082563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6357790|NCT00082563|Amebicides|amebicides|mesh-ancestor
6357791|NCT00082563|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6357792|NCT00082563|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6357793|NCT00082563|Antimalarials|antimalarials|mesh-ancestor
6357794|NCT00082563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6357795|NCT00082563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6357796|NCT00082563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6357797|NCT00082563|Analgesics|analgesics|mesh-ancestor
6357798|NCT00082563|Sensory System Agents|sensory system agents|mesh-ancestor
6357799|NCT00082563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6357800|NCT00082563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6357801|NCT00082563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6357802|NCT00082563|Filaricides|filaricides|mesh-ancestor
6357803|NCT00082563|Antinematodal Agents|antinematodal agents|mesh-ancestor
6357804|NCT00082563|Anthelmintics|anthelmintics|mesh-ancestor
6357805|NCT00082576|Azithromycin|azithromycin|mesh-list
6357806|NCT00082576|Chloroquine|chloroquine|mesh-list
6357807|NCT00082576|Mefloquine|mefloquine|mesh-list
6357808|NCT00082576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6357809|NCT00082576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6357810|NCT00082576|Amebicides|amebicides|mesh-ancestor
6357811|NCT00082576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6357812|NCT00082576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6357813|NCT00082576|Antimalarials|antimalarials|mesh-ancestor
6357814|NCT00082576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6357815|NCT00082589|Eplerenone|eplerenone|mesh-list
6357816|NCT00082589|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6357817|NCT00082589|Hormone Antagonists|hormone antagonists|mesh-ancestor
6357818|NCT00082589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6357819|NCT00082589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6357820|NCT00082589|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6357821|NCT00082589|Diuretics|diuretics|mesh-ancestor
6357822|NCT00082589|Natriuretic Agents|natriuretic agents|mesh-ancestor
6357823|NCT00082589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6357824|NCT00082602|Galantamine|galantamine|mesh-list
6357825|NCT00082602|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6357826|NCT00082602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6357827|NCT00082602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357828|NCT00082602|Cholinergic Agents|cholinergic agents|mesh-ancestor
6357829|NCT00082602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6357830|NCT00082602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6357831|NCT00082602|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6357832|NCT00082602|Autonomic Agents|autonomic agents|mesh-ancestor
6357833|NCT00082602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6357834|NCT00082602|Nootropic Agents|nootropic agents|mesh-ancestor
6357835|NCT00082667|Gefitinib|gefitinib|mesh-list
6357836|NCT00082667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6357837|NCT00082667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6357838|NCT00082667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6357839|NCT00082667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357840|NCT00082706|Leucovorin|leucovorin|mesh-list
6357841|NCT00082706|Gemcitabine|gemcitabine|mesh-list
6357842|NCT00082706|Cisplatin|cisplatin|mesh-list
6357843|NCT00082706|Fluorouracil|fluorouracil|mesh-list
6357844|NCT00082706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6357845|NCT00082706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6357846|NCT00082706|Antimetabolites|antimetabolites|mesh-ancestor
6357847|NCT00082706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357848|NCT00082706|Antiviral Agents|antiviral agents|mesh-ancestor
6357849|NCT00082706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6357850|NCT00082706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6357851|NCT00082706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6357852|NCT00082706|Immunologic Factors|immunologic factors|mesh-ancestor
6357853|NCT00082706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6357854|NCT00082706|Antidotes|antidotes|mesh-ancestor
6357855|NCT00082706|Protective Agents|protective agents|mesh-ancestor
6357856|NCT00082706|Vitamin B Complex|vitamin b complex|mesh-ancestor
6357857|NCT00082706|Vitamins|vitamins|mesh-ancestor
6357858|NCT00082706|Micronutrients|micronutrients|mesh-ancestor
6357859|NCT00082719|Interferons|interferons|mesh-list
6357860|NCT00082719|Interferon-alpha|interferon-alpha|mesh-list
6357861|NCT00082719|Interferon alpha-2|interferon alpha-2|mesh-list
6357862|NCT00082719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6357863|NCT00082719|Antiviral Agents|antiviral agents|mesh-ancestor
6357864|NCT00082719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6357865|NCT00082719|Immunologic Factors|immunologic factors|mesh-ancestor
6357866|NCT00082719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6357867|NCT00082784|Bortezomib|bortezomib|mesh-list
6357868|NCT00082784|Alvocidib|alvocidib|mesh-list
6357869|NCT00082784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6357870|NCT00082784|Growth Inhibitors|growth inhibitors|mesh-ancestor
6357871|NCT00082784|Growth Substances|growth substances|mesh-ancestor
6357872|NCT00082784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6357873|NCT00082784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6357874|NCT00082784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6357875|NCT00082784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357876|NCT00082797|Leucovorin|leucovorin|mesh-list
6357877|NCT00082797|Methotrexate|methotrexate|mesh-list
6357878|NCT00082797|Calcium|calcium|mesh-list
6357879|NCT00082797|Levoleucovorin|levoleucovorin|mesh-list
6357880|NCT00082797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6357881|NCT00082797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6357882|NCT00082797|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6357883|NCT00082797|Abortifacient Agents|abortifacient agents|mesh-ancestor
6357884|NCT00082797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6357885|NCT00082797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6357886|NCT00082797|Antimetabolites|antimetabolites|mesh-ancestor
6357887|NCT00082797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357888|NCT00082797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6357889|NCT00082797|Dermatologic Agents|dermatologic agents|mesh-ancestor
6357890|NCT00082797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6357891|NCT00082797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6357892|NCT00082797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6357893|NCT00082797|Immunologic Factors|immunologic factors|mesh-ancestor
6357894|NCT00082797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6357895|NCT00082797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6357896|NCT00082797|Antidotes|antidotes|mesh-ancestor
6357897|NCT00082797|Protective Agents|protective agents|mesh-ancestor
6357898|NCT00082797|Vitamin B Complex|vitamin b complex|mesh-ancestor
6357899|NCT00082797|Vitamins|vitamins|mesh-ancestor
6357900|NCT00082797|Micronutrients|micronutrients|mesh-ancestor
6357901|NCT00082823|Aflibercept|aflibercept|mesh-list
6357902|NCT00082823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6357903|NCT00082823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6357904|NCT00082823|Growth Substances|growth substances|mesh-ancestor
6357905|NCT00082823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6357906|NCT00082823|Growth Inhibitors|growth inhibitors|mesh-ancestor
6357907|NCT00082823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6357908|NCT00082836|Rituximab|rituximab|mesh-list
6357909|NCT00082836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6357910|NCT00082836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6357911|NCT00082836|Immunologic Factors|immunologic factors|mesh-ancestor
6357912|NCT00082836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6357913|NCT00082836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6357914|NCT00082862|Gemcitabine|gemcitabine|mesh-list
6357915|NCT00082862|Interferons|interferons|mesh-list
6357916|NCT00082862|Interferon-alpha|interferon-alpha|mesh-list
6357917|NCT00082862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6357918|NCT00082862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6357919|NCT00082862|Antimetabolites|antimetabolites|mesh-ancestor
6357920|NCT00082862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357921|NCT00082862|Antiviral Agents|antiviral agents|mesh-ancestor
6357922|NCT00082862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6357923|NCT00082862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6357924|NCT00082862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6357925|NCT00082862|Immunologic Factors|immunologic factors|mesh-ancestor
6357926|NCT00082862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6357927|NCT00082914|Denileukin diftitox|denileukin diftitox|mesh-list
6357928|NCT00082914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6357929|NCT00082927|Ibandronic Acid|ibandronic acid|mesh-list
6357930|NCT00082927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6357931|NCT00082927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6357932|NCT00082940|Denileukin diftitox|denileukin diftitox|mesh-list
6357933|NCT00082940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6357934|NCT00082966|Bortezomib|bortezomib|mesh-list
6357935|NCT00082966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6357936|NCT00083005|Thalidomide|thalidomide|mesh-list
6357937|NCT00083005|Docetaxel|docetaxel|mesh-list
6357938|NCT00083005|Estramustine|estramustine|mesh-list
6357939|NCT00083005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6357940|NCT00083005|Tubulin Modulators|tubulin modulators|mesh-ancestor
6357941|NCT00083005|Antimitotic Agents|antimitotic agents|mesh-ancestor
6357942|NCT00083005|Mitosis Modulators|mitosis modulators|mesh-ancestor
6357943|NCT00083005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357944|NCT00083005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6357945|NCT00083005|Immunologic Factors|immunologic factors|mesh-ancestor
6357946|NCT00083005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6357947|NCT00083005|Leprostatic Agents|leprostatic agents|mesh-ancestor
6357948|NCT00083005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6357949|NCT00083005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6357950|NCT00083005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6357951|NCT00083005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6357952|NCT00083005|Growth Substances|growth substances|mesh-ancestor
6357953|NCT00083005|Growth Inhibitors|growth inhibitors|mesh-ancestor
6357954|NCT00083005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6357955|NCT00083005|Alkylating Agents|alkylating agents|mesh-ancestor
6357956|NCT00083005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6357957|NCT00083031|Cyclophosphamide|cyclophosphamide|mesh-list
6357958|NCT00083031|Bevacizumab|bevacizumab|mesh-list
6357959|NCT00083031|Methotrexate|methotrexate|mesh-list
6357960|NCT00083031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6357961|NCT00083031|Immunologic Factors|immunologic factors|mesh-ancestor
6357962|NCT00083031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6357963|NCT00083031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6357964|NCT00083031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6357965|NCT00083031|Alkylating Agents|alkylating agents|mesh-ancestor
6357966|NCT00083031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357967|NCT00083031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6357968|NCT00083031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6357969|NCT00083031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6357970|NCT00083031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6357971|NCT00083031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6357972|NCT00083031|Growth Substances|growth substances|mesh-ancestor
6357973|NCT00083031|Growth Inhibitors|growth inhibitors|mesh-ancestor
6357974|NCT00083031|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6357975|NCT00083031|Abortifacient Agents|abortifacient agents|mesh-ancestor
6357976|NCT00083031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6357977|NCT00083031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6357978|NCT00083031|Antimetabolites|antimetabolites|mesh-ancestor
6357979|NCT00083031|Dermatologic Agents|dermatologic agents|mesh-ancestor
6357980|NCT00083031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6357981|NCT00083031|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6357982|NCT00083031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6357983|NCT00083057|Paclitaxel|paclitaxel|mesh-list
6357984|NCT00083057|Gefitinib|gefitinib|mesh-list
6357985|NCT00083057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6357986|NCT00083057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6357987|NCT00083057|Tubulin Modulators|tubulin modulators|mesh-ancestor
6357988|NCT00083057|Antimitotic Agents|antimitotic agents|mesh-ancestor
6357989|NCT00083057|Mitosis Modulators|mitosis modulators|mesh-ancestor
6357990|NCT00083057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357991|NCT00083057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6357992|NCT00083057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6357993|NCT00083070|Temozolomide|temozolomide|mesh-list
6357994|NCT00083070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6357995|NCT00083070|Alkylating Agents|alkylating agents|mesh-ancestor
6357996|NCT00083070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6357997|NCT00083070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6357998|NCT00083083|Paclitaxel|paclitaxel|mesh-list
6357999|NCT00083083|Etoposide|etoposide|mesh-list
6358000|NCT00083083|Vinorelbine|vinorelbine|mesh-list
6358001|NCT00083083|Vinblastine|vinblastine|mesh-list
6358002|NCT00083083|Docetaxel|docetaxel|mesh-list
6358003|NCT00083083|Carboplatin|carboplatin|mesh-list
6358004|NCT00083083|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6358005|NCT00083083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6358006|NCT00083083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358007|NCT00083083|Tubulin Modulators|tubulin modulators|mesh-ancestor
6358008|NCT00083083|Antimitotic Agents|antimitotic agents|mesh-ancestor
6358009|NCT00083083|Mitosis Modulators|mitosis modulators|mesh-ancestor
6358010|NCT00083083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358011|NCT00083083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6358012|NCT00083083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6358013|NCT00083083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6358014|NCT00083083|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6394680|NCT00203034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394681|NCT00203060|Rasagiline|rasagiline|mesh-list
6394682|NCT00203060|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6394683|NCT00203060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6394684|NCT00203060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394685|NCT00203060|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6394686|NCT00203060|Protective Agents|protective agents|mesh-ancestor
6394687|NCT00203060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394688|NCT00203073|Mitoxantrone|mitoxantrone|mesh-list
6394689|NCT00203073|Glatiramer Acetate|glatiramer acetate|mesh-list
6394690|NCT00203073|(T,G)-A-L|(t,g)-a-l|mesh-list
6394691|NCT00203073|Analgesics|analgesics|mesh-ancestor
6394692|NCT00203073|Sensory System Agents|sensory system agents|mesh-ancestor
6394693|NCT00203073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6394694|NCT00203073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394695|NCT00203073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6394696|NCT00203073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6394697|NCT00203073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6394698|NCT00203073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6394699|NCT00203073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394700|NCT00203073|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6394701|NCT00203073|Immunologic Factors|immunologic factors|mesh-ancestor
6394702|NCT00203073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6394703|NCT00203073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6394704|NCT00203099|Acetylcysteine|acetylcysteine|mesh-list
6394705|NCT00203099|Glatiramer Acetate|glatiramer acetate|mesh-list
6394706|NCT00203099|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6394707|NCT00203099|(T,G)-A-L|(t,g)-a-l|mesh-list
6358015|NCT00083096|Temozolomide|temozolomide|mesh-list
6358016|NCT00083096|Lonafarnib|lonafarnib|mesh-list
6358017|NCT00083096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6358018|NCT00083096|Alkylating Agents|alkylating agents|mesh-ancestor
6358019|NCT00083096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358020|NCT00083096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358021|NCT00083096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6358022|NCT00083109|Suramin|suramin|mesh-list
6358023|NCT00083109|Fluorouracil|fluorouracil|mesh-list
6358024|NCT00083109|Antimetabolites|antimetabolites|mesh-ancestor
6358025|NCT00083109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358026|NCT00083109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6358027|NCT00083109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358028|NCT00083109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6358029|NCT00083109|Immunologic Factors|immunologic factors|mesh-ancestor
6358030|NCT00083109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6358031|NCT00083109|Antinematodal Agents|antinematodal agents|mesh-ancestor
6358032|NCT00083109|Anthelmintics|anthelmintics|mesh-ancestor
6358033|NCT00083109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6358034|NCT00083109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6358035|NCT00083109|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6358036|NCT00083109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6358037|NCT00083135|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
6358038|NCT00083135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358039|NCT00083135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6358040|NCT00083135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358041|NCT00083135|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6358042|NCT00083148|Capecitabine|capecitabine|mesh-list
6358043|NCT00083148|Irinotecan|irinotecan|mesh-list
6358044|NCT00083148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6358045|NCT00083148|Antimetabolites|antimetabolites|mesh-ancestor
6358046|NCT00083148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358047|NCT00083148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358048|NCT00083148|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6358049|NCT00083148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6358050|NCT00083148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6358051|NCT00083161|Cyclophosphamide|cyclophosphamide|mesh-list
6358052|NCT00083161|Etoposide|etoposide|mesh-list
6358053|NCT00083161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6358054|NCT00083161|Immunologic Factors|immunologic factors|mesh-ancestor
6358055|NCT00083161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6358056|NCT00083161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6358057|NCT00083161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6358058|NCT00083161|Alkylating Agents|alkylating agents|mesh-ancestor
6358059|NCT00083161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358060|NCT00083161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358061|NCT00083161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6358062|NCT00083161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6358063|NCT00083161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6358064|NCT00083161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6358065|NCT00083161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6358066|NCT00083187|Hydroxyurea|hydroxyurea|mesh-list
6358067|NCT00083187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358068|NCT00083187|Antisickling Agents|antisickling agents|mesh-ancestor
6358069|NCT00083187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6358070|NCT00083187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358071|NCT00083187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6358072|NCT00083213|Aflibercept|aflibercept|mesh-list
6358073|NCT00083213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6358074|NCT00083213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6358075|NCT00083213|Growth Substances|growth substances|mesh-ancestor
6358076|NCT00083213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6358077|NCT00083213|Growth Inhibitors|growth inhibitors|mesh-ancestor
6358078|NCT00083213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358079|NCT00083252|Cisplatin|cisplatin|mesh-list
6358080|NCT00083252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358081|NCT00083278|Ipilimumab|ipilimumab|mesh-list
6358082|NCT00083278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6358083|NCT00083278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358084|NCT00083278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6358085|NCT00083278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358086|NCT00083304|Efaproxiral|efaproxiral|mesh-list
6358087|NCT00083304|Antisickling Agents|antisickling agents|mesh-ancestor
6358088|NCT00083343|Caspofungin|caspofungin|mesh-list
6358089|NCT00083343|Antifungal Agents|antifungal agents|mesh-ancestor
6358090|NCT00083343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6358091|NCT00083343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6358092|NCT00083343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358093|NCT00083408|Pamidronate|pamidronate|mesh-list
6358094|NCT00083408|Thalidomide|thalidomide|mesh-list
6358095|NCT00083408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6358096|NCT00083408|Immunologic Factors|immunologic factors|mesh-ancestor
6358097|NCT00083408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6358098|NCT00083408|Leprostatic Agents|leprostatic agents|mesh-ancestor
6358099|NCT00083408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6358100|NCT00083408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6358101|NCT00083408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6358102|NCT00083408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6358103|NCT00083408|Growth Substances|growth substances|mesh-ancestor
6358104|NCT00083408|Growth Inhibitors|growth inhibitors|mesh-ancestor
6358105|NCT00083408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358106|NCT00083408|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6358107|NCT00083434|Epoetin Alfa|epoetin alfa|mesh-list
6358108|NCT00083434|Hematinics|hematinics|mesh-ancestor
6358109|NCT00083460|Thalidomide|thalidomide|mesh-list
6358110|NCT00083460|Dexamethasone|dexamethasone|mesh-list
6358111|NCT00083460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6358112|NCT00083460|Antiemetics|antiemetics|mesh-ancestor
6358113|NCT00083460|Autonomic Agents|autonomic agents|mesh-ancestor
6358114|NCT00083460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6358115|NCT00083460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6358116|NCT00083460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6358117|NCT00083460|Glucocorticoids|glucocorticoids|mesh-ancestor
6358118|NCT00083460|Hormones|hormones|mesh-ancestor
6358119|NCT00083460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6358120|NCT00083460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6358121|NCT00083460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358122|NCT00083460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6358123|NCT00083460|Immunologic Factors|immunologic factors|mesh-ancestor
6358124|NCT00083460|Leprostatic Agents|leprostatic agents|mesh-ancestor
6358125|NCT00083460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6358126|NCT00083460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6358127|NCT00083460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6358128|NCT00083460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6358129|NCT00083460|Growth Substances|growth substances|mesh-ancestor
6017157|NCT00369915|Autonomic Agents|autonomic agents|mesh-ancestor
6017158|NCT00369915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6017159|NCT00369915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017160|NCT00369915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6017161|NCT00369915|Mydriatics|mydriatics|mesh-ancestor
6017162|NCT00369915|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6358130|NCT00083460|Growth Inhibitors|growth inhibitors|mesh-ancestor
6358131|NCT00083486|Epoetin Alfa|epoetin alfa|mesh-list
6358132|NCT00083486|Hematinics|hematinics|mesh-ancestor
6358133|NCT00083525|Capecitabine|capecitabine|mesh-list
6358134|NCT00083525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6358135|NCT00083525|Antimetabolites|antimetabolites|mesh-ancestor
6358136|NCT00083525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358137|NCT00083525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358138|NCT00083538|Thalidomide|thalidomide|mesh-list
6358139|NCT00083538|Dexamethasone|dexamethasone|mesh-list
6358140|NCT00083538|Cyclophosphamide|cyclophosphamide|mesh-list
6358141|NCT00083538|Etoposide|etoposide|mesh-list
6358142|NCT00083538|Doxorubicin|doxorubicin|mesh-list
6358143|NCT00083538|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6358144|NCT00083538|Cisplatin|cisplatin|mesh-list
6358145|NCT00083538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6358146|NCT00083538|Immunologic Factors|immunologic factors|mesh-ancestor
6358147|NCT00083538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6358148|NCT00083538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6358149|NCT00083538|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6358150|NCT00083538|Alkylating Agents|alkylating agents|mesh-ancestor
6358151|NCT00083538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358152|NCT00083538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358153|NCT00083538|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6358154|NCT00083538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6358155|NCT00083538|Antiemetics|antiemetics|mesh-ancestor
6358156|NCT00083538|Autonomic Agents|autonomic agents|mesh-ancestor
6358157|NCT00083538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6358158|NCT00083538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6358159|NCT00083538|Glucocorticoids|glucocorticoids|mesh-ancestor
6358160|NCT00083538|Hormones|hormones|mesh-ancestor
6358161|NCT00083538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6358162|NCT00083538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6358163|NCT00083538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6358164|NCT00083538|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6358165|NCT00083538|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6358166|NCT00083538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6358167|NCT00083538|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6358168|NCT00083538|Leprostatic Agents|leprostatic agents|mesh-ancestor
6358169|NCT00083538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6358170|NCT00083538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6358171|NCT00083538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6358172|NCT00083538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6358173|NCT00083538|Growth Substances|growth substances|mesh-ancestor
6358174|NCT00083538|Growth Inhibitors|growth inhibitors|mesh-ancestor
6358175|NCT00083577|Thalidomide|thalidomide|mesh-list
6358176|NCT00083577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6358177|NCT00083577|Immunologic Factors|immunologic factors|mesh-ancestor
6358178|NCT00083577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6358179|NCT00083577|Leprostatic Agents|leprostatic agents|mesh-ancestor
6358180|NCT00083577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6358181|NCT00083577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6358182|NCT00083577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6358183|NCT00083577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6358184|NCT00083577|Growth Substances|growth substances|mesh-ancestor
6358185|NCT00083577|Growth Inhibitors|growth inhibitors|mesh-ancestor
6358186|NCT00083577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358187|NCT00083590|Huperzine A|huperzine a|mesh-list
6358188|NCT00083590|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6358189|NCT00083590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6358190|NCT00083590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358191|NCT00083590|Cholinergic Agents|cholinergic agents|mesh-ancestor
6358192|NCT00083590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6358193|NCT00083590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6358194|NCT00083590|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6358195|NCT00083590|Protective Agents|protective agents|mesh-ancestor
6358196|NCT00083668|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6358197|NCT00083668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6358198|NCT00083668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6358199|NCT00083668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6394708|NCT00203099|Antiviral Agents|antiviral agents|mesh-ancestor
6358200|NCT00083668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6358201|NCT00083668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6358202|NCT00083668|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6358203|NCT00083668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6358204|NCT00083668|Serotonin Agents|serotonin agents|mesh-ancestor
6358205|NCT00083668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6358206|NCT00083668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358207|NCT00083668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6358208|NCT00083668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6358209|NCT00083668|Dopamine Agents|dopamine agents|mesh-ancestor
6358210|NCT00083681|Thalidomide|thalidomide|mesh-list
6358211|NCT00083681|Dexamethasone|dexamethasone|mesh-list
6017163|NCT00369915|Cholinergic Agents|cholinergic agents|mesh-ancestor
6017164|NCT00369915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6017165|NCT00369915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017166|NCT00369915|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6017167|NCT00369915|Parasympatholytics|parasympatholytics|mesh-ancestor
6017168|NCT00369941|Tenofovir|tenofovir|mesh-list
6017169|NCT00369941|Emtricitabine|emtricitabine|mesh-list
6358212|NCT00083681|Etoposide|etoposide|mesh-list
6358213|NCT00083681|Cyclophosphamide|cyclophosphamide|mesh-list
6358214|NCT00083681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358215|NCT00083681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6358216|NCT00083681|Antiemetics|antiemetics|mesh-ancestor
6358217|NCT00083681|Autonomic Agents|autonomic agents|mesh-ancestor
6358218|NCT00083681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6358219|NCT00083681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6358220|NCT00083681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6358221|NCT00083681|Glucocorticoids|glucocorticoids|mesh-ancestor
6358222|NCT00083681|Hormones|hormones|mesh-ancestor
6358223|NCT00083681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6358224|NCT00083681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6358225|NCT00083681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6358226|NCT00083681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6358227|NCT00083681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6358228|NCT00083681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6358229|NCT00083681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358230|NCT00083681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6358231|NCT00083681|Immunologic Factors|immunologic factors|mesh-ancestor
6017170|NCT00369941|Efavirenz|efavirenz|mesh-list
6017171|NCT00369941|Raltegravir Potassium|raltegravir potassium|mesh-list
6017172|NCT00369941|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6358232|NCT00083681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6358233|NCT00083681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6358234|NCT00083681|Alkylating Agents|alkylating agents|mesh-ancestor
6358235|NCT00083681|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6358236|NCT00083681|Leprostatic Agents|leprostatic agents|mesh-ancestor
6358237|NCT00083681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6358238|NCT00083681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6358239|NCT00083681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6358240|NCT00083681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6358241|NCT00083681|Growth Substances|growth substances|mesh-ancestor
6358242|NCT00083681|Growth Inhibitors|growth inhibitors|mesh-ancestor
6358243|NCT00083694|Thalidomide|thalidomide|mesh-list
6358244|NCT00083694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6358245|NCT00083694|Immunologic Factors|immunologic factors|mesh-ancestor
6358246|NCT00083694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6358247|NCT00083694|Leprostatic Agents|leprostatic agents|mesh-ancestor
6358248|NCT00083694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6358249|NCT00083694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6358250|NCT00083694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6358251|NCT00083694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6358252|NCT00083694|Growth Substances|growth substances|mesh-ancestor
6358253|NCT00083694|Growth Inhibitors|growth inhibitors|mesh-ancestor
6358254|NCT00083694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358255|NCT00083707|Thalidomide|thalidomide|mesh-list
6358256|NCT00083707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6358257|NCT00083707|Immunologic Factors|immunologic factors|mesh-ancestor
6358258|NCT00083707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6358259|NCT00083707|Leprostatic Agents|leprostatic agents|mesh-ancestor
6358260|NCT00083707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6358261|NCT00083707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6358262|NCT00083707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6358263|NCT00083707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6358264|NCT00083707|Growth Substances|growth substances|mesh-ancestor
6358265|NCT00083707|Growth Inhibitors|growth inhibitors|mesh-ancestor
6358266|NCT00083707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358267|NCT00083772|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6358268|NCT00083772|Natriuretic Agents|natriuretic agents|mesh-ancestor
6358269|NCT00083772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6358270|NCT00083785|Talaporfin|talaporfin|mesh-list
6358271|NCT00083785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358272|NCT00083785|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6358273|NCT00083785|Dermatologic Agents|dermatologic agents|mesh-ancestor
6358274|NCT00083824|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6358275|NCT00083824|Medroxyprogesterone|medroxyprogesterone|mesh-list
6358276|NCT00083824|Estrogens|estrogens|mesh-list
6358277|NCT00083824|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6358278|NCT00083824|Hormones|hormones|mesh-ancestor
6358279|NCT00083824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6358280|NCT00083824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6358281|NCT00083824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6358282|NCT00083824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6358283|NCT00083824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6358284|NCT00083824|Contraceptive Agents|contraceptive agents|mesh-ancestor
6358285|NCT00083824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6358286|NCT00083824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6358287|NCT00083824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6358288|NCT00083824|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6358289|NCT00083824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6358290|NCT00083824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358291|NCT00083876|Thalidomide|thalidomide|mesh-list
6358292|NCT00083876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6358293|NCT00083876|Immunologic Factors|immunologic factors|mesh-ancestor
6358294|NCT00083876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6358295|NCT00083876|Leprostatic Agents|leprostatic agents|mesh-ancestor
6358296|NCT00083876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6358297|NCT00083876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6358298|NCT00083876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6358299|NCT00083876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6358300|NCT00083876|Growth Substances|growth substances|mesh-ancestor
6358301|NCT00083876|Growth Inhibitors|growth inhibitors|mesh-ancestor
6358302|NCT00083876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358303|NCT00083902|Thalidomide|thalidomide|mesh-list
6358304|NCT00083902|Dexamethasone|dexamethasone|mesh-list
6358305|NCT00083902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6358306|NCT00083902|Antiemetics|antiemetics|mesh-ancestor
6358307|NCT00083902|Autonomic Agents|autonomic agents|mesh-ancestor
6358308|NCT00083902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6358309|NCT00083902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6358310|NCT00083902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6358311|NCT00083902|Glucocorticoids|glucocorticoids|mesh-ancestor
6358312|NCT00083902|Hormones|hormones|mesh-ancestor
6358313|NCT00083902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6358314|NCT00083902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6358315|NCT00083902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358316|NCT00083902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6358317|NCT00083902|Immunologic Factors|immunologic factors|mesh-ancestor
6358318|NCT00083902|Leprostatic Agents|leprostatic agents|mesh-ancestor
6358319|NCT00083902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6358320|NCT00083902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6358321|NCT00083902|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6358322|NCT00083902|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6358323|NCT00083902|Growth Substances|growth substances|mesh-ancestor
6358324|NCT00083902|Growth Inhibitors|growth inhibitors|mesh-ancestor
6358325|NCT00083954|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6358326|NCT00083954|Antidepressive Agents|antidepressive agents|mesh-ancestor
6358327|NCT00083954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6358328|NCT00083954|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6358329|NCT00083954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6358330|NCT00083954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6358331|NCT00083954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6358332|NCT00083980|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6358333|NCT00083980|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6358334|NCT00083980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6358335|NCT00083980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6358336|NCT00083980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358337|NCT00083980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6358338|NCT00083980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6358339|NCT00083980|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6358340|NCT00083980|Antidepressive Agents|antidepressive agents|mesh-ancestor
6358341|NCT00083980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6358342|NCT00083993|Sirolimus|sirolimus|mesh-list
6358343|NCT00083993|Letrozole|letrozole|mesh-list
6358344|NCT00083993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358345|NCT00083993|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6358346|NCT00083993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6358347|NCT00083993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6358348|NCT00083993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358349|NCT00083993|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6358350|NCT00083993|Hormone Antagonists|hormone antagonists|mesh-ancestor
6358351|NCT00083993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6358352|NCT00083993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6358353|NCT00083993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6358354|NCT00083993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6358355|NCT00083993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6358356|NCT00083993|Antifungal Agents|antifungal agents|mesh-ancestor
6358357|NCT00083993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6358358|NCT00083993|Immunologic Factors|immunologic factors|mesh-ancestor
6358359|NCT00084019|Ritonavir|ritonavir|mesh-list
6358360|NCT00084019|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6358361|NCT00084019|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6358362|NCT00084019|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6358363|NCT00084019|Protease Inhibitors|protease inhibitors|mesh-ancestor
6358364|NCT00084019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6358365|NCT00084019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358366|NCT00084019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6358367|NCT00084019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6358368|NCT00084019|Antiviral Agents|antiviral agents|mesh-ancestor
6358369|NCT00084019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6358370|NCT00084019|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6358371|NCT00084019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6358372|NCT00084032|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6358373|NCT00084032|Antiviral Agents|antiviral agents|mesh-ancestor
6358374|NCT00084032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6358375|NCT00084058|Ritonavir|ritonavir|mesh-list
6358376|NCT00084058|Lopinavir|lopinavir|mesh-list
6358377|NCT00084058|Saquinavir|saquinavir|mesh-list
6358378|NCT00084058|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6358379|NCT00084058|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6358380|NCT00084058|Protease Inhibitors|protease inhibitors|mesh-ancestor
6358381|NCT00084058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5724633|NCT03186040|Lacosamide|lacosamide|mesh-list
6358382|NCT00084058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358383|NCT00084058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6358384|NCT00084058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6358385|NCT00084058|Antiviral Agents|antiviral agents|mesh-ancestor
6358386|NCT00084058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6017173|NCT00369941|Antiviral Agents|antiviral agents|mesh-ancestor
6017174|NCT00369941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6017175|NCT00369941|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6017176|NCT00369941|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6017177|NCT00369941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6018496|NCT00381095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6358387|NCT00084058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6358388|NCT00084058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6358389|NCT00084097|Omalizumab|omalizumab|mesh-list
6358390|NCT00084097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6358391|NCT00084097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6358392|NCT00084097|Respiratory System Agents|respiratory system agents|mesh-ancestor
6358393|NCT00084201|Amoxicillin|amoxicillin|mesh-list
6358394|NCT00084201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6358395|NCT00084201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6358396|NCT00084214|Paclitaxel|paclitaxel|mesh-list
6358397|NCT00084214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6358398|NCT00084214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358399|NCT00084214|Tubulin Modulators|tubulin modulators|mesh-ancestor
6358400|NCT00084214|Antimitotic Agents|antimitotic agents|mesh-ancestor
6358401|NCT00084214|Mitosis Modulators|mitosis modulators|mesh-ancestor
6358402|NCT00084214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358403|NCT00084227|Azithromycin|azithromycin|mesh-list
6358404|NCT00084227|Chloroquine|chloroquine|mesh-list
6358405|NCT00084227|Atovaquone|atovaquone|mesh-list
6358406|NCT00084227|Proguanil|proguanil|mesh-list
6358407|NCT00084227|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
6358408|NCT00084227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6358409|NCT00084227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6358410|NCT00084227|Amebicides|amebicides|mesh-ancestor
6358411|NCT00084227|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6358412|NCT00084227|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6358413|NCT00084227|Antimalarials|antimalarials|mesh-ancestor
6358414|NCT00084227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6358415|NCT00084227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6358416|NCT00084227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358417|NCT00084227|Antimetabolites|antimetabolites|mesh-ancestor
6358418|NCT00084240|Azithromycin|azithromycin|mesh-list
6358419|NCT00084240|Chloroquine|chloroquine|mesh-list
6358420|NCT00084240|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
6358421|NCT00084240|Pyrimethamine|pyrimethamine|mesh-list
6358422|NCT00084240|Sulfadoxine|sulfadoxine|mesh-list
6358423|NCT00084240|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6358424|NCT00084240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6358425|NCT00084240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6358426|NCT00084240|Amebicides|amebicides|mesh-ancestor
6358427|NCT00084240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6358428|NCT00084240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6358429|NCT00084240|Antimalarials|antimalarials|mesh-ancestor
6358430|NCT00084240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6358431|NCT00084240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6358432|NCT00084240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6358433|NCT00084240|Analgesics|analgesics|mesh-ancestor
6358434|NCT00084240|Sensory System Agents|sensory system agents|mesh-ancestor
6358435|NCT00084240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6358436|NCT00084240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6358437|NCT00084240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6358438|NCT00084240|Filaricides|filaricides|mesh-ancestor
6358439|NCT00084240|Antinematodal Agents|antinematodal agents|mesh-ancestor
6358440|NCT00084240|Anthelmintics|anthelmintics|mesh-ancestor
6358441|NCT00084240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6358442|NCT00084240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6358443|NCT00084240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358444|NCT00084240|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6358445|NCT00084240|Renal Agents|renal agents|mesh-ancestor
6358446|NCT00084279|Interferons|interferons|mesh-list
6358447|NCT00084279|Ribavirin|ribavirin|mesh-list
6358448|NCT00084279|Interferon-alpha|interferon-alpha|mesh-list
6358449|NCT00084279|Interferon-gamma|interferon-gamma|mesh-list
6358450|NCT00084279|Interferon alfacon-1|interferon alfacon-1|mesh-list
6358451|NCT00084279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358452|NCT00084279|Antiviral Agents|antiviral agents|mesh-ancestor
6358453|NCT00084279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6358454|NCT00084279|Antimetabolites|antimetabolites|mesh-ancestor
6358455|NCT00084279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358456|NCT00084279|Immunologic Factors|immunologic factors|mesh-ancestor
6358457|NCT00084279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6358458|NCT00084370|Celecoxib|celecoxib|mesh-list
6358459|NCT00084370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6358460|NCT00084370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6358461|NCT00084370|Analgesics|analgesics|mesh-ancestor
6358462|NCT00084370|Sensory System Agents|sensory system agents|mesh-ancestor
6358463|NCT00084370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6358464|NCT00084370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6358465|NCT00084370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6358466|NCT00084370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6358467|NCT00084370|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6358468|NCT00084370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6358469|NCT00084370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6358470|NCT00084370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358471|NCT00084396|Letrozole|letrozole|mesh-list
6358472|NCT00084396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358473|NCT00084396|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6358474|NCT00084396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6358475|NCT00084396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6358476|NCT00084396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358477|NCT00084396|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6358478|NCT00084396|Hormone Antagonists|hormone antagonists|mesh-ancestor
6358479|NCT00084396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6358480|NCT00084396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6358481|NCT00084435|Docetaxel|docetaxel|mesh-list
6358482|NCT00084435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358483|NCT00084435|Tubulin Modulators|tubulin modulators|mesh-ancestor
6358484|NCT00084435|Antimitotic Agents|antimitotic agents|mesh-ancestor
6358485|NCT00084435|Mitosis Modulators|mitosis modulators|mesh-ancestor
6358486|NCT00084435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358487|NCT00084448|Celecoxib|celecoxib|mesh-list
6358488|NCT00084448|Paclitaxel|paclitaxel|mesh-list
6358489|NCT00084448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6358490|NCT00084448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358491|NCT00084448|Tubulin Modulators|tubulin modulators|mesh-ancestor
6358492|NCT00084448|Antimitotic Agents|antimitotic agents|mesh-ancestor
6358493|NCT00084448|Mitosis Modulators|mitosis modulators|mesh-ancestor
6017178|NCT00369941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017179|NCT00369941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6017180|NCT00369941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6017181|NCT00369941|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6017182|NCT00369941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6017183|NCT00369941|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6017184|NCT00369941|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6017185|NCT00369941|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6017186|NCT00369941|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6017187|NCT00369941|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6017188|NCT00369941|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6358494|NCT00084448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358495|NCT00084448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6358496|NCT00084448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6358497|NCT00084448|Analgesics|analgesics|mesh-ancestor
6358498|NCT00084448|Sensory System Agents|sensory system agents|mesh-ancestor
6358499|NCT00084448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6358500|NCT00084448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6358501|NCT00084448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6358502|NCT00084448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6358503|NCT00084448|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6358504|NCT00084448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6358505|NCT00084448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6358506|NCT00084461|Romidepsin|romidepsin|mesh-list
6358507|NCT00084461|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6358508|NCT00084461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358509|NCT00084513|Trastuzumab|trastuzumab|mesh-list
6358510|NCT00084513|Imatinib Mesylate|imatinib mesylate|mesh-list
6358511|NCT00084513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6358512|NCT00084513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358513|NCT00084513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6358514|NCT00084513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6358515|NCT00084513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358516|NCT00084565|Paclitaxel|paclitaxel|mesh-list
6358517|NCT00084565|Topotecan|topotecan|mesh-list
6358518|NCT00084565|Estramustine|estramustine|mesh-list
6358519|NCT00084565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6358520|NCT00084565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358521|NCT00084565|Tubulin Modulators|tubulin modulators|mesh-ancestor
6358522|NCT00084565|Antimitotic Agents|antimitotic agents|mesh-ancestor
6358523|NCT00084565|Mitosis Modulators|mitosis modulators|mesh-ancestor
6358524|NCT00084565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358525|NCT00084565|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6358526|NCT00084565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6358527|NCT00084565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6358528|NCT00084565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6358529|NCT00084565|Alkylating Agents|alkylating agents|mesh-ancestor
6358530|NCT00084565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6358531|NCT00084578|Rosiglitazone|rosiglitazone|mesh-list
6358532|NCT00084578|Celecoxib|celecoxib|mesh-list
6358533|NCT00084578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6358534|NCT00084578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6358535|NCT00084578|Analgesics|analgesics|mesh-ancestor
6358536|NCT00084578|Sensory System Agents|sensory system agents|mesh-ancestor
6358537|NCT00084578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6358538|NCT00084578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6358539|NCT00084578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6358540|NCT00084578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6358541|NCT00084578|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6358542|NCT00084578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6358543|NCT00084578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6358544|NCT00084578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358545|NCT00084578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6358546|NCT00084591|Capecitabine|capecitabine|mesh-list
6358547|NCT00084591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6358548|NCT00084591|Antimetabolites|antimetabolites|mesh-ancestor
6358549|NCT00084591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358550|NCT00084591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358551|NCT00084604|Bevacizumab|bevacizumab|mesh-list
6358552|NCT00084604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6358553|NCT00084604|Irinotecan|irinotecan|mesh-list
6358554|NCT00084604|Antibodies|antibodies|mesh-list
6358555|NCT00084604|Immunoglobulins|immunoglobulins|mesh-list
6358556|NCT00084604|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6358557|NCT00084604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358558|NCT00084604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6358559|NCT00084604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6358560|NCT00084604|Growth Substances|growth substances|mesh-ancestor
6358561|NCT00084604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6358562|NCT00084604|Growth Inhibitors|growth inhibitors|mesh-ancestor
6358563|NCT00084604|Immunologic Factors|immunologic factors|mesh-ancestor
6358564|NCT00084604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6358565|NCT00084604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6358566|NCT00084604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6358567|NCT00084604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358568|NCT00084630|Imatinib Mesylate|imatinib mesylate|mesh-list
6358569|NCT00084630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358570|NCT00084630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6358571|NCT00084630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6358572|NCT00084630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358573|NCT00084643|Capecitabine|capecitabine|mesh-list
6358574|NCT00084643|Oxaliplatin|oxaliplatin|mesh-list
6358575|NCT00084643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6358576|NCT00084643|Antimetabolites|antimetabolites|mesh-ancestor
6358577|NCT00084643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358578|NCT00084643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358579|NCT00084656|Ipilimumab|ipilimumab|mesh-list
6358580|NCT00084656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6358581|NCT00084656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358582|NCT00084656|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6358583|NCT00084656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358584|NCT00084669|Zolpidem|zolpidem|mesh-list
6358585|NCT00084669|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6358586|NCT00084669|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6358587|NCT00084669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6358588|NCT00084669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6358589|NCT00084669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358590|NCT00084669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6358591|NCT00084669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6358592|NCT00084669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6358593|NCT00084669|Antidepressive Agents|antidepressive agents|mesh-ancestor
6358594|NCT00084669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6358595|NCT00084669|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6358596|NCT00084669|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6358597|NCT00084669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6358598|NCT00084669|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6358599|NCT00084669|GABA Agonists|gaba agonists|mesh-ancestor
6358600|NCT00084669|GABA Agents|gaba agents|mesh-ancestor
6358601|NCT00084695|Methylprednisolone|methylprednisolone|mesh-list
6358602|NCT00084695|Cyclophosphamide|cyclophosphamide|mesh-list
6358603|NCT00084695|Melphalan|melphalan|mesh-list
6358604|NCT00084695|Busulfan|busulfan|mesh-list
6358605|NCT00084695|Fludarabine|fludarabine|mesh-list
6358606|NCT00084695|Fludarabine phosphate|fludarabine phosphate|mesh-list
6358607|NCT00084695|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6358608|NCT00084695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6358609|NCT00084695|Immunologic Factors|immunologic factors|mesh-ancestor
6358610|NCT00084695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6358611|NCT00084695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6358612|NCT00084695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6358613|NCT00084695|Alkylating Agents|alkylating agents|mesh-ancestor
6358614|NCT00084695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358615|NCT00084695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358616|NCT00084695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6358617|NCT00084695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6358618|NCT00084695|Antimetabolites|antimetabolites|mesh-ancestor
6358619|NCT00084695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6358620|NCT00084695|Antiemetics|antiemetics|mesh-ancestor
6358621|NCT00084695|Autonomic Agents|autonomic agents|mesh-ancestor
6358622|NCT00084695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6358623|NCT00084695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6358624|NCT00084695|Glucocorticoids|glucocorticoids|mesh-ancestor
6358625|NCT00084695|Hormones|hormones|mesh-ancestor
6358626|NCT00084695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6358627|NCT00084695|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6358628|NCT00084695|Protective Agents|protective agents|mesh-ancestor
6358629|NCT00084708|Calcitriol|calcitriol|mesh-list
6358630|NCT00084708|Dexamethasone|dexamethasone|mesh-list
6358631|NCT00084708|Gefitinib|gefitinib|mesh-list
6358632|NCT00084708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6358633|NCT00084708|Antiemetics|antiemetics|mesh-ancestor
6358634|NCT00084708|Autonomic Agents|autonomic agents|mesh-ancestor
6358635|NCT00084708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6358636|NCT00084708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6358637|NCT00084708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6358638|NCT00084708|Glucocorticoids|glucocorticoids|mesh-ancestor
6358639|NCT00084708|Hormones|hormones|mesh-ancestor
6358640|NCT00084708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6358641|NCT00084708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6358642|NCT00084708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358643|NCT00084708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6358644|NCT00084708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6358645|NCT00084708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358646|NCT00084708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6358647|NCT00084708|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6358648|NCT00084708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6358649|NCT00084708|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6358650|NCT00084708|Vitamins|vitamins|mesh-ancestor
6358651|NCT00084708|Micronutrients|micronutrients|mesh-ancestor
6358652|NCT00084708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6358653|NCT00084721|Celecoxib|celecoxib|mesh-list
6358654|NCT00084721|Irinotecan|irinotecan|mesh-list
6358655|NCT00084721|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6358656|NCT00084721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6358657|NCT00084721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6358658|NCT00084721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358659|NCT00084721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358660|NCT00084721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6358661|NCT00084721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6358662|NCT00084721|Analgesics|analgesics|mesh-ancestor
6358663|NCT00084721|Sensory System Agents|sensory system agents|mesh-ancestor
6358664|NCT00084721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6358665|NCT00084721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6358666|NCT00084721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6358667|NCT00084721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6358668|NCT00084721|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6358669|NCT00084721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6358670|NCT00084734|Docetaxel|docetaxel|mesh-list
6358671|NCT00084734|Capecitabine|capecitabine|mesh-list
6358672|NCT00084734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358673|NCT00084734|Tubulin Modulators|tubulin modulators|mesh-ancestor
6358674|NCT00084734|Antimitotic Agents|antimitotic agents|mesh-ancestor
6358675|NCT00084734|Mitosis Modulators|mitosis modulators|mesh-ancestor
6358676|NCT00084734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358677|NCT00084734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6358678|NCT00084734|Antimetabolites|antimetabolites|mesh-ancestor
6358679|NCT00084773|Fluorouracil|fluorouracil|mesh-list
6358680|NCT00084773|Cetuximab|cetuximab|mesh-list
6358681|NCT00084773|Antimetabolites|antimetabolites|mesh-ancestor
6358682|NCT00084773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358683|NCT00084773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6358684|NCT00084773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358685|NCT00084773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6358686|NCT00084773|Immunologic Factors|immunologic factors|mesh-ancestor
6358687|NCT00084773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6358688|NCT00084773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6358689|NCT00084786|Docetaxel|docetaxel|mesh-list
6358690|NCT00084786|Gefitinib|gefitinib|mesh-list
6358691|NCT00084786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358692|NCT00084786|Tubulin Modulators|tubulin modulators|mesh-ancestor
6358693|NCT00084786|Antimitotic Agents|antimitotic agents|mesh-ancestor
6358694|NCT00084786|Mitosis Modulators|mitosis modulators|mesh-ancestor
6358695|NCT00084786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358696|NCT00084786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6358697|NCT00084786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6358698|NCT00084812|Safingol|safingol|mesh-list
6358699|NCT00084812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6358700|NCT00084812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358701|NCT00084825|Docetaxel|docetaxel|mesh-list
6358702|NCT00084825|Imatinib Mesylate|imatinib mesylate|mesh-list
6358703|NCT00084825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358704|NCT00084825|Tubulin Modulators|tubulin modulators|mesh-ancestor
6358705|NCT00084825|Antimitotic Agents|antimitotic agents|mesh-ancestor
6358706|NCT00084825|Mitosis Modulators|mitosis modulators|mesh-ancestor
6358707|NCT00084825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358708|NCT00084825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6358709|NCT00084825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6358710|NCT00084877|Irinotecan|irinotecan|mesh-list
6358711|NCT00084877|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6358712|NCT00084877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6358713|NCT00084877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6358714|NCT00084877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358715|NCT00084877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358716|NCT00084890|Carboplatin|carboplatin|mesh-list
6358717|NCT00084890|Docetaxel|docetaxel|mesh-list
6358718|NCT00084890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358719|NCT00084890|Tubulin Modulators|tubulin modulators|mesh-ancestor
6358720|NCT00084890|Antimitotic Agents|antimitotic agents|mesh-ancestor
6358721|NCT00084890|Mitosis Modulators|mitosis modulators|mesh-ancestor
6358722|NCT00084890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358723|NCT00084916|Sirolimus|sirolimus|mesh-list
6358724|NCT00084916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6358725|NCT00084916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6358726|NCT00084916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6358727|NCT00084916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358728|NCT00084916|Antifungal Agents|antifungal agents|mesh-ancestor
6358729|NCT00084916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6358730|NCT00084916|Immunologic Factors|immunologic factors|mesh-ancestor
6358731|NCT00084916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394709|NCT00203099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6394710|NCT00203099|Expectorants|expectorants|mesh-ancestor
6394711|NCT00203099|Respiratory System Agents|respiratory system agents|mesh-ancestor
6394712|NCT00203099|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6394713|NCT00203099|Antioxidants|antioxidants|mesh-ancestor
6394714|NCT00203099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394715|NCT00203099|Protective Agents|protective agents|mesh-ancestor
6394716|NCT00203099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394717|NCT00203099|Antidotes|antidotes|mesh-ancestor
6394718|NCT00203099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6394719|NCT00203099|Immunologic Factors|immunologic factors|mesh-ancestor
6394720|NCT00203099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6394721|NCT00203099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6394722|NCT00203112|Minocycline|minocycline|mesh-list
6394723|NCT00203112|Glatiramer Acetate|glatiramer acetate|mesh-list
6394724|NCT00203112|(T,G)-A-L|(t,g)-a-l|mesh-list
6394725|NCT00203112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6394726|NCT00203112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6394727|NCT00203112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6394728|NCT00203112|Immunologic Factors|immunologic factors|mesh-ancestor
6394729|NCT00203112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394730|NCT00203112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6394731|NCT00203112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6394732|NCT00203125|Rasagiline|rasagiline|mesh-list
6394733|NCT00203125|Tyramine|tyramine|mesh-list
6394734|NCT00203125|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6394735|NCT00203125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6394736|NCT00203125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394737|NCT00203125|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6394738|NCT00203125|Protective Agents|protective agents|mesh-ancestor
6394739|NCT00203125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394740|NCT00203125|Sympathomimetics|sympathomimetics|mesh-ancestor
5724634|NCT03186040|Anticonvulsants|anticonvulsants|mesh-ancestor
6394741|NCT00203125|Autonomic Agents|autonomic agents|mesh-ancestor
6358732|NCT00084942|Gemcitabine|gemcitabine|mesh-list
6358733|NCT00084942|Capecitabine|capecitabine|mesh-list
6358734|NCT00084942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6358735|NCT00084942|Antimetabolites|antimetabolites|mesh-ancestor
6358736|NCT00084942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358737|NCT00084942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358738|NCT00084942|Antiviral Agents|antiviral agents|mesh-ancestor
6358739|NCT00084942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6358740|NCT00084942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6358741|NCT00084942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6358742|NCT00084942|Immunologic Factors|immunologic factors|mesh-ancestor
6358743|NCT00084942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6358744|NCT00084981|Decitabine|decitabine|mesh-list
6358745|NCT00084981|Azacitidine|azacitidine|mesh-list
6358746|NCT00084981|Valproic Acid|valproic acid|mesh-list
6358747|NCT00084981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6358748|NCT00084981|Antimetabolites|antimetabolites|mesh-ancestor
6358749|NCT00084981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358750|NCT00084981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358751|NCT00084981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6358752|NCT00084981|Anticonvulsants|anticonvulsants|mesh-ancestor
6358753|NCT00084981|GABA Agents|gaba agents|mesh-ancestor
6358754|NCT00084981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6358755|NCT00084981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6358756|NCT00084981|Antimanic Agents|antimanic agents|mesh-ancestor
6358757|NCT00084981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6358758|NCT00084981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6358759|NCT00084981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6358760|NCT00085020|Trastuzumab|trastuzumab|mesh-list
6358761|NCT00085020|Lapatinib|lapatinib|mesh-list
6358762|NCT00085020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6358763|NCT00085020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358764|NCT00085020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6358765|NCT00085020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6358766|NCT00085020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358767|NCT00085111|Bevacizumab|bevacizumab|mesh-list
6358768|NCT00085111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6358769|NCT00085111|Antibodies|antibodies|mesh-list
6358770|NCT00085111|Immunoglobulins|immunoglobulins|mesh-list
6358771|NCT00085111|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6358772|NCT00085111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358773|NCT00085111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6358774|NCT00085111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6358775|NCT00085111|Growth Substances|growth substances|mesh-ancestor
6358776|NCT00085111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6358777|NCT00085111|Growth Inhibitors|growth inhibitors|mesh-ancestor
6358778|NCT00085111|Immunologic Factors|immunologic factors|mesh-ancestor
6358779|NCT00085124|Cytarabine|cytarabine|mesh-list
6358780|NCT00085124|Daunorubicin|daunorubicin|mesh-list
6358781|NCT00085124|Oblimersen|oblimersen|mesh-list
6358782|NCT00085124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6358783|NCT00085124|Antimetabolites|antimetabolites|mesh-ancestor
6358784|NCT00085124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017189|NCT00369967|Contraceptive Agents|contraceptive agents|mesh-list
6358785|NCT00085124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358786|NCT00085124|Antiviral Agents|antiviral agents|mesh-ancestor
6358787|NCT00085124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6358788|NCT00085124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6358789|NCT00085124|Immunologic Factors|immunologic factors|mesh-ancestor
6358790|NCT00085124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6358791|NCT00085124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6358792|NCT00085124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6358793|NCT00085124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6358794|NCT00085124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6358795|NCT00085150|Immunotoxins|immunotoxins|mesh-list
6358796|NCT00085150|Immunologic Factors|immunologic factors|mesh-ancestor
6358797|NCT00085150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6358798|NCT00085163|Leucovorin|leucovorin|mesh-list
6358799|NCT00085163|Celecoxib|celecoxib|mesh-list
6358800|NCT00085163|Fluorouracil|fluorouracil|mesh-list
6358801|NCT00085163|Calcium|calcium|mesh-list
6358802|NCT00085163|Levoleucovorin|levoleucovorin|mesh-list
6358803|NCT00085163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6358804|NCT00085163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6358805|NCT00085163|Antimetabolites|antimetabolites|mesh-ancestor
6358806|NCT00085163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358807|NCT00085163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6358808|NCT00085163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358809|NCT00085163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6358810|NCT00085163|Immunologic Factors|immunologic factors|mesh-ancestor
6358811|NCT00085163|Antidotes|antidotes|mesh-ancestor
6358812|NCT00085163|Protective Agents|protective agents|mesh-ancestor
6358813|NCT00085163|Vitamin B Complex|vitamin b complex|mesh-ancestor
6358814|NCT00085163|Vitamins|vitamins|mesh-ancestor
6358815|NCT00085163|Micronutrients|micronutrients|mesh-ancestor
6358816|NCT00085163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6358817|NCT00085163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6358818|NCT00085163|Analgesics|analgesics|mesh-ancestor
6358819|NCT00085163|Sensory System Agents|sensory system agents|mesh-ancestor
6358820|NCT00085163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6358821|NCT00085163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6358822|NCT00085163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6358823|NCT00085163|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6358824|NCT00085163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6358825|NCT00085163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6358826|NCT00085189|Freund's Adjuvant|freund's adjuvant|mesh-list
6358827|NCT00085189|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6358828|NCT00085189|Immunologic Factors|immunologic factors|mesh-ancestor
6358829|NCT00085189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6358830|NCT00085228|Docetaxel|docetaxel|mesh-list
6358831|NCT00085228|Oblimersen|oblimersen|mesh-list
6358832|NCT00085228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358833|NCT00085228|Tubulin Modulators|tubulin modulators|mesh-ancestor
6358834|NCT00085228|Antimitotic Agents|antimitotic agents|mesh-ancestor
6358835|NCT00085228|Mitosis Modulators|mitosis modulators|mesh-ancestor
6358836|NCT00085228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358837|NCT00085280|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6358838|NCT00085280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358839|NCT00085280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6358840|NCT00085280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6358841|NCT00085280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358842|NCT00085306|Interferons|interferons|mesh-list
6358843|NCT00085306|Interferon-beta|interferon-beta|mesh-list
6358844|NCT00085306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358845|NCT00085306|Antiviral Agents|antiviral agents|mesh-ancestor
6358846|NCT00085306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6358847|NCT00085306|Immunologic Factors|immunologic factors|mesh-ancestor
6358848|NCT00085306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6358849|NCT00085332|Docetaxel|docetaxel|mesh-list
6358850|NCT00085332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358851|NCT00085332|Tubulin Modulators|tubulin modulators|mesh-ancestor
6358852|NCT00085332|Antimitotic Agents|antimitotic agents|mesh-ancestor
6358853|NCT00085332|Mitosis Modulators|mitosis modulators|mesh-ancestor
6358854|NCT00085332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358855|NCT00085345|Ascorbic Acid|ascorbic acid|mesh-list
6358856|NCT00085345|Melphalan|melphalan|mesh-list
6358857|NCT00085345|Arsenic Trioxide|arsenic trioxide|mesh-list
6358858|NCT00085345|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6358859|NCT00085345|Alkylating Agents|alkylating agents|mesh-ancestor
6358860|NCT00085345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358861|NCT00085345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358862|NCT00085345|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6358863|NCT00085345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6358864|NCT00085345|Immunologic Factors|immunologic factors|mesh-ancestor
6358865|NCT00085345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6358866|NCT00085345|Antioxidants|antioxidants|mesh-ancestor
6358867|NCT00085345|Protective Agents|protective agents|mesh-ancestor
6358868|NCT00085345|Vitamins|vitamins|mesh-ancestor
6358869|NCT00085345|Micronutrients|micronutrients|mesh-ancestor
6358870|NCT00085358|Paclitaxel|paclitaxel|mesh-list
6358871|NCT00085358|Docetaxel|docetaxel|mesh-list
6358872|NCT00085358|Bevacizumab|bevacizumab|mesh-list
6358873|NCT00085358|Carboplatin|carboplatin|mesh-list
6358874|NCT00085358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6358875|NCT00085358|Antibodies|antibodies|mesh-list
6358876|NCT00085358|Immunoglobulins|immunoglobulins|mesh-list
6358877|NCT00085358|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6358878|NCT00085358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6358879|NCT00085358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358880|NCT00085358|Tubulin Modulators|tubulin modulators|mesh-ancestor
6358881|NCT00085358|Antimitotic Agents|antimitotic agents|mesh-ancestor
6358882|NCT00085358|Mitosis Modulators|mitosis modulators|mesh-ancestor
6358883|NCT00085358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358884|NCT00085358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6358885|NCT00085358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6358886|NCT00085358|Growth Substances|growth substances|mesh-ancestor
6358887|NCT00085358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6358888|NCT00085358|Growth Inhibitors|growth inhibitors|mesh-ancestor
6358889|NCT00085358|Immunologic Factors|immunologic factors|mesh-ancestor
6358890|NCT00085384|Interferons|interferons|mesh-list
6358891|NCT00085384|Interferon-alpha|interferon-alpha|mesh-list
6358892|NCT00085384|Interferon alpha-2|interferon alpha-2|mesh-list
6358893|NCT00085384|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6358894|NCT00085384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358895|NCT00085384|Antiviral Agents|antiviral agents|mesh-ancestor
6358896|NCT00085384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6358897|NCT00085384|Immunologic Factors|immunologic factors|mesh-ancestor
6358898|NCT00085384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6358899|NCT00085449|Cyclosporine|cyclosporine|mesh-list
6358900|NCT00085449|Mycophenolic Acid|mycophenolic acid|mesh-list
6358901|NCT00085449|Fludarabine|fludarabine|mesh-list
6358902|NCT00085449|Fludarabine phosphate|fludarabine phosphate|mesh-list
6358903|NCT00085449|Melphalan|melphalan|mesh-list
6358904|NCT00085449|Alemtuzumab|alemtuzumab|mesh-list
6358905|NCT00085449|Cyclosporins|cyclosporins|mesh-list
6358906|NCT00085449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358907|NCT00085449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6358908|NCT00085449|Antimetabolites|antimetabolites|mesh-ancestor
6358909|NCT00085449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358910|NCT00085449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6358911|NCT00085449|Immunologic Factors|immunologic factors|mesh-ancestor
6358912|NCT00085449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6358913|NCT00085449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6358914|NCT00085449|Antifungal Agents|antifungal agents|mesh-ancestor
6358915|NCT00085449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6358916|NCT00085449|Dermatologic Agents|dermatologic agents|mesh-ancestor
6358917|NCT00085449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6358918|NCT00085449|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6358919|NCT00085449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6017190|NCT00369967|NuvaRing|nuvaring|mesh-list
6358920|NCT00085449|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6358921|NCT00085449|Antitubercular Agents|antitubercular agents|mesh-ancestor
6358922|NCT00085449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6358923|NCT00085449|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6358924|NCT00085449|Alkylating Agents|alkylating agents|mesh-ancestor
6358925|NCT00085449|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6358926|NCT00085449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6358927|NCT00085462|Aldesleukin|aldesleukin|mesh-list
6358928|NCT00085462|Cyclophosphamide|cyclophosphamide|mesh-list
6358929|NCT00085462|Fludarabine|fludarabine|mesh-list
6358930|NCT00085462|Fludarabine phosphate|fludarabine phosphate|mesh-list
6358931|NCT00085462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6358932|NCT00085462|Immunologic Factors|immunologic factors|mesh-ancestor
6358933|NCT00085462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6358934|NCT00085462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6358935|NCT00085462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6358936|NCT00085462|Alkylating Agents|alkylating agents|mesh-ancestor
6358937|NCT00085462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358938|NCT00085462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358939|NCT00085462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6358940|NCT00085462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6358941|NCT00085462|Antimetabolites|antimetabolites|mesh-ancestor
6358942|NCT00085462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6358943|NCT00085462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6358944|NCT00085462|Antiviral Agents|antiviral agents|mesh-ancestor
6358945|NCT00085462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6358946|NCT00085475|Imatinib Mesylate|imatinib mesylate|mesh-list
6358947|NCT00085475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358948|NCT00085475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6358949|NCT00085475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6358950|NCT00085475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358951|NCT00085501|Paclitaxel|paclitaxel|mesh-list
6358952|NCT00085501|Carboplatin|carboplatin|mesh-list
6358953|NCT00085501|Cetuximab|cetuximab|mesh-list
6358954|NCT00085501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6358955|NCT00085501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358956|NCT00085501|Tubulin Modulators|tubulin modulators|mesh-ancestor
6358957|NCT00085501|Antimitotic Agents|antimitotic agents|mesh-ancestor
6358958|NCT00085501|Mitosis Modulators|mitosis modulators|mesh-ancestor
6358959|NCT00085501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358960|NCT00085501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6358961|NCT00085527|Romidepsin|romidepsin|mesh-list
6358962|NCT00085527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6358963|NCT00085527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358964|NCT00085553|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6358965|NCT00085553|Tipifarnib|tipifarnib|mesh-list
6358966|NCT00085553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358967|NCT00085553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6358968|NCT00085553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6358969|NCT00085553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358970|NCT00085579|Aldesleukin|aldesleukin|mesh-list
6358971|NCT00085579|Sargramostim|sargramostim|mesh-list
6358972|NCT00085579|Immunologic Factors|immunologic factors|mesh-ancestor
6358973|NCT00085579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6358974|NCT00085579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358975|NCT00085579|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6358976|NCT00085579|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6358977|NCT00085579|Antiviral Agents|antiviral agents|mesh-ancestor
6358978|NCT00085579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6358979|NCT00085696|Rituximab|rituximab|mesh-list
6358980|NCT00085696|Bortezomib|bortezomib|mesh-list
6358981|NCT00085696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6358982|NCT00085696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6358983|NCT00085696|Immunologic Factors|immunologic factors|mesh-ancestor
6358984|NCT00085696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6358985|NCT00085696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6358986|NCT00085748|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6358987|NCT00085748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6358988|NCT00085748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6358989|NCT00085748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6358990|NCT00085748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6358991|NCT00085748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6358992|NCT00085748|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6358993|NCT00085748|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6358994|NCT00085748|Serotonin Agents|serotonin agents|mesh-ancestor
6358995|NCT00085748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6358996|NCT00085748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6358997|NCT00085748|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6358998|NCT00085748|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6358999|NCT00085748|Dopamine Agents|dopamine agents|mesh-ancestor
6359000|NCT00085761|Capsaicin|capsaicin|mesh-list
6359001|NCT00085761|Antipruritics|antipruritics|mesh-ancestor
6359002|NCT00085761|Dermatologic Agents|dermatologic agents|mesh-ancestor
6359003|NCT00085761|Sensory System Agents|sensory system agents|mesh-ancestor
6359004|NCT00085761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6359005|NCT00085761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359006|NCT00085826|Sulindac sulfone|sulindac sulfone|mesh-list
6359007|NCT00085826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359008|NCT00085826|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6359009|NCT00085826|Protective Agents|protective agents|mesh-ancestor
6359010|NCT00085826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359011|NCT00085826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6359012|NCT00085826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6359013|NCT00085826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359014|NCT00085826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6359015|NCT00085826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6359016|NCT00085826|Analgesics|analgesics|mesh-ancestor
6359017|NCT00085826|Sensory System Agents|sensory system agents|mesh-ancestor
6359018|NCT00085826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6359019|NCT00085826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6359020|NCT00085826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6359021|NCT00085891|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6359022|NCT00085891|Antidepressive Agents|antidepressive agents|mesh-ancestor
6359023|NCT00085891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6359024|NCT00085891|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6359025|NCT00085891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6359026|NCT00085891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6359027|NCT00085891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359028|NCT00085943|Ritonavir|ritonavir|mesh-list
6359029|NCT00085943|Lopinavir|lopinavir|mesh-list
6359030|NCT00085943|Fosamprenavir|fosamprenavir|mesh-list
6359031|NCT00085943|Lamivudine|lamivudine|mesh-list
6359032|NCT00085943|Abacavir|abacavir|mesh-list
6359033|NCT00085943|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6359034|NCT00085943|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6359035|NCT00085943|Protease Inhibitors|protease inhibitors|mesh-ancestor
6359036|NCT00085943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6359037|NCT00085943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359038|NCT00085943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6359039|NCT00085943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6359040|NCT00085943|Antiviral Agents|antiviral agents|mesh-ancestor
6359041|NCT00085943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6359042|NCT00085943|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6359043|NCT00085943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6359044|NCT00085943|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6359045|NCT00085943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6359046|NCT00085969|Exenatide|exenatide|mesh-list
6359047|NCT00085969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6359048|NCT00085969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359049|NCT00085969|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6359050|NCT00085969|Incretins|incretins|mesh-ancestor
6359051|NCT00085969|Hormones|hormones|mesh-ancestor
6359052|NCT00085969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6359053|NCT00086034|Motexafin gadolinium|motexafin gadolinium|mesh-list
6359054|NCT00086034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359055|NCT00086034|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6359056|NCT00086034|Dermatologic Agents|dermatologic agents|mesh-ancestor
6359057|NCT00086086|Darbepoetin alfa|darbepoetin alfa|mesh-list
6359058|NCT00086086|Hematinics|hematinics|mesh-ancestor
6359059|NCT00086099|Amifostine|amifostine|mesh-list
6359060|NCT00086099|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6359061|NCT00086099|Protective Agents|protective agents|mesh-ancestor
6359062|NCT00086099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359063|NCT00086112|Risperidone|risperidone|mesh-list
6359064|NCT00086112|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6359065|NCT00086112|Serotonin Agents|serotonin agents|mesh-ancestor
6359066|NCT00086112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6359067|NCT00086112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359068|NCT00086112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359069|NCT00086112|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6359070|NCT00086112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6359071|NCT00086112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6359072|NCT00086112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6359073|NCT00086112|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6359074|NCT00086112|Dopamine Agents|dopamine agents|mesh-ancestor
6359075|NCT00086125|Sirolimus|sirolimus|mesh-list
6359076|NCT00086125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6359077|NCT00086125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6359078|NCT00086125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6359079|NCT00086125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359080|NCT00086125|Antifungal Agents|antifungal agents|mesh-ancestor
6359081|NCT00086125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6359082|NCT00086125|Immunologic Factors|immunologic factors|mesh-ancestor
6359083|NCT00086125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359084|NCT00086177|Progesterone|progesterone|mesh-list
6017191|NCT00369967|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6017192|NCT00369967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017193|NCT00369967|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6017194|NCT00370032|Alosetron|alosetron|mesh-list
6017195|NCT00370032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6017196|NCT00370032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6017197|NCT00370032|Serotonin Agents|serotonin agents|mesh-ancestor
6017198|NCT00370032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6017199|NCT00370032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017200|NCT00370032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017201|NCT00370071|Interferons|interferons|mesh-list
6017202|NCT00370071|Interferon-beta|interferon-beta|mesh-list
6359085|NCT00086177|Progestins|progestins|mesh-ancestor
6359086|NCT00086177|Hormones|hormones|mesh-ancestor
6359087|NCT00086177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6359088|NCT00086177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359089|NCT00086203|Rituximab|rituximab|mesh-list
6359090|NCT00086203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6359091|NCT00086203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359092|NCT00086203|Immunologic Factors|immunologic factors|mesh-ancestor
6359093|NCT00086203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359094|NCT00086203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6359095|NCT00086255|Tiagabine|tiagabine|mesh-list
6359096|NCT00086255|Anticonvulsants|anticonvulsants|mesh-ancestor
6359097|NCT00086255|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
6359098|NCT00086255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6359099|NCT00086255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6359100|NCT00086255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359101|NCT00086255|GABA Agents|gaba agents|mesh-ancestor
6359102|NCT00086255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6359103|NCT00086255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359104|NCT00086268|Zoledronic Acid|zoledronic acid|mesh-list
6359105|NCT00086268|Carboplatin|carboplatin|mesh-list
6359106|NCT00086268|Docetaxel|docetaxel|mesh-list
6359107|NCT00086268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359108|NCT00086268|Tubulin Modulators|tubulin modulators|mesh-ancestor
6359109|NCT00086268|Antimitotic Agents|antimitotic agents|mesh-ancestor
6359110|NCT00086268|Mitosis Modulators|mitosis modulators|mesh-ancestor
6359111|NCT00086268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359112|NCT00086268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6359113|NCT00086268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359114|NCT00086294|Levodopa|levodopa|mesh-list
6359115|NCT00086294|Pimavanserin|pimavanserin|mesh-list
6359116|NCT00086294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6359117|NCT00086294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6359118|NCT00086294|Dopamine Agents|dopamine agents|mesh-ancestor
6359119|NCT00086294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6359120|NCT00086294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359121|NCT00086294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359122|NCT00086294|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6359123|NCT00086294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6359124|NCT00086294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6359125|NCT00086294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6359126|NCT00086294|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6359127|NCT00086294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6359128|NCT00086294|Serotonin Agents|serotonin agents|mesh-ancestor
6359129|NCT00086320|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6359130|NCT00086320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6359131|NCT00086320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6359132|NCT00086320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6359133|NCT00086320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359134|NCT00086320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6359135|NCT00086320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6359136|NCT00086320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6359137|NCT00086320|Serotonin Agents|serotonin agents|mesh-ancestor
6359138|NCT00086320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6359139|NCT00086320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359140|NCT00086320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6359141|NCT00086320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6359142|NCT00086320|Dopamine Agents|dopamine agents|mesh-ancestor
6359143|NCT00086333|Docetaxel|docetaxel|mesh-list
6359144|NCT00086333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359145|NCT00086333|Tubulin Modulators|tubulin modulators|mesh-ancestor
6359146|NCT00086333|Antimitotic Agents|antimitotic agents|mesh-ancestor
6359147|NCT00086333|Mitosis Modulators|mitosis modulators|mesh-ancestor
6359148|NCT00086333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359149|NCT00086359|Ritonavir|ritonavir|mesh-list
6359150|NCT00086359|Lopinavir|lopinavir|mesh-list
6359151|NCT00086359|Lamivudine|lamivudine|mesh-list
6359152|NCT00086359|Zidovudine|zidovudine|mesh-list
6359153|NCT00086359|Abacavir|abacavir|mesh-list
6359154|NCT00086359|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6359155|NCT00086359|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6359156|NCT00086359|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6359157|NCT00086359|Protease Inhibitors|protease inhibitors|mesh-ancestor
6359158|NCT00086359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6359159|NCT00086359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359160|NCT00086359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6359161|NCT00086359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6359162|NCT00086359|Antiviral Agents|antiviral agents|mesh-ancestor
6359163|NCT00086359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6359164|NCT00086359|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6359165|NCT00086359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6359166|NCT00086359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6359167|NCT00086359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6359168|NCT00086359|Antimetabolites|antimetabolites|mesh-ancestor
6359169|NCT00086463|Iloprost|iloprost|mesh-list
6359170|NCT00086463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6359171|NCT00086463|Vasodilator Agents|vasodilator agents|mesh-ancestor
6359172|NCT00086489|Tremelimumab|tremelimumab|mesh-list
6359173|NCT00086489|Ipilimumab|ipilimumab|mesh-list
6359174|NCT00086489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359175|NCT00086489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6359176|NCT00086489|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6359177|NCT00086489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359178|NCT00086528|XL647|xl647|mesh-list
6359179|NCT00086528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359180|NCT00086528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6359181|NCT00086528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6359182|NCT00086528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359183|NCT00086541|Interferons|interferons|mesh-list
6359184|NCT00086541|Ribavirin|ribavirin|mesh-list
6359185|NCT00086541|Interferon alfacon-1|interferon alfacon-1|mesh-list
6359186|NCT00086541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359187|NCT00086541|Antiviral Agents|antiviral agents|mesh-ancestor
6359188|NCT00086541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6359189|NCT00086541|Antimetabolites|antimetabolites|mesh-ancestor
6359190|NCT00086541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359191|NCT00086593|Lamotrigine|lamotrigine|mesh-list
6359192|NCT00086593|Anticonvulsants|anticonvulsants|mesh-ancestor
6359193|NCT00086593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6359194|NCT00086593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6359195|NCT00086593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359196|NCT00086593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6359197|NCT00086593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359198|NCT00086593|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6359199|NCT00086593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6359200|NCT00086593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6359201|NCT00086593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6359202|NCT00086593|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6359203|NCT00086606|Omalizumab|omalizumab|mesh-list
6359204|NCT00086606|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6359205|NCT00086606|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6359206|NCT00086606|Respiratory System Agents|respiratory system agents|mesh-ancestor
6359207|NCT00086632|Oregovomab|oregovomab|mesh-list
6359208|NCT00086632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6359209|NCT00086632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359210|NCT00086645|Dexetimide|dexetimide|mesh-list
6359211|NCT00086645|Citalopram|citalopram|mesh-list
6359212|NCT00086645|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6359213|NCT00086645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6359214|NCT00086645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6359215|NCT00086645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359216|NCT00086645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6359217|NCT00086645|Serotonin Agents|serotonin agents|mesh-ancestor
6359218|NCT00086645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359219|NCT00086645|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6359220|NCT00086645|Antidepressive Agents|antidepressive agents|mesh-ancestor
6359221|NCT00086645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6359222|NCT00086645|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6359223|NCT00086645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6359224|NCT00086645|Parasympatholytics|parasympatholytics|mesh-ancestor
6359225|NCT00086645|Autonomic Agents|autonomic agents|mesh-ancestor
6359226|NCT00086645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6359227|NCT00086645|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6359228|NCT00086645|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6359229|NCT00086645|Cholinergic Agents|cholinergic agents|mesh-ancestor
6359230|NCT00086710|Enfuvirtide|enfuvirtide|mesh-list
6359231|NCT00086710|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6359232|NCT00086710|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6359233|NCT00086710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359234|NCT00086710|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6359235|NCT00086710|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6359236|NCT00086710|Antiviral Agents|antiviral agents|mesh-ancestor
6359237|NCT00086710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6359238|NCT00086736|Eflornithine|eflornithine|mesh-list
6359239|NCT00086736|Bicalutamide|bicalutamide|mesh-list
6359240|NCT00086736|Androgen Antagonists|androgen antagonists|mesh-ancestor
6359241|NCT00086736|Hormone Antagonists|hormone antagonists|mesh-ancestor
6359242|NCT00086736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6359243|NCT00086736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359244|NCT00086736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359245|NCT00086736|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6359246|NCT00086736|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6359247|NCT00086736|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6359248|NCT00086736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6359249|NCT00086736|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
6359250|NCT00086736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6359251|NCT00086736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359252|NCT00086775|Rituximab|rituximab|mesh-list
6359253|NCT00086775|Alemtuzumab|alemtuzumab|mesh-list
6359254|NCT00086775|Fludarabine|fludarabine|mesh-list
6359255|NCT00086775|Fludarabine phosphate|fludarabine phosphate|mesh-list
6359256|NCT00086775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6359257|NCT00086775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359258|NCT00086775|Immunologic Factors|immunologic factors|mesh-ancestor
6359259|NCT00086775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359260|NCT00086775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6359261|NCT00086775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6359262|NCT00086775|Antimetabolites|antimetabolites|mesh-ancestor
6359263|NCT00086775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359264|NCT00086775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6359265|NCT00086801|Gemcitabine|gemcitabine|mesh-list
6359266|NCT00086801|Doxorubicin|doxorubicin|mesh-list
6359267|NCT00086801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6359268|NCT00086801|Vinblastine|vinblastine|mesh-list
6359269|NCT00086801|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6359270|NCT00086801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6359271|NCT00086801|Antimetabolites|antimetabolites|mesh-ancestor
6359272|NCT00086801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359273|NCT00086801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359274|NCT00086801|Antiviral Agents|antiviral agents|mesh-ancestor
6359275|NCT00086801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6359276|NCT00086801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6359277|NCT00086801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6359278|NCT00086801|Immunologic Factors|immunologic factors|mesh-ancestor
6359279|NCT00086801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359280|NCT00086801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6359281|NCT00086801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6359282|NCT00086801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6359283|NCT00086801|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6359284|NCT00086801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6359285|NCT00086801|Tubulin Modulators|tubulin modulators|mesh-ancestor
6359286|NCT00086801|Antimitotic Agents|antimitotic agents|mesh-ancestor
6359287|NCT00086801|Mitosis Modulators|mitosis modulators|mesh-ancestor
6359288|NCT00086827|Romidepsin|romidepsin|mesh-list
6359289|NCT00086827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6359290|NCT00086827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359291|NCT00086840|Sirolimus|sirolimus|mesh-list
6359292|NCT00086840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6359293|NCT00086840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6359294|NCT00086840|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6359295|NCT00086840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359296|NCT00086840|Antifungal Agents|antifungal agents|mesh-ancestor
6359297|NCT00086840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6359298|NCT00086840|Immunologic Factors|immunologic factors|mesh-ancestor
6359299|NCT00086840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359300|NCT00086879|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6359301|NCT00086879|Temozolomide|temozolomide|mesh-list
6359302|NCT00086879|Carmustine|carmustine|mesh-list
6359303|NCT00086879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359304|NCT00086879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6359305|NCT00086879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6359306|NCT00086879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359307|NCT00086879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6359308|NCT00086879|Alkylating Agents|alkylating agents|mesh-ancestor
6359309|NCT00086892|Carboplatin|carboplatin|mesh-list
6359310|NCT00086892|Cetuximab|cetuximab|mesh-list
6359311|NCT00086892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359312|NCT00086892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6359313|NCT00086931|Capecitabine|capecitabine|mesh-list
6359314|NCT00086931|Oxaliplatin|oxaliplatin|mesh-list
6359315|NCT00086931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6359316|NCT00086931|Antimetabolites|antimetabolites|mesh-ancestor
6359317|NCT00086931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359318|NCT00086931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359319|NCT00086944|Rituximab|rituximab|mesh-list
6359320|NCT00086944|Carboplatin|carboplatin|mesh-list
6359321|NCT00086944|Etoposide|etoposide|mesh-list
6359322|NCT00086944|Etoposide phosphate|etoposide phosphate|mesh-list
6359323|NCT00086944|Ifosfamide|ifosfamide|mesh-list
6359324|NCT00086944|Oblimersen|oblimersen|mesh-list
6359325|NCT00086944|Lenograstim|lenograstim|mesh-list
6359326|NCT00086944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6359327|NCT00086944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359328|NCT00086944|Immunologic Factors|immunologic factors|mesh-ancestor
6359329|NCT00086944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359330|NCT00086944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6359331|NCT00086944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6359332|NCT00086944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6359333|NCT00086944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6359334|NCT00086944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6359335|NCT00086944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359336|NCT00086944|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6359337|NCT00086944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6359338|NCT00086944|Alkylating Agents|alkylating agents|mesh-ancestor
6359339|NCT00086970|Ifosfamide|ifosfamide|mesh-list
6359340|NCT00086970|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
6359341|NCT00086970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6359342|NCT00086970|Alkylating Agents|alkylating agents|mesh-ancestor
6359343|NCT00086970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359344|NCT00086970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359345|NCT00086970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6359346|NCT00086983|Oxaliplatin|oxaliplatin|mesh-list
6359347|NCT00086983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359348|NCT00087009|Rituximab|rituximab|mesh-list
6359349|NCT00087009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6359350|NCT00087009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359351|NCT00087009|Immunologic Factors|immunologic factors|mesh-ancestor
6359352|NCT00087009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359353|NCT00087009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6359354|NCT00087035|Docetaxel|docetaxel|mesh-list
6359355|NCT00087035|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6359356|NCT00087035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359357|NCT00087035|Tubulin Modulators|tubulin modulators|mesh-ancestor
6359358|NCT00087035|Antimitotic Agents|antimitotic agents|mesh-ancestor
6359359|NCT00087035|Mitosis Modulators|mitosis modulators|mesh-ancestor
6359360|NCT00087035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359361|NCT00087035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6359362|NCT00087035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6359363|NCT00087048|Topotecan|topotecan|mesh-list
6359364|NCT00087048|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6359365|NCT00087048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6359366|NCT00087048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6359367|NCT00087048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359368|NCT00087048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6394742|NCT00203125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6394743|NCT00203125|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6394744|NCT00203125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6394745|NCT00203125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6394746|NCT00203125|Adrenergic Agents|adrenergic agents|mesh-ancestor
6394747|NCT00203125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6394748|NCT00203138|Rasagiline|rasagiline|mesh-list
6394749|NCT00203138|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6394750|NCT00203138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6394751|NCT00203138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394752|NCT00203138|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6394753|NCT00203138|Protective Agents|protective agents|mesh-ancestor
6394754|NCT00203138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394755|NCT00203164|Rasagiline|rasagiline|mesh-list
6394756|NCT00203164|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6394757|NCT00203164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6394758|NCT00203164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394759|NCT00203164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6394760|NCT00203164|Protective Agents|protective agents|mesh-ancestor
6394761|NCT00203164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394762|NCT00203177|Rasagiline|rasagiline|mesh-list
6394763|NCT00203177|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6394764|NCT00203177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6394765|NCT00203177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394766|NCT00203177|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6394767|NCT00203177|Protective Agents|protective agents|mesh-ancestor
6394768|NCT00203177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394769|NCT00203190|Topiramate|topiramate|mesh-list
6394770|NCT00203190|Anticonvulsants|anticonvulsants|mesh-ancestor
6394771|NCT00203190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6394772|NCT00203190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394773|NCT00203281|Mycophenolic Acid|mycophenolic acid|mesh-list
6394774|NCT00203281|Tacrolimus|tacrolimus|mesh-list
6394775|NCT00203281|Daclizumab|daclizumab|mesh-list
6394776|NCT00203281|Immunoglobulins|immunoglobulins|mesh-list
6394777|NCT00203281|Antibodies|antibodies|mesh-list
6394778|NCT00203281|gamma-Globulins|gamma-globulins|mesh-list
6394779|NCT00203281|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6394780|NCT00203281|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6394781|NCT00203281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6394782|NCT00203281|Immunologic Factors|immunologic factors|mesh-ancestor
6394783|NCT00203281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394784|NCT00203281|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6394785|NCT00203281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6394786|NCT00203281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394787|NCT00203281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6394788|NCT00203281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6394789|NCT00203281|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6394790|NCT00203281|Antitubercular Agents|antitubercular agents|mesh-ancestor
6394791|NCT00203281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6394792|NCT00203281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6394793|NCT00203320|Etanercept|etanercept|mesh-list
6394794|NCT00203320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6394795|NCT00203320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6394796|NCT00203320|Analgesics|analgesics|mesh-ancestor
6394797|NCT00203320|Sensory System Agents|sensory system agents|mesh-ancestor
6394798|NCT00203320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6394799|NCT00203320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359369|NCT00087074|Sirolimus|sirolimus|mesh-list
6359370|NCT00087074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6359371|NCT00087074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6359372|NCT00087074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6359373|NCT00087074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359374|NCT00087074|Antifungal Agents|antifungal agents|mesh-ancestor
6359375|NCT00087074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6359376|NCT00087074|Immunologic Factors|immunologic factors|mesh-ancestor
6359377|NCT00087074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359378|NCT00087087|Pemetrexed|pemetrexed|mesh-list
6359379|NCT00087087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359380|NCT00087087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6359381|NCT00087087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359382|NCT00087087|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6359383|NCT00087087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6359384|NCT00087100|Pemetrexed|pemetrexed|mesh-list
6359385|NCT00087100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359386|NCT00087100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6359387|NCT00087100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359388|NCT00087100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6359389|NCT00087100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6359390|NCT00087113|Pemetrexed|pemetrexed|mesh-list
6017203|NCT00370071|Interferon beta-1b|interferon beta-1b|mesh-list
6359391|NCT00087113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359392|NCT00087113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6359393|NCT00087113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359394|NCT00087113|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6359395|NCT00087113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6359396|NCT00087165|Prednisone|prednisone|mesh-list
6359397|NCT00087165|Docetaxel|docetaxel|mesh-list
6359398|NCT00087165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359399|NCT00087165|Tubulin Modulators|tubulin modulators|mesh-ancestor
6359400|NCT00087165|Antimitotic Agents|antimitotic agents|mesh-ancestor
6359401|NCT00087165|Mitosis Modulators|mitosis modulators|mesh-ancestor
6359402|NCT00087165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359403|NCT00087165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6359404|NCT00087165|Glucocorticoids|glucocorticoids|mesh-ancestor
6359405|NCT00087165|Hormones|hormones|mesh-ancestor
6359406|NCT00087165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6359407|NCT00087165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359408|NCT00087165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6359409|NCT00087178|Cyclophosphamide|cyclophosphamide|mesh-list
6359410|NCT00087178|Doxorubicin|doxorubicin|mesh-list
6359411|NCT00087178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6359412|NCT00087178|Fluorouracil|fluorouracil|mesh-list
6359413|NCT00087178|Epirubicin|epirubicin|mesh-list
6359414|NCT00087178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6359415|NCT00087178|Immunologic Factors|immunologic factors|mesh-ancestor
6359416|NCT00087178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359417|NCT00087178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6359418|NCT00087178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6359419|NCT00087178|Alkylating Agents|alkylating agents|mesh-ancestor
6359420|NCT00087178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359421|NCT00087178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359422|NCT00087178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6359423|NCT00087178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6359424|NCT00087178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6359425|NCT00087178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6359426|NCT00087178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6359427|NCT00087178|Antimetabolites|antimetabolites|mesh-ancestor
6359428|NCT00087178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6359429|NCT00087191|Motexafin lutetium|motexafin lutetium|mesh-list
6359430|NCT00087191|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6359431|NCT00087191|Dermatologic Agents|dermatologic agents|mesh-ancestor
6359432|NCT00087217|Paclitaxel|paclitaxel|mesh-list
6359433|NCT00087217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6359434|NCT00087217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359435|NCT00087217|Tubulin Modulators|tubulin modulators|mesh-ancestor
6359436|NCT00087217|Antimitotic Agents|antimitotic agents|mesh-ancestor
6359437|NCT00087217|Mitosis Modulators|mitosis modulators|mesh-ancestor
6359438|NCT00087217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359439|NCT00087256|Celecoxib|celecoxib|mesh-list
6359440|NCT00087256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6359441|NCT00087256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6359442|NCT00087256|Analgesics|analgesics|mesh-ancestor
6359443|NCT00087256|Sensory System Agents|sensory system agents|mesh-ancestor
6359444|NCT00087256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6359445|NCT00087256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359446|NCT00087256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6359447|NCT00087256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6359448|NCT00087256|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6359449|NCT00087256|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6359450|NCT00087256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6359451|NCT00087256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359452|NCT00087269|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6359453|NCT00087269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359454|NCT00087269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6359455|NCT00087269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6359456|NCT00087269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359457|NCT00087282|Irinotecan|irinotecan|mesh-list
6359458|NCT00087282|Alvocidib|alvocidib|mesh-list
6359459|NCT00087282|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6359460|NCT00087282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6359461|NCT00087282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6359462|NCT00087282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359463|NCT00087282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359464|NCT00087282|Growth Inhibitors|growth inhibitors|mesh-ancestor
6359465|NCT00087282|Growth Substances|growth substances|mesh-ancestor
6359466|NCT00087282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359467|NCT00087282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6359468|NCT00087295|Romidepsin|romidepsin|mesh-list
6359469|NCT00087295|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6359470|NCT00087295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359471|NCT00087334|Capecitabine|capecitabine|mesh-list
6359472|NCT00087334|Oxaliplatin|oxaliplatin|mesh-list
6359473|NCT00087334|Gefitinib|gefitinib|mesh-list
6359474|NCT00087334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6359475|NCT00087334|Antimetabolites|antimetabolites|mesh-ancestor
6359476|NCT00087334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359477|NCT00087334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359478|NCT00087334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6359479|NCT00087334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6359480|NCT00087347|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
6359481|NCT00087347|Hematinics|hematinics|mesh-ancestor
6359482|NCT00087347|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6359483|NCT00087347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6359484|NCT00087373|Metronidazole|metronidazole|mesh-list
6359485|NCT00087373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6359486|NCT00087373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6359487|NCT00087373|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6359488|NCT00087373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6359489|NCT00087399|Gabapentin|gabapentin|mesh-list
6359490|NCT00087399|Antidepressive Agents|antidepressive agents|mesh-list
6359491|NCT00087399|Analgesics|analgesics|mesh-ancestor
6359492|NCT00087399|Sensory System Agents|sensory system agents|mesh-ancestor
6359493|NCT00087399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6359494|NCT00087399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359495|NCT00087399|Anticonvulsants|anticonvulsants|mesh-ancestor
6359496|NCT00087399|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6359497|NCT00087399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6359498|NCT00087399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6359499|NCT00087399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6359500|NCT00087399|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6359501|NCT00087399|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6359502|NCT00087399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6359503|NCT00087399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359504|NCT00087399|Antimanic Agents|antimanic agents|mesh-ancestor
6359505|NCT00087412|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6359506|NCT00087412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359507|NCT00087412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6359508|NCT00087412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6359509|NCT00087412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359510|NCT00087425|Rituximab|rituximab|mesh-list
6359511|NCT00087425|Bryostatin 1|bryostatin 1|mesh-list
6359512|NCT00087425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6359513|NCT00087425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359514|NCT00087425|Immunologic Factors|immunologic factors|mesh-ancestor
6359515|NCT00087425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359516|NCT00087425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6359517|NCT00087425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6359518|NCT00087451|Sirolimus|sirolimus|mesh-list
6359519|NCT00087451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6359520|NCT00087451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6359521|NCT00087451|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6359522|NCT00087451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359523|NCT00087451|Antifungal Agents|antifungal agents|mesh-ancestor
6359524|NCT00087451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6359525|NCT00087451|Immunologic Factors|immunologic factors|mesh-ancestor
6359526|NCT00087451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359527|NCT00087464|Tenofovir|tenofovir|mesh-list
6359528|NCT00087464|Emtricitabine|emtricitabine|mesh-list
6359529|NCT00087464|Nevirapine|nevirapine|mesh-list
6359530|NCT00087464|Antiviral Agents|antiviral agents|mesh-ancestor
6359531|NCT00087464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6359532|NCT00087464|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6359533|NCT00087464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6359534|NCT00087464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6359535|NCT00087464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359536|NCT00087464|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6359537|NCT00087464|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6359538|NCT00087464|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6359539|NCT00087464|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6359540|NCT00087542|Pimavanserin|pimavanserin|mesh-list
6359541|NCT00087542|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6359542|NCT00087542|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6359543|NCT00087542|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6359544|NCT00087542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6359545|NCT00087542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6359546|NCT00087542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359547|NCT00087542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6359548|NCT00087542|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6359549|NCT00087542|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6359550|NCT00087542|Serotonin Agents|serotonin agents|mesh-ancestor
6359551|NCT00087542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6359552|NCT00087542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359553|NCT00087581|Cyclosporine|cyclosporine|mesh-list
6359554|NCT00087581|Mycophenolic Acid|mycophenolic acid|mesh-list
6359555|NCT00087581|Tacrolimus|tacrolimus|mesh-list
6359556|NCT00087581|Cyclosporins|cyclosporins|mesh-list
6359557|NCT00087581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6359558|NCT00087581|Immunologic Factors|immunologic factors|mesh-ancestor
6359559|NCT00087581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359560|NCT00087581|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6359561|NCT00087581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6359562|NCT00087581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359563|NCT00087581|Antifungal Agents|antifungal agents|mesh-ancestor
6359564|NCT00087581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6359565|NCT00087581|Dermatologic Agents|dermatologic agents|mesh-ancestor
6359566|NCT00087581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6359567|NCT00087581|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6359568|NCT00087581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359569|NCT00087581|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6359570|NCT00087581|Antitubercular Agents|antitubercular agents|mesh-ancestor
6359571|NCT00087581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6359572|NCT00087620|Capecitabine|capecitabine|mesh-list
6359573|NCT00087620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6359574|NCT00087620|Antimetabolites|antimetabolites|mesh-ancestor
6359575|NCT00087620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359576|NCT00087620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359577|NCT00087659|Zoledronic Acid|zoledronic acid|mesh-list
6359578|NCT00087659|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6359579|NCT00087659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359580|NCT00087711|Gemcitabine|gemcitabine|mesh-list
6359581|NCT00087711|Pemetrexed|pemetrexed|mesh-list
6359582|NCT00087711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359583|NCT00087711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6359584|NCT00087711|Antimetabolites|antimetabolites|mesh-ancestor
6359585|NCT00087711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359586|NCT00087711|Antiviral Agents|antiviral agents|mesh-ancestor
6359587|NCT00087711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6359588|NCT00087711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6359589|NCT00087711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6359590|NCT00087711|Immunologic Factors|immunologic factors|mesh-ancestor
6359591|NCT00087711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359592|NCT00087711|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6359593|NCT00087711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6359594|NCT00087737|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6359595|NCT00087737|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6359596|NCT00087737|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6359597|NCT00087737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6359598|NCT00087737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359599|NCT00087737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6359600|NCT00087737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359601|NCT00087737|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6359602|NCT00087737|Antidepressive Agents|antidepressive agents|mesh-ancestor
6359603|NCT00087737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6359604|NCT00087750|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6359605|NCT00087750|Antidepressive Agents|antidepressive agents|mesh-ancestor
6359606|NCT00087750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6359607|NCT00087750|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6359608|NCT00087750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6359609|NCT00087750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6359610|NCT00087750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359611|NCT00087802|Gemcitabine|gemcitabine|mesh-list
6359612|NCT00087802|Paclitaxel|paclitaxel|mesh-list
6359613|NCT00087802|Carboplatin|carboplatin|mesh-list
6359614|NCT00087802|Oxaliplatin|oxaliplatin|mesh-list
6359615|NCT00087802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6359616|NCT00087802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359617|NCT00087802|Tubulin Modulators|tubulin modulators|mesh-ancestor
6359618|NCT00087802|Antimitotic Agents|antimitotic agents|mesh-ancestor
6359619|NCT00087802|Mitosis Modulators|mitosis modulators|mesh-ancestor
6359620|NCT00087802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359621|NCT00087802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6359622|NCT00087802|Antimetabolites|antimetabolites|mesh-ancestor
6359623|NCT00087802|Antiviral Agents|antiviral agents|mesh-ancestor
6359624|NCT00087802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6359625|NCT00087802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6359626|NCT00087802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6359627|NCT00087802|Immunologic Factors|immunologic factors|mesh-ancestor
6359628|NCT00087802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359629|NCT00087815|Dexamethasone|dexamethasone|mesh-list
6359630|NCT00087815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6359631|NCT00087815|Antiemetics|antiemetics|mesh-ancestor
6359632|NCT00087815|Autonomic Agents|autonomic agents|mesh-ancestor
6359633|NCT00087815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6359634|NCT00087815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359635|NCT00087815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6359636|NCT00087815|Glucocorticoids|glucocorticoids|mesh-ancestor
6359637|NCT00087815|Hormones|hormones|mesh-ancestor
6359638|NCT00087815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6359639|NCT00087815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6359640|NCT00087815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359641|NCT00087841|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
6359642|NCT00087841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6359643|NCT00087841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359644|NCT00087854|Amonafide|amonafide|mesh-list
6359645|NCT00087854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359646|NCT00087854|Antiviral Agents|antiviral agents|mesh-ancestor
6359647|NCT00087854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6359648|NCT00087854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6359649|NCT00087854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359650|NCT00087867|Bortezomib|bortezomib|mesh-list
6359651|NCT00087867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359652|NCT00087880|Bupropion|bupropion|mesh-list
6359653|NCT00087880|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6359654|NCT00087880|Antidepressive Agents|antidepressive agents|mesh-ancestor
6359655|NCT00087880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6359656|NCT00087880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6359657|NCT00087880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6359658|NCT00087880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6359659|NCT00087880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359660|NCT00087880|Dopamine Agents|dopamine agents|mesh-ancestor
6359661|NCT00087880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6359662|NCT00087880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359663|NCT00087880|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6359664|NCT00087880|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6359665|NCT00087880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6359666|NCT00087945|Lamivudine|lamivudine|mesh-list
6359667|NCT00087945|Zidovudine|zidovudine|mesh-list
6359668|NCT00087945|Abacavir|abacavir|mesh-list
6359669|NCT00087945|Dideoxynucleosides|dideoxynucleosides|mesh-list
6359670|NCT00087945|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6359671|NCT00087945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6359672|NCT00087945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6359673|NCT00087945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359674|NCT00087945|Antiviral Agents|antiviral agents|mesh-ancestor
6359675|NCT00087945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6359676|NCT00087945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6359677|NCT00087945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6359678|NCT00087945|Antimetabolites|antimetabolites|mesh-ancestor
6359679|NCT00088036|Olanzapine|olanzapine|mesh-list
6359680|NCT00088036|Antiemetics|antiemetics|mesh-ancestor
6359681|NCT00088036|Autonomic Agents|autonomic agents|mesh-ancestor
6359682|NCT00088036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6359683|NCT00088036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359684|NCT00088036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6359685|NCT00088036|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6359686|NCT00088036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6359687|NCT00088036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6359688|NCT00088036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6359689|NCT00088036|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6359690|NCT00088036|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6359691|NCT00088036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6359692|NCT00088036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359693|NCT00088036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6359694|NCT00088036|Serotonin Agents|serotonin agents|mesh-ancestor
6359695|NCT00088049|Olanzapine|olanzapine|mesh-list
6359696|NCT00088049|Aripiprazole|aripiprazole|mesh-list
6359697|NCT00088049|Antiemetics|antiemetics|mesh-ancestor
6359698|NCT00088049|Autonomic Agents|autonomic agents|mesh-ancestor
6359699|NCT00088049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6359700|NCT00088049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359701|NCT00088049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6359702|NCT00088049|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6359703|NCT00088049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6359704|NCT00088049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6359705|NCT00088049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6359706|NCT00088049|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6359707|NCT00088049|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6359708|NCT00088049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6359709|NCT00088049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359710|NCT00088049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6359711|NCT00088049|Serotonin Agents|serotonin agents|mesh-ancestor
6359712|NCT00088049|Antidepressive Agents|antidepressive agents|mesh-ancestor
6359713|NCT00088049|Dopamine Agonists|dopamine agonists|mesh-ancestor
6359714|NCT00088049|Dopamine Agents|dopamine agents|mesh-ancestor
6359715|NCT00088049|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6359716|NCT00088049|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6359717|NCT00088049|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6359718|NCT00088049|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6359719|NCT00088049|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6359720|NCT00088049|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6359721|NCT00088075|Risperidone|risperidone|mesh-list
6359722|NCT00088075|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6359723|NCT00088075|Serotonin Agents|serotonin agents|mesh-ancestor
6359724|NCT00088075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6359725|NCT00088075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359726|NCT00088075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359727|NCT00088075|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6359728|NCT00088075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6359729|NCT00088075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6359730|NCT00088075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6359731|NCT00088075|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6359732|NCT00088075|Dopamine Agents|dopamine agents|mesh-ancestor
6359733|NCT00088088|Paclitaxel|paclitaxel|mesh-list
6359734|NCT00088088|Carboplatin|carboplatin|mesh-list
6359735|NCT00088088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6359736|NCT00088088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359737|NCT00088088|Tubulin Modulators|tubulin modulators|mesh-ancestor
6359738|NCT00088088|Antimitotic Agents|antimitotic agents|mesh-ancestor
6359739|NCT00088088|Mitosis Modulators|mitosis modulators|mesh-ancestor
6359740|NCT00088088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359741|NCT00088114|Paclitaxel|paclitaxel|mesh-list
6359742|NCT00088114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6359743|NCT00088114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359744|NCT00088114|Tubulin Modulators|tubulin modulators|mesh-ancestor
6359745|NCT00088114|Antimitotic Agents|antimitotic agents|mesh-ancestor
6359746|NCT00088114|Mitosis Modulators|mitosis modulators|mesh-ancestor
6359747|NCT00088114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359748|NCT00088231|Imatinib Mesylate|imatinib mesylate|mesh-list
6359749|NCT00088231|Vatalanib|vatalanib|mesh-list
6359750|NCT00088231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359751|NCT00088231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6359752|NCT00088231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6359753|NCT00088231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359754|NCT00088270|Leucovorin|leucovorin|mesh-list
6359755|NCT00088270|Fluorouracil|fluorouracil|mesh-list
6359756|NCT00088270|Antimetabolites|antimetabolites|mesh-ancestor
6359757|NCT00088270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359758|NCT00088270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6359759|NCT00088270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359760|NCT00088270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6359761|NCT00088270|Immunologic Factors|immunologic factors|mesh-ancestor
6359762|NCT00088270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359763|NCT00088270|Antidotes|antidotes|mesh-ancestor
6359764|NCT00088270|Protective Agents|protective agents|mesh-ancestor
6359765|NCT00088270|Vitamin B Complex|vitamin b complex|mesh-ancestor
6359766|NCT00088270|Vitamins|vitamins|mesh-ancestor
6359767|NCT00088270|Micronutrients|micronutrients|mesh-ancestor
6359768|NCT00088387|Valproic Acid|valproic acid|mesh-list
6359769|NCT00088387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6359770|NCT00088387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6359771|NCT00088387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359772|NCT00088387|Antimanic Agents|antimanic agents|mesh-ancestor
6359773|NCT00088387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6359774|NCT00088387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6359775|NCT00088387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359776|NCT00088387|Anticonvulsants|anticonvulsants|mesh-ancestor
6359777|NCT00088387|GABA Agents|gaba agents|mesh-ancestor
6359778|NCT00088387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6359779|NCT00088478|Olanzapine|olanzapine|mesh-list
6359780|NCT00088478|Antiemetics|antiemetics|mesh-ancestor
6359781|NCT00088478|Autonomic Agents|autonomic agents|mesh-ancestor
6359782|NCT00088478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6359783|NCT00088478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359784|NCT00088478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6359785|NCT00088478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6359786|NCT00088478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6359787|NCT00088478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6359788|NCT00088478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6359789|NCT00088478|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6359790|NCT00088478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6359791|NCT00088478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6359792|NCT00088478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359793|NCT00088478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6359794|NCT00088478|Serotonin Agents|serotonin agents|mesh-ancestor
6359795|NCT00088491|Olanzapine|olanzapine|mesh-list
6359796|NCT00088491|Antiemetics|antiemetics|mesh-ancestor
6359797|NCT00088491|Autonomic Agents|autonomic agents|mesh-ancestor
6359798|NCT00088491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6359799|NCT00088491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359800|NCT00088491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6359801|NCT00088491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6359802|NCT00088491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6359803|NCT00088491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6359804|NCT00088491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6359805|NCT00088491|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6359806|NCT00088491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6359807|NCT00088491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6359808|NCT00088491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359809|NCT00088491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6359810|NCT00088491|Serotonin Agents|serotonin agents|mesh-ancestor
6359811|NCT00088504|Interferons|interferons|mesh-list
6359812|NCT00088504|Ribavirin|ribavirin|mesh-list
6359813|NCT00088504|Interferon-alpha|interferon-alpha|mesh-list
6359814|NCT00088504|Interferon alpha-2|interferon alpha-2|mesh-list
6359815|NCT00088504|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6359816|NCT00088504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359817|NCT00088504|Antiviral Agents|antiviral agents|mesh-ancestor
6359818|NCT00088504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6359819|NCT00088504|Antimetabolites|antimetabolites|mesh-ancestor
6359820|NCT00088504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359821|NCT00088504|Immunologic Factors|immunologic factors|mesh-ancestor
6359822|NCT00088504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359823|NCT00088543|Thymoglobulin|thymoglobulin|mesh-list
6359824|NCT00088543|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6359825|NCT00088543|Immunologic Factors|immunologic factors|mesh-ancestor
6359826|NCT00088543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359827|NCT00088543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6359828|NCT00088556|Paclitaxel|paclitaxel|mesh-list
6359829|NCT00088556|Carboplatin|carboplatin|mesh-list
6359830|NCT00088556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6359831|NCT00088556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359832|NCT00088556|Tubulin Modulators|tubulin modulators|mesh-ancestor
6359833|NCT00088556|Antimitotic Agents|antimitotic agents|mesh-ancestor
6359834|NCT00088556|Mitosis Modulators|mitosis modulators|mesh-ancestor
6359835|NCT00088556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359836|NCT00088582|Octreotide|octreotide|mesh-list
6359837|NCT00088582|Pasireotide|pasireotide|mesh-list
6359838|NCT00088582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6359839|NCT00088582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6359840|NCT00088582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359841|NCT00088582|Hormones|hormones|mesh-ancestor
6359842|NCT00088582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6359843|NCT00088582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359844|NCT00088608|Pasireotide|pasireotide|mesh-list
6359845|NCT00088608|Hormones|hormones|mesh-ancestor
6359846|NCT00088608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6359847|NCT00088608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359848|NCT00088686|Capsaicin|capsaicin|mesh-list
6359849|NCT00088686|Antipruritics|antipruritics|mesh-ancestor
6359850|NCT00088686|Dermatologic Agents|dermatologic agents|mesh-ancestor
6359851|NCT00088686|Sensory System Agents|sensory system agents|mesh-ancestor
6359852|NCT00088686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6359853|NCT00088686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359854|NCT00088816|Tegafur|tegafur|mesh-list
6359855|NCT00088816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359856|NCT00088816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6359857|NCT00088816|Antimetabolites|antimetabolites|mesh-ancestor
6359858|NCT00088816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359859|NCT00088855|Doxorubicin|doxorubicin|mesh-list
6359860|NCT00088855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6359861|NCT00088855|Bortezomib|bortezomib|mesh-list
6359862|NCT00088855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6359863|NCT00088855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359864|NCT00088855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6359865|NCT00088855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6359866|NCT00088855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6359867|NCT00088855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359868|NCT00088894|Gemcitabine|gemcitabine|mesh-list
6359869|NCT00088894|Bevacizumab|bevacizumab|mesh-list
6359870|NCT00088894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6359871|NCT00088894|Antibodies|antibodies|mesh-list
6359872|NCT00088894|Immunoglobulins|immunoglobulins|mesh-list
6359873|NCT00088894|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6359874|NCT00088894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359875|NCT00088894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6359876|NCT00088894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6359877|NCT00088894|Growth Substances|growth substances|mesh-ancestor
6359878|NCT00088894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018497|NCT00381095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6359879|NCT00088894|Growth Inhibitors|growth inhibitors|mesh-ancestor
6359880|NCT00088894|Immunologic Factors|immunologic factors|mesh-ancestor
6359881|NCT00088894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6359882|NCT00088894|Antimetabolites|antimetabolites|mesh-ancestor
6359883|NCT00088894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359884|NCT00088894|Antiviral Agents|antiviral agents|mesh-ancestor
6359885|NCT00088894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6359886|NCT00088894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6359887|NCT00088894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6359888|NCT00088933|Metronidazole|metronidazole|mesh-list
6359889|NCT00088933|Docetaxel|docetaxel|mesh-list
6359890|NCT00088933|Vaccines|vaccines|mesh-list
6359891|NCT00088933|Sargramostim|sargramostim|mesh-list
6359892|NCT00088933|Immunologic Factors|immunologic factors|mesh-ancestor
6359893|NCT00088933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359894|NCT00088933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359895|NCT00088933|Tubulin Modulators|tubulin modulators|mesh-ancestor
6359896|NCT00088933|Antimitotic Agents|antimitotic agents|mesh-ancestor
6359897|NCT00088933|Mitosis Modulators|mitosis modulators|mesh-ancestor
6359898|NCT00088933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359899|NCT00088933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6359900|NCT00088933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6359901|NCT00088933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6359902|NCT00088933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6359903|NCT00088946|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6359904|NCT00088946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359905|NCT00088946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6359906|NCT00088946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6359907|NCT00088946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359908|NCT00088959|Celecoxib|celecoxib|mesh-list
6359909|NCT00088959|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6359910|NCT00088959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359911|NCT00088959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6359912|NCT00088959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6359913|NCT00088959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359914|NCT00088959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6359915|NCT00088959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6359916|NCT00088959|Analgesics|analgesics|mesh-ancestor
6359917|NCT00088959|Sensory System Agents|sensory system agents|mesh-ancestor
6359918|NCT00088959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6359919|NCT00088959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359920|NCT00088959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6359921|NCT00088959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6359922|NCT00088959|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6359923|NCT00088959|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6359924|NCT00088998|Bevacizumab|bevacizumab|mesh-list
6359925|NCT00088998|Docetaxel|docetaxel|mesh-list
6359926|NCT00088998|Capecitabine|capecitabine|mesh-list
6359927|NCT00088998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6359928|NCT00088998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359929|NCT00088998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6359930|NCT00088998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6359931|NCT00088998|Growth Substances|growth substances|mesh-ancestor
6359932|NCT00088998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359933|NCT00088998|Growth Inhibitors|growth inhibitors|mesh-ancestor
6359934|NCT00088998|Tubulin Modulators|tubulin modulators|mesh-ancestor
6359935|NCT00088998|Antimitotic Agents|antimitotic agents|mesh-ancestor
6359936|NCT00088998|Mitosis Modulators|mitosis modulators|mesh-ancestor
6359937|NCT00088998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359938|NCT00088998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6359939|NCT00088998|Antimetabolites|antimetabolites|mesh-ancestor
6394800|NCT00203320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6394801|NCT00203320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6394802|NCT00203320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6394803|NCT00203320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6394804|NCT00203320|Immunologic Factors|immunologic factors|mesh-ancestor
6394805|NCT00203359|Etanercept|etanercept|mesh-list
6394806|NCT00203359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6394807|NCT00203359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6359940|NCT00089037|Sirolimus|sirolimus|mesh-list
6359941|NCT00089037|Methotrexate|methotrexate|mesh-list
6359942|NCT00089037|Tacrolimus|tacrolimus|mesh-list
6359943|NCT00089037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6359944|NCT00089037|Abortifacient Agents|abortifacient agents|mesh-ancestor
6359945|NCT00089037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6359946|NCT00089037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359947|NCT00089037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6359948|NCT00089037|Antimetabolites|antimetabolites|mesh-ancestor
6359949|NCT00089037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359950|NCT00089037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359951|NCT00089037|Dermatologic Agents|dermatologic agents|mesh-ancestor
6359952|NCT00089037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6359953|NCT00089037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6359954|NCT00089037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6359955|NCT00089037|Immunologic Factors|immunologic factors|mesh-ancestor
6359956|NCT00089037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6359957|NCT00089037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6359958|NCT00089037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6359959|NCT00089037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6359960|NCT00089037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6359961|NCT00089037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6359962|NCT00089037|Antifungal Agents|antifungal agents|mesh-ancestor
6359963|NCT00089050|Cyclosporine|cyclosporine|mesh-list
6359964|NCT00089050|Gemtuzumab|gemtuzumab|mesh-list
6359965|NCT00089050|Cyclosporins|cyclosporins|mesh-list
6359966|NCT00089050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6359967|NCT00089050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359968|NCT00089050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6359969|NCT00089050|Immunologic Factors|immunologic factors|mesh-ancestor
6359970|NCT00089050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359971|NCT00089050|Antifungal Agents|antifungal agents|mesh-ancestor
6359972|NCT00089050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6359973|NCT00089050|Dermatologic Agents|dermatologic agents|mesh-ancestor
6359974|NCT00089050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6359975|NCT00089050|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6359976|NCT00089050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6359977|NCT00089050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6017204|NCT00370071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6017205|NCT00370071|Antiviral Agents|antiviral agents|mesh-ancestor
6017206|NCT00370071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6359978|NCT00089063|Sargramostim|sargramostim|mesh-list
6359979|NCT00089063|Freund's Adjuvant|freund's adjuvant|mesh-list
6359980|NCT00089063|Immunologic Factors|immunologic factors|mesh-ancestor
6359981|NCT00089063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6359982|NCT00089063|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6359983|NCT00089089|Decitabine|decitabine|mesh-list
6359984|NCT00089089|Azacitidine|azacitidine|mesh-list
6359985|NCT00089089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6359986|NCT00089089|Antimetabolites|antimetabolites|mesh-ancestor
6359987|NCT00089089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6359988|NCT00089089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359989|NCT00089089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6359990|NCT00089115|Rituximab|rituximab|mesh-list
6359991|NCT00089115|Immunoglobulins|immunoglobulins|mesh-list
6359992|NCT00089115|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6359993|NCT00089115|Antibodies|antibodies|mesh-list
6359994|NCT00089115|Sargramostim|sargramostim|mesh-list
6359995|NCT00089115|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
6359996|NCT00089115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6359997|NCT00089115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6359998|NCT00089115|Immunologic Factors|immunologic factors|mesh-ancestor
6359999|NCT00089115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360000|NCT00089115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6360001|NCT00089154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6360002|NCT00089154|Antibodies|antibodies|mesh-list
6360003|NCT00089154|Immunoglobulins|immunoglobulins|mesh-list
6360004|NCT00089154|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6360005|NCT00089154|Immunologic Factors|immunologic factors|mesh-ancestor
6360006|NCT00089154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360007|NCT00089154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6360008|NCT00089167|Thalidomide|thalidomide|mesh-list
6360009|NCT00089167|Dexamethasone|dexamethasone|mesh-list
6360010|NCT00089167|Melphalan|melphalan|mesh-list
6360011|NCT00089167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6360012|NCT00089167|Antiemetics|antiemetics|mesh-ancestor
6017207|NCT00370071|Immunologic Factors|immunologic factors|mesh-ancestor
6360013|NCT00089167|Autonomic Agents|autonomic agents|mesh-ancestor
6360014|NCT00089167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6360015|NCT00089167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360016|NCT00089167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6360017|NCT00089167|Glucocorticoids|glucocorticoids|mesh-ancestor
6360018|NCT00089167|Hormones|hormones|mesh-ancestor
6360019|NCT00089167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6360020|NCT00089167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6360021|NCT00089167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6360022|NCT00089167|Immunologic Factors|immunologic factors|mesh-ancestor
6360023|NCT00089167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6360024|NCT00089167|Alkylating Agents|alkylating agents|mesh-ancestor
6360025|NCT00089167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360026|NCT00089167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6360027|NCT00089167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6360028|NCT00089167|Leprostatic Agents|leprostatic agents|mesh-ancestor
6360029|NCT00089167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6360030|NCT00089167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6360031|NCT00089167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6360032|NCT00089167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6360033|NCT00089167|Growth Substances|growth substances|mesh-ancestor
6360034|NCT00089167|Growth Inhibitors|growth inhibitors|mesh-ancestor
6360035|NCT00089193|Sargramostim|sargramostim|mesh-list
6360036|NCT00089193|Freund's Adjuvant|freund's adjuvant|mesh-list
6360037|NCT00089193|Immunologic Factors|immunologic factors|mesh-ancestor
6360038|NCT00089193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360039|NCT00089193|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6360040|NCT00089206|Sargramostim|sargramostim|mesh-list
6360041|NCT00089206|Freund's Adjuvant|freund's adjuvant|mesh-list
6360042|NCT00089206|Immunologic Factors|immunologic factors|mesh-ancestor
6360043|NCT00089206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360044|NCT00089206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6360045|NCT00089219|Sargramostim|sargramostim|mesh-list
6360046|NCT00089219|Freund's Adjuvant|freund's adjuvant|mesh-list
6360047|NCT00089219|Immunologic Factors|immunologic factors|mesh-ancestor
6360048|NCT00089219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360049|NCT00089219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6360050|NCT00089258|Isotretinoin|isotretinoin|mesh-list
6360051|NCT00089258|Antibodies|antibodies|mesh-list
6360052|NCT00089258|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6360053|NCT00089258|Sargramostim|sargramostim|mesh-list
6360054|NCT00089258|Immunologic Factors|immunologic factors|mesh-ancestor
6360055|NCT00089258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360056|NCT00089258|Dermatologic Agents|dermatologic agents|mesh-ancestor
6360057|NCT00089349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6360058|NCT00089349|Alemtuzumab|alemtuzumab|mesh-list
6360059|NCT00089349|Methotrexate|methotrexate|mesh-list
6360060|NCT00089349|Mercaptopurine|mercaptopurine|mesh-list
6360061|NCT00089349|Antibodies|antibodies|mesh-list
6360062|NCT00089349|Immunoglobulins|immunoglobulins|mesh-list
6360063|NCT00089349|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6360064|NCT00089349|Immunologic Factors|immunologic factors|mesh-ancestor
6360065|NCT00089349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360066|NCT00089349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6360067|NCT00089349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6360068|NCT00089349|Abortifacient Agents|abortifacient agents|mesh-ancestor
6360069|NCT00089349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6360070|NCT00089349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6360071|NCT00089349|Antimetabolites|antimetabolites|mesh-ancestor
6360072|NCT00089349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360073|NCT00089349|Dermatologic Agents|dermatologic agents|mesh-ancestor
6360074|NCT00089349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6360075|NCT00089349|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6360076|NCT00089349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6360077|NCT00089349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6360078|NCT00089349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6360079|NCT00089401|Melphalan|melphalan|mesh-list
6360080|NCT00089401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6360081|NCT00089401|Alkylating Agents|alkylating agents|mesh-ancestor
6360082|NCT00089401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360083|NCT00089401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6360084|NCT00089401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6360085|NCT00089401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6360086|NCT00089401|Immunologic Factors|immunologic factors|mesh-ancestor
6360087|NCT00089401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360088|NCT00089427|Temozolomide|temozolomide|mesh-list
6360089|NCT00089427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6360090|NCT00089427|Alkylating Agents|alkylating agents|mesh-ancestor
6360091|NCT00089427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360092|NCT00089427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6360093|NCT00089440|Aripiprazole|aripiprazole|mesh-list
6360094|NCT00089440|Antidepressive Agents|antidepressive agents|mesh-ancestor
6360095|NCT00089440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6360096|NCT00089440|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6360097|NCT00089440|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6360098|NCT00089440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6360099|NCT00089440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360100|NCT00089440|Dopamine Agonists|dopamine agonists|mesh-ancestor
6360101|NCT00089440|Dopamine Agents|dopamine agents|mesh-ancestor
6360102|NCT00089440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6360103|NCT00089440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360104|NCT00089440|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6360105|NCT00089440|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6360106|NCT00089440|Serotonin Agents|serotonin agents|mesh-ancestor
6360107|NCT00089440|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6360108|NCT00089440|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6360109|NCT00089440|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6360110|NCT00089440|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6360111|NCT00089453|Dexamethasone|dexamethasone|mesh-list
6360112|NCT00089453|Cyclophosphamide|cyclophosphamide|mesh-list
6360113|NCT00089453|Melphalan|melphalan|mesh-list
6360114|NCT00089453|Fludarabine|fludarabine|mesh-list
6360115|NCT00089453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6360116|NCT00089453|Immunologic Factors|immunologic factors|mesh-ancestor
6360117|NCT00089453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360118|NCT00089453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6360119|NCT00089453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6360120|NCT00089453|Alkylating Agents|alkylating agents|mesh-ancestor
6360121|NCT00089453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360122|NCT00089453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6360123|NCT00089453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6360124|NCT00089453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6360125|NCT00089453|Antiemetics|antiemetics|mesh-ancestor
6360126|NCT00089453|Autonomic Agents|autonomic agents|mesh-ancestor
6360127|NCT00089453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6360128|NCT00089453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6360129|NCT00089453|Glucocorticoids|glucocorticoids|mesh-ancestor
6360130|NCT00089453|Hormones|hormones|mesh-ancestor
6360131|NCT00089453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6360132|NCT00089453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6360133|NCT00089492|Enfuvirtide|enfuvirtide|mesh-list
6360134|NCT00089492|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6360135|NCT00089492|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6360136|NCT00089492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360137|NCT00089492|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6360138|NCT00089492|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6360139|NCT00089492|Antiviral Agents|antiviral agents|mesh-ancestor
6360140|NCT00089492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6360141|NCT00089518|Valsartan|valsartan|mesh-list
6360142|NCT00089518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6360143|NCT00089518|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6360144|NCT00089518|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6360145|NCT00089518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360146|NCT00089557|Capsaicin|capsaicin|mesh-list
6360147|NCT00089557|Antipruritics|antipruritics|mesh-ancestor
6360148|NCT00089557|Dermatologic Agents|dermatologic agents|mesh-ancestor
6360149|NCT00089557|Sensory System Agents|sensory system agents|mesh-ancestor
6360150|NCT00089557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6360151|NCT00089557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360152|NCT00089570|Terlipressin|terlipressin|mesh-list
6360153|NCT00089570|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6360154|NCT00089570|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6360155|NCT00089622|Levodopa|levodopa|mesh-list
6360156|NCT00089622|Lisuride|lisuride|mesh-list
6360157|NCT00089622|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6360158|NCT00089622|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6360159|NCT00089622|Dopamine Agents|dopamine agents|mesh-ancestor
6360160|NCT00089622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6360161|NCT00089622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360162|NCT00089622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360163|NCT00089622|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6360164|NCT00089622|Serotonin Agents|serotonin agents|mesh-ancestor
6360165|NCT00089622|Dopamine Agonists|dopamine agonists|mesh-ancestor
6360166|NCT00089687|Vanoxerine|vanoxerine|mesh-list
6360167|NCT00089687|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6360168|NCT00089687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6360169|NCT00089687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6360170|NCT00089687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360171|NCT00089687|Dopamine Agents|dopamine agents|mesh-ancestor
6360172|NCT00089687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6360173|NCT00089687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360174|NCT00089700|Ibalizumab|ibalizumab|mesh-list
6360175|NCT00089700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6360176|NCT00089700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6360177|NCT00089700|Antiviral Agents|antiviral agents|mesh-ancestor
6360178|NCT00089700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6360179|NCT00089726|Cyclophosphamide|cyclophosphamide|mesh-list
6360180|NCT00089726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6360181|NCT00089726|Immunologic Factors|immunologic factors|mesh-ancestor
6360182|NCT00089726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360183|NCT00089726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6360184|NCT00089726|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6360185|NCT00089726|Alkylating Agents|alkylating agents|mesh-ancestor
6360186|NCT00089726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360187|NCT00089726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6360188|NCT00089726|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6360189|NCT00089765|Ranibizumab|ranibizumab|mesh-list
6360190|NCT00089765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6360191|NCT00089765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6360192|NCT00089765|Growth Substances|growth substances|mesh-ancestor
6360193|NCT00089765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360194|NCT00089765|Growth Inhibitors|growth inhibitors|mesh-ancestor
6360195|NCT00089765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6360196|NCT00089804|Abetimus|abetimus|mesh-list
6360197|NCT00089804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6360198|NCT00089804|Immunologic Factors|immunologic factors|mesh-ancestor
6360199|NCT00089804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360200|NCT00089830|Squalamine|squalamine|mesh-list
6360201|NCT00089830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6360202|NCT00089830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6360203|NCT00089830|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6360204|NCT00089830|Protective Agents|protective agents|mesh-ancestor
6360205|NCT00089830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360206|NCT00089830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6360207|NCT00089830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6360208|NCT00089830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6360209|NCT00089830|Growth Substances|growth substances|mesh-ancestor
6360210|NCT00089830|Growth Inhibitors|growth inhibitors|mesh-ancestor
6360211|NCT00089856|Prednisone|prednisone|mesh-list
6360212|NCT00089856|Docetaxel|docetaxel|mesh-list
6360213|NCT00089856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6360214|NCT00089856|Glucocorticoids|glucocorticoids|mesh-ancestor
6360215|NCT00089856|Hormones|hormones|mesh-ancestor
6360216|NCT00089856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6360217|NCT00089856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360218|NCT00089856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6360219|NCT00089856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6360220|NCT00089856|Tubulin Modulators|tubulin modulators|mesh-ancestor
6360221|NCT00089856|Antimitotic Agents|antimitotic agents|mesh-ancestor
6360222|NCT00089856|Mitosis Modulators|mitosis modulators|mesh-ancestor
6360223|NCT00089856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360224|NCT00089869|Olanzapine|olanzapine|mesh-list
6360225|NCT00089869|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6360226|NCT00089869|Antiemetics|antiemetics|mesh-ancestor
6360227|NCT00089869|Autonomic Agents|autonomic agents|mesh-ancestor
6360228|NCT00089869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6360229|NCT00089869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360230|NCT00089869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6360231|NCT00089869|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6360232|NCT00089869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6360233|NCT00089869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6360234|NCT00089869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6360235|NCT00089869|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6360236|NCT00089869|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6360237|NCT00089869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6360238|NCT00089869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360239|NCT00089869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6360240|NCT00089869|Serotonin Agents|serotonin agents|mesh-ancestor
6360241|NCT00089869|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6360242|NCT00089869|Adrenergic Agents|adrenergic agents|mesh-ancestor
6360243|NCT00089947|Thymoglobulin|thymoglobulin|mesh-list
6360244|NCT00089947|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6360245|NCT00089947|Immunologic Factors|immunologic factors|mesh-ancestor
6360246|NCT00089947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360247|NCT00089947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6360248|NCT00089960|Motesanib diphosphate|motesanib diphosphate|mesh-list
6360249|NCT00089960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6360250|NCT00089960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6360251|NCT00089960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360252|NCT00090012|Olanzapine|olanzapine|mesh-list
6360253|NCT00090012|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6360254|NCT00090012|Antiemetics|antiemetics|mesh-ancestor
6360255|NCT00090012|Autonomic Agents|autonomic agents|mesh-ancestor
6360256|NCT00090012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6360257|NCT00090012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360258|NCT00090012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6360259|NCT00090012|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6360260|NCT00090012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6360261|NCT00090012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6360262|NCT00090012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6360263|NCT00090012|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6360264|NCT00090012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6360265|NCT00090012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6360266|NCT00090012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360267|NCT00090012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6360268|NCT00090012|Serotonin Agents|serotonin agents|mesh-ancestor
6360269|NCT00090012|Antidepressive Agents|antidepressive agents|mesh-ancestor
6360270|NCT00090025|Leucovorin|leucovorin|mesh-list
6360271|NCT00090025|Fluorouracil|fluorouracil|mesh-list
6360272|NCT00090025|Antimetabolites|antimetabolites|mesh-ancestor
6360273|NCT00090025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360274|NCT00090025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6360275|NCT00090025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6360276|NCT00090025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6360277|NCT00090025|Immunologic Factors|immunologic factors|mesh-ancestor
6360278|NCT00090025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360279|NCT00090025|Antidotes|antidotes|mesh-ancestor
6360280|NCT00090025|Protective Agents|protective agents|mesh-ancestor
6360281|NCT00090025|Vitamin B Complex|vitamin b complex|mesh-ancestor
6360282|NCT00090025|Vitamins|vitamins|mesh-ancestor
6360283|NCT00090025|Micronutrients|micronutrients|mesh-ancestor
6360284|NCT00090038|Rituximab|rituximab|mesh-list
6360285|NCT00090038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6360286|NCT00090038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6360287|NCT00090038|Immunologic Factors|immunologic factors|mesh-ancestor
6360288|NCT00090038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360289|NCT00090038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6360290|NCT00090090|Elsamicin A|elsamicin a|mesh-list
6360291|NCT00090090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6360292|NCT00090090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6360293|NCT00090155|Ondansetron|ondansetron|mesh-list
6360294|NCT00090155|Aprepitant|aprepitant|mesh-list
6360295|NCT00090155|Antiemetics|antiemetics|mesh-ancestor
6360296|NCT00090155|Autonomic Agents|autonomic agents|mesh-ancestor
6360297|NCT00090155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6360298|NCT00090155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360299|NCT00090155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6360300|NCT00090155|Antipruritics|antipruritics|mesh-ancestor
6360301|NCT00090155|Dermatologic Agents|dermatologic agents|mesh-ancestor
6360302|NCT00090155|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6360303|NCT00090155|Serotonin Agents|serotonin agents|mesh-ancestor
6360304|NCT00090155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6360305|NCT00090155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360306|NCT00090155|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6360307|NCT00090155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6360308|NCT00090155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6360309|NCT00090155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6360310|NCT00090155|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6360311|NCT00090155|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6360312|NCT00090194|Immunoglobulins|immunoglobulins|mesh-list
6360313|NCT00090194|Antibodies|antibodies|mesh-list
6360314|NCT00090194|gamma-Globulins|gamma-globulins|mesh-list
6360315|NCT00090194|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6360316|NCT00090194|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6360317|NCT00090194|Immunologic Factors|immunologic factors|mesh-ancestor
6360318|NCT00090194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360319|NCT00090207|Ondansetron|ondansetron|mesh-list
6360320|NCT00090207|Aprepitant|aprepitant|mesh-list
6360321|NCT00090207|Antiemetics|antiemetics|mesh-ancestor
6360322|NCT00090207|Autonomic Agents|autonomic agents|mesh-ancestor
6360323|NCT00090207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6360324|NCT00090207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360325|NCT00090207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6360326|NCT00090207|Antipruritics|antipruritics|mesh-ancestor
6360327|NCT00090207|Dermatologic Agents|dermatologic agents|mesh-ancestor
6360328|NCT00090207|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6360329|NCT00090207|Serotonin Agents|serotonin agents|mesh-ancestor
6360330|NCT00090207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6360331|NCT00090207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360332|NCT00090207|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6360333|NCT00090207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6360334|NCT00090207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6360335|NCT00090207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6360336|NCT00090207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6360337|NCT00090207|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6360338|NCT00090246|Ondansetron|ondansetron|mesh-list
6360339|NCT00090246|Aprepitant|aprepitant|mesh-list
6360340|NCT00090246|Antiemetics|antiemetics|mesh-ancestor
6360341|NCT00090246|Autonomic Agents|autonomic agents|mesh-ancestor
6360342|NCT00090246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6360343|NCT00090246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360344|NCT00090246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6360345|NCT00090246|Antipruritics|antipruritics|mesh-ancestor
6360346|NCT00090246|Dermatologic Agents|dermatologic agents|mesh-ancestor
6360347|NCT00090246|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6360348|NCT00090246|Serotonin Agents|serotonin agents|mesh-ancestor
6360349|NCT00090246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6360350|NCT00090246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360351|NCT00090246|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6360352|NCT00090246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6360353|NCT00090246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6360354|NCT00090246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6360355|NCT00090246|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6360356|NCT00090246|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6360357|NCT00090272|Ertapenem|ertapenem|mesh-list
6360358|NCT00090272|Cefotetan|cefotetan|mesh-list
6360359|NCT00090272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6360360|NCT00090272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6360361|NCT00090311|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6360362|NCT00090311|Antidepressive Agents|antidepressive agents|mesh-ancestor
6360363|NCT00090311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6360364|NCT00090311|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6360365|NCT00090311|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6360366|NCT00090311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6360367|NCT00090311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360368|NCT00090324|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6360369|NCT00090324|Antidepressive Agents|antidepressive agents|mesh-ancestor
6360370|NCT00090324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6360371|NCT00090324|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6360372|NCT00090324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6360373|NCT00090324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6360374|NCT00090324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360375|NCT00090428|Caseins|caseins|mesh-list
6360376|NCT00090428|Chelating Agents|chelating agents|mesh-ancestor
6360377|NCT00090428|Sequestering Agents|sequestering agents|mesh-ancestor
6360378|NCT00090428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360379|NCT00090480|Vaccines|vaccines|mesh-list
6360380|NCT00090480|Immunologic Factors|immunologic factors|mesh-ancestor
6360381|NCT00090480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360382|NCT00090558|Nitroglycerin|nitroglycerin|mesh-list
6360383|NCT00090558|Vasodilator Agents|vasodilator agents|mesh-ancestor
6360384|NCT00090623|Ranibizumab|ranibizumab|mesh-list
6360385|NCT00090623|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6360386|NCT00090623|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6360387|NCT00090623|Growth Substances|growth substances|mesh-ancestor
6360388|NCT00090623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360389|NCT00090623|Growth Inhibitors|growth inhibitors|mesh-ancestor
6360390|NCT00090623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6360391|NCT00090675|Gefitinib|gefitinib|mesh-list
6360392|NCT00090675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6360393|NCT00090675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6360394|NCT00090675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6360395|NCT00090675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360396|NCT00090727|AQ4N|aq4n|mesh-list
6360397|NCT00090727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6360398|NCT00090896|Ipilimumab|ipilimumab|mesh-list
6360399|NCT00090896|Antibodies|antibodies|mesh-list
6360400|NCT00090896|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6360401|NCT00090896|Immunologic Factors|immunologic factors|mesh-ancestor
6360402|NCT00090896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360403|NCT00090896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6360404|NCT00090896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6360405|NCT00090896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6360406|NCT00090896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360407|NCT00090909|Gemcitabine|gemcitabine|mesh-list
6360408|NCT00090909|Dexamethasone|dexamethasone|mesh-list
6360409|NCT00090909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6360410|NCT00090909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6360411|NCT00090909|Antiemetics|antiemetics|mesh-ancestor
6360412|NCT00090909|Autonomic Agents|autonomic agents|mesh-ancestor
6360413|NCT00090909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6360414|NCT00090909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360415|NCT00090909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6360416|NCT00090909|Glucocorticoids|glucocorticoids|mesh-ancestor
6360417|NCT00090909|Hormones|hormones|mesh-ancestor
6360418|NCT00090909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6360419|NCT00090909|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6360420|NCT00090909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6360421|NCT00090909|Antimetabolites|antimetabolites|mesh-ancestor
6360422|NCT00090909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360423|NCT00090909|Antiviral Agents|antiviral agents|mesh-ancestor
6360424|NCT00090909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6360425|NCT00090909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6360426|NCT00090909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6360427|NCT00090909|Immunologic Factors|immunologic factors|mesh-ancestor
6360428|NCT00091039|Metronidazole|metronidazole|mesh-list
6360429|NCT00091039|Paclitaxel|paclitaxel|mesh-list
6360430|NCT00091039|Carboplatin|carboplatin|mesh-list
6360431|NCT00091039|Vaccines|vaccines|mesh-list
6360432|NCT00091039|Immunologic Factors|immunologic factors|mesh-ancestor
6360433|NCT00091039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360434|NCT00091039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6360435|NCT00091039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6360436|NCT00091039|Tubulin Modulators|tubulin modulators|mesh-ancestor
6360437|NCT00091039|Antimitotic Agents|antimitotic agents|mesh-ancestor
6360438|NCT00091039|Mitosis Modulators|mitosis modulators|mesh-ancestor
6360439|NCT00091039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360440|NCT00091039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6360441|NCT00091039|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6360442|NCT00091039|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6360443|NCT00091039|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6360444|NCT00091052|Sargramostim|sargramostim|mesh-list
6360445|NCT00091052|Immunologic Factors|immunologic factors|mesh-ancestor
6360446|NCT00091052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360447|NCT00091078|Imatinib Mesylate|imatinib mesylate|mesh-list
6360448|NCT00091078|Oblimersen|oblimersen|mesh-list
6360449|NCT00091078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6360450|NCT00091078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6360451|NCT00091078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6360452|NCT00091078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360453|NCT00091104|Aldesleukin|aldesleukin|mesh-list
6360454|NCT00091104|Cyclophosphamide|cyclophosphamide|mesh-list
6360455|NCT00091104|Fludarabine|fludarabine|mesh-list
6360456|NCT00091104|Fludarabine phosphate|fludarabine phosphate|mesh-list
6360457|NCT00091104|Freund's Adjuvant|freund's adjuvant|mesh-list
6360458|NCT00091104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6360459|NCT00091104|Immunologic Factors|immunologic factors|mesh-ancestor
6360460|NCT00091104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360461|NCT00091104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6360462|NCT00091104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6360463|NCT00091104|Alkylating Agents|alkylating agents|mesh-ancestor
6360464|NCT00091104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360465|NCT00091104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6360466|NCT00091104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6360467|NCT00091104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6360468|NCT00091104|Antimetabolites|antimetabolites|mesh-ancestor
6360469|NCT00091104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6360470|NCT00091104|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6360471|NCT00091104|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6360472|NCT00091104|Antiviral Agents|antiviral agents|mesh-ancestor
6360473|NCT00091104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6360474|NCT00091117|Bortezomib|bortezomib|mesh-list
6360475|NCT00091117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6360476|NCT00091130|Vaccines|vaccines|mesh-list
6360477|NCT00091130|Immunologic Factors|immunologic factors|mesh-ancestor
6360478|NCT00091130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360479|NCT00091143|Fludarabine|fludarabine|mesh-list
6360480|NCT00091143|Fludarabine phosphate|fludarabine phosphate|mesh-list
6360481|NCT00091143|Freund's Adjuvant|freund's adjuvant|mesh-list
6360482|NCT00091143|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
6360483|NCT00091143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6360484|NCT00091143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6360485|NCT00091143|Antimetabolites|antimetabolites|mesh-ancestor
6360486|NCT00091143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360487|NCT00091143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6360488|NCT00091143|Immunologic Factors|immunologic factors|mesh-ancestor
6360489|NCT00091143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360490|NCT00091143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6360491|NCT00091156|Gefitinib|gefitinib|mesh-list
6360492|NCT00091156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6360493|NCT00091156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6360494|NCT00091156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6360495|NCT00091156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360496|NCT00091182|Oxaliplatin|oxaliplatin|mesh-list
6360497|NCT00091182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6360498|NCT00091195|Romidepsin|romidepsin|mesh-list
6360499|NCT00091195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6360500|NCT00091195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6360501|NCT00091234|Gemtuzumab|gemtuzumab|mesh-list
6360502|NCT00091234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6360503|NCT00091234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6360504|NCT00091247|Tetracycline|tetracycline|mesh-list
6360505|NCT00091247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6360506|NCT00091247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6360507|NCT00091247|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6360508|NCT00091247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6360509|NCT00091247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360510|NCT00091299|Warfarin|warfarin|mesh-list
6360511|NCT00091299|Anticoagulants|anticoagulants|mesh-ancestor
6394808|NCT00203359|Analgesics|analgesics|mesh-ancestor
6394809|NCT00203359|Sensory System Agents|sensory system agents|mesh-ancestor
6394810|NCT00203359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6394811|NCT00203359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394812|NCT00203359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6394813|NCT00203359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6394814|NCT00203359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6394815|NCT00203359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6394816|NCT00203359|Immunologic Factors|immunologic factors|mesh-ancestor
6394817|NCT00203372|Cyclophosphamide|cyclophosphamide|mesh-list
6394818|NCT00203372|Bevacizumab|bevacizumab|mesh-list
6394819|NCT00203372|Docetaxel|docetaxel|mesh-list
6394820|NCT00203372|Doxorubicin|doxorubicin|mesh-list
6394821|NCT00203372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6394822|NCT00203372|Immunologic Factors|immunologic factors|mesh-ancestor
6394823|NCT00203372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394824|NCT00203372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6394825|NCT00203372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6394826|NCT00203372|Alkylating Agents|alkylating agents|mesh-ancestor
6360512|NCT00091312|Leucovorin|leucovorin|mesh-list
6360513|NCT00091312|Fluorouracil|fluorouracil|mesh-list
6017208|NCT00370071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017209|NCT00370071|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6017210|NCT00370149|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6017211|NCT00370149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6017212|NCT00370292|Pemetrexed|pemetrexed|mesh-list
6017213|NCT00370292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6360514|NCT00091312|Irinotecan|irinotecan|mesh-list
6360515|NCT00091312|Calcium|calcium|mesh-list
6360516|NCT00091312|Levoleucovorin|levoleucovorin|mesh-list
6360517|NCT00091312|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6360518|NCT00091312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360519|NCT00091312|Antimetabolites|antimetabolites|mesh-ancestor
6360520|NCT00091312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360521|NCT00091312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6360522|NCT00091312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6360523|NCT00091312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6360524|NCT00091312|Immunologic Factors|immunologic factors|mesh-ancestor
6360525|NCT00091312|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6360526|NCT00091312|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6360527|NCT00091312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6360528|NCT00091312|Antidotes|antidotes|mesh-ancestor
6360529|NCT00091312|Protective Agents|protective agents|mesh-ancestor
6360530|NCT00091312|Vitamin B Complex|vitamin b complex|mesh-ancestor
6360531|NCT00091312|Vitamins|vitamins|mesh-ancestor
6360532|NCT00091312|Micronutrients|micronutrients|mesh-ancestor
6360533|NCT00091325|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
6360534|NCT00091325|Antioxidants|antioxidants|mesh-ancestor
6360535|NCT00091325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360536|NCT00091325|Protective Agents|protective agents|mesh-ancestor
6360537|NCT00091325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360538|NCT00091325|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
6360539|NCT00091325|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6360540|NCT00091325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6360541|NCT00091325|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6360542|NCT00091338|Freund's Adjuvant|freund's adjuvant|mesh-list
6360543|NCT00091338|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6360544|NCT00091338|Immunologic Factors|immunologic factors|mesh-ancestor
6360545|NCT00091338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360546|NCT00091377|Paclitaxel|paclitaxel|mesh-list
6360547|NCT00091377|Cisplatin|cisplatin|mesh-list
6360548|NCT00091377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6360549|NCT00091377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6360550|NCT00091377|Tubulin Modulators|tubulin modulators|mesh-ancestor
6360551|NCT00091377|Antimitotic Agents|antimitotic agents|mesh-ancestor
6017214|NCT00370292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6360552|NCT00091377|Mitosis Modulators|mitosis modulators|mesh-ancestor
6360553|NCT00091377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360554|NCT00091429|Ranolazine|ranolazine|mesh-list
6360555|NCT00091429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6360556|NCT00091429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6360557|NCT00091429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360558|NCT00091468|Nicotine|nicotine|mesh-list
6360559|NCT00091468|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6018498|NCT00381238|Rosiglitazone|rosiglitazone|mesh-list
6360560|NCT00091468|Autonomic Agents|autonomic agents|mesh-ancestor
6360561|NCT00091468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6360562|NCT00091468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360563|NCT00091468|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6360564|NCT00091468|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6360565|NCT00091468|Cholinergic Agents|cholinergic agents|mesh-ancestor
6360566|NCT00091468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6360567|NCT00091468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360568|NCT00091520|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6360569|NCT00091520|Natriuretic Agents|natriuretic agents|mesh-ancestor
6360570|NCT00091520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360571|NCT00091559|Vorinostat|vorinostat|mesh-list
6360572|NCT00091559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6360573|NCT00091559|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6360574|NCT00091559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6360575|NCT00091559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360576|NCT00091598|Ambrisentan|ambrisentan|mesh-list
6360577|NCT00091598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6360578|NCT00091611|Cyclophosphamide|cyclophosphamide|mesh-list
6360579|NCT00091611|Fludarabine|fludarabine|mesh-list
6360580|NCT00091611|Interleukin-2|interleukin-2|mesh-list
6360581|NCT00091611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6360582|NCT00091611|Immunologic Factors|immunologic factors|mesh-ancestor
6360583|NCT00091611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360584|NCT00091611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6360585|NCT00091611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6360586|NCT00091611|Alkylating Agents|alkylating agents|mesh-ancestor
6360587|NCT00091611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360588|NCT00091611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6360589|NCT00091611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6360590|NCT00091611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6360591|NCT00091611|Analgesics|analgesics|mesh-ancestor
6360592|NCT00091611|Sensory System Agents|sensory system agents|mesh-ancestor
6360593|NCT00091611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6360594|NCT00091624|Lenalidomide|lenalidomide|mesh-list
6360595|NCT00091624|Immunologic Factors|immunologic factors|mesh-ancestor
6360596|NCT00091624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360597|NCT00091624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6360598|NCT00091624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6360599|NCT00091624|Growth Substances|growth substances|mesh-ancestor
6360600|NCT00091624|Growth Inhibitors|growth inhibitors|mesh-ancestor
6360601|NCT00091624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6360602|NCT00091650|Olanzapine|olanzapine|mesh-list
6360603|NCT00091650|Antiemetics|antiemetics|mesh-ancestor
6360604|NCT00091650|Autonomic Agents|autonomic agents|mesh-ancestor
6360605|NCT00091650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6360606|NCT00091650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360607|NCT00091650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6360608|NCT00091650|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6360609|NCT00091650|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6360610|NCT00091650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6360611|NCT00091650|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6360612|NCT00091650|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6360613|NCT00091650|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6360614|NCT00091650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6360615|NCT00091650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360616|NCT00091650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6360617|NCT00091650|Serotonin Agents|serotonin agents|mesh-ancestor
6360618|NCT00091663|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6360619|NCT00091663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6360620|NCT00091663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6360621|NCT00091663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6360622|NCT00091663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360623|NCT00091702|Vaccines|vaccines|mesh-list
6360624|NCT00091702|Immunologic Factors|immunologic factors|mesh-ancestor
6360625|NCT00091702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360626|NCT00091715|Bosentan|bosentan|mesh-list
6360627|NCT00091715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6360628|NCT00091715|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6360629|NCT00091715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360630|NCT00091728|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6360631|NCT00091728|Contraceptive Agents|contraceptive agents|mesh-list
6360632|NCT00091728|Medroxyprogesterone|medroxyprogesterone|mesh-list
6360633|NCT00091728|Contraceptives, Oral|contraceptives, oral|mesh-list
6360634|NCT00091728|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
6360635|NCT00091728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6360636|NCT00091728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360637|NCT00091728|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6360638|NCT00091728|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6360639|NCT00091728|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6360640|NCT00091728|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6360641|NCT00091728|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6360642|NCT00091728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6360643|NCT00091728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6360644|NCT00091741|Etanercept|etanercept|mesh-list
6360645|NCT00091741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6360646|NCT00091741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6360647|NCT00091741|Analgesics|analgesics|mesh-ancestor
6360648|NCT00091741|Sensory System Agents|sensory system agents|mesh-ancestor
6360649|NCT00091741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6360650|NCT00091741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360651|NCT00091741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6360652|NCT00091741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6360653|NCT00091741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6360654|NCT00091741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6360655|NCT00091741|Immunologic Factors|immunologic factors|mesh-ancestor
6360656|NCT00091806|Panitumumab|panitumumab|mesh-list
6360657|NCT00091806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6360658|NCT00091806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6360659|NCT00091858|Darbepoetin alfa|darbepoetin alfa|mesh-list
6360660|NCT00091858|Hematinics|hematinics|mesh-ancestor
6360661|NCT00091897|Rituximab|rituximab|mesh-list
6360662|NCT00091897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6360663|NCT00091897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6360664|NCT00091897|Immunologic Factors|immunologic factors|mesh-ancestor
6360665|NCT00091897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360666|NCT00091897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6360667|NCT00091910|Epoetin Alfa|epoetin alfa|mesh-list
6360668|NCT00091910|Hematinics|hematinics|mesh-ancestor
6360669|NCT00091936|Lamivudine|lamivudine|mesh-list
6360670|NCT00091936|Efavirenz|efavirenz|mesh-list
6360671|NCT00091936|Didanosine|didanosine|mesh-list
6360672|NCT00091936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6360673|NCT00091936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6360674|NCT00091936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6360675|NCT00091936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360676|NCT00091936|Antiviral Agents|antiviral agents|mesh-ancestor
6360677|NCT00091936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6360678|NCT00091936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6360679|NCT00091936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6360680|NCT00091936|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6360681|NCT00091936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6360682|NCT00091936|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6360683|NCT00091936|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6360684|NCT00091936|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6360685|NCT00091936|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6360686|NCT00091936|Antimetabolites|antimetabolites|mesh-ancestor
6360687|NCT00092001|Sunitinib|sunitinib|mesh-list
6360688|NCT00092001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6360689|NCT00092001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6360690|NCT00092001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6360691|NCT00092001|Growth Substances|growth substances|mesh-ancestor
6360692|NCT00092001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360693|NCT00092001|Growth Inhibitors|growth inhibitors|mesh-ancestor
6360694|NCT00092001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6360695|NCT00092001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6360696|NCT00092001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360697|NCT00092079|Cholecalciferol|cholecalciferol|mesh-list
6360698|NCT00092079|Alendronate|alendronate|mesh-list
6360699|NCT00092079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6360700|NCT00092079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360701|NCT00092079|Vitamins|vitamins|mesh-ancestor
6360702|NCT00092079|Micronutrients|micronutrients|mesh-ancestor
6360703|NCT00092079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6360704|NCT00092170|Clavulanic Acid|clavulanic acid|mesh-list
6360705|NCT00092170|Clavulanic Acids|clavulanic acids|mesh-list
6360706|NCT00092170|Ertapenem|ertapenem|mesh-list
6360707|NCT00092170|Ticarcillin|ticarcillin|mesh-list
6360708|NCT00092170|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6360709|NCT00092170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6360710|NCT00092170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360711|NCT00092170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6360712|NCT00092170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6360713|NCT00092183|Ondansetron|ondansetron|mesh-list
6360714|NCT00092183|Aprepitant|aprepitant|mesh-list
6360715|NCT00092183|Antiemetics|antiemetics|mesh-ancestor
6360716|NCT00092183|Autonomic Agents|autonomic agents|mesh-ancestor
6360717|NCT00092183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6360718|NCT00092183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360719|NCT00092183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6360720|NCT00092183|Antipruritics|antipruritics|mesh-ancestor
6360721|NCT00092183|Dermatologic Agents|dermatologic agents|mesh-ancestor
6360722|NCT00092183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6360723|NCT00092183|Serotonin Agents|serotonin agents|mesh-ancestor
6360724|NCT00092183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6360725|NCT00092183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360726|NCT00092183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6360727|NCT00092183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6360728|NCT00092183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6360729|NCT00092183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6360730|NCT00092183|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6360731|NCT00092183|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6360732|NCT00092196|Aprepitant|aprepitant|mesh-list
6360733|NCT00092196|Antiemetics|antiemetics|mesh-ancestor
6360734|NCT00092196|Autonomic Agents|autonomic agents|mesh-ancestor
6360735|NCT00092196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6360736|NCT00092196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360737|NCT00092196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6360738|NCT00092196|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6360739|NCT00092196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6360740|NCT00092196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360741|NCT00092274|Ofatumumab|ofatumumab|mesh-list
6360742|NCT00092274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6360743|NCT00092287|Lanreotide|lanreotide|mesh-list
6360744|NCT00092287|Octreotide|octreotide|mesh-list
6360745|NCT00092287|Somatostatin|somatostatin|mesh-list
6360746|NCT00092287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6360747|NCT00092287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6360748|NCT00092287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6360749|NCT00092287|Hormones|hormones|mesh-ancestor
6360750|NCT00092287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6360751|NCT00092287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360752|NCT00092300|Valdecoxib|valdecoxib|mesh-list
6360753|NCT00092300|Rofecoxib|rofecoxib|mesh-list
6360754|NCT00092300|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6360755|NCT00092300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6360756|NCT00092300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6360757|NCT00092300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360758|NCT00092300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6360759|NCT00092300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6360760|NCT00092300|Analgesics|analgesics|mesh-ancestor
6360761|NCT00092300|Sensory System Agents|sensory system agents|mesh-ancestor
6360762|NCT00092300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6360763|NCT00092300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360764|NCT00092300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6360765|NCT00092300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6360766|NCT00092313|Acetaminophen|acetaminophen|mesh-list
6360767|NCT00092313|Rofecoxib|rofecoxib|mesh-list
6360768|NCT00092313|Oxycodone|oxycodone|mesh-list
6360769|NCT00092313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6018499|NCT00381238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6360770|NCT00092313|Analgesics|analgesics|mesh-ancestor
6360771|NCT00092313|Sensory System Agents|sensory system agents|mesh-ancestor
6360772|NCT00092313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6360773|NCT00092313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360774|NCT00092313|Antipyretics|antipyretics|mesh-ancestor
6360775|NCT00092313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6360776|NCT00092313|Narcotics|narcotics|mesh-ancestor
6360777|NCT00092313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6360778|NCT00092313|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6360779|NCT00092313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6360780|NCT00092313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6360781|NCT00092313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360782|NCT00092313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6360783|NCT00092313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6360784|NCT00092313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6360785|NCT00092326|Acetaminophen|acetaminophen|mesh-list
6360786|NCT00092326|Rofecoxib|rofecoxib|mesh-list
6360787|NCT00092326|Oxycodone|oxycodone|mesh-list
6360788|NCT00092326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6360789|NCT00092326|Analgesics|analgesics|mesh-ancestor
6360790|NCT00092326|Sensory System Agents|sensory system agents|mesh-ancestor
6360791|NCT00092326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6360792|NCT00092326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360793|NCT00092326|Antipyretics|antipyretics|mesh-ancestor
6360794|NCT00092326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6360795|NCT00092326|Narcotics|narcotics|mesh-ancestor
6360796|NCT00092326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6360797|NCT00092326|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6360798|NCT00092326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6360799|NCT00092326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6360800|NCT00092326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360801|NCT00092326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6360802|NCT00092326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6360803|NCT00092326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6360804|NCT00092339|Valdecoxib|valdecoxib|mesh-list
6360805|NCT00092339|Rofecoxib|rofecoxib|mesh-list
6360806|NCT00092339|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6360807|NCT00092339|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6360808|NCT00092339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6360809|NCT00092339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360810|NCT00092339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6360811|NCT00092339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6360812|NCT00092339|Analgesics|analgesics|mesh-ancestor
6360813|NCT00092339|Sensory System Agents|sensory system agents|mesh-ancestor
6360814|NCT00092339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6360815|NCT00092339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360816|NCT00092339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6360817|NCT00092339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6360818|NCT00092352|Celecoxib|celecoxib|mesh-list
6360819|NCT00092352|Rofecoxib|rofecoxib|mesh-list
6360820|NCT00092352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6360821|NCT00092352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6360822|NCT00092352|Analgesics|analgesics|mesh-ancestor
6360823|NCT00092352|Sensory System Agents|sensory system agents|mesh-ancestor
6360824|NCT00092352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6360825|NCT00092352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360826|NCT00092352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6360827|NCT00092352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6360828|NCT00092352|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6360829|NCT00092352|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6360830|NCT00092352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6360831|NCT00092352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360832|NCT00092365|Celecoxib|celecoxib|mesh-list
6360833|NCT00092365|Rofecoxib|rofecoxib|mesh-list
6360834|NCT00092365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6360835|NCT00092365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6360836|NCT00092365|Analgesics|analgesics|mesh-ancestor
6360837|NCT00092365|Sensory System Agents|sensory system agents|mesh-ancestor
6360838|NCT00092365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6360839|NCT00092365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360840|NCT00092365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6360841|NCT00092365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6360842|NCT00092365|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6360843|NCT00092365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6360844|NCT00092365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6360845|NCT00092365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360846|NCT00092378|Diclofenac|diclofenac|mesh-list
6360847|NCT00092378|Rofecoxib|rofecoxib|mesh-list
6360848|NCT00092378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6360849|NCT00092378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6360850|NCT00092378|Analgesics|analgesics|mesh-ancestor
6360851|NCT00092378|Sensory System Agents|sensory system agents|mesh-ancestor
6360852|NCT00092378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6360853|NCT00092378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360854|NCT00092378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6360855|NCT00092378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6360856|NCT00092378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6360857|NCT00092378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6360858|NCT00092378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360859|NCT00092378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6360860|NCT00092391|Vaccines|vaccines|mesh-list
6360861|NCT00092391|Immunoglobulins|immunoglobulins|mesh-list
6360862|NCT00092391|Immunologic Factors|immunologic factors|mesh-ancestor
6360863|NCT00092391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360864|NCT00092404|Vaccines|vaccines|mesh-list
6360865|NCT00092404|Immunoglobulins|immunoglobulins|mesh-list
6360866|NCT00092404|Immunologic Factors|immunologic factors|mesh-ancestor
6360867|NCT00092404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360868|NCT00092508|Mesalamine|mesalamine|mesh-list
6360869|NCT00092508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6360870|NCT00092508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6360871|NCT00092508|Analgesics|analgesics|mesh-ancestor
6360872|NCT00092508|Sensory System Agents|sensory system agents|mesh-ancestor
6360873|NCT00092508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6360874|NCT00092508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360875|NCT00092508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6360876|NCT00092508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6360877|NCT00092846|Lovastatin|lovastatin|mesh-list
6360878|NCT00092846|L 647318|l 647318|mesh-list
6360879|NCT00092846|Dihydromevinolin|dihydromevinolin|mesh-list
6360880|NCT00092846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6360881|NCT00092846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6360882|NCT00092846|Antimetabolites|antimetabolites|mesh-ancestor
6360883|NCT00092846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360884|NCT00092846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6360885|NCT00092846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6360886|NCT00092846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6360887|NCT00092924|Mapatumumab|mapatumumab|mesh-list
6360888|NCT00092924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6360889|NCT00092937|Busulfan|busulfan|mesh-list
6360890|NCT00092937|Alkylating Agents|alkylating agents|mesh-ancestor
6360891|NCT00092937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360892|NCT00092937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6360893|NCT00092937|Immunologic Factors|immunologic factors|mesh-ancestor
6360894|NCT00092937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360895|NCT00092937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6360896|NCT00092937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6360897|NCT00092937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6360898|NCT00092976|Factor VIII|factor viii|mesh-list
6360899|NCT00092976|Coagulants|coagulants|mesh-ancestor
6360900|NCT00093002|Fulvestrant|fulvestrant|mesh-list
6360901|NCT00093002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6360902|NCT00093002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6360903|NCT00093002|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6360904|NCT00093002|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6360905|NCT00093002|Hormone Antagonists|hormone antagonists|mesh-ancestor
6360906|NCT00093002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6360907|NCT00093002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360908|NCT00093028|Bortezomib|bortezomib|mesh-list
6360909|NCT00093028|Lenalidomide|lenalidomide|mesh-list
6360910|NCT00093028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6360911|NCT00093028|Immunologic Factors|immunologic factors|mesh-ancestor
6360912|NCT00093028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360913|NCT00093028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6360914|NCT00093028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6360915|NCT00093028|Growth Substances|growth substances|mesh-ancestor
6360916|NCT00093028|Growth Inhibitors|growth inhibitors|mesh-ancestor
6360917|NCT00093067|Daptomycin|daptomycin|mesh-list
6360918|NCT00093067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6360919|NCT00093067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6360920|NCT00093093|Interferons|interferons|mesh-list
6360921|NCT00093093|Ribavirin|ribavirin|mesh-list
6360922|NCT00093093|Interferon-alpha|interferon-alpha|mesh-list
6360923|NCT00093093|Interferon alpha-2|interferon alpha-2|mesh-list
6360924|NCT00093093|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6360925|NCT00093093|Taribavirin|taribavirin|mesh-list
6360926|NCT00093093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6360927|NCT00093093|Antiviral Agents|antiviral agents|mesh-ancestor
6360928|NCT00093093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6360929|NCT00093093|Antimetabolites|antimetabolites|mesh-ancestor
6360930|NCT00093093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360931|NCT00093093|Immunologic Factors|immunologic factors|mesh-ancestor
6360932|NCT00093093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360933|NCT00093119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6360934|NCT00093119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6360935|NCT00093158|Anticoagulants|anticoagulants|mesh-list
6360936|NCT00093158|Bivalirudin|bivalirudin|mesh-list
6360937|NCT00093158|Antithrombins|antithrombins|mesh-ancestor
6360938|NCT00093158|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6360939|NCT00093158|Protease Inhibitors|protease inhibitors|mesh-ancestor
6360940|NCT00093158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6360941|NCT00093158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360942|NCT00093184|Anticoagulants|anticoagulants|mesh-list
6360943|NCT00093184|Bivalirudin|bivalirudin|mesh-list
6360944|NCT00093184|Antithrombins|antithrombins|mesh-ancestor
6360945|NCT00093184|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6360946|NCT00093184|Protease Inhibitors|protease inhibitors|mesh-ancestor
6360947|NCT00093184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6360948|NCT00093184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360949|NCT00093223|Paclitaxel|paclitaxel|mesh-list
6360950|NCT00093223|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6360951|NCT00093223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6360952|NCT00093223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6360953|NCT00093223|Tubulin Modulators|tubulin modulators|mesh-ancestor
6360954|NCT00093223|Antimitotic Agents|antimitotic agents|mesh-ancestor
6360955|NCT00093223|Mitosis Modulators|mitosis modulators|mesh-ancestor
6360956|NCT00093223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360957|NCT00093249|Clevidipine|clevidipine|mesh-list
6360958|NCT00093249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6360959|NCT00093249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6360960|NCT00093249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360961|NCT00093249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6360962|NCT00093249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360963|NCT00093262|Clevidipine|clevidipine|mesh-list
6360964|NCT00093262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6360965|NCT00093262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6360966|NCT00093262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360967|NCT00093262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6360968|NCT00093262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360969|NCT00093288|Bupropion|bupropion|mesh-list
6360970|NCT00093288|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6360971|NCT00093288|Antidepressive Agents|antidepressive agents|mesh-ancestor
6360972|NCT00093288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6360973|NCT00093288|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6360974|NCT00093288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6360975|NCT00093288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6360976|NCT00093288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360977|NCT00093288|Dopamine Agents|dopamine agents|mesh-ancestor
6360978|NCT00093288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6360979|NCT00093288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360980|NCT00093288|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6360981|NCT00093288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6360982|NCT00093288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6360983|NCT00093301|Simendan|simendan|mesh-list
6360984|NCT00093301|Dobutamine|dobutamine|mesh-list
6360985|NCT00093301|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6360986|NCT00093301|Vasodilator Agents|vasodilator agents|mesh-ancestor
6360987|NCT00093301|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6360988|NCT00093301|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6360989|NCT00093301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6360990|NCT00093301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6360991|NCT00093301|Protective Agents|protective agents|mesh-ancestor
6360992|NCT00093301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6360993|NCT00093301|Sympathomimetics|sympathomimetics|mesh-ancestor
6360994|NCT00093301|Autonomic Agents|autonomic agents|mesh-ancestor
6360995|NCT00093301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6360996|NCT00093301|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6360997|NCT00093301|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6360998|NCT00093301|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6360999|NCT00093301|Adrenergic Agents|adrenergic agents|mesh-ancestor
6361000|NCT00093301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6361001|NCT00093314|Ofatumumab|ofatumumab|mesh-list
6361002|NCT00093314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6361003|NCT00093353|Cefixime|cefixime|mesh-list
6361004|NCT00093353|Irinotecan|irinotecan|mesh-list
6361005|NCT00093353|Temozolomide|temozolomide|mesh-list
6361006|NCT00093353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6361007|NCT00093353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6361008|NCT00093353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6361009|NCT00093353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361010|NCT00093353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6361011|NCT00093353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6361012|NCT00093353|Alkylating Agents|alkylating agents|mesh-ancestor
6361013|NCT00093353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6361014|NCT00093353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6361015|NCT00093366|Etanercept|etanercept|mesh-list
6361016|NCT00093366|Arsenic Trioxide|arsenic trioxide|mesh-list
6361017|NCT00093366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6361018|NCT00093366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6361019|NCT00093366|Analgesics|analgesics|mesh-ancestor
6361020|NCT00093366|Sensory System Agents|sensory system agents|mesh-ancestor
6361021|NCT00093366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6361022|NCT00093366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361023|NCT00093366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6361024|NCT00093366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6361025|NCT00093366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6361026|NCT00093366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6361027|NCT00093366|Immunologic Factors|immunologic factors|mesh-ancestor
6361028|NCT00093366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6361029|NCT00093418|Tipifarnib|tipifarnib|mesh-list
6361030|NCT00093418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6361031|NCT00093444|Doxorubicin|doxorubicin|mesh-list
6361032|NCT00093444|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6361033|NCT00093444|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6361034|NCT00093444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6361035|NCT00093444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6361036|NCT00093444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6361037|NCT00093444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6361038|NCT00093444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361039|NCT00093457|Sorafenib|sorafenib|mesh-list
6361040|NCT00093457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6361041|NCT00093457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6361042|NCT00093457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6361043|NCT00093457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361044|NCT00093483|Cytarabine|cytarabine|mesh-list
6361045|NCT00093483|Idarubicin|idarubicin|mesh-list
6361046|NCT00093483|Arsenic Trioxide|arsenic trioxide|mesh-list
6361047|NCT00093483|Immunologic Factors|immunologic factors|mesh-ancestor
6361048|NCT00093483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361049|NCT00093483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6361050|NCT00093483|Antimetabolites|antimetabolites|mesh-ancestor
6361051|NCT00093483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361052|NCT00093483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6361053|NCT00093483|Antiviral Agents|antiviral agents|mesh-ancestor
6361054|NCT00093483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6361055|NCT00093483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6361056|NCT00093483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6361057|NCT00093483|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6361058|NCT00093483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6361059|NCT00093483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6361060|NCT00093509|Doxorubicin|doxorubicin|mesh-list
6361061|NCT00093509|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6361062|NCT00093509|Ifosfamide|ifosfamide|mesh-list
6361063|NCT00093509|Isophosphamide mustard|isophosphamide mustard|mesh-list
6361064|NCT00093509|Mesna|mesna|mesh-list
6361065|NCT00093509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6361066|NCT00093509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6361067|NCT00093509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6361068|NCT00093509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6361069|NCT00093509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6361070|NCT00093509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361071|NCT00093509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6361072|NCT00093509|Alkylating Agents|alkylating agents|mesh-ancestor
6361073|NCT00093509|Protective Agents|protective agents|mesh-ancestor
6361074|NCT00093509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361075|NCT00093522|Fludarabine|fludarabine|mesh-list
6361076|NCT00093522|Fludarabine phosphate|fludarabine phosphate|mesh-list
6361077|NCT00093522|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
6361078|NCT00093522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6361079|NCT00093522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6361080|NCT00093522|Antimetabolites|antimetabolites|mesh-ancestor
6361081|NCT00093522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361082|NCT00093522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6361083|NCT00093522|Immunologic Factors|immunologic factors|mesh-ancestor
6361084|NCT00093522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361085|NCT00093522|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6361086|NCT00093548|Vaccines|vaccines|mesh-list
6361087|NCT00093548|Sargramostim|sargramostim|mesh-list
6361088|NCT00093548|Immunologic Factors|immunologic factors|mesh-ancestor
6361089|NCT00093548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361090|NCT00093561|Lycopene|lycopene|mesh-list
6361091|NCT00093561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6361092|NCT00093561|Antioxidants|antioxidants|mesh-ancestor
6361093|NCT00093561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361094|NCT00093561|Protective Agents|protective agents|mesh-ancestor
6361095|NCT00093561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361096|NCT00093561|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6361097|NCT00093561|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6361098|NCT00093561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6361099|NCT00093587|Cyclosporine|cyclosporine|mesh-list
6361100|NCT00093587|Cyclophosphamide|cyclophosphamide|mesh-list
6361101|NCT00093587|Busulfan|busulfan|mesh-list
6361102|NCT00093587|Cyclosporins|cyclosporins|mesh-list
6361103|NCT00093587|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6361104|NCT00093587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6361105|NCT00093587|Immunologic Factors|immunologic factors|mesh-ancestor
6361106|NCT00093587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361107|NCT00093587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6361108|NCT00093587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6361109|NCT00093587|Alkylating Agents|alkylating agents|mesh-ancestor
6361110|NCT00093587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361111|NCT00093587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6361112|NCT00093587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6361113|NCT00093587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6361114|NCT00093587|Antifungal Agents|antifungal agents|mesh-ancestor
6361115|NCT00093587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6361116|NCT00093587|Dermatologic Agents|dermatologic agents|mesh-ancestor
6361117|NCT00093587|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6394827|NCT00203372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394828|NCT00203372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6394829|NCT00203372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6394830|NCT00203372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6394831|NCT00203372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6394832|NCT00203372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6394833|NCT00203372|Growth Substances|growth substances|mesh-ancestor
6394834|NCT00203372|Growth Inhibitors|growth inhibitors|mesh-ancestor
6394835|NCT00203372|Tubulin Modulators|tubulin modulators|mesh-ancestor
6394836|NCT00203372|Antimitotic Agents|antimitotic agents|mesh-ancestor
6394837|NCT00203372|Mitosis Modulators|mitosis modulators|mesh-ancestor
6394838|NCT00203372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6394839|NCT00203372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6394840|NCT00203372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6394841|NCT00203372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6394842|NCT00203385|Valproic Acid|valproic acid|mesh-list
6394843|NCT00203385|Anticonvulsants|anticonvulsants|mesh-ancestor
6394844|NCT00203385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6394845|NCT00203385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394846|NCT00203385|GABA Agents|gaba agents|mesh-ancestor
6394847|NCT00203385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6394848|NCT00203385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394849|NCT00203385|Antimanic Agents|antimanic agents|mesh-ancestor
6394850|NCT00203385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6394851|NCT00203385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6394852|NCT00203385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6394853|NCT00203450|Zonisamide|zonisamide|mesh-list
6394854|NCT00203450|Anticonvulsants|anticonvulsants|mesh-ancestor
6394855|NCT00203450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6017215|NCT00370292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017216|NCT00370292|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6361118|NCT00093600|Cytarabine|cytarabine|mesh-list
6361119|NCT00093600|Daunorubicin|daunorubicin|mesh-list
6361120|NCT00093600|Midostaurin|midostaurin|mesh-list
6361121|NCT00093600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6361122|NCT00093600|Antimetabolites|antimetabolites|mesh-ancestor
6361123|NCT00093600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361124|NCT00093600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6361125|NCT00093600|Antiviral Agents|antiviral agents|mesh-ancestor
6361126|NCT00093600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6361127|NCT00093600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6361128|NCT00093600|Immunologic Factors|immunologic factors|mesh-ancestor
6361129|NCT00093600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361130|NCT00093600|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6361131|NCT00093600|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6361132|NCT00093600|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6361133|NCT00093600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6361134|NCT00093600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6361135|NCT00093613|Sorafenib|sorafenib|mesh-list
6361136|NCT00093613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6361137|NCT00093613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6361138|NCT00093613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6361139|NCT00093613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361140|NCT00093626|Sorafenib|sorafenib|mesh-list
6361141|NCT00093626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6361142|NCT00093626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6361143|NCT00093626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6361144|NCT00093626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361145|NCT00093639|Everolimus|everolimus|mesh-list
6361146|NCT00093639|Imatinib Mesylate|imatinib mesylate|mesh-list
6361147|NCT00093639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6361148|NCT00093639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6361149|NCT00093639|Immunologic Factors|immunologic factors|mesh-ancestor
6361150|NCT00093639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361151|NCT00093639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6361152|NCT00093639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6361153|NCT00093639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361154|NCT00093652|Oxaliplatin|oxaliplatin|mesh-list
6361155|NCT00093652|Gefitinib|gefitinib|mesh-list
6361156|NCT00093652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6361157|NCT00093652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6361158|NCT00093652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6394856|NCT00203450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6361159|NCT00093652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361160|NCT00093665|Fluorouracil|fluorouracil|mesh-list
6361161|NCT00093665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6361162|NCT00093665|Antimetabolites|antimetabolites|mesh-ancestor
6361163|NCT00093665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361164|NCT00093665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6361165|NCT00093665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6361166|NCT00093665|Immunologic Factors|immunologic factors|mesh-ancestor
6361167|NCT00093665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361168|NCT00093678|Celecoxib|celecoxib|mesh-list
6361169|NCT00093678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6361170|NCT00093678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6361171|NCT00093678|Analgesics|analgesics|mesh-ancestor
6361172|NCT00093678|Sensory System Agents|sensory system agents|mesh-ancestor
6361173|NCT00093678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6361174|NCT00093678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361175|NCT00093678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6361176|NCT00093678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6361177|NCT00093678|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6361178|NCT00093678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6361179|NCT00093678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6361180|NCT00093678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361181|NCT00093704|Ganciclovir|ganciclovir|mesh-list
6361182|NCT00093704|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6361183|NCT00093704|Bortezomib|bortezomib|mesh-list
6361184|NCT00093704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6361185|NCT00093704|Antiviral Agents|antiviral agents|mesh-ancestor
6361186|NCT00093704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6361187|NCT00093704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6361188|NCT00093704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6361189|NCT00093704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361190|NCT00093743|Cyclosporine|cyclosporine|mesh-list
6361191|NCT00093743|Mycophenolic Acid|mycophenolic acid|mesh-list
6361192|NCT00093743|Fludarabine|fludarabine|mesh-list
6361193|NCT00093743|Fludarabine phosphate|fludarabine phosphate|mesh-list
6361194|NCT00093743|Cyclosporins|cyclosporins|mesh-list
6361195|NCT00093743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6361196|NCT00093743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6361197|NCT00093743|Antimetabolites|antimetabolites|mesh-ancestor
6361198|NCT00093743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361199|NCT00093743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6361200|NCT00093743|Immunologic Factors|immunologic factors|mesh-ancestor
6361201|NCT00093743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361202|NCT00093743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6361203|NCT00093743|Antifungal Agents|antifungal agents|mesh-ancestor
6361204|NCT00093743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6361205|NCT00093743|Dermatologic Agents|dermatologic agents|mesh-ancestor
6361206|NCT00093743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6361207|NCT00093743|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6361208|NCT00093743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6361209|NCT00093743|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6361210|NCT00093743|Antitubercular Agents|antitubercular agents|mesh-ancestor
6361211|NCT00093743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6361212|NCT00093769|Rituximab|rituximab|mesh-list
6361213|NCT00093769|Bortezomib|bortezomib|mesh-list
6361214|NCT00093769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6361215|NCT00093769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6361216|NCT00093769|Immunologic Factors|immunologic factors|mesh-ancestor
6361217|NCT00093769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361218|NCT00093769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6361219|NCT00093834|Cyclophosphamide|cyclophosphamide|mesh-list
6361220|NCT00093834|Doxorubicin|doxorubicin|mesh-list
6361221|NCT00093834|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6361222|NCT00093834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6361223|NCT00093834|Immunologic Factors|immunologic factors|mesh-ancestor
6361224|NCT00093834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361225|NCT00093834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6361226|NCT00093834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6361227|NCT00093834|Alkylating Agents|alkylating agents|mesh-ancestor
6361228|NCT00093834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361229|NCT00093834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6361230|NCT00093834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6361231|NCT00093834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6361232|NCT00093834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6361233|NCT00093834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6361234|NCT00093834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6361235|NCT00093860|Propranolol|propranolol|mesh-list
6361236|NCT00093860|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6361237|NCT00093860|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6361238|NCT00093860|Adrenergic Agents|adrenergic agents|mesh-ancestor
6361239|NCT00093860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6361240|NCT00093860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361241|NCT00093860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361242|NCT00093860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6361243|NCT00093860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6361244|NCT00093860|Vasodilator Agents|vasodilator agents|mesh-ancestor
6361245|NCT00093873|Motesanib diphosphate|motesanib diphosphate|mesh-list
6361246|NCT00093873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6361247|NCT00093873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6361248|NCT00093873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361249|NCT00093886|Clevidipine|clevidipine|mesh-list
6361250|NCT00093886|Nitroglycerin|nitroglycerin|mesh-list
6361251|NCT00093886|Vasodilator Agents|vasodilator agents|mesh-ancestor
6361252|NCT00093886|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6361253|NCT00093886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6361254|NCT00093886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361255|NCT00093886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6361256|NCT00093886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361257|NCT00093912|Nitroprusside|nitroprusside|mesh-list
6361258|NCT00093912|Clevidipine|clevidipine|mesh-list
6361259|NCT00093912|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6361260|NCT00093912|Vasodilator Agents|vasodilator agents|mesh-ancestor
6361261|NCT00093912|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6361262|NCT00093912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361263|NCT00093912|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6361264|NCT00093912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6361265|NCT00093912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6361266|NCT00093912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361267|NCT00093925|Nicardipine|nicardipine|mesh-list
6361268|NCT00093925|Clevidipine|clevidipine|mesh-list
6361269|NCT00093925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6361270|NCT00093925|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6361271|NCT00093925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6361272|NCT00093925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361273|NCT00093925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6361274|NCT00093925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361275|NCT00093925|Vasodilator Agents|vasodilator agents|mesh-ancestor
6361276|NCT00093951|(3-aminopropyl)(n-butyl)phosphinic acid|(3-aminopropyl)(n-butyl)phosphinic acid|mesh-list
6361277|NCT00093951|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6361278|NCT00093951|Protective Agents|protective agents|mesh-ancestor
6361279|NCT00093951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361280|NCT00093951|GABA Antagonists|gaba antagonists|mesh-ancestor
6361281|NCT00093951|GABA Agents|gaba agents|mesh-ancestor
6361282|NCT00093951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6361283|NCT00093951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361284|NCT00093977|Darbepoetin alfa|darbepoetin alfa|mesh-list
6361285|NCT00093977|Hematinics|hematinics|mesh-ancestor
6361286|NCT00093990|Tipifarnib|tipifarnib|mesh-list
6361287|NCT00093990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6361288|NCT00094003|Poly I-C|poly i-c|mesh-list
6361289|NCT00094003|Antiviral Agents|antiviral agents|mesh-ancestor
6361290|NCT00094003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6361291|NCT00094003|Interferon Inducers|interferon inducers|mesh-ancestor
6361292|NCT00094003|Immunologic Factors|immunologic factors|mesh-ancestor
6361293|NCT00094003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361294|NCT00094029|Sunitinib|sunitinib|mesh-list
6361295|NCT00094029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6361296|NCT00094029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6361297|NCT00094029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6361298|NCT00094029|Growth Substances|growth substances|mesh-ancestor
6361299|NCT00094029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361300|NCT00094029|Growth Inhibitors|growth inhibitors|mesh-ancestor
6361301|NCT00094029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6361302|NCT00094029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6361303|NCT00094029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361304|NCT00094081|Tirapazamine|tirapazamine|mesh-list
6361305|NCT00094081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6361306|NCT00094120|Squalamine|squalamine|mesh-list
6361307|NCT00094120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6361308|NCT00094120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6361309|NCT00094120|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6361310|NCT00094120|Protective Agents|protective agents|mesh-ancestor
6361311|NCT00094120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361312|NCT00094120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6361313|NCT00094120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6361314|NCT00094120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6361315|NCT00094120|Growth Substances|growth substances|mesh-ancestor
6361316|NCT00094120|Growth Inhibitors|growth inhibitors|mesh-ancestor
6361317|NCT00094146|Octreotide|octreotide|mesh-list
6361318|NCT00094146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6361319|NCT00094146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6361320|NCT00094146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6361321|NCT00094289|Disulfiram|disulfiram|mesh-list
6361322|NCT00094289|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6361323|NCT00094289|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
6361324|NCT00094289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6361325|NCT00094289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361326|NCT00094315|Cocaine|cocaine|mesh-list
6361327|NCT00094315|Anesthetics, Local|anesthetics, local|mesh-ancestor
6361328|NCT00094315|Anesthetics|anesthetics|mesh-ancestor
6361329|NCT00094315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6361330|NCT00094315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361331|NCT00094315|Sensory System Agents|sensory system agents|mesh-ancestor
6361332|NCT00094315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6361333|NCT00094315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6361334|NCT00094315|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6361335|NCT00094315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6361336|NCT00094315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6361337|NCT00094315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361338|NCT00094315|Dopamine Agents|dopamine agents|mesh-ancestor
6361339|NCT00094315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6361340|NCT00094341|Etanercept|etanercept|mesh-list
6361341|NCT00094341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6361342|NCT00094341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6361343|NCT00094341|Analgesics|analgesics|mesh-ancestor
6361344|NCT00094341|Sensory System Agents|sensory system agents|mesh-ancestor
6361345|NCT00094341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6361346|NCT00094341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361347|NCT00094341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6361348|NCT00094341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6361349|NCT00094341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6361350|NCT00094341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6361351|NCT00094341|Immunologic Factors|immunologic factors|mesh-ancestor
6361352|NCT00094367|Lamivudine|lamivudine|mesh-list
6361353|NCT00094367|Abacavir|abacavir|mesh-list
6361354|NCT00094367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6361355|NCT00094367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6361356|NCT00094367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6361357|NCT00094367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361358|NCT00094367|Antiviral Agents|antiviral agents|mesh-ancestor
6361359|NCT00094367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6361360|NCT00094367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6361361|NCT00094367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6361362|NCT00094380|Cyclophosphamide|cyclophosphamide|mesh-list
6361363|NCT00094380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6361364|NCT00094380|Immunologic Factors|immunologic factors|mesh-ancestor
6361365|NCT00094380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361366|NCT00094380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6361367|NCT00094380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6361368|NCT00094380|Alkylating Agents|alkylating agents|mesh-ancestor
6361369|NCT00094380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361370|NCT00094380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6361371|NCT00094380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6361372|NCT00094406|Carbon Monoxide|carbon monoxide|mesh-list
6361373|NCT00094406|Antimetabolites|antimetabolites|mesh-ancestor
6361374|NCT00094406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361375|NCT00094406|Gasotransmitters|gasotransmitters|mesh-ancestor
6361376|NCT00094406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6361377|NCT00094406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361378|NCT00094432|Aripiprazole|aripiprazole|mesh-list
6361379|NCT00094432|Antidepressive Agents|antidepressive agents|mesh-ancestor
6361380|NCT00094432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6361381|NCT00094432|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6361382|NCT00094432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6361383|NCT00094432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6361384|NCT00094432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361385|NCT00094432|Dopamine Agonists|dopamine agonists|mesh-ancestor
6361386|NCT00094432|Dopamine Agents|dopamine agents|mesh-ancestor
6361387|NCT00094432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6361388|NCT00094432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361389|NCT00094432|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6361390|NCT00094432|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6361391|NCT00094432|Serotonin Agents|serotonin agents|mesh-ancestor
6361392|NCT00094432|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6361393|NCT00094432|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6361394|NCT00094432|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6361395|NCT00094432|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6361396|NCT00094484|Cinacalcet|cinacalcet|mesh-list
6361397|NCT00094484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6361398|NCT00094484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361399|NCT00094484|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6361400|NCT00094484|Hormone Antagonists|hormone antagonists|mesh-ancestor
6361401|NCT00094484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6361402|NCT00094523|Fosamprenavir|fosamprenavir|mesh-list
6361403|NCT00094523|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6361404|NCT00094523|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6361405|NCT00094523|Protease Inhibitors|protease inhibitors|mesh-ancestor
6361406|NCT00094523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6361407|NCT00094523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361408|NCT00094523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6361409|NCT00094523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6361410|NCT00094523|Antiviral Agents|antiviral agents|mesh-ancestor
6361411|NCT00094523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6361412|NCT00094549|Valproic Acid|valproic acid|mesh-list
6361413|NCT00094549|Olanzapine|olanzapine|mesh-list
6361414|NCT00094549|Antiemetics|antiemetics|mesh-ancestor
6361415|NCT00094549|Autonomic Agents|autonomic agents|mesh-ancestor
6361416|NCT00094549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6361417|NCT00094549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361418|NCT00094549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6361419|NCT00094549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6361420|NCT00094549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6361421|NCT00094549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6361422|NCT00094549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6361423|NCT00094549|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6361424|NCT00094549|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6361425|NCT00094549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6361426|NCT00094549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361427|NCT00094549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6361428|NCT00094549|Serotonin Agents|serotonin agents|mesh-ancestor
6361429|NCT00094549|Anticonvulsants|anticonvulsants|mesh-ancestor
6361430|NCT00094549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6361431|NCT00094549|GABA Agents|gaba agents|mesh-ancestor
6361432|NCT00094549|Antimanic Agents|antimanic agents|mesh-ancestor
6361433|NCT00094614|Atropine|atropine|mesh-list
6361434|NCT00094614|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6361435|NCT00094614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6361436|NCT00094614|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6361437|NCT00094614|Autonomic Agents|autonomic agents|mesh-ancestor
6361438|NCT00094614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6361439|NCT00094614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361440|NCT00094614|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6361441|NCT00094614|Respiratory System Agents|respiratory system agents|mesh-ancestor
6361442|NCT00094614|Mydriatics|mydriatics|mesh-ancestor
6361443|NCT00094614|Parasympatholytics|parasympatholytics|mesh-ancestor
6361444|NCT00094614|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6361445|NCT00094614|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6361446|NCT00094614|Cholinergic Agents|cholinergic agents|mesh-ancestor
6361447|NCT00094614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6361448|NCT00094614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361449|NCT00094627|Gaboxadol|gaboxadol|mesh-list
6361450|NCT00094627|Analgesics|analgesics|mesh-ancestor
6361451|NCT00094627|Sensory System Agents|sensory system agents|mesh-ancestor
6361452|NCT00094627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6361453|NCT00094627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361454|NCT00094627|Anticonvulsants|anticonvulsants|mesh-ancestor
6361455|NCT00094627|GABA Agonists|gaba agonists|mesh-ancestor
6361456|NCT00094627|GABA Agents|gaba agents|mesh-ancestor
6361457|NCT00094627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6361458|NCT00094627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361459|NCT00094640|Olanzapine|olanzapine|mesh-list
6361460|NCT00094640|Antiemetics|antiemetics|mesh-ancestor
6361461|NCT00094640|Autonomic Agents|autonomic agents|mesh-ancestor
6361462|NCT00094640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6361463|NCT00094640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361464|NCT00094640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6361465|NCT00094640|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6361466|NCT00094640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6361467|NCT00094640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6361468|NCT00094640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6361469|NCT00094640|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6361470|NCT00094640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6361471|NCT00094640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6361472|NCT00094640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361473|NCT00094640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6361474|NCT00094640|Serotonin Agents|serotonin agents|mesh-ancestor
6361475|NCT00094666|Gaboxadol|gaboxadol|mesh-list
6361476|NCT00094666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6361477|NCT00094666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361478|NCT00094666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361479|NCT00094666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6361480|NCT00094666|Analgesics|analgesics|mesh-ancestor
6361481|NCT00094666|Sensory System Agents|sensory system agents|mesh-ancestor
6361482|NCT00094666|Anticonvulsants|anticonvulsants|mesh-ancestor
6361483|NCT00094666|GABA Agonists|gaba agonists|mesh-ancestor
6361484|NCT00094666|GABA Agents|gaba agents|mesh-ancestor
6361485|NCT00094692|Atropine|atropine|mesh-list
6361486|NCT00094692|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6361487|NCT00094692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6361488|NCT00094692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6361489|NCT00094692|Autonomic Agents|autonomic agents|mesh-ancestor
6361490|NCT00094692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6361491|NCT00094692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361492|NCT00094692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6361493|NCT00094692|Respiratory System Agents|respiratory system agents|mesh-ancestor
6361494|NCT00094692|Mydriatics|mydriatics|mesh-ancestor
6361495|NCT00094692|Parasympatholytics|parasympatholytics|mesh-ancestor
6361496|NCT00094692|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6361497|NCT00094692|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6361498|NCT00094692|Cholinergic Agents|cholinergic agents|mesh-ancestor
6361499|NCT00094692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6361500|NCT00094692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361501|NCT00094848|Mapatumumab|mapatumumab|mesh-list
6361502|NCT00094848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6361503|NCT00094926|Risperidone|risperidone|mesh-list
6361504|NCT00094926|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6361505|NCT00094926|Serotonin Agents|serotonin agents|mesh-ancestor
6361506|NCT00094926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6361507|NCT00094926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361508|NCT00094926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361509|NCT00094926|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6361510|NCT00094926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6361511|NCT00094926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6361512|NCT00094926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6361513|NCT00094926|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6361514|NCT00094926|Dopamine Agents|dopamine agents|mesh-ancestor
6361515|NCT00094965|Oxaliplatin|oxaliplatin|mesh-list
6361516|NCT00094965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6361517|NCT00094978|Alvocidib|alvocidib|mesh-list
6361518|NCT00094978|Romidepsin|romidepsin|mesh-list
6361519|NCT00094978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6361520|NCT00094978|Growth Inhibitors|growth inhibitors|mesh-ancestor
6361521|NCT00094978|Growth Substances|growth substances|mesh-ancestor
6361522|NCT00094978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361523|NCT00094978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6361524|NCT00094978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6361525|NCT00094978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361526|NCT00094978|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6361527|NCT00095043|Gaboxadol|gaboxadol|mesh-list
6361528|NCT00095043|Analgesics|analgesics|mesh-ancestor
6361529|NCT00095043|Sensory System Agents|sensory system agents|mesh-ancestor
6361530|NCT00095043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6361531|NCT00095043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361532|NCT00095043|Anticonvulsants|anticonvulsants|mesh-ancestor
6361533|NCT00095043|GABA Agonists|gaba agonists|mesh-ancestor
6361534|NCT00095043|GABA Agents|gaba agents|mesh-ancestor
6361535|NCT00095043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6361536|NCT00095043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361537|NCT00095069|Gaboxadol|gaboxadol|mesh-list
6361538|NCT00095069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6361539|NCT00095069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361540|NCT00095069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361541|NCT00095069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6361542|NCT00095069|Analgesics|analgesics|mesh-ancestor
6361543|NCT00095069|Sensory System Agents|sensory system agents|mesh-ancestor
6361544|NCT00095069|Anticonvulsants|anticonvulsants|mesh-ancestor
6361545|NCT00095069|GABA Agonists|gaba agonists|mesh-ancestor
6361546|NCT00095069|GABA Agents|gaba agents|mesh-ancestor
6361547|NCT00095082|Insulin|insulin|mesh-list
6361548|NCT00095082|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6361549|NCT00095082|Insulin Glargine|insulin glargine|mesh-list
6361550|NCT00095082|Insulin Aspart|insulin aspart|mesh-list
6361551|NCT00095082|Insulin Detemir|insulin detemir|mesh-list
6361552|NCT00095082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6361553|NCT00095082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361554|NCT00095134|Risperidone|risperidone|mesh-list
6361555|NCT00095134|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6361556|NCT00095134|Serotonin Agents|serotonin agents|mesh-ancestor
6361557|NCT00095134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6361558|NCT00095134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361559|NCT00095134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361560|NCT00095134|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6361561|NCT00095134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6361562|NCT00095134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6361563|NCT00095134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6361564|NCT00095134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6361565|NCT00095134|Dopamine Agents|dopamine agents|mesh-ancestor
6361566|NCT00095186|Lactoferrin|lactoferrin|mesh-list
6361567|NCT00095186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6361568|NCT00095225|Bevacizumab|bevacizumab|mesh-list
6361569|NCT00095225|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6361570|NCT00095225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6361571|NCT00095225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6361572|NCT00095225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6361573|NCT00095225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6361574|NCT00095225|Growth Substances|growth substances|mesh-ancestor
6361575|NCT00095225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361576|NCT00095225|Growth Inhibitors|growth inhibitors|mesh-ancestor
6361577|NCT00095225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6361578|NCT00095225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6361579|NCT00095225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361580|NCT00095251|Dexmedetomidine|dexmedetomidine|mesh-list
6361581|NCT00095251|Lorazepam|lorazepam|mesh-list
6361582|NCT00095251|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6361583|NCT00095251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6361584|NCT00095251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361585|NCT00095251|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6361586|NCT00095251|Analgesics|analgesics|mesh-ancestor
6361587|NCT00095251|Sensory System Agents|sensory system agents|mesh-ancestor
6361588|NCT00095251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6361589|NCT00095251|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6361590|NCT00095251|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6361591|NCT00095251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6361592|NCT00095251|Adrenergic Agents|adrenergic agents|mesh-ancestor
6361593|NCT00095251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6361594|NCT00095251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361595|NCT00095251|Anticonvulsants|anticonvulsants|mesh-ancestor
6361596|NCT00095251|Antiemetics|antiemetics|mesh-ancestor
6361597|NCT00095251|Autonomic Agents|autonomic agents|mesh-ancestor
6361598|NCT00095251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6361599|NCT00095251|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6361600|NCT00095251|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6361601|NCT00095251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6361602|NCT00095251|GABA Modulators|gaba modulators|mesh-ancestor
6361603|NCT00095251|GABA Agents|gaba agents|mesh-ancestor
6361604|NCT00095264|Darbepoetin alfa|darbepoetin alfa|mesh-list
6361605|NCT00095264|Hematinics|hematinics|mesh-ancestor
6361606|NCT00095277|Darbepoetin alfa|darbepoetin alfa|mesh-list
6361607|NCT00095277|Hematinics|hematinics|mesh-ancestor
6361608|NCT00095316|Caspofungin|caspofungin|mesh-list
6361609|NCT00095316|Antifungal Agents|antifungal agents|mesh-ancestor
6361610|NCT00095316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6361611|NCT00095316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6361612|NCT00095316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361613|NCT00095329|Sirolimus|sirolimus|mesh-list
6361614|NCT00095329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6361615|NCT00095329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6361616|NCT00095329|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6361617|NCT00095329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6361618|NCT00095329|Antifungal Agents|antifungal agents|mesh-ancestor
6361619|NCT00095329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6361620|NCT00095329|Immunologic Factors|immunologic factors|mesh-ancestor
6361621|NCT00095329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361622|NCT00095355|Valproic Acid|valproic acid|mesh-list
6361623|NCT00095355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6361624|NCT00095355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6361625|NCT00095355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361626|NCT00095355|Antimanic Agents|antimanic agents|mesh-ancestor
6361627|NCT00095355|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6361628|NCT00095355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6361629|NCT00095355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361630|NCT00095355|Anticonvulsants|anticonvulsants|mesh-ancestor
6361631|NCT00095355|GABA Agents|gaba agents|mesh-ancestor
6361632|NCT00095355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6361633|NCT00095368|Amoxicillin|amoxicillin|mesh-list
6361634|NCT00095368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6361635|NCT00095368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6361636|NCT00095433|Ranibizumab|ranibizumab|mesh-list
6361637|NCT00095433|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6361638|NCT00095433|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6361639|NCT00095433|Growth Substances|growth substances|mesh-ancestor
6361640|NCT00095433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361641|NCT00095433|Growth Inhibitors|growth inhibitors|mesh-ancestor
6361642|NCT00095433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6361643|NCT00095446|Insulin Aspart|insulin aspart|mesh-list
6361644|NCT00095446|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6361645|NCT00095446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361646|NCT00095459|Bevacizumab|bevacizumab|mesh-list
6361647|NCT00095459|Sorafenib|sorafenib|mesh-list
6361648|NCT00095459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6361649|NCT00095459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6361650|NCT00095459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6361651|NCT00095459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6361652|NCT00095459|Growth Substances|growth substances|mesh-ancestor
6361653|NCT00095459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361654|NCT00095459|Growth Inhibitors|growth inhibitors|mesh-ancestor
6361655|NCT00095459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6361656|NCT00095459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6361657|NCT00095459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361658|NCT00095472|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
6361659|NCT00095472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6361660|NCT00095472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361661|NCT00095511|Aripiprazole|aripiprazole|mesh-list
6361662|NCT00095511|Antidepressive Agents|antidepressive agents|mesh-ancestor
6361663|NCT00095511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6361664|NCT00095511|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6361665|NCT00095511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6361666|NCT00095511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6361667|NCT00095511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361668|NCT00095511|Dopamine Agonists|dopamine agonists|mesh-ancestor
6361669|NCT00095511|Dopamine Agents|dopamine agents|mesh-ancestor
6361670|NCT00095511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6361671|NCT00095511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361672|NCT00095511|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6361673|NCT00095511|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6361674|NCT00095511|Serotonin Agents|serotonin agents|mesh-ancestor
6361675|NCT00095511|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6361676|NCT00095511|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6361677|NCT00095511|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6361678|NCT00095511|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6361679|NCT00095524|Aripiprazole|aripiprazole|mesh-list
6361680|NCT00095524|Antidepressive Agents|antidepressive agents|mesh-ancestor
6361681|NCT00095524|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6361682|NCT00095524|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6361683|NCT00095524|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6361684|NCT00095524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6361685|NCT00095524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361686|NCT00095524|Dopamine Agonists|dopamine agonists|mesh-ancestor
6361687|NCT00095524|Dopamine Agents|dopamine agents|mesh-ancestor
6361688|NCT00095524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6361689|NCT00095524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361690|NCT00095524|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6361691|NCT00095524|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6361692|NCT00095524|Serotonin Agents|serotonin agents|mesh-ancestor
6361693|NCT00095524|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6361694|NCT00095524|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6361695|NCT00095524|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6361696|NCT00095524|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6394857|NCT00203450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394858|NCT00203450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6394859|NCT00203450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394860|NCT00203463|Topiramate|topiramate|mesh-list
6394861|NCT00203463|Anticonvulsants|anticonvulsants|mesh-ancestor
6394862|NCT00203463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6394863|NCT00203463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394864|NCT00203528|Valproic Acid|valproic acid|mesh-list
6394865|NCT00203528|Risperidone|risperidone|mesh-list
6394866|NCT00203528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6394867|NCT00203528|Serotonin Agents|serotonin agents|mesh-ancestor
6394868|NCT00203528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6394869|NCT00203528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394870|NCT00203528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394871|NCT00203528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6394872|NCT00203528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6394873|NCT00203528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6394874|NCT00203528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6394875|NCT00203528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6394876|NCT00203528|Dopamine Agents|dopamine agents|mesh-ancestor
6394877|NCT00203528|Anticonvulsants|anticonvulsants|mesh-ancestor
6394878|NCT00203528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6394879|NCT00203528|GABA Agents|gaba agents|mesh-ancestor
6394880|NCT00203528|Antimanic Agents|antimanic agents|mesh-ancestor
6394881|NCT00203554|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
6394882|NCT00203554|Vasodilator Agents|vasodilator agents|mesh-ancestor
6361697|NCT00095641|Capecitabine|capecitabine|mesh-list
6361698|NCT00095641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6361699|NCT00095641|Antimetabolites|antimetabolites|mesh-ancestor
6361700|NCT00095641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361701|NCT00095641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6361702|NCT00095654|Rosiglitazone|rosiglitazone|mesh-list
6361703|NCT00095654|Ramipril|ramipril|mesh-list
6361704|NCT00095654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6361705|NCT00095654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361706|NCT00095654|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6361707|NCT00095654|Protease Inhibitors|protease inhibitors|mesh-ancestor
6361708|NCT00095654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6361709|NCT00095654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361710|NCT00095654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6361711|NCT00095667|Lapatinib|lapatinib|mesh-list
6361712|NCT00095667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6361713|NCT00095667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6361714|NCT00095667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6361715|NCT00095667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361716|NCT00095680|Bortezomib|bortezomib|mesh-list
6361717|NCT00095680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6361718|NCT00095693|Sorafenib|sorafenib|mesh-list
6361719|NCT00095693|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6361720|NCT00095693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6361721|NCT00095693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6361722|NCT00095693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6361723|NCT00095693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361724|NCT00095693|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6361725|NCT00095706|Bevacizumab|bevacizumab|mesh-list
6361726|NCT00095706|Trastuzumab|trastuzumab|mesh-list
6361727|NCT00095706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6361728|NCT00095706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6361729|NCT00095706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6361730|NCT00095706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6361731|NCT00095706|Growth Substances|growth substances|mesh-ancestor
6361732|NCT00095706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361733|NCT00095706|Growth Inhibitors|growth inhibitors|mesh-ancestor
6361734|NCT00095719|Aripiprazole|aripiprazole|mesh-list
6017217|NCT00370292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6017218|NCT00370396|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6017219|NCT00370396|Immunologic Factors|immunologic factors|mesh-ancestor
6361735|NCT00095719|Antidepressive Agents|antidepressive agents|mesh-ancestor
6361736|NCT00095719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6361737|NCT00095719|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6361738|NCT00095719|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6361739|NCT00095719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6361740|NCT00095719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361741|NCT00095719|Dopamine Agonists|dopamine agonists|mesh-ancestor
6361742|NCT00095719|Dopamine Agents|dopamine agents|mesh-ancestor
6361743|NCT00095719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6361744|NCT00095719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361745|NCT00095719|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6361746|NCT00095719|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6361747|NCT00095719|Serotonin Agents|serotonin agents|mesh-ancestor
6361748|NCT00095719|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6361749|NCT00095719|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6361750|NCT00095719|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6361751|NCT00095719|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6361752|NCT00095745|Aripiprazole|aripiprazole|mesh-list
6361753|NCT00095745|Antidepressive Agents|antidepressive agents|mesh-list
6361754|NCT00095745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6361755|NCT00095745|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6361756|NCT00095745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6361757|NCT00095745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6361758|NCT00095745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361759|NCT00095745|Dopamine Agonists|dopamine agonists|mesh-ancestor
6361760|NCT00095745|Dopamine Agents|dopamine agents|mesh-ancestor
6361761|NCT00095745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6361762|NCT00095745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361763|NCT00095745|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6361764|NCT00095745|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6361765|NCT00095745|Serotonin Agents|serotonin agents|mesh-ancestor
6361766|NCT00095745|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6361767|NCT00095745|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6361768|NCT00095745|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6361769|NCT00095745|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6361770|NCT00095758|Aripiprazole|aripiprazole|mesh-list
6361771|NCT00095758|Antidepressive Agents|antidepressive agents|mesh-list
6361772|NCT00095758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6361773|NCT00095758|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6361774|NCT00095758|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6361775|NCT00095758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6361776|NCT00095758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361777|NCT00095758|Dopamine Agonists|dopamine agonists|mesh-ancestor
6361778|NCT00095758|Dopamine Agents|dopamine agents|mesh-ancestor
6361779|NCT00095758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6361780|NCT00095758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361781|NCT00095758|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6361782|NCT00095758|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6361783|NCT00095758|Serotonin Agents|serotonin agents|mesh-ancestor
6361784|NCT00095758|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6361785|NCT00095758|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6361786|NCT00095758|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6361787|NCT00095758|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6361788|NCT00095771|Arsenic Trioxide|arsenic trioxide|mesh-list
6361789|NCT00095771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6361790|NCT00095810|Aripiprazole|aripiprazole|mesh-list
6361791|NCT00095810|Antidepressive Agents|antidepressive agents|mesh-ancestor
6361792|NCT00095810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6361793|NCT00095810|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6361794|NCT00095810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6361795|NCT00095810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6361796|NCT00095810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361797|NCT00095810|Dopamine Agonists|dopamine agonists|mesh-ancestor
6361798|NCT00095810|Dopamine Agents|dopamine agents|mesh-ancestor
6361799|NCT00095810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6361800|NCT00095810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361801|NCT00095810|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6361802|NCT00095810|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6361803|NCT00095810|Serotonin Agents|serotonin agents|mesh-ancestor
6361804|NCT00095810|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6361805|NCT00095810|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6361806|NCT00095810|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6361807|NCT00095810|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6361808|NCT00095823|Aripiprazole|aripiprazole|mesh-list
6361809|NCT00095823|Antidepressive Agents|antidepressive agents|mesh-list
6361810|NCT00095823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6361811|NCT00095823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6361812|NCT00095823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6361813|NCT00095823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6361814|NCT00095823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361815|NCT00095823|Dopamine Agonists|dopamine agonists|mesh-ancestor
6361816|NCT00095823|Dopamine Agents|dopamine agents|mesh-ancestor
6361817|NCT00095823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6361818|NCT00095823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361819|NCT00095823|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6361820|NCT00095823|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6361821|NCT00095823|Serotonin Agents|serotonin agents|mesh-ancestor
6361822|NCT00095823|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6361823|NCT00095823|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6361824|NCT00095823|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6361825|NCT00095823|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6361826|NCT00095862|Interferons|interferons|mesh-list
6361827|NCT00095862|Interferon-alpha|interferon-alpha|mesh-list
6361828|NCT00095862|Cyclophosphamide|cyclophosphamide|mesh-list
6361829|NCT00095862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6361830|NCT00095862|Immunologic Factors|immunologic factors|mesh-ancestor
6361831|NCT00095862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361832|NCT00095862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6361833|NCT00095862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6361834|NCT00095862|Alkylating Agents|alkylating agents|mesh-ancestor
6361835|NCT00095862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361836|NCT00095862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6361837|NCT00095862|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6361838|NCT00095862|Antiviral Agents|antiviral agents|mesh-ancestor
6361839|NCT00095862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6361840|NCT00095888|Gemcitabine|gemcitabine|mesh-list
6361841|NCT00095888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6361842|NCT00095888|Antimetabolites|antimetabolites|mesh-ancestor
6361843|NCT00095888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361844|NCT00095888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6361845|NCT00095888|Antiviral Agents|antiviral agents|mesh-ancestor
6361846|NCT00095888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6361847|NCT00095888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6361848|NCT00095888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6361849|NCT00095888|Immunologic Factors|immunologic factors|mesh-ancestor
6361850|NCT00095888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361851|NCT00095901|Capecitabine|capecitabine|mesh-list
6361852|NCT00095901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6361853|NCT00095901|Antimetabolites|antimetabolites|mesh-ancestor
6361854|NCT00095901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361855|NCT00095901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6361856|NCT00095914|Paclitaxel|paclitaxel|mesh-list
6361857|NCT00095914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6361858|NCT00095914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6361859|NCT00095914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6361860|NCT00095914|Tubulin Modulators|tubulin modulators|mesh-ancestor
6361861|NCT00095914|Antimitotic Agents|antimitotic agents|mesh-ancestor
6361862|NCT00095914|Mitosis Modulators|mitosis modulators|mesh-ancestor
6361863|NCT00095914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361864|NCT00095927|Paclitaxel|paclitaxel|mesh-list
6361865|NCT00095927|Carboplatin|carboplatin|mesh-list
6361866|NCT00095927|Amifostine|amifostine|mesh-list
6361867|NCT00095927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6361868|NCT00095927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6361869|NCT00095927|Tubulin Modulators|tubulin modulators|mesh-ancestor
6361870|NCT00095927|Antimitotic Agents|antimitotic agents|mesh-ancestor
6361871|NCT00095927|Mitosis Modulators|mitosis modulators|mesh-ancestor
6361872|NCT00095927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361873|NCT00095927|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6361874|NCT00095927|Protective Agents|protective agents|mesh-ancestor
6361875|NCT00095927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361876|NCT00095966|Gemcitabine|gemcitabine|mesh-list
6361877|NCT00095966|Sorafenib|sorafenib|mesh-list
6361878|NCT00095966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6361879|NCT00095966|Antimetabolites|antimetabolites|mesh-ancestor
6361880|NCT00095966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361881|NCT00095966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6361882|NCT00095966|Antiviral Agents|antiviral agents|mesh-ancestor
6361883|NCT00095966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6361884|NCT00095966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6361885|NCT00095966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6361886|NCT00095966|Immunologic Factors|immunologic factors|mesh-ancestor
6361887|NCT00095966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361888|NCT00095966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6361889|NCT00096005|Bortezomib|bortezomib|mesh-list
6361890|NCT00096005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6361891|NCT00096057|Antibodies|antibodies|mesh-list
6361892|NCT00096057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6361893|NCT00096057|Immunologic Factors|immunologic factors|mesh-ancestor
6361894|NCT00096057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361895|NCT00096070|Gemcitabine|gemcitabine|mesh-list
6361896|NCT00096070|Fluorouracil|fluorouracil|mesh-list
6361897|NCT00096070|Oxaliplatin|oxaliplatin|mesh-list
6361898|NCT00096070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6361899|NCT00096070|Antimetabolites|antimetabolites|mesh-ancestor
6361900|NCT00096070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361901|NCT00096070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6361902|NCT00096070|Antiviral Agents|antiviral agents|mesh-ancestor
6361903|NCT00096070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6361904|NCT00096070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6361905|NCT00096070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6361906|NCT00096070|Immunologic Factors|immunologic factors|mesh-ancestor
6361907|NCT00096070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361908|NCT00096083|Melphalan|melphalan|mesh-list
6361909|NCT00096083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6361910|NCT00096083|Alkylating Agents|alkylating agents|mesh-ancestor
6361911|NCT00096083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361912|NCT00096083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6361913|NCT00096083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6361914|NCT00096083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6361915|NCT00096083|Immunologic Factors|immunologic factors|mesh-ancestor
6361916|NCT00096083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361917|NCT00096096|Mycophenolic Acid|mycophenolic acid|mesh-list
6361918|NCT00096096|Tacrolimus|tacrolimus|mesh-list
6361919|NCT00096096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6361920|NCT00096096|Immunologic Factors|immunologic factors|mesh-ancestor
6361921|NCT00096096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361922|NCT00096096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6361923|NCT00096096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6361924|NCT00096096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361925|NCT00096096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6361926|NCT00096096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6361927|NCT00096096|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6361928|NCT00096096|Antitubercular Agents|antitubercular agents|mesh-ancestor
6361929|NCT00096096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6361930|NCT00096096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6361931|NCT00096148|Cytarabine|cytarabine|mesh-list
6361932|NCT00096148|Bevacizumab|bevacizumab|mesh-list
6361933|NCT00096148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6361934|NCT00096148|Idarubicin|idarubicin|mesh-list
6361935|NCT00096148|Antibodies|antibodies|mesh-list
6361936|NCT00096148|Immunoglobulins|immunoglobulins|mesh-list
6361937|NCT00096148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6361938|NCT00096148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6361939|NCT00096148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6361940|NCT00096148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6361941|NCT00096148|Growth Substances|growth substances|mesh-ancestor
6361942|NCT00096148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361943|NCT00096148|Growth Inhibitors|growth inhibitors|mesh-ancestor
6361944|NCT00096148|Immunologic Factors|immunologic factors|mesh-ancestor
6361945|NCT00096148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6361946|NCT00096148|Antimetabolites|antimetabolites|mesh-ancestor
6361947|NCT00096148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361948|NCT00096148|Antiviral Agents|antiviral agents|mesh-ancestor
6361949|NCT00096148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6361950|NCT00096148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6361951|NCT00096148|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6361952|NCT00096148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6361953|NCT00096148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6361954|NCT00096148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6361955|NCT00096187|Pemetrexed|pemetrexed|mesh-list
6361956|NCT00096187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6361957|NCT00096187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6361958|NCT00096187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361959|NCT00096187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6361960|NCT00096187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6361961|NCT00096291|Paclitaxel|paclitaxel|mesh-list
6361962|NCT00096291|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6361963|NCT00096291|Doxorubicin|doxorubicin|mesh-list
6361964|NCT00096291|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6361965|NCT00096291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6361966|NCT00096291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6361967|NCT00096291|Tubulin Modulators|tubulin modulators|mesh-ancestor
6361968|NCT00096291|Antimitotic Agents|antimitotic agents|mesh-ancestor
6361969|NCT00096291|Mitosis Modulators|mitosis modulators|mesh-ancestor
6361970|NCT00096291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361971|NCT00096291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6361972|NCT00096291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6361973|NCT00096291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6361974|NCT00096291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6361975|NCT00096304|Docetaxel|docetaxel|mesh-list
6361976|NCT00096304|Epirubicin|epirubicin|mesh-list
6361977|NCT00096304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6361978|NCT00096304|Tubulin Modulators|tubulin modulators|mesh-ancestor
6361979|NCT00096304|Antimitotic Agents|antimitotic agents|mesh-ancestor
6361980|NCT00096304|Mitosis Modulators|mitosis modulators|mesh-ancestor
6361981|NCT00096304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361982|NCT00096304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6361983|NCT00096304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6361984|NCT00096304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6361985|NCT00096304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6361986|NCT00096317|Ketoconazole|ketoconazole|mesh-list
6361987|NCT00096317|Antifungal Agents|antifungal agents|mesh-ancestor
6361988|NCT00096317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6361989|NCT00096317|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6361990|NCT00096317|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6361991|NCT00096317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6361992|NCT00096317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6361993|NCT00096317|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6361994|NCT00096317|Hormone Antagonists|hormone antagonists|mesh-ancestor
6361995|NCT00096317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6361996|NCT00096317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6361997|NCT00096317|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6361998|NCT00096330|Folic Acid|folic acid|mesh-list
6361999|NCT00096330|Hematinics|hematinics|mesh-ancestor
6362000|NCT00096330|Vitamin B Complex|vitamin b complex|mesh-ancestor
6362001|NCT00096330|Vitamins|vitamins|mesh-ancestor
6362002|NCT00096330|Micronutrients|micronutrients|mesh-ancestor
6362003|NCT00096330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362004|NCT00096343|Paclitaxel|paclitaxel|mesh-list
6362005|NCT00096343|Carboplatin|carboplatin|mesh-list
6362006|NCT00096343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6362007|NCT00096343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6362008|NCT00096343|Tubulin Modulators|tubulin modulators|mesh-ancestor
6362009|NCT00096343|Antimitotic Agents|antimitotic agents|mesh-ancestor
6362010|NCT00096343|Mitosis Modulators|mitosis modulators|mesh-ancestor
6362011|NCT00096343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362012|NCT00096369|Tamoxifen|tamoxifen|mesh-list
6362013|NCT00096369|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6362014|NCT00096369|Hormone Antagonists|hormone antagonists|mesh-ancestor
6362015|NCT00096369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6362016|NCT00096369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362017|NCT00096369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6362018|NCT00096369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6362019|NCT00096369|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6362020|NCT00096369|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6362021|NCT00096369|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6362022|NCT00096395|Gemcitabine|gemcitabine|mesh-list
6362023|NCT00096395|Sorafenib|sorafenib|mesh-list
6362024|NCT00096395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6362025|NCT00096395|Antimetabolites|antimetabolites|mesh-ancestor
6362026|NCT00096395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362027|NCT00096395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6362028|NCT00096395|Antiviral Agents|antiviral agents|mesh-ancestor
6362029|NCT00096395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6362030|NCT00096395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6362031|NCT00096395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6362032|NCT00096395|Immunologic Factors|immunologic factors|mesh-ancestor
6362033|NCT00096395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362034|NCT00096395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6362035|NCT00096434|Sorafenib|sorafenib|mesh-list
6362036|NCT00096434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6362037|NCT00096434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6362038|NCT00096434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6362039|NCT00096434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362040|NCT00096473|Donepezil|donepezil|mesh-list
6362041|NCT00096473|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6362042|NCT00096473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6362043|NCT00096473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362044|NCT00096473|Cholinergic Agents|cholinergic agents|mesh-ancestor
6362045|NCT00096473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6362046|NCT00096473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362047|NCT00096473|Nootropic Agents|nootropic agents|mesh-ancestor
6362048|NCT00096512|Sorafenib|sorafenib|mesh-list
6362049|NCT00096512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6362050|NCT00096512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6362051|NCT00096512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6362052|NCT00096512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362053|NCT00096525|Lenalidomide|lenalidomide|mesh-list
6362054|NCT00096525|Immunologic Factors|immunologic factors|mesh-ancestor
6362055|NCT00096525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362056|NCT00096525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6362057|NCT00096525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6362058|NCT00096525|Growth Substances|growth substances|mesh-ancestor
6362059|NCT00096525|Growth Inhibitors|growth inhibitors|mesh-ancestor
6362060|NCT00096525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6362061|NCT00096551|Metronidazole|metronidazole|mesh-list
6362062|NCT00096551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6362063|NCT00096551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6362064|NCT00096551|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6362065|NCT00096551|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6362066|NCT00096616|Albuterol|albuterol|mesh-list
6362067|NCT00096616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6362068|NCT00096616|Autonomic Agents|autonomic agents|mesh-ancestor
6362069|NCT00096616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6362070|NCT00096616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362071|NCT00096616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6362072|NCT00096616|Respiratory System Agents|respiratory system agents|mesh-ancestor
6362073|NCT00096616|Tocolytic Agents|tocolytic agents|mesh-ancestor
6362074|NCT00096616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6362075|NCT00096616|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6362076|NCT00096616|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6362077|NCT00096616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6362078|NCT00096616|Adrenergic Agents|adrenergic agents|mesh-ancestor
6362079|NCT00096616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6362080|NCT00096616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362081|NCT00096629|Vaccines|vaccines|mesh-list
6362082|NCT00096629|Immunologic Factors|immunologic factors|mesh-ancestor
6362083|NCT00096629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362084|NCT00096655|Infliximab|infliximab|mesh-list
6362085|NCT00096655|Dermatologic Agents|dermatologic agents|mesh-ancestor
6362086|NCT00096655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6362087|NCT00096655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6362088|NCT00096668|Paclitaxel|paclitaxel|mesh-list
6362089|NCT00096668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6362090|NCT00096668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6362091|NCT00096668|Tubulin Modulators|tubulin modulators|mesh-ancestor
6362092|NCT00096668|Antimitotic Agents|antimitotic agents|mesh-ancestor
6362093|NCT00096668|Mitosis Modulators|mitosis modulators|mesh-ancestor
6362094|NCT00096668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362095|NCT00096694|Levonorgestrel|levonorgestrel|mesh-list
6362096|NCT00096694|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6362097|NCT00096694|Contraceptive Agents|contraceptive agents|mesh-ancestor
6362098|NCT00096694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6362099|NCT00096694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362100|NCT00096694|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6362101|NCT00096694|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6362102|NCT00096694|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6362103|NCT00096707|Deoxyglucose|deoxyglucose|mesh-list
6362104|NCT00096707|Antimetabolites|antimetabolites|mesh-ancestor
6362105|NCT00096707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362106|NCT00096707|Antiviral Agents|antiviral agents|mesh-ancestor
6362107|NCT00096707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6362108|NCT00096720|Levodopa|levodopa|mesh-list
6362109|NCT00096720|Pramipexole|pramipexole|mesh-list
6362110|NCT00096720|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6362111|NCT00096720|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6362112|NCT00096720|Dopamine Agents|dopamine agents|mesh-ancestor
6362113|NCT00096720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6362114|NCT00096720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362115|NCT00096720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362116|NCT00096720|Antioxidants|antioxidants|mesh-ancestor
6362117|NCT00096720|Protective Agents|protective agents|mesh-ancestor
6362118|NCT00096720|Dopamine Agonists|dopamine agonists|mesh-ancestor
6362119|NCT00096798|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
6362120|NCT00096798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6362121|NCT00096798|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6362122|NCT00096811|Entecavir|entecavir|mesh-list
6362123|NCT00096811|Antiviral Agents|antiviral agents|mesh-ancestor
6362124|NCT00096811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6362125|NCT00096837|Motexafin gadolinium|motexafin gadolinium|mesh-list
6362126|NCT00096837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6362127|NCT00096837|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6362128|NCT00096837|Dermatologic Agents|dermatologic agents|mesh-ancestor
6362129|NCT00096850|Ritonavir|ritonavir|mesh-list
6362130|NCT00096850|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6362131|NCT00096850|Rifampin|rifampin|mesh-list
6362132|NCT00096850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6362133|NCT00096850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6362134|NCT00096850|Protease Inhibitors|protease inhibitors|mesh-ancestor
6362135|NCT00096850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6362136|NCT00096850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362137|NCT00096850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6362138|NCT00096850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6362139|NCT00096850|Antiviral Agents|antiviral agents|mesh-ancestor
6362140|NCT00096850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6362141|NCT00096850|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6362142|NCT00096850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6362143|NCT00096850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6362144|NCT00096850|Antitubercular Agents|antitubercular agents|mesh-ancestor
6362145|NCT00096850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6362146|NCT00096850|Leprostatic Agents|leprostatic agents|mesh-ancestor
6362147|NCT00096850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6362148|NCT00096850|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6362149|NCT00096850|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6362150|NCT00096850|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6362151|NCT00096850|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6362152|NCT00096850|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6362153|NCT00096850|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6362154|NCT00096863|Haloperidol|haloperidol|mesh-list
6362155|NCT00096863|Haloperidol decanoate|haloperidol decanoate|mesh-list
6362156|NCT00096863|Ziprasidone|ziprasidone|mesh-list
6362157|NCT00096863|Antiemetics|antiemetics|mesh-ancestor
6362158|NCT00096863|Autonomic Agents|autonomic agents|mesh-ancestor
6362159|NCT00096863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6362160|NCT00096863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362161|NCT00096863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6362162|NCT00096863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6362163|NCT00096863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6394883|NCT00203554|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
6362164|NCT00096863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6362165|NCT00096863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6362166|NCT00096863|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6362167|NCT00096863|Dopamine Agents|dopamine agents|mesh-ancestor
6362168|NCT00096863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6362169|NCT00096863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362170|NCT00096863|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6362171|NCT00096863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6362172|NCT00096863|Serotonin Agents|serotonin agents|mesh-ancestor
6362173|NCT00096915|Darbepoetin alfa|darbepoetin alfa|mesh-list
6362174|NCT00096915|Hematinics|hematinics|mesh-ancestor
6362175|NCT00096967|Bevacizumab|bevacizumab|mesh-list
6362176|NCT00096967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6362177|NCT00096967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6362178|NCT00096967|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6362179|NCT00096967|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6362180|NCT00096967|Growth Substances|growth substances|mesh-ancestor
6362181|NCT00096967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362182|NCT00096967|Growth Inhibitors|growth inhibitors|mesh-ancestor
6362183|NCT00097019|Bevacizumab|bevacizumab|mesh-list
6362184|NCT00097019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6362185|NCT00097019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6362186|NCT00097019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6362187|NCT00097019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6362188|NCT00097019|Growth Substances|growth substances|mesh-ancestor
6362189|NCT00097019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362190|NCT00097019|Growth Inhibitors|growth inhibitors|mesh-ancestor
6362191|NCT00097032|Risperidone|risperidone|mesh-list
6362192|NCT00097032|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6362193|NCT00097032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6362194|NCT00097032|Serotonin Agents|serotonin agents|mesh-ancestor
6362195|NCT00097032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6362196|NCT00097032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362197|NCT00097032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362198|NCT00097032|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6362199|NCT00097032|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6362200|NCT00097032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6362201|NCT00097032|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6362202|NCT00097032|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6362203|NCT00097032|Dopamine Agents|dopamine agents|mesh-ancestor
6362204|NCT00097032|Antidepressive Agents|antidepressive agents|mesh-ancestor
6362205|NCT00097045|Interferons|interferons|mesh-list
6362206|NCT00097045|Ribavirin|ribavirin|mesh-list
6362207|NCT00097045|Interferon omega 1|interferon omega 1|mesh-list
6362208|NCT00097045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6362209|NCT00097045|Antiviral Agents|antiviral agents|mesh-ancestor
6362210|NCT00097045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6362211|NCT00097045|Antimetabolites|antimetabolites|mesh-ancestor
6362212|NCT00097045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362213|NCT00097071|Insulin|insulin|mesh-list
6362214|NCT00097071|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6362215|NCT00097071|Insulin Aspart|insulin aspart|mesh-list
6362216|NCT00097071|Insulin Lispro|insulin lispro|mesh-list
6362217|NCT00097071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6362218|NCT00097071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362219|NCT00097084|Insulin|insulin|mesh-list
6362220|NCT00097084|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6362221|NCT00097084|Insulin Glargine|insulin glargine|mesh-list
6362222|NCT00097084|Insulin Aspart|insulin aspart|mesh-list
6362223|NCT00097084|Insulin Detemir|insulin detemir|mesh-list
6362224|NCT00097084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6362225|NCT00097084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362226|NCT00097110|Ascorbic Acid|ascorbic acid|mesh-list
6362227|NCT00097110|Vitamins|vitamins|mesh-ancestor
6362228|NCT00097110|Micronutrients|micronutrients|mesh-ancestor
6362229|NCT00097110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362230|NCT00097110|Antioxidants|antioxidants|mesh-ancestor
6362231|NCT00097110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362232|NCT00097110|Protective Agents|protective agents|mesh-ancestor
6362233|NCT00097123|Misoprostol|misoprostol|mesh-list
6362234|NCT00097123|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6362235|NCT00097123|Abortifacient Agents|abortifacient agents|mesh-ancestor
6362236|NCT00097123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6362237|NCT00097123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362238|NCT00097123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6362239|NCT00097123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6362240|NCT00097123|Oxytocics|oxytocics|mesh-ancestor
6362241|NCT00097188|Rituximab|rituximab|mesh-list
6362242|NCT00097188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6362243|NCT00097188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6362244|NCT00097188|Immunologic Factors|immunologic factors|mesh-ancestor
6362245|NCT00097188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362246|NCT00097188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6362247|NCT00097214|Carboplatin|carboplatin|mesh-list
6362248|NCT00097214|Cetuximab|cetuximab|mesh-list
6362249|NCT00097214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6362250|NCT00097214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6362251|NCT00097227|Paclitaxel|paclitaxel|mesh-list
6362252|NCT00097227|Carboplatin|carboplatin|mesh-list
6362253|NCT00097227|Cetuximab|cetuximab|mesh-list
6362254|NCT00097227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6362255|NCT00097227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6362256|NCT00097227|Tubulin Modulators|tubulin modulators|mesh-ancestor
6362257|NCT00097227|Antimitotic Agents|antimitotic agents|mesh-ancestor
6362258|NCT00097227|Mitosis Modulators|mitosis modulators|mesh-ancestor
6362259|NCT00097227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362260|NCT00097227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6362261|NCT00097266|Haloperidol|haloperidol|mesh-list
6362262|NCT00097266|Aripiprazole|aripiprazole|mesh-list
6362263|NCT00097266|Haloperidol decanoate|haloperidol decanoate|mesh-list
6362264|NCT00097266|Antidepressive Agents|antidepressive agents|mesh-ancestor
6362265|NCT00097266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6362266|NCT00097266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6362267|NCT00097266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6362268|NCT00097266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6362269|NCT00097266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362270|NCT00097266|Dopamine Agonists|dopamine agonists|mesh-ancestor
6362271|NCT00097266|Dopamine Agents|dopamine agents|mesh-ancestor
6362272|NCT00097266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6362273|NCT00097266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362274|NCT00097266|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6362275|NCT00097266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6362276|NCT00097266|Serotonin Agents|serotonin agents|mesh-ancestor
6362277|NCT00097266|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6362278|NCT00097266|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6362279|NCT00097266|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6362280|NCT00097266|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6362281|NCT00097266|Antiemetics|antiemetics|mesh-ancestor
6362282|NCT00097266|Autonomic Agents|autonomic agents|mesh-ancestor
6362283|NCT00097266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6362284|NCT00097266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6362285|NCT00097266|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6362286|NCT00097279|Metformin|metformin|mesh-list
6362287|NCT00097279|Pioglitazone|pioglitazone|mesh-list
6362288|NCT00097279|Insulin Aspart|insulin aspart|mesh-list
6362289|NCT00097279|Biphasic Insulins|biphasic insulins|mesh-list
6362290|NCT00097279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6362291|NCT00097279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362292|NCT00097318|Interferons|interferons|mesh-list
6362293|NCT00097318|Interferon-beta|interferon-beta|mesh-list
6362294|NCT00097318|Interferon beta-1a|interferon beta-1a|mesh-list
6362295|NCT00097318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6362296|NCT00097318|Antiviral Agents|antiviral agents|mesh-ancestor
6362297|NCT00097318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6362298|NCT00097318|Immunologic Factors|immunologic factors|mesh-ancestor
6362299|NCT00097318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362300|NCT00097318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6362301|NCT00097344|Toremifene|toremifene|mesh-list
6362302|NCT00097344|Letrozole|letrozole|mesh-list
6362303|NCT00097344|Hormones|hormones|mesh-list
6362304|NCT00097344|Atamestane|atamestane|mesh-list
6362305|NCT00097344|Estrogen Antagonists|estrogen antagonists|mesh-list
6362306|NCT00097344|Estrogens|estrogens|mesh-list
6362307|NCT00097344|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-list
6362308|NCT00097344|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-list
6362309|NCT00097344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6362310|NCT00097344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362311|NCT00097344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6362312|NCT00097344|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6362313|NCT00097344|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6362314|NCT00097344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6362315|NCT00097344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362316|NCT00097344|Hormone Antagonists|hormone antagonists|mesh-ancestor
6362317|NCT00097344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6362318|NCT00097344|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6362319|NCT00097344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6362320|NCT00097383|Epirubicin|epirubicin|mesh-list
6362321|NCT00097383|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6362322|NCT00097383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6362323|NCT00097383|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6362324|NCT00097383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6362325|NCT00097383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6362326|NCT00097383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394884|NCT00203554|Protective Agents|protective agents|mesh-ancestor
6394885|NCT00203554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394886|NCT00203567|Carbamazepine|carbamazepine|mesh-list
6394887|NCT00203567|Anticonvulsants|anticonvulsants|mesh-ancestor
6394888|NCT00203567|Antimanic Agents|antimanic agents|mesh-ancestor
6394889|NCT00203567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6394890|NCT00203567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6394891|NCT00203567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394892|NCT00203567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6394893|NCT00203567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6394894|NCT00203567|Analgesics|analgesics|mesh-ancestor
6394895|NCT00203567|Sensory System Agents|sensory system agents|mesh-ancestor
6394896|NCT00203567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6394897|NCT00203567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6394898|NCT00203567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6394899|NCT00203567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394900|NCT00203567|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6394901|NCT00203567|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6394902|NCT00203580|Tinzaparin|tinzaparin|mesh-list
6394903|NCT00203580|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6394904|NCT00203580|Dalteparin|dalteparin|mesh-list
6394905|NCT00203580|Anticoagulants|anticoagulants|mesh-ancestor
6394906|NCT00203580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6394907|NCT00203580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6394908|NCT00203580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394909|NCT00203606|Interferons|interferons|mesh-list
6394910|NCT00203606|Ribavirin|ribavirin|mesh-list
6394911|NCT00203606|Interferon-alpha|interferon-alpha|mesh-list
6394912|NCT00203606|Interferon alpha-2|interferon alpha-2|mesh-list
6394913|NCT00203606|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6394914|NCT00203606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6394915|NCT00203606|Antiviral Agents|antiviral agents|mesh-ancestor
6362327|NCT00097435|Ribavirin|ribavirin|mesh-list
6362328|NCT00097435|Antimetabolites|antimetabolites|mesh-ancestor
6362329|NCT00097435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362330|NCT00097435|Antiviral Agents|antiviral agents|mesh-ancestor
6362331|NCT00097435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6362332|NCT00097734|Ertapenem|ertapenem|mesh-list
6362333|NCT00097734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6362334|NCT00097734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6362335|NCT00097760|Natalizumab|natalizumab|mesh-list
6362336|NCT00097760|Immunologic Factors|immunologic factors|mesh-ancestor
6362337|NCT00097760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362338|NCT00097799|Ritonavir|ritonavir|mesh-list
6362339|NCT00097799|Tipranavir|tipranavir|mesh-list
6362340|NCT00097799|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6362341|NCT00097799|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6362342|NCT00097799|Protease Inhibitors|protease inhibitors|mesh-ancestor
6362343|NCT00097799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6362344|NCT00097799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362345|NCT00097799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6362346|NCT00097799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6362347|NCT00097799|Antiviral Agents|antiviral agents|mesh-ancestor
6362348|NCT00097799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6362349|NCT00097799|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6362350|NCT00097799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6362351|NCT00097812|Zoledronic Acid|zoledronic acid|mesh-list
6362352|NCT00097812|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6362353|NCT00097812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362354|NCT00097825|Zoledronic Acid|zoledronic acid|mesh-list
6362355|NCT00097825|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6362356|NCT00097825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362357|NCT00097851|Docetaxel|docetaxel|mesh-list
6362358|NCT00097851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6362359|NCT00097851|Tubulin Modulators|tubulin modulators|mesh-ancestor
6362360|NCT00097851|Antimitotic Agents|antimitotic agents|mesh-ancestor
6362361|NCT00097851|Mitosis Modulators|mitosis modulators|mesh-ancestor
6362362|NCT00097851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362363|NCT00097877|Insulin|insulin|mesh-list
6362364|NCT00097877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6362365|NCT00097877|Insulin Glargine|insulin glargine|mesh-list
6362366|NCT00097877|Insulin Aspart|insulin aspart|mesh-list
6362367|NCT00097877|Biphasic Insulins|biphasic insulins|mesh-list
6362368|NCT00097877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6362369|NCT00097877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362370|NCT00097903|Camptothecin|camptothecin|mesh-list
6362371|NCT00097903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6362372|NCT00097903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6362373|NCT00097903|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6362374|NCT00097903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6362375|NCT00097903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6362376|NCT00097903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362377|NCT00097916|Memantine|memantine|mesh-list
6362378|NCT00097916|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6362379|NCT00097916|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6362380|NCT00097916|Dopamine Agents|dopamine agents|mesh-ancestor
6362381|NCT00097916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6362382|NCT00097916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362383|NCT00097916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362384|NCT00097916|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6362385|NCT00097916|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6362386|NCT00097929|Vorinostat|vorinostat|mesh-list
6362387|NCT00097929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6362388|NCT00097929|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6362389|NCT00097929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6362390|NCT00097929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362391|NCT00097942|Memantine|memantine|mesh-list
6362392|NCT00097942|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6362393|NCT00097942|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6362394|NCT00097942|Dopamine Agents|dopamine agents|mesh-ancestor
6362395|NCT00097942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6362396|NCT00097942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362397|NCT00097942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362398|NCT00097942|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6362399|NCT00097942|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6362400|NCT00097968|Everolimus|everolimus|mesh-list
6362401|NCT00097968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6362402|NCT00097968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6362403|NCT00097968|Immunologic Factors|immunologic factors|mesh-ancestor
6362404|NCT00097968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362405|NCT00098007|Everolimus|everolimus|mesh-list
6362406|NCT00098007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6362407|NCT00098007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6362408|NCT00098007|Immunologic Factors|immunologic factors|mesh-ancestor
6362409|NCT00098007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362410|NCT00098033|Clofarabine|clofarabine|mesh-list
6362411|NCT00098033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6362412|NCT00098033|Antimetabolites|antimetabolites|mesh-ancestor
6362413|NCT00098033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362414|NCT00098033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6362415|NCT00098046|Famciclovir|famciclovir|mesh-list
6362416|NCT00098046|Antiviral Agents|antiviral agents|mesh-ancestor
6362417|NCT00098046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6362418|NCT00098046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6362419|NCT00098046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6362420|NCT00098046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362421|NCT00098111|Azathioprine|azathioprine|mesh-list
6362422|NCT00098111|Antimetabolites|antimetabolites|mesh-ancestor
6362423|NCT00098111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362424|NCT00098111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6362425|NCT00098111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6362426|NCT00098111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6362427|NCT00098111|Immunologic Factors|immunologic factors|mesh-ancestor
6362428|NCT00098111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362429|NCT00098111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6362430|NCT00098124|Milnacipran|milnacipran|mesh-list
6362431|NCT00098124|Levomilnacipran|levomilnacipran|mesh-list
6362432|NCT00098124|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6362433|NCT00098124|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6362434|NCT00098124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6362435|NCT00098124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362436|NCT00098124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6362437|NCT00098124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362438|NCT00098124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6362439|NCT00098124|Analgesics|analgesics|mesh-ancestor
6362440|NCT00098124|Sensory System Agents|sensory system agents|mesh-ancestor
6362441|NCT00098124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6362442|NCT00098124|Antidepressive Agents|antidepressive agents|mesh-ancestor
6362443|NCT00098124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6362444|NCT00098137|Olmesartan|olmesartan|mesh-list
6362445|NCT00098137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6362446|NCT00098137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6362447|NCT00098137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6362448|NCT00098137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362449|NCT00098241|Everolimus|everolimus|mesh-list
6362450|NCT00098241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6362451|NCT00098241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6362452|NCT00098241|Immunologic Factors|immunologic factors|mesh-ancestor
6362453|NCT00098241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362454|NCT00098280|Eculizumab|eculizumab|mesh-list
6362455|NCT00098280|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6362456|NCT00098280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6362457|NCT00098280|Immunologic Factors|immunologic factors|mesh-ancestor
6362458|NCT00098280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362459|NCT00098319|Folic Acid|folic acid|mesh-list
6362460|NCT00098319|Hematinics|hematinics|mesh-ancestor
6362461|NCT00098319|Vitamin B Complex|vitamin b complex|mesh-ancestor
6362462|NCT00098319|Vitamins|vitamins|mesh-ancestor
6362463|NCT00098319|Micronutrients|micronutrients|mesh-ancestor
6362464|NCT00098319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362465|NCT00098358|Zileuton|zileuton|mesh-list
6362466|NCT00098358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6362467|NCT00098358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6362468|NCT00098358|Analgesics|analgesics|mesh-ancestor
6362469|NCT00098358|Sensory System Agents|sensory system agents|mesh-ancestor
6362470|NCT00098358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6362471|NCT00098358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362472|NCT00098358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6362473|NCT00098358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6362474|NCT00098358|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6362475|NCT00098358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6362476|NCT00098358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362477|NCT00098358|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6362478|NCT00098358|Hormone Antagonists|hormone antagonists|mesh-ancestor
6362479|NCT00098358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6362480|NCT00098384|Rifaximin|rifaximin|mesh-list
6362481|NCT00098384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6362482|NCT00098384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6362483|NCT00098384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6362484|NCT00098397|Romidepsin|romidepsin|mesh-list
6362485|NCT00098397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6362486|NCT00098397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6362487|NCT00098423|Cytarabine|cytarabine|mesh-list
6362488|NCT00098423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6362489|NCT00098423|Antimetabolites|antimetabolites|mesh-ancestor
6362490|NCT00098423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362491|NCT00098423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6362492|NCT00098423|Antiviral Agents|antiviral agents|mesh-ancestor
6362493|NCT00098423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6362494|NCT00098423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6362495|NCT00098423|Immunologic Factors|immunologic factors|mesh-ancestor
6362496|NCT00098423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362497|NCT00098436|Temozolomide|temozolomide|mesh-list
6362498|NCT00098436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6362499|NCT00098436|Alkylating Agents|alkylating agents|mesh-ancestor
6362500|NCT00098436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362501|NCT00098436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6362502|NCT00098462|Sirolimus|sirolimus|mesh-list
6362503|NCT00098462|Gefitinib|gefitinib|mesh-list
6362504|NCT00098462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6362505|NCT00098462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6362506|NCT00098462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6362507|NCT00098462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6362508|NCT00098462|Antifungal Agents|antifungal agents|mesh-ancestor
6362509|NCT00098462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6362510|NCT00098462|Immunologic Factors|immunologic factors|mesh-ancestor
6362511|NCT00098462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362512|NCT00098462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6362513|NCT00098462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6362514|NCT00098462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362515|NCT00098488|Rituximab|rituximab|mesh-list
6362516|NCT00098488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6362517|NCT00098488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6362518|NCT00098488|Immunologic Factors|immunologic factors|mesh-ancestor
6362519|NCT00098488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362520|NCT00098488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6362521|NCT00098501|Sirolimus|sirolimus|mesh-list
6362522|NCT00098501|EKB 569|ekb 569|mesh-list
6362523|NCT00098501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6362524|NCT00098501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6362525|NCT00098501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6362526|NCT00098501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6362527|NCT00098501|Antifungal Agents|antifungal agents|mesh-ancestor
6362528|NCT00098501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6362529|NCT00098501|Immunologic Factors|immunologic factors|mesh-ancestor
6362530|NCT00098501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362531|NCT00098501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6362532|NCT00098501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6362533|NCT00098501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362534|NCT00098527|Romidepsin|romidepsin|mesh-list
6362535|NCT00098527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6362536|NCT00098527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6362537|NCT00098540|Sorafenib|sorafenib|mesh-list
6362538|NCT00098540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6362539|NCT00098540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6362540|NCT00098540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6362541|NCT00098540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362542|NCT00098553|Everolimus|everolimus|mesh-list
6362543|NCT00098553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6362544|NCT00098553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6362545|NCT00098553|Immunologic Factors|immunologic factors|mesh-ancestor
6362546|NCT00098553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362547|NCT00098579|Doxorubicin|doxorubicin|mesh-list
6362548|NCT00098579|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6362549|NCT00098579|Alvocidib|alvocidib|mesh-list
6362550|NCT00098579|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6362551|NCT00098579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6362552|NCT00098579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6362553|NCT00098579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6362554|NCT00098579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6362555|NCT00098579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362556|NCT00098579|Growth Inhibitors|growth inhibitors|mesh-ancestor
6362557|NCT00098579|Growth Substances|growth substances|mesh-ancestor
6362558|NCT00098579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362559|NCT00098579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6362560|NCT00098605|Lapatinib|lapatinib|mesh-list
6362561|NCT00098605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6362562|NCT00098605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6362563|NCT00098605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6362564|NCT00098605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362565|NCT00098618|Interferons|interferons|mesh-list
6362566|NCT00098618|Interferon-alpha|interferon-alpha|mesh-list
6362567|NCT00098618|Interferon alpha-2|interferon alpha-2|mesh-list
6017220|NCT00370396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017221|NCT00370552|Paclitaxel|paclitaxel|mesh-list
6017222|NCT00370552|Epothilones|epothilones|mesh-list
6017223|NCT00370552|Bevacizumab|bevacizumab|mesh-list
6017224|NCT00370552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6017225|NCT00370552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6362568|NCT00098618|Sorafenib|sorafenib|mesh-list
6362569|NCT00098618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6362570|NCT00098618|Antiviral Agents|antiviral agents|mesh-ancestor
6362571|NCT00098618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6362572|NCT00098618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6362573|NCT00098618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6362574|NCT00098618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362575|NCT00098618|Immunologic Factors|immunologic factors|mesh-ancestor
6362576|NCT00098618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362577|NCT00098631|Lapatinib|lapatinib|mesh-list
6362578|NCT00098631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6362579|NCT00098631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6362580|NCT00098631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6362581|NCT00098631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362582|NCT00098683|Amifostine|amifostine|mesh-list
6362583|NCT00098683|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6362584|NCT00098683|Protective Agents|protective agents|mesh-ancestor
6362585|NCT00098683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362586|NCT00098735|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6362587|NCT00098735|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6362588|NCT00098735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362589|NCT00098735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6362590|NCT00098735|Immunologic Factors|immunologic factors|mesh-ancestor
6362591|NCT00098735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362592|NCT00098800|Fenretinide|fenretinide|mesh-list
6362593|NCT00098800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6362594|NCT00098800|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6362595|NCT00098800|Protective Agents|protective agents|mesh-ancestor
6362596|NCT00098800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362597|NCT00098852|Rosiglitazone|rosiglitazone|mesh-list
6362598|NCT00098852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6362599|NCT00098852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362600|NCT00098878|Carboplatin|carboplatin|mesh-list
6362601|NCT00098878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6362602|NCT00098891|Entinostat|entinostat|mesh-list
6362603|NCT00098891|Isotretinoin|isotretinoin|mesh-list
6362604|NCT00098891|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
6362605|NCT00098891|Dermatologic Agents|dermatologic agents|mesh-ancestor
6362606|NCT00098891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6362607|NCT00098891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6362608|NCT00098891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362609|NCT00098917|Vaccines|vaccines|mesh-list
6362610|NCT00098917|Immunologic Factors|immunologic factors|mesh-ancestor
6362611|NCT00098917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362612|NCT00098969|Resveratrol|resveratrol|mesh-list
6362613|NCT00098969|Antioxidants|antioxidants|mesh-ancestor
6362614|NCT00098969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362615|NCT00098969|Protective Agents|protective agents|mesh-ancestor
6362616|NCT00098969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362617|NCT00098969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6362618|NCT00098969|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6362619|NCT00098982|Leucovorin|leucovorin|mesh-list
6362620|NCT00098982|Fluorouracil|fluorouracil|mesh-list
6362621|NCT00098982|Oxaliplatin|oxaliplatin|mesh-list
6362622|NCT00098982|Bortezomib|bortezomib|mesh-list
6362623|NCT00098982|Calcium|calcium|mesh-list
6362624|NCT00098982|Levoleucovorin|levoleucovorin|mesh-list
6362625|NCT00098982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6362626|NCT00098982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362627|NCT00098982|Antimetabolites|antimetabolites|mesh-ancestor
6362628|NCT00098982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362629|NCT00098982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6362630|NCT00098982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6362631|NCT00098982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6362632|NCT00098982|Immunologic Factors|immunologic factors|mesh-ancestor
6362633|NCT00098982|Antidotes|antidotes|mesh-ancestor
6362634|NCT00098982|Protective Agents|protective agents|mesh-ancestor
6362635|NCT00098982|Vitamin B Complex|vitamin b complex|mesh-ancestor
6362636|NCT00098982|Vitamins|vitamins|mesh-ancestor
6362637|NCT00098982|Micronutrients|micronutrients|mesh-ancestor
6362638|NCT00098995|Tirapazamine|tirapazamine|mesh-list
6362639|NCT00098995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6362640|NCT00099008|Genistein|genistein|mesh-list
6362641|NCT00099008|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6362642|NCT00099008|Protective Agents|protective agents|mesh-ancestor
6362643|NCT00099008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362644|NCT00099008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6362645|NCT00099008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6362646|NCT00099008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6362647|NCT00099008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362648|NCT00099008|Phytoestrogens|phytoestrogens|mesh-ancestor
6362649|NCT00099008|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6362650|NCT00099008|Estrogens|estrogens|mesh-ancestor
6362651|NCT00099008|Hormones|hormones|mesh-ancestor
6362652|NCT00099008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6362653|NCT00099060|Lapatinib|lapatinib|mesh-list
6362654|NCT00099060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6362655|NCT00099060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6362656|NCT00099060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6362657|NCT00099060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362658|NCT00099125|Irinotecan|irinotecan|mesh-list
6362659|NCT00099125|Temozolomide|temozolomide|mesh-list
6362660|NCT00099125|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6362661|NCT00099125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6362662|NCT00099125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6362663|NCT00099125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362664|NCT00099125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6362665|NCT00099125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6362666|NCT00099125|Alkylating Agents|alkylating agents|mesh-ancestor
6362667|NCT00099164|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
6362668|NCT00099164|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
6362669|NCT00099164|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6362670|NCT00099164|Hormone Antagonists|hormone antagonists|mesh-ancestor
6362671|NCT00099164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6362672|NCT00099164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362673|NCT00099164|Progestins|progestins|mesh-ancestor
6362674|NCT00099164|Hormones|hormones|mesh-ancestor
6362675|NCT00099177|Zoledronic Acid|zoledronic acid|mesh-list
6362676|NCT00099177|Ibandronic Acid|ibandronic acid|mesh-list
6362677|NCT00099177|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6362678|NCT00099177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362679|NCT00099190|Beta-lapachone|beta-lapachone|mesh-list
6362680|NCT00099190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6362681|NCT00099190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6362682|NCT00099190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6362683|NCT00099190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6362684|NCT00099190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362685|NCT00099190|Antiviral Agents|antiviral agents|mesh-ancestor
6362686|NCT00099203|Zoledronic Acid|zoledronic acid|mesh-list
6362687|NCT00099203|Ibandronic Acid|ibandronic acid|mesh-list
6362688|NCT00099203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6362689|NCT00099203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362690|NCT00099216|Rivastigmine|rivastigmine|mesh-list
6362691|NCT00099216|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6362692|NCT00099216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6362693|NCT00099216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362694|NCT00099216|Cholinergic Agents|cholinergic agents|mesh-ancestor
6362695|NCT00099216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6362696|NCT00099216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362697|NCT00099216|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6362698|NCT00099216|Protective Agents|protective agents|mesh-ancestor
6362699|NCT00099242|Rivastigmine|rivastigmine|mesh-list
6362700|NCT00099242|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6362701|NCT00099242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6362702|NCT00099242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362703|NCT00099242|Cholinergic Agents|cholinergic agents|mesh-ancestor
6362704|NCT00099242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6362705|NCT00099242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362706|NCT00099242|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6362707|NCT00099242|Protective Agents|protective agents|mesh-ancestor
6394916|NCT00203606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6394917|NCT00203606|Antimetabolites|antimetabolites|mesh-ancestor
6394918|NCT00203606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394919|NCT00203606|Immunologic Factors|immunologic factors|mesh-ancestor
6394920|NCT00203606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394921|NCT00203632|Rosiglitazone|rosiglitazone|mesh-list
6394922|NCT00203632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6394923|NCT00203632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394924|NCT00203658|Tinzaparin|tinzaparin|mesh-list
6394925|NCT00203658|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6394926|NCT00203658|Dalteparin|dalteparin|mesh-list
6394927|NCT00203658|Anticoagulants|anticoagulants|mesh-ancestor
6394928|NCT00203658|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6394929|NCT00203658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6394930|NCT00203658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394931|NCT00203684|Flunisolide|flunisolide|mesh-list
6394932|NCT00203684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6394933|NCT00203684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6394934|NCT00203684|Respiratory System Agents|respiratory system agents|mesh-ancestor
6394935|NCT00203697|Minocycline|minocycline|mesh-list
6394936|NCT00203697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6394937|NCT00203697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6394938|NCT00203723|Risperidone|risperidone|mesh-list
6394939|NCT00203723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6394940|NCT00203723|Serotonin Agents|serotonin agents|mesh-ancestor
6394941|NCT00203723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6394942|NCT00203723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394943|NCT00203723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394944|NCT00203723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6394945|NCT00203723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6394946|NCT00203723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6394947|NCT00203723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6394948|NCT00203723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6394949|NCT00203723|Dopamine Agents|dopamine agents|mesh-ancestor
6394950|NCT00203736|Artesunate|artesunate|mesh-list
6394951|NCT00203736|Pyrimethamine|pyrimethamine|mesh-list
6394952|NCT00203736|Sulfadoxine|sulfadoxine|mesh-list
6394953|NCT00203736|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6394954|NCT00203736|Antimalarials|antimalarials|mesh-ancestor
6394955|NCT00203736|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6394956|NCT00203736|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6394957|NCT00203736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6394958|NCT00203736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6394959|NCT00203736|Antiviral Agents|antiviral agents|mesh-ancestor
6394960|NCT00203736|Schistosomicides|schistosomicides|mesh-ancestor
6394961|NCT00203736|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6394962|NCT00203736|Anthelmintics|anthelmintics|mesh-ancestor
6394963|NCT00203736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6394964|NCT00203736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6394965|NCT00203736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394966|NCT00203736|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6017226|NCT00370552|Tubulin Modulators|tubulin modulators|mesh-ancestor
6362708|NCT00099320|Exenatide|exenatide|mesh-list
6362709|NCT00099320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6362710|NCT00099320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362711|NCT00099320|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6362712|NCT00099320|Incretins|incretins|mesh-ancestor
6362713|NCT00099320|Hormones|hormones|mesh-ancestor
6362714|NCT00099320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6362715|NCT00099333|Exenatide|exenatide|mesh-list
6362716|NCT00099333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6362717|NCT00099333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362718|NCT00099333|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6362719|NCT00099333|Incretins|incretins|mesh-ancestor
6362720|NCT00099333|Hormones|hormones|mesh-ancestor
6362721|NCT00099333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6362722|NCT00099450|INS 50589|ins 50589|mesh-list
6362723|NCT00099450|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6362724|NCT00099450|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6362725|NCT00099450|Purinergic Agents|purinergic agents|mesh-ancestor
6362726|NCT00099450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6362727|NCT00099450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362728|NCT00099450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362729|NCT00099489|Interferons|interferons|mesh-list
6362730|NCT00099489|Interferon-beta|interferon-beta|mesh-list
6362731|NCT00099489|Interferon beta-1a|interferon beta-1a|mesh-list
6362732|NCT00099489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6362733|NCT00099489|Antiviral Agents|antiviral agents|mesh-ancestor
6362734|NCT00099489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6362735|NCT00099489|Immunologic Factors|immunologic factors|mesh-ancestor
6362736|NCT00099489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362737|NCT00099489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6362738|NCT00099502|Interferons|interferons|mesh-list
6362739|NCT00099502|Interferon-beta|interferon-beta|mesh-list
6362740|NCT00099502|Glatiramer Acetate|glatiramer acetate|mesh-list
6362741|NCT00099502|Interferon beta-1b|interferon beta-1b|mesh-list
6362742|NCT00099502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6362743|NCT00099502|Antiviral Agents|antiviral agents|mesh-ancestor
6362744|NCT00099502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6362745|NCT00099502|Immunologic Factors|immunologic factors|mesh-ancestor
6362746|NCT00099502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362747|NCT00099502|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6362748|NCT00099502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6362749|NCT00099502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6362750|NCT00099541|Zoledronic Acid|zoledronic acid|mesh-list
6362751|NCT00099541|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6362752|NCT00099541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362753|NCT00099554|Etanercept|etanercept|mesh-list
6362754|NCT00099554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6362755|NCT00099554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6362756|NCT00099554|Analgesics|analgesics|mesh-ancestor
6362757|NCT00099554|Sensory System Agents|sensory system agents|mesh-ancestor
6362758|NCT00099554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6362759|NCT00099554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362760|NCT00099554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6362761|NCT00099554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6362762|NCT00099554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6362763|NCT00099554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6362764|NCT00099554|Immunologic Factors|immunologic factors|mesh-ancestor
6362765|NCT00099606|Dasatinib|dasatinib|mesh-list
6362766|NCT00099606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6362767|NCT00099606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6362768|NCT00099606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6362769|NCT00099606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362770|NCT00099619|Insulin|insulin|mesh-list
6362771|NCT00099619|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6362772|NCT00099619|Insulin Glargine|insulin glargine|mesh-list
6362773|NCT00099619|Exenatide|exenatide|mesh-list
6362774|NCT00099619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6362775|NCT00099619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362776|NCT00099619|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6362777|NCT00099619|Incretins|incretins|mesh-ancestor
6362778|NCT00099619|Hormones|hormones|mesh-ancestor
6362779|NCT00099619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6362780|NCT00099645|Mifepristone|mifepristone|mesh-list
6362781|NCT00099645|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6362782|NCT00099645|Abortifacient Agents|abortifacient agents|mesh-ancestor
6362783|NCT00099645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6362784|NCT00099645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362785|NCT00099645|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6362786|NCT00099645|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6362787|NCT00099645|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6362788|NCT00099645|Contraceptive Agents|contraceptive agents|mesh-ancestor
6362789|NCT00099645|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6362790|NCT00099645|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6362791|NCT00099645|Hormone Antagonists|hormone antagonists|mesh-ancestor
6362792|NCT00099645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6362793|NCT00099645|Luteolytic Agents|luteolytic agents|mesh-ancestor
6362794|NCT00099645|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6362795|NCT00099645|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6362796|NCT00099684|Ezetimibe|ezetimibe|mesh-list
6362797|NCT00099684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6362798|NCT00099684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6362799|NCT00099684|Antimetabolites|antimetabolites|mesh-ancestor
6362800|NCT00099684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362801|NCT00099684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6362802|NCT00099710|Curcumin|curcumin|mesh-list
6362803|NCT00099710|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6362804|NCT00099710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6362805|NCT00099710|Analgesics|analgesics|mesh-ancestor
6362806|NCT00099710|Sensory System Agents|sensory system agents|mesh-ancestor
6362807|NCT00099710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6362808|NCT00099710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362809|NCT00099710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6362810|NCT00099710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6362811|NCT00099710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6362812|NCT00099710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6362813|NCT00099710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362814|NCT00099736|Cyclosporine|cyclosporine|mesh-list
6362815|NCT00099736|Cyclosporins|cyclosporins|mesh-list
6362816|NCT00099736|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6362817|NCT00099736|Antifungal Agents|antifungal agents|mesh-ancestor
6362818|NCT00099736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6362819|NCT00099736|Dermatologic Agents|dermatologic agents|mesh-ancestor
6362820|NCT00099736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6362821|NCT00099736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362822|NCT00099736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6362823|NCT00099736|Immunologic Factors|immunologic factors|mesh-ancestor
6362824|NCT00099736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362825|NCT00099736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6362826|NCT00099736|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6362827|NCT00099736|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6362828|NCT00099749|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6362829|NCT00099749|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6362830|NCT00099749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362831|NCT00099749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6362832|NCT00099749|Immunologic Factors|immunologic factors|mesh-ancestor
6362833|NCT00099749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362834|NCT00099775|Caspofungin|caspofungin|mesh-list
6362835|NCT00099775|Antifungal Agents|antifungal agents|mesh-ancestor
6362836|NCT00099775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6362837|NCT00099775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6362838|NCT00099775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362839|NCT00099788|Ranolazine|ranolazine|mesh-list
6362840|NCT00099788|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6362841|NCT00099788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6362842|NCT00099788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362843|NCT00099801|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6362844|NCT00099801|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6362845|NCT00099801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362846|NCT00099801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6362847|NCT00099801|Immunologic Factors|immunologic factors|mesh-ancestor
6362848|NCT00099801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362849|NCT00099840|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6362850|NCT00099840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6362851|NCT00099866|Metformin|metformin|mesh-list
6362852|NCT00099866|Vildagliptin|vildagliptin|mesh-list
6362853|NCT00099866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6362854|NCT00099866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362855|NCT00099866|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6362856|NCT00099866|Protease Inhibitors|protease inhibitors|mesh-ancestor
6362857|NCT00099866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6362858|NCT00099866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362859|NCT00099892|Vildagliptin|vildagliptin|mesh-list
6362860|NCT00099892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6362861|NCT00099892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362862|NCT00099892|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6362863|NCT00099892|Protease Inhibitors|protease inhibitors|mesh-ancestor
6362864|NCT00099892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6362865|NCT00099892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362866|NCT00099905|Vildagliptin|vildagliptin|mesh-list
6362867|NCT00099905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6362868|NCT00099905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362869|NCT00099905|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6362870|NCT00099905|Protease Inhibitors|protease inhibitors|mesh-ancestor
6362871|NCT00099905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6362872|NCT00099905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362873|NCT00099918|Vildagliptin|vildagliptin|mesh-list
6362874|NCT00099918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6362875|NCT00099918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362876|NCT00099918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6362877|NCT00099918|Protease Inhibitors|protease inhibitors|mesh-ancestor
6362878|NCT00099918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6362879|NCT00099918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362880|NCT00099931|Vildagliptin|vildagliptin|mesh-list
6362881|NCT00099931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6362882|NCT00099931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362883|NCT00099931|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6362884|NCT00099931|Protease Inhibitors|protease inhibitors|mesh-ancestor
6362885|NCT00099931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6362886|NCT00099931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362887|NCT00099944|Glimepiride|glimepiride|mesh-list
6362888|NCT00099944|Vildagliptin|vildagliptin|mesh-list
6362889|NCT00099944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6362890|NCT00099944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6362891|NCT00099944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362892|NCT00099944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6362893|NCT00099944|Immunologic Factors|immunologic factors|mesh-ancestor
6362894|NCT00099944|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6362895|NCT00099944|Protease Inhibitors|protease inhibitors|mesh-ancestor
6362896|NCT00099944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6362897|NCT00099944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362898|NCT00099957|Vildagliptin|vildagliptin|mesh-list
6362899|NCT00099957|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6362900|NCT00099957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362901|NCT00099957|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6362902|NCT00099957|Protease Inhibitors|protease inhibitors|mesh-ancestor
6362903|NCT00099957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6362904|NCT00099957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362905|NCT00099970|Dacarbazine|dacarbazine|mesh-list
6362906|NCT00099970|Volociximab|volociximab|mesh-list
6362907|NCT00099970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6362908|NCT00099970|Alkylating Agents|alkylating agents|mesh-ancestor
6362909|NCT00099970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362910|NCT00099970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6362911|NCT00099970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6362912|NCT00099970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6362913|NCT00099970|Growth Substances|growth substances|mesh-ancestor
6362914|NCT00099970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362915|NCT00099970|Growth Inhibitors|growth inhibitors|mesh-ancestor
6362916|NCT00099996|Ezetimibe|ezetimibe|mesh-list
6362917|NCT00099996|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6362918|NCT00099996|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6362919|NCT00099996|Antimetabolites|antimetabolites|mesh-ancestor
6362920|NCT00099996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362921|NCT00099996|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6362922|NCT00100009|Triamcinolone|triamcinolone|mesh-list
6362923|NCT00100009|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6362924|NCT00100009|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6362925|NCT00100009|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6362926|NCT00100009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6362927|NCT00100009|Glucocorticoids|glucocorticoids|mesh-ancestor
6362928|NCT00100009|Hormones|hormones|mesh-ancestor
6362929|NCT00100009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6362930|NCT00100009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362931|NCT00100009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6362932|NCT00100009|Immunologic Factors|immunologic factors|mesh-ancestor
6362933|NCT00100009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6362934|NCT00100009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362935|NCT00100074|Lobeline|lobeline|mesh-list
6362936|NCT00100074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6362937|NCT00100074|Autonomic Agents|autonomic agents|mesh-ancestor
6362938|NCT00100074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6362939|NCT00100074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362940|NCT00100074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6362941|NCT00100074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6362942|NCT00100074|Cholinergic Agents|cholinergic agents|mesh-ancestor
6362943|NCT00100074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6362944|NCT00100074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362945|NCT00100074|Respiratory System Agents|respiratory system agents|mesh-ancestor
6362946|NCT00100100|Modafinil|modafinil|mesh-list
6362947|NCT00100100|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6362948|NCT00100100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362949|NCT00100100|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6362950|NCT00100100|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6362951|NCT00100100|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6362952|NCT00100100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362953|NCT00100113|Vanoxerine|vanoxerine|mesh-list
6362954|NCT00100113|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6362955|NCT00100113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6362956|NCT00100113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6362957|NCT00100113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362958|NCT00100113|Dopamine Agents|dopamine agents|mesh-ancestor
6362959|NCT00100113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6362960|NCT00100113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362961|NCT00100126|Amoxicillin|amoxicillin|mesh-list
6362962|NCT00100126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6362963|NCT00100126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6362964|NCT00100139|Paclitaxel|paclitaxel|mesh-list
6362965|NCT00100139|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6362966|NCT00100139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6362967|NCT00100139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6362968|NCT00100139|Tubulin Modulators|tubulin modulators|mesh-ancestor
6362969|NCT00100139|Antimitotic Agents|antimitotic agents|mesh-ancestor
6362970|NCT00100139|Mitosis Modulators|mitosis modulators|mesh-ancestor
6362971|NCT00100139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362972|NCT00100243|Abarelix|abarelix|mesh-list
6362973|NCT00100243|Hormone Antagonists|hormone antagonists|mesh-ancestor
6362974|NCT00100243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6362975|NCT00100243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362976|NCT00100269|Antioxidants|antioxidants|mesh-list
6362977|NCT00100269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362978|NCT00100269|Protective Agents|protective agents|mesh-ancestor
6362979|NCT00100269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362980|NCT00100308|Heparin|heparin|mesh-list
6362981|NCT00100308|Anticoagulants|anticoagulants|mesh-ancestor
6362982|NCT00100308|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6362983|NCT00100308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6362984|NCT00100308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6362985|NCT00100412|Phenylephrine|phenylephrine|mesh-list
6362986|NCT00100412|Dobutamine|dobutamine|mesh-list
6362987|NCT00100412|Oxymetazoline|oxymetazoline|mesh-list
6362988|NCT00100412|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6362989|NCT00100412|Mydriatics|mydriatics|mesh-ancestor
6362990|NCT00100412|Autonomic Agents|autonomic agents|mesh-ancestor
6362991|NCT00100412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6362992|NCT00100412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6362993|NCT00100412|Sympathomimetics|sympathomimetics|mesh-ancestor
6362994|NCT00100412|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6362995|NCT00100412|Nasal Decongestants|nasal decongestants|mesh-ancestor
6362996|NCT00100412|Respiratory System Agents|respiratory system agents|mesh-ancestor
6362997|NCT00100412|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6362998|NCT00100412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6362999|NCT00100412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6363000|NCT00100412|Adrenergic Agents|adrenergic agents|mesh-ancestor
6363001|NCT00100412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6363002|NCT00100412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363003|NCT00100412|Protective Agents|protective agents|mesh-ancestor
6363004|NCT00100412|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6363005|NCT00100412|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6363006|NCT00100464|Paroxetine|paroxetine|mesh-list
6363007|NCT00100464|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6363008|NCT00100464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6363009|NCT00100464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6363010|NCT00100464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363011|NCT00100464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6363012|NCT00100464|Serotonin Agents|serotonin agents|mesh-ancestor
6363013|NCT00100464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363014|NCT00100464|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6363015|NCT00100464|Antidepressive Agents|antidepressive agents|mesh-ancestor
6363016|NCT00100464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6363017|NCT00100464|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6363018|NCT00100464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6363019|NCT00100464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6363020|NCT00100477|Etoposide|etoposide|mesh-list
6363021|NCT00100477|Mitoxantrone|mitoxantrone|mesh-list
6363022|NCT00100477|Topotecan|topotecan|mesh-list
6363023|NCT00100477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6363024|NCT00100477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6363025|NCT00100477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6363026|NCT00100477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6363027|NCT00100477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6363028|NCT00100477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363029|NCT00100477|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6363030|NCT00100477|Analgesics|analgesics|mesh-ancestor
6363031|NCT00100477|Sensory System Agents|sensory system agents|mesh-ancestor
6363032|NCT00100477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6363033|NCT00100477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363034|NCT00100555|Zoledronic Acid|zoledronic acid|mesh-list
6363035|NCT00100555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6363036|NCT00100555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363037|NCT00100568|Lamivudine|lamivudine|mesh-list
6363038|NCT00100568|Zidovudine|zidovudine|mesh-list
6363039|NCT00100568|Efavirenz|efavirenz|mesh-list
6363040|NCT00100568|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6363041|NCT00100568|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6363042|NCT00100568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6363043|NCT00100568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6363044|NCT00100568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363045|NCT00100568|Antiviral Agents|antiviral agents|mesh-ancestor
6363046|NCT00100568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6363047|NCT00100568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6363048|NCT00100568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6363049|NCT00100568|Antimetabolites|antimetabolites|mesh-ancestor
6363050|NCT00100568|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6363051|NCT00100568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6363052|NCT00100568|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6363053|NCT00100568|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6363054|NCT00100568|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6363055|NCT00100568|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6363056|NCT00100581|Interferons|interferons|mesh-list
6363057|NCT00100581|Ritonavir|ritonavir|mesh-list
6363058|NCT00100581|Tenofovir|tenofovir|mesh-list
6363059|NCT00100581|Ribavirin|ribavirin|mesh-list
6363060|NCT00100581|Interferon-alpha|interferon-alpha|mesh-list
6363061|NCT00100581|Lamivudine|lamivudine|mesh-list
6363062|NCT00100581|Interferon alpha-2|interferon alpha-2|mesh-list
6363063|NCT00100581|Efavirenz|efavirenz|mesh-list
6363064|NCT00100581|Lopinavir|lopinavir|mesh-list
6363065|NCT00100581|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6363066|NCT00100581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6363067|NCT00100581|Antiviral Agents|antiviral agents|mesh-ancestor
6363068|NCT00100581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6363069|NCT00100581|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6363070|NCT00100581|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6363071|NCT00100581|Protease Inhibitors|protease inhibitors|mesh-ancestor
6363072|NCT00100581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6363073|NCT00100581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363074|NCT00100581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6363075|NCT00100581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6363076|NCT00100581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6363077|NCT00100581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6363078|NCT00100581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6363079|NCT00100581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6363080|NCT00100581|Antimetabolites|antimetabolites|mesh-ancestor
6363081|NCT00100581|Immunologic Factors|immunologic factors|mesh-ancestor
6017227|NCT00370552|Antimitotic Agents|antimitotic agents|mesh-ancestor
6017228|NCT00370552|Mitosis Modulators|mitosis modulators|mesh-ancestor
6017229|NCT00370552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017230|NCT00370552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6017231|NCT00370552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6017232|NCT00370552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6017233|NCT00370552|Growth Substances|growth substances|mesh-ancestor
6363082|NCT00100581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363083|NCT00100581|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6363084|NCT00100581|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6363085|NCT00100581|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6363086|NCT00100581|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6363087|NCT00100581|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6363088|NCT00100594|Lamivudine|lamivudine|mesh-list
6363089|NCT00100594|Zidovudine|zidovudine|mesh-list
6363090|NCT00100594|Efavirenz|efavirenz|mesh-list
6363091|NCT00100594|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6363092|NCT00100594|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6363093|NCT00100594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6363094|NCT00100594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6363095|NCT00100594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363096|NCT00100594|Antiviral Agents|antiviral agents|mesh-ancestor
6363097|NCT00100594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6363098|NCT00100594|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6363099|NCT00100594|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6363100|NCT00100594|Antimetabolites|antimetabolites|mesh-ancestor
6363101|NCT00100594|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6363102|NCT00100594|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6363103|NCT00100594|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6363104|NCT00100594|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6363105|NCT00100594|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6363106|NCT00100594|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6363107|NCT00100620|Zoledronic Acid|zoledronic acid|mesh-list
6363108|NCT00100620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6363109|NCT00100620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363110|NCT00100646|Ritonavir|ritonavir|mesh-list
6363111|NCT00100646|Lopinavir|lopinavir|mesh-list
6363112|NCT00100646|Lamivudine|lamivudine|mesh-list
6363113|NCT00100646|Stavudine|stavudine|mesh-list
6363114|NCT00100646|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6363115|NCT00100646|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6363116|NCT00100646|Protease Inhibitors|protease inhibitors|mesh-ancestor
6363117|NCT00100646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6363118|NCT00100646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363119|NCT00100646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6363120|NCT00100646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6363121|NCT00100646|Antiviral Agents|antiviral agents|mesh-ancestor
6363122|NCT00100646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6363123|NCT00100646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6363124|NCT00100646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6363125|NCT00100646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6363126|NCT00100646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6363127|NCT00100646|Antimetabolites|antimetabolites|mesh-ancestor
6363128|NCT00100685|Volociximab|volociximab|mesh-list
6363129|NCT00100685|Antibodies|antibodies|mesh-list
6363130|NCT00100685|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6363131|NCT00100685|Immunologic Factors|immunologic factors|mesh-ancestor
6363132|NCT00100685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363133|NCT00100685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6363134|NCT00100685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6363135|NCT00100685|Growth Substances|growth substances|mesh-ancestor
6363136|NCT00100685|Growth Inhibitors|growth inhibitors|mesh-ancestor
6363137|NCT00100685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6363138|NCT00100737|Rituximab|rituximab|mesh-list
6363139|NCT00100737|Interleukin-2|interleukin-2|mesh-list
6363140|NCT00100737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6363141|NCT00100737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6363142|NCT00100737|Immunologic Factors|immunologic factors|mesh-ancestor
6363143|NCT00100737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363144|NCT00100737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6363145|NCT00100737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6363146|NCT00100737|Analgesics|analgesics|mesh-ancestor
6363147|NCT00100737|Sensory System Agents|sensory system agents|mesh-ancestor
6363148|NCT00100737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6363149|NCT00100750|Gemcitabine|gemcitabine|mesh-list
6363150|NCT00100750|Tipifarnib|tipifarnib|mesh-list
6363151|NCT00100750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6363152|NCT00100750|Antimetabolites|antimetabolites|mesh-ancestor
6363153|NCT00100750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363154|NCT00100750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6363155|NCT00100750|Antiviral Agents|antiviral agents|mesh-ancestor
6363156|NCT00100750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6363157|NCT00100750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6363158|NCT00100750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6363159|NCT00100750|Immunologic Factors|immunologic factors|mesh-ancestor
6363160|NCT00100750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363161|NCT00100776|Olanzapine|olanzapine|mesh-list
6363162|NCT00100776|Antiemetics|antiemetics|mesh-ancestor
6363163|NCT00100776|Autonomic Agents|autonomic agents|mesh-ancestor
6363164|NCT00100776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6363165|NCT00100776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363166|NCT00100776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6363167|NCT00100776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6363168|NCT00100776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6363169|NCT00100776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6363170|NCT00100776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6363171|NCT00100776|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6363172|NCT00100776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6363173|NCT00100776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6363174|NCT00100776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394967|NCT00203736|Renal Agents|renal agents|mesh-ancestor
6363175|NCT00100776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6363176|NCT00100776|Serotonin Agents|serotonin agents|mesh-ancestor
6363177|NCT00100854|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6363178|NCT00100854|Fulvestrant|fulvestrant|mesh-list
6363179|NCT00100854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6363180|NCT00100854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6363181|NCT00100854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6363182|NCT00100854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363183|NCT00100854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6363184|NCT00100854|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6363185|NCT00100854|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6363186|NCT00100854|Hormone Antagonists|hormone antagonists|mesh-ancestor
6363187|NCT00100854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6363188|NCT00100854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363189|NCT00100880|Lenalidomide|lenalidomide|mesh-list
6363190|NCT00100880|Immunologic Factors|immunologic factors|mesh-ancestor
6363191|NCT00100880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363192|NCT00100880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6363193|NCT00100880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6363194|NCT00100880|Growth Substances|growth substances|mesh-ancestor
6363195|NCT00100880|Growth Inhibitors|growth inhibitors|mesh-ancestor
6363196|NCT00100880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6394968|NCT00203762|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6394969|NCT00203762|Antiviral Agents|antiviral agents|mesh-ancestor
6394970|NCT00203762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6394971|NCT00203775|Risperidone|risperidone|mesh-list
6394972|NCT00203775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6394973|NCT00203775|Serotonin Agents|serotonin agents|mesh-ancestor
6394974|NCT00203775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6394975|NCT00203775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394976|NCT00203775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394977|NCT00203775|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6394978|NCT00203775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6394979|NCT00203775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6394980|NCT00203775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6394981|NCT00203775|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6394982|NCT00203775|Dopamine Agents|dopamine agents|mesh-ancestor
6394983|NCT00203788|Risperidone|risperidone|mesh-list
6394984|NCT00203788|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6394985|NCT00203788|Serotonin Agents|serotonin agents|mesh-ancestor
6394986|NCT00203788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6394987|NCT00203788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6394988|NCT00203788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6394989|NCT00203788|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6394990|NCT00203788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6394991|NCT00203788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6394992|NCT00203788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6394993|NCT00203788|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6394994|NCT00203788|Dopamine Agents|dopamine agents|mesh-ancestor
6394995|NCT00203801|Artesunate|artesunate|mesh-list
6394996|NCT00203801|Lumefantrine|lumefantrine|mesh-list
6394997|NCT00203801|Artemether|artemether|mesh-list
6394998|NCT00203801|Pyrimethamine|pyrimethamine|mesh-list
6394999|NCT00203801|Sulfadoxine|sulfadoxine|mesh-list
6395000|NCT00203801|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6395001|NCT00203801|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6395002|NCT00203801|Antimalarials|antimalarials|mesh-ancestor
6395003|NCT00203801|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6363197|NCT00100893|Proanthocyanidin|proanthocyanidin|mesh-list
6363198|NCT00100893|Procyanidin|procyanidin|mesh-list
6363199|NCT00100893|Antioxidants|antioxidants|mesh-ancestor
6363200|NCT00100893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363201|NCT00100893|Protective Agents|protective agents|mesh-ancestor
6363202|NCT00100893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363203|NCT00100893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6363204|NCT00100893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6363205|NCT00100893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6363206|NCT00100906|Aldesleukin|aldesleukin|mesh-list
6363207|NCT00100906|Interleukin-2|interleukin-2|mesh-list
6363208|NCT00100906|Tretinoin|tretinoin|mesh-list
6363209|NCT00100906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6017234|NCT00370552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017235|NCT00370552|Growth Inhibitors|growth inhibitors|mesh-ancestor
6017236|NCT00370682|Vaccines|vaccines|mesh-list
6017237|NCT00370682|Immunologic Factors|immunologic factors|mesh-ancestor
6017238|NCT00370682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363210|NCT00100906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6363211|NCT00100906|Analgesics|analgesics|mesh-ancestor
6363212|NCT00100906|Sensory System Agents|sensory system agents|mesh-ancestor
6363213|NCT00100906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6363214|NCT00100906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363215|NCT00100906|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6363216|NCT00100906|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6363217|NCT00100906|Antiviral Agents|antiviral agents|mesh-ancestor
6363218|NCT00100906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6363219|NCT00100906|Keratolytic Agents|keratolytic agents|mesh-ancestor
6363220|NCT00100906|Dermatologic Agents|dermatologic agents|mesh-ancestor
6363221|NCT00100945|Gefitinib|gefitinib|mesh-list
6363222|NCT00100945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6363223|NCT00100945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6363224|NCT00100945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6363225|NCT00100945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363226|NCT00100958|Indole-3-carbinol|indole-3-carbinol|mesh-list
6363227|NCT00100958|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6363228|NCT00100958|Protective Agents|protective agents|mesh-ancestor
6363229|NCT00100958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363230|NCT00100958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6363231|NCT00100971|Vaccines|vaccines|mesh-list
6363232|NCT00100971|Immunologic Factors|immunologic factors|mesh-ancestor
6363233|NCT00100971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363234|NCT00100984|Enfuvirtide|enfuvirtide|mesh-list
6363235|NCT00100984|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6363236|NCT00100984|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6363237|NCT00100984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363238|NCT00100984|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6363239|NCT00100984|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6363240|NCT00100984|Antiviral Agents|antiviral agents|mesh-ancestor
6363241|NCT00100984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6363242|NCT00101062|Celecoxib|celecoxib|mesh-list
6363243|NCT00101062|Letrozole|letrozole|mesh-list
6363244|NCT00101062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6363245|NCT00101062|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6363246|NCT00101062|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6363247|NCT00101062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6363248|NCT00101062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363249|NCT00101062|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6363250|NCT00101062|Hormone Antagonists|hormone antagonists|mesh-ancestor
6363251|NCT00101062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6363252|NCT00101062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363253|NCT00101062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6363254|NCT00101062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6363255|NCT00101062|Analgesics|analgesics|mesh-ancestor
6363256|NCT00101062|Sensory System Agents|sensory system agents|mesh-ancestor
6363257|NCT00101062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6363258|NCT00101062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6363259|NCT00101062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6363260|NCT00101062|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6363261|NCT00101062|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6363262|NCT00101075|Capecitabine|capecitabine|mesh-list
6363263|NCT00101075|Oxaliplatin|oxaliplatin|mesh-list
6363264|NCT00101075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6363265|NCT00101075|Antimetabolites|antimetabolites|mesh-ancestor
6017239|NCT00370838|Clonidine|clonidine|mesh-list
6017240|NCT00370838|Levetiracetam|levetiracetam|mesh-list
6363266|NCT00101075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363267|NCT00101075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6363268|NCT00101088|Sirolimus|sirolimus|mesh-list
6363269|NCT00101088|Imatinib Mesylate|imatinib mesylate|mesh-list
6363270|NCT00101088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6363271|NCT00101088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6363272|NCT00101088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6363273|NCT00101088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363274|NCT00101088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6363275|NCT00101088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6363276|NCT00101088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6363277|NCT00101088|Antifungal Agents|antifungal agents|mesh-ancestor
6363278|NCT00101088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6363279|NCT00101088|Immunologic Factors|immunologic factors|mesh-ancestor
6363280|NCT00101088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363281|NCT00101114|Interferons|interferons|mesh-list
6363282|NCT00101114|Interferon-alpha|interferon-alpha|mesh-list
6363283|NCT00101114|Interferon alpha-2|interferon alpha-2|mesh-list
6363284|NCT00101114|Sorafenib|sorafenib|mesh-list
6363285|NCT00101114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6363286|NCT00101114|Antiviral Agents|antiviral agents|mesh-ancestor
6363287|NCT00101114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6363288|NCT00101114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6363289|NCT00101114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6363290|NCT00101114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363291|NCT00101114|Immunologic Factors|immunologic factors|mesh-ancestor
6363292|NCT00101114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363293|NCT00101127|Gemcitabine|gemcitabine|mesh-list
6363294|NCT00101127|Docetaxel|docetaxel|mesh-list
6363295|NCT00101127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6363296|NCT00101127|Antimetabolites|antimetabolites|mesh-ancestor
6363297|NCT00101127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363298|NCT00101127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6363299|NCT00101127|Antiviral Agents|antiviral agents|mesh-ancestor
6363300|NCT00101127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6363301|NCT00101127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6363302|NCT00101127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6363303|NCT00101127|Immunologic Factors|immunologic factors|mesh-ancestor
6363304|NCT00101127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363305|NCT00101127|Tubulin Modulators|tubulin modulators|mesh-ancestor
6363306|NCT00101127|Antimitotic Agents|antimitotic agents|mesh-ancestor
6363307|NCT00101127|Mitosis Modulators|mitosis modulators|mesh-ancestor
6363308|NCT00101140|Fludarabine|fludarabine|mesh-list
6363309|NCT00101140|Fludarabine phosphate|fludarabine phosphate|mesh-list
6363310|NCT00101140|Thiotepa|thiotepa|mesh-list
6363311|NCT00101140|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6363312|NCT00101140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6363313|NCT00101140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6363314|NCT00101140|Antimetabolites|antimetabolites|mesh-ancestor
6363315|NCT00101140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363316|NCT00101140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6363317|NCT00101140|Immunologic Factors|immunologic factors|mesh-ancestor
6363318|NCT00101140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363319|NCT00101140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6363320|NCT00101140|Alkylating Agents|alkylating agents|mesh-ancestor
6363321|NCT00101140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6363322|NCT00101153|Cytarabine|cytarabine|mesh-list
6363323|NCT00101153|Daunorubicin|daunorubicin|mesh-list
6363324|NCT00101153|Tipifarnib|tipifarnib|mesh-list
6363325|NCT00101153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6363326|NCT00101153|Antimetabolites|antimetabolites|mesh-ancestor
6363327|NCT00101153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363328|NCT00101153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6363329|NCT00101153|Antiviral Agents|antiviral agents|mesh-ancestor
6363330|NCT00101153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6363331|NCT00101153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6363332|NCT00101153|Immunologic Factors|immunologic factors|mesh-ancestor
6363333|NCT00101153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363334|NCT00101153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6363335|NCT00101153|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6363336|NCT00101153|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6363337|NCT00101153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6363338|NCT00101179|Azacitidine|azacitidine|mesh-list
6363339|NCT00101179|Entinostat|entinostat|mesh-list
6363340|NCT00101179|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
6363341|NCT00101179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6363342|NCT00101179|Antimetabolites|antimetabolites|mesh-ancestor
6395004|NCT00203801|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6363343|NCT00101179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363344|NCT00101179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6363345|NCT00101179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6363346|NCT00101205|Oxaliplatin|oxaliplatin|mesh-list
6363347|NCT00101205|Etoposide|etoposide|mesh-list
6363348|NCT00101205|Etoposide phosphate|etoposide phosphate|mesh-list
6363349|NCT00101205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6363350|NCT00101205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6363351|NCT00101205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6363352|NCT00101205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6363353|NCT00101205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6363354|NCT00101205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363355|NCT00101231|Alvocidib|alvocidib|mesh-list
6363356|NCT00101231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6363357|NCT00101231|Growth Inhibitors|growth inhibitors|mesh-ancestor
6363358|NCT00101231|Growth Substances|growth substances|mesh-ancestor
6363359|NCT00101231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363360|NCT00101231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6363361|NCT00101231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6363362|NCT00101231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363363|NCT00101270|Oxaliplatin|oxaliplatin|mesh-list
6363364|NCT00101270|Irinotecan|irinotecan|mesh-list
6363365|NCT00101270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6363366|NCT00101270|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6363367|NCT00101270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6363368|NCT00101270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6363369|NCT00101270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363370|NCT00101296|Tipifarnib|tipifarnib|mesh-list
6363371|NCT00101296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6363372|NCT00101309|Aldesleukin|aldesleukin|mesh-list
6363373|NCT00101309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6363374|NCT00101309|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6363375|NCT00101309|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6363376|NCT00101309|Antiviral Agents|antiviral agents|mesh-ancestor
6363377|NCT00101309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6363378|NCT00101335|Celecoxib|celecoxib|mesh-list
6363379|NCT00101335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6363380|NCT00101335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6363381|NCT00101335|Analgesics|analgesics|mesh-ancestor
6363382|NCT00101335|Sensory System Agents|sensory system agents|mesh-ancestor
6363383|NCT00101335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6363384|NCT00101335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363385|NCT00101335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6363386|NCT00101335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6363387|NCT00101335|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6363388|NCT00101335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6363389|NCT00101335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6363390|NCT00101335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363391|NCT00101348|Bevacizumab|bevacizumab|mesh-list
6363392|NCT00101348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6363393|NCT00101348|Cetuximab|cetuximab|mesh-list
6363394|NCT00101348|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6363395|NCT00101348|Antibodies|antibodies|mesh-list
6363396|NCT00101348|Immunoglobulins|immunoglobulins|mesh-list
6363397|NCT00101348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6363398|NCT00101348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6363399|NCT00101348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6363400|NCT00101348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6363401|NCT00101348|Growth Substances|growth substances|mesh-ancestor
6363402|NCT00101348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363403|NCT00101348|Growth Inhibitors|growth inhibitors|mesh-ancestor
6363404|NCT00101348|Immunologic Factors|immunologic factors|mesh-ancestor
6363405|NCT00101348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6363406|NCT00101348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6363407|NCT00101348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363408|NCT00101374|Leflunomide|leflunomide|mesh-list
6363409|NCT00101374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6363410|NCT00101374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363411|NCT00101374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6363412|NCT00101374|Immunologic Factors|immunologic factors|mesh-ancestor
6363413|NCT00101374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363414|NCT00101426|Ranirestat|ranirestat|mesh-list
6363415|NCT00101426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6363416|NCT00101426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363417|NCT00101569|Aripiprazole|aripiprazole|mesh-list
6363418|NCT00101569|Antidepressive Agents|antidepressive agents|mesh-ancestor
6363419|NCT00101569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6363420|NCT00101569|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6363421|NCT00101569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6363422|NCT00101569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6363423|NCT00101569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363424|NCT00101569|Dopamine Agonists|dopamine agonists|mesh-ancestor
6363425|NCT00101569|Dopamine Agents|dopamine agents|mesh-ancestor
6363426|NCT00101569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6363427|NCT00101569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363428|NCT00101569|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6363429|NCT00101569|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6363430|NCT00101569|Serotonin Agents|serotonin agents|mesh-ancestor
6363431|NCT00101569|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6363432|NCT00101569|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6363433|NCT00101569|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6363434|NCT00101569|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6363435|NCT00101634|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6363436|NCT00101634|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6363437|NCT00101634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6363438|NCT00101634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6363439|NCT00101634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363440|NCT00101634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6363441|NCT00101634|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6363442|NCT00101634|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6363443|NCT00101634|Serotonin Agents|serotonin agents|mesh-ancestor
6363444|NCT00101634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6363445|NCT00101634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363446|NCT00101634|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6363447|NCT00101634|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6363448|NCT00101634|Dopamine Agents|dopamine agents|mesh-ancestor
6363449|NCT00101673|Vildagliptin|vildagliptin|mesh-list
6363450|NCT00101673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6363451|NCT00101673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363452|NCT00101673|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6363453|NCT00101673|Protease Inhibitors|protease inhibitors|mesh-ancestor
6363454|NCT00101673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6363455|NCT00101673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363456|NCT00101712|Vildagliptin|vildagliptin|mesh-list
6363457|NCT00101712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6363458|NCT00101712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363459|NCT00101712|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6363460|NCT00101712|Protease Inhibitors|protease inhibitors|mesh-ancestor
6363461|NCT00101712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6363462|NCT00101712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363463|NCT00101738|Mycophenolic Acid|mycophenolic acid|mesh-list
6363464|NCT00101738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6363465|NCT00101738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6363466|NCT00101738|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6363467|NCT00101738|Antitubercular Agents|antitubercular agents|mesh-ancestor
6363468|NCT00101738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6363469|NCT00101738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6363470|NCT00101738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6363471|NCT00101738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363472|NCT00101751|Insulin Aspart|insulin aspart|mesh-list
6363473|NCT00101751|Biphasic Insulins|biphasic insulins|mesh-list
6363474|NCT00101751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6363475|NCT00101751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363476|NCT00101764|Triamcinolone|triamcinolone|mesh-list
6363477|NCT00101764|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6363478|NCT00101764|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6363479|NCT00101764|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6363480|NCT00101764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6363481|NCT00101764|Glucocorticoids|glucocorticoids|mesh-ancestor
6363482|NCT00101764|Hormones|hormones|mesh-ancestor
6363483|NCT00101764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6363484|NCT00101764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363485|NCT00101764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6363486|NCT00101764|Immunologic Factors|immunologic factors|mesh-ancestor
6363487|NCT00101764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6363488|NCT00101764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363489|NCT00101790|Pamidronate|pamidronate|mesh-list
6363490|NCT00101790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6363491|NCT00101790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363492|NCT00101803|Vildagliptin|vildagliptin|mesh-list
6363493|NCT00101803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6363494|NCT00101803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363495|NCT00101803|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6363496|NCT00101803|Protease Inhibitors|protease inhibitors|mesh-ancestor
6363497|NCT00101803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6363498|NCT00101803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363499|NCT00101829|Rituximab|rituximab|mesh-list
6363500|NCT00101829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6363501|NCT00101829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6363502|NCT00101829|Immunologic Factors|immunologic factors|mesh-ancestor
6363503|NCT00101829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363504|NCT00101829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6363505|NCT00101842|Gemcitabine|gemcitabine|mesh-list
6363506|NCT00101842|Pemetrexed|pemetrexed|mesh-list
6363507|NCT00101842|Cisplatin|cisplatin|mesh-list
6363508|NCT00101842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6363509|NCT00101842|Antimetabolites|antimetabolites|mesh-ancestor
6363510|NCT00101842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363511|NCT00101842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6363512|NCT00101842|Antiviral Agents|antiviral agents|mesh-ancestor
6363513|NCT00101842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6363514|NCT00101842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6363515|NCT00101842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6363516|NCT00101842|Immunologic Factors|immunologic factors|mesh-ancestor
6363517|NCT00101842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363518|NCT00101842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6363519|NCT00101842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6363520|NCT00101894|Panitumumab|panitumumab|mesh-list
6363521|NCT00101894|Motesanib diphosphate|motesanib diphosphate|mesh-list
6363522|NCT00101894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6363523|NCT00101894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6363524|NCT00101894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6363525|NCT00101894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6363526|NCT00101894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363527|NCT00101920|Panitumumab|panitumumab|mesh-list
6363528|NCT00101920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6363529|NCT00101920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6363530|NCT00101998|Alvimopan|alvimopan|mesh-list
6363531|NCT00101998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6363532|NCT00102050|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
6363533|NCT00102050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6363534|NCT00102050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363535|NCT00102115|Talaporfin|talaporfin|mesh-list
6363536|NCT00102115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6363537|NCT00102115|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6363538|NCT00102115|Dermatologic Agents|dermatologic agents|mesh-ancestor
6363539|NCT00102141|Drospirenone|drospirenone|mesh-list
6363540|NCT00102141|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6363541|NCT00102141|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6363542|NCT00102141|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6363543|NCT00102141|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
6363544|NCT00102141|Estradiol|estradiol|mesh-list
6363545|NCT00102141|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6363546|NCT00102141|Estrogens|estrogens|mesh-ancestor
6363547|NCT00102141|Hormones|hormones|mesh-ancestor
6363548|NCT00102141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6363549|NCT00102141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363550|NCT00102141|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6363551|NCT00102141|Contraceptive Agents|contraceptive agents|mesh-ancestor
6363552|NCT00102141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6363553|NCT00102141|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6363554|NCT00102141|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6363555|NCT00102141|Hormone Antagonists|hormone antagonists|mesh-ancestor
6363556|NCT00102141|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6363557|NCT00102141|Diuretics|diuretics|mesh-ancestor
6363558|NCT00102141|Natriuretic Agents|natriuretic agents|mesh-ancestor
6363559|NCT00102141|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6363560|NCT00102141|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6363561|NCT00102154|Gaboxadol|gaboxadol|mesh-list
6363562|NCT00102154|Analgesics|analgesics|mesh-ancestor
6363563|NCT00102154|Sensory System Agents|sensory system agents|mesh-ancestor
6363564|NCT00102154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6363565|NCT00102154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363566|NCT00102154|Anticonvulsants|anticonvulsants|mesh-ancestor
6363567|NCT00102154|GABA Agonists|gaba agonists|mesh-ancestor
6363568|NCT00102154|GABA Agents|gaba agents|mesh-ancestor
6363569|NCT00102154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6363570|NCT00102154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363571|NCT00102167|Gaboxadol|gaboxadol|mesh-list
6363572|NCT00102167|Analgesics|analgesics|mesh-ancestor
6363573|NCT00102167|Sensory System Agents|sensory system agents|mesh-ancestor
6363574|NCT00102167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6363575|NCT00102167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363576|NCT00102167|Anticonvulsants|anticonvulsants|mesh-ancestor
6363577|NCT00102167|GABA Agonists|gaba agonists|mesh-ancestor
6363578|NCT00102167|GABA Agents|gaba agents|mesh-ancestor
6363579|NCT00102167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6363580|NCT00102167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363581|NCT00102206|Ritonavir|ritonavir|mesh-list
6363582|NCT00102206|Lopinavir|lopinavir|mesh-list
6363583|NCT00102206|Saquinavir|saquinavir|mesh-list
6363584|NCT00102206|Tenofovir|tenofovir|mesh-list
6363585|NCT00102206|Lamivudine|lamivudine|mesh-list
6363586|NCT00102206|Zidovudine|zidovudine|mesh-list
6363587|NCT00102206|Emtricitabine|emtricitabine|mesh-list
6363588|NCT00102206|Abacavir|abacavir|mesh-list
6363589|NCT00102206|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6363590|NCT00102206|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6363591|NCT00102206|Protease Inhibitors|protease inhibitors|mesh-ancestor
6363592|NCT00102206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6363593|NCT00102206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363594|NCT00102206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6363595|NCT00102206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6363596|NCT00102206|Antiviral Agents|antiviral agents|mesh-ancestor
6363597|NCT00102206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6363598|NCT00102206|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6363599|NCT00102206|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6363600|NCT00102206|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6363601|NCT00102206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6363602|NCT00102206|Antimetabolites|antimetabolites|mesh-ancestor
6363603|NCT00102219|Doxorubicin|doxorubicin|mesh-list
6363604|NCT00102219|Pemetrexed|pemetrexed|mesh-list
6363605|NCT00102219|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6363606|NCT00102219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6363607|NCT00102219|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6363608|NCT00102219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6363609|NCT00102219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6363610|NCT00102219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363611|NCT00102219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6363612|NCT00102219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6363613|NCT00102258|Hormones|hormones|mesh-list
6363614|NCT00102258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6363615|NCT00102258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363616|NCT00102271|Oxypurinol|oxypurinol|mesh-list
6363617|NCT00102271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6363618|NCT00102271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363619|NCT00102284|Levodopa|levodopa|mesh-list
6363620|NCT00102284|Modafinil|modafinil|mesh-list
6363621|NCT00102284|Rivastigmine|rivastigmine|mesh-list
6363622|NCT00102284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6363623|NCT00102284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6363624|NCT00102284|Dopamine Agents|dopamine agents|mesh-ancestor
6363625|NCT00102284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6363626|NCT00102284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363627|NCT00102284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363628|NCT00102284|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6363629|NCT00102284|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6363630|NCT00102284|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6363631|NCT00102284|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6363632|NCT00102284|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6363633|NCT00102284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6363634|NCT00102284|Cholinergic Agents|cholinergic agents|mesh-ancestor
6363635|NCT00102284|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6363636|NCT00102284|Protective Agents|protective agents|mesh-ancestor
6363637|NCT00102310|Z 338|z 338|mesh-list
6363638|NCT00102310|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6363639|NCT00102310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6363640|NCT00102310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363641|NCT00102310|Cholinergic Agents|cholinergic agents|mesh-ancestor
6363642|NCT00102310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6363643|NCT00102310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363644|NCT00102310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6363645|NCT00102375|Topotecan|topotecan|mesh-list
6363646|NCT00102375|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6363647|NCT00102375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6363648|NCT00102375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6363649|NCT00102375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363650|NCT00102375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6363651|NCT00102388|Vildagliptin|vildagliptin|mesh-list
6363652|NCT00102388|Gliclazide|gliclazide|mesh-list
6363653|NCT00102388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6363654|NCT00102388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363655|NCT00102388|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6363656|NCT00102388|Protease Inhibitors|protease inhibitors|mesh-ancestor
6363657|NCT00102388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6363658|NCT00102388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363659|NCT00102414|Gemcitabine|gemcitabine|mesh-list
6363660|NCT00102414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6363661|NCT00102414|Antimetabolites|antimetabolites|mesh-ancestor
6363662|NCT00102414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363663|NCT00102414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6363664|NCT00102414|Antiviral Agents|antiviral agents|mesh-ancestor
6363665|NCT00102414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6363666|NCT00102414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6363667|NCT00102414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6363668|NCT00102414|Immunologic Factors|immunologic factors|mesh-ancestor
6363669|NCT00102414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363670|NCT00102453|Pentoxifylline|pentoxifylline|mesh-list
6363671|NCT00102453|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6363672|NCT00102453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6363673|NCT00102453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363674|NCT00102453|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6363675|NCT00102453|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6363676|NCT00102453|Protective Agents|protective agents|mesh-ancestor
6363677|NCT00102453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363678|NCT00102453|Vasodilator Agents|vasodilator agents|mesh-ancestor
6363679|NCT00102453|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6363680|NCT00102453|Antioxidants|antioxidants|mesh-ancestor
6363681|NCT00102479|Aripiprazole|aripiprazole|mesh-list
6363682|NCT00102479|Antidepressive Agents|antidepressive agents|mesh-ancestor
6363683|NCT00102479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6363684|NCT00102479|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6363685|NCT00102479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6363686|NCT00102479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6363687|NCT00102479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363688|NCT00102479|Dopamine Agonists|dopamine agonists|mesh-ancestor
6363689|NCT00102479|Dopamine Agents|dopamine agents|mesh-ancestor
6363690|NCT00102479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6363691|NCT00102479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363692|NCT00102479|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6363693|NCT00102479|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6363694|NCT00102479|Serotonin Agents|serotonin agents|mesh-ancestor
6363695|NCT00102479|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6363696|NCT00102479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6363697|NCT00102479|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6363698|NCT00102479|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6363699|NCT00102492|Casopitant|casopitant|mesh-list
6363700|NCT00102492|Antiemetics|antiemetics|mesh-ancestor
6363701|NCT00102492|Autonomic Agents|autonomic agents|mesh-ancestor
6363702|NCT00102492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6363703|NCT00102492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363704|NCT00102492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6363705|NCT00102492|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6363706|NCT00102492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6363707|NCT00102492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363708|NCT00102505|Motexafin gadolinium|motexafin gadolinium|mesh-list
6363709|NCT00102505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6363710|NCT00102505|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6363711|NCT00102505|Dermatologic Agents|dermatologic agents|mesh-ancestor
6363712|NCT00102557|Hydroxychloroquine|hydroxychloroquine|mesh-list
6363713|NCT00102557|Antimalarials|antimalarials|mesh-ancestor
6363714|NCT00102557|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6363715|NCT00102557|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6363716|NCT00102557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6363717|NCT00102557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6363718|NCT00102557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363719|NCT00102557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6363720|NCT00102583|Cyclosporine|cyclosporine|mesh-list
6363721|NCT00102583|Cyclosporins|cyclosporins|mesh-list
6363722|NCT00102583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6363723|NCT00102583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363724|NCT00102583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6363725|NCT00102583|Immunologic Factors|immunologic factors|mesh-ancestor
6363726|NCT00102583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363727|NCT00102583|Antifungal Agents|antifungal agents|mesh-ancestor
6363728|NCT00102583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6363729|NCT00102583|Dermatologic Agents|dermatologic agents|mesh-ancestor
6363730|NCT00102583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6363731|NCT00102583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6363732|NCT00102609|Dexamethasone|dexamethasone|mesh-list
6363733|NCT00102609|Doxorubicin|doxorubicin|mesh-list
6363734|NCT00102609|Trabectedin|trabectedin|mesh-list
6363735|NCT00102609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6363736|NCT00102609|Antiemetics|antiemetics|mesh-ancestor
6363737|NCT00102609|Autonomic Agents|autonomic agents|mesh-ancestor
6363738|NCT00102609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6363739|NCT00102609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363740|NCT00102609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6363741|NCT00102609|Glucocorticoids|glucocorticoids|mesh-ancestor
6363742|NCT00102609|Hormones|hormones|mesh-ancestor
6363743|NCT00102609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6363744|NCT00102609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6363745|NCT00102609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6363746|NCT00102609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6363747|NCT00102609|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6363748|NCT00102609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6363749|NCT00102609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6363750|NCT00102609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363751|NCT00102609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6363752|NCT00102609|Alkylating Agents|alkylating agents|mesh-ancestor
6363753|NCT00102622|Paclitaxel|paclitaxel|mesh-list
6363754|NCT00102622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6363755|NCT00102622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6363756|NCT00102622|Tubulin Modulators|tubulin modulators|mesh-ancestor
6363757|NCT00102622|Antimitotic Agents|antimitotic agents|mesh-ancestor
6363758|NCT00102622|Mitosis Modulators|mitosis modulators|mesh-ancestor
6363759|NCT00102622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363760|NCT00102635|Fenretinide|fenretinide|mesh-list
6363761|NCT00102635|Lonafarnib|lonafarnib|mesh-list
6363762|NCT00102635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6363763|NCT00102635|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6363764|NCT00102635|Protective Agents|protective agents|mesh-ancestor
6363765|NCT00102635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363766|NCT00102635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6363767|NCT00102635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395005|NCT00203801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6395006|NCT00203801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6395007|NCT00203801|Antiviral Agents|antiviral agents|mesh-ancestor
6395008|NCT00203801|Schistosomicides|schistosomicides|mesh-ancestor
6395009|NCT00203801|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6395010|NCT00203801|Anthelmintics|anthelmintics|mesh-ancestor
6395011|NCT00203801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6395012|NCT00203801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6395013|NCT00203801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395014|NCT00203801|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6395015|NCT00203801|Renal Agents|renal agents|mesh-ancestor
6395016|NCT00203814|Artesunate|artesunate|mesh-list
6395017|NCT00203814|Pyrimethamine|pyrimethamine|mesh-list
6395018|NCT00203814|Sulfadoxine|sulfadoxine|mesh-list
6395019|NCT00203814|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6395020|NCT00203814|Antimalarials|antimalarials|mesh-ancestor
6395021|NCT00203814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6395022|NCT00203814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6395023|NCT00203814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6395024|NCT00203814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6395025|NCT00203814|Antiviral Agents|antiviral agents|mesh-ancestor
6395026|NCT00203814|Schistosomicides|schistosomicides|mesh-ancestor
6395027|NCT00203814|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6395028|NCT00203814|Anthelmintics|anthelmintics|mesh-ancestor
6395029|NCT00203814|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6395030|NCT00203814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6395031|NCT00203814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395032|NCT00203814|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6395033|NCT00203814|Renal Agents|renal agents|mesh-ancestor
6395034|NCT00203905|Bevacizumab|bevacizumab|mesh-list
6395035|NCT00203905|Fluorouracil|fluorouracil|mesh-list
6395036|NCT00203905|Hydroxyurea|hydroxyurea|mesh-list
6395037|NCT00203905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6395038|NCT00203905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6395039|NCT00203905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6395040|NCT00203905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6395041|NCT00203905|Growth Substances|growth substances|mesh-ancestor
6395042|NCT00203905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395043|NCT00203905|Growth Inhibitors|growth inhibitors|mesh-ancestor
6395044|NCT00203905|Antimetabolites|antimetabolites|mesh-ancestor
6395045|NCT00203905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363768|NCT00102661|Alemtuzumab|alemtuzumab|mesh-list
6363769|NCT00102661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6363770|NCT00102661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6363771|NCT00102674|Cangrelor|cangrelor|mesh-list
6363772|NCT00102674|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6363773|NCT00102674|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6363774|NCT00102674|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6363775|NCT00102674|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6363776|NCT00102674|Purinergic Agents|purinergic agents|mesh-ancestor
6363777|NCT00102674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6363778|NCT00102674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363779|NCT00102674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363780|NCT00102700|Gemcitabine|gemcitabine|mesh-list
6363781|NCT00102700|Beta-lapachone|beta-lapachone|mesh-list
6363782|NCT00102700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6363783|NCT00102700|Antimetabolites|antimetabolites|mesh-ancestor
6363784|NCT00102700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363785|NCT00102700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6363786|NCT00102700|Antiviral Agents|antiviral agents|mesh-ancestor
6363787|NCT00102700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6363788|NCT00102700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6363789|NCT00102700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6363790|NCT00102700|Immunologic Factors|immunologic factors|mesh-ancestor
6363791|NCT00102700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363792|NCT00102700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6363793|NCT00102700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6363794|NCT00102713|Valproic Acid|valproic acid|mesh-list
6363795|NCT00102713|Anticonvulsants|anticonvulsants|mesh-ancestor
6363796|NCT00102713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6363797|NCT00102713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363798|NCT00102713|GABA Agents|gaba agents|mesh-ancestor
6363799|NCT00102713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6363800|NCT00102713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363801|NCT00102713|Antimanic Agents|antimanic agents|mesh-ancestor
6363802|NCT00102713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6363803|NCT00102713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6363804|NCT00102713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6363805|NCT00102752|Gemcitabine|gemcitabine|mesh-list
6363806|NCT00102752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6363807|NCT00102752|Antimetabolites|antimetabolites|mesh-ancestor
6363808|NCT00102752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363809|NCT00102752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6363810|NCT00102752|Antiviral Agents|antiviral agents|mesh-ancestor
6363811|NCT00102752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6363812|NCT00102752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6363813|NCT00102752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6363814|NCT00102752|Immunologic Factors|immunologic factors|mesh-ancestor
6363815|NCT00102752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363816|NCT00102765|Fluticasone|fluticasone|mesh-list
6363817|NCT00102765|Xhance|xhance|mesh-list
6363818|NCT00102765|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6363819|NCT00102765|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6363820|NCT00102765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6363821|NCT00102765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6363822|NCT00102765|Autonomic Agents|autonomic agents|mesh-ancestor
6363823|NCT00102765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6363824|NCT00102765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363825|NCT00102765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6363826|NCT00102765|Respiratory System Agents|respiratory system agents|mesh-ancestor
6363827|NCT00102765|Dermatologic Agents|dermatologic agents|mesh-ancestor
6363828|NCT00102765|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6363829|NCT00102765|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6363830|NCT00102765|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6363831|NCT00102765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6363832|NCT00102765|Adrenergic Agents|adrenergic agents|mesh-ancestor
6363833|NCT00102765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6363834|NCT00102765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363835|NCT00102765|Glucocorticoids|glucocorticoids|mesh-ancestor
6363836|NCT00102765|Hormones|hormones|mesh-ancestor
6363837|NCT00102765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6363838|NCT00102765|Sympathomimetics|sympathomimetics|mesh-ancestor
6363839|NCT00102778|Ritonavir|ritonavir|mesh-list
6363840|NCT00102778|Lopinavir|lopinavir|mesh-list
6363841|NCT00102778|Aplaviroc|aplaviroc|mesh-list
6363842|NCT00102778|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6363843|NCT00102778|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6363844|NCT00102778|Protease Inhibitors|protease inhibitors|mesh-ancestor
6363845|NCT00102778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6363846|NCT00102778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363847|NCT00102778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6363848|NCT00102778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6363849|NCT00102778|Antiviral Agents|antiviral agents|mesh-ancestor
6363850|NCT00102778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6363851|NCT00102778|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6363852|NCT00102778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6363853|NCT00102778|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6363854|NCT00102778|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6363855|NCT00102830|Trebananib|trebananib|mesh-list
6363856|NCT00102830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6363857|NCT00102830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6363858|NCT00102830|Growth Substances|growth substances|mesh-ancestor
6363859|NCT00102830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363860|NCT00102830|Growth Inhibitors|growth inhibitors|mesh-ancestor
6363861|NCT00102830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6363862|NCT00102843|Folic Acid|folic acid|mesh-list
6363863|NCT00102843|Betaine|betaine|mesh-list
6363864|NCT00102843|Hematinics|hematinics|mesh-ancestor
6363865|NCT00102843|Vitamin B Complex|vitamin b complex|mesh-ancestor
6363866|NCT00102843|Vitamins|vitamins|mesh-ancestor
6363867|NCT00102843|Micronutrients|micronutrients|mesh-ancestor
6363868|NCT00102843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363869|NCT00102843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6363870|NCT00102843|Lipotropic Agents|lipotropic agents|mesh-ancestor
6363871|NCT00102843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6363872|NCT00102843|Antimetabolites|antimetabolites|mesh-ancestor
6363873|NCT00102843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363874|NCT00102843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6363875|NCT00102856|Pramipexole|pramipexole|mesh-list
6363876|NCT00102856|Rivastigmine|rivastigmine|mesh-list
6363877|NCT00102856|Antioxidants|antioxidants|mesh-ancestor
6395046|NCT00203905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6363878|NCT00102856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363879|NCT00102856|Protective Agents|protective agents|mesh-ancestor
6363880|NCT00102856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363881|NCT00102856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6363882|NCT00102856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6363883|NCT00102856|Dopamine Agonists|dopamine agonists|mesh-ancestor
6363884|NCT00102856|Dopamine Agents|dopamine agents|mesh-ancestor
6363885|NCT00102856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6363886|NCT00102856|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6363887|NCT00102856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6363888|NCT00102856|Cholinergic Agents|cholinergic agents|mesh-ancestor
6363889|NCT00102856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6363890|NCT00102869|Levodopa|levodopa|mesh-list
6363891|NCT00102869|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6363892|NCT00102869|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6363893|NCT00102869|Dopamine Agents|dopamine agents|mesh-ancestor
6363894|NCT00102869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6363895|NCT00102869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363896|NCT00102869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363897|NCT00102882|Fluticasone|fluticasone|mesh-list
6363898|NCT00102882|Xhance|xhance|mesh-list
6363899|NCT00102882|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6363900|NCT00102882|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6363901|NCT00102882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6363902|NCT00102882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6363903|NCT00102882|Autonomic Agents|autonomic agents|mesh-ancestor
6363904|NCT00102882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6363905|NCT00102882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363906|NCT00102882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6363907|NCT00102882|Respiratory System Agents|respiratory system agents|mesh-ancestor
6363908|NCT00102882|Dermatologic Agents|dermatologic agents|mesh-ancestor
6363909|NCT00102882|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6363910|NCT00102882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6363911|NCT00102882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6363912|NCT00102882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6363913|NCT00102882|Adrenergic Agents|adrenergic agents|mesh-ancestor
6363914|NCT00102882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6363915|NCT00102882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363916|NCT00102882|Glucocorticoids|glucocorticoids|mesh-ancestor
6363917|NCT00102882|Hormones|hormones|mesh-ancestor
6363918|NCT00102882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6363919|NCT00102882|Sympathomimetics|sympathomimetics|mesh-ancestor
6363920|NCT00102908|Zoledronic Acid|zoledronic acid|mesh-list
6363921|NCT00102908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6363922|NCT00102908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363923|NCT00102934|Enfuvirtide|enfuvirtide|mesh-list
6363924|NCT00102934|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6363925|NCT00102934|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6363926|NCT00102934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363927|NCT00102934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6363928|NCT00102934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6363929|NCT00102934|Antiviral Agents|antiviral agents|mesh-ancestor
6363930|NCT00102934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6363931|NCT00102947|Daptomycin|daptomycin|mesh-list
6363932|NCT00102947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6363933|NCT00102947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6363934|NCT00102973|Carboplatin|carboplatin|mesh-list
6363935|NCT00102973|Doxorubicin|doxorubicin|mesh-list
6363936|NCT00102973|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6363937|NCT00102973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6363938|NCT00102973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6363939|NCT00102973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6363940|NCT00102973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6363941|NCT00102973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6363942|NCT00102973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363943|NCT00102986|Ritonavir|ritonavir|mesh-list
6363944|NCT00102986|Lopinavir|lopinavir|mesh-list
6363945|NCT00102986|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6363946|NCT00102986|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6363947|NCT00102986|Protease Inhibitors|protease inhibitors|mesh-ancestor
6363948|NCT00102986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6363949|NCT00102986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363950|NCT00102986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6363951|NCT00102986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6363952|NCT00102986|Antiviral Agents|antiviral agents|mesh-ancestor
6363953|NCT00102986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6363954|NCT00102986|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6363955|NCT00102986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6363956|NCT00103038|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
6363957|NCT00103038|Hematinics|hematinics|mesh-ancestor
6363958|NCT00103038|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6363959|NCT00103038|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6363960|NCT00103051|Gemcitabine|gemcitabine|mesh-list
6363961|NCT00103051|Gefitinib|gefitinib|mesh-list
6363962|NCT00103051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6363963|NCT00103051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6363964|NCT00103051|Antimetabolites|antimetabolites|mesh-ancestor
6363965|NCT00103051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363966|NCT00103051|Antiviral Agents|antiviral agents|mesh-ancestor
6363967|NCT00103051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6363968|NCT00103051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6363969|NCT00103051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6363970|NCT00103051|Immunologic Factors|immunologic factors|mesh-ancestor
6363971|NCT00103051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363972|NCT00103051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6363973|NCT00103103|Leucovorin|leucovorin|mesh-list
6363974|NCT00103103|Fluorouracil|fluorouracil|mesh-list
6363975|NCT00103103|Bortezomib|bortezomib|mesh-list
6363976|NCT00103103|Calcium|calcium|mesh-list
6363977|NCT00103103|Levoleucovorin|levoleucovorin|mesh-list
6363978|NCT00103103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6363979|NCT00103103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6363980|NCT00103103|Antimetabolites|antimetabolites|mesh-ancestor
6363981|NCT00103103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363982|NCT00103103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6363983|NCT00103103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6363984|NCT00103103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6363985|NCT00103103|Immunologic Factors|immunologic factors|mesh-ancestor
6363986|NCT00103103|Antidotes|antidotes|mesh-ancestor
6363987|NCT00103103|Protective Agents|protective agents|mesh-ancestor
6363988|NCT00103103|Vitamin B Complex|vitamin b complex|mesh-ancestor
6363989|NCT00103103|Vitamins|vitamins|mesh-ancestor
6363990|NCT00103103|Micronutrients|micronutrients|mesh-ancestor
6363991|NCT00103168|Imatinib Mesylate|imatinib mesylate|mesh-list
6363992|NCT00103168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6363993|NCT00103168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6363994|NCT00103168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6363995|NCT00103168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6363996|NCT00103233|Trastuzumab|trastuzumab|mesh-list
6363997|NCT00103233|Vinorelbine|vinorelbine|mesh-list
6363998|NCT00103233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6363999|NCT00103233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6364000|NCT00103233|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6364001|NCT00103233|Tubulin Modulators|tubulin modulators|mesh-ancestor
6364002|NCT00103233|Antimitotic Agents|antimitotic agents|mesh-ancestor
6364003|NCT00103233|Mitosis Modulators|mitosis modulators|mesh-ancestor
6364004|NCT00103233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364005|NCT00103246|Silicon|silicon|mesh-list
6364006|NCT00103246|Silicon phthalocyanine|silicon phthalocyanine|mesh-list
6364007|NCT00103246|Trace Elements|trace elements|mesh-ancestor
6364008|NCT00103246|Micronutrients|micronutrients|mesh-ancestor
6364009|NCT00103246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364010|NCT00103246|Antimalarials|antimalarials|mesh-ancestor
6364011|NCT00103246|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6364012|NCT00103246|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6364013|NCT00103246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6364014|NCT00103246|Antiviral Agents|antiviral agents|mesh-ancestor
6364015|NCT00103246|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6364016|NCT00103246|Dermatologic Agents|dermatologic agents|mesh-ancestor
6364017|NCT00103272|Bortezomib|bortezomib|mesh-list
6364018|NCT00103272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6364019|NCT00103298|Leucovorin|leucovorin|mesh-list
6364020|NCT00103298|Fluorouracil|fluorouracil|mesh-list
6364021|NCT00103298|Oxaliplatin|oxaliplatin|mesh-list
6364022|NCT00103298|Melphalan|melphalan|mesh-list
6364023|NCT00103298|Calcium|calcium|mesh-list
6364024|NCT00103298|Levoleucovorin|levoleucovorin|mesh-list
6364025|NCT00103298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6364026|NCT00103298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364027|NCT00103298|Antimetabolites|antimetabolites|mesh-ancestor
6364028|NCT00103298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364029|NCT00103298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6364030|NCT00103298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6364031|NCT00103298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6364032|NCT00103298|Immunologic Factors|immunologic factors|mesh-ancestor
6364033|NCT00103298|Antidotes|antidotes|mesh-ancestor
6364034|NCT00103298|Protective Agents|protective agents|mesh-ancestor
6364035|NCT00103298|Vitamin B Complex|vitamin b complex|mesh-ancestor
6364036|NCT00103298|Vitamins|vitamins|mesh-ancestor
6364037|NCT00103298|Micronutrients|micronutrients|mesh-ancestor
6364038|NCT00103298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6364039|NCT00103298|Alkylating Agents|alkylating agents|mesh-ancestor
6364040|NCT00103298|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6364041|NCT00103324|Lapatinib|lapatinib|mesh-list
6364042|NCT00103324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6364043|NCT00103324|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6364044|NCT00103324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6364045|NCT00103324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364046|NCT00103389|Docetaxel|docetaxel|mesh-list
6364047|NCT00103389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6364048|NCT00103389|Tubulin Modulators|tubulin modulators|mesh-ancestor
6364049|NCT00103389|Antimitotic Agents|antimitotic agents|mesh-ancestor
6364050|NCT00103389|Mitosis Modulators|mitosis modulators|mesh-ancestor
6364051|NCT00103389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364052|NCT00103519|3,5-diiodothyropropionic acid|3,5-diiodothyropropionic acid|mesh-list
6364053|NCT00103519|Hormones|hormones|mesh-ancestor
6364054|NCT00103519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6364055|NCT00103519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364056|NCT00103545|Abagovomab|abagovomab|mesh-list
6364057|NCT00103545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6364058|NCT00103545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6364059|NCT00103571|Olanzapine|olanzapine|mesh-list
6364060|NCT00103571|Aripiprazole|aripiprazole|mesh-list
6364061|NCT00103571|Antiemetics|antiemetics|mesh-ancestor
6364062|NCT00103571|Autonomic Agents|autonomic agents|mesh-ancestor
6364063|NCT00103571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6364064|NCT00103571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364065|NCT00103571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6364066|NCT00103571|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6364067|NCT00103571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6364068|NCT00103571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6364069|NCT00103571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6364070|NCT00103571|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6364071|NCT00103571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6364072|NCT00103571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6364073|NCT00103571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364074|NCT00103571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6364075|NCT00103571|Serotonin Agents|serotonin agents|mesh-ancestor
6364076|NCT00103571|Antidepressive Agents|antidepressive agents|mesh-ancestor
6364077|NCT00103571|Dopamine Agonists|dopamine agonists|mesh-ancestor
6364078|NCT00103571|Dopamine Agents|dopamine agents|mesh-ancestor
6364079|NCT00103571|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6364080|NCT00103571|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6364081|NCT00103571|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6364082|NCT00103571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6364083|NCT00103571|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6364084|NCT00103571|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6364085|NCT00103597|Fludrocortisone|fludrocortisone|mesh-list
6364086|NCT00103597|Domperidone|domperidone|mesh-list
6364087|NCT00103597|Antiemetics|antiemetics|mesh-ancestor
6364088|NCT00103597|Autonomic Agents|autonomic agents|mesh-ancestor
6364089|NCT00103597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6364090|NCT00103597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364091|NCT00103597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6364092|NCT00103597|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6364093|NCT00103597|Dopamine Agents|dopamine agents|mesh-ancestor
6364094|NCT00103597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6364095|NCT00103597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364096|NCT00103597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6364097|NCT00103623|Abarelix|abarelix|mesh-list
6364098|NCT00103623|Hormone Antagonists|hormone antagonists|mesh-ancestor
6364099|NCT00103623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6364100|NCT00103623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364101|NCT00103649|Xaliproden|xaliproden|mesh-list
6364102|NCT00103649|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6364103|NCT00103649|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6364104|NCT00103649|Serotonin Agents|serotonin agents|mesh-ancestor
6364105|NCT00103649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6364106|NCT00103649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364107|NCT00103649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364108|NCT00103701|Dasatinib|dasatinib|mesh-list
5724697|NCT03185364|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6364109|NCT00103701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6364110|NCT00103701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6364111|NCT00103701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6364112|NCT00103701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364113|NCT00103727|Risperidone|risperidone|mesh-list
6364114|NCT00103727|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6364115|NCT00103727|Serotonin Agents|serotonin agents|mesh-ancestor
6364116|NCT00103727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6364117|NCT00103727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364118|NCT00103727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364119|NCT00103727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6364120|NCT00103727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6364121|NCT00103727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6364122|NCT00103727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6364123|NCT00103727|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6364124|NCT00103727|Dopamine Agents|dopamine agents|mesh-ancestor
6364125|NCT00103753|Deferiprone|deferiprone|mesh-list
6364126|NCT00103753|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6364127|NCT00103753|Chelating Agents|chelating agents|mesh-ancestor
6364128|NCT00103753|Sequestering Agents|sequestering agents|mesh-ancestor
6364129|NCT00103753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364130|NCT00103766|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6364131|NCT00103766|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6364132|NCT00103766|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6364133|NCT00103766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364134|NCT00103779|Dacetuzumab|dacetuzumab|mesh-list
6364135|NCT00103779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6364136|NCT00103779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6364137|NCT00103792|Mycophenolic Acid|mycophenolic acid|mesh-list
6364138|NCT00103792|Cyclophosphamide|cyclophosphamide|mesh-list
6364139|NCT00103792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6364140|NCT00103792|Immunologic Factors|immunologic factors|mesh-ancestor
6364141|NCT00103792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364142|NCT00103792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6364143|NCT00103792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6364144|NCT00103792|Alkylating Agents|alkylating agents|mesh-ancestor
6364145|NCT00103792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364146|NCT00103792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6364147|NCT00103792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6364148|NCT00103792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6364149|NCT00103792|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6364150|NCT00103792|Antitubercular Agents|antitubercular agents|mesh-ancestor
6364151|NCT00103792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6364152|NCT00103792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6364153|NCT00103792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6364154|NCT00103805|Levodopa|levodopa|mesh-list
6364155|NCT00103805|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6364156|NCT00103805|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6364157|NCT00103805|Dopamine Agents|dopamine agents|mesh-ancestor
6364158|NCT00103805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6364159|NCT00103805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364160|NCT00103805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364161|NCT00103818|Gaboxadol|gaboxadol|mesh-list
6364162|NCT00103818|Analgesics|analgesics|mesh-ancestor
6364163|NCT00103818|Sensory System Agents|sensory system agents|mesh-ancestor
6364164|NCT00103818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6364165|NCT00103818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364166|NCT00103818|Anticonvulsants|anticonvulsants|mesh-ancestor
6364167|NCT00103818|GABA Agonists|gaba agonists|mesh-ancestor
6364168|NCT00103818|GABA Agents|gaba agents|mesh-ancestor
6364169|NCT00103818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6364170|NCT00103818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364171|NCT00103922|Cilomilast|cilomilast|mesh-list
6364172|NCT00103922|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6364173|NCT00103922|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6364174|NCT00103922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6364175|NCT00103922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364176|NCT00103935|Exenatide|exenatide|mesh-list
6364177|NCT00103935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6364178|NCT00103935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364179|NCT00103935|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6364180|NCT00103935|Incretins|incretins|mesh-ancestor
6364181|NCT00103935|Hormones|hormones|mesh-ancestor
6364182|NCT00103935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6364183|NCT00103948|Donepezil|donepezil|mesh-list
6364184|NCT00103948|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6364185|NCT00103948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6364186|NCT00103948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364187|NCT00103948|Cholinergic Agents|cholinergic agents|mesh-ancestor
6364188|NCT00103948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6364189|NCT00103948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364190|NCT00103948|Nootropic Agents|nootropic agents|mesh-ancestor
6364191|NCT00104013|Xaliproden|xaliproden|mesh-list
6364192|NCT00104013|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6364193|NCT00104013|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6364194|NCT00104013|Serotonin Agents|serotonin agents|mesh-ancestor
6364195|NCT00104013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6364196|NCT00104013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364197|NCT00104013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364198|NCT00104130|Desoxyepothilone B|desoxyepothilone b|mesh-list
6364199|NCT00104130|Tubulin Modulators|tubulin modulators|mesh-ancestor
6364200|NCT00104130|Antimitotic Agents|antimitotic agents|mesh-ancestor
6364201|NCT00104130|Mitosis Modulators|mitosis modulators|mesh-ancestor
6364202|NCT00104130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364203|NCT00104130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6364204|NCT00104169|Epoetin Alfa|epoetin alfa|mesh-list
6364205|NCT00104169|Hematinics|hematinics|mesh-ancestor
6364206|NCT00104182|Insulin|insulin|mesh-list
6364207|NCT00104182|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6364208|NCT00104182|Insulin Detemir|insulin detemir|mesh-list
6364209|NCT00104182|Isophane Insulin, Human|isophane insulin, human|mesh-list
6364210|NCT00104182|Insulin, Isophane|insulin, isophane|mesh-list
6364211|NCT00104182|Isophane insulin, beef|isophane insulin, beef|mesh-list
6364212|NCT00104182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6364213|NCT00104182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364214|NCT00104260|Verapamil|verapamil|mesh-list
6364215|NCT00104260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6364216|NCT00104260|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6364217|NCT00104260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6364218|NCT00104260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364219|NCT00104260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6364220|NCT00104260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364221|NCT00104260|Vasodilator Agents|vasodilator agents|mesh-ancestor
6364222|NCT00104273|Rasagiline|rasagiline|mesh-list
6364223|NCT00104273|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6364224|NCT00104273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6364225|NCT00104273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364226|NCT00104273|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6364227|NCT00104273|Protective Agents|protective agents|mesh-ancestor
6364228|NCT00104273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364229|NCT00104286|Troxacitabine|troxacitabine|mesh-list
6364230|NCT00104286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6364231|NCT00104286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6364232|NCT00104286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6364233|NCT00104286|Antiviral Agents|antiviral agents|mesh-ancestor
6364234|NCT00104286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6364235|NCT00104403|Dexamethasone|dexamethasone|mesh-list
6364236|NCT00104403|Dexamethasone acetate|dexamethasone acetate|mesh-list
6364237|NCT00104403|Ondansetron|ondansetron|mesh-list
6364238|NCT00104403|Casopitant|casopitant|mesh-list
6364239|NCT00104403|BB 1101|bb 1101|mesh-list
6364240|NCT00104403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6364241|NCT00104403|Antiemetics|antiemetics|mesh-ancestor
6364242|NCT00104403|Autonomic Agents|autonomic agents|mesh-ancestor
6364243|NCT00104403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6364244|NCT00104403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364245|NCT00104403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6364246|NCT00104403|Glucocorticoids|glucocorticoids|mesh-ancestor
6364247|NCT00104403|Hormones|hormones|mesh-ancestor
6364248|NCT00104403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6364249|NCT00104403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6364250|NCT00104403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6364251|NCT00104403|Protease Inhibitors|protease inhibitors|mesh-ancestor
6364252|NCT00104403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6364253|NCT00104403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364254|NCT00104403|Antipruritics|antipruritics|mesh-ancestor
6364255|NCT00104403|Dermatologic Agents|dermatologic agents|mesh-ancestor
6364256|NCT00104403|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6364257|NCT00104403|Serotonin Agents|serotonin agents|mesh-ancestor
6364258|NCT00104403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6364259|NCT00104403|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6364260|NCT00104403|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6364261|NCT00104403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6364262|NCT00104403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6364263|NCT00104403|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6364264|NCT00104403|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6364265|NCT00104429|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6364266|NCT00104429|Aplaviroc|aplaviroc|mesh-list
6364267|NCT00104429|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6364268|NCT00104429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6364269|NCT00104429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6364270|NCT00104429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364271|NCT00104429|Antiviral Agents|antiviral agents|mesh-ancestor
6364272|NCT00104429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6364273|NCT00104429|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6364274|NCT00104429|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6364275|NCT00104429|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6364276|NCT00104429|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6364277|NCT00104442|Rivastigmine|rivastigmine|mesh-list
6364278|NCT00104442|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6364279|NCT00104442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6364280|NCT00104442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364281|NCT00104442|Cholinergic Agents|cholinergic agents|mesh-ancestor
6364282|NCT00104442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6364283|NCT00104442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364284|NCT00104442|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6364285|NCT00104442|Protective Agents|protective agents|mesh-ancestor
6395047|NCT00203905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6395048|NCT00203905|Immunologic Factors|immunologic factors|mesh-ancestor
6395049|NCT00203905|Antisickling Agents|antisickling agents|mesh-ancestor
6395050|NCT00203905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6395051|NCT00203905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6395052|NCT00203957|Istradefylline|istradefylline|mesh-list
6395053|NCT00203957|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
6395054|NCT00203957|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6395055|NCT00203957|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6395056|NCT00203957|Purinergic Agents|purinergic agents|mesh-ancestor
6395057|NCT00203957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6395058|NCT00203957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395059|NCT00203957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396991|NCT00209885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6396992|NCT00209885|Antiemetics|antiemetics|mesh-ancestor
6396993|NCT00209885|Autonomic Agents|autonomic agents|mesh-ancestor
6396994|NCT00209885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6396995|NCT00209885|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6396996|NCT00209885|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6396997|NCT00209885|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6396998|NCT00209885|Dopamine Agents|dopamine agents|mesh-ancestor
6396999|NCT00209924|Gaboxadol|gaboxadol|mesh-list
6397000|NCT00209924|Analgesics|analgesics|mesh-ancestor
6397001|NCT00209924|Sensory System Agents|sensory system agents|mesh-ancestor
6397002|NCT00209924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6397003|NCT00209924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397004|NCT00209924|Anticonvulsants|anticonvulsants|mesh-ancestor
6397005|NCT00209924|GABA Agonists|gaba agonists|mesh-ancestor
6397006|NCT00209924|GABA Agents|gaba agents|mesh-ancestor
6397007|NCT00209924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6397008|NCT00209924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397009|NCT00209937|Gaboxadol|gaboxadol|mesh-list
6397010|NCT00209937|Analgesics|analgesics|mesh-ancestor
6397011|NCT00209937|Sensory System Agents|sensory system agents|mesh-ancestor
6397012|NCT00209937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6397013|NCT00209937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397014|NCT00209937|Anticonvulsants|anticonvulsants|mesh-ancestor
6397015|NCT00209937|GABA Agonists|gaba agonists|mesh-ancestor
6397016|NCT00209937|GABA Agents|gaba agents|mesh-ancestor
6397017|NCT00209937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6397018|NCT00209937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397019|NCT00209950|Gaboxadol|gaboxadol|mesh-list
6397020|NCT00209950|Analgesics|analgesics|mesh-ancestor
6397021|NCT00209950|Sensory System Agents|sensory system agents|mesh-ancestor
6364286|NCT00104468|Troxacitabine|troxacitabine|mesh-list
6364287|NCT00104468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6364288|NCT00104468|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6364289|NCT00104468|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6364290|NCT00104468|Antiviral Agents|antiviral agents|mesh-ancestor
6364291|NCT00104468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6364292|NCT00104546|Vitamin K|vitamin k|mesh-list
6364293|NCT00104546|Vitamins|vitamins|mesh-ancestor
6364294|NCT00104546|Micronutrients|micronutrients|mesh-ancestor
6364295|NCT00104546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364296|NCT00104546|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6364297|NCT00104546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6364298|NCT00104546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364299|NCT00104546|Hemostatics|hemostatics|mesh-ancestor
6364300|NCT00104546|Coagulants|coagulants|mesh-ancestor
6364301|NCT00104598|Bupropion|bupropion|mesh-list
6364302|NCT00104598|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6364303|NCT00104598|Antidepressive Agents|antidepressive agents|mesh-ancestor
6364304|NCT00104598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6364305|NCT00104598|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6364306|NCT00104598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6364307|NCT00104598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6364308|NCT00104598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364309|NCT00104598|Dopamine Agents|dopamine agents|mesh-ancestor
6364310|NCT00104598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6364311|NCT00104598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364312|NCT00104598|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6364313|NCT00104598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6364314|NCT00104598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6364315|NCT00104624|Docetaxel|docetaxel|mesh-list
6364316|NCT00104624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6364317|NCT00104624|Tubulin Modulators|tubulin modulators|mesh-ancestor
6364318|NCT00104624|Antimitotic Agents|antimitotic agents|mesh-ancestor
6364319|NCT00104624|Mitosis Modulators|mitosis modulators|mesh-ancestor
6364320|NCT00104624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364321|NCT00104663|Quinacrine|quinacrine|mesh-list
6364322|NCT00104663|Anticestodal Agents|anticestodal agents|mesh-ancestor
6364323|NCT00104663|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6364324|NCT00104663|Anthelmintics|anthelmintics|mesh-ancestor
6364325|NCT00104663|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6364326|NCT00104663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6364327|NCT00104663|Antimalarials|antimalarials|mesh-ancestor
6364328|NCT00104663|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6364329|NCT00104663|Antinematodal Agents|antinematodal agents|mesh-ancestor
6364330|NCT00104663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6364331|NCT00104663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6364332|NCT00104663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364333|NCT00104689|Capecitabine|capecitabine|mesh-list
6364334|NCT00104689|Oxaliplatin|oxaliplatin|mesh-list
6364335|NCT00104689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6364336|NCT00104689|Antimetabolites|antimetabolites|mesh-ancestor
6364337|NCT00104689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364338|NCT00104689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6364339|NCT00104715|Docetaxel|docetaxel|mesh-list
6364340|NCT00104715|Goserelin|goserelin|mesh-list
6364341|NCT00104715|Androgen Antagonists|androgen antagonists|mesh-list
6364342|NCT00104715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6364343|NCT00104715|Tubulin Modulators|tubulin modulators|mesh-ancestor
6364344|NCT00104715|Antimitotic Agents|antimitotic agents|mesh-ancestor
6364345|NCT00104715|Mitosis Modulators|mitosis modulators|mesh-ancestor
6364346|NCT00104715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364347|NCT00104715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6364348|NCT00104715|Hormone Antagonists|hormone antagonists|mesh-ancestor
6364349|NCT00104715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6364350|NCT00104715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364351|NCT00104741|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6364352|NCT00104741|Flutamide|flutamide|mesh-list
6364353|NCT00104741|Luteolytic Agents|luteolytic agents|mesh-ancestor
6364354|NCT00104741|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6364355|NCT00104741|Contraceptive Agents|contraceptive agents|mesh-ancestor
6364356|NCT00104741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6364357|NCT00104741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364358|NCT00104741|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6364359|NCT00104741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6364360|NCT00104741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6364361|NCT00104741|Androgen Antagonists|androgen antagonists|mesh-ancestor
6364362|NCT00104741|Hormone Antagonists|hormone antagonists|mesh-ancestor
6364363|NCT00104741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6364364|NCT00104767|Celecoxib|celecoxib|mesh-list
6364365|NCT00104767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6364366|NCT00104767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6364367|NCT00104767|Analgesics|analgesics|mesh-ancestor
6364368|NCT00104767|Sensory System Agents|sensory system agents|mesh-ancestor
6364369|NCT00104767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6364370|NCT00104767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364371|NCT00104767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6364372|NCT00104767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6364373|NCT00104767|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6364374|NCT00104767|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6364375|NCT00104767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6364376|NCT00104767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364377|NCT00104780|Freund's Adjuvant|freund's adjuvant|mesh-list
6364378|NCT00104780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6364379|NCT00104780|Immunologic Factors|immunologic factors|mesh-ancestor
6364380|NCT00104780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364381|NCT00104793|Carboplatin|carboplatin|mesh-list
6364382|NCT00104793|Irinotecan|irinotecan|mesh-list
6364383|NCT00104793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6364384|NCT00104793|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6364385|NCT00104793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6364386|NCT00104793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6364387|NCT00104793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364388|NCT00104806|Cholecalciferol|cholecalciferol|mesh-list
6364389|NCT00104806|Arsenic Trioxide|arsenic trioxide|mesh-list
6364390|NCT00104806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6364391|NCT00104806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364392|NCT00104806|Vitamins|vitamins|mesh-ancestor
6364393|NCT00104806|Micronutrients|micronutrients|mesh-ancestor
6364394|NCT00104806|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6364395|NCT00104806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6364396|NCT00104819|Immunoglobulins|immunoglobulins|mesh-list
6364397|NCT00104819|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6364398|NCT00104819|Antibodies|antibodies|mesh-list
6364399|NCT00104819|Sargramostim|sargramostim|mesh-list
6364400|NCT00104819|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
6364401|NCT00104819|Immunologic Factors|immunologic factors|mesh-ancestor
6364402|NCT00104819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364403|NCT00104845|Vaccines|vaccines|mesh-list
6364404|NCT00104845|Immunologic Factors|immunologic factors|mesh-ancestor
6364405|NCT00104845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364406|NCT00104910|Cetuximab|cetuximab|mesh-list
6364407|NCT00104910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6364408|NCT00104910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6364409|NCT00104923|Fenretinide|fenretinide|mesh-list
6364410|NCT00104923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6364411|NCT00104923|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6364412|NCT00104923|Protective Agents|protective agents|mesh-ancestor
6364413|NCT00104923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364414|NCT00104949|Trastuzumab|trastuzumab|mesh-list
6364415|NCT00104949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6364416|NCT00104949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6364417|NCT00104962|Lenalidomide|lenalidomide|mesh-list
6364418|NCT00104962|Immunologic Factors|immunologic factors|mesh-ancestor
6364419|NCT00104962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364420|NCT00104962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6364421|NCT00104962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6364422|NCT00104962|Growth Substances|growth substances|mesh-ancestor
6364423|NCT00104962|Growth Inhibitors|growth inhibitors|mesh-ancestor
6364424|NCT00104962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6364425|NCT00104975|Fludarabine|fludarabine|mesh-list
6364426|NCT00104975|Fludarabine phosphate|fludarabine phosphate|mesh-list
6364427|NCT00104975|Melphalan|melphalan|mesh-list
6364428|NCT00104975|Alemtuzumab|alemtuzumab|mesh-list
6364429|NCT00104975|Thiotepa|thiotepa|mesh-list
6364430|NCT00104975|Tacrolimus|tacrolimus|mesh-list
6364431|NCT00104975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6364432|NCT00104975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6364433|NCT00104975|Antimetabolites|antimetabolites|mesh-ancestor
6364434|NCT00104975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364435|NCT00104975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6364436|NCT00104975|Immunologic Factors|immunologic factors|mesh-ancestor
6364437|NCT00104975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364438|NCT00104975|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6364439|NCT00104975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6364440|NCT00104975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6364441|NCT00104975|Alkylating Agents|alkylating agents|mesh-ancestor
6364442|NCT00104975|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6364443|NCT00104975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6364444|NCT00104988|Thalidomide|thalidomide|mesh-list
6364445|NCT00104988|Temozolomide|temozolomide|mesh-list
6364446|NCT00104988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6364447|NCT00104988|Alkylating Agents|alkylating agents|mesh-ancestor
6364448|NCT00104988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364449|NCT00104988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6364450|NCT00104988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6364451|NCT00104988|Immunologic Factors|immunologic factors|mesh-ancestor
6364452|NCT00104988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364453|NCT00104988|Leprostatic Agents|leprostatic agents|mesh-ancestor
6364454|NCT00104988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6364455|NCT00104988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6364456|NCT00104988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6364457|NCT00104988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6364458|NCT00104988|Growth Substances|growth substances|mesh-ancestor
6364459|NCT00104988|Growth Inhibitors|growth inhibitors|mesh-ancestor
6364460|NCT00105040|Levetiracetam|levetiracetam|mesh-list
6364461|NCT00105040|Anticonvulsants|anticonvulsants|mesh-ancestor
6364462|NCT00105040|Nootropic Agents|nootropic agents|mesh-ancestor
6364463|NCT00105105|Mifepristone|mifepristone|mesh-list
6364464|NCT00105105|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6364465|NCT00105105|Abortifacient Agents|abortifacient agents|mesh-ancestor
6364466|NCT00105105|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6364467|NCT00105105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364468|NCT00105105|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6364469|NCT00105105|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6364470|NCT00105105|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6364471|NCT00105105|Contraceptive Agents|contraceptive agents|mesh-ancestor
6364472|NCT00105105|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6364473|NCT00105105|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6364474|NCT00105105|Hormone Antagonists|hormone antagonists|mesh-ancestor
6364475|NCT00105105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6364476|NCT00105105|Luteolytic Agents|luteolytic agents|mesh-ancestor
6364477|NCT00105105|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6364478|NCT00105105|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6364479|NCT00105144|Caspofungin|caspofungin|mesh-list
6364480|NCT00105144|Micafungin|micafungin|mesh-list
6364481|NCT00105144|Antifungal Agents|antifungal agents|mesh-ancestor
6364482|NCT00105144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6364483|NCT00105144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6364484|NCT00105144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364485|NCT00105209|Aspirin|aspirin|mesh-list
6364486|NCT00105209|Clopidogrel|clopidogrel|mesh-list
6364487|NCT00105209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6364488|NCT00105209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6364489|NCT00105209|Analgesics|analgesics|mesh-ancestor
6364490|NCT00105209|Sensory System Agents|sensory system agents|mesh-ancestor
6364491|NCT00105209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6364492|NCT00105209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364493|NCT00105209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6017241|NCT00370838|Analgesics|analgesics|mesh-ancestor
6364494|NCT00105209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6364495|NCT00105209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6364496|NCT00105209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6364497|NCT00105209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364498|NCT00105209|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6364499|NCT00105209|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6364500|NCT00105209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6364501|NCT00105209|Antipyretics|antipyretics|mesh-ancestor
6364502|NCT00105209|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6364503|NCT00105209|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6364504|NCT00105209|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6364505|NCT00105209|Purinergic Agents|purinergic agents|mesh-ancestor
6364506|NCT00105209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6364507|NCT00105287|Fentanyl|fentanyl|mesh-list
6364508|NCT00105287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6364509|NCT00105287|Narcotics|narcotics|mesh-ancestor
6364510|NCT00105287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6364511|NCT00105287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364512|NCT00105287|Analgesics|analgesics|mesh-ancestor
6364513|NCT00105287|Sensory System Agents|sensory system agents|mesh-ancestor
6364514|NCT00105287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6364515|NCT00105287|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6364516|NCT00105287|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6364517|NCT00105287|Anesthetics, General|anesthetics, general|mesh-ancestor
6364518|NCT00105287|Anesthetics|anesthetics|mesh-ancestor
6364519|NCT00105300|Adalimumab|adalimumab|mesh-list
6364520|NCT00105300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6364521|NCT00105300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6364522|NCT00105326|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6364523|NCT00105326|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6364524|NCT00105326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6364525|NCT00105326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6364526|NCT00105326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364527|NCT00105326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6364528|NCT00105326|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6364529|NCT00105326|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6364530|NCT00105326|Serotonin Agents|serotonin agents|mesh-ancestor
6364531|NCT00105326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6395060|NCT00204022|Mycophenolic Acid|mycophenolic acid|mesh-list
6364532|NCT00105326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364533|NCT00105326|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6364534|NCT00105326|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6364535|NCT00105326|Dopamine Agents|dopamine agents|mesh-ancestor
6364536|NCT00105352|Glucagon|glucagon|mesh-list
6364537|NCT00105352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6364538|NCT00105352|Hormones|hormones|mesh-ancestor
6364539|NCT00105352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6364540|NCT00105352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364541|NCT00105404|Triamcinolone|triamcinolone|mesh-list
6364542|NCT00105404|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6364543|NCT00105404|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6364544|NCT00105404|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6364545|NCT00105404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6364546|NCT00105404|Glucocorticoids|glucocorticoids|mesh-ancestor
6364547|NCT00105404|Hormones|hormones|mesh-ancestor
6364548|NCT00105404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6364549|NCT00105404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364550|NCT00105404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6364551|NCT00105404|Immunologic Factors|immunologic factors|mesh-ancestor
6364552|NCT00105404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6364553|NCT00105404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364554|NCT00105495|Deferiprone|deferiprone|mesh-list
6364555|NCT00105495|Deferoxamine|deferoxamine|mesh-list
6364556|NCT00105495|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6364557|NCT00105495|Chelating Agents|chelating agents|mesh-ancestor
6364558|NCT00105495|Sequestering Agents|sequestering agents|mesh-ancestor
6364559|NCT00105495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364560|NCT00105495|Siderophores|siderophores|mesh-ancestor
6364561|NCT00105547|Flurbiprofen|flurbiprofen|mesh-list
6364562|NCT00105547|Analgesics|analgesics|mesh-ancestor
6364563|NCT00105547|Sensory System Agents|sensory system agents|mesh-ancestor
6364564|NCT00105547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6364565|NCT00105547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364566|NCT00105547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6364567|NCT00105547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6364568|NCT00105547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6364569|NCT00105547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6364570|NCT00105547|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6364571|NCT00105547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6364572|NCT00105547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364573|NCT00105937|Fentanyl|fentanyl|mesh-list
6364574|NCT00105937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6364575|NCT00105937|Narcotics|narcotics|mesh-ancestor
6364576|NCT00105937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6364577|NCT00105937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364578|NCT00105937|Analgesics|analgesics|mesh-ancestor
6364579|NCT00105937|Sensory System Agents|sensory system agents|mesh-ancestor
6364580|NCT00105937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6364581|NCT00105937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6364582|NCT00105937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6364583|NCT00105937|Anesthetics, General|anesthetics, general|mesh-ancestor
6364584|NCT00105937|Anesthetics|anesthetics|mesh-ancestor
6364585|NCT00105950|Lapatinib|lapatinib|mesh-list
6364586|NCT00105950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6364587|NCT00105950|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6364588|NCT00105950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6364589|NCT00105950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364590|NCT00106054|Leucovorin|leucovorin|mesh-list
6364591|NCT00106054|Bevacizumab|bevacizumab|mesh-list
6364592|NCT00106054|Irinotecan|irinotecan|mesh-list
6364593|NCT00106054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6364594|NCT00106054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6364595|NCT00106054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6017242|NCT00370838|Sensory System Agents|sensory system agents|mesh-ancestor
6017243|NCT00370838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6017244|NCT00370838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017245|NCT00370838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6017246|NCT00370838|Sympatholytics|sympatholytics|mesh-ancestor
6017247|NCT00370838|Autonomic Agents|autonomic agents|mesh-ancestor
6364596|NCT00106054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6364597|NCT00106054|Growth Substances|growth substances|mesh-ancestor
6364598|NCT00106054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364599|NCT00106054|Growth Inhibitors|growth inhibitors|mesh-ancestor
6364600|NCT00106054|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6364601|NCT00106054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6364602|NCT00106054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6364603|NCT00106054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364604|NCT00106054|Antidotes|antidotes|mesh-ancestor
6364605|NCT00106054|Protective Agents|protective agents|mesh-ancestor
6364606|NCT00106054|Vitamin B Complex|vitamin b complex|mesh-ancestor
6364607|NCT00106054|Vitamins|vitamins|mesh-ancestor
6364608|NCT00106054|Micronutrients|micronutrients|mesh-ancestor
6364609|NCT00106132|Triamcinolone|triamcinolone|mesh-list
6364610|NCT00106132|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6364611|NCT00106132|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6364612|NCT00106132|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6364613|NCT00106132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6364614|NCT00106132|Glucocorticoids|glucocorticoids|mesh-ancestor
6364615|NCT00106132|Hormones|hormones|mesh-ancestor
6364616|NCT00106132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6364617|NCT00106132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364618|NCT00106132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6364619|NCT00106132|Immunologic Factors|immunologic factors|mesh-ancestor
6364620|NCT00106132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6364621|NCT00106132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364622|NCT00106158|Vaccines|vaccines|mesh-list
6364623|NCT00106158|Immunologic Factors|immunologic factors|mesh-ancestor
6364624|NCT00106158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364625|NCT00106171|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6364626|NCT00106171|Antiviral Agents|antiviral agents|mesh-ancestor
6364627|NCT00106171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6364628|NCT00106197|Bupropion|bupropion|mesh-list
6364629|NCT00106197|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6364630|NCT00106197|Antidepressive Agents|antidepressive agents|mesh-ancestor
6364631|NCT00106197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6364632|NCT00106197|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6364633|NCT00106197|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6364634|NCT00106197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6364635|NCT00106197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364636|NCT00106197|Dopamine Agents|dopamine agents|mesh-ancestor
6364637|NCT00106197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6364638|NCT00106197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364639|NCT00106197|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6364640|NCT00106197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6364641|NCT00106197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6395061|NCT00204022|Azathioprine|azathioprine|mesh-list
6395062|NCT00204022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6395063|NCT00204022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6395064|NCT00204022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6395065|NCT00204022|Antitubercular Agents|antitubercular agents|mesh-ancestor
6395066|NCT00204022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6395067|NCT00204022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6395068|NCT00204022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6395069|NCT00204022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395070|NCT00204022|Antimetabolites|antimetabolites|mesh-ancestor
6395071|NCT00204022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6395072|NCT00204022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6395073|NCT00204022|Immunologic Factors|immunologic factors|mesh-ancestor
6395074|NCT00204022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395075|NCT00204022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6395076|NCT00204061|Amisulpride|amisulpride|mesh-list
6395077|NCT00204061|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6017248|NCT00370838|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6364642|NCT00106262|Irinotecan|irinotecan|mesh-list
6364643|NCT00106262|Bortezomib|bortezomib|mesh-list
6364644|NCT00106262|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6364645|NCT00106262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6364646|NCT00106262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6364647|NCT00106262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364648|NCT00106262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6364649|NCT00106288|Amphotericin B|amphotericin b|mesh-list
6364650|NCT00106288|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6364651|NCT00106288|Micafungin|micafungin|mesh-list
6364652|NCT00106288|Amebicides|amebicides|mesh-ancestor
6364653|NCT00106288|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6364654|NCT00106288|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6017249|NCT00370838|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6364655|NCT00106288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6364656|NCT00106288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6364657|NCT00106288|Antifungal Agents|antifungal agents|mesh-ancestor
6364658|NCT00106301|Romidepsin|romidepsin|mesh-list
6364659|NCT00106301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6364660|NCT00106301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6364661|NCT00106314|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
6364662|NCT00106314|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6364663|NCT00106314|Immunologic Factors|immunologic factors|mesh-ancestor
6364664|NCT00106314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364665|NCT00106366|Insulin|insulin|mesh-list
6017250|NCT00370838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6017251|NCT00370838|Adrenergic Agents|adrenergic agents|mesh-ancestor
6364666|NCT00106366|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6364667|NCT00106366|Insulin Glargine|insulin glargine|mesh-list
6364668|NCT00106366|Insulin Aspart|insulin aspart|mesh-list
6364669|NCT00106366|Insulin Detemir|insulin detemir|mesh-list
6364670|NCT00106366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6364671|NCT00106366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364672|NCT00106379|Tenofovir|tenofovir|mesh-list
6364673|NCT00106379|Emtricitabine|emtricitabine|mesh-list
6364674|NCT00106379|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6364675|NCT00106379|Antiviral Agents|antiviral agents|mesh-ancestor
6364676|NCT00106379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6364677|NCT00106379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6364678|NCT00106379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6364679|NCT00106379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6364680|NCT00106379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364681|NCT00106379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6364682|NCT00106379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6364683|NCT00106405|Memantine|memantine|mesh-list
6364684|NCT00106405|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6364685|NCT00106405|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6364686|NCT00106405|Dopamine Agents|dopamine agents|mesh-ancestor
6364687|NCT00106405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6364688|NCT00106405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364689|NCT00106405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364690|NCT00106405|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6364691|NCT00106405|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6364692|NCT00106418|Romidepsin|romidepsin|mesh-list
6364693|NCT00106418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6364694|NCT00106418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6364695|NCT00106496|Tacrolimus|tacrolimus|mesh-list
6364696|NCT00106496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6364697|NCT00106496|Immunologic Factors|immunologic factors|mesh-ancestor
6364698|NCT00106496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364699|NCT00106496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6364700|NCT00106496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6364701|NCT00106496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364702|NCT00106522|Methotrexate|methotrexate|mesh-list
6364703|NCT00106522|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6364704|NCT00106522|Abortifacient Agents|abortifacient agents|mesh-ancestor
6364705|NCT00106522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6017252|NCT00370838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6017253|NCT00370838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364706|NCT00106522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364707|NCT00106522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6364708|NCT00106522|Antimetabolites|antimetabolites|mesh-ancestor
6364709|NCT00106522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364710|NCT00106522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6364711|NCT00106522|Dermatologic Agents|dermatologic agents|mesh-ancestor
6364712|NCT00106522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6364713|NCT00106522|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6364714|NCT00106522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6364715|NCT00106522|Immunologic Factors|immunologic factors|mesh-ancestor
6364716|NCT00106522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6364717|NCT00106522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6364718|NCT00106548|Methotrexate|methotrexate|mesh-list
6364719|NCT00106548|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6364720|NCT00106548|Abortifacient Agents|abortifacient agents|mesh-ancestor
6364721|NCT00106548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6364722|NCT00106548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364723|NCT00106548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6364724|NCT00106548|Antimetabolites|antimetabolites|mesh-ancestor
6364725|NCT00106548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364726|NCT00106548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6364727|NCT00106548|Dermatologic Agents|dermatologic agents|mesh-ancestor
6364728|NCT00106548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6364729|NCT00106548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6364730|NCT00106548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6364731|NCT00106548|Immunologic Factors|immunologic factors|mesh-ancestor
6364732|NCT00106548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6364733|NCT00106548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6364734|NCT00106561|Irbesartan|irbesartan|mesh-list
6364735|NCT00106561|Spironolactone|spironolactone|mesh-list
6364736|NCT00106561|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6364737|NCT00106561|Hormone Antagonists|hormone antagonists|mesh-ancestor
6364738|NCT00106561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6364739|NCT00106561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364740|NCT00106561|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6364741|NCT00106561|Diuretics|diuretics|mesh-ancestor
6364742|NCT00106561|Natriuretic Agents|natriuretic agents|mesh-ancestor
6364743|NCT00106561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6364744|NCT00106561|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6364745|NCT00106561|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6364746|NCT00106561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364747|NCT00106587|Paclitaxel|paclitaxel|mesh-list
6364748|NCT00106587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6364749|NCT00106587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6364750|NCT00106587|Tubulin Modulators|tubulin modulators|mesh-ancestor
6364751|NCT00106587|Antimitotic Agents|antimitotic agents|mesh-ancestor
6364752|NCT00106587|Mitosis Modulators|mitosis modulators|mesh-ancestor
6364753|NCT00106587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364754|NCT00106600|Pixantrone|pixantrone|mesh-list
6364755|NCT00106600|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6364756|NCT00106600|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6364757|NCT00106600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6364758|NCT00106600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364759|NCT00106600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6364760|NCT00106613|Romidepsin|romidepsin|mesh-list
6364761|NCT00106613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6364762|NCT00106613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6364763|NCT00106691|Toremifene|toremifene|mesh-list
6364764|NCT00106691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6364765|NCT00106691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6364766|NCT00106691|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6395078|NCT00204061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6364767|NCT00106691|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6364768|NCT00106691|Hormone Antagonists|hormone antagonists|mesh-ancestor
6364769|NCT00106691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6364770|NCT00106691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364771|NCT00106691|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6364772|NCT00106821|Bromides|bromides|mesh-list
6364773|NCT00106821|Tiotropium Bromide|tiotropium bromide|mesh-list
6364774|NCT00106821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6364775|NCT00106821|Autonomic Agents|autonomic agents|mesh-ancestor
6364776|NCT00106821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6364777|NCT00106821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364778|NCT00106821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6364779|NCT00106821|Respiratory System Agents|respiratory system agents|mesh-ancestor
6364780|NCT00106821|Parasympatholytics|parasympatholytics|mesh-ancestor
6364781|NCT00106821|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6364782|NCT00106821|Cholinergic Agents|cholinergic agents|mesh-ancestor
6364783|NCT00106821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6364784|NCT00106821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364785|NCT00106821|Anticonvulsants|anticonvulsants|mesh-ancestor
6364786|NCT00106834|Infliximab|infliximab|mesh-list
6364787|NCT00106834|Dermatologic Agents|dermatologic agents|mesh-ancestor
6364788|NCT00106834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6364789|NCT00106834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6364790|NCT00106847|Infliximab|infliximab|mesh-list
6364791|NCT00106847|Dermatologic Agents|dermatologic agents|mesh-ancestor
6364792|NCT00106847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6364793|NCT00106847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6364794|NCT00106886|Folic Acid|folic acid|mesh-list
6364795|NCT00106886|Vitamin B 6|vitamin b 6|mesh-list
6364796|NCT00106886|Pyridoxal|pyridoxal|mesh-list
6364797|NCT00106886|Pyridoxine|pyridoxine|mesh-list
6364798|NCT00106886|Vitamins|vitamins|mesh-ancestor
6364799|NCT00106886|Micronutrients|micronutrients|mesh-ancestor
6364800|NCT00106886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364801|NCT00106886|Hematinics|hematinics|mesh-ancestor
6364802|NCT00106886|Vitamin B Complex|vitamin b complex|mesh-ancestor
6364803|NCT00107003|Lapatinib|lapatinib|mesh-list
6364804|NCT00107003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6364805|NCT00107003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6364806|NCT00107003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6364807|NCT00107003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364808|NCT00107016|Letrozole|letrozole|mesh-list
6364809|NCT00107016|Everolimus|everolimus|mesh-list
6017254|NCT00370838|Anticonvulsants|anticonvulsants|mesh-ancestor
6017255|NCT00370838|Nootropic Agents|nootropic agents|mesh-ancestor
6017256|NCT00371150|Entecavir|entecavir|mesh-list
6017257|NCT00371150|Antiviral Agents|antiviral agents|mesh-ancestor
6364810|NCT00107016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6364811|NCT00107016|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6364812|NCT00107016|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6364813|NCT00107016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6364814|NCT00107016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364815|NCT00107016|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6364816|NCT00107016|Hormone Antagonists|hormone antagonists|mesh-ancestor
6364817|NCT00107016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6364818|NCT00107016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364819|NCT00107016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6364820|NCT00107016|Immunologic Factors|immunologic factors|mesh-ancestor
6364821|NCT00107081|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6364822|NCT00107081|Amoxicillin|amoxicillin|mesh-list
6364823|NCT00107081|Ciprofloxacin|ciprofloxacin|mesh-list
6364824|NCT00107081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6364825|NCT00107081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6364826|NCT00107081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6364827|NCT00107081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6364828|NCT00107081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364829|NCT00107081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6364830|NCT00107081|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6364831|NCT00107081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6364832|NCT00107094|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6017258|NCT00371150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6017259|NCT00371176|Cycloserine|cycloserine|mesh-list
6017260|NCT00371176|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6017261|NCT00371176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6017262|NCT00371176|Renal Agents|renal agents|mesh-ancestor
6364833|NCT00107094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6364834|NCT00107107|Pramlintide|pramlintide|mesh-list
6364835|NCT00107107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6364836|NCT00107107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364837|NCT00107237|Everolimus|everolimus|mesh-list
6364838|NCT00107237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6364839|NCT00107237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6364840|NCT00107237|Immunologic Factors|immunologic factors|mesh-ancestor
6364841|NCT00107237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364842|NCT00107250|Paclitaxel|paclitaxel|mesh-list
6364843|NCT00107250|Carboplatin|carboplatin|mesh-list
6364844|NCT00107250|Capecitabine|capecitabine|mesh-list
6364845|NCT00107250|Cediranib|cediranib|mesh-list
6364846|NCT00107250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6364847|NCT00107250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6364848|NCT00107250|Tubulin Modulators|tubulin modulators|mesh-ancestor
6364849|NCT00107250|Antimitotic Agents|antimitotic agents|mesh-ancestor
6364850|NCT00107250|Mitosis Modulators|mitosis modulators|mesh-ancestor
6364851|NCT00107250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364852|NCT00107250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6364853|NCT00107250|Antimetabolites|antimetabolites|mesh-ancestor
6364854|NCT00107250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6364855|NCT00107250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6364856|NCT00107263|Zoledronic Acid|zoledronic acid|mesh-list
6364857|NCT00107263|Letrozole|letrozole|mesh-list
6364858|NCT00107263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6364859|NCT00107263|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6364860|NCT00107263|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6364861|NCT00107263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6364862|NCT00107263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364863|NCT00107263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6017263|NCT00371176|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6017264|NCT00371176|Antitubercular Agents|antitubercular agents|mesh-ancestor
6017265|NCT00371176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6017266|NCT00371176|Antimetabolites|antimetabolites|mesh-ancestor
6017267|NCT00371176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017268|NCT00371254|Dasatinib|dasatinib|mesh-list
6364864|NCT00107263|Hormone Antagonists|hormone antagonists|mesh-ancestor
6364865|NCT00107263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6364866|NCT00107263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364867|NCT00107263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6364868|NCT00107341|Paclitaxel|paclitaxel|mesh-list
6364869|NCT00107341|Carboplatin|carboplatin|mesh-list
6364870|NCT00107341|Bortezomib|bortezomib|mesh-list
6364871|NCT00107341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6364872|NCT00107341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6364873|NCT00107341|Tubulin Modulators|tubulin modulators|mesh-ancestor
6364874|NCT00107341|Antimitotic Agents|antimitotic agents|mesh-ancestor
6364875|NCT00107341|Mitosis Modulators|mitosis modulators|mesh-ancestor
6364876|NCT00107341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364877|NCT00107354|Cytarabine|cytarabine|mesh-list
6364878|NCT00107354|Aldesleukin|aldesleukin|mesh-list
6364879|NCT00107354|Etoposide|etoposide|mesh-list
6364880|NCT00107354|Mitoxantrone|mitoxantrone|mesh-list
6364881|NCT00107354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6364882|NCT00107354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6364883|NCT00107354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6364884|NCT00107354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6364885|NCT00107354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6364886|NCT00107354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364887|NCT00107354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6364888|NCT00107354|Antimetabolites|antimetabolites|mesh-ancestor
6364889|NCT00107354|Antiviral Agents|antiviral agents|mesh-ancestor
6364890|NCT00107354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6364891|NCT00107354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6364892|NCT00107354|Immunologic Factors|immunologic factors|mesh-ancestor
6364893|NCT00107354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364894|NCT00107354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6364895|NCT00107354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6364896|NCT00107354|Analgesics|analgesics|mesh-ancestor
6364897|NCT00107354|Sensory System Agents|sensory system agents|mesh-ancestor
6364898|NCT00107354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6364899|NCT00107393|Capecitabine|capecitabine|mesh-list
6364900|NCT00107393|Trastuzumab|trastuzumab|mesh-list
6364901|NCT00107393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6364902|NCT00107393|Antimetabolites|antimetabolites|mesh-ancestor
6364903|NCT00107393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364904|NCT00107393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6364905|NCT00107393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6364906|NCT00107419|Pemetrexed|pemetrexed|mesh-list
6364907|NCT00107419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6364908|NCT00107419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6364909|NCT00107419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364910|NCT00107419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6364911|NCT00107419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6364912|NCT00107432|Sorafenib|sorafenib|mesh-list
6364913|NCT00107432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6364914|NCT00107432|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6364915|NCT00107432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6364916|NCT00107432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364917|NCT00107458|Valproic Acid|valproic acid|mesh-list
6364918|NCT00107458|Anticonvulsants|anticonvulsants|mesh-ancestor
6364919|NCT00107458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6364920|NCT00107458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364921|NCT00107458|GABA Agents|gaba agents|mesh-ancestor
6364922|NCT00107458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6364923|NCT00107458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364924|NCT00107458|Antimanic Agents|antimanic agents|mesh-ancestor
6364925|NCT00107458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6364926|NCT00107458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6364927|NCT00107458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6364928|NCT00107471|Topotecan|topotecan|mesh-list
6364929|NCT00107471|Lenograstim|lenograstim|mesh-list
6364930|NCT00107471|Sargramostim|sargramostim|mesh-list
6364931|NCT00107471|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6364932|NCT00107471|Immunologic Factors|immunologic factors|mesh-ancestor
6364933|NCT00107471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364934|NCT00107471|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6364935|NCT00107471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6364936|NCT00107471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6364937|NCT00107471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364938|NCT00107471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6364939|NCT00107510|Carboplatin|carboplatin|mesh-list
6364940|NCT00107510|Docetaxel|docetaxel|mesh-list
6364941|NCT00107510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6364942|NCT00107510|Tubulin Modulators|tubulin modulators|mesh-ancestor
6364943|NCT00107510|Antimitotic Agents|antimitotic agents|mesh-ancestor
6364944|NCT00107510|Mitosis Modulators|mitosis modulators|mesh-ancestor
6364945|NCT00107510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364946|NCT00107523|Cytarabine|cytarabine|mesh-list
6364947|NCT00107523|Idarubicin|idarubicin|mesh-list
6364948|NCT00107523|Pravastatin|pravastatin|mesh-list
6364949|NCT00107523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6364950|NCT00107523|Antimetabolites|antimetabolites|mesh-ancestor
6364951|NCT00107523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364952|NCT00107523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6364953|NCT00107523|Antiviral Agents|antiviral agents|mesh-ancestor
6364954|NCT00107523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6364955|NCT00107523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6364956|NCT00107523|Immunologic Factors|immunologic factors|mesh-ancestor
6364957|NCT00107523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364958|NCT00107523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6364959|NCT00107523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6364960|NCT00107523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6364961|NCT00107523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6364962|NCT00107523|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6364963|NCT00107523|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6364964|NCT00107523|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6364965|NCT00107523|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6364966|NCT00107601|Insulin|insulin|mesh-list
6364967|NCT00107601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6364968|NCT00107601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364969|NCT00107731|Valproic Acid|valproic acid|mesh-list
6364970|NCT00107731|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6364971|NCT00107731|Antidepressive Agents|antidepressive agents|mesh-ancestor
6364972|NCT00107731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6364973|NCT00107731|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6364974|NCT00107731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6364975|NCT00107731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6364976|NCT00107731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364977|NCT00107731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6364978|NCT00107731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364979|NCT00107731|Antimanic Agents|antimanic agents|mesh-ancestor
6364980|NCT00107731|Anticonvulsants|anticonvulsants|mesh-ancestor
6364981|NCT00107731|GABA Agents|gaba agents|mesh-ancestor
6364982|NCT00107731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6364983|NCT00107770|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
6364984|NCT00107770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6364985|NCT00107796|Modafinil|modafinil|mesh-list
6364986|NCT00107796|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6364987|NCT00107796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364988|NCT00107796|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6364989|NCT00107796|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6364990|NCT00107796|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6364991|NCT00107796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364992|NCT00107809|Modafinil|modafinil|mesh-list
6364993|NCT00107809|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6364994|NCT00107809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6364995|NCT00107809|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6364996|NCT00107809|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6364997|NCT00107809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6364998|NCT00107809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6364999|NCT00107822|Lidocaine|lidocaine|mesh-list
6365000|NCT00107822|Tetracaine|tetracaine|mesh-list
6365001|NCT00107822|Anesthetics, Local|anesthetics, local|mesh-ancestor
6365002|NCT00107822|Anesthetics|anesthetics|mesh-ancestor
6365003|NCT00107822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6365004|NCT00107822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365005|NCT00107822|Sensory System Agents|sensory system agents|mesh-ancestor
6365006|NCT00107822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6365007|NCT00107822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6365008|NCT00107822|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6365009|NCT00107822|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6365010|NCT00107822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6365011|NCT00107822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365012|NCT00107835|Lidocaine|lidocaine|mesh-list
6365013|NCT00107835|Tetracaine|tetracaine|mesh-list
6365014|NCT00107835|Anesthetics, Local|anesthetics, local|mesh-ancestor
6365015|NCT00107835|Anesthetics|anesthetics|mesh-ancestor
6365016|NCT00107835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6365017|NCT00107835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365018|NCT00107835|Sensory System Agents|sensory system agents|mesh-ancestor
6365019|NCT00107835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6365020|NCT00107835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6365021|NCT00107835|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6365022|NCT00107835|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6365023|NCT00107835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6365024|NCT00107835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365025|NCT00107848|Modafinil|modafinil|mesh-list
6365026|NCT00107848|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6365027|NCT00107848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365028|NCT00107848|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6365029|NCT00107848|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6365030|NCT00107848|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6365031|NCT00107848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365032|NCT00107874|Misoprostol|misoprostol|mesh-list
6365033|NCT00107874|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6365034|NCT00107874|Abortifacient Agents|abortifacient agents|mesh-ancestor
6365035|NCT00107874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6365036|NCT00107874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365037|NCT00107874|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6365038|NCT00107874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6365039|NCT00107874|Oxytocics|oxytocics|mesh-ancestor
6365040|NCT00108004|Pramlintide|pramlintide|mesh-list
6365041|NCT00108004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6365042|NCT00108004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365043|NCT00108017|Timolol|timolol|mesh-list
6365044|NCT00108017|Dorzolamide|dorzolamide|mesh-list
6365045|NCT00108017|Maleic acid|maleic acid|mesh-list
6365046|NCT00108017|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6365047|NCT00108017|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6365048|NCT00108017|Adrenergic Agents|adrenergic agents|mesh-ancestor
6365049|NCT00108017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6365050|NCT00108017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365051|NCT00108017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017269|NCT00371254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6365052|NCT00108017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6365053|NCT00108017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6365054|NCT00108017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6365055|NCT00108017|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6365056|NCT00108095|Ondansetron|ondansetron|mesh-list
6365057|NCT00108095|Antiemetics|antiemetics|mesh-ancestor
6365058|NCT00108095|Autonomic Agents|autonomic agents|mesh-ancestor
6365059|NCT00108095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6365060|NCT00108095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365061|NCT00108095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6365062|NCT00108095|Antipruritics|antipruritics|mesh-ancestor
6365063|NCT00108095|Dermatologic Agents|dermatologic agents|mesh-ancestor
6365064|NCT00108095|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6365065|NCT00108095|Serotonin Agents|serotonin agents|mesh-ancestor
6365066|NCT00108095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6365067|NCT00108095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365068|NCT00108095|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6365069|NCT00108095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6365070|NCT00108095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6365071|NCT00108095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6365072|NCT00108095|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6395079|NCT00204061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6395080|NCT00204061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395081|NCT00204061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6395082|NCT00204061|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6395083|NCT00204061|Dopamine Agents|dopamine agents|mesh-ancestor
6395084|NCT00204061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6395085|NCT00204061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395086|NCT00204061|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6395087|NCT00204061|Antidepressive Agents|antidepressive agents|mesh-ancestor
6395088|NCT00204074|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6395089|NCT00204074|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6395090|NCT00204074|Estradiol|estradiol|mesh-list
6395091|NCT00204074|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6395092|NCT00204074|Estrogens|estrogens|mesh-ancestor
6395093|NCT00204074|Hormones|hormones|mesh-ancestor
6395094|NCT00204074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6395095|NCT00204074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395096|NCT00204074|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6395097|NCT00204074|Contraceptive Agents|contraceptive agents|mesh-ancestor
6395098|NCT00204074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6395099|NCT00204074|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6395100|NCT00204152|Vaccines|vaccines|mesh-list
6395101|NCT00204152|Immunologic Factors|immunologic factors|mesh-ancestor
6395102|NCT00204152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395103|NCT00204191|Tacrolimus|tacrolimus|mesh-list
6395104|NCT00204191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6395105|NCT00204191|Immunologic Factors|immunologic factors|mesh-ancestor
6395106|NCT00204191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395107|NCT00204191|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6395108|NCT00204191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6395109|NCT00204191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395110|NCT00204230|Mycophenolic Acid|mycophenolic acid|mesh-list
6395111|NCT00204230|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6395112|NCT00204230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6395113|NCT00204230|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6395114|NCT00204230|Antitubercular Agents|antitubercular agents|mesh-ancestor
6395115|NCT00204230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6395116|NCT00204230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6395117|NCT00204230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6395118|NCT00204230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395119|NCT00204243|Naltrexone|naltrexone|mesh-list
6395120|NCT00204243|Methadone|methadone|mesh-list
6395121|NCT00204243|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6395122|NCT00204243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6395123|NCT00204243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395124|NCT00204243|Sensory System Agents|sensory system agents|mesh-ancestor
6395125|NCT00204243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6395126|NCT00204243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6365073|NCT00108186|Celecoxib|celecoxib|mesh-list
6365074|NCT00108186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6365075|NCT00108186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6365076|NCT00108186|Analgesics|analgesics|mesh-ancestor
6365077|NCT00108186|Sensory System Agents|sensory system agents|mesh-ancestor
6365078|NCT00108186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6365079|NCT00108186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365080|NCT00108186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6365081|NCT00108186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6365082|NCT00108186|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6365083|NCT00108186|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6365084|NCT00108186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6365085|NCT00108186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365086|NCT00108238|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
6365087|NCT00108238|Estradiol|estradiol|mesh-list
6365088|NCT00108238|Progesterone|progesterone|mesh-list
6365089|NCT00108238|Estrogens|estrogens|mesh-ancestor
6365090|NCT00108238|Hormones|hormones|mesh-ancestor
6365091|NCT00108238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6365092|NCT00108238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365093|NCT00108238|Progestins|progestins|mesh-ancestor
6365094|NCT00108238|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6365095|NCT00108238|Hormone Antagonists|hormone antagonists|mesh-ancestor
6365096|NCT00108238|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6365097|NCT00108238|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6365098|NCT00108238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6365099|NCT00108251|Eplerenone|eplerenone|mesh-list
6365100|NCT00108251|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6365101|NCT00108251|Hormone Antagonists|hormone antagonists|mesh-ancestor
6365102|NCT00108251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6365103|NCT00108251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365104|NCT00108251|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6365105|NCT00108251|Diuretics|diuretics|mesh-ancestor
6365106|NCT00108251|Natriuretic Agents|natriuretic agents|mesh-ancestor
6365107|NCT00108251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6365108|NCT00108316|Fluoxetine|fluoxetine|mesh-list
6365109|NCT00108316|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6365110|NCT00108316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6365111|NCT00108316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6365112|NCT00108316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365113|NCT00108316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6365114|NCT00108316|Serotonin Agents|serotonin agents|mesh-ancestor
6365115|NCT00108316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365116|NCT00108316|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6365117|NCT00108316|Antidepressive Agents|antidepressive agents|mesh-ancestor
6365118|NCT00108316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6365119|NCT00108316|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6365120|NCT00108316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6365121|NCT00108316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6365122|NCT00108368|Olanzapine|olanzapine|mesh-list
6365123|NCT00108368|Risperidone|risperidone|mesh-list
6365124|NCT00108368|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6365125|NCT00108368|Serotonin Agents|serotonin agents|mesh-ancestor
6365126|NCT00108368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6365127|NCT00108368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365128|NCT00108368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365129|NCT00108368|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6365130|NCT00108368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6365131|NCT00108368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6365132|NCT00108368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6365133|NCT00108368|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6365134|NCT00108368|Dopamine Agents|dopamine agents|mesh-ancestor
6365135|NCT00108368|Antiemetics|antiemetics|mesh-ancestor
6365136|NCT00108368|Autonomic Agents|autonomic agents|mesh-ancestor
6365137|NCT00108368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6365138|NCT00108368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6365139|NCT00108368|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6365140|NCT00108368|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6365141|NCT00108368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6365142|NCT00108394|Pamidronate|pamidronate|mesh-list
6365143|NCT00108394|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6365144|NCT00108394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365145|NCT00108420|Prazosin|prazosin|mesh-list
6365146|NCT00108420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6365147|NCT00108420|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6365148|NCT00108420|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6365149|NCT00108420|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6365150|NCT00108420|Adrenergic Agents|adrenergic agents|mesh-ancestor
6365151|NCT00108420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6365152|NCT00108420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365153|NCT00108420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365154|NCT00108446|Lidocaine|lidocaine|mesh-list
6365155|NCT00108446|Fentanyl|fentanyl|mesh-list
6365156|NCT00108446|Dextromethorphan|dextromethorphan|mesh-list
6365157|NCT00108446|Naloxone|naloxone|mesh-list
6365158|NCT00108446|Anesthetics, Local|anesthetics, local|mesh-ancestor
6365159|NCT00108446|Anesthetics|anesthetics|mesh-ancestor
6365160|NCT00108446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6365161|NCT00108446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365162|NCT00108446|Sensory System Agents|sensory system agents|mesh-ancestor
6365163|NCT00108446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6365164|NCT00108446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6365165|NCT00108446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6365166|NCT00108446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6365167|NCT00108446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6365168|NCT00108446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365169|NCT00108446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6365170|NCT00108446|Narcotics|narcotics|mesh-ancestor
6365171|NCT00108446|Analgesics|analgesics|mesh-ancestor
6365172|NCT00108446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6365173|NCT00108446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6365174|NCT00108446|Anesthetics, General|anesthetics, general|mesh-ancestor
6365175|NCT00108446|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6365176|NCT00108446|Antitussive Agents|antitussive agents|mesh-ancestor
6365177|NCT00108446|Respiratory System Agents|respiratory system agents|mesh-ancestor
6365178|NCT00108446|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6365179|NCT00108446|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6365180|NCT00108446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6365181|NCT00108498|Mirtazapine|mirtazapine|mesh-list
6365182|NCT00108498|Antidepressive Agents|antidepressive agents|mesh-ancestor
6365183|NCT00108498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6365184|NCT00108498|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6365185|NCT00108498|Histamine Antagonists|histamine antagonists|mesh-ancestor
6365186|NCT00108498|Histamine Agents|histamine agents|mesh-ancestor
6365187|NCT00108498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6365188|NCT00108498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365189|NCT00108498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365190|NCT00108498|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6365191|NCT00108498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6365192|NCT00108498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6365193|NCT00108498|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6365194|NCT00108498|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6365195|NCT00108498|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6365196|NCT00108498|Adrenergic Agents|adrenergic agents|mesh-ancestor
6365197|NCT00108498|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6365198|NCT00108498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6365199|NCT00108498|Serotonin Agents|serotonin agents|mesh-ancestor
6365200|NCT00108498|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6365201|NCT00108511|Gemfibrozil|gemfibrozil|mesh-list
6365202|NCT00108511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6365203|NCT00108511|Antimetabolites|antimetabolites|mesh-ancestor
6365204|NCT00108511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365205|NCT00108511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6365206|NCT00108511|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6365207|NCT00108511|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6365208|NCT00108511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6365209|NCT00108537|Bupropion|bupropion|mesh-list
6365210|NCT00108537|Nicotine|nicotine|mesh-list
6365211|NCT00108537|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6365212|NCT00108537|Autonomic Agents|autonomic agents|mesh-ancestor
6365213|NCT00108537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6365214|NCT00108537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365215|NCT00108537|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6365216|NCT00108537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6365217|NCT00108537|Cholinergic Agents|cholinergic agents|mesh-ancestor
6365218|NCT00108537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6365219|NCT00108537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365220|NCT00108537|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6365221|NCT00108537|Antidepressive Agents|antidepressive agents|mesh-ancestor
6365222|NCT00108537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6365223|NCT00108537|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6365224|NCT00108537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6365225|NCT00108537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6365226|NCT00108537|Dopamine Agents|dopamine agents|mesh-ancestor
6365227|NCT00108537|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6365228|NCT00108537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6365229|NCT00108537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6365230|NCT00108563|Citalopram|citalopram|mesh-list
6365231|NCT00108563|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6365232|NCT00108563|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6365233|NCT00108563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6365234|NCT00108563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365235|NCT00108563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6365236|NCT00108563|Serotonin Agents|serotonin agents|mesh-ancestor
6365237|NCT00108563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365238|NCT00108563|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6365239|NCT00108563|Antidepressive Agents|antidepressive agents|mesh-ancestor
6365240|NCT00108563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6365241|NCT00108576|Valproic Acid|valproic acid|mesh-list
6365242|NCT00108576|Anticonvulsants|anticonvulsants|mesh-ancestor
6365243|NCT00108576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6365244|NCT00108576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365245|NCT00108576|GABA Agents|gaba agents|mesh-ancestor
6365246|NCT00108576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6365247|NCT00108576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365248|NCT00108576|Antimanic Agents|antimanic agents|mesh-ancestor
6365249|NCT00108576|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6365250|NCT00108576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6365251|NCT00108576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6365252|NCT00108602|Acetazolamide|acetazolamide|mesh-list
6365253|NCT00108602|Anticonvulsants|anticonvulsants|mesh-ancestor
6365254|NCT00108602|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6365255|NCT00108602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6365256|NCT00108602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365257|NCT00108602|Diuretics|diuretics|mesh-ancestor
6365258|NCT00108602|Natriuretic Agents|natriuretic agents|mesh-ancestor
6365259|NCT00108602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365260|NCT00108615|Metformin|metformin|mesh-list
6365261|NCT00108615|Pioglitazone|pioglitazone|mesh-list
6365262|NCT00108615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6365263|NCT00108615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365264|NCT00108667|Levodopa|levodopa|mesh-list
6365265|NCT00108667|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6365266|NCT00108667|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6365267|NCT00108667|Dopamine Agents|dopamine agents|mesh-ancestor
6365268|NCT00108667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6365269|NCT00108667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365270|NCT00108667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365271|NCT00108706|Candesartan|candesartan|mesh-list
6365272|NCT00108706|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6365273|NCT00108706|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6365274|NCT00108706|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6395127|NCT00204243|Narcotics|narcotics|mesh-ancestor
6365275|NCT00108706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365276|NCT00108771|Fentanyl|fentanyl|mesh-list
6365277|NCT00108771|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6365278|NCT00108771|Narcotics|narcotics|mesh-ancestor
6365279|NCT00108771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6365280|NCT00108771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365281|NCT00108771|Analgesics|analgesics|mesh-ancestor
6365282|NCT00108771|Sensory System Agents|sensory system agents|mesh-ancestor
6365283|NCT00108771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6365284|NCT00108771|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6365285|NCT00108771|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6365286|NCT00108771|Anesthetics, General|anesthetics, general|mesh-ancestor
6365287|NCT00108771|Anesthetics|anesthetics|mesh-ancestor
6365288|NCT00108797|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
6365289|NCT00108797|Coagulants|coagulants|mesh-ancestor
6365290|NCT00108849|Estradiol|estradiol|mesh-list
6365291|NCT00108849|Estrogens|estrogens|mesh-ancestor
6365292|NCT00108849|Hormones|hormones|mesh-ancestor
6365293|NCT00108849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6365294|NCT00108849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365295|NCT00108875|BIRC5 protein, human|birc5 protein, human|mesh-list
6365296|NCT00108875|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
6365297|NCT00108875|Protease Inhibitors|protease inhibitors|mesh-ancestor
6365298|NCT00108875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6365299|NCT00108875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365300|NCT00108979|Citalopram|citalopram|mesh-list
6365301|NCT00108979|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6365302|NCT00108979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6365303|NCT00108979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6365304|NCT00108979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365305|NCT00108979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6365306|NCT00108979|Serotonin Agents|serotonin agents|mesh-ancestor
6365307|NCT00108979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365308|NCT00108979|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6365309|NCT00108979|Antidepressive Agents|antidepressive agents|mesh-ancestor
6365310|NCT00108979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6365311|NCT00108992|Diclofenac|diclofenac|mesh-list
6365312|NCT00108992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6365313|NCT00108992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6365314|NCT00108992|Analgesics|analgesics|mesh-ancestor
6365315|NCT00108992|Sensory System Agents|sensory system agents|mesh-ancestor
6365316|NCT00108992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6365317|NCT00108992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365318|NCT00108992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6365319|NCT00108992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6365320|NCT00108992|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6365321|NCT00108992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6365322|NCT00108992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365323|NCT00109044|Citalopram|citalopram|mesh-list
6365324|NCT00109044|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6365325|NCT00109044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6365326|NCT00109044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6365327|NCT00109044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365328|NCT00109044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6365329|NCT00109044|Serotonin Agents|serotonin agents|mesh-ancestor
6365330|NCT00109044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365331|NCT00109044|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6365332|NCT00109044|Antidepressive Agents|antidepressive agents|mesh-ancestor
6365333|NCT00109044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6365334|NCT00109057|Bevacizumab|bevacizumab|mesh-list
6365335|NCT00109057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6365336|NCT00109057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6365337|NCT00109057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6365338|NCT00109057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6365339|NCT00109057|Growth Substances|growth substances|mesh-ancestor
6365340|NCT00109057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365341|NCT00109057|Growth Inhibitors|growth inhibitors|mesh-ancestor
6365342|NCT00109070|Bevacizumab|bevacizumab|mesh-list
6365343|NCT00109070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6365344|NCT00109070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6365345|NCT00109070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6365346|NCT00109070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6365347|NCT00109070|Growth Substances|growth substances|mesh-ancestor
6365348|NCT00109070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365349|NCT00109070|Growth Inhibitors|growth inhibitors|mesh-ancestor
6365350|NCT00109096|Pemetrexed|pemetrexed|mesh-list
6365351|NCT00109096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6365352|NCT00109096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6365353|NCT00109096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365354|NCT00109096|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6365355|NCT00109096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6365356|NCT00109109|Vorinostat|vorinostat|mesh-list
6365357|NCT00109109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6365358|NCT00109109|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6365359|NCT00109109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6365360|NCT00109109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365361|NCT00109135|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
6365362|NCT00109135|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6365363|NCT00109135|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6365364|NCT00109135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6365365|NCT00109135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365366|NCT00109135|Hormones|hormones|mesh-ancestor
6365367|NCT00109135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6365368|NCT00109135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365369|NCT00109148|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
6365370|NCT00109148|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6365371|NCT00109148|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6365372|NCT00109148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6365373|NCT00109148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365374|NCT00109148|Hormones|hormones|mesh-ancestor
6365375|NCT00109148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6365376|NCT00109148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365377|NCT00109161|Antibodies|antibodies|mesh-list
6365378|NCT00109161|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6365379|NCT00109161|Daclizumab|daclizumab|mesh-list
6365380|NCT00109161|Immunologic Factors|immunologic factors|mesh-ancestor
6365381|NCT00109161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365382|NCT00109161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6365383|NCT00109187|Omalizumab|omalizumab|mesh-list
6365384|NCT00109187|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6365385|NCT00109187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6365386|NCT00109187|Respiratory System Agents|respiratory system agents|mesh-ancestor
6365387|NCT00109200|Omalizumab|omalizumab|mesh-list
6365388|NCT00109200|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6365389|NCT00109200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6365390|NCT00109200|Respiratory System Agents|respiratory system agents|mesh-ancestor
6365391|NCT00109226|Bevacizumab|bevacizumab|mesh-list
6365392|NCT00109226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6365393|NCT00109226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6365394|NCT00109226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6365395|NCT00109226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6365396|NCT00109226|Growth Substances|growth substances|mesh-ancestor
6365397|NCT00109226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365398|NCT00109226|Growth Inhibitors|growth inhibitors|mesh-ancestor
6365399|NCT00109239|Bevacizumab|bevacizumab|mesh-list
6365400|NCT00109239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6365401|NCT00109239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6365402|NCT00109239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6365403|NCT00109239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6365404|NCT00109239|Growth Substances|growth substances|mesh-ancestor
6365405|NCT00109239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365406|NCT00109239|Growth Inhibitors|growth inhibitors|mesh-ancestor
6365407|NCT00109265|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6365408|NCT00109265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6365409|NCT00109265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6365410|NCT00109265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6365411|NCT00109265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365412|NCT00109278|Vaccines|vaccines|mesh-list
6365413|NCT00109278|Immunoglobulins|immunoglobulins|mesh-list
6365414|NCT00109278|Immunologic Factors|immunologic factors|mesh-ancestor
6365415|NCT00109278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365416|NCT00109356|AQ4N|aq4n|mesh-list
6365417|NCT00109356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6365418|NCT00109382|Aspirin|aspirin|mesh-list
6365419|NCT00109382|Clopidogrel|clopidogrel|mesh-list
6365420|NCT00109382|Simvastatin|simvastatin|mesh-list
6365421|NCT00109382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6365422|NCT00109382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6365423|NCT00109382|Analgesics|analgesics|mesh-ancestor
6365424|NCT00109382|Sensory System Agents|sensory system agents|mesh-ancestor
6365425|NCT00109382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6365426|NCT00109382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365427|NCT00109382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6365428|NCT00109382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6365429|NCT00109382|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6365430|NCT00109382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6365431|NCT00109382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365432|NCT00109382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6365433|NCT00109382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6365434|NCT00109382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6365435|NCT00109382|Antipyretics|antipyretics|mesh-ancestor
6365436|NCT00109382|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6365437|NCT00109382|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6365438|NCT00109382|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6365439|NCT00109382|Purinergic Agents|purinergic agents|mesh-ancestor
6365440|NCT00109382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6365441|NCT00109382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6365442|NCT00109382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6365443|NCT00109382|Antimetabolites|antimetabolites|mesh-ancestor
6365444|NCT00109382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6365445|NCT00109382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6365446|NCT00109395|Midazolam|midazolam|mesh-list
6365447|NCT00109395|Lorazepam|lorazepam|mesh-list
6365448|NCT00109395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6365449|NCT00109395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6365450|NCT00109395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6365451|NCT00109395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365452|NCT00109395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6365453|NCT00109395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6365454|NCT00109395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6365455|NCT00109395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6365456|NCT00109395|Anesthetics, General|anesthetics, general|mesh-ancestor
6365457|NCT00109395|Anesthetics|anesthetics|mesh-ancestor
6365458|NCT00109395|GABA Modulators|gaba modulators|mesh-ancestor
6365459|NCT00109395|GABA Agents|gaba agents|mesh-ancestor
6365460|NCT00109395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6365461|NCT00109395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365462|NCT00109395|Anticonvulsants|anticonvulsants|mesh-ancestor
6365463|NCT00109395|Antiemetics|antiemetics|mesh-ancestor
6365464|NCT00109395|Autonomic Agents|autonomic agents|mesh-ancestor
6365465|NCT00109395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6365466|NCT00109395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6365467|NCT00109408|Methotrexate|methotrexate|mesh-list
6365468|NCT00109408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6365469|NCT00109408|Abortifacient Agents|abortifacient agents|mesh-ancestor
6365470|NCT00109408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6365471|NCT00109408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365472|NCT00109408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6365473|NCT00109408|Antimetabolites|antimetabolites|mesh-ancestor
6365474|NCT00109408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365475|NCT00109408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6365476|NCT00109408|Dermatologic Agents|dermatologic agents|mesh-ancestor
6365477|NCT00109408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6365478|NCT00109408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6365479|NCT00109408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6365480|NCT00109408|Immunologic Factors|immunologic factors|mesh-ancestor
6365481|NCT00109408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6365482|NCT00109408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6365483|NCT00109551|Folic Acid|folic acid|mesh-list
6365484|NCT00109551|Zinc Sulfate|zinc sulfate|mesh-list
6365485|NCT00109551|Hematinics|hematinics|mesh-ancestor
6365486|NCT00109551|Vitamin B Complex|vitamin b complex|mesh-ancestor
6365487|NCT00109551|Vitamins|vitamins|mesh-ancestor
6365488|NCT00109551|Micronutrients|micronutrients|mesh-ancestor
6365489|NCT00109551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365490|NCT00109551|Astringents|astringents|mesh-ancestor
6365491|NCT00109551|Dermatologic Agents|dermatologic agents|mesh-ancestor
6365492|NCT00109564|Acetylcholine|acetylcholine|mesh-list
6365493|NCT00109564|Nicotinic Agonists|nicotinic agonists|mesh-list
6365494|NCT00109564|Vasodilator Agents|vasodilator agents|mesh-ancestor
6365495|NCT00109564|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6365496|NCT00109564|Cholinergic Agents|cholinergic agents|mesh-ancestor
6017270|NCT00371254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6017271|NCT00371254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6017272|NCT00371254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017273|NCT00371345|Dasatinib|dasatinib|mesh-list
6017274|NCT00371345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6365497|NCT00109564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6365498|NCT00109564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365499|NCT00109564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365500|NCT00109603|Tenofovir|tenofovir|mesh-list
6365501|NCT00109603|Antiviral Agents|antiviral agents|mesh-ancestor
6365502|NCT00109603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6365503|NCT00109603|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6365504|NCT00109603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6365505|NCT00109603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6365506|NCT00109603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365507|NCT00109603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6365508|NCT00109603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6365509|NCT00109616|Chlorhexidine|chlorhexidine|mesh-list
6365510|NCT00109616|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6365511|NCT00109616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6365512|NCT00109616|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6365513|NCT00109616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6365514|NCT00109616|Disinfectants|disinfectants|mesh-ancestor
6365515|NCT00109616|Dermatologic Agents|dermatologic agents|mesh-ancestor
6365516|NCT00109746|Chromium|chromium|mesh-list
6365517|NCT00109746|Picolinic acid|picolinic acid|mesh-list
6365518|NCT00109746|Trace Elements|trace elements|mesh-ancestor
6365519|NCT00109746|Micronutrients|micronutrients|mesh-ancestor
6365520|NCT00109746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365521|NCT00109746|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6365522|NCT00109746|Chelating Agents|chelating agents|mesh-ancestor
6365523|NCT00109746|Sequestering Agents|sequestering agents|mesh-ancestor
6365524|NCT00109746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365525|NCT00109785|Idoxuridine|idoxuridine|mesh-list
6365526|NCT00109785|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6365527|NCT00109785|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6365528|NCT00109785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365529|NCT00109785|Antiviral Agents|antiviral agents|mesh-ancestor
6365530|NCT00109785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6365531|NCT00109785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6365532|NCT00109785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6365533|NCT00109798|Temozolomide|temozolomide|mesh-list
6365534|NCT00109798|Topotecan|topotecan|mesh-list
6365535|NCT00109798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6365536|NCT00109798|Alkylating Agents|alkylating agents|mesh-ancestor
6365537|NCT00109798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365538|NCT00109798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6365539|NCT00109798|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6365540|NCT00109798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6365541|NCT00109798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6365542|NCT00109811|Freund's Adjuvant|freund's adjuvant|mesh-list
6365543|NCT00109811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6365544|NCT00109811|Immunologic Factors|immunologic factors|mesh-ancestor
6365545|NCT00109811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365546|NCT00109824|Decitabine|decitabine|mesh-list
6365547|NCT00109824|Azacitidine|azacitidine|mesh-list
6365548|NCT00109824|Valproic Acid|valproic acid|mesh-list
6365549|NCT00109824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6365550|NCT00109824|Antimetabolites|antimetabolites|mesh-ancestor
6365551|NCT00109824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365552|NCT00109824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6365553|NCT00109824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6365554|NCT00109824|Anticonvulsants|anticonvulsants|mesh-ancestor
6365555|NCT00109824|GABA Agents|gaba agents|mesh-ancestor
6365556|NCT00109824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6365557|NCT00109824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365558|NCT00109824|Antimanic Agents|antimanic agents|mesh-ancestor
6365559|NCT00109824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6365560|NCT00109824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6365561|NCT00109824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6365562|NCT00109941|Analgesics, Opioid|analgesics, opioid|mesh-list
6365563|NCT00109941|Mitogens|mitogens|mesh-list
6365564|NCT00109941|Enkephalin, Methionine|enkephalin, methionine|mesh-list
6365565|NCT00109941|Narcotics|narcotics|mesh-ancestor
6365566|NCT00109941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6365567|NCT00109941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365568|NCT00109941|Analgesics|analgesics|mesh-ancestor
6365569|NCT00109941|Sensory System Agents|sensory system agents|mesh-ancestor
6365570|NCT00109941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6365571|NCT00109941|Mitosis Modulators|mitosis modulators|mesh-ancestor
6365572|NCT00109941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365573|NCT00109941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6395128|NCT00204243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6395129|NCT00204243|Analgesics|analgesics|mesh-ancestor
6395130|NCT00204243|Antitussive Agents|antitussive agents|mesh-ancestor
6395131|NCT00204243|Respiratory System Agents|respiratory system agents|mesh-ancestor
6395132|NCT00204256|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6395133|NCT00204256|Hematinics|hematinics|mesh-ancestor
6395134|NCT00204269|Testosterone|testosterone|mesh-list
6395135|NCT00204269|Androgens|androgens|mesh-ancestor
6395136|NCT00204269|Hormones|hormones|mesh-ancestor
6395137|NCT00204269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6395138|NCT00204269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395139|NCT00204308|Tenofovir|tenofovir|mesh-list
6395140|NCT00204308|Emtricitabine|emtricitabine|mesh-list
6395141|NCT00204308|Antiviral Agents|antiviral agents|mesh-ancestor
6395142|NCT00204308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6395143|NCT00204308|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6395144|NCT00204308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6395145|NCT00204308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6395146|NCT00204308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395147|NCT00204308|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6395148|NCT00204308|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6395149|NCT00204321|Sirolimus|sirolimus|mesh-list
6395150|NCT00204321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6395151|NCT00204321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6395152|NCT00204321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6395153|NCT00204321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6395154|NCT00204321|Antifungal Agents|antifungal agents|mesh-ancestor
6395155|NCT00204321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6395156|NCT00204321|Immunologic Factors|immunologic factors|mesh-ancestor
6395157|NCT00204321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365574|NCT00109954|Cisplatin|cisplatin|mesh-list
6365575|NCT00109954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6365576|NCT00109993|Methylprednisolone|methylprednisolone|mesh-list
6365577|NCT00109993|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6365578|NCT00109993|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6365579|NCT00109993|Prednisolone|prednisolone|mesh-list
6365580|NCT00109993|Prednisolone acetate|prednisolone acetate|mesh-list
6365581|NCT00109993|Alemtuzumab|alemtuzumab|mesh-list
6365582|NCT00109993|Tacrolimus|tacrolimus|mesh-list
6365583|NCT00109993|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6365584|NCT00109993|Prednisolone phosphate|prednisolone phosphate|mesh-list
6365585|NCT00109993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6365586|NCT00109993|Immunologic Factors|immunologic factors|mesh-ancestor
6365587|NCT00109993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365588|NCT00109993|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6365589|NCT00109993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6365590|NCT00109993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365591|NCT00109993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6365592|NCT00109993|Antiemetics|antiemetics|mesh-ancestor
6365593|NCT00109993|Autonomic Agents|autonomic agents|mesh-ancestor
6365594|NCT00109993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6365595|NCT00109993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6365596|NCT00109993|Glucocorticoids|glucocorticoids|mesh-ancestor
6365597|NCT00109993|Hormones|hormones|mesh-ancestor
6365598|NCT00109993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6365599|NCT00109993|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6365600|NCT00109993|Protective Agents|protective agents|mesh-ancestor
6365601|NCT00109993|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6365602|NCT00109993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6365603|NCT00109993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6365604|NCT00110006|Prednisone|prednisone|mesh-list
6365605|NCT00110006|Cyclophosphamide|cyclophosphamide|mesh-list
6365606|NCT00110006|Rituximab|rituximab|mesh-list
6365607|NCT00110006|Doxorubicin|doxorubicin|mesh-list
6365608|NCT00110006|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6365609|NCT00110006|Vincristine|vincristine|mesh-list
6365610|NCT00110006|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6365611|NCT00110006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6365612|NCT00110006|Immunologic Factors|immunologic factors|mesh-ancestor
6365613|NCT00110006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365614|NCT00110006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6365615|NCT00110006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6365616|NCT00110006|Alkylating Agents|alkylating agents|mesh-ancestor
6365617|NCT00110006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365618|NCT00110006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6365619|NCT00110006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6365620|NCT00110006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6365621|NCT00110006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6365622|NCT00110006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6365623|NCT00110006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6017275|NCT00371345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6017276|NCT00371345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6017277|NCT00371345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017278|NCT00371566|Lapatinib|lapatinib|mesh-list
6017279|NCT00371566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6017280|NCT00371566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6017281|NCT00371566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6017282|NCT00371566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017283|NCT00371683|Enoxaparin|enoxaparin|mesh-list
6017284|NCT00371683|Apixaban|apixaban|mesh-list
6017285|NCT00371683|Anticoagulants|anticoagulants|mesh-ancestor
6365624|NCT00110006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6365625|NCT00110006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6365626|NCT00110006|Glucocorticoids|glucocorticoids|mesh-ancestor
6365627|NCT00110006|Hormones|hormones|mesh-ancestor
6365628|NCT00110006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6365629|NCT00110006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6365630|NCT00110006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6365631|NCT00110006|Tubulin Modulators|tubulin modulators|mesh-ancestor
6365632|NCT00110006|Antimitotic Agents|antimitotic agents|mesh-ancestor
6365633|NCT00110006|Mitosis Modulators|mitosis modulators|mesh-ancestor
6365634|NCT00110006|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6365635|NCT00110032|Etanidazole|etanidazole|mesh-list
6365636|NCT00110032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6365637|NCT00110045|Caspofungin|caspofungin|mesh-list
6365638|NCT00110045|Antifungal Agents|antifungal agents|mesh-ancestor
6365639|NCT00110045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6365640|NCT00110045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6365641|NCT00110045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365642|NCT00110058|Interferons|interferons|mesh-list
6365643|NCT00110058|Interferon-alpha|interferon-alpha|mesh-list
6365644|NCT00110058|Cyclosporine|cyclosporine|mesh-list
6365645|NCT00110058|Mycophenolic Acid|mycophenolic acid|mesh-list
6365646|NCT00110058|Fludarabine|fludarabine|mesh-list
6365647|NCT00110058|Fludarabine phosphate|fludarabine phosphate|mesh-list
6365648|NCT00110058|Imatinib Mesylate|imatinib mesylate|mesh-list
6365649|NCT00110058|Cyclosporins|cyclosporins|mesh-list
6365650|NCT00110058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6365651|NCT00110058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6365652|NCT00110058|Antimetabolites|antimetabolites|mesh-ancestor
6365653|NCT00110058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365654|NCT00110058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6365655|NCT00110058|Immunologic Factors|immunologic factors|mesh-ancestor
6365656|NCT00110058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365657|NCT00110058|Antiviral Agents|antiviral agents|mesh-ancestor
6365658|NCT00110058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6365659|NCT00110058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6365660|NCT00110058|Antifungal Agents|antifungal agents|mesh-ancestor
6365661|NCT00110058|Dermatologic Agents|dermatologic agents|mesh-ancestor
6365662|NCT00110058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6365663|NCT00110058|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6365664|NCT00110058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6365665|NCT00110058|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6365666|NCT00110058|Antitubercular Agents|antitubercular agents|mesh-ancestor
6365667|NCT00110058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6365668|NCT00110058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6365669|NCT00110071|Iodine|iodine|mesh-list
6365670|NCT00110071|Cadexomer iodine|cadexomer iodine|mesh-list
6365671|NCT00110071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6365672|NCT00110071|Fludarabine|fludarabine|mesh-list
6365673|NCT00110071|Fludarabine phosphate|fludarabine phosphate|mesh-list
6365674|NCT00110071|Tositumomab I-131|tositumomab i-131|mesh-list
6365675|NCT00110071|Antibodies|antibodies|mesh-list
6365676|NCT00110071|Immunoglobulins|immunoglobulins|mesh-list
6365677|NCT00110071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6365678|NCT00110071|Immunologic Factors|immunologic factors|mesh-ancestor
6365679|NCT00110071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365680|NCT00110071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6395158|NCT00204347|Risperidone|risperidone|mesh-list
6365681|NCT00110071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6365682|NCT00110071|Antimetabolites|antimetabolites|mesh-ancestor
6365683|NCT00110071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365684|NCT00110071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6365685|NCT00110071|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6365686|NCT00110071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6365687|NCT00110071|Trace Elements|trace elements|mesh-ancestor
6365688|NCT00110071|Micronutrients|micronutrients|mesh-ancestor
6365689|NCT00110110|Cyclosporine|cyclosporine|mesh-list
6365690|NCT00110110|Carboplatin|carboplatin|mesh-list
6365691|NCT00110110|Etoposide|etoposide|mesh-list
6365692|NCT00110110|Vincristine|vincristine|mesh-list
6365693|NCT00110110|Cyclosporins|cyclosporins|mesh-list
6365694|NCT00110110|Lenograstim|lenograstim|mesh-list
6365695|NCT00110110|Sargramostim|sargramostim|mesh-list
6365696|NCT00110110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6365697|NCT00110110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6365698|NCT00110110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6365699|NCT00110110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6365700|NCT00110110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6365701|NCT00110110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365702|NCT00110110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6365703|NCT00110110|Immunologic Factors|immunologic factors|mesh-ancestor
6365704|NCT00110110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365705|NCT00110110|Tubulin Modulators|tubulin modulators|mesh-ancestor
6365706|NCT00110110|Antimitotic Agents|antimitotic agents|mesh-ancestor
6365707|NCT00110110|Mitosis Modulators|mitosis modulators|mesh-ancestor
6365708|NCT00110110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6365709|NCT00110110|Antifungal Agents|antifungal agents|mesh-ancestor
6365710|NCT00110110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6365711|NCT00110110|Dermatologic Agents|dermatologic agents|mesh-ancestor
6365712|NCT00110110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6365713|NCT00110110|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6365714|NCT00110123|Fotemustine|fotemustine|mesh-list
6365715|NCT00110123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6365716|NCT00110162|Hormones|hormones|mesh-list
6365717|NCT00110162|Androgen Antagonists|androgen antagonists|mesh-list
6365718|NCT00110162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6365719|NCT00110162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365720|NCT00110162|Hormone Antagonists|hormone antagonists|mesh-ancestor
6365721|NCT00110188|Sirolimus|sirolimus|mesh-list
6365722|NCT00110188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6365723|NCT00110188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6365724|NCT00110188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6365725|NCT00110188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6365726|NCT00110188|Antifungal Agents|antifungal agents|mesh-ancestor
6365727|NCT00110188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6365728|NCT00110188|Immunologic Factors|immunologic factors|mesh-ancestor
6365729|NCT00110188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365730|NCT00110201|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6365731|NCT00110201|Natriuretic Agents|natriuretic agents|mesh-ancestor
6365732|NCT00110201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365733|NCT00110240|Vildagliptin|vildagliptin|mesh-list
6365734|NCT00110240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6365735|NCT00110240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365736|NCT00110240|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6365737|NCT00110240|Protease Inhibitors|protease inhibitors|mesh-ancestor
6365738|NCT00110240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6365739|NCT00110240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365740|NCT00110253|Lidocaine|lidocaine|mesh-list
6365741|NCT00110253|Tetracaine|tetracaine|mesh-list
6365742|NCT00110253|Anesthetics, Local|anesthetics, local|mesh-ancestor
6365743|NCT00110253|Anesthetics|anesthetics|mesh-ancestor
6365744|NCT00110253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6365745|NCT00110253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365746|NCT00110253|Sensory System Agents|sensory system agents|mesh-ancestor
6365747|NCT00110253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6365748|NCT00110253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6365749|NCT00110253|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6365750|NCT00110253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6365751|NCT00110253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6365752|NCT00110253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365753|NCT00110344|Sorafenib|sorafenib|mesh-list
6365754|NCT00110344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6365755|NCT00110344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6365756|NCT00110344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6365757|NCT00110344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365758|NCT00110370|Insulin Glargine|insulin glargine|mesh-list
6365759|NCT00110370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6365760|NCT00110370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365761|NCT00110448|Aspirin|aspirin|mesh-list
6365762|NCT00110448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6365763|NCT00110448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6365764|NCT00110448|Analgesics|analgesics|mesh-ancestor
6365765|NCT00110448|Sensory System Agents|sensory system agents|mesh-ancestor
6365766|NCT00110448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6365767|NCT00110448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365768|NCT00110448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6365769|NCT00110448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6365770|NCT00110448|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6365771|NCT00110448|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6365772|NCT00110448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365773|NCT00110448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6365774|NCT00110448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6365775|NCT00110448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6365776|NCT00110448|Antipyretics|antipyretics|mesh-ancestor
6365777|NCT00110474|Acetaminophen|acetaminophen|mesh-list
6365778|NCT00110474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6365779|NCT00110474|Analgesics|analgesics|mesh-ancestor
6365780|NCT00110474|Sensory System Agents|sensory system agents|mesh-ancestor
6365781|NCT00110474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6365782|NCT00110474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365783|NCT00110474|Antipyretics|antipyretics|mesh-ancestor
6365784|NCT00110578|Aldesleukin|aldesleukin|mesh-list
6365785|NCT00110578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6365786|NCT00110578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6365787|NCT00110578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6365788|NCT00110578|Antiviral Agents|antiviral agents|mesh-ancestor
6365789|NCT00110578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6365790|NCT00110591|Leronlimab|leronlimab|mesh-list
6365791|NCT00110591|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6365792|NCT00110591|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6365793|NCT00110591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365794|NCT00110591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6365795|NCT00110591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6365796|NCT00110591|Antiviral Agents|antiviral agents|mesh-ancestor
6365797|NCT00110591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6365798|NCT00110604|Folic Acid|folic acid|mesh-list
6365799|NCT00110604|Hematinics|hematinics|mesh-ancestor
6365800|NCT00110604|Vitamin B Complex|vitamin b complex|mesh-ancestor
6365801|NCT00110604|Vitamins|vitamins|mesh-ancestor
6365802|NCT00110604|Micronutrients|micronutrients|mesh-ancestor
6365803|NCT00110604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365804|NCT00110630|Nicotine|nicotine|mesh-list
6365805|NCT00110630|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6365806|NCT00110630|Autonomic Agents|autonomic agents|mesh-ancestor
6365807|NCT00110630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6365808|NCT00110630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365809|NCT00110630|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6365810|NCT00110630|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6365811|NCT00110630|Cholinergic Agents|cholinergic agents|mesh-ancestor
6365812|NCT00110630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6365813|NCT00110630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365814|NCT00110669|Prednisone|prednisone|mesh-list
6365815|NCT00110669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6365816|NCT00110669|Glucocorticoids|glucocorticoids|mesh-ancestor
6365817|NCT00110669|Hormones|hormones|mesh-ancestor
6365818|NCT00110669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6365819|NCT00110669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365820|NCT00110669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6365821|NCT00110669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6365822|NCT00110682|Imiquimod|imiquimod|mesh-list
6365823|NCT00110682|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6365824|NCT00110682|Immunologic Factors|immunologic factors|mesh-ancestor
6365825|NCT00110682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365826|NCT00110682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6365827|NCT00110682|Interferon Inducers|interferon inducers|mesh-ancestor
6365828|NCT00110695|Paclitaxel|paclitaxel|mesh-list
6365829|NCT00110695|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6365830|NCT00110695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6365831|NCT00110695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6365832|NCT00110695|Tubulin Modulators|tubulin modulators|mesh-ancestor
6365833|NCT00110695|Antimitotic Agents|antimitotic agents|mesh-ancestor
6365834|NCT00110695|Mitosis Modulators|mitosis modulators|mesh-ancestor
6365835|NCT00110695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365836|NCT00110708|Immunoglobulins|immunoglobulins|mesh-list
6365837|NCT00110708|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6365838|NCT00110708|Antibodies|antibodies|mesh-list
6365839|NCT00110708|Immunologic Factors|immunologic factors|mesh-ancestor
6365840|NCT00110708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365841|NCT00110721|Fluorouracil|fluorouracil|mesh-list
6365842|NCT00110721|Antimetabolites|antimetabolites|mesh-ancestor
6365843|NCT00110721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365844|NCT00110721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6365845|NCT00110721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6365846|NCT00110721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6365847|NCT00110721|Immunologic Factors|immunologic factors|mesh-ancestor
6365848|NCT00110721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365849|NCT00110734|Lidocaine|lidocaine|mesh-list
6365850|NCT00110734|Tetracaine|tetracaine|mesh-list
6365851|NCT00110734|Anesthetics, Local|anesthetics, local|mesh-ancestor
6365852|NCT00110734|Anesthetics|anesthetics|mesh-ancestor
6365853|NCT00110734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6365854|NCT00110734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365855|NCT00110734|Sensory System Agents|sensory system agents|mesh-ancestor
6365856|NCT00110734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6365857|NCT00110734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6365858|NCT00110734|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6365859|NCT00110734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6365860|NCT00110734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6365861|NCT00110734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365862|NCT00110747|Lidocaine|lidocaine|mesh-list
6365863|NCT00110747|Tetracaine|tetracaine|mesh-list
6365864|NCT00110747|Anesthetics, Local|anesthetics, local|mesh-ancestor
6365865|NCT00110747|Anesthetics|anesthetics|mesh-ancestor
6365866|NCT00110747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6365867|NCT00110747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365868|NCT00110747|Sensory System Agents|sensory system agents|mesh-ancestor
6365869|NCT00110747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6365870|NCT00110747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6365871|NCT00110747|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6365872|NCT00110747|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6365873|NCT00110747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6365874|NCT00110747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365875|NCT00110760|Lidocaine|lidocaine|mesh-list
6365876|NCT00110760|Tetracaine|tetracaine|mesh-list
6365877|NCT00110760|Anesthetics, Local|anesthetics, local|mesh-ancestor
6365878|NCT00110760|Anesthetics|anesthetics|mesh-ancestor
6365879|NCT00110760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6365880|NCT00110760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365881|NCT00110760|Sensory System Agents|sensory system agents|mesh-ancestor
6365882|NCT00110760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6365883|NCT00110760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6365884|NCT00110760|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6365885|NCT00110760|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6365886|NCT00110760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6365887|NCT00110760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365888|NCT00110773|Lidocaine|lidocaine|mesh-list
6365889|NCT00110773|Tetracaine|tetracaine|mesh-list
6365890|NCT00110773|Anesthetics, Local|anesthetics, local|mesh-ancestor
6365891|NCT00110773|Anesthetics|anesthetics|mesh-ancestor
6365892|NCT00110773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6365893|NCT00110773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365894|NCT00110773|Sensory System Agents|sensory system agents|mesh-ancestor
6365895|NCT00110773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6365896|NCT00110773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6365897|NCT00110773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6365898|NCT00110773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6365899|NCT00110773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6365900|NCT00110773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365901|NCT00110851|Metformin|metformin|mesh-list
6365902|NCT00110851|Rosiglitazone|rosiglitazone|mesh-list
6365903|NCT00110851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6365904|NCT00110851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365905|NCT00110864|Insulin|insulin|mesh-list
6365906|NCT00110864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6365907|NCT00110864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365908|NCT00110877|Darunavir|darunavir|mesh-list
6365909|NCT00110877|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6365910|NCT00110877|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6365911|NCT00110877|Protease Inhibitors|protease inhibitors|mesh-ancestor
6365912|NCT00110877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6365913|NCT00110877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365914|NCT00110877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6365915|NCT00110877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6365916|NCT00110877|Antiviral Agents|antiviral agents|mesh-ancestor
6365917|NCT00110877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6365918|NCT00110903|Etanercept|etanercept|mesh-list
6365919|NCT00110903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6365920|NCT00110903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6365921|NCT00110903|Analgesics|analgesics|mesh-ancestor
6365922|NCT00110903|Sensory System Agents|sensory system agents|mesh-ancestor
6365923|NCT00110903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6365924|NCT00110903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365925|NCT00110903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6365926|NCT00110903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6365927|NCT00110903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6365928|NCT00110903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6365929|NCT00110903|Immunologic Factors|immunologic factors|mesh-ancestor
6365930|NCT00110916|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6365931|NCT00110916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6365932|NCT00110929|Cinacalcet|cinacalcet|mesh-list
6365933|NCT00110929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6365934|NCT00110929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365935|NCT00110929|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6365936|NCT00110929|Hormone Antagonists|hormone antagonists|mesh-ancestor
6365937|NCT00110929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6365938|NCT00110955|Darbepoetin alfa|darbepoetin alfa|mesh-list
6365939|NCT00110955|Hematinics|hematinics|mesh-ancestor
6365940|NCT00110981|Etanercept|etanercept|mesh-list
6365941|NCT00110981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6365942|NCT00110981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6365943|NCT00110981|Analgesics|analgesics|mesh-ancestor
6365944|NCT00110981|Sensory System Agents|sensory system agents|mesh-ancestor
6365945|NCT00110981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6365946|NCT00110981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365947|NCT00110981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6365948|NCT00110981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6365949|NCT00110981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6365950|NCT00110981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6365951|NCT00110981|Immunologic Factors|immunologic factors|mesh-ancestor
6365952|NCT00111020|Sorafenib|sorafenib|mesh-list
6365953|NCT00111020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6365954|NCT00111020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6365955|NCT00111020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6365956|NCT00111020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365957|NCT00111046|Ibuprofen|ibuprofen|mesh-list
6365958|NCT00111046|Tramadol|tramadol|mesh-list
6365959|NCT00111046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6365960|NCT00111046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6365961|NCT00111046|Analgesics|analgesics|mesh-ancestor
6365962|NCT00111046|Sensory System Agents|sensory system agents|mesh-ancestor
6365963|NCT00111046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6365964|NCT00111046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365965|NCT00111046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6365966|NCT00111046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6365967|NCT00111046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6365968|NCT00111046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6365969|NCT00111046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6365970|NCT00111046|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6365971|NCT00111046|Narcotics|narcotics|mesh-ancestor
6365972|NCT00111046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6365973|NCT00111072|Dexamethasone|dexamethasone|mesh-list
6365974|NCT00111072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6365975|NCT00111072|Antiemetics|antiemetics|mesh-ancestor
6365976|NCT00111072|Autonomic Agents|autonomic agents|mesh-ancestor
6365977|NCT00111072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6365978|NCT00111072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365979|NCT00111072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6365980|NCT00111072|Glucocorticoids|glucocorticoids|mesh-ancestor
6365981|NCT00111072|Hormones|hormones|mesh-ancestor
6365982|NCT00111072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6365983|NCT00111072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6365984|NCT00111072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6365985|NCT00111098|Darbepoetin alfa|darbepoetin alfa|mesh-list
6365986|NCT00111098|Hematinics|hematinics|mesh-ancestor
6365987|NCT00111111|Etanercept|etanercept|mesh-list
6365988|NCT00111111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6365989|NCT00111111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6365990|NCT00111111|Analgesics|analgesics|mesh-ancestor
6365991|NCT00111111|Sensory System Agents|sensory system agents|mesh-ancestor
6365992|NCT00111111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6365993|NCT00111111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6365994|NCT00111111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6365995|NCT00111111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6365996|NCT00111111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6365997|NCT00111111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6365998|NCT00111111|Immunologic Factors|immunologic factors|mesh-ancestor
6365999|NCT00111124|Etanercept|etanercept|mesh-list
6366000|NCT00111124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6366001|NCT00111124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6366002|NCT00111124|Analgesics|analgesics|mesh-ancestor
6366003|NCT00111124|Sensory System Agents|sensory system agents|mesh-ancestor
6366004|NCT00111124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6366005|NCT00111124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366006|NCT00111124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6366007|NCT00111124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6366008|NCT00111124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6366009|NCT00111124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6366010|NCT00111124|Immunologic Factors|immunologic factors|mesh-ancestor
6366011|NCT00111137|Darbepoetin alfa|darbepoetin alfa|mesh-list
6366012|NCT00111137|Hematinics|hematinics|mesh-ancestor
6366013|NCT00111150|Tenofovir|tenofovir|mesh-list
6366014|NCT00111150|Antiviral Agents|antiviral agents|mesh-ancestor
6366015|NCT00111150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6366016|NCT00111150|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6366017|NCT00111150|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6366018|NCT00111150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6366019|NCT00111150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366020|NCT00111150|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6366021|NCT00111150|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6366022|NCT00111163|Artesunate|artesunate|mesh-list
6366023|NCT00111163|Pyrimethamine|pyrimethamine|mesh-list
6366024|NCT00111163|Sulfadoxine|sulfadoxine|mesh-list
6366025|NCT00111163|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6366026|NCT00111163|Amodiaquine|amodiaquine|mesh-list
6366027|NCT00111163|Dapsone|dapsone|mesh-list
6366028|NCT00111163|Chlorproguanil|chlorproguanil|mesh-list
6366029|NCT00111163|Antimalarials|antimalarials|mesh-ancestor
6366030|NCT00111163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6366031|NCT00111163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6366032|NCT00111163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6366033|NCT00111163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6366034|NCT00111163|Antiviral Agents|antiviral agents|mesh-ancestor
6366035|NCT00111163|Schistosomicides|schistosomicides|mesh-ancestor
6366036|NCT00111163|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6366037|NCT00111163|Anthelmintics|anthelmintics|mesh-ancestor
6366038|NCT00111163|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6366039|NCT00111163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6366040|NCT00111163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366041|NCT00111163|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6366042|NCT00111163|Renal Agents|renal agents|mesh-ancestor
6366043|NCT00111163|Leprostatic Agents|leprostatic agents|mesh-ancestor
6366044|NCT00111163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6366045|NCT00111189|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6366046|NCT00111189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6366047|NCT00111189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6366048|NCT00111189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6366049|NCT00111189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366050|NCT00111189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6366051|NCT00111189|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6366052|NCT00111189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6366053|NCT00111189|Serotonin Agents|serotonin agents|mesh-ancestor
6366054|NCT00111189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6366055|NCT00111189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366056|NCT00111189|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6366057|NCT00111189|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6366058|NCT00111189|Dopamine Agents|dopamine agents|mesh-ancestor
6366059|NCT00111215|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
6366060|NCT00111215|Tranexamic Acid|tranexamic acid|mesh-list
6366061|NCT00111215|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6366062|NCT00111215|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6366063|NCT00111215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366064|NCT00111215|Hemostatics|hemostatics|mesh-ancestor
6366065|NCT00111215|Coagulants|coagulants|mesh-ancestor
6366066|NCT00111215|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6366067|NCT00111215|Natriuretic Agents|natriuretic agents|mesh-ancestor
6366068|NCT00111215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366069|NCT00111267|Vitamins|vitamins|mesh-list
6366070|NCT00111267|Folic Acid|folic acid|mesh-list
6366071|NCT00111267|Hydroxocobalamin|hydroxocobalamin|mesh-list
6366072|NCT00111267|Vitamin B 12|vitamin b 12|mesh-list
6366073|NCT00111267|Vitamin B Complex|vitamin b complex|mesh-list
6366074|NCT00111267|Micronutrients|micronutrients|mesh-ancestor
6366075|NCT00111267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366076|NCT00111267|Hematinics|hematinics|mesh-ancestor
6366077|NCT00111280|Etravirine|etravirine|mesh-list
6366078|NCT00111280|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6366079|NCT00111280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6366080|NCT00111280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6366081|NCT00111280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366082|NCT00111280|Antiviral Agents|antiviral agents|mesh-ancestor
6366083|NCT00111280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6366084|NCT00111306|Epratuzumab|epratuzumab|mesh-list
6366085|NCT00111306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6366086|NCT00111306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6366087|NCT00111319|Bortezomib|bortezomib|mesh-list
6366088|NCT00111319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6366089|NCT00111345|Daunorubicin|daunorubicin|mesh-list
6366090|NCT00111345|Idarubicin|idarubicin|mesh-list
6366091|NCT00111345|Cladribine|cladribine|mesh-list
6366092|NCT00111345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6366093|NCT00111345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6366094|NCT00111345|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6366095|NCT00111345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6366096|NCT00111345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6366097|NCT00111345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366098|NCT00111345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6366099|NCT00111345|Immunologic Factors|immunologic factors|mesh-ancestor
6366100|NCT00111345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366101|NCT00111371|Levodopa|levodopa|mesh-list
6366102|NCT00111371|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6366103|NCT00111371|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6366104|NCT00111371|Dopamine Agents|dopamine agents|mesh-ancestor
6366105|NCT00111371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6366106|NCT00111371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366107|NCT00111371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366108|NCT00111397|Interferons|interferons|mesh-list
6366109|NCT00111397|Interferon-gamma|interferon-gamma|mesh-list
6366110|NCT00111397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6366111|NCT00111397|Antiviral Agents|antiviral agents|mesh-ancestor
6366112|NCT00111397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6366113|NCT00111410|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6366114|NCT00111410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6366115|NCT00111436|Etanercept|etanercept|mesh-list
6366116|NCT00111436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6366117|NCT00111436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6366118|NCT00111436|Analgesics|analgesics|mesh-ancestor
6366119|NCT00111436|Sensory System Agents|sensory system agents|mesh-ancestor
6366120|NCT00111436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6366121|NCT00111436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366122|NCT00111436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6366123|NCT00111436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6366124|NCT00111436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6366125|NCT00111436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6366126|NCT00111436|Immunologic Factors|immunologic factors|mesh-ancestor
6366127|NCT00111449|Etanercept|etanercept|mesh-list
6366128|NCT00111449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6366129|NCT00111449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6366130|NCT00111449|Analgesics|analgesics|mesh-ancestor
6366131|NCT00111449|Sensory System Agents|sensory system agents|mesh-ancestor
6366132|NCT00111449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6366133|NCT00111449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366134|NCT00111449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6366135|NCT00111449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6366136|NCT00111449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6366137|NCT00111449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6366138|NCT00111449|Immunologic Factors|immunologic factors|mesh-ancestor
6366139|NCT00111462|Darbepoetin alfa|darbepoetin alfa|mesh-list
6366140|NCT00111462|Hematinics|hematinics|mesh-ancestor
6366141|NCT00111540|Exenatide|exenatide|mesh-list
6366142|NCT00111540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6017286|NCT00371683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6017287|NCT00371683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6017288|NCT00371683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017289|NCT00371683|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6017290|NCT00371683|Antithrombins|antithrombins|mesh-ancestor
6017291|NCT00371683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6366143|NCT00111540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366144|NCT00111540|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6366145|NCT00111540|Incretins|incretins|mesh-ancestor
6366146|NCT00111540|Hormones|hormones|mesh-ancestor
6366147|NCT00111540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6366148|NCT00111566|Eptifibatide|eptifibatide|mesh-list
6366149|NCT00111566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6395159|NCT00204347|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6395160|NCT00204347|Serotonin Agents|serotonin agents|mesh-ancestor
6395161|NCT00204347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6395162|NCT00204347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395163|NCT00204347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395164|NCT00204347|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6395165|NCT00204347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6395166|NCT00204347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6395167|NCT00204347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6395168|NCT00204347|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6395169|NCT00204347|Dopamine Agents|dopamine agents|mesh-ancestor
6395170|NCT00204386|Topiramate|topiramate|mesh-list
6395171|NCT00204386|Anticonvulsants|anticonvulsants|mesh-ancestor
6395172|NCT00204386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6395173|NCT00204386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395174|NCT00204438|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6395175|NCT00204438|Desogestrel|desogestrel|mesh-list
6395176|NCT00204438|Estradiol|estradiol|mesh-list
6395177|NCT00204438|Estrogens|estrogens|mesh-ancestor
6395178|NCT00204438|Hormones|hormones|mesh-ancestor
6395179|NCT00204438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6395180|NCT00204438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395181|NCT00204438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6395182|NCT00204438|Contraceptive Agents|contraceptive agents|mesh-ancestor
6395183|NCT00204438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6395184|NCT00204438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6395185|NCT00204438|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6395186|NCT00204438|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6395187|NCT00204438|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6395188|NCT00204438|Progestins|progestins|mesh-ancestor
6395189|NCT00204451|Levonorgestrel|levonorgestrel|mesh-list
6395190|NCT00204451|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6395191|NCT00204451|Estradiol|estradiol|mesh-list
6395192|NCT00204451|Estrogens|estrogens|mesh-ancestor
6395193|NCT00204451|Hormones|hormones|mesh-ancestor
6397022|NCT00209950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6366150|NCT00111618|Vadimezan|vadimezan|mesh-list
6366151|NCT00111618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6366152|NCT00111631|Metformin|metformin|mesh-list
6366153|NCT00111631|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
6366154|NCT00111631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6366155|NCT00111631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366156|NCT00111631|Protease Inhibitors|protease inhibitors|mesh-ancestor
6366157|NCT00111631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6366158|NCT00111631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366159|NCT00111644|Ceftriaxone|ceftriaxone|mesh-list
6366160|NCT00111644|Lactams|lactams|mesh-list
6366161|NCT00111644|beta-Lactams|beta-lactams|mesh-list
6366162|NCT00111644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6366163|NCT00111644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6366164|NCT00111670|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
6366165|NCT00111670|Protease Inhibitors|protease inhibitors|mesh-ancestor
6366166|NCT00111670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6366167|NCT00111670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366168|NCT00111670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6366169|NCT00111670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366170|NCT00111748|Thalidomide|thalidomide|mesh-list
6366171|NCT00111748|Dexamethasone|dexamethasone|mesh-list
6366172|NCT00111748|Bortezomib|bortezomib|mesh-list
6366173|NCT00111748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6366174|NCT00111748|Antiemetics|antiemetics|mesh-ancestor
6366175|NCT00111748|Autonomic Agents|autonomic agents|mesh-ancestor
6366176|NCT00111748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6366177|NCT00111748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366178|NCT00111748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6366179|NCT00111748|Glucocorticoids|glucocorticoids|mesh-ancestor
6366180|NCT00111748|Hormones|hormones|mesh-ancestor
6366181|NCT00111748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6366182|NCT00111748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6366183|NCT00111748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6366184|NCT00111748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6366185|NCT00111748|Immunologic Factors|immunologic factors|mesh-ancestor
6366186|NCT00111748|Leprostatic Agents|leprostatic agents|mesh-ancestor
6366187|NCT00111748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6366188|NCT00111748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6366189|NCT00111748|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6366190|NCT00111748|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6366191|NCT00111748|Growth Substances|growth substances|mesh-ancestor
6366192|NCT00111748|Growth Inhibitors|growth inhibitors|mesh-ancestor
6366193|NCT00111774|Panitumumab|panitumumab|mesh-list
6366194|NCT00111774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6366195|NCT00111774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6366196|NCT00111787|Paclitaxel|paclitaxel|mesh-list
6366197|NCT00111787|Lapatinib|lapatinib|mesh-list
6366198|NCT00111787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6366199|NCT00111787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6366200|NCT00111787|Tubulin Modulators|tubulin modulators|mesh-ancestor
6366201|NCT00111787|Antimitotic Agents|antimitotic agents|mesh-ancestor
6366202|NCT00111787|Mitosis Modulators|mitosis modulators|mesh-ancestor
6366203|NCT00111787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366204|NCT00111787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6366205|NCT00111787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6366206|NCT00111852|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
6366207|NCT00111852|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6366208|NCT00111852|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6366209|NCT00111852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366210|NCT00111891|Niacin|niacin|mesh-list
6366211|NCT00111891|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6366212|NCT00111891|Antimetabolites|antimetabolites|mesh-ancestor
6366213|NCT00111891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366214|NCT00111891|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6366215|NCT00111891|Vasodilator Agents|vasodilator agents|mesh-ancestor
6366216|NCT00111891|Vitamin B Complex|vitamin b complex|mesh-ancestor
6366217|NCT00111891|Vitamins|vitamins|mesh-ancestor
6366218|NCT00111891|Micronutrients|micronutrients|mesh-ancestor
6366219|NCT00111891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366220|NCT00111904|Paclitaxel|paclitaxel|mesh-list
6366221|NCT00111904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6366222|NCT00111904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6366223|NCT00111904|Tubulin Modulators|tubulin modulators|mesh-ancestor
6366224|NCT00111904|Antimitotic Agents|antimitotic agents|mesh-ancestor
6366225|NCT00111904|Mitosis Modulators|mitosis modulators|mesh-ancestor
6366226|NCT00111904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366227|NCT00111943|Tenofovir|tenofovir|mesh-list
6366228|NCT00111943|Antiviral Agents|antiviral agents|mesh-ancestor
6366229|NCT00111943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6366230|NCT00111943|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6366231|NCT00111943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6366232|NCT00111943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6366233|NCT00111943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366234|NCT00111943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6366235|NCT00111943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6366236|NCT00111956|Etanercept|etanercept|mesh-list
6366237|NCT00111956|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6366238|NCT00111956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6366239|NCT00111956|Analgesics|analgesics|mesh-ancestor
6366240|NCT00111956|Sensory System Agents|sensory system agents|mesh-ancestor
6366241|NCT00111956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6366242|NCT00111956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366243|NCT00111956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6366244|NCT00111956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6366245|NCT00111956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6366246|NCT00111956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6366247|NCT00111956|Immunologic Factors|immunologic factors|mesh-ancestor
6366248|NCT00111995|Darbepoetin alfa|darbepoetin alfa|mesh-list
6366249|NCT00111995|Hematinics|hematinics|mesh-ancestor
6366250|NCT00112008|Darbepoetin alfa|darbepoetin alfa|mesh-list
6366251|NCT00112008|Hematinics|hematinics|mesh-ancestor
6366252|NCT00112021|Pramlintide|pramlintide|mesh-list
6366253|NCT00112021|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
6366254|NCT00112021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6366255|NCT00112021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366256|NCT00112021|Appetite Depressants|appetite depressants|mesh-ancestor
6366257|NCT00112021|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6366258|NCT00112021|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
6366259|NCT00112021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366260|NCT00112034|Methylprednisolone|methylprednisolone|mesh-list
6366261|NCT00112034|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6366262|NCT00112034|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6366263|NCT00112034|Prednisolone|prednisolone|mesh-list
6366264|NCT00112034|Prednisolone acetate|prednisolone acetate|mesh-list
6366265|NCT00112034|Methotrexate|methotrexate|mesh-list
6366266|NCT00112034|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6366267|NCT00112034|Prednisolone phosphate|prednisolone phosphate|mesh-list
6366268|NCT00112034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6366269|NCT00112034|Abortifacient Agents|abortifacient agents|mesh-ancestor
6366270|NCT00112034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6366271|NCT00112034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366272|NCT00112034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6366273|NCT00112034|Antimetabolites|antimetabolites|mesh-ancestor
6366274|NCT00112034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366275|NCT00112034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6366276|NCT00112034|Dermatologic Agents|dermatologic agents|mesh-ancestor
6366277|NCT00112034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6366278|NCT00112034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6366279|NCT00112034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6366280|NCT00112034|Immunologic Factors|immunologic factors|mesh-ancestor
6366281|NCT00112034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6366282|NCT00112034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6366283|NCT00112034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6366284|NCT00112034|Antiemetics|antiemetics|mesh-ancestor
6366285|NCT00112034|Autonomic Agents|autonomic agents|mesh-ancestor
6366286|NCT00112034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6366287|NCT00112034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6366288|NCT00112034|Glucocorticoids|glucocorticoids|mesh-ancestor
6366289|NCT00112034|Hormones|hormones|mesh-ancestor
6366290|NCT00112034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6366291|NCT00112034|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6366292|NCT00112034|Protective Agents|protective agents|mesh-ancestor
6366293|NCT00112034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6366294|NCT00112086|Paclitaxel|paclitaxel|mesh-list
6366295|NCT00112086|Carboplatin|carboplatin|mesh-list
6366296|NCT00112086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6366297|NCT00112086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6366298|NCT00112086|Tubulin Modulators|tubulin modulators|mesh-ancestor
6366299|NCT00112086|Antimitotic Agents|antimitotic agents|mesh-ancestor
6366300|NCT00112086|Mitosis Modulators|mitosis modulators|mesh-ancestor
6366301|NCT00112086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366302|NCT00112138|Gabapentin|gabapentin|mesh-list
6366303|NCT00112138|Analgesics|analgesics|mesh-ancestor
6366304|NCT00112138|Sensory System Agents|sensory system agents|mesh-ancestor
6366305|NCT00112138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6366306|NCT00112138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366307|NCT00112138|Anticonvulsants|anticonvulsants|mesh-ancestor
6017292|NCT00371683|Protease Inhibitors|protease inhibitors|mesh-ancestor
6017293|NCT00371683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6017294|NCT00371761|Interferons|interferons|mesh-list
6017295|NCT00371761|Interferon-alpha|interferon-alpha|mesh-list
6366308|NCT00112138|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6366309|NCT00112138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6366310|NCT00112138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6366311|NCT00112138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6366312|NCT00112138|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6366313|NCT00112138|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6366314|NCT00112138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6366315|NCT00112138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366316|NCT00112138|Antimanic Agents|antimanic agents|mesh-ancestor
6366317|NCT00112164|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
6366318|NCT00112164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6366319|NCT00112281|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
6366320|NCT00112281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6366321|NCT00112281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366322|NCT00112346|Gemcitabine|gemcitabine|mesh-list
6366323|NCT00112346|Cetuximab|cetuximab|mesh-list
6366324|NCT00112346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6366325|NCT00112346|Antimetabolites|antimetabolites|mesh-ancestor
6366326|NCT00112346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366327|NCT00112346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6366328|NCT00112346|Antiviral Agents|antiviral agents|mesh-ancestor
6366329|NCT00112346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6366330|NCT00112346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6366331|NCT00112346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6366332|NCT00112346|Immunologic Factors|immunologic factors|mesh-ancestor
6366333|NCT00112346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366334|NCT00112346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6366335|NCT00112372|Sirolimus|sirolimus|mesh-list
6366336|NCT00112372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6366337|NCT00112372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6366338|NCT00112372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6366339|NCT00112372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6366340|NCT00112372|Antifungal Agents|antifungal agents|mesh-ancestor
6366341|NCT00112372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6366342|NCT00112372|Immunologic Factors|immunologic factors|mesh-ancestor
6366343|NCT00112372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366344|NCT00112476|Sirolimus|sirolimus|mesh-list
6366345|NCT00112476|Bryostatin 1|bryostatin 1|mesh-list
6366346|NCT00112476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6366347|NCT00112476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6366348|NCT00112476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6366349|NCT00112476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6366350|NCT00112476|Antifungal Agents|antifungal agents|mesh-ancestor
6017296|NCT00371761|Interferon alpha-2|interferon alpha-2|mesh-list
6017297|NCT00371761|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6017298|NCT00371761|Adefovir|adefovir|mesh-list
6017299|NCT00371761|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6017300|NCT00371761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6017301|NCT00371761|Antiviral Agents|antiviral agents|mesh-ancestor
6366351|NCT00112476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6017302|NCT00371761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6366352|NCT00112476|Immunologic Factors|immunologic factors|mesh-ancestor
6366353|NCT00112476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366354|NCT00112476|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6366355|NCT00112515|Modafinil|modafinil|mesh-list
6366356|NCT00112515|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6366357|NCT00112515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366358|NCT00112515|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6366359|NCT00112515|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6366360|NCT00112515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6366361|NCT00112515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366362|NCT00112528|Gemcitabine|gemcitabine|mesh-list
6366363|NCT00112528|Bevacizumab|bevacizumab|mesh-list
6366364|NCT00112528|Oxaliplatin|oxaliplatin|mesh-list
6366365|NCT00112528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6366366|NCT00112528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6366367|NCT00112528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6366368|NCT00112528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6366369|NCT00112528|Growth Substances|growth substances|mesh-ancestor
6366370|NCT00112528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366371|NCT00112528|Growth Inhibitors|growth inhibitors|mesh-ancestor
6366372|NCT00112528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6017303|NCT00371761|Immunologic Factors|immunologic factors|mesh-ancestor
6017304|NCT00371761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017305|NCT00371761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6017306|NCT00371761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6017307|NCT00371761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6366373|NCT00112528|Antimetabolites|antimetabolites|mesh-ancestor
6366374|NCT00112528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366375|NCT00112528|Antiviral Agents|antiviral agents|mesh-ancestor
6366376|NCT00112528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6366377|NCT00112528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6366378|NCT00112528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6366379|NCT00112528|Immunologic Factors|immunologic factors|mesh-ancestor
6366380|NCT00112554|Cytarabine|cytarabine|mesh-list
6366381|NCT00112554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6366382|NCT00112554|Antimetabolites|antimetabolites|mesh-ancestor
6366383|NCT00112554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366384|NCT00112554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6366385|NCT00112554|Antiviral Agents|antiviral agents|mesh-ancestor
6366386|NCT00112554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6366387|NCT00112554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6366388|NCT00112554|Immunologic Factors|immunologic factors|mesh-ancestor
6366389|NCT00112554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366390|NCT00112567|Fludarabine|fludarabine|mesh-list
6366391|NCT00112567|Fludarabine phosphate|fludarabine phosphate|mesh-list
6017308|NCT00371761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366392|NCT00112567|Thiotepa|thiotepa|mesh-list
6366393|NCT00112567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6366394|NCT00112567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6366395|NCT00112567|Antimetabolites|antimetabolites|mesh-ancestor
6366396|NCT00112567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366397|NCT00112567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6366398|NCT00112567|Immunologic Factors|immunologic factors|mesh-ancestor
6366399|NCT00112567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366400|NCT00112567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6366401|NCT00112567|Alkylating Agents|alkylating agents|mesh-ancestor
6366402|NCT00112567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6366403|NCT00112619|Topotecan|topotecan|mesh-list
6366404|NCT00112619|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6366405|NCT00112619|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6366406|NCT00112619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6366407|NCT00112619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366408|NCT00112619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6366409|NCT00112632|Imatinib Mesylate|imatinib mesylate|mesh-list
6366410|NCT00112632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6366411|NCT00112632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6366412|NCT00112632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6366413|NCT00112632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017309|NCT00371826|Cyclosporine|cyclosporine|mesh-list
6017310|NCT00371826|Mycophenolic Acid|mycophenolic acid|mesh-list
6366414|NCT00112645|Cyclosporine|cyclosporine|mesh-list
6366415|NCT00112645|Methylprednisolone|methylprednisolone|mesh-list
6366416|NCT00112645|Methotrexate|methotrexate|mesh-list
6366417|NCT00112645|Melphalan|melphalan|mesh-list
6366418|NCT00112645|Busulfan|busulfan|mesh-list
6366419|NCT00112645|Cyclosporins|cyclosporins|mesh-list
6017311|NCT00371826|Prednisone|prednisone|mesh-list
6017312|NCT00371826|Everolimus|everolimus|mesh-list
6366420|NCT00112645|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6366421|NCT00112645|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6366422|NCT00112645|Abortifacient Agents|abortifacient agents|mesh-ancestor
6366423|NCT00112645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6366424|NCT00112645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366425|NCT00112645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6366426|NCT00112645|Antimetabolites|antimetabolites|mesh-ancestor
6366427|NCT00112645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366428|NCT00112645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6366429|NCT00112645|Dermatologic Agents|dermatologic agents|mesh-ancestor
6366430|NCT00112645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6366431|NCT00112645|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6017313|NCT00371826|Cyclosporins|cyclosporins|mesh-list
6017314|NCT00371826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
6017315|NCT00371826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6017316|NCT00371826|Glucocorticoids|glucocorticoids|mesh-ancestor
6017317|NCT00371826|Hormones|hormones|mesh-ancestor
6017318|NCT00371826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6366432|NCT00112645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6366433|NCT00112645|Immunologic Factors|immunologic factors|mesh-ancestor
6366434|NCT00112645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6366435|NCT00112645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6366436|NCT00112645|Antifungal Agents|antifungal agents|mesh-ancestor
6366437|NCT00112645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6366438|NCT00112645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6366439|NCT00112645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6366440|NCT00112645|Alkylating Agents|alkylating agents|mesh-ancestor
6366441|NCT00112645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6366442|NCT00112645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6366443|NCT00112645|Antiemetics|antiemetics|mesh-ancestor
6366444|NCT00112645|Autonomic Agents|autonomic agents|mesh-ancestor
6366445|NCT00112645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6366446|NCT00112645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6366447|NCT00112645|Glucocorticoids|glucocorticoids|mesh-ancestor
6366448|NCT00112645|Hormones|hormones|mesh-ancestor
6366449|NCT00112645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6366450|NCT00112645|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6366451|NCT00112645|Protective Agents|protective agents|mesh-ancestor
6366452|NCT00112658|Leucovorin|leucovorin|mesh-list
6366453|NCT00112658|Gemcitabine|gemcitabine|mesh-list
6366454|NCT00112658|Fluorouracil|fluorouracil|mesh-list
6366455|NCT00112658|Oxaliplatin|oxaliplatin|mesh-list
6366456|NCT00112658|Irinotecan|irinotecan|mesh-list
6366457|NCT00112658|Calcium|calcium|mesh-list
6366458|NCT00112658|Levoleucovorin|levoleucovorin|mesh-list
6366459|NCT00112658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6366460|NCT00112658|Antimetabolites|antimetabolites|mesh-ancestor
6366461|NCT00112658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366462|NCT00112658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6366463|NCT00112658|Antiviral Agents|antiviral agents|mesh-ancestor
6366464|NCT00112658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6366465|NCT00112658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6366466|NCT00112658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6366467|NCT00112658|Immunologic Factors|immunologic factors|mesh-ancestor
6366468|NCT00112658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366469|NCT00112658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6366470|NCT00112658|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6366471|NCT00112658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6366472|NCT00112658|Antidotes|antidotes|mesh-ancestor
6366473|NCT00112658|Protective Agents|protective agents|mesh-ancestor
6366474|NCT00112658|Vitamin B Complex|vitamin b complex|mesh-ancestor
6366475|NCT00112658|Vitamins|vitamins|mesh-ancestor
6366476|NCT00112658|Micronutrients|micronutrients|mesh-ancestor
6366477|NCT00112684|Alvocidib|alvocidib|mesh-list
6366478|NCT00112684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6366479|NCT00112684|Growth Inhibitors|growth inhibitors|mesh-ancestor
6366480|NCT00112684|Growth Substances|growth substances|mesh-ancestor
6366481|NCT00112684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366482|NCT00112684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6366483|NCT00112684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6366484|NCT00112684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366485|NCT00112697|Docetaxel|docetaxel|mesh-list
6366486|NCT00112697|Fluorouracil|fluorouracil|mesh-list
6366487|NCT00112697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6366488|NCT00112697|Tubulin Modulators|tubulin modulators|mesh-ancestor
6366489|NCT00112697|Antimitotic Agents|antimitotic agents|mesh-ancestor
6366490|NCT00112697|Mitosis Modulators|mitosis modulators|mesh-ancestor
6366491|NCT00112697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366492|NCT00112697|Antimetabolites|antimetabolites|mesh-ancestor
6366493|NCT00112697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6366494|NCT00112697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6366495|NCT00112697|Immunologic Factors|immunologic factors|mesh-ancestor
6366496|NCT00112697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017319|NCT00371826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017320|NCT00371826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6017321|NCT00371826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6017322|NCT00371826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6017323|NCT00371826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017324|NCT00371826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6017325|NCT00371826|Immunologic Factors|immunologic factors|mesh-ancestor
6366497|NCT00112710|Gemcitabine|gemcitabine|mesh-list
6366498|NCT00112710|Carboplatin|carboplatin|mesh-list
6366499|NCT00112710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6366500|NCT00112710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6366501|NCT00112710|Antimetabolites|antimetabolites|mesh-ancestor
6366502|NCT00112710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366503|NCT00112710|Antiviral Agents|antiviral agents|mesh-ancestor
6366504|NCT00112710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6366505|NCT00112710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6366506|NCT00112710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6366507|NCT00112710|Immunologic Factors|immunologic factors|mesh-ancestor
6366508|NCT00112710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366509|NCT00112749|Infliximab|infliximab|mesh-list
6366510|NCT00112749|Dermatologic Agents|dermatologic agents|mesh-ancestor
6366511|NCT00112749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6366512|NCT00112749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6366513|NCT00112775|Imatinib Mesylate|imatinib mesylate|mesh-list
6366514|NCT00112775|Dasatinib|dasatinib|mesh-list
6366515|NCT00112775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6366516|NCT00112775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6366517|NCT00112775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6366518|NCT00112775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366519|NCT00112853|Etoposide|etoposide|mesh-list
6366520|NCT00112853|Etoposide phosphate|etoposide phosphate|mesh-list
6366521|NCT00112853|Tipifarnib|tipifarnib|mesh-list
6366522|NCT00112853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6366523|NCT00112853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6366524|NCT00112853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6366525|NCT00112853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6366526|NCT00112853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6366527|NCT00112853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366528|NCT00112879|Ascorbic Acid|ascorbic acid|mesh-list
6366529|NCT00112879|Thalidomide|thalidomide|mesh-list
6366530|NCT00112879|Dexamethasone|dexamethasone|mesh-list
6366531|NCT00112879|Arsenic Trioxide|arsenic trioxide|mesh-list
6366532|NCT00112879|Mitogens|mitogens|mesh-list
6366533|NCT00112879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6366534|NCT00112879|Antiemetics|antiemetics|mesh-ancestor
6366535|NCT00112879|Autonomic Agents|autonomic agents|mesh-ancestor
6366536|NCT00112879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6366537|NCT00112879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366538|NCT00112879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6366539|NCT00112879|Glucocorticoids|glucocorticoids|mesh-ancestor
6366540|NCT00112879|Hormones|hormones|mesh-ancestor
6366541|NCT00112879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6366542|NCT00112879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6366543|NCT00112879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6366544|NCT00112879|Mitosis Modulators|mitosis modulators|mesh-ancestor
6366545|NCT00112879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366546|NCT00112879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6366547|NCT00112879|Immunologic Factors|immunologic factors|mesh-ancestor
6366548|NCT00112879|Leprostatic Agents|leprostatic agents|mesh-ancestor
6366549|NCT00112879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6366550|NCT00112879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6366551|NCT00112879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6366552|NCT00112879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6366553|NCT00112879|Growth Substances|growth substances|mesh-ancestor
6366554|NCT00112879|Growth Inhibitors|growth inhibitors|mesh-ancestor
6366555|NCT00112879|Antioxidants|antioxidants|mesh-ancestor
6366556|NCT00112879|Protective Agents|protective agents|mesh-ancestor
6366557|NCT00112879|Vitamins|vitamins|mesh-ancestor
6366558|NCT00112879|Micronutrients|micronutrients|mesh-ancestor
6366559|NCT00112892|Selenium|selenium|mesh-list
6366560|NCT00112892|Irinotecan|irinotecan|mesh-list
6366561|NCT00112892|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6366562|NCT00112892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6366563|NCT00112892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6366564|NCT00112892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366565|NCT00112892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6366566|NCT00112892|Antioxidants|antioxidants|mesh-ancestor
6366567|NCT00112892|Protective Agents|protective agents|mesh-ancestor
6366568|NCT00112892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366569|NCT00112892|Trace Elements|trace elements|mesh-ancestor
6366570|NCT00112892|Micronutrients|micronutrients|mesh-ancestor
6366571|NCT00112931|Rituximab|rituximab|mesh-list
6366572|NCT00112931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6366573|NCT00112931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6366574|NCT00112931|Immunologic Factors|immunologic factors|mesh-ancestor
6366575|NCT00112931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366576|NCT00112931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6366577|NCT00112983|Eculizumab|eculizumab|mesh-list
6366578|NCT00112983|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6366579|NCT00112983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6366580|NCT00112983|Immunologic Factors|immunologic factors|mesh-ancestor
6366581|NCT00112983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366582|NCT00112996|Thioctic Acid|thioctic acid|mesh-list
6366583|NCT00112996|Antioxidants|antioxidants|mesh-ancestor
6366584|NCT00112996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366585|NCT00112996|Protective Agents|protective agents|mesh-ancestor
6366586|NCT00112996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366587|NCT00112996|Vitamin B Complex|vitamin b complex|mesh-ancestor
6366588|NCT00112996|Vitamins|vitamins|mesh-ancestor
6366589|NCT00112996|Micronutrients|micronutrients|mesh-ancestor
6366590|NCT00113048|Alemtuzumab|alemtuzumab|mesh-list
6366591|NCT00113048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6366592|NCT00113048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6366593|NCT00113074|Nicotine|nicotine|mesh-list
6366594|NCT00113074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6366595|NCT00113074|Autonomic Agents|autonomic agents|mesh-ancestor
6366596|NCT00113074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6366597|NCT00113074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366598|NCT00113074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6366599|NCT00113074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6366600|NCT00113074|Cholinergic Agents|cholinergic agents|mesh-ancestor
6366601|NCT00113074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6366602|NCT00113074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366603|NCT00113100|Ethanol|ethanol|mesh-list
6366604|NCT00113100|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6366605|NCT00113100|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6366606|NCT00113100|Estradiol|estradiol|mesh-list
6366607|NCT00113100|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6366608|NCT00113100|Estrogens|estrogens|mesh-ancestor
6366609|NCT00113100|Hormones|hormones|mesh-ancestor
6366610|NCT00113100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6366611|NCT00113100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366612|NCT00113100|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6366613|NCT00113100|Contraceptive Agents|contraceptive agents|mesh-ancestor
6366614|NCT00113100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6366615|NCT00113100|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6366616|NCT00113100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6366617|NCT00113100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6366618|NCT00113100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6366619|NCT00113113|Rubitecan|rubitecan|mesh-list
6366620|NCT00113113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6366621|NCT00113113|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6366622|NCT00113113|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6366623|NCT00113113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6366624|NCT00113113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366625|NCT00113165|Lamotrigine|lamotrigine|mesh-list
6366626|NCT00113165|Anticonvulsants|anticonvulsants|mesh-ancestor
6366627|NCT00113165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6366628|NCT00113165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6366629|NCT00113165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366630|NCT00113165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6366631|NCT00113165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366632|NCT00113165|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6366633|NCT00113165|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6366634|NCT00113165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6366635|NCT00113165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6366636|NCT00113165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6366637|NCT00113256|Rubitecan|rubitecan|mesh-list
6366638|NCT00113256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6366639|NCT00113256|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6366640|NCT00113256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6366641|NCT00113256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6366642|NCT00113256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366643|NCT00113282|Interleukin-2|interleukin-2|mesh-list
6366644|NCT00113282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6366645|NCT00113282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6366646|NCT00113282|Analgesics|analgesics|mesh-ancestor
6366647|NCT00113282|Sensory System Agents|sensory system agents|mesh-ancestor
6366648|NCT00113282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6366649|NCT00113282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366650|NCT00113347|Docetaxel|docetaxel|mesh-list
6366651|NCT00113347|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6366652|NCT00113347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6366653|NCT00113347|Tubulin Modulators|tubulin modulators|mesh-ancestor
6366654|NCT00113347|Antimitotic Agents|antimitotic agents|mesh-ancestor
6366655|NCT00113347|Mitosis Modulators|mitosis modulators|mesh-ancestor
6366656|NCT00113347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366657|NCT00113347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6366658|NCT00113347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6366659|NCT00113503|Azathioprine|azathioprine|mesh-list
6366660|NCT00113503|Antimetabolites|antimetabolites|mesh-ancestor
6366661|NCT00113503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366662|NCT00113503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6366663|NCT00113503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6366664|NCT00113503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6366665|NCT00113503|Immunologic Factors|immunologic factors|mesh-ancestor
6366666|NCT00113503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366667|NCT00113503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6366668|NCT00113542|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
6366669|NCT00113542|Chelating Agents|chelating agents|mesh-ancestor
6366670|NCT00113542|Sequestering Agents|sequestering agents|mesh-ancestor
6366671|NCT00113542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366672|NCT00113542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6366673|NCT00113542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6366674|NCT00113542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6366675|NCT00113542|Growth Substances|growth substances|mesh-ancestor
6366676|NCT00113542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366677|NCT00113542|Growth Inhibitors|growth inhibitors|mesh-ancestor
6366678|NCT00113542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6366679|NCT00113594|Olanzapine|olanzapine|mesh-list
6366680|NCT00113594|Antiemetics|antiemetics|mesh-ancestor
6366681|NCT00113594|Autonomic Agents|autonomic agents|mesh-ancestor
6366682|NCT00113594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6366683|NCT00113594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366684|NCT00113594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6366685|NCT00113594|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6366686|NCT00113594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6366687|NCT00113594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6366688|NCT00113594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6366689|NCT00113594|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6366690|NCT00113594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6366691|NCT00113594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6366692|NCT00113594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366693|NCT00113594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6366694|NCT00113594|Serotonin Agents|serotonin agents|mesh-ancestor
6366695|NCT00113685|Dextrans|dextrans|mesh-list
6366696|NCT00113685|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6366697|NCT00113685|Anticoagulants|anticoagulants|mesh-ancestor
6366698|NCT00113685|Plasma Substitutes|plasma substitutes|mesh-ancestor
6366699|NCT00113685|Blood Substitutes|blood substitutes|mesh-ancestor
6395194|NCT00204451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6395195|NCT00204451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395196|NCT00204451|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6395197|NCT00204451|Contraceptive Agents|contraceptive agents|mesh-ancestor
6395198|NCT00204451|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6395199|NCT00204451|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6395200|NCT00204451|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6395201|NCT00204451|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6395202|NCT00204451|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6395203|NCT00204503|Valproic Acid|valproic acid|mesh-list
6395204|NCT00204503|Anticonvulsants|anticonvulsants|mesh-ancestor
6395205|NCT00204503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6395206|NCT00204503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395207|NCT00204503|GABA Agents|gaba agents|mesh-ancestor
6395208|NCT00204503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6395209|NCT00204503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395210|NCT00204503|Antimanic Agents|antimanic agents|mesh-ancestor
6395211|NCT00204503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6395212|NCT00204503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6395213|NCT00204503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6395214|NCT00204529|Interferons|interferons|mesh-list
6395215|NCT00204529|Interferon-alpha|interferon-alpha|mesh-list
6395216|NCT00204529|Interferon alpha-2|interferon alpha-2|mesh-list
6395217|NCT00204529|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6395218|NCT00204529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6395219|NCT00204529|Antiviral Agents|antiviral agents|mesh-ancestor
6395220|NCT00204529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6395221|NCT00204529|Immunologic Factors|immunologic factors|mesh-ancestor
6395222|NCT00204529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395223|NCT00204542|Diclofenac|diclofenac|mesh-list
6395224|NCT00204542|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6395225|NCT00204542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6395226|NCT00204542|Analgesics|analgesics|mesh-ancestor
6395227|NCT00204542|Sensory System Agents|sensory system agents|mesh-ancestor
6395228|NCT00204542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6395229|NCT00204542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395230|NCT00204542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6395231|NCT00204542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6395232|NCT00204542|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6395233|NCT00204542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6395234|NCT00204542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395235|NCT00204555|Imiquimod|imiquimod|mesh-list
6395236|NCT00204555|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6395237|NCT00204555|Immunologic Factors|immunologic factors|mesh-ancestor
6395238|NCT00204555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395239|NCT00204555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6395240|NCT00204555|Interferon Inducers|interferon inducers|mesh-ancestor
6395241|NCT00204568|Doxorubicin|doxorubicin|mesh-list
6395242|NCT00204568|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6395243|NCT00204568|Trofosfamide|trofosfamide|mesh-list
6395244|NCT00204568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6395245|NCT00204568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6395246|NCT00204568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6395247|NCT00204568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6395248|NCT00204568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6366700|NCT00113698|Enalapril|enalapril|mesh-list
6366701|NCT00113698|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6366702|NCT00113698|Protease Inhibitors|protease inhibitors|mesh-ancestor
6366703|NCT00113698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6366704|NCT00113698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366705|NCT00113698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6366706|NCT00113737|Fluoxetine|fluoxetine|mesh-list
6366707|NCT00113737|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6366708|NCT00113737|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6366709|NCT00113737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6366710|NCT00113737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366711|NCT00113737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6366712|NCT00113737|Serotonin Agents|serotonin agents|mesh-ancestor
6366713|NCT00113737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366714|NCT00113737|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6366715|NCT00113737|Antidepressive Agents|antidepressive agents|mesh-ancestor
6366716|NCT00113737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6366717|NCT00113737|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6366718|NCT00113737|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6366719|NCT00113737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6366720|NCT00113776|Panitumumab|panitumumab|mesh-list
6366721|NCT00113776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6366722|NCT00113776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6366723|NCT00113802|Epratuzumab|epratuzumab|mesh-list
6366724|NCT00113802|Antibodies|antibodies|mesh-list
6366725|NCT00113802|Immunologic Factors|immunologic factors|mesh-ancestor
6366726|NCT00113802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366727|NCT00113802|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6366728|NCT00113802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6366729|NCT00113815|Topiramate|topiramate|mesh-list
6366730|NCT00113815|Anticonvulsants|anticonvulsants|mesh-ancestor
6366731|NCT00113815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6366732|NCT00113815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366733|NCT00113828|Cyclosporine|cyclosporine|mesh-list
6366734|NCT00113828|Cyclosporins|cyclosporins|mesh-list
6366735|NCT00113828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6366736|NCT00113828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366737|NCT00113828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6366738|NCT00113828|Immunologic Factors|immunologic factors|mesh-ancestor
6366739|NCT00113828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366740|NCT00113828|Antifungal Agents|antifungal agents|mesh-ancestor
6366741|NCT00113828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6366742|NCT00113828|Dermatologic Agents|dermatologic agents|mesh-ancestor
6366743|NCT00113828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6366744|NCT00113828|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6366745|NCT00113854|Mannitol|mannitol|mesh-list
6366746|NCT00113854|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6366747|NCT00113854|Diuretics|diuretics|mesh-ancestor
6366748|NCT00113854|Natriuretic Agents|natriuretic agents|mesh-ancestor
6366749|NCT00113854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366750|NCT00113906|Melatonin|melatonin|mesh-list
6366751|NCT00113906|Antioxidants|antioxidants|mesh-ancestor
6366752|NCT00113906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366753|NCT00113906|Protective Agents|protective agents|mesh-ancestor
6366754|NCT00113906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366755|NCT00113906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6366756|NCT00113945|Cinacalcet|cinacalcet|mesh-list
6366757|NCT00113945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6366758|NCT00113945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366759|NCT00113945|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6366760|NCT00113945|Hormone Antagonists|hormone antagonists|mesh-ancestor
6366761|NCT00113945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6366762|NCT00113958|Cinacalcet|cinacalcet|mesh-list
6366763|NCT00113958|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6366764|NCT00113958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366765|NCT00113958|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6366766|NCT00113958|Hormone Antagonists|hormone antagonists|mesh-ancestor
6366767|NCT00113958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6366768|NCT00113971|Epratuzumab|epratuzumab|mesh-list
6366769|NCT00113971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6366770|NCT00113971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6366771|NCT00113984|Metronidazole|metronidazole|mesh-list
6366772|NCT00113984|Ipilimumab|ipilimumab|mesh-list
6366773|NCT00113984|Sargramostim|sargramostim|mesh-list
6366774|NCT00113984|Immunologic Factors|immunologic factors|mesh-ancestor
6366775|NCT00113984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366776|NCT00113984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6366777|NCT00113984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6366778|NCT00113984|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6366779|NCT00113984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366780|NCT00113984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6366781|NCT00113984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6366782|NCT00113984|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6366783|NCT00113984|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6366784|NCT00114010|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6366785|NCT00114010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6366786|NCT00114010|Immunologic Factors|immunologic factors|mesh-ancestor
6366787|NCT00114010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366788|NCT00114010|Antacids|antacids|mesh-ancestor
6366789|NCT00114010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366790|NCT00114010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6366791|NCT00114023|Imiquimod|imiquimod|mesh-list
6366792|NCT00114023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6366793|NCT00114023|Immunologic Factors|immunologic factors|mesh-ancestor
6366794|NCT00114023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366795|NCT00114023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6366796|NCT00114023|Interferon Inducers|interferon inducers|mesh-ancestor
6366797|NCT00114153|Carboplatin|carboplatin|mesh-list
6366798|NCT00114153|Capecitabine|capecitabine|mesh-list
6366799|NCT00114153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6366800|NCT00114153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6366801|NCT00114153|Antimetabolites|antimetabolites|mesh-ancestor
6366802|NCT00114153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366803|NCT00114179|Gemcitabine|gemcitabine|mesh-list
6366804|NCT00114179|Bevacizumab|bevacizumab|mesh-list
6366805|NCT00114179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6366806|NCT00114179|Capecitabine|capecitabine|mesh-list
6366807|NCT00114179|Antibodies|antibodies|mesh-list
6366808|NCT00114179|Immunoglobulins|immunoglobulins|mesh-list
6366809|NCT00114179|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6366810|NCT00114179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6366811|NCT00114179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6366812|NCT00114179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6366813|NCT00114179|Growth Substances|growth substances|mesh-ancestor
6366814|NCT00114179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366815|NCT00114179|Growth Inhibitors|growth inhibitors|mesh-ancestor
6366816|NCT00114179|Immunologic Factors|immunologic factors|mesh-ancestor
6366817|NCT00114179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6366818|NCT00114179|Antimetabolites|antimetabolites|mesh-ancestor
6366819|NCT00114179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366820|NCT00114179|Antiviral Agents|antiviral agents|mesh-ancestor
6366821|NCT00114179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6366822|NCT00114179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6366823|NCT00114179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6366824|NCT00114192|Thalidomide|thalidomide|mesh-list
6366825|NCT00114192|Docetaxel|docetaxel|mesh-list
6366826|NCT00114192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6366827|NCT00114192|Tubulin Modulators|tubulin modulators|mesh-ancestor
6366828|NCT00114192|Antimitotic Agents|antimitotic agents|mesh-ancestor
6366829|NCT00114192|Mitosis Modulators|mitosis modulators|mesh-ancestor
6366830|NCT00114192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366831|NCT00114192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6366832|NCT00114192|Immunologic Factors|immunologic factors|mesh-ancestor
6366833|NCT00114192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366834|NCT00114192|Leprostatic Agents|leprostatic agents|mesh-ancestor
6366835|NCT00114192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6366836|NCT00114192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6366837|NCT00114192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6366838|NCT00114192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6366839|NCT00114192|Growth Substances|growth substances|mesh-ancestor
6366840|NCT00114192|Growth Inhibitors|growth inhibitors|mesh-ancestor
6366841|NCT00114205|Docetaxel|docetaxel|mesh-list
6366842|NCT00114205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6366843|NCT00114205|Tubulin Modulators|tubulin modulators|mesh-ancestor
6366844|NCT00114205|Antimitotic Agents|antimitotic agents|mesh-ancestor
6366845|NCT00114205|Mitosis Modulators|mitosis modulators|mesh-ancestor
6366846|NCT00114205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366847|NCT00114257|Decitabine|decitabine|mesh-list
6366848|NCT00114257|Romidepsin|romidepsin|mesh-list
6366849|NCT00114257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6366850|NCT00114257|Antimetabolites|antimetabolites|mesh-ancestor
6366851|NCT00114257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366852|NCT00114257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6366853|NCT00114257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6366854|NCT00114257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6366855|NCT00114270|Zoledronic Acid|zoledronic acid|mesh-list
6366856|NCT00114270|Letrozole|letrozole|mesh-list
6366857|NCT00114270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6366858|NCT00114270|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6366859|NCT00114270|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6366860|NCT00114270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6366861|NCT00114270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366862|NCT00114270|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6366863|NCT00114270|Hormone Antagonists|hormone antagonists|mesh-ancestor
6366864|NCT00114270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6366865|NCT00114270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366866|NCT00114270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6366867|NCT00114283|Lapatinib|lapatinib|mesh-list
6366868|NCT00114283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6366869|NCT00114283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6366870|NCT00114283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6366871|NCT00114283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366872|NCT00114361|Ribavirin|ribavirin|mesh-list
6366873|NCT00114361|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6366874|NCT00114361|Antimetabolites|antimetabolites|mesh-ancestor
6366875|NCT00114361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366876|NCT00114361|Antiviral Agents|antiviral agents|mesh-ancestor
6366877|NCT00114361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6366878|NCT00114374|Citalopram|citalopram|mesh-list
6366879|NCT00114374|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6366880|NCT00114374|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6366881|NCT00114374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6366882|NCT00114374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366883|NCT00114374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6366884|NCT00114374|Serotonin Agents|serotonin agents|mesh-ancestor
6366885|NCT00114374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366886|NCT00114374|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6366887|NCT00114374|Antidepressive Agents|antidepressive agents|mesh-ancestor
6366888|NCT00114374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6366889|NCT00114387|Tocopherols|tocopherols|mesh-list
6366890|NCT00114387|Vitamin E|vitamin e|mesh-list
6366891|NCT00114387|Tocotrienols|tocotrienols|mesh-list
6366892|NCT00114387|alpha-Tocopherol|alpha-tocopherol|mesh-list
6366893|NCT00114387|Antioxidants|antioxidants|mesh-ancestor
6366894|NCT00114387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366895|NCT00114387|Protective Agents|protective agents|mesh-ancestor
6366896|NCT00114387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366897|NCT00114387|Vitamins|vitamins|mesh-ancestor
6366898|NCT00114387|Micronutrients|micronutrients|mesh-ancestor
6366899|NCT00114400|Vitamins|vitamins|mesh-list
6366900|NCT00114400|Folic Acid|folic acid|mesh-list
6366901|NCT00114400|Vitamin B 12|vitamin b 12|mesh-list
6366902|NCT00114400|Hydroxocobalamin|hydroxocobalamin|mesh-list
6366903|NCT00114400|Vitamin B 6|vitamin b 6|mesh-list
6366904|NCT00114400|Pyridoxal|pyridoxal|mesh-list
6366905|NCT00114400|Pyridoxine|pyridoxine|mesh-list
6366906|NCT00114400|Vitamin B Complex|vitamin b complex|mesh-list
6366907|NCT00114400|Micronutrients|micronutrients|mesh-ancestor
6366908|NCT00114400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366909|NCT00114400|Hematinics|hematinics|mesh-ancestor
6366910|NCT00114439|Lithium Carbonate|lithium carbonate|mesh-list
6366911|NCT00114439|Antidepressive Agents|antidepressive agents|mesh-ancestor
6366912|NCT00114439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6366913|NCT00114439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6366914|NCT00114439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366915|NCT00114439|Antimanic Agents|antimanic agents|mesh-ancestor
6366916|NCT00114439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6366917|NCT00114439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6366918|NCT00114439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366919|NCT00114478|Epinephrine|epinephrine|mesh-list
6366920|NCT00114478|Albuterol|albuterol|mesh-list
6366921|NCT00114478|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6366922|NCT00114478|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6366923|NCT00114478|Adrenergic Agents|adrenergic agents|mesh-ancestor
6366924|NCT00114478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6366925|NCT00114478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366926|NCT00114478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366927|NCT00114478|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6366928|NCT00114478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6366929|NCT00114478|Autonomic Agents|autonomic agents|mesh-ancestor
6366930|NCT00114478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6366931|NCT00114478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6366932|NCT00114478|Respiratory System Agents|respiratory system agents|mesh-ancestor
6366933|NCT00114478|Mydriatics|mydriatics|mesh-ancestor
6366934|NCT00114478|Sympathomimetics|sympathomimetics|mesh-ancestor
6366935|NCT00114478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6366936|NCT00114478|Tocolytic Agents|tocolytic agents|mesh-ancestor
6366937|NCT00114478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6366938|NCT00114478|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6366939|NCT00114491|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6366940|NCT00114491|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6366941|NCT00114491|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6366942|NCT00114491|Antimetabolites|antimetabolites|mesh-ancestor
6366943|NCT00114491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366944|NCT00114491|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6366945|NCT00114491|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6366946|NCT00114491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6366947|NCT00114556|Zoledronic Acid|zoledronic acid|mesh-list
6366948|NCT00114556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6366949|NCT00114556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366950|NCT00114569|Lorazepam|lorazepam|mesh-list
6366951|NCT00114569|Anticonvulsants|anticonvulsants|mesh-ancestor
6366952|NCT00114569|Antiemetics|antiemetics|mesh-ancestor
6366953|NCT00114569|Autonomic Agents|autonomic agents|mesh-ancestor
6366954|NCT00114569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6366955|NCT00114569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366956|NCT00114569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6366957|NCT00114569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6366958|NCT00114569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6366959|NCT00114569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6366960|NCT00114569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6366961|NCT00114569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6366962|NCT00114569|GABA Modulators|gaba modulators|mesh-ancestor
6366963|NCT00114569|GABA Agents|gaba agents|mesh-ancestor
6366964|NCT00114569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6366965|NCT00114569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366966|NCT00114686|Valproic Acid|valproic acid|mesh-list
6366967|NCT00114686|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6366968|NCT00114686|Antidepressive Agents|antidepressive agents|mesh-ancestor
6366969|NCT00114686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6366970|NCT00114686|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6366971|NCT00114686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6366972|NCT00114686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6366973|NCT00114686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366974|NCT00114686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6366975|NCT00114686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366976|NCT00114686|Antimanic Agents|antimanic agents|mesh-ancestor
6366977|NCT00114686|Anticonvulsants|anticonvulsants|mesh-ancestor
6366978|NCT00114686|GABA Agents|gaba agents|mesh-ancestor
6366979|NCT00114686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6366980|NCT00114764|Lenograstim|lenograstim|mesh-list
6366981|NCT00114764|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6366982|NCT00114764|Immunologic Factors|immunologic factors|mesh-ancestor
6366983|NCT00114764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366984|NCT00114803|Calcitonin|calcitonin|mesh-list
6017326|NCT00371826|Antifungal Agents|antifungal agents|mesh-ancestor
6017327|NCT00371826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6017328|NCT00371826|Dermatologic Agents|dermatologic agents|mesh-ancestor
6017329|NCT00371826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6017330|NCT00371826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6017331|NCT00371826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6017332|NCT00371826|Antitubercular Agents|antitubercular agents|mesh-ancestor
6017333|NCT00371826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6366985|NCT00114803|Salmon calcitonin|salmon calcitonin|mesh-list
6366986|NCT00114803|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
6366987|NCT00114803|Katacalcin|katacalcin|mesh-list
6366988|NCT00114803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6366989|NCT00114803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6366990|NCT00114803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6366991|NCT00114803|Vasodilator Agents|vasodilator agents|mesh-ancestor
6366992|NCT00114816|Docetaxel|docetaxel|mesh-list
6366993|NCT00114816|Capecitabine|capecitabine|mesh-list
6366994|NCT00114816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6366995|NCT00114816|Tubulin Modulators|tubulin modulators|mesh-ancestor
6366996|NCT00114816|Antimitotic Agents|antimitotic agents|mesh-ancestor
6366997|NCT00114816|Mitosis Modulators|mitosis modulators|mesh-ancestor
6366998|NCT00114816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6366999|NCT00114816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6367000|NCT00114816|Antimetabolites|antimetabolites|mesh-ancestor
6367001|NCT00114868|Vitamins|vitamins|mesh-list
6367002|NCT00114868|Vitamin A|vitamin a|mesh-list
6367003|NCT00114868|Retinol palmitate|retinol palmitate|mesh-list
6367004|NCT00114868|Micronutrients|micronutrients|mesh-ancestor
6367005|NCT00114868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367006|NCT00114868|Antioxidants|antioxidants|mesh-ancestor
6367007|NCT00114868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367008|NCT00114868|Protective Agents|protective agents|mesh-ancestor
6367009|NCT00114868|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6367010|NCT00114868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6367011|NCT00114933|Ritonavir|ritonavir|mesh-list
6367012|NCT00114933|Lopinavir|lopinavir|mesh-list
6367013|NCT00114933|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6367014|NCT00114933|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6367015|NCT00114933|Protease Inhibitors|protease inhibitors|mesh-ancestor
6367016|NCT00114933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6367017|NCT00114933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367018|NCT00114933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6367019|NCT00114933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6367020|NCT00114933|Antiviral Agents|antiviral agents|mesh-ancestor
6367021|NCT00114933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6367022|NCT00114933|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6367023|NCT00114933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6367024|NCT00114946|Bevacizumab|bevacizumab|mesh-list
6367025|NCT00114946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6367026|NCT00114946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6367027|NCT00114946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6367028|NCT00114946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6367029|NCT00114946|Growth Substances|growth substances|mesh-ancestor
6367030|NCT00114946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367031|NCT00114946|Growth Inhibitors|growth inhibitors|mesh-ancestor
6367032|NCT00115011|Citalopram|citalopram|mesh-list
6367033|NCT00115011|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6367034|NCT00115011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6367035|NCT00115011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6367036|NCT00115011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367037|NCT00115011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6367038|NCT00115011|Serotonin Agents|serotonin agents|mesh-ancestor
6367039|NCT00115011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367040|NCT00115011|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6367041|NCT00115011|Antidepressive Agents|antidepressive agents|mesh-ancestor
6367042|NCT00115011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6367043|NCT00115024|Estradiol|estradiol|mesh-list
6367044|NCT00115024|Estrogens|estrogens|mesh-ancestor
6367045|NCT00115024|Hormones|hormones|mesh-ancestor
6367046|NCT00115024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6367047|NCT00115024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367048|NCT00115089|Beclomethasone|beclomethasone|mesh-list
6367049|NCT00115089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6367050|NCT00115089|Glucocorticoids|glucocorticoids|mesh-ancestor
6367051|NCT00115089|Hormones|hormones|mesh-ancestor
6367052|NCT00115089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6367053|NCT00115089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367054|NCT00115089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6367055|NCT00115089|Respiratory System Agents|respiratory system agents|mesh-ancestor
6367056|NCT00115102|Fentanyl|fentanyl|mesh-list
6367057|NCT00115102|Ketamine|ketamine|mesh-list
6367058|NCT00115102|Esketamine|esketamine|mesh-list
6367059|NCT00115102|Analgesics|analgesics|mesh-ancestor
6367060|NCT00115102|Sensory System Agents|sensory system agents|mesh-ancestor
6367061|NCT00115102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6367062|NCT00115102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367063|NCT00115102|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6367064|NCT00115102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6367065|NCT00115102|Anesthetics, General|anesthetics, general|mesh-ancestor
6367066|NCT00115102|Anesthetics|anesthetics|mesh-ancestor
6367067|NCT00115102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6367068|NCT00115102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6367069|NCT00115102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6367070|NCT00115102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5724635|NCT03186040|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6367071|NCT00115102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367072|NCT00115102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6367073|NCT00115102|Narcotics|narcotics|mesh-ancestor
6367074|NCT00115102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6367075|NCT00115102|Antidepressive Agents|antidepressive agents|mesh-ancestor
6367076|NCT00115102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6367077|NCT00115115|Dopamine|dopamine|mesh-list
6367078|NCT00115115|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6367079|NCT00115115|Sympathomimetics|sympathomimetics|mesh-ancestor
6367080|NCT00115115|Autonomic Agents|autonomic agents|mesh-ancestor
6367081|NCT00115115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6367082|NCT00115115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367083|NCT00115115|Dopamine Agents|dopamine agents|mesh-ancestor
6367084|NCT00115115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6367085|NCT00115115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367086|NCT00115115|Protective Agents|protective agents|mesh-ancestor
6367087|NCT00115128|Lenograstim|lenograstim|mesh-list
6367088|NCT00115128|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6367089|NCT00115128|Immunologic Factors|immunologic factors|mesh-ancestor
6367090|NCT00115128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367091|NCT00115154|Imiquimod|imiquimod|mesh-list
6367092|NCT00115154|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6367093|NCT00115154|Immunologic Factors|immunologic factors|mesh-ancestor
6367094|NCT00115154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367095|NCT00115154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6367096|NCT00115154|Interferon Inducers|interferon inducers|mesh-ancestor
6367097|NCT00115167|Darbepoetin alfa|darbepoetin alfa|mesh-list
6367098|NCT00115167|Hematinics|hematinics|mesh-ancestor
6367099|NCT00115219|Etanercept|etanercept|mesh-list
6367100|NCT00115219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6367101|NCT00115219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6367102|NCT00115219|Analgesics|analgesics|mesh-ancestor
6367103|NCT00115219|Sensory System Agents|sensory system agents|mesh-ancestor
6367104|NCT00115219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6367105|NCT00115219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367106|NCT00115219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6367107|NCT00115219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6367108|NCT00115219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6367109|NCT00115219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6367110|NCT00115219|Immunologic Factors|immunologic factors|mesh-ancestor
6367111|NCT00115245|Adefovir|adefovir|mesh-list
6367112|NCT00115245|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6367113|NCT00115245|Telbivudine|telbivudine|mesh-list
6367114|NCT00115245|Antiviral Agents|antiviral agents|mesh-ancestor
6367115|NCT00115245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6367116|NCT00115245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6367117|NCT00115245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6367118|NCT00115245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6367119|NCT00115245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367120|NCT00115310|Capsaicin|capsaicin|mesh-list
6367121|NCT00115310|Antipruritics|antipruritics|mesh-ancestor
6367122|NCT00115310|Dermatologic Agents|dermatologic agents|mesh-ancestor
6367123|NCT00115310|Sensory System Agents|sensory system agents|mesh-ancestor
6367124|NCT00115310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6367125|NCT00115310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367126|NCT00115362|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6367127|NCT00115362|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6367128|NCT00115362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6367129|NCT00115362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6367130|NCT00115362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367131|NCT00115362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6367132|NCT00115362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367133|NCT00115362|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6367134|NCT00115362|Antidepressive Agents|antidepressive agents|mesh-ancestor
6367135|NCT00115362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6367136|NCT00115375|Clopidogrel|clopidogrel|mesh-list
6367137|NCT00115375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6367138|NCT00115375|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6367139|NCT00115375|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6367140|NCT00115375|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6367141|NCT00115375|Purinergic Agents|purinergic agents|mesh-ancestor
6367142|NCT00115375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6367143|NCT00115375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367144|NCT00115375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395249|NCT00204568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395250|NCT00204568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6395251|NCT00204568|Immunologic Factors|immunologic factors|mesh-ancestor
6395252|NCT00204568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395253|NCT00204568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6395254|NCT00204568|Alkylating Agents|alkylating agents|mesh-ancestor
6395255|NCT00204581|Aldesleukin|aldesleukin|mesh-list
6395256|NCT00204581|Interleukin-2|interleukin-2|mesh-list
6395257|NCT00204581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6395258|NCT00204581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6395259|NCT00204581|Analgesics|analgesics|mesh-ancestor
6395260|NCT00204581|Sensory System Agents|sensory system agents|mesh-ancestor
6395261|NCT00204581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6395262|NCT00204581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395263|NCT00204581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6395264|NCT00204581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6395265|NCT00204581|Antiviral Agents|antiviral agents|mesh-ancestor
6395266|NCT00204581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6395267|NCT00204620|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6395268|NCT00204620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6395269|NCT00204620|Alkylating Agents|alkylating agents|mesh-ancestor
6395270|NCT00204620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395271|NCT00204620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6395272|NCT00204633|Darbepoetin alfa|darbepoetin alfa|mesh-list
6395273|NCT00204633|Hematinics|hematinics|mesh-ancestor
6395274|NCT00204646|Carboplatin|carboplatin|mesh-list
6395275|NCT00204646|Etoposide|etoposide|mesh-list
6395276|NCT00204646|Doxorubicin|doxorubicin|mesh-list
6395277|NCT00204646|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6395278|NCT00204646|Ifosfamide|ifosfamide|mesh-list
6395279|NCT00204646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6395280|NCT00204646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6395281|NCT00204646|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6367145|NCT00115414|Cyclophosphamide|cyclophosphamide|mesh-list
6367146|NCT00115414|Docetaxel|docetaxel|mesh-list
6367147|NCT00115414|Doxorubicin|doxorubicin|mesh-list
6367148|NCT00115414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6367149|NCT00115414|Immunologic Factors|immunologic factors|mesh-ancestor
6367150|NCT00115414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367151|NCT00115414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6367152|NCT00115414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6367153|NCT00115414|Alkylating Agents|alkylating agents|mesh-ancestor
6367154|NCT00115414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367155|NCT00115414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6367156|NCT00115414|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6367157|NCT00115414|Tubulin Modulators|tubulin modulators|mesh-ancestor
6367158|NCT00115414|Antimitotic Agents|antimitotic agents|mesh-ancestor
6367159|NCT00115414|Mitosis Modulators|mitosis modulators|mesh-ancestor
6367160|NCT00115414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6367161|NCT00115414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6367162|NCT00115414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6367163|NCT00115414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6367164|NCT00115479|Benzocaine|benzocaine|mesh-list
6367165|NCT00115479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367166|NCT00115479|Anesthetics, Local|anesthetics, local|mesh-ancestor
6367167|NCT00115479|Anesthetics|anesthetics|mesh-ancestor
6367168|NCT00115479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6367169|NCT00115479|Sensory System Agents|sensory system agents|mesh-ancestor
6367170|NCT00115479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6367171|NCT00115492|Fluticasone|fluticasone|mesh-list
6367172|NCT00115492|Xhance|xhance|mesh-list
6367173|NCT00115492|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6367174|NCT00115492|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6367175|NCT00115492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6367176|NCT00115492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6367177|NCT00115492|Autonomic Agents|autonomic agents|mesh-ancestor
6367178|NCT00115492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6367179|NCT00115492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367180|NCT00115492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6367181|NCT00115492|Respiratory System Agents|respiratory system agents|mesh-ancestor
6367182|NCT00115492|Dermatologic Agents|dermatologic agents|mesh-ancestor
6367183|NCT00115492|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6367184|NCT00115492|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6367185|NCT00115492|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6367186|NCT00115492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6367187|NCT00115492|Adrenergic Agents|adrenergic agents|mesh-ancestor
6367188|NCT00115492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6367189|NCT00115492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367190|NCT00115492|Glucocorticoids|glucocorticoids|mesh-ancestor
6367191|NCT00115492|Hormones|hormones|mesh-ancestor
6367192|NCT00115492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6367193|NCT00115492|Sympathomimetics|sympathomimetics|mesh-ancestor
6367194|NCT00115518|Cetuximab|cetuximab|mesh-list
6367195|NCT00115518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6367196|NCT00115518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6367197|NCT00115531|Vaccines|vaccines|mesh-list
6367198|NCT00115531|Immunologic Factors|immunologic factors|mesh-ancestor
6367199|NCT00115531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367200|NCT00115544|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
6367201|NCT00115544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6367202|NCT00115544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367203|NCT00115570|Insulin|insulin|mesh-list
6367204|NCT00115570|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6367205|NCT00115570|Insulin Glargine|insulin glargine|mesh-list
6367206|NCT00115570|Insulin Lispro|insulin lispro|mesh-list
6367207|NCT00115570|Insulin glulisine|insulin glulisine|mesh-list
6367208|NCT00115570|Insulin, Isophane|insulin, isophane|mesh-list
6367209|NCT00115570|Isophane Insulin, Human|isophane insulin, human|mesh-list
6367210|NCT00115570|Isophane insulin, beef|isophane insulin, beef|mesh-list
6367211|NCT00115570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6367212|NCT00115570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367213|NCT00115583|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
6367214|NCT00115583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6367215|NCT00115583|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6367216|NCT00115583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367217|NCT00115609|Tenofovir|tenofovir|mesh-list
6367218|NCT00115609|Emtricitabine|emtricitabine|mesh-list
6367219|NCT00115609|Efavirenz|efavirenz|mesh-list
6367220|NCT00115609|Antiviral Agents|antiviral agents|mesh-ancestor
6367221|NCT00115609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6367222|NCT00115609|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6367223|NCT00115609|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6367224|NCT00115609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6367225|NCT00115609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367226|NCT00115609|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6367227|NCT00115609|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6367228|NCT00115609|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6367229|NCT00115609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6367230|NCT00115609|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6367231|NCT00115609|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6367232|NCT00115609|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6367233|NCT00115609|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6367234|NCT00115622|Fluticasone|fluticasone|mesh-list
6367235|NCT00115622|Xhance|xhance|mesh-list
6367236|NCT00115622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6367237|NCT00115622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6367238|NCT00115622|Autonomic Agents|autonomic agents|mesh-ancestor
6367239|NCT00115622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6367240|NCT00115622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367241|NCT00115622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6367242|NCT00115622|Respiratory System Agents|respiratory system agents|mesh-ancestor
6367243|NCT00115622|Dermatologic Agents|dermatologic agents|mesh-ancestor
6367244|NCT00115622|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6367245|NCT00115635|Gemcitabine|gemcitabine|mesh-list
6367246|NCT00115635|Docetaxel|docetaxel|mesh-list
6367247|NCT00115635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6367248|NCT00115635|Antimetabolites|antimetabolites|mesh-ancestor
6367249|NCT00115635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367250|NCT00115635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6367251|NCT00115635|Antiviral Agents|antiviral agents|mesh-ancestor
6367252|NCT00115635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6367253|NCT00115635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6367254|NCT00115635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6367255|NCT00115635|Immunologic Factors|immunologic factors|mesh-ancestor
6367256|NCT00115635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367257|NCT00115635|Tubulin Modulators|tubulin modulators|mesh-ancestor
6367258|NCT00115635|Antimitotic Agents|antimitotic agents|mesh-ancestor
6367259|NCT00115635|Mitosis Modulators|mitosis modulators|mesh-ancestor
6367260|NCT00115648|Zidovudine|zidovudine|mesh-list
6367261|NCT00115648|Nevirapine|nevirapine|mesh-list
6367262|NCT00115648|Antimetabolites|antimetabolites|mesh-ancestor
6395282|NCT00204646|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6367263|NCT00115648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367264|NCT00115648|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6367265|NCT00115648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6367266|NCT00115648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6367267|NCT00115648|Antiviral Agents|antiviral agents|mesh-ancestor
6367268|NCT00115648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6367269|NCT00115648|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6367270|NCT00115648|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6367271|NCT00115648|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6367272|NCT00115648|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6367273|NCT00115661|Rosiglitazone|rosiglitazone|mesh-list
6367274|NCT00115661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6367275|NCT00115661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367276|NCT00115687|Nicotine|nicotine|mesh-list
6367277|NCT00115687|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6367278|NCT00115687|Autonomic Agents|autonomic agents|mesh-ancestor
6367279|NCT00115687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6367280|NCT00115687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367281|NCT00115687|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6367282|NCT00115687|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6367283|NCT00115687|Cholinergic Agents|cholinergic agents|mesh-ancestor
6367284|NCT00115687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6367285|NCT00115687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367286|NCT00115700|Prednisolone|prednisolone|mesh-list
6367287|NCT00115700|Cyclophosphamide|cyclophosphamide|mesh-list
6367288|NCT00115700|Rituximab|rituximab|mesh-list
6367289|NCT00115700|Vincristine|vincristine|mesh-list
6367290|NCT00115700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6367291|NCT00115700|Immunologic Factors|immunologic factors|mesh-ancestor
6367292|NCT00115700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367293|NCT00115700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6367294|NCT00115700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6367295|NCT00115700|Alkylating Agents|alkylating agents|mesh-ancestor
6367296|NCT00115700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367297|NCT00115700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6367298|NCT00115700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6367299|NCT00115700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6367300|NCT00115700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6367301|NCT00115700|Tubulin Modulators|tubulin modulators|mesh-ancestor
6367302|NCT00115700|Antimitotic Agents|antimitotic agents|mesh-ancestor
6367303|NCT00115700|Mitosis Modulators|mitosis modulators|mesh-ancestor
6367304|NCT00115700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6367305|NCT00115700|Glucocorticoids|glucocorticoids|mesh-ancestor
6367306|NCT00115700|Hormones|hormones|mesh-ancestor
6367307|NCT00115700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6367308|NCT00115700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6367309|NCT00115726|Furosemide|furosemide|mesh-list
6367310|NCT00115726|Diuretics|diuretics|mesh-ancestor
6367311|NCT00115726|Natriuretic Agents|natriuretic agents|mesh-ancestor
6367312|NCT00115726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367313|NCT00115726|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6367314|NCT00115726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6367315|NCT00115726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367316|NCT00115752|Valdecoxib|valdecoxib|mesh-list
6367317|NCT00115752|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
6367318|NCT00115752|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6367319|NCT00115752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6367320|NCT00115752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395283|NCT00204646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6367321|NCT00115752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6367322|NCT00115752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6367323|NCT00115752|Analgesics|analgesics|mesh-ancestor
6367324|NCT00115752|Sensory System Agents|sensory system agents|mesh-ancestor
6367325|NCT00115752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6367326|NCT00115752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367327|NCT00115752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6367328|NCT00115752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6367329|NCT00115817|Atorvastatin|atorvastatin|mesh-list
6367330|NCT00115817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6367331|NCT00115817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6367332|NCT00115817|Antimetabolites|antimetabolites|mesh-ancestor
6367333|NCT00115817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367334|NCT00115817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6367335|NCT00115817|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6367336|NCT00115817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6367337|NCT00115830|Atorvastatin|atorvastatin|mesh-list
6367338|NCT00115830|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6367339|NCT00115830|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6367340|NCT00115830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6367341|NCT00115830|Antimetabolites|antimetabolites|mesh-ancestor
6367342|NCT00115830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367343|NCT00115830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6367344|NCT00115830|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6367345|NCT00115830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6367346|NCT00115908|Ribavirin|ribavirin|mesh-list
6367347|NCT00115908|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6367348|NCT00115908|Antimetabolites|antimetabolites|mesh-ancestor
6367349|NCT00115908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367350|NCT00115908|Antiviral Agents|antiviral agents|mesh-ancestor
6367351|NCT00115908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6367352|NCT00115921|Antimalarials|antimalarials|mesh-list
6367353|NCT00115921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6367354|NCT00115921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6367355|NCT00115921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6367356|NCT00115947|Terlipressin|terlipressin|mesh-list
6367357|NCT00115947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6367358|NCT00115947|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6367359|NCT00115973|Insulin Aspart|insulin aspart|mesh-list
6367360|NCT00115973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6367361|NCT00115973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367362|NCT00116064|Lorazepam|lorazepam|mesh-list
6367363|NCT00116064|Paraldehyde|paraldehyde|mesh-list
6367364|NCT00116064|Anticonvulsants|anticonvulsants|mesh-ancestor
6367365|NCT00116064|Antiemetics|antiemetics|mesh-ancestor
6367366|NCT00116064|Autonomic Agents|autonomic agents|mesh-ancestor
6367367|NCT00116064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6367368|NCT00116064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367369|NCT00116064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6367370|NCT00116064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6367371|NCT00116064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6367372|NCT00116064|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6367373|NCT00116064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6367374|NCT00116064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6367375|NCT00116064|GABA Modulators|gaba modulators|mesh-ancestor
6367376|NCT00116064|GABA Agents|gaba agents|mesh-ancestor
6367377|NCT00116064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6367378|NCT00116064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367379|NCT00116103|Tacrolimus|tacrolimus|mesh-list
6367380|NCT00116103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6367381|NCT00116103|Immunologic Factors|immunologic factors|mesh-ancestor
6367382|NCT00116103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367383|NCT00116103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6367384|NCT00116103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6367385|NCT00116103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367386|NCT00116181|Etanercept|etanercept|mesh-list
6367387|NCT00116181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6367388|NCT00116181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6367389|NCT00116181|Analgesics|analgesics|mesh-ancestor
6367390|NCT00116181|Sensory System Agents|sensory system agents|mesh-ancestor
6367391|NCT00116181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6367392|NCT00116181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367393|NCT00116181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6367394|NCT00116181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6367395|NCT00116181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6367396|NCT00116181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6367397|NCT00116181|Immunologic Factors|immunologic factors|mesh-ancestor
6367398|NCT00116259|Aripiprazole|aripiprazole|mesh-list
6367399|NCT00116259|Antidepressive Agents|antidepressive agents|mesh-ancestor
6367400|NCT00116259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6367401|NCT00116259|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6367402|NCT00116259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6367403|NCT00116259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6367404|NCT00116259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367405|NCT00116259|Dopamine Agonists|dopamine agonists|mesh-ancestor
6367406|NCT00116259|Dopamine Agents|dopamine agents|mesh-ancestor
6367407|NCT00116259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6367408|NCT00116259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367409|NCT00116259|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6367410|NCT00116259|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6367411|NCT00116259|Serotonin Agents|serotonin agents|mesh-ancestor
6367412|NCT00116259|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6367413|NCT00116259|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6367414|NCT00116259|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6367415|NCT00116259|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6367416|NCT00116324|Montelukast|montelukast|mesh-list
6367417|NCT00116324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6367418|NCT00116324|Respiratory System Agents|respiratory system agents|mesh-ancestor
6367419|NCT00116324|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6367420|NCT00116324|Hormone Antagonists|hormone antagonists|mesh-ancestor
6367421|NCT00116324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6367422|NCT00116324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367423|NCT00116324|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6367424|NCT00116324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6367425|NCT00116324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367426|NCT00116350|Misoprostol|misoprostol|mesh-list
6367427|NCT00116350|Oxytocin|oxytocin|mesh-list
6367428|NCT00116350|Oxytocics|oxytocics|mesh-ancestor
6367429|NCT00116350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6367430|NCT00116350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367431|NCT00116350|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6367432|NCT00116350|Abortifacient Agents|abortifacient agents|mesh-ancestor
6367433|NCT00116350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6367434|NCT00116350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6367435|NCT00116389|Gemcitabine|gemcitabine|mesh-list
6367436|NCT00116389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6367437|NCT00116389|Antimetabolites|antimetabolites|mesh-ancestor
6367438|NCT00116389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367439|NCT00116389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6367440|NCT00116389|Antiviral Agents|antiviral agents|mesh-ancestor
6367441|NCT00116389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6367442|NCT00116389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6367443|NCT00116389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6367444|NCT00116389|Immunologic Factors|immunologic factors|mesh-ancestor
6367445|NCT00116389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367446|NCT00116402|Fluticasone|fluticasone|mesh-list
6367447|NCT00116402|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6367448|NCT00116402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6367449|NCT00116402|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6367450|NCT00116402|Autonomic Agents|autonomic agents|mesh-ancestor
6367451|NCT00116402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6367452|NCT00116402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367453|NCT00116402|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6367454|NCT00116402|Respiratory System Agents|respiratory system agents|mesh-ancestor
6367455|NCT00116402|Dermatologic Agents|dermatologic agents|mesh-ancestor
6367456|NCT00116402|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6367457|NCT00116402|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6367458|NCT00116402|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6367459|NCT00116402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6367460|NCT00116402|Adrenergic Agents|adrenergic agents|mesh-ancestor
6367461|NCT00116402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6367462|NCT00116402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367463|NCT00116454|Ethiodized Oil|ethiodized oil|mesh-list
6367464|NCT00116454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6367465|NCT00116467|Vaccines|vaccines|mesh-list
6367466|NCT00116467|Immunologic Factors|immunologic factors|mesh-ancestor
6367467|NCT00116467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367468|NCT00116480|Misoprostol|misoprostol|mesh-list
6367469|NCT00116480|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6367470|NCT00116480|Abortifacient Agents|abortifacient agents|mesh-ancestor
6367471|NCT00116480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6367472|NCT00116480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367473|NCT00116480|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6367474|NCT00116480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6367475|NCT00116480|Oxytocics|oxytocics|mesh-ancestor
6367476|NCT00116493|Folic Acid|folic acid|mesh-list
6367477|NCT00116493|Mebendazole|mebendazole|mesh-list
6367478|NCT00116493|Piperazine|piperazine|mesh-list
6367479|NCT00116493|Piperazine citrate|piperazine citrate|mesh-list
6367480|NCT00116493|DMP 777|dmp 777|mesh-list
6367481|NCT00116493|Hematinics|hematinics|mesh-ancestor
6367482|NCT00116493|Vitamin B Complex|vitamin b complex|mesh-ancestor
6367483|NCT00116493|Vitamins|vitamins|mesh-ancestor
6367484|NCT00116493|Micronutrients|micronutrients|mesh-ancestor
6367485|NCT00116493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367486|NCT00116493|Antinematodal Agents|antinematodal agents|mesh-ancestor
6367487|NCT00116493|Anthelmintics|anthelmintics|mesh-ancestor
6367488|NCT00116493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6367489|NCT00116493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6367490|NCT00116493|Tubulin Modulators|tubulin modulators|mesh-ancestor
6367491|NCT00116493|Antimitotic Agents|antimitotic agents|mesh-ancestor
6367492|NCT00116493|Mitosis Modulators|mitosis modulators|mesh-ancestor
6367493|NCT00116493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367494|NCT00116493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6367495|NCT00116493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6367496|NCT00116506|Bevacizumab|bevacizumab|mesh-list
6367497|NCT00116506|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6367498|NCT00116506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6367499|NCT00116506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6367500|NCT00116506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6367501|NCT00116506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6367502|NCT00116506|Growth Substances|growth substances|mesh-ancestor
6367503|NCT00116506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367504|NCT00116506|Growth Inhibitors|growth inhibitors|mesh-ancestor
6367505|NCT00116506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6367506|NCT00116506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6367507|NCT00116506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367508|NCT00116532|Citalopram|citalopram|mesh-list
6367509|NCT00116532|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6367510|NCT00116532|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6367511|NCT00116532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6367512|NCT00116532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367513|NCT00116532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6367514|NCT00116532|Serotonin Agents|serotonin agents|mesh-ancestor
6367515|NCT00116532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367516|NCT00116532|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6367517|NCT00116532|Antidepressive Agents|antidepressive agents|mesh-ancestor
6367518|NCT00116532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6367519|NCT00116545|Troglitazone|troglitazone|mesh-list
6367520|NCT00116545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6367521|NCT00116545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367522|NCT00116597|Vaccines|vaccines|mesh-list
6367523|NCT00116597|Immunologic Factors|immunologic factors|mesh-ancestor
6367524|NCT00116597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367525|NCT00116623|Indomethacin|indomethacin|mesh-list
6367526|NCT00116623|Magnesium Sulfate|magnesium sulfate|mesh-list
6367527|NCT00116623|Analgesics|analgesics|mesh-ancestor
6367528|NCT00116623|Sensory System Agents|sensory system agents|mesh-ancestor
6367529|NCT00116623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6367530|NCT00116623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367531|NCT00116623|Anesthetics|anesthetics|mesh-ancestor
6367532|NCT00116623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6367533|NCT00116623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6367534|NCT00116623|Anticonvulsants|anticonvulsants|mesh-ancestor
6367535|NCT00116623|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6367536|NCT00116623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6367537|NCT00116623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367538|NCT00116623|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6367539|NCT00116623|Tocolytic Agents|tocolytic agents|mesh-ancestor
6367540|NCT00116623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6367541|NCT00116623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6367542|NCT00116623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6367543|NCT00116623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6367544|NCT00116623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6367545|NCT00116623|Gout Suppressants|gout suppressants|mesh-ancestor
6367546|NCT00116623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6367547|NCT00116623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6367548|NCT00116636|Lopinavir|lopinavir|mesh-list
6367549|NCT00116636|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6367550|NCT00116636|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6367551|NCT00116636|Protease Inhibitors|protease inhibitors|mesh-ancestor
6367552|NCT00116636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6367553|NCT00116636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367554|NCT00116636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6367555|NCT00116636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6367556|NCT00116636|Antiviral Agents|antiviral agents|mesh-ancestor
6367557|NCT00116636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6367558|NCT00116636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6367559|NCT00116636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6367560|NCT00116701|Darbepoetin alfa|darbepoetin alfa|mesh-list
6367561|NCT00116701|Hematinics|hematinics|mesh-ancestor
6367562|NCT00116727|Etanercept|etanercept|mesh-list
6367563|NCT00116727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6367564|NCT00116727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6367565|NCT00116727|Analgesics|analgesics|mesh-ancestor
6367566|NCT00116727|Sensory System Agents|sensory system agents|mesh-ancestor
6367567|NCT00116727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6367568|NCT00116727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367569|NCT00116727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6367570|NCT00116727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6367571|NCT00116727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6367572|NCT00116727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6367573|NCT00116727|Immunologic Factors|immunologic factors|mesh-ancestor
6367574|NCT00116870|Lovastatin|lovastatin|mesh-list
6367575|NCT00116870|L 647318|l 647318|mesh-list
6367576|NCT00116870|Dihydromevinolin|dihydromevinolin|mesh-list
6367577|NCT00116870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6367578|NCT00116870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6367579|NCT00116870|Antimetabolites|antimetabolites|mesh-ancestor
6367580|NCT00116870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367581|NCT00116870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6367582|NCT00116870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6367583|NCT00116870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6367584|NCT00116896|Cisplatin|cisplatin|mesh-list
6367585|NCT00116896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6367586|NCT00116922|Metformin|metformin|mesh-list
6367587|NCT00116922|Rosiglitazone|rosiglitazone|mesh-list
6367588|NCT00116922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6367589|NCT00116922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367590|NCT00116935|Imatinib Mesylate|imatinib mesylate|mesh-list
6367591|NCT00116935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6367592|NCT00116935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6367593|NCT00116935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6367594|NCT00116935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367595|NCT00116948|Cimetidine|cimetidine|mesh-list
6367596|NCT00116948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6367597|NCT00116948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6367598|NCT00116948|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6367599|NCT00116948|Histamine Antagonists|histamine antagonists|mesh-ancestor
6367600|NCT00116948|Histamine Agents|histamine agents|mesh-ancestor
6367601|NCT00116948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6367602|NCT00116948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367603|NCT00116948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367604|NCT00116948|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6367605|NCT00116948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6367606|NCT00116948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6367607|NCT00116961|Dexamethasone|dexamethasone|mesh-list
6367608|NCT00116961|Bortezomib|bortezomib|mesh-list
6367609|NCT00116961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6367610|NCT00116961|Antiemetics|antiemetics|mesh-ancestor
6367611|NCT00116961|Autonomic Agents|autonomic agents|mesh-ancestor
6367612|NCT00116961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6367613|NCT00116961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367614|NCT00116961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6367615|NCT00116961|Glucocorticoids|glucocorticoids|mesh-ancestor
6367616|NCT00116961|Hormones|hormones|mesh-ancestor
5724636|NCT03186040|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6367617|NCT00116961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6367618|NCT00116961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6367619|NCT00116961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6367620|NCT00117000|Methyltestosterone|methyltestosterone|mesh-list
6367621|NCT00117000|Testosterone|testosterone|mesh-list
6367622|NCT00117000|Testosterone undecanoate|testosterone undecanoate|mesh-list
6367623|NCT00117000|Testosterone enanthate|testosterone enanthate|mesh-list
6367624|NCT00117000|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6367625|NCT00117000|Androgens|androgens|mesh-ancestor
6367626|NCT00117000|Hormones|hormones|mesh-ancestor
6367627|NCT00117000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6367628|NCT00117000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367629|NCT00117000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6367630|NCT00117000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6367631|NCT00117000|Anabolic Agents|anabolic agents|mesh-ancestor
6367632|NCT00117013|Topotecan|topotecan|mesh-list
6367633|NCT00117013|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6367634|NCT00117013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6367635|NCT00117013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6367636|NCT00117013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367637|NCT00117013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6395284|NCT00204646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395285|NCT00204646|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6395286|NCT00204646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6395287|NCT00204646|Alkylating Agents|alkylating agents|mesh-ancestor
6395288|NCT00204659|Rituximab|rituximab|mesh-list
6395289|NCT00204659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6395290|NCT00204659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6395291|NCT00204659|Immunologic Factors|immunologic factors|mesh-ancestor
6395292|NCT00204659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395293|NCT00204659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6395294|NCT00204698|Rabeprazole|rabeprazole|mesh-list
6395295|NCT00204698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6395296|NCT00204698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6395297|NCT00204698|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6395298|NCT00204698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6395299|NCT00204698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395300|NCT00204737|Prednisone|prednisone|mesh-list
6395301|NCT00204737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6395302|NCT00204737|Glucocorticoids|glucocorticoids|mesh-ancestor
6395303|NCT00204737|Hormones|hormones|mesh-ancestor
6395304|NCT00204737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6395305|NCT00204737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395306|NCT00204737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6395307|NCT00204737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6395308|NCT00204776|Capecitabine|capecitabine|mesh-list
6395309|NCT00204776|Oxaliplatin|oxaliplatin|mesh-list
6395310|NCT00204776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6395311|NCT00204776|Antimetabolites|antimetabolites|mesh-ancestor
6395312|NCT00204776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395313|NCT00204776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6395314|NCT00204789|Eflornithine|eflornithine|mesh-list
6395315|NCT00204789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6395316|NCT00204789|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6395317|NCT00204789|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6395318|NCT00204789|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6395319|NCT00204789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6395320|NCT00204789|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
6395321|NCT00204789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6395322|NCT00204789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395323|NCT00204893|Calcium|calcium|mesh-list
6395324|NCT00204893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6395325|NCT00204893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395326|NCT00204906|Vitamin D|vitamin d|mesh-list
6395327|NCT00204906|Vitamins|vitamins|mesh-ancestor
6395328|NCT00204906|Micronutrients|micronutrients|mesh-ancestor
6395329|NCT00204906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395330|NCT00204906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6395331|NCT00204919|Vitamin D|vitamin d|mesh-list
6395332|NCT00204919|Ergocalciferols|ergocalciferols|mesh-list
6395333|NCT00204919|Vitamins|vitamins|mesh-ancestor
6395334|NCT00204919|Micronutrients|micronutrients|mesh-ancestor
6395335|NCT00204919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395336|NCT00204919|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6395337|NCT00204919|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6395338|NCT00204945|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6367638|NCT00117026|Benphothiamine|benphothiamine|mesh-list
6367639|NCT00117026|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6367640|NCT00117026|Immunologic Factors|immunologic factors|mesh-ancestor
6367641|NCT00117026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367642|NCT00117026|Chelating Agents|chelating agents|mesh-ancestor
6367643|NCT00117026|Sequestering Agents|sequestering agents|mesh-ancestor
6367644|NCT00117026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367645|NCT00117039|Darbepoetin alfa|darbepoetin alfa|mesh-list
6367646|NCT00117039|Hematinics|hematinics|mesh-ancestor
6367647|NCT00117052|Cinacalcet|cinacalcet|mesh-list
6367648|NCT00117052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6367649|NCT00117052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367650|NCT00117052|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6367651|NCT00117052|Hormone Antagonists|hormone antagonists|mesh-ancestor
6367652|NCT00117052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6367653|NCT00117065|Darbepoetin alfa|darbepoetin alfa|mesh-list
6367654|NCT00117065|Hematinics|hematinics|mesh-ancestor
6367655|NCT00117078|Darbepoetin alfa|darbepoetin alfa|mesh-list
6367656|NCT00117078|Hematinics|hematinics|mesh-ancestor
6367657|NCT00117091|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6367658|NCT00117091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6367659|NCT00117104|Darbepoetin alfa|darbepoetin alfa|mesh-list
6367660|NCT00117104|Hematinics|hematinics|mesh-ancestor
6367661|NCT00117117|Darbepoetin alfa|darbepoetin alfa|mesh-list
6367662|NCT00117117|Hematinics|hematinics|mesh-ancestor
6367663|NCT00117130|Darbepoetin alfa|darbepoetin alfa|mesh-list
6367664|NCT00117130|Hematinics|hematinics|mesh-ancestor
6367665|NCT00117182|Budesonide|budesonide|mesh-list
6367666|NCT00117182|Mannitol|mannitol|mesh-list
6367667|NCT00117182|Bromides|bromides|mesh-list
6367668|NCT00117182|Albuterol|albuterol|mesh-list
6367669|NCT00117182|Ipratropium|ipratropium|mesh-list
6367670|NCT00117182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6367671|NCT00117182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6367672|NCT00117182|Autonomic Agents|autonomic agents|mesh-ancestor
6367673|NCT00117182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6367674|NCT00117182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367675|NCT00117182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6367676|NCT00117182|Respiratory System Agents|respiratory system agents|mesh-ancestor
6367677|NCT00117182|Glucocorticoids|glucocorticoids|mesh-ancestor
6367678|NCT00117182|Hormones|hormones|mesh-ancestor
6367679|NCT00117182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6367680|NCT00117182|Anticonvulsants|anticonvulsants|mesh-ancestor
6367681|NCT00117182|Tocolytic Agents|tocolytic agents|mesh-ancestor
6367682|NCT00117182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6367683|NCT00117182|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6367684|NCT00117182|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6367685|NCT00117182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6367686|NCT00117182|Adrenergic Agents|adrenergic agents|mesh-ancestor
6367687|NCT00117182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6367688|NCT00117182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367689|NCT00117182|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6367690|NCT00117182|Diuretics|diuretics|mesh-ancestor
6367691|NCT00117182|Natriuretic Agents|natriuretic agents|mesh-ancestor
6367692|NCT00117182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6367693|NCT00117182|Cholinergic Agents|cholinergic agents|mesh-ancestor
6367694|NCT00117208|Mannitol|mannitol|mesh-list
6367695|NCT00117208|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6367696|NCT00117208|Diuretics|diuretics|mesh-ancestor
6367697|NCT00117208|Natriuretic Agents|natriuretic agents|mesh-ancestor
6367698|NCT00117208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367699|NCT00117234|Darbepoetin alfa|darbepoetin alfa|mesh-list
6367700|NCT00117234|Hematinics|hematinics|mesh-ancestor
6367701|NCT00117247|Darbepoetin alfa|darbepoetin alfa|mesh-list
6367702|NCT00117247|Hematinics|hematinics|mesh-ancestor
6367703|NCT00117260|Levonorgestrel|levonorgestrel|mesh-list
6367704|NCT00117260|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6367705|NCT00117260|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
6367706|NCT00117260|Estradiol|estradiol|mesh-list
6367707|NCT00117260|Estrogens|estrogens|mesh-ancestor
6367708|NCT00117260|Hormones|hormones|mesh-ancestor
6367709|NCT00117260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6367710|NCT00117260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367711|NCT00117260|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6367712|NCT00117260|Contraceptive Agents|contraceptive agents|mesh-ancestor
6367713|NCT00117260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6367714|NCT00117260|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6367715|NCT00117260|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6367716|NCT00117260|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6367717|NCT00117260|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6367718|NCT00117260|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6367719|NCT00117273|Levonorgestrel|levonorgestrel|mesh-list
6367720|NCT00117273|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6367721|NCT00117273|Estradiol|estradiol|mesh-list
6367722|NCT00117273|Estrogens|estrogens|mesh-ancestor
6367723|NCT00117273|Hormones|hormones|mesh-ancestor
6367724|NCT00117273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6367725|NCT00117273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367726|NCT00117273|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6367727|NCT00117273|Contraceptive Agents|contraceptive agents|mesh-ancestor
6367728|NCT00117273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6367729|NCT00117273|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6367730|NCT00117273|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6367731|NCT00117273|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6367732|NCT00117273|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6367733|NCT00117299|Vatalanib|vatalanib|mesh-list
6367734|NCT00117299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6367735|NCT00117299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6367736|NCT00117299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367737|NCT00117351|Bortezomib|bortezomib|mesh-list
6367738|NCT00117351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6367739|NCT00117377|Pimecrolimus|pimecrolimus|mesh-list
6367740|NCT00117377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6367741|NCT00117377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6367742|NCT00117377|Analgesics|analgesics|mesh-ancestor
6367743|NCT00117377|Sensory System Agents|sensory system agents|mesh-ancestor
6367744|NCT00117377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6367745|NCT00117377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367746|NCT00117377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6367747|NCT00117377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6367748|NCT00117377|Dermatologic Agents|dermatologic agents|mesh-ancestor
6367749|NCT00117377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6367750|NCT00117377|Immunologic Factors|immunologic factors|mesh-ancestor
6367751|NCT00117377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6367752|NCT00117377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6367753|NCT00117377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367754|NCT00117403|Vitamins|vitamins|mesh-list
6367755|NCT00117403|Vitamin E|vitamin e|mesh-list
6367756|NCT00117403|Thioctic Acid|thioctic acid|mesh-list
6367757|NCT00117403|Ubiquinone|ubiquinone|mesh-list
6367758|NCT00117403|Micronutrients|micronutrients|mesh-ancestor
6367759|NCT00117403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367760|NCT00117403|Antioxidants|antioxidants|mesh-ancestor
6367761|NCT00117403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367762|NCT00117403|Protective Agents|protective agents|mesh-ancestor
6367763|NCT00117403|Vitamin B Complex|vitamin b complex|mesh-ancestor
6367764|NCT00117442|Paclitaxel|paclitaxel|mesh-list
6367765|NCT00117442|Carboplatin|carboplatin|mesh-list
6367766|NCT00117442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6367767|NCT00117442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6367768|NCT00117442|Tubulin Modulators|tubulin modulators|mesh-ancestor
6367769|NCT00117442|Antimitotic Agents|antimitotic agents|mesh-ancestor
6367770|NCT00117442|Mitosis Modulators|mitosis modulators|mesh-ancestor
6367771|NCT00117442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367772|NCT00117455|Lenograstim|lenograstim|mesh-list
6367773|NCT00117455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6367774|NCT00117455|Immunologic Factors|immunologic factors|mesh-ancestor
6367775|NCT00117455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367776|NCT00117468|Progesterone|progesterone|mesh-list
6367777|NCT00117468|Progestins|progestins|mesh-ancestor
6367778|NCT00117468|Hormones|hormones|mesh-ancestor
6367779|NCT00117468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6367780|NCT00117468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367781|NCT00117494|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6367782|NCT00117494|Pravastatin|pravastatin|mesh-list
6367783|NCT00117494|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6367784|NCT00117494|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6367785|NCT00117494|Antimetabolites|antimetabolites|mesh-ancestor
6367786|NCT00117494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367787|NCT00117494|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6367788|NCT00117494|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6367789|NCT00117494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6367790|NCT00117520|Caffeine|caffeine|mesh-list
6367791|NCT00117520|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6367792|NCT00117520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367793|NCT00117520|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6367794|NCT00117520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6367795|NCT00117520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367796|NCT00117520|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6367797|NCT00117520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6367798|NCT00117520|Purinergic Agents|purinergic agents|mesh-ancestor
6367799|NCT00117520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6367800|NCT00117533|Ribavirin|ribavirin|mesh-list
6367801|NCT00117533|Interferon alpha-2|interferon alpha-2|mesh-list
6367802|NCT00117533|Antimetabolites|antimetabolites|mesh-ancestor
6367803|NCT00117533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367804|NCT00117533|Antiviral Agents|antiviral agents|mesh-ancestor
6367805|NCT00117533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6367806|NCT00117533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6367807|NCT00117546|Methyldopa|methyldopa|mesh-list
6367808|NCT00117546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6367809|NCT00117546|Sympatholytics|sympatholytics|mesh-ancestor
6367810|NCT00117546|Autonomic Agents|autonomic agents|mesh-ancestor
6367811|NCT00117546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6367812|NCT00117546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367813|NCT00117546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6367814|NCT00117546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6367815|NCT00117546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6367816|NCT00117546|Adrenergic Agents|adrenergic agents|mesh-ancestor
6367817|NCT00117546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6367818|NCT00117546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367819|NCT00117611|Omalizumab|omalizumab|mesh-list
6367820|NCT00117611|Antibodies|antibodies|mesh-list
6367821|NCT00117611|Immunologic Factors|immunologic factors|mesh-ancestor
6367822|NCT00117611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367823|NCT00117611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6367824|NCT00117611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6367825|NCT00117611|Respiratory System Agents|respiratory system agents|mesh-ancestor
6367826|NCT00117624|Darbepoetin alfa|darbepoetin alfa|mesh-list
6367827|NCT00117624|Hematinics|hematinics|mesh-ancestor
6367828|NCT00117663|Hormones|hormones|mesh-list
6367829|NCT00117663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6367830|NCT00117663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367831|NCT00117689|Mycophenolic Acid|mycophenolic acid|mesh-list
6367832|NCT00117689|Tacrolimus|tacrolimus|mesh-list
6367833|NCT00117689|Thymoglobulin|thymoglobulin|mesh-list
6367834|NCT00117689|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6367835|NCT00117689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6367836|NCT00117689|Immunologic Factors|immunologic factors|mesh-ancestor
6367837|NCT00117689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367838|NCT00117689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6367839|NCT00117689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6367840|NCT00117689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367841|NCT00117689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6367842|NCT00117689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6367843|NCT00117689|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6367844|NCT00117689|Antitubercular Agents|antitubercular agents|mesh-ancestor
6367845|NCT00117689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6367846|NCT00117689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6367847|NCT00117702|Everolimus|everolimus|mesh-list
6367848|NCT00117702|Tacrolimus|tacrolimus|mesh-list
6367849|NCT00117702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6367850|NCT00117702|Immunologic Factors|immunologic factors|mesh-ancestor
6367851|NCT00117702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367852|NCT00117702|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6367853|NCT00117702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6367854|NCT00117702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367855|NCT00117702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6367856|NCT00117728|Nevirapine|nevirapine|mesh-list
6367857|NCT00117728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6367858|NCT00117728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6367859|NCT00117728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6367860|NCT00117728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367861|NCT00117728|Antiviral Agents|antiviral agents|mesh-ancestor
6367862|NCT00117728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6367863|NCT00117728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6367864|NCT00117728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6367865|NCT00117728|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6367866|NCT00117728|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6367867|NCT00117754|Terbinafine|terbinafine|mesh-list
6367868|NCT00117754|Antifungal Agents|antifungal agents|mesh-ancestor
6367869|NCT00117754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6367870|NCT00117754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6367871|NCT00117754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367872|NCT00117767|Terbinafine|terbinafine|mesh-list
6367873|NCT00117767|Griseofulvin|griseofulvin|mesh-list
6367874|NCT00117767|Antifungal Agents|antifungal agents|mesh-ancestor
6367875|NCT00117767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6367876|NCT00117767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6367877|NCT00117767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367878|NCT00117780|Insulin|insulin|mesh-list
6367879|NCT00117780|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6367880|NCT00117780|Insulin Aspart|insulin aspart|mesh-list
6367881|NCT00117780|Insulin Detemir|insulin detemir|mesh-list
6367882|NCT00117780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6367883|NCT00117780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367884|NCT00117832|Azelastine|azelastine|mesh-list
6367885|NCT00117832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6367886|NCT00117832|Autonomic Agents|autonomic agents|mesh-ancestor
6367887|NCT00117832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6367888|NCT00117832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367889|NCT00117832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6367890|NCT00117832|Respiratory System Agents|respiratory system agents|mesh-ancestor
6367891|NCT00117832|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6367892|NCT00117832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6367893|NCT00117832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367894|NCT00117832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6367895|NCT00117832|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6367896|NCT00117832|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6367897|NCT00117832|Histamine Antagonists|histamine antagonists|mesh-ancestor
6367898|NCT00117832|Histamine Agents|histamine agents|mesh-ancestor
6367899|NCT00117832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6367900|NCT00117897|Lenograstim|lenograstim|mesh-list
6367901|NCT00117897|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6367902|NCT00117897|Immunologic Factors|immunologic factors|mesh-ancestor
6367903|NCT00117897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367904|NCT00117936|Mitogens|mitogens|mesh-list
6367905|NCT00117936|Mitosis Modulators|mitosis modulators|mesh-ancestor
6367906|NCT00117936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367907|NCT00117975|Galiximab|galiximab|mesh-list
6367908|NCT00117975|Rituximab|rituximab|mesh-list
6367909|NCT00117975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6367910|NCT00117975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6367911|NCT00117975|Immunologic Factors|immunologic factors|mesh-ancestor
6367912|NCT00117975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367913|NCT00117975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6367914|NCT00117975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6367915|NCT00118014|Sertraline|sertraline|mesh-list
6367916|NCT00118014|Antidepressive Agents|antidepressive agents|mesh-ancestor
6367917|NCT00118014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6367918|NCT00118014|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6367919|NCT00118014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6367920|NCT00118014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6367921|NCT00118014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367922|NCT00118014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6367923|NCT00118014|Serotonin Agents|serotonin agents|mesh-ancestor
6367924|NCT00118014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367925|NCT00118027|Pyrimethamine|pyrimethamine|mesh-list
6367926|NCT00118027|Sulfadoxine|sulfadoxine|mesh-list
6367927|NCT00118027|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6367928|NCT00118027|Antimalarials|antimalarials|mesh-ancestor
6367929|NCT00118027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6367930|NCT00118027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6367931|NCT00118027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6367932|NCT00118027|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6367933|NCT00118027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6367934|NCT00118027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367935|NCT00118027|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6367936|NCT00118027|Renal Agents|renal agents|mesh-ancestor
6367937|NCT00118066|Calcitriol|calcitriol|mesh-list
6367938|NCT00118066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6367939|NCT00118066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367940|NCT00118066|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6367941|NCT00118066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6367942|NCT00118066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367943|NCT00118066|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6367944|NCT00118066|Vitamins|vitamins|mesh-ancestor
6367945|NCT00118066|Micronutrients|micronutrients|mesh-ancestor
6367946|NCT00118066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6367947|NCT00118105|Bevacizumab|bevacizumab|mesh-list
6367948|NCT00118105|Capecitabine|capecitabine|mesh-list
6367949|NCT00118105|Oxaliplatin|oxaliplatin|mesh-list
6367950|NCT00118105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6367951|NCT00118105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6367952|NCT00118105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6367953|NCT00118105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6367954|NCT00118105|Growth Substances|growth substances|mesh-ancestor
6367955|NCT00118105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367956|NCT00118105|Growth Inhibitors|growth inhibitors|mesh-ancestor
6367957|NCT00118105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6367958|NCT00118105|Antimetabolites|antimetabolites|mesh-ancestor
6367959|NCT00118105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367960|NCT00118170|Sorafenib|sorafenib|mesh-list
6367961|NCT00118170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6367962|NCT00118170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6367963|NCT00118170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6367964|NCT00118170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367965|NCT00118183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6367966|NCT00118183|Cetuximab|cetuximab|mesh-list
6367967|NCT00118183|Docetaxel|docetaxel|mesh-list
6367968|NCT00118183|Bortezomib|bortezomib|mesh-list
6367969|NCT00118183|Antibodies|antibodies|mesh-list
6367970|NCT00118183|Immunoglobulins|immunoglobulins|mesh-list
6367971|NCT00118183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6367972|NCT00118183|Immunologic Factors|immunologic factors|mesh-ancestor
6367973|NCT00118183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367974|NCT00118183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6367975|NCT00118183|Tubulin Modulators|tubulin modulators|mesh-ancestor
6367976|NCT00118183|Antimitotic Agents|antimitotic agents|mesh-ancestor
6367977|NCT00118183|Mitosis Modulators|mitosis modulators|mesh-ancestor
6017334|NCT00372060|Pioglitazone|pioglitazone|mesh-list
6017335|NCT00372060|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6367978|NCT00118183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367979|NCT00118196|Azacitidine|azacitidine|mesh-list
6367980|NCT00118196|Arsenic Trioxide|arsenic trioxide|mesh-list
6367981|NCT00118196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6367982|NCT00118196|Antimetabolites|antimetabolites|mesh-ancestor
6367983|NCT00118196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6367984|NCT00118196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6367985|NCT00118196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6367986|NCT00118222|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
6367987|NCT00118222|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
6367988|NCT00118222|Ether|ether|mesh-list
6367989|NCT00118222|Trioxsalen|trioxsalen|mesh-list
6367990|NCT00118222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6367991|NCT00118222|Dermatologic Agents|dermatologic agents|mesh-ancestor
6367992|NCT00118222|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6367993|NCT00118222|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6367994|NCT00118222|Anesthetics, General|anesthetics, general|mesh-ancestor
6367995|NCT00118222|Anesthetics|anesthetics|mesh-ancestor
6367996|NCT00118222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6367997|NCT00118222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6367998|NCT00118235|Bevacizumab|bevacizumab|mesh-list
6367999|NCT00118235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6368000|NCT00118235|Irinotecan|irinotecan|mesh-list
6017336|NCT00372060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6368001|NCT00118235|Antibodies|antibodies|mesh-list
6368002|NCT00118235|Immunoglobulins|immunoglobulins|mesh-list
6368003|NCT00118235|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6368004|NCT00118235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6368005|NCT00118235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6368006|NCT00118235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6368007|NCT00118235|Growth Substances|growth substances|mesh-ancestor
6368008|NCT00118235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368009|NCT00118235|Growth Inhibitors|growth inhibitors|mesh-ancestor
6368010|NCT00118235|Immunologic Factors|immunologic factors|mesh-ancestor
6368011|NCT00118235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6368012|NCT00118235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6368013|NCT00118235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6368014|NCT00118235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368015|NCT00118261|Leucovorin|leucovorin|mesh-list
6368016|NCT00118261|Bevacizumab|bevacizumab|mesh-list
6368017|NCT00118261|Fluorouracil|fluorouracil|mesh-list
6368018|NCT00118261|Oxaliplatin|oxaliplatin|mesh-list
6368019|NCT00118261|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6368020|NCT00118261|Calcium|calcium|mesh-list
6368021|NCT00118261|Levoleucovorin|levoleucovorin|mesh-list
6368022|NCT00118261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6368023|NCT00118261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6368024|NCT00118261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6368025|NCT00118261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6368026|NCT00118261|Growth Substances|growth substances|mesh-ancestor
6368027|NCT00118261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368028|NCT00118261|Growth Inhibitors|growth inhibitors|mesh-ancestor
6368029|NCT00118261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6368030|NCT00118261|Antimetabolites|antimetabolites|mesh-ancestor
6368031|NCT00118261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368032|NCT00118261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6368033|NCT00118261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6368034|NCT00118261|Immunologic Factors|immunologic factors|mesh-ancestor
6368035|NCT00118261|Antidotes|antidotes|mesh-ancestor
6368036|NCT00118261|Protective Agents|protective agents|mesh-ancestor
6368037|NCT00118261|Vitamin B Complex|vitamin b complex|mesh-ancestor
6368038|NCT00118261|Vitamins|vitamins|mesh-ancestor
6368039|NCT00118261|Micronutrients|micronutrients|mesh-ancestor
6368040|NCT00118261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6368041|NCT00118261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6368042|NCT00118300|Capecitabine|capecitabine|mesh-list
6368043|NCT00118300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6368044|NCT00118300|Antimetabolites|antimetabolites|mesh-ancestor
6368045|NCT00118300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368046|NCT00118300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6368047|NCT00118313|Imiquimod|imiquimod|mesh-list
6368048|NCT00118313|Sargramostim|sargramostim|mesh-list
6368049|NCT00118313|Freund's Adjuvant|freund's adjuvant|mesh-list
6368050|NCT00118313|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
6368051|NCT00118313|Immunologic Factors|immunologic factors|mesh-ancestor
6368052|NCT00118313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368053|NCT00118313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6368054|NCT00118313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6368055|NCT00118313|Interferon Inducers|interferon inducers|mesh-ancestor
6368056|NCT00118313|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6368057|NCT00118313|Protective Agents|protective agents|mesh-ancestor
6368058|NCT00118313|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6368059|NCT00118313|Antioxidants|antioxidants|mesh-ancestor
6368060|NCT00118313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368061|NCT00118326|Lenograstim|lenograstim|mesh-list
6368062|NCT00118326|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6368063|NCT00118326|Immunologic Factors|immunologic factors|mesh-ancestor
6368064|NCT00118326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368065|NCT00118508|Risedronic Acid|risedronic acid|mesh-list
6368066|NCT00118508|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6368067|NCT00118508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6368068|NCT00118508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395339|NCT00204945|Natriuretic Agents|natriuretic agents|mesh-ancestor
6368069|NCT00118508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6368070|NCT00118508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368071|NCT00118508|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6368072|NCT00118638|Darbepoetin alfa|darbepoetin alfa|mesh-list
6368073|NCT00118638|Hematinics|hematinics|mesh-ancestor
6368074|NCT00118690|Fluticasone|fluticasone|mesh-list
6368075|NCT00118690|Xhance|xhance|mesh-list
6368076|NCT00118690|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6368077|NCT00118690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6368078|NCT00118690|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6368079|NCT00118690|Autonomic Agents|autonomic agents|mesh-ancestor
6368080|NCT00118690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6368081|NCT00118690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368082|NCT00118690|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6368083|NCT00118690|Respiratory System Agents|respiratory system agents|mesh-ancestor
6368084|NCT00118690|Dermatologic Agents|dermatologic agents|mesh-ancestor
6368085|NCT00118690|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6368086|NCT00118690|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6368087|NCT00118690|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6368088|NCT00118690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6368089|NCT00118690|Adrenergic Agents|adrenergic agents|mesh-ancestor
6368090|NCT00118690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6368091|NCT00118690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368092|NCT00118768|Interferons|interferons|mesh-list
6368093|NCT00118768|Interferon-alpha|interferon-alpha|mesh-list
6368094|NCT00118768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6368095|NCT00118768|Antiviral Agents|antiviral agents|mesh-ancestor
6368096|NCT00118768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6368097|NCT00118768|Immunologic Factors|immunologic factors|mesh-ancestor
6368098|NCT00118768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368099|NCT00118794|Lumefantrine|lumefantrine|mesh-list
6368100|NCT00118794|Artemether|artemether|mesh-list
6368101|NCT00118794|Dapsone|dapsone|mesh-list
6368102|NCT00118794|Chlorproguanil|chlorproguanil|mesh-list
6368103|NCT00118794|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6368104|NCT00118794|Antimalarials|antimalarials|mesh-ancestor
6368105|NCT00118794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6368106|NCT00118794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6368107|NCT00118794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6368108|NCT00118794|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6368109|NCT00118794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6368110|NCT00118794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368111|NCT00118794|Leprostatic Agents|leprostatic agents|mesh-ancestor
6368112|NCT00118794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6368113|NCT00118807|Artesunate|artesunate|mesh-list
6368114|NCT00118807|Chloroquine|chloroquine|mesh-list
6368115|NCT00118807|Pyrimethamine|pyrimethamine|mesh-list
6368116|NCT00118807|Sulfadoxine|sulfadoxine|mesh-list
6368117|NCT00118807|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6368118|NCT00118807|Amodiaquine|amodiaquine|mesh-list
6368119|NCT00118807|Antimalarials|antimalarials|mesh-ancestor
6368120|NCT00118807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6368121|NCT00118807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6368122|NCT00118807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6368123|NCT00118807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6368124|NCT00118807|Antiviral Agents|antiviral agents|mesh-ancestor
6368125|NCT00118807|Schistosomicides|schistosomicides|mesh-ancestor
6368126|NCT00118807|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6368127|NCT00118807|Anthelmintics|anthelmintics|mesh-ancestor
6368128|NCT00118807|Amebicides|amebicides|mesh-ancestor
6368129|NCT00118807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6368130|NCT00118807|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6368131|NCT00118807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6368132|NCT00118807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368133|NCT00118807|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6368134|NCT00118807|Renal Agents|renal agents|mesh-ancestor
6368135|NCT00118820|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6368136|NCT00118820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6368137|NCT00118937|Metformin|metformin|mesh-list
6368138|NCT00118937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6368139|NCT00118937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368140|NCT00118950|Metformin|metformin|mesh-list
6368141|NCT00118950|Repaglinide|repaglinide|mesh-list
6368142|NCT00118950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6368143|NCT00118950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368144|NCT00118963|Metformin|metformin|mesh-list
6368145|NCT00118963|Insulin Aspart|insulin aspart|mesh-list
6368146|NCT00118963|Repaglinide|repaglinide|mesh-list
6368147|NCT00118963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6368148|NCT00118963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368149|NCT00118976|Lisinopril|lisinopril|mesh-list
6368150|NCT00118976|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6368151|NCT00118976|Protease Inhibitors|protease inhibitors|mesh-ancestor
6368152|NCT00118976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6368153|NCT00118976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368154|NCT00118976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6368155|NCT00118976|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6368156|NCT00118976|Protective Agents|protective agents|mesh-ancestor
6368157|NCT00118976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395340|NCT00204945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395341|NCT00204984|Hydralazine|hydralazine|mesh-list
6395342|NCT00204984|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6395343|NCT00204984|Natriuretic Agents|natriuretic agents|mesh-ancestor
6395344|NCT00204984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395345|NCT00204984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6395346|NCT00204984|Vasodilator Agents|vasodilator agents|mesh-ancestor
6395347|NCT00205166|Caffeine|caffeine|mesh-list
6395348|NCT00205166|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6395349|NCT00205166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395350|NCT00205166|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6395351|NCT00205166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6395352|NCT00205166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395353|NCT00205166|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6395354|NCT00205166|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6395355|NCT00205166|Purinergic Agents|purinergic agents|mesh-ancestor
6395356|NCT00205166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6395357|NCT00205231|Etanercept|etanercept|mesh-list
6395358|NCT00205231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6395359|NCT00205231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6395360|NCT00205231|Analgesics|analgesics|mesh-ancestor
6395361|NCT00205231|Sensory System Agents|sensory system agents|mesh-ancestor
6395362|NCT00205231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6395363|NCT00205231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395364|NCT00205231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6395365|NCT00205231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6395366|NCT00205231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6395367|NCT00205231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6395368|NCT00205231|Immunologic Factors|immunologic factors|mesh-ancestor
6395369|NCT00205283|Nelfinavir|nelfinavir|mesh-list
6395370|NCT00205283|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6395371|NCT00205283|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6395372|NCT00205283|Protease Inhibitors|protease inhibitors|mesh-ancestor
6395373|NCT00205283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6395374|NCT00205283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395375|NCT00205283|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6395376|NCT00205283|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6395377|NCT00205283|Antiviral Agents|antiviral agents|mesh-ancestor
6395378|NCT00205283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6395379|NCT00205322|Leucovorin|leucovorin|mesh-list
6395380|NCT00205322|Capecitabine|capecitabine|mesh-list
6395381|NCT00205322|Oxaliplatin|oxaliplatin|mesh-list
6395382|NCT00205322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6395383|NCT00205322|Antimetabolites|antimetabolites|mesh-ancestor
6395384|NCT00205322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395385|NCT00205322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6395386|NCT00205322|Antidotes|antidotes|mesh-ancestor
6395387|NCT00205322|Protective Agents|protective agents|mesh-ancestor
6395388|NCT00205322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368158|NCT00119002|Dexamethasone|dexamethasone|mesh-list
6368159|NCT00119002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6368160|NCT00119002|Antiemetics|antiemetics|mesh-ancestor
6368161|NCT00119002|Autonomic Agents|autonomic agents|mesh-ancestor
6368162|NCT00119002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6368163|NCT00119002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368164|NCT00119002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6368165|NCT00119002|Glucocorticoids|glucocorticoids|mesh-ancestor
6368166|NCT00119002|Hormones|hormones|mesh-ancestor
6368167|NCT00119002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6368168|NCT00119002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6368169|NCT00119002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6368170|NCT00119119|Tocopherols|tocopherols|mesh-list
6368171|NCT00119119|Vitamin E|vitamin e|mesh-list
6368172|NCT00119119|Tocotrienols|tocotrienols|mesh-list
6368173|NCT00119119|alpha-Tocopherol|alpha-tocopherol|mesh-list
6368174|NCT00119119|Antioxidants|antioxidants|mesh-ancestor
6368175|NCT00119119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368176|NCT00119119|Protective Agents|protective agents|mesh-ancestor
6368177|NCT00119119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368178|NCT00119119|Vitamins|vitamins|mesh-ancestor
6368179|NCT00119119|Micronutrients|micronutrients|mesh-ancestor
6368180|NCT00119132|Artesunate|artesunate|mesh-list
6368181|NCT00119132|Pyrimethamine|pyrimethamine|mesh-list
6368182|NCT00119132|Sulfadoxine|sulfadoxine|mesh-list
6368183|NCT00119132|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6368184|NCT00119132|Amodiaquine|amodiaquine|mesh-list
6368185|NCT00119132|Antimalarials|antimalarials|mesh-ancestor
6368186|NCT00119132|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6368187|NCT00119132|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6368188|NCT00119132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6368189|NCT00119132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6368190|NCT00119132|Antiviral Agents|antiviral agents|mesh-ancestor
6368191|NCT00119132|Schistosomicides|schistosomicides|mesh-ancestor
6368192|NCT00119132|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6368193|NCT00119132|Anthelmintics|anthelmintics|mesh-ancestor
6368194|NCT00119132|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6368195|NCT00119132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6368196|NCT00119132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368197|NCT00119132|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6368198|NCT00119132|Renal Agents|renal agents|mesh-ancestor
6368199|NCT00119145|Artesunate|artesunate|mesh-list
6368200|NCT00119145|Amodiaquine|amodiaquine|mesh-list
6368201|NCT00119145|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6368202|NCT00119145|Antimalarials|antimalarials|mesh-ancestor
6368203|NCT00119145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6368204|NCT00119145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6368205|NCT00119145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6368206|NCT00119145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6368207|NCT00119145|Antiviral Agents|antiviral agents|mesh-ancestor
6368208|NCT00119145|Schistosomicides|schistosomicides|mesh-ancestor
6368209|NCT00119145|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6368210|NCT00119145|Anthelmintics|anthelmintics|mesh-ancestor
6368211|NCT00119171|Capecitabine|capecitabine|mesh-list
6368212|NCT00119171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6368213|NCT00119171|Antimetabolites|antimetabolites|mesh-ancestor
6368214|NCT00119171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368215|NCT00119171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6368216|NCT00119184|Anesthetics|anesthetics|mesh-list
6368217|NCT00119184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6368218|NCT00119184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368219|NCT00119210|Bupropion|bupropion|mesh-list
6368220|NCT00119210|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6368221|NCT00119210|Antidepressive Agents|antidepressive agents|mesh-ancestor
6368222|NCT00119210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6368223|NCT00119210|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6368224|NCT00119210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6368225|NCT00119210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6368226|NCT00119210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368227|NCT00119210|Dopamine Agents|dopamine agents|mesh-ancestor
6368228|NCT00119210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6368229|NCT00119210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368230|NCT00119210|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6368231|NCT00119210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6368232|NCT00119210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6368233|NCT00119236|Irinotecan|irinotecan|mesh-list
6368234|NCT00119236|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6368235|NCT00119236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6368236|NCT00119236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6368237|NCT00119236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368238|NCT00119236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6368239|NCT00119249|Sorafenib|sorafenib|mesh-list
6368240|NCT00119249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6368241|NCT00119249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6368242|NCT00119249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6368243|NCT00119249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368244|NCT00119301|Leucovorin|leucovorin|mesh-list
6368245|NCT00119301|Trimetrexate|trimetrexate|mesh-list
6368246|NCT00119301|Methotrexate|methotrexate|mesh-list
6368247|NCT00119301|Calcium|calcium|mesh-list
6368248|NCT00119301|Levoleucovorin|levoleucovorin|mesh-list
6368249|NCT00119301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6368250|NCT00119301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368251|NCT00119301|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6368252|NCT00119301|Abortifacient Agents|abortifacient agents|mesh-ancestor
6017337|NCT00372060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017338|NCT00372060|Incretins|incretins|mesh-ancestor
6368253|NCT00119301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6368254|NCT00119301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6368255|NCT00119301|Antimetabolites|antimetabolites|mesh-ancestor
6368256|NCT00119301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368257|NCT00119301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6368258|NCT00119301|Dermatologic Agents|dermatologic agents|mesh-ancestor
6368259|NCT00119301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6368260|NCT00119301|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6368261|NCT00119301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6368262|NCT00119301|Immunologic Factors|immunologic factors|mesh-ancestor
6368263|NCT00119301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6368264|NCT00119301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6368265|NCT00119301|Antidotes|antidotes|mesh-ancestor
6368266|NCT00119301|Protective Agents|protective agents|mesh-ancestor
6368267|NCT00119301|Vitamin B Complex|vitamin b complex|mesh-ancestor
6368268|NCT00119301|Vitamins|vitamins|mesh-ancestor
6368269|NCT00119301|Micronutrients|micronutrients|mesh-ancestor
6368270|NCT00119301|Antifungal Agents|antifungal agents|mesh-ancestor
6368271|NCT00119301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6368272|NCT00119314|Gemcitabine|gemcitabine|mesh-list
6368273|NCT00119314|Capecitabine|capecitabine|mesh-list
6368274|NCT00119314|Docetaxel|docetaxel|mesh-list
6368275|NCT00119314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6368276|NCT00119314|Antimetabolites|antimetabolites|mesh-ancestor
6368277|NCT00119314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368278|NCT00119314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6368279|NCT00119314|Antiviral Agents|antiviral agents|mesh-ancestor
6368280|NCT00119314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6368281|NCT00119314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6368282|NCT00119314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6368283|NCT00119314|Immunologic Factors|immunologic factors|mesh-ancestor
6368284|NCT00119314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368285|NCT00119314|Tubulin Modulators|tubulin modulators|mesh-ancestor
6368286|NCT00119314|Antimitotic Agents|antimitotic agents|mesh-ancestor
6368287|NCT00119314|Mitosis Modulators|mitosis modulators|mesh-ancestor
6368288|NCT00119340|Cyclosporine|cyclosporine|mesh-list
6368289|NCT00119340|Mycophenolic Acid|mycophenolic acid|mesh-list
6368290|NCT00119340|Fludarabine|fludarabine|mesh-list
6368291|NCT00119340|Fludarabine phosphate|fludarabine phosphate|mesh-list
6368292|NCT00119340|Cyclosporins|cyclosporins|mesh-list
6368293|NCT00119340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6368294|NCT00119340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6368295|NCT00119340|Antimetabolites|antimetabolites|mesh-ancestor
6368296|NCT00119340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368297|NCT00119340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6368298|NCT00119340|Immunologic Factors|immunologic factors|mesh-ancestor
6368299|NCT00119340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368300|NCT00119340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6368301|NCT00119340|Antifungal Agents|antifungal agents|mesh-ancestor
6368302|NCT00119340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6368303|NCT00119340|Dermatologic Agents|dermatologic agents|mesh-ancestor
6368304|NCT00119340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6368305|NCT00119340|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6368306|NCT00119340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6368307|NCT00119340|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6368308|NCT00119340|Antitubercular Agents|antitubercular agents|mesh-ancestor
6368309|NCT00119340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6368310|NCT00119483|Methyltestosterone|methyltestosterone|mesh-list
6368311|NCT00119483|Testosterone|testosterone|mesh-list
6368312|NCT00119483|Testosterone undecanoate|testosterone undecanoate|mesh-list
6368313|NCT00119483|Testosterone enanthate|testosterone enanthate|mesh-list
6368314|NCT00119483|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6368315|NCT00119483|Androgens|androgens|mesh-ancestor
6368316|NCT00119483|Hormones|hormones|mesh-ancestor
6368317|NCT00119483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6368318|NCT00119483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368319|NCT00119483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6368320|NCT00119483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6368321|NCT00119483|Anabolic Agents|anabolic agents|mesh-ancestor
6368322|NCT00119496|Rosiglitazone|rosiglitazone|mesh-list
6368323|NCT00119496|Beclomethasone|beclomethasone|mesh-list
6368324|NCT00119496|Theophylline|theophylline|mesh-list
6368325|NCT00119496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6368326|NCT00119496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368327|NCT00119496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6368328|NCT00119496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368329|NCT00119496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6368330|NCT00119496|Glucocorticoids|glucocorticoids|mesh-ancestor
6368331|NCT00119496|Hormones|hormones|mesh-ancestor
6368332|NCT00119496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6368333|NCT00119496|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6368334|NCT00119496|Respiratory System Agents|respiratory system agents|mesh-ancestor
6368335|NCT00119496|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6368336|NCT00119496|Autonomic Agents|autonomic agents|mesh-ancestor
6368337|NCT00119496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6368338|NCT00119496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6368339|NCT00119496|Vasodilator Agents|vasodilator agents|mesh-ancestor
6368340|NCT00119496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6368341|NCT00119496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6368342|NCT00119496|Purinergic Agents|purinergic agents|mesh-ancestor
6368343|NCT00119496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6368344|NCT00119587|Darbepoetin alfa|darbepoetin alfa|mesh-list
6368345|NCT00119587|Hematinics|hematinics|mesh-ancestor
6368346|NCT00119613|Darbepoetin alfa|darbepoetin alfa|mesh-list
6368347|NCT00119613|Hematinics|hematinics|mesh-ancestor
6368348|NCT00119626|Disufenton sodium|disufenton sodium|mesh-list
6368349|NCT00119626|Antioxidants|antioxidants|mesh-ancestor
6368350|NCT00119626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368351|NCT00119626|Protective Agents|protective agents|mesh-ancestor
6368352|NCT00119626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368353|NCT00119639|Sorafenib|sorafenib|mesh-list
6368354|NCT00119639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6368355|NCT00119639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6368356|NCT00119639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6368357|NCT00119639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368358|NCT00119652|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6368359|NCT00119652|Paroxetine|paroxetine|mesh-list
6368360|NCT00119652|Antidepressive Agents|antidepressive agents|mesh-ancestor
6368361|NCT00119652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6368362|NCT00119652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6368363|NCT00119652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6368364|NCT00119652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6368365|NCT00119652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368366|NCT00119652|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6368367|NCT00119652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6368368|NCT00119652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6368369|NCT00119652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368370|NCT00119652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6368371|NCT00119652|Serotonin Agents|serotonin agents|mesh-ancestor
6368372|NCT00119652|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6368373|NCT00119652|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6368374|NCT00119652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6368375|NCT00119652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6368376|NCT00119691|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6368377|NCT00119691|Natriuretic Agents|natriuretic agents|mesh-ancestor
6368378|NCT00119691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368379|NCT00119704|Botulinum Toxins|botulinum toxins|mesh-list
6368380|NCT00119704|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6368381|NCT00119704|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6368382|NCT00119704|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6368383|NCT00119704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6368384|NCT00119704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368385|NCT00119704|Cholinergic Agents|cholinergic agents|mesh-ancestor
6368386|NCT00119704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6368387|NCT00119704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368388|NCT00119704|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6368389|NCT00119704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6368390|NCT00119730|Rituximab|rituximab|mesh-list
6368391|NCT00119730|Fludarabine|fludarabine|mesh-list
6368392|NCT00119730|Mitoxantrone|mitoxantrone|mesh-list
6368393|NCT00119730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6368394|NCT00119730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6368395|NCT00119730|Immunologic Factors|immunologic factors|mesh-ancestor
6368396|NCT00119730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368397|NCT00119730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6368398|NCT00119730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368399|NCT00119730|Analgesics|analgesics|mesh-ancestor
6368400|NCT00119730|Sensory System Agents|sensory system agents|mesh-ancestor
6368401|NCT00119730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6368402|NCT00119730|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6368403|NCT00119730|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6368404|NCT00119730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6368405|NCT00119756|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6368406|NCT00119756|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6368407|NCT00119756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6368408|NCT00119756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6368409|NCT00119756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368410|NCT00119756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6368411|NCT00119756|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6368412|NCT00119756|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6368413|NCT00119756|Serotonin Agents|serotonin agents|mesh-ancestor
6368414|NCT00119756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6368415|NCT00119756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368416|NCT00119756|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6368417|NCT00119756|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6368418|NCT00119756|Dopamine Agents|dopamine agents|mesh-ancestor
6368419|NCT00119769|Hormones|hormones|mesh-list
6368420|NCT00119769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6368421|NCT00119769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368422|NCT00119886|Botulinum Toxins|botulinum toxins|mesh-list
6368423|NCT00119886|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6368424|NCT00119886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6368425|NCT00119886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368426|NCT00119886|Cholinergic Agents|cholinergic agents|mesh-ancestor
6368427|NCT00119886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6368428|NCT00119886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368429|NCT00119990|Dialysis Solutions|dialysis solutions|mesh-list
6368430|NCT00119990|Icodextrin|icodextrin|mesh-list
6368431|NCT00119990|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6368432|NCT00120003|Candesartan|candesartan|mesh-list
6368433|NCT00120003|Candesartan cilexetil|candesartan cilexetil|mesh-list
6368434|NCT00120003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6368435|NCT00120003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6368436|NCT00120003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6368437|NCT00120003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368438|NCT00120055|Atorvastatin|atorvastatin|mesh-list
6368439|NCT00120055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6368440|NCT00120055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6368441|NCT00120055|Antimetabolites|antimetabolites|mesh-ancestor
6368442|NCT00120055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368443|NCT00120055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6368444|NCT00120055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6368445|NCT00120055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6368446|NCT00120081|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6368447|NCT00120081|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6368448|NCT00120081|Immunologic Factors|immunologic factors|mesh-ancestor
6368449|NCT00120081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368450|NCT00120081|Antacids|antacids|mesh-ancestor
6368451|NCT00120081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368452|NCT00120081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6368453|NCT00120120|Lenalidomide|lenalidomide|mesh-list
6368454|NCT00120120|Immunologic Factors|immunologic factors|mesh-ancestor
6368455|NCT00120120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368456|NCT00120120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6368457|NCT00120120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6368458|NCT00120120|Growth Substances|growth substances|mesh-ancestor
6368459|NCT00120120|Growth Inhibitors|growth inhibitors|mesh-ancestor
6368460|NCT00120120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6368461|NCT00120133|Atorvastatin|atorvastatin|mesh-list
6368462|NCT00120133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6368463|NCT00120133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6368464|NCT00120133|Antimetabolites|antimetabolites|mesh-ancestor
6368465|NCT00120133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368466|NCT00120133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6368467|NCT00120133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6368468|NCT00120133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6368469|NCT00120172|Bevacizumab|bevacizumab|mesh-list
6368470|NCT00120172|Capecitabine|capecitabine|mesh-list
6368471|NCT00120172|Oxaliplatin|oxaliplatin|mesh-list
6368472|NCT00120172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6368473|NCT00120172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6368474|NCT00120172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6368475|NCT00120172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6368476|NCT00120172|Growth Substances|growth substances|mesh-ancestor
6368477|NCT00120172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368478|NCT00120172|Growth Inhibitors|growth inhibitors|mesh-ancestor
6368479|NCT00120172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6368480|NCT00120172|Antimetabolites|antimetabolites|mesh-ancestor
6368481|NCT00120172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368482|NCT00120185|Interleukin-2|interleukin-2|mesh-list
6368483|NCT00120185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6368484|NCT00120185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6368485|NCT00120185|Analgesics|analgesics|mesh-ancestor
6368486|NCT00120185|Sensory System Agents|sensory system agents|mesh-ancestor
6368487|NCT00120185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6368488|NCT00120185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368489|NCT00120198|Rituximab|rituximab|mesh-list
6368490|NCT00120198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6368491|NCT00120198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6368492|NCT00120198|Immunologic Factors|immunologic factors|mesh-ancestor
6368493|NCT00120198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368494|NCT00120198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6368495|NCT00120237|Misoprostol|misoprostol|mesh-list
6368496|NCT00120237|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6368497|NCT00120237|Abortifacient Agents|abortifacient agents|mesh-ancestor
6368498|NCT00120237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6368499|NCT00120237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368500|NCT00120237|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6368501|NCT00120237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6368502|NCT00120237|Oxytocics|oxytocics|mesh-ancestor
6368503|NCT00120302|Pimecrolimus|pimecrolimus|mesh-list
6368504|NCT00120302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6368505|NCT00120302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6368506|NCT00120302|Analgesics|analgesics|mesh-ancestor
6368507|NCT00120302|Sensory System Agents|sensory system agents|mesh-ancestor
6368508|NCT00120302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6368509|NCT00120302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368510|NCT00120302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6368511|NCT00120302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6368512|NCT00120302|Dermatologic Agents|dermatologic agents|mesh-ancestor
6368513|NCT00120302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6368514|NCT00120302|Immunologic Factors|immunologic factors|mesh-ancestor
6368515|NCT00120302|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6368516|NCT00120302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6368517|NCT00120302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368518|NCT00120315|Esomeprazole|esomeprazole|mesh-list
6368519|NCT00120315|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6368520|NCT00120315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6368521|NCT00120315|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6368522|NCT00120315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6368523|NCT00120315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368524|NCT00120341|Analgesics|analgesics|mesh-list
6368525|NCT00120341|Sensory System Agents|sensory system agents|mesh-ancestor
6368526|NCT00120341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6368527|NCT00120341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368528|NCT00120354|Lamivudine|lamivudine|mesh-list
6368529|NCT00120354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6368530|NCT00120354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6368531|NCT00120354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6368532|NCT00120354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368533|NCT00120354|Antiviral Agents|antiviral agents|mesh-ancestor
6368534|NCT00120354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6368535|NCT00120354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6368536|NCT00120354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6368537|NCT00120367|Tenofovir|tenofovir|mesh-list
6368538|NCT00120367|Emtricitabine|emtricitabine|mesh-list
6368539|NCT00120367|Enfuvirtide|enfuvirtide|mesh-list
6368540|NCT00120367|Antiviral Agents|antiviral agents|mesh-ancestor
6368541|NCT00120367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6368542|NCT00120367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6368543|NCT00120367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6368544|NCT00120367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6368545|NCT00120367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368546|NCT00120367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6368547|NCT00120367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6368548|NCT00120367|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6368549|NCT00120367|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6368550|NCT00120380|Iloprost|iloprost|mesh-list
6368551|NCT00120380|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6368552|NCT00120380|Vasodilator Agents|vasodilator agents|mesh-ancestor
6368553|NCT00120419|Mycophenolic Acid|mycophenolic acid|mesh-list
6368554|NCT00120419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6368555|NCT00120419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6368556|NCT00120419|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6368557|NCT00120419|Antitubercular Agents|antitubercular agents|mesh-ancestor
6368558|NCT00120419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6368559|NCT00120419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6368560|NCT00120419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6368561|NCT00120419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368562|NCT00120432|Phenylephrine|phenylephrine|mesh-list
6368563|NCT00120432|Oxymetazoline|oxymetazoline|mesh-list
6368564|NCT00120432|Tropicamide|tropicamide|mesh-list
6368565|NCT00120432|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6368566|NCT00120432|Mydriatics|mydriatics|mesh-ancestor
6368567|NCT00120432|Autonomic Agents|autonomic agents|mesh-ancestor
6368568|NCT00120432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6368569|NCT00120432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368570|NCT00120432|Sympathomimetics|sympathomimetics|mesh-ancestor
6368571|NCT00120432|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6368572|NCT00120432|Nasal Decongestants|nasal decongestants|mesh-ancestor
6368573|NCT00120432|Respiratory System Agents|respiratory system agents|mesh-ancestor
6368574|NCT00120432|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6368575|NCT00120432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6368576|NCT00120432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6368577|NCT00120432|Adrenergic Agents|adrenergic agents|mesh-ancestor
6368578|NCT00120432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6368579|NCT00120432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368580|NCT00120432|Protective Agents|protective agents|mesh-ancestor
6368581|NCT00120432|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6368582|NCT00120432|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6368583|NCT00120432|Cholinergic Agents|cholinergic agents|mesh-ancestor
6368584|NCT00120471|Tenofovir|tenofovir|mesh-list
6368585|NCT00120471|Antiviral Agents|antiviral agents|mesh-ancestor
6368586|NCT00120471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6368587|NCT00120471|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6368588|NCT00120471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6368589|NCT00120471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6368590|NCT00120471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368591|NCT00120471|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6368592|NCT00120471|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6368593|NCT00120484|Vitamin B 12|vitamin b 12|mesh-list
6368594|NCT00120484|Hydroxocobalamin|hydroxocobalamin|mesh-list
6368595|NCT00120484|Vitamins|vitamins|mesh-ancestor
6368596|NCT00120484|Micronutrients|micronutrients|mesh-ancestor
6368597|NCT00120484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368598|NCT00120484|Vitamin B Complex|vitamin b complex|mesh-ancestor
6368599|NCT00120484|Hematinics|hematinics|mesh-ancestor
6368600|NCT00120497|Hormones|hormones|mesh-list
6368601|NCT00120497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6368602|NCT00120497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368603|NCT00120510|Lamivudine|lamivudine|mesh-list
6368604|NCT00120510|Zidovudine|zidovudine|mesh-list
6368605|NCT00120510|Efavirenz|efavirenz|mesh-list
6368606|NCT00120510|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6368607|NCT00120510|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6368608|NCT00120510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6368609|NCT00120510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6368610|NCT00120510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368611|NCT00120510|Antiviral Agents|antiviral agents|mesh-ancestor
6368612|NCT00120510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6368613|NCT00120510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6368614|NCT00120510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6368615|NCT00120510|Antimetabolites|antimetabolites|mesh-ancestor
6368616|NCT00120510|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6368617|NCT00120510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6368618|NCT00120510|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6368619|NCT00120510|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6368620|NCT00120510|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6368621|NCT00120510|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6368622|NCT00120536|Vildagliptin|vildagliptin|mesh-list
6368623|NCT00120536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6368624|NCT00120536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368625|NCT00120536|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6368626|NCT00120536|Protease Inhibitors|protease inhibitors|mesh-ancestor
6368627|NCT00120536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6368628|NCT00120536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368629|NCT00120601|Naltrexone|naltrexone|mesh-list
6368630|NCT00120601|Acamprosate|acamprosate|mesh-list
6368631|NCT00120601|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6368632|NCT00120601|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6368633|NCT00120601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368634|NCT00120601|Sensory System Agents|sensory system agents|mesh-ancestor
6368635|NCT00120601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6395389|NCT00205322|Vitamin B Complex|vitamin b complex|mesh-ancestor
6395390|NCT00205322|Vitamins|vitamins|mesh-ancestor
6395391|NCT00205322|Micronutrients|micronutrients|mesh-ancestor
6397023|NCT00209950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397024|NCT00209950|Anticonvulsants|anticonvulsants|mesh-ancestor
6397025|NCT00209950|GABA Agonists|gaba agonists|mesh-ancestor
6397026|NCT00209950|GABA Agents|gaba agents|mesh-ancestor
6397027|NCT00209950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6397028|NCT00209950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397029|NCT00209963|Gaboxadol|gaboxadol|mesh-list
6397030|NCT00209963|Analgesics|analgesics|mesh-ancestor
6397031|NCT00209963|Sensory System Agents|sensory system agents|mesh-ancestor
6397032|NCT00209963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6397033|NCT00209963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368636|NCT00120640|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
6368637|NCT00120640|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
6368638|NCT00120640|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6368639|NCT00120640|Hormone Antagonists|hormone antagonists|mesh-ancestor
6368640|NCT00120640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6368641|NCT00120640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368642|NCT00120640|Progestins|progestins|mesh-ancestor
6368643|NCT00120640|Hormones|hormones|mesh-ancestor
6368644|NCT00120653|Metoclopramide|metoclopramide|mesh-list
6368645|NCT00120653|Antiemetics|antiemetics|mesh-ancestor
6368646|NCT00120653|Autonomic Agents|autonomic agents|mesh-ancestor
6368647|NCT00120653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6368648|NCT00120653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368649|NCT00120653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6368650|NCT00120653|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6368651|NCT00120653|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6368652|NCT00120653|Dopamine Agents|dopamine agents|mesh-ancestor
6368653|NCT00120653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6368654|NCT00120653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368655|NCT00120679|Epoetin Alfa|epoetin alfa|mesh-list
6368656|NCT00120679|Darbepoetin alfa|darbepoetin alfa|mesh-list
6368657|NCT00120679|Hematinics|hematinics|mesh-ancestor
6368658|NCT00120692|Epoetin Alfa|epoetin alfa|mesh-list
6368659|NCT00120692|Darbepoetin alfa|darbepoetin alfa|mesh-list
6368660|NCT00120692|Hematinics|hematinics|mesh-ancestor
6368661|NCT00120705|Darbepoetin alfa|darbepoetin alfa|mesh-list
6368662|NCT00120705|Hematinics|hematinics|mesh-ancestor
6368663|NCT00120718|Fasudil|fasudil|mesh-list
6368664|NCT00120718|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6368665|NCT00120718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6368666|NCT00120718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368667|NCT00120718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6368668|NCT00120718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368669|NCT00120718|Vasodilator Agents|vasodilator agents|mesh-ancestor
6368670|NCT00120718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6368671|NCT00120718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6368672|NCT00120731|Acetazolamide|acetazolamide|mesh-list
6368673|NCT00120731|Potassium Citrate|potassium citrate|mesh-list
6368674|NCT00120731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368675|NCT00120731|Anticonvulsants|anticonvulsants|mesh-ancestor
6368676|NCT00120731|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6368677|NCT00120731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6368678|NCT00120731|Diuretics|diuretics|mesh-ancestor
6368679|NCT00120731|Natriuretic Agents|natriuretic agents|mesh-ancestor
6368680|NCT00120731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368681|NCT00120731|Expectorants|expectorants|mesh-ancestor
6368682|NCT00120731|Respiratory System Agents|respiratory system agents|mesh-ancestor
6368683|NCT00120744|Ondansetron|ondansetron|mesh-list
6368684|NCT00120744|Antiemetics|antiemetics|mesh-ancestor
6368685|NCT00120744|Autonomic Agents|autonomic agents|mesh-ancestor
6368686|NCT00120744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6368687|NCT00120744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368688|NCT00120744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6368689|NCT00120744|Antipruritics|antipruritics|mesh-ancestor
6368690|NCT00120744|Dermatologic Agents|dermatologic agents|mesh-ancestor
6368691|NCT00120744|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6368692|NCT00120744|Serotonin Agents|serotonin agents|mesh-ancestor
6368693|NCT00120744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6368694|NCT00120744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368695|NCT00120744|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6368696|NCT00120744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6368697|NCT00120744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6368698|NCT00120744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6368699|NCT00120744|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6368700|NCT00120757|Alendronate|alendronate|mesh-list
6368701|NCT00120757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6368702|NCT00120757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368703|NCT00120770|Anti-Infective Agents|anti-infective agents|mesh-list
6368704|NCT00120783|Ritonavir|ritonavir|mesh-list
6368705|NCT00120783|Indinavir|indinavir|mesh-list
6368706|NCT00120783|Lamivudine|lamivudine|mesh-list
6368707|NCT00120783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6368708|NCT00120783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6368709|NCT00120783|Protease Inhibitors|protease inhibitors|mesh-ancestor
6368710|NCT00120783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6368711|NCT00120783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368712|NCT00120783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6368713|NCT00120783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6368714|NCT00120783|Antiviral Agents|antiviral agents|mesh-ancestor
6368715|NCT00120783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6368716|NCT00120783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6368717|NCT00120783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6368718|NCT00120783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6368719|NCT00120783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6368720|NCT00120796|Lamivudine|lamivudine|mesh-list
6368721|NCT00120796|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6368722|NCT00120796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6368723|NCT00120796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6368724|NCT00120796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368725|NCT00120796|Antiviral Agents|antiviral agents|mesh-ancestor
6368726|NCT00120796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6368727|NCT00120796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6368728|NCT00120796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6368729|NCT00120809|Pyrimethamine|pyrimethamine|mesh-list
6368730|NCT00120809|Sulfadoxine|sulfadoxine|mesh-list
6368731|NCT00120809|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6368732|NCT00120809|Antimalarials|antimalarials|mesh-ancestor
6368733|NCT00120809|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6368734|NCT00120809|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6368735|NCT00120809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6368736|NCT00120809|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6368737|NCT00120809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6368738|NCT00120809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368739|NCT00120809|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6368740|NCT00120809|Renal Agents|renal agents|mesh-ancestor
6368741|NCT00120822|Folic Acid|folic acid|mesh-list
6368742|NCT00120822|Hematinics|hematinics|mesh-ancestor
6368743|NCT00120822|Vitamin B Complex|vitamin b complex|mesh-ancestor
6368744|NCT00120822|Vitamins|vitamins|mesh-ancestor
6368745|NCT00120822|Micronutrients|micronutrients|mesh-ancestor
6368746|NCT00120822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368747|NCT00120835|Interferons|interferons|mesh-list
6368748|NCT00120835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6368749|NCT00120835|Antiviral Agents|antiviral agents|mesh-ancestor
6368750|NCT00120835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6368751|NCT00120861|Interferons|interferons|mesh-list
6368752|NCT00120861|Ribavirin|ribavirin|mesh-list
6368753|NCT00120861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6368754|NCT00120861|Antiviral Agents|antiviral agents|mesh-ancestor
6368755|NCT00120861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6368756|NCT00120861|Antimetabolites|antimetabolites|mesh-ancestor
6368757|NCT00120861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368758|NCT00120887|Atorvastatin|atorvastatin|mesh-list
6368759|NCT00120887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6368760|NCT00120887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6368761|NCT00120887|Antimetabolites|antimetabolites|mesh-ancestor
6368762|NCT00120887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368763|NCT00120887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6368764|NCT00120887|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6368765|NCT00120887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6368766|NCT00120913|Contraceptives, Oral|contraceptives, oral|mesh-list
6368767|NCT00120913|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
6368768|NCT00120913|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6368769|NCT00120913|Contraceptive Agents|contraceptive agents|mesh-ancestor
6368770|NCT00120913|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6368771|NCT00120913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368772|NCT00120939|Motexafin gadolinium|motexafin gadolinium|mesh-list
6368773|NCT00120939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6368774|NCT00120939|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6368775|NCT00120939|Dermatologic Agents|dermatologic agents|mesh-ancestor
6368776|NCT00120952|Cobalt|cobalt|mesh-list
6368777|NCT00120952|Chromium|chromium|mesh-list
6368778|NCT00120952|Trace Elements|trace elements|mesh-ancestor
6368779|NCT00120952|Micronutrients|micronutrients|mesh-ancestor
6368780|NCT00120952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368781|NCT00120978|Fluticasone|fluticasone|mesh-list
6368782|NCT00120978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6368783|NCT00120978|Autonomic Agents|autonomic agents|mesh-ancestor
6368784|NCT00120978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6368785|NCT00120978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368786|NCT00120978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6368787|NCT00120978|Respiratory System Agents|respiratory system agents|mesh-ancestor
6368788|NCT00120978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6368789|NCT00120978|Dermatologic Agents|dermatologic agents|mesh-ancestor
6368790|NCT00120978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6368791|NCT00121017|Ritonavir|ritonavir|mesh-list
6368792|NCT00121017|Lopinavir|lopinavir|mesh-list
6368793|NCT00121017|Tenofovir|tenofovir|mesh-list
6368794|NCT00121017|Emtricitabine|emtricitabine|mesh-list
6368795|NCT00121017|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6368796|NCT00121017|Efavirenz|efavirenz|mesh-list
6368797|NCT00121017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6368798|NCT00121017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6368799|NCT00121017|Protease Inhibitors|protease inhibitors|mesh-ancestor
6368800|NCT00121017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6368801|NCT00121017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368802|NCT00121017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6368803|NCT00121017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6368804|NCT00121017|Antiviral Agents|antiviral agents|mesh-ancestor
6368805|NCT00121017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6368806|NCT00121017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6368807|NCT00121017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6368808|NCT00121017|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6368809|NCT00121017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6368810|NCT00121017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6368811|NCT00121017|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6368812|NCT00121017|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6368813|NCT00121017|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6368814|NCT00121017|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6368815|NCT00121030|Epoetin Alfa|epoetin alfa|mesh-list
6368816|NCT00121030|Darbepoetin alfa|darbepoetin alfa|mesh-list
6368817|NCT00121030|Hematinics|hematinics|mesh-ancestor
6368818|NCT00121043|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6368819|NCT00121043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6368820|NCT00121056|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6368821|NCT00121056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6368822|NCT00121069|Citalopram|citalopram|mesh-list
6368823|NCT00121069|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6368824|NCT00121069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6368825|NCT00121069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6368826|NCT00121069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368827|NCT00121069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6368828|NCT00121069|Serotonin Agents|serotonin agents|mesh-ancestor
6368829|NCT00121069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368830|NCT00121069|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6368831|NCT00121069|Antidepressive Agents|antidepressive agents|mesh-ancestor
6368832|NCT00121069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6368833|NCT00121095|Docetaxel|docetaxel|mesh-list
6368834|NCT00121095|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
6368835|NCT00121095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6368836|NCT00121095|Tubulin Modulators|tubulin modulators|mesh-ancestor
6368837|NCT00121095|Antimitotic Agents|antimitotic agents|mesh-ancestor
6368838|NCT00121095|Mitosis Modulators|mitosis modulators|mesh-ancestor
6368839|NCT00121095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368840|NCT00121095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6368841|NCT00121095|Analgesics|analgesics|mesh-ancestor
6368842|NCT00121095|Sensory System Agents|sensory system agents|mesh-ancestor
6368843|NCT00121095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6368844|NCT00121095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368845|NCT00121147|Travoprost|travoprost|mesh-list
6368846|NCT00121147|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6368847|NCT00121147|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6368848|NCT00121147|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6368849|NCT00121147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6368850|NCT00121147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6368851|NCT00121147|Adrenergic Agents|adrenergic agents|mesh-ancestor
6368852|NCT00121147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6368853|NCT00121147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368854|NCT00121147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368855|NCT00121264|Sorafenib|sorafenib|mesh-list
6368856|NCT00121264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6368857|NCT00121264|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6368858|NCT00121264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6368859|NCT00121264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368860|NCT00121277|Capecitabine|capecitabine|mesh-list
6368861|NCT00121277|Vorinostat|vorinostat|mesh-list
6368862|NCT00121277|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6368863|NCT00121277|Antimetabolites|antimetabolites|mesh-ancestor
6368864|NCT00121277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368865|NCT00121277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6368866|NCT00121277|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6368867|NCT00121277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6368868|NCT00121303|Cytarabine|cytarabine|mesh-list
6368869|NCT00121303|Daunorubicin|daunorubicin|mesh-list
6368870|NCT00121303|Gemtuzumab|gemtuzumab|mesh-list
6368871|NCT00121303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6368872|NCT00121303|Antimetabolites|antimetabolites|mesh-ancestor
6368873|NCT00121303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368874|NCT00121303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6368875|NCT00121303|Antiviral Agents|antiviral agents|mesh-ancestor
6368876|NCT00121303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6368877|NCT00121303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6368878|NCT00121303|Immunologic Factors|immunologic factors|mesh-ancestor
6368879|NCT00121303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368880|NCT00121303|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6368881|NCT00121303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6368882|NCT00121303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6368883|NCT00121303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6368884|NCT00121303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6368885|NCT00121316|Pimecrolimus|pimecrolimus|mesh-list
6368886|NCT00121316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6368887|NCT00121316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6368888|NCT00121316|Analgesics|analgesics|mesh-ancestor
6368889|NCT00121316|Sensory System Agents|sensory system agents|mesh-ancestor
6368890|NCT00121316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6368891|NCT00121316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368892|NCT00121316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6368893|NCT00121316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6368894|NCT00121316|Dermatologic Agents|dermatologic agents|mesh-ancestor
6368895|NCT00121316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6368896|NCT00121316|Immunologic Factors|immunologic factors|mesh-ancestor
6368897|NCT00121316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6368898|NCT00121316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6368899|NCT00121316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368900|NCT00121329|Lidocaine|lidocaine|mesh-list
6368901|NCT00121329|Anesthetics, Local|anesthetics, local|mesh-ancestor
6368902|NCT00121329|Anesthetics|anesthetics|mesh-ancestor
6368903|NCT00121329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6368904|NCT00121329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368905|NCT00121329|Sensory System Agents|sensory system agents|mesh-ancestor
6368906|NCT00121329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6368907|NCT00121329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6368908|NCT00121329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6368909|NCT00121329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6368910|NCT00121329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6368911|NCT00121329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368912|NCT00121381|Pimecrolimus|pimecrolimus|mesh-list
6368913|NCT00121381|Tacrolimus|tacrolimus|mesh-list
6368914|NCT00121381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6368915|NCT00121381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6368916|NCT00121381|Analgesics|analgesics|mesh-ancestor
6368917|NCT00121381|Sensory System Agents|sensory system agents|mesh-ancestor
6368918|NCT00121381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6368919|NCT00121381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368920|NCT00121381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6368921|NCT00121381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6368922|NCT00121381|Dermatologic Agents|dermatologic agents|mesh-ancestor
6368923|NCT00121381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6368924|NCT00121381|Immunologic Factors|immunologic factors|mesh-ancestor
6368925|NCT00121381|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6368926|NCT00121381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6368927|NCT00121381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368928|NCT00121394|Chlorhexidine|chlorhexidine|mesh-list
6368929|NCT00121394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6368930|NCT00121394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6368931|NCT00121394|Disinfectants|disinfectants|mesh-ancestor
6368932|NCT00121407|Verteporfin|verteporfin|mesh-list
6368933|NCT00121407|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6368934|NCT00121407|Dermatologic Agents|dermatologic agents|mesh-ancestor
6368935|NCT00121420|Motexafin gadolinium|motexafin gadolinium|mesh-list
6368936|NCT00121420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6368937|NCT00121420|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6368938|NCT00121420|Dermatologic Agents|dermatologic agents|mesh-ancestor
6368939|NCT00121446|Enoxaparin|enoxaparin|mesh-list
6368940|NCT00121446|Tenecteplase|tenecteplase|mesh-list
6368941|NCT00121446|Clopidogrel|clopidogrel|mesh-list
6368942|NCT00121446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6397034|NCT00209963|Anticonvulsants|anticonvulsants|mesh-ancestor
6368943|NCT00121446|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6368944|NCT00121446|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6368945|NCT00121446|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6368946|NCT00121446|Purinergic Agents|purinergic agents|mesh-ancestor
6368947|NCT00121446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6368948|NCT00121446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368949|NCT00121446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368950|NCT00121446|Anticoagulants|anticoagulants|mesh-ancestor
6368951|NCT00121446|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6368952|NCT00121446|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6368953|NCT00121459|Psyllium|psyllium|mesh-list
6368954|NCT00121459|Calcium polycarbophil|calcium polycarbophil|mesh-list
6368955|NCT00121459|Cathartics|cathartics|mesh-ancestor
6368956|NCT00121459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6368957|NCT00121459|Antidiarrheals|antidiarrheals|mesh-ancestor
6368958|NCT00121498|Lidocaine|lidocaine|mesh-list
6368959|NCT00121498|Anesthetics, Local|anesthetics, local|mesh-list
6368960|NCT00121498|Anesthetics|anesthetics|mesh-list
6368961|NCT00121498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6368962|NCT00121498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368963|NCT00121498|Sensory System Agents|sensory system agents|mesh-ancestor
6368964|NCT00121498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6368965|NCT00121498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6368966|NCT00121498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6368967|NCT00121498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6368968|NCT00121498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6368969|NCT00121498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368970|NCT00121511|Fluorouracil|fluorouracil|mesh-list
6368971|NCT00121511|Antimetabolites|antimetabolites|mesh-ancestor
6368972|NCT00121511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368973|NCT00121511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6368974|NCT00121511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6368975|NCT00121511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6368976|NCT00121511|Immunologic Factors|immunologic factors|mesh-ancestor
6368977|NCT00121511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368978|NCT00121524|Atropine|atropine|mesh-list
6368979|NCT00121524|Amiodarone|amiodarone|mesh-list
6368980|NCT00121524|Epinephrine|epinephrine|mesh-list
6368981|NCT00121524|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6368982|NCT00121524|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6368983|NCT00121524|Adrenergic Agents|adrenergic agents|mesh-ancestor
6368984|NCT00121524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6368985|NCT00121524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6368986|NCT00121524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6368987|NCT00121524|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6368988|NCT00121524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6368989|NCT00121524|Autonomic Agents|autonomic agents|mesh-ancestor
6368990|NCT00121524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6368991|NCT00121524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6368992|NCT00121524|Respiratory System Agents|respiratory system agents|mesh-ancestor
6368993|NCT00121524|Mydriatics|mydriatics|mesh-ancestor
6368994|NCT00121524|Sympathomimetics|sympathomimetics|mesh-ancestor
6368995|NCT00121524|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6368996|NCT00121524|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6368997|NCT00121524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6368998|NCT00121524|Parasympatholytics|parasympatholytics|mesh-ancestor
6368999|NCT00121524|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6369000|NCT00121524|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6369001|NCT00121524|Cholinergic Agents|cholinergic agents|mesh-ancestor
6369002|NCT00121524|Vasodilator Agents|vasodilator agents|mesh-ancestor
6369003|NCT00121524|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6369004|NCT00121524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6369005|NCT00121524|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6369006|NCT00121524|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6369007|NCT00121524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6369008|NCT00121524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6369009|NCT00121524|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6369010|NCT00121524|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6369011|NCT00121524|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6369012|NCT00121550|Clarithromycin|clarithromycin|mesh-list
6369013|NCT00121550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6369014|NCT00121550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6369015|NCT00121550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6369016|NCT00121550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6369017|NCT00121550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369018|NCT00121550|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6369019|NCT00121550|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6369020|NCT00121563|Thalidomide|thalidomide|mesh-list
6369021|NCT00121563|Ibuprofen|ibuprofen|mesh-list
6369022|NCT00121563|Diazepam|diazepam|mesh-list
6369023|NCT00121563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6369024|NCT00121563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6369025|NCT00121563|Analgesics|analgesics|mesh-ancestor
6369026|NCT00121563|Sensory System Agents|sensory system agents|mesh-ancestor
6369027|NCT00121563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6369028|NCT00121563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369029|NCT00121563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6369030|NCT00121563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6369031|NCT00121563|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6369032|NCT00121563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6369033|NCT00121563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369034|NCT00121563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6369035|NCT00121563|Immunologic Factors|immunologic factors|mesh-ancestor
6369036|NCT00121563|Leprostatic Agents|leprostatic agents|mesh-ancestor
6369037|NCT00121563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6369038|NCT00121563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6369039|NCT00121563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6369040|NCT00121563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6369041|NCT00121563|Growth Substances|growth substances|mesh-ancestor
6369042|NCT00121563|Growth Inhibitors|growth inhibitors|mesh-ancestor
6369043|NCT00121563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6369044|NCT00121563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6369045|NCT00121563|Anticonvulsants|anticonvulsants|mesh-ancestor
6369046|NCT00121563|Antiemetics|antiemetics|mesh-ancestor
6369047|NCT00121563|Autonomic Agents|autonomic agents|mesh-ancestor
6369048|NCT00121563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6369049|NCT00121563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6369050|NCT00121563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6369051|NCT00121563|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6369052|NCT00121563|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6369053|NCT00121563|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6369054|NCT00121563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6369055|NCT00121563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6369056|NCT00121563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6369057|NCT00121563|Anesthetics, General|anesthetics, general|mesh-ancestor
6369058|NCT00121563|Anesthetics|anesthetics|mesh-ancestor
6369059|NCT00121563|GABA Modulators|gaba modulators|mesh-ancestor
6369060|NCT00121563|GABA Agents|gaba agents|mesh-ancestor
6369061|NCT00121563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6369062|NCT00121602|Darbepoetin alfa|darbepoetin alfa|mesh-list
6369063|NCT00121602|Hematinics|hematinics|mesh-ancestor
6369064|NCT00121615|Etanercept|etanercept|mesh-list
6369065|NCT00121615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6369066|NCT00121615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6369067|NCT00121615|Analgesics|analgesics|mesh-ancestor
6369068|NCT00121615|Sensory System Agents|sensory system agents|mesh-ancestor
6369069|NCT00121615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6369070|NCT00121615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369071|NCT00121615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6369072|NCT00121615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6369073|NCT00121615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6369074|NCT00121615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6369075|NCT00121615|Immunologic Factors|immunologic factors|mesh-ancestor
6369076|NCT00121628|Motesanib diphosphate|motesanib diphosphate|mesh-list
6369077|NCT00121628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6369078|NCT00121628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5724637|NCT03186040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6369079|NCT00121628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369080|NCT00121680|Lenvatinib|lenvatinib|mesh-list
6369081|NCT00121680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6369082|NCT00121680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6369083|NCT00121680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6369084|NCT00121680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369085|NCT00121784|Mycophenolic Acid|mycophenolic acid|mesh-list
6369086|NCT00121784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6369087|NCT00121784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6369088|NCT00121784|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6369089|NCT00121784|Antitubercular Agents|antitubercular agents|mesh-ancestor
6369090|NCT00121784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6369091|NCT00121784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6369092|NCT00121784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6369093|NCT00121784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369094|NCT00121797|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6369095|NCT00121797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6369096|NCT00121875|Hormones|hormones|mesh-list
6369097|NCT00121875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6369098|NCT00121875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369099|NCT00121888|Paroxetine|paroxetine|mesh-list
6369100|NCT00121888|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6369101|NCT00121888|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6369102|NCT00121888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6369103|NCT00121888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369104|NCT00121888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6369105|NCT00121888|Serotonin Agents|serotonin agents|mesh-ancestor
6369106|NCT00121888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369107|NCT00121888|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6369108|NCT00121888|Antidepressive Agents|antidepressive agents|mesh-ancestor
6369109|NCT00121888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6369110|NCT00121888|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6369111|NCT00121888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6369112|NCT00121888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6369113|NCT00121914|Ethanol|ethanol|mesh-list
6369114|NCT00121914|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6369115|NCT00121914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6369116|NCT00121914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6369117|NCT00121914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369118|NCT00121953|Rosiglitazone|rosiglitazone|mesh-list
6369119|NCT00121953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6369120|NCT00121953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369121|NCT00121966|Insulin|insulin|mesh-list
6369122|NCT00121966|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6369123|NCT00121966|Metformin|metformin|mesh-list
6369124|NCT00121966|Insulin Aspart|insulin aspart|mesh-list
6369125|NCT00121966|Rosiglitazone|rosiglitazone|mesh-list
6369126|NCT00121966|Isophane Insulin, Human|isophane insulin, human|mesh-list
6369127|NCT00121966|Insulin, Isophane|insulin, isophane|mesh-list
6369128|NCT00121966|Isophane insulin, beef|isophane insulin, beef|mesh-list
6369129|NCT00121966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6369130|NCT00121966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369131|NCT00121979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
6369132|NCT00121979|Racivir|racivir|mesh-list
6369133|NCT00121979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6369134|NCT00121979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6369135|NCT00121979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369136|NCT00121979|Antiviral Agents|antiviral agents|mesh-ancestor
6369137|NCT00121979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6369138|NCT00122018|Acetylcysteine|acetylcysteine|mesh-list
6369139|NCT00122018|Fenoldopam|fenoldopam|mesh-list
6369140|NCT00122018|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6369141|NCT00122018|Antiviral Agents|antiviral agents|mesh-ancestor
6369142|NCT00122018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6369143|NCT00122018|Expectorants|expectorants|mesh-ancestor
6369144|NCT00122018|Respiratory System Agents|respiratory system agents|mesh-ancestor
6369145|NCT00122018|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6369146|NCT00122018|Antioxidants|antioxidants|mesh-ancestor
6369147|NCT00122018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369148|NCT00122018|Protective Agents|protective agents|mesh-ancestor
6369149|NCT00122018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369150|NCT00122018|Antidotes|antidotes|mesh-ancestor
6369151|NCT00122018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6369152|NCT00122018|Vasodilator Agents|vasodilator agents|mesh-ancestor
6369153|NCT00122018|Dopamine Agonists|dopamine agonists|mesh-ancestor
6369154|NCT00122018|Dopamine Agents|dopamine agents|mesh-ancestor
6369155|NCT00122018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6369156|NCT00122044|Trihexyphenidyl|trihexyphenidyl|mesh-list
6369157|NCT00122044|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6369158|NCT00122044|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6369159|NCT00122044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6369160|NCT00122044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6369161|NCT00122044|Cholinergic Agents|cholinergic agents|mesh-ancestor
6369162|NCT00122044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6369163|NCT00122044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369164|NCT00122044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369165|NCT00122057|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6369166|NCT00122057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6369167|NCT00122070|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6369168|NCT00122070|Antidepressive Agents|antidepressive agents|mesh-ancestor
6369169|NCT00122070|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6369170|NCT00122070|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6369171|NCT00122070|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6369172|NCT00122070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6369173|NCT00122070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369174|NCT00122096|Valdecoxib|valdecoxib|mesh-list
6369175|NCT00122096|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6369176|NCT00122096|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6369177|NCT00122096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6369178|NCT00122096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369179|NCT00122096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6369180|NCT00122096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6369181|NCT00122096|Analgesics|analgesics|mesh-ancestor
6369182|NCT00122096|Sensory System Agents|sensory system agents|mesh-ancestor
6369183|NCT00122096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6369184|NCT00122096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369185|NCT00122096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6369186|NCT00122096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6369187|NCT00122226|Ritonavir|ritonavir|mesh-list
6369188|NCT00122226|Lopinavir|lopinavir|mesh-list
6369189|NCT00122226|Lamivudine|lamivudine|mesh-list
6369190|NCT00122226|Zidovudine|zidovudine|mesh-list
6369191|NCT00122226|Nevirapine|nevirapine|mesh-list
6369192|NCT00122226|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6369193|NCT00122226|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6369194|NCT00122226|Protease Inhibitors|protease inhibitors|mesh-ancestor
6369195|NCT00122226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6369196|NCT00122226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369197|NCT00122226|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6369198|NCT00122226|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6369199|NCT00122226|Antiviral Agents|antiviral agents|mesh-ancestor
6369200|NCT00122226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6369201|NCT00122226|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6369202|NCT00122226|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6369203|NCT00122226|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6369204|NCT00122226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6369205|NCT00122226|Antimetabolites|antimetabolites|mesh-ancestor
6369206|NCT00122226|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6369207|NCT00122226|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6395392|NCT00205426|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6395393|NCT00205426|Natriuretic Agents|natriuretic agents|mesh-ancestor
6395394|NCT00205426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395395|NCT00205491|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6395396|NCT00205491|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6395397|NCT00205491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6395398|NCT00205491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6395399|NCT00205491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395400|NCT00205491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6395401|NCT00205491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395402|NCT00205491|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6395403|NCT00205491|Antidepressive Agents|antidepressive agents|mesh-ancestor
6395404|NCT00205491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6395405|NCT00205634|Clarithromycin|clarithromycin|mesh-list
6395406|NCT00205634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6395407|NCT00205634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6395408|NCT00205634|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6395409|NCT00205634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6395410|NCT00205634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369208|NCT00122291|Capecitabine|capecitabine|mesh-list
6369209|NCT00122291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6369210|NCT00122291|Antimetabolites|antimetabolites|mesh-ancestor
6369211|NCT00122291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369212|NCT00122291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6369213|NCT00122304|Eculizumab|eculizumab|mesh-list
6369214|NCT00122304|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6369215|NCT00122304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6369216|NCT00122304|Immunologic Factors|immunologic factors|mesh-ancestor
6369217|NCT00122304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369218|NCT00122330|Eculizumab|eculizumab|mesh-list
6369219|NCT00122330|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6369220|NCT00122330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6369221|NCT00122330|Immunologic Factors|immunologic factors|mesh-ancestor
6369222|NCT00122330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369223|NCT00122343|Sirolimus|sirolimus|mesh-list
6369224|NCT00122343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6369225|NCT00122343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6369226|NCT00122343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6369227|NCT00122343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6369228|NCT00122343|Antifungal Agents|antifungal agents|mesh-ancestor
6369229|NCT00122343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6369230|NCT00122343|Immunologic Factors|immunologic factors|mesh-ancestor
6369231|NCT00122343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369232|NCT00122356|Alendronate|alendronate|mesh-list
6369233|NCT00122356|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6369234|NCT00122356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369235|NCT00122434|Tiotropium Bromide|tiotropium bromide|mesh-list
6369236|NCT00122434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6369237|NCT00122434|Autonomic Agents|autonomic agents|mesh-ancestor
6369238|NCT00122434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6369239|NCT00122434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369240|NCT00122434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6369241|NCT00122434|Respiratory System Agents|respiratory system agents|mesh-ancestor
6369242|NCT00122434|Parasympatholytics|parasympatholytics|mesh-ancestor
6369243|NCT00122434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6369244|NCT00122434|Cholinergic Agents|cholinergic agents|mesh-ancestor
6369245|NCT00122434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6369246|NCT00122434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369247|NCT00122473|Imatinib Mesylate|imatinib mesylate|mesh-list
6369248|NCT00122473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6369249|NCT00122473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6369250|NCT00122473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6369251|NCT00122473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369252|NCT00122486|Tenofovir|tenofovir|mesh-list
6369253|NCT00122486|Antiviral Agents|antiviral agents|mesh-ancestor
6369254|NCT00122486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6369255|NCT00122486|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6369256|NCT00122486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6369257|NCT00122486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6369258|NCT00122486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369259|NCT00122486|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6369260|NCT00122486|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6369261|NCT00122499|Tadalafil|tadalafil|mesh-list
6369262|NCT00122499|Vasodilator Agents|vasodilator agents|mesh-ancestor
6369263|NCT00122499|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6369264|NCT00122499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6369265|NCT00122499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6369266|NCT00122499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369267|NCT00122499|Urological Agents|urological agents|mesh-ancestor
6369268|NCT00122512|Tenofovir|tenofovir|mesh-list
6369269|NCT00122512|Antiviral Agents|antiviral agents|mesh-ancestor
6369270|NCT00122512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6369271|NCT00122512|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6369272|NCT00122512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6369273|NCT00122512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6369274|NCT00122512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369275|NCT00122512|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6369276|NCT00122512|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6369277|NCT00122538|Lamivudine|lamivudine|mesh-list
6369278|NCT00122538|Efavirenz|efavirenz|mesh-list
6369279|NCT00122538|Didanosine|didanosine|mesh-list
6369280|NCT00122538|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6369281|NCT00122538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6369282|NCT00122538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6369283|NCT00122538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369284|NCT00122538|Antiviral Agents|antiviral agents|mesh-ancestor
6369285|NCT00122538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6369286|NCT00122538|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6369287|NCT00122538|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6369288|NCT00122538|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6369289|NCT00122538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6369290|NCT00122538|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6369291|NCT00122538|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6369292|NCT00122538|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6369293|NCT00122538|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6369294|NCT00122538|Antimetabolites|antimetabolites|mesh-ancestor
6369295|NCT00122551|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6369296|NCT00122551|Antiviral Agents|antiviral agents|mesh-ancestor
6369297|NCT00122551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6369298|NCT00122577|Ritonavir|ritonavir|mesh-list
6369299|NCT00122577|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6369300|NCT00122577|Tenofovir|tenofovir|mesh-list
6369301|NCT00122577|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6369302|NCT00122577|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6369303|NCT00122577|Protease Inhibitors|protease inhibitors|mesh-ancestor
6369304|NCT00122577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6369305|NCT00122577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369306|NCT00122577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6369307|NCT00122577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6369308|NCT00122577|Antiviral Agents|antiviral agents|mesh-ancestor
6369309|NCT00122577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6369310|NCT00122577|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6369311|NCT00122577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6369312|NCT00122577|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6369313|NCT00122577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6369314|NCT00122590|Ritonavir|ritonavir|mesh-list
6369315|NCT00122590|Lopinavir|lopinavir|mesh-list
6369316|NCT00122590|Nelfinavir|nelfinavir|mesh-list
6369317|NCT00122590|Indinavir|indinavir|mesh-list
6369318|NCT00122590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6369319|NCT00122590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6369320|NCT00122590|Protease Inhibitors|protease inhibitors|mesh-ancestor
6369321|NCT00122590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6369322|NCT00122590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369323|NCT00122590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6369324|NCT00122590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6369325|NCT00122590|Antiviral Agents|antiviral agents|mesh-ancestor
6369326|NCT00122590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6369327|NCT00122590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6369328|NCT00122590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6369329|NCT00122603|Saquinavir|saquinavir|mesh-list
6369330|NCT00122603|Fosamprenavir|fosamprenavir|mesh-list
6369331|NCT00122603|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6369332|NCT00122603|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6369333|NCT00122603|Protease Inhibitors|protease inhibitors|mesh-ancestor
6369334|NCT00122603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6369335|NCT00122603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369336|NCT00122603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6369337|NCT00122603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6369338|NCT00122603|Antiviral Agents|antiviral agents|mesh-ancestor
6369339|NCT00122603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6369340|NCT00122603|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6369341|NCT00122603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6369342|NCT00122616|Ribavirin|ribavirin|mesh-list
6369343|NCT00122616|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6369344|NCT00122616|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6369345|NCT00122616|Antimetabolites|antimetabolites|mesh-ancestor
6369346|NCT00122616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369347|NCT00122616|Antiviral Agents|antiviral agents|mesh-ancestor
6369348|NCT00122616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6369349|NCT00122629|Interferons|interferons|mesh-list
6369350|NCT00122629|Ribavirin|ribavirin|mesh-list
6369351|NCT00122629|Interferon-alpha|interferon-alpha|mesh-list
6369352|NCT00122629|Interferon alpha-2|interferon alpha-2|mesh-list
6369353|NCT00122629|Amantadine|amantadine|mesh-list
6369354|NCT00122629|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6369355|NCT00122629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6369356|NCT00122629|Antiviral Agents|antiviral agents|mesh-ancestor
6369357|NCT00122629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6369358|NCT00122629|Antimetabolites|antimetabolites|mesh-ancestor
6369359|NCT00122629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369360|NCT00122629|Immunologic Factors|immunologic factors|mesh-ancestor
6369361|NCT00122629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369362|NCT00122629|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6369363|NCT00122629|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6369364|NCT00122629|Dopamine Agents|dopamine agents|mesh-ancestor
6369365|NCT00122629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6369366|NCT00122629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6369367|NCT00122629|Analgesics|analgesics|mesh-ancestor
6369368|NCT00122629|Sensory System Agents|sensory system agents|mesh-ancestor
6369369|NCT00122629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6369370|NCT00122655|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
6369371|NCT00122655|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
6369372|NCT00122655|Protease Inhibitors|protease inhibitors|mesh-list
6369373|NCT00122655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6369374|NCT00122655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6369375|NCT00122655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369376|NCT00122655|Antiviral Agents|antiviral agents|mesh-ancestor
6369377|NCT00122655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6369378|NCT00122655|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6369379|NCT00122655|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6369380|NCT00122655|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6369381|NCT00122668|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
6369382|NCT00122668|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
6369383|NCT00122668|Protease Inhibitors|protease inhibitors|mesh-list
6369384|NCT00122668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6369385|NCT00122668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6369386|NCT00122668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369387|NCT00122668|Antiviral Agents|antiviral agents|mesh-ancestor
6369388|NCT00122668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6369389|NCT00122668|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6369390|NCT00122668|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6369391|NCT00122668|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6369392|NCT00122694|Carbon Monoxide|carbon monoxide|mesh-list
6369393|NCT00122694|Antimetabolites|antimetabolites|mesh-ancestor
6369394|NCT00122694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369395|NCT00122694|Gasotransmitters|gasotransmitters|mesh-ancestor
6369396|NCT00122694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6369397|NCT00122694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369398|NCT00122720|Darbepoetin alfa|darbepoetin alfa|mesh-list
6369399|NCT00122720|Hematinics|hematinics|mesh-ancestor
6369400|NCT00122733|Loxapine|loxapine|mesh-list
6369401|NCT00122733|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6017339|NCT00372060|Hormones|hormones|mesh-ancestor
6369402|NCT00122733|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6369403|NCT00122733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6369404|NCT00122733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369405|NCT00122733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6369406|NCT00122733|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6369407|NCT00122733|Dopamine Agents|dopamine agents|mesh-ancestor
6369408|NCT00122733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6369409|NCT00122733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369410|NCT00122746|Cisplatin|cisplatin|mesh-list
6369411|NCT00122746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6369412|NCT00122759|Ketamine|ketamine|mesh-list
6369413|NCT00122759|Analgesics|analgesics|mesh-ancestor
6369414|NCT00122759|Sensory System Agents|sensory system agents|mesh-ancestor
6369415|NCT00122759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6369416|NCT00122759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369417|NCT00122759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6369418|NCT00122759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6369419|NCT00122759|Anesthetics, General|anesthetics, general|mesh-ancestor
6369420|NCT00122759|Anesthetics|anesthetics|mesh-ancestor
6369421|NCT00122759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6369422|NCT00122759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6369423|NCT00122759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6369424|NCT00122759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6369425|NCT00122759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369426|NCT00122772|Cisplatin|cisplatin|mesh-list
6369427|NCT00122772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6369428|NCT00122785|Dexamethasone|dexamethasone|mesh-list
6369429|NCT00122785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6369430|NCT00122785|Antiemetics|antiemetics|mesh-ancestor
6369431|NCT00122785|Autonomic Agents|autonomic agents|mesh-ancestor
6369432|NCT00122785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6369433|NCT00122785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369434|NCT00122785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6369435|NCT00122785|Glucocorticoids|glucocorticoids|mesh-ancestor
6369436|NCT00122785|Hormones|hormones|mesh-ancestor
6369437|NCT00122785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6369438|NCT00122785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6369439|NCT00122785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6369440|NCT00122811|Perindopril|perindopril|mesh-list
6369441|NCT00122811|Indapamide|indapamide|mesh-list
6369442|NCT00122811|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6369443|NCT00122811|Protease Inhibitors|protease inhibitors|mesh-ancestor
6369444|NCT00122811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6369445|NCT00122811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369446|NCT00122811|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6369447|NCT00122811|Diuretics|diuretics|mesh-ancestor
6369448|NCT00122811|Natriuretic Agents|natriuretic agents|mesh-ancestor
6369449|NCT00122811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369450|NCT00122811|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6369451|NCT00122811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6369452|NCT00122824|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6369453|NCT00122824|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6369454|NCT00122824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6369455|NCT00122824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6369456|NCT00122824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369457|NCT00122824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6369458|NCT00122824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369459|NCT00122824|Analgesics|analgesics|mesh-ancestor
6369460|NCT00122824|Sensory System Agents|sensory system agents|mesh-ancestor
6369461|NCT00122824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6369462|NCT00122824|Antidepressive Agents|antidepressive agents|mesh-ancestor
6369463|NCT00122824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6369464|NCT00122824|Dopamine Agents|dopamine agents|mesh-ancestor
6369465|NCT00122837|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6369466|NCT00122837|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6369467|NCT00122837|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6369468|NCT00122837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6369469|NCT00122837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6369470|NCT00122837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369471|NCT00122837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6369472|NCT00122837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369473|NCT00122837|Analgesics|analgesics|mesh-ancestor
6369474|NCT00122837|Sensory System Agents|sensory system agents|mesh-ancestor
6369475|NCT00122837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6369476|NCT00122837|Antidepressive Agents|antidepressive agents|mesh-ancestor
6369477|NCT00122837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6369478|NCT00122837|Dopamine Agents|dopamine agents|mesh-ancestor
6369479|NCT00122837|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6369480|NCT00122850|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6369481|NCT00122850|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6369482|NCT00122850|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6369483|NCT00122850|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6369484|NCT00122850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6369485|NCT00122850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369486|NCT00122850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6369487|NCT00122850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369488|NCT00122850|Analgesics|analgesics|mesh-ancestor
6369489|NCT00122850|Sensory System Agents|sensory system agents|mesh-ancestor
6369490|NCT00122850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6369491|NCT00122850|Antidepressive Agents|antidepressive agents|mesh-ancestor
6369492|NCT00122850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6369493|NCT00122850|Dopamine Agents|dopamine agents|mesh-ancestor
6369494|NCT00122850|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6369495|NCT00122863|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6369496|NCT00122863|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6369497|NCT00122863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6369498|NCT00122863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6369499|NCT00122863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369500|NCT00122863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6369501|NCT00122863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369502|NCT00122863|Analgesics|analgesics|mesh-ancestor
6369503|NCT00122863|Sensory System Agents|sensory system agents|mesh-ancestor
6369504|NCT00122863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6369505|NCT00122863|Antidepressive Agents|antidepressive agents|mesh-ancestor
6369506|NCT00122863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6369507|NCT00122863|Dopamine Agents|dopamine agents|mesh-ancestor
6369508|NCT00122876|Talaporfin|talaporfin|mesh-list
6369509|NCT00122876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6369510|NCT00122876|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6369511|NCT00122876|Dermatologic Agents|dermatologic agents|mesh-ancestor
6369512|NCT00122889|Allicin|allicin|mesh-list
6369513|NCT00122889|Allyl sulfide|allyl sulfide|mesh-list
6369514|NCT00122889|Antioxidants|antioxidants|mesh-ancestor
6369515|NCT00122889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369516|NCT00122889|Protective Agents|protective agents|mesh-ancestor
6369517|NCT00122889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369518|NCT00122889|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6369519|NCT00122889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6369520|NCT00122889|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6369521|NCT00122889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6369522|NCT00122889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6369523|NCT00122889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6369524|NCT00122889|Antimetabolites|antimetabolites|mesh-ancestor
6369525|NCT00122889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6369526|NCT00122889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6369527|NCT00122889|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6369528|NCT00122941|Micronutrients|micronutrients|mesh-list
6369529|NCT00122941|Trace Elements|trace elements|mesh-list
6369530|NCT00122941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369531|NCT00123149|Epoetin Alfa|epoetin alfa|mesh-list
6369532|NCT00123149|Hematinics|hematinics|mesh-ancestor
6369533|NCT00123175|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6369534|NCT00123175|Medroxyprogesterone|medroxyprogesterone|mesh-list
6369535|NCT00123175|Progestins|progestins|mesh-list
6369536|NCT00123175|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6369537|NCT00123175|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6369538|NCT00123175|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6369539|NCT00123175|Contraceptive Agents|contraceptive agents|mesh-ancestor
6369540|NCT00123175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6369541|NCT00123175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369542|NCT00123175|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6369543|NCT00123175|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6369544|NCT00123175|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6369545|NCT00123175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6369546|NCT00123175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6369547|NCT00123175|Hormones|hormones|mesh-ancestor
6369548|NCT00123175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6369549|NCT00123201|Dronabinol|dronabinol|mesh-list
6369550|NCT00123201|Hallucinogens|hallucinogens|mesh-ancestor
6369551|NCT00123201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369552|NCT00123201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6369553|NCT00123201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6369554|NCT00123201|Analgesics|analgesics|mesh-ancestor
6369555|NCT00123201|Sensory System Agents|sensory system agents|mesh-ancestor
6369556|NCT00123201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6369557|NCT00123201|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6369558|NCT00123201|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6369559|NCT00123201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6369560|NCT00123201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369561|NCT00123201|Hormones|hormones|mesh-ancestor
6369562|NCT00123201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6369563|NCT00123227|Rosiglitazone|rosiglitazone|mesh-list
6369564|NCT00123227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6369565|NCT00123227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369566|NCT00123253|Tesamorelin|tesamorelin|mesh-list
6369567|NCT00123253|Growth Substances|growth substances|mesh-ancestor
6369568|NCT00123253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369569|NCT00123266|Plasminogen|plasminogen|mesh-list
6369570|NCT00123266|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6369571|NCT00123266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6369572|NCT00123266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369573|NCT00123279|Plasminogen|plasminogen|mesh-list
6369574|NCT00123279|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6369575|NCT00123279|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6369576|NCT00123279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369577|NCT00123292|Plasminogen|plasminogen|mesh-list
6369578|NCT00123292|Fibrinolysin|fibrinolysin|mesh-list
6369579|NCT00123292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6369580|NCT00123292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6369581|NCT00123292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369582|NCT00123305|Plasminogen|plasminogen|mesh-list
6369583|NCT00123305|Fibrinolysin|fibrinolysin|mesh-list
6369584|NCT00123305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6369585|NCT00123305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6369586|NCT00123305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369587|NCT00123318|Cisplatin|cisplatin|mesh-list
6369588|NCT00123318|Fluorouracil|fluorouracil|mesh-list
6369589|NCT00123318|Epirubicin|epirubicin|mesh-list
6369590|NCT00123318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6369591|NCT00123318|Antimetabolites|antimetabolites|mesh-ancestor
6369592|NCT00123318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369593|NCT00123318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6017340|NCT00372060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6369594|NCT00123318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6369595|NCT00123318|Immunologic Factors|immunologic factors|mesh-ancestor
6369596|NCT00123318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369597|NCT00123318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6369598|NCT00123318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6369599|NCT00123318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6369600|NCT00123318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6369601|NCT00123331|Cyclosporine|cyclosporine|mesh-list
6369602|NCT00123331|Sirolimus|sirolimus|mesh-list
6369603|NCT00123331|Cyclosporins|cyclosporins|mesh-list
6369604|NCT00123331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6369605|NCT00123331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369606|NCT00123331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6369607|NCT00123331|Immunologic Factors|immunologic factors|mesh-ancestor
6369608|NCT00123331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369609|NCT00123331|Antifungal Agents|antifungal agents|mesh-ancestor
6369610|NCT00123331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6369611|NCT00123331|Dermatologic Agents|dermatologic agents|mesh-ancestor
6369612|NCT00123331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6369613|NCT00123331|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6369614|NCT00123331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6369615|NCT00123331|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6369616|NCT00123331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6369617|NCT00123370|Modafinil|modafinil|mesh-list
6369618|NCT00123370|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6369619|NCT00123370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369620|NCT00123370|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6369621|NCT00123370|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6369622|NCT00123370|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6369623|NCT00123370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369624|NCT00123383|Modafinil|modafinil|mesh-list
6369625|NCT00123383|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5724638|NCT03186040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724639|NCT03186001|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5724640|NCT03186001|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5724641|NCT03186001|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5724642|NCT03186001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5724643|NCT03186001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724644|NCT03186001|Cholinergic Agents|cholinergic agents|mesh-ancestor
5724645|NCT03186001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5724646|NCT03186001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724647|NCT03186001|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5724648|NCT03186001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6369626|NCT00123383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369627|NCT00123383|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6369628|NCT00123383|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6369629|NCT00123383|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6369630|NCT00123383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369631|NCT00123461|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
6369632|NCT00123461|Vitamins|vitamins|mesh-ancestor
6369633|NCT00123461|Micronutrients|micronutrients|mesh-ancestor
6369634|NCT00123461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369635|NCT00123461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6369636|NCT00123539|Estrogens|estrogens|mesh-list
6369637|NCT00123539|Hormones|hormones|mesh-ancestor
6369638|NCT00123539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6369639|NCT00123539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369640|NCT00123552|Artesunate|artesunate|mesh-list
6369641|NCT00123552|Lumefantrine|lumefantrine|mesh-list
6369642|NCT00123552|Artemether|artemether|mesh-list
6369643|NCT00123552|Pyrimethamine|pyrimethamine|mesh-list
6369644|NCT00123552|Sulfadoxine|sulfadoxine|mesh-list
6369645|NCT00123552|Amodiaquine|amodiaquine|mesh-list
6369646|NCT00123552|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6369647|NCT00123552|Antimalarials|antimalarials|mesh-ancestor
6369648|NCT00123552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6369649|NCT00123552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6369650|NCT00123552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6369651|NCT00123552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6369652|NCT00123552|Antiviral Agents|antiviral agents|mesh-ancestor
6369653|NCT00123552|Schistosomicides|schistosomicides|mesh-ancestor
6369654|NCT00123552|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6369655|NCT00123552|Anthelmintics|anthelmintics|mesh-ancestor
6369656|NCT00123552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6369657|NCT00123552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6369658|NCT00123552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369659|NCT00123552|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6369660|NCT00123552|Renal Agents|renal agents|mesh-ancestor
6369661|NCT00123578|Pentobarbital|pentobarbital|mesh-list
6369662|NCT00123578|Lorazepam|lorazepam|mesh-list
6369663|NCT00123578|Anticonvulsants|anticonvulsants|mesh-ancestor
6369664|NCT00123578|Antiemetics|antiemetics|mesh-ancestor
6369665|NCT00123578|Autonomic Agents|autonomic agents|mesh-ancestor
6369666|NCT00123578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6369667|NCT00123578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369668|NCT00123578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6369669|NCT00123578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6369670|NCT00123578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6369671|NCT00123578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6369672|NCT00123578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6369673|NCT00123578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6369674|NCT00123578|GABA Modulators|gaba modulators|mesh-ancestor
6369675|NCT00123578|GABA Agents|gaba agents|mesh-ancestor
6369676|NCT00123578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6369677|NCT00123578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369678|NCT00123578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6369679|NCT00123656|Fluticasone|fluticasone|mesh-list
6369680|NCT00123656|Esomeprazole|esomeprazole|mesh-list
6369681|NCT00123656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6369682|NCT00123656|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6369683|NCT00123656|Autonomic Agents|autonomic agents|mesh-ancestor
6369684|NCT00123656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6369685|NCT00123656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369686|NCT00123656|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6369687|NCT00123656|Respiratory System Agents|respiratory system agents|mesh-ancestor
6369688|NCT00123656|Dermatologic Agents|dermatologic agents|mesh-ancestor
6369689|NCT00123656|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6369690|NCT00123656|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6369691|NCT00123656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6369692|NCT00123656|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6369693|NCT00123656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6369694|NCT00123656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369695|NCT00123669|Progesterone|progesterone|mesh-list
6369696|NCT00123669|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
6369697|NCT00123669|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
6369698|NCT00123669|Progestins|progestins|mesh-ancestor
6369699|NCT00123669|Hormones|hormones|mesh-ancestor
6369700|NCT00123669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6369701|NCT00123669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369702|NCT00123669|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6369703|NCT00123669|Hormone Antagonists|hormone antagonists|mesh-ancestor
6369704|NCT00123825|Gemcitabine|gemcitabine|mesh-list
6369705|NCT00123825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6369706|NCT00123825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6369707|NCT00123825|Antimetabolites|antimetabolites|mesh-ancestor
6369708|NCT00123825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369709|NCT00123825|Antiviral Agents|antiviral agents|mesh-ancestor
6369710|NCT00123825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6369711|NCT00123825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6369712|NCT00123825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6369713|NCT00123825|Immunologic Factors|immunologic factors|mesh-ancestor
6369714|NCT00123825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395411|NCT00205634|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6395412|NCT00205634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6395413|NCT00205725|Olanzapine|olanzapine|mesh-list
6395414|NCT00205725|Ziprasidone|ziprasidone|mesh-list
6395415|NCT00205725|Antiemetics|antiemetics|mesh-ancestor
6395416|NCT00205725|Autonomic Agents|autonomic agents|mesh-ancestor
6017341|NCT00372060|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6017342|NCT00372060|Protease Inhibitors|protease inhibitors|mesh-ancestor
6017343|NCT00372060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6017344|NCT00372060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395417|NCT00205725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6395418|NCT00205725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395419|NCT00205725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6395420|NCT00205725|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6395421|NCT00205725|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6395422|NCT00205725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6395423|NCT00205725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6395424|NCT00205725|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6395425|NCT00205725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6395426|NCT00205725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6395427|NCT00205725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395428|NCT00205725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6395429|NCT00205725|Serotonin Agents|serotonin agents|mesh-ancestor
6395430|NCT00205725|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6395431|NCT00205725|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6017345|NCT00372385|Interferons|interferons|mesh-list
6017346|NCT00372385|Ribavirin|ribavirin|mesh-list
6395432|NCT00205725|Dopamine Agents|dopamine agents|mesh-ancestor
6395433|NCT00205738|Olanzapine|olanzapine|mesh-list
6395434|NCT00205738|Risperidone|risperidone|mesh-list
6369715|NCT00123851|Capecitabine|capecitabine|mesh-list
6369716|NCT00123851|Oxaliplatin|oxaliplatin|mesh-list
6369717|NCT00123851|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6369718|NCT00123851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6369719|NCT00123851|Antimetabolites|antimetabolites|mesh-ancestor
6369720|NCT00123851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369721|NCT00123851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6369722|NCT00123851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6369723|NCT00123851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6369724|NCT00123877|Esorubicin|esorubicin|mesh-list
6369725|NCT00123877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6369726|NCT00123877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6369727|NCT00123890|Aplaviroc|aplaviroc|mesh-list
6369728|NCT00123890|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6369729|NCT00123890|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6369730|NCT00123890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369731|NCT00123890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6369732|NCT00123890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6369733|NCT00123890|Antiviral Agents|antiviral agents|mesh-ancestor
6369734|NCT00123890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6369735|NCT00123903|Metoprolol|metoprolol|mesh-list
6369736|NCT00123903|Carvedilol|carvedilol|mesh-list
6369737|NCT00123903|Lisinopril|lisinopril|mesh-list
6369738|NCT00123903|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6369739|NCT00123903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6369740|NCT00123903|Sympatholytics|sympatholytics|mesh-ancestor
6369741|NCT00123903|Autonomic Agents|autonomic agents|mesh-ancestor
6369742|NCT00123903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6369743|NCT00123903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369744|NCT00123903|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6369745|NCT00123903|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6369746|NCT00123903|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6369747|NCT00123903|Adrenergic Agents|adrenergic agents|mesh-ancestor
6369748|NCT00123903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6369749|NCT00123903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369750|NCT00123903|Antioxidants|antioxidants|mesh-ancestor
6369751|NCT00123903|Protective Agents|protective agents|mesh-ancestor
6369752|NCT00123903|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6369753|NCT00123903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6369754|NCT00123903|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6369755|NCT00123903|Vasodilator Agents|vasodilator agents|mesh-ancestor
6369756|NCT00123903|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6369757|NCT00123903|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6369758|NCT00123903|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6369759|NCT00123903|Protease Inhibitors|protease inhibitors|mesh-ancestor
6369760|NCT00123903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6369761|NCT00123903|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6369762|NCT00123916|Benzonidazole|benzonidazole|mesh-list
6369763|NCT00123916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6369764|NCT00123916|Immunologic Factors|immunologic factors|mesh-ancestor
6369765|NCT00123916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369766|NCT00123916|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6369767|NCT00123916|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6369768|NCT00123916|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6369769|NCT00123916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6369770|NCT00123929|Docetaxel|docetaxel|mesh-list
6369771|NCT00123929|Doxorubicin|doxorubicin|mesh-list
6369772|NCT00123929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6369773|NCT00123929|Tubulin Modulators|tubulin modulators|mesh-ancestor
6369774|NCT00123929|Antimitotic Agents|antimitotic agents|mesh-ancestor
6369775|NCT00123929|Mitosis Modulators|mitosis modulators|mesh-ancestor
6369776|NCT00123929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369777|NCT00123929|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6369778|NCT00123929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6369779|NCT00123929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6369780|NCT00123929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6369781|NCT00124059|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6369782|NCT00124059|Antidepressive Agents|antidepressive agents|mesh-ancestor
6369783|NCT00124059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6369784|NCT00124059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6369785|NCT00124059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6369786|NCT00124059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6369787|NCT00124059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369788|NCT00124098|Darbepoetin alfa|darbepoetin alfa|mesh-list
6369789|NCT00124098|Hematinics|hematinics|mesh-ancestor
6369790|NCT00124111|Cyclophosphamide|cyclophosphamide|mesh-list
6369791|NCT00124111|Fluorouracil|fluorouracil|mesh-list
6369792|NCT00124111|Methotrexate|methotrexate|mesh-list
6369793|NCT00124111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6369794|NCT00124111|Immunologic Factors|immunologic factors|mesh-ancestor
6369795|NCT00124111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369796|NCT00124111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6369797|NCT00124111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6369798|NCT00124111|Alkylating Agents|alkylating agents|mesh-ancestor
6369799|NCT00124111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369800|NCT00124111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6369801|NCT00124111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6369802|NCT00124111|Antimetabolites|antimetabolites|mesh-ancestor
6369803|NCT00124111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6369804|NCT00124111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6369805|NCT00124111|Abortifacient Agents|abortifacient agents|mesh-ancestor
6369806|NCT00124111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6369807|NCT00124111|Dermatologic Agents|dermatologic agents|mesh-ancestor
6369808|NCT00124111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6369809|NCT00124111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6369810|NCT00124111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6369811|NCT00124137|Diuretics|diuretics|mesh-list
6369812|NCT00124137|Natriuretic Agents|natriuretic agents|mesh-ancestor
6369813|NCT00124137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369814|NCT00124150|Magnesium Sulfate|magnesium sulfate|mesh-list
6369815|NCT00124150|Analgesics|analgesics|mesh-ancestor
6369816|NCT00124150|Sensory System Agents|sensory system agents|mesh-ancestor
6369817|NCT00124150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6369818|NCT00124150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369819|NCT00124150|Anesthetics|anesthetics|mesh-ancestor
6369820|NCT00124150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6369821|NCT00124150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6369822|NCT00124150|Anticonvulsants|anticonvulsants|mesh-ancestor
6369823|NCT00124150|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6369824|NCT00124150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6369825|NCT00124150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369826|NCT00124150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6369827|NCT00124150|Tocolytic Agents|tocolytic agents|mesh-ancestor
6369828|NCT00124150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6369829|NCT00124241|Lamivudine|lamivudine|mesh-list
6369830|NCT00124241|Telbivudine|telbivudine|mesh-list
6369831|NCT00124241|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6369832|NCT00124241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6369833|NCT00124241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6369834|NCT00124241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369835|NCT00124241|Antiviral Agents|antiviral agents|mesh-ancestor
6369836|NCT00124241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6369837|NCT00124241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6369838|NCT00124241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6369839|NCT00124267|Quinine|quinine|mesh-list
6369840|NCT00124267|Antimalarials|antimalarials|mesh-ancestor
6369841|NCT00124267|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6369842|NCT00124267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5724649|NCT03185871|Celecoxib|celecoxib|mesh-list
6369843|NCT00124267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6369844|NCT00124267|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6369845|NCT00124267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369846|NCT00124267|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6369847|NCT00124267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6369848|NCT00124267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6369849|NCT00124267|Analgesics|analgesics|mesh-ancestor
6369850|NCT00124267|Sensory System Agents|sensory system agents|mesh-ancestor
6369851|NCT00124280|Everolimus|everolimus|mesh-list
6369852|NCT00124280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6369853|NCT00124280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6369854|NCT00124280|Immunologic Factors|immunologic factors|mesh-ancestor
6369855|NCT00124280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369856|NCT00124306|Amitriptyline|amitriptyline|mesh-list
6369857|NCT00124306|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6369858|NCT00124306|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6369859|NCT00124306|Antidepressive Agents|antidepressive agents|mesh-ancestor
6369860|NCT00124306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6369861|NCT00124306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6369862|NCT00124306|Analgesics|analgesics|mesh-ancestor
6369863|NCT00124306|Sensory System Agents|sensory system agents|mesh-ancestor
6369864|NCT00124306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6369865|NCT00124306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369866|NCT00124306|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6369867|NCT00124306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6369868|NCT00124306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6369869|NCT00124306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369870|NCT00124306|Adrenergic Agents|adrenergic agents|mesh-ancestor
6369871|NCT00124306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6369872|NCT00124306|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6369873|NCT00124306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6369874|NCT00124306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6369875|NCT00124332|Rimonabant|rimonabant|mesh-list
6369876|NCT00124332|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6369877|NCT00124332|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
6369878|NCT00124332|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6369879|NCT00124332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6369880|NCT00124332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369881|NCT00124332|Hormones|hormones|mesh-ancestor
6369882|NCT00124332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6369883|NCT00124332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369884|NCT00124358|Buprenorphine|buprenorphine|mesh-list
6369885|NCT00124358|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6369886|NCT00124358|Narcotics|narcotics|mesh-ancestor
6369887|NCT00124358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6369888|NCT00124358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369889|NCT00124358|Analgesics|analgesics|mesh-ancestor
6369890|NCT00124358|Sensory System Agents|sensory system agents|mesh-ancestor
6369891|NCT00124358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6369892|NCT00124358|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6369893|NCT00124384|Modafinil|modafinil|mesh-list
6369894|NCT00124384|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6369895|NCT00124384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369896|NCT00124384|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6369897|NCT00124384|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6369898|NCT00124384|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6369899|NCT00124384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369900|NCT00124397|Atorvastatin|atorvastatin|mesh-list
6369901|NCT00124397|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6369902|NCT00124397|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6369903|NCT00124397|Antimetabolites|antimetabolites|mesh-ancestor
6369904|NCT00124397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369905|NCT00124397|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6369906|NCT00124397|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6369907|NCT00124397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6369908|NCT00124436|Alitretinoin|alitretinoin|mesh-list
6369909|NCT00124436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6369910|NCT00124436|Dermatologic Agents|dermatologic agents|mesh-ancestor
6369911|NCT00124475|Alitretinoin|alitretinoin|mesh-list
6369912|NCT00124475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6369913|NCT00124475|Dermatologic Agents|dermatologic agents|mesh-ancestor
6369914|NCT00124527|Capecitabine|capecitabine|mesh-list
6369915|NCT00124527|Irofulven|irofulven|mesh-list
6369916|NCT00124527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6369917|NCT00124527|Antimetabolites|antimetabolites|mesh-ancestor
6369918|NCT00124527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369919|NCT00124527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6369920|NCT00124527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6369921|NCT00124527|Alkylating Agents|alkylating agents|mesh-ancestor
6369922|NCT00124540|Misoprostol|misoprostol|mesh-list
6369923|NCT00124540|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6369924|NCT00124540|Abortifacient Agents|abortifacient agents|mesh-ancestor
6369925|NCT00124540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6369926|NCT00124540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369927|NCT00124540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6369928|NCT00124540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6369929|NCT00124540|Oxytocics|oxytocics|mesh-ancestor
6369930|NCT00124566|Prednisone|prednisone|mesh-list
6369931|NCT00124566|Capecitabine|capecitabine|mesh-list
6369932|NCT00124566|Mitoxantrone|mitoxantrone|mesh-list
6369933|NCT00124566|Irofulven|irofulven|mesh-list
6369934|NCT00124566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6369935|NCT00124566|Glucocorticoids|glucocorticoids|mesh-ancestor
6369936|NCT00124566|Hormones|hormones|mesh-ancestor
6369937|NCT00124566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6369938|NCT00124566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369939|NCT00124566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6369940|NCT00124566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6369941|NCT00124566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6369942|NCT00124566|Antimetabolites|antimetabolites|mesh-ancestor
6369943|NCT00124566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369944|NCT00124566|Analgesics|analgesics|mesh-ancestor
6369945|NCT00124566|Sensory System Agents|sensory system agents|mesh-ancestor
6369946|NCT00124566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6017347|NCT00372385|Interferon-alpha|interferon-alpha|mesh-list
6369947|NCT00124566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6369948|NCT00124566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6369949|NCT00124566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6369950|NCT00124566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6369951|NCT00124566|Alkylating Agents|alkylating agents|mesh-ancestor
6369952|NCT00124605|Pamidronate|pamidronate|mesh-list
6369953|NCT00124605|Arsenic Trioxide|arsenic trioxide|mesh-list
6369954|NCT00124605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6369955|NCT00124605|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6369956|NCT00124605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369957|NCT00124644|Cytarabine|cytarabine|mesh-list
6369958|NCT00124644|Etoposide|etoposide|mesh-list
6369959|NCT00124644|Daunorubicin|daunorubicin|mesh-list
6369960|NCT00124644|Tipifarnib|tipifarnib|mesh-list
6369961|NCT00124644|Enzyme Inhibitors|enzyme inhibitors|mesh-list
6369962|NCT00124644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6369963|NCT00124644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6369964|NCT00124644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6369965|NCT00124644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6369966|NCT00124644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369967|NCT00124644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6369968|NCT00124644|Antimetabolites|antimetabolites|mesh-ancestor
6369969|NCT00124644|Antiviral Agents|antiviral agents|mesh-ancestor
6369970|NCT00124644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6369971|NCT00124644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6369972|NCT00124644|Immunologic Factors|immunologic factors|mesh-ancestor
6369973|NCT00124644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369974|NCT00124644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6369975|NCT00124683|Bupropion|bupropion|mesh-list
6369976|NCT00124683|Nicotine|nicotine|mesh-list
6369977|NCT00124683|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6369978|NCT00124683|Autonomic Agents|autonomic agents|mesh-ancestor
6369979|NCT00124683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6369980|NCT00124683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6369981|NCT00124683|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6369982|NCT00124683|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6369983|NCT00124683|Cholinergic Agents|cholinergic agents|mesh-ancestor
6369984|NCT00124683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6369985|NCT00124683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6369986|NCT00124683|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6369987|NCT00124683|Antidepressive Agents|antidepressive agents|mesh-ancestor
6369988|NCT00124683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6369989|NCT00124683|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6369990|NCT00124683|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6369991|NCT00124683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6369992|NCT00124683|Dopamine Agents|dopamine agents|mesh-ancestor
6369993|NCT00124683|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6369994|NCT00124683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6369995|NCT00124683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6369996|NCT00124696|Cocaethylene|cocaethylene|mesh-list
6369997|NCT00124696|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6369998|NCT00124696|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6369999|NCT00124696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6370000|NCT00124696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370001|NCT00124696|Dopamine Agents|dopamine agents|mesh-ancestor
6370002|NCT00124696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6370003|NCT00124696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370004|NCT00124722|Bromides|bromides|mesh-list
6370005|NCT00124722|Rocuronium|rocuronium|mesh-list
6370006|NCT00124722|Anticonvulsants|anticonvulsants|mesh-ancestor
6370007|NCT00124722|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6370008|NCT00124722|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6370009|NCT00124722|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6370010|NCT00124722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6370011|NCT00124722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370012|NCT00124787|Dimenhydrinate|dimenhydrinate|mesh-list
6370013|NCT00124787|Antiemetics|antiemetics|mesh-ancestor
6370014|NCT00124787|Autonomic Agents|autonomic agents|mesh-ancestor
6370015|NCT00124787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6370016|NCT00124787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370017|NCT00124787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6370018|NCT00124787|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6370019|NCT00124787|Histamine Antagonists|histamine antagonists|mesh-ancestor
6370020|NCT00124787|Histamine Agents|histamine agents|mesh-ancestor
6370021|NCT00124787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6370022|NCT00124787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370023|NCT00124813|Thalidomide|thalidomide|mesh-list
6370024|NCT00124813|Idarubicin|idarubicin|mesh-list
6370025|NCT00124813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6370026|NCT00124813|Immunologic Factors|immunologic factors|mesh-ancestor
6370027|NCT00124813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370028|NCT00124813|Leprostatic Agents|leprostatic agents|mesh-ancestor
6370029|NCT00124813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6370030|NCT00124813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6370031|NCT00124813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6370032|NCT00124813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6370033|NCT00124813|Growth Substances|growth substances|mesh-ancestor
6370034|NCT00124813|Growth Inhibitors|growth inhibitors|mesh-ancestor
6370035|NCT00124813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6370036|NCT00124813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6370037|NCT00124813|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6370038|NCT00124813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6370039|NCT00124813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6370040|NCT00124813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370041|NCT00124826|Insulin|insulin|mesh-list
6370042|NCT00124826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6370043|NCT00124826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370044|NCT00124839|Naltrexone|naltrexone|mesh-list
6370045|NCT00124839|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6370046|NCT00124839|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6370047|NCT00124839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370048|NCT00124839|Sensory System Agents|sensory system agents|mesh-ancestor
6370049|NCT00124839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6370050|NCT00124891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
6370051|NCT00124930|Olanzapine|olanzapine|mesh-list
6370052|NCT00124930|Antiemetics|antiemetics|mesh-ancestor
6370053|NCT00124930|Autonomic Agents|autonomic agents|mesh-ancestor
6370054|NCT00124930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6370055|NCT00124930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370056|NCT00124930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6370057|NCT00124930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6370058|NCT00124930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6370059|NCT00124930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6370060|NCT00124930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6370061|NCT00124930|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6370062|NCT00124930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6370063|NCT00124930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6370064|NCT00124930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370065|NCT00124930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6370066|NCT00124930|Serotonin Agents|serotonin agents|mesh-ancestor
6370067|NCT00124956|Doxorubicin|doxorubicin|mesh-list
6370068|NCT00124956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6370069|NCT00124956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6370070|NCT00124956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6370071|NCT00124956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6370072|NCT00124956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6370073|NCT00124956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370074|NCT00124969|Amlodipine|amlodipine|mesh-list
6370075|NCT00124969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6370076|NCT00124969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6370077|NCT00124969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6370078|NCT00124969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370079|NCT00124969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6370080|NCT00124969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370081|NCT00124969|Vasodilator Agents|vasodilator agents|mesh-ancestor
6370082|NCT00124995|Terbutaline|terbutaline|mesh-list
6370083|NCT00124995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6370084|NCT00124995|Autonomic Agents|autonomic agents|mesh-ancestor
6370085|NCT00124995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6370086|NCT00124995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370087|NCT00124995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6370088|NCT00124995|Respiratory System Agents|respiratory system agents|mesh-ancestor
6370089|NCT00124995|Sympathomimetics|sympathomimetics|mesh-ancestor
6370090|NCT00124995|Tocolytic Agents|tocolytic agents|mesh-ancestor
6370091|NCT00124995|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6370092|NCT00124995|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6370093|NCT00124995|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6370094|NCT00124995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6370095|NCT00124995|Adrenergic Agents|adrenergic agents|mesh-ancestor
6370096|NCT00124995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6370097|NCT00124995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370098|NCT00125008|Vaccines|vaccines|mesh-list
6370099|NCT00125008|Immunologic Factors|immunologic factors|mesh-ancestor
6370100|NCT00125008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370101|NCT00125021|Capecitabine|capecitabine|mesh-list
6370102|NCT00125021|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6370103|NCT00125021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6370104|NCT00125021|Antimetabolites|antimetabolites|mesh-ancestor
6370105|NCT00125021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017348|NCT00372385|Interferon alpha-2|interferon alpha-2|mesh-list
6370106|NCT00125021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6370107|NCT00125021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6370108|NCT00125021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6370109|NCT00125047|Vaccines|vaccines|mesh-list
6370110|NCT00125047|Immunologic Factors|immunologic factors|mesh-ancestor
6370111|NCT00125047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370112|NCT00125060|Simvastatin|simvastatin|mesh-list
6370113|NCT00125060|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6370114|NCT00125060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6370115|NCT00125060|Antimetabolites|antimetabolites|mesh-ancestor
6370116|NCT00125060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370117|NCT00125060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6370118|NCT00125060|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6370119|NCT00125060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6370120|NCT00125203|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
6370121|NCT00125203|Botulinum Toxins|botulinum toxins|mesh-list
6370122|NCT00125203|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6370123|NCT00125203|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6370124|NCT00125203|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6370125|NCT00125203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6370126|NCT00125203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370127|NCT00125203|Cholinergic Agents|cholinergic agents|mesh-ancestor
6370128|NCT00125203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6370129|NCT00125203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370130|NCT00125203|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6370131|NCT00125203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6370132|NCT00125203|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6370133|NCT00125229|Mannitol|mannitol|mesh-list
6370134|NCT00125229|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6370135|NCT00125229|Diuretics|diuretics|mesh-ancestor
6370136|NCT00125229|Natriuretic Agents|natriuretic agents|mesh-ancestor
6370137|NCT00125229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370138|NCT00125255|Lidocaine|lidocaine|mesh-list
6370139|NCT00125255|Tetracaine|tetracaine|mesh-list
6370140|NCT00125255|Anesthetics, Local|anesthetics, local|mesh-ancestor
6370141|NCT00125255|Anesthetics|anesthetics|mesh-ancestor
6370142|NCT00125255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6370143|NCT00125255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370144|NCT00125255|Sensory System Agents|sensory system agents|mesh-ancestor
6370145|NCT00125255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6370146|NCT00125255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6370147|NCT00125255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6370148|NCT00125255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6370149|NCT00125255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6370150|NCT00125255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370151|NCT00125294|Methadone|methadone|mesh-list
6370152|NCT00125294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6370153|NCT00125294|Narcotics|narcotics|mesh-ancestor
6370154|NCT00125294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6370155|NCT00125294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370156|NCT00125294|Analgesics|analgesics|mesh-ancestor
6370157|NCT00125294|Sensory System Agents|sensory system agents|mesh-ancestor
6370158|NCT00125294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6370159|NCT00125294|Antitussive Agents|antitussive agents|mesh-ancestor
6370160|NCT00125294|Respiratory System Agents|respiratory system agents|mesh-ancestor
6370161|NCT00125307|Tacrolimus|tacrolimus|mesh-list
6370162|NCT00125307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6370163|NCT00125307|Immunologic Factors|immunologic factors|mesh-ancestor
6370164|NCT00125307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370165|NCT00125307|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6370166|NCT00125307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6370167|NCT00125307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370168|NCT00125346|Tobramycin|tobramycin|mesh-list
6370169|NCT00125346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6370170|NCT00125346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6370171|NCT00125385|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6370172|NCT00125385|Immunologic Factors|immunologic factors|mesh-ancestor
6370173|NCT00125385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370174|NCT00125398|Fospropofol|fospropofol|mesh-list
6370175|NCT00125398|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6370176|NCT00125398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6370177|NCT00125398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370178|NCT00125411|Docetaxel|docetaxel|mesh-list
6370179|NCT00125411|Satraplatin|satraplatin|mesh-list
6370180|NCT00125411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6370181|NCT00125411|Tubulin Modulators|tubulin modulators|mesh-ancestor
6370182|NCT00125411|Antimitotic Agents|antimitotic agents|mesh-ancestor
6370183|NCT00125411|Mitosis Modulators|mitosis modulators|mesh-ancestor
6370184|NCT00125411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370185|NCT00125424|Midazolam|midazolam|mesh-list
6370186|NCT00125424|Fospropofol|fospropofol|mesh-list
6370187|NCT00125424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6370188|NCT00125424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6370189|NCT00125424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6370190|NCT00125424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370191|NCT00125424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6370192|NCT00125424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6370193|NCT00125424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6370194|NCT00125424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6370195|NCT00125424|Anesthetics, General|anesthetics, general|mesh-ancestor
6370196|NCT00125424|Anesthetics|anesthetics|mesh-ancestor
6370197|NCT00125424|GABA Modulators|gaba modulators|mesh-ancestor
6370198|NCT00125424|GABA Agents|gaba agents|mesh-ancestor
6370199|NCT00125424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6370200|NCT00125424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370201|NCT00125437|Spironolactone|spironolactone|mesh-list
6370202|NCT00125437|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6370203|NCT00125437|Hormone Antagonists|hormone antagonists|mesh-ancestor
6370204|NCT00125437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6370205|NCT00125437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370206|NCT00125437|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6370207|NCT00125437|Diuretics|diuretics|mesh-ancestor
6370208|NCT00125437|Natriuretic Agents|natriuretic agents|mesh-ancestor
6370209|NCT00125463|Candesartan|candesartan|mesh-list
6370210|NCT00125463|Candesartan cilexetil|candesartan cilexetil|mesh-list
6370211|NCT00125463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6370212|NCT00125463|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6370213|NCT00125463|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6370214|NCT00125463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370215|NCT00125489|Chloroquine|chloroquine|mesh-list
6370216|NCT00125489|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
6370217|NCT00125489|Pyrimethamine|pyrimethamine|mesh-list
6370218|NCT00125489|Sulfadoxine|sulfadoxine|mesh-list
6370219|NCT00125489|Amebicides|amebicides|mesh-ancestor
6370220|NCT00125489|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6370221|NCT00125489|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6370222|NCT00125489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6017349|NCT00372385|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6017350|NCT00372385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6017351|NCT00372385|Antiviral Agents|antiviral agents|mesh-ancestor
6017352|NCT00372385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6017353|NCT00372385|Antimetabolites|antimetabolites|mesh-ancestor
6017354|NCT00372385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017355|NCT00372385|Immunologic Factors|immunologic factors|mesh-ancestor
6017356|NCT00372385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017357|NCT00372424|Docetaxel|docetaxel|mesh-list
6017358|NCT00372424|Trastuzumab|trastuzumab|mesh-list
6017359|NCT00372424|Sunitinib|sunitinib|mesh-list
6017360|NCT00372424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6017361|NCT00372424|Tubulin Modulators|tubulin modulators|mesh-ancestor
6017362|NCT00372424|Antimitotic Agents|antimitotic agents|mesh-ancestor
6017363|NCT00372424|Mitosis Modulators|mitosis modulators|mesh-ancestor
6017364|NCT00372424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370223|NCT00125489|Antimalarials|antimalarials|mesh-ancestor
6370224|NCT00125489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6370225|NCT00125489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6370226|NCT00125489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6370227|NCT00125489|Analgesics|analgesics|mesh-ancestor
6370228|NCT00125489|Sensory System Agents|sensory system agents|mesh-ancestor
6370229|NCT00125489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6370230|NCT00125489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370231|NCT00125489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6017365|NCT00372424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6370232|NCT00125489|Filaricides|filaricides|mesh-ancestor
6370233|NCT00125489|Antinematodal Agents|antinematodal agents|mesh-ancestor
6370234|NCT00125489|Anthelmintics|anthelmintics|mesh-ancestor
6370235|NCT00125489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6370236|NCT00125489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6370237|NCT00125489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370238|NCT00125489|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6370239|NCT00125489|Renal Agents|renal agents|mesh-ancestor
6395435|NCT00205738|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6395436|NCT00205738|Serotonin Agents|serotonin agents|mesh-ancestor
6395437|NCT00205738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6395438|NCT00205738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395439|NCT00205738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395440|NCT00205738|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6395441|NCT00205738|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6395442|NCT00205738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6395443|NCT00205738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6395444|NCT00205738|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6395445|NCT00205738|Dopamine Agents|dopamine agents|mesh-ancestor
6395446|NCT00205738|Antiemetics|antiemetics|mesh-ancestor
6395447|NCT00205738|Autonomic Agents|autonomic agents|mesh-ancestor
6395448|NCT00205738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6395449|NCT00205738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6395450|NCT00205738|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6395451|NCT00205738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6395452|NCT00205738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6395453|NCT00205751|Thalidomide|thalidomide|mesh-list
6395454|NCT00205751|Dexamethasone|dexamethasone|mesh-list
6395455|NCT00205751|Prednisone|prednisone|mesh-list
6395456|NCT00205751|Melphalan|melphalan|mesh-list
6395457|NCT00205751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6395458|NCT00205751|Antiemetics|antiemetics|mesh-ancestor
6395459|NCT00205751|Autonomic Agents|autonomic agents|mesh-ancestor
6395460|NCT00205751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6395461|NCT00205751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395462|NCT00205751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6395463|NCT00205751|Glucocorticoids|glucocorticoids|mesh-ancestor
6395464|NCT00205751|Hormones|hormones|mesh-ancestor
6395465|NCT00205751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6395466|NCT00205751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6395467|NCT00205751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6395468|NCT00205751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6395469|NCT00205751|Alkylating Agents|alkylating agents|mesh-ancestor
6395470|NCT00205751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395471|NCT00205751|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6395472|NCT00205751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6395473|NCT00205751|Immunologic Factors|immunologic factors|mesh-ancestor
6395474|NCT00205751|Leprostatic Agents|leprostatic agents|mesh-ancestor
6395475|NCT00205751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6395476|NCT00205751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6395477|NCT00205751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6395478|NCT00205751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6395479|NCT00205751|Growth Substances|growth substances|mesh-ancestor
6395480|NCT00205751|Growth Inhibitors|growth inhibitors|mesh-ancestor
6395481|NCT00205764|Melphalan|melphalan|mesh-list
6395482|NCT00205764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6395483|NCT00205764|Alkylating Agents|alkylating agents|mesh-ancestor
6395484|NCT00205764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395485|NCT00205764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6395486|NCT00205764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6395487|NCT00205764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6395488|NCT00205764|Immunologic Factors|immunologic factors|mesh-ancestor
6395489|NCT00205764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395490|NCT00205816|Tigecycline|tigecycline|mesh-list
6395491|NCT00205816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6395492|NCT00205816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6395493|NCT00205816|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6395494|NCT00205816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6395495|NCT00205816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395496|NCT00205842|Alvimopan|alvimopan|mesh-list
6395497|NCT00205842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6395498|NCT00205946|Bupropion|bupropion|mesh-list
6395499|NCT00205946|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6395500|NCT00205946|Antidepressive Agents|antidepressive agents|mesh-ancestor
6395501|NCT00205946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6370240|NCT00125554|Metyrapone|metyrapone|mesh-list
6370241|NCT00125554|Antimetabolites|antimetabolites|mesh-ancestor
6370242|NCT00125554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370243|NCT00125554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6370244|NCT00125567|Levodopa|levodopa|mesh-list
6370245|NCT00125567|Carbidopa|carbidopa|mesh-list
6370246|NCT00125567|Entacapone|entacapone|mesh-list
6370247|NCT00125567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6370248|NCT00125567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6370249|NCT00125567|Dopamine Agents|dopamine agents|mesh-ancestor
6370250|NCT00125567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6370251|NCT00125567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370252|NCT00125567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370253|NCT00125567|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6370254|NCT00125567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6370255|NCT00125567|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6370256|NCT00125645|Irbesartan|irbesartan|mesh-list
6370257|NCT00125645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6370258|NCT00125645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6370259|NCT00125645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6370260|NCT00125645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370261|NCT00125671|Warfarin|warfarin|mesh-list
6370262|NCT00125671|Anticoagulants|anticoagulants|mesh-ancestor
6370263|NCT00125684|Morphine|morphine|mesh-list
6370264|NCT00125684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6370265|NCT00125684|Narcotics|narcotics|mesh-ancestor
6370266|NCT00125684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6370267|NCT00125684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370268|NCT00125684|Analgesics|analgesics|mesh-ancestor
6370269|NCT00125684|Sensory System Agents|sensory system agents|mesh-ancestor
6370270|NCT00125684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6370271|NCT00125736|Rabeprazole|rabeprazole|mesh-list
6370272|NCT00125736|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6370273|NCT00125736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6370274|NCT00125736|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6370275|NCT00125736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6370276|NCT00125736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017366|NCT00372424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6017367|NCT00372424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6017368|NCT00372424|Growth Substances|growth substances|mesh-ancestor
6017369|NCT00372424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370277|NCT00125749|Vaccines|vaccines|mesh-list
6370278|NCT00125749|Immunologic Factors|immunologic factors|mesh-ancestor
6370279|NCT00125749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370280|NCT00125801|Hydromorphone|hydromorphone|mesh-list
6370281|NCT00125801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6370282|NCT00125801|Narcotics|narcotics|mesh-ancestor
6370283|NCT00125801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6397035|NCT00209963|GABA Agonists|gaba agonists|mesh-ancestor
6017370|NCT00372424|Growth Inhibitors|growth inhibitors|mesh-ancestor
6370284|NCT00125801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370285|NCT00125801|Analgesics|analgesics|mesh-ancestor
6370286|NCT00125801|Sensory System Agents|sensory system agents|mesh-ancestor
6370287|NCT00125801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6370288|NCT00125814|Interferons|interferons|mesh-list
6370289|NCT00125814|Interferon-alpha|interferon-alpha|mesh-list
6370290|NCT00125814|Interferon alpha-2|interferon alpha-2|mesh-list
6370291|NCT00125814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6370292|NCT00125814|Antiviral Agents|antiviral agents|mesh-ancestor
6370293|NCT00125814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6370294|NCT00125814|Immunologic Factors|immunologic factors|mesh-ancestor
6370295|NCT00125814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370296|NCT00125827|Clofarabine|clofarabine|mesh-list
6370297|NCT00125827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6370298|NCT00125827|Antimetabolites|antimetabolites|mesh-ancestor
6370299|NCT00125827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370300|NCT00125827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6370301|NCT00125840|Clofarabine|clofarabine|mesh-list
6370302|NCT00125840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6370303|NCT00125840|Antimetabolites|antimetabolites|mesh-ancestor
6370304|NCT00125840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370305|NCT00125840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6370306|NCT00125892|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6370307|NCT00125892|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6370308|NCT00125892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6370309|NCT00125892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6370310|NCT00125892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370311|NCT00125892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6370312|NCT00125892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370313|NCT00125892|Analgesics|analgesics|mesh-ancestor
6370314|NCT00125892|Sensory System Agents|sensory system agents|mesh-ancestor
6370315|NCT00125892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6370316|NCT00125892|Antidepressive Agents|antidepressive agents|mesh-ancestor
6370317|NCT00125892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6370318|NCT00125892|Dopamine Agents|dopamine agents|mesh-ancestor
6370319|NCT00125905|Bupropion|bupropion|mesh-list
6370320|NCT00125905|Nicotine|nicotine|mesh-list
6370321|NCT00125905|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6370322|NCT00125905|Autonomic Agents|autonomic agents|mesh-ancestor
6370323|NCT00125905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6370324|NCT00125905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370325|NCT00125905|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6370326|NCT00125905|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6370327|NCT00125905|Cholinergic Agents|cholinergic agents|mesh-ancestor
6370328|NCT00125905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6370329|NCT00125905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370330|NCT00125905|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6370331|NCT00125905|Antidepressive Agents|antidepressive agents|mesh-ancestor
6370332|NCT00125905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6370333|NCT00125905|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6370334|NCT00125905|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6370335|NCT00125905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6370336|NCT00125905|Dopamine Agents|dopamine agents|mesh-ancestor
6370337|NCT00125905|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6370338|NCT00125905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6370339|NCT00125905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6370340|NCT00125918|Tadalafil|tadalafil|mesh-list
6370341|NCT00125918|Vasodilator Agents|vasodilator agents|mesh-ancestor
6370342|NCT00125918|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6370343|NCT00125918|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6370344|NCT00125918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6370345|NCT00125918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370346|NCT00125918|Urological Agents|urological agents|mesh-ancestor
6370347|NCT00125983|Ritonavir|ritonavir|mesh-list
6370348|NCT00125983|Lopinavir|lopinavir|mesh-list
6370349|NCT00125983|Norinyl|norinyl|mesh-list
6370350|NCT00125983|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
6370351|NCT00125983|Ortho Evra|ortho evra|mesh-list
6370352|NCT00125983|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6370353|NCT00125983|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6370354|NCT00125983|Protease Inhibitors|protease inhibitors|mesh-ancestor
6370355|NCT00125983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6370356|NCT00125983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370357|NCT00125983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6370358|NCT00125983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6370359|NCT00125983|Antiviral Agents|antiviral agents|mesh-ancestor
6370360|NCT00125983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6370361|NCT00125983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6370362|NCT00125983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6370363|NCT00125983|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6370364|NCT00125983|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6370365|NCT00125983|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6370366|NCT00125983|Contraceptive Agents|contraceptive agents|mesh-ancestor
6370367|NCT00125983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6370368|NCT00125983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370369|NCT00125983|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6370370|NCT00125983|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6370371|NCT00125983|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
6370372|NCT00125983|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6370373|NCT00125996|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6370374|NCT00125996|Hematinics|hematinics|mesh-ancestor
6370375|NCT00126009|Amisulpride|amisulpride|mesh-list
6370376|NCT00126009|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6370377|NCT00126009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6370378|NCT00126009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6370379|NCT00126009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370380|NCT00126009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6370381|NCT00126009|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6370382|NCT00126009|Dopamine Agents|dopamine agents|mesh-ancestor
6370383|NCT00126009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6370384|NCT00126009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370385|NCT00126009|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6370386|NCT00126009|Antidepressive Agents|antidepressive agents|mesh-ancestor
6370387|NCT00126022|Tedisamil|tedisamil|mesh-list
6370388|NCT00126022|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6370389|NCT00126022|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6370390|NCT00126022|Protective Agents|protective agents|mesh-ancestor
6370391|NCT00126022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370392|NCT00126048|Atorvastatin|atorvastatin|mesh-list
6370393|NCT00126048|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6370394|NCT00126048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6370395|NCT00126048|Antimetabolites|antimetabolites|mesh-ancestor
6370396|NCT00126048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370397|NCT00126048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6370398|NCT00126048|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6370399|NCT00126048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6370400|NCT00126061|Tedisamil|tedisamil|mesh-list
6370401|NCT00126061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6370402|NCT00126061|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6370403|NCT00126061|Protective Agents|protective agents|mesh-ancestor
6370404|NCT00126061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370405|NCT00126074|Tedisamil|tedisamil|mesh-list
6370406|NCT00126074|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6370407|NCT00126074|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6370408|NCT00126074|Protective Agents|protective agents|mesh-ancestor
6370409|NCT00126074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370410|NCT00126087|Dopamine|dopamine|mesh-list
6370411|NCT00126087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6370412|NCT00126087|Sympathomimetics|sympathomimetics|mesh-ancestor
6370413|NCT00126087|Autonomic Agents|autonomic agents|mesh-ancestor
6370414|NCT00126087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6370415|NCT00126087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370416|NCT00126087|Dopamine Agents|dopamine agents|mesh-ancestor
6370417|NCT00126087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6370418|NCT00126087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370419|NCT00126087|Protective Agents|protective agents|mesh-ancestor
6370420|NCT00126100|Sargramostim|sargramostim|mesh-list
6370421|NCT00126100|Lenograstim|lenograstim|mesh-list
6370422|NCT00126100|Immunologic Factors|immunologic factors|mesh-ancestor
6370423|NCT00126100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370424|NCT00126100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6370425|NCT00126139|Abciximab|abciximab|mesh-list
6370426|NCT00126139|Anticoagulants|anticoagulants|mesh-ancestor
6370427|NCT00126139|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6370428|NCT00126204|Doxycycline|doxycycline|mesh-list
6370429|NCT00126204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6370430|NCT00126204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6370431|NCT00126204|Antimalarials|antimalarials|mesh-ancestor
6370432|NCT00126204|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6370433|NCT00126204|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6370434|NCT00126230|Docetaxel|docetaxel|mesh-list
6370435|NCT00126230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6370436|NCT00126230|Tubulin Modulators|tubulin modulators|mesh-ancestor
6370437|NCT00126230|Antimitotic Agents|antimitotic agents|mesh-ancestor
6370438|NCT00126230|Mitosis Modulators|mitosis modulators|mesh-ancestor
6370439|NCT00126230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370440|NCT00126243|Rituximab|rituximab|mesh-list
6370441|NCT00126243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6370442|NCT00126243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6370443|NCT00126243|Immunologic Factors|immunologic factors|mesh-ancestor
6370444|NCT00126243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370445|NCT00126243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6370446|NCT00126256|Leucovorin|leucovorin|mesh-list
6370447|NCT00126256|Fluorouracil|fluorouracil|mesh-list
6370448|NCT00126256|Oxaliplatin|oxaliplatin|mesh-list
6370449|NCT00126256|Irinotecan|irinotecan|mesh-list
6370450|NCT00126256|Antimetabolites|antimetabolites|mesh-ancestor
6370451|NCT00126256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370452|NCT00126256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6370453|NCT00126256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6370454|NCT00126256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6370455|NCT00126256|Immunologic Factors|immunologic factors|mesh-ancestor
6370456|NCT00126256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370457|NCT00126256|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6370458|NCT00126256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6370459|NCT00126256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6370460|NCT00126256|Antidotes|antidotes|mesh-ancestor
6370461|NCT00126256|Protective Agents|protective agents|mesh-ancestor
6370462|NCT00126256|Vitamin B Complex|vitamin b complex|mesh-ancestor
6370463|NCT00126256|Vitamins|vitamins|mesh-ancestor
6370464|NCT00126256|Micronutrients|micronutrients|mesh-ancestor
6370465|NCT00126269|Gemcitabine|gemcitabine|mesh-list
6370466|NCT00126269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6370467|NCT00126269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6370468|NCT00126269|Antimetabolites|antimetabolites|mesh-ancestor
6370469|NCT00126269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370470|NCT00126269|Antiviral Agents|antiviral agents|mesh-ancestor
6370471|NCT00126269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6370472|NCT00126269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6370473|NCT00126269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6370474|NCT00126269|Immunologic Factors|immunologic factors|mesh-ancestor
6370475|NCT00126269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370476|NCT00126282|Cycloserine|cycloserine|mesh-list
6370477|NCT00126282|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6370478|NCT00126282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6370479|NCT00126282|Renal Agents|renal agents|mesh-ancestor
6370480|NCT00126282|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6370481|NCT00126282|Antitubercular Agents|antitubercular agents|mesh-ancestor
6370482|NCT00126282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6370483|NCT00126282|Antimetabolites|antimetabolites|mesh-ancestor
6370484|NCT00126282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370485|NCT00126308|Mannitol|mannitol|mesh-list
6370486|NCT00126308|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6370487|NCT00126308|Diuretics|diuretics|mesh-ancestor
6370488|NCT00126308|Natriuretic Agents|natriuretic agents|mesh-ancestor
6370489|NCT00126308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370490|NCT00126321|Cladribine|cladribine|mesh-list
6370491|NCT00126321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6370492|NCT00126321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6370493|NCT00126321|Immunologic Factors|immunologic factors|mesh-ancestor
6370494|NCT00126321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370495|NCT00126347|Folic Acid|folic acid|mesh-list
6370496|NCT00126347|Betaine|betaine|mesh-list
6370497|NCT00126347|Hematinics|hematinics|mesh-ancestor
6370498|NCT00126347|Vitamin B Complex|vitamin b complex|mesh-ancestor
6370499|NCT00126347|Vitamins|vitamins|mesh-ancestor
6370500|NCT00126347|Micronutrients|micronutrients|mesh-ancestor
6370501|NCT00126347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370502|NCT00126347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6370503|NCT00126347|Lipotropic Agents|lipotropic agents|mesh-ancestor
6370504|NCT00126347|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6370505|NCT00126347|Antimetabolites|antimetabolites|mesh-ancestor
6370506|NCT00126347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370507|NCT00126347|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6370508|NCT00126360|Anastrozole|anastrozole|mesh-list
6370509|NCT00126360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6370510|NCT00126360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6370511|NCT00126360|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6370512|NCT00126360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6370513|NCT00126360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6370514|NCT00126360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370515|NCT00126360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6370516|NCT00126360|Hormone Antagonists|hormone antagonists|mesh-ancestor
6370517|NCT00126360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6370518|NCT00126360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370519|NCT00126373|Bupropion|bupropion|mesh-list
6370520|NCT00126373|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6370521|NCT00126373|Antidepressive Agents|antidepressive agents|mesh-ancestor
6370522|NCT00126373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6370523|NCT00126373|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6370524|NCT00126373|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6370525|NCT00126373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6370526|NCT00126373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370527|NCT00126373|Dopamine Agents|dopamine agents|mesh-ancestor
6370528|NCT00126373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6370529|NCT00126373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370530|NCT00126373|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6370531|NCT00126373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6370532|NCT00126373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6370533|NCT00126386|Zoledronic Acid|zoledronic acid|mesh-list
6370534|NCT00126386|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6370535|NCT00126386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370536|NCT00126399|Doxycycline|doxycycline|mesh-list
6370537|NCT00126399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6370538|NCT00126399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6370539|NCT00126399|Antimalarials|antimalarials|mesh-ancestor
6370540|NCT00126399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6370541|NCT00126399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6370542|NCT00126412|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
6370543|NCT00126412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6370544|NCT00126412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6370545|NCT00126412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370546|NCT00126412|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6370547|NCT00126451|Vorinostat|vorinostat|mesh-list
6370548|NCT00126451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6370549|NCT00126451|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6370550|NCT00126451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6370551|NCT00126451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370552|NCT00126464|Tamoxifen|tamoxifen|mesh-list
6370553|NCT00126464|Fulvestrant|fulvestrant|mesh-list
6370554|NCT00126464|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6370555|NCT00126464|Hormone Antagonists|hormone antagonists|mesh-ancestor
6370556|NCT00126464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6370557|NCT00126464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370558|NCT00126464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6370559|NCT00126464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6370560|NCT00126464|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6370561|NCT00126464|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6370562|NCT00126464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6370563|NCT00126464|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6370564|NCT00126516|Angiotensin II|angiotensin ii|mesh-list
6370565|NCT00126516|Giapreza|giapreza|mesh-list
6370566|NCT00126516|Enzyme Inhibitors|enzyme inhibitors|mesh-list
6370567|NCT00126516|Angiotensinogen|angiotensinogen|mesh-list
6370568|NCT00126516|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6370569|NCT00126516|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
6370570|NCT00126516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370571|NCT00126516|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6370572|NCT00126516|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6370573|NCT00126516|Protease Inhibitors|protease inhibitors|mesh-ancestor
6370574|NCT00126542|Bevacizumab|bevacizumab|mesh-list
6370575|NCT00126542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6370576|NCT00126542|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6370577|NCT00126542|Antibodies|antibodies|mesh-list
6370578|NCT00126542|Immunoglobulins|immunoglobulins|mesh-list
6370579|NCT00126542|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6370580|NCT00126542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6370581|NCT00126542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6370582|NCT00126542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6370583|NCT00126542|Growth Substances|growth substances|mesh-ancestor
6370584|NCT00126542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370585|NCT00126542|Growth Inhibitors|growth inhibitors|mesh-ancestor
6370586|NCT00126542|Immunologic Factors|immunologic factors|mesh-ancestor
6370587|NCT00126542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6370588|NCT00126542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6370589|NCT00126542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370590|NCT00126607|Trastuzumab|trastuzumab|mesh-list
6370591|NCT00126607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6370592|NCT00126607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6370593|NCT00126620|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6370594|NCT00126620|Sorafenib|sorafenib|mesh-list
6370595|NCT00126620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6370596|NCT00126620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6370597|NCT00126620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6370598|NCT00126620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370599|NCT00126633|Gemcitabine|gemcitabine|mesh-list
6370600|NCT00126633|Bevacizumab|bevacizumab|mesh-list
6370601|NCT00126633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6370602|NCT00126633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6370603|NCT00126633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6370604|NCT00126633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6370605|NCT00126633|Growth Substances|growth substances|mesh-ancestor
6370606|NCT00126633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370607|NCT00126633|Growth Inhibitors|growth inhibitors|mesh-ancestor
6370608|NCT00126633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6370609|NCT00126633|Antimetabolites|antimetabolites|mesh-ancestor
6370610|NCT00126633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370611|NCT00126633|Antiviral Agents|antiviral agents|mesh-ancestor
6370612|NCT00126633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6370613|NCT00126633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6370614|NCT00126633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6370615|NCT00126633|Immunologic Factors|immunologic factors|mesh-ancestor
6370616|NCT00126646|Antibodies|antibodies|mesh-list
6370617|NCT00126646|Immunoconjugates|immunoconjugates|mesh-list
6370618|NCT00126646|Immunotoxins|immunotoxins|mesh-list
6370619|NCT00126646|Immunologic Factors|immunologic factors|mesh-ancestor
6370620|NCT00126646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370621|NCT00126672|Sirolimus|sirolimus|mesh-list
6370622|NCT00126672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6370623|NCT00126672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6370624|NCT00126672|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6370625|NCT00126672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6370626|NCT00126672|Antifungal Agents|antifungal agents|mesh-ancestor
6370627|NCT00126672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6370628|NCT00126672|Immunologic Factors|immunologic factors|mesh-ancestor
6397036|NCT00209963|GABA Agents|gaba agents|mesh-ancestor
6370629|NCT00126672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370630|NCT00126698|Ciprofloxacin|ciprofloxacin|mesh-list
6370631|NCT00126698|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6370632|NCT00126698|Trimethoprim|trimethoprim|mesh-list
6370633|NCT00126698|Sulfamethoxazole|sulfamethoxazole|mesh-list
6370634|NCT00126698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6370635|NCT00126698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6370636|NCT00126698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6370637|NCT00126698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6370638|NCT00126698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6370639|NCT00126698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370640|NCT00126698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6370641|NCT00126698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6370642|NCT00126698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6370643|NCT00126698|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6370644|NCT00126698|Renal Agents|renal agents|mesh-ancestor
6370645|NCT00126698|Antimalarials|antimalarials|mesh-ancestor
6370646|NCT00126698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6370647|NCT00126698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6370648|NCT00126698|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6370649|NCT00126698|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6370650|NCT00126698|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6370651|NCT00126763|Fentanyl|fentanyl|mesh-list
6370652|NCT00126763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6370653|NCT00126763|Narcotics|narcotics|mesh-ancestor
6370654|NCT00126763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6370655|NCT00126763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370656|NCT00126763|Analgesics|analgesics|mesh-ancestor
6370657|NCT00126763|Sensory System Agents|sensory system agents|mesh-ancestor
6370658|NCT00126763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6370659|NCT00126763|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6370660|NCT00126763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6370661|NCT00126763|Anesthetics, General|anesthetics, general|mesh-ancestor
6370662|NCT00126763|Anesthetics|anesthetics|mesh-ancestor
6370663|NCT00126789|Fentanyl|fentanyl|mesh-list
6370664|NCT00126789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6370665|NCT00126789|Narcotics|narcotics|mesh-ancestor
6370666|NCT00126789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6370667|NCT00126789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370668|NCT00126789|Analgesics|analgesics|mesh-ancestor
6370669|NCT00126789|Sensory System Agents|sensory system agents|mesh-ancestor
6370670|NCT00126789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6370671|NCT00126789|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6370672|NCT00126789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6370673|NCT00126789|Anesthetics, General|anesthetics, general|mesh-ancestor
6370674|NCT00126789|Anesthetics|anesthetics|mesh-ancestor
6370675|NCT00126880|Lamivudine|lamivudine|mesh-list
6370676|NCT00126880|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6370677|NCT00126880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6370678|NCT00126880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6370679|NCT00126880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370680|NCT00126880|Antiviral Agents|antiviral agents|mesh-ancestor
6370681|NCT00126880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6370682|NCT00126880|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6370683|NCT00126880|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6370684|NCT00126906|Pyrimethamine|pyrimethamine|mesh-list
6370685|NCT00126906|Sulfadoxine|sulfadoxine|mesh-list
6370686|NCT00126906|Antimalarials|antimalarials|mesh-ancestor
6370687|NCT00126906|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6370688|NCT00126906|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6370689|NCT00126906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6370690|NCT00126906|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6370691|NCT00126906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6370692|NCT00126906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370693|NCT00126906|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6370694|NCT00126906|Renal Agents|renal agents|mesh-ancestor
6370695|NCT00126971|Dapsone|dapsone|mesh-list
6370696|NCT00126971|Chlorproguanil|chlorproguanil|mesh-list
6370697|NCT00126971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6370698|NCT00126971|Antimalarials|antimalarials|mesh-ancestor
6370699|NCT00126971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6370700|NCT00126971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6370701|NCT00126971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6370702|NCT00126971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6370703|NCT00126971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370704|NCT00126971|Leprostatic Agents|leprostatic agents|mesh-ancestor
6370705|NCT00126971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6370706|NCT00127010|Vaccines|vaccines|mesh-list
6370707|NCT00127010|Immunoglobulins|immunoglobulins|mesh-list
6370708|NCT00127010|Immunologic Factors|immunologic factors|mesh-ancestor
6370709|NCT00127010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370710|NCT00127023|Vaccines|vaccines|mesh-list
6370711|NCT00127023|Immunoglobulins|immunoglobulins|mesh-list
6370712|NCT00127023|Immunologic Factors|immunologic factors|mesh-ancestor
6370713|NCT00127023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370714|NCT00127049|Gemcitabine|gemcitabine|mesh-list
6370715|NCT00127049|Ifosfamide|ifosfamide|mesh-list
6370716|NCT00127049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6370717|NCT00127049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6370718|NCT00127049|Antimetabolites|antimetabolites|mesh-ancestor
6370719|NCT00127049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370720|NCT00127049|Antiviral Agents|antiviral agents|mesh-ancestor
6370721|NCT00127049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6370722|NCT00127049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6370723|NCT00127049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6370724|NCT00127049|Immunologic Factors|immunologic factors|mesh-ancestor
6370725|NCT00127049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370726|NCT00127049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6370727|NCT00127049|Alkylating Agents|alkylating agents|mesh-ancestor
6370728|NCT00127075|Estradiol|estradiol|mesh-list
6370729|NCT00127075|Estrogens|estrogens|mesh-ancestor
6370730|NCT00127075|Hormones|hormones|mesh-ancestor
6370731|NCT00127075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6370732|NCT00127075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370733|NCT00127088|Docetaxel|docetaxel|mesh-list
6370734|NCT00127088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6370735|NCT00127088|Tubulin Modulators|tubulin modulators|mesh-ancestor
6370736|NCT00127088|Antimitotic Agents|antimitotic agents|mesh-ancestor
6370737|NCT00127088|Mitosis Modulators|mitosis modulators|mesh-ancestor
6370738|NCT00127088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370739|NCT00127114|Amantadine|amantadine|mesh-list
6370740|NCT00127114|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6370741|NCT00127114|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6370742|NCT00127114|Antiviral Agents|antiviral agents|mesh-ancestor
6370743|NCT00127114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6370744|NCT00127114|Dopamine Agents|dopamine agents|mesh-ancestor
6370745|NCT00127114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6370746|NCT00127114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370747|NCT00127114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370748|NCT00127114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6370749|NCT00127114|Analgesics|analgesics|mesh-ancestor
6370750|NCT00127114|Sensory System Agents|sensory system agents|mesh-ancestor
6370751|NCT00127114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6370752|NCT00127127|Vorinostat|vorinostat|mesh-list
6370753|NCT00127127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6370754|NCT00127127|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6370755|NCT00127127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6370756|NCT00127127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370757|NCT00127140|Vorinostat|vorinostat|mesh-list
6370758|NCT00127140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6370759|NCT00127140|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6370760|NCT00127140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6370761|NCT00127140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370762|NCT00127153|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6370763|NCT00127153|Immunologic Factors|immunologic factors|mesh-ancestor
6370764|NCT00127153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370765|NCT00127257|Diazepam|diazepam|mesh-list
6370766|NCT00127257|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6370767|NCT00127257|Anticonvulsants|anticonvulsants|mesh-ancestor
6370768|NCT00127257|Antiemetics|antiemetics|mesh-ancestor
6370769|NCT00127257|Autonomic Agents|autonomic agents|mesh-ancestor
6370770|NCT00127257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6370771|NCT00127257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370772|NCT00127257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6370773|NCT00127257|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6370774|NCT00127257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6370775|NCT00127257|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6370776|NCT00127257|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6370777|NCT00127257|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6370778|NCT00127257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6370779|NCT00127257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6370780|NCT00127257|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6370781|NCT00127257|Anesthetics, General|anesthetics, general|mesh-ancestor
6370782|NCT00127257|Anesthetics|anesthetics|mesh-ancestor
6370783|NCT00127257|GABA Modulators|gaba modulators|mesh-ancestor
6370784|NCT00127257|GABA Agents|gaba agents|mesh-ancestor
6370785|NCT00127257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6370786|NCT00127257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370787|NCT00127270|Darifenacin|darifenacin|mesh-list
6370788|NCT00127270|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6370789|NCT00127270|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6370790|NCT00127270|Cholinergic Agents|cholinergic agents|mesh-ancestor
6370791|NCT00127270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6370792|NCT00127270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370793|NCT00127270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370794|NCT00127270|Urological Agents|urological agents|mesh-ancestor
6395502|NCT00205946|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6395503|NCT00205946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6395504|NCT00205946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6395505|NCT00205946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395506|NCT00205946|Dopamine Agents|dopamine agents|mesh-ancestor
6395507|NCT00205946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6395508|NCT00205946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370795|NCT00127335|Atorvastatin|atorvastatin|mesh-list
6370796|NCT00127335|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6370797|NCT00127335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6370798|NCT00127335|Antimetabolites|antimetabolites|mesh-ancestor
6370799|NCT00127335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370800|NCT00127335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6370801|NCT00127335|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6370802|NCT00127335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6370803|NCT00127387|Etanercept|etanercept|mesh-list
6370804|NCT00127387|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6370805|NCT00127387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6370806|NCT00127387|Analgesics|analgesics|mesh-ancestor
6370807|NCT00127387|Sensory System Agents|sensory system agents|mesh-ancestor
6370808|NCT00127387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6370809|NCT00127387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370810|NCT00127387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6370811|NCT00127387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6370812|NCT00127387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6370813|NCT00127387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6370814|NCT00127387|Immunologic Factors|immunologic factors|mesh-ancestor
6370815|NCT00127478|Atrasentan|atrasentan|mesh-list
6370816|NCT00127478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6370817|NCT00127478|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
6370818|NCT00127478|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6370819|NCT00127478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370820|NCT00127504|Azithromycin|azithromycin|mesh-list
6370821|NCT00127504|Rifampin|rifampin|mesh-list
6370822|NCT00127504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6370823|NCT00127504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6370824|NCT00127504|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6370825|NCT00127504|Antitubercular Agents|antitubercular agents|mesh-ancestor
6370826|NCT00127504|Leprostatic Agents|leprostatic agents|mesh-ancestor
6370827|NCT00127504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6370828|NCT00127504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6370829|NCT00127504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370830|NCT00127504|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6370831|NCT00127504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6370832|NCT00127504|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6370833|NCT00127504|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6370834|NCT00127504|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6370835|NCT00127504|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6370836|NCT00127569|Rituximab|rituximab|mesh-list
6370837|NCT00127569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6017371|NCT00372424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6017372|NCT00372424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6017373|NCT00372528|Pregabalin|pregabalin|mesh-list
6017374|NCT00372528|Analgesics|analgesics|mesh-ancestor
6017375|NCT00372528|Sensory System Agents|sensory system agents|mesh-ancestor
6017376|NCT00372528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6017377|NCT00372528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017378|NCT00372528|Anticonvulsants|anticonvulsants|mesh-ancestor
6017379|NCT00372528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6017380|NCT00372528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6017381|NCT00372528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017382|NCT00372528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6017383|NCT00372528|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6017384|NCT00372528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6017385|NCT00372528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6017386|NCT00372528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6370838|NCT00127569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6370839|NCT00127569|Immunologic Factors|immunologic factors|mesh-ancestor
6370840|NCT00127569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370841|NCT00127569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6370842|NCT00127595|Gemcitabine|gemcitabine|mesh-list
6370843|NCT00127595|Oxaliplatin|oxaliplatin|mesh-list
6370844|NCT00127595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6370845|NCT00127595|Antimetabolites|antimetabolites|mesh-ancestor
6370846|NCT00127595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370847|NCT00127595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6370848|NCT00127595|Antiviral Agents|antiviral agents|mesh-ancestor
6370849|NCT00127595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6370850|NCT00127595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6370851|NCT00127595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6370852|NCT00127595|Immunologic Factors|immunologic factors|mesh-ancestor
6370853|NCT00127595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370854|NCT00127673|Sertraline|sertraline|mesh-list
6370855|NCT00127673|Antidepressive Agents|antidepressive agents|mesh-ancestor
6370856|NCT00127673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6370857|NCT00127673|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6370858|NCT00127673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6370859|NCT00127673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6370860|NCT00127673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370861|NCT00127673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6370862|NCT00127673|Serotonin Agents|serotonin agents|mesh-ancestor
6370863|NCT00127673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370864|NCT00127686|Dextromethorphan|dextromethorphan|mesh-list
6370865|NCT00127686|Antitussive Agents|antitussive agents|mesh-ancestor
6370866|NCT00127686|Respiratory System Agents|respiratory system agents|mesh-ancestor
6370867|NCT00127686|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6370868|NCT00127686|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6370869|NCT00127686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6370870|NCT00127686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370871|NCT00127686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370872|NCT00127764|Dexamethasone|dexamethasone|mesh-list
6370873|NCT00127764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6370874|NCT00127764|Antiemetics|antiemetics|mesh-ancestor
6370875|NCT00127764|Autonomic Agents|autonomic agents|mesh-ancestor
6370876|NCT00127764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6370877|NCT00127764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370878|NCT00127764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6370879|NCT00127764|Glucocorticoids|glucocorticoids|mesh-ancestor
6370880|NCT00127764|Hormones|hormones|mesh-ancestor
6370881|NCT00127764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6370882|NCT00127764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6370883|NCT00127764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6370884|NCT00127777|Amantadine|amantadine|mesh-list
6370885|NCT00127777|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6370886|NCT00127777|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6370887|NCT00127777|Antiviral Agents|antiviral agents|mesh-ancestor
6370888|NCT00127777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6370889|NCT00127777|Dopamine Agents|dopamine agents|mesh-ancestor
6370890|NCT00127777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6370891|NCT00127777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017387|NCT00372567|Sunitinib|sunitinib|mesh-list
6370892|NCT00127777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370893|NCT00127777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6370894|NCT00127777|Analgesics|analgesics|mesh-ancestor
6370895|NCT00127777|Sensory System Agents|sensory system agents|mesh-ancestor
6017388|NCT00372567|Imatinib Mesylate|imatinib mesylate|mesh-list
6017389|NCT00372567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6017390|NCT00372567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6017391|NCT00372567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6370896|NCT00127777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6370897|NCT00127829|Gefitinib|gefitinib|mesh-list
6370898|NCT00127829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6017392|NCT00372567|Growth Substances|growth substances|mesh-ancestor
6017393|NCT00372567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017394|NCT00372567|Growth Inhibitors|growth inhibitors|mesh-ancestor
6017395|NCT00372567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6017396|NCT00372567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6017397|NCT00372567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017398|NCT00372593|Cytarabine|cytarabine|mesh-list
6017399|NCT00372593|Etoposide|etoposide|mesh-list
6017400|NCT00372593|Daunorubicin|daunorubicin|mesh-list
6017401|NCT00372593|Mitoxantrone|mitoxantrone|mesh-list
6017402|NCT00372593|Asparaginase|asparaginase|mesh-list
6017403|NCT00372593|Gemtuzumab|gemtuzumab|mesh-list
6370899|NCT00127829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6017404|NCT00372593|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6017405|NCT00372593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6017406|NCT00372593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6017407|NCT00372593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6370900|NCT00127829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6370901|NCT00127829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370902|NCT00127868|Selenium|selenium|mesh-list
6370903|NCT00127868|Ketoconazole|ketoconazole|mesh-list
6370904|NCT00127868|Ciclopirox|ciclopirox|mesh-list
6370905|NCT00127868|Griseofulvin|griseofulvin|mesh-list
6370906|NCT00127868|Selenium disulfide|selenium disulfide|mesh-list
6370907|NCT00127868|Antifungal Agents|antifungal agents|mesh-ancestor
6370908|NCT00127868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6370909|NCT00127868|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6370910|NCT00127868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6370911|NCT00127868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6370912|NCT00127868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370913|NCT00127868|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6370914|NCT00127868|Hormone Antagonists|hormone antagonists|mesh-ancestor
6370915|NCT00127868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6370916|NCT00127868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370917|NCT00127868|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6370918|NCT00127868|Antioxidants|antioxidants|mesh-ancestor
6370919|NCT00127868|Protective Agents|protective agents|mesh-ancestor
6370920|NCT00127868|Trace Elements|trace elements|mesh-ancestor
6370921|NCT00127868|Micronutrients|micronutrients|mesh-ancestor
6370922|NCT00127868|Dermatologic Agents|dermatologic agents|mesh-ancestor
6370923|NCT00127881|Zanolimumab|zanolimumab|mesh-list
6370924|NCT00127881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6370925|NCT00127881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6370926|NCT00127907|Vasopressins|vasopressins|mesh-list
6370927|NCT00127907|Arginine Vasopressin|arginine vasopressin|mesh-list
6370928|NCT00127907|Epinephrine|epinephrine|mesh-list
6370929|NCT00127907|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6370930|NCT00127907|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6370931|NCT00127907|Adrenergic Agents|adrenergic agents|mesh-ancestor
6370932|NCT00127907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6370933|NCT00127907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370934|NCT00127907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370935|NCT00127907|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6370936|NCT00127907|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6370937|NCT00127907|Autonomic Agents|autonomic agents|mesh-ancestor
6370938|NCT00127907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6370939|NCT00127907|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6370940|NCT00127907|Respiratory System Agents|respiratory system agents|mesh-ancestor
6370941|NCT00127907|Mydriatics|mydriatics|mesh-ancestor
6370942|NCT00127907|Sympathomimetics|sympathomimetics|mesh-ancestor
6370943|NCT00127907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6370944|NCT00127907|Hemostatics|hemostatics|mesh-ancestor
6370945|NCT00127907|Coagulants|coagulants|mesh-ancestor
6370946|NCT00127907|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6370947|NCT00127907|Natriuretic Agents|natriuretic agents|mesh-ancestor
6370948|NCT00127920|Bevacizumab|bevacizumab|mesh-list
6370949|NCT00127920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6370950|NCT00127920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6370951|NCT00127920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6370952|NCT00127920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6370953|NCT00127920|Growth Substances|growth substances|mesh-ancestor
6370954|NCT00127920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6370955|NCT00127920|Growth Inhibitors|growth inhibitors|mesh-ancestor
6370956|NCT00127959|Tenofovir|tenofovir|mesh-list
6370957|NCT00127959|Zidovudine|zidovudine|mesh-list
6370958|NCT00127959|Emtricitabine|emtricitabine|mesh-list
6370959|NCT00127959|Efavirenz|efavirenz|mesh-list
6370960|NCT00127959|Antiviral Agents|antiviral agents|mesh-ancestor
6370961|NCT00127959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6370962|NCT00127959|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6370963|NCT00127959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6370964|NCT00127959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6370965|NCT00127959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370966|NCT00127959|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6370967|NCT00127959|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6370968|NCT00127959|Antimetabolites|antimetabolites|mesh-ancestor
6370969|NCT00127959|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6370970|NCT00127959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6370971|NCT00127959|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6370972|NCT00127959|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6370973|NCT00127959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6370974|NCT00127959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6370975|NCT00127972|Lamivudine|lamivudine|mesh-list
6370976|NCT00127972|Efavirenz|efavirenz|mesh-list
6370977|NCT00127972|Nevirapine|nevirapine|mesh-list
6370978|NCT00127972|Stavudine|stavudine|mesh-list
6370979|NCT00127972|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6370980|NCT00127972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6370981|NCT00127972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6370982|NCT00127972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6370983|NCT00127972|Antiviral Agents|antiviral agents|mesh-ancestor
6370984|NCT00127972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6370985|NCT00127972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6370986|NCT00127972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6370987|NCT00127972|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6370988|NCT00127972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6370989|NCT00127972|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6370990|NCT00127972|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6370991|NCT00127972|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6370992|NCT00127972|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6370993|NCT00127972|Antimetabolites|antimetabolites|mesh-ancestor
6370994|NCT00127985|Prednisolone|prednisolone|mesh-list
6370995|NCT00127985|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6370996|NCT00127985|Methylprednisolone|methylprednisolone|mesh-list
6370997|NCT00127985|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6370998|NCT00127985|Prednisolone acetate|prednisolone acetate|mesh-list
6370999|NCT00127985|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6371000|NCT00127985|Prednisolone phosphate|prednisolone phosphate|mesh-list
6371001|NCT00127985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6371002|NCT00127985|Glucocorticoids|glucocorticoids|mesh-ancestor
6371003|NCT00127985|Hormones|hormones|mesh-ancestor
6371004|NCT00127985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6371005|NCT00127985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371006|NCT00127985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6371007|NCT00127985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6371008|NCT00127985|Antiemetics|antiemetics|mesh-ancestor
6371009|NCT00127985|Autonomic Agents|autonomic agents|mesh-ancestor
6371010|NCT00127985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6371011|NCT00127985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6371012|NCT00127985|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6371013|NCT00127985|Protective Agents|protective agents|mesh-ancestor
6371014|NCT00127998|Artesunate|artesunate|mesh-list
6371015|NCT00127998|Chloroquine|chloroquine|mesh-list
6371016|NCT00127998|Lumefantrine|lumefantrine|mesh-list
6371017|NCT00127998|Artemether|artemether|mesh-list
6371018|NCT00127998|Pyrimethamine|pyrimethamine|mesh-list
6371019|NCT00127998|Sulfadoxine|sulfadoxine|mesh-list
6371020|NCT00127998|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6371021|NCT00127998|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6371022|NCT00127998|Amodiaquine|amodiaquine|mesh-list
6371023|NCT00127998|Mefloquine|mefloquine|mesh-list
6371024|NCT00127998|Antimalarials|antimalarials|mesh-ancestor
6371025|NCT00127998|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6371026|NCT00127998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6371027|NCT00127998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6371028|NCT00127998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6371029|NCT00127998|Antiviral Agents|antiviral agents|mesh-ancestor
6371030|NCT00127998|Schistosomicides|schistosomicides|mesh-ancestor
6371031|NCT00127998|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6371032|NCT00127998|Anthelmintics|anthelmintics|mesh-ancestor
6371033|NCT00127998|Amebicides|amebicides|mesh-ancestor
6371034|NCT00127998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6371035|NCT00127998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6371036|NCT00127998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6371037|NCT00127998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371038|NCT00127998|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6371039|NCT00127998|Renal Agents|renal agents|mesh-ancestor
6371040|NCT00128037|Mitomycins|mitomycins|mesh-list
6371041|NCT00128037|Mitomycin|mitomycin|mesh-list
6371042|NCT00128037|Vindesine|vindesine|mesh-list
6371043|NCT00128037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6371044|NCT00128037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6371045|NCT00128037|Alkylating Agents|alkylating agents|mesh-ancestor
6371046|NCT00128037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371047|NCT00128037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6371048|NCT00128037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6371049|NCT00128037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6371050|NCT00128037|Tubulin Modulators|tubulin modulators|mesh-ancestor
6371051|NCT00128037|Antimitotic Agents|antimitotic agents|mesh-ancestor
6371052|NCT00128037|Mitosis Modulators|mitosis modulators|mesh-ancestor
6371053|NCT00128154|Chromium|chromium|mesh-list
6371054|NCT00128154|Picolinic acid|picolinic acid|mesh-list
6371055|NCT00128154|Trace Elements|trace elements|mesh-ancestor
6371056|NCT00128154|Micronutrients|micronutrients|mesh-ancestor
6371057|NCT00128154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371058|NCT00128154|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6371059|NCT00128154|Chelating Agents|chelating agents|mesh-ancestor
6371060|NCT00128154|Sequestering Agents|sequestering agents|mesh-ancestor
6371061|NCT00128154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371062|NCT00128232|Octreotide|octreotide|mesh-list
6371063|NCT00128232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6371064|NCT00128232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6371065|NCT00128232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6371066|NCT00128245|Pimecrolimus|pimecrolimus|mesh-list
6371067|NCT00128245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6371068|NCT00128245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6371069|NCT00128245|Analgesics|analgesics|mesh-ancestor
6371070|NCT00128245|Sensory System Agents|sensory system agents|mesh-ancestor
6371071|NCT00128245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6371072|NCT00128245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371073|NCT00128245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6371074|NCT00128245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6371075|NCT00128245|Dermatologic Agents|dermatologic agents|mesh-ancestor
6371076|NCT00128245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6371077|NCT00128245|Immunologic Factors|immunologic factors|mesh-ancestor
6371078|NCT00128245|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6371079|NCT00128245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6371080|NCT00128245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371081|NCT00128271|Bavituximab|bavituximab|mesh-list
6371082|NCT00128271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6371083|NCT00128271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6371084|NCT00128297|Pamidronate|pamidronate|mesh-list
6371085|NCT00128297|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6371086|NCT00128297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371087|NCT00128310|Gemcitabine|gemcitabine|mesh-list
6371088|NCT00128310|Vinorelbine|vinorelbine|mesh-list
6371089|NCT00128310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6371090|NCT00128310|Antimetabolites|antimetabolites|mesh-ancestor
6371091|NCT00128310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371092|NCT00128310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6371093|NCT00128310|Antiviral Agents|antiviral agents|mesh-ancestor
6371094|NCT00128310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6371095|NCT00128310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6371096|NCT00128310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6371097|NCT00128310|Immunologic Factors|immunologic factors|mesh-ancestor
6371098|NCT00128310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371099|NCT00128310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6371100|NCT00128310|Tubulin Modulators|tubulin modulators|mesh-ancestor
6371101|NCT00128310|Antimitotic Agents|antimitotic agents|mesh-ancestor
6371102|NCT00128310|Mitosis Modulators|mitosis modulators|mesh-ancestor
6371103|NCT00128323|Nystatin|nystatin|mesh-list
6371104|NCT00128323|Gentian Violet|gentian violet|mesh-list
6371105|NCT00128323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6371106|NCT00128323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6371107|NCT00128323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6371108|NCT00128323|Antifungal Agents|antifungal agents|mesh-ancestor
6371109|NCT00128323|Ionophores|ionophores|mesh-ancestor
6371110|NCT00128323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6371111|NCT00128323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371112|NCT00128323|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6371113|NCT00128414|Colchicine|colchicine|mesh-list
6371114|NCT00128414|Gout Suppressants|gout suppressants|mesh-ancestor
6371115|NCT00128414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6371116|NCT00128414|Tubulin Modulators|tubulin modulators|mesh-ancestor
6371117|NCT00128414|Antimitotic Agents|antimitotic agents|mesh-ancestor
6371118|NCT00128414|Mitosis Modulators|mitosis modulators|mesh-ancestor
6371119|NCT00128414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371120|NCT00128414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6371121|NCT00128427|Colchicine|colchicine|mesh-list
6371122|NCT00128427|Gout Suppressants|gout suppressants|mesh-ancestor
6371123|NCT00128427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6017408|NCT00372593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6017409|NCT00372593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017410|NCT00372593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6017411|NCT00372593|Antimetabolites|antimetabolites|mesh-ancestor
6017412|NCT00372593|Antiviral Agents|antiviral agents|mesh-ancestor
6017413|NCT00372593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6017414|NCT00372593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6371124|NCT00128427|Tubulin Modulators|tubulin modulators|mesh-ancestor
6371125|NCT00128427|Antimitotic Agents|antimitotic agents|mesh-ancestor
6371126|NCT00128427|Mitosis Modulators|mitosis modulators|mesh-ancestor
6371127|NCT00128427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371128|NCT00128427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6371129|NCT00128440|Tiotropium Bromide|tiotropium bromide|mesh-list
6371130|NCT00128440|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6371131|NCT00128440|Autonomic Agents|autonomic agents|mesh-ancestor
6371132|NCT00128440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6371133|NCT00128440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371134|NCT00128440|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6371135|NCT00128440|Respiratory System Agents|respiratory system agents|mesh-ancestor
6371136|NCT00128440|Parasympatholytics|parasympatholytics|mesh-ancestor
6371137|NCT00128440|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6371138|NCT00128440|Cholinergic Agents|cholinergic agents|mesh-ancestor
6371139|NCT00128440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6371140|NCT00128440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371141|NCT00128453|Colchicine|colchicine|mesh-list
6371142|NCT00128453|Gout Suppressants|gout suppressants|mesh-ancestor
6371143|NCT00128453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6371144|NCT00128453|Tubulin Modulators|tubulin modulators|mesh-ancestor
6371145|NCT00128453|Antimitotic Agents|antimitotic agents|mesh-ancestor
6371146|NCT00128453|Mitosis Modulators|mitosis modulators|mesh-ancestor
6371147|NCT00128453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371148|NCT00128453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6371149|NCT00128466|Gentamicins|gentamicins|mesh-list
6371150|NCT00128466|Streptomycin|streptomycin|mesh-list
6371151|NCT00128466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6371152|NCT00128466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6371153|NCT00128466|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6371154|NCT00128466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6371155|NCT00128466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371156|NCT00128479|Mifepristone|mifepristone|mesh-list
6371157|NCT00128479|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6371158|NCT00128479|Abortifacient Agents|abortifacient agents|mesh-ancestor
6371159|NCT00128479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6371160|NCT00128479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371161|NCT00128479|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6371162|NCT00128479|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6371163|NCT00128479|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6371164|NCT00128479|Contraceptive Agents|contraceptive agents|mesh-ancestor
6371165|NCT00128479|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6371166|NCT00128479|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6371167|NCT00128479|Hormone Antagonists|hormone antagonists|mesh-ancestor
6371168|NCT00128479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6371169|NCT00128479|Luteolytic Agents|luteolytic agents|mesh-ancestor
6371170|NCT00128479|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6371171|NCT00128479|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6371172|NCT00128505|Mifepristone|mifepristone|mesh-list
6371173|NCT00128505|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6371174|NCT00128505|Abortifacient Agents|abortifacient agents|mesh-ancestor
6371175|NCT00128505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6371176|NCT00128505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371177|NCT00128505|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6371178|NCT00128505|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6371179|NCT00128505|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6371180|NCT00128505|Contraceptive Agents|contraceptive agents|mesh-ancestor
6371181|NCT00128505|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6371182|NCT00128505|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6371183|NCT00128505|Hormone Antagonists|hormone antagonists|mesh-ancestor
6371184|NCT00128505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6371185|NCT00128505|Luteolytic Agents|luteolytic agents|mesh-ancestor
6371186|NCT00128505|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6371187|NCT00128505|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6371188|NCT00128518|Perindopril|perindopril|mesh-list
6371189|NCT00128518|Indapamide|indapamide|mesh-list
6371190|NCT00128518|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6371191|NCT00128518|Protease Inhibitors|protease inhibitors|mesh-ancestor
6371192|NCT00128518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6371193|NCT00128518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371194|NCT00128518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6371195|NCT00128518|Diuretics|diuretics|mesh-ancestor
6371196|NCT00128518|Natriuretic Agents|natriuretic agents|mesh-ancestor
6371197|NCT00128518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371198|NCT00128518|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6371199|NCT00128518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6371200|NCT00128531|Leuprolide|leuprolide|mesh-list
6371201|NCT00128531|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6371202|NCT00128531|Fertility Agents|fertility agents|mesh-ancestor
6371203|NCT00128531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6371204|NCT00128531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371205|NCT00128531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6371206|NCT00128531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6371207|NCT00128544|Telbivudine|telbivudine|mesh-list
6371208|NCT00128544|Antiviral Agents|antiviral agents|mesh-ancestor
6371209|NCT00128544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6371210|NCT00128544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6371211|NCT00128544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6371212|NCT00128544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371213|NCT00128557|Vitamin A|vitamin a|mesh-list
6371214|NCT00128557|Vitamins|vitamins|mesh-ancestor
6371215|NCT00128557|Micronutrients|micronutrients|mesh-ancestor
6371216|NCT00128557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371217|NCT00128596|Arsenic Trioxide|arsenic trioxide|mesh-list
6371218|NCT00128596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6371219|NCT00128622|Denileukin diftitox|denileukin diftitox|mesh-list
6371220|NCT00128622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6371221|NCT00128635|Antibodies|antibodies|mesh-list
6371222|NCT00128635|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6371223|NCT00128635|Immunologic Factors|immunologic factors|mesh-ancestor
6371224|NCT00128635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371225|NCT00128700|Temozolomide|temozolomide|mesh-list
6371226|NCT00128700|Vatalanib|vatalanib|mesh-list
6371227|NCT00128700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6371228|NCT00128700|Alkylating Agents|alkylating agents|mesh-ancestor
6371229|NCT00128700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371230|NCT00128700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6371231|NCT00128700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6371232|NCT00128700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6371233|NCT00128739|Budesonide|budesonide|mesh-list
6371234|NCT00128739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6371235|NCT00128739|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6371236|NCT00128739|Autonomic Agents|autonomic agents|mesh-ancestor
6371237|NCT00128739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6371238|NCT00128739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371239|NCT00128739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6371240|NCT00128739|Respiratory System Agents|respiratory system agents|mesh-ancestor
6371241|NCT00128739|Glucocorticoids|glucocorticoids|mesh-ancestor
6371242|NCT00128739|Hormones|hormones|mesh-ancestor
6371243|NCT00128739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6371244|NCT00128752|Beta Carotene|beta carotene|mesh-list
6371245|NCT00128752|Carotenoids|carotenoids|mesh-list
6371246|NCT00128752|Antioxidants|antioxidants|mesh-ancestor
6371247|NCT00128752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371248|NCT00128752|Protective Agents|protective agents|mesh-ancestor
6371249|NCT00128752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371250|NCT00128752|Provitamins|provitamins|mesh-ancestor
6371251|NCT00128752|Vitamins|vitamins|mesh-ancestor
6371252|NCT00128752|Micronutrients|micronutrients|mesh-ancestor
6371253|NCT00128778|Doxorubicin|doxorubicin|mesh-list
6371254|NCT00128778|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6371255|NCT00128778|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6371256|NCT00128778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6371257|NCT00128778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6371258|NCT00128778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6371259|NCT00128778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6371260|NCT00128778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371261|NCT00128791|Nitroprusside|nitroprusside|mesh-list
6371262|NCT00128791|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6371263|NCT00128791|Vasodilator Agents|vasodilator agents|mesh-ancestor
6371264|NCT00128791|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6371265|NCT00128791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371266|NCT00128804|Beta Carotene|beta carotene|mesh-list
6371267|NCT00128804|Carotenoids|carotenoids|mesh-list
6371268|NCT00128804|Antioxidants|antioxidants|mesh-ancestor
6371269|NCT00128804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371270|NCT00128804|Protective Agents|protective agents|mesh-ancestor
6371271|NCT00128804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371272|NCT00128804|Provitamins|provitamins|mesh-ancestor
6371273|NCT00128804|Vitamins|vitamins|mesh-ancestor
6371274|NCT00128804|Micronutrients|micronutrients|mesh-ancestor
6371275|NCT00128843|Anastrozole|anastrozole|mesh-list
6371276|NCT00128843|Exemestane|exemestane|mesh-list
6371277|NCT00128843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6371278|NCT00128843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6371279|NCT00128843|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6371280|NCT00128843|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6371281|NCT00128843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6371282|NCT00128843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371283|NCT00128843|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6371284|NCT00128843|Hormone Antagonists|hormone antagonists|mesh-ancestor
6371285|NCT00128843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6371286|NCT00128843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371287|NCT00128856|Gemcitabine|gemcitabine|mesh-list
6371288|NCT00128856|Paclitaxel|paclitaxel|mesh-list
6371289|NCT00128856|Doxorubicin|doxorubicin|mesh-list
6371290|NCT00128856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6371291|NCT00128856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6371292|NCT00128856|Tubulin Modulators|tubulin modulators|mesh-ancestor
6371293|NCT00128856|Antimitotic Agents|antimitotic agents|mesh-ancestor
6371294|NCT00128856|Mitosis Modulators|mitosis modulators|mesh-ancestor
6371295|NCT00128856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371296|NCT00128856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6371297|NCT00128856|Antimetabolites|antimetabolites|mesh-ancestor
6371298|NCT00128856|Antiviral Agents|antiviral agents|mesh-ancestor
6371299|NCT00128856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6371300|NCT00128856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6371301|NCT00128856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6371302|NCT00128856|Immunologic Factors|immunologic factors|mesh-ancestor
6371303|NCT00128856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371304|NCT00128856|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6371305|NCT00128856|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6371306|NCT00128856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6371307|NCT00128895|Azathioprine|azathioprine|mesh-list
6371308|NCT00128895|Antimetabolites|antimetabolites|mesh-ancestor
6371309|NCT00128895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371310|NCT00128895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6371311|NCT00128895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6371312|NCT00128895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6371313|NCT00128895|Immunologic Factors|immunologic factors|mesh-ancestor
6371314|NCT00128895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371315|NCT00128895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6371316|NCT00128908|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6371317|NCT00128908|Antiviral Agents|antiviral agents|mesh-ancestor
6371318|NCT00128908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6371319|NCT00128934|Levonorgestrel|levonorgestrel|mesh-list
6371320|NCT00128934|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6371321|NCT00128934|Estradiol|estradiol|mesh-list
6371322|NCT00128934|Estrogens|estrogens|mesh-ancestor
6371323|NCT00128934|Hormones|hormones|mesh-ancestor
6371324|NCT00128934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6371325|NCT00128934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371326|NCT00128934|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6371327|NCT00128934|Contraceptive Agents|contraceptive agents|mesh-ancestor
6371328|NCT00128934|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6371329|NCT00128934|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6371330|NCT00128934|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6371331|NCT00128934|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6371332|NCT00128934|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6371333|NCT00128947|Mycophenolic Acid|mycophenolic acid|mesh-list
6371334|NCT00128947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6371335|NCT00128947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6371336|NCT00128947|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6371337|NCT00128947|Antitubercular Agents|antitubercular agents|mesh-ancestor
6371338|NCT00128947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6371339|NCT00128947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6371340|NCT00128947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6371341|NCT00128947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395509|NCT00205946|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6395510|NCT00205946|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6395511|NCT00205946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6395512|NCT00206024|Esomeprazole|esomeprazole|mesh-list
6395513|NCT00206024|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6395514|NCT00206024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6395515|NCT00206024|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6371342|NCT00129038|Aspirin|aspirin|mesh-list
6371343|NCT00129038|Dipyridamole|dipyridamole|mesh-list
6371344|NCT00129038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6371345|NCT00129038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6371346|NCT00129038|Analgesics|analgesics|mesh-ancestor
6371347|NCT00129038|Sensory System Agents|sensory system agents|mesh-ancestor
6371348|NCT00129038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6371349|NCT00129038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371350|NCT00129038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6371351|NCT00129038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6371352|NCT00129038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6371353|NCT00129038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6371354|NCT00129038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371355|NCT00129038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6371356|NCT00129038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6371357|NCT00129038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6371358|NCT00129038|Antipyretics|antipyretics|mesh-ancestor
6371359|NCT00129038|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6371360|NCT00129038|Vasodilator Agents|vasodilator agents|mesh-ancestor
6371361|NCT00129090|Rituximab|rituximab|mesh-list
6371362|NCT00129090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6371363|NCT00129090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6371364|NCT00129090|Immunologic Factors|immunologic factors|mesh-ancestor
6371365|NCT00129090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371366|NCT00129090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6371367|NCT00129142|Toremifene|toremifene|mesh-list
6371368|NCT00129142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6371369|NCT00129142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6371370|NCT00129142|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6371371|NCT00129142|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6371372|NCT00129142|Hormone Antagonists|hormone antagonists|mesh-ancestor
6371373|NCT00129142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6371374|NCT00129142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371375|NCT00129142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6371376|NCT00129155|Treosulfan|treosulfan|mesh-list
6371377|NCT00129155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6371378|NCT00129155|Alkylating Agents|alkylating agents|mesh-ancestor
6371379|NCT00129155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371380|NCT00129155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6371381|NCT00129168|Cytarabine|cytarabine|mesh-list
6371382|NCT00129168|Daunorubicin|daunorubicin|mesh-list
6371383|NCT00129168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6371384|NCT00129168|Antimetabolites|antimetabolites|mesh-ancestor
6371385|NCT00129168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371386|NCT00129168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6371387|NCT00129168|Antiviral Agents|antiviral agents|mesh-ancestor
6371388|NCT00129168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6371389|NCT00129168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6371390|NCT00129168|Immunologic Factors|immunologic factors|mesh-ancestor
6371391|NCT00129168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371392|NCT00129168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6371393|NCT00129168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6371394|NCT00129168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6371395|NCT00129168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6371396|NCT00129181|Levodopa|levodopa|mesh-list
6371397|NCT00129181|Carbidopa|carbidopa|mesh-list
6371398|NCT00129181|Cabergoline|cabergoline|mesh-list
6371399|NCT00129181|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
6371400|NCT00129181|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6371401|NCT00129181|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6371402|NCT00129181|Dopamine Agents|dopamine agents|mesh-ancestor
6371403|NCT00129181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6371404|NCT00129181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371405|NCT00129181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371406|NCT00129181|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6371407|NCT00129181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6371408|NCT00129181|Dopamine Agonists|dopamine agonists|mesh-ancestor
6371409|NCT00129181|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6371410|NCT00129181|Immunologic Factors|immunologic factors|mesh-ancestor
6371411|NCT00129207|Bortezomib|bortezomib|mesh-list
6371412|NCT00129207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6371413|NCT00129233|Amlodipine|amlodipine|mesh-list
6371414|NCT00129233|Valsartan|valsartan|mesh-list
6371415|NCT00129233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6371416|NCT00129233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6371417|NCT00129233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6371418|NCT00129233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371419|NCT00129233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6371420|NCT00129233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371421|NCT00129233|Vasodilator Agents|vasodilator agents|mesh-ancestor
6371422|NCT00129233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6371423|NCT00129233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6371424|NCT00129298|Tiagabine|tiagabine|mesh-list
6371425|NCT00129298|Anticonvulsants|anticonvulsants|mesh-ancestor
6371426|NCT00129298|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
6371427|NCT00129298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6371428|NCT00129298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6371429|NCT00129298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371430|NCT00129298|GABA Agents|gaba agents|mesh-ancestor
6371431|NCT00129298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6371432|NCT00129298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371433|NCT00129337|Bavituximab|bavituximab|mesh-list
6371434|NCT00129337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6371435|NCT00129337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6371436|NCT00129363|Carvedilol|carvedilol|mesh-list
6371437|NCT00129363|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6371438|NCT00129363|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6371439|NCT00129363|Adrenergic Agents|adrenergic agents|mesh-ancestor
6371440|NCT00129363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6371441|NCT00129363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371442|NCT00129363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371443|NCT00129363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6371444|NCT00129363|Antioxidants|antioxidants|mesh-ancestor
6371445|NCT00129363|Protective Agents|protective agents|mesh-ancestor
6371446|NCT00129363|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6371447|NCT00129363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6371448|NCT00129363|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6371449|NCT00129363|Vasodilator Agents|vasodilator agents|mesh-ancestor
6371450|NCT00129363|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6017415|NCT00372593|Immunologic Factors|immunologic factors|mesh-ancestor
6017416|NCT00372593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017417|NCT00372593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6017418|NCT00372593|Analgesics|analgesics|mesh-ancestor
6017419|NCT00372593|Sensory System Agents|sensory system agents|mesh-ancestor
6017420|NCT00372593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6017421|NCT00372593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6017422|NCT00372619|Cytarabine|cytarabine|mesh-list
6017423|NCT00372619|Methotrexate|methotrexate|mesh-list
6017424|NCT00372619|Clofarabine|clofarabine|mesh-list
6017425|NCT00372619|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6017426|NCT00372619|Abortifacient Agents|abortifacient agents|mesh-ancestor
6017427|NCT00372619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6017428|NCT00372619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017429|NCT00372619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6017430|NCT00372619|Antimetabolites|antimetabolites|mesh-ancestor
6371451|NCT00129363|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6371452|NCT00129506|Methotrexate|methotrexate|mesh-list
6371453|NCT00129506|Misoprostol|misoprostol|mesh-list
6371454|NCT00129506|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6371455|NCT00129506|Abortifacient Agents|abortifacient agents|mesh-ancestor
6371456|NCT00129506|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6371457|NCT00129506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371458|NCT00129506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6371459|NCT00129506|Antimetabolites|antimetabolites|mesh-ancestor
6371460|NCT00129506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371461|NCT00129506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6371462|NCT00129506|Dermatologic Agents|dermatologic agents|mesh-ancestor
6371463|NCT00129506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6371464|NCT00129506|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6371465|NCT00129506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6371466|NCT00129506|Immunologic Factors|immunologic factors|mesh-ancestor
6371467|NCT00129506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6371468|NCT00129506|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6371469|NCT00129506|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6371470|NCT00129506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6371471|NCT00129506|Oxytocics|oxytocics|mesh-ancestor
6371472|NCT00129519|Imiquimod|imiquimod|mesh-list
6371473|NCT00129519|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6371474|NCT00129519|Immunologic Factors|immunologic factors|mesh-ancestor
6371475|NCT00129519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371476|NCT00129519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6371477|NCT00129519|Interferon Inducers|interferon inducers|mesh-ancestor
6371478|NCT00129597|Ketamine|ketamine|mesh-list
6371479|NCT00129597|Analgesics|analgesics|mesh-ancestor
6371480|NCT00129597|Sensory System Agents|sensory system agents|mesh-ancestor
6371481|NCT00129597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6371482|NCT00129597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371483|NCT00129597|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6371484|NCT00129597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6371485|NCT00129597|Anesthetics, General|anesthetics, general|mesh-ancestor
6371486|NCT00129597|Anesthetics|anesthetics|mesh-ancestor
6371487|NCT00129597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6371488|NCT00129597|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6371489|NCT00129597|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6371490|NCT00129597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6371491|NCT00129597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371492|NCT00129688|Amikacin|amikacin|mesh-list
6371493|NCT00129688|Cloxacillin|cloxacillin|mesh-list
6371494|NCT00129688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6371495|NCT00129688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6371496|NCT00129753|Alemtuzumab|alemtuzumab|mesh-list
6371497|NCT00129753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6371498|NCT00129753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6371499|NCT00129805|Aspirin|aspirin|mesh-list
6371500|NCT00129805|Sarpogrelate|sarpogrelate|mesh-list
6371501|NCT00129805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6371502|NCT00129805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6371503|NCT00129805|Analgesics|analgesics|mesh-ancestor
6371504|NCT00129805|Sensory System Agents|sensory system agents|mesh-ancestor
6371505|NCT00129805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6371506|NCT00129805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371507|NCT00129805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6371508|NCT00129805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6371509|NCT00129805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6371510|NCT00129805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6371511|NCT00129805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371512|NCT00129805|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6371513|NCT00129805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6371514|NCT00129805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6371515|NCT00129805|Antipyretics|antipyretics|mesh-ancestor
6371516|NCT00129805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6371517|NCT00129805|Serotonin Agents|serotonin agents|mesh-ancestor
6371518|NCT00129805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6371519|NCT00129818|Famciclovir|famciclovir|mesh-list
6371520|NCT00129818|Antiviral Agents|antiviral agents|mesh-ancestor
6371521|NCT00129818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6371522|NCT00129818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6371523|NCT00129818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6371524|NCT00129818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371525|NCT00129844|Motexafin gadolinium|motexafin gadolinium|mesh-list
6371526|NCT00129844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6371527|NCT00129844|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6371528|NCT00129844|Dermatologic Agents|dermatologic agents|mesh-ancestor
6371529|NCT00129857|HU 211|hu 211|mesh-list
6371530|NCT00129857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6371531|NCT00129857|Antiemetics|antiemetics|mesh-ancestor
6371532|NCT00129857|Autonomic Agents|autonomic agents|mesh-ancestor
6371533|NCT00129857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6371534|NCT00129857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371535|NCT00129857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6371536|NCT00129857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6371537|NCT00129857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6371538|NCT00129857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6371539|NCT00129857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371540|NCT00129857|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6371541|NCT00129857|Protective Agents|protective agents|mesh-ancestor
6371542|NCT00129870|Oxaliplatin|oxaliplatin|mesh-list
6371543|NCT00129870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6371544|NCT00129896|Docetaxel|docetaxel|mesh-list
6371545|NCT00129896|Doxorubicin|doxorubicin|mesh-list
6371546|NCT00129896|Trastuzumab|trastuzumab|mesh-list
6371547|NCT00129896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6371548|NCT00129896|Tubulin Modulators|tubulin modulators|mesh-ancestor
6371549|NCT00129896|Antimitotic Agents|antimitotic agents|mesh-ancestor
6371550|NCT00129896|Mitosis Modulators|mitosis modulators|mesh-ancestor
6371551|NCT00129896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371552|NCT00129896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6371553|NCT00129896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6371554|NCT00129896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6371555|NCT00129896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6371556|NCT00129896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6371557|NCT00129922|Paclitaxel|paclitaxel|mesh-list
6371558|NCT00129922|Cyclophosphamide|cyclophosphamide|mesh-list
6371559|NCT00129922|Fluorouracil|fluorouracil|mesh-list
6371560|NCT00129922|Epirubicin|epirubicin|mesh-list
6371561|NCT00129922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6371562|NCT00129922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6371563|NCT00129922|Tubulin Modulators|tubulin modulators|mesh-ancestor
6371564|NCT00129922|Antimitotic Agents|antimitotic agents|mesh-ancestor
6371565|NCT00129922|Mitosis Modulators|mitosis modulators|mesh-ancestor
6371566|NCT00129922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371567|NCT00129922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6371568|NCT00129922|Immunologic Factors|immunologic factors|mesh-ancestor
6371569|NCT00129922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371570|NCT00129922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6395516|NCT00206024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6371571|NCT00129922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6371572|NCT00129922|Alkylating Agents|alkylating agents|mesh-ancestor
6371573|NCT00129922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6371574|NCT00129922|Antimetabolites|antimetabolites|mesh-ancestor
6371575|NCT00129922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6371576|NCT00129922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6371577|NCT00129922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6371578|NCT00129922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6371579|NCT00129922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6371580|NCT00129948|Troxacitabine|troxacitabine|mesh-list
6371581|NCT00129948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6371582|NCT00129948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6371583|NCT00129948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6371584|NCT00129948|Antiviral Agents|antiviral agents|mesh-ancestor
6371585|NCT00129948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6371586|NCT00130000|Eculizumab|eculizumab|mesh-list
6371587|NCT00130000|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6371588|NCT00130000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6371589|NCT00130000|Immunologic Factors|immunologic factors|mesh-ancestor
6371590|NCT00130000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371591|NCT00130013|Amoxicillin|amoxicillin|mesh-list
6371592|NCT00130013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6371593|NCT00130013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6371594|NCT00130026|Caffeine|caffeine|mesh-list
6371595|NCT00130026|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6371596|NCT00130026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371597|NCT00130026|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6371598|NCT00130026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6371599|NCT00130026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371600|NCT00130026|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6371601|NCT00130026|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6371602|NCT00130026|Purinergic Agents|purinergic agents|mesh-ancestor
6371603|NCT00130026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6371604|NCT00130065|Folic Acid|folic acid|mesh-list
6371605|NCT00130065|Pyrimethamine|pyrimethamine|mesh-list
6371606|NCT00130065|Sulfadoxine|sulfadoxine|mesh-list
6371607|NCT00130065|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6371608|NCT00130065|Hematinics|hematinics|mesh-ancestor
6371609|NCT00130065|Vitamin B Complex|vitamin b complex|mesh-ancestor
6371610|NCT00130065|Vitamins|vitamins|mesh-ancestor
6371611|NCT00130065|Micronutrients|micronutrients|mesh-ancestor
6371612|NCT00130065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371613|NCT00130065|Antimalarials|antimalarials|mesh-ancestor
6371614|NCT00130065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6371615|NCT00130065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6371616|NCT00130065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6371617|NCT00130065|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6371618|NCT00130065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6371619|NCT00130065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371620|NCT00130065|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6371621|NCT00130065|Renal Agents|renal agents|mesh-ancestor
6371622|NCT00130091|Clonidine|clonidine|mesh-list
6371623|NCT00130091|Analgesics|analgesics|mesh-ancestor
6371624|NCT00130091|Sensory System Agents|sensory system agents|mesh-ancestor
6371625|NCT00130091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6371626|NCT00130091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371627|NCT00130091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6371628|NCT00130091|Sympatholytics|sympatholytics|mesh-ancestor
6371629|NCT00130091|Autonomic Agents|autonomic agents|mesh-ancestor
6371630|NCT00130091|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6371631|NCT00130091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6371632|NCT00130091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6371633|NCT00130091|Adrenergic Agents|adrenergic agents|mesh-ancestor
6371634|NCT00130091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6371635|NCT00130091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371636|NCT00130143|Amifostine|amifostine|mesh-list
6371637|NCT00130143|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6371638|NCT00130143|Protective Agents|protective agents|mesh-ancestor
6371639|NCT00130143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371640|NCT00130156|Doxazosin|doxazosin|mesh-list
6371641|NCT00130156|Bunazosin|bunazosin|mesh-list
6371642|NCT00130156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6371643|NCT00130156|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6371644|NCT00130156|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6371645|NCT00130156|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6371646|NCT00130156|Adrenergic Agents|adrenergic agents|mesh-ancestor
6371647|NCT00130156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6371648|NCT00130156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371649|NCT00130156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371650|NCT00130195|Cytarabine|cytarabine|mesh-list
6371651|NCT00130195|Dexamethasone|dexamethasone|mesh-list
6371652|NCT00130195|Prednisolone|prednisolone|mesh-list
6371653|NCT00130195|Cyclophosphamide|cyclophosphamide|mesh-list
6371654|NCT00130195|Methotrexate|methotrexate|mesh-list
6371655|NCT00130195|Vincristine|vincristine|mesh-list
6371656|NCT00130195|Imatinib Mesylate|imatinib mesylate|mesh-list
6371657|NCT00130195|Daunorubicin|daunorubicin|mesh-list
6371658|NCT00130195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6371659|NCT00130195|Immunologic Factors|immunologic factors|mesh-ancestor
6371660|NCT00130195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371661|NCT00130195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6371662|NCT00130195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6371663|NCT00130195|Alkylating Agents|alkylating agents|mesh-ancestor
6371664|NCT00130195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371665|NCT00130195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6371666|NCT00130195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6371667|NCT00130195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6371668|NCT00130195|Antiemetics|antiemetics|mesh-ancestor
6371669|NCT00130195|Autonomic Agents|autonomic agents|mesh-ancestor
6371670|NCT00130195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6371671|NCT00130195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6371672|NCT00130195|Glucocorticoids|glucocorticoids|mesh-ancestor
6371673|NCT00130195|Hormones|hormones|mesh-ancestor
6371674|NCT00130195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6371675|NCT00130195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6371676|NCT00130195|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6371677|NCT00130195|Abortifacient Agents|abortifacient agents|mesh-ancestor
6371678|NCT00130195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6371679|NCT00130195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6371680|NCT00130195|Antimetabolites|antimetabolites|mesh-ancestor
6371681|NCT00130195|Dermatologic Agents|dermatologic agents|mesh-ancestor
6371682|NCT00130195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6371683|NCT00130195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6371684|NCT00130195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6371685|NCT00130195|Antiviral Agents|antiviral agents|mesh-ancestor
6371686|NCT00130195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6371687|NCT00130195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6371688|NCT00130195|Tubulin Modulators|tubulin modulators|mesh-ancestor
6371689|NCT00130195|Antimitotic Agents|antimitotic agents|mesh-ancestor
6017431|NCT00372619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017432|NCT00372619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6017433|NCT00372619|Dermatologic Agents|dermatologic agents|mesh-ancestor
6017434|NCT00372619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6017435|NCT00372619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6017436|NCT00372619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6371690|NCT00130195|Mitosis Modulators|mitosis modulators|mesh-ancestor
6371691|NCT00130195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6371692|NCT00130195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6371693|NCT00130195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6371694|NCT00130195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6371695|NCT00130221|Chlorhexidine|chlorhexidine|mesh-list
6371696|NCT00130221|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6371697|NCT00130221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6371698|NCT00130221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6371699|NCT00130221|Disinfectants|disinfectants|mesh-ancestor
6371700|NCT00130221|Dermatologic Agents|dermatologic agents|mesh-ancestor
6371701|NCT00130234|Omalizumab|omalizumab|mesh-list
6371702|NCT00130234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6371703|NCT00130234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6371704|NCT00130234|Respiratory System Agents|respiratory system agents|mesh-ancestor
6371705|NCT00130325|Isoniazid|isoniazid|mesh-list
6371706|NCT00130325|Antitubercular Agents|antitubercular agents|mesh-ancestor
6371707|NCT00130325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6371708|NCT00130325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6371709|NCT00130325|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6371710|NCT00130325|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6371711|NCT00130325|Antimetabolites|antimetabolites|mesh-ancestor
6371712|NCT00130325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371713|NCT00130325|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6371714|NCT00130338|Rivastigmine|rivastigmine|mesh-list
6371715|NCT00130338|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6371716|NCT00130338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6371717|NCT00130338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371718|NCT00130338|Cholinergic Agents|cholinergic agents|mesh-ancestor
6371719|NCT00130338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6371720|NCT00130338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371721|NCT00130338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6371722|NCT00130338|Protective Agents|protective agents|mesh-ancestor
6371723|NCT00130351|Formoterol Fumarate|formoterol fumarate|mesh-list
6371724|NCT00130351|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6371725|NCT00130351|Autonomic Agents|autonomic agents|mesh-ancestor
6371726|NCT00130351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6371727|NCT00130351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371728|NCT00130351|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6371729|NCT00130351|Respiratory System Agents|respiratory system agents|mesh-ancestor
6371730|NCT00130351|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6371731|NCT00130351|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6371732|NCT00130351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6371733|NCT00130351|Adrenergic Agents|adrenergic agents|mesh-ancestor
6371734|NCT00130351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6371735|NCT00130351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371736|NCT00130364|Pimecrolimus|pimecrolimus|mesh-list
6371737|NCT00130364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6371738|NCT00130364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6371739|NCT00130364|Analgesics|analgesics|mesh-ancestor
6371740|NCT00130364|Sensory System Agents|sensory system agents|mesh-ancestor
6371741|NCT00130364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6371742|NCT00130364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371743|NCT00130364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6371744|NCT00130364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6371745|NCT00130364|Dermatologic Agents|dermatologic agents|mesh-ancestor
6371746|NCT00130364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6371747|NCT00130364|Immunologic Factors|immunologic factors|mesh-ancestor
6371748|NCT00130364|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6371749|NCT00130364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6371750|NCT00130364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371751|NCT00130390|Nitazoxanide|nitazoxanide|mesh-list
6371752|NCT00130390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6371753|NCT00130390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6371754|NCT00130403|Risedronic Acid|risedronic acid|mesh-list
6371755|NCT00130403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6371756|NCT00130403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6371757|NCT00130403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371758|NCT00130403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6371759|NCT00130403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371760|NCT00130403|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6371761|NCT00130455|Citalopram|citalopram|mesh-list
6371762|NCT00130455|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6017437|NCT00372619|Immunologic Factors|immunologic factors|mesh-ancestor
6371763|NCT00130455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6371764|NCT00130455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6371765|NCT00130455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371766|NCT00130455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6371767|NCT00130455|Serotonin Agents|serotonin agents|mesh-ancestor
6371768|NCT00130455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371769|NCT00130455|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6371770|NCT00130455|Antidepressive Agents|antidepressive agents|mesh-ancestor
6371771|NCT00130455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6371772|NCT00130468|Hyaluronic Acid|hyaluronic acid|mesh-list
6371773|NCT00130468|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6371774|NCT00130468|Immunologic Factors|immunologic factors|mesh-ancestor
6371775|NCT00130468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371776|NCT00130468|Viscosupplements|viscosupplements|mesh-ancestor
6371777|NCT00130468|Protective Agents|protective agents|mesh-ancestor
6371778|NCT00130481|Atorvastatin|atorvastatin|mesh-list
6371779|NCT00130481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6371780|NCT00130481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6371781|NCT00130481|Antimetabolites|antimetabolites|mesh-ancestor
6371782|NCT00130481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371783|NCT00130481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6371784|NCT00130481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6371785|NCT00130481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6371786|NCT00130494|Zoledronic Acid|zoledronic acid|mesh-list
6371787|NCT00130494|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6371788|NCT00130494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371789|NCT00130507|Capecitabine|capecitabine|mesh-list
6371790|NCT00130507|Trastuzumab|trastuzumab|mesh-list
6371791|NCT00130507|Vinorelbine|vinorelbine|mesh-list
6371792|NCT00130507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6371793|NCT00130507|Antimetabolites|antimetabolites|mesh-ancestor
6371794|NCT00130507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371795|NCT00130507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6371796|NCT00130507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6371797|NCT00130507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6371798|NCT00130507|Tubulin Modulators|tubulin modulators|mesh-ancestor
6371799|NCT00130507|Antimitotic Agents|antimitotic agents|mesh-ancestor
6371800|NCT00130507|Mitosis Modulators|mitosis modulators|mesh-ancestor
6371801|NCT00130546|Sirolimus|sirolimus|mesh-list
6371802|NCT00130546|Paclitaxel|paclitaxel|mesh-list
6371803|NCT00130546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6371804|NCT00130546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6371805|NCT00130546|Tubulin Modulators|tubulin modulators|mesh-ancestor
6371806|NCT00130546|Antimitotic Agents|antimitotic agents|mesh-ancestor
6371807|NCT00130546|Mitosis Modulators|mitosis modulators|mesh-ancestor
6371808|NCT00130546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371809|NCT00130546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6371810|NCT00130546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6371811|NCT00130546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6371812|NCT00130546|Antifungal Agents|antifungal agents|mesh-ancestor
6371813|NCT00130546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6371814|NCT00130546|Immunologic Factors|immunologic factors|mesh-ancestor
6371815|NCT00130546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371816|NCT00130572|Pimecrolimus|pimecrolimus|mesh-list
6371817|NCT00130572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6371818|NCT00130572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6371819|NCT00130572|Analgesics|analgesics|mesh-ancestor
6371820|NCT00130572|Sensory System Agents|sensory system agents|mesh-ancestor
6371821|NCT00130572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6371822|NCT00130572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371823|NCT00130572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6371824|NCT00130572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6371825|NCT00130572|Dermatologic Agents|dermatologic agents|mesh-ancestor
6371826|NCT00130572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6371827|NCT00130572|Immunologic Factors|immunologic factors|mesh-ancestor
6371828|NCT00130572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6371829|NCT00130572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6371830|NCT00130572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371831|NCT00130585|Folic Acid|folic acid|mesh-list
6371832|NCT00130585|Vitamin B Complex|vitamin b complex|mesh-list
6371833|NCT00130585|Hematinics|hematinics|mesh-ancestor
6371834|NCT00130585|Vitamins|vitamins|mesh-ancestor
6371835|NCT00130585|Micronutrients|micronutrients|mesh-ancestor
6371836|NCT00130585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371837|NCT00130676|Mifepristone|mifepristone|mesh-list
6371838|NCT00130676|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6371839|NCT00130676|Abortifacient Agents|abortifacient agents|mesh-ancestor
6371840|NCT00130676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6371841|NCT00130676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371842|NCT00130676|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6371843|NCT00130676|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6371844|NCT00130676|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6371845|NCT00130676|Contraceptive Agents|contraceptive agents|mesh-ancestor
6371846|NCT00130676|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6371847|NCT00130676|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6371848|NCT00130676|Hormone Antagonists|hormone antagonists|mesh-ancestor
6371849|NCT00130676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6371850|NCT00130676|Luteolytic Agents|luteolytic agents|mesh-ancestor
6371851|NCT00130676|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6371852|NCT00130676|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6371853|NCT00130702|Gefitinib|gefitinib|mesh-list
6371854|NCT00130702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6371855|NCT00130702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6371856|NCT00130702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6371857|NCT00130702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371858|NCT00130754|Thymoglobulin|thymoglobulin|mesh-list
6371859|NCT00130754|Immunologic Factors|immunologic factors|mesh-ancestor
6371860|NCT00130754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371861|NCT00130754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6371862|NCT00130767|Finasteride|finasteride|mesh-list
6371863|NCT00130767|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6371864|NCT00130767|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6371865|NCT00130767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6371866|NCT00130767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371867|NCT00130767|Hormone Antagonists|hormone antagonists|mesh-ancestor
6371868|NCT00130767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6371869|NCT00130767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371870|NCT00130767|Urological Agents|urological agents|mesh-ancestor
6371871|NCT00130819|Buprenorphine|buprenorphine|mesh-list
6371872|NCT00130819|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6371873|NCT00130819|Narcotics|narcotics|mesh-ancestor
6371874|NCT00130819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6371875|NCT00130819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371876|NCT00130819|Analgesics|analgesics|mesh-ancestor
6371877|NCT00130819|Sensory System Agents|sensory system agents|mesh-ancestor
6371878|NCT00130819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6371879|NCT00130819|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6371880|NCT00130845|Octreotide|octreotide|mesh-list
6371881|NCT00130845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6371882|NCT00130845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6371883|NCT00130845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6371884|NCT00130858|Carboplatin|carboplatin|mesh-list
6371885|NCT00130858|Topotecan|topotecan|mesh-list
6371886|NCT00130858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6371887|NCT00130858|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6371888|NCT00130858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6371889|NCT00130858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6371890|NCT00130858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371891|NCT00130871|Simendan|simendan|mesh-list
6371892|NCT00130871|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6371893|NCT00130871|Vasodilator Agents|vasodilator agents|mesh-ancestor
6371894|NCT00130871|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6371895|NCT00130871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6371896|NCT00130871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6371897|NCT00130871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371898|NCT00130871|Protective Agents|protective agents|mesh-ancestor
6017438|NCT00372619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6371899|NCT00130871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395517|NCT00206024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395518|NCT00206050|Esomeprazole|esomeprazole|mesh-list
6395519|NCT00206050|Pantoprazole|pantoprazole|mesh-list
6395520|NCT00206050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6395521|NCT00206050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6395522|NCT00206050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6395523|NCT00206050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6395524|NCT00206050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395525|NCT00206063|Ximelagatran|ximelagatran|mesh-list
6395526|NCT00206063|Antithrombins|antithrombins|mesh-ancestor
6395527|NCT00206063|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6395528|NCT00206063|Protease Inhibitors|protease inhibitors|mesh-ancestor
6395529|NCT00206063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6395530|NCT00206063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395531|NCT00206063|Anticoagulants|anticoagulants|mesh-ancestor
6395532|NCT00206089|Ximelagatran|ximelagatran|mesh-list
6395533|NCT00206089|Melagatran|melagatran|mesh-list
6395534|NCT00206089|Antithrombins|antithrombins|mesh-ancestor
6395535|NCT00206089|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6395536|NCT00206089|Protease Inhibitors|protease inhibitors|mesh-ancestor
6395537|NCT00206089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6395538|NCT00206089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395539|NCT00206089|Anticoagulants|anticoagulants|mesh-ancestor
6395540|NCT00206115|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6395541|NCT00206115|Antidepressive Agents|antidepressive agents|mesh-ancestor
6395542|NCT00206115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6395543|NCT00206115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6395544|NCT00206115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6395545|NCT00206115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6395546|NCT00206115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395547|NCT00206128|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6395548|NCT00206128|Antidepressive Agents|antidepressive agents|mesh-ancestor
6395549|NCT00206128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6395550|NCT00206128|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6395551|NCT00206128|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6395552|NCT00206128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6395553|NCT00206128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395554|NCT00206141|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6395555|NCT00206141|Antidepressive Agents|antidepressive agents|mesh-ancestor
6395556|NCT00206141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6395557|NCT00206141|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6395558|NCT00206141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6395559|NCT00206141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6395560|NCT00206141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395561|NCT00206154|Budesonide|budesonide|mesh-list
6395562|NCT00206154|Formoterol Fumarate|formoterol fumarate|mesh-list
6395563|NCT00206154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6395564|NCT00206154|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6395565|NCT00206154|Autonomic Agents|autonomic agents|mesh-ancestor
6395566|NCT00206154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6395567|NCT00206154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395568|NCT00206154|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6395569|NCT00206154|Respiratory System Agents|respiratory system agents|mesh-ancestor
6395570|NCT00206154|Glucocorticoids|glucocorticoids|mesh-ancestor
6395571|NCT00206154|Hormones|hormones|mesh-ancestor
6371900|NCT00130884|Simendan|simendan|mesh-list
6371901|NCT00130884|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6371902|NCT00130884|Vasodilator Agents|vasodilator agents|mesh-ancestor
6371903|NCT00130884|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6371904|NCT00130884|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6371905|NCT00130884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6371906|NCT00130884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371907|NCT00130884|Protective Agents|protective agents|mesh-ancestor
6371908|NCT00130884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371909|NCT00130897|Sunitinib|sunitinib|mesh-list
6371910|NCT00130897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6371911|NCT00130897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6371912|NCT00130897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6371913|NCT00130897|Growth Substances|growth substances|mesh-ancestor
6371914|NCT00130897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371915|NCT00130897|Growth Inhibitors|growth inhibitors|mesh-ancestor
6371916|NCT00130897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6371917|NCT00130897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6371918|NCT00130897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371919|NCT00130910|Albendazole|albendazole|mesh-list
6017439|NCT00372619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6017440|NCT00372619|Antiviral Agents|antiviral agents|mesh-ancestor
6371920|NCT00130910|Anthelmintics|anthelmintics|mesh-ancestor
6371921|NCT00130910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6017441|NCT00372619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6017442|NCT00372697|Octreotide|octreotide|mesh-list
6017443|NCT00372697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6371922|NCT00130910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6371923|NCT00130910|Anticestodal Agents|anticestodal agents|mesh-ancestor
6371924|NCT00130910|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6371925|NCT00130910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6371926|NCT00130910|Tubulin Modulators|tubulin modulators|mesh-ancestor
6371927|NCT00130910|Antimitotic Agents|antimitotic agents|mesh-ancestor
6371928|NCT00130910|Mitosis Modulators|mitosis modulators|mesh-ancestor
6371929|NCT00130910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371930|NCT00130910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6371931|NCT00130936|Carboplatin|carboplatin|mesh-list
6371932|NCT00130936|Capecitabine|capecitabine|mesh-list
6371933|NCT00130936|Epirubicin|epirubicin|mesh-list
6371934|NCT00130936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6371935|NCT00130936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6371936|NCT00130936|Antimetabolites|antimetabolites|mesh-ancestor
6371937|NCT00130936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371938|NCT00130936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6371939|NCT00130936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6371940|NCT00130936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6371941|NCT00130936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6371942|NCT00130975|Candesartan|candesartan|mesh-list
6371943|NCT00130975|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6371944|NCT00130975|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6371945|NCT00130975|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6371946|NCT00130975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371947|NCT00131027|Cytarabine|cytarabine|mesh-list
6371948|NCT00131027|Dexamethasone|dexamethasone|mesh-list
6371949|NCT00131027|Prednisolone|prednisolone|mesh-list
6017444|NCT00372697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6371950|NCT00131027|Cyclophosphamide|cyclophosphamide|mesh-list
6371951|NCT00131027|Doxorubicin|doxorubicin|mesh-list
6371952|NCT00131027|Methotrexate|methotrexate|mesh-list
6371953|NCT00131027|Etoposide|etoposide|mesh-list
6371954|NCT00131027|Vincristine|vincristine|mesh-list
6371955|NCT00131027|Daunorubicin|daunorubicin|mesh-list
6371956|NCT00131027|Asparaginase|asparaginase|mesh-list
6371957|NCT00131027|Mercaptopurine|mercaptopurine|mesh-list
6371958|NCT00131027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6371959|NCT00131027|Immunologic Factors|immunologic factors|mesh-ancestor
6371960|NCT00131027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6371961|NCT00131027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6371962|NCT00131027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6371963|NCT00131027|Alkylating Agents|alkylating agents|mesh-ancestor
6371964|NCT00131027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6371965|NCT00131027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6371966|NCT00131027|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6371967|NCT00131027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6371968|NCT00131027|Antiemetics|antiemetics|mesh-ancestor
6371969|NCT00131027|Autonomic Agents|autonomic agents|mesh-ancestor
6371970|NCT00131027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6371971|NCT00131027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6371972|NCT00131027|Glucocorticoids|glucocorticoids|mesh-ancestor
6371973|NCT00131027|Hormones|hormones|mesh-ancestor
6017445|NCT00372697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6017446|NCT00372775|Sunitinib|sunitinib|mesh-list
6017447|NCT00372775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6017448|NCT00372775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6371974|NCT00131027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6371975|NCT00131027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6371976|NCT00131027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6371977|NCT00131027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6371978|NCT00131027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6371979|NCT00131027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6371980|NCT00131027|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6371981|NCT00131027|Abortifacient Agents|abortifacient agents|mesh-ancestor
6371982|NCT00131027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6371983|NCT00131027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6371984|NCT00131027|Antimetabolites|antimetabolites|mesh-ancestor
6371985|NCT00131027|Dermatologic Agents|dermatologic agents|mesh-ancestor
6371986|NCT00131027|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6371987|NCT00131027|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6371988|NCT00131027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6371989|NCT00131027|Antiviral Agents|antiviral agents|mesh-ancestor
6371990|NCT00131027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6371991|NCT00131027|Tubulin Modulators|tubulin modulators|mesh-ancestor
6371992|NCT00131027|Antimitotic Agents|antimitotic agents|mesh-ancestor
6371993|NCT00131027|Mitosis Modulators|mitosis modulators|mesh-ancestor
6017449|NCT00372775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6371994|NCT00131040|Aprotinin|aprotinin|mesh-list
6371995|NCT00131040|Hemostatics|hemostatics|mesh-ancestor
6371996|NCT00131040|Coagulants|coagulants|mesh-ancestor
6371997|NCT00131040|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6371998|NCT00131040|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6371999|NCT00131040|Protease Inhibitors|protease inhibitors|mesh-ancestor
6372000|NCT00131040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6372001|NCT00131040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372002|NCT00131053|Cytarabine|cytarabine|mesh-list
6372003|NCT00131053|Dexamethasone|dexamethasone|mesh-list
6372004|NCT00131053|Prednisolone|prednisolone|mesh-list
6372005|NCT00131053|Hydrocortisone|hydrocortisone|mesh-list
6372006|NCT00131053|Cyclophosphamide|cyclophosphamide|mesh-list
6372007|NCT00131053|Methotrexate|methotrexate|mesh-list
6372008|NCT00131053|Vincristine|vincristine|mesh-list
6372009|NCT00131053|Asparaginase|asparaginase|mesh-list
6372010|NCT00131053|Mercaptopurine|mercaptopurine|mesh-list
6372011|NCT00131053|Pirarubicin|pirarubicin|mesh-list
6372012|NCT00131053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6372013|NCT00131053|Immunologic Factors|immunologic factors|mesh-ancestor
6372014|NCT00131053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372015|NCT00131053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6372016|NCT00131053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6372017|NCT00131053|Alkylating Agents|alkylating agents|mesh-ancestor
6372018|NCT00131053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372019|NCT00131053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6372020|NCT00131053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6372021|NCT00131053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6372022|NCT00131053|Antiemetics|antiemetics|mesh-ancestor
6372023|NCT00131053|Autonomic Agents|autonomic agents|mesh-ancestor
6372024|NCT00131053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6372025|NCT00131053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6372026|NCT00131053|Glucocorticoids|glucocorticoids|mesh-ancestor
6372027|NCT00131053|Hormones|hormones|mesh-ancestor
6372028|NCT00131053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6372029|NCT00131053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6372030|NCT00131053|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6372031|NCT00131053|Abortifacient Agents|abortifacient agents|mesh-ancestor
6372032|NCT00131053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6372033|NCT00131053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6372034|NCT00131053|Antimetabolites|antimetabolites|mesh-ancestor
6372035|NCT00131053|Dermatologic Agents|dermatologic agents|mesh-ancestor
6372036|NCT00131053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6372037|NCT00131053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6372038|NCT00131053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6372039|NCT00131053|Antiviral Agents|antiviral agents|mesh-ancestor
6372040|NCT00131053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6372041|NCT00131053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6372042|NCT00131053|Tubulin Modulators|tubulin modulators|mesh-ancestor
6372043|NCT00131053|Antimitotic Agents|antimitotic agents|mesh-ancestor
6372044|NCT00131053|Mitosis Modulators|mitosis modulators|mesh-ancestor
6372045|NCT00131118|Zoledronic Acid|zoledronic acid|mesh-list
6372046|NCT00131118|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6372047|NCT00131118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372048|NCT00131144|Octreotide|octreotide|mesh-list
6372049|NCT00131144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6372050|NCT00131144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6372051|NCT00131144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6372052|NCT00131183|Testosterone undecanoate|testosterone undecanoate|mesh-list
6372053|NCT00131183|Androgens|androgens|mesh-ancestor
6372054|NCT00131183|Hormones|hormones|mesh-ancestor
6372055|NCT00131183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6372056|NCT00131183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372057|NCT00131235|Azithromycin|azithromycin|mesh-list
6372058|NCT00131235|Pyrimethamine|pyrimethamine|mesh-list
6372059|NCT00131235|Sulfadoxine|sulfadoxine|mesh-list
6372060|NCT00131235|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6372061|NCT00131235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6372062|NCT00131235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6372063|NCT00131235|Antimalarials|antimalarials|mesh-ancestor
6372064|NCT00131235|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6372065|NCT00131235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6372066|NCT00131235|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6372067|NCT00131235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6372068|NCT00131235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372069|NCT00131235|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6372070|NCT00131235|Renal Agents|renal agents|mesh-ancestor
6372071|NCT00131261|Dexamethasone|dexamethasone|mesh-list
6372072|NCT00131261|Belinostat|belinostat|mesh-list
6372073|NCT00131261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6372074|NCT00131261|Antiemetics|antiemetics|mesh-ancestor
6372075|NCT00131261|Autonomic Agents|autonomic agents|mesh-ancestor
6372076|NCT00131261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6372077|NCT00131261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372078|NCT00131261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6372079|NCT00131261|Glucocorticoids|glucocorticoids|mesh-ancestor
6372080|NCT00131261|Hormones|hormones|mesh-ancestor
6372081|NCT00131261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6372082|NCT00131261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6372083|NCT00131261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6372084|NCT00131261|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6372085|NCT00131261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6372086|NCT00131261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372087|NCT00131274|Imatinib Mesylate|imatinib mesylate|mesh-list
6372088|NCT00131274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6372089|NCT00131274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6372090|NCT00131274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6372091|NCT00131274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372092|NCT00131300|Hylan|hylan|mesh-list
6372093|NCT00131300|Viscosupplements|viscosupplements|mesh-ancestor
6372094|NCT00131300|Protective Agents|protective agents|mesh-ancestor
6372095|NCT00131300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372096|NCT00131313|Cyclophosphamide|cyclophosphamide|mesh-list
6372097|NCT00131313|Rituximab|rituximab|mesh-list
6372098|NCT00131313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6372099|NCT00131313|Immunologic Factors|immunologic factors|mesh-ancestor
6372100|NCT00131313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372101|NCT00131313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6372102|NCT00131313|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6372103|NCT00131313|Alkylating Agents|alkylating agents|mesh-ancestor
6372104|NCT00131313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372105|NCT00131313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6372106|NCT00131313|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6372107|NCT00131313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6372108|NCT00131326|Hylan|hylan|mesh-list
6372109|NCT00131326|Viscosupplements|viscosupplements|mesh-ancestor
6372110|NCT00131326|Protective Agents|protective agents|mesh-ancestor
6372111|NCT00131326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372112|NCT00131339|Cycloserine|cycloserine|mesh-list
6372113|NCT00131339|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6372114|NCT00131339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6372115|NCT00131339|Renal Agents|renal agents|mesh-ancestor
6372116|NCT00131339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6372117|NCT00131339|Antitubercular Agents|antitubercular agents|mesh-ancestor
6372118|NCT00131339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6372119|NCT00131339|Antimetabolites|antimetabolites|mesh-ancestor
6372120|NCT00131339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372121|NCT00131391|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
6372122|NCT00131391|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6372123|NCT00131391|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6372124|NCT00131391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6372125|NCT00131391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372126|NCT00131391|Hormones|hormones|mesh-ancestor
6372127|NCT00131391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6372128|NCT00131391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372129|NCT00131404|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
6372130|NCT00131404|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6372131|NCT00131404|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6372132|NCT00131404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6372133|NCT00131404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372134|NCT00131404|Hormones|hormones|mesh-ancestor
6372135|NCT00131404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6372136|NCT00131404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372137|NCT00131430|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
6372138|NCT00131430|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6372139|NCT00131430|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6372140|NCT00131430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6372141|NCT00131430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372142|NCT00131430|Hormones|hormones|mesh-ancestor
6372143|NCT00131430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6372144|NCT00131430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372145|NCT00131443|Topiramate|topiramate|mesh-list
6372146|NCT00131443|Anticonvulsants|anticonvulsants|mesh-ancestor
6372147|NCT00131443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6372148|NCT00131443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372149|NCT00131482|Thrombin|thrombin|mesh-list
6372150|NCT00131482|Hemostatics|hemostatics|mesh-ancestor
6372151|NCT00131482|Coagulants|coagulants|mesh-ancestor
6372152|NCT00131495|Testosterone|testosterone|mesh-list
6372153|NCT00131495|Androgens|androgens|mesh-ancestor
6372154|NCT00131495|Hormones|hormones|mesh-ancestor
6372155|NCT00131495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6372156|NCT00131495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372157|NCT00131521|Acetylcysteine|acetylcysteine|mesh-list
6372158|NCT00131521|Antiviral Agents|antiviral agents|mesh-ancestor
6372159|NCT00131521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6372160|NCT00131521|Expectorants|expectorants|mesh-ancestor
6372161|NCT00131521|Respiratory System Agents|respiratory system agents|mesh-ancestor
6372162|NCT00131521|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6372163|NCT00131521|Antioxidants|antioxidants|mesh-ancestor
6372164|NCT00131521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372165|NCT00131521|Protective Agents|protective agents|mesh-ancestor
6372166|NCT00131521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372167|NCT00131703|Chloroquine|chloroquine|mesh-list
6372168|NCT00131703|Pyrimethamine|pyrimethamine|mesh-list
6372169|NCT00131703|Sulfadoxine|sulfadoxine|mesh-list
6372170|NCT00131703|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6372171|NCT00131703|Amodiaquine|amodiaquine|mesh-list
6372172|NCT00131703|Amebicides|amebicides|mesh-ancestor
6372173|NCT00131703|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6372174|NCT00131703|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6372175|NCT00131703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6372176|NCT00131703|Antimalarials|antimalarials|mesh-ancestor
6372177|NCT00131703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6372178|NCT00131703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6372179|NCT00131703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6372180|NCT00131703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372181|NCT00131703|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6372182|NCT00131703|Renal Agents|renal agents|mesh-ancestor
6372183|NCT00131716|Pyrimethamine|pyrimethamine|mesh-list
6372184|NCT00131716|Sulfadoxine|sulfadoxine|mesh-list
6372185|NCT00131716|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6372186|NCT00131716|Antimalarials|antimalarials|mesh-ancestor
6372187|NCT00131716|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6372188|NCT00131716|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6372189|NCT00131716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6372190|NCT00131716|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6372191|NCT00131716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6372192|NCT00131716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372193|NCT00131716|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6372194|NCT00131716|Renal Agents|renal agents|mesh-ancestor
6372195|NCT00131742|Lamivudine|lamivudine|mesh-list
6372196|NCT00131742|Telbivudine|telbivudine|mesh-list
6372197|NCT00131742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6372198|NCT00131742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6372199|NCT00131742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6372200|NCT00131742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372201|NCT00131742|Antiviral Agents|antiviral agents|mesh-ancestor
6372202|NCT00131742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6372203|NCT00131742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6372204|NCT00131742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6372205|NCT00131755|Diazoxide|diazoxide|mesh-list
6372206|NCT00131755|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6372207|NCT00131755|Vasodilator Agents|vasodilator agents|mesh-ancestor
6372208|NCT00131768|Hylan|hylan|mesh-list
6372209|NCT00131768|Viscosupplements|viscosupplements|mesh-ancestor
6372210|NCT00131768|Protective Agents|protective agents|mesh-ancestor
6372211|NCT00131768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372212|NCT00131846|Diuretics|diuretics|mesh-list
6372213|NCT00131846|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
6372214|NCT00131846|Natriuretic Agents|natriuretic agents|mesh-ancestor
6372215|NCT00131846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372216|NCT00131846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6372217|NCT00131846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372218|NCT00131963|Paclitaxel|paclitaxel|mesh-list
6372219|NCT00131963|Cyclophosphamide|cyclophosphamide|mesh-list
6372220|NCT00131963|Doxorubicin|doxorubicin|mesh-list
6372221|NCT00131963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6372222|NCT00131963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6372223|NCT00131963|Tubulin Modulators|tubulin modulators|mesh-ancestor
6372224|NCT00131963|Antimitotic Agents|antimitotic agents|mesh-ancestor
6372225|NCT00131963|Mitosis Modulators|mitosis modulators|mesh-ancestor
6372226|NCT00131963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372227|NCT00131963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6372228|NCT00131963|Immunologic Factors|immunologic factors|mesh-ancestor
6372229|NCT00131963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372230|NCT00131963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6372231|NCT00131963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6372232|NCT00131963|Alkylating Agents|alkylating agents|mesh-ancestor
6372233|NCT00131963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6372234|NCT00131963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6372235|NCT00131963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6372236|NCT00131963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6372237|NCT00131963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6372238|NCT00131989|Sorafenib|sorafenib|mesh-list
6372239|NCT00131989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6372240|NCT00131989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6372241|NCT00131989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6372242|NCT00131989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372243|NCT00132054|Irinotecan|irinotecan|mesh-list
6372244|NCT00132054|Amrubicin|amrubicin|mesh-list
6372245|NCT00132054|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6372246|NCT00132054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6372247|NCT00132054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6372248|NCT00132054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372249|NCT00132054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6372250|NCT00132067|Vorinostat|vorinostat|mesh-list
6372251|NCT00132067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6372252|NCT00132067|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6372253|NCT00132067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6372254|NCT00132067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372255|NCT00132093|Eplerenone|eplerenone|mesh-list
6372256|NCT00132093|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6372257|NCT00132093|Hormone Antagonists|hormone antagonists|mesh-ancestor
6372258|NCT00132093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6372259|NCT00132093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372260|NCT00132093|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6372261|NCT00132093|Diuretics|diuretics|mesh-ancestor
6372262|NCT00132093|Natriuretic Agents|natriuretic agents|mesh-ancestor
6372263|NCT00132093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6372264|NCT00132106|Phentolamine|phentolamine|mesh-list
6372265|NCT00132106|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6372266|NCT00132106|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6372267|NCT00132106|Adrenergic Agents|adrenergic agents|mesh-ancestor
6372268|NCT00132106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6372269|NCT00132106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372270|NCT00132106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372271|NCT00132106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6372272|NCT00132119|Nalmefene|nalmefene|mesh-list
6372273|NCT00132119|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6372274|NCT00132119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372275|NCT00132119|Sensory System Agents|sensory system agents|mesh-ancestor
6372276|NCT00132119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6372277|NCT00132158|Irinotecan|irinotecan|mesh-list
6372278|NCT00132158|Gefitinib|gefitinib|mesh-list
6372279|NCT00132158|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6372280|NCT00132158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6372281|NCT00132158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6372282|NCT00132158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372283|NCT00132158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6372284|NCT00132158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6372285|NCT00132184|Vitamin D|vitamin d|mesh-list
6372286|NCT00132184|Vitamins|vitamins|mesh-ancestor
6372287|NCT00132184|Micronutrients|micronutrients|mesh-ancestor
6372288|NCT00132184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372289|NCT00132184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6372290|NCT00132210|Interferons|interferons|mesh-list
6372291|NCT00132210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6372292|NCT00132210|Antiviral Agents|antiviral agents|mesh-ancestor
6372293|NCT00132210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6372294|NCT00132236|Nicotine|nicotine|mesh-list
6372295|NCT00132236|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6372296|NCT00132236|Autonomic Agents|autonomic agents|mesh-ancestor
6372297|NCT00132236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6372298|NCT00132236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372299|NCT00132236|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6372300|NCT00132236|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6372301|NCT00132236|Cholinergic Agents|cholinergic agents|mesh-ancestor
6372302|NCT00132236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6372303|NCT00132236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372304|NCT00132275|Amoxicillin|amoxicillin|mesh-list
6372305|NCT00132275|Clavulanic Acid|clavulanic acid|mesh-list
6372306|NCT00132275|Clavulanic Acids|clavulanic acids|mesh-list
6372307|NCT00132275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6372308|NCT00132275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6372309|NCT00132275|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6372310|NCT00132275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6372311|NCT00132275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372312|NCT00132379|Docetaxel|docetaxel|mesh-list
6372313|NCT00132379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6372314|NCT00132379|Tubulin Modulators|tubulin modulators|mesh-ancestor
6372315|NCT00132379|Antimitotic Agents|antimitotic agents|mesh-ancestor
6372316|NCT00132379|Mitosis Modulators|mitosis modulators|mesh-ancestor
6372317|NCT00132379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372318|NCT00132418|Etanercept|etanercept|mesh-list
6372319|NCT00132418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6372320|NCT00132418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6372321|NCT00132418|Analgesics|analgesics|mesh-ancestor
6372322|NCT00132418|Sensory System Agents|sensory system agents|mesh-ancestor
6372323|NCT00132418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6372324|NCT00132418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372325|NCT00132418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6372326|NCT00132418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6372327|NCT00132418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6372328|NCT00132418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6372329|NCT00132418|Immunologic Factors|immunologic factors|mesh-ancestor
6372330|NCT00132431|Cinacalcet|cinacalcet|mesh-list
6372331|NCT00132431|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6372332|NCT00132431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372333|NCT00132431|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6372334|NCT00132431|Hormone Antagonists|hormone antagonists|mesh-ancestor
6372335|NCT00132431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6372336|NCT00132444|UC-781|uc-781|mesh-list
6372337|NCT00132444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6372338|NCT00132444|Antiviral Agents|antiviral agents|mesh-ancestor
6372339|NCT00132444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6395572|NCT00206154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6395573|NCT00206154|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6395574|NCT00206154|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6395575|NCT00206154|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6395576|NCT00206154|Adrenergic Agents|adrenergic agents|mesh-ancestor
6395577|NCT00206154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6395578|NCT00206154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395579|NCT00206167|Budesonide|budesonide|mesh-list
6395580|NCT00206167|Formoterol Fumarate|formoterol fumarate|mesh-list
6395581|NCT00206167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6395582|NCT00206167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6395583|NCT00206167|Autonomic Agents|autonomic agents|mesh-ancestor
6395584|NCT00206167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6395585|NCT00206167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395586|NCT00206167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6395587|NCT00206167|Respiratory System Agents|respiratory system agents|mesh-ancestor
6395588|NCT00206167|Glucocorticoids|glucocorticoids|mesh-ancestor
6395589|NCT00206167|Hormones|hormones|mesh-ancestor
6395590|NCT00206167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6395591|NCT00206167|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6395592|NCT00206167|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6395593|NCT00206167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6395594|NCT00206167|Adrenergic Agents|adrenergic agents|mesh-ancestor
6395595|NCT00206167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6395596|NCT00206167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395597|NCT00206180|Esomeprazole|esomeprazole|mesh-list
6395598|NCT00206180|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6395599|NCT00206180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6395600|NCT00206180|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6395601|NCT00206180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6395602|NCT00206180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395603|NCT00206193|Misoprostol|misoprostol|mesh-list
6395604|NCT00206193|Sulprostone|sulprostone|mesh-list
6372340|NCT00132535|Chloroquine|chloroquine|mesh-list
6372341|NCT00132535|Pyrimethamine|pyrimethamine|mesh-list
6372342|NCT00132535|Sulfadoxine|sulfadoxine|mesh-list
6372343|NCT00132535|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6372344|NCT00132535|Amebicides|amebicides|mesh-ancestor
6372345|NCT00132535|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6372346|NCT00132535|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6372347|NCT00132535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6372348|NCT00132535|Antimalarials|antimalarials|mesh-ancestor
6372349|NCT00132535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6372350|NCT00132535|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6372351|NCT00132535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6372352|NCT00132535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372353|NCT00132535|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6372354|NCT00132535|Renal Agents|renal agents|mesh-ancestor
6372355|NCT00132548|Artesunate|artesunate|mesh-list
6372356|NCT00132548|Pyrimethamine|pyrimethamine|mesh-list
6372357|NCT00132548|Sulfadoxine|sulfadoxine|mesh-list
6372358|NCT00132548|Amodiaquine|amodiaquine|mesh-list
6372359|NCT00132548|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6372360|NCT00132548|Antimalarials|antimalarials|mesh-ancestor
6372361|NCT00132548|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6372362|NCT00132548|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6372363|NCT00132548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6372364|NCT00132548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6372365|NCT00132548|Antiviral Agents|antiviral agents|mesh-ancestor
6372366|NCT00132548|Schistosomicides|schistosomicides|mesh-ancestor
6372367|NCT00132548|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6372368|NCT00132548|Anthelmintics|anthelmintics|mesh-ancestor
6372369|NCT00132548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6372370|NCT00132548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6372371|NCT00132548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372372|NCT00132548|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6372373|NCT00132548|Renal Agents|renal agents|mesh-ancestor
6372374|NCT00132561|Artesunate|artesunate|mesh-list
6372375|NCT00132561|Pyrimethamine|pyrimethamine|mesh-list
6372376|NCT00132561|Sulfadoxine|sulfadoxine|mesh-list
6372377|NCT00132561|Antimalarials|antimalarials|mesh-ancestor
6372378|NCT00132561|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6372379|NCT00132561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6372380|NCT00132561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6372381|NCT00132561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6372382|NCT00132561|Antiviral Agents|antiviral agents|mesh-ancestor
6372383|NCT00132561|Schistosomicides|schistosomicides|mesh-ancestor
6372384|NCT00132561|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6372385|NCT00132561|Anthelmintics|anthelmintics|mesh-ancestor
6372386|NCT00132561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6372387|NCT00132561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6372388|NCT00132561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372389|NCT00132561|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6372390|NCT00132561|Renal Agents|renal agents|mesh-ancestor
6372391|NCT00132587|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
6372392|NCT00132587|Vasodilator Agents|vasodilator agents|mesh-ancestor
6372393|NCT00132587|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
6372394|NCT00132587|Protective Agents|protective agents|mesh-ancestor
6372395|NCT00132587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372396|NCT00132600|Bacitracin|bacitracin|mesh-list
6372397|NCT00132600|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6372398|NCT00132600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6372399|NCT00132600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6372400|NCT00132613|Bleomycin|bleomycin|mesh-list
6372401|NCT00132613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6372402|NCT00132613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6372403|NCT00132639|Docetaxel|docetaxel|mesh-list
6372404|NCT00132639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6372405|NCT00132639|Tubulin Modulators|tubulin modulators|mesh-ancestor
6372406|NCT00132639|Antimitotic Agents|antimitotic agents|mesh-ancestor
6372407|NCT00132639|Mitosis Modulators|mitosis modulators|mesh-ancestor
6372408|NCT00132639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372409|NCT00132652|Lamivudine|lamivudine|mesh-list
6372410|NCT00132652|Telbivudine|telbivudine|mesh-list
6372411|NCT00132652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6372412|NCT00132652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6372413|NCT00132652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6372414|NCT00132652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372415|NCT00132652|Antiviral Agents|antiviral agents|mesh-ancestor
6372416|NCT00132652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6372417|NCT00132652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6372418|NCT00132652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6372419|NCT00132743|Cilostazol|cilostazol|mesh-list
6372420|NCT00132743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6372421|NCT00132743|Autonomic Agents|autonomic agents|mesh-ancestor
6372422|NCT00132743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6372423|NCT00132743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372424|NCT00132743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6372425|NCT00132743|Respiratory System Agents|respiratory system agents|mesh-ancestor
6372426|NCT00132743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6372427|NCT00132743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6372428|NCT00132743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372429|NCT00132743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6372430|NCT00132743|Vasodilator Agents|vasodilator agents|mesh-ancestor
6372431|NCT00132743|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6372432|NCT00132743|Protective Agents|protective agents|mesh-ancestor
6372433|NCT00132743|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6372434|NCT00132743|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6372435|NCT00132743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6372436|NCT00132756|Estramustine|estramustine|mesh-list
6372437|NCT00132756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6372438|NCT00132756|Alkylating Agents|alkylating agents|mesh-ancestor
6372439|NCT00132756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372440|NCT00132756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6372441|NCT00132756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6372442|NCT00132821|Bupropion|bupropion|mesh-list
6372443|NCT00132821|Nicotine|nicotine|mesh-list
6372444|NCT00132821|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6372445|NCT00132821|Autonomic Agents|autonomic agents|mesh-ancestor
6372446|NCT00132821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6372447|NCT00132821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372448|NCT00132821|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6372449|NCT00132821|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6372450|NCT00132821|Cholinergic Agents|cholinergic agents|mesh-ancestor
6372451|NCT00132821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6372452|NCT00132821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372453|NCT00132821|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6372454|NCT00132821|Antidepressive Agents|antidepressive agents|mesh-ancestor
6372455|NCT00132821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6372456|NCT00132821|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6372457|NCT00132821|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6372458|NCT00132821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6372459|NCT00132821|Dopamine Agents|dopamine agents|mesh-ancestor
6372460|NCT00132821|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6372461|NCT00132821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6372462|NCT00132821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6372463|NCT00132860|Azithromycin|azithromycin|mesh-list
6372464|NCT00132860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6372465|NCT00132860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6372466|NCT00132886|Tolvaptan|tolvaptan|mesh-list
6372467|NCT00132886|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6372468|NCT00132886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372469|NCT00132886|Natriuretic Agents|natriuretic agents|mesh-ancestor
6372470|NCT00132886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372471|NCT00132899|Methotrexate|methotrexate|mesh-list
6372472|NCT00132899|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6372473|NCT00132899|Abortifacient Agents|abortifacient agents|mesh-ancestor
6372474|NCT00132899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6372475|NCT00132899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372476|NCT00132899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6372477|NCT00132899|Antimetabolites|antimetabolites|mesh-ancestor
6372478|NCT00132899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372479|NCT00132899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6372480|NCT00132899|Dermatologic Agents|dermatologic agents|mesh-ancestor
6372481|NCT00132899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6372482|NCT00132899|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6372483|NCT00132899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6372484|NCT00132899|Immunologic Factors|immunologic factors|mesh-ancestor
6372485|NCT00132899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6372486|NCT00132899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6372487|NCT00132912|Vorapaxar|vorapaxar|mesh-list
6372488|NCT00132912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6372489|NCT00132925|Triamcinolone|triamcinolone|mesh-list
6372490|NCT00132925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6372491|NCT00132925|Glucocorticoids|glucocorticoids|mesh-ancestor
6372492|NCT00132925|Hormones|hormones|mesh-ancestor
6372493|NCT00132925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6372494|NCT00132925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372495|NCT00132938|Telithromycin|telithromycin|mesh-list
6372496|NCT00132938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6372497|NCT00132938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6372498|NCT00132951|Azithromycin|azithromycin|mesh-list
6372499|NCT00132951|Telithromycin|telithromycin|mesh-list
6372500|NCT00132951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6372501|NCT00132951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6372502|NCT00133003|Abciximab|abciximab|mesh-list
6372503|NCT00133003|Anticoagulants|anticoagulants|mesh-ancestor
6372504|NCT00133003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6372505|NCT00133029|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6372506|NCT00133029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6372507|NCT00133042|Omalizumab|omalizumab|mesh-list
6372508|NCT00133042|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6372509|NCT00133042|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6372510|NCT00133042|Respiratory System Agents|respiratory system agents|mesh-ancestor
6372511|NCT00133081|Anticonvulsants|anticonvulsants|mesh-list
6372512|NCT00133172|Mycophenolic Acid|mycophenolic acid|mesh-list
6372513|NCT00133172|Prednisone|prednisone|mesh-list
6372514|NCT00133172|Tacrolimus|tacrolimus|mesh-list
6372515|NCT00133172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6372516|NCT00133172|Glucocorticoids|glucocorticoids|mesh-ancestor
6372517|NCT00133172|Hormones|hormones|mesh-ancestor
6372518|NCT00133172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6372519|NCT00133172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372520|NCT00133172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6372521|NCT00133172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6372522|NCT00133172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6372523|NCT00133172|Immunologic Factors|immunologic factors|mesh-ancestor
6372524|NCT00133172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6372525|NCT00133172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6372526|NCT00133172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372527|NCT00133172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6372528|NCT00133172|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6372529|NCT00133172|Antitubercular Agents|antitubercular agents|mesh-ancestor
6372530|NCT00133172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6372531|NCT00133172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6372532|NCT00133185|Losartan|losartan|mesh-list
6372533|NCT00133185|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6372534|NCT00133185|Telmisartan|telmisartan|mesh-list
6372535|NCT00133185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6372536|NCT00133185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6372537|NCT00133185|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6372538|NCT00133185|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6372539|NCT00133185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372540|NCT00133185|Diuretics|diuretics|mesh-ancestor
6372541|NCT00133185|Natriuretic Agents|natriuretic agents|mesh-ancestor
6372542|NCT00133185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372543|NCT00133185|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6372544|NCT00133185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6372545|NCT00133198|Pramipexole|pramipexole|mesh-list
6372546|NCT00133198|Antioxidants|antioxidants|mesh-ancestor
6372547|NCT00133198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372548|NCT00133198|Protective Agents|protective agents|mesh-ancestor
6372549|NCT00133198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372550|NCT00133198|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6372551|NCT00133198|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6372552|NCT00133198|Dopamine Agonists|dopamine agonists|mesh-ancestor
6372553|NCT00133198|Dopamine Agents|dopamine agents|mesh-ancestor
6372554|NCT00133198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6372555|NCT00133224|Prednisone|prednisone|mesh-list
6372556|NCT00133224|Docetaxel|docetaxel|mesh-list
6372557|NCT00133224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6372558|NCT00133224|Tubulin Modulators|tubulin modulators|mesh-ancestor
6372559|NCT00133224|Antimitotic Agents|antimitotic agents|mesh-ancestor
6372560|NCT00133224|Mitosis Modulators|mitosis modulators|mesh-ancestor
6372561|NCT00133224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372562|NCT00133224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6372563|NCT00133224|Glucocorticoids|glucocorticoids|mesh-ancestor
6372564|NCT00133224|Hormones|hormones|mesh-ancestor
6372565|NCT00133224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6372566|NCT00133224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372567|NCT00133224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6372568|NCT00133237|Sirolimus|sirolimus|mesh-list
6372569|NCT00133237|Paclitaxel|paclitaxel|mesh-list
6372570|NCT00133237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6372571|NCT00133237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6372572|NCT00133237|Tubulin Modulators|tubulin modulators|mesh-ancestor
6372573|NCT00133237|Antimitotic Agents|antimitotic agents|mesh-ancestor
6372574|NCT00133237|Mitosis Modulators|mitosis modulators|mesh-ancestor
6372575|NCT00133237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372576|NCT00133237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6372577|NCT00133237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6372578|NCT00133237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6372579|NCT00133237|Antifungal Agents|antifungal agents|mesh-ancestor
6372580|NCT00133237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6372581|NCT00133237|Immunologic Factors|immunologic factors|mesh-ancestor
6372582|NCT00133237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372583|NCT00133250|Heparin|heparin|mesh-list
6372584|NCT00133250|Calcium heparin|calcium heparin|mesh-list
6372585|NCT00133250|Abciximab|abciximab|mesh-list
6372586|NCT00133250|Anticoagulants|anticoagulants|mesh-ancestor
6372587|NCT00133250|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6372588|NCT00133250|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6372589|NCT00133250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372590|NCT00133250|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6372591|NCT00133276|Citalopram|citalopram|mesh-list
6372592|NCT00133276|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6372593|NCT00133276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6372594|NCT00133276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6372595|NCT00133276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372596|NCT00133276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6372597|NCT00133276|Serotonin Agents|serotonin agents|mesh-ancestor
6372598|NCT00133276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372599|NCT00133276|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6372600|NCT00133276|Antidepressive Agents|antidepressive agents|mesh-ancestor
6372601|NCT00133276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6372602|NCT00133315|Adalimumab|adalimumab|mesh-list
6372603|NCT00133315|Etanercept|etanercept|mesh-list
6372604|NCT00133315|Infliximab|infliximab|mesh-list
6372605|NCT00133315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6372606|NCT00133315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6372607|NCT00133315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6372608|NCT00133315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6372609|NCT00133315|Analgesics|analgesics|mesh-ancestor
6372610|NCT00133315|Sensory System Agents|sensory system agents|mesh-ancestor
6372611|NCT00133315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6372612|NCT00133315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372613|NCT00133315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6372614|NCT00133315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6372615|NCT00133315|Immunologic Factors|immunologic factors|mesh-ancestor
6372616|NCT00133315|Dermatologic Agents|dermatologic agents|mesh-ancestor
6372617|NCT00133328|Valsartan|valsartan|mesh-list
6372618|NCT00133328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6372619|NCT00133328|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6372620|NCT00133328|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6372621|NCT00133328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372622|NCT00133341|Parthenolide|parthenolide|mesh-list
6372623|NCT00133341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6372624|NCT00133341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6372625|NCT00133341|Analgesics|analgesics|mesh-ancestor
6372626|NCT00133341|Sensory System Agents|sensory system agents|mesh-ancestor
6372627|NCT00133341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6372628|NCT00133341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372629|NCT00133341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6372630|NCT00133341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6372631|NCT00133354|Anastrozole|anastrozole|mesh-list
6372632|NCT00133354|Hormones|hormones|mesh-list
6372633|NCT00133354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6372634|NCT00133354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372635|NCT00133354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6372636|NCT00133354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6372637|NCT00133354|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6372638|NCT00133354|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6372639|NCT00133354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6372640|NCT00133354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372641|NCT00133354|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6372642|NCT00133354|Hormone Antagonists|hormone antagonists|mesh-ancestor
6372643|NCT00133367|Sirolimus|sirolimus|mesh-list
6372644|NCT00133367|Fludarabine|fludarabine|mesh-list
6372645|NCT00133367|Melphalan|melphalan|mesh-list
6372646|NCT00133367|Tacrolimus|tacrolimus|mesh-list
6372647|NCT00133367|Thymoglobulin|thymoglobulin|mesh-list
6372648|NCT00133367|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6372649|NCT00133367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6372650|NCT00133367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372651|NCT00133367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6372652|NCT00133367|Immunologic Factors|immunologic factors|mesh-ancestor
6372653|NCT00133367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372654|NCT00133367|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6372655|NCT00133367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6372656|NCT00133367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6372657|NCT00133367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6372658|NCT00133367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6372659|NCT00133367|Antifungal Agents|antifungal agents|mesh-ancestor
6372660|NCT00133367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6372661|NCT00133367|Alkylating Agents|alkylating agents|mesh-ancestor
6372662|NCT00133367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6372663|NCT00133380|Atorvastatin|atorvastatin|mesh-list
6372664|NCT00133380|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6372665|NCT00133380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6372666|NCT00133380|Antimetabolites|antimetabolites|mesh-ancestor
6372667|NCT00133380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372668|NCT00133380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6372669|NCT00133380|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6372670|NCT00133380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6372671|NCT00133393|Pentoxifylline|pentoxifylline|mesh-list
6372672|NCT00133393|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6372673|NCT00133393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6372674|NCT00133393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372675|NCT00133393|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6372676|NCT00133393|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6372677|NCT00133393|Protective Agents|protective agents|mesh-ancestor
6372678|NCT00133393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372679|NCT00133393|Vasodilator Agents|vasodilator agents|mesh-ancestor
6372680|NCT00133393|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6372681|NCT00133393|Antioxidants|antioxidants|mesh-ancestor
6372682|NCT00133406|Vitamin A|vitamin a|mesh-list
6372683|NCT00133406|Glycine|glycine|mesh-list
6372684|NCT00133406|Vitamins|vitamins|mesh-ancestor
6372685|NCT00133406|Micronutrients|micronutrients|mesh-ancestor
6372686|NCT00133406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372687|NCT00133406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372688|NCT00133406|Glycine Agents|glycine agents|mesh-ancestor
6372689|NCT00133406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6372690|NCT00133419|Vitamins|vitamins|mesh-list
6372691|NCT00133419|Vitamin A|vitamin a|mesh-list
6372692|NCT00133419|Zinc|zinc|mesh-list
6372693|NCT00133419|Trace Elements|trace elements|mesh-list
6372694|NCT00133419|Micronutrients|micronutrients|mesh-list
6372695|NCT00133419|Retinol palmitate|retinol palmitate|mesh-list
6372696|NCT00133419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372697|NCT00133419|Antioxidants|antioxidants|mesh-ancestor
6372698|NCT00133419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372699|NCT00133419|Protective Agents|protective agents|mesh-ancestor
6372700|NCT00133419|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6372701|NCT00133419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6372702|NCT00133445|Vaccines|vaccines|mesh-list
6372703|NCT00133445|Immunologic Factors|immunologic factors|mesh-ancestor
6372704|NCT00133445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372705|NCT00133458|Albendazole|albendazole|mesh-list
6372706|NCT00133458|Anthelmintics|anthelmintics|mesh-ancestor
6372707|NCT00133458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6372708|NCT00133458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6372709|NCT00133458|Anticestodal Agents|anticestodal agents|mesh-ancestor
6372710|NCT00133458|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6372711|NCT00133458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6372712|NCT00133458|Tubulin Modulators|tubulin modulators|mesh-ancestor
6372713|NCT00133458|Antimitotic Agents|antimitotic agents|mesh-ancestor
6372714|NCT00133458|Mitosis Modulators|mitosis modulators|mesh-ancestor
6372715|NCT00133458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372716|NCT00133458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6372717|NCT00133523|Vaccines|vaccines|mesh-list
6372718|NCT00133523|Immunologic Factors|immunologic factors|mesh-ancestor
6372719|NCT00133523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372720|NCT00133549|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6372721|NCT00133549|Immunologic Factors|immunologic factors|mesh-ancestor
6372722|NCT00133549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372723|NCT00133562|Glycine|glycine|mesh-list
6372724|NCT00133562|Glycine Agents|glycine agents|mesh-ancestor
6372725|NCT00133562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6372726|NCT00133562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372727|NCT00133562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372728|NCT00133627|Ketotifen|ketotifen|mesh-list
6372729|NCT00133627|Antipruritics|antipruritics|mesh-ancestor
6372730|NCT00133627|Dermatologic Agents|dermatologic agents|mesh-ancestor
6372731|NCT00133627|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6372732|NCT00133627|Histamine Antagonists|histamine antagonists|mesh-ancestor
6372733|NCT00133627|Histamine Agents|histamine agents|mesh-ancestor
6372734|NCT00133627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6372735|NCT00133627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372736|NCT00133627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372737|NCT00133627|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6372738|NCT00133640|Cholecalciferol|cholecalciferol|mesh-list
6372739|NCT00133640|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6372740|NCT00133640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372741|NCT00133640|Vitamins|vitamins|mesh-ancestor
6372742|NCT00133640|Micronutrients|micronutrients|mesh-ancestor
6372743|NCT00133640|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6372744|NCT00133692|Atenolol|atenolol|mesh-list
6372745|NCT00133692|Verapamil|verapamil|mesh-list
6372746|NCT00133692|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6372747|NCT00133692|Trandolapril|trandolapril|mesh-list
6372748|NCT00133692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6372749|NCT00133692|Diuretics|diuretics|mesh-ancestor
6372750|NCT00133692|Natriuretic Agents|natriuretic agents|mesh-ancestor
6372751|NCT00133692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372752|NCT00133692|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6372753|NCT00133692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6372754|NCT00133692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372755|NCT00133692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6372756|NCT00133692|Sympatholytics|sympatholytics|mesh-ancestor
6372757|NCT00133692|Autonomic Agents|autonomic agents|mesh-ancestor
6372758|NCT00133692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6372759|NCT00133692|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6372760|NCT00133692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6372761|NCT00133692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6372762|NCT00133692|Adrenergic Agents|adrenergic agents|mesh-ancestor
6372763|NCT00133692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6372764|NCT00133692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6372765|NCT00133692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6372766|NCT00133692|Vasodilator Agents|vasodilator agents|mesh-ancestor
6372767|NCT00133692|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6372768|NCT00133692|Protease Inhibitors|protease inhibitors|mesh-ancestor
6372769|NCT00133692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6372770|NCT00133731|Heparin|heparin|mesh-list
6372771|NCT00133731|Calcium heparin|calcium heparin|mesh-list
6372772|NCT00133731|Otamixaban|otamixaban|mesh-list
6372773|NCT00133731|Anticoagulants|anticoagulants|mesh-ancestor
6372774|NCT00133731|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6372775|NCT00133731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6372776|NCT00133731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372777|NCT00133731|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6372778|NCT00133731|Antithrombins|antithrombins|mesh-ancestor
6372779|NCT00133731|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6372780|NCT00133731|Protease Inhibitors|protease inhibitors|mesh-ancestor
6372781|NCT00133731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6372782|NCT00133744|Folic Acid|folic acid|mesh-list
6372783|NCT00133744|Vitamin B Complex|vitamin b complex|mesh-list
6372784|NCT00133744|Vitamins|vitamins|mesh-ancestor
6372785|NCT00133744|Micronutrients|micronutrients|mesh-ancestor
6372786|NCT00133744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372787|NCT00133744|Hematinics|hematinics|mesh-ancestor
6372788|NCT00133757|Bupropion|bupropion|mesh-list
6372789|NCT00133757|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6372790|NCT00133757|Antidepressive Agents|antidepressive agents|mesh-ancestor
6372791|NCT00133757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6372792|NCT00133757|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6372793|NCT00133757|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6372794|NCT00133757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6372795|NCT00133757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372796|NCT00133757|Dopamine Agents|dopamine agents|mesh-ancestor
6372797|NCT00133757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6372798|NCT00133757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372799|NCT00133757|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6372800|NCT00133757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6372801|NCT00133757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6372802|NCT00133770|Pantoprazole|pantoprazole|mesh-list
6372803|NCT00133770|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6372804|NCT00133770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6372805|NCT00133770|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6372806|NCT00133770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6372807|NCT00133770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372808|NCT00133796|Trastuzumab|trastuzumab|mesh-list
6372809|NCT00133796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6372810|NCT00133796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6372811|NCT00133822|Risperidone|risperidone|mesh-list
6372812|NCT00133822|Sertraline|sertraline|mesh-list
6372813|NCT00133822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6372814|NCT00133822|Serotonin Agents|serotonin agents|mesh-ancestor
6372815|NCT00133822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6372816|NCT00133822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372817|NCT00133822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372818|NCT00133822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6372819|NCT00133822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6017450|NCT00372775|Growth Substances|growth substances|mesh-ancestor
6372820|NCT00133822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6372821|NCT00133822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6372822|NCT00133822|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6372823|NCT00133822|Dopamine Agents|dopamine agents|mesh-ancestor
6372824|NCT00133822|Antidepressive Agents|antidepressive agents|mesh-ancestor
6372825|NCT00133822|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6372826|NCT00133822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6372827|NCT00133822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6372828|NCT00133848|Retapamulin|retapamulin|mesh-list
6372829|NCT00133848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6372830|NCT00133848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6372831|NCT00133861|Botulinum Toxins|botulinum toxins|mesh-list
6372832|NCT00133861|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6372833|NCT00133861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6372834|NCT00133861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372835|NCT00133861|Cholinergic Agents|cholinergic agents|mesh-ancestor
6372836|NCT00133861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6372837|NCT00133861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372838|NCT00133874|Retapamulin|retapamulin|mesh-list
6372839|NCT00133874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6372840|NCT00133874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6372841|NCT00133887|Sirolimus|sirolimus|mesh-list
6372842|NCT00133887|Cyclosporine|cyclosporine|mesh-list
6372843|NCT00133887|Tacrolimus|tacrolimus|mesh-list
6372844|NCT00133887|Cyclosporins|cyclosporins|mesh-list
6372845|NCT00133887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6372846|NCT00133887|Immunologic Factors|immunologic factors|mesh-ancestor
6372847|NCT00133887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372848|NCT00133887|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6372849|NCT00133887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6372850|NCT00133887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372851|NCT00133887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6372852|NCT00133887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6372853|NCT00133887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6372854|NCT00133887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6372855|NCT00133887|Antifungal Agents|antifungal agents|mesh-ancestor
6372856|NCT00133887|Dermatologic Agents|dermatologic agents|mesh-ancestor
6372857|NCT00133887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6395605|NCT00206193|Mifepristone|mifepristone|mesh-list
6395606|NCT00206193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6395607|NCT00206193|Abortifacient Agents|abortifacient agents|mesh-ancestor
6395608|NCT00206193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6395609|NCT00206193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395610|NCT00206193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6395611|NCT00206193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6395612|NCT00206193|Oxytocics|oxytocics|mesh-ancestor
6395613|NCT00206193|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6395614|NCT00206193|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6395615|NCT00206193|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6395616|NCT00206193|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6395617|NCT00206193|Contraceptive Agents|contraceptive agents|mesh-ancestor
6395618|NCT00206193|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6395619|NCT00206193|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6395620|NCT00206193|Hormone Antagonists|hormone antagonists|mesh-ancestor
6395621|NCT00206193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6395622|NCT00206193|Luteolytic Agents|luteolytic agents|mesh-ancestor
6395623|NCT00206193|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6395624|NCT00206193|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6395625|NCT00206219|Methotrexate|methotrexate|mesh-list
6395626|NCT00206219|Gefitinib|gefitinib|mesh-list
6395627|NCT00206219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6395628|NCT00206219|Abortifacient Agents|abortifacient agents|mesh-ancestor
6395629|NCT00206219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6395630|NCT00206219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395631|NCT00206219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6395632|NCT00206219|Antimetabolites|antimetabolites|mesh-ancestor
6395633|NCT00206219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395634|NCT00206219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6395635|NCT00206219|Dermatologic Agents|dermatologic agents|mesh-ancestor
6395636|NCT00206219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6395637|NCT00206219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6395638|NCT00206219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6395639|NCT00206219|Immunologic Factors|immunologic factors|mesh-ancestor
6395640|NCT00206219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6395641|NCT00206219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6395642|NCT00206219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6372858|NCT00134030|Interferons|interferons|mesh-list
6372859|NCT00134030|Interferon-alpha|interferon-alpha|mesh-list
6372860|NCT00134030|Interferon alpha-2|interferon alpha-2|mesh-list
6372861|NCT00134030|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6372862|NCT00134030|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
6372863|NCT00134030|Cisplatin|cisplatin|mesh-list
6372864|NCT00134030|Doxorubicin|doxorubicin|mesh-list
6372865|NCT00134030|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6372866|NCT00134030|Methotrexate|methotrexate|mesh-list
6372867|NCT00134030|Etoposide|etoposide|mesh-list
6372868|NCT00134030|Etoposide phosphate|etoposide phosphate|mesh-list
6372869|NCT00134030|Ifosfamide|ifosfamide|mesh-list
6372870|NCT00134030|Isophosphamide mustard|isophosphamide mustard|mesh-list
6372871|NCT00134030|Podophyllotoxin|podophyllotoxin|mesh-list
6372872|NCT00134030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6372873|NCT00134030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6372874|NCT00134030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6372875|NCT00134030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6372876|NCT00134030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6372877|NCT00134030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372878|NCT00134030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6372879|NCT00134030|Abortifacient Agents|abortifacient agents|mesh-ancestor
6372880|NCT00134030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6372881|NCT00134030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372882|NCT00134030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6372883|NCT00134030|Antimetabolites|antimetabolites|mesh-ancestor
6372884|NCT00134030|Dermatologic Agents|dermatologic agents|mesh-ancestor
6372885|NCT00134030|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6372886|NCT00134030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6372887|NCT00134030|Immunologic Factors|immunologic factors|mesh-ancestor
6372888|NCT00134030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6372889|NCT00134030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6372890|NCT00134030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6372891|NCT00134030|Antiviral Agents|antiviral agents|mesh-ancestor
6372892|NCT00134030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6372893|NCT00134030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6372894|NCT00134030|Alkylating Agents|alkylating agents|mesh-ancestor
6372895|NCT00134030|Keratolytic Agents|keratolytic agents|mesh-ancestor
6372896|NCT00134030|Tubulin Modulators|tubulin modulators|mesh-ancestor
6372897|NCT00134030|Antimitotic Agents|antimitotic agents|mesh-ancestor
6372898|NCT00134030|Mitosis Modulators|mitosis modulators|mesh-ancestor
6372899|NCT00134069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6372900|NCT00134069|Cetuximab|cetuximab|mesh-list
6372901|NCT00134069|Irinotecan|irinotecan|mesh-list
6372902|NCT00134069|Sorafenib|sorafenib|mesh-list
6372903|NCT00134069|Antibodies|antibodies|mesh-list
6372904|NCT00134069|Immunoglobulins|immunoglobulins|mesh-list
6372905|NCT00134069|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6372906|NCT00134069|Immunologic Factors|immunologic factors|mesh-ancestor
6372907|NCT00134069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372908|NCT00134069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6372909|NCT00134069|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6372910|NCT00134069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6372911|NCT00134069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6372912|NCT00134069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372913|NCT00134069|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6372914|NCT00134095|Irinotecan|irinotecan|mesh-list
6372915|NCT00134095|Tegafur|tegafur|mesh-list
6372916|NCT00134095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6372917|NCT00134095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6372918|NCT00134095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6372919|NCT00134095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372920|NCT00134095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6372921|NCT00134095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6372922|NCT00134095|Antimetabolites|antimetabolites|mesh-ancestor
6372923|NCT00134147|Insulin|insulin|mesh-list
6372924|NCT00134147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6372925|NCT00134147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372926|NCT00134160|Amlodipine|amlodipine|mesh-list
6372927|NCT00134160|Olmesartan|olmesartan|mesh-list
6372928|NCT00134160|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6372929|NCT00134160|Calcium Channel Blockers|calcium channel blockers|mesh-list
6372930|NCT00134160|Calcium|calcium|mesh-list
6372931|NCT00134160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6372932|NCT00134160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372933|NCT00134160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6372934|NCT00134160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6372935|NCT00134160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372936|NCT00134160|Vasodilator Agents|vasodilator agents|mesh-ancestor
6372937|NCT00134160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6372938|NCT00134160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6372939|NCT00134173|Atorvastatin|atorvastatin|mesh-list
6372940|NCT00134173|Torcetrapib|torcetrapib|mesh-list
6372941|NCT00134173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6372942|NCT00134173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6372943|NCT00134173|Antimetabolites|antimetabolites|mesh-ancestor
6372944|NCT00134173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372945|NCT00134173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6372946|NCT00134173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6372947|NCT00134173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6372948|NCT00134186|Motexafin gadolinium|motexafin gadolinium|mesh-list
6372949|NCT00134186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6372950|NCT00134186|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6372951|NCT00134186|Dermatologic Agents|dermatologic agents|mesh-ancestor
6372952|NCT00134199|Sibutramine|sibutramine|mesh-list
6372953|NCT00134199|Antidepressive Agents|antidepressive agents|mesh-ancestor
6372954|NCT00134199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6372955|NCT00134199|Appetite Depressants|appetite depressants|mesh-ancestor
6372956|NCT00134199|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6372957|NCT00134212|Epinephrine|epinephrine|mesh-list
6372958|NCT00134212|Norepinephrine|norepinephrine|mesh-list
6372959|NCT00134212|Dopexamine|dopexamine|mesh-list
6372960|NCT00134212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6372961|NCT00134212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6372962|NCT00134212|Adrenergic Agents|adrenergic agents|mesh-ancestor
6372963|NCT00134212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6372964|NCT00134212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372965|NCT00134212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372966|NCT00134212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6372967|NCT00134212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6372968|NCT00134212|Autonomic Agents|autonomic agents|mesh-ancestor
6372969|NCT00134212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6372970|NCT00134212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6372971|NCT00134212|Respiratory System Agents|respiratory system agents|mesh-ancestor
6372972|NCT00134212|Mydriatics|mydriatics|mesh-ancestor
6372973|NCT00134212|Sympathomimetics|sympathomimetics|mesh-ancestor
6372974|NCT00134212|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6372975|NCT00134212|Vasodilator Agents|vasodilator agents|mesh-ancestor
6372976|NCT00134212|Dopamine Agonists|dopamine agonists|mesh-ancestor
6372977|NCT00134212|Dopamine Agents|dopamine agents|mesh-ancestor
6372978|NCT00134290|Metformin|metformin|mesh-list
6372979|NCT00134290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6372980|NCT00134290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372981|NCT00134303|Metformin|metformin|mesh-list
6372982|NCT00134303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6372983|NCT00134303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372984|NCT00134355|Vatalanib|vatalanib|mesh-list
6372985|NCT00134355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6372986|NCT00134355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6372987|NCT00134355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6372988|NCT00134368|Etanercept|etanercept|mesh-list
6372989|NCT00134368|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6372990|NCT00134368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6372991|NCT00134368|Analgesics|analgesics|mesh-ancestor
6372992|NCT00134368|Sensory System Agents|sensory system agents|mesh-ancestor
6372993|NCT00134368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6372994|NCT00134368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6372995|NCT00134368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6372996|NCT00134368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6372997|NCT00134368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6372998|NCT00134368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6372999|NCT00134368|Immunologic Factors|immunologic factors|mesh-ancestor
6373000|NCT00134394|Etanercept|etanercept|mesh-list
6373001|NCT00134394|Tacrolimus|tacrolimus|mesh-list
6373002|NCT00134394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6373003|NCT00134394|Immunologic Factors|immunologic factors|mesh-ancestor
6373004|NCT00134394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373005|NCT00134394|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6373006|NCT00134394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6373007|NCT00134394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6373008|NCT00134394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6373009|NCT00134394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6373010|NCT00134394|Analgesics|analgesics|mesh-ancestor
6373011|NCT00134394|Sensory System Agents|sensory system agents|mesh-ancestor
6373012|NCT00134394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6373013|NCT00134394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6373014|NCT00134394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6373015|NCT00134394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6373016|NCT00134420|Clonidine|clonidine|mesh-list
6373017|NCT00134420|Mitogens|mitogens|mesh-list
6373018|NCT00134420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373019|NCT00134420|Mitosis Modulators|mitosis modulators|mesh-ancestor
6373020|NCT00134420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6373021|NCT00134420|Analgesics|analgesics|mesh-ancestor
6373022|NCT00134420|Sensory System Agents|sensory system agents|mesh-ancestor
6373023|NCT00134420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6373024|NCT00134420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6373025|NCT00134420|Sympatholytics|sympatholytics|mesh-ancestor
6373026|NCT00134420|Autonomic Agents|autonomic agents|mesh-ancestor
6373027|NCT00134420|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6373028|NCT00134420|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6373029|NCT00134420|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6373030|NCT00134420|Adrenergic Agents|adrenergic agents|mesh-ancestor
6373031|NCT00134420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6373032|NCT00134485|Atorvastatin|atorvastatin|mesh-list
6373033|NCT00134485|Torcetrapib|torcetrapib|mesh-list
6373034|NCT00134485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6373035|NCT00134485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6373036|NCT00134485|Antimetabolites|antimetabolites|mesh-ancestor
6373037|NCT00134485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6373038|NCT00134485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6373039|NCT00134485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6373040|NCT00134485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6373041|NCT00134498|Atorvastatin|atorvastatin|mesh-list
6373042|NCT00134498|Torcetrapib|torcetrapib|mesh-list
6373043|NCT00134498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6373044|NCT00134498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6373045|NCT00134498|Antimetabolites|antimetabolites|mesh-ancestor
6373046|NCT00134498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6373047|NCT00134498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6373048|NCT00134498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6373049|NCT00134498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6373050|NCT00134511|Atorvastatin|atorvastatin|mesh-list
6373051|NCT00134511|Torcetrapib|torcetrapib|mesh-list
6373052|NCT00134511|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6373053|NCT00134511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6373054|NCT00134511|Antimetabolites|antimetabolites|mesh-ancestor
6373055|NCT00134511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6373056|NCT00134511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6373057|NCT00134511|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6373058|NCT00134511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6373059|NCT00134550|Atorvastatin|atorvastatin|mesh-list
6373060|NCT00134550|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6373061|NCT00134550|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6373062|NCT00134550|Antimetabolites|antimetabolites|mesh-ancestor
6373063|NCT00134550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6373064|NCT00134550|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6373065|NCT00134550|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6373066|NCT00134550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6373067|NCT00134641|Gemcitabine|gemcitabine|mesh-list
6373068|NCT00134641|Vinorelbine|vinorelbine|mesh-list
6373069|NCT00134641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6373070|NCT00134641|Antimetabolites|antimetabolites|mesh-ancestor
6373071|NCT00134641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6373072|NCT00134641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6373073|NCT00134641|Antiviral Agents|antiviral agents|mesh-ancestor
6373074|NCT00134641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6373075|NCT00134641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6373076|NCT00134641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6373077|NCT00134641|Immunologic Factors|immunologic factors|mesh-ancestor
6373078|NCT00134641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373079|NCT00134641|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6373080|NCT00134641|Tubulin Modulators|tubulin modulators|mesh-ancestor
6373081|NCT00134641|Antimitotic Agents|antimitotic agents|mesh-ancestor
6373082|NCT00134641|Mitosis Modulators|mitosis modulators|mesh-ancestor
6373083|NCT00134654|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6373084|NCT00134654|Estrogens|estrogens|mesh-ancestor
6373085|NCT00134654|Hormones|hormones|mesh-ancestor
6373086|NCT00134654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6373087|NCT00134654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373088|NCT00134667|Verteporfin|verteporfin|mesh-list
6373089|NCT00134667|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6373090|NCT00134667|Dermatologic Agents|dermatologic agents|mesh-ancestor
6373091|NCT00134680|Trastuzumab|trastuzumab|mesh-list
6373092|NCT00134680|Letrozole|letrozole|mesh-list
6373093|NCT00134680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6373094|NCT00134680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6373095|NCT00134680|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6373096|NCT00134680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6373097|NCT00134680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6373098|NCT00134680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6373099|NCT00134680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6373100|NCT00134680|Hormone Antagonists|hormone antagonists|mesh-ancestor
6373101|NCT00134680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6373102|NCT00134680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373103|NCT00134693|Prednisolone|prednisolone|mesh-list
6373104|NCT00134693|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6373105|NCT00134693|Methylprednisolone|methylprednisolone|mesh-list
6373106|NCT00134693|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6373107|NCT00134693|Prednisolone acetate|prednisolone acetate|mesh-list
6373108|NCT00134693|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6373109|NCT00134693|Prednisolone phosphate|prednisolone phosphate|mesh-list
6373110|NCT00134693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6373111|NCT00134693|Glucocorticoids|glucocorticoids|mesh-ancestor
6373112|NCT00134693|Hormones|hormones|mesh-ancestor
6373113|NCT00134693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6373114|NCT00134693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373115|NCT00134693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6373116|NCT00134693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6373117|NCT00134693|Antiemetics|antiemetics|mesh-ancestor
6373118|NCT00134693|Autonomic Agents|autonomic agents|mesh-ancestor
6373119|NCT00134693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6373120|NCT00134693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6373121|NCT00134693|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6373122|NCT00134693|Protective Agents|protective agents|mesh-ancestor
6373123|NCT00134706|Carboplatin|carboplatin|mesh-list
6373124|NCT00134706|Docetaxel|docetaxel|mesh-list
6373125|NCT00134706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6373126|NCT00134706|Tubulin Modulators|tubulin modulators|mesh-ancestor
6373127|NCT00134706|Antimitotic Agents|antimitotic agents|mesh-ancestor
6373128|NCT00134706|Mitosis Modulators|mitosis modulators|mesh-ancestor
6373129|NCT00134706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6373130|NCT00134745|Estradiol|estradiol|mesh-list
6373131|NCT00134745|Estrogens|estrogens|mesh-ancestor
6373132|NCT00134745|Hormones|hormones|mesh-ancestor
6373133|NCT00134745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6373134|NCT00134745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373135|NCT00134758|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
6373136|NCT00134758|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6373137|NCT00134758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6373138|NCT00134810|Botulinum Toxins|botulinum toxins|mesh-list
6373139|NCT00134810|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6373140|NCT00134810|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6373141|NCT00134810|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6373142|NCT00134810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6373143|NCT00134810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6373144|NCT00134810|Cholinergic Agents|cholinergic agents|mesh-ancestor
6373145|NCT00134810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6373146|NCT00134810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373147|NCT00134810|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6373148|NCT00134810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6373149|NCT00134875|Buprenorphine|buprenorphine|mesh-list
6373150|NCT00134875|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6373151|NCT00134875|Naloxone|naloxone|mesh-list
6373152|NCT00134875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6373153|NCT00134875|Narcotics|narcotics|mesh-ancestor
6373154|NCT00134875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6373155|NCT00134875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373156|NCT00134875|Analgesics|analgesics|mesh-ancestor
6373157|NCT00134875|Sensory System Agents|sensory system agents|mesh-ancestor
6373158|NCT00134875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6373159|NCT00134875|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6373160|NCT00134888|Buprenorphine|buprenorphine|mesh-list
6373161|NCT00134888|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6373162|NCT00134888|Naloxone|naloxone|mesh-list
6373163|NCT00134888|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6373164|NCT00134888|Narcotics|narcotics|mesh-ancestor
6373165|NCT00134888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6373166|NCT00134888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373167|NCT00134888|Analgesics|analgesics|mesh-ancestor
6373168|NCT00134888|Sensory System Agents|sensory system agents|mesh-ancestor
6373169|NCT00134888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6373170|NCT00134888|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6373171|NCT00134914|Buprenorphine|buprenorphine|mesh-list
6373172|NCT00134914|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6373173|NCT00134914|Narcotics|narcotics|mesh-ancestor
6373174|NCT00134914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6373175|NCT00134914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373176|NCT00134914|Analgesics|analgesics|mesh-ancestor
6373177|NCT00134914|Sensory System Agents|sensory system agents|mesh-ancestor
6373178|NCT00134914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6373179|NCT00134914|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6373180|NCT00134953|Rivastigmine|rivastigmine|mesh-list
6373181|NCT00134953|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6373182|NCT00134953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6373183|NCT00134953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6373184|NCT00134953|Cholinergic Agents|cholinergic agents|mesh-ancestor
6373185|NCT00134953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6373186|NCT00134953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373187|NCT00134953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6373188|NCT00134953|Protective Agents|protective agents|mesh-ancestor
6373189|NCT00134966|Levodopa|levodopa|mesh-list
6373190|NCT00134966|Carbidopa|carbidopa|mesh-list
6373191|NCT00134966|Entacapone|entacapone|mesh-list
6373192|NCT00134966|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6373193|NCT00134966|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6373194|NCT00134966|Dopamine Agents|dopamine agents|mesh-ancestor
6373195|NCT00134966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6373196|NCT00134966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6373197|NCT00134966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373198|NCT00134966|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6373199|NCT00134966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6373200|NCT00134966|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6373201|NCT00134979|Formoterol Fumarate|formoterol fumarate|mesh-list
6373202|NCT00134979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6373203|NCT00134979|Autonomic Agents|autonomic agents|mesh-ancestor
6373204|NCT00134979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6373205|NCT00134979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373206|NCT00134979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6373207|NCT00134979|Respiratory System Agents|respiratory system agents|mesh-ancestor
6373208|NCT00134979|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6373209|NCT00134979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6373210|NCT00134979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6373211|NCT00134979|Adrenergic Agents|adrenergic agents|mesh-ancestor
6373212|NCT00134979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6373213|NCT00134979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6373214|NCT00134992|Prednisolone|prednisolone|mesh-list
6373215|NCT00134992|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6373216|NCT00134992|Methylprednisolone|methylprednisolone|mesh-list
6373217|NCT00134992|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6373218|NCT00134992|Prednisolone acetate|prednisolone acetate|mesh-list
6373219|NCT00134992|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6373220|NCT00134992|Prednisolone phosphate|prednisolone phosphate|mesh-list
6373221|NCT00134992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6373222|NCT00134992|Glucocorticoids|glucocorticoids|mesh-ancestor
6373223|NCT00134992|Hormones|hormones|mesh-ancestor
6373224|NCT00134992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6373225|NCT00134992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373226|NCT00134992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6373227|NCT00134992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6373228|NCT00134992|Antiemetics|antiemetics|mesh-ancestor
6373229|NCT00134992|Autonomic Agents|autonomic agents|mesh-ancestor
6373230|NCT00134992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6373231|NCT00134992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6373232|NCT00134992|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6373233|NCT00134992|Protective Agents|protective agents|mesh-ancestor
6373234|NCT00135005|Imatinib Mesylate|imatinib mesylate|mesh-list
6373235|NCT00135005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6373236|NCT00135005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6373237|NCT00135005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6373238|NCT00135005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6373239|NCT00135018|Celecoxib|celecoxib|mesh-list
6373240|NCT00135018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6373241|NCT00135018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6373242|NCT00135018|Analgesics|analgesics|mesh-ancestor
6373243|NCT00135018|Sensory System Agents|sensory system agents|mesh-ancestor
6373244|NCT00135018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6373245|NCT00135018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373246|NCT00135018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6373247|NCT00135018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6373248|NCT00135018|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6373249|NCT00135018|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6373250|NCT00135018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6373251|NCT00135018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6373252|NCT00135057|Insulin|insulin|mesh-list
6373253|NCT00135057|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6373254|NCT00135057|Insulin Glargine|insulin glargine|mesh-list
6373255|NCT00135057|Insulin glulisine|insulin glulisine|mesh-list
6373256|NCT00135057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6373257|NCT00135057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373258|NCT00135070|Insulin Detemir|insulin detemir|mesh-list
6373259|NCT00135070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6373260|NCT00135070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373261|NCT00135083|Insulin glulisine|insulin glulisine|mesh-list
6373262|NCT00135083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6373263|NCT00135083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373264|NCT00135096|Insulin|insulin|mesh-list
6373265|NCT00135096|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6373266|NCT00135096|Insulin Glargine|insulin glargine|mesh-list
6373267|NCT00135096|Insulin glulisine|insulin glulisine|mesh-list
6373268|NCT00135096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6373269|NCT00135096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373270|NCT00135122|Prednisolone|prednisolone|mesh-list
6373271|NCT00135122|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6373272|NCT00135122|Methylprednisolone|methylprednisolone|mesh-list
6373273|NCT00135122|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6373274|NCT00135122|Prednisolone acetate|prednisolone acetate|mesh-list
6373275|NCT00135122|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6373276|NCT00135122|Prednisolone phosphate|prednisolone phosphate|mesh-list
6373277|NCT00135122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6373278|NCT00135122|Glucocorticoids|glucocorticoids|mesh-ancestor
6373279|NCT00135122|Hormones|hormones|mesh-ancestor
6373280|NCT00135122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6373281|NCT00135122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373282|NCT00135122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6373283|NCT00135122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6373284|NCT00135122|Antiemetics|antiemetics|mesh-ancestor
6373285|NCT00135122|Autonomic Agents|autonomic agents|mesh-ancestor
6373286|NCT00135122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6373287|NCT00135122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6373288|NCT00135122|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6373289|NCT00135122|Protective Agents|protective agents|mesh-ancestor
6373290|NCT00135135|Carboplatin|carboplatin|mesh-list
6373291|NCT00135135|Doxorubicin|doxorubicin|mesh-list
6373292|NCT00135135|Irinotecan|irinotecan|mesh-list
6373293|NCT00135135|Etoposide|etoposide|mesh-list
6373294|NCT00135135|Melphalan|melphalan|mesh-list
6373295|NCT00135135|Topotecan|topotecan|mesh-list
6373296|NCT00135135|Gefitinib|gefitinib|mesh-list
6373297|NCT00135135|Tretinoin|tretinoin|mesh-list
6373298|NCT00135135|Isotretinoin|isotretinoin|mesh-list
6373299|NCT00135135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6373300|NCT00135135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6373301|NCT00135135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6373302|NCT00135135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6373303|NCT00135135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6373304|NCT00135135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6373305|NCT00135135|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6373306|NCT00135135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6373307|NCT00135135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6373308|NCT00135135|Alkylating Agents|alkylating agents|mesh-ancestor
6373309|NCT00135135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6373310|NCT00135135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6373311|NCT00135135|Immunologic Factors|immunologic factors|mesh-ancestor
6373312|NCT00135135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373313|NCT00135135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6373314|NCT00135135|Keratolytic Agents|keratolytic agents|mesh-ancestor
6373315|NCT00135135|Dermatologic Agents|dermatologic agents|mesh-ancestor
6373316|NCT00135187|Dexamethasone|dexamethasone|mesh-list
6373317|NCT00135187|Bortezomib|bortezomib|mesh-list
6373318|NCT00135187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6373319|NCT00135187|Antiemetics|antiemetics|mesh-ancestor
6373320|NCT00135187|Autonomic Agents|autonomic agents|mesh-ancestor
6373321|NCT00135187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6373322|NCT00135187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373323|NCT00135187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6373324|NCT00135187|Glucocorticoids|glucocorticoids|mesh-ancestor
6373325|NCT00135187|Hormones|hormones|mesh-ancestor
6373326|NCT00135187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6373327|NCT00135187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6373328|NCT00135187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6373329|NCT00135304|Vitamin D|vitamin d|mesh-list
6373330|NCT00135304|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
6017451|NCT00372775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017452|NCT00372775|Growth Inhibitors|growth inhibitors|mesh-ancestor
6017453|NCT00372775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6017454|NCT00372775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6017455|NCT00372775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017456|NCT00372905|Rituximab|rituximab|mesh-list
6017457|NCT00372905|Bortezomib|bortezomib|mesh-list
6017458|NCT00372905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6017459|NCT00372905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6017460|NCT00372905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6017461|NCT00372905|Immunologic Factors|immunologic factors|mesh-ancestor
6017462|NCT00372905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373331|NCT00135304|Cinacalcet|cinacalcet|mesh-list
6373332|NCT00135304|Vitamins|vitamins|mesh-ancestor
6373333|NCT00135304|Micronutrients|micronutrients|mesh-ancestor
6373334|NCT00135304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373335|NCT00135304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6373336|NCT00135304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6373337|NCT00135304|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6373338|NCT00135304|Hormone Antagonists|hormone antagonists|mesh-ancestor
6373339|NCT00135304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6373340|NCT00135317|Darbepoetin alfa|darbepoetin alfa|mesh-list
6373341|NCT00135317|Hematinics|hematinics|mesh-ancestor
6373342|NCT00135408|Budesonide|budesonide|mesh-list
6373343|NCT00135408|Ipilimumab|ipilimumab|mesh-list
6373344|NCT00135408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6373345|NCT00135408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6373346|NCT00135408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6373347|NCT00135408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6373348|NCT00135408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6373349|NCT00135408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6373350|NCT00135408|Autonomic Agents|autonomic agents|mesh-ancestor
6373351|NCT00135408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6373352|NCT00135408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373353|NCT00135408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6373354|NCT00135408|Respiratory System Agents|respiratory system agents|mesh-ancestor
6373355|NCT00135408|Glucocorticoids|glucocorticoids|mesh-ancestor
6373356|NCT00135408|Hormones|hormones|mesh-ancestor
6373357|NCT00135408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6373358|NCT00135434|Ritonavir|ritonavir|mesh-list
6373359|NCT00135434|Lopinavir|lopinavir|mesh-list
6373360|NCT00135434|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6373361|NCT00135434|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6373362|NCT00135434|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6373363|NCT00135434|Protease Inhibitors|protease inhibitors|mesh-ancestor
6373364|NCT00135434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6373365|NCT00135434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6373366|NCT00135434|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6373367|NCT00135434|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6373368|NCT00135434|Antiviral Agents|antiviral agents|mesh-ancestor
6373369|NCT00135434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6373370|NCT00135434|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6373371|NCT00135434|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6373372|NCT00135473|Insulin|insulin|mesh-list
6373373|NCT00135473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6373374|NCT00135473|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
6373375|NCT00135473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6373376|NCT00135473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373377|NCT00135473|Plasma Substitutes|plasma substitutes|mesh-ancestor
6373378|NCT00135473|Blood Substitutes|blood substitutes|mesh-ancestor
6373379|NCT00135499|Prednisone|prednisone|mesh-list
6373380|NCT00135499|Cyclophosphamide|cyclophosphamide|mesh-list
6373381|NCT00135499|Rituximab|rituximab|mesh-list
6373382|NCT00135499|Doxorubicin|doxorubicin|mesh-list
6373383|NCT00135499|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6373384|NCT00135499|Vincristine|vincristine|mesh-list
6373385|NCT00135499|Bleomycin|bleomycin|mesh-list
6373386|NCT00135499|Vindesine|vindesine|mesh-list
6373387|NCT00135499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6373388|NCT00135499|Immunologic Factors|immunologic factors|mesh-ancestor
6373389|NCT00135499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373390|NCT00135499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6373391|NCT00135499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6373392|NCT00135499|Alkylating Agents|alkylating agents|mesh-ancestor
6373393|NCT00135499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6373394|NCT00135499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6373395|NCT00135499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6373396|NCT00135499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6373397|NCT00135499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6373398|NCT00135499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6373399|NCT00135499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6373400|NCT00135499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6373401|NCT00135499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6373402|NCT00135499|Glucocorticoids|glucocorticoids|mesh-ancestor
6373403|NCT00135499|Hormones|hormones|mesh-ancestor
6373404|NCT00135499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6373405|NCT00135499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6373406|NCT00135499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6373407|NCT00135499|Tubulin Modulators|tubulin modulators|mesh-ancestor
6373408|NCT00135499|Antimitotic Agents|antimitotic agents|mesh-ancestor
6373409|NCT00135499|Mitosis Modulators|mitosis modulators|mesh-ancestor
6373410|NCT00135525|Paroxetine|paroxetine|mesh-list
6373411|NCT00135525|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6373412|NCT00135525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6373413|NCT00135525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6373414|NCT00135525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6373415|NCT00135525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6373416|NCT00135525|Serotonin Agents|serotonin agents|mesh-ancestor
6373417|NCT00135525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373418|NCT00135525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6373419|NCT00135525|Antidepressive Agents|antidepressive agents|mesh-ancestor
6373420|NCT00135525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6373421|NCT00135525|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6373422|NCT00135525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6373423|NCT00135525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6373424|NCT00135551|Benidipine|benidipine|mesh-list
6373425|NCT00135551|Diuretics|diuretics|mesh-list
6373426|NCT00135551|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
6373427|NCT00135551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
6373428|NCT00135551|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
6373429|NCT00135551|Natriuretic Agents|natriuretic agents|mesh-ancestor
6373430|NCT00135551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373431|NCT00135551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6373432|NCT00135551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6373433|NCT00135551|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6373434|NCT00135551|Adrenergic Agents|adrenergic agents|mesh-ancestor
6373435|NCT00135551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6373436|NCT00135551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6373437|NCT00135551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6373438|NCT00135551|Vasodilator Agents|vasodilator agents|mesh-ancestor
6373439|NCT00135577|Alvimopan|alvimopan|mesh-list
6373440|NCT00135577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6373441|NCT00135603|Amoxicillin|amoxicillin|mesh-list
6373442|NCT00135603|Clavulanic Acid|clavulanic acid|mesh-list
6373443|NCT00135603|Clavulanic Acids|clavulanic acids|mesh-list
6373444|NCT00135603|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6373445|NCT00135603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6373446|NCT00135603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6373447|NCT00135603|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6373448|NCT00135603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6373449|NCT00135603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395643|NCT00206232|Spironolactone|spironolactone|mesh-list
6395644|NCT00206232|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6395645|NCT00206232|Hormone Antagonists|hormone antagonists|mesh-ancestor
6395646|NCT00206232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6395647|NCT00206232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395648|NCT00206232|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6395649|NCT00206232|Diuretics|diuretics|mesh-ancestor
6395650|NCT00206232|Natriuretic Agents|natriuretic agents|mesh-ancestor
6395651|NCT00206258|Pramlintide|pramlintide|mesh-list
6395652|NCT00206258|Glucagon|glucagon|mesh-list
6395653|NCT00206258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6395654|NCT00206258|Hormones|hormones|mesh-ancestor
6395655|NCT00206258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6395656|NCT00206258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395657|NCT00206258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6395658|NCT00206297|Pramlintide|pramlintide|mesh-list
6395659|NCT00206297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6395660|NCT00206297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395661|NCT00206310|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6373450|NCT00135668|Nitroprusside|nitroprusside|mesh-list
6373451|NCT00135668|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6373452|NCT00135668|Vasodilator Agents|vasodilator agents|mesh-ancestor
6373453|NCT00135668|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6373454|NCT00135668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6373455|NCT00135681|Nedocromil|nedocromil|mesh-list
6373456|NCT00135681|Budesonide|budesonide|mesh-list
6373457|NCT00135681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6373458|NCT00135681|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6373459|NCT00135681|Autonomic Agents|autonomic agents|mesh-ancestor
6373460|NCT00135681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6373461|NCT00135681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373462|NCT00135681|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6373463|NCT00135681|Respiratory System Agents|respiratory system agents|mesh-ancestor
6373464|NCT00135681|Glucocorticoids|glucocorticoids|mesh-ancestor
6373465|NCT00135681|Hormones|hormones|mesh-ancestor
6373466|NCT00135681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6373467|NCT00135681|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
6373468|NCT00135681|Immunologic Factors|immunologic factors|mesh-ancestor
6373469|NCT00135681|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6373470|NCT00135720|Etanercept|etanercept|mesh-list
6373471|NCT00135720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6373472|NCT00135720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6373473|NCT00135720|Analgesics|analgesics|mesh-ancestor
6373474|NCT00135720|Sensory System Agents|sensory system agents|mesh-ancestor
6373475|NCT00135720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6373476|NCT00135720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373477|NCT00135720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6373478|NCT00135720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6373479|NCT00135720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6373480|NCT00135720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6373481|NCT00135720|Immunologic Factors|immunologic factors|mesh-ancestor
6373482|NCT00135733|Alefacept|alefacept|mesh-list
6373483|NCT00135733|Dermatologic Agents|dermatologic agents|mesh-ancestor
6373484|NCT00135733|Immunologic Factors|immunologic factors|mesh-ancestor
6373485|NCT00135733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373486|NCT00135746|Nicotine|nicotine|mesh-list
6373487|NCT00135746|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6373488|NCT00135746|Autonomic Agents|autonomic agents|mesh-ancestor
6373489|NCT00135746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6373490|NCT00135746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373491|NCT00135746|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6373492|NCT00135746|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6373493|NCT00135746|Cholinergic Agents|cholinergic agents|mesh-ancestor
6373494|NCT00135746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6373495|NCT00135746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6373496|NCT00135759|Naltrexone|naltrexone|mesh-list
6373497|NCT00135759|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6373498|NCT00135759|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6373499|NCT00135759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373500|NCT00135759|Sensory System Agents|sensory system agents|mesh-ancestor
6373501|NCT00135759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6373502|NCT00135785|Bupropion|bupropion|mesh-list
6373503|NCT00135785|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6373504|NCT00135785|Antidepressive Agents|antidepressive agents|mesh-ancestor
6373505|NCT00135785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6373506|NCT00135785|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6373507|NCT00135785|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6373508|NCT00135785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6373509|NCT00135785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6373510|NCT00135785|Dopamine Agents|dopamine agents|mesh-ancestor
6373511|NCT00135785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6373512|NCT00135785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373513|NCT00135785|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6373514|NCT00135785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6373515|NCT00135785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6373516|NCT00135811|Cyclosporine|cyclosporine|mesh-list
6373517|NCT00135811|Dexamethasone|dexamethasone|mesh-list
6373518|NCT00135811|Cyclosporins|cyclosporins|mesh-list
6373519|NCT00135811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6373520|NCT00135811|Antiemetics|antiemetics|mesh-ancestor
6373521|NCT00135811|Autonomic Agents|autonomic agents|mesh-ancestor
6373522|NCT00135811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6373523|NCT00135811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373524|NCT00135811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6373525|NCT00135811|Glucocorticoids|glucocorticoids|mesh-ancestor
6373526|NCT00135811|Hormones|hormones|mesh-ancestor
6373527|NCT00135811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6373528|NCT00135811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6373529|NCT00135811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6373530|NCT00135811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6373531|NCT00135811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6373532|NCT00135811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6017463|NCT00372905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6017464|NCT00372970|Botulinum Toxins|botulinum toxins|mesh-list
6017465|NCT00372970|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6373533|NCT00135811|Immunologic Factors|immunologic factors|mesh-ancestor
6373534|NCT00135811|Antifungal Agents|antifungal agents|mesh-ancestor
6373535|NCT00135811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6373536|NCT00135811|Dermatologic Agents|dermatologic agents|mesh-ancestor
6373537|NCT00135811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6373538|NCT00135811|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6373539|NCT00135824|Povidone|povidone|mesh-list
6373540|NCT00135824|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6373541|NCT00135824|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6373542|NCT00135824|Plasma Substitutes|plasma substitutes|mesh-ancestor
6373543|NCT00135824|Blood Substitutes|blood substitutes|mesh-ancestor
6373544|NCT00135837|Verteporfin|verteporfin|mesh-list
6373545|NCT00135837|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6373546|NCT00135837|Dermatologic Agents|dermatologic agents|mesh-ancestor
6373547|NCT00135863|Tinzaparin|tinzaparin|mesh-list
6373548|NCT00135863|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6373549|NCT00135863|Dalteparin|dalteparin|mesh-list
6373550|NCT00135863|Anticoagulants|anticoagulants|mesh-ancestor
6373551|NCT00135863|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6373552|NCT00135863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6373553|NCT00135863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6373554|NCT00135876|Dalteparin|dalteparin|mesh-list
6373555|NCT00135876|Tinzaparin|tinzaparin|mesh-list
6373556|NCT00135876|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6373557|NCT00135876|Anticoagulants|anticoagulants|mesh-ancestor
6373558|NCT00135876|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6373559|NCT00135876|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6373560|NCT00135876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6373561|NCT00135902|Progesterone|progesterone|mesh-list
6373562|NCT00135902|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
6373563|NCT00135902|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
6373564|NCT00135902|Progestins|progestins|mesh-ancestor
6373565|NCT00135902|Hormones|hormones|mesh-ancestor
6373566|NCT00135902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6373567|NCT00135902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373568|NCT00135902|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6373569|NCT00135902|Hormone Antagonists|hormone antagonists|mesh-ancestor
6373570|NCT00135928|Sargramostim|sargramostim|mesh-list
6373571|NCT00135928|Lenograstim|lenograstim|mesh-list
6373572|NCT00135928|Immunologic Factors|immunologic factors|mesh-ancestor
6373573|NCT00135928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373574|NCT00135928|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6373575|NCT00135941|Insulin|insulin|mesh-list
6373576|NCT00135941|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6373577|NCT00135941|Insulin Glargine|insulin glargine|mesh-list
6373578|NCT00135941|Insulin glulisine|insulin glulisine|mesh-list
6373579|NCT00135941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6373580|NCT00135941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373581|NCT00135954|Prednisolone|prednisolone|mesh-list
6373582|NCT00135954|Cyclophosphamide|cyclophosphamide|mesh-list
6373583|NCT00135954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6373584|NCT00135954|Immunologic Factors|immunologic factors|mesh-ancestor
6373585|NCT00135954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373586|NCT00135954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6373587|NCT00135954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6373588|NCT00135954|Alkylating Agents|alkylating agents|mesh-ancestor
6373589|NCT00135954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6373590|NCT00135954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6373591|NCT00135954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6373592|NCT00135954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6373593|NCT00135954|Glucocorticoids|glucocorticoids|mesh-ancestor
6373594|NCT00135954|Hormones|hormones|mesh-ancestor
6373595|NCT00135954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6373596|NCT00135954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6373597|NCT00135967|Mycophenolic Acid|mycophenolic acid|mesh-list
6373598|NCT00135967|Prednisone|prednisone|mesh-list
6373599|NCT00135967|Methylprednisolone|methylprednisolone|mesh-list
6373600|NCT00135967|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6373601|NCT00135967|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6373602|NCT00135967|Prednisolone|prednisolone|mesh-list
6373603|NCT00135967|Prednisolone acetate|prednisolone acetate|mesh-list
6373604|NCT00135967|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6373605|NCT00135967|Prednisolone phosphate|prednisolone phosphate|mesh-list
6373606|NCT00135967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6373607|NCT00135967|Glucocorticoids|glucocorticoids|mesh-ancestor
6373608|NCT00135967|Hormones|hormones|mesh-ancestor
6373609|NCT00135967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6373610|NCT00135967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373611|NCT00135967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6373612|NCT00135967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6373613|NCT00135967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6373614|NCT00135967|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6373615|NCT00135967|Antitubercular Agents|antitubercular agents|mesh-ancestor
6373616|NCT00135967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6373617|NCT00135967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6373618|NCT00135967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6373619|NCT00135967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6373620|NCT00135967|Antiemetics|antiemetics|mesh-ancestor
6373621|NCT00135967|Autonomic Agents|autonomic agents|mesh-ancestor
6373622|NCT00135967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6373623|NCT00135967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6373624|NCT00135967|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6373625|NCT00135967|Protective Agents|protective agents|mesh-ancestor
6373626|NCT00135993|Rotigotine|rotigotine|mesh-list
6373627|NCT00135993|Dopamine Agonists|dopamine agonists|mesh-ancestor
6373628|NCT00135993|Dopamine Agents|dopamine agents|mesh-ancestor
6373629|NCT00135993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6373630|NCT00135993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6373631|NCT00135993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373632|NCT00136045|Rotigotine|rotigotine|mesh-list
6373633|NCT00136045|Dopamine Agonists|dopamine agonists|mesh-ancestor
6373634|NCT00136045|Dopamine Agents|dopamine agents|mesh-ancestor
6373635|NCT00136045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6373636|NCT00136045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6373637|NCT00136045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373638|NCT00136058|Alendronate|alendronate|mesh-list
6373639|NCT00136058|Risedronic Acid|risedronic acid|mesh-list
6373640|NCT00136058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6373641|NCT00136058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373642|NCT00136058|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6373643|NCT00136058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6373644|NCT00136058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6373645|NCT00136058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6373646|NCT00136110|Valproic Acid|valproic acid|mesh-list
6373647|NCT00136110|Anticonvulsants|anticonvulsants|mesh-ancestor
6373648|NCT00136110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6373649|NCT00136110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6373650|NCT00136110|GABA Agents|gaba agents|mesh-ancestor
6373651|NCT00136110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6373652|NCT00136110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373653|NCT00136110|Antimanic Agents|antimanic agents|mesh-ancestor
6373654|NCT00136110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6373655|NCT00136110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6373656|NCT00136110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6373657|NCT00136175|Gemcitabine|gemcitabine|mesh-list
6373658|NCT00136175|Paclitaxel|paclitaxel|mesh-list
6373659|NCT00136175|Carboplatin|carboplatin|mesh-list
6373660|NCT00136175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6373661|NCT00136175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6373662|NCT00136175|Tubulin Modulators|tubulin modulators|mesh-ancestor
6373663|NCT00136175|Antimitotic Agents|antimitotic agents|mesh-ancestor
6373664|NCT00136175|Mitosis Modulators|mitosis modulators|mesh-ancestor
6373665|NCT00136175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6373666|NCT00136175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6373667|NCT00136175|Antimetabolites|antimetabolites|mesh-ancestor
6373668|NCT00136175|Antiviral Agents|antiviral agents|mesh-ancestor
6373669|NCT00136175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6373670|NCT00136175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6373671|NCT00136175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6373672|NCT00136175|Immunologic Factors|immunologic factors|mesh-ancestor
6373673|NCT00136175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373674|NCT00136188|Folic Acid|folic acid|mesh-list
6373675|NCT00136188|Hematinics|hematinics|mesh-ancestor
6373676|NCT00136188|Vitamin B Complex|vitamin b complex|mesh-ancestor
6373677|NCT00136188|Vitamins|vitamins|mesh-ancestor
6373678|NCT00136188|Micronutrients|micronutrients|mesh-ancestor
6373679|NCT00136188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373680|NCT00136201|Tigecycline|tigecycline|mesh-list
6373681|NCT00136201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6373682|NCT00136201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6373683|NCT00136201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6373684|NCT00136201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6373685|NCT00136201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6373686|NCT00136266|Vitamin D|vitamin d|mesh-list
6373687|NCT00136266|Vitamins|vitamins|mesh-list
6373688|NCT00136266|Vitamin A|vitamin a|mesh-list
6373689|NCT00136266|Ferrous fumarate|ferrous fumarate|mesh-list
6373690|NCT00136266|Micronutrients|micronutrients|mesh-ancestor
6373691|NCT00136266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373692|NCT00136266|Trace Elements|trace elements|mesh-ancestor
6373693|NCT00136266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6373694|NCT00136292|Daptomycin|daptomycin|mesh-list
6373695|NCT00136292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6373696|NCT00136292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6373697|NCT00136344|Levofloxacin|levofloxacin|mesh-list
6373698|NCT00136344|Ofloxacin|ofloxacin|mesh-list
6373699|NCT00136344|Cefuroxime|cefuroxime|mesh-list
6373700|NCT00136344|Cefuroxime axetil|cefuroxime axetil|mesh-list
6373701|NCT00136344|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6373702|NCT00136344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6373703|NCT00136344|Renal Agents|renal agents|mesh-ancestor
6373704|NCT00136344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6373705|NCT00136344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6373706|NCT00136344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6373707|NCT00136344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6373708|NCT00136344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6373709|NCT00136344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6373710|NCT00136344|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6373711|NCT00136344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6373712|NCT00136370|Chlorhexidine|chlorhexidine|mesh-list
6373713|NCT00136370|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6373714|NCT00136370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6373715|NCT00136370|Disinfectants|disinfectants|mesh-ancestor
6373716|NCT00136383|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6373717|NCT00136383|Paroxetine|paroxetine|mesh-list
6373718|NCT00136383|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6373719|NCT00136383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6373720|NCT00136383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6373721|NCT00136383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6373722|NCT00136383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6373723|NCT00136383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373724|NCT00136383|Analgesics|analgesics|mesh-ancestor
6373725|NCT00136383|Sensory System Agents|sensory system agents|mesh-ancestor
6373726|NCT00136383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6373727|NCT00136383|Antidepressive Agents|antidepressive agents|mesh-ancestor
6373728|NCT00136383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6373729|NCT00136383|Dopamine Agents|dopamine agents|mesh-ancestor
6373730|NCT00136383|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6017466|NCT00372970|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6373731|NCT00136383|Serotonin Agents|serotonin agents|mesh-ancestor
6373732|NCT00136383|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6373733|NCT00136383|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6373734|NCT00136383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6373735|NCT00136383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6373736|NCT00136396|Rituximab|rituximab|mesh-list
6373737|NCT00136396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6373738|NCT00136396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6373739|NCT00136396|Immunologic Factors|immunologic factors|mesh-ancestor
6373740|NCT00136396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373741|NCT00136396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6373742|NCT00136409|Imatinib Mesylate|imatinib mesylate|mesh-list
6373743|NCT00136409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6373744|NCT00136409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6373745|NCT00136409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6373746|NCT00136409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6373747|NCT00136435|Leucovorin|leucovorin|mesh-list
6373748|NCT00136435|Cytarabine|cytarabine|mesh-list
6373749|NCT00136435|Dexamethasone|dexamethasone|mesh-list
6373750|NCT00136435|Prednisone|prednisone|mesh-list
6373751|NCT00136435|Hydrocortisone|hydrocortisone|mesh-list
6373752|NCT00136435|Doxorubicin|doxorubicin|mesh-list
6373753|NCT00136435|Methotrexate|methotrexate|mesh-list
6373754|NCT00136435|Vincristine|vincristine|mesh-list
6373755|NCT00136435|Asparaginase|asparaginase|mesh-list
6373756|NCT00136435|Mercaptopurine|mercaptopurine|mesh-list
6373757|NCT00136435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6373758|NCT00136435|Antiemetics|antiemetics|mesh-ancestor
6373759|NCT00136435|Autonomic Agents|autonomic agents|mesh-ancestor
6373760|NCT00136435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6373761|NCT00136435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373762|NCT00136435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6373763|NCT00136435|Glucocorticoids|glucocorticoids|mesh-ancestor
6373764|NCT00136435|Hormones|hormones|mesh-ancestor
6373765|NCT00136435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6373766|NCT00136435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6373767|NCT00136435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6373768|NCT00136435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6373769|NCT00136435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6373770|NCT00136435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6373771|NCT00136435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6373772|NCT00136435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6373773|NCT00136435|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6373774|NCT00136435|Abortifacient Agents|abortifacient agents|mesh-ancestor
6373775|NCT00136435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6373776|NCT00136435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6373777|NCT00136435|Antimetabolites|antimetabolites|mesh-ancestor
6373778|NCT00136435|Dermatologic Agents|dermatologic agents|mesh-ancestor
6373779|NCT00136435|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6373780|NCT00136435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6373781|NCT00136435|Immunologic Factors|immunologic factors|mesh-ancestor
6373782|NCT00136435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6373783|NCT00136435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6373784|NCT00136435|Antiviral Agents|antiviral agents|mesh-ancestor
6373785|NCT00136435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6373786|NCT00136435|Antidotes|antidotes|mesh-ancestor
6373787|NCT00136435|Protective Agents|protective agents|mesh-ancestor
6373788|NCT00136435|Vitamin B Complex|vitamin b complex|mesh-ancestor
6373789|NCT00136435|Vitamins|vitamins|mesh-ancestor
6373790|NCT00136435|Micronutrients|micronutrients|mesh-ancestor
6373791|NCT00136435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6373792|NCT00136435|Tubulin Modulators|tubulin modulators|mesh-ancestor
6373793|NCT00136435|Antimitotic Agents|antimitotic agents|mesh-ancestor
6373794|NCT00136435|Mitosis Modulators|mitosis modulators|mesh-ancestor
6373795|NCT00136448|Cytarabine|cytarabine|mesh-list
6373796|NCT00136448|Interleukin-2|interleukin-2|mesh-list
6017467|NCT00372970|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6017468|NCT00372970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6017469|NCT00372970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6373797|NCT00136448|Daunorubicin|daunorubicin|mesh-list
6373798|NCT00136448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6373799|NCT00136448|Antimetabolites|antimetabolites|mesh-ancestor
6373800|NCT00136448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6373801|NCT00136448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6373802|NCT00136448|Antiviral Agents|antiviral agents|mesh-ancestor
6373803|NCT00136448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6373804|NCT00136448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6373805|NCT00136448|Immunologic Factors|immunologic factors|mesh-ancestor
6373806|NCT00136448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373807|NCT00136448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6373808|NCT00136448|Analgesics|analgesics|mesh-ancestor
6373809|NCT00136448|Sensory System Agents|sensory system agents|mesh-ancestor
6373810|NCT00136448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6373811|NCT00136448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6373812|NCT00136448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6373813|NCT00136448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6373814|NCT00136448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6373815|NCT00136461|Tretinoin|tretinoin|mesh-list
6373816|NCT00136461|Bryostatin 1|bryostatin 1|mesh-list
6373817|NCT00136461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6373818|NCT00136461|Keratolytic Agents|keratolytic agents|mesh-ancestor
6373819|NCT00136461|Dermatologic Agents|dermatologic agents|mesh-ancestor
6373820|NCT00136461|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6373821|NCT00136461|Immunologic Factors|immunologic factors|mesh-ancestor
6373822|NCT00136461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373823|NCT00136474|Amifostine|amifostine|mesh-list
6373824|NCT00136474|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6373825|NCT00136474|Protective Agents|protective agents|mesh-ancestor
6373826|NCT00136474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373827|NCT00136487|Celecoxib|celecoxib|mesh-list
6373828|NCT00136487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6373829|NCT00136487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6373830|NCT00136487|Analgesics|analgesics|mesh-ancestor
6373831|NCT00136487|Sensory System Agents|sensory system agents|mesh-ancestor
6373832|NCT00136487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6373833|NCT00136487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373834|NCT00136487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6373835|NCT00136487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6373836|NCT00136487|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6373837|NCT00136487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6373838|NCT00136487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6373839|NCT00136487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6373840|NCT00136526|Docetaxel|docetaxel|mesh-list
6373841|NCT00136526|Fosfestrol|fosfestrol|mesh-list
6373842|NCT00136526|Diethylstilbestrol|diethylstilbestrol|mesh-list
6373843|NCT00136526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6373844|NCT00136526|Tubulin Modulators|tubulin modulators|mesh-ancestor
6373845|NCT00136526|Antimitotic Agents|antimitotic agents|mesh-ancestor
6373846|NCT00136526|Mitosis Modulators|mitosis modulators|mesh-ancestor
6373847|NCT00136526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6373848|NCT00136526|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6373849|NCT00136526|Estrogens|estrogens|mesh-ancestor
6373850|NCT00136526|Hormones|hormones|mesh-ancestor
6373851|NCT00136526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6373852|NCT00136526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373853|NCT00136526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6373854|NCT00136539|Cyclophosphamide|cyclophosphamide|mesh-list
6373855|NCT00136539|Doxorubicin|doxorubicin|mesh-list
6373856|NCT00136539|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6373857|NCT00136539|Trastuzumab|trastuzumab|mesh-list
6373858|NCT00136539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6373859|NCT00136539|Immunologic Factors|immunologic factors|mesh-ancestor
6373860|NCT00136539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373861|NCT00136539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6373862|NCT00136539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6373863|NCT00136539|Alkylating Agents|alkylating agents|mesh-ancestor
6373864|NCT00136539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6373865|NCT00136539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6373866|NCT00136539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6373867|NCT00136539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6373868|NCT00136539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6373869|NCT00136539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6373870|NCT00136539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6373871|NCT00136539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6373872|NCT00136552|Rituximab|rituximab|mesh-list
6373873|NCT00136552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6373874|NCT00136552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6373875|NCT00136552|Immunologic Factors|immunologic factors|mesh-ancestor
6373876|NCT00136552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373877|NCT00136552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6373878|NCT00136565|Prednisone|prednisone|mesh-list
6373879|NCT00136565|Cyclophosphamide|cyclophosphamide|mesh-list
6373880|NCT00136565|Doxorubicin|doxorubicin|mesh-list
6373881|NCT00136565|Bortezomib|bortezomib|mesh-list
6373882|NCT00136565|Bleomycin|bleomycin|mesh-list
6373883|NCT00136565|Vindesine|vindesine|mesh-list
6373884|NCT00136565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6373885|NCT00136565|Immunologic Factors|immunologic factors|mesh-ancestor
6373886|NCT00136565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373887|NCT00136565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6373888|NCT00136565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6373889|NCT00136565|Alkylating Agents|alkylating agents|mesh-ancestor
6373890|NCT00136565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6373891|NCT00136565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6373892|NCT00136565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6373893|NCT00136565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6373894|NCT00136565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6373895|NCT00136565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6373896|NCT00136565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6373897|NCT00136565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6373898|NCT00136565|Glucocorticoids|glucocorticoids|mesh-ancestor
6373899|NCT00136565|Hormones|hormones|mesh-ancestor
6373900|NCT00136565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6373901|NCT00136565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6373902|NCT00136565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6373903|NCT00136565|Tubulin Modulators|tubulin modulators|mesh-ancestor
6373904|NCT00136565|Antimitotic Agents|antimitotic agents|mesh-ancestor
6373905|NCT00136565|Mitosis Modulators|mitosis modulators|mesh-ancestor
6373906|NCT00136578|Carboplatin|carboplatin|mesh-list
6373907|NCT00136578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6373908|NCT00136591|Bortezomib|bortezomib|mesh-list
6373909|NCT00136591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6373910|NCT00136617|Chlordiazepoxide|chlordiazepoxide|mesh-list
6373911|NCT00136617|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6373912|NCT00136617|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6373913|NCT00136617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6373914|NCT00136617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373915|NCT00136617|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6373916|NCT00136617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6373917|NCT00136617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6373918|NCT00136617|GABA Modulators|gaba modulators|mesh-ancestor
6373919|NCT00136617|GABA Agents|gaba agents|mesh-ancestor
6373920|NCT00136617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6373921|NCT00136617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6373922|NCT00136656|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6373923|NCT00136656|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6373924|NCT00136656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6373925|NCT00136656|Antitubercular Agents|antitubercular agents|mesh-ancestor
6373926|NCT00136734|Methylphenidate|methylphenidate|mesh-list
6373927|NCT00136734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6373928|NCT00136734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373929|NCT00136734|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6373930|NCT00136734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6373931|NCT00136734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6373932|NCT00136734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6373933|NCT00136734|Dopamine Agents|dopamine agents|mesh-ancestor
6373934|NCT00136734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6373935|NCT00136747|Memantine|memantine|mesh-list
6373936|NCT00136747|Bupropion|bupropion|mesh-list
6373937|NCT00136747|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6373938|NCT00136747|Antidepressive Agents|antidepressive agents|mesh-ancestor
6373939|NCT00136747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6373940|NCT00136747|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6373941|NCT00136747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6373942|NCT00136747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6373943|NCT00136747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6373944|NCT00136747|Dopamine Agents|dopamine agents|mesh-ancestor
6373945|NCT00136747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6373946|NCT00136747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373947|NCT00136747|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6373948|NCT00136747|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6373949|NCT00136747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6373950|NCT00136747|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6373951|NCT00136747|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6373952|NCT00136747|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6373953|NCT00136747|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6373954|NCT00136773|Amlodipine|amlodipine|mesh-list
6373955|NCT00136773|Benazepril|benazepril|mesh-list
6373956|NCT00136773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6373957|NCT00136773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6373958|NCT00136773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6373959|NCT00136773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6373960|NCT00136773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6373961|NCT00136773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373962|NCT00136773|Vasodilator Agents|vasodilator agents|mesh-ancestor
6373963|NCT00136773|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6373964|NCT00136773|Protease Inhibitors|protease inhibitors|mesh-ancestor
6373965|NCT00136773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6373966|NCT00136786|Memantine|memantine|mesh-list
6373967|NCT00136786|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6373968|NCT00136786|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6373969|NCT00136786|Dopamine Agents|dopamine agents|mesh-ancestor
6373970|NCT00136786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6373971|NCT00136786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6373972|NCT00136786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373973|NCT00136786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6373974|NCT00136786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6373975|NCT00136825|Acetylcysteine|acetylcysteine|mesh-list
6373976|NCT00136825|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6373977|NCT00136825|Antiviral Agents|antiviral agents|mesh-ancestor
6373978|NCT00136825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6373979|NCT00136825|Expectorants|expectorants|mesh-ancestor
6373980|NCT00136825|Respiratory System Agents|respiratory system agents|mesh-ancestor
6373981|NCT00136825|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6373982|NCT00136825|Antioxidants|antioxidants|mesh-ancestor
6373983|NCT00136825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6373984|NCT00136825|Protective Agents|protective agents|mesh-ancestor
6373985|NCT00136825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373986|NCT00136825|Antidotes|antidotes|mesh-ancestor
6373987|NCT00136851|Amlodipine|amlodipine|mesh-list
6373988|NCT00136851|Benazepril|benazepril|mesh-list
6373989|NCT00136851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6373990|NCT00136851|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6373991|NCT00136851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6373992|NCT00136851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6373993|NCT00136851|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6373994|NCT00136851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6373995|NCT00136851|Vasodilator Agents|vasodilator agents|mesh-ancestor
6373996|NCT00136851|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6373997|NCT00136851|Protease Inhibitors|protease inhibitors|mesh-ancestor
6373998|NCT00136851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6373999|NCT00136929|Fibrinolytic Agents|fibrinolytic agents|mesh-list
6374000|NCT00136929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6374001|NCT00136929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374002|NCT00136942|Atorvastatin|atorvastatin|mesh-list
6374003|NCT00136942|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6374004|NCT00136942|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6374005|NCT00136942|Antimetabolites|antimetabolites|mesh-ancestor
6374006|NCT00136942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374007|NCT00136942|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6374008|NCT00136942|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6374009|NCT00136942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6374010|NCT00136968|Voriconazole|voriconazole|mesh-list
6374011|NCT00136968|Antifungal Agents|antifungal agents|mesh-ancestor
6374012|NCT00136968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6374013|NCT00136968|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6374014|NCT00136968|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6374015|NCT00136968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6374016|NCT00136968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374017|NCT00136968|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6374018|NCT00136968|Hormone Antagonists|hormone antagonists|mesh-ancestor
6374019|NCT00136968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6374020|NCT00136968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374021|NCT00136968|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6374022|NCT00136981|Atorvastatin|atorvastatin|mesh-list
6374023|NCT00136981|Torcetrapib|torcetrapib|mesh-list
6374024|NCT00136981|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6374025|NCT00136981|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6374026|NCT00136981|Antimetabolites|antimetabolites|mesh-ancestor
6374027|NCT00136981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374028|NCT00136981|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6374029|NCT00136981|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6374030|NCT00136981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6374031|NCT00136994|Ziprasidone|ziprasidone|mesh-list
6374032|NCT00136994|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6374033|NCT00136994|Serotonin Agents|serotonin agents|mesh-ancestor
6374034|NCT00136994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6374035|NCT00136994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374036|NCT00136994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374037|NCT00136994|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6374038|NCT00136994|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6374039|NCT00136994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6374040|NCT00136994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6374041|NCT00136994|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6374042|NCT00136994|Dopamine Agents|dopamine agents|mesh-ancestor
6374043|NCT00137007|Azithromycin|azithromycin|mesh-list
6374044|NCT00137007|Ampicillin|ampicillin|mesh-list
6374045|NCT00137007|Sulbactam|sulbactam|mesh-list
6374046|NCT00137007|Sultamicillin|sultamicillin|mesh-list
6374047|NCT00137007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6374048|NCT00137007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6374049|NCT00137007|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6374050|NCT00137007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6374051|NCT00137007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374052|NCT00137020|Ziprasidone|ziprasidone|mesh-list
6374053|NCT00137020|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6374054|NCT00137020|Serotonin Agents|serotonin agents|mesh-ancestor
6374055|NCT00137020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6374056|NCT00137020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374057|NCT00137020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374058|NCT00137020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6374059|NCT00137020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6374060|NCT00137020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6374061|NCT00137020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6374062|NCT00137020|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6374063|NCT00137020|Dopamine Agents|dopamine agents|mesh-ancestor
6374064|NCT00137033|Celecoxib|celecoxib|mesh-list
6374065|NCT00137033|Naproxen|naproxen|mesh-list
6374066|NCT00137033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6374067|NCT00137033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6374068|NCT00137033|Analgesics|analgesics|mesh-ancestor
6374069|NCT00137033|Sensory System Agents|sensory system agents|mesh-ancestor
6374070|NCT00137033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6374071|NCT00137033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374072|NCT00137033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6374073|NCT00137033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6374074|NCT00137033|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6374075|NCT00137033|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6374076|NCT00137033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6374077|NCT00137033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374078|NCT00137033|Gout Suppressants|gout suppressants|mesh-ancestor
6374079|NCT00137059|Acetaminophen|acetaminophen|mesh-list
6374080|NCT00137059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6374081|NCT00137059|Analgesics|analgesics|mesh-ancestor
6374082|NCT00137059|Sensory System Agents|sensory system agents|mesh-ancestor
6374083|NCT00137059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6374084|NCT00137059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374085|NCT00137059|Antipyretics|antipyretics|mesh-ancestor
6374086|NCT00137072|Sildenafil Citrate|sildenafil citrate|mesh-list
6374087|NCT00137072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374088|NCT00137072|Vasodilator Agents|vasodilator agents|mesh-ancestor
6374089|NCT00137072|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6374090|NCT00137072|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6374091|NCT00137072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6374092|NCT00137072|Urological Agents|urological agents|mesh-ancestor
6374093|NCT00137085|Ketamine|ketamine|mesh-list
6374094|NCT00137085|Analgesics|analgesics|mesh-ancestor
6374095|NCT00137085|Sensory System Agents|sensory system agents|mesh-ancestor
6374096|NCT00137085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6374097|NCT00137085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374098|NCT00137085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6374099|NCT00137085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6374100|NCT00137085|Anesthetics, General|anesthetics, general|mesh-ancestor
6374101|NCT00137085|Anesthetics|anesthetics|mesh-ancestor
6374102|NCT00137085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6374103|NCT00137085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6374104|NCT00137085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6374105|NCT00137085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6374106|NCT00137085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374107|NCT00137098|Caffeine|caffeine|mesh-list
6374108|NCT00137098|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6374109|NCT00137098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374110|NCT00137098|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6374111|NCT00137098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6374112|NCT00137098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374113|NCT00137098|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6374114|NCT00137098|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6374115|NCT00137098|Purinergic Agents|purinergic agents|mesh-ancestor
6374116|NCT00137098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6395662|NCT00206310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6395663|NCT00206310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6395664|NCT00206310|Antimetabolites|antimetabolites|mesh-ancestor
6395665|NCT00206310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395666|NCT00206310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6395667|NCT00206310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6395668|NCT00206310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6395669|NCT00206388|Cyclophosphamide|cyclophosphamide|mesh-list
6395670|NCT00206388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6395671|NCT00206388|Immunologic Factors|immunologic factors|mesh-ancestor
6395672|NCT00206388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395673|NCT00206388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6395674|NCT00206388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6395675|NCT00206388|Alkylating Agents|alkylating agents|mesh-ancestor
6395676|NCT00206388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395677|NCT00206388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6395678|NCT00206388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6395679|NCT00206401|Insulin Glargine|insulin glargine|mesh-list
6395680|NCT00206401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6395681|NCT00206401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395682|NCT00206414|Gefitinib|gefitinib|mesh-list
6395683|NCT00206414|Fulvestrant|fulvestrant|mesh-list
6395684|NCT00206414|Anastrozole|anastrozole|mesh-list
6395685|NCT00206414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6395686|NCT00206414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6395687|NCT00206414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6395688|NCT00206414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395689|NCT00206414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6395690|NCT00206414|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6395691|NCT00206414|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6395692|NCT00206414|Hormone Antagonists|hormone antagonists|mesh-ancestor
6395693|NCT00206414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6395694|NCT00206414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395695|NCT00206414|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6395696|NCT00206414|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6395697|NCT00206453|Docetaxel|docetaxel|mesh-list
6395698|NCT00206453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6395699|NCT00206453|Tubulin Modulators|tubulin modulators|mesh-ancestor
6395700|NCT00206453|Antimitotic Agents|antimitotic agents|mesh-ancestor
6395701|NCT00206453|Mitosis Modulators|mitosis modulators|mesh-ancestor
6395702|NCT00206453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395703|NCT00206466|Docetaxel|docetaxel|mesh-list
6395704|NCT00206466|Doxorubicin|doxorubicin|mesh-list
6395705|NCT00206466|Cyclophosphamide|cyclophosphamide|mesh-list
6395706|NCT00206466|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6395707|NCT00206466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6395708|NCT00206466|Tubulin Modulators|tubulin modulators|mesh-ancestor
6395709|NCT00206466|Antimitotic Agents|antimitotic agents|mesh-ancestor
6374117|NCT00137202|Diphenhydramine|diphenhydramine|mesh-list
6374118|NCT00137202|Promethazine|promethazine|mesh-list
6374119|NCT00137202|Ondansetron|ondansetron|mesh-list
6374120|NCT00137202|Antiemetics|antiemetics|mesh-ancestor
6374121|NCT00137202|Autonomic Agents|autonomic agents|mesh-ancestor
6374122|NCT00137202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6374123|NCT00137202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374124|NCT00137202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6374125|NCT00137202|Antipruritics|antipruritics|mesh-ancestor
6374126|NCT00137202|Dermatologic Agents|dermatologic agents|mesh-ancestor
6374127|NCT00137202|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6374128|NCT00137202|Serotonin Agents|serotonin agents|mesh-ancestor
6374129|NCT00137202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6374130|NCT00137202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374131|NCT00137202|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6374132|NCT00137202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6374133|NCT00137202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6374134|NCT00137202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6374135|NCT00137202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6374136|NCT00137202|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6374137|NCT00137202|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6374138|NCT00137202|Anesthetics, Local|anesthetics, local|mesh-ancestor
6374139|NCT00137202|Anesthetics|anesthetics|mesh-ancestor
6374140|NCT00137202|Sensory System Agents|sensory system agents|mesh-ancestor
6374141|NCT00137202|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6374142|NCT00137202|Histamine Antagonists|histamine antagonists|mesh-ancestor
6374143|NCT00137202|Histamine Agents|histamine agents|mesh-ancestor
6374144|NCT00137202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6374145|NCT00137254|Insulin|insulin|mesh-list
6374146|NCT00137254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6374147|NCT00137254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374148|NCT00137345|Sirolimus|sirolimus|mesh-list
6374149|NCT00137345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6374150|NCT00137345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6374151|NCT00137345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6374152|NCT00137345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6374153|NCT00137345|Antifungal Agents|antifungal agents|mesh-ancestor
6374154|NCT00137345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6374155|NCT00137345|Immunologic Factors|immunologic factors|mesh-ancestor
6374156|NCT00137345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374157|NCT00137358|Amifostine|amifostine|mesh-list
6374158|NCT00137358|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6374159|NCT00137358|Protective Agents|protective agents|mesh-ancestor
6374160|NCT00137358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374161|NCT00137397|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6374162|NCT00137397|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6374163|NCT00137397|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6374164|NCT00137397|Cholinergic Agents|cholinergic agents|mesh-ancestor
6374165|NCT00137397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6374166|NCT00137397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374167|NCT00137397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374168|NCT00137397|Urological Agents|urological agents|mesh-ancestor
6374169|NCT00137410|Celecoxib|celecoxib|mesh-list
6374170|NCT00137410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6374171|NCT00137410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6374172|NCT00137410|Analgesics|analgesics|mesh-ancestor
6374173|NCT00137410|Sensory System Agents|sensory system agents|mesh-ancestor
6374174|NCT00137410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6374175|NCT00137410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374176|NCT00137410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6374177|NCT00137410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6374178|NCT00137410|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6374179|NCT00137410|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6374180|NCT00137410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6374181|NCT00137410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374182|NCT00137462|Atorvastatin|atorvastatin|mesh-list
6374183|NCT00137462|Torcetrapib|torcetrapib|mesh-list
6374184|NCT00137462|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6374185|NCT00137462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6374186|NCT00137462|Antimetabolites|antimetabolites|mesh-ancestor
6374187|NCT00137462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374188|NCT00137462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6374189|NCT00137462|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6374190|NCT00137462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6374191|NCT00137501|Nifedipine|nifedipine|mesh-list
6374192|NCT00137501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6374193|NCT00137501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6374194|NCT00137501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374195|NCT00137501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6374196|NCT00137501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374197|NCT00137501|Vasodilator Agents|vasodilator agents|mesh-ancestor
6374198|NCT00137501|Tocolytic Agents|tocolytic agents|mesh-ancestor
6374199|NCT00137501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6374200|NCT00137514|Chloroquine|chloroquine|mesh-list
6374201|NCT00137514|Amodiaquine|amodiaquine|mesh-list
6374202|NCT00137514|Amebicides|amebicides|mesh-ancestor
6374203|NCT00137514|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6374204|NCT00137514|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6374205|NCT00137514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6374206|NCT00137514|Antimalarials|antimalarials|mesh-ancestor
6374207|NCT00137514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6374208|NCT00137527|Anesthetics|anesthetics|mesh-list
6374209|NCT00137527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6374210|NCT00137527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374211|NCT00137540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
6374212|NCT00137553|Pyrimethamine|pyrimethamine|mesh-list
6374213|NCT00137553|Sulfadoxine|sulfadoxine|mesh-list
6374214|NCT00137553|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6374215|NCT00137553|Antimalarials|antimalarials|mesh-ancestor
6374216|NCT00137553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6374217|NCT00137553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6374218|NCT00137553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6374219|NCT00137553|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6374220|NCT00137553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6374221|NCT00137553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374222|NCT00137553|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6374223|NCT00137553|Renal Agents|renal agents|mesh-ancestor
6374224|NCT00137566|Acetaminophen|acetaminophen|mesh-list
6374225|NCT00137566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6374226|NCT00137566|Analgesics|analgesics|mesh-ancestor
6374227|NCT00137566|Sensory System Agents|sensory system agents|mesh-ancestor
6374228|NCT00137566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6374229|NCT00137566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374230|NCT00137566|Antipyretics|antipyretics|mesh-ancestor
6374231|NCT00137605|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6374232|NCT00137605|Immunologic Factors|immunologic factors|mesh-ancestor
6374233|NCT00137605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374234|NCT00137657|Trimethoprim|trimethoprim|mesh-list
6374235|NCT00137657|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6374236|NCT00137657|Sulfamethoxazole|sulfamethoxazole|mesh-list
6374237|NCT00137657|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6374238|NCT00137657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6374239|NCT00137657|Renal Agents|renal agents|mesh-ancestor
6374240|NCT00137657|Antimalarials|antimalarials|mesh-ancestor
6374241|NCT00137657|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6374242|NCT00137657|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6374243|NCT00137657|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6374244|NCT00137657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6374245|NCT00137657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374246|NCT00137657|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6374247|NCT00137657|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6374248|NCT00137657|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6374249|NCT00137657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6374250|NCT00137696|Vaccines|vaccines|mesh-list
6374251|NCT00137696|Immunologic Factors|immunologic factors|mesh-ancestor
6374252|NCT00137696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374253|NCT00137709|Lamotrigine|lamotrigine|mesh-list
6374254|NCT00137709|Valproic Acid|valproic acid|mesh-list
6374255|NCT00137709|Anticonvulsants|anticonvulsants|mesh-ancestor
6374256|NCT00137709|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6374257|NCT00137709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6374258|NCT00137709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374259|NCT00137709|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6374260|NCT00137709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374261|NCT00137709|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6374262|NCT00137709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6374263|NCT00137709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6374264|NCT00137709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6374265|NCT00137709|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6374266|NCT00137709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6374267|NCT00137709|GABA Agents|gaba agents|mesh-ancestor
6374268|NCT00137709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6374269|NCT00137709|Antimanic Agents|antimanic agents|mesh-ancestor
6374270|NCT00137735|Gabapentin|gabapentin|mesh-list
6374271|NCT00137735|Analgesics|analgesics|mesh-ancestor
6374272|NCT00137735|Sensory System Agents|sensory system agents|mesh-ancestor
6374273|NCT00137735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6374274|NCT00137735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374275|NCT00137735|Anticonvulsants|anticonvulsants|mesh-ancestor
6374276|NCT00137735|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6374277|NCT00137735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6374278|NCT00137735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6374279|NCT00137735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6374280|NCT00137735|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6374281|NCT00137735|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6374282|NCT00137735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6374283|NCT00137735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374284|NCT00137735|Antimanic Agents|antimanic agents|mesh-ancestor
6374285|NCT00137761|Docetaxel|docetaxel|mesh-list
6374286|NCT00137761|Gefitinib|gefitinib|mesh-list
6374287|NCT00137761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6374288|NCT00137761|Tubulin Modulators|tubulin modulators|mesh-ancestor
6374289|NCT00137761|Antimitotic Agents|antimitotic agents|mesh-ancestor
6374290|NCT00137761|Mitosis Modulators|mitosis modulators|mesh-ancestor
6374291|NCT00137761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374292|NCT00137761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6374293|NCT00137761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6374294|NCT00137774|Bevacizumab|bevacizumab|mesh-list
6374295|NCT00137774|Temozolomide|temozolomide|mesh-list
6374296|NCT00137774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6374297|NCT00137774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6374298|NCT00137774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6374299|NCT00137774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6374300|NCT00137774|Growth Substances|growth substances|mesh-ancestor
6374301|NCT00137774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374302|NCT00137774|Growth Inhibitors|growth inhibitors|mesh-ancestor
6374303|NCT00137774|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6374304|NCT00137774|Alkylating Agents|alkylating agents|mesh-ancestor
6374305|NCT00137774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374306|NCT00137787|Ciprofloxacin|ciprofloxacin|mesh-list
6374307|NCT00137787|Cefepime|cefepime|mesh-list
6374308|NCT00137787|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6374309|NCT00137787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6374310|NCT00137787|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6374311|NCT00137787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6374312|NCT00137787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6374313|NCT00137787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374314|NCT00137787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6374315|NCT00137787|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6374316|NCT00137787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6374317|NCT00137800|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6374318|NCT00137800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6374319|NCT00137800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6374320|NCT00137800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6374321|NCT00137800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374322|NCT00137813|Bevacizumab|bevacizumab|mesh-list
6374323|NCT00137813|Docetaxel|docetaxel|mesh-list
6374324|NCT00137813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6374325|NCT00137813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6374326|NCT00137813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6374327|NCT00137813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6374328|NCT00137813|Growth Substances|growth substances|mesh-ancestor
6374329|NCT00137813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374330|NCT00137813|Growth Inhibitors|growth inhibitors|mesh-ancestor
6374331|NCT00137813|Tubulin Modulators|tubulin modulators|mesh-ancestor
6374332|NCT00137813|Antimitotic Agents|antimitotic agents|mesh-ancestor
6374333|NCT00137813|Mitosis Modulators|mitosis modulators|mesh-ancestor
6374334|NCT00137813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374335|NCT00137826|Bevacizumab|bevacizumab|mesh-list
6374336|NCT00137826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6374337|NCT00137826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6374338|NCT00137826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6374339|NCT00137826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6374340|NCT00137826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6374341|NCT00137826|Growth Substances|growth substances|mesh-ancestor
6374342|NCT00137826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374343|NCT00137826|Growth Inhibitors|growth inhibitors|mesh-ancestor
6374344|NCT00137826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6374345|NCT00137826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6374346|NCT00137826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374347|NCT00137852|Celecoxib|celecoxib|mesh-list
6374348|NCT00137852|Irinotecan|irinotecan|mesh-list
6374349|NCT00137852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6374350|NCT00137852|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6374351|NCT00137852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6374352|NCT00137852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6374353|NCT00137852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374354|NCT00137852|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6374355|NCT00137852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6374356|NCT00137852|Analgesics|analgesics|mesh-ancestor
6374357|NCT00137852|Sensory System Agents|sensory system agents|mesh-ancestor
6374358|NCT00137852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6374359|NCT00137852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374360|NCT00137852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6374361|NCT00137852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6374362|NCT00137852|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6374363|NCT00137852|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6374364|NCT00137995|Cytarabine|cytarabine|mesh-list
6374365|NCT00137995|Dexamethasone|dexamethasone|mesh-list
6374366|NCT00137995|Rituximab|rituximab|mesh-list
6374367|NCT00137995|Etoposide|etoposide|mesh-list
6374368|NCT00137995|Etoposide phosphate|etoposide phosphate|mesh-list
6374369|NCT00137995|Melphalan|melphalan|mesh-list
6374370|NCT00137995|Ifosfamide|ifosfamide|mesh-list
6374371|NCT00137995|Carboplatin|carboplatin|mesh-list
6374372|NCT00137995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6374373|NCT00137995|Antiemetics|antiemetics|mesh-ancestor
6374374|NCT00137995|Autonomic Agents|autonomic agents|mesh-ancestor
6374375|NCT00137995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6017470|NCT00372970|Cholinergic Agents|cholinergic agents|mesh-ancestor
6017471|NCT00372970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6017472|NCT00372970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017473|NCT00372970|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6017474|NCT00372970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6017475|NCT00372996|Fulvestrant|fulvestrant|mesh-list
6017476|NCT00372996|Exemestane|exemestane|mesh-list
6017477|NCT00372996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6017478|NCT00372996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6374376|NCT00137995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374377|NCT00137995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6374378|NCT00137995|Glucocorticoids|glucocorticoids|mesh-ancestor
6374379|NCT00137995|Hormones|hormones|mesh-ancestor
6374380|NCT00137995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6374381|NCT00137995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6374382|NCT00137995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6374383|NCT00137995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6374384|NCT00137995|Immunologic Factors|immunologic factors|mesh-ancestor
6374385|NCT00137995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6374386|NCT00137995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6374387|NCT00137995|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6374388|NCT00137995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6374389|NCT00137995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6374390|NCT00137995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374391|NCT00137995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6374392|NCT00137995|Antimetabolites|antimetabolites|mesh-ancestor
6374393|NCT00137995|Antiviral Agents|antiviral agents|mesh-ancestor
6374394|NCT00137995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6374395|NCT00137995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6374396|NCT00137995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6374397|NCT00137995|Alkylating Agents|alkylating agents|mesh-ancestor
6374398|NCT00137995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6374399|NCT00138060|Fluorouracil|fluorouracil|mesh-list
6374400|NCT00138060|Irinotecan|irinotecan|mesh-list
6374401|NCT00138060|Antimetabolites|antimetabolites|mesh-ancestor
6374402|NCT00138060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374403|NCT00138060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6017479|NCT00372996|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6374404|NCT00138060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6374405|NCT00138060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6374406|NCT00138060|Immunologic Factors|immunologic factors|mesh-ancestor
6374407|NCT00138060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374408|NCT00138060|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6374409|NCT00138060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6374410|NCT00138060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6374411|NCT00138099|Dalteparin|dalteparin|mesh-list
6374412|NCT00138099|Tinzaparin|tinzaparin|mesh-list
6395710|NCT00206466|Mitosis Modulators|mitosis modulators|mesh-ancestor
6017480|NCT00372996|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6374413|NCT00138099|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6374414|NCT00138099|Anticoagulants|anticoagulants|mesh-ancestor
6374415|NCT00138099|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6374416|NCT00138099|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6374417|NCT00138099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374418|NCT00138112|Vancomycin|vancomycin|mesh-list
6374419|NCT00138112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6374420|NCT00138112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6374421|NCT00138138|Methylphenidate|methylphenidate|mesh-list
6374422|NCT00138138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6374423|NCT00138138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374424|NCT00138138|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6374425|NCT00138138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6374426|NCT00138138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6374427|NCT00138138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374428|NCT00138138|Dopamine Agents|dopamine agents|mesh-ancestor
6374429|NCT00138138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6374430|NCT00138164|Denileukin diftitox|denileukin diftitox|mesh-list
6374431|NCT00138164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6374432|NCT00138177|Leucovorin|leucovorin|mesh-list
6374433|NCT00138177|Fluorouracil|fluorouracil|mesh-list
6374434|NCT00138177|Oxaliplatin|oxaliplatin|mesh-list
6374435|NCT00138177|Vorinostat|vorinostat|mesh-list
6374436|NCT00138177|Calcium|calcium|mesh-list
6374437|NCT00138177|Levoleucovorin|levoleucovorin|mesh-list
6374438|NCT00138177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6374439|NCT00138177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374440|NCT00138177|Antimetabolites|antimetabolites|mesh-ancestor
6374441|NCT00138177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374442|NCT00138177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6374443|NCT00138177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6374444|NCT00138177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6374445|NCT00138177|Immunologic Factors|immunologic factors|mesh-ancestor
6374446|NCT00138177|Antidotes|antidotes|mesh-ancestor
6374447|NCT00138177|Protective Agents|protective agents|mesh-ancestor
6374448|NCT00138177|Vitamin B Complex|vitamin b complex|mesh-ancestor
6374449|NCT00138177|Vitamins|vitamins|mesh-ancestor
6374450|NCT00138177|Micronutrients|micronutrients|mesh-ancestor
6374451|NCT00138177|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6374452|NCT00138177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6374453|NCT00138216|Irinotecan|irinotecan|mesh-list
6374454|NCT00138216|Vincristine|vincristine|mesh-list
6374455|NCT00138216|Temozolomide|temozolomide|mesh-list
6374456|NCT00138216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6374457|NCT00138216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6374458|NCT00138216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6374459|NCT00138216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374460|NCT00138216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6374461|NCT00138216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6374462|NCT00138216|Tubulin Modulators|tubulin modulators|mesh-ancestor
6374463|NCT00138216|Antimitotic Agents|antimitotic agents|mesh-ancestor
6374464|NCT00138216|Mitosis Modulators|mitosis modulators|mesh-ancestor
6374465|NCT00138216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6374466|NCT00138216|Alkylating Agents|alkylating agents|mesh-ancestor
6374467|NCT00138229|Aldesleukin|aldesleukin|mesh-list
6374468|NCT00138229|Cyclophosphamide|cyclophosphamide|mesh-list
6374469|NCT00138229|Fludarabine|fludarabine|mesh-list
6374470|NCT00138229|Fludarabine phosphate|fludarabine phosphate|mesh-list
6374471|NCT00138229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6374472|NCT00138229|Immunologic Factors|immunologic factors|mesh-ancestor
6374473|NCT00138229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374474|NCT00138229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6374475|NCT00138229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6374476|NCT00138229|Alkylating Agents|alkylating agents|mesh-ancestor
6397037|NCT00209963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6374477|NCT00138229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374478|NCT00138229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6374479|NCT00138229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6374480|NCT00138229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6374481|NCT00138229|Antimetabolites|antimetabolites|mesh-ancestor
6374482|NCT00138229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6374483|NCT00138229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6374484|NCT00138229|Antiviral Agents|antiviral agents|mesh-ancestor
6374485|NCT00138229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6374486|NCT00138242|Carboplatin|carboplatin|mesh-list
6374487|NCT00138242|Docetaxel|docetaxel|mesh-list
6374488|NCT00138242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6374489|NCT00138242|Tubulin Modulators|tubulin modulators|mesh-ancestor
6374490|NCT00138242|Antimitotic Agents|antimitotic agents|mesh-ancestor
6374491|NCT00138242|Mitosis Modulators|mitosis modulators|mesh-ancestor
6374492|NCT00138242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374493|NCT00138359|Niclosamide|niclosamide|mesh-list
6374494|NCT00138359|Anticestodal Agents|anticestodal agents|mesh-ancestor
6374495|NCT00138359|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6374496|NCT00138359|Anthelmintics|anthelmintics|mesh-ancestor
6374497|NCT00138359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6374498|NCT00138359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6374499|NCT00138359|Antinematodal Agents|antinematodal agents|mesh-ancestor
6374500|NCT00138411|Ciprofloxacin|ciprofloxacin|mesh-list
6374501|NCT00138411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6374502|NCT00138411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6374503|NCT00138411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6374504|NCT00138411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6374505|NCT00138411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6374506|NCT00138411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374507|NCT00138411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6374508|NCT00138411|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6374509|NCT00138411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6374510|NCT00138515|Vildagliptin|vildagliptin|mesh-list
6374511|NCT00138515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6374512|NCT00138515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374513|NCT00138515|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6374514|NCT00138515|Protease Inhibitors|protease inhibitors|mesh-ancestor
6374515|NCT00138515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6374516|NCT00138515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374517|NCT00138541|Vildagliptin|vildagliptin|mesh-list
6374518|NCT00138541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6374519|NCT00138541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374520|NCT00138541|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6374521|NCT00138541|Protease Inhibitors|protease inhibitors|mesh-ancestor
6374522|NCT00138541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6374523|NCT00138541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374524|NCT00138554|Pioglitazone|pioglitazone|mesh-list
6374525|NCT00138554|Vildagliptin|vildagliptin|mesh-list
6374526|NCT00138554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6374527|NCT00138554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374528|NCT00138554|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6374529|NCT00138554|Protease Inhibitors|protease inhibitors|mesh-ancestor
6374530|NCT00138554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6374531|NCT00138554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374532|NCT00138567|Vildagliptin|vildagliptin|mesh-list
6374533|NCT00138567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6374534|NCT00138567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374535|NCT00138567|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6374536|NCT00138567|Protease Inhibitors|protease inhibitors|mesh-ancestor
6374537|NCT00138567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6374538|NCT00138567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374539|NCT00138580|Vildagliptin|vildagliptin|mesh-list
6374540|NCT00138580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6374541|NCT00138580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374542|NCT00138580|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6374543|NCT00138580|Protease Inhibitors|protease inhibitors|mesh-ancestor
6374544|NCT00138580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6374545|NCT00138580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374546|NCT00138593|Vildagliptin|vildagliptin|mesh-list
6374547|NCT00138593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6374548|NCT00138593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374549|NCT00138593|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6374550|NCT00138593|Protease Inhibitors|protease inhibitors|mesh-ancestor
6374551|NCT00138593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6374552|NCT00138593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374553|NCT00138606|Vildagliptin|vildagliptin|mesh-list
6374554|NCT00138606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6374555|NCT00138606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374556|NCT00138606|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6374557|NCT00138606|Protease Inhibitors|protease inhibitors|mesh-ancestor
6374558|NCT00138606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6374559|NCT00138606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374560|NCT00138619|Vildagliptin|vildagliptin|mesh-list
6374561|NCT00138619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6374562|NCT00138619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374563|NCT00138619|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6374564|NCT00138619|Protease Inhibitors|protease inhibitors|mesh-ancestor
6374565|NCT00138619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6374566|NCT00138619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374567|NCT00138632|Vatalanib|vatalanib|mesh-list
6374568|NCT00138632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6374569|NCT00138632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6374570|NCT00138632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395711|NCT00206466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374571|NCT00138710|Letrozole|letrozole|mesh-list
6374572|NCT00138710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6374573|NCT00138710|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6374574|NCT00138710|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6374575|NCT00138710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6374576|NCT00138710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374577|NCT00138710|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6374578|NCT00138710|Hormone Antagonists|hormone antagonists|mesh-ancestor
6374579|NCT00138710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6374580|NCT00138710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374581|NCT00138736|Lectins|lectins|mesh-list
6374582|NCT00138736|Agglutinins|agglutinins|mesh-ancestor
6374583|NCT00138736|Immunologic Factors|immunologic factors|mesh-ancestor
6374584|NCT00138736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374585|NCT00138736|Coagulants|coagulants|mesh-ancestor
6374586|NCT00138801|Doxycycline|doxycycline|mesh-list
6374587|NCT00138801|Ceftriaxone|ceftriaxone|mesh-list
6374588|NCT00138801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6374589|NCT00138801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6374590|NCT00138801|Antimalarials|antimalarials|mesh-ancestor
6374591|NCT00138801|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6374592|NCT00138801|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6374593|NCT00138866|Risedronic Acid|risedronic acid|mesh-list
6374594|NCT00138866|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6374595|NCT00138866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6374596|NCT00138866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374597|NCT00138866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6374598|NCT00138866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374599|NCT00138866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6374600|NCT00138944|Eplerenone|eplerenone|mesh-list
6374601|NCT00138944|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6374602|NCT00138944|Hormone Antagonists|hormone antagonists|mesh-ancestor
6374603|NCT00138944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6374604|NCT00138944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374605|NCT00138944|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6374606|NCT00138944|Diuretics|diuretics|mesh-ancestor
6374607|NCT00138944|Natriuretic Agents|natriuretic agents|mesh-ancestor
6374608|NCT00138944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6374609|NCT00138970|Mycophenolic Acid|mycophenolic acid|mesh-list
6374610|NCT00138970|Cyclosporine|cyclosporine|mesh-list
6374611|NCT00138970|Prednisolone|prednisolone|mesh-list
6374612|NCT00138970|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6374613|NCT00138970|Methylprednisolone|methylprednisolone|mesh-list
6374614|NCT00138970|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6374615|NCT00138970|Prednisolone acetate|prednisolone acetate|mesh-list
6374616|NCT00138970|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6374617|NCT00138970|Prednisolone phosphate|prednisolone phosphate|mesh-list
6374618|NCT00138970|Daclizumab|daclizumab|mesh-list
6374619|NCT00138970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6374620|NCT00138970|Glucocorticoids|glucocorticoids|mesh-ancestor
6374621|NCT00138970|Hormones|hormones|mesh-ancestor
6374622|NCT00138970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6374623|NCT00138970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374624|NCT00138970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6374625|NCT00138970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6374626|NCT00138970|Antiemetics|antiemetics|mesh-ancestor
6374627|NCT00138970|Autonomic Agents|autonomic agents|mesh-ancestor
6374628|NCT00138970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6374629|NCT00138970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6374630|NCT00138970|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6374631|NCT00138970|Protective Agents|protective agents|mesh-ancestor
6374632|NCT00138970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6374633|NCT00138970|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6374634|NCT00138970|Antitubercular Agents|antitubercular agents|mesh-ancestor
6374635|NCT00138970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6374636|NCT00138970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6374637|NCT00138970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6374638|NCT00138970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374639|NCT00138970|Antifungal Agents|antifungal agents|mesh-ancestor
6374640|NCT00138970|Dermatologic Agents|dermatologic agents|mesh-ancestor
6374641|NCT00138970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6374642|NCT00138970|Immunologic Factors|immunologic factors|mesh-ancestor
6374643|NCT00138970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6374644|NCT00138970|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6374645|NCT00138983|Vitamin D|vitamin d|mesh-list
6374646|NCT00138983|Alendronate|alendronate|mesh-list
6374647|NCT00138983|Alfacalcidol|alfacalcidol|mesh-list
6374648|NCT00138983|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
6374649|NCT00138983|Vitamins|vitamins|mesh-ancestor
6374650|NCT00138983|Micronutrients|micronutrients|mesh-ancestor
6374651|NCT00138983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374652|NCT00138983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6374653|NCT00139009|Cyclosporine|cyclosporine|mesh-list
6374654|NCT00139009|Cyclosporins|cyclosporins|mesh-list
6374655|NCT00139009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6374656|NCT00139009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374657|NCT00139009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6374658|NCT00139009|Immunologic Factors|immunologic factors|mesh-ancestor
6374659|NCT00139009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374660|NCT00139009|Antifungal Agents|antifungal agents|mesh-ancestor
6374661|NCT00139009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6374662|NCT00139009|Dermatologic Agents|dermatologic agents|mesh-ancestor
6374663|NCT00139009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6374664|NCT00139009|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6374665|NCT00139035|Cyclosporine|cyclosporine|mesh-list
6374666|NCT00139035|Cyclosporins|cyclosporins|mesh-list
6374667|NCT00139035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6374668|NCT00139035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374669|NCT00139035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6374670|NCT00139035|Immunologic Factors|immunologic factors|mesh-ancestor
6374671|NCT00139035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374672|NCT00139035|Antifungal Agents|antifungal agents|mesh-ancestor
6374673|NCT00139035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6374674|NCT00139035|Dermatologic Agents|dermatologic agents|mesh-ancestor
6374675|NCT00139035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6374676|NCT00139035|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6374677|NCT00139061|Atorvastatin|atorvastatin|mesh-list
6374678|NCT00139061|Torcetrapib|torcetrapib|mesh-list
6374679|NCT00139061|Fenofibrate|fenofibrate|mesh-list
6374680|NCT00139061|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6374681|NCT00139061|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6374682|NCT00139061|Antimetabolites|antimetabolites|mesh-ancestor
6374683|NCT00139061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374684|NCT00139061|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6374685|NCT00139061|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6374686|NCT00139061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6374687|NCT00139074|Valproic Acid|valproic acid|mesh-list
6374688|NCT00139074|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6374689|NCT00139074|Antidepressive Agents|antidepressive agents|mesh-ancestor
6374690|NCT00139074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6374691|NCT00139074|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6374692|NCT00139074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6374693|NCT00139074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6374694|NCT00139074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374695|NCT00139074|Anticonvulsants|anticonvulsants|mesh-ancestor
6374696|NCT00139074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6374697|NCT00139074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374698|NCT00139074|GABA Agents|gaba agents|mesh-ancestor
6374699|NCT00139074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6374700|NCT00139074|Antimanic Agents|antimanic agents|mesh-ancestor
6374701|NCT00139100|Anti-Infective Agents|anti-infective agents|mesh-list
6374702|NCT00139100|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6374703|NCT00139152|Omalizumab|omalizumab|mesh-list
6374704|NCT00139152|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6374705|NCT00139152|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6374706|NCT00139152|Respiratory System Agents|respiratory system agents|mesh-ancestor
6374707|NCT00139165|Budesonide|budesonide|mesh-list
6374708|NCT00139165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6374709|NCT00139165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6374710|NCT00139165|Autonomic Agents|autonomic agents|mesh-ancestor
6374711|NCT00139165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6374712|NCT00139165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374713|NCT00139165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6374714|NCT00139165|Respiratory System Agents|respiratory system agents|mesh-ancestor
6374715|NCT00139165|Glucocorticoids|glucocorticoids|mesh-ancestor
6374716|NCT00139165|Hormones|hormones|mesh-ancestor
6374717|NCT00139165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6374718|NCT00139204|Carbon-11 methionine|carbon-11 methionine|mesh-list
6374719|NCT00139204|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6374720|NCT00139204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374721|NCT00139217|Nitric Oxide|nitric oxide|mesh-list
6374722|NCT00139217|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6374723|NCT00139217|Autonomic Agents|autonomic agents|mesh-ancestor
6374724|NCT00139217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6374725|NCT00139217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374726|NCT00139217|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6374727|NCT00139217|Respiratory System Agents|respiratory system agents|mesh-ancestor
6374728|NCT00139217|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6374729|NCT00139217|Antioxidants|antioxidants|mesh-ancestor
6374730|NCT00139217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374731|NCT00139217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6374732|NCT00139217|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6374733|NCT00139217|Vasodilator Agents|vasodilator agents|mesh-ancestor
6374734|NCT00139217|Gasotransmitters|gasotransmitters|mesh-ancestor
6374735|NCT00139217|Protective Agents|protective agents|mesh-ancestor
6374736|NCT00139230|Leucovorin|leucovorin|mesh-list
6374737|NCT00139230|Ciprofloxacin|ciprofloxacin|mesh-list
6374738|NCT00139230|Fluorouracil|fluorouracil|mesh-list
6374739|NCT00139230|Docetaxel|docetaxel|mesh-list
6374740|NCT00139230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6374741|NCT00139230|Antimetabolites|antimetabolites|mesh-ancestor
6374742|NCT00139230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374743|NCT00139230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6374744|NCT00139230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6374745|NCT00139230|Immunologic Factors|immunologic factors|mesh-ancestor
6374746|NCT00139230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374747|NCT00139230|Antidotes|antidotes|mesh-ancestor
6374748|NCT00139230|Protective Agents|protective agents|mesh-ancestor
6374749|NCT00139230|Vitamin B Complex|vitamin b complex|mesh-ancestor
6374750|NCT00139230|Vitamins|vitamins|mesh-ancestor
6374751|NCT00139230|Micronutrients|micronutrients|mesh-ancestor
6374752|NCT00139230|Tubulin Modulators|tubulin modulators|mesh-ancestor
6374753|NCT00139230|Antimitotic Agents|antimitotic agents|mesh-ancestor
6374754|NCT00139230|Mitosis Modulators|mitosis modulators|mesh-ancestor
6374755|NCT00139230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6374756|NCT00139230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6374757|NCT00139230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6374758|NCT00139230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6374759|NCT00139230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6374760|NCT00139230|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6374761|NCT00139230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6374762|NCT00139243|Leucovorin|leucovorin|mesh-list
6374763|NCT00139243|Fluorouracil|fluorouracil|mesh-list
6374764|NCT00139243|Docetaxel|docetaxel|mesh-list
6374765|NCT00139243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6374766|NCT00139243|Antimetabolites|antimetabolites|mesh-ancestor
6374767|NCT00139243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374768|NCT00139243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6374769|NCT00139243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6374770|NCT00139243|Immunologic Factors|immunologic factors|mesh-ancestor
6374771|NCT00139243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374772|NCT00139243|Antidotes|antidotes|mesh-ancestor
6374773|NCT00139243|Protective Agents|protective agents|mesh-ancestor
6374774|NCT00139243|Vitamin B Complex|vitamin b complex|mesh-ancestor
6374775|NCT00139243|Vitamins|vitamins|mesh-ancestor
6374776|NCT00139243|Micronutrients|micronutrients|mesh-ancestor
6374777|NCT00139243|Tubulin Modulators|tubulin modulators|mesh-ancestor
6374778|NCT00139243|Antimitotic Agents|antimitotic agents|mesh-ancestor
6374779|NCT00139243|Mitosis Modulators|mitosis modulators|mesh-ancestor
6374780|NCT00139256|Betamethasone|betamethasone|mesh-list
6374781|NCT00139256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6374782|NCT00139256|Glucocorticoids|glucocorticoids|mesh-ancestor
6374783|NCT00139256|Hormones|hormones|mesh-ancestor
6374784|NCT00139256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6374785|NCT00139256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374786|NCT00139256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6374787|NCT00139256|Respiratory System Agents|respiratory system agents|mesh-ancestor
6374788|NCT00139269|Docetaxel|docetaxel|mesh-list
6374789|NCT00139269|Fluorouracil|fluorouracil|mesh-list
6374790|NCT00139269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6374791|NCT00139269|Tubulin Modulators|tubulin modulators|mesh-ancestor
6374792|NCT00139269|Antimitotic Agents|antimitotic agents|mesh-ancestor
6374793|NCT00139269|Mitosis Modulators|mitosis modulators|mesh-ancestor
6374794|NCT00139269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374795|NCT00139269|Antimetabolites|antimetabolites|mesh-ancestor
6374796|NCT00139269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6374797|NCT00139269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6374798|NCT00139269|Immunologic Factors|immunologic factors|mesh-ancestor
6374799|NCT00139269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374800|NCT00139282|Squalamine|squalamine|mesh-list
6374801|NCT00139282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6374802|NCT00139282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6374803|NCT00139282|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6374804|NCT00139282|Protective Agents|protective agents|mesh-ancestor
6374805|NCT00139282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374806|NCT00139282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6374807|NCT00139282|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6374808|NCT00139282|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6374809|NCT00139282|Growth Substances|growth substances|mesh-ancestor
6374810|NCT00139282|Growth Inhibitors|growth inhibitors|mesh-ancestor
6374811|NCT00139360|Bevacizumab|bevacizumab|mesh-list
6374812|NCT00139360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6374813|NCT00139360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6374814|NCT00139360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6374815|NCT00139360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6374816|NCT00139360|Growth Substances|growth substances|mesh-ancestor
6374817|NCT00139360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374818|NCT00139360|Growth Inhibitors|growth inhibitors|mesh-ancestor
6374819|NCT00139373|Donepezil|donepezil|mesh-list
6374820|NCT00139373|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6374821|NCT00139373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6374822|NCT00139373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374823|NCT00139373|Cholinergic Agents|cholinergic agents|mesh-ancestor
6374824|NCT00139373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6374825|NCT00139373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374826|NCT00139373|Nootropic Agents|nootropic agents|mesh-ancestor
6374827|NCT00139386|Candesartan|candesartan|mesh-list
6374828|NCT00139386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6374829|NCT00139386|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6374830|NCT00139386|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6374831|NCT00139386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374832|NCT00139516|Nicotine|nicotine|mesh-list
6374833|NCT00139516|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6374834|NCT00139516|Autonomic Agents|autonomic agents|mesh-ancestor
6374835|NCT00139516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6374836|NCT00139516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374837|NCT00139516|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6374838|NCT00139516|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6374839|NCT00139516|Cholinergic Agents|cholinergic agents|mesh-ancestor
6374840|NCT00139516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6374841|NCT00139516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374842|NCT00139555|Amlodipine|amlodipine|mesh-list
6374843|NCT00139555|Benazepril|benazepril|mesh-list
6374844|NCT00139555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6374845|NCT00139555|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6374846|NCT00139555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6374847|NCT00139555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374848|NCT00139555|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6374849|NCT00139555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374850|NCT00139555|Vasodilator Agents|vasodilator agents|mesh-ancestor
6374851|NCT00139555|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6374852|NCT00139555|Protease Inhibitors|protease inhibitors|mesh-ancestor
6374853|NCT00139555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6374854|NCT00139568|Tegaserod|tegaserod|mesh-list
6374855|NCT00139568|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6374856|NCT00139568|Serotonin Agents|serotonin agents|mesh-ancestor
6374857|NCT00139568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6374858|NCT00139568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374859|NCT00139568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374860|NCT00139581|Pimecrolimus|pimecrolimus|mesh-list
6374861|NCT00139581|Tacrolimus|tacrolimus|mesh-list
6374862|NCT00139581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6374863|NCT00139581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6374864|NCT00139581|Analgesics|analgesics|mesh-ancestor
6374865|NCT00139581|Sensory System Agents|sensory system agents|mesh-ancestor
6374866|NCT00139581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6374867|NCT00139581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374868|NCT00139581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6374869|NCT00139581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6374870|NCT00139581|Dermatologic Agents|dermatologic agents|mesh-ancestor
6374871|NCT00139581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6374872|NCT00139581|Immunologic Factors|immunologic factors|mesh-ancestor
6374873|NCT00139581|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6374874|NCT00139581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6374875|NCT00139581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374876|NCT00139620|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6374877|NCT00139620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6374878|NCT00139620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6374879|NCT00139620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6374880|NCT00139620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374881|NCT00139633|Carboplatin|carboplatin|mesh-list
6374882|NCT00139633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6374883|NCT00139646|Diclofenac|diclofenac|mesh-list
6374884|NCT00139646|Parecoxib|parecoxib|mesh-list
6374885|NCT00139646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6374886|NCT00139646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6374887|NCT00139646|Analgesics|analgesics|mesh-ancestor
6374888|NCT00139646|Sensory System Agents|sensory system agents|mesh-ancestor
6374889|NCT00139646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6374890|NCT00139646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374891|NCT00139646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6374892|NCT00139646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6374893|NCT00139646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6374894|NCT00139646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6374895|NCT00139646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374896|NCT00139646|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6374897|NCT00139685|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6374898|NCT00139685|Contraceptive Agents|contraceptive agents|mesh-list
6374899|NCT00139685|Medroxyprogesterone|medroxyprogesterone|mesh-list
6374900|NCT00139685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6374901|NCT00139685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374902|NCT00139685|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6374903|NCT00139685|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6374904|NCT00139685|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6374905|NCT00139685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6374906|NCT00139685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6374907|NCT00139685|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6374908|NCT00139685|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6374909|NCT00139685|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6374910|NCT00139698|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6374911|NCT00139698|Olmesartan|olmesartan|mesh-list
6374912|NCT00139698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6374913|NCT00139698|Diuretics|diuretics|mesh-ancestor
6374914|NCT00139698|Natriuretic Agents|natriuretic agents|mesh-ancestor
6374915|NCT00139698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374916|NCT00139698|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6374917|NCT00139698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6374918|NCT00139698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374919|NCT00139698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6374920|NCT00139698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6374921|NCT00139711|Docetaxel|docetaxel|mesh-list
6374922|NCT00139711|Irinotecan|irinotecan|mesh-list
6374923|NCT00139711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6374924|NCT00139711|Tubulin Modulators|tubulin modulators|mesh-ancestor
6374925|NCT00139711|Antimitotic Agents|antimitotic agents|mesh-ancestor
6374926|NCT00139711|Mitosis Modulators|mitosis modulators|mesh-ancestor
6374927|NCT00139711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374928|NCT00139711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6374929|NCT00139711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6374930|NCT00139711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6374931|NCT00139724|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6374932|NCT00139724|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6374933|NCT00139724|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6374934|NCT00139724|Cholinergic Agents|cholinergic agents|mesh-ancestor
6374935|NCT00139724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6374936|NCT00139724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374937|NCT00139724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374938|NCT00139724|Urological Agents|urological agents|mesh-ancestor
6374939|NCT00139750|Varenicline|varenicline|mesh-list
6374940|NCT00139750|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6374941|NCT00139750|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6374942|NCT00139750|Cholinergic Agents|cholinergic agents|mesh-ancestor
6374943|NCT00139750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6374944|NCT00139750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374945|NCT00139750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374946|NCT00139815|Enoxaparin|enoxaparin|mesh-list
6374947|NCT00139815|PENTA|penta|mesh-list
6374948|NCT00139815|Fondaparinux|fondaparinux|mesh-list
6374949|NCT00139815|Anticoagulants|anticoagulants|mesh-ancestor
6374950|NCT00139815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6374951|NCT00139815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6374952|NCT00139815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374953|NCT00139815|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6374954|NCT00139815|Antithrombins|antithrombins|mesh-ancestor
6374955|NCT00139815|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6374956|NCT00139815|Protease Inhibitors|protease inhibitors|mesh-ancestor
6374957|NCT00139815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6374958|NCT00139841|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6374959|NCT00139841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6374960|NCT00139841|Alkylating Agents|alkylating agents|mesh-ancestor
6374961|NCT00139841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374962|NCT00139841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6374963|NCT00139854|Alprazolam|alprazolam|mesh-list
6374964|NCT00139854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6374965|NCT00139854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6374966|NCT00139854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374967|NCT00139854|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6374968|NCT00139854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6374969|NCT00139854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6374970|NCT00139854|GABA Modulators|gaba modulators|mesh-ancestor
6374971|NCT00139854|GABA Agents|gaba agents|mesh-ancestor
6374972|NCT00139854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6374973|NCT00139854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374974|NCT00139867|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
6374975|NCT00139867|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6374976|NCT00139867|Immunologic Factors|immunologic factors|mesh-ancestor
6374977|NCT00139867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374978|NCT00139867|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6374979|NCT00139867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6374980|NCT00139867|Dopamine Agonists|dopamine agonists|mesh-ancestor
6374981|NCT00139867|Dopamine Agents|dopamine agents|mesh-ancestor
6374982|NCT00139867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6374983|NCT00139867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374984|NCT00139880|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
6374985|NCT00139880|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6374986|NCT00139880|Immunologic Factors|immunologic factors|mesh-ancestor
6374987|NCT00139880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374988|NCT00139880|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6374989|NCT00139880|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6374990|NCT00139880|Dopamine Agonists|dopamine agonists|mesh-ancestor
6374991|NCT00139880|Dopamine Agents|dopamine agents|mesh-ancestor
6374992|NCT00139880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6374993|NCT00139880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6374994|NCT00139893|Metoclopramide|metoclopramide|mesh-list
6374995|NCT00139893|Antiemetics|antiemetics|mesh-ancestor
6374996|NCT00139893|Autonomic Agents|autonomic agents|mesh-ancestor
6374997|NCT00139893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6374998|NCT00139893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6374999|NCT00139893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6375000|NCT00139893|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6375001|NCT00139893|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6375002|NCT00139893|Dopamine Agents|dopamine agents|mesh-ancestor
6375003|NCT00139893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6375004|NCT00139893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375005|NCT00139932|Formoterol Fumarate|formoterol fumarate|mesh-list
6375006|NCT00139932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6375007|NCT00139932|Autonomic Agents|autonomic agents|mesh-ancestor
6375008|NCT00139932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6375009|NCT00139932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375010|NCT00139932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6375011|NCT00139932|Respiratory System Agents|respiratory system agents|mesh-ancestor
6375012|NCT00139932|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6375013|NCT00139932|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6375014|NCT00139932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6375015|NCT00139932|Adrenergic Agents|adrenergic agents|mesh-ancestor
6375016|NCT00139932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6375017|NCT00139932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375018|NCT00140010|Epoetin Alfa|epoetin alfa|mesh-list
6375019|NCT00140010|Hematinics|hematinics|mesh-ancestor
6375020|NCT00140023|Azithromycin|azithromycin|mesh-list
6375021|NCT00140023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6375022|NCT00140023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6375023|NCT00140062|Latanoprost|latanoprost|mesh-list
6375024|NCT00140062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6375025|NCT00140062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6375026|NCT00140075|Cyclophosphamide|cyclophosphamide|mesh-list
6375027|NCT00140075|Epirubicin|epirubicin|mesh-list
6375028|NCT00140075|Taxane|taxane|mesh-list
6375029|NCT00140075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6375030|NCT00140075|Immunologic Factors|immunologic factors|mesh-ancestor
6375031|NCT00140075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375032|NCT00140075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6375033|NCT00140075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6375034|NCT00140075|Alkylating Agents|alkylating agents|mesh-ancestor
6375035|NCT00140075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375036|NCT00140075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6375037|NCT00140075|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6375038|NCT00140075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6375039|NCT00140075|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6375040|NCT00140075|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6375041|NCT00140075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6375042|NCT00140101|Paclitaxel|paclitaxel|mesh-list
6375043|NCT00140101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6375044|NCT00140101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6375045|NCT00140101|Tubulin Modulators|tubulin modulators|mesh-ancestor
6375046|NCT00140101|Antimitotic Agents|antimitotic agents|mesh-ancestor
6375047|NCT00140101|Mitosis Modulators|mitosis modulators|mesh-ancestor
6375048|NCT00140101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375049|NCT00140114|Misoprostol|misoprostol|mesh-list
6375050|NCT00140114|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6375051|NCT00140114|Abortifacient Agents|abortifacient agents|mesh-ancestor
6375052|NCT00140114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6375053|NCT00140114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375054|NCT00140114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6375055|NCT00140114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6375056|NCT00140114|Oxytocics|oxytocics|mesh-ancestor
6375057|NCT00140153|Testosterone|testosterone|mesh-list
6375058|NCT00140153|Androgens|androgens|mesh-ancestor
6375059|NCT00140153|Hormones|hormones|mesh-ancestor
6375060|NCT00140153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6375061|NCT00140153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375062|NCT00140166|Pyridoxine|pyridoxine|mesh-list
6375063|NCT00140166|Niacinamide|niacinamide|mesh-list
6375064|NCT00140166|Niacin|niacin|mesh-list
6375065|NCT00140166|Nicotinic Acids|nicotinic acids|mesh-list
6375066|NCT00140166|Vitamin B Complex|vitamin b complex|mesh-ancestor
6375067|NCT00140166|Vitamins|vitamins|mesh-ancestor
6375068|NCT00140166|Micronutrients|micronutrients|mesh-ancestor
6375069|NCT00140166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375070|NCT00140166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6375071|NCT00140166|Antimetabolites|antimetabolites|mesh-ancestor
6375072|NCT00140166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375073|NCT00140166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6375074|NCT00140166|Vasodilator Agents|vasodilator agents|mesh-ancestor
6395712|NCT00206466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6395713|NCT00206466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6395714|NCT00206466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6395715|NCT00206466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6395716|NCT00206466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6395717|NCT00206466|Immunologic Factors|immunologic factors|mesh-ancestor
6395718|NCT00206466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395719|NCT00206466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6395720|NCT00206466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6395721|NCT00206466|Alkylating Agents|alkylating agents|mesh-ancestor
6395722|NCT00206466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6395723|NCT00206492|Tamoxifen|tamoxifen|mesh-list
6395724|NCT00206492|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6395725|NCT00206492|Hormone Antagonists|hormone antagonists|mesh-ancestor
6395726|NCT00206492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6395727|NCT00206492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395728|NCT00206492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6375075|NCT00140218|Pramipexole|pramipexole|mesh-list
6375076|NCT00140218|Antioxidants|antioxidants|mesh-ancestor
6375077|NCT00140218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375078|NCT00140218|Protective Agents|protective agents|mesh-ancestor
6375079|NCT00140218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375080|NCT00140218|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6375081|NCT00140218|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6375082|NCT00140218|Dopamine Agonists|dopamine agonists|mesh-ancestor
6375083|NCT00140218|Dopamine Agents|dopamine agents|mesh-ancestor
6375084|NCT00140218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6375085|NCT00140257|Citalopram|citalopram|mesh-list
6375086|NCT00140257|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6375087|NCT00140257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6375088|NCT00140257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6375089|NCT00140257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375090|NCT00140257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6375091|NCT00140257|Serotonin Agents|serotonin agents|mesh-ancestor
6375092|NCT00140257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375093|NCT00140257|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6375094|NCT00140257|Antidepressive Agents|antidepressive agents|mesh-ancestor
6375095|NCT00140257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6375096|NCT00140296|Contraceptive Agents|contraceptive agents|mesh-list
6375097|NCT00140296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6375098|NCT00140296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375099|NCT00140309|Moxifloxacin|moxifloxacin|mesh-list
6375100|NCT00140309|Rifampin|rifampin|mesh-list
6375101|NCT00140309|Isoniazid|isoniazid|mesh-list
6375102|NCT00140309|Pyrazinamide|pyrazinamide|mesh-list
6375103|NCT00140309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6375104|NCT00140309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6375105|NCT00140309|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6375106|NCT00140309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6375107|NCT00140309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6375108|NCT00140309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375109|NCT00140309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6375110|NCT00140309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6375111|NCT00140309|Antitubercular Agents|antitubercular agents|mesh-ancestor
6375112|NCT00140309|Leprostatic Agents|leprostatic agents|mesh-ancestor
6375113|NCT00140309|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6375114|NCT00140309|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6375115|NCT00140309|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6375116|NCT00140309|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6375117|NCT00140309|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6375118|NCT00140309|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6375119|NCT00140309|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6375120|NCT00140309|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6375121|NCT00140309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6375122|NCT00140309|Antimetabolites|antimetabolites|mesh-ancestor
6375123|NCT00140309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6375124|NCT00140361|Artesunate|artesunate|mesh-list
6375125|NCT00140361|Lumefantrine|lumefantrine|mesh-list
6375126|NCT00140361|Artemether|artemether|mesh-list
6375127|NCT00140361|Pyrimethamine|pyrimethamine|mesh-list
6375128|NCT00140361|Sulfadoxine|sulfadoxine|mesh-list
6375129|NCT00140361|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6375130|NCT00140361|Antimalarials|antimalarials|mesh-ancestor
6375131|NCT00140361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6375132|NCT00140361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6375133|NCT00140361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6375134|NCT00140361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6375135|NCT00140361|Antiviral Agents|antiviral agents|mesh-ancestor
6375136|NCT00140361|Schistosomicides|schistosomicides|mesh-ancestor
6375137|NCT00140361|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6375138|NCT00140361|Anthelmintics|anthelmintics|mesh-ancestor
6375139|NCT00140361|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6375140|NCT00140361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6375141|NCT00140361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375142|NCT00140361|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6375143|NCT00140361|Renal Agents|renal agents|mesh-ancestor
6375144|NCT00140452|Thalidomide|thalidomide|mesh-list
6375145|NCT00140452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6375146|NCT00140452|Immunologic Factors|immunologic factors|mesh-ancestor
6375147|NCT00140452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375148|NCT00140452|Leprostatic Agents|leprostatic agents|mesh-ancestor
6375149|NCT00140452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6375150|NCT00140452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6375151|NCT00140452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6375152|NCT00140452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6375153|NCT00140452|Growth Substances|growth substances|mesh-ancestor
6375154|NCT00140452|Growth Inhibitors|growth inhibitors|mesh-ancestor
6375155|NCT00140452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6375156|NCT00140465|Clopidogrel|clopidogrel|mesh-list
6375157|NCT00140465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6375158|NCT00140465|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6375159|NCT00140465|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6375160|NCT00140465|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6375161|NCT00140465|Purinergic Agents|purinergic agents|mesh-ancestor
6375162|NCT00140465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6375163|NCT00140465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375164|NCT00140465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375165|NCT00140478|Mifepristone|mifepristone|mesh-list
6375166|NCT00140478|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6375167|NCT00140478|Abortifacient Agents|abortifacient agents|mesh-ancestor
6375168|NCT00140478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6375169|NCT00140478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375170|NCT00140478|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6375171|NCT00140478|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6375172|NCT00140478|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6375173|NCT00140478|Contraceptive Agents|contraceptive agents|mesh-ancestor
6375174|NCT00140478|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6375175|NCT00140478|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6375176|NCT00140478|Hormone Antagonists|hormone antagonists|mesh-ancestor
6375177|NCT00140478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6375178|NCT00140478|Luteolytic Agents|luteolytic agents|mesh-ancestor
6375179|NCT00140478|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6375180|NCT00140478|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6375181|NCT00140517|Chloroquine|chloroquine|mesh-list
6375182|NCT00140517|Pyrimethamine|pyrimethamine|mesh-list
6375183|NCT00140517|Sulfadoxine|sulfadoxine|mesh-list
6375184|NCT00140517|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6375185|NCT00140517|Amebicides|amebicides|mesh-ancestor
6375186|NCT00140517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6375187|NCT00140517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6375188|NCT00140517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6375189|NCT00140517|Antimalarials|antimalarials|mesh-ancestor
6375190|NCT00140517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6375191|NCT00140517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6375192|NCT00140517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6375193|NCT00140517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375194|NCT00140517|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6375195|NCT00140517|Renal Agents|renal agents|mesh-ancestor
6375196|NCT00140530|Sirolimus|sirolimus|mesh-list
6375197|NCT00140530|Paclitaxel|paclitaxel|mesh-list
6375198|NCT00140530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6375199|NCT00140530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6375200|NCT00140530|Tubulin Modulators|tubulin modulators|mesh-ancestor
6375201|NCT00140530|Antimitotic Agents|antimitotic agents|mesh-ancestor
6375202|NCT00140530|Mitosis Modulators|mitosis modulators|mesh-ancestor
6375203|NCT00140530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375204|NCT00140530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6375205|NCT00140530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6375206|NCT00140530|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6375207|NCT00140530|Antifungal Agents|antifungal agents|mesh-ancestor
6375208|NCT00140530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6375209|NCT00140530|Immunologic Factors|immunologic factors|mesh-ancestor
6375210|NCT00140530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375211|NCT00140543|Mycophenolic Acid|mycophenolic acid|mesh-list
6375212|NCT00140543|Sirolimus|sirolimus|mesh-list
6375213|NCT00140543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6375214|NCT00140543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6375215|NCT00140543|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6375216|NCT00140543|Antitubercular Agents|antitubercular agents|mesh-ancestor
6375217|NCT00140543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6375218|NCT00140543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6375219|NCT00140543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6375220|NCT00140543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375221|NCT00140543|Antifungal Agents|antifungal agents|mesh-ancestor
6375222|NCT00140543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6375223|NCT00140543|Immunologic Factors|immunologic factors|mesh-ancestor
6375224|NCT00140543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375225|NCT00140569|Interferons|interferons|mesh-list
6375226|NCT00140569|Fludarabine|fludarabine|mesh-list
6375227|NCT00140569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6375228|NCT00140569|Antiviral Agents|antiviral agents|mesh-ancestor
6375229|NCT00140569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6375230|NCT00140582|Rituximab|rituximab|mesh-list
6375231|NCT00140582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6375232|NCT00140582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6375233|NCT00140582|Immunologic Factors|immunologic factors|mesh-ancestor
6375234|NCT00140582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375235|NCT00140582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6375236|NCT00140595|Cyclophosphamide|cyclophosphamide|mesh-list
6375237|NCT00140595|Rituximab|rituximab|mesh-list
6375238|NCT00140595|Doxorubicin|doxorubicin|mesh-list
6375239|NCT00140595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6375240|NCT00140595|Immunologic Factors|immunologic factors|mesh-ancestor
6375241|NCT00140595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375242|NCT00140595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6375243|NCT00140595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6375244|NCT00140595|Alkylating Agents|alkylating agents|mesh-ancestor
6375245|NCT00140595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375246|NCT00140595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6375247|NCT00140595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6375248|NCT00140595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6375249|NCT00140595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6375250|NCT00140595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6375251|NCT00140595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6375252|NCT00140595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6375253|NCT00140647|Rosiglitazone|rosiglitazone|mesh-list
6375254|NCT00140647|Ramipril|ramipril|mesh-list
6375255|NCT00140647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6375256|NCT00140647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375257|NCT00140647|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6375258|NCT00140647|Protease Inhibitors|protease inhibitors|mesh-ancestor
6375259|NCT00140647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6375260|NCT00140647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375261|NCT00140647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6375262|NCT00140660|Rituximab|rituximab|mesh-list
6375263|NCT00140660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6375264|NCT00140660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6375265|NCT00140660|Immunologic Factors|immunologic factors|mesh-ancestor
6375266|NCT00140660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375267|NCT00140660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6375268|NCT00140712|Ropinirole|ropinirole|mesh-list
6375269|NCT00140712|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6375270|NCT00140712|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6375271|NCT00140712|Dopamine Agonists|dopamine agonists|mesh-ancestor
6375272|NCT00140712|Dopamine Agents|dopamine agents|mesh-ancestor
6375273|NCT00140712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6375274|NCT00140712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375275|NCT00140712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375276|NCT00140725|Interferons|interferons|mesh-list
6375277|NCT00140725|Interferon-alpha|interferon-alpha|mesh-list
6375278|NCT00140725|Lamivudine|lamivudine|mesh-list
6375279|NCT00140725|Interferon alpha-2|interferon alpha-2|mesh-list
6375280|NCT00140725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6375281|NCT00140725|Antiviral Agents|antiviral agents|mesh-ancestor
6375282|NCT00140725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6375283|NCT00140725|Immunologic Factors|immunologic factors|mesh-ancestor
6375284|NCT00140725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375285|NCT00140725|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6375286|NCT00140725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6375287|NCT00140725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6375288|NCT00140725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375289|NCT00140725|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6375290|NCT00140725|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6375291|NCT00140751|Ritonavir|ritonavir|mesh-list
6375292|NCT00140751|Lopinavir|lopinavir|mesh-list
6375293|NCT00140751|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6375294|NCT00140751|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6375295|NCT00140751|Protease Inhibitors|protease inhibitors|mesh-ancestor
6375296|NCT00140751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6375297|NCT00140751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375298|NCT00140751|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6375299|NCT00140751|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6375300|NCT00140751|Antiviral Agents|antiviral agents|mesh-ancestor
6375301|NCT00140751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6375302|NCT00140751|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6375303|NCT00140751|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6375304|NCT00140764|Metronidazole|metronidazole|mesh-list
6375305|NCT00140764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6375306|NCT00140764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6375307|NCT00140764|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6375308|NCT00140764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6375309|NCT00140790|Valsartan|valsartan|mesh-list
6375310|NCT00140790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6375311|NCT00140790|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6375312|NCT00140790|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6375313|NCT00140790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375314|NCT00140803|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6375315|NCT00140803|Verteporfin|verteporfin|mesh-list
6375316|NCT00140803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6375317|NCT00140803|Glucocorticoids|glucocorticoids|mesh-ancestor
6375318|NCT00140803|Hormones|hormones|mesh-ancestor
6375319|NCT00140803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6375320|NCT00140803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375321|NCT00140803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6375322|NCT00140803|Immunologic Factors|immunologic factors|mesh-ancestor
6375323|NCT00140803|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6375324|NCT00140803|Dermatologic Agents|dermatologic agents|mesh-ancestor
6375325|NCT00140868|Phenobarbital|phenobarbital|mesh-list
6375326|NCT00140868|Anticonvulsants|anticonvulsants|mesh-ancestor
6375327|NCT00140868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6375328|NCT00140868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6375329|NCT00140868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375330|NCT00140868|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6375331|NCT00140868|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6375332|NCT00140868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6375333|NCT00140868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375334|NCT00140868|GABA Modulators|gaba modulators|mesh-ancestor
6375335|NCT00140868|GABA Agents|gaba agents|mesh-ancestor
6375336|NCT00140868|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6375337|NCT00140868|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6375338|NCT00140868|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6375339|NCT00140894|Rofecoxib|rofecoxib|mesh-list
6375340|NCT00140894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375341|NCT00140894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375342|NCT00140894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6375343|NCT00140894|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6375344|NCT00140894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6375345|NCT00140894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6375346|NCT00140894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6375347|NCT00140894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6375348|NCT00140894|Analgesics|analgesics|mesh-ancestor
6375349|NCT00140894|Sensory System Agents|sensory system agents|mesh-ancestor
6375350|NCT00140894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6375351|NCT00140894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6375352|NCT00140920|Diclofenac|diclofenac|mesh-list
6375353|NCT00140920|Rofecoxib|rofecoxib|mesh-list
6375354|NCT00140920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6375355|NCT00140920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6375356|NCT00140920|Analgesics|analgesics|mesh-ancestor
6375357|NCT00140920|Sensory System Agents|sensory system agents|mesh-ancestor
6375358|NCT00140920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6375359|NCT00140920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375360|NCT00140920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6375361|NCT00140920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6375362|NCT00140920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6375363|NCT00140920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6375364|NCT00140920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375365|NCT00140920|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6375366|NCT00140933|Diclofenac|diclofenac|mesh-list
6375367|NCT00140933|Rofecoxib|rofecoxib|mesh-list
6375368|NCT00140933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6375369|NCT00140933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6375370|NCT00140933|Analgesics|analgesics|mesh-ancestor
6375371|NCT00140933|Sensory System Agents|sensory system agents|mesh-ancestor
6375372|NCT00140933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6375373|NCT00140933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375374|NCT00140933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6375375|NCT00140933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6375376|NCT00140933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6375377|NCT00140933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6375378|NCT00140933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375379|NCT00140933|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6375380|NCT00140998|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6375381|NCT00140998|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6375382|NCT00140998|Estradiol|estradiol|mesh-list
6375383|NCT00140998|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6375384|NCT00140998|Estrogens|estrogens|mesh-ancestor
6375385|NCT00140998|Hormones|hormones|mesh-ancestor
6375386|NCT00140998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6375387|NCT00140998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375388|NCT00140998|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6375389|NCT00140998|Contraceptive Agents|contraceptive agents|mesh-ancestor
6375390|NCT00140998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6375391|NCT00140998|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6375392|NCT00141011|Ancrod|ancrod|mesh-list
6375393|NCT00141011|Anticoagulants|anticoagulants|mesh-ancestor
6375394|NCT00141011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6375395|NCT00141011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6375396|NCT00141011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375397|NCT00141050|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
6375398|NCT00141050|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6375399|NCT00141050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375400|NCT00141050|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6375401|NCT00141050|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6375402|NCT00141050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6375403|NCT00141050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375404|NCT00141050|Dopamine Agents|dopamine agents|mesh-ancestor
6375405|NCT00141050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6375406|NCT00141063|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
6375407|NCT00141063|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6375408|NCT00141063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375409|NCT00141063|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6375410|NCT00141063|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6375411|NCT00141063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6375412|NCT00141063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375413|NCT00141063|Dopamine Agents|dopamine agents|mesh-ancestor
6375414|NCT00141063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6375415|NCT00141089|Tegaserod|tegaserod|mesh-list
6375416|NCT00141089|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6375417|NCT00141089|Serotonin Agents|serotonin agents|mesh-ancestor
6375418|NCT00141089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6375419|NCT00141089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375420|NCT00141089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375421|NCT00141141|Atorvastatin|atorvastatin|mesh-list
6375422|NCT00141141|Simvastatin|simvastatin|mesh-list
6375423|NCT00141141|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6375424|NCT00141141|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6375425|NCT00141141|Antimetabolites|antimetabolites|mesh-ancestor
6375426|NCT00141141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375427|NCT00141141|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6375428|NCT00141141|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6375429|NCT00141141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6375430|NCT00141154|Celecoxib|celecoxib|mesh-list
6375431|NCT00141154|Loxoprofen|loxoprofen|mesh-list
6375432|NCT00141154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6375433|NCT00141154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6375434|NCT00141154|Analgesics|analgesics|mesh-ancestor
6375435|NCT00141154|Sensory System Agents|sensory system agents|mesh-ancestor
6375436|NCT00141154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6375437|NCT00141154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375438|NCT00141154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6375439|NCT00141154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6375440|NCT00141154|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6375441|NCT00141154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6375442|NCT00141154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6375443|NCT00141154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375444|NCT00141167|Varenicline|varenicline|mesh-list
6375445|NCT00141167|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6375446|NCT00141167|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6375447|NCT00141167|Cholinergic Agents|cholinergic agents|mesh-ancestor
6375448|NCT00141167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6375449|NCT00141167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375450|NCT00141167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375451|NCT00141193|Celecoxib|celecoxib|mesh-list
6375452|NCT00141193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6375453|NCT00141193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6375454|NCT00141193|Analgesics|analgesics|mesh-ancestor
6375455|NCT00141193|Sensory System Agents|sensory system agents|mesh-ancestor
6375456|NCT00141193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6375457|NCT00141193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375458|NCT00141193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6375459|NCT00141193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6375460|NCT00141193|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6375461|NCT00141193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6375462|NCT00141193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6375463|NCT00141193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375464|NCT00141206|Varenicline|varenicline|mesh-list
6375465|NCT00141206|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6375466|NCT00141206|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6375467|NCT00141206|Cholinergic Agents|cholinergic agents|mesh-ancestor
6375468|NCT00141206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6375469|NCT00141206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375470|NCT00141206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375471|NCT00141232|Atorvastatin|atorvastatin|mesh-list
6375472|NCT00141232|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6375473|NCT00141232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6375474|NCT00141232|Antimetabolites|antimetabolites|mesh-ancestor
6375475|NCT00141232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375476|NCT00141232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6375477|NCT00141232|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6375478|NCT00141232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6375479|NCT00141245|Pregabalin|pregabalin|mesh-list
6375480|NCT00141245|Analgesics|analgesics|mesh-ancestor
6375481|NCT00141245|Sensory System Agents|sensory system agents|mesh-ancestor
6375482|NCT00141245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6375483|NCT00141245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375484|NCT00141245|Anticonvulsants|anticonvulsants|mesh-ancestor
6375485|NCT00141245|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6375486|NCT00141245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6375487|NCT00141245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375488|NCT00141245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6375489|NCT00141245|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6375490|NCT00141245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6375491|NCT00141245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6375492|NCT00141245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6375493|NCT00141258|Pregabalin|pregabalin|mesh-list
6375494|NCT00141258|Analgesics|analgesics|mesh-ancestor
6375495|NCT00141258|Sensory System Agents|sensory system agents|mesh-ancestor
6375496|NCT00141258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6375497|NCT00141258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375498|NCT00141258|Anticonvulsants|anticonvulsants|mesh-ancestor
6375499|NCT00141258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6375500|NCT00141258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6375501|NCT00141258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375502|NCT00141258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6375503|NCT00141258|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6375504|NCT00141258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6375505|NCT00141258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6375506|NCT00141258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6375507|NCT00141310|Sildenafil Citrate|sildenafil citrate|mesh-list
6375508|NCT00141310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375509|NCT00141310|Vasodilator Agents|vasodilator agents|mesh-ancestor
6375510|NCT00141310|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6375511|NCT00141310|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6375512|NCT00141310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6375513|NCT00141310|Urological Agents|urological agents|mesh-ancestor
6375514|NCT00141336|Pregabalin|pregabalin|mesh-list
6375515|NCT00141336|Analgesics|analgesics|mesh-ancestor
6375516|NCT00141336|Sensory System Agents|sensory system agents|mesh-ancestor
6375517|NCT00141336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6017481|NCT00372996|Hormone Antagonists|hormone antagonists|mesh-ancestor
6017482|NCT00372996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6017483|NCT00372996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017484|NCT00372996|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6017485|NCT00372996|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6017486|NCT00372996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6017487|NCT00372996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017488|NCT00373113|Capecitabine|capecitabine|mesh-list
6017489|NCT00373113|Sunitinib|sunitinib|mesh-list
6017490|NCT00373113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6017491|NCT00373113|Antimetabolites|antimetabolites|mesh-ancestor
6375518|NCT00141336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375519|NCT00141336|Anticonvulsants|anticonvulsants|mesh-ancestor
6375520|NCT00141336|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6375521|NCT00141336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6375522|NCT00141336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375523|NCT00141336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6375524|NCT00141336|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6375525|NCT00141336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6375526|NCT00141336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6375527|NCT00141336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6375528|NCT00141362|Pregabalin|pregabalin|mesh-list
6375529|NCT00141362|Analgesics|analgesics|mesh-ancestor
6375530|NCT00141362|Sensory System Agents|sensory system agents|mesh-ancestor
6375531|NCT00141362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6375532|NCT00141362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375533|NCT00141362|Anticonvulsants|anticonvulsants|mesh-ancestor
6375534|NCT00141362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6375535|NCT00141362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6375536|NCT00141362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375537|NCT00141362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6375538|NCT00141362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6375539|NCT00141362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6375540|NCT00141362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6375541|NCT00141362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6375542|NCT00141375|Pregabalin|pregabalin|mesh-list
6375543|NCT00141375|Analgesics|analgesics|mesh-ancestor
6375544|NCT00141375|Sensory System Agents|sensory system agents|mesh-ancestor
6375545|NCT00141375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6375546|NCT00141375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375547|NCT00141375|Anticonvulsants|anticonvulsants|mesh-ancestor
6375548|NCT00141375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6375549|NCT00141375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6375550|NCT00141375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375551|NCT00141375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6375552|NCT00141375|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6375553|NCT00141375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6375554|NCT00141375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6375555|NCT00141375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6375556|NCT00141388|Pregabalin|pregabalin|mesh-list
6375557|NCT00141388|Analgesics|analgesics|mesh-ancestor
6375558|NCT00141388|Sensory System Agents|sensory system agents|mesh-ancestor
6375559|NCT00141388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6375560|NCT00141388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375561|NCT00141388|Anticonvulsants|anticonvulsants|mesh-ancestor
6375562|NCT00141388|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6375563|NCT00141388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6375564|NCT00141388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375565|NCT00141388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6375566|NCT00141388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6375567|NCT00141388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6375568|NCT00141388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6375569|NCT00141388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6375570|NCT00141401|Pregabalin|pregabalin|mesh-list
6375571|NCT00141401|Analgesics|analgesics|mesh-ancestor
6375572|NCT00141401|Sensory System Agents|sensory system agents|mesh-ancestor
6375573|NCT00141401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6375574|NCT00141401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375575|NCT00141401|Anticonvulsants|anticonvulsants|mesh-ancestor
6375576|NCT00141401|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6375577|NCT00141401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6375578|NCT00141401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375579|NCT00141401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6375580|NCT00141401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6375581|NCT00141401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6375582|NCT00141401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6375583|NCT00141401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6375584|NCT00141414|Pregabalin|pregabalin|mesh-list
6375585|NCT00141414|Analgesics|analgesics|mesh-ancestor
6375586|NCT00141414|Sensory System Agents|sensory system agents|mesh-ancestor
6375587|NCT00141414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6375588|NCT00141414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375589|NCT00141414|Anticonvulsants|anticonvulsants|mesh-ancestor
6375590|NCT00141414|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6375591|NCT00141414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6375592|NCT00141414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375593|NCT00141414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6375594|NCT00141414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6375595|NCT00141414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6375596|NCT00141414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6375597|NCT00141414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6375598|NCT00141427|Pregabalin|pregabalin|mesh-list
6375599|NCT00141427|Analgesics|analgesics|mesh-ancestor
6375600|NCT00141427|Sensory System Agents|sensory system agents|mesh-ancestor
6375601|NCT00141427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6375602|NCT00141427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375603|NCT00141427|Anticonvulsants|anticonvulsants|mesh-ancestor
6375604|NCT00141427|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6375605|NCT00141427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6375606|NCT00141427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375607|NCT00141427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6375608|NCT00141427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6375609|NCT00141427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6375610|NCT00141427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6375611|NCT00141427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6375612|NCT00141492|Testosterone|testosterone|mesh-list
6375613|NCT00141492|Androgens|androgens|mesh-ancestor
6375614|NCT00141492|Hormones|hormones|mesh-ancestor
6375615|NCT00141492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6375616|NCT00141492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375617|NCT00141531|Apaziquone|apaziquone|mesh-list
6375618|NCT00141531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6375619|NCT00141544|Methyltestosterone|methyltestosterone|mesh-list
6375620|NCT00141544|Estrogens|estrogens|mesh-list
6375621|NCT00141544|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
6375622|NCT00141544|Estrone|estrone|mesh-list
6375623|NCT00141544|Testosterone|testosterone|mesh-list
6375624|NCT00141544|Testosterone undecanoate|testosterone undecanoate|mesh-list
6375625|NCT00141544|Testosterone enanthate|testosterone enanthate|mesh-list
6375626|NCT00141544|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6375627|NCT00141544|Hormones|hormones|mesh-ancestor
6375628|NCT00141544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6375629|NCT00141544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375630|NCT00141544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6375631|NCT00141544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6375632|NCT00141544|Anabolic Agents|anabolic agents|mesh-ancestor
6375633|NCT00141544|Androgens|androgens|mesh-ancestor
6375634|NCT00141557|Methyltestosterone|methyltestosterone|mesh-list
6375635|NCT00141557|Estrogens|estrogens|mesh-list
6375636|NCT00141557|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
6375637|NCT00141557|Estrone|estrone|mesh-list
6375638|NCT00141557|Testosterone|testosterone|mesh-list
6375639|NCT00141557|Testosterone undecanoate|testosterone undecanoate|mesh-list
6375640|NCT00141557|Testosterone enanthate|testosterone enanthate|mesh-list
6375641|NCT00141557|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6375642|NCT00141557|Hormones|hormones|mesh-ancestor
6375643|NCT00141557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6375644|NCT00141557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375645|NCT00141557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6375646|NCT00141557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6375647|NCT00141557|Anabolic Agents|anabolic agents|mesh-ancestor
6375648|NCT00141557|Androgens|androgens|mesh-ancestor
6375649|NCT00141570|Methyltestosterone|methyltestosterone|mesh-list
6375650|NCT00141570|Estrogens|estrogens|mesh-list
6375651|NCT00141570|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
6375652|NCT00141570|Testosterone|testosterone|mesh-list
6375653|NCT00141570|Testosterone undecanoate|testosterone undecanoate|mesh-list
6375654|NCT00141570|Testosterone enanthate|testosterone enanthate|mesh-list
6375655|NCT00141570|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6375656|NCT00141570|Hormones|hormones|mesh-ancestor
6375657|NCT00141570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6375658|NCT00141570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375659|NCT00141570|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6375660|NCT00141570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6375661|NCT00141570|Anabolic Agents|anabolic agents|mesh-ancestor
6375662|NCT00141570|Androgens|androgens|mesh-ancestor
6375663|NCT00141583|Candesartan|candesartan|mesh-list
6375664|NCT00141583|Enalapril|enalapril|mesh-list
6375665|NCT00141583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6375666|NCT00141583|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6375667|NCT00141583|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6375668|NCT00141583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375669|NCT00141583|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6375670|NCT00141583|Protease Inhibitors|protease inhibitors|mesh-ancestor
6375671|NCT00141583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6375672|NCT00141596|Amiloride|amiloride|mesh-list
6375673|NCT00141596|Furosemide|furosemide|mesh-list
6375674|NCT00141596|Diuretics|diuretics|mesh-ancestor
6375675|NCT00141596|Natriuretic Agents|natriuretic agents|mesh-ancestor
6375676|NCT00141596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375677|NCT00141596|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6375678|NCT00141596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6375679|NCT00141596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375680|NCT00141596|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
6375681|NCT00141596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6375682|NCT00141596|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
6375683|NCT00141596|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6375684|NCT00141648|Prednisolone|prednisolone|mesh-list
6375685|NCT00141648|Cyclophosphamide|cyclophosphamide|mesh-list
6375686|NCT00141648|Doxorubicin|doxorubicin|mesh-list
6375687|NCT00141648|Vincristine|vincristine|mesh-list
6375688|NCT00141648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6375689|NCT00141648|Immunologic Factors|immunologic factors|mesh-ancestor
6375690|NCT00141648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375691|NCT00141648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6375692|NCT00141648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6375693|NCT00141648|Alkylating Agents|alkylating agents|mesh-ancestor
6375694|NCT00141648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375695|NCT00141648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6375696|NCT00141648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6375697|NCT00141648|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6375698|NCT00141648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6375699|NCT00141648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6375700|NCT00141648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6375701|NCT00141648|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6375702|NCT00141648|Tubulin Modulators|tubulin modulators|mesh-ancestor
6375703|NCT00141648|Antimitotic Agents|antimitotic agents|mesh-ancestor
6375704|NCT00141648|Mitosis Modulators|mitosis modulators|mesh-ancestor
6375705|NCT00141648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6375706|NCT00141648|Glucocorticoids|glucocorticoids|mesh-ancestor
6375707|NCT00141648|Hormones|hormones|mesh-ancestor
6375708|NCT00141648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6375709|NCT00141648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6375710|NCT00141700|Rituximab|rituximab|mesh-list
6375711|NCT00141700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6375712|NCT00141700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6375713|NCT00141700|Immunologic Factors|immunologic factors|mesh-ancestor
6375714|NCT00141700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375715|NCT00141700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6375716|NCT00141713|Etanercept|etanercept|mesh-list
6375717|NCT00141713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6375718|NCT00141713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6375719|NCT00141713|Analgesics|analgesics|mesh-ancestor
6375720|NCT00141713|Sensory System Agents|sensory system agents|mesh-ancestor
6375721|NCT00141713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6375722|NCT00141713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375723|NCT00141713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6375724|NCT00141713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6375725|NCT00141713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6375726|NCT00141713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6375727|NCT00141713|Immunologic Factors|immunologic factors|mesh-ancestor
6375728|NCT00141791|Etanercept|etanercept|mesh-list
6375729|NCT00141791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6375730|NCT00141791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6375731|NCT00141791|Analgesics|analgesics|mesh-ancestor
6375732|NCT00141791|Sensory System Agents|sensory system agents|mesh-ancestor
6375733|NCT00141791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6375734|NCT00141791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375735|NCT00141791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6375736|NCT00141791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6375737|NCT00141791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6375738|NCT00141791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6375739|NCT00141791|Immunologic Factors|immunologic factors|mesh-ancestor
6375740|NCT00141804|Sirolimus|sirolimus|mesh-list
6375741|NCT00141804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6375742|NCT00141804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6375743|NCT00141804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6375744|NCT00141804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6375745|NCT00141804|Antifungal Agents|antifungal agents|mesh-ancestor
6375746|NCT00141804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6375747|NCT00141804|Immunologic Factors|immunologic factors|mesh-ancestor
6375748|NCT00141804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375749|NCT00141830|Methotrexate|methotrexate|mesh-list
6375750|NCT00141830|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6375751|NCT00141830|Abortifacient Agents|abortifacient agents|mesh-ancestor
6375752|NCT00141830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6375753|NCT00141830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375754|NCT00141830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6375755|NCT00141830|Antimetabolites|antimetabolites|mesh-ancestor
6017492|NCT00373113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375756|NCT00141830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375757|NCT00141830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6375758|NCT00141830|Dermatologic Agents|dermatologic agents|mesh-ancestor
6375759|NCT00141830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6375760|NCT00141830|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6375761|NCT00141830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6375762|NCT00141830|Immunologic Factors|immunologic factors|mesh-ancestor
6017493|NCT00373113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6017494|NCT00373113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6017495|NCT00373113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6017496|NCT00373113|Growth Substances|growth substances|mesh-ancestor
6375763|NCT00141830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6375764|NCT00141830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6375765|NCT00141843|Factor VIII|factor viii|mesh-list
6375766|NCT00141843|Coagulants|coagulants|mesh-ancestor
6395729|NCT00206492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6395730|NCT00206492|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6395731|NCT00206492|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6395732|NCT00206492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6395733|NCT00206505|Docetaxel|docetaxel|mesh-list
6395734|NCT00206505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6395735|NCT00206505|Tubulin Modulators|tubulin modulators|mesh-ancestor
6395736|NCT00206505|Antimitotic Agents|antimitotic agents|mesh-ancestor
6395737|NCT00206505|Mitosis Modulators|mitosis modulators|mesh-ancestor
6395738|NCT00206505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395739|NCT00206544|Tamoxifen|tamoxifen|mesh-list
6395740|NCT00206544|Progesterone|progesterone|mesh-list
6395741|NCT00206544|Progestins|progestins|mesh-ancestor
6395742|NCT00206544|Hormones|hormones|mesh-ancestor
6395743|NCT00206544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6395744|NCT00206544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395745|NCT00206544|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6395746|NCT00206544|Hormone Antagonists|hormone antagonists|mesh-ancestor
6395747|NCT00206544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6395748|NCT00206544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6395749|NCT00206544|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6395750|NCT00206544|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6395751|NCT00206544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6395752|NCT00206557|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
6395753|NCT00206557|Estradiol|estradiol|mesh-list
6395754|NCT00206557|Estrogens|estrogens|mesh-ancestor
6395755|NCT00206557|Hormones|hormones|mesh-ancestor
6395756|NCT00206557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6395757|NCT00206557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395758|NCT00206557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6395759|NCT00206557|Hormone Antagonists|hormone antagonists|mesh-ancestor
6395760|NCT00206557|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6395761|NCT00206557|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6395762|NCT00206557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6395763|NCT00206570|Estradiol|estradiol|mesh-list
6395764|NCT00206570|Estrogens|estrogens|mesh-ancestor
6395765|NCT00206570|Hormones|hormones|mesh-ancestor
6395766|NCT00206570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6395767|NCT00206570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395768|NCT00206596|Sargramostim|sargramostim|mesh-list
6395769|NCT00206596|Immunologic Factors|immunologic factors|mesh-ancestor
6395770|NCT00206596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395771|NCT00206622|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6395772|NCT00206622|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6395773|NCT00206622|Levonorgestrel|levonorgestrel|mesh-list
6395774|NCT00206622|Estradiol|estradiol|mesh-list
6395775|NCT00206622|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6395776|NCT00206622|Estrogens|estrogens|mesh-ancestor
6395777|NCT00206622|Hormones|hormones|mesh-ancestor
6395778|NCT00206622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6395779|NCT00206622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395780|NCT00206622|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6395781|NCT00206622|Contraceptive Agents|contraceptive agents|mesh-ancestor
6395782|NCT00206622|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6395783|NCT00206622|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6395784|NCT00206622|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6395785|NCT00206622|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6395786|NCT00206635|Interferons|interferons|mesh-list
6395787|NCT00206635|Interferon-beta|interferon-beta|mesh-list
6395788|NCT00206635|Interferon beta-1b|interferon beta-1b|mesh-list
6395789|NCT00206635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6395790|NCT00206635|Antiviral Agents|antiviral agents|mesh-ancestor
6395791|NCT00206635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6395792|NCT00206635|Immunologic Factors|immunologic factors|mesh-ancestor
6375767|NCT00141882|Memantine|memantine|mesh-list
6375768|NCT00141882|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6375769|NCT00141882|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6375770|NCT00141882|Dopamine Agents|dopamine agents|mesh-ancestor
6375771|NCT00141882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6375772|NCT00141882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375773|NCT00141882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375774|NCT00141882|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6375775|NCT00141882|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6375776|NCT00141895|Misoprostol|misoprostol|mesh-list
6375777|NCT00141895|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6375778|NCT00141895|Abortifacient Agents|abortifacient agents|mesh-ancestor
6375779|NCT00141895|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6375780|NCT00141895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375781|NCT00141895|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6375782|NCT00141895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6375783|NCT00141895|Oxytocics|oxytocics|mesh-ancestor
6375784|NCT00141908|Castor Oil|castor oil|mesh-list
6375785|NCT00141908|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
6375786|NCT00141908|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
6375787|NCT00141908|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6375788|NCT00141908|Hormone Antagonists|hormone antagonists|mesh-ancestor
6375789|NCT00141908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6375790|NCT00141908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375791|NCT00141908|Progestins|progestins|mesh-ancestor
6375792|NCT00141908|Hormones|hormones|mesh-ancestor
6375793|NCT00141908|Cathartics|cathartics|mesh-ancestor
6375794|NCT00141908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6375795|NCT00141947|Bexarotene|bexarotene|mesh-list
6375796|NCT00141947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6375797|NCT00141960|Famotidine|famotidine|mesh-list
6375798|NCT00141960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6375799|NCT00141960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6375800|NCT00141960|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6375801|NCT00141960|Histamine Antagonists|histamine antagonists|mesh-ancestor
6375802|NCT00141960|Histamine Agents|histamine agents|mesh-ancestor
6375803|NCT00141960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6375804|NCT00141960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375805|NCT00141960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375806|NCT00141986|Vitamin D|vitamin d|mesh-list
6375807|NCT00141986|Ergocalciferols|ergocalciferols|mesh-list
6375808|NCT00141986|Cholecalciferol|cholecalciferol|mesh-list
6375809|NCT00141986|Vitamins|vitamins|mesh-list
6375810|NCT00141986|Micronutrients|micronutrients|mesh-ancestor
6375811|NCT00141986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375812|NCT00141986|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6375813|NCT00141986|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6375814|NCT00142025|Oxcarbazepine|oxcarbazepine|mesh-list
6375815|NCT00142025|Anticonvulsants|anticonvulsants|mesh-ancestor
6375816|NCT00142025|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6375817|NCT00142025|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6375818|NCT00142025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6375819|NCT00142025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375820|NCT00142025|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6375821|NCT00142025|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6375822|NCT00142038|Docetaxel|docetaxel|mesh-list
6375823|NCT00142038|Capecitabine|capecitabine|mesh-list
6375824|NCT00142038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6375825|NCT00142038|Tubulin Modulators|tubulin modulators|mesh-ancestor
6375826|NCT00142038|Antimitotic Agents|antimitotic agents|mesh-ancestor
6375827|NCT00142038|Mitosis Modulators|mitosis modulators|mesh-ancestor
6375828|NCT00142038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375829|NCT00142038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6375830|NCT00142038|Antimetabolites|antimetabolites|mesh-ancestor
6375831|NCT00142051|Nitric Oxide|nitric oxide|mesh-list
6375832|NCT00142051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6375833|NCT00142051|Autonomic Agents|autonomic agents|mesh-ancestor
6375834|NCT00142051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6375835|NCT00142051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375836|NCT00142051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6375837|NCT00142051|Respiratory System Agents|respiratory system agents|mesh-ancestor
6375838|NCT00142051|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6375839|NCT00142051|Antioxidants|antioxidants|mesh-ancestor
6375840|NCT00142051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375841|NCT00142051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6375842|NCT00142051|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6375843|NCT00142051|Vasodilator Agents|vasodilator agents|mesh-ancestor
6375844|NCT00142051|Gasotransmitters|gasotransmitters|mesh-ancestor
6375845|NCT00142051|Protective Agents|protective agents|mesh-ancestor
6375846|NCT00142129|Bortezomib|bortezomib|mesh-list
6375847|NCT00142129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6375848|NCT00142155|Rituximab|rituximab|mesh-list
6375849|NCT00142155|Antibodies|antibodies|mesh-list
6375850|NCT00142155|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6375851|NCT00142155|Immunologic Factors|immunologic factors|mesh-ancestor
6375852|NCT00142155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375853|NCT00142155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6375854|NCT00142155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6375855|NCT00142155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6375856|NCT00142181|Alemtuzumab|alemtuzumab|mesh-list
6375857|NCT00142181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6375858|NCT00142181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6375859|NCT00142207|Pyrimethamine|pyrimethamine|mesh-list
6375860|NCT00142207|Sulfadoxine|sulfadoxine|mesh-list
6375861|NCT00142207|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6375862|NCT00142207|Antimalarials|antimalarials|mesh-ancestor
6375863|NCT00142207|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6375864|NCT00142207|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6375865|NCT00142207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6375866|NCT00142207|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6375867|NCT00142207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6375868|NCT00142207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375869|NCT00142207|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6375870|NCT00142207|Renal Agents|renal agents|mesh-ancestor
6375871|NCT00142233|N-Methylaspartate|n-methylaspartate|mesh-list
6375872|NCT00142233|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
6375873|NCT00142233|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6375874|NCT00142233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6375875|NCT00142233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375876|NCT00142233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375877|NCT00142246|Amodiaquine|amodiaquine|mesh-list
6375878|NCT00142246|Antimalarials|antimalarials|mesh-ancestor
6375879|NCT00142246|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6375880|NCT00142246|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6375881|NCT00142246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6375882|NCT00142324|Donepezil|donepezil|mesh-list
6375883|NCT00142324|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6375884|NCT00142324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6375885|NCT00142324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375886|NCT00142324|Cholinergic Agents|cholinergic agents|mesh-ancestor
6375887|NCT00142324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6375888|NCT00142324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375889|NCT00142324|Nootropic Agents|nootropic agents|mesh-ancestor
6375890|NCT00142337|Zidovudine|zidovudine|mesh-list
6375891|NCT00142337|Didanosine|didanosine|mesh-list
6375892|NCT00142337|Antimetabolites|antimetabolites|mesh-ancestor
6375893|NCT00142337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375894|NCT00142337|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6375895|NCT00142337|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6375896|NCT00142337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6375897|NCT00142337|Antiviral Agents|antiviral agents|mesh-ancestor
6375898|NCT00142337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6375899|NCT00142337|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6375900|NCT00142337|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6375901|NCT00142350|Fluorouracil|fluorouracil|mesh-list
6375902|NCT00142350|Irinotecan|irinotecan|mesh-list
6375903|NCT00142350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6375904|NCT00142350|Antimetabolites|antimetabolites|mesh-ancestor
6375905|NCT00142350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375906|NCT00142350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6375907|NCT00142350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6375908|NCT00142350|Immunologic Factors|immunologic factors|mesh-ancestor
6375909|NCT00142350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375910|NCT00142350|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6375911|NCT00142350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6375912|NCT00142350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6375913|NCT00142402|Modafinil|modafinil|mesh-list
6375914|NCT00142402|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6375915|NCT00142402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375916|NCT00142402|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6375917|NCT00142402|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6375918|NCT00142402|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6375919|NCT00142402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375920|NCT00142428|Cetuximab|cetuximab|mesh-list
6375921|NCT00142428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6375922|NCT00142428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6375923|NCT00142467|Gemcitabine|gemcitabine|mesh-list
6375924|NCT00142467|Bevacizumab|bevacizumab|mesh-list
6375925|NCT00142467|Oxaliplatin|oxaliplatin|mesh-list
6375926|NCT00142467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6375927|NCT00142467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6375928|NCT00142467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6375929|NCT00142467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6375930|NCT00142467|Growth Substances|growth substances|mesh-ancestor
6375931|NCT00142467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375932|NCT00142467|Growth Inhibitors|growth inhibitors|mesh-ancestor
6375933|NCT00142467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6375934|NCT00142467|Antimetabolites|antimetabolites|mesh-ancestor
6375935|NCT00142467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375936|NCT00142467|Antiviral Agents|antiviral agents|mesh-ancestor
6375937|NCT00142467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6375938|NCT00142467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6375939|NCT00142467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6375940|NCT00142467|Immunologic Factors|immunologic factors|mesh-ancestor
6375941|NCT00142480|Bevacizumab|bevacizumab|mesh-list
6375942|NCT00142480|Capecitabine|capecitabine|mesh-list
6375943|NCT00142480|Oxaliplatin|oxaliplatin|mesh-list
6375944|NCT00142480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6375945|NCT00142480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6375946|NCT00142480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6375947|NCT00142480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6375948|NCT00142480|Growth Substances|growth substances|mesh-ancestor
6375949|NCT00142480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375950|NCT00142480|Growth Inhibitors|growth inhibitors|mesh-ancestor
6375951|NCT00142480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6375952|NCT00142480|Antimetabolites|antimetabolites|mesh-ancestor
6375953|NCT00142480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375954|NCT00142493|Midazolam|midazolam|mesh-list
6375955|NCT00142493|Dexmedetomidine|dexmedetomidine|mesh-list
6375956|NCT00142493|Thiopental|thiopental|mesh-list
6375957|NCT00142493|Propofol|propofol|mesh-list
6375958|NCT00142493|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6375959|NCT00142493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6375960|NCT00142493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375961|NCT00142493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6375962|NCT00142493|Anesthetics, General|anesthetics, general|mesh-ancestor
6375963|NCT00142493|Anesthetics|anesthetics|mesh-ancestor
6375964|NCT00142493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6375965|NCT00142493|Analgesics|analgesics|mesh-ancestor
6375966|NCT00142493|Sensory System Agents|sensory system agents|mesh-ancestor
6375967|NCT00142493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6375968|NCT00142493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6375969|NCT00142493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6375970|NCT00142493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6375971|NCT00142493|Adrenergic Agents|adrenergic agents|mesh-ancestor
6375972|NCT00142493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6375973|NCT00142493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375974|NCT00142493|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6375975|NCT00142493|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6375976|NCT00142493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6375977|NCT00142493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6375978|NCT00142493|GABA Modulators|gaba modulators|mesh-ancestor
6375979|NCT00142493|GABA Agents|gaba agents|mesh-ancestor
6375980|NCT00142493|Anticonvulsants|anticonvulsants|mesh-ancestor
6375981|NCT00142545|Apomorphine|apomorphine|mesh-list
6375982|NCT00142545|Emetics|emetics|mesh-ancestor
6375983|NCT00142545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6375984|NCT00142545|Autonomic Agents|autonomic agents|mesh-ancestor
6375985|NCT00142545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6375986|NCT00142545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6375987|NCT00142545|Dopamine Agonists|dopamine agonists|mesh-ancestor
6375988|NCT00142545|Dopamine Agents|dopamine agents|mesh-ancestor
6375989|NCT00142545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6375990|NCT00142545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375991|NCT00142571|Gemcitabine|gemcitabine|mesh-list
6375992|NCT00142571|Docetaxel|docetaxel|mesh-list
6375993|NCT00142571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6375994|NCT00142571|Antimetabolites|antimetabolites|mesh-ancestor
6375995|NCT00142571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6375996|NCT00142571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6375997|NCT00142571|Antiviral Agents|antiviral agents|mesh-ancestor
6375998|NCT00142571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6375999|NCT00142571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6376000|NCT00142571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6376001|NCT00142571|Immunologic Factors|immunologic factors|mesh-ancestor
6376002|NCT00142571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376003|NCT00142571|Tubulin Modulators|tubulin modulators|mesh-ancestor
6376004|NCT00142571|Antimitotic Agents|antimitotic agents|mesh-ancestor
6376005|NCT00142571|Mitosis Modulators|mitosis modulators|mesh-ancestor
6376006|NCT00142584|Metoprolol|metoprolol|mesh-list
6376007|NCT00142584|Nebivolol|nebivolol|mesh-list
6376008|NCT00142584|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6376009|NCT00142584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6376010|NCT00142584|Sympatholytics|sympatholytics|mesh-ancestor
6376011|NCT00142584|Autonomic Agents|autonomic agents|mesh-ancestor
6376012|NCT00142584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6376013|NCT00142584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376014|NCT00142584|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6376015|NCT00142584|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6376016|NCT00142584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6376017|NCT00142584|Adrenergic Agents|adrenergic agents|mesh-ancestor
6376018|NCT00142584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6376019|NCT00142584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376020|NCT00142584|Vasodilator Agents|vasodilator agents|mesh-ancestor
6376021|NCT00142584|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6376022|NCT00142584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6376023|NCT00142584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6376024|NCT00142610|Vitamins|vitamins|mesh-list
6376025|NCT00142610|Vitamin E|vitamin e|mesh-list
6376026|NCT00142610|Micronutrients|micronutrients|mesh-ancestor
6376027|NCT00142610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376028|NCT00142610|Antioxidants|antioxidants|mesh-ancestor
6376029|NCT00142610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376030|NCT00142610|Protective Agents|protective agents|mesh-ancestor
6376031|NCT00142727|Analgesics, Opioid|analgesics, opioid|mesh-list
6376032|NCT00142727|Methadone|methadone|mesh-list
6376033|NCT00142727|Narcotic Antagonists|narcotic antagonists|mesh-list
6376034|NCT00142727|Narcotics|narcotics|mesh-ancestor
6376035|NCT00142727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6376036|NCT00142727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376037|NCT00142727|Analgesics|analgesics|mesh-ancestor
6376038|NCT00142727|Sensory System Agents|sensory system agents|mesh-ancestor
6376039|NCT00142727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6376040|NCT00142727|Antitussive Agents|antitussive agents|mesh-ancestor
6376041|NCT00142727|Respiratory System Agents|respiratory system agents|mesh-ancestor
6376042|NCT00142779|Fluoxetine|fluoxetine|mesh-list
6376043|NCT00142779|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6376044|NCT00142779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6376045|NCT00142779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6376046|NCT00142779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376047|NCT00142779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6376048|NCT00142779|Serotonin Agents|serotonin agents|mesh-ancestor
6376049|NCT00142779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376050|NCT00142779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6376051|NCT00142779|Antidepressive Agents|antidepressive agents|mesh-ancestor
6376052|NCT00142779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6376053|NCT00142779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6376054|NCT00142779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6376055|NCT00142779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6376056|NCT00142844|Naltrexone|naltrexone|mesh-list
6376057|NCT00142844|Disulfiram|disulfiram|mesh-list
6376058|NCT00142844|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6376059|NCT00142844|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6376060|NCT00142844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376061|NCT00142844|Sensory System Agents|sensory system agents|mesh-ancestor
6376062|NCT00142844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6376063|NCT00142844|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
6376064|NCT00142844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6376065|NCT00142844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376066|NCT00142870|Bupropion|bupropion|mesh-list
6376067|NCT00142870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6376068|NCT00142870|Antidepressive Agents|antidepressive agents|mesh-ancestor
6376069|NCT00142870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6376070|NCT00142870|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6376071|NCT00142870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6376072|NCT00142870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6376073|NCT00142870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376074|NCT00142870|Dopamine Agents|dopamine agents|mesh-ancestor
6376075|NCT00142870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6376076|NCT00142870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376077|NCT00142870|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6376078|NCT00142870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6376079|NCT00142870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6376080|NCT00142883|Pregabalin|pregabalin|mesh-list
6376081|NCT00142883|Analgesics|analgesics|mesh-ancestor
6376082|NCT00142883|Sensory System Agents|sensory system agents|mesh-ancestor
6376083|NCT00142883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6376084|NCT00142883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376085|NCT00142883|Anticonvulsants|anticonvulsants|mesh-ancestor
6376086|NCT00142883|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6376087|NCT00142883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6376088|NCT00142883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376089|NCT00142883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6376090|NCT00142883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6376091|NCT00142883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6376092|NCT00142883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6376093|NCT00142883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6376094|NCT00142896|Morphine|morphine|mesh-list
6376095|NCT00142896|Tramadol|tramadol|mesh-list
6376096|NCT00142896|Naloxone|naloxone|mesh-list
6376097|NCT00142896|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6376098|NCT00142896|Narcotics|narcotics|mesh-ancestor
6376099|NCT00142896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6376100|NCT00142896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376101|NCT00142896|Analgesics|analgesics|mesh-ancestor
6376102|NCT00142896|Sensory System Agents|sensory system agents|mesh-ancestor
6376103|NCT00142896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6376104|NCT00142896|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6376105|NCT00142948|Naltrexone|naltrexone|mesh-list
6376106|NCT00142948|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6376107|NCT00142948|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6376108|NCT00142948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376109|NCT00142948|Sensory System Agents|sensory system agents|mesh-ancestor
6376110|NCT00142948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6376111|NCT00142961|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6376112|NCT00142961|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6376113|NCT00142961|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6376114|NCT00142961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6376115|NCT00142961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376116|NCT00142961|Adrenergic Agents|adrenergic agents|mesh-ancestor
6376117|NCT00142961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6376118|NCT00142961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376119|NCT00142974|Tegaserod|tegaserod|mesh-list
6376120|NCT00142974|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6376121|NCT00142974|Serotonin Agents|serotonin agents|mesh-ancestor
6376122|NCT00142974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6376123|NCT00142974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376124|NCT00142974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376125|NCT00142987|Tegaserod|tegaserod|mesh-list
6376126|NCT00142987|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6376127|NCT00142987|Serotonin Agents|serotonin agents|mesh-ancestor
6376128|NCT00142987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6376129|NCT00142987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376130|NCT00142987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376131|NCT00143000|Ribavirin|ribavirin|mesh-list
6376132|NCT00143000|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6376133|NCT00143000|Antimetabolites|antimetabolites|mesh-ancestor
6376134|NCT00143000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376135|NCT00143000|Antiviral Agents|antiviral agents|mesh-ancestor
6376136|NCT00143000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6376137|NCT00143026|Levodopa|levodopa|mesh-list
6376138|NCT00143026|Carbidopa|carbidopa|mesh-list
6376139|NCT00143026|Entacapone|entacapone|mesh-list
6376140|NCT00143026|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6376141|NCT00143026|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6376142|NCT00143026|Dopamine Agents|dopamine agents|mesh-ancestor
6376143|NCT00143026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6376144|NCT00143026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376145|NCT00143026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376146|NCT00143026|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6376147|NCT00143026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6376148|NCT00143026|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6376149|NCT00143065|Rituximab|rituximab|mesh-list
6376150|NCT00143065|Alemtuzumab|alemtuzumab|mesh-list
6376151|NCT00143065|Fludarabine|fludarabine|mesh-list
6376152|NCT00143065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6376153|NCT00143065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6376154|NCT00143065|Immunologic Factors|immunologic factors|mesh-ancestor
6376155|NCT00143065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376156|NCT00143065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6376157|NCT00143091|Sertraline|sertraline|mesh-list
6376158|NCT00143091|Antidepressive Agents|antidepressive agents|mesh-ancestor
6376159|NCT00143091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6376160|NCT00143091|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6376161|NCT00143091|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6376162|NCT00143091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6376163|NCT00143091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376164|NCT00143091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6376165|NCT00143091|Serotonin Agents|serotonin agents|mesh-ancestor
6376166|NCT00143091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376167|NCT00143104|Insulin|insulin|mesh-list
6376168|NCT00143104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6376169|NCT00143104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376170|NCT00143130|Pregabalin|pregabalin|mesh-list
6376171|NCT00143130|Analgesics|analgesics|mesh-ancestor
6376172|NCT00143130|Sensory System Agents|sensory system agents|mesh-ancestor
6376173|NCT00143130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6376174|NCT00143130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376175|NCT00143130|Anticonvulsants|anticonvulsants|mesh-ancestor
6376176|NCT00143130|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6376177|NCT00143130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6376178|NCT00143130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376179|NCT00143130|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6376180|NCT00143130|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6376181|NCT00143130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6376182|NCT00143130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6376183|NCT00143130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6376184|NCT00143143|Pregabalin|pregabalin|mesh-list
6376185|NCT00143143|Analgesics|analgesics|mesh-ancestor
6376186|NCT00143143|Sensory System Agents|sensory system agents|mesh-ancestor
6376187|NCT00143143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6376188|NCT00143143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376189|NCT00143143|Anticonvulsants|anticonvulsants|mesh-ancestor
6376190|NCT00143143|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6376191|NCT00143143|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6376192|NCT00143143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376193|NCT00143143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6376194|NCT00143143|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6376195|NCT00143143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6376196|NCT00143143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6376197|NCT00143143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6376198|NCT00143156|Pregabalin|pregabalin|mesh-list
6376199|NCT00143156|Analgesics|analgesics|mesh-ancestor
6376200|NCT00143156|Sensory System Agents|sensory system agents|mesh-ancestor
6376201|NCT00143156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6376202|NCT00143156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376203|NCT00143156|Anticonvulsants|anticonvulsants|mesh-ancestor
6376204|NCT00143156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6376205|NCT00143156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6376206|NCT00143156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376207|NCT00143156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6376208|NCT00143156|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6376209|NCT00143156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6376210|NCT00143156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6376211|NCT00143156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6376212|NCT00143169|Parecoxib|parecoxib|mesh-list
6376213|NCT00143169|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6376214|NCT00143169|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6376215|NCT00143169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6376216|NCT00143169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376217|NCT00143169|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6376218|NCT00143169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6376219|NCT00143169|Analgesics|analgesics|mesh-ancestor
6376220|NCT00143169|Sensory System Agents|sensory system agents|mesh-ancestor
6376221|NCT00143169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6376222|NCT00143169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376223|NCT00143169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6376224|NCT00143169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6376225|NCT00143195|Amlodipine|amlodipine|mesh-list
6376226|NCT00143195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6376227|NCT00143195|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6376228|NCT00143195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6376229|NCT00143195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376230|NCT00143195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6376231|NCT00143195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376232|NCT00143195|Vasodilator Agents|vasodilator agents|mesh-ancestor
6376233|NCT00143221|Sildenafil Citrate|sildenafil citrate|mesh-list
6376234|NCT00143221|Vasodilator Agents|vasodilator agents|mesh-ancestor
6376235|NCT00143221|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6376236|NCT00143221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6376237|NCT00143221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6376238|NCT00143221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376239|NCT00143221|Urological Agents|urological agents|mesh-ancestor
6376240|NCT00143234|Amlodipine|amlodipine|mesh-list
6376241|NCT00143234|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
6376242|NCT00143234|Atorvastatin|atorvastatin|mesh-list
6376243|NCT00143234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6376244|NCT00143234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6376245|NCT00143234|Antimetabolites|antimetabolites|mesh-ancestor
6376246|NCT00143234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376247|NCT00143234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6376248|NCT00143234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6376249|NCT00143234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6376250|NCT00143234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6376251|NCT00143234|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6376252|NCT00143234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6376253|NCT00143234|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6376254|NCT00143234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376255|NCT00143234|Vasodilator Agents|vasodilator agents|mesh-ancestor
6376256|NCT00143260|Sildenafil Citrate|sildenafil citrate|mesh-list
6376257|NCT00143260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376258|NCT00143260|Vasodilator Agents|vasodilator agents|mesh-ancestor
6376259|NCT00143260|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6376260|NCT00143260|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6376261|NCT00143260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6376262|NCT00143260|Urological Agents|urological agents|mesh-ancestor
6376263|NCT00143286|Varenicline|varenicline|mesh-list
6376264|NCT00143286|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6376265|NCT00143286|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6376266|NCT00143286|Cholinergic Agents|cholinergic agents|mesh-ancestor
6376267|NCT00143286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6376268|NCT00143286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376269|NCT00143286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376270|NCT00143299|Varenicline|varenicline|mesh-list
6376271|NCT00143299|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6376272|NCT00143299|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6376273|NCT00143299|Cholinergic Agents|cholinergic agents|mesh-ancestor
6376274|NCT00143299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6376275|NCT00143299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376276|NCT00143299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376277|NCT00143325|Varenicline|varenicline|mesh-list
6376278|NCT00143325|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6376279|NCT00143325|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6376280|NCT00143325|Cholinergic Agents|cholinergic agents|mesh-ancestor
6376281|NCT00143325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6376282|NCT00143325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376283|NCT00143325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376284|NCT00143338|Insulin|insulin|mesh-list
6376285|NCT00143338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6376286|NCT00143338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376287|NCT00143351|Ziprasidone|ziprasidone|mesh-list
6376288|NCT00143351|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6376289|NCT00143351|Serotonin Agents|serotonin agents|mesh-ancestor
6376290|NCT00143351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6376291|NCT00143351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376292|NCT00143351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376293|NCT00143351|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6376294|NCT00143351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6376295|NCT00143351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6376296|NCT00143351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6376297|NCT00143351|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6376298|NCT00143351|Dopamine Agents|dopamine agents|mesh-ancestor
6376299|NCT00143364|Varenicline|varenicline|mesh-list
6376300|NCT00143364|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6376301|NCT00143364|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6376302|NCT00143364|Cholinergic Agents|cholinergic agents|mesh-ancestor
6376303|NCT00143364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6376304|NCT00143364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376305|NCT00143364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376306|NCT00143377|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6376307|NCT00143377|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6376308|NCT00143377|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6376309|NCT00143377|Cholinergic Agents|cholinergic agents|mesh-ancestor
6376310|NCT00143377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6376311|NCT00143377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376312|NCT00143377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376313|NCT00143377|Urological Agents|urological agents|mesh-ancestor
6376314|NCT00143429|Latanoprost|latanoprost|mesh-list
6376315|NCT00143429|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6376316|NCT00143429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6376317|NCT00143442|Reboxetine|reboxetine|mesh-list
6376318|NCT00143442|Antidepressive Agents|antidepressive agents|mesh-ancestor
6376319|NCT00143442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6376320|NCT00143442|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6376321|NCT00143442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6376322|NCT00143442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6376323|NCT00143442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376324|NCT00143442|Adrenergic Agents|adrenergic agents|mesh-ancestor
6376325|NCT00143442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6376326|NCT00143442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376327|NCT00143481|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6376328|NCT00143481|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6376329|NCT00143481|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6376330|NCT00143481|Cholinergic Agents|cholinergic agents|mesh-ancestor
6376331|NCT00143481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6376332|NCT00143481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376333|NCT00143481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376334|NCT00143481|Urological Agents|urological agents|mesh-ancestor
6395793|NCT00206635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395794|NCT00206635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6395795|NCT00206648|Interferon beta-1b|interferon beta-1b|mesh-list
6395796|NCT00206648|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6395797|NCT00206648|Immunologic Factors|immunologic factors|mesh-ancestor
6395798|NCT00206648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395799|NCT00206661|Molgramostim|molgramostim|mesh-list
6395800|NCT00206661|Sargramostim|sargramostim|mesh-list
6395801|NCT00206661|Immunologic Factors|immunologic factors|mesh-ancestor
6395802|NCT00206661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395803|NCT00206661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6395804|NCT00206674|Sargramostim|sargramostim|mesh-list
6395805|NCT00206674|Immunologic Factors|immunologic factors|mesh-ancestor
6395806|NCT00206674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395807|NCT00206700|Sargramostim|sargramostim|mesh-list
6395808|NCT00206700|Immunologic Factors|immunologic factors|mesh-ancestor
6395809|NCT00206700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395810|NCT00206713|Sargramostim|sargramostim|mesh-list
6395811|NCT00206713|Immunologic Factors|immunologic factors|mesh-ancestor
6395812|NCT00206713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395813|NCT00206739|Pyrimethamine|pyrimethamine|mesh-list
6395814|NCT00206739|Sulfadoxine|sulfadoxine|mesh-list
6395815|NCT00206739|Antimalarials|antimalarials|mesh-ancestor
6395816|NCT00206739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6395817|NCT00206739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6395818|NCT00206739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6395819|NCT00206739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6395820|NCT00206739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6395821|NCT00206739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395822|NCT00206739|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6395823|NCT00206739|Renal Agents|renal agents|mesh-ancestor
6395824|NCT00206765|Risperidone|risperidone|mesh-list
6395825|NCT00206765|Paroxetine|paroxetine|mesh-list
6395826|NCT00206765|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6395827|NCT00206765|Serotonin Agents|serotonin agents|mesh-ancestor
6395828|NCT00206765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6395829|NCT00206765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395830|NCT00206765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395831|NCT00206765|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6395832|NCT00206765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6395833|NCT00206765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6395834|NCT00206765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6395835|NCT00206765|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6395836|NCT00206765|Dopamine Agents|dopamine agents|mesh-ancestor
6395837|NCT00206765|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6395838|NCT00206765|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6395839|NCT00206765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6395840|NCT00206765|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6395841|NCT00206765|Antidepressive Agents|antidepressive agents|mesh-ancestor
6395842|NCT00206765|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6395843|NCT00206765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6395844|NCT00206765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6395845|NCT00206778|Lamotrigine|lamotrigine|mesh-list
6395846|NCT00206778|Valproic Acid|valproic acid|mesh-list
6395847|NCT00206778|Anticonvulsants|anticonvulsants|mesh-ancestor
6395848|NCT00206778|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6395849|NCT00206778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6395850|NCT00206778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395851|NCT00206778|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6395852|NCT00206778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395853|NCT00206778|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6395854|NCT00206778|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6395855|NCT00206778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6395856|NCT00206778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6395857|NCT00206778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6395858|NCT00206778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6395859|NCT00206778|GABA Agents|gaba agents|mesh-ancestor
6395860|NCT00206778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6395861|NCT00206778|Antimanic Agents|antimanic agents|mesh-ancestor
6376335|NCT00143520|Pioglitazone|pioglitazone|mesh-list
6376336|NCT00143520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6376337|NCT00143520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376338|NCT00143533|Cefpodoxime|cefpodoxime|mesh-list
6376339|NCT00143533|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
6376340|NCT00143533|Irinotecan|irinotecan|mesh-list
6376341|NCT00143533|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6376342|NCT00143533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6376343|NCT00143533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6376344|NCT00143533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376345|NCT00143533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6376346|NCT00143533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6376347|NCT00143533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6376348|NCT00143546|Defibrotide|defibrotide|mesh-list
6376349|NCT00143546|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6376350|NCT00143546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6376351|NCT00143546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376352|NCT00143546|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6376353|NCT00143559|Antibodies|antibodies|mesh-list
6376354|NCT00143559|Immunologic Factors|immunologic factors|mesh-ancestor
6376355|NCT00143559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376356|NCT00143572|Hydroxyurea|hydroxyurea|mesh-list
6376357|NCT00143572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6376358|NCT00143572|Antisickling Agents|antisickling agents|mesh-ancestor
6376359|NCT00143572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6376360|NCT00143572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376361|NCT00143572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6376362|NCT00143624|Rosiglitazone|rosiglitazone|mesh-list
6376363|NCT00143624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6376364|NCT00143624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376365|NCT00143676|Atorvastatin|atorvastatin|mesh-list
6376366|NCT00143676|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6376367|NCT00143676|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6376368|NCT00143676|Antimetabolites|antimetabolites|mesh-ancestor
6376369|NCT00143676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376370|NCT00143676|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6376371|NCT00143676|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6376372|NCT00143676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6376373|NCT00143689|Ritonavir|ritonavir|mesh-list
6376374|NCT00143689|Lopinavir|lopinavir|mesh-list
6376375|NCT00143689|Lamivudine|lamivudine|mesh-list
6376376|NCT00143689|Zidovudine|zidovudine|mesh-list
6376377|NCT00143689|Nevirapine|nevirapine|mesh-list
6376378|NCT00143689|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6376379|NCT00143689|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6376380|NCT00143689|Protease Inhibitors|protease inhibitors|mesh-ancestor
6376381|NCT00143689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6376382|NCT00143689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376383|NCT00143689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6376384|NCT00143689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6376385|NCT00143689|Antiviral Agents|antiviral agents|mesh-ancestor
6376386|NCT00143689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6376387|NCT00143689|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6376388|NCT00143689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6376389|NCT00143689|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6376390|NCT00143689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6376391|NCT00143689|Antimetabolites|antimetabolites|mesh-ancestor
6376392|NCT00143689|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6376393|NCT00143689|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6376394|NCT00143702|Riboflavin|riboflavin|mesh-list
6376395|NCT00143702|Thiamine|thiamine|mesh-list
6376396|NCT00143702|Abacavir|abacavir|mesh-list
6376397|NCT00143702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6376398|NCT00143702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6376399|NCT00143702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6376400|NCT00143702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376401|NCT00143702|Antiviral Agents|antiviral agents|mesh-ancestor
6376402|NCT00143702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6376403|NCT00143702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6376404|NCT00143702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6376405|NCT00143702|Vitamin B Complex|vitamin b complex|mesh-ancestor
6376406|NCT00143702|Vitamins|vitamins|mesh-ancestor
6376407|NCT00143702|Micronutrients|micronutrients|mesh-ancestor
6376408|NCT00143702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376409|NCT00143702|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6376410|NCT00143702|Dermatologic Agents|dermatologic agents|mesh-ancestor
6376411|NCT00143715|Vitamin K|vitamin k|mesh-list
6376412|NCT00143715|Vitamin K 1|vitamin k 1|mesh-list
6376413|NCT00143715|Vitamins|vitamins|mesh-ancestor
6376414|NCT00143715|Micronutrients|micronutrients|mesh-ancestor
6376415|NCT00143715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376416|NCT00143715|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6376417|NCT00143715|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6376418|NCT00143715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376419|NCT00143715|Hemostatics|hemostatics|mesh-ancestor
6376420|NCT00143715|Coagulants|coagulants|mesh-ancestor
6376421|NCT00143728|Lamivudine|lamivudine|mesh-list
6376422|NCT00143728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6376423|NCT00143728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6376424|NCT00143728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6376425|NCT00143728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376426|NCT00143728|Antiviral Agents|antiviral agents|mesh-ancestor
6376427|NCT00143728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6376428|NCT00143728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6376429|NCT00143728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6376430|NCT00143741|Atorvastatin|atorvastatin|mesh-list
6376431|NCT00143741|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6376432|NCT00143741|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6376433|NCT00143741|Antimetabolites|antimetabolites|mesh-ancestor
6376434|NCT00143741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376435|NCT00143741|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6376436|NCT00143741|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6376437|NCT00143741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6376438|NCT00143780|Vaccines|vaccines|mesh-list
6376439|NCT00143780|Immunologic Factors|immunologic factors|mesh-ancestor
6376440|NCT00143780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376441|NCT00143806|Cyclosporine|cyclosporine|mesh-list
6376442|NCT00143806|Alefacept|alefacept|mesh-list
6376443|NCT00143806|Cyclosporins|cyclosporins|mesh-list
6376444|NCT00143806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6376445|NCT00143806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376446|NCT00143806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6376447|NCT00143806|Immunologic Factors|immunologic factors|mesh-ancestor
6376448|NCT00143806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376449|NCT00143806|Antifungal Agents|antifungal agents|mesh-ancestor
6376450|NCT00143806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6376451|NCT00143806|Dermatologic Agents|dermatologic agents|mesh-ancestor
6376452|NCT00143806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6376453|NCT00143806|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6376454|NCT00143871|Rituximab|rituximab|mesh-list
6376455|NCT00143871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6376456|NCT00143871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6376457|NCT00143871|Immunologic Factors|immunologic factors|mesh-ancestor
6376458|NCT00143871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376459|NCT00143871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6376460|NCT00143949|Losartan|losartan|mesh-list
6376461|NCT00143949|Enalapril|enalapril|mesh-list
6376462|NCT00143949|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6376463|NCT00143949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6376464|NCT00143949|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6376465|NCT00143949|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6376466|NCT00143949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376467|NCT00143949|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6376468|NCT00143949|Protease Inhibitors|protease inhibitors|mesh-ancestor
6376469|NCT00143949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6376470|NCT00143975|Cytarabine|cytarabine|mesh-list
6376471|NCT00143975|Mitoxantrone|mitoxantrone|mesh-list
6376472|NCT00143975|Gemtuzumab|gemtuzumab|mesh-list
6376473|NCT00143975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6376474|NCT00143975|Antimetabolites|antimetabolites|mesh-ancestor
6376475|NCT00143975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376476|NCT00143975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6376477|NCT00143975|Antiviral Agents|antiviral agents|mesh-ancestor
6376478|NCT00143975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6376479|NCT00143975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6376480|NCT00143975|Immunologic Factors|immunologic factors|mesh-ancestor
6376481|NCT00143975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376482|NCT00143975|Analgesics|analgesics|mesh-ancestor
6376483|NCT00143975|Sensory System Agents|sensory system agents|mesh-ancestor
6376484|NCT00143975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6376485|NCT00143975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6376486|NCT00143975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6376487|NCT00143975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6376488|NCT00143975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6376489|NCT00144040|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6376490|NCT00144040|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6376491|NCT00144040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6376492|NCT00144040|Antitubercular Agents|antitubercular agents|mesh-ancestor
6376493|NCT00144053|Paclitaxel|paclitaxel|mesh-list
6376494|NCT00144053|Vindesine|vindesine|mesh-list
6376495|NCT00144053|Carboplatin|carboplatin|mesh-list
6376496|NCT00144053|Irinotecan|irinotecan|mesh-list
6376497|NCT00144053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6376498|NCT00144053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6376499|NCT00144053|Tubulin Modulators|tubulin modulators|mesh-ancestor
6376500|NCT00144053|Antimitotic Agents|antimitotic agents|mesh-ancestor
6376501|NCT00144053|Mitosis Modulators|mitosis modulators|mesh-ancestor
6376502|NCT00144053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376503|NCT00144053|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6376504|NCT00144053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6376505|NCT00144053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6376506|NCT00144066|Gefitinib|gefitinib|mesh-list
6376507|NCT00144066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6376508|NCT00144066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6376509|NCT00144066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6376510|NCT00144066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376511|NCT00144118|Sevoflurane|sevoflurane|mesh-list
6376512|NCT00144118|Isoflurane|isoflurane|mesh-list
6376513|NCT00144118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6376514|NCT00144118|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6376515|NCT00144118|Anesthetics, General|anesthetics, general|mesh-ancestor
6376516|NCT00144118|Anesthetics|anesthetics|mesh-ancestor
6376517|NCT00144118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6376518|NCT00144118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376519|NCT00144131|Darbepoetin alfa|darbepoetin alfa|mesh-list
6376520|NCT00144131|Hematinics|hematinics|mesh-ancestor
6376521|NCT00144144|Calcium Channel Blockers|calcium channel blockers|mesh-list
6376522|NCT00144144|Angiotensin II|angiotensin ii|mesh-list
6376523|NCT00144144|Giapreza|giapreza|mesh-list
6376524|NCT00144144|Calcium|calcium|mesh-list
6376525|NCT00144144|Angiotensinogen|angiotensinogen|mesh-list
6376526|NCT00144144|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
6376527|NCT00144144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6376528|NCT00144144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376529|NCT00144144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6376530|NCT00144144|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6376531|NCT00144144|Protease Inhibitors|protease inhibitors|mesh-ancestor
6376532|NCT00144144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6376533|NCT00144144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376534|NCT00144144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6376535|NCT00144157|Zidovudine|zidovudine|mesh-list
6376536|NCT00144157|Nevirapine|nevirapine|mesh-list
6376537|NCT00144157|Antimetabolites|antimetabolites|mesh-ancestor
6376538|NCT00144157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376539|NCT00144157|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6376540|NCT00144157|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6376541|NCT00144157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6376542|NCT00144157|Antiviral Agents|antiviral agents|mesh-ancestor
6376543|NCT00144157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6376544|NCT00144157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6376545|NCT00144157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6376546|NCT00144157|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6376547|NCT00144157|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6376548|NCT00144183|Zidovudine|zidovudine|mesh-list
6376549|NCT00144183|Nevirapine|nevirapine|mesh-list
6376550|NCT00144183|Antimetabolites|antimetabolites|mesh-ancestor
6376551|NCT00144183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376552|NCT00144183|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6376553|NCT00144183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6376554|NCT00144183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6376555|NCT00144183|Antiviral Agents|antiviral agents|mesh-ancestor
6376556|NCT00144183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6376557|NCT00144183|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6376558|NCT00144183|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6376559|NCT00144183|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6376560|NCT00144183|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6376561|NCT00144196|Tiotropium Bromide|tiotropium bromide|mesh-list
6376562|NCT00144196|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6376563|NCT00144196|Autonomic Agents|autonomic agents|mesh-ancestor
6376564|NCT00144196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6376565|NCT00144196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376566|NCT00144196|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6376567|NCT00144196|Respiratory System Agents|respiratory system agents|mesh-ancestor
6376568|NCT00144196|Parasympatholytics|parasympatholytics|mesh-ancestor
6376569|NCT00144196|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6376570|NCT00144196|Cholinergic Agents|cholinergic agents|mesh-ancestor
6376571|NCT00144196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6376572|NCT00144196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376573|NCT00144209|Levodopa|levodopa|mesh-list
6376574|NCT00144209|Pramipexole|pramipexole|mesh-list
6376575|NCT00144209|Benserazide|benserazide|mesh-list
6376576|NCT00144209|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6376577|NCT00144209|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6376578|NCT00144209|Dopamine Agents|dopamine agents|mesh-ancestor
6376579|NCT00144209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6376580|NCT00144209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376581|NCT00144209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376582|NCT00144209|Antioxidants|antioxidants|mesh-ancestor
6376583|NCT00144209|Protective Agents|protective agents|mesh-ancestor
6376584|NCT00144209|Dopamine Agonists|dopamine agonists|mesh-ancestor
6376585|NCT00144209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6376586|NCT00144222|Telmisartan|telmisartan|mesh-list
6376587|NCT00144222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6376588|NCT00144222|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6376589|NCT00144222|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6376590|NCT00144222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376591|NCT00144248|Nevirapine|nevirapine|mesh-list
6376592|NCT00144248|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6376593|NCT00144248|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6376594|NCT00144248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6376595|NCT00144248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376596|NCT00144248|Antiviral Agents|antiviral agents|mesh-ancestor
6376597|NCT00144248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6376598|NCT00144248|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6376599|NCT00144248|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6376600|NCT00144248|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6376601|NCT00144248|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6376602|NCT00144261|Nevirapine|nevirapine|mesh-list
6376603|NCT00144261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6376604|NCT00144261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6376605|NCT00144261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6376606|NCT00144261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376607|NCT00144261|Antiviral Agents|antiviral agents|mesh-ancestor
6376608|NCT00144261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6376609|NCT00144261|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6376610|NCT00144261|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6376611|NCT00144261|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6376612|NCT00144261|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6376613|NCT00144274|Ambroxol|ambroxol|mesh-list
6376614|NCT00144274|Expectorants|expectorants|mesh-ancestor
6376615|NCT00144274|Respiratory System Agents|respiratory system agents|mesh-ancestor
6376616|NCT00144287|Ritonavir|ritonavir|mesh-list
6376617|NCT00144287|Tipranavir|tipranavir|mesh-list
6376618|NCT00144287|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6376619|NCT00144287|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6376620|NCT00144287|Protease Inhibitors|protease inhibitors|mesh-ancestor
6376621|NCT00144287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6376622|NCT00144287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376623|NCT00144287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6376624|NCT00144287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6376625|NCT00144287|Antiviral Agents|antiviral agents|mesh-ancestor
6376626|NCT00144287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6376627|NCT00144287|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6376628|NCT00144287|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6376629|NCT00144326|Bromides|bromides|mesh-list
6376630|NCT00144326|Tiotropium Bromide|tiotropium bromide|mesh-list
6376631|NCT00144326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6376632|NCT00144326|Autonomic Agents|autonomic agents|mesh-ancestor
6376633|NCT00144326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6376634|NCT00144326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376635|NCT00144326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6376636|NCT00144326|Respiratory System Agents|respiratory system agents|mesh-ancestor
6376637|NCT00144326|Parasympatholytics|parasympatholytics|mesh-ancestor
6376638|NCT00144326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6376639|NCT00144326|Cholinergic Agents|cholinergic agents|mesh-ancestor
6376640|NCT00144326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6376641|NCT00144326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376642|NCT00144326|Anticonvulsants|anticonvulsants|mesh-ancestor
6376643|NCT00144352|Pyrimethamine|pyrimethamine|mesh-list
6376644|NCT00144352|Sulfadoxine|sulfadoxine|mesh-list
6376645|NCT00144352|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6376646|NCT00144352|Antimalarials|antimalarials|mesh-ancestor
6376647|NCT00144352|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6376648|NCT00144352|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6376649|NCT00144352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6376650|NCT00144352|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6376651|NCT00144352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6376652|NCT00144352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376653|NCT00144352|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6376654|NCT00144352|Renal Agents|renal agents|mesh-ancestor
6376655|NCT00144365|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6376656|NCT00144365|Antiviral Agents|antiviral agents|mesh-ancestor
6376657|NCT00144365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6376658|NCT00144378|Irinotecan|irinotecan|mesh-list
6376659|NCT00144378|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6376660|NCT00144378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6376661|NCT00144378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6376662|NCT00144378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376663|NCT00144378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6376664|NCT00144417|Moxifloxacin|moxifloxacin|mesh-list
6376665|NCT00144417|Rifampin|rifampin|mesh-list
6376666|NCT00144417|Isoniazid|isoniazid|mesh-list
6376667|NCT00144417|Pyrazinamide|pyrazinamide|mesh-list
6376668|NCT00144417|Ethambutol|ethambutol|mesh-list
6376669|NCT00144417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6376670|NCT00144417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6376671|NCT00144417|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6376672|NCT00144417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6376673|NCT00144417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6376674|NCT00144417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376675|NCT00144417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6376676|NCT00144417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6376677|NCT00144417|Antitubercular Agents|antitubercular agents|mesh-ancestor
6376678|NCT00144417|Leprostatic Agents|leprostatic agents|mesh-ancestor
6376679|NCT00144417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6376680|NCT00144417|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6376681|NCT00144417|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6376682|NCT00144417|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6376683|NCT00144417|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6376684|NCT00144417|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6376685|NCT00144417|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6376686|NCT00144417|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6376687|NCT00144417|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6376688|NCT00144417|Antimetabolites|antimetabolites|mesh-ancestor
6376689|NCT00144417|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6376690|NCT00144430|Pentostatin|pentostatin|mesh-list
6376691|NCT00144430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6376692|NCT00144430|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
6376693|NCT00144430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6376694|NCT00144430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376695|NCT00144456|Alfacalcidol|alfacalcidol|mesh-list
6376696|NCT00144456|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
6376697|NCT00144456|Eldecalcitol|eldecalcitol|mesh-list
6376698|NCT00144456|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6376699|NCT00144456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376700|NCT00144456|Vitamins|vitamins|mesh-ancestor
6376701|NCT00144456|Micronutrients|micronutrients|mesh-ancestor
6376702|NCT00144469|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6376703|NCT00144469|Antiviral Agents|antiviral agents|mesh-ancestor
6376704|NCT00144469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6376705|NCT00144482|Epoetin Alfa|epoetin alfa|mesh-list
6376706|NCT00144482|Hematinics|hematinics|mesh-ancestor
6376707|NCT00144495|Epoetin Alfa|epoetin alfa|mesh-list
6376708|NCT00144495|Hematinics|hematinics|mesh-ancestor
6376709|NCT00144677|Sirolimus|sirolimus|mesh-list
6376710|NCT00144677|Tacrolimus|tacrolimus|mesh-list
6376711|NCT00144677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6376712|NCT00144677|Immunologic Factors|immunologic factors|mesh-ancestor
6376713|NCT00144677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376714|NCT00144677|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6376715|NCT00144677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6376716|NCT00144677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376717|NCT00144677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6376718|NCT00144677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6376719|NCT00144677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6376720|NCT00144677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6376721|NCT00144677|Antifungal Agents|antifungal agents|mesh-ancestor
6376722|NCT00144703|Sirolimus|sirolimus|mesh-list
6376723|NCT00144703|Tacrolimus|tacrolimus|mesh-list
6376724|NCT00144703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6376725|NCT00144703|Immunologic Factors|immunologic factors|mesh-ancestor
6376726|NCT00144703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376727|NCT00144703|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6376728|NCT00144703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6376729|NCT00144703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376730|NCT00144703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6376731|NCT00144703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6376732|NCT00144703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6376733|NCT00144703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6376734|NCT00144703|Antifungal Agents|antifungal agents|mesh-ancestor
6376735|NCT00144716|Insect Repellents|insect repellents|mesh-list
6376736|NCT00144716|Protective Agents|protective agents|mesh-ancestor
6376737|NCT00144716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376738|NCT00144755|Darbepoetin alfa|darbepoetin alfa|mesh-list
6376739|NCT00144755|Hematinics|hematinics|mesh-ancestor
6376740|NCT00144807|Cyclophosphamide|cyclophosphamide|mesh-list
6376741|NCT00144807|Rituximab|rituximab|mesh-list
6376742|NCT00144807|Doxorubicin|doxorubicin|mesh-list
6376743|NCT00144807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6376744|NCT00144807|Immunologic Factors|immunologic factors|mesh-ancestor
6376745|NCT00144807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376746|NCT00144807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6376747|NCT00144807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6376748|NCT00144807|Alkylating Agents|alkylating agents|mesh-ancestor
6376749|NCT00144807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376750|NCT00144807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6376751|NCT00144807|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6376752|NCT00144807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6376753|NCT00144807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6376754|NCT00144807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6376755|NCT00144807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6376756|NCT00144807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6376757|NCT00144820|Hyaluronic Acid|hyaluronic acid|mesh-list
6376758|NCT00144820|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6376759|NCT00144820|Immunologic Factors|immunologic factors|mesh-ancestor
6376760|NCT00144820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376761|NCT00144820|Viscosupplements|viscosupplements|mesh-ancestor
6376762|NCT00144820|Protective Agents|protective agents|mesh-ancestor
6376763|NCT00144833|Ritonavir|ritonavir|mesh-list
6376764|NCT00144833|Lopinavir|lopinavir|mesh-list
6376765|NCT00144833|Fosamprenavir|fosamprenavir|mesh-list
6376766|NCT00144833|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6376767|NCT00144833|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6376768|NCT00144833|Protease Inhibitors|protease inhibitors|mesh-ancestor
6376769|NCT00144833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6376770|NCT00144833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376771|NCT00144833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6376772|NCT00144833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6376773|NCT00144833|Antiviral Agents|antiviral agents|mesh-ancestor
6376774|NCT00144833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6376775|NCT00144833|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6376776|NCT00144833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6376777|NCT00144846|Albuterol|albuterol|mesh-list
6376778|NCT00144846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6376779|NCT00144846|Autonomic Agents|autonomic agents|mesh-ancestor
6376780|NCT00144846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6376781|NCT00144846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376782|NCT00144846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6376783|NCT00144846|Respiratory System Agents|respiratory system agents|mesh-ancestor
6376784|NCT00144846|Tocolytic Agents|tocolytic agents|mesh-ancestor
6376785|NCT00144846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6376786|NCT00144846|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6376787|NCT00144846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6376788|NCT00144846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6376789|NCT00144846|Adrenergic Agents|adrenergic agents|mesh-ancestor
6376790|NCT00144846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6376791|NCT00144846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376792|NCT00144872|Lamotrigine|lamotrigine|mesh-list
6376793|NCT00144872|Anticonvulsants|anticonvulsants|mesh-ancestor
6376794|NCT00144872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6376795|NCT00144872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6376796|NCT00144872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376797|NCT00144872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6376798|NCT00144872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376799|NCT00144872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6376800|NCT00144872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6376801|NCT00144872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6376802|NCT00144872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6376803|NCT00144872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6376804|NCT00144911|Fluticasone|fluticasone|mesh-list
6376805|NCT00144911|Xhance|xhance|mesh-list
6376806|NCT00144911|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6376807|NCT00144911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6376808|NCT00144911|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6376809|NCT00144911|Autonomic Agents|autonomic agents|mesh-ancestor
6376810|NCT00144911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6376811|NCT00144911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376812|NCT00144911|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6376813|NCT00144911|Respiratory System Agents|respiratory system agents|mesh-ancestor
6376814|NCT00144911|Dermatologic Agents|dermatologic agents|mesh-ancestor
6376815|NCT00144911|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6376816|NCT00144911|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6376817|NCT00144911|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6376818|NCT00144911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6376819|NCT00144911|Adrenergic Agents|adrenergic agents|mesh-ancestor
6376820|NCT00144911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6376821|NCT00144911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376822|NCT00144976|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6376823|NCT00144976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6376824|NCT00144976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6376825|NCT00144976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6376826|NCT00144976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376827|NCT00144989|Cisplatin|cisplatin|mesh-list
6376828|NCT00144989|Irinotecan|irinotecan|mesh-list
6376829|NCT00144989|Etoposide|etoposide|mesh-list
6376830|NCT00144989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6376831|NCT00144989|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6376832|NCT00144989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6376833|NCT00144989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6376834|NCT00144989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376835|NCT00144989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6376836|NCT00144989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6395862|NCT00206856|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6395863|NCT00206856|Natriuretic Agents|natriuretic agents|mesh-ancestor
6395864|NCT00206856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395865|NCT00206934|Dexetimide|dexetimide|mesh-list
6395866|NCT00206934|Citalopram|citalopram|mesh-list
6395867|NCT00206934|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6395868|NCT00206934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6395869|NCT00206934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6395870|NCT00206934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395871|NCT00206934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6395872|NCT00206934|Serotonin Agents|serotonin agents|mesh-ancestor
6395873|NCT00206934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395874|NCT00206934|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6395875|NCT00206934|Antidepressive Agents|antidepressive agents|mesh-ancestor
6395876|NCT00206934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6395877|NCT00206934|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6395878|NCT00206934|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6395879|NCT00206934|Parasympatholytics|parasympatholytics|mesh-ancestor
6395880|NCT00206934|Autonomic Agents|autonomic agents|mesh-ancestor
6395881|NCT00206934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6395882|NCT00206934|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6395883|NCT00206934|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6395884|NCT00206934|Cholinergic Agents|cholinergic agents|mesh-ancestor
6395885|NCT00206947|Ziprasidone|ziprasidone|mesh-list
6395886|NCT00206947|Donepezil|donepezil|mesh-list
6395887|NCT00206947|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6395888|NCT00206947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6395889|NCT00206947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395890|NCT00206947|Cholinergic Agents|cholinergic agents|mesh-ancestor
6395891|NCT00206947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6395892|NCT00206947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395893|NCT00206947|Nootropic Agents|nootropic agents|mesh-ancestor
6395894|NCT00206947|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6395895|NCT00206947|Serotonin Agents|serotonin agents|mesh-ancestor
6395896|NCT00206947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6395897|NCT00206947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6395898|NCT00206947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6395899|NCT00206947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6395900|NCT00206947|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6395901|NCT00206947|Dopamine Agents|dopamine agents|mesh-ancestor
6395902|NCT00206960|Risperidone|risperidone|mesh-list
6395903|NCT00206960|Clopenthixol|clopenthixol|mesh-list
6395904|NCT00206960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6395905|NCT00206960|Serotonin Agents|serotonin agents|mesh-ancestor
6395906|NCT00206960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6395907|NCT00206960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395908|NCT00206960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395909|NCT00206960|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6395910|NCT00206960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6395911|NCT00206960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6395912|NCT00206960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6395913|NCT00206960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6395914|NCT00206960|Dopamine Agents|dopamine agents|mesh-ancestor
6395915|NCT00206973|Mannitol|mannitol|mesh-list
6395916|NCT00206973|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6395917|NCT00206973|Diuretics|diuretics|mesh-ancestor
6395918|NCT00206973|Natriuretic Agents|natriuretic agents|mesh-ancestor
6395919|NCT00206973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376837|NCT00145002|Lenograstim|lenograstim|mesh-list
6376838|NCT00145002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6376839|NCT00145002|Immunologic Factors|immunologic factors|mesh-ancestor
6376840|NCT00145002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376841|NCT00145028|Carboplatin|carboplatin|mesh-list
6376842|NCT00145028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6376843|NCT00145093|Chromium|chromium|mesh-list
6376844|NCT00145093|Trace Elements|trace elements|mesh-ancestor
6376845|NCT00145093|Micronutrients|micronutrients|mesh-ancestor
6376846|NCT00145093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376847|NCT00145106|Minocycline|minocycline|mesh-list
6376848|NCT00145106|Tazarotene|tazarotene|mesh-list
6376849|NCT00145106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6376850|NCT00145106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6376851|NCT00145106|Dermatologic Agents|dermatologic agents|mesh-ancestor
6376852|NCT00145106|Keratolytic Agents|keratolytic agents|mesh-ancestor
6376853|NCT00145171|Apomorphine|apomorphine|mesh-list
6376854|NCT00145171|Emetics|emetics|mesh-ancestor
6376855|NCT00145171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376856|NCT00145171|Autonomic Agents|autonomic agents|mesh-ancestor
6376857|NCT00145171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6376858|NCT00145171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6376859|NCT00145171|Dopamine Agonists|dopamine agonists|mesh-ancestor
6376860|NCT00145171|Dopamine Agents|dopamine agents|mesh-ancestor
6376861|NCT00145171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6376862|NCT00145171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376863|NCT00145184|Vitamins|vitamins|mesh-list
6376864|NCT00145184|Vitamin B Complex|vitamin b complex|mesh-list
6376865|NCT00145184|Micronutrients|micronutrients|mesh-ancestor
6376866|NCT00145184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376867|NCT00145210|Atenolol|atenolol|mesh-list
6376868|NCT00145210|Nebivolol|nebivolol|mesh-list
6376869|NCT00145210|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6376870|NCT00145210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6376871|NCT00145210|Sympatholytics|sympatholytics|mesh-ancestor
6376872|NCT00145210|Autonomic Agents|autonomic agents|mesh-ancestor
6376873|NCT00145210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6376874|NCT00145210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376875|NCT00145210|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6376876|NCT00145210|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6376877|NCT00145210|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6376878|NCT00145210|Adrenergic Agents|adrenergic agents|mesh-ancestor
6376879|NCT00145210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6376880|NCT00145210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376881|NCT00145210|Vasodilator Agents|vasodilator agents|mesh-ancestor
6376882|NCT00145210|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6376883|NCT00145210|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6376884|NCT00145210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6376885|NCT00145236|Nebivolol|nebivolol|mesh-list
6376886|NCT00145236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6376887|NCT00145236|Vasodilator Agents|vasodilator agents|mesh-ancestor
6376888|NCT00145236|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6376889|NCT00145236|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6376890|NCT00145236|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6376891|NCT00145236|Adrenergic Agents|adrenergic agents|mesh-ancestor
6376892|NCT00145236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6376893|NCT00145236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376894|NCT00145236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376895|NCT00145275|Zoledronic Acid|zoledronic acid|mesh-list
6376896|NCT00145275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6376897|NCT00145275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376898|NCT00145301|Lumiracoxib|lumiracoxib|mesh-list
6376899|NCT00145301|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6376900|NCT00145301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6376901|NCT00145301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6376902|NCT00145301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376903|NCT00145301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6376904|NCT00145301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6376905|NCT00145301|Analgesics|analgesics|mesh-ancestor
6376906|NCT00145301|Sensory System Agents|sensory system agents|mesh-ancestor
6376907|NCT00145301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6376908|NCT00145301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376909|NCT00145301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6376910|NCT00145301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6376911|NCT00145314|Leucovorin|leucovorin|mesh-list
6376912|NCT00145314|Folic Acid|folic acid|mesh-list
6376913|NCT00145314|Fluorouracil|fluorouracil|mesh-list
6376914|NCT00145314|Oxaliplatin|oxaliplatin|mesh-list
6376915|NCT00145314|Cetuximab|cetuximab|mesh-list
6376916|NCT00145314|Levoleucovorin|levoleucovorin|mesh-list
6376917|NCT00145314|Antimetabolites|antimetabolites|mesh-ancestor
6376918|NCT00145314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376919|NCT00145314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6376920|NCT00145314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6376921|NCT00145314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6376922|NCT00145314|Immunologic Factors|immunologic factors|mesh-ancestor
6376923|NCT00145314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376924|NCT00145314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6376925|NCT00145314|Antidotes|antidotes|mesh-ancestor
6376926|NCT00145314|Protective Agents|protective agents|mesh-ancestor
6376927|NCT00145314|Vitamin B Complex|vitamin b complex|mesh-ancestor
6376928|NCT00145314|Vitamins|vitamins|mesh-ancestor
6376929|NCT00145314|Micronutrients|micronutrients|mesh-ancestor
6376930|NCT00145314|Hematinics|hematinics|mesh-ancestor
6376931|NCT00145340|Pioglitazone|pioglitazone|mesh-list
6376932|NCT00145340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6376933|NCT00145340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376934|NCT00145353|Insulin Aspart|insulin aspart|mesh-list
6376935|NCT00145353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6376936|NCT00145353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376937|NCT00145379|Metformin|metformin|mesh-list
6376938|NCT00145379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6376939|NCT00145379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376940|NCT00145405|Octreotide|octreotide|mesh-list
6376941|NCT00145405|Lanreotide|lanreotide|mesh-list
6376942|NCT00145405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6376943|NCT00145405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6376944|NCT00145405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6376945|NCT00145444|Olanzapine|olanzapine|mesh-list
6376946|NCT00145444|Ziprasidone|ziprasidone|mesh-list
6376947|NCT00145444|Antiemetics|antiemetics|mesh-ancestor
6376948|NCT00145444|Autonomic Agents|autonomic agents|mesh-ancestor
6376949|NCT00145444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6376950|NCT00145444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376951|NCT00145444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6376952|NCT00145444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6376953|NCT00145444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6376954|NCT00145444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6376955|NCT00145444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6376956|NCT00145444|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6376957|NCT00145444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6376958|NCT00145444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6376959|NCT00145444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376960|NCT00145444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6376961|NCT00145444|Serotonin Agents|serotonin agents|mesh-ancestor
6376962|NCT00145444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6376963|NCT00145444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6376964|NCT00145444|Dopamine Agents|dopamine agents|mesh-ancestor
6376965|NCT00145483|Sildenafil Citrate|sildenafil citrate|mesh-list
6376966|NCT00145483|Vasodilator Agents|vasodilator agents|mesh-ancestor
6376967|NCT00145483|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6376968|NCT00145483|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6376969|NCT00145483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6376970|NCT00145483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376971|NCT00145483|Urological Agents|urological agents|mesh-ancestor
6376972|NCT00145522|Tibolone|tibolone|mesh-list
6376973|NCT00145522|Estradiol|estradiol|mesh-list
6376974|NCT00145522|Dydrogesterone|dydrogesterone|mesh-list
6376975|NCT00145522|Estrogens|estrogens|mesh-ancestor
6376976|NCT00145522|Hormones|hormones|mesh-ancestor
6376977|NCT00145522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6376978|NCT00145522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6376979|NCT00145522|Progestins|progestins|mesh-ancestor
6376980|NCT00145522|Androgen Antagonists|androgen antagonists|mesh-ancestor
6376981|NCT00145522|Hormone Antagonists|hormone antagonists|mesh-ancestor
6376982|NCT00145522|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6376983|NCT00145522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6376984|NCT00145522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6376985|NCT00145522|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6376986|NCT00145522|Anabolic Agents|anabolic agents|mesh-ancestor
6376987|NCT00145561|Ritonavir|ritonavir|mesh-list
6376988|NCT00145561|Saquinavir|saquinavir|mesh-list
6376989|NCT00145561|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6376990|NCT00145561|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6376991|NCT00145561|Protease Inhibitors|protease inhibitors|mesh-ancestor
6376992|NCT00145561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6376993|NCT00145561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6376994|NCT00145561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6376995|NCT00145561|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6376996|NCT00145561|Antiviral Agents|antiviral agents|mesh-ancestor
6376997|NCT00145561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6376998|NCT00145561|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6376999|NCT00145561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6377000|NCT00145613|Antibodies|antibodies|mesh-list
6377001|NCT00145613|Immunologic Factors|immunologic factors|mesh-ancestor
6377002|NCT00145613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6377003|NCT00145639|Carboplatin|carboplatin|mesh-list
6377004|NCT00145639|Doxorubicin|doxorubicin|mesh-list
6377005|NCT00145639|Ifosfamide|ifosfamide|mesh-list
6377006|NCT00145639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6377007|NCT00145639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6377008|NCT00145639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6377009|NCT00145639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6377010|NCT00145639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6377011|NCT00145639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377012|NCT00145639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6377013|NCT00145639|Alkylating Agents|alkylating agents|mesh-ancestor
6377014|NCT00145652|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6377015|NCT00145652|Hematinics|hematinics|mesh-ancestor
6377016|NCT00145665|Telbivudine|telbivudine|mesh-list
6377017|NCT00145665|Antiviral Agents|antiviral agents|mesh-ancestor
6377018|NCT00145665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6377019|NCT00145665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6377020|NCT00145665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6377021|NCT00145665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377022|NCT00145691|Oxcarbazepine|oxcarbazepine|mesh-list
6377023|NCT00145691|Anticonvulsants|anticonvulsants|mesh-ancestor
6377024|NCT00145691|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6377025|NCT00145691|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6377026|NCT00145691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6377027|NCT00145691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377028|NCT00145691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6377029|NCT00145691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6377030|NCT00145730|Ibuprofen|ibuprofen|mesh-list
6377031|NCT00145730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6377032|NCT00145730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6377033|NCT00145730|Analgesics|analgesics|mesh-ancestor
6377034|NCT00145730|Sensory System Agents|sensory system agents|mesh-ancestor
6377035|NCT00145730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6377036|NCT00145730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6377037|NCT00145730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6377038|NCT00145730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6377039|NCT00145730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6377040|NCT00145730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6377041|NCT00145730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377042|NCT00145847|Naltrexone|naltrexone|mesh-list
6377043|NCT00145847|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6377044|NCT00145847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6377045|NCT00145847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6377046|NCT00145847|Sensory System Agents|sensory system agents|mesh-ancestor
6377047|NCT00145847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6377048|NCT00145873|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6377049|NCT00145873|Natriuretic Agents|natriuretic agents|mesh-ancestor
6377050|NCT00145873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6377051|NCT00145886|Parathyroid Hormone|parathyroid hormone|mesh-list
6377052|NCT00145886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6377053|NCT00145886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6377054|NCT00145925|Gliclazide|gliclazide|mesh-list
6377055|NCT00145925|Perindopril|perindopril|mesh-list
6377056|NCT00145925|Indapamide|indapamide|mesh-list
6377057|NCT00145925|Indapamide, perindopril drug combination|indapamide, perindopril drug combination|mesh-list
6377058|NCT00145925|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6377059|NCT00145925|Protease Inhibitors|protease inhibitors|mesh-ancestor
6377060|NCT00145925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6377061|NCT00145925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377062|NCT00145925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6377063|NCT00145925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6377064|NCT00145925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6377065|NCT00145925|Diuretics|diuretics|mesh-ancestor
6377066|NCT00145925|Natriuretic Agents|natriuretic agents|mesh-ancestor
6377067|NCT00145925|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6377068|NCT00145925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6377069|NCT00145938|Sildenafil Citrate|sildenafil citrate|mesh-list
6377070|NCT00145938|Vasodilator Agents|vasodilator agents|mesh-ancestor
6377071|NCT00145938|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6377072|NCT00145938|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6377073|NCT00145938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6377074|NCT00145938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377075|NCT00145938|Urological Agents|urological agents|mesh-ancestor
6377076|NCT00145990|Methacholine Chloride|methacholine chloride|mesh-list
6377077|NCT00145990|Miotics|miotics|mesh-ancestor
6377078|NCT00145990|Autonomic Agents|autonomic agents|mesh-ancestor
6377079|NCT00145990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6377080|NCT00145990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6377081|NCT00145990|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6377082|NCT00145990|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
6377083|NCT00145990|Respiratory System Agents|respiratory system agents|mesh-ancestor
6377084|NCT00145990|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6377085|NCT00145990|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6377086|NCT00145990|Cholinergic Agents|cholinergic agents|mesh-ancestor
6377087|NCT00145990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6377088|NCT00145990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377089|NCT00146016|Amantadine|amantadine|mesh-list
6377090|NCT00146016|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6377091|NCT00146016|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6377092|NCT00146016|Antiviral Agents|antiviral agents|mesh-ancestor
6377093|NCT00146016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6377094|NCT00146016|Dopamine Agents|dopamine agents|mesh-ancestor
6377095|NCT00146016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6377096|NCT00146016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377097|NCT00146016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6377098|NCT00146016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6377099|NCT00146016|Analgesics|analgesics|mesh-ancestor
6377100|NCT00146016|Sensory System Agents|sensory system agents|mesh-ancestor
6377101|NCT00146016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6377102|NCT00146042|Erythromycin|erythromycin|mesh-list
6377103|NCT00146042|Erythromycin Estolate|erythromycin estolate|mesh-list
6377104|NCT00146042|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
6377105|NCT00146042|Erythromycin stearate|erythromycin stearate|mesh-list
6377106|NCT00146042|Docetaxel|docetaxel|mesh-list
6377107|NCT00146042|Trastuzumab|trastuzumab|mesh-list
6377108|NCT00146042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6377109|NCT00146042|Tubulin Modulators|tubulin modulators|mesh-ancestor
6377110|NCT00146042|Antimitotic Agents|antimitotic agents|mesh-ancestor
6377111|NCT00146042|Mitosis Modulators|mitosis modulators|mesh-ancestor
6377112|NCT00146042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377113|NCT00146042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6377114|NCT00146042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6377115|NCT00146042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6377116|NCT00146042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6377117|NCT00146042|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6377118|NCT00146042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6377119|NCT00146068|Interferon beta-1a|interferon beta-1a|mesh-list
6377120|NCT00146068|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6377121|NCT00146068|Immunologic Factors|immunologic factors|mesh-ancestor
6377122|NCT00146068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6377123|NCT00146068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6377124|NCT00146068|Antiviral Agents|antiviral agents|mesh-ancestor
6377125|NCT00146068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6377126|NCT00146120|Etoposide|etoposide|mesh-list
6377127|NCT00146120|Idarubicin|idarubicin|mesh-list
6377128|NCT00146120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6377129|NCT00146120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6377130|NCT00146120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6377131|NCT00146120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6377132|NCT00146120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6377133|NCT00146120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377134|NCT00146120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6377135|NCT00146146|Letrozole|letrozole|mesh-list
6377136|NCT00146146|Methyltestosterone|methyltestosterone|mesh-list
6377137|NCT00146146|Dutasteride|dutasteride|mesh-list
6377138|NCT00146146|Testosterone|testosterone|mesh-list
6377139|NCT00146146|Testosterone undecanoate|testosterone undecanoate|mesh-list
6377140|NCT00146146|Testosterone enanthate|testosterone enanthate|mesh-list
6377141|NCT00146146|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6377142|NCT00146146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6377143|NCT00146146|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6377144|NCT00146146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6377145|NCT00146146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6377146|NCT00146146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377147|NCT00146146|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6377148|NCT00146146|Hormone Antagonists|hormone antagonists|mesh-ancestor
6377149|NCT00146146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6377150|NCT00146146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6377151|NCT00146146|Androgens|androgens|mesh-ancestor
6377152|NCT00146146|Hormones|hormones|mesh-ancestor
6377153|NCT00146146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6377154|NCT00146146|Anabolic Agents|anabolic agents|mesh-ancestor
6377155|NCT00146146|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6377156|NCT00146159|Mitoxantrone|mitoxantrone|mesh-list
6377157|NCT00146159|Analgesics|analgesics|mesh-ancestor
6377158|NCT00146159|Sensory System Agents|sensory system agents|mesh-ancestor
6377159|NCT00146159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6377160|NCT00146159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6377161|NCT00146159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6377162|NCT00146159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6377163|NCT00146159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6377164|NCT00146159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6377165|NCT00146159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395920|NCT00206986|Clonidine|clonidine|mesh-list
6377166|NCT00146211|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
6377167|NCT00146211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6377168|NCT00146211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6377169|NCT00146224|Epoetin Alfa|epoetin alfa|mesh-list
6377170|NCT00146224|Hematinics|hematinics|mesh-ancestor
6377171|NCT00146237|Phenytoin|phenytoin|mesh-list
6377172|NCT00146237|Anticonvulsants|anticonvulsants|mesh-ancestor
6377173|NCT00146237|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6377174|NCT00146237|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6377175|NCT00146237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6377176|NCT00146237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377177|NCT00146237|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6377178|NCT00146237|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6377179|NCT00146250|Nitrous Oxide|nitrous oxide|mesh-list
6377180|NCT00146250|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6377181|NCT00146250|Anesthetics, General|anesthetics, general|mesh-ancestor
6377182|NCT00146250|Anesthetics|anesthetics|mesh-ancestor
6377183|NCT00146250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6377184|NCT00146250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6377185|NCT00146250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6377186|NCT00146250|Analgesics|analgesics|mesh-ancestor
6377187|NCT00146250|Sensory System Agents|sensory system agents|mesh-ancestor
6377188|NCT00146250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6377189|NCT00146276|Gemcitabine|gemcitabine|mesh-list
6377190|NCT00146276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6377191|NCT00146276|Antimetabolites|antimetabolites|mesh-ancestor
6377192|NCT00146276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377193|NCT00146276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6377194|NCT00146276|Antiviral Agents|antiviral agents|mesh-ancestor
6377195|NCT00146276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6377196|NCT00146276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6377197|NCT00146276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6377198|NCT00146276|Immunologic Factors|immunologic factors|mesh-ancestor
6377199|NCT00146276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6377200|NCT00146289|Telmisartan|telmisartan|mesh-list
6377201|NCT00146289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6377202|NCT00146289|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6377203|NCT00146289|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6377204|NCT00146289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377205|NCT00146341|Telmisartan|telmisartan|mesh-list
6377206|NCT00146341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6377207|NCT00146341|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6377208|NCT00146341|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6377209|NCT00146341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377210|NCT00146380|Lamivudine|lamivudine|mesh-list
6377211|NCT00146380|Zidovudine|zidovudine|mesh-list
6377212|NCT00146380|Nevirapine|nevirapine|mesh-list
6377213|NCT00146380|Nelfinavir|nelfinavir|mesh-list
6377214|NCT00146380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6377215|NCT00146380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6377216|NCT00146380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6377217|NCT00146380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377218|NCT00146380|Antiviral Agents|antiviral agents|mesh-ancestor
6377219|NCT00146380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6377220|NCT00146380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6377221|NCT00146380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6377222|NCT00146380|Antimetabolites|antimetabolites|mesh-ancestor
6377223|NCT00146380|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6377224|NCT00146380|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6377225|NCT00146380|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6377226|NCT00146380|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6377227|NCT00146380|Protease Inhibitors|protease inhibitors|mesh-ancestor
6377228|NCT00146458|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6377229|NCT00146458|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6377230|NCT00146458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377231|NCT00146471|Levetiracetam|levetiracetam|mesh-list
6377232|NCT00146471|Anticonvulsants|anticonvulsants|mesh-ancestor
6377233|NCT00146471|Nootropic Agents|nootropic agents|mesh-ancestor
6377234|NCT00146484|Insulin|insulin|mesh-list
6377235|NCT00146484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6377236|NCT00146484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6377237|NCT00146497|Budesonide|budesonide|mesh-list
6377238|NCT00146497|Pulmonary Surfactants|pulmonary surfactants|mesh-list
6377239|NCT00146497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6377240|NCT00146497|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6377241|NCT00146497|Autonomic Agents|autonomic agents|mesh-ancestor
6377242|NCT00146497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6377243|NCT00146497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6377244|NCT00146497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6377245|NCT00146497|Respiratory System Agents|respiratory system agents|mesh-ancestor
6377246|NCT00146497|Glucocorticoids|glucocorticoids|mesh-ancestor
6377247|NCT00146497|Hormones|hormones|mesh-ancestor
6377248|NCT00146497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6377249|NCT00146523|Mifepristone|mifepristone|mesh-list
6377250|NCT00146523|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6377251|NCT00146523|Abortifacient Agents|abortifacient agents|mesh-ancestor
6377252|NCT00146523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6377253|NCT00146523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6377254|NCT00146523|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6377255|NCT00146523|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6377256|NCT00146523|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6377257|NCT00146523|Contraceptive Agents|contraceptive agents|mesh-ancestor
6377258|NCT00146523|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6377259|NCT00146523|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6377260|NCT00146523|Hormone Antagonists|hormone antagonists|mesh-ancestor
6377261|NCT00146523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6377262|NCT00146523|Luteolytic Agents|luteolytic agents|mesh-ancestor
6377263|NCT00146523|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6377264|NCT00146523|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6377265|NCT00146549|Paclitaxel|paclitaxel|mesh-list
6377266|NCT00146549|Vinorelbine|vinorelbine|mesh-list
6377267|NCT00146549|Docetaxel|docetaxel|mesh-list
6377268|NCT00146549|Trastuzumab|trastuzumab|mesh-list
6377269|NCT00146549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6377270|NCT00146549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6377271|NCT00146549|Tubulin Modulators|tubulin modulators|mesh-ancestor
6377272|NCT00146549|Antimitotic Agents|antimitotic agents|mesh-ancestor
6377273|NCT00146549|Mitosis Modulators|mitosis modulators|mesh-ancestor
6377274|NCT00146549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377275|NCT00146549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6377276|NCT00146562|Paclitaxel|paclitaxel|mesh-list
6377277|NCT00146562|Cyclophosphamide|cyclophosphamide|mesh-list
6377278|NCT00146562|Doxorubicin|doxorubicin|mesh-list
6377279|NCT00146562|Darbepoetin alfa|darbepoetin alfa|mesh-list
6377280|NCT00146562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6377281|NCT00146562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6377282|NCT00146562|Tubulin Modulators|tubulin modulators|mesh-ancestor
6377283|NCT00146562|Antimitotic Agents|antimitotic agents|mesh-ancestor
6377284|NCT00146562|Mitosis Modulators|mitosis modulators|mesh-ancestor
6377285|NCT00146562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377286|NCT00146562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6377287|NCT00146562|Immunologic Factors|immunologic factors|mesh-ancestor
6377288|NCT00146562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6377289|NCT00146562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6377290|NCT00146562|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6377291|NCT00146562|Alkylating Agents|alkylating agents|mesh-ancestor
6377292|NCT00146562|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6377293|NCT00146562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6377294|NCT00146562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6377295|NCT00146562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6377296|NCT00146562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6377297|NCT00146562|Hematinics|hematinics|mesh-ancestor
6395921|NCT00206986|Analgesics|analgesics|mesh-ancestor
6395922|NCT00206986|Sensory System Agents|sensory system agents|mesh-ancestor
6395923|NCT00206986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6395924|NCT00206986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395925|NCT00206986|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6395926|NCT00206986|Sympatholytics|sympatholytics|mesh-ancestor
6395927|NCT00206986|Autonomic Agents|autonomic agents|mesh-ancestor
6395928|NCT00206986|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6395929|NCT00206986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6395930|NCT00206986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6395931|NCT00206986|Adrenergic Agents|adrenergic agents|mesh-ancestor
6395932|NCT00206986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6395933|NCT00206986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397038|NCT00209963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397039|NCT00209989|Tipifarnib|tipifarnib|mesh-list
6397040|NCT00209989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6397096|NCT00210210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397097|NCT00210301|Modafinil|modafinil|mesh-list
6397098|NCT00210301|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6397099|NCT00210301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397100|NCT00210301|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6397101|NCT00210301|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6397102|NCT00210301|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6397103|NCT00210301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397104|NCT00210314|Cytarabine|cytarabine|mesh-list
6397105|NCT00210314|Methotrexate|methotrexate|mesh-list
6397106|NCT00210314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6397107|NCT00210314|Abortifacient Agents|abortifacient agents|mesh-ancestor
6397108|NCT00210314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6397109|NCT00210314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397110|NCT00210314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6397111|NCT00210314|Antimetabolites|antimetabolites|mesh-ancestor
6397112|NCT00210314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397113|NCT00210314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6397114|NCT00210314|Dermatologic Agents|dermatologic agents|mesh-ancestor
6397115|NCT00210314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6397116|NCT00210314|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6397117|NCT00210314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6397118|NCT00210314|Immunologic Factors|immunologic factors|mesh-ancestor
6397119|NCT00210314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5724650|NCT03185871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6377298|NCT00146575|Sirolimus|sirolimus|mesh-list
6377299|NCT00146575|Paclitaxel|paclitaxel|mesh-list
6377300|NCT00146575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6377301|NCT00146575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6377302|NCT00146575|Tubulin Modulators|tubulin modulators|mesh-ancestor
6377303|NCT00146575|Antimitotic Agents|antimitotic agents|mesh-ancestor
6377304|NCT00146575|Mitosis Modulators|mitosis modulators|mesh-ancestor
6377305|NCT00146575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377306|NCT00146575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6377307|NCT00146575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6377308|NCT00146575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6017497|NCT00373113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017498|NCT00373113|Growth Inhibitors|growth inhibitors|mesh-ancestor
6017499|NCT00373113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6377309|NCT00146575|Antifungal Agents|antifungal agents|mesh-ancestor
6377310|NCT00146575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6377311|NCT00146575|Immunologic Factors|immunologic factors|mesh-ancestor
6377312|NCT00146575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6377313|NCT00146588|Cyclophosphamide|cyclophosphamide|mesh-list
6377314|NCT00146588|Capecitabine|capecitabine|mesh-list
6377315|NCT00146588|Epirubicin|epirubicin|mesh-list
6377316|NCT00146588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6377317|NCT00146588|Immunologic Factors|immunologic factors|mesh-ancestor
6377318|NCT00146588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6377319|NCT00146588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6377320|NCT00146588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6377321|NCT00146588|Alkylating Agents|alkylating agents|mesh-ancestor
6377322|NCT00146588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377323|NCT00146588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6377324|NCT00146588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6377325|NCT00146588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6377326|NCT00146588|Antimetabolites|antimetabolites|mesh-ancestor
6377327|NCT00146588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6377328|NCT00146588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6377329|NCT00146588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6377330|NCT00146588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6377331|NCT00146601|Fulvestrant|fulvestrant|mesh-list
6377332|NCT00146601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6377333|NCT00146601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6377334|NCT00146601|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6377335|NCT00146601|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6377336|NCT00146601|Hormone Antagonists|hormone antagonists|mesh-ancestor
6377337|NCT00146601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6377338|NCT00146601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6377339|NCT00146614|Sirolimus|sirolimus|mesh-list
6377340|NCT00146614|Methotrexate|methotrexate|mesh-list
6377341|NCT00146614|Tacrolimus|tacrolimus|mesh-list
6377342|NCT00146614|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6377343|NCT00146614|Abortifacient Agents|abortifacient agents|mesh-ancestor
6377344|NCT00146614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6377345|NCT00146614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6377346|NCT00146614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6377347|NCT00146614|Antimetabolites|antimetabolites|mesh-ancestor
6377348|NCT00146614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377349|NCT00146614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6377350|NCT00146614|Dermatologic Agents|dermatologic agents|mesh-ancestor
6377351|NCT00146614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6377352|NCT00146614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6377353|NCT00146614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6377354|NCT00146614|Immunologic Factors|immunologic factors|mesh-ancestor
6377355|NCT00146614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6377356|NCT00146614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6377357|NCT00146614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6377358|NCT00146614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6377359|NCT00146614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6377360|NCT00146614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6377361|NCT00146614|Antifungal Agents|antifungal agents|mesh-ancestor
6377362|NCT00146627|Eflornithine|eflornithine|mesh-list
6377363|NCT00146627|Nifurtimox|nifurtimox|mesh-list
6377364|NCT00146627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6377365|NCT00146627|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6377366|NCT00146627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6377367|NCT00146627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6377368|NCT00146627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6377369|NCT00146627|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
6377370|NCT00146627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6377371|NCT00146627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377372|NCT00146718|Pyrimethamine|pyrimethamine|mesh-list
6377373|NCT00146718|Sulfadoxine|sulfadoxine|mesh-list
6377374|NCT00146718|Amodiaquine|amodiaquine|mesh-list
6377375|NCT00146718|Antimalarials|antimalarials|mesh-ancestor
6377376|NCT00146718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6377377|NCT00146718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6377378|NCT00146718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6377379|NCT00146718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6377380|NCT00146718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6377381|NCT00146718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377382|NCT00146718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6377383|NCT00146718|Renal Agents|renal agents|mesh-ancestor
6377384|NCT00146731|Artesunate|artesunate|mesh-list
6377385|NCT00146731|Amodiaquine|amodiaquine|mesh-list
6377386|NCT00146731|Dapsone|dapsone|mesh-list
6377387|NCT00146731|Chlorproguanil|chlorproguanil|mesh-list
6377388|NCT00146731|Antimalarials|antimalarials|mesh-ancestor
6377389|NCT00146731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6377390|NCT00146731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6377391|NCT00146731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6377392|NCT00146731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6377393|NCT00146731|Antiviral Agents|antiviral agents|mesh-ancestor
6377394|NCT00146731|Schistosomicides|schistosomicides|mesh-ancestor
6377395|NCT00146731|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6377396|NCT00146731|Anthelmintics|anthelmintics|mesh-ancestor
6377397|NCT00146731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6377398|NCT00146731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6377399|NCT00146731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377400|NCT00146731|Leprostatic Agents|leprostatic agents|mesh-ancestor
6377401|NCT00146731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6377402|NCT00146783|Pyrimethamine|pyrimethamine|mesh-list
6377403|NCT00146783|Sulfadoxine|sulfadoxine|mesh-list
6377404|NCT00146783|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6377405|NCT00146783|Amodiaquine|amodiaquine|mesh-list
6377406|NCT00146783|Antimalarials|antimalarials|mesh-ancestor
6377407|NCT00146783|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6377408|NCT00146783|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6017500|NCT00373113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6377409|NCT00146783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6377410|NCT00146783|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6377411|NCT00146783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6377412|NCT00146783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377413|NCT00146783|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6377414|NCT00146783|Renal Agents|renal agents|mesh-ancestor
6377415|NCT00146835|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6377416|NCT00146835|Immunologic Factors|immunologic factors|mesh-ancestor
6377417|NCT00146835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6377418|NCT00146900|Citalopram|citalopram|mesh-list
6377419|NCT00146900|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6377420|NCT00146900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6377421|NCT00146900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6377422|NCT00146900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377423|NCT00146900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6377424|NCT00146900|Serotonin Agents|serotonin agents|mesh-ancestor
6377425|NCT00146900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6377426|NCT00146900|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6377427|NCT00146900|Antidepressive Agents|antidepressive agents|mesh-ancestor
6377428|NCT00146900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6377429|NCT00146913|Interferons|interferons|mesh-list
6377430|NCT00146913|Imatinib Mesylate|imatinib mesylate|mesh-list
6377431|NCT00146913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6377432|NCT00146913|Antiviral Agents|antiviral agents|mesh-ancestor
6377433|NCT00146913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6377434|NCT00146913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6377435|NCT00146913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6377436|NCT00146913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377437|NCT00146926|Lidocaine|lidocaine|mesh-list
6377438|NCT00146926|Ephedrine|ephedrine|mesh-list
6377439|NCT00146926|Ketamine|ketamine|mesh-list
6377440|NCT00146926|Anesthetics, Local|anesthetics, local|mesh-ancestor
6377441|NCT00146926|Anesthetics|anesthetics|mesh-ancestor
6377442|NCT00146926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6377443|NCT00146926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6377444|NCT00146926|Sensory System Agents|sensory system agents|mesh-ancestor
6377445|NCT00146926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6377446|NCT00146926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6377447|NCT00146926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6377448|NCT00146926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6377449|NCT00146926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6377450|NCT00146926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377451|NCT00146926|Analgesics|analgesics|mesh-ancestor
6377452|NCT00146926|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6377453|NCT00146926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6377454|NCT00146926|Anesthetics, General|anesthetics, general|mesh-ancestor
6377455|NCT00146926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6377456|NCT00146926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6377457|NCT00146926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6377458|NCT00146926|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6377459|NCT00146926|Sympathomimetics|sympathomimetics|mesh-ancestor
6377460|NCT00146926|Autonomic Agents|autonomic agents|mesh-ancestor
6377461|NCT00146926|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6377462|NCT00146926|Adrenergic Agents|adrenergic agents|mesh-ancestor
6377463|NCT00147004|Hydrocortisone|hydrocortisone|mesh-list
6377464|NCT00147004|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6377465|NCT00147004|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6377466|NCT00147004|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6377467|NCT00147004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6377468|NCT00147121|Rituximab|rituximab|mesh-list
6377469|NCT00147121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6377470|NCT00147121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6377471|NCT00147121|Immunologic Factors|immunologic factors|mesh-ancestor
6377472|NCT00147121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6377473|NCT00147121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6377474|NCT00147160|Temozolomide|temozolomide|mesh-list
6377475|NCT00147160|Cisplatin|cisplatin|mesh-list
6377476|NCT00147160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6377477|NCT00147160|Alkylating Agents|alkylating agents|mesh-ancestor
6377478|NCT00147160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377479|NCT00147160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6377480|NCT00147186|Hylan|hylan|mesh-list
6377481|NCT00147186|Viscosupplements|viscosupplements|mesh-ancestor
6377482|NCT00147186|Protective Agents|protective agents|mesh-ancestor
6377483|NCT00147186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6377484|NCT00147264|Telmisartan|telmisartan|mesh-list
6377485|NCT00147264|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6377486|NCT00147264|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6377487|NCT00147264|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6377488|NCT00147264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377489|NCT00147303|Sarpogrelate|sarpogrelate|mesh-list
6377490|NCT00147303|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6377491|NCT00147303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6377492|NCT00147303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377493|NCT00147303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6377494|NCT00147303|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6377495|NCT00147303|Serotonin Agents|serotonin agents|mesh-ancestor
6377496|NCT00147303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6377497|NCT00147303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6377498|NCT00147355|Acetaminophen|acetaminophen|mesh-list
6377499|NCT00147355|Ibuprofen|ibuprofen|mesh-list
6377500|NCT00147355|Codeine|codeine|mesh-list
6377501|NCT00147355|Ondansetron|ondansetron|mesh-list
6377502|NCT00147355|Metoclopramide|metoclopramide|mesh-list
6395934|NCT00206999|Imipramine|imipramine|mesh-list
6377503|NCT00147355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6377504|NCT00147355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6377505|NCT00147355|Analgesics|analgesics|mesh-ancestor
6377506|NCT00147355|Sensory System Agents|sensory system agents|mesh-ancestor
6377507|NCT00147355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6377508|NCT00147355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6377509|NCT00147355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6377510|NCT00147355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6377511|NCT00147355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6377512|NCT00147355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6377513|NCT00147355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377514|NCT00147355|Antipyretics|antipyretics|mesh-ancestor
6377515|NCT00147355|Antiemetics|antiemetics|mesh-ancestor
6377516|NCT00147355|Autonomic Agents|autonomic agents|mesh-ancestor
6377517|NCT00147355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6377518|NCT00147355|Antipruritics|antipruritics|mesh-ancestor
6377519|NCT00147355|Dermatologic Agents|dermatologic agents|mesh-ancestor
6377520|NCT00147355|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6377521|NCT00147355|Serotonin Agents|serotonin agents|mesh-ancestor
6377522|NCT00147355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6377523|NCT00147355|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6377524|NCT00147355|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6377525|NCT00147355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6377526|NCT00147355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6377527|NCT00147355|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6377528|NCT00147355|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6377529|NCT00147355|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6017501|NCT00373256|Paclitaxel|paclitaxel|mesh-list
6017502|NCT00373256|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6017503|NCT00373256|Bevacizumab|bevacizumab|mesh-list
6017504|NCT00373256|Sunitinib|sunitinib|mesh-list
6017505|NCT00373256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6377530|NCT00147355|Dopamine Agents|dopamine agents|mesh-ancestor
6377531|NCT00147355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6377532|NCT00147355|Narcotics|narcotics|mesh-ancestor
6377533|NCT00147355|Antitussive Agents|antitussive agents|mesh-ancestor
6377534|NCT00147355|Respiratory System Agents|respiratory system agents|mesh-ancestor
6377535|NCT00147381|Alemtuzumab|alemtuzumab|mesh-list
6377536|NCT00147381|Tacrolimus|tacrolimus|mesh-list
6377537|NCT00147381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6377538|NCT00147381|Immunologic Factors|immunologic factors|mesh-ancestor
6377539|NCT00147381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6377540|NCT00147381|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6377541|NCT00147381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6377542|NCT00147381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377543|NCT00147381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6377544|NCT00147381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6377545|NCT00147394|Risperidone|risperidone|mesh-list
6377546|NCT00147394|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6377547|NCT00147394|Serotonin Agents|serotonin agents|mesh-ancestor
6377548|NCT00147394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6377549|NCT00147394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377550|NCT00147394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6377551|NCT00147394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6377552|NCT00147394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6377553|NCT00147394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6377554|NCT00147394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6377555|NCT00147394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6377556|NCT00147394|Dopamine Agents|dopamine agents|mesh-ancestor
6377557|NCT00147511|Linezolid|linezolid|mesh-list
6377558|NCT00147511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6377559|NCT00147511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6377560|NCT00147511|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6377561|NCT00147511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6377562|NCT00147511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377563|NCT00147524|Quinapril|quinapril|mesh-list
6377564|NCT00147524|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6377565|NCT00147524|Protease Inhibitors|protease inhibitors|mesh-ancestor
6377566|NCT00147524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6377567|NCT00147524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017506|NCT00373256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6377568|NCT00147524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6377569|NCT00147563|Eplerenone|eplerenone|mesh-list
6377570|NCT00147563|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6377571|NCT00147563|Hormone Antagonists|hormone antagonists|mesh-ancestor
6377572|NCT00147563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6377573|NCT00147563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6377574|NCT00147563|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6377575|NCT00147563|Diuretics|diuretics|mesh-ancestor
6377576|NCT00147563|Natriuretic Agents|natriuretic agents|mesh-ancestor
6377577|NCT00147563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6377578|NCT00147589|Eplerenone|eplerenone|mesh-list
6377579|NCT00147589|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6377580|NCT00147589|Hormone Antagonists|hormone antagonists|mesh-ancestor
6377581|NCT00147589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6377582|NCT00147589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6377583|NCT00147589|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6377584|NCT00147589|Diuretics|diuretics|mesh-ancestor
6377585|NCT00147589|Natriuretic Agents|natriuretic agents|mesh-ancestor
6377586|NCT00147589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6377587|NCT00147602|Atorvastatin|atorvastatin|mesh-list
6377588|NCT00147602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6377589|NCT00147602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6377590|NCT00147602|Antimetabolites|antimetabolites|mesh-ancestor
6377591|NCT00147602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377592|NCT00147602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6377593|NCT00147602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6377594|NCT00147602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6377595|NCT00147615|Eplerenone|eplerenone|mesh-list
6377596|NCT00147615|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6377597|NCT00147615|Hormone Antagonists|hormone antagonists|mesh-ancestor
6377598|NCT00147615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6377599|NCT00147615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6377600|NCT00147615|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6377601|NCT00147615|Diuretics|diuretics|mesh-ancestor
6377602|NCT00147615|Natriuretic Agents|natriuretic agents|mesh-ancestor
6377603|NCT00147615|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6377604|NCT00147628|Sildenafil Citrate|sildenafil citrate|mesh-list
6377605|NCT00147628|Citric Acid|citric acid|mesh-list
6377606|NCT00147628|Sodium Citrate|sodium citrate|mesh-list
6377607|NCT00147628|Anticoagulants|anticoagulants|mesh-ancestor
6377608|NCT00147628|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6377609|NCT00147628|Chelating Agents|chelating agents|mesh-ancestor
6377610|NCT00147628|Sequestering Agents|sequestering agents|mesh-ancestor
6377611|NCT00147628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377612|NCT00147628|Vasodilator Agents|vasodilator agents|mesh-ancestor
6377613|NCT00147628|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6377614|NCT00147628|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6377615|NCT00147628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6377616|NCT00147628|Urological Agents|urological agents|mesh-ancestor
6377617|NCT00147654|Tamsulosin|tamsulosin|mesh-list
6377618|NCT00147654|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6377619|NCT00147654|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6377620|NCT00147654|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6377621|NCT00147654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6377622|NCT00147654|Adrenergic Agents|adrenergic agents|mesh-ancestor
6377623|NCT00147654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6377624|NCT00147654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377625|NCT00147654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6377626|NCT00147654|Urological Agents|urological agents|mesh-ancestor
6377627|NCT00147654|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6377628|NCT00147654|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6377629|NCT00147654|Cholinergic Agents|cholinergic agents|mesh-ancestor
6377630|NCT00147667|Erythromycin|erythromycin|mesh-list
6377631|NCT00147667|Erythromycin Estolate|erythromycin estolate|mesh-list
6377632|NCT00147667|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
6377633|NCT00147667|Erythromycin stearate|erythromycin stearate|mesh-list
6377634|NCT00147667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6377635|NCT00147667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6377636|NCT00147667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6377637|NCT00147667|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6377638|NCT00147667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6377639|NCT00147667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377640|NCT00147680|Paclitaxel|paclitaxel|mesh-list
6377641|NCT00147680|Carboplatin|carboplatin|mesh-list
6377642|NCT00147680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6377643|NCT00147680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6377644|NCT00147680|Tubulin Modulators|tubulin modulators|mesh-ancestor
6377645|NCT00147680|Antimitotic Agents|antimitotic agents|mesh-ancestor
6377646|NCT00147680|Mitosis Modulators|mitosis modulators|mesh-ancestor
6377647|NCT00147680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377648|NCT00147719|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
6377649|NCT00147719|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6377650|NCT00147719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6377651|NCT00147719|Antimetabolites|antimetabolites|mesh-ancestor
6377652|NCT00147719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377653|NCT00147719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6377654|NCT00147758|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
6377655|NCT00147758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6377656|NCT00147758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6377657|NCT00147758|Antimetabolites|antimetabolites|mesh-ancestor
6377658|NCT00147758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377659|NCT00147758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6377660|NCT00147771|Imiquimod|imiquimod|mesh-list
6377661|NCT00147771|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6377662|NCT00147771|Immunologic Factors|immunologic factors|mesh-ancestor
6377663|NCT00147771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6377664|NCT00147771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6377665|NCT00147771|Interferon Inducers|interferon inducers|mesh-ancestor
6377666|NCT00147784|Interferons|interferons|mesh-list
6377667|NCT00147784|Ribavirin|ribavirin|mesh-list
6377668|NCT00147784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6377669|NCT00147784|Antiviral Agents|antiviral agents|mesh-ancestor
6377670|NCT00147784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6377671|NCT00147784|Antimetabolites|antimetabolites|mesh-ancestor
6377672|NCT00147784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377673|NCT00147836|Insulin|insulin|mesh-list
6377674|NCT00147836|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6377675|NCT00147836|Metformin|metformin|mesh-list
6377676|NCT00147836|Gliclazide|gliclazide|mesh-list
6377677|NCT00147836|Isophane Insulin, Human|isophane insulin, human|mesh-list
6377678|NCT00147836|Insulin, Isophane|insulin, isophane|mesh-list
6377679|NCT00147836|Isophane insulin, beef|isophane insulin, beef|mesh-list
6377680|NCT00147836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6377681|NCT00147836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6377682|NCT00147862|Tranexamic Acid|tranexamic acid|mesh-list
6377683|NCT00147862|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6377684|NCT00147862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6377685|NCT00147862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377686|NCT00147862|Hemostatics|hemostatics|mesh-ancestor
6377687|NCT00147862|Coagulants|coagulants|mesh-ancestor
6377688|NCT00147875|Gemcitabine|gemcitabine|mesh-list
6377689|NCT00147875|Prednisone|prednisone|mesh-list
6377690|NCT00147875|Doxorubicin|doxorubicin|mesh-list
6377691|NCT00147875|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6377692|NCT00147875|Vinblastine|vinblastine|mesh-list
6377693|NCT00147875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6377694|NCT00147875|Antimetabolites|antimetabolites|mesh-ancestor
6377695|NCT00147875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377696|NCT00147875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6377697|NCT00147875|Antiviral Agents|antiviral agents|mesh-ancestor
6377698|NCT00147875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6377699|NCT00147875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6377700|NCT00147875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6377701|NCT00147875|Immunologic Factors|immunologic factors|mesh-ancestor
6377702|NCT00147875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6377703|NCT00147875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6377704|NCT00147875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6377705|NCT00147875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6377706|NCT00147875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6377707|NCT00147875|Glucocorticoids|glucocorticoids|mesh-ancestor
6377708|NCT00147875|Hormones|hormones|mesh-ancestor
6377709|NCT00147875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6377710|NCT00147875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6377711|NCT00147875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6377712|NCT00147875|Tubulin Modulators|tubulin modulators|mesh-ancestor
6377713|NCT00147875|Antimitotic Agents|antimitotic agents|mesh-ancestor
6017507|NCT00373256|Tubulin Modulators|tubulin modulators|mesh-ancestor
6377714|NCT00147875|Mitosis Modulators|mitosis modulators|mesh-ancestor
6377715|NCT00147901|Cyclophosphamide|cyclophosphamide|mesh-list
6377716|NCT00147901|Fludarabine|fludarabine|mesh-list
6377717|NCT00147901|Alemtuzumab|alemtuzumab|mesh-list
6377718|NCT00147901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6377719|NCT00147901|Immunologic Factors|immunologic factors|mesh-ancestor
6377720|NCT00147901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6377721|NCT00147901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6377722|NCT00147901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6377723|NCT00147901|Alkylating Agents|alkylating agents|mesh-ancestor
6377724|NCT00147901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377725|NCT00147901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6377726|NCT00147901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6377727|NCT00147901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6377728|NCT00147914|Amoxicillin|amoxicillin|mesh-list
6377729|NCT00147914|Clavulanic Acid|clavulanic acid|mesh-list
6377730|NCT00147914|Clavulanic Acids|clavulanic acids|mesh-list
6377731|NCT00147914|Cefdinir|cefdinir|mesh-list
6377732|NCT00147914|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6377733|NCT00147914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6377734|NCT00147914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6377735|NCT00147914|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6377736|NCT00147914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6377737|NCT00147914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377738|NCT00147953|Rituximab|rituximab|mesh-list
6377739|NCT00147953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6377740|NCT00147953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6377741|NCT00147953|Immunologic Factors|immunologic factors|mesh-ancestor
6377742|NCT00147953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6377743|NCT00147953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6377744|NCT00147979|Heparin|heparin|mesh-list
6377745|NCT00147979|Calcium heparin|calcium heparin|mesh-list
6377746|NCT00147979|Anticoagulants|anticoagulants|mesh-ancestor
6377747|NCT00147979|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6377748|NCT00147979|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6377749|NCT00147979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377750|NCT00148005|Cholinergic Antagonists|cholinergic antagonists|mesh-list
6377751|NCT00148005|Cholinergic Agents|cholinergic agents|mesh-ancestor
6377752|NCT00148005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6377753|NCT00148005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377754|NCT00148005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6377755|NCT00148018|Dexamethasone|dexamethasone|mesh-list
6377756|NCT00148018|Bortezomib|bortezomib|mesh-list
6377757|NCT00148018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6377758|NCT00148018|Antiemetics|antiemetics|mesh-ancestor
6377759|NCT00148018|Autonomic Agents|autonomic agents|mesh-ancestor
6377760|NCT00148018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6377761|NCT00148018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6377762|NCT00148018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6377763|NCT00148018|Glucocorticoids|glucocorticoids|mesh-ancestor
6377764|NCT00148018|Hormones|hormones|mesh-ancestor
6377765|NCT00148018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6377766|NCT00148018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6377767|NCT00148018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6377768|NCT00148031|Interferons|interferons|mesh-list
6377769|NCT00148031|Ribavirin|ribavirin|mesh-list
6377770|NCT00148031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6377771|NCT00148031|Antiviral Agents|antiviral agents|mesh-ancestor
6377772|NCT00148031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6377773|NCT00148031|Antimetabolites|antimetabolites|mesh-ancestor
6377774|NCT00148031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377775|NCT00148070|Erythromycin|erythromycin|mesh-list
6377776|NCT00148070|Erythromycin Estolate|erythromycin estolate|mesh-list
6377777|NCT00148070|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
6377778|NCT00148070|Erythromycin stearate|erythromycin stearate|mesh-list
6377779|NCT00148070|Docetaxel|docetaxel|mesh-list
6377780|NCT00148070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6377781|NCT00148070|Tubulin Modulators|tubulin modulators|mesh-ancestor
6377782|NCT00148070|Antimitotic Agents|antimitotic agents|mesh-ancestor
6377783|NCT00148070|Mitosis Modulators|mitosis modulators|mesh-ancestor
6377784|NCT00148070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377785|NCT00148070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6377786|NCT00148070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6377787|NCT00148070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6377788|NCT00148070|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6377789|NCT00148070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6377790|NCT00148083|Risperidone|risperidone|mesh-list
6377791|NCT00148083|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6377792|NCT00148083|Serotonin Agents|serotonin agents|mesh-ancestor
6377793|NCT00148083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6377794|NCT00148083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377795|NCT00148083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6377796|NCT00148083|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6377797|NCT00148083|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6377798|NCT00148083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6377799|NCT00148083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6377800|NCT00148083|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6377801|NCT00148083|Dopamine Agents|dopamine agents|mesh-ancestor
6377802|NCT00148135|Gemcitabine|gemcitabine|mesh-list
6377803|NCT00148135|Carboplatin|carboplatin|mesh-list
6377804|NCT00148135|Capecitabine|capecitabine|mesh-list
6377805|NCT00148135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6377806|NCT00148135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6377807|NCT00148135|Antimetabolites|antimetabolites|mesh-ancestor
6377808|NCT00148135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377809|NCT00148135|Antiviral Agents|antiviral agents|mesh-ancestor
6377810|NCT00148135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6377811|NCT00148135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6377812|NCT00148135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6377813|NCT00148135|Immunologic Factors|immunologic factors|mesh-ancestor
6377814|NCT00148135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6377815|NCT00148148|Amphotericin B|amphotericin b|mesh-list
6377816|NCT00148148|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6377817|NCT00148148|Caspofungin|caspofungin|mesh-list
6377818|NCT00148148|Amebicides|amebicides|mesh-ancestor
6377819|NCT00148148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6377820|NCT00148148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6377821|NCT00148148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6377822|NCT00148148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6377823|NCT00148148|Antifungal Agents|antifungal agents|mesh-ancestor
6377824|NCT00148148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6377825|NCT00148148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377826|NCT00148252|Mycophenolic Acid|mycophenolic acid|mesh-list
6377827|NCT00148252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6377828|NCT00148252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6377829|NCT00148252|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6377830|NCT00148252|Antitubercular Agents|antitubercular agents|mesh-ancestor
6377831|NCT00148252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6377832|NCT00148252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6377833|NCT00148252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6377834|NCT00148252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377835|NCT00148265|Triamcinolone|triamcinolone|mesh-list
6377836|NCT00148265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6377837|NCT00148265|Glucocorticoids|glucocorticoids|mesh-ancestor
6377838|NCT00148265|Hormones|hormones|mesh-ancestor
6377839|NCT00148265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6377840|NCT00148265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395935|NCT00206999|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6395936|NCT00206999|Antidepressive Agents|antidepressive agents|mesh-ancestor
6395937|NCT00206999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6395938|NCT00206999|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6395939|NCT00206999|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6395940|NCT00206999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6395941|NCT00206999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395942|NCT00206999|Adrenergic Agents|adrenergic agents|mesh-ancestor
6395943|NCT00206999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6395944|NCT00206999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395945|NCT00207051|Cetuximab|cetuximab|mesh-list
6395946|NCT00207051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6395947|NCT00207051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6395948|NCT00207064|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6395949|NCT00207064|Antidepressive Agents|antidepressive agents|mesh-ancestor
6395950|NCT00207064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6395951|NCT00207064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6395952|NCT00207064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6395953|NCT00207064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6395954|NCT00207064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395955|NCT00207077|Cetuximab|cetuximab|mesh-list
6395956|NCT00207077|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6395957|NCT00207077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6395958|NCT00207077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6395959|NCT00207077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6395960|NCT00207077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6395961|NCT00207077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395962|NCT00207116|Cetuximab|cetuximab|mesh-list
6395963|NCT00207116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6395964|NCT00207116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6395965|NCT00207129|Capecitabine|capecitabine|mesh-list
6395966|NCT00207129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6395967|NCT00207129|Antimetabolites|antimetabolites|mesh-ancestor
6395968|NCT00207129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395969|NCT00207129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6395970|NCT00207155|Cetuximab|cetuximab|mesh-list
6395971|NCT00207155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6395972|NCT00207155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6395973|NCT00207311|Interferons|interferons|mesh-list
6395974|NCT00207311|Interferon-alpha|interferon-alpha|mesh-list
6395975|NCT00207311|Interferon alpha-2|interferon alpha-2|mesh-list
6395976|NCT00207311|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6395977|NCT00207311|Orlistat|orlistat|mesh-list
6395978|NCT00207311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6395979|NCT00207311|Antiviral Agents|antiviral agents|mesh-ancestor
6395980|NCT00207311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6395981|NCT00207311|Immunologic Factors|immunologic factors|mesh-ancestor
6377841|NCT00148278|Dobutamine|dobutamine|mesh-list
6377842|NCT00148278|Epinephrine|epinephrine|mesh-list
6377843|NCT00148278|Norepinephrine|norepinephrine|mesh-list
6377844|NCT00148278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6377845|NCT00148278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6377846|NCT00148278|Adrenergic Agents|adrenergic agents|mesh-ancestor
6377847|NCT00148278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6377848|NCT00148278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377849|NCT00148278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6377850|NCT00148278|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6377851|NCT00148278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6377852|NCT00148278|Autonomic Agents|autonomic agents|mesh-ancestor
6377853|NCT00148278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6377854|NCT00148278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6377855|NCT00148278|Respiratory System Agents|respiratory system agents|mesh-ancestor
6377856|NCT00148278|Mydriatics|mydriatics|mesh-ancestor
6377857|NCT00148278|Sympathomimetics|sympathomimetics|mesh-ancestor
6377858|NCT00148278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6377859|NCT00148278|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6377860|NCT00148278|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6377861|NCT00148278|Protective Agents|protective agents|mesh-ancestor
6377862|NCT00148291|Docetaxel|docetaxel|mesh-list
6377863|NCT00148291|Vinorelbine|vinorelbine|mesh-list
6377864|NCT00148291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6377865|NCT00148291|Tubulin Modulators|tubulin modulators|mesh-ancestor
6377866|NCT00148291|Antimitotic Agents|antimitotic agents|mesh-ancestor
6377867|NCT00148291|Mitosis Modulators|mitosis modulators|mesh-ancestor
6377868|NCT00148291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017508|NCT00373256|Antimitotic Agents|antimitotic agents|mesh-ancestor
6017509|NCT00373256|Mitosis Modulators|mitosis modulators|mesh-ancestor
6377869|NCT00148291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6377870|NCT00148330|Triamcinolone|triamcinolone|mesh-list
6377871|NCT00148330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6377872|NCT00148330|Glucocorticoids|glucocorticoids|mesh-ancestor
6377873|NCT00148330|Hormones|hormones|mesh-ancestor
6377874|NCT00148330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6377875|NCT00148330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6377876|NCT00148356|Paclitaxel|paclitaxel|mesh-list
6377877|NCT00148356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6377878|NCT00148356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6377879|NCT00148356|Tubulin Modulators|tubulin modulators|mesh-ancestor
6377880|NCT00148356|Antimitotic Agents|antimitotic agents|mesh-ancestor
6377881|NCT00148356|Mitosis Modulators|mitosis modulators|mesh-ancestor
6377882|NCT00148356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377883|NCT00148382|Cetilistat|cetilistat|mesh-list
6377884|NCT00148382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6377885|NCT00148382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377886|NCT00148382|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6017510|NCT00373256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377887|NCT00148382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6377888|NCT00148395|Gemcitabine|gemcitabine|mesh-list
6377889|NCT00148395|Carboplatin|carboplatin|mesh-list
6377890|NCT00148395|Ifosfamide|ifosfamide|mesh-list
6377891|NCT00148395|Mitomycins|mitomycins|mesh-list
6377892|NCT00148395|Mitomycin|mitomycin|mesh-list
6377893|NCT00148395|Vinorelbine|vinorelbine|mesh-list
6377894|NCT00148395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6377895|NCT00148395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6377896|NCT00148395|Antimetabolites|antimetabolites|mesh-ancestor
6377897|NCT00148395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377898|NCT00148395|Antiviral Agents|antiviral agents|mesh-ancestor
6377899|NCT00148395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6377900|NCT00148395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6377901|NCT00148395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6377902|NCT00148395|Immunologic Factors|immunologic factors|mesh-ancestor
6377903|NCT00148395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6377904|NCT00148395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6377905|NCT00148395|Alkylating Agents|alkylating agents|mesh-ancestor
6377906|NCT00148395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6377907|NCT00148395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6377908|NCT00148395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6377909|NCT00148395|Tubulin Modulators|tubulin modulators|mesh-ancestor
6377910|NCT00148395|Antimitotic Agents|antimitotic agents|mesh-ancestor
6377911|NCT00148395|Mitosis Modulators|mitosis modulators|mesh-ancestor
6377912|NCT00148408|Montelukast|montelukast|mesh-list
6377913|NCT00148408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6377914|NCT00148408|Respiratory System Agents|respiratory system agents|mesh-ancestor
6377915|NCT00148408|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6377916|NCT00148408|Hormone Antagonists|hormone antagonists|mesh-ancestor
6377917|NCT00148408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6377918|NCT00148408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6377919|NCT00148408|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6377920|NCT00148408|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6377921|NCT00148408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377922|NCT00148421|Epoetin Alfa|epoetin alfa|mesh-list
6377923|NCT00148421|Darbepoetin alfa|darbepoetin alfa|mesh-list
6377924|NCT00148421|Hematinics|hematinics|mesh-ancestor
6377925|NCT00148447|Citalopram|citalopram|mesh-list
6377926|NCT00148447|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6377927|NCT00148447|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6377928|NCT00148447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6377929|NCT00148447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377930|NCT00148447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6377931|NCT00148447|Serotonin Agents|serotonin agents|mesh-ancestor
6377932|NCT00148447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6377933|NCT00148447|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6377934|NCT00148447|Antidepressive Agents|antidepressive agents|mesh-ancestor
6377935|NCT00148447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6377936|NCT00148460|Tenecteplase|tenecteplase|mesh-list
6377937|NCT00148460|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6377938|NCT00148460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6377939|NCT00148460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377940|NCT00148473|Misoprostol|misoprostol|mesh-list
6377941|NCT00148473|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6377942|NCT00148473|Abortifacient Agents|abortifacient agents|mesh-ancestor
6377943|NCT00148473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6377944|NCT00148473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6377945|NCT00148473|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6377946|NCT00148473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6377947|NCT00148473|Oxytocics|oxytocics|mesh-ancestor
6377948|NCT00148499|Benzocaine|benzocaine|mesh-list
6377949|NCT00148499|Ambroxol|ambroxol|mesh-list
6377950|NCT00148499|Anesthetics, Local|anesthetics, local|mesh-ancestor
6377951|NCT00148499|Anesthetics|anesthetics|mesh-ancestor
6377952|NCT00148499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6377953|NCT00148499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6377954|NCT00148499|Sensory System Agents|sensory system agents|mesh-ancestor
6377955|NCT00148499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6377956|NCT00148499|Expectorants|expectorants|mesh-ancestor
6377957|NCT00148499|Respiratory System Agents|respiratory system agents|mesh-ancestor
6377958|NCT00148551|Triamcinolone|triamcinolone|mesh-list
6377959|NCT00148551|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6377960|NCT00148551|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6377961|NCT00148551|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6377962|NCT00148551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6377963|NCT00148551|Glucocorticoids|glucocorticoids|mesh-ancestor
6377964|NCT00148551|Hormones|hormones|mesh-ancestor
6377965|NCT00148551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6377966|NCT00148551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6377967|NCT00148551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6377968|NCT00148551|Immunologic Factors|immunologic factors|mesh-ancestor
6377969|NCT00148551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6377970|NCT00148551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377971|NCT00148564|Olanzapine|olanzapine|mesh-list
6377972|NCT00148564|Ziprasidone|ziprasidone|mesh-list
6377973|NCT00148564|Antiemetics|antiemetics|mesh-ancestor
6377974|NCT00148564|Autonomic Agents|autonomic agents|mesh-ancestor
6377975|NCT00148564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6377976|NCT00148564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6377977|NCT00148564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6377978|NCT00148564|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6377979|NCT00148564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6377980|NCT00148564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6377981|NCT00148564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6377982|NCT00148564|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6377983|NCT00148564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6377984|NCT00148564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6377985|NCT00148564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377986|NCT00148564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6377987|NCT00148564|Serotonin Agents|serotonin agents|mesh-ancestor
6377988|NCT00148564|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6377989|NCT00148564|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6377990|NCT00148564|Dopamine Agents|dopamine agents|mesh-ancestor
6377991|NCT00148590|Memantine|memantine|mesh-list
6377992|NCT00148590|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6377993|NCT00148590|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6377994|NCT00148590|Dopamine Agents|dopamine agents|mesh-ancestor
6377995|NCT00148590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6377996|NCT00148590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6377997|NCT00148590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6377998|NCT00148590|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6377999|NCT00148590|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6378000|NCT00148603|Montelukast|montelukast|mesh-list
6378001|NCT00148603|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6378002|NCT00148603|Respiratory System Agents|respiratory system agents|mesh-ancestor
6378003|NCT00148603|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6378004|NCT00148603|Hormone Antagonists|hormone antagonists|mesh-ancestor
6378005|NCT00148603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6378006|NCT00148603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378007|NCT00148603|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6378008|NCT00148603|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6378009|NCT00148603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378010|NCT00148616|Memantine|memantine|mesh-list
6378011|NCT00148616|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6378012|NCT00148616|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6378013|NCT00148616|Dopamine Agents|dopamine agents|mesh-ancestor
6378014|NCT00148616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6378015|NCT00148616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378016|NCT00148616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378017|NCT00148616|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6378018|NCT00148616|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6378019|NCT00148681|Paclitaxel|paclitaxel|mesh-list
6378020|NCT00148681|Vinorelbine|vinorelbine|mesh-list
6378021|NCT00148681|Cyclophosphamide|cyclophosphamide|mesh-list
6378022|NCT00148681|Doxorubicin|doxorubicin|mesh-list
6378023|NCT00148681|Trastuzumab|trastuzumab|mesh-list
6378024|NCT00148681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6378025|NCT00148681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6378026|NCT00148681|Tubulin Modulators|tubulin modulators|mesh-ancestor
6378027|NCT00148681|Antimitotic Agents|antimitotic agents|mesh-ancestor
6378028|NCT00148681|Mitosis Modulators|mitosis modulators|mesh-ancestor
6378029|NCT00148681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378030|NCT00148681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6378031|NCT00148681|Immunologic Factors|immunologic factors|mesh-ancestor
6378032|NCT00148681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378033|NCT00148681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6378034|NCT00148681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6378035|NCT00148681|Alkylating Agents|alkylating agents|mesh-ancestor
6378036|NCT00148681|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6378037|NCT00148681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6378038|NCT00148681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6378039|NCT00148681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6378040|NCT00148681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6378041|NCT00148681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6378042|NCT00148694|Cisplatin|cisplatin|mesh-list
6378043|NCT00148694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6378044|NCT00148707|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
6378045|NCT00148707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6378046|NCT00148720|Capecitabine|capecitabine|mesh-list
6378047|NCT00148720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6378048|NCT00148720|Antimetabolites|antimetabolites|mesh-ancestor
6378049|NCT00148720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378050|NCT00148720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6378051|NCT00148746|Cyclosporine|cyclosporine|mesh-list
6378052|NCT00148746|Prednisolone|prednisolone|mesh-list
6378053|NCT00148746|Pimecrolimus|pimecrolimus|mesh-list
6378054|NCT00148746|Prednicarbate|prednicarbate|mesh-list
6378055|NCT00148746|Tacrolimus|tacrolimus|mesh-list
6378056|NCT00148746|Cyclosporins|cyclosporins|mesh-list
6378057|NCT00148746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6378058|NCT00148746|Immunologic Factors|immunologic factors|mesh-ancestor
6378059|NCT00148746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378060|NCT00148746|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6378061|NCT00148746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6378062|NCT00148746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378063|NCT00148746|Antifungal Agents|antifungal agents|mesh-ancestor
6378064|NCT00148746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6378065|NCT00148746|Dermatologic Agents|dermatologic agents|mesh-ancestor
6378066|NCT00148746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6378067|NCT00148746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6378068|NCT00148746|Glucocorticoids|glucocorticoids|mesh-ancestor
6378069|NCT00148746|Hormones|hormones|mesh-ancestor
6378070|NCT00148746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6378071|NCT00148746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6378072|NCT00148746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6378073|NCT00148746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6378074|NCT00148746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6378075|NCT00148746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6378076|NCT00148746|Analgesics|analgesics|mesh-ancestor
6378077|NCT00148746|Sensory System Agents|sensory system agents|mesh-ancestor
6378078|NCT00148772|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6378079|NCT00148772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6378080|NCT00148772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6378081|NCT00148772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6378082|NCT00148772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378083|NCT00148785|Ritonavir|ritonavir|mesh-list
6378084|NCT00148785|Indinavir|indinavir|mesh-list
6378085|NCT00148785|Fosamprenavir|fosamprenavir|mesh-list
6378086|NCT00148785|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6378087|NCT00148785|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6378088|NCT00148785|Protease Inhibitors|protease inhibitors|mesh-ancestor
6378089|NCT00148785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6378090|NCT00148785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378091|NCT00148785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6378092|NCT00148785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6378093|NCT00148785|Antiviral Agents|antiviral agents|mesh-ancestor
6378094|NCT00148785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6378095|NCT00148785|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6378096|NCT00148785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6378097|NCT00148824|Vaccines|vaccines|mesh-list
6378098|NCT00148824|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6378099|NCT00148824|Immunologic Factors|immunologic factors|mesh-ancestor
6378100|NCT00148824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378101|NCT00148837|Interferons|interferons|mesh-list
6378102|NCT00148837|Ribavirin|ribavirin|mesh-list
6378103|NCT00148837|Interferon-alpha|interferon-alpha|mesh-list
6378104|NCT00148837|Interferon alpha-2|interferon alpha-2|mesh-list
6378105|NCT00148837|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6378106|NCT00148837|Prazosin|prazosin|mesh-list
6378107|NCT00148837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6378108|NCT00148837|Antiviral Agents|antiviral agents|mesh-ancestor
6378109|NCT00148837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6378110|NCT00148837|Antimetabolites|antimetabolites|mesh-ancestor
6378111|NCT00148837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378112|NCT00148837|Immunologic Factors|immunologic factors|mesh-ancestor
6378113|NCT00148837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378114|NCT00148837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6378115|NCT00148837|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6378116|NCT00148837|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6378117|NCT00148837|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6378118|NCT00148837|Adrenergic Agents|adrenergic agents|mesh-ancestor
6378119|NCT00148837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6378120|NCT00148850|Pioglitazone|pioglitazone|mesh-list
6378121|NCT00148850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6378122|NCT00148850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378123|NCT00148863|Interferons|interferons|mesh-list
6378124|NCT00148863|Ribavirin|ribavirin|mesh-list
6378125|NCT00148863|Interferon-alpha|interferon-alpha|mesh-list
6378126|NCT00148863|Interferon alpha-2|interferon alpha-2|mesh-list
6378127|NCT00148863|Interferon-gamma|interferon-gamma|mesh-list
6378128|NCT00148863|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6378129|NCT00148863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6378130|NCT00148863|Antiviral Agents|antiviral agents|mesh-ancestor
6378131|NCT00148863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6378132|NCT00148863|Antimetabolites|antimetabolites|mesh-ancestor
6378133|NCT00148863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378134|NCT00148863|Immunologic Factors|immunologic factors|mesh-ancestor
6378135|NCT00148863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378136|NCT00148876|Capecitabine|capecitabine|mesh-list
6378137|NCT00148876|Trastuzumab|trastuzumab|mesh-list
6378138|NCT00148876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6378139|NCT00148876|Antimetabolites|antimetabolites|mesh-ancestor
6378140|NCT00148876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378141|NCT00148876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6017511|NCT00373256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6017512|NCT00373256|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6378142|NCT00148876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6378143|NCT00148902|Docetaxel|docetaxel|mesh-list
6378144|NCT00148902|Lapatinib|lapatinib|mesh-list
6378145|NCT00148902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6378146|NCT00148902|Tubulin Modulators|tubulin modulators|mesh-ancestor
6378147|NCT00148902|Antimitotic Agents|antimitotic agents|mesh-ancestor
6378148|NCT00148902|Mitosis Modulators|mitosis modulators|mesh-ancestor
6378149|NCT00148902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378150|NCT00148902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6378151|NCT00148902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6378152|NCT00148915|Ibandronic Acid|ibandronic acid|mesh-list
6378153|NCT00148915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6378154|NCT00148915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378155|NCT00149019|Antibodies|antibodies|mesh-list
6378156|NCT00149019|Antibodies, Bispecific|antibodies, bispecific|mesh-list
6378157|NCT00149019|Immunologic Factors|immunologic factors|mesh-ancestor
6378158|NCT00149019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378159|NCT00149058|Epoetin Alfa|epoetin alfa|mesh-list
6378160|NCT00149058|Hematinics|hematinics|mesh-ancestor
6378161|NCT00149084|Amoxicillin|amoxicillin|mesh-list
6378162|NCT00149084|Clarithromycin|clarithromycin|mesh-list
6378163|NCT00149084|Lansoprazole|lansoprazole|mesh-list
6378164|NCT00149084|Dexlansoprazole|dexlansoprazole|mesh-list
6378165|NCT00149084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6378166|NCT00149084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6378167|NCT00149084|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6378168|NCT00149084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6378169|NCT00149084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378170|NCT00149084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6378171|NCT00149084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6378172|NCT00149084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6378173|NCT00149084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6378174|NCT00149084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6378175|NCT00149110|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6378176|NCT00149110|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6397041|NCT00210002|Darbepoetin alfa|darbepoetin alfa|mesh-list
6378177|NCT00149110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6378178|NCT00149110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6378179|NCT00149110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378180|NCT00149110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6378181|NCT00149110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378182|NCT00149110|Analgesics|analgesics|mesh-ancestor
6378183|NCT00149110|Sensory System Agents|sensory system agents|mesh-ancestor
6378184|NCT00149110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6378185|NCT00149110|Antidepressive Agents|antidepressive agents|mesh-ancestor
6378186|NCT00149110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6378187|NCT00149110|Dopamine Agents|dopamine agents|mesh-ancestor
6378188|NCT00149123|Hydrocortisone|hydrocortisone|mesh-list
6378189|NCT00149123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6378190|NCT00149136|Imatinib Mesylate|imatinib mesylate|mesh-list
6378191|NCT00149136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6378192|NCT00149136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6378193|NCT00149136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6378194|NCT00149136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378195|NCT00149149|Polaprezinc|polaprezinc|mesh-list
6378196|NCT00149149|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6378197|NCT00149149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6378198|NCT00149162|Aldesleukin|aldesleukin|mesh-list
6378199|NCT00149162|Interleukin-2|interleukin-2|mesh-list
6378200|NCT00149162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6378201|NCT00149162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6378202|NCT00149162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6378203|NCT00149162|Antiviral Agents|antiviral agents|mesh-ancestor
6378204|NCT00149162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6378205|NCT00149162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6378206|NCT00149162|Analgesics|analgesics|mesh-ancestor
6378207|NCT00149162|Sensory System Agents|sensory system agents|mesh-ancestor
6378208|NCT00149162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6378209|NCT00149162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378210|NCT00149188|Lanreotide|lanreotide|mesh-list
6378211|NCT00149188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6378212|NCT00149201|Fluorouracil|fluorouracil|mesh-list
6378213|NCT00149201|Antimetabolites|antimetabolites|mesh-ancestor
6378214|NCT00149201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378215|NCT00149201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6378216|NCT00149201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6378217|NCT00149201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6378218|NCT00149201|Immunologic Factors|immunologic factors|mesh-ancestor
6378219|NCT00149201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378220|NCT00149240|Botulinum Toxins|botulinum toxins|mesh-list
6378221|NCT00149240|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6378222|NCT00149240|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6378223|NCT00149240|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6378224|NCT00149240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6378225|NCT00149240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378226|NCT00149240|Cholinergic Agents|cholinergic agents|mesh-ancestor
6378227|NCT00149240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6378228|NCT00149240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378229|NCT00149240|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6378230|NCT00149240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6378231|NCT00149253|Etoricoxib|etoricoxib|mesh-list
6378232|NCT00149253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378233|NCT00149253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6378234|NCT00149253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6378235|NCT00149253|Analgesics|analgesics|mesh-ancestor
6378236|NCT00149253|Sensory System Agents|sensory system agents|mesh-ancestor
6378237|NCT00149253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6378238|NCT00149253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6378239|NCT00149253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6378240|NCT00149253|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6378241|NCT00149253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6378242|NCT00149253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6378243|NCT00149253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378244|NCT00149292|Olanzapine|olanzapine|mesh-list
6378245|NCT00149292|Antiemetics|antiemetics|mesh-ancestor
6378246|NCT00149292|Autonomic Agents|autonomic agents|mesh-ancestor
6378247|NCT00149292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6378248|NCT00149292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378249|NCT00149292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6378250|NCT00149292|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6378251|NCT00149292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6378252|NCT00149292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6378253|NCT00149292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6378254|NCT00149292|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6378255|NCT00149292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6378256|NCT00149292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6378257|NCT00149292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378258|NCT00149292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6378259|NCT00149292|Serotonin Agents|serotonin agents|mesh-ancestor
6378260|NCT00149383|Rosiglitazone|rosiglitazone|mesh-list
6378261|NCT00149383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6378262|NCT00149383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378263|NCT00149539|Buprenorphine|buprenorphine|mesh-list
6378264|NCT00149539|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6378265|NCT00149539|Naloxone|naloxone|mesh-list
6378266|NCT00149539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6378267|NCT00149539|Narcotics|narcotics|mesh-ancestor
6378268|NCT00149539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6378269|NCT00149539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378270|NCT00149539|Analgesics|analgesics|mesh-ancestor
6378271|NCT00149539|Sensory System Agents|sensory system agents|mesh-ancestor
6378272|NCT00149539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6378273|NCT00149539|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6378274|NCT00149565|Interferon alpha-2|interferon alpha-2|mesh-list
6378275|NCT00149565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6378276|NCT00149565|Antiviral Agents|antiviral agents|mesh-ancestor
6378277|NCT00149565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6378278|NCT00149578|Leucovorin|leucovorin|mesh-list
6378279|NCT00149578|Gemcitabine|gemcitabine|mesh-list
6378280|NCT00149578|Oxaliplatin|oxaliplatin|mesh-list
6378281|NCT00149578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6378282|NCT00149578|Antimetabolites|antimetabolites|mesh-ancestor
6378283|NCT00149578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378284|NCT00149578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6378285|NCT00149578|Antiviral Agents|antiviral agents|mesh-ancestor
6378286|NCT00149578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6378287|NCT00149578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6378288|NCT00149578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6378289|NCT00149578|Immunologic Factors|immunologic factors|mesh-ancestor
6378290|NCT00149578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378291|NCT00149578|Antidotes|antidotes|mesh-ancestor
6378292|NCT00149578|Protective Agents|protective agents|mesh-ancestor
6378293|NCT00149578|Vitamin B Complex|vitamin b complex|mesh-ancestor
6378294|NCT00149578|Vitamins|vitamins|mesh-ancestor
6378295|NCT00149578|Micronutrients|micronutrients|mesh-ancestor
6378296|NCT00149604|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
6378297|NCT00149604|Estrogens|estrogens|mesh-list
6378298|NCT00149604|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6378299|NCT00149604|Hormones|hormones|mesh-ancestor
6378300|NCT00149604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6378301|NCT00149604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378302|NCT00149604|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6378303|NCT00149604|Hormone Antagonists|hormone antagonists|mesh-ancestor
6378304|NCT00149604|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6378305|NCT00149604|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6378306|NCT00149604|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6378307|NCT00149617|Buspirone|buspirone|mesh-list
6378308|NCT00149617|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6378309|NCT00149617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6378310|NCT00149617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6378311|NCT00149617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378312|NCT00149617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6378313|NCT00149617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6378314|NCT00149617|Serotonin Agents|serotonin agents|mesh-ancestor
6378315|NCT00149617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6378316|NCT00149617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378317|NCT00149656|Selenium|selenium|mesh-list
6378318|NCT00149656|Antioxidants|antioxidants|mesh-ancestor
6378319|NCT00149656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378320|NCT00149656|Protective Agents|protective agents|mesh-ancestor
6378321|NCT00149656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378322|NCT00149656|Trace Elements|trace elements|mesh-ancestor
6378323|NCT00149656|Micronutrients|micronutrients|mesh-ancestor
6378324|NCT00149708|Hormones|hormones|mesh-list
6378325|NCT00149708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6378326|NCT00149708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395982|NCT00207311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395983|NCT00207311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395984|NCT00207311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6395985|NCT00207311|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6395986|NCT00207311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6395987|NCT00207363|Interferons|interferons|mesh-list
6395988|NCT00207363|Ribavirin|ribavirin|mesh-list
6395989|NCT00207363|Interferon-alpha|interferon-alpha|mesh-list
6395990|NCT00207363|Interferon alpha-2|interferon alpha-2|mesh-list
6395991|NCT00207363|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6395992|NCT00207363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6395993|NCT00207363|Antiviral Agents|antiviral agents|mesh-ancestor
6395994|NCT00207363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6395995|NCT00207363|Antimetabolites|antimetabolites|mesh-ancestor
6395996|NCT00207363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6395997|NCT00207363|Immunologic Factors|immunologic factors|mesh-ancestor
6395998|NCT00207363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6395999|NCT00207402|Rosiglitazone|rosiglitazone|mesh-list
6396000|NCT00207402|Interferons|interferons|mesh-list
6396001|NCT00207402|Ribavirin|ribavirin|mesh-list
6396002|NCT00207402|Interferon alfacon-1|interferon alfacon-1|mesh-list
6396003|NCT00207402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6396004|NCT00207402|Antiviral Agents|antiviral agents|mesh-ancestor
6396005|NCT00207402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6396006|NCT00207402|Antimetabolites|antimetabolites|mesh-ancestor
6396007|NCT00207402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396008|NCT00207402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6396009|NCT00207402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396010|NCT00207428|Carbamazepine|carbamazepine|mesh-list
6396011|NCT00207428|Anticonvulsants|anticonvulsants|mesh-ancestor
6396012|NCT00207428|Antimanic Agents|antimanic agents|mesh-ancestor
6396013|NCT00207428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6396014|NCT00207428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6396015|NCT00207428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396016|NCT00207428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6396017|NCT00207428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6378327|NCT00149851|Tegaserod|tegaserod|mesh-list
6378328|NCT00149851|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6378329|NCT00149851|Serotonin Agents|serotonin agents|mesh-ancestor
6378330|NCT00149851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6378331|NCT00149851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378332|NCT00149851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378333|NCT00149864|Mycophenolic Acid|mycophenolic acid|mesh-list
6378334|NCT00149864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6378335|NCT00149864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6378336|NCT00149864|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6378337|NCT00149864|Antitubercular Agents|antitubercular agents|mesh-ancestor
6378338|NCT00149864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6378339|NCT00149864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6378340|NCT00149864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6378341|NCT00149864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378342|NCT00149877|Tegaserod|tegaserod|mesh-list
6378343|NCT00149877|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6378344|NCT00149877|Serotonin Agents|serotonin agents|mesh-ancestor
6378345|NCT00149877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6378346|NCT00149877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378347|NCT00149877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378348|NCT00149903|Mycophenolic Acid|mycophenolic acid|mesh-list
6378349|NCT00149903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6378350|NCT00149903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6378351|NCT00149903|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6378352|NCT00149903|Antitubercular Agents|antitubercular agents|mesh-ancestor
6378353|NCT00149903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6378354|NCT00149903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6378355|NCT00149903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6378356|NCT00149903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378357|NCT00149916|Mycophenolic Acid|mycophenolic acid|mesh-list
6378358|NCT00149916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6378359|NCT00149916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6378360|NCT00149916|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6378361|NCT00149916|Antitubercular Agents|antitubercular agents|mesh-ancestor
6378362|NCT00149916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6378363|NCT00149916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6378364|NCT00149916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6378365|NCT00149916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378366|NCT00149929|Mycophenolic Acid|mycophenolic acid|mesh-list
6378367|NCT00149929|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6378368|NCT00149929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6378369|NCT00149929|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6378370|NCT00149929|Antitubercular Agents|antitubercular agents|mesh-ancestor
6378371|NCT00149929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6378372|NCT00149929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6378373|NCT00149929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6378374|NCT00149929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378375|NCT00149942|Mycophenolic Acid|mycophenolic acid|mesh-list
6378376|NCT00149942|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6378377|NCT00149942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6378378|NCT00149942|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6378379|NCT00149942|Antitubercular Agents|antitubercular agents|mesh-ancestor
6378380|NCT00149942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6378381|NCT00149942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6378382|NCT00149942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6378383|NCT00149942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378384|NCT00149968|Mycophenolic Acid|mycophenolic acid|mesh-list
6378385|NCT00149968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6378386|NCT00149968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6378387|NCT00149968|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6378388|NCT00149968|Antitubercular Agents|antitubercular agents|mesh-ancestor
6378389|NCT00149968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6378390|NCT00149968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6378391|NCT00149968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6378392|NCT00149968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378393|NCT00149981|Everolimus|everolimus|mesh-list
6378394|NCT00149981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6378395|NCT00149981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6378396|NCT00149981|Immunologic Factors|immunologic factors|mesh-ancestor
6378397|NCT00149981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378398|NCT00150007|Mycophenolic Acid|mycophenolic acid|mesh-list
6396018|NCT00207428|Analgesics|analgesics|mesh-ancestor
6378399|NCT00150007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6378400|NCT00150007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6378401|NCT00150007|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6378402|NCT00150007|Antitubercular Agents|antitubercular agents|mesh-ancestor
6378403|NCT00150007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6378404|NCT00150007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6378405|NCT00150007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6378406|NCT00150007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378407|NCT00150020|Mycophenolic Acid|mycophenolic acid|mesh-list
6378408|NCT00150020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6378409|NCT00150020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6378410|NCT00150020|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6378411|NCT00150020|Antitubercular Agents|antitubercular agents|mesh-ancestor
6378412|NCT00150020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6378413|NCT00150020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6378414|NCT00150020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6378415|NCT00150020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378416|NCT00150046|Everolimus|everolimus|mesh-list
6378417|NCT00150046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6378418|NCT00150046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6378419|NCT00150046|Immunologic Factors|immunologic factors|mesh-ancestor
6378420|NCT00150046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378421|NCT00150059|Pimecrolimus|pimecrolimus|mesh-list
6378422|NCT00150059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6378423|NCT00150059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6378424|NCT00150059|Analgesics|analgesics|mesh-ancestor
6378425|NCT00150059|Sensory System Agents|sensory system agents|mesh-ancestor
6378426|NCT00150059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6378427|NCT00150059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378428|NCT00150059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6378429|NCT00150059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6378430|NCT00150059|Dermatologic Agents|dermatologic agents|mesh-ancestor
6378431|NCT00150059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6378432|NCT00150059|Immunologic Factors|immunologic factors|mesh-ancestor
6378433|NCT00150059|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6378434|NCT00150059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6378435|NCT00150059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378436|NCT00150072|Imatinib Mesylate|imatinib mesylate|mesh-list
6378437|NCT00150072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6378438|NCT00150072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6378439|NCT00150072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6378440|NCT00150072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378441|NCT00150085|Cyclosporine|cyclosporine|mesh-list
6378442|NCT00150085|Cyclosporins|cyclosporins|mesh-list
6378443|NCT00150085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6378444|NCT00150085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378445|NCT00150085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6378446|NCT00150085|Immunologic Factors|immunologic factors|mesh-ancestor
6378447|NCT00150085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378448|NCT00150085|Antifungal Agents|antifungal agents|mesh-ancestor
6378449|NCT00150085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6378450|NCT00150085|Dermatologic Agents|dermatologic agents|mesh-ancestor
6378451|NCT00150085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6378452|NCT00150085|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6378453|NCT00150111|Rituximab|rituximab|mesh-list
6378454|NCT00150111|Vaccines|vaccines|mesh-list
6378455|NCT00150111|Methimazole|methimazole|mesh-list
6378456|NCT00150111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6378457|NCT00150111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6378458|NCT00150111|Immunologic Factors|immunologic factors|mesh-ancestor
6378459|NCT00150111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378460|NCT00150111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6378461|NCT00150111|Antithyroid Agents|antithyroid agents|mesh-ancestor
6378462|NCT00150111|Hormone Antagonists|hormone antagonists|mesh-ancestor
6378463|NCT00150111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6378464|NCT00150124|Methimazole|methimazole|mesh-list
6378465|NCT00150124|Antithyroid Agents|antithyroid agents|mesh-ancestor
6378466|NCT00150124|Hormone Antagonists|hormone antagonists|mesh-ancestor
6378467|NCT00150124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6378468|NCT00150124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378469|NCT00150137|Methimazole|methimazole|mesh-list
6378470|NCT00150137|Antithyroid Agents|antithyroid agents|mesh-ancestor
6378471|NCT00150137|Hormone Antagonists|hormone antagonists|mesh-ancestor
6378472|NCT00150137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6378473|NCT00150137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378474|NCT00150215|Olanzapine|olanzapine|mesh-list
6378475|NCT00150215|Antiemetics|antiemetics|mesh-ancestor
6378476|NCT00150215|Autonomic Agents|autonomic agents|mesh-ancestor
6378477|NCT00150215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6378478|NCT00150215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378479|NCT00150215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6378480|NCT00150215|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6378481|NCT00150215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6378482|NCT00150215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6378483|NCT00150215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6378484|NCT00150215|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6378485|NCT00150215|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6378486|NCT00150215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6378487|NCT00150215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378488|NCT00150215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6378489|NCT00150215|Serotonin Agents|serotonin agents|mesh-ancestor
6378490|NCT00150228|Varenicline|varenicline|mesh-list
6378491|NCT00150228|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6378492|NCT00150228|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6378493|NCT00150228|Cholinergic Agents|cholinergic agents|mesh-ancestor
6378494|NCT00150228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6378495|NCT00150228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378496|NCT00150228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378497|NCT00150241|Varenicline|varenicline|mesh-list
6378498|NCT00150241|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6378499|NCT00150241|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6378500|NCT00150241|Cholinergic Agents|cholinergic agents|mesh-ancestor
6378501|NCT00150241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6378502|NCT00150241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378503|NCT00150241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378504|NCT00150254|Varenicline|varenicline|mesh-list
6378505|NCT00150254|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6378506|NCT00150254|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6378507|NCT00150254|Cholinergic Agents|cholinergic agents|mesh-ancestor
6378508|NCT00150254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6378509|NCT00150254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378510|NCT00150254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378511|NCT00150280|Ibuprofen|ibuprofen|mesh-list
6378512|NCT00150280|Celecoxib|celecoxib|mesh-list
6378513|NCT00150280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6378514|NCT00150280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6378515|NCT00150280|Analgesics|analgesics|mesh-ancestor
6378516|NCT00150280|Sensory System Agents|sensory system agents|mesh-ancestor
6378517|NCT00150280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6378518|NCT00150280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378519|NCT00150280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6378520|NCT00150280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6378521|NCT00150280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6378522|NCT00150280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6378523|NCT00150280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378524|NCT00150280|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6378525|NCT00150293|Pregabalin|pregabalin|mesh-list
6378526|NCT00150293|Analgesics|analgesics|mesh-ancestor
6378527|NCT00150293|Sensory System Agents|sensory system agents|mesh-ancestor
6378528|NCT00150293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6378529|NCT00150293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378530|NCT00150293|Anticonvulsants|anticonvulsants|mesh-ancestor
6378531|NCT00150293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6378532|NCT00150293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6378533|NCT00150293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378534|NCT00150293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6378535|NCT00150293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6378536|NCT00150293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6378537|NCT00150293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6378538|NCT00150293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6378539|NCT00150306|Sertraline|sertraline|mesh-list
6378540|NCT00150306|Antidepressive Agents|antidepressive agents|mesh-ancestor
6378541|NCT00150306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6378542|NCT00150306|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6378543|NCT00150306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6378544|NCT00150306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6378545|NCT00150306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378546|NCT00150306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6378547|NCT00150306|Serotonin Agents|serotonin agents|mesh-ancestor
6378548|NCT00150306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378549|NCT00150332|Linezolid|linezolid|mesh-list
6378550|NCT00150332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6378551|NCT00150332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6378552|NCT00150332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6378553|NCT00150332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6378554|NCT00150332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378555|NCT00150358|Sildenafil Citrate|sildenafil citrate|mesh-list
6378556|NCT00150358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378557|NCT00150358|Vasodilator Agents|vasodilator agents|mesh-ancestor
6378558|NCT00150358|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6378559|NCT00150358|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6378560|NCT00150358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6378561|NCT00150358|Urological Agents|urological agents|mesh-ancestor
6378562|NCT00150371|Atorvastatin|atorvastatin|mesh-list
6378563|NCT00150371|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6378564|NCT00150371|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6378565|NCT00150371|Antimetabolites|antimetabolites|mesh-ancestor
6378566|NCT00150371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378567|NCT00150371|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6378568|NCT00150371|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6378569|NCT00150371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6378570|NCT00150384|Amlodipine|amlodipine|mesh-list
6378571|NCT00150384|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
6378572|NCT00150384|Atorvastatin|atorvastatin|mesh-list
6378573|NCT00150384|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6378574|NCT00150384|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6378575|NCT00150384|Antimetabolites|antimetabolites|mesh-ancestor
6378576|NCT00150384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378577|NCT00150384|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6378578|NCT00150384|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6378579|NCT00150384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6378580|NCT00150384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6378581|NCT00150384|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6378582|NCT00150384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6378583|NCT00150384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6378584|NCT00150384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378585|NCT00150384|Vasodilator Agents|vasodilator agents|mesh-ancestor
6378586|NCT00150410|Insulin|insulin|mesh-list
6378587|NCT00150410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6378588|NCT00150410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378589|NCT00150423|Pregabalin|pregabalin|mesh-list
6378590|NCT00150423|Analgesics|analgesics|mesh-ancestor
6378591|NCT00150423|Sensory System Agents|sensory system agents|mesh-ancestor
6378592|NCT00150423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6378593|NCT00150423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378594|NCT00150423|Anticonvulsants|anticonvulsants|mesh-ancestor
6378595|NCT00150423|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6378596|NCT00150423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6378597|NCT00150423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378598|NCT00150423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6378599|NCT00150423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6378600|NCT00150423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6378601|NCT00150423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6378602|NCT00150423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6378603|NCT00150436|Pregabalin|pregabalin|mesh-list
6378604|NCT00150436|Analgesics|analgesics|mesh-ancestor
6378605|NCT00150436|Sensory System Agents|sensory system agents|mesh-ancestor
6378606|NCT00150436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6378607|NCT00150436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378608|NCT00150436|Anticonvulsants|anticonvulsants|mesh-ancestor
6378609|NCT00150436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6378610|NCT00150436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6378611|NCT00150436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378612|NCT00150436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6378613|NCT00150436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6378614|NCT00150436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6378615|NCT00150436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6378616|NCT00150436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6378617|NCT00150449|Pregabalin|pregabalin|mesh-list
6378618|NCT00150449|Analgesics|analgesics|mesh-ancestor
6378619|NCT00150449|Sensory System Agents|sensory system agents|mesh-ancestor
6378620|NCT00150449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6378621|NCT00150449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378622|NCT00150449|Anticonvulsants|anticonvulsants|mesh-ancestor
6378623|NCT00150449|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6378624|NCT00150449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6378625|NCT00150449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378626|NCT00150449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6378627|NCT00150449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6378628|NCT00150449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6378629|NCT00150449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6378630|NCT00150449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6378631|NCT00150527|Dexamethasone|dexamethasone|mesh-list
6378632|NCT00150527|Citalopram|citalopram|mesh-list
6378633|NCT00150527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6378634|NCT00150527|Antiemetics|antiemetics|mesh-ancestor
6378635|NCT00150527|Autonomic Agents|autonomic agents|mesh-ancestor
6378636|NCT00150527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6378637|NCT00150527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378638|NCT00150527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6378639|NCT00150527|Glucocorticoids|glucocorticoids|mesh-ancestor
6378640|NCT00150527|Hormones|hormones|mesh-ancestor
6378641|NCT00150527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6378642|NCT00150527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6378643|NCT00150527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6378644|NCT00150527|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6378645|NCT00150527|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6378646|NCT00150527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6378647|NCT00150527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378648|NCT00150527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6378649|NCT00150527|Serotonin Agents|serotonin agents|mesh-ancestor
6378650|NCT00150527|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6378651|NCT00150527|Antidepressive Agents|antidepressive agents|mesh-ancestor
6378652|NCT00150527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6378653|NCT00150553|Carbamazepine|carbamazepine|mesh-list
6378654|NCT00150553|Anticonvulsants|anticonvulsants|mesh-ancestor
6378655|NCT00150553|Antimanic Agents|antimanic agents|mesh-ancestor
6378656|NCT00150553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6378657|NCT00150553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6378658|NCT00150553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378659|NCT00150553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6378660|NCT00150553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6378661|NCT00150553|Analgesics|analgesics|mesh-ancestor
6378662|NCT00150553|Sensory System Agents|sensory system agents|mesh-ancestor
6378663|NCT00150553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6378664|NCT00150553|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6378665|NCT00150553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6378666|NCT00150553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378667|NCT00150553|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6378668|NCT00150553|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6378669|NCT00150579|Amphetamine|amphetamine|mesh-list
6378670|NCT00150579|Dextroamphetamine|dextroamphetamine|mesh-list
6378671|NCT00150579|Adderall|adderall|mesh-list
6378672|NCT00150579|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6378673|NCT00150579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378674|NCT00150579|Sympathomimetics|sympathomimetics|mesh-ancestor
6378675|NCT00150579|Autonomic Agents|autonomic agents|mesh-ancestor
6378676|NCT00150579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6378677|NCT00150579|Dopamine Agents|dopamine agents|mesh-ancestor
6378678|NCT00150579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6378679|NCT00150579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378680|NCT00150579|Adrenergic Agents|adrenergic agents|mesh-ancestor
6378681|NCT00150579|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6378682|NCT00150579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6378683|NCT00150579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6378684|NCT00150579|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6378685|NCT00150605|Carbamazepine|carbamazepine|mesh-list
6378686|NCT00150605|Anticonvulsants|anticonvulsants|mesh-ancestor
6378687|NCT00150605|Antimanic Agents|antimanic agents|mesh-ancestor
6378688|NCT00150605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6378689|NCT00150605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6378690|NCT00150605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378691|NCT00150605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6378692|NCT00150605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6378693|NCT00150605|Analgesics|analgesics|mesh-ancestor
6378694|NCT00150605|Sensory System Agents|sensory system agents|mesh-ancestor
6378695|NCT00150605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6378696|NCT00150605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6378697|NCT00150605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6378698|NCT00150605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378699|NCT00150605|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6378700|NCT00150605|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6378701|NCT00150631|Candesartan|candesartan|mesh-list
6378702|NCT00150631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6378703|NCT00150631|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6378704|NCT00150631|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6378705|NCT00150631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378706|NCT00150657|Gemcitabine|gemcitabine|mesh-list
6378707|NCT00150657|Bevacizumab|bevacizumab|mesh-list
6378708|NCT00150657|Carboplatin|carboplatin|mesh-list
6378709|NCT00150657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6378710|NCT00150657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6378711|NCT00150657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6378712|NCT00150657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6378713|NCT00150657|Growth Substances|growth substances|mesh-ancestor
6378714|NCT00150657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378715|NCT00150657|Growth Inhibitors|growth inhibitors|mesh-ancestor
6378716|NCT00150657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6378717|NCT00150657|Antimetabolites|antimetabolites|mesh-ancestor
6378718|NCT00150657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378719|NCT00150657|Antiviral Agents|antiviral agents|mesh-ancestor
6378720|NCT00150657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6378721|NCT00150657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6378722|NCT00150657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6378723|NCT00150657|Immunologic Factors|immunologic factors|mesh-ancestor
6378724|NCT00150670|Cisplatin|cisplatin|mesh-list
6378725|NCT00150670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6378726|NCT00150696|Risedronic Acid|risedronic acid|mesh-list
6378727|NCT00150696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6378728|NCT00150696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6378729|NCT00150696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378730|NCT00150696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6378731|NCT00150696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378732|NCT00150696|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6378733|NCT00150709|Levetiracetam|levetiracetam|mesh-list
6378734|NCT00150709|Anticonvulsants|anticonvulsants|mesh-ancestor
6378735|NCT00150709|Nootropic Agents|nootropic agents|mesh-ancestor
6378736|NCT00150722|Atorvastatin|atorvastatin|mesh-list
6378737|NCT00150722|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6378738|NCT00150722|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6378739|NCT00150722|Antimetabolites|antimetabolites|mesh-ancestor
6378740|NCT00150722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378741|NCT00150722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6378742|NCT00150722|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6378743|NCT00150722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6378744|NCT00150735|Levetiracetam|levetiracetam|mesh-list
6378745|NCT00150735|Anticonvulsants|anticonvulsants|mesh-ancestor
6378746|NCT00150735|Nootropic Agents|nootropic agents|mesh-ancestor
6378747|NCT00150748|Levetiracetam|levetiracetam|mesh-list
6378748|NCT00150748|Anticonvulsants|anticonvulsants|mesh-ancestor
6378749|NCT00150748|Nootropic Agents|nootropic agents|mesh-ancestor
6378750|NCT00150761|Levocetirizine|levocetirizine|mesh-list
6378751|NCT00150761|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6378752|NCT00150761|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6378753|NCT00150761|Histamine Antagonists|histamine antagonists|mesh-ancestor
6378754|NCT00150761|Histamine Agents|histamine agents|mesh-ancestor
6378755|NCT00150761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6378756|NCT00150761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378757|NCT00150761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378758|NCT00150774|Levetiracetam|levetiracetam|mesh-list
6378759|NCT00150774|Anticonvulsants|anticonvulsants|mesh-ancestor
6378760|NCT00150774|Nootropic Agents|nootropic agents|mesh-ancestor
6378761|NCT00150787|Levetiracetam|levetiracetam|mesh-list
6378762|NCT00150787|Anticonvulsants|anticonvulsants|mesh-ancestor
6378763|NCT00150787|Nootropic Agents|nootropic agents|mesh-ancestor
6378764|NCT00150826|Quinapril|quinapril|mesh-list
6378765|NCT00150826|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6378766|NCT00150826|Protease Inhibitors|protease inhibitors|mesh-ancestor
6378767|NCT00150826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6378768|NCT00150826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378769|NCT00150826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6378770|NCT00150839|Mirtazapine|mirtazapine|mesh-list
6378771|NCT00150839|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6378772|NCT00150839|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6378773|NCT00150839|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6378774|NCT00150839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6378775|NCT00150839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378776|NCT00150839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6378777|NCT00150839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378778|NCT00150839|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6378779|NCT00150839|Antidepressive Agents|antidepressive agents|mesh-ancestor
6378780|NCT00150839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6378781|NCT00150839|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6378782|NCT00150839|Histamine Antagonists|histamine antagonists|mesh-ancestor
6378783|NCT00150839|Histamine Agents|histamine agents|mesh-ancestor
6378784|NCT00150839|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6378785|NCT00150839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6378786|NCT00150839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6378787|NCT00150839|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6378788|NCT00150839|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6378789|NCT00150839|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6378790|NCT00150839|Adrenergic Agents|adrenergic agents|mesh-ancestor
6378791|NCT00150839|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6378792|NCT00150839|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6378793|NCT00150839|Serotonin Agents|serotonin agents|mesh-ancestor
6378794|NCT00150839|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6378795|NCT00150852|Vancomycin|vancomycin|mesh-list
6378796|NCT00150852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6378797|NCT00150852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6378798|NCT00150865|Ropivacaine|ropivacaine|mesh-list
6378799|NCT00150865|Anesthetics, Local|anesthetics, local|mesh-ancestor
6378800|NCT00150865|Anesthetics|anesthetics|mesh-ancestor
6378801|NCT00150865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6378802|NCT00150865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378803|NCT00150865|Sensory System Agents|sensory system agents|mesh-ancestor
6378804|NCT00150865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6378805|NCT00150891|Cyclosporine|cyclosporine|mesh-list
6378806|NCT00150891|Mycophenolic Acid|mycophenolic acid|mesh-list
6378807|NCT00150891|Azathioprine|azathioprine|mesh-list
6378808|NCT00150891|Tacrolimus|tacrolimus|mesh-list
6378809|NCT00150891|Cyclosporins|cyclosporins|mesh-list
6378810|NCT00150891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6378811|NCT00150891|Immunologic Factors|immunologic factors|mesh-ancestor
5724651|NCT03185871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5724652|NCT03185871|Analgesics|analgesics|mesh-ancestor
5724653|NCT03185871|Sensory System Agents|sensory system agents|mesh-ancestor
5724654|NCT03185871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5724655|NCT03185871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724656|NCT03185871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5724657|NCT03185871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5724658|NCT03185871|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5724659|NCT03185871|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5724660|NCT03185871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5724661|NCT03185871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724662|NCT03185988|Trastuzumab|trastuzumab|mesh-list
5724663|NCT03185988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5724664|NCT03185988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6378812|NCT00150891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378813|NCT00150891|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6378814|NCT00150891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6378815|NCT00150891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378816|NCT00150891|Antifungal Agents|antifungal agents|mesh-ancestor
6378817|NCT00150891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6378818|NCT00150891|Dermatologic Agents|dermatologic agents|mesh-ancestor
6378819|NCT00150891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6378820|NCT00150891|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6378821|NCT00150891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6378822|NCT00150891|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6378823|NCT00150891|Antitubercular Agents|antitubercular agents|mesh-ancestor
6378824|NCT00150891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6378825|NCT00150891|Antimetabolites|antimetabolites|mesh-ancestor
6378826|NCT00150891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6378827|NCT00150982|Alefacept|alefacept|mesh-list
6378828|NCT00150982|Dermatologic Agents|dermatologic agents|mesh-ancestor
6378829|NCT00150982|Immunologic Factors|immunologic factors|mesh-ancestor
6378830|NCT00150982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378831|NCT00150995|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
6378832|NCT00150995|Chelating Agents|chelating agents|mesh-ancestor
6378833|NCT00150995|Sequestering Agents|sequestering agents|mesh-ancestor
6378834|NCT00150995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378835|NCT00150995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6378836|NCT00150995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6378837|NCT00150995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6378838|NCT00150995|Growth Substances|growth substances|mesh-ancestor
6378839|NCT00150995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378840|NCT00150995|Growth Inhibitors|growth inhibitors|mesh-ancestor
6378841|NCT00150995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6378842|NCT00151008|Bexarotene|bexarotene|mesh-list
6378843|NCT00151008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6378844|NCT00151034|Gemcitabine|gemcitabine|mesh-list
6378845|NCT00151034|Paclitaxel|paclitaxel|mesh-list
6378846|NCT00151034|Carboplatin|carboplatin|mesh-list
6378847|NCT00151034|Trastuzumab|trastuzumab|mesh-list
6378848|NCT00151034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6378849|NCT00151034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6378850|NCT00151034|Tubulin Modulators|tubulin modulators|mesh-ancestor
6378851|NCT00151034|Antimitotic Agents|antimitotic agents|mesh-ancestor
6378852|NCT00151034|Mitosis Modulators|mitosis modulators|mesh-ancestor
6378853|NCT00151034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378854|NCT00151034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6378855|NCT00151034|Antimetabolites|antimetabolites|mesh-ancestor
6378856|NCT00151034|Antiviral Agents|antiviral agents|mesh-ancestor
6378857|NCT00151034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6378858|NCT00151034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6378859|NCT00151034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6378860|NCT00151034|Immunologic Factors|immunologic factors|mesh-ancestor
6378861|NCT00151034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378862|NCT00151034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6378863|NCT00151047|Docetaxel|docetaxel|mesh-list
6378864|NCT00151047|Capecitabine|capecitabine|mesh-list
6378865|NCT00151047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6378866|NCT00151047|Tubulin Modulators|tubulin modulators|mesh-ancestor
6378867|NCT00151047|Antimitotic Agents|antimitotic agents|mesh-ancestor
6378868|NCT00151047|Mitosis Modulators|mitosis modulators|mesh-ancestor
6378869|NCT00151047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378870|NCT00151047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6378871|NCT00151047|Antimetabolites|antimetabolites|mesh-ancestor
6378872|NCT00151060|Paclitaxel|paclitaxel|mesh-list
6378873|NCT00151060|Etoposide|etoposide|mesh-list
6378874|NCT00151060|Estramustine|estramustine|mesh-list
6378875|NCT00151060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6378876|NCT00151060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6378877|NCT00151060|Tubulin Modulators|tubulin modulators|mesh-ancestor
6378878|NCT00151060|Antimitotic Agents|antimitotic agents|mesh-ancestor
6378879|NCT00151060|Mitosis Modulators|mitosis modulators|mesh-ancestor
6378880|NCT00151060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378881|NCT00151060|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6378882|NCT00151060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6378883|NCT00151060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6378884|NCT00151060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6378885|NCT00151060|Alkylating Agents|alkylating agents|mesh-ancestor
6378886|NCT00151060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6378887|NCT00151073|Zoledronic Acid|zoledronic acid|mesh-list
6378888|NCT00151073|Docetaxel|docetaxel|mesh-list
6378889|NCT00151073|Estramustine|estramustine|mesh-list
6378890|NCT00151073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6378891|NCT00151073|Tubulin Modulators|tubulin modulators|mesh-ancestor
6378892|NCT00151073|Antimitotic Agents|antimitotic agents|mesh-ancestor
6378893|NCT00151073|Mitosis Modulators|mitosis modulators|mesh-ancestor
6378894|NCT00151073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378895|NCT00151073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6378896|NCT00151073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378897|NCT00151073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6378898|NCT00151073|Alkylating Agents|alkylating agents|mesh-ancestor
6378899|NCT00151073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6378900|NCT00151086|Vinorelbine|vinorelbine|mesh-list
6378901|NCT00151086|Estramustine|estramustine|mesh-list
6378902|NCT00151086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6378903|NCT00151086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6378904|NCT00151086|Tubulin Modulators|tubulin modulators|mesh-ancestor
6378905|NCT00151086|Antimitotic Agents|antimitotic agents|mesh-ancestor
6378906|NCT00151086|Mitosis Modulators|mitosis modulators|mesh-ancestor
6378907|NCT00151086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378908|NCT00151086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6378909|NCT00151086|Alkylating Agents|alkylating agents|mesh-ancestor
6378910|NCT00151086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6378911|NCT00151112|Anesthetics|anesthetics|mesh-list
6378912|NCT00151112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6378913|NCT00151112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378914|NCT00151125|Oprelvekin|oprelvekin|mesh-list
6378915|NCT00151125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6378916|NCT00151138|Atenolol|atenolol|mesh-list
6378917|NCT00151138|Lisinopril|lisinopril|mesh-list
6378918|NCT00151138|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6378919|NCT00151138|Protease Inhibitors|protease inhibitors|mesh-ancestor
6378920|NCT00151138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6378921|NCT00151138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378922|NCT00151138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6378923|NCT00151138|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6378924|NCT00151138|Protective Agents|protective agents|mesh-ancestor
6378925|NCT00151138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378926|NCT00151138|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6378927|NCT00151138|Sympatholytics|sympatholytics|mesh-ancestor
6378928|NCT00151138|Autonomic Agents|autonomic agents|mesh-ancestor
6378929|NCT00151138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6378930|NCT00151138|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6378931|NCT00151138|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6378932|NCT00151138|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6378933|NCT00151138|Adrenergic Agents|adrenergic agents|mesh-ancestor
6378934|NCT00151138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6378935|NCT00151203|Clarithromycin|clarithromycin|mesh-list
6378936|NCT00151203|Dexamethasone|dexamethasone|mesh-list
6378937|NCT00151203|Lenalidomide|lenalidomide|mesh-list
6378938|NCT00151203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6378939|NCT00151203|Antiemetics|antiemetics|mesh-ancestor
6378940|NCT00151203|Autonomic Agents|autonomic agents|mesh-ancestor
6378941|NCT00151203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6378942|NCT00151203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378943|NCT00151203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6378944|NCT00151203|Glucocorticoids|glucocorticoids|mesh-ancestor
6378945|NCT00151203|Hormones|hormones|mesh-ancestor
6378946|NCT00151203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6378947|NCT00151203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6378948|NCT00151203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6378949|NCT00151203|Immunologic Factors|immunologic factors|mesh-ancestor
6378950|NCT00151203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6378951|NCT00151203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6378952|NCT00151203|Growth Substances|growth substances|mesh-ancestor
6378953|NCT00151203|Growth Inhibitors|growth inhibitors|mesh-ancestor
6378954|NCT00151203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6378955|NCT00151203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6378956|NCT00151203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6378957|NCT00151203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6378958|NCT00151203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378959|NCT00151203|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6378960|NCT00151203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6378961|NCT00151242|Cytarabine|cytarabine|mesh-list
6378962|NCT00151242|Etoposide|etoposide|mesh-list
6378963|NCT00151242|Idarubicin|idarubicin|mesh-list
6378964|NCT00151242|Tretinoin|tretinoin|mesh-list
6378965|NCT00151242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6378966|NCT00151242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6378967|NCT00151242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6378968|NCT00151242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6378969|NCT00151242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6378970|NCT00151242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378971|NCT00151242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6378972|NCT00151242|Antimetabolites|antimetabolites|mesh-ancestor
6378973|NCT00151242|Antiviral Agents|antiviral agents|mesh-ancestor
6378974|NCT00151242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6378975|NCT00151242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6378976|NCT00151242|Immunologic Factors|immunologic factors|mesh-ancestor
6378977|NCT00151242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378978|NCT00151242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6378979|NCT00151242|Keratolytic Agents|keratolytic agents|mesh-ancestor
6378980|NCT00151242|Dermatologic Agents|dermatologic agents|mesh-ancestor
6378981|NCT00151255|Cytarabine|cytarabine|mesh-list
6378982|NCT00151255|Mitoxantrone|mitoxantrone|mesh-list
6378983|NCT00151255|Idarubicin|idarubicin|mesh-list
6378984|NCT00151255|Tretinoin|tretinoin|mesh-list
6378985|NCT00151255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6378986|NCT00151255|Antimetabolites|antimetabolites|mesh-ancestor
6378987|NCT00151255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6378988|NCT00151255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6378989|NCT00151255|Antiviral Agents|antiviral agents|mesh-ancestor
6378990|NCT00151255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6378991|NCT00151255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6378992|NCT00151255|Immunologic Factors|immunologic factors|mesh-ancestor
6378993|NCT00151255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6378994|NCT00151255|Analgesics|analgesics|mesh-ancestor
6378995|NCT00151255|Sensory System Agents|sensory system agents|mesh-ancestor
6378996|NCT00151255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6378997|NCT00151255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6378998|NCT00151255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6378999|NCT00151255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6379000|NCT00151255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6379001|NCT00151255|Keratolytic Agents|keratolytic agents|mesh-ancestor
6379002|NCT00151255|Dermatologic Agents|dermatologic agents|mesh-ancestor
6379003|NCT00151294|Dexetimide|dexetimide|mesh-list
6379004|NCT00151294|Citalopram|citalopram|mesh-list
6379005|NCT00151294|Antidepressive Agents|antidepressive agents|mesh-list
6379006|NCT00151294|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6379007|NCT00151294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6379008|NCT00151294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6379009|NCT00151294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379010|NCT00151294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6379011|NCT00151294|Serotonin Agents|serotonin agents|mesh-ancestor
6379012|NCT00151294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379013|NCT00151294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6379014|NCT00151294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6379015|NCT00151294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6379016|NCT00151294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6379017|NCT00151294|Parasympatholytics|parasympatholytics|mesh-ancestor
6379018|NCT00151294|Autonomic Agents|autonomic agents|mesh-ancestor
6379019|NCT00151294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6379020|NCT00151294|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6379021|NCT00151294|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6379022|NCT00151294|Cholinergic Agents|cholinergic agents|mesh-ancestor
6396019|NCT00207428|Sensory System Agents|sensory system agents|mesh-ancestor
6396020|NCT00207428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6396021|NCT00207428|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6396022|NCT00207428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6396023|NCT00207428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396024|NCT00207428|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6396025|NCT00207428|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6396026|NCT00207532|Folic Acid|folic acid|mesh-list
6396027|NCT00207532|Hematinics|hematinics|mesh-ancestor
6396028|NCT00207532|Vitamin B Complex|vitamin b complex|mesh-ancestor
6396029|NCT00207532|Vitamins|vitamins|mesh-ancestor
6396030|NCT00207532|Micronutrients|micronutrients|mesh-ancestor
6396031|NCT00207532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396032|NCT00207558|Folic Acid|folic acid|mesh-list
6396033|NCT00207558|Hematinics|hematinics|mesh-ancestor
6396034|NCT00207558|Vitamin B Complex|vitamin b complex|mesh-ancestor
6396035|NCT00207558|Vitamins|vitamins|mesh-ancestor
6396036|NCT00207558|Micronutrients|micronutrients|mesh-ancestor
6396037|NCT00207558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396038|NCT00207584|Doxycycline|doxycycline|mesh-list
6396039|NCT00207584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6396040|NCT00207584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6396041|NCT00207584|Antimalarials|antimalarials|mesh-ancestor
6396042|NCT00207584|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6396043|NCT00207584|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6396044|NCT00207662|Infliximab|infliximab|mesh-list
6396045|NCT00207662|Dermatologic Agents|dermatologic agents|mesh-ancestor
6396046|NCT00207662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6396047|NCT00207662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6396048|NCT00207675|Infliximab|infliximab|mesh-list
6396049|NCT00207675|Dermatologic Agents|dermatologic agents|mesh-ancestor
6396050|NCT00207675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6396051|NCT00207675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6396052|NCT00207688|Infliximab|infliximab|mesh-list
6396053|NCT00207688|Dermatologic Agents|dermatologic agents|mesh-ancestor
6396054|NCT00207688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6396055|NCT00207688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6396056|NCT00207701|Infliximab|infliximab|mesh-list
6396057|NCT00207701|Dermatologic Agents|dermatologic agents|mesh-ancestor
6396058|NCT00207701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6396059|NCT00207701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6396060|NCT00207753|Ivermectin|ivermectin|mesh-list
6396061|NCT00207753|Albendazole|albendazole|mesh-list
6396062|NCT00207753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6396063|NCT00207753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6396064|NCT00207753|Anthelmintics|anthelmintics|mesh-ancestor
6396065|NCT00207753|Anticestodal Agents|anticestodal agents|mesh-ancestor
6396066|NCT00207753|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6396067|NCT00207753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6396068|NCT00207753|Tubulin Modulators|tubulin modulators|mesh-ancestor
6396069|NCT00207753|Antimitotic Agents|antimitotic agents|mesh-ancestor
6396070|NCT00207753|Mitosis Modulators|mitosis modulators|mesh-ancestor
6396071|NCT00207753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396072|NCT00207753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6396073|NCT00207766|Infliximab|infliximab|mesh-list
6396074|NCT00207766|Dermatologic Agents|dermatologic agents|mesh-ancestor
6396075|NCT00207766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6396076|NCT00207766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6396077|NCT00207779|Heparin|heparin|mesh-list
6379023|NCT00151346|Fentanyl|fentanyl|mesh-list
6379024|NCT00151346|Bupivacaine|bupivacaine|mesh-list
6379025|NCT00151346|Anesthetics, Local|anesthetics, local|mesh-ancestor
6379026|NCT00151346|Anesthetics|anesthetics|mesh-ancestor
6379027|NCT00151346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6379028|NCT00151346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379029|NCT00151346|Sensory System Agents|sensory system agents|mesh-ancestor
6379030|NCT00151346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6379031|NCT00151346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6379032|NCT00151346|Narcotics|narcotics|mesh-ancestor
6379033|NCT00151346|Analgesics|analgesics|mesh-ancestor
6379034|NCT00151346|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6379035|NCT00151346|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6379036|NCT00151346|Anesthetics, General|anesthetics, general|mesh-ancestor
6379037|NCT00151450|Pregabalin|pregabalin|mesh-list
6379038|NCT00151450|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6379039|NCT00151450|Analgesics|analgesics|mesh-ancestor
6379040|NCT00151450|Sensory System Agents|sensory system agents|mesh-ancestor
6379041|NCT00151450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6379042|NCT00151450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379043|NCT00151450|Anticonvulsants|anticonvulsants|mesh-ancestor
6379044|NCT00151450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6379045|NCT00151450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6379046|NCT00151450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379047|NCT00151450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6379048|NCT00151450|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6379049|NCT00151450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6379050|NCT00151450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6379051|NCT00151450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6379052|NCT00151450|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6379053|NCT00151450|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6379054|NCT00151450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6379055|NCT00151450|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6379056|NCT00151450|Antidepressive Agents|antidepressive agents|mesh-ancestor
6379057|NCT00151463|Sildenafil Citrate|sildenafil citrate|mesh-list
6379058|NCT00151463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379059|NCT00151463|Vasodilator Agents|vasodilator agents|mesh-ancestor
6379060|NCT00151463|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6379061|NCT00151463|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6379062|NCT00151463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6379063|NCT00151463|Urological Agents|urological agents|mesh-ancestor
6379064|NCT00151489|Pregabalin|pregabalin|mesh-list
6379065|NCT00151489|Analgesics|analgesics|mesh-ancestor
6379066|NCT00151489|Sensory System Agents|sensory system agents|mesh-ancestor
6379067|NCT00151489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6379068|NCT00151489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379069|NCT00151489|Anticonvulsants|anticonvulsants|mesh-ancestor
6379070|NCT00151489|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6379071|NCT00151489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6379072|NCT00151489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379073|NCT00151489|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6379074|NCT00151489|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6379075|NCT00151489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6379076|NCT00151489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6379077|NCT00151489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6379078|NCT00151502|Atorvastatin|atorvastatin|mesh-list
6379079|NCT00151502|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6379080|NCT00151502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6379081|NCT00151502|Antimetabolites|antimetabolites|mesh-ancestor
6379082|NCT00151502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379083|NCT00151502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6379084|NCT00151502|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6379085|NCT00151502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6379086|NCT00151515|Minoxidil|minoxidil|mesh-list
6379087|NCT00151515|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6379088|NCT00151515|Vasodilator Agents|vasodilator agents|mesh-ancestor
6379089|NCT00151528|Pregabalin|pregabalin|mesh-list
6379090|NCT00151528|Analgesics|analgesics|mesh-ancestor
6379091|NCT00151528|Sensory System Agents|sensory system agents|mesh-ancestor
6396078|NCT00207779|Anticoagulants|anticoagulants|mesh-ancestor
6379092|NCT00151528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6379093|NCT00151528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379094|NCT00151528|Anticonvulsants|anticonvulsants|mesh-ancestor
6379095|NCT00151528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6379096|NCT00151528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6379097|NCT00151528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379098|NCT00151528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6379099|NCT00151528|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6379100|NCT00151528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6379101|NCT00151528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6379102|NCT00151528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6379103|NCT00151541|Dapsone|dapsone|mesh-list
6379104|NCT00151541|Adapalene|adapalene|mesh-list
6379105|NCT00151541|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6379106|NCT00151541|Dermatologic Agents|dermatologic agents|mesh-ancestor
6379107|NCT00151541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6379108|NCT00151541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6379109|NCT00151541|Analgesics|analgesics|mesh-ancestor
6379110|NCT00151541|Sensory System Agents|sensory system agents|mesh-ancestor
6379111|NCT00151541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6379112|NCT00151541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379113|NCT00151541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6379114|NCT00151541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6379115|NCT00151541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6379116|NCT00151541|Antimalarials|antimalarials|mesh-ancestor
6379117|NCT00151541|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6379118|NCT00151541|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6379119|NCT00151541|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6379120|NCT00151541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6379121|NCT00151541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379122|NCT00151541|Leprostatic Agents|leprostatic agents|mesh-ancestor
6379123|NCT00151541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6379124|NCT00151567|Tamsulosin|tamsulosin|mesh-list
6379125|NCT00151567|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6379126|NCT00151567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6379127|NCT00151567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6379128|NCT00151567|Adrenergic Agents|adrenergic agents|mesh-ancestor
6379129|NCT00151567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6379130|NCT00151567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379131|NCT00151567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379132|NCT00151567|Urological Agents|urological agents|mesh-ancestor
6379133|NCT00151580|Ribavirin|ribavirin|mesh-list
6379134|NCT00151580|Antimetabolites|antimetabolites|mesh-ancestor
6379135|NCT00151580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379136|NCT00151580|Antiviral Agents|antiviral agents|mesh-ancestor
6379137|NCT00151580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6379138|NCT00151619|Amlodipine|amlodipine|mesh-list
6379139|NCT00151619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6379140|NCT00151619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6379141|NCT00151619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6379142|NCT00151619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379143|NCT00151619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6379144|NCT00151619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379145|NCT00151619|Vasodilator Agents|vasodilator agents|mesh-ancestor
6379146|NCT00151632|Mycophenolic Acid|mycophenolic acid|mesh-list
6379147|NCT00151632|Tacrolimus|tacrolimus|mesh-list
6379148|NCT00151632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6379149|NCT00151632|Immunologic Factors|immunologic factors|mesh-ancestor
5724665|NCT03185845|Warfarin|warfarin|mesh-list
6379150|NCT00151632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379151|NCT00151632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6379152|NCT00151632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6379153|NCT00151632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379154|NCT00151632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6379155|NCT00151632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6379156|NCT00151632|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6379157|NCT00151632|Antitubercular Agents|antitubercular agents|mesh-ancestor
6379158|NCT00151632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6379159|NCT00151632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6379160|NCT00151684|Diazoxide|diazoxide|mesh-list
6379161|NCT00151684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6379162|NCT00151684|Vasodilator Agents|vasodilator agents|mesh-ancestor
6379163|NCT00151697|Insulin Aspart|insulin aspart|mesh-list
6379164|NCT00151697|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6379165|NCT00151697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6379166|NCT00151697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379167|NCT00151710|Pioglitazone|pioglitazone|mesh-list
6379168|NCT00151710|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6379169|NCT00151710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379170|NCT00151736|Etodolac|etodolac|mesh-list
6379171|NCT00151736|Chlorambucil|chlorambucil|mesh-list
6379172|NCT00151736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6379173|NCT00151736|Alkylating Agents|alkylating agents|mesh-ancestor
6379174|NCT00151736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379175|NCT00151736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6379176|NCT00151736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6379177|NCT00151736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6379178|NCT00151736|Analgesics|analgesics|mesh-ancestor
6379179|NCT00151736|Sensory System Agents|sensory system agents|mesh-ancestor
6379180|NCT00151736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6379181|NCT00151736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379182|NCT00151736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6379183|NCT00151736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6379184|NCT00151736|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6379185|NCT00151736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6379186|NCT00151736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6379187|NCT00151749|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
6379188|NCT00151749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6379189|NCT00151749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6379190|NCT00151749|Antimetabolites|antimetabolites|mesh-ancestor
6379191|NCT00151749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379192|NCT00151749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6379193|NCT00151762|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
6379194|NCT00151762|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6379195|NCT00151762|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6379196|NCT00151762|Antimetabolites|antimetabolites|mesh-ancestor
6379197|NCT00151762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379198|NCT00151762|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6379199|NCT00151801|Interferons|interferons|mesh-list
6379200|NCT00151801|Interferon-beta|interferon-beta|mesh-list
6379201|NCT00151801|Interferon beta-1a|interferon beta-1a|mesh-list
6379202|NCT00151801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6379203|NCT00151801|Antiviral Agents|antiviral agents|mesh-ancestor
6379204|NCT00151801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6379205|NCT00151801|Immunologic Factors|immunologic factors|mesh-ancestor
6379206|NCT00151801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379207|NCT00151801|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6379208|NCT00151827|Losartan|losartan|mesh-list
6379209|NCT00151827|Olmesartan|olmesartan|mesh-list
6379210|NCT00151827|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6379211|NCT00151827|Furosemide|furosemide|mesh-list
6379212|NCT00151827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6379213|NCT00151827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6379214|NCT00151827|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6379215|NCT00151827|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6379216|NCT00151827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379217|NCT00151827|Diuretics|diuretics|mesh-ancestor
6379218|NCT00151827|Natriuretic Agents|natriuretic agents|mesh-ancestor
6379219|NCT00151827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396079|NCT00207779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6379220|NCT00151827|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6379221|NCT00151827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6379222|NCT00151944|Mesalamine|mesalamine|mesh-list
6379223|NCT00151944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6379224|NCT00151944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6379225|NCT00151944|Analgesics|analgesics|mesh-ancestor
6379226|NCT00151944|Sensory System Agents|sensory system agents|mesh-ancestor
6379227|NCT00151944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6379228|NCT00151944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379229|NCT00151944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6379230|NCT00151944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6379231|NCT00151957|Methylphenidate|methylphenidate|mesh-list
6379232|NCT00151957|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6379233|NCT00151957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379234|NCT00151957|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6379235|NCT00151957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6379236|NCT00151957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6379237|NCT00151957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379238|NCT00151957|Dopamine Agents|dopamine agents|mesh-ancestor
6379239|NCT00151957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6379240|NCT00151970|Methylphenidate|methylphenidate|mesh-list
6379241|NCT00151970|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6379242|NCT00151970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379243|NCT00151970|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6379244|NCT00151970|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6379245|NCT00151970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6379246|NCT00151970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379247|NCT00151970|Dopamine Agents|dopamine agents|mesh-ancestor
6379248|NCT00151970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6379249|NCT00151983|Methylphenidate|methylphenidate|mesh-list
6379250|NCT00151983|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6379251|NCT00151983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379252|NCT00151983|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6379253|NCT00151983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6379254|NCT00151983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6379255|NCT00151983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379256|NCT00151983|Dopamine Agents|dopamine agents|mesh-ancestor
6379257|NCT00151983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6379258|NCT00152022|Amphetamine|amphetamine|mesh-list
6379259|NCT00152022|Dextroamphetamine|dextroamphetamine|mesh-list
6379260|NCT00152022|Adderall|adderall|mesh-list
6379261|NCT00152022|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6379262|NCT00152022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379263|NCT00152022|Sympathomimetics|sympathomimetics|mesh-ancestor
6379264|NCT00152022|Autonomic Agents|autonomic agents|mesh-ancestor
6379265|NCT00152022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6379266|NCT00152022|Dopamine Agents|dopamine agents|mesh-ancestor
6379267|NCT00152022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6379268|NCT00152022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379269|NCT00152022|Adrenergic Agents|adrenergic agents|mesh-ancestor
6379270|NCT00152022|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6379271|NCT00152022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6379272|NCT00152022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6379273|NCT00152022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6379274|NCT00152035|Amphetamine|amphetamine|mesh-list
6379275|NCT00152035|Dextroamphetamine|dextroamphetamine|mesh-list
6379276|NCT00152035|Adderall|adderall|mesh-list
6379277|NCT00152035|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6379278|NCT00152035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379279|NCT00152035|Sympathomimetics|sympathomimetics|mesh-ancestor
6379280|NCT00152035|Autonomic Agents|autonomic agents|mesh-ancestor
6379281|NCT00152035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6379282|NCT00152035|Dopamine Agents|dopamine agents|mesh-ancestor
6379283|NCT00152035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6379284|NCT00152035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379285|NCT00152035|Adrenergic Agents|adrenergic agents|mesh-ancestor
6379286|NCT00152035|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6379287|NCT00152035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6379288|NCT00152035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6379289|NCT00152035|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6379290|NCT00152048|Eflornithine|eflornithine|mesh-list
6379291|NCT00152048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6379292|NCT00152048|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6379293|NCT00152048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6379294|NCT00152048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6379295|NCT00152048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6379296|NCT00152048|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
6379297|NCT00152048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6379298|NCT00152048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379299|NCT00152100|Alemtuzumab|alemtuzumab|mesh-list
6379300|NCT00152100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6379301|NCT00152100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6379302|NCT00152126|Melphalan|melphalan|mesh-list
6379303|NCT00152126|Busulfan|busulfan|mesh-list
6379304|NCT00152126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6379305|NCT00152126|Alkylating Agents|alkylating agents|mesh-ancestor
6379306|NCT00152126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379307|NCT00152126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6379308|NCT00152126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6379309|NCT00152126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6379310|NCT00152126|Immunologic Factors|immunologic factors|mesh-ancestor
6379311|NCT00152126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379312|NCT00152139|Antibodies|antibodies|mesh-list
6379313|NCT00152139|Immunologic Factors|immunologic factors|mesh-ancestor
6379314|NCT00152139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379315|NCT00152178|Tamoxifen|tamoxifen|mesh-list
6379316|NCT00152178|Cyclophosphamide|cyclophosphamide|mesh-list
6379317|NCT00152178|Fluorouracil|fluorouracil|mesh-list
6379318|NCT00152178|Methotrexate|methotrexate|mesh-list
6379319|NCT00152178|Tegafur|tegafur|mesh-list
6379320|NCT00152178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6379321|NCT00152178|Immunologic Factors|immunologic factors|mesh-ancestor
6379322|NCT00152178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379323|NCT00152178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6379324|NCT00152178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6379325|NCT00152178|Alkylating Agents|alkylating agents|mesh-ancestor
6379326|NCT00152178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379327|NCT00152178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6379328|NCT00152178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6379329|NCT00152178|Antimetabolites|antimetabolites|mesh-ancestor
6379330|NCT00152178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6379331|NCT00152178|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6379332|NCT00152178|Abortifacient Agents|abortifacient agents|mesh-ancestor
6379333|NCT00152178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6379334|NCT00152178|Dermatologic Agents|dermatologic agents|mesh-ancestor
6379335|NCT00152178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6379336|NCT00152178|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6379337|NCT00152178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6379338|NCT00152178|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6379339|NCT00152178|Hormone Antagonists|hormone antagonists|mesh-ancestor
6379340|NCT00152178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6379341|NCT00152178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6379342|NCT00152178|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6379343|NCT00152178|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6379344|NCT00152178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6379345|NCT00152191|Cyclophosphamide|cyclophosphamide|mesh-list
6379346|NCT00152191|Fluorouracil|fluorouracil|mesh-list
6379347|NCT00152191|Methotrexate|methotrexate|mesh-list
6379348|NCT00152191|Tegafur|tegafur|mesh-list
6379349|NCT00152191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6379350|NCT00152191|Immunologic Factors|immunologic factors|mesh-ancestor
6379351|NCT00152191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379352|NCT00152191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6379353|NCT00152191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6379354|NCT00152191|Alkylating Agents|alkylating agents|mesh-ancestor
6379355|NCT00152191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379356|NCT00152191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6379357|NCT00152191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6379358|NCT00152191|Antimetabolites|antimetabolites|mesh-ancestor
6379359|NCT00152191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6379360|NCT00152191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6379361|NCT00152191|Abortifacient Agents|abortifacient agents|mesh-ancestor
6379362|NCT00152191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6379363|NCT00152191|Dermatologic Agents|dermatologic agents|mesh-ancestor
6379364|NCT00152191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6379365|NCT00152191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6379366|NCT00152191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6379367|NCT00152204|Pyrimethamine|pyrimethamine|mesh-list
6379368|NCT00152204|Sulfadoxine|sulfadoxine|mesh-list
6379369|NCT00152204|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6379370|NCT00152204|Antimalarials|antimalarials|mesh-ancestor
6379371|NCT00152204|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6379372|NCT00152204|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6379373|NCT00152204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6379374|NCT00152204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6379375|NCT00152204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6379376|NCT00152204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379377|NCT00152204|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6379378|NCT00152204|Renal Agents|renal agents|mesh-ancestor
6379379|NCT00152230|Tegafur|tegafur|mesh-list
6379380|NCT00152230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6379381|NCT00152230|Antimetabolites|antimetabolites|mesh-ancestor
6379382|NCT00152230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379383|NCT00152230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6379384|NCT00152243|Tegafur|tegafur|mesh-list
6379385|NCT00152243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6379386|NCT00152243|Antimetabolites|antimetabolites|mesh-ancestor
6379387|NCT00152243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379388|NCT00152243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6379389|NCT00152282|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6379390|NCT00152282|Estrogens|estrogens|mesh-ancestor
6379391|NCT00152282|Hormones|hormones|mesh-ancestor
6379392|NCT00152282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6379393|NCT00152282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379394|NCT00152295|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6379395|NCT00152295|Estrogens|estrogens|mesh-ancestor
6379396|NCT00152295|Hormones|hormones|mesh-ancestor
6379397|NCT00152295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6379398|NCT00152295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379399|NCT00152308|Sirolimus|sirolimus|mesh-list
6379400|NCT00152308|Ethanol|ethanol|mesh-list
6379401|NCT00152308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6379402|NCT00152308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6379403|NCT00152308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6379404|NCT00152308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6379405|NCT00152308|Antifungal Agents|antifungal agents|mesh-ancestor
6379406|NCT00152308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6379407|NCT00152308|Immunologic Factors|immunologic factors|mesh-ancestor
6379408|NCT00152308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379409|NCT00152308|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6379410|NCT00152308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6379411|NCT00152360|Orlistat|orlistat|mesh-list
6379412|NCT00152360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6379413|NCT00152360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379414|NCT00152360|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6379415|NCT00152360|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6379416|NCT00152373|Levetiracetam|levetiracetam|mesh-list
6379417|NCT00152373|Anticonvulsants|anticonvulsants|mesh-ancestor
6379418|NCT00152373|Nootropic Agents|nootropic agents|mesh-ancestor
6379419|NCT00152386|Certolizumab Pegol|certolizumab pegol|mesh-list
6379420|NCT00152386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6379421|NCT00152386|Immunologic Factors|immunologic factors|mesh-ancestor
6379422|NCT00152386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379423|NCT00152386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6379424|NCT00152399|Somatostatin|somatostatin|mesh-list
6379425|NCT00152399|Hormones|hormones|mesh-ancestor
6379426|NCT00152399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6379427|NCT00152399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379428|NCT00152412|Levocetirizine|levocetirizine|mesh-list
6379429|NCT00152412|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6379430|NCT00152412|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6379431|NCT00152412|Histamine Antagonists|histamine antagonists|mesh-ancestor
6379432|NCT00152412|Histamine Agents|histamine agents|mesh-ancestor
6379433|NCT00152412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6379434|NCT00152412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379435|NCT00152412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379436|NCT00152425|Certolizumab Pegol|certolizumab pegol|mesh-list
6379437|NCT00152425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6379438|NCT00152425|Immunologic Factors|immunologic factors|mesh-ancestor
6379439|NCT00152425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379440|NCT00152425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6379441|NCT00152438|Progesterone|progesterone|mesh-list
6379442|NCT00152438|Progestins|progestins|mesh-ancestor
6379443|NCT00152438|Hormones|hormones|mesh-ancestor
6379444|NCT00152438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6379445|NCT00152438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379446|NCT00152477|Paclitaxel|paclitaxel|mesh-list
6379447|NCT00152477|Carboplatin|carboplatin|mesh-list
6379448|NCT00152477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6379449|NCT00152477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6379450|NCT00152477|Tubulin Modulators|tubulin modulators|mesh-ancestor
6379451|NCT00152477|Antimitotic Agents|antimitotic agents|mesh-ancestor
6379452|NCT00152477|Mitosis Modulators|mitosis modulators|mesh-ancestor
6379453|NCT00152477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379454|NCT00152490|Certolizumab Pegol|certolizumab pegol|mesh-list
6379455|NCT00152490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6379456|NCT00152490|Immunologic Factors|immunologic factors|mesh-ancestor
6379457|NCT00152490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379458|NCT00152490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6379459|NCT00152542|Nitric Oxide|nitric oxide|mesh-list
6379460|NCT00152542|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6379461|NCT00152542|Autonomic Agents|autonomic agents|mesh-ancestor
6379462|NCT00152542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6379463|NCT00152542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379464|NCT00152542|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6379465|NCT00152542|Respiratory System Agents|respiratory system agents|mesh-ancestor
6379466|NCT00152542|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6379467|NCT00152542|Antioxidants|antioxidants|mesh-ancestor
6379468|NCT00152542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379469|NCT00152542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6379470|NCT00152542|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6379471|NCT00152542|Vasodilator Agents|vasodilator agents|mesh-ancestor
6379472|NCT00152542|Gasotransmitters|gasotransmitters|mesh-ancestor
6379473|NCT00152542|Protective Agents|protective agents|mesh-ancestor
6379474|NCT00152581|Interferons|interferons|mesh-list
6379475|NCT00152581|Ribavirin|ribavirin|mesh-list
6379476|NCT00152581|Interferon-alpha|interferon-alpha|mesh-list
6379477|NCT00152581|Interferon alpha-2|interferon alpha-2|mesh-list
6379478|NCT00152581|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6379479|NCT00152581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6379480|NCT00152581|Antiviral Agents|antiviral agents|mesh-ancestor
6379481|NCT00152581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6379482|NCT00152581|Antimetabolites|antimetabolites|mesh-ancestor
6379483|NCT00152581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379484|NCT00152581|Immunologic Factors|immunologic factors|mesh-ancestor
6379485|NCT00152581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379486|NCT00152594|Voriconazole|voriconazole|mesh-list
6379487|NCT00152594|Antifungal Agents|antifungal agents|mesh-ancestor
6379488|NCT00152594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6379489|NCT00152594|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6379490|NCT00152594|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6379491|NCT00152594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6379492|NCT00152594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379493|NCT00152594|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6379494|NCT00152594|Hormone Antagonists|hormone antagonists|mesh-ancestor
6379495|NCT00152594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6379496|NCT00152594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379497|NCT00152594|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6379498|NCT00152620|Dexamethasone|dexamethasone|mesh-list
6379499|NCT00152620|Methylprednisolone|methylprednisolone|mesh-list
6379500|NCT00152620|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6379501|NCT00152620|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6379502|NCT00152620|Prednisolone|prednisolone|mesh-list
6379503|NCT00152620|Prednisolone acetate|prednisolone acetate|mesh-list
6379504|NCT00152620|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6379505|NCT00152620|Prednisolone phosphate|prednisolone phosphate|mesh-list
6379506|NCT00152620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6379507|NCT00152620|Antiemetics|antiemetics|mesh-ancestor
6379508|NCT00152620|Autonomic Agents|autonomic agents|mesh-ancestor
6379509|NCT00152620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6379510|NCT00152620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379511|NCT00152620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6379512|NCT00152620|Glucocorticoids|glucocorticoids|mesh-ancestor
6379513|NCT00152620|Hormones|hormones|mesh-ancestor
6379514|NCT00152620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6379515|NCT00152620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6379516|NCT00152620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6379517|NCT00152620|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6379518|NCT00152620|Protective Agents|protective agents|mesh-ancestor
6379519|NCT00152633|Losartan|losartan|mesh-list
6379520|NCT00152633|Metoprolol|metoprolol|mesh-list
6379521|NCT00152633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6379522|NCT00152633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6379523|NCT00152633|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6379524|NCT00152633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6379525|NCT00152633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379526|NCT00152633|Sympatholytics|sympatholytics|mesh-ancestor
6379527|NCT00152633|Autonomic Agents|autonomic agents|mesh-ancestor
6379528|NCT00152633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6379529|NCT00152633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379530|NCT00152633|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6379531|NCT00152633|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6379532|NCT00152633|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6379533|NCT00152633|Adrenergic Agents|adrenergic agents|mesh-ancestor
6379534|NCT00152633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6379535|NCT00152646|Clopidogrel|clopidogrel|mesh-list
6379536|NCT00152646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6379537|NCT00152646|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6379538|NCT00152646|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6379539|NCT00152646|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6379540|NCT00152646|Purinergic Agents|purinergic agents|mesh-ancestor
6379541|NCT00152646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6379542|NCT00152646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379543|NCT00152646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379544|NCT00152698|Irbesartan|irbesartan|mesh-list
6379545|NCT00152698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6379546|NCT00152698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6379547|NCT00152698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6379548|NCT00152698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379549|NCT00152724|Aspirin|aspirin|mesh-list
6379550|NCT00152724|Celecoxib|celecoxib|mesh-list
6379551|NCT00152724|Indomethacin|indomethacin|mesh-list
6379552|NCT00152724|Nitroprusside|nitroprusside|mesh-list
6379553|NCT00152724|Acetylcholine|acetylcholine|mesh-list
6379554|NCT00152724|Capsaicin|capsaicin|mesh-list
6379555|NCT00152724|Clopidogrel|clopidogrel|mesh-list
6379556|NCT00152724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6379557|NCT00152724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6379558|NCT00152724|Analgesics|analgesics|mesh-ancestor
6379559|NCT00152724|Sensory System Agents|sensory system agents|mesh-ancestor
6379560|NCT00152724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6379561|NCT00152724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379562|NCT00152724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6379563|NCT00152724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6379564|NCT00152724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6379565|NCT00152724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6379566|NCT00152724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379567|NCT00152724|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6379568|NCT00152724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6379569|NCT00152724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6379570|NCT00152724|Antipyretics|antipyretics|mesh-ancestor
6379571|NCT00152724|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6379572|NCT00152724|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6379573|NCT00152724|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6379574|NCT00152724|Purinergic Agents|purinergic agents|mesh-ancestor
6379575|NCT00152724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6379576|NCT00152724|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6379577|NCT00152724|Antipruritics|antipruritics|mesh-ancestor
6379578|NCT00152724|Dermatologic Agents|dermatologic agents|mesh-ancestor
6379579|NCT00152724|Gout Suppressants|gout suppressants|mesh-ancestor
6379580|NCT00152724|Tocolytic Agents|tocolytic agents|mesh-ancestor
6379581|NCT00152724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6379582|NCT00152724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6379583|NCT00152724|Vasodilator Agents|vasodilator agents|mesh-ancestor
6379584|NCT00152724|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6379585|NCT00152724|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6379586|NCT00152724|Cholinergic Agents|cholinergic agents|mesh-ancestor
6379587|NCT00152750|Clonidine|clonidine|mesh-list
6379588|NCT00152750|Analgesics|analgesics|mesh-ancestor
6379589|NCT00152750|Sensory System Agents|sensory system agents|mesh-ancestor
6379590|NCT00152750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6379591|NCT00152750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379592|NCT00152750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6379593|NCT00152750|Sympatholytics|sympatholytics|mesh-ancestor
6379594|NCT00152750|Autonomic Agents|autonomic agents|mesh-ancestor
6379595|NCT00152750|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6379596|NCT00152750|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6379597|NCT00152750|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6379598|NCT00152750|Adrenergic Agents|adrenergic agents|mesh-ancestor
6379599|NCT00152750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6379600|NCT00152750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396080|NCT00207779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6396081|NCT00207779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396082|NCT00207792|Lenograstim|lenograstim|mesh-list
6396083|NCT00207792|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6396084|NCT00207792|Immunologic Factors|immunologic factors|mesh-ancestor
6396085|NCT00207792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396086|NCT00207831|Tegafur|tegafur|mesh-list
6396087|NCT00207831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6396088|NCT00207831|Antimetabolites|antimetabolites|mesh-ancestor
6396089|NCT00207831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396090|NCT00207831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6396091|NCT00207844|Selenium|selenium|mesh-list
6396092|NCT00207844|Selenious Acid|selenious acid|mesh-list
6396093|NCT00207844|Sodium Selenite|sodium selenite|mesh-list
6396094|NCT00207844|Antioxidants|antioxidants|mesh-ancestor
6396095|NCT00207844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396096|NCT00207844|Protective Agents|protective agents|mesh-ancestor
6396097|NCT00207844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396098|NCT00207844|Trace Elements|trace elements|mesh-ancestor
6396099|NCT00207844|Micronutrients|micronutrients|mesh-ancestor
6396100|NCT00207948|Ritonavir|ritonavir|mesh-list
6396101|NCT00207948|Lopinavir|lopinavir|mesh-list
6396102|NCT00207948|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6396103|NCT00207948|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6396104|NCT00207948|Protease Inhibitors|protease inhibitors|mesh-ancestor
6396105|NCT00207948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6396106|NCT00207948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396107|NCT00207948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6396108|NCT00207948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6396109|NCT00207948|Antiviral Agents|antiviral agents|mesh-ancestor
6396110|NCT00207948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6396111|NCT00207948|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6396112|NCT00207948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6396113|NCT00208039|Calfactant|calfactant|mesh-list
6396114|NCT00208039|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
6396115|NCT00208039|Respiratory System Agents|respiratory system agents|mesh-ancestor
6396116|NCT00208065|Pseudoephedrine|pseudoephedrine|mesh-list
6396117|NCT00208065|Ephedrine|ephedrine|mesh-list
6396118|NCT00208065|Almotriptan|almotriptan|mesh-list
6396119|NCT00208065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6396120|NCT00208065|Autonomic Agents|autonomic agents|mesh-ancestor
6396121|NCT00208065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6396122|NCT00208065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396123|NCT00208065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6396124|NCT00208065|Respiratory System Agents|respiratory system agents|mesh-ancestor
6396125|NCT00208065|Nasal Decongestants|nasal decongestants|mesh-ancestor
6396126|NCT00208065|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6396127|NCT00208065|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6396128|NCT00208065|Sympathomimetics|sympathomimetics|mesh-ancestor
6396129|NCT00208065|Adrenergic Agents|adrenergic agents|mesh-ancestor
6396130|NCT00208065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6379601|NCT00152802|Vaccines|vaccines|mesh-list
6379602|NCT00152802|Immunologic Factors|immunologic factors|mesh-ancestor
6379603|NCT00152802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379604|NCT00152815|Vitamin E|vitamin e|mesh-list
6379605|NCT00152815|Antioxidants|antioxidants|mesh-list
6379606|NCT00152815|Vitamins|vitamins|mesh-ancestor
6379607|NCT00152815|Micronutrients|micronutrients|mesh-ancestor
6379608|NCT00152815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379609|NCT00152815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379610|NCT00152815|Protective Agents|protective agents|mesh-ancestor
6379611|NCT00152828|Celecoxib|celecoxib|mesh-list
6379612|NCT00152828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6379613|NCT00152828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6379614|NCT00152828|Analgesics|analgesics|mesh-ancestor
6379615|NCT00152828|Sensory System Agents|sensory system agents|mesh-ancestor
6379616|NCT00152828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6379617|NCT00152828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379618|NCT00152828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6379619|NCT00152828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6379620|NCT00152828|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6379621|NCT00152828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6379622|NCT00152828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6379623|NCT00152828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379624|NCT00152841|Vitamin E|vitamin e|mesh-list
6379625|NCT00152841|Vitamins|vitamins|mesh-ancestor
6379626|NCT00152841|Micronutrients|micronutrients|mesh-ancestor
6379627|NCT00152841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379628|NCT00152841|Antioxidants|antioxidants|mesh-ancestor
6379629|NCT00152841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379630|NCT00152841|Protective Agents|protective agents|mesh-ancestor
6379631|NCT00152854|Acetaminophen|acetaminophen|mesh-list
6379632|NCT00152854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6379633|NCT00152854|Analgesics|analgesics|mesh-ancestor
6379634|NCT00152854|Sensory System Agents|sensory system agents|mesh-ancestor
6379635|NCT00152854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6379636|NCT00152854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379637|NCT00152854|Antipyretics|antipyretics|mesh-ancestor
6379638|NCT00152867|Dexamethasone|dexamethasone|mesh-list
6379639|NCT00152867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6379640|NCT00152867|Antiemetics|antiemetics|mesh-ancestor
6379641|NCT00152867|Autonomic Agents|autonomic agents|mesh-ancestor
6379642|NCT00152867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6379643|NCT00152867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379644|NCT00152867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6379645|NCT00152867|Glucocorticoids|glucocorticoids|mesh-ancestor
6379646|NCT00152867|Hormones|hormones|mesh-ancestor
6379647|NCT00152867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6379648|NCT00152867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6379649|NCT00152867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6379650|NCT00152893|Chromium|chromium|mesh-list
6379651|NCT00152893|Niacin|niacin|mesh-list
6379652|NCT00152893|Trace Elements|trace elements|mesh-ancestor
6379653|NCT00152893|Micronutrients|micronutrients|mesh-ancestor
6379654|NCT00152893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379655|NCT00152893|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6379656|NCT00152893|Antimetabolites|antimetabolites|mesh-ancestor
6379657|NCT00152893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379658|NCT00152893|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6379659|NCT00152893|Vasodilator Agents|vasodilator agents|mesh-ancestor
6379660|NCT00152893|Vitamin B Complex|vitamin b complex|mesh-ancestor
6379661|NCT00152893|Vitamins|vitamins|mesh-ancestor
6379662|NCT00152919|Meloxicam|meloxicam|mesh-list
6379663|NCT00152919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6379664|NCT00152919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6379665|NCT00152919|Analgesics|analgesics|mesh-ancestor
6379666|NCT00152919|Sensory System Agents|sensory system agents|mesh-ancestor
6379667|NCT00152919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6379668|NCT00152919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379669|NCT00152919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6379670|NCT00152919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6379671|NCT00152919|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6379672|NCT00152919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6379673|NCT00152919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6379674|NCT00152919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379675|NCT00152932|Dorzolamide|dorzolamide|mesh-list
6379676|NCT00152932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6379677|NCT00152932|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6379678|NCT00152932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6379679|NCT00152932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379680|NCT00152945|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6379681|NCT00152945|Glycerol|glycerol|mesh-list
6379682|NCT00152945|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6379683|NCT00152945|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6379684|NCT00152945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6379685|NCT00152945|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6379686|NCT00152945|Protective Agents|protective agents|mesh-ancestor
6379687|NCT00152945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379688|NCT00152958|Pramipexole|pramipexole|mesh-list
6379689|NCT00152958|Antioxidants|antioxidants|mesh-ancestor
6379690|NCT00152958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379691|NCT00152958|Protective Agents|protective agents|mesh-ancestor
6379692|NCT00152958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379693|NCT00152958|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6379694|NCT00152958|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6379695|NCT00152958|Dopamine Agonists|dopamine agonists|mesh-ancestor
6379696|NCT00152958|Dopamine Agents|dopamine agents|mesh-ancestor
6379697|NCT00152958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6379698|NCT00152984|Tiotropium Bromide|tiotropium bromide|mesh-list
6379699|NCT00152984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6379700|NCT00152984|Autonomic Agents|autonomic agents|mesh-ancestor
6379701|NCT00152984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6379702|NCT00152984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379703|NCT00152984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6379704|NCT00152984|Respiratory System Agents|respiratory system agents|mesh-ancestor
6379705|NCT00152984|Parasympatholytics|parasympatholytics|mesh-ancestor
6379706|NCT00152984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6379707|NCT00152984|Cholinergic Agents|cholinergic agents|mesh-ancestor
6379708|NCT00152984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6379709|NCT00152984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379710|NCT00152997|Pramipexole|pramipexole|mesh-list
6379711|NCT00152997|Antioxidants|antioxidants|mesh-ancestor
6379712|NCT00152997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379713|NCT00152997|Protective Agents|protective agents|mesh-ancestor
6379714|NCT00152997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379715|NCT00152997|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6379716|NCT00152997|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6379717|NCT00152997|Dopamine Agonists|dopamine agonists|mesh-ancestor
6379718|NCT00152997|Dopamine Agents|dopamine agents|mesh-ancestor
6379719|NCT00152997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6379720|NCT00153023|Valsartan|valsartan|mesh-list
6379721|NCT00153023|Telmisartan|telmisartan|mesh-list
6379722|NCT00153023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6379723|NCT00153023|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6379724|NCT00153023|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6379725|NCT00153023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379726|NCT00153049|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6379727|NCT00153049|Telmisartan|telmisartan|mesh-list
6379728|NCT00153049|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
6379729|NCT00153049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6379730|NCT00153049|Diuretics|diuretics|mesh-ancestor
6379731|NCT00153049|Natriuretic Agents|natriuretic agents|mesh-ancestor
6379732|NCT00153049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379733|NCT00153049|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6379734|NCT00153049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6379735|NCT00153049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379736|NCT00153049|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6379737|NCT00153049|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6379738|NCT00153075|Fenoterol|fenoterol|mesh-list
6379739|NCT00153075|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
6379740|NCT00153075|Ipratropium|ipratropium|mesh-list
6379741|NCT00153075|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6379742|NCT00153075|Autonomic Agents|autonomic agents|mesh-ancestor
6379743|NCT00153075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6379744|NCT00153075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379745|NCT00153075|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6379746|NCT00153075|Respiratory System Agents|respiratory system agents|mesh-ancestor
6379747|NCT00153075|Sympathomimetics|sympathomimetics|mesh-ancestor
6379748|NCT00153075|Tocolytic Agents|tocolytic agents|mesh-ancestor
6379749|NCT00153075|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6379750|NCT00153075|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6379751|NCT00153075|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6379752|NCT00153075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6379753|NCT00153075|Adrenergic Agents|adrenergic agents|mesh-ancestor
6379754|NCT00153075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6379755|NCT00153075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379756|NCT00153075|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6379757|NCT00153075|Cholinergic Agents|cholinergic agents|mesh-ancestor
6379758|NCT00153088|Telmisartan|telmisartan|mesh-list
6379759|NCT00153088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6379760|NCT00153088|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6379761|NCT00153088|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6379762|NCT00153088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379763|NCT00153114|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
6379764|NCT00153114|Laxatives|laxatives|mesh-ancestor
6379765|NCT00153114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6379766|NCT00153127|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
6379767|NCT00153127|Laxatives|laxatives|mesh-ancestor
6379768|NCT00153127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6379769|NCT00153140|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
6017513|NCT00373256|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6017514|NCT00373256|Growth Substances|growth substances|mesh-ancestor
6017515|NCT00373256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017516|NCT00373256|Growth Inhibitors|growth inhibitors|mesh-ancestor
6017517|NCT00373256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6379770|NCT00153140|Laxatives|laxatives|mesh-ancestor
6379771|NCT00153140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6379772|NCT00153153|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
6379773|NCT00153153|Laxatives|laxatives|mesh-ancestor
6379774|NCT00153153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6379775|NCT00153192|Dronabinol|dronabinol|mesh-list
6379776|NCT00153192|Hallucinogens|hallucinogens|mesh-ancestor
6379777|NCT00153192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379778|NCT00153192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6379779|NCT00153192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6379780|NCT00153192|Analgesics|analgesics|mesh-ancestor
6379781|NCT00153192|Sensory System Agents|sensory system agents|mesh-ancestor
6379782|NCT00153192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6379783|NCT00153192|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6379784|NCT00153192|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6379785|NCT00153192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6379786|NCT00153192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379787|NCT00153192|Hormones|hormones|mesh-ancestor
6379788|NCT00153192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6379789|NCT00153244|Lamotrigine|lamotrigine|mesh-list
6379790|NCT00153244|Anticonvulsants|anticonvulsants|mesh-ancestor
6379791|NCT00153244|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6379792|NCT00153244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6379793|NCT00153244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379794|NCT00153244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6379795|NCT00153244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379796|NCT00153244|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6379797|NCT00153244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6379798|NCT00153244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6379799|NCT00153244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6379800|NCT00153244|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6379801|NCT00153270|Valproic Acid|valproic acid|mesh-list
6379802|NCT00153270|Anticonvulsants|anticonvulsants|mesh-ancestor
6379803|NCT00153270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6379804|NCT00153270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379805|NCT00153270|GABA Agents|gaba agents|mesh-ancestor
6379806|NCT00153270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6379807|NCT00153270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379808|NCT00153270|Antimanic Agents|antimanic agents|mesh-ancestor
6379809|NCT00153270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6379810|NCT00153270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6379811|NCT00153270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6379812|NCT00153283|Gabapentin|gabapentin|mesh-list
6379813|NCT00153283|Analgesics|analgesics|mesh-ancestor
6379814|NCT00153283|Sensory System Agents|sensory system agents|mesh-ancestor
6379815|NCT00153283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6379816|NCT00153283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379817|NCT00153283|Anticonvulsants|anticonvulsants|mesh-ancestor
6379818|NCT00153283|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6379819|NCT00153283|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6379820|NCT00153283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6379821|NCT00153283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6379822|NCT00153283|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6379823|NCT00153283|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6379824|NCT00153283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6379825|NCT00153283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379826|NCT00153283|Antimanic Agents|antimanic agents|mesh-ancestor
6379827|NCT00153296|Carbamazepine|carbamazepine|mesh-list
6379828|NCT00153296|Anticonvulsants|anticonvulsants|mesh-ancestor
6379829|NCT00153296|Antimanic Agents|antimanic agents|mesh-ancestor
6379830|NCT00153296|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6379831|NCT00153296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6379832|NCT00153296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379833|NCT00153296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6379834|NCT00153296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6379835|NCT00153296|Analgesics|analgesics|mesh-ancestor
6379836|NCT00153296|Sensory System Agents|sensory system agents|mesh-ancestor
6379837|NCT00153296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6379838|NCT00153296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6379839|NCT00153296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6379840|NCT00153296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379841|NCT00153296|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6379842|NCT00153296|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6379843|NCT00153491|Lumefantrine|lumefantrine|mesh-list
6379844|NCT00153491|Artemether|artemether|mesh-list
6379845|NCT00153491|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6379846|NCT00153491|Antimalarials|antimalarials|mesh-ancestor
6379847|NCT00153491|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6379848|NCT00153491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6379849|NCT00153491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6379850|NCT00153517|Metronidazole|metronidazole|mesh-list
6379851|NCT00153517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6379852|NCT00153517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6379853|NCT00153517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6379854|NCT00153517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6379855|NCT00153530|Methotrexate|methotrexate|mesh-list
6379856|NCT00153530|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6379857|NCT00153530|Abortifacient Agents|abortifacient agents|mesh-ancestor
6379858|NCT00153530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6379859|NCT00153530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379860|NCT00153530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6379861|NCT00153530|Antimetabolites|antimetabolites|mesh-ancestor
6379862|NCT00153530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379863|NCT00153530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6379864|NCT00153530|Dermatologic Agents|dermatologic agents|mesh-ancestor
6379865|NCT00153530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6379866|NCT00153530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6379867|NCT00153530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6379868|NCT00153530|Immunologic Factors|immunologic factors|mesh-ancestor
6379869|NCT00153530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6379870|NCT00153530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6379871|NCT00153543|Vaccines|vaccines|mesh-list
6379872|NCT00153543|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6379873|NCT00153543|Immunologic Factors|immunologic factors|mesh-ancestor
6379874|NCT00153543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379875|NCT00153556|Vaccines|vaccines|mesh-list
6379876|NCT00153556|Immunologic Factors|immunologic factors|mesh-ancestor
6379877|NCT00153556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379878|NCT00153634|Azithromycin|azithromycin|mesh-list
6379879|NCT00153634|Ciprofloxacin|ciprofloxacin|mesh-list
6379880|NCT00153634|Meropenem|meropenem|mesh-list
6379881|NCT00153634|Tazobactam|tazobactam|mesh-list
6379882|NCT00153634|Piperacillin|piperacillin|mesh-list
6379883|NCT00153634|Tobramycin|tobramycin|mesh-list
6379884|NCT00153634|Clavulanic Acid|clavulanic acid|mesh-list
6379885|NCT00153634|Amikacin|amikacin|mesh-list
6379886|NCT00153634|Ceftazidime|ceftazidime|mesh-list
6379887|NCT00153634|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
6379888|NCT00153634|Ticarcillin|ticarcillin|mesh-list
6379889|NCT00153634|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
6379890|NCT00153634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6379891|NCT00153634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6379892|NCT00153634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6379893|NCT00153634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6379894|NCT00153634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6379895|NCT00153634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379896|NCT00153634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6379897|NCT00153634|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6379898|NCT00153634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6379899|NCT00153634|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6379900|NCT00153660|Celecoxib|celecoxib|mesh-list
6379901|NCT00153660|Naproxen|naproxen|mesh-list
6379902|NCT00153660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6379903|NCT00153660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6379904|NCT00153660|Analgesics|analgesics|mesh-ancestor
6379905|NCT00153660|Sensory System Agents|sensory system agents|mesh-ancestor
6379906|NCT00153660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6379907|NCT00153660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379908|NCT00153660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6379909|NCT00153660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6379910|NCT00153660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6379911|NCT00153660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6379912|NCT00153660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6379913|NCT00153660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379914|NCT00153660|Gout Suppressants|gout suppressants|mesh-ancestor
6379915|NCT00153673|Celecoxib|celecoxib|mesh-list
6379916|NCT00153673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6379917|NCT00153673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6379918|NCT00153673|Analgesics|analgesics|mesh-ancestor
6379919|NCT00153673|Sensory System Agents|sensory system agents|mesh-ancestor
6379920|NCT00153673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6379921|NCT00153673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379922|NCT00153673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6379923|NCT00153673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6379924|NCT00153673|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6379925|NCT00153673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6379926|NCT00153673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6379927|NCT00153673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379928|NCT00153699|Topiramate|topiramate|mesh-list
6379929|NCT00153699|Anticonvulsants|anticonvulsants|mesh-ancestor
6379930|NCT00153699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6379931|NCT00153699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379932|NCT00153725|Aspirin|aspirin|mesh-list
6379933|NCT00153725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6379934|NCT00153725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6379935|NCT00153725|Analgesics|analgesics|mesh-ancestor
6379936|NCT00153725|Sensory System Agents|sensory system agents|mesh-ancestor
6379937|NCT00153725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6379938|NCT00153725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379939|NCT00153725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6379940|NCT00153725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6379941|NCT00153725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6379942|NCT00153725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6379943|NCT00153725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379944|NCT00153725|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6379945|NCT00153725|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6379946|NCT00153725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6379947|NCT00153725|Antipyretics|antipyretics|mesh-ancestor
6379948|NCT00153764|Vitamins|vitamins|mesh-list
6379949|NCT00153764|Micronutrients|micronutrients|mesh-ancestor
6379950|NCT00153764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379951|NCT00153868|Darbepoetin alfa|darbepoetin alfa|mesh-list
6379952|NCT00153868|Hematinics|hematinics|mesh-ancestor
6379953|NCT00153881|Carboplatin|carboplatin|mesh-list
6379954|NCT00153881|Docetaxel|docetaxel|mesh-list
6379955|NCT00153881|Capecitabine|capecitabine|mesh-list
6379956|NCT00153881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6379957|NCT00153881|Tubulin Modulators|tubulin modulators|mesh-ancestor
6379958|NCT00153881|Antimitotic Agents|antimitotic agents|mesh-ancestor
6379959|NCT00153881|Mitosis Modulators|mitosis modulators|mesh-ancestor
6379960|NCT00153881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379961|NCT00153881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6379962|NCT00153881|Antimetabolites|antimetabolites|mesh-ancestor
6379963|NCT00153907|Capecitabine|capecitabine|mesh-list
6379964|NCT00153907|Vinorelbine|vinorelbine|mesh-list
6379965|NCT00153907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6379966|NCT00153907|Antimetabolites|antimetabolites|mesh-ancestor
6379967|NCT00153907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379968|NCT00153907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6379969|NCT00153907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6379970|NCT00153907|Tubulin Modulators|tubulin modulators|mesh-ancestor
6379971|NCT00153907|Antimitotic Agents|antimitotic agents|mesh-ancestor
6379972|NCT00153907|Mitosis Modulators|mitosis modulators|mesh-ancestor
6379973|NCT00153933|Lenalidomide|lenalidomide|mesh-list
6379974|NCT00153933|Bortezomib|bortezomib|mesh-list
6379975|NCT00153933|Immunologic Factors|immunologic factors|mesh-ancestor
6379976|NCT00153933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379977|NCT00153933|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6379978|NCT00153933|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6379979|NCT00153933|Growth Substances|growth substances|mesh-ancestor
6379980|NCT00153933|Growth Inhibitors|growth inhibitors|mesh-ancestor
6379981|NCT00153933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6379982|NCT00153946|Edaravone|edaravone|mesh-list
6379983|NCT00153946|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6379984|NCT00153946|Antioxidants|antioxidants|mesh-ancestor
6379985|NCT00153946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379986|NCT00153946|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6379987|NCT00153946|Protective Agents|protective agents|mesh-ancestor
6379988|NCT00153946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379989|NCT00153972|Levodopa|levodopa|mesh-list
6379990|NCT00153972|Cabergoline|cabergoline|mesh-list
6379991|NCT00153972|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6379992|NCT00153972|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6379993|NCT00153972|Dopamine Agents|dopamine agents|mesh-ancestor
6379994|NCT00153972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6379995|NCT00153972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6379996|NCT00153972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6379997|NCT00153972|Dopamine Agonists|dopamine agonists|mesh-ancestor
6379998|NCT00153998|Leucovorin|leucovorin|mesh-list
6379999|NCT00153998|Folic Acid|folic acid|mesh-list
6380000|NCT00153998|Fluorouracil|fluorouracil|mesh-list
6380001|NCT00153998|Oxaliplatin|oxaliplatin|mesh-list
6380002|NCT00153998|Irinotecan|irinotecan|mesh-list
6380003|NCT00153998|Cetuximab|cetuximab|mesh-list
6380004|NCT00153998|Levoleucovorin|levoleucovorin|mesh-list
6380005|NCT00153998|Antimetabolites|antimetabolites|mesh-ancestor
6380006|NCT00153998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380007|NCT00153998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6380008|NCT00153998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6380009|NCT00153998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6380010|NCT00153998|Immunologic Factors|immunologic factors|mesh-ancestor
6380011|NCT00153998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6380012|NCT00153998|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6380013|NCT00153998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6380014|NCT00153998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6380015|NCT00153998|Antidotes|antidotes|mesh-ancestor
6380016|NCT00153998|Protective Agents|protective agents|mesh-ancestor
6380017|NCT00153998|Vitamin B Complex|vitamin b complex|mesh-ancestor
6380018|NCT00153998|Vitamins|vitamins|mesh-ancestor
6380019|NCT00153998|Micronutrients|micronutrients|mesh-ancestor
6380020|NCT00153998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6380021|NCT00153998|Hematinics|hematinics|mesh-ancestor
6380022|NCT00154011|Rosiglitazone|rosiglitazone|mesh-list
6380023|NCT00154011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6380024|NCT00154011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6380025|NCT00154024|Irbesartan|irbesartan|mesh-list
6380026|NCT00154024|Atorvastatin|atorvastatin|mesh-list
6380027|NCT00154024|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6380028|NCT00154024|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6380029|NCT00154024|Antimetabolites|antimetabolites|mesh-ancestor
6380030|NCT00154024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380031|NCT00154024|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6380032|NCT00154024|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6380033|NCT00154024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6380034|NCT00154024|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6380035|NCT00154024|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6380036|NCT00154024|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6380037|NCT00154037|Pioglitazone|pioglitazone|mesh-list
6380038|NCT00154037|Candesartan|candesartan|mesh-list
6380039|NCT00154037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6380040|NCT00154037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6380041|NCT00154037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6380042|NCT00154037|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6380043|NCT00154037|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6380044|NCT00154037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380045|NCT00154050|Candesartan|candesartan|mesh-list
6380046|NCT00154050|Quinapril|quinapril|mesh-list
6380047|NCT00154050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6380048|NCT00154050|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6380049|NCT00154050|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6380050|NCT00154050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380051|NCT00154050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6380052|NCT00154050|Protease Inhibitors|protease inhibitors|mesh-ancestor
6380053|NCT00154050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6380054|NCT00154076|Topiramate|topiramate|mesh-list
6380055|NCT00154076|Zonisamide|zonisamide|mesh-list
6380056|NCT00154076|Anticonvulsants|anticonvulsants|mesh-ancestor
6380057|NCT00154076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6380058|NCT00154076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6380059|NCT00154076|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6380060|NCT00154076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6380061|NCT00154076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380062|NCT00154076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6380063|NCT00154089|Masoprocol|masoprocol|mesh-list
6380064|NCT00154089|Antioxidants|antioxidants|mesh-ancestor
6380065|NCT00154089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380066|NCT00154089|Protective Agents|protective agents|mesh-ancestor
6380067|NCT00154089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6380068|NCT00154089|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6380069|NCT00154089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6380070|NCT00154089|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6380071|NCT00154089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6380072|NCT00154089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6380073|NCT00154089|Analgesics|analgesics|mesh-ancestor
6380074|NCT00154089|Sensory System Agents|sensory system agents|mesh-ancestor
6380075|NCT00154089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6380076|NCT00154089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6380077|NCT00154089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6380078|NCT00154115|Simendan|simendan|mesh-list
6380079|NCT00154115|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6380080|NCT00154115|Vasodilator Agents|vasodilator agents|mesh-ancestor
6380081|NCT00154115|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6380082|NCT00154115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6380083|NCT00154115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6380084|NCT00154115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380085|NCT00154115|Protective Agents|protective agents|mesh-ancestor
6380086|NCT00154115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6380087|NCT00154128|Salicylic Acid|salicylic acid|mesh-list
6380088|NCT00154128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6380089|NCT00154128|Antifungal Agents|antifungal agents|mesh-ancestor
6380090|NCT00154128|Keratolytic Agents|keratolytic agents|mesh-ancestor
6380091|NCT00154128|Dermatologic Agents|dermatologic agents|mesh-ancestor
6380092|NCT00154141|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6380093|NCT00154141|Hemostatics|hemostatics|mesh-ancestor
6380094|NCT00154141|Coagulants|coagulants|mesh-ancestor
6380095|NCT00154167|Phentolamine|phentolamine|mesh-list
6380096|NCT00154167|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6380097|NCT00154167|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6380098|NCT00154167|Adrenergic Agents|adrenergic agents|mesh-ancestor
6380099|NCT00154167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6380100|NCT00154167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380101|NCT00154167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6380102|NCT00154167|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6380103|NCT00154180|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6380104|NCT00154180|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6380105|NCT00154180|Estradiol|estradiol|mesh-list
6380106|NCT00154180|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6380107|NCT00154180|Estrogens|estrogens|mesh-list
6380108|NCT00154180|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6380109|NCT00154180|Progesterone|progesterone|mesh-list
6380110|NCT00154180|Hormones|hormones|mesh-ancestor
6380111|NCT00154180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6380112|NCT00154180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6380113|NCT00154180|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6380114|NCT00154180|Contraceptive Agents|contraceptive agents|mesh-ancestor
6380115|NCT00154180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6380116|NCT00154180|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6380117|NCT00154180|Progestins|progestins|mesh-ancestor
6380118|NCT00154193|Cyclosporine|cyclosporine|mesh-list
6380119|NCT00154193|Cyclosporins|cyclosporins|mesh-list
6380120|NCT00154193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6380121|NCT00154193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380122|NCT00154193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6380123|NCT00154193|Immunologic Factors|immunologic factors|mesh-ancestor
6380124|NCT00154193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6380125|NCT00154193|Antifungal Agents|antifungal agents|mesh-ancestor
6380126|NCT00154193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6380127|NCT00154193|Dermatologic Agents|dermatologic agents|mesh-ancestor
6380128|NCT00154193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6380129|NCT00154193|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6380130|NCT00154206|Mycophenolic Acid|mycophenolic acid|mesh-list
6380131|NCT00154206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6380132|NCT00154206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6380133|NCT00154206|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6380134|NCT00154206|Antitubercular Agents|antitubercular agents|mesh-ancestor
6380135|NCT00154206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6380136|NCT00154206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6380137|NCT00154206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6380138|NCT00154206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380139|NCT00154219|Lumiracoxib|lumiracoxib|mesh-list
6380140|NCT00154219|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6380141|NCT00154219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6380142|NCT00154219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6380143|NCT00154219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380144|NCT00154219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6380145|NCT00154219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6380146|NCT00154219|Analgesics|analgesics|mesh-ancestor
6380147|NCT00154219|Sensory System Agents|sensory system agents|mesh-ancestor
6380148|NCT00154219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6380149|NCT00154219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6380150|NCT00154219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6380151|NCT00154219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6380152|NCT00154232|Mycophenolic Acid|mycophenolic acid|mesh-list
6380153|NCT00154232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6380154|NCT00154232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6380155|NCT00154232|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6380156|NCT00154232|Antitubercular Agents|antitubercular agents|mesh-ancestor
6380157|NCT00154232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6380158|NCT00154232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6380159|NCT00154232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6380160|NCT00154232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380161|NCT00154245|Mycophenolic Acid|mycophenolic acid|mesh-list
6380162|NCT00154245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6380163|NCT00154245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6380164|NCT00154245|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6380165|NCT00154245|Antitubercular Agents|antitubercular agents|mesh-ancestor
6380166|NCT00154245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6380167|NCT00154245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6380168|NCT00154245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6380169|NCT00154245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380170|NCT00154258|Clozapine|clozapine|mesh-list
6380171|NCT00154258|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6380172|NCT00154258|Serotonin Agents|serotonin agents|mesh-ancestor
6380173|NCT00154258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6380174|NCT00154258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380175|NCT00154258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6380176|NCT00154258|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6380177|NCT00154258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6380178|NCT00154258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6380179|NCT00154258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6380180|NCT00154258|GABA Antagonists|gaba antagonists|mesh-ancestor
6380181|NCT00154258|GABA Agents|gaba agents|mesh-ancestor
6396131|NCT00208065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396132|NCT00208065|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6396133|NCT00208065|Serotonin Agents|serotonin agents|mesh-ancestor
6396134|NCT00208117|Sertraline|sertraline|mesh-list
6396135|NCT00208117|Simvastatin|simvastatin|mesh-list
6396136|NCT00208117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6396137|NCT00208117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6396138|NCT00208117|Antimetabolites|antimetabolites|mesh-ancestor
6396139|NCT00208117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396140|NCT00208117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6396141|NCT00208117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6396142|NCT00208117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6396143|NCT00208117|Antidepressive Agents|antidepressive agents|mesh-ancestor
6396144|NCT00208117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6396145|NCT00208117|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6380182|NCT00154271|Valsartan|valsartan|mesh-list
6380183|NCT00154271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6380184|NCT00154271|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6380185|NCT00154271|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6380186|NCT00154271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380187|NCT00154323|Oxcarbazepine|oxcarbazepine|mesh-list
6380188|NCT00154323|Anticonvulsants|anticonvulsants|mesh-ancestor
6380189|NCT00154323|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6380190|NCT00154323|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6380191|NCT00154323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6380192|NCT00154323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380193|NCT00154323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6380194|NCT00154323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6380195|NCT00154336|Methotrexate|methotrexate|mesh-list
6380196|NCT00154336|Imatinib Mesylate|imatinib mesylate|mesh-list
6380197|NCT00154336|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6380198|NCT00154336|Abortifacient Agents|abortifacient agents|mesh-ancestor
6380199|NCT00154336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6380200|NCT00154336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6380201|NCT00154336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6380202|NCT00154336|Antimetabolites|antimetabolites|mesh-ancestor
6380203|NCT00154336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380204|NCT00154336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6380205|NCT00154336|Dermatologic Agents|dermatologic agents|mesh-ancestor
6380206|NCT00154336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6380207|NCT00154336|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6380208|NCT00154336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6380209|NCT00154336|Immunologic Factors|immunologic factors|mesh-ancestor
6380210|NCT00154336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6380211|NCT00154336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6380212|NCT00154336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6380213|NCT00154349|Imatinib Mesylate|imatinib mesylate|mesh-list
6380214|NCT00154349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6380215|NCT00154349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6380216|NCT00154349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6380217|NCT00154349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380218|NCT00154362|Oxcarbazepine|oxcarbazepine|mesh-list
6380219|NCT00154362|Anticonvulsants|anticonvulsants|mesh-ancestor
6380220|NCT00154362|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6380221|NCT00154362|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6017518|NCT00373256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6017519|NCT00373295|Baclofen|baclofen|mesh-list
6017520|NCT00373295|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6380222|NCT00154362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6380223|NCT00154362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380224|NCT00154362|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6380225|NCT00154362|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6380226|NCT00154388|Imatinib Mesylate|imatinib mesylate|mesh-list
6380227|NCT00154388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6380228|NCT00154388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6380229|NCT00154388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6380230|NCT00154388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380231|NCT00154401|Liraglutide|liraglutide|mesh-list
6380232|NCT00154401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6380233|NCT00154401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6380234|NCT00154401|Incretins|incretins|mesh-ancestor
6380235|NCT00154401|Hormones|hormones|mesh-ancestor
6380236|NCT00154401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6380237|NCT00154414|Liraglutide|liraglutide|mesh-list
6380238|NCT00154414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6380239|NCT00154414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6380240|NCT00154414|Incretins|incretins|mesh-ancestor
6380241|NCT00154414|Hormones|hormones|mesh-ancestor
6380242|NCT00154414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6380243|NCT00154440|Amoxicillin|amoxicillin|mesh-list
6380244|NCT00154440|Metronidazole|metronidazole|mesh-list
6380245|NCT00154440|Clarithromycin|clarithromycin|mesh-list
6380246|NCT00154440|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
6380247|NCT00154440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6380248|NCT00154440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6380249|NCT00154440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6380250|NCT00154440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6380251|NCT00154440|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6380252|NCT00154440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6380253|NCT00154440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380254|NCT00154440|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6380255|NCT00154440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6380256|NCT00154661|Pentoxifylline|pentoxifylline|mesh-list
6380257|NCT00154661|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6380258|NCT00154661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6380259|NCT00154661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380260|NCT00154661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6380261|NCT00154661|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6380262|NCT00154661|Protective Agents|protective agents|mesh-ancestor
6380263|NCT00154661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6380264|NCT00154661|Vasodilator Agents|vasodilator agents|mesh-ancestor
6380265|NCT00154661|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6380266|NCT00154661|Antioxidants|antioxidants|mesh-ancestor
6380267|NCT00154687|Paclitaxel|paclitaxel|mesh-list
6380268|NCT00154687|Fluorouracil|fluorouracil|mesh-list
6380269|NCT00154687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6380270|NCT00154687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6380271|NCT00154687|Tubulin Modulators|tubulin modulators|mesh-ancestor
6380272|NCT00154687|Antimitotic Agents|antimitotic agents|mesh-ancestor
6380273|NCT00154687|Mitosis Modulators|mitosis modulators|mesh-ancestor
6380274|NCT00154687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380275|NCT00154687|Antimetabolites|antimetabolites|mesh-ancestor
6380276|NCT00154687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6380277|NCT00154687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6380278|NCT00154687|Immunologic Factors|immunologic factors|mesh-ancestor
6380279|NCT00154687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6380280|NCT00154700|Folic Acid|folic acid|mesh-list
6380281|NCT00154700|Paclitaxel|paclitaxel|mesh-list
6380282|NCT00154700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6380283|NCT00154700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6380284|NCT00154700|Tubulin Modulators|tubulin modulators|mesh-ancestor
6380285|NCT00154700|Antimitotic Agents|antimitotic agents|mesh-ancestor
6380286|NCT00154700|Mitosis Modulators|mitosis modulators|mesh-ancestor
6380287|NCT00154700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380288|NCT00154700|Hematinics|hematinics|mesh-ancestor
6380289|NCT00154700|Vitamin B Complex|vitamin b complex|mesh-ancestor
6380290|NCT00154700|Vitamins|vitamins|mesh-ancestor
6380291|NCT00154700|Micronutrients|micronutrients|mesh-ancestor
6380292|NCT00154700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6380293|NCT00154726|Paclitaxel|paclitaxel|mesh-list
6380294|NCT00154726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6380295|NCT00154726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6380296|NCT00154726|Tubulin Modulators|tubulin modulators|mesh-ancestor
6380297|NCT00154726|Antimitotic Agents|antimitotic agents|mesh-ancestor
6380298|NCT00154726|Mitosis Modulators|mitosis modulators|mesh-ancestor
6380299|NCT00154726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380300|NCT00154739|Gemcitabine|gemcitabine|mesh-list
6380301|NCT00154739|Epirubicin|epirubicin|mesh-list
6380302|NCT00154739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6380303|NCT00154739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6380304|NCT00154739|Antimetabolites|antimetabolites|mesh-ancestor
6380305|NCT00154739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380306|NCT00154739|Antiviral Agents|antiviral agents|mesh-ancestor
6380307|NCT00154739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6380308|NCT00154739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6380309|NCT00154739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6380310|NCT00154739|Immunologic Factors|immunologic factors|mesh-ancestor
6380311|NCT00154739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6380312|NCT00154739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6380313|NCT00154739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6380314|NCT00154739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6380315|NCT00154778|Leucovorin|leucovorin|mesh-list
6380316|NCT00154778|Antidotes|antidotes|mesh-ancestor
6380317|NCT00154778|Protective Agents|protective agents|mesh-ancestor
6380318|NCT00154778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6380319|NCT00154778|Vitamin B Complex|vitamin b complex|mesh-ancestor
6380320|NCT00154778|Vitamins|vitamins|mesh-ancestor
6380321|NCT00154778|Micronutrients|micronutrients|mesh-ancestor
6380322|NCT00154791|Gemcitabine|gemcitabine|mesh-list
6380323|NCT00154791|Oxaliplatin|oxaliplatin|mesh-list
6380324|NCT00154791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6380325|NCT00154791|Antimetabolites|antimetabolites|mesh-ancestor
6380326|NCT00154791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380327|NCT00154791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6380328|NCT00154791|Antiviral Agents|antiviral agents|mesh-ancestor
6380329|NCT00154791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6380330|NCT00154791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6380331|NCT00154791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6380332|NCT00154791|Immunologic Factors|immunologic factors|mesh-ancestor
6380333|NCT00154791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6380334|NCT00154804|Paclitaxel|paclitaxel|mesh-list
6380335|NCT00154804|Cisplatin|cisplatin|mesh-list
6380336|NCT00154804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6380337|NCT00154804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6380338|NCT00154804|Tubulin Modulators|tubulin modulators|mesh-ancestor
6380339|NCT00154804|Antimitotic Agents|antimitotic agents|mesh-ancestor
6380340|NCT00154804|Mitosis Modulators|mitosis modulators|mesh-ancestor
6380341|NCT00154804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380342|NCT00154843|Lycopene|lycopene|mesh-list
6380343|NCT00154843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6380344|NCT00154843|Antioxidants|antioxidants|mesh-ancestor
6380345|NCT00154843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380346|NCT00154843|Protective Agents|protective agents|mesh-ancestor
6380347|NCT00154843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6380348|NCT00154843|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6380349|NCT00154843|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6380350|NCT00154843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6380351|NCT00154869|Ribavirin|ribavirin|mesh-list
6380352|NCT00154869|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6380353|NCT00154869|Antimetabolites|antimetabolites|mesh-ancestor
6380354|NCT00154869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380355|NCT00154869|Antiviral Agents|antiviral agents|mesh-ancestor
6380356|NCT00154869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6380357|NCT00154882|Paclitaxel|paclitaxel|mesh-list
6380358|NCT00154882|Cisplatin|cisplatin|mesh-list
6380359|NCT00154882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6380360|NCT00154882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6380361|NCT00154882|Tubulin Modulators|tubulin modulators|mesh-ancestor
6380362|NCT00154882|Antimitotic Agents|antimitotic agents|mesh-ancestor
6380363|NCT00154882|Mitosis Modulators|mitosis modulators|mesh-ancestor
6380364|NCT00154882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380365|NCT00154895|Minocycline|minocycline|mesh-list
6380366|NCT00154895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6380367|NCT00154895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6380368|NCT00155064|Losartan|losartan|mesh-list
6380369|NCT00155064|Captopril|captopril|mesh-list
6380370|NCT00155064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6380371|NCT00155064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6380372|NCT00155064|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6380373|NCT00155064|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6380374|NCT00155064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380375|NCT00155064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6380376|NCT00155064|Protease Inhibitors|protease inhibitors|mesh-ancestor
6380377|NCT00155064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6380378|NCT00155233|Morphine|morphine|mesh-list
6380379|NCT00155233|Nalbuphine|nalbuphine|mesh-list
6380380|NCT00155233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6380381|NCT00155233|Narcotics|narcotics|mesh-ancestor
6380382|NCT00155233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6380383|NCT00155233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6380384|NCT00155233|Analgesics|analgesics|mesh-ancestor
6380385|NCT00155233|Sensory System Agents|sensory system agents|mesh-ancestor
6380386|NCT00155233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6380387|NCT00155246|Pentoxifylline|pentoxifylline|mesh-list
6380388|NCT00155246|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6380389|NCT00155246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6380390|NCT00155246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380391|NCT00155246|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6380392|NCT00155246|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6380393|NCT00155246|Protective Agents|protective agents|mesh-ancestor
6380394|NCT00155246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6380395|NCT00155246|Vasodilator Agents|vasodilator agents|mesh-ancestor
6380396|NCT00155246|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6380397|NCT00155246|Antioxidants|antioxidants|mesh-ancestor
6380398|NCT00155259|Docetaxel|docetaxel|mesh-list
6380399|NCT00155259|Capecitabine|capecitabine|mesh-list
6380400|NCT00155259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6380401|NCT00155259|Tubulin Modulators|tubulin modulators|mesh-ancestor
6380402|NCT00155259|Antimitotic Agents|antimitotic agents|mesh-ancestor
6380403|NCT00155259|Mitosis Modulators|mitosis modulators|mesh-ancestor
6380404|NCT00155259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380405|NCT00155259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6380406|NCT00155259|Antimetabolites|antimetabolites|mesh-ancestor
6380407|NCT00155272|Thalidomide|thalidomide|mesh-list
6380408|NCT00155272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6380409|NCT00155272|Immunologic Factors|immunologic factors|mesh-ancestor
6380410|NCT00155272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6380411|NCT00155272|Leprostatic Agents|leprostatic agents|mesh-ancestor
6380412|NCT00155272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6380413|NCT00155272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6380414|NCT00155272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6380415|NCT00155272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6380416|NCT00155272|Growth Substances|growth substances|mesh-ancestor
6380417|NCT00155272|Growth Inhibitors|growth inhibitors|mesh-ancestor
6380418|NCT00155272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6380419|NCT00155350|Pioglitazone|pioglitazone|mesh-list
6380420|NCT00155350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6380421|NCT00155350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6380422|NCT00155376|Morphine|morphine|mesh-list
6380423|NCT00155376|Glucagon|glucagon|mesh-list
6380424|NCT00155376|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6380425|NCT00155376|Narcotics|narcotics|mesh-ancestor
6380426|NCT00155376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6380427|NCT00155376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6380428|NCT00155376|Analgesics|analgesics|mesh-ancestor
6380429|NCT00155376|Sensory System Agents|sensory system agents|mesh-ancestor
6380430|NCT00155376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6380431|NCT00155376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6380432|NCT00155376|Hormones|hormones|mesh-ancestor
6380433|NCT00155376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6380434|NCT00155402|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6380435|NCT00155402|Hemostatics|hemostatics|mesh-ancestor
6380436|NCT00155402|Coagulants|coagulants|mesh-ancestor
6380437|NCT00155558|Leucovorin|leucovorin|mesh-list
6380438|NCT00155558|Fluorouracil|fluorouracil|mesh-list
6380439|NCT00155558|Antimetabolites|antimetabolites|mesh-ancestor
6380440|NCT00155558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380441|NCT00155558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6380442|NCT00155558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6380443|NCT00155558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6380444|NCT00155558|Immunologic Factors|immunologic factors|mesh-ancestor
6380445|NCT00155558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6380446|NCT00155558|Antidotes|antidotes|mesh-ancestor
6380447|NCT00155558|Protective Agents|protective agents|mesh-ancestor
6380448|NCT00155558|Vitamin B Complex|vitamin b complex|mesh-ancestor
6380449|NCT00155558|Vitamins|vitamins|mesh-ancestor
6380450|NCT00155558|Micronutrients|micronutrients|mesh-ancestor
6396146|NCT00208117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6396147|NCT00208117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6396148|NCT00208117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6396149|NCT00208117|Serotonin Agents|serotonin agents|mesh-ancestor
6396150|NCT00208117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396151|NCT00208130|Topiramate|topiramate|mesh-list
6396152|NCT00208130|Anticonvulsants|anticonvulsants|mesh-ancestor
6396153|NCT00208130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6396154|NCT00208130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396155|NCT00208143|Risperidone|risperidone|mesh-list
6396156|NCT00208143|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6396157|NCT00208143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6396158|NCT00208143|Serotonin Agents|serotonin agents|mesh-ancestor
6396159|NCT00208143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6396160|NCT00208143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396161|NCT00208143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396162|NCT00208143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6396163|NCT00208143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6396164|NCT00208143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6380451|NCT00155714|Sildenafil Citrate|sildenafil citrate|mesh-list
6380452|NCT00155714|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
6380453|NCT00155714|Vasodilator Agents|vasodilator agents|mesh-ancestor
6380454|NCT00155714|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6380455|NCT00155714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6380456|NCT00155714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380457|NCT00155714|Urological Agents|urological agents|mesh-ancestor
6380458|NCT00155883|Leucovorin|leucovorin|mesh-list
6380459|NCT00155883|Fluorouracil|fluorouracil|mesh-list
6380460|NCT00155883|Antimetabolites|antimetabolites|mesh-ancestor
6380461|NCT00155883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380462|NCT00155883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6380463|NCT00155883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6380464|NCT00155883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6380465|NCT00155883|Immunologic Factors|immunologic factors|mesh-ancestor
6380466|NCT00155883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6380467|NCT00155883|Antidotes|antidotes|mesh-ancestor
6380468|NCT00155883|Protective Agents|protective agents|mesh-ancestor
6380469|NCT00155883|Vitamin B Complex|vitamin b complex|mesh-ancestor
6380470|NCT00155883|Vitamins|vitamins|mesh-ancestor
6380471|NCT00155883|Micronutrients|micronutrients|mesh-ancestor
6380472|NCT00156078|Pregabalin|pregabalin|mesh-list
6380473|NCT00156078|Analgesics|analgesics|mesh-ancestor
6380474|NCT00156078|Sensory System Agents|sensory system agents|mesh-ancestor
6380475|NCT00156078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6380476|NCT00156078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6380477|NCT00156078|Anticonvulsants|anticonvulsants|mesh-ancestor
6380478|NCT00156078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6380479|NCT00156078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6380480|NCT00156078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380481|NCT00156078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6380482|NCT00156078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6380483|NCT00156078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6380484|NCT00156078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6380485|NCT00156078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6380486|NCT00156286|Imatinib Mesylate|imatinib mesylate|mesh-list
6380487|NCT00156286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6380488|NCT00156286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6380489|NCT00156286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6380490|NCT00156286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380491|NCT00156299|Dexamethasone|dexamethasone|mesh-list
6380492|NCT00156299|Choline magnesium trisalicylate|choline magnesium trisalicylate|mesh-list
6380493|NCT00156299|Choline|choline|mesh-list
6380494|NCT00156299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6380495|NCT00156299|Antiemetics|antiemetics|mesh-ancestor
6380496|NCT00156299|Autonomic Agents|autonomic agents|mesh-ancestor
6380497|NCT00156299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6380498|NCT00156299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6380499|NCT00156299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6380500|NCT00156299|Glucocorticoids|glucocorticoids|mesh-ancestor
6380501|NCT00156299|Hormones|hormones|mesh-ancestor
6380502|NCT00156299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6380503|NCT00156299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6380504|NCT00156299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6380505|NCT00156299|Lipotropic Agents|lipotropic agents|mesh-ancestor
6380506|NCT00156299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6380507|NCT00156299|Antimetabolites|antimetabolites|mesh-ancestor
6380508|NCT00156299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380509|NCT00156299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6380510|NCT00156299|Nootropic Agents|nootropic agents|mesh-ancestor
6380511|NCT00156299|Analgesics|analgesics|mesh-ancestor
6380512|NCT00156299|Sensory System Agents|sensory system agents|mesh-ancestor
6380513|NCT00156299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6380514|NCT00156299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6380515|NCT00156299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6380516|NCT00156312|Docetaxel|docetaxel|mesh-list
6380517|NCT00156312|Capecitabine|capecitabine|mesh-list
6380518|NCT00156312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6380519|NCT00156312|Tubulin Modulators|tubulin modulators|mesh-ancestor
6380520|NCT00156312|Antimitotic Agents|antimitotic agents|mesh-ancestor
6380521|NCT00156312|Mitosis Modulators|mitosis modulators|mesh-ancestor
6380522|NCT00156312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380523|NCT00156312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6380524|NCT00156312|Antimetabolites|antimetabolites|mesh-ancestor
6380525|NCT00156325|Citalopram|citalopram|mesh-list
6380526|NCT00156325|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6380527|NCT00156325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6380528|NCT00156325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6380529|NCT00156325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380530|NCT00156325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6380531|NCT00156325|Serotonin Agents|serotonin agents|mesh-ancestor
6380532|NCT00156325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6380533|NCT00156325|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6380534|NCT00156325|Antidepressive Agents|antidepressive agents|mesh-ancestor
6380535|NCT00156325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6380536|NCT00156377|Mupirocin|mupirocin|mesh-list
6380537|NCT00156377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6380538|NCT00156377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6380539|NCT00156377|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6380540|NCT00156377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6380541|NCT00156377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380542|NCT00156403|Amlodipine|amlodipine|mesh-list
6380543|NCT00156403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6380544|NCT00156403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6380545|NCT00156403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6380546|NCT00156403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380547|NCT00156403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6380548|NCT00156403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6380549|NCT00156403|Vasodilator Agents|vasodilator agents|mesh-ancestor
6380550|NCT00156520|Aminocaproic Acid|aminocaproic acid|mesh-list
6380551|NCT00156520|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6380552|NCT00156520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6380553|NCT00156520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380554|NCT00156520|Hemostatics|hemostatics|mesh-ancestor
6380555|NCT00156520|Coagulants|coagulants|mesh-ancestor
6380556|NCT00156546|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6380557|NCT00156546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6380558|NCT00156611|Abciximab|abciximab|mesh-list
6380559|NCT00156611|Anticoagulants|anticoagulants|mesh-ancestor
6380560|NCT00156611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6380561|NCT00156650|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6380562|NCT00156650|Medroxyprogesterone|medroxyprogesterone|mesh-list
6380563|NCT00156650|Testosterone|testosterone|mesh-list
6380564|NCT00156650|Acyline|acyline|mesh-list
6380565|NCT00156650|Androgens|androgens|mesh-ancestor
6380566|NCT00156650|Hormones|hormones|mesh-ancestor
6380567|NCT00156650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6380568|NCT00156650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6380569|NCT00156650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6380570|NCT00156650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6380571|NCT00156650|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6380572|NCT00156650|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6380573|NCT00156650|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6380574|NCT00156650|Contraceptive Agents|contraceptive agents|mesh-ancestor
6380575|NCT00156650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6380576|NCT00156650|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6380577|NCT00156650|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6380578|NCT00156650|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6380579|NCT00156650|Hormone Antagonists|hormone antagonists|mesh-ancestor
6380580|NCT00156689|Levetiracetam|levetiracetam|mesh-list
6380581|NCT00156689|Anticonvulsants|anticonvulsants|mesh-ancestor
6380582|NCT00156689|Nootropic Agents|nootropic agents|mesh-ancestor
6380583|NCT00156858|Busulfan|busulfan|mesh-list
6380584|NCT00156858|Alkylating Agents|alkylating agents|mesh-ancestor
6380585|NCT00156858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380586|NCT00156858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6380587|NCT00156858|Immunologic Factors|immunologic factors|mesh-ancestor
6380588|NCT00156858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6380589|NCT00156858|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6380590|NCT00156858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6380591|NCT00156858|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6380592|NCT00156884|Cisplatin|cisplatin|mesh-list
6380593|NCT00156884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6380594|NCT00156897|Orlistat|orlistat|mesh-list
6380595|NCT00156897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6380596|NCT00156897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380597|NCT00156897|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6380598|NCT00156897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6380599|NCT00156949|Epoetin Alfa|epoetin alfa|mesh-list
6380600|NCT00156949|Hematinics|hematinics|mesh-ancestor
6380601|NCT00156962|Epoetin Alfa|epoetin alfa|mesh-list
6380602|NCT00156962|Hematinics|hematinics|mesh-ancestor
6380603|NCT00156975|Capecitabine|capecitabine|mesh-list
6380604|NCT00156975|Oxaliplatin|oxaliplatin|mesh-list
6380605|NCT00156975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6380606|NCT00156975|Antimetabolites|antimetabolites|mesh-ancestor
6380607|NCT00156975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380608|NCT00156975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6380609|NCT00156988|Sulfadiazine|sulfadiazine|mesh-list
6380610|NCT00156988|Silver Sulfadiazine|silver sulfadiazine|mesh-list
6380611|NCT00156988|Cerium nitrate|cerium nitrate|mesh-list
6380612|NCT00156988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6380613|NCT00156988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6380614|NCT00156988|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6380615|NCT00156988|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6380616|NCT00156988|Coccidiostats|coccidiostats|mesh-ancestor
6380617|NCT00156988|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6380618|NCT00157040|Factor VIII|factor viii|mesh-list
6380619|NCT00157040|Coagulants|coagulants|mesh-ancestor
6380620|NCT00157053|Factor VIII|factor viii|mesh-list
6380621|NCT00157053|Coagulants|coagulants|mesh-ancestor
6380622|NCT00157066|Ergocalciferols|ergocalciferols|mesh-list
6380623|NCT00157066|Vitamin D|vitamin d|mesh-list
6380624|NCT00157066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6380625|NCT00157066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6380626|NCT00157066|Vitamins|vitamins|mesh-ancestor
6380627|NCT00157066|Micronutrients|micronutrients|mesh-ancestor
6380628|NCT00157066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6380629|NCT00157079|Immunoglobulins|immunoglobulins|mesh-list
6380630|NCT00157079|Antibodies|antibodies|mesh-list
6380631|NCT00157079|gamma-Globulins|gamma-globulins|mesh-list
6380632|NCT00157079|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6380633|NCT00157079|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6380634|NCT00157079|Immunologic Factors|immunologic factors|mesh-ancestor
6380635|NCT00157079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6380636|NCT00157092|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
6380637|NCT00157092|Protein C Inhibitor|protein c inhibitor|mesh-list
6380638|NCT00157092|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6380639|NCT00157092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6380640|NCT00157092|Protease Inhibitors|protease inhibitors|mesh-ancestor
6380641|NCT00157092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6380642|NCT00157092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380643|NCT00157105|Factor VIII|factor viii|mesh-list
6380644|NCT00157105|Coagulants|coagulants|mesh-ancestor
6380645|NCT00157118|Protein C|protein c|mesh-list
6380646|NCT00157118|Anticoagulants|anticoagulants|mesh-ancestor
6380647|NCT00157118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6380648|NCT00157118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6380649|NCT00157118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380650|NCT00157131|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6380651|NCT00157131|Hemostatics|hemostatics|mesh-ancestor
6380652|NCT00157131|Coagulants|coagulants|mesh-ancestor
6380653|NCT00157235|Bromides|bromides|mesh-list
6380654|NCT00157235|Tiotropium Bromide|tiotropium bromide|mesh-list
6380655|NCT00157235|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6380656|NCT00157235|Autonomic Agents|autonomic agents|mesh-ancestor
6380657|NCT00157235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6380658|NCT00157235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6380659|NCT00157235|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6380660|NCT00157235|Respiratory System Agents|respiratory system agents|mesh-ancestor
6380661|NCT00157235|Parasympatholytics|parasympatholytics|mesh-ancestor
6380662|NCT00157235|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6380663|NCT00157235|Cholinergic Agents|cholinergic agents|mesh-ancestor
6380664|NCT00157235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6380665|NCT00157235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380666|NCT00157235|Anticonvulsants|anticonvulsants|mesh-ancestor
6380667|NCT00157261|Tenecteplase|tenecteplase|mesh-list
6380668|NCT00157261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6380669|NCT00157261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6380670|NCT00157261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380671|NCT00157274|Alemtuzumab|alemtuzumab|mesh-list
6380672|NCT00157274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6380673|NCT00157274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6380674|NCT00157300|Epoetin Alfa|epoetin alfa|mesh-list
6380675|NCT00157300|Hematinics|hematinics|mesh-ancestor
6380676|NCT00157326|Tadalafil|tadalafil|mesh-list
6380677|NCT00157326|Vasodilator Agents|vasodilator agents|mesh-ancestor
6380678|NCT00157326|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6380679|NCT00157326|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6380680|NCT00157326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6380681|NCT00157326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380682|NCT00157326|Urological Agents|urological agents|mesh-ancestor
6380683|NCT00157378|Haloperidol|haloperidol|mesh-list
6380684|NCT00157378|Risperidone|risperidone|mesh-list
6380685|NCT00157378|Haloperidol decanoate|haloperidol decanoate|mesh-list
6380686|NCT00157378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6380687|NCT00157378|Serotonin Agents|serotonin agents|mesh-ancestor
6380688|NCT00157378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6380689|NCT00157378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380690|NCT00157378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6380691|NCT00157378|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6380692|NCT00157378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6380693|NCT00157378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6380694|NCT00157378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6380695|NCT00157378|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6380696|NCT00157378|Dopamine Agents|dopamine agents|mesh-ancestor
6380697|NCT00157378|Antiemetics|antiemetics|mesh-ancestor
6380698|NCT00157378|Autonomic Agents|autonomic agents|mesh-ancestor
6380699|NCT00157378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6380700|NCT00157378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6380701|NCT00157378|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6380702|NCT00157482|Simvastatin|simvastatin|mesh-list
6380703|NCT00157482|Ezetimibe|ezetimibe|mesh-list
6380704|NCT00157482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6380705|NCT00157482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6380706|NCT00157482|Antimetabolites|antimetabolites|mesh-ancestor
6380707|NCT00157482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380708|NCT00157482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6380709|NCT00157482|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6380710|NCT00157482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6380711|NCT00157508|Nitroaspirin|nitroaspirin|mesh-list
6380712|NCT00157508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6380713|NCT00157508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6380714|NCT00157508|Analgesics|analgesics|mesh-ancestor
6380715|NCT00157508|Sensory System Agents|sensory system agents|mesh-ancestor
6380716|NCT00157508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6380717|NCT00157508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6380718|NCT00157508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6380719|NCT00157508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6380720|NCT00157508|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6380721|NCT00157508|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6380722|NCT00157508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380723|NCT00157508|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6380724|NCT00157508|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
6380725|NCT00157508|Protease Inhibitors|protease inhibitors|mesh-ancestor
6380726|NCT00157508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6380727|NCT00157547|Fluvoxamine|fluvoxamine|mesh-list
6380728|NCT00157547|Citalopram|citalopram|mesh-list
6380729|NCT00157547|Fluoxetine|fluoxetine|mesh-list
6380730|NCT00157547|Paroxetine|paroxetine|mesh-list
6380731|NCT00157547|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6380732|NCT00157547|Sertraline|sertraline|mesh-list
6380733|NCT00157547|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
6380734|NCT00157547|Serotonin|serotonin|mesh-list
6380735|NCT00157547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6380736|NCT00157547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6380737|NCT00157547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380738|NCT00157547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6380739|NCT00157547|Serotonin Agents|serotonin agents|mesh-ancestor
6380740|NCT00157547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6380741|NCT00157547|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6380742|NCT00157547|Antidepressive Agents|antidepressive agents|mesh-ancestor
6380743|NCT00157547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6380744|NCT00157547|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6380745|NCT00157547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6380746|NCT00157547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6380747|NCT00157547|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6380748|NCT00157547|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6380749|NCT00157547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6380750|NCT00157547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6380751|NCT00157547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6380752|NCT00157547|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6380753|NCT00157547|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6380754|NCT00157586|Manidipine|manidipine|mesh-list
6380755|NCT00157586|Delapril|delapril|mesh-list
6380756|NCT00157586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6380757|NCT00157586|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6380758|NCT00157586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6380759|NCT00157586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380760|NCT00157586|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6380761|NCT00157586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6380762|NCT00157586|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6380763|NCT00157586|Protease Inhibitors|protease inhibitors|mesh-ancestor
6380764|NCT00157586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6380765|NCT00157651|Warfarin|warfarin|mesh-list
6380766|NCT00157651|Anticoagulants|anticoagulants|mesh-ancestor
6380767|NCT00157677|Fibrin fragment D|fibrin fragment d|mesh-list
6380768|NCT00157677|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6380769|NCT00157677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6380770|NCT00157677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380771|NCT00157677|Hemostatics|hemostatics|mesh-ancestor
6380772|NCT00157677|Coagulants|coagulants|mesh-ancestor
6380773|NCT00157690|Alendronate|alendronate|mesh-list
6380774|NCT00157690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6380775|NCT00157690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6380776|NCT00157716|Pyridoxal|pyridoxal|mesh-list
6380777|NCT00157716|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
6380778|NCT00157716|Vitamin B Complex|vitamin b complex|mesh-ancestor
6380779|NCT00157716|Vitamins|vitamins|mesh-ancestor
6380780|NCT00157716|Micronutrients|micronutrients|mesh-ancestor
6380781|NCT00157716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6380782|NCT00157729|Pyridoxal|pyridoxal|mesh-list
6380783|NCT00157729|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
6380784|NCT00157729|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6380785|NCT00157729|Protease Inhibitors|protease inhibitors|mesh-ancestor
6380786|NCT00157729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6380787|NCT00157729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380788|NCT00157729|Vitamin B Complex|vitamin b complex|mesh-ancestor
6380789|NCT00157729|Vitamins|vitamins|mesh-ancestor
6380790|NCT00157729|Micronutrients|micronutrients|mesh-ancestor
6380791|NCT00157729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6380792|NCT00157859|Chloroquine|chloroquine|mesh-list
6380793|NCT00157859|Pyrimethamine|pyrimethamine|mesh-list
6380794|NCT00157859|Sulfadoxine|sulfadoxine|mesh-list
6380795|NCT00157859|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6380796|NCT00157859|Amebicides|amebicides|mesh-ancestor
6380797|NCT00157859|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6380798|NCT00157859|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6380799|NCT00157859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6380800|NCT00157859|Antimalarials|antimalarials|mesh-ancestor
6380801|NCT00157859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6380802|NCT00157859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6380803|NCT00157859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6380804|NCT00157859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380805|NCT00157859|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6380806|NCT00157859|Renal Agents|renal agents|mesh-ancestor
6380807|NCT00157872|Naproxen|naproxen|mesh-list
6380808|NCT00157872|Rofecoxib|rofecoxib|mesh-list
6380809|NCT00157872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6380810|NCT00157872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6380811|NCT00157872|Analgesics|analgesics|mesh-ancestor
6380812|NCT00157872|Sensory System Agents|sensory system agents|mesh-ancestor
6380813|NCT00157872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6380814|NCT00157872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6380815|NCT00157872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6380816|NCT00157872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6380817|NCT00157872|Gout Suppressants|gout suppressants|mesh-ancestor
6380818|NCT00157872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6380819|NCT00157872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6380820|NCT00157872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380821|NCT00157872|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6380822|NCT00157885|Artesunate|artesunate|mesh-list
6380823|NCT00157885|Amodiaquine|amodiaquine|mesh-list
6380824|NCT00157885|Antimalarials|antimalarials|mesh-ancestor
6380825|NCT00157885|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6380826|NCT00157885|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6380827|NCT00157885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6380828|NCT00157885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6380829|NCT00157885|Antiviral Agents|antiviral agents|mesh-ancestor
6380830|NCT00157885|Schistosomicides|schistosomicides|mesh-ancestor
6380831|NCT00157885|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6380832|NCT00157885|Anthelmintics|anthelmintics|mesh-ancestor
6380833|NCT00157898|Metronidazole|metronidazole|mesh-list
6380834|NCT00157898|Ceftriaxone|ceftriaxone|mesh-list
6380835|NCT00157898|Ertapenem|ertapenem|mesh-list
6380836|NCT00157898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6380837|NCT00157898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6380838|NCT00157898|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6380839|NCT00157898|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6380840|NCT00157976|Tin etiopurpurin|tin etiopurpurin|mesh-list
6380841|NCT00157976|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6380842|NCT00157976|Dermatologic Agents|dermatologic agents|mesh-ancestor
6380843|NCT00158002|Topiramate|topiramate|mesh-list
6380844|NCT00158002|Anticonvulsants|anticonvulsants|mesh-ancestor
6380845|NCT00158002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6380846|NCT00158002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6380847|NCT00158028|Risperidone|risperidone|mesh-list
6380848|NCT00158028|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6380849|NCT00158028|Serotonin Agents|serotonin agents|mesh-ancestor
6380850|NCT00158028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6380851|NCT00158028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380852|NCT00158028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6380853|NCT00158028|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6380854|NCT00158028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6380855|NCT00158028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6380856|NCT00158028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6380857|NCT00158028|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6380858|NCT00158028|Dopamine Agents|dopamine agents|mesh-ancestor
6380859|NCT00158041|Amifostine|amifostine|mesh-list
6380860|NCT00158041|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6380861|NCT00158041|Protective Agents|protective agents|mesh-ancestor
6380862|NCT00158041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6380863|NCT00158093|Moxifloxacin|moxifloxacin|mesh-list
6380864|NCT00158093|Atenolol|atenolol|mesh-list
6380865|NCT00158093|Nebivolol|nebivolol|mesh-list
6380866|NCT00158093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6380867|NCT00158093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6380868|NCT00158093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6380869|NCT00158093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6380870|NCT00158093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6380871|NCT00158093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380872|NCT00158093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6380873|NCT00158093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6380874|NCT00158093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6380875|NCT00158093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6380876|NCT00158093|Sympatholytics|sympatholytics|mesh-ancestor
6380877|NCT00158093|Autonomic Agents|autonomic agents|mesh-ancestor
6380878|NCT00158093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6380879|NCT00158093|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6380880|NCT00158093|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6380881|NCT00158093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6380882|NCT00158093|Adrenergic Agents|adrenergic agents|mesh-ancestor
6380883|NCT00158093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6380884|NCT00158093|Vasodilator Agents|vasodilator agents|mesh-ancestor
6380885|NCT00158093|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6380886|NCT00158093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6380887|NCT00158093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6380888|NCT00158132|Amantadine|amantadine|mesh-list
6380889|NCT00158132|Propranolol|propranolol|mesh-list
6380890|NCT00158132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6380891|NCT00158132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6380892|NCT00158132|Adrenergic Agents|adrenergic agents|mesh-ancestor
6380893|NCT00158132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6380894|NCT00158132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380895|NCT00158132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6380896|NCT00158132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6380897|NCT00158132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6380898|NCT00158132|Vasodilator Agents|vasodilator agents|mesh-ancestor
6380899|NCT00158132|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6380900|NCT00158132|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6380901|NCT00158132|Antiviral Agents|antiviral agents|mesh-ancestor
6380902|NCT00158132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6380903|NCT00158132|Dopamine Agents|dopamine agents|mesh-ancestor
6380904|NCT00158132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6380905|NCT00158132|Analgesics|analgesics|mesh-ancestor
6380906|NCT00158132|Sensory System Agents|sensory system agents|mesh-ancestor
6380907|NCT00158132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6380908|NCT00158158|Nicotine|nicotine|mesh-list
6380909|NCT00158158|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6380910|NCT00158158|Autonomic Agents|autonomic agents|mesh-ancestor
6380911|NCT00158158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6380912|NCT00158158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6380913|NCT00158158|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6380914|NCT00158158|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6380915|NCT00158158|Cholinergic Agents|cholinergic agents|mesh-ancestor
6380916|NCT00158158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6380917|NCT00158158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380918|NCT00158171|Folic Acid|folic acid|mesh-list
6380919|NCT00158171|Nicotine|nicotine|mesh-list
6380920|NCT00158171|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6380921|NCT00158171|Autonomic Agents|autonomic agents|mesh-ancestor
6380922|NCT00158171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6380923|NCT00158171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6380924|NCT00158171|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6380925|NCT00158171|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6380926|NCT00158171|Cholinergic Agents|cholinergic agents|mesh-ancestor
6380927|NCT00158171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6380928|NCT00158171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380929|NCT00158171|Hematinics|hematinics|mesh-ancestor
6380930|NCT00158171|Vitamin B Complex|vitamin b complex|mesh-ancestor
6380931|NCT00158171|Vitamins|vitamins|mesh-ancestor
6380932|NCT00158171|Micronutrients|micronutrients|mesh-ancestor
6380933|NCT00158210|Rivastigmine|rivastigmine|mesh-list
6380934|NCT00158210|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6380935|NCT00158210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6380936|NCT00158210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380937|NCT00158210|Cholinergic Agents|cholinergic agents|mesh-ancestor
6380938|NCT00158210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6380939|NCT00158210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6380940|NCT00158210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6380941|NCT00158210|Protective Agents|protective agents|mesh-ancestor
6380942|NCT00158236|Buprenorphine|buprenorphine|mesh-list
6380943|NCT00158236|Hydromorphone|hydromorphone|mesh-list
6380944|NCT00158236|Naloxone|naloxone|mesh-list
6380945|NCT00158236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6380946|NCT00158236|Narcotics|narcotics|mesh-ancestor
6380947|NCT00158236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6380948|NCT00158236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6380949|NCT00158236|Analgesics|analgesics|mesh-ancestor
6380950|NCT00158236|Sensory System Agents|sensory system agents|mesh-ancestor
6380951|NCT00158236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6380952|NCT00158236|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6380953|NCT00158275|Antidepressive Agents|antidepressive agents|mesh-list
6380954|NCT00158275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6380955|NCT00158301|Fluoxetine|fluoxetine|mesh-list
6380956|NCT00158301|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6380957|NCT00158301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6380958|NCT00158301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6380959|NCT00158301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380960|NCT00158301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6380961|NCT00158301|Serotonin Agents|serotonin agents|mesh-ancestor
6380962|NCT00158301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6380963|NCT00158301|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6380964|NCT00158301|Antidepressive Agents|antidepressive agents|mesh-ancestor
6380965|NCT00158301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6380966|NCT00158301|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6380967|NCT00158301|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6380968|NCT00158301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6380969|NCT00158405|Ritonavir|ritonavir|mesh-list
6380970|NCT00158405|Indinavir|indinavir|mesh-list
6380971|NCT00158405|Lamivudine|lamivudine|mesh-list
6380972|NCT00158405|Zidovudine|zidovudine|mesh-list
6380973|NCT00158405|Efavirenz|efavirenz|mesh-list
6380974|NCT00158405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6380975|NCT00158405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6380976|NCT00158405|Protease Inhibitors|protease inhibitors|mesh-ancestor
6380977|NCT00158405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6380978|NCT00158405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6380979|NCT00158405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6380980|NCT00158405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6380981|NCT00158405|Antiviral Agents|antiviral agents|mesh-ancestor
6380982|NCT00158405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6380983|NCT00158405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6380984|NCT00158405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6380985|NCT00158405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6380986|NCT00158405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6380987|NCT00158405|Antimetabolites|antimetabolites|mesh-ancestor
6380988|NCT00158405|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6380989|NCT00158405|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6380990|NCT00158405|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6380991|NCT00158405|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6380992|NCT00158405|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6380993|NCT00158457|Tenofovir|tenofovir|mesh-list
6380994|NCT00158457|Emtricitabine|emtricitabine|mesh-list
6380995|NCT00158457|Efavirenz|efavirenz|mesh-list
6380996|NCT00158457|Antiviral Agents|antiviral agents|mesh-ancestor
6380997|NCT00158457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6380998|NCT00158457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6380999|NCT00158457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6381000|NCT00158457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6381001|NCT00158457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381002|NCT00158457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6381003|NCT00158457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6381004|NCT00158457|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6381005|NCT00158457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6381006|NCT00158457|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6381007|NCT00158457|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6381008|NCT00158457|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6381009|NCT00158457|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6381010|NCT00158470|Lamivudine|lamivudine|mesh-list
6381011|NCT00158470|Efavirenz|efavirenz|mesh-list
6381012|NCT00158470|Didanosine|didanosine|mesh-list
6381013|NCT00158470|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6381014|NCT00158470|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6381015|NCT00158470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6381016|NCT00158470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381017|NCT00158470|Antiviral Agents|antiviral agents|mesh-ancestor
6381018|NCT00158470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6381019|NCT00158470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6381020|NCT00158470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6381021|NCT00158470|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6381022|NCT00158470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6381023|NCT00158470|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6381024|NCT00158470|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6381025|NCT00158470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6381026|NCT00158470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6381027|NCT00158470|Antimetabolites|antimetabolites|mesh-ancestor
6381028|NCT00158483|Acyclovir|acyclovir|mesh-list
6381029|NCT00158483|Antiviral Agents|antiviral agents|mesh-ancestor
6381030|NCT00158483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6381031|NCT00158496|Interferons|interferons|mesh-list
6381032|NCT00158496|Ribavirin|ribavirin|mesh-list
6381033|NCT00158496|Interferon-alpha|interferon-alpha|mesh-list
6381034|NCT00158496|Interferon alpha-2|interferon alpha-2|mesh-list
6381035|NCT00158496|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6381036|NCT00158496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6381037|NCT00158496|Antiviral Agents|antiviral agents|mesh-ancestor
6381038|NCT00158496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6381039|NCT00158496|Antimetabolites|antimetabolites|mesh-ancestor
6381040|NCT00158496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381041|NCT00158496|Immunologic Factors|immunologic factors|mesh-ancestor
6381042|NCT00158496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381043|NCT00158509|Valacyclovir|valacyclovir|mesh-list
6381044|NCT00158509|Antiviral Agents|antiviral agents|mesh-ancestor
6381045|NCT00158509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6381046|NCT00158522|Interferons|interferons|mesh-list
6381047|NCT00158522|Interferon-alpha|interferon-alpha|mesh-list
6381048|NCT00158522|Interferon alpha-2|interferon alpha-2|mesh-list
6381049|NCT00158522|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6381050|NCT00158522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6381051|NCT00158522|Antiviral Agents|antiviral agents|mesh-ancestor
6381052|NCT00158522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6381053|NCT00158522|Immunologic Factors|immunologic factors|mesh-ancestor
6381054|NCT00158522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381055|NCT00158548|Artesunate|artesunate|mesh-list
6381056|NCT00158548|Chloroquine|chloroquine|mesh-list
6381057|NCT00158548|Primaquine|primaquine|mesh-list
6381058|NCT00158548|Amodiaquine|amodiaquine|mesh-list
6381059|NCT00158548|Antimalarials|antimalarials|mesh-ancestor
6381060|NCT00158548|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6381061|NCT00158548|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6381062|NCT00158548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6381063|NCT00158548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6381064|NCT00158548|Antiviral Agents|antiviral agents|mesh-ancestor
6381065|NCT00158548|Schistosomicides|schistosomicides|mesh-ancestor
6381066|NCT00158548|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6381067|NCT00158548|Anthelmintics|anthelmintics|mesh-ancestor
6381068|NCT00158548|Amebicides|amebicides|mesh-ancestor
6381069|NCT00158548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6381070|NCT00158561|Pyrimethamine|pyrimethamine|mesh-list
6381071|NCT00158561|Sulfadoxine|sulfadoxine|mesh-list
6381072|NCT00158561|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6381073|NCT00158561|Dapsone|dapsone|mesh-list
6381074|NCT00158561|Chlorproguanil|chlorproguanil|mesh-list
6381075|NCT00158561|Antimalarials|antimalarials|mesh-ancestor
6381076|NCT00158561|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6381077|NCT00158561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6381078|NCT00158561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6381079|NCT00158561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6381080|NCT00158561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6381081|NCT00158561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381082|NCT00158561|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6381083|NCT00158561|Renal Agents|renal agents|mesh-ancestor
6381084|NCT00158561|Leprostatic Agents|leprostatic agents|mesh-ancestor
6381085|NCT00158561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6381086|NCT00158574|Pyrimethamine|pyrimethamine|mesh-list
6381087|NCT00158574|Sulfadoxine|sulfadoxine|mesh-list
6381088|NCT00158574|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6381089|NCT00158574|Dapsone|dapsone|mesh-list
6381090|NCT00158574|Mefloquine|mefloquine|mesh-list
6381091|NCT00158574|Chlorproguanil|chlorproguanil|mesh-list
6381092|NCT00158574|Proguanil|proguanil|mesh-list
6381093|NCT00158574|Antimalarials|antimalarials|mesh-ancestor
6381094|NCT00158574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6381095|NCT00158574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6381096|NCT00158574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6381097|NCT00158574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6381098|NCT00158574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6381099|NCT00158574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381100|NCT00158574|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6381101|NCT00158574|Renal Agents|renal agents|mesh-ancestor
6381102|NCT00158574|Leprostatic Agents|leprostatic agents|mesh-ancestor
6381103|NCT00158574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6381104|NCT00158574|Antimetabolites|antimetabolites|mesh-ancestor
6381105|NCT00158587|Primaquine|primaquine|mesh-list
6381106|NCT00158587|Antimalarials|antimalarials|mesh-ancestor
6381107|NCT00158587|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6381108|NCT00158587|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6381109|NCT00158587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6381110|NCT00158652|Carboplatin|carboplatin|mesh-list
6381111|NCT00158652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6381112|NCT00158678|Cisplatin|cisplatin|mesh-list
6381113|NCT00158678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6381114|NCT00158691|Amifostine|amifostine|mesh-list
6381115|NCT00158691|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6381116|NCT00158691|Protective Agents|protective agents|mesh-ancestor
6381117|NCT00158691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381118|NCT00158704|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6381119|NCT00158704|Antiviral Agents|antiviral agents|mesh-ancestor
6381120|NCT00158704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6381121|NCT00158704|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6381122|NCT00158704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6381123|NCT00158704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6381124|NCT00158704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381125|NCT00158717|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6381126|NCT00158717|Antiviral Agents|antiviral agents|mesh-ancestor
6381127|NCT00158717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6381128|NCT00158717|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6381129|NCT00158717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6381130|NCT00158717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6381131|NCT00158717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381132|NCT00158730|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6381133|NCT00158730|Antifungal Agents|antifungal agents|mesh-ancestor
5724666|NCT03185845|Anticoagulants|anticoagulants|mesh-ancestor
5724667|NCT03185611|Rifaximin|rifaximin|mesh-list
6381134|NCT00158730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6381135|NCT00158730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6381136|NCT00158730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6381137|NCT00158782|Lapatinib|lapatinib|mesh-list
6381138|NCT00158782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6381139|NCT00158782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6381140|NCT00158782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6381141|NCT00158782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381142|NCT00158821|Tenofovir|tenofovir|mesh-list
6381143|NCT00158821|Lamivudine|lamivudine|mesh-list
6381144|NCT00158821|Efavirenz|efavirenz|mesh-list
6381145|NCT00158821|Stavudine|stavudine|mesh-list
6381146|NCT00158821|Antiviral Agents|antiviral agents|mesh-ancestor
6381147|NCT00158821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6381148|NCT00158821|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6381149|NCT00158821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6381150|NCT00158821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6381151|NCT00158821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381152|NCT00158821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6381153|NCT00158821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6381154|NCT00158821|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6381155|NCT00158821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6381156|NCT00158821|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6381157|NCT00158821|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6381158|NCT00158821|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6381159|NCT00158821|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6381160|NCT00158821|Antimetabolites|antimetabolites|mesh-ancestor
6381161|NCT00158834|Fluticasone|fluticasone|mesh-list
6381162|NCT00158834|Xhance|xhance|mesh-list
6381163|NCT00158834|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6381164|NCT00158834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6381165|NCT00158834|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6381166|NCT00158834|Autonomic Agents|autonomic agents|mesh-ancestor
6381167|NCT00158834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6381168|NCT00158834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381169|NCT00158834|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6381170|NCT00158834|Respiratory System Agents|respiratory system agents|mesh-ancestor
6381171|NCT00158834|Dermatologic Agents|dermatologic agents|mesh-ancestor
6381172|NCT00158834|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6381173|NCT00158834|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6381174|NCT00158834|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6381175|NCT00158834|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6381176|NCT00158834|Adrenergic Agents|adrenergic agents|mesh-ancestor
6381177|NCT00158834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6381178|NCT00158834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381179|NCT00158847|Fluticasone|fluticasone|mesh-list
6381180|NCT00158847|Xhance|xhance|mesh-list
6381181|NCT00158847|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6381182|NCT00158847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6381183|NCT00158847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6381184|NCT00158847|Autonomic Agents|autonomic agents|mesh-ancestor
6381185|NCT00158847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6381186|NCT00158847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381187|NCT00158847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6381188|NCT00158847|Respiratory System Agents|respiratory system agents|mesh-ancestor
6381189|NCT00158847|Dermatologic Agents|dermatologic agents|mesh-ancestor
6381190|NCT00158847|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6381191|NCT00158847|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6381192|NCT00158847|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6381193|NCT00158847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6381194|NCT00158847|Adrenergic Agents|adrenergic agents|mesh-ancestor
6381195|NCT00158847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6381196|NCT00158847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381197|NCT00158873|Fentanyl|fentanyl|mesh-list
6381198|NCT00158873|Midazolam|midazolam|mesh-list
6381199|NCT00158873|Morphine|morphine|mesh-list
6381200|NCT00158873|Remifentanil|remifentanil|mesh-list
6381201|NCT00158873|Lorazepam|lorazepam|mesh-list
6381202|NCT00158873|Propofol|propofol|mesh-list
6381203|NCT00158873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6381204|NCT00158873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6381205|NCT00158873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381206|NCT00158873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6381207|NCT00158873|Anesthetics, General|anesthetics, general|mesh-ancestor
6381208|NCT00158873|Anesthetics|anesthetics|mesh-ancestor
6381209|NCT00158873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6381210|NCT00158873|Narcotics|narcotics|mesh-ancestor
6381211|NCT00158873|Analgesics|analgesics|mesh-ancestor
6381212|NCT00158873|Sensory System Agents|sensory system agents|mesh-ancestor
6381213|NCT00158873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6381214|NCT00158873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6381215|NCT00158873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6381216|NCT00158873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6381217|NCT00158873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6381218|NCT00158873|GABA Modulators|gaba modulators|mesh-ancestor
6381219|NCT00158873|GABA Agents|gaba agents|mesh-ancestor
6381220|NCT00158873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6381221|NCT00158873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381222|NCT00158873|Anticonvulsants|anticonvulsants|mesh-ancestor
6381223|NCT00158873|Antiemetics|antiemetics|mesh-ancestor
6381224|NCT00158873|Autonomic Agents|autonomic agents|mesh-ancestor
6381225|NCT00158873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6381226|NCT00158886|Topotecan|topotecan|mesh-list
6381227|NCT00158886|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6381228|NCT00158886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6381229|NCT00158886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6381230|NCT00158886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381231|NCT00158886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6396165|NCT00208143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6396166|NCT00208143|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6396167|NCT00208143|Dopamine Agents|dopamine agents|mesh-ancestor
6396168|NCT00208143|Antidepressive Agents|antidepressive agents|mesh-ancestor
6396169|NCT00208156|Mifepristone|mifepristone|mesh-list
6396170|NCT00208156|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6396171|NCT00208156|Abortifacient Agents|abortifacient agents|mesh-ancestor
6396172|NCT00208156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6396173|NCT00208156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396174|NCT00208156|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6396175|NCT00208156|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6396176|NCT00208156|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6396177|NCT00208156|Contraceptive Agents|contraceptive agents|mesh-ancestor
6396178|NCT00208156|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6396179|NCT00208156|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6396180|NCT00208156|Hormone Antagonists|hormone antagonists|mesh-ancestor
6396181|NCT00208156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6396182|NCT00208156|Luteolytic Agents|luteolytic agents|mesh-ancestor
6396183|NCT00208156|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6396184|NCT00208156|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6396185|NCT00208169|Aripiprazole|aripiprazole|mesh-list
6396186|NCT00208169|Antidepressive Agents|antidepressive agents|mesh-ancestor
6396187|NCT00208169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6396188|NCT00208169|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6396189|NCT00208169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6396190|NCT00208169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6396191|NCT00208169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396192|NCT00208169|Dopamine Agonists|dopamine agonists|mesh-ancestor
6396193|NCT00208169|Dopamine Agents|dopamine agents|mesh-ancestor
6396194|NCT00208169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6396195|NCT00208169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396196|NCT00208169|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6396197|NCT00208169|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6396198|NCT00208169|Serotonin Agents|serotonin agents|mesh-ancestor
6396199|NCT00208169|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6396200|NCT00208169|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6396201|NCT00208169|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6396202|NCT00208169|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6396203|NCT00208182|Risperidone|risperidone|mesh-list
6396204|NCT00208182|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6396205|NCT00208182|Serotonin Agents|serotonin agents|mesh-ancestor
6396206|NCT00208182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6396207|NCT00208182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396208|NCT00208182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396209|NCT00208182|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6396210|NCT00208182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6396211|NCT00208182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6396212|NCT00208182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6396213|NCT00208182|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6396214|NCT00208182|Dopamine Agents|dopamine agents|mesh-ancestor
6396215|NCT00208195|Valproic Acid|valproic acid|mesh-list
6396216|NCT00208195|Anticonvulsants|anticonvulsants|mesh-ancestor
6396217|NCT00208195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6396218|NCT00208195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396219|NCT00208195|GABA Agents|gaba agents|mesh-ancestor
6396220|NCT00208195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5724668|NCT03185611|Azathioprine|azathioprine|mesh-list
6381232|NCT00158990|Sertraline|sertraline|mesh-list
6381233|NCT00158990|Antidepressive Agents|antidepressive agents|mesh-ancestor
6381234|NCT00158990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6381235|NCT00158990|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6381236|NCT00158990|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6381237|NCT00158990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6381238|NCT00158990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381239|NCT00158990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6381240|NCT00158990|Serotonin Agents|serotonin agents|mesh-ancestor
6381241|NCT00158990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381242|NCT00159016|Imatinib Mesylate|imatinib mesylate|mesh-list
6381243|NCT00159016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6381244|NCT00159016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6381245|NCT00159016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6381246|NCT00159016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381247|NCT00159081|Haloperidol|haloperidol|mesh-list
6381248|NCT00159081|Risperidone|risperidone|mesh-list
6381249|NCT00159081|Haloperidol decanoate|haloperidol decanoate|mesh-list
6381250|NCT00159081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6381251|NCT00159081|Serotonin Agents|serotonin agents|mesh-ancestor
6381252|NCT00159081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6381253|NCT00159081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381254|NCT00159081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381255|NCT00159081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6381256|NCT00159081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6381257|NCT00159081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6381258|NCT00159081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6381259|NCT00159081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6381260|NCT00159081|Dopamine Agents|dopamine agents|mesh-ancestor
6381261|NCT00159081|Antiemetics|antiemetics|mesh-ancestor
6381262|NCT00159081|Autonomic Agents|autonomic agents|mesh-ancestor
6381263|NCT00159081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6381264|NCT00159081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6381265|NCT00159081|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6381266|NCT00159094|Vinorelbine|vinorelbine|mesh-list
6381267|NCT00159094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6381268|NCT00159094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6381269|NCT00159094|Tubulin Modulators|tubulin modulators|mesh-ancestor
6381270|NCT00159094|Antimitotic Agents|antimitotic agents|mesh-ancestor
6381271|NCT00159094|Mitosis Modulators|mitosis modulators|mesh-ancestor
6381272|NCT00159094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381273|NCT00159107|Acamprosate|acamprosate|mesh-list
6381274|NCT00159107|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6381275|NCT00159120|Antipsychotic Agents|antipsychotic agents|mesh-list
6381276|NCT00159120|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6381277|NCT00159120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6381278|NCT00159120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381279|NCT00159120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6381280|NCT00159133|Lorazepam|lorazepam|mesh-list
6381281|NCT00159133|Antipsychotic Agents|antipsychotic agents|mesh-list
6381282|NCT00159133|Anticonvulsants|anticonvulsants|mesh-ancestor
6381283|NCT00159133|Antiemetics|antiemetics|mesh-ancestor
6381284|NCT00159133|Autonomic Agents|autonomic agents|mesh-ancestor
6381285|NCT00159133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6381286|NCT00159133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381287|NCT00159133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6381288|NCT00159133|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6381289|NCT00159133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6381290|NCT00159133|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6381291|NCT00159133|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6381292|NCT00159133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6381293|NCT00159133|GABA Modulators|gaba modulators|mesh-ancestor
6381294|NCT00159133|GABA Agents|gaba agents|mesh-ancestor
6381295|NCT00159133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6381296|NCT00159133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381297|NCT00159146|Pindolol|pindolol|mesh-list
6381298|NCT00159146|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6381299|NCT00159146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6381300|NCT00159146|Adrenergic Agents|adrenergic agents|mesh-ancestor
6381301|NCT00159146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6381302|NCT00159146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381303|NCT00159146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381304|NCT00159146|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6381305|NCT00159146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6381306|NCT00159146|Serotonin Agents|serotonin agents|mesh-ancestor
6381307|NCT00159146|Vasodilator Agents|vasodilator agents|mesh-ancestor
6381308|NCT00159159|Cyclosporine|cyclosporine|mesh-list
6381309|NCT00159159|Cyclosporins|cyclosporins|mesh-list
6381310|NCT00159159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6381311|NCT00159159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381312|NCT00159159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6381313|NCT00159159|Immunologic Factors|immunologic factors|mesh-ancestor
6381314|NCT00159159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381315|NCT00159159|Antifungal Agents|antifungal agents|mesh-ancestor
6381316|NCT00159159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6381317|NCT00159159|Dermatologic Agents|dermatologic agents|mesh-ancestor
6381318|NCT00159159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6381319|NCT00159159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6381320|NCT00159211|Pioglitazone|pioglitazone|mesh-list
6381321|NCT00159211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6381322|NCT00159211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381323|NCT00159224|Ritonavir|ritonavir|mesh-list
6381324|NCT00159224|Lopinavir|lopinavir|mesh-list
6381325|NCT00159224|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6381326|NCT00159224|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6381327|NCT00159224|Protease Inhibitors|protease inhibitors|mesh-ancestor
6381328|NCT00159224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6381329|NCT00159224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381330|NCT00159224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6381331|NCT00159224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6381332|NCT00159224|Antiviral Agents|antiviral agents|mesh-ancestor
6381333|NCT00159224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6381334|NCT00159224|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6381335|NCT00159224|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6381336|NCT00159302|Nitric Oxide|nitric oxide|mesh-list
6381337|NCT00159302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6381338|NCT00159302|Autonomic Agents|autonomic agents|mesh-ancestor
6381339|NCT00159302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6381340|NCT00159302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381341|NCT00159302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6381342|NCT00159302|Respiratory System Agents|respiratory system agents|mesh-ancestor
6381343|NCT00159302|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6381344|NCT00159302|Antioxidants|antioxidants|mesh-ancestor
6381345|NCT00159302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381346|NCT00159302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6381347|NCT00159302|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6381348|NCT00159302|Vasodilator Agents|vasodilator agents|mesh-ancestor
6381349|NCT00159302|Gasotransmitters|gasotransmitters|mesh-ancestor
6381350|NCT00159302|Protective Agents|protective agents|mesh-ancestor
6381351|NCT00159380|Pimagedine|pimagedine|mesh-list
6381352|NCT00159380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6381353|NCT00159380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381354|NCT00159445|Gemcitabine|gemcitabine|mesh-list
6381355|NCT00159445|Capecitabine|capecitabine|mesh-list
6381356|NCT00159445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6381357|NCT00159445|Antimetabolites|antimetabolites|mesh-ancestor
6381358|NCT00159445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381359|NCT00159445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6381360|NCT00159445|Antiviral Agents|antiviral agents|mesh-ancestor
6381361|NCT00159445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6381362|NCT00159445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6381363|NCT00159445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6381364|NCT00159445|Immunologic Factors|immunologic factors|mesh-ancestor
6381365|NCT00159445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381366|NCT00159458|Gemcitabine|gemcitabine|mesh-list
6381367|NCT00159458|Oxaliplatin|oxaliplatin|mesh-list
6381368|NCT00159458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6381369|NCT00159458|Antimetabolites|antimetabolites|mesh-ancestor
6381370|NCT00159458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381371|NCT00159458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6381372|NCT00159458|Antiviral Agents|antiviral agents|mesh-ancestor
6381373|NCT00159458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6381374|NCT00159458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6381375|NCT00159458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6381376|NCT00159458|Immunologic Factors|immunologic factors|mesh-ancestor
6381377|NCT00159458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381378|NCT00159471|Gemcitabine|gemcitabine|mesh-list
6381379|NCT00159471|Capecitabine|capecitabine|mesh-list
6381380|NCT00159471|Docetaxel|docetaxel|mesh-list
6381381|NCT00159471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6381382|NCT00159471|Antimetabolites|antimetabolites|mesh-ancestor
6381383|NCT00159471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381384|NCT00159471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6381385|NCT00159471|Antiviral Agents|antiviral agents|mesh-ancestor
6381386|NCT00159471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6381387|NCT00159471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6381388|NCT00159471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6381389|NCT00159471|Immunologic Factors|immunologic factors|mesh-ancestor
6381390|NCT00159471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381391|NCT00159471|Tubulin Modulators|tubulin modulators|mesh-ancestor
6381392|NCT00159471|Antimitotic Agents|antimitotic agents|mesh-ancestor
6381393|NCT00159471|Mitosis Modulators|mitosis modulators|mesh-ancestor
6381394|NCT00159484|Celecoxib|celecoxib|mesh-list
6381395|NCT00159484|Epothilone B|epothilone b|mesh-list
6381396|NCT00159484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6381397|NCT00159484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6381398|NCT00159484|Analgesics|analgesics|mesh-ancestor
6381399|NCT00159484|Sensory System Agents|sensory system agents|mesh-ancestor
6381400|NCT00159484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6381401|NCT00159484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381402|NCT00159484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6381403|NCT00159484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6381404|NCT00159484|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6381405|NCT00159484|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6381406|NCT00159484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6381407|NCT00159484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381408|NCT00159484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6381409|NCT00159484|Tubulin Modulators|tubulin modulators|mesh-ancestor
6381410|NCT00159484|Antimitotic Agents|antimitotic agents|mesh-ancestor
6381411|NCT00159484|Mitosis Modulators|mitosis modulators|mesh-ancestor
6381412|NCT00159510|Nitric Oxide|nitric oxide|mesh-list
6381413|NCT00159510|Methylene Blue|methylene blue|mesh-list
6381414|NCT00159510|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6381415|NCT00159510|Autonomic Agents|autonomic agents|mesh-ancestor
6381416|NCT00159510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6381417|NCT00159510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381418|NCT00159510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6381419|NCT00159510|Respiratory System Agents|respiratory system agents|mesh-ancestor
6381420|NCT00159510|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6381421|NCT00159510|Antioxidants|antioxidants|mesh-ancestor
6381422|NCT00159510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381423|NCT00159510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6381424|NCT00159510|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6381425|NCT00159510|Vasodilator Agents|vasodilator agents|mesh-ancestor
6381426|NCT00159510|Gasotransmitters|gasotransmitters|mesh-ancestor
6381427|NCT00159510|Protective Agents|protective agents|mesh-ancestor
6381428|NCT00159510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6381429|NCT00159536|Metformin|metformin|mesh-list
6381430|NCT00159536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6381431|NCT00159536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381432|NCT00159575|Metformin|metformin|mesh-list
6381433|NCT00159575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6381434|NCT00159575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381435|NCT00159614|Rolofylline|rolofylline|mesh-list
6381436|NCT00159614|Diuretics|diuretics|mesh-ancestor
6381437|NCT00159614|Natriuretic Agents|natriuretic agents|mesh-ancestor
6381438|NCT00159614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381439|NCT00159627|Rolofylline|rolofylline|mesh-list
6381440|NCT00159627|Diuretics|diuretics|mesh-ancestor
6381441|NCT00159627|Natriuretic Agents|natriuretic agents|mesh-ancestor
6381442|NCT00159627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381443|NCT00159653|Timolol|timolol|mesh-list
6381444|NCT00159653|Latanoprost|latanoprost|mesh-list
6381445|NCT00159653|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6381446|NCT00159653|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6381447|NCT00159653|Adrenergic Agents|adrenergic agents|mesh-ancestor
6381448|NCT00159653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6381449|NCT00159653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381450|NCT00159653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381451|NCT00159653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6381452|NCT00159653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6381453|NCT00159653|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6381454|NCT00159653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6381455|NCT00159666|Pregabalin|pregabalin|mesh-list
6381456|NCT00159666|Analgesics|analgesics|mesh-ancestor
6381457|NCT00159666|Sensory System Agents|sensory system agents|mesh-ancestor
6381458|NCT00159666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6381459|NCT00159666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381460|NCT00159666|Anticonvulsants|anticonvulsants|mesh-ancestor
6381461|NCT00159666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6381462|NCT00159666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6381463|NCT00159666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381464|NCT00159666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6381465|NCT00159666|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6381466|NCT00159666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6381467|NCT00159666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6381468|NCT00159666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6381469|NCT00159679|Pregabalin|pregabalin|mesh-list
6381470|NCT00159679|Analgesics|analgesics|mesh-ancestor
6381471|NCT00159679|Sensory System Agents|sensory system agents|mesh-ancestor
6381472|NCT00159679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6381473|NCT00159679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381474|NCT00159679|Anticonvulsants|anticonvulsants|mesh-ancestor
6381475|NCT00159679|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6381476|NCT00159679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6381477|NCT00159679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381478|NCT00159679|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6381479|NCT00159679|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6381480|NCT00159679|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6381481|NCT00159679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6381482|NCT00159679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6381483|NCT00159692|Amlodipine|amlodipine|mesh-list
6381484|NCT00159692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6381485|NCT00159692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6381486|NCT00159692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6381487|NCT00159692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381488|NCT00159692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6381489|NCT00159692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381490|NCT00159692|Vasodilator Agents|vasodilator agents|mesh-ancestor
6381491|NCT00159705|Pregabalin|pregabalin|mesh-list
6381492|NCT00159705|Analgesics|analgesics|mesh-ancestor
6381493|NCT00159705|Sensory System Agents|sensory system agents|mesh-ancestor
6381494|NCT00159705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6381495|NCT00159705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381496|NCT00159705|Anticonvulsants|anticonvulsants|mesh-ancestor
6381497|NCT00159705|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6381498|NCT00159705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6381499|NCT00159705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381500|NCT00159705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6381501|NCT00159705|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6381502|NCT00159705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6381503|NCT00159705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6381504|NCT00159705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6381505|NCT00159718|Amlodipine|amlodipine|mesh-list
6381506|NCT00159718|Atorvastatin|atorvastatin|mesh-list
6381507|NCT00159718|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6381508|NCT00159718|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6381509|NCT00159718|Antimetabolites|antimetabolites|mesh-ancestor
6381510|NCT00159718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381511|NCT00159718|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6381512|NCT00159718|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6381513|NCT00159718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6381514|NCT00159718|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6381515|NCT00159718|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6381516|NCT00159718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6381517|NCT00159718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6381518|NCT00159718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381519|NCT00159718|Vasodilator Agents|vasodilator agents|mesh-ancestor
6381520|NCT00159731|Pregabalin|pregabalin|mesh-list
6381521|NCT00159731|Analgesics|analgesics|mesh-ancestor
6381522|NCT00159731|Sensory System Agents|sensory system agents|mesh-ancestor
6381523|NCT00159731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6381524|NCT00159731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381525|NCT00159731|Anticonvulsants|anticonvulsants|mesh-ancestor
6381526|NCT00159731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6381527|NCT00159731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6381528|NCT00159731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381529|NCT00159731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6381530|NCT00159731|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6381531|NCT00159731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6381532|NCT00159731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6381533|NCT00159731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6381534|NCT00159757|Ziprasidone|ziprasidone|mesh-list
6381535|NCT00159757|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6381536|NCT00159757|Serotonin Agents|serotonin agents|mesh-ancestor
6381537|NCT00159757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6381538|NCT00159757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381539|NCT00159757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381540|NCT00159757|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6381541|NCT00159757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6381542|NCT00159757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6381543|NCT00159757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6381544|NCT00159757|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6381545|NCT00159757|Dopamine Agents|dopamine agents|mesh-ancestor
6381546|NCT00159770|Olanzapine|olanzapine|mesh-list
6381547|NCT00159770|Risperidone|risperidone|mesh-list
6381548|NCT00159770|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6381549|NCT00159770|Ziprasidone|ziprasidone|mesh-list
6381550|NCT00159770|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6381551|NCT00159770|Serotonin Agents|serotonin agents|mesh-ancestor
6381552|NCT00159770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6381553|NCT00159770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381554|NCT00159770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381555|NCT00159770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6381556|NCT00159770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6381557|NCT00159770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6381558|NCT00159770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6381559|NCT00159770|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6381560|NCT00159770|Dopamine Agents|dopamine agents|mesh-ancestor
6381561|NCT00159770|Antiemetics|antiemetics|mesh-ancestor
6381562|NCT00159770|Autonomic Agents|autonomic agents|mesh-ancestor
6381563|NCT00159770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6381564|NCT00159770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6381565|NCT00159770|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6381566|NCT00159770|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6381567|NCT00159770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6381568|NCT00159770|Antidepressive Agents|antidepressive agents|mesh-ancestor
6381569|NCT00159809|Sildenafil Citrate|sildenafil citrate|mesh-list
6381570|NCT00159809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381571|NCT00159809|Vasodilator Agents|vasodilator agents|mesh-ancestor
6381572|NCT00159809|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6381573|NCT00159809|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6381574|NCT00159809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6381575|NCT00159809|Urological Agents|urological agents|mesh-ancestor
6381576|NCT00159835|Atorvastatin|atorvastatin|mesh-list
6381577|NCT00159835|Simvastatin|simvastatin|mesh-list
6381578|NCT00159835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6381579|NCT00159835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6381580|NCT00159835|Antimetabolites|antimetabolites|mesh-ancestor
6381581|NCT00159835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381582|NCT00159835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6381583|NCT00159835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6381584|NCT00159835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6381585|NCT00159887|Sildenafil Citrate|sildenafil citrate|mesh-list
6381586|NCT00159887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381587|NCT00159887|Vasodilator Agents|vasodilator agents|mesh-ancestor
6381588|NCT00159887|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6381589|NCT00159887|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6381590|NCT00159887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6381591|NCT00159887|Urological Agents|urological agents|mesh-ancestor
6381592|NCT00159900|Sildenafil Citrate|sildenafil citrate|mesh-list
6381593|NCT00159900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381594|NCT00159900|Vasodilator Agents|vasodilator agents|mesh-ancestor
6381595|NCT00159900|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6381596|NCT00159900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6381597|NCT00159900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6381598|NCT00159900|Urological Agents|urological agents|mesh-ancestor
6381599|NCT00159952|Insulin|insulin|mesh-list
6381600|NCT00159952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6381601|NCT00159952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381602|NCT00159978|Alovudine|alovudine|mesh-list
6381603|NCT00159978|Antiviral Agents|antiviral agents|mesh-ancestor
6381604|NCT00159978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6381605|NCT00160030|Cisplatin|cisplatin|mesh-list
6381606|NCT00160030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6381607|NCT00160043|Vatalanib|vatalanib|mesh-list
6381608|NCT00160043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6381609|NCT00160043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6381610|NCT00160043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381611|NCT00160069|Sagopilone|sagopilone|mesh-list
6381612|NCT00160069|Epothilones|epothilones|mesh-list
6381613|NCT00160069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6381614|NCT00160069|Tubulin Modulators|tubulin modulators|mesh-ancestor
6381615|NCT00160069|Antimitotic Agents|antimitotic agents|mesh-ancestor
6381616|NCT00160069|Mitosis Modulators|mitosis modulators|mesh-ancestor
6381617|NCT00160069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381618|NCT00160160|Eprosartan|eprosartan|mesh-list
6381619|NCT00160160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6381620|NCT00160160|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
6381621|NCT00160160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6381622|NCT00160160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381623|NCT00160173|Estradiol|estradiol|mesh-list
6381624|NCT00160173|Estrogens|estrogens|mesh-ancestor
6381625|NCT00160173|Hormones|hormones|mesh-ancestor
6381626|NCT00160173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6381627|NCT00160173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381628|NCT00160186|Pancreatin|pancreatin|mesh-list
6381629|NCT00160186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6381630|NCT00160238|Betahistine|betahistine|mesh-list
6381631|NCT00160238|Vasodilator Agents|vasodilator agents|mesh-ancestor
6381632|NCT00160238|Histamine Agonists|histamine agonists|mesh-ancestor
6381633|NCT00160238|Histamine Agents|histamine agents|mesh-ancestor
6381634|NCT00160238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6381635|NCT00160238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381636|NCT00160238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381637|NCT00160264|Vitamin D|vitamin d|mesh-list
6381638|NCT00160264|Lactulose|lactulose|mesh-list
6381639|NCT00160264|Calcium|calcium|mesh-list
6381640|NCT00160264|Vitamins|vitamins|mesh-ancestor
6381641|NCT00160264|Micronutrients|micronutrients|mesh-ancestor
6381642|NCT00160264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381643|NCT00160264|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6381644|NCT00160264|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6381645|NCT00160264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6381646|NCT00160277|Moxonidine|moxonidine|mesh-list
6381647|NCT00160277|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6381648|NCT00160290|Lactulose|lactulose|mesh-list
6381649|NCT00160290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6381650|NCT00160316|Estradiol|estradiol|mesh-list
6381651|NCT00160316|Dydrogesterone|dydrogesterone|mesh-list
6381652|NCT00160316|Estrogens|estrogens|mesh-ancestor
6381653|NCT00160316|Hormones|hormones|mesh-ancestor
6381654|NCT00160316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6381655|NCT00160316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381656|NCT00160316|Progestins|progestins|mesh-ancestor
6381657|NCT00160329|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6381658|NCT00160329|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6381659|NCT00160329|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6381660|NCT00160329|Protease Inhibitors|protease inhibitors|mesh-ancestor
6381661|NCT00160329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6381662|NCT00160329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381663|NCT00160329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6381664|NCT00160329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6381665|NCT00160329|Antiviral Agents|antiviral agents|mesh-ancestor
6381666|NCT00160329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6381667|NCT00160342|Methyltestosterone|methyltestosterone|mesh-list
6381668|NCT00160342|Estrogens|estrogens|mesh-list
6381669|NCT00160342|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
6381670|NCT00160342|Estrone|estrone|mesh-list
6381671|NCT00160342|Testosterone|testosterone|mesh-list
6381672|NCT00160342|Testosterone undecanoate|testosterone undecanoate|mesh-list
6381673|NCT00160342|Testosterone enanthate|testosterone enanthate|mesh-list
6381674|NCT00160342|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6381675|NCT00160342|Hormones|hormones|mesh-ancestor
6381676|NCT00160342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6381677|NCT00160342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381678|NCT00160342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6381679|NCT00160342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6381680|NCT00160342|Anabolic Agents|anabolic agents|mesh-ancestor
6381681|NCT00160342|Androgens|androgens|mesh-ancestor
6381682|NCT00160355|Fludarabine|fludarabine|mesh-list
6381683|NCT00160355|Melphalan|melphalan|mesh-list
6381684|NCT00160355|Thiotepa|thiotepa|mesh-list
6381685|NCT00160355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6381686|NCT00160355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381687|NCT00160355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6381688|NCT00160355|Immunologic Factors|immunologic factors|mesh-ancestor
6381689|NCT00160355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381690|NCT00160355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6381691|NCT00160355|Alkylating Agents|alkylating agents|mesh-ancestor
6381692|NCT00160355|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6381693|NCT00160394|Adapalene|adapalene|mesh-list
6381694|NCT00160394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6381695|NCT00160394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6381696|NCT00160394|Analgesics|analgesics|mesh-ancestor
6381697|NCT00160394|Sensory System Agents|sensory system agents|mesh-ancestor
6381698|NCT00160394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6381699|NCT00160394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381700|NCT00160394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6381701|NCT00160394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6381702|NCT00160394|Dermatologic Agents|dermatologic agents|mesh-ancestor
6381703|NCT00160407|Orlistat|orlistat|mesh-list
6381704|NCT00160407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6381705|NCT00160407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381706|NCT00160407|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6381707|NCT00160407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6396221|NCT00208195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396222|NCT00208195|Antimanic Agents|antimanic agents|mesh-ancestor
6396223|NCT00208195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6396224|NCT00208195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6396225|NCT00208195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6396226|NCT00208208|Ziprasidone|ziprasidone|mesh-list
6396227|NCT00208208|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6396228|NCT00208208|Serotonin Agents|serotonin agents|mesh-ancestor
6396229|NCT00208208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6396230|NCT00208208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396231|NCT00208208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396232|NCT00208208|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6396233|NCT00208208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6396234|NCT00208208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6396235|NCT00208208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6396236|NCT00208208|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6396237|NCT00208208|Dopamine Agents|dopamine agents|mesh-ancestor
6396238|NCT00208221|Telmisartan|telmisartan|mesh-list
6396239|NCT00208221|Ramipril|ramipril|mesh-list
6396240|NCT00208221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6396241|NCT00208221|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6396242|NCT00208221|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6396243|NCT00208221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396244|NCT00208221|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6396245|NCT00208221|Protease Inhibitors|protease inhibitors|mesh-ancestor
6396246|NCT00208221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6396247|NCT00208234|Omalizumab|omalizumab|mesh-list
6396248|NCT00208234|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6396249|NCT00208234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6396250|NCT00208234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6396251|NCT00208234|Respiratory System Agents|respiratory system agents|mesh-ancestor
6396252|NCT00208234|Immunologic Factors|immunologic factors|mesh-ancestor
6396253|NCT00208234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396254|NCT00208260|Leucovorin|leucovorin|mesh-list
6396255|NCT00208260|Fluorouracil|fluorouracil|mesh-list
6396256|NCT00208260|Oxaliplatin|oxaliplatin|mesh-list
6396257|NCT00208260|Folfirinox|folfirinox|mesh-list
6396258|NCT00208260|Antimetabolites|antimetabolites|mesh-ancestor
6396259|NCT00208260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396260|NCT00208260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6396261|NCT00208260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6396262|NCT00208260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6396263|NCT00208260|Immunologic Factors|immunologic factors|mesh-ancestor
6396264|NCT00208260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396265|NCT00208260|Antidotes|antidotes|mesh-ancestor
6381708|NCT00160485|Glyburide|glyburide|mesh-list
6381709|NCT00160485|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6381710|NCT00160485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381711|NCT00160498|Lercanidipine|lercanidipine|mesh-list
6381712|NCT00160498|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6381713|NCT00160498|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6381714|NCT00160498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6381715|NCT00160498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381716|NCT00160498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6381717|NCT00160498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381718|NCT00160511|Levetiracetam|levetiracetam|mesh-list
6381719|NCT00160511|Anticonvulsants|anticonvulsants|mesh-ancestor
6381720|NCT00160511|Nootropic Agents|nootropic agents|mesh-ancestor
6381721|NCT00160537|Levocetirizine|levocetirizine|mesh-list
6381722|NCT00160537|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6381723|NCT00160537|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6381724|NCT00160537|Histamine Antagonists|histamine antagonists|mesh-ancestor
6381725|NCT00160537|Histamine Agents|histamine agents|mesh-ancestor
6381726|NCT00160537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6381727|NCT00160537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381728|NCT00160537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381729|NCT00160550|Levetiracetam|levetiracetam|mesh-list
6381730|NCT00160550|Anticonvulsants|anticonvulsants|mesh-ancestor
6381731|NCT00160550|Nootropic Agents|nootropic agents|mesh-ancestor
6381732|NCT00160576|Levetiracetam|levetiracetam|mesh-list
6381733|NCT00160576|Anticonvulsants|anticonvulsants|mesh-ancestor
6381734|NCT00160576|Nootropic Agents|nootropic agents|mesh-ancestor
6381735|NCT00160589|Levocetirizine|levocetirizine|mesh-list
6381736|NCT00160589|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6381737|NCT00160589|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6381738|NCT00160589|Histamine Antagonists|histamine antagonists|mesh-ancestor
6381739|NCT00160589|Histamine Agents|histamine agents|mesh-ancestor
6381740|NCT00160589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6381741|NCT00160589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381742|NCT00160589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381743|NCT00160602|Certolizumab Pegol|certolizumab pegol|mesh-list
6381744|NCT00160602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6381745|NCT00160602|Immunologic Factors|immunologic factors|mesh-ancestor
6381746|NCT00160602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381747|NCT00160602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6381748|NCT00160628|Levetiracetam|levetiracetam|mesh-list
6381749|NCT00160628|Anticonvulsants|anticonvulsants|mesh-ancestor
6381750|NCT00160628|Nootropic Agents|nootropic agents|mesh-ancestor
6381751|NCT00160745|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6381752|NCT00160745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6381753|NCT00160745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6381754|NCT00160745|Antimetabolites|antimetabolites|mesh-ancestor
6381755|NCT00160745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381756|NCT00160745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6381757|NCT00160745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6381758|NCT00160745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6381759|NCT00160849|Lopinavir|lopinavir|mesh-list
6381760|NCT00160849|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6381761|NCT00160849|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6381762|NCT00160849|Protease Inhibitors|protease inhibitors|mesh-ancestor
6381763|NCT00160849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6381764|NCT00160849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381765|NCT00160849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6381766|NCT00160849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6381767|NCT00160849|Antiviral Agents|antiviral agents|mesh-ancestor
6381768|NCT00160849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6381769|NCT00160849|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6381770|NCT00160849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6381771|NCT00160875|Irinotecan|irinotecan|mesh-list
6381772|NCT00160875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6381773|NCT00160875|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6381774|NCT00160875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6381775|NCT00160875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6381776|NCT00160875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381777|NCT00160888|Nitroprusside|nitroprusside|mesh-list
6381778|NCT00160888|Acetylcholine|acetylcholine|mesh-list
6381779|NCT00160888|Bradykinin|bradykinin|mesh-list
6381780|NCT00160888|Kininogens|kininogens|mesh-list
6381781|NCT00160888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6381782|NCT00160888|Vasodilator Agents|vasodilator agents|mesh-ancestor
6381783|NCT00160888|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6381784|NCT00160888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381785|NCT00160888|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6381786|NCT00160888|Cholinergic Agents|cholinergic agents|mesh-ancestor
6381787|NCT00160888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6381788|NCT00160888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381789|NCT00160888|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
6381790|NCT00160888|Protease Inhibitors|protease inhibitors|mesh-ancestor
6381791|NCT00160888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6381792|NCT00160927|Nitroprusside|nitroprusside|mesh-list
6381793|NCT00160927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6381794|NCT00160927|Vasodilator Agents|vasodilator agents|mesh-ancestor
6381795|NCT00160927|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6381796|NCT00160927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381797|NCT00160966|Cyclosporine|cyclosporine|mesh-list
6381798|NCT00160966|Mycophenolic Acid|mycophenolic acid|mesh-list
6381799|NCT00160966|Everolimus|everolimus|mesh-list
6381800|NCT00160966|Tacrolimus|tacrolimus|mesh-list
6381801|NCT00160966|Cyclosporins|cyclosporins|mesh-list
6381802|NCT00160966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6381803|NCT00160966|Immunologic Factors|immunologic factors|mesh-ancestor
6381804|NCT00160966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381805|NCT00160966|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6381806|NCT00160966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6396266|NCT00208260|Protective Agents|protective agents|mesh-ancestor
6381807|NCT00160966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381808|NCT00160966|Antifungal Agents|antifungal agents|mesh-ancestor
6381809|NCT00160966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6381810|NCT00160966|Dermatologic Agents|dermatologic agents|mesh-ancestor
6381811|NCT00160966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6381812|NCT00160966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6381813|NCT00160966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6381814|NCT00160966|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6381815|NCT00160966|Antitubercular Agents|antitubercular agents|mesh-ancestor
6381816|NCT00160966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6381817|NCT00161018|Risperidone|risperidone|mesh-list
6381818|NCT00161018|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6381819|NCT00161018|Fluphenazine|fluphenazine|mesh-list
6381820|NCT00161018|Fluphenazine depot|fluphenazine depot|mesh-list
6381821|NCT00161018|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
6381822|NCT00161018|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6381823|NCT00161018|Serotonin Agents|serotonin agents|mesh-ancestor
6381824|NCT00161018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6381825|NCT00161018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381826|NCT00161018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381827|NCT00161018|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6381828|NCT00161018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6381829|NCT00161018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6381830|NCT00161018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6381831|NCT00161018|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6381832|NCT00161018|Dopamine Agents|dopamine agents|mesh-ancestor
6381833|NCT00161018|Antidepressive Agents|antidepressive agents|mesh-ancestor
6381834|NCT00161031|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6381835|NCT00161031|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6381836|NCT00161031|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6381837|NCT00161031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6381838|NCT00161031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381839|NCT00161031|Adrenergic Agents|adrenergic agents|mesh-ancestor
6381840|NCT00161031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6381841|NCT00161031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381842|NCT00161044|Galantamine|galantamine|mesh-list
6381843|NCT00161044|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6381844|NCT00161044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6381845|NCT00161044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381846|NCT00161044|Cholinergic Agents|cholinergic agents|mesh-ancestor
6381847|NCT00161044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6381848|NCT00161044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381849|NCT00161044|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6381850|NCT00161044|Autonomic Agents|autonomic agents|mesh-ancestor
6381851|NCT00161044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6381852|NCT00161044|Nootropic Agents|nootropic agents|mesh-ancestor
6381853|NCT00161070|Aspirin|aspirin|mesh-list
6381854|NCT00161070|Dipyridamole|dipyridamole|mesh-list
6381855|NCT00161070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6381856|NCT00161070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6381857|NCT00161070|Analgesics|analgesics|mesh-ancestor
6381858|NCT00161070|Sensory System Agents|sensory system agents|mesh-ancestor
6381859|NCT00161070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6381860|NCT00161070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381861|NCT00161070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6381862|NCT00161070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6381863|NCT00161070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6381864|NCT00161070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6381865|NCT00161070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381866|NCT00161070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6381867|NCT00161070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6381868|NCT00161070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6381869|NCT00161070|Antipyretics|antipyretics|mesh-ancestor
6381870|NCT00161070|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6381871|NCT00161070|Vasodilator Agents|vasodilator agents|mesh-ancestor
6381872|NCT00161083|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
6381873|NCT00161083|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6381874|NCT00161083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6381875|NCT00161096|Pantoprazole|pantoprazole|mesh-list
6381876|NCT00161096|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6381877|NCT00161096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6381878|NCT00161096|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6381879|NCT00161096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6381880|NCT00161096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381881|NCT00161122|Vaccines|vaccines|mesh-list
6381882|NCT00161122|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6381883|NCT00161122|Immunologic Factors|immunologic factors|mesh-ancestor
6381884|NCT00161122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381885|NCT00161200|Pantoprazole|pantoprazole|mesh-list
6381886|NCT00161200|Ranitidine|ranitidine|mesh-list
6381887|NCT00161200|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
6381888|NCT00161200|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6381889|NCT00161200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6381890|NCT00161200|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6381891|NCT00161200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6396267|NCT00208260|Vitamin B Complex|vitamin b complex|mesh-ancestor
6381892|NCT00161200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381893|NCT00161200|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6381894|NCT00161200|Histamine Antagonists|histamine antagonists|mesh-ancestor
6381895|NCT00161200|Histamine Agents|histamine agents|mesh-ancestor
6381896|NCT00161200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6381897|NCT00161200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381898|NCT00161226|Levonorgestrel|levonorgestrel|mesh-list
6381899|NCT00161226|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6381900|NCT00161226|Contraceptive Agents|contraceptive agents|mesh-ancestor
6381901|NCT00161226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6381902|NCT00161226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381903|NCT00161226|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6381904|NCT00161226|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6381905|NCT00161226|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6381906|NCT00161239|Prednisone|prednisone|mesh-list
6381907|NCT00161239|Methotrexate|methotrexate|mesh-list
6381908|NCT00161239|Asparaginase|asparaginase|mesh-list
6381909|NCT00161239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6381910|NCT00161239|Glucocorticoids|glucocorticoids|mesh-ancestor
6381911|NCT00161239|Hormones|hormones|mesh-ancestor
6381912|NCT00161239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6381913|NCT00161239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381914|NCT00161239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6381915|NCT00161239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6381916|NCT00161239|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6381917|NCT00161239|Abortifacient Agents|abortifacient agents|mesh-ancestor
6381918|NCT00161239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6381919|NCT00161239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6381920|NCT00161239|Antimetabolites|antimetabolites|mesh-ancestor
6381921|NCT00161239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381922|NCT00161239|Dermatologic Agents|dermatologic agents|mesh-ancestor
6381923|NCT00161239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6381924|NCT00161239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6381925|NCT00161239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6381926|NCT00161239|Immunologic Factors|immunologic factors|mesh-ancestor
6381927|NCT00161239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6381928|NCT00161239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6381929|NCT00161278|Paclitaxel|paclitaxel|mesh-list
6381930|NCT00161278|Carboplatin|carboplatin|mesh-list
6381931|NCT00161278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6381932|NCT00161278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6381933|NCT00161278|Tubulin Modulators|tubulin modulators|mesh-ancestor
6381934|NCT00161278|Antimitotic Agents|antimitotic agents|mesh-ancestor
6381935|NCT00161278|Mitosis Modulators|mitosis modulators|mesh-ancestor
6381936|NCT00161278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381937|NCT00161291|Bevacizumab|bevacizumab|mesh-list
6381938|NCT00161291|Letrozole|letrozole|mesh-list
6381939|NCT00161291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6381940|NCT00161291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6381941|NCT00161291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6381942|NCT00161291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6381943|NCT00161291|Growth Substances|growth substances|mesh-ancestor
6381944|NCT00161291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381945|NCT00161291|Growth Inhibitors|growth inhibitors|mesh-ancestor
6381946|NCT00161291|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6381947|NCT00161291|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6381948|NCT00161291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6381949|NCT00161291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381950|NCT00161291|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6381951|NCT00161291|Hormone Antagonists|hormone antagonists|mesh-ancestor
6381952|NCT00161291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6381953|NCT00161304|Methyltestosterone|methyltestosterone|mesh-list
6381954|NCT00161304|Testosterone|testosterone|mesh-list
6381955|NCT00161304|Testosterone undecanoate|testosterone undecanoate|mesh-list
6381956|NCT00161304|Testosterone enanthate|testosterone enanthate|mesh-list
6381957|NCT00161304|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6381958|NCT00161304|Androgens|androgens|mesh-ancestor
6381959|NCT00161304|Hormones|hormones|mesh-ancestor
6381960|NCT00161304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6396268|NCT00208260|Vitamins|vitamins|mesh-ancestor
6381961|NCT00161304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381962|NCT00161304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6381963|NCT00161304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6381964|NCT00161304|Anabolic Agents|anabolic agents|mesh-ancestor
6381965|NCT00161330|Amoxicillin|amoxicillin|mesh-list
6381966|NCT00161330|Ceftriaxone|ceftriaxone|mesh-list
6381967|NCT00161330|Clavulanic Acids|clavulanic acids|mesh-list
6381968|NCT00161330|Clavulanic Acid|clavulanic acid|mesh-list
6381969|NCT00161330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6381970|NCT00161330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6381971|NCT00161330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6381972|NCT00161330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381973|NCT00161330|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6381974|NCT00161356|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6381975|NCT00161356|Antifungal Agents|antifungal agents|mesh-ancestor
6381976|NCT00161356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6381977|NCT00161356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6381978|NCT00161356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6381979|NCT00161421|Leuprolide|leuprolide|mesh-list
6381980|NCT00161421|Testosterone|testosterone|mesh-list
6381981|NCT00161421|Dutasteride|dutasteride|mesh-list
6381982|NCT00161421|Androgens|androgens|mesh-ancestor
6381983|NCT00161421|Hormones|hormones|mesh-ancestor
6381984|NCT00161421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6381985|NCT00161421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6381986|NCT00161421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6381987|NCT00161421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6381988|NCT00161421|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6381989|NCT00161421|Fertility Agents|fertility agents|mesh-ancestor
6381990|NCT00161421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6381991|NCT00161421|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6381992|NCT00161421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6381993|NCT00161421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6381994|NCT00161421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6381995|NCT00161421|Hormone Antagonists|hormone antagonists|mesh-ancestor
6381996|NCT00161434|Valacyclovir|valacyclovir|mesh-list
6381997|NCT00161434|Antiviral Agents|antiviral agents|mesh-ancestor
6381998|NCT00161434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6381999|NCT00161447|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6382000|NCT00161447|Medroxyprogesterone|medroxyprogesterone|mesh-list
6382001|NCT00161447|Testosterone|testosterone|mesh-list
6382002|NCT00161447|Acyline|acyline|mesh-list
6382003|NCT00161447|Androgens|androgens|mesh-ancestor
6382004|NCT00161447|Hormones|hormones|mesh-ancestor
6382005|NCT00161447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6382006|NCT00161447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382007|NCT00161447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6382008|NCT00161447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6382009|NCT00161447|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6382010|NCT00161447|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6382011|NCT00161447|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6382012|NCT00161447|Contraceptive Agents|contraceptive agents|mesh-ancestor
6382013|NCT00161447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6382014|NCT00161447|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6382015|NCT00161447|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6382016|NCT00161447|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6382017|NCT00161447|Hormone Antagonists|hormone antagonists|mesh-ancestor
6382018|NCT00161486|Methyltestosterone|methyltestosterone|mesh-list
6382019|NCT00161486|Testosterone|testosterone|mesh-list
6382020|NCT00161486|Testosterone undecanoate|testosterone undecanoate|mesh-list
6382021|NCT00161486|Testosterone enanthate|testosterone enanthate|mesh-list
6382022|NCT00161486|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6382023|NCT00161486|Acyline|acyline|mesh-list
6382024|NCT00161486|Androgens|androgens|mesh-ancestor
6382025|NCT00161486|Hormones|hormones|mesh-ancestor
6382026|NCT00161486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6382027|NCT00161486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382028|NCT00161486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6382029|NCT00161486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6382030|NCT00161486|Anabolic Agents|anabolic agents|mesh-ancestor
6382031|NCT00161486|Hormone Antagonists|hormone antagonists|mesh-ancestor
6382032|NCT00161564|Rituximab|rituximab|mesh-list
6382033|NCT00161564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6382034|NCT00161564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6382035|NCT00161564|Immunologic Factors|immunologic factors|mesh-ancestor
6382036|NCT00161564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382037|NCT00161564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6382038|NCT00161577|Ketorolac|ketorolac|mesh-list
6382039|NCT00161577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6382040|NCT00161577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6382041|NCT00161577|Analgesics|analgesics|mesh-ancestor
6382042|NCT00161577|Sensory System Agents|sensory system agents|mesh-ancestor
6382043|NCT00161577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6382044|NCT00161577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382045|NCT00161577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6382046|NCT00161577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6382047|NCT00161577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6382048|NCT00161577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6382049|NCT00161577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382050|NCT00161590|Alemtuzumab|alemtuzumab|mesh-list
6382051|NCT00161590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6382052|NCT00161590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6382053|NCT00161655|Etanercept|etanercept|mesh-list
6382054|NCT00161655|Methotrexate|methotrexate|mesh-list
6382055|NCT00161655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6382056|NCT00161655|Abortifacient Agents|abortifacient agents|mesh-ancestor
6382057|NCT00161655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6382058|NCT00161655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382059|NCT00161655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6382060|NCT00161655|Antimetabolites|antimetabolites|mesh-ancestor
6382061|NCT00161655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382062|NCT00161655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6382063|NCT00161655|Dermatologic Agents|dermatologic agents|mesh-ancestor
6382064|NCT00161655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6382065|NCT00161655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6382066|NCT00161655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6382067|NCT00161655|Immunologic Factors|immunologic factors|mesh-ancestor
6382068|NCT00161655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6382069|NCT00161655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6382070|NCT00161655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6382071|NCT00161655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6382072|NCT00161655|Analgesics|analgesics|mesh-ancestor
6382073|NCT00161655|Sensory System Agents|sensory system agents|mesh-ancestor
6382074|NCT00161655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6382075|NCT00161655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6382076|NCT00161655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6382077|NCT00161668|Gemtuzumab|gemtuzumab|mesh-list
6382078|NCT00161668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6382079|NCT00161668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6382080|NCT00161681|Levonorgestrel|levonorgestrel|mesh-list
6382081|NCT00161681|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6382082|NCT00161681|Estradiol|estradiol|mesh-list
6382083|NCT00161681|Estrogens|estrogens|mesh-ancestor
6382084|NCT00161681|Hormones|hormones|mesh-ancestor
6382085|NCT00161681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6382086|NCT00161681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382087|NCT00161681|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6382088|NCT00161681|Contraceptive Agents|contraceptive agents|mesh-ancestor
6382089|NCT00161681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6382090|NCT00161681|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6382091|NCT00161681|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6382092|NCT00161681|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6382093|NCT00161681|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6382094|NCT00161707|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
6382095|NCT00161707|Protein C Inhibitor|protein c inhibitor|mesh-list
6382096|NCT00161707|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6382097|NCT00161707|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6382098|NCT00161707|Protease Inhibitors|protease inhibitors|mesh-ancestor
6382099|NCT00161707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6382100|NCT00161707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382101|NCT00161720|Protein C|protein c|mesh-list
6382102|NCT00161720|Anticoagulants|anticoagulants|mesh-ancestor
6382103|NCT00161720|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6382104|NCT00161720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6382105|NCT00161720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382106|NCT00161733|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6382107|NCT00161733|Hemostatics|hemostatics|mesh-ancestor
6382108|NCT00161733|Coagulants|coagulants|mesh-ancestor
6382109|NCT00161759|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6382110|NCT00161759|Thrombin|thrombin|mesh-list
6382111|NCT00161759|Hemostatics|hemostatics|mesh-ancestor
6382112|NCT00161759|Coagulants|coagulants|mesh-ancestor
6382113|NCT00161811|Vaccines|vaccines|mesh-list
6382114|NCT00161811|Immunologic Factors|immunologic factors|mesh-ancestor
6382115|NCT00161811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382116|NCT00161837|Vaccines|vaccines|mesh-list
6382117|NCT00161837|Immunologic Factors|immunologic factors|mesh-ancestor
6382118|NCT00161837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382119|NCT00161902|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6382120|NCT00161902|Hemostatics|hemostatics|mesh-ancestor
6382121|NCT00161902|Coagulants|coagulants|mesh-ancestor
6382122|NCT00161915|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6382123|NCT00161915|Hemostatics|hemostatics|mesh-ancestor
6382124|NCT00161915|Coagulants|coagulants|mesh-ancestor
6396269|NCT00208260|Micronutrients|micronutrients|mesh-ancestor
6396270|NCT00208273|Letrozole|letrozole|mesh-list
6396271|NCT00208273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6396272|NCT00208273|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6396273|NCT00208273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6396274|NCT00208273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6396275|NCT00208273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396276|NCT00208273|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6396277|NCT00208273|Hormone Antagonists|hormone antagonists|mesh-ancestor
6396278|NCT00208273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6396279|NCT00208273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396280|NCT00208299|Adenosine|adenosine|mesh-list
6396281|NCT00208299|Regadenoson|regadenoson|mesh-list
6396282|NCT00208299|Analgesics|analgesics|mesh-ancestor
6396283|NCT00208299|Sensory System Agents|sensory system agents|mesh-ancestor
6396284|NCT00208299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6396285|NCT00208299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396286|NCT00208299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6396287|NCT00208299|Vasodilator Agents|vasodilator agents|mesh-ancestor
6396288|NCT00208299|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6396289|NCT00208299|Purinergic Agonists|purinergic agonists|mesh-ancestor
6396290|NCT00208299|Purinergic Agents|purinergic agents|mesh-ancestor
6396291|NCT00208299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6396292|NCT00208299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396293|NCT00208299|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
6396294|NCT00208312|Adenosine|adenosine|mesh-list
6396295|NCT00208312|Regadenoson|regadenoson|mesh-list
6396296|NCT00208312|Analgesics|analgesics|mesh-ancestor
6396297|NCT00208312|Sensory System Agents|sensory system agents|mesh-ancestor
6396298|NCT00208312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6396299|NCT00208312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396300|NCT00208312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6396301|NCT00208312|Vasodilator Agents|vasodilator agents|mesh-ancestor
6396302|NCT00208312|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6396303|NCT00208312|Purinergic Agonists|purinergic agonists|mesh-ancestor
6396304|NCT00208312|Purinergic Agents|purinergic agents|mesh-ancestor
6396305|NCT00208312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6396306|NCT00208312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396307|NCT00208312|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
6396308|NCT00208403|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
6396309|NCT00208403|Vasodilator Agents|vasodilator agents|mesh-ancestor
6396310|NCT00208403|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
6396311|NCT00208403|Protective Agents|protective agents|mesh-ancestor
6396312|NCT00208403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396313|NCT00208442|Methyclothiazide|methyclothiazide|mesh-list
6396314|NCT00208442|Diuretics|diuretics|mesh-ancestor
6382125|NCT00161980|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6382126|NCT00161980|Hemostatics|hemostatics|mesh-ancestor
6382127|NCT00161980|Coagulants|coagulants|mesh-ancestor
6382128|NCT00161993|Immunoglobulins|immunoglobulins|mesh-list
6382129|NCT00161993|Antibodies|antibodies|mesh-list
6382130|NCT00161993|gamma-Globulins|gamma-globulins|mesh-list
6382131|NCT00161993|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6382132|NCT00161993|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6382133|NCT00161993|Immunologic Factors|immunologic factors|mesh-ancestor
6382134|NCT00161993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382135|NCT00162006|Immunoglobulins|immunoglobulins|mesh-list
6382136|NCT00162006|Antibodies|antibodies|mesh-list
6382137|NCT00162006|gamma-Globulins|gamma-globulins|mesh-list
6382138|NCT00162006|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6382139|NCT00162006|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6382140|NCT00162006|Immunologic Factors|immunologic factors|mesh-ancestor
6382141|NCT00162006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382142|NCT00162019|Factor VIII|factor viii|mesh-list
6382143|NCT00162019|Coagulants|coagulants|mesh-ancestor
6382144|NCT00162045|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
6382145|NCT00162045|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6382146|NCT00162045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382147|NCT00162110|Cetuximab|cetuximab|mesh-list
6382148|NCT00162110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6382149|NCT00162110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6382150|NCT00162149|Ritonavir|ritonavir|mesh-list
6382151|NCT00162149|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6382152|NCT00162149|Nevirapine|nevirapine|mesh-list
6382153|NCT00162149|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6382154|NCT00162149|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6382155|NCT00162149|Protease Inhibitors|protease inhibitors|mesh-ancestor
6382156|NCT00162149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6382157|NCT00162149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382158|NCT00162149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6382159|NCT00162149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6382160|NCT00162149|Antiviral Agents|antiviral agents|mesh-ancestor
6382161|NCT00162149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6382162|NCT00162149|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6382163|NCT00162149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6382164|NCT00162149|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6382165|NCT00162149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6382166|NCT00162149|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6382167|NCT00162149|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6382168|NCT00162188|Efavirenz|efavirenz|mesh-list
6382169|NCT00162188|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6382170|NCT00162188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6382171|NCT00162188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6382172|NCT00162188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382173|NCT00162188|Antiviral Agents|antiviral agents|mesh-ancestor
6382174|NCT00162188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6382175|NCT00162188|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6382176|NCT00162188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6382177|NCT00162188|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6382178|NCT00162188|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6382179|NCT00162188|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6382180|NCT00162188|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6382181|NCT00162201|Abatacept|abatacept|mesh-list
6382182|NCT00162201|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6382183|NCT00162201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382184|NCT00162201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6382185|NCT00162201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6382186|NCT00162201|Immunologic Factors|immunologic factors|mesh-ancestor
6382187|NCT00162201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382188|NCT00162201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6382189|NCT00162214|Ketoconazole|ketoconazole|mesh-list
6382190|NCT00162214|Dasatinib|dasatinib|mesh-list
6382191|NCT00162214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6382192|NCT00162214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6382193|NCT00162214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6382194|NCT00162214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382195|NCT00162214|Antifungal Agents|antifungal agents|mesh-ancestor
6382196|NCT00162214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6382197|NCT00162214|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6382198|NCT00162214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6382199|NCT00162214|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6382200|NCT00162214|Hormone Antagonists|hormone antagonists|mesh-ancestor
6382201|NCT00162214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6382202|NCT00162214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382203|NCT00162214|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6382204|NCT00162227|Efavirenz|efavirenz|mesh-list
6382205|NCT00162227|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6382206|NCT00162227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6382207|NCT00162227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6382208|NCT00162227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382209|NCT00162227|Antiviral Agents|antiviral agents|mesh-ancestor
6382210|NCT00162227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6382211|NCT00162227|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6382212|NCT00162227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6382213|NCT00162227|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6382214|NCT00162227|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6382215|NCT00162227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6382216|NCT00162227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6382217|NCT00162305|Dapagliflozin|dapagliflozin|mesh-list
6382218|NCT00162305|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6382219|NCT00162305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382220|NCT00162305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6382221|NCT00162305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382222|NCT00162318|Cetuximab|cetuximab|mesh-list
6382223|NCT00162318|Gefitinib|gefitinib|mesh-list
6382224|NCT00162318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6382225|NCT00162318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6382226|NCT00162318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6382227|NCT00162318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6382228|NCT00162318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382229|NCT00162331|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
6382230|NCT00162331|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6382231|NCT00162331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382232|NCT00162344|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
6382233|NCT00162344|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6382234|NCT00162344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382235|NCT00162357|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
6382236|NCT00162357|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6382237|NCT00162357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382238|NCT00162383|Dapsone|dapsone|mesh-list
6382239|NCT00162383|Debrisoquin|debrisoquin|mesh-list
6382240|NCT00162383|Mephenytoin|mephenytoin|mesh-list
6382241|NCT00162383|Caffeine|caffeine|mesh-list
6382242|NCT00162383|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6382243|NCT00162383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382244|NCT00162383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6382245|NCT00162383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6382246|NCT00162383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382247|NCT00162383|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6382248|NCT00162383|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6382249|NCT00162383|Purinergic Agents|purinergic agents|mesh-ancestor
6382250|NCT00162383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6382251|NCT00162383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6382252|NCT00162383|Antimalarials|antimalarials|mesh-ancestor
6382253|NCT00162383|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6382254|NCT00162383|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6382255|NCT00162383|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6382256|NCT00162383|Leprostatic Agents|leprostatic agents|mesh-ancestor
6382257|NCT00162383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6382258|NCT00162383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6382259|NCT00162383|Sympatholytics|sympatholytics|mesh-ancestor
6382260|NCT00162383|Autonomic Agents|autonomic agents|mesh-ancestor
6382261|NCT00162383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6382262|NCT00162383|Adrenergic Agents|adrenergic agents|mesh-ancestor
6382263|NCT00162383|Anticonvulsants|anticonvulsants|mesh-ancestor
6382264|NCT00162396|Albuterol|albuterol|mesh-list
6382265|NCT00162396|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6382266|NCT00162396|Autonomic Agents|autonomic agents|mesh-ancestor
6382267|NCT00162396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6382268|NCT00162396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382269|NCT00162396|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6382270|NCT00162396|Respiratory System Agents|respiratory system agents|mesh-ancestor
6382271|NCT00162396|Tocolytic Agents|tocolytic agents|mesh-ancestor
6382272|NCT00162396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6382273|NCT00162396|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6382274|NCT00162396|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6382275|NCT00162396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6382276|NCT00162396|Adrenergic Agents|adrenergic agents|mesh-ancestor
6382277|NCT00162396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6382278|NCT00162396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382279|NCT00162409|Folic Acid|folic acid|mesh-list
6382280|NCT00162409|Hematinics|hematinics|mesh-ancestor
6382281|NCT00162409|Vitamin B Complex|vitamin b complex|mesh-ancestor
6382282|NCT00162409|Vitamins|vitamins|mesh-ancestor
6382283|NCT00162409|Micronutrients|micronutrients|mesh-ancestor
6382284|NCT00162409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382285|NCT00162422|Albuterol|albuterol|mesh-list
6382286|NCT00162422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6382287|NCT00162422|Autonomic Agents|autonomic agents|mesh-ancestor
6382288|NCT00162422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6382289|NCT00162422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382290|NCT00162422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6382291|NCT00162422|Respiratory System Agents|respiratory system agents|mesh-ancestor
6382292|NCT00162422|Tocolytic Agents|tocolytic agents|mesh-ancestor
6382293|NCT00162422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6382294|NCT00162422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6382295|NCT00162422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6382296|NCT00162422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6382297|NCT00162422|Adrenergic Agents|adrenergic agents|mesh-ancestor
6382298|NCT00162422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6382299|NCT00162422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382300|NCT00162435|Warfarin|warfarin|mesh-list
6382301|NCT00162435|Anticoagulants|anticoagulants|mesh-ancestor
6382302|NCT00162461|Phenytoin|phenytoin|mesh-list
6382303|NCT00162461|Anticonvulsants|anticonvulsants|mesh-ancestor
6382304|NCT00162461|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6382305|NCT00162461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6382306|NCT00162461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6382307|NCT00162461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382308|NCT00162461|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6382309|NCT00162461|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6382310|NCT00162474|Phenytoin|phenytoin|mesh-list
6382311|NCT00162474|Warfarin|warfarin|mesh-list
6382312|NCT00162474|Anticoagulants|anticoagulants|mesh-ancestor
6382313|NCT00162474|Anticonvulsants|anticonvulsants|mesh-ancestor
6382314|NCT00162474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6382315|NCT00162474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6382316|NCT00162474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6382317|NCT00162474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382318|NCT00162474|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6382319|NCT00162474|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6382320|NCT00162487|Albuterol|albuterol|mesh-list
6382321|NCT00162487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6382322|NCT00162487|Autonomic Agents|autonomic agents|mesh-ancestor
6382323|NCT00162487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6382324|NCT00162487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382325|NCT00162487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6382326|NCT00162487|Respiratory System Agents|respiratory system agents|mesh-ancestor
6382327|NCT00162487|Tocolytic Agents|tocolytic agents|mesh-ancestor
6382328|NCT00162487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6382329|NCT00162487|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6382330|NCT00162487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6382331|NCT00162487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6382332|NCT00162487|Adrenergic Agents|adrenergic agents|mesh-ancestor
6382333|NCT00162487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6382334|NCT00162487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382335|NCT00162526|Tocopherols|tocopherols|mesh-list
6382336|NCT00162526|Vitamin E|vitamin e|mesh-list
6382337|NCT00162526|Tocotrienols|tocotrienols|mesh-list
6382338|NCT00162526|alpha-Tocopherol|alpha-tocopherol|mesh-list
6382339|NCT00162526|Antioxidants|antioxidants|mesh-ancestor
6382340|NCT00162526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382341|NCT00162526|Protective Agents|protective agents|mesh-ancestor
6382342|NCT00162526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382343|NCT00162526|Vitamins|vitamins|mesh-ancestor
6382344|NCT00162526|Micronutrients|micronutrients|mesh-ancestor
6382345|NCT00162552|Pentoxifylline|pentoxifylline|mesh-list
6382346|NCT00162552|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6382347|NCT00162552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6382348|NCT00162552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382349|NCT00162552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6382350|NCT00162552|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6382351|NCT00162552|Protective Agents|protective agents|mesh-ancestor
6382352|NCT00162552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382353|NCT00162552|Vasodilator Agents|vasodilator agents|mesh-ancestor
6382354|NCT00162552|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6382355|NCT00162552|Antioxidants|antioxidants|mesh-ancestor
6382356|NCT00162565|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
6382357|NCT00162565|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6382358|NCT00162565|Adrenergic Agents|adrenergic agents|mesh-ancestor
6382359|NCT00162565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6382360|NCT00162565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382361|NCT00162565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382362|NCT00162591|Remifentanil|remifentanil|mesh-list
6382363|NCT00162591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6382364|NCT00162591|Narcotics|narcotics|mesh-ancestor
6382365|NCT00162591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6382366|NCT00162591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382367|NCT00162591|Analgesics|analgesics|mesh-ancestor
6382368|NCT00162591|Sensory System Agents|sensory system agents|mesh-ancestor
6382369|NCT00162591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6382370|NCT00162604|Cefuroxime|cefuroxime|mesh-list
6382371|NCT00162604|Cefuroxime axetil|cefuroxime axetil|mesh-list
6382372|NCT00162604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6382373|NCT00162604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6382374|NCT00162643|Ritonavir|ritonavir|mesh-list
6382375|NCT00162643|Lopinavir|lopinavir|mesh-list
6382376|NCT00162643|Lamivudine|lamivudine|mesh-list
6382377|NCT00162643|Zidovudine|zidovudine|mesh-list
6382378|NCT00162643|Efavirenz|efavirenz|mesh-list
6382379|NCT00162643|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6382380|NCT00162643|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6382381|NCT00162643|Protease Inhibitors|protease inhibitors|mesh-ancestor
6382382|NCT00162643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6382383|NCT00162643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382384|NCT00162643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6382385|NCT00162643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6382386|NCT00162643|Antiviral Agents|antiviral agents|mesh-ancestor
6396315|NCT00208442|Natriuretic Agents|natriuretic agents|mesh-ancestor
6382387|NCT00162643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6382388|NCT00162643|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6382389|NCT00162643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6382390|NCT00162643|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6382391|NCT00162643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6382392|NCT00162643|Antimetabolites|antimetabolites|mesh-ancestor
6382393|NCT00162643|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6382394|NCT00162643|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6382395|NCT00162643|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6382396|NCT00162643|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6382397|NCT00162643|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6382398|NCT00162656|Cyclophosphamide|cyclophosphamide|mesh-list
6382399|NCT00162656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6382400|NCT00162656|Immunologic Factors|immunologic factors|mesh-ancestor
6382401|NCT00162656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382402|NCT00162656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6382403|NCT00162656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6382404|NCT00162656|Alkylating Agents|alkylating agents|mesh-ancestor
6382405|NCT00162656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382406|NCT00162656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6382407|NCT00162656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6382408|NCT00162669|Bevacizumab|bevacizumab|mesh-list
6382409|NCT00162669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6382410|NCT00162669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6382411|NCT00162669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6382412|NCT00162669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6382413|NCT00162669|Growth Substances|growth substances|mesh-ancestor
6382414|NCT00162669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382415|NCT00162669|Growth Inhibitors|growth inhibitors|mesh-ancestor
6382416|NCT00162682|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6382417|NCT00162682|Antiviral Agents|antiviral agents|mesh-ancestor
6382418|NCT00162682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6382419|NCT00162695|Etoposide|etoposide|mesh-list
6382420|NCT00162695|Vincristine|vincristine|mesh-list
6382421|NCT00162695|Epirubicin|epirubicin|mesh-list
6382422|NCT00162695|Ifosfamide|ifosfamide|mesh-list
6382423|NCT00162695|Carboplatin|carboplatin|mesh-list
6382424|NCT00162695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6382425|NCT00162695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6382426|NCT00162695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6382427|NCT00162695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6382428|NCT00162695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6382429|NCT00162695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382430|NCT00162695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6382431|NCT00162695|Alkylating Agents|alkylating agents|mesh-ancestor
6382432|NCT00162695|Tubulin Modulators|tubulin modulators|mesh-ancestor
6382433|NCT00162695|Antimitotic Agents|antimitotic agents|mesh-ancestor
6382434|NCT00162695|Mitosis Modulators|mitosis modulators|mesh-ancestor
6382435|NCT00162695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6382436|NCT00162721|Doxorubicin|doxorubicin|mesh-list
6382437|NCT00162721|Ifosfamide|ifosfamide|mesh-list
6382438|NCT00162721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6382439|NCT00162721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6382440|NCT00162721|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6382441|NCT00162721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6382442|NCT00162721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6382443|NCT00162721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382444|NCT00162721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6382445|NCT00162721|Alkylating Agents|alkylating agents|mesh-ancestor
6382446|NCT00162734|Interferons|interferons|mesh-list
6382447|NCT00162734|Ribavirin|ribavirin|mesh-list
6382448|NCT00162734|Interferon alfacon-1|interferon alfacon-1|mesh-list
6382449|NCT00162734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6382450|NCT00162734|Antiviral Agents|antiviral agents|mesh-ancestor
6382451|NCT00162734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6382452|NCT00162734|Antimetabolites|antimetabolites|mesh-ancestor
6382453|NCT00162734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382454|NCT00162760|Thalidomide|thalidomide|mesh-list
6382455|NCT00162760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6382456|NCT00162760|Immunologic Factors|immunologic factors|mesh-ancestor
6382457|NCT00162760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382458|NCT00162760|Leprostatic Agents|leprostatic agents|mesh-ancestor
6382459|NCT00162760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6382460|NCT00162760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6382461|NCT00162760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6382462|NCT00162760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6382463|NCT00162760|Growth Substances|growth substances|mesh-ancestor
6382464|NCT00162760|Growth Inhibitors|growth inhibitors|mesh-ancestor
6382465|NCT00162760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6382466|NCT00162786|Hydroxyzine|hydroxyzine|mesh-list
6382467|NCT00162786|Antipruritics|antipruritics|mesh-ancestor
6382468|NCT00162786|Dermatologic Agents|dermatologic agents|mesh-ancestor
6382469|NCT00162786|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6382470|NCT00162786|Histamine Antagonists|histamine antagonists|mesh-ancestor
6382471|NCT00162786|Histamine Agents|histamine agents|mesh-ancestor
6382472|NCT00162786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6382473|NCT00162786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382474|NCT00162786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382475|NCT00162799|Triflusal|triflusal|mesh-list
6382476|NCT00162799|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6382477|NCT00162812|Epirubicin|epirubicin|mesh-list
6382478|NCT00162812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6382479|NCT00162812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6382480|NCT00162812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6382481|NCT00162812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6382482|NCT00162812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6382483|NCT00162812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382484|NCT00162851|Alemtuzumab|alemtuzumab|mesh-list
6382485|NCT00162851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6382486|NCT00162851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6382487|NCT00162864|Montelukast|montelukast|mesh-list
6382488|NCT00162864|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6382489|NCT00162864|Respiratory System Agents|respiratory system agents|mesh-ancestor
6382490|NCT00162864|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6382491|NCT00162864|Hormone Antagonists|hormone antagonists|mesh-ancestor
6382492|NCT00162864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6382493|NCT00162864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382494|NCT00162864|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6382495|NCT00162864|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6382496|NCT00162864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382497|NCT00162877|Esomeprazole|esomeprazole|mesh-list
6382498|NCT00162877|Rabeprazole|rabeprazole|mesh-list
6382499|NCT00162877|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6382500|NCT00162877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6382501|NCT00162877|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6382502|NCT00162877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6382503|NCT00162877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382504|NCT00162916|Citalopram|citalopram|mesh-list
6382505|NCT00162916|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6382506|NCT00162916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6382507|NCT00162916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6382508|NCT00162916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382509|NCT00162916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6382510|NCT00162916|Serotonin Agents|serotonin agents|mesh-ancestor
6382511|NCT00162916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382512|NCT00162916|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6382513|NCT00162916|Antidepressive Agents|antidepressive agents|mesh-ancestor
6382514|NCT00162916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6382515|NCT00162955|Valsartan|valsartan|mesh-list
6382516|NCT00162955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6382517|NCT00162955|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6382518|NCT00162955|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6382519|NCT00162955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382520|NCT00162968|Citalopram|citalopram|mesh-list
6382521|NCT00162968|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6382522|NCT00162968|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6382523|NCT00162968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6382524|NCT00162968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382525|NCT00162968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6382526|NCT00162968|Serotonin Agents|serotonin agents|mesh-ancestor
6382527|NCT00162968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382528|NCT00162968|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6382529|NCT00162968|Antidepressive Agents|antidepressive agents|mesh-ancestor
6382530|NCT00162968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6382531|NCT00163046|Gabapentin|gabapentin|mesh-list
6382532|NCT00163046|Analgesics|analgesics|mesh-ancestor
6382533|NCT00163046|Sensory System Agents|sensory system agents|mesh-ancestor
6382534|NCT00163046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6382535|NCT00163046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382536|NCT00163046|Anticonvulsants|anticonvulsants|mesh-ancestor
6382537|NCT00163046|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6382538|NCT00163046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6382539|NCT00163046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6382540|NCT00163046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6382541|NCT00163046|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6382542|NCT00163046|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6382543|NCT00163046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6382544|NCT00163046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382545|NCT00163046|Antimanic Agents|antimanic agents|mesh-ancestor
6382546|NCT00163072|Megestrol Acetate|megestrol acetate|mesh-list
6382547|NCT00163072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6382548|NCT00163072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6382549|NCT00163072|Appetite Stimulants|appetite stimulants|mesh-ancestor
6382550|NCT00163072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6382551|NCT00163072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382552|NCT00163111|Amphotericin B|amphotericin b|mesh-list
6382553|NCT00163111|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6382554|NCT00163111|Fluconazole|fluconazole|mesh-list
6382555|NCT00163111|Amebicides|amebicides|mesh-ancestor
6382556|NCT00163111|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6382557|NCT00163111|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6382558|NCT00163111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6382559|NCT00163111|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6382560|NCT00163111|Antifungal Agents|antifungal agents|mesh-ancestor
6382561|NCT00163111|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6382562|NCT00163111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6382563|NCT00163111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6382564|NCT00163111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382565|NCT00163111|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6382566|NCT00163111|Hormone Antagonists|hormone antagonists|mesh-ancestor
6382567|NCT00163111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6382568|NCT00163111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382569|NCT00163111|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6382570|NCT00163111|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6382571|NCT00163137|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
6382572|NCT00163137|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6382573|NCT00163137|Hormone Antagonists|hormone antagonists|mesh-ancestor
6382574|NCT00163137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6382575|NCT00163137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382576|NCT00163137|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6382577|NCT00163137|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6382578|NCT00163137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6382579|NCT00163150|Atorvastatin|atorvastatin|mesh-list
6382580|NCT00163150|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6382581|NCT00163150|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6382582|NCT00163150|Antimetabolites|antimetabolites|mesh-ancestor
6382583|NCT00163150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382584|NCT00163150|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6382585|NCT00163150|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6382586|NCT00163150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6382587|NCT00163202|Atorvastatin|atorvastatin|mesh-list
6382588|NCT00163202|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6382589|NCT00163202|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6382590|NCT00163202|Antimetabolites|antimetabolites|mesh-ancestor
6382591|NCT00163202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382592|NCT00163202|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6382593|NCT00163202|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6382594|NCT00163202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6382595|NCT00163241|Celecoxib|celecoxib|mesh-list
6382596|NCT00163241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6382597|NCT00163241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6382598|NCT00163241|Analgesics|analgesics|mesh-ancestor
6382599|NCT00163241|Sensory System Agents|sensory system agents|mesh-ancestor
6382600|NCT00163241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6382601|NCT00163241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382602|NCT00163241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6382603|NCT00163241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6382604|NCT00163241|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6382605|NCT00163241|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6382606|NCT00163241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6382607|NCT00163241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382608|NCT00163254|Abciximab|abciximab|mesh-list
6382609|NCT00163254|Anticoagulants|anticoagulants|mesh-ancestor
6382610|NCT00163254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6382611|NCT00163267|Clopidogrel|clopidogrel|mesh-list
6382612|NCT00163267|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6382613|NCT00163267|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6382614|NCT00163267|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6382615|NCT00163267|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6382616|NCT00163267|Purinergic Agents|purinergic agents|mesh-ancestor
6382617|NCT00163267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6382618|NCT00163267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382619|NCT00163267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382620|NCT00163306|Pantoprazole|pantoprazole|mesh-list
6382621|NCT00163306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6382622|NCT00163306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6382623|NCT00163306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6382624|NCT00163306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6382625|NCT00163306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382626|NCT00163319|Ciclesonide|ciclesonide|mesh-list
6382627|NCT00163319|Glucocorticoids|glucocorticoids|mesh-ancestor
6382628|NCT00163319|Hormones|hormones|mesh-ancestor
6382629|NCT00163319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6382630|NCT00163319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382631|NCT00163319|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6382632|NCT00163332|Ciclesonide|ciclesonide|mesh-list
6382633|NCT00163332|Glucocorticoids|glucocorticoids|mesh-ancestor
6382634|NCT00163332|Hormones|hormones|mesh-ancestor
6382635|NCT00163332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6382636|NCT00163332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382637|NCT00163332|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6382638|NCT00163345|Ciclesonide|ciclesonide|mesh-list
6382639|NCT00163345|Glucocorticoids|glucocorticoids|mesh-ancestor
6382640|NCT00163345|Hormones|hormones|mesh-ancestor
6382641|NCT00163345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6382642|NCT00163345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382643|NCT00163345|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6382644|NCT00163358|Ciclesonide|ciclesonide|mesh-list
6382645|NCT00163358|Glucocorticoids|glucocorticoids|mesh-ancestor
6382646|NCT00163358|Hormones|hormones|mesh-ancestor
6382647|NCT00163358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6382648|NCT00163358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382649|NCT00163358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6382650|NCT00163371|Ciclesonide|ciclesonide|mesh-list
6382651|NCT00163371|Glucocorticoids|glucocorticoids|mesh-ancestor
6382652|NCT00163371|Hormones|hormones|mesh-ancestor
6382653|NCT00163371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6382654|NCT00163371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382655|NCT00163371|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6382656|NCT00163384|Ciclesonide|ciclesonide|mesh-list
6382657|NCT00163384|Glucocorticoids|glucocorticoids|mesh-ancestor
6382658|NCT00163384|Hormones|hormones|mesh-ancestor
6382659|NCT00163384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6382660|NCT00163384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382661|NCT00163384|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6382662|NCT00163397|Ciclesonide|ciclesonide|mesh-list
6382663|NCT00163397|Glucocorticoids|glucocorticoids|mesh-ancestor
6382664|NCT00163397|Hormones|hormones|mesh-ancestor
6382665|NCT00163397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6382666|NCT00163397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382667|NCT00163397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6382668|NCT00163410|Ciclesonide|ciclesonide|mesh-list
6382669|NCT00163410|Glucocorticoids|glucocorticoids|mesh-ancestor
6382670|NCT00163410|Hormones|hormones|mesh-ancestor
6382671|NCT00163410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6382672|NCT00163410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382673|NCT00163410|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6382674|NCT00163423|Ciclesonide|ciclesonide|mesh-list
6382675|NCT00163423|Glucocorticoids|glucocorticoids|mesh-ancestor
6382676|NCT00163423|Hormones|hormones|mesh-ancestor
6382677|NCT00163423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6382678|NCT00163423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382679|NCT00163423|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6382680|NCT00163436|Ciclesonide|ciclesonide|mesh-list
6382681|NCT00163436|Glucocorticoids|glucocorticoids|mesh-ancestor
6382682|NCT00163436|Hormones|hormones|mesh-ancestor
6382683|NCT00163436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6382684|NCT00163436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382685|NCT00163436|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6382686|NCT00163449|Ciclesonide|ciclesonide|mesh-list
6382687|NCT00163449|Glucocorticoids|glucocorticoids|mesh-ancestor
6382688|NCT00163449|Hormones|hormones|mesh-ancestor
6382689|NCT00163449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6382690|NCT00163449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382691|NCT00163449|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6382692|NCT00163462|Ciclesonide|ciclesonide|mesh-list
6382693|NCT00163462|Glucocorticoids|glucocorticoids|mesh-ancestor
6382694|NCT00163462|Hormones|hormones|mesh-ancestor
6382695|NCT00163462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6382696|NCT00163462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382697|NCT00163462|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6382698|NCT00163488|Ciclesonide|ciclesonide|mesh-list
6382699|NCT00163488|Glucocorticoids|glucocorticoids|mesh-ancestor
6382700|NCT00163488|Hormones|hormones|mesh-ancestor
6382701|NCT00163488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6382702|NCT00163488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382703|NCT00163488|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6396316|NCT00208442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396317|NCT00208442|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6396318|NCT00208442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6396319|NCT00208442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397042|NCT00210002|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6397043|NCT00210002|Hematinics|hematinics|mesh-ancestor
6397044|NCT00210028|Tamoxifen|tamoxifen|mesh-list
6397045|NCT00210028|Tipifarnib|tipifarnib|mesh-list
6397046|NCT00210028|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6397047|NCT00210028|Hormone Antagonists|hormone antagonists|mesh-ancestor
6397048|NCT00210028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6397049|NCT00210028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397050|NCT00210028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6397051|NCT00210028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6397052|NCT00210028|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6397053|NCT00210028|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6397054|NCT00210028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6397055|NCT00210041|Gemcitabine|gemcitabine|mesh-list
6397056|NCT00210041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6397057|NCT00210041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6397058|NCT00210041|Antimetabolites|antimetabolites|mesh-ancestor
6397059|NCT00210041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397060|NCT00210041|Antiviral Agents|antiviral agents|mesh-ancestor
6397061|NCT00210041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6397062|NCT00210041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6397063|NCT00210041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6397064|NCT00210041|Immunologic Factors|immunologic factors|mesh-ancestor
6397065|NCT00210041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397066|NCT00210132|Ropivacaine|ropivacaine|mesh-list
6397067|NCT00210132|Anesthetics, Local|anesthetics, local|mesh-ancestor
6397068|NCT00210132|Anesthetics|anesthetics|mesh-ancestor
6397069|NCT00210132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6397070|NCT00210132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397071|NCT00210132|Sensory System Agents|sensory system agents|mesh-ancestor
6397072|NCT00210132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6397073|NCT00210158|Nitrous Oxide|nitrous oxide|mesh-list
6397074|NCT00210158|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6397075|NCT00210158|Anesthetics, General|anesthetics, general|mesh-ancestor
6397076|NCT00210158|Anesthetics|anesthetics|mesh-ancestor
6397077|NCT00210158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6397078|NCT00210158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397079|NCT00210158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6397080|NCT00210158|Analgesics|analgesics|mesh-ancestor
6397081|NCT00210158|Sensory System Agents|sensory system agents|mesh-ancestor
6397082|NCT00210158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6397083|NCT00210210|Ketamine|ketamine|mesh-list
6397084|NCT00210210|Analgesics|analgesics|mesh-ancestor
6397085|NCT00210210|Sensory System Agents|sensory system agents|mesh-ancestor
6397086|NCT00210210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6382704|NCT00163501|Ciclesonide|ciclesonide|mesh-list
6382705|NCT00163501|Glucocorticoids|glucocorticoids|mesh-ancestor
6382706|NCT00163501|Hormones|hormones|mesh-ancestor
6382707|NCT00163501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6382708|NCT00163501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382709|NCT00163501|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6382710|NCT00163514|Ciclesonide|ciclesonide|mesh-list
6382711|NCT00163514|Glucocorticoids|glucocorticoids|mesh-ancestor
6382712|NCT00163514|Hormones|hormones|mesh-ancestor
6382713|NCT00163514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6382714|NCT00163514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382715|NCT00163514|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6382716|NCT00163540|Formaldehyde|formaldehyde|mesh-list
6382717|NCT00163540|Disinfectants|disinfectants|mesh-ancestor
6382718|NCT00163540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6382719|NCT00163553|Meperidine|meperidine|mesh-list
6382720|NCT00163553|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6382721|NCT00163553|Narcotics|narcotics|mesh-ancestor
6382722|NCT00163553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6382723|NCT00163553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382724|NCT00163553|Analgesics|analgesics|mesh-ancestor
6382725|NCT00163553|Sensory System Agents|sensory system agents|mesh-ancestor
6382726|NCT00163553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6382727|NCT00163553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6382728|NCT00163566|Dihydrotestosterone|dihydrotestosterone|mesh-list
6382729|NCT00163566|Androgens|androgens|mesh-ancestor
6382730|NCT00163566|Hormones|hormones|mesh-ancestor
6382731|NCT00163566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6382732|NCT00163566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382733|NCT00163592|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6382734|NCT00163592|Hemostatics|hemostatics|mesh-ancestor
6382735|NCT00163592|Coagulants|coagulants|mesh-ancestor
6382736|NCT00163605|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6382737|NCT00163605|Thrombin|thrombin|mesh-list
6382738|NCT00163605|Calcium|calcium|mesh-list
6382739|NCT00163605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6382740|NCT00163605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382741|NCT00163605|Hemostatics|hemostatics|mesh-ancestor
6382742|NCT00163605|Coagulants|coagulants|mesh-ancestor
6382743|NCT00163618|Formaldehyde|formaldehyde|mesh-list
6382744|NCT00163618|Disinfectants|disinfectants|mesh-ancestor
6382745|NCT00163618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6382746|NCT00163748|Gemcitabine|gemcitabine|mesh-list
6382747|NCT00163748|Vinorelbine|vinorelbine|mesh-list
6382748|NCT00163748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6382749|NCT00163748|Antimetabolites|antimetabolites|mesh-ancestor
6382750|NCT00163748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382751|NCT00163748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6382752|NCT00163748|Antiviral Agents|antiviral agents|mesh-ancestor
6382753|NCT00163748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6382754|NCT00163748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6382755|NCT00163748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6382756|NCT00163748|Immunologic Factors|immunologic factors|mesh-ancestor
6382757|NCT00163748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382758|NCT00163748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6382759|NCT00163748|Tubulin Modulators|tubulin modulators|mesh-ancestor
6382760|NCT00163748|Antimitotic Agents|antimitotic agents|mesh-ancestor
6382761|NCT00163748|Mitosis Modulators|mitosis modulators|mesh-ancestor
6382762|NCT00163761|Gemcitabine|gemcitabine|mesh-list
6382763|NCT00163761|Vinorelbine|vinorelbine|mesh-list
6382764|NCT00163761|Ifosfamide|ifosfamide|mesh-list
6382765|NCT00163761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6382766|NCT00163761|Antimetabolites|antimetabolites|mesh-ancestor
6382767|NCT00163761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382768|NCT00163761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6382769|NCT00163761|Antiviral Agents|antiviral agents|mesh-ancestor
6382770|NCT00163761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6382771|NCT00163761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6382772|NCT00163761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6382773|NCT00163761|Immunologic Factors|immunologic factors|mesh-ancestor
6396320|NCT00208520|Lamotrigine|lamotrigine|mesh-list
6382774|NCT00163761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382775|NCT00163761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6382776|NCT00163761|Tubulin Modulators|tubulin modulators|mesh-ancestor
6382777|NCT00163761|Antimitotic Agents|antimitotic agents|mesh-ancestor
6382778|NCT00163761|Mitosis Modulators|mitosis modulators|mesh-ancestor
6382779|NCT00163761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6382780|NCT00163761|Alkylating Agents|alkylating agents|mesh-ancestor
6382781|NCT00163969|Ketamine|ketamine|mesh-list
6382782|NCT00163969|Analgesics|analgesics|mesh-ancestor
6382783|NCT00163969|Sensory System Agents|sensory system agents|mesh-ancestor
6382784|NCT00163969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6382785|NCT00163969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382786|NCT00163969|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6382787|NCT00163969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6382788|NCT00163969|Anesthetics, General|anesthetics, general|mesh-ancestor
6382789|NCT00163969|Anesthetics|anesthetics|mesh-ancestor
6382790|NCT00163969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6382791|NCT00163969|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6382792|NCT00163969|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6382793|NCT00163969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6382794|NCT00163969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382795|NCT00163982|Norfloxacin|norfloxacin|mesh-list
6382796|NCT00163982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6382797|NCT00163982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6382798|NCT00163982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6382799|NCT00163982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6382800|NCT00163982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6382801|NCT00163982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382802|NCT00163982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6382803|NCT00163982|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6382804|NCT00163982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6382805|NCT00164008|Zoledronic Acid|zoledronic acid|mesh-list
6382806|NCT00164008|Pamidronate|pamidronate|mesh-list
6382807|NCT00164008|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6382808|NCT00164008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382809|NCT00164047|Nitrous Oxide|nitrous oxide|mesh-list
6382810|NCT00164047|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6382811|NCT00164047|Anesthetics, General|anesthetics, general|mesh-ancestor
6382812|NCT00164047|Anesthetics|anesthetics|mesh-ancestor
6382813|NCT00164047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6382814|NCT00164047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382815|NCT00164047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6382816|NCT00164047|Analgesics|analgesics|mesh-ancestor
6382817|NCT00164047|Sensory System Agents|sensory system agents|mesh-ancestor
6382818|NCT00164047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6382819|NCT00164086|Atorvastatin|atorvastatin|mesh-list
6382820|NCT00164086|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6382821|NCT00164086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6382822|NCT00164086|Antimetabolites|antimetabolites|mesh-ancestor
6382823|NCT00164086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382824|NCT00164086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6382825|NCT00164086|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6382826|NCT00164086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6382827|NCT00164112|Azithromycin|azithromycin|mesh-list
6382828|NCT00164112|Levofloxacin|levofloxacin|mesh-list
6382829|NCT00164112|Ofloxacin|ofloxacin|mesh-list
6382830|NCT00164112|Telithromycin|telithromycin|mesh-list
6382831|NCT00164112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6382832|NCT00164112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6382833|NCT00164112|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6382834|NCT00164112|Renal Agents|renal agents|mesh-ancestor
6382835|NCT00164112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6382836|NCT00164112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6382837|NCT00164112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6382838|NCT00164112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382839|NCT00164112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6382840|NCT00164112|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6382841|NCT00164112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6382842|NCT00164125|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
6382843|NCT00164125|Laxatives|laxatives|mesh-ancestor
6382844|NCT00164125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6382845|NCT00164164|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
6382846|NCT00164164|Laxatives|laxatives|mesh-ancestor
6382847|NCT00164164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6382848|NCT00164216|Artesunate|artesunate|mesh-list
6382849|NCT00164216|Mefloquine|mefloquine|mesh-list
6382850|NCT00164216|Antimalarials|antimalarials|mesh-ancestor
6382851|NCT00164216|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6382852|NCT00164216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6382853|NCT00164216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6382854|NCT00164216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6382855|NCT00164216|Antiviral Agents|antiviral agents|mesh-ancestor
6382856|NCT00164216|Schistosomicides|schistosomicides|mesh-ancestor
6382857|NCT00164216|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6382858|NCT00164216|Anthelmintics|anthelmintics|mesh-ancestor
6382859|NCT00164242|Galantamine|galantamine|mesh-list
6382860|NCT00164242|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6382861|NCT00164242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6382862|NCT00164242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382863|NCT00164242|Cholinergic Agents|cholinergic agents|mesh-ancestor
6382864|NCT00164242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6382865|NCT00164242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382866|NCT00164242|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6382867|NCT00164242|Autonomic Agents|autonomic agents|mesh-ancestor
6382868|NCT00164242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6382869|NCT00164242|Nootropic Agents|nootropic agents|mesh-ancestor
6382870|NCT00164255|Artesunate|artesunate|mesh-list
6382871|NCT00164255|Pyrimethamine|pyrimethamine|mesh-list
6382872|NCT00164255|Sulfadoxine|sulfadoxine|mesh-list
6382873|NCT00164255|Antimalarials|antimalarials|mesh-ancestor
6382874|NCT00164255|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6382875|NCT00164255|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6382876|NCT00164255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6382877|NCT00164255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6382878|NCT00164255|Antiviral Agents|antiviral agents|mesh-ancestor
6382879|NCT00164255|Schistosomicides|schistosomicides|mesh-ancestor
6382880|NCT00164255|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6382881|NCT00164255|Anthelmintics|anthelmintics|mesh-ancestor
6382882|NCT00164255|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6382883|NCT00164255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6382884|NCT00164255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382885|NCT00164255|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6382886|NCT00164255|Renal Agents|renal agents|mesh-ancestor
6382887|NCT00164281|Isoniazid|isoniazid|mesh-list
6382888|NCT00164281|Antitubercular Agents|antitubercular agents|mesh-ancestor
6382889|NCT00164281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6382890|NCT00164281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6382891|NCT00164281|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6382892|NCT00164281|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6382893|NCT00164281|Antimetabolites|antimetabolites|mesh-ancestor
6382894|NCT00164281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382895|NCT00164281|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6382896|NCT00164359|Artesunate|artesunate|mesh-list
6382897|NCT00164359|Amodiaquine|amodiaquine|mesh-list
6382898|NCT00164359|Dapsone|dapsone|mesh-list
6382899|NCT00164359|Chlorproguanil|chlorproguanil|mesh-list
6382900|NCT00164359|Antimalarials|antimalarials|mesh-ancestor
6382901|NCT00164359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6382902|NCT00164359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6382903|NCT00164359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6382904|NCT00164359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6382905|NCT00164359|Antiviral Agents|antiviral agents|mesh-ancestor
6382906|NCT00164359|Schistosomicides|schistosomicides|mesh-ancestor
6382907|NCT00164359|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6382908|NCT00164359|Anthelmintics|anthelmintics|mesh-ancestor
6382909|NCT00164359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6382910|NCT00164359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6382911|NCT00164359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382912|NCT00164359|Leprostatic Agents|leprostatic agents|mesh-ancestor
6382913|NCT00164359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6382914|NCT00164411|Vaccines|vaccines|mesh-list
6382915|NCT00164411|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6382916|NCT00164411|Immunologic Factors|immunologic factors|mesh-ancestor
6382917|NCT00164411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6382918|NCT00164424|Acyclovir|acyclovir|mesh-list
6382919|NCT00164424|Antiviral Agents|antiviral agents|mesh-ancestor
6382920|NCT00164424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6382921|NCT00164450|Isoniazid|isoniazid|mesh-list
6382922|NCT00164450|Rifapentine|rifapentine|mesh-list
6382923|NCT00164450|Antitubercular Agents|antitubercular agents|mesh-ancestor
6382924|NCT00164450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6382925|NCT00164450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6382926|NCT00164450|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6382927|NCT00164450|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6382928|NCT00164450|Antimetabolites|antimetabolites|mesh-ancestor
6382929|NCT00164450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382930|NCT00164450|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6382931|NCT00164450|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6382932|NCT00164450|Leprostatic Agents|leprostatic agents|mesh-ancestor
6382933|NCT00164463|Moxifloxacin|moxifloxacin|mesh-list
5724669|NCT03185611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6382934|NCT00164463|Isoniazid|isoniazid|mesh-list
6382935|NCT00164463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6382936|NCT00164463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6382937|NCT00164463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6382938|NCT00164463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6382939|NCT00164463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6382940|NCT00164463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382941|NCT00164463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6382942|NCT00164463|Antitubercular Agents|antitubercular agents|mesh-ancestor
6382943|NCT00164463|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6382944|NCT00164463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6382945|NCT00164463|Antimetabolites|antimetabolites|mesh-ancestor
6382946|NCT00164463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6382947|NCT00164710|Artesunate|artesunate|mesh-list
6382948|NCT00164710|Lumefantrine|lumefantrine|mesh-list
6382949|NCT00164710|Artemether|artemether|mesh-list
6382950|NCT00164710|Pyrimethamine|pyrimethamine|mesh-list
6382951|NCT00164710|Sulfadoxine|sulfadoxine|mesh-list
6382952|NCT00164710|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6382953|NCT00164710|Amodiaquine|amodiaquine|mesh-list
6382954|NCT00164710|Dapsone|dapsone|mesh-list
6382955|NCT00164710|Chlorproguanil|chlorproguanil|mesh-list
6382956|NCT00164710|Antimalarials|antimalarials|mesh-ancestor
6382957|NCT00164710|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6382958|NCT00164710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6382959|NCT00164710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6382960|NCT00164710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6382961|NCT00164710|Antiviral Agents|antiviral agents|mesh-ancestor
6382962|NCT00164710|Schistosomicides|schistosomicides|mesh-ancestor
6382963|NCT00164710|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6382964|NCT00164710|Anthelmintics|anthelmintics|mesh-ancestor
6382965|NCT00164710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6382966|NCT00164710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6382967|NCT00164710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382968|NCT00164710|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6382969|NCT00164710|Renal Agents|renal agents|mesh-ancestor
6382970|NCT00164710|Leprostatic Agents|leprostatic agents|mesh-ancestor
6382971|NCT00164710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6382972|NCT00164736|Ritonavir|ritonavir|mesh-list
6382973|NCT00164736|Lopinavir|lopinavir|mesh-list
6382974|NCT00164736|Lamivudine|lamivudine|mesh-list
6382975|NCT00164736|Zidovudine|zidovudine|mesh-list
6382976|NCT00164736|Nevirapine|nevirapine|mesh-list
6382977|NCT00164736|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6382978|NCT00164736|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6382979|NCT00164736|Protease Inhibitors|protease inhibitors|mesh-ancestor
6382980|NCT00164736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6382981|NCT00164736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6382982|NCT00164736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6382983|NCT00164736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6382984|NCT00164736|Antiviral Agents|antiviral agents|mesh-ancestor
6382985|NCT00164736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6382986|NCT00164736|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6382987|NCT00164736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6382988|NCT00164736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6382989|NCT00164736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6382990|NCT00164736|Antimetabolites|antimetabolites|mesh-ancestor
6382991|NCT00164736|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6382992|NCT00164736|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6382993|NCT00164749|Curcumin|curcumin|mesh-list
6382994|NCT00164749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6382995|NCT00164749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6382996|NCT00164749|Analgesics|analgesics|mesh-ancestor
6382997|NCT00164749|Sensory System Agents|sensory system agents|mesh-ancestor
6382998|NCT00164749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6382999|NCT00164749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383000|NCT00164749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6383001|NCT00164749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6383002|NCT00164749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6383003|NCT00164749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6383004|NCT00164749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383005|NCT00164775|Imipramine|imipramine|mesh-list
6383006|NCT00164775|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6383007|NCT00164775|Antidepressive Agents|antidepressive agents|mesh-ancestor
6383008|NCT00164775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6383009|NCT00164775|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6383010|NCT00164775|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6383011|NCT00164775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6383012|NCT00164775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383013|NCT00164775|Adrenergic Agents|adrenergic agents|mesh-ancestor
6383014|NCT00164775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6383015|NCT00164775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383016|NCT00164788|Esomeprazole|esomeprazole|mesh-list
6383017|NCT00164788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6383018|NCT00164788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6383019|NCT00164788|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6383020|NCT00164788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6383021|NCT00164788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383022|NCT00164801|Diltiazem|diltiazem|mesh-list
6383023|NCT00164801|Baclofen|baclofen|mesh-list
6383024|NCT00164801|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6383025|NCT00164801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383026|NCT00164801|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6383027|NCT00164801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6383028|NCT00164801|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6383029|NCT00164801|GABA Agonists|gaba agonists|mesh-ancestor
6383030|NCT00164801|GABA Agents|gaba agents|mesh-ancestor
6383031|NCT00164801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6383032|NCT00164801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383033|NCT00164801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6383034|NCT00164801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6383035|NCT00164801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6383036|NCT00164801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6383037|NCT00164801|Vasodilator Agents|vasodilator agents|mesh-ancestor
6396321|NCT00208520|Carbamazepine|carbamazepine|mesh-list
6396322|NCT00208520|Levetiracetam|levetiracetam|mesh-list
6396323|NCT00208520|Anticonvulsants|anticonvulsants|mesh-ancestor
6396324|NCT00208520|Nootropic Agents|nootropic agents|mesh-ancestor
6396325|NCT00208520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6396326|NCT00208520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6396327|NCT00208520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396328|NCT00208520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6396329|NCT00208520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396330|NCT00208520|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6396331|NCT00208520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6396332|NCT00208520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6396333|NCT00208520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6396334|NCT00208520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6396335|NCT00208520|Antimanic Agents|antimanic agents|mesh-ancestor
6396336|NCT00208520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6396337|NCT00208520|Analgesics|analgesics|mesh-ancestor
6396338|NCT00208520|Sensory System Agents|sensory system agents|mesh-ancestor
6396339|NCT00208520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6396340|NCT00208520|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6396341|NCT00208520|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6396342|NCT00208533|Aripiprazole|aripiprazole|mesh-list
6396343|NCT00208533|Antidepressive Agents|antidepressive agents|mesh-ancestor
6396344|NCT00208533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6396345|NCT00208533|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6396346|NCT00208533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6396347|NCT00208533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6396348|NCT00208533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396349|NCT00208533|Dopamine Agonists|dopamine agonists|mesh-ancestor
6396350|NCT00208533|Dopamine Agents|dopamine agents|mesh-ancestor
6396351|NCT00208533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6396352|NCT00208533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396353|NCT00208533|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6396354|NCT00208533|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6396355|NCT00208533|Serotonin Agents|serotonin agents|mesh-ancestor
6396356|NCT00208533|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6396357|NCT00208533|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6396358|NCT00208533|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6396359|NCT00208533|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6396360|NCT00208546|Bevacizumab|bevacizumab|mesh-list
6396361|NCT00208546|Cetuximab|cetuximab|mesh-list
6396362|NCT00208546|Capecitabine|capecitabine|mesh-list
6383038|NCT00164840|Esomeprazole|esomeprazole|mesh-list
6383039|NCT00164840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6383040|NCT00164840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6383041|NCT00164840|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6383042|NCT00164840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6383043|NCT00164840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383044|NCT00164866|Omeprazole|omeprazole|mesh-list
6383045|NCT00164866|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6383046|NCT00164866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6383047|NCT00164866|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6383048|NCT00164866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6383049|NCT00164866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383050|NCT00164892|Rofecoxib|rofecoxib|mesh-list
6383051|NCT00164892|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6383052|NCT00164892|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6383053|NCT00164892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6383054|NCT00164892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383055|NCT00164892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6383056|NCT00164892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6383057|NCT00164892|Analgesics|analgesics|mesh-ancestor
6383058|NCT00164892|Sensory System Agents|sensory system agents|mesh-ancestor
6383059|NCT00164892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6383060|NCT00164892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383061|NCT00164892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6383062|NCT00164892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6383063|NCT00164931|Omeprazole|omeprazole|mesh-list
6383064|NCT00164931|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6383065|NCT00164931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6383066|NCT00164931|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6383067|NCT00164931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6383068|NCT00164931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383069|NCT00164970|Vitamin B 12|vitamin b 12|mesh-list
6383070|NCT00164970|Hydroxocobalamin|hydroxocobalamin|mesh-list
6383071|NCT00164970|Vitamins|vitamins|mesh-ancestor
6383072|NCT00164970|Micronutrients|micronutrients|mesh-ancestor
6383073|NCT00164970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383074|NCT00164970|Vitamin B Complex|vitamin b complex|mesh-ancestor
6383075|NCT00164970|Hematinics|hematinics|mesh-ancestor
6383076|NCT00164996|Anesthetics|anesthetics|mesh-list
6383077|NCT00164996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6383078|NCT00164996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383079|NCT00165035|Paclitaxel|paclitaxel|mesh-list
6383080|NCT00165035|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6383081|NCT00165035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6383082|NCT00165035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6383083|NCT00165035|Tubulin Modulators|tubulin modulators|mesh-ancestor
6383084|NCT00165035|Antimitotic Agents|antimitotic agents|mesh-ancestor
6383085|NCT00165035|Mitosis Modulators|mitosis modulators|mesh-ancestor
6383086|NCT00165035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383087|NCT00165048|Rofecoxib|rofecoxib|mesh-list
6383088|NCT00165048|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6383089|NCT00165048|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6383090|NCT00165048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6383091|NCT00165048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383092|NCT00165048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6383093|NCT00165048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6383094|NCT00165048|Analgesics|analgesics|mesh-ancestor
6383095|NCT00165048|Sensory System Agents|sensory system agents|mesh-ancestor
6383096|NCT00165048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6383097|NCT00165048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383098|NCT00165048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6383099|NCT00165048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6383100|NCT00165074|Calfactant|calfactant|mesh-list
6383101|NCT00165074|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
6383102|NCT00165074|Respiratory System Agents|respiratory system agents|mesh-ancestor
6383103|NCT00165087|Doxorubicin|doxorubicin|mesh-list
6383104|NCT00165087|Dexrazoxane|dexrazoxane|mesh-list
6383105|NCT00165087|Asparaginase|asparaginase|mesh-list
6383106|NCT00165087|Razoxane|razoxane|mesh-list
6383107|NCT00165087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6383108|NCT00165087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6383109|NCT00165087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6383110|NCT00165087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6383111|NCT00165087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6383112|NCT00165087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383113|NCT00165087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6383114|NCT00165087|Protective Agents|protective agents|mesh-ancestor
6383115|NCT00165087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383116|NCT00165087|Antimitotic Agents|antimitotic agents|mesh-ancestor
6383117|NCT00165087|Mitosis Modulators|mitosis modulators|mesh-ancestor
6383118|NCT00165139|Cyclophosphamide|cyclophosphamide|mesh-list
6383119|NCT00165139|Melphalan|melphalan|mesh-list
6383120|NCT00165139|Ifosfamide|ifosfamide|mesh-list
6383121|NCT00165139|Carboplatin|carboplatin|mesh-list
6383122|NCT00165139|Etoposide|etoposide|mesh-list
6383123|NCT00165139|Vincristine|vincristine|mesh-list
6383124|NCT00165139|Doxorubicin|doxorubicin|mesh-list
6383125|NCT00165139|Sargramostim|sargramostim|mesh-list
6383126|NCT00165139|Lenograstim|lenograstim|mesh-list
6383127|NCT00165139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6383128|NCT00165139|Immunologic Factors|immunologic factors|mesh-ancestor
6383129|NCT00165139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383130|NCT00165139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6383131|NCT00165139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6383132|NCT00165139|Alkylating Agents|alkylating agents|mesh-ancestor
6383133|NCT00165139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383134|NCT00165139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6383135|NCT00165139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6383136|NCT00165139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6383137|NCT00165139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6383138|NCT00165139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6383139|NCT00165139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6383140|NCT00165139|Tubulin Modulators|tubulin modulators|mesh-ancestor
6383141|NCT00165139|Antimitotic Agents|antimitotic agents|mesh-ancestor
6383142|NCT00165139|Mitosis Modulators|mitosis modulators|mesh-ancestor
6383143|NCT00165139|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6383144|NCT00165139|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6383145|NCT00165178|Leucovorin|leucovorin|mesh-list
6383146|NCT00165178|Cytarabine|cytarabine|mesh-list
6383147|NCT00165178|Dexamethasone|dexamethasone|mesh-list
6383148|NCT00165178|Prednisone|prednisone|mesh-list
6383149|NCT00165178|Hydrocortisone|hydrocortisone|mesh-list
6383150|NCT00165178|Doxorubicin|doxorubicin|mesh-list
6383151|NCT00165178|Methotrexate|methotrexate|mesh-list
6383152|NCT00165178|Vincristine|vincristine|mesh-list
6383153|NCT00165178|Asparaginase|asparaginase|mesh-list
6383154|NCT00165178|Dexrazoxane|dexrazoxane|mesh-list
6383155|NCT00165178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6383156|NCT00165178|Antiemetics|antiemetics|mesh-ancestor
6383157|NCT00165178|Autonomic Agents|autonomic agents|mesh-ancestor
6383158|NCT00165178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6383159|NCT00165178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383160|NCT00165178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6383161|NCT00165178|Glucocorticoids|glucocorticoids|mesh-ancestor
6383162|NCT00165178|Hormones|hormones|mesh-ancestor
6383163|NCT00165178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6383164|NCT00165178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6383165|NCT00165178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6383166|NCT00165178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6383167|NCT00165178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6383168|NCT00165178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6383169|NCT00165178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6383170|NCT00165178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383171|NCT00165178|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6383172|NCT00165178|Abortifacient Agents|abortifacient agents|mesh-ancestor
6383173|NCT00165178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6383174|NCT00165178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6383175|NCT00165178|Antimetabolites|antimetabolites|mesh-ancestor
6383176|NCT00165178|Dermatologic Agents|dermatologic agents|mesh-ancestor
6383177|NCT00165178|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6383178|NCT00165178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6383179|NCT00165178|Immunologic Factors|immunologic factors|mesh-ancestor
6383180|NCT00165178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6383181|NCT00165178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6383182|NCT00165178|Antiviral Agents|antiviral agents|mesh-ancestor
6383183|NCT00165178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6383184|NCT00165178|Antidotes|antidotes|mesh-ancestor
6383185|NCT00165178|Protective Agents|protective agents|mesh-ancestor
6383186|NCT00165178|Vitamin B Complex|vitamin b complex|mesh-ancestor
6383187|NCT00165178|Vitamins|vitamins|mesh-ancestor
6383188|NCT00165178|Micronutrients|micronutrients|mesh-ancestor
6383189|NCT00165178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6383190|NCT00165178|Tubulin Modulators|tubulin modulators|mesh-ancestor
6383191|NCT00165178|Antimitotic Agents|antimitotic agents|mesh-ancestor
6383192|NCT00165178|Mitosis Modulators|mitosis modulators|mesh-ancestor
6383193|NCT00165178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6383194|NCT00165191|Doxorubicin|doxorubicin|mesh-list
6383195|NCT00165191|Fluorouracil|fluorouracil|mesh-list
6383196|NCT00165191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6383197|NCT00165191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6383198|NCT00165191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6383199|NCT00165191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6383200|NCT00165191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6383201|NCT00165191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383202|NCT00165191|Antimetabolites|antimetabolites|mesh-ancestor
6383203|NCT00165191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6383204|NCT00165191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6383205|NCT00165191|Immunologic Factors|immunologic factors|mesh-ancestor
6383206|NCT00165191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383207|NCT00165204|Tibolone|tibolone|mesh-list
6383208|NCT00165204|Androgen Antagonists|androgen antagonists|mesh-ancestor
6383209|NCT00165204|Hormone Antagonists|hormone antagonists|mesh-ancestor
6383210|NCT00165204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6383211|NCT00165204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383212|NCT00165204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6383213|NCT00165204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6383214|NCT00165204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6383215|NCT00165204|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6383216|NCT00165204|Anabolic Agents|anabolic agents|mesh-ancestor
6383217|NCT00165204|Hormones|hormones|mesh-ancestor
6383218|NCT00165217|Thalidomide|thalidomide|mesh-list
6383219|NCT00165217|Capecitabine|capecitabine|mesh-list
6383220|NCT00165217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6383221|NCT00165217|Antimetabolites|antimetabolites|mesh-ancestor
6383222|NCT00165217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383223|NCT00165217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6383224|NCT00165217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6383225|NCT00165217|Immunologic Factors|immunologic factors|mesh-ancestor
6383226|NCT00165217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383227|NCT00165217|Leprostatic Agents|leprostatic agents|mesh-ancestor
6383228|NCT00165217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6383229|NCT00165217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6383230|NCT00165217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6383231|NCT00165217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6383232|NCT00165217|Growth Substances|growth substances|mesh-ancestor
6383233|NCT00165217|Growth Inhibitors|growth inhibitors|mesh-ancestor
6383234|NCT00165230|Thalidomide|thalidomide|mesh-list
6383235|NCT00165230|Temozolomide|temozolomide|mesh-list
6383236|NCT00165230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6383237|NCT00165230|Immunologic Factors|immunologic factors|mesh-ancestor
6383238|NCT00165230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383239|NCT00165230|Leprostatic Agents|leprostatic agents|mesh-ancestor
6383240|NCT00165230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6383241|NCT00165230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6383242|NCT00165230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6383243|NCT00165230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6383244|NCT00165230|Growth Substances|growth substances|mesh-ancestor
6383245|NCT00165230|Growth Inhibitors|growth inhibitors|mesh-ancestor
6383246|NCT00165230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6383247|NCT00165230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6383248|NCT00165230|Alkylating Agents|alkylating agents|mesh-ancestor
6383249|NCT00165230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383250|NCT00165295|Sildenafil Citrate|sildenafil citrate|mesh-list
6383251|NCT00165295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383252|NCT00165295|Vasodilator Agents|vasodilator agents|mesh-ancestor
6383253|NCT00165295|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6383254|NCT00165295|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6383255|NCT00165295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6383256|NCT00165295|Urological Agents|urological agents|mesh-ancestor
6383257|NCT00165308|Tamoxifen|tamoxifen|mesh-list
6383258|NCT00165308|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6383259|NCT00165308|Hormone Antagonists|hormone antagonists|mesh-ancestor
6383260|NCT00165308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6383261|NCT00165308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383262|NCT00165308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6383263|NCT00165308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6383264|NCT00165308|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6383265|NCT00165308|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6383266|NCT00165308|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6383267|NCT00165334|Cetuximab|cetuximab|mesh-list
6383268|NCT00165334|Vinorelbine|vinorelbine|mesh-list
6383269|NCT00165334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6383270|NCT00165334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6383271|NCT00165334|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6383272|NCT00165334|Tubulin Modulators|tubulin modulators|mesh-ancestor
6383273|NCT00165334|Antimitotic Agents|antimitotic agents|mesh-ancestor
6383274|NCT00165334|Mitosis Modulators|mitosis modulators|mesh-ancestor
6383275|NCT00165334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383276|NCT00165347|Vatalanib|vatalanib|mesh-list
6383277|NCT00165347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6383278|NCT00165347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6383279|NCT00165347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383280|NCT00165360|Temozolomide|temozolomide|mesh-list
6383281|NCT00165360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6383282|NCT00165360|Alkylating Agents|alkylating agents|mesh-ancestor
6383283|NCT00165360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383284|NCT00165360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6383285|NCT00165373|Endostatins|endostatins|mesh-list
6383286|NCT00165373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6383287|NCT00165373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6383288|NCT00165373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6383289|NCT00165373|Growth Substances|growth substances|mesh-ancestor
6383290|NCT00165373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383291|NCT00165373|Growth Inhibitors|growth inhibitors|mesh-ancestor
6383292|NCT00165399|Docetaxel|docetaxel|mesh-list
6383293|NCT00165399|Goserelin|goserelin|mesh-list
6383294|NCT00165399|Bicalutamide|bicalutamide|mesh-list
6383295|NCT00165399|Estramustine|estramustine|mesh-list
6383296|NCT00165399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6383297|NCT00165399|Tubulin Modulators|tubulin modulators|mesh-ancestor
6383298|NCT00165399|Antimitotic Agents|antimitotic agents|mesh-ancestor
6383299|NCT00165399|Mitosis Modulators|mitosis modulators|mesh-ancestor
6017521|NCT00373295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017522|NCT00373295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6017523|NCT00373295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6017524|NCT00373295|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6017525|NCT00373295|GABA Agonists|gaba agonists|mesh-ancestor
6017526|NCT00373295|GABA Agents|gaba agents|mesh-ancestor
6017527|NCT00373295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6017528|NCT00373295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017529|NCT00373334|Nizatidine|nizatidine|mesh-list
6017530|NCT00373334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6017531|NCT00373334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6017532|NCT00373334|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6017533|NCT00373334|Histamine Antagonists|histamine antagonists|mesh-ancestor
6017534|NCT00373334|Histamine Agents|histamine agents|mesh-ancestor
6017535|NCT00373334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6017536|NCT00373334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017537|NCT00373334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383300|NCT00165399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383301|NCT00165399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6383302|NCT00165399|Androgen Antagonists|androgen antagonists|mesh-ancestor
6383303|NCT00165399|Hormone Antagonists|hormone antagonists|mesh-ancestor
6383304|NCT00165399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6383305|NCT00165399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383306|NCT00165399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6383307|NCT00165399|Alkylating Agents|alkylating agents|mesh-ancestor
6383308|NCT00165451|Thalidomide|thalidomide|mesh-list
6383309|NCT00165451|Celecoxib|celecoxib|mesh-list
6383310|NCT00165451|Cyclophosphamide|cyclophosphamide|mesh-list
6383311|NCT00165451|Etoposide|etoposide|mesh-list
6383312|NCT00165451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6383313|NCT00165451|Immunologic Factors|immunologic factors|mesh-ancestor
6383314|NCT00165451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383315|NCT00165451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6383316|NCT00165451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6383317|NCT00165451|Alkylating Agents|alkylating agents|mesh-ancestor
6383318|NCT00165451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383319|NCT00165451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6383320|NCT00165451|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6383321|NCT00165451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6383322|NCT00165451|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6383323|NCT00165451|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6383324|NCT00165451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6383325|NCT00165451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6383326|NCT00165451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6383327|NCT00165451|Analgesics|analgesics|mesh-ancestor
6383328|NCT00165451|Sensory System Agents|sensory system agents|mesh-ancestor
6383329|NCT00165451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6383330|NCT00165451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6383331|NCT00165451|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6383332|NCT00165451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6383333|NCT00165451|Leprostatic Agents|leprostatic agents|mesh-ancestor
6383334|NCT00165451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6383335|NCT00165451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6383336|NCT00165451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6383337|NCT00165451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6383338|NCT00165451|Growth Substances|growth substances|mesh-ancestor
6383339|NCT00165451|Growth Inhibitors|growth inhibitors|mesh-ancestor
6383340|NCT00165464|Irinotecan|irinotecan|mesh-list
6383341|NCT00165464|Docetaxel|docetaxel|mesh-list
6383342|NCT00165464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6383343|NCT00165464|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6383344|NCT00165464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6383345|NCT00165464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6383346|NCT00165464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383347|NCT00165464|Tubulin Modulators|tubulin modulators|mesh-ancestor
6383348|NCT00165464|Antimitotic Agents|antimitotic agents|mesh-ancestor
6383349|NCT00165464|Mitosis Modulators|mitosis modulators|mesh-ancestor
6383350|NCT00165477|Lenalidomide|lenalidomide|mesh-list
6383351|NCT00165477|Immunologic Factors|immunologic factors|mesh-ancestor
6383352|NCT00165477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383353|NCT00165477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6383354|NCT00165477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6383355|NCT00165477|Growth Substances|growth substances|mesh-ancestor
6383356|NCT00165477|Growth Inhibitors|growth inhibitors|mesh-ancestor
6383357|NCT00165477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6383358|NCT00165490|Irinotecan|irinotecan|mesh-list
6383359|NCT00165490|Cetuximab|cetuximab|mesh-list
6383360|NCT00165490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6383361|NCT00165490|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6383362|NCT00165490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6383363|NCT00165490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6383364|NCT00165490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383365|NCT00165490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6383366|NCT00165516|Sodium thiosulfate|sodium thiosulfate|mesh-list
6383367|NCT00165516|Antidotes|antidotes|mesh-ancestor
6383368|NCT00165516|Protective Agents|protective agents|mesh-ancestor
6383369|NCT00165516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383370|NCT00165516|Antioxidants|antioxidants|mesh-ancestor
6383371|NCT00165516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383372|NCT00165516|Antitubercular Agents|antitubercular agents|mesh-ancestor
6383373|NCT00165516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6383374|NCT00165516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6383375|NCT00165516|Chelating Agents|chelating agents|mesh-ancestor
6383376|NCT00165516|Sequestering Agents|sequestering agents|mesh-ancestor
6383377|NCT00165555|Sodium thiosulfate|sodium thiosulfate|mesh-list
6383378|NCT00165555|Antidotes|antidotes|mesh-ancestor
6383379|NCT00165555|Protective Agents|protective agents|mesh-ancestor
6383380|NCT00165555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383381|NCT00165555|Antioxidants|antioxidants|mesh-ancestor
6383382|NCT00165555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383383|NCT00165555|Antitubercular Agents|antitubercular agents|mesh-ancestor
6383384|NCT00165555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6383385|NCT00165555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6383386|NCT00165555|Chelating Agents|chelating agents|mesh-ancestor
6383387|NCT00165555|Sequestering Agents|sequestering agents|mesh-ancestor
6383388|NCT00165568|Bevacizumab|bevacizumab|mesh-list
6383389|NCT00165568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6383390|NCT00165568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6383391|NCT00165568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6383392|NCT00165568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6383393|NCT00165568|Growth Substances|growth substances|mesh-ancestor
6383394|NCT00165568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383395|NCT00165568|Growth Inhibitors|growth inhibitors|mesh-ancestor
6383396|NCT00165594|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
6383397|NCT00165594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6383398|NCT00165594|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6383399|NCT00165594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6383400|NCT00165594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383401|NCT00165633|Vitamin K 2|vitamin k 2|mesh-list
6383402|NCT00165633|Menatetrenone|menatetrenone|mesh-list
6383403|NCT00165633|Hemostatics|hemostatics|mesh-ancestor
6383404|NCT00165633|Coagulants|coagulants|mesh-ancestor
6383405|NCT00165633|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6383406|NCT00165633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6383407|NCT00165633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383408|NCT00165633|Vitamins|vitamins|mesh-ancestor
6383409|NCT00165633|Micronutrients|micronutrients|mesh-ancestor
6383410|NCT00165633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383411|NCT00165659|Donepezil|donepezil|mesh-list
6383412|NCT00165659|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6383413|NCT00165659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6383414|NCT00165659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383415|NCT00165659|Cholinergic Agents|cholinergic agents|mesh-ancestor
6383416|NCT00165659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6383417|NCT00165659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383418|NCT00165659|Nootropic Agents|nootropic agents|mesh-ancestor
6383419|NCT00165685|Sibutramine|sibutramine|mesh-list
6383420|NCT00165685|Antidepressive Agents|antidepressive agents|mesh-ancestor
6383421|NCT00165685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6383422|NCT00165685|Appetite Depressants|appetite depressants|mesh-ancestor
6383423|NCT00165685|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6383424|NCT00165737|Donepezil|donepezil|mesh-list
6383425|NCT00165737|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6383426|NCT00165737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6383427|NCT00165737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383428|NCT00165737|Cholinergic Agents|cholinergic agents|mesh-ancestor
6383429|NCT00165737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6383430|NCT00165737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383431|NCT00165737|Nootropic Agents|nootropic agents|mesh-ancestor
6383432|NCT00165750|Donepezil|donepezil|mesh-list
6383433|NCT00165750|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6383434|NCT00165750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6383435|NCT00165750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383436|NCT00165750|Cholinergic Agents|cholinergic agents|mesh-ancestor
6383437|NCT00165750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6383438|NCT00165750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383439|NCT00165750|Nootropic Agents|nootropic agents|mesh-ancestor
6383440|NCT00165763|Donepezil|donepezil|mesh-list
6383441|NCT00165763|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6383442|NCT00165763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6383443|NCT00165763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383444|NCT00165763|Cholinergic Agents|cholinergic agents|mesh-ancestor
6383445|NCT00165763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6383446|NCT00165763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383447|NCT00165763|Nootropic Agents|nootropic agents|mesh-ancestor
6383448|NCT00165815|Donepezil|donepezil|mesh-list
6383449|NCT00165815|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6383450|NCT00165815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6383451|NCT00165815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383452|NCT00165815|Cholinergic Agents|cholinergic agents|mesh-ancestor
6383453|NCT00165815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6383454|NCT00165815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383455|NCT00165815|Nootropic Agents|nootropic agents|mesh-ancestor
6383456|NCT00165828|Zonisamide|zonisamide|mesh-list
6383457|NCT00165828|Anticonvulsants|anticonvulsants|mesh-ancestor
6383458|NCT00165828|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6383459|NCT00165828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6383460|NCT00165828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383461|NCT00165828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6383462|NCT00165828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383463|NCT00165854|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
6383464|NCT00165854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6383465|NCT00165854|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6383466|NCT00165854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6383467|NCT00165854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383468|NCT00165867|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
6383469|NCT00165867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6383470|NCT00165867|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6383471|NCT00165867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6383472|NCT00165867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383473|NCT00165880|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
6383474|NCT00165880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6383475|NCT00165880|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6383476|NCT00165880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6383477|NCT00165880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383478|NCT00166010|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6383479|NCT00166010|Natriuretic Agents|natriuretic agents|mesh-ancestor
6383480|NCT00166010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383481|NCT00166127|Simendan|simendan|mesh-list
6383482|NCT00166127|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6383483|NCT00166127|Vasodilator Agents|vasodilator agents|mesh-ancestor
6383484|NCT00166127|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6383485|NCT00166127|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6383486|NCT00166127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6383487|NCT00166127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383488|NCT00166127|Protective Agents|protective agents|mesh-ancestor
6383489|NCT00166127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383490|NCT00166153|Mycophenolic Acid|mycophenolic acid|mesh-list
6383491|NCT00166153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6383492|NCT00166153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6383493|NCT00166153|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6383494|NCT00166153|Antitubercular Agents|antitubercular agents|mesh-ancestor
6383495|NCT00166153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6383496|NCT00166153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6383497|NCT00166153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6383498|NCT00166153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383499|NCT00166244|Mycophenolic Acid|mycophenolic acid|mesh-list
6383500|NCT00166244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6383501|NCT00166244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6383502|NCT00166244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6383503|NCT00166244|Antitubercular Agents|antitubercular agents|mesh-ancestor
6383504|NCT00166244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6383505|NCT00166244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6383506|NCT00166244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6383507|NCT00166244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383508|NCT00166400|Metoprolol|metoprolol|mesh-list
6383509|NCT00166400|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6383510|NCT00166400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6383511|NCT00166400|Sympatholytics|sympatholytics|mesh-ancestor
6383512|NCT00166400|Autonomic Agents|autonomic agents|mesh-ancestor
6383513|NCT00166400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6383514|NCT00166400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383515|NCT00166400|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6383516|NCT00166400|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6383517|NCT00166400|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6383518|NCT00166400|Adrenergic Agents|adrenergic agents|mesh-ancestor
6383519|NCT00166400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6383520|NCT00166400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396363|NCT00208546|Oxaliplatin|oxaliplatin|mesh-list
6396364|NCT00208546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6396365|NCT00208546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6396366|NCT00208546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6396367|NCT00208546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6396368|NCT00208546|Growth Substances|growth substances|mesh-ancestor
6396369|NCT00208546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396370|NCT00208546|Growth Inhibitors|growth inhibitors|mesh-ancestor
6396371|NCT00208546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6396372|NCT00208546|Antimetabolites|antimetabolites|mesh-ancestor
6396373|NCT00208546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383521|NCT00166413|Thalidomide|thalidomide|mesh-list
6383522|NCT00166413|Lenalidomide|lenalidomide|mesh-list
6383523|NCT00166413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6383524|NCT00166413|Immunologic Factors|immunologic factors|mesh-ancestor
6383525|NCT00166413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383526|NCT00166413|Leprostatic Agents|leprostatic agents|mesh-ancestor
6383527|NCT00166413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6383528|NCT00166413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6383529|NCT00166413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6383530|NCT00166413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6383531|NCT00166413|Growth Substances|growth substances|mesh-ancestor
6383532|NCT00166413|Growth Inhibitors|growth inhibitors|mesh-ancestor
6383533|NCT00166413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6383534|NCT00166426|Sulindac sulfone|sulindac sulfone|mesh-list
6383535|NCT00166426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6383536|NCT00166426|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6383537|NCT00166426|Protective Agents|protective agents|mesh-ancestor
6383538|NCT00166426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383539|NCT00166426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6383540|NCT00166426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6383541|NCT00166426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383542|NCT00166426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6383543|NCT00166426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6383544|NCT00166426|Analgesics|analgesics|mesh-ancestor
6383545|NCT00166426|Sensory System Agents|sensory system agents|mesh-ancestor
6383546|NCT00166426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6383547|NCT00166426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6383548|NCT00166426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6383549|NCT00166465|Leucovorin|leucovorin|mesh-list
6383550|NCT00166465|Fluorouracil|fluorouracil|mesh-list
6383551|NCT00166465|Oxaliplatin|oxaliplatin|mesh-list
6383552|NCT00166465|Antimetabolites|antimetabolites|mesh-ancestor
6383553|NCT00166465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383554|NCT00166465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6383555|NCT00166465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6383556|NCT00166465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6383557|NCT00166465|Immunologic Factors|immunologic factors|mesh-ancestor
6383558|NCT00166465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383559|NCT00166465|Antidotes|antidotes|mesh-ancestor
6383560|NCT00166465|Protective Agents|protective agents|mesh-ancestor
6383561|NCT00166465|Vitamin B Complex|vitamin b complex|mesh-ancestor
6383562|NCT00166465|Vitamins|vitamins|mesh-ancestor
6383563|NCT00166465|Micronutrients|micronutrients|mesh-ancestor
6383564|NCT00166478|Sulindac sulfone|sulindac sulfone|mesh-list
6383565|NCT00166478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6383566|NCT00166478|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6383567|NCT00166478|Protective Agents|protective agents|mesh-ancestor
6383568|NCT00166478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383569|NCT00166478|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6383570|NCT00166478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6383571|NCT00166478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383572|NCT00166478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6383573|NCT00166478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6383574|NCT00166478|Analgesics|analgesics|mesh-ancestor
6383575|NCT00166478|Sensory System Agents|sensory system agents|mesh-ancestor
6383576|NCT00166478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6383577|NCT00166478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6383578|NCT00166478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6383579|NCT00166491|Insulin|insulin|mesh-list
6383580|NCT00166491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6383581|NCT00166491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383582|NCT00166556|Alemtuzumab|alemtuzumab|mesh-list
6383583|NCT00166556|Tacrolimus|tacrolimus|mesh-list
6383584|NCT00166556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6383585|NCT00166556|Immunologic Factors|immunologic factors|mesh-ancestor
6383586|NCT00166556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383587|NCT00166556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6383588|NCT00166556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6383589|NCT00166556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383590|NCT00166556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6383591|NCT00166556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6383592|NCT00166595|Risperidone|risperidone|mesh-list
6383593|NCT00166595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6383594|NCT00166595|Serotonin Agents|serotonin agents|mesh-ancestor
6383595|NCT00166595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6383596|NCT00166595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383597|NCT00166595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383598|NCT00166595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6383599|NCT00166595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6383600|NCT00166595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6383601|NCT00166595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6383602|NCT00166595|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6383603|NCT00166595|Dopamine Agents|dopamine agents|mesh-ancestor
6383604|NCT00166621|Buspirone|buspirone|mesh-list
6383605|NCT00166621|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6383606|NCT00166621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6383607|NCT00166621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6383608|NCT00166621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383609|NCT00166621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6383610|NCT00166621|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6383611|NCT00166621|Serotonin Agents|serotonin agents|mesh-ancestor
6383612|NCT00166621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6383613|NCT00166621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383614|NCT00166686|Clonidine|clonidine|mesh-list
6383615|NCT00166686|Analgesics|analgesics|mesh-ancestor
6383616|NCT00166686|Sensory System Agents|sensory system agents|mesh-ancestor
6383617|NCT00166686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6383618|NCT00166686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383619|NCT00166686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6383620|NCT00166686|Sympatholytics|sympatholytics|mesh-ancestor
6383621|NCT00166686|Autonomic Agents|autonomic agents|mesh-ancestor
6383622|NCT00166686|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6383623|NCT00166686|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6383624|NCT00166686|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6383625|NCT00166686|Adrenergic Agents|adrenergic agents|mesh-ancestor
6383626|NCT00166686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6383627|NCT00166686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383628|NCT00166725|Octreotide|octreotide|mesh-list
6383629|NCT00166725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6383630|NCT00166725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6383631|NCT00166725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6383632|NCT00166803|Rosiglitazone|rosiglitazone|mesh-list
6383633|NCT00166803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6383634|NCT00166803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383635|NCT00166816|Cyclosporine|cyclosporine|mesh-list
6383636|NCT00166816|Sirolimus|sirolimus|mesh-list
6383637|NCT00166816|Tacrolimus|tacrolimus|mesh-list
6383638|NCT00166816|Cyclosporins|cyclosporins|mesh-list
6383639|NCT00166816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6383640|NCT00166816|Immunologic Factors|immunologic factors|mesh-ancestor
6383641|NCT00166816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383642|NCT00166816|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6383643|NCT00166816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6383644|NCT00166816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383645|NCT00166816|Antifungal Agents|antifungal agents|mesh-ancestor
6383646|NCT00166816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6383647|NCT00166816|Dermatologic Agents|dermatologic agents|mesh-ancestor
6383648|NCT00166816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6383649|NCT00166816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6383650|NCT00166816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6383651|NCT00166816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6383652|NCT00166829|Mycophenolic Acid|mycophenolic acid|mesh-list
6383653|NCT00166829|Sirolimus|sirolimus|mesh-list
6383654|NCT00166829|Tacrolimus|tacrolimus|mesh-list
6383655|NCT00166829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6383656|NCT00166829|Immunologic Factors|immunologic factors|mesh-ancestor
6383657|NCT00166829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383658|NCT00166829|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6383659|NCT00166829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6383660|NCT00166829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383661|NCT00166829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6383662|NCT00166829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6383663|NCT00166829|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6383664|NCT00166829|Antitubercular Agents|antitubercular agents|mesh-ancestor
6383665|NCT00166829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6383666|NCT00166829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6383667|NCT00166829|Antifungal Agents|antifungal agents|mesh-ancestor
6383668|NCT00166842|Cyclosporine|cyclosporine|mesh-list
6383669|NCT00166842|Sirolimus|sirolimus|mesh-list
6383670|NCT00166842|Tacrolimus|tacrolimus|mesh-list
6383671|NCT00166842|Cyclosporins|cyclosporins|mesh-list
6383672|NCT00166842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6383673|NCT00166842|Immunologic Factors|immunologic factors|mesh-ancestor
6383674|NCT00166842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383675|NCT00166842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6383676|NCT00166842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6383677|NCT00166842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383678|NCT00166842|Antifungal Agents|antifungal agents|mesh-ancestor
6383679|NCT00166842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6383680|NCT00166842|Dermatologic Agents|dermatologic agents|mesh-ancestor
6383681|NCT00166842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6383682|NCT00166842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6383683|NCT00166842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6383684|NCT00166842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6383685|NCT00166868|Neomycin|neomycin|mesh-list
6383686|NCT00166868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6383687|NCT00166868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6383688|NCT00166868|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6383689|NCT00166868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6383690|NCT00166868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383691|NCT00166881|Docetaxel|docetaxel|mesh-list
6383692|NCT00166881|Irinotecan|irinotecan|mesh-list
6383693|NCT00166881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6383694|NCT00166881|Tubulin Modulators|tubulin modulators|mesh-ancestor
6383695|NCT00166881|Antimitotic Agents|antimitotic agents|mesh-ancestor
6383696|NCT00166881|Mitosis Modulators|mitosis modulators|mesh-ancestor
6383697|NCT00166881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383698|NCT00166881|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6383699|NCT00166881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6383700|NCT00166881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6383701|NCT00167141|Contraceptive Agents|contraceptive agents|mesh-list
6383702|NCT00167141|Contraceptive Agents, Male|contraceptive agents, male|mesh-list
6383703|NCT00167141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6383704|NCT00167141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383705|NCT00167154|Risperidone|risperidone|mesh-list
6383706|NCT00167154|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6383707|NCT00167154|Serotonin Agents|serotonin agents|mesh-ancestor
6383708|NCT00167154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6383709|NCT00167154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383710|NCT00167154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383711|NCT00167154|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6383712|NCT00167154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6383713|NCT00167154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6383714|NCT00167154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6383715|NCT00167154|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6383716|NCT00167154|Dopamine Agents|dopamine agents|mesh-ancestor
6383717|NCT00167232|Naltrexone|naltrexone|mesh-list
6383718|NCT00167232|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6383719|NCT00167232|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6383720|NCT00167232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383721|NCT00167232|Sensory System Agents|sensory system agents|mesh-ancestor
6383722|NCT00167232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6383723|NCT00167297|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6383724|NCT00167297|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6383725|NCT00167297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6383726|NCT00167297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6383727|NCT00167297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383728|NCT00167297|Adrenergic Agents|adrenergic agents|mesh-ancestor
6383729|NCT00167297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6383730|NCT00167297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383731|NCT00167375|Eszopiclone|eszopiclone|mesh-list
6383732|NCT00167375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6383733|NCT00167375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6383734|NCT00167375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383735|NCT00167401|Docetaxel|docetaxel|mesh-list
6383736|NCT00167401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6383737|NCT00167401|Tubulin Modulators|tubulin modulators|mesh-ancestor
6383738|NCT00167401|Antimitotic Agents|antimitotic agents|mesh-ancestor
6383739|NCT00167401|Mitosis Modulators|mitosis modulators|mesh-ancestor
6383740|NCT00167401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383741|NCT00167479|Risperidone|risperidone|mesh-list
6383742|NCT00167479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6383743|NCT00167479|Serotonin Agents|serotonin agents|mesh-ancestor
6383744|NCT00167479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6383745|NCT00167479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383746|NCT00167479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383747|NCT00167479|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6383748|NCT00167479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6383749|NCT00167479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6383750|NCT00167479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6383751|NCT00167479|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6383752|NCT00167479|Dopamine Agents|dopamine agents|mesh-ancestor
6383753|NCT00167492|Mycophenolic Acid|mycophenolic acid|mesh-list
6383754|NCT00167492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6383755|NCT00167492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6383756|NCT00167492|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6383757|NCT00167492|Antitubercular Agents|antitubercular agents|mesh-ancestor
6383758|NCT00167492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6383759|NCT00167492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6383760|NCT00167492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6383761|NCT00167492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383762|NCT00167518|Triamcinolone|triamcinolone|mesh-list
6383763|NCT00167518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6383764|NCT00167518|Glucocorticoids|glucocorticoids|mesh-ancestor
6383765|NCT00167518|Hormones|hormones|mesh-ancestor
6383766|NCT00167518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6383767|NCT00167518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383768|NCT00167557|Interferons|interferons|mesh-list
6383769|NCT00167557|Ribavirin|ribavirin|mesh-list
6383770|NCT00167557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6383771|NCT00167557|Antiviral Agents|antiviral agents|mesh-ancestor
6383772|NCT00167557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6383773|NCT00167557|Antimetabolites|antimetabolites|mesh-ancestor
6383774|NCT00167557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383775|NCT00167583|Interferons|interferons|mesh-list
6383776|NCT00167583|Interferon-alpha|interferon-alpha|mesh-list
6383777|NCT00167583|Interferon alpha-2|interferon alpha-2|mesh-list
6383778|NCT00167583|Cyclosporine|cyclosporine|mesh-list
6383779|NCT00167583|Cyclosporins|cyclosporins|mesh-list
6383780|NCT00167583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6383781|NCT00167583|Antiviral Agents|antiviral agents|mesh-ancestor
6383782|NCT00167583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6383783|NCT00167583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6383784|NCT00167583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383785|NCT00167583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6383786|NCT00167583|Immunologic Factors|immunologic factors|mesh-ancestor
6383787|NCT00167583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383788|NCT00167583|Antifungal Agents|antifungal agents|mesh-ancestor
6383789|NCT00167583|Dermatologic Agents|dermatologic agents|mesh-ancestor
6383790|NCT00167583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6383791|NCT00167583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6383792|NCT00167609|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
6383793|NCT00167609|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6383794|NCT00167609|Immunologic Factors|immunologic factors|mesh-ancestor
6383795|NCT00167609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383796|NCT00167648|Leuprolide|leuprolide|mesh-list
6383797|NCT00167648|Goserelin|goserelin|mesh-list
6383798|NCT00167648|Estradiol|estradiol|mesh-list
6383799|NCT00167648|Estrogens|estrogens|mesh-ancestor
6383800|NCT00167648|Hormones|hormones|mesh-ancestor
6383801|NCT00167648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6383802|NCT00167648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383803|NCT00167648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6383804|NCT00167648|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6383805|NCT00167648|Fertility Agents|fertility agents|mesh-ancestor
6383806|NCT00167648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6383807|NCT00167648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6383808|NCT00167674|Zidovudine|zidovudine|mesh-list
6383809|NCT00167674|Nevirapine|nevirapine|mesh-list
6383810|NCT00167674|Antimetabolites|antimetabolites|mesh-ancestor
6383811|NCT00167674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383812|NCT00167674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6383813|NCT00167674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6383814|NCT00167674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6383815|NCT00167674|Antiviral Agents|antiviral agents|mesh-ancestor
6383816|NCT00167674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6383817|NCT00167674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6383818|NCT00167674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6383819|NCT00167674|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6383820|NCT00167674|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6383821|NCT00167687|Prazosin|prazosin|mesh-list
6383822|NCT00167687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6383823|NCT00167687|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6383824|NCT00167687|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6383825|NCT00167687|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6383826|NCT00167687|Adrenergic Agents|adrenergic agents|mesh-ancestor
6383827|NCT00167687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6383828|NCT00167687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383829|NCT00167687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383830|NCT00167713|Ibuprofen|ibuprofen|mesh-list
6383831|NCT00167713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6383832|NCT00167713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6383833|NCT00167713|Analgesics|analgesics|mesh-ancestor
6383834|NCT00167713|Sensory System Agents|sensory system agents|mesh-ancestor
6383835|NCT00167713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6383836|NCT00167713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383837|NCT00167713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6383838|NCT00167713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6383839|NCT00167713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6383840|NCT00167713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6383841|NCT00167713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383842|NCT00167739|Pyrimethamine|pyrimethamine|mesh-list
6383843|NCT00167739|Sulfadoxine|sulfadoxine|mesh-list
6383844|NCT00167739|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6383845|NCT00167739|Quinine|quinine|mesh-list
6383846|NCT00167739|Antimalarials|antimalarials|mesh-ancestor
6383847|NCT00167739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6383848|NCT00167739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6383849|NCT00167739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6383850|NCT00167739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6383851|NCT00167739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6383852|NCT00167739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383853|NCT00167739|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6383854|NCT00167739|Renal Agents|renal agents|mesh-ancestor
6383855|NCT00167739|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6383856|NCT00167739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383857|NCT00167739|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6383858|NCT00167739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6383859|NCT00167739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6383860|NCT00167739|Analgesics|analgesics|mesh-ancestor
6383861|NCT00167739|Sensory System Agents|sensory system agents|mesh-ancestor
6383862|NCT00167765|Abciximab|abciximab|mesh-list
6383863|NCT00167765|Anticoagulants|anticoagulants|mesh-ancestor
6383864|NCT00167765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6383865|NCT00167791|Rituximab|rituximab|mesh-list
6383866|NCT00167791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6383867|NCT00167791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6383868|NCT00167791|Immunologic Factors|immunologic factors|mesh-ancestor
6383869|NCT00167791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383870|NCT00167791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6383871|NCT00167817|Aripiprazole|aripiprazole|mesh-list
6383872|NCT00167817|Antidepressive Agents|antidepressive agents|mesh-ancestor
6383873|NCT00167817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6383874|NCT00167817|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6383875|NCT00167817|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6383876|NCT00167817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6383877|NCT00167817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383878|NCT00167817|Dopamine Agonists|dopamine agonists|mesh-ancestor
6383879|NCT00167817|Dopamine Agents|dopamine agents|mesh-ancestor
6383880|NCT00167817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6383881|NCT00167817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383882|NCT00167817|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6383883|NCT00167817|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6383884|NCT00167817|Serotonin Agents|serotonin agents|mesh-ancestor
6383885|NCT00167817|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6383886|NCT00167817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6383887|NCT00167817|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6383888|NCT00167817|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6383889|NCT00167843|Pyrimethamine|pyrimethamine|mesh-list
6383890|NCT00167843|Sulfadoxine|sulfadoxine|mesh-list
6383891|NCT00167843|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6383892|NCT00167843|Antimalarials|antimalarials|mesh-ancestor
6383893|NCT00167843|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6383894|NCT00167843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6383895|NCT00167843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6383896|NCT00167843|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6383897|NCT00167843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6383898|NCT00167843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383899|NCT00167843|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6383900|NCT00167843|Renal Agents|renal agents|mesh-ancestor
6383901|NCT00167856|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6383902|NCT00167856|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6383903|NCT00167856|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6383904|NCT00167856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6383905|NCT00167856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383906|NCT00167856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6383907|NCT00167856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383908|NCT00167856|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6383909|NCT00167856|Antidepressive Agents|antidepressive agents|mesh-ancestor
6383910|NCT00167856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6383911|NCT00167882|Mesalamine|mesalamine|mesh-list
6383912|NCT00167882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6383913|NCT00167882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6383914|NCT00167882|Analgesics|analgesics|mesh-ancestor
6383915|NCT00167882|Sensory System Agents|sensory system agents|mesh-ancestor
6383916|NCT00167882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6383917|NCT00167882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383918|NCT00167882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6383919|NCT00167882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6383920|NCT00167908|Amifostine|amifostine|mesh-list
6383921|NCT00167908|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6383922|NCT00167908|Protective Agents|protective agents|mesh-ancestor
6383923|NCT00167908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383924|NCT00167921|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6383925|NCT00167921|Estrogens|estrogens|mesh-ancestor
6383926|NCT00167921|Hormones|hormones|mesh-ancestor
6383927|NCT00167921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6383928|NCT00167921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383929|NCT00167947|Cyclosporine|cyclosporine|mesh-list
6383930|NCT00167947|Sirolimus|sirolimus|mesh-list
6383931|NCT00167947|Cyclosporins|cyclosporins|mesh-list
6383932|NCT00167947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6383933|NCT00167947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383934|NCT00167947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6383935|NCT00167947|Immunologic Factors|immunologic factors|mesh-ancestor
6383936|NCT00167947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383937|NCT00167947|Antifungal Agents|antifungal agents|mesh-ancestor
6383938|NCT00167947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6383939|NCT00167947|Dermatologic Agents|dermatologic agents|mesh-ancestor
6383940|NCT00167947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6383941|NCT00167947|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6383942|NCT00167947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6383943|NCT00167947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6383944|NCT00167947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6383945|NCT00167960|Tazobactam|tazobactam|mesh-list
6383946|NCT00167960|Piperacillin|piperacillin|mesh-list
6383947|NCT00167960|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
6383948|NCT00167960|Lactams|lactams|mesh-list
6383949|NCT00167960|beta-Lactams|beta-lactams|mesh-list
6383950|NCT00167960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6383951|NCT00167960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6383952|NCT00167960|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6383953|NCT00167960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6383954|NCT00167960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383955|NCT00167986|Vancomycin|vancomycin|mesh-list
6383956|NCT00167986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6383957|NCT00167986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6383958|NCT00167999|Tazobactam|tazobactam|mesh-list
6383959|NCT00167999|Piperacillin|piperacillin|mesh-list
6383960|NCT00167999|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
6383961|NCT00167999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6383962|NCT00167999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6383963|NCT00167999|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6383964|NCT00167999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6383965|NCT00167999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383966|NCT00168012|Immunoglobulins|immunoglobulins|mesh-list
6383967|NCT00168012|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6383968|NCT00168012|Antibodies|antibodies|mesh-list
6383969|NCT00168012|Immunologic Factors|immunologic factors|mesh-ancestor
6383970|NCT00168012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383971|NCT00168025|Immunoglobulins|immunoglobulins|mesh-list
6383972|NCT00168025|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6383973|NCT00168025|Antibodies|antibodies|mesh-list
6383974|NCT00168025|Immunologic Factors|immunologic factors|mesh-ancestor
6383975|NCT00168025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383976|NCT00168051|Factor VIII|factor viii|mesh-list
6383977|NCT00168051|Coagulants|coagulants|mesh-ancestor
6383978|NCT00168077|Thrombin|thrombin|mesh-list
6383979|NCT00168077|Hemostatics|hemostatics|mesh-ancestor
6383980|NCT00168077|Coagulants|coagulants|mesh-ancestor
6383981|NCT00168090|Factor VIII|factor viii|mesh-list
6383982|NCT00168090|Coagulants|coagulants|mesh-ancestor
6383983|NCT00168168|Lenograstim|lenograstim|mesh-list
6383984|NCT00168168|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6383985|NCT00168168|Immunologic Factors|immunologic factors|mesh-ancestor
6383986|NCT00168168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383987|NCT00168181|Pilocarpine|pilocarpine|mesh-list
6383988|NCT00168181|Miotics|miotics|mesh-ancestor
6383989|NCT00168181|Autonomic Agents|autonomic agents|mesh-ancestor
6383990|NCT00168181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6383991|NCT00168181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6383992|NCT00168181|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6383993|NCT00168181|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6383994|NCT00168181|Cholinergic Agents|cholinergic agents|mesh-ancestor
6383995|NCT00168181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6383996|NCT00168181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6383997|NCT00168350|Memantine|memantine|mesh-list
6383998|NCT00168350|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6383999|NCT00168350|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6384000|NCT00168350|Dopamine Agents|dopamine agents|mesh-ancestor
6384001|NCT00168350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6384002|NCT00168350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384003|NCT00168350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384004|NCT00168350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6384005|NCT00168350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6384006|NCT00168363|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6384007|NCT00168363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6384008|NCT00168363|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6384009|NCT00168363|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6384010|NCT00168363|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6384011|NCT00168363|Adrenergic Agents|adrenergic agents|mesh-ancestor
6384012|NCT00168363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6384013|NCT00168363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384014|NCT00168363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384015|NCT00168402|Botulinum Toxins|botulinum toxins|mesh-list
6384016|NCT00168402|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6384017|NCT00168402|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6384018|NCT00168402|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6384019|NCT00168402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6384020|NCT00168402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384021|NCT00168402|Cholinergic Agents|cholinergic agents|mesh-ancestor
6384022|NCT00168402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6384023|NCT00168402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384024|NCT00168402|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6384025|NCT00168402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6384026|NCT00168415|Botulinum Toxins|botulinum toxins|mesh-list
6384027|NCT00168415|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6384028|NCT00168415|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6384029|NCT00168415|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6384030|NCT00168415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6384031|NCT00168415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384032|NCT00168415|Cholinergic Agents|cholinergic agents|mesh-ancestor
6384033|NCT00168415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6384034|NCT00168415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384035|NCT00168415|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6384036|NCT00168415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6384037|NCT00168441|Botulinum Toxins|botulinum toxins|mesh-list
6384038|NCT00168441|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6384039|NCT00168441|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6396374|NCT00208559|Ziprasidone|ziprasidone|mesh-list
6384040|NCT00168441|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6384041|NCT00168441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6384042|NCT00168441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384043|NCT00168441|Cholinergic Agents|cholinergic agents|mesh-ancestor
6384044|NCT00168441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6384045|NCT00168441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384046|NCT00168441|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6384047|NCT00168441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6384048|NCT00168467|Ramipril|ramipril|mesh-list
6384049|NCT00168467|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6384050|NCT00168467|Protease Inhibitors|protease inhibitors|mesh-ancestor
6384051|NCT00168467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6384052|NCT00168467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384053|NCT00168467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6384054|NCT00168480|Botulinum Toxins|botulinum toxins|mesh-list
6384055|NCT00168480|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6384056|NCT00168480|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6384057|NCT00168480|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6384058|NCT00168480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6384059|NCT00168480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384060|NCT00168480|Cholinergic Agents|cholinergic agents|mesh-ancestor
6384061|NCT00168480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6384062|NCT00168480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384063|NCT00168480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6384064|NCT00168480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6384065|NCT00168493|Antidepressive Agents|antidepressive agents|mesh-list
6384066|NCT00168493|Serotonin|serotonin|mesh-list
6384067|NCT00168493|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
6384068|NCT00168493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6384069|NCT00168493|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6384070|NCT00168493|Serotonin Agents|serotonin agents|mesh-ancestor
6384071|NCT00168493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6384072|NCT00168493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384073|NCT00168493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384074|NCT00168493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6384075|NCT00168493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6384076|NCT00168519|Nitroprusside|nitroprusside|mesh-list
6384077|NCT00168519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6384078|NCT00168519|Vasodilator Agents|vasodilator agents|mesh-ancestor
6384079|NCT00168519|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6384080|NCT00168519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384081|NCT00168532|Trimethoprim|trimethoprim|mesh-list
6384082|NCT00168532|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6384083|NCT00168532|Sulfamethoxazole|sulfamethoxazole|mesh-list
6384084|NCT00168532|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6384085|NCT00168532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6384086|NCT00168532|Renal Agents|renal agents|mesh-ancestor
6384087|NCT00168532|Antimalarials|antimalarials|mesh-ancestor
6384088|NCT00168532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6384089|NCT00168532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6384090|NCT00168532|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6384091|NCT00168532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6384092|NCT00168532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384093|NCT00168532|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6384094|NCT00168532|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6384095|NCT00168532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6384096|NCT00168532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6384097|NCT00168584|Vitamin A|vitamin a|mesh-list
6384098|NCT00168584|Vitamins|vitamins|mesh-ancestor
6384099|NCT00168584|Micronutrients|micronutrients|mesh-ancestor
6384100|NCT00168584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384101|NCT00168597|Vitamin A|vitamin a|mesh-list
6384102|NCT00168597|Vitamins|vitamins|mesh-ancestor
6384103|NCT00168597|Micronutrients|micronutrients|mesh-ancestor
6384104|NCT00168597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384105|NCT00168610|Vitamin A|vitamin a|mesh-list
6384106|NCT00168610|Vitamins|vitamins|mesh-ancestor
6384107|NCT00168610|Micronutrients|micronutrients|mesh-ancestor
6384108|NCT00168610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384109|NCT00168623|Vitamin A|vitamin a|mesh-list
6384110|NCT00168623|Vitamins|vitamins|mesh-ancestor
6384111|NCT00168623|Micronutrients|micronutrients|mesh-ancestor
6384112|NCT00168623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384113|NCT00168636|Vitamin A|vitamin a|mesh-list
6384114|NCT00168636|Vitamins|vitamins|mesh-ancestor
6384115|NCT00168636|Micronutrients|micronutrients|mesh-ancestor
6384116|NCT00168636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384117|NCT00168649|Vitamin A|vitamin a|mesh-list
6384118|NCT00168649|Vitamins|vitamins|mesh-ancestor
6384119|NCT00168649|Micronutrients|micronutrients|mesh-ancestor
6384120|NCT00168649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384121|NCT00168688|Micronutrients|micronutrients|mesh-list
6384122|NCT00168688|Trace Elements|trace elements|mesh-list
6384123|NCT00168688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384124|NCT00168701|Dimethyl Fumarate|dimethyl fumarate|mesh-list
6384125|NCT00168701|Dermatologic Agents|dermatologic agents|mesh-ancestor
6384126|NCT00168701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6384127|NCT00168701|Immunologic Factors|immunologic factors|mesh-ancestor
6384128|NCT00168701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384129|NCT00168714|Interferons|interferons|mesh-list
6384130|NCT00168714|Interferon-beta|interferon-beta|mesh-list
6384131|NCT00168714|Interferon beta-1a|interferon beta-1a|mesh-list
6384132|NCT00168714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6384133|NCT00168714|Antiviral Agents|antiviral agents|mesh-ancestor
6384134|NCT00168714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6384135|NCT00168714|Immunologic Factors|immunologic factors|mesh-ancestor
6384136|NCT00168714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384137|NCT00168714|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6384138|NCT00168740|Rituximab|rituximab|mesh-list
6384139|NCT00168740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6384140|NCT00168740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6384141|NCT00168740|Immunologic Factors|immunologic factors|mesh-ancestor
6384142|NCT00168740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384143|NCT00168740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6384144|NCT00168753|Alefacept|alefacept|mesh-list
6384145|NCT00168753|Dermatologic Agents|dermatologic agents|mesh-ancestor
6384146|NCT00168753|Immunologic Factors|immunologic factors|mesh-ancestor
6384147|NCT00168753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384148|NCT00168766|Interferons|interferons|mesh-list
6384149|NCT00168766|Interferon-beta|interferon-beta|mesh-list
6384150|NCT00168766|Interferon beta-1a|interferon beta-1a|mesh-list
6384151|NCT00168766|Methylprednisolone|methylprednisolone|mesh-list
6384152|NCT00168766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6384153|NCT00168766|Antiviral Agents|antiviral agents|mesh-ancestor
6384154|NCT00168766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6384155|NCT00168766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6384156|NCT00168766|Antiemetics|antiemetics|mesh-ancestor
6384157|NCT00168766|Autonomic Agents|autonomic agents|mesh-ancestor
6384158|NCT00168766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6384159|NCT00168766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384160|NCT00168766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6384161|NCT00168766|Glucocorticoids|glucocorticoids|mesh-ancestor
6384162|NCT00168766|Hormones|hormones|mesh-ancestor
6384163|NCT00168766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6384164|NCT00168766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6384165|NCT00168766|Protective Agents|protective agents|mesh-ancestor
6384166|NCT00168766|Immunologic Factors|immunologic factors|mesh-ancestor
6384167|NCT00168766|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6384168|NCT00168779|Valsartan|valsartan|mesh-list
6384169|NCT00168779|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6384170|NCT00168779|Telmisartan|telmisartan|mesh-list
6384171|NCT00168779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6384172|NCT00168779|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6384173|NCT00168779|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6384174|NCT00168779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384175|NCT00168779|Diuretics|diuretics|mesh-ancestor
6384176|NCT00168779|Natriuretic Agents|natriuretic agents|mesh-ancestor
6384177|NCT00168779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384178|NCT00168779|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6384179|NCT00168779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6384180|NCT00168792|Tenecteplase|tenecteplase|mesh-list
6384181|NCT00168792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6384182|NCT00168792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6384183|NCT00168792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384184|NCT00168857|Losartan|losartan|mesh-list
6384185|NCT00168857|Telmisartan|telmisartan|mesh-list
6384186|NCT00168857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6384187|NCT00168857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6384188|NCT00168857|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6384189|NCT00168857|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6384190|NCT00168857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384191|NCT00168870|Gemcitabine|gemcitabine|mesh-list
6384192|NCT00168870|Treosulfan|treosulfan|mesh-list
6384193|NCT00168870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6384194|NCT00168870|Antimetabolites|antimetabolites|mesh-ancestor
6384195|NCT00168870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384196|NCT00168870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6384197|NCT00168870|Antiviral Agents|antiviral agents|mesh-ancestor
6384198|NCT00168870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6384199|NCT00168870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6384200|NCT00168870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6384201|NCT00168870|Immunologic Factors|immunologic factors|mesh-ancestor
6384202|NCT00168870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384203|NCT00168870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6384204|NCT00168870|Alkylating Agents|alkylating agents|mesh-ancestor
6384205|NCT00168883|Paclitaxel|paclitaxel|mesh-list
6384206|NCT00168883|Vinorelbine|vinorelbine|mesh-list
6384207|NCT00168883|Carboplatin|carboplatin|mesh-list
6384208|NCT00168883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6384209|NCT00168883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6384210|NCT00168883|Tubulin Modulators|tubulin modulators|mesh-ancestor
6384211|NCT00168883|Antimitotic Agents|antimitotic agents|mesh-ancestor
6384212|NCT00168883|Mitosis Modulators|mitosis modulators|mesh-ancestor
6384213|NCT00168883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384214|NCT00168896|Carboplatin|carboplatin|mesh-list
6384215|NCT00168896|Irinotecan|irinotecan|mesh-list
6384216|NCT00168896|Etoposide|etoposide|mesh-list
6384217|NCT00168896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6384218|NCT00168896|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6384219|NCT00168896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6384220|NCT00168896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6384221|NCT00168896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384222|NCT00168896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6384223|NCT00168896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6384224|NCT00168909|Alfacalcidol|alfacalcidol|mesh-list
6384225|NCT00168909|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
6384226|NCT00168909|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6384227|NCT00168909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384228|NCT00168909|Vitamins|vitamins|mesh-ancestor
6384229|NCT00168909|Micronutrients|micronutrients|mesh-ancestor
6384230|NCT00168922|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6384231|NCT00168922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6384232|NCT00168922|Alkylating Agents|alkylating agents|mesh-ancestor
6384233|NCT00168922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384234|NCT00168922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6384235|NCT00168948|Pyrimethamine|pyrimethamine|mesh-list
6384236|NCT00168948|Antimalarials|antimalarials|mesh-ancestor
6384237|NCT00168948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6384238|NCT00168948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6384239|NCT00168948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6384240|NCT00168948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6384241|NCT00168948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6384242|NCT00168948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384243|NCT00169000|Docetaxel|docetaxel|mesh-list
6384244|NCT00169000|Capecitabine|capecitabine|mesh-list
6384245|NCT00169000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6384246|NCT00169000|Tubulin Modulators|tubulin modulators|mesh-ancestor
6384247|NCT00169000|Antimitotic Agents|antimitotic agents|mesh-ancestor
6384248|NCT00169000|Mitosis Modulators|mitosis modulators|mesh-ancestor
6384249|NCT00169000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384250|NCT00169000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6384251|NCT00169000|Antimetabolites|antimetabolites|mesh-ancestor
6384252|NCT00169013|Gabapentin|gabapentin|mesh-list
6384253|NCT00169013|Analgesics|analgesics|mesh-ancestor
6384254|NCT00169013|Sensory System Agents|sensory system agents|mesh-ancestor
6384255|NCT00169013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6384256|NCT00169013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384257|NCT00169013|Anticonvulsants|anticonvulsants|mesh-ancestor
6384258|NCT00169013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6384259|NCT00169013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6384260|NCT00169013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6384261|NCT00169013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6384262|NCT00169013|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6384263|NCT00169013|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6384264|NCT00169013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6384265|NCT00169013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384266|NCT00169013|Antimanic Agents|antimanic agents|mesh-ancestor
6384267|NCT00169026|Antipsychotic Agents|antipsychotic agents|mesh-list
6384268|NCT00169026|Clozapine|clozapine|mesh-list
6384269|NCT00169026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6384270|NCT00169026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6384271|NCT00169026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384272|NCT00169026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6384273|NCT00169026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6384274|NCT00169026|Serotonin Agents|serotonin agents|mesh-ancestor
6384275|NCT00169026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6384276|NCT00169026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384277|NCT00169026|GABA Antagonists|gaba antagonists|mesh-ancestor
6384278|NCT00169026|GABA Agents|gaba agents|mesh-ancestor
6384279|NCT00169039|Chlorpromazine|chlorpromazine|mesh-list
6384280|NCT00169039|Clozapine|clozapine|mesh-list
6384281|NCT00169039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6384282|NCT00169039|Serotonin Agents|serotonin agents|mesh-ancestor
6384283|NCT00169039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6384284|NCT00169039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384285|NCT00169039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384286|NCT00169039|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6384287|NCT00169039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6384288|NCT00169039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6384289|NCT00169039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6384290|NCT00169039|GABA Antagonists|gaba antagonists|mesh-ancestor
6384291|NCT00169039|GABA Agents|gaba agents|mesh-ancestor
6384292|NCT00169039|Antiemetics|antiemetics|mesh-ancestor
6384293|NCT00169039|Autonomic Agents|autonomic agents|mesh-ancestor
6384294|NCT00169039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6384295|NCT00169039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6384296|NCT00169039|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6384297|NCT00169039|Dopamine Agents|dopamine agents|mesh-ancestor
6384298|NCT00169065|Olanzapine|olanzapine|mesh-list
6384299|NCT00169065|Clozapine|clozapine|mesh-list
6384300|NCT00169065|Antiemetics|antiemetics|mesh-ancestor
6384301|NCT00169065|Autonomic Agents|autonomic agents|mesh-ancestor
6384302|NCT00169065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6384303|NCT00169065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384304|NCT00169065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6384305|NCT00169065|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6384306|NCT00169065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6384307|NCT00169065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6384308|NCT00169065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6384309|NCT00169065|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6384310|NCT00169065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6384311|NCT00169065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6384312|NCT00169065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384313|NCT00169065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6384314|NCT00169065|Serotonin Agents|serotonin agents|mesh-ancestor
6384315|NCT00169065|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6384316|NCT00169065|GABA Antagonists|gaba antagonists|mesh-ancestor
6384317|NCT00169065|GABA Agents|gaba agents|mesh-ancestor
6384318|NCT00169078|Chloroquine|chloroquine|mesh-list
6384319|NCT00169078|Amebicides|amebicides|mesh-ancestor
6384320|NCT00169078|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6384321|NCT00169078|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6384322|NCT00169078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6384323|NCT00169078|Antimalarials|antimalarials|mesh-ancestor
6384324|NCT00169078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6384325|NCT00169091|Haloperidol|haloperidol|mesh-list
6384326|NCT00169091|Haloperidol decanoate|haloperidol decanoate|mesh-list
6384327|NCT00169091|Clozapine|clozapine|mesh-list
6384328|NCT00169091|Antiemetics|antiemetics|mesh-ancestor
6384329|NCT00169091|Autonomic Agents|autonomic agents|mesh-ancestor
6384330|NCT00169091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6384331|NCT00169091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384332|NCT00169091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6384333|NCT00169091|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6384334|NCT00169091|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6384335|NCT00169091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6384336|NCT00169091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6384337|NCT00169091|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6384338|NCT00169091|Dopamine Agents|dopamine agents|mesh-ancestor
6384339|NCT00169091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6384340|NCT00169091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384341|NCT00169091|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6384342|NCT00169091|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6384343|NCT00169091|Serotonin Agents|serotonin agents|mesh-ancestor
6384344|NCT00169091|GABA Antagonists|gaba antagonists|mesh-ancestor
6384345|NCT00169091|GABA Agents|gaba agents|mesh-ancestor
6384346|NCT00169130|Cyclophosphamide|cyclophosphamide|mesh-list
6384347|NCT00169130|Doxorubicin|doxorubicin|mesh-list
6384348|NCT00169130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6384349|NCT00169130|Immunologic Factors|immunologic factors|mesh-ancestor
6384350|NCT00169130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384351|NCT00169130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6384352|NCT00169130|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6384353|NCT00169130|Alkylating Agents|alkylating agents|mesh-ancestor
6384354|NCT00169130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384355|NCT00169130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6384356|NCT00169130|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6384357|NCT00169130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6384358|NCT00169130|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6384359|NCT00169130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6384360|NCT00169130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6384361|NCT00169143|Rituximab|rituximab|mesh-list
6384362|NCT00169143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6384363|NCT00169143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6384364|NCT00169143|Immunologic Factors|immunologic factors|mesh-ancestor
6384365|NCT00169143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384366|NCT00169143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6384367|NCT00169156|Prednisone|prednisone|mesh-list
6384368|NCT00169156|Cyclophosphamide|cyclophosphamide|mesh-list
6384369|NCT00169156|Rituximab|rituximab|mesh-list
6384370|NCT00169156|Doxorubicin|doxorubicin|mesh-list
6384371|NCT00169156|Vincristine|vincristine|mesh-list
6384372|NCT00169156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6384373|NCT00169156|Immunologic Factors|immunologic factors|mesh-ancestor
6384374|NCT00169156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384375|NCT00169156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6384376|NCT00169156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6384377|NCT00169156|Alkylating Agents|alkylating agents|mesh-ancestor
6384378|NCT00169156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384379|NCT00169156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6384380|NCT00169156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6384381|NCT00169156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6384382|NCT00169156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6384383|NCT00169156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6384384|NCT00169156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6384385|NCT00169156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6384386|NCT00169156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6384387|NCT00169156|Glucocorticoids|glucocorticoids|mesh-ancestor
6384388|NCT00169156|Hormones|hormones|mesh-ancestor
6384389|NCT00169156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6384390|NCT00169156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6384391|NCT00169156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6384392|NCT00169156|Tubulin Modulators|tubulin modulators|mesh-ancestor
6384393|NCT00169156|Antimitotic Agents|antimitotic agents|mesh-ancestor
6384394|NCT00169156|Mitosis Modulators|mitosis modulators|mesh-ancestor
6384395|NCT00169169|Rituximab|rituximab|mesh-list
6384396|NCT00169169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6384397|NCT00169169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6384398|NCT00169169|Immunologic Factors|immunologic factors|mesh-ancestor
6384399|NCT00169169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384400|NCT00169169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6384401|NCT00169182|Nicotinic Acids|nicotinic acids|mesh-list
6384402|NCT00169182|Niacin|niacin|mesh-list
6384403|NCT00169182|Docetaxel|docetaxel|mesh-list
6384404|NCT00169182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6384405|NCT00169182|Tubulin Modulators|tubulin modulators|mesh-ancestor
6384406|NCT00169182|Antimitotic Agents|antimitotic agents|mesh-ancestor
6384407|NCT00169182|Mitosis Modulators|mitosis modulators|mesh-ancestor
6384408|NCT00169182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384409|NCT00169182|Vitamin B Complex|vitamin b complex|mesh-ancestor
6384410|NCT00169182|Vitamins|vitamins|mesh-ancestor
6384411|NCT00169182|Micronutrients|micronutrients|mesh-ancestor
6384412|NCT00169182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384413|NCT00169182|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6384414|NCT00169182|Antimetabolites|antimetabolites|mesh-ancestor
6384415|NCT00169182|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6384416|NCT00169182|Vasodilator Agents|vasodilator agents|mesh-ancestor
6384417|NCT00169195|Gemcitabine|gemcitabine|mesh-list
6384418|NCT00169195|Rituximab|rituximab|mesh-list
6384419|NCT00169195|Oxaliplatin|oxaliplatin|mesh-list
6384420|NCT00169195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6384421|NCT00169195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6384422|NCT00169195|Immunologic Factors|immunologic factors|mesh-ancestor
6384423|NCT00169195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384424|NCT00169195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6384425|NCT00169195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6384426|NCT00169195|Antimetabolites|antimetabolites|mesh-ancestor
6384427|NCT00169195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384428|NCT00169195|Antiviral Agents|antiviral agents|mesh-ancestor
6384429|NCT00169195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6384430|NCT00169195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6384431|NCT00169195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6384432|NCT00169208|Rituximab|rituximab|mesh-list
6384433|NCT00169208|Fludarabine|fludarabine|mesh-list
6384434|NCT00169208|Mitoxantrone|mitoxantrone|mesh-list
6384435|NCT00169208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6384436|NCT00169208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6384437|NCT00169208|Immunologic Factors|immunologic factors|mesh-ancestor
6384438|NCT00169208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384439|NCT00169208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6384440|NCT00169208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384441|NCT00169208|Analgesics|analgesics|mesh-ancestor
6384442|NCT00169208|Sensory System Agents|sensory system agents|mesh-ancestor
6384443|NCT00169208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6384444|NCT00169208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6384445|NCT00169208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6384446|NCT00169208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6384447|NCT00169221|Gefitinib|gefitinib|mesh-list
6384448|NCT00169221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6384449|NCT00169221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6384450|NCT00169221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6384451|NCT00169221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384452|NCT00169234|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6384453|NCT00169234|Immunologic Factors|immunologic factors|mesh-ancestor
6384454|NCT00169234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384455|NCT00169247|Cetuximab|cetuximab|mesh-list
6384456|NCT00169247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6384457|NCT00169247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6384458|NCT00169299|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6384459|NCT00169299|Medroxyprogesterone|medroxyprogesterone|mesh-list
6384460|NCT00169299|Estrogens|estrogens|mesh-list
6384461|NCT00169299|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6384462|NCT00169299|Hormones|hormones|mesh-ancestor
6384463|NCT00169299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6384464|NCT00169299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384465|NCT00169299|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6384466|NCT00169299|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6384467|NCT00169299|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6384468|NCT00169299|Contraceptive Agents|contraceptive agents|mesh-ancestor
6384469|NCT00169299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6384470|NCT00169299|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6384471|NCT00169299|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6384472|NCT00169299|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6384473|NCT00169299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6384474|NCT00169299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6384475|NCT00169416|Valacyclovir|valacyclovir|mesh-list
6384476|NCT00169416|Antiviral Agents|antiviral agents|mesh-ancestor
6384477|NCT00169416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6384478|NCT00169468|Rituximab|rituximab|mesh-list
6384479|NCT00169468|Bortezomib|bortezomib|mesh-list
6384480|NCT00169468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6384481|NCT00169468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6384482|NCT00169468|Immunologic Factors|immunologic factors|mesh-ancestor
6384483|NCT00169468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384484|NCT00169468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6396375|NCT00208559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6396376|NCT00208559|Serotonin Agents|serotonin agents|mesh-ancestor
6396377|NCT00208559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6396378|NCT00208559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396379|NCT00208559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396380|NCT00208559|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6396381|NCT00208559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6396382|NCT00208559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6396383|NCT00208559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6396384|NCT00208559|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6396385|NCT00208559|Dopamine Agents|dopamine agents|mesh-ancestor
6396386|NCT00208572|Citalopram|citalopram|mesh-list
6396387|NCT00208572|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6396388|NCT00208572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6396389|NCT00208572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6396390|NCT00208572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396391|NCT00208572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6396392|NCT00208572|Serotonin Agents|serotonin agents|mesh-ancestor
6396393|NCT00208572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396394|NCT00208572|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6396395|NCT00208572|Antidepressive Agents|antidepressive agents|mesh-ancestor
6396396|NCT00208572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6396397|NCT00208585|Sertraline|sertraline|mesh-list
6396398|NCT00208585|Antidepressive Agents|antidepressive agents|mesh-ancestor
6396399|NCT00208585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6396400|NCT00208585|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6396401|NCT00208585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6396402|NCT00208585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6396403|NCT00208585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396404|NCT00208585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6396405|NCT00208585|Serotonin Agents|serotonin agents|mesh-ancestor
6396406|NCT00208585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396407|NCT00208611|Vitamins|vitamins|mesh-list
6396408|NCT00208611|Vitamin B 12|vitamin b 12|mesh-list
6396409|NCT00208611|Hydroxocobalamin|hydroxocobalamin|mesh-list
6396410|NCT00208611|Vitamin B Complex|vitamin b complex|mesh-list
6396411|NCT00208611|Micronutrients|micronutrients|mesh-ancestor
6396412|NCT00208611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396413|NCT00208611|Hematinics|hematinics|mesh-ancestor
6396414|NCT00208702|Sertraline|sertraline|mesh-list
6396415|NCT00208702|Antidepressive Agents|antidepressive agents|mesh-ancestor
6396416|NCT00208702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6396417|NCT00208702|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6396418|NCT00208702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6396419|NCT00208702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6396420|NCT00208702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396421|NCT00208702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6396422|NCT00208702|Serotonin Agents|serotonin agents|mesh-ancestor
6396423|NCT00208702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396424|NCT00208715|Modafinil|modafinil|mesh-list
6396425|NCT00208715|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6396426|NCT00208715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396427|NCT00208715|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6396428|NCT00208715|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6396429|NCT00208715|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6396430|NCT00208715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396431|NCT00208741|Tiagabine|tiagabine|mesh-list
6396432|NCT00208741|Anticonvulsants|anticonvulsants|mesh-ancestor
6396433|NCT00208741|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
6396434|NCT00208741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6396435|NCT00208741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6396436|NCT00208741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396437|NCT00208741|GABA Agents|gaba agents|mesh-ancestor
6396438|NCT00208741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6396439|NCT00208741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396440|NCT00208793|Calcium, Dietary|calcium, dietary|mesh-list
6396441|NCT00208793|Vitamin D|vitamin d|mesh-list
6396442|NCT00208793|Ergocalciferols|ergocalciferols|mesh-list
6396443|NCT00208793|Cholecalciferol|cholecalciferol|mesh-list
6396444|NCT00208793|Vitamins|vitamins|mesh-list
6396445|NCT00208793|Calcium|calcium|mesh-list
6396446|NCT00208793|Micronutrients|micronutrients|mesh-ancestor
6384485|NCT00169520|Docetaxel|docetaxel|mesh-list
6384486|NCT00169520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6384487|NCT00169520|Tubulin Modulators|tubulin modulators|mesh-ancestor
6384488|NCT00169520|Antimitotic Agents|antimitotic agents|mesh-ancestor
6384489|NCT00169520|Mitosis Modulators|mitosis modulators|mesh-ancestor
6384490|NCT00169520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384491|NCT00169533|Lapatinib|lapatinib|mesh-list
6384492|NCT00169533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6384493|NCT00169533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6384494|NCT00169533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6384495|NCT00169533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384496|NCT00169546|Fluticasone|fluticasone|mesh-list
6384497|NCT00169546|Xhance|xhance|mesh-list
6384498|NCT00169546|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6384499|NCT00169546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6384500|NCT00169546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6384501|NCT00169546|Autonomic Agents|autonomic agents|mesh-ancestor
6384502|NCT00169546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6384503|NCT00169546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384504|NCT00169546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6384505|NCT00169546|Respiratory System Agents|respiratory system agents|mesh-ancestor
6384506|NCT00169546|Dermatologic Agents|dermatologic agents|mesh-ancestor
6384507|NCT00169546|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6384508|NCT00169546|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6384509|NCT00169546|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6384510|NCT00169546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6384511|NCT00169546|Adrenergic Agents|adrenergic agents|mesh-ancestor
6384512|NCT00169546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6384513|NCT00169546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384514|NCT00169559|Fenofibrate|fenofibrate|mesh-list
6384515|NCT00169559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6384516|NCT00169559|Antimetabolites|antimetabolites|mesh-ancestor
6384517|NCT00169559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384518|NCT00169559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6384519|NCT00169572|Dexamethasone|dexamethasone|mesh-list
6384520|NCT00169572|Ondansetron|ondansetron|mesh-list
6384521|NCT00169572|Aprepitant|aprepitant|mesh-list
6384522|NCT00169572|Fosaprepitant|fosaprepitant|mesh-list
6384523|NCT00169572|Casopitant|casopitant|mesh-list
6384524|NCT00169572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6384525|NCT00169572|Antiemetics|antiemetics|mesh-ancestor
6384526|NCT00169572|Autonomic Agents|autonomic agents|mesh-ancestor
6384527|NCT00169572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6384528|NCT00169572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384529|NCT00169572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6384530|NCT00169572|Glucocorticoids|glucocorticoids|mesh-ancestor
6384531|NCT00169572|Hormones|hormones|mesh-ancestor
6384532|NCT00169572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6384533|NCT00169572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6384534|NCT00169572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6384535|NCT00169572|Antipruritics|antipruritics|mesh-ancestor
6384536|NCT00169572|Dermatologic Agents|dermatologic agents|mesh-ancestor
6384537|NCT00169572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6384538|NCT00169572|Serotonin Agents|serotonin agents|mesh-ancestor
6384539|NCT00169572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6384540|NCT00169572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384541|NCT00169572|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6384542|NCT00169572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6384543|NCT00169572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6384544|NCT00169572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6384545|NCT00169572|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6384546|NCT00169572|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6384547|NCT00169585|Levofloxacin|levofloxacin|mesh-list
6384548|NCT00169585|Ofloxacin|ofloxacin|mesh-list
6384549|NCT00169585|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6384550|NCT00169585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6384551|NCT00169585|Renal Agents|renal agents|mesh-ancestor
6384552|NCT00169585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6384553|NCT00169585|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6384554|NCT00169585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6384555|NCT00169585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6384556|NCT00169585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384557|NCT00169585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6384558|NCT00169585|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6384559|NCT00169585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6384560|NCT00169611|Methylphenidate|methylphenidate|mesh-list
6384561|NCT00169611|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6384562|NCT00169611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384563|NCT00169611|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6384564|NCT00169611|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6384565|NCT00169611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6384566|NCT00169611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384567|NCT00169611|Dopamine Agents|dopamine agents|mesh-ancestor
6384568|NCT00169611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6384569|NCT00169624|Metformin|metformin|mesh-list
6384570|NCT00169624|Gliclazide|gliclazide|mesh-list
6384571|NCT00169624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6384572|NCT00169624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384573|NCT00169728|Vaccines|vaccines|mesh-list
6384574|NCT00169728|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6384575|NCT00169728|Immunologic Factors|immunologic factors|mesh-ancestor
6384576|NCT00169728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384577|NCT00169819|Abciximab|abciximab|mesh-list
6384578|NCT00169819|Anticoagulants|anticoagulants|mesh-ancestor
6384579|NCT00169819|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6384580|NCT00169832|Rosiglitazone|rosiglitazone|mesh-list
6384581|NCT00169832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6384582|NCT00169832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384583|NCT00169845|Tocopherols|tocopherols|mesh-list
6384584|NCT00169845|Vitamin E|vitamin e|mesh-list
6384585|NCT00169845|alpha-Tocopherol|alpha-tocopherol|mesh-list
6384586|NCT00169845|Beta Carotene|beta carotene|mesh-list
6384587|NCT00169845|Carotenoids|carotenoids|mesh-list
6384588|NCT00169845|Antioxidants|antioxidants|mesh-ancestor
6384589|NCT00169845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384590|NCT00169845|Protective Agents|protective agents|mesh-ancestor
6384591|NCT00169845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384592|NCT00169845|Vitamins|vitamins|mesh-ancestor
6384593|NCT00169845|Micronutrients|micronutrients|mesh-ancestor
6384594|NCT00169845|Provitamins|provitamins|mesh-ancestor
6384595|NCT00169923|Rosiglitazone|rosiglitazone|mesh-list
6384596|NCT00169923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6384597|NCT00169923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384598|NCT00169949|Aripiprazole|aripiprazole|mesh-list
6384599|NCT00169949|Antidepressive Agents|antidepressive agents|mesh-ancestor
6384600|NCT00169949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6384601|NCT00169949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6384602|NCT00169949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6384603|NCT00169949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6384604|NCT00169949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384605|NCT00169949|Dopamine Agonists|dopamine agonists|mesh-ancestor
6384606|NCT00169949|Dopamine Agents|dopamine agents|mesh-ancestor
6384607|NCT00169949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6384608|NCT00169949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384609|NCT00169949|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6384610|NCT00169949|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6384611|NCT00169949|Serotonin Agents|serotonin agents|mesh-ancestor
6384612|NCT00169949|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6384613|NCT00169949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6384614|NCT00169949|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6384615|NCT00169949|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6384616|NCT00169988|Risperidone|risperidone|mesh-list
6384617|NCT00169988|Sertraline|sertraline|mesh-list
6384618|NCT00169988|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6384619|NCT00169988|Serotonin Agents|serotonin agents|mesh-ancestor
6384620|NCT00169988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6384621|NCT00169988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384622|NCT00169988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384623|NCT00169988|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6384624|NCT00169988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6384625|NCT00169988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6384626|NCT00169988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6384627|NCT00169988|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6384628|NCT00169988|Dopamine Agents|dopamine agents|mesh-ancestor
6384629|NCT00169988|Antidepressive Agents|antidepressive agents|mesh-ancestor
6384630|NCT00169988|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6384631|NCT00169988|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6384632|NCT00169988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6384633|NCT00170001|Esomeprazole|esomeprazole|mesh-list
6384634|NCT00170001|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6384635|NCT00170001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6384636|NCT00170001|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6384637|NCT00170001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6384638|NCT00170001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384639|NCT00170053|Sirolimus|sirolimus|mesh-list
6384640|NCT00170053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6384641|NCT00170053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6384642|NCT00170053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6384643|NCT00170053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6384644|NCT00170053|Antifungal Agents|antifungal agents|mesh-ancestor
6384645|NCT00170053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6384646|NCT00170053|Immunologic Factors|immunologic factors|mesh-ancestor
6384647|NCT00170053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384648|NCT00170183|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6384649|NCT00170183|Natriuretic Agents|natriuretic agents|mesh-ancestor
6384650|NCT00170183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384651|NCT00170196|Prednisone|prednisone|mesh-list
6384652|NCT00170196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6384653|NCT00170196|Glucocorticoids|glucocorticoids|mesh-ancestor
6384654|NCT00170196|Hormones|hormones|mesh-ancestor
6384655|NCT00170196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6384656|NCT00170196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384657|NCT00170196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6384658|NCT00170196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6384659|NCT00170209|Rifampin|rifampin|mesh-list
6384660|NCT00170209|Isoniazid|isoniazid|mesh-list
6384661|NCT00170209|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6384662|NCT00170209|Antitubercular Agents|antitubercular agents|mesh-ancestor
6384663|NCT00170209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6384664|NCT00170209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6384665|NCT00170209|Leprostatic Agents|leprostatic agents|mesh-ancestor
6384666|NCT00170209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6384667|NCT00170209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6384668|NCT00170209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384669|NCT00170209|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6384670|NCT00170209|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6384671|NCT00170209|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6384672|NCT00170209|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6384673|NCT00170209|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6384674|NCT00170209|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6384675|NCT00170209|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6384676|NCT00170209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6384677|NCT00170209|Antimetabolites|antimetabolites|mesh-ancestor
6384678|NCT00170209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6384679|NCT00170222|Doxycycline|doxycycline|mesh-list
6384680|NCT00170222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6384681|NCT00170222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6384682|NCT00170222|Antimalarials|antimalarials|mesh-ancestor
6384683|NCT00170222|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6384684|NCT00170222|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6384685|NCT00170378|Enoxaparin|enoxaparin|mesh-list
6384686|NCT00170378|Anticoagulants|anticoagulants|mesh-ancestor
6384687|NCT00170378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6384688|NCT00170378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6384689|NCT00170378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384690|NCT00170404|Vitamins|vitamins|mesh-list
6384691|NCT00170404|Folic Acid|folic acid|mesh-list
6384692|NCT00170404|Vitamin A|vitamin a|mesh-list
6384693|NCT00170404|Thiamine|thiamine|mesh-list
6384694|NCT00170404|Selenium|selenium|mesh-list
6384695|NCT00170404|Micronutrients|micronutrients|mesh-list
6384696|NCT00170404|Trace Elements|trace elements|mesh-list
6384697|NCT00170404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384698|NCT00170404|Hematinics|hematinics|mesh-ancestor
6384699|NCT00170404|Vitamin B Complex|vitamin b complex|mesh-ancestor
6384700|NCT00170404|Antioxidants|antioxidants|mesh-ancestor
6384701|NCT00170404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384702|NCT00170404|Protective Agents|protective agents|mesh-ancestor
6384703|NCT00170430|Fluconazole|fluconazole|mesh-list
6384704|NCT00170430|Antifungal Agents|antifungal agents|mesh-ancestor
6384705|NCT00170430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6384706|NCT00170430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6384707|NCT00170430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6384708|NCT00170430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6384709|NCT00170430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384710|NCT00170430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6384711|NCT00170430|Hormone Antagonists|hormone antagonists|mesh-ancestor
6384712|NCT00170430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6384713|NCT00170430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384714|NCT00170430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6384715|NCT00170430|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6384716|NCT00170456|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6384717|NCT00170456|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6384718|NCT00170456|Immunologic Factors|immunologic factors|mesh-ancestor
6384719|NCT00170456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384720|NCT00170456|Antacids|antacids|mesh-ancestor
6384721|NCT00170456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384722|NCT00170456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6384723|NCT00170469|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6384724|NCT00170469|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6384725|NCT00170469|Immunologic Factors|immunologic factors|mesh-ancestor
6384726|NCT00170469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384727|NCT00170469|Antacids|antacids|mesh-ancestor
6384728|NCT00170469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384729|NCT00170469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6384730|NCT00170547|Vaccines|vaccines|mesh-list
6384731|NCT00170547|Immunologic Factors|immunologic factors|mesh-ancestor
6384732|NCT00170547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384733|NCT00170573|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6384734|NCT00170573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6384735|NCT00170573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6384736|NCT00170612|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6384737|NCT00170612|Immunologic Factors|immunologic factors|mesh-ancestor
6384738|NCT00170612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384739|NCT00170664|Paclitaxel|paclitaxel|mesh-list
6384740|NCT00170664|Carboplatin|carboplatin|mesh-list
6384741|NCT00170664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6384742|NCT00170664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6384743|NCT00170664|Tubulin Modulators|tubulin modulators|mesh-ancestor
6384744|NCT00170664|Antimitotic Agents|antimitotic agents|mesh-ancestor
6384745|NCT00170664|Mitosis Modulators|mitosis modulators|mesh-ancestor
6384746|NCT00170664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384747|NCT00170677|Topotecan|topotecan|mesh-list
6384748|NCT00170677|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6384749|NCT00170677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6384750|NCT00170677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6384751|NCT00170677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384752|NCT00170677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6384753|NCT00170690|Treosulfan|treosulfan|mesh-list
6384754|NCT00170690|Busulfan|busulfan|mesh-list
6384755|NCT00170690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6384756|NCT00170690|Alkylating Agents|alkylating agents|mesh-ancestor
6384757|NCT00170690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384758|NCT00170690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6384759|NCT00170690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6384760|NCT00170690|Immunologic Factors|immunologic factors|mesh-ancestor
6384761|NCT00170690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384762|NCT00170690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6384763|NCT00170729|Prednisolone|prednisolone|mesh-list
6384764|NCT00170729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6384765|NCT00170729|Methylprednisolone|methylprednisolone|mesh-list
6384766|NCT00170729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6384767|NCT00170729|Prednisolone acetate|prednisolone acetate|mesh-list
6384768|NCT00170729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6384769|NCT00170729|Prednisolone phosphate|prednisolone phosphate|mesh-list
6384770|NCT00170729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6384771|NCT00170729|Glucocorticoids|glucocorticoids|mesh-ancestor
6384772|NCT00170729|Hormones|hormones|mesh-ancestor
6384773|NCT00170729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6384774|NCT00170729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384775|NCT00170729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6384776|NCT00170729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6384777|NCT00170729|Antiemetics|antiemetics|mesh-ancestor
6384778|NCT00170729|Autonomic Agents|autonomic agents|mesh-ancestor
6384779|NCT00170729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6384780|NCT00170729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6384781|NCT00170729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6384782|NCT00170729|Protective Agents|protective agents|mesh-ancestor
6384783|NCT00170742|Octreotide|octreotide|mesh-list
6384784|NCT00170742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6384785|NCT00170742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6384786|NCT00170742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6384787|NCT00170755|Darifenacin|darifenacin|mesh-list
6384788|NCT00170755|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6384789|NCT00170755|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6384790|NCT00170755|Cholinergic Agents|cholinergic agents|mesh-ancestor
6384791|NCT00170755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6384792|NCT00170755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384793|NCT00170755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384794|NCT00170755|Urological Agents|urological agents|mesh-ancestor
6384795|NCT00170768|Oxybutynin|oxybutynin|mesh-list
6384796|NCT00170768|Darifenacin|darifenacin|mesh-list
6384797|NCT00170768|Parasympatholytics|parasympatholytics|mesh-ancestor
6384798|NCT00170768|Autonomic Agents|autonomic agents|mesh-ancestor
6384799|NCT00170768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6384800|NCT00170768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384801|NCT00170768|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6384802|NCT00170768|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6384803|NCT00170768|Cholinergic Agents|cholinergic agents|mesh-ancestor
6384804|NCT00170768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6384805|NCT00170768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384806|NCT00170768|Urological Agents|urological agents|mesh-ancestor
6384807|NCT00170781|Lumiracoxib|lumiracoxib|mesh-list
6384808|NCT00170781|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6384809|NCT00170781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6384810|NCT00170781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6384811|NCT00170781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384812|NCT00170781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6384813|NCT00170781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6384814|NCT00170781|Analgesics|analgesics|mesh-ancestor
6384815|NCT00170781|Sensory System Agents|sensory system agents|mesh-ancestor
6384816|NCT00170781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6384817|NCT00170781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384818|NCT00170781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6384819|NCT00170781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6384820|NCT00170794|Everolimus|everolimus|mesh-list
6384821|NCT00170794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6384822|NCT00170794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6384823|NCT00170794|Immunologic Factors|immunologic factors|mesh-ancestor
6384824|NCT00170794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384825|NCT00170820|Everolimus|everolimus|mesh-list
6384826|NCT00170820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6384827|NCT00170820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6384828|NCT00170820|Immunologic Factors|immunologic factors|mesh-ancestor
6384829|NCT00170820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384830|NCT00170833|Everolimus|everolimus|mesh-list
6384831|NCT00170833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6384832|NCT00170833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6384833|NCT00170833|Immunologic Factors|immunologic factors|mesh-ancestor
6384834|NCT00170833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384835|NCT00170859|Everolimus|everolimus|mesh-list
6384836|NCT00170859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6384837|NCT00170859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6384838|NCT00170859|Immunologic Factors|immunologic factors|mesh-ancestor
6384839|NCT00170859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384840|NCT00170872|Lumiracoxib|lumiracoxib|mesh-list
6384841|NCT00170872|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6384842|NCT00170872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6384843|NCT00170872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6384844|NCT00170872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384845|NCT00170872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6384846|NCT00170872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6384847|NCT00170872|Analgesics|analgesics|mesh-ancestor
6384848|NCT00170872|Sensory System Agents|sensory system agents|mesh-ancestor
6384849|NCT00170872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6384850|NCT00170872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384851|NCT00170872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6384852|NCT00170872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6384853|NCT00170885|Everolimus|everolimus|mesh-list
6384854|NCT00170885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6384855|NCT00170885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6384856|NCT00170885|Immunologic Factors|immunologic factors|mesh-ancestor
6384857|NCT00170885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384858|NCT00170898|Lumiracoxib|lumiracoxib|mesh-list
6384859|NCT00170898|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6384860|NCT00170898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6384861|NCT00170898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6384862|NCT00170898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384863|NCT00170898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6384864|NCT00170898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6384865|NCT00170898|Analgesics|analgesics|mesh-ancestor
6384866|NCT00170898|Sensory System Agents|sensory system agents|mesh-ancestor
6384867|NCT00170898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6384868|NCT00170898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384869|NCT00170898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6384870|NCT00170898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6396447|NCT00208793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396448|NCT00208793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6396449|NCT00208793|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6396450|NCT00208819|Valproic Acid|valproic acid|mesh-list
6396451|NCT00208819|Olanzapine|olanzapine|mesh-list
6396452|NCT00208819|Risperidone|risperidone|mesh-list
6396453|NCT00208819|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6396454|NCT00208819|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6396455|NCT00208819|Serotonin Agents|serotonin agents|mesh-ancestor
6396456|NCT00208819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6396457|NCT00208819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396458|NCT00208819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396459|NCT00208819|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6396460|NCT00208819|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6396461|NCT00208819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6396462|NCT00208819|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6396463|NCT00208819|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6396464|NCT00208819|Dopamine Agents|dopamine agents|mesh-ancestor
6396465|NCT00208819|Antiemetics|antiemetics|mesh-ancestor
6396466|NCT00208819|Autonomic Agents|autonomic agents|mesh-ancestor
6396467|NCT00208819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6396468|NCT00208819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6396469|NCT00208819|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6396470|NCT00208819|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6396471|NCT00208819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6396472|NCT00208819|Antidepressive Agents|antidepressive agents|mesh-ancestor
6396473|NCT00208819|Anticonvulsants|anticonvulsants|mesh-ancestor
6384871|NCT00170924|Valsartan|valsartan|mesh-list
6384872|NCT00170924|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6384873|NCT00170924|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6384874|NCT00170924|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6384875|NCT00170924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384876|NCT00170937|Valsartan|valsartan|mesh-list
6384877|NCT00170937|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6384878|NCT00170937|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6384879|NCT00170937|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6384880|NCT00170937|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6384881|NCT00170937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384882|NCT00170937|Diuretics|diuretics|mesh-ancestor
6384883|NCT00170937|Natriuretic Agents|natriuretic agents|mesh-ancestor
6384884|NCT00170937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384885|NCT00170937|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6384886|NCT00170937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6384887|NCT00170963|Amlodipine|amlodipine|mesh-list
6384888|NCT00170963|Valsartan|valsartan|mesh-list
6384889|NCT00170963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6384890|NCT00170963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6384891|NCT00170963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6384892|NCT00170963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384893|NCT00170963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6384894|NCT00170963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384895|NCT00170963|Vasodilator Agents|vasodilator agents|mesh-ancestor
6384896|NCT00170963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6384897|NCT00170963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6384898|NCT00170976|Amlodipine|amlodipine|mesh-list
6384899|NCT00170976|Valsartan|valsartan|mesh-list
6384900|NCT00170976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6384901|NCT00170976|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6384902|NCT00170976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6384903|NCT00170976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384904|NCT00170976|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6384905|NCT00170976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384906|NCT00170976|Vasodilator Agents|vasodilator agents|mesh-ancestor
6384907|NCT00170976|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6384908|NCT00170976|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6384909|NCT00170989|Valsartan|valsartan|mesh-list
6384910|NCT00170989|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6384911|NCT00170989|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6384912|NCT00170989|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6384913|NCT00170989|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6384914|NCT00170989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384915|NCT00170989|Diuretics|diuretics|mesh-ancestor
6384916|NCT00170989|Natriuretic Agents|natriuretic agents|mesh-ancestor
6384917|NCT00170989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384918|NCT00170989|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6384919|NCT00170989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6384920|NCT00171002|Amlodipine|amlodipine|mesh-list
6384921|NCT00171002|Valsartan|valsartan|mesh-list
6384922|NCT00171002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6384923|NCT00171002|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6384924|NCT00171002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6384925|NCT00171002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384926|NCT00171002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6384927|NCT00171002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384928|NCT00171002|Vasodilator Agents|vasodilator agents|mesh-ancestor
6384929|NCT00171002|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6384930|NCT00171002|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6384931|NCT00171015|Valsartan|valsartan|mesh-list
6384932|NCT00171015|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6384933|NCT00171015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6384934|NCT00171015|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6384935|NCT00171015|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6384936|NCT00171015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384937|NCT00171015|Diuretics|diuretics|mesh-ancestor
6384938|NCT00171015|Natriuretic Agents|natriuretic agents|mesh-ancestor
6384939|NCT00171015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384940|NCT00171015|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6384941|NCT00171015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6384942|NCT00171028|Valsartan|valsartan|mesh-list
6384943|NCT00171028|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6384944|NCT00171028|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6384945|NCT00171028|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6384946|NCT00171028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384947|NCT00171041|Valsartan|valsartan|mesh-list
6384948|NCT00171041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6384949|NCT00171041|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6384950|NCT00171041|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6384951|NCT00171041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384952|NCT00171067|Valsartan|valsartan|mesh-list
6384953|NCT00171067|Lisinopril|lisinopril|mesh-list
6384954|NCT00171067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6384955|NCT00171067|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6384956|NCT00171067|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6384957|NCT00171067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384958|NCT00171067|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6384959|NCT00171067|Protease Inhibitors|protease inhibitors|mesh-ancestor
6384960|NCT00171067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6384961|NCT00171067|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6384962|NCT00171067|Protective Agents|protective agents|mesh-ancestor
6384963|NCT00171067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6384964|NCT00171080|Valsartan|valsartan|mesh-list
6384965|NCT00171080|Irbesartan|irbesartan|mesh-list
6384966|NCT00171080|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6384967|NCT00171080|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6384968|NCT00171080|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6384969|NCT00171080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384970|NCT00171093|Valsartan|valsartan|mesh-list
6384971|NCT00171093|Simvastatin|simvastatin|mesh-list
6384972|NCT00171093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6384973|NCT00171093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6384974|NCT00171093|Antimetabolites|antimetabolites|mesh-ancestor
6384975|NCT00171093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384976|NCT00171093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6384977|NCT00171093|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6384978|NCT00171093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6384979|NCT00171093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6384980|NCT00171093|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6384981|NCT00171093|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6384982|NCT00171106|Valsartan|valsartan|mesh-list
6384983|NCT00171106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6384984|NCT00171106|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6384985|NCT00171106|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6384986|NCT00171106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384987|NCT00171119|Valsartan|valsartan|mesh-list
6384988|NCT00171119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6384989|NCT00171119|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6384990|NCT00171119|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6384991|NCT00171119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384992|NCT00171132|Atenolol|atenolol|mesh-list
6384993|NCT00171132|Valsartan|valsartan|mesh-list
6384994|NCT00171132|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6384995|NCT00171132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6384996|NCT00171132|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6384997|NCT00171132|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6384998|NCT00171132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6384999|NCT00171132|Diuretics|diuretics|mesh-ancestor
6385000|NCT00171132|Natriuretic Agents|natriuretic agents|mesh-ancestor
6385001|NCT00171132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385002|NCT00171132|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6385003|NCT00171132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6385004|NCT00171132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6385005|NCT00171132|Sympatholytics|sympatholytics|mesh-ancestor
6385006|NCT00171132|Autonomic Agents|autonomic agents|mesh-ancestor
6385007|NCT00171132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6385008|NCT00171132|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6385009|NCT00171132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6385010|NCT00171132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6385011|NCT00171132|Adrenergic Agents|adrenergic agents|mesh-ancestor
6385012|NCT00171132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6385013|NCT00171145|Darifenacin|darifenacin|mesh-list
6385014|NCT00171145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6385015|NCT00171145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6385016|NCT00171145|Cholinergic Agents|cholinergic agents|mesh-ancestor
6385017|NCT00171145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6385018|NCT00171145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385019|NCT00171145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385020|NCT00171145|Urological Agents|urological agents|mesh-ancestor
6385021|NCT00171171|Deferasirox|deferasirox|mesh-list
6385022|NCT00171171|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6385023|NCT00171171|Chelating Agents|chelating agents|mesh-ancestor
6385024|NCT00171171|Sequestering Agents|sequestering agents|mesh-ancestor
6385025|NCT00171171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385026|NCT00171184|Darifenacin|darifenacin|mesh-list
6385027|NCT00171184|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6385028|NCT00171184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6385029|NCT00171184|Cholinergic Agents|cholinergic agents|mesh-ancestor
6385030|NCT00171184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6385031|NCT00171184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385032|NCT00171184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385033|NCT00171184|Urological Agents|urological agents|mesh-ancestor
6385034|NCT00171288|Ezetimibe|ezetimibe|mesh-list
6385035|NCT00171288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6385036|NCT00171288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6385037|NCT00171288|Antimetabolites|antimetabolites|mesh-ancestor
6385038|NCT00171288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385039|NCT00171288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6385040|NCT00171327|Valsartan|valsartan|mesh-list
6385041|NCT00171327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6385042|NCT00171327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6385043|NCT00171327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6385044|NCT00171327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385045|NCT00171353|Valsartan|valsartan|mesh-list
6385046|NCT00171353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6385047|NCT00171353|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6385048|NCT00171353|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6385049|NCT00171353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385050|NCT00171366|Amlodipine|amlodipine|mesh-list
6385051|NCT00171366|Benazepril|benazepril|mesh-list
6385052|NCT00171366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6385053|NCT00171366|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6385054|NCT00171366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6385055|NCT00171366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385056|NCT00171366|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6385057|NCT00171366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385058|NCT00171366|Vasodilator Agents|vasodilator agents|mesh-ancestor
6385059|NCT00171366|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6385060|NCT00171366|Protease Inhibitors|protease inhibitors|mesh-ancestor
6385061|NCT00171366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6385062|NCT00171379|Mycophenolic Acid|mycophenolic acid|mesh-list
6385063|NCT00171379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6385064|NCT00171379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6385065|NCT00171379|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6385066|NCT00171379|Antitubercular Agents|antitubercular agents|mesh-ancestor
6385067|NCT00171379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6385068|NCT00171379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6385069|NCT00171379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6385070|NCT00171379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385071|NCT00171392|Mycophenolic Acid|mycophenolic acid|mesh-list
6385072|NCT00171392|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6385073|NCT00171392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6385074|NCT00171392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6385075|NCT00171392|Antitubercular Agents|antitubercular agents|mesh-ancestor
6385076|NCT00171392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6385077|NCT00171392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6385078|NCT00171392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6385079|NCT00171392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385080|NCT00171418|Tegaserod|tegaserod|mesh-list
6385081|NCT00171418|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6385082|NCT00171418|Serotonin Agents|serotonin agents|mesh-ancestor
6385083|NCT00171418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6385084|NCT00171418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385085|NCT00171418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385086|NCT00171431|Tegaserod|tegaserod|mesh-list
6385087|NCT00171431|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6385088|NCT00171431|Serotonin Agents|serotonin agents|mesh-ancestor
6385089|NCT00171431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6385090|NCT00171431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385091|NCT00171431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385092|NCT00171457|Tegaserod|tegaserod|mesh-list
6385093|NCT00171457|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6385094|NCT00171457|Serotonin Agents|serotonin agents|mesh-ancestor
6385095|NCT00171457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6385096|NCT00171457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385097|NCT00171457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385098|NCT00171470|Tegaserod|tegaserod|mesh-list
6385099|NCT00171470|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6385100|NCT00171470|Serotonin Agents|serotonin agents|mesh-ancestor
6385101|NCT00171470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6385102|NCT00171470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385103|NCT00171470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385104|NCT00171483|Tegaserod|tegaserod|mesh-list
6385105|NCT00171483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6385106|NCT00171483|Serotonin Agents|serotonin agents|mesh-ancestor
6385107|NCT00171483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6385108|NCT00171483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385109|NCT00171483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385110|NCT00171496|Cyclosporine|cyclosporine|mesh-list
6385111|NCT00171496|Tacrolimus|tacrolimus|mesh-list
6385112|NCT00171496|Cyclosporins|cyclosporins|mesh-list
6385113|NCT00171496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6385114|NCT00171496|Immunologic Factors|immunologic factors|mesh-ancestor
6385115|NCT00171496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385116|NCT00171496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6385117|NCT00171496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6385118|NCT00171496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385119|NCT00171496|Antifungal Agents|antifungal agents|mesh-ancestor
6385120|NCT00171496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6385121|NCT00171496|Dermatologic Agents|dermatologic agents|mesh-ancestor
6385122|NCT00171496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6385123|NCT00171509|Cyclosporine|cyclosporine|mesh-list
6385124|NCT00171509|Cyclosporins|cyclosporins|mesh-list
6385125|NCT00171509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6385126|NCT00171509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385127|NCT00171509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6385128|NCT00171509|Immunologic Factors|immunologic factors|mesh-ancestor
6385129|NCT00171509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385130|NCT00171509|Antifungal Agents|antifungal agents|mesh-ancestor
6385131|NCT00171509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6385132|NCT00171509|Dermatologic Agents|dermatologic agents|mesh-ancestor
6385133|NCT00171509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6385134|NCT00171509|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6385135|NCT00171522|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
6385136|NCT00171522|Tegaserod|tegaserod|mesh-list
6385137|NCT00171522|Laxatives|laxatives|mesh-ancestor
6385138|NCT00171522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6385139|NCT00171522|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6385140|NCT00171522|Serotonin Agents|serotonin agents|mesh-ancestor
6385141|NCT00171522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6385142|NCT00171522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385143|NCT00171522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385144|NCT00171535|Amlodipine|amlodipine|mesh-list
6385145|NCT00171535|Valsartan|valsartan|mesh-list
6385146|NCT00171535|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6385147|NCT00171535|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6385148|NCT00171535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6385149|NCT00171535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385150|NCT00171535|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6385151|NCT00171535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385152|NCT00171535|Vasodilator Agents|vasodilator agents|mesh-ancestor
6385153|NCT00171535|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6385154|NCT00171535|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6385155|NCT00171561|Valsartan|valsartan|mesh-list
6385156|NCT00171561|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6385157|NCT00171561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6385158|NCT00171561|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6385159|NCT00171561|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6385160|NCT00171561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385161|NCT00171561|Diuretics|diuretics|mesh-ancestor
6385162|NCT00171561|Natriuretic Agents|natriuretic agents|mesh-ancestor
6385163|NCT00171561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385164|NCT00171561|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6385165|NCT00171561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6385166|NCT00171574|Valsartan|valsartan|mesh-list
6385167|NCT00171574|Lisinopril|lisinopril|mesh-list
6385168|NCT00171574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6385169|NCT00171574|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6385170|NCT00171574|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6385171|NCT00171574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385172|NCT00171574|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6385173|NCT00171574|Protease Inhibitors|protease inhibitors|mesh-ancestor
6385174|NCT00171574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6385175|NCT00171574|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6385176|NCT00171574|Protective Agents|protective agents|mesh-ancestor
6385177|NCT00171574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385178|NCT00171587|Vatalanib|vatalanib|mesh-list
6385179|NCT00171587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6385180|NCT00171587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6385181|NCT00171587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385182|NCT00171600|Valsartan|valsartan|mesh-list
6385183|NCT00171600|Lisinopril|lisinopril|mesh-list
6385184|NCT00171600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6385185|NCT00171600|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6385186|NCT00171600|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6385187|NCT00171600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385188|NCT00171600|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6385189|NCT00171600|Protease Inhibitors|protease inhibitors|mesh-ancestor
6385190|NCT00171600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6385191|NCT00171600|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6385192|NCT00171600|Protective Agents|protective agents|mesh-ancestor
6385193|NCT00171600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385194|NCT00171613|Octreotide|octreotide|mesh-list
6385195|NCT00171613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6385196|NCT00171613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6385197|NCT00171613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6385198|NCT00171626|Diclofenac|diclofenac|mesh-list
6385199|NCT00171626|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6385200|NCT00171626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6385201|NCT00171626|Analgesics|analgesics|mesh-ancestor
6385202|NCT00171626|Sensory System Agents|sensory system agents|mesh-ancestor
6385203|NCT00171626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6385204|NCT00171626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385205|NCT00171626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6385206|NCT00171626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6385207|NCT00171626|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6385208|NCT00171626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6385209|NCT00171626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385210|NCT00171639|Zoledronic Acid|zoledronic acid|mesh-list
6385211|NCT00171639|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6385212|NCT00171639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385213|NCT00171652|Diclofenac|diclofenac|mesh-list
6385214|NCT00171652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6385215|NCT00171652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6385216|NCT00171652|Analgesics|analgesics|mesh-ancestor
6385217|NCT00171652|Sensory System Agents|sensory system agents|mesh-ancestor
6385218|NCT00171652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6385219|NCT00171652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385220|NCT00171652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6385221|NCT00171652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6385222|NCT00171652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6385223|NCT00171652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6385224|NCT00171652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385225|NCT00171665|Diclofenac|diclofenac|mesh-list
6385226|NCT00171665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6385227|NCT00171665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6385228|NCT00171665|Analgesics|analgesics|mesh-ancestor
6385229|NCT00171665|Sensory System Agents|sensory system agents|mesh-ancestor
6385230|NCT00171665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6385231|NCT00171665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385232|NCT00171665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6385233|NCT00171665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6385234|NCT00171665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6385235|NCT00171665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6385236|NCT00171665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385237|NCT00171678|Diclofenac|diclofenac|mesh-list
6385238|NCT00171678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6385239|NCT00171678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6385240|NCT00171678|Analgesics|analgesics|mesh-ancestor
6385241|NCT00171678|Sensory System Agents|sensory system agents|mesh-ancestor
6385242|NCT00171678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6385243|NCT00171678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385244|NCT00171678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6385245|NCT00171678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6385246|NCT00171678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6385247|NCT00171678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6385248|NCT00171678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385249|NCT00171691|Diclofenac|diclofenac|mesh-list
6385250|NCT00171691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6385251|NCT00171691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6385252|NCT00171691|Analgesics|analgesics|mesh-ancestor
6385253|NCT00171691|Sensory System Agents|sensory system agents|mesh-ancestor
6385254|NCT00171691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6385255|NCT00171691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385256|NCT00171691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6385257|NCT00171691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6385258|NCT00171691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6385259|NCT00171691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6385260|NCT00171691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385261|NCT00171717|Cyclosporine|cyclosporine|mesh-list
6385262|NCT00171717|Cyclosporins|cyclosporins|mesh-list
6385263|NCT00171717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6385264|NCT00171717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385265|NCT00171717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6385266|NCT00171717|Immunologic Factors|immunologic factors|mesh-ancestor
6385267|NCT00171717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385268|NCT00171717|Antifungal Agents|antifungal agents|mesh-ancestor
6385269|NCT00171717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6385270|NCT00171717|Dermatologic Agents|dermatologic agents|mesh-ancestor
6385271|NCT00171717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6385272|NCT00171717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6385273|NCT00171743|Cyclosporine|cyclosporine|mesh-list
6385274|NCT00171743|Cyclosporins|cyclosporins|mesh-list
6385275|NCT00171743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6385276|NCT00171743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385277|NCT00171743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6385278|NCT00171743|Immunologic Factors|immunologic factors|mesh-ancestor
6385279|NCT00171743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385280|NCT00171743|Antifungal Agents|antifungal agents|mesh-ancestor
6385281|NCT00171743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6385282|NCT00171743|Dermatologic Agents|dermatologic agents|mesh-ancestor
6385283|NCT00171743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6385284|NCT00171743|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6385285|NCT00171756|Atenolol|atenolol|mesh-list
6385286|NCT00171756|Valsartan|valsartan|mesh-list
6385287|NCT00171756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6385288|NCT00171756|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6385289|NCT00171756|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6385290|NCT00171756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385291|NCT00171756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6385292|NCT00171756|Sympatholytics|sympatholytics|mesh-ancestor
6385293|NCT00171756|Autonomic Agents|autonomic agents|mesh-ancestor
6385294|NCT00171756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6385295|NCT00171756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385296|NCT00171756|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6385297|NCT00171756|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6385298|NCT00171756|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6385299|NCT00171756|Adrenergic Agents|adrenergic agents|mesh-ancestor
6385300|NCT00171756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6385301|NCT00171769|Certoparin|certoparin|mesh-list
6385302|NCT00171769|Anticoagulants|anticoagulants|mesh-ancestor
6385303|NCT00171782|Valsartan|valsartan|mesh-list
6385304|NCT00171782|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6385305|NCT00171782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6385306|NCT00171782|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6385307|NCT00171782|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6385308|NCT00171782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385309|NCT00171782|Diuretics|diuretics|mesh-ancestor
6385310|NCT00171782|Natriuretic Agents|natriuretic agents|mesh-ancestor
6385311|NCT00171782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385312|NCT00171782|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6385313|NCT00171782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6385314|NCT00171795|Rivastigmine|rivastigmine|mesh-list
6385315|NCT00171795|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6385316|NCT00171795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6385317|NCT00171795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385318|NCT00171795|Cholinergic Agents|cholinergic agents|mesh-ancestor
6385319|NCT00171795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6385320|NCT00171795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385321|NCT00171795|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6385322|NCT00171795|Protective Agents|protective agents|mesh-ancestor
6385323|NCT00171808|Letrozole|letrozole|mesh-list
6385324|NCT00171808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6385325|NCT00171808|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6385326|NCT00171808|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6385327|NCT00171808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6385328|NCT00171808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385329|NCT00171808|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6385330|NCT00171808|Hormone Antagonists|hormone antagonists|mesh-ancestor
6385331|NCT00171808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6385332|NCT00171808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385333|NCT00171821|Deferasirox|deferasirox|mesh-list
6385334|NCT00171821|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6385335|NCT00171821|Chelating Agents|chelating agents|mesh-ancestor
6385336|NCT00171821|Sequestering Agents|sequestering agents|mesh-ancestor
6385337|NCT00171821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385338|NCT00171847|Trastuzumab|trastuzumab|mesh-list
6385339|NCT00171847|Letrozole|letrozole|mesh-list
6385340|NCT00171847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6385341|NCT00171847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6385342|NCT00171847|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6385343|NCT00171847|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6385344|NCT00171847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6385345|NCT00171847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385346|NCT00171847|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6385347|NCT00171847|Hormone Antagonists|hormone antagonists|mesh-ancestor
6385348|NCT00171847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6385349|NCT00171847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385350|NCT00171860|Imatinib Mesylate|imatinib mesylate|mesh-list
6385351|NCT00171860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6385352|NCT00171860|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6385353|NCT00171860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6385354|NCT00171860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385355|NCT00171886|Octreotide|octreotide|mesh-list
6385356|NCT00171886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6385357|NCT00171886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6385358|NCT00171886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6385359|NCT00171899|Imatinib Mesylate|imatinib mesylate|mesh-list
6385360|NCT00171899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6385361|NCT00171899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6385362|NCT00171899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6385363|NCT00171899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385364|NCT00171912|Imatinib Mesylate|imatinib mesylate|mesh-list
6385365|NCT00171912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6385366|NCT00171912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6385367|NCT00171912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6385368|NCT00171912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385369|NCT00171938|Imatinib Mesylate|imatinib mesylate|mesh-list
6385370|NCT00171938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6385371|NCT00171938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6385372|NCT00171938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6385373|NCT00171938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385374|NCT00171964|Zoledronic Acid|zoledronic acid|mesh-list
6385375|NCT00171964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6385376|NCT00171964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385377|NCT00171977|Imatinib Mesylate|imatinib mesylate|mesh-list
6385378|NCT00171977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6385379|NCT00171977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6385380|NCT00171977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6385381|NCT00171977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385382|NCT00171990|Famciclovir|famciclovir|mesh-list
6385383|NCT00171990|Antiviral Agents|antiviral agents|mesh-ancestor
6385384|NCT00171990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6385385|NCT00171990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6385386|NCT00171990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6385387|NCT00171990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385388|NCT00172003|Zoledronic Acid|zoledronic acid|mesh-list
6385389|NCT00172003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6385390|NCT00172003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385391|NCT00172016|Zoledronic Acid|zoledronic acid|mesh-list
6385392|NCT00172016|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6385393|NCT00172016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385394|NCT00172029|Zoledronic Acid|zoledronic acid|mesh-list
6385395|NCT00172029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6385396|NCT00172029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385397|NCT00172055|Zoledronic Acid|zoledronic acid|mesh-list
6385398|NCT00172055|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6385399|NCT00172055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385400|NCT00172068|Vitamin D|vitamin d|mesh-list
6385401|NCT00172068|Zoledronic Acid|zoledronic acid|mesh-list
6385402|NCT00172068|Calcium|calcium|mesh-list
6385403|NCT00172068|Vitamins|vitamins|mesh-ancestor
6385404|NCT00172068|Micronutrients|micronutrients|mesh-ancestor
6385405|NCT00172068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385406|NCT00172068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6385407|NCT00172068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6385408|NCT00172107|Parathyroid Hormone|parathyroid hormone|mesh-list
6385409|NCT00172107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6385410|NCT00172107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385411|NCT00172172|Calcium|calcium|mesh-list
6385412|NCT00172172|Parathyroid Hormone|parathyroid hormone|mesh-list
6385413|NCT00172172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6385414|NCT00172172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385415|NCT00172302|Ascorbic Acid|ascorbic acid|mesh-list
6385416|NCT00172302|Vitamins|vitamins|mesh-ancestor
6385417|NCT00172302|Micronutrients|micronutrients|mesh-ancestor
6385418|NCT00172302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385419|NCT00172302|Antioxidants|antioxidants|mesh-ancestor
6385420|NCT00172302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385421|NCT00172302|Protective Agents|protective agents|mesh-ancestor
6385422|NCT00172354|Hydrocortisone|hydrocortisone|mesh-list
6385423|NCT00172354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6385424|NCT00172367|Lycopene|lycopene|mesh-list
6385425|NCT00172367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6385426|NCT00172367|Antioxidants|antioxidants|mesh-ancestor
6385427|NCT00172367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385428|NCT00172367|Protective Agents|protective agents|mesh-ancestor
6385429|NCT00172367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385430|NCT00172367|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6385431|NCT00172367|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6385432|NCT00172367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6385433|NCT00172380|Docetaxel|docetaxel|mesh-list
6385434|NCT00172380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6385435|NCT00172380|Tubulin Modulators|tubulin modulators|mesh-ancestor
6385436|NCT00172380|Antimitotic Agents|antimitotic agents|mesh-ancestor
6385437|NCT00172380|Mitosis Modulators|mitosis modulators|mesh-ancestor
6385438|NCT00172380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385439|NCT00172419|Atorvastatin|atorvastatin|mesh-list
6385440|NCT00172419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6385441|NCT00172419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6385442|NCT00172419|Antimetabolites|antimetabolites|mesh-ancestor
6385443|NCT00172419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385444|NCT00172419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6385445|NCT00172419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6385446|NCT00172419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6396474|NCT00208819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6396475|NCT00208819|GABA Agents|gaba agents|mesh-ancestor
6396476|NCT00208819|Antimanic Agents|antimanic agents|mesh-ancestor
6396477|NCT00208858|Topiramate|topiramate|mesh-list
6396478|NCT00208858|Anticonvulsants|anticonvulsants|mesh-ancestor
6396479|NCT00208858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6396480|NCT00208858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396481|NCT00208897|Fluoxetine|fluoxetine|mesh-list
6396482|NCT00208897|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6396483|NCT00208897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6396484|NCT00208897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6396485|NCT00208897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396486|NCT00208897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6396487|NCT00208897|Serotonin Agents|serotonin agents|mesh-ancestor
6396488|NCT00208897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396489|NCT00208897|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6396490|NCT00208897|Antidepressive Agents|antidepressive agents|mesh-ancestor
6396491|NCT00208897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6396492|NCT00208897|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6396493|NCT00208897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6396494|NCT00208897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6396495|NCT00208923|Cyclophosphamide|cyclophosphamide|mesh-list
6396496|NCT00208923|Busulfan|busulfan|mesh-list
6396497|NCT00208923|Fludarabine|fludarabine|mesh-list
6396498|NCT00208923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6396499|NCT00208923|Immunologic Factors|immunologic factors|mesh-ancestor
6396500|NCT00208923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396501|NCT00208923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6396502|NCT00208923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6396503|NCT00208923|Alkylating Agents|alkylating agents|mesh-ancestor
6396504|NCT00208923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396505|NCT00208923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6396506|NCT00208923|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6396507|NCT00208936|Fluorouracil|fluorouracil|mesh-list
6396508|NCT00208936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6396509|NCT00208936|Antimetabolites|antimetabolites|mesh-ancestor
6396510|NCT00208936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396511|NCT00208936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6396512|NCT00208936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6396513|NCT00208936|Immunologic Factors|immunologic factors|mesh-ancestor
6396514|NCT00208936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396515|NCT00209014|Thalidomide|thalidomide|mesh-list
6396516|NCT00209014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6396517|NCT00209014|Immunologic Factors|immunologic factors|mesh-ancestor
6396518|NCT00209014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396519|NCT00209014|Leprostatic Agents|leprostatic agents|mesh-ancestor
6396520|NCT00209014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6396521|NCT00209014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6396522|NCT00209014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6396523|NCT00209014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6396524|NCT00209014|Growth Substances|growth substances|mesh-ancestor
6396525|NCT00209014|Growth Inhibitors|growth inhibitors|mesh-ancestor
6396526|NCT00209014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6396527|NCT00209079|Docetaxel|docetaxel|mesh-list
6396528|NCT00209079|Imatinib Mesylate|imatinib mesylate|mesh-list
6396529|NCT00209079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6396530|NCT00209079|Tubulin Modulators|tubulin modulators|mesh-ancestor
6396531|NCT00209079|Antimitotic Agents|antimitotic agents|mesh-ancestor
6385447|NCT00172809|Interferons|interferons|mesh-list
6385448|NCT00172809|Interferon-alpha|interferon-alpha|mesh-list
6385449|NCT00172809|Interferon alpha-2|interferon alpha-2|mesh-list
6385450|NCT00172809|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6385451|NCT00172809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6385452|NCT00172809|Antiviral Agents|antiviral agents|mesh-ancestor
6385453|NCT00172809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6385454|NCT00172809|Immunologic Factors|immunologic factors|mesh-ancestor
6385455|NCT00172809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385456|NCT00173667|Nifedipine|nifedipine|mesh-list
6385457|NCT00173667|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6385458|NCT00173667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6385459|NCT00173667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385460|NCT00173667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6385461|NCT00173667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385462|NCT00173667|Vasodilator Agents|vasodilator agents|mesh-ancestor
6385463|NCT00173667|Tocolytic Agents|tocolytic agents|mesh-ancestor
6385464|NCT00173667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6396532|NCT00209079|Mitosis Modulators|mitosis modulators|mesh-ancestor
6396533|NCT00209079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396534|NCT00209079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6396535|NCT00209079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6396536|NCT00209118|Paroxetine|paroxetine|mesh-list
6396537|NCT00209118|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6396538|NCT00209118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6396539|NCT00209118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6396540|NCT00209118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396541|NCT00209118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6396542|NCT00209118|Serotonin Agents|serotonin agents|mesh-ancestor
6396543|NCT00209118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396544|NCT00209118|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6396545|NCT00209118|Antidepressive Agents|antidepressive agents|mesh-ancestor
6396546|NCT00209118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6396547|NCT00209118|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6396548|NCT00209118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6396549|NCT00209118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6396550|NCT00209144|Insulin|insulin|mesh-list
6396551|NCT00209144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6396552|NCT00209144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396553|NCT00209209|Interferons|interferons|mesh-list
6396554|NCT00209209|Interferon-alpha|interferon-alpha|mesh-list
6396555|NCT00209209|Interferon alpha-2|interferon alpha-2|mesh-list
6396556|NCT00209209|Prednisone|prednisone|mesh-list
6396557|NCT00209209|Cyclophosphamide|cyclophosphamide|mesh-list
6396558|NCT00209209|Rituximab|rituximab|mesh-list
6396559|NCT00209209|Doxorubicin|doxorubicin|mesh-list
6396560|NCT00209209|Fludarabine|fludarabine|mesh-list
6396561|NCT00209209|Vincristine|vincristine|mesh-list
6396562|NCT00209209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6396563|NCT00209209|Immunologic Factors|immunologic factors|mesh-ancestor
6396564|NCT00209209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396565|NCT00209209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6396566|NCT00209209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6396567|NCT00209209|Alkylating Agents|alkylating agents|mesh-ancestor
6396568|NCT00209209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396569|NCT00209209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6396570|NCT00209209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6396571|NCT00209209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6396572|NCT00209209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6396573|NCT00209209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6396574|NCT00209209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6396575|NCT00209209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6396576|NCT00209209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6396577|NCT00209209|Glucocorticoids|glucocorticoids|mesh-ancestor
6396578|NCT00209209|Hormones|hormones|mesh-ancestor
6396579|NCT00209209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6396580|NCT00209209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6396581|NCT00209209|Antiviral Agents|antiviral agents|mesh-ancestor
6396582|NCT00209209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6396583|NCT00209209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6396584|NCT00209209|Tubulin Modulators|tubulin modulators|mesh-ancestor
6385465|NCT00173745|Botulinum Toxins|botulinum toxins|mesh-list
6385466|NCT00173745|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6385467|NCT00173745|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6385468|NCT00173745|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6385469|NCT00173745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6385470|NCT00173745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385471|NCT00173745|Cholinergic Agents|cholinergic agents|mesh-ancestor
6385472|NCT00173745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6385473|NCT00173745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385474|NCT00173745|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6385475|NCT00173745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6385476|NCT00173862|Gemcitabine|gemcitabine|mesh-list
6385477|NCT00173862|Ifosfamide|ifosfamide|mesh-list
6385478|NCT00173862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6385479|NCT00173862|Antimetabolites|antimetabolites|mesh-ancestor
6385480|NCT00173862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385481|NCT00173862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6385482|NCT00173862|Antiviral Agents|antiviral agents|mesh-ancestor
6385483|NCT00173862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6385484|NCT00173862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6385485|NCT00173862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6385486|NCT00173862|Immunologic Factors|immunologic factors|mesh-ancestor
6385487|NCT00173862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385488|NCT00173862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6385489|NCT00173862|Alkylating Agents|alkylating agents|mesh-ancestor
6385490|NCT00173875|Gefitinib|gefitinib|mesh-list
6385491|NCT00173875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6385492|NCT00173875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6385493|NCT00173875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6385494|NCT00173875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385495|NCT00173888|Gemcitabine|gemcitabine|mesh-list
6385496|NCT00173888|Cisplatin|cisplatin|mesh-list
6385497|NCT00173888|Docetaxel|docetaxel|mesh-list
6385498|NCT00173888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6385499|NCT00173888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6385500|NCT00173888|Antimetabolites|antimetabolites|mesh-ancestor
6385501|NCT00173888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385502|NCT00173888|Antiviral Agents|antiviral agents|mesh-ancestor
6385503|NCT00173888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6385504|NCT00173888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6385505|NCT00173888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6385506|NCT00173888|Immunologic Factors|immunologic factors|mesh-ancestor
6385507|NCT00173888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385508|NCT00173888|Tubulin Modulators|tubulin modulators|mesh-ancestor
6385509|NCT00173888|Antimitotic Agents|antimitotic agents|mesh-ancestor
6385510|NCT00173888|Mitosis Modulators|mitosis modulators|mesh-ancestor
6385511|NCT00173901|Ceftazidime|ceftazidime|mesh-list
6385512|NCT00173901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6385513|NCT00173901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6385514|NCT00174174|Modafinil|modafinil|mesh-list
6385515|NCT00174174|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6385516|NCT00174174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385517|NCT00174174|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6385518|NCT00174174|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6385519|NCT00174174|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6385520|NCT00174174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385521|NCT00174200|Risperidone|risperidone|mesh-list
6385522|NCT00174200|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6385523|NCT00174200|Serotonin Agents|serotonin agents|mesh-ancestor
6385524|NCT00174200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6385525|NCT00174200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385526|NCT00174200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385527|NCT00174200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6385528|NCT00174200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6385529|NCT00174200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6385530|NCT00174200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6385531|NCT00174200|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6385532|NCT00174200|Dopamine Agents|dopamine agents|mesh-ancestor
6385533|NCT00174226|Buspirone|buspirone|mesh-list
6385534|NCT00174226|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6385535|NCT00174226|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6385536|NCT00174226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6385537|NCT00174226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6385538|NCT00174226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385539|NCT00174226|Adrenergic Agents|adrenergic agents|mesh-ancestor
6385540|NCT00174226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6385541|NCT00174226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385542|NCT00174226|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6385543|NCT00174226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6385544|NCT00174226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6385545|NCT00174226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6385546|NCT00174226|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6385547|NCT00174226|Serotonin Agents|serotonin agents|mesh-ancestor
6385548|NCT00174239|Levodopa|levodopa|mesh-list
6385549|NCT00174239|Carbidopa|carbidopa|mesh-list
6385550|NCT00174239|Cabergoline|cabergoline|mesh-list
6385551|NCT00174239|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6385552|NCT00174239|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6385553|NCT00174239|Dopamine Agents|dopamine agents|mesh-ancestor
6385554|NCT00174239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6385555|NCT00174239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385556|NCT00174239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385557|NCT00174239|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6385558|NCT00174239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6385559|NCT00174239|Dopamine Agonists|dopamine agonists|mesh-ancestor
6537226|NCT00821444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6537227|NCT00821444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537228|NCT00821444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385560|NCT00174304|Amlodipine|amlodipine|mesh-list
6385561|NCT00174304|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
6385562|NCT00174304|Atorvastatin|atorvastatin|mesh-list
6385563|NCT00174304|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6385564|NCT00174304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6537229|NCT00821444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6537230|NCT00821444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6385565|NCT00174304|Antimetabolites|antimetabolites|mesh-ancestor
6385566|NCT00174304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385567|NCT00174304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6385568|NCT00174304|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6385569|NCT00174304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6385570|NCT00174304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6385571|NCT00174304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6385572|NCT00174304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6385573|NCT00174304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6385574|NCT00174304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385575|NCT00174304|Vasodilator Agents|vasodilator agents|mesh-ancestor
6385576|NCT00174317|Celecoxib|celecoxib|mesh-list
6385577|NCT00174317|Diclofenac|diclofenac|mesh-list
6385578|NCT00174317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6385579|NCT00174317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6385580|NCT00174317|Analgesics|analgesics|mesh-ancestor
6385581|NCT00174317|Sensory System Agents|sensory system agents|mesh-ancestor
6385582|NCT00174317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6385583|NCT00174317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385584|NCT00174317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6385585|NCT00174317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6385586|NCT00174317|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6385587|NCT00174317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6385588|NCT00174317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6385589|NCT00174317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385590|NCT00174330|Amlodipine|amlodipine|mesh-list
6385591|NCT00174330|Atorvastatin|atorvastatin|mesh-list
6385592|NCT00174330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6385593|NCT00174330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6385594|NCT00174330|Antimetabolites|antimetabolites|mesh-ancestor
6385595|NCT00174330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385596|NCT00174330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6385597|NCT00174330|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6385598|NCT00174330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6385599|NCT00174330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6385600|NCT00174330|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6385601|NCT00174330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6385602|NCT00174330|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6385603|NCT00174330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385604|NCT00174330|Vasodilator Agents|vasodilator agents|mesh-ancestor
6385605|NCT00174343|Exemestane|exemestane|mesh-list
6385606|NCT00174343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6385607|NCT00174343|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6385608|NCT00174343|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6385609|NCT00174343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6385610|NCT00174343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385611|NCT00174343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6385612|NCT00174343|Hormone Antagonists|hormone antagonists|mesh-ancestor
6385613|NCT00174343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6385614|NCT00174343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385615|NCT00174356|Paclitaxel|paclitaxel|mesh-list
6385616|NCT00174356|Carboplatin|carboplatin|mesh-list
6385617|NCT00174356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6385618|NCT00174356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6385619|NCT00174356|Tubulin Modulators|tubulin modulators|mesh-ancestor
6385620|NCT00174356|Antimitotic Agents|antimitotic agents|mesh-ancestor
6385621|NCT00174356|Mitosis Modulators|mitosis modulators|mesh-ancestor
6385622|NCT00174356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385623|NCT00174395|Eletriptan|eletriptan|mesh-list
6385624|NCT00174395|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6385625|NCT00174395|Serotonin Agents|serotonin agents|mesh-ancestor
6385626|NCT00174395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6385627|NCT00174395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385628|NCT00174395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385629|NCT00174434|Paclitaxel|paclitaxel|mesh-list
6385630|NCT00174434|Sunitinib|sunitinib|mesh-list
6385631|NCT00174434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6385632|NCT00174434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6385633|NCT00174434|Tubulin Modulators|tubulin modulators|mesh-ancestor
6385634|NCT00174434|Antimitotic Agents|antimitotic agents|mesh-ancestor
6385635|NCT00174434|Mitosis Modulators|mitosis modulators|mesh-ancestor
6385636|NCT00174434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385637|NCT00174434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6385638|NCT00174434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6385639|NCT00174434|Growth Substances|growth substances|mesh-ancestor
6385640|NCT00174434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385641|NCT00174434|Growth Inhibitors|growth inhibitors|mesh-ancestor
6385642|NCT00174434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6385643|NCT00174434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6385644|NCT00174473|Voriconazole|voriconazole|mesh-list
6385645|NCT00174473|Antifungal Agents|antifungal agents|mesh-ancestor
6385646|NCT00174473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6385647|NCT00174473|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6385648|NCT00174473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6385649|NCT00174473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6385650|NCT00174473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385651|NCT00174473|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6385652|NCT00174473|Hormone Antagonists|hormone antagonists|mesh-ancestor
6385653|NCT00174473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6385654|NCT00174473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385655|NCT00174473|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6385656|NCT00174486|Tadalafil|tadalafil|mesh-list
6385657|NCT00174486|Vasodilator Agents|vasodilator agents|mesh-ancestor
6385658|NCT00174486|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6385659|NCT00174486|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6385660|NCT00174486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6385661|NCT00174486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385662|NCT00174486|Urological Agents|urological agents|mesh-ancestor
6385663|NCT00174499|Nicotine|nicotine|mesh-list
6385664|NCT00174499|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6385665|NCT00174499|Autonomic Agents|autonomic agents|mesh-ancestor
6385666|NCT00174499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6385667|NCT00174499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385668|NCT00174499|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6385669|NCT00174499|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6385670|NCT00174499|Cholinergic Agents|cholinergic agents|mesh-ancestor
6385671|NCT00174499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6385672|NCT00174499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385673|NCT00174512|Moxifloxacin|moxifloxacin|mesh-list
6385674|NCT00174512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6385675|NCT00174512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6385676|NCT00174512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6385677|NCT00174512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6385678|NCT00174512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6385679|NCT00174512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385680|NCT00174512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6385681|NCT00174538|Codeine|codeine|mesh-list
6385682|NCT00174538|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6385683|NCT00174538|Narcotics|narcotics|mesh-ancestor
6385684|NCT00174538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6385685|NCT00174538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385686|NCT00174538|Analgesics|analgesics|mesh-ancestor
6385687|NCT00174538|Sensory System Agents|sensory system agents|mesh-ancestor
6385688|NCT00174538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6385689|NCT00174538|Antitussive Agents|antitussive agents|mesh-ancestor
6385690|NCT00174538|Respiratory System Agents|respiratory system agents|mesh-ancestor
6385691|NCT00174551|Prazosin|prazosin|mesh-list
6385692|NCT00174551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6385693|NCT00174551|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6385694|NCT00174551|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6385695|NCT00174551|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6385696|NCT00174551|Adrenergic Agents|adrenergic agents|mesh-ancestor
6385697|NCT00174551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6385698|NCT00174551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385699|NCT00174551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385700|NCT00174564|Oxaliplatin|oxaliplatin|mesh-list
6385701|NCT00174564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6385702|NCT00174577|Risperidone|risperidone|mesh-list
6385703|NCT00174577|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6385704|NCT00174577|Serotonin Agents|serotonin agents|mesh-ancestor
6385705|NCT00174577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6385706|NCT00174577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385707|NCT00174577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385708|NCT00174577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6385709|NCT00174577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6385710|NCT00174577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6385711|NCT00174577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6385712|NCT00174577|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6385713|NCT00174577|Dopamine Agents|dopamine agents|mesh-ancestor
6385714|NCT00174590|Risperidone|risperidone|mesh-list
6385715|NCT00174590|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6385716|NCT00174590|Serotonin Agents|serotonin agents|mesh-ancestor
6385717|NCT00174590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6385718|NCT00174590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385719|NCT00174590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385720|NCT00174590|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6385721|NCT00174590|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6385722|NCT00174590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6385723|NCT00174590|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6385724|NCT00174590|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6385725|NCT00174590|Dopamine Agents|dopamine agents|mesh-ancestor
6385726|NCT00174603|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6385727|NCT00174603|Antidepressive Agents|antidepressive agents|mesh-ancestor
6537231|NCT00821444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6537232|NCT00821444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6537233|NCT00821444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6537234|NCT00821444|Dopamine Agents|dopamine agents|mesh-ancestor
6537235|NCT00821457|Mitogens|mitogens|mesh-list
6537236|NCT00821457|Mitosis Modulators|mitosis modulators|mesh-ancestor
6537237|NCT00821457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537238|NCT00821483|Frovatriptan|frovatriptan|mesh-list
6537239|NCT00821483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6537240|NCT00821483|Serotonin Agents|serotonin agents|mesh-ancestor
6537241|NCT00821483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6537242|NCT00821483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537243|NCT00821483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6537244|NCT00821496|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6537245|NCT00821496|Norethindrone|norethindrone|mesh-list
6537246|NCT00821496|Norethindrone Acetate|norethindrone acetate|mesh-list
6385728|NCT00174603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6385729|NCT00174603|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6385730|NCT00174603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6385731|NCT00174603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6385732|NCT00174603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385733|NCT00174616|Capecitabine|capecitabine|mesh-list
6385734|NCT00174616|Oxaliplatin|oxaliplatin|mesh-list
6385735|NCT00174616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6385736|NCT00174616|Antimetabolites|antimetabolites|mesh-ancestor
6385737|NCT00174616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385738|NCT00174616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6385739|NCT00174629|Gemcitabine|gemcitabine|mesh-list
6385740|NCT00174629|Docetaxel|docetaxel|mesh-list
6385741|NCT00174629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6385742|NCT00174629|Antimetabolites|antimetabolites|mesh-ancestor
6385743|NCT00174629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385744|NCT00174629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6385745|NCT00174629|Antiviral Agents|antiviral agents|mesh-ancestor
6385746|NCT00174629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6385747|NCT00174629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6385748|NCT00174629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6385749|NCT00174629|Immunologic Factors|immunologic factors|mesh-ancestor
6385750|NCT00174629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385751|NCT00174629|Tubulin Modulators|tubulin modulators|mesh-ancestor
6385752|NCT00174629|Antimitotic Agents|antimitotic agents|mesh-ancestor
6385753|NCT00174629|Mitosis Modulators|mitosis modulators|mesh-ancestor
6385754|NCT00174642|Insulin|insulin|mesh-list
6385755|NCT00174642|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6385756|NCT00174642|Metformin|metformin|mesh-list
6385757|NCT00174642|Insulin Glargine|insulin glargine|mesh-list
6385758|NCT00174642|Insulin glulisine|insulin glulisine|mesh-list
6385759|NCT00174642|Secretagogues|secretagogues|mesh-list
6385760|NCT00174642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6385761|NCT00174642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385762|NCT00174655|Cyclophosphamide|cyclophosphamide|mesh-list
6385763|NCT00174655|Docetaxel|docetaxel|mesh-list
6385764|NCT00174655|Doxorubicin|doxorubicin|mesh-list
6385765|NCT00174655|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6385766|NCT00174655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6385767|NCT00174655|Immunologic Factors|immunologic factors|mesh-ancestor
6385768|NCT00174655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385769|NCT00174655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6385770|NCT00174655|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6385771|NCT00174655|Alkylating Agents|alkylating agents|mesh-ancestor
6385772|NCT00174655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385773|NCT00174655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6385774|NCT00174655|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6385775|NCT00174655|Tubulin Modulators|tubulin modulators|mesh-ancestor
6385776|NCT00174655|Antimitotic Agents|antimitotic agents|mesh-ancestor
6385777|NCT00174655|Mitosis Modulators|mitosis modulators|mesh-ancestor
6385778|NCT00174655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6385779|NCT00174655|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6385780|NCT00174655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6385781|NCT00174655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6385782|NCT00174668|Insulin|insulin|mesh-list
6385783|NCT00174668|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6385784|NCT00174668|Insulin Glargine|insulin glargine|mesh-list
6385785|NCT00174668|Insulin glulisine|insulin glulisine|mesh-list
6385786|NCT00174668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6385787|NCT00174668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385788|NCT00174681|Insulin Glargine|insulin glargine|mesh-list
6385789|NCT00174681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6385790|NCT00174681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385791|NCT00174694|Telithromycin|telithromycin|mesh-list
6385792|NCT00174694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6385793|NCT00174694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6385794|NCT00174707|Cyclophosphamide|cyclophosphamide|mesh-list
6385795|NCT00174707|Docetaxel|docetaxel|mesh-list
6385796|NCT00174707|Methotrexate|methotrexate|mesh-list
6385797|NCT00174707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6385798|NCT00174707|Immunologic Factors|immunologic factors|mesh-ancestor
6385799|NCT00174707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385800|NCT00174707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6385801|NCT00174707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6385802|NCT00174707|Alkylating Agents|alkylating agents|mesh-ancestor
6385803|NCT00174707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385804|NCT00174707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6385805|NCT00174707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6385806|NCT00174707|Tubulin Modulators|tubulin modulators|mesh-ancestor
6385807|NCT00174707|Antimitotic Agents|antimitotic agents|mesh-ancestor
6385808|NCT00174707|Mitosis Modulators|mitosis modulators|mesh-ancestor
6385809|NCT00174707|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6385810|NCT00174707|Abortifacient Agents|abortifacient agents|mesh-ancestor
6385811|NCT00174707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6385812|NCT00174707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6385813|NCT00174707|Antimetabolites|antimetabolites|mesh-ancestor
6385814|NCT00174707|Dermatologic Agents|dermatologic agents|mesh-ancestor
6385815|NCT00174707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6385816|NCT00174707|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6385817|NCT00174707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6385818|NCT00174720|Ciclesonide|ciclesonide|mesh-list
6385819|NCT00174720|Glucocorticoids|glucocorticoids|mesh-ancestor
6385820|NCT00174720|Hormones|hormones|mesh-ancestor
6385821|NCT00174720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6385822|NCT00174720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385823|NCT00174720|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6385824|NCT00174733|Ciclesonide|ciclesonide|mesh-list
6385825|NCT00174733|Glucocorticoids|glucocorticoids|mesh-ancestor
6385826|NCT00174733|Hormones|hormones|mesh-ancestor
6385827|NCT00174733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6396585|NCT00209209|Antimitotic Agents|antimitotic agents|mesh-ancestor
6385828|NCT00174733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385829|NCT00174733|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6385830|NCT00174759|Clopidogrel|clopidogrel|mesh-list
6385831|NCT00174759|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6385832|NCT00174759|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6385833|NCT00174759|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6385834|NCT00174759|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6385835|NCT00174759|Purinergic Agents|purinergic agents|mesh-ancestor
6385836|NCT00174759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6385837|NCT00174759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385838|NCT00174759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385839|NCT00174772|Cisplatin|cisplatin|mesh-list
6385840|NCT00174772|Docetaxel|docetaxel|mesh-list
6385841|NCT00174772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6385842|NCT00174772|Tubulin Modulators|tubulin modulators|mesh-ancestor
6385843|NCT00174772|Antimitotic Agents|antimitotic agents|mesh-ancestor
6385844|NCT00174772|Mitosis Modulators|mitosis modulators|mesh-ancestor
6385845|NCT00174772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385846|NCT00174798|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6385847|NCT00174798|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6385848|NCT00174798|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6385849|NCT00174798|Cholinergic Agents|cholinergic agents|mesh-ancestor
6385850|NCT00174798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6385851|NCT00174798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385852|NCT00174798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385853|NCT00174798|Urological Agents|urological agents|mesh-ancestor
6385854|NCT00174811|Telithromycin|telithromycin|mesh-list
6385855|NCT00174811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6385856|NCT00174811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6385857|NCT00174824|Insulin Glargine|insulin glargine|mesh-list
6385858|NCT00174824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6385859|NCT00174824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385860|NCT00174863|SR 31747|sr 31747|mesh-list
6385861|NCT00174863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6385862|NCT00174863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385863|NCT00174863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6385864|NCT00174863|Immunologic Factors|immunologic factors|mesh-ancestor
6385865|NCT00174863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385866|NCT00174876|Aripiprazole|aripiprazole|mesh-list
6385867|NCT00174876|Antidepressive Agents|antidepressive agents|mesh-ancestor
6385868|NCT00174876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6385869|NCT00174876|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6385870|NCT00174876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6385871|NCT00174876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6385872|NCT00174876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017538|NCT00373360|Treprostinil|treprostinil|mesh-list
6017539|NCT00373360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6385873|NCT00174876|Dopamine Agonists|dopamine agonists|mesh-ancestor
6385874|NCT00174876|Dopamine Agents|dopamine agents|mesh-ancestor
6385875|NCT00174876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6385876|NCT00174876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385877|NCT00174876|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6385878|NCT00174876|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6385879|NCT00174876|Serotonin Agents|serotonin agents|mesh-ancestor
6385880|NCT00174876|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6385881|NCT00174876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6385882|NCT00174876|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6385883|NCT00174876|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6385884|NCT00174902|Aspirin|aspirin|mesh-list
6385885|NCT00174902|Propranolol|propranolol|mesh-list
6385886|NCT00174902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6385887|NCT00174902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6385888|NCT00174902|Analgesics|analgesics|mesh-ancestor
6385889|NCT00174902|Sensory System Agents|sensory system agents|mesh-ancestor
6385890|NCT00174902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6385891|NCT00174902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385892|NCT00174902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6385893|NCT00174902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6385894|NCT00174902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6385895|NCT00174902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6385896|NCT00174902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385897|NCT00174902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6385898|NCT00174902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6385899|NCT00174902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6385900|NCT00174902|Antipyretics|antipyretics|mesh-ancestor
6385901|NCT00174902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6385902|NCT00174902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6385903|NCT00174902|Adrenergic Agents|adrenergic agents|mesh-ancestor
6385904|NCT00174902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6385905|NCT00174902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6385906|NCT00174902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6385907|NCT00174902|Vasodilator Agents|vasodilator agents|mesh-ancestor
6385908|NCT00174928|Lansoprazole|lansoprazole|mesh-list
6385909|NCT00174928|Dexlansoprazole|dexlansoprazole|mesh-list
6385910|NCT00174928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6385911|NCT00174928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6385912|NCT00174928|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6385913|NCT00174928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6385914|NCT00174928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385915|NCT00174993|Pioglitazone|pioglitazone|mesh-list
6385916|NCT00174993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6385917|NCT00174993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385918|NCT00175032|Aspirin|aspirin|mesh-list
6385919|NCT00175032|Celecoxib|celecoxib|mesh-list
6385920|NCT00175032|Naproxen|naproxen|mesh-list
6385921|NCT00175032|Lansoprazole|lansoprazole|mesh-list
6385922|NCT00175032|Dexlansoprazole|dexlansoprazole|mesh-list
6385923|NCT00175032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6385924|NCT00175032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6385925|NCT00175032|Analgesics|analgesics|mesh-ancestor
6385926|NCT00175032|Sensory System Agents|sensory system agents|mesh-ancestor
6385927|NCT00175032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6385928|NCT00175032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385929|NCT00175032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6385930|NCT00175032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6385931|NCT00175032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6385932|NCT00175032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6385933|NCT00175032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385934|NCT00175032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6385935|NCT00175032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6017540|NCT00373386|Hormones|hormones|mesh-list
6385936|NCT00175032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6385937|NCT00175032|Antipyretics|antipyretics|mesh-ancestor
6385938|NCT00175032|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6385939|NCT00175032|Gout Suppressants|gout suppressants|mesh-ancestor
6385940|NCT00175032|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6385941|NCT00175032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6385942|NCT00175032|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6385943|NCT00175045|Lansoprazole|lansoprazole|mesh-list
6385944|NCT00175045|Dexlansoprazole|dexlansoprazole|mesh-list
6385945|NCT00175045|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6385946|NCT00175045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6385947|NCT00175045|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6385948|NCT00175045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6385949|NCT00175045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385950|NCT00175123|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6385951|NCT00175123|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6385952|NCT00175123|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6385953|NCT00175123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6385954|NCT00175123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385955|NCT00175123|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6385956|NCT00175123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6385957|NCT00175123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385958|NCT00175123|Cholinergic Agents|cholinergic agents|mesh-ancestor
6385959|NCT00175123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6385960|NCT00175162|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
6385961|NCT00175162|Vasodilator Agents|vasodilator agents|mesh-ancestor
6385962|NCT00175162|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
6385963|NCT00175162|Protective Agents|protective agents|mesh-ancestor
6385964|NCT00175162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385965|NCT00175227|Furosemide|furosemide|mesh-list
6385966|NCT00175227|Mannitol|mannitol|mesh-list
6385967|NCT00175227|Diuretics|diuretics|mesh-ancestor
6385968|NCT00175227|Natriuretic Agents|natriuretic agents|mesh-ancestor
6385969|NCT00175227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385970|NCT00175227|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6385971|NCT00175227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6385972|NCT00175227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6385973|NCT00175227|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6396586|NCT00209209|Mitosis Modulators|mitosis modulators|mesh-ancestor
6396587|NCT00209222|Cytarabine|cytarabine|mesh-list
6396588|NCT00209222|Dexamethasone|dexamethasone|mesh-list
6396589|NCT00209222|Prednisone|prednisone|mesh-list
6396590|NCT00209222|Cyclophosphamide|cyclophosphamide|mesh-list
6396591|NCT00209222|Melphalan|melphalan|mesh-list
6396592|NCT00209222|Rituximab|rituximab|mesh-list
6396593|NCT00209222|Doxorubicin|doxorubicin|mesh-list
6396594|NCT00209222|Etoposide|etoposide|mesh-list
6396595|NCT00209222|Vincristine|vincristine|mesh-list
6396596|NCT00209222|Cisplatin|cisplatin|mesh-list
6396597|NCT00209222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6396598|NCT00209222|Immunologic Factors|immunologic factors|mesh-ancestor
6396599|NCT00209222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396600|NCT00209222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6396601|NCT00209222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6396602|NCT00209222|Alkylating Agents|alkylating agents|mesh-ancestor
6396603|NCT00209222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396604|NCT00209222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6396605|NCT00209222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6396606|NCT00209222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6396607|NCT00209222|Antiemetics|antiemetics|mesh-ancestor
6396608|NCT00209222|Autonomic Agents|autonomic agents|mesh-ancestor
6396609|NCT00209222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6396610|NCT00209222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6396611|NCT00209222|Glucocorticoids|glucocorticoids|mesh-ancestor
6396612|NCT00209222|Hormones|hormones|mesh-ancestor
6396613|NCT00209222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6396614|NCT00209222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6396615|NCT00209222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6396616|NCT00209222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6385974|NCT00175253|Alemtuzumab|alemtuzumab|mesh-list
6385975|NCT00175253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6385976|NCT00175253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6385977|NCT00175266|Alemtuzumab|alemtuzumab|mesh-list
6385978|NCT00175266|Infliximab|infliximab|mesh-list
6385979|NCT00175266|Dermatologic Agents|dermatologic agents|mesh-ancestor
6385980|NCT00175266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6385981|NCT00175266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6385982|NCT00175266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6385983|NCT00175266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6385984|NCT00175305|Octreotide|octreotide|mesh-list
6385985|NCT00175305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6385986|NCT00175305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6385987|NCT00175305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6385988|NCT00175357|Methadone|methadone|mesh-list
6385989|NCT00175357|Heroin|heroin|mesh-list
6385990|NCT00175357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6385991|NCT00175357|Narcotics|narcotics|mesh-ancestor
6385992|NCT00175357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6385993|NCT00175357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6385994|NCT00175357|Analgesics|analgesics|mesh-ancestor
6385995|NCT00175357|Sensory System Agents|sensory system agents|mesh-ancestor
6385996|NCT00175357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6385997|NCT00175357|Antitussive Agents|antitussive agents|mesh-ancestor
6385998|NCT00175357|Respiratory System Agents|respiratory system agents|mesh-ancestor
6385999|NCT00175370|Vancomycin|vancomycin|mesh-list
6386000|NCT00175370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6386001|NCT00175370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6386002|NCT00175383|Hormones|hormones|mesh-list
6386003|NCT00175383|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
6386004|NCT00175383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6386005|NCT00175383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386006|NCT00175396|Ascorbic Acid|ascorbic acid|mesh-list
6386007|NCT00175396|Leuprolide|leuprolide|mesh-list
6386008|NCT00175396|Methyltestosterone|methyltestosterone|mesh-list
6386009|NCT00175396|Flutamide|flutamide|mesh-list
6386010|NCT00175396|Bicalutamide|bicalutamide|mesh-list
6386011|NCT00175396|Nilutamide|nilutamide|mesh-list
6386012|NCT00175396|Buserelin|buserelin|mesh-list
6386013|NCT00175396|Androgens|androgens|mesh-list
6386014|NCT00175396|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6386015|NCT00175396|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6386016|NCT00175396|Fertility Agents|fertility agents|mesh-ancestor
6386017|NCT00175396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6386018|NCT00175396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386019|NCT00175396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6386020|NCT00175396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6386021|NCT00175396|Androgen Antagonists|androgen antagonists|mesh-ancestor
6386022|NCT00175396|Hormone Antagonists|hormone antagonists|mesh-ancestor
6386023|NCT00175396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6386024|NCT00175396|Hormones|hormones|mesh-ancestor
6386025|NCT00175396|Antioxidants|antioxidants|mesh-ancestor
6386026|NCT00175396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386027|NCT00175396|Protective Agents|protective agents|mesh-ancestor
6386028|NCT00175396|Vitamins|vitamins|mesh-ancestor
6386029|NCT00175396|Micronutrients|micronutrients|mesh-ancestor
6386030|NCT00175396|Estrogens|estrogens|mesh-ancestor
6386031|NCT00175396|Anabolic Agents|anabolic agents|mesh-ancestor
6386032|NCT00175435|Vaccines|vaccines|mesh-list
6386033|NCT00175435|Immunologic Factors|immunologic factors|mesh-ancestor
6386034|NCT00175435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386035|NCT00175513|Valacyclovir|valacyclovir|mesh-list
6386036|NCT00175513|Antiviral Agents|antiviral agents|mesh-ancestor
6386037|NCT00175513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6386038|NCT00175565|Fluticasone|fluticasone|mesh-list
6386039|NCT00175565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6386040|NCT00175565|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6386041|NCT00175565|Autonomic Agents|autonomic agents|mesh-ancestor
6386042|NCT00175565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6386043|NCT00175565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386044|NCT00175565|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6386045|NCT00175565|Respiratory System Agents|respiratory system agents|mesh-ancestor
6386046|NCT00175565|Dermatologic Agents|dermatologic agents|mesh-ancestor
6386047|NCT00175565|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6386048|NCT00175591|Bupivacaine|bupivacaine|mesh-list
6386049|NCT00175591|Anesthetics, Local|anesthetics, local|mesh-ancestor
6386050|NCT00175591|Anesthetics|anesthetics|mesh-ancestor
6386051|NCT00175591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6386052|NCT00175591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386053|NCT00175591|Sensory System Agents|sensory system agents|mesh-ancestor
6386054|NCT00175591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6386055|NCT00175617|Minoxidil|minoxidil|mesh-list
6386056|NCT00175617|Spironolactone|spironolactone|mesh-list
6386057|NCT00175617|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6386058|NCT00175617|Hormone Antagonists|hormone antagonists|mesh-ancestor
6386059|NCT00175617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6386060|NCT00175617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386061|NCT00175617|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6386062|NCT00175617|Diuretics|diuretics|mesh-ancestor
6386063|NCT00175617|Natriuretic Agents|natriuretic agents|mesh-ancestor
6386064|NCT00175617|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6386065|NCT00175617|Vasodilator Agents|vasodilator agents|mesh-ancestor
6386066|NCT00175630|Bupivacaine|bupivacaine|mesh-list
6386067|NCT00175630|Anesthetics, Local|anesthetics, local|mesh-ancestor
6386068|NCT00175630|Anesthetics|anesthetics|mesh-ancestor
6386069|NCT00175630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6386070|NCT00175630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386071|NCT00175630|Sensory System Agents|sensory system agents|mesh-ancestor
6386072|NCT00175630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6386073|NCT00175643|Imiquimod|imiquimod|mesh-list
6386074|NCT00175643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6386075|NCT00175643|Immunologic Factors|immunologic factors|mesh-ancestor
6386076|NCT00175643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386077|NCT00175643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6386078|NCT00175643|Interferon Inducers|interferon inducers|mesh-ancestor
6386079|NCT00175682|Prazosin|prazosin|mesh-list
6386080|NCT00175682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6386081|NCT00175682|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6386082|NCT00175682|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6386083|NCT00175682|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6386084|NCT00175682|Adrenergic Agents|adrenergic agents|mesh-ancestor
6386085|NCT00175682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6386086|NCT00175682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386087|NCT00175682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386088|NCT00175695|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
6386089|NCT00175695|Protein C|protein c|mesh-list
6386090|NCT00175695|Anticoagulants|anticoagulants|mesh-ancestor
6386091|NCT00175695|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6386092|NCT00175695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6386093|NCT00175695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386094|NCT00175695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6386095|NCT00175747|Budesonide|budesonide|mesh-list
6386096|NCT00175747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6386097|NCT00175747|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6386098|NCT00175747|Autonomic Agents|autonomic agents|mesh-ancestor
6386099|NCT00175747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6386100|NCT00175747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386101|NCT00175747|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6386102|NCT00175747|Respiratory System Agents|respiratory system agents|mesh-ancestor
6386103|NCT00175747|Glucocorticoids|glucocorticoids|mesh-ancestor
6386104|NCT00175747|Hormones|hormones|mesh-ancestor
6386105|NCT00175747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6386106|NCT00175812|Tretinoin|tretinoin|mesh-list
6386107|NCT00175812|Theophylline|theophylline|mesh-list
6386108|NCT00175812|Valproic Acid|valproic acid|mesh-list
6386109|NCT00175812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6386110|NCT00175812|Keratolytic Agents|keratolytic agents|mesh-ancestor
6386111|NCT00175812|Dermatologic Agents|dermatologic agents|mesh-ancestor
6386112|NCT00175812|Anticonvulsants|anticonvulsants|mesh-ancestor
6386113|NCT00175812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6386114|NCT00175812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386115|NCT00175812|GABA Agents|gaba agents|mesh-ancestor
6386116|NCT00175812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6386117|NCT00175812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386118|NCT00175812|Antimanic Agents|antimanic agents|mesh-ancestor
6386119|NCT00175812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6386120|NCT00175812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6386121|NCT00175812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6386122|NCT00175812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6386123|NCT00175812|Autonomic Agents|autonomic agents|mesh-ancestor
6386124|NCT00175812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6386125|NCT00175812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6386126|NCT00175812|Respiratory System Agents|respiratory system agents|mesh-ancestor
6386127|NCT00175812|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6386128|NCT00175812|Vasodilator Agents|vasodilator agents|mesh-ancestor
6386129|NCT00175812|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6386130|NCT00175812|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6386131|NCT00175812|Purinergic Agents|purinergic agents|mesh-ancestor
6386132|NCT00175838|Aspirin|aspirin|mesh-list
6386133|NCT00175838|Hydroxyurea|hydroxyurea|mesh-list
6386134|NCT00175838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6386135|NCT00175838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6386136|NCT00175838|Analgesics|analgesics|mesh-ancestor
6386137|NCT00175838|Sensory System Agents|sensory system agents|mesh-ancestor
6386138|NCT00175838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6386139|NCT00175838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386140|NCT00175838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6386141|NCT00175838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6386142|NCT00175838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6017541|NCT00373386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6017542|NCT00373386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017543|NCT00373399|Dronabinol|dronabinol|mesh-list
6017544|NCT00373399|Hallucinogens|hallucinogens|mesh-ancestor
6017545|NCT00373399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017546|NCT00373399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6386143|NCT00175838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6386144|NCT00175838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386145|NCT00175838|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6386146|NCT00175838|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6017547|NCT00373399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6386147|NCT00175838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6386148|NCT00175838|Antipyretics|antipyretics|mesh-ancestor
6386149|NCT00175838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6386150|NCT00175838|Antisickling Agents|antisickling agents|mesh-ancestor
6386151|NCT00175838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6386152|NCT00175890|Levetiracetam|levetiracetam|mesh-list
6386153|NCT00175890|Anticonvulsants|anticonvulsants|mesh-ancestor
6386154|NCT00175890|Nootropic Agents|nootropic agents|mesh-ancestor
6386155|NCT00175903|Carbamazepine|carbamazepine|mesh-list
6386156|NCT00175903|Levetiracetam|levetiracetam|mesh-list
6386157|NCT00175903|Valproic Acid|valproic acid|mesh-list
6386158|NCT00175903|Anticonvulsants|anticonvulsants|mesh-ancestor
6386159|NCT00175903|Nootropic Agents|nootropic agents|mesh-ancestor
6386160|NCT00175903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6386161|NCT00175903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386162|NCT00175903|GABA Agents|gaba agents|mesh-ancestor
6386163|NCT00175903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6386164|NCT00175903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386165|NCT00175903|Antimanic Agents|antimanic agents|mesh-ancestor
6386166|NCT00175903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6386167|NCT00175903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6386168|NCT00175903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6386169|NCT00175903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6386170|NCT00175903|Analgesics|analgesics|mesh-ancestor
6386171|NCT00175903|Sensory System Agents|sensory system agents|mesh-ancestor
6386172|NCT00175903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6386173|NCT00175903|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6386174|NCT00175903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6386175|NCT00175903|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6386176|NCT00175903|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6386177|NCT00175929|Brivaracetam|brivaracetam|mesh-list
6386178|NCT00175929|Anticonvulsants|anticonvulsants|mesh-ancestor
6386179|NCT00175955|Levetiracetam|levetiracetam|mesh-list
6386180|NCT00175955|Anticonvulsants|anticonvulsants|mesh-ancestor
6386181|NCT00175955|Nootropic Agents|nootropic agents|mesh-ancestor
6386182|NCT00175981|Sildenafil Citrate|sildenafil citrate|mesh-list
6386183|NCT00175981|Fluvoxamine|fluvoxamine|mesh-list
6386184|NCT00175981|Vasodilator Agents|vasodilator agents|mesh-ancestor
6386185|NCT00175981|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6386186|NCT00175981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6386187|NCT00175981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6386188|NCT00175981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386189|NCT00175981|Urological Agents|urological agents|mesh-ancestor
6386190|NCT00175981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6386191|NCT00175981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6386192|NCT00175981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6386193|NCT00175981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386194|NCT00175981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6386195|NCT00175981|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6386196|NCT00175981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6386197|NCT00175981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6386198|NCT00175981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6386199|NCT00175981|Serotonin Agents|serotonin agents|mesh-ancestor
6386200|NCT00175981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6386201|NCT00175981|Antidepressive Agents|antidepressive agents|mesh-ancestor
6386202|NCT00175981|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6386203|NCT00175981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6386204|NCT00175981|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6386205|NCT00176020|Nicotinic Acids|nicotinic acids|mesh-list
6386206|NCT00176020|Niacin|niacin|mesh-list
6386207|NCT00176020|Niacinamide|niacinamide|mesh-list
6386208|NCT00176020|Vitamin B Complex|vitamin b complex|mesh-ancestor
6386209|NCT00176020|Vitamins|vitamins|mesh-ancestor
6386210|NCT00176020|Micronutrients|micronutrients|mesh-ancestor
6386211|NCT00176020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386212|NCT00176020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6386213|NCT00176020|Antimetabolites|antimetabolites|mesh-ancestor
6386214|NCT00176020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386215|NCT00176020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6386216|NCT00176020|Vasodilator Agents|vasodilator agents|mesh-ancestor
6386217|NCT00176046|Viscum album peptide|viscum album peptide|mesh-list
6386218|NCT00176046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6386219|NCT00176046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6386220|NCT00176046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6386221|NCT00176046|Antiviral Agents|antiviral agents|mesh-ancestor
6386222|NCT00176046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6386223|NCT00176059|Immunoglobulins|immunoglobulins|mesh-list
6386224|NCT00176059|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6386225|NCT00176059|Antibodies|antibodies|mesh-list
6386226|NCT00176059|gamma-Globulins|gamma-globulins|mesh-list
6386227|NCT00176059|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6386228|NCT00176059|Immunologic Factors|immunologic factors|mesh-ancestor
6386229|NCT00176059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386230|NCT00176098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
6386231|NCT00176098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6386232|NCT00176098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386233|NCT00176241|Gemcitabine|gemcitabine|mesh-list
6386234|NCT00176241|Paclitaxel|paclitaxel|mesh-list
6386235|NCT00176241|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6386236|NCT00176241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6386237|NCT00176241|Tubulin Modulators|tubulin modulators|mesh-ancestor
6386238|NCT00176241|Antimitotic Agents|antimitotic agents|mesh-ancestor
6386239|NCT00176241|Mitosis Modulators|mitosis modulators|mesh-ancestor
6386240|NCT00176241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386241|NCT00176241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6386242|NCT00176241|Antimetabolites|antimetabolites|mesh-ancestor
6386243|NCT00176241|Antiviral Agents|antiviral agents|mesh-ancestor
6386244|NCT00176241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6386245|NCT00176241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6386246|NCT00176241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6386247|NCT00176241|Immunologic Factors|immunologic factors|mesh-ancestor
6386248|NCT00176241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386249|NCT00176267|Paclitaxel|paclitaxel|mesh-list
6386250|NCT00176267|Carboplatin|carboplatin|mesh-list
6386251|NCT00176267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6386252|NCT00176267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6386253|NCT00176267|Tubulin Modulators|tubulin modulators|mesh-ancestor
6386254|NCT00176267|Antimitotic Agents|antimitotic agents|mesh-ancestor
6386255|NCT00176267|Mitosis Modulators|mitosis modulators|mesh-ancestor
6386256|NCT00176267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386257|NCT00176280|Dexamethasone|dexamethasone|mesh-list
6386258|NCT00176280|Sargramostim|sargramostim|mesh-list
6386259|NCT00176280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6386260|NCT00176280|Antiemetics|antiemetics|mesh-ancestor
6386261|NCT00176280|Autonomic Agents|autonomic agents|mesh-ancestor
6386262|NCT00176280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6386263|NCT00176280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386264|NCT00176280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6386265|NCT00176280|Glucocorticoids|glucocorticoids|mesh-ancestor
6386266|NCT00176280|Hormones|hormones|mesh-ancestor
6386267|NCT00176280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6386268|NCT00176280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6386269|NCT00176280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6386270|NCT00176280|Immunologic Factors|immunologic factors|mesh-ancestor
6017548|NCT00373399|Analgesics|analgesics|mesh-ancestor
6017549|NCT00373399|Sensory System Agents|sensory system agents|mesh-ancestor
6017550|NCT00373399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6017551|NCT00373399|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6017552|NCT00373399|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6017553|NCT00373399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6017554|NCT00373399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017555|NCT00373399|Hormones|hormones|mesh-ancestor
6017556|NCT00373399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6017557|NCT00373425|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6017558|NCT00373425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6017559|NCT00373425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6017560|NCT00373425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6386271|NCT00176293|Dexamethasone|dexamethasone|mesh-list
6386272|NCT00176293|Doxorubicin|doxorubicin|mesh-list
6386273|NCT00176293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6386274|NCT00176293|Antiemetics|antiemetics|mesh-ancestor
6386275|NCT00176293|Autonomic Agents|autonomic agents|mesh-ancestor
6386276|NCT00176293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6386277|NCT00176293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386278|NCT00176293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6386279|NCT00176293|Glucocorticoids|glucocorticoids|mesh-ancestor
6386280|NCT00176293|Hormones|hormones|mesh-ancestor
6386281|NCT00176293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6386282|NCT00176293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6386283|NCT00176293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6386284|NCT00176293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6386285|NCT00176293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6386286|NCT00176293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6386287|NCT00176293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6386288|NCT00176293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386289|NCT00176332|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6386290|NCT00176332|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6386291|NCT00176332|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6386292|NCT00176332|Antimetabolites|antimetabolites|mesh-ancestor
6386293|NCT00176332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386294|NCT00176332|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6386295|NCT00176332|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6386296|NCT00176332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6386297|NCT00176449|Bupropion|bupropion|mesh-list
6386298|NCT00176449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6386299|NCT00176449|Antidepressive Agents|antidepressive agents|mesh-ancestor
6386300|NCT00176449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6386301|NCT00176449|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6386302|NCT00176449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6386303|NCT00176449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6386304|NCT00176449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386305|NCT00176449|Dopamine Agents|dopamine agents|mesh-ancestor
6386306|NCT00176449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6386307|NCT00176449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386308|NCT00176449|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6386309|NCT00176449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6386310|NCT00176449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6386311|NCT00176475|Rituximab|rituximab|mesh-list
6386312|NCT00176475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6386313|NCT00176475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6386314|NCT00176475|Immunologic Factors|immunologic factors|mesh-ancestor
6386315|NCT00176475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386316|NCT00176475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6386317|NCT00176514|Antineoplastic Agents|antineoplastic agents|mesh-list
6386318|NCT00176527|Interferons|interferons|mesh-list
6386319|NCT00176527|Interferon-alpha|interferon-alpha|mesh-list
6386320|NCT00176527|Interferon alpha-2|interferon alpha-2|mesh-list
6386321|NCT00176527|Docetaxel|docetaxel|mesh-list
6386322|NCT00176527|Estramustine|estramustine|mesh-list
6386323|NCT00176527|Isotretinoin|isotretinoin|mesh-list
6386324|NCT00176527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6386325|NCT00176527|Tubulin Modulators|tubulin modulators|mesh-ancestor
6386326|NCT00176527|Antimitotic Agents|antimitotic agents|mesh-ancestor
6386327|NCT00176527|Mitosis Modulators|mitosis modulators|mesh-ancestor
6386328|NCT00176527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386329|NCT00176527|Antiviral Agents|antiviral agents|mesh-ancestor
6386330|NCT00176527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6386331|NCT00176527|Immunologic Factors|immunologic factors|mesh-ancestor
6386332|NCT00176527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386333|NCT00176527|Dermatologic Agents|dermatologic agents|mesh-ancestor
6386334|NCT00176527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6386335|NCT00176527|Alkylating Agents|alkylating agents|mesh-ancestor
6386336|NCT00176527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6386337|NCT00176540|Dextromethorphan|dextromethorphan|mesh-list
6386338|NCT00176540|Antitussive Agents|antitussive agents|mesh-ancestor
6386339|NCT00176540|Respiratory System Agents|respiratory system agents|mesh-ancestor
6386340|NCT00176540|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6386341|NCT00176540|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6386342|NCT00176540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6386343|NCT00176540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386344|NCT00176540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386345|NCT00176553|Dextromethorphan|dextromethorphan|mesh-list
6386346|NCT00176553|Antitussive Agents|antitussive agents|mesh-ancestor
6386347|NCT00176553|Respiratory System Agents|respiratory system agents|mesh-ancestor
6386348|NCT00176553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6386349|NCT00176553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6386350|NCT00176553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6386351|NCT00176553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386352|NCT00176553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386353|NCT00176618|Curcumin|curcumin|mesh-list
6386354|NCT00176618|Sulindac|sulindac|mesh-list
6386355|NCT00176618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6386356|NCT00176618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6386357|NCT00176618|Analgesics|analgesics|mesh-ancestor
6386358|NCT00176618|Sensory System Agents|sensory system agents|mesh-ancestor
6386359|NCT00176618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6386360|NCT00176618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386361|NCT00176618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6386362|NCT00176618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6386363|NCT00176618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6386364|NCT00176618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6386365|NCT00176618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386366|NCT00176618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6386367|NCT00176670|Midazolam|midazolam|mesh-list
6386368|NCT00176670|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6386369|NCT00176670|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6386370|NCT00176670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6386371|NCT00176670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386372|NCT00176670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6386373|NCT00176670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6386374|NCT00176670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6386375|NCT00176670|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6386376|NCT00176670|Anesthetics, General|anesthetics, general|mesh-ancestor
6386377|NCT00176670|Anesthetics|anesthetics|mesh-ancestor
6386378|NCT00176670|GABA Modulators|gaba modulators|mesh-ancestor
6386379|NCT00176670|GABA Agents|gaba agents|mesh-ancestor
6386380|NCT00176670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6386381|NCT00176670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386382|NCT00176696|Anesthetics|anesthetics|mesh-list
6386383|NCT00176696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6386384|NCT00176696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386385|NCT00176735|Capecitabine|capecitabine|mesh-list
6386386|NCT00176735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6386387|NCT00176735|Antimetabolites|antimetabolites|mesh-ancestor
6386388|NCT00176735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386389|NCT00176735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6386390|NCT00176761|Interleukin-2|interleukin-2|mesh-list
6386391|NCT00176761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6386392|NCT00176761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6386393|NCT00176761|Analgesics|analgesics|mesh-ancestor
6386394|NCT00176761|Sensory System Agents|sensory system agents|mesh-ancestor
6386395|NCT00176761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6386396|NCT00176761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396617|NCT00209222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6396618|NCT00209222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6396619|NCT00209222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6396620|NCT00209222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6396621|NCT00209222|Tubulin Modulators|tubulin modulators|mesh-ancestor
6396622|NCT00209222|Antimitotic Agents|antimitotic agents|mesh-ancestor
6017561|NCT00373425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017562|NCT00373490|Vorinostat|vorinostat|mesh-list
6396623|NCT00209222|Mitosis Modulators|mitosis modulators|mesh-ancestor
6396624|NCT00209222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6396625|NCT00209222|Antimetabolites|antimetabolites|mesh-ancestor
6396626|NCT00209222|Antiviral Agents|antiviral agents|mesh-ancestor
6396627|NCT00209222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6396628|NCT00209261|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
6396629|NCT00209261|Hemostatics|hemostatics|mesh-ancestor
6396630|NCT00209261|Coagulants|coagulants|mesh-ancestor
6396631|NCT00209261|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6396632|NCT00209261|Natriuretic Agents|natriuretic agents|mesh-ancestor
6396633|NCT00209261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396634|NCT00209300|Mesalamine|mesalamine|mesh-list
6396635|NCT00209300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6396636|NCT00209300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6396637|NCT00209300|Analgesics|analgesics|mesh-ancestor
6396638|NCT00209300|Sensory System Agents|sensory system agents|mesh-ancestor
6396639|NCT00209300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6396640|NCT00209300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396641|NCT00209300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6396642|NCT00209300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6396643|NCT00209313|Acyclovir|acyclovir|mesh-list
6396644|NCT00209313|Antiviral Agents|antiviral agents|mesh-ancestor
6396645|NCT00209313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6396646|NCT00209352|Acyclovir|acyclovir|mesh-list
6396647|NCT00209352|Antiviral Agents|antiviral agents|mesh-ancestor
6396648|NCT00209352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6396649|NCT00209469|Alendronate|alendronate|mesh-list
6537247|NCT00821496|Norinyl|norinyl|mesh-list
6386397|NCT00176774|Leucovorin|leucovorin|mesh-list
6386398|NCT00176774|Fluorouracil|fluorouracil|mesh-list
6386399|NCT00176774|Irinotecan|irinotecan|mesh-list
6386400|NCT00176774|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
6386401|NCT00176774|Antimetabolites|antimetabolites|mesh-ancestor
6386402|NCT00176774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386403|NCT00176774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6386404|NCT00176774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6386405|NCT00176774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6386406|NCT00176774|Immunologic Factors|immunologic factors|mesh-ancestor
6386407|NCT00176774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386408|NCT00176774|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6386409|NCT00176774|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6386410|NCT00176774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6386411|NCT00176774|Antidotes|antidotes|mesh-ancestor
6386412|NCT00176774|Protective Agents|protective agents|mesh-ancestor
6386413|NCT00176774|Vitamin B Complex|vitamin b complex|mesh-ancestor
6386414|NCT00176774|Vitamins|vitamins|mesh-ancestor
6386415|NCT00176774|Micronutrients|micronutrients|mesh-ancestor
6386416|NCT00176774|Chelating Agents|chelating agents|mesh-ancestor
6386417|NCT00176774|Sequestering Agents|sequestering agents|mesh-ancestor
6386418|NCT00176774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6386419|NCT00176774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6386420|NCT00176774|Growth Substances|growth substances|mesh-ancestor
6386421|NCT00176774|Growth Inhibitors|growth inhibitors|mesh-ancestor
6386422|NCT00176787|Capecitabine|capecitabine|mesh-list
6386423|NCT00176787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6386424|NCT00176787|Antimetabolites|antimetabolites|mesh-ancestor
6386425|NCT00176787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386426|NCT00176787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6386427|NCT00176813|Gemcitabine|gemcitabine|mesh-list
6386428|NCT00176813|Celecoxib|celecoxib|mesh-list
6386429|NCT00176813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6386430|NCT00176813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6386431|NCT00176813|Antimetabolites|antimetabolites|mesh-ancestor
6386432|NCT00176813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386433|NCT00176813|Antiviral Agents|antiviral agents|mesh-ancestor
6386434|NCT00176813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6386435|NCT00176813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6386436|NCT00176813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6386437|NCT00176813|Immunologic Factors|immunologic factors|mesh-ancestor
6386438|NCT00176813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386439|NCT00176813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6386440|NCT00176813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6386441|NCT00176813|Analgesics|analgesics|mesh-ancestor
6386442|NCT00176813|Sensory System Agents|sensory system agents|mesh-ancestor
6386443|NCT00176813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6386444|NCT00176813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6386445|NCT00176813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6386446|NCT00176813|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6386447|NCT00176813|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6386448|NCT00176943|Imiquimod|imiquimod|mesh-list
6386449|NCT00176943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6386450|NCT00176943|Immunologic Factors|immunologic factors|mesh-ancestor
6386451|NCT00176943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386452|NCT00176943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6386453|NCT00176943|Interferon Inducers|interferon inducers|mesh-ancestor
6386454|NCT00176969|Capsaicin|capsaicin|mesh-list
6386455|NCT00176969|Antipruritics|antipruritics|mesh-ancestor
6386456|NCT00176969|Dermatologic Agents|dermatologic agents|mesh-ancestor
6386457|NCT00176969|Sensory System Agents|sensory system agents|mesh-ancestor
6386458|NCT00176969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6386459|NCT00176969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386460|NCT00176982|Hydroxychloroquine|hydroxychloroquine|mesh-list
6386461|NCT00176982|Antimalarials|antimalarials|mesh-ancestor
6386462|NCT00176982|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6386463|NCT00176982|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6386464|NCT00176982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6386465|NCT00176982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6386466|NCT00176982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386467|NCT00176982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6386468|NCT00176995|Eflornithine|eflornithine|mesh-list
6386469|NCT00176995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6386470|NCT00176995|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6386471|NCT00176995|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6386472|NCT00176995|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6386473|NCT00176995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6386474|NCT00176995|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
6386475|NCT00176995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6386476|NCT00176995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386477|NCT00177008|Aripiprazole|aripiprazole|mesh-list
6386478|NCT00177008|Antidepressive Agents|antidepressive agents|mesh-ancestor
6386479|NCT00177008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6386480|NCT00177008|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6386481|NCT00177008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6386482|NCT00177008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6386483|NCT00177008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386484|NCT00177008|Dopamine Agonists|dopamine agonists|mesh-ancestor
6386485|NCT00177008|Dopamine Agents|dopamine agents|mesh-ancestor
6386486|NCT00177008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6386487|NCT00177008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386488|NCT00177008|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6386489|NCT00177008|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6386490|NCT00177008|Serotonin Agents|serotonin agents|mesh-ancestor
6386491|NCT00177008|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6386492|NCT00177008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6386493|NCT00177008|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6386494|NCT00177008|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6386495|NCT00177021|Imiquimod|imiquimod|mesh-list
6386496|NCT00177021|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6386497|NCT00177021|Immunologic Factors|immunologic factors|mesh-ancestor
6386498|NCT00177021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386499|NCT00177021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6386500|NCT00177021|Interferon Inducers|interferon inducers|mesh-ancestor
6386501|NCT00177060|Hydromorphone|hydromorphone|mesh-list
6386502|NCT00177060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6386503|NCT00177060|Narcotics|narcotics|mesh-ancestor
6386504|NCT00177060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6386505|NCT00177060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386506|NCT00177060|Analgesics|analgesics|mesh-ancestor
6386507|NCT00177060|Sensory System Agents|sensory system agents|mesh-ancestor
6386508|NCT00177060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6386509|NCT00177086|Alfuzosin|alfuzosin|mesh-list
6386510|NCT00177086|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6386511|NCT00177086|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6386512|NCT00177086|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6386513|NCT00177086|Adrenergic Agents|adrenergic agents|mesh-ancestor
6386514|NCT00177086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6386515|NCT00177086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386516|NCT00177086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386517|NCT00177086|Urological Agents|urological agents|mesh-ancestor
6386518|NCT00177099|Tacrolimus|tacrolimus|mesh-list
6386519|NCT00177099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6386520|NCT00177099|Immunologic Factors|immunologic factors|mesh-ancestor
6386521|NCT00177099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386522|NCT00177099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6386523|NCT00177099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6386524|NCT00177099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386525|NCT00177138|Alemtuzumab|alemtuzumab|mesh-list
6386526|NCT00177138|Tacrolimus|tacrolimus|mesh-list
6386527|NCT00177138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6386528|NCT00177138|Immunologic Factors|immunologic factors|mesh-ancestor
6386529|NCT00177138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386530|NCT00177138|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6386531|NCT00177138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6386532|NCT00177138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386533|NCT00177138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6386534|NCT00177138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6386535|NCT00177242|Gefitinib|gefitinib|mesh-list
6386536|NCT00177242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6386537|NCT00177242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6386538|NCT00177242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6386539|NCT00177242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386540|NCT00177281|Belotecan|belotecan|mesh-list
6386541|NCT00177281|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6386542|NCT00177281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6386543|NCT00177281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6386544|NCT00177281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386545|NCT00177281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6386546|NCT00177333|Doxycycline|doxycycline|mesh-list
6386547|NCT00177333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6386548|NCT00177333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6386549|NCT00177333|Antimalarials|antimalarials|mesh-ancestor
6386550|NCT00177333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6386551|NCT00177333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6386552|NCT00177372|Misoprostol|misoprostol|mesh-list
6386553|NCT00177372|Mifepristone|mifepristone|mesh-list
6386554|NCT00177372|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6386555|NCT00177372|Abortifacient Agents|abortifacient agents|mesh-ancestor
6386556|NCT00177372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6386557|NCT00177372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386558|NCT00177372|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6386559|NCT00177372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6386560|NCT00177372|Oxytocics|oxytocics|mesh-ancestor
6386561|NCT00177372|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6386562|NCT00177372|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6386563|NCT00177372|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6386564|NCT00177372|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6386565|NCT00177372|Contraceptive Agents|contraceptive agents|mesh-ancestor
6386566|NCT00177372|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6386567|NCT00177372|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6386568|NCT00177372|Hormone Antagonists|hormone antagonists|mesh-ancestor
6386569|NCT00177372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6386570|NCT00177372|Luteolytic Agents|luteolytic agents|mesh-ancestor
6386571|NCT00177372|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6386572|NCT00177372|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6386573|NCT00177398|Insulin|insulin|mesh-list
6386574|NCT00177398|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6386575|NCT00177398|Insulin Glargine|insulin glargine|mesh-list
6386576|NCT00177398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6386577|NCT00177398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386578|NCT00177411|Hormones|hormones|mesh-list
6386579|NCT00177411|Parathyroid Hormone|parathyroid hormone|mesh-list
6386580|NCT00177411|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
6386581|NCT00177411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6386582|NCT00177411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386583|NCT00177411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6386584|NCT00177424|Sertraline|sertraline|mesh-list
6386585|NCT00177424|Antidepressive Agents|antidepressive agents|mesh-ancestor
6386586|NCT00177424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6386587|NCT00177424|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6386588|NCT00177424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6386589|NCT00177424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6386590|NCT00177424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386591|NCT00177424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6386592|NCT00177424|Serotonin Agents|serotonin agents|mesh-ancestor
6386593|NCT00177424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386594|NCT00177528|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6386595|NCT00177528|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6386596|NCT00177528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6386597|NCT00177528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6386598|NCT00177528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386599|NCT00177528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6386600|NCT00177528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386601|NCT00177528|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6386602|NCT00177528|Antidepressive Agents|antidepressive agents|mesh-ancestor
6386603|NCT00177528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6386604|NCT00177567|Lamotrigine|lamotrigine|mesh-list
6386605|NCT00177567|Valproic Acid|valproic acid|mesh-list
6386606|NCT00177567|Olanzapine|olanzapine|mesh-list
6386607|NCT00177567|Risperidone|risperidone|mesh-list
6386608|NCT00177567|Lithium Carbonate|lithium carbonate|mesh-list
6386609|NCT00177567|Mirtazapine|mirtazapine|mesh-list
6386610|NCT00177567|Tranylcypromine|tranylcypromine|mesh-list
6386611|NCT00177567|Bupropion|bupropion|mesh-list
6386612|NCT00177567|Paroxetine|paroxetine|mesh-list
6386613|NCT00177567|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6386614|NCT00177567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6386615|NCT00177567|Serotonin Agents|serotonin agents|mesh-ancestor
6386616|NCT00177567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6386617|NCT00177567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386618|NCT00177567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386619|NCT00177567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6386620|NCT00177567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6386621|NCT00177567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6386622|NCT00177567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6386623|NCT00177567|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6386624|NCT00177567|Dopamine Agents|dopamine agents|mesh-ancestor
6386625|NCT00177567|Antiemetics|antiemetics|mesh-ancestor
6386626|NCT00177567|Autonomic Agents|autonomic agents|mesh-ancestor
6386627|NCT00177567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6386628|NCT00177567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6386629|NCT00177567|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6386630|NCT00177567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6386631|NCT00177567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6386632|NCT00177567|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6386633|NCT00177567|Antidepressive Agents|antidepressive agents|mesh-ancestor
6386634|NCT00177567|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6386635|NCT00177567|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6386636|NCT00177567|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6386637|NCT00177567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6386638|NCT00177567|Antimanic Agents|antimanic agents|mesh-ancestor
6386639|NCT00177567|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6386640|NCT00177567|Anticonvulsants|anticonvulsants|mesh-ancestor
6386641|NCT00177567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6386642|NCT00177567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6386643|NCT00177567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6386644|NCT00177567|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6386645|NCT00177567|Histamine Antagonists|histamine antagonists|mesh-ancestor
6386646|NCT00177567|Histamine Agents|histamine agents|mesh-ancestor
6386647|NCT00177567|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6386648|NCT00177567|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6386649|NCT00177567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6386650|NCT00177567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6386651|NCT00177567|Adrenergic Agents|adrenergic agents|mesh-ancestor
6386652|NCT00177567|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6386653|NCT00177567|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6386654|NCT00177567|GABA Agents|gaba agents|mesh-ancestor
6386655|NCT00177567|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6386656|NCT00177580|Pravastatin|pravastatin|mesh-list
6386657|NCT00177580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6386658|NCT00177580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6386659|NCT00177580|Antimetabolites|antimetabolites|mesh-ancestor
6386660|NCT00177580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386661|NCT00177580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6386662|NCT00177580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6386663|NCT00177580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6386664|NCT00177619|Alendronate|alendronate|mesh-list
6386665|NCT00177619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6386666|NCT00177619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386667|NCT00177684|Amphotericin B|amphotericin b|mesh-list
6386668|NCT00177684|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6386669|NCT00177684|Amebicides|amebicides|mesh-ancestor
6386670|NCT00177684|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6386671|NCT00177684|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6386672|NCT00177684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6386673|NCT00177684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6386674|NCT00177684|Antifungal Agents|antifungal agents|mesh-ancestor
6386675|NCT00177710|Amphotericin B|amphotericin b|mesh-list
6386676|NCT00177710|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6386677|NCT00177710|Amebicides|amebicides|mesh-ancestor
6386678|NCT00177710|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6386679|NCT00177710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6386680|NCT00177710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6386681|NCT00177710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6386682|NCT00177710|Antifungal Agents|antifungal agents|mesh-ancestor
6386683|NCT00177749|Posaconazole|posaconazole|mesh-list
6386684|NCT00177749|Antifungal Agents|antifungal agents|mesh-ancestor
6386685|NCT00177749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6386686|NCT00177749|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6386687|NCT00177749|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6386688|NCT00177749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6386689|NCT00177749|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6386690|NCT00177749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6386691|NCT00177749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6386692|NCT00177749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386693|NCT00177749|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6386694|NCT00177749|Hormone Antagonists|hormone antagonists|mesh-ancestor
6386695|NCT00177749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6386696|NCT00177749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386697|NCT00177853|Celecoxib|celecoxib|mesh-list
6386698|NCT00177853|Irinotecan|irinotecan|mesh-list
6386699|NCT00177853|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6386700|NCT00177853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6386701|NCT00177853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6386702|NCT00177853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386703|NCT00177853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6386704|NCT00177853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6386705|NCT00177853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6386706|NCT00177853|Analgesics|analgesics|mesh-ancestor
6386707|NCT00177853|Sensory System Agents|sensory system agents|mesh-ancestor
6386708|NCT00177853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6386709|NCT00177853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386710|NCT00177853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6386711|NCT00177853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6386712|NCT00177853|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6386713|NCT00177853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6386714|NCT00177996|Sertraline|sertraline|mesh-list
6386715|NCT00177996|Antidepressive Agents|antidepressive agents|mesh-ancestor
6386716|NCT00177996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6386717|NCT00177996|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6386718|NCT00177996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6386719|NCT00177996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6386720|NCT00177996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386721|NCT00177996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6386722|NCT00177996|Serotonin Agents|serotonin agents|mesh-ancestor
6537248|NCT00821496|Estradiol|estradiol|mesh-list
6386723|NCT00177996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386724|NCT00178035|Paroxetine|paroxetine|mesh-list
6386725|NCT00178035|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6386726|NCT00178035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6386727|NCT00178035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6386728|NCT00178035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386729|NCT00178035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6386730|NCT00178035|Serotonin Agents|serotonin agents|mesh-ancestor
6386731|NCT00178035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386732|NCT00178035|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6386733|NCT00178035|Antidepressive Agents|antidepressive agents|mesh-ancestor
6386734|NCT00178035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6386735|NCT00178035|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6386736|NCT00178035|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6386737|NCT00178035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6386738|NCT00178048|Paroxetine|paroxetine|mesh-list
6386739|NCT00178048|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6386740|NCT00178048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6386741|NCT00178048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6386742|NCT00178048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386743|NCT00178048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6386744|NCT00178048|Serotonin Agents|serotonin agents|mesh-ancestor
6386745|NCT00178048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386746|NCT00178048|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6386747|NCT00178048|Antidepressive Agents|antidepressive agents|mesh-ancestor
6386748|NCT00178048|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6386749|NCT00178048|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6386750|NCT00178048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6386751|NCT00178048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6386752|NCT00178100|Paroxetine|paroxetine|mesh-list
6386753|NCT00178100|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6386754|NCT00178100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6386755|NCT00178100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6386756|NCT00178100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386757|NCT00178100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6386758|NCT00178100|Serotonin Agents|serotonin agents|mesh-ancestor
6386759|NCT00178100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386760|NCT00178100|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6386761|NCT00178100|Antidepressive Agents|antidepressive agents|mesh-ancestor
6386762|NCT00178100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6386763|NCT00178100|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6386764|NCT00178100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6386765|NCT00178100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6386766|NCT00178113|Lycopene|lycopene|mesh-list
6386767|NCT00178113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6386768|NCT00178113|Antioxidants|antioxidants|mesh-ancestor
6386769|NCT00178113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386770|NCT00178113|Protective Agents|protective agents|mesh-ancestor
6386771|NCT00178113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386772|NCT00178113|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6386773|NCT00178113|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6386774|NCT00178113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6386775|NCT00178269|Docetaxel|docetaxel|mesh-list
6386776|NCT00178269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6386777|NCT00178269|Tubulin Modulators|tubulin modulators|mesh-ancestor
6386778|NCT00178269|Antimitotic Agents|antimitotic agents|mesh-ancestor
6386779|NCT00178269|Mitosis Modulators|mitosis modulators|mesh-ancestor
6386780|NCT00178269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386781|NCT00178373|Modafinil|modafinil|mesh-list
6386782|NCT00178373|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6386783|NCT00178373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386784|NCT00178373|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6386785|NCT00178373|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6386786|NCT00178373|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6386787|NCT00178373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017563|NCT00373490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6017564|NCT00373490|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6017565|NCT00373490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6017566|NCT00373490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017567|NCT00373529|Clofarabine|clofarabine|mesh-list
6017568|NCT00373529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6017569|NCT00373529|Antimetabolites|antimetabolites|mesh-ancestor
6017570|NCT00373529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017571|NCT00373529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6018500|NCT00381238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396650|NCT00209469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6396651|NCT00209469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396652|NCT00209482|Metformin|metformin|mesh-list
6396653|NCT00209482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6396654|NCT00209482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396655|NCT00209495|Dexamethasone|dexamethasone|mesh-list
6396656|NCT00209495|Pregabalin|pregabalin|mesh-list
6396657|NCT00209495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6396658|NCT00209495|Antiemetics|antiemetics|mesh-ancestor
6396659|NCT00209495|Autonomic Agents|autonomic agents|mesh-ancestor
6396660|NCT00209495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6396661|NCT00209495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396662|NCT00209495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6396663|NCT00209495|Glucocorticoids|glucocorticoids|mesh-ancestor
6396664|NCT00209495|Hormones|hormones|mesh-ancestor
6396665|NCT00209495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6396666|NCT00209495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6396667|NCT00209495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6396668|NCT00209495|Analgesics|analgesics|mesh-ancestor
6396669|NCT00209495|Sensory System Agents|sensory system agents|mesh-ancestor
6396670|NCT00209495|Anticonvulsants|anticonvulsants|mesh-ancestor
6396671|NCT00209495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6396672|NCT00209495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6396673|NCT00209495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396674|NCT00209495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6396675|NCT00209495|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6396676|NCT00209495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6396677|NCT00209495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6396678|NCT00209495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6396679|NCT00209521|Propofol|propofol|mesh-list
6396680|NCT00209521|Fospropofol|fospropofol|mesh-list
6396681|NCT00209521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6396682|NCT00209521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6396683|NCT00209521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396684|NCT00209521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6396685|NCT00209521|Anesthetics, General|anesthetics, general|mesh-ancestor
6386788|NCT00178451|Abciximab|abciximab|mesh-list
6386789|NCT00178451|Anticoagulants|anticoagulants|mesh-ancestor
6386790|NCT00178451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6386791|NCT00178620|Reteplase|reteplase|mesh-list
6386792|NCT00178620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6386793|NCT00178620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6386794|NCT00178620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386795|NCT00178698|Gemcitabine|gemcitabine|mesh-list
6386796|NCT00178698|Interferons|interferons|mesh-list
6386797|NCT00178698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6386798|NCT00178698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6386799|NCT00178698|Antimetabolites|antimetabolites|mesh-ancestor
6386800|NCT00178698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386801|NCT00178698|Antiviral Agents|antiviral agents|mesh-ancestor
6386802|NCT00178698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6386803|NCT00178698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6386804|NCT00178698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6386805|NCT00178698|Immunologic Factors|immunologic factors|mesh-ancestor
6386806|NCT00178698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386807|NCT00178763|Gemcitabine|gemcitabine|mesh-list
6386808|NCT00178763|Interferons|interferons|mesh-list
6386809|NCT00178763|Interferon-alpha|interferon-alpha|mesh-list
6386810|NCT00178763|Cisplatin|cisplatin|mesh-list
6386811|NCT00178763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6386812|NCT00178763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6386813|NCT00178763|Antimetabolites|antimetabolites|mesh-ancestor
6386814|NCT00178763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386815|NCT00178763|Antiviral Agents|antiviral agents|mesh-ancestor
6386816|NCT00178763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6386817|NCT00178763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6386818|NCT00178763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6386819|NCT00178763|Immunologic Factors|immunologic factors|mesh-ancestor
6386820|NCT00178763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386821|NCT00178802|Interferons|interferons|mesh-list
6386822|NCT00178802|Doxorubicin|doxorubicin|mesh-list
6386823|NCT00178802|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6386824|NCT00178802|Fluorouracil|fluorouracil|mesh-list
6386825|NCT00178802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6386826|NCT00178802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6386827|NCT00178802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6386828|NCT00178802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6386829|NCT00178802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6386830|NCT00178802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386831|NCT00178802|Antimetabolites|antimetabolites|mesh-ancestor
6386832|NCT00178802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6386833|NCT00178802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6386834|NCT00178802|Immunologic Factors|immunologic factors|mesh-ancestor
6386835|NCT00178802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386836|NCT00178802|Antiviral Agents|antiviral agents|mesh-ancestor
6386837|NCT00178802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6386838|NCT00178828|Bupropion|bupropion|mesh-list
6386839|NCT00178828|Sertraline|sertraline|mesh-list
6386840|NCT00178828|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6386841|NCT00178828|Antidepressive Agents|antidepressive agents|mesh-ancestor
6386842|NCT00178828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6386843|NCT00178828|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6017572|NCT00373685|Celecoxib|celecoxib|mesh-list
6017573|NCT00373685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6017574|NCT00373685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6017575|NCT00373685|Analgesics|analgesics|mesh-ancestor
6017576|NCT00373685|Sensory System Agents|sensory system agents|mesh-ancestor
6017577|NCT00373685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6017578|NCT00373685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386844|NCT00178828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6386845|NCT00178828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6386846|NCT00178828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386847|NCT00178828|Dopamine Agents|dopamine agents|mesh-ancestor
6386848|NCT00178828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6386849|NCT00178828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386850|NCT00178828|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6386851|NCT00178828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6386852|NCT00178828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6386853|NCT00178828|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6386854|NCT00178828|Serotonin Agents|serotonin agents|mesh-ancestor
6386855|NCT00178854|Risperidone|risperidone|mesh-list
6386856|NCT00178854|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6386857|NCT00178854|Serotonin Agents|serotonin agents|mesh-ancestor
6386858|NCT00178854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6386859|NCT00178854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386860|NCT00178854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386861|NCT00178854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6386862|NCT00178854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6386863|NCT00178854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6386864|NCT00178854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6386865|NCT00178854|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6386866|NCT00178854|Dopamine Agents|dopamine agents|mesh-ancestor
6386867|NCT00178945|Botulinum Toxins|botulinum toxins|mesh-list
6386868|NCT00178945|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6386869|NCT00178945|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6386870|NCT00178945|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6386871|NCT00178945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6386872|NCT00178945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386873|NCT00178945|Cholinergic Agents|cholinergic agents|mesh-ancestor
6386874|NCT00178945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6386875|NCT00178945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386876|NCT00178945|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6386877|NCT00178945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6386878|NCT00178971|Buspirone|buspirone|mesh-list
6386879|NCT00178971|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6386880|NCT00178971|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6386881|NCT00178971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6386882|NCT00178971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386883|NCT00178971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6386884|NCT00178971|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6386885|NCT00178971|Serotonin Agents|serotonin agents|mesh-ancestor
6386886|NCT00178971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6386887|NCT00178971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386888|NCT00179023|Trimethaphan|trimethaphan|mesh-list
6386889|NCT00179023|Pseudoephedrine|pseudoephedrine|mesh-list
6386890|NCT00179023|Ephedrine|ephedrine|mesh-list
6386891|NCT00179023|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
6386892|NCT00179023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6386893|NCT00179023|Autonomic Agents|autonomic agents|mesh-ancestor
6386894|NCT00179023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6386895|NCT00179023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386896|NCT00179023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6386897|NCT00179023|Respiratory System Agents|respiratory system agents|mesh-ancestor
6386898|NCT00179023|Nasal Decongestants|nasal decongestants|mesh-ancestor
6386899|NCT00179023|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6386900|NCT00179023|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6386901|NCT00179023|Sympathomimetics|sympathomimetics|mesh-ancestor
6386902|NCT00179023|Adrenergic Agents|adrenergic agents|mesh-ancestor
6386903|NCT00179023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6386904|NCT00179023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386905|NCT00179023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6386906|NCT00179023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6386907|NCT00179023|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
6386908|NCT00179023|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
6386909|NCT00179023|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6386910|NCT00179023|Cholinergic Agents|cholinergic agents|mesh-ancestor
6386911|NCT00179023|Vasodilator Agents|vasodilator agents|mesh-ancestor
6386912|NCT00179062|Olanzapine|olanzapine|mesh-list
6386913|NCT00179062|Risperidone|risperidone|mesh-list
6386914|NCT00179062|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6386915|NCT00179062|Serotonin Agents|serotonin agents|mesh-ancestor
6386916|NCT00179062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6386917|NCT00179062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386918|NCT00179062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386919|NCT00179062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6386920|NCT00179062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6386921|NCT00179062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6386922|NCT00179062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6386923|NCT00179062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6386924|NCT00179062|Dopamine Agents|dopamine agents|mesh-ancestor
6386925|NCT00179062|Antiemetics|antiemetics|mesh-ancestor
6386926|NCT00179062|Autonomic Agents|autonomic agents|mesh-ancestor
6386927|NCT00179062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6386928|NCT00179062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6386929|NCT00179062|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6017579|NCT00373685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6017580|NCT00373685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6017581|NCT00373685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6017582|NCT00373685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6386930|NCT00179062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6386931|NCT00179062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6386932|NCT00179114|Baclofen|baclofen|mesh-list
6386933|NCT00179114|Botulinum Toxins|botulinum toxins|mesh-list
6386934|NCT00179114|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6386935|NCT00179114|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6386936|NCT00179114|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6386937|NCT00179114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6386938|NCT00179114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386939|NCT00179114|Cholinergic Agents|cholinergic agents|mesh-ancestor
6386940|NCT00179114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6386941|NCT00179114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386942|NCT00179114|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6386943|NCT00179114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6386944|NCT00179114|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6386945|NCT00179114|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6386946|NCT00179114|GABA Agonists|gaba agonists|mesh-ancestor
6386947|NCT00179114|GABA Agents|gaba agents|mesh-ancestor
6386948|NCT00179231|Olanzapine|olanzapine|mesh-list
6386949|NCT00179231|Clozapine|clozapine|mesh-list
6386950|NCT00179231|Antiemetics|antiemetics|mesh-ancestor
6386951|NCT00179231|Autonomic Agents|autonomic agents|mesh-ancestor
6386952|NCT00179231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6386953|NCT00179231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386954|NCT00179231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6386955|NCT00179231|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6386956|NCT00179231|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6386957|NCT00179231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6386958|NCT00179231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6386959|NCT00179231|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6386960|NCT00179231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6386961|NCT00179231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6386962|NCT00179231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386963|NCT00179231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6386964|NCT00179231|Serotonin Agents|serotonin agents|mesh-ancestor
6386965|NCT00179231|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6386966|NCT00179231|GABA Antagonists|gaba antagonists|mesh-ancestor
6386967|NCT00179231|GABA Agents|gaba agents|mesh-ancestor
6386968|NCT00179244|Bupropion|bupropion|mesh-list
6386969|NCT00179244|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6386970|NCT00179244|Antidepressive Agents|antidepressive agents|mesh-ancestor
6386971|NCT00179244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6386972|NCT00179244|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6386973|NCT00179244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6386974|NCT00179244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6386975|NCT00179244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386976|NCT00179244|Dopamine Agents|dopamine agents|mesh-ancestor
6386977|NCT00179244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6386978|NCT00179244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386979|NCT00179244|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6386980|NCT00179244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6386981|NCT00179244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6386982|NCT00179257|Sertraline|sertraline|mesh-list
6386983|NCT00179257|Antidepressive Agents|antidepressive agents|mesh-ancestor
6386984|NCT00179257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6386985|NCT00179257|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6386986|NCT00179257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6386987|NCT00179257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6386988|NCT00179257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6386989|NCT00179257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6386990|NCT00179257|Serotonin Agents|serotonin agents|mesh-ancestor
6386991|NCT00179257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6386992|NCT00179283|Sertraline|sertraline|mesh-list
6386993|NCT00179283|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6386994|NCT00179283|Antidepressive Agents|antidepressive agents|mesh-ancestor
6386995|NCT00179283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6386996|NCT00179283|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6386997|NCT00179283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6386998|NCT00179283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6386999|NCT00179283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387000|NCT00179283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6387001|NCT00179283|Serotonin Agents|serotonin agents|mesh-ancestor
6387002|NCT00179283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387003|NCT00179283|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6387004|NCT00179283|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6387005|NCT00179465|Tiagabine|tiagabine|mesh-list
6387006|NCT00179465|Antipsychotic Agents|antipsychotic agents|mesh-list
6387007|NCT00179465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6387008|NCT00179465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6387009|NCT00179465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387010|NCT00179465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6387011|NCT00179465|Anticonvulsants|anticonvulsants|mesh-ancestor
6387012|NCT00179465|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
6387013|NCT00179465|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6387014|NCT00179465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6387015|NCT00179465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387016|NCT00179465|GABA Agents|gaba agents|mesh-ancestor
6387017|NCT00179465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6387018|NCT00179608|Lenalidomide|lenalidomide|mesh-list
6387019|NCT00179608|Immunologic Factors|immunologic factors|mesh-ancestor
6387020|NCT00179608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387021|NCT00179608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6387022|NCT00179608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6387023|NCT00179608|Growth Substances|growth substances|mesh-ancestor
6387024|NCT00179608|Growth Inhibitors|growth inhibitors|mesh-ancestor
6387025|NCT00179608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6387026|NCT00179686|Lenalidomide|lenalidomide|mesh-list
6387027|NCT00179686|Immunologic Factors|immunologic factors|mesh-ancestor
6387028|NCT00179686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387029|NCT00179686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6387030|NCT00179686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6387031|NCT00179686|Growth Substances|growth substances|mesh-ancestor
6387032|NCT00179686|Growth Inhibitors|growth inhibitors|mesh-ancestor
6387033|NCT00179686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6387034|NCT00179699|Pemetrexed|pemetrexed|mesh-list
6387035|NCT00179699|Lenalidomide|lenalidomide|mesh-list
6387036|NCT00179699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6387037|NCT00179699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6387038|NCT00179699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387039|NCT00179699|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6387040|NCT00179699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6387041|NCT00179699|Immunologic Factors|immunologic factors|mesh-ancestor
6387042|NCT00179699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387043|NCT00179699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6387044|NCT00179699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6387045|NCT00179699|Growth Substances|growth substances|mesh-ancestor
6387046|NCT00179699|Growth Inhibitors|growth inhibitors|mesh-ancestor
6387047|NCT00179712|Topotecan|topotecan|mesh-list
6387048|NCT00179712|Lenalidomide|lenalidomide|mesh-list
6387049|NCT00179712|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6387050|NCT00179712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6387051|NCT00179712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6387052|NCT00179712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387053|NCT00179712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6387054|NCT00179712|Immunologic Factors|immunologic factors|mesh-ancestor
6396686|NCT00209521|Anesthetics|anesthetics|mesh-ancestor
6387055|NCT00179712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387056|NCT00179712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6387057|NCT00179712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6387058|NCT00179712|Growth Substances|growth substances|mesh-ancestor
6387059|NCT00179712|Growth Inhibitors|growth inhibitors|mesh-ancestor
6387060|NCT00179725|Doxorubicin|doxorubicin|mesh-list
6387061|NCT00179725|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6387062|NCT00179725|Lenalidomide|lenalidomide|mesh-list
6387063|NCT00179725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6387064|NCT00179725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6387065|NCT00179725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6387066|NCT00179725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6387067|NCT00179725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6387068|NCT00179725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387069|NCT00179725|Immunologic Factors|immunologic factors|mesh-ancestor
6387070|NCT00179725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387071|NCT00179725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6387072|NCT00179725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6387073|NCT00179725|Growth Substances|growth substances|mesh-ancestor
6387074|NCT00179725|Growth Inhibitors|growth inhibitors|mesh-ancestor
6387075|NCT00179738|Lenalidomide|lenalidomide|mesh-list
6387076|NCT00179738|Immunologic Factors|immunologic factors|mesh-ancestor
6387077|NCT00179738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387078|NCT00179738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6387079|NCT00179738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6387080|NCT00179738|Growth Substances|growth substances|mesh-ancestor
6387081|NCT00179738|Growth Inhibitors|growth inhibitors|mesh-ancestor
6387082|NCT00179738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6387083|NCT00179751|Gemcitabine|gemcitabine|mesh-list
6387084|NCT00179751|Lenalidomide|lenalidomide|mesh-list
6387085|NCT00179751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6387086|NCT00179751|Antimetabolites|antimetabolites|mesh-ancestor
6387087|NCT00179751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387088|NCT00179751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6387089|NCT00179751|Antiviral Agents|antiviral agents|mesh-ancestor
6387090|NCT00179751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6387091|NCT00179751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6387092|NCT00179751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6387093|NCT00179751|Immunologic Factors|immunologic factors|mesh-ancestor
6387094|NCT00179751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387095|NCT00179751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6387096|NCT00179751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6387097|NCT00179751|Growth Substances|growth substances|mesh-ancestor
6387098|NCT00179751|Growth Inhibitors|growth inhibitors|mesh-ancestor
6387099|NCT00179764|Busulfan|busulfan|mesh-list
6387100|NCT00179764|Alkylating Agents|alkylating agents|mesh-ancestor
6387101|NCT00179764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387102|NCT00179764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6387103|NCT00179764|Immunologic Factors|immunologic factors|mesh-ancestor
6387104|NCT00179764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387105|NCT00179764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6387106|NCT00179764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6387107|NCT00179764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6387108|NCT00179816|Cyclophosphamide|cyclophosphamide|mesh-list
6387109|NCT00179816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6387110|NCT00179816|Immunologic Factors|immunologic factors|mesh-ancestor
6387111|NCT00179816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387112|NCT00179816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6387113|NCT00179816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6387114|NCT00179816|Alkylating Agents|alkylating agents|mesh-ancestor
6387115|NCT00179816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387116|NCT00179816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6387117|NCT00179816|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6387118|NCT00179881|Thalidomide|thalidomide|mesh-list
6387119|NCT00179881|Carboplatin|carboplatin|mesh-list
6387120|NCT00179881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6387121|NCT00179881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6387122|NCT00179881|Immunologic Factors|immunologic factors|mesh-ancestor
6387123|NCT00179881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387124|NCT00179881|Leprostatic Agents|leprostatic agents|mesh-ancestor
6387125|NCT00179881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6387126|NCT00179881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6387127|NCT00179881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6387128|NCT00179881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6387129|NCT00179881|Growth Substances|growth substances|mesh-ancestor
6387130|NCT00179881|Growth Inhibitors|growth inhibitors|mesh-ancestor
6387131|NCT00179920|Carboplatin|carboplatin|mesh-list
6387132|NCT00179920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6387133|NCT00180011|Omalizumab|omalizumab|mesh-list
6387134|NCT00180011|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6387135|NCT00180011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6387136|NCT00180011|Respiratory System Agents|respiratory system agents|mesh-ancestor
6387137|NCT00180024|Irbesartan|irbesartan|mesh-list
6387138|NCT00180024|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6387139|NCT00180024|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6387140|NCT00180024|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6387141|NCT00180024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387142|NCT00180037|Ubiquinone|ubiquinone|mesh-list
6387143|NCT00180037|Coenzyme Q10|coenzyme q10|mesh-list
6387144|NCT00180037|Micronutrients|micronutrients|mesh-ancestor
6387145|NCT00180037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387146|NCT00180037|Vitamins|vitamins|mesh-ancestor
6387147|NCT00180050|Budesonide|budesonide|mesh-list
6387148|NCT00180050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6387149|NCT00180050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6387150|NCT00180050|Autonomic Agents|autonomic agents|mesh-ancestor
6387151|NCT00180050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6387152|NCT00180050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387153|NCT00180050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6387154|NCT00180050|Respiratory System Agents|respiratory system agents|mesh-ancestor
6387155|NCT00180050|Glucocorticoids|glucocorticoids|mesh-ancestor
6387156|NCT00180050|Hormones|hormones|mesh-ancestor
6387157|NCT00180050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6387158|NCT00180063|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
6387159|NCT00180063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6387160|NCT00180063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387161|NCT00180076|Budesonide|budesonide|mesh-list
6387162|NCT00180076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6387163|NCT00180076|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6387164|NCT00180076|Autonomic Agents|autonomic agents|mesh-ancestor
6387165|NCT00180076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6387166|NCT00180076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387167|NCT00180076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6387168|NCT00180076|Respiratory System Agents|respiratory system agents|mesh-ancestor
6387169|NCT00180076|Glucocorticoids|glucocorticoids|mesh-ancestor
6387170|NCT00180076|Hormones|hormones|mesh-ancestor
6387171|NCT00180076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6387172|NCT00180089|Budesonide|budesonide|mesh-list
6387173|NCT00180089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6387174|NCT00180089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6387175|NCT00180089|Autonomic Agents|autonomic agents|mesh-ancestor
6387176|NCT00180089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6387177|NCT00180089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387178|NCT00180089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6387179|NCT00180089|Respiratory System Agents|respiratory system agents|mesh-ancestor
6387180|NCT00180089|Glucocorticoids|glucocorticoids|mesh-ancestor
6387181|NCT00180089|Hormones|hormones|mesh-ancestor
6387182|NCT00180089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6396687|NCT00209534|Fospropofol|fospropofol|mesh-list
6396688|NCT00209534|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6396689|NCT00209534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6396690|NCT00209534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396691|NCT00209547|Fospropofol|fospropofol|mesh-list
6396692|NCT00209547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6396693|NCT00209547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6396694|NCT00209547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396695|NCT00209573|Fospropofol|fospropofol|mesh-list
6396696|NCT00209573|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6396697|NCT00209573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6396698|NCT00209573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396699|NCT00209586|Fospropofol|fospropofol|mesh-list
6396700|NCT00209586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6396701|NCT00209586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6396702|NCT00209586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396703|NCT00209599|Fospropofol|fospropofol|mesh-list
6396704|NCT00209599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6396705|NCT00209599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6396706|NCT00209599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396707|NCT00209612|Paclitaxel|paclitaxel|mesh-list
6396708|NCT00209612|Irinotecan|irinotecan|mesh-list
6396709|NCT00209612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6396710|NCT00209612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6396711|NCT00209612|Tubulin Modulators|tubulin modulators|mesh-ancestor
6396712|NCT00209612|Antimitotic Agents|antimitotic agents|mesh-ancestor
6396713|NCT00209612|Mitosis Modulators|mitosis modulators|mesh-ancestor
6397087|NCT00210210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387183|NCT00180102|Cytarabine|cytarabine|mesh-list
6387184|NCT00180102|Mitoxantrone|mitoxantrone|mesh-list
6387185|NCT00180102|Amsacrine|amsacrine|mesh-list
6387186|NCT00180102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6387187|NCT00180102|Antimetabolites|antimetabolites|mesh-ancestor
6387188|NCT00180102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387189|NCT00180102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6387190|NCT00180102|Antiviral Agents|antiviral agents|mesh-ancestor
6387191|NCT00180102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6387192|NCT00180102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6387193|NCT00180102|Immunologic Factors|immunologic factors|mesh-ancestor
6387194|NCT00180102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387195|NCT00180102|Analgesics|analgesics|mesh-ancestor
6387196|NCT00180102|Sensory System Agents|sensory system agents|mesh-ancestor
6387197|NCT00180102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6387198|NCT00180102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6387199|NCT00180102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6387200|NCT00180102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6387201|NCT00180115|Cytarabine|cytarabine|mesh-list
6387202|NCT00180115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6387203|NCT00180115|Antimetabolites|antimetabolites|mesh-ancestor
6387204|NCT00180115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387205|NCT00180115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6387206|NCT00180115|Antiviral Agents|antiviral agents|mesh-ancestor
6387207|NCT00180115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6387208|NCT00180115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6387209|NCT00180115|Immunologic Factors|immunologic factors|mesh-ancestor
6387210|NCT00180115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387211|NCT00180128|Cytarabine|cytarabine|mesh-list
6387212|NCT00180128|Daunorubicin|daunorubicin|mesh-list
6387213|NCT00180128|Mitoxantrone|mitoxantrone|mesh-list
6387214|NCT00180128|Idarubicin|idarubicin|mesh-list
6387215|NCT00180128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6387216|NCT00180128|Antimetabolites|antimetabolites|mesh-ancestor
6387217|NCT00180128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387218|NCT00180128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6387219|NCT00180128|Antiviral Agents|antiviral agents|mesh-ancestor
6387220|NCT00180128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6387221|NCT00180128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6387222|NCT00180128|Immunologic Factors|immunologic factors|mesh-ancestor
6387223|NCT00180128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387224|NCT00180128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6387225|NCT00180128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6387226|NCT00180128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6387227|NCT00180128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6387228|NCT00180128|Analgesics|analgesics|mesh-ancestor
6387229|NCT00180128|Sensory System Agents|sensory system agents|mesh-ancestor
6387230|NCT00180128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6387231|NCT00180141|Pimecrolimus|pimecrolimus|mesh-list
6397088|NCT00210210|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6387232|NCT00180141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6387233|NCT00180141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6387234|NCT00180141|Analgesics|analgesics|mesh-ancestor
6387235|NCT00180141|Sensory System Agents|sensory system agents|mesh-ancestor
6387236|NCT00180141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6387237|NCT00180141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387238|NCT00180141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6387239|NCT00180141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6387240|NCT00180141|Dermatologic Agents|dermatologic agents|mesh-ancestor
6387241|NCT00180141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6387242|NCT00180141|Immunologic Factors|immunologic factors|mesh-ancestor
6387243|NCT00180141|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6387244|NCT00180141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6387245|NCT00180141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387246|NCT00180310|Paclitaxel|paclitaxel|mesh-list
6387247|NCT00180310|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6387248|NCT00180310|Everolimus|everolimus|mesh-list
6387249|NCT00180310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6387250|NCT00180310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6387251|NCT00180310|Tubulin Modulators|tubulin modulators|mesh-ancestor
6387252|NCT00180310|Antimitotic Agents|antimitotic agents|mesh-ancestor
6387253|NCT00180310|Mitosis Modulators|mitosis modulators|mesh-ancestor
6387254|NCT00180310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387255|NCT00180310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6387256|NCT00180310|Immunologic Factors|immunologic factors|mesh-ancestor
6387257|NCT00180310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387258|NCT00180622|Nitric Oxide|nitric oxide|mesh-list
6387259|NCT00180622|Carbon Monoxide|carbon monoxide|mesh-list
6387260|NCT00180622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6387261|NCT00180622|Autonomic Agents|autonomic agents|mesh-ancestor
6387262|NCT00180622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6387263|NCT00180622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387264|NCT00180622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6387265|NCT00180622|Respiratory System Agents|respiratory system agents|mesh-ancestor
6387266|NCT00180622|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6387267|NCT00180622|Antioxidants|antioxidants|mesh-ancestor
6387268|NCT00180622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387269|NCT00180622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6387270|NCT00180622|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6387271|NCT00180622|Vasodilator Agents|vasodilator agents|mesh-ancestor
6387272|NCT00180622|Gasotransmitters|gasotransmitters|mesh-ancestor
6387273|NCT00180622|Protective Agents|protective agents|mesh-ancestor
6387274|NCT00180622|Antimetabolites|antimetabolites|mesh-ancestor
6387275|NCT00180635|Pimagedine|pimagedine|mesh-list
6387276|NCT00180635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6017583|NCT00373685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6387277|NCT00180635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387278|NCT00180791|Carboplatin|carboplatin|mesh-list
6387279|NCT00180791|Etoposide|etoposide|mesh-list
6387280|NCT00180791|Melphalan|melphalan|mesh-list
6387281|NCT00180791|Thiotepa|thiotepa|mesh-list
6387282|NCT00180791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6387283|NCT00180791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6387284|NCT00180791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6387285|NCT00180791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6387286|NCT00180791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6387287|NCT00180791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387288|NCT00180791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6387289|NCT00180791|Alkylating Agents|alkylating agents|mesh-ancestor
6387290|NCT00180791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6387291|NCT00180791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6387292|NCT00180791|Immunologic Factors|immunologic factors|mesh-ancestor
6387293|NCT00180791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387294|NCT00180830|Imatinib Mesylate|imatinib mesylate|mesh-list
6387295|NCT00180830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6387296|NCT00180830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6387297|NCT00180830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6387298|NCT00180830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387299|NCT00180843|Bromides|bromides|mesh-list
6387300|NCT00180843|Albuterol|albuterol|mesh-list
6387301|NCT00180843|Ipratropium|ipratropium|mesh-list
6387302|NCT00180843|Anticonvulsants|anticonvulsants|mesh-ancestor
6387303|NCT00180843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6387304|NCT00180843|Autonomic Agents|autonomic agents|mesh-ancestor
6387305|NCT00180843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6387306|NCT00180843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387307|NCT00180843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6387308|NCT00180843|Respiratory System Agents|respiratory system agents|mesh-ancestor
6387309|NCT00180843|Tocolytic Agents|tocolytic agents|mesh-ancestor
6387310|NCT00180843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6387311|NCT00180843|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6387312|NCT00180843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6387313|NCT00180843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6387314|NCT00180843|Adrenergic Agents|adrenergic agents|mesh-ancestor
6387315|NCT00180843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6017584|NCT00373685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017585|NCT00373880|Cocaine|cocaine|mesh-list
6017586|NCT00373880|Aripiprazole|aripiprazole|mesh-list
6017587|NCT00373880|Antidepressive Agents|antidepressive agents|mesh-ancestor
6017588|NCT00373880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6387316|NCT00180843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387317|NCT00180843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6387318|NCT00180843|Cholinergic Agents|cholinergic agents|mesh-ancestor
6387319|NCT00180882|Rituximab|rituximab|mesh-list
6387320|NCT00180882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6387321|NCT00180882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6387322|NCT00180882|Immunologic Factors|immunologic factors|mesh-ancestor
6387323|NCT00180882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387324|NCT00180882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6387325|NCT00180895|Rituximab|rituximab|mesh-list
6387326|NCT00180895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6387327|NCT00180895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6387328|NCT00180895|Immunologic Factors|immunologic factors|mesh-ancestor
6387329|NCT00180895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387330|NCT00180895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6387331|NCT00180908|Doxorubicin|doxorubicin|mesh-list
6387332|NCT00180908|Etoposide|etoposide|mesh-list
6387333|NCT00180908|Methotrexate|methotrexate|mesh-list
6387334|NCT00180908|Ifosfamide|ifosfamide|mesh-list
6387335|NCT00180908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6387336|NCT00180908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6387337|NCT00180908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6387338|NCT00180908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6387339|NCT00180908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6387340|NCT00180908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387341|NCT00180908|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6387342|NCT00180908|Abortifacient Agents|abortifacient agents|mesh-ancestor
6387343|NCT00180908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6387344|NCT00180908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387345|NCT00180908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6387346|NCT00180908|Antimetabolites|antimetabolites|mesh-ancestor
6387347|NCT00180908|Dermatologic Agents|dermatologic agents|mesh-ancestor
6387348|NCT00180908|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6387349|NCT00180908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6387350|NCT00180908|Immunologic Factors|immunologic factors|mesh-ancestor
6387351|NCT00180908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6387352|NCT00180908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6387353|NCT00180908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6387354|NCT00180908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6387355|NCT00180908|Alkylating Agents|alkylating agents|mesh-ancestor
6387356|NCT00180921|Imatinib Mesylate|imatinib mesylate|mesh-list
6387357|NCT00180921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6387358|NCT00180921|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6387359|NCT00180921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6387360|NCT00180921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387361|NCT00180947|Vinorelbine|vinorelbine|mesh-list
6387362|NCT00180947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6387363|NCT00180947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6387364|NCT00180947|Tubulin Modulators|tubulin modulators|mesh-ancestor
6387365|NCT00180947|Antimitotic Agents|antimitotic agents|mesh-ancestor
6387366|NCT00180947|Mitosis Modulators|mitosis modulators|mesh-ancestor
6387367|NCT00180947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387368|NCT00180960|Oxaliplatin|oxaliplatin|mesh-list
6387369|NCT00180960|Irinotecan|irinotecan|mesh-list
6387370|NCT00180960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6387371|NCT00180960|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6387372|NCT00180960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6387373|NCT00180960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6387374|NCT00180960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387375|NCT00180973|Hydroxyurea|hydroxyurea|mesh-list
6387376|NCT00180973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6387377|NCT00180973|Antisickling Agents|antisickling agents|mesh-ancestor
6387378|NCT00180973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6387379|NCT00180973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387380|NCT00180973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6387381|NCT00181012|Lidocaine|lidocaine|mesh-list
6387382|NCT00181012|Anesthetics, Local|anesthetics, local|mesh-ancestor
6387383|NCT00181012|Anesthetics|anesthetics|mesh-ancestor
6387384|NCT00181012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6387385|NCT00181012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387386|NCT00181012|Sensory System Agents|sensory system agents|mesh-ancestor
6387387|NCT00181012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6387388|NCT00181012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6387389|NCT00181012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6387390|NCT00181012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6387391|NCT00181012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6387392|NCT00181012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387393|NCT00181025|Melphalan|melphalan|mesh-list
6387394|NCT00181025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6387395|NCT00181025|Alkylating Agents|alkylating agents|mesh-ancestor
6387396|NCT00181025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387397|NCT00181025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6387398|NCT00181025|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6387399|NCT00181025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6387400|NCT00181025|Immunologic Factors|immunologic factors|mesh-ancestor
6387401|NCT00181025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387402|NCT00181116|Levetiracetam|levetiracetam|mesh-list
6387403|NCT00181116|Anticonvulsants|anticonvulsants|mesh-ancestor
6387404|NCT00181116|Nootropic Agents|nootropic agents|mesh-ancestor
6387405|NCT00181142|Daclizumab|daclizumab|mesh-list
6387406|NCT00181142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6387407|NCT00181142|Immunologic Factors|immunologic factors|mesh-ancestor
6387408|NCT00181142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387409|NCT00181181|Atorvastatin|atorvastatin|mesh-list
6387410|NCT00181181|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6387411|NCT00181181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6387412|NCT00181181|Antimetabolites|antimetabolites|mesh-ancestor
6387413|NCT00181181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387414|NCT00181181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6387415|NCT00181181|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6387416|NCT00181181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6387417|NCT00181220|Valproic Acid|valproic acid|mesh-list
6387418|NCT00181220|Anticonvulsants|anticonvulsants|mesh-ancestor
6387419|NCT00181220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6387420|NCT00181220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387421|NCT00181220|GABA Agents|gaba agents|mesh-ancestor
6387422|NCT00181220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6387423|NCT00181220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387424|NCT00181220|Antimanic Agents|antimanic agents|mesh-ancestor
6387425|NCT00181220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6387426|NCT00181220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6387427|NCT00181220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6387428|NCT00181246|Fentanyl|fentanyl|mesh-list
6387429|NCT00181246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6387430|NCT00181246|Narcotics|narcotics|mesh-ancestor
6387431|NCT00181246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6387432|NCT00181246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387433|NCT00181246|Analgesics|analgesics|mesh-ancestor
6387434|NCT00181246|Sensory System Agents|sensory system agents|mesh-ancestor
6387435|NCT00181246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6387436|NCT00181246|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6387437|NCT00181246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6387438|NCT00181246|Anesthetics, General|anesthetics, general|mesh-ancestor
6387439|NCT00181246|Anesthetics|anesthetics|mesh-ancestor
6387440|NCT00181272|Azithromycin|azithromycin|mesh-list
6387441|NCT00181272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6387442|NCT00181272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6387443|NCT00181298|Memantine|memantine|mesh-list
6387444|NCT00181298|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6387445|NCT00181298|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6387446|NCT00181298|Dopamine Agents|dopamine agents|mesh-ancestor
6387447|NCT00181298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6387448|NCT00181298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387449|NCT00181298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387450|NCT00181298|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6387451|NCT00181298|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6387452|NCT00181532|Celecoxib|celecoxib|mesh-list
6387453|NCT00181532|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6387454|NCT00181532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6387455|NCT00181532|Analgesics|analgesics|mesh-ancestor
6387456|NCT00181532|Sensory System Agents|sensory system agents|mesh-ancestor
6387457|NCT00181532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6387458|NCT00181532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387459|NCT00181532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6387460|NCT00181532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6387461|NCT00181532|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6387462|NCT00181532|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6387463|NCT00181532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6387464|NCT00181532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387465|NCT00181558|Zoledronic Acid|zoledronic acid|mesh-list
6387466|NCT00181558|Atrasentan|atrasentan|mesh-list
6387467|NCT00181558|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6387468|NCT00181558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387469|NCT00181558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6387470|NCT00181558|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
6387471|NCT00181558|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6387472|NCT00181558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387473|NCT00181571|Methylphenidate|methylphenidate|mesh-list
6387474|NCT00181571|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6387475|NCT00181571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387476|NCT00181571|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6387477|NCT00181571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6387478|NCT00181571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6387479|NCT00181571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387480|NCT00181571|Dopamine Agents|dopamine agents|mesh-ancestor
6387481|NCT00181571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6387482|NCT00181584|Zoledronic Acid|zoledronic acid|mesh-list
6387483|NCT00181584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6387484|NCT00181584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387485|NCT00181597|Hydrocortisone|hydrocortisone|mesh-list
6387486|NCT00181597|Trilostane|trilostane|mesh-list
6387487|NCT00181597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6387488|NCT00181597|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6387489|NCT00181597|Abortifacient Agents|abortifacient agents|mesh-ancestor
6387490|NCT00181597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6387491|NCT00181597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387492|NCT00181597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6387493|NCT00181597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6387494|NCT00181597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387495|NCT00181636|Galantamine|galantamine|mesh-list
6387496|NCT00181636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6387497|NCT00181636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6387498|NCT00181636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387499|NCT00181636|Cholinergic Agents|cholinergic agents|mesh-ancestor
6387500|NCT00181636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6387501|NCT00181636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387502|NCT00181636|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6387503|NCT00181636|Autonomic Agents|autonomic agents|mesh-ancestor
6387504|NCT00181636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6387505|NCT00181636|Nootropic Agents|nootropic agents|mesh-ancestor
6387506|NCT00181662|Curcumin|curcumin|mesh-list
6387507|NCT00181662|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6387508|NCT00181662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6387509|NCT00181662|Analgesics|analgesics|mesh-ancestor
6387510|NCT00181662|Sensory System Agents|sensory system agents|mesh-ancestor
6387511|NCT00181662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6387512|NCT00181662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387513|NCT00181662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6387514|NCT00181662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6387515|NCT00181662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6387516|NCT00181662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6387517|NCT00181662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387518|NCT00181675|Galantamine|galantamine|mesh-list
6387519|NCT00181675|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6387520|NCT00181675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6387521|NCT00181675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387522|NCT00181675|Cholinergic Agents|cholinergic agents|mesh-ancestor
6387523|NCT00181675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6387524|NCT00181675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387525|NCT00181675|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6387526|NCT00181675|Autonomic Agents|autonomic agents|mesh-ancestor
6387527|NCT00181675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6387528|NCT00181675|Nootropic Agents|nootropic agents|mesh-ancestor
6387529|NCT00181688|Anastrozole|anastrozole|mesh-list
6387530|NCT00181688|Gefitinib|gefitinib|mesh-list
6387531|NCT00181688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6387532|NCT00181688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6387533|NCT00181688|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6387534|NCT00181688|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6387535|NCT00181688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6387536|NCT00181688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387537|NCT00181688|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6387538|NCT00181688|Hormone Antagonists|hormone antagonists|mesh-ancestor
6387539|NCT00181688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6387540|NCT00181688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387541|NCT00181688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6387542|NCT00181701|Paclitaxel|paclitaxel|mesh-list
6387543|NCT00181701|Carboplatin|carboplatin|mesh-list
6387544|NCT00181701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6387545|NCT00181701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6387546|NCT00181701|Tubulin Modulators|tubulin modulators|mesh-ancestor
6387547|NCT00181701|Antimitotic Agents|antimitotic agents|mesh-ancestor
6387548|NCT00181701|Mitosis Modulators|mitosis modulators|mesh-ancestor
6387549|NCT00181701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387550|NCT00181727|Valproic Acid|valproic acid|mesh-list
6387551|NCT00181727|Anticonvulsants|anticonvulsants|mesh-ancestor
6387552|NCT00181727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6387553|NCT00181727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387554|NCT00181727|GABA Agents|gaba agents|mesh-ancestor
6387555|NCT00181727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6387556|NCT00181727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387557|NCT00181727|Antimanic Agents|antimanic agents|mesh-ancestor
6387558|NCT00181727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6387559|NCT00181727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6387560|NCT00181727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6387561|NCT00181740|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6387562|NCT00181740|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6387563|NCT00181740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6387564|NCT00181740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6387565|NCT00181740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387566|NCT00181740|Adrenergic Agents|adrenergic agents|mesh-ancestor
6387567|NCT00181740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6387568|NCT00181740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387569|NCT00181779|Aripiprazole|aripiprazole|mesh-list
6387570|NCT00181779|Antidepressive Agents|antidepressive agents|mesh-ancestor
6387571|NCT00181779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6387572|NCT00181779|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6387573|NCT00181779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6387574|NCT00181779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6387575|NCT00181779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387576|NCT00181779|Dopamine Agonists|dopamine agonists|mesh-ancestor
6387577|NCT00181779|Dopamine Agents|dopamine agents|mesh-ancestor
6387578|NCT00181779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6387579|NCT00181779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387580|NCT00181779|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6387581|NCT00181779|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6387582|NCT00181779|Serotonin Agents|serotonin agents|mesh-ancestor
6387583|NCT00181779|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6387584|NCT00181779|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6387585|NCT00181779|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6387586|NCT00181779|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6396714|NCT00209612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396715|NCT00209612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6396716|NCT00209612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6396717|NCT00209612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6396718|NCT00209625|Leucovorin|leucovorin|mesh-list
6396719|NCT00209625|Fluorouracil|fluorouracil|mesh-list
6396720|NCT00209625|Irinotecan|irinotecan|mesh-list
6396721|NCT00209625|Antimetabolites|antimetabolites|mesh-ancestor
6396722|NCT00209625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396723|NCT00209625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6396724|NCT00209625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6396725|NCT00209625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6396726|NCT00209625|Immunologic Factors|immunologic factors|mesh-ancestor
6396727|NCT00209625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396728|NCT00209625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6396729|NCT00209625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6396730|NCT00209625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6396731|NCT00209625|Antidotes|antidotes|mesh-ancestor
6396732|NCT00209625|Protective Agents|protective agents|mesh-ancestor
6396733|NCT00209625|Vitamin B Complex|vitamin b complex|mesh-ancestor
6396734|NCT00209625|Vitamins|vitamins|mesh-ancestor
6396735|NCT00209625|Micronutrients|micronutrients|mesh-ancestor
6396736|NCT00209638|Irinotecan|irinotecan|mesh-list
6396737|NCT00209638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6396738|NCT00209638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6396739|NCT00209638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6396740|NCT00209638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396741|NCT00209638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6387587|NCT00181818|Bupropion|bupropion|mesh-list
6387588|NCT00181818|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6387589|NCT00181818|Antidepressive Agents|antidepressive agents|mesh-ancestor
6387590|NCT00181818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6387591|NCT00181818|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6387592|NCT00181818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6387593|NCT00181818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6387594|NCT00181818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387595|NCT00181818|Dopamine Agents|dopamine agents|mesh-ancestor
6387596|NCT00181818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6387597|NCT00181818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387598|NCT00181818|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6387599|NCT00181818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6387600|NCT00181818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6387601|NCT00181870|Carbamazepine|carbamazepine|mesh-list
6387602|NCT00181870|Anticonvulsants|anticonvulsants|mesh-ancestor
6387603|NCT00181870|Antimanic Agents|antimanic agents|mesh-ancestor
6387604|NCT00181870|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6387605|NCT00181870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6387606|NCT00181870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387607|NCT00181870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6387608|NCT00181870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6387609|NCT00181870|Analgesics|analgesics|mesh-ancestor
6387610|NCT00181870|Sensory System Agents|sensory system agents|mesh-ancestor
6387611|NCT00181870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6387612|NCT00181870|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6387613|NCT00181870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6387614|NCT00181870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387615|NCT00181870|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6387616|NCT00181870|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6387617|NCT00181896|Bupropion|bupropion|mesh-list
6387618|NCT00181896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6387619|NCT00181896|Antidepressive Agents|antidepressive agents|mesh-ancestor
6387620|NCT00181896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6387621|NCT00181896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6387622|NCT00181896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6387623|NCT00181896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6387624|NCT00181896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387625|NCT00181896|Dopamine Agents|dopamine agents|mesh-ancestor
6387626|NCT00181896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6387627|NCT00181896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387628|NCT00181896|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6387629|NCT00181896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6387630|NCT00181896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6387631|NCT00181922|Ziprasidone|ziprasidone|mesh-list
6387632|NCT00181922|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6387633|NCT00181922|Serotonin Agents|serotonin agents|mesh-ancestor
6387634|NCT00181922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6387635|NCT00181922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387636|NCT00181922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387637|NCT00181922|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6387638|NCT00181922|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6387639|NCT00181922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6387640|NCT00181922|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6387641|NCT00181922|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6387642|NCT00181922|Dopamine Agents|dopamine agents|mesh-ancestor
6387643|NCT00181935|Olanzapine|olanzapine|mesh-list
6387644|NCT00181935|Risperidone|risperidone|mesh-list
6387645|NCT00181935|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6387646|NCT00181935|Serotonin Agents|serotonin agents|mesh-ancestor
6387647|NCT00181935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6387648|NCT00181935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387649|NCT00181935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387650|NCT00181935|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6387651|NCT00181935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6387652|NCT00181935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6387653|NCT00181935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6387654|NCT00181935|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6387655|NCT00181935|Dopamine Agents|dopamine agents|mesh-ancestor
6387656|NCT00181935|Antiemetics|antiemetics|mesh-ancestor
6387657|NCT00181935|Autonomic Agents|autonomic agents|mesh-ancestor
6387658|NCT00181935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6387659|NCT00181935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6387660|NCT00181935|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6387661|NCT00181935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6387662|NCT00181935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6387663|NCT00181948|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6387664|NCT00181948|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6387665|NCT00181948|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6387666|NCT00181948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6387667|NCT00181948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387668|NCT00181948|Adrenergic Agents|adrenergic agents|mesh-ancestor
6387669|NCT00181948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6387670|NCT00181948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387671|NCT00181974|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6387672|NCT00181974|Hemostatics|hemostatics|mesh-ancestor
6387673|NCT00181974|Coagulants|coagulants|mesh-ancestor
6387674|NCT00181987|Methylphenidate|methylphenidate|mesh-list
6387675|NCT00181987|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6387676|NCT00181987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387677|NCT00181987|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6387678|NCT00181987|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6387679|NCT00181987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6387680|NCT00181987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387681|NCT00181987|Dopamine Agents|dopamine agents|mesh-ancestor
6387682|NCT00181987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6387683|NCT00182013|Olanzapine|olanzapine|mesh-list
6387684|NCT00182013|Risperidone|risperidone|mesh-list
6387685|NCT00182013|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6387686|NCT00182013|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6387687|NCT00182013|Serotonin Agents|serotonin agents|mesh-ancestor
6387688|NCT00182013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6387689|NCT00182013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387690|NCT00182013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387691|NCT00182013|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6387692|NCT00182013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6387693|NCT00182013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6387694|NCT00182013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6387695|NCT00182013|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6387696|NCT00182013|Dopamine Agents|dopamine agents|mesh-ancestor
6387697|NCT00182013|Antiemetics|antiemetics|mesh-ancestor
6387698|NCT00182013|Autonomic Agents|autonomic agents|mesh-ancestor
6387699|NCT00182013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6387700|NCT00182013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6387701|NCT00182013|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6387702|NCT00182013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6387703|NCT00182013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6387704|NCT00182013|Antidepressive Agents|antidepressive agents|mesh-ancestor
6387705|NCT00182039|Metoprolol|metoprolol|mesh-list
6387706|NCT00182039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6387707|NCT00182039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6387708|NCT00182039|Sympatholytics|sympatholytics|mesh-ancestor
6387709|NCT00182039|Autonomic Agents|autonomic agents|mesh-ancestor
6387710|NCT00182039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6387711|NCT00182039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387712|NCT00182039|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6387713|NCT00182039|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6387714|NCT00182039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6387715|NCT00182039|Adrenergic Agents|adrenergic agents|mesh-ancestor
6387716|NCT00182039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6387717|NCT00182039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387718|NCT00182052|Rosiglitazone|rosiglitazone|mesh-list
6387719|NCT00182052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6387720|NCT00182052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387721|NCT00182104|Warfarin|warfarin|mesh-list
6387722|NCT00182104|Anticoagulants|anticoagulants|mesh-ancestor
6387723|NCT00182143|Heparin|heparin|mesh-list
6387724|NCT00182143|Calcium heparin|calcium heparin|mesh-list
6387725|NCT00182143|Dalteparin|dalteparin|mesh-list
6387726|NCT00182143|Tinzaparin|tinzaparin|mesh-list
6387727|NCT00182143|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6387728|NCT00182143|Anticoagulants|anticoagulants|mesh-ancestor
6387729|NCT00182143|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6387730|NCT00182143|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6387731|NCT00182143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387732|NCT00182169|Hormones|hormones|mesh-list
6387733|NCT00182169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6387734|NCT00182169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387735|NCT00182221|Fibrin fragment D|fibrin fragment d|mesh-list
6387736|NCT00182221|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6387737|NCT00182221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6387738|NCT00182221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387739|NCT00182221|Hemostatics|hemostatics|mesh-ancestor
6387740|NCT00182221|Coagulants|coagulants|mesh-ancestor
6387741|NCT00182260|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
6387742|NCT00182260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6387743|NCT00182260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387744|NCT00182312|Caffeine|caffeine|mesh-list
6387745|NCT00182312|Caffeine citrate|caffeine citrate|mesh-list
6387746|NCT00182312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387747|NCT00182312|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6387748|NCT00182312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387749|NCT00182312|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6387750|NCT00182312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6387751|NCT00182312|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6387752|NCT00182312|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6387753|NCT00182312|Purinergic Agents|purinergic agents|mesh-ancestor
6387754|NCT00182312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6387755|NCT00182351|Fibrin fragment D|fibrin fragment d|mesh-list
6387756|NCT00182351|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6387757|NCT00182351|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6387758|NCT00182351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387759|NCT00182351|Hemostatics|hemostatics|mesh-ancestor
6387760|NCT00182351|Coagulants|coagulants|mesh-ancestor
6387761|NCT00182364|Heparin|heparin|mesh-list
6387762|NCT00182364|Calcium heparin|calcium heparin|mesh-list
6387763|NCT00182364|Dalteparin|dalteparin|mesh-list
6387764|NCT00182364|Tinzaparin|tinzaparin|mesh-list
6387765|NCT00182364|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6387766|NCT00182364|Anticoagulants|anticoagulants|mesh-ancestor
6387767|NCT00182364|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6387768|NCT00182364|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6387769|NCT00182364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387770|NCT00182377|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
6387771|NCT00182377|Plasma Substitutes|plasma substitutes|mesh-ancestor
6387772|NCT00182377|Blood Substitutes|blood substitutes|mesh-ancestor
6387773|NCT00182429|Metronidazole|metronidazole|mesh-list
6387774|NCT00182429|Rifampin|rifampin|mesh-list
6387775|NCT00182429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6387776|NCT00182429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6387777|NCT00182429|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6387778|NCT00182429|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6387779|NCT00182429|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6387780|NCT00182429|Antitubercular Agents|antitubercular agents|mesh-ancestor
6387781|NCT00182429|Leprostatic Agents|leprostatic agents|mesh-ancestor
6387782|NCT00182429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6387783|NCT00182429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6387784|NCT00182429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387785|NCT00182429|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6387786|NCT00182429|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6387787|NCT00182429|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6387788|NCT00182429|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6387789|NCT00182429|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6387790|NCT00182429|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6387791|NCT00182442|Olanzapine|olanzapine|mesh-list
6387792|NCT00182442|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6387793|NCT00182442|Antiemetics|antiemetics|mesh-ancestor
6387794|NCT00182442|Autonomic Agents|autonomic agents|mesh-ancestor
6387795|NCT00182442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6387796|NCT00182442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387797|NCT00182442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6387798|NCT00182442|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6387799|NCT00182442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6387800|NCT00182442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6387801|NCT00182442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6387802|NCT00182442|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6387803|NCT00182442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6387804|NCT00182442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6387805|NCT00182442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387806|NCT00182442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6387807|NCT00182442|Serotonin Agents|serotonin agents|mesh-ancestor
6387808|NCT00182442|Antidepressive Agents|antidepressive agents|mesh-ancestor
6387809|NCT00182455|Topiramate|topiramate|mesh-list
6387810|NCT00182455|Anticonvulsants|anticonvulsants|mesh-ancestor
6387811|NCT00182455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6387812|NCT00182455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387813|NCT00182494|Metformin|metformin|mesh-list
6387814|NCT00182494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6387815|NCT00182494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387816|NCT00182507|Olanzapine|olanzapine|mesh-list
6387817|NCT00182507|Antiemetics|antiemetics|mesh-ancestor
6387818|NCT00182507|Autonomic Agents|autonomic agents|mesh-ancestor
6387819|NCT00182507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6387820|NCT00182507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387821|NCT00182507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6387822|NCT00182507|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6387823|NCT00182507|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6387824|NCT00182507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6387825|NCT00182507|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6387826|NCT00182507|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6387827|NCT00182507|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6387828|NCT00182507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6387829|NCT00182507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387830|NCT00182507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6387831|NCT00182507|Serotonin Agents|serotonin agents|mesh-ancestor
6387832|NCT00182520|Topiramate|topiramate|mesh-list
6387833|NCT00182520|Anticonvulsants|anticonvulsants|mesh-ancestor
6387834|NCT00182520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6387835|NCT00182520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387836|NCT00182533|Sertraline|sertraline|mesh-list
6387837|NCT00182533|Antidepressive Agents|antidepressive agents|mesh-ancestor
6387838|NCT00182533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6387839|NCT00182533|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6387840|NCT00182533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6387841|NCT00182533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6387842|NCT00182533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387843|NCT00182533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6387844|NCT00182533|Serotonin Agents|serotonin agents|mesh-ancestor
6387845|NCT00182533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387846|NCT00182559|Cyclosporine|cyclosporine|mesh-list
6387847|NCT00182559|Tacrolimus|tacrolimus|mesh-list
6387848|NCT00182559|Cyclosporins|cyclosporins|mesh-list
6387849|NCT00182559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6387850|NCT00182559|Immunologic Factors|immunologic factors|mesh-ancestor
6387851|NCT00182559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387852|NCT00182559|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6387853|NCT00182559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6387854|NCT00182559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387855|NCT00182559|Antifungal Agents|antifungal agents|mesh-ancestor
6387856|NCT00182559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6387857|NCT00182559|Dermatologic Agents|dermatologic agents|mesh-ancestor
6387858|NCT00182559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6387859|NCT00182572|Naltrexone|naltrexone|mesh-list
6387860|NCT00182572|Buprenorphine|buprenorphine|mesh-list
6387861|NCT00182572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6387862|NCT00182572|Narcotics|narcotics|mesh-ancestor
6387863|NCT00182572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6387864|NCT00182572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387865|NCT00182572|Analgesics|analgesics|mesh-ancestor
6387866|NCT00182572|Sensory System Agents|sensory system agents|mesh-ancestor
6387867|NCT00182572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6387868|NCT00182572|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6387869|NCT00182572|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6387870|NCT00182611|Tegafur|tegafur|mesh-list
6387871|NCT00182611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6387872|NCT00182611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6387873|NCT00182611|Antimetabolites|antimetabolites|mesh-ancestor
6387874|NCT00182611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387875|NCT00182650|Aldesleukin|aldesleukin|mesh-list
6387876|NCT00182650|Rituximab|rituximab|mesh-list
6387877|NCT00182650|Fludarabine|fludarabine|mesh-list
6387878|NCT00182650|Fludarabine phosphate|fludarabine phosphate|mesh-list
6387879|NCT00182650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6387880|NCT00182650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6387881|NCT00182650|Immunologic Factors|immunologic factors|mesh-ancestor
6387882|NCT00182650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387883|NCT00182650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6387884|NCT00182650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6387885|NCT00182650|Antimetabolites|antimetabolites|mesh-ancestor
6387886|NCT00182650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387887|NCT00182650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6387888|NCT00182650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6387889|NCT00182650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6387890|NCT00182650|Antiviral Agents|antiviral agents|mesh-ancestor
6387891|NCT00182650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6387892|NCT00182663|Thalidomide|thalidomide|mesh-list
6387893|NCT00182663|Clarithromycin|clarithromycin|mesh-list
6387894|NCT00182663|Dexamethasone|dexamethasone|mesh-list
6387895|NCT00182663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6387896|NCT00182663|Antiemetics|antiemetics|mesh-ancestor
6387897|NCT00182663|Autonomic Agents|autonomic agents|mesh-ancestor
6387898|NCT00182663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6387899|NCT00182663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387900|NCT00182663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6387901|NCT00182663|Glucocorticoids|glucocorticoids|mesh-ancestor
6387902|NCT00182663|Hormones|hormones|mesh-ancestor
6387903|NCT00182663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6387904|NCT00182663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6387905|NCT00182663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6387906|NCT00182663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6387907|NCT00182663|Immunologic Factors|immunologic factors|mesh-ancestor
6387908|NCT00182663|Leprostatic Agents|leprostatic agents|mesh-ancestor
6387909|NCT00182663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6387910|NCT00182663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6387911|NCT00182663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6387912|NCT00182663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6387913|NCT00182663|Growth Substances|growth substances|mesh-ancestor
6387914|NCT00182663|Growth Inhibitors|growth inhibitors|mesh-ancestor
6387915|NCT00182663|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6387916|NCT00182663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6387917|NCT00182663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387918|NCT00182663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6387919|NCT00182663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6387920|NCT00182702|Epothilones|epothilones|mesh-list
6387921|NCT00182702|Epothilone B|epothilone b|mesh-list
6387922|NCT00182702|Tubulin Modulators|tubulin modulators|mesh-ancestor
6387923|NCT00182702|Antimitotic Agents|antimitotic agents|mesh-ancestor
6387924|NCT00182702|Mitosis Modulators|mitosis modulators|mesh-ancestor
6387925|NCT00182702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387926|NCT00182702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6387927|NCT00182715|Leucovorin|leucovorin|mesh-list
6387928|NCT00182715|Fluorouracil|fluorouracil|mesh-list
6387929|NCT00182715|Capecitabine|capecitabine|mesh-list
6387930|NCT00182715|Oxaliplatin|oxaliplatin|mesh-list
6387931|NCT00182715|Cetuximab|cetuximab|mesh-list
6387932|NCT00182715|Calcium|calcium|mesh-list
6387933|NCT00182715|Levoleucovorin|levoleucovorin|mesh-list
6387934|NCT00182715|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6387935|NCT00182715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387936|NCT00182715|Antimetabolites|antimetabolites|mesh-ancestor
6387937|NCT00182715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387938|NCT00182715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6387939|NCT00182715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6387940|NCT00182715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6387941|NCT00182715|Immunologic Factors|immunologic factors|mesh-ancestor
6387942|NCT00182715|Antidotes|antidotes|mesh-ancestor
6387943|NCT00182715|Protective Agents|protective agents|mesh-ancestor
6387944|NCT00182715|Vitamin B Complex|vitamin b complex|mesh-ancestor
6387945|NCT00182715|Vitamins|vitamins|mesh-ancestor
6387946|NCT00182715|Micronutrients|micronutrients|mesh-ancestor
6387947|NCT00182715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6387948|NCT00182741|Calcitriol|calcitriol|mesh-list
6387949|NCT00182741|Prednisone|prednisone|mesh-list
6387950|NCT00182741|Mitoxantrone|mitoxantrone|mesh-list
6387951|NCT00182741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6387952|NCT00182741|Glucocorticoids|glucocorticoids|mesh-ancestor
6387953|NCT00182741|Hormones|hormones|mesh-ancestor
6387954|NCT00182741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6387955|NCT00182741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387956|NCT00182741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6387957|NCT00182741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6387958|NCT00182741|Analgesics|analgesics|mesh-ancestor
6387959|NCT00182741|Sensory System Agents|sensory system agents|mesh-ancestor
6387960|NCT00182741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6387961|NCT00182741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6387962|NCT00182741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6387963|NCT00182741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6387964|NCT00182741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387965|NCT00182741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6387966|NCT00182741|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6387967|NCT00182741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6387968|NCT00182741|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6387969|NCT00182741|Vitamins|vitamins|mesh-ancestor
6387970|NCT00182741|Micronutrients|micronutrients|mesh-ancestor
6387971|NCT00182741|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6387972|NCT00182806|Gemcitabine|gemcitabine|mesh-list
6387973|NCT00182806|Irinotecan|irinotecan|mesh-list
6387974|NCT00182806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6387975|NCT00182806|Antimetabolites|antimetabolites|mesh-ancestor
6387976|NCT00182806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387977|NCT00182806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6387978|NCT00182806|Antiviral Agents|antiviral agents|mesh-ancestor
6387979|NCT00182806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6387980|NCT00182806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6387981|NCT00182806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6387982|NCT00182806|Immunologic Factors|immunologic factors|mesh-ancestor
6387983|NCT00182806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387984|NCT00182806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6387985|NCT00182806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6387986|NCT00182819|Temozolomide|temozolomide|mesh-list
6387987|NCT00182819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6387988|NCT00182819|Alkylating Agents|alkylating agents|mesh-ancestor
6387989|NCT00182819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387990|NCT00182819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6387991|NCT00182845|Donepezil|donepezil|mesh-list
6387992|NCT00182845|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6387993|NCT00182845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6387994|NCT00182845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6387995|NCT00182845|Cholinergic Agents|cholinergic agents|mesh-ancestor
6387996|NCT00182845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6387997|NCT00182845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6387998|NCT00182845|Nootropic Agents|nootropic agents|mesh-ancestor
6387999|NCT00182871|Testosterone|testosterone|mesh-list
6388000|NCT00182871|Androgens|androgens|mesh-ancestor
6388001|NCT00182871|Hormones|hormones|mesh-ancestor
6388002|NCT00182871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6388003|NCT00182871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388004|NCT00182884|Donepezil|donepezil|mesh-list
6388005|NCT00182884|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6388006|NCT00182884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6388007|NCT00182884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388008|NCT00182884|Cholinergic Agents|cholinergic agents|mesh-ancestor
6388009|NCT00182884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6388010|NCT00182884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388011|NCT00182884|Nootropic Agents|nootropic agents|mesh-ancestor
6388012|NCT00183001|Vitamin K|vitamin k|mesh-list
6388013|NCT00183001|Vitamins|vitamins|mesh-ancestor
6388014|NCT00183001|Micronutrients|micronutrients|mesh-ancestor
6388015|NCT00183001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388016|NCT00183001|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6388017|NCT00183001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6388018|NCT00183001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388019|NCT00183001|Hemostatics|hemostatics|mesh-ancestor
6388020|NCT00183001|Coagulants|coagulants|mesh-ancestor
6388021|NCT00183040|Hormones|hormones|mesh-list
6388022|NCT00183040|Testosterone|testosterone|mesh-list
6388023|NCT00183040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6388024|NCT00183040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388025|NCT00183040|Androgens|androgens|mesh-ancestor
6388026|NCT00183222|Naltrexone|naltrexone|mesh-list
6388027|NCT00183222|Ondansetron|ondansetron|mesh-list
6388028|NCT00183222|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6388029|NCT00183222|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6388030|NCT00183222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388031|NCT00183222|Sensory System Agents|sensory system agents|mesh-ancestor
6388032|NCT00183222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6388033|NCT00183222|Antiemetics|antiemetics|mesh-ancestor
6388034|NCT00183222|Autonomic Agents|autonomic agents|mesh-ancestor
6388035|NCT00183222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6388036|NCT00183222|Antipruritics|antipruritics|mesh-ancestor
6388037|NCT00183222|Dermatologic Agents|dermatologic agents|mesh-ancestor
6388038|NCT00183222|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6388039|NCT00183222|Serotonin Agents|serotonin agents|mesh-ancestor
6388040|NCT00183222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6388041|NCT00183222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388042|NCT00183222|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6388043|NCT00183222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6388044|NCT00183222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6388045|NCT00183222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6388046|NCT00183222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6388047|NCT00183235|Aripiprazole|aripiprazole|mesh-list
6388048|NCT00183235|Antidepressive Agents|antidepressive agents|mesh-ancestor
6388049|NCT00183235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6388050|NCT00183235|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6388051|NCT00183235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6388052|NCT00183235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6388053|NCT00183235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388054|NCT00183235|Dopamine Agonists|dopamine agonists|mesh-ancestor
6388055|NCT00183235|Dopamine Agents|dopamine agents|mesh-ancestor
6388056|NCT00183235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6388057|NCT00183235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388058|NCT00183235|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6388059|NCT00183235|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6388060|NCT00183235|Serotonin Agents|serotonin agents|mesh-ancestor
6388061|NCT00183235|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6388062|NCT00183235|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6388063|NCT00183235|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6388064|NCT00183235|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6388065|NCT00183404|Olanzapine|olanzapine|mesh-list
6388066|NCT00183404|Antiemetics|antiemetics|mesh-ancestor
6388067|NCT00183404|Autonomic Agents|autonomic agents|mesh-ancestor
6388068|NCT00183404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6388069|NCT00183404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388070|NCT00183404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6388071|NCT00183404|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6388072|NCT00183404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6388073|NCT00183404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6388074|NCT00183404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6388075|NCT00183404|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6388076|NCT00183404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6388077|NCT00183404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6388078|NCT00183404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388079|NCT00183404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6388080|NCT00183404|Serotonin Agents|serotonin agents|mesh-ancestor
6396742|NCT00209651|Irinotecan|irinotecan|mesh-list
6396743|NCT00209651|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6396744|NCT00209651|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6396745|NCT00209651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6396746|NCT00209651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396747|NCT00209651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6396748|NCT00209664|Irinotecan|irinotecan|mesh-list
6396749|NCT00209664|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6396750|NCT00209664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6388081|NCT00183560|Antidepressive Agents|antidepressive agents|mesh-list
6388082|NCT00183560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6388083|NCT00183612|Olanzapine|olanzapine|mesh-list
6388084|NCT00183612|Antiemetics|antiemetics|mesh-ancestor
6388085|NCT00183612|Autonomic Agents|autonomic agents|mesh-ancestor
6388086|NCT00183612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6388087|NCT00183612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388088|NCT00183612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6388089|NCT00183612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6388090|NCT00183612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6388091|NCT00183612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6388092|NCT00183612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6388093|NCT00183612|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6388094|NCT00183612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6388095|NCT00183612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6388096|NCT00183612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388097|NCT00183612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6388098|NCT00183612|Serotonin Agents|serotonin agents|mesh-ancestor
6388099|NCT00183742|Docetaxel|docetaxel|mesh-list
6388100|NCT00183742|Doxorubicin|doxorubicin|mesh-list
6388101|NCT00183742|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6388102|NCT00183742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6388103|NCT00183742|Tubulin Modulators|tubulin modulators|mesh-ancestor
6388104|NCT00183742|Antimitotic Agents|antimitotic agents|mesh-ancestor
6388105|NCT00183742|Mitosis Modulators|mitosis modulators|mesh-ancestor
6388106|NCT00183742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388107|NCT00183742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6388108|NCT00183742|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6388109|NCT00183742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6388110|NCT00183742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6388111|NCT00183807|Celecoxib|celecoxib|mesh-list
6388112|NCT00183807|Irinotecan|irinotecan|mesh-list
6388113|NCT00183807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6388114|NCT00183807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6017589|NCT00373880|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6388115|NCT00183807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6388116|NCT00183807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6388117|NCT00183807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388118|NCT00183807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6388119|NCT00183807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6388120|NCT00183807|Analgesics|analgesics|mesh-ancestor
6388121|NCT00183807|Sensory System Agents|sensory system agents|mesh-ancestor
6388122|NCT00183807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6388123|NCT00183807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388124|NCT00183807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6388125|NCT00183807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6388126|NCT00183807|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6388127|NCT00183807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6388128|NCT00183820|Gemcitabine|gemcitabine|mesh-list
6388129|NCT00183820|Paclitaxel|paclitaxel|mesh-list
6388130|NCT00183820|Oxaliplatin|oxaliplatin|mesh-list
6388131|NCT00183820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6388132|NCT00183820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6388133|NCT00183820|Tubulin Modulators|tubulin modulators|mesh-ancestor
6388134|NCT00183820|Antimitotic Agents|antimitotic agents|mesh-ancestor
6388135|NCT00183820|Mitosis Modulators|mitosis modulators|mesh-ancestor
6388136|NCT00183820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388137|NCT00183820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6388138|NCT00183820|Antimetabolites|antimetabolites|mesh-ancestor
6388139|NCT00183820|Antiviral Agents|antiviral agents|mesh-ancestor
6388140|NCT00183820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6388141|NCT00183820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6388142|NCT00183820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6388143|NCT00183820|Immunologic Factors|immunologic factors|mesh-ancestor
6388144|NCT00183820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388145|NCT00183833|Capecitabine|capecitabine|mesh-list
6388146|NCT00183833|Imatinib Mesylate|imatinib mesylate|mesh-list
6388147|NCT00183833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6388148|NCT00183833|Antimetabolites|antimetabolites|mesh-ancestor
6388149|NCT00183833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388150|NCT00183833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6388151|NCT00183833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6388152|NCT00183833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6388153|NCT00183846|Irinotecan|irinotecan|mesh-list
6388154|NCT00183846|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6388155|NCT00183846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6388156|NCT00183846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6388157|NCT00183846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388158|NCT00183846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6388159|NCT00183859|Irinotecan|irinotecan|mesh-list
6388160|NCT00183859|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6388161|NCT00183859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6388162|NCT00183859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6388163|NCT00183859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388164|NCT00183859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6388165|NCT00183885|Mitomycins|mitomycins|mesh-list
6388166|NCT00183885|Mitomycin|mitomycin|mesh-list
6388167|NCT00183885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6388168|NCT00183885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6388169|NCT00183885|Alkylating Agents|alkylating agents|mesh-ancestor
6388170|NCT00183885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388171|NCT00183885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6388172|NCT00183885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6388173|NCT00183898|Capecitabine|capecitabine|mesh-list
6388174|NCT00183898|Oxaliplatin|oxaliplatin|mesh-list
6388175|NCT00183898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6388176|NCT00183898|Antimetabolites|antimetabolites|mesh-ancestor
6388177|NCT00183898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388178|NCT00183898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6388179|NCT00183911|Leucovorin|leucovorin|mesh-list
6017590|NCT00373880|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6388180|NCT00183911|Fluorouracil|fluorouracil|mesh-list
6388181|NCT00183911|Floxuridine|floxuridine|mesh-list
6388182|NCT00183911|Antimetabolites|antimetabolites|mesh-ancestor
6388183|NCT00183911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388184|NCT00183911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6388185|NCT00183911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6388186|NCT00183911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6388187|NCT00183911|Immunologic Factors|immunologic factors|mesh-ancestor
6388188|NCT00183911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388189|NCT00183911|Antidotes|antidotes|mesh-ancestor
6388190|NCT00183911|Protective Agents|protective agents|mesh-ancestor
6388191|NCT00183911|Vitamin B Complex|vitamin b complex|mesh-ancestor
6388192|NCT00183911|Vitamins|vitamins|mesh-ancestor
6388193|NCT00183911|Micronutrients|micronutrients|mesh-ancestor
6388194|NCT00183924|Carboplatin|carboplatin|mesh-list
6388195|NCT00183924|Docetaxel|docetaxel|mesh-list
6388196|NCT00183924|Estramustine|estramustine|mesh-list
6388197|NCT00183924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6388198|NCT00183924|Tubulin Modulators|tubulin modulators|mesh-ancestor
6388199|NCT00183924|Antimitotic Agents|antimitotic agents|mesh-ancestor
6388200|NCT00183924|Mitosis Modulators|mitosis modulators|mesh-ancestor
6388201|NCT00183924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388202|NCT00183924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6388203|NCT00183924|Alkylating Agents|alkylating agents|mesh-ancestor
6388204|NCT00183924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6388205|NCT00183937|Docetaxel|docetaxel|mesh-list
6388206|NCT00183937|Bortezomib|bortezomib|mesh-list
6388207|NCT00183937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6388208|NCT00183937|Tubulin Modulators|tubulin modulators|mesh-ancestor
6388209|NCT00183937|Antimitotic Agents|antimitotic agents|mesh-ancestor
6388210|NCT00183937|Mitosis Modulators|mitosis modulators|mesh-ancestor
6388211|NCT00183937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388212|NCT00183950|Noscapine|noscapine|mesh-list
6388213|NCT00183950|Antitussive Agents|antitussive agents|mesh-ancestor
6388214|NCT00183950|Respiratory System Agents|respiratory system agents|mesh-ancestor
6388215|NCT00183976|Rituximab|rituximab|mesh-list
6388216|NCT00183976|Doxorubicin|doxorubicin|mesh-list
6388217|NCT00183976|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6388218|NCT00183976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6388219|NCT00183976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6388220|NCT00183976|Immunologic Factors|immunologic factors|mesh-ancestor
6388221|NCT00183976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388222|NCT00183976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6388223|NCT00183976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6388224|NCT00183976|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6388225|NCT00183976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6388226|NCT00183976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6388227|NCT00183976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388228|NCT00183989|Rituximab|rituximab|mesh-list
6388229|NCT00183989|Fludarabine|fludarabine|mesh-list
6388230|NCT00183989|Mitoxantrone|mitoxantrone|mesh-list
6388231|NCT00183989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6388232|NCT00183989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6388233|NCT00183989|Immunologic Factors|immunologic factors|mesh-ancestor
6388234|NCT00183989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388235|NCT00183989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6388236|NCT00183989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388237|NCT00183989|Analgesics|analgesics|mesh-ancestor
6388238|NCT00183989|Sensory System Agents|sensory system agents|mesh-ancestor
6388239|NCT00183989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6388240|NCT00183989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6388241|NCT00183989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6388242|NCT00183989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6388243|NCT00184015|Bevacizumab|bevacizumab|mesh-list
6388244|NCT00184015|Bortezomib|bortezomib|mesh-list
6388245|NCT00184015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6388246|NCT00184015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6388247|NCT00184015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6388248|NCT00184015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6388249|NCT00184015|Growth Substances|growth substances|mesh-ancestor
6388250|NCT00184015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388251|NCT00184015|Growth Inhibitors|growth inhibitors|mesh-ancestor
6388252|NCT00184041|Cytarabine|cytarabine|mesh-list
6388253|NCT00184041|Prednisone|prednisone|mesh-list
6388254|NCT00184041|Methotrexate|methotrexate|mesh-list
6388255|NCT00184041|Cyclophosphamide|cyclophosphamide|mesh-list
6388256|NCT00184041|Vincristine|vincristine|mesh-list
6388257|NCT00184041|Daunorubicin|daunorubicin|mesh-list
6388258|NCT00184041|Asparaginase|asparaginase|mesh-list
6388259|NCT00184041|Mercaptopurine|mercaptopurine|mesh-list
6388260|NCT00184041|Thioguanine|thioguanine|mesh-list
6388261|NCT00184041|Pegaspargase|pegaspargase|mesh-list
6388262|NCT00184041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6388263|NCT00184041|Glucocorticoids|glucocorticoids|mesh-ancestor
6388264|NCT00184041|Hormones|hormones|mesh-ancestor
6388265|NCT00184041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6388266|NCT00184041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388267|NCT00184041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6388268|NCT00184041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6388269|NCT00184041|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6388270|NCT00184041|Abortifacient Agents|abortifacient agents|mesh-ancestor
6388271|NCT00184041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6388272|NCT00184041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6388273|NCT00184041|Antimetabolites|antimetabolites|mesh-ancestor
6388274|NCT00184041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388275|NCT00184041|Dermatologic Agents|dermatologic agents|mesh-ancestor
6388276|NCT00184041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6388277|NCT00184041|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6388278|NCT00184041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6388279|NCT00184041|Immunologic Factors|immunologic factors|mesh-ancestor
6388280|NCT00184041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6388281|NCT00184041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6388282|NCT00184041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6388283|NCT00184041|Alkylating Agents|alkylating agents|mesh-ancestor
6388284|NCT00184041|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6388285|NCT00184041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6388286|NCT00184041|Tubulin Modulators|tubulin modulators|mesh-ancestor
6388287|NCT00184041|Antimitotic Agents|antimitotic agents|mesh-ancestor
6388288|NCT00184041|Mitosis Modulators|mitosis modulators|mesh-ancestor
6388289|NCT00184041|Antiviral Agents|antiviral agents|mesh-ancestor
6388290|NCT00184041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6388291|NCT00184041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6388292|NCT00184041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6388293|NCT00184041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6388294|NCT00184106|Paroxetine|paroxetine|mesh-list
6388295|NCT00184106|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6388296|NCT00184106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6388297|NCT00184106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6388298|NCT00184106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388299|NCT00184106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6388300|NCT00184106|Serotonin Agents|serotonin agents|mesh-ancestor
6388301|NCT00184106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388302|NCT00184106|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6388303|NCT00184106|Antidepressive Agents|antidepressive agents|mesh-ancestor
6388304|NCT00184106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6388305|NCT00184106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6388306|NCT00184106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6388307|NCT00184106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6388308|NCT00184171|Budesonide|budesonide|mesh-list
6388309|NCT00184171|Bismuth|bismuth|mesh-list
6388310|NCT00184171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6388311|NCT00184171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6388312|NCT00184171|Autonomic Agents|autonomic agents|mesh-ancestor
6388313|NCT00184171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6388314|NCT00184171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388315|NCT00184171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6388316|NCT00184171|Respiratory System Agents|respiratory system agents|mesh-ancestor
6388317|NCT00184171|Glucocorticoids|glucocorticoids|mesh-ancestor
6388318|NCT00184171|Hormones|hormones|mesh-ancestor
6388319|NCT00184171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6388320|NCT00184171|Antacids|antacids|mesh-ancestor
6388321|NCT00184171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388322|NCT00184171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6388323|NCT00184197|Botulinum Toxins|botulinum toxins|mesh-list
6388324|NCT00184197|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6017591|NCT00373880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6017592|NCT00373880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388325|NCT00184197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6388326|NCT00184197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388327|NCT00184197|Cholinergic Agents|cholinergic agents|mesh-ancestor
6388328|NCT00184197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6388329|NCT00184197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388330|NCT00184496|Methadone|methadone|mesh-list
6388331|NCT00184496|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6388332|NCT00184496|Narcotics|narcotics|mesh-ancestor
6388333|NCT00184496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6388334|NCT00184496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388335|NCT00184496|Analgesics|analgesics|mesh-ancestor
6388336|NCT00184496|Sensory System Agents|sensory system agents|mesh-ancestor
6388337|NCT00184496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6388338|NCT00184496|Antitussive Agents|antitussive agents|mesh-ancestor
6388339|NCT00184496|Respiratory System Agents|respiratory system agents|mesh-ancestor
6388340|NCT00184522|Esomeprazole|esomeprazole|mesh-list
6388341|NCT00184522|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6388342|NCT00184522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6388343|NCT00184522|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6388344|NCT00184522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6388345|NCT00184522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388346|NCT00184561|Insulin Aspart|insulin aspart|mesh-list
6388347|NCT00184561|Biphasic Insulins|biphasic insulins|mesh-list
6388348|NCT00184561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6388349|NCT00184561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388350|NCT00184574|Metformin|metformin|mesh-list
6388351|NCT00184574|Insulin Aspart|insulin aspart|mesh-list
6388352|NCT00184574|Biphasic Insulins|biphasic insulins|mesh-list
6388353|NCT00184574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6388354|NCT00184574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388355|NCT00184587|Candesartan|candesartan|mesh-list
6388356|NCT00184587|Candesartan cilexetil|candesartan cilexetil|mesh-list
6388357|NCT00184587|Angiotensin II|angiotensin ii|mesh-list
6388358|NCT00184587|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
6388359|NCT00184587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6388360|NCT00184587|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6388361|NCT00184587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388362|NCT00184587|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6388363|NCT00184613|Insulin|insulin|mesh-list
6388364|NCT00184613|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6388365|NCT00184613|Insulin Glargine|insulin glargine|mesh-list
6388366|NCT00184613|Insulin Aspart|insulin aspart|mesh-list
6388367|NCT00184613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6388368|NCT00184613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388369|NCT00184626|Insulin|insulin|mesh-list
6388370|NCT00184626|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6388371|NCT00184626|Metformin|metformin|mesh-list
6388372|NCT00184626|Insulin Glargine|insulin glargine|mesh-list
6388373|NCT00184626|Insulin Aspart|insulin aspart|mesh-list
6388374|NCT00184626|Biphasic Insulins|biphasic insulins|mesh-list
6388375|NCT00184626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6388376|NCT00184626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388377|NCT00184639|Insulin Detemir|insulin detemir|mesh-list
6388378|NCT00184639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6388379|NCT00184639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388380|NCT00184665|Insulin|insulin|mesh-list
6388381|NCT00184665|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6388382|NCT00184665|Insulin Aspart|insulin aspart|mesh-list
6388383|NCT00184665|Insulin Detemir|insulin detemir|mesh-list
6388384|NCT00184665|Isophane Insulin, Human|isophane insulin, human|mesh-list
6388385|NCT00184665|Insulin, Isophane|insulin, isophane|mesh-list
6388386|NCT00184665|Isophane insulin, beef|isophane insulin, beef|mesh-list
6388387|NCT00184665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6388388|NCT00184665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388389|NCT00184795|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6388390|NCT00184795|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6388391|NCT00184795|Norethindrone|norethindrone|mesh-list
6388392|NCT00184795|Norethindrone Acetate|norethindrone acetate|mesh-list
6388393|NCT00184795|Estradiol|estradiol|mesh-list
6388394|NCT00184795|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6388395|NCT00184795|Estrogens|estrogens|mesh-ancestor
6388396|NCT00184795|Hormones|hormones|mesh-ancestor
6388397|NCT00184795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6388398|NCT00184795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388399|NCT00184795|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6388400|NCT00184795|Contraceptive Agents|contraceptive agents|mesh-ancestor
6388401|NCT00184795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6388402|NCT00184795|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6388403|NCT00184795|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6388404|NCT00184795|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6388405|NCT00184795|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6388406|NCT00184821|Glyburide|glyburide|mesh-list
6388407|NCT00184821|Adenosine|adenosine|mesh-list
6388408|NCT00184821|Diazoxide|diazoxide|mesh-list
6388409|NCT00184821|Annexin A5|annexin a5|mesh-list
6388410|NCT00184821|Analgesics|analgesics|mesh-ancestor
6388411|NCT00184821|Sensory System Agents|sensory system agents|mesh-ancestor
6388412|NCT00184821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6388413|NCT00184821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388414|NCT00184821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6388415|NCT00184821|Vasodilator Agents|vasodilator agents|mesh-ancestor
6388416|NCT00184821|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6388417|NCT00184821|Purinergic Agonists|purinergic agonists|mesh-ancestor
6388418|NCT00184821|Purinergic Agents|purinergic agents|mesh-ancestor
6388419|NCT00184821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6388420|NCT00184821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388421|NCT00184821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6388422|NCT00184821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6388423|NCT00184821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6388424|NCT00184847|Adenosine|adenosine|mesh-list
6388425|NCT00184847|Acetylcholine|acetylcholine|mesh-list
6388426|NCT00184847|Caffeine|caffeine|mesh-list
6388427|NCT00184847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6388428|NCT00184847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388429|NCT00184847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6388430|NCT00184847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6388431|NCT00184847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388432|NCT00184847|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6388433|NCT00184847|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6388434|NCT00184847|Purinergic Agents|purinergic agents|mesh-ancestor
6388435|NCT00184847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6388436|NCT00184847|Analgesics|analgesics|mesh-ancestor
6388437|NCT00184847|Sensory System Agents|sensory system agents|mesh-ancestor
6388438|NCT00184847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6388439|NCT00184847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6388440|NCT00184847|Vasodilator Agents|vasodilator agents|mesh-ancestor
6388441|NCT00184847|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6388442|NCT00184847|Purinergic Agonists|purinergic agonists|mesh-ancestor
6388443|NCT00184847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6388444|NCT00184847|Cholinergic Agents|cholinergic agents|mesh-ancestor
6388445|NCT00184886|Methotrexate|methotrexate|mesh-list
6388446|NCT00184886|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6388447|NCT00184886|Abortifacient Agents|abortifacient agents|mesh-ancestor
6388448|NCT00184886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6388449|NCT00184886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388450|NCT00184886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6388451|NCT00184886|Antimetabolites|antimetabolites|mesh-ancestor
6388452|NCT00184886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388453|NCT00184886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6388454|NCT00184886|Dermatologic Agents|dermatologic agents|mesh-ancestor
6388455|NCT00184886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6388456|NCT00184886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6396751|NCT00209664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6388457|NCT00184886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6388458|NCT00184886|Immunologic Factors|immunologic factors|mesh-ancestor
6388459|NCT00184886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6388460|NCT00184886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6388461|NCT00184899|Heparin|heparin|mesh-list
6388462|NCT00184899|Calcium heparin|calcium heparin|mesh-list
6388463|NCT00184899|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6388464|NCT00184899|Glycerol|glycerol|mesh-list
6388465|NCT00184899|Anticoagulants|anticoagulants|mesh-ancestor
6388466|NCT00184899|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6388467|NCT00184899|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6388468|NCT00184899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388469|NCT00184899|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6388470|NCT00184899|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6388471|NCT00184899|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6388472|NCT00184899|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6388473|NCT00184899|Protective Agents|protective agents|mesh-ancestor
6388474|NCT00184899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388475|NCT00184912|Caffeine|caffeine|mesh-list
6388476|NCT00184912|Annexin A5|annexin a5|mesh-list
6388477|NCT00184912|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6388478|NCT00184912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388479|NCT00184912|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6388480|NCT00184912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6388481|NCT00184912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388482|NCT00184912|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6388483|NCT00184912|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6388484|NCT00184912|Purinergic Agents|purinergic agents|mesh-ancestor
6388485|NCT00184912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6388486|NCT00184938|Morphine|morphine|mesh-list
6388487|NCT00184938|Naloxone|naloxone|mesh-list
6388488|NCT00184938|Annexin A5|annexin a5|mesh-list
6388489|NCT00184938|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6388490|NCT00184938|Narcotics|narcotics|mesh-ancestor
6388491|NCT00184938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6388492|NCT00184938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388493|NCT00184938|Analgesics|analgesics|mesh-ancestor
6388494|NCT00184938|Sensory System Agents|sensory system agents|mesh-ancestor
6388495|NCT00184938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6388496|NCT00184938|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6388497|NCT00184938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6388498|NCT00184938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388499|NCT00184951|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6388500|NCT00184951|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6388501|NCT00184951|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6388502|NCT00184951|Antimetabolites|antimetabolites|mesh-ancestor
6388503|NCT00184951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388504|NCT00184951|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6388505|NCT00184951|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6388506|NCT00184951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6388507|NCT00184977|Fluticasone|fluticasone|mesh-list
6388508|NCT00184977|Xhance|xhance|mesh-list
6388509|NCT00184977|Acetylcysteine|acetylcysteine|mesh-list
6388510|NCT00184977|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6388511|NCT00184977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6388512|NCT00184977|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6388513|NCT00184977|Autonomic Agents|autonomic agents|mesh-ancestor
6388514|NCT00184977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6388515|NCT00184977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388516|NCT00184977|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6388517|NCT00184977|Respiratory System Agents|respiratory system agents|mesh-ancestor
6388518|NCT00184977|Dermatologic Agents|dermatologic agents|mesh-ancestor
6388519|NCT00184977|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6388520|NCT00184977|Antiviral Agents|antiviral agents|mesh-ancestor
6388521|NCT00184977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6388522|NCT00184977|Expectorants|expectorants|mesh-ancestor
6388523|NCT00184977|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6388524|NCT00184977|Antioxidants|antioxidants|mesh-ancestor
6537249|NCT00821496|Estrogens|estrogens|mesh-ancestor
6388525|NCT00184977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388526|NCT00184977|Protective Agents|protective agents|mesh-ancestor
6388527|NCT00184977|Antidotes|antidotes|mesh-ancestor
6396752|NCT00209664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396753|NCT00209664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6396754|NCT00209677|Gemcitabine|gemcitabine|mesh-list
6396755|NCT00209677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6396756|NCT00209677|Antimetabolites|antimetabolites|mesh-ancestor
6396757|NCT00209677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396758|NCT00209677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6396759|NCT00209677|Antiviral Agents|antiviral agents|mesh-ancestor
6396760|NCT00209677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6396761|NCT00209677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6396762|NCT00209677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6396763|NCT00209677|Immunologic Factors|immunologic factors|mesh-ancestor
6396764|NCT00209677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396765|NCT00209690|Cisplatin|cisplatin|mesh-list
6396766|NCT00209690|Docetaxel|docetaxel|mesh-list
6396767|NCT00209690|Fluorouracil|fluorouracil|mesh-list
6396768|NCT00209690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6396769|NCT00209690|Tubulin Modulators|tubulin modulators|mesh-ancestor
6396770|NCT00209690|Antimitotic Agents|antimitotic agents|mesh-ancestor
6396771|NCT00209690|Mitosis Modulators|mitosis modulators|mesh-ancestor
6396772|NCT00209690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396773|NCT00209690|Antimetabolites|antimetabolites|mesh-ancestor
6396774|NCT00209690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6396775|NCT00209690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6396776|NCT00209690|Immunologic Factors|immunologic factors|mesh-ancestor
6396777|NCT00209690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396778|NCT00209703|Leucovorin|leucovorin|mesh-list
6396779|NCT00209703|Fluorouracil|fluorouracil|mesh-list
6396780|NCT00209703|Oxaliplatin|oxaliplatin|mesh-list
6396781|NCT00209703|Levoleucovorin|levoleucovorin|mesh-list
6396782|NCT00209703|Antimetabolites|antimetabolites|mesh-ancestor
6396783|NCT00209703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396784|NCT00209703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6396785|NCT00209703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6396786|NCT00209703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6396787|NCT00209703|Immunologic Factors|immunologic factors|mesh-ancestor
6396788|NCT00209703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396789|NCT00209703|Antidotes|antidotes|mesh-ancestor
6396790|NCT00209703|Protective Agents|protective agents|mesh-ancestor
6396791|NCT00209703|Vitamin B Complex|vitamin b complex|mesh-ancestor
6396792|NCT00209703|Vitamins|vitamins|mesh-ancestor
6396793|NCT00209703|Micronutrients|micronutrients|mesh-ancestor
6396794|NCT00209716|Cisplatin|cisplatin|mesh-list
6396795|NCT00209716|Docetaxel|docetaxel|mesh-list
6396796|NCT00209716|Fluorouracil|fluorouracil|mesh-list
6396797|NCT00209716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6396798|NCT00209716|Tubulin Modulators|tubulin modulators|mesh-ancestor
6388528|NCT00184990|Pimagedine|pimagedine|mesh-list
6388529|NCT00184990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6388530|NCT00184990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388531|NCT00185003|Tolbutamide|tolbutamide|mesh-list
6388532|NCT00185003|Potassium Channel Blockers|potassium channel blockers|mesh-list
6388533|NCT00185003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388534|NCT00185003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6388535|NCT00185003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388536|NCT00185003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6388537|NCT00185055|Valsartan|valsartan|mesh-list
6388538|NCT00185055|Olmesartan|olmesartan|mesh-list
6388539|NCT00185055|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6388540|NCT00185055|Irbesartan|irbesartan|mesh-list
6388541|NCT00185055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6388542|NCT00185055|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6388543|NCT00185055|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6388544|NCT00185055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388545|NCT00185068|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6388546|NCT00185068|Olmesartan|olmesartan|mesh-list
6388547|NCT00185068|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6388548|NCT00185068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6388549|NCT00185068|Diuretics|diuretics|mesh-ancestor
6388550|NCT00185068|Natriuretic Agents|natriuretic agents|mesh-ancestor
6388551|NCT00185068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388552|NCT00185068|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6388553|NCT00185068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6388554|NCT00185068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388555|NCT00185068|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6388556|NCT00185068|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6388557|NCT00185094|Losartan|losartan|mesh-list
6388558|NCT00185094|Atenolol|atenolol|mesh-list
6388559|NCT00185094|Olmesartan|olmesartan|mesh-list
6388560|NCT00185094|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6388561|NCT00185094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6388562|NCT00185094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6388563|NCT00185094|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6388564|NCT00185094|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6388565|NCT00185094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388566|NCT00185094|Sympatholytics|sympatholytics|mesh-ancestor
6388567|NCT00185094|Autonomic Agents|autonomic agents|mesh-ancestor
6388568|NCT00185094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6388569|NCT00185094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388570|NCT00185094|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6388571|NCT00185094|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6388572|NCT00185094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6388573|NCT00185094|Adrenergic Agents|adrenergic agents|mesh-ancestor
6388574|NCT00185094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6388575|NCT00185107|Simvastatin|simvastatin|mesh-list
6388576|NCT00185107|Ezetimibe|ezetimibe|mesh-list
6388577|NCT00185107|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
6388578|NCT00185107|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6388579|NCT00185107|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6388580|NCT00185107|Antimetabolites|antimetabolites|mesh-ancestor
6388581|NCT00185107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388582|NCT00185107|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6388583|NCT00185107|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6388584|NCT00185107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6388585|NCT00185120|Amlodipine|amlodipine|mesh-list
6388586|NCT00185120|Olmesartan|olmesartan|mesh-list
6388587|NCT00185120|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6388588|NCT00185120|Benazepril|benazepril|mesh-list
6388589|NCT00185120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6388590|NCT00185120|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6388591|NCT00185120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6388592|NCT00185120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388593|NCT00185120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6388594|NCT00185120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388595|NCT00185120|Vasodilator Agents|vasodilator agents|mesh-ancestor
6388596|NCT00185120|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6388597|NCT00185120|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6388598|NCT00185120|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6388599|NCT00185120|Protease Inhibitors|protease inhibitors|mesh-ancestor
6388600|NCT00185120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6388601|NCT00185133|Amlodipine|amlodipine|mesh-list
6388602|NCT00185133|Olmesartan|olmesartan|mesh-list
6388603|NCT00185133|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6388604|NCT00185133|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6388605|NCT00185133|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6388606|NCT00185133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6388607|NCT00185133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388608|NCT00185133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6388609|NCT00185133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388610|NCT00185133|Vasodilator Agents|vasodilator agents|mesh-ancestor
6388611|NCT00185133|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6388612|NCT00185133|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6388613|NCT00185159|Olmesartan|olmesartan|mesh-list
6388614|NCT00185159|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6388615|NCT00185159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6388616|NCT00185159|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6388617|NCT00185159|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6388618|NCT00185159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388619|NCT00185172|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6388620|NCT00185172|Olmesartan|olmesartan|mesh-list
6388621|NCT00185172|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6388622|NCT00185172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6388623|NCT00185172|Diuretics|diuretics|mesh-ancestor
6388624|NCT00185172|Natriuretic Agents|natriuretic agents|mesh-ancestor
6388625|NCT00185172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388626|NCT00185172|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6388627|NCT00185172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6388628|NCT00185172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388629|NCT00185172|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6388630|NCT00185172|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6388631|NCT00185185|Atenolol|atenolol|mesh-list
6388632|NCT00185185|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6388633|NCT00185185|Olmesartan|olmesartan|mesh-list
6388634|NCT00185185|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6388635|NCT00185185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6388636|NCT00185185|Diuretics|diuretics|mesh-ancestor
6388637|NCT00185185|Natriuretic Agents|natriuretic agents|mesh-ancestor
6388638|NCT00185185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388639|NCT00185185|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6388640|NCT00185185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6388641|NCT00185185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388642|NCT00185185|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6388643|NCT00185185|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6388644|NCT00185185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6388645|NCT00185185|Sympatholytics|sympatholytics|mesh-ancestor
6388646|NCT00185185|Autonomic Agents|autonomic agents|mesh-ancestor
6388647|NCT00185185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6388648|NCT00185185|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6388649|NCT00185185|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6388650|NCT00185185|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6388651|NCT00185185|Adrenergic Agents|adrenergic agents|mesh-ancestor
6388652|NCT00185185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6388653|NCT00185198|Testosterone|testosterone|mesh-list
6388654|NCT00185198|Androgens|androgens|mesh-ancestor
6388655|NCT00185198|Hormones|hormones|mesh-ancestor
6388656|NCT00185198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6388657|NCT00185198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388658|NCT00185224|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
6388659|NCT00185224|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6388660|NCT00185224|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6388661|NCT00185224|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6388662|NCT00185224|Contraceptive Agents|contraceptive agents|mesh-ancestor
6388663|NCT00185224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6388664|NCT00185224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388665|NCT00185224|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6388666|NCT00185224|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6388667|NCT00185224|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6388668|NCT00185224|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
6388669|NCT00185224|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6388670|NCT00185224|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6388671|NCT00185237|Estradiol|estradiol|mesh-list
6388672|NCT00185237|Estrogens|estrogens|mesh-ancestor
6388673|NCT00185237|Hormones|hormones|mesh-ancestor
6388674|NCT00185237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6388675|NCT00185237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388676|NCT00185250|Interferons|interferons|mesh-list
6388677|NCT00185250|Interferon-beta|interferon-beta|mesh-list
6388678|NCT00185250|Interferon beta-1b|interferon beta-1b|mesh-list
6388679|NCT00185250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6388680|NCT00185250|Antiviral Agents|antiviral agents|mesh-ancestor
6388681|NCT00185250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6388682|NCT00185250|Immunologic Factors|immunologic factors|mesh-ancestor
6388683|NCT00185250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388684|NCT00185250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6388685|NCT00185302|Entinostat|entinostat|mesh-list
6388686|NCT00185302|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
6388687|NCT00185302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6388688|NCT00185302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6388689|NCT00185302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388690|NCT00185315|Iloprost|iloprost|mesh-list
6388691|NCT00185315|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6388692|NCT00185315|Vasodilator Agents|vasodilator agents|mesh-ancestor
6388693|NCT00185328|Estradiol|estradiol|mesh-list
6388694|NCT00185328|Estrogens|estrogens|mesh-ancestor
6388695|NCT00185328|Hormones|hormones|mesh-ancestor
6388696|NCT00185328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6388697|NCT00185328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388698|NCT00185419|Desogestrel|desogestrel|mesh-list
6388699|NCT00185419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6388700|NCT00185419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388701|NCT00185419|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6388702|NCT00185419|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6388703|NCT00185419|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6388704|NCT00185419|Contraceptive Agents|contraceptive agents|mesh-ancestor
6388705|NCT00185419|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6388706|NCT00185419|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6388707|NCT00185419|Progestins|progestins|mesh-ancestor
6388708|NCT00185419|Hormones|hormones|mesh-ancestor
6388709|NCT00185419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6388710|NCT00185445|Fludarabine|fludarabine|mesh-list
6388711|NCT00185445|Fludarabine phosphate|fludarabine phosphate|mesh-list
6388712|NCT00185445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6388713|NCT00185445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6388714|NCT00185445|Antimetabolites|antimetabolites|mesh-ancestor
6388715|NCT00185445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388716|NCT00185445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6388717|NCT00185445|Immunologic Factors|immunologic factors|mesh-ancestor
6388718|NCT00185445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388719|NCT00185510|Methylprednisolone|methylprednisolone|mesh-list
6388720|NCT00185510|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6388721|NCT00185510|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6388722|NCT00185510|Prednisolone|prednisolone|mesh-list
6388723|NCT00185510|Prednisolone acetate|prednisolone acetate|mesh-list
6388724|NCT00185510|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
6388725|NCT00185510|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6388726|NCT00185510|Prednisolone phosphate|prednisolone phosphate|mesh-list
6388727|NCT00185510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6388728|NCT00185510|Antiemetics|antiemetics|mesh-ancestor
6388729|NCT00185510|Autonomic Agents|autonomic agents|mesh-ancestor
6388730|NCT00185510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6388731|NCT00185510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388732|NCT00185510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6388733|NCT00185510|Glucocorticoids|glucocorticoids|mesh-ancestor
6388734|NCT00185510|Hormones|hormones|mesh-ancestor
6388735|NCT00185510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6388736|NCT00185510|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6388737|NCT00185510|Protective Agents|protective agents|mesh-ancestor
6388738|NCT00185510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6388739|NCT00185510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6388740|NCT00185562|Adalimumab|adalimumab|mesh-list
6388741|NCT00185562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6388742|NCT00185562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6388743|NCT00185575|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6388744|NCT00185575|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6388745|NCT00185575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6388746|NCT00185575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6388747|NCT00185575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388748|NCT00185575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6388749|NCT00185575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388750|NCT00185575|Analgesics|analgesics|mesh-ancestor
6388751|NCT00185575|Sensory System Agents|sensory system agents|mesh-ancestor
6388752|NCT00185575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6388753|NCT00185575|Antidepressive Agents|antidepressive agents|mesh-ancestor
6388754|NCT00185575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6388755|NCT00185575|Dopamine Agents|dopamine agents|mesh-ancestor
6388756|NCT00185705|Telmisartan|telmisartan|mesh-list
6388757|NCT00185705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6388758|NCT00185705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6388759|NCT00185705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6388760|NCT00185705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388761|NCT00185783|Hydrocortisone|hydrocortisone|mesh-list
6388762|NCT00185783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6388763|NCT00185796|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6388764|NCT00185796|Immunologic Factors|immunologic factors|mesh-ancestor
6388765|NCT00185796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388766|NCT00185796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6388767|NCT00185835|Gefitinib|gefitinib|mesh-list
6388768|NCT00185835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6388769|NCT00185835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6388770|NCT00185835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6388771|NCT00185835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388772|NCT00185861|Arsenic Trioxide|arsenic trioxide|mesh-list
6388773|NCT00185861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6388774|NCT00185887|Terbutaline|terbutaline|mesh-list
6388775|NCT00185887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6388776|NCT00185887|Autonomic Agents|autonomic agents|mesh-ancestor
6388777|NCT00185887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6388778|NCT00185887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388779|NCT00185887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6388780|NCT00185887|Respiratory System Agents|respiratory system agents|mesh-ancestor
6388781|NCT00185887|Sympathomimetics|sympathomimetics|mesh-ancestor
6388782|NCT00185887|Tocolytic Agents|tocolytic agents|mesh-ancestor
6388783|NCT00185887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6388784|NCT00185887|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6388785|NCT00185887|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6388786|NCT00185887|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6388787|NCT00185887|Adrenergic Agents|adrenergic agents|mesh-ancestor
6537250|NCT00821496|Hormones|hormones|mesh-ancestor
6537251|NCT00821496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6537252|NCT00821496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388788|NCT00185887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6388789|NCT00185887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388790|NCT00185939|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6388791|NCT00185939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6388792|NCT00185939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6388793|NCT00185939|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6388794|NCT00185939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6388795|NCT00185939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388796|NCT00185952|Nifedipine|nifedipine|mesh-list
6388797|NCT00185952|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6388798|NCT00185952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6396799|NCT00209716|Antimitotic Agents|antimitotic agents|mesh-ancestor
6388799|NCT00185952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388800|NCT00185952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6388801|NCT00185952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388802|NCT00185952|Vasodilator Agents|vasodilator agents|mesh-ancestor
6388803|NCT00185952|Tocolytic Agents|tocolytic agents|mesh-ancestor
6388804|NCT00185952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6388805|NCT00185991|Gentamicins|gentamicins|mesh-list
6388806|NCT00185991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6388807|NCT00185991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6388808|NCT00185991|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6388809|NCT00185991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6388810|NCT00185991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388811|NCT00186082|Cefoxitin|cefoxitin|mesh-list
6388812|NCT00186082|Cefotetan|cefotetan|mesh-list
6388813|NCT00186082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6388814|NCT00186082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6388815|NCT00186264|Hydrocortisone|hydrocortisone|mesh-list
6388816|NCT00186264|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6388817|NCT00186264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6388818|NCT00186264|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6388819|NCT00186264|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6388820|NCT00186264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6388821|NCT00186264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388822|NCT00186264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6388823|NCT00186264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388824|NCT00186264|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6388825|NCT00186264|Antidepressive Agents|antidepressive agents|mesh-ancestor
6388826|NCT00186264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6388827|NCT00186277|Docetaxel|docetaxel|mesh-list
6388828|NCT00186277|Oxaliplatin|oxaliplatin|mesh-list
6388829|NCT00186277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6388830|NCT00186277|Tubulin Modulators|tubulin modulators|mesh-ancestor
6388831|NCT00186277|Antimitotic Agents|antimitotic agents|mesh-ancestor
6388832|NCT00186277|Mitosis Modulators|mitosis modulators|mesh-ancestor
6388833|NCT00186277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6537253|NCT00821496|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6537254|NCT00821496|Contraceptive Agents|contraceptive agents|mesh-ancestor
6537255|NCT00821496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6537256|NCT00821496|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6537257|NCT00821496|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6537258|NCT00821496|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6388834|NCT00186316|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
6388835|NCT00186316|Immunologic Factors|immunologic factors|mesh-ancestor
6388836|NCT00186316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388837|NCT00186329|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6388838|NCT00186329|Natriuretic Agents|natriuretic agents|mesh-ancestor
6388839|NCT00186329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388840|NCT00186420|Docetaxel|docetaxel|mesh-list
6388841|NCT00186420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6388842|NCT00186420|Tubulin Modulators|tubulin modulators|mesh-ancestor
6388843|NCT00186420|Antimitotic Agents|antimitotic agents|mesh-ancestor
6388844|NCT00186420|Mitosis Modulators|mitosis modulators|mesh-ancestor
6388845|NCT00186420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388846|NCT00186589|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6388847|NCT00186589|Immunologic Factors|immunologic factors|mesh-ancestor
6388848|NCT00186589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396800|NCT00209716|Mitosis Modulators|mitosis modulators|mesh-ancestor
6396801|NCT00209716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388849|NCT00186706|Selenium|selenium|mesh-list
6388850|NCT00186706|Antioxidants|antioxidants|mesh-ancestor
6388851|NCT00186706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388852|NCT00186706|Protective Agents|protective agents|mesh-ancestor
6388853|NCT00186706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388854|NCT00186706|Trace Elements|trace elements|mesh-ancestor
6388855|NCT00186706|Micronutrients|micronutrients|mesh-ancestor
6388856|NCT00186745|Tinzaparin|tinzaparin|mesh-list
6388857|NCT00186745|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6388858|NCT00186745|Dalteparin|dalteparin|mesh-list
6388859|NCT00186745|Anticoagulants|anticoagulants|mesh-ancestor
6388860|NCT00186745|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6388861|NCT00186745|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6388862|NCT00186745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388863|NCT00186797|Cyclophosphamide|cyclophosphamide|mesh-list
6388864|NCT00186797|Fludarabine|fludarabine|mesh-list
6388865|NCT00186797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6388866|NCT00186797|Immunologic Factors|immunologic factors|mesh-ancestor
6388867|NCT00186797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388868|NCT00186797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6388869|NCT00186797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6388870|NCT00186797|Alkylating Agents|alkylating agents|mesh-ancestor
6388871|NCT00186797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388872|NCT00186797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6388873|NCT00186797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6388874|NCT00186810|Cyclophosphamide|cyclophosphamide|mesh-list
6388875|NCT00186810|Busulfan|busulfan|mesh-list
6388876|NCT00186810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6388877|NCT00186810|Immunologic Factors|immunologic factors|mesh-ancestor
6388878|NCT00186810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388879|NCT00186810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6388880|NCT00186810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6388881|NCT00186810|Alkylating Agents|alkylating agents|mesh-ancestor
6388882|NCT00186810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388883|NCT00186810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6388884|NCT00186810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6388885|NCT00186823|Antibodies|antibodies|mesh-list
6388886|NCT00186823|Immunologic Factors|immunologic factors|mesh-ancestor
6388887|NCT00186823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388888|NCT00186849|Cyclophosphamide|cyclophosphamide|mesh-list
6388889|NCT00186849|Ifosfamide|ifosfamide|mesh-list
6388890|NCT00186849|Carboplatin|carboplatin|mesh-list
6388891|NCT00186849|Doxorubicin|doxorubicin|mesh-list
6388892|NCT00186849|Etoposide|etoposide|mesh-list
6388893|NCT00186849|Topotecan|topotecan|mesh-list
6388894|NCT00186849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6388895|NCT00186849|Immunologic Factors|immunologic factors|mesh-ancestor
6388896|NCT00186849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388897|NCT00186849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6388898|NCT00186849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6388899|NCT00186849|Alkylating Agents|alkylating agents|mesh-ancestor
6388900|NCT00186849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388901|NCT00186849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6388902|NCT00186849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6388903|NCT00186849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6388904|NCT00186849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6388905|NCT00186849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6388906|NCT00186849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6388907|NCT00186849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6388908|NCT00186849|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6388909|NCT00186862|Interleukin-2|interleukin-2|mesh-list
6388910|NCT00186862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6388911|NCT00186862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6388912|NCT00186862|Analgesics|analgesics|mesh-ancestor
6388913|NCT00186862|Sensory System Agents|sensory system agents|mesh-ancestor
6388914|NCT00186862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6388915|NCT00186862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388916|NCT00186940|Rasburicase|rasburicase|mesh-list
6388917|NCT00186940|Gout Suppressants|gout suppressants|mesh-ancestor
6388918|NCT00186940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6388919|NCT00186966|Cytarabine|cytarabine|mesh-list
6388920|NCT00186966|Cyclophosphamide|cyclophosphamide|mesh-list
6388921|NCT00186966|Melphalan|melphalan|mesh-list
6388922|NCT00186966|Busulfan|busulfan|mesh-list
6388923|NCT00186966|Fludarabine|fludarabine|mesh-list
6388924|NCT00186966|Etoposide|etoposide|mesh-list
6388925|NCT00186966|Daunorubicin|daunorubicin|mesh-list
6388926|NCT00186966|Thioguanine|thioguanine|mesh-list
6388927|NCT00186966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6388928|NCT00186966|Immunologic Factors|immunologic factors|mesh-ancestor
6388929|NCT00186966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388930|NCT00186966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6388931|NCT00186966|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6388932|NCT00186966|Alkylating Agents|alkylating agents|mesh-ancestor
6388933|NCT00186966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388934|NCT00186966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6388935|NCT00186966|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6388936|NCT00186966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6388937|NCT00186966|Antimetabolites|antimetabolites|mesh-ancestor
6388938|NCT00186966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6388939|NCT00186966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6388940|NCT00186966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6388941|NCT00186966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6388942|NCT00186966|Antiviral Agents|antiviral agents|mesh-ancestor
6388943|NCT00186966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6388944|NCT00186966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6388945|NCT00186979|Cefixime|cefixime|mesh-list
6388946|NCT00186979|Cefpodoxime|cefpodoxime|mesh-list
6388947|NCT00186979|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
6388948|NCT00186979|Irinotecan|irinotecan|mesh-list
6388949|NCT00186979|Vincristine|vincristine|mesh-list
6388950|NCT00186979|Gefitinib|gefitinib|mesh-list
6388951|NCT00186979|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6388952|NCT00186979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6388953|NCT00186979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6388954|NCT00186979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388955|NCT00186979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6388956|NCT00186979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6388957|NCT00186979|Tubulin Modulators|tubulin modulators|mesh-ancestor
6388958|NCT00186979|Antimitotic Agents|antimitotic agents|mesh-ancestor
6388959|NCT00186979|Mitosis Modulators|mitosis modulators|mesh-ancestor
6388960|NCT00186979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6388961|NCT00186979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6388962|NCT00186979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6388963|NCT00187005|Cytarabine|cytarabine|mesh-list
6388964|NCT00187005|Dexamethasone|dexamethasone|mesh-list
6388965|NCT00187005|Prednisone|prednisone|mesh-list
6388966|NCT00187005|Cyclophosphamide|cyclophosphamide|mesh-list
6388967|NCT00187005|Methotrexate|methotrexate|mesh-list
6388968|NCT00187005|Etoposide|etoposide|mesh-list
6388969|NCT00187005|Vincristine|vincristine|mesh-list
6388970|NCT00187005|Daunorubicin|daunorubicin|mesh-list
6388971|NCT00187005|Asparaginase|asparaginase|mesh-list
6388972|NCT00187005|Mercaptopurine|mercaptopurine|mesh-list
6388973|NCT00187005|Idarubicin|idarubicin|mesh-list
6388974|NCT00187005|Pegaspargase|pegaspargase|mesh-list
6388975|NCT00187005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6388976|NCT00187005|Immunologic Factors|immunologic factors|mesh-ancestor
6388977|NCT00187005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6388978|NCT00187005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6388979|NCT00187005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6388980|NCT00187005|Alkylating Agents|alkylating agents|mesh-ancestor
6388981|NCT00187005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6388982|NCT00187005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6388983|NCT00187005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6388984|NCT00187005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6388985|NCT00187005|Antiemetics|antiemetics|mesh-ancestor
6388986|NCT00187005|Autonomic Agents|autonomic agents|mesh-ancestor
6388987|NCT00187005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6388988|NCT00187005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6388989|NCT00187005|Glucocorticoids|glucocorticoids|mesh-ancestor
6388990|NCT00187005|Hormones|hormones|mesh-ancestor
6388991|NCT00187005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6388992|NCT00187005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6388993|NCT00187005|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6388994|NCT00187005|Abortifacient Agents|abortifacient agents|mesh-ancestor
6388995|NCT00187005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6388996|NCT00187005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6388997|NCT00187005|Antimetabolites|antimetabolites|mesh-ancestor
6388998|NCT00187005|Dermatologic Agents|dermatologic agents|mesh-ancestor
6388999|NCT00187005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6389000|NCT00187005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6389001|NCT00187005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6389002|NCT00187005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6389003|NCT00187005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6389004|NCT00187005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6389005|NCT00187005|Antiviral Agents|antiviral agents|mesh-ancestor
6389006|NCT00187005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6389007|NCT00187005|Tubulin Modulators|tubulin modulators|mesh-ancestor
6389008|NCT00187005|Antimitotic Agents|antimitotic agents|mesh-ancestor
6389009|NCT00187005|Mitosis Modulators|mitosis modulators|mesh-ancestor
6389010|NCT00187005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6389011|NCT00187031|Topotecan|topotecan|mesh-list
6389012|NCT00187031|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6389013|NCT00187031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6389014|NCT00187031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6389015|NCT00187031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389016|NCT00187031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6389017|NCT00187057|Cytarabine|cytarabine|mesh-list
6389018|NCT00187057|Dexamethasone|dexamethasone|mesh-list
6389019|NCT00187057|Prednisone|prednisone|mesh-list
6389020|NCT00187057|Cyclophosphamide|cyclophosphamide|mesh-list
6389021|NCT00187057|Doxorubicin|doxorubicin|mesh-list
6389022|NCT00187057|Methotrexate|methotrexate|mesh-list
6389023|NCT00187057|Etoposide|etoposide|mesh-list
6389024|NCT00187057|Vincristine|vincristine|mesh-list
6389025|NCT00187057|Daunorubicin|daunorubicin|mesh-list
6389026|NCT00187057|Asparaginase|asparaginase|mesh-list
6389027|NCT00187057|Mercaptopurine|mercaptopurine|mesh-list
6389028|NCT00187057|Vinblastine|vinblastine|mesh-list
6389029|NCT00187057|Procarbazine|procarbazine|mesh-list
6389030|NCT00187057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6389031|NCT00187057|Immunologic Factors|immunologic factors|mesh-ancestor
6389032|NCT00187057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389033|NCT00187057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6389034|NCT00187057|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6389035|NCT00187057|Alkylating Agents|alkylating agents|mesh-ancestor
6389036|NCT00187057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389037|NCT00187057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6389038|NCT00187057|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6389039|NCT00187057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6389040|NCT00187057|Antiemetics|antiemetics|mesh-ancestor
6389041|NCT00187057|Autonomic Agents|autonomic agents|mesh-ancestor
6389042|NCT00187057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6389043|NCT00187057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6389044|NCT00187057|Glucocorticoids|glucocorticoids|mesh-ancestor
6389045|NCT00187057|Hormones|hormones|mesh-ancestor
6389046|NCT00187057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6389047|NCT00187057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6389048|NCT00187057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6389049|NCT00187057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6389050|NCT00187057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6389051|NCT00187057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6389052|NCT00187057|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6389053|NCT00187057|Abortifacient Agents|abortifacient agents|mesh-ancestor
6389054|NCT00187057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6389055|NCT00187057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6389056|NCT00187057|Antimetabolites|antimetabolites|mesh-ancestor
6389057|NCT00187057|Dermatologic Agents|dermatologic agents|mesh-ancestor
6389058|NCT00187057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6389059|NCT00187057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6389060|NCT00187057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6389061|NCT00187057|Antiviral Agents|antiviral agents|mesh-ancestor
6389062|NCT00187057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6389063|NCT00187057|Tubulin Modulators|tubulin modulators|mesh-ancestor
6389064|NCT00187057|Antimitotic Agents|antimitotic agents|mesh-ancestor
6389065|NCT00187057|Mitosis Modulators|mitosis modulators|mesh-ancestor
6389066|NCT00187070|Cytarabine|cytarabine|mesh-list
6389067|NCT00187070|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6389068|NCT00187070|Dexamethasone|dexamethasone|mesh-list
6389069|NCT00187070|Prednisone|prednisone|mesh-list
6389070|NCT00187070|Cyclophosphamide|cyclophosphamide|mesh-list
6389071|NCT00187070|Ifosfamide|ifosfamide|mesh-list
6389072|NCT00187070|Carboplatin|carboplatin|mesh-list
6389073|NCT00187070|Doxorubicin|doxorubicin|mesh-list
6389074|NCT00187070|Methotrexate|methotrexate|mesh-list
6389075|NCT00187070|Etoposide|etoposide|mesh-list
6389076|NCT00187070|Vincristine|vincristine|mesh-list
6389077|NCT00187070|Vinblastine|vinblastine|mesh-list
6389078|NCT00187070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6389079|NCT00187070|Immunologic Factors|immunologic factors|mesh-ancestor
6389080|NCT00187070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389081|NCT00187070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6389082|NCT00187070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6389083|NCT00187070|Alkylating Agents|alkylating agents|mesh-ancestor
6389084|NCT00187070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389085|NCT00187070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6389086|NCT00187070|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6389087|NCT00187070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6389088|NCT00187070|Antiemetics|antiemetics|mesh-ancestor
6389089|NCT00187070|Autonomic Agents|autonomic agents|mesh-ancestor
6389090|NCT00187070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6389091|NCT00187070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6389092|NCT00187070|Glucocorticoids|glucocorticoids|mesh-ancestor
6389093|NCT00187070|Hormones|hormones|mesh-ancestor
6389094|NCT00187070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6389095|NCT00187070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6389096|NCT00187070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6389097|NCT00187070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6389098|NCT00187070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6389099|NCT00187070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6389100|NCT00187070|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6389101|NCT00187070|Abortifacient Agents|abortifacient agents|mesh-ancestor
6389102|NCT00187070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6389103|NCT00187070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6389104|NCT00187070|Antimetabolites|antimetabolites|mesh-ancestor
6389105|NCT00187070|Dermatologic Agents|dermatologic agents|mesh-ancestor
6389106|NCT00187070|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6389107|NCT00187070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6389108|NCT00187070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6389109|NCT00187070|Antiviral Agents|antiviral agents|mesh-ancestor
6389110|NCT00187070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6389111|NCT00187070|Tubulin Modulators|tubulin modulators|mesh-ancestor
6389112|NCT00187070|Antimitotic Agents|antimitotic agents|mesh-ancestor
6389113|NCT00187070|Mitosis Modulators|mitosis modulators|mesh-ancestor
6389114|NCT00187070|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6389115|NCT00187070|Renal Agents|renal agents|mesh-ancestor
6389116|NCT00187070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6389117|NCT00187070|Antimalarials|antimalarials|mesh-ancestor
6389118|NCT00187070|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6389119|NCT00187070|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6389120|NCT00187083|Dexamethasone|dexamethasone|mesh-list
6389121|NCT00187083|Methotrexate|methotrexate|mesh-list
6389122|NCT00187083|Fludarabine|fludarabine|mesh-list
6389123|NCT00187083|Etoposide|etoposide|mesh-list
6389124|NCT00187083|Vincristine|vincristine|mesh-list
6389125|NCT00187083|Topotecan|topotecan|mesh-list
6389126|NCT00187083|Asparaginase|asparaginase|mesh-list
6389127|NCT00187083|Mercaptopurine|mercaptopurine|mesh-list
6389128|NCT00187083|Idarubicin|idarubicin|mesh-list
6389129|NCT00187083|Pegaspargase|pegaspargase|mesh-list
6389130|NCT00187083|Teniposide|teniposide|mesh-list
6389131|NCT00187083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6389132|NCT00187083|Antiemetics|antiemetics|mesh-ancestor
6389133|NCT00187083|Autonomic Agents|autonomic agents|mesh-ancestor
6389134|NCT00187083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6389135|NCT00187083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389136|NCT00187083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6389137|NCT00187083|Glucocorticoids|glucocorticoids|mesh-ancestor
6389138|NCT00187083|Hormones|hormones|mesh-ancestor
6389139|NCT00187083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6389140|NCT00187083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6389141|NCT00187083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6389142|NCT00187083|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6389143|NCT00187083|Abortifacient Agents|abortifacient agents|mesh-ancestor
6389144|NCT00187083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6389145|NCT00187083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6389146|NCT00187083|Antimetabolites|antimetabolites|mesh-ancestor
6389147|NCT00187083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389148|NCT00187083|Dermatologic Agents|dermatologic agents|mesh-ancestor
6389149|NCT00187083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6389150|NCT00187083|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6389151|NCT00187083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6389152|NCT00187083|Immunologic Factors|immunologic factors|mesh-ancestor
6389153|NCT00187083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6389154|NCT00187083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6389155|NCT00187083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6389156|NCT00187083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6389157|NCT00187083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6389158|NCT00187083|Tubulin Modulators|tubulin modulators|mesh-ancestor
6389159|NCT00187083|Antimitotic Agents|antimitotic agents|mesh-ancestor
6389160|NCT00187083|Mitosis Modulators|mitosis modulators|mesh-ancestor
6389161|NCT00187083|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6389162|NCT00187083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6389163|NCT00187122|Cytarabine|cytarabine|mesh-list
6389164|NCT00187122|Dexamethasone|dexamethasone|mesh-list
6389165|NCT00187122|Prednisone|prednisone|mesh-list
6389166|NCT00187122|Cyclophosphamide|cyclophosphamide|mesh-list
6389167|NCT00187122|Methotrexate|methotrexate|mesh-list
6389168|NCT00187122|Etoposide|etoposide|mesh-list
6389169|NCT00187122|Vincristine|vincristine|mesh-list
6389170|NCT00187122|Asparaginase|asparaginase|mesh-list
6389171|NCT00187122|Mercaptopurine|mercaptopurine|mesh-list
6389172|NCT00187122|Daunorubicin|daunorubicin|mesh-list
6389173|NCT00187122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6389174|NCT00187122|Immunologic Factors|immunologic factors|mesh-ancestor
6389175|NCT00187122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389176|NCT00187122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6389177|NCT00187122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6389178|NCT00187122|Alkylating Agents|alkylating agents|mesh-ancestor
6389179|NCT00187122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389180|NCT00187122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6389181|NCT00187122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6389182|NCT00187122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6389183|NCT00187122|Antiemetics|antiemetics|mesh-ancestor
6389184|NCT00187122|Autonomic Agents|autonomic agents|mesh-ancestor
6389185|NCT00187122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6389186|NCT00187122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6389187|NCT00187122|Glucocorticoids|glucocorticoids|mesh-ancestor
6389188|NCT00187122|Hormones|hormones|mesh-ancestor
6389189|NCT00187122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6389190|NCT00187122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6389191|NCT00187122|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6389192|NCT00187122|Abortifacient Agents|abortifacient agents|mesh-ancestor
6389193|NCT00187122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6389194|NCT00187122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6389195|NCT00187122|Antimetabolites|antimetabolites|mesh-ancestor
6389196|NCT00187122|Dermatologic Agents|dermatologic agents|mesh-ancestor
6389197|NCT00187122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6389198|NCT00187122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6389199|NCT00187122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6389200|NCT00187122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6389201|NCT00187122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6389202|NCT00187122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6389203|NCT00187122|Antiviral Agents|antiviral agents|mesh-ancestor
6389204|NCT00187122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6389205|NCT00187122|Tubulin Modulators|tubulin modulators|mesh-ancestor
6389206|NCT00187122|Antimitotic Agents|antimitotic agents|mesh-ancestor
6389207|NCT00187122|Mitosis Modulators|mitosis modulators|mesh-ancestor
6389208|NCT00187122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6389209|NCT00187161|Cytarabine|cytarabine|mesh-list
6389210|NCT00187161|Cyclophosphamide|cyclophosphamide|mesh-list
6389211|NCT00187161|Doxorubicin|doxorubicin|mesh-list
6389212|NCT00187161|Methotrexate|methotrexate|mesh-list
6389213|NCT00187161|Etoposide|etoposide|mesh-list
6389214|NCT00187161|Vincristine|vincristine|mesh-list
6389215|NCT00187161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6389216|NCT00187161|Immunologic Factors|immunologic factors|mesh-ancestor
6389217|NCT00187161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389218|NCT00187161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6389219|NCT00187161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6389220|NCT00187161|Alkylating Agents|alkylating agents|mesh-ancestor
6389221|NCT00187161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389222|NCT00187161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6389223|NCT00187161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6389224|NCT00187161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6389225|NCT00187161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6389226|NCT00187161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6389227|NCT00187161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6389228|NCT00187161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6389229|NCT00187161|Abortifacient Agents|abortifacient agents|mesh-ancestor
6389230|NCT00187161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6389231|NCT00187161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6389232|NCT00187161|Antimetabolites|antimetabolites|mesh-ancestor
6389233|NCT00187161|Dermatologic Agents|dermatologic agents|mesh-ancestor
6389234|NCT00187161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6389235|NCT00187161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6389236|NCT00187161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6389237|NCT00187161|Antiviral Agents|antiviral agents|mesh-ancestor
6389238|NCT00187161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6389239|NCT00187161|Tubulin Modulators|tubulin modulators|mesh-ancestor
6389240|NCT00187161|Antimitotic Agents|antimitotic agents|mesh-ancestor
6389241|NCT00187161|Mitosis Modulators|mitosis modulators|mesh-ancestor
6389242|NCT00187174|Everolimus|everolimus|mesh-list
6389243|NCT00187174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6389244|NCT00187174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6389245|NCT00187174|Immunologic Factors|immunologic factors|mesh-ancestor
6389246|NCT00187174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389247|NCT00187330|Acetylcysteine|acetylcysteine|mesh-list
6389248|NCT00187330|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6389249|NCT00187330|Antiviral Agents|antiviral agents|mesh-ancestor
6389250|NCT00187330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6389251|NCT00187330|Expectorants|expectorants|mesh-ancestor
6389252|NCT00187330|Respiratory System Agents|respiratory system agents|mesh-ancestor
6389253|NCT00187330|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6389254|NCT00187330|Antioxidants|antioxidants|mesh-ancestor
6389255|NCT00187330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389256|NCT00187330|Protective Agents|protective agents|mesh-ancestor
6389257|NCT00187330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389258|NCT00187330|Antidotes|antidotes|mesh-ancestor
6389259|NCT00187408|Heparin|heparin|mesh-list
6389260|NCT00187408|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6389261|NCT00187408|Tinzaparin|tinzaparin|mesh-list
6389262|NCT00187408|Dalteparin|dalteparin|mesh-list
6389263|NCT00187408|Anticoagulants|anticoagulants|mesh-ancestor
6389264|NCT00187408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6389265|NCT00187408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6389266|NCT00187408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389267|NCT00187447|Indomethacin|indomethacin|mesh-list
6389268|NCT00187447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6389269|NCT00187447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6389270|NCT00187447|Analgesics|analgesics|mesh-ancestor
6389271|NCT00187447|Sensory System Agents|sensory system agents|mesh-ancestor
6389272|NCT00187447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6389273|NCT00187447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389274|NCT00187447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6389275|NCT00187447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6389276|NCT00187447|Gout Suppressants|gout suppressants|mesh-ancestor
6389277|NCT00187447|Tocolytic Agents|tocolytic agents|mesh-ancestor
6389278|NCT00187447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6389279|NCT00187447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6389280|NCT00187447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6389281|NCT00187447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389282|NCT00187499|Fluticasone|fluticasone|mesh-list
6389283|NCT00187499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6389284|NCT00187499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6389285|NCT00187499|Autonomic Agents|autonomic agents|mesh-ancestor
6389286|NCT00187499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6389287|NCT00187499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389288|NCT00187499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6389289|NCT00187499|Respiratory System Agents|respiratory system agents|mesh-ancestor
6389290|NCT00187499|Dermatologic Agents|dermatologic agents|mesh-ancestor
6389291|NCT00187499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6389292|NCT00187525|Memantine|memantine|mesh-list
6389293|NCT00187525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6389294|NCT00187525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6389295|NCT00187525|Dopamine Agents|dopamine agents|mesh-ancestor
6389296|NCT00187525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6389297|NCT00187525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389298|NCT00187525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389299|NCT00187525|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6389300|NCT00187525|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6389301|NCT00187551|Enfuvirtide|enfuvirtide|mesh-list
6389302|NCT00187551|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6389303|NCT00187551|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6389304|NCT00187551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389305|NCT00187551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6389306|NCT00187551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6389307|NCT00187551|Antiviral Agents|antiviral agents|mesh-ancestor
6389308|NCT00187551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6389309|NCT00187564|Thioctic Acid|thioctic acid|mesh-list
6389310|NCT00187564|Antioxidants|antioxidants|mesh-ancestor
6389311|NCT00187564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389312|NCT00187564|Protective Agents|protective agents|mesh-ancestor
6389313|NCT00187564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389314|NCT00187564|Vitamin B Complex|vitamin b complex|mesh-ancestor
6389315|NCT00187564|Vitamins|vitamins|mesh-ancestor
6389316|NCT00187564|Micronutrients|micronutrients|mesh-ancestor
6389317|NCT00187577|Bimatoprost|bimatoprost|mesh-list
6389318|NCT00187577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6389319|NCT00187577|Latanoprost|latanoprost|mesh-list
6389320|NCT00187577|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6389321|NCT00187577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6389322|NCT00187707|Gabapentin|gabapentin|mesh-list
6389323|NCT00187707|Analgesics|analgesics|mesh-ancestor
6389324|NCT00187707|Sensory System Agents|sensory system agents|mesh-ancestor
6389325|NCT00187707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6389326|NCT00187707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389327|NCT00187707|Anticonvulsants|anticonvulsants|mesh-ancestor
6389328|NCT00187707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6389329|NCT00187707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6389330|NCT00187707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6389331|NCT00187707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6389332|NCT00187707|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6389333|NCT00187707|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6389334|NCT00187707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6389335|NCT00187707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389336|NCT00187707|Antimanic Agents|antimanic agents|mesh-ancestor
6389337|NCT00187746|Adefovir|adefovir|mesh-list
6389338|NCT00187746|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6389339|NCT00187746|Antiviral Agents|antiviral agents|mesh-ancestor
6389340|NCT00187746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6389341|NCT00187746|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6389342|NCT00187746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6389343|NCT00187746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6389344|NCT00187746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389345|NCT00187759|Cephalexin|cephalexin|mesh-list
6389346|NCT00187759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6389347|NCT00187759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6389348|NCT00187798|Metformin|metformin|mesh-list
6389349|NCT00187798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6389350|NCT00187798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389351|NCT00187915|Cyclosporine|cyclosporine|mesh-list
6389352|NCT00187915|Mycophenolic Acid|mycophenolic acid|mesh-list
6389353|NCT00187915|Tacrolimus|tacrolimus|mesh-list
6389354|NCT00187915|Cyclosporins|cyclosporins|mesh-list
6389355|NCT00187915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6017593|NCT00373880|Dopamine Agonists|dopamine agonists|mesh-ancestor
6389356|NCT00187915|Immunologic Factors|immunologic factors|mesh-ancestor
6389357|NCT00187915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389358|NCT00187915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6389359|NCT00187915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6389360|NCT00187915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389361|NCT00187915|Antifungal Agents|antifungal agents|mesh-ancestor
6389362|NCT00187915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6389363|NCT00187915|Dermatologic Agents|dermatologic agents|mesh-ancestor
6389364|NCT00187915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6389365|NCT00187915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6389366|NCT00187915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6389367|NCT00187915|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6389368|NCT00187915|Antitubercular Agents|antitubercular agents|mesh-ancestor
6389369|NCT00187915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6389370|NCT00187928|Topiramate|topiramate|mesh-list
6389371|NCT00187928|Anticonvulsants|anticonvulsants|mesh-ancestor
6389372|NCT00187928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6389373|NCT00187928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389374|NCT00187941|Mycophenolic Acid|mycophenolic acid|mesh-list
6389375|NCT00187941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6389376|NCT00187941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6389377|NCT00187941|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6389378|NCT00187941|Antitubercular Agents|antitubercular agents|mesh-ancestor
6389379|NCT00187941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6389380|NCT00187941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6389381|NCT00187941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6389382|NCT00187941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389383|NCT00187993|Hormones|hormones|mesh-list
6389384|NCT00187993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6389385|NCT00187993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389386|NCT00188006|Heparin|heparin|mesh-list
6389387|NCT00188006|Anticoagulants|anticoagulants|mesh-ancestor
6389388|NCT00188006|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6389389|NCT00188006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6389390|NCT00188006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389391|NCT00188045|Propranolol|propranolol|mesh-list
6389392|NCT00188045|Spironolactone|spironolactone|mesh-list
6389393|NCT00188045|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6389394|NCT00188045|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6389395|NCT00188045|Adrenergic Agents|adrenergic agents|mesh-ancestor
6389396|NCT00188045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6017594|NCT00373880|Dopamine Agents|dopamine agents|mesh-ancestor
6017595|NCT00373880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6389397|NCT00188045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389398|NCT00188045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389399|NCT00188045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6017596|NCT00373880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017597|NCT00373880|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6017598|NCT00373880|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6017599|NCT00373880|Serotonin Agents|serotonin agents|mesh-ancestor
6017600|NCT00373880|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6017601|NCT00373880|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6017602|NCT00373880|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6017603|NCT00373880|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6017604|NCT00373880|Anesthetics, Local|anesthetics, local|mesh-ancestor
6017605|NCT00373880|Anesthetics|anesthetics|mesh-ancestor
6017606|NCT00373880|Sensory System Agents|sensory system agents|mesh-ancestor
6017607|NCT00373880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6017608|NCT00373880|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6017609|NCT00373880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6017610|NCT00373880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6017611|NCT00373880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6389400|NCT00188045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6389401|NCT00188045|Vasodilator Agents|vasodilator agents|mesh-ancestor
6389402|NCT00188045|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6389403|NCT00188045|Hormone Antagonists|hormone antagonists|mesh-ancestor
6389404|NCT00188045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6389405|NCT00188045|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6389406|NCT00188045|Diuretics|diuretics|mesh-ancestor
6389407|NCT00188045|Natriuretic Agents|natriuretic agents|mesh-ancestor
6389408|NCT00188071|Acetaminophen|acetaminophen|mesh-list
6389409|NCT00188071|Ketoprofen|ketoprofen|mesh-list
6389410|NCT00188071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6389411|NCT00188071|Analgesics|analgesics|mesh-ancestor
6389412|NCT00188071|Sensory System Agents|sensory system agents|mesh-ancestor
6389413|NCT00188071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6389414|NCT00188071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389415|NCT00188071|Antipyretics|antipyretics|mesh-ancestor
6389416|NCT00188071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6389417|NCT00188071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6389418|NCT00188071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6389419|NCT00188071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6389420|NCT00188071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6389421|NCT00188071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389422|NCT00188136|Fludarabine|fludarabine|mesh-list
6389423|NCT00188136|Melphalan|melphalan|mesh-list
6389424|NCT00188136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6389425|NCT00188136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389426|NCT00188136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6389427|NCT00188136|Immunologic Factors|immunologic factors|mesh-ancestor
6389428|NCT00188136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389429|NCT00188136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6389430|NCT00188136|Alkylating Agents|alkylating agents|mesh-ancestor
6389431|NCT00188136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6396802|NCT00209716|Antimetabolites|antimetabolites|mesh-ancestor
6396803|NCT00209716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6396804|NCT00209716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6396805|NCT00209716|Immunologic Factors|immunologic factors|mesh-ancestor
6396806|NCT00209716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396807|NCT00209729|Docetaxel|docetaxel|mesh-list
6396808|NCT00209729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6396809|NCT00209729|Tubulin Modulators|tubulin modulators|mesh-ancestor
6396810|NCT00209729|Antimitotic Agents|antimitotic agents|mesh-ancestor
6396811|NCT00209729|Mitosis Modulators|mitosis modulators|mesh-ancestor
6396812|NCT00209729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396813|NCT00209742|Leucovorin|leucovorin|mesh-list
6396814|NCT00209742|polysaccharide-K|polysaccharide-k|mesh-list
6396815|NCT00209742|Tegafur|tegafur|mesh-list
6396816|NCT00209742|Levoleucovorin|levoleucovorin|mesh-list
6396817|NCT00209742|Antidotes|antidotes|mesh-ancestor
6396818|NCT00209742|Protective Agents|protective agents|mesh-ancestor
6396819|NCT00209742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6396820|NCT00209742|Vitamin B Complex|vitamin b complex|mesh-ancestor
6396821|NCT00209742|Vitamins|vitamins|mesh-ancestor
6396822|NCT00209742|Micronutrients|micronutrients|mesh-ancestor
6396823|NCT00209742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6396824|NCT00209742|Antimetabolites|antimetabolites|mesh-ancestor
6396825|NCT00209742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6396826|NCT00209742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6396827|NCT00209742|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6389432|NCT00188227|Midazolam|midazolam|mesh-list
6389433|NCT00188227|Pirinitramide|pirinitramide|mesh-list
6389434|NCT00188227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
6389435|NCT00188227|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6389436|NCT00188227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6017612|NCT00373958|Vaccines|vaccines|mesh-list
6017613|NCT00373958|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6017614|NCT00373958|Immunologic Factors|immunologic factors|mesh-ancestor
6017615|NCT00373958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017616|NCT00374088|Acetylcysteine|acetylcysteine|mesh-list
6017617|NCT00374088|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6017618|NCT00374088|Antiviral Agents|antiviral agents|mesh-ancestor
6017619|NCT00374088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6017620|NCT00374088|Expectorants|expectorants|mesh-ancestor
6017621|NCT00374088|Respiratory System Agents|respiratory system agents|mesh-ancestor
6017622|NCT00374088|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6017623|NCT00374088|Antioxidants|antioxidants|mesh-ancestor
6017624|NCT00374088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017625|NCT00374088|Protective Agents|protective agents|mesh-ancestor
6017626|NCT00374088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017627|NCT00374088|Antidotes|antidotes|mesh-ancestor
6017628|NCT00374140|Everolimus|everolimus|mesh-list
6017629|NCT00374140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6017630|NCT00374140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6017631|NCT00374140|Immunologic Factors|immunologic factors|mesh-ancestor
6017632|NCT00374140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389437|NCT00188227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389438|NCT00188227|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6389439|NCT00188227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6389440|NCT00188227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6389441|NCT00188227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6389442|NCT00188227|Anesthetics, General|anesthetics, general|mesh-ancestor
6389443|NCT00188227|Anesthetics|anesthetics|mesh-ancestor
6389444|NCT00188227|GABA Modulators|gaba modulators|mesh-ancestor
6389445|NCT00188227|GABA Agents|gaba agents|mesh-ancestor
6389446|NCT00188227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6389447|NCT00188227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389448|NCT00188227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6389449|NCT00188227|Narcotics|narcotics|mesh-ancestor
6389450|NCT00188227|Analgesics|analgesics|mesh-ancestor
6389451|NCT00188227|Sensory System Agents|sensory system agents|mesh-ancestor
6389452|NCT00188227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6389453|NCT00188240|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6389454|NCT00188240|Antiviral Agents|antiviral agents|mesh-ancestor
6017633|NCT00374231|Mycophenolic Acid|mycophenolic acid|mesh-list
6017634|NCT00374231|Prednisone|prednisone|mesh-list
6017635|NCT00374231|Tacrolimus|tacrolimus|mesh-list
6017636|NCT00374231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6017637|NCT00374231|Glucocorticoids|glucocorticoids|mesh-ancestor
6017638|NCT00374231|Hormones|hormones|mesh-ancestor
6017639|NCT00374231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6017640|NCT00374231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017641|NCT00374231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6017642|NCT00374231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6017643|NCT00374231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6017644|NCT00374231|Immunologic Factors|immunologic factors|mesh-ancestor
6017645|NCT00374231|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6017646|NCT00374231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6017647|NCT00374231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017648|NCT00374231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6017649|NCT00374231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6017650|NCT00374231|Antitubercular Agents|antitubercular agents|mesh-ancestor
6017651|NCT00374231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6017652|NCT00374231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6017653|NCT00374244|Pimozide|pimozide|mesh-list
6017654|NCT00374244|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6017655|NCT00374244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6389455|NCT00188240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6389456|NCT00188266|Fluorouracil|fluorouracil|mesh-list
6389457|NCT00188266|Cisplatin|cisplatin|mesh-list
6389458|NCT00188266|Antimetabolites|antimetabolites|mesh-ancestor
6018501|NCT00381303|Ritonavir|ritonavir|mesh-list
6389459|NCT00188266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389460|NCT00188266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6389461|NCT00188266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6389462|NCT00188266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6389463|NCT00188266|Immunologic Factors|immunologic factors|mesh-ancestor
6389464|NCT00188266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389465|NCT00188383|Amantadine|amantadine|mesh-list
6389466|NCT00188383|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6389467|NCT00188383|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6389468|NCT00188383|Antiviral Agents|antiviral agents|mesh-ancestor
6389469|NCT00188383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6389470|NCT00188383|Dopamine Agents|dopamine agents|mesh-ancestor
6389471|NCT00188383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6389472|NCT00188383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389473|NCT00188383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389474|NCT00188383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6389475|NCT00188383|Analgesics|analgesics|mesh-ancestor
6389476|NCT00188383|Sensory System Agents|sensory system agents|mesh-ancestor
6389477|NCT00188383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6389478|NCT00188396|Citalopram|citalopram|mesh-list
6389479|NCT00188396|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6389480|NCT00188396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6389481|NCT00188396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6389482|NCT00188396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389483|NCT00188396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6389484|NCT00188396|Serotonin Agents|serotonin agents|mesh-ancestor
6389485|NCT00188396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389486|NCT00188396|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6389487|NCT00188396|Antidepressive Agents|antidepressive agents|mesh-ancestor
6389488|NCT00188396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6389489|NCT00188539|Anesthetics|anesthetics|mesh-list
6389490|NCT00188539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6389491|NCT00188539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389492|NCT00188552|Tocopherols|tocopherols|mesh-list
6389493|NCT00188552|Vitamin E|vitamin e|mesh-list
6389494|NCT00188552|Tocotrienols|tocotrienols|mesh-list
6389495|NCT00188552|alpha-Tocopherol|alpha-tocopherol|mesh-list
6389496|NCT00188552|Pentoxifylline|pentoxifylline|mesh-list
6389497|NCT00188552|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6389498|NCT00188552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6389499|NCT00188552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389500|NCT00188552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6389501|NCT00188552|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6389502|NCT00188552|Protective Agents|protective agents|mesh-ancestor
6389503|NCT00188552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389504|NCT00188552|Vasodilator Agents|vasodilator agents|mesh-ancestor
6389505|NCT00188552|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6389506|NCT00188552|Antioxidants|antioxidants|mesh-ancestor
6389507|NCT00188552|Vitamins|vitamins|mesh-ancestor
6389508|NCT00188552|Micronutrients|micronutrients|mesh-ancestor
6389509|NCT00188565|Celecoxib|celecoxib|mesh-list
6389510|NCT00188565|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6389511|NCT00188565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6389512|NCT00188565|Analgesics|analgesics|mesh-ancestor
6389513|NCT00188565|Sensory System Agents|sensory system agents|mesh-ancestor
6389514|NCT00188565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6389515|NCT00188565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389516|NCT00188565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6389517|NCT00188565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6389518|NCT00188565|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6389519|NCT00188565|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6389520|NCT00188565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6389521|NCT00188565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389522|NCT00188604|Selenious Acid|selenious acid|mesh-list
6389523|NCT00188604|Sodium Selenite|sodium selenite|mesh-list
6389524|NCT00188604|Trace Elements|trace elements|mesh-ancestor
6389525|NCT00188604|Micronutrients|micronutrients|mesh-ancestor
6389526|NCT00188604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389527|NCT00188617|Gefitinib|gefitinib|mesh-list
6389528|NCT00188617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6389529|NCT00188617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6389530|NCT00188617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6389531|NCT00188617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389532|NCT00188630|Acetylcysteine|acetylcysteine|mesh-list
6389533|NCT00188630|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6389534|NCT00188630|Antiviral Agents|antiviral agents|mesh-ancestor
6389535|NCT00188630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6389536|NCT00188630|Expectorants|expectorants|mesh-ancestor
6389537|NCT00188630|Respiratory System Agents|respiratory system agents|mesh-ancestor
6389538|NCT00188630|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6389539|NCT00188630|Antioxidants|antioxidants|mesh-ancestor
6389540|NCT00188630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389541|NCT00188630|Protective Agents|protective agents|mesh-ancestor
6389542|NCT00188630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389543|NCT00188630|Antidotes|antidotes|mesh-ancestor
6389544|NCT00188643|Lamotrigine|lamotrigine|mesh-list
6389545|NCT00188643|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6389546|NCT00188643|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6389547|NCT00188643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6389548|NCT00188643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6389549|NCT00188643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389550|NCT00188643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6389551|NCT00188643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389552|NCT00188643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6389553|NCT00188643|Antidepressive Agents|antidepressive agents|mesh-ancestor
6389554|NCT00188643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6389555|NCT00188643|Anticonvulsants|anticonvulsants|mesh-ancestor
6389556|NCT00188643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6389557|NCT00188643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6389558|NCT00188643|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6389559|NCT00188643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6389560|NCT00188643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6389561|NCT00188643|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6389562|NCT00188669|Tocopherols|tocopherols|mesh-list
6389563|NCT00188669|Vitamin E|vitamin e|mesh-list
6389564|NCT00188669|Tocotrienols|tocotrienols|mesh-list
6389565|NCT00188669|alpha-Tocopherol|alpha-tocopherol|mesh-list
6389566|NCT00188669|Pentoxifylline|pentoxifylline|mesh-list
6389567|NCT00188669|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6389568|NCT00188669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6389569|NCT00188669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389570|NCT00188669|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6389571|NCT00188669|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6389572|NCT00188669|Protective Agents|protective agents|mesh-ancestor
6389573|NCT00188669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389574|NCT00188669|Vasodilator Agents|vasodilator agents|mesh-ancestor
6389575|NCT00188669|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6389576|NCT00188669|Antioxidants|antioxidants|mesh-ancestor
6389577|NCT00188669|Vitamins|vitamins|mesh-ancestor
6389578|NCT00188669|Micronutrients|micronutrients|mesh-ancestor
6389579|NCT00188773|Acetylcysteine|acetylcysteine|mesh-list
6389580|NCT00188773|Heparin|heparin|mesh-list
6389581|NCT00188773|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6389582|NCT00188773|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6389583|NCT00188773|Anticoagulants|anticoagulants|mesh-ancestor
6389584|NCT00188773|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6389585|NCT00188773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6389586|NCT00188773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389587|NCT00188773|Antiviral Agents|antiviral agents|mesh-ancestor
6389588|NCT00188773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6389589|NCT00188773|Expectorants|expectorants|mesh-ancestor
6389590|NCT00188773|Respiratory System Agents|respiratory system agents|mesh-ancestor
6389591|NCT00188773|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6389592|NCT00188773|Antioxidants|antioxidants|mesh-ancestor
6389593|NCT00188773|Protective Agents|protective agents|mesh-ancestor
6389594|NCT00188773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389595|NCT00188773|Antidotes|antidotes|mesh-ancestor
6389596|NCT00188773|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6389597|NCT00188773|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6389598|NCT00188773|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6389599|NCT00188812|Donepezil|donepezil|mesh-list
6389600|NCT00188812|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6389601|NCT00188812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6389602|NCT00188812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389603|NCT00188812|Cholinergic Agents|cholinergic agents|mesh-ancestor
6389604|NCT00188812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6389605|NCT00188812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389606|NCT00188812|Nootropic Agents|nootropic agents|mesh-ancestor
6389607|NCT00188825|Basiliximab|basiliximab|mesh-list
6389608|NCT00188825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6389609|NCT00188825|Immunologic Factors|immunologic factors|mesh-ancestor
6389610|NCT00188825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389611|NCT00188864|Dexamethasone|dexamethasone|mesh-list
6389612|NCT00188864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6389613|NCT00188864|Antiemetics|antiemetics|mesh-ancestor
6389614|NCT00188864|Autonomic Agents|autonomic agents|mesh-ancestor
6389615|NCT00188864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6389616|NCT00188864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389617|NCT00188864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6389618|NCT00188864|Glucocorticoids|glucocorticoids|mesh-ancestor
6389619|NCT00188864|Hormones|hormones|mesh-ancestor
6389620|NCT00188864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6389621|NCT00188864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6389622|NCT00188864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6389623|NCT00188877|Fluorouracil|fluorouracil|mesh-list
6389624|NCT00188877|Antimetabolites|antimetabolites|mesh-ancestor
6389625|NCT00188877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389626|NCT00188877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6389627|NCT00188877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6389628|NCT00188877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6389629|NCT00188877|Immunologic Factors|immunologic factors|mesh-ancestor
6389630|NCT00188877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389631|NCT00188929|Deoxyglucose|deoxyglucose|mesh-list
6389632|NCT00188929|Antimetabolites|antimetabolites|mesh-ancestor
6389633|NCT00188929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389634|NCT00188929|Antiviral Agents|antiviral agents|mesh-ancestor
6389635|NCT00188929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6389636|NCT00188942|Olanzapine|olanzapine|mesh-list
6389637|NCT00188942|Fluoxetine|fluoxetine|mesh-list
6389638|NCT00188942|Antiemetics|antiemetics|mesh-ancestor
6389639|NCT00188942|Autonomic Agents|autonomic agents|mesh-ancestor
6389640|NCT00188942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6389641|NCT00188942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389642|NCT00188942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6389643|NCT00188942|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6389644|NCT00188942|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6389645|NCT00188942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6389646|NCT00188942|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6389647|NCT00188942|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6389648|NCT00188942|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6389649|NCT00188942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6389650|NCT00188942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389651|NCT00188942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6389652|NCT00188942|Serotonin Agents|serotonin agents|mesh-ancestor
6389653|NCT00188942|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6389654|NCT00188942|Antidepressive Agents|antidepressive agents|mesh-ancestor
6389655|NCT00188942|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6389656|NCT00188942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6389657|NCT00188942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6389658|NCT00188955|Sirolimus|sirolimus|mesh-list
6389659|NCT00188955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6389660|NCT00188955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6389661|NCT00188955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6389662|NCT00188955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6389663|NCT00188955|Antifungal Agents|antifungal agents|mesh-ancestor
6389664|NCT00188955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6389665|NCT00188955|Immunologic Factors|immunologic factors|mesh-ancestor
6389666|NCT00188955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389667|NCT00188994|Insulin|insulin|mesh-list
6389668|NCT00188994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6389669|NCT00188994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389670|NCT00189007|Allopurinol|allopurinol|mesh-list
6389671|NCT00189007|Mannitol|mannitol|mesh-list
6389672|NCT00189007|Antimetabolites|antimetabolites|mesh-ancestor
6389673|NCT00189007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389674|NCT00189007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6389675|NCT00189007|Gout Suppressants|gout suppressants|mesh-ancestor
6389676|NCT00189007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6389677|NCT00189007|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6389678|NCT00189007|Antioxidants|antioxidants|mesh-ancestor
6389679|NCT00189007|Protective Agents|protective agents|mesh-ancestor
6389680|NCT00189007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389681|NCT00189007|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6389682|NCT00189007|Diuretics|diuretics|mesh-ancestor
6389683|NCT00189007|Natriuretic Agents|natriuretic agents|mesh-ancestor
6389684|NCT00189020|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6389685|NCT00189020|Immunologic Factors|immunologic factors|mesh-ancestor
6389686|NCT00189020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389687|NCT00189033|Psyllium|psyllium|mesh-list
6389688|NCT00189033|Cathartics|cathartics|mesh-ancestor
6389689|NCT00189033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6389690|NCT00189059|Amitriptyline|amitriptyline|mesh-list
6389691|NCT00189059|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6389692|NCT00189059|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6389693|NCT00189059|Antidepressive Agents|antidepressive agents|mesh-ancestor
6389694|NCT00189059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6389695|NCT00189059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6389696|NCT00189059|Analgesics|analgesics|mesh-ancestor
6389697|NCT00189059|Sensory System Agents|sensory system agents|mesh-ancestor
6389698|NCT00189059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6389699|NCT00189059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389700|NCT00189059|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6389701|NCT00189059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6389702|NCT00189059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6389703|NCT00189059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389704|NCT00189059|Adrenergic Agents|adrenergic agents|mesh-ancestor
6389705|NCT00189059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6389706|NCT00189059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6389707|NCT00189059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6389708|NCT00189059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6389709|NCT00189072|Gabapentin|gabapentin|mesh-list
6389710|NCT00189072|Analgesics|analgesics|mesh-ancestor
6389711|NCT00189072|Sensory System Agents|sensory system agents|mesh-ancestor
6389712|NCT00189072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6389713|NCT00189072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389714|NCT00189072|Anticonvulsants|anticonvulsants|mesh-ancestor
6389715|NCT00189072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6389716|NCT00189072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6389717|NCT00189072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6389718|NCT00189072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6389719|NCT00189072|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6389720|NCT00189072|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6389721|NCT00189072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6389722|NCT00189072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389723|NCT00189072|Antimanic Agents|antimanic agents|mesh-ancestor
6389724|NCT00189085|Simvastatin|simvastatin|mesh-list
6389725|NCT00189085|Ezetimibe|ezetimibe|mesh-list
6389726|NCT00189085|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
6389727|NCT00189085|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6389728|NCT00189085|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6389729|NCT00189085|Antimetabolites|antimetabolites|mesh-ancestor
6389730|NCT00189085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389731|NCT00189085|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6396828|NCT00209742|Immunologic Factors|immunologic factors|mesh-ancestor
6389732|NCT00189085|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6389733|NCT00189085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6389734|NCT00189124|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
6389735|NCT00189124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6389736|NCT00189124|Immunologic Factors|immunologic factors|mesh-ancestor
6389737|NCT00189124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389738|NCT00189150|Mycophenolic Acid|mycophenolic acid|mesh-list
6389739|NCT00189150|Valganciclovir|valganciclovir|mesh-list
6389740|NCT00189150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6389741|NCT00189150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6389742|NCT00189150|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6389743|NCT00189150|Antitubercular Agents|antitubercular agents|mesh-ancestor
6389744|NCT00189150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6389745|NCT00189150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6389746|NCT00189150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6389747|NCT00189150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389748|NCT00189150|Antiviral Agents|antiviral agents|mesh-ancestor
6389749|NCT00189163|Pioglitazone|pioglitazone|mesh-list
6389750|NCT00189163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6389751|NCT00189163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389752|NCT00189176|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
6389753|NCT00189176|Chelating Agents|chelating agents|mesh-ancestor
6389754|NCT00189176|Sequestering Agents|sequestering agents|mesh-ancestor
6389755|NCT00189176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389756|NCT00189176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6389757|NCT00189176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6389758|NCT00189176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6389759|NCT00189176|Growth Substances|growth substances|mesh-ancestor
6389760|NCT00189176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389761|NCT00189176|Growth Inhibitors|growth inhibitors|mesh-ancestor
6389762|NCT00189176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6389763|NCT00189345|Catumaxomab|catumaxomab|mesh-list
6389764|NCT00189345|Muromonab-CD3|muromonab-cd3|mesh-list
6389765|NCT00189345|Immunologic Factors|immunologic factors|mesh-ancestor
6389766|NCT00189345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389767|NCT00189345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6389768|NCT00189345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6389769|NCT00189358|Tamoxifen|tamoxifen|mesh-list
6389770|NCT00189358|Gefitinib|gefitinib|mesh-list
6389771|NCT00189358|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6017656|NCT00374244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6017657|NCT00374244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6017658|NCT00374244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6017659|NCT00374244|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6017660|NCT00374244|Dopamine Agents|dopamine agents|mesh-ancestor
6017661|NCT00374244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6017662|NCT00374244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389772|NCT00189358|Hormone Antagonists|hormone antagonists|mesh-ancestor
6389773|NCT00189358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6389774|NCT00189358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389775|NCT00189358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6389776|NCT00189358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6389777|NCT00189358|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6389778|NCT00189358|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6389779|NCT00189358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6389780|NCT00189358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6389781|NCT00189358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6389782|NCT00189358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389783|NCT00189371|Paclitaxel|paclitaxel|mesh-list
6389784|NCT00189371|Carboplatin|carboplatin|mesh-list
6389785|NCT00189371|Epoetin Alfa|epoetin alfa|mesh-list
6389786|NCT00189371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6389787|NCT00189371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6389788|NCT00189371|Tubulin Modulators|tubulin modulators|mesh-ancestor
6389789|NCT00189371|Antimitotic Agents|antimitotic agents|mesh-ancestor
6389790|NCT00189371|Mitosis Modulators|mitosis modulators|mesh-ancestor
6389791|NCT00189371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389792|NCT00189371|Hematinics|hematinics|mesh-ancestor
6389793|NCT00189384|Gentamicins|gentamicins|mesh-list
6389794|NCT00189384|Ceftriaxone|ceftriaxone|mesh-list
6389795|NCT00189384|Penicillins|penicillins|mesh-list
6389796|NCT00189384|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6389797|NCT00189384|Penicillin G Procaine|penicillin g procaine|mesh-list
6389798|NCT00189384|Penicillin G|penicillin g|mesh-list
6389799|NCT00189384|Penicillin G Benzathine|penicillin g benzathine|mesh-list
6389800|NCT00189384|Procaine|procaine|mesh-list
6389801|NCT00189384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6389802|NCT00189384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6389803|NCT00189384|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6389804|NCT00189384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6389805|NCT00189384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389806|NCT00189384|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6389807|NCT00189384|Renal Agents|renal agents|mesh-ancestor
6389808|NCT00189384|Antimalarials|antimalarials|mesh-ancestor
6389809|NCT00189384|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6389810|NCT00189384|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6389811|NCT00189384|Anesthetics, Local|anesthetics, local|mesh-ancestor
6389812|NCT00189384|Anesthetics|anesthetics|mesh-ancestor
6389813|NCT00189384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6017663|NCT00374244|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6017664|NCT00374322|Lapatinib|lapatinib|mesh-list
6017665|NCT00374322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6017666|NCT00374322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6017667|NCT00374322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6017668|NCT00374322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6017669|NCT00374556|Eszopiclone|eszopiclone|mesh-list
6389814|NCT00189384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6389815|NCT00189384|Sensory System Agents|sensory system agents|mesh-ancestor
6389816|NCT00189384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6389817|NCT00189397|Azathioprine|azathioprine|mesh-list
6389818|NCT00189397|Antimetabolites|antimetabolites|mesh-ancestor
6389819|NCT00189397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6389820|NCT00189397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6389821|NCT00189397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6389822|NCT00189397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6389823|NCT00189397|Immunologic Factors|immunologic factors|mesh-ancestor
6397120|NCT00210314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6397121|NCT00210314|Antiviral Agents|antiviral agents|mesh-ancestor
6397122|NCT00210314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6397123|NCT00210327|Bortezomib|bortezomib|mesh-list
6397124|NCT00210327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6397125|NCT00210340|Rituximab|rituximab|mesh-list
6397126|NCT00210340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6397127|NCT00210340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6397128|NCT00210340|Immunologic Factors|immunologic factors|mesh-ancestor
6397129|NCT00210340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397130|NCT00210340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6397131|NCT00210366|Idarubicin|idarubicin|mesh-list
6397132|NCT00210366|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6397133|NCT00210366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6397134|NCT00210366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6397135|NCT00210366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6397136|NCT00210366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6397137|NCT00210366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397138|NCT00210379|Rituximab|rituximab|mesh-list
6397139|NCT00210379|Methotrexate|methotrexate|mesh-list
6397140|NCT00210379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6397141|NCT00210379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6397142|NCT00210379|Immunologic Factors|immunologic factors|mesh-ancestor
6397143|NCT00210379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397144|NCT00210379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6397145|NCT00210379|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6397146|NCT00210379|Abortifacient Agents|abortifacient agents|mesh-ancestor
6397147|NCT00210379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6397148|NCT00210379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6397149|NCT00210379|Antimetabolites|antimetabolites|mesh-ancestor
6397150|NCT00210379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397151|NCT00210379|Dermatologic Agents|dermatologic agents|mesh-ancestor
6397152|NCT00210379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6397153|NCT00210379|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6397154|NCT00210379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6397155|NCT00210379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6397156|NCT00210392|Bortezomib|bortezomib|mesh-list
6397157|NCT00210392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6397158|NCT00210405|Micronutrients|micronutrients|mesh-list
6397159|NCT00210405|Trace Elements|trace elements|mesh-list
6397160|NCT00210405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397161|NCT00210444|Botulinum Toxins|botulinum toxins|mesh-list
6397162|NCT00210444|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6397163|NCT00210444|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6397164|NCT00210444|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6397165|NCT00210444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6397166|NCT00210444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397167|NCT00210444|Cholinergic Agents|cholinergic agents|mesh-ancestor
6397168|NCT00210444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6397169|NCT00210444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397170|NCT00210444|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6397171|NCT00210444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6397172|NCT00210457|Lanreotide|lanreotide|mesh-list
6397173|NCT00210457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6397174|NCT00210483|Almotriptan|almotriptan|mesh-list
6397175|NCT00210483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6397176|NCT00210483|Serotonin Agents|serotonin agents|mesh-ancestor
6397177|NCT00210483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6397178|NCT00210483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397179|NCT00210483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397180|NCT00210496|Topiramate|topiramate|mesh-list
6397181|NCT00210496|Almotriptan|almotriptan|mesh-list
6397182|NCT00210496|Anticonvulsants|anticonvulsants|mesh-ancestor
6397183|NCT00210496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6397184|NCT00210496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397185|NCT00210496|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6397186|NCT00210496|Serotonin Agents|serotonin agents|mesh-ancestor
6397187|NCT00210496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6397188|NCT00210496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397189|NCT00210509|Almotriptan|almotriptan|mesh-list
6397190|NCT00210509|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6397191|NCT00210509|Serotonin Agents|serotonin agents|mesh-ancestor
6397192|NCT00210509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6397193|NCT00210509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397194|NCT00210509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397195|NCT00210535|Topiramate|topiramate|mesh-list
6397196|NCT00210535|Anticonvulsants|anticonvulsants|mesh-ancestor
6397197|NCT00210535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6397198|NCT00210535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397199|NCT00210548|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6397200|NCT00210548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6397201|NCT00210548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6397202|NCT00210548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6397203|NCT00210548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397204|NCT00210548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6397205|NCT00210548|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6397206|NCT00210548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6397207|NCT00210548|Serotonin Agents|serotonin agents|mesh-ancestor
6397208|NCT00210548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6397209|NCT00210548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397210|NCT00210548|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6397211|NCT00210548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6397212|NCT00210548|Dopamine Agents|dopamine agents|mesh-ancestor
6397213|NCT00210561|Acetaminophen|acetaminophen|mesh-list
6397214|NCT00210561|Tramadol|tramadol|mesh-list
6397215|NCT00210561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6397216|NCT00210561|Analgesics|analgesics|mesh-ancestor
6397217|NCT00210561|Sensory System Agents|sensory system agents|mesh-ancestor
6397218|NCT00210561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6397219|NCT00210561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397220|NCT00210561|Antipyretics|antipyretics|mesh-ancestor
6397221|NCT00210561|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6397222|NCT00210561|Narcotics|narcotics|mesh-ancestor
6397223|NCT00210561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6397224|NCT00210574|Topiramate|topiramate|mesh-list
6397225|NCT00210574|Anticonvulsants|anticonvulsants|mesh-ancestor
6397226|NCT00210574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6397227|NCT00210574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397228|NCT00210587|Epoetin Alfa|epoetin alfa|mesh-list
6397229|NCT00210587|Hematinics|hematinics|mesh-ancestor
6397230|NCT00210600|Epoetin Alfa|epoetin alfa|mesh-list
6397231|NCT00210600|Hematinics|hematinics|mesh-ancestor
6397232|NCT00210665|Trabectedin|trabectedin|mesh-list
6397233|NCT00210665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6397234|NCT00210665|Alkylating Agents|alkylating agents|mesh-ancestor
6397235|NCT00210665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397236|NCT00210665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6397237|NCT00210691|Risperidone|risperidone|mesh-list
6397238|NCT00210691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6397239|NCT00210691|Serotonin Agents|serotonin agents|mesh-ancestor
6397240|NCT00210691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6397241|NCT00210691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397242|NCT00210691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397243|NCT00210691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6397244|NCT00210691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6397245|NCT00210691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6397246|NCT00210691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6397247|NCT00210691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6397248|NCT00210691|Dopamine Agents|dopamine agents|mesh-ancestor
6397249|NCT00210717|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6397250|NCT00210717|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6397251|NCT00210717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6397252|NCT00210717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6397253|NCT00210717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397254|NCT00210717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6397255|NCT00210717|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6397256|NCT00210717|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6397257|NCT00210717|Serotonin Agents|serotonin agents|mesh-ancestor
6397258|NCT00210717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6397259|NCT00210717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397260|NCT00210717|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6397261|NCT00210717|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6397262|NCT00210717|Dopamine Agents|dopamine agents|mesh-ancestor
6397263|NCT00210730|Epoetin Alfa|epoetin alfa|mesh-list
6397264|NCT00210730|Hematinics|hematinics|mesh-ancestor
6397265|NCT00210743|Epoetin Alfa|epoetin alfa|mesh-list
6397266|NCT00210743|Hematinics|hematinics|mesh-ancestor
6397267|NCT00210756|Epoetin Alfa|epoetin alfa|mesh-list
6397268|NCT00210756|Hematinics|hematinics|mesh-ancestor
6397269|NCT00210769|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6397270|NCT00210769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6397271|NCT00210769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6458829|NCT00442052|Analgesics|analgesics|mesh-ancestor
6397272|NCT00210769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6397273|NCT00210769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397274|NCT00210769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6397275|NCT00210769|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6397276|NCT00210769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6397277|NCT00210769|Serotonin Agents|serotonin agents|mesh-ancestor
6397278|NCT00210769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6397279|NCT00210769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397280|NCT00210769|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6397281|NCT00210769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6397282|NCT00210769|Dopamine Agents|dopamine agents|mesh-ancestor
6397283|NCT00210782|Topiramate|topiramate|mesh-list
6397284|NCT00210782|Phenytoin|phenytoin|mesh-list
6397285|NCT00210782|Anticonvulsants|anticonvulsants|mesh-ancestor
6397286|NCT00210782|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6397287|NCT00210782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397288|NCT00210782|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6397289|NCT00210782|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6397290|NCT00210782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6397291|NCT00210782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397292|NCT00210782|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6397293|NCT00210782|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6397294|NCT00210795|Epoetin Alfa|epoetin alfa|mesh-list
6397295|NCT00210795|Hematinics|hematinics|mesh-ancestor
6397296|NCT00210808|Topiramate|topiramate|mesh-list
6397297|NCT00210808|Anticonvulsants|anticonvulsants|mesh-ancestor
6397298|NCT00210808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6397299|NCT00210808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397300|NCT00210821|Topiramate|topiramate|mesh-list
6397301|NCT00210821|Anticonvulsants|anticonvulsants|mesh-ancestor
6018519|NCT00381550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6018520|NCT00381550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6018521|NCT00381550|Immunologic Factors|immunologic factors|mesh-ancestor
6018522|NCT00381550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018523|NCT00381615|Vaccines|vaccines|mesh-list
6397302|NCT00210821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6397303|NCT00210821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397304|NCT00210834|Epoetin Alfa|epoetin alfa|mesh-list
6397305|NCT00210834|Hematinics|hematinics|mesh-ancestor
6397306|NCT00210847|Acetaminophen|acetaminophen|mesh-list
6397307|NCT00210847|Tramadol|tramadol|mesh-list
6397308|NCT00210847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6397309|NCT00210847|Analgesics|analgesics|mesh-ancestor
6397310|NCT00210847|Sensory System Agents|sensory system agents|mesh-ancestor
6397311|NCT00210847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6397312|NCT00210847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397313|NCT00210847|Antipyretics|antipyretics|mesh-ancestor
6397314|NCT00210847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6397315|NCT00210847|Narcotics|narcotics|mesh-ancestor
6397316|NCT00210847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6397317|NCT00210860|Topiramate|topiramate|mesh-list
6397318|NCT00210860|Anticonvulsants|anticonvulsants|mesh-ancestor
6397319|NCT00210860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6397320|NCT00210860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397321|NCT00210873|Topiramate|topiramate|mesh-list
6397322|NCT00210873|Anticonvulsants|anticonvulsants|mesh-ancestor
6397323|NCT00210873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6397324|NCT00210873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397325|NCT00210886|Levofloxacin|levofloxacin|mesh-list
6397326|NCT00210886|Ofloxacin|ofloxacin|mesh-list
6397327|NCT00210886|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6397328|NCT00210886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6397329|NCT00210886|Renal Agents|renal agents|mesh-ancestor
6397330|NCT00210886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6397331|NCT00210886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6397332|NCT00210886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6397333|NCT00210886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6397334|NCT00210886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397335|NCT00210886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6397336|NCT00210886|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6397337|NCT00210886|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6397338|NCT00210899|Vancomycin|vancomycin|mesh-list
6397339|NCT00210899|Ceftazidime|ceftazidime|mesh-list
6397340|NCT00210899|Ceftobiprole|ceftobiprole|mesh-list
6397341|NCT00210899|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
6397342|NCT00210899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6397343|NCT00210899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6397344|NCT00210912|Topiramate|topiramate|mesh-list
6397345|NCT00210912|Anticonvulsants|anticonvulsants|mesh-ancestor
6397346|NCT00210912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6397347|NCT00210912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397348|NCT00210925|Topiramate|topiramate|mesh-list
6397349|NCT00210925|Anticonvulsants|anticonvulsants|mesh-ancestor
6397350|NCT00210925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6397351|NCT00210925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397352|NCT00210938|Doripenem|doripenem|mesh-list
6397353|NCT00210938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6397354|NCT00210938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6397355|NCT00210990|Doripenem|doripenem|mesh-list
6397356|NCT00210990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6397357|NCT00210990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6397358|NCT00211003|Doripenem|doripenem|mesh-list
6397359|NCT00211003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6397360|NCT00211003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6397361|NCT00211016|Doripenem|doripenem|mesh-list
6397362|NCT00211016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6397363|NCT00211016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6397364|NCT00211120|Epoetin Alfa|epoetin alfa|mesh-list
6397365|NCT00211120|Hematinics|hematinics|mesh-ancestor
6397366|NCT00211133|Epoetin Alfa|epoetin alfa|mesh-list
6397367|NCT00211133|Hematinics|hematinics|mesh-ancestor
6397368|NCT00211146|Epoetin Alfa|epoetin alfa|mesh-list
6397369|NCT00211146|Hematinics|hematinics|mesh-ancestor
6397370|NCT00211198|Denileukin diftitox|denileukin diftitox|mesh-list
6397371|NCT00211198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6397372|NCT00211224|Riluzole|riluzole|mesh-list
6397373|NCT00211224|Anticonvulsants|anticonvulsants|mesh-ancestor
6397374|NCT00211224|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6397375|NCT00211224|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6397376|NCT00211224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6397377|NCT00211224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397378|NCT00211224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397379|NCT00211224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6397380|NCT00211224|Protective Agents|protective agents|mesh-ancestor
6397381|NCT00211250|Valproic Acid|valproic acid|mesh-list
6397382|NCT00211250|Anticonvulsants|anticonvulsants|mesh-ancestor
6397383|NCT00211250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6397384|NCT00211250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397385|NCT00211250|GABA Agents|gaba agents|mesh-ancestor
6397386|NCT00211250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6397387|NCT00211250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397388|NCT00211250|Antimanic Agents|antimanic agents|mesh-ancestor
6397389|NCT00211250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6397390|NCT00211250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6397391|NCT00211250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6397392|NCT00211276|Denileukin diftitox|denileukin diftitox|mesh-list
6397393|NCT00211276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6397394|NCT00211302|Aripiprazole|aripiprazole|mesh-list
6397395|NCT00211302|Antidepressive Agents|antidepressive agents|mesh-ancestor
6397396|NCT00211302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6397397|NCT00211302|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6397398|NCT00211302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6397399|NCT00211302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6397400|NCT00211302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397401|NCT00211302|Dopamine Agonists|dopamine agonists|mesh-ancestor
6397402|NCT00211302|Dopamine Agents|dopamine agents|mesh-ancestor
6397403|NCT00211302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6397404|NCT00211302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397405|NCT00211302|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6397406|NCT00211302|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6397407|NCT00211302|Serotonin Agents|serotonin agents|mesh-ancestor
6397408|NCT00211302|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6397409|NCT00211302|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6397410|NCT00211302|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6397411|NCT00211302|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6397412|NCT00211315|Anecortave|anecortave|mesh-list
6397413|NCT00211315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6397414|NCT00211315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6397415|NCT00211315|Growth Substances|growth substances|mesh-ancestor
6397416|NCT00211315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397417|NCT00211315|Growth Inhibitors|growth inhibitors|mesh-ancestor
6397418|NCT00211315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6397419|NCT00211328|Anecortave|anecortave|mesh-list
6397420|NCT00211328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6397421|NCT00211328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6397422|NCT00211328|Growth Substances|growth substances|mesh-ancestor
6397423|NCT00211328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397424|NCT00211328|Growth Inhibitors|growth inhibitors|mesh-ancestor
6397425|NCT00211328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6397426|NCT00211341|Vitamin A|vitamin a|mesh-list
6397427|NCT00211341|Vitamins|vitamins|mesh-ancestor
6397428|NCT00211341|Micronutrients|micronutrients|mesh-ancestor
6397429|NCT00211341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397430|NCT00211354|Anecortave|anecortave|mesh-list
6397431|NCT00211354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6397432|NCT00211354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6397433|NCT00211354|Growth Substances|growth substances|mesh-ancestor
6397434|NCT00211354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397435|NCT00211354|Growth Inhibitors|growth inhibitors|mesh-ancestor
6397436|NCT00211354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6397437|NCT00211367|Anecortave|anecortave|mesh-list
6397438|NCT00211367|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6397439|NCT00211367|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6397440|NCT00211367|Growth Substances|growth substances|mesh-ancestor
6397441|NCT00211367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397442|NCT00211367|Growth Inhibitors|growth inhibitors|mesh-ancestor
6397443|NCT00211367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6397444|NCT00211380|Aripiprazole|aripiprazole|mesh-list
6397445|NCT00211380|Antidepressive Agents|antidepressive agents|mesh-ancestor
6397446|NCT00211380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6397447|NCT00211380|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6397448|NCT00211380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6397449|NCT00211380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6397450|NCT00211380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397451|NCT00211380|Dopamine Agonists|dopamine agonists|mesh-ancestor
6397452|NCT00211380|Dopamine Agents|dopamine agents|mesh-ancestor
6397453|NCT00211380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6397454|NCT00211380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397455|NCT00211380|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6462001|NCT00457054|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6397456|NCT00211380|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6397457|NCT00211380|Serotonin Agents|serotonin agents|mesh-ancestor
6397458|NCT00211380|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6397459|NCT00211380|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6397460|NCT00211380|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6397461|NCT00211380|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6397462|NCT00211393|Ketoconazole|ketoconazole|mesh-list
6397463|NCT00211393|Antifungal Agents|antifungal agents|mesh-ancestor
6397464|NCT00211393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6397465|NCT00211393|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6397466|NCT00211393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6397467|NCT00211393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6397468|NCT00211393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397469|NCT00211393|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6397470|NCT00211393|Hormone Antagonists|hormone antagonists|mesh-ancestor
6397471|NCT00211393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6397472|NCT00211393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397473|NCT00211393|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6397474|NCT00211406|Anecortave|anecortave|mesh-list
6397475|NCT00211406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6397476|NCT00211406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6397477|NCT00211406|Growth Substances|growth substances|mesh-ancestor
6397478|NCT00211406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397479|NCT00211406|Growth Inhibitors|growth inhibitors|mesh-ancestor
6397480|NCT00211406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6397481|NCT00211419|Triamcinolone|triamcinolone|mesh-list
6397482|NCT00211419|Anecortave|anecortave|mesh-list
6397483|NCT00211419|Verteporfin|verteporfin|mesh-list
6397484|NCT00211419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6397485|NCT00211419|Glucocorticoids|glucocorticoids|mesh-ancestor
6538115|NCT00825864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6538116|NCT00825864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6538117|NCT00825864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6538118|NCT00825864|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6538119|NCT00825864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6397486|NCT00211419|Hormones|hormones|mesh-ancestor
6397487|NCT00211419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6397488|NCT00211419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397489|NCT00211419|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6397490|NCT00211419|Dermatologic Agents|dermatologic agents|mesh-ancestor
6397491|NCT00211419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6397492|NCT00211419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6397493|NCT00211419|Growth Substances|growth substances|mesh-ancestor
6397494|NCT00211419|Growth Inhibitors|growth inhibitors|mesh-ancestor
6397495|NCT00211419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6397496|NCT00211432|Anecortave|anecortave|mesh-list
6397497|NCT00211432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6397498|NCT00211432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6397499|NCT00211432|Growth Substances|growth substances|mesh-ancestor
6397500|NCT00211432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397501|NCT00211432|Growth Inhibitors|growth inhibitors|mesh-ancestor
6397502|NCT00211432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6397503|NCT00211445|Verteporfin|verteporfin|mesh-list
6397504|NCT00211445|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6397505|NCT00211445|Dermatologic Agents|dermatologic agents|mesh-ancestor
6397506|NCT00211458|Anecortave|anecortave|mesh-list
6397507|NCT00211458|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6397508|NCT00211458|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6397509|NCT00211458|Growth Substances|growth substances|mesh-ancestor
6397510|NCT00211458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397511|NCT00211458|Growth Inhibitors|growth inhibitors|mesh-ancestor
6397512|NCT00211458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6397513|NCT00211471|Anecortave|anecortave|mesh-list
6397514|NCT00211471|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6397515|NCT00211471|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6397516|NCT00211471|Growth Substances|growth substances|mesh-ancestor
6397517|NCT00211471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397518|NCT00211471|Growth Inhibitors|growth inhibitors|mesh-ancestor
6462002|NCT00457054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6397519|NCT00211471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6397520|NCT00211484|Anecortave|anecortave|mesh-list
6397521|NCT00211484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6397522|NCT00211484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6397523|NCT00211484|Growth Substances|growth substances|mesh-ancestor
6397524|NCT00211484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397525|NCT00211484|Growth Inhibitors|growth inhibitors|mesh-ancestor
6397526|NCT00211484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6458830|NCT00442052|Sensory System Agents|sensory system agents|mesh-ancestor
6458831|NCT00442052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6458832|NCT00442052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458833|NCT00442052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6458834|NCT00442052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6458835|NCT00442052|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6458836|NCT00442052|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6458837|NCT00442052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458838|NCT00442052|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6458839|NCT00442052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6458840|NCT00442052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6458841|NCT00442052|Antipyretics|antipyretics|mesh-ancestor
6458842|NCT00442052|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6458843|NCT00442052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6458844|NCT00442052|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6458845|NCT00442182|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
6458846|NCT00442182|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6458847|NCT00442182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6458848|NCT00442182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458849|NCT00442221|Naproxen|naproxen|mesh-list
6458850|NCT00442221|Sumatriptan|sumatriptan|mesh-list
6458851|NCT00442221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6458852|NCT00442221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6458853|NCT00442221|Analgesics|analgesics|mesh-ancestor
6458854|NCT00442221|Sensory System Agents|sensory system agents|mesh-ancestor
6458855|NCT00442221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6458856|NCT00442221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458857|NCT00442221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6458858|NCT00442221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6458859|NCT00442221|Gout Suppressants|gout suppressants|mesh-ancestor
6458860|NCT00442221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6458861|NCT00442221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6458862|NCT00442221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458863|NCT00442221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6458864|NCT00442221|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6458865|NCT00442221|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6458866|NCT00442221|Serotonin Agents|serotonin agents|mesh-ancestor
6458867|NCT00442221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6458868|NCT00442234|Monteplase|monteplase|mesh-list
6458869|NCT00442234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6458870|NCT00442234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6458871|NCT00442234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458872|NCT00442273|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6458873|NCT00442273|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6458874|NCT00442312|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
6458875|NCT00442312|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6458876|NCT00442312|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6458877|NCT00442312|Adrenergic Agents|adrenergic agents|mesh-ancestor
6458878|NCT00442312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6458879|NCT00442312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458880|NCT00442312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458881|NCT00442312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6458882|NCT00442312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6458883|NCT00442312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6397527|NCT00211497|Omiganan pentahydrochloride|omiganan pentahydrochloride|mesh-list
6397528|NCT00211497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6397529|NCT00211523|Omiganan pentahydrochloride|omiganan pentahydrochloride|mesh-list
6397530|NCT00211523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6397531|NCT00211562|Vitamin E|vitamin e|mesh-list
6397532|NCT00211562|Olanzapine|olanzapine|mesh-list
6397533|NCT00211562|Vitamins|vitamins|mesh-ancestor
6397534|NCT00211562|Micronutrients|micronutrients|mesh-ancestor
6397535|NCT00211562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397536|NCT00211562|Antiemetics|antiemetics|mesh-ancestor
6397537|NCT00211562|Autonomic Agents|autonomic agents|mesh-ancestor
6397538|NCT00211562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6397539|NCT00211562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6397540|NCT00211562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6397541|NCT00211562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6397542|NCT00211562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6397543|NCT00211562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6397544|NCT00211562|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6397545|NCT00211562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6397546|NCT00211562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6397547|NCT00211562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397548|NCT00211562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6397549|NCT00211562|Serotonin Agents|serotonin agents|mesh-ancestor
6397550|NCT00211562|Antioxidants|antioxidants|mesh-ancestor
6397551|NCT00211562|Protective Agents|protective agents|mesh-ancestor
6397552|NCT00211588|Galantamine|galantamine|mesh-list
6397553|NCT00211588|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6397554|NCT00211588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6397555|NCT00211588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397556|NCT00211588|Cholinergic Agents|cholinergic agents|mesh-ancestor
6397557|NCT00211588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6397558|NCT00211588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397559|NCT00211588|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6397560|NCT00211588|Autonomic Agents|autonomic agents|mesh-ancestor
6397561|NCT00211588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6397562|NCT00211588|Nootropic Agents|nootropic agents|mesh-ancestor
6397563|NCT00211614|Lansoprazole|lansoprazole|mesh-list
6397564|NCT00211614|Dexlansoprazole|dexlansoprazole|mesh-list
6397565|NCT00211614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6397566|NCT00211614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6397567|NCT00211614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6397568|NCT00211614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6397569|NCT00211614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397570|NCT00211653|Acetylcysteine|acetylcysteine|mesh-list
6397571|NCT00211653|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6397572|NCT00211653|Antiviral Agents|antiviral agents|mesh-ancestor
6397573|NCT00211653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6397574|NCT00211653|Expectorants|expectorants|mesh-ancestor
6397575|NCT00211653|Respiratory System Agents|respiratory system agents|mesh-ancestor
6397576|NCT00211653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6397577|NCT00211653|Antioxidants|antioxidants|mesh-ancestor
6397578|NCT00211653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397579|NCT00211653|Protective Agents|protective agents|mesh-ancestor
6397580|NCT00211653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397581|NCT00211653|Antidotes|antidotes|mesh-ancestor
6397582|NCT00211679|Botulinum Toxins|botulinum toxins|mesh-list
6397583|NCT00211679|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6397584|NCT00211679|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6397585|NCT00211679|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6397586|NCT00211679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6397587|NCT00211679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397588|NCT00211679|Cholinergic Agents|cholinergic agents|mesh-ancestor
6397589|NCT00211679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6397590|NCT00211679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397591|NCT00211679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6397592|NCT00211679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6397593|NCT00211705|Pravastatin|pravastatin|mesh-list
6397594|NCT00211705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6397595|NCT00211705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6397596|NCT00211705|Antimetabolites|antimetabolites|mesh-ancestor
6397597|NCT00211705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397598|NCT00211705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6397599|NCT00211705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6397600|NCT00211705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6397601|NCT00211718|Botulinum Toxins|botulinum toxins|mesh-list
6397602|NCT00211718|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6397603|NCT00211718|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6397604|NCT00211718|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6397605|NCT00211718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6397606|NCT00211718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397607|NCT00211718|Cholinergic Agents|cholinergic agents|mesh-ancestor
6397608|NCT00211718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6397609|NCT00211718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397610|NCT00211718|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6397611|NCT00211718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6397612|NCT00211744|Topiramate|topiramate|mesh-list
6397613|NCT00211744|Anticonvulsants|anticonvulsants|mesh-ancestor
6397614|NCT00211744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6397615|NCT00211744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397616|NCT00211796|Valproic Acid|valproic acid|mesh-list
6397617|NCT00211796|Anticonvulsants|anticonvulsants|mesh-ancestor
6397618|NCT00211796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6397619|NCT00211796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397620|NCT00211796|GABA Agents|gaba agents|mesh-ancestor
6397621|NCT00211796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6397622|NCT00211796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397623|NCT00211796|Antimanic Agents|antimanic agents|mesh-ancestor
6397624|NCT00211796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6397625|NCT00211796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6397626|NCT00211796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6397627|NCT00211848|Interferons|interferons|mesh-list
6397628|NCT00211848|Ribavirin|ribavirin|mesh-list
6397629|NCT00211848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6397630|NCT00211848|Antiviral Agents|antiviral agents|mesh-ancestor
6397631|NCT00211848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6397632|NCT00211848|Antimetabolites|antimetabolites|mesh-ancestor
6397633|NCT00211848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397634|NCT00211939|Atorvastatin|atorvastatin|mesh-list
6397635|NCT00211939|Calcium|calcium|mesh-list
6397636|NCT00211939|Sevelamer|sevelamer|mesh-list
6397637|NCT00211939|Calcium acetate|calcium acetate|mesh-list
6397638|NCT00211939|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6397639|NCT00211939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397640|NCT00211939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6397641|NCT00211939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6397642|NCT00211939|Antimetabolites|antimetabolites|mesh-ancestor
6397643|NCT00211939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397644|NCT00211939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6397645|NCT00211939|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6397646|NCT00211939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6397647|NCT00211939|Chelating Agents|chelating agents|mesh-ancestor
6397648|NCT00211939|Sequestering Agents|sequestering agents|mesh-ancestor
6397649|NCT00211952|Celecoxib|celecoxib|mesh-list
6397650|NCT00211952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6397651|NCT00211952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6397652|NCT00211952|Analgesics|analgesics|mesh-ancestor
6397653|NCT00211952|Sensory System Agents|sensory system agents|mesh-ancestor
6397654|NCT00211952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6397655|NCT00211952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397656|NCT00211952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6397657|NCT00211952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6397658|NCT00211952|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6397659|NCT00211952|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6397660|NCT00211952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6397661|NCT00211952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397662|NCT00211978|Calcium|calcium|mesh-list
6397663|NCT00211978|Calcium acetate|calcium acetate|mesh-list
6397664|NCT00211978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6397665|NCT00211978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397666|NCT00211978|Chelating Agents|chelating agents|mesh-ancestor
6397667|NCT00211978|Sequestering Agents|sequestering agents|mesh-ancestor
6397668|NCT00211978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397669|NCT00212004|Pioglitazone|pioglitazone|mesh-list
6397670|NCT00212004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6397671|NCT00212004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397672|NCT00212017|Voglibose|voglibose|mesh-list
6397673|NCT00212017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6397674|NCT00212017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397675|NCT00212017|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6397676|NCT00212017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6397677|NCT00212017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397678|NCT00212030|Nicorandil|nicorandil|mesh-list
6397679|NCT00212030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6397680|NCT00212030|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6397681|NCT00212030|Vasodilator Agents|vasodilator agents|mesh-ancestor
6397682|NCT00212030|Vitamin B Complex|vitamin b complex|mesh-ancestor
6397683|NCT00212030|Vitamins|vitamins|mesh-ancestor
6397684|NCT00212030|Micronutrients|micronutrients|mesh-ancestor
6397685|NCT00212030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397686|NCT00212043|Gemcitabine|gemcitabine|mesh-list
6397687|NCT00212043|Carboplatin|carboplatin|mesh-list
6397688|NCT00212043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6397689|NCT00212043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6397690|NCT00212043|Antimetabolites|antimetabolites|mesh-ancestor
6397691|NCT00212043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397692|NCT00212043|Antiviral Agents|antiviral agents|mesh-ancestor
6397693|NCT00212043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6397694|NCT00212043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6397695|NCT00212043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6397696|NCT00212043|Immunologic Factors|immunologic factors|mesh-ancestor
6397697|NCT00212043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397698|NCT00212069|Gemcitabine|gemcitabine|mesh-list
6397699|NCT00212069|Carboplatin|carboplatin|mesh-list
6397700|NCT00212069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6397701|NCT00212069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6397702|NCT00212069|Antimetabolites|antimetabolites|mesh-ancestor
6397703|NCT00212069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397704|NCT00212069|Antiviral Agents|antiviral agents|mesh-ancestor
6397705|NCT00212069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6397706|NCT00212069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6397707|NCT00212069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6397708|NCT00212069|Immunologic Factors|immunologic factors|mesh-ancestor
6397709|NCT00212069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397710|NCT00212082|Docetaxel|docetaxel|mesh-list
6397711|NCT00212082|Doxorubicin|doxorubicin|mesh-list
6397712|NCT00212082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6397713|NCT00212082|Tubulin Modulators|tubulin modulators|mesh-ancestor
6397714|NCT00212082|Antimitotic Agents|antimitotic agents|mesh-ancestor
6397715|NCT00212082|Mitosis Modulators|mitosis modulators|mesh-ancestor
6397716|NCT00212082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397717|NCT00212082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6397718|NCT00212082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6397719|NCT00212082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6397720|NCT00212082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6397721|NCT00212095|Ketoconazole|ketoconazole|mesh-list
6397722|NCT00212095|Docetaxel|docetaxel|mesh-list
6397723|NCT00212095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6397724|NCT00212095|Tubulin Modulators|tubulin modulators|mesh-ancestor
6397725|NCT00212095|Antimitotic Agents|antimitotic agents|mesh-ancestor
6397726|NCT00212095|Mitosis Modulators|mitosis modulators|mesh-ancestor
6397727|NCT00212095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397728|NCT00212095|Antifungal Agents|antifungal agents|mesh-ancestor
6397729|NCT00212095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6397730|NCT00212095|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6397731|NCT00212095|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6397732|NCT00212095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6397733|NCT00212095|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6397734|NCT00212095|Hormone Antagonists|hormone antagonists|mesh-ancestor
6397735|NCT00212095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6397736|NCT00212095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397737|NCT00212095|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6397738|NCT00212108|Celecoxib|celecoxib|mesh-list
6397739|NCT00212108|Gefitinib|gefitinib|mesh-list
6397740|NCT00212108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6397741|NCT00212108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6397742|NCT00212108|Analgesics|analgesics|mesh-ancestor
6397743|NCT00212108|Sensory System Agents|sensory system agents|mesh-ancestor
6397744|NCT00212108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6397745|NCT00212108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397746|NCT00212108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6018524|NCT00381615|Immunologic Factors|immunologic factors|mesh-ancestor
6397747|NCT00212108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6397748|NCT00212108|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6397749|NCT00212108|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6397750|NCT00212108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6397751|NCT00212108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397752|NCT00212108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6397753|NCT00212108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6397754|NCT00212147|Anesthetics|anesthetics|mesh-list
6397755|NCT00212147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6397756|NCT00212147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397757|NCT00212173|Sibutramine|sibutramine|mesh-list
6397758|NCT00212173|Antidepressive Agents|antidepressive agents|mesh-ancestor
6397759|NCT00212173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6397760|NCT00212173|Appetite Depressants|appetite depressants|mesh-ancestor
6397761|NCT00212173|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6397762|NCT00212186|Selenium|selenium|mesh-list
6397763|NCT00212186|Antioxidants|antioxidants|mesh-ancestor
6397764|NCT00212186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397765|NCT00212186|Protective Agents|protective agents|mesh-ancestor
6397766|NCT00212186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397767|NCT00212186|Trace Elements|trace elements|mesh-ancestor
6397768|NCT00212186|Micronutrients|micronutrients|mesh-ancestor
6397769|NCT00212199|Orlistat|orlistat|mesh-list
6397770|NCT00212199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6397771|NCT00212199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397772|NCT00212199|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6397773|NCT00212199|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6397774|NCT00212212|Selenium|selenium|mesh-list
6397775|NCT00212212|Antioxidants|antioxidants|mesh-ancestor
6397776|NCT00212212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397777|NCT00212212|Protective Agents|protective agents|mesh-ancestor
6397778|NCT00212212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397779|NCT00212212|Trace Elements|trace elements|mesh-ancestor
6397780|NCT00212212|Micronutrients|micronutrients|mesh-ancestor
6397781|NCT00212277|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6397782|NCT00212277|Norethindrone|norethindrone|mesh-list
6397783|NCT00212277|Norethindrone Acetate|norethindrone acetate|mesh-list
6397784|NCT00212277|Estradiol|estradiol|mesh-list
6397785|NCT00212277|Estrogens|estrogens|mesh-ancestor
6397786|NCT00212277|Hormones|hormones|mesh-ancestor
6397787|NCT00212277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6397788|NCT00212277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397789|NCT00212277|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6397790|NCT00212277|Contraceptive Agents|contraceptive agents|mesh-ancestor
6397791|NCT00212277|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6397792|NCT00212277|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6397793|NCT00212277|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6397794|NCT00212277|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6397795|NCT00212277|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6397796|NCT00212290|Pioglitazone|pioglitazone|mesh-list
6397797|NCT00212290|Nateglinide|nateglinide|mesh-list
6397798|NCT00212290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6397799|NCT00212290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397800|NCT00212316|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
6397801|NCT00212316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6397802|NCT00212342|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6397803|NCT00212342|Norethindrone|norethindrone|mesh-list
6397804|NCT00212342|Norethindrone Acetate|norethindrone acetate|mesh-list
6397805|NCT00212342|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6397806|NCT00212342|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6397807|NCT00212342|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6397808|NCT00212342|Contraceptive Agents|contraceptive agents|mesh-ancestor
6397809|NCT00212342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6397810|NCT00212342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397811|NCT00212342|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6397812|NCT00212342|Estrogens|estrogens|mesh-ancestor
6397813|NCT00212342|Hormones|hormones|mesh-ancestor
6397814|NCT00212342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6397815|NCT00212342|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6397816|NCT00212472|Factor VIII|factor viii|mesh-list
6397817|NCT00212472|Coagulants|coagulants|mesh-ancestor
6397818|NCT00212589|Leucovorin|leucovorin|mesh-list
6397819|NCT00212589|Folic Acid|folic acid|mesh-list
6397820|NCT00212589|Fluorouracil|fluorouracil|mesh-list
6397821|NCT00212589|Capecitabine|capecitabine|mesh-list
6397822|NCT00212589|Levoleucovorin|levoleucovorin|mesh-list
6397823|NCT00212589|Antimetabolites|antimetabolites|mesh-ancestor
6397824|NCT00212589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397825|NCT00212589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6397826|NCT00212589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6397827|NCT00212589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6397828|NCT00212589|Immunologic Factors|immunologic factors|mesh-ancestor
6397829|NCT00212589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397830|NCT00212589|Antidotes|antidotes|mesh-ancestor
6397831|NCT00212589|Protective Agents|protective agents|mesh-ancestor
6397832|NCT00212589|Vitamin B Complex|vitamin b complex|mesh-ancestor
6397833|NCT00212589|Vitamins|vitamins|mesh-ancestor
6397834|NCT00212589|Micronutrients|micronutrients|mesh-ancestor
6397835|NCT00212589|Hematinics|hematinics|mesh-ancestor
6397836|NCT00212602|Aprepitant|aprepitant|mesh-list
6397837|NCT00212602|Fosaprepitant|fosaprepitant|mesh-list
6397838|NCT00212602|Antiemetics|antiemetics|mesh-ancestor
6397839|NCT00212602|Autonomic Agents|autonomic agents|mesh-ancestor
6397840|NCT00212602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6397841|NCT00212602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397842|NCT00212602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6397843|NCT00212602|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6397844|NCT00212602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6397845|NCT00212602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397846|NCT00212615|Capecitabine|capecitabine|mesh-list
6397847|NCT00212615|Oxaliplatin|oxaliplatin|mesh-list
6397848|NCT00212615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6397849|NCT00212615|Antimetabolites|antimetabolites|mesh-ancestor
6397850|NCT00212615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397851|NCT00212615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6397852|NCT00212654|Landiolol|landiolol|mesh-list
6397853|NCT00212654|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6397854|NCT00212654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6397855|NCT00212654|Adrenergic Agents|adrenergic agents|mesh-ancestor
6397856|NCT00212654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6397857|NCT00212654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397858|NCT00212654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397859|NCT00212654|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6397860|NCT00212680|Landiolol|landiolol|mesh-list
6397861|NCT00212680|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6397862|NCT00212680|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6397863|NCT00212680|Adrenergic Agents|adrenergic agents|mesh-ancestor
6397864|NCT00212680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6397865|NCT00212680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397866|NCT00212680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397867|NCT00212680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6397868|NCT00212810|Topiramate|topiramate|mesh-list
6397869|NCT00212810|Anticonvulsants|anticonvulsants|mesh-ancestor
6397870|NCT00212810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6397871|NCT00212810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397872|NCT00212823|Almotriptan|almotriptan|mesh-list
6397873|NCT00212823|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6397874|NCT00212823|Serotonin Agents|serotonin agents|mesh-ancestor
6397875|NCT00212823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6397876|NCT00212823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397877|NCT00212823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397878|NCT00212875|Epoetin Alfa|epoetin alfa|mesh-list
6397879|NCT00212875|Hematinics|hematinics|mesh-ancestor
6458884|NCT00442325|Atorvastatin|atorvastatin|mesh-list
6458885|NCT00442325|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6458886|NCT00442325|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6458887|NCT00442325|Antimetabolites|antimetabolites|mesh-ancestor
6458888|NCT00442325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458889|NCT00442325|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6458890|NCT00442325|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6458891|NCT00442325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6458892|NCT00442390|Hydrocortisone|hydrocortisone|mesh-list
6458893|NCT00442390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6458894|NCT00442403|Chloroquine|chloroquine|mesh-list
6458895|NCT00442403|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
6458896|NCT00442403|Amebicides|amebicides|mesh-ancestor
6458897|NCT00442403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6458898|NCT00442403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6458899|NCT00442403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6458900|NCT00442403|Antimalarials|antimalarials|mesh-ancestor
6458901|NCT00442403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6458902|NCT00442403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458903|NCT00442403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6458904|NCT00442403|Immunologic Factors|immunologic factors|mesh-ancestor
6458905|NCT00442455|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6458906|NCT00442455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6458907|NCT00442455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6458908|NCT00442455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6458909|NCT00442455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458910|NCT00442481|Citalopram|citalopram|mesh-list
6458911|NCT00442481|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6458912|NCT00442481|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6458913|NCT00442481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6458914|NCT00442481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458915|NCT00442481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6458916|NCT00442481|Serotonin Agents|serotonin agents|mesh-ancestor
6458917|NCT00442481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458918|NCT00442481|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6458919|NCT00442481|Antidepressive Agents|antidepressive agents|mesh-ancestor
6458920|NCT00442481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6458921|NCT00442494|Hydrocortisone|hydrocortisone|mesh-list
6458922|NCT00442494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6458923|NCT00442546|Pregabalin|pregabalin|mesh-list
6458924|NCT00442546|Analgesics|analgesics|mesh-ancestor
6458925|NCT00442546|Sensory System Agents|sensory system agents|mesh-ancestor
6458926|NCT00442546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6458927|NCT00442546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458928|NCT00442546|Anticonvulsants|anticonvulsants|mesh-ancestor
6458929|NCT00442546|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6458930|NCT00442546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6458931|NCT00442546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458932|NCT00442546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6458933|NCT00442546|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6458934|NCT00442546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6458935|NCT00442546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6458936|NCT00442546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6458937|NCT00442585|Ibuprofen|ibuprofen|mesh-list
6458938|NCT00442585|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6458939|NCT00442585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6458940|NCT00442585|Analgesics|analgesics|mesh-ancestor
6458941|NCT00442585|Sensory System Agents|sensory system agents|mesh-ancestor
6458942|NCT00442585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6458943|NCT00442585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458944|NCT00442585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6458945|NCT00442585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6458946|NCT00442585|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6458947|NCT00442585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6462245|NCT00458250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6397880|NCT00213070|Miglitol|miglitol|mesh-list
6397881|NCT00213070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6397882|NCT00213070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6018525|NCT00381615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018526|NCT00381641|Sunitinib|sunitinib|mesh-list
6018527|NCT00381641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6018528|NCT00381641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6018529|NCT00381641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6397883|NCT00213070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6018530|NCT00381641|Growth Substances|growth substances|mesh-ancestor
6397884|NCT00213070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397885|NCT00213070|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6397886|NCT00213096|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6397887|NCT00213096|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6397888|NCT00213096|Levonorgestrel|levonorgestrel|mesh-list
6397889|NCT00213096|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6397890|NCT00213096|ST 1435|st 1435|mesh-list
6397891|NCT00213096|Contraceptive Agents|contraceptive agents|mesh-list
6397892|NCT00213096|Contraceptives, Oral|contraceptives, oral|mesh-list
6018531|NCT00381641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018532|NCT00381641|Growth Inhibitors|growth inhibitors|mesh-ancestor
6018533|NCT00381641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6018534|NCT00381641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6397893|NCT00213096|Estradiol|estradiol|mesh-list
6397894|NCT00213096|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6397895|NCT00213096|Estrogens|estrogens|mesh-ancestor
6397896|NCT00213096|Hormones|hormones|mesh-ancestor
6397897|NCT00213096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6397898|NCT00213096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397899|NCT00213096|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6397900|NCT00213096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6397901|NCT00213096|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6397902|NCT00213096|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6397903|NCT00213096|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6397904|NCT00213109|Miglitol|miglitol|mesh-list
6397905|NCT00213109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6397906|NCT00213109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397907|NCT00213109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6397908|NCT00213109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397909|NCT00213109|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6397910|NCT00213122|Miglitol|miglitol|mesh-list
6397911|NCT00213122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6397912|NCT00213122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397913|NCT00213122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6397914|NCT00213122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397915|NCT00213122|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6397916|NCT00213200|Morphine|morphine|mesh-list
6397917|NCT00213200|Tetracaine|tetracaine|mesh-list
6397918|NCT00213200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6397919|NCT00213200|Narcotics|narcotics|mesh-ancestor
6397920|NCT00213200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6397921|NCT00213200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397922|NCT00213200|Analgesics|analgesics|mesh-ancestor
6397923|NCT00213200|Sensory System Agents|sensory system agents|mesh-ancestor
6397924|NCT00213200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6397925|NCT00213200|Anesthetics, Local|anesthetics, local|mesh-ancestor
6397926|NCT00213200|Anesthetics|anesthetics|mesh-ancestor
6397927|NCT00213226|Dexamethasone|dexamethasone|mesh-list
6397928|NCT00213226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6397929|NCT00213226|Antiemetics|antiemetics|mesh-ancestor
6397930|NCT00213226|Autonomic Agents|autonomic agents|mesh-ancestor
6397931|NCT00213226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6397932|NCT00213226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397933|NCT00213226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6397934|NCT00213226|Glucocorticoids|glucocorticoids|mesh-ancestor
6397935|NCT00213226|Hormones|hormones|mesh-ancestor
6397936|NCT00213226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6397937|NCT00213226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6397938|NCT00213226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6397939|NCT00213252|Prednisolone|prednisolone|mesh-list
6397940|NCT00213252|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6397941|NCT00213252|Methylprednisolone|methylprednisolone|mesh-list
6397942|NCT00213252|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6397943|NCT00213252|Prednisolone acetate|prednisolone acetate|mesh-list
6397944|NCT00213252|Montelukast|montelukast|mesh-list
6397945|NCT00213252|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6397946|NCT00213252|Prednisolone phosphate|prednisolone phosphate|mesh-list
6397947|NCT00213252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6397948|NCT00213252|Glucocorticoids|glucocorticoids|mesh-ancestor
6397949|NCT00213252|Hormones|hormones|mesh-ancestor
6397950|NCT00213252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6397951|NCT00213252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397952|NCT00213252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6397953|NCT00213252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6397954|NCT00213252|Antiemetics|antiemetics|mesh-ancestor
6397955|NCT00213252|Autonomic Agents|autonomic agents|mesh-ancestor
6397956|NCT00213252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6397957|NCT00213252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6397958|NCT00213252|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6397959|NCT00213252|Protective Agents|protective agents|mesh-ancestor
6397960|NCT00213252|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6397961|NCT00213252|Respiratory System Agents|respiratory system agents|mesh-ancestor
6397962|NCT00213252|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6397963|NCT00213252|Hormone Antagonists|hormone antagonists|mesh-ancestor
6397964|NCT00213252|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6397965|NCT00213252|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6397966|NCT00213252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397967|NCT00213265|Vaccines|vaccines|mesh-list
6397968|NCT00213265|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6397969|NCT00213265|Immunologic Factors|immunologic factors|mesh-ancestor
6397970|NCT00213265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397971|NCT00213278|Vinblastine|vinblastine|mesh-list
6397972|NCT00213278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6397973|NCT00213278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6397974|NCT00213278|Tubulin Modulators|tubulin modulators|mesh-ancestor
6397975|NCT00213278|Antimitotic Agents|antimitotic agents|mesh-ancestor
6397976|NCT00213278|Mitosis Modulators|mitosis modulators|mesh-ancestor
6397977|NCT00213278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397978|NCT00213291|Darbepoetin alfa|darbepoetin alfa|mesh-list
6397979|NCT00213291|Hematinics|hematinics|mesh-ancestor
6397980|NCT00213486|Irinotecan|irinotecan|mesh-list
6397981|NCT00213486|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6397982|NCT00213486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6397983|NCT00213486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6397984|NCT00213486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6397985|NCT00213486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6397986|NCT00213512|Rituximab|rituximab|mesh-list
6397987|NCT00213512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6397988|NCT00213512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6397989|NCT00213512|Immunologic Factors|immunologic factors|mesh-ancestor
6397990|NCT00213512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397991|NCT00213512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6397992|NCT00213538|Methotrexate|methotrexate|mesh-list
6397993|NCT00213538|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6397994|NCT00213538|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6397995|NCT00213538|Abortifacient Agents|abortifacient agents|mesh-ancestor
6397996|NCT00213538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6397997|NCT00213538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6397998|NCT00213538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6397999|NCT00213538|Antimetabolites|antimetabolites|mesh-ancestor
6398000|NCT00213538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398001|NCT00213538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6398002|NCT00213538|Dermatologic Agents|dermatologic agents|mesh-ancestor
6398003|NCT00213538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6398004|NCT00213538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6398005|NCT00213538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6398006|NCT00213538|Immunologic Factors|immunologic factors|mesh-ancestor
6398007|NCT00213538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6398008|NCT00213538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6398009|NCT00213551|Antioxidants|antioxidants|mesh-list
6398010|NCT00213551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398011|NCT00213551|Protective Agents|protective agents|mesh-ancestor
6398012|NCT00213551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398013|NCT00213564|Methotrexate|methotrexate|mesh-list
6398014|NCT00213564|Infliximab|infliximab|mesh-list
6398015|NCT00213564|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6398016|NCT00213564|Abortifacient Agents|abortifacient agents|mesh-ancestor
6398017|NCT00213564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6398018|NCT00213564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398019|NCT00213564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6398020|NCT00213564|Antimetabolites|antimetabolites|mesh-ancestor
6398021|NCT00213564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398022|NCT00213564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6398023|NCT00213564|Dermatologic Agents|dermatologic agents|mesh-ancestor
6398024|NCT00213564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6398025|NCT00213564|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6398026|NCT00213564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6398027|NCT00213564|Immunologic Factors|immunologic factors|mesh-ancestor
6398028|NCT00213564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6398029|NCT00213564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6398030|NCT00213564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6398031|NCT00213577|Botulinum Toxins|botulinum toxins|mesh-list
6398032|NCT00213577|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6398033|NCT00213577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6398034|NCT00213577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398035|NCT00213577|Cholinergic Agents|cholinergic agents|mesh-ancestor
6398036|NCT00213577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6398037|NCT00213577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398038|NCT00213590|Cyclosporine|cyclosporine|mesh-list
6398039|NCT00213590|Cyclosporins|cyclosporins|mesh-list
6398040|NCT00213590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6398041|NCT00213590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398042|NCT00213590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6398043|NCT00213590|Immunologic Factors|immunologic factors|mesh-ancestor
6398044|NCT00213590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398045|NCT00213590|Antifungal Agents|antifungal agents|mesh-ancestor
6398046|NCT00213590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6398047|NCT00213590|Dermatologic Agents|dermatologic agents|mesh-ancestor
6398048|NCT00213590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6398049|NCT00213590|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6398050|NCT00213694|Celecoxib|celecoxib|mesh-list
6398051|NCT00213694|Docetaxel|docetaxel|mesh-list
6398052|NCT00213694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6398053|NCT00213694|Tubulin Modulators|tubulin modulators|mesh-ancestor
6398054|NCT00213694|Antimitotic Agents|antimitotic agents|mesh-ancestor
6398055|NCT00213694|Mitosis Modulators|mitosis modulators|mesh-ancestor
6398056|NCT00213694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398057|NCT00213694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6398058|NCT00213694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6398059|NCT00213694|Analgesics|analgesics|mesh-ancestor
6398060|NCT00213694|Sensory System Agents|sensory system agents|mesh-ancestor
6398061|NCT00213694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6398062|NCT00213694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398063|NCT00213694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6398064|NCT00213694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6398065|NCT00213694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6398066|NCT00213694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6398067|NCT00213694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6398068|NCT00213759|Lenograstim|lenograstim|mesh-list
6398069|NCT00213759|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6398070|NCT00213759|Immunologic Factors|immunologic factors|mesh-ancestor
6398071|NCT00213759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398072|NCT00214032|Pycnogenols|pycnogenols|mesh-list
6398073|NCT00214032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6398074|NCT00214032|Immunologic Factors|immunologic factors|mesh-ancestor
6398075|NCT00214032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398076|NCT00214032|Antioxidants|antioxidants|mesh-ancestor
6398077|NCT00214032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398078|NCT00214032|Protective Agents|protective agents|mesh-ancestor
6398079|NCT00214032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6398080|NCT00214058|Carboplatin|carboplatin|mesh-list
6398081|NCT00214058|Docetaxel|docetaxel|mesh-list
6398082|NCT00214058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6398083|NCT00214058|Tubulin Modulators|tubulin modulators|mesh-ancestor
6398084|NCT00214058|Antimitotic Agents|antimitotic agents|mesh-ancestor
6398085|NCT00214058|Mitosis Modulators|mitosis modulators|mesh-ancestor
6398086|NCT00214058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398087|NCT00214084|Allopurinol|allopurinol|mesh-list
6398088|NCT00214084|Antimetabolites|antimetabolites|mesh-ancestor
6398089|NCT00214084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398090|NCT00214084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6398091|NCT00214084|Gout Suppressants|gout suppressants|mesh-ancestor
6398092|NCT00214084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6398093|NCT00214084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6398094|NCT00214084|Antioxidants|antioxidants|mesh-ancestor
6398095|NCT00214084|Protective Agents|protective agents|mesh-ancestor
6398096|NCT00214084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398097|NCT00214110|Tamoxifen|tamoxifen|mesh-list
6398098|NCT00214110|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6398099|NCT00214110|Hormone Antagonists|hormone antagonists|mesh-ancestor
6398100|NCT00214110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6398101|NCT00214110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398102|NCT00214110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6398103|NCT00214110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6398104|NCT00214110|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6398105|NCT00214110|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6398106|NCT00214110|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6398107|NCT00214214|Alemtuzumab|alemtuzumab|mesh-list
6398108|NCT00214214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6398109|NCT00214214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6398110|NCT00214240|Immunoglobulins|immunoglobulins|mesh-list
6398111|NCT00214240|Antibodies|antibodies|mesh-list
6398112|NCT00214240|gamma-Globulins|gamma-globulins|mesh-list
6398113|NCT00214240|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6398114|NCT00214240|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6398115|NCT00214240|Immunologic Factors|immunologic factors|mesh-ancestor
6398116|NCT00214240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398117|NCT00214253|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
6398118|NCT00214253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6398119|NCT00214253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398120|NCT00214266|Mycophenolic Acid|mycophenolic acid|mesh-list
6398121|NCT00214266|Rituximab|rituximab|mesh-list
6398122|NCT00214266|Alemtuzumab|alemtuzumab|mesh-list
6398123|NCT00214266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6398124|NCT00214266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6398125|NCT00214266|Immunologic Factors|immunologic factors|mesh-ancestor
6398126|NCT00214266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398127|NCT00214266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6398128|NCT00214266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6398129|NCT00214266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6398130|NCT00214266|Antitubercular Agents|antitubercular agents|mesh-ancestor
6398131|NCT00214266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6398132|NCT00214266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6398133|NCT00214266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6398134|NCT00214266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398135|NCT00214318|Metoprolol|metoprolol|mesh-list
6398136|NCT00214318|Carvedilol|carvedilol|mesh-list
6398137|NCT00214318|Terbutaline|terbutaline|mesh-list
6398138|NCT00214318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6398139|NCT00214318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6398140|NCT00214318|Sympatholytics|sympatholytics|mesh-ancestor
6398141|NCT00214318|Autonomic Agents|autonomic agents|mesh-ancestor
6398142|NCT00214318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6398143|NCT00214318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398144|NCT00214318|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6398145|NCT00214318|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6398146|NCT00214318|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6398147|NCT00214318|Adrenergic Agents|adrenergic agents|mesh-ancestor
6398148|NCT00214318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6398149|NCT00214318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398150|NCT00214318|Antioxidants|antioxidants|mesh-ancestor
6398151|NCT00214318|Protective Agents|protective agents|mesh-ancestor
6398152|NCT00214318|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6398153|NCT00214318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6398154|NCT00214318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6398155|NCT00214318|Vasodilator Agents|vasodilator agents|mesh-ancestor
6398156|NCT00214318|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6398157|NCT00214318|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6398158|NCT00214318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6398159|NCT00214318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6398160|NCT00214318|Respiratory System Agents|respiratory system agents|mesh-ancestor
6398161|NCT00214318|Sympathomimetics|sympathomimetics|mesh-ancestor
6398162|NCT00214318|Tocolytic Agents|tocolytic agents|mesh-ancestor
6398163|NCT00214318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6398164|NCT00214318|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6398165|NCT00214318|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6398166|NCT00214318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6398167|NCT00214331|Azithromycin|azithromycin|mesh-list
6398168|NCT00214331|Ciprofloxacin|ciprofloxacin|mesh-list
6398169|NCT00214331|Gentamicins|gentamicins|mesh-list
6398170|NCT00214331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6398171|NCT00214331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6398172|NCT00214331|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6398173|NCT00214331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6398174|NCT00214331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6398175|NCT00214331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398176|NCT00214331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6398177|NCT00214331|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6398178|NCT00214331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6398179|NCT00214331|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6398180|NCT00214370|Fentanyl|fentanyl|mesh-list
6398181|NCT00214370|Propofol|propofol|mesh-list
6398182|NCT00214370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6398183|NCT00214370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6398184|NCT00214370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398185|NCT00214370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6398186|NCT00214370|Anesthetics, General|anesthetics, general|mesh-ancestor
6398187|NCT00214370|Anesthetics|anesthetics|mesh-ancestor
6398188|NCT00214370|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6398189|NCT00214370|Narcotics|narcotics|mesh-ancestor
6398190|NCT00214370|Analgesics|analgesics|mesh-ancestor
6398191|NCT00214370|Sensory System Agents|sensory system agents|mesh-ancestor
6398192|NCT00214370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6398193|NCT00214370|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6398194|NCT00214435|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6398195|NCT00214435|Antiviral Agents|antiviral agents|mesh-ancestor
6398196|NCT00214435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6398197|NCT00214552|Rabeprazole|rabeprazole|mesh-list
6398198|NCT00214552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6398199|NCT00214552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6398200|NCT00214552|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6398201|NCT00214552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6398202|NCT00214552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398203|NCT00214578|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6398204|NCT00214578|Antidepressive Agents|antidepressive agents|mesh-ancestor
6398205|NCT00214578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6398206|NCT00214578|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6398207|NCT00214578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6398208|NCT00214578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6398209|NCT00214578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458948|NCT00442585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458949|NCT00442637|Bevacizumab|bevacizumab|mesh-list
6458950|NCT00442637|Capecitabine|capecitabine|mesh-list
6458951|NCT00442637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6458952|NCT00442637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6458953|NCT00442637|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6458954|NCT00442637|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6458955|NCT00442637|Growth Substances|growth substances|mesh-ancestor
6458956|NCT00442637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458957|NCT00442637|Growth Inhibitors|growth inhibitors|mesh-ancestor
6458958|NCT00442637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6458959|NCT00442637|Antimetabolites|antimetabolites|mesh-ancestor
6458960|NCT00442637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458961|NCT00442676|Celecoxib|celecoxib|mesh-list
6458962|NCT00442676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6458963|NCT00442676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6458964|NCT00442676|Analgesics|analgesics|mesh-ancestor
6398210|NCT00214604|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6398211|NCT00214604|Pravastatin|pravastatin|mesh-list
6398212|NCT00214604|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6398213|NCT00214604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6398214|NCT00214604|Antimetabolites|antimetabolites|mesh-ancestor
6398215|NCT00214604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398216|NCT00214604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6398217|NCT00214604|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6398218|NCT00214604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6398219|NCT00214617|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6398220|NCT00214617|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6398221|NCT00214617|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6398222|NCT00214617|Antimetabolites|antimetabolites|mesh-ancestor
6398223|NCT00214617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398224|NCT00214617|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6398225|NCT00214617|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6398226|NCT00214617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6398227|NCT00214630|Atorvastatin|atorvastatin|mesh-list
6398228|NCT00214630|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6398229|NCT00214630|Calcium|calcium|mesh-list
6398230|NCT00214630|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6398231|NCT00214630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398232|NCT00214630|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6398233|NCT00214630|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6398234|NCT00214630|Antimetabolites|antimetabolites|mesh-ancestor
6398235|NCT00214630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398236|NCT00214630|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6398237|NCT00214630|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6398238|NCT00214630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6398239|NCT00214643|Clindamycin|clindamycin|mesh-list
6398240|NCT00214643|Clindamycin palmitate|clindamycin palmitate|mesh-list
6398241|NCT00214643|Clindamycin phosphate|clindamycin phosphate|mesh-list
6398242|NCT00214643|Fosmidomycin|fosmidomycin|mesh-list
6398243|NCT00214643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6398244|NCT00214643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6398245|NCT00214643|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6398246|NCT00214643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6398247|NCT00214643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398248|NCT00214682|Vitamin B 12|vitamin b 12|mesh-list
6398249|NCT00214682|Hydroxocobalamin|hydroxocobalamin|mesh-list
6398250|NCT00214682|Vitamins|vitamins|mesh-ancestor
6398251|NCT00214682|Micronutrients|micronutrients|mesh-ancestor
6398252|NCT00214682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398253|NCT00214682|Vitamin B Complex|vitamin b complex|mesh-ancestor
6398254|NCT00214682|Hematinics|hematinics|mesh-ancestor
6398255|NCT00214695|Dialysis Solutions|dialysis solutions|mesh-list
6398256|NCT00214695|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6398257|NCT00214721|Dialysis Solutions|dialysis solutions|mesh-list
6398258|NCT00214721|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6398259|NCT00214825|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6398260|NCT00214825|Eplerenone|eplerenone|mesh-list
6398261|NCT00214825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6398262|NCT00214825|Diuretics|diuretics|mesh-ancestor
6398263|NCT00214825|Natriuretic Agents|natriuretic agents|mesh-ancestor
6398264|NCT00214825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398265|NCT00214825|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6398266|NCT00214825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6398267|NCT00214825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398268|NCT00214825|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6398269|NCT00214825|Hormone Antagonists|hormone antagonists|mesh-ancestor
6398270|NCT00214825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6398271|NCT00214825|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6398272|NCT00214851|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6398273|NCT00214851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6398274|NCT00214864|Docetaxel|docetaxel|mesh-list
6398275|NCT00214864|Capecitabine|capecitabine|mesh-list
6398276|NCT00214864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6398277|NCT00214864|Tubulin Modulators|tubulin modulators|mesh-ancestor
6398278|NCT00214864|Antimitotic Agents|antimitotic agents|mesh-ancestor
6398279|NCT00214864|Mitosis Modulators|mitosis modulators|mesh-ancestor
6398280|NCT00214864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398281|NCT00214864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6398282|NCT00214864|Antimetabolites|antimetabolites|mesh-ancestor
6398283|NCT00214877|Methylene Blue|methylene blue|mesh-list
6398284|NCT00214877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6398285|NCT00214877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6018535|NCT00381641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6018536|NCT00381680|Leucovorin|leucovorin|mesh-list
6018537|NCT00381680|Cytarabine|cytarabine|mesh-list
6018538|NCT00381680|Dexamethasone|dexamethasone|mesh-list
6018539|NCT00381680|Prednisone|prednisone|mesh-list
6018540|NCT00381680|Cyclophosphamide|cyclophosphamide|mesh-list
6018541|NCT00381680|Doxorubicin|doxorubicin|mesh-list
6398286|NCT00214916|Insulin|insulin|mesh-list
6398287|NCT00214916|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6398288|NCT00214916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6398289|NCT00214916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398290|NCT00214942|Fentanyl|fentanyl|mesh-list
6398291|NCT00214942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6398292|NCT00214942|Narcotics|narcotics|mesh-ancestor
6398293|NCT00214942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6398294|NCT00214942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398295|NCT00214942|Analgesics|analgesics|mesh-ancestor
6398296|NCT00214942|Sensory System Agents|sensory system agents|mesh-ancestor
6398297|NCT00214942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6398298|NCT00214942|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6398299|NCT00214942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6398300|NCT00214942|Anesthetics, General|anesthetics, general|mesh-ancestor
6398301|NCT00214942|Anesthetics|anesthetics|mesh-ancestor
6398302|NCT00214955|Fentanyl|fentanyl|mesh-list
6398303|NCT00214955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6398304|NCT00214955|Narcotics|narcotics|mesh-ancestor
6398305|NCT00214955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6398306|NCT00214955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398307|NCT00214955|Analgesics|analgesics|mesh-ancestor
6398308|NCT00214955|Sensory System Agents|sensory system agents|mesh-ancestor
6398309|NCT00214955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6398310|NCT00214955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6398311|NCT00214955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6398312|NCT00214955|Anesthetics, General|anesthetics, general|mesh-ancestor
6398313|NCT00214955|Anesthetics|anesthetics|mesh-ancestor
6398314|NCT00214981|Modafinil|modafinil|mesh-list
6398315|NCT00214981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6398316|NCT00214981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398317|NCT00214981|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6398318|NCT00214981|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6398319|NCT00214981|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6398320|NCT00214981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398321|NCT00214994|Tiagabine|tiagabine|mesh-list
6398322|NCT00214994|Anticonvulsants|anticonvulsants|mesh-ancestor
6398323|NCT00214994|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
6398324|NCT00214994|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6398325|NCT00214994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6398326|NCT00214994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398327|NCT00214994|GABA Agents|gaba agents|mesh-ancestor
6398328|NCT00214994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6398329|NCT00214994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398330|NCT00215007|Levofloxacin|levofloxacin|mesh-list
6398331|NCT00215007|Ofloxacin|ofloxacin|mesh-list
6398332|NCT00215007|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6398333|NCT00215007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6398334|NCT00215007|Renal Agents|renal agents|mesh-ancestor
6398335|NCT00215007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6398336|NCT00215007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6398337|NCT00215007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6398338|NCT00215007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6398339|NCT00215007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398340|NCT00215007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6398341|NCT00215007|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6398342|NCT00215007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6398343|NCT00215046|Methotrexate|methotrexate|mesh-list
6398344|NCT00215046|Vinblastine|vinblastine|mesh-list
6398345|NCT00215046|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6398346|NCT00215046|Abortifacient Agents|abortifacient agents|mesh-ancestor
6398347|NCT00215046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6398348|NCT00215046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398349|NCT00215046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6398350|NCT00215046|Antimetabolites|antimetabolites|mesh-ancestor
6398351|NCT00215046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398352|NCT00215046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6398353|NCT00215046|Dermatologic Agents|dermatologic agents|mesh-ancestor
6398354|NCT00215046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6398355|NCT00215046|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6398356|NCT00215046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6398357|NCT00215046|Immunologic Factors|immunologic factors|mesh-ancestor
6398358|NCT00215046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6398359|NCT00215046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6398360|NCT00215046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6398361|NCT00215046|Tubulin Modulators|tubulin modulators|mesh-ancestor
6398362|NCT00215046|Antimitotic Agents|antimitotic agents|mesh-ancestor
6398363|NCT00215046|Mitosis Modulators|mitosis modulators|mesh-ancestor
6398364|NCT00215124|Lenograstim|lenograstim|mesh-list
6398365|NCT00215124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6398366|NCT00215124|Immunologic Factors|immunologic factors|mesh-ancestor
6398367|NCT00215124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398368|NCT00215163|Paroxetine|paroxetine|mesh-list
6398369|NCT00215163|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6398370|NCT00215163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6398371|NCT00215163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6398372|NCT00215163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398373|NCT00215163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6398374|NCT00215163|Serotonin Agents|serotonin agents|mesh-ancestor
6398375|NCT00215163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398376|NCT00215163|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6398377|NCT00215163|Antidepressive Agents|antidepressive agents|mesh-ancestor
6398378|NCT00215163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6398379|NCT00215163|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6018542|NCT00381680|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6398380|NCT00215163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6398381|NCT00215163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6398382|NCT00215176|Modafinil|modafinil|mesh-list
6398383|NCT00215176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6398384|NCT00215176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398385|NCT00215176|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6398386|NCT00215176|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6398387|NCT00215176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6398388|NCT00215176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398389|NCT00215202|Gefitinib|gefitinib|mesh-list
6398390|NCT00215202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6398391|NCT00215202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6398392|NCT00215202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6398393|NCT00215202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398394|NCT00215228|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6398395|NCT00215228|Citalopram|citalopram|mesh-list
6398396|NCT00215228|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6398397|NCT00215228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6398398|NCT00215228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6398399|NCT00215228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398400|NCT00215228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6398401|NCT00215228|Serotonin Agents|serotonin agents|mesh-ancestor
6398402|NCT00215228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398403|NCT00215228|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6398404|NCT00215228|Antidepressive Agents|antidepressive agents|mesh-ancestor
6398405|NCT00215228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6398406|NCT00215228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6398407|NCT00215228|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6398408|NCT00215228|Analgesics|analgesics|mesh-ancestor
6398409|NCT00215228|Sensory System Agents|sensory system agents|mesh-ancestor
6398410|NCT00215228|Dopamine Agents|dopamine agents|mesh-ancestor
6398411|NCT00215241|Risperidone|risperidone|mesh-list
6398412|NCT00215241|Sertraline|sertraline|mesh-list
6398413|NCT00215241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6398414|NCT00215241|Serotonin Agents|serotonin agents|mesh-ancestor
6398415|NCT00215241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6398416|NCT00215241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398417|NCT00215241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398418|NCT00215241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6398419|NCT00215241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6398420|NCT00215241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6398421|NCT00215241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6398422|NCT00215241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6398423|NCT00215241|Dopamine Agents|dopamine agents|mesh-ancestor
6398424|NCT00215241|Antidepressive Agents|antidepressive agents|mesh-ancestor
6398425|NCT00215241|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6398426|NCT00215241|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6398427|NCT00215241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6398428|NCT00215254|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6398429|NCT00215254|Antidepressive Agents|antidepressive agents|mesh-ancestor
6398430|NCT00215254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6398431|NCT00215254|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6398432|NCT00215254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6398433|NCT00215254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6398434|NCT00215254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398435|NCT00215267|Praziquantel|praziquantel|mesh-list
6398436|NCT00215267|Anthelmintics|anthelmintics|mesh-ancestor
6398437|NCT00215267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6398438|NCT00215267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6398439|NCT00215280|Ivermectin|ivermectin|mesh-list
6398440|NCT00215280|Albendazole|albendazole|mesh-list
6398441|NCT00215280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6398442|NCT00215280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6398443|NCT00215280|Anthelmintics|anthelmintics|mesh-ancestor
6398444|NCT00215280|Anticestodal Agents|anticestodal agents|mesh-ancestor
6398445|NCT00215280|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6398446|NCT00215280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6398447|NCT00215280|Tubulin Modulators|tubulin modulators|mesh-ancestor
6398448|NCT00215280|Antimitotic Agents|antimitotic agents|mesh-ancestor
6398449|NCT00215280|Mitosis Modulators|mitosis modulators|mesh-ancestor
6398450|NCT00215280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398451|NCT00215280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6398452|NCT00215345|Celecoxib|celecoxib|mesh-list
6398453|NCT00215345|Docetaxel|docetaxel|mesh-list
6398454|NCT00215345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6398455|NCT00215345|Tubulin Modulators|tubulin modulators|mesh-ancestor
6398456|NCT00215345|Antimitotic Agents|antimitotic agents|mesh-ancestor
6398457|NCT00215345|Mitosis Modulators|mitosis modulators|mesh-ancestor
6398458|NCT00215345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398459|NCT00215345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6398460|NCT00215345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6398461|NCT00215345|Analgesics|analgesics|mesh-ancestor
6398462|NCT00215345|Sensory System Agents|sensory system agents|mesh-ancestor
6398463|NCT00215345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6398464|NCT00215345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398465|NCT00215345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6398466|NCT00215345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6398467|NCT00215345|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6398468|NCT00215345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6398469|NCT00215345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6398470|NCT00215358|Formoterol Fumarate|formoterol fumarate|mesh-list
6398471|NCT00215358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6398472|NCT00215358|Autonomic Agents|autonomic agents|mesh-ancestor
6398473|NCT00215358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6398474|NCT00215358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398475|NCT00215358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6398476|NCT00215358|Respiratory System Agents|respiratory system agents|mesh-ancestor
6398477|NCT00215358|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6398478|NCT00215358|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6398479|NCT00215358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6398480|NCT00215358|Adrenergic Agents|adrenergic agents|mesh-ancestor
6398481|NCT00215358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6398482|NCT00215358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398483|NCT00215371|Formoterol Fumarate|formoterol fumarate|mesh-list
6398484|NCT00215371|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6398485|NCT00215371|Autonomic Agents|autonomic agents|mesh-ancestor
6398486|NCT00215371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6398487|NCT00215371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398488|NCT00215371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6398489|NCT00215371|Respiratory System Agents|respiratory system agents|mesh-ancestor
6398490|NCT00215371|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6398491|NCT00215371|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6398492|NCT00215371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6398493|NCT00215371|Adrenergic Agents|adrenergic agents|mesh-ancestor
6398494|NCT00215371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6398495|NCT00215371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398496|NCT00215384|Formoterol Fumarate|formoterol fumarate|mesh-list
6398497|NCT00215384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6398498|NCT00215384|Autonomic Agents|autonomic agents|mesh-ancestor
6398499|NCT00215384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6398500|NCT00215384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398501|NCT00215384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6398502|NCT00215384|Respiratory System Agents|respiratory system agents|mesh-ancestor
6398503|NCT00215384|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6398504|NCT00215384|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6398505|NCT00215384|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6398506|NCT00215384|Adrenergic Agents|adrenergic agents|mesh-ancestor
6398507|NCT00215384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6398508|NCT00215384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398509|NCT00215397|Formoterol Fumarate|formoterol fumarate|mesh-list
6398510|NCT00215397|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6398511|NCT00215397|Autonomic Agents|autonomic agents|mesh-ancestor
6398512|NCT00215397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6398513|NCT00215397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398514|NCT00215397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6398515|NCT00215397|Respiratory System Agents|respiratory system agents|mesh-ancestor
6398516|NCT00215397|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6398517|NCT00215397|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6398518|NCT00215397|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6398519|NCT00215397|Adrenergic Agents|adrenergic agents|mesh-ancestor
6398520|NCT00215397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6398521|NCT00215397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398522|NCT00215410|Formoterol Fumarate|formoterol fumarate|mesh-list
6398523|NCT00215410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6398524|NCT00215410|Autonomic Agents|autonomic agents|mesh-ancestor
6398525|NCT00215410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6398526|NCT00215410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398527|NCT00215410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6398528|NCT00215410|Respiratory System Agents|respiratory system agents|mesh-ancestor
6398529|NCT00215410|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6398530|NCT00215410|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6398531|NCT00215410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6398532|NCT00215410|Adrenergic Agents|adrenergic agents|mesh-ancestor
6398533|NCT00215410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6398534|NCT00215410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398535|NCT00215423|Formoterol Fumarate|formoterol fumarate|mesh-list
6398536|NCT00215423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6398537|NCT00215423|Autonomic Agents|autonomic agents|mesh-ancestor
6398538|NCT00215423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6398539|NCT00215423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398540|NCT00215423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6398541|NCT00215423|Respiratory System Agents|respiratory system agents|mesh-ancestor
6398542|NCT00215423|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6398543|NCT00215423|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6398544|NCT00215423|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6398545|NCT00215423|Adrenergic Agents|adrenergic agents|mesh-ancestor
6398546|NCT00215423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6398547|NCT00215423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398548|NCT00215436|Formoterol Fumarate|formoterol fumarate|mesh-list
6398549|NCT00215436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6398550|NCT00215436|Autonomic Agents|autonomic agents|mesh-ancestor
6398551|NCT00215436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6398552|NCT00215436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398553|NCT00215436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6398554|NCT00215436|Respiratory System Agents|respiratory system agents|mesh-ancestor
6398555|NCT00215436|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6398556|NCT00215436|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6398557|NCT00215436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6398558|NCT00215436|Adrenergic Agents|adrenergic agents|mesh-ancestor
6398559|NCT00215436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6398560|NCT00215436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398561|NCT00215449|Formoterol Fumarate|formoterol fumarate|mesh-list
6398562|NCT00215449|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6018543|NCT00381680|Methotrexate|methotrexate|mesh-list
6018544|NCT00381680|Etoposide|etoposide|mesh-list
6018545|NCT00381680|Vincristine|vincristine|mesh-list
6398563|NCT00215449|Autonomic Agents|autonomic agents|mesh-ancestor
6398564|NCT00215449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6398565|NCT00215449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398566|NCT00215449|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6398567|NCT00215449|Respiratory System Agents|respiratory system agents|mesh-ancestor
6398568|NCT00215449|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6398569|NCT00215449|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6398570|NCT00215449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6398571|NCT00215449|Adrenergic Agents|adrenergic agents|mesh-ancestor
6398572|NCT00215449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6398573|NCT00215449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398574|NCT00215462|Vinorelbine|vinorelbine|mesh-list
6398575|NCT00215462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6398576|NCT00215462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6398577|NCT00215462|Tubulin Modulators|tubulin modulators|mesh-ancestor
6398578|NCT00215462|Antimitotic Agents|antimitotic agents|mesh-ancestor
6398579|NCT00215462|Mitosis Modulators|mitosis modulators|mesh-ancestor
6398580|NCT00215462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398581|NCT00215501|Fluorouracil|fluorouracil|mesh-list
6398582|NCT00215501|Capecitabine|capecitabine|mesh-list
6398583|NCT00215501|Irinotecan|irinotecan|mesh-list
6398584|NCT00215501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6398585|NCT00215501|Antimetabolites|antimetabolites|mesh-ancestor
5501176|NCT04476992|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6018546|NCT00381680|Etoposide phosphate|etoposide phosphate|mesh-list
6398586|NCT00215501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398587|NCT00215501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6398588|NCT00215501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6398589|NCT00215501|Immunologic Factors|immunologic factors|mesh-ancestor
6398590|NCT00215501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398591|NCT00215501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6398592|NCT00215501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6398593|NCT00215501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6398594|NCT00215514|Fluorouracil|fluorouracil|mesh-list
6398595|NCT00215514|Epirubicin|epirubicin|mesh-list
6398596|NCT00215514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6398597|NCT00215514|Antimetabolites|antimetabolites|mesh-ancestor
6398598|NCT00215514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398599|NCT00215514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6398600|NCT00215514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6398601|NCT00215514|Immunologic Factors|immunologic factors|mesh-ancestor
6398602|NCT00215514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398603|NCT00215514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6398604|NCT00215514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6398605|NCT00215514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6398606|NCT00215514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6398607|NCT00215579|Risperidone|risperidone|mesh-list
6398608|NCT00215579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6398609|NCT00215579|Serotonin Agents|serotonin agents|mesh-ancestor
6398610|NCT00215579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6398611|NCT00215579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398612|NCT00215579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398613|NCT00215579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6398614|NCT00215579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6398615|NCT00215579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6398616|NCT00215579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6398617|NCT00215579|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6398618|NCT00215579|Dopamine Agents|dopamine agents|mesh-ancestor
6398619|NCT00215592|Zonisamide|zonisamide|mesh-list
6398620|NCT00215592|Anticonvulsants|anticonvulsants|mesh-ancestor
6398621|NCT00215592|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6398622|NCT00215592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6398623|NCT00215592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398624|NCT00215592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6398625|NCT00215592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398626|NCT00215631|Tadalafil|tadalafil|mesh-list
6398627|NCT00215631|Vasodilator Agents|vasodilator agents|mesh-ancestor
6398628|NCT00215631|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6398629|NCT00215631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6398630|NCT00215631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6398631|NCT00215631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398632|NCT00215631|Urological Agents|urological agents|mesh-ancestor
6398633|NCT00215709|Docetaxel|docetaxel|mesh-list
6398634|NCT00215709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6398635|NCT00215709|Tubulin Modulators|tubulin modulators|mesh-ancestor
6398636|NCT00215709|Antimitotic Agents|antimitotic agents|mesh-ancestor
6398637|NCT00215709|Mitosis Modulators|mitosis modulators|mesh-ancestor
6398638|NCT00215709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398639|NCT00215722|Cetuximab|cetuximab|mesh-list
6398640|NCT00215722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6398641|NCT00215722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6398642|NCT00215748|Dexamethasone|dexamethasone|mesh-list
6398643|NCT00215748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6398644|NCT00215748|Antiemetics|antiemetics|mesh-ancestor
6398645|NCT00215748|Autonomic Agents|autonomic agents|mesh-ancestor
6398646|NCT00215748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6398647|NCT00215748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398648|NCT00215748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6398649|NCT00215748|Glucocorticoids|glucocorticoids|mesh-ancestor
6398650|NCT00215748|Hormones|hormones|mesh-ancestor
6398651|NCT00215748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6398652|NCT00215748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6398653|NCT00215748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6398654|NCT00215774|Flecainide|flecainide|mesh-list
6398655|NCT00215774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6398656|NCT00215774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6398657|NCT00215774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6398658|NCT00215774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6398659|NCT00215774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398660|NCT00215800|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
6398661|NCT00215800|Antiviral Agents|antiviral agents|mesh-ancestor
6398662|NCT00215800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6398663|NCT00215813|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
6398664|NCT00215813|Poly I-C|poly i-c|mesh-list
6398665|NCT00215813|Antiviral Agents|antiviral agents|mesh-ancestor
6398666|NCT00215813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6398667|NCT00215813|Interferon Inducers|interferon inducers|mesh-ancestor
6398668|NCT00215813|Immunologic Factors|immunologic factors|mesh-ancestor
6398669|NCT00215813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398670|NCT00215826|Interferon-alpha|interferon-alpha|mesh-list
6398671|NCT00215826|Antiviral Agents|antiviral agents|mesh-ancestor
6398672|NCT00215826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6398673|NCT00215826|Immunologic Factors|immunologic factors|mesh-ancestor
6398674|NCT00215826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398675|NCT00215839|Ribavirin|ribavirin|mesh-list
6398676|NCT00215839|Antimetabolites|antimetabolites|mesh-ancestor
6398677|NCT00215839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398678|NCT00215839|Antiviral Agents|antiviral agents|mesh-ancestor
6398679|NCT00215839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6398680|NCT00215865|Ribavirin|ribavirin|mesh-list
6398681|NCT00215865|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6398682|NCT00215865|Antimetabolites|antimetabolites|mesh-ancestor
6398683|NCT00215865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398684|NCT00215865|Antiviral Agents|antiviral agents|mesh-ancestor
6398685|NCT00215865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6398686|NCT00215891|Interferons|interferons|mesh-list
6398687|NCT00215891|Ribavirin|ribavirin|mesh-list
6398688|NCT00215891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6398689|NCT00215891|Antiviral Agents|antiviral agents|mesh-ancestor
6398690|NCT00215891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6398691|NCT00215891|Antimetabolites|antimetabolites|mesh-ancestor
6398692|NCT00215891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398693|NCT00215956|Topotecan|topotecan|mesh-list
6398694|NCT00215956|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6398695|NCT00215956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6398696|NCT00215956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6398697|NCT00215956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398698|NCT00215956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6398699|NCT00215982|Capecitabine|capecitabine|mesh-list
6398700|NCT00215982|Oxaliplatin|oxaliplatin|mesh-list
6398701|NCT00215982|Irinotecan|irinotecan|mesh-list
6398702|NCT00215982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6398703|NCT00215982|Antimetabolites|antimetabolites|mesh-ancestor
6398704|NCT00215982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398705|NCT00215982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6398706|NCT00215982|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6398707|NCT00215982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6398708|NCT00215982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6398709|NCT00215995|Cisplatin|cisplatin|mesh-list
6398710|NCT00215995|Irinotecan|irinotecan|mesh-list
6398711|NCT00215995|Gefitinib|gefitinib|mesh-list
6398712|NCT00215995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6398713|NCT00215995|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6398714|NCT00215995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6398715|NCT00215995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6398716|NCT00215995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398717|NCT00215995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6398718|NCT00216008|Docetaxel|docetaxel|mesh-list
6398719|NCT00216008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6398720|NCT00216008|Tubulin Modulators|tubulin modulators|mesh-ancestor
6398721|NCT00216008|Antimitotic Agents|antimitotic agents|mesh-ancestor
6398722|NCT00216008|Mitosis Modulators|mitosis modulators|mesh-ancestor
6398723|NCT00216008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398724|NCT00216021|Capecitabine|capecitabine|mesh-list
6398725|NCT00216021|Oxaliplatin|oxaliplatin|mesh-list
6398726|NCT00216021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6398727|NCT00216021|Antimetabolites|antimetabolites|mesh-ancestor
6398728|NCT00216021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398729|NCT00216021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6398730|NCT00216034|polysaccharide-K|polysaccharide-k|mesh-list
6398731|NCT00216034|Tegafur|tegafur|mesh-list
6398732|NCT00216034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6398733|NCT00216034|Antimetabolites|antimetabolites|mesh-ancestor
6398734|NCT00216034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398735|NCT00216034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6398736|NCT00216034|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6398737|NCT00216034|Immunologic Factors|immunologic factors|mesh-ancestor
6398738|NCT00216034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398739|NCT00216034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6398740|NCT00216034|Antiviral Agents|antiviral agents|mesh-ancestor
6398741|NCT00216034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6398742|NCT00216034|Interferon Inducers|interferon inducers|mesh-ancestor
6398743|NCT00216034|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6398744|NCT00216034|Protective Agents|protective agents|mesh-ancestor
6398745|NCT00216047|Trastuzumab|trastuzumab|mesh-list
6398746|NCT00216047|Vatalanib|vatalanib|mesh-list
6398747|NCT00216047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6398748|NCT00216047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6398749|NCT00216047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6398750|NCT00216047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6398751|NCT00216047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398752|NCT00216073|Capecitabine|capecitabine|mesh-list
6398753|NCT00216073|Oxaliplatin|oxaliplatin|mesh-list
6398754|NCT00216073|Trastuzumab|trastuzumab|mesh-list
6398755|NCT00216073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6398756|NCT00216073|Antimetabolites|antimetabolites|mesh-ancestor
6398757|NCT00216073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398758|NCT00216073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6398759|NCT00216073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6398760|NCT00216112|Docetaxel|docetaxel|mesh-list
6398761|NCT00216112|Imatinib Mesylate|imatinib mesylate|mesh-list
6398762|NCT00216112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6398763|NCT00216112|Tubulin Modulators|tubulin modulators|mesh-ancestor
6398764|NCT00216112|Antimitotic Agents|antimitotic agents|mesh-ancestor
6398765|NCT00216112|Mitosis Modulators|mitosis modulators|mesh-ancestor
6398766|NCT00216112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398767|NCT00216112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6398768|NCT00216112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6398769|NCT00216138|Docetaxel|docetaxel|mesh-list
6398770|NCT00216138|Capecitabine|capecitabine|mesh-list
6398771|NCT00216138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6398772|NCT00216138|Tubulin Modulators|tubulin modulators|mesh-ancestor
6398773|NCT00216138|Antimitotic Agents|antimitotic agents|mesh-ancestor
6398774|NCT00216138|Mitosis Modulators|mitosis modulators|mesh-ancestor
6398775|NCT00216138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398776|NCT00216138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6398777|NCT00216138|Antimetabolites|antimetabolites|mesh-ancestor
6398778|NCT00216151|Zoledronic Acid|zoledronic acid|mesh-list
6398779|NCT00216151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6398780|NCT00216151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398781|NCT00216164|Gemcitabine|gemcitabine|mesh-list
6398782|NCT00216164|Rituximab|rituximab|mesh-list
6398783|NCT00216164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6398784|NCT00216164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6398785|NCT00216164|Immunologic Factors|immunologic factors|mesh-ancestor
6398786|NCT00216164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398787|NCT00216164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6398788|NCT00216164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6398789|NCT00216164|Antimetabolites|antimetabolites|mesh-ancestor
6398790|NCT00216164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398791|NCT00216164|Antiviral Agents|antiviral agents|mesh-ancestor
6398792|NCT00216164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6398793|NCT00216164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6398794|NCT00216164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6398795|NCT00216177|Adalimumab|adalimumab|mesh-list
6398796|NCT00216177|Infliximab|infliximab|mesh-list
6398797|NCT00216177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6398798|NCT00216177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6398799|NCT00216177|Dermatologic Agents|dermatologic agents|mesh-ancestor
6398800|NCT00216177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6458965|NCT00442676|Sensory System Agents|sensory system agents|mesh-ancestor
6458966|NCT00442676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6458967|NCT00442676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458968|NCT00442676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6458969|NCT00442676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6458970|NCT00442676|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6458971|NCT00442676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6458972|NCT00442676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6458973|NCT00442676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458974|NCT00442741|Epothilone B|epothilone b|mesh-list
6458975|NCT00442741|Epothilones|epothilones|mesh-list
6458976|NCT00442741|Omeprazole|omeprazole|mesh-list
6458977|NCT00442741|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6458978|NCT00442741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6458979|NCT00442741|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6458980|NCT00442741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6458981|NCT00442741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458982|NCT00442741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6458983|NCT00442741|Tubulin Modulators|tubulin modulators|mesh-ancestor
6458984|NCT00442741|Antimitotic Agents|antimitotic agents|mesh-ancestor
6458985|NCT00442741|Mitosis Modulators|mitosis modulators|mesh-ancestor
6458986|NCT00442780|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
6458987|NCT00442780|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
6458988|NCT00442780|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6458989|NCT00442780|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6458990|NCT00442780|Purinergic Agents|purinergic agents|mesh-ancestor
6458991|NCT00442780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6458992|NCT00442780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458993|NCT00442780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458994|NCT00442793|Epoetin Alfa|epoetin alfa|mesh-list
6458995|NCT00442793|Hematinics|hematinics|mesh-ancestor
6458996|NCT00442819|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
6458997|NCT00442819|Vasodilator Agents|vasodilator agents|mesh-ancestor
6458998|NCT00442819|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
6458999|NCT00442819|Protective Agents|protective agents|mesh-ancestor
6459000|NCT00442819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459001|NCT00442832|Vancomycin|vancomycin|mesh-list
6459002|NCT00442832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6459003|NCT00442832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6459004|NCT00442845|Atorvastatin|atorvastatin|mesh-list
6398801|NCT00216190|Midazolam|midazolam|mesh-list
6398802|NCT00216190|Dexmedetomidine|dexmedetomidine|mesh-list
6398803|NCT00216190|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6398804|NCT00216190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6398805|NCT00216190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398806|NCT00216190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6398807|NCT00216190|Analgesics|analgesics|mesh-ancestor
6398808|NCT00216190|Sensory System Agents|sensory system agents|mesh-ancestor
6398809|NCT00216190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6398810|NCT00216190|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6398811|NCT00216190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6398812|NCT00216190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6398813|NCT00216190|Adrenergic Agents|adrenergic agents|mesh-ancestor
6398814|NCT00216190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6398815|NCT00216190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398816|NCT00216190|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6398817|NCT00216190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6398818|NCT00216190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6398819|NCT00216190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6398820|NCT00216190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6398821|NCT00216190|Anesthetics, General|anesthetics, general|mesh-ancestor
6398822|NCT00216190|Anesthetics|anesthetics|mesh-ancestor
6398823|NCT00216190|GABA Modulators|gaba modulators|mesh-ancestor
6398824|NCT00216190|GABA Agents|gaba agents|mesh-ancestor
6398825|NCT00216216|Pemetrexed|pemetrexed|mesh-list
6398826|NCT00216216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6398827|NCT00216216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6398828|NCT00216216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398829|NCT00216216|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6398830|NCT00216216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6398831|NCT00216268|Ribavirin|ribavirin|mesh-list
6398832|NCT00216268|Antimetabolites|antimetabolites|mesh-ancestor
6398833|NCT00216268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398834|NCT00216268|Antiviral Agents|antiviral agents|mesh-ancestor
6398835|NCT00216268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6398836|NCT00216281|Clozapine|clozapine|mesh-list
6398837|NCT00216281|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6398838|NCT00216281|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6398839|NCT00216281|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6398840|NCT00216281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6398841|NCT00216281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398842|NCT00216281|Adrenergic Agents|adrenergic agents|mesh-ancestor
6398843|NCT00216281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6398844|NCT00216281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398845|NCT00216281|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6398846|NCT00216281|Serotonin Agents|serotonin agents|mesh-ancestor
6398847|NCT00216281|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6398848|NCT00216281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6398849|NCT00216281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6398850|NCT00216281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6398851|NCT00216281|GABA Antagonists|gaba antagonists|mesh-ancestor
6398852|NCT00216281|GABA Agents|gaba agents|mesh-ancestor
6398853|NCT00216294|Secretin|secretin|mesh-list
6398854|NCT00216294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6398855|NCT00216294|Hormones|hormones|mesh-ancestor
6398856|NCT00216294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6398857|NCT00216294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398858|NCT00216346|Amphotericin B|amphotericin b|mesh-list
6398859|NCT00216346|Paromomycin|paromomycin|mesh-list
6398860|NCT00216346|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6398861|NCT00216346|Amebicides|amebicides|mesh-ancestor
6398862|NCT00216346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6398863|NCT00216346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6398864|NCT00216346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6398865|NCT00216346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6398866|NCT00216346|Antifungal Agents|antifungal agents|mesh-ancestor
6398867|NCT00216359|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6398868|NCT00216359|Enfuvirtide|enfuvirtide|mesh-list
6398869|NCT00216359|Antiviral Agents|antiviral agents|mesh-ancestor
6398870|NCT00216359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6398871|NCT00216359|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6398872|NCT00216359|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6398873|NCT00216359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398874|NCT00216359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6398875|NCT00216372|Lanreotide|lanreotide|mesh-list
6398876|NCT00216372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6398877|NCT00216385|Gatifloxacin|gatifloxacin|mesh-list
6398878|NCT00216385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6398879|NCT00216385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6398880|NCT00216385|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6398881|NCT00216385|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6398882|NCT00216385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6398883|NCT00216385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6398884|NCT00216385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6398885|NCT00216385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398886|NCT00216385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6398887|NCT00216398|Lanreotide|lanreotide|mesh-list
6398888|NCT00216398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6398889|NCT00216411|Botulinum Toxins|botulinum toxins|mesh-list
6398890|NCT00216411|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6398891|NCT00216411|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6398892|NCT00216411|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6398893|NCT00216411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6398894|NCT00216411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398895|NCT00216411|Cholinergic Agents|cholinergic agents|mesh-ancestor
6398896|NCT00216411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6398897|NCT00216411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398898|NCT00216411|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6398899|NCT00216411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6398900|NCT00216424|Capecitabine|capecitabine|mesh-list
6398901|NCT00216424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6398902|NCT00216424|Antimetabolites|antimetabolites|mesh-ancestor
6398903|NCT00216424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398904|NCT00216424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6398905|NCT00216437|Capecitabine|capecitabine|mesh-list
6398906|NCT00216437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6398907|NCT00216437|Antimetabolites|antimetabolites|mesh-ancestor
6398908|NCT00216437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398909|NCT00216437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6398910|NCT00216450|Rabeprazole|rabeprazole|mesh-list
6398911|NCT00216450|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6398912|NCT00216450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6398913|NCT00216450|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6398914|NCT00216450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6398915|NCT00216450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398916|NCT00216463|Mipomersen|mipomersen|mesh-list
6398917|NCT00216463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6398918|NCT00216463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6398919|NCT00216463|Antimetabolites|antimetabolites|mesh-ancestor
6398920|NCT00216463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398921|NCT00216463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6398922|NCT00216489|Rabeprazole|rabeprazole|mesh-list
6398923|NCT00216489|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6398924|NCT00216489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6398925|NCT00216489|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6398926|NCT00216489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6398927|NCT00216489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398928|NCT00216502|Galantamine|galantamine|mesh-list
6398929|NCT00216502|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6398930|NCT00216502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6398931|NCT00216502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6018547|NCT00381680|Asparaginase|asparaginase|mesh-list
6018548|NCT00381680|Mercaptopurine|mercaptopurine|mesh-list
6018549|NCT00381680|Pegaspargase|pegaspargase|mesh-list
6018550|NCT00381680|Levoleucovorin|levoleucovorin|mesh-list
6018551|NCT00381680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6018552|NCT00381680|Immunologic Factors|immunologic factors|mesh-ancestor
6018553|NCT00381680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018554|NCT00381680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6018555|NCT00381680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6018556|NCT00381680|Alkylating Agents|alkylating agents|mesh-ancestor
6018557|NCT00381680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6018558|NCT00381680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6018559|NCT00381680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6398932|NCT00216502|Cholinergic Agents|cholinergic agents|mesh-ancestor
6398933|NCT00216502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6398934|NCT00216502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398935|NCT00216502|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6398936|NCT00216502|Autonomic Agents|autonomic agents|mesh-ancestor
6018560|NCT00381680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6018561|NCT00381680|Antiemetics|antiemetics|mesh-ancestor
6398937|NCT00216502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6398938|NCT00216502|Nootropic Agents|nootropic agents|mesh-ancestor
6398939|NCT00216515|Galantamine|galantamine|mesh-list
6398940|NCT00216515|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6398941|NCT00216515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6398942|NCT00216515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398943|NCT00216515|Cholinergic Agents|cholinergic agents|mesh-ancestor
6398944|NCT00216515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6398945|NCT00216515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398946|NCT00216515|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6398947|NCT00216515|Autonomic Agents|autonomic agents|mesh-ancestor
6018562|NCT00381680|Autonomic Agents|autonomic agents|mesh-ancestor
6018563|NCT00381680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6018564|NCT00381680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6018565|NCT00381680|Glucocorticoids|glucocorticoids|mesh-ancestor
6018566|NCT00381680|Hormones|hormones|mesh-ancestor
6018567|NCT00381680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6398948|NCT00216515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6398949|NCT00216515|Nootropic Agents|nootropic agents|mesh-ancestor
6398950|NCT00216528|Risperidone|risperidone|mesh-list
6398951|NCT00216528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6398952|NCT00216528|Serotonin Agents|serotonin agents|mesh-ancestor
6398953|NCT00216528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6398954|NCT00216528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398955|NCT00216528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398956|NCT00216528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6398957|NCT00216528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6398958|NCT00216528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6398959|NCT00216528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6398960|NCT00216528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6398961|NCT00216528|Dopamine Agents|dopamine agents|mesh-ancestor
6398962|NCT00216541|Epoetin Alfa|epoetin alfa|mesh-list
6398963|NCT00216541|Hematinics|hematinics|mesh-ancestor
6398964|NCT00216554|Risperidone|risperidone|mesh-list
6398965|NCT00216554|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6398966|NCT00216554|Serotonin Agents|serotonin agents|mesh-ancestor
6398967|NCT00216554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6398968|NCT00216554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398969|NCT00216554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398970|NCT00216554|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6398971|NCT00216554|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6398972|NCT00216554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6398973|NCT00216554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6398974|NCT00216554|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6398975|NCT00216554|Dopamine Agents|dopamine agents|mesh-ancestor
6398976|NCT00216567|Topiramate|topiramate|mesh-list
6398977|NCT00216567|Anticonvulsants|anticonvulsants|mesh-ancestor
6398978|NCT00216567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6398979|NCT00216567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398980|NCT00216580|Risperidone|risperidone|mesh-list
6398981|NCT00216580|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6398982|NCT00216580|Serotonin Agents|serotonin agents|mesh-ancestor
6398983|NCT00216580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6398984|NCT00216580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6398985|NCT00216580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398986|NCT00216580|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6398987|NCT00216580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6398988|NCT00216580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6398989|NCT00216580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6398990|NCT00216580|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6398991|NCT00216580|Dopamine Agents|dopamine agents|mesh-ancestor
6398992|NCT00216606|Topiramate|topiramate|mesh-list
6398993|NCT00216606|Anticonvulsants|anticonvulsants|mesh-ancestor
6398994|NCT00216606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6398995|NCT00216606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6398996|NCT00216619|Topiramate|topiramate|mesh-list
6398997|NCT00216619|Anticonvulsants|anticonvulsants|mesh-ancestor
6398998|NCT00216619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6398999|NCT00216619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399000|NCT00216632|Risperidone|risperidone|mesh-list
6399001|NCT00216632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6399002|NCT00216632|Serotonin Agents|serotonin agents|mesh-ancestor
6399003|NCT00216632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6399004|NCT00216632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399005|NCT00216632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399006|NCT00216632|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6399007|NCT00216632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6399008|NCT00216632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6399009|NCT00216632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6399010|NCT00216632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6399011|NCT00216632|Dopamine Agents|dopamine agents|mesh-ancestor
6399012|NCT00216645|Doxorubicin|doxorubicin|mesh-list
6399013|NCT00216645|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6399014|NCT00216645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6399015|NCT00216645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6399016|NCT00216645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6399017|NCT00216645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6399018|NCT00216645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6399019|NCT00216645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399020|NCT00216658|Fentanyl|fentanyl|mesh-list
6399021|NCT00216658|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6399022|NCT00216658|Narcotics|narcotics|mesh-ancestor
6399023|NCT00216658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6399024|NCT00216658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399025|NCT00216658|Analgesics|analgesics|mesh-ancestor
6399026|NCT00216658|Sensory System Agents|sensory system agents|mesh-ancestor
6399027|NCT00216658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6399028|NCT00216658|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6399029|NCT00216658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6399030|NCT00216658|Anesthetics, General|anesthetics, general|mesh-ancestor
6399031|NCT00216658|Anesthetics|anesthetics|mesh-ancestor
6399032|NCT00216684|Fentanyl|fentanyl|mesh-list
6399033|NCT00216684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6399034|NCT00216684|Narcotics|narcotics|mesh-ancestor
6399035|NCT00216684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6399036|NCT00216684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399037|NCT00216684|Analgesics|analgesics|mesh-ancestor
6399038|NCT00216684|Sensory System Agents|sensory system agents|mesh-ancestor
6399039|NCT00216684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6399040|NCT00216684|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6399041|NCT00216684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6399042|NCT00216684|Anesthetics, General|anesthetics, general|mesh-ancestor
6399043|NCT00216684|Anesthetics|anesthetics|mesh-ancestor
6399044|NCT00216697|Bortezomib|bortezomib|mesh-list
6399045|NCT00216697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6399046|NCT00216723|Aripiprazole|aripiprazole|mesh-list
6399047|NCT00216723|Antidepressive Agents|antidepressive agents|mesh-ancestor
6399048|NCT00216723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6399049|NCT00216723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6399050|NCT00216723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6399051|NCT00216723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6399052|NCT00216723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399053|NCT00216723|Dopamine Agonists|dopamine agonists|mesh-ancestor
6399054|NCT00216723|Dopamine Agents|dopamine agents|mesh-ancestor
6399055|NCT00216723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6399056|NCT00216723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399057|NCT00216723|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6399058|NCT00216723|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6399059|NCT00216723|Serotonin Agents|serotonin agents|mesh-ancestor
6399060|NCT00216723|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6399061|NCT00216723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6399062|NCT00216723|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6399063|NCT00216723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6399064|NCT00216762|Rituximab|rituximab|mesh-list
6399065|NCT00216762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6399066|NCT00216762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6399067|NCT00216762|Immunologic Factors|immunologic factors|mesh-ancestor
6399068|NCT00216762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399069|NCT00216762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6399070|NCT00216775|Interferons|interferons|mesh-list
6399071|NCT00216775|Ribavirin|ribavirin|mesh-list
6399072|NCT00216775|Interferon-alpha|interferon-alpha|mesh-list
6399073|NCT00216775|Interferon alpha-2|interferon alpha-2|mesh-list
6399074|NCT00216775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6399075|NCT00216775|Antiviral Agents|antiviral agents|mesh-ancestor
6399076|NCT00216775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6399077|NCT00216775|Antimetabolites|antimetabolites|mesh-ancestor
6399078|NCT00216775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399079|NCT00216775|Immunologic Factors|immunologic factors|mesh-ancestor
6399080|NCT00216775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399081|NCT00216788|Esomeprazole|esomeprazole|mesh-list
6399082|NCT00216788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6399083|NCT00216788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6399084|NCT00216788|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6399085|NCT00216788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6399086|NCT00216788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399087|NCT00216827|Betamethasone|betamethasone|mesh-list
6399088|NCT00216827|Betamethasone Valerate|betamethasone valerate|mesh-list
6399089|NCT00216827|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
6399090|NCT00216827|Betamethasone benzoate|betamethasone benzoate|mesh-list
6399091|NCT00216827|Calcipotriene|calcipotriene|mesh-list
6399092|NCT00216827|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
6399093|NCT00216827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6399094|NCT00216827|Glucocorticoids|glucocorticoids|mesh-ancestor
6399095|NCT00216827|Hormones|hormones|mesh-ancestor
6399096|NCT00216827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6399097|NCT00216827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399098|NCT00216827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6399099|NCT00216827|Respiratory System Agents|respiratory system agents|mesh-ancestor
6399100|NCT00216827|Dermatologic Agents|dermatologic agents|mesh-ancestor
6399101|NCT00216840|Betamethasone|betamethasone|mesh-list
6399102|NCT00216840|Betamethasone Valerate|betamethasone valerate|mesh-list
6399103|NCT00216840|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
6399104|NCT00216840|Betamethasone benzoate|betamethasone benzoate|mesh-list
6399105|NCT00216840|Calcipotriene|calcipotriene|mesh-list
6399106|NCT00216840|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
6399107|NCT00216840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6399108|NCT00216840|Glucocorticoids|glucocorticoids|mesh-ancestor
6399109|NCT00216840|Hormones|hormones|mesh-ancestor
6399110|NCT00216840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6399111|NCT00216840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399112|NCT00216840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6399113|NCT00216840|Respiratory System Agents|respiratory system agents|mesh-ancestor
6399114|NCT00216840|Dermatologic Agents|dermatologic agents|mesh-ancestor
6399115|NCT00216866|Dalteparin|dalteparin|mesh-list
6399116|NCT00216866|Tinzaparin|tinzaparin|mesh-list
6399117|NCT00216866|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6399118|NCT00216866|Warfarin|warfarin|mesh-list
6399119|NCT00216866|Anticoagulants|anticoagulants|mesh-ancestor
6399120|NCT00216866|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6399121|NCT00216866|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6399122|NCT00216866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399123|NCT00216879|Betamethasone|betamethasone|mesh-list
6399124|NCT00216879|Betamethasone Valerate|betamethasone valerate|mesh-list
6399125|NCT00216879|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
6399126|NCT00216879|Betamethasone benzoate|betamethasone benzoate|mesh-list
6399127|NCT00216879|Calcipotriene|calcipotriene|mesh-list
6399128|NCT00216879|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
6399129|NCT00216879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6399130|NCT00216879|Glucocorticoids|glucocorticoids|mesh-ancestor
6399131|NCT00216879|Hormones|hormones|mesh-ancestor
6399132|NCT00216879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6399133|NCT00216879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399134|NCT00216879|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6399135|NCT00216879|Respiratory System Agents|respiratory system agents|mesh-ancestor
6399136|NCT00216879|Dermatologic Agents|dermatologic agents|mesh-ancestor
6399137|NCT00216892|Betamethasone|betamethasone|mesh-list
6399138|NCT00216892|Calcipotriene|calcipotriene|mesh-list
6399139|NCT00216892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6399140|NCT00216892|Glucocorticoids|glucocorticoids|mesh-ancestor
6399141|NCT00216892|Hormones|hormones|mesh-ancestor
6399142|NCT00216892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6399143|NCT00216892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399144|NCT00216892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6399145|NCT00216892|Respiratory System Agents|respiratory system agents|mesh-ancestor
6399146|NCT00216892|Dermatologic Agents|dermatologic agents|mesh-ancestor
6399147|NCT00216918|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6399148|NCT00216918|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6399149|NCT00216918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6399150|NCT00216918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6399151|NCT00216918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399152|NCT00216918|Adrenergic Agents|adrenergic agents|mesh-ancestor
6399153|NCT00216918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6399154|NCT00216918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399155|NCT00216931|Iloprost|iloprost|mesh-list
6399156|NCT00216931|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6399157|NCT00216931|Vasodilator Agents|vasodilator agents|mesh-ancestor
6399158|NCT00217009|Furocoumarins|furocoumarins|mesh-list
6399159|NCT00217009|Dermatologic Agents|dermatologic agents|mesh-ancestor
6399160|NCT00217009|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6399161|NCT00217048|Yohimbine|yohimbine|mesh-list
6399162|NCT00217048|Mydriatics|mydriatics|mesh-ancestor
6399163|NCT00217048|Autonomic Agents|autonomic agents|mesh-ancestor
6399164|NCT00217048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6399165|NCT00217048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399166|NCT00217048|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6399167|NCT00217048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6399168|NCT00217048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6399169|NCT00217048|Adrenergic Agents|adrenergic agents|mesh-ancestor
6399170|NCT00217048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6399171|NCT00217048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399172|NCT00217048|Urological Agents|urological agents|mesh-ancestor
6399173|NCT00217152|Mycophenolic Acid|mycophenolic acid|mesh-list
6399174|NCT00217152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6399175|NCT00217152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6399176|NCT00217152|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6399177|NCT00217152|Antitubercular Agents|antitubercular agents|mesh-ancestor
6399178|NCT00217152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6399179|NCT00217152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6399180|NCT00217152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6399181|NCT00217152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399182|NCT00217178|Folic Acid|folic acid|mesh-list
6399183|NCT00217178|Vitamins|vitamins|mesh-ancestor
6399184|NCT00217178|Micronutrients|micronutrients|mesh-ancestor
6399185|NCT00217178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399186|NCT00217178|Hematinics|hematinics|mesh-ancestor
6018568|NCT00381680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6018569|NCT00381680|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6018570|NCT00381680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6018571|NCT00381680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6018572|NCT00381680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6018573|NCT00381680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6399187|NCT00217178|Vitamin B Complex|vitamin b complex|mesh-ancestor
6399188|NCT00217191|Ibuprofen|ibuprofen|mesh-list
6399189|NCT00217191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6399190|NCT00217191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6399191|NCT00217191|Analgesics|analgesics|mesh-ancestor
6399192|NCT00217191|Sensory System Agents|sensory system agents|mesh-ancestor
6399193|NCT00217191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6399194|NCT00217191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399195|NCT00217191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6399196|NCT00217191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6399197|NCT00217191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6399198|NCT00217191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6399199|NCT00217191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399200|NCT00217204|Pancrelipase|pancrelipase|mesh-list
6399201|NCT00217204|Pancreatin|pancreatin|mesh-list
6399202|NCT00217204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6399203|NCT00217243|Lidocaine|lidocaine|mesh-list
6399204|NCT00217243|Anesthetics, Local|anesthetics, local|mesh-ancestor
6399205|NCT00217243|Anesthetics|anesthetics|mesh-ancestor
6399206|NCT00217243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6399207|NCT00217243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399208|NCT00217243|Sensory System Agents|sensory system agents|mesh-ancestor
6399209|NCT00217243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6399210|NCT00217243|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6399211|NCT00217243|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6399212|NCT00217243|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6399213|NCT00217243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6399214|NCT00217243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399215|NCT00217282|Gemcitabine|gemcitabine|mesh-list
6399216|NCT00217282|Bevacizumab|bevacizumab|mesh-list
6399217|NCT00217282|Oxaliplatin|oxaliplatin|mesh-list
6399218|NCT00217282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6399219|NCT00217282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6399220|NCT00217282|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6399221|NCT00217282|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6399222|NCT00217282|Growth Substances|growth substances|mesh-ancestor
6399223|NCT00217282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399224|NCT00217282|Growth Inhibitors|growth inhibitors|mesh-ancestor
6399225|NCT00217282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6399226|NCT00217282|Antimetabolites|antimetabolites|mesh-ancestor
6399227|NCT00217282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399228|NCT00217282|Antiviral Agents|antiviral agents|mesh-ancestor
6399229|NCT00217282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6399230|NCT00217282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6399231|NCT00217282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6399232|NCT00217282|Immunologic Factors|immunologic factors|mesh-ancestor
6399233|NCT00217295|Topiramate|topiramate|mesh-list
6399234|NCT00217295|Anticonvulsants|anticonvulsants|mesh-ancestor
6399235|NCT00217295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6399236|NCT00217295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399237|NCT00217373|Interferons|interferons|mesh-list
6399238|NCT00217373|Interferon-alpha|interferon-alpha|mesh-list
6399239|NCT00217373|Interferon alpha-2|interferon alpha-2|mesh-list
6399240|NCT00217373|Metronidazole|metronidazole|mesh-list
6399241|NCT00217373|Vaccines|vaccines|mesh-list
6399242|NCT00217373|Sargramostim|sargramostim|mesh-list
6399243|NCT00217373|Immunologic Factors|immunologic factors|mesh-ancestor
6399244|NCT00217373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399245|NCT00217373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6399246|NCT00217373|Antiviral Agents|antiviral agents|mesh-ancestor
6399247|NCT00217373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6399248|NCT00217373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6399249|NCT00217373|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6399250|NCT00217373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6399251|NCT00217386|Etanercept|etanercept|mesh-list
6399252|NCT00217386|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6399253|NCT00217386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6399254|NCT00217386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6399255|NCT00217386|Analgesics|analgesics|mesh-ancestor
6399256|NCT00217386|Sensory System Agents|sensory system agents|mesh-ancestor
6399257|NCT00217386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6399258|NCT00217386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399259|NCT00217386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6399260|NCT00217386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6399261|NCT00217386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6399262|NCT00217386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6399263|NCT00217386|Immunologic Factors|immunologic factors|mesh-ancestor
6399264|NCT00217412|Vorinostat|vorinostat|mesh-list
6399265|NCT00217412|Isotretinoin|isotretinoin|mesh-list
6399266|NCT00217412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6399267|NCT00217412|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6399268|NCT00217412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6399269|NCT00217412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399270|NCT00217412|Dermatologic Agents|dermatologic agents|mesh-ancestor
6399271|NCT00217451|Clindamycin|clindamycin|mesh-list
6399272|NCT00217451|Clindamycin palmitate|clindamycin palmitate|mesh-list
6399273|NCT00217451|Clindamycin phosphate|clindamycin phosphate|mesh-list
6399274|NCT00217451|Fosmidomycin|fosmidomycin|mesh-list
6399275|NCT00217451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6399276|NCT00217451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6399277|NCT00217451|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6399278|NCT00217451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6399279|NCT00217451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399280|NCT00217477|Gemcitabine|gemcitabine|mesh-list
6399281|NCT00217477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6399282|NCT00217477|Antimetabolites|antimetabolites|mesh-ancestor
6399283|NCT00217477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399284|NCT00217477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6399285|NCT00217477|Antiviral Agents|antiviral agents|mesh-ancestor
6399286|NCT00217477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6399287|NCT00217477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6399288|NCT00217477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6399289|NCT00217477|Immunologic Factors|immunologic factors|mesh-ancestor
6399290|NCT00217477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399291|NCT00217503|Zidovudine|zidovudine|mesh-list
6399292|NCT00217503|Valganciclovir|valganciclovir|mesh-list
6399293|NCT00217503|Ganciclovir|ganciclovir|mesh-list
6399294|NCT00217503|Cyclophosphamide|cyclophosphamide|mesh-list
6399295|NCT00217503|Bevacizumab|bevacizumab|mesh-list
6399296|NCT00217503|Doxorubicin|doxorubicin|mesh-list
6399297|NCT00217503|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6399298|NCT00217503|Etoposide|etoposide|mesh-list
6399299|NCT00217503|Bortezomib|bortezomib|mesh-list
6399300|NCT00217503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6399301|NCT00217503|Immunologic Factors|immunologic factors|mesh-ancestor
6399302|NCT00217503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399303|NCT00217503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6399304|NCT00217503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6399305|NCT00217503|Alkylating Agents|alkylating agents|mesh-ancestor
6399306|NCT00217503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399307|NCT00217503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6399308|NCT00217503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6399309|NCT00217503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6399310|NCT00217503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6399311|NCT00217503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6399312|NCT00217503|Growth Substances|growth substances|mesh-ancestor
6399313|NCT00217503|Growth Inhibitors|growth inhibitors|mesh-ancestor
6399314|NCT00217503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6399315|NCT00217503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6399316|NCT00217503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6399317|NCT00217503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6399318|NCT00217503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6399319|NCT00217503|Antimetabolites|antimetabolites|mesh-ancestor
6399320|NCT00217503|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6399321|NCT00217503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6399322|NCT00217503|Antiviral Agents|antiviral agents|mesh-ancestor
6399323|NCT00217503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6399324|NCT00217503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6399325|NCT00217503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6399326|NCT00217516|Selenium|selenium|mesh-list
6399327|NCT00217516|Antioxidants|antioxidants|mesh-ancestor
6399328|NCT00217516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399329|NCT00217516|Protective Agents|protective agents|mesh-ancestor
6399330|NCT00217516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399331|NCT00217516|Trace Elements|trace elements|mesh-ancestor
6399332|NCT00217516|Micronutrients|micronutrients|mesh-ancestor
6399333|NCT00217529|Carboplatin|carboplatin|mesh-list
6399334|NCT00217529|Docetaxel|docetaxel|mesh-list
6399335|NCT00217529|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6399336|NCT00217529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6399337|NCT00217529|Tubulin Modulators|tubulin modulators|mesh-ancestor
6399338|NCT00217529|Antimitotic Agents|antimitotic agents|mesh-ancestor
6399339|NCT00217529|Mitosis Modulators|mitosis modulators|mesh-ancestor
6399340|NCT00217529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399341|NCT00217529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6399342|NCT00217529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6399343|NCT00217542|Interferons|interferons|mesh-list
6399344|NCT00217542|Interferon-alpha|interferon-alpha|mesh-list
6399345|NCT00217542|Interferon alpha-2|interferon alpha-2|mesh-list
6399346|NCT00217542|Azacitidine|azacitidine|mesh-list
6399347|NCT00217542|Amifostine|amifostine|mesh-list
6399348|NCT00217542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6399349|NCT00217542|Antiviral Agents|antiviral agents|mesh-ancestor
6399350|NCT00217542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6399351|NCT00217542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6399352|NCT00217542|Antimetabolites|antimetabolites|mesh-ancestor
6399353|NCT00217542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399354|NCT00217542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6399355|NCT00217542|Immunologic Factors|immunologic factors|mesh-ancestor
6399356|NCT00217542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399357|NCT00217542|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6399358|NCT00217542|Protective Agents|protective agents|mesh-ancestor
6399359|NCT00217555|Gemcitabine|gemcitabine|mesh-list
6399360|NCT00217555|Topotecan|topotecan|mesh-list
6399361|NCT00217555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6399362|NCT00217555|Antimetabolites|antimetabolites|mesh-ancestor
6399363|NCT00217555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399364|NCT00217555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6399365|NCT00217555|Antiviral Agents|antiviral agents|mesh-ancestor
6399366|NCT00217555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6399367|NCT00217555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6399368|NCT00217555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6399369|NCT00217555|Immunologic Factors|immunologic factors|mesh-ancestor
6399370|NCT00217555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399371|NCT00217555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6399372|NCT00217555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6399373|NCT00217568|Carboplatin|carboplatin|mesh-list
6399374|NCT00217568|Docetaxel|docetaxel|mesh-list
6399375|NCT00217568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6399376|NCT00217568|Tubulin Modulators|tubulin modulators|mesh-ancestor
6399377|NCT00217568|Antimitotic Agents|antimitotic agents|mesh-ancestor
6399378|NCT00217568|Mitosis Modulators|mitosis modulators|mesh-ancestor
6399379|NCT00217568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399380|NCT00217607|Paclitaxel|paclitaxel|mesh-list
6399381|NCT00217607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6399382|NCT00217607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6399383|NCT00217607|Tubulin Modulators|tubulin modulators|mesh-ancestor
6399384|NCT00217607|Antimitotic Agents|antimitotic agents|mesh-ancestor
6399385|NCT00217607|Mitosis Modulators|mitosis modulators|mesh-ancestor
6399386|NCT00217607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399387|NCT00217646|Sorafenib|sorafenib|mesh-list
6399388|NCT00217646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6399389|NCT00217646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6399390|NCT00217646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6399391|NCT00217646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399392|NCT00217659|Anastrozole|anastrozole|mesh-list
6399393|NCT00217659|Goserelin|goserelin|mesh-list
6399394|NCT00217659|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6399395|NCT00217659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6399396|NCT00217659|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6399397|NCT00217659|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6399398|NCT00217659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6399399|NCT00217659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399400|NCT00217659|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6399401|NCT00217659|Hormone Antagonists|hormone antagonists|mesh-ancestor
6399402|NCT00217659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6399403|NCT00217659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399404|NCT00217698|Gemcitabine|gemcitabine|mesh-list
6399405|NCT00217698|Gefitinib|gefitinib|mesh-list
6399406|NCT00217698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6399407|NCT00217698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6399408|NCT00217698|Antimetabolites|antimetabolites|mesh-ancestor
6399409|NCT00217698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399410|NCT00217698|Antiviral Agents|antiviral agents|mesh-ancestor
6399411|NCT00217698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6399412|NCT00217698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6399413|NCT00217698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6399414|NCT00217698|Immunologic Factors|immunologic factors|mesh-ancestor
6399415|NCT00217698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399416|NCT00217698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6399417|NCT00217711|Capecitabine|capecitabine|mesh-list
6399418|NCT00217711|Oxaliplatin|oxaliplatin|mesh-list
6399419|NCT00217711|Irinotecan|irinotecan|mesh-list
6399420|NCT00217711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6399421|NCT00217711|Antimetabolites|antimetabolites|mesh-ancestor
6399422|NCT00217711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399423|NCT00217711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6399424|NCT00217711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6399425|NCT00217711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6399426|NCT00217711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6459005|NCT00442845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6459006|NCT00442845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6459007|NCT00442845|Antimetabolites|antimetabolites|mesh-ancestor
6459008|NCT00442845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459009|NCT00442845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6459010|NCT00442845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6459011|NCT00442845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6459012|NCT00443105|Tacrolimus|tacrolimus|mesh-list
6459013|NCT00443105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6459014|NCT00443105|Immunologic Factors|immunologic factors|mesh-ancestor
6459015|NCT00443105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459016|NCT00443105|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6459017|NCT00443105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6459018|NCT00443105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459019|NCT00443144|Hormones|hormones|mesh-list
6459020|NCT00443144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6459021|NCT00443144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459022|NCT00443170|Rosiglitazone|rosiglitazone|mesh-list
6459023|NCT00443170|Flurbiprofen|flurbiprofen|mesh-list
6459024|NCT00443170|Midazolam|midazolam|mesh-list
6459025|NCT00443170|Caffeine|caffeine|mesh-list
6459026|NCT00443170|Omeprazole|omeprazole|mesh-list
6459027|NCT00443170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6459028|NCT00443170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6459029|NCT00443170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6459030|NCT00443170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459031|NCT00443170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6459032|NCT00443170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6399427|NCT00217815|Efungumab|efungumab|mesh-list
6399428|NCT00217815|Docetaxel|docetaxel|mesh-list
6399429|NCT00217815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6399430|NCT00217815|Tubulin Modulators|tubulin modulators|mesh-ancestor
6399431|NCT00217815|Antimitotic Agents|antimitotic agents|mesh-ancestor
6399432|NCT00217815|Mitosis Modulators|mitosis modulators|mesh-ancestor
6399433|NCT00217815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399434|NCT00217815|Antifungal Agents|antifungal agents|mesh-ancestor
6399435|NCT00217815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6399436|NCT00217828|Citalopram|citalopram|mesh-list
6399437|NCT00217828|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6399438|NCT00217828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6399439|NCT00217828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6399440|NCT00217828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399441|NCT00217828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6399442|NCT00217828|Serotonin Agents|serotonin agents|mesh-ancestor
6399443|NCT00217828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399444|NCT00217828|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6399445|NCT00217828|Antidepressive Agents|antidepressive agents|mesh-ancestor
6399446|NCT00217828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6399447|NCT00217932|Valproic Acid|valproic acid|mesh-list
6399448|NCT00217932|Anticonvulsants|anticonvulsants|mesh-ancestor
6399449|NCT00217932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6399450|NCT00217932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399451|NCT00217932|GABA Agents|gaba agents|mesh-ancestor
6399452|NCT00217932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6399453|NCT00217932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399454|NCT00217932|Antimanic Agents|antimanic agents|mesh-ancestor
6399455|NCT00217932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6399456|NCT00217932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6399457|NCT00217932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6399458|NCT00218049|Vanoxerine|vanoxerine|mesh-list
6399459|NCT00218049|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6399460|NCT00218049|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6399461|NCT00218049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6399462|NCT00218049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399463|NCT00218049|Dopamine Agents|dopamine agents|mesh-ancestor
6399464|NCT00218049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6399465|NCT00218049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399466|NCT00218075|Levodopa|levodopa|mesh-list
6399467|NCT00218075|Carbidopa|carbidopa|mesh-list
6399468|NCT00218075|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6399469|NCT00218075|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6399470|NCT00218075|Dopamine Agents|dopamine agents|mesh-ancestor
6399471|NCT00218075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6399472|NCT00218075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399473|NCT00218075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399474|NCT00218075|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6399475|NCT00218075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6399476|NCT00218101|Buprenorphine|buprenorphine|mesh-list
6399477|NCT00218101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6399478|NCT00218101|Narcotics|narcotics|mesh-ancestor
6399479|NCT00218101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6399480|NCT00218101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399481|NCT00218101|Analgesics|analgesics|mesh-ancestor
6399482|NCT00218101|Sensory System Agents|sensory system agents|mesh-ancestor
6399483|NCT00218101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6399484|NCT00218101|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6399485|NCT00218114|Valproic Acid|valproic acid|mesh-list
6399486|NCT00218114|Anticonvulsants|anticonvulsants|mesh-ancestor
6399487|NCT00218114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6399488|NCT00218114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399489|NCT00218114|GABA Agents|gaba agents|mesh-ancestor
6399490|NCT00218114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6399491|NCT00218114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399492|NCT00218114|Antimanic Agents|antimanic agents|mesh-ancestor
6399493|NCT00218114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6399494|NCT00218114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6399495|NCT00218114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6399496|NCT00218127|Methadyl Acetate|methadyl acetate|mesh-list
6399497|NCT00218127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6399498|NCT00218127|Narcotics|narcotics|mesh-ancestor
6399499|NCT00218127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6399500|NCT00218127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399501|NCT00218127|Analgesics|analgesics|mesh-ancestor
6399502|NCT00218127|Sensory System Agents|sensory system agents|mesh-ancestor
6399503|NCT00218127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6399504|NCT00218140|Nicotine|nicotine|mesh-list
6399505|NCT00218140|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6399506|NCT00218140|Autonomic Agents|autonomic agents|mesh-ancestor
6399507|NCT00218140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6399508|NCT00218140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399509|NCT00218140|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6399510|NCT00218140|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6399511|NCT00218140|Cholinergic Agents|cholinergic agents|mesh-ancestor
6399512|NCT00218140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6399513|NCT00218140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399514|NCT00218153|Naltrexone|naltrexone|mesh-list
6399515|NCT00218153|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6399516|NCT00218153|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6399517|NCT00218153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399518|NCT00218153|Sensory System Agents|sensory system agents|mesh-ancestor
6399519|NCT00218153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6399520|NCT00218166|Triazolam|triazolam|mesh-list
6399521|NCT00218166|Tiagabine|tiagabine|mesh-list
6399522|NCT00218166|Baclofen|baclofen|mesh-list
6399523|NCT00218166|GABA Agonists|gaba agonists|mesh-list
6399524|NCT00218166|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6399525|NCT00218166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399526|NCT00218166|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6399527|NCT00218166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6399528|NCT00218166|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6399529|NCT00218166|GABA Agents|gaba agents|mesh-ancestor
6399530|NCT00218166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6399531|NCT00218166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399532|NCT00218166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6399533|NCT00218166|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6399534|NCT00218166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6399535|NCT00218166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6399536|NCT00218166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6399537|NCT00218166|GABA Modulators|gaba modulators|mesh-ancestor
6399538|NCT00218166|Anticonvulsants|anticonvulsants|mesh-ancestor
6399539|NCT00218166|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
6399540|NCT00218166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6399541|NCT00218166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6399542|NCT00218205|Celecoxib|celecoxib|mesh-list
6399543|NCT00218205|Epirubicin|epirubicin|mesh-list
6399544|NCT00218205|Estramustine|estramustine|mesh-list
6399545|NCT00218205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6399546|NCT00218205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6399547|NCT00218205|Analgesics|analgesics|mesh-ancestor
6399548|NCT00218205|Sensory System Agents|sensory system agents|mesh-ancestor
6399549|NCT00218205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6399550|NCT00218205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399551|NCT00218205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6399552|NCT00218205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6399553|NCT00218205|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6399554|NCT00218205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6399555|NCT00218205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6399556|NCT00218205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399557|NCT00218205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6399558|NCT00218205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6399559|NCT00218205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6399560|NCT00218205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6399561|NCT00218205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6399562|NCT00218205|Alkylating Agents|alkylating agents|mesh-ancestor
6399563|NCT00218205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6399564|NCT00218218|Nicotine|nicotine|mesh-list
6399565|NCT00218218|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6399566|NCT00218218|Autonomic Agents|autonomic agents|mesh-ancestor
6399567|NCT00218218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6399568|NCT00218218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399569|NCT00218218|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6399570|NCT00218218|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6399571|NCT00218218|Cholinergic Agents|cholinergic agents|mesh-ancestor
6399572|NCT00218218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6399573|NCT00218218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399574|NCT00218231|Bupropion|bupropion|mesh-list
6399575|NCT00218231|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6399576|NCT00218231|Antidepressive Agents|antidepressive agents|mesh-ancestor
6399577|NCT00218231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6399578|NCT00218231|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6399579|NCT00218231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6399580|NCT00218231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6399581|NCT00218231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399582|NCT00218231|Dopamine Agents|dopamine agents|mesh-ancestor
6399583|NCT00218231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6399584|NCT00218231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399585|NCT00218231|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6399586|NCT00218231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6399587|NCT00218231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6399588|NCT00218244|Lobeline|lobeline|mesh-list
6399589|NCT00218244|Nicotine|nicotine|mesh-list
6399590|NCT00218244|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6399591|NCT00218244|Autonomic Agents|autonomic agents|mesh-ancestor
6399592|NCT00218244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6399593|NCT00218244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399594|NCT00218244|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6399595|NCT00218244|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6399596|NCT00218244|Cholinergic Agents|cholinergic agents|mesh-ancestor
6399597|NCT00218244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6399598|NCT00218244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399599|NCT00218244|Respiratory System Agents|respiratory system agents|mesh-ancestor
6399600|NCT00218283|Nicotine|nicotine|mesh-list
6399601|NCT00218283|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6399602|NCT00218283|Autonomic Agents|autonomic agents|mesh-ancestor
6399603|NCT00218283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6399604|NCT00218283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399605|NCT00218283|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6399606|NCT00218283|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6399607|NCT00218283|Cholinergic Agents|cholinergic agents|mesh-ancestor
6399608|NCT00218283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6399609|NCT00218283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399610|NCT00218309|Hydromorphone|hydromorphone|mesh-list
6399611|NCT00218309|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6399612|NCT00218309|Narcotics|narcotics|mesh-ancestor
6399613|NCT00218309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6399614|NCT00218309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399615|NCT00218309|Analgesics|analgesics|mesh-ancestor
6399616|NCT00218309|Sensory System Agents|sensory system agents|mesh-ancestor
6399617|NCT00218309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6399618|NCT00218322|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6399619|NCT00218322|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6399620|NCT00218322|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6399621|NCT00218322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6399622|NCT00218322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399623|NCT00218322|Adrenergic Agents|adrenergic agents|mesh-ancestor
6399624|NCT00218322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6399625|NCT00218322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399626|NCT00218348|Amphetamine|amphetamine|mesh-list
6399627|NCT00218348|Dextroamphetamine|dextroamphetamine|mesh-list
6399628|NCT00218348|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6399629|NCT00218348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399630|NCT00218348|Sympathomimetics|sympathomimetics|mesh-ancestor
6399631|NCT00218348|Autonomic Agents|autonomic agents|mesh-ancestor
6399632|NCT00218348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6399633|NCT00218348|Dopamine Agents|dopamine agents|mesh-ancestor
6399634|NCT00218348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6399635|NCT00218348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399636|NCT00218348|Adrenergic Agents|adrenergic agents|mesh-ancestor
6399637|NCT00218348|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6399638|NCT00218348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6399639|NCT00218348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6399640|NCT00218348|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6399641|NCT00218361|Hydromorphone|hydromorphone|mesh-list
6399642|NCT00218361|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6399643|NCT00218361|Narcotics|narcotics|mesh-ancestor
6399644|NCT00218361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6399645|NCT00218361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399646|NCT00218361|Analgesics|analgesics|mesh-ancestor
6399647|NCT00218361|Sensory System Agents|sensory system agents|mesh-ancestor
6399648|NCT00218361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6399649|NCT00218374|Gabapentin|gabapentin|mesh-list
6399650|NCT00218374|Analgesics|analgesics|mesh-ancestor
6399651|NCT00218374|Sensory System Agents|sensory system agents|mesh-ancestor
6399652|NCT00218374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6399653|NCT00218374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399654|NCT00218374|Anticonvulsants|anticonvulsants|mesh-ancestor
6399655|NCT00218374|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6399656|NCT00218374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6399657|NCT00218374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6399658|NCT00218374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6399659|NCT00218374|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6399660|NCT00218374|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6399661|NCT00218374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6399662|NCT00218374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399663|NCT00218374|Antimanic Agents|antimanic agents|mesh-ancestor
6399664|NCT00218413|Vaccines|vaccines|mesh-list
6399665|NCT00218413|Immunologic Factors|immunologic factors|mesh-ancestor
6399666|NCT00218413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399667|NCT00218504|Dronabinol|dronabinol|mesh-list
6399668|NCT00218504|Hallucinogens|hallucinogens|mesh-ancestor
6399669|NCT00218504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399670|NCT00218504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6399671|NCT00218504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6399672|NCT00218504|Analgesics|analgesics|mesh-ancestor
6399673|NCT00218504|Sensory System Agents|sensory system agents|mesh-ancestor
6399674|NCT00218504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6399675|NCT00218504|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6399676|NCT00218504|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6399677|NCT00218504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6399678|NCT00218504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399679|NCT00218504|Hormones|hormones|mesh-ancestor
6399680|NCT00218504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6399681|NCT00218517|Selegiline|selegiline|mesh-list
6399682|NCT00218517|Antidepressive Agents|antidepressive agents|mesh-ancestor
6399683|NCT00218517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6399684|NCT00218517|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6399685|NCT00218517|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6399686|NCT00218517|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6399687|NCT00218517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6399688|NCT00218517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399689|NCT00218517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6399690|NCT00218517|Protective Agents|protective agents|mesh-ancestor
6399691|NCT00218517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399692|NCT00218530|Lofexidine|lofexidine|mesh-list
6399693|NCT00218530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6399694|NCT00218530|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6399695|NCT00218530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399696|NCT00218530|Sensory System Agents|sensory system agents|mesh-ancestor
6399697|NCT00218530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6399698|NCT00218530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6399699|NCT00218530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6399700|NCT00218530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6399701|NCT00218530|Adrenergic Agents|adrenergic agents|mesh-ancestor
6399702|NCT00218530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6399703|NCT00218530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399704|NCT00218569|Naltrexone|naltrexone|mesh-list
6399705|NCT00218569|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6399706|NCT00218569|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6399707|NCT00218569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399708|NCT00218569|Sensory System Agents|sensory system agents|mesh-ancestor
6399709|NCT00218569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6399710|NCT00218608|Disulfiram|disulfiram|mesh-list
6399711|NCT00218608|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6399712|NCT00218608|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
6399713|NCT00218608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6399714|NCT00218608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399715|NCT00218621|Buprenorphine|buprenorphine|mesh-list
6399716|NCT00218621|Methadone|methadone|mesh-list
6399717|NCT00218621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6399718|NCT00218621|Narcotics|narcotics|mesh-ancestor
6399719|NCT00218621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6399720|NCT00218621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399721|NCT00218621|Analgesics|analgesics|mesh-ancestor
6399722|NCT00218621|Sensory System Agents|sensory system agents|mesh-ancestor
6399723|NCT00218621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6399724|NCT00218621|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6399725|NCT00218621|Antitussive Agents|antitussive agents|mesh-ancestor
6399726|NCT00218621|Respiratory System Agents|respiratory system agents|mesh-ancestor
6399727|NCT00218660|Naltrexone|naltrexone|mesh-list
6399728|NCT00218660|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6399729|NCT00218660|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6399730|NCT00218660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399731|NCT00218660|Sensory System Agents|sensory system agents|mesh-ancestor
6399732|NCT00218660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6399733|NCT00218790|Dialysis Solutions|dialysis solutions|mesh-list
6399734|NCT00218790|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6399735|NCT00218855|Thalidomide|thalidomide|mesh-list
6399736|NCT00218855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6399737|NCT00218855|Immunologic Factors|immunologic factors|mesh-ancestor
6399738|NCT00218855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399739|NCT00218855|Leprostatic Agents|leprostatic agents|mesh-ancestor
6399740|NCT00218855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6399741|NCT00218855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6399742|NCT00218855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6399743|NCT00218855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6399744|NCT00218855|Growth Substances|growth substances|mesh-ancestor
6399745|NCT00218855|Growth Inhibitors|growth inhibitors|mesh-ancestor
6399746|NCT00218855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6399747|NCT00219219|Zoledronic Acid|zoledronic acid|mesh-list
6399748|NCT00219219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6399749|NCT00219219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399750|NCT00219232|Rivastigmine|rivastigmine|mesh-list
6399751|NCT00219232|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6399752|NCT00219232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6399753|NCT00219232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399754|NCT00219232|Cholinergic Agents|cholinergic agents|mesh-ancestor
6399755|NCT00219232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6399756|NCT00219232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399757|NCT00219232|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6399758|NCT00219232|Protective Agents|protective agents|mesh-ancestor
6399759|NCT00219245|Rivastigmine|rivastigmine|mesh-list
6399760|NCT00219245|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6399761|NCT00219245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6399762|NCT00219245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399763|NCT00219245|Cholinergic Agents|cholinergic agents|mesh-ancestor
6399764|NCT00219245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6399765|NCT00219245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399766|NCT00219245|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6399767|NCT00219245|Protective Agents|protective agents|mesh-ancestor
6399768|NCT00219258|Zoledronic Acid|zoledronic acid|mesh-list
6399769|NCT00219258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6399770|NCT00219258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399771|NCT00219271|Zoledronic Acid|zoledronic acid|mesh-list
6399772|NCT00219271|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6399773|NCT00219271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399774|NCT00219310|Famciclovir|famciclovir|mesh-list
6399775|NCT00219310|Antiviral Agents|antiviral agents|mesh-ancestor
6399776|NCT00219310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6399777|NCT00219310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6399778|NCT00219310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6399779|NCT00219310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399780|NCT00219323|Omalizumab|omalizumab|mesh-list
6399781|NCT00219323|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6399782|NCT00219323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6399783|NCT00219323|Respiratory System Agents|respiratory system agents|mesh-ancestor
6399784|NCT00219375|Sivelestat|sivelestat|mesh-list
6399785|NCT00219375|Glycine|glycine|mesh-list
6399786|NCT00219375|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6399787|NCT00219375|Protease Inhibitors|protease inhibitors|mesh-ancestor
6399788|NCT00219375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6399789|NCT00219375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399790|NCT00219375|Glycine Agents|glycine agents|mesh-ancestor
6399791|NCT00219375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6399792|NCT00219375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399793|NCT00219388|Simendan|simendan|mesh-list
6399794|NCT00219388|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6399795|NCT00219388|Vasodilator Agents|vasodilator agents|mesh-ancestor
6399796|NCT00219388|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6399797|NCT00219388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6399798|NCT00219388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6399799|NCT00219388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399800|NCT00219388|Protective Agents|protective agents|mesh-ancestor
6399801|NCT00219388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399802|NCT00219401|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6399803|NCT00219401|Immunologic Factors|immunologic factors|mesh-ancestor
6399804|NCT00219401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459033|NCT00443170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6459034|NCT00443170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6459035|NCT00443170|Anesthetics, General|anesthetics, general|mesh-ancestor
6459036|NCT00443170|Anesthetics|anesthetics|mesh-ancestor
6459037|NCT00443170|GABA Modulators|gaba modulators|mesh-ancestor
6459038|NCT00443170|GABA Agents|gaba agents|mesh-ancestor
6459039|NCT00443170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6459040|NCT00443170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459041|NCT00443170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6459042|NCT00443170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6459043|NCT00443170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6459044|NCT00443170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6459045|NCT00443170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6459046|NCT00443170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6459047|NCT00443170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6459048|NCT00443170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6459049|NCT00443170|Purinergic Agents|purinergic agents|mesh-ancestor
6459050|NCT00443170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6459051|NCT00443170|Analgesics|analgesics|mesh-ancestor
6459052|NCT00443170|Sensory System Agents|sensory system agents|mesh-ancestor
6459053|NCT00443170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6459054|NCT00443170|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6459055|NCT00443170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6459056|NCT00443170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6459057|NCT00443170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6459058|NCT00443170|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6459059|NCT00443222|Infliximab|infliximab|mesh-list
6459060|NCT00443222|Dermatologic Agents|dermatologic agents|mesh-ancestor
6459061|NCT00443222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6459062|NCT00443222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6462003|NCT00457054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462004|NCT00457054|Antimanic Agents|antimanic agents|mesh-ancestor
6462005|NCT00457054|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6462006|NCT00457054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6462007|NCT00457054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462008|NCT00457067|Ranibizumab|ranibizumab|mesh-list
6462009|NCT00457067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6462010|NCT00457067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6462011|NCT00457067|Growth Substances|growth substances|mesh-ancestor
6462012|NCT00457067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462013|NCT00457067|Growth Inhibitors|growth inhibitors|mesh-ancestor
6462014|NCT00457067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6462015|NCT00457093|Insulin Glargine|insulin glargine|mesh-list
6462016|NCT00457093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6462017|NCT00457093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462018|NCT00457106|Risperidone|risperidone|mesh-list
6462019|NCT00457106|Paroxetine|paroxetine|mesh-list
6462020|NCT00457106|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6462021|NCT00457106|Serotonin Agents|serotonin agents|mesh-ancestor
6399805|NCT00219440|Metformin|metformin|mesh-list
6399806|NCT00219440|Pioglitazone|pioglitazone|mesh-list
6399807|NCT00219440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6399808|NCT00219440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399809|NCT00219466|Zinc|zinc|mesh-list
6399810|NCT00219466|Tocopherols|tocopherols|mesh-list
6399811|NCT00219466|Vitamin E|vitamin e|mesh-list
6399812|NCT00219466|Tocotrienols|tocotrienols|mesh-list
6399813|NCT00219466|alpha-Tocopherol|alpha-tocopherol|mesh-list
6399814|NCT00219466|Zinc Oxide|zinc oxide|mesh-list
6399815|NCT00219466|Trace Elements|trace elements|mesh-ancestor
6399816|NCT00219466|Micronutrients|micronutrients|mesh-ancestor
6399817|NCT00219466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399818|NCT00219466|Antioxidants|antioxidants|mesh-ancestor
6399819|NCT00219466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399820|NCT00219466|Protective Agents|protective agents|mesh-ancestor
6399821|NCT00219466|Vitamins|vitamins|mesh-ancestor
6399822|NCT00219466|Dermatologic Agents|dermatologic agents|mesh-ancestor
6399823|NCT00219466|Sunscreening Agents|sunscreening agents|mesh-ancestor
6399824|NCT00219466|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6399825|NCT00219479|Phenytoin|phenytoin|mesh-list
6399826|NCT00219479|Anticonvulsants|anticonvulsants|mesh-ancestor
6399827|NCT00219479|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6399828|NCT00219479|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6399829|NCT00219479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6399830|NCT00219479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399831|NCT00219479|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6399832|NCT00219479|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6399833|NCT00219570|Clindamycin|clindamycin|mesh-list
6399834|NCT00219570|Clindamycin palmitate|clindamycin palmitate|mesh-list
6399835|NCT00219570|Clindamycin phosphate|clindamycin phosphate|mesh-list
6399836|NCT00219570|Nadifloxacin|nadifloxacin|mesh-list
6399837|NCT00219570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6399838|NCT00219570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6399839|NCT00219570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6399840|NCT00219570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6399841|NCT00219570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399842|NCT00219570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6399843|NCT00219570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6399844|NCT00219570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6399845|NCT00219596|Timolol|timolol|mesh-list
6399846|NCT00219596|Latanoprost|latanoprost|mesh-list
6399847|NCT00219596|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6399848|NCT00219596|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6399849|NCT00219596|Adrenergic Agents|adrenergic agents|mesh-ancestor
6399850|NCT00219596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6399851|NCT00219596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399852|NCT00219596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399853|NCT00219596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6399854|NCT00219596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6399855|NCT00219596|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6399856|NCT00219596|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6399857|NCT00219700|Ibuprofen|ibuprofen|mesh-list
6399858|NCT00219700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6399859|NCT00219700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6399860|NCT00219700|Analgesics|analgesics|mesh-ancestor
6399861|NCT00219700|Sensory System Agents|sensory system agents|mesh-ancestor
6399862|NCT00219700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6399863|NCT00219700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399864|NCT00219700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6399865|NCT00219700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6399866|NCT00219700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6399867|NCT00219700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6399868|NCT00219700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399869|NCT00219713|Nitrous Oxide|nitrous oxide|mesh-list
6399870|NCT00219713|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6399871|NCT00219713|Anesthetics, General|anesthetics, general|mesh-ancestor
6399872|NCT00219713|Anesthetics|anesthetics|mesh-ancestor
6399873|NCT00219713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6399874|NCT00219713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399875|NCT00219713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6399876|NCT00219713|Analgesics|analgesics|mesh-ancestor
6399877|NCT00219713|Sensory System Agents|sensory system agents|mesh-ancestor
6399878|NCT00219713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6399879|NCT00219726|Imatinib Mesylate|imatinib mesylate|mesh-list
6399880|NCT00219726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6399881|NCT00219726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6399882|NCT00219726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6399883|NCT00219726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399884|NCT00219739|Interferons|interferons|mesh-list
6399885|NCT00219739|Cytarabine|cytarabine|mesh-list
6399886|NCT00219739|Imatinib Mesylate|imatinib mesylate|mesh-list
6399887|NCT00219739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6399888|NCT00219739|Antiviral Agents|antiviral agents|mesh-ancestor
6399889|NCT00219739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6399890|NCT00219739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6399891|NCT00219739|Antimetabolites|antimetabolites|mesh-ancestor
6399892|NCT00219739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399893|NCT00219739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6399894|NCT00219739|Immunologic Factors|immunologic factors|mesh-ancestor
6399895|NCT00219739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399896|NCT00219739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6399897|NCT00219739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6399898|NCT00219752|Imatinib Mesylate|imatinib mesylate|mesh-list
6399899|NCT00219752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6399900|NCT00219752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6399901|NCT00219752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6399902|NCT00219752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399903|NCT00219765|Cytarabine|cytarabine|mesh-list
6399904|NCT00219765|Imatinib Mesylate|imatinib mesylate|mesh-list
6399905|NCT00219765|Daunorubicin|daunorubicin|mesh-list
6399906|NCT00219765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6399907|NCT00219765|Antimetabolites|antimetabolites|mesh-ancestor
6399908|NCT00219765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399909|NCT00219765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6399910|NCT00219765|Antiviral Agents|antiviral agents|mesh-ancestor
6399911|NCT00219765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6399912|NCT00219765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6399913|NCT00219765|Immunologic Factors|immunologic factors|mesh-ancestor
6399914|NCT00219765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399915|NCT00219765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6399916|NCT00219765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6399917|NCT00219765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6399918|NCT00219765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6399919|NCT00219765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6399920|NCT00219778|Mifepristone|mifepristone|mesh-list
6399921|NCT00219778|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6399922|NCT00219778|Abortifacient Agents|abortifacient agents|mesh-ancestor
6399923|NCT00219778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6399924|NCT00219778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399925|NCT00219778|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6399926|NCT00219778|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6399927|NCT00219778|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6399928|NCT00219778|Contraceptive Agents|contraceptive agents|mesh-ancestor
6399929|NCT00219778|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6399930|NCT00219778|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6399931|NCT00219778|Hormone Antagonists|hormone antagonists|mesh-ancestor
6399932|NCT00219778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6399933|NCT00219778|Luteolytic Agents|luteolytic agents|mesh-ancestor
6399934|NCT00219778|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6399935|NCT00219778|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6399936|NCT00219804|Tetrabenazine|tetrabenazine|mesh-list
6399937|NCT00219804|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6399938|NCT00219804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6399939|NCT00219804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6399940|NCT00219804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399941|NCT00219804|Adrenergic Agents|adrenergic agents|mesh-ancestor
6399942|NCT00219804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6399943|NCT00219804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399944|NCT00219856|Propofol|propofol|mesh-list
6399945|NCT00219856|Desflurane|desflurane|mesh-list
6399946|NCT00219856|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6399947|NCT00219856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6399948|NCT00219856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399949|NCT00219856|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6399950|NCT00219856|Anesthetics, General|anesthetics, general|mesh-ancestor
6399951|NCT00219856|Anesthetics|anesthetics|mesh-ancestor
6399952|NCT00219856|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6399953|NCT00219869|Galantamine|galantamine|mesh-list
6399954|NCT00219869|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6399955|NCT00219869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6399956|NCT00219869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399957|NCT00219869|Cholinergic Agents|cholinergic agents|mesh-ancestor
6399958|NCT00219869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6399959|NCT00219869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399960|NCT00219869|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6399961|NCT00219869|Autonomic Agents|autonomic agents|mesh-ancestor
6399962|NCT00219869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6399963|NCT00219869|Nootropic Agents|nootropic agents|mesh-ancestor
6399964|NCT00219882|Turmeric extract|turmeric extract|mesh-list
6399965|NCT00219882|Antioxidants|antioxidants|mesh-ancestor
6399966|NCT00219882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399967|NCT00219882|Protective Agents|protective agents|mesh-ancestor
6399968|NCT00219882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399969|NCT00219895|Ibuprofen|ibuprofen|mesh-list
6399970|NCT00219895|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6399971|NCT00219895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6399972|NCT00219895|Analgesics|analgesics|mesh-ancestor
6399973|NCT00219895|Sensory System Agents|sensory system agents|mesh-ancestor
6399974|NCT00219895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6399975|NCT00219895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399976|NCT00219895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6399977|NCT00219895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6399978|NCT00219895|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6399979|NCT00219895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6399980|NCT00219895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399981|NCT00219908|Mitoxantrone|mitoxantrone|mesh-list
6399982|NCT00219908|Analgesics|analgesics|mesh-ancestor
6399983|NCT00219908|Sensory System Agents|sensory system agents|mesh-ancestor
6399984|NCT00219908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6399985|NCT00219908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399986|NCT00219908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6399987|NCT00219908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6399988|NCT00219908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6399989|NCT00219908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6399990|NCT00219908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6399991|NCT00219921|Morphine|morphine|mesh-list
6399992|NCT00219921|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6399993|NCT00219921|Narcotics|narcotics|mesh-ancestor
6399994|NCT00219921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6399995|NCT00219921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6399996|NCT00219921|Analgesics|analgesics|mesh-ancestor
6399997|NCT00219921|Sensory System Agents|sensory system agents|mesh-ancestor
6399998|NCT00219921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6399999|NCT00219934|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6400000|NCT00219934|Antiviral Agents|antiviral agents|mesh-ancestor
6400001|NCT00219934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6400002|NCT00219973|Bemiparin|bemiparin|mesh-list
6400003|NCT00219973|Anticoagulants|anticoagulants|mesh-ancestor
6400004|NCT00220051|Capecitabine|capecitabine|mesh-list
6400005|NCT00220051|Oxaliplatin|oxaliplatin|mesh-list
6400006|NCT00220051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6400007|NCT00220051|Antimetabolites|antimetabolites|mesh-ancestor
6400008|NCT00220051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400009|NCT00220051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6400010|NCT00220064|Leucovorin|leucovorin|mesh-list
6400011|NCT00220064|Fluorouracil|fluorouracil|mesh-list
6400012|NCT00220064|Irinotecan|irinotecan|mesh-list
6400013|NCT00220064|Antimetabolites|antimetabolites|mesh-ancestor
6400014|NCT00220064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400015|NCT00220064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6400016|NCT00220064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6400017|NCT00220064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6400018|NCT00220064|Immunologic Factors|immunologic factors|mesh-ancestor
6400019|NCT00220064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400020|NCT00220064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6400021|NCT00220064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6400022|NCT00220064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6400023|NCT00220064|Antidotes|antidotes|mesh-ancestor
6400024|NCT00220064|Protective Agents|protective agents|mesh-ancestor
6400025|NCT00220064|Vitamin B Complex|vitamin b complex|mesh-ancestor
6400026|NCT00220064|Vitamins|vitamins|mesh-ancestor
6400027|NCT00220064|Micronutrients|micronutrients|mesh-ancestor
6400028|NCT00220103|Capecitabine|capecitabine|mesh-list
6400029|NCT00220103|Epirubicin|epirubicin|mesh-list
6400030|NCT00220103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6400031|NCT00220103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6400032|NCT00220103|Antimetabolites|antimetabolites|mesh-ancestor
6400033|NCT00220103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400034|NCT00220103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6400035|NCT00220103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6400036|NCT00220103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6400037|NCT00220103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6400038|NCT00220116|Capecitabine|capecitabine|mesh-list
6400039|NCT00220116|Oxaliplatin|oxaliplatin|mesh-list
6400040|NCT00220116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6400041|NCT00220116|Antimetabolites|antimetabolites|mesh-ancestor
6400042|NCT00220116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400043|NCT00220116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6400044|NCT00220129|Capecitabine|capecitabine|mesh-list
6400045|NCT00220129|Epirubicin|epirubicin|mesh-list
6400046|NCT00220129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6400047|NCT00220129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6400048|NCT00220129|Antimetabolites|antimetabolites|mesh-ancestor
6400049|NCT00220129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400050|NCT00220129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6400051|NCT00220129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6400052|NCT00220129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6400053|NCT00220129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6400054|NCT00220155|Gemcitabine|gemcitabine|mesh-list
6400055|NCT00220155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6400056|NCT00220155|Antimetabolites|antimetabolites|mesh-ancestor
6400057|NCT00220155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400058|NCT00220155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6400059|NCT00220155|Antiviral Agents|antiviral agents|mesh-ancestor
6400060|NCT00220155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6400061|NCT00220155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6400062|NCT00220155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6400063|NCT00220155|Immunologic Factors|immunologic factors|mesh-ancestor
6400064|NCT00220155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400065|NCT00220168|Capecitabine|capecitabine|mesh-list
6400066|NCT00220168|Irinotecan|irinotecan|mesh-list
6400067|NCT00220168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6400068|NCT00220168|Antimetabolites|antimetabolites|mesh-ancestor
6400069|NCT00220168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400070|NCT00220168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6400071|NCT00220168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6400072|NCT00220168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6400073|NCT00220168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6400074|NCT00220194|Leuprolide|leuprolide|mesh-list
6400075|NCT00220194|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6400076|NCT00220194|Fertility Agents|fertility agents|mesh-ancestor
6400077|NCT00220194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6400078|NCT00220194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400079|NCT00220194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6400080|NCT00220194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6400081|NCT00220220|Amlodipine|amlodipine|mesh-list
6400082|NCT00220220|Olmesartan|olmesartan|mesh-list
6400083|NCT00220220|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6400084|NCT00220220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6400085|NCT00220220|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6400086|NCT00220220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6400087|NCT00220220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400088|NCT00220220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6400089|NCT00220220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400090|NCT00220220|Vasodilator Agents|vasodilator agents|mesh-ancestor
6400091|NCT00220220|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6400092|NCT00220220|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6400093|NCT00220233|Amlodipine|amlodipine|mesh-list
6400094|NCT00220233|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6400095|NCT00220233|Olmesartan|olmesartan|mesh-list
6400096|NCT00220233|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6400097|NCT00220233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6400098|NCT00220233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6400099|NCT00220233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6400100|NCT00220233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400101|NCT00220233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6400102|NCT00220233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400103|NCT00220233|Vasodilator Agents|vasodilator agents|mesh-ancestor
6400104|NCT00220233|Diuretics|diuretics|mesh-ancestor
6400105|NCT00220233|Natriuretic Agents|natriuretic agents|mesh-ancestor
6400106|NCT00220233|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6400107|NCT00220233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6400108|NCT00220233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6400109|NCT00220259|Fluticasone|fluticasone|mesh-list
6400110|NCT00220259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6400111|NCT00220259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6400112|NCT00220259|Autonomic Agents|autonomic agents|mesh-ancestor
6400113|NCT00220259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6400114|NCT00220259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400115|NCT00220259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6400116|NCT00220259|Respiratory System Agents|respiratory system agents|mesh-ancestor
6400117|NCT00220259|Dermatologic Agents|dermatologic agents|mesh-ancestor
6400118|NCT00220259|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6400119|NCT00220285|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6400120|NCT00220285|Immunologic Factors|immunologic factors|mesh-ancestor
6400121|NCT00220285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400122|NCT00220298|Methyltestosterone|methyltestosterone|mesh-list
6400123|NCT00220298|Testosterone|testosterone|mesh-list
6400124|NCT00220298|Testosterone undecanoate|testosterone undecanoate|mesh-list
6400125|NCT00220298|Testosterone enanthate|testosterone enanthate|mesh-list
6400126|NCT00220298|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6400127|NCT00220298|Androgens|androgens|mesh-ancestor
6400128|NCT00220298|Hormones|hormones|mesh-ancestor
6400129|NCT00220298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6400130|NCT00220298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400131|NCT00220298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6400132|NCT00220298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6400133|NCT00220298|Anabolic Agents|anabolic agents|mesh-ancestor
6400134|NCT00220311|Fludarabine|fludarabine|mesh-list
6400135|NCT00220311|Fludarabine phosphate|fludarabine phosphate|mesh-list
6400136|NCT00220311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6400137|NCT00220311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6400138|NCT00220311|Antimetabolites|antimetabolites|mesh-ancestor
6400139|NCT00220311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400140|NCT00220311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6400141|NCT00220311|Immunologic Factors|immunologic factors|mesh-ancestor
6400142|NCT00220311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400143|NCT00220324|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
6400144|NCT00220324|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6400145|NCT00220324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6400146|NCT00220324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6400147|NCT00220324|Contraceptive Agents|contraceptive agents|mesh-ancestor
6400148|NCT00220324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6400149|NCT00220324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400150|NCT00220324|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6400151|NCT00220324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6400152|NCT00220324|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6400153|NCT00220324|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
6400154|NCT00220324|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6400155|NCT00220324|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6400156|NCT00220337|Lacosamide|lacosamide|mesh-list
6400157|NCT00220337|Anticonvulsants|anticonvulsants|mesh-ancestor
6400158|NCT00220337|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6400159|NCT00220337|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6400160|NCT00220337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6400161|NCT00220337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400162|NCT00220350|Leuprolide|leuprolide|mesh-list
6400163|NCT00220350|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6400164|NCT00220350|Fertility Agents|fertility agents|mesh-ancestor
6400165|NCT00220350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6400166|NCT00220350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400167|NCT00220350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6400168|NCT00220350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6400169|NCT00220428|Vaccines|vaccines|mesh-list
6400170|NCT00220428|Immunologic Factors|immunologic factors|mesh-ancestor
6400171|NCT00220428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400172|NCT00220454|Hydrocortisone|hydrocortisone|mesh-list
6400173|NCT00220454|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6400174|NCT00220454|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6400175|NCT00220454|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6400176|NCT00220454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6400177|NCT00220480|Citalopram|citalopram|mesh-list
6400178|NCT00220480|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6400179|NCT00220480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6400180|NCT00220480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6400181|NCT00220480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400182|NCT00220480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6400183|NCT00220480|Serotonin Agents|serotonin agents|mesh-ancestor
6400184|NCT00220480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400185|NCT00220480|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6400186|NCT00220480|Antidepressive Agents|antidepressive agents|mesh-ancestor
6400187|NCT00220480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6400188|NCT00220493|Methylphenidate|methylphenidate|mesh-list
6400189|NCT00220493|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6400190|NCT00220493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400191|NCT00220493|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6400192|NCT00220493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6400193|NCT00220493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6400194|NCT00220493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400195|NCT00220493|Dopamine Agents|dopamine agents|mesh-ancestor
6400196|NCT00220493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6400197|NCT00220506|Modafinil|modafinil|mesh-list
6400198|NCT00220506|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6400199|NCT00220506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400200|NCT00220506|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6400201|NCT00220506|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6400202|NCT00220506|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6459063|NCT00443235|Thalidomide|thalidomide|mesh-list
6400203|NCT00220506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400204|NCT00220532|Folic Acid|folic acid|mesh-list
6400205|NCT00220532|Riboflavin|riboflavin|mesh-list
6400206|NCT00220532|Hematinics|hematinics|mesh-ancestor
6400207|NCT00220532|Vitamin B Complex|vitamin b complex|mesh-ancestor
6400208|NCT00220532|Vitamins|vitamins|mesh-ancestor
6400209|NCT00220532|Micronutrients|micronutrients|mesh-ancestor
6400210|NCT00220532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400211|NCT00220532|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6400212|NCT00220532|Dermatologic Agents|dermatologic agents|mesh-ancestor
6400213|NCT00220584|Donepezil|donepezil|mesh-list
6400214|NCT00220584|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6400215|NCT00220584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6400216|NCT00220584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400217|NCT00220584|Cholinergic Agents|cholinergic agents|mesh-ancestor
6400218|NCT00220584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6400219|NCT00220584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400220|NCT00220584|Nootropic Agents|nootropic agents|mesh-ancestor
6400221|NCT00220623|Antidepressive Agents|antidepressive agents|mesh-list
6400222|NCT00220623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6400223|NCT00220649|Leucovorin|leucovorin|mesh-list
6400224|NCT00220649|Gemcitabine|gemcitabine|mesh-list
6400225|NCT00220649|Fluorouracil|fluorouracil|mesh-list
6400226|NCT00220649|Oxaliplatin|oxaliplatin|mesh-list
6400227|NCT00220649|Irinotecan|irinotecan|mesh-list
6400228|NCT00220649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6400229|NCT00220649|Antimetabolites|antimetabolites|mesh-ancestor
6400230|NCT00220649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400231|NCT00220649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6400232|NCT00220649|Antiviral Agents|antiviral agents|mesh-ancestor
6400233|NCT00220649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6400234|NCT00220649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6400235|NCT00220649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6400236|NCT00220649|Immunologic Factors|immunologic factors|mesh-ancestor
6400237|NCT00220649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400238|NCT00220649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6018574|NCT00381680|Abortifacient Agents|abortifacient agents|mesh-ancestor
6018575|NCT00381680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6400239|NCT00220649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6400240|NCT00220649|Antidotes|antidotes|mesh-ancestor
6018576|NCT00381680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6018577|NCT00381680|Antimetabolites|antimetabolites|mesh-ancestor
6400241|NCT00220649|Protective Agents|protective agents|mesh-ancestor
6400242|NCT00220649|Vitamin B Complex|vitamin b complex|mesh-ancestor
6400243|NCT00220649|Vitamins|vitamins|mesh-ancestor
6400244|NCT00220649|Micronutrients|micronutrients|mesh-ancestor
6400245|NCT00220675|Epoetin Alfa|epoetin alfa|mesh-list
6400246|NCT00220675|Hematinics|hematinics|mesh-ancestor
6400247|NCT00220714|Antipsychotic Agents|antipsychotic agents|mesh-list
6400248|NCT00220714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6400249|NCT00220714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6400250|NCT00220714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400251|NCT00220714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6400252|NCT00220766|Immunoglobulins|immunoglobulins|mesh-list
6400253|NCT00220766|Antibodies|antibodies|mesh-list
6400254|NCT00220766|gamma-Globulins|gamma-globulins|mesh-list
6400255|NCT00220766|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6400256|NCT00220766|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6400257|NCT00220766|Immunoglobulin G|immunoglobulin g|mesh-list
6400258|NCT00220766|Immunologic Factors|immunologic factors|mesh-ancestor
6400259|NCT00220766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400260|NCT00220818|Lansoprazole|lansoprazole|mesh-list
6400261|NCT00220818|Dexlansoprazole|dexlansoprazole|mesh-list
6400262|NCT00220818|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6400263|NCT00220818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6400264|NCT00220818|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6400265|NCT00220818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6400266|NCT00220818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459064|NCT00443235|Prednisone|prednisone|mesh-list
6459065|NCT00443235|Melphalan|melphalan|mesh-list
6459066|NCT00443235|Bortezomib|bortezomib|mesh-list
6459067|NCT00443235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6459068|NCT00443235|Glucocorticoids|glucocorticoids|mesh-ancestor
6459069|NCT00443235|Hormones|hormones|mesh-ancestor
6018578|NCT00381680|Dermatologic Agents|dermatologic agents|mesh-ancestor
6459070|NCT00443235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6459071|NCT00443235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459072|NCT00443235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6459073|NCT00443235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6400267|NCT00220831|Vitamin E|vitamin e|mesh-list
6400268|NCT00220831|Vitamins|vitamins|mesh-ancestor
6400269|NCT00220831|Micronutrients|micronutrients|mesh-ancestor
6400270|NCT00220831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400271|NCT00220831|Antioxidants|antioxidants|mesh-ancestor
6400272|NCT00220831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400273|NCT00220831|Protective Agents|protective agents|mesh-ancestor
6400274|NCT00220844|Amitriptyline|amitriptyline|mesh-list
6400275|NCT00220844|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6400276|NCT00220844|Desipramine|desipramine|mesh-list
6400277|NCT00220844|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6400278|NCT00220844|Antidepressive Agents|antidepressive agents|mesh-ancestor
6400279|NCT00220844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6400280|NCT00220844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6400281|NCT00220844|Analgesics|analgesics|mesh-ancestor
6400282|NCT00220844|Sensory System Agents|sensory system agents|mesh-ancestor
6400283|NCT00220844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6400284|NCT00220844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400285|NCT00220844|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6400286|NCT00220844|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6400287|NCT00220844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6400288|NCT00220844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400289|NCT00220844|Adrenergic Agents|adrenergic agents|mesh-ancestor
6400290|NCT00220844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6400291|NCT00220844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6400292|NCT00220844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6400293|NCT00220844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6400294|NCT00220844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6400295|NCT00220857|Rabeprazole|rabeprazole|mesh-list
6400296|NCT00220857|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6400297|NCT00220857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6400298|NCT00220857|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6400299|NCT00220857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6400300|NCT00220857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400301|NCT00220896|Donepezil|donepezil|mesh-list
6400302|NCT00220896|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6400303|NCT00220896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6400304|NCT00220896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400305|NCT00220896|Cholinergic Agents|cholinergic agents|mesh-ancestor
6400306|NCT00220896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6400307|NCT00220896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400308|NCT00220896|Nootropic Agents|nootropic agents|mesh-ancestor
6400309|NCT00220909|Lansoprazole|lansoprazole|mesh-list
6400310|NCT00220909|Dexlansoprazole|dexlansoprazole|mesh-list
6400311|NCT00220909|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6400312|NCT00220909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6400313|NCT00220909|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6400314|NCT00220909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6400315|NCT00220909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400316|NCT00220922|Ethanol|ethanol|mesh-list
6400317|NCT00220922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6400318|NCT00220922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6400319|NCT00220922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6400320|NCT00220922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400321|NCT00220987|Insulin|insulin|mesh-list
6400322|NCT00220987|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6400323|NCT00220987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6400324|NCT00220987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400325|NCT00221000|Methoxsalen|methoxsalen|mesh-list
6400326|NCT00221000|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6400327|NCT00221000|Dermatologic Agents|dermatologic agents|mesh-ancestor
6400328|NCT00221026|Methoxsalen|methoxsalen|mesh-list
6400329|NCT00221026|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6400330|NCT00221026|Dermatologic Agents|dermatologic agents|mesh-ancestor
6400331|NCT00221039|Methoxsalen|methoxsalen|mesh-list
6400332|NCT00221039|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6400333|NCT00221039|Dermatologic Agents|dermatologic agents|mesh-ancestor
6400334|NCT00221052|Diclofenac|diclofenac|mesh-list
6400335|NCT00221052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6400336|NCT00221052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6400337|NCT00221052|Analgesics|analgesics|mesh-ancestor
6400338|NCT00221052|Sensory System Agents|sensory system agents|mesh-ancestor
6400339|NCT00221052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6400340|NCT00221052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400341|NCT00221052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6400342|NCT00221052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6400343|NCT00221052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6400344|NCT00221052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6400345|NCT00221052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400346|NCT00221156|Acarbose|acarbose|mesh-list
6400347|NCT00221156|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6400348|NCT00221156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6400349|NCT00221156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400350|NCT00221156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6400351|NCT00221156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400352|NCT00221260|Anesthetics|anesthetics|mesh-list
6400353|NCT00221260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6400354|NCT00221260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400355|NCT00221286|Interferons|interferons|mesh-list
6400356|NCT00221286|Tenofovir|tenofovir|mesh-list
6400357|NCT00221286|Interferon-alpha|interferon-alpha|mesh-list
6400358|NCT00221286|Interferon alpha-2|interferon alpha-2|mesh-list
6400359|NCT00221286|Emtricitabine|emtricitabine|mesh-list
6400360|NCT00221286|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6400361|NCT00221286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6400362|NCT00221286|Antiviral Agents|antiviral agents|mesh-ancestor
6400363|NCT00221286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6400364|NCT00221286|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6400365|NCT00221286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6400366|NCT00221286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6400367|NCT00221286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6018579|NCT00381680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6018580|NCT00381680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6018581|NCT00381680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6018582|NCT00381680|Antiviral Agents|antiviral agents|mesh-ancestor
6018583|NCT00381680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6400368|NCT00221286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6400369|NCT00221286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6400370|NCT00221286|Immunologic Factors|immunologic factors|mesh-ancestor
6400371|NCT00221286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400372|NCT00221312|Alendronate|alendronate|mesh-list
6400373|NCT00221312|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6400374|NCT00221312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400375|NCT00221325|Rituximab|rituximab|mesh-list
6400376|NCT00221325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6400377|NCT00221325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6400378|NCT00221325|Immunologic Factors|immunologic factors|mesh-ancestor
6400379|NCT00221325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400380|NCT00221325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6400381|NCT00221364|Azithromycin|azithromycin|mesh-list
6400382|NCT00221364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6400383|NCT00221364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6400384|NCT00221390|Ropinirole|ropinirole|mesh-list
6400385|NCT00221390|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6400386|NCT00221390|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6400387|NCT00221390|Dopamine Agonists|dopamine agonists|mesh-ancestor
6400388|NCT00221390|Dopamine Agents|dopamine agents|mesh-ancestor
6400389|NCT00221390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6400390|NCT00221390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400391|NCT00221390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400392|NCT00221416|Aripiprazole|aripiprazole|mesh-list
6400393|NCT00221416|Antidepressive Agents|antidepressive agents|mesh-ancestor
6400394|NCT00221416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6400395|NCT00221416|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6400396|NCT00221416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6400397|NCT00221416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6400398|NCT00221416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400399|NCT00221416|Dopamine Agonists|dopamine agonists|mesh-ancestor
6400400|NCT00221416|Dopamine Agents|dopamine agents|mesh-ancestor
6400401|NCT00221416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6400402|NCT00221416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400403|NCT00221416|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6400404|NCT00221416|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6018584|NCT00381680|Antidotes|antidotes|mesh-ancestor
6400405|NCT00221416|Serotonin Agents|serotonin agents|mesh-ancestor
6400406|NCT00221416|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6400407|NCT00221416|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6400408|NCT00221416|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6400409|NCT00221416|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6400410|NCT00221429|Valproic Acid|valproic acid|mesh-list
6400411|NCT00221429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6400412|NCT00221429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6400413|NCT00221429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400414|NCT00221429|Antimanic Agents|antimanic agents|mesh-ancestor
6400415|NCT00221429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6400416|NCT00221429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6400417|NCT00221429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400418|NCT00221429|Anticonvulsants|anticonvulsants|mesh-ancestor
6400419|NCT00221429|GABA Agents|gaba agents|mesh-ancestor
6400420|NCT00221429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6400421|NCT00221442|Zonisamide|zonisamide|mesh-list
6400422|NCT00221442|Anticonvulsants|anticonvulsants|mesh-ancestor
6400423|NCT00221442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6400424|NCT00221442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6400425|NCT00221442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400426|NCT00221442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6400427|NCT00221442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400428|NCT00221468|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6400429|NCT00221468|Antidepressive Agents|antidepressive agents|mesh-ancestor
6400430|NCT00221468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6400431|NCT00221468|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6400432|NCT00221468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6400433|NCT00221468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6400434|NCT00221468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400435|NCT00221481|Valproic Acid|valproic acid|mesh-list
6400436|NCT00221481|Olanzapine|olanzapine|mesh-list
6400437|NCT00221481|Antiemetics|antiemetics|mesh-ancestor
6400438|NCT00221481|Autonomic Agents|autonomic agents|mesh-ancestor
6400439|NCT00221481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6400440|NCT00221481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400441|NCT00221481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6400442|NCT00221481|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6400443|NCT00221481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6400444|NCT00221481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6400445|NCT00221481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6400446|NCT00221481|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6400447|NCT00221481|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6400448|NCT00221481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6400449|NCT00221481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400450|NCT00221481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6400451|NCT00221481|Serotonin Agents|serotonin agents|mesh-ancestor
6400452|NCT00221481|Anticonvulsants|anticonvulsants|mesh-ancestor
6400453|NCT00221481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6400454|NCT00221481|GABA Agents|gaba agents|mesh-ancestor
6400455|NCT00221481|Antimanic Agents|antimanic agents|mesh-ancestor
6400456|NCT00221494|Pindolol|pindolol|mesh-list
6400457|NCT00221494|Citalopram|citalopram|mesh-list
6400458|NCT00221494|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6400459|NCT00221494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6400460|NCT00221494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6400461|NCT00221494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400462|NCT00221494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6400463|NCT00221494|Serotonin Agents|serotonin agents|mesh-ancestor
6400464|NCT00221494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501177|NCT04476992|Antioxidants|antioxidants|mesh-ancestor
6400465|NCT00221494|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6400466|NCT00221494|Antidepressive Agents|antidepressive agents|mesh-ancestor
6400467|NCT00221494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6400468|NCT00221494|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6400469|NCT00221494|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6400470|NCT00221494|Adrenergic Agents|adrenergic agents|mesh-ancestor
6400471|NCT00221494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6400472|NCT00221494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6400473|NCT00221494|Vasodilator Agents|vasodilator agents|mesh-ancestor
6400474|NCT00221520|Midazolam|midazolam|mesh-list
6400475|NCT00221520|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6400476|NCT00221520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6400477|NCT00221520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6400478|NCT00221520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400479|NCT00221520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6400480|NCT00221520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6400481|NCT00221520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6400482|NCT00221520|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6400483|NCT00221520|Anesthetics, General|anesthetics, general|mesh-ancestor
6400484|NCT00221520|Anesthetics|anesthetics|mesh-ancestor
6400485|NCT00221520|GABA Modulators|gaba modulators|mesh-ancestor
6400486|NCT00221520|GABA Agents|gaba agents|mesh-ancestor
6400487|NCT00221520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6400488|NCT00221520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400489|NCT00221598|Dialysis Solutions|dialysis solutions|mesh-list
6400490|NCT00221598|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6400491|NCT00221611|Baclofen|baclofen|mesh-list
6400492|NCT00221611|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6400493|NCT00221611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400494|NCT00221611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6400495|NCT00221611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6400496|NCT00221611|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6400497|NCT00221611|GABA Agonists|gaba agonists|mesh-ancestor
6400498|NCT00221611|GABA Agents|gaba agents|mesh-ancestor
6400499|NCT00221611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6400500|NCT00221611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400501|NCT00221624|Ribavirin|ribavirin|mesh-list
6400502|NCT00221624|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6400503|NCT00221624|Amantadine|amantadine|mesh-list
6400504|NCT00221624|Antimetabolites|antimetabolites|mesh-ancestor
6400505|NCT00221624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400506|NCT00221624|Antiviral Agents|antiviral agents|mesh-ancestor
6400507|NCT00221624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6400508|NCT00221624|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6400509|NCT00221624|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6400510|NCT00221624|Dopamine Agents|dopamine agents|mesh-ancestor
6400511|NCT00221624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6400512|NCT00221624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400513|NCT00221624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6400514|NCT00221624|Analgesics|analgesics|mesh-ancestor
6400515|NCT00221624|Sensory System Agents|sensory system agents|mesh-ancestor
6400516|NCT00221624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6400517|NCT00221637|Valproic Acid|valproic acid|mesh-list
6400518|NCT00221637|Anticonvulsants|anticonvulsants|mesh-ancestor
6400519|NCT00221637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6400520|NCT00221637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400521|NCT00221637|GABA Agents|gaba agents|mesh-ancestor
6400522|NCT00221637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6400523|NCT00221637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400524|NCT00221637|Antimanic Agents|antimanic agents|mesh-ancestor
6400525|NCT00221637|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6400526|NCT00221637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6400527|NCT00221637|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6400528|NCT00221650|Ribavirin|ribavirin|mesh-list
6400529|NCT00221650|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6400530|NCT00221650|Antimetabolites|antimetabolites|mesh-ancestor
6400531|NCT00221650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400532|NCT00221650|Antiviral Agents|antiviral agents|mesh-ancestor
6400533|NCT00221650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6400534|NCT00221689|Baclofen|baclofen|mesh-list
6400535|NCT00221689|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6400536|NCT00221689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400537|NCT00221689|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6400538|NCT00221689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6400539|NCT00221689|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6400540|NCT00221689|GABA Agonists|gaba agonists|mesh-ancestor
6400541|NCT00221689|GABA Agents|gaba agents|mesh-ancestor
6400542|NCT00221689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6400543|NCT00221689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400544|NCT00221702|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6400545|NCT00221702|Antiviral Agents|antiviral agents|mesh-ancestor
6400546|NCT00221702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6400547|NCT00221754|Pravastatin|pravastatin|mesh-list
6400548|NCT00221754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6400549|NCT00221754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6400550|NCT00221754|Antimetabolites|antimetabolites|mesh-ancestor
6400551|NCT00221754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400552|NCT00221754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6400553|NCT00221754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6400554|NCT00221754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6400555|NCT00221845|Telmisartan|telmisartan|mesh-list
6400556|NCT00221845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6400557|NCT00221845|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6400558|NCT00221845|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6400559|NCT00221845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400560|NCT00221871|Ketamine|ketamine|mesh-list
6400561|NCT00221871|Analgesics|analgesics|mesh-ancestor
6400562|NCT00221871|Sensory System Agents|sensory system agents|mesh-ancestor
6400563|NCT00221871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6400564|NCT00221871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400565|NCT00221871|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6400566|NCT00221871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6400567|NCT00221871|Anesthetics, General|anesthetics, general|mesh-ancestor
6400568|NCT00221871|Anesthetics|anesthetics|mesh-ancestor
6400569|NCT00221871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6400570|NCT00221871|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6400571|NCT00221871|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6400572|NCT00221871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6400573|NCT00221871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400574|NCT00221962|Aripiprazole|aripiprazole|mesh-list
6400575|NCT00221962|Antidepressive Agents|antidepressive agents|mesh-ancestor
6400576|NCT00221962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6400577|NCT00221962|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6400578|NCT00221962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6400579|NCT00221962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6400580|NCT00221962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400581|NCT00221962|Dopamine Agonists|dopamine agonists|mesh-ancestor
6400582|NCT00221962|Dopamine Agents|dopamine agents|mesh-ancestor
6400583|NCT00221962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6400584|NCT00221962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400585|NCT00221962|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6400586|NCT00221962|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6400587|NCT00221962|Serotonin Agents|serotonin agents|mesh-ancestor
6018585|NCT00381680|Protective Agents|protective agents|mesh-ancestor
6018586|NCT00381680|Vitamin B Complex|vitamin b complex|mesh-ancestor
6018587|NCT00381680|Vitamins|vitamins|mesh-ancestor
6018588|NCT00381680|Micronutrients|micronutrients|mesh-ancestor
6018589|NCT00381680|Tubulin Modulators|tubulin modulators|mesh-ancestor
6400588|NCT00221962|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6400589|NCT00221962|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6400590|NCT00221962|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6400591|NCT00221962|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6400592|NCT00221975|Lamotrigine|lamotrigine|mesh-list
6400593|NCT00221975|Valproic Acid|valproic acid|mesh-list
6400594|NCT00221975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6400595|NCT00221975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6400596|NCT00221975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400597|NCT00221975|Antimanic Agents|antimanic agents|mesh-ancestor
6400598|NCT00221975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6400599|NCT00221975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6400600|NCT00221975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400601|NCT00221975|Anticonvulsants|anticonvulsants|mesh-ancestor
6400602|NCT00221975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6400603|NCT00221975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6400604|NCT00221975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6400605|NCT00221975|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6400606|NCT00221975|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6400607|NCT00221975|GABA Agents|gaba agents|mesh-ancestor
6400608|NCT00221975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6400609|NCT00221988|Levetiracetam|levetiracetam|mesh-list
6400610|NCT00221988|Anticonvulsants|anticonvulsants|mesh-ancestor
6400611|NCT00221988|Nootropic Agents|nootropic agents|mesh-ancestor
6400612|NCT00222053|Thalidomide|thalidomide|mesh-list
6400613|NCT00222053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6400614|NCT00222053|Immunologic Factors|immunologic factors|mesh-ancestor
6400615|NCT00222053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400616|NCT00222053|Leprostatic Agents|leprostatic agents|mesh-ancestor
6400617|NCT00222053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6400618|NCT00222053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6400619|NCT00222053|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6400620|NCT00222053|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6400621|NCT00222053|Growth Substances|growth substances|mesh-ancestor
6400622|NCT00222053|Growth Inhibitors|growth inhibitors|mesh-ancestor
6400623|NCT00222053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6400624|NCT00222079|Esomeprazole|esomeprazole|mesh-list
6400625|NCT00222079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6400626|NCT00222079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6400627|NCT00222079|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6400628|NCT00222079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6400629|NCT00222079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400630|NCT00222144|Docetaxel|docetaxel|mesh-list
6400631|NCT00222144|Imatinib Mesylate|imatinib mesylate|mesh-list
6400632|NCT00222144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6400633|NCT00222144|Tubulin Modulators|tubulin modulators|mesh-ancestor
6400634|NCT00222144|Antimitotic Agents|antimitotic agents|mesh-ancestor
6400635|NCT00222144|Mitosis Modulators|mitosis modulators|mesh-ancestor
6400636|NCT00222144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400637|NCT00222144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6400638|NCT00222144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6400639|NCT00222170|Rabeprazole|rabeprazole|mesh-list
6400640|NCT00222170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6400641|NCT00222170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6400642|NCT00222170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6400643|NCT00222170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6400644|NCT00222170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400645|NCT00222183|Pimecrolimus|pimecrolimus|mesh-list
6400646|NCT00222183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6400647|NCT00222183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6400648|NCT00222183|Analgesics|analgesics|mesh-ancestor
6400649|NCT00222183|Sensory System Agents|sensory system agents|mesh-ancestor
6400650|NCT00222183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6400651|NCT00222183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400652|NCT00222183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6400653|NCT00222183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6400654|NCT00222183|Dermatologic Agents|dermatologic agents|mesh-ancestor
6400655|NCT00222183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6400656|NCT00222183|Immunologic Factors|immunologic factors|mesh-ancestor
6400657|NCT00222183|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6400658|NCT00222183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6400659|NCT00222183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400660|NCT00222235|Cycloserine|cycloserine|mesh-list
6400661|NCT00222235|Glycine|glycine|mesh-list
6400662|NCT00222235|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6400663|NCT00222235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6400664|NCT00222235|Renal Agents|renal agents|mesh-ancestor
6400665|NCT00222235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6400666|NCT00222235|Antitubercular Agents|antitubercular agents|mesh-ancestor
6400667|NCT00222235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6400668|NCT00222235|Antimetabolites|antimetabolites|mesh-ancestor
6400669|NCT00222235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400670|NCT00222235|Glycine Agents|glycine agents|mesh-ancestor
6400671|NCT00222235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6400672|NCT00222235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459074|NCT00443235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6459075|NCT00443235|Alkylating Agents|alkylating agents|mesh-ancestor
6459076|NCT00443235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459077|NCT00443235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6459078|NCT00443235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6459079|NCT00443235|Immunologic Factors|immunologic factors|mesh-ancestor
6459080|NCT00443235|Leprostatic Agents|leprostatic agents|mesh-ancestor
6459081|NCT00443235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6459082|NCT00443235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6459083|NCT00443235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6459084|NCT00443235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6459085|NCT00443235|Growth Substances|growth substances|mesh-ancestor
6459086|NCT00443235|Growth Inhibitors|growth inhibitors|mesh-ancestor
6459087|NCT00443339|Darbepoetin alfa|darbepoetin alfa|mesh-list
6400673|NCT00222261|Aspirin|aspirin|mesh-list
6400674|NCT00222261|Clopidogrel|clopidogrel|mesh-list
6400675|NCT00222261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6400676|NCT00222261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6400677|NCT00222261|Analgesics|analgesics|mesh-ancestor
6400678|NCT00222261|Sensory System Agents|sensory system agents|mesh-ancestor
6400679|NCT00222261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6400680|NCT00222261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400681|NCT00222261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6400682|NCT00222261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6400683|NCT00222261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6400684|NCT00222261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6400685|NCT00222261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400686|NCT00222261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6400687|NCT00222261|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6400688|NCT00222261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6400689|NCT00222261|Antipyretics|antipyretics|mesh-ancestor
6400690|NCT00222261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6400691|NCT00222261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6400692|NCT00222261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6400693|NCT00222261|Purinergic Agents|purinergic agents|mesh-ancestor
6400694|NCT00222261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6400695|NCT00222443|Irinotecan|irinotecan|mesh-list
6400696|NCT00222443|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6400697|NCT00222443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6400698|NCT00222443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6400699|NCT00222443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400700|NCT00222443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6400701|NCT00222469|Gemcitabine|gemcitabine|mesh-list
6400702|NCT00222469|Bevacizumab|bevacizumab|mesh-list
6400703|NCT00222469|Oxaliplatin|oxaliplatin|mesh-list
6400704|NCT00222469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6400705|NCT00222469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6400706|NCT00222469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6400707|NCT00222469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6400708|NCT00222469|Growth Substances|growth substances|mesh-ancestor
6400709|NCT00222469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400710|NCT00222469|Growth Inhibitors|growth inhibitors|mesh-ancestor
6400711|NCT00222469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6400712|NCT00222469|Antimetabolites|antimetabolites|mesh-ancestor
6400713|NCT00222469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400714|NCT00222469|Antiviral Agents|antiviral agents|mesh-ancestor
6400715|NCT00222469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6400716|NCT00222469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6400717|NCT00222469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6400718|NCT00222469|Immunologic Factors|immunologic factors|mesh-ancestor
6400719|NCT00222482|Valproic Acid|valproic acid|mesh-list
6400720|NCT00222482|Anticonvulsants|anticonvulsants|mesh-ancestor
6400721|NCT00222482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6400722|NCT00222482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400723|NCT00222482|GABA Agents|gaba agents|mesh-ancestor
6400724|NCT00222482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6400725|NCT00222482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400726|NCT00222482|Antimanic Agents|antimanic agents|mesh-ancestor
6018590|NCT00381680|Antimitotic Agents|antimitotic agents|mesh-ancestor
6018591|NCT00381680|Mitosis Modulators|mitosis modulators|mesh-ancestor
6400727|NCT00222482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6400728|NCT00222482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6400729|NCT00222482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6400730|NCT00222495|Olanzapine|olanzapine|mesh-list
6400731|NCT00222495|Risperidone|risperidone|mesh-list
6400732|NCT00222495|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6018592|NCT00381693|Azacitidine|azacitidine|mesh-list
6400733|NCT00222495|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6400734|NCT00222495|Serotonin Agents|serotonin agents|mesh-ancestor
6400735|NCT00222495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6400736|NCT00222495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400737|NCT00222495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400738|NCT00222495|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6400739|NCT00222495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6400740|NCT00222495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6400741|NCT00222495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6400742|NCT00222495|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6400743|NCT00222495|Dopamine Agents|dopamine agents|mesh-ancestor
6400744|NCT00222495|Antiemetics|antiemetics|mesh-ancestor
6400745|NCT00222495|Autonomic Agents|autonomic agents|mesh-ancestor
6400746|NCT00222495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6400747|NCT00222495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6018593|NCT00381693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5501178|NCT04476992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501179|NCT04476992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5501180|NCT04476992|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5501181|NCT04476992|Vasodilator Agents|vasodilator agents|mesh-ancestor
6018594|NCT00381693|Antimetabolites|antimetabolites|mesh-ancestor
6400748|NCT00222495|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6400749|NCT00222495|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6400750|NCT00222495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6400751|NCT00222495|Antidepressive Agents|antidepressive agents|mesh-ancestor
6400752|NCT00222521|Insulin Glargine|insulin glargine|mesh-list
6400753|NCT00222521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6400754|NCT00222521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400755|NCT00222534|Acetazolamide|acetazolamide|mesh-list
6400756|NCT00222534|Anticonvulsants|anticonvulsants|mesh-ancestor
6400757|NCT00222534|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6400758|NCT00222534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6400759|NCT00222534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400760|NCT00222534|Diuretics|diuretics|mesh-ancestor
6400761|NCT00222534|Natriuretic Agents|natriuretic agents|mesh-ancestor
6400762|NCT00222534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400763|NCT00222547|Vitamin A|vitamin a|mesh-list
6400764|NCT00222547|Albendazole|albendazole|mesh-list
6400765|NCT00222547|Vitamins|vitamins|mesh-ancestor
6400766|NCT00222547|Micronutrients|micronutrients|mesh-ancestor
6400767|NCT00222547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400768|NCT00222547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400769|NCT00222547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6400770|NCT00222547|Anthelmintics|anthelmintics|mesh-ancestor
6400771|NCT00222547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6400772|NCT00222547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6400773|NCT00222547|Anticestodal Agents|anticestodal agents|mesh-ancestor
6400774|NCT00222547|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6400775|NCT00222547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6400776|NCT00222547|Tubulin Modulators|tubulin modulators|mesh-ancestor
6400777|NCT00222547|Antimitotic Agents|antimitotic agents|mesh-ancestor
6400778|NCT00222547|Mitosis Modulators|mitosis modulators|mesh-ancestor
6400779|NCT00222573|Metoprolol|metoprolol|mesh-list
6400780|NCT00222573|Clopidogrel|clopidogrel|mesh-list
6400781|NCT00222573|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6400782|NCT00222573|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6400783|NCT00222573|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6400784|NCT00222573|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6400785|NCT00222573|Purinergic Agents|purinergic agents|mesh-ancestor
6400786|NCT00222573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6400787|NCT00222573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400788|NCT00222573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400789|NCT00222573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6400790|NCT00222573|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6400791|NCT00222573|Sympatholytics|sympatholytics|mesh-ancestor
6400792|NCT00222573|Autonomic Agents|autonomic agents|mesh-ancestor
6400793|NCT00222573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6400794|NCT00222573|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6400795|NCT00222573|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6400796|NCT00222573|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6400797|NCT00222573|Adrenergic Agents|adrenergic agents|mesh-ancestor
6400798|NCT00222638|Vaccines|vaccines|mesh-list
6400799|NCT00222638|Immunologic Factors|immunologic factors|mesh-ancestor
6400800|NCT00222638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400801|NCT00222651|Tenecteplase|tenecteplase|mesh-list
6400802|NCT00222651|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6400803|NCT00222651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6400804|NCT00222651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400805|NCT00222677|Aspirin|aspirin|mesh-list
6400806|NCT00222677|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6400807|NCT00222677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6400808|NCT00222677|Analgesics|analgesics|mesh-ancestor
6400809|NCT00222677|Sensory System Agents|sensory system agents|mesh-ancestor
6400810|NCT00222677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6400811|NCT00222677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400812|NCT00222677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6400813|NCT00222677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6400814|NCT00222677|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6400815|NCT00222677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6400816|NCT00222677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400817|NCT00222677|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6400818|NCT00222677|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6400819|NCT00222677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6400820|NCT00222677|Antipyretics|antipyretics|mesh-ancestor
6400821|NCT00222794|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6400822|NCT00222794|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6400823|NCT00222794|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6400824|NCT00222794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6400825|NCT00222794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400826|NCT00222794|Adrenergic Agents|adrenergic agents|mesh-ancestor
6400827|NCT00222794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6400828|NCT00222794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400829|NCT00222820|Citalopram|citalopram|mesh-list
6400830|NCT00222820|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6400831|NCT00222820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6400832|NCT00222820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6400833|NCT00222820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400834|NCT00222820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6400835|NCT00222820|Serotonin Agents|serotonin agents|mesh-ancestor
6400836|NCT00222820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400837|NCT00222820|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6400838|NCT00222820|Antidepressive Agents|antidepressive agents|mesh-ancestor
6400839|NCT00222820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6400840|NCT00222833|Aripiprazole|aripiprazole|mesh-list
6400841|NCT00222833|Antidepressive Agents|antidepressive agents|mesh-ancestor
6400842|NCT00222833|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6400843|NCT00222833|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6400844|NCT00222833|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6400845|NCT00222833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6400846|NCT00222833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400847|NCT00222833|Dopamine Agonists|dopamine agonists|mesh-ancestor
6400848|NCT00222833|Dopamine Agents|dopamine agents|mesh-ancestor
6400849|NCT00222833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6400850|NCT00222833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400851|NCT00222833|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6400852|NCT00222833|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6400853|NCT00222833|Serotonin Agents|serotonin agents|mesh-ancestor
6400854|NCT00222833|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6400855|NCT00222833|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6400856|NCT00222833|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6400857|NCT00222833|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6400858|NCT00222872|Hormones|hormones|mesh-list
6400859|NCT00222872|Parathyroid Hormone|parathyroid hormone|mesh-list
6400860|NCT00222872|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
6400861|NCT00222872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6400862|NCT00222872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400863|NCT00222872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6400864|NCT00222976|Naproxen|naproxen|mesh-list
6400865|NCT00222976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6400866|NCT00222976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6400867|NCT00222976|Analgesics|analgesics|mesh-ancestor
6400868|NCT00222976|Sensory System Agents|sensory system agents|mesh-ancestor
6400869|NCT00222976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6400870|NCT00222976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400871|NCT00222976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6400872|NCT00222976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6400873|NCT00222976|Gout Suppressants|gout suppressants|mesh-ancestor
6400874|NCT00222976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6400875|NCT00222976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6400876|NCT00222976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400877|NCT00223002|Chlorhexidine|chlorhexidine|mesh-list
6400878|NCT00223002|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6400879|NCT00223002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6400880|NCT00223002|Disinfectants|disinfectants|mesh-ancestor
6400881|NCT00223015|Tacrolimus|tacrolimus|mesh-list
6400882|NCT00223015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6400883|NCT00223015|Immunologic Factors|immunologic factors|mesh-ancestor
6400884|NCT00223015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400885|NCT00223015|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6400886|NCT00223015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6400887|NCT00223015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400888|NCT00223028|Sirolimus|sirolimus|mesh-list
6400889|NCT00223028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6400890|NCT00223028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6400891|NCT00223028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6400892|NCT00223028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6400893|NCT00223028|Antifungal Agents|antifungal agents|mesh-ancestor
6400894|NCT00223028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6400895|NCT00223028|Immunologic Factors|immunologic factors|mesh-ancestor
6400896|NCT00223028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400897|NCT00223054|Cyclosporine|cyclosporine|mesh-list
6400898|NCT00223054|Sirolimus|sirolimus|mesh-list
6400899|NCT00223054|Everolimus|everolimus|mesh-list
6400900|NCT00223054|Tacrolimus|tacrolimus|mesh-list
6400901|NCT00223054|Cyclosporins|cyclosporins|mesh-list
6400902|NCT00223054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6400903|NCT00223054|Immunologic Factors|immunologic factors|mesh-ancestor
6400904|NCT00223054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400905|NCT00223054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6400906|NCT00223054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6400907|NCT00223054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400908|NCT00223054|Antifungal Agents|antifungal agents|mesh-ancestor
6400909|NCT00223054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6400910|NCT00223054|Dermatologic Agents|dermatologic agents|mesh-ancestor
6400911|NCT00223054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6400912|NCT00223054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6400913|NCT00223054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6400914|NCT00223054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6400915|NCT00223145|Goserelin|goserelin|mesh-list
6400916|NCT00223145|Bicalutamide|bicalutamide|mesh-list
6400917|NCT00223145|Androgens|androgens|mesh-list
6400918|NCT00223145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6400919|NCT00223145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6400920|NCT00223145|Androgen Antagonists|androgen antagonists|mesh-ancestor
6400921|NCT00223145|Hormone Antagonists|hormone antagonists|mesh-ancestor
6400922|NCT00223145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6400923|NCT00223145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400924|NCT00223145|Hormones|hormones|mesh-ancestor
6400925|NCT00223171|Androgens|androgens|mesh-list
6400926|NCT00223171|Hormones|hormones|mesh-ancestor
6400927|NCT00223171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6400928|NCT00223171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400929|NCT00223210|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6400930|NCT00223210|Antidepressive Agents|antidepressive agents|mesh-ancestor
6400931|NCT00223210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6400932|NCT00223210|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6400933|NCT00223210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6400934|NCT00223210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6400935|NCT00223210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400936|NCT00223223|Levetiracetam|levetiracetam|mesh-list
6400937|NCT00223223|Anticonvulsants|anticonvulsants|mesh-ancestor
6400938|NCT00223223|Nootropic Agents|nootropic agents|mesh-ancestor
6400939|NCT00223249|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6400940|NCT00223249|Antidepressive Agents|antidepressive agents|mesh-ancestor
6400941|NCT00223249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6400942|NCT00223249|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6400943|NCT00223249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6400944|NCT00223249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6400945|NCT00223249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400946|NCT00223275|Naltrexone|naltrexone|mesh-list
6400947|NCT00223275|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6400948|NCT00223275|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6400949|NCT00223275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400950|NCT00223275|Sensory System Agents|sensory system agents|mesh-ancestor
6400951|NCT00223275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6400952|NCT00223288|Citalopram|citalopram|mesh-list
6400953|NCT00223288|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6400954|NCT00223288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6400955|NCT00223288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6400956|NCT00223288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400957|NCT00223288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6400958|NCT00223288|Serotonin Agents|serotonin agents|mesh-ancestor
6400959|NCT00223288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400960|NCT00223288|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6400961|NCT00223288|Antidepressive Agents|antidepressive agents|mesh-ancestor
6400962|NCT00223288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6400963|NCT00223301|Mycophenolic Acid|mycophenolic acid|mesh-list
6400964|NCT00223301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6400965|NCT00223301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6400966|NCT00223301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6400967|NCT00223301|Antitubercular Agents|antitubercular agents|mesh-ancestor
6400968|NCT00223301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6400969|NCT00223301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6400970|NCT00223301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6400971|NCT00223301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400972|NCT00223418|Aripiprazole|aripiprazole|mesh-list
6400973|NCT00223418|Antidepressive Agents|antidepressive agents|mesh-ancestor
6400974|NCT00223418|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6400975|NCT00223418|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6400976|NCT00223418|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6400977|NCT00223418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6400978|NCT00223418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400979|NCT00223418|Dopamine Agonists|dopamine agonists|mesh-ancestor
6400980|NCT00223418|Dopamine Agents|dopamine agents|mesh-ancestor
6400981|NCT00223418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6400982|NCT00223418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400983|NCT00223418|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6400984|NCT00223418|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6400985|NCT00223418|Serotonin Agents|serotonin agents|mesh-ancestor
6400986|NCT00223418|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6400987|NCT00223418|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6400988|NCT00223418|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6400989|NCT00223418|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6400990|NCT00223509|Lamotrigine|lamotrigine|mesh-list
6400991|NCT00223509|Anticonvulsants|anticonvulsants|mesh-ancestor
6018595|NCT00381693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6018596|NCT00381693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6018597|NCT00381693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6018598|NCT00381706|Leucovorin|leucovorin|mesh-list
6018599|NCT00381706|Cisplatin|cisplatin|mesh-list
6018600|NCT00381706|Fluorouracil|fluorouracil|mesh-list
6018601|NCT00381706|Oxaliplatin|oxaliplatin|mesh-list
6018602|NCT00381706|Irinotecan|irinotecan|mesh-list
6018603|NCT00381706|Cetuximab|cetuximab|mesh-list
6018604|NCT00381706|Epirubicin|epirubicin|mesh-list
6018605|NCT00381706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6018606|NCT00381706|Antimetabolites|antimetabolites|mesh-ancestor
6018607|NCT00381706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6018608|NCT00381706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6018609|NCT00381706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6018610|NCT00381706|Immunologic Factors|immunologic factors|mesh-ancestor
6018611|NCT00381706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018612|NCT00381706|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6018613|NCT00381706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6400992|NCT00223509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6400993|NCT00223509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6400994|NCT00223509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6400995|NCT00223509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6400996|NCT00223509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6400997|NCT00223509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6400998|NCT00223509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6400999|NCT00223509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6401000|NCT00223509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6401001|NCT00223509|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6401002|NCT00223548|Mesna|mesna|mesh-list
6401003|NCT00223548|Protective Agents|protective agents|mesh-ancestor
6401004|NCT00223548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018614|NCT00381706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6401005|NCT00223561|Methylphenidate|methylphenidate|mesh-list
6401006|NCT00223561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6401007|NCT00223561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6401008|NCT00223561|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6401009|NCT00223561|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6401010|NCT00223561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6401011|NCT00223561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6401012|NCT00223561|Dopamine Agents|dopamine agents|mesh-ancestor
6401013|NCT00223561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6401014|NCT00223613|Insulin|insulin|mesh-list
6401015|NCT00223613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6401016|NCT00223613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6401017|NCT00223626|Topiramate|topiramate|mesh-list
6401018|NCT00223626|Anticonvulsants|anticonvulsants|mesh-ancestor
6401019|NCT00223626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6401020|NCT00223626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6401021|NCT00223639|Topiramate|topiramate|mesh-list
6401022|NCT00223639|Anticonvulsants|anticonvulsants|mesh-ancestor
6401023|NCT00223639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6401024|NCT00223639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6401025|NCT00223691|Acarbose|acarbose|mesh-list
6401026|NCT00223691|Diphenhydramine|diphenhydramine|mesh-list
6401027|NCT00223691|Promethazine|promethazine|mesh-list
6401028|NCT00223691|Ibuprofen|ibuprofen|mesh-list
6401029|NCT00223691|Celecoxib|celecoxib|mesh-list
6401030|NCT00223691|Indomethacin|indomethacin|mesh-list
6401031|NCT00223691|Octreotide|octreotide|mesh-list
6401032|NCT00223691|Phenylephrine|phenylephrine|mesh-list
6401033|NCT00223691|Acetazolamide|acetazolamide|mesh-list
6401034|NCT00223691|Midodrine|midodrine|mesh-list
6401035|NCT00223691|Pseudoephedrine|pseudoephedrine|mesh-list
6401036|NCT00223691|Ephedrine|ephedrine|mesh-list
6401037|NCT00223691|Oxymetazoline|oxymetazoline|mesh-list
6401038|NCT00223691|Ergotamine|ergotamine|mesh-list
6401039|NCT00223691|Bromides|bromides|mesh-list
6401040|NCT00223691|Levodopa|levodopa|mesh-list
6401041|NCT00223691|Carbidopa|carbidopa|mesh-list
6401042|NCT00223691|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
6401043|NCT00223691|Tranylcypromine|tranylcypromine|mesh-list
6401044|NCT00223691|Methylphenidate|methylphenidate|mesh-list
6401045|NCT00223691|Caffeine|caffeine|mesh-list
6401046|NCT00223691|Modafinil|modafinil|mesh-list
6401047|NCT00223691|Rivastigmine|rivastigmine|mesh-list
6401048|NCT00223691|Ranitidine|ranitidine|mesh-list
6401049|NCT00223691|Yohimbine|yohimbine|mesh-list
6401050|NCT00223691|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
6401051|NCT00223691|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6401052|NCT00223691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6401053|NCT00223691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6401054|NCT00223691|Analgesics|analgesics|mesh-ancestor
6401055|NCT00223691|Sensory System Agents|sensory system agents|mesh-ancestor
6401056|NCT00223691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6401057|NCT00223691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6401058|NCT00223691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6401059|NCT00223691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6401060|NCT00223691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6401061|NCT00223691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6401062|NCT00223691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6401063|NCT00223691|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6401064|NCT00223691|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6401065|NCT00223691|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6401066|NCT00223691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6401067|NCT00223691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6401068|NCT00223691|Dopamine Agents|dopamine agents|mesh-ancestor
6401069|NCT00223691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6401070|NCT00223691|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6401071|NCT00223691|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6401072|NCT00223691|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6401073|NCT00223691|Purinergic Agents|purinergic agents|mesh-ancestor
6401074|NCT00223691|Anticonvulsants|anticonvulsants|mesh-ancestor
6401075|NCT00223691|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6401076|NCT00223691|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6401077|NCT00223691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6401078|NCT00223691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6459088|NCT00443339|Hematinics|hematinics|mesh-ancestor
6401079|NCT00223691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6401080|NCT00223691|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6401081|NCT00223691|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6401082|NCT00223691|Adrenergic Agents|adrenergic agents|mesh-ancestor
6401083|NCT00223691|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6401084|NCT00223691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6401085|NCT00223691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6401086|NCT00223691|Anesthetics, Local|anesthetics, local|mesh-ancestor
6401087|NCT00223691|Anesthetics|anesthetics|mesh-ancestor
6401088|NCT00223691|Antiemetics|antiemetics|mesh-ancestor
6401089|NCT00223691|Autonomic Agents|autonomic agents|mesh-ancestor
6401090|NCT00223691|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6401091|NCT00223691|Histamine Antagonists|histamine antagonists|mesh-ancestor
6401092|NCT00223691|Histamine Agents|histamine agents|mesh-ancestor
6401093|NCT00223691|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6401094|NCT00223691|Antipruritics|antipruritics|mesh-ancestor
6401095|NCT00223691|Dermatologic Agents|dermatologic agents|mesh-ancestor
6401096|NCT00223691|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6401097|NCT00223691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6401098|NCT00223691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6401099|NCT00223691|Gout Suppressants|gout suppressants|mesh-ancestor
6401100|NCT00223691|Tocolytic Agents|tocolytic agents|mesh-ancestor
6401101|NCT00223691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6401102|NCT00223691|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6401103|NCT00223691|Diuretics|diuretics|mesh-ancestor
6401104|NCT00223691|Natriuretic Agents|natriuretic agents|mesh-ancestor
6401105|NCT00223691|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6401106|NCT00223691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6401107|NCT00223691|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6401108|NCT00223691|Cholinergic Agents|cholinergic agents|mesh-ancestor
6401109|NCT00223691|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6401110|NCT00223691|Protective Agents|protective agents|mesh-ancestor
6401111|NCT00223691|Sympathomimetics|sympathomimetics|mesh-ancestor
6401112|NCT00223691|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6401113|NCT00223691|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6401114|NCT00223691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6401115|NCT00223691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6401116|NCT00223691|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6401117|NCT00223691|Immunologic Factors|immunologic factors|mesh-ancestor
6401118|NCT00223691|Dopamine Agonists|dopamine agonists|mesh-ancestor
6401119|NCT00223691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6401120|NCT00223691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6401121|NCT00223691|Respiratory System Agents|respiratory system agents|mesh-ancestor
6401122|NCT00223691|Nasal Decongestants|nasal decongestants|mesh-ancestor
6401123|NCT00223691|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6401124|NCT00223691|Mydriatics|mydriatics|mesh-ancestor
6401125|NCT00223691|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6401126|NCT00223691|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6401127|NCT00223691|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6401128|NCT00223691|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6401129|NCT00223691|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6401130|NCT00223691|Urological Agents|urological agents|mesh-ancestor
6401131|NCT00223691|Antidepressive Agents|antidepressive agents|mesh-ancestor
6401132|NCT00223691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6401133|NCT00223691|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6401134|NCT00223691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6401135|NCT00223691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6401136|NCT00223691|Oxytocics|oxytocics|mesh-ancestor
6401137|NCT00223691|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6401138|NCT00223691|Serotonin Agents|serotonin agents|mesh-ancestor
6401139|NCT00223717|Aspirin|aspirin|mesh-list
6401140|NCT00223717|Losartan|losartan|mesh-list
6401141|NCT00223717|Metoprolol|metoprolol|mesh-list
6401142|NCT00223717|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6401143|NCT00223717|Clonidine|clonidine|mesh-list
6401144|NCT00223717|Eplerenone|eplerenone|mesh-list
6401145|NCT00223717|Nebivolol|nebivolol|mesh-list
6401146|NCT00223717|Bosentan|bosentan|mesh-list
6401147|NCT00223717|Diltiazem|diltiazem|mesh-list
6401148|NCT00223717|Guanfacine|guanfacine|mesh-list
6401149|NCT00223717|Prazosin|prazosin|mesh-list
6401150|NCT00223717|Hydralazine|hydralazine|mesh-list
6401151|NCT00223717|Captopril|captopril|mesh-list
6401152|NCT00223717|Nifedipine|nifedipine|mesh-list
6401153|NCT00223717|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
6401154|NCT00223717|Sildenafil Citrate|sildenafil citrate|mesh-list
6401155|NCT00223717|Nitroglycerin|nitroglycerin|mesh-list
6401156|NCT00223717|Dipyridamole|dipyridamole|mesh-list
6401157|NCT00223717|Carbidopa|carbidopa|mesh-list
6401158|NCT00223717|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
6401159|NCT00223717|Tamsulosin|tamsulosin|mesh-list
6401160|NCT00223717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6401161|NCT00223717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6401162|NCT00223717|Analgesics|analgesics|mesh-ancestor
6401163|NCT00223717|Sensory System Agents|sensory system agents|mesh-ancestor
6401164|NCT00223717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6401165|NCT00223717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6401166|NCT00223717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6401167|NCT00223717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6401168|NCT00223717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6401169|NCT00223717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6401170|NCT00223717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6401171|NCT00223717|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6401172|NCT00223717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6401173|NCT00223717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6401174|NCT00223717|Antipyretics|antipyretics|mesh-ancestor
6401175|NCT00223717|Vasodilator Agents|vasodilator agents|mesh-ancestor
6401176|NCT00223717|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6401177|NCT00223717|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6401178|NCT00223717|Urological Agents|urological agents|mesh-ancestor
6401179|NCT00223717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6401180|NCT00223717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6401181|NCT00223717|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6401182|NCT00223717|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6401183|NCT00223717|Diuretics|diuretics|mesh-ancestor
6401184|NCT00223717|Natriuretic Agents|natriuretic agents|mesh-ancestor
6401185|NCT00223717|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6401186|NCT00223717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6401187|NCT00223717|Sympatholytics|sympatholytics|mesh-ancestor
6401188|NCT00223717|Autonomic Agents|autonomic agents|mesh-ancestor
6401189|NCT00223717|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6401190|NCT00223717|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6401191|NCT00223717|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6401192|NCT00223717|Adrenergic Agents|adrenergic agents|mesh-ancestor
6401193|NCT00223717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6401194|NCT00223717|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6401195|NCT00223717|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6401196|NCT00223717|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6401197|NCT00223717|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6401198|NCT00223717|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6401199|NCT00223717|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6401200|NCT00223717|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6401201|NCT00223717|Dopamine Agents|dopamine agents|mesh-ancestor
6401202|NCT00223717|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6401203|NCT00223717|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6401204|NCT00223717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6401205|NCT00223717|Tocolytic Agents|tocolytic agents|mesh-ancestor
6401206|NCT00223717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6401207|NCT00223717|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6401208|NCT00223717|Hormone Antagonists|hormone antagonists|mesh-ancestor
6401209|NCT00223717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6401210|NCT00223717|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6401211|NCT00223717|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6401212|NCT00223717|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6401213|NCT00223717|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6401214|NCT00223717|Hemostatics|hemostatics|mesh-ancestor
6401215|NCT00223717|Coagulants|coagulants|mesh-ancestor
6401216|NCT00223717|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6401217|NCT00223717|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6401218|NCT00223717|Protease Inhibitors|protease inhibitors|mesh-ancestor
6459089|NCT00443482|Formoterol Fumarate|formoterol fumarate|mesh-list
6459090|NCT00443482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6459091|NCT00443482|Autonomic Agents|autonomic agents|mesh-ancestor
6459092|NCT00443482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6459093|NCT00443482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459094|NCT00443482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6459095|NCT00443482|Respiratory System Agents|respiratory system agents|mesh-ancestor
6459096|NCT00443482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6459097|NCT00443482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6459098|NCT00443482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6459099|NCT00443482|Adrenergic Agents|adrenergic agents|mesh-ancestor
6459100|NCT00443482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6459101|NCT00443482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459102|NCT00443508|Everolimus|everolimus|mesh-list
6459103|NCT00443508|Tacrolimus|tacrolimus|mesh-list
6459104|NCT00443508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6459105|NCT00443508|Immunologic Factors|immunologic factors|mesh-ancestor
6459106|NCT00443508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459107|NCT00443508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6459108|NCT00443508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6459109|NCT00443508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459110|NCT00443508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6459111|NCT00443521|Triamcinolone|triamcinolone|mesh-list
6459112|NCT00443521|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6459113|NCT00443521|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6459114|NCT00443521|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6459115|NCT00443521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6459116|NCT00443521|Glucocorticoids|glucocorticoids|mesh-ancestor
6459117|NCT00443521|Hormones|hormones|mesh-ancestor
6459118|NCT00443521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6459119|NCT00443521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459120|NCT00443521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6459121|NCT00443521|Immunologic Factors|immunologic factors|mesh-ancestor
6459122|NCT00443521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6459123|NCT00443521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459124|NCT00443573|Protein C|protein c|mesh-list
6459125|NCT00443573|Anticoagulants|anticoagulants|mesh-list
6459126|NCT00443573|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6459127|NCT00443573|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6459128|NCT00443573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459129|NCT00443612|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6459130|NCT00443612|Irbesartan|irbesartan|mesh-list
6459131|NCT00443612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6459132|NCT00443612|Diuretics|diuretics|mesh-ancestor
6459133|NCT00443612|Natriuretic Agents|natriuretic agents|mesh-ancestor
6459134|NCT00443612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459135|NCT00443612|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6459136|NCT00443612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6459137|NCT00443612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459138|NCT00443612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6459139|NCT00443612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6459140|NCT00443690|Rolofylline|rolofylline|mesh-list
6459141|NCT00443690|Diuretics|diuretics|mesh-ancestor
6401219|NCT00223743|Zonisamide|zonisamide|mesh-list
6401220|NCT00223743|Anticonvulsants|anticonvulsants|mesh-ancestor
6018615|NCT00381706|Antidotes|antidotes|mesh-ancestor
6018616|NCT00381706|Protective Agents|protective agents|mesh-ancestor
6018617|NCT00381706|Vitamin B Complex|vitamin b complex|mesh-ancestor
6401221|NCT00223743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6401222|NCT00223743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6401223|NCT00223743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6401224|NCT00223743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6401225|NCT00223743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6401226|NCT00223769|Oxandrolone|oxandrolone|mesh-list
6401227|NCT00223769|Androgens|androgens|mesh-ancestor
6401228|NCT00223769|Hormones|hormones|mesh-ancestor
6401229|NCT00223769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6401230|NCT00223769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6401231|NCT00223769|Anabolic Agents|anabolic agents|mesh-ancestor
6401232|NCT00223860|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6401233|NCT00223860|Hormones|hormones|mesh-list
6401234|NCT00223860|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
6401235|NCT00223860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6401236|NCT00223860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6401237|NCT00223860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6401238|NCT00223925|Maribavir|maribavir|mesh-list
6401239|NCT00223925|Antiviral Agents|antiviral agents|mesh-ancestor
6401240|NCT00223925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6401241|NCT00223938|Ferric gluconate|ferric gluconate|mesh-list
6401242|NCT00223938|Ferric Compounds|ferric compounds|mesh-list
6401243|NCT00223938|Hematinics|hematinics|mesh-ancestor
6401244|NCT00223964|Ferric gluconate|ferric gluconate|mesh-list
6401245|NCT00223964|Hematinics|hematinics|mesh-ancestor
6401246|NCT00224068|Ferric gluconate|ferric gluconate|mesh-list
6401247|NCT00224068|Hematinics|hematinics|mesh-ancestor
6401248|NCT00224081|Ferric gluconate|ferric gluconate|mesh-list
6401249|NCT00224081|Hematinics|hematinics|mesh-ancestor
6401250|NCT00224094|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6401251|NCT00224094|Estrogens|estrogens|mesh-ancestor
6401252|NCT00224094|Hormones|hormones|mesh-ancestor
6401253|NCT00224094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6401254|NCT00224094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6401255|NCT00224146|Oxybutynin|oxybutynin|mesh-list
6401256|NCT00224146|Parasympatholytics|parasympatholytics|mesh-ancestor
6401257|NCT00224146|Autonomic Agents|autonomic agents|mesh-ancestor
6401258|NCT00224146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6401259|NCT00224146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6401260|NCT00224146|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6401261|NCT00224146|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6401262|NCT00224146|Cholinergic Agents|cholinergic agents|mesh-ancestor
6401263|NCT00224146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6401264|NCT00224146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6401265|NCT00224146|Urological Agents|urological agents|mesh-ancestor
6401266|NCT00224302|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6401267|NCT00224302|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6401268|NCT00224302|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6401269|NCT00224302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6401270|NCT00224302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6401271|NCT00224302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6401272|NCT00224302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6401273|NCT00224302|Analgesics|analgesics|mesh-ancestor
6401274|NCT00224302|Sensory System Agents|sensory system agents|mesh-ancestor
6401275|NCT00224302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6401276|NCT00224302|Antidepressive Agents|antidepressive agents|mesh-ancestor
6018618|NCT00381706|Vitamins|vitamins|mesh-ancestor
6401277|NCT00224302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6401278|NCT00224302|Dopamine Agents|dopamine agents|mesh-ancestor
6401279|NCT00224315|Risperidone|risperidone|mesh-list
6401280|NCT00224315|Ziprasidone|ziprasidone|mesh-list
6401281|NCT00224315|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6401282|NCT00224315|Serotonin Agents|serotonin agents|mesh-ancestor
6401283|NCT00224315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6401284|NCT00224315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6401285|NCT00224315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6401286|NCT00224315|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6401287|NCT00224315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6401288|NCT00224315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6401289|NCT00224315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6401290|NCT00224315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6401291|NCT00224315|Dopamine Agents|dopamine agents|mesh-ancestor
6401292|NCT00224354|Interleukin-2|interleukin-2|mesh-list
6401293|NCT00224354|Denileukin diftitox|denileukin diftitox|mesh-list
6401294|NCT00224354|Immunotoxins|immunotoxins|mesh-list
6401295|NCT00224354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6401296|NCT00224354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6401297|NCT00224354|Analgesics|analgesics|mesh-ancestor
6401298|NCT00224354|Sensory System Agents|sensory system agents|mesh-ancestor
6401299|NCT00224354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6401300|NCT00224354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6401301|NCT00224354|Immunologic Factors|immunologic factors|mesh-ancestor
6401302|NCT00224393|Etanercept|etanercept|mesh-list
6401303|NCT00224393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6401304|NCT00224393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6401305|NCT00224393|Analgesics|analgesics|mesh-ancestor
6401306|NCT00224393|Sensory System Agents|sensory system agents|mesh-ancestor
6401307|NCT00224393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6401308|NCT00224393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6401309|NCT00224393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6401310|NCT00224393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6401311|NCT00224393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6401312|NCT00224393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6401313|NCT00224393|Immunologic Factors|immunologic factors|mesh-ancestor
6401314|NCT00224419|Nicotine|nicotine|mesh-list
6401315|NCT00224419|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6401316|NCT00224419|Autonomic Agents|autonomic agents|mesh-ancestor
6401317|NCT00224419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6401318|NCT00224419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6401319|NCT00224419|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6401320|NCT00224419|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6401321|NCT00224419|Cholinergic Agents|cholinergic agents|mesh-ancestor
6401322|NCT00224419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6401323|NCT00224419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6401324|NCT00224445|Ritonavir|ritonavir|mesh-list
6401325|NCT00224445|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6401326|NCT00224445|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6401327|NCT00224445|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6401328|NCT00224445|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6401329|NCT00224445|Protease Inhibitors|protease inhibitors|mesh-ancestor
6401330|NCT00224445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6401331|NCT00224445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6401332|NCT00224445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6401333|NCT00224445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6401334|NCT00224445|Antiviral Agents|antiviral agents|mesh-ancestor
6401335|NCT00224445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6401336|NCT00224445|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6401337|NCT00224445|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6401338|NCT00224445|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6401339|NCT00224445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5501182|NCT04476992|Gasotransmitters|gasotransmitters|mesh-ancestor
6401340|NCT00224458|Efavirenz|efavirenz|mesh-list
6401341|NCT00224458|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6401342|NCT00224458|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6401343|NCT00224458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6401344|NCT00224458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6401345|NCT00224458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6401346|NCT00224458|Antiviral Agents|antiviral agents|mesh-ancestor
6401347|NCT00224458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6401348|NCT00224458|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6401349|NCT00224458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6401350|NCT00224458|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6401351|NCT00224458|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6401352|NCT00224458|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6401353|NCT00224458|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6401354|NCT00224458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6401355|NCT00224458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6401356|NCT00224471|Vaccines|vaccines|mesh-list
6401357|NCT00224471|Immunologic Factors|immunologic factors|mesh-ancestor
6401358|NCT00224471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6401359|NCT00224510|Lamotrigine|lamotrigine|mesh-list
6401360|NCT00224510|Anticonvulsants|anticonvulsants|mesh-ancestor
6401361|NCT00224510|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6401362|NCT00224510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6401363|NCT00224510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6401364|NCT00224510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6401365|NCT00224510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6401366|NCT00224510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6401367|NCT00224510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6401368|NCT00224510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6401369|NCT00224510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6401370|NCT00224510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6401371|NCT00224523|Mometasone Furoate|mometasone furoate|mesh-list
6401372|NCT00224523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6401373|NCT00224523|Dermatologic Agents|dermatologic agents|mesh-ancestor
6401374|NCT00224523|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6401375|NCT00224549|Amlodipine|amlodipine|mesh-list
6401376|NCT00224549|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6401377|NCT00224549|Irbesartan|irbesartan|mesh-list
6401378|NCT00224549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6401379|NCT00224549|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6401380|NCT00224549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6401381|NCT00224549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6401382|NCT00224549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6401383|NCT00224549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6401384|NCT00224549|Vasodilator Agents|vasodilator agents|mesh-ancestor
6401385|NCT00224549|Diuretics|diuretics|mesh-ancestor
6401386|NCT00224549|Natriuretic Agents|natriuretic agents|mesh-ancestor
6401387|NCT00224549|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6401388|NCT00224549|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6401389|NCT00224549|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6401390|NCT00224588|Ketamine|ketamine|mesh-list
6401391|NCT00224588|Analgesics|analgesics|mesh-ancestor
6401392|NCT00224588|Sensory System Agents|sensory system agents|mesh-ancestor
6401393|NCT00224588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6401394|NCT00224588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6401395|NCT00224588|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6401396|NCT00224588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6401397|NCT00224588|Anesthetics, General|anesthetics, general|mesh-ancestor
6401398|NCT00224588|Anesthetics|anesthetics|mesh-ancestor
6401399|NCT00224588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6401400|NCT00224588|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6401401|NCT00224588|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6401402|NCT00224588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6401403|NCT00224588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6401404|NCT00224640|Iron Chelating Agents|iron chelating agents|mesh-list
6401405|NCT00224640|Chelating Agents|chelating agents|mesh-ancestor
6401406|NCT00224640|Sequestering Agents|sequestering agents|mesh-ancestor
6401407|NCT00224640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6401408|NCT00224679|Aspirin|aspirin|mesh-list
6401409|NCT00224679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6401410|NCT00224679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6401411|NCT00224679|Analgesics|analgesics|mesh-ancestor
6401412|NCT00224679|Sensory System Agents|sensory system agents|mesh-ancestor
6401413|NCT00224679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6401414|NCT00224679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6401415|NCT00224679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6401416|NCT00224679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6401417|NCT00224679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6401418|NCT00224679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6401419|NCT00224679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6401420|NCT00224679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6401421|NCT00224679|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6401422|NCT00224679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6401423|NCT00224679|Antipyretics|antipyretics|mesh-ancestor
6401424|NCT00224692|Ketamine|ketamine|mesh-list
6401425|NCT00224692|Analgesics|analgesics|mesh-ancestor
6401426|NCT00224692|Sensory System Agents|sensory system agents|mesh-ancestor
6401427|NCT00224692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6401428|NCT00224692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6401429|NCT00224692|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6401430|NCT00224692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6401431|NCT00224692|Anesthetics, General|anesthetics, general|mesh-ancestor
6401432|NCT00224692|Anesthetics|anesthetics|mesh-ancestor
6401433|NCT00224692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6401434|NCT00224692|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6401435|NCT00224692|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6401436|NCT00224692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6401437|NCT00224692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6401438|NCT00224809|Aspirin|aspirin|mesh-list
6401439|NCT00224809|Spironolactone|spironolactone|mesh-list
6401440|NCT00224809|Clopidogrel|clopidogrel|mesh-list
6401441|NCT00224809|Enzyme Inhibitors|enzyme inhibitors|mesh-list
6401442|NCT00224809|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6401443|NCT00224809|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
6401444|NCT00224809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6401445|NCT00224809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6401446|NCT00224809|Analgesics|analgesics|mesh-ancestor
6401447|NCT00224809|Sensory System Agents|sensory system agents|mesh-ancestor
6401448|NCT00224809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6401449|NCT00224809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6401450|NCT00224809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6401451|NCT00224809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6401452|NCT00224809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6401453|NCT00224809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6401454|NCT00224809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6401455|NCT00224809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6401456|NCT00224809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6401457|NCT00224809|Antipyretics|antipyretics|mesh-ancestor
6401458|NCT00224809|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6401459|NCT00224809|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6401460|NCT00224809|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6401461|NCT00224809|Purinergic Agents|purinergic agents|mesh-ancestor
6401462|NCT00224809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6401463|NCT00224809|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6401464|NCT00224809|Hormone Antagonists|hormone antagonists|mesh-ancestor
6401465|NCT00224809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6401466|NCT00224809|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6401467|NCT00224809|Diuretics|diuretics|mesh-ancestor
6401468|NCT00224809|Natriuretic Agents|natriuretic agents|mesh-ancestor
6401469|NCT00224809|Protease Inhibitors|protease inhibitors|mesh-ancestor
6401470|NCT00224822|Aripiprazole|aripiprazole|mesh-list
6401471|NCT00224822|Antidepressive Agents|antidepressive agents|mesh-ancestor
6401472|NCT00224822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6401473|NCT00224822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6401474|NCT00224822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6401475|NCT00224822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6401476|NCT00224822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6401477|NCT00224822|Dopamine Agonists|dopamine agonists|mesh-ancestor
6401478|NCT00224822|Dopamine Agents|dopamine agents|mesh-ancestor
6401479|NCT00224822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6401480|NCT00224822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6401481|NCT00224822|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6401482|NCT00224822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6401483|NCT00224822|Serotonin Agents|serotonin agents|mesh-ancestor
6401484|NCT00224822|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6401485|NCT00224822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6401486|NCT00224822|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6401487|NCT00224822|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6401488|NCT00224978|Chloroquine|chloroquine|mesh-list
6401489|NCT00224978|Amebicides|amebicides|mesh-ancestor
6401490|NCT00224978|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6401491|NCT00224978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6401492|NCT00224978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6401493|NCT00224978|Antimalarials|antimalarials|mesh-ancestor
6401494|NCT00224978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6401495|NCT00225030|Antihypertensive Agents|antihypertensive agents|mesh-list
6401496|NCT00225043|Phenylephrine|phenylephrine|mesh-list
6401497|NCT00225043|Epinephrine|epinephrine|mesh-list
6401498|NCT00225043|Oxymetazoline|oxymetazoline|mesh-list
6401499|NCT00225043|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6401500|NCT00225043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6401501|NCT00225043|Adrenergic Agents|adrenergic agents|mesh-ancestor
6401502|NCT00225043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6401503|NCT00225043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6401504|NCT00225043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6401505|NCT00225043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6401506|NCT00225043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6401507|NCT00225043|Autonomic Agents|autonomic agents|mesh-ancestor
6401508|NCT00225043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6401509|NCT00225043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6401510|NCT00225043|Respiratory System Agents|respiratory system agents|mesh-ancestor
6401511|NCT00225043|Mydriatics|mydriatics|mesh-ancestor
6401512|NCT00225043|Sympathomimetics|sympathomimetics|mesh-ancestor
6401513|NCT00225043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6401514|NCT00225043|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6401515|NCT00225043|Nasal Decongestants|nasal decongestants|mesh-ancestor
6401516|NCT00225043|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6401517|NCT00225043|Protective Agents|protective agents|mesh-ancestor
6401518|NCT00225056|Docetaxel|docetaxel|mesh-list
6401519|NCT00225056|Capecitabine|capecitabine|mesh-list
6401520|NCT00225056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6401521|NCT00225056|Tubulin Modulators|tubulin modulators|mesh-ancestor
6401522|NCT00225056|Antimitotic Agents|antimitotic agents|mesh-ancestor
6401523|NCT00225056|Mitosis Modulators|mitosis modulators|mesh-ancestor
6401524|NCT00225056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6401525|NCT00225056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6401526|NCT00225056|Antimetabolites|antimetabolites|mesh-ancestor
6401527|NCT00225108|Tinzaparin|tinzaparin|mesh-list
6401528|NCT00225108|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6401529|NCT00225108|Dalteparin|dalteparin|mesh-list
6401530|NCT00225108|Anticoagulants|anticoagulants|mesh-ancestor
6401531|NCT00225108|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6401532|NCT00225108|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6401533|NCT00225108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6401534|NCT00225160|Acetylcarnitine|acetylcarnitine|mesh-list
6401535|NCT00225160|Vitamin B Complex|vitamin b complex|mesh-ancestor
6401536|NCT00225160|Vitamins|vitamins|mesh-ancestor
6401537|NCT00225160|Micronutrients|micronutrients|mesh-ancestor
6401538|NCT00225160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6401539|NCT00225160|Nootropic Agents|nootropic agents|mesh-ancestor
6401540|NCT00225173|Gemcitabine|gemcitabine|mesh-list
6401541|NCT00225173|Prednisone|prednisone|mesh-list
6401542|NCT00225173|Cyclophosphamide|cyclophosphamide|mesh-list
6401543|NCT00225173|Doxorubicin|doxorubicin|mesh-list
6401544|NCT00225173|Etoposide|etoposide|mesh-list
6401545|NCT00225173|Etoposide phosphate|etoposide phosphate|mesh-list
6401546|NCT00225173|Vincristine|vincristine|mesh-list
6401547|NCT00225173|Vinorelbine|vinorelbine|mesh-list
6401548|NCT00225173|Bleomycin|bleomycin|mesh-list
6401549|NCT00225173|Vinblastine|vinblastine|mesh-list
6401550|NCT00225173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6401551|NCT00225173|Immunologic Factors|immunologic factors|mesh-ancestor
6401552|NCT00225173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6401553|NCT00225173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6401554|NCT00225173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6401555|NCT00225173|Alkylating Agents|alkylating agents|mesh-ancestor
6401556|NCT00225173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6401557|NCT00225173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6401558|NCT00225173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6401559|NCT00225173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6401560|NCT00225173|Antimetabolites|antimetabolites|mesh-ancestor
6401561|NCT00225173|Antiviral Agents|antiviral agents|mesh-ancestor
6401562|NCT00225173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6401563|NCT00225173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6401564|NCT00225173|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6401565|NCT00225173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6401566|NCT00225173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6401567|NCT00225173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6401568|NCT00225173|Glucocorticoids|glucocorticoids|mesh-ancestor
6401569|NCT00225173|Hormones|hormones|mesh-ancestor
6401570|NCT00225173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6401571|NCT00225173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6401572|NCT00225173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6401573|NCT00225173|Tubulin Modulators|tubulin modulators|mesh-ancestor
6401574|NCT00225173|Antimitotic Agents|antimitotic agents|mesh-ancestor
6401575|NCT00225173|Mitosis Modulators|mitosis modulators|mesh-ancestor
6401576|NCT00225225|Rosiglitazone|rosiglitazone|mesh-list
6401577|NCT00225225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6401578|NCT00225225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6401579|NCT00225238|Esomeprazole|esomeprazole|mesh-list
6401580|NCT00225238|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6401581|NCT00225238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6401582|NCT00225238|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6401583|NCT00225238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6401584|NCT00225238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6401585|NCT00225264|Pioglitazone|pioglitazone|mesh-list
6401586|NCT00225264|Glimepiride|glimepiride|mesh-list
6401587|NCT00225264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6401588|NCT00225264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6401589|NCT00225264|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6401590|NCT00225264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6401591|NCT00225264|Immunologic Factors|immunologic factors|mesh-ancestor
6401592|NCT00225290|Thalidomide|thalidomide|mesh-list
6401593|NCT00225290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6401594|NCT00225290|Immunologic Factors|immunologic factors|mesh-ancestor
6401595|NCT00225290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6401596|NCT00225290|Leprostatic Agents|leprostatic agents|mesh-ancestor
6401597|NCT00225290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6401598|NCT00225290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6401599|NCT00225290|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6401600|NCT00225290|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6401601|NCT00225290|Growth Substances|growth substances|mesh-ancestor
6401602|NCT00225290|Growth Inhibitors|growth inhibitors|mesh-ancestor
6401603|NCT00225290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6401604|NCT00225303|Etravirine|etravirine|mesh-list
6401605|NCT00225303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6401606|NCT00225303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6401607|NCT00225303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6401608|NCT00225303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6401609|NCT00225303|Antiviral Agents|antiviral agents|mesh-ancestor
6401610|NCT00225303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6401611|NCT00225342|Rosiglitazone|rosiglitazone|mesh-list
6401612|NCT00225342|Gliclazide|gliclazide|mesh-list
6018619|NCT00381706|Micronutrients|micronutrients|mesh-ancestor
6018620|NCT00381706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6018621|NCT00381706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6018622|NCT00381706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6018623|NCT00381797|Deoxyglucose|deoxyglucose|mesh-list
6401613|NCT00225342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6401614|NCT00225342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6401615|NCT00225355|Rosiglitazone|rosiglitazone|mesh-list
6401616|NCT00225355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6401617|NCT00225355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459142|NCT00443690|Natriuretic Agents|natriuretic agents|mesh-ancestor
6459143|NCT00443690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459144|NCT00443716|Estrogens|estrogens|mesh-list
6459145|NCT00443716|Hormones|hormones|mesh-ancestor
6459146|NCT00443716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6459147|NCT00443716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459148|NCT00443794|Aspirin|aspirin|mesh-list
6459149|NCT00443794|Atenolol|atenolol|mesh-list
6459150|NCT00443794|Ramipril|ramipril|mesh-list
6459151|NCT00443794|Simvastatin|simvastatin|mesh-list
6401618|NCT00225381|Anesthetics|anesthetics|mesh-list
6401619|NCT00225381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6401620|NCT00225381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6401621|NCT00225433|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6401622|NCT00225433|Ganirelix|ganirelix|mesh-list
6401623|NCT00225433|Hormones|hormones|mesh-ancestor
6401624|NCT00225433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6401625|NCT00225433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6401626|NCT00225433|Hormone Antagonists|hormone antagonists|mesh-ancestor
6401627|NCT00225485|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6401628|NCT00225485|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6401629|NCT00225485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6401630|NCT00225485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6401631|NCT00225485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6401632|NCT00225485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6401633|NCT00225485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6401634|NCT00225485|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6401635|NCT00225485|Antidepressive Agents|antidepressive agents|mesh-ancestor
6401636|NCT00225485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6401637|NCT00225511|Milnacipran|milnacipran|mesh-list
6401638|NCT00225511|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6401639|NCT00225511|Levomilnacipran|levomilnacipran|mesh-list
6401640|NCT00225511|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6401641|NCT00225511|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6401642|NCT00225511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6401643|NCT00225511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6401644|NCT00225511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6401645|NCT00225511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6401646|NCT00225511|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6401647|NCT00225511|Antidepressive Agents|antidepressive agents|mesh-ancestor
6401648|NCT00225511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6401649|NCT00225511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6401650|NCT00225511|Analgesics|analgesics|mesh-ancestor
6401651|NCT00225511|Sensory System Agents|sensory system agents|mesh-ancestor
6401652|NCT00225511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6401653|NCT00225524|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6401654|NCT00225524|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6401655|NCT00225524|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6401656|NCT00225524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6401657|NCT00225524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6401658|NCT00225524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6401659|NCT00225524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6401660|NCT00225524|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6401661|NCT00225524|Antidepressive Agents|antidepressive agents|mesh-ancestor
6401662|NCT00225524|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6401663|NCT00225589|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6401664|NCT00225589|Calcium|calcium|mesh-list
6401665|NCT00225589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6401666|NCT00225589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6401667|NCT00225589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6401668|NCT00225589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6401669|NCT00225589|Antimetabolites|antimetabolites|mesh-ancestor
6401670|NCT00225589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6401671|NCT00225589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6401672|NCT00225589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6401673|NCT00225589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6401674|NCT00225615|Verapamil|verapamil|mesh-list
6401675|NCT00225615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6401676|NCT00225615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6401677|NCT00225615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6401678|NCT00225615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6401679|NCT00225615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6401680|NCT00225615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6401681|NCT00225615|Vasodilator Agents|vasodilator agents|mesh-ancestor
6401682|NCT00225667|Irbesartan|irbesartan|mesh-list
6401683|NCT00225667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6401684|NCT00225667|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6401685|NCT00225667|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6401686|NCT00225667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6401687|NCT00225706|Ibuprofen|ibuprofen|mesh-list
6401688|NCT00225706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6401689|NCT00225706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6401690|NCT00225706|Analgesics|analgesics|mesh-ancestor
6401691|NCT00225706|Sensory System Agents|sensory system agents|mesh-ancestor
6401692|NCT00225706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6401693|NCT00225706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6401694|NCT00225706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6401695|NCT00225706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6401696|NCT00225706|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6401697|NCT00225706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6401698|NCT00225706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6401699|NCT00225797|Oxymorphone|oxymorphone|mesh-list
6401700|NCT00225797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6401701|NCT00225797|Narcotics|narcotics|mesh-ancestor
6401702|NCT00225797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6401703|NCT00225797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6401704|NCT00225797|Analgesics|analgesics|mesh-ancestor
6401705|NCT00225797|Sensory System Agents|sensory system agents|mesh-ancestor
6401706|NCT00225797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6401707|NCT00225797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6401708|NCT00225849|Aspirin|aspirin|mesh-list
6401709|NCT00225849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6401710|NCT00225849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6401711|NCT00225849|Analgesics|analgesics|mesh-ancestor
6401712|NCT00225849|Sensory System Agents|sensory system agents|mesh-ancestor
6401713|NCT00225849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6401714|NCT00225849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6401715|NCT00225849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6401716|NCT00225849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6401717|NCT00225849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6401718|NCT00225849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6401719|NCT00225849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6401720|NCT00225849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6401721|NCT00225849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6401722|NCT00225849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6401723|NCT00225849|Antipyretics|antipyretics|mesh-ancestor
6401724|NCT00225862|Ropinirole|ropinirole|mesh-list
6401725|NCT00225862|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6401726|NCT00225862|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6401727|NCT00225862|Dopamine Agonists|dopamine agonists|mesh-ancestor
6401728|NCT00225862|Dopamine Agents|dopamine agents|mesh-ancestor
6401729|NCT00225862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6401730|NCT00225862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6401731|NCT00225862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6401732|NCT00225875|Rituximab|rituximab|mesh-list
6401733|NCT00225875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6401734|NCT00225875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6401735|NCT00225875|Immunologic Factors|immunologic factors|mesh-ancestor
6401736|NCT00225875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6401737|NCT00225875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6401738|NCT00225901|Mitogens|mitogens|mesh-list
6401739|NCT00225901|Mitosis Modulators|mitosis modulators|mesh-ancestor
6401740|NCT00225901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6401741|NCT00225914|Paroxetine|paroxetine|mesh-list
6401742|NCT00225914|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6401743|NCT00225914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6401744|NCT00225914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6401745|NCT00225914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6401746|NCT00225914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6401747|NCT00225914|Serotonin Agents|serotonin agents|mesh-ancestor
6401748|NCT00225914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6401749|NCT00225914|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6401750|NCT00225914|Antidepressive Agents|antidepressive agents|mesh-ancestor
6401751|NCT00225914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6401752|NCT00225914|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6401753|NCT00225914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6401754|NCT00225914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6401755|NCT00225979|Octreotide|octreotide|mesh-list
6401756|NCT00225979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6401757|NCT00225979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6401758|NCT00225979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6401759|NCT00225992|Arsenic Trioxide|arsenic trioxide|mesh-list
6401760|NCT00225992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6401761|NCT00226005|Vatalanib|vatalanib|mesh-list
6401762|NCT00226005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6401763|NCT00226005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6401764|NCT00226005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6401765|NCT00226044|Omeprazole|omeprazole|mesh-list
6401766|NCT00226044|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6401767|NCT00226044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6401768|NCT00226044|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6401769|NCT00226044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6401770|NCT00226044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6401771|NCT00226096|Metoprolol|metoprolol|mesh-list
6401772|NCT00226096|Clonidine|clonidine|mesh-list
6401773|NCT00226096|Nitroprusside|nitroprusside|mesh-list
6401774|NCT00226096|Hydralazine|hydralazine|mesh-list
6401775|NCT00226096|Labetalol|labetalol|mesh-list
6401776|NCT00226096|Nicardipine|nicardipine|mesh-list
6401777|NCT00226096|Phentolamine|phentolamine|mesh-list
6401778|NCT00226096|Urapidil|urapidil|mesh-list
6401779|NCT00226096|Enalaprilat|enalaprilat|mesh-list
6401780|NCT00226096|Nitroglycerin|nitroglycerin|mesh-list
6401781|NCT00226096|Esmolol|esmolol|mesh-list
6401782|NCT00226096|Glycerol|glycerol|mesh-list
6401783|NCT00226096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6401784|NCT00226096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6401785|NCT00226096|Sympatholytics|sympatholytics|mesh-ancestor
6401786|NCT00226096|Autonomic Agents|autonomic agents|mesh-ancestor
6401787|NCT00226096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6401788|NCT00226096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501183|NCT04476992|Protective Agents|protective agents|mesh-ancestor
6401789|NCT00226096|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6401790|NCT00226096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6401791|NCT00226096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6401792|NCT00226096|Adrenergic Agents|adrenergic agents|mesh-ancestor
6401793|NCT00226096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6401794|NCT00226096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6401795|NCT00226096|Analgesics|analgesics|mesh-ancestor
6401796|NCT00226096|Sensory System Agents|sensory system agents|mesh-ancestor
6401797|NCT00226096|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6401798|NCT00226096|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6401799|NCT00226096|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6401800|NCT00226096|Vasodilator Agents|vasodilator agents|mesh-ancestor
6401801|NCT00226096|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6401802|NCT00226096|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6401803|NCT00226096|Protective Agents|protective agents|mesh-ancestor
6401804|NCT00226096|Sympathomimetics|sympathomimetics|mesh-ancestor
6401805|NCT00226096|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6401806|NCT00226096|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6401807|NCT00226096|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6401808|NCT00226096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6401809|NCT00226096|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6401810|NCT00226096|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6401811|NCT00226096|Serotonin Agents|serotonin agents|mesh-ancestor
6401812|NCT00226096|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6401813|NCT00226096|Protease Inhibitors|protease inhibitors|mesh-ancestor
6401814|NCT00226096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6401815|NCT00226109|Spironolactone|spironolactone|mesh-list
6401816|NCT00226109|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6401817|NCT00226109|Hormone Antagonists|hormone antagonists|mesh-ancestor
6401818|NCT00226109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6401819|NCT00226109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6401820|NCT00226109|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6401821|NCT00226109|Diuretics|diuretics|mesh-ancestor
6401822|NCT00226109|Natriuretic Agents|natriuretic agents|mesh-ancestor
6401823|NCT00226122|Indomethacin|indomethacin|mesh-list
6401824|NCT00226122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6401825|NCT00226122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6401826|NCT00226122|Analgesics|analgesics|mesh-ancestor
6401827|NCT00226122|Sensory System Agents|sensory system agents|mesh-ancestor
6401828|NCT00226122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6401829|NCT00226122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6401830|NCT00226122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6401831|NCT00226122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6401832|NCT00226122|Gout Suppressants|gout suppressants|mesh-ancestor
6401833|NCT00226122|Tocolytic Agents|tocolytic agents|mesh-ancestor
6401834|NCT00226122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6401835|NCT00226122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6401836|NCT00226122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6401837|NCT00226122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6401838|NCT00226135|Lamotrigine|lamotrigine|mesh-list
6401839|NCT00226135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6401840|NCT00226135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6401841|NCT00226135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6401842|NCT00226135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6401843|NCT00226135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6401844|NCT00226135|Anticonvulsants|anticonvulsants|mesh-ancestor
6401845|NCT00226135|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6401846|NCT00226135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6401847|NCT00226135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6401848|NCT00226135|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6401849|NCT00226135|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6401850|NCT00226200|Omalizumab|omalizumab|mesh-list
6401851|NCT00226200|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6401852|NCT00226200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6401853|NCT00226200|Respiratory System Agents|respiratory system agents|mesh-ancestor
6401854|NCT00226317|Aripiprazole|aripiprazole|mesh-list
6401855|NCT00226317|Antidepressive Agents|antidepressive agents|mesh-ancestor
6401856|NCT00226317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6401857|NCT00226317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6401858|NCT00226317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6401859|NCT00226317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6401860|NCT00226317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6401861|NCT00226317|Dopamine Agonists|dopamine agonists|mesh-ancestor
6401862|NCT00226317|Dopamine Agents|dopamine agents|mesh-ancestor
6401863|NCT00226317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6401864|NCT00226317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6401865|NCT00226317|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6401866|NCT00226317|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6401867|NCT00226317|Serotonin Agents|serotonin agents|mesh-ancestor
6401868|NCT00226317|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6401869|NCT00226317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6401870|NCT00226317|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6401871|NCT00226317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6401872|NCT00226330|Pioglitazone|pioglitazone|mesh-list
6401873|NCT00226330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6401874|NCT00226330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6401875|NCT00226343|Valproic Acid|valproic acid|mesh-list
6401876|NCT00226343|Anticonvulsants|anticonvulsants|mesh-ancestor
6401877|NCT00226343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6401878|NCT00226343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6401879|NCT00226343|GABA Agents|gaba agents|mesh-ancestor
6401880|NCT00226343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6401881|NCT00226343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6401882|NCT00226343|Antimanic Agents|antimanic agents|mesh-ancestor
6401883|NCT00226343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6401884|NCT00226343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6401885|NCT00226343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6401886|NCT00226356|Betaine|betaine|mesh-list
6401887|NCT00226356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6401888|NCT00226356|Lipotropic Agents|lipotropic agents|mesh-ancestor
6401889|NCT00226356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6401890|NCT00226356|Antimetabolites|antimetabolites|mesh-ancestor
6401891|NCT00226356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6401892|NCT00226356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6401893|NCT00226382|Interferons|interferons|mesh-list
6401894|NCT00226382|Interferon-alpha|interferon-alpha|mesh-list
6401895|NCT00226382|Interferon alpha-2|interferon alpha-2|mesh-list
6401896|NCT00226382|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6401897|NCT00226382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6401898|NCT00226382|Antiviral Agents|antiviral agents|mesh-ancestor
6401899|NCT00226382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6401900|NCT00226382|Immunologic Factors|immunologic factors|mesh-ancestor
6401901|NCT00226382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6401902|NCT00226395|Oxymorphone|oxymorphone|mesh-list
6401903|NCT00226395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6401904|NCT00226395|Narcotics|narcotics|mesh-ancestor
6401905|NCT00226395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6401906|NCT00226395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6401907|NCT00226395|Analgesics|analgesics|mesh-ancestor
6401908|NCT00226395|Sensory System Agents|sensory system agents|mesh-ancestor
6401909|NCT00226395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6401910|NCT00226395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6401911|NCT00226408|Interferons|interferons|mesh-list
6401912|NCT00226408|Interferon-alpha|interferon-alpha|mesh-list
6401913|NCT00226408|Interferon alpha-2|interferon alpha-2|mesh-list
6401914|NCT00226408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6401915|NCT00226408|Antiviral Agents|antiviral agents|mesh-ancestor
6401916|NCT00226408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6401917|NCT00226408|Immunologic Factors|immunologic factors|mesh-ancestor
6401918|NCT00226408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6401919|NCT00226421|Oxymorphone|oxymorphone|mesh-list
6401920|NCT00226421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6401921|NCT00226421|Narcotics|narcotics|mesh-ancestor
6401922|NCT00226421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6401923|NCT00226421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6401924|NCT00226421|Analgesics|analgesics|mesh-ancestor
6401925|NCT00226421|Sensory System Agents|sensory system agents|mesh-ancestor
6401926|NCT00226421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6401927|NCT00226421|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6401928|NCT00226434|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6401929|NCT00226434|Antiviral Agents|antiviral agents|mesh-ancestor
6401930|NCT00226434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6401931|NCT00226447|Interferons|interferons|mesh-list
6401932|NCT00226447|Lamivudine|lamivudine|mesh-list
6401933|NCT00226447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6401934|NCT00226447|Antiviral Agents|antiviral agents|mesh-ancestor
6401935|NCT00226447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6401936|NCT00226447|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6401937|NCT00226447|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6401938|NCT00226447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6401939|NCT00226447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6401940|NCT00226447|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6401941|NCT00226447|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6401942|NCT00226473|Dacarbazine|dacarbazine|mesh-list
6401943|NCT00226473|Vindesine|vindesine|mesh-list
6401944|NCT00226473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6401945|NCT00226473|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6401946|NCT00226473|Alkylating Agents|alkylating agents|mesh-ancestor
6401947|NCT00226473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6401948|NCT00226473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6401949|NCT00226473|Tubulin Modulators|tubulin modulators|mesh-ancestor
6401950|NCT00226473|Antimitotic Agents|antimitotic agents|mesh-ancestor
6401951|NCT00226473|Mitosis Modulators|mitosis modulators|mesh-ancestor
6401952|NCT00226512|Alemtuzumab|alemtuzumab|mesh-list
6401953|NCT00226512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6401954|NCT00226512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6401955|NCT00226538|Fluconazole|fluconazole|mesh-list
6401956|NCT00226538|Rifampin|rifampin|mesh-list
6401957|NCT00226538|Diclofenac|diclofenac|mesh-list
6401958|NCT00226538|Phenytoin|phenytoin|mesh-list
6401959|NCT00226538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6401960|NCT00226538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6401961|NCT00226538|Analgesics|analgesics|mesh-ancestor
6401962|NCT00226538|Sensory System Agents|sensory system agents|mesh-ancestor
6401963|NCT00226538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6401964|NCT00226538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6401965|NCT00226538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6401966|NCT00226538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6401967|NCT00226538|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6401968|NCT00226538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6401969|NCT00226538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6401970|NCT00226538|Antifungal Agents|antifungal agents|mesh-ancestor
6401971|NCT00226538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6401972|NCT00226538|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6401973|NCT00226538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6401974|NCT00226538|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6401975|NCT00226538|Hormone Antagonists|hormone antagonists|mesh-ancestor
6401976|NCT00226538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6401977|NCT00226538|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6401978|NCT00226538|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6401979|NCT00226538|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6401980|NCT00226538|Antitubercular Agents|antitubercular agents|mesh-ancestor
6401981|NCT00226538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6401982|NCT00226538|Leprostatic Agents|leprostatic agents|mesh-ancestor
6401983|NCT00226538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6401984|NCT00226538|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6401985|NCT00226538|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6401986|NCT00226538|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6401987|NCT00226538|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6401988|NCT00226538|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6401989|NCT00226538|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6401990|NCT00226538|Anticonvulsants|anticonvulsants|mesh-ancestor
6401991|NCT00226538|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6401992|NCT00226538|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6401993|NCT00226538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6401994|NCT00226538|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6401995|NCT00226551|Isoproterenol|isoproterenol|mesh-list
6401996|NCT00226551|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6401997|NCT00226551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6401998|NCT00226551|Adrenergic Agents|adrenergic agents|mesh-ancestor
6401999|NCT00226551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6402000|NCT00226551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402001|NCT00226551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402002|NCT00226551|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6402003|NCT00226551|Autonomic Agents|autonomic agents|mesh-ancestor
6402004|NCT00226551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6402005|NCT00226551|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6402006|NCT00226551|Respiratory System Agents|respiratory system agents|mesh-ancestor
6402007|NCT00226551|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6402008|NCT00226551|Sympathomimetics|sympathomimetics|mesh-ancestor
6402009|NCT00226551|Protective Agents|protective agents|mesh-ancestor
6402010|NCT00226564|Alfentanil|alfentanil|mesh-list
6402011|NCT00226564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6402012|NCT00226564|Narcotics|narcotics|mesh-ancestor
6402013|NCT00226564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6402014|NCT00226564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402015|NCT00226564|Analgesics|analgesics|mesh-ancestor
6402016|NCT00226564|Sensory System Agents|sensory system agents|mesh-ancestor
6402017|NCT00226564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6402018|NCT00226564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6402019|NCT00226564|Anesthetics, General|anesthetics, general|mesh-ancestor
6402020|NCT00226564|Anesthetics|anesthetics|mesh-ancestor
6402021|NCT00226668|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
6402022|NCT00226668|Hormones|hormones|mesh-ancestor
6402023|NCT00226668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6402024|NCT00226668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402025|NCT00226694|Citalopram|citalopram|mesh-list
6402026|NCT00226694|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6402027|NCT00226694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6402028|NCT00226694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6402029|NCT00226694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402030|NCT00226694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6402031|NCT00226694|Serotonin Agents|serotonin agents|mesh-ancestor
6402032|NCT00226694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402033|NCT00226694|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6402034|NCT00226694|Antidepressive Agents|antidepressive agents|mesh-ancestor
6402035|NCT00226694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6402036|NCT00226707|Pimecrolimus|pimecrolimus|mesh-list
6402037|NCT00226707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6402038|NCT00226707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6402039|NCT00226707|Analgesics|analgesics|mesh-ancestor
6402040|NCT00226707|Sensory System Agents|sensory system agents|mesh-ancestor
6402041|NCT00226707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6402042|NCT00226707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402043|NCT00226707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6402044|NCT00226707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6402045|NCT00226707|Dermatologic Agents|dermatologic agents|mesh-ancestor
6402046|NCT00226707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6402047|NCT00226707|Immunologic Factors|immunologic factors|mesh-ancestor
6402048|NCT00226707|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6402049|NCT00226707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6402050|NCT00226707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402051|NCT00226746|Gemcitabine|gemcitabine|mesh-list
6402052|NCT00226746|Paclitaxel|paclitaxel|mesh-list
6402053|NCT00226746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6402054|NCT00226746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6402055|NCT00226746|Tubulin Modulators|tubulin modulators|mesh-ancestor
6402056|NCT00226746|Antimitotic Agents|antimitotic agents|mesh-ancestor
6402057|NCT00226746|Mitosis Modulators|mitosis modulators|mesh-ancestor
6402058|NCT00226746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402059|NCT00226746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6402060|NCT00226746|Antimetabolites|antimetabolites|mesh-ancestor
6402061|NCT00226746|Antiviral Agents|antiviral agents|mesh-ancestor
6402062|NCT00226746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6402063|NCT00226746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6402064|NCT00226746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6402065|NCT00226746|Immunologic Factors|immunologic factors|mesh-ancestor
6402066|NCT00226746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402067|NCT00226785|Dexmedetomidine|dexmedetomidine|mesh-list
6402068|NCT00226785|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6402069|NCT00226785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6402070|NCT00226785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402071|NCT00226785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6402072|NCT00226785|Analgesics|analgesics|mesh-ancestor
6402073|NCT00226785|Sensory System Agents|sensory system agents|mesh-ancestor
6402074|NCT00226785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6402075|NCT00226785|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6402076|NCT00226785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6402077|NCT00226785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6402078|NCT00226785|Adrenergic Agents|adrenergic agents|mesh-ancestor
6402079|NCT00226785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6402080|NCT00226785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402081|NCT00226798|Capecitabine|capecitabine|mesh-list
6402082|NCT00226798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6402083|NCT00226798|Antimetabolites|antimetabolites|mesh-ancestor
6402084|NCT00226798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402085|NCT00226798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6402086|NCT00226824|Galantamine|galantamine|mesh-list
6402087|NCT00226824|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6402088|NCT00226824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6402089|NCT00226824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402090|NCT00226824|Cholinergic Agents|cholinergic agents|mesh-ancestor
6402091|NCT00226824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6402092|NCT00226824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402093|NCT00226824|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6402094|NCT00226824|Autonomic Agents|autonomic agents|mesh-ancestor
6402095|NCT00226824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6402096|NCT00226824|Nootropic Agents|nootropic agents|mesh-ancestor
6402097|NCT00226837|Nitrous Oxide|nitrous oxide|mesh-list
6402098|NCT00226837|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6402099|NCT00226837|Anesthetics, General|anesthetics, general|mesh-ancestor
6402100|NCT00226837|Anesthetics|anesthetics|mesh-ancestor
6402101|NCT00226837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6402102|NCT00226837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402103|NCT00226837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6402104|NCT00226837|Analgesics|analgesics|mesh-ancestor
6018624|NCT00381797|Bevacizumab|bevacizumab|mesh-list
6018625|NCT00381797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6018626|NCT00381797|Irinotecan|irinotecan|mesh-list
6018627|NCT00381797|Camptothecin|camptothecin|mesh-list
6402105|NCT00226837|Sensory System Agents|sensory system agents|mesh-ancestor
6402106|NCT00226837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6459152|NCT00443794|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
6459153|NCT00443794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6459154|NCT00443794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6459155|NCT00443794|Analgesics|analgesics|mesh-ancestor
6459156|NCT00443794|Sensory System Agents|sensory system agents|mesh-ancestor
6459157|NCT00443794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6459158|NCT00443794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459159|NCT00443794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6459160|NCT00443794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6459161|NCT00443794|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6459162|NCT00443794|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6459163|NCT00443794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459164|NCT00443794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6459165|NCT00443794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6459166|NCT00443794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6459167|NCT00443794|Antipyretics|antipyretics|mesh-ancestor
6459168|NCT00443794|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6459169|NCT00443794|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6459170|NCT00443794|Antimetabolites|antimetabolites|mesh-ancestor
6459171|NCT00443794|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6459172|NCT00443794|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6459173|NCT00443794|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6459174|NCT00443794|Protease Inhibitors|protease inhibitors|mesh-ancestor
6459175|NCT00443794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6459176|NCT00443794|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6459177|NCT00443794|Sympatholytics|sympatholytics|mesh-ancestor
6459178|NCT00443794|Autonomic Agents|autonomic agents|mesh-ancestor
6459179|NCT00443794|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6459180|NCT00443794|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6459181|NCT00443794|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6459182|NCT00443794|Adrenergic Agents|adrenergic agents|mesh-ancestor
6459183|NCT00443794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6459184|NCT00443794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6459185|NCT00443794|Diuretics|diuretics|mesh-ancestor
6459186|NCT00443794|Natriuretic Agents|natriuretic agents|mesh-ancestor
6459187|NCT00443924|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6459188|NCT00443924|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6459189|NCT00443937|Mycophenolic Acid|mycophenolic acid|mesh-list
6459190|NCT00443937|Everolimus|everolimus|mesh-list
6459191|NCT00443937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6459192|NCT00443937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6459193|NCT00443937|Immunologic Factors|immunologic factors|mesh-ancestor
6459194|NCT00443937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459195|NCT00443937|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6459196|NCT00443937|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6459197|NCT00443937|Antitubercular Agents|antitubercular agents|mesh-ancestor
6459198|NCT00443937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6459199|NCT00443937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6459200|NCT00443937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6459201|NCT00443937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459202|NCT00443950|Etanercept|etanercept|mesh-list
6459203|NCT00443950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6459204|NCT00443950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6459205|NCT00443950|Analgesics|analgesics|mesh-ancestor
6459206|NCT00443950|Sensory System Agents|sensory system agents|mesh-ancestor
6459207|NCT00443950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6459208|NCT00443950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459209|NCT00443950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6459210|NCT00443950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6459211|NCT00443950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6459212|NCT00443950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6459213|NCT00443950|Immunologic Factors|immunologic factors|mesh-ancestor
6459214|NCT00443963|Esomeprazole|esomeprazole|mesh-list
6459215|NCT00443963|Ranitidine|ranitidine|mesh-list
6459216|NCT00443963|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6018628|NCT00381797|Endothelial Growth Factors|endothelial growth factors|mesh-list
6402107|NCT00226889|Bosentan|bosentan|mesh-list
6402108|NCT00226889|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6402109|NCT00226889|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6402110|NCT00226889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402111|NCT00226915|Paclitaxel|paclitaxel|mesh-list
6402112|NCT00226915|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6402113|NCT00226915|Carboplatin|carboplatin|mesh-list
6402114|NCT00226915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6402115|NCT00226915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6402116|NCT00226915|Tubulin Modulators|tubulin modulators|mesh-ancestor
6402117|NCT00226915|Antimitotic Agents|antimitotic agents|mesh-ancestor
6402118|NCT00226915|Mitosis Modulators|mitosis modulators|mesh-ancestor
6402119|NCT00226915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402120|NCT00226954|Zoledronic Acid|zoledronic acid|mesh-list
6402121|NCT00226954|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6402122|NCT00226954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402123|NCT00226967|Octreotide|octreotide|mesh-list
6402124|NCT00226967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6402125|NCT00226967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6402126|NCT00226967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6402127|NCT00226980|Thalidomide|thalidomide|mesh-list
6402128|NCT00226980|Capecitabine|capecitabine|mesh-list
6402129|NCT00226980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6402130|NCT00226980|Antimetabolites|antimetabolites|mesh-ancestor
6402131|NCT00226980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402132|NCT00226980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6402133|NCT00226980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6402134|NCT00226980|Immunologic Factors|immunologic factors|mesh-ancestor
6402135|NCT00226980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402136|NCT00226980|Leprostatic Agents|leprostatic agents|mesh-ancestor
6402137|NCT00226980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6402138|NCT00226980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6402139|NCT00226980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6402140|NCT00226980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6402141|NCT00226980|Growth Substances|growth substances|mesh-ancestor
6402142|NCT00226980|Growth Inhibitors|growth inhibitors|mesh-ancestor
6402143|NCT00227032|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6402144|NCT00227032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6402145|NCT00227032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6402146|NCT00227032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6402147|NCT00227032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402148|NCT00227084|Hemostatics|hemostatics|mesh-list
6402149|NCT00227084|Coagulants|coagulants|mesh-ancestor
6402150|NCT00227097|Anticoagulants|anticoagulants|mesh-list
6402151|NCT00227110|Pioglitazone|pioglitazone|mesh-list
6402152|NCT00227110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6402153|NCT00227110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402154|NCT00227123|Risperidone|risperidone|mesh-list
6402155|NCT00227123|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6402156|NCT00227123|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6402157|NCT00227123|Serotonin Agents|serotonin agents|mesh-ancestor
6402158|NCT00227123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6402159|NCT00227123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402160|NCT00227123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402161|NCT00227123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6402162|NCT00227123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6402163|NCT00227123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6402164|NCT00227123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5501184|NCT04476628|Budesonide|budesonide|mesh-list
6402165|NCT00227123|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6402166|NCT00227123|Dopamine Agents|dopamine agents|mesh-ancestor
6402167|NCT00227123|Antidepressive Agents|antidepressive agents|mesh-ancestor
6402168|NCT00227136|Serotonin|serotonin|mesh-list
6402169|NCT00227136|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6402170|NCT00227136|Serotonin Agents|serotonin agents|mesh-ancestor
6402171|NCT00227136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6402172|NCT00227136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402173|NCT00227136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402174|NCT00227188|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6402175|NCT00227188|Immunologic Factors|immunologic factors|mesh-ancestor
6402176|NCT00227188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402177|NCT00227253|Hormones|hormones|mesh-list
6402178|NCT00227253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6402179|NCT00227253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402180|NCT00227292|Citalopram|citalopram|mesh-list
6402181|NCT00227292|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6402182|NCT00227292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6402183|NCT00227292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6402184|NCT00227292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402185|NCT00227292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6402186|NCT00227292|Serotonin Agents|serotonin agents|mesh-ancestor
6402187|NCT00227292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402188|NCT00227292|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6402189|NCT00227292|Antidepressive Agents|antidepressive agents|mesh-ancestor
6402190|NCT00227292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6402191|NCT00227318|Candesartan cilexetil|candesartan cilexetil|mesh-list
6402192|NCT00227318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6402193|NCT00227318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6402194|NCT00227318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6402195|NCT00227318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402196|NCT00227331|Amoxicillin|amoxicillin|mesh-list
6402197|NCT00227331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6402198|NCT00227331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6402199|NCT00227357|Buprenorphine|buprenorphine|mesh-list
6402200|NCT00227357|Methadone|methadone|mesh-list
6402201|NCT00227357|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6402202|NCT00227357|Naloxone|naloxone|mesh-list
6402203|NCT00227357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6402204|NCT00227357|Narcotics|narcotics|mesh-ancestor
6402205|NCT00227357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6402206|NCT00227357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402207|NCT00227357|Analgesics|analgesics|mesh-ancestor
6402208|NCT00227357|Sensory System Agents|sensory system agents|mesh-ancestor
6402209|NCT00227357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6402210|NCT00227357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6402211|NCT00227357|Antitussive Agents|antitussive agents|mesh-ancestor
6402212|NCT00227357|Respiratory System Agents|respiratory system agents|mesh-ancestor
6402213|NCT00227409|Edetic Acid|edetic acid|mesh-list
6402214|NCT00227409|Calcium|calcium|mesh-list
6402215|NCT00227409|Pentetic Acid|pentetic acid|mesh-list
6402216|NCT00227409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6402217|NCT00227409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402218|NCT00227409|Anticoagulants|anticoagulants|mesh-ancestor
6402219|NCT00227409|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6402220|NCT00227409|Chelating Agents|chelating agents|mesh-ancestor
6402221|NCT00227409|Sequestering Agents|sequestering agents|mesh-ancestor
6402222|NCT00227409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402223|NCT00227409|Antidotes|antidotes|mesh-ancestor
6402224|NCT00227409|Protective Agents|protective agents|mesh-ancestor
6402225|NCT00227409|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6402226|NCT00227448|Phenylephrine|phenylephrine|mesh-list
6402227|NCT00227448|Oxymetazoline|oxymetazoline|mesh-list
6402228|NCT00227448|Midodrine|midodrine|mesh-list
6402229|NCT00227448|Norepinephrine|norepinephrine|mesh-list
6402230|NCT00227448|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6402231|NCT00227448|Mydriatics|mydriatics|mesh-ancestor
6402232|NCT00227448|Autonomic Agents|autonomic agents|mesh-ancestor
6402233|NCT00227448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6402234|NCT00227448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402235|NCT00227448|Sympathomimetics|sympathomimetics|mesh-ancestor
6402236|NCT00227448|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6402237|NCT00227448|Nasal Decongestants|nasal decongestants|mesh-ancestor
6402238|NCT00227448|Respiratory System Agents|respiratory system agents|mesh-ancestor
6402239|NCT00227448|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6402240|NCT00227448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6402241|NCT00227448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6402242|NCT00227448|Adrenergic Agents|adrenergic agents|mesh-ancestor
6402243|NCT00227448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6402244|NCT00227448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402245|NCT00227448|Protective Agents|protective agents|mesh-ancestor
6402246|NCT00227461|Levetiracetam|levetiracetam|mesh-list
6402247|NCT00227461|Anticonvulsants|anticonvulsants|mesh-ancestor
6402248|NCT00227461|Nootropic Agents|nootropic agents|mesh-ancestor
6402249|NCT00227474|Vaccines|vaccines|mesh-list
6402250|NCT00227474|Immunologic Factors|immunologic factors|mesh-ancestor
6402251|NCT00227474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402252|NCT00227500|Pravastatin|pravastatin|mesh-list
6402253|NCT00227500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6402254|NCT00227500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6402255|NCT00227500|Antimetabolites|antimetabolites|mesh-ancestor
6402256|NCT00227500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402257|NCT00227500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6402258|NCT00227500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6402259|NCT00227500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6402260|NCT00227513|Bortezomib|bortezomib|mesh-list
6402261|NCT00227513|Vorinostat|vorinostat|mesh-list
6402262|NCT00227513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6402263|NCT00227513|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6402264|NCT00227513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6402265|NCT00227513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402266|NCT00227565|Carboplatin|carboplatin|mesh-list
6402267|NCT00227565|Pemetrexed|pemetrexed|mesh-list
6402268|NCT00227565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6402269|NCT00227565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6402270|NCT00227565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402271|NCT00227565|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6402272|NCT00227565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6402273|NCT00227630|Pemetrexed|pemetrexed|mesh-list
6402274|NCT00227630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6402275|NCT00227630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6402276|NCT00227630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402277|NCT00227630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6402278|NCT00227630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6402279|NCT00227656|Interferons|interferons|mesh-list
6402280|NCT00227656|Interferon-alpha|interferon-alpha|mesh-list
6402281|NCT00227656|Interferon alpha-2|interferon alpha-2|mesh-list
6402282|NCT00227656|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6402283|NCT00227656|Capecitabine|capecitabine|mesh-list
6402284|NCT00227656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6402285|NCT00227656|Antimetabolites|antimetabolites|mesh-ancestor
6402286|NCT00227656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402287|NCT00227656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6402288|NCT00227656|Antiviral Agents|antiviral agents|mesh-ancestor
6402289|NCT00227656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6402290|NCT00227656|Immunologic Factors|immunologic factors|mesh-ancestor
6402291|NCT00227656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402292|NCT00227669|Gemcitabine|gemcitabine|mesh-list
6402293|NCT00227669|Docetaxel|docetaxel|mesh-list
6402294|NCT00227669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6402295|NCT00227669|Antimetabolites|antimetabolites|mesh-ancestor
6402296|NCT00227669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402297|NCT00227669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6402298|NCT00227669|Antiviral Agents|antiviral agents|mesh-ancestor
6402299|NCT00227669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6402300|NCT00227669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6402301|NCT00227669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6402302|NCT00227669|Immunologic Factors|immunologic factors|mesh-ancestor
6402303|NCT00227669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402304|NCT00227669|Tubulin Modulators|tubulin modulators|mesh-ancestor
6402305|NCT00227669|Antimitotic Agents|antimitotic agents|mesh-ancestor
6402306|NCT00227669|Mitosis Modulators|mitosis modulators|mesh-ancestor
6402307|NCT00227682|Ascorbic Acid|ascorbic acid|mesh-list
6402308|NCT00227682|Thalidomide|thalidomide|mesh-list
6402309|NCT00227682|Dexamethasone|dexamethasone|mesh-list
6402310|NCT00227682|Arsenic Trioxide|arsenic trioxide|mesh-list
6402311|NCT00227682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6402312|NCT00227682|Antiemetics|antiemetics|mesh-ancestor
6402313|NCT00227682|Autonomic Agents|autonomic agents|mesh-ancestor
6402314|NCT00227682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6402315|NCT00227682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402316|NCT00227682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6402317|NCT00227682|Glucocorticoids|glucocorticoids|mesh-ancestor
6402318|NCT00227682|Hormones|hormones|mesh-ancestor
6402319|NCT00227682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6402320|NCT00227682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6402321|NCT00227682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6402322|NCT00227682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6402323|NCT00227682|Immunologic Factors|immunologic factors|mesh-ancestor
6402324|NCT00227682|Leprostatic Agents|leprostatic agents|mesh-ancestor
6402325|NCT00227682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6402326|NCT00227682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6402327|NCT00227682|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6402328|NCT00227682|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6402329|NCT00227682|Growth Substances|growth substances|mesh-ancestor
6402330|NCT00227682|Growth Inhibitors|growth inhibitors|mesh-ancestor
6402331|NCT00227682|Antioxidants|antioxidants|mesh-ancestor
6402332|NCT00227682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402333|NCT00227682|Protective Agents|protective agents|mesh-ancestor
6402334|NCT00227682|Vitamins|vitamins|mesh-ancestor
6402335|NCT00227682|Micronutrients|micronutrients|mesh-ancestor
6402336|NCT00227695|Rituximab|rituximab|mesh-list
6402337|NCT00227695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6402338|NCT00227695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6402339|NCT00227695|Immunologic Factors|immunologic factors|mesh-ancestor
6402340|NCT00227695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402341|NCT00227695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6402342|NCT00227708|Docetaxel|docetaxel|mesh-list
6402343|NCT00227708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6402344|NCT00227708|Tubulin Modulators|tubulin modulators|mesh-ancestor
6402345|NCT00227708|Antimitotic Agents|antimitotic agents|mesh-ancestor
6402346|NCT00227708|Mitosis Modulators|mitosis modulators|mesh-ancestor
6402347|NCT00227708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402348|NCT00227734|Capecitabine|capecitabine|mesh-list
6402349|NCT00227734|Oxaliplatin|oxaliplatin|mesh-list
6402350|NCT00227734|Cetuximab|cetuximab|mesh-list
6402351|NCT00227734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6402352|NCT00227734|Antimetabolites|antimetabolites|mesh-ancestor
6402353|NCT00227734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402354|NCT00227734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6402355|NCT00227734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6402356|NCT00227747|Capecitabine|capecitabine|mesh-list
6402357|NCT00227747|Oxaliplatin|oxaliplatin|mesh-list
6402358|NCT00227747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6402359|NCT00227747|Antimetabolites|antimetabolites|mesh-ancestor
6018629|NCT00381797|Antibodies|antibodies|mesh-list
6018630|NCT00381797|Immunoglobulins|immunoglobulins|mesh-list
6018631|NCT00381797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6018632|NCT00381797|Immunoglobulin G|immunoglobulin g|mesh-list
6018633|NCT00381797|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6018634|NCT00381797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6018635|NCT00381797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6018636|NCT00381797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6402360|NCT00227747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402361|NCT00227747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6402362|NCT00227773|Octreotide|octreotide|mesh-list
6402363|NCT00227773|Hormones|hormones|mesh-list
6402364|NCT00227773|Somatostatin|somatostatin|mesh-list
6402365|NCT00227773|Mitogens|mitogens|mesh-list
6402366|NCT00227773|Enzyme Inhibitors|enzyme inhibitors|mesh-list
6402367|NCT00227773|Vatalanib|vatalanib|mesh-list
6402368|NCT00227773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6402369|NCT00227773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402370|NCT00227773|Mitosis Modulators|mitosis modulators|mesh-ancestor
6538120|NCT00825864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6018637|NCT00381797|Growth Substances|growth substances|mesh-ancestor
6402371|NCT00227773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402372|NCT00227773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6402373|NCT00227773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6402374|NCT00227773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6402375|NCT00227773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6402376|NCT00227812|Bupropion|bupropion|mesh-list
6402377|NCT00227812|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6402378|NCT00227812|Antidepressive Agents|antidepressive agents|mesh-ancestor
6402379|NCT00227812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6402380|NCT00227812|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6402381|NCT00227812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6402382|NCT00227812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6402383|NCT00227812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402384|NCT00227812|Dopamine Agents|dopamine agents|mesh-ancestor
6402385|NCT00227812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6402386|NCT00227812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402387|NCT00227812|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6402388|NCT00227812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6402389|NCT00227812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6402390|NCT00227942|Zolpidem|zolpidem|mesh-list
6402391|NCT00227942|Estrogens|estrogens|mesh-list
6402392|NCT00227942|Hormones|hormones|mesh-ancestor
6402393|NCT00227942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6402394|NCT00227942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402395|NCT00227942|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6402396|NCT00227942|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6402397|NCT00227942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6402398|NCT00227942|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6402399|NCT00227942|GABA Agonists|gaba agonists|mesh-ancestor
6402400|NCT00227942|GABA Agents|gaba agents|mesh-ancestor
6402401|NCT00227942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6402402|NCT00227942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402403|NCT00227955|Imipramine|imipramine|mesh-list
6402404|NCT00227955|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6402405|NCT00227955|Antidepressive Agents|antidepressive agents|mesh-ancestor
6402406|NCT00227955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6402407|NCT00227955|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6402408|NCT00227955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6402409|NCT00227955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6402410|NCT00227955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402411|NCT00227955|Adrenergic Agents|adrenergic agents|mesh-ancestor
6402412|NCT00227955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6402413|NCT00227955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402414|NCT00227981|Fluoxetine|fluoxetine|mesh-list
6402415|NCT00227981|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6402416|NCT00227981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6402417|NCT00227981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6402418|NCT00227981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402419|NCT00227981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6402420|NCT00227981|Serotonin Agents|serotonin agents|mesh-ancestor
6402421|NCT00227981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402422|NCT00227981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6402423|NCT00227981|Antidepressive Agents|antidepressive agents|mesh-ancestor
6402424|NCT00227981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6402425|NCT00227981|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6402426|NCT00227981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6402427|NCT00227981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6402428|NCT00228007|Antidepressive Agents|antidepressive agents|mesh-list
6402429|NCT00228007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6402430|NCT00228020|Cyclosporine|cyclosporine|mesh-list
6402431|NCT00228020|Mycophenolic Acid|mycophenolic acid|mesh-list
6402432|NCT00228020|Prednisone|prednisone|mesh-list
6402433|NCT00228020|Cyclosporins|cyclosporins|mesh-list
6402434|NCT00228020|Basiliximab|basiliximab|mesh-list
6402435|NCT00228020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6402436|NCT00228020|Glucocorticoids|glucocorticoids|mesh-ancestor
6402437|NCT00228020|Hormones|hormones|mesh-ancestor
6402438|NCT00228020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6402439|NCT00228020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402440|NCT00228020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6402441|NCT00228020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6402442|NCT00228020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6402443|NCT00228020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402444|NCT00228020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6402445|NCT00228020|Immunologic Factors|immunologic factors|mesh-ancestor
6402446|NCT00228020|Antifungal Agents|antifungal agents|mesh-ancestor
6402447|NCT00228020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6402448|NCT00228020|Dermatologic Agents|dermatologic agents|mesh-ancestor
6402449|NCT00228020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6402450|NCT00228020|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6402451|NCT00228020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6402452|NCT00228020|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6402453|NCT00228020|Antitubercular Agents|antitubercular agents|mesh-ancestor
6402454|NCT00228020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6402455|NCT00228033|Calcium Carbonate|calcium carbonate|mesh-list
6402456|NCT00228033|Calcium|calcium|mesh-list
6402457|NCT00228033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6402458|NCT00228033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402459|NCT00228033|Antacids|antacids|mesh-ancestor
6402460|NCT00228033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402461|NCT00228033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6402462|NCT00228046|Valproic Acid|valproic acid|mesh-list
6402463|NCT00228046|Methylphenidate|methylphenidate|mesh-list
6402464|NCT00228046|Amphetamine|amphetamine|mesh-list
6402465|NCT00228046|Dextroamphetamine|dextroamphetamine|mesh-list
6402466|NCT00228046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6402467|NCT00228046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402468|NCT00228046|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6402469|NCT00228046|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6402470|NCT00228046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6402471|NCT00228046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402472|NCT00228046|Dopamine Agents|dopamine agents|mesh-ancestor
6402473|NCT00228046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6402474|NCT00228046|Sympathomimetics|sympathomimetics|mesh-ancestor
6402475|NCT00228046|Autonomic Agents|autonomic agents|mesh-ancestor
6402476|NCT00228046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6402477|NCT00228046|Adrenergic Agents|adrenergic agents|mesh-ancestor
6402478|NCT00228046|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6402479|NCT00228046|Anticonvulsants|anticonvulsants|mesh-ancestor
6402480|NCT00228046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6402481|NCT00228046|GABA Agents|gaba agents|mesh-ancestor
6402482|NCT00228046|Antimanic Agents|antimanic agents|mesh-ancestor
6402483|NCT00228046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6402484|NCT00228046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6402485|NCT00228046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6402486|NCT00228163|Teriflunomide|teriflunomide|mesh-list
6402487|NCT00228163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6402488|NCT00228163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6402489|NCT00228163|Analgesics|analgesics|mesh-ancestor
6402490|NCT00228163|Sensory System Agents|sensory system agents|mesh-ancestor
6402491|NCT00228163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6402492|NCT00228163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402493|NCT00228163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6402494|NCT00228163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6402495|NCT00228163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6402496|NCT00228163|Immunologic Factors|immunologic factors|mesh-ancestor
6402497|NCT00228228|Vaccines|vaccines|mesh-list
6402498|NCT00228228|Immunologic Factors|immunologic factors|mesh-ancestor
6402499|NCT00228228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402500|NCT00228254|Vitamin A|vitamin a|mesh-list
6402501|NCT00228254|Vitamins|vitamins|mesh-ancestor
6402502|NCT00228254|Micronutrients|micronutrients|mesh-ancestor
6402503|NCT00228254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402504|NCT00228267|Propofol|propofol|mesh-list
6402505|NCT00228267|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6402506|NCT00228267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6402507|NCT00228267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402508|NCT00228267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6402509|NCT00228267|Anesthetics, General|anesthetics, general|mesh-ancestor
6402510|NCT00228267|Anesthetics|anesthetics|mesh-ancestor
6402511|NCT00228319|Vitamins|vitamins|mesh-list
6402512|NCT00228319|Ascorbic Acid|ascorbic acid|mesh-list
6402513|NCT00228319|Vitamin E|vitamin e|mesh-list
6402514|NCT00228319|Vitamin A|vitamin a|mesh-list
6402515|NCT00228319|Carboplatin|carboplatin|mesh-list
6402516|NCT00228319|Carotenoids|carotenoids|mesh-list
6402517|NCT00228319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6402518|NCT00228319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402519|NCT00228319|Micronutrients|micronutrients|mesh-ancestor
6402520|NCT00228319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402521|NCT00228319|Antioxidants|antioxidants|mesh-ancestor
6402522|NCT00228319|Protective Agents|protective agents|mesh-ancestor
6402523|NCT00228358|Cyclophosphamide|cyclophosphamide|mesh-list
6402524|NCT00228358|Interleukin-2|interleukin-2|mesh-list
6402525|NCT00228358|Denileukin diftitox|denileukin diftitox|mesh-list
6402526|NCT00228358|Immunotoxins|immunotoxins|mesh-list
6402527|NCT00228358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6402528|NCT00228358|Immunologic Factors|immunologic factors|mesh-ancestor
6402529|NCT00228358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402530|NCT00228358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6402531|NCT00228358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6402532|NCT00228358|Alkylating Agents|alkylating agents|mesh-ancestor
6402533|NCT00228358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402534|NCT00228358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6402535|NCT00228358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6402536|NCT00228358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6402537|NCT00228358|Analgesics|analgesics|mesh-ancestor
6402538|NCT00228358|Sensory System Agents|sensory system agents|mesh-ancestor
6402539|NCT00228358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6402540|NCT00228397|Sirolimus|sirolimus|mesh-list
6402541|NCT00228397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6402542|NCT00228397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6402543|NCT00228397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6402544|NCT00228397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6402545|NCT00228397|Antifungal Agents|antifungal agents|mesh-ancestor
6402546|NCT00228397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6402547|NCT00228397|Immunologic Factors|immunologic factors|mesh-ancestor
6402548|NCT00228397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402549|NCT00228410|Vancomycin|vancomycin|mesh-list
6402550|NCT00228410|Tigecycline|tigecycline|mesh-list
6402551|NCT00228410|Aztreonam|aztreonam|mesh-list
6402552|NCT00228410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6402553|NCT00228410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6402554|NCT00228410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6402555|NCT00228410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6402556|NCT00228410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402557|NCT00228462|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6402558|NCT00228462|Antidepressive Agents|antidepressive agents|mesh-ancestor
6402559|NCT00228462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6402560|NCT00228462|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6402561|NCT00228462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6402562|NCT00228462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6402563|NCT00228462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402564|NCT00228475|Budesonide|budesonide|mesh-list
6402565|NCT00228475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6402566|NCT00228475|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6402567|NCT00228475|Autonomic Agents|autonomic agents|mesh-ancestor
6402568|NCT00228475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6402569|NCT00228475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402570|NCT00228475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6402571|NCT00228475|Respiratory System Agents|respiratory system agents|mesh-ancestor
6402572|NCT00228475|Glucocorticoids|glucocorticoids|mesh-ancestor
6402573|NCT00228475|Hormones|hormones|mesh-ancestor
6402574|NCT00228475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6402575|NCT00228488|Gefitinib|gefitinib|mesh-list
6402576|NCT00228488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6402577|NCT00228488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6402578|NCT00228488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6402579|NCT00228488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459217|NCT00443963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6459218|NCT00443963|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6459219|NCT00443963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6459220|NCT00443963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459221|NCT00443963|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6459222|NCT00443963|Histamine Antagonists|histamine antagonists|mesh-ancestor
6459223|NCT00443963|Histamine Agents|histamine agents|mesh-ancestor
6459224|NCT00443963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6459225|NCT00443963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459226|NCT00444015|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6459227|NCT00444015|Dasatinib|dasatinib|mesh-list
6459228|NCT00444015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6459229|NCT00444015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6459230|NCT00444015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6459231|NCT00444015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459232|NCT00444041|Bevacizumab|bevacizumab|mesh-list
6459233|NCT00444041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6459234|NCT00444041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6459235|NCT00444041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6459236|NCT00444041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6459237|NCT00444041|Growth Substances|growth substances|mesh-ancestor
6459238|NCT00444041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459239|NCT00444041|Growth Inhibitors|growth inhibitors|mesh-ancestor
6459240|NCT00444093|Antidiarrheals|antidiarrheals|mesh-list
6459241|NCT00444093|Loperamide|loperamide|mesh-list
6459242|NCT00444093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6459243|NCT00444132|Clopidogrel|clopidogrel|mesh-list
6459244|NCT00444132|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6459245|NCT00444132|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6459246|NCT00444132|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6459247|NCT00444132|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6459248|NCT00444132|Purinergic Agents|purinergic agents|mesh-ancestor
6459249|NCT00444132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6459250|NCT00444132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459251|NCT00444132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459252|NCT00444171|Insulin|insulin|mesh-list
6459253|NCT00444171|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6459254|NCT00444171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6459255|NCT00444171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459256|NCT00444184|Timolol|timolol|mesh-list
6459257|NCT00444184|Travoprost|travoprost|mesh-list
6459258|NCT00444184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6459259|NCT00444184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6459260|NCT00444184|Adrenergic Agents|adrenergic agents|mesh-ancestor
6459261|NCT00444184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6459262|NCT00444184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459263|NCT00444184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459264|NCT00444184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6459265|NCT00444184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6459266|NCT00444223|Fluorides|fluorides|mesh-list
6459267|NCT00444223|Cariostatic Agents|cariostatic agents|mesh-ancestor
6459268|NCT00444223|Protective Agents|protective agents|mesh-ancestor
6459269|NCT00444223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459270|NCT00444236|Esomeprazole|esomeprazole|mesh-list
6459271|NCT00444236|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6459272|NCT00444236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6459273|NCT00444236|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6459274|NCT00444236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6459275|NCT00444236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459276|NCT00444249|Dipivefrin|dipivefrin|mesh-list
6459277|NCT00444249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6459278|NCT00444249|Adrenergic Agents|adrenergic agents|mesh-ancestor
6459279|NCT00444249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6459280|NCT00444249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402580|NCT00228514|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6402581|NCT00228514|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6402582|NCT00228514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6402583|NCT00228514|Antimetabolites|antimetabolites|mesh-ancestor
6402584|NCT00228514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402585|NCT00228514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6402586|NCT00228514|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6402587|NCT00228514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6402588|NCT00228527|Esomeprazole|esomeprazole|mesh-list
6402589|NCT00228527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6402590|NCT00228527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6402591|NCT00228527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6402592|NCT00228527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6402593|NCT00228527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402594|NCT00228540|Modafinil|modafinil|mesh-list
6402595|NCT00228540|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6402596|NCT00228540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402597|NCT00228540|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6402598|NCT00228540|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6402599|NCT00228540|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6402600|NCT00228540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402601|NCT00228592|Immunoglobulins|immunoglobulins|mesh-list
6402602|NCT00228592|Antibodies|antibodies|mesh-list
6402603|NCT00228592|gamma-Globulins|gamma-globulins|mesh-list
6402604|NCT00228592|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6402605|NCT00228592|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6402606|NCT00228592|Immunologic Factors|immunologic factors|mesh-ancestor
6402607|NCT00228592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402608|NCT00228605|Fentanyl|fentanyl|mesh-list
6402609|NCT00228605|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6402610|NCT00228605|Narcotics|narcotics|mesh-ancestor
6402611|NCT00228605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6402612|NCT00228605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402613|NCT00228605|Analgesics|analgesics|mesh-ancestor
6402614|NCT00228605|Sensory System Agents|sensory system agents|mesh-ancestor
6402615|NCT00228605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6402616|NCT00228605|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6402617|NCT00228605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6402618|NCT00228605|Anesthetics, General|anesthetics, general|mesh-ancestor
6402619|NCT00228605|Anesthetics|anesthetics|mesh-ancestor
6402620|NCT00228839|Infliximab|infliximab|mesh-list
6402621|NCT00228839|Dermatologic Agents|dermatologic agents|mesh-ancestor
6402622|NCT00228839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6402623|NCT00228839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6402624|NCT00228852|Fludarabine|fludarabine|mesh-list
6402625|NCT00228852|Busulfan|busulfan|mesh-list
6402626|NCT00228852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6402627|NCT00228852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402628|NCT00228852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6402629|NCT00228852|Immunologic Factors|immunologic factors|mesh-ancestor
6402630|NCT00228852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402631|NCT00228852|Alkylating Agents|alkylating agents|mesh-ancestor
6402632|NCT00228852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6402633|NCT00228852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6402634|NCT00228865|Insulin|insulin|mesh-list
6402635|NCT00228865|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6402636|NCT00228865|Insulin, Isophane|insulin, isophane|mesh-list
6402637|NCT00228865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6402638|NCT00228865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402639|NCT00228878|Insulin|insulin|mesh-list
6402640|NCT00228878|Insulin Aspart|insulin aspart|mesh-list
6402641|NCT00228878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6402642|NCT00228878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402643|NCT00228891|Insulin|insulin|mesh-list
6402644|NCT00228891|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6402645|NCT00228891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6402646|NCT00228891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402647|NCT00228904|Insulin|insulin|mesh-list
6402648|NCT00228904|Insulin Lispro|insulin lispro|mesh-list
6402649|NCT00228904|Insulin Aspart|insulin aspart|mesh-list
6402650|NCT00228904|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6402651|NCT00228904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6402652|NCT00228904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402653|NCT00228930|Tamoxifen|tamoxifen|mesh-list
6402654|NCT00228930|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6402655|NCT00228930|Hormone Antagonists|hormone antagonists|mesh-ancestor
6402656|NCT00228930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6402657|NCT00228930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402658|NCT00228930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6402659|NCT00228930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6402660|NCT00228930|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6402661|NCT00228930|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6402662|NCT00228930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6402663|NCT00228982|Vancomycin|vancomycin|mesh-list
6402664|NCT00228982|Ceftobiprole|ceftobiprole|mesh-list
6402665|NCT00228982|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
6402666|NCT00228982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6402667|NCT00228982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6402668|NCT00228995|Epoetin Alfa|epoetin alfa|mesh-list
6402669|NCT00228995|Hematinics|hematinics|mesh-ancestor
6402670|NCT00229060|Doripenem|doripenem|mesh-list
6402671|NCT00229060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6402672|NCT00229060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6402673|NCT00229112|Tazobactam|tazobactam|mesh-list
6402674|NCT00229112|Piperacillin|piperacillin|mesh-list
6402675|NCT00229112|Ertapenem|ertapenem|mesh-list
6402676|NCT00229112|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
6402677|NCT00229112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402678|NCT00229112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6402679|NCT00229112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6402680|NCT00229112|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6402681|NCT00229112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6402682|NCT00229125|Gabapentin|gabapentin|mesh-list
6402683|NCT00229125|Lorazepam|lorazepam|mesh-list
6402684|NCT00229125|Analgesics|analgesics|mesh-ancestor
6402685|NCT00229125|Sensory System Agents|sensory system agents|mesh-ancestor
6402686|NCT00229125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6402687|NCT00229125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402688|NCT00229125|Anticonvulsants|anticonvulsants|mesh-ancestor
6402689|NCT00229125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6402690|NCT00229125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6402691|NCT00229125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6402692|NCT00229125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6402693|NCT00229125|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6538121|NCT00825864|Analgesics|analgesics|mesh-ancestor
6402694|NCT00229125|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6402695|NCT00229125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6402696|NCT00229125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402697|NCT00229125|Antimanic Agents|antimanic agents|mesh-ancestor
6402698|NCT00229125|Antiemetics|antiemetics|mesh-ancestor
6402699|NCT00229125|Autonomic Agents|autonomic agents|mesh-ancestor
6402700|NCT00229125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6402701|NCT00229125|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6402702|NCT00229125|GABA Modulators|gaba modulators|mesh-ancestor
6402703|NCT00229125|GABA Agents|gaba agents|mesh-ancestor
6402704|NCT00229138|Tacrolimus|tacrolimus|mesh-list
6402705|NCT00229138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6402706|NCT00229138|Immunologic Factors|immunologic factors|mesh-ancestor
6402707|NCT00229138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402708|NCT00229138|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6402709|NCT00229138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6402710|NCT00229138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402711|NCT00229216|Tinidazole|tinidazole|mesh-list
6402712|NCT00229216|Alkylating Agents|alkylating agents|mesh-ancestor
6402713|NCT00229216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402714|NCT00229216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6402715|NCT00229216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6402716|NCT00229216|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
6402717|NCT00229216|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6402718|NCT00229216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6402719|NCT00229242|Diuretics|diuretics|mesh-list
6402720|NCT00229242|Natriuretic Agents|natriuretic agents|mesh-ancestor
6402721|NCT00229242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402722|NCT00229333|Citalopram|citalopram|mesh-list
6402723|NCT00229333|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6402724|NCT00229333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6402725|NCT00229333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6402726|NCT00229333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402727|NCT00229333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6402728|NCT00229333|Serotonin Agents|serotonin agents|mesh-ancestor
6402729|NCT00229333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402730|NCT00229333|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6402731|NCT00229333|Antidepressive Agents|antidepressive agents|mesh-ancestor
6402732|NCT00229333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6402733|NCT00229385|Ziprasidone|ziprasidone|mesh-list
6402734|NCT00229385|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6402735|NCT00229385|Serotonin Agents|serotonin agents|mesh-ancestor
6402736|NCT00229385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6402737|NCT00229385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402738|NCT00229385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402739|NCT00229385|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6402740|NCT00229385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6402741|NCT00229385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6402742|NCT00229385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6402743|NCT00229385|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6402744|NCT00229385|Dopamine Agents|dopamine agents|mesh-ancestor
6402745|NCT00229424|Famotidine|famotidine|mesh-list
6402746|NCT00229424|Lafutidine|lafutidine|mesh-list
6402747|NCT00229424|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6402748|NCT00229424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6402749|NCT00229424|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6402750|NCT00229424|Histamine Antagonists|histamine antagonists|mesh-ancestor
6402751|NCT00229424|Histamine Agents|histamine agents|mesh-ancestor
6402752|NCT00229424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6402753|NCT00229424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402754|NCT00229424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402755|NCT00229450|Estrogens|estrogens|mesh-list
6402756|NCT00229450|Hormones|hormones|mesh-ancestor
6402757|NCT00229450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6402758|NCT00229450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402759|NCT00229476|Sertraline|sertraline|mesh-list
6402760|NCT00229476|Antidepressive Agents|antidepressive agents|mesh-ancestor
6402761|NCT00229476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6402762|NCT00229476|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6402763|NCT00229476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6402764|NCT00229476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6402765|NCT00229476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402766|NCT00229476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6402767|NCT00229476|Serotonin Agents|serotonin agents|mesh-ancestor
6402768|NCT00229476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402769|NCT00229515|Sirolimus|sirolimus|mesh-list
6402770|NCT00229515|polysaccharide-K|polysaccharide-k|mesh-list
6402771|NCT00229515|Tirofiban|tirofiban|mesh-list
6402772|NCT00229515|Abciximab|abciximab|mesh-list
6402773|NCT00229515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6402774|NCT00229515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6402775|NCT00229515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6402776|NCT00229515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6402777|NCT00229515|Antifungal Agents|antifungal agents|mesh-ancestor
6402778|NCT00229515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6402779|NCT00229515|Immunologic Factors|immunologic factors|mesh-ancestor
6402780|NCT00229515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402781|NCT00229515|Anticoagulants|anticoagulants|mesh-ancestor
6402782|NCT00229515|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6402783|NCT00229515|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6402784|NCT00229515|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6402785|NCT00229515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402786|NCT00229515|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6402787|NCT00229515|Antiviral Agents|antiviral agents|mesh-ancestor
6402788|NCT00229515|Interferon Inducers|interferon inducers|mesh-ancestor
6402789|NCT00229515|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6402790|NCT00229515|Protective Agents|protective agents|mesh-ancestor
6402791|NCT00229528|Paroxetine|paroxetine|mesh-list
6402792|NCT00229528|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6402793|NCT00229528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6402794|NCT00229528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6402795|NCT00229528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402796|NCT00229528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6402797|NCT00229528|Serotonin Agents|serotonin agents|mesh-ancestor
6402798|NCT00229528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402799|NCT00229528|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6402800|NCT00229528|Antidepressive Agents|antidepressive agents|mesh-ancestor
6402801|NCT00229528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6402802|NCT00229528|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6402803|NCT00229528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6402804|NCT00229528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6402805|NCT00229567|Lidocaine|lidocaine|mesh-list
6402806|NCT00229567|Ketamine|ketamine|mesh-list
6402807|NCT00229567|Anesthetics, Local|anesthetics, local|mesh-ancestor
6402808|NCT00229567|Anesthetics|anesthetics|mesh-ancestor
6402809|NCT00229567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6402810|NCT00229567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402811|NCT00229567|Sensory System Agents|sensory system agents|mesh-ancestor
6402812|NCT00229567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6402813|NCT00229567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6402814|NCT00229567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6402815|NCT00229567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6402816|NCT00229567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6402817|NCT00229567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402818|NCT00229567|Analgesics|analgesics|mesh-ancestor
6402819|NCT00229567|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6402820|NCT00229567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6402821|NCT00229567|Anesthetics, General|anesthetics, general|mesh-ancestor
6402822|NCT00229567|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6402823|NCT00229567|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6402824|NCT00229567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6402825|NCT00229593|ST 1435|st 1435|mesh-list
6402826|NCT00229593|Testosterone|testosterone|mesh-list
6402827|NCT00229593|Androgens|androgens|mesh-ancestor
6402828|NCT00229593|Hormones|hormones|mesh-ancestor
6402829|NCT00229593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6402830|NCT00229593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402831|NCT00229593|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6402832|NCT00229593|Contraceptive Agents|contraceptive agents|mesh-ancestor
6402833|NCT00229593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6402834|NCT00229593|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6402835|NCT00229632|Idebenone|idebenone|mesh-list
6402836|NCT00229632|Antioxidants|antioxidants|mesh-ancestor
6402837|NCT00229632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402838|NCT00229632|Protective Agents|protective agents|mesh-ancestor
6402839|NCT00229632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402840|NCT00229645|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6402841|NCT00229645|Antidepressive Agents|antidepressive agents|mesh-ancestor
6402842|NCT00229645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6402843|NCT00229645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6402844|NCT00229645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6402845|NCT00229645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6402846|NCT00229645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402847|NCT00229684|Pioglitazone|pioglitazone|mesh-list
6402848|NCT00229684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6402849|NCT00229684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402850|NCT00229697|Tamoxifen|tamoxifen|mesh-list
6402851|NCT00229697|Gefitinib|gefitinib|mesh-list
6402852|NCT00229697|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6402853|NCT00229697|Hormone Antagonists|hormone antagonists|mesh-ancestor
6402854|NCT00229697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6402855|NCT00229697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402856|NCT00229697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6402857|NCT00229697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6402858|NCT00229697|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6402859|NCT00229697|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6402860|NCT00229697|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6402861|NCT00229697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6402862|NCT00229697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6402863|NCT00229697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402864|NCT00229775|Chloroquine|chloroquine|mesh-list
6402865|NCT00229775|Artemether|artemether|mesh-list
6402866|NCT00229775|Pyrimethamine|pyrimethamine|mesh-list
6402867|NCT00229775|Sulfadoxine|sulfadoxine|mesh-list
6402868|NCT00229775|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6402869|NCT00229775|Amebicides|amebicides|mesh-ancestor
6402870|NCT00229775|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6402871|NCT00229775|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6402872|NCT00229775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6402873|NCT00229775|Antimalarials|antimalarials|mesh-ancestor
6402874|NCT00229775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6402875|NCT00229775|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6402876|NCT00229775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6402877|NCT00229775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402878|NCT00229775|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6402879|NCT00229775|Renal Agents|renal agents|mesh-ancestor
6402880|NCT00229918|Triamcinolone|triamcinolone|mesh-list
6402881|NCT00229918|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6402882|NCT00229918|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6402883|NCT00229918|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6402884|NCT00229918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6402885|NCT00229918|Glucocorticoids|glucocorticoids|mesh-ancestor
6402886|NCT00229918|Hormones|hormones|mesh-ancestor
6402887|NCT00229918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6402888|NCT00229918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402889|NCT00229918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6402890|NCT00229918|Immunologic Factors|immunologic factors|mesh-ancestor
6402891|NCT00229918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6402892|NCT00229918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402893|NCT00229944|Azithromycin|azithromycin|mesh-list
6402894|NCT00229944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6402895|NCT00229944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6402896|NCT00229996|Leuprolide|leuprolide|mesh-list
6402897|NCT00229996|Norethindrone|norethindrone|mesh-list
6402898|NCT00229996|Norethindrone Acetate|norethindrone acetate|mesh-list
6538122|NCT00825864|Sensory System Agents|sensory system agents|mesh-ancestor
6538123|NCT00825864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6538124|NCT00825864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6538125|NCT00825864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6018638|NCT00381797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018639|NCT00381797|Growth Inhibitors|growth inhibitors|mesh-ancestor
6018640|NCT00381797|Immunologic Factors|immunologic factors|mesh-ancestor
6402899|NCT00229996|Contraceptive Agents|contraceptive agents|mesh-list
6402900|NCT00229996|Contraceptives, Oral|contraceptives, oral|mesh-list
6402901|NCT00229996|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6402902|NCT00229996|Fertility Agents|fertility agents|mesh-ancestor
6402903|NCT00229996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6402904|NCT00229996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402905|NCT00229996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6402906|NCT00229996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6402907|NCT00229996|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6402908|NCT00229996|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6402909|NCT00229996|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6402910|NCT00229996|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6402911|NCT00230035|Mycophenolic Acid|mycophenolic acid|mesh-list
6402912|NCT00230035|Methylprednisolone|methylprednisolone|mesh-list
6402913|NCT00230035|Rituximab|rituximab|mesh-list
6402914|NCT00230035|Methotrexate|methotrexate|mesh-list
6402915|NCT00230035|Azathioprine|azathioprine|mesh-list
6402916|NCT00230035|Immunoglobulins|immunoglobulins|mesh-list
6402917|NCT00230035|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6402918|NCT00230035|Antibodies|antibodies|mesh-list
6402919|NCT00230035|Sargramostim|sargramostim|mesh-list
6402920|NCT00230035|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6402921|NCT00230035|gamma-Globulins|gamma-globulins|mesh-list
6402922|NCT00230035|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6402923|NCT00230035|Leflunomide|leflunomide|mesh-list
6402924|NCT00230035|Thymoglobulin|thymoglobulin|mesh-list
6402925|NCT00230035|Immunosuppressive Agents|immunosuppressive agents|mesh-list
6402926|NCT00230035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6402927|NCT00230035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6402928|NCT00230035|Immunologic Factors|immunologic factors|mesh-ancestor
6402929|NCT00230035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402930|NCT00230035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6402931|NCT00230035|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6402932|NCT00230035|Abortifacient Agents|abortifacient agents|mesh-ancestor
6402933|NCT00230035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6402934|NCT00230035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6402935|NCT00230035|Antimetabolites|antimetabolites|mesh-ancestor
6402936|NCT00230035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402937|NCT00230035|Dermatologic Agents|dermatologic agents|mesh-ancestor
6402938|NCT00230035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6402939|NCT00230035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6402940|NCT00230035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6402941|NCT00230035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6402942|NCT00230035|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6402943|NCT00230035|Antitubercular Agents|antitubercular agents|mesh-ancestor
6402944|NCT00230035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6402945|NCT00230035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6402946|NCT00230035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6402947|NCT00230035|Antiemetics|antiemetics|mesh-ancestor
6402948|NCT00230035|Autonomic Agents|autonomic agents|mesh-ancestor
6402949|NCT00230035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6402950|NCT00230035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6402951|NCT00230035|Glucocorticoids|glucocorticoids|mesh-ancestor
6402952|NCT00230035|Hormones|hormones|mesh-ancestor
6402953|NCT00230035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6402954|NCT00230035|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6402955|NCT00230035|Protective Agents|protective agents|mesh-ancestor
6459281|NCT00444249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459282|NCT00444314|Sunitinib|sunitinib|mesh-list
6459283|NCT00444314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6459284|NCT00444314|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6459285|NCT00444314|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6459286|NCT00444314|Growth Substances|growth substances|mesh-ancestor
6459287|NCT00444314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459288|NCT00444314|Growth Inhibitors|growth inhibitors|mesh-ancestor
6655345|NCT01463332|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6402956|NCT00230204|Antibodies|antibodies|mesh-list
6402957|NCT00230204|Immunologic Factors|immunologic factors|mesh-ancestor
6402958|NCT00230204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402959|NCT00230217|Rasburicase|rasburicase|mesh-list
6402960|NCT00230217|Gout Suppressants|gout suppressants|mesh-ancestor
6402961|NCT00230217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6402962|NCT00230321|Darbepoetin alfa|darbepoetin alfa|mesh-list
6402963|NCT00230321|Hematinics|hematinics|mesh-ancestor
6402964|NCT00230334|Imatinib Mesylate|imatinib mesylate|mesh-list
6402965|NCT00230334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6402966|NCT00230334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6402967|NCT00230334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6402968|NCT00230334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402969|NCT00230373|Imiquimod|imiquimod|mesh-list
6402970|NCT00230373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6402971|NCT00230373|Immunologic Factors|immunologic factors|mesh-ancestor
6402972|NCT00230373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402973|NCT00230373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6402974|NCT00230373|Interferon Inducers|interferon inducers|mesh-ancestor
6402975|NCT00230399|Celecoxib|celecoxib|mesh-list
6402976|NCT00230399|Capecitabine|capecitabine|mesh-list
6402977|NCT00230399|Irinotecan|irinotecan|mesh-list
6402978|NCT00230399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6402979|NCT00230399|Antimetabolites|antimetabolites|mesh-ancestor
6402980|NCT00230399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6402981|NCT00230399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6402982|NCT00230399|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6402983|NCT00230399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6402984|NCT00230399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6402985|NCT00230399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6402986|NCT00230399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6402987|NCT00230399|Analgesics|analgesics|mesh-ancestor
6402988|NCT00230399|Sensory System Agents|sensory system agents|mesh-ancestor
6402989|NCT00230399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6402990|NCT00230399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6402991|NCT00230399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6402992|NCT00230399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6402993|NCT00230399|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6402994|NCT00230399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6402995|NCT00230451|Paclitaxel|paclitaxel|mesh-list
6402996|NCT00230451|Fluorouracil|fluorouracil|mesh-list
6402997|NCT00230451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6402998|NCT00230451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6402999|NCT00230451|Tubulin Modulators|tubulin modulators|mesh-ancestor
6403000|NCT00230451|Antimitotic Agents|antimitotic agents|mesh-ancestor
6403001|NCT00230451|Mitosis Modulators|mitosis modulators|mesh-ancestor
6403002|NCT00230451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403003|NCT00230451|Antimetabolites|antimetabolites|mesh-ancestor
6403004|NCT00230451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6403005|NCT00230451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6403006|NCT00230451|Immunologic Factors|immunologic factors|mesh-ancestor
6403007|NCT00230451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403008|NCT00230464|Vildagliptin|vildagliptin|mesh-list
6403009|NCT00230464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6403010|NCT00230464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403011|NCT00230464|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6538126|NCT00825864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403012|NCT00230464|Protease Inhibitors|protease inhibitors|mesh-ancestor
6403013|NCT00230464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6403014|NCT00230464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403015|NCT00230477|Lamivudine|lamivudine|mesh-list
6403016|NCT00230477|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6403017|NCT00230477|Adefovir|adefovir|mesh-list
6403018|NCT00230477|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6403019|NCT00230477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6403020|NCT00230477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6403021|NCT00230477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403022|NCT00230477|Antiviral Agents|antiviral agents|mesh-ancestor
6403023|NCT00230477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6403024|NCT00230477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6403025|NCT00230477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6403026|NCT00230490|Adefovir|adefovir|mesh-list
6403027|NCT00230490|Pradefovir|pradefovir|mesh-list
6403028|NCT00230490|Antiviral Agents|antiviral agents|mesh-ancestor
6403029|NCT00230490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6403030|NCT00230490|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6403031|NCT00230490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6403032|NCT00230490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6403033|NCT00230490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403034|NCT00230490|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6403035|NCT00230503|Adefovir|adefovir|mesh-list
6403036|NCT00230503|Pradefovir|pradefovir|mesh-list
6403037|NCT00230503|Antiviral Agents|antiviral agents|mesh-ancestor
6403038|NCT00230503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6403039|NCT00230503|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6403040|NCT00230503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6403041|NCT00230503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6403042|NCT00230503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403043|NCT00230503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6403044|NCT00230516|Lansoprazole|lansoprazole|mesh-list
6403045|NCT00230516|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6403046|NCT00230516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6403047|NCT00230516|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6403048|NCT00230516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6403049|NCT00230516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403050|NCT00230529|Infliximab|infliximab|mesh-list
6403051|NCT00230529|Dermatologic Agents|dermatologic agents|mesh-ancestor
6403052|NCT00230529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6403053|NCT00230529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6403054|NCT00230542|Carboplatin|carboplatin|mesh-list
6403055|NCT00230542|Pemetrexed|pemetrexed|mesh-list
6403056|NCT00230542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6403057|NCT00230542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6403058|NCT00230542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403059|NCT00230542|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6403060|NCT00230542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6403061|NCT00230568|Donepezil|donepezil|mesh-list
6403062|NCT00230568|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6403063|NCT00230568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6403064|NCT00230568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403065|NCT00230568|Cholinergic Agents|cholinergic agents|mesh-ancestor
6403066|NCT00230568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6403067|NCT00230568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403068|NCT00230568|Nootropic Agents|nootropic agents|mesh-ancestor
6403069|NCT00230594|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
6403070|NCT00230594|Hemostatics|hemostatics|mesh-ancestor
6403071|NCT00230594|Coagulants|coagulants|mesh-ancestor
6403072|NCT00230594|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6403073|NCT00230594|Natriuretic Agents|natriuretic agents|mesh-ancestor
6403074|NCT00230594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403075|NCT00230698|Topiramate|topiramate|mesh-list
6403076|NCT00230698|Anticonvulsants|anticonvulsants|mesh-ancestor
6403077|NCT00230698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6403078|NCT00230698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403079|NCT00230763|Timolol|timolol|mesh-list
6403080|NCT00230763|Latanoprost|latanoprost|mesh-list
6403081|NCT00230763|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6403082|NCT00230763|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6403083|NCT00230763|Adrenergic Agents|adrenergic agents|mesh-ancestor
6403084|NCT00230763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6403085|NCT00230763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403086|NCT00230763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403087|NCT00230763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6403088|NCT00230763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6403089|NCT00230763|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6403090|NCT00230763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6403091|NCT00230776|Pregabalin|pregabalin|mesh-list
6403092|NCT00230776|Analgesics|analgesics|mesh-ancestor
6403093|NCT00230776|Sensory System Agents|sensory system agents|mesh-ancestor
6403094|NCT00230776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6403095|NCT00230776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403096|NCT00230776|Anticonvulsants|anticonvulsants|mesh-ancestor
6403097|NCT00230776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6403098|NCT00230776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6403099|NCT00230776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403100|NCT00230776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6403101|NCT00230776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6403102|NCT00230776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6403103|NCT00230776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6403104|NCT00230776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6403105|NCT00230789|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6403106|NCT00230789|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6403107|NCT00230789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6403108|NCT00230789|Cholinergic Agents|cholinergic agents|mesh-ancestor
6403109|NCT00230789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6403110|NCT00230789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403111|NCT00230789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403112|NCT00230789|Urological Agents|urological agents|mesh-ancestor
6403113|NCT00230815|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6403114|NCT00230815|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6403115|NCT00230815|Hormones|hormones|mesh-ancestor
6403116|NCT00230815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6403117|NCT00230815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403118|NCT00230815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6403119|NCT00230867|Acyclovir|acyclovir|mesh-list
6403120|NCT00230867|Antiviral Agents|antiviral agents|mesh-ancestor
6403121|NCT00230867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6403122|NCT00230958|Interferons|interferons|mesh-list
6403123|NCT00230958|Ribavirin|ribavirin|mesh-list
6403124|NCT00230958|Interferon-alpha|interferon-alpha|mesh-list
6403125|NCT00230958|Interferon alpha-2|interferon alpha-2|mesh-list
6403126|NCT00230958|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6403127|NCT00230958|Taribavirin|taribavirin|mesh-list
6403128|NCT00230958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6403129|NCT00230958|Antiviral Agents|antiviral agents|mesh-ancestor
6403130|NCT00230958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6403131|NCT00230958|Antimetabolites|antimetabolites|mesh-ancestor
6403132|NCT00230958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403133|NCT00230958|Immunologic Factors|immunologic factors|mesh-ancestor
6403134|NCT00230958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403135|NCT00230984|Methyltestosterone|methyltestosterone|mesh-list
6403136|NCT00230984|Testosterone|testosterone|mesh-list
6403137|NCT00230984|Testosterone undecanoate|testosterone undecanoate|mesh-list
6403138|NCT00230984|Testosterone enanthate|testosterone enanthate|mesh-list
6403139|NCT00230984|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6403140|NCT00230984|Androgens|androgens|mesh-ancestor
6403141|NCT00230984|Hormones|hormones|mesh-ancestor
6403142|NCT00230984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6403143|NCT00230984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403144|NCT00230984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6403145|NCT00230984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6403146|NCT00230984|Anabolic Agents|anabolic agents|mesh-ancestor
6403147|NCT00230997|Galantamine|galantamine|mesh-list
6403148|NCT00230997|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6403149|NCT00230997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6403150|NCT00230997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403151|NCT00230997|Cholinergic Agents|cholinergic agents|mesh-ancestor
6403152|NCT00230997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6403153|NCT00230997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403154|NCT00230997|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6403155|NCT00230997|Autonomic Agents|autonomic agents|mesh-ancestor
6403156|NCT00230997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6403157|NCT00230997|Nootropic Agents|nootropic agents|mesh-ancestor
6403158|NCT00231023|Triamcinolone|triamcinolone|mesh-list
6403159|NCT00231023|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6403160|NCT00231023|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6403161|NCT00231023|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6403162|NCT00231023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6403163|NCT00231023|Glucocorticoids|glucocorticoids|mesh-ancestor
6403164|NCT00231023|Hormones|hormones|mesh-ancestor
6403165|NCT00231023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6403166|NCT00231023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403167|NCT00231023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6403168|NCT00231023|Immunologic Factors|immunologic factors|mesh-ancestor
6403169|NCT00231023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6403170|NCT00231023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403171|NCT00231075|Paclitaxel|paclitaxel|mesh-list
6403172|NCT00231075|Carboplatin|carboplatin|mesh-list
6403173|NCT00231075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6403174|NCT00231075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6403175|NCT00231075|Tubulin Modulators|tubulin modulators|mesh-ancestor
6403176|NCT00231075|Antimitotic Agents|antimitotic agents|mesh-ancestor
6403177|NCT00231075|Mitosis Modulators|mitosis modulators|mesh-ancestor
6403178|NCT00231075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403179|NCT00231101|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6403180|NCT00231101|Antidepressive Agents|antidepressive agents|mesh-ancestor
6403181|NCT00231101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6403182|NCT00231101|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6403183|NCT00231101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6403184|NCT00231101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6403185|NCT00231101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403186|NCT00231140|Thalidomide|thalidomide|mesh-list
6403187|NCT00231140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6403188|NCT00231140|Immunologic Factors|immunologic factors|mesh-ancestor
6403189|NCT00231140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403190|NCT00231140|Leprostatic Agents|leprostatic agents|mesh-ancestor
6403191|NCT00231140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6403192|NCT00231140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6403193|NCT00231140|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6403194|NCT00231140|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6403195|NCT00231140|Growth Substances|growth substances|mesh-ancestor
6403196|NCT00231140|Growth Inhibitors|growth inhibitors|mesh-ancestor
6403197|NCT00231140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6403198|NCT00231192|Repaglinide|repaglinide|mesh-list
6403199|NCT00231192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6403200|NCT00231192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403201|NCT00231218|Ascorbic Acid|ascorbic acid|mesh-list
6403202|NCT00231218|Propolis|propolis|mesh-list
6403203|NCT00231218|Vitamins|vitamins|mesh-ancestor
6403204|NCT00231218|Micronutrients|micronutrients|mesh-ancestor
6403205|NCT00231218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403206|NCT00231218|Antioxidants|antioxidants|mesh-ancestor
6403207|NCT00231218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403208|NCT00231218|Protective Agents|protective agents|mesh-ancestor
6403209|NCT00231218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6403210|NCT00231244|Sirolimus|sirolimus|mesh-list
6403211|NCT00231244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6403212|NCT00231244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6403213|NCT00231244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6403214|NCT00231244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6403215|NCT00231244|Antifungal Agents|antifungal agents|mesh-ancestor
6403216|NCT00231244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6403217|NCT00231244|Immunologic Factors|immunologic factors|mesh-ancestor
6403218|NCT00231244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403219|NCT00231322|Praziquantel|praziquantel|mesh-list
6403220|NCT00231322|Anthelmintics|anthelmintics|mesh-ancestor
6403221|NCT00231322|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6403222|NCT00231322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6403223|NCT00231335|Citalopram|citalopram|mesh-list
6403224|NCT00231335|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6403225|NCT00231335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6403226|NCT00231335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6403227|NCT00231335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403228|NCT00231335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6403229|NCT00231335|Serotonin Agents|serotonin agents|mesh-ancestor
6403230|NCT00231335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403231|NCT00231335|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6403232|NCT00231335|Antidepressive Agents|antidepressive agents|mesh-ancestor
6403233|NCT00231335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6403234|NCT00231348|Nefazodone|nefazodone|mesh-list
6403235|NCT00231348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6403236|NCT00231348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6403237|NCT00231348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6403238|NCT00231348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403239|NCT00231348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6403240|NCT00231348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403241|NCT00231348|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6403242|NCT00231348|Antidepressive Agents|antidepressive agents|mesh-ancestor
6403243|NCT00231348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6403244|NCT00231348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6403245|NCT00231348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6403246|NCT00231348|Serotonin Agents|serotonin agents|mesh-ancestor
6403247|NCT00231387|Rosiglitazone|rosiglitazone|mesh-list
6403248|NCT00231387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6403249|NCT00231387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403250|NCT00231452|Artesunate|artesunate|mesh-list
6403251|NCT00231452|Pyrimethamine|pyrimethamine|mesh-list
6403252|NCT00231452|Sulfadoxine|sulfadoxine|mesh-list
6403253|NCT00231452|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6403254|NCT00231452|Antimalarials|antimalarials|mesh-ancestor
6403255|NCT00231452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6403256|NCT00231452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6403257|NCT00231452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6403258|NCT00231452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6403259|NCT00231452|Antiviral Agents|antiviral agents|mesh-ancestor
6403260|NCT00231452|Schistosomicides|schistosomicides|mesh-ancestor
6403261|NCT00231452|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6403262|NCT00231452|Anthelmintics|anthelmintics|mesh-ancestor
6403263|NCT00231452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6403264|NCT00231452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6403265|NCT00231452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403266|NCT00231452|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6403267|NCT00231452|Renal Agents|renal agents|mesh-ancestor
6403268|NCT00231491|Botulinum Toxins|botulinum toxins|mesh-list
6403269|NCT00231491|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6403270|NCT00231491|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6403271|NCT00231491|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6403272|NCT00231491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6403273|NCT00231491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403274|NCT00231491|Cholinergic Agents|cholinergic agents|mesh-ancestor
6403275|NCT00231491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6403276|NCT00231491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403277|NCT00231491|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6403278|NCT00231491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6403279|NCT00231517|Morphine|morphine|mesh-list
6403280|NCT00231517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6403281|NCT00231517|Narcotics|narcotics|mesh-ancestor
6403282|NCT00231517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6403283|NCT00231517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403284|NCT00231517|Analgesics|analgesics|mesh-ancestor
6403285|NCT00231517|Sensory System Agents|sensory system agents|mesh-ancestor
6403286|NCT00231517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6403287|NCT00231530|Topiramate|topiramate|mesh-list
6403288|NCT00231530|Anticonvulsants|anticonvulsants|mesh-ancestor
6403289|NCT00231530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6403290|NCT00231530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403291|NCT00231556|Topiramate|topiramate|mesh-list
6403292|NCT00231556|Anticonvulsants|anticonvulsants|mesh-ancestor
6403293|NCT00231556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6403294|NCT00231556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403295|NCT00231569|Mipomersen|mipomersen|mesh-list
6403296|NCT00231569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6403297|NCT00231569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6403298|NCT00231569|Antimetabolites|antimetabolites|mesh-ancestor
6403299|NCT00231569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403300|NCT00231569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6403301|NCT00231582|Paclitaxel|paclitaxel|mesh-list
6403302|NCT00231582|Etoposide|etoposide|mesh-list
6403303|NCT00231582|Carboplatin|carboplatin|mesh-list
6403304|NCT00231582|Epirubicin|epirubicin|mesh-list
6403305|NCT00231582|Ifosfamide|ifosfamide|mesh-list
6403306|NCT00231582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6403307|NCT00231582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6403308|NCT00231582|Tubulin Modulators|tubulin modulators|mesh-ancestor
6403309|NCT00231582|Antimitotic Agents|antimitotic agents|mesh-ancestor
6403310|NCT00231582|Mitosis Modulators|mitosis modulators|mesh-ancestor
6403311|NCT00231582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403312|NCT00231582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6403313|NCT00231582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6403314|NCT00231582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6403315|NCT00231582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6403316|NCT00231582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6403317|NCT00231582|Alkylating Agents|alkylating agents|mesh-ancestor
6403318|NCT00231595|Topiramate|topiramate|mesh-list
6403319|NCT00231595|Anticonvulsants|anticonvulsants|mesh-ancestor
6403320|NCT00231595|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6403321|NCT00231595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403322|NCT00231608|Topiramate|topiramate|mesh-list
6403323|NCT00231608|Anticonvulsants|anticonvulsants|mesh-ancestor
6403324|NCT00231608|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6403325|NCT00231608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403326|NCT00231621|Topiramate|topiramate|mesh-list
6403327|NCT00231621|Anticonvulsants|anticonvulsants|mesh-ancestor
6403328|NCT00231621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6403329|NCT00231621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403330|NCT00231634|Topiramate|topiramate|mesh-list
6403331|NCT00231634|Anticonvulsants|anticonvulsants|mesh-ancestor
6403332|NCT00231634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6403333|NCT00231634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403334|NCT00231647|Topiramate|topiramate|mesh-list
6403335|NCT00231647|Anticonvulsants|anticonvulsants|mesh-ancestor
6403336|NCT00231647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6403337|NCT00231647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403338|NCT00231660|Topiramate|topiramate|mesh-list
6403339|NCT00231660|Anticonvulsants|anticonvulsants|mesh-ancestor
6403340|NCT00231660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6403341|NCT00231660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403342|NCT00231673|Topiramate|topiramate|mesh-list
6403343|NCT00231673|Anticonvulsants|anticonvulsants|mesh-ancestor
6403344|NCT00231673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6403345|NCT00231673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403346|NCT00231725|Insulin Lispro|insulin lispro|mesh-list
6403347|NCT00231725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6403348|NCT00231725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459289|NCT00444314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6459290|NCT00444314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6459291|NCT00444314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459292|NCT00444340|Etanercept|etanercept|mesh-list
6459293|NCT00444340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6459294|NCT00444340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6459295|NCT00444340|Analgesics|analgesics|mesh-ancestor
6459296|NCT00444340|Sensory System Agents|sensory system agents|mesh-ancestor
6459297|NCT00444340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6459298|NCT00444340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459299|NCT00444340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6459300|NCT00444340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6459301|NCT00444340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6459302|NCT00444340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6459303|NCT00444340|Immunologic Factors|immunologic factors|mesh-ancestor
6459304|NCT00444379|Ritonavir|ritonavir|mesh-list
6459305|NCT00444379|Lopinavir|lopinavir|mesh-list
6459306|NCT00444379|Tenofovir|tenofovir|mesh-list
6459307|NCT00444379|Emtricitabine|emtricitabine|mesh-list
6459308|NCT00444379|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6459309|NCT00444379|Efavirenz|efavirenz|mesh-list
6459310|NCT00444379|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6459311|NCT00444379|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6459312|NCT00444379|Protease Inhibitors|protease inhibitors|mesh-ancestor
6459313|NCT00444379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6459314|NCT00444379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459315|NCT00444379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6403349|NCT00231738|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
6403350|NCT00231738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6403351|NCT00231738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6403352|NCT00231764|Daclizumab|daclizumab|mesh-list
6403353|NCT00231764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6403354|NCT00231764|Immunologic Factors|immunologic factors|mesh-ancestor
6403355|NCT00231764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403356|NCT00231829|Celecoxib|celecoxib|mesh-list
6403357|NCT00231829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6403358|NCT00231829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6403359|NCT00231829|Analgesics|analgesics|mesh-ancestor
6403360|NCT00231829|Sensory System Agents|sensory system agents|mesh-ancestor
6403361|NCT00231829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6403362|NCT00231829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403363|NCT00231829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6403364|NCT00231829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6403365|NCT00231829|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6403366|NCT00231829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6403367|NCT00231829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6403368|NCT00231829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403369|NCT00231855|Docetaxel|docetaxel|mesh-list
6403370|NCT00231855|Topotecan|topotecan|mesh-list
6403371|NCT00231855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6403372|NCT00231855|Tubulin Modulators|tubulin modulators|mesh-ancestor
6403373|NCT00231855|Antimitotic Agents|antimitotic agents|mesh-ancestor
6403374|NCT00231855|Mitosis Modulators|mitosis modulators|mesh-ancestor
6403375|NCT00231855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403376|NCT00231855|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6403377|NCT00231855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6403378|NCT00231855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6403379|NCT00231959|Pramipexole|pramipexole|mesh-list
6403380|NCT00231959|Antioxidants|antioxidants|mesh-ancestor
6403381|NCT00231959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403382|NCT00231959|Protective Agents|protective agents|mesh-ancestor
6403383|NCT00231959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403384|NCT00231959|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6403385|NCT00231959|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6403386|NCT00231959|Dopamine Agonists|dopamine agonists|mesh-ancestor
6403387|NCT00231959|Dopamine Agents|dopamine agents|mesh-ancestor
6403388|NCT00231959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6403389|NCT00231998|Pimecrolimus|pimecrolimus|mesh-list
6403390|NCT00231998|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6403391|NCT00231998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6403392|NCT00231998|Analgesics|analgesics|mesh-ancestor
6403393|NCT00231998|Sensory System Agents|sensory system agents|mesh-ancestor
6403394|NCT00231998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6403395|NCT00231998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403396|NCT00231998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6403397|NCT00231998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6403398|NCT00231998|Dermatologic Agents|dermatologic agents|mesh-ancestor
6403399|NCT00231998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6403400|NCT00231998|Immunologic Factors|immunologic factors|mesh-ancestor
6403401|NCT00231998|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6403402|NCT00231998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6403403|NCT00231998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403404|NCT00232011|Pimecrolimus|pimecrolimus|mesh-list
6403405|NCT00232011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6403406|NCT00232011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6403407|NCT00232011|Analgesics|analgesics|mesh-ancestor
6403408|NCT00232011|Sensory System Agents|sensory system agents|mesh-ancestor
6403409|NCT00232011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6403410|NCT00232011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403411|NCT00232011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6403412|NCT00232011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6403413|NCT00232011|Dermatologic Agents|dermatologic agents|mesh-ancestor
6403414|NCT00232011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6403415|NCT00232011|Immunologic Factors|immunologic factors|mesh-ancestor
6403416|NCT00232011|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6403417|NCT00232011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6403418|NCT00232011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403419|NCT00232024|Tegaserod|tegaserod|mesh-list
6403420|NCT00232024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6403421|NCT00232024|Serotonin Agents|serotonin agents|mesh-ancestor
6403422|NCT00232024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6403423|NCT00232024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403424|NCT00232024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403425|NCT00232037|Tegaserod|tegaserod|mesh-list
6403426|NCT00232037|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6403427|NCT00232037|Serotonin Agents|serotonin agents|mesh-ancestor
6403428|NCT00232037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6403429|NCT00232037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403430|NCT00232037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403431|NCT00232050|Omalizumab|omalizumab|mesh-list
6403432|NCT00232050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6403433|NCT00232050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6403434|NCT00232050|Respiratory System Agents|respiratory system agents|mesh-ancestor
6403435|NCT00232063|Cyclosporine|cyclosporine|mesh-list
6403436|NCT00232063|Cyclosporins|cyclosporins|mesh-list
6403437|NCT00232063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6403438|NCT00232063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403439|NCT00232063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6403440|NCT00232063|Immunologic Factors|immunologic factors|mesh-ancestor
6403441|NCT00232063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403442|NCT00232063|Antifungal Agents|antifungal agents|mesh-ancestor
6403443|NCT00232063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6403444|NCT00232063|Dermatologic Agents|dermatologic agents|mesh-ancestor
6403445|NCT00232063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6403446|NCT00232063|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6403447|NCT00232076|Cyclosporine|cyclosporine|mesh-list
6403448|NCT00232076|Cyclosporins|cyclosporins|mesh-list
6403449|NCT00232076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6403450|NCT00232076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403451|NCT00232076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6403452|NCT00232076|Immunologic Factors|immunologic factors|mesh-ancestor
6403453|NCT00232076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403454|NCT00232076|Antifungal Agents|antifungal agents|mesh-ancestor
6403455|NCT00232076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6403456|NCT00232076|Dermatologic Agents|dermatologic agents|mesh-ancestor
6403457|NCT00232076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6403458|NCT00232076|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6403459|NCT00232089|Tegaserod|tegaserod|mesh-list
6403460|NCT00232089|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6403461|NCT00232089|Serotonin Agents|serotonin agents|mesh-ancestor
6403462|NCT00232089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6403463|NCT00232089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403464|NCT00232089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403465|NCT00232102|Tegaserod|tegaserod|mesh-list
6403466|NCT00232102|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6403467|NCT00232102|Serotonin Agents|serotonin agents|mesh-ancestor
6403468|NCT00232102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6403469|NCT00232102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403470|NCT00232102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403471|NCT00232115|Pimecrolimus|pimecrolimus|mesh-list
6403472|NCT00232115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6403473|NCT00232115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6403474|NCT00232115|Analgesics|analgesics|mesh-ancestor
6403475|NCT00232115|Sensory System Agents|sensory system agents|mesh-ancestor
6403476|NCT00232115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6403477|NCT00232115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403478|NCT00232115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6403479|NCT00232115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6403480|NCT00232115|Dermatologic Agents|dermatologic agents|mesh-ancestor
6403481|NCT00232115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6403482|NCT00232115|Immunologic Factors|immunologic factors|mesh-ancestor
6403483|NCT00232115|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6403484|NCT00232115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6403485|NCT00232115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403486|NCT00232154|Azithromycin|azithromycin|mesh-list
6403487|NCT00232154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6403488|NCT00232154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6403489|NCT00232167|Indiplon|indiplon|mesh-list
6403490|NCT00232167|Sertraline|sertraline|mesh-list
6403491|NCT00232167|Antidepressive Agents|antidepressive agents|mesh-ancestor
6403492|NCT00232167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6403493|NCT00232167|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6403494|NCT00232167|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6403495|NCT00232167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6403496|NCT00232167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403497|NCT00232167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6403498|NCT00232167|Serotonin Agents|serotonin agents|mesh-ancestor
6403499|NCT00232167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403500|NCT00232167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6403501|NCT00232167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6403502|NCT00232167|GABA Modulators|gaba modulators|mesh-ancestor
6403503|NCT00232167|GABA Agents|gaba agents|mesh-ancestor
6403504|NCT00232206|Docetaxel|docetaxel|mesh-list
6403505|NCT00232206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6403506|NCT00232206|Tubulin Modulators|tubulin modulators|mesh-ancestor
6403507|NCT00232206|Antimitotic Agents|antimitotic agents|mesh-ancestor
6403508|NCT00232206|Mitosis Modulators|mitosis modulators|mesh-ancestor
6403509|NCT00232206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403510|NCT00232271|Enoxaparin|enoxaparin|mesh-list
6403511|NCT00232271|Anticoagulants|anticoagulants|mesh-ancestor
6403512|NCT00232271|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6403513|NCT00232271|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6403514|NCT00232271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403515|NCT00232284|Sertraline|sertraline|mesh-list
6403516|NCT00232284|Antidepressive Agents|antidepressive agents|mesh-ancestor
6403517|NCT00232284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6403518|NCT00232284|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6403519|NCT00232284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6403520|NCT00232284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6403521|NCT00232284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403522|NCT00232284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6403523|NCT00232284|Serotonin Agents|serotonin agents|mesh-ancestor
6403524|NCT00232284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403525|NCT00232336|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6403526|NCT00232336|Antidepressive Agents|antidepressive agents|mesh-ancestor
6403527|NCT00232336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6403528|NCT00232336|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6403529|NCT00232336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6403530|NCT00232336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6403531|NCT00232336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403532|NCT00232349|Galantamine|galantamine|mesh-list
6403533|NCT00232349|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6403534|NCT00232349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6403535|NCT00232349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403536|NCT00232349|Cholinergic Agents|cholinergic agents|mesh-ancestor
6403537|NCT00232349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6403538|NCT00232349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403539|NCT00232349|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6403540|NCT00232349|Autonomic Agents|autonomic agents|mesh-ancestor
6403541|NCT00232349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6403542|NCT00232349|Nootropic Agents|nootropic agents|mesh-ancestor
6403543|NCT00232362|Pioglitazone|pioglitazone|mesh-list
6403544|NCT00232362|Rosiglitazone|rosiglitazone|mesh-list
6403545|NCT00232362|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6403546|NCT00232362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403547|NCT00232375|Insulin|insulin|mesh-list
6403548|NCT00232375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6403549|NCT00232375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403550|NCT00232414|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6403551|NCT00232414|Antidepressive Agents|antidepressive agents|mesh-ancestor
6403552|NCT00232414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6403553|NCT00232414|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6403554|NCT00232414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6403555|NCT00232414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6403556|NCT00232414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403557|NCT00232492|Ketamine|ketamine|mesh-list
6403558|NCT00232492|Analgesics|analgesics|mesh-ancestor
6403559|NCT00232492|Sensory System Agents|sensory system agents|mesh-ancestor
6403560|NCT00232492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6403561|NCT00232492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403562|NCT00232492|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6403563|NCT00232492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6403564|NCT00232492|Anesthetics, General|anesthetics, general|mesh-ancestor
6403565|NCT00232492|Anesthetics|anesthetics|mesh-ancestor
6403566|NCT00232492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6403567|NCT00232492|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6403568|NCT00232492|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6403569|NCT00232492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6403570|NCT00232492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403571|NCT00232531|Niacin|niacin|mesh-list
6403572|NCT00232531|Nicotinic Acids|nicotinic acids|mesh-list
6403573|NCT00232531|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6403574|NCT00232531|Antimetabolites|antimetabolites|mesh-ancestor
6403575|NCT00232531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403576|NCT00232531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6403577|NCT00232531|Vasodilator Agents|vasodilator agents|mesh-ancestor
6403578|NCT00232531|Vitamin B Complex|vitamin b complex|mesh-ancestor
6403579|NCT00232531|Vitamins|vitamins|mesh-ancestor
6403580|NCT00232531|Micronutrients|micronutrients|mesh-ancestor
6403581|NCT00232531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403582|NCT00232570|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6403583|NCT00232570|Antidepressive Agents|antidepressive agents|mesh-ancestor
6403584|NCT00232570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6403585|NCT00232570|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6403586|NCT00232570|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6403587|NCT00232570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6403588|NCT00232570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403589|NCT00232622|Streptokinase|streptokinase|mesh-list
6403590|NCT00232622|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6403591|NCT00232622|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6403592|NCT00232622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403593|NCT00232648|Budesonide|budesonide|mesh-list
6403594|NCT00232648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6403595|NCT00232648|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6403596|NCT00232648|Autonomic Agents|autonomic agents|mesh-ancestor
6403597|NCT00232648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6403598|NCT00232648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403599|NCT00232648|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6403600|NCT00232648|Respiratory System Agents|respiratory system agents|mesh-ancestor
6403601|NCT00232648|Glucocorticoids|glucocorticoids|mesh-ancestor
6403602|NCT00232648|Hormones|hormones|mesh-ancestor
6403603|NCT00232648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6403604|NCT00232661|Tamoxifen|tamoxifen|mesh-list
6403605|NCT00232661|Anastrozole|anastrozole|mesh-list
6403606|NCT00232661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6403607|NCT00232661|Hormone Antagonists|hormone antagonists|mesh-ancestor
6403608|NCT00232661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6403609|NCT00232661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403610|NCT00232661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6403611|NCT00232661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6403612|NCT00232661|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6403613|NCT00232661|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6403614|NCT00232661|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6403615|NCT00232661|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6403616|NCT00232661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6403617|NCT00232661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6403618|NCT00232661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403619|NCT00232674|Budesonide|budesonide|mesh-list
6403620|NCT00232674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6403621|NCT00232674|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6403622|NCT00232674|Autonomic Agents|autonomic agents|mesh-ancestor
6403623|NCT00232674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6403624|NCT00232674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403625|NCT00232674|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6403626|NCT00232674|Respiratory System Agents|respiratory system agents|mesh-ancestor
6403627|NCT00232674|Glucocorticoids|glucocorticoids|mesh-ancestor
6403628|NCT00232674|Hormones|hormones|mesh-ancestor
6403629|NCT00232674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6403630|NCT00232687|Aripiprazole|aripiprazole|mesh-list
6403631|NCT00232687|Antidepressive Agents|antidepressive agents|mesh-ancestor
6403632|NCT00232687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6403633|NCT00232687|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6403634|NCT00232687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6403635|NCT00232687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6403636|NCT00232687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403637|NCT00232687|Dopamine Agonists|dopamine agonists|mesh-ancestor
6403638|NCT00232687|Dopamine Agents|dopamine agents|mesh-ancestor
6403639|NCT00232687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6403640|NCT00232687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403641|NCT00232687|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6403642|NCT00232687|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6403643|NCT00232687|Serotonin Agents|serotonin agents|mesh-ancestor
6403644|NCT00232687|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6403645|NCT00232687|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6403646|NCT00232687|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6403647|NCT00232687|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6403648|NCT00232700|Citalopram|citalopram|mesh-list
6403649|NCT00232700|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6403650|NCT00232700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6403651|NCT00232700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6403652|NCT00232700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403653|NCT00232700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6403654|NCT00232700|Serotonin Agents|serotonin agents|mesh-ancestor
6403655|NCT00232700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403656|NCT00232700|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6403657|NCT00232700|Antidepressive Agents|antidepressive agents|mesh-ancestor
6403658|NCT00232700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6403659|NCT00232765|Sirolimus|sirolimus|mesh-list
6403660|NCT00232765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6403661|NCT00232765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6403662|NCT00232765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6403663|NCT00232765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6403664|NCT00232765|Antifungal Agents|antifungal agents|mesh-ancestor
6403665|NCT00232765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6403666|NCT00232765|Immunologic Factors|immunologic factors|mesh-ancestor
6403667|NCT00232765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403668|NCT00232817|Nicotine|nicotine|mesh-list
6403669|NCT00232817|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6403670|NCT00232817|Autonomic Agents|autonomic agents|mesh-ancestor
6403671|NCT00232817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6403672|NCT00232817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403673|NCT00232817|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6403674|NCT00232817|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6403675|NCT00232817|Cholinergic Agents|cholinergic agents|mesh-ancestor
6403676|NCT00232817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6403677|NCT00232817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403678|NCT00232856|Sirolimus|sirolimus|mesh-list
6403679|NCT00232856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6403680|NCT00232856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6403681|NCT00232856|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6403682|NCT00232856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6403683|NCT00232856|Antifungal Agents|antifungal agents|mesh-ancestor
6403684|NCT00232856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6403685|NCT00232856|Immunologic Factors|immunologic factors|mesh-ancestor
6403686|NCT00232856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403687|NCT00232882|Atenolol|atenolol|mesh-list
6403688|NCT00232882|Candesartan|candesartan|mesh-list
6403689|NCT00232882|Candesartan cilexetil|candesartan cilexetil|mesh-list
6403690|NCT00232882|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
6403691|NCT00232882|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6403692|NCT00232882|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6403693|NCT00232882|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6403694|NCT00232882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403695|NCT00232882|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6403696|NCT00232882|Sympatholytics|sympatholytics|mesh-ancestor
6403697|NCT00232882|Autonomic Agents|autonomic agents|mesh-ancestor
6538127|NCT00825864|Protease Inhibitors|protease inhibitors|mesh-ancestor
6403698|NCT00232882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6403699|NCT00232882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403700|NCT00232882|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6403701|NCT00232882|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6403702|NCT00232882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6403703|NCT00232882|Adrenergic Agents|adrenergic agents|mesh-ancestor
6403704|NCT00232882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6403705|NCT00232882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6403706|NCT00232882|Diuretics|diuretics|mesh-ancestor
6403707|NCT00232882|Natriuretic Agents|natriuretic agents|mesh-ancestor
6403708|NCT00232895|Propofol|propofol|mesh-list
6403709|NCT00232895|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6403710|NCT00232895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6403711|NCT00232895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403712|NCT00232895|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6403713|NCT00232895|Anesthetics, General|anesthetics, general|mesh-ancestor
6403714|NCT00232895|Anesthetics|anesthetics|mesh-ancestor
6403715|NCT00232908|Enfuvirtide|enfuvirtide|mesh-list
6403716|NCT00232908|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6403717|NCT00232908|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6403718|NCT00232908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403719|NCT00232908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6403720|NCT00232908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6403721|NCT00232908|Antiviral Agents|antiviral agents|mesh-ancestor
6403722|NCT00232908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6403723|NCT00232934|Thalidomide|thalidomide|mesh-list
6403724|NCT00232934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6403725|NCT00232934|Immunologic Factors|immunologic factors|mesh-ancestor
6403726|NCT00232934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403727|NCT00232934|Leprostatic Agents|leprostatic agents|mesh-ancestor
6403728|NCT00232934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6403729|NCT00232934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6403730|NCT00232934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6403731|NCT00232934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6403732|NCT00232934|Growth Substances|growth substances|mesh-ancestor
6403733|NCT00232934|Growth Inhibitors|growth inhibitors|mesh-ancestor
6403734|NCT00232934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6403735|NCT00232947|Vaccines|vaccines|mesh-list
6403736|NCT00232947|Immunologic Factors|immunologic factors|mesh-ancestor
6403737|NCT00232947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403738|NCT00233012|Topiramate|topiramate|mesh-list
6403739|NCT00233012|Anticonvulsants|anticonvulsants|mesh-ancestor
6403740|NCT00233012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6403741|NCT00233012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403742|NCT00233025|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6403743|NCT00233025|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6403744|NCT00233025|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6403745|NCT00233025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6403746|NCT00233025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403747|NCT00233025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6403748|NCT00233025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403749|NCT00233025|Analgesics|analgesics|mesh-ancestor
6403750|NCT00233025|Sensory System Agents|sensory system agents|mesh-ancestor
6403751|NCT00233025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6403752|NCT00233025|Antidepressive Agents|antidepressive agents|mesh-ancestor
6403753|NCT00233025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6403754|NCT00233025|Dopamine Agents|dopamine agents|mesh-ancestor
6403755|NCT00233038|Ethanol|ethanol|mesh-list
6403756|NCT00233038|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6403757|NCT00233038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6403758|NCT00233038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6403759|NCT00233038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403760|NCT00233051|Fluticasone|fluticasone|mesh-list
6403761|NCT00233051|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6403762|NCT00233051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6403763|NCT00233051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6403764|NCT00233051|Autonomic Agents|autonomic agents|mesh-ancestor
6403765|NCT00233051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6403766|NCT00233051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403767|NCT00233051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6403768|NCT00233051|Respiratory System Agents|respiratory system agents|mesh-ancestor
6403769|NCT00233051|Dermatologic Agents|dermatologic agents|mesh-ancestor
6403770|NCT00233051|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6403771|NCT00233051|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6403772|NCT00233051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6403773|NCT00233051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6403774|NCT00233051|Adrenergic Agents|adrenergic agents|mesh-ancestor
6403775|NCT00233051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6403776|NCT00233051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403777|NCT00233155|Capsaicin|capsaicin|mesh-list
6403778|NCT00233155|Antipruritics|antipruritics|mesh-ancestor
6403779|NCT00233155|Dermatologic Agents|dermatologic agents|mesh-ancestor
6403780|NCT00233155|Sensory System Agents|sensory system agents|mesh-ancestor
6403781|NCT00233155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6403782|NCT00233155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459316|NCT00444379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6459317|NCT00444379|Antiviral Agents|antiviral agents|mesh-ancestor
6459318|NCT00444379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6459319|NCT00444379|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6459320|NCT00444379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6459321|NCT00444379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6459322|NCT00444379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6459323|NCT00444379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6459324|NCT00444379|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6459325|NCT00444379|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6459326|NCT00444379|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6459327|NCT00444379|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6459328|NCT00444418|Naltrexone|naltrexone|mesh-list
6459329|NCT00444418|Naloxone|naloxone|mesh-list
6459330|NCT00444418|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6459331|NCT00444418|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6403783|NCT00233337|Artemether|artemether|mesh-list
6403784|NCT00233337|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6403785|NCT00233337|Antimalarials|antimalarials|mesh-ancestor
6403786|NCT00233337|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6403787|NCT00233337|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6403788|NCT00233337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6403789|NCT00233376|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6403790|NCT00233376|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6403791|NCT00233376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6403792|NCT00233376|Antitubercular Agents|antitubercular agents|mesh-ancestor
6459332|NCT00444418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459333|NCT00444418|Sensory System Agents|sensory system agents|mesh-ancestor
6459334|NCT00444418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6459335|NCT00444470|Tranexamic Acid|tranexamic acid|mesh-list
6459336|NCT00444470|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6459337|NCT00444470|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6459338|NCT00444470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459339|NCT00444470|Hemostatics|hemostatics|mesh-ancestor
6459340|NCT00444470|Coagulants|coagulants|mesh-ancestor
6459341|NCT00444522|Alprazolam|alprazolam|mesh-list
6459342|NCT00444522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6459343|NCT00444522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6459344|NCT00444522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459345|NCT00444522|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6459346|NCT00444522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6459347|NCT00444522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6459348|NCT00444522|GABA Modulators|gaba modulators|mesh-ancestor
6459349|NCT00444522|GABA Agents|gaba agents|mesh-ancestor
6459350|NCT00444522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6459351|NCT00444522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459352|NCT00444548|Reboxetine|reboxetine|mesh-list
6459353|NCT00444548|Antidepressive Agents|antidepressive agents|mesh-ancestor
6459354|NCT00444548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6459355|NCT00444548|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6459356|NCT00444548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6459357|NCT00444548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6459358|NCT00444548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459359|NCT00444548|Adrenergic Agents|adrenergic agents|mesh-ancestor
6459360|NCT00444548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6459361|NCT00444548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459362|NCT00444561|Pramlintide|pramlintide|mesh-list
6459363|NCT00444561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6403793|NCT00233532|Verapamil|verapamil|mesh-list
6403794|NCT00233532|Trandolapril|trandolapril|mesh-list
6403795|NCT00233532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6403796|NCT00233532|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6403797|NCT00233532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6403798|NCT00233532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403799|NCT00233532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6403800|NCT00233532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403801|NCT00233532|Vasodilator Agents|vasodilator agents|mesh-ancestor
6403802|NCT00233532|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6403803|NCT00233532|Protease Inhibitors|protease inhibitors|mesh-ancestor
6403804|NCT00233532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6403805|NCT00233532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6403806|NCT00233545|Miltefosine|miltefosine|mesh-list
6403807|NCT00233545|Antifungal Agents|antifungal agents|mesh-ancestor
6403808|NCT00233545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6403809|NCT00233545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6403810|NCT00233545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6403811|NCT00233545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6403812|NCT00233558|Adalimumab|adalimumab|mesh-list
6403813|NCT00233558|Methotrexate|methotrexate|mesh-list
6403814|NCT00233558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6403815|NCT00233558|Abortifacient Agents|abortifacient agents|mesh-ancestor
6403816|NCT00233558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6403817|NCT00233558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403818|NCT00233558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6403819|NCT00233558|Antimetabolites|antimetabolites|mesh-ancestor
6403820|NCT00233558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403821|NCT00233558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6403822|NCT00233558|Dermatologic Agents|dermatologic agents|mesh-ancestor
6403823|NCT00233558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6403824|NCT00233558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6403825|NCT00233558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6403826|NCT00233558|Immunologic Factors|immunologic factors|mesh-ancestor
6403827|NCT00233558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6403828|NCT00233558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6403829|NCT00233558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6403830|NCT00233571|Adalimumab|adalimumab|mesh-list
6403831|NCT00233571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6403832|NCT00233571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6403833|NCT00233584|Budesonide|budesonide|mesh-list
6403834|NCT00233584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6403835|NCT00233584|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6403836|NCT00233584|Autonomic Agents|autonomic agents|mesh-ancestor
6403837|NCT00233584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6403838|NCT00233584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403839|NCT00233584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6403840|NCT00233584|Respiratory System Agents|respiratory system agents|mesh-ancestor
6403841|NCT00233584|Glucocorticoids|glucocorticoids|mesh-ancestor
6403842|NCT00233584|Hormones|hormones|mesh-ancestor
6403843|NCT00233584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6403844|NCT00233597|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
6403845|NCT00233597|Hematinics|hematinics|mesh-ancestor
6403846|NCT00233597|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6403847|NCT00233597|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6403848|NCT00233610|Tamoxifen|tamoxifen|mesh-list
6403849|NCT00233610|Bicalutamide|bicalutamide|mesh-list
6403850|NCT00233610|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6403851|NCT00233610|Hormone Antagonists|hormone antagonists|mesh-ancestor
6403852|NCT00233610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6403853|NCT00233610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403854|NCT00233610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6403855|NCT00233610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6403856|NCT00233610|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6403857|NCT00233610|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6403858|NCT00233610|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6403859|NCT00233610|Androgen Antagonists|androgen antagonists|mesh-ancestor
6403860|NCT00233623|Leucovorin|leucovorin|mesh-list
6403861|NCT00233623|Fluorouracil|fluorouracil|mesh-list
6403862|NCT00233623|Irinotecan|irinotecan|mesh-list
6403863|NCT00233623|Gefitinib|gefitinib|mesh-list
6403864|NCT00233623|Antimetabolites|antimetabolites|mesh-ancestor
6403865|NCT00233623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403866|NCT00233623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6403867|NCT00233623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6403868|NCT00233623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6403869|NCT00233623|Immunologic Factors|immunologic factors|mesh-ancestor
6403870|NCT00233623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403871|NCT00233623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6403872|NCT00233623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6403873|NCT00233623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6403874|NCT00233623|Antidotes|antidotes|mesh-ancestor
6403875|NCT00233623|Protective Agents|protective agents|mesh-ancestor
6403876|NCT00233623|Vitamin B Complex|vitamin b complex|mesh-ancestor
6403877|NCT00233623|Vitamins|vitamins|mesh-ancestor
6403878|NCT00233623|Micronutrients|micronutrients|mesh-ancestor
6403879|NCT00233623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6403880|NCT00233636|Gefitinib|gefitinib|mesh-list
6403881|NCT00233636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6403882|NCT00233636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6403883|NCT00233636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6403884|NCT00233636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403885|NCT00233662|Alefacept|alefacept|mesh-list
6403886|NCT00233662|Dermatologic Agents|dermatologic agents|mesh-ancestor
6403887|NCT00233662|Immunologic Factors|immunologic factors|mesh-ancestor
6403888|NCT00233662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403889|NCT00233675|Tiagabine|tiagabine|mesh-list
6403890|NCT00233675|Anticonvulsants|anticonvulsants|mesh-ancestor
6403891|NCT00233675|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
6403892|NCT00233675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6403893|NCT00233675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6403894|NCT00233675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403895|NCT00233675|GABA Agents|gaba agents|mesh-ancestor
6403896|NCT00233675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6403897|NCT00233675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403898|NCT00233714|Sirolimus|sirolimus|mesh-list
6403899|NCT00233714|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6403900|NCT00233714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6403901|NCT00233714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6403902|NCT00233714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6403903|NCT00233714|Antifungal Agents|antifungal agents|mesh-ancestor
6403904|NCT00233714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6403905|NCT00233714|Immunologic Factors|immunologic factors|mesh-ancestor
6403906|NCT00233714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403907|NCT00233766|Sirolimus|sirolimus|mesh-list
6403908|NCT00233766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6403909|NCT00233766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6403910|NCT00233766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6403911|NCT00233766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6403912|NCT00233766|Antifungal Agents|antifungal agents|mesh-ancestor
6403913|NCT00233766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6403914|NCT00233766|Immunologic Factors|immunologic factors|mesh-ancestor
6403915|NCT00233766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403916|NCT00233779|Sirolimus|sirolimus|mesh-list
6403917|NCT00233779|Heparin|heparin|mesh-list
6403918|NCT00233779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6403919|NCT00233779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6403920|NCT00233779|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6403921|NCT00233779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6403922|NCT00233779|Antifungal Agents|antifungal agents|mesh-ancestor
6403923|NCT00233779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6403924|NCT00233779|Immunologic Factors|immunologic factors|mesh-ancestor
6403925|NCT00233779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403926|NCT00233779|Anticoagulants|anticoagulants|mesh-ancestor
6403927|NCT00233779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6403928|NCT00233779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6403929|NCT00233779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403930|NCT00233792|Sirolimus|sirolimus|mesh-list
6403931|NCT00233792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6403932|NCT00233792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6403933|NCT00233792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6403934|NCT00233792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6403935|NCT00233792|Antifungal Agents|antifungal agents|mesh-ancestor
6403936|NCT00233792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6403937|NCT00233792|Immunologic Factors|immunologic factors|mesh-ancestor
6403938|NCT00233792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403939|NCT00233805|Sirolimus|sirolimus|mesh-list
6403940|NCT00233805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6403941|NCT00233805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6403942|NCT00233805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6403943|NCT00233805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6403944|NCT00233805|Antifungal Agents|antifungal agents|mesh-ancestor
6403945|NCT00233805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6403946|NCT00233805|Immunologic Factors|immunologic factors|mesh-ancestor
6403947|NCT00233805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403948|NCT00233818|Sirolimus|sirolimus|mesh-list
6403949|NCT00233818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6403950|NCT00233818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6403951|NCT00233818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6403952|NCT00233818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6403953|NCT00233818|Antifungal Agents|antifungal agents|mesh-ancestor
6403954|NCT00233818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6403955|NCT00233818|Immunologic Factors|immunologic factors|mesh-ancestor
6403956|NCT00233818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403957|NCT00233883|Enfuvirtide|enfuvirtide|mesh-list
6403958|NCT00233883|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6403959|NCT00233883|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6403960|NCT00233883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403961|NCT00233883|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6403962|NCT00233883|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6403963|NCT00233883|Antiviral Agents|antiviral agents|mesh-ancestor
6403964|NCT00233883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6403965|NCT00233896|Beclomethasone|beclomethasone|mesh-list
6403966|NCT00233896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6403967|NCT00233896|Glucocorticoids|glucocorticoids|mesh-ancestor
6403968|NCT00233896|Hormones|hormones|mesh-ancestor
6403969|NCT00233896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6403970|NCT00233896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403971|NCT00233896|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6403972|NCT00233896|Respiratory System Agents|respiratory system agents|mesh-ancestor
6403973|NCT00233909|Gemtuzumab|gemtuzumab|mesh-list
6403974|NCT00233909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6403975|NCT00233909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6403976|NCT00233935|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
6403977|NCT00233935|Antioxidants|antioxidants|mesh-ancestor
6403978|NCT00233935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403979|NCT00233935|Protective Agents|protective agents|mesh-ancestor
6403980|NCT00233935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403981|NCT00233935|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
6403982|NCT00233935|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6403983|NCT00233935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6403984|NCT00233935|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6403985|NCT00233961|Lenograstim|lenograstim|mesh-list
6403986|NCT00233961|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6403987|NCT00233961|Immunologic Factors|immunologic factors|mesh-ancestor
6403988|NCT00233961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6403989|NCT00234000|Azacitidine|azacitidine|mesh-list
6403990|NCT00234000|Arsenic Trioxide|arsenic trioxide|mesh-list
6403991|NCT00234000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6403992|NCT00234000|Antimetabolites|antimetabolites|mesh-ancestor
6403993|NCT00234000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6403994|NCT00234000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6403995|NCT00234000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6403996|NCT00234026|Gemcitabine|gemcitabine|mesh-list
6403997|NCT00234026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6403998|NCT00234026|Antimetabolites|antimetabolites|mesh-ancestor
6403999|NCT00234026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6404000|NCT00234026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6404001|NCT00234026|Antiviral Agents|antiviral agents|mesh-ancestor
6404002|NCT00234026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6404003|NCT00234026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6404004|NCT00234026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6404005|NCT00234026|Immunologic Factors|immunologic factors|mesh-ancestor
6404006|NCT00234026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404007|NCT00234091|Ritonavir|ritonavir|mesh-list
6404008|NCT00234091|Lopinavir|lopinavir|mesh-list
6404009|NCT00234091|Nelfinavir|nelfinavir|mesh-list
6404010|NCT00234091|Lamivudine|lamivudine|mesh-list
6404011|NCT00234091|Zidovudine|zidovudine|mesh-list
6404012|NCT00234091|Nevirapine|nevirapine|mesh-list
6404013|NCT00234091|Abacavir|abacavir|mesh-list
6404014|NCT00234091|Efavirenz|efavirenz|mesh-list
6404015|NCT00234091|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6404016|NCT00234091|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6404017|NCT00234091|Protease Inhibitors|protease inhibitors|mesh-ancestor
6404018|NCT00234091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6404019|NCT00234091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6404020|NCT00234091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6404021|NCT00234091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6404022|NCT00234091|Antiviral Agents|antiviral agents|mesh-ancestor
6404023|NCT00234091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6404024|NCT00234091|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6404025|NCT00234091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6404026|NCT00234091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6404027|NCT00234091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6404028|NCT00234091|Antimetabolites|antimetabolites|mesh-ancestor
6404029|NCT00234091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6404030|NCT00234091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6404031|NCT00234091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6404032|NCT00234091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6404033|NCT00234091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6404034|NCT00234117|Rabeprazole|rabeprazole|mesh-list
6404035|NCT00234117|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6404036|NCT00234117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6404037|NCT00234117|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6404038|NCT00234117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6404039|NCT00234117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6404040|NCT00234143|Darbepoetin alfa|darbepoetin alfa|mesh-list
6404041|NCT00234143|Hematinics|hematinics|mesh-ancestor
6404042|NCT00234182|Interferons|interferons|mesh-list
6404043|NCT00234182|Interferon-alpha|interferon-alpha|mesh-list
6404044|NCT00234182|Interferon alpha-2|interferon alpha-2|mesh-list
6404045|NCT00234182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6404046|NCT00234182|Antiviral Agents|antiviral agents|mesh-ancestor
6404047|NCT00234182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6404048|NCT00234182|Immunologic Factors|immunologic factors|mesh-ancestor
6404049|NCT00234182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404050|NCT00234195|Bupropion|bupropion|mesh-list
6404051|NCT00234195|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6404052|NCT00234195|Antidepressive Agents|antidepressive agents|mesh-ancestor
6404053|NCT00234195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6404054|NCT00234195|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6404055|NCT00234195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6404056|NCT00234195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6404057|NCT00234195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6404058|NCT00234195|Dopamine Agents|dopamine agents|mesh-ancestor
6404059|NCT00234195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6404060|NCT00234195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501185|NCT04476628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5501186|NCT04476628|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5501187|NCT04476628|Autonomic Agents|autonomic agents|mesh-ancestor
5501188|NCT04476628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5501189|NCT04476628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501190|NCT04476628|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5501191|NCT04476628|Respiratory System Agents|respiratory system agents|mesh-ancestor
5501192|NCT04476628|Glucocorticoids|glucocorticoids|mesh-ancestor
5501193|NCT04476628|Hormones|hormones|mesh-ancestor
5501194|NCT04476628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5501195|NCT04476550|Lenograstim|lenograstim|mesh-list
5501196|NCT04476550|Sargramostim|sargramostim|mesh-list
5501197|NCT04476550|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5501198|NCT04476550|Immunologic Factors|immunologic factors|mesh-ancestor
5501199|NCT04476550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501200|NCT04476511|Cholecalciferol|cholecalciferol|mesh-list
6404061|NCT00234195|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6404062|NCT00234195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6404063|NCT00234195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6404064|NCT00234234|Adalimumab|adalimumab|mesh-list
6404065|NCT00234234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6404066|NCT00234234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6404067|NCT00234299|Aspirin|aspirin|mesh-list
6404068|NCT00234299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6404069|NCT00234299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6404070|NCT00234299|Analgesics|analgesics|mesh-ancestor
6404071|NCT00234299|Sensory System Agents|sensory system agents|mesh-ancestor
6404072|NCT00234299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6404073|NCT00234299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404074|NCT00234299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6404075|NCT00234299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6404076|NCT00234299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6404077|NCT00234299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6404078|NCT00234299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6404079|NCT00234299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6404080|NCT00234299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6404081|NCT00234299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6404082|NCT00234299|Antipyretics|antipyretics|mesh-ancestor
6404083|NCT00234312|Citalopram|citalopram|mesh-list
6404084|NCT00234312|Sertraline|sertraline|mesh-list
6404085|NCT00234312|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6404086|NCT00234312|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6404087|NCT00234312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6404088|NCT00234312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6404089|NCT00234312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6404090|NCT00234312|Serotonin Agents|serotonin agents|mesh-ancestor
6404091|NCT00234312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404092|NCT00234312|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6404093|NCT00234312|Antidepressive Agents|antidepressive agents|mesh-ancestor
6404094|NCT00234312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6404095|NCT00234377|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6404096|NCT00234377|Antidepressive Agents|antidepressive agents|mesh-ancestor
6404097|NCT00234377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6404098|NCT00234377|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6404099|NCT00234377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6404100|NCT00234377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6404101|NCT00234377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404102|NCT00234390|Budesonide|budesonide|mesh-list
6404103|NCT00234390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6404104|NCT00234390|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6404105|NCT00234390|Autonomic Agents|autonomic agents|mesh-ancestor
6404106|NCT00234390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6404107|NCT00234390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404108|NCT00234390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6404109|NCT00234390|Respiratory System Agents|respiratory system agents|mesh-ancestor
6404110|NCT00234390|Glucocorticoids|glucocorticoids|mesh-ancestor
6404111|NCT00234390|Hormones|hormones|mesh-ancestor
6404112|NCT00234390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6404113|NCT00234403|Fulvestrant|fulvestrant|mesh-list
6404114|NCT00234403|Gefitinib|gefitinib|mesh-list
6404115|NCT00234403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6404116|NCT00234403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6404117|NCT00234403|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6404118|NCT00234403|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6404119|NCT00234403|Hormone Antagonists|hormone antagonists|mesh-ancestor
6404120|NCT00234403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6404121|NCT00234403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404122|NCT00234403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6404123|NCT00234403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6018641|NCT00381797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6404124|NCT00234403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6404125|NCT00234416|Gemcitabine|gemcitabine|mesh-list
6404126|NCT00234416|Gefitinib|gefitinib|mesh-list
6404127|NCT00234416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6404128|NCT00234416|Antimetabolites|antimetabolites|mesh-ancestor
6404129|NCT00234416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6404130|NCT00234416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6404131|NCT00234416|Antiviral Agents|antiviral agents|mesh-ancestor
6404132|NCT00234416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6404133|NCT00234416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6404134|NCT00234416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6404135|NCT00234416|Immunologic Factors|immunologic factors|mesh-ancestor
6404136|NCT00234416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404137|NCT00234416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6404138|NCT00234429|Gefitinib|gefitinib|mesh-list
6404139|NCT00234429|Raltitrexed|raltitrexed|mesh-list
6404140|NCT00234429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6404141|NCT00234429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6404142|NCT00234429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6404143|NCT00234429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6404144|NCT00234429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6404145|NCT00234429|Antimetabolites|antimetabolites|mesh-ancestor
6404146|NCT00234429|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6404147|NCT00234442|Gefitinib|gefitinib|mesh-list
6404148|NCT00234442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6404149|NCT00234442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6404150|NCT00234442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6404151|NCT00234442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6404152|NCT00234455|Sirolimus|sirolimus|mesh-list
6404153|NCT00234455|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6404154|NCT00234455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6404155|NCT00234455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6404156|NCT00234455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6404157|NCT00234455|Antifungal Agents|antifungal agents|mesh-ancestor
6404158|NCT00234455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6404159|NCT00234455|Immunologic Factors|immunologic factors|mesh-ancestor
6404160|NCT00234455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404161|NCT00234468|Gefitinib|gefitinib|mesh-list
6404162|NCT00234468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6404163|NCT00234468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6404164|NCT00234468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6404165|NCT00234468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6404166|NCT00234507|Botulinum Toxins|botulinum toxins|mesh-list
6404167|NCT00234507|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6404168|NCT00234507|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6404169|NCT00234507|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6404170|NCT00234507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6404171|NCT00234507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6404172|NCT00234507|Cholinergic Agents|cholinergic agents|mesh-ancestor
6404173|NCT00234507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6404174|NCT00234507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404175|NCT00234507|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6404176|NCT00234507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6404177|NCT00234546|Botulinum Toxins|botulinum toxins|mesh-list
6404178|NCT00234546|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6404179|NCT00234546|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6404180|NCT00234546|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6404181|NCT00234546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6404182|NCT00234546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6404183|NCT00234546|Cholinergic Agents|cholinergic agents|mesh-ancestor
6404184|NCT00234546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6404185|NCT00234546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404186|NCT00234546|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6404187|NCT00234546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6404188|NCT00234572|Lanreotide|lanreotide|mesh-list
6404189|NCT00234572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6404190|NCT00234598|Chlorhexidine|chlorhexidine|mesh-list
6404191|NCT00234598|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6404192|NCT00234598|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6404193|NCT00234598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6404194|NCT00234598|Disinfectants|disinfectants|mesh-ancestor
6404195|NCT00234598|Dermatologic Agents|dermatologic agents|mesh-ancestor
6404196|NCT00234637|Memantine|memantine|mesh-list
6404197|NCT00234637|Rivastigmine|rivastigmine|mesh-list
6404198|NCT00234637|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6404199|NCT00234637|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6404200|NCT00234637|Dopamine Agents|dopamine agents|mesh-ancestor
6404201|NCT00234637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6404202|NCT00234637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6404203|NCT00234637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404204|NCT00234637|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6404205|NCT00234637|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6404206|NCT00234637|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6404207|NCT00234637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6404208|NCT00234637|Cholinergic Agents|cholinergic agents|mesh-ancestor
6404209|NCT00234637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6404210|NCT00234637|Protective Agents|protective agents|mesh-ancestor
6404211|NCT00234676|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6404212|NCT00234676|Estrogens|estrogens|mesh-ancestor
6404213|NCT00234676|Hormones|hormones|mesh-ancestor
6404214|NCT00234676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6404215|NCT00234676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404216|NCT00234689|Naltrexone|naltrexone|mesh-list
6404217|NCT00234689|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6404218|NCT00234689|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6404219|NCT00234689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404220|NCT00234689|Sensory System Agents|sensory system agents|mesh-ancestor
6404221|NCT00234689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6404222|NCT00234819|Bazedoxifene|bazedoxifene|mesh-list
6404223|NCT00234819|Estrogens|estrogens|mesh-list
6404224|NCT00234819|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6404225|NCT00234819|Hormones|hormones|mesh-ancestor
6404226|NCT00234819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6404227|NCT00234819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404228|NCT00234819|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6404229|NCT00234819|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6404230|NCT00234819|Hormone Antagonists|hormone antagonists|mesh-ancestor
6404231|NCT00234819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6404232|NCT00234845|Adalimumab|adalimumab|mesh-list
6404233|NCT00234845|Methotrexate|methotrexate|mesh-list
6404234|NCT00234845|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6404235|NCT00234845|Abortifacient Agents|abortifacient agents|mesh-ancestor
6404236|NCT00234845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6404237|NCT00234845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404238|NCT00234845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6404239|NCT00234845|Antimetabolites|antimetabolites|mesh-ancestor
6404240|NCT00234845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6404241|NCT00234845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6404242|NCT00234845|Dermatologic Agents|dermatologic agents|mesh-ancestor
6404243|NCT00234845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6404244|NCT00234845|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6404245|NCT00234845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6404246|NCT00234845|Immunologic Factors|immunologic factors|mesh-ancestor
6404247|NCT00234845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6404248|NCT00234845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6404249|NCT00234845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6404250|NCT00234858|Losartan|losartan|mesh-list
6404251|NCT00234858|Verapamil|verapamil|mesh-list
6404252|NCT00234858|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6404253|NCT00234858|Trandolapril|trandolapril|mesh-list
6404254|NCT00234858|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6404255|NCT00234858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6404256|NCT00234858|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6404257|NCT00234858|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6404258|NCT00234858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6404259|NCT00234858|Diuretics|diuretics|mesh-ancestor
6404260|NCT00234858|Natriuretic Agents|natriuretic agents|mesh-ancestor
6404261|NCT00234858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404262|NCT00234858|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6404263|NCT00234858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6404264|NCT00234858|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6404265|NCT00234858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6404266|NCT00234858|Vasodilator Agents|vasodilator agents|mesh-ancestor
6404267|NCT00234858|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6404268|NCT00234858|Protease Inhibitors|protease inhibitors|mesh-ancestor
6404269|NCT00234858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6404270|NCT00234871|Verapamil|verapamil|mesh-list
6404271|NCT00234871|Amlodipine|amlodipine|mesh-list
6404272|NCT00234871|Benazepril|benazepril|mesh-list
6404273|NCT00234871|Trandolapril|trandolapril|mesh-list
6404274|NCT00234871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6404275|NCT00234871|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6404276|NCT00234871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6404277|NCT00234871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6404278|NCT00234871|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6404279|NCT00234871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404280|NCT00234871|Vasodilator Agents|vasodilator agents|mesh-ancestor
6018642|NCT00381797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6538128|NCT00825942|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6404281|NCT00234871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6404282|NCT00234871|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6404283|NCT00234871|Protease Inhibitors|protease inhibitors|mesh-ancestor
6404284|NCT00234871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6459364|NCT00444561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459365|NCT00444574|Methylphenidate|methylphenidate|mesh-list
6459366|NCT00444574|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6459367|NCT00444574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459368|NCT00444574|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6459369|NCT00444574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6459370|NCT00444574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6459371|NCT00444574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459372|NCT00444574|Dopamine Agents|dopamine agents|mesh-ancestor
6459373|NCT00444574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6459374|NCT00444613|Vitamin B 12|vitamin b 12|mesh-list
6459375|NCT00444613|Vitamin B Complex|vitamin b complex|mesh-ancestor
6459376|NCT00444613|Vitamins|vitamins|mesh-ancestor
6459377|NCT00444613|Micronutrients|micronutrients|mesh-ancestor
6459378|NCT00444613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459379|NCT00444639|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6459380|NCT00444639|Luteolytic Agents|luteolytic agents|mesh-ancestor
6459381|NCT00444639|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6459382|NCT00444639|Contraceptive Agents|contraceptive agents|mesh-ancestor
6459383|NCT00444639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6459384|NCT00444639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459385|NCT00444639|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6459386|NCT00444639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6459387|NCT00444639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6459388|NCT00444652|Enoxaparin|enoxaparin|mesh-list
6459389|NCT00444652|Anticoagulants|anticoagulants|mesh-ancestor
6459390|NCT00444652|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6459391|NCT00444652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6459392|NCT00444652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459393|NCT00444665|Travoprost|travoprost|mesh-list
6459394|NCT00444665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6459395|NCT00444717|Pitavastatin|pitavastatin|mesh-list
6459396|NCT00444717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6459397|NCT00444717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6459398|NCT00444717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6459399|NCT00444717|Antimetabolites|antimetabolites|mesh-ancestor
6459400|NCT00444717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459401|NCT00444717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6459402|NCT00444717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6459403|NCT00444756|Lidocaine|lidocaine|mesh-list
6459404|NCT00444756|Anesthetics, Local|anesthetics, local|mesh-ancestor
6459405|NCT00444756|Anesthetics|anesthetics|mesh-ancestor
6459406|NCT00444756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6459407|NCT00444756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459408|NCT00444756|Sensory System Agents|sensory system agents|mesh-ancestor
6459409|NCT00444756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6459410|NCT00444756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6459411|NCT00444756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6459412|NCT00444756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6459413|NCT00444756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6459414|NCT00444756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459415|NCT00444808|Calcitonin|calcitonin|mesh-list
6459416|NCT00444808|Salmon calcitonin|salmon calcitonin|mesh-list
6459417|NCT00444808|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
6459418|NCT00444808|Katacalcin|katacalcin|mesh-list
6459419|NCT00444808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6459420|NCT00444808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459421|NCT00444808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6459422|NCT00444808|Vasodilator Agents|vasodilator agents|mesh-ancestor
6459423|NCT00444834|Carvedilol|carvedilol|mesh-list
6459424|NCT00444834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6459425|NCT00444834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6459426|NCT00444834|Adrenergic Agents|adrenergic agents|mesh-ancestor
6459427|NCT00444834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6459428|NCT00444834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459429|NCT00444834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459430|NCT00444834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6459431|NCT00444834|Antioxidants|antioxidants|mesh-ancestor
6538129|NCT00825942|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6404285|NCT00234897|Adalimumab|adalimumab|mesh-list
6404286|NCT00234897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6404287|NCT00234897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6404288|NCT00234910|Ritonavir|ritonavir|mesh-list
6404289|NCT00234910|Lopinavir|lopinavir|mesh-list
6404290|NCT00234910|Tenofovir|tenofovir|mesh-list
6404291|NCT00234910|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6404292|NCT00234910|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6404293|NCT00234910|Protease Inhibitors|protease inhibitors|mesh-ancestor
6404294|NCT00234910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6404295|NCT00234910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6404296|NCT00234910|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6404297|NCT00234910|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6404298|NCT00234910|Antiviral Agents|antiviral agents|mesh-ancestor
6404299|NCT00234910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6404300|NCT00234910|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6404301|NCT00234910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6404302|NCT00234910|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6404303|NCT00234910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6404304|NCT00234923|Ritonavir|ritonavir|mesh-list
6404305|NCT00234923|Lopinavir|lopinavir|mesh-list
6404306|NCT00234923|Lamivudine|lamivudine|mesh-list
6404307|NCT00234923|Zidovudine|zidovudine|mesh-list
6404308|NCT00234923|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6404309|NCT00234923|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6404310|NCT00234923|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6404311|NCT00234923|Protease Inhibitors|protease inhibitors|mesh-ancestor
6404312|NCT00234923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6404313|NCT00234923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6404314|NCT00234923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6404315|NCT00234923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6404316|NCT00234923|Antiviral Agents|antiviral agents|mesh-ancestor
6404317|NCT00234923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6404318|NCT00234923|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6404319|NCT00234923|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6404320|NCT00234923|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6404321|NCT00234923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6404322|NCT00234923|Antimetabolites|antimetabolites|mesh-ancestor
6404323|NCT00234936|Adalimumab|adalimumab|mesh-list
6404324|NCT00234936|Methotrexate|methotrexate|mesh-list
6404325|NCT00234936|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6404326|NCT00234936|Abortifacient Agents|abortifacient agents|mesh-ancestor
6404327|NCT00234936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6404328|NCT00234936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404329|NCT00234936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6404330|NCT00234936|Antimetabolites|antimetabolites|mesh-ancestor
6404331|NCT00234936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6404332|NCT00234936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6404333|NCT00234936|Dermatologic Agents|dermatologic agents|mesh-ancestor
6404334|NCT00234936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6404335|NCT00234936|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6018643|NCT00381797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6018644|NCT00381797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6018645|NCT00381797|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6018646|NCT00381797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6018647|NCT00381797|Antimetabolites|antimetabolites|mesh-ancestor
6018648|NCT00381797|Antiviral Agents|antiviral agents|mesh-ancestor
6404336|NCT00234936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6404337|NCT00234936|Immunologic Factors|immunologic factors|mesh-ancestor
6404338|NCT00234936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6404339|NCT00234936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6404340|NCT00234936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6404341|NCT00234949|Cephalexin|cephalexin|mesh-list
6404342|NCT00234949|Cefdinir|cefdinir|mesh-list
6404343|NCT00234949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6404344|NCT00234949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6404345|NCT00234962|Ritonavir|ritonavir|mesh-list
6404346|NCT00234962|Lopinavir|lopinavir|mesh-list
6404347|NCT00234962|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6404348|NCT00234962|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6404349|NCT00234962|Protease Inhibitors|protease inhibitors|mesh-ancestor
6404350|NCT00234962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6404351|NCT00234962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6404352|NCT00234962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6404353|NCT00234962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6404354|NCT00234962|Antiviral Agents|antiviral agents|mesh-ancestor
6404355|NCT00234962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6404356|NCT00234962|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6404357|NCT00234962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6404358|NCT00234975|Ritonavir|ritonavir|mesh-list
6404359|NCT00234975|Lopinavir|lopinavir|mesh-list
6404360|NCT00234975|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6404361|NCT00234975|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6404362|NCT00234975|Protease Inhibitors|protease inhibitors|mesh-ancestor
6404363|NCT00234975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6404364|NCT00234975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6404365|NCT00234975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6404366|NCT00234975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6404367|NCT00234975|Antiviral Agents|antiviral agents|mesh-ancestor
6404368|NCT00234975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6404369|NCT00234975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6404370|NCT00234975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6404371|NCT00234988|Sibutramine|sibutramine|mesh-list
6404372|NCT00234988|Antidepressive Agents|antidepressive agents|mesh-ancestor
6404373|NCT00234988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6404374|NCT00234988|Appetite Depressants|appetite depressants|mesh-ancestor
6404375|NCT00234988|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6404376|NCT00235001|Verapamil|verapamil|mesh-list
6404377|NCT00235001|Trandolapril|trandolapril|mesh-list
6404378|NCT00235001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6404379|NCT00235001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6404380|NCT00235001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6404381|NCT00235001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6404382|NCT00235001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6404383|NCT00235001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404384|NCT00235001|Vasodilator Agents|vasodilator agents|mesh-ancestor
6404385|NCT00235001|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6404386|NCT00235001|Protease Inhibitors|protease inhibitors|mesh-ancestor
6404387|NCT00235001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6404388|NCT00235001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6404389|NCT00235014|Verapamil|verapamil|mesh-list
6404390|NCT00235014|Trandolapril|trandolapril|mesh-list
6404391|NCT00235014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6404392|NCT00235014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6404393|NCT00235014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6404394|NCT00235014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6404395|NCT00235014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6404396|NCT00235014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404397|NCT00235014|Vasodilator Agents|vasodilator agents|mesh-ancestor
6404398|NCT00235014|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6404399|NCT00235014|Protease Inhibitors|protease inhibitors|mesh-ancestor
6404400|NCT00235014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6404401|NCT00235014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6404402|NCT00235053|Fluticasone|fluticasone|mesh-list
6404403|NCT00235053|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6404404|NCT00235053|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6404405|NCT00235053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6404406|NCT00235053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6404407|NCT00235053|Autonomic Agents|autonomic agents|mesh-ancestor
6404408|NCT00235053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6404409|NCT00235053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404410|NCT00235053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6404411|NCT00235053|Respiratory System Agents|respiratory system agents|mesh-ancestor
6404412|NCT00235053|Dermatologic Agents|dermatologic agents|mesh-ancestor
6404413|NCT00235053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6404414|NCT00235053|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6404415|NCT00235053|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6404416|NCT00235053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6404417|NCT00235053|Adrenergic Agents|adrenergic agents|mesh-ancestor
6404418|NCT00235053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6404419|NCT00235053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6404420|NCT00235053|Glucocorticoids|glucocorticoids|mesh-ancestor
6404421|NCT00235053|Hormones|hormones|mesh-ancestor
6404422|NCT00235053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6404423|NCT00235053|Sympathomimetics|sympathomimetics|mesh-ancestor
6404424|NCT00235079|Colchicine|colchicine|mesh-list
6018649|NCT00381797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6018650|NCT00381810|Acetaminophen|acetaminophen|mesh-list
6404425|NCT00235079|Gout Suppressants|gout suppressants|mesh-ancestor
6404426|NCT00235079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6404427|NCT00235079|Tubulin Modulators|tubulin modulators|mesh-ancestor
6018651|NCT00381810|Diphenhydramine|diphenhydramine|mesh-list
6018652|NCT00381810|Promethazine|promethazine|mesh-list
6018653|NCT00381810|Methylprednisolone|methylprednisolone|mesh-list
6018654|NCT00381810|Rituximab|rituximab|mesh-list
6018655|NCT00381810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6018656|NCT00381810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6018657|NCT00381810|Immunologic Factors|immunologic factors|mesh-ancestor
6018658|NCT00381810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018659|NCT00381810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6404428|NCT00235079|Antimitotic Agents|antimitotic agents|mesh-ancestor
6404429|NCT00235079|Mitosis Modulators|mitosis modulators|mesh-ancestor
6404430|NCT00235079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6404431|NCT00235079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6404432|NCT00235092|Sirolimus|sirolimus|mesh-list
6404433|NCT00235092|Paclitaxel|paclitaxel|mesh-list
6404434|NCT00235092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6404435|NCT00235092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6404436|NCT00235092|Tubulin Modulators|tubulin modulators|mesh-ancestor
6404437|NCT00235092|Antimitotic Agents|antimitotic agents|mesh-ancestor
6404438|NCT00235092|Mitosis Modulators|mitosis modulators|mesh-ancestor
6404439|NCT00235092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6404440|NCT00235092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6404441|NCT00235092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6404442|NCT00235092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6404443|NCT00235092|Antifungal Agents|antifungal agents|mesh-ancestor
6404444|NCT00235092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6404445|NCT00235092|Immunologic Factors|immunologic factors|mesh-ancestor
6404446|NCT00235092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404447|NCT00235105|Adalimumab|adalimumab|mesh-list
6404448|NCT00235105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6404449|NCT00235105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6404450|NCT00235144|Sirolimus|sirolimus|mesh-list
6404451|NCT00235144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6404452|NCT00235144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6404453|NCT00235144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6404454|NCT00235144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6404455|NCT00235144|Antifungal Agents|antifungal agents|mesh-ancestor
6404456|NCT00235144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6404457|NCT00235144|Immunologic Factors|immunologic factors|mesh-ancestor
6404458|NCT00235144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404459|NCT00235157|Sirolimus|sirolimus|mesh-list
6404460|NCT00235157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6404461|NCT00235157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6404462|NCT00235157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6404463|NCT00235157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6404464|NCT00235157|Antifungal Agents|antifungal agents|mesh-ancestor
6404465|NCT00235157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6404466|NCT00235157|Immunologic Factors|immunologic factors|mesh-ancestor
6404467|NCT00235157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404468|NCT00235196|Anti-Infective Agents|anti-infective agents|mesh-list
6404469|NCT00235196|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6404470|NCT00235209|Anti-Infective Agents|anti-infective agents|mesh-list
6404471|NCT00235209|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6404472|NCT00235222|Stavudine|stavudine|mesh-list
6404473|NCT00235222|Antimetabolites|antimetabolites|mesh-ancestor
6404474|NCT00235222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6404475|NCT00235222|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6404476|NCT00235222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6404477|NCT00235222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6404478|NCT00235222|Antiviral Agents|antiviral agents|mesh-ancestor
6404479|NCT00235222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6404480|NCT00235222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6404481|NCT00235222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6404482|NCT00235235|Gemcitabine|gemcitabine|mesh-list
6404483|NCT00235235|Cyclophosphamide|cyclophosphamide|mesh-list
6404484|NCT00235235|Doxorubicin|doxorubicin|mesh-list
6404485|NCT00235235|Capecitabine|capecitabine|mesh-list
6404486|NCT00235235|Vinorelbine|vinorelbine|mesh-list
6404487|NCT00235235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6404488|NCT00235235|Immunologic Factors|immunologic factors|mesh-ancestor
6404489|NCT00235235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404490|NCT00235235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6404491|NCT00235235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6404492|NCT00235235|Alkylating Agents|alkylating agents|mesh-ancestor
6404493|NCT00235235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6404494|NCT00235235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6404495|NCT00235235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6404496|NCT00235235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6404497|NCT00235235|Antimetabolites|antimetabolites|mesh-ancestor
6404498|NCT00235235|Antiviral Agents|antiviral agents|mesh-ancestor
6404499|NCT00235235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6404500|NCT00235235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6404501|NCT00235235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6404502|NCT00235235|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6404503|NCT00235235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6404504|NCT00235235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6404505|NCT00235235|Tubulin Modulators|tubulin modulators|mesh-ancestor
6404506|NCT00235235|Antimitotic Agents|antimitotic agents|mesh-ancestor
6404507|NCT00235235|Mitosis Modulators|mitosis modulators|mesh-ancestor
6404508|NCT00235248|Aspirin|aspirin|mesh-list
6404509|NCT00235248|Warfarin|warfarin|mesh-list
6404510|NCT00235248|Clopidogrel|clopidogrel|mesh-list
6404511|NCT00235248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6404512|NCT00235248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6404513|NCT00235248|Analgesics|analgesics|mesh-ancestor
6404514|NCT00235248|Sensory System Agents|sensory system agents|mesh-ancestor
6404515|NCT00235248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6404516|NCT00235248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404517|NCT00235248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6404518|NCT00235248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6404519|NCT00235248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6404520|NCT00235248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6404521|NCT00235248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6404522|NCT00235248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6404523|NCT00235248|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6404524|NCT00235248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6404525|NCT00235248|Antipyretics|antipyretics|mesh-ancestor
6404526|NCT00235248|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6404527|NCT00235248|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6404528|NCT00235248|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6404529|NCT00235248|Purinergic Agents|purinergic agents|mesh-ancestor
6404530|NCT00235248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6404531|NCT00235248|Anticoagulants|anticoagulants|mesh-ancestor
6404532|NCT00235261|Dexamethasone|dexamethasone|mesh-list
6404533|NCT00235261|Pregabalin|pregabalin|mesh-list
6404534|NCT00235261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6404535|NCT00235261|Antiemetics|antiemetics|mesh-ancestor
6404536|NCT00235261|Autonomic Agents|autonomic agents|mesh-ancestor
6404537|NCT00235261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6404538|NCT00235261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404539|NCT00235261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6404540|NCT00235261|Glucocorticoids|glucocorticoids|mesh-ancestor
6404541|NCT00235261|Hormones|hormones|mesh-ancestor
6404542|NCT00235261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6404543|NCT00235261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6404544|NCT00235261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6404545|NCT00235261|Analgesics|analgesics|mesh-ancestor
6404546|NCT00235261|Sensory System Agents|sensory system agents|mesh-ancestor
6404547|NCT00235261|Anticonvulsants|anticonvulsants|mesh-ancestor
6404548|NCT00235261|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5503585|NCT04457765|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6404549|NCT00235261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6404550|NCT00235261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459432|NCT00444834|Protective Agents|protective agents|mesh-ancestor
6404551|NCT00235261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6404552|NCT00235261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6404553|NCT00235261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6404554|NCT00235261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6404555|NCT00235261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6404556|NCT00235274|Secretin|secretin|mesh-list
6404557|NCT00235274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6404558|NCT00235274|Hormones|hormones|mesh-ancestor
6404559|NCT00235274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6404560|NCT00235274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404561|NCT00235287|Candesartan|candesartan|mesh-list
6404562|NCT00235287|Candesartan cilexetil|candesartan cilexetil|mesh-list
6404563|NCT00235287|Enalapril|enalapril|mesh-list
6404564|NCT00235287|Enalaprilat|enalaprilat|mesh-list
6404565|NCT00235287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6404566|NCT00235287|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6404567|NCT00235287|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6404568|NCT00235287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6404569|NCT00235287|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6404570|NCT00235287|Protease Inhibitors|protease inhibitors|mesh-ancestor
6404571|NCT00235287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6404572|NCT00235300|Thymoglobulin|thymoglobulin|mesh-list
6404573|NCT00235300|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6404574|NCT00235300|Basiliximab|basiliximab|mesh-list
6404575|NCT00235300|Immunologic Factors|immunologic factors|mesh-ancestor
6404576|NCT00235300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404577|NCT00235300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6404578|NCT00235313|Nicotine|nicotine|mesh-list
6404579|NCT00235313|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6404580|NCT00235313|Autonomic Agents|autonomic agents|mesh-ancestor
6404581|NCT00235313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6404582|NCT00235313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404583|NCT00235313|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6404584|NCT00235313|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6018660|NCT00381810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6018661|NCT00381810|Analgesics|analgesics|mesh-ancestor
6018662|NCT00381810|Sensory System Agents|sensory system agents|mesh-ancestor
6018663|NCT00381810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6018664|NCT00381810|Antipyretics|antipyretics|mesh-ancestor
6018665|NCT00381810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6018666|NCT00381810|Antiemetics|antiemetics|mesh-ancestor
6018667|NCT00381810|Autonomic Agents|autonomic agents|mesh-ancestor
6018668|NCT00381810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6018669|NCT00381810|Glucocorticoids|glucocorticoids|mesh-ancestor
6018670|NCT00381810|Hormones|hormones|mesh-ancestor
6018671|NCT00381810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6018672|NCT00381810|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6018673|NCT00381810|Protective Agents|protective agents|mesh-ancestor
6018674|NCT00381810|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6018675|NCT00381810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6404585|NCT00235313|Cholinergic Agents|cholinergic agents|mesh-ancestor
6404586|NCT00235313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6404587|NCT00235313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6404588|NCT00235508|Eszopiclone|eszopiclone|mesh-list
6404589|NCT00235508|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6404590|NCT00235508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6404591|NCT00235508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404592|NCT00235521|Iloprost|iloprost|mesh-list
6404593|NCT00235521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6404594|NCT00235521|Vasodilator Agents|vasodilator agents|mesh-ancestor
6404595|NCT00235560|Sirolimus|sirolimus|mesh-list
6404596|NCT00235560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6404597|NCT00235560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6404598|NCT00235560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6404599|NCT00235560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6404600|NCT00235560|Antifungal Agents|antifungal agents|mesh-ancestor
6404601|NCT00235560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6404602|NCT00235560|Immunologic Factors|immunologic factors|mesh-ancestor
6404603|NCT00235560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404604|NCT00235651|Amphotericin B|amphotericin b|mesh-list
6404605|NCT00235651|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6404606|NCT00235651|Amebicides|amebicides|mesh-ancestor
6404607|NCT00235651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6404608|NCT00235651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6404609|NCT00235651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6018676|NCT00381810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6404610|NCT00235651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6404611|NCT00235651|Antifungal Agents|antifungal agents|mesh-ancestor
6404612|NCT00235703|Anti-Infective Agents|anti-infective agents|mesh-list
6404613|NCT00235703|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6404614|NCT00235729|Lofexidine|lofexidine|mesh-list
6404615|NCT00235729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6404616|NCT00235729|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6404617|NCT00235729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404618|NCT00235729|Sensory System Agents|sensory system agents|mesh-ancestor
6404619|NCT00235729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6404620|NCT00235729|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6404621|NCT00235729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6404622|NCT00235729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6404623|NCT00235729|Adrenergic Agents|adrenergic agents|mesh-ancestor
6404624|NCT00235729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6404625|NCT00235729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6404626|NCT00235781|Thymoglobulin|thymoglobulin|mesh-list
6404627|NCT00235781|Immunologic Factors|immunologic factors|mesh-ancestor
6404628|NCT00235781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404629|NCT00235781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6404630|NCT00235794|Sirolimus|sirolimus|mesh-list
6404631|NCT00235794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6404632|NCT00235794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6404633|NCT00235794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6404634|NCT00235794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6404635|NCT00235794|Antifungal Agents|antifungal agents|mesh-ancestor
6404636|NCT00235794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6404637|NCT00235794|Immunologic Factors|immunologic factors|mesh-ancestor
6404638|NCT00235794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404639|NCT00235820|Adalimumab|adalimumab|mesh-list
6404640|NCT00235820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6404641|NCT00235820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6404642|NCT00235859|Adalimumab|adalimumab|mesh-list
6404643|NCT00235859|Methotrexate|methotrexate|mesh-list
6404644|NCT00235859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6404645|NCT00235859|Abortifacient Agents|abortifacient agents|mesh-ancestor
6404646|NCT00235859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6404647|NCT00235859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404648|NCT00235859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6404649|NCT00235859|Antimetabolites|antimetabolites|mesh-ancestor
6404650|NCT00235859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6404651|NCT00235859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6404652|NCT00235859|Dermatologic Agents|dermatologic agents|mesh-ancestor
6404653|NCT00235859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6404654|NCT00235859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6404655|NCT00235859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6404656|NCT00235859|Immunologic Factors|immunologic factors|mesh-ancestor
6404657|NCT00235859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6404658|NCT00235859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6404659|NCT00235859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6404660|NCT00235885|Adalimumab|adalimumab|mesh-list
6404661|NCT00235885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6404662|NCT00235885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6018677|NCT00381810|Anesthetics, Local|anesthetics, local|mesh-ancestor
6404663|NCT00235898|Leucovorin|leucovorin|mesh-list
6404664|NCT00235898|Fluorouracil|fluorouracil|mesh-list
6404665|NCT00235898|Antimetabolites|antimetabolites|mesh-ancestor
6404666|NCT00235898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6404667|NCT00235898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6404668|NCT00235898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6404669|NCT00235898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6404670|NCT00235898|Immunologic Factors|immunologic factors|mesh-ancestor
6404671|NCT00235898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404672|NCT00235898|Antidotes|antidotes|mesh-ancestor
6404673|NCT00235898|Protective Agents|protective agents|mesh-ancestor
6404674|NCT00235898|Vitamin B Complex|vitamin b complex|mesh-ancestor
6404675|NCT00235898|Vitamins|vitamins|mesh-ancestor
6404676|NCT00235898|Micronutrients|micronutrients|mesh-ancestor
6404677|NCT00235911|Budesonide|budesonide|mesh-list
6404678|NCT00235911|Formoterol Fumarate|formoterol fumarate|mesh-list
6404679|NCT00235911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6404680|NCT00235911|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6404681|NCT00235911|Autonomic Agents|autonomic agents|mesh-ancestor
6404682|NCT00235911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6404683|NCT00235911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404684|NCT00235911|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6404685|NCT00235911|Respiratory System Agents|respiratory system agents|mesh-ancestor
6404686|NCT00235911|Glucocorticoids|glucocorticoids|mesh-ancestor
6404687|NCT00235911|Hormones|hormones|mesh-ancestor
6404688|NCT00235911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6404689|NCT00235911|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6404690|NCT00235911|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6404691|NCT00235911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6404692|NCT00235911|Adrenergic Agents|adrenergic agents|mesh-ancestor
6404693|NCT00235911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6404694|NCT00235911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6404695|NCT00235937|Anastrozole|anastrozole|mesh-list
6404696|NCT00235937|Goserelin|goserelin|mesh-list
6404697|NCT00235937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6404698|NCT00235937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6404699|NCT00235937|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6404700|NCT00235937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6404701|NCT00235937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6404702|NCT00235937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6404703|NCT00235937|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6404704|NCT00235937|Hormone Antagonists|hormone antagonists|mesh-ancestor
6404705|NCT00235937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6404706|NCT00235937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404707|NCT00235950|Clopidogrel|clopidogrel|mesh-list
6404708|NCT00235950|Atorvastatin|atorvastatin|mesh-list
6404709|NCT00235950|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6404710|NCT00235950|Simvastatin|simvastatin|mesh-list
6404711|NCT00235950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6404712|NCT00235950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6404713|NCT00235950|Antimetabolites|antimetabolites|mesh-ancestor
6404714|NCT00235950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6404715|NCT00235950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6404716|NCT00235950|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6404717|NCT00235950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6404718|NCT00235950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6404719|NCT00235950|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6404720|NCT00235950|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6404721|NCT00235950|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6404722|NCT00235950|Purinergic Agents|purinergic agents|mesh-ancestor
6404723|NCT00235950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6018678|NCT00381810|Anesthetics|anesthetics|mesh-ancestor
6018679|NCT00381810|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6018680|NCT00381810|Histamine Antagonists|histamine antagonists|mesh-ancestor
6018681|NCT00381810|Histamine Agents|histamine agents|mesh-ancestor
6018682|NCT00381810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6018683|NCT00381810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6018684|NCT00381810|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6018685|NCT00381810|Antipruritics|antipruritics|mesh-ancestor
6404724|NCT00235950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404725|NCT00235963|Simvastatin|simvastatin|mesh-list
6404726|NCT00235963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6404727|NCT00235963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6404728|NCT00235963|Antimetabolites|antimetabolites|mesh-ancestor
6404729|NCT00235963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6404730|NCT00235963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6404731|NCT00235963|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6404732|NCT00235963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6404733|NCT00236002|Alendronate|alendronate|mesh-list
6404734|NCT00236002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6404735|NCT00236002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404736|NCT00236015|Tiagabine|tiagabine|mesh-list
6404737|NCT00236015|Anticonvulsants|anticonvulsants|mesh-ancestor
6404738|NCT00236015|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
6404739|NCT00236015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6404740|NCT00236015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6404741|NCT00236015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6404742|NCT00236015|GABA Agents|gaba agents|mesh-ancestor
6404743|NCT00236015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6404744|NCT00236015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404745|NCT00236028|Infliximab|infliximab|mesh-list
6404746|NCT00236028|Dermatologic Agents|dermatologic agents|mesh-ancestor
6404747|NCT00236028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6404748|NCT00236028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6404749|NCT00236054|Tiagabine|tiagabine|mesh-list
6404750|NCT00236054|Anticonvulsants|anticonvulsants|mesh-ancestor
6404751|NCT00236054|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
6404752|NCT00236054|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6404753|NCT00236054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6404754|NCT00236054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6404755|NCT00236054|GABA Agents|gaba agents|mesh-ancestor
6404756|NCT00236054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6404757|NCT00236054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404758|NCT00236067|Tiagabine|tiagabine|mesh-list
6404759|NCT00236067|Anticonvulsants|anticonvulsants|mesh-ancestor
6404760|NCT00236067|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
6404761|NCT00236067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6404762|NCT00236067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6404763|NCT00236067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6404764|NCT00236067|GABA Agents|gaba agents|mesh-ancestor
6404765|NCT00236067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6404766|NCT00236067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404767|NCT00236093|Fentanyl|fentanyl|mesh-list
6404768|NCT00236093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6404769|NCT00236093|Narcotics|narcotics|mesh-ancestor
6404770|NCT00236093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6404771|NCT00236093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404772|NCT00236093|Analgesics|analgesics|mesh-ancestor
6404773|NCT00236093|Sensory System Agents|sensory system agents|mesh-ancestor
6404774|NCT00236093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6404775|NCT00236093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6404776|NCT00236093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6404777|NCT00236093|Anesthetics, General|anesthetics, general|mesh-ancestor
6404778|NCT00236093|Anesthetics|anesthetics|mesh-ancestor
6404779|NCT00236106|Mometasone Furoate|mometasone furoate|mesh-list
6404780|NCT00236106|Tacrolimus|tacrolimus|mesh-list
6404781|NCT00236106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6404782|NCT00236106|Immunologic Factors|immunologic factors|mesh-ancestor
6404783|NCT00236106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404784|NCT00236106|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6404785|NCT00236106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6404786|NCT00236106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6404787|NCT00236106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6404788|NCT00236106|Dermatologic Agents|dermatologic agents|mesh-ancestor
6404789|NCT00236106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6404790|NCT00236145|Fentanyl|fentanyl|mesh-list
6404791|NCT00236145|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6404792|NCT00236145|Narcotics|narcotics|mesh-ancestor
6404793|NCT00236145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6404794|NCT00236145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404795|NCT00236145|Analgesics|analgesics|mesh-ancestor
6404796|NCT00236145|Sensory System Agents|sensory system agents|mesh-ancestor
6404797|NCT00236145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6404798|NCT00236145|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6404799|NCT00236145|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6404800|NCT00236145|Anesthetics, General|anesthetics, general|mesh-ancestor
6404801|NCT00236145|Anesthetics|anesthetics|mesh-ancestor
6404802|NCT00236171|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
6404803|NCT00236171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6404804|NCT00236223|Dexamethasone|dexamethasone|mesh-list
6404805|NCT00236223|Ketamine|ketamine|mesh-list
6404806|NCT00236223|Gabapentin|gabapentin|mesh-list
6404807|NCT00236223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6404808|NCT00236223|Antiemetics|antiemetics|mesh-ancestor
6404809|NCT00236223|Autonomic Agents|autonomic agents|mesh-ancestor
6404810|NCT00236223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6404811|NCT00236223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404812|NCT00236223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6404813|NCT00236223|Glucocorticoids|glucocorticoids|mesh-ancestor
6404814|NCT00236223|Hormones|hormones|mesh-ancestor
6404815|NCT00236223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6404816|NCT00236223|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6404817|NCT00236223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6404818|NCT00236223|Analgesics|analgesics|mesh-ancestor
6404819|NCT00236223|Sensory System Agents|sensory system agents|mesh-ancestor
6404820|NCT00236223|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6018686|NCT00381810|Dermatologic Agents|dermatologic agents|mesh-ancestor
6018687|NCT00381862|Leucovorin|leucovorin|mesh-list
6018688|NCT00381862|Dexamethasone|dexamethasone|mesh-list
6018689|NCT00381862|Fluorouracil|fluorouracil|mesh-list
6018690|NCT00381862|Oxaliplatin|oxaliplatin|mesh-list
6018691|NCT00381862|Irinotecan|irinotecan|mesh-list
6018692|NCT00381862|Camptothecin|camptothecin|mesh-list
6018693|NCT00381862|Aprepitant|aprepitant|mesh-list
6018694|NCT00381862|Palonosetron|palonosetron|mesh-list
6404821|NCT00236223|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6018695|NCT00381862|Levoleucovorin|levoleucovorin|mesh-list
6018696|NCT00381862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6404822|NCT00236223|Anesthetics, General|anesthetics, general|mesh-ancestor
6404823|NCT00236223|Anesthetics|anesthetics|mesh-ancestor
6538130|NCT00826046|Remestemcel-l|remestemcel-l|mesh-list
6018697|NCT00381862|Antiemetics|antiemetics|mesh-ancestor
6018698|NCT00381862|Autonomic Agents|autonomic agents|mesh-ancestor
6018699|NCT00381862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6018700|NCT00381862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018701|NCT00381862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6404824|NCT00236223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6404825|NCT00236223|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6404826|NCT00236223|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6404827|NCT00236223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6404828|NCT00236223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6404829|NCT00236223|Anticonvulsants|anticonvulsants|mesh-ancestor
6404830|NCT00236223|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6404831|NCT00236223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6404832|NCT00236223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6404833|NCT00236223|Antimanic Agents|antimanic agents|mesh-ancestor
6404834|NCT00236249|Lidocaine|lidocaine|mesh-list
6404835|NCT00236249|Anesthetics, Local|anesthetics, local|mesh-ancestor
6404836|NCT00236249|Anesthetics|anesthetics|mesh-ancestor
6404837|NCT00236249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6404838|NCT00236249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404839|NCT00236249|Sensory System Agents|sensory system agents|mesh-ancestor
6404840|NCT00236249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6404841|NCT00236249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6404842|NCT00236249|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6404843|NCT00236249|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6404844|NCT00236249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6404845|NCT00236249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6404846|NCT00236275|Telbivudine|telbivudine|mesh-list
6404847|NCT00236275|Antiviral Agents|antiviral agents|mesh-ancestor
6404848|NCT00236275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6404849|NCT00236275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6404850|NCT00236275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6404851|NCT00236275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6404852|NCT00236288|Bupropion|bupropion|mesh-list
6404853|NCT00236288|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6404854|NCT00236288|Antidepressive Agents|antidepressive agents|mesh-ancestor
6404855|NCT00236288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6404856|NCT00236288|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6404857|NCT00236288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6404858|NCT00236288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6404859|NCT00236288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6404860|NCT00236288|Dopamine Agents|dopamine agents|mesh-ancestor
6404861|NCT00236288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6404862|NCT00236288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404863|NCT00236288|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6404864|NCT00236288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6404865|NCT00236288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6404866|NCT00236301|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6404867|NCT00236301|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6404868|NCT00236301|Estradiol|estradiol|mesh-list
6404869|NCT00236301|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6404870|NCT00236301|Estrogens|estrogens|mesh-ancestor
6404871|NCT00236301|Hormones|hormones|mesh-ancestor
6404872|NCT00236301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6404873|NCT00236301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404874|NCT00236301|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6404875|NCT00236301|Contraceptive Agents|contraceptive agents|mesh-ancestor
6404876|NCT00236301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6404877|NCT00236301|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6404878|NCT00236327|Fentanyl|fentanyl|mesh-list
6404879|NCT00236327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6404880|NCT00236327|Narcotics|narcotics|mesh-ancestor
6404881|NCT00236327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6404882|NCT00236327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404883|NCT00236327|Analgesics|analgesics|mesh-ancestor
6404884|NCT00236327|Sensory System Agents|sensory system agents|mesh-ancestor
6404885|NCT00236327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6404886|NCT00236327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6404887|NCT00236327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6404888|NCT00236327|Anesthetics, General|anesthetics, general|mesh-ancestor
6404889|NCT00236327|Anesthetics|anesthetics|mesh-ancestor
6404890|NCT00236353|Risperidone|risperidone|mesh-list
6404891|NCT00236353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6404892|NCT00236353|Serotonin Agents|serotonin agents|mesh-ancestor
6404893|NCT00236353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6404894|NCT00236353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6404895|NCT00236353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404896|NCT00236353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6404897|NCT00236353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6404898|NCT00236353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6404899|NCT00236353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6404900|NCT00236353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6404901|NCT00236353|Dopamine Agents|dopamine agents|mesh-ancestor
6404902|NCT00236366|Fentanyl|fentanyl|mesh-list
6404903|NCT00236366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6404904|NCT00236366|Narcotics|narcotics|mesh-ancestor
6404905|NCT00236366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6404906|NCT00236366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404907|NCT00236366|Analgesics|analgesics|mesh-ancestor
6404908|NCT00236366|Sensory System Agents|sensory system agents|mesh-ancestor
6404909|NCT00236366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6404910|NCT00236366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6404911|NCT00236366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6404912|NCT00236366|Anesthetics, General|anesthetics, general|mesh-ancestor
6404913|NCT00236366|Anesthetics|anesthetics|mesh-ancestor
6404914|NCT00236379|Olanzapine|olanzapine|mesh-list
6404915|NCT00236379|Risperidone|risperidone|mesh-list
6404916|NCT00236379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6404917|NCT00236379|Serotonin Agents|serotonin agents|mesh-ancestor
6404918|NCT00236379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6404919|NCT00236379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6404920|NCT00236379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404921|NCT00236379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6404922|NCT00236379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6404923|NCT00236379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6404924|NCT00236379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6404925|NCT00236379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6404926|NCT00236379|Dopamine Agents|dopamine agents|mesh-ancestor
6404927|NCT00236379|Antiemetics|antiemetics|mesh-ancestor
6404928|NCT00236379|Autonomic Agents|autonomic agents|mesh-ancestor
6404929|NCT00236379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6404930|NCT00236379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6404931|NCT00236379|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6404932|NCT00236379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6404933|NCT00236379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6018702|NCT00381862|Glucocorticoids|glucocorticoids|mesh-ancestor
6018703|NCT00381862|Hormones|hormones|mesh-ancestor
6018704|NCT00381862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6018705|NCT00381862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6018706|NCT00381862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6404934|NCT00236392|Rabeprazole|rabeprazole|mesh-list
6404935|NCT00236392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6404936|NCT00236392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6404937|NCT00236392|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6404938|NCT00236392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6404939|NCT00236392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6404940|NCT00236405|Epoetin Alfa|epoetin alfa|mesh-list
6404941|NCT00236405|Hematinics|hematinics|mesh-ancestor
6404942|NCT00236418|Topiramate|topiramate|mesh-list
6404943|NCT00236418|Anticonvulsants|anticonvulsants|mesh-ancestor
6404944|NCT00236418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6404945|NCT00236418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404946|NCT00236431|Galantamine|galantamine|mesh-list
6404947|NCT00236431|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6404948|NCT00236431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6404949|NCT00236431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6404950|NCT00236431|Cholinergic Agents|cholinergic agents|mesh-ancestor
6404951|NCT00236431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6404952|NCT00236431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404953|NCT00236431|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6404954|NCT00236431|Autonomic Agents|autonomic agents|mesh-ancestor
6404955|NCT00236431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6404956|NCT00236431|Nootropic Agents|nootropic agents|mesh-ancestor
6404957|NCT00236444|Risperidone|risperidone|mesh-list
6404958|NCT00236444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6404959|NCT00236444|Serotonin Agents|serotonin agents|mesh-ancestor
6404960|NCT00236444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6404961|NCT00236444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6404962|NCT00236444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404963|NCT00236444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6404964|NCT00236444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6404965|NCT00236444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6404966|NCT00236444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6404967|NCT00236444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6404968|NCT00236444|Dopamine Agents|dopamine agents|mesh-ancestor
6459433|NCT00444834|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6459434|NCT00444834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6459435|NCT00444834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6459436|NCT00444834|Vasodilator Agents|vasodilator agents|mesh-ancestor
6459437|NCT00444834|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6459438|NCT00444834|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6459439|NCT00444873|Lanreotide|lanreotide|mesh-list
6459440|NCT00444873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6459441|NCT00444886|Botulinum Toxins|botulinum toxins|mesh-list
6459442|NCT00444886|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6459443|NCT00444886|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6459444|NCT00444886|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6459445|NCT00444886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6459446|NCT00444886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459447|NCT00444886|Cholinergic Agents|cholinergic agents|mesh-ancestor
6459448|NCT00444886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6459449|NCT00444886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459450|NCT00444886|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6459451|NCT00444886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6459452|NCT00445016|Anesthetics|anesthetics|mesh-list
6459453|NCT00445016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6459454|NCT00445016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459455|NCT00445042|Sorafenib|sorafenib|mesh-list
6459456|NCT00445042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6459457|NCT00445042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6459458|NCT00445042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6459459|NCT00445042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459460|NCT00445055|Droperidol|droperidol|mesh-list
6459461|NCT00445055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6459462|NCT00445055|Antiemetics|antiemetics|mesh-ancestor
6459463|NCT00445055|Autonomic Agents|autonomic agents|mesh-ancestor
6459464|NCT00445055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6459465|NCT00445055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459466|NCT00445055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6459467|NCT00445055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6459468|NCT00445055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6459469|NCT00445055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6459470|NCT00445055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6459471|NCT00445055|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6459472|NCT00445055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6459473|NCT00445055|Dopamine Agents|dopamine agents|mesh-ancestor
6459474|NCT00445055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6459475|NCT00445055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462022|NCT00457106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6462023|NCT00457106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462024|NCT00457106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462025|NCT00457106|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6462026|NCT00457106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6462027|NCT00457106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6404969|NCT00236457|Risperidone|risperidone|mesh-list
6404970|NCT00236457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6404971|NCT00236457|Serotonin Agents|serotonin agents|mesh-ancestor
6404972|NCT00236457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6404973|NCT00236457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6404974|NCT00236457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404975|NCT00236457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6404976|NCT00236457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6404977|NCT00236457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6404978|NCT00236457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6404979|NCT00236457|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6404980|NCT00236457|Dopamine Agents|dopamine agents|mesh-ancestor
6404981|NCT00236470|Risperidone|risperidone|mesh-list
6404982|NCT00236470|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6404983|NCT00236470|Serotonin Agents|serotonin agents|mesh-ancestor
6404984|NCT00236470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6404985|NCT00236470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6404986|NCT00236470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6404987|NCT00236470|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6404988|NCT00236470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6404989|NCT00236470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6404990|NCT00236470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6404991|NCT00236470|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6018707|NCT00381862|Antimetabolites|antimetabolites|mesh-ancestor
6018708|NCT00381862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6018709|NCT00381862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6018710|NCT00381862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6018711|NCT00381862|Immunologic Factors|immunologic factors|mesh-ancestor
6018712|NCT00381862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6018713|NCT00381862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6018714|NCT00381862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6018715|NCT00381862|Antidotes|antidotes|mesh-ancestor
6018716|NCT00381862|Protective Agents|protective agents|mesh-ancestor
6404992|NCT00236470|Dopamine Agents|dopamine agents|mesh-ancestor
6404993|NCT00236483|Acetaminophen|acetaminophen|mesh-list
6404994|NCT00236483|Tramadol|tramadol|mesh-list
6404995|NCT00236483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6404996|NCT00236483|Analgesics|analgesics|mesh-ancestor
6404997|NCT00236483|Sensory System Agents|sensory system agents|mesh-ancestor
6404998|NCT00236483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6404999|NCT00236483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405000|NCT00236483|Antipyretics|antipyretics|mesh-ancestor
6405001|NCT00236483|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6405002|NCT00236483|Narcotics|narcotics|mesh-ancestor
6405003|NCT00236483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6405004|NCT00236496|Topiramate|topiramate|mesh-list
6405005|NCT00236496|Anticonvulsants|anticonvulsants|mesh-ancestor
6405006|NCT00236496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6405007|NCT00236496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405008|NCT00236509|Topiramate|topiramate|mesh-list
6405009|NCT00236509|Anticonvulsants|anticonvulsants|mesh-ancestor
6405010|NCT00236509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6405011|NCT00236509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405012|NCT00236522|Levofloxacin|levofloxacin|mesh-list
6405013|NCT00236522|Ofloxacin|ofloxacin|mesh-list
6405014|NCT00236522|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6405015|NCT00236522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6405016|NCT00236522|Renal Agents|renal agents|mesh-ancestor
6405017|NCT00236522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6405018|NCT00236522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6405019|NCT00236522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6405020|NCT00236522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6405021|NCT00236522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6405022|NCT00236522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6405023|NCT00236522|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6405024|NCT00236522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6405025|NCT00236535|Acetaminophen|acetaminophen|mesh-list
6405026|NCT00236535|Tramadol|tramadol|mesh-list
6405027|NCT00236535|Hydrocodone|hydrocodone|mesh-list
6405028|NCT00236535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6405029|NCT00236535|Analgesics|analgesics|mesh-ancestor
6018717|NCT00381862|Vitamin B Complex|vitamin b complex|mesh-ancestor
6405030|NCT00236535|Sensory System Agents|sensory system agents|mesh-ancestor
6405031|NCT00236535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6405032|NCT00236535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405033|NCT00236535|Antipyretics|antipyretics|mesh-ancestor
6405034|NCT00236535|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6405035|NCT00236535|Narcotics|narcotics|mesh-ancestor
6405036|NCT00236535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6405037|NCT00236535|Antitussive Agents|antitussive agents|mesh-ancestor
6405038|NCT00236535|Respiratory System Agents|respiratory system agents|mesh-ancestor
6405039|NCT00236548|Risperidone|risperidone|mesh-list
6405040|NCT00236548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6405041|NCT00236548|Serotonin Agents|serotonin agents|mesh-ancestor
6405042|NCT00236548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6405043|NCT00236548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6405044|NCT00236548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405045|NCT00236548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6405046|NCT00236548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6405047|NCT00236548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6405048|NCT00236548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6405049|NCT00236548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6405050|NCT00236548|Dopamine Agents|dopamine agents|mesh-ancestor
6405051|NCT00236561|Topiramate|topiramate|mesh-list
6405052|NCT00236561|Propranolol|propranolol|mesh-list
6405053|NCT00236561|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6405054|NCT00236561|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6405055|NCT00236561|Adrenergic Agents|adrenergic agents|mesh-ancestor
6405056|NCT00236561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6405057|NCT00236561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6405058|NCT00236561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405059|NCT00236561|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6405060|NCT00236561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6405061|NCT00236561|Vasodilator Agents|vasodilator agents|mesh-ancestor
6405062|NCT00236561|Anticonvulsants|anticonvulsants|mesh-ancestor
6405063|NCT00236561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6405064|NCT00236574|Galantamine|galantamine|mesh-list
6405065|NCT00236574|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6405066|NCT00236574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6405067|NCT00236574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6405068|NCT00236574|Cholinergic Agents|cholinergic agents|mesh-ancestor
6405069|NCT00236574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6405070|NCT00236574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405071|NCT00236574|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6405072|NCT00236574|Autonomic Agents|autonomic agents|mesh-ancestor
6405073|NCT00236574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6405074|NCT00236574|Nootropic Agents|nootropic agents|mesh-ancestor
6405075|NCT00236587|Risperidone|risperidone|mesh-list
6405076|NCT00236587|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6405077|NCT00236587|Serotonin Agents|serotonin agents|mesh-ancestor
6405078|NCT00236587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6405079|NCT00236587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6405080|NCT00236587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405081|NCT00236587|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6405082|NCT00236587|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6405083|NCT00236587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6405084|NCT00236587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6405085|NCT00236587|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6405086|NCT00236587|Dopamine Agents|dopamine agents|mesh-ancestor
6405087|NCT00236600|Topiramate|topiramate|mesh-list
6405088|NCT00236600|Anticonvulsants|anticonvulsants|mesh-ancestor
6405089|NCT00236600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6405090|NCT00236600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405091|NCT00236613|Topiramate|topiramate|mesh-list
6405092|NCT00236613|Anticonvulsants|anticonvulsants|mesh-ancestor
6405093|NCT00236613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6405094|NCT00236613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405095|NCT00236626|Topiramate|topiramate|mesh-list
6405096|NCT00236626|Anticonvulsants|anticonvulsants|mesh-ancestor
6405097|NCT00236626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6405098|NCT00236626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405099|NCT00236639|Topiramate|topiramate|mesh-list
6405100|NCT00236639|Anticonvulsants|anticonvulsants|mesh-ancestor
6405101|NCT00236639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6405102|NCT00236639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405103|NCT00236652|Levofloxacin|levofloxacin|mesh-list
6405104|NCT00236652|Ofloxacin|ofloxacin|mesh-list
6405105|NCT00236652|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6405106|NCT00236652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6405107|NCT00236652|Renal Agents|renal agents|mesh-ancestor
6405108|NCT00236652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6405109|NCT00236652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6405110|NCT00236652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6405111|NCT00236652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6405112|NCT00236652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6405113|NCT00236652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6405114|NCT00236652|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6405115|NCT00236652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6405116|NCT00236665|Topiramate|topiramate|mesh-list
6405117|NCT00236665|Anticonvulsants|anticonvulsants|mesh-ancestor
6405118|NCT00236665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6405119|NCT00236665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405120|NCT00236678|Epoetin Alfa|epoetin alfa|mesh-list
6405121|NCT00236678|Hematinics|hematinics|mesh-ancestor
6405122|NCT00236691|Topiramate|topiramate|mesh-list
6405123|NCT00236691|Anticonvulsants|anticonvulsants|mesh-ancestor
6405124|NCT00236691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6405125|NCT00236691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405126|NCT00236704|Topiramate|topiramate|mesh-list
6405127|NCT00236704|Anticonvulsants|anticonvulsants|mesh-ancestor
6405128|NCT00236704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6405129|NCT00236704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405130|NCT00236717|Topiramate|topiramate|mesh-list
6405131|NCT00236717|Carbamazepine|carbamazepine|mesh-list
6405132|NCT00236717|Valproic Acid|valproic acid|mesh-list
6405133|NCT00236717|Anticonvulsants|anticonvulsants|mesh-ancestor
6405134|NCT00236717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6405135|NCT00236717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405136|NCT00236717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6405137|NCT00236717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6405138|NCT00236717|GABA Agents|gaba agents|mesh-ancestor
6405139|NCT00236717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6405140|NCT00236717|Antimanic Agents|antimanic agents|mesh-ancestor
6405141|NCT00236717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6405142|NCT00236717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6405143|NCT00236717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6405144|NCT00236717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6405145|NCT00236717|Analgesics|analgesics|mesh-ancestor
6405146|NCT00236717|Sensory System Agents|sensory system agents|mesh-ancestor
6405147|NCT00236717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6405148|NCT00236717|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6405149|NCT00236717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6405150|NCT00236717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6405151|NCT00236717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6405152|NCT00236730|Topiramate|topiramate|mesh-list
6405153|NCT00236730|Anticonvulsants|anticonvulsants|mesh-ancestor
6405154|NCT00236730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6405155|NCT00236730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405156|NCT00236743|Topiramate|topiramate|mesh-list
6405157|NCT00236743|Anticonvulsants|anticonvulsants|mesh-ancestor
6405158|NCT00236743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6405159|NCT00236743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405160|NCT00236756|Topiramate|topiramate|mesh-list
6405161|NCT00236756|Anticonvulsants|anticonvulsants|mesh-ancestor
6405162|NCT00236756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6405163|NCT00236756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405164|NCT00236769|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6405165|NCT00236769|Norelgestromin|norelgestromin|mesh-list
6405166|NCT00236769|Estradiol|estradiol|mesh-list
6405167|NCT00236769|Estrogens|estrogens|mesh-ancestor
6405168|NCT00236769|Hormones|hormones|mesh-ancestor
6405169|NCT00236769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6405170|NCT00236769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405171|NCT00236769|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6405172|NCT00236769|Contraceptive Agents|contraceptive agents|mesh-ancestor
6405173|NCT00236769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6405174|NCT00236769|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6405175|NCT00236769|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6405176|NCT00236769|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6405177|NCT00236782|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6405178|NCT00236782|Norelgestromin|norelgestromin|mesh-list
6405179|NCT00236782|Estradiol|estradiol|mesh-list
6405180|NCT00236782|Estrogens|estrogens|mesh-ancestor
6405181|NCT00236782|Hormones|hormones|mesh-ancestor
6405182|NCT00236782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6405183|NCT00236782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405184|NCT00236782|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6405185|NCT00236782|Contraceptive Agents|contraceptive agents|mesh-ancestor
6405186|NCT00236782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6405187|NCT00236782|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6405188|NCT00236782|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6405189|NCT00236782|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6405190|NCT00236795|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6405191|NCT00236795|Norelgestromin|norelgestromin|mesh-list
6405192|NCT00236795|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
6405193|NCT00236795|Estradiol|estradiol|mesh-list
6405194|NCT00236795|Estrogens|estrogens|mesh-ancestor
6405195|NCT00236795|Hormones|hormones|mesh-ancestor
6405196|NCT00236795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6405197|NCT00236795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405198|NCT00236795|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6405199|NCT00236795|Contraceptive Agents|contraceptive agents|mesh-ancestor
6405200|NCT00236795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6405201|NCT00236795|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6405202|NCT00236795|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6405203|NCT00236795|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6405204|NCT00236795|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6405205|NCT00236795|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6405206|NCT00236795|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
6405207|NCT00236795|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6405208|NCT00236795|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6405209|NCT00236808|Levofloxacin|levofloxacin|mesh-list
6405210|NCT00236808|Ofloxacin|ofloxacin|mesh-list
6405211|NCT00236808|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6405212|NCT00236808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6405213|NCT00236808|Renal Agents|renal agents|mesh-ancestor
6405214|NCT00236808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6405215|NCT00236808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6405216|NCT00236808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6405217|NCT00236808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6405218|NCT00236808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6405219|NCT00236808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6405220|NCT00236808|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6405221|NCT00236808|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6405222|NCT00236821|Levofloxacin|levofloxacin|mesh-list
6405223|NCT00236821|Ofloxacin|ofloxacin|mesh-list
6405224|NCT00236821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6405225|NCT00236821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6405226|NCT00236821|Renal Agents|renal agents|mesh-ancestor
6405227|NCT00236821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6405228|NCT00236821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6405229|NCT00236821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6405230|NCT00236821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6405231|NCT00236821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6405232|NCT00236821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6405233|NCT00236821|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6405234|NCT00236821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6405235|NCT00236834|Levofloxacin|levofloxacin|mesh-list
6405236|NCT00236834|Ofloxacin|ofloxacin|mesh-list
6405237|NCT00236834|Imipenem|imipenem|mesh-list
6405238|NCT00236834|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6405239|NCT00236834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6405240|NCT00236834|Renal Agents|renal agents|mesh-ancestor
6405241|NCT00236834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6405242|NCT00236834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6405243|NCT00236834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6405244|NCT00236834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6405245|NCT00236834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6405246|NCT00236834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6405247|NCT00236834|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6405248|NCT00236834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6405249|NCT00236847|Topiramate|topiramate|mesh-list
6405250|NCT00236847|Anticonvulsants|anticonvulsants|mesh-ancestor
6405251|NCT00236847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6405252|NCT00236847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405253|NCT00236860|Topiramate|topiramate|mesh-list
6405254|NCT00236860|Anticonvulsants|anticonvulsants|mesh-ancestor
6405255|NCT00236860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6405256|NCT00236860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405257|NCT00236873|Topiramate|topiramate|mesh-list
6405258|NCT00236873|Anticonvulsants|anticonvulsants|mesh-ancestor
6405259|NCT00236873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6405260|NCT00236873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405261|NCT00236886|Topiramate|topiramate|mesh-list
6405262|NCT00236886|Anticonvulsants|anticonvulsants|mesh-ancestor
6405263|NCT00236886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6459476|NCT00445081|Cyclosporine|cyclosporine|mesh-list
6405264|NCT00236886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405265|NCT00236912|Metronidazole|metronidazole|mesh-list
6405266|NCT00236912|Levofloxacin|levofloxacin|mesh-list
6405267|NCT00236912|Ofloxacin|ofloxacin|mesh-list
6405268|NCT00236912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6405269|NCT00236912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6405270|NCT00236912|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6405271|NCT00236912|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6405272|NCT00236912|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6405273|NCT00236912|Renal Agents|renal agents|mesh-ancestor
6405274|NCT00236912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6405275|NCT00236912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6405276|NCT00236912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6405277|NCT00236912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6405278|NCT00236912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6405279|NCT00236912|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6405280|NCT00236912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6405281|NCT00236925|Hydrocortisone|hydrocortisone|mesh-list
6405282|NCT00236925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6405283|NCT00236964|Epoetin Alfa|epoetin alfa|mesh-list
6405284|NCT00236964|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6405285|NCT00236964|Hematinics|hematinics|mesh-ancestor
6405286|NCT00236990|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
6405287|NCT00236990|Anticoagulants|anticoagulants|mesh-ancestor
6405288|NCT00237016|Doxycycline|doxycycline|mesh-list
6405289|NCT00237016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6405290|NCT00237016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6405291|NCT00237016|Antimalarials|antimalarials|mesh-ancestor
6405292|NCT00237016|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6405293|NCT00237016|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6405294|NCT00237068|Lansoprazole|lansoprazole|mesh-list
6405295|NCT00237068|Dexlansoprazole|dexlansoprazole|mesh-list
6405296|NCT00237068|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6405297|NCT00237068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6405298|NCT00237068|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6405299|NCT00237068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6405300|NCT00237068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6405301|NCT00237120|Imatinib Mesylate|imatinib mesylate|mesh-list
6405302|NCT00237120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6405303|NCT00237120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6405304|NCT00237120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6405305|NCT00237120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6405306|NCT00237133|Letrozole|letrozole|mesh-list
6405307|NCT00237133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6405308|NCT00237133|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6405309|NCT00237133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6405310|NCT00237133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6405311|NCT00237133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6405312|NCT00237133|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6405313|NCT00237133|Hormone Antagonists|hormone antagonists|mesh-ancestor
6405314|NCT00237133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6405315|NCT00237133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405316|NCT00237146|Zoledronic Acid|zoledronic acid|mesh-list
6405317|NCT00237146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6405318|NCT00237146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405319|NCT00237159|Zoledronic Acid|zoledronic acid|mesh-list
6405320|NCT00237159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6405321|NCT00237159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405322|NCT00237172|Imatinib Mesylate|imatinib mesylate|mesh-list
6405323|NCT00237172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6405324|NCT00237172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6405325|NCT00237172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6405326|NCT00237172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6405327|NCT00237198|Letrozole|letrozole|mesh-list
6405328|NCT00237198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6405329|NCT00237198|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6405330|NCT00237198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6405331|NCT00237198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6405332|NCT00237198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6405333|NCT00237198|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6405334|NCT00237198|Hormone Antagonists|hormone antagonists|mesh-ancestor
6405335|NCT00237198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6405336|NCT00237198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405337|NCT00237211|Letrozole|letrozole|mesh-list
6405338|NCT00237211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6405339|NCT00237211|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6405340|NCT00237211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6405341|NCT00237211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6405342|NCT00237211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6405343|NCT00237211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6405344|NCT00237211|Hormone Antagonists|hormone antagonists|mesh-ancestor
6405345|NCT00237211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6405346|NCT00237211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405347|NCT00237224|Letrozole|letrozole|mesh-list
6405348|NCT00237224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6405349|NCT00237224|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6405350|NCT00237224|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6405351|NCT00237224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6405352|NCT00237224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6405353|NCT00237224|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6405354|NCT00237224|Hormone Antagonists|hormone antagonists|mesh-ancestor
6405355|NCT00237224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6405356|NCT00237224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405357|NCT00237237|Vildagliptin|vildagliptin|mesh-list
6405358|NCT00237237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6405359|NCT00237237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405360|NCT00237237|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6405361|NCT00237237|Protease Inhibitors|protease inhibitors|mesh-ancestor
6405362|NCT00237237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6405363|NCT00237237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6405364|NCT00237250|Vildagliptin|vildagliptin|mesh-list
6405365|NCT00237250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6405366|NCT00237250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405367|NCT00237250|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6405368|NCT00237250|Protease Inhibitors|protease inhibitors|mesh-ancestor
6405369|NCT00237250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6405370|NCT00237250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6405371|NCT00237263|Entacapone|entacapone|mesh-list
6405372|NCT00237263|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6405373|NCT00237263|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6405374|NCT00237263|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6405375|NCT00237263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6405376|NCT00237263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6405377|NCT00237289|Topiramate|topiramate|mesh-list
6405378|NCT00237289|Anticonvulsants|anticonvulsants|mesh-ancestor
6405379|NCT00237289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6405380|NCT00237289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405381|NCT00237302|Topiramate|topiramate|mesh-list
6405382|NCT00237302|Anticonvulsants|anticonvulsants|mesh-ancestor
6405383|NCT00237302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6405384|NCT00237302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405385|NCT00237328|Heparin|heparin|mesh-list
6405386|NCT00237328|Anticoagulants|anticoagulants|mesh-ancestor
6405387|NCT00237328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6405388|NCT00237328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6405389|NCT00237328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6405390|NCT00237341|Fentanyl|fentanyl|mesh-list
6405391|NCT00237341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6405392|NCT00237341|Narcotics|narcotics|mesh-ancestor
6405393|NCT00237341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6405394|NCT00237341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405395|NCT00237341|Analgesics|analgesics|mesh-ancestor
6405396|NCT00237341|Sensory System Agents|sensory system agents|mesh-ancestor
6405397|NCT00237341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6405398|NCT00237341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6405399|NCT00237341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6405400|NCT00237341|Anesthetics, General|anesthetics, general|mesh-ancestor
6405401|NCT00237341|Anesthetics|anesthetics|mesh-ancestor
6405402|NCT00237367|Rabeprazole|rabeprazole|mesh-list
6405403|NCT00237367|Pantoprazole|pantoprazole|mesh-list
6405404|NCT00237367|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6405405|NCT00237367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6405406|NCT00237367|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6405407|NCT00237367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6405408|NCT00237367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6405409|NCT00237393|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6405410|NCT00237393|Antidepressive Agents|antidepressive agents|mesh-ancestor
6405411|NCT00237393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6405412|NCT00237393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6405413|NCT00237393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6405414|NCT00237393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6405415|NCT00237393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405416|NCT00237419|Infliximab|infliximab|mesh-list
6405417|NCT00237419|Dermatologic Agents|dermatologic agents|mesh-ancestor
6405418|NCT00237419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6405419|NCT00237419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6405420|NCT00237445|Azithromycin|azithromycin|mesh-list
6405421|NCT00237445|Telithromycin|telithromycin|mesh-list
6405422|NCT00237445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6405423|NCT00237445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6405424|NCT00237471|Insulin|insulin|mesh-list
6405425|NCT00237471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6405426|NCT00237471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405427|NCT00237484|Interferons|interferons|mesh-list
6405428|NCT00237484|Ribavirin|ribavirin|mesh-list
6405429|NCT00237484|Interferon-alpha|interferon-alpha|mesh-list
6405430|NCT00237484|Interferon alpha-2|interferon alpha-2|mesh-list
6405431|NCT00237484|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6405432|NCT00237484|Infliximab|infliximab|mesh-list
6405433|NCT00237484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6405434|NCT00237484|Antiviral Agents|antiviral agents|mesh-ancestor
6405435|NCT00237484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6405436|NCT00237484|Antimetabolites|antimetabolites|mesh-ancestor
6405437|NCT00237484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6405438|NCT00237484|Immunologic Factors|immunologic factors|mesh-ancestor
6405439|NCT00237484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405440|NCT00237484|Dermatologic Agents|dermatologic agents|mesh-ancestor
6405441|NCT00237484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6405442|NCT00237484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6405443|NCT00237497|Zopiclone|zopiclone|mesh-list
6405444|NCT00237497|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6405445|NCT00237497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6405446|NCT00237497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405447|NCT00237510|Terazosin|terazosin|mesh-list
6405448|NCT00237510|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6405449|NCT00237510|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6405450|NCT00237510|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6405451|NCT00237510|Adrenergic Agents|adrenergic agents|mesh-ancestor
6405452|NCT00237510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6405453|NCT00237510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6405454|NCT00237510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405455|NCT00237510|Urological Agents|urological agents|mesh-ancestor
6405456|NCT00237523|Iodine|iodine|mesh-list
6405457|NCT00237523|Cadexomer iodine|cadexomer iodine|mesh-list
6405458|NCT00237523|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6405459|NCT00237523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6405460|NCT00237523|Trace Elements|trace elements|mesh-ancestor
6405461|NCT00237523|Micronutrients|micronutrients|mesh-ancestor
6405462|NCT00237523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405463|NCT00237536|Lonidamine|lonidamine|mesh-list
6405464|NCT00237536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6405465|NCT00237536|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
6405466|NCT00237536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405467|NCT00237536|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6405468|NCT00237536|Contraceptive Agents|contraceptive agents|mesh-ancestor
6405469|NCT00237536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6405470|NCT00237536|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6405471|NCT00237536|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6405472|NCT00237536|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6405473|NCT00237536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6405474|NCT00237575|Gemcitabine|gemcitabine|mesh-list
6405475|NCT00237575|Sargramostim|sargramostim|mesh-list
6405476|NCT00237575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6405477|NCT00237575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6405478|NCT00237575|Antimetabolites|antimetabolites|mesh-ancestor
6405479|NCT00237575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6405480|NCT00237575|Antiviral Agents|antiviral agents|mesh-ancestor
6405481|NCT00237575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6405482|NCT00237575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6405483|NCT00237575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6405484|NCT00237575|Immunologic Factors|immunologic factors|mesh-ancestor
6405485|NCT00237575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405486|NCT00237588|Losartan|losartan|mesh-list
6405487|NCT00237588|Amlodipine|amlodipine|mesh-list
6405488|NCT00237588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6405489|NCT00237588|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6405490|NCT00237588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6405491|NCT00237588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6405492|NCT00237588|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6405493|NCT00237588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405494|NCT00237588|Vasodilator Agents|vasodilator agents|mesh-ancestor
6405495|NCT00237588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6405496|NCT00237588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6405497|NCT00237588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6405498|NCT00237614|Acetylcysteine|acetylcysteine|mesh-list
6405499|NCT00237614|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6405500|NCT00237614|Antiviral Agents|antiviral agents|mesh-ancestor
6405501|NCT00237614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6405502|NCT00237614|Expectorants|expectorants|mesh-ancestor
6405503|NCT00237614|Respiratory System Agents|respiratory system agents|mesh-ancestor
6405504|NCT00237614|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6405505|NCT00237614|Antioxidants|antioxidants|mesh-ancestor
6405506|NCT00237614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6405507|NCT00237614|Protective Agents|protective agents|mesh-ancestor
6405508|NCT00237614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405509|NCT00237614|Antidotes|antidotes|mesh-ancestor
6405510|NCT00237627|Doxorubicin|doxorubicin|mesh-list
6405511|NCT00237627|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6405512|NCT00237627|Bortezomib|bortezomib|mesh-list
6405513|NCT00237627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6405514|NCT00237627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6405515|NCT00237627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6405516|NCT00237627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6405517|NCT00237627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6405518|NCT00237627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6405519|NCT00237653|Valganciclovir|valganciclovir|mesh-list
6405520|NCT00237653|Antiviral Agents|antiviral agents|mesh-ancestor
6405521|NCT00237653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6405522|NCT00237705|Metoclopramide|metoclopramide|mesh-list
6405523|NCT00237705|Antiemetics|antiemetics|mesh-ancestor
6405524|NCT00237705|Autonomic Agents|autonomic agents|mesh-ancestor
6405525|NCT00237705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6405526|NCT00237705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405527|NCT00237705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6405528|NCT00237705|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6405529|NCT00237705|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6405530|NCT00237705|Dopamine Agents|dopamine agents|mesh-ancestor
6405531|NCT00237705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6405532|NCT00237705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6405533|NCT00237731|Morphine|morphine|mesh-list
6405534|NCT00237731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6405535|NCT00237731|Narcotics|narcotics|mesh-ancestor
6405536|NCT00237731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6405537|NCT00237731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405538|NCT00237731|Analgesics|analgesics|mesh-ancestor
6405539|NCT00237731|Sensory System Agents|sensory system agents|mesh-ancestor
6405540|NCT00237731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6405541|NCT00237783|Dialysis Solutions|dialysis solutions|mesh-list
6405542|NCT00237783|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6405543|NCT00237861|Olanzapine|olanzapine|mesh-list
6405544|NCT00237861|Risperidone|risperidone|mesh-list
6405545|NCT00237861|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6405546|NCT00237861|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6405547|NCT00237861|Serotonin Agents|serotonin agents|mesh-ancestor
6405548|NCT00237861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6405549|NCT00237861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6405550|NCT00237861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405551|NCT00237861|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6405552|NCT00237861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6405553|NCT00237861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6405554|NCT00237861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6405555|NCT00237861|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6405556|NCT00237861|Dopamine Agents|dopamine agents|mesh-ancestor
6405557|NCT00237861|Antiemetics|antiemetics|mesh-ancestor
6405558|NCT00237861|Autonomic Agents|autonomic agents|mesh-ancestor
6405559|NCT00237861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6405560|NCT00237861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6405561|NCT00237861|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6405562|NCT00237861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6405563|NCT00237861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6405564|NCT00237861|Antidepressive Agents|antidepressive agents|mesh-ancestor
6405565|NCT00237874|Aripiprazole|aripiprazole|mesh-list
6405566|NCT00237874|Antidepressive Agents|antidepressive agents|mesh-ancestor
6405567|NCT00237874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6405568|NCT00237874|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6405569|NCT00237874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6405570|NCT00237874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6405571|NCT00237874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405572|NCT00237874|Dopamine Agonists|dopamine agonists|mesh-ancestor
6405573|NCT00237874|Dopamine Agents|dopamine agents|mesh-ancestor
6405574|NCT00237874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6405575|NCT00237874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6405576|NCT00237874|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6405577|NCT00237874|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6405578|NCT00237874|Serotonin Agents|serotonin agents|mesh-ancestor
6405579|NCT00237874|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6405580|NCT00237874|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6405581|NCT00237874|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6405582|NCT00237874|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6405583|NCT00237887|Adalimumab|adalimumab|mesh-list
6405584|NCT00237887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6405585|NCT00237887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6405586|NCT00237900|Leucovorin|leucovorin|mesh-list
6405587|NCT00237900|Fluorouracil|fluorouracil|mesh-list
6405588|NCT00237900|Gefitinib|gefitinib|mesh-list
6405589|NCT00237900|Antimetabolites|antimetabolites|mesh-ancestor
6405590|NCT00237900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6405591|NCT00237900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6405592|NCT00237900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6405593|NCT00237900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6405594|NCT00237900|Immunologic Factors|immunologic factors|mesh-ancestor
6405595|NCT00237900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405596|NCT00237900|Antidotes|antidotes|mesh-ancestor
6405597|NCT00237900|Protective Agents|protective agents|mesh-ancestor
6405598|NCT00237900|Vitamin B Complex|vitamin b complex|mesh-ancestor
6405599|NCT00237900|Vitamins|vitamins|mesh-ancestor
6405600|NCT00237900|Micronutrients|micronutrients|mesh-ancestor
6405601|NCT00237900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6405602|NCT00237900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6405603|NCT00237913|Olanzapine|olanzapine|mesh-list
6405604|NCT00237913|Risperidone|risperidone|mesh-list
6405605|NCT00237913|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6405606|NCT00237913|Aripiprazole|aripiprazole|mesh-list
6405607|NCT00237913|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6405608|NCT00237913|Serotonin Agents|serotonin agents|mesh-ancestor
6405609|NCT00237913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6405610|NCT00237913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6405611|NCT00237913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405612|NCT00237913|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6405613|NCT00237913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6405614|NCT00237913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6405615|NCT00237913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6405616|NCT00237913|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6405617|NCT00237913|Dopamine Agents|dopamine agents|mesh-ancestor
6405618|NCT00237913|Antiemetics|antiemetics|mesh-ancestor
6405619|NCT00237913|Autonomic Agents|autonomic agents|mesh-ancestor
6405620|NCT00237913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6405621|NCT00237913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6405622|NCT00237913|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6405623|NCT00237913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6405624|NCT00237913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6405625|NCT00237913|Antidepressive Agents|antidepressive agents|mesh-ancestor
6405626|NCT00237913|Dopamine Agonists|dopamine agonists|mesh-ancestor
6405627|NCT00237913|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6405628|NCT00237913|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6405629|NCT00237913|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6405630|NCT00237913|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6405631|NCT00237939|Aripiprazole|aripiprazole|mesh-list
6018718|NCT00381862|Vitamins|vitamins|mesh-ancestor
6405632|NCT00237939|Antidepressive Agents|antidepressive agents|mesh-ancestor
6405633|NCT00237939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6405634|NCT00237939|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6405635|NCT00237939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6405636|NCT00237939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6405637|NCT00237939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405638|NCT00237939|Dopamine Agonists|dopamine agonists|mesh-ancestor
6405639|NCT00237939|Dopamine Agents|dopamine agents|mesh-ancestor
6405640|NCT00237939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6405641|NCT00237939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6405642|NCT00237939|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6405643|NCT00237939|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6405644|NCT00237939|Serotonin Agents|serotonin agents|mesh-ancestor
6405645|NCT00237939|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6405646|NCT00237939|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6405647|NCT00237939|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6405648|NCT00237939|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6405649|NCT00237952|Chelating Agents|chelating agents|mesh-list
6405650|NCT00237952|Sequestering Agents|sequestering agents|mesh-ancestor
6405651|NCT00237952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459477|NCT00445081|Prednisolone|prednisolone|mesh-list
6459478|NCT00445081|Cyclosporins|cyclosporins|mesh-list
6459479|NCT00445081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6459480|NCT00445081|Glucocorticoids|glucocorticoids|mesh-ancestor
6459481|NCT00445081|Hormones|hormones|mesh-ancestor
6459482|NCT00445081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6459483|NCT00445081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459484|NCT00445081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6459485|NCT00445081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6459486|NCT00445081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6459487|NCT00445081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459488|NCT00445081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6459489|NCT00445081|Immunologic Factors|immunologic factors|mesh-ancestor
6459490|NCT00445081|Antifungal Agents|antifungal agents|mesh-ancestor
6459491|NCT00445081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6459492|NCT00445081|Dermatologic Agents|dermatologic agents|mesh-ancestor
6459493|NCT00445081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6459494|NCT00445081|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6459495|NCT00445094|Vancomycin|vancomycin|mesh-list
6459496|NCT00445094|Imipenem|imipenem|mesh-list
6459497|NCT00445094|Amikacin|amikacin|mesh-list
6459498|NCT00445094|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
6459499|NCT00445094|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
6459500|NCT00445094|Cilastatin|cilastatin|mesh-list
6459501|NCT00445094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6459502|NCT00445094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6459503|NCT00445094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459504|NCT00445094|Protease Inhibitors|protease inhibitors|mesh-ancestor
6459505|NCT00445094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6459506|NCT00445094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6459507|NCT00445159|Treprostinil|treprostinil|mesh-list
6459508|NCT00445159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6459509|NCT00445185|Vaccines|vaccines|mesh-list
6459510|NCT00445185|Immunologic Factors|immunologic factors|mesh-ancestor
6459511|NCT00445185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459512|NCT00445250|Calcipotriene|calcipotriene|mesh-list
6459513|NCT00445250|Dermatologic Agents|dermatologic agents|mesh-ancestor
6459514|NCT00445276|Diacetylrhein|diacetylrhein|mesh-list
6459515|NCT00445276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6459516|NCT00445406|Bevacizumab|bevacizumab|mesh-list
6459517|NCT00445406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6459518|NCT00445406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6459519|NCT00445406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6459520|NCT00445406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6459521|NCT00445406|Growth Substances|growth substances|mesh-ancestor
6405652|NCT00238004|Nicotinic Acids|nicotinic acids|mesh-list
6405653|NCT00238004|Niacin|niacin|mesh-list
6405654|NCT00238004|Niacinamide|niacinamide|mesh-list
6405655|NCT00238004|Vitamin B Complex|vitamin b complex|mesh-ancestor
6405656|NCT00238004|Vitamins|vitamins|mesh-ancestor
6405657|NCT00238004|Micronutrients|micronutrients|mesh-ancestor
6405658|NCT00238004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405659|NCT00238004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6405660|NCT00238004|Antimetabolites|antimetabolites|mesh-ancestor
6405661|NCT00238004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6405662|NCT00238004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6405663|NCT00238004|Vasodilator Agents|vasodilator agents|mesh-ancestor
6405664|NCT00238017|Artesunate|artesunate|mesh-list
6405665|NCT00238017|Amodiaquine|amodiaquine|mesh-list
6405666|NCT00238017|Antimalarials|antimalarials|mesh-ancestor
6405667|NCT00238017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6405668|NCT00238017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6405669|NCT00238017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6405670|NCT00238017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6405671|NCT00238017|Antiviral Agents|antiviral agents|mesh-ancestor
6405672|NCT00238017|Schistosomicides|schistosomicides|mesh-ancestor
6405673|NCT00238017|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6405674|NCT00238017|Anthelmintics|anthelmintics|mesh-ancestor
6405675|NCT00238043|Epoetin Alfa|epoetin alfa|mesh-list
6405676|NCT00238043|Hematinics|hematinics|mesh-ancestor
6405677|NCT00238056|Domperidone|domperidone|mesh-list
6405678|NCT00238056|Antiemetics|antiemetics|mesh-ancestor
6405679|NCT00238056|Autonomic Agents|autonomic agents|mesh-ancestor
6405680|NCT00238056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6405681|NCT00238056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405682|NCT00238056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6405683|NCT00238056|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6405684|NCT00238056|Dopamine Agents|dopamine agents|mesh-ancestor
6405685|NCT00238056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6405686|NCT00238056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6405687|NCT00238082|Beclomethasone|beclomethasone|mesh-list
6405688|NCT00238082|Norflurane|norflurane|mesh-list
6405689|NCT00238082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6405690|NCT00238082|Glucocorticoids|glucocorticoids|mesh-ancestor
6405691|NCT00238082|Hormones|hormones|mesh-ancestor
6405692|NCT00238082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6405693|NCT00238082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405694|NCT00238082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6405695|NCT00238082|Respiratory System Agents|respiratory system agents|mesh-ancestor
6405696|NCT00238082|Anesthetics|anesthetics|mesh-ancestor
6405697|NCT00238082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6405698|NCT00238147|Carboplatin|carboplatin|mesh-list
6405699|NCT00238147|Docetaxel|docetaxel|mesh-list
6405700|NCT00238147|Capecitabine|capecitabine|mesh-list
6405701|NCT00238147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6405702|NCT00238147|Tubulin Modulators|tubulin modulators|mesh-ancestor
6405703|NCT00238147|Antimitotic Agents|antimitotic agents|mesh-ancestor
6405704|NCT00238147|Mitosis Modulators|mitosis modulators|mesh-ancestor
6405705|NCT00238147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6405706|NCT00238147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6405707|NCT00238147|Antimetabolites|antimetabolites|mesh-ancestor
6405708|NCT00238160|Fluorouracil|fluorouracil|mesh-list
6405709|NCT00238160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6405710|NCT00238160|Antimetabolites|antimetabolites|mesh-ancestor
6405711|NCT00238160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6405712|NCT00238160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6405713|NCT00238160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6405714|NCT00238160|Immunologic Factors|immunologic factors|mesh-ancestor
6405715|NCT00238160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405716|NCT00238173|Acetylcysteine|acetylcysteine|mesh-list
6405717|NCT00238173|Sodium thiosulfate|sodium thiosulfate|mesh-list
6405718|NCT00238173|Cyclophosphamide|cyclophosphamide|mesh-list
6405719|NCT00238173|Carboplatin|carboplatin|mesh-list
6405720|NCT00238173|Etoposide|etoposide|mesh-list
6405721|NCT00238173|Etoposide phosphate|etoposide phosphate|mesh-list
6405722|NCT00238173|Mannitol|mannitol|mesh-list
6405723|NCT00238173|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6405724|NCT00238173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6405725|NCT00238173|Immunologic Factors|immunologic factors|mesh-ancestor
6405726|NCT00238173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405727|NCT00238173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6405728|NCT00238173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6405729|NCT00238173|Alkylating Agents|alkylating agents|mesh-ancestor
6405730|NCT00238173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6405731|NCT00238173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6405732|NCT00238173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6405733|NCT00238173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6405734|NCT00238173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6405735|NCT00238173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6405736|NCT00238173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6405737|NCT00238173|Antiviral Agents|antiviral agents|mesh-ancestor
6405738|NCT00238173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6405739|NCT00238173|Expectorants|expectorants|mesh-ancestor
6405740|NCT00238173|Respiratory System Agents|respiratory system agents|mesh-ancestor
6405741|NCT00238173|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6405742|NCT00238173|Antioxidants|antioxidants|mesh-ancestor
6405743|NCT00238173|Protective Agents|protective agents|mesh-ancestor
6405744|NCT00238173|Antidotes|antidotes|mesh-ancestor
6405745|NCT00238173|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6405746|NCT00238173|Diuretics|diuretics|mesh-ancestor
6405747|NCT00238173|Natriuretic Agents|natriuretic agents|mesh-ancestor
6405748|NCT00238173|Antitubercular Agents|antitubercular agents|mesh-ancestor
6405749|NCT00238173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6405750|NCT00238173|Chelating Agents|chelating agents|mesh-ancestor
6405751|NCT00238173|Sequestering Agents|sequestering agents|mesh-ancestor
6405752|NCT00238199|Calcitriol|calcitriol|mesh-list
6405753|NCT00238199|Docetaxel|docetaxel|mesh-list
6405754|NCT00238199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6405755|NCT00238199|Tubulin Modulators|tubulin modulators|mesh-ancestor
6405756|NCT00238199|Antimitotic Agents|antimitotic agents|mesh-ancestor
6405757|NCT00238199|Mitosis Modulators|mitosis modulators|mesh-ancestor
6405758|NCT00238199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6405759|NCT00238199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6405760|NCT00238199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405761|NCT00238199|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6405762|NCT00238199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6405763|NCT00238199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6405764|NCT00238199|Vitamins|vitamins|mesh-ancestor
6405765|NCT00238199|Micronutrients|micronutrients|mesh-ancestor
6405766|NCT00238199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6405767|NCT00238212|Sorafenib|sorafenib|mesh-list
6405768|NCT00238212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6405769|NCT00238212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6405770|NCT00238212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6405771|NCT00238212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6405772|NCT00238225|Calcitriol|calcitriol|mesh-list
6405773|NCT00238225|Ketoconazole|ketoconazole|mesh-list
6405774|NCT00238225|Dexamethasone|dexamethasone|mesh-list
6405775|NCT00238225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6405776|NCT00238225|Antiemetics|antiemetics|mesh-ancestor
6405777|NCT00238225|Autonomic Agents|autonomic agents|mesh-ancestor
6405778|NCT00238225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6405779|NCT00238225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405780|NCT00238225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6405781|NCT00238225|Glucocorticoids|glucocorticoids|mesh-ancestor
6405782|NCT00238225|Hormones|hormones|mesh-ancestor
6405783|NCT00238225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6405784|NCT00238225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6405785|NCT00238225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6405786|NCT00238225|Antifungal Agents|antifungal agents|mesh-ancestor
6405787|NCT00238225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6405788|NCT00238225|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6405789|NCT00238225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6405790|NCT00238225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6405791|NCT00238225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6405792|NCT00238225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6405793|NCT00238225|Hormone Antagonists|hormone antagonists|mesh-ancestor
6405794|NCT00238225|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6405795|NCT00238225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6405796|NCT00238225|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6405797|NCT00238225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6405798|NCT00238225|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6405799|NCT00238225|Vitamins|vitamins|mesh-ancestor
6405800|NCT00238225|Micronutrients|micronutrients|mesh-ancestor
6405801|NCT00238225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6405802|NCT00238251|Temozolomide|temozolomide|mesh-list
6405803|NCT00238251|Gefitinib|gefitinib|mesh-list
6405804|NCT00238251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6405805|NCT00238251|Alkylating Agents|alkylating agents|mesh-ancestor
6405806|NCT00238251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6405807|NCT00238251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6405808|NCT00238251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6405809|NCT00238251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6405810|NCT00238277|Temozolomide|temozolomide|mesh-list
6405811|NCT00238277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6405812|NCT00238277|Alkylating Agents|alkylating agents|mesh-ancestor
6405813|NCT00238277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6405814|NCT00238277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6405815|NCT00238290|Trastuzumab|trastuzumab|mesh-list
6405816|NCT00238290|Letrozole|letrozole|mesh-list
6405817|NCT00238290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6405818|NCT00238290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6405819|NCT00238290|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6405820|NCT00238290|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6405821|NCT00238290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6405822|NCT00238290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6405823|NCT00238290|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6405824|NCT00238290|Hormone Antagonists|hormone antagonists|mesh-ancestor
6405825|NCT00238290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6405826|NCT00238290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405827|NCT00238316|Letrozole|letrozole|mesh-list
6405828|NCT00238316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6405829|NCT00238316|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6405830|NCT00238316|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6405831|NCT00238316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6405832|NCT00238316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6405833|NCT00238316|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6405834|NCT00238316|Hormone Antagonists|hormone antagonists|mesh-ancestor
6405835|NCT00238316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6405836|NCT00238316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405837|NCT00238329|Interferons|interferons|mesh-list
6405838|NCT00238329|Interferon-alpha|interferon-alpha|mesh-list
6405839|NCT00238329|Interferon alpha-2|interferon alpha-2|mesh-list
6405840|NCT00238329|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6405841|NCT00238329|Thalidomide|thalidomide|mesh-list
6405842|NCT00238329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6405843|NCT00238329|Antiviral Agents|antiviral agents|mesh-ancestor
6405844|NCT00238329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6405845|NCT00238329|Immunologic Factors|immunologic factors|mesh-ancestor
6405846|NCT00238329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405847|NCT00238329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6405848|NCT00238329|Leprostatic Agents|leprostatic agents|mesh-ancestor
6405849|NCT00238329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6405850|NCT00238329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6405851|NCT00238329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6405852|NCT00238329|Growth Substances|growth substances|mesh-ancestor
6405853|NCT00238329|Growth Inhibitors|growth inhibitors|mesh-ancestor
6405854|NCT00238368|Cytarabine|cytarabine|mesh-list
6405855|NCT00238368|Prednisone|prednisone|mesh-list
6405856|NCT00238368|Methylprednisolone|methylprednisolone|mesh-list
6405857|NCT00238368|Cyclophosphamide|cyclophosphamide|mesh-list
6405858|NCT00238368|Busulfan|busulfan|mesh-list
6405859|NCT00238368|Rituximab|rituximab|mesh-list
6405860|NCT00238368|Doxorubicin|doxorubicin|mesh-list
6405861|NCT00238368|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6405862|NCT00238368|Etoposide|etoposide|mesh-list
6405863|NCT00238368|Vincristine|vincristine|mesh-list
6405864|NCT00238368|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6405865|NCT00238368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6405866|NCT00238368|Immunologic Factors|immunologic factors|mesh-ancestor
6405867|NCT00238368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405868|NCT00238368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6405869|NCT00238368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6405870|NCT00238368|Alkylating Agents|alkylating agents|mesh-ancestor
6405871|NCT00238368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6405872|NCT00238368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6405873|NCT00238368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6405874|NCT00238368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6405875|NCT00238368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6405876|NCT00238368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6405877|NCT00238368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6405878|NCT00238368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6405879|NCT00238368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6405880|NCT00238368|Glucocorticoids|glucocorticoids|mesh-ancestor
6405881|NCT00238368|Hormones|hormones|mesh-ancestor
6405882|NCT00238368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6405883|NCT00238368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6405884|NCT00238368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6405885|NCT00238368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6405886|NCT00238368|Antimetabolites|antimetabolites|mesh-ancestor
6405887|NCT00238368|Antiviral Agents|antiviral agents|mesh-ancestor
6405888|NCT00238368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6405889|NCT00238368|Tubulin Modulators|tubulin modulators|mesh-ancestor
6405890|NCT00238368|Antimitotic Agents|antimitotic agents|mesh-ancestor
6405891|NCT00238368|Mitosis Modulators|mitosis modulators|mesh-ancestor
6405892|NCT00238368|Antiemetics|antiemetics|mesh-ancestor
6405893|NCT00238368|Autonomic Agents|autonomic agents|mesh-ancestor
6405894|NCT00238368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6405895|NCT00238368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6405896|NCT00238368|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6405897|NCT00238368|Protective Agents|protective agents|mesh-ancestor
6405898|NCT00238368|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6405899|NCT00238394|Cediranib|cediranib|mesh-list
6405900|NCT00238394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6405901|NCT00238394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6405902|NCT00238394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6405903|NCT00238394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6405904|NCT00238407|Docetaxel|docetaxel|mesh-list
6405905|NCT00238407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6405906|NCT00238407|Tubulin Modulators|tubulin modulators|mesh-ancestor
6405907|NCT00238407|Antimitotic Agents|antimitotic agents|mesh-ancestor
6405908|NCT00238407|Mitosis Modulators|mitosis modulators|mesh-ancestor
6405909|NCT00238407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6405910|NCT00238459|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6405911|NCT00238459|Vaccines|vaccines|mesh-list
6405912|NCT00238459|Immunologic Factors|immunologic factors|mesh-ancestor
6405913|NCT00238459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405914|NCT00238459|Antiviral Agents|antiviral agents|mesh-ancestor
6405915|NCT00238459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6405916|NCT00238472|Nateglinide|nateglinide|mesh-list
6405917|NCT00238472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6405918|NCT00238472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405919|NCT00238498|Vildagliptin|vildagliptin|mesh-list
6405920|NCT00238498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6405921|NCT00238498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405922|NCT00238498|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6405923|NCT00238498|Protease Inhibitors|protease inhibitors|mesh-ancestor
6405924|NCT00238498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6405925|NCT00238498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6405926|NCT00238537|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6405927|NCT00238537|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6405928|NCT00238537|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6405929|NCT00238537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6405930|NCT00238563|Triamcinolone|triamcinolone|mesh-list
6405931|NCT00238563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6405932|NCT00238563|Glucocorticoids|glucocorticoids|mesh-ancestor
6405933|NCT00238563|Hormones|hormones|mesh-ancestor
6405934|NCT00238563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6405935|NCT00238563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405936|NCT00238628|Bexarotene|bexarotene|mesh-list
6405937|NCT00238628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6405938|NCT00238641|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
6405939|NCT00238641|Botulinum Toxins|botulinum toxins|mesh-list
6405940|NCT00238641|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6405941|NCT00238641|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6405942|NCT00238641|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6405943|NCT00238641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6405944|NCT00238641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6405945|NCT00238641|Cholinergic Agents|cholinergic agents|mesh-ancestor
6405946|NCT00238641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6405947|NCT00238641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405948|NCT00238641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6405949|NCT00238641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6405950|NCT00238641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6405951|NCT00238667|Aspirin|aspirin|mesh-list
6405952|NCT00238667|Heparin|heparin|mesh-list
6405953|NCT00238667|Calcium heparin|calcium heparin|mesh-list
6405954|NCT00238667|Dipyridamole|dipyridamole|mesh-list
6405955|NCT00238667|Warfarin|warfarin|mesh-list
6405956|NCT00238667|Anticoagulants|anticoagulants|mesh-list
6405957|NCT00238667|Clopidogrel|clopidogrel|mesh-list
6405958|NCT00238667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6405959|NCT00238667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6405960|NCT00238667|Analgesics|analgesics|mesh-ancestor
6405961|NCT00238667|Sensory System Agents|sensory system agents|mesh-ancestor
6405962|NCT00238667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6405963|NCT00238667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405964|NCT00238667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6405965|NCT00238667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6405966|NCT00238667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6405967|NCT00238667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6405968|NCT00238667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6405969|NCT00238667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6405970|NCT00238667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6405971|NCT00238667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6405972|NCT00238667|Antipyretics|antipyretics|mesh-ancestor
6405973|NCT00238667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6405974|NCT00238667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6405975|NCT00238667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6405976|NCT00238667|Purinergic Agents|purinergic agents|mesh-ancestor
6405977|NCT00238667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6405978|NCT00238667|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6405979|NCT00238667|Vasodilator Agents|vasodilator agents|mesh-ancestor
6405980|NCT00238719|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6405981|NCT00238719|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6405982|NCT00238719|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6405983|NCT00238719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6405984|NCT00238719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6405985|NCT00238719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6405986|NCT00238719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405987|NCT00238719|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6405988|NCT00238719|Antidepressive Agents|antidepressive agents|mesh-ancestor
6405989|NCT00238719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6405990|NCT00238732|Bazedoxifene|bazedoxifene|mesh-list
6405991|NCT00238732|Estrogens|estrogens|mesh-list
6405992|NCT00238732|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6405993|NCT00238732|Hormones|hormones|mesh-ancestor
6405994|NCT00238732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6405995|NCT00238732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6405996|NCT00238732|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6405997|NCT00238732|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6405998|NCT00238732|Hormone Antagonists|hormone antagonists|mesh-ancestor
6405999|NCT00238732|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6406000|NCT00238745|Bazedoxifene|bazedoxifene|mesh-list
6406001|NCT00238745|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6406002|NCT00238745|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6406003|NCT00238745|Hormone Antagonists|hormone antagonists|mesh-ancestor
6406004|NCT00238745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6406005|NCT00238745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406006|NCT00238745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6406007|NCT00238784|Budesonide|budesonide|mesh-list
6406008|NCT00238784|Formoterol Fumarate|formoterol fumarate|mesh-list
6406009|NCT00238784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6406010|NCT00238784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6406011|NCT00238784|Autonomic Agents|autonomic agents|mesh-ancestor
6406012|NCT00238784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6406013|NCT00238784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406014|NCT00238784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6406015|NCT00238784|Respiratory System Agents|respiratory system agents|mesh-ancestor
6406016|NCT00238784|Glucocorticoids|glucocorticoids|mesh-ancestor
6406017|NCT00238784|Hormones|hormones|mesh-ancestor
6406018|NCT00238784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6406019|NCT00238784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6406020|NCT00238784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6406021|NCT00238784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6406022|NCT00238784|Adrenergic Agents|adrenergic agents|mesh-ancestor
6406023|NCT00238784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6406024|NCT00238784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406025|NCT00238797|Gefitinib|gefitinib|mesh-list
6406026|NCT00238797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6406027|NCT00238797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6406028|NCT00238797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6406029|NCT00238797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406030|NCT00238849|Oxaliplatin|oxaliplatin|mesh-list
6406031|NCT00238849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6406032|NCT00238901|Basiliximab|basiliximab|mesh-list
6406033|NCT00238901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6406034|NCT00238901|Immunologic Factors|immunologic factors|mesh-ancestor
6406035|NCT00238901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406036|NCT00238914|Naltrexone|naltrexone|mesh-list
6406037|NCT00238914|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6406038|NCT00238914|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6406039|NCT00238914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406040|NCT00238914|Sensory System Agents|sensory system agents|mesh-ancestor
6406041|NCT00238914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6406042|NCT00238927|Fluticasone|fluticasone|mesh-list
6406043|NCT00238927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6406044|NCT00238927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6406045|NCT00238927|Autonomic Agents|autonomic agents|mesh-ancestor
6406046|NCT00238927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6406047|NCT00238927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406048|NCT00238927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6406049|NCT00238927|Respiratory System Agents|respiratory system agents|mesh-ancestor
6406050|NCT00238927|Dermatologic Agents|dermatologic agents|mesh-ancestor
6406051|NCT00238927|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6406052|NCT00238940|Mycophenolic Acid|mycophenolic acid|mesh-list
6406053|NCT00238940|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6406054|NCT00238940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6406055|NCT00238940|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6406056|NCT00238940|Antitubercular Agents|antitubercular agents|mesh-ancestor
6406057|NCT00238940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6406058|NCT00238940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6406059|NCT00238940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6406060|NCT00238940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406061|NCT00238953|Mycophenolic Acid|mycophenolic acid|mesh-list
6406062|NCT00238953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6406063|NCT00238953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6406064|NCT00238953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6406065|NCT00238953|Antitubercular Agents|antitubercular agents|mesh-ancestor
6406066|NCT00238953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6406067|NCT00238953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6406068|NCT00238953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6406069|NCT00238953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406070|NCT00238966|Mycophenolic Acid|mycophenolic acid|mesh-list
6406071|NCT00238966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6406072|NCT00238966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6406073|NCT00238966|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6406074|NCT00238966|Antitubercular Agents|antitubercular agents|mesh-ancestor
6406075|NCT00238966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6406076|NCT00238966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6406077|NCT00238966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6406078|NCT00238966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406079|NCT00238979|Mycophenolic Acid|mycophenolic acid|mesh-list
6406080|NCT00238979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6406081|NCT00238979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6406082|NCT00238979|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6406083|NCT00238979|Antitubercular Agents|antitubercular agents|mesh-ancestor
6406084|NCT00238979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6406085|NCT00238979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6406086|NCT00238979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6406087|NCT00238979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406088|NCT00238992|Mycophenolic Acid|mycophenolic acid|mesh-list
6406089|NCT00238992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6406090|NCT00238992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6406091|NCT00238992|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6406092|NCT00238992|Antitubercular Agents|antitubercular agents|mesh-ancestor
6406093|NCT00238992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6406094|NCT00238992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6406095|NCT00238992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6406096|NCT00238992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406097|NCT00239018|Mycophenolic Acid|mycophenolic acid|mesh-list
6406098|NCT00239018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6406099|NCT00239018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6406100|NCT00239018|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6406101|NCT00239018|Antitubercular Agents|antitubercular agents|mesh-ancestor
6406102|NCT00239018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6406103|NCT00239018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6406104|NCT00239018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6406105|NCT00239018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406106|NCT00239031|Mycophenolic Acid|mycophenolic acid|mesh-list
6406107|NCT00239031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6406108|NCT00239031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6406109|NCT00239031|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6406110|NCT00239031|Antitubercular Agents|antitubercular agents|mesh-ancestor
6406111|NCT00239031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6406112|NCT00239031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6406113|NCT00239031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6406114|NCT00239031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406115|NCT00239044|Mycophenolic Acid|mycophenolic acid|mesh-list
6406116|NCT00239044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6406117|NCT00239044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6406118|NCT00239044|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6406119|NCT00239044|Antitubercular Agents|antitubercular agents|mesh-ancestor
6406120|NCT00239044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6406121|NCT00239044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6406122|NCT00239044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6406123|NCT00239044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406124|NCT00239057|Mycophenolic Acid|mycophenolic acid|mesh-list
6406125|NCT00239057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6406126|NCT00239057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6406127|NCT00239057|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6406128|NCT00239057|Antitubercular Agents|antitubercular agents|mesh-ancestor
6406129|NCT00239057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6406130|NCT00239057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6406131|NCT00239057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6406132|NCT00239057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406133|NCT00239070|Mycophenolic Acid|mycophenolic acid|mesh-list
6406134|NCT00239070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6406135|NCT00239070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6406136|NCT00239070|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6406137|NCT00239070|Antitubercular Agents|antitubercular agents|mesh-ancestor
6406138|NCT00239070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6406139|NCT00239070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6406140|NCT00239070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6406141|NCT00239070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406142|NCT00239083|Mycophenolic Acid|mycophenolic acid|mesh-list
6406143|NCT00239083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6406144|NCT00239083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6406145|NCT00239083|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6406146|NCT00239083|Antitubercular Agents|antitubercular agents|mesh-ancestor
6406147|NCT00239083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6406148|NCT00239083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6406149|NCT00239083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6018719|NCT00381862|Micronutrients|micronutrients|mesh-ancestor
6406150|NCT00239083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406151|NCT00239096|Losartan|losartan|mesh-list
6406152|NCT00239096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6406153|NCT00239096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6406154|NCT00239096|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6406155|NCT00239096|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6406156|NCT00239096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406157|NCT00239109|Olanzapine|olanzapine|mesh-list
6406158|NCT00239109|Ziprasidone|ziprasidone|mesh-list
6406159|NCT00239109|Antiemetics|antiemetics|mesh-ancestor
6406160|NCT00239109|Autonomic Agents|autonomic agents|mesh-ancestor
6406161|NCT00239109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6406162|NCT00239109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406163|NCT00239109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6406164|NCT00239109|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6406165|NCT00239109|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6406166|NCT00239109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6406167|NCT00239109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6406168|NCT00239109|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6406169|NCT00239109|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6406170|NCT00239109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6406171|NCT00239109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406172|NCT00239109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6406173|NCT00239109|Serotonin Agents|serotonin agents|mesh-ancestor
6406174|NCT00239109|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6406175|NCT00239109|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6406176|NCT00239109|Dopamine Agents|dopamine agents|mesh-ancestor
6406177|NCT00239161|Levofloxacin|levofloxacin|mesh-list
6406178|NCT00239161|Ofloxacin|ofloxacin|mesh-list
6406179|NCT00239161|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6406180|NCT00239161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6406181|NCT00239161|Renal Agents|renal agents|mesh-ancestor
6406182|NCT00239161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6406183|NCT00239161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6406184|NCT00239161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6406185|NCT00239161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6406186|NCT00239161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406187|NCT00239161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6406188|NCT00239161|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6406189|NCT00239161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6406190|NCT00239174|Surinabant|surinabant|mesh-list
6406191|NCT00239174|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
6406192|NCT00239174|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6406193|NCT00239174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6406194|NCT00239174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406195|NCT00239174|Hormones|hormones|mesh-ancestor
6406196|NCT00239174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6406197|NCT00239174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406198|NCT00239200|Lapatinib|lapatinib|mesh-list
6406199|NCT00239200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6406200|NCT00239200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6406201|NCT00239200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6406202|NCT00239200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406203|NCT00239239|Darbepoetin alfa|darbepoetin alfa|mesh-list
6406204|NCT00239239|Hematinics|hematinics|mesh-ancestor
6406205|NCT00239252|Interferons|interferons|mesh-list
6406206|NCT00239252|Interferon alfacon-1|interferon alfacon-1|mesh-list
6406207|NCT00239252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6406208|NCT00239252|Antiviral Agents|antiviral agents|mesh-ancestor
6406209|NCT00239252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6406210|NCT00239278|Prednisolone|prednisolone|mesh-list
6406211|NCT00239278|Budesonide|budesonide|mesh-list
6406212|NCT00239278|Formoterol Fumarate|formoterol fumarate|mesh-list
6406213|NCT00239278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6406214|NCT00239278|Glucocorticoids|glucocorticoids|mesh-ancestor
6406215|NCT00239278|Hormones|hormones|mesh-ancestor
6406216|NCT00239278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6406217|NCT00239278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406218|NCT00239278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6406219|NCT00239278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6406220|NCT00239278|Autonomic Agents|autonomic agents|mesh-ancestor
6406221|NCT00239278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6406222|NCT00239278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6406223|NCT00239278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6406224|NCT00239278|Respiratory System Agents|respiratory system agents|mesh-ancestor
6018720|NCT00381862|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6018721|NCT00381862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6018722|NCT00381862|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6018723|NCT00381862|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6018724|NCT00381862|Serotonin Agents|serotonin agents|mesh-ancestor
6018725|NCT00381862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6018726|NCT00381888|PENTA|penta|mesh-list
6018727|NCT00381888|Fondaparinux|fondaparinux|mesh-list
6018728|NCT00381888|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6018729|NCT00381888|Antithrombins|antithrombins|mesh-ancestor
6018730|NCT00381888|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6018731|NCT00381888|Protease Inhibitors|protease inhibitors|mesh-ancestor
6018732|NCT00381888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6018733|NCT00381888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6018734|NCT00381888|Anticoagulants|anticoagulants|mesh-ancestor
6406225|NCT00239278|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6406226|NCT00239278|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6406227|NCT00239278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6406228|NCT00239278|Adrenergic Agents|adrenergic agents|mesh-ancestor
6406229|NCT00239278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6406230|NCT00239278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406231|NCT00239291|Gefitinib|gefitinib|mesh-list
6406232|NCT00239291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6406233|NCT00239291|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6406234|NCT00239291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6406235|NCT00239291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406236|NCT00239304|Gefitinib|gefitinib|mesh-list
6406237|NCT00239304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6406238|NCT00239304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6406239|NCT00239304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6406240|NCT00239304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406241|NCT00239330|Atorvastatin|atorvastatin|mesh-list
6406242|NCT00239330|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6406243|NCT00239330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6406244|NCT00239330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6406245|NCT00239330|Antimetabolites|antimetabolites|mesh-ancestor
6406246|NCT00239330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406247|NCT00239330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6406248|NCT00239330|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6406249|NCT00239330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6406250|NCT00239343|Gefitinib|gefitinib|mesh-list
6406251|NCT00239343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6406252|NCT00239343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6406253|NCT00239343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6406254|NCT00239343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406255|NCT00239369|Telmisartan|telmisartan|mesh-list
6406256|NCT00239369|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6406257|NCT00239369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6406258|NCT00239369|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6406259|NCT00239369|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6406260|NCT00239369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406261|NCT00239369|Diuretics|diuretics|mesh-ancestor
6406262|NCT00239369|Natriuretic Agents|natriuretic agents|mesh-ancestor
6406263|NCT00239369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406264|NCT00239369|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6406265|NCT00239369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6406266|NCT00239382|Meloxicam|meloxicam|mesh-list
6406267|NCT00239382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6406268|NCT00239382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6406269|NCT00239382|Analgesics|analgesics|mesh-ancestor
6406270|NCT00239382|Sensory System Agents|sensory system agents|mesh-ancestor
6406271|NCT00239382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6406272|NCT00239382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406273|NCT00239382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6406274|NCT00239382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6406275|NCT00239382|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6406276|NCT00239382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6406277|NCT00239382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6406278|NCT00239382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406279|NCT00239395|Meloxicam|meloxicam|mesh-list
6406280|NCT00239395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6406281|NCT00239395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6406282|NCT00239395|Analgesics|analgesics|mesh-ancestor
6406283|NCT00239395|Sensory System Agents|sensory system agents|mesh-ancestor
6406284|NCT00239395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6406285|NCT00239395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406286|NCT00239395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6406287|NCT00239395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6406288|NCT00239395|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6406289|NCT00239395|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6406290|NCT00239395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6406291|NCT00239395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406292|NCT00239408|Bromides|bromides|mesh-list
6406293|NCT00239408|Tiotropium Bromide|tiotropium bromide|mesh-list
6406294|NCT00239408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6406295|NCT00239408|Autonomic Agents|autonomic agents|mesh-ancestor
6406296|NCT00239408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6406297|NCT00239408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406298|NCT00239408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6406299|NCT00239408|Respiratory System Agents|respiratory system agents|mesh-ancestor
6406300|NCT00239408|Parasympatholytics|parasympatholytics|mesh-ancestor
6406301|NCT00239408|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6406302|NCT00239408|Cholinergic Agents|cholinergic agents|mesh-ancestor
6406303|NCT00239408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6406304|NCT00239408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406305|NCT00239408|Anticonvulsants|anticonvulsants|mesh-ancestor
6406306|NCT00239421|Fluticasone|fluticasone|mesh-list
6406307|NCT00239421|Xhance|xhance|mesh-list
6406308|NCT00239421|Formoterol Fumarate|formoterol fumarate|mesh-list
6406309|NCT00239421|Tiotropium Bromide|tiotropium bromide|mesh-list
6406310|NCT00239421|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6406311|NCT00239421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6406312|NCT00239421|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6406313|NCT00239421|Autonomic Agents|autonomic agents|mesh-ancestor
6406314|NCT00239421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6406315|NCT00239421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406316|NCT00239421|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6406317|NCT00239421|Respiratory System Agents|respiratory system agents|mesh-ancestor
6406318|NCT00239421|Dermatologic Agents|dermatologic agents|mesh-ancestor
6406319|NCT00239421|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6406320|NCT00239421|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6406321|NCT00239421|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6406322|NCT00239421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6406323|NCT00239421|Adrenergic Agents|adrenergic agents|mesh-ancestor
6406324|NCT00239421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6406325|NCT00239421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406326|NCT00239421|Parasympatholytics|parasympatholytics|mesh-ancestor
6406327|NCT00239421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6406328|NCT00239421|Cholinergic Agents|cholinergic agents|mesh-ancestor
6406329|NCT00239434|Bromides|bromides|mesh-list
6406330|NCT00239434|Tiotropium Bromide|tiotropium bromide|mesh-list
6406331|NCT00239434|Ipratropium|ipratropium|mesh-list
6406332|NCT00239434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6406333|NCT00239434|Autonomic Agents|autonomic agents|mesh-ancestor
6406334|NCT00239434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6406335|NCT00239434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406336|NCT00239434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6406337|NCT00239434|Respiratory System Agents|respiratory system agents|mesh-ancestor
6406338|NCT00239434|Parasympatholytics|parasympatholytics|mesh-ancestor
6406339|NCT00239434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6406340|NCT00239434|Cholinergic Agents|cholinergic agents|mesh-ancestor
6406341|NCT00239434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6406342|NCT00239434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406343|NCT00239434|Anticonvulsants|anticonvulsants|mesh-ancestor
6406344|NCT00239447|Tiotropium Bromide|tiotropium bromide|mesh-list
6406345|NCT00239447|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6406346|NCT00239447|Autonomic Agents|autonomic agents|mesh-ancestor
6406347|NCT00239447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6406348|NCT00239447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406349|NCT00239447|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6406350|NCT00239447|Respiratory System Agents|respiratory system agents|mesh-ancestor
6406351|NCT00239447|Parasympatholytics|parasympatholytics|mesh-ancestor
6406352|NCT00239447|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6406353|NCT00239447|Cholinergic Agents|cholinergic agents|mesh-ancestor
6406354|NCT00239447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6406355|NCT00239447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406356|NCT00239460|Tiotropium Bromide|tiotropium bromide|mesh-list
6406357|NCT00239460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6406358|NCT00239460|Autonomic Agents|autonomic agents|mesh-ancestor
6406359|NCT00239460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6406360|NCT00239460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406361|NCT00239460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6406362|NCT00239460|Respiratory System Agents|respiratory system agents|mesh-ancestor
6406363|NCT00239460|Parasympatholytics|parasympatholytics|mesh-ancestor
6406364|NCT00239460|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6406365|NCT00239460|Cholinergic Agents|cholinergic agents|mesh-ancestor
6406366|NCT00239460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6406367|NCT00239460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406368|NCT00239473|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6406369|NCT00239473|Tiotropium Bromide|tiotropium bromide|mesh-list
6406370|NCT00239473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6406371|NCT00239473|Autonomic Agents|autonomic agents|mesh-ancestor
6406372|NCT00239473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6406373|NCT00239473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406374|NCT00239473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6406375|NCT00239473|Respiratory System Agents|respiratory system agents|mesh-ancestor
6406376|NCT00239473|Parasympatholytics|parasympatholytics|mesh-ancestor
6406377|NCT00239473|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6406378|NCT00239473|Cholinergic Agents|cholinergic agents|mesh-ancestor
6406379|NCT00239473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6462028|NCT00457106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6406380|NCT00239473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406381|NCT00239486|Pramipexole|pramipexole|mesh-list
6406382|NCT00239486|Antioxidants|antioxidants|mesh-ancestor
6406383|NCT00239486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406384|NCT00239486|Protective Agents|protective agents|mesh-ancestor
6406385|NCT00239486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406386|NCT00239486|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6406387|NCT00239486|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6406388|NCT00239486|Dopamine Agonists|dopamine agonists|mesh-ancestor
6406389|NCT00239486|Dopamine Agents|dopamine agents|mesh-ancestor
6406390|NCT00239486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6459522|NCT00445406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459523|NCT00445406|Growth Inhibitors|growth inhibitors|mesh-ancestor
6459524|NCT00445497|Amoxicillin|amoxicillin|mesh-list
6459525|NCT00445497|Ciprofloxacin|ciprofloxacin|mesh-list
6459526|NCT00445497|Clavulanic Acid|clavulanic acid|mesh-list
6459527|NCT00445497|Clavulanic Acids|clavulanic acids|mesh-list
6459528|NCT00445497|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6459529|NCT00445497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6459530|NCT00445497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6459531|NCT00445497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6459532|NCT00445497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6459533|NCT00445497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6459534|NCT00445497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459535|NCT00445497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6459536|NCT00445497|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6459537|NCT00445497|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6459538|NCT00445497|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6459539|NCT00445510|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
6459540|NCT00445510|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6459541|NCT00445510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6459542|NCT00445510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6459543|NCT00445510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459544|NCT00445523|Interferons|interferons|mesh-list
6459545|NCT00445523|Interferon-alpha|interferon-alpha|mesh-list
6459546|NCT00445523|Vaccines|vaccines|mesh-list
6459547|NCT00445523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6459548|NCT00445523|Antiviral Agents|antiviral agents|mesh-ancestor
6459549|NCT00445523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6459550|NCT00445523|Immunologic Factors|immunologic factors|mesh-ancestor
6459551|NCT00445523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459552|NCT00445575|Risedronic Acid|risedronic acid|mesh-list
6459553|NCT00445575|Etidronic Acid|etidronic acid|mesh-list
6459554|NCT00445575|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6459555|NCT00445575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6459556|NCT00445575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459557|NCT00445575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6459558|NCT00445575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459559|NCT00445575|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6459560|NCT00445796|Artesunate|artesunate|mesh-list
6459561|NCT00445796|Amodiaquine|amodiaquine|mesh-list
6459562|NCT00445796|Antimalarials|antimalarials|mesh-ancestor
6459563|NCT00445796|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6406391|NCT00239499|Fluticasone|fluticasone|mesh-list
6406392|NCT00239499|Tiotropium Bromide|tiotropium bromide|mesh-list
6406393|NCT00239499|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6406394|NCT00239499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6406395|NCT00239499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6406396|NCT00239499|Autonomic Agents|autonomic agents|mesh-ancestor
6406397|NCT00239499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6406398|NCT00239499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406399|NCT00239499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6406400|NCT00239499|Respiratory System Agents|respiratory system agents|mesh-ancestor
6406401|NCT00239499|Dermatologic Agents|dermatologic agents|mesh-ancestor
6406402|NCT00239499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6406403|NCT00239499|Parasympatholytics|parasympatholytics|mesh-ancestor
6406404|NCT00239499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6406405|NCT00239499|Cholinergic Agents|cholinergic agents|mesh-ancestor
6406406|NCT00239499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6406407|NCT00239499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406408|NCT00239499|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6406409|NCT00239499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6406410|NCT00239499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6406411|NCT00239499|Adrenergic Agents|adrenergic agents|mesh-ancestor
6406412|NCT00239512|Ibuprofen|ibuprofen|mesh-list
6406413|NCT00239512|Indomethacin|indomethacin|mesh-list
6406414|NCT00239512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6406415|NCT00239512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6406416|NCT00239512|Analgesics|analgesics|mesh-ancestor
6406417|NCT00239512|Sensory System Agents|sensory system agents|mesh-ancestor
6406418|NCT00239512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6406419|NCT00239512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406420|NCT00239512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6406421|NCT00239512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6406422|NCT00239512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6406423|NCT00239512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6406424|NCT00239512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406425|NCT00239512|Gout Suppressants|gout suppressants|mesh-ancestor
6406426|NCT00239512|Tocolytic Agents|tocolytic agents|mesh-ancestor
6406427|NCT00239512|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6406428|NCT00239538|Valsartan|valsartan|mesh-list
6406429|NCT00239538|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6406430|NCT00239538|Telmisartan|telmisartan|mesh-list
6406431|NCT00239538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6406432|NCT00239538|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6406433|NCT00239538|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6406434|NCT00239538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406435|NCT00239538|Diuretics|diuretics|mesh-ancestor
6406436|NCT00239538|Natriuretic Agents|natriuretic agents|mesh-ancestor
6406437|NCT00239538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406438|NCT00239538|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6406439|NCT00239538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6406440|NCT00239551|Lansoprazole|lansoprazole|mesh-list
6406441|NCT00239551|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6406442|NCT00239551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6406443|NCT00239551|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6406444|NCT00239551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6406445|NCT00239551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406446|NCT00239616|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6406447|NCT00239616|Hematinics|hematinics|mesh-ancestor
6406448|NCT00239629|Teriparatide|teriparatide|mesh-list
6406449|NCT00239629|Strontium ranelate|strontium ranelate|mesh-list
6406450|NCT00239629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6406451|NCT00239629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406452|NCT00239629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6406453|NCT00239707|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
6406454|NCT00239707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6406455|NCT00239707|Incretins|incretins|mesh-ancestor
6406456|NCT00239707|Hormones|hormones|mesh-ancestor
6406457|NCT00239707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6406458|NCT00239707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406459|NCT00239746|Ibuprofen|ibuprofen|mesh-list
6406460|NCT00239746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6459564|NCT00445796|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6406461|NCT00239746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6406462|NCT00239746|Analgesics|analgesics|mesh-ancestor
6406463|NCT00239746|Sensory System Agents|sensory system agents|mesh-ancestor
6406464|NCT00239746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6406465|NCT00239746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406466|NCT00239746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6406467|NCT00239746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6406468|NCT00239746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6406469|NCT00239746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6406470|NCT00239746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406471|NCT00239785|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6406472|NCT00239785|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6406473|NCT00239785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406474|NCT00239785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6406475|NCT00239785|Immunologic Factors|immunologic factors|mesh-ancestor
6406476|NCT00239785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406477|NCT00239798|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6406478|NCT00239798|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6406479|NCT00239798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406480|NCT00239798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6406481|NCT00239798|Immunologic Factors|immunologic factors|mesh-ancestor
6406482|NCT00239798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406483|NCT00239811|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6406484|NCT00239811|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6406485|NCT00239811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406486|NCT00239811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6406487|NCT00239811|Immunologic Factors|immunologic factors|mesh-ancestor
6406488|NCT00239811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406489|NCT00239863|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6406490|NCT00239863|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6406491|NCT00239863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406492|NCT00239863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6406493|NCT00239863|Immunologic Factors|immunologic factors|mesh-ancestor
6406494|NCT00239863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406495|NCT00239876|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6406496|NCT00239876|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6406497|NCT00239876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406498|NCT00239876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6406499|NCT00239876|Immunologic Factors|immunologic factors|mesh-ancestor
6406500|NCT00239876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406501|NCT00239889|Calcitonin|calcitonin|mesh-list
6406502|NCT00239889|Salmon calcitonin|salmon calcitonin|mesh-list
6406503|NCT00239889|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
6406504|NCT00239889|Katacalcin|katacalcin|mesh-list
6406505|NCT00239889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6406506|NCT00239889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406507|NCT00239889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6406508|NCT00239889|Vasodilator Agents|vasodilator agents|mesh-ancestor
6406509|NCT00239902|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6406510|NCT00239902|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6406511|NCT00239902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406512|NCT00239902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6406513|NCT00239902|Immunologic Factors|immunologic factors|mesh-ancestor
6406514|NCT00239902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406515|NCT00239954|Citalopram|citalopram|mesh-list
6406516|NCT00239954|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6406517|NCT00239954|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6406518|NCT00239954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6406519|NCT00239954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406520|NCT00239954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6406521|NCT00239954|Serotonin Agents|serotonin agents|mesh-ancestor
6406522|NCT00239954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406523|NCT00239954|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6406524|NCT00239954|Antidepressive Agents|antidepressive agents|mesh-ancestor
6406525|NCT00239954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6406526|NCT00239967|Rimonabant|rimonabant|mesh-list
6406527|NCT00239967|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6406528|NCT00239967|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
6406529|NCT00239967|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6406530|NCT00239967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6406531|NCT00239967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406532|NCT00239967|Hormones|hormones|mesh-ancestor
6406533|NCT00239967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6406534|NCT00239967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406535|NCT00239980|Dalteparin|dalteparin|mesh-list
6406536|NCT00239980|Tinzaparin|tinzaparin|mesh-list
6406537|NCT00239980|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6406538|NCT00239980|Anticoagulants|anticoagulants|mesh-ancestor
6406539|NCT00239980|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6406540|NCT00239980|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6406541|NCT00239980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406542|NCT00239993|Glatiramer Acetate|glatiramer acetate|mesh-list
6406543|NCT00239993|(T,G)-A-L|(t,g)-a-l|mesh-list
6406544|NCT00239993|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6406545|NCT00239993|Immunologic Factors|immunologic factors|mesh-ancestor
6406546|NCT00239993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406547|NCT00239993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6406548|NCT00239993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6406549|NCT00240006|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6406550|NCT00240019|Furosemide|furosemide|mesh-list
6406551|NCT00240019|Diuretics|diuretics|mesh-ancestor
6406552|NCT00240019|Natriuretic Agents|natriuretic agents|mesh-ancestor
6406553|NCT00240019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406554|NCT00240019|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6406555|NCT00240019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6406556|NCT00240019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406557|NCT00240032|Cetirizine|cetirizine|mesh-list
6406558|NCT00240032|Glatiramer Acetate|glatiramer acetate|mesh-list
6406559|NCT00240032|(T,G)-A-L|(t,g)-a-l|mesh-list
6406560|NCT00240032|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6406561|NCT00240032|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6406562|NCT00240032|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6406563|NCT00240032|Histamine Antagonists|histamine antagonists|mesh-ancestor
6406564|NCT00240032|Histamine Agents|histamine agents|mesh-ancestor
6406565|NCT00240032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6406566|NCT00240032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406567|NCT00240032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406568|NCT00240032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6406569|NCT00240032|Immunologic Factors|immunologic factors|mesh-ancestor
6406570|NCT00240032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6406571|NCT00240032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6406572|NCT00240045|Octreotide|octreotide|mesh-list
6406573|NCT00240045|Midodrine|midodrine|mesh-list
6406574|NCT00240045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6406575|NCT00240045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6406576|NCT00240045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6406577|NCT00240045|Sympathomimetics|sympathomimetics|mesh-ancestor
6406578|NCT00240045|Autonomic Agents|autonomic agents|mesh-ancestor
6406579|NCT00240045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6018735|NCT00381888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6406580|NCT00240045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406581|NCT00240045|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6406582|NCT00240045|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6406583|NCT00240045|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6406584|NCT00240045|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6406585|NCT00240045|Adrenergic Agents|adrenergic agents|mesh-ancestor
6406586|NCT00240045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6406587|NCT00240045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406588|NCT00240058|Phenylephrine|phenylephrine|mesh-list
6406589|NCT00240058|Oxymetazoline|oxymetazoline|mesh-list
6406590|NCT00240058|Nitric Oxide|nitric oxide|mesh-list
6406591|NCT00240058|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6406592|NCT00240058|Mydriatics|mydriatics|mesh-ancestor
6406593|NCT00240058|Autonomic Agents|autonomic agents|mesh-ancestor
6406594|NCT00240058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6406595|NCT00240058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406596|NCT00240058|Sympathomimetics|sympathomimetics|mesh-ancestor
6406597|NCT00240058|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6406598|NCT00240058|Nasal Decongestants|nasal decongestants|mesh-ancestor
6406599|NCT00240058|Respiratory System Agents|respiratory system agents|mesh-ancestor
6406600|NCT00240058|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6406601|NCT00240058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6406602|NCT00240058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6406603|NCT00240058|Adrenergic Agents|adrenergic agents|mesh-ancestor
6406604|NCT00240058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6406605|NCT00240058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406606|NCT00240058|Protective Agents|protective agents|mesh-ancestor
6406607|NCT00240058|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6406608|NCT00240058|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6406609|NCT00240058|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6406610|NCT00240058|Antioxidants|antioxidants|mesh-ancestor
6406611|NCT00240058|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6406612|NCT00240058|Vasodilator Agents|vasodilator agents|mesh-ancestor
6406613|NCT00240058|Gasotransmitters|gasotransmitters|mesh-ancestor
6406614|NCT00240084|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6406615|NCT00240084|Natriuretic Agents|natriuretic agents|mesh-ancestor
6406616|NCT00240084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406617|NCT00240123|Diphenhydramine|diphenhydramine|mesh-list
6406618|NCT00240123|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6406619|NCT00240123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6406620|NCT00240123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6406621|NCT00240123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406622|NCT00240123|Anesthetics, Local|anesthetics, local|mesh-ancestor
6406623|NCT00240123|Anesthetics|anesthetics|mesh-ancestor
6406624|NCT00240123|Sensory System Agents|sensory system agents|mesh-ancestor
6406625|NCT00240123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6406626|NCT00240123|Antiemetics|antiemetics|mesh-ancestor
6406627|NCT00240123|Autonomic Agents|autonomic agents|mesh-ancestor
6406628|NCT00240123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6406629|NCT00240123|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6406630|NCT00240123|Histamine Antagonists|histamine antagonists|mesh-ancestor
6406631|NCT00240123|Histamine Agents|histamine agents|mesh-ancestor
6406632|NCT00240123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6406633|NCT00240123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406634|NCT00240123|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6406635|NCT00240149|Insulin|insulin|mesh-list
6406636|NCT00240149|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6406637|NCT00240149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6406638|NCT00240149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406639|NCT00240214|Sirolimus|sirolimus|mesh-list
6406640|NCT00240214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6406641|NCT00240214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6406642|NCT00240214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6406643|NCT00240214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6406644|NCT00240214|Antifungal Agents|antifungal agents|mesh-ancestor
6406645|NCT00240214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6406646|NCT00240214|Immunologic Factors|immunologic factors|mesh-ancestor
6406647|NCT00240214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406648|NCT00240253|Pramlintide|pramlintide|mesh-list
6406649|NCT00240253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6406650|NCT00240253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406651|NCT00240266|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6406652|NCT00240266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6406653|NCT00240266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6406654|NCT00240266|Antimetabolites|antimetabolites|mesh-ancestor
6406655|NCT00240266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406656|NCT00240266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6406657|NCT00240266|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6406658|NCT00240266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6406659|NCT00240279|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6406660|NCT00240279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6406661|NCT00240279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6406662|NCT00240279|Antimetabolites|antimetabolites|mesh-ancestor
6406663|NCT00240279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406664|NCT00240279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6406665|NCT00240279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6406666|NCT00240279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6406667|NCT00240292|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6406668|NCT00240292|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6406669|NCT00240292|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6406670|NCT00240292|Antimetabolites|antimetabolites|mesh-ancestor
6406671|NCT00240292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406672|NCT00240292|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6406673|NCT00240292|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6406674|NCT00240292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6406675|NCT00240305|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6406676|NCT00240305|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6406677|NCT00240305|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6406678|NCT00240305|Antimetabolites|antimetabolites|mesh-ancestor
6406679|NCT00240305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406680|NCT00240305|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6406681|NCT00240305|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6406682|NCT00240305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6406683|NCT00240318|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6406684|NCT00240318|Calcium|calcium|mesh-list
6406685|NCT00240318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6406686|NCT00240318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406687|NCT00240318|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6406688|NCT00240318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6406689|NCT00240318|Antimetabolites|antimetabolites|mesh-ancestor
6406690|NCT00240318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406691|NCT00240318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6406692|NCT00240318|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6406693|NCT00240318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6406694|NCT00240396|Narcotics|narcotics|mesh-list
6406695|NCT00240396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6406696|NCT00240396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406697|NCT00240396|Analgesics|analgesics|mesh-ancestor
6406698|NCT00240396|Sensory System Agents|sensory system agents|mesh-ancestor
6406699|NCT00240396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6406700|NCT00240409|Pramipexole|pramipexole|mesh-list
6406701|NCT00240409|Bromocriptine|bromocriptine|mesh-list
6406702|NCT00240409|Antioxidants|antioxidants|mesh-ancestor
6406703|NCT00240409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406704|NCT00240409|Protective Agents|protective agents|mesh-ancestor
6406705|NCT00240409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406706|NCT00240409|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6406707|NCT00240409|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6406708|NCT00240409|Dopamine Agonists|dopamine agonists|mesh-ancestor
6406709|NCT00240409|Dopamine Agents|dopamine agents|mesh-ancestor
6406710|NCT00240409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6406711|NCT00240409|Hormone Antagonists|hormone antagonists|mesh-ancestor
6406712|NCT00240409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6406713|NCT00240422|Telmisartan|telmisartan|mesh-list
6406714|NCT00240422|Ramipril|ramipril|mesh-list
6406715|NCT00240422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6406716|NCT00240422|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6406717|NCT00240422|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6406718|NCT00240422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406719|NCT00240422|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6406720|NCT00240422|Protease Inhibitors|protease inhibitors|mesh-ancestor
6406721|NCT00240422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6406722|NCT00240435|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6406723|NCT00240435|Tiotropium Bromide|tiotropium bromide|mesh-list
6406724|NCT00240435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6406725|NCT00240435|Autonomic Agents|autonomic agents|mesh-ancestor
6406726|NCT00240435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6406727|NCT00240435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406728|NCT00240435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6406729|NCT00240435|Respiratory System Agents|respiratory system agents|mesh-ancestor
6406730|NCT00240435|Parasympatholytics|parasympatholytics|mesh-ancestor
6406731|NCT00240435|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6406732|NCT00240435|Cholinergic Agents|cholinergic agents|mesh-ancestor
6406733|NCT00240435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6406734|NCT00240435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406735|NCT00240448|Valsartan|valsartan|mesh-list
6406736|NCT00240448|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6406737|NCT00240448|Telmisartan|telmisartan|mesh-list
6406738|NCT00240448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6406739|NCT00240448|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6406740|NCT00240448|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6406741|NCT00240448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406742|NCT00240448|Diuretics|diuretics|mesh-ancestor
6406743|NCT00240448|Natriuretic Agents|natriuretic agents|mesh-ancestor
6406744|NCT00240448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406745|NCT00240448|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6406746|NCT00240448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6406747|NCT00240474|Amlodipine|amlodipine|mesh-list
6406748|NCT00240474|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6406749|NCT00240474|Telmisartan|telmisartan|mesh-list
6406750|NCT00240474|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6406751|NCT00240474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6406752|NCT00240474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6406753|NCT00240474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406754|NCT00240474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6406755|NCT00240474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406756|NCT00240474|Vasodilator Agents|vasodilator agents|mesh-ancestor
6406757|NCT00240474|Diuretics|diuretics|mesh-ancestor
6406758|NCT00240474|Natriuretic Agents|natriuretic agents|mesh-ancestor
6406759|NCT00240474|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6462029|NCT00457106|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6406760|NCT00240474|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6406761|NCT00240474|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6406762|NCT00240513|Minocycline|minocycline|mesh-list
6406763|NCT00240513|Tretinoin|tretinoin|mesh-list
6406764|NCT00240513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6406765|NCT00240513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6406766|NCT00240513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6406767|NCT00240513|Keratolytic Agents|keratolytic agents|mesh-ancestor
6406768|NCT00240513|Dermatologic Agents|dermatologic agents|mesh-ancestor
6406769|NCT00240552|Fosamprenavir|fosamprenavir|mesh-list
6406770|NCT00240552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6406771|NCT00240552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6406772|NCT00240552|Protease Inhibitors|protease inhibitors|mesh-ancestor
6406773|NCT00240552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6406774|NCT00240552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406775|NCT00240552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6406776|NCT00240552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6406777|NCT00240552|Antiviral Agents|antiviral agents|mesh-ancestor
6406778|NCT00240552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6406779|NCT00240604|Rosiglitazone|rosiglitazone|mesh-list
6406780|NCT00240604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6406781|NCT00240604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406782|NCT00240617|Naproxen|naproxen|mesh-list
6406783|NCT00240617|Sumatriptan|sumatriptan|mesh-list
6406784|NCT00240617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6406785|NCT00240617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6406786|NCT00240617|Analgesics|analgesics|mesh-ancestor
6406787|NCT00240617|Sensory System Agents|sensory system agents|mesh-ancestor
6406788|NCT00240617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6406789|NCT00240617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406790|NCT00240617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6406791|NCT00240617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6406792|NCT00240617|Gout Suppressants|gout suppressants|mesh-ancestor
6406793|NCT00240617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6406794|NCT00240617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6406795|NCT00240617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406796|NCT00240617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6406797|NCT00240617|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6406798|NCT00240617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6406799|NCT00240617|Serotonin Agents|serotonin agents|mesh-ancestor
6406800|NCT00240617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6406801|NCT00240630|Naproxen|naproxen|mesh-list
6406802|NCT00240630|Sumatriptan|sumatriptan|mesh-list
6406803|NCT00240630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6406804|NCT00240630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6406805|NCT00240630|Analgesics|analgesics|mesh-ancestor
6406806|NCT00240630|Sensory System Agents|sensory system agents|mesh-ancestor
6406807|NCT00240630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6406808|NCT00240630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406809|NCT00240630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6406810|NCT00240630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6406811|NCT00240630|Gout Suppressants|gout suppressants|mesh-ancestor
6406812|NCT00240630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6406813|NCT00240630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6406814|NCT00240630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406815|NCT00240630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6406816|NCT00240630|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6406817|NCT00240630|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6406818|NCT00240630|Serotonin Agents|serotonin agents|mesh-ancestor
6406819|NCT00240630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6406820|NCT00240656|Carvedilol|carvedilol|mesh-list
6406821|NCT00240656|Captopril|captopril|mesh-list
6406822|NCT00240656|Spironolactone|spironolactone|mesh-list
6406823|NCT00240656|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6406824|NCT00240656|Hormone Antagonists|hormone antagonists|mesh-ancestor
6406825|NCT00240656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6406826|NCT00240656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406827|NCT00240656|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6406828|NCT00240656|Diuretics|diuretics|mesh-ancestor
6406829|NCT00240656|Natriuretic Agents|natriuretic agents|mesh-ancestor
6406830|NCT00240656|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6406831|NCT00240656|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6406832|NCT00240656|Adrenergic Agents|adrenergic agents|mesh-ancestor
6406833|NCT00240656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6406834|NCT00240656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406835|NCT00240656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6406836|NCT00240656|Antioxidants|antioxidants|mesh-ancestor
6406837|NCT00240656|Protective Agents|protective agents|mesh-ancestor
6406838|NCT00240656|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6406839|NCT00240656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6406840|NCT00240656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6406841|NCT00240656|Vasodilator Agents|vasodilator agents|mesh-ancestor
6406842|NCT00240656|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6406843|NCT00240656|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6406844|NCT00240656|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6406845|NCT00240656|Protease Inhibitors|protease inhibitors|mesh-ancestor
6406846|NCT00240656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6406847|NCT00240682|Cetuximab|cetuximab|mesh-list
6406848|NCT00240682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6406849|NCT00240682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6406850|NCT00240695|Galantamine|galantamine|mesh-list
6406851|NCT00240695|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6406852|NCT00240695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6406853|NCT00240695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406854|NCT00240695|Cholinergic Agents|cholinergic agents|mesh-ancestor
6406855|NCT00240695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6406856|NCT00240695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406857|NCT00240695|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6406858|NCT00240695|Autonomic Agents|autonomic agents|mesh-ancestor
6406859|NCT00240695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6406860|NCT00240695|Nootropic Agents|nootropic agents|mesh-ancestor
6406861|NCT00240708|Risperidone|risperidone|mesh-list
6406862|NCT00240708|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6406863|NCT00240708|Serotonin Agents|serotonin agents|mesh-ancestor
6406864|NCT00240708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6406865|NCT00240708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406866|NCT00240708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406867|NCT00240708|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6406868|NCT00240708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6406869|NCT00240708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6406870|NCT00240708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6406871|NCT00240708|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6406872|NCT00240708|Dopamine Agents|dopamine agents|mesh-ancestor
6406873|NCT00240721|Topiramate|topiramate|mesh-list
6406874|NCT00240721|Anticonvulsants|anticonvulsants|mesh-ancestor
6406875|NCT00240721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6406876|NCT00240721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406877|NCT00240734|Epoetin Alfa|epoetin alfa|mesh-list
6406878|NCT00240734|Hematinics|hematinics|mesh-ancestor
6406879|NCT00240747|Quinupristin-dalfopristin|quinupristin-dalfopristin|mesh-list
6406880|NCT00240747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6406881|NCT00240747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6406882|NCT00240747|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6406883|NCT00240747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6406884|NCT00240747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406885|NCT00240760|Memantine|memantine|mesh-list
6406886|NCT00240760|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6406887|NCT00240760|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6406888|NCT00240760|Dopamine Agents|dopamine agents|mesh-ancestor
6406889|NCT00240760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6406890|NCT00240760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406891|NCT00240760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406892|NCT00240760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6406893|NCT00240760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6406894|NCT00240773|Acetaminophen|acetaminophen|mesh-list
6406895|NCT00240773|Naproxen|naproxen|mesh-list
6406896|NCT00240773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6406897|NCT00240773|Analgesics|analgesics|mesh-ancestor
6406898|NCT00240773|Sensory System Agents|sensory system agents|mesh-ancestor
6406899|NCT00240773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6406900|NCT00240773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406901|NCT00240773|Antipyretics|antipyretics|mesh-ancestor
6406902|NCT00240773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6406903|NCT00240773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6406904|NCT00240773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6406905|NCT00240773|Gout Suppressants|gout suppressants|mesh-ancestor
6406906|NCT00240773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6406907|NCT00240773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6406908|NCT00240773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406909|NCT00240786|Acetaminophen|acetaminophen|mesh-list
6406910|NCT00240786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6406911|NCT00240786|Analgesics|analgesics|mesh-ancestor
6406912|NCT00240786|Sensory System Agents|sensory system agents|mesh-ancestor
6406913|NCT00240786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6406914|NCT00240786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406915|NCT00240786|Antipyretics|antipyretics|mesh-ancestor
6406916|NCT00240799|Acetaminophen|acetaminophen|mesh-list
6406917|NCT00240799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6406918|NCT00240799|Analgesics|analgesics|mesh-ancestor
6406919|NCT00240799|Sensory System Agents|sensory system agents|mesh-ancestor
6406920|NCT00240799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6406921|NCT00240799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406922|NCT00240799|Antipyretics|antipyretics|mesh-ancestor
6406923|NCT00240812|Ibuprofen|ibuprofen|mesh-list
6406924|NCT00240812|Pseudoephedrine|pseudoephedrine|mesh-list
6406925|NCT00240812|Ephedrine|ephedrine|mesh-list
6406926|NCT00240812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6406927|NCT00240812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6406928|NCT00240812|Analgesics|analgesics|mesh-ancestor
6406929|NCT00240812|Sensory System Agents|sensory system agents|mesh-ancestor
6406930|NCT00240812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6406931|NCT00240812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406932|NCT00240812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6406933|NCT00240812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6406934|NCT00240812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6406935|NCT00240812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6406936|NCT00240812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406937|NCT00240812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6406938|NCT00240812|Autonomic Agents|autonomic agents|mesh-ancestor
6406939|NCT00240812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6406940|NCT00240812|Respiratory System Agents|respiratory system agents|mesh-ancestor
6406941|NCT00240812|Nasal Decongestants|nasal decongestants|mesh-ancestor
6406942|NCT00240812|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6406943|NCT00240812|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6406944|NCT00240812|Sympathomimetics|sympathomimetics|mesh-ancestor
6406945|NCT00240812|Adrenergic Agents|adrenergic agents|mesh-ancestor
6406946|NCT00240812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6406947|NCT00240825|Acetaminophen|acetaminophen|mesh-list
6406948|NCT00240825|Ibuprofen|ibuprofen|mesh-list
6406949|NCT00240825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6406950|NCT00240825|Analgesics|analgesics|mesh-ancestor
6406951|NCT00240825|Sensory System Agents|sensory system agents|mesh-ancestor
6406952|NCT00240825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6406953|NCT00240825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406954|NCT00240825|Antipyretics|antipyretics|mesh-ancestor
6406955|NCT00240825|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6406956|NCT00240825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6406957|NCT00240825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6406958|NCT00240825|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6406959|NCT00240825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6406960|NCT00240825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406961|NCT00240838|Acetaminophen|acetaminophen|mesh-list
6406962|NCT00240838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6406963|NCT00240838|Analgesics|analgesics|mesh-ancestor
6406964|NCT00240838|Sensory System Agents|sensory system agents|mesh-ancestor
6406965|NCT00240838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6406966|NCT00240838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406967|NCT00240838|Antipyretics|antipyretics|mesh-ancestor
6406968|NCT00240851|Acetaminophen|acetaminophen|mesh-list
6406969|NCT00240851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6406970|NCT00240851|Analgesics|analgesics|mesh-ancestor
6406971|NCT00240851|Sensory System Agents|sensory system agents|mesh-ancestor
6406972|NCT00240851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6406973|NCT00240851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406974|NCT00240851|Antipyretics|antipyretics|mesh-ancestor
6406975|NCT00240864|Acetaminophen|acetaminophen|mesh-list
6406976|NCT00240864|Ibuprofen|ibuprofen|mesh-list
6406977|NCT00240864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6406978|NCT00240864|Analgesics|analgesics|mesh-ancestor
6406979|NCT00240864|Sensory System Agents|sensory system agents|mesh-ancestor
6406980|NCT00240864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6406981|NCT00240864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406982|NCT00240864|Antipyretics|antipyretics|mesh-ancestor
6406983|NCT00240864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6406984|NCT00240864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6406985|NCT00240864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6406986|NCT00240864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6406987|NCT00240864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6406988|NCT00240864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6406989|NCT00240916|Vaccines|vaccines|mesh-list
6406990|NCT00240916|Immunoglobulins|immunoglobulins|mesh-list
6406991|NCT00240916|Immunologic Factors|immunologic factors|mesh-ancestor
6406992|NCT00240916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6406993|NCT00240929|Palivizumab|palivizumab|mesh-list
6406994|NCT00240929|Antiviral Agents|antiviral agents|mesh-ancestor
6406995|NCT00240929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6406996|NCT00240942|Letrozole|letrozole|mesh-list
6406997|NCT00240942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6406998|NCT00240942|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6406999|NCT00240942|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6407000|NCT00240942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6407001|NCT00240942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407002|NCT00240942|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6407003|NCT00240942|Hormone Antagonists|hormone antagonists|mesh-ancestor
6407004|NCT00240942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6407005|NCT00240942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407006|NCT00240955|Mycophenolic Acid|mycophenolic acid|mesh-list
6407007|NCT00240955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6407008|NCT00240955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6407009|NCT00240955|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6407010|NCT00240955|Antitubercular Agents|antitubercular agents|mesh-ancestor
6407011|NCT00240955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6407012|NCT00240955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6407013|NCT00240955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6407014|NCT00240955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407015|NCT00241007|Valsartan|valsartan|mesh-list
6407016|NCT00241007|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6407017|NCT00241007|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6407018|NCT00241007|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6407019|NCT00241007|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6407020|NCT00241007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407021|NCT00241007|Diuretics|diuretics|mesh-ancestor
6407022|NCT00241007|Natriuretic Agents|natriuretic agents|mesh-ancestor
6407023|NCT00241007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407024|NCT00241007|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6407025|NCT00241007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6407026|NCT00241020|Octreotide|octreotide|mesh-list
6407027|NCT00241020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6407028|NCT00241020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6407029|NCT00241020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6407030|NCT00241046|Letrozole|letrozole|mesh-list
6407031|NCT00241046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6407032|NCT00241046|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6407033|NCT00241046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6407034|NCT00241046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6407035|NCT00241046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407036|NCT00241046|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6407037|NCT00241046|Hormone Antagonists|hormone antagonists|mesh-ancestor
6407038|NCT00241046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6407039|NCT00241046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407040|NCT00241059|Mycophenolic Acid|mycophenolic acid|mesh-list
6407041|NCT00241059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6407042|NCT00241059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6407043|NCT00241059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6407044|NCT00241059|Antitubercular Agents|antitubercular agents|mesh-ancestor
6407045|NCT00241059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6407046|NCT00241059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6407047|NCT00241059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6407048|NCT00241059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407049|NCT00241072|Valsartan|valsartan|mesh-list
6407050|NCT00241072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6407051|NCT00241072|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6407052|NCT00241072|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6407053|NCT00241072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407054|NCT00241085|Valsartan|valsartan|mesh-list
6407055|NCT00241085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6407056|NCT00241085|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6407057|NCT00241085|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6407058|NCT00241085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407059|NCT00241098|Valsartan|valsartan|mesh-list
6407060|NCT00241098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6407061|NCT00241098|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6407062|NCT00241098|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6407063|NCT00241098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407064|NCT00241111|Zoledronic Acid|zoledronic acid|mesh-list
6407065|NCT00241111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6407066|NCT00241111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407067|NCT00241124|Valsartan|valsartan|mesh-list
6407068|NCT00241124|Lisinopril|lisinopril|mesh-list
6407069|NCT00241124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6407070|NCT00241124|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6407071|NCT00241124|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6407072|NCT00241124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407073|NCT00241124|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6407074|NCT00241124|Protease Inhibitors|protease inhibitors|mesh-ancestor
6407075|NCT00241124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6407076|NCT00241124|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6407077|NCT00241124|Protective Agents|protective agents|mesh-ancestor
6407078|NCT00241124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407079|NCT00241137|Valsartan|valsartan|mesh-list
6407080|NCT00241137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6407081|NCT00241137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6462030|NCT00457106|Dopamine Agents|dopamine agents|mesh-ancestor
6407082|NCT00241137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6407083|NCT00241137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407084|NCT00241150|Valsartan|valsartan|mesh-list
6407085|NCT00241150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6407086|NCT00241150|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6407087|NCT00241150|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6407088|NCT00241150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459565|NCT00445796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6459566|NCT00445796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6459567|NCT00445796|Antiviral Agents|antiviral agents|mesh-ancestor
6459568|NCT00445796|Schistosomicides|schistosomicides|mesh-ancestor
6459569|NCT00445796|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6459570|NCT00445796|Anthelmintics|anthelmintics|mesh-ancestor
6459571|NCT00445861|Docetaxel|docetaxel|mesh-list
6459572|NCT00445861|Cetuximab|cetuximab|mesh-list
6459573|NCT00445861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6459574|NCT00445861|Tubulin Modulators|tubulin modulators|mesh-ancestor
6459575|NCT00445861|Antimitotic Agents|antimitotic agents|mesh-ancestor
6459576|NCT00445861|Mitosis Modulators|mitosis modulators|mesh-ancestor
6459577|NCT00445861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459578|NCT00445861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6459579|NCT00445874|Ketotifen|ketotifen|mesh-list
6459580|NCT00445874|Antipruritics|antipruritics|mesh-ancestor
6459581|NCT00445874|Dermatologic Agents|dermatologic agents|mesh-ancestor
6459582|NCT00445874|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6459583|NCT00445874|Histamine Antagonists|histamine antagonists|mesh-ancestor
6459584|NCT00445874|Histamine Agents|histamine agents|mesh-ancestor
6459585|NCT00445874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6459586|NCT00445874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459587|NCT00445874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459588|NCT00445874|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6459589|NCT00445900|Thalidomide|thalidomide|mesh-list
6459590|NCT00445900|Prednisone|prednisone|mesh-list
6459591|NCT00445900|Cyclophosphamide|cyclophosphamide|mesh-list
6459592|NCT00445900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6459593|NCT00445900|Immunologic Factors|immunologic factors|mesh-ancestor
6459594|NCT00445900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459595|NCT00445900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6459596|NCT00445900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6459597|NCT00445900|Alkylating Agents|alkylating agents|mesh-ancestor
6459598|NCT00445900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459599|NCT00445900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6459600|NCT00445900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6459601|NCT00445900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6459602|NCT00445900|Glucocorticoids|glucocorticoids|mesh-ancestor
6459603|NCT00445900|Hormones|hormones|mesh-ancestor
6459604|NCT00445900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6459605|NCT00445900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6459606|NCT00445900|Leprostatic Agents|leprostatic agents|mesh-ancestor
6459607|NCT00445900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6459608|NCT00445900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6459609|NCT00445900|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6459610|NCT00445900|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6459611|NCT00445900|Growth Substances|growth substances|mesh-ancestor
6459612|NCT00445900|Growth Inhibitors|growth inhibitors|mesh-ancestor
6459613|NCT00445965|Antibodies|antibodies|mesh-list
6459614|NCT00445965|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6407089|NCT00241163|Thrombin|thrombin|mesh-list
6407090|NCT00241163|Hemostatics|hemostatics|mesh-ancestor
6407091|NCT00241163|Coagulants|coagulants|mesh-ancestor
6407092|NCT00241189|Sirolimus|sirolimus|mesh-list
6407093|NCT00241189|Methotrexate|methotrexate|mesh-list
6407094|NCT00241189|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6407095|NCT00241189|Abortifacient Agents|abortifacient agents|mesh-ancestor
6407096|NCT00241189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6407097|NCT00241189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407098|NCT00241189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6407099|NCT00241189|Antimetabolites|antimetabolites|mesh-ancestor
6407100|NCT00241189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407101|NCT00241189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6407102|NCT00241189|Dermatologic Agents|dermatologic agents|mesh-ancestor
6407103|NCT00241189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6407104|NCT00241189|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6407105|NCT00241189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6407106|NCT00241189|Immunologic Factors|immunologic factors|mesh-ancestor
6407107|NCT00241189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6407108|NCT00241189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6407109|NCT00241189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6407110|NCT00241189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6407111|NCT00241189|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6407112|NCT00241189|Antifungal Agents|antifungal agents|mesh-ancestor
6407113|NCT00241215|Botulinum Toxins|botulinum toxins|mesh-list
6407114|NCT00241215|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6407115|NCT00241215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6407116|NCT00241215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407117|NCT00241215|Cholinergic Agents|cholinergic agents|mesh-ancestor
6407118|NCT00241215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6407119|NCT00241215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407120|NCT00241241|Interferons|interferons|mesh-list
6407121|NCT00241241|Interferon-alpha|interferon-alpha|mesh-list
6407122|NCT00241241|Interferon alpha-2|interferon alpha-2|mesh-list
6407123|NCT00241241|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6407124|NCT00241241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6407125|NCT00241241|Antiviral Agents|antiviral agents|mesh-ancestor
6407126|NCT00241241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6407127|NCT00241241|Immunologic Factors|immunologic factors|mesh-ancestor
6407128|NCT00241241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407129|NCT00241254|Methylprednisolone|methylprednisolone|mesh-list
6407130|NCT00241254|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6407131|NCT00241254|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6407132|NCT00241254|Prednisolone|prednisolone|mesh-list
6407133|NCT00241254|Prednisolone acetate|prednisolone acetate|mesh-list
6407134|NCT00241254|Cyclophosphamide|cyclophosphamide|mesh-list
6407135|NCT00241254|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6407136|NCT00241254|Prednisolone phosphate|prednisolone phosphate|mesh-list
6407137|NCT00241254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6407138|NCT00241254|Immunologic Factors|immunologic factors|mesh-ancestor
6407139|NCT00241254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407140|NCT00241254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6407141|NCT00241254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6407142|NCT00241254|Alkylating Agents|alkylating agents|mesh-ancestor
6407143|NCT00241254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407144|NCT00241254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6407145|NCT00241254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6407146|NCT00241254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6407147|NCT00241254|Antiemetics|antiemetics|mesh-ancestor
6407148|NCT00241254|Autonomic Agents|autonomic agents|mesh-ancestor
6407149|NCT00241254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6407150|NCT00241254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6407151|NCT00241254|Glucocorticoids|glucocorticoids|mesh-ancestor
6407152|NCT00241254|Hormones|hormones|mesh-ancestor
6407153|NCT00241254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6407154|NCT00241254|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6407155|NCT00241254|Protective Agents|protective agents|mesh-ancestor
6407156|NCT00241254|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6407157|NCT00241332|Fentanyl|fentanyl|mesh-list
6407158|NCT00241332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6407159|NCT00241332|Narcotics|narcotics|mesh-ancestor
6407160|NCT00241332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6407161|NCT00241332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407162|NCT00241332|Analgesics|analgesics|mesh-ancestor
6407163|NCT00241332|Sensory System Agents|sensory system agents|mesh-ancestor
6407164|NCT00241332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6407165|NCT00241332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6407166|NCT00241332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6407167|NCT00241332|Anesthetics, General|anesthetics, general|mesh-ancestor
6407168|NCT00241332|Anesthetics|anesthetics|mesh-ancestor
6407169|NCT00241345|Valganciclovir|valganciclovir|mesh-list
6407170|NCT00241345|Ganciclovir|ganciclovir|mesh-list
6407171|NCT00241345|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6407172|NCT00241345|Antiviral Agents|antiviral agents|mesh-ancestor
6407173|NCT00241345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6407174|NCT00241345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6407175|NCT00241345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6407176|NCT00241345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407177|NCT00241371|Clofarabine|clofarabine|mesh-list
6407178|NCT00241371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6407179|NCT00241371|Antimetabolites|antimetabolites|mesh-ancestor
6407180|NCT00241371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407181|NCT00241371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6407182|NCT00241423|Exenatide|exenatide|mesh-list
6407183|NCT00241423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6407184|NCT00241423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407185|NCT00241423|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6407186|NCT00241423|Incretins|incretins|mesh-ancestor
6407187|NCT00241423|Hormones|hormones|mesh-ancestor
6407188|NCT00241423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6407189|NCT00241436|Anastrozole|anastrozole|mesh-list
6407190|NCT00241436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6407191|NCT00241436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6407192|NCT00241436|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6407193|NCT00241436|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6407194|NCT00241436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6407195|NCT00241436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407196|NCT00241436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6407197|NCT00241436|Hormone Antagonists|hormone antagonists|mesh-ancestor
6407198|NCT00241436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6407199|NCT00241436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407200|NCT00241449|Tamoxifen|tamoxifen|mesh-list
6407201|NCT00241449|Fulvestrant|fulvestrant|mesh-list
6407202|NCT00241449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6407203|NCT00241449|Hormone Antagonists|hormone antagonists|mesh-ancestor
6407204|NCT00241449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6407205|NCT00241449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407206|NCT00241449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6407207|NCT00241449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6407208|NCT00241449|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6407209|NCT00241449|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6407210|NCT00241449|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6407211|NCT00241449|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6407212|NCT00241475|Gefitinib|gefitinib|mesh-list
6407213|NCT00241475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6407214|NCT00241475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6407215|NCT00241475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6407216|NCT00241475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407217|NCT00241488|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6407218|NCT00241488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6407219|NCT00241488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6407220|NCT00241488|Antimetabolites|antimetabolites|mesh-ancestor
6407221|NCT00241488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407222|NCT00241488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6407223|NCT00241488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6407224|NCT00241488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6407225|NCT00241501|Esomeprazole|esomeprazole|mesh-list
6407226|NCT00241501|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6407227|NCT00241501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6407228|NCT00241501|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6407229|NCT00241501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6407230|NCT00241501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407231|NCT00241514|Esomeprazole|esomeprazole|mesh-list
6407232|NCT00241514|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6407233|NCT00241514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6407234|NCT00241514|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6407235|NCT00241514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6407236|NCT00241514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407237|NCT00241527|Esomeprazole|esomeprazole|mesh-list
6407238|NCT00241527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6407239|NCT00241527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6407240|NCT00241527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6407241|NCT00241527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6407242|NCT00241527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407243|NCT00241540|Esomeprazole|esomeprazole|mesh-list
6407244|NCT00241540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6407245|NCT00241540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6407246|NCT00241540|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6407247|NCT00241540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6407248|NCT00241540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407249|NCT00241553|Esomeprazole|esomeprazole|mesh-list
6407250|NCT00241553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6407251|NCT00241553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6407252|NCT00241553|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6407253|NCT00241553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6407254|NCT00241553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407255|NCT00241605|Metformin|metformin|mesh-list
6407256|NCT00241605|Rosiglitazone|rosiglitazone|mesh-list
6407257|NCT00241605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6407258|NCT00241605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407259|NCT00241618|Interferons|interferons|mesh-list
6407260|NCT00241618|Ribavirin|ribavirin|mesh-list
6407261|NCT00241618|Interferon-alpha|interferon-alpha|mesh-list
6407262|NCT00241618|Interferon alpha-2|interferon alpha-2|mesh-list
6407263|NCT00241618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6407264|NCT00241618|Antiviral Agents|antiviral agents|mesh-ancestor
6407265|NCT00241618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6407266|NCT00241618|Antimetabolites|antimetabolites|mesh-ancestor
6407267|NCT00241618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407268|NCT00241618|Immunologic Factors|immunologic factors|mesh-ancestor
6407269|NCT00241618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407270|NCT00241670|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6407271|NCT00241670|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6407272|NCT00241670|Dermatologic Agents|dermatologic agents|mesh-ancestor
6407273|NCT00241722|Alvimopan|alvimopan|mesh-list
6407274|NCT00241722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6018736|NCT00381888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6018737|NCT00381940|Bortezomib|bortezomib|mesh-list
6018738|NCT00381940|Vinorelbine|vinorelbine|mesh-list
6018739|NCT00381940|Ifosfamide|ifosfamide|mesh-list
6018740|NCT00381940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6407275|NCT00241982|Prednisolone|prednisolone|mesh-list
6407276|NCT00241982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6407277|NCT00241982|Glucocorticoids|glucocorticoids|mesh-ancestor
6407278|NCT00241982|Hormones|hormones|mesh-ancestor
6407279|NCT00241982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6407280|NCT00241982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407281|NCT00241982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6407282|NCT00241982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6407283|NCT00241995|Anticonvulsants|anticonvulsants|mesh-list
6407284|NCT00242008|Rotigotine|rotigotine|mesh-list
6407285|NCT00242008|Dopamine Agonists|dopamine agonists|mesh-ancestor
6407286|NCT00242008|Dopamine Agents|dopamine agents|mesh-ancestor
6407287|NCT00242008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6407288|NCT00242008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407289|NCT00242008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407290|NCT00242164|Dialysis Solutions|dialysis solutions|mesh-list
6407291|NCT00242164|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6407292|NCT00242177|Pioglitazone|pioglitazone|mesh-list
6407293|NCT00242177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6407294|NCT00242177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407295|NCT00242190|Gemcitabine|gemcitabine|mesh-list
6407296|NCT00242190|Oxaliplatin|oxaliplatin|mesh-list
6407297|NCT00242190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6407298|NCT00242190|Antimetabolites|antimetabolites|mesh-ancestor
6407299|NCT00242190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407300|NCT00242190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6407301|NCT00242190|Antiviral Agents|antiviral agents|mesh-ancestor
6407302|NCT00242190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6407303|NCT00242190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6407304|NCT00242190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6407305|NCT00242190|Immunologic Factors|immunologic factors|mesh-ancestor
6407306|NCT00242190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407307|NCT00242203|Zoledronic Acid|zoledronic acid|mesh-list
6407308|NCT00242203|Docetaxel|docetaxel|mesh-list
6407309|NCT00242203|Trastuzumab|trastuzumab|mesh-list
6407310|NCT00242203|Epirubicin|epirubicin|mesh-list
6407311|NCT00242203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6407312|NCT00242203|Tubulin Modulators|tubulin modulators|mesh-ancestor
6407313|NCT00242203|Antimitotic Agents|antimitotic agents|mesh-ancestor
6407314|NCT00242203|Mitosis Modulators|mitosis modulators|mesh-ancestor
6407315|NCT00242203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407316|NCT00242203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6407317|NCT00242203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6407318|NCT00242203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6407319|NCT00242203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6407320|NCT00242203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6407321|NCT00242203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6407322|NCT00242203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407323|NCT00242268|Simvastatin|simvastatin|mesh-list
6407324|NCT00242268|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6407325|NCT00242268|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6407326|NCT00242268|Antimetabolites|antimetabolites|mesh-ancestor
6407327|NCT00242268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407328|NCT00242268|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6407329|NCT00242268|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6407330|NCT00242268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6407331|NCT00242346|Candesartan|candesartan|mesh-list
6407332|NCT00242346|Candesartan cilexetil|candesartan cilexetil|mesh-list
6407333|NCT00242346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6407334|NCT00242346|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6407335|NCT00242346|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6407336|NCT00242346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407337|NCT00242359|Omalizumab|omalizumab|mesh-list
6407338|NCT00242359|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6407339|NCT00242359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6407340|NCT00242359|Respiratory System Agents|respiratory system agents|mesh-ancestor
6407341|NCT00242372|Insulin|insulin|mesh-list
6407342|NCT00242372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6407343|NCT00242372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407344|NCT00242411|Budesonide|budesonide|mesh-list
6407345|NCT00242411|Formoterol Fumarate|formoterol fumarate|mesh-list
6407346|NCT00242411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6407347|NCT00242411|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6407348|NCT00242411|Autonomic Agents|autonomic agents|mesh-ancestor
6407349|NCT00242411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6407350|NCT00242411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407351|NCT00242411|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6407352|NCT00242411|Respiratory System Agents|respiratory system agents|mesh-ancestor
6407353|NCT00242411|Glucocorticoids|glucocorticoids|mesh-ancestor
6407354|NCT00242411|Hormones|hormones|mesh-ancestor
6407355|NCT00242411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6407356|NCT00242411|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6407357|NCT00242411|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6407358|NCT00242411|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6407359|NCT00242411|Adrenergic Agents|adrenergic agents|mesh-ancestor
6407360|NCT00242411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6407361|NCT00242411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407362|NCT00242437|Thrombin|thrombin|mesh-list
6407363|NCT00242437|Hemostatics|hemostatics|mesh-list
6407364|NCT00242437|Coagulants|coagulants|mesh-ancestor
6407365|NCT00242450|Metoclopramide|metoclopramide|mesh-list
6407366|NCT00242450|Antiemetics|antiemetics|mesh-ancestor
6407367|NCT00242450|Autonomic Agents|autonomic agents|mesh-ancestor
6407368|NCT00242450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6407369|NCT00242450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407370|NCT00242450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6407371|NCT00242450|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6407372|NCT00242450|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6407373|NCT00242450|Dopamine Agents|dopamine agents|mesh-ancestor
6407374|NCT00242450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6407375|NCT00242450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407376|NCT00242463|Nandrolone Decanoate|nandrolone decanoate|mesh-list
6407377|NCT00242463|Nandrolone|nandrolone|mesh-list
6407378|NCT00242463|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
6407379|NCT00242463|Testosterone Congeners|testosterone congeners|mesh-list
6407380|NCT00242463|Androgens|androgens|mesh-ancestor
6407381|NCT00242463|Hormones|hormones|mesh-ancestor
6407382|NCT00242463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6407383|NCT00242463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407384|NCT00242463|Anabolic Agents|anabolic agents|mesh-ancestor
6407385|NCT00242463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6407386|NCT00242528|Zoledronic Acid|zoledronic acid|mesh-list
6407387|NCT00242528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6407388|NCT00242528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407389|NCT00242541|Octreotide|octreotide|mesh-list
6407390|NCT00242541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6407391|NCT00242541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6407392|NCT00242541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6407393|NCT00242554|Zoledronic Acid|zoledronic acid|mesh-list
6407394|NCT00242554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6407395|NCT00242554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407396|NCT00242593|Rosiglitazone|rosiglitazone|mesh-list
6407397|NCT00242593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6407398|NCT00242593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407399|NCT00242606|Lamotrigine|lamotrigine|mesh-list
6407400|NCT00242606|Levetiracetam|levetiracetam|mesh-list
6407401|NCT00242606|Anticonvulsants|anticonvulsants|mesh-ancestor
6407402|NCT00242606|Nootropic Agents|nootropic agents|mesh-ancestor
6407403|NCT00242606|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6407404|NCT00242606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6407405|NCT00242606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407406|NCT00242606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6407407|NCT00242606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407408|NCT00242606|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6407409|NCT00242606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6407410|NCT00242606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6407411|NCT00242606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6407412|NCT00242606|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6407413|NCT00242697|Anesthetics|anesthetics|mesh-list
6407414|NCT00242697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6407415|NCT00242697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459615|NCT00445965|Immunologic Factors|immunologic factors|mesh-ancestor
6459616|NCT00445965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407416|NCT00242736|Esomeprazole|esomeprazole|mesh-list
6407417|NCT00242736|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6407418|NCT00242736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6407419|NCT00242736|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6407420|NCT00242736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6407421|NCT00242736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407422|NCT00242749|Gefitinib|gefitinib|mesh-list
6407423|NCT00242749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6407424|NCT00242749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6407425|NCT00242749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6407426|NCT00242749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407427|NCT00242762|Docetaxel|docetaxel|mesh-list
6407428|NCT00242762|Gefitinib|gefitinib|mesh-list
6407429|NCT00242762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6407430|NCT00242762|Tubulin Modulators|tubulin modulators|mesh-ancestor
6407431|NCT00242762|Antimitotic Agents|antimitotic agents|mesh-ancestor
6407432|NCT00242762|Mitosis Modulators|mitosis modulators|mesh-ancestor
6407433|NCT00242762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407434|NCT00242762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6407435|NCT00242762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6407436|NCT00242775|Fluticasone|fluticasone|mesh-list
6407437|NCT00242775|Budesonide|budesonide|mesh-list
6407438|NCT00242775|Formoterol Fumarate|formoterol fumarate|mesh-list
6407439|NCT00242775|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6407440|NCT00242775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6407441|NCT00242775|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6407442|NCT00242775|Autonomic Agents|autonomic agents|mesh-ancestor
6407443|NCT00242775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6407444|NCT00242775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407445|NCT00242775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6407446|NCT00242775|Respiratory System Agents|respiratory system agents|mesh-ancestor
6407447|NCT00242775|Dermatologic Agents|dermatologic agents|mesh-ancestor
6407448|NCT00242775|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6407449|NCT00242775|Glucocorticoids|glucocorticoids|mesh-ancestor
6407450|NCT00242775|Hormones|hormones|mesh-ancestor
6407451|NCT00242775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6407452|NCT00242775|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6407453|NCT00242775|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6407454|NCT00242775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6407455|NCT00242775|Adrenergic Agents|adrenergic agents|mesh-ancestor
6407456|NCT00242775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6407457|NCT00242775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407458|NCT00242788|Capecitabine|capecitabine|mesh-list
6407459|NCT00242788|Gefitinib|gefitinib|mesh-list
6407460|NCT00242788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6407461|NCT00242788|Antimetabolites|antimetabolites|mesh-ancestor
6407462|NCT00242788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407463|NCT00242788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6407464|NCT00242788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6407465|NCT00242788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6407466|NCT00242801|Gefitinib|gefitinib|mesh-list
6407467|NCT00242801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6407468|NCT00242801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6407469|NCT00242801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6407470|NCT00242801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407471|NCT00242814|Amlodipine|amlodipine|mesh-list
6407472|NCT00242814|Telmisartan|telmisartan|mesh-list
6407473|NCT00242814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6407474|NCT00242814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6407475|NCT00242814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6407476|NCT00242814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407477|NCT00242814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6407478|NCT00242814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407479|NCT00242814|Vasodilator Agents|vasodilator agents|mesh-ancestor
6407480|NCT00242814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6407481|NCT00242814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6407482|NCT00242853|Nitric Oxide|nitric oxide|mesh-list
6407483|NCT00242853|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6407484|NCT00242853|Autonomic Agents|autonomic agents|mesh-ancestor
6407485|NCT00242853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6407486|NCT00242853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407487|NCT00242853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6407488|NCT00242853|Respiratory System Agents|respiratory system agents|mesh-ancestor
6407489|NCT00242853|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6407490|NCT00242853|Antioxidants|antioxidants|mesh-ancestor
6407491|NCT00242853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407492|NCT00242853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6407493|NCT00242853|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6407494|NCT00242853|Vasodilator Agents|vasodilator agents|mesh-ancestor
6407495|NCT00242853|Gasotransmitters|gasotransmitters|mesh-ancestor
6407496|NCT00242853|Protective Agents|protective agents|mesh-ancestor
6407497|NCT00242879|Ritonavir|ritonavir|mesh-list
6407498|NCT00242879|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6407499|NCT00242879|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6407500|NCT00242879|Protease Inhibitors|protease inhibitors|mesh-ancestor
6407501|NCT00242879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6407502|NCT00242879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407503|NCT00242879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6407504|NCT00242879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6407505|NCT00242879|Antiviral Agents|antiviral agents|mesh-ancestor
6407506|NCT00242879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6407507|NCT00242879|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6407508|NCT00242879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6407509|NCT00242918|Docetaxel|docetaxel|mesh-list
6407510|NCT00242918|Gefitinib|gefitinib|mesh-list
6407511|NCT00242918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6407512|NCT00242918|Tubulin Modulators|tubulin modulators|mesh-ancestor
6407513|NCT00242918|Antimitotic Agents|antimitotic agents|mesh-ancestor
6407514|NCT00242918|Mitosis Modulators|mitosis modulators|mesh-ancestor
6407515|NCT00242918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407516|NCT00242918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6407517|NCT00242918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6407518|NCT00242944|Atorvastatin|atorvastatin|mesh-list
6407519|NCT00242944|Pitavastatin|pitavastatin|mesh-list
6407520|NCT00242944|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6407521|NCT00242944|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6407522|NCT00242944|Antimetabolites|antimetabolites|mesh-ancestor
6407523|NCT00242944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407524|NCT00242944|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6407525|NCT00242944|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6407526|NCT00242944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6407527|NCT00242996|Cyclophosphamide|cyclophosphamide|mesh-list
6407528|NCT00242996|Carmustine|carmustine|mesh-list
6407529|NCT00242996|Rituximab|rituximab|mesh-list
6407530|NCT00242996|Etoposide|etoposide|mesh-list
6407531|NCT00242996|Sargramostim|sargramostim|mesh-list
6407532|NCT00242996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6407533|NCT00242996|Immunologic Factors|immunologic factors|mesh-ancestor
6407534|NCT00242996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407535|NCT00242996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6407536|NCT00242996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6407537|NCT00242996|Alkylating Agents|alkylating agents|mesh-ancestor
6407538|NCT00242996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407539|NCT00242996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6407540|NCT00242996|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6407541|NCT00242996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6407542|NCT00242996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6407543|NCT00242996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6407544|NCT00242996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6407545|NCT00242996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6407546|NCT00243009|Cyclosporine|cyclosporine|mesh-list
6407547|NCT00243009|Mycophenolic Acid|mycophenolic acid|mesh-list
6407548|NCT00243009|Fludarabine|fludarabine|mesh-list
6407549|NCT00243009|Fludarabine phosphate|fludarabine phosphate|mesh-list
6407550|NCT00243009|Cyclosporins|cyclosporins|mesh-list
6407551|NCT00243009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6407552|NCT00243009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6407553|NCT00243009|Antimetabolites|antimetabolites|mesh-ancestor
6407554|NCT00243009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407555|NCT00243009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6407556|NCT00243009|Immunologic Factors|immunologic factors|mesh-ancestor
6407557|NCT00243009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407558|NCT00243009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6407559|NCT00243009|Antifungal Agents|antifungal agents|mesh-ancestor
6407560|NCT00243009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6407561|NCT00243009|Dermatologic Agents|dermatologic agents|mesh-ancestor
6407562|NCT00243009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6407563|NCT00243009|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6407564|NCT00243009|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6407565|NCT00243009|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6407566|NCT00243009|Antitubercular Agents|antitubercular agents|mesh-ancestor
6407567|NCT00243009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6407568|NCT00243035|Bortezomib|bortezomib|mesh-list
6407569|NCT00243035|Tipifarnib|tipifarnib|mesh-list
6407570|NCT00243035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6407571|NCT00243100|Gemcitabine|gemcitabine|mesh-list
6407572|NCT00243100|Vorinostat|vorinostat|mesh-list
6407573|NCT00243100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6407574|NCT00243100|Antimetabolites|antimetabolites|mesh-ancestor
6407575|NCT00243100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407576|NCT00243100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6407577|NCT00243100|Antiviral Agents|antiviral agents|mesh-ancestor
6407578|NCT00243100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6407579|NCT00243100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6407580|NCT00243100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6407581|NCT00243100|Immunologic Factors|immunologic factors|mesh-ancestor
6407582|NCT00243100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407583|NCT00243100|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6407584|NCT00243113|Docetaxel|docetaxel|mesh-list
6407585|NCT00243113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6407586|NCT00243113|Tubulin Modulators|tubulin modulators|mesh-ancestor
6407587|NCT00243113|Antimitotic Agents|antimitotic agents|mesh-ancestor
6407588|NCT00243113|Mitosis Modulators|mitosis modulators|mesh-ancestor
6407589|NCT00243113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407590|NCT00243178|Clopidogrel|clopidogrel|mesh-list
6407591|NCT00243178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6407592|NCT00243178|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6407593|NCT00243178|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6407594|NCT00243178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6407595|NCT00243178|Purinergic Agents|purinergic agents|mesh-ancestor
6407596|NCT00243178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6407597|NCT00243178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407598|NCT00243178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407599|NCT00243204|Docetaxel|docetaxel|mesh-list
6407600|NCT00243204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6407601|NCT00243204|Tubulin Modulators|tubulin modulators|mesh-ancestor
6407602|NCT00243204|Antimitotic Agents|antimitotic agents|mesh-ancestor
6407603|NCT00243204|Mitosis Modulators|mitosis modulators|mesh-ancestor
6407604|NCT00243204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407605|NCT00243256|Cholecalciferol|cholecalciferol|mesh-list
6407606|NCT00243256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6407607|NCT00243256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407608|NCT00243256|Vitamins|vitamins|mesh-ancestor
6407609|NCT00243256|Micronutrients|micronutrients|mesh-ancestor
6407610|NCT00243256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6407611|NCT00243399|Oxandrolone|oxandrolone|mesh-list
6407612|NCT00243399|Androgens|androgens|mesh-ancestor
6407613|NCT00243399|Hormones|hormones|mesh-ancestor
6407614|NCT00243399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6407615|NCT00243399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407616|NCT00243399|Anabolic Agents|anabolic agents|mesh-ancestor
6407617|NCT00243464|Betamethasone|betamethasone|mesh-list
6407618|NCT00243464|Betamethasone Valerate|betamethasone valerate|mesh-list
6407619|NCT00243464|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
6407620|NCT00243464|Betamethasone benzoate|betamethasone benzoate|mesh-list
6407621|NCT00243464|Calcipotriene|calcipotriene|mesh-list
6407622|NCT00243464|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
6407623|NCT00243464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6407624|NCT00243464|Glucocorticoids|glucocorticoids|mesh-ancestor
6407625|NCT00243464|Hormones|hormones|mesh-ancestor
6407626|NCT00243464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6407627|NCT00243464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407628|NCT00243464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6407629|NCT00243464|Respiratory System Agents|respiratory system agents|mesh-ancestor
6407630|NCT00243464|Dermatologic Agents|dermatologic agents|mesh-ancestor
6407631|NCT00243477|Citalopram|citalopram|mesh-list
6407632|NCT00243477|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6407633|NCT00243477|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6407634|NCT00243477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6407635|NCT00243477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407636|NCT00243477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6407637|NCT00243477|Serotonin Agents|serotonin agents|mesh-ancestor
6407638|NCT00243477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407639|NCT00243477|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6407640|NCT00243477|Antidepressive Agents|antidepressive agents|mesh-ancestor
6407641|NCT00243477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6407642|NCT00243646|Bicalutamide|bicalutamide|mesh-list
6407643|NCT00243646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407644|NCT00243646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6407645|NCT00243646|Androgen Antagonists|androgen antagonists|mesh-ancestor
6407646|NCT00243646|Hormone Antagonists|hormone antagonists|mesh-ancestor
6407647|NCT00243646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6407648|NCT00243672|Atorvastatin|atorvastatin|mesh-list
6407649|NCT00243672|Gemfibrozil|gemfibrozil|mesh-list
6407650|NCT00243672|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6407651|NCT00243672|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6407652|NCT00243672|Antimetabolites|antimetabolites|mesh-ancestor
6407653|NCT00243672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407654|NCT00243672|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6407655|NCT00243672|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6407656|NCT00243672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6407657|NCT00243672|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6407658|NCT00243672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6407659|NCT00243711|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6407660|NCT00243711|Glycerol|glycerol|mesh-list
6407661|NCT00243711|Laxatives|laxatives|mesh-ancestor
6407662|NCT00243711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6407663|NCT00243711|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6407664|NCT00243711|Protective Agents|protective agents|mesh-ancestor
6407665|NCT00243711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407666|NCT00243724|Esomeprazole|esomeprazole|mesh-list
6407667|NCT00243724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6407668|NCT00243724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6407669|NCT00243724|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6407670|NCT00243724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6407671|NCT00243724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407672|NCT00243737|Artesunate|artesunate|mesh-list
6407673|NCT00243737|Mefloquine|mefloquine|mesh-list
6407674|NCT00243737|Antimalarials|antimalarials|mesh-ancestor
6407675|NCT00243737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6407676|NCT00243737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6407677|NCT00243737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6407678|NCT00243737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6407679|NCT00243737|Antiviral Agents|antiviral agents|mesh-ancestor
6407680|NCT00243737|Schistosomicides|schistosomicides|mesh-ancestor
6407681|NCT00243737|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6407682|NCT00243737|Anthelmintics|anthelmintics|mesh-ancestor
6407683|NCT00243750|Methotrexate|methotrexate|mesh-list
6407684|NCT00243750|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6407685|NCT00243750|Abortifacient Agents|abortifacient agents|mesh-ancestor
6407686|NCT00243750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6407687|NCT00243750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407688|NCT00243750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6407689|NCT00243750|Antimetabolites|antimetabolites|mesh-ancestor
6407690|NCT00243750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407691|NCT00243750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6407692|NCT00243750|Dermatologic Agents|dermatologic agents|mesh-ancestor
6407693|NCT00243750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6407694|NCT00243750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6407695|NCT00243750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6407696|NCT00243750|Immunologic Factors|immunologic factors|mesh-ancestor
6407697|NCT00243750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6407698|NCT00243750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6407699|NCT00243789|Pentoxifylline|pentoxifylline|mesh-list
6407700|NCT00243789|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6407701|NCT00243789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6407702|NCT00243789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407703|NCT00243789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6407704|NCT00243789|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6407705|NCT00243789|Protective Agents|protective agents|mesh-ancestor
6407706|NCT00243789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407707|NCT00243789|Vasodilator Agents|vasodilator agents|mesh-ancestor
6407708|NCT00243789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6407709|NCT00243789|Antioxidants|antioxidants|mesh-ancestor
6407710|NCT00243815|Ibuprofen|ibuprofen|mesh-list
6407711|NCT00243815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6407712|NCT00243815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6407713|NCT00243815|Analgesics|analgesics|mesh-ancestor
6407714|NCT00243815|Sensory System Agents|sensory system agents|mesh-ancestor
6407715|NCT00243815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6407716|NCT00243815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407717|NCT00243815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6407718|NCT00243815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6407719|NCT00243815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6407720|NCT00243815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6407721|NCT00243815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407722|NCT00243854|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6407723|NCT00243854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6407724|NCT00243854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6407725|NCT00243854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6407726|NCT00243854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407727|NCT00243880|Lovastatin|lovastatin|mesh-list
6407728|NCT00243880|L 647318|l 647318|mesh-list
6538131|NCT00826046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6538132|NCT00826046|Antiviral Agents|antiviral agents|mesh-ancestor
6407729|NCT00243880|Dihydromevinolin|dihydromevinolin|mesh-list
6407730|NCT00243880|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6407731|NCT00243880|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6407732|NCT00243880|Antimetabolites|antimetabolites|mesh-ancestor
6407733|NCT00243880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407734|NCT00243880|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6407735|NCT00243880|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6407736|NCT00243880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6407737|NCT00243893|Doxycycline|doxycycline|mesh-list
6407738|NCT00243893|Minocycline|minocycline|mesh-list
6407739|NCT00243893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6407740|NCT00243893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6407741|NCT00243893|Antimalarials|antimalarials|mesh-ancestor
6407742|NCT00243893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6407743|NCT00243893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6407744|NCT00243945|Rotigotine|rotigotine|mesh-list
6407745|NCT00243945|Dopamine Agonists|dopamine agonists|mesh-ancestor
6407746|NCT00243945|Dopamine Agents|dopamine agents|mesh-ancestor
6407747|NCT00243945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6407748|NCT00243945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407749|NCT00243945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407750|NCT00243984|Topiramate|topiramate|mesh-list
6407751|NCT00243984|Anticonvulsants|anticonvulsants|mesh-ancestor
6407752|NCT00243984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6407753|NCT00243984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407754|NCT00244023|Methyltestosterone|methyltestosterone|mesh-list
6407755|NCT00244023|Testosterone|testosterone|mesh-list
6407756|NCT00244023|Testosterone undecanoate|testosterone undecanoate|mesh-list
6407757|NCT00244023|Testosterone enanthate|testosterone enanthate|mesh-list
6407758|NCT00244023|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6407759|NCT00244023|Androgens|androgens|mesh-ancestor
6407760|NCT00244023|Hormones|hormones|mesh-ancestor
6407761|NCT00244023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6407762|NCT00244023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407763|NCT00244023|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6407764|NCT00244023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6407765|NCT00244023|Anabolic Agents|anabolic agents|mesh-ancestor
6407766|NCT00244075|Hormones|hormones|mesh-list
6407767|NCT00244075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6407768|NCT00244075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407769|NCT00244127|Prednisone|prednisone|mesh-list
6407770|NCT00244127|Cyclophosphamide|cyclophosphamide|mesh-list
6407771|NCT00244127|Rituximab|rituximab|mesh-list
6407772|NCT00244127|Vincristine|vincristine|mesh-list
6407773|NCT00244127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6407774|NCT00244127|Immunologic Factors|immunologic factors|mesh-ancestor
6407775|NCT00244127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407776|NCT00244127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6538133|NCT00826046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6407777|NCT00244127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6407778|NCT00244127|Alkylating Agents|alkylating agents|mesh-ancestor
6407779|NCT00244127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407780|NCT00244127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6407781|NCT00244127|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6407782|NCT00244127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6407783|NCT00244127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6407784|NCT00244127|Glucocorticoids|glucocorticoids|mesh-ancestor
6407785|NCT00244127|Hormones|hormones|mesh-ancestor
6407786|NCT00244127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6407787|NCT00244127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6407788|NCT00244127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6407789|NCT00244127|Tubulin Modulators|tubulin modulators|mesh-ancestor
6407790|NCT00244127|Antimitotic Agents|antimitotic agents|mesh-ancestor
6407791|NCT00244127|Mitosis Modulators|mitosis modulators|mesh-ancestor
6407792|NCT00244153|Dexamethasone|dexamethasone|mesh-list
6407793|NCT00244153|Morphine|morphine|mesh-list
6407794|NCT00244153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6407795|NCT00244153|Antiemetics|antiemetics|mesh-ancestor
6407796|NCT00244153|Autonomic Agents|autonomic agents|mesh-ancestor
6407797|NCT00244153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6407798|NCT00244153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407799|NCT00244153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6407800|NCT00244153|Glucocorticoids|glucocorticoids|mesh-ancestor
6407801|NCT00244153|Hormones|hormones|mesh-ancestor
6407802|NCT00244153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6407803|NCT00244153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6407804|NCT00244153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6407805|NCT00244153|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6407806|NCT00244153|Narcotics|narcotics|mesh-ancestor
6407807|NCT00244153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6407808|NCT00244153|Analgesics|analgesics|mesh-ancestor
6407809|NCT00244153|Sensory System Agents|sensory system agents|mesh-ancestor
6407810|NCT00244166|Prednisolone|prednisolone|mesh-list
6407811|NCT00244166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6407812|NCT00244166|Glucocorticoids|glucocorticoids|mesh-ancestor
6407813|NCT00244166|Hormones|hormones|mesh-ancestor
6407814|NCT00244166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6407815|NCT00244166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407816|NCT00244166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6407817|NCT00244166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6407818|NCT00244179|Interferons|interferons|mesh-list
6407819|NCT00244179|Interferon-gamma|interferon-gamma|mesh-list
6407820|NCT00244179|Infliximab|infliximab|mesh-list
6407821|NCT00244179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6407822|NCT00244179|Antiviral Agents|antiviral agents|mesh-ancestor
6407823|NCT00244179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6407824|NCT00244179|Dermatologic Agents|dermatologic agents|mesh-ancestor
6407825|NCT00244179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6407826|NCT00244179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6407827|NCT00244192|Infliximab|infliximab|mesh-list
6407828|NCT00244192|Dermatologic Agents|dermatologic agents|mesh-ancestor
6407829|NCT00244192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6407830|NCT00244192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6407831|NCT00244283|Sevoflurane|sevoflurane|mesh-list
6407832|NCT00244283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6407833|NCT00244283|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6407834|NCT00244283|Anesthetics, General|anesthetics, general|mesh-ancestor
6407835|NCT00244283|Anesthetics|anesthetics|mesh-ancestor
6407836|NCT00244283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6407837|NCT00244283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407838|NCT00244296|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6407839|NCT00244296|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6407840|NCT00244296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6407841|NCT00244296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6407842|NCT00244296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407843|NCT00244296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6407844|NCT00244296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407845|NCT00244296|Analgesics|analgesics|mesh-ancestor
6407846|NCT00244296|Sensory System Agents|sensory system agents|mesh-ancestor
6407847|NCT00244296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6407848|NCT00244296|Antidepressive Agents|antidepressive agents|mesh-ancestor
6407849|NCT00244296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6407850|NCT00244296|Dopamine Agents|dopamine agents|mesh-ancestor
6407851|NCT00244309|Tamsulosin|tamsulosin|mesh-list
6407852|NCT00244309|Dutasteride|dutasteride|mesh-list
6407853|NCT00244309|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6407854|NCT00244309|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6407855|NCT00244309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6407856|NCT00244309|Adrenergic Agents|adrenergic agents|mesh-ancestor
6407857|NCT00244309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6407858|NCT00244309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407859|NCT00244309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407860|NCT00244309|Urological Agents|urological agents|mesh-ancestor
6407861|NCT00244309|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6407862|NCT00244309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6407863|NCT00244309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6407864|NCT00244309|Hormone Antagonists|hormone antagonists|mesh-ancestor
6407865|NCT00244309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6459617|NCT00446004|Imatinib Mesylate|imatinib mesylate|mesh-list
6459618|NCT00446004|Omeprazole|omeprazole|mesh-list
6459619|NCT00446004|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
6459620|NCT00446004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6459621|NCT00446004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6459622|NCT00446004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6459623|NCT00446004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459624|NCT00446004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6459625|NCT00446004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6459626|NCT00446017|Milrinone|milrinone|mesh-list
6459627|NCT00446017|Epinephrine|epinephrine|mesh-list
6459628|NCT00446017|Racepinephrine|racepinephrine|mesh-list
6459629|NCT00446017|Epinephryl borate|epinephryl borate|mesh-list
6459630|NCT00446017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6459631|NCT00446017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6459632|NCT00446017|Adrenergic Agents|adrenergic agents|mesh-ancestor
6459633|NCT00446017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6459634|NCT00446017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459635|NCT00446017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459636|NCT00446017|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6459637|NCT00446017|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6459638|NCT00446017|Autonomic Agents|autonomic agents|mesh-ancestor
6459639|NCT00446017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6459640|NCT00446017|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6459641|NCT00446017|Respiratory System Agents|respiratory system agents|mesh-ancestor
6459642|NCT00446017|Mydriatics|mydriatics|mesh-ancestor
6459643|NCT00446017|Sympathomimetics|sympathomimetics|mesh-ancestor
6459644|NCT00446017|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6459645|NCT00446017|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6459646|NCT00446017|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6459647|NCT00446017|Vasodilator Agents|vasodilator agents|mesh-ancestor
6459648|NCT00446017|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6459649|NCT00446017|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6459650|NCT00446017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6459651|NCT00446017|Protective Agents|protective agents|mesh-ancestor
6459652|NCT00446043|Adapalene|adapalene|mesh-list
6459653|NCT00446043|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
6459654|NCT00446043|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6459655|NCT00446043|Dermatologic Agents|dermatologic agents|mesh-ancestor
6459656|NCT00446043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6459657|NCT00446043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6459658|NCT00446043|Analgesics|analgesics|mesh-ancestor
6459659|NCT00446043|Sensory System Agents|sensory system agents|mesh-ancestor
6459660|NCT00446043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6459661|NCT00446043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459662|NCT00446043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6459663|NCT00446043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6459664|NCT00446069|Morphine|morphine|mesh-list
6459665|NCT00446069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6459666|NCT00446069|Narcotics|narcotics|mesh-ancestor
6459667|NCT00446069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6459668|NCT00446069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459669|NCT00446069|Analgesics|analgesics|mesh-ancestor
6459670|NCT00446069|Sensory System Agents|sensory system agents|mesh-ancestor
6459671|NCT00446069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6459672|NCT00446082|Pasireotide|pasireotide|mesh-list
6459673|NCT00446082|Hormones|hormones|mesh-ancestor
6538134|NCT00826163|Budesonide|budesonide|mesh-list
6407866|NCT00244348|Fluorouracil|fluorouracil|mesh-list
6407867|NCT00244348|Oxaliplatin|oxaliplatin|mesh-list
6407868|NCT00244348|Antimetabolites|antimetabolites|mesh-ancestor
6407869|NCT00244348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407870|NCT00244348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6407871|NCT00244348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6407872|NCT00244348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6407873|NCT00244348|Immunologic Factors|immunologic factors|mesh-ancestor
6407874|NCT00244348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407875|NCT00244361|Rituximab|rituximab|mesh-list
6407876|NCT00244361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6407877|NCT00244361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6407878|NCT00244361|Immunologic Factors|immunologic factors|mesh-ancestor
6407879|NCT00244361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407880|NCT00244361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6407881|NCT00244426|Aspirin|aspirin|mesh-list
6407882|NCT00244426|Indobufen|indobufen|mesh-list
6407883|NCT00244426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6407884|NCT00244426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6407885|NCT00244426|Analgesics|analgesics|mesh-ancestor
6407886|NCT00244426|Sensory System Agents|sensory system agents|mesh-ancestor
6407887|NCT00244426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6407888|NCT00244426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407889|NCT00244426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6407890|NCT00244426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6407891|NCT00244426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6407892|NCT00244426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6407893|NCT00244426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407894|NCT00244426|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6407895|NCT00244426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6407896|NCT00244426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6407897|NCT00244426|Antipyretics|antipyretics|mesh-ancestor
6407898|NCT00244439|Permethrin|permethrin|mesh-list
6407899|NCT00244439|Malathion|malathion|mesh-list
6407900|NCT00244439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6407901|NCT00244439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407902|NCT00244439|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6407903|NCT00244439|Cholinergic Agents|cholinergic agents|mesh-ancestor
6407904|NCT00244439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6407905|NCT00244439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407906|NCT00244452|Cetrorelix|cetrorelix|mesh-list
6407907|NCT00244452|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6407908|NCT00244452|Fertility Agents|fertility agents|mesh-ancestor
6407909|NCT00244452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6407910|NCT00244452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407911|NCT00244452|Hormone Antagonists|hormone antagonists|mesh-ancestor
6407912|NCT00244452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6407913|NCT00244504|Moxonidine|moxonidine|mesh-list
6407914|NCT00244504|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6407915|NCT00244517|Remifentanil|remifentanil|mesh-list
6407916|NCT00244517|Sevoflurane|sevoflurane|mesh-list
6407917|NCT00244517|Desflurane|desflurane|mesh-list
6407918|NCT00244517|Isoflurane|isoflurane|mesh-list
6407919|NCT00244517|Anesthetics|anesthetics|mesh-ancestor
6407920|NCT00244517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6407921|NCT00244517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407922|NCT00244517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6407923|NCT00244517|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6407924|NCT00244517|Anesthetics, General|anesthetics, general|mesh-ancestor
6407925|NCT00244517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6407926|NCT00244517|Narcotics|narcotics|mesh-ancestor
6407927|NCT00244517|Analgesics|analgesics|mesh-ancestor
6407928|NCT00244517|Sensory System Agents|sensory system agents|mesh-ancestor
6407929|NCT00244517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6407930|NCT00244530|Nifedipine|nifedipine|mesh-list
6407931|NCT00244530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6407932|NCT00244530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6407933|NCT00244530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407934|NCT00244530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6407935|NCT00244530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407936|NCT00244530|Vasodilator Agents|vasodilator agents|mesh-ancestor
6407937|NCT00244530|Tocolytic Agents|tocolytic agents|mesh-ancestor
6407938|NCT00244530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6407939|NCT00244556|Etanercept|etanercept|mesh-list
6407940|NCT00244556|Methotrexate|methotrexate|mesh-list
6407941|NCT00244556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6407942|NCT00244556|Abortifacient Agents|abortifacient agents|mesh-ancestor
6407943|NCT00244556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6407944|NCT00244556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407945|NCT00244556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6407946|NCT00244556|Antimetabolites|antimetabolites|mesh-ancestor
6407947|NCT00244556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407948|NCT00244556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6407949|NCT00244556|Dermatologic Agents|dermatologic agents|mesh-ancestor
6407950|NCT00244556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6407951|NCT00244556|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6407952|NCT00244556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6407953|NCT00244556|Immunologic Factors|immunologic factors|mesh-ancestor
6407954|NCT00244556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6407955|NCT00244556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6407956|NCT00244556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6407957|NCT00244556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6407958|NCT00244556|Analgesics|analgesics|mesh-ancestor
6407959|NCT00244556|Sensory System Agents|sensory system agents|mesh-ancestor
6407960|NCT00244556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6407961|NCT00244556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6407962|NCT00244556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6407963|NCT00244608|Budesonide|budesonide|mesh-list
6407964|NCT00244608|Terbutaline|terbutaline|mesh-list
6407965|NCT00244608|Formoterol Fumarate|formoterol fumarate|mesh-list
6407966|NCT00244608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6407967|NCT00244608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6407968|NCT00244608|Autonomic Agents|autonomic agents|mesh-ancestor
6407969|NCT00244608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6407970|NCT00244608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6407971|NCT00244608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6407972|NCT00244608|Respiratory System Agents|respiratory system agents|mesh-ancestor
6407973|NCT00244608|Glucocorticoids|glucocorticoids|mesh-ancestor
6407974|NCT00244608|Hormones|hormones|mesh-ancestor
6407975|NCT00244608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6407976|NCT00244608|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6407977|NCT00244608|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6407978|NCT00244608|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6407979|NCT00244608|Adrenergic Agents|adrenergic agents|mesh-ancestor
6407980|NCT00244608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6407981|NCT00244608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407982|NCT00244608|Sympathomimetics|sympathomimetics|mesh-ancestor
6407983|NCT00244608|Tocolytic Agents|tocolytic agents|mesh-ancestor
6407984|NCT00244608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6407985|NCT00244738|Castor Oil|castor oil|mesh-list
6407986|NCT00244738|Cathartics|cathartics|mesh-ancestor
6407987|NCT00244738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6407988|NCT00244829|Imatinib Mesylate|imatinib mesylate|mesh-list
6407989|NCT00244829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6407990|NCT00244829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6407991|NCT00244829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6407992|NCT00244829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407993|NCT00244907|Risedronic Acid|risedronic acid|mesh-list
6407994|NCT00244907|Genistein|genistein|mesh-list
6407995|NCT00244907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6407996|NCT00244907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6407997|NCT00244907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6407998|NCT00244907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6407999|NCT00244907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408000|NCT00244907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6408001|NCT00244907|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6408002|NCT00244907|Protective Agents|protective agents|mesh-ancestor
6408003|NCT00244907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6408004|NCT00244907|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6408005|NCT00244907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6408006|NCT00244907|Phytoestrogens|phytoestrogens|mesh-ancestor
6408007|NCT00244907|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6408008|NCT00244907|Estrogens|estrogens|mesh-ancestor
6408009|NCT00244907|Hormones|hormones|mesh-ancestor
6408010|NCT00244907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6408011|NCT00244920|Squalamine|squalamine|mesh-list
6408012|NCT00244920|Leuprolide|leuprolide|mesh-list
6408013|NCT00244920|Bicalutamide|bicalutamide|mesh-list
6408014|NCT00244920|Hormones|hormones|mesh-list
6408015|NCT00244920|Androgen Antagonists|androgen antagonists|mesh-list
6408016|NCT00244920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6408017|NCT00244920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408018|NCT00244920|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6408019|NCT00244920|Fertility Agents|fertility agents|mesh-ancestor
6408020|NCT00244920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6408021|NCT00244920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6408022|NCT00244920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6408023|NCT00244920|Hormone Antagonists|hormone antagonists|mesh-ancestor
6408024|NCT00244920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6408025|NCT00244920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6408026|NCT00244920|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6408027|NCT00244920|Protective Agents|protective agents|mesh-ancestor
6408028|NCT00244920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6408029|NCT00244920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6408030|NCT00244920|Growth Substances|growth substances|mesh-ancestor
6408031|NCT00244920|Growth Inhibitors|growth inhibitors|mesh-ancestor
6408032|NCT00244946|Cytarabine|cytarabine|mesh-list
6408033|NCT00244946|Etoposide|etoposide|mesh-list
6408034|NCT00244946|Melphalan|melphalan|mesh-list
6408035|NCT00244946|Carmustine|carmustine|mesh-list
6408036|NCT00244946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6408037|NCT00244946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6408038|NCT00244946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6408039|NCT00244946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6408040|NCT00244946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6408041|NCT00244946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408042|NCT00244946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6408043|NCT00244946|Antimetabolites|antimetabolites|mesh-ancestor
6408044|NCT00244946|Antiviral Agents|antiviral agents|mesh-ancestor
6408045|NCT00244946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6408046|NCT00244946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6408047|NCT00244946|Immunologic Factors|immunologic factors|mesh-ancestor
6408048|NCT00244946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408049|NCT00244946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6408050|NCT00244946|Alkylating Agents|alkylating agents|mesh-ancestor
6408051|NCT00244946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6408052|NCT00244959|Anastrozole|anastrozole|mesh-list
6408053|NCT00244959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6408054|NCT00244959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6408055|NCT00244959|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6408056|NCT00244959|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6408057|NCT00244959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6408058|NCT00244959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408059|NCT00244959|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6408060|NCT00244959|Hormone Antagonists|hormone antagonists|mesh-ancestor
6408061|NCT00244959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6408062|NCT00244959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408063|NCT00244972|Sorafenib|sorafenib|mesh-list
6408064|NCT00244972|Tipifarnib|tipifarnib|mesh-list
6408065|NCT00244972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6408066|NCT00244972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6408067|NCT00244972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6408068|NCT00244972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408069|NCT00244998|Fulvestrant|fulvestrant|mesh-list
6408070|NCT00244998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6408071|NCT00244998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6408072|NCT00244998|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6408073|NCT00244998|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6408074|NCT00244998|Hormone Antagonists|hormone antagonists|mesh-ancestor
6408075|NCT00244998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6408076|NCT00244998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408077|NCT00245024|Sulindac|sulindac|mesh-list
6408078|NCT00245024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6408079|NCT00245024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6408080|NCT00245024|Analgesics|analgesics|mesh-ancestor
6408081|NCT00245024|Sensory System Agents|sensory system agents|mesh-ancestor
6408082|NCT00245024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6408083|NCT00245024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408084|NCT00245024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6408085|NCT00245024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6408086|NCT00245024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6408087|NCT00245024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6408088|NCT00245024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6408089|NCT00245024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408090|NCT00245089|Dactinomycin|dactinomycin|mesh-list
6408091|NCT00245089|Cyclophosphamide|cyclophosphamide|mesh-list
6408092|NCT00245089|Vincristine|vincristine|mesh-list
6408093|NCT00245089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6408094|NCT00245089|Immunologic Factors|immunologic factors|mesh-ancestor
6408095|NCT00245089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408096|NCT00245089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6408097|NCT00245089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6408098|NCT00245089|Alkylating Agents|alkylating agents|mesh-ancestor
6408099|NCT00245089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408100|NCT00245089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6408101|NCT00245089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6408102|NCT00245089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6408103|NCT00245089|Tubulin Modulators|tubulin modulators|mesh-ancestor
6408104|NCT00245089|Antimitotic Agents|antimitotic agents|mesh-ancestor
6408105|NCT00245089|Mitosis Modulators|mitosis modulators|mesh-ancestor
6408106|NCT00245089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6408107|NCT00245089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6408108|NCT00245089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6408109|NCT00245089|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6408110|NCT00245089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6408111|NCT00245089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6408112|NCT00245115|Cyclophosphamide|cyclophosphamide|mesh-list
6408113|NCT00245115|Busulfan|busulfan|mesh-list
6408114|NCT00245115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6408115|NCT00245115|Immunologic Factors|immunologic factors|mesh-ancestor
6408116|NCT00245115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408117|NCT00245115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6408118|NCT00245115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6408119|NCT00245115|Alkylating Agents|alkylating agents|mesh-ancestor
6408120|NCT00245115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408121|NCT00245115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6408122|NCT00245115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6408123|NCT00245141|Dactinomycin|dactinomycin|mesh-list
6408124|NCT00245141|Cyclophosphamide|cyclophosphamide|mesh-list
6408125|NCT00245141|Vincristine|vincristine|mesh-list
6408126|NCT00245141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6408127|NCT00245141|Immunologic Factors|immunologic factors|mesh-ancestor
6408128|NCT00245141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408129|NCT00245141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6408130|NCT00245141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6408131|NCT00245141|Alkylating Agents|alkylating agents|mesh-ancestor
6408132|NCT00245141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408133|NCT00245141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6408134|NCT00245141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6408135|NCT00245141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6408136|NCT00245141|Tubulin Modulators|tubulin modulators|mesh-ancestor
6408137|NCT00245141|Antimitotic Agents|antimitotic agents|mesh-ancestor
6408138|NCT00245141|Mitosis Modulators|mitosis modulators|mesh-ancestor
6408139|NCT00245141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6408140|NCT00245141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6408141|NCT00245141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6408142|NCT00245141|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6408143|NCT00245141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6408144|NCT00245141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6408145|NCT00245154|Paclitaxel|paclitaxel|mesh-list
6408146|NCT00245154|Carboplatin|carboplatin|mesh-list
6408147|NCT00245154|Cediranib|cediranib|mesh-list
6408148|NCT00245154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6408149|NCT00245154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6408150|NCT00245154|Tubulin Modulators|tubulin modulators|mesh-ancestor
6408151|NCT00245154|Antimitotic Agents|antimitotic agents|mesh-ancestor
6408152|NCT00245154|Mitosis Modulators|mitosis modulators|mesh-ancestor
6408153|NCT00245154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408154|NCT00245154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6408155|NCT00245154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6408156|NCT00245206|Olanzapine|olanzapine|mesh-list
6408157|NCT00245206|Risperidone|risperidone|mesh-list
6408158|NCT00245206|Aripiprazole|aripiprazole|mesh-list
6408159|NCT00245206|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6408160|NCT00245206|Serotonin Agents|serotonin agents|mesh-ancestor
6408161|NCT00245206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6408162|NCT00245206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408163|NCT00245206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408164|NCT00245206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6408165|NCT00245206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6408166|NCT00245206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6408167|NCT00245206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6408168|NCT00245206|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6408169|NCT00245206|Dopamine Agents|dopamine agents|mesh-ancestor
6408170|NCT00245206|Antiemetics|antiemetics|mesh-ancestor
6408171|NCT00245206|Autonomic Agents|autonomic agents|mesh-ancestor
6408172|NCT00245206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6408173|NCT00245206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6408174|NCT00245206|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6408175|NCT00245206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6408176|NCT00245206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6408177|NCT00245206|Antidepressive Agents|antidepressive agents|mesh-ancestor
6408178|NCT00245206|Dopamine Agonists|dopamine agonists|mesh-ancestor
6408179|NCT00245206|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6408180|NCT00245206|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6408181|NCT00245206|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6408182|NCT00245206|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6408183|NCT00245245|Factor VIII|factor viii|mesh-list
6408184|NCT00245245|Coagulants|coagulants|mesh-ancestor
6408185|NCT00245258|Sildenafil Citrate|sildenafil citrate|mesh-list
6408186|NCT00245258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408187|NCT00245258|Vasodilator Agents|vasodilator agents|mesh-ancestor
6408188|NCT00245258|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6408189|NCT00245258|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6408190|NCT00245258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6408191|NCT00245258|Urological Agents|urological agents|mesh-ancestor
6408192|NCT00245297|Factor VIII|factor viii|mesh-list
6408193|NCT00245297|Coagulants|coagulants|mesh-ancestor
6408194|NCT00245336|Thrombin|thrombin|mesh-list
6408195|NCT00245336|Hemostatics|hemostatics|mesh-ancestor
6408196|NCT00245336|Coagulants|coagulants|mesh-ancestor
6408197|NCT00245375|Acetaminophen|acetaminophen|mesh-list
6408198|NCT00245375|Ibuprofen|ibuprofen|mesh-list
6408199|NCT00245375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6408200|NCT00245375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6408201|NCT00245375|Analgesics|analgesics|mesh-ancestor
6408202|NCT00245375|Sensory System Agents|sensory system agents|mesh-ancestor
6408203|NCT00245375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6408204|NCT00245375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408205|NCT00245375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6408206|NCT00245375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6408207|NCT00245375|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6408208|NCT00245375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6408209|NCT00245375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408210|NCT00245375|Antipyretics|antipyretics|mesh-ancestor
6408211|NCT00245401|Sirolimus|sirolimus|mesh-list
6408212|NCT00245401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6408213|NCT00245401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6408214|NCT00245401|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6408215|NCT00245401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6408216|NCT00245401|Antifungal Agents|antifungal agents|mesh-ancestor
6408217|NCT00245401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6408218|NCT00245401|Immunologic Factors|immunologic factors|mesh-ancestor
6408219|NCT00245401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408220|NCT00245414|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6408221|NCT00245414|Interferon-alpha|interferon-alpha|mesh-list
6408222|NCT00245414|Antiviral Agents|antiviral agents|mesh-ancestor
6408223|NCT00245414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6408224|NCT00245414|Immunologic Factors|immunologic factors|mesh-ancestor
6408225|NCT00245414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408226|NCT00245427|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6408227|NCT00245427|Lactams|lactams|mesh-list
6408228|NCT00245427|beta-Lactams|beta-lactams|mesh-list
6408229|NCT00245427|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6408230|NCT00245427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6408231|NCT00245427|Antitubercular Agents|antitubercular agents|mesh-ancestor
6408232|NCT00245440|Azithromycin|azithromycin|mesh-list
6408233|NCT00245440|Telithromycin|telithromycin|mesh-list
6408234|NCT00245440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6408235|NCT00245440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6408236|NCT00245453|Azithromycin|azithromycin|mesh-list
6408237|NCT00245453|Clarithromycin|clarithromycin|mesh-list
6408238|NCT00245453|Telithromycin|telithromycin|mesh-list
6408239|NCT00245453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6408240|NCT00245453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6408241|NCT00245453|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6408242|NCT00245453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6408243|NCT00245453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408244|NCT00245453|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6408245|NCT00245453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6408246|NCT00245505|Mesalamine|mesalamine|mesh-list
6408247|NCT00245505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6408248|NCT00245505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6408249|NCT00245505|Analgesics|analgesics|mesh-ancestor
6408250|NCT00245505|Sensory System Agents|sensory system agents|mesh-ancestor
6408251|NCT00245505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6408252|NCT00245505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408253|NCT00245505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6408254|NCT00245505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6408255|NCT00245596|Sildenafil Citrate|sildenafil citrate|mesh-list
6408256|NCT00245596|Vasodilator Agents|vasodilator agents|mesh-ancestor
6408257|NCT00245596|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6408258|NCT00245596|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6408259|NCT00245596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6408260|NCT00245596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408261|NCT00245596|Urological Agents|urological agents|mesh-ancestor
6408262|NCT00245609|Pregabalin|pregabalin|mesh-list
6408263|NCT00245609|Alprazolam|alprazolam|mesh-list
6408264|NCT00245609|Analgesics|analgesics|mesh-ancestor
6408265|NCT00245609|Sensory System Agents|sensory system agents|mesh-ancestor
6408266|NCT00245609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6408267|NCT00245609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408268|NCT00245609|Anticonvulsants|anticonvulsants|mesh-ancestor
6408269|NCT00245609|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6408270|NCT00245609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6408271|NCT00245609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408272|NCT00245609|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6408273|NCT00245609|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6408274|NCT00245609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6408275|NCT00245609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6408276|NCT00245609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6408277|NCT00245609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6408278|NCT00245609|GABA Modulators|gaba modulators|mesh-ancestor
6408279|NCT00245609|GABA Agents|gaba agents|mesh-ancestor
6408280|NCT00245609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6408281|NCT00245661|Temazepam|temazepam|mesh-list
6408282|NCT00245661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6408283|NCT00245661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6408284|NCT00245661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408285|NCT00245661|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6408286|NCT00245661|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6408287|NCT00245661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6408288|NCT00245661|GABA Modulators|gaba modulators|mesh-ancestor
6408289|NCT00245661|GABA Agents|gaba agents|mesh-ancestor
6408290|NCT00245661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6408291|NCT00245661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408292|NCT00245674|Amisulpride|amisulpride|mesh-list
6408293|NCT00245674|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6408294|NCT00245674|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6408295|NCT00245674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6408296|NCT00245674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408297|NCT00245674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6408298|NCT00245674|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6408299|NCT00245674|Dopamine Agents|dopamine agents|mesh-ancestor
6408300|NCT00245674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6408301|NCT00245674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408302|NCT00245674|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6408303|NCT00245674|Antidepressive Agents|antidepressive agents|mesh-ancestor
5501201|NCT04476511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5501202|NCT04476511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501203|NCT04476511|Vitamins|vitamins|mesh-ancestor
5501204|NCT04476511|Micronutrients|micronutrients|mesh-ancestor
5501205|NCT04476511|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5501206|NCT04476680|Vitamin D|vitamin d|mesh-list
5501207|NCT04476680|Vitamins|vitamins|mesh-ancestor
5501208|NCT04476680|Micronutrients|micronutrients|mesh-ancestor
5501209|NCT04476680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408304|NCT00245713|Levetiracetam|levetiracetam|mesh-list
6408305|NCT00245713|Anticonvulsants|anticonvulsants|mesh-ancestor
6408306|NCT00245713|Nootropic Agents|nootropic agents|mesh-ancestor
6408307|NCT00245739|Darunavir|darunavir|mesh-list
6408308|NCT00245739|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6408309|NCT00245739|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6408310|NCT00245739|Protease Inhibitors|protease inhibitors|mesh-ancestor
6408311|NCT00245739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6408312|NCT00245739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408313|NCT00245739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6408314|NCT00245739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6408315|NCT00245739|Antiviral Agents|antiviral agents|mesh-ancestor
6408316|NCT00245739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6408317|NCT00245791|Levofloxacin|levofloxacin|mesh-list
6408318|NCT00245791|Ofloxacin|ofloxacin|mesh-list
6408319|NCT00245791|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6408320|NCT00245791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6408321|NCT00245791|Renal Agents|renal agents|mesh-ancestor
6408322|NCT00245791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6408323|NCT00245791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6408324|NCT00245791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5501210|NCT04476680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5501211|NCT04476745|Vitamin D|vitamin d|mesh-list
5501212|NCT04476745|Cholecalciferol|cholecalciferol|mesh-list
5501213|NCT04476745|Vitamins|vitamins|mesh-ancestor
5501214|NCT04476745|Micronutrients|micronutrients|mesh-ancestor
5501215|NCT04476745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501216|NCT04476745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5501217|NCT04476745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6408325|NCT00245791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6408326|NCT00245791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408327|NCT00245791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6408328|NCT00245791|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6408329|NCT00245791|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6408330|NCT00245895|Darbepoetin alfa|darbepoetin alfa|mesh-list
6408331|NCT00245895|Hematinics|hematinics|mesh-ancestor
6408332|NCT00245908|Azithromycin|azithromycin|mesh-list
6408333|NCT00245908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6408334|NCT00245908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6408335|NCT00245921|Levonorgestrel|levonorgestrel|mesh-list
6408336|NCT00245921|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6408337|NCT00245921|Estradiol|estradiol|mesh-list
6408338|NCT00245921|Estrogens|estrogens|mesh-ancestor
6408339|NCT00245921|Hormones|hormones|mesh-ancestor
6408340|NCT00245921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6408341|NCT00245921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408342|NCT00245921|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6408343|NCT00245921|Contraceptive Agents|contraceptive agents|mesh-ancestor
6408344|NCT00245921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6408345|NCT00245921|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6408346|NCT00245921|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6408347|NCT00245921|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6408348|NCT00245921|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6408349|NCT00245934|Etanercept|etanercept|mesh-list
6408350|NCT00245934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6408351|NCT00245934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6408352|NCT00245934|Analgesics|analgesics|mesh-ancestor
6408353|NCT00245934|Sensory System Agents|sensory system agents|mesh-ancestor
6408354|NCT00245934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6408355|NCT00245934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408356|NCT00245934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6408357|NCT00245934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6408358|NCT00245934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6408359|NCT00245934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6408360|NCT00245934|Immunologic Factors|immunologic factors|mesh-ancestor
6459674|NCT00446082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6459675|NCT00446082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459676|NCT00446173|Cyclophosphamide|cyclophosphamide|mesh-list
6459677|NCT00446173|Busulfan|busulfan|mesh-list
6459678|NCT00446173|Sargramostim|sargramostim|mesh-list
6459679|NCT00446173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6459680|NCT00446173|Immunologic Factors|immunologic factors|mesh-ancestor
6459681|NCT00446173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459682|NCT00446173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6459683|NCT00446173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6459684|NCT00446173|Alkylating Agents|alkylating agents|mesh-ancestor
6459685|NCT00446173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459686|NCT00446173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6459687|NCT00446173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6459688|NCT00446212|Propofol|propofol|mesh-list
6459689|NCT00446212|Desflurane|desflurane|mesh-list
6459690|NCT00446212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6459691|NCT00446212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6459692|NCT00446212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408361|NCT00246064|Infliximab|infliximab|mesh-list
6408362|NCT00246064|Dermatologic Agents|dermatologic agents|mesh-ancestor
6408363|NCT00246064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6408364|NCT00246064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6408365|NCT00246103|Cyclophosphamide|cyclophosphamide|mesh-list
6408366|NCT00246103|Fluorouracil|fluorouracil|mesh-list
6408367|NCT00246103|Epirubicin|epirubicin|mesh-list
6408368|NCT00246103|Valproic Acid|valproic acid|mesh-list
6408369|NCT00246103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6408370|NCT00246103|Immunologic Factors|immunologic factors|mesh-ancestor
6408371|NCT00246103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408372|NCT00246103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6408373|NCT00246103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6408374|NCT00246103|Alkylating Agents|alkylating agents|mesh-ancestor
6408375|NCT00246103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408376|NCT00246103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6408377|NCT00246103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6408378|NCT00246103|Antimetabolites|antimetabolites|mesh-ancestor
6408379|NCT00246103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6408380|NCT00246103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6408381|NCT00246103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6408382|NCT00246103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6408383|NCT00246103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6408384|NCT00246103|Anticonvulsants|anticonvulsants|mesh-ancestor
6408385|NCT00246103|GABA Agents|gaba agents|mesh-ancestor
6408386|NCT00246103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6408387|NCT00246103|Antimanic Agents|antimanic agents|mesh-ancestor
6408388|NCT00246103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6408389|NCT00246103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6408390|NCT00246103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6408391|NCT00246142|Botulinum Toxins|botulinum toxins|mesh-list
6408392|NCT00246142|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6408393|NCT00246142|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6408394|NCT00246142|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6408395|NCT00246142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6408396|NCT00246142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408397|NCT00246142|Cholinergic Agents|cholinergic agents|mesh-ancestor
6408398|NCT00246142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6408399|NCT00246142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408400|NCT00246142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6408401|NCT00246142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6408402|NCT00246155|Botulinum Toxins|botulinum toxins|mesh-list
6408403|NCT00246155|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6408404|NCT00246155|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6408405|NCT00246155|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6408406|NCT00246155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6408407|NCT00246155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408408|NCT00246155|Cholinergic Agents|cholinergic agents|mesh-ancestor
6408409|NCT00246155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6408410|NCT00246155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408411|NCT00246155|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6408412|NCT00246155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6408413|NCT00246168|Acetaminophen|acetaminophen|mesh-list
6408414|NCT00246168|Tramadol|tramadol|mesh-list
6408415|NCT00246168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6408416|NCT00246168|Analgesics|analgesics|mesh-ancestor
6408417|NCT00246168|Sensory System Agents|sensory system agents|mesh-ancestor
6408418|NCT00246168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6408419|NCT00246168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408420|NCT00246168|Antipyretics|antipyretics|mesh-ancestor
6408421|NCT00246168|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6408422|NCT00246168|Narcotics|narcotics|mesh-ancestor
6408423|NCT00246168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6408424|NCT00246194|Risperidone|risperidone|mesh-list
6408425|NCT00246194|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6408426|NCT00246194|Serotonin Agents|serotonin agents|mesh-ancestor
6408427|NCT00246194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6408428|NCT00246194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408429|NCT00246194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408430|NCT00246194|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6408431|NCT00246194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6408432|NCT00246194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6408433|NCT00246194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6408434|NCT00246194|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6408435|NCT00246194|Dopamine Agents|dopamine agents|mesh-ancestor
6408436|NCT00246207|Methylphenidate|methylphenidate|mesh-list
6408437|NCT00246207|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6408438|NCT00246207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408439|NCT00246207|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6408440|NCT00246207|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6408441|NCT00246207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6408442|NCT00246207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408443|NCT00246207|Dopamine Agents|dopamine agents|mesh-ancestor
6408444|NCT00246207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6408445|NCT00246220|Methylphenidate|methylphenidate|mesh-list
6408446|NCT00246220|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6408447|NCT00246220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408448|NCT00246220|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6408449|NCT00246220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6408450|NCT00246220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6408451|NCT00246220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408452|NCT00246220|Dopamine Agents|dopamine agents|mesh-ancestor
6408453|NCT00246220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6408454|NCT00246233|Methylphenidate|methylphenidate|mesh-list
6408455|NCT00246233|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6408456|NCT00246233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408457|NCT00246233|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6408458|NCT00246233|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6408459|NCT00246233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6408460|NCT00246233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408461|NCT00246233|Dopamine Agents|dopamine agents|mesh-ancestor
6408462|NCT00246233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6408463|NCT00246246|Risperidone|risperidone|mesh-list
6408464|NCT00246246|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6408465|NCT00246246|Serotonin Agents|serotonin agents|mesh-ancestor
6408466|NCT00246246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6408467|NCT00246246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408468|NCT00246246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408469|NCT00246246|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6408470|NCT00246246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6408471|NCT00246246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6408472|NCT00246246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6408473|NCT00246246|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6408474|NCT00246246|Dopamine Agents|dopamine agents|mesh-ancestor
6408475|NCT00246272|Risperidone|risperidone|mesh-list
6408476|NCT00246272|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6408477|NCT00246272|Serotonin Agents|serotonin agents|mesh-ancestor
6408478|NCT00246272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6408479|NCT00246272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408480|NCT00246272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408481|NCT00246272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6408482|NCT00246272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6408483|NCT00246272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6408484|NCT00246272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6408485|NCT00246272|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6408486|NCT00246272|Dopamine Agents|dopamine agents|mesh-ancestor
6408487|NCT00246285|Risperidone|risperidone|mesh-list
6408488|NCT00246285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6408489|NCT00246285|Serotonin Agents|serotonin agents|mesh-ancestor
6408490|NCT00246285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6408491|NCT00246285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408492|NCT00246285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408493|NCT00246285|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6408494|NCT00246285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6408495|NCT00246285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6408496|NCT00246285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6408497|NCT00246285|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6408498|NCT00246285|Dopamine Agents|dopamine agents|mesh-ancestor
6408499|NCT00246298|Epoetin Alfa|epoetin alfa|mesh-list
6408500|NCT00246298|Hematinics|hematinics|mesh-ancestor
6408501|NCT00246363|Silymarin|silymarin|mesh-list
6408502|NCT00246363|Antioxidants|antioxidants|mesh-ancestor
6408503|NCT00246363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408504|NCT00246363|Protective Agents|protective agents|mesh-ancestor
6408505|NCT00246363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408506|NCT00246389|Cyclobenzaprine|cyclobenzaprine|mesh-list
6408507|NCT00246389|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6408508|NCT00246389|Antidepressive Agents|antidepressive agents|mesh-ancestor
6408509|NCT00246389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6408510|NCT00246389|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6408511|NCT00246389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408512|NCT00246389|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6408513|NCT00246389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6408514|NCT00246389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6408515|NCT00246389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6408516|NCT00246402|Acipimox|acipimox|mesh-list
6408517|NCT00246402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6408518|NCT00246402|Antimetabolites|antimetabolites|mesh-ancestor
6408519|NCT00246402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408520|NCT00246402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6408521|NCT00246415|Memantine|memantine|mesh-list
6408522|NCT00246415|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6408523|NCT00246415|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6408524|NCT00246415|Dopamine Agents|dopamine agents|mesh-ancestor
6408525|NCT00246415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6408526|NCT00246415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501218|NCT04476459|Apatinib|apatinib|mesh-list
6408527|NCT00246415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408528|NCT00246415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6408529|NCT00246415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6408530|NCT00246467|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6408531|NCT00246467|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6408532|NCT00246467|Immunologic Factors|immunologic factors|mesh-ancestor
6408533|NCT00246467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408534|NCT00246467|Antacids|antacids|mesh-ancestor
6408535|NCT00246467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408536|NCT00246467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6408537|NCT00246532|Morphine|morphine|mesh-list
6408538|NCT00246532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6408539|NCT00246532|Narcotics|narcotics|mesh-ancestor
6408540|NCT00246532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6408541|NCT00246532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408542|NCT00246532|Analgesics|analgesics|mesh-ancestor
6408543|NCT00246532|Sensory System Agents|sensory system agents|mesh-ancestor
6408544|NCT00246532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6408545|NCT00246597|Epoetin Alfa|epoetin alfa|mesh-list
6408546|NCT00246597|Hematinics|hematinics|mesh-ancestor
6408547|NCT00246610|Nelfinavir|nelfinavir|mesh-list
6408548|NCT00246610|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6408549|NCT00246610|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6408550|NCT00246610|Protease Inhibitors|protease inhibitors|mesh-ancestor
6408551|NCT00246610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6408552|NCT00246610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408553|NCT00246610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6408554|NCT00246610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6408555|NCT00246610|Antiviral Agents|antiviral agents|mesh-ancestor
6408556|NCT00246610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6408557|NCT00246623|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6408558|NCT00246623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408559|NCT00246636|Fenofibrate|fenofibrate|mesh-list
6408560|NCT00246636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6408561|NCT00246636|Antimetabolites|antimetabolites|mesh-ancestor
6408562|NCT00246636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408563|NCT00246636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6408564|NCT00246675|Furosemide|furosemide|mesh-list
6408565|NCT00246675|Diuretics|diuretics|mesh-ancestor
6408566|NCT00246675|Natriuretic Agents|natriuretic agents|mesh-ancestor
6408567|NCT00246675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408568|NCT00246675|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6408569|NCT00246675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6408570|NCT00246675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408571|NCT00246688|Sagopilone|sagopilone|mesh-list
6408572|NCT00246688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6408573|NCT00246701|Simvastatin|simvastatin|mesh-list
6408574|NCT00246701|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6408575|NCT00246701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6408576|NCT00246701|Antimetabolites|antimetabolites|mesh-ancestor
6408577|NCT00246701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408578|NCT00246701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6408579|NCT00246701|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6408580|NCT00246701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6408581|NCT00246909|Pantoprazole|pantoprazole|mesh-list
6408582|NCT00246909|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6408583|NCT00246909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6408584|NCT00246909|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6408585|NCT00246909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6408586|NCT00246909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408587|NCT00246974|Gemcitabine|gemcitabine|mesh-list
6408588|NCT00246974|Gefitinib|gefitinib|mesh-list
6408589|NCT00246974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6408590|NCT00246974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6408591|NCT00246974|Antimetabolites|antimetabolites|mesh-ancestor
6408592|NCT00246974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408593|NCT00246974|Antiviral Agents|antiviral agents|mesh-ancestor
6408594|NCT00246974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6408595|NCT00246974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6408596|NCT00246974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6408597|NCT00246974|Immunologic Factors|immunologic factors|mesh-ancestor
6408598|NCT00246974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408599|NCT00246974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6408600|NCT00247026|Ubiquinone|ubiquinone|mesh-list
6408601|NCT00247026|Coenzyme Q10|coenzyme q10|mesh-list
6408602|NCT00247026|Curcumin|curcumin|mesh-list
6408603|NCT00247026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6408604|NCT00247026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6408605|NCT00247026|Analgesics|analgesics|mesh-ancestor
6408606|NCT00247026|Sensory System Agents|sensory system agents|mesh-ancestor
6408607|NCT00247026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6408608|NCT00247026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408609|NCT00247026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6408610|NCT00247026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6408611|NCT00247026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6408612|NCT00247026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6408613|NCT00247026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408614|NCT00247026|Micronutrients|micronutrients|mesh-ancestor
6408615|NCT00247026|Vitamins|vitamins|mesh-ancestor
6408616|NCT00247052|Diclofenac|diclofenac|mesh-list
6408617|NCT00247052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6408618|NCT00247052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6408619|NCT00247052|Analgesics|analgesics|mesh-ancestor
6408620|NCT00247052|Sensory System Agents|sensory system agents|mesh-ancestor
6408621|NCT00247052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6408622|NCT00247052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408623|NCT00247052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6408624|NCT00247052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6408625|NCT00247052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6408626|NCT00247052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6408627|NCT00247052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408628|NCT00247078|Antivenins|antivenins|mesh-list
6408629|NCT00247078|Immunologic Factors|immunologic factors|mesh-ancestor
6408630|NCT00247078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408631|NCT00247117|Metformin|metformin|mesh-list
6408632|NCT00247117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6408633|NCT00247117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408634|NCT00247130|Omeprazole|omeprazole|mesh-list
6408635|NCT00247130|Ranitidine|ranitidine|mesh-list
6408636|NCT00247130|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
6408637|NCT00247130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6408638|NCT00247130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6408639|NCT00247130|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6408640|NCT00247130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6408641|NCT00247130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408642|NCT00247130|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6408643|NCT00247130|Histamine Antagonists|histamine antagonists|mesh-ancestor
6408644|NCT00247130|Histamine Agents|histamine agents|mesh-ancestor
6408645|NCT00247130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6408646|NCT00247130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408647|NCT00247143|Lopinavir|lopinavir|mesh-list
6408648|NCT00247143|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6408649|NCT00247143|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6408650|NCT00247143|Protease Inhibitors|protease inhibitors|mesh-ancestor
6408651|NCT00247143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6408652|NCT00247143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408653|NCT00247143|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6408654|NCT00247143|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6408655|NCT00247143|Antiviral Agents|antiviral agents|mesh-ancestor
6408656|NCT00247143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6408657|NCT00247143|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6408658|NCT00247143|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6408659|NCT00247169|Progesterone|progesterone|mesh-list
6408660|NCT00247169|Progestins|progestins|mesh-ancestor
6408661|NCT00247169|Hormones|hormones|mesh-ancestor
6408662|NCT00247169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6408663|NCT00247169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408664|NCT00247208|Paclitaxel|paclitaxel|mesh-list
6408665|NCT00247208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6408666|NCT00247208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6408667|NCT00247208|Tubulin Modulators|tubulin modulators|mesh-ancestor
6408668|NCT00247208|Antimitotic Agents|antimitotic agents|mesh-ancestor
6408669|NCT00247208|Mitosis Modulators|mitosis modulators|mesh-ancestor
6408670|NCT00247208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408671|NCT00247247|Entacapone|entacapone|mesh-list
6408672|NCT00247247|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6408673|NCT00247247|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6408674|NCT00247247|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6408675|NCT00247247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6408676|NCT00247247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408677|NCT00247364|Levetiracetam|levetiracetam|mesh-list
6408678|NCT00247364|Anticonvulsants|anticonvulsants|mesh-ancestor
6408679|NCT00247364|Nootropic Agents|nootropic agents|mesh-ancestor
6408680|NCT00247403|Deoxyglucose|deoxyglucose|mesh-list
6408681|NCT00247403|Antimetabolites|antimetabolites|mesh-ancestor
6408682|NCT00247403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408683|NCT00247403|Antiviral Agents|antiviral agents|mesh-ancestor
6408684|NCT00247403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6408685|NCT00247481|Docetaxel|docetaxel|mesh-list
6408686|NCT00247481|Gefitinib|gefitinib|mesh-list
6408687|NCT00247481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6408688|NCT00247481|Tubulin Modulators|tubulin modulators|mesh-ancestor
6408689|NCT00247481|Antimitotic Agents|antimitotic agents|mesh-ancestor
6408690|NCT00247481|Mitosis Modulators|mitosis modulators|mesh-ancestor
6408691|NCT00247481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408692|NCT00247481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6408693|NCT00247481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6408694|NCT00247494|Mycophenolic Acid|mycophenolic acid|mesh-list
6408695|NCT00247494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6408696|NCT00247494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6408697|NCT00247494|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6408698|NCT00247494|Antitubercular Agents|antitubercular agents|mesh-ancestor
6408699|NCT00247494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6408700|NCT00247494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6408701|NCT00247494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6408702|NCT00247494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408703|NCT00247507|Acetylcysteine|acetylcysteine|mesh-list
6408704|NCT00247507|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6408705|NCT00247507|Antiviral Agents|antiviral agents|mesh-ancestor
6408706|NCT00247507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6408707|NCT00247507|Expectorants|expectorants|mesh-ancestor
6408708|NCT00247507|Respiratory System Agents|respiratory system agents|mesh-ancestor
6408709|NCT00247507|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6408710|NCT00247507|Antioxidants|antioxidants|mesh-ancestor
6408711|NCT00247507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408712|NCT00247507|Protective Agents|protective agents|mesh-ancestor
6408713|NCT00247507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408714|NCT00247507|Antidotes|antidotes|mesh-ancestor
6408715|NCT00247559|Botulinum Toxins|botulinum toxins|mesh-list
6408716|NCT00247559|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6408717|NCT00247559|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6408718|NCT00247559|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6408719|NCT00247559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6408720|NCT00247559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408721|NCT00247559|Cholinergic Agents|cholinergic agents|mesh-ancestor
6408722|NCT00247559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6408723|NCT00247559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408724|NCT00247559|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6408725|NCT00247559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6408726|NCT00247572|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6408727|NCT00247572|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6408728|NCT00247572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408729|NCT00247572|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6408730|NCT00247572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6408731|NCT00247572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6408732|NCT00247572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408733|NCT00247572|Dopamine Agents|dopamine agents|mesh-ancestor
6408734|NCT00247572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6408735|NCT00247585|Ethanol|ethanol|mesh-list
6018741|NCT00381940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6018742|NCT00381940|Tubulin Modulators|tubulin modulators|mesh-ancestor
6018743|NCT00381940|Antimitotic Agents|antimitotic agents|mesh-ancestor
6018744|NCT00381940|Mitosis Modulators|mitosis modulators|mesh-ancestor
6018745|NCT00381940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6018746|NCT00381940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6018747|NCT00381940|Alkylating Agents|alkylating agents|mesh-ancestor
6408736|NCT00247585|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6408737|NCT00247585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6408738|NCT00247585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6408739|NCT00247585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459693|NCT00446212|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6459694|NCT00446212|Anesthetics, General|anesthetics, general|mesh-ancestor
6459695|NCT00446212|Anesthetics|anesthetics|mesh-ancestor
6459696|NCT00446212|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6459697|NCT00446225|Gemcitabine|gemcitabine|mesh-list
6459698|NCT00446225|Carboplatin|carboplatin|mesh-list
6459699|NCT00446225|Docetaxel|docetaxel|mesh-list
6459700|NCT00446225|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6459701|NCT00446225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6459702|NCT00446225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6459703|NCT00446225|Antimetabolites|antimetabolites|mesh-ancestor
6459704|NCT00446225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459705|NCT00446225|Antiviral Agents|antiviral agents|mesh-ancestor
6459706|NCT00446225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6459707|NCT00446225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6459708|NCT00446225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6459709|NCT00446225|Immunologic Factors|immunologic factors|mesh-ancestor
6459710|NCT00446225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459711|NCT00446225|Tubulin Modulators|tubulin modulators|mesh-ancestor
6459712|NCT00446225|Antimitotic Agents|antimitotic agents|mesh-ancestor
6459713|NCT00446225|Mitosis Modulators|mitosis modulators|mesh-ancestor
6459714|NCT00446225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6459715|NCT00446303|Azacitidine|azacitidine|mesh-list
6459716|NCT00446303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6459717|NCT00446303|Antimetabolites|antimetabolites|mesh-ancestor
6408740|NCT00247650|Zoledronic Acid|zoledronic acid|mesh-list
6408741|NCT00247650|Letrozole|letrozole|mesh-list
6408742|NCT00247650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6408743|NCT00247650|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6408744|NCT00247650|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6408745|NCT00247650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6408746|NCT00247650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408747|NCT00247650|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6408748|NCT00247650|Hormone Antagonists|hormone antagonists|mesh-ancestor
6408749|NCT00247650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6408750|NCT00247650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408751|NCT00247650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6408752|NCT00247663|Letrozole|letrozole|mesh-list
6408753|NCT00247663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6408754|NCT00247663|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6408755|NCT00247663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6408756|NCT00247663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6408757|NCT00247663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408758|NCT00247663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6408759|NCT00247663|Hormone Antagonists|hormone antagonists|mesh-ancestor
6408760|NCT00247663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6408761|NCT00247663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408762|NCT00247702|Warfarin|warfarin|mesh-list
6408763|NCT00247702|Anticoagulants|anticoagulants|mesh-ancestor
6408764|NCT00247715|Pantoprazole|pantoprazole|mesh-list
6408765|NCT00247715|Ranitidine|ranitidine|mesh-list
6408766|NCT00247715|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
6408767|NCT00247715|Magnesium Oxide|magnesium oxide|mesh-list
6408768|NCT00247715|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6408769|NCT00247715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6408770|NCT00247715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6408771|NCT00247715|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6408772|NCT00247715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6408773|NCT00247715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408774|NCT00247715|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6408775|NCT00247715|Histamine Antagonists|histamine antagonists|mesh-ancestor
6408776|NCT00247715|Histamine Agents|histamine agents|mesh-ancestor
6408777|NCT00247715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6408778|NCT00247715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408779|NCT00247715|Antacids|antacids|mesh-ancestor
6408780|NCT00247715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6408781|NCT00247715|Immunologic Factors|immunologic factors|mesh-ancestor
6408782|NCT00247741|Lidocaine|lidocaine|mesh-list
6408783|NCT00247741|Carticaine|carticaine|mesh-list
6408784|NCT00247741|Anesthetics, Local|anesthetics, local|mesh-ancestor
6408785|NCT00247741|Anesthetics|anesthetics|mesh-ancestor
6408786|NCT00247741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6408787|NCT00247741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408788|NCT00247741|Sensory System Agents|sensory system agents|mesh-ancestor
6408789|NCT00247741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6408790|NCT00247741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6408791|NCT00247741|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6408792|NCT00247741|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6408793|NCT00247741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6408794|NCT00247741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408795|NCT00247910|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6408796|NCT00247910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6408797|NCT00247910|Diuretics|diuretics|mesh-ancestor
6408798|NCT00247910|Natriuretic Agents|natriuretic agents|mesh-ancestor
6408799|NCT00247910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408800|NCT00247910|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6408801|NCT00247910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6408802|NCT00247910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408803|NCT00247988|Carboplatin|carboplatin|mesh-list
6408804|NCT00247988|Docetaxel|docetaxel|mesh-list
6408805|NCT00247988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6408806|NCT00247988|Tubulin Modulators|tubulin modulators|mesh-ancestor
6408807|NCT00247988|Antimitotic Agents|antimitotic agents|mesh-ancestor
6408808|NCT00247988|Mitosis Modulators|mitosis modulators|mesh-ancestor
6408809|NCT00247988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408810|NCT00248053|Curcumin|curcumin|mesh-list
6408811|NCT00248053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6408812|NCT00248053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6408813|NCT00248053|Analgesics|analgesics|mesh-ancestor
6408814|NCT00248053|Sensory System Agents|sensory system agents|mesh-ancestor
6408815|NCT00248053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6408816|NCT00248053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408817|NCT00248053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6408818|NCT00248053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6408819|NCT00248053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6408820|NCT00248053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6408821|NCT00248053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408822|NCT00248092|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6408823|NCT00248092|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6408824|NCT00248092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408825|NCT00248092|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6408826|NCT00248092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6408827|NCT00248092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6408828|NCT00248092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408829|NCT00248092|Dopamine Agents|dopamine agents|mesh-ancestor
6408830|NCT00248092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6408831|NCT00248118|Bupropion|bupropion|mesh-list
6408832|NCT00248118|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6408833|NCT00248118|Antidepressive Agents|antidepressive agents|mesh-ancestor
6408834|NCT00248118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6408835|NCT00248118|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6408836|NCT00248118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6408837|NCT00248118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6408838|NCT00248118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408839|NCT00248118|Dopamine Agents|dopamine agents|mesh-ancestor
6408840|NCT00248118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6408841|NCT00248118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408842|NCT00248118|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6408843|NCT00248118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6408844|NCT00248118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6408845|NCT00248131|Octreotide|octreotide|mesh-list
6408846|NCT00248131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6408847|NCT00248131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6408848|NCT00248131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6408849|NCT00248144|Famciclovir|famciclovir|mesh-list
6408850|NCT00248144|Antiviral Agents|antiviral agents|mesh-ancestor
6408851|NCT00248144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6408852|NCT00248144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6408853|NCT00248144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6408854|NCT00248144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408855|NCT00248157|Octreotide|octreotide|mesh-list
6408856|NCT00248157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6408857|NCT00248157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6408858|NCT00248157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6408859|NCT00248183|Naluzotan|naluzotan|mesh-list
6408860|NCT00248183|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6408861|NCT00248183|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6408862|NCT00248183|Serotonin Agents|serotonin agents|mesh-ancestor
6408863|NCT00248183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6408864|NCT00248183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408865|NCT00248183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408866|NCT00248209|Bupropion|bupropion|mesh-list
6408867|NCT00248209|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6408868|NCT00248209|Antidepressive Agents|antidepressive agents|mesh-ancestor
6408869|NCT00248209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6408870|NCT00248209|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6408871|NCT00248209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6408872|NCT00248209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6408873|NCT00248209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408874|NCT00248209|Dopamine Agents|dopamine agents|mesh-ancestor
6408875|NCT00248209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6408876|NCT00248209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408877|NCT00248209|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6408878|NCT00248209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6408879|NCT00248209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6408880|NCT00248248|Doxorubicin|doxorubicin|mesh-list
6408881|NCT00248248|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6408882|NCT00248248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6408883|NCT00248248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6408884|NCT00248248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6408885|NCT00248248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6408886|NCT00248248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6408887|NCT00248248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408888|NCT00248261|Ziprasidone|ziprasidone|mesh-list
6408889|NCT00248261|Sertraline|sertraline|mesh-list
6408890|NCT00248261|Antidepressive Agents|antidepressive agents|mesh-ancestor
6408891|NCT00248261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6408892|NCT00248261|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6408893|NCT00248261|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6408894|NCT00248261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6408895|NCT00248261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408896|NCT00248261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6408897|NCT00248261|Serotonin Agents|serotonin agents|mesh-ancestor
6408898|NCT00248261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408899|NCT00248261|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6408900|NCT00248261|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6408901|NCT00248261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6408902|NCT00248261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6408903|NCT00248261|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6408904|NCT00248261|Dopamine Agents|dopamine agents|mesh-ancestor
6408905|NCT00248300|Chlorhexidine|chlorhexidine|mesh-list
6408906|NCT00248300|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6408907|NCT00248300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6408908|NCT00248300|Disinfectants|disinfectants|mesh-ancestor
6408909|NCT00248313|Sirolimus|sirolimus|mesh-list
6408910|NCT00248313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6408911|NCT00248313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6408912|NCT00248313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6408913|NCT00248313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6408914|NCT00248313|Antifungal Agents|antifungal agents|mesh-ancestor
6408915|NCT00248313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6408916|NCT00248313|Immunologic Factors|immunologic factors|mesh-ancestor
6408917|NCT00248313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408918|NCT00248339|Ribavirin|ribavirin|mesh-list
6408919|NCT00248339|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6408920|NCT00248339|Epoetin Alfa|epoetin alfa|mesh-list
6408921|NCT00248339|Antimetabolites|antimetabolites|mesh-ancestor
6408922|NCT00248339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408923|NCT00248339|Antiviral Agents|antiviral agents|mesh-ancestor
6408924|NCT00248339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6408925|NCT00248339|Hematinics|hematinics|mesh-ancestor
6408926|NCT00248430|Aldesleukin|aldesleukin|mesh-list
6408927|NCT00248430|Melphalan|melphalan|mesh-list
6408928|NCT00248430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6408929|NCT00248430|Alkylating Agents|alkylating agents|mesh-ancestor
6408930|NCT00248430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408931|NCT00248430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6408932|NCT00248430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6408933|NCT00248430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6408934|NCT00248430|Immunologic Factors|immunologic factors|mesh-ancestor
6408935|NCT00248430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408936|NCT00248430|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6408937|NCT00248430|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6408938|NCT00248430|Antiviral Agents|antiviral agents|mesh-ancestor
6408939|NCT00248430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6408940|NCT00248456|Betamethasone|betamethasone|mesh-list
6408941|NCT00248456|Betamethasone Valerate|betamethasone valerate|mesh-list
6408942|NCT00248456|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
6408943|NCT00248456|Betamethasone benzoate|betamethasone benzoate|mesh-list
6408944|NCT00248456|Calcipotriene|calcipotriene|mesh-list
6408945|NCT00248456|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
6408946|NCT00248456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6408947|NCT00248456|Glucocorticoids|glucocorticoids|mesh-ancestor
6408948|NCT00248456|Hormones|hormones|mesh-ancestor
6408949|NCT00248456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6408950|NCT00248456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408951|NCT00248456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6408952|NCT00248456|Respiratory System Agents|respiratory system agents|mesh-ancestor
6408953|NCT00248456|Dermatologic Agents|dermatologic agents|mesh-ancestor
6408954|NCT00248482|Cisplatin|cisplatin|mesh-list
6408955|NCT00248482|Irinotecan|irinotecan|mesh-list
6408956|NCT00248482|Imatinib Mesylate|imatinib mesylate|mesh-list
6408957|NCT00248482|Camptothecin|camptothecin|mesh-list
6408958|NCT00248482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6408959|NCT00248482|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6408960|NCT00248482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6408961|NCT00248482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6408962|NCT00248482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408963|NCT00248482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6408964|NCT00248482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6408965|NCT00248703|Docetaxel|docetaxel|mesh-list
6408966|NCT00248703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6408967|NCT00248703|Tubulin Modulators|tubulin modulators|mesh-ancestor
6408968|NCT00248703|Antimitotic Agents|antimitotic agents|mesh-ancestor
6408969|NCT00248703|Mitosis Modulators|mitosis modulators|mesh-ancestor
6408970|NCT00248703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408971|NCT00248716|Ferrous gluconate|ferrous gluconate|mesh-list
6408972|NCT00248716|Hematinics|hematinics|mesh-ancestor
6408973|NCT00248729|Midazolam|midazolam|mesh-list
6408974|NCT00248729|Etomidate|etomidate|mesh-list
6408975|NCT00248729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6408976|NCT00248729|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6408977|NCT00248729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6408978|NCT00248729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408979|NCT00248729|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6408980|NCT00248729|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6408981|NCT00248729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6408982|NCT00248729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6408983|NCT00248729|Anesthetics, General|anesthetics, general|mesh-ancestor
6408984|NCT00248729|Anesthetics|anesthetics|mesh-ancestor
6408985|NCT00248729|GABA Modulators|gaba modulators|mesh-ancestor
6408986|NCT00248729|GABA Agents|gaba agents|mesh-ancestor
6408987|NCT00248729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6408988|NCT00248729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6408989|NCT00248963|Levonorgestrel|levonorgestrel|mesh-list
6408990|NCT00248963|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6408991|NCT00248963|Estradiol|estradiol|mesh-list
6408992|NCT00248963|Estrogens|estrogens|mesh-ancestor
6408993|NCT00248963|Hormones|hormones|mesh-ancestor
6408994|NCT00248963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6408995|NCT00248963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6408996|NCT00248963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6408997|NCT00248963|Contraceptive Agents|contraceptive agents|mesh-ancestor
6408998|NCT00248963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6408999|NCT00248963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6409000|NCT00248963|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6409001|NCT00248963|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6409002|NCT00248963|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6409003|NCT00248989|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
6409004|NCT00248989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6409005|NCT00248989|Immunologic Factors|immunologic factors|mesh-ancestor
6409006|NCT00248989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409007|NCT00249041|Etanercept|etanercept|mesh-list
6409008|NCT00249041|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6409009|NCT00249041|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6409010|NCT00249041|Analgesics|analgesics|mesh-ancestor
6409011|NCT00249041|Sensory System Agents|sensory system agents|mesh-ancestor
6409012|NCT00249041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6409013|NCT00249041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409014|NCT00249041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6409015|NCT00249041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6409016|NCT00249041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6409017|NCT00249041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6409018|NCT00249041|Immunologic Factors|immunologic factors|mesh-ancestor
6409019|NCT00249106|Vaccines|vaccines|mesh-list
6409020|NCT00249106|Immunologic Factors|immunologic factors|mesh-ancestor
6409021|NCT00249106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409022|NCT00249119|Risperidone|risperidone|mesh-list
6409023|NCT00249119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6409024|NCT00249119|Serotonin Agents|serotonin agents|mesh-ancestor
6409025|NCT00249119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6409026|NCT00249119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409027|NCT00249119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409028|NCT00249119|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6409029|NCT00249119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6409030|NCT00249119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6409031|NCT00249119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6409032|NCT00249119|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6409033|NCT00249119|Dopamine Agents|dopamine agents|mesh-ancestor
6409034|NCT00249132|Risperidone|risperidone|mesh-list
6409035|NCT00249132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6409036|NCT00249132|Serotonin Agents|serotonin agents|mesh-ancestor
6409037|NCT00249132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6409038|NCT00249132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409039|NCT00249132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409040|NCT00249132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6409041|NCT00249132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6409042|NCT00249132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6409043|NCT00249132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6409044|NCT00249132|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6409045|NCT00249132|Dopamine Agents|dopamine agents|mesh-ancestor
6409046|NCT00249145|Risperidone|risperidone|mesh-list
6409047|NCT00249145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6409048|NCT00249145|Serotonin Agents|serotonin agents|mesh-ancestor
6409049|NCT00249145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6409050|NCT00249145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409051|NCT00249145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409052|NCT00249145|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6409053|NCT00249145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6409054|NCT00249145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6409055|NCT00249145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6409056|NCT00249145|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6409057|NCT00249145|Dopamine Agents|dopamine agents|mesh-ancestor
6409058|NCT00249158|Risperidone|risperidone|mesh-list
6409059|NCT00249158|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6409060|NCT00249158|Serotonin Agents|serotonin agents|mesh-ancestor
6409061|NCT00249158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6409062|NCT00249158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409063|NCT00249158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409064|NCT00249158|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6409065|NCT00249158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6409066|NCT00249158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6409067|NCT00249158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6409068|NCT00249158|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6409069|NCT00249158|Dopamine Agents|dopamine agents|mesh-ancestor
6409070|NCT00249171|Risperidone|risperidone|mesh-list
6409071|NCT00249171|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6409072|NCT00249171|Serotonin Agents|serotonin agents|mesh-ancestor
6409073|NCT00249171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6409074|NCT00249171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409075|NCT00249171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409076|NCT00249171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6409077|NCT00249171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6409078|NCT00249171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6409079|NCT00249171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6409080|NCT00249171|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6409081|NCT00249171|Dopamine Agents|dopamine agents|mesh-ancestor
6409082|NCT00249197|Levofloxacin|levofloxacin|mesh-list
6409083|NCT00249197|Ofloxacin|ofloxacin|mesh-list
6409084|NCT00249197|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6409085|NCT00249197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6409086|NCT00249197|Renal Agents|renal agents|mesh-ancestor
6409087|NCT00249197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6409088|NCT00249197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6409089|NCT00249197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6409090|NCT00249197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6409091|NCT00249197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409092|NCT00249197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6409093|NCT00249197|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6409094|NCT00249197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6409095|NCT00249210|Levofloxacin|levofloxacin|mesh-list
6409096|NCT00249210|Ofloxacin|ofloxacin|mesh-list
6409097|NCT00249210|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6409098|NCT00249210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6018748|NCT00382031|Zalutumumab|zalutumumab|mesh-list
6409099|NCT00249210|Renal Agents|renal agents|mesh-ancestor
6409100|NCT00249210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6409101|NCT00249210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6409102|NCT00249210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6409103|NCT00249210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6409104|NCT00249210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409105|NCT00249210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6409106|NCT00249210|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6409107|NCT00249210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6409108|NCT00249223|Risperidone|risperidone|mesh-list
6409109|NCT00249223|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6409110|NCT00249223|Serotonin Agents|serotonin agents|mesh-ancestor
6409111|NCT00249223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6409112|NCT00249223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409113|NCT00249223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409114|NCT00249223|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6409115|NCT00249223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6409116|NCT00249223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6409117|NCT00249223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6409118|NCT00249223|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6409119|NCT00249223|Dopamine Agents|dopamine agents|mesh-ancestor
6409120|NCT00249236|Risperidone|risperidone|mesh-list
6409121|NCT00249236|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6409122|NCT00249236|Serotonin Agents|serotonin agents|mesh-ancestor
6409123|NCT00249236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6409124|NCT00249236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409125|NCT00249236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409126|NCT00249236|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6409127|NCT00249236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6409128|NCT00249236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6409129|NCT00249236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6409130|NCT00249236|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6409131|NCT00249236|Dopamine Agents|dopamine agents|mesh-ancestor
6459718|NCT00446303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459719|NCT00446303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6459720|NCT00446303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6459721|NCT00446316|Imatinib Mesylate|imatinib mesylate|mesh-list
6459722|NCT00446316|Antacids|antacids|mesh-list
6459723|NCT00446316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6459724|NCT00446316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6459725|NCT00446316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6459726|NCT00446316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459727|NCT00446316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6459728|NCT00446329|Cinacalcet|cinacalcet|mesh-list
6459729|NCT00446329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6459730|NCT00446329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459731|NCT00446329|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6459732|NCT00446329|Hormone Antagonists|hormone antagonists|mesh-ancestor
6459733|NCT00446329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6459734|NCT00446368|Everolimus|everolimus|mesh-list
6459735|NCT00446368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6459736|NCT00446368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6459737|NCT00446368|Immunologic Factors|immunologic factors|mesh-ancestor
6459738|NCT00446368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459739|NCT00446420|Fentanyl|fentanyl|mesh-list
6459740|NCT00446420|Midazolam|midazolam|mesh-list
6459741|NCT00446420|Propofol|propofol|mesh-list
6459742|NCT00446420|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6459743|NCT00446420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6459744|NCT00446420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459745|NCT00446420|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6459746|NCT00446420|Anesthetics, General|anesthetics, general|mesh-ancestor
6459747|NCT00446420|Anesthetics|anesthetics|mesh-ancestor
6459748|NCT00446420|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6459749|NCT00446420|Narcotics|narcotics|mesh-ancestor
6459750|NCT00446420|Analgesics|analgesics|mesh-ancestor
6409132|NCT00249353|Methylphenidate|methylphenidate|mesh-list
6409133|NCT00249353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6409134|NCT00249353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409135|NCT00249353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6409136|NCT00249353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6409137|NCT00249353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6409138|NCT00249353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409139|NCT00249353|Dopamine Agents|dopamine agents|mesh-ancestor
6409140|NCT00249353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6409141|NCT00249366|Lorazepam|lorazepam|mesh-list
6409142|NCT00249366|Anticonvulsants|anticonvulsants|mesh-ancestor
6409143|NCT00249366|Antiemetics|antiemetics|mesh-ancestor
6409144|NCT00249366|Autonomic Agents|autonomic agents|mesh-ancestor
6409145|NCT00249366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6409146|NCT00249366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409147|NCT00249366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6409148|NCT00249366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6409149|NCT00249366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6409150|NCT00249366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6409151|NCT00249366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6409152|NCT00249366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6409153|NCT00249366|GABA Modulators|gaba modulators|mesh-ancestor
6409154|NCT00249366|GABA Agents|gaba agents|mesh-ancestor
6409155|NCT00249366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6409156|NCT00249366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409157|NCT00249405|Citalopram|citalopram|mesh-list
6409158|NCT00249405|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6409159|NCT00249405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6409160|NCT00249405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6409161|NCT00249405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409162|NCT00249405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6409163|NCT00249405|Serotonin Agents|serotonin agents|mesh-ancestor
6409164|NCT00249405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409165|NCT00249405|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6409166|NCT00249405|Antidepressive Agents|antidepressive agents|mesh-ancestor
6409167|NCT00249405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6409168|NCT00249431|Sertraline|sertraline|mesh-list
6409169|NCT00249431|Antidepressive Agents|antidepressive agents|mesh-ancestor
6409170|NCT00249431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6409171|NCT00249431|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6409172|NCT00249431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6409173|NCT00249431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6409174|NCT00249431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409175|NCT00249431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6409176|NCT00249431|Serotonin Agents|serotonin agents|mesh-ancestor
6409177|NCT00249431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409178|NCT00249483|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6409179|NCT00249483|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6409180|NCT00249483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6409181|NCT00249483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6409182|NCT00249483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409183|NCT00249483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6409184|NCT00249483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409185|NCT00249483|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6409186|NCT00249483|Antidepressive Agents|antidepressive agents|mesh-ancestor
6409187|NCT00249483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6409188|NCT00249509|Bupropion|bupropion|mesh-list
6409189|NCT00249509|Nefazodone|nefazodone|mesh-list
6409190|NCT00249509|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6409191|NCT00249509|Antidepressive Agents|antidepressive agents|mesh-ancestor
6409192|NCT00249509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6409193|NCT00249509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6409194|NCT00249509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6409195|NCT00249509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6409196|NCT00249509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409197|NCT00249509|Dopamine Agents|dopamine agents|mesh-ancestor
6409198|NCT00249509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6409199|NCT00249509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409200|NCT00249509|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6409201|NCT00249509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6409202|NCT00249509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6409203|NCT00249509|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6409204|NCT00249509|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6409205|NCT00249509|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6409206|NCT00249509|Serotonin Agents|serotonin agents|mesh-ancestor
6409207|NCT00249574|Buprenorphine|buprenorphine|mesh-list
6409208|NCT00249574|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6409209|NCT00249574|Naloxone|naloxone|mesh-list
6409210|NCT00249574|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6409211|NCT00249574|Narcotics|narcotics|mesh-ancestor
6409212|NCT00249574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6409213|NCT00249574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409214|NCT00249574|Analgesics|analgesics|mesh-ancestor
6409215|NCT00249574|Sensory System Agents|sensory system agents|mesh-ancestor
6409216|NCT00249574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6409217|NCT00249574|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6409218|NCT00249587|Methadone|methadone|mesh-list
6409219|NCT00249587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6409220|NCT00249587|Narcotics|narcotics|mesh-ancestor
6409221|NCT00249587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6409222|NCT00249587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409223|NCT00249587|Analgesics|analgesics|mesh-ancestor
6409224|NCT00249587|Sensory System Agents|sensory system agents|mesh-ancestor
6409225|NCT00249587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6409226|NCT00249587|Antitussive Agents|antitussive agents|mesh-ancestor
6409227|NCT00249587|Respiratory System Agents|respiratory system agents|mesh-ancestor
6409228|NCT00249691|Topiramate|topiramate|mesh-list
6409229|NCT00249691|Anticonvulsants|anticonvulsants|mesh-ancestor
6409230|NCT00249691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6409231|NCT00249691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409232|NCT00249704|Vitamin D|vitamin d|mesh-list
6409233|NCT00249704|Ergocalciferols|ergocalciferols|mesh-list
6409234|NCT00249704|Vitamins|vitamins|mesh-list
6409235|NCT00249704|Micronutrients|micronutrients|mesh-ancestor
6409236|NCT00249704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409237|NCT00249704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6409238|NCT00249704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6409239|NCT00249730|Sildenafil Citrate|sildenafil citrate|mesh-list
6409240|NCT00249730|Vasodilator Agents|vasodilator agents|mesh-ancestor
6409241|NCT00249730|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6409242|NCT00249730|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6409243|NCT00249730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6409244|NCT00249730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409245|NCT00249730|Urological Agents|urological agents|mesh-ancestor
6409246|NCT00249782|Metronidazole|metronidazole|mesh-list
6409247|NCT00249782|Dapsone|dapsone|mesh-list
6409248|NCT00249782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6409249|NCT00249782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6409250|NCT00249782|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6409251|NCT00249782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6409252|NCT00249782|Antimalarials|antimalarials|mesh-ancestor
6409253|NCT00249782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6409254|NCT00249782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6409255|NCT00249782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409256|NCT00249782|Leprostatic Agents|leprostatic agents|mesh-ancestor
6409257|NCT00249847|Paroxetine|paroxetine|mesh-list
6409258|NCT00249847|Estrogens|estrogens|mesh-list
6409259|NCT00249847|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6409260|NCT00249847|Hormones|hormones|mesh-ancestor
6409261|NCT00249847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6409262|NCT00249847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409263|NCT00249847|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6409264|NCT00249847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6409265|NCT00249847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6409266|NCT00249847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409267|NCT00249847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6409268|NCT00249847|Serotonin Agents|serotonin agents|mesh-ancestor
6409269|NCT00249847|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6409270|NCT00249847|Antidepressive Agents|antidepressive agents|mesh-ancestor
6409271|NCT00249847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6409272|NCT00249847|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6409273|NCT00249847|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6409274|NCT00249847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6409275|NCT00249860|Interferons|interferons|mesh-list
6409276|NCT00249860|Ribavirin|ribavirin|mesh-list
6409277|NCT00249860|Interferon-beta|interferon-beta|mesh-list
6409278|NCT00249860|Interferon beta-1a|interferon beta-1a|mesh-list
6409279|NCT00249860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6409280|NCT00249860|Antiviral Agents|antiviral agents|mesh-ancestor
6409281|NCT00249860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6409282|NCT00249860|Antimetabolites|antimetabolites|mesh-ancestor
6409283|NCT00249860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409284|NCT00249860|Immunologic Factors|immunologic factors|mesh-ancestor
6409285|NCT00249860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409286|NCT00249860|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6409287|NCT00249886|Citalopram|citalopram|mesh-list
6409288|NCT00249886|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6409289|NCT00249886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6409290|NCT00249886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6409291|NCT00249886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409292|NCT00249886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6409293|NCT00249886|Serotonin Agents|serotonin agents|mesh-ancestor
6409294|NCT00249886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409295|NCT00249886|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6409296|NCT00249886|Antidepressive Agents|antidepressive agents|mesh-ancestor
6409297|NCT00249886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6409298|NCT00249899|Atorvastatin|atorvastatin|mesh-list
6409299|NCT00249899|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6409300|NCT00249899|Simvastatin|simvastatin|mesh-list
6409301|NCT00249899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
6409302|NCT00249899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6409303|NCT00249899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6409304|NCT00249899|Antimetabolites|antimetabolites|mesh-ancestor
6409305|NCT00249899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409306|NCT00249899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6409307|NCT00249899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6409308|NCT00249912|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6409309|NCT00249912|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6409310|NCT00249912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6409311|NCT00249912|Antimetabolites|antimetabolites|mesh-ancestor
6409312|NCT00249912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409313|NCT00249912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6409314|NCT00249912|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6409315|NCT00249912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6409316|NCT00249938|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
6409317|NCT00249938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6409318|NCT00249938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6409319|NCT00249938|Antimetabolites|antimetabolites|mesh-ancestor
6409320|NCT00249938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409321|NCT00249938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6409322|NCT00249964|Paclitaxel|paclitaxel|mesh-list
6409323|NCT00249964|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6409324|NCT00249964|Carboplatin|carboplatin|mesh-list
6409325|NCT00249964|Temozolomide|temozolomide|mesh-list
6409326|NCT00249964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6409327|NCT00249964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6409328|NCT00249964|Tubulin Modulators|tubulin modulators|mesh-ancestor
6409329|NCT00249964|Antimitotic Agents|antimitotic agents|mesh-ancestor
6409330|NCT00249964|Mitosis Modulators|mitosis modulators|mesh-ancestor
6409331|NCT00249964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409332|NCT00249964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6409333|NCT00249964|Alkylating Agents|alkylating agents|mesh-ancestor
6409334|NCT00249977|Capecitabine|capecitabine|mesh-list
6409335|NCT00249977|Irinotecan|irinotecan|mesh-list
6409336|NCT00249977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6409337|NCT00249977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6409338|NCT00249977|Antimetabolites|antimetabolites|mesh-ancestor
6409339|NCT00249977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409340|NCT00249977|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6409341|NCT00249977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6409342|NCT00249977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6409343|NCT00250029|Capecitabine|capecitabine|mesh-list
6409344|NCT00250029|Oxaliplatin|oxaliplatin|mesh-list
6409345|NCT00250029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6409346|NCT00250029|Antimetabolites|antimetabolites|mesh-ancestor
6409347|NCT00250029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409348|NCT00250029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6409349|NCT00250042|Imatinib Mesylate|imatinib mesylate|mesh-list
6409350|NCT00250042|Arsenic Trioxide|arsenic trioxide|mesh-list
6409351|NCT00250042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6409352|NCT00250042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6409353|NCT00250042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6409354|NCT00250042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409355|NCT00250068|Rubitecan|rubitecan|mesh-list
6409356|NCT00250068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6409357|NCT00250068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6409358|NCT00250068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6409359|NCT00250068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6409360|NCT00250068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409361|NCT00250081|Botulinum Toxins|botulinum toxins|mesh-list
6409362|NCT00250081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6409363|NCT00250081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6409364|NCT00250081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409365|NCT00250081|Cholinergic Agents|cholinergic agents|mesh-ancestor
6409366|NCT00250081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6409367|NCT00250081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409368|NCT00250094|Topotecan|topotecan|mesh-list
6409369|NCT00250094|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6409370|NCT00250094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6409371|NCT00250094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6409372|NCT00250094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409373|NCT00250094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6409374|NCT00250120|Camptothecin|camptothecin|mesh-list
6409375|NCT00250120|Rubitecan|rubitecan|mesh-list
6409376|NCT00250120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6409377|NCT00250120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6409378|NCT00250120|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6409379|NCT00250120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6409380|NCT00250120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6409381|NCT00250120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409382|NCT00250172|Rolipram|rolipram|mesh-list
6409383|NCT00250172|Antidepressive Agents|antidepressive agents|mesh-ancestor
6409384|NCT00250172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6409385|NCT00250172|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6409386|NCT00250172|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6409387|NCT00250172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6409388|NCT00250172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409389|NCT00250185|Acetylcholine|acetylcholine|mesh-list
6409390|NCT00250185|Vasodilator Agents|vasodilator agents|mesh-ancestor
6409391|NCT00250185|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6409392|NCT00250185|Cholinergic Agents|cholinergic agents|mesh-ancestor
6018749|NCT00382031|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6018750|NCT00382031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6018751|NCT00382031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6018752|NCT00382031|Immunologic Factors|immunologic factors|mesh-ancestor
6018753|NCT00382031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018754|NCT00382070|Letrozole|letrozole|mesh-list
6018755|NCT00382070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6018756|NCT00382070|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6018757|NCT00382070|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6409393|NCT00250185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6409394|NCT00250185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409395|NCT00250185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409396|NCT00250237|Haloperidol|haloperidol|mesh-list
6409397|NCT00250237|Haloperidol decanoate|haloperidol decanoate|mesh-list
6409398|NCT00250237|Antiemetics|antiemetics|mesh-ancestor
6409399|NCT00250237|Autonomic Agents|autonomic agents|mesh-ancestor
6409400|NCT00250237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6409401|NCT00250237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409402|NCT00250237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6409403|NCT00250237|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6409404|NCT00250237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6409405|NCT00250237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6409406|NCT00250237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6409407|NCT00250237|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6409408|NCT00250237|Dopamine Agents|dopamine agents|mesh-ancestor
6409409|NCT00250237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6409410|NCT00250237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409411|NCT00250237|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6409412|NCT00250315|Dobutamine|dobutamine|mesh-list
6409413|NCT00250315|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6409414|NCT00250315|Sympathomimetics|sympathomimetics|mesh-ancestor
6409415|NCT00250315|Autonomic Agents|autonomic agents|mesh-ancestor
6409416|NCT00250315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6409417|NCT00250315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409418|NCT00250315|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6409419|NCT00250315|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6409420|NCT00250315|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6409421|NCT00250315|Adrenergic Agents|adrenergic agents|mesh-ancestor
6409422|NCT00250315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6409423|NCT00250315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409424|NCT00250315|Protective Agents|protective agents|mesh-ancestor
6409425|NCT00250354|Risperidone|risperidone|mesh-list
6409426|NCT00250354|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6409427|NCT00250354|Serotonin Agents|serotonin agents|mesh-ancestor
5501219|NCT04476459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6409428|NCT00250354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6409429|NCT00250354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409430|NCT00250354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409431|NCT00250354|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6409432|NCT00250354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6409433|NCT00250354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6409434|NCT00250354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6409435|NCT00250354|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6409436|NCT00250354|Dopamine Agents|dopamine agents|mesh-ancestor
6409437|NCT00250367|Risperidone|risperidone|mesh-list
6409438|NCT00250367|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6409439|NCT00250367|Serotonin Agents|serotonin agents|mesh-ancestor
6409440|NCT00250367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6409441|NCT00250367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409442|NCT00250367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409443|NCT00250367|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5501220|NCT04476459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6409444|NCT00250367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6409445|NCT00250367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6409446|NCT00250367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6409447|NCT00250367|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6409448|NCT00250367|Dopamine Agents|dopamine agents|mesh-ancestor
6409449|NCT00250393|Istradefylline|istradefylline|mesh-list
6409450|NCT00250393|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
6409451|NCT00250393|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6409452|NCT00250393|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6409453|NCT00250393|Purinergic Agents|purinergic agents|mesh-ancestor
6409454|NCT00250393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6409455|NCT00250393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409456|NCT00250393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409457|NCT00250536|Nandrolone Decanoate|nandrolone decanoate|mesh-list
6409458|NCT00250536|Nandrolone|nandrolone|mesh-list
5501221|NCT04476459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5501222|NCT04476459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501223|NCT04476121|Aspirin|aspirin|mesh-list
5501224|NCT04476121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5501225|NCT04476121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5501226|NCT04476121|Analgesics|analgesics|mesh-ancestor
5501227|NCT04476121|Sensory System Agents|sensory system agents|mesh-ancestor
5501228|NCT04476121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5501229|NCT04476121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501230|NCT04476121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5501231|NCT04476121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5501232|NCT04476121|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5501233|NCT04476121|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5501234|NCT04476121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501235|NCT04476121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6409459|NCT00250536|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
6409460|NCT00250536|Androgens|androgens|mesh-ancestor
6409461|NCT00250536|Hormones|hormones|mesh-ancestor
6409462|NCT00250536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6409463|NCT00250536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409464|NCT00250536|Anabolic Agents|anabolic agents|mesh-ancestor
6409465|NCT00250536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6409466|NCT00250562|Valsartan|valsartan|mesh-list
6409467|NCT00250562|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6409468|NCT00250562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6409469|NCT00250562|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6409470|NCT00250562|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6409471|NCT00250562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409472|NCT00250562|Diuretics|diuretics|mesh-ancestor
6409473|NCT00250562|Natriuretic Agents|natriuretic agents|mesh-ancestor
6409474|NCT00250562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409475|NCT00250562|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6409476|NCT00250562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6409477|NCT00250575|Clozapine|clozapine|mesh-list
6409478|NCT00250575|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6409479|NCT00250575|Serotonin Agents|serotonin agents|mesh-ancestor
6409480|NCT00250575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6409481|NCT00250575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409482|NCT00250575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409483|NCT00250575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6409484|NCT00250575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6409485|NCT00250575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6409486|NCT00250575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6409487|NCT00250575|GABA Antagonists|gaba antagonists|mesh-ancestor
6409488|NCT00250575|GABA Agents|gaba agents|mesh-ancestor
6409489|NCT00250640|Iloprost|iloprost|mesh-list
6409490|NCT00250640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6409491|NCT00250640|Vasodilator Agents|vasodilator agents|mesh-ancestor
6409492|NCT00250692|Nitrous Oxide|nitrous oxide|mesh-list
6409493|NCT00250692|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6409494|NCT00250692|Anesthetics, General|anesthetics, general|mesh-ancestor
6409495|NCT00250692|Anesthetics|anesthetics|mesh-ancestor
6409496|NCT00250692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6409497|NCT00250692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409498|NCT00250692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6409499|NCT00250692|Analgesics|analgesics|mesh-ancestor
6409500|NCT00250692|Sensory System Agents|sensory system agents|mesh-ancestor
6409501|NCT00250692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6409502|NCT00250744|Gabapentin|gabapentin|mesh-list
6409503|NCT00250744|Aprepitant|aprepitant|mesh-list
6409504|NCT00250744|Fosaprepitant|fosaprepitant|mesh-list
6409505|NCT00250744|Analgesics|analgesics|mesh-ancestor
6409506|NCT00250744|Sensory System Agents|sensory system agents|mesh-ancestor
6409507|NCT00250744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6409508|NCT00250744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409509|NCT00250744|Anticonvulsants|anticonvulsants|mesh-ancestor
6409510|NCT00250744|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6409511|NCT00250744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6409512|NCT00250744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6409513|NCT00250744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6409514|NCT00250744|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6409515|NCT00250744|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6409516|NCT00250744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6409517|NCT00250744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409518|NCT00250744|Antimanic Agents|antimanic agents|mesh-ancestor
6409519|NCT00250744|Antiemetics|antiemetics|mesh-ancestor
6409520|NCT00250744|Autonomic Agents|autonomic agents|mesh-ancestor
6409521|NCT00250744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6409522|NCT00250744|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6409523|NCT00250796|Interferons|interferons|mesh-list
6409524|NCT00250796|Interferon-alpha|interferon-alpha|mesh-list
6409525|NCT00250796|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
6409526|NCT00250796|Thalidomide|thalidomide|mesh-list
6409527|NCT00250796|Octreotide|octreotide|mesh-list
6409528|NCT00250796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6409529|NCT00250796|Antiviral Agents|antiviral agents|mesh-ancestor
6409530|NCT00250796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6409531|NCT00250796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6409532|NCT00250796|Immunologic Factors|immunologic factors|mesh-ancestor
6409533|NCT00250796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409534|NCT00250796|Leprostatic Agents|leprostatic agents|mesh-ancestor
6409535|NCT00250796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6409536|NCT00250796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6409537|NCT00250796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6409538|NCT00250796|Growth Substances|growth substances|mesh-ancestor
6409539|NCT00250796|Growth Inhibitors|growth inhibitors|mesh-ancestor
6409540|NCT00250796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6409541|NCT00250796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6409542|NCT00250861|Aldesleukin|aldesleukin|mesh-list
6409543|NCT00250861|Rituximab|rituximab|mesh-list
6409544|NCT00250861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6409545|NCT00250861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6409546|NCT00250861|Immunologic Factors|immunologic factors|mesh-ancestor
6409547|NCT00250861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409548|NCT00250861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6409549|NCT00250861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6409550|NCT00250861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6409551|NCT00250861|Antiviral Agents|antiviral agents|mesh-ancestor
6409552|NCT00250861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6409553|NCT00250874|Docetaxel|docetaxel|mesh-list
6018758|NCT00382070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6409554|NCT00250874|Doxorubicin|doxorubicin|mesh-list
6409555|NCT00250874|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6409556|NCT00250874|Trastuzumab|trastuzumab|mesh-list
6409557|NCT00250874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6409558|NCT00250874|Tubulin Modulators|tubulin modulators|mesh-ancestor
6409559|NCT00250874|Antimitotic Agents|antimitotic agents|mesh-ancestor
6409560|NCT00250874|Mitosis Modulators|mitosis modulators|mesh-ancestor
6409561|NCT00250874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409562|NCT00250874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6409563|NCT00250874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6409564|NCT00250874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6409565|NCT00250874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6409566|NCT00250874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6409567|NCT00250952|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6409568|NCT00250952|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6409569|NCT00250952|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6409570|NCT00250952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6409571|NCT00250952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409572|NCT00250952|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6409573|NCT00250952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6409574|NCT00250952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409575|NCT00250952|Cholinergic Agents|cholinergic agents|mesh-ancestor
6409576|NCT00250952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6459751|NCT00446420|Sensory System Agents|sensory system agents|mesh-ancestor
6459752|NCT00446420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6459753|NCT00446420|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6459754|NCT00446420|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6459755|NCT00446420|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6459756|NCT00446420|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6459757|NCT00446420|GABA Modulators|gaba modulators|mesh-ancestor
6459758|NCT00446420|GABA Agents|gaba agents|mesh-ancestor
6459759|NCT00446420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6459760|NCT00446420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459761|NCT00446433|Lenalidomide|lenalidomide|mesh-list
6459762|NCT00446433|Immunologic Factors|immunologic factors|mesh-ancestor
6459763|NCT00446433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459764|NCT00446433|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6459765|NCT00446433|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6459766|NCT00446433|Growth Substances|growth substances|mesh-ancestor
6459767|NCT00446433|Growth Inhibitors|growth inhibitors|mesh-ancestor
6459768|NCT00446433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6459769|NCT00446472|Becaplermin|becaplermin|mesh-list
6459770|NCT00446472|Anticoagulants|anticoagulants|mesh-ancestor
6409577|NCT00250978|Bevacizumab|bevacizumab|mesh-list
6409578|NCT00250978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6409579|NCT00250978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6409580|NCT00250978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6409581|NCT00250978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6409582|NCT00250978|Growth Substances|growth substances|mesh-ancestor
6409583|NCT00250978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409584|NCT00250978|Growth Inhibitors|growth inhibitors|mesh-ancestor
6409585|NCT00250991|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6409586|NCT00250991|Eptifibatide|eptifibatide|mesh-list
6409587|NCT00250991|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6409588|NCT00250991|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6409589|NCT00250991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409590|NCT00250991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6409591|NCT00251017|Vancomycin|vancomycin|mesh-list
6409592|NCT00251017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6409593|NCT00251017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6409594|NCT00251030|Nelfinavir|nelfinavir|mesh-list
6409595|NCT00251030|Omeprazole|omeprazole|mesh-list
6409596|NCT00251030|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6409597|NCT00251030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6409598|NCT00251030|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6409599|NCT00251030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6409600|NCT00251030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409601|NCT00251030|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6409602|NCT00251030|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6409603|NCT00251030|Protease Inhibitors|protease inhibitors|mesh-ancestor
6409604|NCT00251030|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6409605|NCT00251030|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6409606|NCT00251030|Antiviral Agents|antiviral agents|mesh-ancestor
6409607|NCT00251030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6409608|NCT00251056|Mannitol|mannitol|mesh-list
6409609|NCT00251056|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6409610|NCT00251056|Diuretics|diuretics|mesh-ancestor
6409611|NCT00251056|Natriuretic Agents|natriuretic agents|mesh-ancestor
6409612|NCT00251056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409613|NCT00251082|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6409614|NCT00251082|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6409615|NCT00251082|Estradiol|estradiol|mesh-list
6409616|NCT00251082|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6409617|NCT00251082|Dydrogesterone|dydrogesterone|mesh-list
6409618|NCT00251082|Estrogens|estrogens|mesh-ancestor
6409619|NCT00251082|Hormones|hormones|mesh-ancestor
6409620|NCT00251082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6409621|NCT00251082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409622|NCT00251082|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6409623|NCT00251082|Contraceptive Agents|contraceptive agents|mesh-ancestor
6409624|NCT00251082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6409625|NCT00251082|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6409626|NCT00251082|Progestins|progestins|mesh-ancestor
6409627|NCT00251095|Paclitaxel|paclitaxel|mesh-list
6409628|NCT00251095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6409629|NCT00251095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6409630|NCT00251095|Tubulin Modulators|tubulin modulators|mesh-ancestor
6409631|NCT00251095|Antimitotic Agents|antimitotic agents|mesh-ancestor
6409632|NCT00251095|Mitosis Modulators|mitosis modulators|mesh-ancestor
6409633|NCT00251095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409634|NCT00251186|Capecitabine|capecitabine|mesh-list
6409635|NCT00251186|Cetuximab|cetuximab|mesh-list
6409636|NCT00251186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6409637|NCT00251186|Antimetabolites|antimetabolites|mesh-ancestor
6409638|NCT00251186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409639|NCT00251186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6409640|NCT00251186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6409641|NCT00251277|Rituximab|rituximab|mesh-list
6409642|NCT00251277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6409643|NCT00251277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6409644|NCT00251277|Immunologic Factors|immunologic factors|mesh-ancestor
6409645|NCT00251277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409646|NCT00251277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6409647|NCT00251355|Gemcitabine|gemcitabine|mesh-list
6409648|NCT00251355|Fluorouracil|fluorouracil|mesh-list
6409649|NCT00251355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6409650|NCT00251355|Antimetabolites|antimetabolites|mesh-ancestor
6409651|NCT00251355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409652|NCT00251355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6409653|NCT00251355|Antiviral Agents|antiviral agents|mesh-ancestor
6409654|NCT00251355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6409655|NCT00251355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6409656|NCT00251355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6409657|NCT00251355|Immunologic Factors|immunologic factors|mesh-ancestor
6409658|NCT00251355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409659|NCT00251368|9-aminocamptothecin|9-aminocamptothecin|mesh-list
6409660|NCT00251368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6409661|NCT00251381|Cetuximab|cetuximab|mesh-list
6409662|NCT00251381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6409663|NCT00251381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6409664|NCT00251394|Rituximab|rituximab|mesh-list
6409665|NCT00251394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6409666|NCT00251394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6409667|NCT00251394|Immunologic Factors|immunologic factors|mesh-ancestor
6409668|NCT00251394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409669|NCT00251394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6409670|NCT00251407|Docetaxel|docetaxel|mesh-list
6409671|NCT00251407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6409672|NCT00251407|Tubulin Modulators|tubulin modulators|mesh-ancestor
6409673|NCT00251407|Antimitotic Agents|antimitotic agents|mesh-ancestor
6409674|NCT00251407|Mitosis Modulators|mitosis modulators|mesh-ancestor
6409675|NCT00251407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409676|NCT00251433|Docetaxel|docetaxel|mesh-list
6409677|NCT00251433|Trastuzumab|trastuzumab|mesh-list
6409678|NCT00251433|Lapatinib|lapatinib|mesh-list
6409679|NCT00251433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6409680|NCT00251433|Tubulin Modulators|tubulin modulators|mesh-ancestor
6409681|NCT00251433|Antimitotic Agents|antimitotic agents|mesh-ancestor
6409682|NCT00251433|Mitosis Modulators|mitosis modulators|mesh-ancestor
6409683|NCT00251433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409684|NCT00251433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6409685|NCT00251433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6409686|NCT00251433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6409687|NCT00251459|Ranibizumab|ranibizumab|mesh-list
6409688|NCT00251459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6409689|NCT00251459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6409690|NCT00251459|Growth Substances|growth substances|mesh-ancestor
6409691|NCT00251459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409692|NCT00251459|Growth Inhibitors|growth inhibitors|mesh-ancestor
6409693|NCT00251459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6409694|NCT00251472|Paclitaxel|paclitaxel|mesh-list
6409695|NCT00251472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6409696|NCT00251472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6409697|NCT00251472|Tubulin Modulators|tubulin modulators|mesh-ancestor
6409698|NCT00251472|Antimitotic Agents|antimitotic agents|mesh-ancestor
6409699|NCT00251472|Mitosis Modulators|mitosis modulators|mesh-ancestor
6409700|NCT00251472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409701|NCT00251485|Cetuximab|cetuximab|mesh-list
6409702|NCT00251485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6409703|NCT00251485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6409704|NCT00251498|Cetuximab|cetuximab|mesh-list
6409705|NCT00251498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6409706|NCT00251498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6409707|NCT00251511|Arsenic Trioxide|arsenic trioxide|mesh-list
6409708|NCT00251511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6409709|NCT00251524|Bevacizumab|bevacizumab|mesh-list
6409710|NCT00251524|Oxaliplatin|oxaliplatin|mesh-list
6409711|NCT00251524|Pemetrexed|pemetrexed|mesh-list
6409712|NCT00251524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6409713|NCT00251524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6409714|NCT00251524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6409715|NCT00251524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6409716|NCT00251524|Growth Substances|growth substances|mesh-ancestor
6409717|NCT00251524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409718|NCT00251524|Growth Inhibitors|growth inhibitors|mesh-ancestor
6409719|NCT00251524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6409720|NCT00251524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409721|NCT00251524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6409722|NCT00251524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6409723|NCT00251550|Pemetrexed|pemetrexed|mesh-list
6409724|NCT00251550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6409725|NCT00251550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6409726|NCT00251550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409727|NCT00251550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6409728|NCT00251550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6409729|NCT00251602|Propranolol|propranolol|mesh-list
6409730|NCT00251602|Atropine|atropine|mesh-list
6409731|NCT00251602|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6409732|NCT00251602|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6538135|NCT00826163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6409733|NCT00251602|Adrenergic Agents|adrenergic agents|mesh-ancestor
6409734|NCT00251602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6409735|NCT00251602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409736|NCT00251602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409737|NCT00251602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6409738|NCT00251602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6409739|NCT00251602|Vasodilator Agents|vasodilator agents|mesh-ancestor
6409740|NCT00251602|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6409741|NCT00251602|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6409742|NCT00251602|Autonomic Agents|autonomic agents|mesh-ancestor
6409743|NCT00251602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6409744|NCT00251602|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6409745|NCT00251602|Respiratory System Agents|respiratory system agents|mesh-ancestor
6409746|NCT00251602|Mydriatics|mydriatics|mesh-ancestor
6409747|NCT00251602|Parasympatholytics|parasympatholytics|mesh-ancestor
6409748|NCT00251602|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6409749|NCT00251602|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6409750|NCT00251602|Cholinergic Agents|cholinergic agents|mesh-ancestor
6409751|NCT00251654|Anesthetics|anesthetics|mesh-list
6409752|NCT00251654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6409753|NCT00251654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409754|NCT00251680|Atorvastatin|atorvastatin|mesh-list
6409755|NCT00251680|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6409756|NCT00251680|Simvastatin|simvastatin|mesh-list
6409757|NCT00251680|Fenofibrate|fenofibrate|mesh-list
6409758|NCT00251680|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6409759|NCT00251680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6409760|NCT00251680|Antimetabolites|antimetabolites|mesh-ancestor
6409761|NCT00251680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409762|NCT00251680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6409763|NCT00251680|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6409764|NCT00251680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6409765|NCT00251706|Amiodarone|amiodarone|mesh-list
6409766|NCT00251706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6409767|NCT00251706|Vasodilator Agents|vasodilator agents|mesh-ancestor
6409768|NCT00251706|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6409769|NCT00251706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6409770|NCT00251706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409771|NCT00251706|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6409772|NCT00251706|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6409773|NCT00251706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6409774|NCT00251706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6409775|NCT00251706|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6409776|NCT00251706|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6409777|NCT00251706|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6409778|NCT00251732|Antidepressive Agents|antidepressive agents|mesh-list
6409779|NCT00251732|Nortriptyline|nortriptyline|mesh-list
6409780|NCT00251732|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
6409781|NCT00251732|Rabeprazole|rabeprazole|mesh-list
6409782|NCT00251732|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6409783|NCT00251732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6409784|NCT00251732|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6409785|NCT00251732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6409786|NCT00251732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409787|NCT00251732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6409788|NCT00251732|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6409789|NCT00251732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6409790|NCT00251732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6409791|NCT00251732|Adrenergic Agents|adrenergic agents|mesh-ancestor
6409792|NCT00251732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6409793|NCT00251732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409794|NCT00251784|Sildenafil Citrate|sildenafil citrate|mesh-list
6409795|NCT00251784|Vasodilator Agents|vasodilator agents|mesh-ancestor
6409796|NCT00251784|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6409797|NCT00251784|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6409798|NCT00251784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6409799|NCT00251784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409800|NCT00251784|Urological Agents|urological agents|mesh-ancestor
6409801|NCT00251797|Thalidomide|thalidomide|mesh-list
6409802|NCT00251797|Irinotecan|irinotecan|mesh-list
6409803|NCT00251797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6409804|NCT00251797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6409805|NCT00251797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6409806|NCT00251797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409807|NCT00251797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6409808|NCT00251797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6409809|NCT00251797|Immunologic Factors|immunologic factors|mesh-ancestor
6409810|NCT00251797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409811|NCT00251797|Leprostatic Agents|leprostatic agents|mesh-ancestor
6409812|NCT00251797|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6409813|NCT00251797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6409814|NCT00251797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6409815|NCT00251797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6409816|NCT00251797|Growth Substances|growth substances|mesh-ancestor
6409817|NCT00251797|Growth Inhibitors|growth inhibitors|mesh-ancestor
6409818|NCT00251823|Eptifibatide|eptifibatide|mesh-list
6409819|NCT00251823|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6409820|NCT00251849|KRM 1648|krm 1648|mesh-list
6409821|NCT00251849|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6409822|NCT00251849|Antitubercular Agents|antitubercular agents|mesh-ancestor
6409823|NCT00251849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6409824|NCT00251849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6409825|NCT00251849|Leprostatic Agents|leprostatic agents|mesh-ancestor
6409826|NCT00251888|Irinotecan|irinotecan|mesh-list
6409827|NCT00251888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6409828|NCT00251888|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6409829|NCT00251888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6409830|NCT00251888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6409831|NCT00251888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409832|NCT00251901|Esomeprazole|esomeprazole|mesh-list
6409833|NCT00251901|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6409834|NCT00251901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6409835|NCT00251901|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6409836|NCT00251901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6409837|NCT00251901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409838|NCT00251914|Esomeprazole|esomeprazole|mesh-list
6409839|NCT00251914|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6409840|NCT00251914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6409841|NCT00251914|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6409842|NCT00251914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6409843|NCT00251914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409844|NCT00251940|Glyburide|glyburide|mesh-list
6409845|NCT00251940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6409846|NCT00251940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409847|NCT00251953|Metformin|metformin|mesh-list
6409848|NCT00251953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6409849|NCT00251953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409850|NCT00251966|Esomeprazole|esomeprazole|mesh-list
6409851|NCT00251966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6409852|NCT00251966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6409853|NCT00251966|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6409854|NCT00251966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6409855|NCT00251966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409856|NCT00251992|Esomeprazole|esomeprazole|mesh-list
6409857|NCT00251992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6409858|NCT00251992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6409859|NCT00251992|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6409860|NCT00251992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6409861|NCT00251992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409862|NCT00252044|Pergolide|pergolide|mesh-list
6409863|NCT00252044|Dopamine Agonists|dopamine agonists|mesh-ancestor
6409864|NCT00252044|Dopamine Agents|dopamine agents|mesh-ancestor
6409865|NCT00252044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6409866|NCT00252044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409867|NCT00252044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409868|NCT00252122|Ketamine|ketamine|mesh-list
6409869|NCT00252122|Analgesics|analgesics|mesh-ancestor
6409870|NCT00252122|Sensory System Agents|sensory system agents|mesh-ancestor
6409871|NCT00252122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6409872|NCT00252122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409873|NCT00252122|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6409874|NCT00252122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6409875|NCT00252122|Anesthetics, General|anesthetics, general|mesh-ancestor
6409876|NCT00252122|Anesthetics|anesthetics|mesh-ancestor
6409877|NCT00252122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6409878|NCT00252122|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6409879|NCT00252122|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6409880|NCT00252122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6409881|NCT00252122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409882|NCT00252200|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6409883|NCT00252200|Natriuretic Agents|natriuretic agents|mesh-ancestor
6409884|NCT00252200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409885|NCT00252226|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6409886|NCT00252226|Antidepressive Agents|antidepressive agents|mesh-ancestor
6409887|NCT00252226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6409888|NCT00252226|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6409889|NCT00252226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6409890|NCT00252226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6409891|NCT00252226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409892|NCT00252278|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6409893|NCT00252278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6409894|NCT00252278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6409895|NCT00252278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6409896|NCT00252278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409897|NCT00252278|Adrenergic Agents|adrenergic agents|mesh-ancestor
6409898|NCT00252278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6409899|NCT00252278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409900|NCT00252291|Methacholine Chloride|methacholine chloride|mesh-list
6409901|NCT00252291|Miotics|miotics|mesh-ancestor
6409902|NCT00252291|Autonomic Agents|autonomic agents|mesh-ancestor
6409903|NCT00252291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6409904|NCT00252291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409905|NCT00252291|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5501236|NCT04476121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6409906|NCT00252291|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
6409907|NCT00252291|Respiratory System Agents|respiratory system agents|mesh-ancestor
6409908|NCT00252291|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6409909|NCT00252291|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6409910|NCT00252291|Cholinergic Agents|cholinergic agents|mesh-ancestor
6409911|NCT00252291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6409912|NCT00252291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409913|NCT00252304|Zinc Sulfate|zinc sulfate|mesh-list
6409914|NCT00252304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409915|NCT00252304|Astringents|astringents|mesh-ancestor
6409916|NCT00252304|Dermatologic Agents|dermatologic agents|mesh-ancestor
6409917|NCT00252317|Captopril|captopril|mesh-list
6409918|NCT00252317|Trandolapril|trandolapril|mesh-list
6409919|NCT00252317|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6409920|NCT00252317|Protease Inhibitors|protease inhibitors|mesh-ancestor
6409921|NCT00252317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6409922|NCT00252317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409923|NCT00252317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6409924|NCT00252330|Amibegron|amibegron|mesh-list
6409925|NCT00252330|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6409926|NCT00252330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6409927|NCT00252330|Adrenergic Agents|adrenergic agents|mesh-ancestor
6409928|NCT00252330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6409929|NCT00252330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409930|NCT00252330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409931|NCT00252343|Amibegron|amibegron|mesh-list
6409932|NCT00252343|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6409933|NCT00252343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6409934|NCT00252343|Adrenergic Agents|adrenergic agents|mesh-ancestor
6409935|NCT00252343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6409936|NCT00252343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409937|NCT00252343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409938|NCT00252356|Amibegron|amibegron|mesh-list
6409939|NCT00252356|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6409940|NCT00252356|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6409941|NCT00252356|Adrenergic Agents|adrenergic agents|mesh-ancestor
6409942|NCT00252356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6409943|NCT00252356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409944|NCT00252356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409945|NCT00252369|Infliximab|infliximab|mesh-list
6409946|NCT00252369|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6409947|NCT00252369|Dermatologic Agents|dermatologic agents|mesh-ancestor
6409948|NCT00252369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6409949|NCT00252369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6409950|NCT00252369|Hemostatics|hemostatics|mesh-ancestor
6409951|NCT00252369|Coagulants|coagulants|mesh-ancestor
6409952|NCT00252408|Hormones|hormones|mesh-list
6409953|NCT00252408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6409954|NCT00252408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409955|NCT00252421|Nitroglycerin|nitroglycerin|mesh-list
6409956|NCT00252421|Vasodilator Agents|vasodilator agents|mesh-ancestor
6409957|NCT00252434|Methamphetamine|methamphetamine|mesh-list
6409958|NCT00252434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6409959|NCT00252434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409960|NCT00252434|Sympathomimetics|sympathomimetics|mesh-ancestor
6409961|NCT00252434|Autonomic Agents|autonomic agents|mesh-ancestor
6409962|NCT00252434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6409963|NCT00252434|Dopamine Agents|dopamine agents|mesh-ancestor
6409964|NCT00252434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6409965|NCT00252434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409966|NCT00252434|Adrenergic Agents|adrenergic agents|mesh-ancestor
6409967|NCT00252434|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6409968|NCT00252434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6409969|NCT00252434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6409970|NCT00252434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6409971|NCT00252603|Galantamine|galantamine|mesh-list
6409972|NCT00252603|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6409973|NCT00252603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6409974|NCT00252603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409975|NCT00252603|Cholinergic Agents|cholinergic agents|mesh-ancestor
6409976|NCT00252603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6409977|NCT00252603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409978|NCT00252603|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6409979|NCT00252603|Autonomic Agents|autonomic agents|mesh-ancestor
6409980|NCT00252603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6409981|NCT00252603|Nootropic Agents|nootropic agents|mesh-ancestor
6409982|NCT00252642|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6409983|NCT00252642|Antiviral Agents|antiviral agents|mesh-ancestor
6409984|NCT00252642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6459771|NCT00446472|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
6459772|NCT00446472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6459773|NCT00446472|Growth Substances|growth substances|mesh-ancestor
6459774|NCT00446472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459775|NCT00446524|Amlodipine|amlodipine|mesh-list
6459776|NCT00446524|Valsartan|valsartan|mesh-list
6459777|NCT00446524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6459778|NCT00446524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6459779|NCT00446524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6459780|NCT00446524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459781|NCT00446524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6459782|NCT00446524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459783|NCT00446524|Vasodilator Agents|vasodilator agents|mesh-ancestor
6459784|NCT00446524|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6459785|NCT00446524|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6459786|NCT00446537|Methylphenidate|methylphenidate|mesh-list
6459787|NCT00446537|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6459788|NCT00446537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501237|NCT04476121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6459789|NCT00446537|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6459790|NCT00446537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6459791|NCT00446537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6459792|NCT00446537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459793|NCT00446537|Dopamine Agents|dopamine agents|mesh-ancestor
6459794|NCT00446537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6459795|NCT00446576|Epoetin Alfa|epoetin alfa|mesh-list
6459796|NCT00446576|Hematinics|hematinics|mesh-ancestor
6459797|NCT00446589|Teriparatide|teriparatide|mesh-list
6459798|NCT00446589|Ibandronic Acid|ibandronic acid|mesh-list
6459799|NCT00446589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6459800|NCT00446589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459801|NCT00446589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6459802|NCT00446602|Epoetin Alfa|epoetin alfa|mesh-list
6459803|NCT00446602|Hematinics|hematinics|mesh-ancestor
6459804|NCT00446667|Mannitol|mannitol|mesh-list
6409985|NCT00252655|Sirolimus|sirolimus|mesh-list
6409986|NCT00252655|Tacrolimus|tacrolimus|mesh-list
6409987|NCT00252655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6409988|NCT00252655|Immunologic Factors|immunologic factors|mesh-ancestor
6409989|NCT00252655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6409990|NCT00252655|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6409991|NCT00252655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6409992|NCT00252655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6409993|NCT00252655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6409994|NCT00252655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6409995|NCT00252655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6409996|NCT00252655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6409997|NCT00252655|Antifungal Agents|antifungal agents|mesh-ancestor
6409998|NCT00252668|Etanercept|etanercept|mesh-list
6409999|NCT00252668|Methotrexate|methotrexate|mesh-list
6410000|NCT00252668|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6410001|NCT00252668|Abortifacient Agents|abortifacient agents|mesh-ancestor
6410002|NCT00252668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6410003|NCT00252668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410004|NCT00252668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6410005|NCT00252668|Antimetabolites|antimetabolites|mesh-ancestor
6410006|NCT00252668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410007|NCT00252668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6410008|NCT00252668|Dermatologic Agents|dermatologic agents|mesh-ancestor
6410009|NCT00252668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6410010|NCT00252668|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6410011|NCT00252668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6410012|NCT00252668|Immunologic Factors|immunologic factors|mesh-ancestor
6410013|NCT00252668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6410014|NCT00252668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6410015|NCT00252668|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6410016|NCT00252668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6410017|NCT00252668|Analgesics|analgesics|mesh-ancestor
6410018|NCT00252668|Sensory System Agents|sensory system agents|mesh-ancestor
6410019|NCT00252668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6410020|NCT00252668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6410021|NCT00252668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6410022|NCT00252707|Docetaxel|docetaxel|mesh-list
6410023|NCT00252707|Gefitinib|gefitinib|mesh-list
6410024|NCT00252707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6410025|NCT00252707|Tubulin Modulators|tubulin modulators|mesh-ancestor
6410026|NCT00252707|Antimitotic Agents|antimitotic agents|mesh-ancestor
6410027|NCT00252707|Mitosis Modulators|mitosis modulators|mesh-ancestor
6410028|NCT00252707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410029|NCT00252707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6410030|NCT00252707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6410031|NCT00252785|Budesonide|budesonide|mesh-list
6410032|NCT00252785|Theophylline|theophylline|mesh-list
6410033|NCT00252785|Formoterol Fumarate|formoterol fumarate|mesh-list
6410034|NCT00252785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6410035|NCT00252785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6410036|NCT00252785|Autonomic Agents|autonomic agents|mesh-ancestor
6410037|NCT00252785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6410038|NCT00252785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410039|NCT00252785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6410040|NCT00252785|Respiratory System Agents|respiratory system agents|mesh-ancestor
6410041|NCT00252785|Glucocorticoids|glucocorticoids|mesh-ancestor
6410042|NCT00252785|Hormones|hormones|mesh-ancestor
6410043|NCT00252785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6410044|NCT00252785|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6410045|NCT00252785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6410046|NCT00252785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6410047|NCT00252785|Adrenergic Agents|adrenergic agents|mesh-ancestor
6410048|NCT00252785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6410049|NCT00252785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410050|NCT00252785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6410051|NCT00252785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6410052|NCT00252785|Vasodilator Agents|vasodilator agents|mesh-ancestor
6410053|NCT00252785|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6410054|NCT00252785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6410055|NCT00252785|Purinergic Agents|purinergic agents|mesh-ancestor
6410056|NCT00252798|Paclitaxel|paclitaxel|mesh-list
6410057|NCT00252798|Carboplatin|carboplatin|mesh-list
6410058|NCT00252798|Gefitinib|gefitinib|mesh-list
6410059|NCT00252798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6410060|NCT00252798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6410061|NCT00252798|Tubulin Modulators|tubulin modulators|mesh-ancestor
6410062|NCT00252798|Antimitotic Agents|antimitotic agents|mesh-ancestor
6410063|NCT00252798|Mitosis Modulators|mitosis modulators|mesh-ancestor
6410064|NCT00252798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410065|NCT00252798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6410066|NCT00252798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6410067|NCT00252811|Gefitinib|gefitinib|mesh-list
6410068|NCT00252811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6410069|NCT00252811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6410070|NCT00252811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6410071|NCT00252811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410072|NCT00252824|Budesonide|budesonide|mesh-list
6410073|NCT00252824|Formoterol Fumarate|formoterol fumarate|mesh-list
6410074|NCT00252824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6410075|NCT00252824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6410076|NCT00252824|Autonomic Agents|autonomic agents|mesh-ancestor
6410077|NCT00252824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6410078|NCT00252824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410079|NCT00252824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6410080|NCT00252824|Respiratory System Agents|respiratory system agents|mesh-ancestor
6410081|NCT00252824|Glucocorticoids|glucocorticoids|mesh-ancestor
6410082|NCT00252824|Hormones|hormones|mesh-ancestor
6410083|NCT00252824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6410084|NCT00252824|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6410085|NCT00252824|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6410086|NCT00252824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6410087|NCT00252824|Adrenergic Agents|adrenergic agents|mesh-ancestor
6410088|NCT00252824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6410089|NCT00252824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410090|NCT00252863|Fluticasone|fluticasone|mesh-list
6410091|NCT00252863|Xhance|xhance|mesh-list
6410092|NCT00252863|Budesonide|budesonide|mesh-list
6410093|NCT00252863|Theophylline|theophylline|mesh-list
6410094|NCT00252863|Albuterol|albuterol|mesh-list
6410095|NCT00252863|Terbutaline|terbutaline|mesh-list
6410096|NCT00252863|Formoterol Fumarate|formoterol fumarate|mesh-list
6410097|NCT00252863|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6410098|NCT00252863|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6410099|NCT00252863|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6410100|NCT00252863|Montelukast|montelukast|mesh-list
6410101|NCT00252863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6410102|NCT00252863|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6410103|NCT00252863|Autonomic Agents|autonomic agents|mesh-ancestor
6410104|NCT00252863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6410105|NCT00252863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410106|NCT00252863|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6410107|NCT00252863|Respiratory System Agents|respiratory system agents|mesh-ancestor
6410108|NCT00252863|Dermatologic Agents|dermatologic agents|mesh-ancestor
6410109|NCT00252863|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6410110|NCT00252863|Glucocorticoids|glucocorticoids|mesh-ancestor
6410111|NCT00252863|Hormones|hormones|mesh-ancestor
6410112|NCT00252863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6410113|NCT00252863|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6410114|NCT00252863|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6410115|NCT00252863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6410116|NCT00252863|Adrenergic Agents|adrenergic agents|mesh-ancestor
6410117|NCT00252863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6410118|NCT00252863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410119|NCT00252863|Tocolytic Agents|tocolytic agents|mesh-ancestor
6410120|NCT00252863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6410121|NCT00252863|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6410122|NCT00252863|Hormone Antagonists|hormone antagonists|mesh-ancestor
6410123|NCT00252863|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6410124|NCT00252863|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6410125|NCT00252863|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6410126|NCT00252863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6410127|NCT00252863|Vasodilator Agents|vasodilator agents|mesh-ancestor
6410128|NCT00252863|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6410129|NCT00252863|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6410130|NCT00252863|Purinergic Agents|purinergic agents|mesh-ancestor
6410131|NCT00252863|Sympathomimetics|sympathomimetics|mesh-ancestor
6410132|NCT00252889|Doxorubicin|doxorubicin|mesh-list
6410133|NCT00252889|Topotecan|topotecan|mesh-list
6410134|NCT00252889|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
6410135|NCT00252889|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6410136|NCT00252889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6410137|NCT00252889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6410138|NCT00252889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6410139|NCT00252889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6410140|NCT00252889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410141|NCT00252928|Troclosene|troclosene|mesh-list
6410142|NCT00252928|Antifungal Agents|antifungal agents|mesh-ancestor
6410143|NCT00252928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6410144|NCT00252928|Antiviral Agents|antiviral agents|mesh-ancestor
6410145|NCT00252928|Disinfectants|disinfectants|mesh-ancestor
6410146|NCT00252954|Levetiracetam|levetiracetam|mesh-list
6410147|NCT00252954|Anticonvulsants|anticonvulsants|mesh-ancestor
6410148|NCT00252954|Nootropic Agents|nootropic agents|mesh-ancestor
6410149|NCT00253058|Cetirizine|cetirizine|mesh-list
6410150|NCT00253058|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6410151|NCT00253058|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6410152|NCT00253058|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6410153|NCT00253058|Histamine Antagonists|histamine antagonists|mesh-ancestor
6410154|NCT00253058|Histamine Agents|histamine agents|mesh-ancestor
6410155|NCT00253058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6410156|NCT00253058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410157|NCT00253058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410158|NCT00253110|Haloperidol|haloperidol|mesh-list
6410159|NCT00253110|Risperidone|risperidone|mesh-list
6410160|NCT00253110|Haloperidol decanoate|haloperidol decanoate|mesh-list
6410161|NCT00253110|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6410162|NCT00253110|Serotonin Agents|serotonin agents|mesh-ancestor
6410163|NCT00253110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6410164|NCT00253110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410165|NCT00253110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410166|NCT00253110|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6410167|NCT00253110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6410168|NCT00253110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6410169|NCT00253110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6410170|NCT00253110|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6410171|NCT00253110|Dopamine Agents|dopamine agents|mesh-ancestor
6410172|NCT00253110|Antiemetics|antiemetics|mesh-ancestor
6410173|NCT00253110|Autonomic Agents|autonomic agents|mesh-ancestor
6410174|NCT00253110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6410175|NCT00253110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6410176|NCT00253110|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6410177|NCT00253123|Risperidone|risperidone|mesh-list
6410178|NCT00253123|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6410179|NCT00253123|Serotonin Agents|serotonin agents|mesh-ancestor
6410180|NCT00253123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6410181|NCT00253123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410182|NCT00253123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410183|NCT00253123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6410184|NCT00253123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6410185|NCT00253123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6410186|NCT00253123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6410187|NCT00253123|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6410188|NCT00253123|Dopamine Agents|dopamine agents|mesh-ancestor
6410189|NCT00253136|Risperidone|risperidone|mesh-list
6410190|NCT00253136|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6410191|NCT00253136|Serotonin Agents|serotonin agents|mesh-ancestor
6410192|NCT00253136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6410193|NCT00253136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410194|NCT00253136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410195|NCT00253136|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6410196|NCT00253136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6410197|NCT00253136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6410198|NCT00253136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6410199|NCT00253136|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6410200|NCT00253136|Dopamine Agents|dopamine agents|mesh-ancestor
6410201|NCT00253149|Risperidone|risperidone|mesh-list
6410202|NCT00253149|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6410203|NCT00253149|Serotonin Agents|serotonin agents|mesh-ancestor
6410204|NCT00253149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6410205|NCT00253149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410206|NCT00253149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410207|NCT00253149|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6410208|NCT00253149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6410209|NCT00253149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6410210|NCT00253149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6410211|NCT00253149|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6410212|NCT00253149|Dopamine Agents|dopamine agents|mesh-ancestor
6410213|NCT00253162|Risperidone|risperidone|mesh-list
6410214|NCT00253162|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6410215|NCT00253162|Serotonin Agents|serotonin agents|mesh-ancestor
6410216|NCT00253162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6410217|NCT00253162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410218|NCT00253162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410219|NCT00253162|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6410220|NCT00253162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6410221|NCT00253162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6410222|NCT00253162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6410223|NCT00253162|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6410224|NCT00253162|Dopamine Agents|dopamine agents|mesh-ancestor
6410225|NCT00253175|Topiramate|topiramate|mesh-list
6410226|NCT00253175|Anticonvulsants|anticonvulsants|mesh-ancestor
6410227|NCT00253175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6410228|NCT00253175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410229|NCT00253188|Galantamine|galantamine|mesh-list
6410230|NCT00253188|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6410231|NCT00253188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6410232|NCT00253188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410233|NCT00253188|Cholinergic Agents|cholinergic agents|mesh-ancestor
6410234|NCT00253188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6410235|NCT00253188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410236|NCT00253188|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6410237|NCT00253188|Autonomic Agents|autonomic agents|mesh-ancestor
6410238|NCT00253188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6410239|NCT00253188|Nootropic Agents|nootropic agents|mesh-ancestor
6410240|NCT00253201|Galantamine|galantamine|mesh-list
6410241|NCT00253201|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6410242|NCT00253201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6410243|NCT00253201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410244|NCT00253201|Cholinergic Agents|cholinergic agents|mesh-ancestor
6410245|NCT00253201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6410246|NCT00253201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410247|NCT00253201|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6410248|NCT00253201|Autonomic Agents|autonomic agents|mesh-ancestor
6410249|NCT00253201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6410250|NCT00253201|Nootropic Agents|nootropic agents|mesh-ancestor
6410251|NCT00253214|Galantamine|galantamine|mesh-list
6410252|NCT00253214|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6410253|NCT00253214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6410254|NCT00253214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410255|NCT00253214|Cholinergic Agents|cholinergic agents|mesh-ancestor
6410256|NCT00253214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6410257|NCT00253214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410258|NCT00253214|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6410259|NCT00253214|Autonomic Agents|autonomic agents|mesh-ancestor
6410260|NCT00253214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6410261|NCT00253214|Nootropic Agents|nootropic agents|mesh-ancestor
6410262|NCT00253227|Galantamine|galantamine|mesh-list
6410263|NCT00253227|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6410264|NCT00253227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6410265|NCT00253227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410266|NCT00253227|Cholinergic Agents|cholinergic agents|mesh-ancestor
6410267|NCT00253227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6410268|NCT00253227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410269|NCT00253227|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6410270|NCT00253227|Autonomic Agents|autonomic agents|mesh-ancestor
6410271|NCT00253227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6410272|NCT00253227|Nootropic Agents|nootropic agents|mesh-ancestor
6410273|NCT00253266|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6410274|NCT00253266|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6410275|NCT00253266|Antidepressive Agents|antidepressive agents|mesh-ancestor
6410276|NCT00253266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6410277|NCT00253266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6410278|NCT00253266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6410279|NCT00253266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6410280|NCT00253266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410281|NCT00253266|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6410282|NCT00253266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6410283|NCT00253266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6410284|NCT00253266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410285|NCT00253266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6410286|NCT00253266|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6410287|NCT00253305|Terbinafine|terbinafine|mesh-list
6410288|NCT00253305|Naftifine|naftifine|mesh-list
6410289|NCT00253305|Antifungal Agents|antifungal agents|mesh-ancestor
6410290|NCT00253305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6410291|NCT00253305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6410292|NCT00253305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410293|NCT00253318|Dexamethasone|dexamethasone|mesh-list
6410294|NCT00253318|Docetaxel|docetaxel|mesh-list
6410295|NCT00253318|Everolimus|everolimus|mesh-list
6410296|NCT00253318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6410297|NCT00253318|Antiemetics|antiemetics|mesh-ancestor
6410298|NCT00253318|Autonomic Agents|autonomic agents|mesh-ancestor
6410299|NCT00253318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6410300|NCT00253318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410301|NCT00253318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6410302|NCT00253318|Glucocorticoids|glucocorticoids|mesh-ancestor
6410303|NCT00253318|Hormones|hormones|mesh-ancestor
6410304|NCT00253318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6410305|NCT00253318|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6410306|NCT00253318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6410307|NCT00253318|Tubulin Modulators|tubulin modulators|mesh-ancestor
6410308|NCT00253318|Antimitotic Agents|antimitotic agents|mesh-ancestor
6410309|NCT00253318|Mitosis Modulators|mitosis modulators|mesh-ancestor
6410310|NCT00253318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410311|NCT00253318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6018759|NCT00382070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6018760|NCT00382070|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6018761|NCT00382070|Hormone Antagonists|hormone antagonists|mesh-ancestor
6410312|NCT00253318|Immunologic Factors|immunologic factors|mesh-ancestor
6410313|NCT00253331|Nitroglycerin|nitroglycerin|mesh-list
6410314|NCT00253331|Vasodilator Agents|vasodilator agents|mesh-ancestor
6410315|NCT00253344|Docetaxel|docetaxel|mesh-list
6410316|NCT00253344|Lenalidomide|lenalidomide|mesh-list
6410317|NCT00253344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6410318|NCT00253344|Tubulin Modulators|tubulin modulators|mesh-ancestor
6410319|NCT00253344|Antimitotic Agents|antimitotic agents|mesh-ancestor
6410320|NCT00253344|Mitosis Modulators|mitosis modulators|mesh-ancestor
6410321|NCT00253344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410322|NCT00253344|Immunologic Factors|immunologic factors|mesh-ancestor
6410323|NCT00253344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410324|NCT00253344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6410325|NCT00253344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6410326|NCT00253344|Growth Substances|growth substances|mesh-ancestor
6410327|NCT00253344|Growth Inhibitors|growth inhibitors|mesh-ancestor
6410328|NCT00253396|Heparin|heparin|mesh-list
6410329|NCT00253396|Enoxaparin|enoxaparin|mesh-list
6410330|NCT00253396|Calcium heparin|calcium heparin|mesh-list
6410331|NCT00253396|Anticoagulants|anticoagulants|mesh-ancestor
6410332|NCT00253396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6410333|NCT00253396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6053204|NCT00593554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410334|NCT00253396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410335|NCT00253422|Fulvestrant|fulvestrant|mesh-list
6410336|NCT00253422|Anastrozole|anastrozole|mesh-list
6410337|NCT00253422|Exemestane|exemestane|mesh-list
6410338|NCT00253422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6410339|NCT00253422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6410340|NCT00253422|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6410341|NCT00253422|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6410342|NCT00253422|Hormone Antagonists|hormone antagonists|mesh-ancestor
6410343|NCT00253422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6410344|NCT00253422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410345|NCT00253422|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6410346|NCT00253422|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6410347|NCT00253422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6410348|NCT00253422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410349|NCT00253461|Topotecan|topotecan|mesh-list
6410350|NCT00253461|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6410351|NCT00253461|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6410352|NCT00253461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6410353|NCT00253461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6410354|NCT00253461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410355|NCT00253461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6410356|NCT00253461|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6410357|NCT00253474|Interferons|interferons|mesh-list
6410358|NCT00253474|Interferon-alpha|interferon-alpha|mesh-list
6410359|NCT00253474|Interferon alpha-2|interferon alpha-2|mesh-list
6410360|NCT00253474|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6410361|NCT00253474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6410362|NCT00253474|Antiviral Agents|antiviral agents|mesh-ancestor
6410363|NCT00253474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6410364|NCT00253474|Immunologic Factors|immunologic factors|mesh-ancestor
6410365|NCT00253474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410366|NCT00253487|Temozolomide|temozolomide|mesh-list
6410367|NCT00253487|Busulfan|busulfan|mesh-list
6410368|NCT00253487|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
6410369|NCT00253487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6410370|NCT00253487|Alkylating Agents|alkylating agents|mesh-ancestor
6410371|NCT00253487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410372|NCT00253487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6410373|NCT00253487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6410374|NCT00253487|Immunologic Factors|immunologic factors|mesh-ancestor
6410375|NCT00253487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018762|NCT00382070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6018763|NCT00382070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018764|NCT00382109|Sirolimus|sirolimus|mesh-list
6018765|NCT00382109|Cyclophosphamide|cyclophosphamide|mesh-list
6018766|NCT00382109|Thiotepa|thiotepa|mesh-list
6018767|NCT00382109|Methotrexate|methotrexate|mesh-list
6018768|NCT00382109|Tacrolimus|tacrolimus|mesh-list
6018769|NCT00382109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6018770|NCT00382109|Immunologic Factors|immunologic factors|mesh-ancestor
6018771|NCT00382109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018772|NCT00382109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6018773|NCT00382109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6018774|NCT00382109|Alkylating Agents|alkylating agents|mesh-ancestor
6018775|NCT00382109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6018776|NCT00382109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6410376|NCT00253487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6410377|NCT00253487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6410378|NCT00253500|Epirubicin|epirubicin|mesh-list
6410379|NCT00253500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6410380|NCT00253500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6410381|NCT00253500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6459805|NCT00446667|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6410382|NCT00253500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6410383|NCT00253500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6018777|NCT00382109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6018778|NCT00382109|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6018779|NCT00382109|Abortifacient Agents|abortifacient agents|mesh-ancestor
6410384|NCT00253500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410385|NCT00253526|Gemcitabine|gemcitabine|mesh-list
6410386|NCT00253526|Bevacizumab|bevacizumab|mesh-list
6410387|NCT00253526|Antibodies|antibodies|mesh-list
6410388|NCT00253526|Immunoglobulins|immunoglobulins|mesh-list
6410389|NCT00253526|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6410390|NCT00253526|Mitogens|mitogens|mesh-list
6410391|NCT00253526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6018780|NCT00382109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6410392|NCT00253526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6410393|NCT00253526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6410394|NCT00253526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6410395|NCT00253526|Growth Substances|growth substances|mesh-ancestor
6410396|NCT00253526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410397|NCT00253526|Growth Inhibitors|growth inhibitors|mesh-ancestor
6410398|NCT00253526|Immunologic Factors|immunologic factors|mesh-ancestor
6410399|NCT00253526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6410400|NCT00253526|Antimetabolites|antimetabolites|mesh-ancestor
6410401|NCT00253526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410402|NCT00253526|Antiviral Agents|antiviral agents|mesh-ancestor
6410403|NCT00253526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6410404|NCT00253526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6410405|NCT00253526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6410406|NCT00253526|Mitosis Modulators|mitosis modulators|mesh-ancestor
6410407|NCT00253539|Tamoxifen|tamoxifen|mesh-list
6410408|NCT00253539|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6410409|NCT00253539|Hormone Antagonists|hormone antagonists|mesh-ancestor
6410410|NCT00253539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6410411|NCT00253539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410412|NCT00253539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6410413|NCT00253539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6410414|NCT00253539|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6410415|NCT00253539|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6410416|NCT00253539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6410417|NCT00253552|Cyclosporine|cyclosporine|mesh-list
6410418|NCT00253552|Cyclophosphamide|cyclophosphamide|mesh-list
6410419|NCT00253552|Busulfan|busulfan|mesh-list
6410420|NCT00253552|Methotrexate|methotrexate|mesh-list
6410421|NCT00253552|Etoposide|etoposide|mesh-list
6410422|NCT00253552|Cyclosporins|cyclosporins|mesh-list
6410423|NCT00253552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6410424|NCT00253552|Immunologic Factors|immunologic factors|mesh-ancestor
6410425|NCT00253552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410426|NCT00253552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6410427|NCT00253552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6410428|NCT00253552|Alkylating Agents|alkylating agents|mesh-ancestor
6410429|NCT00253552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410430|NCT00253552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6410431|NCT00253552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6410432|NCT00253552|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6410433|NCT00253552|Abortifacient Agents|abortifacient agents|mesh-ancestor
6410434|NCT00253552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6410435|NCT00253552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6410436|NCT00253552|Antimetabolites|antimetabolites|mesh-ancestor
6410437|NCT00253552|Dermatologic Agents|dermatologic agents|mesh-ancestor
6410438|NCT00253552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6410439|NCT00253552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6410440|NCT00253552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6410441|NCT00253552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6410442|NCT00253552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6410443|NCT00253552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6410444|NCT00253552|Antifungal Agents|antifungal agents|mesh-ancestor
6410445|NCT00253552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6410446|NCT00253552|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6410447|NCT00253565|Capecitabine|capecitabine|mesh-list
6410448|NCT00253565|Imatinib Mesylate|imatinib mesylate|mesh-list
6410449|NCT00253565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6410450|NCT00253565|Antimetabolites|antimetabolites|mesh-ancestor
6410451|NCT00253565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410452|NCT00253565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6410453|NCT00253565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6410454|NCT00253565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6410455|NCT00253578|Sorafenib|sorafenib|mesh-list
6410456|NCT00253578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6410457|NCT00253578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6410458|NCT00253578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6410459|NCT00253578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410460|NCT00253591|Vinorelbine|vinorelbine|mesh-list
6410461|NCT00253591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6410462|NCT00253591|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6410463|NCT00253591|Tubulin Modulators|tubulin modulators|mesh-ancestor
6410464|NCT00253591|Antimitotic Agents|antimitotic agents|mesh-ancestor
6410465|NCT00253591|Mitosis Modulators|mitosis modulators|mesh-ancestor
6410466|NCT00253591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410467|NCT00253617|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
6410468|NCT00253617|Trioxsalen|trioxsalen|mesh-list
6410469|NCT00253617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6410470|NCT00253617|Dermatologic Agents|dermatologic agents|mesh-ancestor
6410471|NCT00253617|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6410472|NCT00253721|Melphalan|melphalan|mesh-list
6410473|NCT00253721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6410474|NCT00253721|Alkylating Agents|alkylating agents|mesh-ancestor
6410475|NCT00253721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410476|NCT00253721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6410477|NCT00253721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6410478|NCT00253721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6410479|NCT00253721|Immunologic Factors|immunologic factors|mesh-ancestor
6410480|NCT00253721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410481|NCT00253773|Acetaminophen|acetaminophen|mesh-list
6410482|NCT00253773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6410483|NCT00253773|Analgesics|analgesics|mesh-ancestor
6410484|NCT00253773|Sensory System Agents|sensory system agents|mesh-ancestor
6410485|NCT00253773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6410486|NCT00253773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410487|NCT00253773|Antipyretics|antipyretics|mesh-ancestor
6410488|NCT00253799|Hylan|hylan|mesh-list
6410489|NCT00253799|Viscosupplements|viscosupplements|mesh-ancestor
6410490|NCT00253799|Protective Agents|protective agents|mesh-ancestor
6410491|NCT00253799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410492|NCT00253851|Heparin|heparin|mesh-list
6410493|NCT00253851|Calcium heparin|calcium heparin|mesh-list
6410494|NCT00253851|Anticoagulants|anticoagulants|mesh-ancestor
6410495|NCT00253851|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6410496|NCT00253851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6410497|NCT00253851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410498|NCT00253903|SR 46349B|sr 46349b|mesh-list
6410499|NCT00253903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6410500|NCT00253903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6410501|NCT00253903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410502|NCT00253903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6410503|NCT00253903|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6410504|NCT00253903|Serotonin Agents|serotonin agents|mesh-ancestor
6410505|NCT00253903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6410506|NCT00253903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410507|NCT00253929|Adenosine|adenosine|mesh-list
6410508|NCT00253929|Nitroprusside|nitroprusside|mesh-list
6410509|NCT00253929|Acetylcholine|acetylcholine|mesh-list
6410510|NCT00253929|Caffeine|caffeine|mesh-list
6410511|NCT00253929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6410512|NCT00253929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410513|NCT00253929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6410514|NCT00253929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6410515|NCT00253929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410516|NCT00253929|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6410517|NCT00253929|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6410518|NCT00253929|Purinergic Agents|purinergic agents|mesh-ancestor
6410519|NCT00253929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6410520|NCT00253929|Analgesics|analgesics|mesh-ancestor
6410521|NCT00253929|Sensory System Agents|sensory system agents|mesh-ancestor
6410522|NCT00253929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6410523|NCT00253929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6410524|NCT00253929|Vasodilator Agents|vasodilator agents|mesh-ancestor
6410525|NCT00253929|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6410526|NCT00253929|Purinergic Agonists|purinergic agonists|mesh-ancestor
6410527|NCT00253929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6410528|NCT00253929|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6410529|NCT00253929|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6410530|NCT00253929|Cholinergic Agents|cholinergic agents|mesh-ancestor
6410531|NCT00253955|Levofloxacin|levofloxacin|mesh-list
6410532|NCT00253955|Ofloxacin|ofloxacin|mesh-list
6410533|NCT00253955|Tazobactam|tazobactam|mesh-list
6410534|NCT00253955|Piperacillin|piperacillin|mesh-list
6410535|NCT00253955|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
6410536|NCT00253955|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6410537|NCT00253955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6410538|NCT00253955|Renal Agents|renal agents|mesh-ancestor
6410539|NCT00253955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6410540|NCT00253955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6410541|NCT00253955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6410542|NCT00253955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6410543|NCT00253955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410544|NCT00253955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6410545|NCT00253955|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6410546|NCT00253955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6410547|NCT00253955|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6410548|NCT00254007|Citalopram|citalopram|mesh-list
6410549|NCT00254007|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6410550|NCT00254007|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6410551|NCT00254007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6410552|NCT00254007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410553|NCT00254007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6410554|NCT00254007|Serotonin Agents|serotonin agents|mesh-ancestor
6410555|NCT00254007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410556|NCT00254007|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6410557|NCT00254007|Antidepressive Agents|antidepressive agents|mesh-ancestor
6410558|NCT00254007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6410559|NCT00254020|Citalopram|citalopram|mesh-list
6410560|NCT00254020|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6410561|NCT00254020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6410562|NCT00254020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6410563|NCT00254020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410564|NCT00254020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6410565|NCT00254020|Serotonin Agents|serotonin agents|mesh-ancestor
6410566|NCT00254020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410567|NCT00254020|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6410568|NCT00254020|Antidepressive Agents|antidepressive agents|mesh-ancestor
6410569|NCT00254020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6410570|NCT00254033|Methylphenidate|methylphenidate|mesh-list
6410571|NCT00254033|Dextroamphetamine|dextroamphetamine|mesh-list
6410572|NCT00254033|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6410573|NCT00254033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410574|NCT00254033|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6410575|NCT00254033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6410576|NCT00254033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6410577|NCT00254033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410578|NCT00254033|Dopamine Agents|dopamine agents|mesh-ancestor
6410579|NCT00254033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6410580|NCT00254046|Etravirine|etravirine|mesh-list
6410581|NCT00254046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6410582|NCT00254046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6410583|NCT00254046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6410584|NCT00254046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410585|NCT00254046|Antiviral Agents|antiviral agents|mesh-ancestor
6410586|NCT00254046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6410587|NCT00254085|Insulin Aspart|insulin aspart|mesh-list
6410588|NCT00254085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6410589|NCT00254085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410590|NCT00254137|Capecitabine|capecitabine|mesh-list
6410591|NCT00254137|Oxaliplatin|oxaliplatin|mesh-list
6410592|NCT00254137|Irinotecan|irinotecan|mesh-list
6410593|NCT00254137|Cetuximab|cetuximab|mesh-list
6410594|NCT00254137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6410595|NCT00254137|Antimetabolites|antimetabolites|mesh-ancestor
6410596|NCT00254137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410597|NCT00254137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6410598|NCT00254137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6410599|NCT00254137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6410600|NCT00254137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6410601|NCT00254137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6410602|NCT00254176|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
6410603|NCT00254176|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6410604|NCT00254176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6410605|NCT00254189|Levonorgestrel|levonorgestrel|mesh-list
6410606|NCT00254189|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6410607|NCT00254189|Estradiol|estradiol|mesh-list
6410608|NCT00254189|Estrogens|estrogens|mesh-ancestor
6410609|NCT00254189|Hormones|hormones|mesh-ancestor
6410610|NCT00254189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6410611|NCT00254189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410612|NCT00254189|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6410613|NCT00254189|Contraceptive Agents|contraceptive agents|mesh-ancestor
6410614|NCT00254189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6410615|NCT00254189|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6410616|NCT00254189|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6410617|NCT00254189|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6410618|NCT00254189|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6410619|NCT00254202|Iloperidone|iloperidone|mesh-list
6410620|NCT00254202|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6410621|NCT00254202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6410622|NCT00254202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6410623|NCT00254202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410624|NCT00254202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6459806|NCT00446667|Diuretics|diuretics|mesh-ancestor
6459807|NCT00446667|Natriuretic Agents|natriuretic agents|mesh-ancestor
6459808|NCT00446667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459809|NCT00446680|Mannitol|mannitol|mesh-list
6459810|NCT00446680|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6410625|NCT00254241|Risperidone|risperidone|mesh-list
6410626|NCT00254241|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6410627|NCT00254241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6410628|NCT00254241|Serotonin Agents|serotonin agents|mesh-ancestor
6410629|NCT00254241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6410630|NCT00254241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410631|NCT00254241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410632|NCT00254241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6410633|NCT00254241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6410634|NCT00254241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6410635|NCT00254241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6410636|NCT00254241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6410637|NCT00254241|Dopamine Agents|dopamine agents|mesh-ancestor
6410638|NCT00254241|Antidepressive Agents|antidepressive agents|mesh-ancestor
6410639|NCT00254254|Exenatide|exenatide|mesh-list
6410640|NCT00254254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6410641|NCT00254254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410642|NCT00254254|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6410643|NCT00254254|Incretins|incretins|mesh-ancestor
6410644|NCT00254254|Hormones|hormones|mesh-ancestor
6410645|NCT00254254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6410646|NCT00254267|Motesanib diphosphate|motesanib diphosphate|mesh-list
6410647|NCT00254267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6410648|NCT00254267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6410649|NCT00254267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410650|NCT00254319|Bevacizumab|bevacizumab|mesh-list
6410651|NCT00254319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6410652|NCT00254319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6410653|NCT00254319|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6410654|NCT00254319|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6410655|NCT00254319|Growth Substances|growth substances|mesh-ancestor
6410656|NCT00254319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410657|NCT00254319|Growth Inhibitors|growth inhibitors|mesh-ancestor
6410658|NCT00254345|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
6410659|NCT00254345|Vasodilator Agents|vasodilator agents|mesh-ancestor
6410660|NCT00254345|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
6410661|NCT00254345|Protective Agents|protective agents|mesh-ancestor
6410662|NCT00254345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410663|NCT00254371|Androgens|androgens|mesh-list
6410664|NCT00254371|Hormones|hormones|mesh-ancestor
6410665|NCT00254371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6410666|NCT00254371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410667|NCT00254384|Cisplatin|cisplatin|mesh-list
6410668|NCT00254384|Docetaxel|docetaxel|mesh-list
6410669|NCT00254384|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6410670|NCT00254384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6410671|NCT00254384|Tubulin Modulators|tubulin modulators|mesh-ancestor
6410672|NCT00254384|Antimitotic Agents|antimitotic agents|mesh-ancestor
6410673|NCT00254384|Mitosis Modulators|mitosis modulators|mesh-ancestor
6410674|NCT00254384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410675|NCT00254384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6410676|NCT00254384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6410677|NCT00254423|Dasatinib|dasatinib|mesh-list
6410678|NCT00254423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6410679|NCT00254423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6410680|NCT00254423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6410681|NCT00254423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410682|NCT00254436|Epoetin Alfa|epoetin alfa|mesh-list
6410683|NCT00254436|Hematinics|hematinics|mesh-ancestor
6410684|NCT00254449|Capsaicin|capsaicin|mesh-list
6410685|NCT00254449|Antipruritics|antipruritics|mesh-ancestor
6410686|NCT00254449|Dermatologic Agents|dermatologic agents|mesh-ancestor
6410687|NCT00254449|Sensory System Agents|sensory system agents|mesh-ancestor
6410688|NCT00254449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6410689|NCT00254449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410690|NCT00254475|Valsartan|valsartan|mesh-list
6410691|NCT00254475|Simvastatin|simvastatin|mesh-list
6410692|NCT00254475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6410693|NCT00254475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6410694|NCT00254475|Antimetabolites|antimetabolites|mesh-ancestor
6410695|NCT00254475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410696|NCT00254475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6410697|NCT00254475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6410698|NCT00254475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6410699|NCT00254475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6410700|NCT00254475|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6410701|NCT00254475|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6410702|NCT00254553|Methyltestosterone|methyltestosterone|mesh-list
6410703|NCT00254553|Testosterone|testosterone|mesh-list
6410704|NCT00254553|Testosterone undecanoate|testosterone undecanoate|mesh-list
6410705|NCT00254553|Testosterone enanthate|testosterone enanthate|mesh-list
6410706|NCT00254553|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6410707|NCT00254553|Androgens|androgens|mesh-ancestor
6410708|NCT00254553|Hormones|hormones|mesh-ancestor
6410709|NCT00254553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6410710|NCT00254553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410711|NCT00254553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6410712|NCT00254553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6410713|NCT00254553|Anabolic Agents|anabolic agents|mesh-ancestor
6410714|NCT00254618|Mesalamine|mesalamine|mesh-list
6410715|NCT00254618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6410716|NCT00254618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6410717|NCT00254618|Analgesics|analgesics|mesh-ancestor
6410718|NCT00254618|Sensory System Agents|sensory system agents|mesh-ancestor
6410719|NCT00254618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6410720|NCT00254618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410721|NCT00254618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6410722|NCT00254618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6410723|NCT00254631|Oxycodone|oxycodone|mesh-list
6410724|NCT00254631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6410725|NCT00254631|Narcotics|narcotics|mesh-ancestor
6410726|NCT00254631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6410727|NCT00254631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410728|NCT00254631|Analgesics|analgesics|mesh-ancestor
6410729|NCT00254631|Sensory System Agents|sensory system agents|mesh-ancestor
6410730|NCT00254631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6410731|NCT00254657|Levetiracetam|levetiracetam|mesh-list
6410732|NCT00254657|Anticonvulsants|anticonvulsants|mesh-ancestor
6410733|NCT00254657|Nootropic Agents|nootropic agents|mesh-ancestor
6410734|NCT00254670|Naltrexone|naltrexone|mesh-list
6410735|NCT00254670|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6410736|NCT00254670|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6410737|NCT00254670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410738|NCT00254670|Sensory System Agents|sensory system agents|mesh-ancestor
6410739|NCT00254670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6410740|NCT00254709|Sirolimus|sirolimus|mesh-list
6410741|NCT00254709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6410742|NCT00254709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6410743|NCT00254709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6410744|NCT00254709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6410745|NCT00254709|Antifungal Agents|antifungal agents|mesh-ancestor
6410746|NCT00254709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6410747|NCT00254709|Immunologic Factors|immunologic factors|mesh-ancestor
6410748|NCT00254709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410749|NCT00254735|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6410750|NCT00254735|Clomipramine|clomipramine|mesh-list
6410751|NCT00254735|Antidepressive Agents|antidepressive agents|mesh-ancestor
6410752|NCT00254735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6410753|NCT00254735|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6410754|NCT00254735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6410755|NCT00254735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6410756|NCT00254735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410757|NCT00254735|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6410758|NCT00254735|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6410759|NCT00254735|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6410760|NCT00254735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6410761|NCT00254735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410762|NCT00254735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6410763|NCT00254735|Serotonin Agents|serotonin agents|mesh-ancestor
6410764|NCT00254748|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6410765|NCT00254748|Antidepressive Agents|antidepressive agents|mesh-ancestor
6410766|NCT00254748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6410767|NCT00254748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6410768|NCT00254748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6410769|NCT00254748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6410770|NCT00254748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410771|NCT00254774|Valproic Acid|valproic acid|mesh-list
6410772|NCT00254774|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6410773|NCT00254774|Antidepressive Agents|antidepressive agents|mesh-ancestor
6410774|NCT00254774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6410775|NCT00254774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6410776|NCT00254774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6410777|NCT00254774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6410778|NCT00254774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410779|NCT00254774|Anticonvulsants|anticonvulsants|mesh-ancestor
6410780|NCT00254774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6410781|NCT00254774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410782|NCT00254774|GABA Agents|gaba agents|mesh-ancestor
6410783|NCT00254774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6410784|NCT00254774|Antimanic Agents|antimanic agents|mesh-ancestor
6410785|NCT00254787|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6410786|NCT00254787|Antidepressive Agents|antidepressive agents|mesh-ancestor
6410787|NCT00254787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6410788|NCT00254787|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6410789|NCT00254787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6410790|NCT00254787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6410791|NCT00254787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410792|NCT00254800|Exenatide|exenatide|mesh-list
6410793|NCT00254800|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6410794|NCT00254800|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6410795|NCT00254800|Levonorgestrel|levonorgestrel|mesh-list
6410796|NCT00254800|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6410797|NCT00254800|Estradiol|estradiol|mesh-list
6410798|NCT00254800|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6410799|NCT00254800|Estrogens|estrogens|mesh-ancestor
6410800|NCT00254800|Hormones|hormones|mesh-ancestor
6410801|NCT00254800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6410802|NCT00254800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410803|NCT00254800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6410804|NCT00254800|Contraceptive Agents|contraceptive agents|mesh-ancestor
6410805|NCT00254800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6410806|NCT00254800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6410807|NCT00254800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6410808|NCT00254800|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6410809|NCT00254800|Incretins|incretins|mesh-ancestor
6410810|NCT00254800|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6410811|NCT00254800|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6410812|NCT00254800|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6410813|NCT00254813|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6410814|NCT00254813|Antidepressive Agents|antidepressive agents|mesh-ancestor
6410815|NCT00254813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6410816|NCT00254813|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6410817|NCT00254813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6410818|NCT00254813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6410819|NCT00254813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410820|NCT00254865|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6410821|NCT00254865|Norelgestromin|norelgestromin|mesh-list
6410822|NCT00254865|Contraceptive Agents|contraceptive agents|mesh-list
6410823|NCT00254865|Estradiol|estradiol|mesh-list
6410824|NCT00254865|Estrogens|estrogens|mesh-ancestor
6410825|NCT00254865|Hormones|hormones|mesh-ancestor
6410826|NCT00254865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6410827|NCT00254865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410828|NCT00254865|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6410829|NCT00254865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6410830|NCT00254865|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6410831|NCT00254865|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6410832|NCT00254865|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6410833|NCT00254878|Methylphenidate|methylphenidate|mesh-list
6410834|NCT00254878|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6410835|NCT00254878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410836|NCT00254878|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6410837|NCT00254878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6410838|NCT00254878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6410839|NCT00254878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410840|NCT00254878|Dopamine Agents|dopamine agents|mesh-ancestor
6410841|NCT00254878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6410842|NCT00254917|Vaccines|vaccines|mesh-list
6410843|NCT00254917|Immunologic Factors|immunologic factors|mesh-ancestor
6410844|NCT00254917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410845|NCT00254930|Risperidone|risperidone|mesh-list
6410846|NCT00254930|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6410847|NCT00254930|Serotonin Agents|serotonin agents|mesh-ancestor
6410848|NCT00254930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6410849|NCT00254930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410850|NCT00254930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410851|NCT00254930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6410852|NCT00254930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6410853|NCT00254930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6410854|NCT00254930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6410855|NCT00254930|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6410856|NCT00254930|Dopamine Agents|dopamine agents|mesh-ancestor
6410857|NCT00254956|Ciclesonide|ciclesonide|mesh-list
6410858|NCT00254956|Glucocorticoids|glucocorticoids|mesh-ancestor
6410859|NCT00254956|Hormones|hormones|mesh-ancestor
6410860|NCT00254956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6410861|NCT00254956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410862|NCT00254956|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6410863|NCT00255073|Baclofen|baclofen|mesh-list
6410864|NCT00255073|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6410865|NCT00255073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410866|NCT00255073|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6410867|NCT00255073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6410868|NCT00255073|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6410869|NCT00255073|GABA Agonists|gaba agonists|mesh-ancestor
6410870|NCT00255073|GABA Agents|gaba agents|mesh-ancestor
6410871|NCT00255073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6410872|NCT00255073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410873|NCT00255138|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6410874|NCT00255138|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6410875|NCT00255138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6410876|NCT00255138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6410877|NCT00255138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410878|NCT00255138|Adrenergic Agents|adrenergic agents|mesh-ancestor
6410879|NCT00255138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6410880|NCT00255138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410881|NCT00255216|Policosanol|policosanol|mesh-list
6410882|NCT00255216|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6410883|NCT00255216|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6410884|NCT00255216|Antimetabolites|antimetabolites|mesh-ancestor
6410885|NCT00255216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410886|NCT00255216|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6410887|NCT00255216|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6410888|NCT00255242|Simvastatin|simvastatin|mesh-list
6410889|NCT00255242|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6410890|NCT00255242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6410891|NCT00255242|Antimetabolites|antimetabolites|mesh-ancestor
6410892|NCT00255242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410893|NCT00255242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6410894|NCT00255242|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6410895|NCT00255242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6410896|NCT00255255|Budesonide|budesonide|mesh-list
6410897|NCT00255255|Formoterol Fumarate|formoterol fumarate|mesh-list
6410898|NCT00255255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6410899|NCT00255255|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6410900|NCT00255255|Autonomic Agents|autonomic agents|mesh-ancestor
6410901|NCT00255255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6410902|NCT00255255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410903|NCT00255255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6410904|NCT00255255|Respiratory System Agents|respiratory system agents|mesh-ancestor
6410905|NCT00255255|Glucocorticoids|glucocorticoids|mesh-ancestor
6410906|NCT00255255|Hormones|hormones|mesh-ancestor
6410907|NCT00255255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6410908|NCT00255255|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6410909|NCT00255255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6410910|NCT00255255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6410911|NCT00255255|Adrenergic Agents|adrenergic agents|mesh-ancestor
6410912|NCT00255255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6410913|NCT00255255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410914|NCT00255268|Goserelin|goserelin|mesh-list
6410915|NCT00255268|Bicalutamide|bicalutamide|mesh-list
6410916|NCT00255268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6410917|NCT00255268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6410918|NCT00255268|Androgen Antagonists|androgen antagonists|mesh-ancestor
6410919|NCT00255268|Hormone Antagonists|hormone antagonists|mesh-ancestor
6410920|NCT00255268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6410921|NCT00255268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410922|NCT00255372|Lactulose|lactulose|mesh-list
6410923|NCT00255372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6410924|NCT00255385|Micronutrients|micronutrients|mesh-list
6410925|NCT00255385|Trace Elements|trace elements|mesh-list
6410926|NCT00255385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410927|NCT00255424|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
6410928|NCT00255424|Hematinics|hematinics|mesh-ancestor
6410929|NCT00255424|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6410930|NCT00255424|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6410931|NCT00255437|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
6410932|NCT00255437|Hematinics|hematinics|mesh-ancestor
6410933|NCT00255437|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6410934|NCT00255437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6410935|NCT00255450|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
6410936|NCT00255450|Hematinics|hematinics|mesh-ancestor
6410937|NCT00255450|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6410938|NCT00255450|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6410939|NCT00255463|Gefitinib|gefitinib|mesh-list
6410940|NCT00255463|Anastrozole|anastrozole|mesh-list
6410941|NCT00255463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6410942|NCT00255463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6410943|NCT00255463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6410944|NCT00255463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410945|NCT00255463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6410946|NCT00255463|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6410947|NCT00255463|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6410948|NCT00255463|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6410949|NCT00255463|Hormone Antagonists|hormone antagonists|mesh-ancestor
6410950|NCT00255463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6410951|NCT00255463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410952|NCT00255476|Gefitinib|gefitinib|mesh-list
6410953|NCT00255476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6410954|NCT00255476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6410955|NCT00255476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6410956|NCT00255476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410957|NCT00255489|Gefitinib|gefitinib|mesh-list
6410958|NCT00255489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6410959|NCT00255489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6410960|NCT00255489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6410961|NCT00255489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410962|NCT00255502|Metoprolol|metoprolol|mesh-list
6410963|NCT00255502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6410964|NCT00255502|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6410965|NCT00255502|Sympatholytics|sympatholytics|mesh-ancestor
6410966|NCT00255502|Autonomic Agents|autonomic agents|mesh-ancestor
6410967|NCT00255502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6410968|NCT00255502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410969|NCT00255502|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6410970|NCT00255502|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6410971|NCT00255502|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6410972|NCT00255502|Adrenergic Agents|adrenergic agents|mesh-ancestor
6410973|NCT00255502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6410974|NCT00255502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410975|NCT00255515|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6410976|NCT00255515|Antidepressive Agents|antidepressive agents|mesh-ancestor
6410977|NCT00255515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6410978|NCT00255515|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6410979|NCT00255515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6410980|NCT00255515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6410981|NCT00255515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410982|NCT00255528|Metoprolol|metoprolol|mesh-list
6410983|NCT00255528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6410984|NCT00255528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6410985|NCT00255528|Sympatholytics|sympatholytics|mesh-ancestor
6410986|NCT00255528|Autonomic Agents|autonomic agents|mesh-ancestor
6410987|NCT00255528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6410988|NCT00255528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410989|NCT00255528|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6410990|NCT00255528|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6410991|NCT00255528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6410992|NCT00255528|Adrenergic Agents|adrenergic agents|mesh-ancestor
6410993|NCT00255528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6410994|NCT00255528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6410995|NCT00255541|Glyburide|glyburide|mesh-list
6410996|NCT00255541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6410997|NCT00255541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6410998|NCT00255554|Citalopram|citalopram|mesh-list
6410999|NCT00255554|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6411000|NCT00255554|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6411001|NCT00255554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6411002|NCT00255554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411003|NCT00255554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6411004|NCT00255554|Serotonin Agents|serotonin agents|mesh-ancestor
6411005|NCT00255554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411006|NCT00255554|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6411007|NCT00255554|Antidepressive Agents|antidepressive agents|mesh-ancestor
6411008|NCT00255554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6411009|NCT00255567|Paromomycin|paromomycin|mesh-list
6411010|NCT00255567|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
6411011|NCT00255567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6411012|NCT00255567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6411013|NCT00255567|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6411014|NCT00255567|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6411015|NCT00255567|Schistosomicides|schistosomicides|mesh-ancestor
6411016|NCT00255567|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6411017|NCT00255567|Anthelmintics|anthelmintics|mesh-ancestor
6411018|NCT00255593|Rituximab|rituximab|mesh-list
6411019|NCT00255593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6411020|NCT00255593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6411021|NCT00255593|Immunologic Factors|immunologic factors|mesh-ancestor
6411022|NCT00255593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411023|NCT00255593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6411024|NCT00255606|Prednisone|prednisone|mesh-list
6411025|NCT00255606|Docetaxel|docetaxel|mesh-list
6411026|NCT00255606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6411027|NCT00255606|Tubulin Modulators|tubulin modulators|mesh-ancestor
6411028|NCT00255606|Antimitotic Agents|antimitotic agents|mesh-ancestor
6411029|NCT00255606|Mitosis Modulators|mitosis modulators|mesh-ancestor
6411030|NCT00255606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411031|NCT00255606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6411032|NCT00255606|Glucocorticoids|glucocorticoids|mesh-ancestor
6411033|NCT00255606|Hormones|hormones|mesh-ancestor
6411034|NCT00255606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6411035|NCT00255606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411036|NCT00255606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6411037|NCT00255658|Sirolimus|sirolimus|mesh-list
6411038|NCT00255658|Sorafenib|sorafenib|mesh-list
6411039|NCT00255658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6411040|NCT00255658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6411041|NCT00255658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6411042|NCT00255658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411043|NCT00255658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6018781|NCT00382109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6018782|NCT00382109|Antimetabolites|antimetabolites|mesh-ancestor
6018783|NCT00382109|Dermatologic Agents|dermatologic agents|mesh-ancestor
6411044|NCT00255658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6411045|NCT00255658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6411046|NCT00255658|Antifungal Agents|antifungal agents|mesh-ancestor
6411047|NCT00255658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6411048|NCT00255658|Immunologic Factors|immunologic factors|mesh-ancestor
6411049|NCT00255658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411050|NCT00255710|Mycophenolic Acid|mycophenolic acid|mesh-list
6411051|NCT00255710|Cyclophosphamide|cyclophosphamide|mesh-list
6411052|NCT00255710|Fludarabine|fludarabine|mesh-list
6411053|NCT00255710|Fludarabine phosphate|fludarabine phosphate|mesh-list
6411054|NCT00255710|Tacrolimus|tacrolimus|mesh-list
6411055|NCT00255710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6411056|NCT00255710|Immunologic Factors|immunologic factors|mesh-ancestor
6411057|NCT00255710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411058|NCT00255710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6411059|NCT00255710|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6411060|NCT00255710|Alkylating Agents|alkylating agents|mesh-ancestor
6411061|NCT00255710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411062|NCT00255710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6411063|NCT00255710|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6411064|NCT00255710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6411065|NCT00255710|Antimetabolites|antimetabolites|mesh-ancestor
6411066|NCT00255710|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6411067|NCT00255710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6411068|NCT00255710|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6411069|NCT00255710|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6411070|NCT00255710|Antitubercular Agents|antitubercular agents|mesh-ancestor
6411071|NCT00255710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6411072|NCT00255710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6411073|NCT00255749|Epoetin Alfa|epoetin alfa|mesh-list
6411074|NCT00255749|Hematinics|hematinics|mesh-ancestor
6411075|NCT00255762|Paclitaxel|paclitaxel|mesh-list
6411076|NCT00255762|Bevacizumab|bevacizumab|mesh-list
6411077|NCT00255762|Carboplatin|carboplatin|mesh-list
6411078|NCT00255762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6411079|NCT00255762|Antibodies|antibodies|mesh-list
6411080|NCT00255762|Immunoglobulins|immunoglobulins|mesh-list
6411081|NCT00255762|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6411082|NCT00255762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6411083|NCT00255762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6411084|NCT00255762|Tubulin Modulators|tubulin modulators|mesh-ancestor
6411085|NCT00255762|Antimitotic Agents|antimitotic agents|mesh-ancestor
6411086|NCT00255762|Mitosis Modulators|mitosis modulators|mesh-ancestor
6411087|NCT00255762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411088|NCT00255762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6411089|NCT00255762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6411090|NCT00255762|Growth Substances|growth substances|mesh-ancestor
6411091|NCT00255762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411092|NCT00255762|Growth Inhibitors|growth inhibitors|mesh-ancestor
6411093|NCT00255762|Immunologic Factors|immunologic factors|mesh-ancestor
6411094|NCT00255788|Everolimus|everolimus|mesh-list
6411095|NCT00255788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6411096|NCT00255788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6411097|NCT00255788|Immunologic Factors|immunologic factors|mesh-ancestor
6411098|NCT00255788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411099|NCT00255879|Olanzapine|olanzapine|mesh-list
6411100|NCT00255879|Risperidone|risperidone|mesh-list
6411101|NCT00255879|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6411102|NCT00255879|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6411103|NCT00255879|Serotonin Agents|serotonin agents|mesh-ancestor
6411104|NCT00255879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6411105|NCT00255879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459811|NCT00446680|Diuretics|diuretics|mesh-ancestor
6411106|NCT00255879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411107|NCT00255879|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6411108|NCT00255879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6411109|NCT00255879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6411110|NCT00255879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6411111|NCT00255879|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6411112|NCT00255879|Dopamine Agents|dopamine agents|mesh-ancestor
6411113|NCT00255879|Antiemetics|antiemetics|mesh-ancestor
6411114|NCT00255879|Autonomic Agents|autonomic agents|mesh-ancestor
6411115|NCT00255879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6411116|NCT00255879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6411117|NCT00255879|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6411118|NCT00255879|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6411119|NCT00255879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6411120|NCT00255879|Antidepressive Agents|antidepressive agents|mesh-ancestor
6411121|NCT00255918|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
6411122|NCT00255918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6411123|NCT00255918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6411124|NCT00255918|Cholinergic Agents|cholinergic agents|mesh-ancestor
6411125|NCT00255918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6411126|NCT00255918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411127|NCT00255918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459812|NCT00446680|Natriuretic Agents|natriuretic agents|mesh-ancestor
6459813|NCT00446680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459814|NCT00446771|Mannitol|mannitol|mesh-list
6459815|NCT00446771|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6459816|NCT00446771|Diuretics|diuretics|mesh-ancestor
6459817|NCT00446771|Natriuretic Agents|natriuretic agents|mesh-ancestor
6459818|NCT00446771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459819|NCT00446784|Methotrexate|methotrexate|mesh-list
6459820|NCT00446784|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6459821|NCT00446784|Abortifacient Agents|abortifacient agents|mesh-ancestor
6459822|NCT00446784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6459823|NCT00446784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459824|NCT00446784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6459825|NCT00446784|Antimetabolites|antimetabolites|mesh-ancestor
6459826|NCT00446784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459827|NCT00446784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6459828|NCT00446784|Dermatologic Agents|dermatologic agents|mesh-ancestor
6459829|NCT00446784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6411128|NCT00255996|Linezolid|linezolid|mesh-list
6411129|NCT00255996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6411130|NCT00255996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6411131|NCT00255996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6411132|NCT00255996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6411133|NCT00255996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411134|NCT00256009|Misoprostol|misoprostol|mesh-list
6411135|NCT00256009|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6411136|NCT00256009|Abortifacient Agents|abortifacient agents|mesh-ancestor
6411137|NCT00256009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6411138|NCT00256009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411139|NCT00256009|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6411140|NCT00256009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6411141|NCT00256009|Oxytocics|oxytocics|mesh-ancestor
6411142|NCT00256100|PENTA|penta|mesh-list
6411143|NCT00256100|Fondaparinux|fondaparinux|mesh-list
6411144|NCT00256100|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6411145|NCT00256100|Antithrombins|antithrombins|mesh-ancestor
6411146|NCT00256100|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6411147|NCT00256100|Protease Inhibitors|protease inhibitors|mesh-ancestor
6411148|NCT00256100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6411149|NCT00256100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411150|NCT00256100|Anticoagulants|anticoagulants|mesh-ancestor
6411151|NCT00256100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6411152|NCT00256100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6411153|NCT00256178|Simvastatin|simvastatin|mesh-list
6411154|NCT00256178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6411155|NCT00256178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6411156|NCT00256178|Antimetabolites|antimetabolites|mesh-ancestor
6411157|NCT00256178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411158|NCT00256178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6411159|NCT00256178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6411160|NCT00256178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6411161|NCT00256230|Disulfiram|disulfiram|mesh-list
6411162|NCT00256230|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6411163|NCT00256230|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
6411164|NCT00256230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6411165|NCT00256230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411166|NCT00256256|Glucagon|glucagon|mesh-list
6411167|NCT00256256|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6411168|NCT00256256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6411169|NCT00256256|Hormones|hormones|mesh-ancestor
6411170|NCT00256256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6411171|NCT00256256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411172|NCT00256256|Incretins|incretins|mesh-ancestor
6411173|NCT00256269|Oxaliplatin|oxaliplatin|mesh-list
6411174|NCT00256269|Irinotecan|irinotecan|mesh-list
6411175|NCT00256269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6018784|NCT00382109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6018785|NCT00382109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6411176|NCT00256269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6018786|NCT00382109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6018787|NCT00382109|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6018788|NCT00382109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6018789|NCT00382109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6018790|NCT00382109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6018791|NCT00382109|Antifungal Agents|antifungal agents|mesh-ancestor
6018792|NCT00382148|Omalizumab|omalizumab|mesh-list
6411177|NCT00256269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6411178|NCT00256269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6411179|NCT00256269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411180|NCT00256321|Celecoxib|celecoxib|mesh-list
6411181|NCT00256321|Capecitabine|capecitabine|mesh-list
6411182|NCT00256321|Oxaliplatin|oxaliplatin|mesh-list
6411183|NCT00256321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6411184|NCT00256321|Antimetabolites|antimetabolites|mesh-ancestor
6411185|NCT00256321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411186|NCT00256321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6411187|NCT00256321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6411188|NCT00256321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6411189|NCT00256321|Analgesics|analgesics|mesh-ancestor
6411190|NCT00256321|Sensory System Agents|sensory system agents|mesh-ancestor
6411191|NCT00256321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6411192|NCT00256321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411193|NCT00256321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6411194|NCT00256321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6411195|NCT00256321|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6411196|NCT00256321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6411197|NCT00256321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6411198|NCT00256334|Resveratrol|resveratrol|mesh-list
6411199|NCT00256334|Antioxidants|antioxidants|mesh-ancestor
6411200|NCT00256334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411201|NCT00256334|Protective Agents|protective agents|mesh-ancestor
6411202|NCT00256334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411203|NCT00256334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6411204|NCT00256334|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6411205|NCT00256347|Morphine|morphine|mesh-list
6411206|NCT00256347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6411207|NCT00256347|Narcotics|narcotics|mesh-ancestor
6411208|NCT00256347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6411209|NCT00256347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411210|NCT00256347|Analgesics|analgesics|mesh-ancestor
6411211|NCT00256347|Sensory System Agents|sensory system agents|mesh-ancestor
6411212|NCT00256347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6411213|NCT00256399|Alfuzosin|alfuzosin|mesh-list
6411214|NCT00256399|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6411215|NCT00256399|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6411216|NCT00256399|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6411217|NCT00256399|Adrenergic Agents|adrenergic agents|mesh-ancestor
6411218|NCT00256399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6411219|NCT00256399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411220|NCT00256399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411221|NCT00256399|Urological Agents|urological agents|mesh-ancestor
6411222|NCT00256542|Lidocaine|lidocaine|mesh-list
6411223|NCT00256542|Heparin|heparin|mesh-list
6411224|NCT00256542|Anesthetics, Local|anesthetics, local|mesh-ancestor
6411225|NCT00256542|Anesthetics|anesthetics|mesh-ancestor
6411226|NCT00256542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6411227|NCT00256542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411228|NCT00256542|Sensory System Agents|sensory system agents|mesh-ancestor
6411229|NCT00256542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6411230|NCT00256542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6411231|NCT00256542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6411232|NCT00256542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6411233|NCT00256542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6411234|NCT00256542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411235|NCT00256542|Anticoagulants|anticoagulants|mesh-ancestor
6411236|NCT00256542|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6411237|NCT00256542|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6411238|NCT00256646|Rosiglitazone|rosiglitazone|mesh-list
6411239|NCT00256646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6018793|NCT00382148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6411240|NCT00256646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411241|NCT00256711|Vinorelbine|vinorelbine|mesh-list
6411242|NCT00256711|Gefitinib|gefitinib|mesh-list
6411243|NCT00256711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6411244|NCT00256711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6411245|NCT00256711|Tubulin Modulators|tubulin modulators|mesh-ancestor
6411246|NCT00256711|Antimitotic Agents|antimitotic agents|mesh-ancestor
6411247|NCT00256711|Mitosis Modulators|mitosis modulators|mesh-ancestor
6411248|NCT00256711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411249|NCT00256711|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6411250|NCT00256711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6411251|NCT00256737|Omeprazole|omeprazole|mesh-list
6411252|NCT00256737|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6411253|NCT00256737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6411254|NCT00256737|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6411255|NCT00256737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6411256|NCT00256737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411257|NCT00256828|Lamivudine|lamivudine|mesh-list
6411258|NCT00256828|Efavirenz|efavirenz|mesh-list
6411259|NCT00256828|Didanosine|didanosine|mesh-list
6411260|NCT00256828|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6411261|NCT00256828|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6411262|NCT00256828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6411263|NCT00256828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411264|NCT00256828|Antiviral Agents|antiviral agents|mesh-ancestor
6411265|NCT00256828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6411266|NCT00256828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6411267|NCT00256828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6411268|NCT00256828|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6411269|NCT00256828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6411270|NCT00256828|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6411271|NCT00256828|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6411272|NCT00256828|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6411273|NCT00256828|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6411274|NCT00256828|Antimetabolites|antimetabolites|mesh-ancestor
6411275|NCT00256893|Ropinirole|ropinirole|mesh-list
6411276|NCT00256893|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6411277|NCT00256893|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6411278|NCT00256893|Dopamine Agonists|dopamine agonists|mesh-ancestor
6411279|NCT00256893|Dopamine Agents|dopamine agents|mesh-ancestor
6411280|NCT00256893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6411281|NCT00256893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411282|NCT00256893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411283|NCT00256932|Alvimopan|alvimopan|mesh-list
6411284|NCT00256932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6411285|NCT00257023|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6411286|NCT00257023|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6411287|NCT00257023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6411288|NCT00257023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5501238|NCT04476121|Antipyretics|antipyretics|mesh-ancestor
5501239|NCT04476212|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5501240|NCT04476212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6411289|NCT00257023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411290|NCT00257023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6411291|NCT00257023|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6411292|NCT00257023|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6411293|NCT00257023|Serotonin Agents|serotonin agents|mesh-ancestor
6411294|NCT00257023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6411295|NCT00257023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411296|NCT00257023|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6411297|NCT00257023|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6411298|NCT00257023|Dopamine Agents|dopamine agents|mesh-ancestor
6411299|NCT00257036|Levofloxacin|levofloxacin|mesh-list
6411300|NCT00257036|Ofloxacin|ofloxacin|mesh-list
6411301|NCT00257036|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6411302|NCT00257036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6411303|NCT00257036|Renal Agents|renal agents|mesh-ancestor
6411304|NCT00257036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6411305|NCT00257036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6411306|NCT00257036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6411307|NCT00257036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6411308|NCT00257036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411309|NCT00257036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6411310|NCT00257036|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6411311|NCT00257036|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6411312|NCT00257049|Levofloxacin|levofloxacin|mesh-list
6411313|NCT00257049|Ofloxacin|ofloxacin|mesh-list
6411314|NCT00257049|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6411315|NCT00257049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6411316|NCT00257049|Renal Agents|renal agents|mesh-ancestor
6411317|NCT00257049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6411318|NCT00257049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6411319|NCT00257049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6411320|NCT00257049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5501241|NCT04476173|Morphine|morphine|mesh-list
5501242|NCT04476173|Methoxyflurane|methoxyflurane|mesh-list
6411321|NCT00257049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411322|NCT00257049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6411323|NCT00257049|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6411324|NCT00257049|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6411325|NCT00257062|Levofloxacin|levofloxacin|mesh-list
6411326|NCT00257062|Ofloxacin|ofloxacin|mesh-list
6411327|NCT00257062|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6411328|NCT00257062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6411329|NCT00257062|Renal Agents|renal agents|mesh-ancestor
6411330|NCT00257062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6411331|NCT00257062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6411332|NCT00257062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6411333|NCT00257062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6411334|NCT00257062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411335|NCT00257062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6411336|NCT00257062|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6411337|NCT00257062|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6018794|NCT00382148|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6018795|NCT00382148|Respiratory System Agents|respiratory system agents|mesh-ancestor
6018796|NCT00382265|Tamsulosin|tamsulosin|mesh-list
6411338|NCT00257075|Risperidone|risperidone|mesh-list
6411339|NCT00257075|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6411340|NCT00257075|Serotonin Agents|serotonin agents|mesh-ancestor
6411341|NCT00257075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6411342|NCT00257075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411343|NCT00257075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411344|NCT00257075|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6411345|NCT00257075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6411346|NCT00257075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6411347|NCT00257075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6411348|NCT00257075|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6411349|NCT00257075|Dopamine Agents|dopamine agents|mesh-ancestor
6411350|NCT00257114|Bortezomib|bortezomib|mesh-list
6411351|NCT00257114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6411352|NCT00257127|Vaccines|vaccines|mesh-list
6411353|NCT00257127|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6411354|NCT00257127|Immunologic Factors|immunologic factors|mesh-ancestor
6411355|NCT00257127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411356|NCT00257140|Levofloxacin|levofloxacin|mesh-list
6411357|NCT00257140|Ofloxacin|ofloxacin|mesh-list
6411358|NCT00257140|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6411359|NCT00257140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6411360|NCT00257140|Renal Agents|renal agents|mesh-ancestor
6411361|NCT00257140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6411362|NCT00257140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6411363|NCT00257140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6411364|NCT00257140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6411365|NCT00257140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411366|NCT00257140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6411367|NCT00257140|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6411368|NCT00257140|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6411369|NCT00257257|Rimonabant|rimonabant|mesh-list
6411370|NCT00257257|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6411371|NCT00257257|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
6411372|NCT00257257|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6411373|NCT00257257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6411374|NCT00257257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411375|NCT00257257|Hormones|hormones|mesh-ancestor
6411376|NCT00257257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6411377|NCT00257257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411378|NCT00257270|Gabapentin|gabapentin|mesh-list
6411379|NCT00257270|Analgesics|analgesics|mesh-ancestor
6411380|NCT00257270|Sensory System Agents|sensory system agents|mesh-ancestor
6411381|NCT00257270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6411382|NCT00257270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411383|NCT00257270|Anticonvulsants|anticonvulsants|mesh-ancestor
6411384|NCT00257270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6411385|NCT00257270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6411386|NCT00257270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6411387|NCT00257270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6411388|NCT00257270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6411389|NCT00257270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6411390|NCT00257270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6411391|NCT00257270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411392|NCT00257270|Antimanic Agents|antimanic agents|mesh-ancestor
6411393|NCT00257348|Docetaxel|docetaxel|mesh-list
6411394|NCT00257348|Capecitabine|capecitabine|mesh-list
6411395|NCT00257348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6411396|NCT00257348|Tubulin Modulators|tubulin modulators|mesh-ancestor
6411397|NCT00257348|Antimitotic Agents|antimitotic agents|mesh-ancestor
6411398|NCT00257348|Mitosis Modulators|mitosis modulators|mesh-ancestor
6411399|NCT00257348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411400|NCT00257348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6411401|NCT00257348|Antimetabolites|antimetabolites|mesh-ancestor
6411402|NCT00257361|Cycloserine|cycloserine|mesh-list
6411403|NCT00257361|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6411404|NCT00257361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6411405|NCT00257361|Renal Agents|renal agents|mesh-ancestor
6411406|NCT00257361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6411407|NCT00257361|Antitubercular Agents|antitubercular agents|mesh-ancestor
6411408|NCT00257361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6411409|NCT00257361|Antimetabolites|antimetabolites|mesh-ancestor
6411410|NCT00257361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411411|NCT00257387|Cyclosporine|cyclosporine|mesh-list
6018797|NCT00382265|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6018798|NCT00382265|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6018799|NCT00382265|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6018800|NCT00382265|Adrenergic Agents|adrenergic agents|mesh-ancestor
6018801|NCT00382265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6411412|NCT00257387|Cyclosporins|cyclosporins|mesh-list
6411413|NCT00257387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6411414|NCT00257387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411415|NCT00257387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6411416|NCT00257387|Immunologic Factors|immunologic factors|mesh-ancestor
6411417|NCT00257387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411418|NCT00257387|Antifungal Agents|antifungal agents|mesh-ancestor
6411419|NCT00257387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6411420|NCT00257387|Dermatologic Agents|dermatologic agents|mesh-ancestor
6411421|NCT00257387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6411422|NCT00257387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6411423|NCT00257426|Octreotide|octreotide|mesh-list
6411424|NCT00257426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6411425|NCT00257426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6411426|NCT00257426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6411427|NCT00257452|Moxifloxacin|moxifloxacin|mesh-list
6411428|NCT00257452|Tiotropium Bromide|tiotropium bromide|mesh-list
6411429|NCT00257452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6411430|NCT00257452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6411431|NCT00257452|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6411432|NCT00257452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6411433|NCT00257452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6411434|NCT00257452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411435|NCT00257452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6411436|NCT00257452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411437|NCT00257452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6411438|NCT00257452|Autonomic Agents|autonomic agents|mesh-ancestor
6411439|NCT00257452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6411440|NCT00257452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6411441|NCT00257452|Respiratory System Agents|respiratory system agents|mesh-ancestor
6411442|NCT00257452|Parasympatholytics|parasympatholytics|mesh-ancestor
6411443|NCT00257452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6411444|NCT00257452|Cholinergic Agents|cholinergic agents|mesh-ancestor
6411445|NCT00257452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6411446|NCT00257465|Vaccines|vaccines|mesh-list
6411447|NCT00257465|Immunologic Factors|immunologic factors|mesh-ancestor
6411448|NCT00257465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411449|NCT00257491|Telmisartan|telmisartan|mesh-list
6411450|NCT00257491|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6411451|NCT00257491|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6411452|NCT00257491|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6411453|NCT00257491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411454|NCT00257530|Imiquimod|imiquimod|mesh-list
6411455|NCT00257530|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6411456|NCT00257530|Immunologic Factors|immunologic factors|mesh-ancestor
6411457|NCT00257530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411458|NCT00257530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6411459|NCT00257530|Interferon Inducers|interferon inducers|mesh-ancestor
6411460|NCT00257569|Cetirizine|cetirizine|mesh-list
6411461|NCT00257569|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6411462|NCT00257569|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6411463|NCT00257569|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6411464|NCT00257569|Histamine Antagonists|histamine antagonists|mesh-ancestor
6411465|NCT00257569|Histamine Agents|histamine agents|mesh-ancestor
6411466|NCT00257569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6411467|NCT00257569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411468|NCT00257569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411469|NCT00257582|Cetirizine|cetirizine|mesh-list
6411470|NCT00257582|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6411471|NCT00257582|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6411472|NCT00257582|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6411473|NCT00257582|Histamine Antagonists|histamine antagonists|mesh-ancestor
6411474|NCT00257582|Histamine Agents|histamine agents|mesh-ancestor
6411475|NCT00257582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6411476|NCT00257582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411477|NCT00257582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411478|NCT00257595|Cetirizine|cetirizine|mesh-list
6411479|NCT00257595|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6411480|NCT00257595|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6411481|NCT00257595|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6411482|NCT00257595|Histamine Antagonists|histamine antagonists|mesh-ancestor
6411483|NCT00257595|Histamine Agents|histamine agents|mesh-ancestor
6411484|NCT00257595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6411485|NCT00257595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411486|NCT00257595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459830|NCT00446784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6459831|NCT00446784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6459832|NCT00446784|Immunologic Factors|immunologic factors|mesh-ancestor
6459833|NCT00446784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6459834|NCT00446784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6459835|NCT00446810|Benphothiamine|benphothiamine|mesh-list
6459836|NCT00446810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6459837|NCT00446810|Immunologic Factors|immunologic factors|mesh-ancestor
6459838|NCT00446810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459839|NCT00446810|Chelating Agents|chelating agents|mesh-ancestor
6459840|NCT00446810|Sequestering Agents|sequestering agents|mesh-ancestor
6459841|NCT00446810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459842|NCT00446836|Paclitaxel|paclitaxel|mesh-list
6459843|NCT00446836|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
6459844|NCT00446836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6459845|NCT00446836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6459846|NCT00446836|Tubulin Modulators|tubulin modulators|mesh-ancestor
6411487|NCT00257621|Ritonavir|ritonavir|mesh-list
6411488|NCT00257621|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6411489|NCT00257621|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6411490|NCT00257621|Protease Inhibitors|protease inhibitors|mesh-ancestor
6411491|NCT00257621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6411492|NCT00257621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411493|NCT00257621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6411494|NCT00257621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6411495|NCT00257621|Antiviral Agents|antiviral agents|mesh-ancestor
6411496|NCT00257621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6411497|NCT00257621|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6411498|NCT00257621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6411499|NCT00257634|Dexamethasone|dexamethasone|mesh-list
6411500|NCT00257634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6411501|NCT00257634|Antiemetics|antiemetics|mesh-ancestor
6411502|NCT00257634|Autonomic Agents|autonomic agents|mesh-ancestor
6411503|NCT00257634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6411504|NCT00257634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411505|NCT00257634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6411506|NCT00257634|Glucocorticoids|glucocorticoids|mesh-ancestor
6411507|NCT00257634|Hormones|hormones|mesh-ancestor
6411508|NCT00257634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6411509|NCT00257634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6411510|NCT00257634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6411511|NCT00257699|Metronidazole|metronidazole|mesh-list
6411512|NCT00257699|Ciprofloxacin|ciprofloxacin|mesh-list
6411513|NCT00257699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6411514|NCT00257699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6411515|NCT00257699|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6411516|NCT00257699|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6411517|NCT00257699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6411518|NCT00257699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6411519|NCT00257699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6411520|NCT00257699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411521|NCT00257699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6411522|NCT00257699|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6411523|NCT00257699|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6411524|NCT00257712|Hormones|hormones|mesh-list
6411525|NCT00257712|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
6411526|NCT00257712|Tesamorelin|tesamorelin|mesh-list
6411527|NCT00257712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6411528|NCT00257712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411529|NCT00257712|Growth Substances|growth substances|mesh-ancestor
6411530|NCT00257790|Tobramycin|tobramycin|mesh-list
6411531|NCT00257790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6411532|NCT00257790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6411533|NCT00257803|Oxytocin|oxytocin|mesh-list
6411534|NCT00257803|Oxytocics|oxytocics|mesh-ancestor
6411535|NCT00257803|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6411536|NCT00257803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411537|NCT00257816|Topotecan|topotecan|mesh-list
6411538|NCT00257816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6411539|NCT00257816|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6411540|NCT00257816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6411541|NCT00257816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6411542|NCT00257816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411543|NCT00257829|Methazolamide|methazolamide|mesh-list
6411544|NCT00257829|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6411545|NCT00257829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6411546|NCT00257829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411547|NCT00257829|Diuretics|diuretics|mesh-ancestor
6411548|NCT00257829|Natriuretic Agents|natriuretic agents|mesh-ancestor
6411549|NCT00257829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411550|NCT00257855|Lamotrigine|lamotrigine|mesh-list
6411551|NCT00257855|Anticonvulsants|anticonvulsants|mesh-ancestor
6411552|NCT00257855|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6411553|NCT00257855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6411554|NCT00257855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411555|NCT00257855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6411556|NCT00257855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411557|NCT00257855|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6411558|NCT00257855|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6411559|NCT00257855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6411560|NCT00257855|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6411561|NCT00257855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6411562|NCT00257868|Rivastigmine|rivastigmine|mesh-list
6411563|NCT00257868|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6411564|NCT00257868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6411565|NCT00257868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411566|NCT00257868|Cholinergic Agents|cholinergic agents|mesh-ancestor
6411567|NCT00257868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6411568|NCT00257868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411569|NCT00257868|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6411570|NCT00257868|Protective Agents|protective agents|mesh-ancestor
6411571|NCT00257959|Amiodarone|amiodarone|mesh-list
6411572|NCT00257959|Sotalol|sotalol|mesh-list
6411573|NCT00257959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
6411574|NCT00257959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6411575|NCT00257959|Vasodilator Agents|vasodilator agents|mesh-ancestor
6411576|NCT00257959|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6411577|NCT00257959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6411578|NCT00257959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411579|NCT00257959|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6411580|NCT00257959|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6411581|NCT00257959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6411582|NCT00257959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6411583|NCT00257959|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6411584|NCT00257959|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6411585|NCT00257959|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6411586|NCT00257959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6411587|NCT00257959|Adrenergic Agents|adrenergic agents|mesh-ancestor
6411588|NCT00257959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6411589|NCT00257959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411590|NCT00257959|Sympatholytics|sympatholytics|mesh-ancestor
6411591|NCT00257959|Autonomic Agents|autonomic agents|mesh-ancestor
6411592|NCT00257959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6411593|NCT00257972|Aripiprazole|aripiprazole|mesh-list
6411594|NCT00257972|Antidepressive Agents|antidepressive agents|mesh-ancestor
6411595|NCT00257972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6411596|NCT00257972|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6411597|NCT00257972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6411598|NCT00257972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6411599|NCT00257972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411600|NCT00257972|Dopamine Agonists|dopamine agonists|mesh-ancestor
6411601|NCT00257972|Dopamine Agents|dopamine agents|mesh-ancestor
6411602|NCT00257972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6411603|NCT00257972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411604|NCT00257972|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6411605|NCT00257972|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6411606|NCT00257972|Serotonin Agents|serotonin agents|mesh-ancestor
6411607|NCT00257972|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6411608|NCT00257972|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6411609|NCT00257972|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6411610|NCT00257972|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6411611|NCT00258050|Lapatinib|lapatinib|mesh-list
6411612|NCT00258050|Midazolam|midazolam|mesh-list
6411613|NCT00258050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6411614|NCT00258050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6411615|NCT00258050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6411616|NCT00258050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411617|NCT00258050|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6411618|NCT00258050|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6411619|NCT00258050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6411620|NCT00258050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6411621|NCT00258050|Anesthetics, General|anesthetics, general|mesh-ancestor
6411622|NCT00258050|Anesthetics|anesthetics|mesh-ancestor
6411623|NCT00258050|GABA Modulators|gaba modulators|mesh-ancestor
6411624|NCT00258050|GABA Agents|gaba agents|mesh-ancestor
6411625|NCT00258050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6411626|NCT00258050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411627|NCT00258050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6411628|NCT00258050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6411629|NCT00258050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6411630|NCT00258063|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6411631|NCT00258063|Norelgestromin|norelgestromin|mesh-list
6411632|NCT00258063|Contraceptive Agents|contraceptive agents|mesh-list
6411633|NCT00258063|Estradiol|estradiol|mesh-list
6411634|NCT00258063|Estrogens|estrogens|mesh-ancestor
6411635|NCT00258063|Hormones|hormones|mesh-ancestor
6411636|NCT00258063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6411637|NCT00258063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411638|NCT00258063|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6411639|NCT00258063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6411640|NCT00258063|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6411641|NCT00258063|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6411642|NCT00258063|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6411643|NCT00258076|Contraceptive Agents|contraceptive agents|mesh-list
6411644|NCT00258076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6411645|NCT00258076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411646|NCT00258089|Levofloxacin|levofloxacin|mesh-list
6411647|NCT00258089|Ofloxacin|ofloxacin|mesh-list
6411648|NCT00258089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6411649|NCT00258089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6411650|NCT00258089|Renal Agents|renal agents|mesh-ancestor
6411651|NCT00258089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6411652|NCT00258089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6411653|NCT00258089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6411654|NCT00258089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6411655|NCT00258089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411656|NCT00258089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6411657|NCT00258089|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6411658|NCT00258089|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6411659|NCT00258102|Levofloxacin|levofloxacin|mesh-list
6411660|NCT00258102|Ofloxacin|ofloxacin|mesh-list
6411661|NCT00258102|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6411662|NCT00258102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6411663|NCT00258102|Renal Agents|renal agents|mesh-ancestor
6411664|NCT00258102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6411665|NCT00258102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6411666|NCT00258102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6411667|NCT00258102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6411668|NCT00258102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411669|NCT00258102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6411670|NCT00258102|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6411671|NCT00258102|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6411672|NCT00258115|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
6411673|NCT00258115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6411674|NCT00258115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6411675|NCT00258115|Analgesics|analgesics|mesh-ancestor
6411676|NCT00258115|Sensory System Agents|sensory system agents|mesh-ancestor
6411677|NCT00258115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6411678|NCT00258115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411679|NCT00258115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6411680|NCT00258115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6411681|NCT00258193|Linaclotide|linaclotide|mesh-list
6411682|NCT00258193|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
6411683|NCT00258193|Enzyme Activators|enzyme activators|mesh-ancestor
6411684|NCT00258193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411685|NCT00258193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6411686|NCT00258232|Celecoxib|celecoxib|mesh-list
6411687|NCT00258232|Capecitabine|capecitabine|mesh-list
6411688|NCT00258232|Irinotecan|irinotecan|mesh-list
6411689|NCT00258232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6411690|NCT00258232|Antimetabolites|antimetabolites|mesh-ancestor
6411691|NCT00258232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411692|NCT00258232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6411693|NCT00258232|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6411694|NCT00258232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6411695|NCT00258232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6411696|NCT00258232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6411697|NCT00258232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6411698|NCT00258232|Analgesics|analgesics|mesh-ancestor
6411699|NCT00258232|Sensory System Agents|sensory system agents|mesh-ancestor
6411700|NCT00258232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6411701|NCT00258232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411702|NCT00258232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6411703|NCT00258232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6411704|NCT00258232|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6411705|NCT00258232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6411706|NCT00258245|Aspirin|aspirin|mesh-list
6411707|NCT00258245|Vitamins|vitamins|mesh-list
6411708|NCT00258245|Ascorbic Acid|ascorbic acid|mesh-list
6411709|NCT00258245|Thalidomide|thalidomide|mesh-list
6411710|NCT00258245|Dexamethasone|dexamethasone|mesh-list
6411711|NCT00258245|Dexamethasone acetate|dexamethasone acetate|mesh-list
6411712|NCT00258245|Aspirin, aluminum hydroxide, magnesium hydroxide drug combination|aspirin, aluminum hydroxide, magnesium hydroxide drug combination|mesh-list
6411713|NCT00258245|Bortezomib|bortezomib|mesh-list
6411714|NCT00258245|Arsenic Trioxide|arsenic trioxide|mesh-list
6411715|NCT00258245|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
6411716|NCT00258245|BB 1101|bb 1101|mesh-list
6411717|NCT00258245|Micronutrients|micronutrients|mesh-ancestor
6411718|NCT00258245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411719|NCT00258245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6411720|NCT00258245|Antiemetics|antiemetics|mesh-ancestor
6411721|NCT00258245|Autonomic Agents|autonomic agents|mesh-ancestor
6411722|NCT00258245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6411723|NCT00258245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6411724|NCT00258245|Glucocorticoids|glucocorticoids|mesh-ancestor
6411725|NCT00258245|Hormones|hormones|mesh-ancestor
6459847|NCT00446836|Antimitotic Agents|antimitotic agents|mesh-ancestor
6411726|NCT00258245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6411727|NCT00258245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6411728|NCT00258245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6411729|NCT00258245|Protease Inhibitors|protease inhibitors|mesh-ancestor
6411730|NCT00258245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6411731|NCT00258245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411732|NCT00258245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6411733|NCT00258245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6411734|NCT00258245|Analgesics|analgesics|mesh-ancestor
6411735|NCT00258245|Sensory System Agents|sensory system agents|mesh-ancestor
6411736|NCT00258245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6411737|NCT00258245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6411738|NCT00258245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6411739|NCT00258245|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6411740|NCT00258245|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6411741|NCT00258245|Antipyretics|antipyretics|mesh-ancestor
6411742|NCT00258245|Antioxidants|antioxidants|mesh-ancestor
6411743|NCT00258245|Protective Agents|protective agents|mesh-ancestor
6411744|NCT00258245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6411745|NCT00258245|Immunologic Factors|immunologic factors|mesh-ancestor
6411746|NCT00258245|Leprostatic Agents|leprostatic agents|mesh-ancestor
6411747|NCT00258245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6411748|NCT00258245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6411749|NCT00258245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6411750|NCT00258245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6411751|NCT00258245|Growth Substances|growth substances|mesh-ancestor
6411752|NCT00258245|Growth Inhibitors|growth inhibitors|mesh-ancestor
6411753|NCT00258258|Zoledronic Acid|zoledronic acid|mesh-list
6411754|NCT00258258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6411755|NCT00258258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411756|NCT00258271|Cytarabine|cytarabine|mesh-list
6411757|NCT00258271|Imatinib Mesylate|imatinib mesylate|mesh-list
6411758|NCT00258271|Cladribine|cladribine|mesh-list
6411759|NCT00258271|Immunologic Factors|immunologic factors|mesh-ancestor
6411760|NCT00258271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411761|NCT00258271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6411762|NCT00258271|Antimetabolites|antimetabolites|mesh-ancestor
6411763|NCT00258271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411764|NCT00258271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6411765|NCT00258271|Antiviral Agents|antiviral agents|mesh-ancestor
6411766|NCT00258271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6411767|NCT00258271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6411768|NCT00258271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6411769|NCT00258271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6411770|NCT00258284|Docetaxel|docetaxel|mesh-list
6411771|NCT00258284|Capecitabine|capecitabine|mesh-list
6411772|NCT00258284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6411773|NCT00258284|Tubulin Modulators|tubulin modulators|mesh-ancestor
6411774|NCT00258284|Antimitotic Agents|antimitotic agents|mesh-ancestor
6411775|NCT00258284|Mitosis Modulators|mitosis modulators|mesh-ancestor
6411776|NCT00258284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411777|NCT00258284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6411778|NCT00258284|Antimetabolites|antimetabolites|mesh-ancestor
6411779|NCT00258297|Gefitinib|gefitinib|mesh-list
6411780|NCT00258297|Enzyme Inhibitors|enzyme inhibitors|mesh-list
6411781|NCT00258297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6411782|NCT00258297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6411783|NCT00258297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411784|NCT00258323|Fluorouracil|fluorouracil|mesh-list
6411785|NCT00258323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6411786|NCT00258323|Antimetabolites|antimetabolites|mesh-ancestor
6411787|NCT00258323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411788|NCT00258323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6411789|NCT00258323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6411790|NCT00258323|Immunologic Factors|immunologic factors|mesh-ancestor
6411791|NCT00258323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411792|NCT00258336|Rituximab|rituximab|mesh-list
6411793|NCT00258336|Immunoglobulins|immunoglobulins|mesh-list
6411794|NCT00258336|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6411795|NCT00258336|Antibodies|antibodies|mesh-list
6411796|NCT00258336|Sargramostim|sargramostim|mesh-list
6411797|NCT00258336|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
6411798|NCT00258336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6411799|NCT00258336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6411800|NCT00258336|Immunologic Factors|immunologic factors|mesh-ancestor
6459848|NCT00446836|Mitosis Modulators|mitosis modulators|mesh-ancestor
6411801|NCT00258336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411802|NCT00258336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6411803|NCT00258375|Docetaxel|docetaxel|mesh-list
6411804|NCT00258375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6411805|NCT00258375|Tubulin Modulators|tubulin modulators|mesh-ancestor
6411806|NCT00258375|Antimitotic Agents|antimitotic agents|mesh-ancestor
6411807|NCT00258375|Mitosis Modulators|mitosis modulators|mesh-ancestor
6411808|NCT00258375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411809|NCT00258388|Prednisone|prednisone|mesh-list
6411810|NCT00258388|Docetaxel|docetaxel|mesh-list
6411811|NCT00258388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6411812|NCT00258388|Tubulin Modulators|tubulin modulators|mesh-ancestor
6411813|NCT00258388|Antimitotic Agents|antimitotic agents|mesh-ancestor
6411814|NCT00258388|Mitosis Modulators|mitosis modulators|mesh-ancestor
6411815|NCT00258388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411816|NCT00258388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6411817|NCT00258388|Glucocorticoids|glucocorticoids|mesh-ancestor
6411818|NCT00258388|Hormones|hormones|mesh-ancestor
6411819|NCT00258388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6411820|NCT00258388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411821|NCT00258388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6411822|NCT00258479|Modafinil|modafinil|mesh-list
6411823|NCT00258479|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6411824|NCT00258479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411825|NCT00258479|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6411826|NCT00258479|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6411827|NCT00258479|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6411828|NCT00258479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411829|NCT00258557|Darunavir|darunavir|mesh-list
6411830|NCT00258557|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6411831|NCT00258557|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6411832|NCT00258557|Protease Inhibitors|protease inhibitors|mesh-ancestor
6411833|NCT00258557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6411834|NCT00258557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411835|NCT00258557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6411836|NCT00258557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6411837|NCT00258557|Antiviral Agents|antiviral agents|mesh-ancestor
6411838|NCT00258557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6411839|NCT00258596|Sirolimus|sirolimus|mesh-list
6411840|NCT00258596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6411841|NCT00258596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6411842|NCT00258596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6411843|NCT00258596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6411844|NCT00258596|Antifungal Agents|antifungal agents|mesh-ancestor
6411845|NCT00258596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6411846|NCT00258596|Immunologic Factors|immunologic factors|mesh-ancestor
6411847|NCT00258596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411848|NCT00258609|Botulinum Toxins|botulinum toxins|mesh-list
6411849|NCT00258609|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6411850|NCT00258609|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6411851|NCT00258609|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6411852|NCT00258609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6411853|NCT00258609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411854|NCT00258609|Cholinergic Agents|cholinergic agents|mesh-ancestor
6411855|NCT00258609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6411856|NCT00258609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411857|NCT00258609|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6411858|NCT00258609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6411859|NCT00258622|Lidocaine|lidocaine|mesh-list
6411860|NCT00258622|Anesthetics, Local|anesthetics, local|mesh-ancestor
6411861|NCT00258622|Anesthetics|anesthetics|mesh-ancestor
6411862|NCT00258622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6411863|NCT00258622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411864|NCT00258622|Sensory System Agents|sensory system agents|mesh-ancestor
6411865|NCT00258622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6411866|NCT00258622|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6411867|NCT00258622|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6411868|NCT00258622|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6411869|NCT00258622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6411870|NCT00258622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411871|NCT00258739|Gemcitabine|gemcitabine|mesh-list
6411872|NCT00258739|Carboplatin|carboplatin|mesh-list
6411873|NCT00258739|Docetaxel|docetaxel|mesh-list
6411874|NCT00258739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6411875|NCT00258739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6411876|NCT00258739|Antimetabolites|antimetabolites|mesh-ancestor
6411877|NCT00258739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411878|NCT00258739|Antiviral Agents|antiviral agents|mesh-ancestor
6411879|NCT00258739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6411880|NCT00258739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6411881|NCT00258739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6411882|NCT00258739|Immunologic Factors|immunologic factors|mesh-ancestor
6411883|NCT00258739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411884|NCT00258739|Tubulin Modulators|tubulin modulators|mesh-ancestor
6411885|NCT00258739|Antimitotic Agents|antimitotic agents|mesh-ancestor
6411886|NCT00258739|Mitosis Modulators|mitosis modulators|mesh-ancestor
6411887|NCT00258765|Zoledronic Acid|zoledronic acid|mesh-list
6411888|NCT00258765|Docetaxel|docetaxel|mesh-list
6411889|NCT00258765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6411890|NCT00258765|Tubulin Modulators|tubulin modulators|mesh-ancestor
6411891|NCT00258765|Antimitotic Agents|antimitotic agents|mesh-ancestor
6411892|NCT00258765|Mitosis Modulators|mitosis modulators|mesh-ancestor
6411893|NCT00258765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411894|NCT00258765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6411895|NCT00258765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411896|NCT00258791|Ibuprofen|ibuprofen|mesh-list
6411897|NCT00258791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6411898|NCT00258791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6411899|NCT00258791|Analgesics|analgesics|mesh-ancestor
6411900|NCT00258791|Sensory System Agents|sensory system agents|mesh-ancestor
6411901|NCT00258791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6411902|NCT00258791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411903|NCT00258791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6411904|NCT00258791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6411905|NCT00258791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6411906|NCT00258791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6411907|NCT00258791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411908|NCT00258804|Insulin Glargine|insulin glargine|mesh-list
6411909|NCT00258804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6411910|NCT00258804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411911|NCT00258843|Vaccines|vaccines|mesh-list
6411912|NCT00258843|Immunologic Factors|immunologic factors|mesh-ancestor
6411913|NCT00258843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411914|NCT00259051|Omeprazole|omeprazole|mesh-list
6411915|NCT00259051|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6411916|NCT00259051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6411917|NCT00259051|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6411918|NCT00259051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6411919|NCT00259051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411920|NCT00259064|Gefitinib|gefitinib|mesh-list
6411921|NCT00259064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6411922|NCT00259064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6411923|NCT00259064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6411924|NCT00259064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411925|NCT00259077|Omeprazole|omeprazole|mesh-list
6411926|NCT00259077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6411927|NCT00259077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6411928|NCT00259077|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6411929|NCT00259077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6411930|NCT00259077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411931|NCT00259116|Methocarbamol|methocarbamol|mesh-list
6411932|NCT00259116|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6411933|NCT00259116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411934|NCT00259116|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6411935|NCT00259116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6411936|NCT00259129|Sorafenib|sorafenib|mesh-list
6411937|NCT00259129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6411938|NCT00259129|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6411939|NCT00259129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6411940|NCT00259129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411941|NCT00259142|Chloroquine|chloroquine|mesh-list
6411942|NCT00259142|Pyrimethamine|pyrimethamine|mesh-list
6411943|NCT00259142|Sulfadoxine|sulfadoxine|mesh-list
6411944|NCT00259142|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6411945|NCT00259142|Amebicides|amebicides|mesh-ancestor
6411946|NCT00259142|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6411947|NCT00259142|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6411948|NCT00259142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6411949|NCT00259142|Antimalarials|antimalarials|mesh-ancestor
6411950|NCT00259142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6411951|NCT00259142|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6411952|NCT00259142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6411953|NCT00259142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411954|NCT00259142|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6411955|NCT00259142|Renal Agents|renal agents|mesh-ancestor
6411956|NCT00259155|Rifaximin|rifaximin|mesh-list
6411957|NCT00259155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6411958|NCT00259155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6411959|NCT00259155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6411960|NCT00259168|Nateglinide|nateglinide|mesh-list
6411961|NCT00259168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6411962|NCT00259168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411963|NCT00259181|Chlorhexidine|chlorhexidine|mesh-list
6411964|NCT00259181|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6411965|NCT00259181|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
6411966|NCT00259181|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6411967|NCT00259181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6411968|NCT00259181|Disinfectants|disinfectants|mesh-ancestor
6411969|NCT00259181|Dermatologic Agents|dermatologic agents|mesh-ancestor
6411970|NCT00259181|Vasodilator Agents|vasodilator agents|mesh-ancestor
6411971|NCT00259181|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
6411972|NCT00259181|Protective Agents|protective agents|mesh-ancestor
6411973|NCT00259181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411974|NCT00259220|Erythromycin|erythromycin|mesh-list
6411975|NCT00259220|Erythromycin Estolate|erythromycin estolate|mesh-list
6411976|NCT00259220|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
6411977|NCT00259220|Erythromycin stearate|erythromycin stearate|mesh-list
6411978|NCT00259220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6411979|NCT00259220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6411980|NCT00259220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6411981|NCT00259220|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6411982|NCT00259220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6411983|NCT00259220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459849|NCT00446836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459850|NCT00446862|Losartan|losartan|mesh-list
6459851|NCT00446862|Enalapril|enalapril|mesh-list
6459852|NCT00446862|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
6459853|NCT00446862|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6459854|NCT00446862|Enzyme Inhibitors|enzyme inhibitors|mesh-list
6459855|NCT00446862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6459856|NCT00446862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6459857|NCT00446862|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6459858|NCT00446862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459859|NCT00446862|Protease Inhibitors|protease inhibitors|mesh-ancestor
6459860|NCT00446901|Selenium|selenium|mesh-list
6459861|NCT00446901|Antioxidants|antioxidants|mesh-ancestor
6411984|NCT00259363|Oxaliplatin|oxaliplatin|mesh-list
6411985|NCT00259363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6411986|NCT00259376|Dronedarone|dronedarone|mesh-list
6411987|NCT00259376|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6411988|NCT00259402|Fluorouracil|fluorouracil|mesh-list
6411989|NCT00259402|Oxaliplatin|oxaliplatin|mesh-list
6411990|NCT00259402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6411991|NCT00259402|Antimetabolites|antimetabolites|mesh-ancestor
6411992|NCT00259402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6411993|NCT00259402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6411994|NCT00259402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6411995|NCT00259402|Immunologic Factors|immunologic factors|mesh-ancestor
6411996|NCT00259402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6411997|NCT00259428|Dronedarone|dronedarone|mesh-list
6411998|NCT00259428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6411999|NCT00259441|Simvastatin|simvastatin|mesh-list
6412000|NCT00259441|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6412001|NCT00259441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6412002|NCT00259441|Antimetabolites|antimetabolites|mesh-ancestor
6412003|NCT00259441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412004|NCT00259441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6412005|NCT00259441|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6412006|NCT00259441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6412007|NCT00259636|Zonisamide|zonisamide|mesh-list
6412008|NCT00259636|Anticonvulsants|anticonvulsants|mesh-ancestor
6412009|NCT00259636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6412010|NCT00259636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6412011|NCT00259636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412012|NCT00259636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6412013|NCT00259636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412014|NCT00259662|Atorvastatin|atorvastatin|mesh-list
6412015|NCT00259662|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6412016|NCT00259662|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6412017|NCT00259662|Antimetabolites|antimetabolites|mesh-ancestor
6412018|NCT00259662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412019|NCT00259662|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6412020|NCT00259662|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6412021|NCT00259662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6412022|NCT00259675|Gemcitabine|gemcitabine|mesh-list
6412023|NCT00259675|Carboplatin|carboplatin|mesh-list
6412024|NCT00259675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6412025|NCT00259675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6412026|NCT00259675|Antimetabolites|antimetabolites|mesh-ancestor
6412027|NCT00259675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412028|NCT00259675|Antiviral Agents|antiviral agents|mesh-ancestor
6412029|NCT00259675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6412030|NCT00259675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6412031|NCT00259675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6412032|NCT00259675|Immunologic Factors|immunologic factors|mesh-ancestor
6412033|NCT00259675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412034|NCT00259701|Nitroglycerin|nitroglycerin|mesh-list
6412035|NCT00259701|Acetylcholine|acetylcholine|mesh-list
6412036|NCT00259701|Vasodilator Agents|vasodilator agents|mesh-ancestor
6412037|NCT00259701|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6412038|NCT00259701|Cholinergic Agents|cholinergic agents|mesh-ancestor
6412039|NCT00259701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6412040|NCT00259701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412041|NCT00259701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412042|NCT00259714|Dialysis Solutions|dialysis solutions|mesh-list
6412043|NCT00259714|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6412044|NCT00259766|Budesonide|budesonide|mesh-list
6412045|NCT00259766|Terbutaline|terbutaline|mesh-list
6412046|NCT00259766|Formoterol Fumarate|formoterol fumarate|mesh-list
5501243|NCT04476173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6412047|NCT00259766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6412048|NCT00259766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6412049|NCT00259766|Autonomic Agents|autonomic agents|mesh-ancestor
6412050|NCT00259766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6412051|NCT00259766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412052|NCT00259766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6412053|NCT00259766|Respiratory System Agents|respiratory system agents|mesh-ancestor
6412054|NCT00259766|Glucocorticoids|glucocorticoids|mesh-ancestor
6412055|NCT00259766|Hormones|hormones|mesh-ancestor
6412056|NCT00259766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6412057|NCT00259766|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6412058|NCT00259766|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6412059|NCT00259766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6412060|NCT00259766|Adrenergic Agents|adrenergic agents|mesh-ancestor
6412061|NCT00259766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6412062|NCT00259766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412063|NCT00259766|Sympathomimetics|sympathomimetics|mesh-ancestor
6412064|NCT00259766|Tocolytic Agents|tocolytic agents|mesh-ancestor
6412065|NCT00259766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6412066|NCT00259779|Prednisolone|prednisolone|mesh-list
6412067|NCT00259779|Budesonide|budesonide|mesh-list
6412068|NCT00259779|Formoterol Fumarate|formoterol fumarate|mesh-list
6412069|NCT00259779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6412070|NCT00259779|Glucocorticoids|glucocorticoids|mesh-ancestor
6412071|NCT00259779|Hormones|hormones|mesh-ancestor
6412072|NCT00259779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6412073|NCT00259779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412074|NCT00259779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6412075|NCT00259779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6412076|NCT00259779|Autonomic Agents|autonomic agents|mesh-ancestor
6412077|NCT00259779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6412078|NCT00259779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6412079|NCT00259779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6412080|NCT00259779|Respiratory System Agents|respiratory system agents|mesh-ancestor
6412081|NCT00259779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6412082|NCT00259779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6412083|NCT00259779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6412084|NCT00259779|Adrenergic Agents|adrenergic agents|mesh-ancestor
6412085|NCT00259779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6412086|NCT00259779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412087|NCT00259792|Budesonide|budesonide|mesh-list
6412088|NCT00259792|Formoterol Fumarate|formoterol fumarate|mesh-list
6412089|NCT00259792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6412090|NCT00259792|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6412091|NCT00259792|Autonomic Agents|autonomic agents|mesh-ancestor
6412092|NCT00259792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6412093|NCT00259792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053205|NCT00593554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6412094|NCT00259792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6412095|NCT00259792|Respiratory System Agents|respiratory system agents|mesh-ancestor
6412096|NCT00259792|Glucocorticoids|glucocorticoids|mesh-ancestor
6412097|NCT00259792|Hormones|hormones|mesh-ancestor
6412098|NCT00259792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6412099|NCT00259792|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6412100|NCT00259792|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6412101|NCT00259792|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6412102|NCT00259792|Adrenergic Agents|adrenergic agents|mesh-ancestor
6412103|NCT00259792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6412104|NCT00259792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412105|NCT00259805|Rituximab|rituximab|mesh-list
6412106|NCT00259805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6412107|NCT00259805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6412108|NCT00259805|Immunologic Factors|immunologic factors|mesh-ancestor
6412109|NCT00259805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412110|NCT00259805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6412111|NCT00259870|Olanzapine|olanzapine|mesh-list
6412112|NCT00259870|Antiemetics|antiemetics|mesh-ancestor
6412113|NCT00259870|Autonomic Agents|autonomic agents|mesh-ancestor
6412114|NCT00259870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6412115|NCT00259870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412116|NCT00259870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6412117|NCT00259870|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6412118|NCT00259870|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6412119|NCT00259870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6412120|NCT00259870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6412121|NCT00259870|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6412122|NCT00259870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6412123|NCT00259870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6412124|NCT00259870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412125|NCT00259870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6412126|NCT00259870|Serotonin Agents|serotonin agents|mesh-ancestor
6412127|NCT00259883|Paroxetine|paroxetine|mesh-list
6412128|NCT00259883|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6412129|NCT00259883|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6412130|NCT00259883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6412131|NCT00259883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412132|NCT00259883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6412133|NCT00259883|Serotonin Agents|serotonin agents|mesh-ancestor
6412134|NCT00259883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412135|NCT00259883|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6412136|NCT00259883|Antidepressive Agents|antidepressive agents|mesh-ancestor
6412137|NCT00259883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6412138|NCT00259883|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6412139|NCT00259883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6412140|NCT00259883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6412141|NCT00259896|Exenatide|exenatide|mesh-list
6412142|NCT00259896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6412143|NCT00259896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412144|NCT00259896|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6412145|NCT00259896|Incretins|incretins|mesh-ancestor
6412146|NCT00259896|Hormones|hormones|mesh-ancestor
6412147|NCT00259896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6412148|NCT00259922|Alvimopan|alvimopan|mesh-list
6412149|NCT00259922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6412150|NCT00259935|Topotecan|topotecan|mesh-list
6412151|NCT00259935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6412152|NCT00259935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6412153|NCT00259935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6412154|NCT00259935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412155|NCT00259935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6412156|NCT00259974|Rituximab|rituximab|mesh-list
6412157|NCT00259974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6412158|NCT00259974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6412159|NCT00259974|Immunologic Factors|immunologic factors|mesh-ancestor
6412160|NCT00259974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412161|NCT00259974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6412162|NCT00259987|Lapatinib|lapatinib|mesh-list
6412163|NCT00259987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6412164|NCT00259987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6412165|NCT00259987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6412166|NCT00259987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412167|NCT00260026|Docetaxel|docetaxel|mesh-list
6412168|NCT00260026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6412169|NCT00260026|Tubulin Modulators|tubulin modulators|mesh-ancestor
6412170|NCT00260026|Antimitotic Agents|antimitotic agents|mesh-ancestor
6412171|NCT00260026|Mitosis Modulators|mitosis modulators|mesh-ancestor
6412172|NCT00260026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412173|NCT00260039|Vaccines|vaccines|mesh-list
6412174|NCT00260039|Immunologic Factors|immunologic factors|mesh-ancestor
6412175|NCT00260039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412176|NCT00260052|Epoetin Alfa|epoetin alfa|mesh-list
6412177|NCT00260052|Hematinics|hematinics|mesh-ancestor
6412178|NCT00260143|Methyltestosterone|methyltestosterone|mesh-list
6412179|NCT00260143|Testosterone|testosterone|mesh-list
6412180|NCT00260143|Testosterone undecanoate|testosterone undecanoate|mesh-list
6412181|NCT00260143|Testosterone enanthate|testosterone enanthate|mesh-list
6412182|NCT00260143|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6412183|NCT00260143|Androgens|androgens|mesh-ancestor
6412184|NCT00260143|Hormones|hormones|mesh-ancestor
6412185|NCT00260143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6412186|NCT00260143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412187|NCT00260143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6412188|NCT00260143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6412189|NCT00260143|Anabolic Agents|anabolic agents|mesh-ancestor
6412190|NCT00260247|Carbamazepine|carbamazepine|mesh-list
6412191|NCT00260247|Oxcarbazepine|oxcarbazepine|mesh-list
6412192|NCT00260247|Anticonvulsants|anticonvulsants|mesh-ancestor
6412193|NCT00260247|Antimanic Agents|antimanic agents|mesh-ancestor
6412194|NCT00260247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6412195|NCT00260247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6412196|NCT00260247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412197|NCT00260247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6412198|NCT00260247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6412199|NCT00260247|Analgesics|analgesics|mesh-ancestor
6412200|NCT00260247|Sensory System Agents|sensory system agents|mesh-ancestor
6412201|NCT00260247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6412202|NCT00260247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6412203|NCT00260247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6412204|NCT00260247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412205|NCT00260247|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6412206|NCT00260247|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6412207|NCT00260247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6412208|NCT00260260|Oxycodone|oxycodone|mesh-list
6412209|NCT00260260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6412210|NCT00260260|Narcotics|narcotics|mesh-ancestor
6412211|NCT00260260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6412212|NCT00260260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412213|NCT00260260|Analgesics|analgesics|mesh-ancestor
6412214|NCT00260260|Sensory System Agents|sensory system agents|mesh-ancestor
6412215|NCT00260260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6412216|NCT00260325|Valdecoxib|valdecoxib|mesh-list
6412217|NCT00260325|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6412218|NCT00260325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6412219|NCT00260325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6412220|NCT00260325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412221|NCT00260325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6412222|NCT00260325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6412223|NCT00260325|Analgesics|analgesics|mesh-ancestor
6412224|NCT00260325|Sensory System Agents|sensory system agents|mesh-ancestor
6412225|NCT00260325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6412226|NCT00260325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412227|NCT00260325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6412228|NCT00260325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6412229|NCT00260351|Vaccines|vaccines|mesh-list
6412230|NCT00260351|Immunologic Factors|immunologic factors|mesh-ancestor
6412231|NCT00260351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412232|NCT00260364|Gemcitabine|gemcitabine|mesh-list
6412233|NCT00260364|Bevacizumab|bevacizumab|mesh-list
6412234|NCT00260364|Capecitabine|capecitabine|mesh-list
6412235|NCT00260364|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6412236|NCT00260364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6412237|NCT00260364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6412238|NCT00260364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6412239|NCT00260364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6412240|NCT00260364|Growth Substances|growth substances|mesh-ancestor
6412241|NCT00260364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412242|NCT00260364|Growth Inhibitors|growth inhibitors|mesh-ancestor
6412243|NCT00260364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6412244|NCT00260364|Antimetabolites|antimetabolites|mesh-ancestor
6412245|NCT00260364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412246|NCT00260364|Antiviral Agents|antiviral agents|mesh-ancestor
6412247|NCT00260364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6412248|NCT00260364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6412249|NCT00260364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6412250|NCT00260364|Immunologic Factors|immunologic factors|mesh-ancestor
6412251|NCT00260364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6412252|NCT00260390|Methyltestosterone|methyltestosterone|mesh-list
6412253|NCT00260390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6412254|NCT00260390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6412255|NCT00260390|Anabolic Agents|anabolic agents|mesh-ancestor
6412256|NCT00260390|Hormones|hormones|mesh-ancestor
6412257|NCT00260390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6412258|NCT00260390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412259|NCT00260416|Abciximab|abciximab|mesh-list
6412260|NCT00260416|Anticoagulants|anticoagulants|mesh-ancestor
6412261|NCT00260416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6412262|NCT00260520|Dalteparin|dalteparin|mesh-list
6412263|NCT00260520|Tinzaparin|tinzaparin|mesh-list
6412264|NCT00260520|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6412265|NCT00260520|Anticoagulants|anticoagulants|mesh-ancestor
6412266|NCT00260520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6412267|NCT00260520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6412268|NCT00260520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412269|NCT00260611|Docetaxel|docetaxel|mesh-list
6412270|NCT00260611|Oxaliplatin|oxaliplatin|mesh-list
6412271|NCT00260611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6412272|NCT00260611|Tubulin Modulators|tubulin modulators|mesh-ancestor
6412273|NCT00260611|Antimitotic Agents|antimitotic agents|mesh-ancestor
6412274|NCT00260611|Mitosis Modulators|mitosis modulators|mesh-ancestor
6412275|NCT00260611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412276|NCT00260624|Citalopram|citalopram|mesh-list
6412277|NCT00260624|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6412278|NCT00260624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6412279|NCT00260624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6412280|NCT00260624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412281|NCT00260624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6412282|NCT00260624|Serotonin Agents|serotonin agents|mesh-ancestor
6412283|NCT00260624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412284|NCT00260624|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6412285|NCT00260624|Antidepressive Agents|antidepressive agents|mesh-ancestor
6412286|NCT00260624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6412287|NCT00260702|Omalizumab|omalizumab|mesh-list
6412288|NCT00260702|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6412289|NCT00260702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6412290|NCT00260702|Respiratory System Agents|respiratory system agents|mesh-ancestor
6412291|NCT00260793|Ropinirole|ropinirole|mesh-list
6412292|NCT00260793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6412293|NCT00260793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6412294|NCT00260793|Dopamine Agonists|dopamine agonists|mesh-ancestor
6412295|NCT00260793|Dopamine Agents|dopamine agents|mesh-ancestor
6412296|NCT00260793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6412297|NCT00260793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412298|NCT00260793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412299|NCT00260819|Bosentan|bosentan|mesh-list
6412300|NCT00260819|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6412301|NCT00260819|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6412302|NCT00260819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459862|NCT00446901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459863|NCT00446901|Protective Agents|protective agents|mesh-ancestor
6459864|NCT00446901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459865|NCT00446901|Trace Elements|trace elements|mesh-ancestor
6459866|NCT00446901|Micronutrients|micronutrients|mesh-ancestor
6459867|NCT00446940|Atorvastatin|atorvastatin|mesh-list
6459868|NCT00446940|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6459869|NCT00446940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6459870|NCT00446940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6459871|NCT00446940|Antimetabolites|antimetabolites|mesh-ancestor
6459872|NCT00446940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459873|NCT00446940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6459874|NCT00446940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6459875|NCT00446940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6459876|NCT00446953|Betamethasone|betamethasone|mesh-list
6459877|NCT00446953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6459878|NCT00446953|Glucocorticoids|glucocorticoids|mesh-ancestor
6459879|NCT00446953|Hormones|hormones|mesh-ancestor
6459880|NCT00446953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6459881|NCT00446953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459882|NCT00446953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6459883|NCT00446953|Respiratory System Agents|respiratory system agents|mesh-ancestor
6459884|NCT00446979|UC-781|uc-781|mesh-list
6459885|NCT00446979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6459886|NCT00446979|Antiviral Agents|antiviral agents|mesh-ancestor
6459887|NCT00446979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6459888|NCT00447018|Mannitol|mannitol|mesh-list
6459889|NCT00447018|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6459890|NCT00447018|Diuretics|diuretics|mesh-ancestor
6459891|NCT00447018|Natriuretic Agents|natriuretic agents|mesh-ancestor
6459892|NCT00447018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459893|NCT00447031|Triamcinolone|triamcinolone|mesh-list
6459894|NCT00447031|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6412303|NCT00260988|Dalteparin|dalteparin|mesh-list
6412304|NCT00260988|Tinzaparin|tinzaparin|mesh-list
6412305|NCT00260988|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6412306|NCT00260988|Anticoagulants|anticoagulants|mesh-ancestor
6412307|NCT00260988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6412308|NCT00260988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6412309|NCT00260988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412310|NCT00261027|Exemestane|exemestane|mesh-list
6412311|NCT00261027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6412312|NCT00261027|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6412313|NCT00261027|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6412314|NCT00261027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6412315|NCT00261027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412316|NCT00261027|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6412317|NCT00261027|Hormone Antagonists|hormone antagonists|mesh-ancestor
6412318|NCT00261027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6412319|NCT00261027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412320|NCT00261053|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
6412321|NCT00261053|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6412322|NCT00261053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6412323|NCT00261053|Immunologic Factors|immunologic factors|mesh-ancestor
6412324|NCT00261053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412325|NCT00261079|Fexofenadine|fexofenadine|mesh-list
6412326|NCT00261079|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6412327|NCT00261079|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6412328|NCT00261079|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6412329|NCT00261079|Histamine Antagonists|histamine antagonists|mesh-ancestor
6412330|NCT00261079|Histamine Agents|histamine agents|mesh-ancestor
6412331|NCT00261079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6412332|NCT00261079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412333|NCT00261079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412334|NCT00261092|Oxaliplatin|oxaliplatin|mesh-list
6412335|NCT00261092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6412336|NCT00261105|Telithromycin|telithromycin|mesh-list
6412337|NCT00261105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6412338|NCT00261105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6412339|NCT00261118|Rituximab|rituximab|mesh-list
6412340|NCT00261118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6412341|NCT00261118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6412342|NCT00261118|Immunologic Factors|immunologic factors|mesh-ancestor
6412343|NCT00261118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412344|NCT00261118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6412345|NCT00261131|Botulinum Toxins|botulinum toxins|mesh-list
6412346|NCT00261131|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6412347|NCT00261131|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6412348|NCT00261131|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6412349|NCT00261131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6412350|NCT00261131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412351|NCT00261131|Cholinergic Agents|cholinergic agents|mesh-ancestor
6412352|NCT00261131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6412353|NCT00261131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412354|NCT00261131|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6412355|NCT00261131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6412356|NCT00261170|Bupropion|bupropion|mesh-list
6412357|NCT00261170|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6412358|NCT00261170|Antidepressive Agents|antidepressive agents|mesh-ancestor
6412359|NCT00261170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6412360|NCT00261170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6412361|NCT00261170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6412362|NCT00261170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6412363|NCT00261170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412364|NCT00261170|Dopamine Agents|dopamine agents|mesh-ancestor
6412365|NCT00261170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6412366|NCT00261170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412367|NCT00261170|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6412368|NCT00261170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6412369|NCT00261170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6412370|NCT00261183|Melatonin|melatonin|mesh-list
6412371|NCT00261183|Antioxidants|antioxidants|mesh-ancestor
6412372|NCT00261183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412373|NCT00261183|Protective Agents|protective agents|mesh-ancestor
6412374|NCT00261183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412375|NCT00261183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6412376|NCT00261222|Amodiaquine|amodiaquine|mesh-list
6412377|NCT00261222|Antimalarials|antimalarials|mesh-ancestor
6412378|NCT00261222|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6412379|NCT00261222|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6412380|NCT00261222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6412381|NCT00261248|Vaccines|vaccines|mesh-list
6412382|NCT00261248|Immunologic Factors|immunologic factors|mesh-ancestor
6412383|NCT00261248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412384|NCT00261261|Midazolam|midazolam|mesh-list
6412385|NCT00261261|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6412386|NCT00261261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6412387|NCT00261261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6412388|NCT00261261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412389|NCT00261261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6412390|NCT00261261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6412391|NCT00261261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6412392|NCT00261261|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6412393|NCT00261261|Anesthetics, General|anesthetics, general|mesh-ancestor
6412394|NCT00261261|Anesthetics|anesthetics|mesh-ancestor
6412395|NCT00261261|GABA Modulators|gaba modulators|mesh-ancestor
6412396|NCT00261261|GABA Agents|gaba agents|mesh-ancestor
6412397|NCT00261261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6412398|NCT00261261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412399|NCT00261287|Ciclesonide|ciclesonide|mesh-list
6412400|NCT00261287|Glucocorticoids|glucocorticoids|mesh-ancestor
6412401|NCT00261287|Hormones|hormones|mesh-ancestor
6412402|NCT00261287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6412403|NCT00261287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412404|NCT00261287|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6412405|NCT00261300|Pantoprazole|pantoprazole|mesh-list
6412406|NCT00261300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6412407|NCT00261300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6412408|NCT00261300|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6412409|NCT00261300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6412410|NCT00261300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412411|NCT00261313|Darbepoetin alfa|darbepoetin alfa|mesh-list
6412412|NCT00261313|Hematinics|hematinics|mesh-ancestor
6412413|NCT00261326|Simvastatin|simvastatin|mesh-list
6412414|NCT00261326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6412415|NCT00261326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6412416|NCT00261326|Antimetabolites|antimetabolites|mesh-ancestor
6412417|NCT00261326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412418|NCT00261326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6412419|NCT00261326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6412420|NCT00261326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6412421|NCT00261339|Pantoprazole|pantoprazole|mesh-list
6412422|NCT00261339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6412423|NCT00261339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6412424|NCT00261339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6412425|NCT00261339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6412426|NCT00261339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412427|NCT00261352|Metformin|metformin|mesh-list
6412428|NCT00261352|Fenofibrate|fenofibrate|mesh-list
6412429|NCT00261352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6412430|NCT00261352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412431|NCT00261352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6412432|NCT00261352|Antimetabolites|antimetabolites|mesh-ancestor
6412433|NCT00261352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412434|NCT00261352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6412435|NCT00261365|Ipilimumab|ipilimumab|mesh-list
6412436|NCT00261365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6412437|NCT00261365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6412438|NCT00261365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6412439|NCT00261365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412440|NCT00261378|Doxorubicin|doxorubicin|mesh-list
6412441|NCT00261378|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6412442|NCT00261378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6412443|NCT00261378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6412444|NCT00261378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6412445|NCT00261378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6412446|NCT00261378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6412447|NCT00261378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412448|NCT00261391|Marimastat|marimastat|mesh-list
6412449|NCT00261391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6412450|NCT00261391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412451|NCT00261469|Topiramate|topiramate|mesh-list
6412452|NCT00261469|Anticonvulsants|anticonvulsants|mesh-ancestor
6412453|NCT00261469|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6412454|NCT00261469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412455|NCT00261482|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6412456|NCT00261482|Norelgestromin|norelgestromin|mesh-list
6412457|NCT00261482|Estradiol|estradiol|mesh-list
6412458|NCT00261482|Estrogens|estrogens|mesh-ancestor
6412459|NCT00261482|Hormones|hormones|mesh-ancestor
6412460|NCT00261482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6412461|NCT00261482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412462|NCT00261482|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6412463|NCT00261482|Contraceptive Agents|contraceptive agents|mesh-ancestor
5501244|NCT04476173|Narcotics|narcotics|mesh-ancestor
6412464|NCT00261482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6412465|NCT00261482|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6412466|NCT00261482|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6412467|NCT00261482|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6412468|NCT00261508|Risperidone|risperidone|mesh-list
6412469|NCT00261508|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6412470|NCT00261508|Serotonin Agents|serotonin agents|mesh-ancestor
6412471|NCT00261508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6412472|NCT00261508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412473|NCT00261508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412474|NCT00261508|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6412475|NCT00261508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6412476|NCT00261508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6412477|NCT00261508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6412478|NCT00261508|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6412479|NCT00261508|Dopamine Agents|dopamine agents|mesh-ancestor
6412480|NCT00261521|Epoetin Alfa|epoetin alfa|mesh-list
6412481|NCT00261521|Hematinics|hematinics|mesh-ancestor
6412482|NCT00261547|Rituximab|rituximab|mesh-list
6412483|NCT00261547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6412484|NCT00261547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6412485|NCT00261547|Immunologic Factors|immunologic factors|mesh-ancestor
6412486|NCT00261547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412487|NCT00261547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6412488|NCT00261560|Acetaminophen|acetaminophen|mesh-list
6412489|NCT00261560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6412490|NCT00261560|Analgesics|analgesics|mesh-ancestor
6412491|NCT00261560|Sensory System Agents|sensory system agents|mesh-ancestor
6412492|NCT00261560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6412493|NCT00261560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412494|NCT00261560|Antipyretics|antipyretics|mesh-ancestor
6412495|NCT00261573|Galantamine|galantamine|mesh-list
6412496|NCT00261573|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6412497|NCT00261573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6412498|NCT00261573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412499|NCT00261573|Cholinergic Agents|cholinergic agents|mesh-ancestor
6412500|NCT00261573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6412501|NCT00261573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412502|NCT00261573|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6412503|NCT00261573|Autonomic Agents|autonomic agents|mesh-ancestor
6412504|NCT00261573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6412505|NCT00261573|Nootropic Agents|nootropic agents|mesh-ancestor
6412506|NCT00261586|Aspirin|aspirin|mesh-list
6412507|NCT00261586|Acetaminophen|acetaminophen|mesh-list
6412508|NCT00261586|Ibuprofen|ibuprofen|mesh-list
6412509|NCT00261586|Celecoxib|celecoxib|mesh-list
6412510|NCT00261586|Naproxen|naproxen|mesh-list
6412511|NCT00261586|Rofecoxib|rofecoxib|mesh-list
6412512|NCT00261586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6412513|NCT00261586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6412514|NCT00261586|Analgesics|analgesics|mesh-ancestor
6412515|NCT00261586|Sensory System Agents|sensory system agents|mesh-ancestor
6412516|NCT00261586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6412517|NCT00261586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412518|NCT00261586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6412519|NCT00261586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6412520|NCT00261586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6412521|NCT00261586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6412522|NCT00261586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412523|NCT00261586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6412524|NCT00261586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6412525|NCT00261586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6412526|NCT00261586|Antipyretics|antipyretics|mesh-ancestor
6412527|NCT00261586|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6412528|NCT00261586|Gout Suppressants|gout suppressants|mesh-ancestor
6412529|NCT00261599|Midazolam|midazolam|mesh-list
6412530|NCT00261599|Fospropofol|fospropofol|mesh-list
6412531|NCT00261599|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6412532|NCT00261599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6412533|NCT00261599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6412534|NCT00261599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412535|NCT00261599|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6412536|NCT00261599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6412537|NCT00261599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6412538|NCT00261599|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6412539|NCT00261599|Anesthetics, General|anesthetics, general|mesh-ancestor
6412540|NCT00261599|Anesthetics|anesthetics|mesh-ancestor
6412541|NCT00261599|GABA Modulators|gaba modulators|mesh-ancestor
6412542|NCT00261599|GABA Agents|gaba agents|mesh-ancestor
6412543|NCT00261599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6412544|NCT00261599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412545|NCT00261612|Dexamethasone|dexamethasone|mesh-list
6412546|NCT00261612|Rituximab|rituximab|mesh-list
6412547|NCT00261612|Bortezomib|bortezomib|mesh-list
6412548|NCT00261612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6412549|NCT00261612|Antiemetics|antiemetics|mesh-ancestor
6412550|NCT00261612|Autonomic Agents|autonomic agents|mesh-ancestor
6412551|NCT00261612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6412552|NCT00261612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412553|NCT00261612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6412554|NCT00261612|Glucocorticoids|glucocorticoids|mesh-ancestor
6412555|NCT00261612|Hormones|hormones|mesh-ancestor
6412556|NCT00261612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6412557|NCT00261612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6412558|NCT00261612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6412559|NCT00261612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6412560|NCT00261612|Immunologic Factors|immunologic factors|mesh-ancestor
6412561|NCT00261612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6412562|NCT00261625|Alendronate|alendronate|mesh-list
6412563|NCT00261625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6412564|NCT00261625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412565|NCT00261677|Epoetin Alfa|epoetin alfa|mesh-list
6412566|NCT00261677|Hematinics|hematinics|mesh-ancestor
6412567|NCT00261703|Cisplatin|cisplatin|mesh-list
6412568|NCT00261703|Docetaxel|docetaxel|mesh-list
6412569|NCT00261703|Fluorouracil|fluorouracil|mesh-list
6412570|NCT00261703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6412571|NCT00261703|Tubulin Modulators|tubulin modulators|mesh-ancestor
6412572|NCT00261703|Antimitotic Agents|antimitotic agents|mesh-ancestor
6412573|NCT00261703|Mitosis Modulators|mitosis modulators|mesh-ancestor
6412574|NCT00261703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412575|NCT00261703|Antimetabolites|antimetabolites|mesh-ancestor
6412576|NCT00261703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6412577|NCT00261703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6412578|NCT00261703|Immunologic Factors|immunologic factors|mesh-ancestor
6412579|NCT00261703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412580|NCT00261729|Prazosin|prazosin|mesh-list
6412581|NCT00261729|Paroxetine|paroxetine|mesh-list
6412582|NCT00261729|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6412583|NCT00261729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6412584|NCT00261729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6412585|NCT00261729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412586|NCT00261729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6412587|NCT00261729|Serotonin Agents|serotonin agents|mesh-ancestor
6412588|NCT00261729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412589|NCT00261729|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6412590|NCT00261729|Antidepressive Agents|antidepressive agents|mesh-ancestor
6412591|NCT00261729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6412592|NCT00261729|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6412593|NCT00261729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6412594|NCT00261729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6412595|NCT00261729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6412596|NCT00261729|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6412597|NCT00261729|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6412598|NCT00261729|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6412599|NCT00261729|Adrenergic Agents|adrenergic agents|mesh-ancestor
6412600|NCT00261742|Penicillins|penicillins|mesh-list
6412601|NCT00261742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6412602|NCT00261742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6412603|NCT00261755|Analgesics|analgesics|mesh-list
6412604|NCT00261755|Sensory System Agents|sensory system agents|mesh-ancestor
6412605|NCT00261755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6412606|NCT00261755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412607|NCT00261820|Mycophenolic Acid|mycophenolic acid|mesh-list
6412608|NCT00261820|Sirolimus|sirolimus|mesh-list
6412609|NCT00261820|Methylprednisolone|methylprednisolone|mesh-list
6412610|NCT00261820|Prednisolone|prednisolone|mesh-list
6412611|NCT00261820|Tacrolimus|tacrolimus|mesh-list
6412612|NCT00261820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6412613|NCT00261820|Immunologic Factors|immunologic factors|mesh-ancestor
6412614|NCT00261820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412615|NCT00261820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6412616|NCT00261820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6412617|NCT00261820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412618|NCT00261820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6412619|NCT00261820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6412620|NCT00261820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6412621|NCT00261820|Antitubercular Agents|antitubercular agents|mesh-ancestor
6412622|NCT00261820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6412623|NCT00261820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6412624|NCT00261820|Antifungal Agents|antifungal agents|mesh-ancestor
6412625|NCT00261820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6412626|NCT00261820|Antiemetics|antiemetics|mesh-ancestor
6412627|NCT00261820|Autonomic Agents|autonomic agents|mesh-ancestor
6412628|NCT00261820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6412629|NCT00261820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6412630|NCT00261820|Glucocorticoids|glucocorticoids|mesh-ancestor
6412631|NCT00261820|Hormones|hormones|mesh-ancestor
6412632|NCT00261820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6412633|NCT00261820|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6412634|NCT00261820|Protective Agents|protective agents|mesh-ancestor
6412635|NCT00261820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6412636|NCT00261872|Methylphenidate|methylphenidate|mesh-list
6412637|NCT00261872|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6412638|NCT00261872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412639|NCT00261872|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6412640|NCT00261872|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6412641|NCT00261872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6412642|NCT00261872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412643|NCT00261872|Dopamine Agents|dopamine agents|mesh-ancestor
6412644|NCT00261872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6412645|NCT00261911|Sibutramine|sibutramine|mesh-list
6412646|NCT00261911|Antidepressive Agents|antidepressive agents|mesh-ancestor
6412647|NCT00261911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6412648|NCT00261911|Appetite Depressants|appetite depressants|mesh-ancestor
6412649|NCT00261911|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6412650|NCT00261937|Furosemide|furosemide|mesh-list
6412651|NCT00261937|Diuretics|diuretics|mesh-ancestor
6412652|NCT00261937|Natriuretic Agents|natriuretic agents|mesh-ancestor
6412653|NCT00261937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412654|NCT00261937|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6412655|NCT00261937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6412656|NCT00261937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412657|NCT00261976|Infliximab|infliximab|mesh-list
6412658|NCT00261976|Dermatologic Agents|dermatologic agents|mesh-ancestor
6412659|NCT00261976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6412660|NCT00261976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6412661|NCT00262015|Vaccines|vaccines|mesh-list
6412662|NCT00262015|Immunologic Factors|immunologic factors|mesh-ancestor
6412663|NCT00262015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412664|NCT00262054|Heparin|heparin|mesh-list
6412665|NCT00262054|Calcium heparin|calcium heparin|mesh-list
6412666|NCT00262054|Bivalirudin|bivalirudin|mesh-list
6412667|NCT00262054|Anticoagulants|anticoagulants|mesh-ancestor
6412668|NCT00262054|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6412669|NCT00262054|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6412670|NCT00262054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412671|NCT00262054|Antithrombins|antithrombins|mesh-ancestor
6412672|NCT00262054|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6412673|NCT00262054|Protease Inhibitors|protease inhibitors|mesh-ancestor
6412674|NCT00262054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6412675|NCT00262132|Mycophenolic Acid|mycophenolic acid|mesh-list
6412676|NCT00262132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6412677|NCT00262132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6018802|NCT00382265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6018803|NCT00382265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018804|NCT00382265|Urological Agents|urological agents|mesh-ancestor
6018805|NCT00382590|Cytarabine|cytarabine|mesh-list
6018806|NCT00382590|Azacitidine|azacitidine|mesh-list
6018807|NCT00382590|Valproic Acid|valproic acid|mesh-list
6018808|NCT00382590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6018809|NCT00382590|Antimetabolites|antimetabolites|mesh-ancestor
6018810|NCT00382590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6018811|NCT00382590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6018812|NCT00382590|Antiviral Agents|antiviral agents|mesh-ancestor
6018813|NCT00382590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6018814|NCT00382590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6018815|NCT00382590|Immunologic Factors|immunologic factors|mesh-ancestor
6053206|NCT00593554|Alkylating Agents|alkylating agents|mesh-ancestor
6412678|NCT00262132|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6412679|NCT00262132|Antitubercular Agents|antitubercular agents|mesh-ancestor
6412680|NCT00262132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6412681|NCT00262132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6412682|NCT00262132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6412683|NCT00262132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412684|NCT00262210|Prednisolone|prednisolone|mesh-list
6412685|NCT00262210|Cyclophosphamide|cyclophosphamide|mesh-list
6412686|NCT00262210|Etoposide|etoposide|mesh-list
6412687|NCT00262210|Epirubicin|epirubicin|mesh-list
6412688|NCT00262210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6412689|NCT00262210|Immunologic Factors|immunologic factors|mesh-ancestor
6412690|NCT00262210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412691|NCT00262210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6412692|NCT00262210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6412693|NCT00262210|Alkylating Agents|alkylating agents|mesh-ancestor
6412694|NCT00262210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412695|NCT00262210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6412696|NCT00262210|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6412697|NCT00262210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6412698|NCT00262210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6412699|NCT00262210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6412700|NCT00262210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6412701|NCT00262210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6412702|NCT00262210|Glucocorticoids|glucocorticoids|mesh-ancestor
6412703|NCT00262210|Hormones|hormones|mesh-ancestor
6412704|NCT00262210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6412705|NCT00262210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6412706|NCT00262210|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6412707|NCT00262262|Levetiracetam|levetiracetam|mesh-list
6412708|NCT00262262|Anticonvulsants|anticonvulsants|mesh-ancestor
6412709|NCT00262262|Nootropic Agents|nootropic agents|mesh-ancestor
6412710|NCT00262275|Aspirin|aspirin|mesh-list
6018816|NCT00382590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018817|NCT00382590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6018818|NCT00382590|Anticonvulsants|anticonvulsants|mesh-ancestor
6018819|NCT00382590|GABA Agents|gaba agents|mesh-ancestor
6412711|NCT00262275|Clopidogrel|clopidogrel|mesh-list
6412712|NCT00262275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6412713|NCT00262275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6412714|NCT00262275|Analgesics|analgesics|mesh-ancestor
6412715|NCT00262275|Sensory System Agents|sensory system agents|mesh-ancestor
6412716|NCT00262275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6412717|NCT00262275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412718|NCT00262275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6412719|NCT00262275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6412720|NCT00262275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6412721|NCT00262275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6412722|NCT00262275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412723|NCT00262275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6412724|NCT00262275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6412725|NCT00262275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6412726|NCT00262275|Antipyretics|antipyretics|mesh-ancestor
6412727|NCT00262275|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6412728|NCT00262275|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6412729|NCT00262275|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6412730|NCT00262275|Purinergic Agents|purinergic agents|mesh-ancestor
6412731|NCT00262275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6412732|NCT00262288|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
6412733|NCT00262288|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6412734|NCT00262288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6412735|NCT00262288|Immunologic Factors|immunologic factors|mesh-ancestor
6018820|NCT00382590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6018821|NCT00382590|Antimanic Agents|antimanic agents|mesh-ancestor
6412736|NCT00262288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412737|NCT00262327|Endostatins|endostatins|mesh-list
6412738|NCT00262327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6412739|NCT00262327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6412740|NCT00262327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6412741|NCT00262327|Growth Substances|growth substances|mesh-ancestor
6412742|NCT00262327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412743|NCT00262327|Growth Inhibitors|growth inhibitors|mesh-ancestor
6412744|NCT00262379|Epoetin Alfa|epoetin alfa|mesh-list
6412745|NCT00262379|Hematinics|hematinics|mesh-ancestor
6412746|NCT00262392|Pamidronate|pamidronate|mesh-list
6412747|NCT00262392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6412748|NCT00262392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412749|NCT00262405|Prednisone|prednisone|mesh-list
6412750|NCT00262405|Zileuton|zileuton|mesh-list
6412751|NCT00262405|Azathioprine|azathioprine|mesh-list
6412752|NCT00262405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6412753|NCT00262405|Glucocorticoids|glucocorticoids|mesh-ancestor
6412754|NCT00262405|Hormones|hormones|mesh-ancestor
6412755|NCT00262405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6412756|NCT00262405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412757|NCT00262405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6412758|NCT00262405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6412759|NCT00262405|Antimetabolites|antimetabolites|mesh-ancestor
6412760|NCT00262405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412761|NCT00262405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6412762|NCT00262405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6412763|NCT00262405|Immunologic Factors|immunologic factors|mesh-ancestor
6412764|NCT00262405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6412765|NCT00262405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6412766|NCT00262405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6412767|NCT00262405|Analgesics|analgesics|mesh-ancestor
6412768|NCT00262405|Sensory System Agents|sensory system agents|mesh-ancestor
6412769|NCT00262405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6412770|NCT00262405|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6412771|NCT00262405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6412772|NCT00262405|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6412773|NCT00262405|Hormone Antagonists|hormone antagonists|mesh-ancestor
6412774|NCT00262418|Ivermectin|ivermectin|mesh-list
6412775|NCT00262418|Permethrin|permethrin|mesh-list
6412776|NCT00262418|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6412777|NCT00262418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6412778|NCT00262418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6412779|NCT00262418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459895|NCT00447031|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6459896|NCT00447031|Bevacizumab|bevacizumab|mesh-list
6459897|NCT00447031|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6459898|NCT00447031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6459899|NCT00447031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6459900|NCT00447031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6459901|NCT00447031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6459902|NCT00447031|Growth Substances|growth substances|mesh-ancestor
6459903|NCT00447031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459904|NCT00447031|Growth Inhibitors|growth inhibitors|mesh-ancestor
6459905|NCT00447031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6459906|NCT00447031|Glucocorticoids|glucocorticoids|mesh-ancestor
6459907|NCT00447031|Hormones|hormones|mesh-ancestor
6459908|NCT00447031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6459909|NCT00447031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6459910|NCT00447031|Immunologic Factors|immunologic factors|mesh-ancestor
6459911|NCT00447031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6459912|NCT00447031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459913|NCT00447070|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6459914|NCT00447070|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6459915|NCT00447070|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6459916|NCT00447070|Protease Inhibitors|protease inhibitors|mesh-ancestor
6459917|NCT00447070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6459918|NCT00447070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459919|NCT00447070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6459920|NCT00447070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6459921|NCT00447070|Antiviral Agents|antiviral agents|mesh-ancestor
6459922|NCT00447070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6462031|NCT00457106|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6462032|NCT00457106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6462033|NCT00457106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6462034|NCT00457106|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6462035|NCT00457106|Antidepressive Agents|antidepressive agents|mesh-ancestor
6462036|NCT00457106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6462037|NCT00457106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6462038|NCT00457106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6462039|NCT00457119|Everolimus|everolimus|mesh-list
6462040|NCT00457119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6462041|NCT00457119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6462042|NCT00457119|Immunologic Factors|immunologic factors|mesh-ancestor
6462043|NCT00457119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462044|NCT00457145|Ranibizumab|ranibizumab|mesh-list
6462045|NCT00457145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6462046|NCT00457145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6462047|NCT00457145|Growth Substances|growth substances|mesh-ancestor
6462048|NCT00457145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462049|NCT00457145|Growth Inhibitors|growth inhibitors|mesh-ancestor
6462050|NCT00457145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6462051|NCT00457223|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6462052|NCT00457223|Hemostatics|hemostatics|mesh-ancestor
6462053|NCT00457223|Coagulants|coagulants|mesh-ancestor
6462054|NCT00457340|Atorvastatin|atorvastatin|mesh-list
6462055|NCT00457340|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6462056|NCT00457340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6462057|NCT00457340|Antimetabolites|antimetabolites|mesh-ancestor
6462058|NCT00457340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462059|NCT00457340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6462060|NCT00457340|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6462061|NCT00457340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6462062|NCT00457405|Dipyridamole|dipyridamole|mesh-list
6462063|NCT00457405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6462064|NCT00457405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6462065|NCT00457405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462066|NCT00457405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6462067|NCT00457405|Vasodilator Agents|vasodilator agents|mesh-ancestor
6462068|NCT00457470|Rucaparib|rucaparib|mesh-list
6462069|NCT00457470|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6462070|NCT00457470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6412780|NCT00262470|Indomethacin|indomethacin|mesh-list
6412781|NCT00262470|Octreotide|octreotide|mesh-list
6412782|NCT00262470|Propranolol|propranolol|mesh-list
6412783|NCT00262470|Clonidine|clonidine|mesh-list
6412784|NCT00262470|Mecamylamine|mecamylamine|mesh-list
6412785|NCT00262470|Acetazolamide|acetazolamide|mesh-list
6412786|NCT00262470|Isosorbide|isosorbide|mesh-list
6412787|NCT00262470|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
6412788|NCT00262470|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
6412789|NCT00262470|Midodrine|midodrine|mesh-list
6412790|NCT00262470|Memantine|memantine|mesh-list
6412791|NCT00262470|Entacapone|entacapone|mesh-list
6412792|NCT00262470|Melatonin|melatonin|mesh-list
6412793|NCT00262470|Modafinil|modafinil|mesh-list
6412794|NCT00262470|Sertraline|sertraline|mesh-list
6412795|NCT00262470|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6412796|NCT00262470|Antioxidants|antioxidants|mesh-ancestor
6412797|NCT00262470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412798|NCT00262470|Protective Agents|protective agents|mesh-ancestor
6412799|NCT00262470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412800|NCT00262470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6412801|NCT00262470|Antidepressive Agents|antidepressive agents|mesh-ancestor
6412802|NCT00262470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6412803|NCT00262470|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6412804|NCT00262470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6412805|NCT00262470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6412806|NCT00262470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6412807|NCT00262470|Serotonin Agents|serotonin agents|mesh-ancestor
6412808|NCT00262470|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6412809|NCT00262470|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6412810|NCT00262470|Adrenergic Agents|adrenergic agents|mesh-ancestor
6412811|NCT00262470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6412812|NCT00262470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6412813|NCT00262470|Vasodilator Agents|vasodilator agents|mesh-ancestor
6412814|NCT00262470|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6412815|NCT00262470|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6412816|NCT00262470|Dopamine Agents|dopamine agents|mesh-ancestor
6412817|NCT00262470|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6412818|NCT00262470|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6412819|NCT00262470|Analgesics|analgesics|mesh-ancestor
6412820|NCT00262470|Sensory System Agents|sensory system agents|mesh-ancestor
6412821|NCT00262470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6412822|NCT00262470|Sympatholytics|sympatholytics|mesh-ancestor
6412823|NCT00262470|Autonomic Agents|autonomic agents|mesh-ancestor
6412824|NCT00262470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6412825|NCT00262470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6412826|NCT00262470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6412827|NCT00262470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6459923|NCT00447213|Insulin|insulin|mesh-list
6412828|NCT00262470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6412829|NCT00262470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6412830|NCT00262470|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6412831|NCT00262470|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6412832|NCT00262470|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6412833|NCT00262470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6412834|NCT00262470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6412835|NCT00262470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6412836|NCT00262470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6412837|NCT00262470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6412838|NCT00262470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6412839|NCT00262470|Gout Suppressants|gout suppressants|mesh-ancestor
6412840|NCT00262470|Tocolytic Agents|tocolytic agents|mesh-ancestor
6412841|NCT00262470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6412842|NCT00262470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6412843|NCT00262470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6412844|NCT00262470|Anticonvulsants|anticonvulsants|mesh-ancestor
6412845|NCT00262470|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6412846|NCT00262470|Diuretics|diuretics|mesh-ancestor
6412847|NCT00262470|Natriuretic Agents|natriuretic agents|mesh-ancestor
6412848|NCT00262470|Sympathomimetics|sympathomimetics|mesh-ancestor
6412849|NCT00262470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6412850|NCT00262470|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6412851|NCT00262470|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6412852|NCT00262470|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6412853|NCT00262470|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6412854|NCT00262470|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
6412855|NCT00262470|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
6412856|NCT00262470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6412857|NCT00262470|Cholinergic Agents|cholinergic agents|mesh-ancestor
6412858|NCT00262483|Ribavirin|ribavirin|mesh-list
6412859|NCT00262483|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6412860|NCT00262483|Antimetabolites|antimetabolites|mesh-ancestor
6459924|NCT00447213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6412861|NCT00262483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412862|NCT00262483|Antiviral Agents|antiviral agents|mesh-ancestor
6412863|NCT00262483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6412864|NCT00262548|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6412865|NCT00262548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6412866|NCT00262548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6412867|NCT00262548|Antimetabolites|antimetabolites|mesh-ancestor
6412868|NCT00262548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412869|NCT00262548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6412870|NCT00262548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6412871|NCT00262548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6412872|NCT00262561|Aspirin|aspirin|mesh-list
6412873|NCT00262561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6412874|NCT00262561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6412875|NCT00262561|Analgesics|analgesics|mesh-ancestor
6412876|NCT00262561|Sensory System Agents|sensory system agents|mesh-ancestor
6412877|NCT00262561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6412878|NCT00262561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412879|NCT00262561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6412880|NCT00262561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6412881|NCT00262561|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6412882|NCT00262561|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6412883|NCT00262561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412884|NCT00262561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6412885|NCT00262561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6412886|NCT00262561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6412887|NCT00262561|Antipyretics|antipyretics|mesh-ancestor
6412888|NCT00262574|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6412889|NCT00262574|Natriuretic Agents|natriuretic agents|mesh-ancestor
6412890|NCT00262574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412891|NCT00262587|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6412892|NCT00262587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6412893|NCT00262587|Autonomic Agents|autonomic agents|mesh-ancestor
6412894|NCT00262587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6412895|NCT00262587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412896|NCT00262587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6412897|NCT00262587|Respiratory System Agents|respiratory system agents|mesh-ancestor
6412898|NCT00262587|Glucocorticoids|glucocorticoids|mesh-ancestor
6412899|NCT00262587|Hormones|hormones|mesh-ancestor
6412900|NCT00262587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6412901|NCT00262587|Sympathomimetics|sympathomimetics|mesh-ancestor
6412902|NCT00262769|Gemcitabine|gemcitabine|mesh-list
6412903|NCT00262769|Cisplatin|cisplatin|mesh-list
6412904|NCT00262769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6412905|NCT00262769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6412906|NCT00262769|Antimetabolites|antimetabolites|mesh-ancestor
6412907|NCT00262769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412908|NCT00262769|Antiviral Agents|antiviral agents|mesh-ancestor
6412909|NCT00262769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6412910|NCT00262769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6412911|NCT00262769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6412912|NCT00262769|Immunologic Factors|immunologic factors|mesh-ancestor
6412913|NCT00262769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412914|NCT00262782|Fludarabine|fludarabine|mesh-list
6412915|NCT00262782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6412916|NCT00262795|Fludarabine|fludarabine|mesh-list
6412917|NCT00262795|Chlorambucil|chlorambucil|mesh-list
6412918|NCT00262795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6412919|NCT00262795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412920|NCT00262795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6412921|NCT00262795|Alkylating Agents|alkylating agents|mesh-ancestor
6412922|NCT00262808|Leucovorin|leucovorin|mesh-list
6412923|NCT00262808|Fluorouracil|fluorouracil|mesh-list
6412924|NCT00262808|Oxaliplatin|oxaliplatin|mesh-list
6412925|NCT00262808|Calcium|calcium|mesh-list
6412926|NCT00262808|Sargramostim|sargramostim|mesh-list
6412927|NCT00262808|Levoleucovorin|levoleucovorin|mesh-list
6412928|NCT00262808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6412929|NCT00262808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412930|NCT00262808|Antimetabolites|antimetabolites|mesh-ancestor
6412931|NCT00262808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412932|NCT00262808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6412933|NCT00262808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6412934|NCT00262808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6412935|NCT00262808|Immunologic Factors|immunologic factors|mesh-ancestor
6412936|NCT00262808|Antidotes|antidotes|mesh-ancestor
6412937|NCT00262808|Protective Agents|protective agents|mesh-ancestor
6412938|NCT00262808|Vitamin B Complex|vitamin b complex|mesh-ancestor
6412939|NCT00262808|Vitamins|vitamins|mesh-ancestor
6412940|NCT00262808|Micronutrients|micronutrients|mesh-ancestor
6412941|NCT00262886|Mycophenolic Acid|mycophenolic acid|mesh-list
6412942|NCT00262886|Cyclophosphamide|cyclophosphamide|mesh-list
6412943|NCT00262886|Fludarabine|fludarabine|mesh-list
6412944|NCT00262886|Fludarabine phosphate|fludarabine phosphate|mesh-list
6412945|NCT00262886|Tacrolimus|tacrolimus|mesh-list
6412946|NCT00262886|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6412947|NCT00262886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6412948|NCT00262886|Immunologic Factors|immunologic factors|mesh-ancestor
6412949|NCT00262886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412950|NCT00262886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6412951|NCT00262886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6412952|NCT00262886|Alkylating Agents|alkylating agents|mesh-ancestor
6412953|NCT00262886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412954|NCT00262886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6412955|NCT00262886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6412956|NCT00262886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6412957|NCT00262886|Antimetabolites|antimetabolites|mesh-ancestor
6412958|NCT00262886|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6412959|NCT00262886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6412960|NCT00262886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6412961|NCT00262886|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6412962|NCT00262886|Antitubercular Agents|antitubercular agents|mesh-ancestor
6412963|NCT00262886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6412964|NCT00262886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6412965|NCT00262977|Aspirin|aspirin|mesh-list
6412966|NCT00262977|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6412967|NCT00262977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6412968|NCT00262977|Analgesics|analgesics|mesh-ancestor
6412969|NCT00262977|Sensory System Agents|sensory system agents|mesh-ancestor
6412970|NCT00262977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6412971|NCT00262977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412972|NCT00262977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6412973|NCT00262977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6412974|NCT00262977|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6412975|NCT00262977|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6412976|NCT00262977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412977|NCT00262977|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6412978|NCT00262977|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6412979|NCT00262977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6412980|NCT00262977|Antipyretics|antipyretics|mesh-ancestor
6412981|NCT00263003|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6412982|NCT00263003|Irbesartan|irbesartan|mesh-list
6412983|NCT00263003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6412984|NCT00263003|Diuretics|diuretics|mesh-ancestor
6412985|NCT00263003|Natriuretic Agents|natriuretic agents|mesh-ancestor
6412986|NCT00263003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6412987|NCT00263003|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6412988|NCT00263003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6412989|NCT00263003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412990|NCT00263003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6412991|NCT00263003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6412992|NCT00263016|Docetaxel|docetaxel|mesh-list
6412993|NCT00263016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6412994|NCT00263016|Tubulin Modulators|tubulin modulators|mesh-ancestor
6412995|NCT00263016|Antimitotic Agents|antimitotic agents|mesh-ancestor
6412996|NCT00263016|Mitosis Modulators|mitosis modulators|mesh-ancestor
6412997|NCT00263016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6412998|NCT00263029|Capecitabine|capecitabine|mesh-list
6412999|NCT00263029|Oxaliplatin|oxaliplatin|mesh-list
6413000|NCT00263029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6413001|NCT00263029|Antimetabolites|antimetabolites|mesh-ancestor
6413002|NCT00263029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413003|NCT00263029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6413004|NCT00263055|Oxaliplatin|oxaliplatin|mesh-list
6413005|NCT00263055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6413006|NCT00263068|Rotigotine|rotigotine|mesh-list
6413007|NCT00263068|Dopamine Agonists|dopamine agonists|mesh-ancestor
6413008|NCT00263068|Dopamine Agents|dopamine agents|mesh-ancestor
6413009|NCT00263068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6413010|NCT00263068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413011|NCT00263068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413012|NCT00263094|Rofecoxib|rofecoxib|mesh-list
6018822|NCT00382590|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6413013|NCT00263094|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6413014|NCT00263094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6413015|NCT00263094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6413016|NCT00263094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413017|NCT00263094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6413018|NCT00263094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6413019|NCT00263094|Analgesics|analgesics|mesh-ancestor
6413020|NCT00263094|Sensory System Agents|sensory system agents|mesh-ancestor
6413021|NCT00263094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6413022|NCT00263094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413023|NCT00263094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6413024|NCT00263094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6413025|NCT00263133|Sertraline|sertraline|mesh-list
6413026|NCT00263133|Antidepressive Agents|antidepressive agents|mesh-ancestor
6413027|NCT00263133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6413028|NCT00263133|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6413029|NCT00263133|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6413030|NCT00263133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6413031|NCT00263133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413032|NCT00263133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6413033|NCT00263133|Serotonin Agents|serotonin agents|mesh-ancestor
6413034|NCT00263133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413035|NCT00263185|Vitamin D|vitamin d|mesh-list
6413036|NCT00263185|Ergocalciferols|ergocalciferols|mesh-list
6413037|NCT00263185|Vitamins|vitamins|mesh-list
6413038|NCT00263185|Calcium Carbonate|calcium carbonate|mesh-list
6413039|NCT00263185|Calcium|calcium|mesh-list
6413040|NCT00263185|Micronutrients|micronutrients|mesh-ancestor
6413041|NCT00263185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413042|NCT00263185|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6413043|NCT00263185|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6413044|NCT00263185|Antacids|antacids|mesh-ancestor
6413045|NCT00263185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413046|NCT00263185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6413047|NCT00263198|Letrozole|letrozole|mesh-list
6413048|NCT00263198|Vatalanib|vatalanib|mesh-list
6413049|NCT00263198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6413050|NCT00263198|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6413051|NCT00263198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6413052|NCT00263198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6413053|NCT00263198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413054|NCT00263198|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6413055|NCT00263198|Hormone Antagonists|hormone antagonists|mesh-ancestor
6413056|NCT00263198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6413057|NCT00263198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413058|NCT00263198|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6413059|NCT00263263|Sirolimus|sirolimus|mesh-list
6413060|NCT00263263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6413061|NCT00263263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6413062|NCT00263263|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6413063|NCT00263263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6413064|NCT00263263|Antifungal Agents|antifungal agents|mesh-ancestor
6413065|NCT00263263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6413066|NCT00263263|Immunologic Factors|immunologic factors|mesh-ancestor
6413067|NCT00263263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413068|NCT00263276|Metformin|metformin|mesh-list
6413069|NCT00263276|Dapagliflozin|dapagliflozin|mesh-list
6413070|NCT00263276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6413071|NCT00263276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413072|NCT00263276|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6413073|NCT00263276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413074|NCT00263302|Dexamethasone|dexamethasone|mesh-list
6413075|NCT00263302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6413076|NCT00263302|Antiemetics|antiemetics|mesh-ancestor
6413077|NCT00263302|Autonomic Agents|autonomic agents|mesh-ancestor
6413078|NCT00263302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6413079|NCT00263302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413080|NCT00263302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6413081|NCT00263302|Glucocorticoids|glucocorticoids|mesh-ancestor
6413082|NCT00263302|Hormones|hormones|mesh-ancestor
6413083|NCT00263302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6413084|NCT00263302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6413085|NCT00263302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6413086|NCT00263315|Amphotericin B|amphotericin b|mesh-list
6413087|NCT00263315|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6413088|NCT00263315|Amebicides|amebicides|mesh-ancestor
6413089|NCT00263315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6413090|NCT00263315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6413091|NCT00263315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6413092|NCT00263315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6413093|NCT00263315|Antifungal Agents|antifungal agents|mesh-ancestor
6413094|NCT00263354|Oxaliplatin|oxaliplatin|mesh-list
6413095|NCT00263354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6413096|NCT00263393|Atenolol|atenolol|mesh-list
6413097|NCT00263393|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6413098|NCT00263393|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6413099|NCT00263393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6413100|NCT00263393|Diuretics|diuretics|mesh-ancestor
6413101|NCT00263393|Natriuretic Agents|natriuretic agents|mesh-ancestor
6413102|NCT00263393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413103|NCT00263393|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6413104|NCT00263393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6413105|NCT00263393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413106|NCT00263393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6413107|NCT00263393|Sympatholytics|sympatholytics|mesh-ancestor
6413108|NCT00263393|Autonomic Agents|autonomic agents|mesh-ancestor
6413109|NCT00263393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6413110|NCT00263393|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6413111|NCT00263393|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6413112|NCT00263393|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6413113|NCT00263393|Adrenergic Agents|adrenergic agents|mesh-ancestor
6413114|NCT00263393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6413115|NCT00263393|Protease Inhibitors|protease inhibitors|mesh-ancestor
6413116|NCT00263393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6413117|NCT00263406|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6413118|NCT00263406|Protease Inhibitors|protease inhibitors|mesh-ancestor
6413119|NCT00263406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6413120|NCT00263406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413121|NCT00263458|Buprenorphine|buprenorphine|mesh-list
6413122|NCT00263458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6413123|NCT00263458|Narcotics|narcotics|mesh-ancestor
6413124|NCT00263458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6413125|NCT00263458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413126|NCT00263458|Analgesics|analgesics|mesh-ancestor
6413127|NCT00263458|Sensory System Agents|sensory system agents|mesh-ancestor
6413128|NCT00263458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6413129|NCT00263458|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6413130|NCT00263484|Zoledronic Acid|zoledronic acid|mesh-list
6413131|NCT00263484|Thalidomide|thalidomide|mesh-list
6413132|NCT00263484|Dexamethasone|dexamethasone|mesh-list
6413133|NCT00263484|Dexamethasone acetate|dexamethasone acetate|mesh-list
6413134|NCT00263484|BB 1101|bb 1101|mesh-list
6413135|NCT00263484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6413136|NCT00263484|Antiemetics|antiemetics|mesh-ancestor
6413137|NCT00263484|Autonomic Agents|autonomic agents|mesh-ancestor
6413138|NCT00263484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6413139|NCT00263484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413140|NCT00263484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6413141|NCT00263484|Glucocorticoids|glucocorticoids|mesh-ancestor
6413142|NCT00263484|Hormones|hormones|mesh-ancestor
6413143|NCT00263484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6413144|NCT00263484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6413145|NCT00263484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6413146|NCT00263484|Protease Inhibitors|protease inhibitors|mesh-ancestor
6413147|NCT00263484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6413148|NCT00263484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413149|NCT00263484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6413150|NCT00263484|Immunologic Factors|immunologic factors|mesh-ancestor
6413151|NCT00263484|Leprostatic Agents|leprostatic agents|mesh-ancestor
6413152|NCT00263484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6413153|NCT00263484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6413154|NCT00263484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6413155|NCT00263484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6413156|NCT00263484|Growth Substances|growth substances|mesh-ancestor
6413157|NCT00263484|Growth Inhibitors|growth inhibitors|mesh-ancestor
6413158|NCT00263484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6413159|NCT00263705|Capecitabine|capecitabine|mesh-list
6413160|NCT00263705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6413161|NCT00263705|Antimetabolites|antimetabolites|mesh-ancestor
6413162|NCT00263705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413163|NCT00263705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6413164|NCT00263718|Betamethasone|betamethasone|mesh-list
6413165|NCT00263718|Betamethasone Valerate|betamethasone valerate|mesh-list
6413166|NCT00263718|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
6413167|NCT00263718|Betamethasone benzoate|betamethasone benzoate|mesh-list
6413168|NCT00263718|Calcipotriene|calcipotriene|mesh-list
6413169|NCT00263718|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
6413170|NCT00263718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6413171|NCT00263718|Glucocorticoids|glucocorticoids|mesh-ancestor
6413172|NCT00263718|Hormones|hormones|mesh-ancestor
6413173|NCT00263718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6413174|NCT00263718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413175|NCT00263718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6413176|NCT00263718|Respiratory System Agents|respiratory system agents|mesh-ancestor
6413177|NCT00263718|Dermatologic Agents|dermatologic agents|mesh-ancestor
6413178|NCT00263744|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6413179|NCT00263744|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6413180|NCT00263744|Immunologic Factors|immunologic factors|mesh-ancestor
6413181|NCT00263744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413182|NCT00263744|Antacids|antacids|mesh-ancestor
6413183|NCT00263744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413184|NCT00263744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6413185|NCT00263796|Oxytocin|oxytocin|mesh-list
6413186|NCT00263796|Oxytocics|oxytocics|mesh-ancestor
6413187|NCT00263796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6413188|NCT00263796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413189|NCT00263822|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6413190|NCT00263822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6413191|NCT00263822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6413192|NCT00263822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6413193|NCT00263822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413194|NCT00263965|Metformin|metformin|mesh-list
6413195|NCT00263965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6413196|NCT00263965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413197|NCT00263978|Defibrotide|defibrotide|mesh-list
6413198|NCT00263978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6413199|NCT00263978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6413200|NCT00263978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413201|NCT00263978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6413202|NCT00264069|Antipsychotic Agents|antipsychotic agents|mesh-list
6413203|NCT00264069|Antidepressive Agents|antidepressive agents|mesh-list
6413204|NCT00264069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6413205|NCT00264069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6413206|NCT00264069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6413207|NCT00264069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413208|NCT00264082|Zoledronic Acid|zoledronic acid|mesh-list
6413209|NCT00264082|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6413210|NCT00264082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413211|NCT00264108|Epoetin Alfa|epoetin alfa|mesh-list
6413212|NCT00264108|Darbepoetin alfa|darbepoetin alfa|mesh-list
6413213|NCT00264108|Hematinics|hematinics|mesh-ancestor
6413214|NCT00264134|Carboplatin|carboplatin|mesh-list
6413215|NCT00264134|Docetaxel|docetaxel|mesh-list
6413216|NCT00264134|Irinotecan|irinotecan|mesh-list
6413217|NCT00264134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6018823|NCT00382590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6018824|NCT00382590|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6018825|NCT00382720|Docetaxel|docetaxel|mesh-list
6018826|NCT00382720|Capecitabine|capecitabine|mesh-list
6018827|NCT00382720|Oxaliplatin|oxaliplatin|mesh-list
6018828|NCT00382720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6018829|NCT00382720|Tubulin Modulators|tubulin modulators|mesh-ancestor
6018830|NCT00382720|Antimitotic Agents|antimitotic agents|mesh-ancestor
6413218|NCT00264134|Tubulin Modulators|tubulin modulators|mesh-ancestor
6413219|NCT00264134|Antimitotic Agents|antimitotic agents|mesh-ancestor
6413220|NCT00264134|Mitosis Modulators|mitosis modulators|mesh-ancestor
6413221|NCT00264134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413222|NCT00264134|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6413223|NCT00264134|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6413224|NCT00264134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6413225|NCT00264173|Valproic Acid|valproic acid|mesh-list
6413226|NCT00264173|Anticonvulsants|anticonvulsants|mesh-ancestor
6018831|NCT00382720|Mitosis Modulators|mitosis modulators|mesh-ancestor
6413227|NCT00264173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6413228|NCT00264173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413229|NCT00264173|GABA Agents|gaba agents|mesh-ancestor
6413230|NCT00264173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6413231|NCT00264173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413232|NCT00264173|Antimanic Agents|antimanic agents|mesh-ancestor
6413233|NCT00264173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6413234|NCT00264173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6413235|NCT00264173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6413236|NCT00264186|Norepinephrine|norepinephrine|mesh-list
6413237|NCT00264186|Nitroglycerin|nitroglycerin|mesh-list
6413238|NCT00264186|Acetylcholine|acetylcholine|mesh-list
6413239|NCT00264186|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6413240|NCT00264186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6413241|NCT00264186|Adrenergic Agents|adrenergic agents|mesh-ancestor
6413242|NCT00264186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6413243|NCT00264186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413244|NCT00264186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413245|NCT00264186|Sympathomimetics|sympathomimetics|mesh-ancestor
6413246|NCT00264186|Autonomic Agents|autonomic agents|mesh-ancestor
6413247|NCT00264186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6413248|NCT00264186|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6413249|NCT00264186|Vasodilator Agents|vasodilator agents|mesh-ancestor
6413250|NCT00264186|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6413251|NCT00264186|Cholinergic Agents|cholinergic agents|mesh-ancestor
6459925|NCT00447213|Insulin Glargine|insulin glargine|mesh-list
6459926|NCT00447213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6459927|NCT00447213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459928|NCT00447239|Insulin|insulin|mesh-list
6459929|NCT00447239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6459930|NCT00447239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459931|NCT00447304|Moxifloxacin|moxifloxacin|mesh-list
6459932|NCT00447304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6459933|NCT00447304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6459934|NCT00447304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6459935|NCT00447304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6459936|NCT00447304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6459937|NCT00447304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459938|NCT00447304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6459939|NCT00447356|Interferons|interferons|mesh-list
6459940|NCT00447356|Interferon-alpha|interferon-alpha|mesh-list
6459941|NCT00447356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6459942|NCT00447356|Antiviral Agents|antiviral agents|mesh-ancestor
6459943|NCT00447356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6459944|NCT00447356|Immunologic Factors|immunologic factors|mesh-ancestor
6459945|NCT00447356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459946|NCT00447369|Pregabalin|pregabalin|mesh-list
6459947|NCT00447369|Valproic Acid|valproic acid|mesh-list
6459948|NCT00447369|Analgesics|analgesics|mesh-ancestor
6459949|NCT00447369|Sensory System Agents|sensory system agents|mesh-ancestor
6459950|NCT00447369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6459951|NCT00447369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459952|NCT00447369|Anticonvulsants|anticonvulsants|mesh-ancestor
6459953|NCT00447369|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6459954|NCT00447369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6459955|NCT00447369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459956|NCT00447369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6459957|NCT00447369|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6459958|NCT00447369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6459959|NCT00447369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6459960|NCT00447369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6459961|NCT00447369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6459962|NCT00447369|GABA Agents|gaba agents|mesh-ancestor
6459963|NCT00447369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6459964|NCT00447369|Antimanic Agents|antimanic agents|mesh-ancestor
6459965|NCT00447473|Ketoconazole|ketoconazole|mesh-list
6459966|NCT00447473|Mitoxantrone|mitoxantrone|mesh-list
6459967|NCT00447473|Analgesics|analgesics|mesh-ancestor
6459968|NCT00447473|Sensory System Agents|sensory system agents|mesh-ancestor
6459969|NCT00447473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6459970|NCT00447473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459971|NCT00447473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6459972|NCT00447473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6459973|NCT00447473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6459974|NCT00447473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6459975|NCT00447473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413252|NCT00264212|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6413253|NCT00264212|Irbesartan|irbesartan|mesh-list
6413254|NCT00264212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6413255|NCT00264212|Diuretics|diuretics|mesh-ancestor
6413256|NCT00264212|Natriuretic Agents|natriuretic agents|mesh-ancestor
6413257|NCT00264212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413258|NCT00264212|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6413259|NCT00264212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6413260|NCT00264212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413261|NCT00264212|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6413262|NCT00264212|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6413263|NCT00264225|Codeine|codeine|mesh-list
6413264|NCT00264225|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6413265|NCT00264225|Narcotics|narcotics|mesh-ancestor
6413266|NCT00264225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6413267|NCT00264225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413268|NCT00264225|Analgesics|analgesics|mesh-ancestor
6413269|NCT00264225|Sensory System Agents|sensory system agents|mesh-ancestor
6413270|NCT00264225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6413271|NCT00264225|Antitussive Agents|antitussive agents|mesh-ancestor
6413272|NCT00264225|Respiratory System Agents|respiratory system agents|mesh-ancestor
6413273|NCT00264251|Rosiglitazone|rosiglitazone|mesh-list
6413274|NCT00264251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6413275|NCT00264251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413276|NCT00264277|Vitamin K|vitamin k|mesh-list
6413277|NCT00264277|Anticoagulants|anticoagulants|mesh-list
6413278|NCT00264277|Vitamins|vitamins|mesh-ancestor
6413279|NCT00264277|Micronutrients|micronutrients|mesh-ancestor
6413280|NCT00264277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413281|NCT00264277|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6413282|NCT00264277|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6413283|NCT00264277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413284|NCT00264277|Hemostatics|hemostatics|mesh-ancestor
6413285|NCT00264277|Coagulants|coagulants|mesh-ancestor
6413286|NCT00264355|Cyclosporine|cyclosporine|mesh-list
6413287|NCT00264355|Cyclosporins|cyclosporins|mesh-list
6413288|NCT00264355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6413289|NCT00264355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413290|NCT00264355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6413291|NCT00264355|Immunologic Factors|immunologic factors|mesh-ancestor
6413292|NCT00264355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413293|NCT00264355|Antifungal Agents|antifungal agents|mesh-ancestor
6413294|NCT00264355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6413295|NCT00264355|Dermatologic Agents|dermatologic agents|mesh-ancestor
6413296|NCT00264355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6413297|NCT00264355|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6413298|NCT00264368|Ganciclovir|ganciclovir|mesh-list
6413299|NCT00264368|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6413300|NCT00264368|Antiviral Agents|antiviral agents|mesh-ancestor
6413301|NCT00264368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6413302|NCT00264368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6413303|NCT00264368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6413304|NCT00264368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413305|NCT00264407|Hormones|hormones|mesh-list
6413306|NCT00264407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6413307|NCT00264407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413308|NCT00264420|Zoledronic Acid|zoledronic acid|mesh-list
6413309|NCT00264420|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6413310|NCT00264420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413311|NCT00264446|Eniluracil|eniluracil|mesh-list
6413312|NCT00264446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6413313|NCT00264446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413314|NCT00264459|Immunologic Factors|immunologic factors|mesh-list
6413315|NCT00264459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413316|NCT00264472|Eniluracil|eniluracil|mesh-list
6413317|NCT00264472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6413318|NCT00264472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413319|NCT00264485|Fentanyl|fentanyl|mesh-list
6413320|NCT00264485|Morphine|morphine|mesh-list
6413321|NCT00264485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6413322|NCT00264485|Narcotics|narcotics|mesh-ancestor
6413323|NCT00264485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6413324|NCT00264485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413325|NCT00264485|Analgesics|analgesics|mesh-ancestor
6413326|NCT00264485|Sensory System Agents|sensory system agents|mesh-ancestor
6413327|NCT00264485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6413328|NCT00264485|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6413329|NCT00264485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6413330|NCT00264485|Anesthetics, General|anesthetics, general|mesh-ancestor
6413331|NCT00264485|Anesthetics|anesthetics|mesh-ancestor
6413332|NCT00264615|Lamotrigine|lamotrigine|mesh-list
6413333|NCT00264615|Anticonvulsants|anticonvulsants|mesh-ancestor
6413334|NCT00264615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6413335|NCT00264615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6413336|NCT00264615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413337|NCT00264615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6413338|NCT00264615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413339|NCT00264615|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6413340|NCT00264615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6413341|NCT00264615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6413342|NCT00264615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6413343|NCT00264615|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6413344|NCT00264628|Casopitant|casopitant|mesh-list
6413345|NCT00264628|Antiemetics|antiemetics|mesh-ancestor
6413346|NCT00264628|Autonomic Agents|autonomic agents|mesh-ancestor
6413347|NCT00264628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6413348|NCT00264628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413349|NCT00264628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6413350|NCT00264628|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6413351|NCT00264628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6413352|NCT00264628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413353|NCT00264654|Paroxetine|paroxetine|mesh-list
6413354|NCT00264654|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6413355|NCT00264654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6413356|NCT00264654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6413357|NCT00264654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413358|NCT00264654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6413359|NCT00264654|Serotonin Agents|serotonin agents|mesh-ancestor
6413360|NCT00264654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413361|NCT00264654|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6413362|NCT00264654|Antidepressive Agents|antidepressive agents|mesh-ancestor
6413363|NCT00264654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6413364|NCT00264654|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6413365|NCT00264654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6413366|NCT00264654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6413367|NCT00264680|Lamotrigine|lamotrigine|mesh-list
6413368|NCT00264680|Anticonvulsants|anticonvulsants|mesh-list
6413369|NCT00264680|Valproic Acid|valproic acid|mesh-list
6413370|NCT00264680|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6413371|NCT00264680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6413372|NCT00264680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413373|NCT00264680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6413374|NCT00264680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413375|NCT00264680|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6413376|NCT00264680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6413377|NCT00264680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6413378|NCT00264680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6413379|NCT00264680|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6413380|NCT00264680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6413381|NCT00264680|GABA Agents|gaba agents|mesh-ancestor
6413382|NCT00264680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6413383|NCT00264680|Antimanic Agents|antimanic agents|mesh-ancestor
6413384|NCT00264719|Metoclopramide|metoclopramide|mesh-list
6413385|NCT00264719|Antiemetics|antiemetics|mesh-ancestor
6413386|NCT00264719|Autonomic Agents|autonomic agents|mesh-ancestor
6413387|NCT00264719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6413388|NCT00264719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413389|NCT00264719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6413390|NCT00264719|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6413391|NCT00264719|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6413392|NCT00264719|Dopamine Agents|dopamine agents|mesh-ancestor
6413393|NCT00264719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6413394|NCT00264719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413395|NCT00264901|Insulin Detemir|insulin detemir|mesh-list
6413396|NCT00264901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6413397|NCT00264901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413398|NCT00264914|Satavaptan|satavaptan|mesh-list
6413399|NCT00264914|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6413400|NCT00264914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413401|NCT00264914|Natriuretic Agents|natriuretic agents|mesh-ancestor
6413402|NCT00264914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413403|NCT00264927|Satavaptan|satavaptan|mesh-list
6413404|NCT00264927|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6413405|NCT00264927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413406|NCT00264927|Natriuretic Agents|natriuretic agents|mesh-ancestor
6413407|NCT00264927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413408|NCT00264953|Prednisone|prednisone|mesh-list
6413409|NCT00264953|Etoposide|etoposide|mesh-list
6413410|NCT00264953|Vincristine|vincristine|mesh-list
6413411|NCT00264953|Doxorubicin|doxorubicin|mesh-list
6413412|NCT00264953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6413413|NCT00264953|Bleomycin|bleomycin|mesh-list
6413414|NCT00264953|Vinblastine|vinblastine|mesh-list
6413415|NCT00264953|Procarbazine|procarbazine|mesh-list
6413416|NCT00264953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6413417|NCT00264953|Glucocorticoids|glucocorticoids|mesh-ancestor
6413418|NCT00264953|Hormones|hormones|mesh-ancestor
6413419|NCT00264953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6413420|NCT00264953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413421|NCT00264953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6413422|NCT00264953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6413423|NCT00264953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6413424|NCT00264953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6413425|NCT00264953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6413426|NCT00264953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6413427|NCT00264953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413428|NCT00264953|Tubulin Modulators|tubulin modulators|mesh-ancestor
6413429|NCT00264953|Antimitotic Agents|antimitotic agents|mesh-ancestor
6413430|NCT00264953|Mitosis Modulators|mitosis modulators|mesh-ancestor
6413431|NCT00264953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6413432|NCT00265005|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6413433|NCT00265005|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6413434|NCT00265005|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6413435|NCT00265005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413436|NCT00265018|Doxorubicin|doxorubicin|mesh-list
6413437|NCT00265018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6413438|NCT00265018|Bleomycin|bleomycin|mesh-list
6413439|NCT00265018|Vinblastine|vinblastine|mesh-list
6413440|NCT00265018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6413441|NCT00265018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6459976|NCT00447473|Antifungal Agents|antifungal agents|mesh-ancestor
6413442|NCT00265018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6413443|NCT00265018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6413444|NCT00265018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6413445|NCT00265018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413446|NCT00265018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6413447|NCT00265018|Tubulin Modulators|tubulin modulators|mesh-ancestor
6413448|NCT00265018|Antimitotic Agents|antimitotic agents|mesh-ancestor
6413449|NCT00265018|Mitosis Modulators|mitosis modulators|mesh-ancestor
6413450|NCT00265031|Prednisone|prednisone|mesh-list
6413451|NCT00265031|Cyclophosphamide|cyclophosphamide|mesh-list
6413452|NCT00265031|Etoposide|etoposide|mesh-list
6413453|NCT00265031|Vincristine|vincristine|mesh-list
6413454|NCT00265031|Doxorubicin|doxorubicin|mesh-list
6413455|NCT00265031|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6413456|NCT00265031|Bleomycin|bleomycin|mesh-list
6413457|NCT00265031|Procarbazine|procarbazine|mesh-list
6413458|NCT00265031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6413459|NCT00265031|Immunologic Factors|immunologic factors|mesh-ancestor
6413460|NCT00265031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413461|NCT00265031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6413462|NCT00265031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6413463|NCT00265031|Alkylating Agents|alkylating agents|mesh-ancestor
6413464|NCT00265031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413465|NCT00265031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6413466|NCT00265031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6413467|NCT00265031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6413468|NCT00265031|Glucocorticoids|glucocorticoids|mesh-ancestor
6413469|NCT00265031|Hormones|hormones|mesh-ancestor
6413470|NCT00265031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6413471|NCT00265031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6413472|NCT00265031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6413473|NCT00265031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6413474|NCT00265031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6413475|NCT00265031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6413476|NCT00265031|Tubulin Modulators|tubulin modulators|mesh-ancestor
6413477|NCT00265031|Antimitotic Agents|antimitotic agents|mesh-ancestor
6413478|NCT00265031|Mitosis Modulators|mitosis modulators|mesh-ancestor
6413479|NCT00265031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6413480|NCT00265070|Gefitinib|gefitinib|mesh-list
6413481|NCT00265070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6413482|NCT00265070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6413483|NCT00265070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6413484|NCT00265070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413485|NCT00265135|Siltuximab|siltuximab|mesh-list
6413486|NCT00265135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6413487|NCT00265252|Alendronate|alendronate|mesh-list
6413488|NCT00265252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6413489|NCT00265252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413490|NCT00265265|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6413491|NCT00265265|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6413492|NCT00265265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6413493|NCT00265265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6413494|NCT00265265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413495|NCT00265265|Adrenergic Agents|adrenergic agents|mesh-ancestor
6413496|NCT00265265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6413497|NCT00265265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413498|NCT00265278|Modafinil|modafinil|mesh-list
6413499|NCT00265278|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6413500|NCT00265278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413501|NCT00265278|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6413502|NCT00265278|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6413503|NCT00265278|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6413504|NCT00265278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413505|NCT00265291|Fluoxetine|fluoxetine|mesh-list
6413506|NCT00265291|Desipramine|desipramine|mesh-list
6413507|NCT00265291|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6413508|NCT00265291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6413509|NCT00265291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6413510|NCT00265291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413511|NCT00265291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6413512|NCT00265291|Serotonin Agents|serotonin agents|mesh-ancestor
6413513|NCT00265291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413514|NCT00265291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6413515|NCT00265291|Antidepressive Agents|antidepressive agents|mesh-ancestor
6413516|NCT00265291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6413517|NCT00265291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6413518|NCT00265291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6413519|NCT00265291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6413520|NCT00265291|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6413521|NCT00265291|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6413522|NCT00265291|Adrenergic Agents|adrenergic agents|mesh-ancestor
6413523|NCT00265304|Ketoprofen|ketoprofen|mesh-list
6413524|NCT00265304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6413525|NCT00265304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5501245|NCT04476173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6413526|NCT00265304|Analgesics|analgesics|mesh-ancestor
6413527|NCT00265304|Sensory System Agents|sensory system agents|mesh-ancestor
6413528|NCT00265304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6413529|NCT00265304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413530|NCT00265304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6413531|NCT00265304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6413532|NCT00265304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6413533|NCT00265304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6413534|NCT00265304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413535|NCT00265408|Aspirin|aspirin|mesh-list
6413536|NCT00265408|Warfarin|warfarin|mesh-list
6413537|NCT00265408|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6413538|NCT00265408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6413539|NCT00265408|Analgesics|analgesics|mesh-ancestor
6413540|NCT00265408|Sensory System Agents|sensory system agents|mesh-ancestor
6413541|NCT00265408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6413542|NCT00265408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413543|NCT00265408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6413544|NCT00265408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6413545|NCT00265408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6413546|NCT00265408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6413547|NCT00265408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413548|NCT00265408|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6413549|NCT00265408|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6413550|NCT00265408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6413551|NCT00265408|Antipyretics|antipyretics|mesh-ancestor
6413552|NCT00265408|Anticoagulants|anticoagulants|mesh-ancestor
6413553|NCT00265460|Lobeline|lobeline|mesh-list
6413554|NCT00265460|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6413555|NCT00265460|Autonomic Agents|autonomic agents|mesh-ancestor
6413556|NCT00265460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6413557|NCT00265460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413558|NCT00265460|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6413559|NCT00265460|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6413560|NCT00265460|Cholinergic Agents|cholinergic agents|mesh-ancestor
6413561|NCT00265460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6413562|NCT00265460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413563|NCT00265460|Respiratory System Agents|respiratory system agents|mesh-ancestor
6413564|NCT00265486|Epoetin Alfa|epoetin alfa|mesh-list
6413565|NCT00265486|Hematinics|hematinics|mesh-ancestor
6413566|NCT00265551|Olanzapine|olanzapine|mesh-list
6413567|NCT00265551|Antiemetics|antiemetics|mesh-ancestor
6413568|NCT00265551|Autonomic Agents|autonomic agents|mesh-ancestor
6413569|NCT00265551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6413570|NCT00265551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413571|NCT00265551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6413572|NCT00265551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6413573|NCT00265551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6413574|NCT00265551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6413575|NCT00265551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6413576|NCT00265551|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6413577|NCT00265551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6413578|NCT00265551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6413579|NCT00265551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413580|NCT00265551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6413581|NCT00265551|Serotonin Agents|serotonin agents|mesh-ancestor
6413582|NCT00265642|Irbesartan|irbesartan|mesh-list
6413583|NCT00265642|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6413584|NCT00265642|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6413585|NCT00265642|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6413586|NCT00265642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413587|NCT00265694|Gemcitabine|gemcitabine|mesh-list
6413588|NCT00265694|Carboplatin|carboplatin|mesh-list
6413589|NCT00265694|Vinorelbine|vinorelbine|mesh-list
6413590|NCT00265694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6413591|NCT00265694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6413592|NCT00265694|Antimetabolites|antimetabolites|mesh-ancestor
6413593|NCT00265694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413594|NCT00265694|Antiviral Agents|antiviral agents|mesh-ancestor
6413595|NCT00265694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6413596|NCT00265694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6413597|NCT00265694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6413598|NCT00265694|Immunologic Factors|immunologic factors|mesh-ancestor
6413599|NCT00265694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413600|NCT00265694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6018832|NCT00382720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413601|NCT00265694|Tubulin Modulators|tubulin modulators|mesh-ancestor
6413602|NCT00265694|Antimitotic Agents|antimitotic agents|mesh-ancestor
6413603|NCT00265694|Mitosis Modulators|mitosis modulators|mesh-ancestor
6413604|NCT00265733|Paclitaxel|paclitaxel|mesh-list
6413605|NCT00265733|Capecitabine|capecitabine|mesh-list
6413606|NCT00265733|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
6413607|NCT00265733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6413608|NCT00265733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6413609|NCT00265733|Tubulin Modulators|tubulin modulators|mesh-ancestor
6413610|NCT00265733|Antimitotic Agents|antimitotic agents|mesh-ancestor
6413611|NCT00265733|Mitosis Modulators|mitosis modulators|mesh-ancestor
6413612|NCT00265733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413613|NCT00265733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6413614|NCT00265733|Antimetabolites|antimetabolites|mesh-ancestor
6413615|NCT00265746|Metformin|metformin|mesh-list
6413616|NCT00265746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6413617|NCT00265746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413618|NCT00265772|Prednisolone|prednisolone|mesh-list
6413619|NCT00265772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6413620|NCT00265772|Glucocorticoids|glucocorticoids|mesh-ancestor
6413621|NCT00265772|Hormones|hormones|mesh-ancestor
6413622|NCT00265772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6413623|NCT00265772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413624|NCT00265772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6413625|NCT00265772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6413626|NCT00265811|Cetuximab|cetuximab|mesh-list
6413627|NCT00265811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6413628|NCT00265811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6413629|NCT00265824|Bevacizumab|bevacizumab|mesh-list
6413630|NCT00265824|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6413631|NCT00265824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6413632|NCT00265824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6413633|NCT00265824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6413634|NCT00265824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6413635|NCT00265824|Growth Substances|growth substances|mesh-ancestor
6413636|NCT00265824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413637|NCT00265824|Growth Inhibitors|growth inhibitors|mesh-ancestor
6413638|NCT00265824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6413639|NCT00265824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6413640|NCT00265824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413641|NCT00265863|Mitomycins|mitomycins|mesh-list
6413642|NCT00265863|Mitomycin|mitomycin|mesh-list
6413643|NCT00265863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6413644|NCT00265863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6413645|NCT00265863|Alkylating Agents|alkylating agents|mesh-ancestor
6413646|NCT00265863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413647|NCT00265863|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6413648|NCT00265863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6413649|NCT00265876|Gemcitabine|gemcitabine|mesh-list
6413650|NCT00265876|Saracatinib|saracatinib|mesh-list
6413651|NCT00265876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6018833|NCT00382720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6018834|NCT00382720|Antimetabolites|antimetabolites|mesh-ancestor
6018835|NCT00382733|Topotecan|topotecan|mesh-list
6018836|NCT00382733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6018837|NCT00382733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6018838|NCT00382733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6018839|NCT00382733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413652|NCT00265876|Antimetabolites|antimetabolites|mesh-ancestor
6413653|NCT00265876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413654|NCT00265876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6413655|NCT00265876|Antiviral Agents|antiviral agents|mesh-ancestor
6413656|NCT00265876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6413657|NCT00265876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6413658|NCT00265876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6413659|NCT00265876|Immunologic Factors|immunologic factors|mesh-ancestor
6413660|NCT00265876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413661|NCT00265915|Rituximab|rituximab|mesh-list
6413662|NCT00265915|Sargramostim|sargramostim|mesh-list
6413663|NCT00265915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6413664|NCT00265915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6413665|NCT00265915|Immunologic Factors|immunologic factors|mesh-ancestor
6413666|NCT00265915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413667|NCT00265915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6413668|NCT00265928|Rituximab|rituximab|mesh-list
6413669|NCT00265928|Bortezomib|bortezomib|mesh-list
6413670|NCT00265928|Antibodies|antibodies|mesh-list
6413671|NCT00265928|Immunoglobulins|immunoglobulins|mesh-list
6413672|NCT00265928|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6413673|NCT00265928|Enzyme Inhibitors|enzyme inhibitors|mesh-list
6413674|NCT00265928|Immunologic Factors|immunologic factors|mesh-ancestor
6413675|NCT00265928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413676|NCT00265928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6413677|NCT00265928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6413678|NCT00265928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6413679|NCT00265928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413680|NCT00265967|Irbesartan|irbesartan|mesh-list
6413681|NCT00265967|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6413682|NCT00265967|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6413683|NCT00265967|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6413684|NCT00265967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413685|NCT00265993|Enoxaparin|enoxaparin|mesh-list
6413686|NCT00265993|Anticoagulants|anticoagulants|mesh-ancestor
6413687|NCT00265993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6413688|NCT00265993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6413689|NCT00265993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6459977|NCT00447473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6459978|NCT00447473|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6459979|NCT00447473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6459980|NCT00447473|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6459981|NCT00447473|Hormone Antagonists|hormone antagonists|mesh-ancestor
6459982|NCT00447473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6459983|NCT00447473|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6459984|NCT00447577|Loteprednol Etabonate|loteprednol etabonate|mesh-list
6459985|NCT00447577|Tobramycin|tobramycin|mesh-list
6459986|NCT00447577|Dexamethasone|dexamethasone|mesh-list
6459987|NCT00447577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6459988|NCT00447577|Antiemetics|antiemetics|mesh-ancestor
6459989|NCT00447577|Autonomic Agents|autonomic agents|mesh-ancestor
6459990|NCT00447577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6459991|NCT00447577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6459992|NCT00447577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6459993|NCT00447577|Glucocorticoids|glucocorticoids|mesh-ancestor
6459994|NCT00447577|Hormones|hormones|mesh-ancestor
6459995|NCT00447577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6459996|NCT00447577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6459997|NCT00447577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6459998|NCT00447577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6459999|NCT00447577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6460000|NCT00447577|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6460001|NCT00447681|Fezakinumab|fezakinumab|mesh-list
6460002|NCT00447681|Dermatologic Agents|dermatologic agents|mesh-ancestor
6413690|NCT00266058|Ritonavir|ritonavir|mesh-list
6413691|NCT00266058|Lopinavir|lopinavir|mesh-list
6413692|NCT00266058|Efavirenz|efavirenz|mesh-list
6413693|NCT00266058|Lumefantrine|lumefantrine|mesh-list
6413694|NCT00266058|Artemether|artemether|mesh-list
6413695|NCT00266058|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6413696|NCT00266058|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6413697|NCT00266058|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6413698|NCT00266058|Protease Inhibitors|protease inhibitors|mesh-ancestor
6413699|NCT00266058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6413700|NCT00266058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413701|NCT00266058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6413702|NCT00266058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6413703|NCT00266058|Antiviral Agents|antiviral agents|mesh-ancestor
6413704|NCT00266058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6413705|NCT00266058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6413706|NCT00266058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6413707|NCT00266058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6413708|NCT00266058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6413709|NCT00266058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6413710|NCT00266058|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6413711|NCT00266058|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6413712|NCT00266058|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6413713|NCT00266058|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6413714|NCT00266058|Antimalarials|antimalarials|mesh-ancestor
6413715|NCT00266058|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6413716|NCT00266058|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6413717|NCT00266097|Gemcitabine|gemcitabine|mesh-list
6413718|NCT00266097|Oxaliplatin|oxaliplatin|mesh-list
6413719|NCT00266097|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6413720|NCT00266097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6413721|NCT00266097|Antimetabolites|antimetabolites|mesh-ancestor
6413722|NCT00266097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413723|NCT00266097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6413724|NCT00266097|Antiviral Agents|antiviral agents|mesh-ancestor
6413725|NCT00266097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6413726|NCT00266097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6413727|NCT00266097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6413728|NCT00266097|Immunologic Factors|immunologic factors|mesh-ancestor
6413729|NCT00266097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413730|NCT00266097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6413731|NCT00266123|Sirolimus|sirolimus|mesh-list
6413732|NCT00266123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6413733|NCT00266123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6413734|NCT00266123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6413735|NCT00266123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6413736|NCT00266123|Antifungal Agents|antifungal agents|mesh-ancestor
6413737|NCT00266123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6413738|NCT00266123|Immunologic Factors|immunologic factors|mesh-ancestor
6413739|NCT00266123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413740|NCT00266136|Cytarabine|cytarabine|mesh-list
6413741|NCT00266136|Cyclophosphamide|cyclophosphamide|mesh-list
6413742|NCT00266136|Daunorubicin|daunorubicin|mesh-list
6413743|NCT00266136|Thioguanine|thioguanine|mesh-list
6413744|NCT00266136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6413745|NCT00266136|Immunologic Factors|immunologic factors|mesh-ancestor
6413746|NCT00266136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413747|NCT00266136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6413748|NCT00266136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6413749|NCT00266136|Alkylating Agents|alkylating agents|mesh-ancestor
6413750|NCT00266136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413751|NCT00266136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6413752|NCT00266136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6413753|NCT00266136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6413754|NCT00266136|Antimetabolites|antimetabolites|mesh-ancestor
6413755|NCT00266136|Antiviral Agents|antiviral agents|mesh-ancestor
6413756|NCT00266136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6413757|NCT00266136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6413758|NCT00266136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6413759|NCT00266136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6413760|NCT00266136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6413761|NCT00266149|Lamotrigine|lamotrigine|mesh-list
6413762|NCT00266149|Anticonvulsants|anticonvulsants|mesh-ancestor
6413763|NCT00266149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6413764|NCT00266149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6413765|NCT00266149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413766|NCT00266149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6413767|NCT00266149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413768|NCT00266149|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6413769|NCT00266149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6413770|NCT00266149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6413771|NCT00266149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6413772|NCT00266149|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6413773|NCT00266162|Bosentan|bosentan|mesh-list
6413774|NCT00266162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6413775|NCT00266162|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6413776|NCT00266162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413777|NCT00266214|Lidocaine|lidocaine|mesh-list
6413778|NCT00266214|Anesthetics, Local|anesthetics, local|mesh-ancestor
6413779|NCT00266214|Anesthetics|anesthetics|mesh-ancestor
6413780|NCT00266214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6413781|NCT00266214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413782|NCT00266214|Sensory System Agents|sensory system agents|mesh-ancestor
6413783|NCT00266214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6413784|NCT00266214|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6413785|NCT00266214|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6413786|NCT00266214|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6413787|NCT00266214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6413788|NCT00266214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413789|NCT00266253|Metformin|metformin|mesh-list
6413790|NCT00266253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6413791|NCT00266253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413792|NCT00266318|Interferons|interferons|mesh-list
6413793|NCT00266318|Ribavirin|ribavirin|mesh-list
6413794|NCT00266318|Interferon alfacon-1|interferon alfacon-1|mesh-list
6413795|NCT00266318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6413796|NCT00266318|Antiviral Agents|antiviral agents|mesh-ancestor
6413797|NCT00266318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6413798|NCT00266318|Antimetabolites|antimetabolites|mesh-ancestor
6413799|NCT00266318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413800|NCT00266344|Gaboxadol|gaboxadol|mesh-list
6413801|NCT00266344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6413802|NCT00266344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413803|NCT00266344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413804|NCT00266344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6413805|NCT00266344|Analgesics|analgesics|mesh-ancestor
6413806|NCT00266344|Sensory System Agents|sensory system agents|mesh-ancestor
6413807|NCT00266344|Anticonvulsants|anticonvulsants|mesh-ancestor
6413808|NCT00266344|GABA Agonists|gaba agonists|mesh-ancestor
6413809|NCT00266344|GABA Agents|gaba agents|mesh-ancestor
6413810|NCT00266357|Gaboxadol|gaboxadol|mesh-list
6413811|NCT00266357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6413812|NCT00266357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413813|NCT00266357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413814|NCT00266357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6413815|NCT00266357|Analgesics|analgesics|mesh-ancestor
6413816|NCT00266357|Sensory System Agents|sensory system agents|mesh-ancestor
6413817|NCT00266357|Anticonvulsants|anticonvulsants|mesh-ancestor
6413818|NCT00266357|GABA Agonists|gaba agonists|mesh-ancestor
6413819|NCT00266357|GABA Agents|gaba agents|mesh-ancestor
6413820|NCT00266448|Chlorhexidine|chlorhexidine|mesh-list
6413821|NCT00266448|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6413822|NCT00266448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6413823|NCT00266448|Disinfectants|disinfectants|mesh-ancestor
6413824|NCT00266487|Vitamins|vitamins|mesh-list
6413825|NCT00266487|Folic Acid|folic acid|mesh-list
6413826|NCT00266487|Vitamin B 12|vitamin b 12|mesh-list
6413827|NCT00266487|Hydroxocobalamin|hydroxocobalamin|mesh-list
6413828|NCT00266487|Vitamin B 6|vitamin b 6|mesh-list
6413829|NCT00266487|Pyridoxal|pyridoxal|mesh-list
6413830|NCT00266487|Pyridoxine|pyridoxine|mesh-list
6413831|NCT00266487|Vitamin B Complex|vitamin b complex|mesh-list
6413832|NCT00266487|Micronutrients|micronutrients|mesh-ancestor
6413833|NCT00266487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413834|NCT00266487|Hematinics|hematinics|mesh-ancestor
6413835|NCT00266539|Fentanyl|fentanyl|mesh-list
6413836|NCT00266539|Morphine|morphine|mesh-list
6413837|NCT00266539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6413838|NCT00266539|Narcotics|narcotics|mesh-ancestor
6413839|NCT00266539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6413840|NCT00266539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413841|NCT00266539|Analgesics|analgesics|mesh-ancestor
6413842|NCT00266539|Sensory System Agents|sensory system agents|mesh-ancestor
6413843|NCT00266539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6413844|NCT00266539|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6413845|NCT00266539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6413846|NCT00266539|Anesthetics, General|anesthetics, general|mesh-ancestor
6413847|NCT00266539|Anesthetics|anesthetics|mesh-ancestor
6413848|NCT00266552|Risperidone|risperidone|mesh-list
6413849|NCT00266552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6413850|NCT00266552|Serotonin Agents|serotonin agents|mesh-ancestor
6413851|NCT00266552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6413852|NCT00266552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413853|NCT00266552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413854|NCT00266552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6413855|NCT00266552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6413856|NCT00266552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6413857|NCT00266552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6413858|NCT00266552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6413859|NCT00266552|Dopamine Agents|dopamine agents|mesh-ancestor
6413860|NCT00266578|Fluticasone|fluticasone|mesh-list
6413861|NCT00266578|Xhance|xhance|mesh-list
6413862|NCT00266578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6413863|NCT00266578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6413864|NCT00266578|Autonomic Agents|autonomic agents|mesh-ancestor
6413865|NCT00266578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6413866|NCT00266578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413867|NCT00266578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6413868|NCT00266578|Respiratory System Agents|respiratory system agents|mesh-ancestor
6413869|NCT00266578|Dermatologic Agents|dermatologic agents|mesh-ancestor
6413870|NCT00266578|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6413871|NCT00266591|Topiramate|topiramate|mesh-list
6413872|NCT00266591|Anticonvulsants|anticonvulsants|mesh-ancestor
6413873|NCT00266591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6413874|NCT00266591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413875|NCT00266604|Topiramate|topiramate|mesh-list
6413876|NCT00266604|Anticonvulsants|anticonvulsants|mesh-ancestor
6413877|NCT00266604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6413878|NCT00266604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413879|NCT00266617|Epoetin Alfa|epoetin alfa|mesh-list
6413880|NCT00266617|Hematinics|hematinics|mesh-ancestor
6413881|NCT00266643|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6413882|NCT00266643|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6413883|NCT00266643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6413884|NCT00266643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6413885|NCT00266643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413886|NCT00266643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6413887|NCT00266643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413888|NCT00266643|Analgesics|analgesics|mesh-ancestor
6413889|NCT00266643|Sensory System Agents|sensory system agents|mesh-ancestor
6413890|NCT00266643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6413891|NCT00266643|Antidepressive Agents|antidepressive agents|mesh-ancestor
6413892|NCT00266643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6413893|NCT00266643|Dopamine Agents|dopamine agents|mesh-ancestor
6413894|NCT00266669|Nitroglycerin|nitroglycerin|mesh-list
6413895|NCT00266669|Vasodilator Agents|vasodilator agents|mesh-ancestor
6413896|NCT00266721|Pancrelipase|pancrelipase|mesh-list
6413897|NCT00266721|Pancreatin|pancreatin|mesh-list
6413898|NCT00266721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6413899|NCT00266747|Amibegron|amibegron|mesh-list
6413900|NCT00266747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6018840|NCT00382733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6018841|NCT00382824|Ubiquinone|ubiquinone|mesh-list
6018842|NCT00382824|Coenzyme Q10|coenzyme q10|mesh-list
6018843|NCT00382824|Micronutrients|micronutrients|mesh-ancestor
6413901|NCT00266747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6413902|NCT00266747|Adrenergic Agents|adrenergic agents|mesh-ancestor
6413903|NCT00266747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6413904|NCT00266747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413905|NCT00266747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413906|NCT00266786|Ketorolac|ketorolac|mesh-list
6413907|NCT00266786|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6413908|NCT00266786|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6413909|NCT00266786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6413910|NCT00266786|Analgesics|analgesics|mesh-ancestor
6413911|NCT00266786|Sensory System Agents|sensory system agents|mesh-ancestor
6413912|NCT00266786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6413913|NCT00266786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413914|NCT00266786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6413915|NCT00266786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6413916|NCT00266786|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6413917|NCT00266786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6413918|NCT00266786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413919|NCT00266838|Dexamethasone|dexamethasone|mesh-list
6413920|NCT00266838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6413921|NCT00266838|Antiemetics|antiemetics|mesh-ancestor
6413922|NCT00266838|Autonomic Agents|autonomic agents|mesh-ancestor
6413923|NCT00266838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6413924|NCT00266838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413925|NCT00266838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6413926|NCT00266838|Glucocorticoids|glucocorticoids|mesh-ancestor
6413927|NCT00266838|Hormones|hormones|mesh-ancestor
6413928|NCT00266838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6413929|NCT00266838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6413930|NCT00266838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6413931|NCT00267163|Donepezil|donepezil|mesh-list
6413932|NCT00267163|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6413933|NCT00267163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6413934|NCT00267163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413935|NCT00267163|Cholinergic Agents|cholinergic agents|mesh-ancestor
6413936|NCT00267163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6413937|NCT00267163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413938|NCT00267163|Nootropic Agents|nootropic agents|mesh-ancestor
6413939|NCT00267176|Lumiracoxib|lumiracoxib|mesh-list
6413940|NCT00267176|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6413941|NCT00267176|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6413942|NCT00267176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6413943|NCT00267176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413944|NCT00267176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6413945|NCT00267176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6018844|NCT00382824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413946|NCT00267176|Analgesics|analgesics|mesh-ancestor
6413947|NCT00267176|Sensory System Agents|sensory system agents|mesh-ancestor
6413948|NCT00267176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6413949|NCT00267176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413950|NCT00267176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6413951|NCT00267176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6413952|NCT00267215|Lumiracoxib|lumiracoxib|mesh-list
6413953|NCT00267215|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6413954|NCT00267215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6413955|NCT00267215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6413956|NCT00267215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413957|NCT00267215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6413958|NCT00267215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6413959|NCT00267215|Analgesics|analgesics|mesh-ancestor
6413960|NCT00267215|Sensory System Agents|sensory system agents|mesh-ancestor
6413961|NCT00267215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6413962|NCT00267215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413963|NCT00267215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6413964|NCT00267215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6413965|NCT00267254|Atorvastatin|atorvastatin|mesh-list
6413966|NCT00267254|Simvastatin|simvastatin|mesh-list
6413967|NCT00267254|Torcetrapib|torcetrapib|mesh-list
6413968|NCT00267254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6413969|NCT00267254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6413970|NCT00267254|Antimetabolites|antimetabolites|mesh-ancestor
6413971|NCT00267254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413972|NCT00267254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6413973|NCT00267254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6413974|NCT00267254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6413975|NCT00267267|Atorvastatin|atorvastatin|mesh-list
6413976|NCT00267267|Simvastatin|simvastatin|mesh-list
6413977|NCT00267267|Ezetimibe|ezetimibe|mesh-list
6413978|NCT00267267|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
6413979|NCT00267267|Torcetrapib|torcetrapib|mesh-list
6413980|NCT00267267|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6413981|NCT00267267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6413982|NCT00267267|Antimetabolites|antimetabolites|mesh-ancestor
6413983|NCT00267267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6413984|NCT00267267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6413985|NCT00267267|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6413986|NCT00267267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6413987|NCT00267306|Visilizumab|visilizumab|mesh-list
6413988|NCT00267306|Immunologic Factors|immunologic factors|mesh-ancestor
6413989|NCT00267306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413990|NCT00267319|Glatiramer Acetate|glatiramer acetate|mesh-list
6413991|NCT00267319|(T,G)-A-L|(t,g)-a-l|mesh-list
6413992|NCT00267319|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6413993|NCT00267319|Immunologic Factors|immunologic factors|mesh-ancestor
6413994|NCT00267319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6413995|NCT00267319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6413996|NCT00267319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6413997|NCT00267332|Modafinil|modafinil|mesh-list
5501246|NCT04476173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501247|NCT04476173|Analgesics|analgesics|mesh-ancestor
5501248|NCT04476173|Sensory System Agents|sensory system agents|mesh-ancestor
5501249|NCT04476173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5501250|NCT04476173|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5501251|NCT04476173|Anesthetics, General|anesthetics, general|mesh-ancestor
5501252|NCT04476173|Anesthetics|anesthetics|mesh-ancestor
5501253|NCT04476186|Acyclovir|acyclovir|mesh-list
5501254|NCT04476186|Antiviral Agents|antiviral agents|mesh-ancestor
5501255|NCT04476186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5501256|NCT04476069|Ibuprofen|ibuprofen|mesh-list
5501257|NCT04476069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5501258|NCT04476069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5501259|NCT04476069|Analgesics|analgesics|mesh-ancestor
5501260|NCT04476069|Sensory System Agents|sensory system agents|mesh-ancestor
6413998|NCT00267332|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6413999|NCT00267332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414000|NCT00267332|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6414001|NCT00267332|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6414002|NCT00267332|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6414003|NCT00267332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414004|NCT00267384|Acetylcysteine|acetylcysteine|mesh-list
6414005|NCT00267384|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6414006|NCT00267384|Antiviral Agents|antiviral agents|mesh-ancestor
6414007|NCT00267384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6414008|NCT00267384|Expectorants|expectorants|mesh-ancestor
6414009|NCT00267384|Respiratory System Agents|respiratory system agents|mesh-ancestor
6414010|NCT00267384|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6414011|NCT00267384|Antioxidants|antioxidants|mesh-ancestor
6414012|NCT00267384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414013|NCT00267384|Protective Agents|protective agents|mesh-ancestor
6414014|NCT00267384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414015|NCT00267384|Antidotes|antidotes|mesh-ancestor
6414016|NCT00267514|Sevelamer|sevelamer|mesh-list
6414017|NCT00267514|Chelating Agents|chelating agents|mesh-ancestor
6414018|NCT00267514|Sequestering Agents|sequestering agents|mesh-ancestor
6414019|NCT00267514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501261|NCT04476069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5501262|NCT04476069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501263|NCT04476069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5501264|NCT04476069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5501265|NCT04476069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5501266|NCT04476069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6414020|NCT00267540|Cholecalciferol|cholecalciferol|mesh-list
6414021|NCT00267540|Vitamins|vitamins|mesh-ancestor
6414022|NCT00267540|Micronutrients|micronutrients|mesh-ancestor
5501267|NCT04476069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501268|NCT04476199|Decitabine|decitabine|mesh-list
5501269|NCT04476199|Venetoclax|venetoclax|mesh-list
5501270|NCT04476199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5501271|NCT04476199|Antimetabolites|antimetabolites|mesh-ancestor
5501272|NCT04476199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501273|NCT04476199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5501274|NCT04476199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6414023|NCT00267540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414024|NCT00267540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6414025|NCT00267540|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6414026|NCT00267553|Toremifene|toremifene|mesh-list
6414027|NCT00267553|Letrozole|letrozole|mesh-list
6414028|NCT00267553|Atamestane|atamestane|mesh-list
6414029|NCT00267553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6414030|NCT00267553|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6414031|NCT00267553|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5501275|NCT04475705|Propofol|propofol|mesh-list
5501276|NCT04475705|Sevoflurane|sevoflurane|mesh-list
6414032|NCT00267553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6414033|NCT00267553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414034|NCT00267553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6414035|NCT00267553|Hormone Antagonists|hormone antagonists|mesh-ancestor
6414036|NCT00267553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6414037|NCT00267553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414038|NCT00267553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6414039|NCT00267553|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6414040|NCT00267553|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6414041|NCT00267553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6414042|NCT00267657|Reserpine|reserpine|mesh-list
6414043|NCT00267657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6414044|NCT00267657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6414045|NCT00267657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6414046|NCT00267657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6414047|NCT00267657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414048|NCT00267657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6414049|NCT00267657|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6414050|NCT00267657|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6414051|NCT00267657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6414052|NCT00267657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414053|NCT00267657|Adrenergic Agents|adrenergic agents|mesh-ancestor
6414054|NCT00267657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6414055|NCT00267683|Insulin Aspart|insulin aspart|mesh-list
6414056|NCT00267683|Glyburide|glyburide|mesh-list
6414057|NCT00267683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6414058|NCT00267683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414059|NCT00267709|Visilizumab|visilizumab|mesh-list
6414060|NCT00267709|Immunologic Factors|immunologic factors|mesh-ancestor
6414061|NCT00267709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414062|NCT00267722|Visilizumab|visilizumab|mesh-list
6414063|NCT00267722|Immunologic Factors|immunologic factors|mesh-ancestor
6414064|NCT00267722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414065|NCT00267813|Bupropion|bupropion|mesh-list
6414066|NCT00267813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6414067|NCT00267813|Antidepressive Agents|antidepressive agents|mesh-ancestor
6414068|NCT00267813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6414069|NCT00267813|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6414070|NCT00267813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6414071|NCT00267813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6414072|NCT00267813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414073|NCT00267813|Dopamine Agents|dopamine agents|mesh-ancestor
6414074|NCT00267813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6414075|NCT00267813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414076|NCT00267813|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6414077|NCT00267813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6414078|NCT00267813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6414079|NCT00267826|Rituximab|rituximab|mesh-list
6414080|NCT00267826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6414081|NCT00267826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6414082|NCT00267826|Immunologic Factors|immunologic factors|mesh-ancestor
6414083|NCT00267826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414084|NCT00267826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6460003|NCT00447759|Ibuprofen|ibuprofen|mesh-list
6460004|NCT00447759|Celecoxib|celecoxib|mesh-list
6460005|NCT00447759|Diclofenac|diclofenac|mesh-list
6460006|NCT00447759|Naproxen|naproxen|mesh-list
6460007|NCT00447759|Meloxicam|meloxicam|mesh-list
6460008|NCT00447759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6460009|NCT00447759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6460010|NCT00447759|Analgesics|analgesics|mesh-ancestor
6460011|NCT00447759|Sensory System Agents|sensory system agents|mesh-ancestor
6460012|NCT00447759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6414085|NCT00267917|Fenoterol|fenoterol|mesh-list
6414086|NCT00267917|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
6414087|NCT00267917|Ipratropium|ipratropium|mesh-list
6414088|NCT00267917|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6414089|NCT00267917|Autonomic Agents|autonomic agents|mesh-ancestor
6414090|NCT00267917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6414091|NCT00267917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414092|NCT00267917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6414093|NCT00267917|Respiratory System Agents|respiratory system agents|mesh-ancestor
6414094|NCT00267917|Sympathomimetics|sympathomimetics|mesh-ancestor
6414095|NCT00267917|Tocolytic Agents|tocolytic agents|mesh-ancestor
6414096|NCT00267917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6414097|NCT00267917|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6414098|NCT00267917|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6414099|NCT00267917|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6414100|NCT00267917|Adrenergic Agents|adrenergic agents|mesh-ancestor
6414101|NCT00267917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6414102|NCT00267917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414103|NCT00267917|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6414104|NCT00267917|Cholinergic Agents|cholinergic agents|mesh-ancestor
6414105|NCT00267943|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6414106|NCT00267943|Telmisartan|telmisartan|mesh-list
6414107|NCT00267943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6414108|NCT00267943|Diuretics|diuretics|mesh-ancestor
6414109|NCT00267943|Natriuretic Agents|natriuretic agents|mesh-ancestor
6414110|NCT00267943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414111|NCT00267943|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6414112|NCT00267943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6414113|NCT00267943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414114|NCT00267943|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6414115|NCT00267943|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6414116|NCT00268138|Fluorides|fluorides|mesh-list
6414117|NCT00268138|Cariostatic Agents|cariostatic agents|mesh-ancestor
6414118|NCT00268138|Protective Agents|protective agents|mesh-ancestor
6414119|NCT00268138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414120|NCT00268151|Capecitabine|capecitabine|mesh-list
6414121|NCT00268151|Oxaliplatin|oxaliplatin|mesh-list
6414122|NCT00268151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6414123|NCT00268151|Antimetabolites|antimetabolites|mesh-ancestor
6414124|NCT00268151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414125|NCT00268151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6414126|NCT00268177|Fluticasone|fluticasone|mesh-list
6414127|NCT00268177|Xhance|xhance|mesh-list
6414128|NCT00268177|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6414129|NCT00268177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6414130|NCT00268177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6414131|NCT00268177|Autonomic Agents|autonomic agents|mesh-ancestor
6414132|NCT00268177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6414133|NCT00268177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414134|NCT00268177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6414135|NCT00268177|Respiratory System Agents|respiratory system agents|mesh-ancestor
6414136|NCT00268177|Dermatologic Agents|dermatologic agents|mesh-ancestor
6414137|NCT00268177|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6414138|NCT00268177|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6414139|NCT00268177|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6414140|NCT00268177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6414141|NCT00268177|Adrenergic Agents|adrenergic agents|mesh-ancestor
6414142|NCT00268177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6414143|NCT00268177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414144|NCT00268216|Fluticasone|fluticasone|mesh-list
6414145|NCT00268216|Xhance|xhance|mesh-list
6414146|NCT00268216|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6414147|NCT00268216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6414148|NCT00268216|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6414149|NCT00268216|Autonomic Agents|autonomic agents|mesh-ancestor
6414150|NCT00268216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6414151|NCT00268216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414152|NCT00268216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6414153|NCT00268216|Respiratory System Agents|respiratory system agents|mesh-ancestor
6414154|NCT00268216|Dermatologic Agents|dermatologic agents|mesh-ancestor
6414155|NCT00268216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6414156|NCT00268216|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6414157|NCT00268216|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6414158|NCT00268216|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6414159|NCT00268216|Adrenergic Agents|adrenergic agents|mesh-ancestor
6414160|NCT00268216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6414161|NCT00268216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414162|NCT00268229|Cytarabine|cytarabine|mesh-list
6414163|NCT00268229|Imatinib Mesylate|imatinib mesylate|mesh-list
6414164|NCT00268229|Daunorubicin|daunorubicin|mesh-list
6414165|NCT00268229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6414166|NCT00268229|Antimetabolites|antimetabolites|mesh-ancestor
6414167|NCT00268229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414168|NCT00268229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6414169|NCT00268229|Antiviral Agents|antiviral agents|mesh-ancestor
6414170|NCT00268229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6414171|NCT00268229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6414172|NCT00268229|Immunologic Factors|immunologic factors|mesh-ancestor
6414173|NCT00268229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414174|NCT00268229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6414175|NCT00268229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6414176|NCT00268229|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6414177|NCT00268229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6414178|NCT00268229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6414179|NCT00268255|Gefitinib|gefitinib|mesh-list
6414180|NCT00268255|Enzyme Inhibitors|enzyme inhibitors|mesh-list
6414181|NCT00268255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6414182|NCT00268255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6414183|NCT00268255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414184|NCT00268333|Leucovorin|leucovorin|mesh-list
6414185|NCT00268333|Fluorouracil|fluorouracil|mesh-list
6414186|NCT00268333|Oxaliplatin|oxaliplatin|mesh-list
6414187|NCT00268333|Calcium|calcium|mesh-list
6414188|NCT00268333|Levoleucovorin|levoleucovorin|mesh-list
6414189|NCT00268333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6414190|NCT00268333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414191|NCT00268333|Antimetabolites|antimetabolites|mesh-ancestor
6414192|NCT00268333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414193|NCT00268333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6414194|NCT00268333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6414195|NCT00268333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6414196|NCT00268333|Immunologic Factors|immunologic factors|mesh-ancestor
6414197|NCT00268333|Antidotes|antidotes|mesh-ancestor
6414198|NCT00268333|Protective Agents|protective agents|mesh-ancestor
6414199|NCT00268333|Vitamin B Complex|vitamin b complex|mesh-ancestor
6414200|NCT00268333|Vitamins|vitamins|mesh-ancestor
6414201|NCT00268333|Micronutrients|micronutrients|mesh-ancestor
6414202|NCT00268359|Bevacizumab|bevacizumab|mesh-list
6414203|NCT00268359|Irinotecan|irinotecan|mesh-list
6414204|NCT00268359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6414205|NCT00268359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6414206|NCT00268359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6414207|NCT00268359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6414208|NCT00268359|Growth Substances|growth substances|mesh-ancestor
6414209|NCT00268359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414210|NCT00268359|Growth Inhibitors|growth inhibitors|mesh-ancestor
6414211|NCT00268359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6414212|NCT00268359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6414213|NCT00268359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6414214|NCT00268359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414215|NCT00268372|Docetaxel|docetaxel|mesh-list
6414216|NCT00268372|Fluorouracil|fluorouracil|mesh-list
6414217|NCT00268372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6414218|NCT00268372|Tubulin Modulators|tubulin modulators|mesh-ancestor
6414219|NCT00268372|Antimitotic Agents|antimitotic agents|mesh-ancestor
5724698|NCT03185364|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6414220|NCT00268372|Mitosis Modulators|mitosis modulators|mesh-ancestor
6414221|NCT00268372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414222|NCT00268372|Antimetabolites|antimetabolites|mesh-ancestor
6414223|NCT00268372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6414224|NCT00268372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6414225|NCT00268372|Immunologic Factors|immunologic factors|mesh-ancestor
6414226|NCT00268372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414227|NCT00268398|Leucovorin|leucovorin|mesh-list
6414228|NCT00268398|Folic Acid|folic acid|mesh-list
6414229|NCT00268398|Fluorouracil|fluorouracil|mesh-list
6414230|NCT00268398|Oxaliplatin|oxaliplatin|mesh-list
6414231|NCT00268398|Irinotecan|irinotecan|mesh-list
6414232|NCT00268398|Levoleucovorin|levoleucovorin|mesh-list
6414233|NCT00268398|Antimetabolites|antimetabolites|mesh-ancestor
6414234|NCT00268398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414235|NCT00268398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6414236|NCT00268398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6414237|NCT00268398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6414238|NCT00268398|Immunologic Factors|immunologic factors|mesh-ancestor
6414239|NCT00268398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414240|NCT00268398|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6414241|NCT00268398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6414242|NCT00268398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6414243|NCT00268398|Antidotes|antidotes|mesh-ancestor
6414244|NCT00268398|Protective Agents|protective agents|mesh-ancestor
6414245|NCT00268398|Vitamin B Complex|vitamin b complex|mesh-ancestor
6414246|NCT00268398|Vitamins|vitamins|mesh-ancestor
6414247|NCT00268398|Micronutrients|micronutrients|mesh-ancestor
6414248|NCT00268398|Hematinics|hematinics|mesh-ancestor
6414249|NCT00268411|Gemcitabine|gemcitabine|mesh-list
6414250|NCT00268411|Oxaliplatin|oxaliplatin|mesh-list
6414251|NCT00268411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6414252|NCT00268411|Antimetabolites|antimetabolites|mesh-ancestor
6414253|NCT00268411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414254|NCT00268411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6414255|NCT00268411|Antiviral Agents|antiviral agents|mesh-ancestor
6414256|NCT00268411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6414257|NCT00268411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6414258|NCT00268411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6414259|NCT00268411|Immunologic Factors|immunologic factors|mesh-ancestor
6414260|NCT00268411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414261|NCT00268476|Zoledronic Acid|zoledronic acid|mesh-list
6414262|NCT00268476|Metformin|metformin|mesh-list
6414263|NCT00268476|Prednisone|prednisone|mesh-list
6414264|NCT00268476|Prednisolone|prednisolone|mesh-list
6414265|NCT00268476|Celecoxib|celecoxib|mesh-list
6414266|NCT00268476|Docetaxel|docetaxel|mesh-list
6414267|NCT00268476|Estradiol|estradiol|mesh-list
6414268|NCT00268476|Androgens|androgens|mesh-list
6414269|NCT00268476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6414270|NCT00268476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414271|NCT00268476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6414272|NCT00268476|Tubulin Modulators|tubulin modulators|mesh-ancestor
6414273|NCT00268476|Antimitotic Agents|antimitotic agents|mesh-ancestor
6414274|NCT00268476|Mitosis Modulators|mitosis modulators|mesh-ancestor
6414275|NCT00268476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414276|NCT00268476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6414277|NCT00268476|Glucocorticoids|glucocorticoids|mesh-ancestor
6414278|NCT00268476|Hormones|hormones|mesh-ancestor
6414279|NCT00268476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6414280|NCT00268476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6414281|NCT00268476|Estrogens|estrogens|mesh-ancestor
6414282|NCT00268476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6414283|NCT00268476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6414284|NCT00268476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6414285|NCT00268476|Analgesics|analgesics|mesh-ancestor
6414286|NCT00268476|Sensory System Agents|sensory system agents|mesh-ancestor
6414287|NCT00268476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6414288|NCT00268476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6414289|NCT00268476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6414290|NCT00268476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6414291|NCT00268476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6414292|NCT00268489|Bevacizumab|bevacizumab|mesh-list
6414293|NCT00268489|Pemetrexed|pemetrexed|mesh-list
6414294|NCT00268489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6414295|NCT00268489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6414296|NCT00268489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6414297|NCT00268489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6414298|NCT00268489|Growth Substances|growth substances|mesh-ancestor
6018845|NCT00382824|Vitamins|vitamins|mesh-ancestor
6018846|NCT00382993|Naproxen|naproxen|mesh-list
6018847|NCT00382993|Sumatriptan|sumatriptan|mesh-list
6018848|NCT00382993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6018849|NCT00382993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6018850|NCT00382993|Analgesics|analgesics|mesh-ancestor
6018851|NCT00382993|Sensory System Agents|sensory system agents|mesh-ancestor
6018852|NCT00382993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6018853|NCT00382993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018854|NCT00382993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6018855|NCT00382993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6018856|NCT00382993|Gout Suppressants|gout suppressants|mesh-ancestor
6018857|NCT00382993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6018858|NCT00382993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6414299|NCT00268489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414300|NCT00268489|Growth Inhibitors|growth inhibitors|mesh-ancestor
6414301|NCT00268489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6414302|NCT00268489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414303|NCT00268489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6414304|NCT00268489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6414305|NCT00268515|Cyclosporine|cyclosporine|mesh-list
6414306|NCT00268515|Prednisone|prednisone|mesh-list
6414307|NCT00268515|Azathioprine|azathioprine|mesh-list
6414308|NCT00268515|Tacrolimus|tacrolimus|mesh-list
6414309|NCT00268515|Cyclosporins|cyclosporins|mesh-list
6414310|NCT00268515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6414311|NCT00268515|Glucocorticoids|glucocorticoids|mesh-ancestor
6414312|NCT00268515|Hormones|hormones|mesh-ancestor
6414313|NCT00268515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6414314|NCT00268515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414315|NCT00268515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6414316|NCT00268515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6414317|NCT00268515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6414318|NCT00268515|Immunologic Factors|immunologic factors|mesh-ancestor
6414319|NCT00268515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6414320|NCT00268515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6414321|NCT00268515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414322|NCT00268515|Antifungal Agents|antifungal agents|mesh-ancestor
6414323|NCT00268515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6414324|NCT00268515|Dermatologic Agents|dermatologic agents|mesh-ancestor
6414325|NCT00268515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6414326|NCT00268515|Antimetabolites|antimetabolites|mesh-ancestor
6414327|NCT00268515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6414328|NCT00268528|Methotrexate|methotrexate|mesh-list
6414329|NCT00268528|Mercaptopurine|mercaptopurine|mesh-list
6414330|NCT00268528|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6414331|NCT00268528|Abortifacient Agents|abortifacient agents|mesh-ancestor
6414332|NCT00268528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6414333|NCT00268528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414334|NCT00268528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6414335|NCT00268528|Antimetabolites|antimetabolites|mesh-ancestor
6414336|NCT00268528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414337|NCT00268528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6414338|NCT00268528|Dermatologic Agents|dermatologic agents|mesh-ancestor
6414339|NCT00268528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6414340|NCT00268528|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6414341|NCT00268528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6414342|NCT00268528|Immunologic Factors|immunologic factors|mesh-ancestor
6414343|NCT00268528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6414344|NCT00268528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6414345|NCT00268554|Dipyridamole|dipyridamole|mesh-list
6414346|NCT00268554|Caffeine|caffeine|mesh-list
6414347|NCT00268554|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6414348|NCT00268554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414349|NCT00268554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6414350|NCT00268554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6414351|NCT00268554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414352|NCT00268554|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6414353|NCT00268554|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6414354|NCT00268554|Purinergic Agents|purinergic agents|mesh-ancestor
6414355|NCT00268554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6414356|NCT00268554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6414357|NCT00268554|Vasodilator Agents|vasodilator agents|mesh-ancestor
6414358|NCT00268567|Prednisone|prednisone|mesh-list
6414359|NCT00268567|Leflunomide|leflunomide|mesh-list
6414360|NCT00268567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6414361|NCT00268567|Glucocorticoids|glucocorticoids|mesh-ancestor
6414362|NCT00268567|Hormones|hormones|mesh-ancestor
6414363|NCT00268567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6414364|NCT00268567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414365|NCT00268567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6414366|NCT00268567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6414367|NCT00268567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6414368|NCT00268567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414369|NCT00268567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6414370|NCT00268567|Immunologic Factors|immunologic factors|mesh-ancestor
6414371|NCT00268593|Prednisone|prednisone|mesh-list
6414372|NCT00268593|Docetaxel|docetaxel|mesh-list
6414373|NCT00268593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6414374|NCT00268593|Tubulin Modulators|tubulin modulators|mesh-ancestor
6414375|NCT00268593|Antimitotic Agents|antimitotic agents|mesh-ancestor
6414376|NCT00268593|Mitosis Modulators|mitosis modulators|mesh-ancestor
6414377|NCT00268593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414378|NCT00268593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6414379|NCT00268593|Glucocorticoids|glucocorticoids|mesh-ancestor
6414380|NCT00268593|Hormones|hormones|mesh-ancestor
6414381|NCT00268593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6414382|NCT00268593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414383|NCT00268593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6414384|NCT00268619|Ramipril|ramipril|mesh-list
6414385|NCT00268619|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6414386|NCT00268619|Protease Inhibitors|protease inhibitors|mesh-ancestor
6414387|NCT00268619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6414388|NCT00268619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414389|NCT00268619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6414390|NCT00268632|Risedronic Acid|risedronic acid|mesh-list
6414391|NCT00268632|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6414392|NCT00268632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6414393|NCT00268632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414394|NCT00268632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6414395|NCT00268632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414396|NCT00268632|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6414397|NCT00268645|Insulin Glargine|insulin glargine|mesh-list
6414398|NCT00268645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6414399|NCT00268645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414400|NCT00268671|Docetaxel|docetaxel|mesh-list
6414401|NCT00268671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6414402|NCT00268671|Tubulin Modulators|tubulin modulators|mesh-ancestor
6414403|NCT00268671|Antimitotic Agents|antimitotic agents|mesh-ancestor
6414404|NCT00268671|Mitosis Modulators|mitosis modulators|mesh-ancestor
6414405|NCT00268671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414406|NCT00268684|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6414407|NCT00268684|Temozolomide|temozolomide|mesh-list
6414408|NCT00268684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6414409|NCT00268684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6414410|NCT00268684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6414411|NCT00268684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414412|NCT00268684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6414413|NCT00268684|Alkylating Agents|alkylating agents|mesh-ancestor
6414414|NCT00268697|Ezetimibe|ezetimibe|mesh-list
6414415|NCT00268697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6414416|NCT00268697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6414417|NCT00268697|Antimetabolites|antimetabolites|mesh-ancestor
6414418|NCT00268697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414419|NCT00268697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6414420|NCT00268710|Docetaxel|docetaxel|mesh-list
6414421|NCT00268710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6414422|NCT00268710|Tubulin Modulators|tubulin modulators|mesh-ancestor
6414423|NCT00268710|Antimitotic Agents|antimitotic agents|mesh-ancestor
6414424|NCT00268710|Mitosis Modulators|mitosis modulators|mesh-ancestor
6414425|NCT00268710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414426|NCT00268723|Albuterol|albuterol|mesh-list
6414427|NCT00268723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6414428|NCT00268723|Autonomic Agents|autonomic agents|mesh-ancestor
6414429|NCT00268723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6414430|NCT00268723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414431|NCT00268723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6414432|NCT00268723|Respiratory System Agents|respiratory system agents|mesh-ancestor
6414433|NCT00268723|Tocolytic Agents|tocolytic agents|mesh-ancestor
6414434|NCT00268723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6414435|NCT00268723|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6414436|NCT00268723|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6414437|NCT00268723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6414438|NCT00268723|Adrenergic Agents|adrenergic agents|mesh-ancestor
6414439|NCT00268723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6414440|NCT00268723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414441|NCT00268749|Glycine|glycine|mesh-list
6414442|NCT00268749|Glycine Agents|glycine agents|mesh-ancestor
6414443|NCT00268749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6414444|NCT00268749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414445|NCT00268749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414446|NCT00268788|Immunoglobulins|immunoglobulins|mesh-list
6414447|NCT00268788|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6414448|NCT00268788|Antibodies|antibodies|mesh-list
6414449|NCT00268788|gamma-Globulins|gamma-globulins|mesh-list
6414450|NCT00268788|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6414451|NCT00268788|Immunologic Factors|immunologic factors|mesh-ancestor
6414452|NCT00268788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414453|NCT00268814|Methadone|methadone|mesh-list
6414454|NCT00268814|Heroin|heroin|mesh-list
6414455|NCT00268814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6414456|NCT00268814|Narcotics|narcotics|mesh-ancestor
6414457|NCT00268814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6414458|NCT00268814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414459|NCT00268814|Analgesics|analgesics|mesh-ancestor
6414460|NCT00268814|Sensory System Agents|sensory system agents|mesh-ancestor
6414461|NCT00268814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6414462|NCT00268814|Antitussive Agents|antitussive agents|mesh-ancestor
6414463|NCT00268814|Respiratory System Agents|respiratory system agents|mesh-ancestor
6414464|NCT00268827|Lopinavir|lopinavir|mesh-list
6414465|NCT00268827|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6414466|NCT00268827|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6414467|NCT00268827|Protease Inhibitors|protease inhibitors|mesh-ancestor
6414468|NCT00268827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6414469|NCT00268827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414470|NCT00268827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6414471|NCT00268827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6414472|NCT00268827|Antiviral Agents|antiviral agents|mesh-ancestor
6414473|NCT00268827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6414474|NCT00268827|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6414475|NCT00268827|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6414476|NCT00268840|Gemcitabine|gemcitabine|mesh-list
6414477|NCT00268840|Docetaxel|docetaxel|mesh-list
6414478|NCT00268840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6414479|NCT00268840|Antimetabolites|antimetabolites|mesh-ancestor
6414480|NCT00268840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414481|NCT00268840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6414482|NCT00268840|Antiviral Agents|antiviral agents|mesh-ancestor
6414483|NCT00268840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6414484|NCT00268840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6414485|NCT00268840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6414486|NCT00268840|Immunologic Factors|immunologic factors|mesh-ancestor
6414487|NCT00268840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414488|NCT00268840|Tubulin Modulators|tubulin modulators|mesh-ancestor
6414489|NCT00268840|Antimitotic Agents|antimitotic agents|mesh-ancestor
6414490|NCT00268840|Mitosis Modulators|mitosis modulators|mesh-ancestor
6414491|NCT00268879|Renzapride|renzapride|mesh-list
6414492|NCT00268879|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6414493|NCT00268879|Serotonin Agents|serotonin agents|mesh-ancestor
6414494|NCT00268879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6414495|NCT00268879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414496|NCT00268879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414497|NCT00268918|Docetaxel|docetaxel|mesh-list
6414498|NCT00268918|Vatalanib|vatalanib|mesh-list
6414499|NCT00268918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6414500|NCT00268918|Tubulin Modulators|tubulin modulators|mesh-ancestor
6414501|NCT00268918|Antimitotic Agents|antimitotic agents|mesh-ancestor
6414502|NCT00268918|Mitosis Modulators|mitosis modulators|mesh-ancestor
6414503|NCT00268918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414504|NCT00268918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6414505|NCT00268918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6414506|NCT00268957|Sevelamer|sevelamer|mesh-list
6414507|NCT00268957|Chelating Agents|chelating agents|mesh-ancestor
6414508|NCT00268957|Sequestering Agents|sequestering agents|mesh-ancestor
6414509|NCT00268957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414510|NCT00268970|Paclitaxel|paclitaxel|mesh-list
6414511|NCT00268970|Satraplatin|satraplatin|mesh-list
6414512|NCT00268970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6414513|NCT00268970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6414514|NCT00268970|Tubulin Modulators|tubulin modulators|mesh-ancestor
6414515|NCT00268970|Antimitotic Agents|antimitotic agents|mesh-ancestor
6414516|NCT00268970|Mitosis Modulators|mitosis modulators|mesh-ancestor
6414517|NCT00268970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538136|NCT00826163|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6538137|NCT00826163|Autonomic Agents|autonomic agents|mesh-ancestor
6538138|NCT00826163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6538139|NCT00826163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538140|NCT00826163|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6538141|NCT00826163|Respiratory System Agents|respiratory system agents|mesh-ancestor
6538142|NCT00826163|Glucocorticoids|glucocorticoids|mesh-ancestor
6538143|NCT00826163|Hormones|hormones|mesh-ancestor
6414518|NCT00269035|Risperidone|risperidone|mesh-list
6414519|NCT00269035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6414520|NCT00269035|Serotonin Agents|serotonin agents|mesh-ancestor
6414521|NCT00269035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6414522|NCT00269035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414523|NCT00269035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414524|NCT00269035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6414525|NCT00269035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6414526|NCT00269035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6414527|NCT00269035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6414528|NCT00269035|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6414529|NCT00269035|Dopamine Agents|dopamine agents|mesh-ancestor
6414530|NCT00269061|Pioglitazone|pioglitazone|mesh-list
6414531|NCT00269061|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6414532|NCT00269061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414533|NCT00269126|Fluticasone|fluticasone|mesh-list
6414534|NCT00269126|Xhance|xhance|mesh-list
6414535|NCT00269126|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6414536|NCT00269126|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6414537|NCT00269126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6414538|NCT00269126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6414539|NCT00269126|Autonomic Agents|autonomic agents|mesh-ancestor
6414540|NCT00269126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6414541|NCT00269126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414542|NCT00269126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6414543|NCT00269126|Respiratory System Agents|respiratory system agents|mesh-ancestor
6414544|NCT00269126|Dermatologic Agents|dermatologic agents|mesh-ancestor
6414545|NCT00269126|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6414546|NCT00269126|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6414547|NCT00269126|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6414548|NCT00269126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6414549|NCT00269126|Adrenergic Agents|adrenergic agents|mesh-ancestor
6414550|NCT00269126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6414551|NCT00269126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414552|NCT00269126|Glucocorticoids|glucocorticoids|mesh-ancestor
6414553|NCT00269126|Hormones|hormones|mesh-ancestor
6414554|NCT00269126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6414555|NCT00269126|Sympathomimetics|sympathomimetics|mesh-ancestor
6414556|NCT00269204|Niacin|niacin|mesh-list
6414557|NCT00269204|Niacinamide|niacinamide|mesh-list
6414558|NCT00269204|Nicotinic Acids|nicotinic acids|mesh-list
6414559|NCT00269204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6414560|NCT00269204|Antimetabolites|antimetabolites|mesh-ancestor
6414561|NCT00269204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414562|NCT00269204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6414563|NCT00269204|Vasodilator Agents|vasodilator agents|mesh-ancestor
6414564|NCT00269204|Vitamin B Complex|vitamin b complex|mesh-ancestor
6414565|NCT00269204|Vitamins|vitamins|mesh-ancestor
6414566|NCT00269204|Micronutrients|micronutrients|mesh-ancestor
6414567|NCT00269204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414568|NCT00269217|Niacin|niacin|mesh-list
6414569|NCT00269217|Niacinamide|niacinamide|mesh-list
6414570|NCT00269217|Nicotinic Acids|nicotinic acids|mesh-list
6414571|NCT00269217|Simvastatin|simvastatin|mesh-list
6414572|NCT00269217|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6414573|NCT00269217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6414574|NCT00269217|Antimetabolites|antimetabolites|mesh-ancestor
6414575|NCT00269217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414576|NCT00269217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6414577|NCT00269217|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6414578|NCT00269217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6414579|NCT00269217|Vasodilator Agents|vasodilator agents|mesh-ancestor
6414580|NCT00269217|Vitamin B Complex|vitamin b complex|mesh-ancestor
6414581|NCT00269217|Vitamins|vitamins|mesh-ancestor
6414582|NCT00269217|Micronutrients|micronutrients|mesh-ancestor
6414583|NCT00269217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414584|NCT00269243|Quinapril|quinapril|mesh-list
6414585|NCT00269243|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6414586|NCT00269243|Protease Inhibitors|protease inhibitors|mesh-ancestor
6414587|NCT00269243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6414588|NCT00269243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414589|NCT00269243|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6414590|NCT00269269|Antihypertensive Agents|antihypertensive agents|mesh-list
6414591|NCT00269334|Paroxetine|paroxetine|mesh-list
6414592|NCT00269334|Citalopram|citalopram|mesh-list
6414593|NCT00269334|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6414594|NCT00269334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6414595|NCT00269334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6414596|NCT00269334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414597|NCT00269334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6414598|NCT00269334|Serotonin Agents|serotonin agents|mesh-ancestor
6414599|NCT00269334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414600|NCT00269334|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6414601|NCT00269334|Antidepressive Agents|antidepressive agents|mesh-ancestor
6414602|NCT00269334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6414603|NCT00269334|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6414604|NCT00269334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6414605|NCT00269334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6414606|NCT00269386|Clarithromycin|clarithromycin|mesh-list
6414607|NCT00269386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6414608|NCT00269386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5724699|NCT03185364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6018859|NCT00382993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6018860|NCT00382993|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6414609|NCT00269386|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6414610|NCT00269386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6414611|NCT00269386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414612|NCT00269386|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6414613|NCT00269386|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6414614|NCT00269412|Rifaximin|rifaximin|mesh-list
6414615|NCT00269412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6414616|NCT00269412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6414617|NCT00269412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6460013|NCT00447759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460014|NCT00447759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6460015|NCT00447759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6460016|NCT00447759|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6460017|NCT00447759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6460018|NCT00447759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460019|NCT00447759|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6460020|NCT00447759|Gout Suppressants|gout suppressants|mesh-ancestor
6460021|NCT00447863|Levonorgestrel|levonorgestrel|mesh-list
6460022|NCT00447863|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6460023|NCT00447863|Estradiol|estradiol|mesh-list
6460024|NCT00447863|Estrogens|estrogens|mesh-ancestor
6460025|NCT00447863|Hormones|hormones|mesh-ancestor
6018861|NCT00382993|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6018862|NCT00382993|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6460026|NCT00447863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6460027|NCT00447863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460028|NCT00447863|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6460029|NCT00447863|Contraceptive Agents|contraceptive agents|mesh-ancestor
6460030|NCT00447863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6460031|NCT00447863|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6460032|NCT00447863|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6460033|NCT00447863|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6414618|NCT00269542|Iron|iron|mesh-list
6414619|NCT00269542|Folic Acid|folic acid|mesh-list
6414620|NCT00269542|Vitamin B Complex|vitamin b complex|mesh-list
6414621|NCT00269542|Trace Elements|trace elements|mesh-ancestor
6414622|NCT00269542|Micronutrients|micronutrients|mesh-ancestor
6414623|NCT00269542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414624|NCT00269542|Hematinics|hematinics|mesh-ancestor
6414625|NCT00269542|Vitamins|vitamins|mesh-ancestor
6414626|NCT00269555|Genistein|genistein|mesh-list
6414627|NCT00269555|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6414628|NCT00269555|Protective Agents|protective agents|mesh-ancestor
6414629|NCT00269555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414630|NCT00269555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6414631|NCT00269555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6414632|NCT00269555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6414633|NCT00269555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414634|NCT00269555|Phytoestrogens|phytoestrogens|mesh-ancestor
6414635|NCT00269555|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6414636|NCT00269555|Estrogens|estrogens|mesh-ancestor
6414637|NCT00269555|Hormones|hormones|mesh-ancestor
6414638|NCT00269555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6414639|NCT00269568|Misoprostol|misoprostol|mesh-list
6414640|NCT00269568|Mifepristone|mifepristone|mesh-list
6414641|NCT00269568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6414642|NCT00269568|Abortifacient Agents|abortifacient agents|mesh-ancestor
6414643|NCT00269568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6414644|NCT00269568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414645|NCT00269568|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6414646|NCT00269568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6414647|NCT00269568|Oxytocics|oxytocics|mesh-ancestor
6414648|NCT00269568|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6414649|NCT00269568|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6414650|NCT00269568|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6414651|NCT00269568|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6414652|NCT00269568|Contraceptive Agents|contraceptive agents|mesh-ancestor
6414653|NCT00269568|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6414654|NCT00269568|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6414655|NCT00269568|Hormone Antagonists|hormone antagonists|mesh-ancestor
6414656|NCT00269568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6414657|NCT00269568|Luteolytic Agents|luteolytic agents|mesh-ancestor
6414658|NCT00269568|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6414659|NCT00269568|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6414660|NCT00269594|Lamotrigine|lamotrigine|mesh-list
6414661|NCT00269594|Anticonvulsants|anticonvulsants|mesh-ancestor
6414662|NCT00269594|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6414663|NCT00269594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6414664|NCT00269594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414665|NCT00269594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6414666|NCT00269594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414667|NCT00269594|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6414668|NCT00269594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6414669|NCT00269594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6414670|NCT00269594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6414671|NCT00269594|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6414672|NCT00269607|Naltrexone|naltrexone|mesh-list
6414673|NCT00269607|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6414674|NCT00269607|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6414675|NCT00269607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414676|NCT00269607|Sensory System Agents|sensory system agents|mesh-ancestor
6414677|NCT00269607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6414678|NCT00269620|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6414679|NCT00269620|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6414680|NCT00269620|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6414681|NCT00269620|Etonogestrel|etonogestrel|mesh-list
6414682|NCT00269620|NuvaRing|nuvaring|mesh-list
6414683|NCT00269620|Norelgestromin|norelgestromin|mesh-list
6414684|NCT00269620|Ortho Evra|ortho evra|mesh-list
6414685|NCT00269620|Contraceptive Agents|contraceptive agents|mesh-list
6414686|NCT00269620|Estradiol|estradiol|mesh-list
6414687|NCT00269620|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6414688|NCT00269620|Estrogens|estrogens|mesh-ancestor
6414689|NCT00269620|Hormones|hormones|mesh-ancestor
6414690|NCT00269620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6414691|NCT00269620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414692|NCT00269620|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6414693|NCT00269620|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6414694|NCT00269620|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6414695|NCT00269620|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6414696|NCT00269620|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6414697|NCT00269672|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6414698|NCT00269672|Immunologic Factors|immunologic factors|mesh-ancestor
6414699|NCT00269672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414700|NCT00269685|Vasopressins|vasopressins|mesh-list
6414701|NCT00269685|Arginine Vasopressin|arginine vasopressin|mesh-list
6414702|NCT00269685|Hemostatics|hemostatics|mesh-ancestor
6414703|NCT00269685|Coagulants|coagulants|mesh-ancestor
6414704|NCT00269685|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6414705|NCT00269685|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6414706|NCT00269685|Natriuretic Agents|natriuretic agents|mesh-ancestor
6414707|NCT00269685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414708|NCT00269724|Oxybutynin|oxybutynin|mesh-list
6414709|NCT00269724|Parasympatholytics|parasympatholytics|mesh-ancestor
6414710|NCT00269724|Autonomic Agents|autonomic agents|mesh-ancestor
6414711|NCT00269724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6414712|NCT00269724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414713|NCT00269724|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6414714|NCT00269724|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6414715|NCT00269724|Cholinergic Agents|cholinergic agents|mesh-ancestor
6414716|NCT00269724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6414717|NCT00269724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414718|NCT00269724|Urological Agents|urological agents|mesh-ancestor
6414719|NCT00269737|Fentanyl|fentanyl|mesh-list
6414720|NCT00269737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6414721|NCT00269737|Narcotics|narcotics|mesh-ancestor
6414722|NCT00269737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6414723|NCT00269737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414724|NCT00269737|Analgesics|analgesics|mesh-ancestor
6414725|NCT00269737|Sensory System Agents|sensory system agents|mesh-ancestor
6414726|NCT00269737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6414727|NCT00269737|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6414728|NCT00269737|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6414729|NCT00269737|Anesthetics, General|anesthetics, general|mesh-ancestor
6414730|NCT00269737|Anesthetics|anesthetics|mesh-ancestor
6414731|NCT00269750|Oxybutynin|oxybutynin|mesh-list
6414732|NCT00269750|Parasympatholytics|parasympatholytics|mesh-ancestor
6414733|NCT00269750|Autonomic Agents|autonomic agents|mesh-ancestor
6414734|NCT00269750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6414735|NCT00269750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414736|NCT00269750|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6414737|NCT00269750|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6414738|NCT00269750|Cholinergic Agents|cholinergic agents|mesh-ancestor
6414739|NCT00269750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6414740|NCT00269750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414741|NCT00269750|Urological Agents|urological agents|mesh-ancestor
6414742|NCT00269763|Fentanyl|fentanyl|mesh-list
6414743|NCT00269763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6414744|NCT00269763|Narcotics|narcotics|mesh-ancestor
6414745|NCT00269763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6414746|NCT00269763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414747|NCT00269763|Analgesics|analgesics|mesh-ancestor
6414748|NCT00269763|Sensory System Agents|sensory system agents|mesh-ancestor
6414749|NCT00269763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6414750|NCT00269763|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6414751|NCT00269763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6414752|NCT00269763|Anesthetics, General|anesthetics, general|mesh-ancestor
6414753|NCT00269763|Anesthetics|anesthetics|mesh-ancestor
6414754|NCT00269776|Methylphenidate|methylphenidate|mesh-list
6414755|NCT00269776|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6414756|NCT00269776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414757|NCT00269776|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6414758|NCT00269776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6414759|NCT00269776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6414760|NCT00269776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414761|NCT00269776|Dopamine Agents|dopamine agents|mesh-ancestor
6414762|NCT00269776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6414763|NCT00269789|Methylphenidate|methylphenidate|mesh-list
6414764|NCT00269789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6414765|NCT00269789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414766|NCT00269789|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6414767|NCT00269789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6414768|NCT00269789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6414769|NCT00269789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414770|NCT00269789|Dopamine Agents|dopamine agents|mesh-ancestor
6414771|NCT00269789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6414772|NCT00269802|Methylphenidate|methylphenidate|mesh-list
6414773|NCT00269802|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6414774|NCT00269802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414775|NCT00269802|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6414776|NCT00269802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6414777|NCT00269802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6414778|NCT00269802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414779|NCT00269802|Dopamine Agents|dopamine agents|mesh-ancestor
6414780|NCT00269802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6414781|NCT00269815|Methylphenidate|methylphenidate|mesh-list
6414782|NCT00269815|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6414783|NCT00269815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414784|NCT00269815|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6414785|NCT00269815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6414786|NCT00269815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6414787|NCT00269815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414788|NCT00269815|Dopamine Agents|dopamine agents|mesh-ancestor
6414789|NCT00269815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6414790|NCT00269828|Paclitaxel|paclitaxel|mesh-list
6414791|NCT00269828|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6414792|NCT00269828|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
6414793|NCT00269828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6414794|NCT00269828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6414795|NCT00269828|Tubulin Modulators|tubulin modulators|mesh-ancestor
6414796|NCT00269828|Antimitotic Agents|antimitotic agents|mesh-ancestor
6414797|NCT00269828|Mitosis Modulators|mitosis modulators|mesh-ancestor
6414798|NCT00269828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414799|NCT00269841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6414800|NCT00269841|Infliximab|infliximab|mesh-list
6414801|NCT00269841|Antibodies|antibodies|mesh-list
6414802|NCT00269841|Immunoglobulins|immunoglobulins|mesh-list
6414803|NCT00269841|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6414804|NCT00269841|Immunologic Factors|immunologic factors|mesh-ancestor
6414805|NCT00269841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414806|NCT00269841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6414807|NCT00269841|Dermatologic Agents|dermatologic agents|mesh-ancestor
6414808|NCT00269841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6414809|NCT00269841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6414810|NCT00269854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6414811|NCT00269854|Infliximab|infliximab|mesh-list
6414812|NCT00269854|Antibodies|antibodies|mesh-list
6414813|NCT00269854|Immunoglobulins|immunoglobulins|mesh-list
6414814|NCT00269854|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6414815|NCT00269854|Immunologic Factors|immunologic factors|mesh-ancestor
6414816|NCT00269854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414817|NCT00269854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6414818|NCT00269854|Dermatologic Agents|dermatologic agents|mesh-ancestor
6414819|NCT00269854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6414820|NCT00269854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6414821|NCT00269867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6414822|NCT00269867|Infliximab|infliximab|mesh-list
6414823|NCT00269867|Antibodies|antibodies|mesh-list
6414824|NCT00269867|Immunoglobulins|immunoglobulins|mesh-list
6414825|NCT00269867|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6414826|NCT00269867|Immunologic Factors|immunologic factors|mesh-ancestor
6414827|NCT00269867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414828|NCT00269867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6414829|NCT00269867|Dermatologic Agents|dermatologic agents|mesh-ancestor
6414830|NCT00269867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6414831|NCT00269867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6414832|NCT00269880|Heparin|heparin|mesh-list
6414833|NCT00269880|Abciximab|abciximab|mesh-list
6414834|NCT00269880|Anticoagulants|anticoagulants|mesh-ancestor
6414835|NCT00269880|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6414836|NCT00269880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6414837|NCT00269880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414838|NCT00269880|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6414839|NCT00269893|Abciximab|abciximab|mesh-list
6414840|NCT00269893|Anticoagulants|anticoagulants|mesh-ancestor
6414841|NCT00269893|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6414842|NCT00269906|Abciximab|abciximab|mesh-list
6414843|NCT00269906|Anticoagulants|anticoagulants|mesh-ancestor
6414844|NCT00269906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6414845|NCT00269932|Levofloxacin|levofloxacin|mesh-list
6414846|NCT00269932|Ofloxacin|ofloxacin|mesh-list
6414847|NCT00269932|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6414848|NCT00269932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6414849|NCT00269932|Renal Agents|renal agents|mesh-ancestor
6414850|NCT00269932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6414851|NCT00269932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6414852|NCT00269932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6414853|NCT00269932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6414854|NCT00269932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414855|NCT00269932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6414856|NCT00269932|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6414857|NCT00269932|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6414858|NCT00269945|Epoetin Alfa|epoetin alfa|mesh-list
6414859|NCT00269945|Hematinics|hematinics|mesh-ancestor
6414860|NCT00269958|Epoetin Alfa|epoetin alfa|mesh-list
6414861|NCT00269958|Hematinics|hematinics|mesh-ancestor
6414862|NCT00269971|Epoetin Alfa|epoetin alfa|mesh-list
6414863|NCT00269971|Hematinics|hematinics|mesh-ancestor
6414864|NCT00269984|Epoetin Alfa|epoetin alfa|mesh-list
6414865|NCT00269984|Hematinics|hematinics|mesh-ancestor
6414866|NCT00269997|Epoetin Alfa|epoetin alfa|mesh-list
6414867|NCT00269997|Hematinics|hematinics|mesh-ancestor
6414868|NCT00270010|Epoetin Alfa|epoetin alfa|mesh-list
6414869|NCT00270010|Hematinics|hematinics|mesh-ancestor
6414870|NCT00270023|Epoetin Alfa|epoetin alfa|mesh-list
6414871|NCT00270023|Hematinics|hematinics|mesh-ancestor
6414872|NCT00270036|Epoetin Alfa|epoetin alfa|mesh-list
6414873|NCT00270036|Hematinics|hematinics|mesh-ancestor
6414874|NCT00270049|Epoetin Alfa|epoetin alfa|mesh-list
6414875|NCT00270049|Hematinics|hematinics|mesh-ancestor
6414876|NCT00270062|Epoetin Alfa|epoetin alfa|mesh-list
6414877|NCT00270062|Hematinics|hematinics|mesh-ancestor
6414878|NCT00270075|Epoetin Alfa|epoetin alfa|mesh-list
6414879|NCT00270075|Hematinics|hematinics|mesh-ancestor
6414880|NCT00270088|Epoetin Alfa|epoetin alfa|mesh-list
6414881|NCT00270088|Hematinics|hematinics|mesh-ancestor
6414882|NCT00270101|Epoetin Alfa|epoetin alfa|mesh-list
6414883|NCT00270101|Hematinics|hematinics|mesh-ancestor
6414884|NCT00270114|Epoetin Alfa|epoetin alfa|mesh-list
6414885|NCT00270114|Hematinics|hematinics|mesh-ancestor
6414886|NCT00270127|Epoetin Alfa|epoetin alfa|mesh-list
6414887|NCT00270127|Hematinics|hematinics|mesh-ancestor
6414888|NCT00270140|Epoetin Alfa|epoetin alfa|mesh-list
6414889|NCT00270140|Hematinics|hematinics|mesh-ancestor
6414890|NCT00270153|Enalapril|enalapril|mesh-list
6414891|NCT00270153|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6414892|NCT00270153|Protease Inhibitors|protease inhibitors|mesh-ancestor
6414893|NCT00270153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6414894|NCT00270153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414895|NCT00270153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6414896|NCT00270166|Epoetin Alfa|epoetin alfa|mesh-list
6414897|NCT00270166|Hematinics|hematinics|mesh-ancestor
6414898|NCT00270179|Epoetin Alfa|epoetin alfa|mesh-list
6414899|NCT00270179|Hematinics|hematinics|mesh-ancestor
6414900|NCT00270270|Epoetin Alfa|epoetin alfa|mesh-list
6414901|NCT00270270|Hematinics|hematinics|mesh-ancestor
6414902|NCT00270283|Epoetin Alfa|epoetin alfa|mesh-list
6414903|NCT00270283|Hematinics|hematinics|mesh-ancestor
6414904|NCT00270322|Fentanyl|fentanyl|mesh-list
6414905|NCT00270322|Morphine|morphine|mesh-list
6414906|NCT00270322|Bupivacaine|bupivacaine|mesh-list
6414907|NCT00270322|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6414908|NCT00270322|Narcotics|narcotics|mesh-ancestor
6414909|NCT00270322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6414910|NCT00270322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414911|NCT00270322|Analgesics|analgesics|mesh-ancestor
6414912|NCT00270322|Sensory System Agents|sensory system agents|mesh-ancestor
6414913|NCT00270322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6414914|NCT00270322|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6414915|NCT00270322|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6414916|NCT00270322|Anesthetics, General|anesthetics, general|mesh-ancestor
6414917|NCT00270322|Anesthetics|anesthetics|mesh-ancestor
6414918|NCT00270322|Anesthetics, Local|anesthetics, local|mesh-ancestor
6414919|NCT00270335|Propofol|propofol|mesh-list
6414920|NCT00270335|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6414921|NCT00270335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6414922|NCT00270335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414923|NCT00270335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6414924|NCT00270335|Anesthetics, General|anesthetics, general|mesh-ancestor
6414925|NCT00270335|Anesthetics|anesthetics|mesh-ancestor
6414926|NCT00270348|Ciclesonide|ciclesonide|mesh-list
6414927|NCT00270348|Glucocorticoids|glucocorticoids|mesh-ancestor
6414928|NCT00270348|Hormones|hormones|mesh-ancestor
6414929|NCT00270348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6414930|NCT00270348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414931|NCT00270348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6414932|NCT00270361|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6414933|NCT00270361|Natriuretic Agents|natriuretic agents|mesh-ancestor
6414934|NCT00270361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414935|NCT00270374|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6414936|NCT00270374|Natriuretic Agents|natriuretic agents|mesh-ancestor
6414937|NCT00270374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414938|NCT00270387|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6414939|NCT00270387|Natriuretic Agents|natriuretic agents|mesh-ancestor
6414940|NCT00270387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414941|NCT00270400|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6414942|NCT00270400|Natriuretic Agents|natriuretic agents|mesh-ancestor
6414943|NCT00270400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414944|NCT00270413|Sunitinib|sunitinib|mesh-list
6414945|NCT00270413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6414946|NCT00270413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6414947|NCT00270413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6414948|NCT00270413|Growth Substances|growth substances|mesh-ancestor
6414949|NCT00270413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6414950|NCT00270413|Growth Inhibitors|growth inhibitors|mesh-ancestor
6414951|NCT00270413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6414952|NCT00270413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6414953|NCT00270413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414954|NCT00270426|Benazepril|benazepril|mesh-list
6414955|NCT00270426|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6414956|NCT00270426|Protease Inhibitors|protease inhibitors|mesh-ancestor
6414957|NCT00270426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6414958|NCT00270426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414959|NCT00270426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6414960|NCT00270478|Hydroxyurea|hydroxyurea|mesh-list
6414961|NCT00270478|Epoetin Alfa|epoetin alfa|mesh-list
6414962|NCT00270478|Hematinics|hematinics|mesh-ancestor
6414963|NCT00270478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6414964|NCT00270478|Antisickling Agents|antisickling agents|mesh-ancestor
6414965|NCT00270478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6414966|NCT00270478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414967|NCT00270478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6414968|NCT00270491|Paclitaxel|paclitaxel|mesh-list
6414969|NCT00270491|Capecitabine|capecitabine|mesh-list
6414970|NCT00270491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6414971|NCT00270491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6414972|NCT00270491|Tubulin Modulators|tubulin modulators|mesh-ancestor
6414973|NCT00270491|Antimitotic Agents|antimitotic agents|mesh-ancestor
6414974|NCT00270491|Mitosis Modulators|mitosis modulators|mesh-ancestor
6414975|NCT00270491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414976|NCT00270491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6414977|NCT00270491|Antimetabolites|antimetabolites|mesh-ancestor
6414978|NCT00270517|Telithromycin|telithromycin|mesh-list
6414979|NCT00270517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6414980|NCT00270517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6414981|NCT00270530|Pyrimethamine|pyrimethamine|mesh-list
6414982|NCT00270530|Sulfadoxine|sulfadoxine|mesh-list
6414983|NCT00270530|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6414984|NCT00270530|Antimalarials|antimalarials|mesh-ancestor
6414985|NCT00270530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6414986|NCT00270530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6414987|NCT00270530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6414988|NCT00270530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6414989|NCT00270530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6414990|NCT00270530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414991|NCT00270530|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6414992|NCT00270530|Renal Agents|renal agents|mesh-ancestor
6414993|NCT00270543|Leucovorin|leucovorin|mesh-list
6414994|NCT00270543|Fluorouracil|fluorouracil|mesh-list
6414995|NCT00270543|Docetaxel|docetaxel|mesh-list
6414996|NCT00270543|Antimetabolites|antimetabolites|mesh-ancestor
6414997|NCT00270543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6414998|NCT00270543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6414999|NCT00270543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6415000|NCT00270543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6415001|NCT00270543|Immunologic Factors|immunologic factors|mesh-ancestor
6415002|NCT00270543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415003|NCT00270543|Antidotes|antidotes|mesh-ancestor
6415004|NCT00270543|Protective Agents|protective agents|mesh-ancestor
6415005|NCT00270543|Vitamin B Complex|vitamin b complex|mesh-ancestor
6415006|NCT00270543|Vitamins|vitamins|mesh-ancestor
6415007|NCT00270543|Micronutrients|micronutrients|mesh-ancestor
6415008|NCT00270543|Tubulin Modulators|tubulin modulators|mesh-ancestor
6415009|NCT00270543|Antimitotic Agents|antimitotic agents|mesh-ancestor
6415010|NCT00270543|Mitosis Modulators|mitosis modulators|mesh-ancestor
6415011|NCT00270556|Tenofovir|tenofovir|mesh-list
6415012|NCT00270556|Abacavir|abacavir|mesh-list
6415013|NCT00270556|Antiviral Agents|antiviral agents|mesh-ancestor
6415014|NCT00270556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6415015|NCT00270556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6415016|NCT00270556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6415017|NCT00270556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6415018|NCT00270556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415019|NCT00270556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6415020|NCT00270556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6415021|NCT00270569|Cisplatin|cisplatin|mesh-list
6415022|NCT00270569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6415023|NCT00270582|Gemcitabine|gemcitabine|mesh-list
6415024|NCT00270582|Docetaxel|docetaxel|mesh-list
6415025|NCT00270582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6415026|NCT00270582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6415027|NCT00270582|Antimetabolites|antimetabolites|mesh-ancestor
6415028|NCT00270582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415029|NCT00270582|Antiviral Agents|antiviral agents|mesh-ancestor
6415030|NCT00270582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6415031|NCT00270582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6415032|NCT00270582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6415033|NCT00270582|Immunologic Factors|immunologic factors|mesh-ancestor
6415034|NCT00270582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415035|NCT00270582|Tubulin Modulators|tubulin modulators|mesh-ancestor
6415036|NCT00270582|Antimitotic Agents|antimitotic agents|mesh-ancestor
6415037|NCT00270582|Mitosis Modulators|mitosis modulators|mesh-ancestor
6415038|NCT00270647|Vitamins|vitamins|mesh-list
6415039|NCT00270647|Ascorbic Acid|ascorbic acid|mesh-list
6415040|NCT00270647|Vitamin E|vitamin e|mesh-list
6415041|NCT00270647|Beta Carotene|beta carotene|mesh-list
6415042|NCT00270647|Carotenoids|carotenoids|mesh-list
6415043|NCT00270647|Micronutrients|micronutrients|mesh-ancestor
6415044|NCT00270647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415045|NCT00270647|Antioxidants|antioxidants|mesh-ancestor
6415046|NCT00270647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415047|NCT00270647|Protective Agents|protective agents|mesh-ancestor
6415048|NCT00270647|Provitamins|provitamins|mesh-ancestor
6415049|NCT00270751|Minocycline|minocycline|mesh-list
6415050|NCT00270751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6415051|NCT00270751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6415052|NCT00270777|Promethazine|promethazine|mesh-list
6415053|NCT00270777|Diphenhydramine|diphenhydramine|mesh-list
6415054|NCT00270777|Hydrocortisone|hydrocortisone|mesh-list
6415055|NCT00270777|Epinephrine|epinephrine|mesh-list
6415056|NCT00270777|Racepinephrine|racepinephrine|mesh-list
6415057|NCT00270777|Epinephryl borate|epinephryl borate|mesh-list
6415058|NCT00270777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6415059|NCT00270777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6415060|NCT00270777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6415061|NCT00270777|Adrenergic Agents|adrenergic agents|mesh-ancestor
6415062|NCT00270777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6415063|NCT00270777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415064|NCT00270777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415065|NCT00270777|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6415066|NCT00270777|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6415067|NCT00270777|Autonomic Agents|autonomic agents|mesh-ancestor
6415068|NCT00270777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6415069|NCT00270777|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6415070|NCT00270777|Respiratory System Agents|respiratory system agents|mesh-ancestor
6415071|NCT00270777|Mydriatics|mydriatics|mesh-ancestor
6415072|NCT00270777|Sympathomimetics|sympathomimetics|mesh-ancestor
6415073|NCT00270777|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6415074|NCT00270777|Antipruritics|antipruritics|mesh-ancestor
6415075|NCT00270777|Dermatologic Agents|dermatologic agents|mesh-ancestor
6415076|NCT00270777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6415077|NCT00270777|Histamine Antagonists|histamine antagonists|mesh-ancestor
6415078|NCT00270777|Histamine Agents|histamine agents|mesh-ancestor
6415079|NCT00270777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6415080|NCT00270777|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6415081|NCT00270777|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6415082|NCT00270777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6415083|NCT00270777|Anesthetics, Local|anesthetics, local|mesh-ancestor
6415084|NCT00270777|Anesthetics|anesthetics|mesh-ancestor
6415085|NCT00270777|Sensory System Agents|sensory system agents|mesh-ancestor
6415086|NCT00270777|Antiemetics|antiemetics|mesh-ancestor
6415087|NCT00270777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6415088|NCT00270816|Interferons|interferons|mesh-list
6415089|NCT00270816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6415090|NCT00270816|Antiviral Agents|antiviral agents|mesh-ancestor
6415091|NCT00270816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6415092|NCT00270829|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6415093|NCT00270829|Natriuretic Agents|natriuretic agents|mesh-ancestor
6415094|NCT00270829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415095|NCT00270881|Cytarabine|cytarabine|mesh-list
6415096|NCT00270881|Cyclophosphamide|cyclophosphamide|mesh-list
6415097|NCT00270881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6415098|NCT00270881|Immunologic Factors|immunologic factors|mesh-ancestor
6415099|NCT00270881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415100|NCT00270881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6415101|NCT00270881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6415102|NCT00270881|Alkylating Agents|alkylating agents|mesh-ancestor
6415103|NCT00270881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415104|NCT00270881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6415105|NCT00270881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6415106|NCT00270881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6415107|NCT00270881|Antimetabolites|antimetabolites|mesh-ancestor
6415108|NCT00270881|Antiviral Agents|antiviral agents|mesh-ancestor
6415109|NCT00270881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6415110|NCT00270907|Gemcitabine|gemcitabine|mesh-list
6415111|NCT00270907|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
6415112|NCT00270907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6415113|NCT00270907|Antimetabolites|antimetabolites|mesh-ancestor
6415114|NCT00270907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415115|NCT00270907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6415116|NCT00270907|Antiviral Agents|antiviral agents|mesh-ancestor
6415117|NCT00270907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6415118|NCT00270907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6415119|NCT00270907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6415120|NCT00270907|Immunologic Factors|immunologic factors|mesh-ancestor
6415121|NCT00270907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460034|NCT00447863|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6460035|NCT00447915|Vitamin D|vitamin d|mesh-list
6460036|NCT00447915|Cholecalciferol|cholecalciferol|mesh-list
6460037|NCT00447915|Ibandronic Acid|ibandronic acid|mesh-list
6460038|NCT00447915|Calcium|calcium|mesh-list
6460039|NCT00447915|Vitamins|vitamins|mesh-ancestor
6460040|NCT00447915|Micronutrients|micronutrients|mesh-ancestor
6460041|NCT00447915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460042|NCT00447915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6460043|NCT00447915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6460044|NCT00447928|Nitroglycerin|nitroglycerin|mesh-list
6460045|NCT00447928|Vasodilator Agents|vasodilator agents|mesh-ancestor
6460046|NCT00447967|Leucovorin|leucovorin|mesh-list
6460047|NCT00447967|Fluorouracil|fluorouracil|mesh-list
6460048|NCT00447967|Oxaliplatin|oxaliplatin|mesh-list
6460049|NCT00447967|Irinotecan|irinotecan|mesh-list
6415122|NCT00271050|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6415123|NCT00271050|Immunologic Factors|immunologic factors|mesh-ancestor
6415124|NCT00271050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415125|NCT00271063|Annamycin|annamycin|mesh-list
6415126|NCT00271063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6415127|NCT00271063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6415128|NCT00271206|Progesterone|progesterone|mesh-list
6415129|NCT00271206|Progestins|progestins|mesh-ancestor
6415130|NCT00271206|Hormones|hormones|mesh-ancestor
6415131|NCT00271206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6415132|NCT00271206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415133|NCT00271245|Selenium|selenium|mesh-list
6415134|NCT00271245|Selenic Acid|selenic acid|mesh-list
6415135|NCT00271245|Antioxidants|antioxidants|mesh-ancestor
6415136|NCT00271245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415137|NCT00271245|Protective Agents|protective agents|mesh-ancestor
6415138|NCT00271245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415139|NCT00271245|Trace Elements|trace elements|mesh-ancestor
6415140|NCT00271245|Micronutrients|micronutrients|mesh-ancestor
6415141|NCT00271271|Gemcitabine|gemcitabine|mesh-list
6415142|NCT00271271|Vinorelbine|vinorelbine|mesh-list
6415143|NCT00271271|Oxaliplatin|oxaliplatin|mesh-list
6415144|NCT00271271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6415145|NCT00271271|Antimetabolites|antimetabolites|mesh-ancestor
6415146|NCT00271271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415147|NCT00271271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6415148|NCT00271271|Antiviral Agents|antiviral agents|mesh-ancestor
6415149|NCT00271271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6415150|NCT00271271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6415151|NCT00271271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6415152|NCT00271271|Immunologic Factors|immunologic factors|mesh-ancestor
6415153|NCT00271271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415154|NCT00271271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6415155|NCT00271271|Tubulin Modulators|tubulin modulators|mesh-ancestor
6415156|NCT00271271|Antimitotic Agents|antimitotic agents|mesh-ancestor
6415157|NCT00271271|Mitosis Modulators|mitosis modulators|mesh-ancestor
6415158|NCT00271284|Insulin|insulin|mesh-list
6415159|NCT00271284|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6415160|NCT00271284|Insulin Glargine|insulin glargine|mesh-list
6415161|NCT00271284|Insulin Detemir|insulin detemir|mesh-list
6415162|NCT00271284|Insulin glulisine|insulin glulisine|mesh-list
6415163|NCT00271284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6018863|NCT00382993|Serotonin Agents|serotonin agents|mesh-ancestor
6018864|NCT00382993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6018865|NCT00383019|Latanoprost|latanoprost|mesh-list
6018866|NCT00383019|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5724700|NCT03185364|Urological Agents|urological agents|mesh-ancestor
6018867|NCT00383019|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6018868|NCT00383149|Cetuximab|cetuximab|mesh-list
6415164|NCT00271284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415165|NCT00271323|Docetaxel|docetaxel|mesh-list
6415166|NCT00271323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6415167|NCT00271323|Tubulin Modulators|tubulin modulators|mesh-ancestor
6415168|NCT00271323|Antimitotic Agents|antimitotic agents|mesh-ancestor
6415169|NCT00271323|Mitosis Modulators|mitosis modulators|mesh-ancestor
6415170|NCT00271323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415171|NCT00271336|Pentoxifylline|pentoxifylline|mesh-list
6415172|NCT00271336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6415173|NCT00271336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6415174|NCT00271336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415175|NCT00271336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6415176|NCT00271336|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6415177|NCT00271336|Protective Agents|protective agents|mesh-ancestor
6415178|NCT00271336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415179|NCT00271336|Vasodilator Agents|vasodilator agents|mesh-ancestor
6415180|NCT00271336|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6415181|NCT00271336|Antioxidants|antioxidants|mesh-ancestor
6415182|NCT00271349|Budesonide|budesonide|mesh-list
6415183|NCT00271349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6415184|NCT00271349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6415185|NCT00271349|Autonomic Agents|autonomic agents|mesh-ancestor
6415186|NCT00271349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6415187|NCT00271349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415188|NCT00271349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6415189|NCT00271349|Respiratory System Agents|respiratory system agents|mesh-ancestor
6415190|NCT00271349|Glucocorticoids|glucocorticoids|mesh-ancestor
6415191|NCT00271349|Hormones|hormones|mesh-ancestor
6415192|NCT00271349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6415193|NCT00271401|Heparin|heparin|mesh-list
6415194|NCT00271401|Anticoagulants|anticoagulants|mesh-ancestor
6415195|NCT00271401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6415196|NCT00271401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6415197|NCT00271401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6018869|NCT00383149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6018870|NCT00383149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6018871|NCT00383162|Naproxen|naproxen|mesh-list
6018872|NCT00383162|Sumatriptan|sumatriptan|mesh-list
6018873|NCT00383162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6018874|NCT00383162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6415198|NCT00271414|Fentanyl|fentanyl|mesh-list
6415199|NCT00271414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6415200|NCT00271414|Narcotics|narcotics|mesh-ancestor
6415201|NCT00271414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6415202|NCT00271414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415203|NCT00271414|Analgesics|analgesics|mesh-ancestor
6415204|NCT00271414|Sensory System Agents|sensory system agents|mesh-ancestor
6415205|NCT00271414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6415206|NCT00271414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6415207|NCT00271414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6415208|NCT00271414|Anesthetics, General|anesthetics, general|mesh-ancestor
6415209|NCT00271414|Anesthetics|anesthetics|mesh-ancestor
6415210|NCT00271427|Selenium|selenium|mesh-list
6415211|NCT00271427|Antioxidants|antioxidants|mesh-ancestor
6415212|NCT00271427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415213|NCT00271427|Protective Agents|protective agents|mesh-ancestor
6415214|NCT00271427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415215|NCT00271427|Trace Elements|trace elements|mesh-ancestor
6415216|NCT00271427|Micronutrients|micronutrients|mesh-ancestor
6415217|NCT00271440|Chlorhexidine|chlorhexidine|mesh-list
6415218|NCT00271440|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6415219|NCT00271440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6415220|NCT00271440|Disinfectants|disinfectants|mesh-ancestor
6415221|NCT00271453|Fentanyl|fentanyl|mesh-list
6415222|NCT00271453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6415223|NCT00271453|Narcotics|narcotics|mesh-ancestor
6415224|NCT00271453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6415225|NCT00271453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415226|NCT00271453|Analgesics|analgesics|mesh-ancestor
6415227|NCT00271453|Sensory System Agents|sensory system agents|mesh-ancestor
6415228|NCT00271453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6415229|NCT00271453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6415230|NCT00271453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6415231|NCT00271453|Anesthetics, General|anesthetics, general|mesh-ancestor
6415232|NCT00271453|Anesthetics|anesthetics|mesh-ancestor
6415233|NCT00271466|Fentanyl|fentanyl|mesh-list
6415234|NCT00271466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6415235|NCT00271466|Narcotics|narcotics|mesh-ancestor
6415236|NCT00271466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6415237|NCT00271466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415238|NCT00271466|Analgesics|analgesics|mesh-ancestor
6415239|NCT00271466|Sensory System Agents|sensory system agents|mesh-ancestor
6460050|NCT00447967|Antimetabolites|antimetabolites|mesh-ancestor
6415240|NCT00271466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6415241|NCT00271466|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6415242|NCT00271466|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6415243|NCT00271466|Anesthetics, General|anesthetics, general|mesh-ancestor
6415244|NCT00271466|Anesthetics|anesthetics|mesh-ancestor
6415245|NCT00271492|Atrasentan|atrasentan|mesh-list
6415246|NCT00271492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6415247|NCT00271492|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
6415248|NCT00271492|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6415249|NCT00271492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415250|NCT00271518|Hormones|hormones|mesh-list
6415251|NCT00271518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6415252|NCT00271518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415253|NCT00271557|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6415254|NCT00271557|Natriuretic Agents|natriuretic agents|mesh-ancestor
6415255|NCT00271557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415256|NCT00271583|Levonorgestrel|levonorgestrel|mesh-list
6415257|NCT00271583|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6415258|NCT00271583|Contraceptive Agents|contraceptive agents|mesh-ancestor
6415259|NCT00271583|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6415260|NCT00271583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415261|NCT00271583|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6415262|NCT00271583|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6415263|NCT00271583|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6415264|NCT00271635|Ascorbic Acid|ascorbic acid|mesh-list
6415265|NCT00271635|Vitamins|vitamins|mesh-ancestor
6415266|NCT00271635|Micronutrients|micronutrients|mesh-ancestor
6415267|NCT00271635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415268|NCT00271635|Antioxidants|antioxidants|mesh-ancestor
6415269|NCT00271635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415270|NCT00271635|Protective Agents|protective agents|mesh-ancestor
6415271|NCT00271713|Calcium, Dietary|calcium, dietary|mesh-list
6415272|NCT00271713|Vitamin D|vitamin d|mesh-list
6415273|NCT00271713|Ergocalciferols|ergocalciferols|mesh-list
6415274|NCT00271713|Ibandronic Acid|ibandronic acid|mesh-list
6415275|NCT00271713|Vitamins|vitamins|mesh-list
6415276|NCT00271713|Calcium|calcium|mesh-list
6415277|NCT00271713|Micronutrients|micronutrients|mesh-ancestor
6415278|NCT00271713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415279|NCT00271713|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6415280|NCT00271713|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6415281|NCT00271791|Prednisone|prednisone|mesh-list
6415282|NCT00271791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6415283|NCT00271791|Glucocorticoids|glucocorticoids|mesh-ancestor
6415284|NCT00271791|Hormones|hormones|mesh-ancestor
6415285|NCT00271791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6415286|NCT00271791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415287|NCT00271791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6415288|NCT00271791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6415289|NCT00271804|Bortezomib|bortezomib|mesh-list
6415290|NCT00271804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6415291|NCT00271973|Oxycodone|oxycodone|mesh-list
6415292|NCT00271973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6415293|NCT00271973|Narcotics|narcotics|mesh-ancestor
6415294|NCT00271973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5724701|NCT03185403|Sufentanil|sufentanil|mesh-list
6415295|NCT00271973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415296|NCT00271973|Analgesics|analgesics|mesh-ancestor
6415297|NCT00271973|Sensory System Agents|sensory system agents|mesh-ancestor
6415298|NCT00271973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6415299|NCT00272012|Insulin glulisine|insulin glulisine|mesh-list
6415300|NCT00272012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6415301|NCT00272012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415302|NCT00272025|Citalopram|citalopram|mesh-list
6415303|NCT00272025|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6415304|NCT00272025|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6415305|NCT00272025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6415306|NCT00272025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415307|NCT00272025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6415308|NCT00272025|Serotonin Agents|serotonin agents|mesh-ancestor
6415309|NCT00272025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415310|NCT00272025|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6415311|NCT00272025|Antidepressive Agents|antidepressive agents|mesh-ancestor
6415312|NCT00272025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6415313|NCT00272051|Xaliproden|xaliproden|mesh-list
6415314|NCT00272051|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6415315|NCT00272051|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6415316|NCT00272051|Serotonin Agents|serotonin agents|mesh-ancestor
6415317|NCT00272051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6415318|NCT00272051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415319|NCT00272051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415320|NCT00272064|Insulin|insulin|mesh-list
6415321|NCT00272064|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6415322|NCT00272064|Metformin|metformin|mesh-list
6415323|NCT00272064|Insulin Glargine|insulin glargine|mesh-list
6415324|NCT00272064|Insulin glulisine|insulin glulisine|mesh-list
6415325|NCT00272064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6415326|NCT00272064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415327|NCT00272077|Insulin Glargine|insulin glargine|mesh-list
6415328|NCT00272077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6415329|NCT00272077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415330|NCT00272090|Insulin Glargine|insulin glargine|mesh-list
6415331|NCT00272090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6415332|NCT00272090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415333|NCT00272116|Vitamins|vitamins|mesh-list
6415334|NCT00272116|Vitamin A|vitamin a|mesh-list
6415335|NCT00272116|Retinol palmitate|retinol palmitate|mesh-list
6415336|NCT00272116|Micronutrients|micronutrients|mesh-ancestor
6415337|NCT00272116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415338|NCT00272116|Antioxidants|antioxidants|mesh-ancestor
6415339|NCT00272116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415340|NCT00272116|Protective Agents|protective agents|mesh-ancestor
6415341|NCT00272116|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6415342|NCT00272116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6415343|NCT00272207|Nabilone|nabilone|mesh-list
6415344|NCT00272207|Antiemetics|antiemetics|mesh-ancestor
6415345|NCT00272207|Autonomic Agents|autonomic agents|mesh-ancestor
6415346|NCT00272207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6415347|NCT00272207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415348|NCT00272207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6415349|NCT00272207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6415350|NCT00272207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6415351|NCT00272207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6415352|NCT00272207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6415353|NCT00272285|Granisetron|granisetron|mesh-list
6415354|NCT00272285|Ramosetron|ramosetron|mesh-list
6415355|NCT00272285|Antiemetics|antiemetics|mesh-ancestor
6415356|NCT00272285|Autonomic Agents|autonomic agents|mesh-ancestor
6415357|NCT00272285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6415358|NCT00272285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415359|NCT00272285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6415360|NCT00272285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6415361|NCT00272285|Serotonin Agents|serotonin agents|mesh-ancestor
6415362|NCT00272285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6415363|NCT00272285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415364|NCT00272324|Aspirin|aspirin|mesh-list
6415365|NCT00272324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6415366|NCT00272324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6415367|NCT00272324|Analgesics|analgesics|mesh-ancestor
6415368|NCT00272324|Sensory System Agents|sensory system agents|mesh-ancestor
6415369|NCT00272324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6415370|NCT00272324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415371|NCT00272324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6415372|NCT00272324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6415373|NCT00272324|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6415374|NCT00272324|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6415375|NCT00272324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415376|NCT00272324|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6415377|NCT00272324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6415378|NCT00272324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6415379|NCT00272324|Antipyretics|antipyretics|mesh-ancestor
6415380|NCT00272415|Temozolomide|temozolomide|mesh-list
6415381|NCT00272415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6415382|NCT00272415|Alkylating Agents|alkylating agents|mesh-ancestor
6415383|NCT00272415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415384|NCT00272415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6415385|NCT00272428|Ascorbic Acid|ascorbic acid|mesh-list
6415386|NCT00272428|Vitamin E|vitamin e|mesh-list
6415387|NCT00272428|Beta Carotene|beta carotene|mesh-list
6415388|NCT00272428|Selenium|selenium|mesh-list
6415389|NCT00272428|Carotenoids|carotenoids|mesh-list
6415390|NCT00272428|Vitamins|vitamins|mesh-ancestor
6415391|NCT00272428|Micronutrients|micronutrients|mesh-ancestor
6415392|NCT00272428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415393|NCT00272428|Antioxidants|antioxidants|mesh-ancestor
6415394|NCT00272428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415395|NCT00272428|Protective Agents|protective agents|mesh-ancestor
6415396|NCT00272428|Trace Elements|trace elements|mesh-ancestor
6415397|NCT00272428|Provitamins|provitamins|mesh-ancestor
6415398|NCT00272454|Aspirin|aspirin|mesh-list
6415399|NCT00272454|Cilostazol|cilostazol|mesh-list
6415400|NCT00272454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6415401|NCT00272454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6415402|NCT00272454|Analgesics|analgesics|mesh-ancestor
6415403|NCT00272454|Sensory System Agents|sensory system agents|mesh-ancestor
6415404|NCT00272454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6415405|NCT00272454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415406|NCT00272454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6415407|NCT00272454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6415408|NCT00272454|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6415409|NCT00272454|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6415410|NCT00272454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415411|NCT00272454|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6415412|NCT00272454|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6415413|NCT00272454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6415414|NCT00272454|Antipyretics|antipyretics|mesh-ancestor
6415415|NCT00272454|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6415416|NCT00272454|Autonomic Agents|autonomic agents|mesh-ancestor
6415417|NCT00272454|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6415418|NCT00272454|Respiratory System Agents|respiratory system agents|mesh-ancestor
6415419|NCT00272454|Vasodilator Agents|vasodilator agents|mesh-ancestor
6415420|NCT00272454|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6415421|NCT00272454|Protective Agents|protective agents|mesh-ancestor
6415422|NCT00272454|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6415423|NCT00272454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6415424|NCT00272467|Omeprazole|omeprazole|mesh-list
6415425|NCT00272467|Rebamipide|rebamipide|mesh-list
6415426|NCT00272467|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6415427|NCT00272467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6415428|NCT00272467|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6415429|NCT00272467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6415430|NCT00272467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415431|NCT00272467|Antioxidants|antioxidants|mesh-ancestor
6415432|NCT00272467|Protective Agents|protective agents|mesh-ancestor
6415433|NCT00272467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415434|NCT00272480|Lamivudine|lamivudine|mesh-list
6415435|NCT00272480|Zidovudine|zidovudine|mesh-list
6415436|NCT00272480|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6415437|NCT00272480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6415438|NCT00272480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6415439|NCT00272480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415440|NCT00272480|Antiviral Agents|antiviral agents|mesh-ancestor
6415441|NCT00272480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6415442|NCT00272480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6415443|NCT00272480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6415444|NCT00272480|Antimetabolites|antimetabolites|mesh-ancestor
6415445|NCT00272493|Vaccines|vaccines|mesh-list
6415446|NCT00272493|Immunologic Factors|immunologic factors|mesh-ancestor
6415447|NCT00272493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415448|NCT00272558|Carboplatin|carboplatin|mesh-list
6415449|NCT00272558|Vinorelbine|vinorelbine|mesh-list
6415450|NCT00272558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6415451|NCT00272558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6415452|NCT00272558|Tubulin Modulators|tubulin modulators|mesh-ancestor
6018875|NCT00383162|Analgesics|analgesics|mesh-ancestor
6018876|NCT00383162|Sensory System Agents|sensory system agents|mesh-ancestor
6018877|NCT00383162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6018878|NCT00383162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415453|NCT00272558|Antimitotic Agents|antimitotic agents|mesh-ancestor
6415454|NCT00272558|Mitosis Modulators|mitosis modulators|mesh-ancestor
6415455|NCT00272558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415456|NCT00272584|Risperidone|risperidone|mesh-list
6415457|NCT00272584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6415458|NCT00272584|Serotonin Agents|serotonin agents|mesh-ancestor
6415459|NCT00272584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6415460|NCT00272584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415461|NCT00272584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415462|NCT00272584|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6415463|NCT00272584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6415464|NCT00272584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6415465|NCT00272584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6415466|NCT00272584|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6415467|NCT00272584|Dopamine Agents|dopamine agents|mesh-ancestor
6415468|NCT00272597|Risperidone|risperidone|mesh-list
6415469|NCT00272597|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6415470|NCT00272597|Serotonin Agents|serotonin agents|mesh-ancestor
6415471|NCT00272597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6415472|NCT00272597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415473|NCT00272597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415474|NCT00272597|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6415475|NCT00272597|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6415476|NCT00272597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6415477|NCT00272597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6415478|NCT00272597|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6415479|NCT00272597|Dopamine Agents|dopamine agents|mesh-ancestor
6415480|NCT00272610|Vitamin A|vitamin a|mesh-list
6415481|NCT00272610|Vitamins|vitamins|mesh-ancestor
6415482|NCT00272610|Micronutrients|micronutrients|mesh-ancestor
6018879|NCT00383162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6018880|NCT00383162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6018881|NCT00383162|Gout Suppressants|gout suppressants|mesh-ancestor
6018882|NCT00383162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6018883|NCT00383162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6018884|NCT00383162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415483|NCT00272610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460051|NCT00447967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460052|NCT00447967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6415484|NCT00272636|Amiodarone|amiodarone|mesh-list
6415485|NCT00272636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6415486|NCT00272636|Vasodilator Agents|vasodilator agents|mesh-ancestor
6415487|NCT00272636|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6415488|NCT00272636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6415489|NCT00272636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415490|NCT00272636|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6415491|NCT00272636|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6415492|NCT00272636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6415493|NCT00272636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6415494|NCT00272636|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6415495|NCT00272636|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6415496|NCT00272636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6415497|NCT00272675|Chlorhexidine|chlorhexidine|mesh-list
6415498|NCT00272675|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6415499|NCT00272675|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6415500|NCT00272675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6415501|NCT00272675|Disinfectants|disinfectants|mesh-ancestor
6415502|NCT00272675|Dermatologic Agents|dermatologic agents|mesh-ancestor
6415503|NCT00272688|Levodopa|levodopa|mesh-list
6415504|NCT00272688|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6415505|NCT00272688|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6415506|NCT00272688|Dopamine Agents|dopamine agents|mesh-ancestor
6415507|NCT00272688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6415508|NCT00272688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415509|NCT00272688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415510|NCT00272701|Esomeprazole|esomeprazole|mesh-list
6415511|NCT00272701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6415512|NCT00272701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6415513|NCT00272701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6415514|NCT00272701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6415515|NCT00272701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415516|NCT00272714|Afimoxifene|afimoxifene|mesh-list
6415517|NCT00272714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6415518|NCT00272714|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6415519|NCT00272714|Hormone Antagonists|hormone antagonists|mesh-ancestor
6415520|NCT00272714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6415521|NCT00272714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415522|NCT00272714|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6018885|NCT00383162|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6018886|NCT00383162|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6018887|NCT00383162|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6018888|NCT00383162|Serotonin Agents|serotonin agents|mesh-ancestor
6018889|NCT00383162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6018890|NCT00383266|Carboplatin|carboplatin|mesh-list
6415523|NCT00272714|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6415524|NCT00272740|Fulvestrant|fulvestrant|mesh-list
6415525|NCT00272740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6415526|NCT00272740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6415527|NCT00272740|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6415528|NCT00272740|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6415529|NCT00272740|Hormone Antagonists|hormone antagonists|mesh-ancestor
6415530|NCT00272740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6415531|NCT00272740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018891|NCT00383266|Pemetrexed|pemetrexed|mesh-list
6018892|NCT00383266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6415532|NCT00272753|Budesonide|budesonide|mesh-list
6415533|NCT00272753|Albuterol|albuterol|mesh-list
6415534|NCT00272753|Formoterol Fumarate|formoterol fumarate|mesh-list
6415535|NCT00272753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6415536|NCT00272753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6415537|NCT00272753|Autonomic Agents|autonomic agents|mesh-ancestor
6415538|NCT00272753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6415539|NCT00272753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415540|NCT00272753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6415541|NCT00272753|Respiratory System Agents|respiratory system agents|mesh-ancestor
6415542|NCT00272753|Glucocorticoids|glucocorticoids|mesh-ancestor
6415543|NCT00272753|Hormones|hormones|mesh-ancestor
6415544|NCT00272753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6415545|NCT00272753|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6415546|NCT00272753|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6415547|NCT00272753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6415548|NCT00272753|Adrenergic Agents|adrenergic agents|mesh-ancestor
6415549|NCT00272753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6415550|NCT00272753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415551|NCT00272753|Tocolytic Agents|tocolytic agents|mesh-ancestor
6415552|NCT00272753|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6415553|NCT00272805|Carvedilol|carvedilol|mesh-list
6415554|NCT00272805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6415555|NCT00272805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6415556|NCT00272805|Adrenergic Agents|adrenergic agents|mesh-ancestor
6415557|NCT00272805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6415558|NCT00272805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415559|NCT00272805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415560|NCT00272805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6415561|NCT00272805|Antioxidants|antioxidants|mesh-ancestor
6415562|NCT00272805|Protective Agents|protective agents|mesh-ancestor
6415563|NCT00272805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6415564|NCT00272805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6415565|NCT00272805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6415566|NCT00272805|Vasodilator Agents|vasodilator agents|mesh-ancestor
6415567|NCT00272805|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6415568|NCT00272805|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6415569|NCT00272831|Cilostazol|cilostazol|mesh-list
6415570|NCT00272831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6415571|NCT00272831|Autonomic Agents|autonomic agents|mesh-ancestor
6415572|NCT00272831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6415573|NCT00272831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415574|NCT00272831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6415575|NCT00272831|Respiratory System Agents|respiratory system agents|mesh-ancestor
6415576|NCT00272831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6415577|NCT00272831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6415578|NCT00272831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415579|NCT00272831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6415580|NCT00272831|Vasodilator Agents|vasodilator agents|mesh-ancestor
6415581|NCT00272831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6415582|NCT00272831|Protective Agents|protective agents|mesh-ancestor
6415583|NCT00272831|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6415584|NCT00272831|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6415585|NCT00272831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6415586|NCT00272870|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
6415587|NCT00272870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6415588|NCT00272870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6415589|NCT00272870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415590|NCT00272896|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
6415591|NCT00272896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6415592|NCT00272896|Vasodilator Agents|vasodilator agents|mesh-ancestor
6415593|NCT00272896|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6415594|NCT00272896|Protective Agents|protective agents|mesh-ancestor
6415595|NCT00272896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415596|NCT00272909|Piclozotan|piclozotan|mesh-list
6415597|NCT00272909|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6415598|NCT00272909|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6415599|NCT00272909|Serotonin Agents|serotonin agents|mesh-ancestor
6415600|NCT00272909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6415601|NCT00272909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415602|NCT00272909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415603|NCT00272935|Estrogens|estrogens|mesh-list
6415604|NCT00272935|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6415605|NCT00272935|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
6415606|NCT00272935|Hormones|hormones|mesh-ancestor
6415607|NCT00272935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6415608|NCT00272935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415609|NCT00272948|Defibrotide|defibrotide|mesh-list
6415610|NCT00272948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6415611|NCT00272948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6415612|NCT00272948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415613|NCT00272948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6415614|NCT00273013|Montelukast|montelukast|mesh-list
6415615|NCT00273013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6415616|NCT00273013|Respiratory System Agents|respiratory system agents|mesh-ancestor
6415617|NCT00273013|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6415618|NCT00273013|Hormone Antagonists|hormone antagonists|mesh-ancestor
6415619|NCT00273013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6415620|NCT00273013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415621|NCT00273013|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6415622|NCT00273013|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6415623|NCT00273013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415624|NCT00273026|Fluticasone|fluticasone|mesh-list
6415625|NCT00273026|Xhance|xhance|mesh-list
6415626|NCT00273026|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6415627|NCT00273026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6415628|NCT00273026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6415629|NCT00273026|Autonomic Agents|autonomic agents|mesh-ancestor
6415630|NCT00273026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6415631|NCT00273026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415632|NCT00273026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6415633|NCT00273026|Respiratory System Agents|respiratory system agents|mesh-ancestor
6415634|NCT00273026|Dermatologic Agents|dermatologic agents|mesh-ancestor
6415635|NCT00273026|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6415636|NCT00273026|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6415637|NCT00273026|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6415638|NCT00273026|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6415639|NCT00273026|Adrenergic Agents|adrenergic agents|mesh-ancestor
6415640|NCT00273026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6415641|NCT00273026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415642|NCT00273039|Paroxetine|paroxetine|mesh-list
6415643|NCT00273039|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6415644|NCT00273039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6415645|NCT00273039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6415646|NCT00273039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415647|NCT00273039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6415648|NCT00273039|Serotonin Agents|serotonin agents|mesh-ancestor
6415649|NCT00273039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415650|NCT00273039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6415651|NCT00273039|Antidepressive Agents|antidepressive agents|mesh-ancestor
6415652|NCT00273039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6415653|NCT00273039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6415654|NCT00273039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6415655|NCT00273039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6415656|NCT00273065|Neosaxitoxin|neosaxitoxin|mesh-list
6415657|NCT00273065|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6415658|NCT00273065|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6415659|NCT00273065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6415660|NCT00273065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415661|NCT00273247|Interferons|interferons|mesh-list
6415662|NCT00273247|Interferon-alpha|interferon-alpha|mesh-list
6415663|NCT00273247|Interferon alpha-2|interferon alpha-2|mesh-list
6415664|NCT00273247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6415665|NCT00273247|Antiviral Agents|antiviral agents|mesh-ancestor
6415666|NCT00273247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6415667|NCT00273247|Immunologic Factors|immunologic factors|mesh-ancestor
6415668|NCT00273247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415669|NCT00273299|Valsartan|valsartan|mesh-list
6415670|NCT00273299|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6415671|NCT00273299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6415672|NCT00273299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6415673|NCT00273299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6415674|NCT00273299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415675|NCT00273299|Diuretics|diuretics|mesh-ancestor
6415676|NCT00273299|Natriuretic Agents|natriuretic agents|mesh-ancestor
6415677|NCT00273299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415678|NCT00273299|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6415679|NCT00273299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6415680|NCT00273312|Epothilone B|epothilone b|mesh-list
6415681|NCT00273312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6415682|NCT00273312|Tubulin Modulators|tubulin modulators|mesh-ancestor
6415683|NCT00273312|Antimitotic Agents|antimitotic agents|mesh-ancestor
6415684|NCT00273312|Mitosis Modulators|mitosis modulators|mesh-ancestor
6415685|NCT00273312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415686|NCT00273338|Calcitriol|calcitriol|mesh-list
6415687|NCT00273338|Docetaxel|docetaxel|mesh-list
6415688|NCT00273338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6415689|NCT00273338|Tubulin Modulators|tubulin modulators|mesh-ancestor
6415690|NCT00273338|Antimitotic Agents|antimitotic agents|mesh-ancestor
6415691|NCT00273338|Mitosis Modulators|mitosis modulators|mesh-ancestor
6415692|NCT00273338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415693|NCT00273338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6415694|NCT00273338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415695|NCT00273338|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6415696|NCT00273338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6415697|NCT00273338|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6415698|NCT00273338|Vitamins|vitamins|mesh-ancestor
6415699|NCT00273338|Micronutrients|micronutrients|mesh-ancestor
6415700|NCT00273338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6415701|NCT00273377|Dexamethasone|dexamethasone|mesh-list
6415702|NCT00273377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6415703|NCT00273377|Antiemetics|antiemetics|mesh-ancestor
6415704|NCT00273377|Autonomic Agents|autonomic agents|mesh-ancestor
6415705|NCT00273377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6415706|NCT00273377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415707|NCT00273377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6415708|NCT00273377|Glucocorticoids|glucocorticoids|mesh-ancestor
6415709|NCT00273377|Hormones|hormones|mesh-ancestor
6415710|NCT00273377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6415711|NCT00273377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6415712|NCT00273377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6415713|NCT00273390|Infliximab|infliximab|mesh-list
6415714|NCT00273390|Dermatologic Agents|dermatologic agents|mesh-ancestor
6415715|NCT00273390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6415716|NCT00273390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6415717|NCT00273416|Sildenafil Citrate|sildenafil citrate|mesh-list
6415718|NCT00273416|Vasodilator Agents|vasodilator agents|mesh-ancestor
6415719|NCT00273416|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6415720|NCT00273416|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6415721|NCT00273416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6415722|NCT00273416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415723|NCT00273416|Urological Agents|urological agents|mesh-ancestor
6415724|NCT00273429|Timolol|timolol|mesh-list
6415725|NCT00273429|Dorzolamide|dorzolamide|mesh-list
6415726|NCT00273429|Latanoprost|latanoprost|mesh-list
6415727|NCT00273429|Maleic acid|maleic acid|mesh-list
6415728|NCT00273429|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6415729|NCT00273429|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6415730|NCT00273429|Adrenergic Agents|adrenergic agents|mesh-ancestor
6415731|NCT00273429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6415732|NCT00273429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415733|NCT00273429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415734|NCT00273429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6415735|NCT00273429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6415736|NCT00273429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6415737|NCT00273429|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6415738|NCT00273429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6415739|NCT00273429|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6415740|NCT00273442|Timolol|timolol|mesh-list
6415741|NCT00273442|Dorzolamide|dorzolamide|mesh-list
6415742|NCT00273442|Maleic acid|maleic acid|mesh-list
6415743|NCT00273442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6415744|NCT00273442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6415745|NCT00273442|Adrenergic Agents|adrenergic agents|mesh-ancestor
6415746|NCT00273442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6415747|NCT00273442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415748|NCT00273442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415749|NCT00273442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6415750|NCT00273442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6415751|NCT00273442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6415752|NCT00273442|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6415753|NCT00273455|Timolol|timolol|mesh-list
6415754|NCT00273455|Bimatoprost|bimatoprost|mesh-list
6415755|NCT00273455|Dorzolamide|dorzolamide|mesh-list
6415756|NCT00273455|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6415757|NCT00273455|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6415758|NCT00273455|Adrenergic Agents|adrenergic agents|mesh-ancestor
6415759|NCT00273455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6415760|NCT00273455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415761|NCT00273455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415762|NCT00273455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6415763|NCT00273455|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6415764|NCT00273455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6415765|NCT00273455|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6415766|NCT00273468|Granisetron|granisetron|mesh-list
6415767|NCT00273468|Antiemetics|antiemetics|mesh-ancestor
6415768|NCT00273468|Autonomic Agents|autonomic agents|mesh-ancestor
6415769|NCT00273468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6415770|NCT00273468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415771|NCT00273468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6415772|NCT00273468|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6415773|NCT00273468|Serotonin Agents|serotonin agents|mesh-ancestor
6415774|NCT00273468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6415775|NCT00273468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415776|NCT00273481|Timolol|timolol|mesh-list
6415777|NCT00273481|Dorzolamide|dorzolamide|mesh-list
6415778|NCT00273481|Latanoprost|latanoprost|mesh-list
6415779|NCT00273481|Maleic acid|maleic acid|mesh-list
6415780|NCT00273481|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6415781|NCT00273481|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6415782|NCT00273481|Adrenergic Agents|adrenergic agents|mesh-ancestor
6415783|NCT00273481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6415784|NCT00273481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415785|NCT00273481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415786|NCT00273481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6415787|NCT00273481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6415788|NCT00273481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6415789|NCT00273481|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6415790|NCT00273481|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6415791|NCT00273481|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6415792|NCT00273507|Paclitaxel|paclitaxel|mesh-list
6415793|NCT00273507|Carboplatin|carboplatin|mesh-list
6415794|NCT00273507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6415795|NCT00273507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6415796|NCT00273507|Tubulin Modulators|tubulin modulators|mesh-ancestor
6415797|NCT00273507|Antimitotic Agents|antimitotic agents|mesh-ancestor
6415798|NCT00273507|Mitosis Modulators|mitosis modulators|mesh-ancestor
6415799|NCT00273507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415800|NCT00273520|Telithromycin|telithromycin|mesh-list
6415801|NCT00273520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6415802|NCT00273520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6415803|NCT00273533|Ramipril|ramipril|mesh-list
6415804|NCT00273533|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6415805|NCT00273533|Protease Inhibitors|protease inhibitors|mesh-ancestor
6415806|NCT00273533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6415807|NCT00273533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415808|NCT00273533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6415809|NCT00273546|Docetaxel|docetaxel|mesh-list
6415810|NCT00273546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6415811|NCT00273546|Tubulin Modulators|tubulin modulators|mesh-ancestor
6415812|NCT00273546|Antimitotic Agents|antimitotic agents|mesh-ancestor
6415813|NCT00273546|Mitosis Modulators|mitosis modulators|mesh-ancestor
6415814|NCT00273546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415815|NCT00273559|Prednisone|prednisone|mesh-list
6415816|NCT00273559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6415817|NCT00273559|Glucocorticoids|glucocorticoids|mesh-ancestor
6415818|NCT00273559|Hormones|hormones|mesh-ancestor
6415819|NCT00273559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6415820|NCT00273559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415821|NCT00273559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6415822|NCT00273559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6415823|NCT00273611|Vitamin D|vitamin d|mesh-list
6415824|NCT00273611|Vitamins|vitamins|mesh-ancestor
6415825|NCT00273611|Micronutrients|micronutrients|mesh-ancestor
6415826|NCT00273611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415827|NCT00273611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6415828|NCT00273624|Olanzapine|olanzapine|mesh-list
6415829|NCT00273624|Antiemetics|antiemetics|mesh-ancestor
6415830|NCT00273624|Autonomic Agents|autonomic agents|mesh-ancestor
6415831|NCT00273624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6415832|NCT00273624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415833|NCT00273624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6415834|NCT00273624|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6415835|NCT00273624|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6415836|NCT00273624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6415837|NCT00273624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6415838|NCT00273624|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6415839|NCT00273624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6415840|NCT00273624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6415841|NCT00273624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415842|NCT00273624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6415843|NCT00273624|Serotonin Agents|serotonin agents|mesh-ancestor
6415844|NCT00273676|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6415845|NCT00273676|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6415846|NCT00273676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6415847|NCT00273676|Antitubercular Agents|antitubercular agents|mesh-ancestor
6415848|NCT00273689|Albuterol|albuterol|mesh-list
6415849|NCT00273689|Montelukast|montelukast|mesh-list
6415850|NCT00273689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6415851|NCT00273689|Respiratory System Agents|respiratory system agents|mesh-ancestor
6415852|NCT00273689|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6415853|NCT00273689|Hormone Antagonists|hormone antagonists|mesh-ancestor
6415854|NCT00273689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6415855|NCT00273689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415856|NCT00273689|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6415857|NCT00273689|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6415858|NCT00273689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415859|NCT00273689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6415860|NCT00273689|Autonomic Agents|autonomic agents|mesh-ancestor
6415861|NCT00273689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6415862|NCT00273689|Tocolytic Agents|tocolytic agents|mesh-ancestor
6415863|NCT00273689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6415864|NCT00273689|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6415865|NCT00273689|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6415866|NCT00273689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6415867|NCT00273689|Adrenergic Agents|adrenergic agents|mesh-ancestor
6415868|NCT00273689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6415869|NCT00273702|Acetylcysteine|acetylcysteine|mesh-list
6415870|NCT00273702|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6415871|NCT00273702|Antiviral Agents|antiviral agents|mesh-ancestor
6415872|NCT00273702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6415873|NCT00273702|Expectorants|expectorants|mesh-ancestor
6415874|NCT00273702|Respiratory System Agents|respiratory system agents|mesh-ancestor
6415875|NCT00273702|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6415876|NCT00273702|Antioxidants|antioxidants|mesh-ancestor
6415877|NCT00273702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415878|NCT00273702|Protective Agents|protective agents|mesh-ancestor
6415879|NCT00273702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415880|NCT00273702|Antidotes|antidotes|mesh-ancestor
6415881|NCT00273741|Methylphenidate|methylphenidate|mesh-list
6415882|NCT00273741|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6415883|NCT00273741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415884|NCT00273741|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6415885|NCT00273741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6415886|NCT00273741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6415887|NCT00273741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415888|NCT00273741|Dopamine Agents|dopamine agents|mesh-ancestor
6415889|NCT00273741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6415890|NCT00273767|Epoetin Alfa|epoetin alfa|mesh-list
6415891|NCT00273767|Hematinics|hematinics|mesh-ancestor
6415892|NCT00273871|Cyclosporine|cyclosporine|mesh-list
6415893|NCT00273871|Tacrolimus|tacrolimus|mesh-list
6415894|NCT00273871|Cyclosporins|cyclosporins|mesh-list
6415895|NCT00273871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6415896|NCT00273871|Immunologic Factors|immunologic factors|mesh-ancestor
6415897|NCT00273871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415898|NCT00273871|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6415899|NCT00273871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6415900|NCT00273871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415901|NCT00273871|Antifungal Agents|antifungal agents|mesh-ancestor
6415902|NCT00273871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6415903|NCT00273871|Dermatologic Agents|dermatologic agents|mesh-ancestor
6415904|NCT00273871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6415905|NCT00273884|Cytarabine|cytarabine|mesh-list
6415906|NCT00273884|Amonafide|amonafide|mesh-list
6415907|NCT00273884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6415908|NCT00273884|Antimetabolites|antimetabolites|mesh-ancestor
6415909|NCT00273884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415910|NCT00273884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6415911|NCT00273884|Antiviral Agents|antiviral agents|mesh-ancestor
6415912|NCT00273884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6415913|NCT00273884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6415914|NCT00273884|Immunologic Factors|immunologic factors|mesh-ancestor
6415915|NCT00273884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415916|NCT00273884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6415917|NCT00273949|Lactulose|lactulose|mesh-list
5501277|NCT04475705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5501278|NCT04475705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5501279|NCT04475705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501280|NCT04475705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6415918|NCT00273949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6415919|NCT00273962|Albuterol|albuterol|mesh-list
6415920|NCT00273962|Ipratropium|ipratropium|mesh-list
6415921|NCT00273962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6415922|NCT00273962|Autonomic Agents|autonomic agents|mesh-ancestor
6415923|NCT00273962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6415924|NCT00273962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415925|NCT00273962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6415926|NCT00273962|Respiratory System Agents|respiratory system agents|mesh-ancestor
6415927|NCT00273962|Tocolytic Agents|tocolytic agents|mesh-ancestor
6415928|NCT00273962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6415929|NCT00273962|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6415930|NCT00273962|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6415931|NCT00273962|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6415932|NCT00273962|Adrenergic Agents|adrenergic agents|mesh-ancestor
6415933|NCT00273962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6415934|NCT00273962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415935|NCT00273962|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6415936|NCT00273962|Cholinergic Agents|cholinergic agents|mesh-ancestor
6415937|NCT00273975|Lamivudine|lamivudine|mesh-list
6415938|NCT00273975|Zidovudine|zidovudine|mesh-list
6415939|NCT00273975|Nevirapine|nevirapine|mesh-list
6415940|NCT00273975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6415941|NCT00273975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6415942|NCT00273975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6415943|NCT00273975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415944|NCT00273975|Antiviral Agents|antiviral agents|mesh-ancestor
6415945|NCT00273975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6415946|NCT00273975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6415947|NCT00273975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6415948|NCT00273975|Antimetabolites|antimetabolites|mesh-ancestor
6415949|NCT00273975|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6415950|NCT00273975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6415951|NCT00273988|Nevirapine|nevirapine|mesh-list
6415952|NCT00273988|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6415953|NCT00273988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6415954|NCT00273988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6415955|NCT00273988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415956|NCT00273988|Antiviral Agents|antiviral agents|mesh-ancestor
6415957|NCT00273988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6415958|NCT00273988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6415959|NCT00273988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6415960|NCT00273988|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6415961|NCT00273988|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6415962|NCT00274001|Nevirapine|nevirapine|mesh-list
6415963|NCT00274001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6415964|NCT00274001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6415965|NCT00274001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6415966|NCT00274001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415967|NCT00274001|Antiviral Agents|antiviral agents|mesh-ancestor
6415968|NCT00274001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6415969|NCT00274001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6415970|NCT00274001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6415971|NCT00274001|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6415972|NCT00274001|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6415973|NCT00274014|Tiotropium Bromide|tiotropium bromide|mesh-list
6415974|NCT00274014|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6415975|NCT00274014|Autonomic Agents|autonomic agents|mesh-ancestor
6415976|NCT00274014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6415977|NCT00274014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415978|NCT00274014|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6415979|NCT00274014|Respiratory System Agents|respiratory system agents|mesh-ancestor
6415980|NCT00274014|Parasympatholytics|parasympatholytics|mesh-ancestor
6415981|NCT00274014|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6415982|NCT00274014|Cholinergic Agents|cholinergic agents|mesh-ancestor
6415983|NCT00274014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6415984|NCT00274014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415985|NCT00274027|Bromides|bromides|mesh-list
6415986|NCT00274027|Tiotropium Bromide|tiotropium bromide|mesh-list
6415987|NCT00274027|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6415988|NCT00274027|Autonomic Agents|autonomic agents|mesh-ancestor
6415989|NCT00274027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6415990|NCT00274027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6415991|NCT00274027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6415992|NCT00274027|Respiratory System Agents|respiratory system agents|mesh-ancestor
6415993|NCT00274027|Parasympatholytics|parasympatholytics|mesh-ancestor
6415994|NCT00274027|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6415995|NCT00274027|Cholinergic Agents|cholinergic agents|mesh-ancestor
6415996|NCT00274027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6415997|NCT00274027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6415998|NCT00274027|Anticonvulsants|anticonvulsants|mesh-ancestor
6415999|NCT00274040|Tiotropium Bromide|tiotropium bromide|mesh-list
6416000|NCT00274040|Ipratropium|ipratropium|mesh-list
6416001|NCT00274040|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6416002|NCT00274040|Autonomic Agents|autonomic agents|mesh-ancestor
6416003|NCT00274040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6416004|NCT00274040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416005|NCT00274040|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6416006|NCT00274040|Respiratory System Agents|respiratory system agents|mesh-ancestor
6416007|NCT00274040|Parasympatholytics|parasympatholytics|mesh-ancestor
6416008|NCT00274040|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6416009|NCT00274040|Cholinergic Agents|cholinergic agents|mesh-ancestor
6416010|NCT00274040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6416011|NCT00274040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416012|NCT00274053|Tiotropium Bromide|tiotropium bromide|mesh-list
6416013|NCT00274053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6416014|NCT00274053|Autonomic Agents|autonomic agents|mesh-ancestor
6416015|NCT00274053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6416016|NCT00274053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416017|NCT00274053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6416018|NCT00274053|Respiratory System Agents|respiratory system agents|mesh-ancestor
6416019|NCT00274053|Parasympatholytics|parasympatholytics|mesh-ancestor
6416020|NCT00274053|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6416021|NCT00274053|Cholinergic Agents|cholinergic agents|mesh-ancestor
6416022|NCT00274053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6416023|NCT00274053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416024|NCT00274066|Fenoterol|fenoterol|mesh-list
6416025|NCT00274066|Tiotropium Bromide|tiotropium bromide|mesh-list
6416026|NCT00274066|Ipratropium|ipratropium|mesh-list
6416027|NCT00274066|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6416028|NCT00274066|Autonomic Agents|autonomic agents|mesh-ancestor
6416029|NCT00274066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6416030|NCT00274066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416031|NCT00274066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6416032|NCT00274066|Respiratory System Agents|respiratory system agents|mesh-ancestor
6416033|NCT00274066|Parasympatholytics|parasympatholytics|mesh-ancestor
6416034|NCT00274066|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6416035|NCT00274066|Cholinergic Agents|cholinergic agents|mesh-ancestor
6416036|NCT00274066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6416037|NCT00274066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416038|NCT00274066|Sympathomimetics|sympathomimetics|mesh-ancestor
6416039|NCT00274066|Tocolytic Agents|tocolytic agents|mesh-ancestor
6416040|NCT00274066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6416041|NCT00274066|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6416042|NCT00274066|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6416043|NCT00274066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6416044|NCT00274066|Adrenergic Agents|adrenergic agents|mesh-ancestor
6416045|NCT00274079|Tiotropium Bromide|tiotropium bromide|mesh-list
6416046|NCT00274079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6416047|NCT00274079|Autonomic Agents|autonomic agents|mesh-ancestor
6416048|NCT00274079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6416049|NCT00274079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416050|NCT00274079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6416051|NCT00274079|Respiratory System Agents|respiratory system agents|mesh-ancestor
6416052|NCT00274079|Parasympatholytics|parasympatholytics|mesh-ancestor
6018893|NCT00383266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6018894|NCT00383266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6018895|NCT00383266|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6018896|NCT00383266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6018897|NCT00383331|Gemcitabine|gemcitabine|mesh-list
6018898|NCT00383331|Pemetrexed|pemetrexed|mesh-list
6416053|NCT00274079|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6416054|NCT00274079|Cholinergic Agents|cholinergic agents|mesh-ancestor
6416055|NCT00274079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6416056|NCT00274079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416057|NCT00274092|Tiotropium Bromide|tiotropium bromide|mesh-list
6416058|NCT00274092|Ipratropium|ipratropium|mesh-list
6416059|NCT00274092|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6416060|NCT00274092|Autonomic Agents|autonomic agents|mesh-ancestor
6416061|NCT00274092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6416062|NCT00274092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416063|NCT00274092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6416064|NCT00274092|Respiratory System Agents|respiratory system agents|mesh-ancestor
6416065|NCT00274092|Parasympatholytics|parasympatholytics|mesh-ancestor
6416066|NCT00274092|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6416067|NCT00274092|Cholinergic Agents|cholinergic agents|mesh-ancestor
6416068|NCT00274092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6416069|NCT00274092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416070|NCT00274105|Telmisartan|telmisartan|mesh-list
6416071|NCT00274105|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6416072|NCT00274105|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6416073|NCT00274105|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6416074|NCT00274105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416075|NCT00274118|Telmisartan|telmisartan|mesh-list
6416076|NCT00274118|Enalapril|enalapril|mesh-list
6416077|NCT00274118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6416078|NCT00274118|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6416079|NCT00274118|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6416080|NCT00274118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416081|NCT00274118|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6416082|NCT00274118|Protease Inhibitors|protease inhibitors|mesh-ancestor
6416083|NCT00274118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6460053|NCT00447967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6460054|NCT00447967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6460055|NCT00447967|Immunologic Factors|immunologic factors|mesh-ancestor
6460056|NCT00447967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460057|NCT00447967|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6460058|NCT00447967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6460059|NCT00447967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6460060|NCT00447967|Antidotes|antidotes|mesh-ancestor
6460061|NCT00447967|Protective Agents|protective agents|mesh-ancestor
6460062|NCT00447967|Vitamin B Complex|vitamin b complex|mesh-ancestor
6460063|NCT00447967|Vitamins|vitamins|mesh-ancestor
6460064|NCT00447967|Micronutrients|micronutrients|mesh-ancestor
6460065|NCT00448097|Docetaxel|docetaxel|mesh-list
6460066|NCT00448097|Cetuximab|cetuximab|mesh-list
6460067|NCT00448097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6460068|NCT00448097|Tubulin Modulators|tubulin modulators|mesh-ancestor
6460069|NCT00448097|Antimitotic Agents|antimitotic agents|mesh-ancestor
6460070|NCT00448097|Mitosis Modulators|mitosis modulators|mesh-ancestor
6460071|NCT00448097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460072|NCT00448097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6460073|NCT00448110|Diclofenac|diclofenac|mesh-list
6460074|NCT00448110|Ketorolac|ketorolac|mesh-list
6460075|NCT00448110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6460076|NCT00448110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6460077|NCT00448110|Analgesics|analgesics|mesh-ancestor
6460078|NCT00448110|Sensory System Agents|sensory system agents|mesh-ancestor
6460079|NCT00448110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6460080|NCT00448110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460081|NCT00448110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6460082|NCT00448110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6460083|NCT00448110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6460084|NCT00448110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6460085|NCT00448110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460086|NCT00448149|Everolimus|everolimus|mesh-list
6460087|NCT00448149|Sorafenib|sorafenib|mesh-list
6460088|NCT00448149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6460089|NCT00448149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6460090|NCT00448149|Immunologic Factors|immunologic factors|mesh-ancestor
6460091|NCT00448149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460092|NCT00448149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6460093|NCT00448149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6460094|NCT00448149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6018899|NCT00383331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6018900|NCT00383331|Antimetabolites|antimetabolites|mesh-ancestor
6018901|NCT00383331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6018902|NCT00383331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6018903|NCT00383331|Antiviral Agents|antiviral agents|mesh-ancestor
6018904|NCT00383331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6018905|NCT00383331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6416084|NCT00274131|Pramipexole|pramipexole|mesh-list
6416085|NCT00274131|Antioxidants|antioxidants|mesh-ancestor
6018906|NCT00383331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6416086|NCT00274131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416087|NCT00274131|Protective Agents|protective agents|mesh-ancestor
6416088|NCT00274131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416089|NCT00274131|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6416090|NCT00274131|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6416091|NCT00274131|Dopamine Agonists|dopamine agonists|mesh-ancestor
6416092|NCT00274131|Dopamine Agents|dopamine agents|mesh-ancestor
6416093|NCT00274131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6416094|NCT00274144|Telmisartan|telmisartan|mesh-list
6416095|NCT00274144|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6416096|NCT00274144|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6416097|NCT00274144|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6416098|NCT00274144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416099|NCT00274170|Octreotide|octreotide|mesh-list
6416100|NCT00274170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6416101|NCT00274170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6416102|NCT00274170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6416103|NCT00274235|Pyrimethamine|pyrimethamine|mesh-list
6416104|NCT00274235|Sulfadoxine|sulfadoxine|mesh-list
6416105|NCT00274235|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6416106|NCT00274235|Mefloquine|mefloquine|mesh-list
6416107|NCT00274235|Antimalarials|antimalarials|mesh-ancestor
6416108|NCT00274235|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6416109|NCT00274235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6416110|NCT00274235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6416111|NCT00274235|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6416112|NCT00274235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6416113|NCT00274235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416114|NCT00274235|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6416115|NCT00274235|Renal Agents|renal agents|mesh-ancestor
6416116|NCT00274274|Insulin|insulin|mesh-list
6416117|NCT00274274|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6416118|NCT00274274|Insulin Aspart|insulin aspart|mesh-list
6416119|NCT00274274|Insulin Detemir|insulin detemir|mesh-list
6416120|NCT00274274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6416121|NCT00274274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416122|NCT00274326|Satavaptan|satavaptan|mesh-list
6416123|NCT00274326|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6416124|NCT00274326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416125|NCT00274326|Natriuretic Agents|natriuretic agents|mesh-ancestor
6416126|NCT00274326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416127|NCT00274339|Lansoprazole|lansoprazole|mesh-list
6416128|NCT00274339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6416129|NCT00274339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6416130|NCT00274339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6416131|NCT00274339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6416132|NCT00274339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416133|NCT00274352|Adalimumab|adalimumab|mesh-list
6416134|NCT00274352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6416135|NCT00274352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6416136|NCT00274391|Amiloride|amiloride|mesh-list
6416137|NCT00274391|Diuretics|diuretics|mesh-ancestor
6416138|NCT00274391|Natriuretic Agents|natriuretic agents|mesh-ancestor
6416139|NCT00274391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416140|NCT00274391|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
6416141|NCT00274391|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6416142|NCT00274391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6416143|NCT00274391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416144|NCT00274391|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
6416145|NCT00274391|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6416146|NCT00274404|Valacyclovir|valacyclovir|mesh-list
6416147|NCT00274404|Antiviral Agents|antiviral agents|mesh-ancestor
6416148|NCT00274404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6416149|NCT00274417|Dutasteride|dutasteride|mesh-list
6416150|NCT00274417|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6416151|NCT00274417|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6416152|NCT00274417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6416153|NCT00274417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416154|NCT00274417|Hormone Antagonists|hormone antagonists|mesh-ancestor
6416155|NCT00274417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6416156|NCT00274417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416157|NCT00274430|Dexamethasone|dexamethasone|mesh-list
6416158|NCT00274430|Tadalafil|tadalafil|mesh-list
6416159|NCT00274430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6416160|NCT00274430|Antiemetics|antiemetics|mesh-ancestor
6416161|NCT00274430|Autonomic Agents|autonomic agents|mesh-ancestor
6416162|NCT00274430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6416163|NCT00274430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416164|NCT00274430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6416165|NCT00274430|Glucocorticoids|glucocorticoids|mesh-ancestor
6416166|NCT00274430|Hormones|hormones|mesh-ancestor
6416167|NCT00274430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6416168|NCT00274430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6416169|NCT00274430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6416170|NCT00274430|Vasodilator Agents|vasodilator agents|mesh-ancestor
6416171|NCT00274430|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6416172|NCT00274430|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6416173|NCT00274430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6416174|NCT00274430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416175|NCT00274430|Urological Agents|urological agents|mesh-ancestor
6416176|NCT00274443|Carboplatin|carboplatin|mesh-list
6416177|NCT00274443|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6416178|NCT00274443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6416179|NCT00274495|Rosiglitazone|rosiglitazone|mesh-list
6416180|NCT00274495|Ribavirin|ribavirin|mesh-list
6416181|NCT00274495|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6416182|NCT00274495|Antimetabolites|antimetabolites|mesh-ancestor
6416183|NCT00274495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416184|NCT00274495|Antiviral Agents|antiviral agents|mesh-ancestor
6416185|NCT00274495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6416186|NCT00274495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6416187|NCT00274495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416188|NCT00274508|Bromides|bromides|mesh-list
6416189|NCT00274508|Tiotropium Bromide|tiotropium bromide|mesh-list
6416190|NCT00274508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6416191|NCT00274508|Autonomic Agents|autonomic agents|mesh-ancestor
6416192|NCT00274508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6416193|NCT00274508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416194|NCT00274508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6416195|NCT00274508|Respiratory System Agents|respiratory system agents|mesh-ancestor
6416196|NCT00274508|Parasympatholytics|parasympatholytics|mesh-ancestor
6416197|NCT00274508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6416198|NCT00274508|Cholinergic Agents|cholinergic agents|mesh-ancestor
6416199|NCT00274508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6416200|NCT00274508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416201|NCT00274508|Anticonvulsants|anticonvulsants|mesh-ancestor
6416202|NCT00274521|Tiotropium Bromide|tiotropium bromide|mesh-list
6416203|NCT00274521|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6416204|NCT00274521|Autonomic Agents|autonomic agents|mesh-ancestor
6416205|NCT00274521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6416206|NCT00274521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416207|NCT00274521|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6416208|NCT00274521|Respiratory System Agents|respiratory system agents|mesh-ancestor
6416209|NCT00274521|Parasympatholytics|parasympatholytics|mesh-ancestor
6416210|NCT00274521|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6416211|NCT00274521|Cholinergic Agents|cholinergic agents|mesh-ancestor
6416212|NCT00274521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6416213|NCT00274521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416214|NCT00274534|Tiotropium Bromide|tiotropium bromide|mesh-list
6416215|NCT00274534|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6416216|NCT00274534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6416217|NCT00274534|Autonomic Agents|autonomic agents|mesh-ancestor
6416218|NCT00274534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6416219|NCT00274534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416220|NCT00274534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6416221|NCT00274534|Respiratory System Agents|respiratory system agents|mesh-ancestor
6416222|NCT00274534|Parasympatholytics|parasympatholytics|mesh-ancestor
6416223|NCT00274534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6416224|NCT00274534|Cholinergic Agents|cholinergic agents|mesh-ancestor
6416225|NCT00274534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6416226|NCT00274534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416227|NCT00274534|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6416228|NCT00274534|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6416229|NCT00274534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6416230|NCT00274534|Adrenergic Agents|adrenergic agents|mesh-ancestor
6416231|NCT00274547|Tiotropium Bromide|tiotropium bromide|mesh-list
6416232|NCT00274547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6416233|NCT00274547|Autonomic Agents|autonomic agents|mesh-ancestor
6416234|NCT00274547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6416235|NCT00274547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416236|NCT00274547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6416237|NCT00274547|Respiratory System Agents|respiratory system agents|mesh-ancestor
6416238|NCT00274547|Parasympatholytics|parasympatholytics|mesh-ancestor
6416239|NCT00274547|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6416240|NCT00274547|Cholinergic Agents|cholinergic agents|mesh-ancestor
6416241|NCT00274547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6416242|NCT00274547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416243|NCT00274560|Tiotropium Bromide|tiotropium bromide|mesh-list
6416244|NCT00274560|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6416245|NCT00274560|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6416246|NCT00274560|Autonomic Agents|autonomic agents|mesh-ancestor
6416247|NCT00274560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6416248|NCT00274560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416249|NCT00274560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6416250|NCT00274560|Respiratory System Agents|respiratory system agents|mesh-ancestor
6416251|NCT00274560|Parasympatholytics|parasympatholytics|mesh-ancestor
6416252|NCT00274560|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6416253|NCT00274560|Cholinergic Agents|cholinergic agents|mesh-ancestor
6416254|NCT00274560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6416255|NCT00274560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416256|NCT00274560|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6416257|NCT00274560|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6416258|NCT00274560|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6416259|NCT00274560|Adrenergic Agents|adrenergic agents|mesh-ancestor
6416260|NCT00274573|Bromides|bromides|mesh-list
6416261|NCT00274573|Tiotropium Bromide|tiotropium bromide|mesh-list
6416262|NCT00274573|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6416263|NCT00274573|Autonomic Agents|autonomic agents|mesh-ancestor
6416264|NCT00274573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6018907|NCT00383331|Immunologic Factors|immunologic factors|mesh-ancestor
6018908|NCT00383331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018909|NCT00383331|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6018910|NCT00383331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6018911|NCT00383448|Cyclosporine|cyclosporine|mesh-list
6018912|NCT00383448|Melphalan|melphalan|mesh-list
6018913|NCT00383448|Alemtuzumab|alemtuzumab|mesh-list
6018914|NCT00383448|Hydroxyurea|hydroxyurea|mesh-list
6018915|NCT00383448|Clofarabine|clofarabine|mesh-list
6018916|NCT00383448|Cyclosporins|cyclosporins|mesh-list
6416265|NCT00274573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416266|NCT00274573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6416267|NCT00274573|Respiratory System Agents|respiratory system agents|mesh-ancestor
6416268|NCT00274573|Parasympatholytics|parasympatholytics|mesh-ancestor
6416269|NCT00274573|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6416270|NCT00274573|Cholinergic Agents|cholinergic agents|mesh-ancestor
6416271|NCT00274573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6018917|NCT00383448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6018918|NCT00383448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416272|NCT00274573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416273|NCT00274573|Anticonvulsants|anticonvulsants|mesh-ancestor
6416274|NCT00274586|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
6416275|NCT00274586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6416276|NCT00274599|Telmisartan|telmisartan|mesh-list
6416277|NCT00274599|Ramipril|ramipril|mesh-list
6416278|NCT00274599|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6416279|NCT00274599|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6416280|NCT00274599|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6416281|NCT00274599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416282|NCT00274599|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6416283|NCT00274599|Protease Inhibitors|protease inhibitors|mesh-ancestor
6416284|NCT00274599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6416285|NCT00274612|Telmisartan|telmisartan|mesh-list
6416286|NCT00274612|Ramipril|ramipril|mesh-list
6416287|NCT00274612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6416288|NCT00274612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6416289|NCT00274612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6416290|NCT00274612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416291|NCT00274612|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6416292|NCT00274612|Protease Inhibitors|protease inhibitors|mesh-ancestor
6416293|NCT00274612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6416294|NCT00274638|Losartan|losartan|mesh-list
6416295|NCT00274638|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6416296|NCT00274638|Telmisartan|telmisartan|mesh-list
6416297|NCT00274638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6416298|NCT00274638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6416299|NCT00274638|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6416300|NCT00274638|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6416301|NCT00274638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416302|NCT00274638|Diuretics|diuretics|mesh-ancestor
6416303|NCT00274638|Natriuretic Agents|natriuretic agents|mesh-ancestor
6416304|NCT00274638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416305|NCT00274638|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6416306|NCT00274638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6416307|NCT00274677|Lamotrigine|lamotrigine|mesh-list
6416308|NCT00274677|Anticonvulsants|anticonvulsants|mesh-ancestor
6416309|NCT00274677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6416310|NCT00274677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6416311|NCT00274677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416312|NCT00274677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6416313|NCT00274677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416314|NCT00274677|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6416315|NCT00274677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6416316|NCT00274677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6416317|NCT00274677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6416318|NCT00274677|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6416319|NCT00274690|Casopitant|casopitant|mesh-list
6416320|NCT00274690|Antiemetics|antiemetics|mesh-ancestor
6416321|NCT00274690|Autonomic Agents|autonomic agents|mesh-ancestor
6416322|NCT00274690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6416323|NCT00274690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416324|NCT00274690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6416325|NCT00274690|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6416326|NCT00274690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6416327|NCT00274690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416328|NCT00274794|Rituximab|rituximab|mesh-list
6416329|NCT00274794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6416330|NCT00274794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6416331|NCT00274794|Immunologic Factors|immunologic factors|mesh-ancestor
6416332|NCT00274794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416333|NCT00274794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6416334|NCT00274807|Cytarabine|cytarabine|mesh-list
6416335|NCT00274807|Etoposide|etoposide|mesh-list
6416336|NCT00274807|Mitoxantrone|mitoxantrone|mesh-list
6416337|NCT00274807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6416338|NCT00274807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6416339|NCT00274807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6416340|NCT00274807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6416341|NCT00274807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6416342|NCT00274807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416343|NCT00274807|Immunologic Factors|immunologic factors|mesh-ancestor
6416344|NCT00274807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416345|NCT00274807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6416346|NCT00274807|Antimetabolites|antimetabolites|mesh-ancestor
6416347|NCT00274807|Antiviral Agents|antiviral agents|mesh-ancestor
6416348|NCT00274807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6416349|NCT00274807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6416350|NCT00274807|Analgesics|analgesics|mesh-ancestor
6416351|NCT00274807|Sensory System Agents|sensory system agents|mesh-ancestor
6416352|NCT00274807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6416353|NCT00274820|Ascorbic Acid|ascorbic acid|mesh-list
6416354|NCT00274820|Thalidomide|thalidomide|mesh-list
6416355|NCT00274820|Dexamethasone|dexamethasone|mesh-list
6416356|NCT00274820|Arsenic Trioxide|arsenic trioxide|mesh-list
6416357|NCT00274820|Vitamins|vitamins|mesh-ancestor
6416358|NCT00274820|Micronutrients|micronutrients|mesh-ancestor
6416359|NCT00274820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416360|NCT00274820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6416361|NCT00274820|Antiemetics|antiemetics|mesh-ancestor
6416362|NCT00274820|Autonomic Agents|autonomic agents|mesh-ancestor
6416363|NCT00274820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6416364|NCT00274820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6416365|NCT00274820|Glucocorticoids|glucocorticoids|mesh-ancestor
6416366|NCT00274820|Hormones|hormones|mesh-ancestor
6416367|NCT00274820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6416368|NCT00274820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6416369|NCT00274820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6416370|NCT00274820|Antioxidants|antioxidants|mesh-ancestor
6416371|NCT00274820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416372|NCT00274820|Protective Agents|protective agents|mesh-ancestor
6416373|NCT00274820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6416374|NCT00274820|Immunologic Factors|immunologic factors|mesh-ancestor
6416375|NCT00274820|Leprostatic Agents|leprostatic agents|mesh-ancestor
6416376|NCT00274820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6416377|NCT00274820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6416378|NCT00274820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6416379|NCT00274820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6416380|NCT00274820|Growth Substances|growth substances|mesh-ancestor
6416381|NCT00274820|Growth Inhibitors|growth inhibitors|mesh-ancestor
6416382|NCT00274833|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6416383|NCT00274833|Temozolomide|temozolomide|mesh-list
6416384|NCT00274833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6416385|NCT00274833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6416386|NCT00274833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6416387|NCT00274833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416388|NCT00274833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6416389|NCT00274833|Alkylating Agents|alkylating agents|mesh-ancestor
6416390|NCT00274859|Gemcitabine|gemcitabine|mesh-list
6416391|NCT00274859|Oxaliplatin|oxaliplatin|mesh-list
6416392|NCT00274859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6416393|NCT00274859|Antimetabolites|antimetabolites|mesh-ancestor
6416394|NCT00274859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416395|NCT00274859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6416396|NCT00274859|Antiviral Agents|antiviral agents|mesh-ancestor
6416397|NCT00274859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6416398|NCT00274859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6416399|NCT00274859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6416400|NCT00274859|Immunologic Factors|immunologic factors|mesh-ancestor
6416401|NCT00274859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416402|NCT00274872|Leucovorin|leucovorin|mesh-list
6416403|NCT00274872|Fluorouracil|fluorouracil|mesh-list
6416404|NCT00274872|Oxaliplatin|oxaliplatin|mesh-list
6416405|NCT00274872|Calcium|calcium|mesh-list
6416406|NCT00274872|Levoleucovorin|levoleucovorin|mesh-list
6416407|NCT00274872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6416408|NCT00274872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416409|NCT00274872|Antimetabolites|antimetabolites|mesh-ancestor
6416410|NCT00274872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416411|NCT00274872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6416412|NCT00274872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6416413|NCT00274872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6416414|NCT00274872|Immunologic Factors|immunologic factors|mesh-ancestor
6416415|NCT00274872|Antidotes|antidotes|mesh-ancestor
6416416|NCT00274872|Protective Agents|protective agents|mesh-ancestor
6416417|NCT00274872|Vitamin B Complex|vitamin b complex|mesh-ancestor
6416418|NCT00274872|Vitamins|vitamins|mesh-ancestor
6416419|NCT00274872|Micronutrients|micronutrients|mesh-ancestor
6416420|NCT00274885|Oxaliplatin|oxaliplatin|mesh-list
6416421|NCT00274885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6416422|NCT00274898|Celecoxib|celecoxib|mesh-list
6416423|NCT00274898|Docetaxel|docetaxel|mesh-list
6416424|NCT00274898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6416425|NCT00274898|Tubulin Modulators|tubulin modulators|mesh-ancestor
6416426|NCT00274898|Antimitotic Agents|antimitotic agents|mesh-ancestor
6416427|NCT00274898|Mitosis Modulators|mitosis modulators|mesh-ancestor
6416428|NCT00274898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416429|NCT00274898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6416430|NCT00274898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6416431|NCT00274898|Analgesics|analgesics|mesh-ancestor
6416432|NCT00274898|Sensory System Agents|sensory system agents|mesh-ancestor
6416433|NCT00274898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6416434|NCT00274898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416435|NCT00274898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6416436|NCT00274898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6416437|NCT00274898|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6416438|NCT00274898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6416439|NCT00274898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6416440|NCT00274911|Vincristine|vincristine|mesh-list
6416441|NCT00274911|Lomustine|lomustine|mesh-list
6416442|NCT00274911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6416443|NCT00274911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6416444|NCT00274911|Tubulin Modulators|tubulin modulators|mesh-ancestor
6416445|NCT00274911|Antimitotic Agents|antimitotic agents|mesh-ancestor
6416446|NCT00274911|Mitosis Modulators|mitosis modulators|mesh-ancestor
6416447|NCT00274911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416448|NCT00274911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6416449|NCT00274911|Alkylating Agents|alkylating agents|mesh-ancestor
6416450|NCT00274950|Carboplatin|carboplatin|mesh-list
6416451|NCT00274950|Etoposide|etoposide|mesh-list
6416452|NCT00274950|Ifosfamide|ifosfamide|mesh-list
6416453|NCT00274950|Bleomycin|bleomycin|mesh-list
6416454|NCT00274950|Vinblastine|vinblastine|mesh-list
6416455|NCT00274950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6416456|NCT00274950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6416457|NCT00274950|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6416458|NCT00274950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6416459|NCT00274950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6416460|NCT00274950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416461|NCT00274950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6416462|NCT00274950|Alkylating Agents|alkylating agents|mesh-ancestor
6416463|NCT00274950|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6416464|NCT00274950|Tubulin Modulators|tubulin modulators|mesh-ancestor
6416465|NCT00274950|Antimitotic Agents|antimitotic agents|mesh-ancestor
6416466|NCT00274950|Mitosis Modulators|mitosis modulators|mesh-ancestor
6416467|NCT00274963|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6416468|NCT00274963|Mitoxantrone|mitoxantrone|mesh-list
6416469|NCT00274963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6416470|NCT00274963|Alkylating Agents|alkylating agents|mesh-ancestor
6416471|NCT00274963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416472|NCT00274963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6416473|NCT00274963|Analgesics|analgesics|mesh-ancestor
6416474|NCT00274963|Sensory System Agents|sensory system agents|mesh-ancestor
6416475|NCT00274963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6416476|NCT00274963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416477|NCT00274963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6416478|NCT00274963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6416479|NCT00274963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6416480|NCT00274976|Alemtuzumab|alemtuzumab|mesh-list
6416481|NCT00274976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6416482|NCT00274976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6416483|NCT00274989|Rituximab|rituximab|mesh-list
6416484|NCT00274989|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6416485|NCT00274989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6416486|NCT00274989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6416487|NCT00274989|Immunologic Factors|immunologic factors|mesh-ancestor
6416488|NCT00274989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416489|NCT00274989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6416490|NCT00274989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6416491|NCT00274989|Alkylating Agents|alkylating agents|mesh-ancestor
6416492|NCT00274989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416493|NCT00275015|Cytarabine|cytarabine|mesh-list
6416494|NCT00275015|Dexamethasone|dexamethasone|mesh-list
6416495|NCT00275015|Cyclophosphamide|cyclophosphamide|mesh-list
6416496|NCT00275015|Melphalan|melphalan|mesh-list
6416497|NCT00275015|Carmustine|carmustine|mesh-list
6416498|NCT00275015|Fludarabine|fludarabine|mesh-list
6416499|NCT00275015|Fludarabine phosphate|fludarabine phosphate|mesh-list
6416500|NCT00275015|Etoposide|etoposide|mesh-list
6416501|NCT00275015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6416502|NCT00275015|Immunologic Factors|immunologic factors|mesh-ancestor
6416503|NCT00275015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416504|NCT00275015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6416505|NCT00275015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6416506|NCT00275015|Alkylating Agents|alkylating agents|mesh-ancestor
6416507|NCT00275015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416508|NCT00275015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6416509|NCT00275015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6416510|NCT00275015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6416511|NCT00275015|Antiemetics|antiemetics|mesh-ancestor
6416512|NCT00275015|Autonomic Agents|autonomic agents|mesh-ancestor
6416513|NCT00275015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6416514|NCT00275015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6416515|NCT00275015|Glucocorticoids|glucocorticoids|mesh-ancestor
6416516|NCT00275015|Hormones|hormones|mesh-ancestor
6416517|NCT00275015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6416518|NCT00275015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6416519|NCT00275015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6416520|NCT00275015|Antimetabolites|antimetabolites|mesh-ancestor
6416521|NCT00275015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6416522|NCT00275015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6416523|NCT00275015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6416524|NCT00275015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6416525|NCT00275015|Antiviral Agents|antiviral agents|mesh-ancestor
6416526|NCT00275015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6416527|NCT00275041|Irinotecan|irinotecan|mesh-list
6416528|NCT00275041|Cetuximab|cetuximab|mesh-list
6416529|NCT00275041|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6538144|NCT00826163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6538145|NCT00826254|Vitamins|vitamins|mesh-list
6538146|NCT00826254|Vitamin K|vitamin k|mesh-list
6538147|NCT00826254|Micronutrients|micronutrients|mesh-ancestor
5501281|NCT04475705|Anesthetics, General|anesthetics, general|mesh-ancestor
6416530|NCT00275041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6416531|NCT00275041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6416532|NCT00275041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416533|NCT00275041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6416534|NCT00275041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6416535|NCT00275054|Cyclophosphamide|cyclophosphamide|mesh-list
6416536|NCT00275054|Rituximab|rituximab|mesh-list
6416537|NCT00275054|Fludarabine|fludarabine|mesh-list
6416538|NCT00275054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6416539|NCT00275054|Immunologic Factors|immunologic factors|mesh-ancestor
6416540|NCT00275054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416541|NCT00275054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6416542|NCT00275054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6416543|NCT00275054|Alkylating Agents|alkylating agents|mesh-ancestor
6416544|NCT00275054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416545|NCT00275054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6416546|NCT00275054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6416547|NCT00275054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6416548|NCT00275067|Temozolomide|temozolomide|mesh-list
6416549|NCT00275067|Arsenic Trioxide|arsenic trioxide|mesh-list
6416550|NCT00275067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6416551|NCT00275067|Alkylating Agents|alkylating agents|mesh-ancestor
6416552|NCT00275067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416553|NCT00275067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6416554|NCT00275080|Decitabine|decitabine|mesh-list
6416555|NCT00275080|Azacitidine|azacitidine|mesh-list
6416556|NCT00275080|Vorinostat|vorinostat|mesh-list
6416557|NCT00275080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6416558|NCT00275080|Antimetabolites|antimetabolites|mesh-ancestor
6416559|NCT00275080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416560|NCT00275080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6416561|NCT00275080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6416562|NCT00275080|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6416563|NCT00275093|Sirolimus|sirolimus|mesh-list
6416564|NCT00275093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6416565|NCT00275093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6416566|NCT00275093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6416567|NCT00275093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6416568|NCT00275093|Antifungal Agents|antifungal agents|mesh-ancestor
6416569|NCT00275093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6416570|NCT00275093|Immunologic Factors|immunologic factors|mesh-ancestor
6416571|NCT00275093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416572|NCT00275106|Leucovorin|leucovorin|mesh-list
6416573|NCT00275106|Cytarabine|cytarabine|mesh-list
6416574|NCT00275106|Dexamethasone|dexamethasone|mesh-list
6416575|NCT00275106|Prednisolone|prednisolone|mesh-list
6416576|NCT00275106|Cyclophosphamide|cyclophosphamide|mesh-list
6416577|NCT00275106|Doxorubicin|doxorubicin|mesh-list
6416578|NCT00275106|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6416579|NCT00275106|Methotrexate|methotrexate|mesh-list
6416580|NCT00275106|Vincristine|vincristine|mesh-list
6416581|NCT00275106|Daunorubicin|daunorubicin|mesh-list
6416582|NCT00275106|Asparaginase|asparaginase|mesh-list
6416583|NCT00275106|Mercaptopurine|mercaptopurine|mesh-list
6416584|NCT00275106|Thioguanine|thioguanine|mesh-list
6416585|NCT00275106|Levoleucovorin|levoleucovorin|mesh-list
6416586|NCT00275106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6416587|NCT00275106|Immunologic Factors|immunologic factors|mesh-ancestor
6416588|NCT00275106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416589|NCT00275106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6416590|NCT00275106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6416591|NCT00275106|Alkylating Agents|alkylating agents|mesh-ancestor
6538148|NCT00826254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416592|NCT00275106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416593|NCT00275106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6416594|NCT00275106|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6416595|NCT00275106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6416596|NCT00275106|Antiemetics|antiemetics|mesh-ancestor
6416597|NCT00275106|Autonomic Agents|autonomic agents|mesh-ancestor
6416598|NCT00275106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6416599|NCT00275106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6416600|NCT00275106|Glucocorticoids|glucocorticoids|mesh-ancestor
6416601|NCT00275106|Hormones|hormones|mesh-ancestor
6416602|NCT00275106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6416603|NCT00275106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6416604|NCT00275106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6416605|NCT00275106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6416606|NCT00275106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6416607|NCT00275106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6416608|NCT00275106|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6416609|NCT00275106|Abortifacient Agents|abortifacient agents|mesh-ancestor
6416610|NCT00275106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6416611|NCT00275106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6416612|NCT00275106|Antimetabolites|antimetabolites|mesh-ancestor
6416613|NCT00275106|Dermatologic Agents|dermatologic agents|mesh-ancestor
6416614|NCT00275106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6416615|NCT00275106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6416616|NCT00275106|Antiviral Agents|antiviral agents|mesh-ancestor
6416617|NCT00275106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6416618|NCT00275106|Antidotes|antidotes|mesh-ancestor
6416619|NCT00275106|Protective Agents|protective agents|mesh-ancestor
6416620|NCT00275106|Vitamin B Complex|vitamin b complex|mesh-ancestor
6416621|NCT00275106|Vitamins|vitamins|mesh-ancestor
6416622|NCT00275106|Micronutrients|micronutrients|mesh-ancestor
6416623|NCT00275106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6416624|NCT00275106|Tubulin Modulators|tubulin modulators|mesh-ancestor
6416625|NCT00275106|Antimitotic Agents|antimitotic agents|mesh-ancestor
6416626|NCT00275106|Mitosis Modulators|mitosis modulators|mesh-ancestor
6416627|NCT00275119|Gemcitabine|gemcitabine|mesh-list
6416628|NCT00275119|Fluorouracil|fluorouracil|mesh-list
6416629|NCT00275119|Oxaliplatin|oxaliplatin|mesh-list
6416630|NCT00275119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6416631|NCT00275119|Antimetabolites|antimetabolites|mesh-ancestor
6416632|NCT00275119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416633|NCT00275119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6416634|NCT00275119|Antiviral Agents|antiviral agents|mesh-ancestor
6416635|NCT00275119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6416636|NCT00275119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6416637|NCT00275119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6416638|NCT00275119|Immunologic Factors|immunologic factors|mesh-ancestor
6416639|NCT00275119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416640|NCT00275132|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5501282|NCT04475705|Anesthetics|anesthetics|mesh-ancestor
6416641|NCT00275132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6416642|NCT00275132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6416643|NCT00275132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6416644|NCT00275132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416645|NCT00275184|Metoclopramide|metoclopramide|mesh-list
6416646|NCT00275184|Antiemetics|antiemetics|mesh-ancestor
6416647|NCT00275184|Autonomic Agents|autonomic agents|mesh-ancestor
6416648|NCT00275184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6416649|NCT00275184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416650|NCT00275184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6416651|NCT00275184|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6416652|NCT00275184|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6416653|NCT00275184|Dopamine Agents|dopamine agents|mesh-ancestor
6416654|NCT00275184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6416655|NCT00275184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416656|NCT00275197|Sertraline|sertraline|mesh-list
6416657|NCT00275197|Antidepressive Agents|antidepressive agents|mesh-ancestor
6416658|NCT00275197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6416659|NCT00275197|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6416660|NCT00275197|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6416661|NCT00275197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6416662|NCT00275197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416663|NCT00275197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6416664|NCT00275197|Serotonin Agents|serotonin agents|mesh-ancestor
6416665|NCT00275197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416666|NCT00275210|Oxaliplatin|oxaliplatin|mesh-list
6416667|NCT00275210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6416668|NCT00275236|Rotigotine|rotigotine|mesh-list
6416669|NCT00275236|Dopamine Agonists|dopamine agonists|mesh-ancestor
6416670|NCT00275236|Dopamine Agents|dopamine agents|mesh-ancestor
6416671|NCT00275236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6416672|NCT00275236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416673|NCT00275236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416674|NCT00275249|Levorphanol|levorphanol|mesh-list
6416675|NCT00275249|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6416676|NCT00275249|Narcotics|narcotics|mesh-ancestor
6416677|NCT00275249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6416678|NCT00275249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018919|NCT00383448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6416679|NCT00275249|Analgesics|analgesics|mesh-ancestor
6416680|NCT00275249|Sensory System Agents|sensory system agents|mesh-ancestor
6416681|NCT00275249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6416682|NCT00275314|Valganciclovir|valganciclovir|mesh-list
6416683|NCT00275314|Antiviral Agents|antiviral agents|mesh-ancestor
6416684|NCT00275314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6416685|NCT00275405|Allyl sulfide|allyl sulfide|mesh-list
6416686|NCT00275405|Antioxidants|antioxidants|mesh-ancestor
6416687|NCT00275405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416688|NCT00275405|Protective Agents|protective agents|mesh-ancestor
6416689|NCT00275405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018920|NCT00383448|Immunologic Factors|immunologic factors|mesh-ancestor
6416690|NCT00275405|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6416691|NCT00275405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6460095|NCT00448214|Warfarin|warfarin|mesh-list
6416692|NCT00275405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6416693|NCT00275405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6416694|NCT00275418|Beta Carotene|beta carotene|mesh-list
6416695|NCT00275418|Carotenoids|carotenoids|mesh-list
6416696|NCT00275418|Antioxidants|antioxidants|mesh-ancestor
6416697|NCT00275418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416698|NCT00275418|Protective Agents|protective agents|mesh-ancestor
6416699|NCT00275418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416700|NCT00275418|Provitamins|provitamins|mesh-ancestor
6416701|NCT00275418|Vitamins|vitamins|mesh-ancestor
6416702|NCT00275418|Micronutrients|micronutrients|mesh-ancestor
6416703|NCT00275444|Tipranavir|tipranavir|mesh-list
6416704|NCT00275444|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6416705|NCT00275444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6416706|NCT00275444|Antiviral Agents|antiviral agents|mesh-ancestor
6416707|NCT00275444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6416708|NCT00275457|Pramipexole|pramipexole|mesh-list
6416709|NCT00275457|Antioxidants|antioxidants|mesh-ancestor
6416710|NCT00275457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416711|NCT00275457|Protective Agents|protective agents|mesh-ancestor
6416712|NCT00275457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416713|NCT00275457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6416714|NCT00275457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6416715|NCT00275457|Dopamine Agonists|dopamine agonists|mesh-ancestor
6416716|NCT00275457|Dopamine Agents|dopamine agents|mesh-ancestor
6416717|NCT00275457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6416718|NCT00275522|Sirolimus|sirolimus|mesh-list
6416719|NCT00275522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6416720|NCT00275522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6416721|NCT00275522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6416722|NCT00275522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6416723|NCT00275522|Antifungal Agents|antifungal agents|mesh-ancestor
6416724|NCT00275522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6416725|NCT00275522|Immunologic Factors|immunologic factors|mesh-ancestor
6416726|NCT00275522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416727|NCT00275535|Mycophenolic Acid|mycophenolic acid|mesh-list
6416728|NCT00275535|Sirolimus|sirolimus|mesh-list
6416729|NCT00275535|Prednisone|prednisone|mesh-list
6416730|NCT00275535|Tacrolimus|tacrolimus|mesh-list
6416731|NCT00275535|Thymoglobulin|thymoglobulin|mesh-list
6416732|NCT00275535|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6416733|NCT00275535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6416734|NCT00275535|Glucocorticoids|glucocorticoids|mesh-ancestor
6416735|NCT00275535|Hormones|hormones|mesh-ancestor
6416736|NCT00275535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6416737|NCT00275535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416738|NCT00275535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6416739|NCT00275535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6416740|NCT00275535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6416741|NCT00275535|Immunologic Factors|immunologic factors|mesh-ancestor
6416742|NCT00275535|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6416743|NCT00275535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6416744|NCT00275535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416745|NCT00275535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6416746|NCT00275535|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6416747|NCT00275535|Antitubercular Agents|antitubercular agents|mesh-ancestor
6416748|NCT00275535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6416749|NCT00275535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6416750|NCT00275535|Antifungal Agents|antifungal agents|mesh-ancestor
6416751|NCT00275548|Ribavirin|ribavirin|mesh-list
6416752|NCT00275548|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6416753|NCT00275548|Antimetabolites|antimetabolites|mesh-ancestor
6416754|NCT00275548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416755|NCT00275548|Antiviral Agents|antiviral agents|mesh-ancestor
6416756|NCT00275548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6416757|NCT00275600|Vitamin E|vitamin e|mesh-list
6416758|NCT00275600|Vitamins|vitamins|mesh-ancestor
6416759|NCT00275600|Micronutrients|micronutrients|mesh-ancestor
6416760|NCT00275600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416761|NCT00275600|Antioxidants|antioxidants|mesh-ancestor
6416762|NCT00275600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416763|NCT00275600|Protective Agents|protective agents|mesh-ancestor
6416764|NCT00275613|Rituximab|rituximab|mesh-list
6416765|NCT00275613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6416766|NCT00275613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6416767|NCT00275613|Immunologic Factors|immunologic factors|mesh-ancestor
6416768|NCT00275613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416769|NCT00275613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6416770|NCT00275639|Losartan|losartan|mesh-list
6416771|NCT00275639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6416772|NCT00275639|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6416773|NCT00275639|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6416774|NCT00275639|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6416775|NCT00275639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416776|NCT00275652|Lamivudine|lamivudine|mesh-list
6416777|NCT00275652|Telbivudine|telbivudine|mesh-list
6416778|NCT00275652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6416779|NCT00275652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6416780|NCT00275652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6416781|NCT00275652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416782|NCT00275652|Antiviral Agents|antiviral agents|mesh-ancestor
6416783|NCT00275652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6416784|NCT00275652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6416785|NCT00275652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6416786|NCT00275665|Valganciclovir|valganciclovir|mesh-list
6416787|NCT00275665|Antiviral Agents|antiviral agents|mesh-ancestor
6416788|NCT00275665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6416789|NCT00275730|Indomethacin|indomethacin|mesh-list
6416790|NCT00275730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6416791|NCT00275730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6416792|NCT00275730|Analgesics|analgesics|mesh-ancestor
6416793|NCT00275730|Sensory System Agents|sensory system agents|mesh-ancestor
6416794|NCT00275730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6416795|NCT00275730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416796|NCT00275730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6416797|NCT00275730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6416798|NCT00275730|Gout Suppressants|gout suppressants|mesh-ancestor
6416799|NCT00275730|Tocolytic Agents|tocolytic agents|mesh-ancestor
6416800|NCT00275730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6416801|NCT00275730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6416802|NCT00275730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6416803|NCT00275730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416804|NCT00275756|Timolol|timolol|mesh-list
6416805|NCT00275756|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6416806|NCT00275756|Dorzolamide|dorzolamide|mesh-list
6416807|NCT00275756|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6416808|NCT00275756|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6416809|NCT00275756|Adrenergic Agents|adrenergic agents|mesh-ancestor
6416810|NCT00275756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6416811|NCT00275756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416812|NCT00275756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416813|NCT00275756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6416814|NCT00275756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6416815|NCT00275756|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6416816|NCT00275756|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6416817|NCT00275756|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6416818|NCT00275756|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6416819|NCT00275756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6460096|NCT00448214|Anticoagulants|anticoagulants|mesh-ancestor
6460097|NCT00448240|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6460098|NCT00448240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6460099|NCT00448240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6416820|NCT00275912|Oxcarbazepine|oxcarbazepine|mesh-list
6416821|NCT00275912|Anticonvulsants|anticonvulsants|mesh-ancestor
6416822|NCT00275912|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6416823|NCT00275912|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6416824|NCT00275912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6416825|NCT00275912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416826|NCT00275912|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6416827|NCT00275912|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6416828|NCT00275925|Oxcarbazepine|oxcarbazepine|mesh-list
6416829|NCT00275925|Anticonvulsants|anticonvulsants|mesh-ancestor
6416830|NCT00275925|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6416831|NCT00275925|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6416832|NCT00275925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6416833|NCT00275925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416834|NCT00275925|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6416835|NCT00275925|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6416836|NCT00275938|Interferons|interferons|mesh-list
6416837|NCT00275938|Ribavirin|ribavirin|mesh-list
6416838|NCT00275938|Interferon-alpha|interferon-alpha|mesh-list
6416839|NCT00275938|Interferon alpha-2|interferon alpha-2|mesh-list
6416840|NCT00275938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6416841|NCT00275938|Antiviral Agents|antiviral agents|mesh-ancestor
6416842|NCT00275938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6416843|NCT00275938|Antimetabolites|antimetabolites|mesh-ancestor
6416844|NCT00275938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416845|NCT00275938|Immunologic Factors|immunologic factors|mesh-ancestor
6416846|NCT00275938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416847|NCT00275951|Cetuximab|cetuximab|mesh-list
6416848|NCT00275951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6416849|NCT00275951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6416850|NCT00276003|Gemcitabine|gemcitabine|mesh-list
6416851|NCT00276003|Irinotecan|irinotecan|mesh-list
6416852|NCT00276003|Allopurinol|allopurinol|mesh-list
6416853|NCT00276003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6416854|NCT00276003|Antimetabolites|antimetabolites|mesh-ancestor
6416855|NCT00276003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416856|NCT00276003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6416857|NCT00276003|Antiviral Agents|antiviral agents|mesh-ancestor
6416858|NCT00276003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6416859|NCT00276003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6416860|NCT00276003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6416861|NCT00276003|Immunologic Factors|immunologic factors|mesh-ancestor
6416862|NCT00276003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416863|NCT00276003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6416864|NCT00276003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6416865|NCT00276003|Gout Suppressants|gout suppressants|mesh-ancestor
6416866|NCT00276003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6416867|NCT00276003|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6416868|NCT00276003|Antioxidants|antioxidants|mesh-ancestor
6416869|NCT00276003|Protective Agents|protective agents|mesh-ancestor
6416870|NCT00276029|Etanercept|etanercept|mesh-list
6416871|NCT00276029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6416872|NCT00276029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6416873|NCT00276029|Analgesics|analgesics|mesh-ancestor
5724702|NCT03185403|Ropivacaine|ropivacaine|mesh-list
6416874|NCT00276029|Sensory System Agents|sensory system agents|mesh-ancestor
6416875|NCT00276029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6416876|NCT00276029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416877|NCT00276029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6416878|NCT00276029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6416879|NCT00276029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6416880|NCT00276029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6416881|NCT00276029|Immunologic Factors|immunologic factors|mesh-ancestor
6416882|NCT00276055|Gemcitabine|gemcitabine|mesh-list
6416883|NCT00276055|Bevacizumab|bevacizumab|mesh-list
6416884|NCT00276055|Docetaxel|docetaxel|mesh-list
6416885|NCT00276055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6416886|NCT00276055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6416887|NCT00276055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6416888|NCT00276055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6416889|NCT00276055|Growth Substances|growth substances|mesh-ancestor
6416890|NCT00276055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416891|NCT00276055|Growth Inhibitors|growth inhibitors|mesh-ancestor
6416892|NCT00276055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6416893|NCT00276055|Antimetabolites|antimetabolites|mesh-ancestor
6416894|NCT00276055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416895|NCT00276055|Antiviral Agents|antiviral agents|mesh-ancestor
6416896|NCT00276055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5501283|NCT04475705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6416897|NCT00276055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6416898|NCT00276055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6416899|NCT00276055|Immunologic Factors|immunologic factors|mesh-ancestor
6416900|NCT00276055|Tubulin Modulators|tubulin modulators|mesh-ancestor
6416901|NCT00276055|Antimitotic Agents|antimitotic agents|mesh-ancestor
6416902|NCT00276055|Mitosis Modulators|mitosis modulators|mesh-ancestor
6416903|NCT00276068|Lidocaine|lidocaine|mesh-list
6416904|NCT00276068|Desipramine|desipramine|mesh-list
6416905|NCT00276068|Anesthetics, Local|anesthetics, local|mesh-ancestor
6416906|NCT00276068|Anesthetics|anesthetics|mesh-ancestor
6416907|NCT00276068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6416908|NCT00276068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416909|NCT00276068|Sensory System Agents|sensory system agents|mesh-ancestor
6416910|NCT00276068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6416911|NCT00276068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6416912|NCT00276068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6416913|NCT00276068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6416914|NCT00276068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6416915|NCT00276068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416916|NCT00276068|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6416917|NCT00276068|Antidepressive Agents|antidepressive agents|mesh-ancestor
6416918|NCT00276068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6416919|NCT00276068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6416920|NCT00276068|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6416921|NCT00276068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6416922|NCT00276068|Adrenergic Agents|adrenergic agents|mesh-ancestor
6416923|NCT00276068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6416924|NCT00276081|Gabapentin|gabapentin|mesh-list
6416925|NCT00276081|Estrogens|estrogens|mesh-list
6416926|NCT00276081|Analgesics|analgesics|mesh-ancestor
6416927|NCT00276081|Sensory System Agents|sensory system agents|mesh-ancestor
6416928|NCT00276081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6416929|NCT00276081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416930|NCT00276081|Anticonvulsants|anticonvulsants|mesh-ancestor
6416931|NCT00276081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6416932|NCT00276081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6416933|NCT00276081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6416934|NCT00276081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6416935|NCT00276081|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6416936|NCT00276081|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6416937|NCT00276081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6416938|NCT00276081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416939|NCT00276081|Antimanic Agents|antimanic agents|mesh-ancestor
6416940|NCT00276081|Hormones|hormones|mesh-ancestor
6416941|NCT00276081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6416942|NCT00276107|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6416943|NCT00276107|Immunologic Factors|immunologic factors|mesh-ancestor
6416944|NCT00276107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416945|NCT00276133|Atorvastatin|atorvastatin|mesh-list
6416946|NCT00276133|Probucol|probucol|mesh-list
6416947|NCT00276133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6416948|NCT00276133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6416949|NCT00276133|Antimetabolites|antimetabolites|mesh-ancestor
6416950|NCT00276133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416951|NCT00276133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6416952|NCT00276133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6416953|NCT00276133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6416954|NCT00276133|Antioxidants|antioxidants|mesh-ancestor
6416955|NCT00276133|Protective Agents|protective agents|mesh-ancestor
6416956|NCT00276133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416957|NCT00276146|Dipyridamole|dipyridamole|mesh-list
6416958|NCT00276146|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6416959|NCT00276146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6416960|NCT00276146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416961|NCT00276146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6416962|NCT00276146|Vasodilator Agents|vasodilator agents|mesh-ancestor
6416963|NCT00276172|Natalizumab|natalizumab|mesh-list
6416964|NCT00276172|Immunologic Factors|immunologic factors|mesh-ancestor
6416965|NCT00276172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416966|NCT00276185|Botulinum Toxins|botulinum toxins|mesh-list
6416967|NCT00276185|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6416968|NCT00276185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6416969|NCT00276185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416970|NCT00276185|Cholinergic Agents|cholinergic agents|mesh-ancestor
6416971|NCT00276185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6416972|NCT00276185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416973|NCT00276198|Vitamin D|vitamin d|mesh-list
6416974|NCT00276198|Vitamin A|vitamin a|mesh-list
6416975|NCT00276198|Vitamins|vitamins|mesh-ancestor
6416976|NCT00276198|Micronutrients|micronutrients|mesh-ancestor
6416977|NCT00276198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416978|NCT00276198|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6416979|NCT00276276|Topotecan|topotecan|mesh-list
6416980|NCT00276276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6416981|NCT00276276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6416982|NCT00276276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6416983|NCT00276276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416984|NCT00276276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6416985|NCT00276289|Spironolactone|spironolactone|mesh-list
6416986|NCT00276289|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6416987|NCT00276289|Hormone Antagonists|hormone antagonists|mesh-ancestor
6416988|NCT00276289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6416989|NCT00276289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6416990|NCT00276289|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6416991|NCT00276289|Diuretics|diuretics|mesh-ancestor
6416992|NCT00276289|Natriuretic Agents|natriuretic agents|mesh-ancestor
6416993|NCT00276315|Botulinum Toxins|botulinum toxins|mesh-list
6416994|NCT00276315|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6416995|NCT00276315|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6416996|NCT00276315|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6416997|NCT00276315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6416998|NCT00276315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6416999|NCT00276315|Cholinergic Agents|cholinergic agents|mesh-ancestor
6417000|NCT00276315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6417001|NCT00276315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417002|NCT00276315|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6417003|NCT00276315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6417004|NCT00276393|Insulin|insulin|mesh-list
6417005|NCT00276393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6417006|NCT00276393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417007|NCT00276445|Beta-1,3-glucan|beta-1,3-glucan|mesh-list
6417008|NCT00276445|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6417009|NCT00276445|Immunologic Factors|immunologic factors|mesh-ancestor
6417010|NCT00276445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417011|NCT00276497|Pioglitazone|pioglitazone|mesh-list
6417012|NCT00276497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6417013|NCT00276497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417014|NCT00276523|Interferons|interferons|mesh-list
6417015|NCT00276523|Interferon-alpha|interferon-alpha|mesh-list
6417016|NCT00276523|Interferon alpha-2|interferon alpha-2|mesh-list
6417017|NCT00276523|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6417018|NCT00276523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6417019|NCT00276523|Antiviral Agents|antiviral agents|mesh-ancestor
6417020|NCT00276523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6417021|NCT00276523|Immunologic Factors|immunologic factors|mesh-ancestor
6417022|NCT00276523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417023|NCT00276536|Interferons|interferons|mesh-list
6417024|NCT00276536|Interferon-alpha|interferon-alpha|mesh-list
6417025|NCT00276536|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
6417026|NCT00276536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6417027|NCT00276536|Antiviral Agents|antiviral agents|mesh-ancestor
6417028|NCT00276536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6417029|NCT00276536|Immunologic Factors|immunologic factors|mesh-ancestor
6417030|NCT00276536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417031|NCT00276575|Bevacizumab|bevacizumab|mesh-list
6417032|NCT00276575|Everolimus|everolimus|mesh-list
6417033|NCT00276575|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6417034|NCT00276575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6417035|NCT00276575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6417036|NCT00276575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6417037|NCT00276575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6417038|NCT00276575|Growth Substances|growth substances|mesh-ancestor
6417039|NCT00276575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417040|NCT00276575|Growth Inhibitors|growth inhibitors|mesh-ancestor
6417041|NCT00276575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6417042|NCT00276575|Immunologic Factors|immunologic factors|mesh-ancestor
6417043|NCT00276575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6417044|NCT00276575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6417045|NCT00276575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6417046|NCT00276588|Gemcitabine|gemcitabine|mesh-list
6417047|NCT00276588|Paclitaxel|paclitaxel|mesh-list
6417048|NCT00276588|Carboplatin|carboplatin|mesh-list
6417049|NCT00276588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6417050|NCT00276588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6417051|NCT00276588|Tubulin Modulators|tubulin modulators|mesh-ancestor
6417052|NCT00276588|Antimitotic Agents|antimitotic agents|mesh-ancestor
6417053|NCT00276588|Mitosis Modulators|mitosis modulators|mesh-ancestor
6417054|NCT00276588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6417055|NCT00276588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6417056|NCT00276588|Antimetabolites|antimetabolites|mesh-ancestor
6417057|NCT00276588|Antiviral Agents|antiviral agents|mesh-ancestor
6417058|NCT00276588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6417059|NCT00276588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6417060|NCT00276588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6417061|NCT00276588|Immunologic Factors|immunologic factors|mesh-ancestor
6417062|NCT00276588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417063|NCT00276601|Cytarabine|cytarabine|mesh-list
6417064|NCT00276601|Methotrexate|methotrexate|mesh-list
6417065|NCT00276601|Mercaptopurine|mercaptopurine|mesh-list
6417066|NCT00276601|Daunorubicin|daunorubicin|mesh-list
6417067|NCT00276601|Arsenic Trioxide|arsenic trioxide|mesh-list
6417068|NCT00276601|Tretinoin|tretinoin|mesh-list
6417069|NCT00276601|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6417070|NCT00276601|Abortifacient Agents|abortifacient agents|mesh-ancestor
6417071|NCT00276601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6417072|NCT00276601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417073|NCT00276601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6417074|NCT00276601|Antimetabolites|antimetabolites|mesh-ancestor
6417075|NCT00276601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6417076|NCT00276601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6417077|NCT00276601|Dermatologic Agents|dermatologic agents|mesh-ancestor
6417078|NCT00276601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6417079|NCT00276601|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6417080|NCT00276601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6417081|NCT00276601|Immunologic Factors|immunologic factors|mesh-ancestor
6417082|NCT00276601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6417083|NCT00276601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6417084|NCT00276601|Antiviral Agents|antiviral agents|mesh-ancestor
6417085|NCT00276601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6417086|NCT00276601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6417087|NCT00276601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6417088|NCT00276601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6417089|NCT00276601|Keratolytic Agents|keratolytic agents|mesh-ancestor
6417090|NCT00276640|Carboplatin|carboplatin|mesh-list
6417091|NCT00276640|Etoposide|etoposide|mesh-list
6417092|NCT00276640|Vincristine|vincristine|mesh-list
6417093|NCT00276640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6417094|NCT00276640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6417095|NCT00276640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6417096|NCT00276640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6417097|NCT00276640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6417098|NCT00276640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6417099|NCT00276640|Tubulin Modulators|tubulin modulators|mesh-ancestor
6417100|NCT00276640|Antimitotic Agents|antimitotic agents|mesh-ancestor
6417101|NCT00276640|Mitosis Modulators|mitosis modulators|mesh-ancestor
6417102|NCT00276666|Vincristine|vincristine|mesh-list
6417103|NCT00276666|Lomustine|lomustine|mesh-list
6417104|NCT00276666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6417105|NCT00276666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6417106|NCT00276666|Tubulin Modulators|tubulin modulators|mesh-ancestor
6417107|NCT00276666|Antimitotic Agents|antimitotic agents|mesh-ancestor
6417108|NCT00276666|Mitosis Modulators|mitosis modulators|mesh-ancestor
6417109|NCT00276666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6417110|NCT00276666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6417111|NCT00276666|Alkylating Agents|alkylating agents|mesh-ancestor
6417112|NCT00276679|Temozolomide|temozolomide|mesh-list
6417113|NCT00276679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6417114|NCT00276679|Alkylating Agents|alkylating agents|mesh-ancestor
6417115|NCT00276679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6417116|NCT00276679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6417117|NCT00276692|Irinotecan|irinotecan|mesh-list
6417118|NCT00276692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6417119|NCT00276692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6417120|NCT00276692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6417121|NCT00276692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6417122|NCT00276692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6417123|NCT00276705|Thalidomide|thalidomide|mesh-list
6417124|NCT00276705|Cyclophosphamide|cyclophosphamide|mesh-list
6417125|NCT00276705|Doxorubicin|doxorubicin|mesh-list
6417126|NCT00276705|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6417127|NCT00276705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6417128|NCT00276705|Immunologic Factors|immunologic factors|mesh-ancestor
6417129|NCT00276705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417130|NCT00276705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6417131|NCT00276705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6417132|NCT00276705|Alkylating Agents|alkylating agents|mesh-ancestor
6417133|NCT00276705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6417134|NCT00276705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6417135|NCT00276705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6417136|NCT00276705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6417137|NCT00276705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6417138|NCT00276705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6417139|NCT00276705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6417140|NCT00276705|Leprostatic Agents|leprostatic agents|mesh-ancestor
6417141|NCT00276705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6417142|NCT00276705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6417143|NCT00276705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6417144|NCT00276705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6417145|NCT00276705|Growth Substances|growth substances|mesh-ancestor
6417146|NCT00276705|Growth Inhibitors|growth inhibitors|mesh-ancestor
6417147|NCT00276718|Carboplatin|carboplatin|mesh-list
6417148|NCT00276718|Etoposide|etoposide|mesh-list
6417149|NCT00276718|Bleomycin|bleomycin|mesh-list
6417150|NCT00276718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6417151|NCT00276718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6417152|NCT00276718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6417153|NCT00276718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6417154|NCT00276718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6417155|NCT00276718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6417156|NCT00276718|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6417157|NCT00276731|Cyclophosphamide|cyclophosphamide|mesh-list
6417158|NCT00276731|Carboplatin|carboplatin|mesh-list
6417159|NCT00276731|Etoposide|etoposide|mesh-list
6417160|NCT00276731|Vincristine|vincristine|mesh-list
6417161|NCT00276731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6417162|NCT00276731|Immunologic Factors|immunologic factors|mesh-ancestor
6417163|NCT00276731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417164|NCT00276731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6417165|NCT00276731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6417166|NCT00276731|Alkylating Agents|alkylating agents|mesh-ancestor
6417167|NCT00276731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6417168|NCT00276731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6417169|NCT00276731|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6417170|NCT00276731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6417171|NCT00276731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6417172|NCT00276731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6417173|NCT00276731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6417174|NCT00276731|Tubulin Modulators|tubulin modulators|mesh-ancestor
6417175|NCT00276731|Antimitotic Agents|antimitotic agents|mesh-ancestor
6417176|NCT00276731|Mitosis Modulators|mitosis modulators|mesh-ancestor
6417177|NCT00276757|Leucovorin|leucovorin|mesh-list
6417178|NCT00276757|Prednisolone|prednisolone|mesh-list
6417179|NCT00276757|Methotrexate|methotrexate|mesh-list
6417180|NCT00276757|Vinblastine|vinblastine|mesh-list
6417181|NCT00276757|Calcium|calcium|mesh-list
6417182|NCT00276757|Levoleucovorin|levoleucovorin|mesh-list
6417183|NCT00276757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6417184|NCT00276757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417185|NCT00276757|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6417186|NCT00276757|Abortifacient Agents|abortifacient agents|mesh-ancestor
6417187|NCT00276757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6417188|NCT00276757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6417189|NCT00276757|Antimetabolites|antimetabolites|mesh-ancestor
6417190|NCT00276757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6417191|NCT00276757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6417192|NCT00276757|Dermatologic Agents|dermatologic agents|mesh-ancestor
6417193|NCT00276757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6417194|NCT00276757|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6417195|NCT00276757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6417196|NCT00276757|Immunologic Factors|immunologic factors|mesh-ancestor
6417197|NCT00276757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6417198|NCT00276757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6417199|NCT00276757|Antidotes|antidotes|mesh-ancestor
6417200|NCT00276757|Protective Agents|protective agents|mesh-ancestor
6417201|NCT00276757|Vitamin B Complex|vitamin b complex|mesh-ancestor
6417202|NCT00276757|Vitamins|vitamins|mesh-ancestor
6417203|NCT00276757|Micronutrients|micronutrients|mesh-ancestor
6417204|NCT00276757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6417205|NCT00276757|Glucocorticoids|glucocorticoids|mesh-ancestor
6417206|NCT00276757|Hormones|hormones|mesh-ancestor
6417207|NCT00276757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6417208|NCT00276757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6417209|NCT00276757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6417210|NCT00276757|Tubulin Modulators|tubulin modulators|mesh-ancestor
6417211|NCT00276757|Antimitotic Agents|antimitotic agents|mesh-ancestor
6417212|NCT00276757|Mitosis Modulators|mitosis modulators|mesh-ancestor
6417213|NCT00276770|Fluorides|fluorides|mesh-list
6417214|NCT00276770|Cariostatic Agents|cariostatic agents|mesh-ancestor
6417215|NCT00276770|Protective Agents|protective agents|mesh-ancestor
6417216|NCT00276770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417217|NCT00276783|Pemetrexed|pemetrexed|mesh-list
6417218|NCT00276783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6417219|NCT00276783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6417220|NCT00276783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6417221|NCT00276783|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6417222|NCT00276783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6417223|NCT00276796|Paclitaxel|paclitaxel|mesh-list
6417224|NCT00276796|Topotecan|topotecan|mesh-list
6417225|NCT00276796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6417226|NCT00276796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6417227|NCT00276796|Tubulin Modulators|tubulin modulators|mesh-ancestor
6417228|NCT00276796|Antimitotic Agents|antimitotic agents|mesh-ancestor
6417229|NCT00276796|Mitosis Modulators|mitosis modulators|mesh-ancestor
6417230|NCT00276796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6417231|NCT00276796|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6417232|NCT00276796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6417233|NCT00276796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6417234|NCT00276809|Cytarabine|cytarabine|mesh-list
6417235|NCT00276809|Dexamethasone|dexamethasone|mesh-list
6417236|NCT00276809|Cyclophosphamide|cyclophosphamide|mesh-list
6417237|NCT00276809|Melphalan|melphalan|mesh-list
6417238|NCT00276809|Carmustine|carmustine|mesh-list
6417239|NCT00276809|Fludarabine|fludarabine|mesh-list
6417240|NCT00276809|Fludarabine phosphate|fludarabine phosphate|mesh-list
6417241|NCT00276809|Etoposide|etoposide|mesh-list
6417242|NCT00276809|Alemtuzumab|alemtuzumab|mesh-list
6417243|NCT00276809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6417244|NCT00276809|Immunologic Factors|immunologic factors|mesh-ancestor
6417245|NCT00276809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417246|NCT00276809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6417247|NCT00276809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6417248|NCT00276809|Alkylating Agents|alkylating agents|mesh-ancestor
6417249|NCT00276809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6417250|NCT00276809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6417251|NCT00276809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6417252|NCT00276809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6417253|NCT00276809|Antiemetics|antiemetics|mesh-ancestor
6417254|NCT00276809|Autonomic Agents|autonomic agents|mesh-ancestor
6417255|NCT00276809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6417256|NCT00276809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6417257|NCT00276809|Glucocorticoids|glucocorticoids|mesh-ancestor
6417258|NCT00276809|Hormones|hormones|mesh-ancestor
6417259|NCT00276809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6417260|NCT00276809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6417261|NCT00276809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6417262|NCT00276809|Antimetabolites|antimetabolites|mesh-ancestor
6417263|NCT00276809|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6417264|NCT00276809|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6417265|NCT00276809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6417266|NCT00276809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6417267|NCT00276809|Antiviral Agents|antiviral agents|mesh-ancestor
6417268|NCT00276809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6417269|NCT00276809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6018921|NCT00383448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417270|NCT00276835|Aldesleukin|aldesleukin|mesh-list
6417271|NCT00276835|Interleukin-2|interleukin-2|mesh-list
6417272|NCT00276835|Genistein|genistein|mesh-list
6417273|NCT00276835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6417274|NCT00276835|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6417275|NCT00276835|Analgesics|analgesics|mesh-ancestor
6417276|NCT00276835|Sensory System Agents|sensory system agents|mesh-ancestor
6417277|NCT00276835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6417278|NCT00276835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417279|NCT00276835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6417280|NCT00276835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6417281|NCT00276835|Antiviral Agents|antiviral agents|mesh-ancestor
6417282|NCT00276835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6417283|NCT00276835|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6417284|NCT00276835|Protective Agents|protective agents|mesh-ancestor
6417285|NCT00276835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6417286|NCT00276835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6417287|NCT00276835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6417288|NCT00276835|Phytoestrogens|phytoestrogens|mesh-ancestor
6417289|NCT00276835|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6417290|NCT00276835|Estrogens|estrogens|mesh-ancestor
6417291|NCT00276835|Hormones|hormones|mesh-ancestor
6417292|NCT00276835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6417293|NCT00276848|Vidarabine|vidarabine|mesh-list
6417294|NCT00276848|Cyclophosphamide|cyclophosphamide|mesh-list
6417295|NCT00276848|Fludarabine|fludarabine|mesh-list
6417296|NCT00276848|Fludarabine phosphate|fludarabine phosphate|mesh-list
6417297|NCT00276848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6417298|NCT00276848|Immunologic Factors|immunologic factors|mesh-ancestor
6417299|NCT00276848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417300|NCT00276848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6417301|NCT00276848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6417302|NCT00276848|Alkylating Agents|alkylating agents|mesh-ancestor
6460100|NCT00448240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6417303|NCT00276848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6417304|NCT00276848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6417305|NCT00276848|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6417306|NCT00276848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6417307|NCT00276848|Antimetabolites|antimetabolites|mesh-ancestor
6417308|NCT00276848|Antiviral Agents|antiviral agents|mesh-ancestor
6417309|NCT00276848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6417310|NCT00276874|Aripiprazole|aripiprazole|mesh-list
6417311|NCT00276874|Antidepressive Agents|antidepressive agents|mesh-ancestor
6417312|NCT00276874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6417313|NCT00276874|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6417314|NCT00276874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6417315|NCT00276874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6417316|NCT00276874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417317|NCT00276874|Dopamine Agonists|dopamine agonists|mesh-ancestor
6417318|NCT00276874|Dopamine Agents|dopamine agents|mesh-ancestor
6417319|NCT00276874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6417320|NCT00276874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6417321|NCT00276874|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6417322|NCT00276874|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6417323|NCT00276874|Serotonin Agents|serotonin agents|mesh-ancestor
6417324|NCT00276874|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6417325|NCT00276874|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6417326|NCT00276874|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6417327|NCT00276874|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6417328|NCT00276900|Sertraline|sertraline|mesh-list
6417329|NCT00276900|Antidepressive Agents|antidepressive agents|mesh-ancestor
6417330|NCT00276900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6417331|NCT00276900|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6417332|NCT00276900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6417333|NCT00276900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6417334|NCT00276900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6417335|NCT00276900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6417336|NCT00276900|Serotonin Agents|serotonin agents|mesh-ancestor
6417337|NCT00276900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417338|NCT00276926|Imatinib Mesylate|imatinib mesylate|mesh-list
6417339|NCT00276926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6417340|NCT00276926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6417341|NCT00276926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6417342|NCT00276926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6417343|NCT00276965|Lithium Carbonate|lithium carbonate|mesh-list
6417344|NCT00276965|Sertraline|sertraline|mesh-list
6417345|NCT00276965|Antidepressive Agents|antidepressive agents|mesh-ancestor
6417346|NCT00276965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6417347|NCT00276965|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6417348|NCT00276965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6417349|NCT00276965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6417350|NCT00276965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6417351|NCT00276965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6417352|NCT00276965|Serotonin Agents|serotonin agents|mesh-ancestor
6417353|NCT00276965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417354|NCT00276965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6417355|NCT00276965|Antimanic Agents|antimanic agents|mesh-ancestor
6417356|NCT00276965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6417357|NCT00276965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6417358|NCT00276978|Aripiprazole|aripiprazole|mesh-list
6417359|NCT00276978|Antidepressive Agents|antidepressive agents|mesh-ancestor
6417360|NCT00276978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6417361|NCT00276978|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6417362|NCT00276978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6417363|NCT00276978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6417364|NCT00276978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417365|NCT00276978|Dopamine Agonists|dopamine agonists|mesh-ancestor
6417366|NCT00276978|Dopamine Agents|dopamine agents|mesh-ancestor
6417367|NCT00276978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6417368|NCT00276978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6417369|NCT00276978|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6417370|NCT00276978|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6417371|NCT00276978|Serotonin Agents|serotonin agents|mesh-ancestor
6417372|NCT00276978|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6417373|NCT00276978|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6417374|NCT00276978|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6417375|NCT00276978|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6417376|NCT00277017|Interferons|interferons|mesh-list
6417377|NCT00277017|Thalidomide|thalidomide|mesh-list
6417378|NCT00277017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6417379|NCT00277017|Antiviral Agents|antiviral agents|mesh-ancestor
6417380|NCT00277017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6417381|NCT00277017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6417382|NCT00277017|Immunologic Factors|immunologic factors|mesh-ancestor
6417383|NCT00277017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417384|NCT00277017|Leprostatic Agents|leprostatic agents|mesh-ancestor
6417385|NCT00277017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6417386|NCT00277017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6417387|NCT00277017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6417388|NCT00277017|Growth Substances|growth substances|mesh-ancestor
6417389|NCT00277017|Growth Inhibitors|growth inhibitors|mesh-ancestor
6417390|NCT00277030|Pulmonary Surfactants|pulmonary surfactants|mesh-list
6417391|NCT00277030|Respiratory System Agents|respiratory system agents|mesh-ancestor
6417392|NCT00277043|Paclitaxel|paclitaxel|mesh-list
6417393|NCT00277043|Docetaxel|docetaxel|mesh-list
6417394|NCT00277043|Taxane|taxane|mesh-list
6417395|NCT00277043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6417396|NCT00277043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6417397|NCT00277043|Tubulin Modulators|tubulin modulators|mesh-ancestor
6417398|NCT00277043|Antimitotic Agents|antimitotic agents|mesh-ancestor
6417399|NCT00277043|Mitosis Modulators|mitosis modulators|mesh-ancestor
6417400|NCT00277043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6417401|NCT00277069|Carboplatin|carboplatin|mesh-list
6417402|NCT00277069|Capecitabine|capecitabine|mesh-list
6417403|NCT00277069|Vinorelbine|vinorelbine|mesh-list
6417404|NCT00277069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6417405|NCT00277069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6417406|NCT00277069|Antimetabolites|antimetabolites|mesh-ancestor
6417407|NCT00277069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6417408|NCT00277069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6417409|NCT00277069|Tubulin Modulators|tubulin modulators|mesh-ancestor
6417410|NCT00277069|Antimitotic Agents|antimitotic agents|mesh-ancestor
6417411|NCT00277069|Mitosis Modulators|mitosis modulators|mesh-ancestor
6417412|NCT00277082|Camptothecin|camptothecin|mesh-list
6417413|NCT00277082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6417414|NCT00277082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6417415|NCT00277082|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6417416|NCT00277082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6417417|NCT00277082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6417418|NCT00277082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6417419|NCT00277108|Citalopram|citalopram|mesh-list
6417420|NCT00277108|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6417421|NCT00277108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6417422|NCT00277108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6417423|NCT00277108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6417424|NCT00277108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6417425|NCT00277108|Serotonin Agents|serotonin agents|mesh-ancestor
6417426|NCT00277108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417427|NCT00277108|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6417428|NCT00277108|Antidepressive Agents|antidepressive agents|mesh-ancestor
6417429|NCT00277108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6417430|NCT00277199|Abatacept|abatacept|mesh-list
6417431|NCT00277199|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6417432|NCT00277199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6417433|NCT00277199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6417434|NCT00277199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6417435|NCT00277199|Immunologic Factors|immunologic factors|mesh-ancestor
6417436|NCT00277199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417437|NCT00277199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6417438|NCT00277225|Abatacept|abatacept|mesh-list
6417439|NCT00277225|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6417440|NCT00277225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6417441|NCT00277225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6417442|NCT00277225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6417443|NCT00277225|Immunologic Factors|immunologic factors|mesh-ancestor
6417444|NCT00277225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417445|NCT00277225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6417446|NCT00277251|Alendronate|alendronate|mesh-list
6417447|NCT00277251|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6417448|NCT00277251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417449|NCT00277264|Tiotropium Bromide|tiotropium bromide|mesh-list
6417450|NCT00277264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6417451|NCT00277264|Autonomic Agents|autonomic agents|mesh-ancestor
6417452|NCT00277264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6417453|NCT00277264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417454|NCT00277264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6417455|NCT00277264|Respiratory System Agents|respiratory system agents|mesh-ancestor
6417456|NCT00277264|Parasympatholytics|parasympatholytics|mesh-ancestor
6417457|NCT00277264|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6417458|NCT00277264|Cholinergic Agents|cholinergic agents|mesh-ancestor
6417459|NCT00277264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6417460|NCT00277264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6417461|NCT00277342|Insulin|insulin|mesh-list
6417462|NCT00277342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6417463|NCT00277342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460101|NCT00448240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460102|NCT00448253|Immunoglobulins|immunoglobulins|mesh-list
6460103|NCT00448253|Immunologic Factors|immunologic factors|mesh-ancestor
6460104|NCT00448253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460105|NCT00448266|Cyclophosphamide|cyclophosphamide|mesh-list
6460106|NCT00448266|Thiotepa|thiotepa|mesh-list
6460107|NCT00448266|Carboplatin|carboplatin|mesh-list
6460108|NCT00448266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6460109|NCT00448266|Immunologic Factors|immunologic factors|mesh-ancestor
6460110|NCT00448266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460111|NCT00448266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6460112|NCT00448266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6460113|NCT00448266|Alkylating Agents|alkylating agents|mesh-ancestor
6460114|NCT00448266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460115|NCT00448266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6417464|NCT00277472|Valsartan|valsartan|mesh-list
6417465|NCT00277472|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6417466|NCT00277472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6417467|NCT00277472|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6417468|NCT00277472|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6417469|NCT00277472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6018922|NCT00383448|Antifungal Agents|antifungal agents|mesh-ancestor
6018923|NCT00383448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6417470|NCT00277472|Diuretics|diuretics|mesh-ancestor
6417471|NCT00277472|Natriuretic Agents|natriuretic agents|mesh-ancestor
6417472|NCT00277472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417473|NCT00277472|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6417474|NCT00277472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6417475|NCT00277498|Timolol|timolol|mesh-list
6018924|NCT00383448|Dermatologic Agents|dermatologic agents|mesh-ancestor
6018925|NCT00383448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6018926|NCT00383448|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6417476|NCT00277498|Latanoprost|latanoprost|mesh-list
6417477|NCT00277498|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6417478|NCT00277498|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6417479|NCT00277498|Adrenergic Agents|adrenergic agents|mesh-ancestor
6417480|NCT00277498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6417481|NCT00277498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6417482|NCT00277498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417483|NCT00277498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6417484|NCT00277498|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6417485|NCT00277498|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6417486|NCT00277498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6417487|NCT00277511|Levofloxacin|levofloxacin|mesh-list
6417488|NCT00277511|Ofloxacin|ofloxacin|mesh-list
6417489|NCT00277511|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6417490|NCT00277511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6417491|NCT00277511|Renal Agents|renal agents|mesh-ancestor
6417492|NCT00277511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6417493|NCT00277511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6417494|NCT00277511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6417495|NCT00277511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6417496|NCT00277511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6417497|NCT00277511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6417498|NCT00277511|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6417499|NCT00277511|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6417500|NCT00277537|Mannitol|mannitol|mesh-list
6417501|NCT00277537|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6417502|NCT00277537|Diuretics|diuretics|mesh-ancestor
6417503|NCT00277537|Natriuretic Agents|natriuretic agents|mesh-ancestor
6417504|NCT00277537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417505|NCT00277550|Tegaserod|tegaserod|mesh-list
6417506|NCT00277550|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6417507|NCT00277550|Serotonin Agents|serotonin agents|mesh-ancestor
6417508|NCT00277550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6417509|NCT00277550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6417510|NCT00277550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417511|NCT00277589|Iodine|iodine|mesh-list
6417512|NCT00277589|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6417513|NCT00277589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6417514|NCT00277589|Trace Elements|trace elements|mesh-ancestor
6417515|NCT00277589|Micronutrients|micronutrients|mesh-ancestor
6417516|NCT00277589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417517|NCT00277602|Riluzole|riluzole|mesh-list
6417518|NCT00277602|Anticonvulsants|anticonvulsants|mesh-ancestor
6417519|NCT00277602|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6417520|NCT00277602|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6417521|NCT00277602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6417522|NCT00277602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6417523|NCT00277602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417524|NCT00277602|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6417525|NCT00277602|Protective Agents|protective agents|mesh-ancestor
6417526|NCT00277641|Lamotrigine|lamotrigine|mesh-list
6417527|NCT00277641|Anticonvulsants|anticonvulsants|mesh-ancestor
6417528|NCT00277641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6417529|NCT00277641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6417530|NCT00277641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6417531|NCT00277641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6417532|NCT00277641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417533|NCT00277641|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6417534|NCT00277641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6417535|NCT00277641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6417536|NCT00277641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6417537|NCT00277641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6417538|NCT00277654|Risperidone|risperidone|mesh-list
6417539|NCT00277654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6417540|NCT00277654|Serotonin Agents|serotonin agents|mesh-ancestor
6417541|NCT00277654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6417542|NCT00277654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6417543|NCT00277654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417544|NCT00277654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6417545|NCT00277654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6417546|NCT00277654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6417547|NCT00277654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6417548|NCT00277654|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6417549|NCT00277654|Dopamine Agents|dopamine agents|mesh-ancestor
6417550|NCT00277667|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6417551|NCT00277667|Antidepressive Agents|antidepressive agents|mesh-ancestor
6417552|NCT00277667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6417553|NCT00277667|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6417554|NCT00277667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6417555|NCT00277667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6417556|NCT00277667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018927|NCT00383448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6417557|NCT00277693|Spironolactone|spironolactone|mesh-list
6417558|NCT00277693|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6417559|NCT00277693|Hormone Antagonists|hormone antagonists|mesh-ancestor
6417560|NCT00277693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6417561|NCT00277693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018928|NCT00383448|Alkylating Agents|alkylating agents|mesh-ancestor
6018929|NCT00383448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6018930|NCT00383448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6018931|NCT00383448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6417562|NCT00277693|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6417563|NCT00277693|Diuretics|diuretics|mesh-ancestor
6417564|NCT00277693|Natriuretic Agents|natriuretic agents|mesh-ancestor
6417565|NCT00277706|Vitamin D|vitamin d|mesh-list
6417566|NCT00277706|Calcium|calcium|mesh-list
6417567|NCT00277706|Vitamins|vitamins|mesh-ancestor
6417568|NCT00277706|Micronutrients|micronutrients|mesh-ancestor
6417569|NCT00277706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417570|NCT00277706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6417571|NCT00277706|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6417572|NCT00277758|Interferons|interferons|mesh-list
6417573|NCT00277758|Ribavirin|ribavirin|mesh-list
6417574|NCT00277758|Interferon-alpha|interferon-alpha|mesh-list
6417575|NCT00277758|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6417576|NCT00277758|Interleukin-2|interleukin-2|mesh-list
6417577|NCT00277758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6417578|NCT00277758|Antiviral Agents|antiviral agents|mesh-ancestor
6417579|NCT00277758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6417580|NCT00277758|Antimetabolites|antimetabolites|mesh-ancestor
6417581|NCT00277758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6417582|NCT00277758|Immunologic Factors|immunologic factors|mesh-ancestor
6417583|NCT00277758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417584|NCT00277758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6417585|NCT00277758|Analgesics|analgesics|mesh-ancestor
6417586|NCT00277758|Sensory System Agents|sensory system agents|mesh-ancestor
6417587|NCT00277758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6417588|NCT00277862|Ribavirin|ribavirin|mesh-list
6417589|NCT00277862|Interferon-alpha|interferon-alpha|mesh-list
6417590|NCT00277862|Interferon alpha-2|interferon alpha-2|mesh-list
6417591|NCT00277862|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
6417592|NCT00277862|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6417593|NCT00277862|Antimetabolites|antimetabolites|mesh-ancestor
6417594|NCT00277862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6018932|NCT00383448|Antisickling Agents|antisickling agents|mesh-ancestor
6018933|NCT00383448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6018934|NCT00383448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6018935|NCT00383448|Antimetabolites|antimetabolites|mesh-ancestor
6018936|NCT00383565|Romidepsin|romidepsin|mesh-list
6018937|NCT00383565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6417595|NCT00277862|Antiviral Agents|antiviral agents|mesh-ancestor
6417596|NCT00277862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6417597|NCT00277862|Immunologic Factors|immunologic factors|mesh-ancestor
6417598|NCT00277862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417599|NCT00277862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6417600|NCT00278070|Vinorelbine|vinorelbine|mesh-list
6417601|NCT00278070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6417602|NCT00278070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6417603|NCT00278070|Tubulin Modulators|tubulin modulators|mesh-ancestor
6417604|NCT00278070|Antimitotic Agents|antimitotic agents|mesh-ancestor
6417605|NCT00278070|Mitosis Modulators|mitosis modulators|mesh-ancestor
6417606|NCT00278070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6417607|NCT00278083|Nitric Oxide|nitric oxide|mesh-list
6417608|NCT00278083|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6417609|NCT00278083|Autonomic Agents|autonomic agents|mesh-ancestor
6417610|NCT00278083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6417611|NCT00278083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417612|NCT00278083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6417613|NCT00278083|Respiratory System Agents|respiratory system agents|mesh-ancestor
6417614|NCT00278083|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6417615|NCT00278083|Antioxidants|antioxidants|mesh-ancestor
6417616|NCT00278083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6417617|NCT00278083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6417618|NCT00278083|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6417619|NCT00278083|Vasodilator Agents|vasodilator agents|mesh-ancestor
6417620|NCT00278083|Gasotransmitters|gasotransmitters|mesh-ancestor
6417621|NCT00278083|Protective Agents|protective agents|mesh-ancestor
6417622|NCT00278122|Paclitaxel|paclitaxel|mesh-list
6417623|NCT00278122|Sargramostim|sargramostim|mesh-list
6417624|NCT00278122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6417625|NCT00278122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6417626|NCT00278122|Tubulin Modulators|tubulin modulators|mesh-ancestor
6417627|NCT00278122|Antimitotic Agents|antimitotic agents|mesh-ancestor
6417628|NCT00278122|Mitosis Modulators|mitosis modulators|mesh-ancestor
6417629|NCT00278122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6417630|NCT00278122|Immunologic Factors|immunologic factors|mesh-ancestor
6417631|NCT00278122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417632|NCT00278174|Interferons|interferons|mesh-list
6417633|NCT00278174|Interferon-alpha|interferon-alpha|mesh-list
6417634|NCT00278174|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
6417635|NCT00278174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6417636|NCT00278174|Antiviral Agents|antiviral agents|mesh-ancestor
6417637|NCT00278174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6417638|NCT00278174|Immunologic Factors|immunologic factors|mesh-ancestor
6417639|NCT00278174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417640|NCT00278187|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6417641|NCT00278187|Volociximab|volociximab|mesh-list
6417642|NCT00278187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6417643|NCT00278187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6417644|NCT00278187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6417645|NCT00278187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6417646|NCT00278187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6417647|NCT00278187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6417648|NCT00278187|Growth Substances|growth substances|mesh-ancestor
6417649|NCT00278187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417650|NCT00278187|Growth Inhibitors|growth inhibitors|mesh-ancestor
6417651|NCT00278213|Cyclophosphamide|cyclophosphamide|mesh-list
6417652|NCT00278213|Fludarabine|fludarabine|mesh-list
6417653|NCT00278213|Fludarabine phosphate|fludarabine phosphate|mesh-list
6417654|NCT00278213|Mitoxantrone|mitoxantrone|mesh-list
6417655|NCT00278213|Alemtuzumab|alemtuzumab|mesh-list
6417656|NCT00278213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6417657|NCT00278213|Immunologic Factors|immunologic factors|mesh-ancestor
6417658|NCT00278213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417659|NCT00278213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6417660|NCT00278213|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6417661|NCT00278213|Alkylating Agents|alkylating agents|mesh-ancestor
6417662|NCT00278213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6417663|NCT00278213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6417664|NCT00278213|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6417665|NCT00278213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6417666|NCT00278213|Antimetabolites|antimetabolites|mesh-ancestor
6417667|NCT00278213|Analgesics|analgesics|mesh-ancestor
6417668|NCT00278213|Sensory System Agents|sensory system agents|mesh-ancestor
6417669|NCT00278213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6417670|NCT00278213|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6417671|NCT00278213|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6417672|NCT00278213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6417673|NCT00278213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6417674|NCT00278252|Etoposide|etoposide|mesh-list
6417675|NCT00278252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6417676|NCT00278252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6417677|NCT00278252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6417678|NCT00278252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6417679|NCT00278252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6417680|NCT00278252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6417681|NCT00278265|Vidarabine|vidarabine|mesh-list
6417682|NCT00278265|Methotrexate|methotrexate|mesh-list
6417683|NCT00278265|Fludarabine phosphate|fludarabine phosphate|mesh-list
6417684|NCT00278265|Fludarabine|fludarabine|mesh-list
6417685|NCT00278265|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6417686|NCT00278265|Abortifacient Agents|abortifacient agents|mesh-ancestor
6417687|NCT00278265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6417688|NCT00278265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417689|NCT00278265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6417690|NCT00278265|Antimetabolites|antimetabolites|mesh-ancestor
6417691|NCT00278265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6417692|NCT00278265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6417693|NCT00278265|Dermatologic Agents|dermatologic agents|mesh-ancestor
6417694|NCT00278265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6417695|NCT00278265|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6417696|NCT00278265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6417697|NCT00278265|Immunologic Factors|immunologic factors|mesh-ancestor
6417698|NCT00278265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6417699|NCT00278265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6417700|NCT00278265|Antiviral Agents|antiviral agents|mesh-ancestor
6417701|NCT00278265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6417702|NCT00278278|Prednisone|prednisone|mesh-list
6417703|NCT00278278|Methotrexate|methotrexate|mesh-list
6417704|NCT00278278|Etoposide|etoposide|mesh-list
6417705|NCT00278278|Vincristine|vincristine|mesh-list
6417706|NCT00278278|Ifosfamide|ifosfamide|mesh-list
6417707|NCT00278278|Lomustine|lomustine|mesh-list
6417708|NCT00278278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6417709|NCT00278278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6417710|NCT00278278|Glucocorticoids|glucocorticoids|mesh-ancestor
6417711|NCT00278278|Hormones|hormones|mesh-ancestor
6417712|NCT00278278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6417713|NCT00278278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417714|NCT00278278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6417715|NCT00278278|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6417716|NCT00278278|Abortifacient Agents|abortifacient agents|mesh-ancestor
6417717|NCT00278278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6417718|NCT00278278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6417719|NCT00278278|Antimetabolites|antimetabolites|mesh-ancestor
6417720|NCT00278278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6417721|NCT00278278|Dermatologic Agents|dermatologic agents|mesh-ancestor
6417722|NCT00278278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6417723|NCT00278278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6417724|NCT00278278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6417725|NCT00278278|Immunologic Factors|immunologic factors|mesh-ancestor
6417726|NCT00278278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6417727|NCT00278278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6417728|NCT00278278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6417729|NCT00278278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6417730|NCT00278278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6417731|NCT00278278|Tubulin Modulators|tubulin modulators|mesh-ancestor
6417732|NCT00278278|Antimitotic Agents|antimitotic agents|mesh-ancestor
6417733|NCT00278278|Mitosis Modulators|mitosis modulators|mesh-ancestor
6417734|NCT00278278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6417735|NCT00278278|Alkylating Agents|alkylating agents|mesh-ancestor
6417736|NCT00278330|Vorinostat|vorinostat|mesh-list
6417737|NCT00278330|Alvocidib|alvocidib|mesh-list
6417738|NCT00278330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6417739|NCT00278330|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6417740|NCT00278330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6417741|NCT00278330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6417742|NCT00278330|Growth Inhibitors|growth inhibitors|mesh-ancestor
6417743|NCT00278330|Growth Substances|growth substances|mesh-ancestor
6417744|NCT00278330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417745|NCT00278330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6417746|NCT00278343|Cediranib|cediranib|mesh-list
6417747|NCT00278343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6417748|NCT00278343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6417749|NCT00278343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6417750|NCT00278343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6417751|NCT00278369|Aldesleukin|aldesleukin|mesh-list
6417752|NCT00278369|Interleukin-2|interleukin-2|mesh-list
6417753|NCT00278369|Denileukin diftitox|denileukin diftitox|mesh-list
6417754|NCT00278369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6417755|NCT00278369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6417756|NCT00278369|Analgesics|analgesics|mesh-ancestor
6417757|NCT00278369|Sensory System Agents|sensory system agents|mesh-ancestor
6417758|NCT00278369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6417759|NCT00278369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417760|NCT00278369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6417761|NCT00278369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6417762|NCT00278369|Antiviral Agents|antiviral agents|mesh-ancestor
6417763|NCT00278369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6417764|NCT00278382|Sorafenib|sorafenib|mesh-list
6417765|NCT00278382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6417766|NCT00278382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6417767|NCT00278382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6417768|NCT00278382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6417769|NCT00278408|Prednisone|prednisone|mesh-list
6417770|NCT00278408|Cyclophosphamide|cyclophosphamide|mesh-list
6417771|NCT00278408|Rituximab|rituximab|mesh-list
6417772|NCT00278408|Doxorubicin|doxorubicin|mesh-list
6417773|NCT00278408|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6417774|NCT00278408|Vincristine|vincristine|mesh-list
6417775|NCT00278408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6417776|NCT00278408|Immunologic Factors|immunologic factors|mesh-ancestor
6417777|NCT00278408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417778|NCT00278408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6417779|NCT00278408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6417780|NCT00278408|Alkylating Agents|alkylating agents|mesh-ancestor
6417781|NCT00278408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6417782|NCT00278408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6417783|NCT00278408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6417784|NCT00278408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6417785|NCT00278408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6417786|NCT00278408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6417787|NCT00278408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6417788|NCT00278408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6417789|NCT00278408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6417790|NCT00278408|Glucocorticoids|glucocorticoids|mesh-ancestor
6417791|NCT00278408|Hormones|hormones|mesh-ancestor
6417792|NCT00278408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6417793|NCT00278408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6417794|NCT00278408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6417795|NCT00278408|Tubulin Modulators|tubulin modulators|mesh-ancestor
6417796|NCT00278408|Antimitotic Agents|antimitotic agents|mesh-ancestor
6417797|NCT00278408|Mitosis Modulators|mitosis modulators|mesh-ancestor
6417798|NCT00278421|Prednisone|prednisone|mesh-list
6417799|NCT00278421|Cyclophosphamide|cyclophosphamide|mesh-list
6417800|NCT00278421|Rituximab|rituximab|mesh-list
6417801|NCT00278421|Doxorubicin|doxorubicin|mesh-list
6417802|NCT00278421|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6417803|NCT00278421|Vincristine|vincristine|mesh-list
6417804|NCT00278421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6417805|NCT00278421|Immunologic Factors|immunologic factors|mesh-ancestor
6417806|NCT00278421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417807|NCT00278421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6417808|NCT00278421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6417809|NCT00278421|Alkylating Agents|alkylating agents|mesh-ancestor
6417810|NCT00278421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6417811|NCT00278421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6417812|NCT00278421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6417813|NCT00278421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6417814|NCT00278421|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6417815|NCT00278421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6417816|NCT00278421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6417817|NCT00278421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6417818|NCT00278421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6417819|NCT00278421|Glucocorticoids|glucocorticoids|mesh-ancestor
6417820|NCT00278421|Hormones|hormones|mesh-ancestor
6417821|NCT00278421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6417822|NCT00278421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6417823|NCT00278421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6417824|NCT00278421|Tubulin Modulators|tubulin modulators|mesh-ancestor
6417825|NCT00278421|Antimitotic Agents|antimitotic agents|mesh-ancestor
6417826|NCT00278421|Mitosis Modulators|mitosis modulators|mesh-ancestor
6417827|NCT00278434|Zoledronic Acid|zoledronic acid|mesh-list
6417828|NCT00278434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6417829|NCT00278434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417830|NCT00278460|Gemcitabine|gemcitabine|mesh-list
6417831|NCT00278460|Docetaxel|docetaxel|mesh-list
6417832|NCT00278460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6417833|NCT00278460|Antimetabolites|antimetabolites|mesh-ancestor
6417834|NCT00278460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6417835|NCT00278460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6417836|NCT00278460|Antiviral Agents|antiviral agents|mesh-ancestor
6417837|NCT00278460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6417838|NCT00278460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6417839|NCT00278460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6417840|NCT00278460|Immunologic Factors|immunologic factors|mesh-ancestor
6417841|NCT00278460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417842|NCT00278460|Tubulin Modulators|tubulin modulators|mesh-ancestor
6417843|NCT00278460|Antimitotic Agents|antimitotic agents|mesh-ancestor
6417844|NCT00278460|Mitosis Modulators|mitosis modulators|mesh-ancestor
6417845|NCT00278694|Oxaliplatin|oxaliplatin|mesh-list
6417846|NCT00278694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6417847|NCT00278772|Valproic Acid|valproic acid|mesh-list
6417848|NCT00278772|Anticonvulsants|anticonvulsants|mesh-ancestor
6417849|NCT00278772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6417850|NCT00278772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6417851|NCT00278772|GABA Agents|gaba agents|mesh-ancestor
6417852|NCT00278772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6417853|NCT00278772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417854|NCT00278772|Antimanic Agents|antimanic agents|mesh-ancestor
6417855|NCT00278772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6417856|NCT00278772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6417857|NCT00278772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6417858|NCT00278824|Fentanyl|fentanyl|mesh-list
6417859|NCT00278824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6417860|NCT00278824|Narcotics|narcotics|mesh-ancestor
6417861|NCT00278824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6417862|NCT00278824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417863|NCT00278824|Analgesics|analgesics|mesh-ancestor
6417864|NCT00278824|Sensory System Agents|sensory system agents|mesh-ancestor
6417865|NCT00278824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6417866|NCT00278824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6417867|NCT00278824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6417868|NCT00278824|Anesthetics, General|anesthetics, general|mesh-ancestor
6417869|NCT00278824|Anesthetics|anesthetics|mesh-ancestor
6417870|NCT00278928|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6417871|NCT00278928|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6417872|NCT00278928|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6417873|NCT00278928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6417874|NCT00278941|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6417875|NCT00278941|Antidepressive Agents|antidepressive agents|mesh-ancestor
6417876|NCT00278941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6417877|NCT00278941|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6417878|NCT00278941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6018938|NCT00383565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6018939|NCT00383643|Sodium Oxybate|sodium oxybate|mesh-list
6018940|NCT00383643|Zolpidem|zolpidem|mesh-list
6018941|NCT00383643|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6018942|NCT00383643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6018943|NCT00383643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6018944|NCT00383643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018945|NCT00383643|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6018946|NCT00383643|GABA Agonists|gaba agonists|mesh-ancestor
6018947|NCT00383643|GABA Agents|gaba agents|mesh-ancestor
6018948|NCT00383643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6018949|NCT00383643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6018950|NCT00383643|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6417879|NCT00278941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6417880|NCT00278941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417881|NCT00278967|Bisacodyl|bisacodyl|mesh-list
6417882|NCT00278967|Cathartics|cathartics|mesh-ancestor
6417883|NCT00278967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6417884|NCT00278967|Laxatives|laxatives|mesh-ancestor
6417885|NCT00279019|Tiotropium Bromide|tiotropium bromide|mesh-list
6417886|NCT00279019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6417887|NCT00279019|Autonomic Agents|autonomic agents|mesh-ancestor
6417888|NCT00279019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6417889|NCT00279019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417890|NCT00279019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6417891|NCT00279019|Respiratory System Agents|respiratory system agents|mesh-ancestor
6417892|NCT00279019|Parasympatholytics|parasympatholytics|mesh-ancestor
6417893|NCT00279019|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6417894|NCT00279019|Cholinergic Agents|cholinergic agents|mesh-ancestor
6417895|NCT00279019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6417896|NCT00279019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6417897|NCT00279045|Metformin|metformin|mesh-list
6417898|NCT00279045|Rosiglitazone|rosiglitazone|mesh-list
6417899|NCT00279045|Glyburide|glyburide|mesh-list
6417900|NCT00279045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6417901|NCT00279045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417902|NCT00279084|Epoetin Alfa|epoetin alfa|mesh-list
6417903|NCT00279084|Hematinics|hematinics|mesh-ancestor
6460116|NCT00448266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6460117|NCT00448292|Naluzotan|naluzotan|mesh-list
6460118|NCT00448292|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6460119|NCT00448292|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6460120|NCT00448292|Serotonin Agents|serotonin agents|mesh-ancestor
6460121|NCT00448292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6460122|NCT00448292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460123|NCT00448292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460124|NCT00448305|Paclitaxel|paclitaxel|mesh-list
6460125|NCT00448305|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6460126|NCT00448305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6460127|NCT00448305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6460128|NCT00448305|Tubulin Modulators|tubulin modulators|mesh-ancestor
6460129|NCT00448305|Antimitotic Agents|antimitotic agents|mesh-ancestor
6460130|NCT00448305|Mitosis Modulators|mitosis modulators|mesh-ancestor
6460131|NCT00448305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460132|NCT00448383|Adalimumab|adalimumab|mesh-list
6460133|NCT00448383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6460134|NCT00448383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6460135|NCT00448396|Epothilone B|epothilone b|mesh-list
6460136|NCT00448396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6460137|NCT00448396|Tubulin Modulators|tubulin modulators|mesh-ancestor
6460138|NCT00448396|Antimitotic Agents|antimitotic agents|mesh-ancestor
6460139|NCT00448396|Mitosis Modulators|mitosis modulators|mesh-ancestor
6460140|NCT00448396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460141|NCT00448409|Sargramostim|sargramostim|mesh-list
6460142|NCT00448409|Immunologic Factors|immunologic factors|mesh-ancestor
6460143|NCT00448409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460144|NCT00448461|Heparin|heparin|mesh-list
6460145|NCT00448461|Bivalirudin|bivalirudin|mesh-list
6417904|NCT00279110|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6417905|NCT00279110|Antiviral Agents|antiviral agents|mesh-ancestor
6417906|NCT00279110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6417907|NCT00279123|Pantoprazole|pantoprazole|mesh-list
6417908|NCT00279123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6417909|NCT00279123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6417910|NCT00279123|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6417911|NCT00279123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6417912|NCT00279123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6417913|NCT00279162|Betamethasone|betamethasone|mesh-list
6417914|NCT00279162|Calcipotriene|calcipotriene|mesh-list
6417915|NCT00279162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6417916|NCT00279162|Glucocorticoids|glucocorticoids|mesh-ancestor
6417917|NCT00279162|Hormones|hormones|mesh-ancestor
6417918|NCT00279162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6417919|NCT00279162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417920|NCT00279162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6417921|NCT00279162|Respiratory System Agents|respiratory system agents|mesh-ancestor
6417922|NCT00279162|Dermatologic Agents|dermatologic agents|mesh-ancestor
6417923|NCT00279240|Metformin|metformin|mesh-list
6417924|NCT00279240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6417925|NCT00279240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417926|NCT00279253|Clonidine|clonidine|mesh-list
6417927|NCT00279253|Analgesics|analgesics|mesh-ancestor
6417928|NCT00279253|Sensory System Agents|sensory system agents|mesh-ancestor
6417929|NCT00279253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6417930|NCT00279253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417931|NCT00279253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6417932|NCT00279253|Sympatholytics|sympatholytics|mesh-ancestor
6417933|NCT00279253|Autonomic Agents|autonomic agents|mesh-ancestor
6417934|NCT00279253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6417935|NCT00279253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6417936|NCT00279253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6417937|NCT00279253|Adrenergic Agents|adrenergic agents|mesh-ancestor
6417938|NCT00279253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6417939|NCT00279253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6417940|NCT00279266|Thiamine|thiamine|mesh-list
6417941|NCT00279266|Vitamin B Complex|vitamin b complex|mesh-ancestor
6417942|NCT00279266|Vitamins|vitamins|mesh-ancestor
6417943|NCT00279266|Micronutrients|micronutrients|mesh-ancestor
6417944|NCT00279266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417945|NCT00279344|Fentanyl|fentanyl|mesh-list
6417946|NCT00279344|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6417947|NCT00279344|Narcotics|narcotics|mesh-ancestor
6417948|NCT00279344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6417949|NCT00279344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417950|NCT00279344|Analgesics|analgesics|mesh-ancestor
6417951|NCT00279344|Sensory System Agents|sensory system agents|mesh-ancestor
6417952|NCT00279344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6417953|NCT00279344|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6417954|NCT00279344|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6417955|NCT00279344|Anesthetics, General|anesthetics, general|mesh-ancestor
6417956|NCT00279344|Anesthetics|anesthetics|mesh-ancestor
6417957|NCT00279383|Thrombin|thrombin|mesh-list
6417958|NCT00279383|Hemostatics|hemostatics|mesh-ancestor
6417959|NCT00279383|Coagulants|coagulants|mesh-ancestor
6417960|NCT00279422|Visilizumab|visilizumab|mesh-list
6417961|NCT00279422|Immunologic Factors|immunologic factors|mesh-ancestor
6417962|NCT00279422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417963|NCT00279435|Visilizumab|visilizumab|mesh-list
6417964|NCT00279435|Immunologic Factors|immunologic factors|mesh-ancestor
6417965|NCT00279435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417966|NCT00279448|Tamoxifen|tamoxifen|mesh-list
6417967|NCT00279448|Exemestane|exemestane|mesh-list
6417968|NCT00279448|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6417969|NCT00279448|Hormone Antagonists|hormone antagonists|mesh-ancestor
6417970|NCT00279448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6417971|NCT00279448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417972|NCT00279448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6417973|NCT00279448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6417974|NCT00279448|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6417975|NCT00279448|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6417976|NCT00279448|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6417977|NCT00279448|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6417978|NCT00279448|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6417979|NCT00279448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6417980|NCT00279448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6417981|NCT00279461|Vitamin D|vitamin d|mesh-list
6417982|NCT00279461|Ergocalciferols|ergocalciferols|mesh-list
6417983|NCT00279461|Cholecalciferol|cholecalciferol|mesh-list
6417984|NCT00279461|Vitamins|vitamins|mesh-list
6417985|NCT00279461|Micronutrients|micronutrients|mesh-ancestor
6417986|NCT00279461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417987|NCT00279461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6417988|NCT00279461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6417989|NCT00279487|Gabapentin|gabapentin|mesh-list
6417990|NCT00279487|Analgesics|analgesics|mesh-ancestor
6417991|NCT00279487|Sensory System Agents|sensory system agents|mesh-ancestor
6417992|NCT00279487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6417993|NCT00279487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6417994|NCT00279487|Anticonvulsants|anticonvulsants|mesh-ancestor
6417995|NCT00279487|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6417996|NCT00279487|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6417997|NCT00279487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6417998|NCT00279487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6417999|NCT00279487|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6418000|NCT00279487|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6418001|NCT00279487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6418002|NCT00279487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418003|NCT00279487|Antimanic Agents|antimanic agents|mesh-ancestor
6418004|NCT00279539|Mitogens|mitogens|mesh-list
6418005|NCT00279539|Endothelial Growth Factors|endothelial growth factors|mesh-list
6418006|NCT00279539|Mitosis Modulators|mitosis modulators|mesh-ancestor
6418007|NCT00279539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418008|NCT00279539|Growth Substances|growth substances|mesh-ancestor
6418009|NCT00279539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418010|NCT00279565|Interferons|interferons|mesh-list
6418011|NCT00279565|Ribavirin|ribavirin|mesh-list
6418012|NCT00279565|Interferon-alpha|interferon-alpha|mesh-list
6418013|NCT00279565|Interferon alpha-2|interferon alpha-2|mesh-list
6418014|NCT00279565|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6418015|NCT00279565|Buprenorphine|buprenorphine|mesh-list
6418016|NCT00279565|Methadone|methadone|mesh-list
6418017|NCT00279565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6418018|NCT00279565|Antiviral Agents|antiviral agents|mesh-ancestor
6418019|NCT00279565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6418020|NCT00279565|Antimetabolites|antimetabolites|mesh-ancestor
6418021|NCT00279565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418022|NCT00279565|Immunologic Factors|immunologic factors|mesh-ancestor
6418023|NCT00279565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418024|NCT00279565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6418025|NCT00279565|Narcotics|narcotics|mesh-ancestor
6418026|NCT00279565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6418027|NCT00279565|Analgesics|analgesics|mesh-ancestor
6418028|NCT00279565|Sensory System Agents|sensory system agents|mesh-ancestor
6418029|NCT00279565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6418030|NCT00279565|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6418031|NCT00279565|Antitussive Agents|antitussive agents|mesh-ancestor
6418032|NCT00279565|Respiratory System Agents|respiratory system agents|mesh-ancestor
6418033|NCT00279578|Tranexamic Acid|tranexamic acid|mesh-list
6418034|NCT00279578|Factor VIII|factor viii|mesh-list
6418035|NCT00279578|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6418036|NCT00279578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6418037|NCT00279578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418038|NCT00279578|Hemostatics|hemostatics|mesh-ancestor
6418039|NCT00279578|Coagulants|coagulants|mesh-ancestor
6418040|NCT00279617|Levetiracetam|levetiracetam|mesh-list
6418041|NCT00279617|Anticonvulsants|anticonvulsants|mesh-ancestor
6418042|NCT00279617|Nootropic Agents|nootropic agents|mesh-ancestor
6418043|NCT00279734|Abatacept|abatacept|mesh-list
6418044|NCT00279734|Vaccines|vaccines|mesh-list
6418045|NCT00279734|Immunologic Factors|immunologic factors|mesh-ancestor
6418046|NCT00279734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418047|NCT00279734|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6418048|NCT00279734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418049|NCT00279734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6418050|NCT00279734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6418051|NCT00279734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6418052|NCT00279747|Naproxen|naproxen|mesh-list
6418053|NCT00279747|Meloxicam|meloxicam|mesh-list
6418054|NCT00279747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6418055|NCT00279747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6418056|NCT00279747|Analgesics|analgesics|mesh-ancestor
6418057|NCT00279747|Sensory System Agents|sensory system agents|mesh-ancestor
6418058|NCT00279747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6418059|NCT00279747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418060|NCT00279747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6418061|NCT00279747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6418062|NCT00279747|Gout Suppressants|gout suppressants|mesh-ancestor
6418063|NCT00279747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6418064|NCT00279747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6418065|NCT00279747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418066|NCT00279747|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6418067|NCT00279760|Abatacept|abatacept|mesh-list
6418068|NCT00279760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6418069|NCT00279760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418070|NCT00279760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6418071|NCT00279760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6418072|NCT00279760|Immunologic Factors|immunologic factors|mesh-ancestor
6418073|NCT00279760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418074|NCT00279760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6418075|NCT00279825|Levodopa|levodopa|mesh-list
6418076|NCT00279825|Carbidopa|carbidopa|mesh-list
6418077|NCT00279825|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
6418078|NCT00279825|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6418079|NCT00279825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6418080|NCT00279825|Dopamine Agents|dopamine agents|mesh-ancestor
6418081|NCT00279825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6418082|NCT00279825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418083|NCT00279825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418084|NCT00279825|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6418085|NCT00279825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6418086|NCT00279825|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6418087|NCT00279825|Immunologic Factors|immunologic factors|mesh-ancestor
6418088|NCT00279825|Dopamine Agonists|dopamine agonists|mesh-ancestor
6418089|NCT00279903|Cortisone|cortisone|mesh-list
6418090|NCT00279903|Botulinum Toxins|botulinum toxins|mesh-list
6418091|NCT00279903|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6418092|NCT00279903|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6418093|NCT00279903|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6418094|NCT00279903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6418095|NCT00279903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418096|NCT00279903|Cholinergic Agents|cholinergic agents|mesh-ancestor
6418097|NCT00279903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6418098|NCT00279903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418099|NCT00279903|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6418100|NCT00279903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6418101|NCT00279903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6418102|NCT00280007|Bevacizumab|bevacizumab|mesh-list
6418103|NCT00280007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6418104|NCT00280007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6418105|NCT00280007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6418106|NCT00280007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6418107|NCT00280007|Growth Substances|growth substances|mesh-ancestor
6418108|NCT00280007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418109|NCT00280007|Growth Inhibitors|growth inhibitors|mesh-ancestor
6418110|NCT00280033|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6418111|NCT00280033|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6418112|NCT00280033|Immunologic Factors|immunologic factors|mesh-ancestor
6418113|NCT00280033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418114|NCT00280033|Antacids|antacids|mesh-ancestor
6418115|NCT00280033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418116|NCT00280033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6418117|NCT00280046|Insulin Aspart|insulin aspart|mesh-list
6418118|NCT00280046|Biphasic Insulins|biphasic insulins|mesh-list
6418119|NCT00280046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6418120|NCT00280046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418121|NCT00280098|Docetaxel|docetaxel|mesh-list
6418122|NCT00280098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6418123|NCT00280098|Tubulin Modulators|tubulin modulators|mesh-ancestor
6418124|NCT00280098|Antimitotic Agents|antimitotic agents|mesh-ancestor
6418125|NCT00280098|Mitosis Modulators|mitosis modulators|mesh-ancestor
6418126|NCT00280098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418127|NCT00280176|Fluorouracil|fluorouracil|mesh-list
6418128|NCT00280176|Bortezomib|bortezomib|mesh-list
6418129|NCT00280176|Antimetabolites|antimetabolites|mesh-ancestor
6418130|NCT00280176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418131|NCT00280176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6418132|NCT00280176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6418133|NCT00280176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6418134|NCT00280176|Immunologic Factors|immunologic factors|mesh-ancestor
6418135|NCT00280176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418136|NCT00280215|Losartan|losartan|mesh-list
6418137|NCT00280215|Lisinopril|lisinopril|mesh-list
6418138|NCT00280215|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
6418139|NCT00280215|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6418140|NCT00280215|Enzyme Inhibitors|enzyme inhibitors|mesh-list
6418141|NCT00280215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6418142|NCT00280215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6418143|NCT00280215|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6418144|NCT00280215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418145|NCT00280215|Protease Inhibitors|protease inhibitors|mesh-ancestor
6418146|NCT00280215|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6418147|NCT00280215|Protective Agents|protective agents|mesh-ancestor
6418148|NCT00280215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418149|NCT00280267|Testosterone|testosterone|mesh-list
6418150|NCT00280267|Androgens|androgens|mesh-ancestor
6418151|NCT00280267|Hormones|hormones|mesh-ancestor
6418152|NCT00280267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6418153|NCT00280267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418154|NCT00280280|Baclofen|baclofen|mesh-list
6418155|NCT00280280|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6418156|NCT00280280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418157|NCT00280280|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6418158|NCT00280280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6418159|NCT00280280|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6418160|NCT00280280|GABA Agonists|gaba agonists|mesh-ancestor
6418161|NCT00280280|GABA Agents|gaba agents|mesh-ancestor
6418162|NCT00280280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6418163|NCT00280280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418164|NCT00280358|Fluticasone|fluticasone|mesh-list
6418165|NCT00280358|Xhance|xhance|mesh-list
6418166|NCT00280358|Formoterol Fumarate|formoterol fumarate|mesh-list
6418167|NCT00280358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6418168|NCT00280358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6418169|NCT00280358|Autonomic Agents|autonomic agents|mesh-ancestor
6418170|NCT00280358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6418171|NCT00280358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418172|NCT00280358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6418173|NCT00280358|Respiratory System Agents|respiratory system agents|mesh-ancestor
6418174|NCT00280358|Dermatologic Agents|dermatologic agents|mesh-ancestor
6418175|NCT00280358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6418176|NCT00280358|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6418177|NCT00280358|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6418178|NCT00280358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6418179|NCT00280358|Adrenergic Agents|adrenergic agents|mesh-ancestor
6418180|NCT00280358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6418181|NCT00280358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418182|NCT00280371|Formoterol Fumarate|formoterol fumarate|mesh-list
6418183|NCT00280371|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6418184|NCT00280371|Autonomic Agents|autonomic agents|mesh-ancestor
6418185|NCT00280371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6418186|NCT00280371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418187|NCT00280371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6418188|NCT00280371|Respiratory System Agents|respiratory system agents|mesh-ancestor
6418189|NCT00280371|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6418190|NCT00280371|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6418191|NCT00280371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6418192|NCT00280371|Adrenergic Agents|adrenergic agents|mesh-ancestor
6418193|NCT00280371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6418194|NCT00280371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418195|NCT00280423|Casopitant|casopitant|mesh-list
6418196|NCT00280423|Antiemetics|antiemetics|mesh-ancestor
6418197|NCT00280423|Autonomic Agents|autonomic agents|mesh-ancestor
6418198|NCT00280423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6418199|NCT00280423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418200|NCT00280423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6418201|NCT00280423|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6418202|NCT00280423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6418203|NCT00280423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418204|NCT00280436|Casopitant|casopitant|mesh-list
6418205|NCT00280436|Antiemetics|antiemetics|mesh-ancestor
6418206|NCT00280436|Autonomic Agents|autonomic agents|mesh-ancestor
6418207|NCT00280436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6418208|NCT00280436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418209|NCT00280436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6418210|NCT00280436|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6418211|NCT00280436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6418212|NCT00280436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501284|NCT04475705|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5501285|NCT04475887|Iron|iron|mesh-list
5501286|NCT04475887|Trace Elements|trace elements|mesh-ancestor
5501287|NCT04475887|Micronutrients|micronutrients|mesh-ancestor
5501288|NCT04475887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501289|NCT04475835|Heparin|heparin|mesh-list
5501290|NCT04475835|Bivalirudin|bivalirudin|mesh-list
5501291|NCT04475835|Anticoagulants|anticoagulants|mesh-ancestor
5501292|NCT04475835|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5501293|NCT04475835|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5501294|NCT04475835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501295|NCT04475835|Antithrombins|antithrombins|mesh-ancestor
5501296|NCT04475835|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5501297|NCT04475835|Protease Inhibitors|protease inhibitors|mesh-ancestor
5501298|NCT04475835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5501299|NCT04475991|Maraviroc|maraviroc|mesh-list
5501300|NCT04475991|Favipiravir|favipiravir|mesh-list
6418213|NCT00280462|Nifedipine|nifedipine|mesh-list
6418214|NCT00280462|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5501301|NCT04475991|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5501302|NCT04475991|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6418215|NCT00280462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6418216|NCT00280462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418217|NCT00280462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6418218|NCT00280462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418219|NCT00280462|Vasodilator Agents|vasodilator agents|mesh-ancestor
6418220|NCT00280462|Tocolytic Agents|tocolytic agents|mesh-ancestor
6418221|NCT00280462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6418222|NCT00280501|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6418223|NCT00280501|Sulpiride|sulpiride|mesh-list
6418224|NCT00280501|Antidepressive Agents|antidepressive agents|mesh-ancestor
6418225|NCT00280501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6418226|NCT00280501|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6418227|NCT00280501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6418228|NCT00280501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6418229|NCT00280501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418230|NCT00280501|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6418231|NCT00280501|Dopamine Agents|dopamine agents|mesh-ancestor
6418232|NCT00280501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6418233|NCT00280501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418234|NCT00280501|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6418235|NCT00280514|Moxifloxacin|moxifloxacin|mesh-list
6418236|NCT00280514|Cefpirome|cefpirome|mesh-list
6418237|NCT00280514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6418238|NCT00280514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6418239|NCT00280514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6418240|NCT00280514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6418241|NCT00280514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6418242|NCT00280514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418243|NCT00280514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6418244|NCT00280540|Valsartan|valsartan|mesh-list
6418245|NCT00280540|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6418246|NCT00280540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6418247|NCT00280540|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6418248|NCT00280540|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6418249|NCT00280540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418250|NCT00280540|Diuretics|diuretics|mesh-ancestor
6418251|NCT00280540|Natriuretic Agents|natriuretic agents|mesh-ancestor
6418252|NCT00280540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418253|NCT00280540|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6418254|NCT00280540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6418255|NCT00280553|Bupivacaine|bupivacaine|mesh-list
6418256|NCT00280553|Anesthetics, Local|anesthetics, local|mesh-ancestor
6418257|NCT00280553|Anesthetics|anesthetics|mesh-ancestor
6418258|NCT00280553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6418259|NCT00280553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418260|NCT00280553|Sensory System Agents|sensory system agents|mesh-ancestor
6418261|NCT00280553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6418262|NCT00280605|Alfuzosin|alfuzosin|mesh-list
6418263|NCT00280605|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6418264|NCT00280605|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6418265|NCT00280605|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6418266|NCT00280605|Adrenergic Agents|adrenergic agents|mesh-ancestor
6418267|NCT00280605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6418268|NCT00280605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418269|NCT00280605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418270|NCT00280605|Urological Agents|urological agents|mesh-ancestor
6418271|NCT00280618|Oxaliplatin|oxaliplatin|mesh-list
6418272|NCT00280618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6418273|NCT00280644|Leflunomide|leflunomide|mesh-list
6418274|NCT00280644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6418275|NCT00280644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418276|NCT00280644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6418277|NCT00280644|Immunologic Factors|immunologic factors|mesh-ancestor
6418278|NCT00280644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418279|NCT00280696|Levetiracetam|levetiracetam|mesh-list
6018951|NCT00383643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6418280|NCT00280696|Anticonvulsants|anticonvulsants|mesh-ancestor
6418281|NCT00280696|Nootropic Agents|nootropic agents|mesh-ancestor
6460146|NCT00448461|Anticoagulants|anticoagulants|mesh-ancestor
6460147|NCT00448461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6460148|NCT00448461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6460149|NCT00448461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460150|NCT00448461|Antithrombins|antithrombins|mesh-ancestor
6460151|NCT00448461|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6460152|NCT00448461|Protease Inhibitors|protease inhibitors|mesh-ancestor
6460153|NCT00448461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6460154|NCT00448552|Capecitabine|capecitabine|mesh-list
6460155|NCT00448552|Oxaliplatin|oxaliplatin|mesh-list
6460156|NCT00448552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6460157|NCT00448552|Antimetabolites|antimetabolites|mesh-ancestor
6460158|NCT00448552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460159|NCT00448552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6460160|NCT00448578|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6460161|NCT00448578|Antidepressive Agents|antidepressive agents|mesh-ancestor
6460162|NCT00448578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6460163|NCT00448578|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6460164|NCT00448578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6460165|NCT00448578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6460166|NCT00448578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460167|NCT00448643|Cisplatin|cisplatin|mesh-list
6460168|NCT00448643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6460169|NCT00448734|Docetaxel|docetaxel|mesh-list
6460170|NCT00448734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6460171|NCT00448734|Tubulin Modulators|tubulin modulators|mesh-ancestor
6460172|NCT00448734|Antimitotic Agents|antimitotic agents|mesh-ancestor
6460173|NCT00448734|Mitosis Modulators|mitosis modulators|mesh-ancestor
6460174|NCT00448734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460175|NCT00448786|Niacinamide|niacinamide|mesh-list
6460176|NCT00448786|Motesanib diphosphate|motesanib diphosphate|mesh-list
6460177|NCT00448786|Imetelstat|imetelstat|mesh-list
6460178|NCT00448786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6460179|NCT00448786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6460180|NCT00448786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460181|NCT00448786|Vitamin B Complex|vitamin b complex|mesh-ancestor
6460182|NCT00448786|Vitamins|vitamins|mesh-ancestor
6460183|NCT00448786|Micronutrients|micronutrients|mesh-ancestor
6460184|NCT00448786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460185|NCT00448825|Topiramate|topiramate|mesh-list
6460186|NCT00448825|Anticonvulsants|anticonvulsants|mesh-ancestor
6460187|NCT00448825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6460188|NCT00448825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460189|NCT00448838|Gemcitabine|gemcitabine|mesh-list
6460190|NCT00448838|Oxaliplatin|oxaliplatin|mesh-list
6460191|NCT00448838|Cetuximab|cetuximab|mesh-list
6460192|NCT00448838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6460193|NCT00448838|Antimetabolites|antimetabolites|mesh-ancestor
6460194|NCT00448838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460195|NCT00448838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6460196|NCT00448838|Antiviral Agents|antiviral agents|mesh-ancestor
6460197|NCT00448838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6460198|NCT00448838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6460199|NCT00448838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6460200|NCT00448838|Immunologic Factors|immunologic factors|mesh-ancestor
6460201|NCT00448838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418282|NCT00280774|Memantine|memantine|mesh-list
6418283|NCT00280774|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6418284|NCT00280774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6418285|NCT00280774|Dopamine Agents|dopamine agents|mesh-ancestor
6418286|NCT00280774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6418287|NCT00280774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418288|NCT00280774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418289|NCT00280774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6418290|NCT00280774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6418291|NCT00280787|Paclitaxel|paclitaxel|mesh-list
6418292|NCT00280787|Carboplatin|carboplatin|mesh-list
6418293|NCT00280787|Irinotecan|irinotecan|mesh-list
6418294|NCT00280787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6418295|NCT00280787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6418296|NCT00280787|Tubulin Modulators|tubulin modulators|mesh-ancestor
6418297|NCT00280787|Antimitotic Agents|antimitotic agents|mesh-ancestor
6418298|NCT00280787|Mitosis Modulators|mitosis modulators|mesh-ancestor
6418299|NCT00280787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418300|NCT00280787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6418301|NCT00280787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6418302|NCT00280787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6418303|NCT00280839|Topiramate|topiramate|mesh-list
6418304|NCT00280839|Anticonvulsants|anticonvulsants|mesh-ancestor
6418305|NCT00280839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6418306|NCT00280839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418307|NCT00280865|Pioglitazone|pioglitazone|mesh-list
6418308|NCT00280865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6418309|NCT00280865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418310|NCT00280878|Gemcitabine|gemcitabine|mesh-list
6418311|NCT00280878|Rituximab|rituximab|mesh-list
6418312|NCT00280878|Vinorelbine|vinorelbine|mesh-list
6418313|NCT00280878|Ifosfamide|ifosfamide|mesh-list
6418314|NCT00280878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6418315|NCT00280878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6418316|NCT00280878|Immunologic Factors|immunologic factors|mesh-ancestor
6418317|NCT00280878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418318|NCT00280878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6418319|NCT00280878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6418320|NCT00280878|Antimetabolites|antimetabolites|mesh-ancestor
6418321|NCT00280878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418322|NCT00280878|Antiviral Agents|antiviral agents|mesh-ancestor
6418323|NCT00280878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6418324|NCT00280878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6418325|NCT00280878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6418326|NCT00280878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6018952|NCT00383643|Anesthetics, General|anesthetics, general|mesh-ancestor
6018953|NCT00383643|Anesthetics|anesthetics|mesh-ancestor
6018954|NCT00383747|Nicotine|nicotine|mesh-list
6018955|NCT00383747|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6418327|NCT00280878|Tubulin Modulators|tubulin modulators|mesh-ancestor
6418328|NCT00280878|Antimitotic Agents|antimitotic agents|mesh-ancestor
6418329|NCT00280878|Mitosis Modulators|mitosis modulators|mesh-ancestor
6418330|NCT00280878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6418331|NCT00280878|Alkylating Agents|alkylating agents|mesh-ancestor
6418332|NCT00280930|Letrozole|letrozole|mesh-list
6418333|NCT00280930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6418334|NCT00280930|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6418335|NCT00280930|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6418336|NCT00280930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6418337|NCT00280930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418338|NCT00280930|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6418339|NCT00280930|Hormone Antagonists|hormone antagonists|mesh-ancestor
6418340|NCT00280930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6418341|NCT00280930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418342|NCT00280956|Natalizumab|natalizumab|mesh-list
6418343|NCT00280956|Immunologic Factors|immunologic factors|mesh-ancestor
6018956|NCT00383747|Autonomic Agents|autonomic agents|mesh-ancestor
6418344|NCT00280956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418345|NCT00280969|Efavirenz|efavirenz|mesh-list
6418346|NCT00280969|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6418347|NCT00280969|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6418348|NCT00280969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6418349|NCT00280969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6418350|NCT00280969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418351|NCT00280969|Antiviral Agents|antiviral agents|mesh-ancestor
6418352|NCT00280969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6418353|NCT00280969|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6418354|NCT00280969|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6418355|NCT00280969|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6418356|NCT00280969|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6418357|NCT00280969|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6418358|NCT00280969|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6418359|NCT00280969|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6418360|NCT00280969|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6418361|NCT00280969|Protease Inhibitors|protease inhibitors|mesh-ancestor
6018957|NCT00383747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6418362|NCT00280969|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6418363|NCT00280969|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6418364|NCT00280995|Mipomersen|mipomersen|mesh-list
6418365|NCT00280995|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6418366|NCT00280995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6418367|NCT00280995|Antimetabolites|antimetabolites|mesh-ancestor
6418368|NCT00280995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418369|NCT00280995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6418370|NCT00281008|Mipomersen|mipomersen|mesh-list
6418371|NCT00281008|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6418372|NCT00281008|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6418373|NCT00281008|Antimetabolites|antimetabolites|mesh-ancestor
6418374|NCT00281008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418375|NCT00281008|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6418376|NCT00281125|Pemetrexed|pemetrexed|mesh-list
6418377|NCT00281125|Vatalanib|vatalanib|mesh-list
6418378|NCT00281125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6418379|NCT00281125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6418380|NCT00281125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418381|NCT00281125|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6418382|NCT00281125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6418383|NCT00281125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6418384|NCT00281255|Allopurinol|allopurinol|mesh-list
6418385|NCT00281255|Dobutamine|dobutamine|mesh-list
6418386|NCT00281255|Antimetabolites|antimetabolites|mesh-ancestor
6418387|NCT00281255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418388|NCT00281255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6418389|NCT00281255|Gout Suppressants|gout suppressants|mesh-ancestor
6018958|NCT00383747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018959|NCT00383747|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6018960|NCT00383747|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6018961|NCT00383747|Cholinergic Agents|cholinergic agents|mesh-ancestor
6018962|NCT00383747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6018963|NCT00383747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418390|NCT00281255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6418391|NCT00281255|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6418392|NCT00281255|Antioxidants|antioxidants|mesh-ancestor
6418393|NCT00281255|Protective Agents|protective agents|mesh-ancestor
6418394|NCT00281255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418395|NCT00281255|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6018964|NCT00383786|Vofopitant|vofopitant|mesh-list
6018965|NCT00383786|Antiemetics|antiemetics|mesh-ancestor
6018966|NCT00383786|Autonomic Agents|autonomic agents|mesh-ancestor
6018967|NCT00383786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6418396|NCT00281255|Sympathomimetics|sympathomimetics|mesh-ancestor
6418397|NCT00281255|Autonomic Agents|autonomic agents|mesh-ancestor
6418398|NCT00281255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6418399|NCT00281255|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6418400|NCT00281255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6418401|NCT00281255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6418402|NCT00281255|Adrenergic Agents|adrenergic agents|mesh-ancestor
6418403|NCT00281255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6418404|NCT00281281|Vancomycin|vancomycin|mesh-list
6418405|NCT00281281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6418406|NCT00281281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6418407|NCT00281307|Tocopherols|tocopherols|mesh-list
6418408|NCT00281307|Vitamin E|vitamin e|mesh-list
6418409|NCT00281307|Tocotrienols|tocotrienols|mesh-list
6418410|NCT00281307|alpha-Tocopherol|alpha-tocopherol|mesh-list
6418411|NCT00281307|Antioxidants|antioxidants|mesh-ancestor
6418412|NCT00281307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418413|NCT00281307|Protective Agents|protective agents|mesh-ancestor
6418414|NCT00281307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418415|NCT00281307|Vitamins|vitamins|mesh-ancestor
6418416|NCT00281307|Micronutrients|micronutrients|mesh-ancestor
6418417|NCT00281476|Simvastatin|simvastatin|mesh-list
6418418|NCT00281476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6418419|NCT00281476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6418420|NCT00281476|Antimetabolites|antimetabolites|mesh-ancestor
6418421|NCT00281476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418422|NCT00281476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6418423|NCT00281476|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6418424|NCT00281476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6418425|NCT00281489|Anesthetics|anesthetics|mesh-list
6418426|NCT00281489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6418427|NCT00281489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418428|NCT00281502|Rifaximin|rifaximin|mesh-list
6418429|NCT00281502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6418430|NCT00281502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6418431|NCT00281502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6418432|NCT00281515|Lonafarnib|lonafarnib|mesh-list
6418433|NCT00281515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6418434|NCT00281515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418435|NCT00281567|Tiotropium Bromide|tiotropium bromide|mesh-list
6418436|NCT00281567|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6418437|NCT00281567|Autonomic Agents|autonomic agents|mesh-ancestor
6418438|NCT00281567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6418439|NCT00281567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418440|NCT00281567|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6418441|NCT00281567|Respiratory System Agents|respiratory system agents|mesh-ancestor
6418442|NCT00281567|Parasympatholytics|parasympatholytics|mesh-ancestor
6418443|NCT00281567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6418444|NCT00281567|Cholinergic Agents|cholinergic agents|mesh-ancestor
6418445|NCT00281567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6418446|NCT00281567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418447|NCT00281593|Telmisartan|telmisartan|mesh-list
6418448|NCT00281593|Ramipril|ramipril|mesh-list
6018968|NCT00383786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018969|NCT00383786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6018970|NCT00383786|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6418449|NCT00281593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6418450|NCT00281593|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6418451|NCT00281593|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6418452|NCT00281593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418453|NCT00281593|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6418454|NCT00281593|Protease Inhibitors|protease inhibitors|mesh-ancestor
6418455|NCT00281593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6418456|NCT00281606|Ritonavir|ritonavir|mesh-list
6418457|NCT00281606|Lopinavir|lopinavir|mesh-list
6418458|NCT00281606|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6418459|NCT00281606|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6418460|NCT00281606|Protease Inhibitors|protease inhibitors|mesh-ancestor
6418461|NCT00281606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6418462|NCT00281606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418463|NCT00281606|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6418464|NCT00281606|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6418465|NCT00281606|Antiviral Agents|antiviral agents|mesh-ancestor
6418466|NCT00281606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6418467|NCT00281606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6418468|NCT00281606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6418469|NCT00281619|Mycophenolic Acid|mycophenolic acid|mesh-list
6418470|NCT00281619|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6018971|NCT00383786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6018972|NCT00383786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6018973|NCT00383942|Misoprostol|misoprostol|mesh-list
6018974|NCT00383942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6418471|NCT00281619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6418472|NCT00281619|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6418473|NCT00281619|Antitubercular Agents|antitubercular agents|mesh-ancestor
6418474|NCT00281619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6418475|NCT00281619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6418476|NCT00281619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6418477|NCT00281619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418478|NCT00281645|Analgesics|analgesics|mesh-list
6418479|NCT00281645|Sensory System Agents|sensory system agents|mesh-ancestor
6418480|NCT00281645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6418481|NCT00281645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418482|NCT00281710|Methylprednisolone|methylprednisolone|mesh-list
6418483|NCT00281710|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6418484|NCT00281710|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6418485|NCT00281710|Prednisolone|prednisolone|mesh-list
6418486|NCT00281710|Prednisolone acetate|prednisolone acetate|mesh-list
6418487|NCT00281710|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6418488|NCT00281710|Prednisolone phosphate|prednisolone phosphate|mesh-list
6418489|NCT00281710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6418490|NCT00281710|Antiemetics|antiemetics|mesh-ancestor
6418491|NCT00281710|Autonomic Agents|autonomic agents|mesh-ancestor
6418492|NCT00281710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6418493|NCT00281710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418494|NCT00281710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6418495|NCT00281710|Glucocorticoids|glucocorticoids|mesh-ancestor
6418496|NCT00281710|Hormones|hormones|mesh-ancestor
6418497|NCT00281710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6418498|NCT00281710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6418499|NCT00281710|Protective Agents|protective agents|mesh-ancestor
6418500|NCT00281710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6418501|NCT00281710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6418502|NCT00281788|Paclitaxel|paclitaxel|mesh-list
6418503|NCT00281788|Carboplatin|carboplatin|mesh-list
6418504|NCT00281788|Capecitabine|capecitabine|mesh-list
6418505|NCT00281788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6418506|NCT00281788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6418507|NCT00281788|Tubulin Modulators|tubulin modulators|mesh-ancestor
6418508|NCT00281788|Antimitotic Agents|antimitotic agents|mesh-ancestor
6418509|NCT00281788|Mitosis Modulators|mitosis modulators|mesh-ancestor
6418510|NCT00281788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418511|NCT00281788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6418512|NCT00281788|Antimetabolites|antimetabolites|mesh-ancestor
6418513|NCT00281866|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6418514|NCT00281866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6418515|NCT00281866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6418516|NCT00281866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6418517|NCT00281866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418518|NCT00281892|Vidarabine|vidarabine|mesh-list
6418519|NCT00281892|Fludarabine|fludarabine|mesh-list
6418520|NCT00281892|Fludarabine phosphate|fludarabine phosphate|mesh-list
6418521|NCT00281892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6418522|NCT00281892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6418523|NCT00281892|Antimetabolites|antimetabolites|mesh-ancestor
6418524|NCT00281892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418525|NCT00281892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6418526|NCT00281892|Immunologic Factors|immunologic factors|mesh-ancestor
6418527|NCT00281892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418528|NCT00281892|Antiviral Agents|antiviral agents|mesh-ancestor
6418529|NCT00281892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6418530|NCT00281905|Cyclophosphamide|cyclophosphamide|mesh-list
6418531|NCT00281905|Carboplatin|carboplatin|mesh-list
6418532|NCT00281905|Methotrexate|methotrexate|mesh-list
6418533|NCT00281905|Vincristine|vincristine|mesh-list
6418534|NCT00281905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6418535|NCT00281905|Immunologic Factors|immunologic factors|mesh-ancestor
6418536|NCT00281905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418537|NCT00281905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6418538|NCT00281905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6418539|NCT00281905|Alkylating Agents|alkylating agents|mesh-ancestor
6418540|NCT00281905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418541|NCT00281905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6418542|NCT00281905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6418543|NCT00281905|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6418544|NCT00281905|Abortifacient Agents|abortifacient agents|mesh-ancestor
6418545|NCT00281905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6418546|NCT00281905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6418547|NCT00281905|Antimetabolites|antimetabolites|mesh-ancestor
6418548|NCT00281905|Dermatologic Agents|dermatologic agents|mesh-ancestor
6418549|NCT00281905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6418550|NCT00281905|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6418551|NCT00281905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6418552|NCT00281905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6418553|NCT00281905|Tubulin Modulators|tubulin modulators|mesh-ancestor
6418554|NCT00281905|Antimitotic Agents|antimitotic agents|mesh-ancestor
6418555|NCT00281905|Mitosis Modulators|mitosis modulators|mesh-ancestor
6418556|NCT00281931|Cyclophosphamide|cyclophosphamide|mesh-list
6418557|NCT00281931|Rituximab|rituximab|mesh-list
6418558|NCT00281931|Fludarabine|fludarabine|mesh-list
6418559|NCT00281931|Fludarabine phosphate|fludarabine phosphate|mesh-list
6418560|NCT00281931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6418561|NCT00281931|Immunologic Factors|immunologic factors|mesh-ancestor
6418562|NCT00281931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418563|NCT00281931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6418564|NCT00281931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6418565|NCT00281931|Alkylating Agents|alkylating agents|mesh-ancestor
6418566|NCT00281931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418567|NCT00281931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6418568|NCT00281931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6418569|NCT00281931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6418570|NCT00281931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6418571|NCT00281931|Antimetabolites|antimetabolites|mesh-ancestor
6418572|NCT00281944|Leucovorin|leucovorin|mesh-list
6418573|NCT00281944|Fluorouracil|fluorouracil|mesh-list
6418574|NCT00281944|Oxaliplatin|oxaliplatin|mesh-list
6418575|NCT00281944|Calcium|calcium|mesh-list
6418576|NCT00281944|Levoleucovorin|levoleucovorin|mesh-list
6418577|NCT00281944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6418578|NCT00281944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418579|NCT00281944|Antimetabolites|antimetabolites|mesh-ancestor
6418580|NCT00281944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418581|NCT00281944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6418582|NCT00281944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6418583|NCT00281944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6418584|NCT00281944|Immunologic Factors|immunologic factors|mesh-ancestor
6418585|NCT00281944|Antidotes|antidotes|mesh-ancestor
6418586|NCT00281944|Protective Agents|protective agents|mesh-ancestor
6418587|NCT00281944|Vitamin B Complex|vitamin b complex|mesh-ancestor
6418588|NCT00281944|Vitamins|vitamins|mesh-ancestor
6418589|NCT00281944|Micronutrients|micronutrients|mesh-ancestor
6418590|NCT00281970|Docetaxel|docetaxel|mesh-list
6418591|NCT00281970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6418592|NCT00281970|Tubulin Modulators|tubulin modulators|mesh-ancestor
6418593|NCT00281970|Antimitotic Agents|antimitotic agents|mesh-ancestor
6418594|NCT00281970|Mitosis Modulators|mitosis modulators|mesh-ancestor
6418595|NCT00281970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418596|NCT00281983|Cyclosporine|cyclosporine|mesh-list
6418597|NCT00281983|Mycophenolic Acid|mycophenolic acid|mesh-list
6418598|NCT00281983|Cyclophosphamide|cyclophosphamide|mesh-list
6418599|NCT00281983|Busulfan|busulfan|mesh-list
6418600|NCT00281983|Rituximab|rituximab|mesh-list
6418601|NCT00281983|Methotrexate|methotrexate|mesh-list
6418602|NCT00281983|Fludarabine|fludarabine|mesh-list
6418603|NCT00281983|Fludarabine phosphate|fludarabine phosphate|mesh-list
6418604|NCT00281983|Alemtuzumab|alemtuzumab|mesh-list
6418605|NCT00281983|Cyclosporins|cyclosporins|mesh-list
6418606|NCT00281983|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6418607|NCT00281983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6418608|NCT00281983|Immunologic Factors|immunologic factors|mesh-ancestor
6418609|NCT00281983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418610|NCT00281983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6418611|NCT00281983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6418612|NCT00281983|Alkylating Agents|alkylating agents|mesh-ancestor
6418613|NCT00281983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418614|NCT00281983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6418615|NCT00281983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6418616|NCT00281983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6418617|NCT00281983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6418618|NCT00281983|Abortifacient Agents|abortifacient agents|mesh-ancestor
6418619|NCT00281983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6418620|NCT00281983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6418621|NCT00281983|Antimetabolites|antimetabolites|mesh-ancestor
6418622|NCT00281983|Dermatologic Agents|dermatologic agents|mesh-ancestor
6418623|NCT00281983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6418624|NCT00281983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6418625|NCT00281983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6418626|NCT00281983|Antifungal Agents|antifungal agents|mesh-ancestor
6418627|NCT00281983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6418628|NCT00281983|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6418629|NCT00281983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6418630|NCT00281983|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6418631|NCT00281983|Antitubercular Agents|antitubercular agents|mesh-ancestor
6418632|NCT00281983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6418633|NCT00281996|Gemcitabine|gemcitabine|mesh-list
6418634|NCT00281996|Imatinib Mesylate|imatinib mesylate|mesh-list
6418635|NCT00281996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6418636|NCT00281996|Antimetabolites|antimetabolites|mesh-ancestor
6418637|NCT00281996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418638|NCT00281996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6418639|NCT00281996|Antiviral Agents|antiviral agents|mesh-ancestor
6418640|NCT00281996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6418641|NCT00281996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6418642|NCT00281996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6418643|NCT00281996|Immunologic Factors|immunologic factors|mesh-ancestor
6418644|NCT00281996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418645|NCT00281996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6418646|NCT00282061|Melatonin|melatonin|mesh-list
6418647|NCT00282061|Antioxidants|antioxidants|mesh-ancestor
6418648|NCT00282061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6018975|NCT00383942|Abortifacient Agents|abortifacient agents|mesh-ancestor
6418649|NCT00282061|Protective Agents|protective agents|mesh-ancestor
6418650|NCT00282061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418651|NCT00282061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6418652|NCT00282100|Gefitinib|gefitinib|mesh-list
6418653|NCT00282100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6418654|NCT00282100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6418655|NCT00282100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6418656|NCT00282100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418657|NCT00282126|Potassium Citrate|potassium citrate|mesh-list
6418658|NCT00282126|Diuretics|diuretics|mesh-ancestor
6418659|NCT00282126|Natriuretic Agents|natriuretic agents|mesh-ancestor
6418660|NCT00282126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418661|NCT00282126|Expectorants|expectorants|mesh-ancestor
6418662|NCT00282126|Respiratory System Agents|respiratory system agents|mesh-ancestor
6418663|NCT00282139|Aripiprazole|aripiprazole|mesh-list
6418664|NCT00282139|Antidepressive Agents|antidepressive agents|mesh-ancestor
6418665|NCT00282139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6418666|NCT00282139|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6418667|NCT00282139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6418668|NCT00282139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6418669|NCT00282139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418670|NCT00282139|Dopamine Agonists|dopamine agonists|mesh-ancestor
6418671|NCT00282139|Dopamine Agents|dopamine agents|mesh-ancestor
6418672|NCT00282139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6418673|NCT00282139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418674|NCT00282139|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6418675|NCT00282139|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6418676|NCT00282139|Serotonin Agents|serotonin agents|mesh-ancestor
6418677|NCT00282139|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6418678|NCT00282139|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6418679|NCT00282139|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6418680|NCT00282139|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6418681|NCT00282165|Naratriptan|naratriptan|mesh-list
6418682|NCT00282165|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6418683|NCT00282165|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6418684|NCT00282165|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6418685|NCT00282165|Serotonin Agents|serotonin agents|mesh-ancestor
6418686|NCT00282165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6418687|NCT00282165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418688|NCT00282165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418689|NCT00282178|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6418690|NCT00282178|Candesartan|candesartan|mesh-list
6418691|NCT00282178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6418692|NCT00282178|Diuretics|diuretics|mesh-ancestor
6418693|NCT00282178|Natriuretic Agents|natriuretic agents|mesh-ancestor
6418694|NCT00282178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418695|NCT00282178|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6418696|NCT00282178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6418697|NCT00282178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418698|NCT00282178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6418699|NCT00282178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6418700|NCT00282217|Sirolimus|sirolimus|mesh-list
6418701|NCT00282217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6418702|NCT00282217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6418703|NCT00282217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6418704|NCT00282217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6418705|NCT00282217|Antifungal Agents|antifungal agents|mesh-ancestor
6418706|NCT00282217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6418707|NCT00282217|Immunologic Factors|immunologic factors|mesh-ancestor
6418708|NCT00282217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418709|NCT00282360|Trimetazidine|trimetazidine|mesh-list
6418710|NCT00282360|Vasodilator Agents|vasodilator agents|mesh-ancestor
6418711|NCT00282386|Rofecoxib|rofecoxib|mesh-list
6418712|NCT00282386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418713|NCT00282386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418714|NCT00282386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6418715|NCT00282386|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6418716|NCT00282386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6418717|NCT00282386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6418718|NCT00282386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6418719|NCT00282386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6418720|NCT00282386|Analgesics|analgesics|mesh-ancestor
6418721|NCT00282386|Sensory System Agents|sensory system agents|mesh-ancestor
6418722|NCT00282386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6418723|NCT00282386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6418724|NCT00282399|Decitabine|decitabine|mesh-list
6418725|NCT00282399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6418726|NCT00282399|Antimetabolites|antimetabolites|mesh-ancestor
6418727|NCT00282399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418728|NCT00282399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6418729|NCT00282399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6418730|NCT00282451|Insulin|insulin|mesh-list
6418731|NCT00282451|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6418732|NCT00282451|Insulin Aspart|insulin aspart|mesh-list
6418733|NCT00282451|Insulin, Long-Acting|insulin, long-acting|mesh-list
6418734|NCT00282451|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6418735|NCT00282451|Biphasic Insulins|biphasic insulins|mesh-list
6418736|NCT00282451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6418737|NCT00282451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460202|NCT00448838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6460203|NCT00448903|Bemiparin|bemiparin|mesh-list
6460204|NCT00448903|Anticoagulants|anticoagulants|mesh-ancestor
6460205|NCT00448942|Chlorhexidine|chlorhexidine|mesh-list
6460206|NCT00448942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6460207|NCT00448942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6460208|NCT00448942|Disinfectants|disinfectants|mesh-ancestor
6462071|NCT00457470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462072|NCT00457470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6462073|NCT00457483|Valsartan|valsartan|mesh-list
6462074|NCT00457483|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6462075|NCT00457483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6462076|NCT00457483|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6462077|NCT00457483|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6462078|NCT00457483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462079|NCT00457483|Diuretics|diuretics|mesh-ancestor
6462080|NCT00457483|Natriuretic Agents|natriuretic agents|mesh-ancestor
6462081|NCT00457483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462082|NCT00457483|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6462083|NCT00457483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6462084|NCT00457509|Vaccines|vaccines|mesh-list
6462085|NCT00457509|Immunologic Factors|immunologic factors|mesh-ancestor
6462086|NCT00457509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462087|NCT00457652|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6462088|NCT00457652|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6462089|NCT00457652|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6462090|NCT00457652|Antimetabolites|antimetabolites|mesh-ancestor
6462091|NCT00457652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462092|NCT00457652|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6462093|NCT00457652|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6462094|NCT00457652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6462095|NCT00457678|Dexamethasone|dexamethasone|mesh-list
6462096|NCT00457678|Ranibizumab|ranibizumab|mesh-list
6462097|NCT00457678|Verteporfin|verteporfin|mesh-list
6462098|NCT00457678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6462099|NCT00457678|Antiemetics|antiemetics|mesh-ancestor
6462100|NCT00457678|Autonomic Agents|autonomic agents|mesh-ancestor
6462101|NCT00457678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6462102|NCT00457678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462103|NCT00457678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6462104|NCT00457678|Glucocorticoids|glucocorticoids|mesh-ancestor
6462105|NCT00457678|Hormones|hormones|mesh-ancestor
6462106|NCT00457678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6418738|NCT00282503|Methylprednisolone|methylprednisolone|mesh-list
6418739|NCT00282503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6418740|NCT00282503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6418741|NCT00282503|Prednisolone|prednisolone|mesh-list
6418742|NCT00282503|Prednisolone acetate|prednisolone acetate|mesh-list
6418743|NCT00282503|Methoxsalen|methoxsalen|mesh-list
6418744|NCT00282503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6418745|NCT00282503|Prednisolone phosphate|prednisolone phosphate|mesh-list
6418746|NCT00282503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6418747|NCT00282503|Antiemetics|antiemetics|mesh-ancestor
6418748|NCT00282503|Autonomic Agents|autonomic agents|mesh-ancestor
6418749|NCT00282503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6418750|NCT00282503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418751|NCT00282503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6418752|NCT00282503|Glucocorticoids|glucocorticoids|mesh-ancestor
6418753|NCT00282503|Hormones|hormones|mesh-ancestor
6418754|NCT00282503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6418755|NCT00282503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6418756|NCT00282503|Protective Agents|protective agents|mesh-ancestor
6418757|NCT00282503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6418758|NCT00282503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6418759|NCT00282503|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6418760|NCT00282503|Dermatologic Agents|dermatologic agents|mesh-ancestor
6418761|NCT00282594|Insulin|insulin|mesh-list
6418762|NCT00282594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6418763|NCT00282594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418764|NCT00282607|Udenafil|udenafil|mesh-list
6418765|NCT00282607|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6418766|NCT00282607|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6418767|NCT00282607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6418768|NCT00282607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418769|NCT00282698|Insulin|insulin|mesh-list
6418770|NCT00282698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6418771|NCT00282698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418772|NCT00282724|Liarozole|liarozole|mesh-list
6418773|NCT00282724|Androgen Antagonists|androgen antagonists|mesh-ancestor
6418774|NCT00282724|Hormone Antagonists|hormone antagonists|mesh-ancestor
6418775|NCT00282724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6418776|NCT00282724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418777|NCT00282724|Dermatologic Agents|dermatologic agents|mesh-ancestor
6418778|NCT00282724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6418779|NCT00282724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418780|NCT00282724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6418781|NCT00282724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6418782|NCT00282932|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6418783|NCT00282932|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6418784|NCT00282932|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6418785|NCT00282932|Cholinergic Agents|cholinergic agents|mesh-ancestor
6418786|NCT00282932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6418787|NCT00282932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418788|NCT00282932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418789|NCT00282932|Urological Agents|urological agents|mesh-ancestor
6418790|NCT00282945|Metformin|metformin|mesh-list
6418791|NCT00282945|Rosiglitazone|rosiglitazone|mesh-list
6418792|NCT00282945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6418793|NCT00282945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418794|NCT00282958|Botulinum Toxins|botulinum toxins|mesh-list
6418795|NCT00282958|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6418796|NCT00282958|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6418797|NCT00282958|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6418798|NCT00282958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6418799|NCT00282958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418800|NCT00282958|Cholinergic Agents|cholinergic agents|mesh-ancestor
6418801|NCT00282958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6418802|NCT00282958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418803|NCT00282958|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6418804|NCT00282958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6418805|NCT00282997|Pregabalin|pregabalin|mesh-list
6418806|NCT00282997|Analgesics|analgesics|mesh-ancestor
6418807|NCT00282997|Sensory System Agents|sensory system agents|mesh-ancestor
6418808|NCT00282997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6418809|NCT00282997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418810|NCT00282997|Anticonvulsants|anticonvulsants|mesh-ancestor
6418811|NCT00282997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6418812|NCT00282997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6418813|NCT00282997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418814|NCT00282997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6418815|NCT00282997|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6418816|NCT00282997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6418817|NCT00282997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6418818|NCT00282997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6418819|NCT00283036|Irbesartan|irbesartan|mesh-list
6418820|NCT00283036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6418821|NCT00283036|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6418822|NCT00283036|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6418823|NCT00283036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418824|NCT00283088|Plasminogen|plasminogen|mesh-list
6418825|NCT00283088|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6418826|NCT00283088|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6418827|NCT00283088|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6418828|NCT00283088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418829|NCT00283101|Dacetuzumab|dacetuzumab|mesh-list
6418830|NCT00283101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6418831|NCT00283101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6418832|NCT00283114|Lintuzumab|lintuzumab|mesh-list
6418833|NCT00283114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6418834|NCT00283114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6418835|NCT00283179|Risperidone|risperidone|mesh-list
6418836|NCT00283179|Aripiprazole|aripiprazole|mesh-list
6418837|NCT00283179|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6418838|NCT00283179|Serotonin Agents|serotonin agents|mesh-ancestor
6418839|NCT00283179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6418840|NCT00283179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418841|NCT00283179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418842|NCT00283179|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6418843|NCT00283179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6418844|NCT00283179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6418845|NCT00283179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6418846|NCT00283179|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6418847|NCT00283179|Dopamine Agents|dopamine agents|mesh-ancestor
6418848|NCT00283179|Antidepressive Agents|antidepressive agents|mesh-ancestor
6418849|NCT00283179|Dopamine Agonists|dopamine agonists|mesh-ancestor
6418850|NCT00283179|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6418851|NCT00283179|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6418852|NCT00283179|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6418853|NCT00283179|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6418854|NCT00283192|Sertraline|sertraline|mesh-list
6418855|NCT00283192|Antidepressive Agents|antidepressive agents|mesh-ancestor
6418856|NCT00283192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6418857|NCT00283192|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6418858|NCT00283192|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6418859|NCT00283192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6418860|NCT00283192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418861|NCT00283192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6418862|NCT00283192|Serotonin Agents|serotonin agents|mesh-ancestor
6418863|NCT00283192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418864|NCT00283218|Insulin Aspart|insulin aspart|mesh-list
6418865|NCT00283218|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6418866|NCT00283218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6418867|NCT00283218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418868|NCT00283309|Riluzole|riluzole|mesh-list
6418869|NCT00283309|Memantine|memantine|mesh-list
6418870|NCT00283309|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6418871|NCT00283309|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6418872|NCT00283309|Dopamine Agents|dopamine agents|mesh-ancestor
6418873|NCT00283309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6418874|NCT00283309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418875|NCT00283309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418876|NCT00283309|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6418877|NCT00283309|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6418878|NCT00283309|Anticonvulsants|anticonvulsants|mesh-ancestor
6418879|NCT00283309|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6418880|NCT00283309|Protective Agents|protective agents|mesh-ancestor
6418881|NCT00283335|Gemfibrozil|gemfibrozil|mesh-list
6418882|NCT00283335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6418883|NCT00283335|Antimetabolites|antimetabolites|mesh-ancestor
6418884|NCT00283335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418885|NCT00283335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6418886|NCT00283335|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6418887|NCT00283335|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6418888|NCT00283335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6418889|NCT00283465|Epoetin Alfa|epoetin alfa|mesh-list
6418890|NCT00283465|Hematinics|hematinics|mesh-ancestor
6418891|NCT00283478|Gemcitabine|gemcitabine|mesh-list
6418892|NCT00283478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6418893|NCT00283478|Antimetabolites|antimetabolites|mesh-ancestor
6418894|NCT00283478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418895|NCT00283478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6418896|NCT00283478|Antiviral Agents|antiviral agents|mesh-ancestor
6418897|NCT00283478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6418898|NCT00283478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6418899|NCT00283478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6418900|NCT00283478|Immunologic Factors|immunologic factors|mesh-ancestor
6418901|NCT00283478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418902|NCT00283517|Antipsychotic Agents|antipsychotic agents|mesh-list
6418903|NCT00283517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6418904|NCT00283517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6418905|NCT00283517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418906|NCT00283517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6418907|NCT00283543|Temozolomide|temozolomide|mesh-list
6418908|NCT00283543|Carmustine|carmustine|mesh-list
6418909|NCT00283543|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6418910|NCT00283543|Alkylating Agents|alkylating agents|mesh-ancestor
6418911|NCT00283543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418912|NCT00283543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6418913|NCT00283556|Irinotecan|irinotecan|mesh-list
6418914|NCT00283556|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6418915|NCT00283556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6418916|NCT00283556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6418917|NCT00283556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418918|NCT00283556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6418919|NCT00283621|Doxorubicin|doxorubicin|mesh-list
6418920|NCT00283621|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6418921|NCT00283621|Ifosfamide|ifosfamide|mesh-list
6418922|NCT00283621|Darbepoetin alfa|darbepoetin alfa|mesh-list
6418923|NCT00283621|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6418924|NCT00283621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6418925|NCT00283621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6418926|NCT00283621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6418927|NCT00283621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6418928|NCT00283621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418929|NCT00283621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6418930|NCT00283621|Alkylating Agents|alkylating agents|mesh-ancestor
6418931|NCT00283621|Hematinics|hematinics|mesh-ancestor
6418932|NCT00283634|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6418933|NCT00283634|Bortezomib|bortezomib|mesh-list
6418934|NCT00283634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6418935|NCT00283634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6418936|NCT00283634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6418937|NCT00283634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418938|NCT00283660|Zinc Oxide|zinc oxide|mesh-list
6418939|NCT00283660|Dermatologic Agents|dermatologic agents|mesh-ancestor
6418940|NCT00283660|Sunscreening Agents|sunscreening agents|mesh-ancestor
6418941|NCT00283660|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6418942|NCT00283660|Protective Agents|protective agents|mesh-ancestor
6418943|NCT00283660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418944|NCT00283699|Albendazole|albendazole|mesh-list
6418945|NCT00283699|Anthelmintics|anthelmintics|mesh-ancestor
6418946|NCT00283699|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6418947|NCT00283699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6418948|NCT00283699|Anticestodal Agents|anticestodal agents|mesh-ancestor
6418949|NCT00283699|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6418950|NCT00283699|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6418951|NCT00283699|Tubulin Modulators|tubulin modulators|mesh-ancestor
6418952|NCT00283699|Antimitotic Agents|antimitotic agents|mesh-ancestor
6418953|NCT00283699|Mitosis Modulators|mitosis modulators|mesh-ancestor
6418954|NCT00283699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418955|NCT00283699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6418956|NCT00283751|Insulin|insulin|mesh-list
6418957|NCT00283751|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6418958|NCT00283751|Insulin Glargine|insulin glargine|mesh-list
6418959|NCT00283751|Insulin Detemir|insulin detemir|mesh-list
6418960|NCT00283751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6418961|NCT00283751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418962|NCT00283764|Latanoprost|latanoprost|mesh-list
6418963|NCT00283764|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6418964|NCT00283764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6418965|NCT00283777|Chromium|chromium|mesh-list
6418966|NCT00283777|Picolinic acid|picolinic acid|mesh-list
6418967|NCT00283777|Trace Elements|trace elements|mesh-ancestor
6418968|NCT00283777|Micronutrients|micronutrients|mesh-ancestor
6418969|NCT00283777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418970|NCT00283777|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6418971|NCT00283777|Chelating Agents|chelating agents|mesh-ancestor
6418972|NCT00283777|Sequestering Agents|sequestering agents|mesh-ancestor
6418973|NCT00283777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418974|NCT00283790|Zolpidem|zolpidem|mesh-list
6418975|NCT00283790|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6418976|NCT00283790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6418977|NCT00283790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6418978|NCT00283790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418979|NCT00283790|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6418980|NCT00283790|GABA Agonists|gaba agonists|mesh-ancestor
6418981|NCT00283790|GABA Agents|gaba agents|mesh-ancestor
6418982|NCT00283790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6418983|NCT00283790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418984|NCT00283829|Docetaxel|docetaxel|mesh-list
6418985|NCT00283829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6418986|NCT00283829|Tubulin Modulators|tubulin modulators|mesh-ancestor
6418987|NCT00283829|Antimitotic Agents|antimitotic agents|mesh-ancestor
6418988|NCT00283829|Mitosis Modulators|mitosis modulators|mesh-ancestor
6418989|NCT00283829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6418990|NCT00283946|Zolpidem|zolpidem|mesh-list
6418991|NCT00283946|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6418992|NCT00283946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6418993|NCT00283946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6418994|NCT00283946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6418995|NCT00283946|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6418996|NCT00283946|GABA Agonists|gaba agonists|mesh-ancestor
6418997|NCT00283946|GABA Agents|gaba agents|mesh-ancestor
6418998|NCT00283946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6418999|NCT00283946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419000|NCT00283985|Dexamethasone|dexamethasone|mesh-list
6419001|NCT00283985|Methotrexate|methotrexate|mesh-list
6419002|NCT00283985|Asparaginase|asparaginase|mesh-list
6419003|NCT00283985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6419004|NCT00283985|Antiemetics|antiemetics|mesh-ancestor
6419005|NCT00283985|Autonomic Agents|autonomic agents|mesh-ancestor
6419006|NCT00283985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6419007|NCT00283985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419008|NCT00283985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6419009|NCT00283985|Glucocorticoids|glucocorticoids|mesh-ancestor
6419010|NCT00283985|Hormones|hormones|mesh-ancestor
6419011|NCT00283985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6419012|NCT00283985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6419013|NCT00283985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6419014|NCT00283985|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6419015|NCT00283985|Abortifacient Agents|abortifacient agents|mesh-ancestor
6419016|NCT00283985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6419017|NCT00283985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6419018|NCT00283985|Antimetabolites|antimetabolites|mesh-ancestor
6419019|NCT00283985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419020|NCT00283985|Dermatologic Agents|dermatologic agents|mesh-ancestor
6419021|NCT00283985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6419022|NCT00283985|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6419023|NCT00283985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6419024|NCT00283985|Immunologic Factors|immunologic factors|mesh-ancestor
6419025|NCT00283985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6419026|NCT00283985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6419027|NCT00284024|Domperidone|domperidone|mesh-list
6419028|NCT00284024|Antiemetics|antiemetics|mesh-ancestor
6419029|NCT00284024|Autonomic Agents|autonomic agents|mesh-ancestor
6419030|NCT00284024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6419031|NCT00284024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419032|NCT00284024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6419033|NCT00284024|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6419034|NCT00284024|Dopamine Agents|dopamine agents|mesh-ancestor
6419035|NCT00284024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6419036|NCT00284024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419037|NCT00284193|Thrombin|thrombin|mesh-list
6419038|NCT00284193|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
6419039|NCT00284193|Factor VIII|factor viii|mesh-list
6419040|NCT00284193|Hemostatics|hemostatics|mesh-ancestor
6419041|NCT00284193|Coagulants|coagulants|mesh-ancestor
6419042|NCT00284206|Risperidone|risperidone|mesh-list
6419043|NCT00284206|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6419044|NCT00284206|Serotonin Agents|serotonin agents|mesh-ancestor
6419045|NCT00284206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6419046|NCT00284206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419047|NCT00284206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419048|NCT00284206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6419049|NCT00284206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6419050|NCT00284206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6419051|NCT00284206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6419052|NCT00284206|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6419053|NCT00284206|Dopamine Agents|dopamine agents|mesh-ancestor
6419054|NCT00284232|Insulin|insulin|mesh-list
6419055|NCT00284232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6419056|NCT00284232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419057|NCT00284258|Irinotecan|irinotecan|mesh-list
6419058|NCT00284258|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6419059|NCT00284258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6419060|NCT00284258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6419061|NCT00284258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419062|NCT00284258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6460209|NCT00448981|Hand Sanitizers|hand sanitizers|mesh-list
6460210|NCT00448981|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6460211|NCT00448981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6460212|NCT00448981|Disinfectants|disinfectants|mesh-ancestor
6460213|NCT00449020|Carboplatin|carboplatin|mesh-list
6460214|NCT00449020|Docetaxel|docetaxel|mesh-list
6460215|NCT00449020|Irinotecan|irinotecan|mesh-list
6460216|NCT00449020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6460217|NCT00449020|Tubulin Modulators|tubulin modulators|mesh-ancestor
6460218|NCT00449020|Antimitotic Agents|antimitotic agents|mesh-ancestor
6460219|NCT00449020|Mitosis Modulators|mitosis modulators|mesh-ancestor
6460220|NCT00449020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460221|NCT00449020|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6460222|NCT00449020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6460223|NCT00449020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6460224|NCT00449059|Nitroglycerin|nitroglycerin|mesh-list
6460225|NCT00449059|Vasodilator Agents|vasodilator agents|mesh-ancestor
6460226|NCT00449137|Leucovorin|leucovorin|mesh-list
6460227|NCT00449137|Fluorouracil|fluorouracil|mesh-list
6460228|NCT00449137|Arsenic Trioxide|arsenic trioxide|mesh-list
6460229|NCT00449137|Calcium|calcium|mesh-list
6460230|NCT00449137|Levoleucovorin|levoleucovorin|mesh-list
6460231|NCT00449137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6460232|NCT00449137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460233|NCT00449137|Antimetabolites|antimetabolites|mesh-ancestor
6460234|NCT00449137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460235|NCT00449137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6460236|NCT00449137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6460237|NCT00449137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6460238|NCT00449137|Immunologic Factors|immunologic factors|mesh-ancestor
6460239|NCT00449137|Antidotes|antidotes|mesh-ancestor
6460240|NCT00449137|Protective Agents|protective agents|mesh-ancestor
6460241|NCT00449137|Vitamin B Complex|vitamin b complex|mesh-ancestor
6460242|NCT00449137|Vitamins|vitamins|mesh-ancestor
6460243|NCT00449137|Micronutrients|micronutrients|mesh-ancestor
6460244|NCT00449202|Oleoyl-estrone|oleoyl-estrone|mesh-list
6460245|NCT00449202|Estrone|estrone|mesh-list
6460246|NCT00449202|Estrogens|estrogens|mesh-ancestor
6460247|NCT00449202|Hormones|hormones|mesh-ancestor
6460248|NCT00449202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6419063|NCT00284271|Prednisone|prednisone|mesh-list
6419064|NCT00284271|Cyclophosphamide|cyclophosphamide|mesh-list
6419065|NCT00284271|Vincristine|vincristine|mesh-list
6419066|NCT00284271|Bleomycin|bleomycin|mesh-list
6419067|NCT00284271|Epoetin Alfa|epoetin alfa|mesh-list
6419068|NCT00284271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6018976|NCT00383942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6419069|NCT00284271|Immunologic Factors|immunologic factors|mesh-ancestor
6419070|NCT00284271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419071|NCT00284271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6419072|NCT00284271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6419073|NCT00284271|Alkylating Agents|alkylating agents|mesh-ancestor
6419074|NCT00284271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419075|NCT00284271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6419076|NCT00284271|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6419077|NCT00284271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6419078|NCT00284271|Glucocorticoids|glucocorticoids|mesh-ancestor
6419079|NCT00284271|Hormones|hormones|mesh-ancestor
6419080|NCT00284271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6419081|NCT00284271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6419082|NCT00284271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6419083|NCT00284271|Tubulin Modulators|tubulin modulators|mesh-ancestor
6419084|NCT00284271|Antimitotic Agents|antimitotic agents|mesh-ancestor
6419085|NCT00284271|Mitosis Modulators|mitosis modulators|mesh-ancestor
6419086|NCT00284271|Hematinics|hematinics|mesh-ancestor
6419087|NCT00284271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6419088|NCT00284323|Adenosine|adenosine|mesh-list
6419089|NCT00284323|Analgesics|analgesics|mesh-ancestor
6419090|NCT00284323|Sensory System Agents|sensory system agents|mesh-ancestor
6419091|NCT00284323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6419092|NCT00284323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419093|NCT00284323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6419094|NCT00284323|Vasodilator Agents|vasodilator agents|mesh-ancestor
6419095|NCT00284323|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6419096|NCT00284323|Purinergic Agonists|purinergic agonists|mesh-ancestor
6419097|NCT00284323|Purinergic Agents|purinergic agents|mesh-ancestor
6419098|NCT00284323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6419099|NCT00284323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419100|NCT00284336|Cyclophosphamide|cyclophosphamide|mesh-list
6419101|NCT00284336|Doxorubicin|doxorubicin|mesh-list
6419102|NCT00284336|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6419103|NCT00284336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6419104|NCT00284336|Immunologic Factors|immunologic factors|mesh-ancestor
6419105|NCT00284336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419106|NCT00284336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6419107|NCT00284336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6419108|NCT00284336|Alkylating Agents|alkylating agents|mesh-ancestor
6419109|NCT00284336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419110|NCT00284336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6419111|NCT00284336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6419112|NCT00284336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6419113|NCT00284336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6419114|NCT00284336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6419115|NCT00284336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6419116|NCT00284427|Ascorbic Acid|ascorbic acid|mesh-list
6419117|NCT00284427|Vitamins|vitamins|mesh-ancestor
6419118|NCT00284427|Micronutrients|micronutrients|mesh-ancestor
6419119|NCT00284427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419120|NCT00284427|Antioxidants|antioxidants|mesh-ancestor
6419121|NCT00284427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419122|NCT00284427|Protective Agents|protective agents|mesh-ancestor
6419123|NCT00284505|Thalidomide|thalidomide|mesh-list
6419124|NCT00284505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6419125|NCT00284505|Immunologic Factors|immunologic factors|mesh-ancestor
6419126|NCT00284505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419127|NCT00284505|Leprostatic Agents|leprostatic agents|mesh-ancestor
6419128|NCT00284505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6419129|NCT00284505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6419130|NCT00284505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6419131|NCT00284505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6419132|NCT00284505|Growth Substances|growth substances|mesh-ancestor
6419133|NCT00284505|Growth Inhibitors|growth inhibitors|mesh-ancestor
6419134|NCT00284505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6419135|NCT00284531|Daclizumab|daclizumab|mesh-list
6419136|NCT00284531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6419137|NCT00284531|Immunologic Factors|immunologic factors|mesh-ancestor
6419138|NCT00284531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419139|NCT00284583|Lidocaine|lidocaine|mesh-list
6419140|NCT00284583|Anesthetics, Local|anesthetics, local|mesh-ancestor
6419141|NCT00284583|Anesthetics|anesthetics|mesh-ancestor
6419142|NCT00284583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6419143|NCT00284583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419144|NCT00284583|Sensory System Agents|sensory system agents|mesh-ancestor
6419145|NCT00284583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6419146|NCT00284583|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6419147|NCT00284583|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6419148|NCT00284583|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6419149|NCT00284583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6419150|NCT00284583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419151|NCT00284687|Artesunate|artesunate|mesh-list
6419152|NCT00284687|Antimalarials|antimalarials|mesh-ancestor
6419153|NCT00284687|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6018977|NCT00383942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018978|NCT00383942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6018979|NCT00383942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6018980|NCT00383942|Oxytocics|oxytocics|mesh-ancestor
6018981|NCT00384033|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6018982|NCT00384033|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6053207|NCT00593554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6419154|NCT00284687|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6419155|NCT00284687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6419156|NCT00284687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6419157|NCT00284687|Antiviral Agents|antiviral agents|mesh-ancestor
6419158|NCT00284687|Schistosomicides|schistosomicides|mesh-ancestor
6419159|NCT00284687|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6419160|NCT00284687|Anthelmintics|anthelmintics|mesh-ancestor
6419161|NCT00284752|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6419162|NCT00284752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6419163|NCT00284765|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
6419164|NCT00284765|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6419165|NCT00284765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6419166|NCT00284765|Analgesics|analgesics|mesh-ancestor
6419167|NCT00284765|Sensory System Agents|sensory system agents|mesh-ancestor
6419168|NCT00284765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6419169|NCT00284765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419170|NCT00284765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6419171|NCT00284765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6419172|NCT00284778|Docetaxel|docetaxel|mesh-list
6419173|NCT00284778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6419174|NCT00284778|Tubulin Modulators|tubulin modulators|mesh-ancestor
6419175|NCT00284778|Antimitotic Agents|antimitotic agents|mesh-ancestor
6419176|NCT00284778|Mitosis Modulators|mitosis modulators|mesh-ancestor
6419177|NCT00284778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419178|NCT00284791|Lamotrigine|lamotrigine|mesh-list
6419179|NCT00284791|Sertraline|sertraline|mesh-list
6419180|NCT00284791|Fluoxetine|fluoxetine|mesh-list
6419181|NCT00284791|Antidepressive Agents|antidepressive agents|mesh-ancestor
6419182|NCT00284791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6419183|NCT00284791|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6419184|NCT00284791|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6419185|NCT00284791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6419186|NCT00284791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419187|NCT00284791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6419188|NCT00284791|Serotonin Agents|serotonin agents|mesh-ancestor
6419189|NCT00284791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419190|NCT00284791|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5724703|NCT03185403|Anesthetics, Local|anesthetics, local|mesh-ancestor
6419191|NCT00284791|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6419192|NCT00284791|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6419193|NCT00284791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6419194|NCT00284791|Anticonvulsants|anticonvulsants|mesh-ancestor
6419195|NCT00284791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6419196|NCT00284791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6419197|NCT00284791|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6018983|NCT00384033|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6018984|NCT00384033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6018985|NCT00384033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6419198|NCT00284791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6419199|NCT00284791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6419200|NCT00284791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6419201|NCT00284921|Mycophenolic Acid|mycophenolic acid|mesh-list
6419202|NCT00284921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6419203|NCT00284921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6419204|NCT00284921|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6419205|NCT00284921|Antitubercular Agents|antitubercular agents|mesh-ancestor
6419206|NCT00284921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6419207|NCT00284921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6419208|NCT00284921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6419209|NCT00284921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419210|NCT00284947|Prednisone|prednisone|mesh-list
6419211|NCT00284947|Prednisolone|prednisolone|mesh-list
6419212|NCT00284947|Methylprednisolone|methylprednisolone|mesh-list
6419213|NCT00284947|Basiliximab|basiliximab|mesh-list
6419214|NCT00284947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6419215|NCT00284947|Glucocorticoids|glucocorticoids|mesh-ancestor
6419216|NCT00284947|Hormones|hormones|mesh-ancestor
6419217|NCT00284947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6419218|NCT00284947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419219|NCT00284947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6419220|NCT00284947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6419221|NCT00284947|Antiemetics|antiemetics|mesh-ancestor
6419222|NCT00284947|Autonomic Agents|autonomic agents|mesh-ancestor
6419223|NCT00284947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6419224|NCT00284947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6419225|NCT00284947|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6419226|NCT00284947|Protective Agents|protective agents|mesh-ancestor
6419227|NCT00284947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6419228|NCT00284947|Immunologic Factors|immunologic factors|mesh-ancestor
6419229|NCT00285051|Ondansetron|ondansetron|mesh-list
6419230|NCT00285051|Antiemetics|antiemetics|mesh-ancestor
6419231|NCT00285051|Autonomic Agents|autonomic agents|mesh-ancestor
6419232|NCT00285051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6419233|NCT00285051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419234|NCT00285051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6419235|NCT00285051|Antipruritics|antipruritics|mesh-ancestor
6419236|NCT00285051|Dermatologic Agents|dermatologic agents|mesh-ancestor
6018986|NCT00384033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6018987|NCT00384033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6018988|NCT00384033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018989|NCT00384033|Analgesics|analgesics|mesh-ancestor
6419237|NCT00285051|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6419238|NCT00285051|Serotonin Agents|serotonin agents|mesh-ancestor
6419239|NCT00285051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6419240|NCT00285051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419241|NCT00285051|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6419242|NCT00285051|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6419243|NCT00285051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6419244|NCT00285051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6419245|NCT00285051|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6419246|NCT00285090|Calcium, Dietary|calcium, dietary|mesh-list
6419247|NCT00285090|Vitamin D|vitamin d|mesh-list
6419248|NCT00285090|Ergocalciferols|ergocalciferols|mesh-list
6419249|NCT00285090|Vitamins|vitamins|mesh-list
6419250|NCT00285090|Calcium|calcium|mesh-list
6419251|NCT00285090|Micronutrients|micronutrients|mesh-ancestor
6419252|NCT00285090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018990|NCT00384033|Sensory System Agents|sensory system agents|mesh-ancestor
6018991|NCT00384033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6018992|NCT00384033|Antidepressive Agents|antidepressive agents|mesh-ancestor
6018993|NCT00384033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6018994|NCT00384033|Dopamine Agents|dopamine agents|mesh-ancestor
6018995|NCT00384059|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6018996|NCT00384059|Immunologic Factors|immunologic factors|mesh-ancestor
6018997|NCT00384059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6018998|NCT00384085|Insulin|insulin|mesh-list
6018999|NCT00384085|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6019000|NCT00384085|Insulin Glargine|insulin glargine|mesh-list
6419253|NCT00285090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6419254|NCT00285090|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6419255|NCT00285142|Rosiglitazone|rosiglitazone|mesh-list
6419256|NCT00285142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6419257|NCT00285142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419258|NCT00285155|Bupropion|bupropion|mesh-list
6419259|NCT00285155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6419260|NCT00285155|Antidepressive Agents|antidepressive agents|mesh-ancestor
6419261|NCT00285155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6419262|NCT00285155|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6419263|NCT00285155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6419264|NCT00285155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6419265|NCT00285155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419266|NCT00285155|Dopamine Agents|dopamine agents|mesh-ancestor
6419267|NCT00285155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6419268|NCT00285155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419269|NCT00285155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6419270|NCT00285155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6419271|NCT00285155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6419272|NCT00285181|Simvastatin|simvastatin|mesh-list
6419273|NCT00285181|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6419274|NCT00285181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6419275|NCT00285181|Antimetabolites|antimetabolites|mesh-ancestor
6419276|NCT00285181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419277|NCT00285181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6419278|NCT00285181|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6419279|NCT00285181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6419280|NCT00285298|Pentoxifylline|pentoxifylline|mesh-list
6419281|NCT00285298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6419282|NCT00285298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6419283|NCT00285298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419284|NCT00285298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6419285|NCT00285298|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6419286|NCT00285298|Protective Agents|protective agents|mesh-ancestor
6419287|NCT00285298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419288|NCT00285298|Vasodilator Agents|vasodilator agents|mesh-ancestor
6419289|NCT00285298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6419290|NCT00285298|Antioxidants|antioxidants|mesh-ancestor
6419291|NCT00285350|Mycophenolic Acid|mycophenolic acid|mesh-list
6419292|NCT00285350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6419293|NCT00285350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6419294|NCT00285350|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6419295|NCT00285350|Antitubercular Agents|antitubercular agents|mesh-ancestor
6419296|NCT00285350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6419297|NCT00285350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6419298|NCT00285350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6419299|NCT00285350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419300|NCT00285376|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
6419301|NCT00285376|Antidepressive Agents|antidepressive agents|mesh-ancestor
6419302|NCT00285376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6419303|NCT00285376|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6419304|NCT00285376|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6419305|NCT00285376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6419306|NCT00285376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419307|NCT00285376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6419308|NCT00285376|Serotonin Agents|serotonin agents|mesh-ancestor
6419309|NCT00285376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419310|NCT00285376|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6419311|NCT00285376|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6419312|NCT00285389|Dexamethasone|dexamethasone|mesh-list
6419313|NCT00285389|Cyclophosphamide|cyclophosphamide|mesh-list
6419314|NCT00285389|Melphalan|melphalan|mesh-list
6419315|NCT00285389|Chlorambucil|chlorambucil|mesh-list
6419316|NCT00285389|Rituximab|rituximab|mesh-list
6419317|NCT00285389|Vincristine|vincristine|mesh-list
6419318|NCT00285389|Doxorubicin|doxorubicin|mesh-list
6419319|NCT00285389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6419320|NCT00285389|Immunologic Factors|immunologic factors|mesh-ancestor
6419321|NCT00285389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419322|NCT00285389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6419323|NCT00285389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6419324|NCT00285389|Alkylating Agents|alkylating agents|mesh-ancestor
6419325|NCT00285389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419326|NCT00285389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6419327|NCT00285389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6419328|NCT00285389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6419329|NCT00285389|Antiemetics|antiemetics|mesh-ancestor
6419330|NCT00285389|Autonomic Agents|autonomic agents|mesh-ancestor
6419331|NCT00285389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6419332|NCT00285389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6419333|NCT00285389|Glucocorticoids|glucocorticoids|mesh-ancestor
6419334|NCT00285389|Hormones|hormones|mesh-ancestor
6419335|NCT00285389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6419336|NCT00285389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6419337|NCT00285389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6419338|NCT00285389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6419339|NCT00285389|Tubulin Modulators|tubulin modulators|mesh-ancestor
6419340|NCT00285389|Antimitotic Agents|antimitotic agents|mesh-ancestor
6419341|NCT00285389|Mitosis Modulators|mitosis modulators|mesh-ancestor
6419342|NCT00285389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6419343|NCT00285389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6419344|NCT00285389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6419345|NCT00285389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6419346|NCT00285415|Carboplatin|carboplatin|mesh-list
6419347|NCT00285415|Docetaxel|docetaxel|mesh-list
6419348|NCT00285415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6419349|NCT00285415|Tubulin Modulators|tubulin modulators|mesh-ancestor
6419350|NCT00285415|Antimitotic Agents|antimitotic agents|mesh-ancestor
6419351|NCT00285415|Mitosis Modulators|mitosis modulators|mesh-ancestor
6419352|NCT00285415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419353|NCT00285428|Veltuzumab|veltuzumab|mesh-list
6419354|NCT00285428|Antibodies|antibodies|mesh-list
6419355|NCT00285428|Immunologic Factors|immunologic factors|mesh-ancestor
6419356|NCT00285428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419357|NCT00285428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6419358|NCT00285493|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6419359|NCT00285493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6419360|NCT00285519|Doxazosin|doxazosin|mesh-list
6419361|NCT00285519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6419362|NCT00285519|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6419363|NCT00285519|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6419364|NCT00285519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6419365|NCT00285519|Adrenergic Agents|adrenergic agents|mesh-ancestor
6419366|NCT00285519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6419367|NCT00285519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419368|NCT00285519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419369|NCT00285597|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
6419370|NCT00285597|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6419371|NCT00285597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6419372|NCT00285623|Thrombin|thrombin|mesh-list
6419373|NCT00285623|Hemostatics|hemostatics|mesh-ancestor
6419374|NCT00285623|Coagulants|coagulants|mesh-ancestor
6419375|NCT00285662|Artesunate|artesunate|mesh-list
6419376|NCT00285662|Pyrimethamine|pyrimethamine|mesh-list
6019001|NCT00384085|Insulin glulisine|insulin glulisine|mesh-list
6019002|NCT00384085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6019003|NCT00384085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419377|NCT00285662|Sulfadoxine|sulfadoxine|mesh-list
6419378|NCT00285662|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6419379|NCT00285662|Amodiaquine|amodiaquine|mesh-list
6419380|NCT00285662|Antimalarials|antimalarials|mesh-ancestor
6419381|NCT00285662|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6419382|NCT00285662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6419383|NCT00285662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6419384|NCT00285662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6419385|NCT00285662|Antiviral Agents|antiviral agents|mesh-ancestor
6419386|NCT00285662|Schistosomicides|schistosomicides|mesh-ancestor
6419387|NCT00285662|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6419388|NCT00285662|Anthelmintics|anthelmintics|mesh-ancestor
6419389|NCT00285662|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6419390|NCT00285662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6419391|NCT00285662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419392|NCT00285662|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6419393|NCT00285662|Renal Agents|renal agents|mesh-ancestor
6419394|NCT00285675|Calcitriol|calcitriol|mesh-list
6419395|NCT00285675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6419396|NCT00285675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419397|NCT00285675|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6419398|NCT00285675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6419399|NCT00285675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419400|NCT00285675|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6419401|NCT00285675|Vitamins|vitamins|mesh-ancestor
6419402|NCT00285675|Micronutrients|micronutrients|mesh-ancestor
6419403|NCT00285675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6419404|NCT00285727|Ropinirole|ropinirole|mesh-list
6419405|NCT00285727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6419406|NCT00285727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6419407|NCT00285727|Dopamine Agonists|dopamine agonists|mesh-ancestor
6419408|NCT00285727|Dopamine Agents|dopamine agents|mesh-ancestor
6419409|NCT00285727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6419410|NCT00285727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419411|NCT00285727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419412|NCT00285766|Selegiline|selegiline|mesh-list
6419413|NCT00285766|Antidepressive Agents|antidepressive agents|mesh-ancestor
6419414|NCT00285766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6419415|NCT00285766|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6019004|NCT00384176|Leucovorin|leucovorin|mesh-list
6019005|NCT00384176|Bevacizumab|bevacizumab|mesh-list
6019006|NCT00384176|Fluorouracil|fluorouracil|mesh-list
6019007|NCT00384176|Oxaliplatin|oxaliplatin|mesh-list
6019008|NCT00384176|Cediranib|cediranib|mesh-list
6419416|NCT00285766|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6419417|NCT00285766|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6419418|NCT00285766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6419419|NCT00285766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419420|NCT00285766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6419421|NCT00285766|Protective Agents|protective agents|mesh-ancestor
6419422|NCT00285766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419423|NCT00285805|Rosiglitazone|rosiglitazone|mesh-list
6419424|NCT00285805|Amiloride|amiloride|mesh-list
6419425|NCT00285805|Furosemide|furosemide|mesh-list
6419426|NCT00285805|Diuretics|diuretics|mesh-ancestor
6419427|NCT00285805|Natriuretic Agents|natriuretic agents|mesh-ancestor
6419428|NCT00285805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419429|NCT00285805|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6419430|NCT00285805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6419431|NCT00285805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419432|NCT00285805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6419433|NCT00285805|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
6419434|NCT00285805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6419435|NCT00285805|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
6419436|NCT00285805|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6460249|NCT00449202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460250|NCT00449202|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6460251|NCT00449254|Oleoyl-estrone|oleoyl-estrone|mesh-list
6460252|NCT00449254|Estrone|estrone|mesh-list
6460253|NCT00449254|Estrogens|estrogens|mesh-ancestor
6460254|NCT00449254|Hormones|hormones|mesh-ancestor
6460255|NCT00449254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6460256|NCT00449254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460257|NCT00449254|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6460258|NCT00449280|Sirolimus|sirolimus|mesh-list
6460259|NCT00449280|Sorafenib|sorafenib|mesh-list
6460260|NCT00449280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6019009|NCT00384176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6019010|NCT00384176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6419437|NCT00285844|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
6419438|NCT00285844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6419439|NCT00285844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419440|NCT00285883|Saquinavir|saquinavir|mesh-list
6419441|NCT00285883|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6419442|NCT00285883|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6419443|NCT00285883|Protease Inhibitors|protease inhibitors|mesh-ancestor
6419444|NCT00285883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6419445|NCT00285883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419446|NCT00285883|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6419447|NCT00285883|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6419448|NCT00285883|Antiviral Agents|antiviral agents|mesh-ancestor
6419449|NCT00285883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6419450|NCT00285883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6419451|NCT00285883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6419452|NCT00285896|Glucagon|glucagon|mesh-list
6419453|NCT00285896|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6419454|NCT00285896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6419455|NCT00285896|Hormones|hormones|mesh-ancestor
6419456|NCT00285896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6419457|NCT00285896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419458|NCT00285896|Incretins|incretins|mesh-ancestor
6419459|NCT00286013|Gemcitabine|gemcitabine|mesh-list
6419460|NCT00286013|Oxaliplatin|oxaliplatin|mesh-list
6419461|NCT00286013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6419462|NCT00286013|Antimetabolites|antimetabolites|mesh-ancestor
6419463|NCT00286013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419464|NCT00286013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6419465|NCT00286013|Antiviral Agents|antiviral agents|mesh-ancestor
6419466|NCT00286013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6419467|NCT00286013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6419468|NCT00286013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6419469|NCT00286013|Immunologic Factors|immunologic factors|mesh-ancestor
6419470|NCT00286013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419471|NCT00286026|Azithromycin|azithromycin|mesh-list
6419472|NCT00286026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6419473|NCT00286026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6419474|NCT00286052|Naloxone|naloxone|mesh-list
6419475|NCT00286052|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6419476|NCT00286052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419477|NCT00286052|Sensory System Agents|sensory system agents|mesh-ancestor
6419478|NCT00286052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6419479|NCT00286104|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6419480|NCT00286104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6419481|NCT00286117|Tamoxifen|tamoxifen|mesh-list
6419482|NCT00286117|Anastrozole|anastrozole|mesh-list
6419483|NCT00286117|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6419484|NCT00286117|Hormone Antagonists|hormone antagonists|mesh-ancestor
6419485|NCT00286117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6419486|NCT00286117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419487|NCT00286117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6419488|NCT00286117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6419489|NCT00286117|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6419490|NCT00286117|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6419491|NCT00286117|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6419492|NCT00286117|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6419493|NCT00286117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6419494|NCT00286117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6419495|NCT00286117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419496|NCT00286130|Leucovorin|leucovorin|mesh-list
6419497|NCT00286130|Oxaliplatin|oxaliplatin|mesh-list
6419498|NCT00286130|Irinotecan|irinotecan|mesh-list
6419499|NCT00286130|Cetuximab|cetuximab|mesh-list
6419500|NCT00286130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6419501|NCT00286130|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6019011|NCT00384176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6419502|NCT00286130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6419503|NCT00286130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6419504|NCT00286130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419505|NCT00286130|Antidotes|antidotes|mesh-ancestor
6419506|NCT00286130|Protective Agents|protective agents|mesh-ancestor
6419507|NCT00286130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419508|NCT00286130|Vitamin B Complex|vitamin b complex|mesh-ancestor
6419509|NCT00286130|Vitamins|vitamins|mesh-ancestor
6419510|NCT00286130|Micronutrients|micronutrients|mesh-ancestor
6419511|NCT00286130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6419512|NCT00286143|Fentanyl|fentanyl|mesh-list
6419513|NCT00286143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6419514|NCT00286143|Narcotics|narcotics|mesh-ancestor
6419515|NCT00286143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6419516|NCT00286143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419517|NCT00286143|Analgesics|analgesics|mesh-ancestor
6419518|NCT00286143|Sensory System Agents|sensory system agents|mesh-ancestor
6419519|NCT00286143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6419520|NCT00286143|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6419521|NCT00286143|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6419522|NCT00286143|Anesthetics, General|anesthetics, general|mesh-ancestor
6419523|NCT00286143|Anesthetics|anesthetics|mesh-ancestor
6419524|NCT00286169|Amrubicin|amrubicin|mesh-list
6419525|NCT00286169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6419526|NCT00286208|Misoprostol|misoprostol|mesh-list
6419527|NCT00286208|Mifepristone|mifepristone|mesh-list
6419528|NCT00286208|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6419529|NCT00286208|Abortifacient Agents|abortifacient agents|mesh-ancestor
6419530|NCT00286208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6419531|NCT00286208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419532|NCT00286208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6419533|NCT00286208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6419534|NCT00286208|Oxytocics|oxytocics|mesh-ancestor
6419535|NCT00286208|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6419536|NCT00286208|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6419537|NCT00286208|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6419538|NCT00286208|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6419539|NCT00286208|Contraceptive Agents|contraceptive agents|mesh-ancestor
6419540|NCT00286208|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6419541|NCT00286208|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6419542|NCT00286208|Hormone Antagonists|hormone antagonists|mesh-ancestor
6019012|NCT00384176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6019013|NCT00384176|Growth Substances|growth substances|mesh-ancestor
6019014|NCT00384176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419543|NCT00286208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6419544|NCT00286208|Luteolytic Agents|luteolytic agents|mesh-ancestor
6419545|NCT00286208|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6419546|NCT00286208|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6419547|NCT00286260|Levetiracetam|levetiracetam|mesh-list
6419548|NCT00286260|Anticonvulsants|anticonvulsants|mesh-ancestor
6419549|NCT00286260|Nootropic Agents|nootropic agents|mesh-ancestor
6419550|NCT00286273|Heparin|heparin|mesh-list
6419551|NCT00286273|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6419552|NCT00286273|Tinzaparin|tinzaparin|mesh-list
6419553|NCT00286273|Dalteparin|dalteparin|mesh-list
6419554|NCT00286273|Nadroparin|nadroparin|mesh-list
6419555|NCT00286273|Citric Acid|citric acid|mesh-list
6419556|NCT00286273|Sodium Citrate|sodium citrate|mesh-list
6419557|NCT00286273|Anticoagulants|anticoagulants|mesh-ancestor
6419558|NCT00286273|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6419559|NCT00286273|Chelating Agents|chelating agents|mesh-ancestor
6419560|NCT00286273|Sequestering Agents|sequestering agents|mesh-ancestor
6419561|NCT00286273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419562|NCT00286273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6419563|NCT00286273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6419564|NCT00286312|Atorvastatin|atorvastatin|mesh-list
6419565|NCT00286312|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6419566|NCT00286312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6419567|NCT00286312|Antimetabolites|antimetabolites|mesh-ancestor
6419568|NCT00286312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419569|NCT00286312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6419570|NCT00286312|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6419571|NCT00286312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6419572|NCT00286351|Goserelin|goserelin|mesh-list
6419573|NCT00286351|Anastrozole|anastrozole|mesh-list
6419574|NCT00286351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6419575|NCT00286351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6419576|NCT00286351|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6419577|NCT00286351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6419578|NCT00286351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6419579|NCT00286351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419580|NCT00286351|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6419581|NCT00286351|Hormone Antagonists|hormone antagonists|mesh-ancestor
6419582|NCT00286351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6419583|NCT00286351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419584|NCT00286364|Androgens|androgens|mesh-list
6419585|NCT00286364|Aromatase Inhibitors|aromatase inhibitors|mesh-list
6419586|NCT00286364|Hormones|hormones|mesh-ancestor
6419587|NCT00286364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6419588|NCT00286364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419589|NCT00286364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6419590|NCT00286364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6419591|NCT00286364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419592|NCT00286364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6419593|NCT00286364|Hormone Antagonists|hormone antagonists|mesh-ancestor
6419594|NCT00286403|Fenoldopam|fenoldopam|mesh-list
6419595|NCT00286403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419596|NCT00286403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6419597|NCT00286403|Vasodilator Agents|vasodilator agents|mesh-ancestor
6419598|NCT00286403|Dopamine Agonists|dopamine agonists|mesh-ancestor
6419599|NCT00286403|Dopamine Agents|dopamine agents|mesh-ancestor
6419600|NCT00286403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6419601|NCT00286403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419602|NCT00286416|Omalizumab|omalizumab|mesh-list
6419603|NCT00286416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6419604|NCT00286416|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6419605|NCT00286416|Respiratory System Agents|respiratory system agents|mesh-ancestor
6419606|NCT00286481|Simvastatin|simvastatin|mesh-list
6419607|NCT00286481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6419608|NCT00286481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6419609|NCT00286481|Antimetabolites|antimetabolites|mesh-ancestor
6419610|NCT00286481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419611|NCT00286481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6419612|NCT00286481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6419613|NCT00286481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6419614|NCT00286585|Propofol|propofol|mesh-list
6419615|NCT00286585|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
6419616|NCT00286585|Anesthetics|anesthetics|mesh-list
6019015|NCT00384176|Growth Inhibitors|growth inhibitors|mesh-ancestor
6019016|NCT00384176|Antimetabolites|antimetabolites|mesh-ancestor
6019017|NCT00384176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019018|NCT00384176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6019019|NCT00384176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6019020|NCT00384176|Immunologic Factors|immunologic factors|mesh-ancestor
6419617|NCT00286585|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6419618|NCT00286585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6419619|NCT00286585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019021|NCT00384176|Antidotes|antidotes|mesh-ancestor
6419620|NCT00286585|Anesthetics, General|anesthetics, general|mesh-ancestor
6419621|NCT00286611|Amifostine|amifostine|mesh-list
6419622|NCT00286611|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6419623|NCT00286611|Protective Agents|protective agents|mesh-ancestor
6419624|NCT00286611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419625|NCT00286624|Cyclosporine|cyclosporine|mesh-list
6419626|NCT00286624|Everolimus|everolimus|mesh-list
6419627|NCT00286624|Cyclosporins|cyclosporins|mesh-list
6419628|NCT00286624|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6419629|NCT00286624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6419630|NCT00286624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419631|NCT00286624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6419632|NCT00286624|Immunologic Factors|immunologic factors|mesh-ancestor
6419633|NCT00286624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419634|NCT00286624|Antifungal Agents|antifungal agents|mesh-ancestor
6419635|NCT00286624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6419636|NCT00286624|Dermatologic Agents|dermatologic agents|mesh-ancestor
6419637|NCT00286624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6419638|NCT00286624|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6419639|NCT00286624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6419640|NCT00286689|Hormones|hormones|mesh-list
6419641|NCT00286689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6419642|NCT00286689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419643|NCT00286780|Gossypol acetic acid|gossypol acetic acid|mesh-list
6419644|NCT00286780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6419645|NCT00286780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6419646|NCT00286780|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6419647|NCT00286780|Contraceptive Agents|contraceptive agents|mesh-ancestor
6419648|NCT00286780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6419649|NCT00286780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419650|NCT00286780|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
6419651|NCT00286780|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
6419652|NCT00286780|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6419653|NCT00286871|Tacrolimus|tacrolimus|mesh-list
6419654|NCT00286871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6419655|NCT00286871|Immunologic Factors|immunologic factors|mesh-ancestor
6419656|NCT00286871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419657|NCT00286871|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6419658|NCT00286871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6419659|NCT00286871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419660|NCT00286923|Topiramate|topiramate|mesh-list
6419661|NCT00286923|Anticonvulsants|anticonvulsants|mesh-ancestor
6419662|NCT00286923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6419663|NCT00286923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419664|NCT00286936|Zolpidem|zolpidem|mesh-list
6419665|NCT00286936|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6419666|NCT00286936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6419667|NCT00286936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6419668|NCT00286936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419669|NCT00286936|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6419670|NCT00286936|GABA Agonists|gaba agonists|mesh-ancestor
6419671|NCT00286936|GABA Agents|gaba agents|mesh-ancestor
6419672|NCT00286936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6419673|NCT00286936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419674|NCT00286962|Insulin|insulin|mesh-list
6419675|NCT00286962|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6419676|NCT00286962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6419677|NCT00286962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419678|NCT00286988|Topiramate|topiramate|mesh-list
6419679|NCT00286988|Anticonvulsants|anticonvulsants|mesh-ancestor
6419680|NCT00286988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6419681|NCT00286988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419682|NCT00287027|Antipsychotic Agents|antipsychotic agents|mesh-list
6419683|NCT00287027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419684|NCT00287027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6419685|NCT00287027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6419686|NCT00287027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6419687|NCT00287066|Insulin|insulin|mesh-list
6419688|NCT00287066|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6419689|NCT00287066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6419690|NCT00287066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419691|NCT00287105|Imatinib Mesylate|imatinib mesylate|mesh-list
6419692|NCT00287105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6419693|NCT00287105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6419694|NCT00287105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6419695|NCT00287105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419696|NCT00287157|Tizanidine|tizanidine|mesh-list
6419697|NCT00287157|Analgesics|analgesics|mesh-ancestor
6419698|NCT00287157|Sensory System Agents|sensory system agents|mesh-ancestor
6419699|NCT00287157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6419700|NCT00287157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419701|NCT00287157|Anticonvulsants|anticonvulsants|mesh-ancestor
6419702|NCT00287157|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6419703|NCT00287157|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6419704|NCT00287157|Parasympatholytics|parasympatholytics|mesh-ancestor
6419705|NCT00287157|Autonomic Agents|autonomic agents|mesh-ancestor
6419706|NCT00287157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6419707|NCT00287157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6419708|NCT00287157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6419709|NCT00287157|Adrenergic Agents|adrenergic agents|mesh-ancestor
6419710|NCT00287157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6419711|NCT00287157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419712|NCT00287170|Calcitriol|calcitriol|mesh-list
6419713|NCT00287170|Mercaptopurine|mercaptopurine|mesh-list
6419714|NCT00287170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6419715|NCT00287170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419716|NCT00287170|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6419717|NCT00287170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6419718|NCT00287170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419719|NCT00287170|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6419720|NCT00287170|Vitamins|vitamins|mesh-ancestor
6419721|NCT00287170|Micronutrients|micronutrients|mesh-ancestor
6419722|NCT00287170|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6419723|NCT00287170|Antimetabolites|antimetabolites|mesh-ancestor
6419724|NCT00287170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6419725|NCT00287170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6419726|NCT00287170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6419727|NCT00287170|Immunologic Factors|immunologic factors|mesh-ancestor
6419728|NCT00287170|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6419729|NCT00287170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6419730|NCT00287209|Amiodarone|amiodarone|mesh-list
6419731|NCT00287209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6419732|NCT00287209|Vasodilator Agents|vasodilator agents|mesh-ancestor
6419733|NCT00287209|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6419734|NCT00287209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6419735|NCT00287209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419736|NCT00287209|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6419737|NCT00287209|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6419738|NCT00287209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6419739|NCT00287209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6419740|NCT00287209|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6419741|NCT00287209|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6419742|NCT00287209|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6419743|NCT00287261|Zoledronic Acid|zoledronic acid|mesh-list
6419744|NCT00287261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6419745|NCT00287261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419746|NCT00287300|Azithromycin|azithromycin|mesh-list
6419747|NCT00287300|Artesunate|artesunate|mesh-list
6419748|NCT00287300|Pyrimethamine|pyrimethamine|mesh-list
6419749|NCT00287300|Sulfadoxine|sulfadoxine|mesh-list
6419750|NCT00287300|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6419751|NCT00287300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6419752|NCT00287300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6419753|NCT00287300|Antimalarials|antimalarials|mesh-ancestor
6419754|NCT00287300|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6419755|NCT00287300|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6419756|NCT00287300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6419757|NCT00287300|Antiviral Agents|antiviral agents|mesh-ancestor
6419758|NCT00287300|Schistosomicides|schistosomicides|mesh-ancestor
6419759|NCT00287300|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6419760|NCT00287300|Anthelmintics|anthelmintics|mesh-ancestor
6419761|NCT00287300|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6419762|NCT00287300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6419763|NCT00287300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419764|NCT00287300|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6419765|NCT00287300|Renal Agents|renal agents|mesh-ancestor
6419766|NCT00287313|Vitamin K|vitamin k|mesh-list
6419767|NCT00287313|Vitamins|vitamins|mesh-ancestor
6419768|NCT00287313|Micronutrients|micronutrients|mesh-ancestor
6419769|NCT00287313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419770|NCT00287313|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6419771|NCT00287313|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6419772|NCT00287313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419773|NCT00287313|Hemostatics|hemostatics|mesh-ancestor
6419774|NCT00287313|Coagulants|coagulants|mesh-ancestor
6419775|NCT00287326|Clonidine|clonidine|mesh-list
6019022|NCT00384176|Protective Agents|protective agents|mesh-ancestor
6019023|NCT00384176|Vitamin B Complex|vitamin b complex|mesh-ancestor
6019024|NCT00384176|Vitamins|vitamins|mesh-ancestor
6019025|NCT00384176|Micronutrients|micronutrients|mesh-ancestor
6019026|NCT00384176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6419776|NCT00287326|Morphine|morphine|mesh-list
6419777|NCT00287326|Bupivacaine|bupivacaine|mesh-list
6419778|NCT00287326|Anesthetics, Local|anesthetics, local|mesh-ancestor
6419779|NCT00287326|Anesthetics|anesthetics|mesh-ancestor
6419780|NCT00287326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6419781|NCT00287326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419782|NCT00287326|Sensory System Agents|sensory system agents|mesh-ancestor
6419783|NCT00287326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6419784|NCT00287326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6419785|NCT00287326|Narcotics|narcotics|mesh-ancestor
6419786|NCT00287326|Analgesics|analgesics|mesh-ancestor
6419787|NCT00287326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6419788|NCT00287326|Sympatholytics|sympatholytics|mesh-ancestor
6419789|NCT00287326|Autonomic Agents|autonomic agents|mesh-ancestor
6419790|NCT00287326|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6419791|NCT00287326|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6419792|NCT00287326|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6419793|NCT00287326|Adrenergic Agents|adrenergic agents|mesh-ancestor
6419794|NCT00287326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6419795|NCT00287326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419796|NCT00287352|Amantadine|amantadine|mesh-list
6419797|NCT00287352|Olanzapine|olanzapine|mesh-list
6419798|NCT00287352|Antiemetics|antiemetics|mesh-ancestor
6419799|NCT00287352|Autonomic Agents|autonomic agents|mesh-ancestor
6419800|NCT00287352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6419801|NCT00287352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419802|NCT00287352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6419803|NCT00287352|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6419804|NCT00287352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6419805|NCT00287352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6419806|NCT00287352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6419807|NCT00287352|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6419808|NCT00287352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6419809|NCT00287352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6419810|NCT00287352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419811|NCT00287352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6419812|NCT00287352|Serotonin Agents|serotonin agents|mesh-ancestor
6419813|NCT00287352|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6419814|NCT00287352|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6419815|NCT00287352|Antiviral Agents|antiviral agents|mesh-ancestor
6419816|NCT00287352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6419817|NCT00287352|Dopamine Agents|dopamine agents|mesh-ancestor
6419818|NCT00287352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6419819|NCT00287352|Analgesics|analgesics|mesh-ancestor
6419820|NCT00287352|Sensory System Agents|sensory system agents|mesh-ancestor
6419821|NCT00287378|Omalizumab|omalizumab|mesh-list
6419822|NCT00287378|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6419823|NCT00287378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6419824|NCT00287378|Respiratory System Agents|respiratory system agents|mesh-ancestor
6419825|NCT00287391|Rabeprazole|rabeprazole|mesh-list
6019027|NCT00384176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6019028|NCT00384189|Ciclesonide|ciclesonide|mesh-list
6019029|NCT00384189|Albuterol|albuterol|mesh-list
6419826|NCT00287391|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6419827|NCT00287391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6419828|NCT00287391|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6419829|NCT00287391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6419830|NCT00287391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419831|NCT00287430|Hormones|hormones|mesh-list
6419832|NCT00287430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6419833|NCT00287430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019030|NCT00384189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6019031|NCT00384189|Autonomic Agents|autonomic agents|mesh-ancestor
6419834|NCT00287443|Hormones|hormones|mesh-list
6419835|NCT00287443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6419836|NCT00287443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419837|NCT00287456|Insulin|insulin|mesh-list
6419838|NCT00287456|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6419839|NCT00287456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6419840|NCT00287456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419841|NCT00287495|Sorafenib|sorafenib|mesh-list
6419842|NCT00287495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6419843|NCT00287495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6419844|NCT00287495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6419845|NCT00287495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460261|NCT00449280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6460262|NCT00449280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6460263|NCT00449280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460264|NCT00449280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6460265|NCT00449280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6460266|NCT00449280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6460267|NCT00449280|Antifungal Agents|antifungal agents|mesh-ancestor
6460268|NCT00449280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6460269|NCT00449280|Immunologic Factors|immunologic factors|mesh-ancestor
6019032|NCT00384189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6019033|NCT00384189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019034|NCT00384189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6019035|NCT00384189|Respiratory System Agents|respiratory system agents|mesh-ancestor
6019036|NCT00384189|Tocolytic Agents|tocolytic agents|mesh-ancestor
6419846|NCT00287521|Timolol|timolol|mesh-list
6419847|NCT00287521|Latanoprost|latanoprost|mesh-list
6419848|NCT00287521|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6419849|NCT00287521|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6419850|NCT00287521|Adrenergic Agents|adrenergic agents|mesh-ancestor
6419851|NCT00287521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6419852|NCT00287521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419853|NCT00287521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419854|NCT00287521|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6419855|NCT00287521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6419856|NCT00287521|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6419857|NCT00287521|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6419858|NCT00287534|Tamoxifen|tamoxifen|mesh-list
6419859|NCT00287534|Anastrozole|anastrozole|mesh-list
6419860|NCT00287534|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6419861|NCT00287534|Hormone Antagonists|hormone antagonists|mesh-ancestor
6419862|NCT00287534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6419863|NCT00287534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419864|NCT00287534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6419865|NCT00287534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6419866|NCT00287534|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6419867|NCT00287534|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6419868|NCT00287534|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6419869|NCT00287534|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6419870|NCT00287534|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6419871|NCT00287534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6419872|NCT00287534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419873|NCT00287560|Propofol|propofol|mesh-list
6419874|NCT00287560|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6419875|NCT00287560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6419876|NCT00287560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419877|NCT00287560|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6419878|NCT00287560|Anesthetics, General|anesthetics, general|mesh-ancestor
6419879|NCT00287560|Anesthetics|anesthetics|mesh-ancestor
6419880|NCT00287651|Insulin|insulin|mesh-list
6419881|NCT00287651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6419882|NCT00287651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6419883|NCT00287651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419884|NCT00287664|Terlipressin|terlipressin|mesh-list
6419885|NCT00287664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6419886|NCT00287664|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6419887|NCT00287677|Hormones|hormones|mesh-list
6419888|NCT00287677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6419889|NCT00287677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419890|NCT00287742|Risperidone|risperidone|mesh-list
6419891|NCT00287742|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6419892|NCT00287742|Serotonin Agents|serotonin agents|mesh-ancestor
6419893|NCT00287742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6419894|NCT00287742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419895|NCT00287742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419896|NCT00287742|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6419897|NCT00287742|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6419898|NCT00287742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6419899|NCT00287742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6419900|NCT00287742|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6419901|NCT00287742|Dopamine Agents|dopamine agents|mesh-ancestor
6419902|NCT00287768|Docetaxel|docetaxel|mesh-list
6419903|NCT00287768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6419904|NCT00287768|Tubulin Modulators|tubulin modulators|mesh-ancestor
6419905|NCT00287768|Antimitotic Agents|antimitotic agents|mesh-ancestor
6419906|NCT00287768|Mitosis Modulators|mitosis modulators|mesh-ancestor
6419907|NCT00287768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419908|NCT00287781|Lidocaine|lidocaine|mesh-list
6419909|NCT00287781|Anesthetics, Local|anesthetics, local|mesh-ancestor
6419910|NCT00287781|Anesthetics|anesthetics|mesh-ancestor
6419911|NCT00287781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6419912|NCT00287781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419913|NCT00287781|Sensory System Agents|sensory system agents|mesh-ancestor
6419914|NCT00287781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6019037|NCT00384189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6019038|NCT00384189|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6019039|NCT00384189|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6019040|NCT00384189|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6019041|NCT00384189|Adrenergic Agents|adrenergic agents|mesh-ancestor
6019042|NCT00384189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6019043|NCT00384189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019044|NCT00384189|Glucocorticoids|glucocorticoids|mesh-ancestor
6019045|NCT00384189|Hormones|hormones|mesh-ancestor
6053208|NCT00593606|Rotigotine|rotigotine|mesh-list
6419915|NCT00287781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6419916|NCT00287781|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6419917|NCT00287781|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6419918|NCT00287781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6419919|NCT00287781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419920|NCT00287794|Diazepam|diazepam|mesh-list
6419921|NCT00287794|Melatonin|melatonin|mesh-list
6419922|NCT00287794|Antioxidants|antioxidants|mesh-ancestor
6419923|NCT00287794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419924|NCT00287794|Protective Agents|protective agents|mesh-ancestor
6419925|NCT00287794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419926|NCT00287794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6419927|NCT00287794|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6419928|NCT00287794|Anticonvulsants|anticonvulsants|mesh-ancestor
6419929|NCT00287794|Antiemetics|antiemetics|mesh-ancestor
6419930|NCT00287794|Autonomic Agents|autonomic agents|mesh-ancestor
6419931|NCT00287794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6419932|NCT00287794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6419933|NCT00287794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6419934|NCT00287794|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6419935|NCT00287794|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6419936|NCT00287794|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6419937|NCT00287794|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6419938|NCT00287794|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6419939|NCT00287794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6419940|NCT00287794|Anesthetics, General|anesthetics, general|mesh-ancestor
6419941|NCT00287794|Anesthetics|anesthetics|mesh-ancestor
6419942|NCT00287794|GABA Modulators|gaba modulators|mesh-ancestor
6419943|NCT00287794|GABA Agents|gaba agents|mesh-ancestor
6419944|NCT00287794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6419945|NCT00287820|Olanzapine|olanzapine|mesh-list
6419946|NCT00287820|Risperidone|risperidone|mesh-list
6419947|NCT00287820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6419948|NCT00287820|Serotonin Agents|serotonin agents|mesh-ancestor
6419949|NCT00287820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6419950|NCT00287820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419951|NCT00287820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419952|NCT00287820|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6419953|NCT00287820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6419954|NCT00287820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6419955|NCT00287820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6419956|NCT00287820|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6419957|NCT00287820|Dopamine Agents|dopamine agents|mesh-ancestor
6419958|NCT00287820|Antiemetics|antiemetics|mesh-ancestor
6419959|NCT00287820|Autonomic Agents|autonomic agents|mesh-ancestor
6419960|NCT00287820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6419961|NCT00287820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6419962|NCT00287820|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6419963|NCT00287820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6419964|NCT00287820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6419965|NCT00287846|Imatinib Mesylate|imatinib mesylate|mesh-list
6419966|NCT00287846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6419967|NCT00287846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6419968|NCT00287846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6419969|NCT00287846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419970|NCT00287859|Topotecan|topotecan|mesh-list
6419971|NCT00287859|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6419972|NCT00287859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6419973|NCT00287859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6419974|NCT00287859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419975|NCT00287859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6419976|NCT00287885|Docetaxel|docetaxel|mesh-list
6419977|NCT00287885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6419978|NCT00287885|Tubulin Modulators|tubulin modulators|mesh-ancestor
6419979|NCT00287885|Antimitotic Agents|antimitotic agents|mesh-ancestor
6419980|NCT00287885|Mitosis Modulators|mitosis modulators|mesh-ancestor
6419981|NCT00287885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419982|NCT00287911|Topotecan|topotecan|mesh-list
6419983|NCT00287911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6419984|NCT00287911|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6419985|NCT00287911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6419986|NCT00287911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6419987|NCT00287911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419988|NCT00287924|Methotrexate|methotrexate|mesh-list
6419989|NCT00287924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6419990|NCT00287924|Abortifacient Agents|abortifacient agents|mesh-ancestor
6419991|NCT00287924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6419992|NCT00287924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6419993|NCT00287924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6419994|NCT00287924|Antimetabolites|antimetabolites|mesh-ancestor
6419995|NCT00287924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6419996|NCT00287924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6419997|NCT00287924|Dermatologic Agents|dermatologic agents|mesh-ancestor
6419998|NCT00287924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6419999|NCT00287924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6420000|NCT00287924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6420001|NCT00287924|Immunologic Factors|immunologic factors|mesh-ancestor
6420002|NCT00287924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6420003|NCT00287924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6420004|NCT00287937|Paclitaxel|paclitaxel|mesh-list
6420005|NCT00287937|Carboplatin|carboplatin|mesh-list
6420006|NCT00287937|Vorinostat|vorinostat|mesh-list
6420007|NCT00287937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6420008|NCT00287937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6420009|NCT00287937|Tubulin Modulators|tubulin modulators|mesh-ancestor
6420010|NCT00287937|Antimitotic Agents|antimitotic agents|mesh-ancestor
6420011|NCT00287937|Mitosis Modulators|mitosis modulators|mesh-ancestor
6420012|NCT00287937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420013|NCT00287937|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6420014|NCT00287937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6420015|NCT00287950|Cyclophosphamide|cyclophosphamide|mesh-list
6420016|NCT00287950|Carboplatin|carboplatin|mesh-list
6420017|NCT00287950|Etoposide|etoposide|mesh-list
6420018|NCT00287950|Vincristine|vincristine|mesh-list
6420019|NCT00287950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6420020|NCT00287950|Immunologic Factors|immunologic factors|mesh-ancestor
6420021|NCT00287950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420022|NCT00287950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6420023|NCT00287950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6420024|NCT00287950|Alkylating Agents|alkylating agents|mesh-ancestor
6420025|NCT00287950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420026|NCT00287950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6420027|NCT00287950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6420028|NCT00287950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6420029|NCT00287950|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6420030|NCT00287950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6420031|NCT00287950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6420032|NCT00287950|Tubulin Modulators|tubulin modulators|mesh-ancestor
6420033|NCT00287950|Antimitotic Agents|antimitotic agents|mesh-ancestor
6420034|NCT00287950|Mitosis Modulators|mitosis modulators|mesh-ancestor
6420035|NCT00287963|Topotecan|topotecan|mesh-list
6420036|NCT00287963|Vinorelbine|vinorelbine|mesh-list
6420037|NCT00287963|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6420038|NCT00287963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6420039|NCT00287963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6420040|NCT00287963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420041|NCT00287963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6420042|NCT00287963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6420043|NCT00287963|Tubulin Modulators|tubulin modulators|mesh-ancestor
6420044|NCT00287963|Antimitotic Agents|antimitotic agents|mesh-ancestor
6420045|NCT00287963|Mitosis Modulators|mitosis modulators|mesh-ancestor
6420046|NCT00287976|Irinotecan|irinotecan|mesh-list
6420047|NCT00287976|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6420048|NCT00287976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5724704|NCT03185403|Anesthetics|anesthetics|mesh-ancestor
6420049|NCT00287976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6420050|NCT00287976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420051|NCT00287976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6420052|NCT00288002|Cyclophosphamide|cyclophosphamide|mesh-list
6420053|NCT00288002|Docetaxel|docetaxel|mesh-list
6420054|NCT00288002|Capecitabine|capecitabine|mesh-list
6019046|NCT00384189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6019047|NCT00384189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6019048|NCT00384332|Olanzapine|olanzapine|mesh-list
6019049|NCT00384332|Antiemetics|antiemetics|mesh-ancestor
6019050|NCT00384332|Autonomic Agents|autonomic agents|mesh-ancestor
6019051|NCT00384332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6019052|NCT00384332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420055|NCT00288002|Trastuzumab|trastuzumab|mesh-list
6019053|NCT00384332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6019054|NCT00384332|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6019055|NCT00384332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6019056|NCT00384332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6019057|NCT00384332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6019058|NCT00384332|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6019059|NCT00384332|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6019060|NCT00384332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6019061|NCT00384332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019062|NCT00384332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6420056|NCT00288002|Epirubicin|epirubicin|mesh-list
6420057|NCT00288002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6420058|NCT00288002|Immunologic Factors|immunologic factors|mesh-ancestor
6420059|NCT00288002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420060|NCT00288002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6420061|NCT00288002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6420062|NCT00288002|Alkylating Agents|alkylating agents|mesh-ancestor
6420063|NCT00288002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420064|NCT00288002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6420065|NCT00288002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6420066|NCT00288002|Tubulin Modulators|tubulin modulators|mesh-ancestor
6420067|NCT00288002|Antimitotic Agents|antimitotic agents|mesh-ancestor
6420068|NCT00288002|Mitosis Modulators|mitosis modulators|mesh-ancestor
6420069|NCT00288002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6420070|NCT00288002|Antimetabolites|antimetabolites|mesh-ancestor
6420071|NCT00288002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6420072|NCT00288002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6420073|NCT00288002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6420074|NCT00288002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6420075|NCT00288002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6420076|NCT00288028|Bortezomib|bortezomib|mesh-list
6420077|NCT00288028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6420078|NCT00288041|Paclitaxel|paclitaxel|mesh-list
6420079|NCT00288041|Carboplatin|carboplatin|mesh-list
6420080|NCT00288041|Bortezomib|bortezomib|mesh-list
6420081|NCT00288041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6420082|NCT00288041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6420083|NCT00288041|Tubulin Modulators|tubulin modulators|mesh-ancestor
6420084|NCT00288041|Antimitotic Agents|antimitotic agents|mesh-ancestor
6420085|NCT00288041|Mitosis Modulators|mitosis modulators|mesh-ancestor
6420086|NCT00288041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420087|NCT00288158|Allopurinol|allopurinol|mesh-list
6420088|NCT00288158|Probenecid|probenecid|mesh-list
6420089|NCT00288158|Antimetabolites|antimetabolites|mesh-ancestor
6420090|NCT00288158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420091|NCT00288158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6420092|NCT00288158|Gout Suppressants|gout suppressants|mesh-ancestor
6420093|NCT00288158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6420094|NCT00288158|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6420095|NCT00288158|Antioxidants|antioxidants|mesh-ancestor
6420096|NCT00288158|Protective Agents|protective agents|mesh-ancestor
6420097|NCT00288158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420098|NCT00288158|Uricosuric Agents|uricosuric agents|mesh-ancestor
6420099|NCT00288158|Renal Agents|renal agents|mesh-ancestor
6420100|NCT00288171|Allopurinol|allopurinol|mesh-list
6420101|NCT00288171|Antimetabolites|antimetabolites|mesh-ancestor
6420102|NCT00288171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420103|NCT00288171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6420104|NCT00288171|Gout Suppressants|gout suppressants|mesh-ancestor
6420105|NCT00288171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6420106|NCT00288171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6420107|NCT00288171|Antioxidants|antioxidants|mesh-ancestor
6420108|NCT00288171|Protective Agents|protective agents|mesh-ancestor
6420109|NCT00288171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420110|NCT00288184|Allopurinol|allopurinol|mesh-list
6420111|NCT00288184|Antimetabolites|antimetabolites|mesh-ancestor
6420112|NCT00288184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420113|NCT00288184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6420114|NCT00288184|Gout Suppressants|gout suppressants|mesh-ancestor
6420115|NCT00288184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6420116|NCT00288184|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6420117|NCT00288184|Antioxidants|antioxidants|mesh-ancestor
6420118|NCT00288184|Protective Agents|protective agents|mesh-ancestor
6420119|NCT00288184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420120|NCT00288197|Voriconazole|voriconazole|mesh-list
6420121|NCT00288197|Antifungal Agents|antifungal agents|mesh-ancestor
6420122|NCT00288197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6420123|NCT00288197|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6420124|NCT00288197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6420125|NCT00288197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6420126|NCT00288197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420127|NCT00288197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6420128|NCT00288197|Hormone Antagonists|hormone antagonists|mesh-ancestor
6420129|NCT00288197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6420130|NCT00288197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420131|NCT00288197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6420132|NCT00288223|Telithromycin|telithromycin|mesh-list
6420133|NCT00288223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6420134|NCT00288223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6420135|NCT00288236|Rimonabant|rimonabant|mesh-list
6420136|NCT00288236|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6420137|NCT00288236|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
6420138|NCT00288236|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6420139|NCT00288236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6420140|NCT00288236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420141|NCT00288236|Hormones|hormones|mesh-ancestor
6420142|NCT00288236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6420143|NCT00288236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420144|NCT00288249|Sagopilone|sagopilone|mesh-list
6420145|NCT00288249|Epothilones|epothilones|mesh-list
6420146|NCT00288249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6420147|NCT00288249|Tubulin Modulators|tubulin modulators|mesh-ancestor
6420148|NCT00288249|Antimitotic Agents|antimitotic agents|mesh-ancestor
6420149|NCT00288249|Mitosis Modulators|mitosis modulators|mesh-ancestor
6420150|NCT00288249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420151|NCT00288262|Melatonin|melatonin|mesh-list
6420152|NCT00288262|Antioxidants|antioxidants|mesh-ancestor
6420153|NCT00288262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420154|NCT00288262|Protective Agents|protective agents|mesh-ancestor
6420155|NCT00288262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420156|NCT00288262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6420157|NCT00288353|Aripiprazole|aripiprazole|mesh-list
6420158|NCT00288353|Ziprasidone|ziprasidone|mesh-list
6420159|NCT00288353|Antidepressive Agents|antidepressive agents|mesh-ancestor
6420160|NCT00288353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6420161|NCT00288353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6420162|NCT00288353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6420163|NCT00288353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6420164|NCT00288353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420165|NCT00288353|Dopamine Agonists|dopamine agonists|mesh-ancestor
6420166|NCT00288353|Dopamine Agents|dopamine agents|mesh-ancestor
6420167|NCT00288353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6420168|NCT00288353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420169|NCT00288353|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6420170|NCT00288353|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6420171|NCT00288353|Serotonin Agents|serotonin agents|mesh-ancestor
6420172|NCT00288353|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6420173|NCT00288353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6420174|NCT00288353|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6420175|NCT00288353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6420176|NCT00288379|Budesonide|budesonide|mesh-list
6420177|NCT00288379|Formoterol Fumarate|formoterol fumarate|mesh-list
6420178|NCT00288379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6420179|NCT00288379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6420180|NCT00288379|Autonomic Agents|autonomic agents|mesh-ancestor
6420181|NCT00288379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6420182|NCT00288379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420183|NCT00288379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6420184|NCT00288379|Respiratory System Agents|respiratory system agents|mesh-ancestor
6420185|NCT00288379|Glucocorticoids|glucocorticoids|mesh-ancestor
6420186|NCT00288379|Hormones|hormones|mesh-ancestor
6420187|NCT00288379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6420188|NCT00288379|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6019063|NCT00384332|Serotonin Agents|serotonin agents|mesh-ancestor
6019064|NCT00384397|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6019065|NCT00384397|Immunologic Factors|immunologic factors|mesh-ancestor
6019066|NCT00384397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019067|NCT00384449|Ranibizumab|ranibizumab|mesh-list
6019068|NCT00384449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6019069|NCT00384449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6019070|NCT00384449|Growth Substances|growth substances|mesh-ancestor
6420189|NCT00288379|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6420190|NCT00288379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6420191|NCT00288379|Adrenergic Agents|adrenergic agents|mesh-ancestor
6420192|NCT00288379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6420193|NCT00288379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420194|NCT00288431|Sirolimus|sirolimus|mesh-list
6420195|NCT00288431|Doxorubicin|doxorubicin|mesh-list
6420196|NCT00288431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6420197|NCT00288431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6420198|NCT00288431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6420199|NCT00288431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6420200|NCT00288431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6420201|NCT00288431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420202|NCT00288431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6420203|NCT00288431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6420204|NCT00288431|Antifungal Agents|antifungal agents|mesh-ancestor
6420205|NCT00288431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6420206|NCT00288431|Immunologic Factors|immunologic factors|mesh-ancestor
6420207|NCT00288431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420208|NCT00288444|Docetaxel|docetaxel|mesh-list
6420209|NCT00288444|Lonafarnib|lonafarnib|mesh-list
6420210|NCT00288444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6420211|NCT00288444|Tubulin Modulators|tubulin modulators|mesh-ancestor
6420212|NCT00288444|Antimitotic Agents|antimitotic agents|mesh-ancestor
6420213|NCT00288444|Mitosis Modulators|mitosis modulators|mesh-ancestor
6420214|NCT00288444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420215|NCT00288444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6420216|NCT00288470|Hylan|hylan|mesh-list
6420217|NCT00288470|Viscosupplements|viscosupplements|mesh-ancestor
6420218|NCT00288470|Protective Agents|protective agents|mesh-ancestor
6420219|NCT00288470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420220|NCT00288483|Policosanol|policosanol|mesh-list
6420221|NCT00288483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6420222|NCT00288483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6420223|NCT00288483|Antimetabolites|antimetabolites|mesh-ancestor
6420224|NCT00288483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420225|NCT00288483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6420226|NCT00288483|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6420227|NCT00288522|Lanreotide|lanreotide|mesh-list
6420228|NCT00288522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6420229|NCT00288535|Sirolimus|sirolimus|mesh-list
6420230|NCT00288535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6420231|NCT00288535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6420232|NCT00288535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6420233|NCT00288535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6420234|NCT00288535|Antifungal Agents|antifungal agents|mesh-ancestor
6420235|NCT00288535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6420236|NCT00288535|Immunologic Factors|immunologic factors|mesh-ancestor
6420237|NCT00288535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420238|NCT00288548|Metoprolol|metoprolol|mesh-list
6420239|NCT00288548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6420240|NCT00288548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6420241|NCT00288548|Sympatholytics|sympatholytics|mesh-ancestor
6420242|NCT00288548|Autonomic Agents|autonomic agents|mesh-ancestor
6420243|NCT00288548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6420244|NCT00288548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420245|NCT00288548|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6420246|NCT00288548|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6420247|NCT00288548|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6420248|NCT00288548|Adrenergic Agents|adrenergic agents|mesh-ancestor
6420249|NCT00288548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6420250|NCT00288548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420251|NCT00288561|Ranibizumab|ranibizumab|mesh-list
6420252|NCT00288561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6420253|NCT00288561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6420254|NCT00288561|Growth Substances|growth substances|mesh-ancestor
6420255|NCT00288561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420256|NCT00288561|Growth Inhibitors|growth inhibitors|mesh-ancestor
6420257|NCT00288561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6420258|NCT00288652|Reboxetine|reboxetine|mesh-list
6420259|NCT00288652|Antidepressive Agents|antidepressive agents|mesh-ancestor
6420260|NCT00288652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6420261|NCT00288652|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6420262|NCT00288652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6420263|NCT00288652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6420264|NCT00288652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420265|NCT00288652|Adrenergic Agents|adrenergic agents|mesh-ancestor
6420266|NCT00288652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6420267|NCT00288652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420268|NCT00288717|Telmisartan|telmisartan|mesh-list
6420269|NCT00288717|Candesartan|candesartan|mesh-list
6420270|NCT00288717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6420271|NCT00288717|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6420272|NCT00288717|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6420273|NCT00288717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420274|NCT00288730|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6420275|NCT00288730|Natriuretic Agents|natriuretic agents|mesh-ancestor
6420276|NCT00288730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420277|NCT00288743|Insulin|insulin|mesh-list
6420278|NCT00288743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5503586|NCT04457765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6420279|NCT00288743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420280|NCT00288769|Vitamin B 12|vitamin b 12|mesh-list
6420281|NCT00288769|Hydroxocobalamin|hydroxocobalamin|mesh-list
6420282|NCT00288769|Vitamins|vitamins|mesh-ancestor
6420283|NCT00288769|Micronutrients|micronutrients|mesh-ancestor
6420284|NCT00288769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420285|NCT00288769|Vitamin B Complex|vitamin b complex|mesh-ancestor
6420286|NCT00288769|Hematinics|hematinics|mesh-ancestor
6420287|NCT00288782|Mirtazapine|mirtazapine|mesh-list
6420288|NCT00288782|Antidepressive Agents|antidepressive agents|mesh-ancestor
6420289|NCT00288782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6420290|NCT00288782|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6420291|NCT00288782|Histamine Antagonists|histamine antagonists|mesh-ancestor
6420292|NCT00288782|Histamine Agents|histamine agents|mesh-ancestor
6420293|NCT00288782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6420294|NCT00288782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420295|NCT00288782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420296|NCT00288782|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6420297|NCT00288782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6420298|NCT00288782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6420299|NCT00288782|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6420300|NCT00288782|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6420301|NCT00288782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6420302|NCT00288782|Adrenergic Agents|adrenergic agents|mesh-ancestor
6420303|NCT00288782|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6420304|NCT00288782|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6420305|NCT00288782|Serotonin Agents|serotonin agents|mesh-ancestor
6420306|NCT00288782|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6420307|NCT00288873|Cholecalciferol|cholecalciferol|mesh-list
6420308|NCT00288873|Ergocalciferols|ergocalciferols|mesh-list
6420309|NCT00288873|Vitamin D|vitamin d|mesh-list
6420310|NCT00288873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6420311|NCT00288873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420312|NCT00288873|Vitamins|vitamins|mesh-ancestor
6420313|NCT00288873|Micronutrients|micronutrients|mesh-ancestor
6420314|NCT00288873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6420315|NCT00288951|Travoprost|travoprost|mesh-list
6420316|NCT00288951|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6420317|NCT00289042|Enoxaparin|enoxaparin|mesh-list
6420318|NCT00289042|Anticoagulants|anticoagulants|mesh-ancestor
6420319|NCT00289042|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6420320|NCT00289042|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6420321|NCT00289042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460270|NCT00449280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460271|NCT00449319|Daunorubicin|daunorubicin|mesh-list
6460272|NCT00449319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6460273|NCT00449319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6460274|NCT00449319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6460275|NCT00449319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6460276|NCT00449319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6460277|NCT00449319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420322|NCT00289250|Artesunate|artesunate|mesh-list
6420323|NCT00289250|Pyrimethamine|pyrimethamine|mesh-list
6420324|NCT00289250|Sulfadoxine|sulfadoxine|mesh-list
6420325|NCT00289250|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6420326|NCT00289250|Antimalarials|antimalarials|mesh-ancestor
6420327|NCT00289250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6420328|NCT00289250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6420329|NCT00289250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6420330|NCT00289250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6420331|NCT00289250|Antiviral Agents|antiviral agents|mesh-ancestor
6420332|NCT00289250|Schistosomicides|schistosomicides|mesh-ancestor
6420333|NCT00289250|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6420334|NCT00289250|Anthelmintics|anthelmintics|mesh-ancestor
6420335|NCT00289250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6420336|NCT00289250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6420337|NCT00289250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420338|NCT00289250|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6420339|NCT00289250|Renal Agents|renal agents|mesh-ancestor
6420340|NCT00289263|Paclitaxel|paclitaxel|mesh-list
6420341|NCT00289263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6420342|NCT00289263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6420343|NCT00289263|Tubulin Modulators|tubulin modulators|mesh-ancestor
6420344|NCT00289263|Antimitotic Agents|antimitotic agents|mesh-ancestor
6420345|NCT00289263|Mitosis Modulators|mitosis modulators|mesh-ancestor
6420346|NCT00289263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420347|NCT00289354|Chromium|chromium|mesh-list
6420348|NCT00289354|Biotin|biotin|mesh-list
6420349|NCT00289354|Picolinic acid|picolinic acid|mesh-list
6420350|NCT00289354|Trace Elements|trace elements|mesh-ancestor
6420351|NCT00289354|Micronutrients|micronutrients|mesh-ancestor
6420352|NCT00289354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420353|NCT00289354|Vitamin B Complex|vitamin b complex|mesh-ancestor
6420354|NCT00289354|Vitamins|vitamins|mesh-ancestor
6420355|NCT00289354|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6420356|NCT00289354|Chelating Agents|chelating agents|mesh-ancestor
6420357|NCT00289354|Sequestering Agents|sequestering agents|mesh-ancestor
6420358|NCT00289354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420359|NCT00289406|Amlodipine|amlodipine|mesh-list
6420360|NCT00289406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6420361|NCT00289406|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6420362|NCT00289406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6420363|NCT00289406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420364|NCT00289406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6420365|NCT00289406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420366|NCT00289406|Vasodilator Agents|vasodilator agents|mesh-ancestor
6420367|NCT00289419|Ketorolac|ketorolac|mesh-list
6420368|NCT00289419|Epinephrine|epinephrine|mesh-list
6420369|NCT00289419|Racepinephrine|racepinephrine|mesh-list
6420370|NCT00289419|Morphine|morphine|mesh-list
6420371|NCT00289419|Ropivacaine|ropivacaine|mesh-list
6420372|NCT00289419|Epinephryl borate|epinephryl borate|mesh-list
6420373|NCT00289419|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6420374|NCT00289419|Narcotics|narcotics|mesh-ancestor
6420375|NCT00289419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6420376|NCT00289419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420377|NCT00289419|Analgesics|analgesics|mesh-ancestor
6420378|NCT00289419|Sensory System Agents|sensory system agents|mesh-ancestor
6420379|NCT00289419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6420380|NCT00289419|Anesthetics, Local|anesthetics, local|mesh-ancestor
6420381|NCT00289419|Anesthetics|anesthetics|mesh-ancestor
6420382|NCT00289419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6420383|NCT00289419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6420384|NCT00289419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6420385|NCT00289419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6420386|NCT00289419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6420387|NCT00289419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6420388|NCT00289419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420389|NCT00289419|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6420390|NCT00289419|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6420391|NCT00289419|Adrenergic Agents|adrenergic agents|mesh-ancestor
6420392|NCT00289419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6420393|NCT00289419|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6420394|NCT00289419|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6420395|NCT00289419|Autonomic Agents|autonomic agents|mesh-ancestor
6420396|NCT00289419|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6420397|NCT00289419|Respiratory System Agents|respiratory system agents|mesh-ancestor
6420398|NCT00289419|Mydriatics|mydriatics|mesh-ancestor
6420399|NCT00289419|Sympathomimetics|sympathomimetics|mesh-ancestor
6420400|NCT00289419|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6420401|NCT00289445|Leucovorin|leucovorin|mesh-list
6420402|NCT00289445|Folic Acid|folic acid|mesh-list
6420403|NCT00289445|Mitomycins|mitomycins|mesh-list
6420404|NCT00289445|Mitomycin|mitomycin|mesh-list
6420405|NCT00289445|Levoleucovorin|levoleucovorin|mesh-list
6420406|NCT00289445|Antidotes|antidotes|mesh-ancestor
6420407|NCT00289445|Protective Agents|protective agents|mesh-ancestor
6420408|NCT00289445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420409|NCT00289445|Vitamin B Complex|vitamin b complex|mesh-ancestor
6420410|NCT00289445|Vitamins|vitamins|mesh-ancestor
6420411|NCT00289445|Micronutrients|micronutrients|mesh-ancestor
6420412|NCT00289445|Hematinics|hematinics|mesh-ancestor
6420413|NCT00289445|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6420414|NCT00289445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6420415|NCT00289445|Alkylating Agents|alkylating agents|mesh-ancestor
6420416|NCT00289445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420417|NCT00289445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6420418|NCT00289445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6420419|NCT00289510|Vaccines|vaccines|mesh-list
6420420|NCT00289510|Immunologic Factors|immunologic factors|mesh-ancestor
6420421|NCT00289510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420422|NCT00289588|Mupirocin|mupirocin|mesh-list
6420423|NCT00289588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6420424|NCT00289588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6420425|NCT00289588|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6420426|NCT00289588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6420427|NCT00289588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420428|NCT00289601|Eptifibatide|eptifibatide|mesh-list
6420429|NCT00289601|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6420430|NCT00289627|Ipilimumab|ipilimumab|mesh-list
6420431|NCT00289627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6420432|NCT00289627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6420433|NCT00289627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6420434|NCT00289627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420435|NCT00289809|Ifosfamide|ifosfamide|mesh-list
6420436|NCT00289809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6420437|NCT00289809|Alkylating Agents|alkylating agents|mesh-ancestor
6420438|NCT00289809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420439|NCT00289809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6420440|NCT00289835|Paclitaxel|paclitaxel|mesh-list
6420441|NCT00289835|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6420442|NCT00289835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6420443|NCT00289835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6420444|NCT00289835|Tubulin Modulators|tubulin modulators|mesh-ancestor
6420445|NCT00289835|Antimitotic Agents|antimitotic agents|mesh-ancestor
6420446|NCT00289835|Mitosis Modulators|mitosis modulators|mesh-ancestor
6420447|NCT00289835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420448|NCT00289861|Risperidone|risperidone|mesh-list
6420449|NCT00289861|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6420450|NCT00289861|Serotonin Agents|serotonin agents|mesh-ancestor
6420451|NCT00289861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6420452|NCT00289861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420453|NCT00289861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420454|NCT00289861|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6420455|NCT00289861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6420456|NCT00289861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6420457|NCT00289861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6420458|NCT00289861|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6420459|NCT00289861|Dopamine Agents|dopamine agents|mesh-ancestor
6420460|NCT00289926|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
6420461|NCT00289926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6420462|NCT00289926|Immunologic Factors|immunologic factors|mesh-ancestor
6420463|NCT00289926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420464|NCT00289952|Valproic Acid|valproic acid|mesh-list
6420465|NCT00289952|Anticonvulsants|anticonvulsants|mesh-ancestor
6420466|NCT00289952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6420467|NCT00289952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420468|NCT00289952|GABA Agents|gaba agents|mesh-ancestor
6420469|NCT00289952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6420470|NCT00289952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420471|NCT00289952|Antimanic Agents|antimanic agents|mesh-ancestor
6420472|NCT00289952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6420473|NCT00289952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6420474|NCT00289952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6420475|NCT00290004|Motexafin gadolinium|motexafin gadolinium|mesh-list
6420476|NCT00290004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6420477|NCT00290004|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6420478|NCT00290004|Dermatologic Agents|dermatologic agents|mesh-ancestor
6420479|NCT00290017|Pemetrexed|pemetrexed|mesh-list
6420480|NCT00290017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6420481|NCT00290017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6420482|NCT00290017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420483|NCT00290017|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6420484|NCT00290017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6420485|NCT00290030|Alfuzosin|alfuzosin|mesh-list
6420486|NCT00290030|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6420487|NCT00290030|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6420488|NCT00290030|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6420489|NCT00290030|Adrenergic Agents|adrenergic agents|mesh-ancestor
6420490|NCT00290030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6420491|NCT00290030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420492|NCT00290030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420493|NCT00290030|Urological Agents|urological agents|mesh-ancestor
6420494|NCT00290043|Insulin glulisine|insulin glulisine|mesh-list
6420495|NCT00290043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6420496|NCT00290043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420497|NCT00290069|Sirolimus|sirolimus|mesh-list
6420498|NCT00290069|Tacrolimus|tacrolimus|mesh-list
6420499|NCT00290069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6420500|NCT00290069|Immunologic Factors|immunologic factors|mesh-ancestor
6420501|NCT00290069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420502|NCT00290069|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6420503|NCT00290069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6420504|NCT00290069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420505|NCT00290069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6420506|NCT00290069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6420507|NCT00290069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6420508|NCT00290069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6420509|NCT00290069|Antifungal Agents|antifungal agents|mesh-ancestor
6420510|NCT00290082|Midazolam|midazolam|mesh-list
6420511|NCT00290082|Loxapine|loxapine|mesh-list
6420512|NCT00290082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6420513|NCT00290082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6420514|NCT00290082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6420515|NCT00290082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420516|NCT00290082|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6420517|NCT00290082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6420518|NCT00290082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6420519|NCT00290082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6420520|NCT00290082|Anesthetics, General|anesthetics, general|mesh-ancestor
6420521|NCT00290082|Anesthetics|anesthetics|mesh-ancestor
6420522|NCT00290082|GABA Modulators|gaba modulators|mesh-ancestor
6420523|NCT00290082|GABA Agents|gaba agents|mesh-ancestor
6420524|NCT00290082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6420525|NCT00290082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420526|NCT00290082|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6420527|NCT00290082|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6420528|NCT00290082|Dopamine Agents|dopamine agents|mesh-ancestor
6420529|NCT00290108|Propofol|propofol|mesh-list
6420530|NCT00290108|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6420531|NCT00290108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6420532|NCT00290108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420533|NCT00290108|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6420534|NCT00290108|Anesthetics, General|anesthetics, general|mesh-ancestor
6420535|NCT00290108|Anesthetics|anesthetics|mesh-ancestor
6420536|NCT00290121|Olanzapine|olanzapine|mesh-list
6420537|NCT00290121|Antiemetics|antiemetics|mesh-ancestor
6420538|NCT00290121|Autonomic Agents|autonomic agents|mesh-ancestor
6420539|NCT00290121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6460278|NCT00449397|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6420540|NCT00290121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420541|NCT00290121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6420542|NCT00290121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6420543|NCT00290121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6420544|NCT00290121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6420545|NCT00290121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6420546|NCT00290121|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6420547|NCT00290121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6420548|NCT00290121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6420549|NCT00290121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420550|NCT00290121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6420551|NCT00290121|Serotonin Agents|serotonin agents|mesh-ancestor
6420552|NCT00290173|Ritodrine|ritodrine|mesh-list
6420553|NCT00290173|Sympathomimetics|sympathomimetics|mesh-ancestor
6420554|NCT00290173|Autonomic Agents|autonomic agents|mesh-ancestor
6420555|NCT00290173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6420556|NCT00290173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420557|NCT00290173|Tocolytic Agents|tocolytic agents|mesh-ancestor
6420558|NCT00290173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6420559|NCT00290173|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6420560|NCT00290173|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6420561|NCT00290173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6420562|NCT00290173|Adrenergic Agents|adrenergic agents|mesh-ancestor
6420563|NCT00290173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6420564|NCT00290173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420565|NCT00290264|Budesonide|budesonide|mesh-list
6420566|NCT00290264|Formoterol Fumarate|formoterol fumarate|mesh-list
6420567|NCT00290264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6420568|NCT00290264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6420569|NCT00290264|Autonomic Agents|autonomic agents|mesh-ancestor
6420570|NCT00290264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6420571|NCT00290264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420572|NCT00290264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6420573|NCT00290264|Respiratory System Agents|respiratory system agents|mesh-ancestor
6420574|NCT00290264|Glucocorticoids|glucocorticoids|mesh-ancestor
6420575|NCT00290264|Hormones|hormones|mesh-ancestor
6420576|NCT00290264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6420577|NCT00290264|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6420578|NCT00290264|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6420579|NCT00290264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6420580|NCT00290264|Adrenergic Agents|adrenergic agents|mesh-ancestor
6420581|NCT00290264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6420582|NCT00290264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420583|NCT00290394|Rosiglitazone|rosiglitazone|mesh-list
6420584|NCT00290394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6420585|NCT00290394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420586|NCT00290420|Chloroquine|chloroquine|mesh-list
6420587|NCT00290420|Amebicides|amebicides|mesh-ancestor
6420588|NCT00290420|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6420589|NCT00290420|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6420590|NCT00290420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6420591|NCT00290420|Antimalarials|antimalarials|mesh-ancestor
6420592|NCT00290420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6420593|NCT00290485|Imatinib Mesylate|imatinib mesylate|mesh-list
6420594|NCT00290485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6420595|NCT00290485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6420596|NCT00290485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6420597|NCT00290485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420598|NCT00290511|Vidarabine|vidarabine|mesh-list
6420599|NCT00290511|Dexamethasone|dexamethasone|mesh-list
6420600|NCT00290511|Rituximab|rituximab|mesh-list
6420601|NCT00290511|Fludarabine|fludarabine|mesh-list
6420602|NCT00290511|Fludarabine phosphate|fludarabine phosphate|mesh-list
6420603|NCT00290511|Mitoxantrone|mitoxantrone|mesh-list
6420604|NCT00290511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6420605|NCT00290511|Antiemetics|antiemetics|mesh-ancestor
6420606|NCT00290511|Autonomic Agents|autonomic agents|mesh-ancestor
6420607|NCT00290511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6420608|NCT00290511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420609|NCT00290511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6420610|NCT00290511|Glucocorticoids|glucocorticoids|mesh-ancestor
6420611|NCT00290511|Hormones|hormones|mesh-ancestor
6420612|NCT00290511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6420613|NCT00290511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6420614|NCT00290511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6420615|NCT00290511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6420616|NCT00290511|Immunologic Factors|immunologic factors|mesh-ancestor
6420617|NCT00290511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6420618|NCT00290511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6420619|NCT00290511|Antimetabolites|antimetabolites|mesh-ancestor
6420620|NCT00290511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420621|NCT00290511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6420622|NCT00290511|Antiviral Agents|antiviral agents|mesh-ancestor
6019071|NCT00384449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019072|NCT00384449|Growth Inhibitors|growth inhibitors|mesh-ancestor
6019073|NCT00384449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6019074|NCT00384670|Vaccines|vaccines|mesh-list
6019075|NCT00384670|Immunologic Factors|immunologic factors|mesh-ancestor
6019076|NCT00384670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019077|NCT00384774|Lasmiditan|lasmiditan|mesh-list
6019078|NCT00384774|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6019079|NCT00384774|Serotonin Agents|serotonin agents|mesh-ancestor
6420623|NCT00290511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6420624|NCT00290511|Analgesics|analgesics|mesh-ancestor
6420625|NCT00290511|Sensory System Agents|sensory system agents|mesh-ancestor
6420626|NCT00290511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6420627|NCT00290511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6420628|NCT00290511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6420629|NCT00290602|Methylprednisolone|methylprednisolone|mesh-list
6420630|NCT00290602|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6420631|NCT00290602|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6420632|NCT00290602|Prednisolone|prednisolone|mesh-list
6420633|NCT00290602|Prednisolone acetate|prednisolone acetate|mesh-list
6420634|NCT00290602|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6420635|NCT00290602|Prednisolone phosphate|prednisolone phosphate|mesh-list
6420636|NCT00290602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6420637|NCT00290602|Antiemetics|antiemetics|mesh-ancestor
6420638|NCT00290602|Autonomic Agents|autonomic agents|mesh-ancestor
6420639|NCT00290602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6420640|NCT00290602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420641|NCT00290602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6420642|NCT00290602|Glucocorticoids|glucocorticoids|mesh-ancestor
6420643|NCT00290602|Hormones|hormones|mesh-ancestor
6420644|NCT00290602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6420645|NCT00290602|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6420646|NCT00290602|Protective Agents|protective agents|mesh-ancestor
6420647|NCT00290602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6420648|NCT00290602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6420649|NCT00290628|Cyclosporine|cyclosporine|mesh-list
6420650|NCT00290628|Mycophenolic Acid|mycophenolic acid|mesh-list
6420651|NCT00290628|Methylprednisolone|methylprednisolone|mesh-list
6420652|NCT00290628|Cyclophosphamide|cyclophosphamide|mesh-list
6420653|NCT00290628|Melphalan|melphalan|mesh-list
6420654|NCT00290628|Busulfan|busulfan|mesh-list
6420655|NCT00290628|Cyclosporins|cyclosporins|mesh-list
6420656|NCT00290628|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6420657|NCT00290628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6420658|NCT00290628|Immunologic Factors|immunologic factors|mesh-ancestor
6420659|NCT00290628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420660|NCT00290628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6420661|NCT00290628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6420662|NCT00290628|Alkylating Agents|alkylating agents|mesh-ancestor
6420663|NCT00290628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420664|NCT00290628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6420665|NCT00290628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6420666|NCT00290628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6420667|NCT00290628|Antifungal Agents|antifungal agents|mesh-ancestor
6420668|NCT00290628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6420669|NCT00290628|Dermatologic Agents|dermatologic agents|mesh-ancestor
6420670|NCT00290628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6420671|NCT00290628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6420672|NCT00290628|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6420673|NCT00290628|Antitubercular Agents|antitubercular agents|mesh-ancestor
6420674|NCT00290628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6420675|NCT00290628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6420676|NCT00290628|Antiemetics|antiemetics|mesh-ancestor
6420677|NCT00290628|Autonomic Agents|autonomic agents|mesh-ancestor
6420678|NCT00290628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6019080|NCT00384774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6053209|NCT00593606|Dopamine Agonists|dopamine agonists|mesh-ancestor
6420679|NCT00290628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6420680|NCT00290628|Glucocorticoids|glucocorticoids|mesh-ancestor
6420681|NCT00290628|Hormones|hormones|mesh-ancestor
6460279|NCT00449397|Antidepressive Agents|antidepressive agents|mesh-ancestor
6420682|NCT00290628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6420683|NCT00290628|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6420684|NCT00290628|Protective Agents|protective agents|mesh-ancestor
6420685|NCT00290641|Cyclosporine|cyclosporine|mesh-list
6420686|NCT00290641|Mycophenolic Acid|mycophenolic acid|mesh-list
6420687|NCT00290641|Cyclophosphamide|cyclophosphamide|mesh-list
6420688|NCT00290641|Fludarabine|fludarabine|mesh-list
6420689|NCT00290641|Fludarabine phosphate|fludarabine phosphate|mesh-list
6420690|NCT00290641|Cyclosporins|cyclosporins|mesh-list
6420691|NCT00290641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6420692|NCT00290641|Immunologic Factors|immunologic factors|mesh-ancestor
6420693|NCT00290641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420694|NCT00290641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6420695|NCT00290641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6420696|NCT00290641|Alkylating Agents|alkylating agents|mesh-ancestor
6420697|NCT00290641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420698|NCT00290641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6420699|NCT00290641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6420700|NCT00290641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6420701|NCT00290641|Antimetabolites|antimetabolites|mesh-ancestor
6420702|NCT00290641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6420703|NCT00290641|Antifungal Agents|antifungal agents|mesh-ancestor
6420704|NCT00290641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6420705|NCT00290641|Dermatologic Agents|dermatologic agents|mesh-ancestor
6420706|NCT00290641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6420707|NCT00290641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6420708|NCT00290641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6420709|NCT00290641|Antitubercular Agents|antitubercular agents|mesh-ancestor
6420710|NCT00290641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6420711|NCT00290667|Prednisone|prednisone|mesh-list
6420712|NCT00290667|Cyclophosphamide|cyclophosphamide|mesh-list
6420713|NCT00290667|Rituximab|rituximab|mesh-list
6420714|NCT00290667|Doxorubicin|doxorubicin|mesh-list
6420715|NCT00290667|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6420716|NCT00290667|Vincristine|vincristine|mesh-list
6420717|NCT00290667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6420718|NCT00290667|Immunologic Factors|immunologic factors|mesh-ancestor
6420719|NCT00290667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420720|NCT00290667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6420721|NCT00290667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6420722|NCT00290667|Alkylating Agents|alkylating agents|mesh-ancestor
6420723|NCT00290667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420724|NCT00290667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6420725|NCT00290667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6420726|NCT00290667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6420727|NCT00290667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6420728|NCT00290667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6420729|NCT00290667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6420730|NCT00290667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6420731|NCT00290667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6420732|NCT00290667|Glucocorticoids|glucocorticoids|mesh-ancestor
6420733|NCT00290667|Hormones|hormones|mesh-ancestor
6420734|NCT00290667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6420735|NCT00290667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6420736|NCT00290667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6420737|NCT00290667|Tubulin Modulators|tubulin modulators|mesh-ancestor
6420738|NCT00290667|Antimitotic Agents|antimitotic agents|mesh-ancestor
6420739|NCT00290667|Mitosis Modulators|mitosis modulators|mesh-ancestor
6420740|NCT00290680|Celecoxib|celecoxib|mesh-list
6420741|NCT00290680|Bortezomib|bortezomib|mesh-list
6420742|NCT00290680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6420743|NCT00290680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6420744|NCT00290680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6420745|NCT00290680|Analgesics|analgesics|mesh-ancestor
6420746|NCT00290680|Sensory System Agents|sensory system agents|mesh-ancestor
6420747|NCT00290680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6420748|NCT00290680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420749|NCT00290680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6420750|NCT00290680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6420751|NCT00290680|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6420752|NCT00290680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6420753|NCT00290680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6420754|NCT00290680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420755|NCT00290719|Irinotecan|irinotecan|mesh-list
6420756|NCT00290719|Gefitinib|gefitinib|mesh-list
6420757|NCT00290719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6420758|NCT00290719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6420759|NCT00290719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6420760|NCT00290719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6420761|NCT00290719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420762|NCT00290719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6420763|NCT00290758|Genistein|genistein|mesh-list
6420764|NCT00290758|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6420765|NCT00290758|Protective Agents|protective agents|mesh-ancestor
6420766|NCT00290758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420767|NCT00290758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6420768|NCT00290758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6420769|NCT00290758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6420770|NCT00290758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420771|NCT00290758|Phytoestrogens|phytoestrogens|mesh-ancestor
6420772|NCT00290758|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6420773|NCT00290758|Estrogens|estrogens|mesh-ancestor
6420774|NCT00290758|Hormones|hormones|mesh-ancestor
6420775|NCT00290758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6420776|NCT00290823|Albendazole|albendazole|mesh-list
6420777|NCT00290823|Dexamethasone|dexamethasone|mesh-list
6420778|NCT00290823|Omeprazole|omeprazole|mesh-list
6420779|NCT00290823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6420780|NCT00290823|Antiemetics|antiemetics|mesh-ancestor
6420781|NCT00290823|Autonomic Agents|autonomic agents|mesh-ancestor
6420782|NCT00290823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6420783|NCT00290823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420784|NCT00290823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6420785|NCT00290823|Glucocorticoids|glucocorticoids|mesh-ancestor
6420786|NCT00290823|Hormones|hormones|mesh-ancestor
6420787|NCT00290823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6420788|NCT00290823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6420789|NCT00290823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6420790|NCT00290823|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6420791|NCT00290823|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6420792|NCT00290823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6420793|NCT00290823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420794|NCT00290823|Anthelmintics|anthelmintics|mesh-ancestor
6420795|NCT00290823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6420796|NCT00290823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6420797|NCT00290823|Anticestodal Agents|anticestodal agents|mesh-ancestor
6420798|NCT00290823|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6420799|NCT00290823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6420800|NCT00290823|Tubulin Modulators|tubulin modulators|mesh-ancestor
6420801|NCT00290823|Antimitotic Agents|antimitotic agents|mesh-ancestor
6420802|NCT00290823|Mitosis Modulators|mitosis modulators|mesh-ancestor
6420803|NCT00290836|Thrombin|thrombin|mesh-list
6420804|NCT00290836|Aprotinin|aprotinin|mesh-list
6420805|NCT00290836|Hemostatics|hemostatics|mesh-ancestor
6420806|NCT00290836|Coagulants|coagulants|mesh-ancestor
6420807|NCT00290836|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6420808|NCT00290836|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6420809|NCT00290836|Protease Inhibitors|protease inhibitors|mesh-ancestor
6420810|NCT00290836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6420811|NCT00290836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420812|NCT00290849|Bivalirudin|bivalirudin|mesh-list
6420813|NCT00290849|Antithrombins|antithrombins|mesh-ancestor
6420814|NCT00290849|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6420815|NCT00290849|Protease Inhibitors|protease inhibitors|mesh-ancestor
6420816|NCT00290849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6460280|NCT00449397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6420817|NCT00290849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420818|NCT00290849|Anticoagulants|anticoagulants|mesh-ancestor
6420819|NCT00290901|Celecoxib|celecoxib|mesh-list
6420820|NCT00290901|Tramadol|tramadol|mesh-list
6420821|NCT00290901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6420822|NCT00290901|Narcotics|narcotics|mesh-ancestor
6420823|NCT00290901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6420824|NCT00290901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420825|NCT00290901|Analgesics|analgesics|mesh-ancestor
6420826|NCT00290901|Sensory System Agents|sensory system agents|mesh-ancestor
6420827|NCT00290901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6420828|NCT00290901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6420829|NCT00290901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6420830|NCT00290901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6420831|NCT00290901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6420832|NCT00290901|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6420833|NCT00290901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6420834|NCT00290901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6420835|NCT00290901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420836|NCT00290914|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
6420837|NCT00290914|Antidepressive Agents|antidepressive agents|mesh-ancestor
6420838|NCT00290914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6420839|NCT00290914|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6420840|NCT00290914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6420841|NCT00290914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6420842|NCT00290914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420843|NCT00290914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6420844|NCT00290914|Serotonin Agents|serotonin agents|mesh-ancestor
6420845|NCT00290914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420846|NCT00290914|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6420847|NCT00290914|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6420848|NCT00290927|Insulin glulisine|insulin glulisine|mesh-list
6420849|NCT00290927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6420850|NCT00290927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420851|NCT00290940|Metformin|metformin|mesh-list
6420852|NCT00290940|Pioglitazone|pioglitazone|mesh-list
6420853|NCT00290940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6420854|NCT00290940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420855|NCT00290979|Insulin glulisine|insulin glulisine|mesh-list
6420856|NCT00290979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6420857|NCT00290979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420858|NCT00290992|Rasburicase|rasburicase|mesh-list
6420859|NCT00290992|Gout Suppressants|gout suppressants|mesh-ancestor
6420860|NCT00290992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6420861|NCT00291005|Docetaxel|docetaxel|mesh-list
6420862|NCT00291005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6420863|NCT00291005|Tubulin Modulators|tubulin modulators|mesh-ancestor
6420864|NCT00291005|Antimitotic Agents|antimitotic agents|mesh-ancestor
6420865|NCT00291005|Mitosis Modulators|mitosis modulators|mesh-ancestor
6420866|NCT00291005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420867|NCT00291109|Letrozole|letrozole|mesh-list
6420868|NCT00291109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6420869|NCT00291109|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6019081|NCT00384774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019082|NCT00384774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019083|NCT00384839|Azacitidine|azacitidine|mesh-list
6019084|NCT00384839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6019085|NCT00384839|Antimetabolites|antimetabolites|mesh-ancestor
6019086|NCT00384839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019087|NCT00384839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6019088|NCT00384839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6420870|NCT00291109|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6420871|NCT00291109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6420872|NCT00291109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420873|NCT00291109|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6420874|NCT00291109|Hormone Antagonists|hormone antagonists|mesh-ancestor
6420875|NCT00291109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6420876|NCT00291109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420877|NCT00291122|Celecoxib|celecoxib|mesh-list
6420878|NCT00291122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6420879|NCT00291122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6420880|NCT00291122|Analgesics|analgesics|mesh-ancestor
6420881|NCT00291122|Sensory System Agents|sensory system agents|mesh-ancestor
6420882|NCT00291122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6420883|NCT00291122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420884|NCT00291122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6420885|NCT00291122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6420886|NCT00291122|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6420887|NCT00291122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6420888|NCT00291122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6420889|NCT00291122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420890|NCT00291148|Pregabalin|pregabalin|mesh-list
6420891|NCT00291148|Paroxetine|paroxetine|mesh-list
6420892|NCT00291148|Analgesics|analgesics|mesh-ancestor
6420893|NCT00291148|Sensory System Agents|sensory system agents|mesh-ancestor
5501303|NCT04475991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501304|NCT04475991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5501305|NCT04475991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5501306|NCT04475991|Antiviral Agents|antiviral agents|mesh-ancestor
5501307|NCT04475991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5501308|NCT04475991|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
5501309|NCT04475276|Thioctic Acid|thioctic acid|mesh-list
5501310|NCT04475276|Antioxidants|antioxidants|mesh-ancestor
5501311|NCT04475276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501312|NCT04475276|Protective Agents|protective agents|mesh-ancestor
5501313|NCT04475276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501314|NCT04475276|Vitamin B Complex|vitamin b complex|mesh-ancestor
5501315|NCT04475276|Vitamins|vitamins|mesh-ancestor
5501316|NCT04475276|Micronutrients|micronutrients|mesh-ancestor
6420894|NCT00291148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5501317|NCT04475302|BCG Vaccine|bcg vaccine|mesh-list
6420895|NCT00291148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420896|NCT00291148|Anticonvulsants|anticonvulsants|mesh-ancestor
6420897|NCT00291148|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6420898|NCT00291148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6420899|NCT00291148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420900|NCT00291148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6420901|NCT00291148|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6420902|NCT00291148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6420903|NCT00291148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6420904|NCT00291148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6420905|NCT00291148|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6420906|NCT00291148|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6420907|NCT00291148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6420908|NCT00291148|Serotonin Agents|serotonin agents|mesh-ancestor
6420909|NCT00291148|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6420910|NCT00291148|Antidepressive Agents|antidepressive agents|mesh-ancestor
6420911|NCT00291148|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6420912|NCT00291148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6420913|NCT00291148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6460281|NCT00449397|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6460282|NCT00449397|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6460283|NCT00449397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6460284|NCT00449397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460285|NCT00449410|Atorvastatin|atorvastatin|mesh-list
6460286|NCT00449410|Ezetimibe|ezetimibe|mesh-list
6460287|NCT00449410|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6460288|NCT00449410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6460289|NCT00449410|Antimetabolites|antimetabolites|mesh-ancestor
6460290|NCT00449410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460291|NCT00449410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6460292|NCT00449410|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6460293|NCT00449410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6460294|NCT00449423|Acipimox|acipimox|mesh-list
6460295|NCT00449423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6460296|NCT00449423|Antimetabolites|antimetabolites|mesh-ancestor
6460297|NCT00449423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460298|NCT00449423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5501318|NCT04475302|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6420914|NCT00291213|Levetiracetam|levetiracetam|mesh-list
6420915|NCT00291213|Anticonvulsants|anticonvulsants|mesh-ancestor
6420916|NCT00291213|Nootropic Agents|nootropic agents|mesh-ancestor
6420917|NCT00291369|Interferons|interferons|mesh-list
6420918|NCT00291369|Interferon-alpha|interferon-alpha|mesh-list
6420919|NCT00291369|Interleukin-2|interleukin-2|mesh-list
6420920|NCT00291369|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6420921|NCT00291369|Medroxyprogesterone|medroxyprogesterone|mesh-list
6420922|NCT00291369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6420923|NCT00291369|Antiviral Agents|antiviral agents|mesh-ancestor
6420924|NCT00291369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6420925|NCT00291369|Immunologic Factors|immunologic factors|mesh-ancestor
6420926|NCT00291369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420927|NCT00291369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6420928|NCT00291369|Analgesics|analgesics|mesh-ancestor
6420929|NCT00291369|Sensory System Agents|sensory system agents|mesh-ancestor
6420930|NCT00291369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6420931|NCT00291369|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6420932|NCT00291369|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6420933|NCT00291369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6420934|NCT00291369|Contraceptive Agents|contraceptive agents|mesh-ancestor
6420935|NCT00291369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6420936|NCT00291369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6420937|NCT00291369|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6420938|NCT00291369|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6420939|NCT00291369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6420940|NCT00291382|Fluticasone|fluticasone|mesh-list
6420941|NCT00291382|Xhance|xhance|mesh-list
6420942|NCT00291382|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6420943|NCT00291382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6420944|NCT00291382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6420945|NCT00291382|Autonomic Agents|autonomic agents|mesh-ancestor
6420946|NCT00291382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6420947|NCT00291382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420948|NCT00291382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6420949|NCT00291382|Respiratory System Agents|respiratory system agents|mesh-ancestor
6420950|NCT00291382|Dermatologic Agents|dermatologic agents|mesh-ancestor
6420951|NCT00291382|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6420952|NCT00291382|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6420953|NCT00291382|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6420954|NCT00291382|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6420955|NCT00291382|Adrenergic Agents|adrenergic agents|mesh-ancestor
6420956|NCT00291382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6420957|NCT00291382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420958|NCT00291408|Nitric Oxide|nitric oxide|mesh-list
6420959|NCT00291408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6420960|NCT00291408|Autonomic Agents|autonomic agents|mesh-ancestor
6420961|NCT00291408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6420962|NCT00291408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420963|NCT00291408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6420964|NCT00291408|Respiratory System Agents|respiratory system agents|mesh-ancestor
6420965|NCT00291408|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6420966|NCT00291408|Antioxidants|antioxidants|mesh-ancestor
6420967|NCT00291408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420968|NCT00291408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6420969|NCT00291408|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6420970|NCT00291408|Vasodilator Agents|vasodilator agents|mesh-ancestor
6420971|NCT00291408|Gasotransmitters|gasotransmitters|mesh-ancestor
6420972|NCT00291408|Protective Agents|protective agents|mesh-ancestor
6420973|NCT00291525|Warfarin|warfarin|mesh-list
6420974|NCT00291525|Anticoagulants|anticoagulants|mesh-ancestor
6420975|NCT00291538|Bortezomib|bortezomib|mesh-list
6420976|NCT00291538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6420977|NCT00291616|Interferons|interferons|mesh-list
6420978|NCT00291616|Interferon-alpha|interferon-alpha|mesh-list
6420979|NCT00291616|Interferon alpha-2|interferon alpha-2|mesh-list
6420980|NCT00291616|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6420981|NCT00291616|Thymalfasin|thymalfasin|mesh-list
6420982|NCT00291616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6420983|NCT00291616|Antiviral Agents|antiviral agents|mesh-ancestor
6420984|NCT00291616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6420985|NCT00291616|Immunologic Factors|immunologic factors|mesh-ancestor
6420986|NCT00291616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6420987|NCT00291616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6420988|NCT00291707|Pemetrexed|pemetrexed|mesh-list
6420989|NCT00291707|Cetuximab|cetuximab|mesh-list
6420990|NCT00291707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6420991|NCT00291707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6420992|NCT00291707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6420993|NCT00291707|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6420994|NCT00291707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6420995|NCT00291707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6420996|NCT00291720|Spironolactone|spironolactone|mesh-list
6420997|NCT00291720|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6420998|NCT00291720|Hormone Antagonists|hormone antagonists|mesh-ancestor
6420999|NCT00291720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6421000|NCT00291720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421001|NCT00291720|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6421002|NCT00291720|Diuretics|diuretics|mesh-ancestor
6421003|NCT00291720|Natriuretic Agents|natriuretic agents|mesh-ancestor
6421004|NCT00291733|Levetiracetam|levetiracetam|mesh-list
6421005|NCT00291733|Anticonvulsants|anticonvulsants|mesh-ancestor
6421006|NCT00291733|Nootropic Agents|nootropic agents|mesh-ancestor
6421007|NCT00291746|Esomeprazole|esomeprazole|mesh-list
6421008|NCT00291746|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6421009|NCT00291746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6421010|NCT00291746|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6421011|NCT00291746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6421012|NCT00291746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421013|NCT00291759|Tamoxifen|tamoxifen|mesh-list
6421014|NCT00291759|Anastrozole|anastrozole|mesh-list
6421015|NCT00291759|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6421016|NCT00291759|Hormone Antagonists|hormone antagonists|mesh-ancestor
6421017|NCT00291759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6421018|NCT00291759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421019|NCT00291759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6421020|NCT00291759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6421021|NCT00291759|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6421022|NCT00291759|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6421023|NCT00291759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6421024|NCT00291759|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6421025|NCT00291759|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6421026|NCT00291759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6421027|NCT00291759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421028|NCT00291772|Pramlintide|pramlintide|mesh-list
6421029|NCT00291772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6421030|NCT00291772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421031|NCT00291785|Leucovorin|leucovorin|mesh-list
6421032|NCT00291785|Folic Acid|folic acid|mesh-list
6421033|NCT00291785|Fluorouracil|fluorouracil|mesh-list
6421034|NCT00291785|Levoleucovorin|levoleucovorin|mesh-list
6421035|NCT00291785|Antimetabolites|antimetabolites|mesh-ancestor
6421036|NCT00291785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421037|NCT00291785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6421038|NCT00291785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6421039|NCT00291785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6421040|NCT00291785|Immunologic Factors|immunologic factors|mesh-ancestor
6421041|NCT00291785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421042|NCT00291785|Antidotes|antidotes|mesh-ancestor
6421043|NCT00291785|Protective Agents|protective agents|mesh-ancestor
6421044|NCT00291785|Vitamin B Complex|vitamin b complex|mesh-ancestor
6421045|NCT00291785|Vitamins|vitamins|mesh-ancestor
6421046|NCT00291785|Micronutrients|micronutrients|mesh-ancestor
6421047|NCT00291785|Hematinics|hematinics|mesh-ancestor
6421048|NCT00291811|Plerixafor|plerixafor|mesh-list
6421049|NCT00291811|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6421050|NCT00291811|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6421051|NCT00291811|Antiviral Agents|antiviral agents|mesh-ancestor
6421052|NCT00291811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6421053|NCT00291850|Paclitaxel|paclitaxel|mesh-list
6421054|NCT00291850|Cisplatin|cisplatin|mesh-list
6421055|NCT00291850|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6421056|NCT00291850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6421057|NCT00291850|Tubulin Modulators|tubulin modulators|mesh-ancestor
6421058|NCT00291850|Antimitotic Agents|antimitotic agents|mesh-ancestor
6421059|NCT00291850|Mitosis Modulators|mitosis modulators|mesh-ancestor
6421060|NCT00291850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421061|NCT00291863|Simvastatin|simvastatin|mesh-list
6421062|NCT00291863|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6421063|NCT00291863|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6421064|NCT00291863|Antimetabolites|antimetabolites|mesh-ancestor
6421065|NCT00291863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421066|NCT00291863|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6421067|NCT00291863|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6421068|NCT00291863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6421069|NCT00291915|Adalimumab|adalimumab|mesh-list
6421070|NCT00291915|Methotrexate|methotrexate|mesh-list
6421071|NCT00291915|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6421072|NCT00291915|Abortifacient Agents|abortifacient agents|mesh-ancestor
6421073|NCT00291915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6421074|NCT00291915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421075|NCT00291915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6421076|NCT00291915|Antimetabolites|antimetabolites|mesh-ancestor
6421077|NCT00291915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421078|NCT00291915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6421079|NCT00291915|Dermatologic Agents|dermatologic agents|mesh-ancestor
6421080|NCT00291915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6421081|NCT00291915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6421082|NCT00291915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6421083|NCT00291915|Immunologic Factors|immunologic factors|mesh-ancestor
6421084|NCT00291915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6421085|NCT00291915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6421086|NCT00291915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6421087|NCT00291980|Vaccines|vaccines|mesh-list
6421088|NCT00291980|Immunologic Factors|immunologic factors|mesh-ancestor
6421089|NCT00291980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421090|NCT00292071|Caspofungin|caspofungin|mesh-list
6421091|NCT00292071|Antifungal Agents|antifungal agents|mesh-ancestor
6421092|NCT00292071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6421093|NCT00292071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6421094|NCT00292071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421095|NCT00292110|Methadone|methadone|mesh-list
6421096|NCT00292110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6421097|NCT00292110|Narcotics|narcotics|mesh-ancestor
6421098|NCT00292110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6421099|NCT00292110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421100|NCT00292110|Analgesics|analgesics|mesh-ancestor
6421101|NCT00292110|Sensory System Agents|sensory system agents|mesh-ancestor
6421102|NCT00292110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6421103|NCT00292110|Antitussive Agents|antitussive agents|mesh-ancestor
6421104|NCT00292110|Respiratory System Agents|respiratory system agents|mesh-ancestor
6421105|NCT00292123|Methadone|methadone|mesh-list
6421106|NCT00292123|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6421107|NCT00292123|Narcotics|narcotics|mesh-ancestor
6421108|NCT00292123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6421109|NCT00292123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421110|NCT00292123|Analgesics|analgesics|mesh-ancestor
6421111|NCT00292123|Sensory System Agents|sensory system agents|mesh-ancestor
6421112|NCT00292123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6421113|NCT00292123|Antitussive Agents|antitussive agents|mesh-ancestor
6421114|NCT00292123|Respiratory System Agents|respiratory system agents|mesh-ancestor
6421115|NCT00292201|Atorvastatin|atorvastatin|mesh-list
6421116|NCT00292201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6421117|NCT00292201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6421118|NCT00292201|Antimetabolites|antimetabolites|mesh-ancestor
6421119|NCT00292201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421120|NCT00292201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6421121|NCT00292201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6421122|NCT00292201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6421123|NCT00292214|Acetaminophen|acetaminophen|mesh-list
6421124|NCT00292214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6421125|NCT00292214|Analgesics|analgesics|mesh-ancestor
6421126|NCT00292214|Sensory System Agents|sensory system agents|mesh-ancestor
6421127|NCT00292214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6421128|NCT00292214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421129|NCT00292214|Antipyretics|antipyretics|mesh-ancestor
6421130|NCT00292253|Interferon beta-1a|interferon beta-1a|mesh-list
6421131|NCT00292253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6421132|NCT00292253|Immunologic Factors|immunologic factors|mesh-ancestor
6421133|NCT00292253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421134|NCT00292253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6421135|NCT00292253|Antiviral Agents|antiviral agents|mesh-ancestor
6421136|NCT00292253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6421137|NCT00292266|Interferon beta-1a|interferon beta-1a|mesh-list
6421138|NCT00292266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6421139|NCT00292266|Immunologic Factors|immunologic factors|mesh-ancestor
6421140|NCT00292266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421141|NCT00292266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6421142|NCT00292266|Antiviral Agents|antiviral agents|mesh-ancestor
6421143|NCT00292266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6421144|NCT00292279|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6421145|NCT00292279|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6421146|NCT00292279|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6421147|NCT00292279|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6421148|NCT00292344|Rifaximin|rifaximin|mesh-list
6421149|NCT00292344|Loperamide|loperamide|mesh-list
6421150|NCT00292344|Antidiarrheals|antidiarrheals|mesh-list
6421151|NCT00292344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6421152|NCT00292344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6421153|NCT00292344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6421154|NCT00292409|Aripiprazole|aripiprazole|mesh-list
6421155|NCT00292409|Antidepressive Agents|antidepressive agents|mesh-ancestor
6421156|NCT00292409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6421157|NCT00292409|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6421158|NCT00292409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6421159|NCT00292409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6421160|NCT00292409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421161|NCT00292409|Dopamine Agonists|dopamine agonists|mesh-ancestor
6421162|NCT00292409|Dopamine Agents|dopamine agents|mesh-ancestor
6421163|NCT00292409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6421164|NCT00292409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421165|NCT00292409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6421166|NCT00292409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6421167|NCT00292409|Serotonin Agents|serotonin agents|mesh-ancestor
6421168|NCT00292409|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6421169|NCT00292409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6421170|NCT00292409|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6421171|NCT00292409|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6421172|NCT00292448|Tiotropium Bromide|tiotropium bromide|mesh-list
6421173|NCT00292448|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6421174|NCT00292448|Autonomic Agents|autonomic agents|mesh-ancestor
6421175|NCT00292448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6421176|NCT00292448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421177|NCT00292448|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6421178|NCT00292448|Respiratory System Agents|respiratory system agents|mesh-ancestor
6421179|NCT00292448|Parasympatholytics|parasympatholytics|mesh-ancestor
6421180|NCT00292448|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6421181|NCT00292448|Cholinergic Agents|cholinergic agents|mesh-ancestor
6421182|NCT00292448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6421183|NCT00292448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421184|NCT00292526|Enalapril|enalapril|mesh-list
6421185|NCT00292526|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6421186|NCT00292526|Protease Inhibitors|protease inhibitors|mesh-ancestor
6421187|NCT00292526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6421188|NCT00292526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421189|NCT00292526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6421190|NCT00292695|Ifosfamide|ifosfamide|mesh-list
6421191|NCT00292695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6421192|NCT00292695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6421193|NCT00292695|Alkylating Agents|alkylating agents|mesh-ancestor
6421194|NCT00292695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421195|NCT00292708|Cefmetazole|cefmetazole|mesh-list
6421196|NCT00292708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6421197|NCT00292708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6421198|NCT00292721|Celecoxib|celecoxib|mesh-list
6421199|NCT00292721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6421200|NCT00292721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6421201|NCT00292721|Analgesics|analgesics|mesh-ancestor
6421202|NCT00292721|Sensory System Agents|sensory system agents|mesh-ancestor
6421203|NCT00292721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6421204|NCT00292721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421205|NCT00292721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6421206|NCT00292721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6421207|NCT00292721|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6421208|NCT00292721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6421209|NCT00292721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6421210|NCT00292721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421211|NCT00292734|Zolpidem|zolpidem|mesh-list
6421212|NCT00292734|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6421213|NCT00292734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6421214|NCT00292734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6421215|NCT00292734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421216|NCT00292734|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6421217|NCT00292734|GABA Agonists|gaba agonists|mesh-ancestor
6421218|NCT00292734|GABA Agents|gaba agents|mesh-ancestor
6421219|NCT00292734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6421220|NCT00292734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421221|NCT00292747|Ibuprofen|ibuprofen|mesh-list
6421222|NCT00292747|Drotaverin|drotaverin|mesh-list
6421223|NCT00292747|Papaverine|papaverine|mesh-list
6421224|NCT00292747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6421225|NCT00292747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6421226|NCT00292747|Analgesics|analgesics|mesh-ancestor
6421227|NCT00292747|Sensory System Agents|sensory system agents|mesh-ancestor
6421228|NCT00292747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6421229|NCT00292747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421230|NCT00292747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6421231|NCT00292747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6421232|NCT00292747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6421233|NCT00292747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6421234|NCT00292747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421235|NCT00292747|Parasympatholytics|parasympatholytics|mesh-ancestor
6421236|NCT00292747|Autonomic Agents|autonomic agents|mesh-ancestor
6421237|NCT00292747|Vasodilator Agents|vasodilator agents|mesh-ancestor
6421238|NCT00292747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6421239|NCT00292747|Urological Agents|urological agents|mesh-ancestor
6421240|NCT00292760|Alemtuzumab|alemtuzumab|mesh-list
6421241|NCT00292760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6421242|NCT00292760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6421243|NCT00292799|Metformin|metformin|mesh-list
6421244|NCT00292799|Orlistat|orlistat|mesh-list
6421245|NCT00292799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6421246|NCT00292799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421247|NCT00292799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6421248|NCT00292799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421249|NCT00292799|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6421250|NCT00292799|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6421251|NCT00292838|Fluticasone|fluticasone|mesh-list
6421252|NCT00292838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6421253|NCT00292838|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6421254|NCT00292838|Autonomic Agents|autonomic agents|mesh-ancestor
6421255|NCT00292838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6421256|NCT00292838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421257|NCT00292838|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6421258|NCT00292838|Respiratory System Agents|respiratory system agents|mesh-ancestor
6421259|NCT00292838|Dermatologic Agents|dermatologic agents|mesh-ancestor
6421260|NCT00292838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6421261|NCT00292890|Insulin|insulin|mesh-list
6421262|NCT00292890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6421263|NCT00292890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421264|NCT00292929|Artesunate|artesunate|mesh-list
6421265|NCT00292929|Antimalarials|antimalarials|mesh-ancestor
6421266|NCT00292929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6421267|NCT00292929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6421268|NCT00292929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6421269|NCT00292929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6421270|NCT00292929|Antiviral Agents|antiviral agents|mesh-ancestor
6421271|NCT00292929|Schistosomicides|schistosomicides|mesh-ancestor
6421272|NCT00292929|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6421273|NCT00292929|Anthelmintics|anthelmintics|mesh-ancestor
6421274|NCT00292955|Cetuximab|cetuximab|mesh-list
6421275|NCT00292955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6421276|NCT00292955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6460299|NCT00449436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
6460300|NCT00449436|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
6460301|NCT00449436|Protease Inhibitors|protease inhibitors|mesh-list
6460302|NCT00449436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6460303|NCT00449436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6460304|NCT00449436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460305|NCT00449436|Antiviral Agents|antiviral agents|mesh-ancestor
6460306|NCT00449436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6460307|NCT00449436|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6460308|NCT00449436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6460309|NCT00449436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6460310|NCT00449449|Lidocaine|lidocaine|mesh-list
6460311|NCT00449449|Anesthetics, Local|anesthetics, local|mesh-ancestor
6460312|NCT00449449|Anesthetics|anesthetics|mesh-ancestor
6421277|NCT00293072|Rituximab|rituximab|mesh-list
6421278|NCT00293072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6421279|NCT00293072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6421280|NCT00293072|Immunologic Factors|immunologic factors|mesh-ancestor
6421281|NCT00293072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421282|NCT00293072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6421283|NCT00293085|Docetaxel|docetaxel|mesh-list
6421284|NCT00293085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6421285|NCT00293085|Tubulin Modulators|tubulin modulators|mesh-ancestor
6421286|NCT00293085|Antimitotic Agents|antimitotic agents|mesh-ancestor
6421287|NCT00293085|Mitosis Modulators|mitosis modulators|mesh-ancestor
6421288|NCT00293085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421289|NCT00293098|Deferiprone|deferiprone|mesh-list
6421290|NCT00293098|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6421291|NCT00293098|Chelating Agents|chelating agents|mesh-ancestor
6421292|NCT00293098|Sequestering Agents|sequestering agents|mesh-ancestor
6421293|NCT00293098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421294|NCT00293111|Etodolac|etodolac|mesh-list
6421295|NCT00293111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6421296|NCT00293111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6421297|NCT00293111|Analgesics|analgesics|mesh-ancestor
6421298|NCT00293111|Sensory System Agents|sensory system agents|mesh-ancestor
6421299|NCT00293111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6421300|NCT00293111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421301|NCT00293111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6421302|NCT00293111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6421303|NCT00293111|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6421304|NCT00293111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6421305|NCT00293111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6421306|NCT00293111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421307|NCT00293124|Imatinib Mesylate|imatinib mesylate|mesh-list
6421308|NCT00293124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6421309|NCT00293124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6421310|NCT00293124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6421311|NCT00293124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421312|NCT00293150|Eplerenone|eplerenone|mesh-list
6421313|NCT00293150|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6421314|NCT00293150|Hormone Antagonists|hormone antagonists|mesh-ancestor
6421315|NCT00293150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6421316|NCT00293150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421317|NCT00293150|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6421318|NCT00293150|Diuretics|diuretics|mesh-ancestor
6421319|NCT00293150|Natriuretic Agents|natriuretic agents|mesh-ancestor
6421320|NCT00293150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6421321|NCT00293163|Hylan|hylan|mesh-list
6421322|NCT00293163|Viscosupplements|viscosupplements|mesh-ancestor
6421323|NCT00293163|Protective Agents|protective agents|mesh-ancestor
6421324|NCT00293163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421325|NCT00293176|Donepezil|donepezil|mesh-list
6421326|NCT00293176|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6421327|NCT00293176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6421328|NCT00293176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421329|NCT00293176|Cholinergic Agents|cholinergic agents|mesh-ancestor
6421330|NCT00293176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6421331|NCT00293176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421332|NCT00293176|Nootropic Agents|nootropic agents|mesh-ancestor
6421333|NCT00293228|Isoniazid|isoniazid|mesh-list
6421334|NCT00293228|Antitubercular Agents|antitubercular agents|mesh-ancestor
6421335|NCT00293228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6421336|NCT00293228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6421337|NCT00293228|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6421338|NCT00293228|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6421339|NCT00293228|Antimetabolites|antimetabolites|mesh-ancestor
6421340|NCT00293228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421341|NCT00293228|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6421342|NCT00293280|Lomustine|lomustine|mesh-list
6421343|NCT00293280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6421344|NCT00293280|Alkylating Agents|alkylating agents|mesh-ancestor
6421345|NCT00293280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421346|NCT00293280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6421347|NCT00293319|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
6421348|NCT00293319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6421349|NCT00293319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6421350|NCT00293319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421351|NCT00293319|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6421352|NCT00293332|Bevacizumab|bevacizumab|mesh-list
6421353|NCT00293332|Carboplatin|carboplatin|mesh-list
6421354|NCT00293332|Docetaxel|docetaxel|mesh-list
6421355|NCT00293332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6421356|NCT00293332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6421357|NCT00293332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6421358|NCT00293332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6421359|NCT00293332|Growth Substances|growth substances|mesh-ancestor
6421360|NCT00293332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421361|NCT00293332|Growth Inhibitors|growth inhibitors|mesh-ancestor
6421362|NCT00293332|Tubulin Modulators|tubulin modulators|mesh-ancestor
6421363|NCT00293332|Antimitotic Agents|antimitotic agents|mesh-ancestor
6421364|NCT00293332|Mitosis Modulators|mitosis modulators|mesh-ancestor
6421365|NCT00293332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421366|NCT00293345|Gemcitabine|gemcitabine|mesh-list
6421367|NCT00293345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6421368|NCT00293345|Antimetabolites|antimetabolites|mesh-ancestor
6421369|NCT00293345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421370|NCT00293345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6421371|NCT00293345|Antiviral Agents|antiviral agents|mesh-ancestor
6421372|NCT00293345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6421373|NCT00293345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6421374|NCT00293345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6421375|NCT00293345|Immunologic Factors|immunologic factors|mesh-ancestor
6421376|NCT00293345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421377|NCT00293358|Carboplatin|carboplatin|mesh-list
6421378|NCT00293358|Etoposide|etoposide|mesh-list
6421379|NCT00293358|Ifosfamide|ifosfamide|mesh-list
6421380|NCT00293358|Etoposide phosphate|etoposide phosphate|mesh-list
6421381|NCT00293358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6421382|NCT00293358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6421383|NCT00293358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6421384|NCT00293358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6421385|NCT00293358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6421386|NCT00293358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421387|NCT00293358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6421388|NCT00293358|Alkylating Agents|alkylating agents|mesh-ancestor
6421389|NCT00293371|Prednisone|prednisone|mesh-list
6421390|NCT00293371|Docetaxel|docetaxel|mesh-list
6421391|NCT00293371|Vatalanib|vatalanib|mesh-list
6421392|NCT00293371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6421393|NCT00293371|Tubulin Modulators|tubulin modulators|mesh-ancestor
6421394|NCT00293371|Antimitotic Agents|antimitotic agents|mesh-ancestor
6421395|NCT00293371|Mitosis Modulators|mitosis modulators|mesh-ancestor
6421396|NCT00293371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421397|NCT00293371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6421398|NCT00293371|Glucocorticoids|glucocorticoids|mesh-ancestor
6421399|NCT00293371|Hormones|hormones|mesh-ancestor
6421400|NCT00293371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6421401|NCT00293371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421402|NCT00293371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6421403|NCT00293371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6421404|NCT00293371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6421405|NCT00293410|Cyclophosphamide|cyclophosphamide|mesh-list
6421406|NCT00293410|Clofarabine|clofarabine|mesh-list
6421407|NCT00293410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6421408|NCT00293410|Immunologic Factors|immunologic factors|mesh-ancestor
6421409|NCT00293410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421410|NCT00293410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6421411|NCT00293410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6421412|NCT00293410|Alkylating Agents|alkylating agents|mesh-ancestor
6421413|NCT00293410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421414|NCT00293410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6421415|NCT00293410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6421416|NCT00293410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6421417|NCT00293410|Antimetabolites|antimetabolites|mesh-ancestor
6421418|NCT00293436|Celecoxib|celecoxib|mesh-list
6421419|NCT00293436|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6421420|NCT00293436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6421421|NCT00293436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6421422|NCT00293436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6421423|NCT00293436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421424|NCT00293436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6421425|NCT00293436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6421426|NCT00293436|Analgesics|analgesics|mesh-ancestor
6421427|NCT00293436|Sensory System Agents|sensory system agents|mesh-ancestor
6421428|NCT00293436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6421429|NCT00293436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421430|NCT00293436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6421431|NCT00293436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6421432|NCT00293436|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6421433|NCT00293436|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6421434|NCT00293475|Sodium thiosulfate|sodium thiosulfate|mesh-list
6421435|NCT00293475|Rituximab|rituximab|mesh-list
6421436|NCT00293475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6421437|NCT00293475|Carboplatin|carboplatin|mesh-list
6421438|NCT00293475|Methotrexate|methotrexate|mesh-list
6421439|NCT00293475|Mannitol|mannitol|mesh-list
6421440|NCT00293475|Antibodies|antibodies|mesh-list
6421441|NCT00293475|Immunoglobulins|immunoglobulins|mesh-list
6421442|NCT00293475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6421443|NCT00293475|Antidotes|antidotes|mesh-list
6421444|NCT00293475|Immunologic Factors|immunologic factors|mesh-ancestor
6421445|NCT00293475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421446|NCT00293475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6421447|NCT00293475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6421448|NCT00293475|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6421449|NCT00293475|Abortifacient Agents|abortifacient agents|mesh-ancestor
6421450|NCT00293475|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6421451|NCT00293475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6421452|NCT00293475|Antimetabolites|antimetabolites|mesh-ancestor
6421453|NCT00293475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421454|NCT00293475|Dermatologic Agents|dermatologic agents|mesh-ancestor
5501319|NCT04475302|Immunologic Factors|immunologic factors|mesh-ancestor
6421455|NCT00293475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6421456|NCT00293475|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6421457|NCT00293475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6421458|NCT00293475|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6421459|NCT00293475|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6421460|NCT00293475|Diuretics|diuretics|mesh-ancestor
6421461|NCT00293475|Natriuretic Agents|natriuretic agents|mesh-ancestor
6421462|NCT00293475|Protective Agents|protective agents|mesh-ancestor
6421463|NCT00293475|Antioxidants|antioxidants|mesh-ancestor
6421464|NCT00293475|Antitubercular Agents|antitubercular agents|mesh-ancestor
6421465|NCT00293475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6421466|NCT00293475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6421467|NCT00293475|Chelating Agents|chelating agents|mesh-ancestor
6421468|NCT00293475|Sequestering Agents|sequestering agents|mesh-ancestor
6421469|NCT00293501|Tinzaparin|tinzaparin|mesh-list
6421470|NCT00293501|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6421471|NCT00293501|Dalteparin|dalteparin|mesh-list
6421472|NCT00293501|Anticoagulants|anticoagulants|mesh-ancestor
6421473|NCT00293501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6421474|NCT00293501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6421475|NCT00293501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421476|NCT00293514|Thrombin|thrombin|mesh-list
6421477|NCT00293514|Hemostatics|hemostatics|mesh-ancestor
6421478|NCT00293514|Coagulants|coagulants|mesh-ancestor
6421479|NCT00293527|Interferons|interferons|mesh-list
6421480|NCT00293527|Interferon-alpha|interferon-alpha|mesh-list
6421481|NCT00293527|Interferon alpha-2|interferon alpha-2|mesh-list
6421482|NCT00293527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6421483|NCT00293527|Antiviral Agents|antiviral agents|mesh-ancestor
6421484|NCT00293527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6421485|NCT00293527|Immunologic Factors|immunologic factors|mesh-ancestor
6421486|NCT00293527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421487|NCT00293592|Dexamethasone|dexamethasone|mesh-list
6421488|NCT00293592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6421489|NCT00293592|Antiemetics|antiemetics|mesh-ancestor
6421490|NCT00293592|Autonomic Agents|autonomic agents|mesh-ancestor
6421491|NCT00293592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6421492|NCT00293592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421493|NCT00293592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6421494|NCT00293592|Glucocorticoids|glucocorticoids|mesh-ancestor
6421495|NCT00293592|Hormones|hormones|mesh-ancestor
6421496|NCT00293592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6421497|NCT00293592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6421498|NCT00293592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6421499|NCT00293631|Ketorolac|ketorolac|mesh-list
6421500|NCT00293631|Lornoxicam|lornoxicam|mesh-list
6421501|NCT00293631|Piroxicam|piroxicam|mesh-list
6421502|NCT00293631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6421503|NCT00293631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6421504|NCT00293631|Analgesics|analgesics|mesh-ancestor
6421505|NCT00293631|Sensory System Agents|sensory system agents|mesh-ancestor
6421506|NCT00293631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6421507|NCT00293631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421508|NCT00293631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6421509|NCT00293631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6421510|NCT00293631|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6421511|NCT00293631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6421512|NCT00293631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421513|NCT00293644|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
6421514|NCT00293644|Antiemetics|antiemetics|mesh-ancestor
6421515|NCT00293644|Autonomic Agents|autonomic agents|mesh-ancestor
6421516|NCT00293644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6421517|NCT00293644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421518|NCT00293644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6421519|NCT00293644|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6421520|NCT00293644|Histamine Antagonists|histamine antagonists|mesh-ancestor
6421521|NCT00293644|Histamine Agents|histamine agents|mesh-ancestor
6421522|NCT00293644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6421523|NCT00293644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421524|NCT00293657|Lornoxicam|lornoxicam|mesh-list
6421525|NCT00293657|Piroxicam|piroxicam|mesh-list
6421526|NCT00293657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6421527|NCT00293657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6421528|NCT00293657|Analgesics|analgesics|mesh-ancestor
6421529|NCT00293657|Sensory System Agents|sensory system agents|mesh-ancestor
6421530|NCT00293657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6421531|NCT00293657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421532|NCT00293657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6421533|NCT00293657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6421534|NCT00293657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6421535|NCT00293657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6421536|NCT00293657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421537|NCT00293670|Goserelin|goserelin|mesh-list
6421538|NCT00293670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6421539|NCT00293670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6421540|NCT00293696|Goserelin|goserelin|mesh-list
6421541|NCT00293696|Bicalutamide|bicalutamide|mesh-list
6421542|NCT00293696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6421543|NCT00293696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6421544|NCT00293696|Androgen Antagonists|androgen antagonists|mesh-ancestor
6421545|NCT00293696|Hormone Antagonists|hormone antagonists|mesh-ancestor
6421546|NCT00293696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6421547|NCT00293696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421548|NCT00293735|Labetalol|labetalol|mesh-list
6421549|NCT00293735|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6421550|NCT00293735|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6421551|NCT00293735|Adrenergic Agents|adrenergic agents|mesh-ancestor
6421552|NCT00293735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6421553|NCT00293735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421554|NCT00293735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421555|NCT00293735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6421556|NCT00293735|Sympathomimetics|sympathomimetics|mesh-ancestor
6019089|NCT00384865|Aspirin|aspirin|mesh-list
6019090|NCT00384865|Simvastatin|simvastatin|mesh-list
6421557|NCT00293735|Autonomic Agents|autonomic agents|mesh-ancestor
6421558|NCT00293735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6421559|NCT00293735|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6421560|NCT00293735|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6421561|NCT00293761|Travoprost|travoprost|mesh-list
6421562|NCT00293761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6421563|NCT00293787|Timolol|timolol|mesh-list
6421564|NCT00293787|Travoprost|travoprost|mesh-list
6421565|NCT00293787|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6421566|NCT00293787|Latanoprost|latanoprost|mesh-list
6421567|NCT00293787|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6421568|NCT00293787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6421569|NCT00293787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6421570|NCT00293787|Adrenergic Agents|adrenergic agents|mesh-ancestor
6421571|NCT00293787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6421572|NCT00293787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421573|NCT00293787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421574|NCT00293787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6421575|NCT00293787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6421576|NCT00293800|Timolol|timolol|mesh-list
6421577|NCT00293800|Travoprost|travoprost|mesh-list
6421578|NCT00293800|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6421579|NCT00293800|Latanoprost|latanoprost|mesh-list
6421580|NCT00293800|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6421581|NCT00293800|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6421582|NCT00293800|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6421583|NCT00293800|Adrenergic Agents|adrenergic agents|mesh-ancestor
6421584|NCT00293800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6421585|NCT00293800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421586|NCT00293800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421587|NCT00293800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6421588|NCT00293800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6421589|NCT00293826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6421590|NCT00293826|Immunologic Factors|immunologic factors|mesh-ancestor
6421591|NCT00293826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421592|NCT00293839|Oxybutynin|oxybutynin|mesh-list
6019091|NCT00384865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6019092|NCT00384865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6019093|NCT00384865|Analgesics|analgesics|mesh-ancestor
6019094|NCT00384865|Sensory System Agents|sensory system agents|mesh-ancestor
6019095|NCT00384865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6053210|NCT00593606|Dopamine Agents|dopamine agents|mesh-ancestor
6421593|NCT00293839|Parasympatholytics|parasympatholytics|mesh-ancestor
6421594|NCT00293839|Autonomic Agents|autonomic agents|mesh-ancestor
6019096|NCT00384865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019097|NCT00384865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6421595|NCT00293839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6421596|NCT00293839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421597|NCT00293839|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6421598|NCT00293839|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6421599|NCT00293839|Cholinergic Agents|cholinergic agents|mesh-ancestor
6421600|NCT00293839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6421601|NCT00293839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421602|NCT00293839|Urological Agents|urological agents|mesh-ancestor
6421603|NCT00293891|Tacrolimus|tacrolimus|mesh-list
6421604|NCT00293891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6421605|NCT00293891|Immunologic Factors|immunologic factors|mesh-ancestor
6421606|NCT00293891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421607|NCT00293891|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6421608|NCT00293891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6421609|NCT00293891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421610|NCT00293917|Tacrolimus|tacrolimus|mesh-list
6421611|NCT00293917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6421612|NCT00293917|Immunologic Factors|immunologic factors|mesh-ancestor
6421613|NCT00293917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421614|NCT00293917|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6421615|NCT00293917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6421616|NCT00293917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421617|NCT00293930|Tacrolimus|tacrolimus|mesh-list
6421618|NCT00293930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6421619|NCT00293930|Immunologic Factors|immunologic factors|mesh-ancestor
6421620|NCT00293930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421621|NCT00293930|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6421622|NCT00293930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6421623|NCT00293930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421624|NCT00293969|Morphine|morphine|mesh-list
6421625|NCT00293969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6421626|NCT00293969|Narcotics|narcotics|mesh-ancestor
6421627|NCT00293969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6421628|NCT00293969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421629|NCT00293969|Analgesics|analgesics|mesh-ancestor
6421630|NCT00293969|Sensory System Agents|sensory system agents|mesh-ancestor
6421631|NCT00293969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6421632|NCT00294008|Risperidone|risperidone|mesh-list
6421633|NCT00294008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6421634|NCT00294008|Serotonin Agents|serotonin agents|mesh-ancestor
6421635|NCT00294008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6421636|NCT00294008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421637|NCT00294008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421638|NCT00294008|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6421639|NCT00294008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6421640|NCT00294008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6421641|NCT00294008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6421642|NCT00294008|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6421643|NCT00294008|Dopamine Agents|dopamine agents|mesh-ancestor
6421644|NCT00294086|Valsartan|valsartan|mesh-list
6421645|NCT00294086|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6421646|NCT00294086|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6421647|NCT00294086|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6421648|NCT00294086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421649|NCT00294099|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6421650|NCT00294099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6421651|NCT00294099|Immunologic Factors|immunologic factors|mesh-ancestor
6421652|NCT00294099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421653|NCT00294099|Antacids|antacids|mesh-ancestor
6421654|NCT00294099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421655|NCT00294099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6421656|NCT00294112|Remestemcel-l|remestemcel-l|mesh-list
6421657|NCT00294112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6421658|NCT00294112|Antiviral Agents|antiviral agents|mesh-ancestor
6421659|NCT00294112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6421660|NCT00294164|Hormones|hormones|mesh-list
6421661|NCT00294164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6421662|NCT00294164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421663|NCT00294190|Topotecan|topotecan|mesh-list
6421664|NCT00294190|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6421665|NCT00294190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6421666|NCT00294190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6421667|NCT00294190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421668|NCT00294190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6421669|NCT00294203|Epoetin Alfa|epoetin alfa|mesh-list
6421670|NCT00294203|Hematinics|hematinics|mesh-ancestor
6421671|NCT00294255|Risperidone|risperidone|mesh-list
6421672|NCT00294255|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6421673|NCT00294255|Serotonin Agents|serotonin agents|mesh-ancestor
6421674|NCT00294255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6421675|NCT00294255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421676|NCT00294255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421677|NCT00294255|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6421678|NCT00294255|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6421679|NCT00294255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6421680|NCT00294255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6421681|NCT00294255|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6421682|NCT00294255|Dopamine Agents|dopamine agents|mesh-ancestor
6421683|NCT00294294|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6421684|NCT00294294|Immunologic Factors|immunologic factors|mesh-ancestor
6421685|NCT00294294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421686|NCT00294359|Bevacizumab|bevacizumab|mesh-list
6421687|NCT00294359|Capecitabine|capecitabine|mesh-list
6421688|NCT00294359|Mitomycins|mitomycins|mesh-list
6421689|NCT00294359|Mitomycin|mitomycin|mesh-list
6421690|NCT00294359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6421691|NCT00294359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6421692|NCT00294359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6421693|NCT00294359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6421694|NCT00294359|Growth Substances|growth substances|mesh-ancestor
6421695|NCT00294359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421696|NCT00294359|Growth Inhibitors|growth inhibitors|mesh-ancestor
6421697|NCT00294359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6421698|NCT00294359|Antimetabolites|antimetabolites|mesh-ancestor
6421699|NCT00294359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421700|NCT00294359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6421701|NCT00294359|Alkylating Agents|alkylating agents|mesh-ancestor
6421702|NCT00294359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6421703|NCT00294359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6421704|NCT00294385|Gemcitabine|gemcitabine|mesh-list
6421705|NCT00294385|Docetaxel|docetaxel|mesh-list
6421706|NCT00294385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6421707|NCT00294385|Antimetabolites|antimetabolites|mesh-ancestor
6421708|NCT00294385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421709|NCT00294385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6421710|NCT00294385|Antiviral Agents|antiviral agents|mesh-ancestor
6421711|NCT00294385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6421712|NCT00294385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6421713|NCT00294385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6421714|NCT00294385|Immunologic Factors|immunologic factors|mesh-ancestor
6421715|NCT00294385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421716|NCT00294385|Tubulin Modulators|tubulin modulators|mesh-ancestor
6421717|NCT00294385|Antimitotic Agents|antimitotic agents|mesh-ancestor
6421718|NCT00294385|Mitosis Modulators|mitosis modulators|mesh-ancestor
6421719|NCT00294437|Zoledronic Acid|zoledronic acid|mesh-list
6421720|NCT00294437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6421721|NCT00294437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421722|NCT00294463|Tibolone|tibolone|mesh-list
6421723|NCT00294463|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6421724|NCT00294463|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6421725|NCT00294463|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6421726|NCT00294463|Medroxyprogesterone|medroxyprogesterone|mesh-list
6421727|NCT00294463|Estradiol|estradiol|mesh-list
6421728|NCT00294463|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6421729|NCT00294463|Progesterone|progesterone|mesh-list
6421730|NCT00294463|Estrogens|estrogens|mesh-ancestor
6421731|NCT00294463|Hormones|hormones|mesh-ancestor
6421732|NCT00294463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6421733|NCT00294463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421734|NCT00294463|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6421735|NCT00294463|Contraceptive Agents|contraceptive agents|mesh-ancestor
6421736|NCT00294463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6421737|NCT00294463|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6421738|NCT00294463|Progestins|progestins|mesh-ancestor
6421739|NCT00294463|Androgen Antagonists|androgen antagonists|mesh-ancestor
6421740|NCT00294463|Hormone Antagonists|hormone antagonists|mesh-ancestor
6421741|NCT00294463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6421742|NCT00294463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6421743|NCT00294463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6421744|NCT00294463|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6421745|NCT00294463|Anabolic Agents|anabolic agents|mesh-ancestor
6421746|NCT00294463|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6421747|NCT00294463|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6421748|NCT00294463|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6421749|NCT00294463|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6421750|NCT00294502|Minocycline|minocycline|mesh-list
6421751|NCT00294502|Gentamicins|gentamicins|mesh-list
6421752|NCT00294502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421753|NCT00294502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6421754|NCT00294502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6421755|NCT00294502|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6421756|NCT00294502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6421757|NCT00294567|Amlodipine|amlodipine|mesh-list
6421758|NCT00294567|Calcium Channel Blockers|calcium channel blockers|mesh-list
6421759|NCT00294567|Calcium|calcium|mesh-list
6421760|NCT00294567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6421761|NCT00294567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421762|NCT00294567|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6421763|NCT00294567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6421764|NCT00294567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421765|NCT00294567|Vasodilator Agents|vasodilator agents|mesh-ancestor
6421766|NCT00294580|Maloprim|maloprim|mesh-list
6421767|NCT00294580|Antimalarials|antimalarials|mesh-ancestor
6421768|NCT00294580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6421769|NCT00294580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6421770|NCT00294580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6421771|NCT00294593|Leucovorin|leucovorin|mesh-list
6421772|NCT00294593|Folic Acid|folic acid|mesh-list
6421773|NCT00294593|Levoleucovorin|levoleucovorin|mesh-list
6421774|NCT00294593|Antidotes|antidotes|mesh-ancestor
6421775|NCT00294593|Protective Agents|protective agents|mesh-ancestor
6421776|NCT00294593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421777|NCT00294593|Vitamin B Complex|vitamin b complex|mesh-ancestor
6421778|NCT00294593|Vitamins|vitamins|mesh-ancestor
6421779|NCT00294593|Micronutrients|micronutrients|mesh-ancestor
6421780|NCT00294593|Hematinics|hematinics|mesh-ancestor
6421781|NCT00294606|Phenylephrine|phenylephrine|mesh-list
6421782|NCT00294606|Oxymetazoline|oxymetazoline|mesh-list
6421783|NCT00294606|Norepinephrine|norepinephrine|mesh-list
6421784|NCT00294606|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6421785|NCT00294606|Mydriatics|mydriatics|mesh-ancestor
6421786|NCT00294606|Autonomic Agents|autonomic agents|mesh-ancestor
6421787|NCT00294606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6421788|NCT00294606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421789|NCT00294606|Sympathomimetics|sympathomimetics|mesh-ancestor
6421790|NCT00294606|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6421791|NCT00294606|Nasal Decongestants|nasal decongestants|mesh-ancestor
6421792|NCT00294606|Respiratory System Agents|respiratory system agents|mesh-ancestor
6421793|NCT00294606|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6421794|NCT00294606|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6421795|NCT00294606|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6421796|NCT00294606|Adrenergic Agents|adrenergic agents|mesh-ancestor
6421797|NCT00294606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6421798|NCT00294606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421799|NCT00294606|Protective Agents|protective agents|mesh-ancestor
6421800|NCT00294619|Hormones|hormones|mesh-list
6421801|NCT00294619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6421802|NCT00294619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421803|NCT00294736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6421804|NCT00294736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6421805|NCT00294736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6421806|NCT00294736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6421807|NCT00294736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421808|NCT00294749|Ciprofloxacin|ciprofloxacin|mesh-list
6421809|NCT00294749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6421810|NCT00294749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6421811|NCT00294749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6421812|NCT00294749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6421813|NCT00294749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6421814|NCT00294749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421815|NCT00294749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6421816|NCT00294749|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6421817|NCT00294749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6460313|NCT00449449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6460314|NCT00449449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460315|NCT00449449|Sensory System Agents|sensory system agents|mesh-ancestor
6460316|NCT00449449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6460317|NCT00449449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6460318|NCT00449449|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6460319|NCT00449449|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6460320|NCT00449449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6460321|NCT00449449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460322|NCT00449488|Epoetin Alfa|epoetin alfa|mesh-list
6460323|NCT00449488|Hematinics|hematinics|mesh-ancestor
6460324|NCT00449501|Budesonide|budesonide|mesh-list
6460325|NCT00449501|Formoterol Fumarate|formoterol fumarate|mesh-list
6460326|NCT00449501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6460327|NCT00449501|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6460328|NCT00449501|Autonomic Agents|autonomic agents|mesh-ancestor
6460329|NCT00449501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6460330|NCT00449501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460331|NCT00449501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6460332|NCT00449501|Respiratory System Agents|respiratory system agents|mesh-ancestor
6460333|NCT00449501|Glucocorticoids|glucocorticoids|mesh-ancestor
6460334|NCT00449501|Hormones|hormones|mesh-ancestor
6460335|NCT00449501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6460336|NCT00449501|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6460337|NCT00449501|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6421818|NCT00294775|Candesartan|candesartan|mesh-list
6421819|NCT00294775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6421820|NCT00294775|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6421821|NCT00294775|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6421822|NCT00294775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503587|NCT04457466|Mitogens|mitogens|mesh-list
6421823|NCT00294853|Calcium|calcium|mesh-list
6421824|NCT00294853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6421825|NCT00294853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421826|NCT00294892|Nevirapine|nevirapine|mesh-list
6421827|NCT00294892|Carbamazepine|carbamazepine|mesh-list
6421828|NCT00294892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6421829|NCT00294892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6421830|NCT00294892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6421831|NCT00294892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421832|NCT00294892|Antiviral Agents|antiviral agents|mesh-ancestor
6421833|NCT00294892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6421834|NCT00294892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6421835|NCT00294892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6421836|NCT00294892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6421837|NCT00294892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6421838|NCT00294892|Anticonvulsants|anticonvulsants|mesh-ancestor
6421839|NCT00294892|Antimanic Agents|antimanic agents|mesh-ancestor
6421840|NCT00294892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6421841|NCT00294892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6421842|NCT00294892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421843|NCT00294892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6421844|NCT00294892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6421845|NCT00294892|Analgesics|analgesics|mesh-ancestor
6421846|NCT00294892|Sensory System Agents|sensory system agents|mesh-ancestor
6421847|NCT00294892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6421848|NCT00294892|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6421849|NCT00294892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6421850|NCT00294918|Hormones|hormones|mesh-list
6421851|NCT00294918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6421852|NCT00294918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421853|NCT00294931|Bevacizumab|bevacizumab|mesh-list
6421854|NCT00294931|Carboplatin|carboplatin|mesh-list
6421855|NCT00294931|Irinotecan|irinotecan|mesh-list
6421856|NCT00294931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6421857|NCT00294931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6421858|NCT00294931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6421859|NCT00294931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6421860|NCT00294931|Growth Substances|growth substances|mesh-ancestor
6421861|NCT00294931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421862|NCT00294931|Growth Inhibitors|growth inhibitors|mesh-ancestor
6421863|NCT00294931|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6421864|NCT00294931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6421865|NCT00294931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6421866|NCT00294931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421867|NCT00294944|Idazoxan|idazoxan|mesh-list
6421868|NCT00294944|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6421869|NCT00294944|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6421870|NCT00294944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6421871|NCT00294944|Adrenergic Agents|adrenergic agents|mesh-ancestor
6421872|NCT00294944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6421873|NCT00294944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421874|NCT00294944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421875|NCT00294996|Doxorubicin|doxorubicin|mesh-list
6421876|NCT00294996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6421877|NCT00294996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6421878|NCT00294996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6421879|NCT00294996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6421880|NCT00294996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6421881|NCT00294996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421882|NCT00295035|Celecoxib|celecoxib|mesh-list
6421883|NCT00295035|Curcumin|curcumin|mesh-list
6421884|NCT00295035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6421885|NCT00295035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6421886|NCT00295035|Analgesics|analgesics|mesh-ancestor
6421887|NCT00295035|Sensory System Agents|sensory system agents|mesh-ancestor
6421888|NCT00295035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6421889|NCT00295035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421890|NCT00295035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6421891|NCT00295035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6421892|NCT00295035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6421893|NCT00295035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6421894|NCT00295035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6421895|NCT00295035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503588|NCT04457466|Mitosis Modulators|mitosis modulators|mesh-ancestor
6421896|NCT00295035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6421897|NCT00295100|Tamoxifen|tamoxifen|mesh-list
6421898|NCT00295100|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6421899|NCT00295100|Hormone Antagonists|hormone antagonists|mesh-ancestor
6421900|NCT00295100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6421901|NCT00295100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421902|NCT00295100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6421903|NCT00295100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6421904|NCT00295100|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6421905|NCT00295100|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6421906|NCT00295100|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6421907|NCT00295165|Sargramostim|sargramostim|mesh-list
6421908|NCT00295165|Immunologic Factors|immunologic factors|mesh-ancestor
6421909|NCT00295165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421910|NCT00295178|Vancomycin|vancomycin|mesh-list
6421911|NCT00295178|Daptomycin|daptomycin|mesh-list
6421912|NCT00295178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6421913|NCT00295178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6421914|NCT00295191|Dialysis Solutions|dialysis solutions|mesh-list
6421915|NCT00295191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6421916|NCT00295243|Topotecan|topotecan|mesh-list
6421917|NCT00295243|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6421918|NCT00295243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6421919|NCT00295243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6421920|NCT00295243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421921|NCT00295243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6421922|NCT00295282|Antibodies|antibodies|mesh-list
6421923|NCT00295282|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6421924|NCT00295282|Immunologic Factors|immunologic factors|mesh-ancestor
6421925|NCT00295282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421926|NCT00295308|Clonidine|clonidine|mesh-list
6421927|NCT00295308|Analgesics|analgesics|mesh-ancestor
6421928|NCT00295308|Sensory System Agents|sensory system agents|mesh-ancestor
6421929|NCT00295308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6421930|NCT00295308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421931|NCT00295308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6421932|NCT00295308|Sympatholytics|sympatholytics|mesh-ancestor
6421933|NCT00295308|Autonomic Agents|autonomic agents|mesh-ancestor
6421934|NCT00295308|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6421935|NCT00295308|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6421936|NCT00295308|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6421937|NCT00295308|Adrenergic Agents|adrenergic agents|mesh-ancestor
6421938|NCT00295308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6421939|NCT00295308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421940|NCT00295347|Fludrocortisone|fludrocortisone|mesh-list
6421941|NCT00295347|Spironolactone|spironolactone|mesh-list
6421942|NCT00295347|Citalopram|citalopram|mesh-list
6421943|NCT00295347|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6421944|NCT00295347|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6421945|NCT00295347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6421946|NCT00295347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421947|NCT00295347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6421948|NCT00295347|Serotonin Agents|serotonin agents|mesh-ancestor
6421949|NCT00295347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421950|NCT00295347|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6421951|NCT00295347|Antidepressive Agents|antidepressive agents|mesh-ancestor
6421952|NCT00295347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6421953|NCT00295347|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6421954|NCT00295347|Hormone Antagonists|hormone antagonists|mesh-ancestor
6421955|NCT00295347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6421956|NCT00295347|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6421957|NCT00295347|Diuretics|diuretics|mesh-ancestor
6421958|NCT00295347|Natriuretic Agents|natriuretic agents|mesh-ancestor
6421959|NCT00295347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6421960|NCT00295373|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6421961|NCT00295373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6421962|NCT00295373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6421963|NCT00295373|Antimetabolites|antimetabolites|mesh-ancestor
6421964|NCT00295373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421965|NCT00295373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6421966|NCT00295373|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6421967|NCT00295373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6421968|NCT00295386|Zopiclone|zopiclone|mesh-list
6421969|NCT00295386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6421970|NCT00295386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6421971|NCT00295386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724705|NCT03185403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6421972|NCT00295412|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6421973|NCT00295412|Antidepressive Agents|antidepressive agents|mesh-ancestor
6421974|NCT00295412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6421975|NCT00295412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6421976|NCT00295412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6421977|NCT00295412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6421978|NCT00295412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421979|NCT00295425|Cyclosporine|cyclosporine|mesh-list
6421980|NCT00295425|Mycophenolic Acid|mycophenolic acid|mesh-list
6421981|NCT00295425|Cyclosporins|cyclosporins|mesh-list
6421982|NCT00295425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6421983|NCT00295425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6421984|NCT00295425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6421985|NCT00295425|Immunologic Factors|immunologic factors|mesh-ancestor
6019098|NCT00384865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5724706|NCT03185403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724707|NCT03185403|Sensory System Agents|sensory system agents|mesh-ancestor
5724708|NCT03185403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5724709|NCT03185403|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5724710|NCT03185403|Narcotics|narcotics|mesh-ancestor
5724711|NCT03185403|Analgesics|analgesics|mesh-ancestor
6421986|NCT00295425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6421987|NCT00295425|Antifungal Agents|antifungal agents|mesh-ancestor
6421988|NCT00295425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6421989|NCT00295425|Dermatologic Agents|dermatologic agents|mesh-ancestor
6421990|NCT00295425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6421991|NCT00295425|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6421992|NCT00295425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6421993|NCT00295425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6421994|NCT00295425|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6421995|NCT00295425|Antitubercular Agents|antitubercular agents|mesh-ancestor
6421996|NCT00295425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6421997|NCT00295464|Betamethasone|betamethasone|mesh-list
6421998|NCT00295464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6421999|NCT00295464|Glucocorticoids|glucocorticoids|mesh-ancestor
6422000|NCT00295464|Hormones|hormones|mesh-ancestor
6422001|NCT00295464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6422002|NCT00295464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422003|NCT00295464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6422004|NCT00295464|Respiratory System Agents|respiratory system agents|mesh-ancestor
6422005|NCT00295542|Atenolol|atenolol|mesh-list
6422006|NCT00295542|Valsartan|valsartan|mesh-list
6019099|NCT00384865|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6422007|NCT00295542|Telmisartan|telmisartan|mesh-list
6422008|NCT00295542|Carvedilol|carvedilol|mesh-list
6422009|NCT00295542|Olmesartan|olmesartan|mesh-list
6422010|NCT00295542|Enalapril|enalapril|mesh-list
6422011|NCT00295542|Lisinopril|lisinopril|mesh-list
6422012|NCT00295542|Nebivolol|nebivolol|mesh-list
6422013|NCT00295542|Antihypertensive Agents|antihypertensive agents|mesh-list
6422014|NCT00295542|Doxazosin|doxazosin|mesh-list
6422015|NCT00295542|Indapamide|indapamide|mesh-list
6422016|NCT00295542|Quinapril|quinapril|mesh-list
6422017|NCT00295542|Torsemide|torsemide|mesh-list
6422018|NCT00295542|Spirapril|spirapril|mesh-list
6422019|NCT00295542|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
6422020|NCT00295542|Diuretics|diuretics|mesh-list
6422021|NCT00295542|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6422022|NCT00295542|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6422023|NCT00295542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422024|NCT00295542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6422025|NCT00295542|Adrenergic Agents|adrenergic agents|mesh-ancestor
6422026|NCT00295542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6422027|NCT00295542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422028|NCT00295542|Antioxidants|antioxidants|mesh-ancestor
6422029|NCT00295542|Protective Agents|protective agents|mesh-ancestor
6422030|NCT00295542|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6422031|NCT00295542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6422032|NCT00295542|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6422033|NCT00295542|Vasodilator Agents|vasodilator agents|mesh-ancestor
6422034|NCT00295542|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6422035|NCT00295542|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6422036|NCT00295542|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6422037|NCT00295542|Protease Inhibitors|protease inhibitors|mesh-ancestor
6422038|NCT00295542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6422039|NCT00295542|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6422040|NCT00295542|Natriuretic Agents|natriuretic agents|mesh-ancestor
6422041|NCT00295542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5724712|NCT03185403|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6422042|NCT00295542|Sympatholytics|sympatholytics|mesh-ancestor
6422043|NCT00295542|Autonomic Agents|autonomic agents|mesh-ancestor
6422044|NCT00295542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6422045|NCT00295542|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6422046|NCT00295542|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6422047|NCT00295542|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6422048|NCT00295542|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6422049|NCT00295542|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6422050|NCT00295542|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6422051|NCT00295555|Doxazosin|doxazosin|mesh-list
6422052|NCT00295555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6422053|NCT00295555|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6422054|NCT00295555|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6422055|NCT00295555|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6422056|NCT00295555|Adrenergic Agents|adrenergic agents|mesh-ancestor
6422057|NCT00295555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6422058|NCT00295555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422059|NCT00295555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422060|NCT00295594|Tacrolimus|tacrolimus|mesh-list
6422061|NCT00295594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6422062|NCT00295594|Immunologic Factors|immunologic factors|mesh-ancestor
6422063|NCT00295594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422064|NCT00295594|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6422065|NCT00295594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6422066|NCT00295594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422067|NCT00295607|Antibodies|antibodies|mesh-list
6422068|NCT00295607|Tacrolimus|tacrolimus|mesh-list
6422069|NCT00295607|Immunologic Factors|immunologic factors|mesh-ancestor
6422070|NCT00295607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422071|NCT00295607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6422072|NCT00295607|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6422073|NCT00295607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6422074|NCT00295607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422075|NCT00295646|Tamoxifen|tamoxifen|mesh-list
6422076|NCT00295646|Zoledronic Acid|zoledronic acid|mesh-list
6422077|NCT00295646|Anastrozole|anastrozole|mesh-list
6422078|NCT00295646|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6422079|NCT00295646|Hormone Antagonists|hormone antagonists|mesh-ancestor
6422080|NCT00295646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6422081|NCT00295646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422082|NCT00295646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6422083|NCT00295646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6422084|NCT00295646|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6422085|NCT00295646|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6422086|NCT00295646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6422087|NCT00295646|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6422088|NCT00295646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6422089|NCT00295646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6422090|NCT00295646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422091|NCT00295672|Vinorelbine|vinorelbine|mesh-list
6422092|NCT00295672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6422093|NCT00295672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6422094|NCT00295672|Tubulin Modulators|tubulin modulators|mesh-ancestor
6422095|NCT00295672|Antimitotic Agents|antimitotic agents|mesh-ancestor
6422096|NCT00295672|Mitosis Modulators|mitosis modulators|mesh-ancestor
6422097|NCT00295672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422098|NCT00295685|Antacids|antacids|mesh-list
6422099|NCT00295685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422100|NCT00295685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6422101|NCT00295698|Diethylcarbamazine|diethylcarbamazine|mesh-list
6422102|NCT00295698|Filaricides|filaricides|mesh-ancestor
6422103|NCT00295698|Antinematodal Agents|antinematodal agents|mesh-ancestor
6422104|NCT00295698|Anthelmintics|anthelmintics|mesh-ancestor
6422105|NCT00295698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6422106|NCT00295698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6422107|NCT00295698|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6422108|NCT00295698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6422109|NCT00295698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422110|NCT00295776|Lamotrigine|lamotrigine|mesh-list
6422111|NCT00295776|Anticonvulsants|anticonvulsants|mesh-ancestor
6422112|NCT00295776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6422113|NCT00295776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6422114|NCT00295776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422115|NCT00295776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6422116|NCT00295776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422117|NCT00295776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6422118|NCT00295776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6422119|NCT00295776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6422120|NCT00295776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6422121|NCT00295776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6422122|NCT00295789|Paclitaxel|paclitaxel|mesh-list
6422123|NCT00295789|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6422124|NCT00295789|Carboplatin|carboplatin|mesh-list
6422125|NCT00295789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6422126|NCT00295789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6422127|NCT00295789|Tubulin Modulators|tubulin modulators|mesh-ancestor
6422128|NCT00295789|Antimitotic Agents|antimitotic agents|mesh-ancestor
6422129|NCT00295789|Mitosis Modulators|mitosis modulators|mesh-ancestor
6422130|NCT00295789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422131|NCT00295815|Lomustine|lomustine|mesh-list
6422132|NCT00295815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6422133|NCT00295815|Alkylating Agents|alkylating agents|mesh-ancestor
6422134|NCT00295815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422135|NCT00295815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6422136|NCT00295841|Cytarabine|cytarabine|mesh-list
6422137|NCT00295841|Clofarabine|clofarabine|mesh-list
6422138|NCT00295841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6422139|NCT00295841|Antimetabolites|antimetabolites|mesh-ancestor
6422140|NCT00295841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422141|NCT00295841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6422142|NCT00295841|Antiviral Agents|antiviral agents|mesh-ancestor
6422143|NCT00295841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6422144|NCT00295841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6422145|NCT00295841|Immunologic Factors|immunologic factors|mesh-ancestor
6422146|NCT00295841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422147|NCT00295893|Paclitaxel|paclitaxel|mesh-list
6422148|NCT00295893|Docetaxel|docetaxel|mesh-list
6422149|NCT00295893|Cyclophosphamide|cyclophosphamide|mesh-list
6422150|NCT00295893|Carboplatin|carboplatin|mesh-list
6422151|NCT00295893|Doxorubicin|doxorubicin|mesh-list
6422152|NCT00295893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6422153|NCT00295893|Trastuzumab|trastuzumab|mesh-list
6422154|NCT00295893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6422155|NCT00295893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6422156|NCT00295893|Tubulin Modulators|tubulin modulators|mesh-ancestor
6422157|NCT00295893|Antimitotic Agents|antimitotic agents|mesh-ancestor
6422158|NCT00295893|Mitosis Modulators|mitosis modulators|mesh-ancestor
6422159|NCT00295893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422160|NCT00295893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6422161|NCT00295893|Immunologic Factors|immunologic factors|mesh-ancestor
6422162|NCT00295893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422163|NCT00295893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6422164|NCT00295893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6422165|NCT00295893|Alkylating Agents|alkylating agents|mesh-ancestor
6422166|NCT00295893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6422167|NCT00295893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6422168|NCT00295893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6422169|NCT00295893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6422170|NCT00295893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6422171|NCT00295893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6422172|NCT00295919|Ketoconazole|ketoconazole|mesh-list
6422173|NCT00295919|Fenretinide|fenretinide|mesh-list
6422174|NCT00295919|Antifungal Agents|antifungal agents|mesh-ancestor
6422175|NCT00295919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6422176|NCT00295919|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6422177|NCT00295919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6422178|NCT00295919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6422179|NCT00295919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422180|NCT00295919|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6422181|NCT00295919|Hormone Antagonists|hormone antagonists|mesh-ancestor
6422182|NCT00295919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6422183|NCT00295919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422184|NCT00295919|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6422185|NCT00295919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6422186|NCT00295919|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6422187|NCT00295919|Protective Agents|protective agents|mesh-ancestor
6422188|NCT00295945|Fentanyl|fentanyl|mesh-list
6422189|NCT00295945|Hydromorphone|hydromorphone|mesh-list
6422190|NCT00295945|Ropivacaine|ropivacaine|mesh-list
6422191|NCT00295945|Anesthetics, Local|anesthetics, local|mesh-ancestor
6422192|NCT00295945|Anesthetics|anesthetics|mesh-ancestor
6422193|NCT00295945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6422194|NCT00295945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422195|NCT00295945|Sensory System Agents|sensory system agents|mesh-ancestor
6422196|NCT00295945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6422197|NCT00295945|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6422198|NCT00295945|Narcotics|narcotics|mesh-ancestor
6422199|NCT00295945|Analgesics|analgesics|mesh-ancestor
6422200|NCT00295945|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6422201|NCT00295945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6422202|NCT00295945|Anesthetics, General|anesthetics, general|mesh-ancestor
6422203|NCT00295958|Freund's Adjuvant|freund's adjuvant|mesh-list
6422204|NCT00295958|Immunotoxins|immunotoxins|mesh-list
6422205|NCT00295958|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6422206|NCT00295958|Immunologic Factors|immunologic factors|mesh-ancestor
6422207|NCT00295958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422208|NCT00295971|Fludarabine|fludarabine|mesh-list
6422209|NCT00295971|Fludarabine phosphate|fludarabine phosphate|mesh-list
6422210|NCT00295971|Thiotepa|thiotepa|mesh-list
6422211|NCT00295971|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6422212|NCT00295971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6422213|NCT00295971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6422214|NCT00295971|Antimetabolites|antimetabolites|mesh-ancestor
6422215|NCT00295971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422216|NCT00295971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6422217|NCT00295971|Immunologic Factors|immunologic factors|mesh-ancestor
6422218|NCT00295971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422219|NCT00295971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6422220|NCT00295971|Alkylating Agents|alkylating agents|mesh-ancestor
6422221|NCT00295971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6422222|NCT00295984|Nicotine|nicotine|mesh-list
6422223|NCT00295984|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6422224|NCT00295984|Autonomic Agents|autonomic agents|mesh-ancestor
6422225|NCT00295984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6422226|NCT00295984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422227|NCT00295984|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6422228|NCT00295984|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6422229|NCT00295984|Cholinergic Agents|cholinergic agents|mesh-ancestor
6422230|NCT00295984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6422231|NCT00295984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422232|NCT00295997|Mycophenolic Acid|mycophenolic acid|mesh-list
6422233|NCT00295997|Cyclophosphamide|cyclophosphamide|mesh-list
6422234|NCT00295997|Busulfan|busulfan|mesh-list
6422235|NCT00295997|Methotrexate|methotrexate|mesh-list
6422236|NCT00295997|Fludarabine|fludarabine|mesh-list
6422237|NCT00295997|Fludarabine phosphate|fludarabine phosphate|mesh-list
6422238|NCT00295997|Tacrolimus|tacrolimus|mesh-list
6422239|NCT00295997|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6422240|NCT00295997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6422241|NCT00295997|Immunologic Factors|immunologic factors|mesh-ancestor
6422242|NCT00295997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422243|NCT00295997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6422244|NCT00295997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6422245|NCT00295997|Alkylating Agents|alkylating agents|mesh-ancestor
6422246|NCT00295997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422247|NCT00295997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6422248|NCT00295997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6422249|NCT00295997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6422250|NCT00295997|Abortifacient Agents|abortifacient agents|mesh-ancestor
6422251|NCT00295997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6422252|NCT00295997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6422253|NCT00295997|Antimetabolites|antimetabolites|mesh-ancestor
6422254|NCT00295997|Dermatologic Agents|dermatologic agents|mesh-ancestor
6422255|NCT00295997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6422256|NCT00295997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6422257|NCT00295997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6422258|NCT00295997|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6422259|NCT00295997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6422260|NCT00295997|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6422261|NCT00295997|Antitubercular Agents|antitubercular agents|mesh-ancestor
6422262|NCT00295997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6422263|NCT00295997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6422264|NCT00296010|Cyclophosphamide|cyclophosphamide|mesh-list
6422265|NCT00296010|Doxorubicin|doxorubicin|mesh-list
6422266|NCT00296010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6422267|NCT00296010|Methotrexate|methotrexate|mesh-list
6422268|NCT00296010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6422269|NCT00296010|Immunologic Factors|immunologic factors|mesh-ancestor
6422270|NCT00296010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422271|NCT00296010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6422272|NCT00296010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6422273|NCT00296010|Alkylating Agents|alkylating agents|mesh-ancestor
6422274|NCT00296010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422275|NCT00296010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6422276|NCT00296010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6422277|NCT00296010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6422278|NCT00296010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6422279|NCT00296010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6422280|NCT00296010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6422281|NCT00296010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6422282|NCT00296010|Abortifacient Agents|abortifacient agents|mesh-ancestor
6422283|NCT00296010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6422284|NCT00296010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6422285|NCT00296010|Antimetabolites|antimetabolites|mesh-ancestor
6538149|NCT00826254|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6538150|NCT00826254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6538151|NCT00826254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538152|NCT00826254|Hemostatics|hemostatics|mesh-ancestor
6538153|NCT00826254|Coagulants|coagulants|mesh-ancestor
6422286|NCT00296010|Dermatologic Agents|dermatologic agents|mesh-ancestor
6422287|NCT00296010|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6422288|NCT00296010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6422289|NCT00296023|Methotrexate|methotrexate|mesh-list
6422290|NCT00296023|Fludarabine phosphate|fludarabine phosphate|mesh-list
6422291|NCT00296023|Fludarabine|fludarabine|mesh-list
6422292|NCT00296023|Busulfan|busulfan|mesh-list
6422293|NCT00296023|Tacrolimus|tacrolimus|mesh-list
6422294|NCT00296023|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6422295|NCT00296023|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6422296|NCT00296023|Abortifacient Agents|abortifacient agents|mesh-ancestor
6422297|NCT00296023|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6422298|NCT00296023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422299|NCT00296023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6422300|NCT00296023|Antimetabolites|antimetabolites|mesh-ancestor
6422301|NCT00296023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422302|NCT00296023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6422303|NCT00296023|Dermatologic Agents|dermatologic agents|mesh-ancestor
6422304|NCT00296023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6422305|NCT00296023|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6422306|NCT00296023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6422307|NCT00296023|Immunologic Factors|immunologic factors|mesh-ancestor
6422308|NCT00296023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6422309|NCT00296023|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6422310|NCT00296023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6422311|NCT00296023|Alkylating Agents|alkylating agents|mesh-ancestor
6422312|NCT00296023|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6422313|NCT00296023|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6422314|NCT00296049|Vancomycin|vancomycin|mesh-list
6422315|NCT00296049|Daptomycin|daptomycin|mesh-list
6422316|NCT00296049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6422317|NCT00296049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6422318|NCT00296062|Bevacizumab|bevacizumab|mesh-list
6422319|NCT00296062|Capecitabine|capecitabine|mesh-list
6422320|NCT00296062|Oxaliplatin|oxaliplatin|mesh-list
6422321|NCT00296062|Irinotecan|irinotecan|mesh-list
6422322|NCT00296062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6422323|NCT00296062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6422324|NCT00296062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6422325|NCT00296062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6422326|NCT00296062|Growth Substances|growth substances|mesh-ancestor
6422327|NCT00296062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422328|NCT00296062|Growth Inhibitors|growth inhibitors|mesh-ancestor
6422329|NCT00296062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6422330|NCT00296062|Antimetabolites|antimetabolites|mesh-ancestor
6422331|NCT00296062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422332|NCT00296062|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6422333|NCT00296062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6422334|NCT00296062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6422335|NCT00296127|Celecoxib|celecoxib|mesh-list
6422336|NCT00296127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6422337|NCT00296127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6422338|NCT00296127|Analgesics|analgesics|mesh-ancestor
6460338|NCT00449501|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6422339|NCT00296127|Sensory System Agents|sensory system agents|mesh-ancestor
6422340|NCT00296127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6422341|NCT00296127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422342|NCT00296127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6422343|NCT00296127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6422344|NCT00296127|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6422345|NCT00296127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6422346|NCT00296127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6422347|NCT00296127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422348|NCT00296179|Zolpidem|zolpidem|mesh-list
6422349|NCT00296179|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6422350|NCT00296179|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6422351|NCT00296179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6422352|NCT00296179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422353|NCT00296179|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6422354|NCT00296179|GABA Agonists|gaba agonists|mesh-ancestor
6422355|NCT00296179|GABA Agents|gaba agents|mesh-ancestor
6422356|NCT00296179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6422357|NCT00296179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422358|NCT00296205|Cyclophosphamide|cyclophosphamide|mesh-list
6422359|NCT00296205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6422360|NCT00296205|Immunologic Factors|immunologic factors|mesh-ancestor
6422361|NCT00296205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422362|NCT00296205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6422363|NCT00296205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6422364|NCT00296205|Alkylating Agents|alkylating agents|mesh-ancestor
6422365|NCT00296205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422366|NCT00296205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6422367|NCT00296205|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6422368|NCT00296218|Irbesartan|irbesartan|mesh-list
6422369|NCT00296218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6422370|NCT00296218|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6422371|NCT00296218|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6422372|NCT00296218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422373|NCT00296257|Rimacalib|rimacalib|mesh-list
6422374|NCT00296257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6422375|NCT00296257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6422376|NCT00296257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422377|NCT00296309|Tacrolimus|tacrolimus|mesh-list
6422378|NCT00296309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6422379|NCT00296309|Immunologic Factors|immunologic factors|mesh-ancestor
6422380|NCT00296309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422381|NCT00296309|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6422382|NCT00296309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6422383|NCT00296309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422384|NCT00296348|Mycophenolic Acid|mycophenolic acid|mesh-list
6422385|NCT00296348|Tacrolimus|tacrolimus|mesh-list
6422386|NCT00296348|Daclizumab|daclizumab|mesh-list
6422387|NCT00296348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6422388|NCT00296348|Immunologic Factors|immunologic factors|mesh-ancestor
6422389|NCT00296348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422390|NCT00296348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6422391|NCT00296348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6422392|NCT00296348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422393|NCT00296348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6422394|NCT00296348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6422395|NCT00296348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6422396|NCT00296348|Antitubercular Agents|antitubercular agents|mesh-ancestor
6422397|NCT00296348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6422398|NCT00296348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6422399|NCT00296361|Tacrolimus|tacrolimus|mesh-list
6422400|NCT00296361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6422401|NCT00296361|Immunologic Factors|immunologic factors|mesh-ancestor
6422402|NCT00296361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422403|NCT00296361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6422404|NCT00296361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6422405|NCT00296361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422406|NCT00296387|Atorvastatin|atorvastatin|mesh-list
6422407|NCT00296387|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6422408|NCT00296387|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6422409|NCT00296387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6422410|NCT00296387|Antimetabolites|antimetabolites|mesh-ancestor
6422411|NCT00296387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422412|NCT00296387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6422413|NCT00296387|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6422414|NCT00296387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6460339|NCT00449501|Adrenergic Agents|adrenergic agents|mesh-ancestor
6460340|NCT00449501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6460341|NCT00449501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460342|NCT00449514|Tamoxifen|tamoxifen|mesh-list
6460343|NCT00449514|Clomiphene|clomiphene|mesh-list
6460344|NCT00449514|Enclomiphene|enclomiphene|mesh-list
6460345|NCT00449514|Zuclomiphene|zuclomiphene|mesh-list
6460346|NCT00449514|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6460347|NCT00449514|Hormone Antagonists|hormone antagonists|mesh-ancestor
6460348|NCT00449514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6460349|NCT00449514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460350|NCT00449514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6460351|NCT00449514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6460352|NCT00449514|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6460353|NCT00449514|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6460354|NCT00449514|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6460355|NCT00449514|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6460356|NCT00449514|Fertility Agents|fertility agents|mesh-ancestor
6422415|NCT00296465|Citric Acid|citric acid|mesh-list
6422416|NCT00296465|Sodium Citrate|sodium citrate|mesh-list
6422417|NCT00296465|Clomiphene|clomiphene|mesh-list
6422418|NCT00296465|Enclomiphene|enclomiphene|mesh-list
6422419|NCT00296465|Zuclomiphene|zuclomiphene|mesh-list
6422420|NCT00296465|Hormones|hormones|mesh-list
6422421|NCT00296465|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
6422422|NCT00296465|Anticoagulants|anticoagulants|mesh-ancestor
6422423|NCT00296465|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6422424|NCT00296465|Chelating Agents|chelating agents|mesh-ancestor
6422425|NCT00296465|Sequestering Agents|sequestering agents|mesh-ancestor
6422426|NCT00296465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422427|NCT00296465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6422428|NCT00296465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422429|NCT00296465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6422430|NCT00296465|Hormone Antagonists|hormone antagonists|mesh-ancestor
6422431|NCT00296465|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6422432|NCT00296465|Fertility Agents|fertility agents|mesh-ancestor
6422433|NCT00296465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6422434|NCT00296465|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6422435|NCT00296465|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6422436|NCT00296478|Progesterone|progesterone|mesh-list
6422437|NCT00296478|Progestins|progestins|mesh-ancestor
6422438|NCT00296478|Hormones|hormones|mesh-ancestor
6422439|NCT00296478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6422440|NCT00296478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422441|NCT00296530|Fluticasone|fluticasone|mesh-list
6422442|NCT00296530|Xhance|xhance|mesh-list
6422443|NCT00296530|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6422444|NCT00296530|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6422445|NCT00296530|Montelukast|montelukast|mesh-list
6422446|NCT00296530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6422447|NCT00296530|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6422448|NCT00296530|Autonomic Agents|autonomic agents|mesh-ancestor
6422449|NCT00296530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6422450|NCT00296530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422451|NCT00296530|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6422452|NCT00296530|Respiratory System Agents|respiratory system agents|mesh-ancestor
6422453|NCT00296530|Dermatologic Agents|dermatologic agents|mesh-ancestor
6422454|NCT00296530|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6422455|NCT00296530|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6422456|NCT00296530|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6422457|NCT00296530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6422458|NCT00296530|Adrenergic Agents|adrenergic agents|mesh-ancestor
6422459|NCT00296530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6422460|NCT00296530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422461|NCT00296530|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6422462|NCT00296530|Hormone Antagonists|hormone antagonists|mesh-ancestor
6422463|NCT00296530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6422464|NCT00296530|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6422465|NCT00296530|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6422466|NCT00296530|Glucocorticoids|glucocorticoids|mesh-ancestor
6422467|NCT00296530|Hormones|hormones|mesh-ancestor
6422468|NCT00296530|Sympathomimetics|sympathomimetics|mesh-ancestor
6422469|NCT00296608|Leucovorin|leucovorin|mesh-list
6422470|NCT00296608|Fluorouracil|fluorouracil|mesh-list
6422471|NCT00296608|Calcium|calcium|mesh-list
6422472|NCT00296608|Levoleucovorin|levoleucovorin|mesh-list
6422473|NCT00296608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6422474|NCT00296608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422475|NCT00296608|Antimetabolites|antimetabolites|mesh-ancestor
6422476|NCT00296608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019100|NCT00384865|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6019101|NCT00384865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422477|NCT00296608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6422478|NCT00296608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6422479|NCT00296608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6422480|NCT00296608|Immunologic Factors|immunologic factors|mesh-ancestor
6422481|NCT00296608|Antidotes|antidotes|mesh-ancestor
6422482|NCT00296608|Protective Agents|protective agents|mesh-ancestor
6422483|NCT00296608|Vitamin B Complex|vitamin b complex|mesh-ancestor
6422484|NCT00296608|Vitamins|vitamins|mesh-ancestor
6422485|NCT00296608|Micronutrients|micronutrients|mesh-ancestor
6422486|NCT00296634|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6422487|NCT00296634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6422488|NCT00296634|Immunologic Factors|immunologic factors|mesh-ancestor
6422489|NCT00296634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422490|NCT00296634|Antacids|antacids|mesh-ancestor
6422491|NCT00296634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422492|NCT00296634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6422493|NCT00296686|Tranylcypromine|tranylcypromine|mesh-list
6422494|NCT00296686|Dextroamphetamine|dextroamphetamine|mesh-list
6422495|NCT00296686|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6422496|NCT00296686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422497|NCT00296686|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6422498|NCT00296686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6422499|NCT00296686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6422500|NCT00296686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422501|NCT00296686|Dopamine Agents|dopamine agents|mesh-ancestor
6422502|NCT00296686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6422503|NCT00296686|Antidepressive Agents|antidepressive agents|mesh-ancestor
6422504|NCT00296686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6422505|NCT00296686|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6422506|NCT00296686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6422507|NCT00296686|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6422508|NCT00296686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6422509|NCT00296686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6422510|NCT00296699|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6422511|NCT00296699|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6422512|NCT00296699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6422513|NCT00296699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6422514|NCT00296699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422515|NCT00296699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6422516|NCT00296699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422517|NCT00296699|Analgesics|analgesics|mesh-ancestor
6422518|NCT00296699|Sensory System Agents|sensory system agents|mesh-ancestor
6422519|NCT00296699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6422520|NCT00296699|Antidepressive Agents|antidepressive agents|mesh-ancestor
6422521|NCT00296699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6422522|NCT00296699|Dopamine Agents|dopamine agents|mesh-ancestor
6422523|NCT00296712|Dexetimide|dexetimide|mesh-list
6422524|NCT00296712|Citalopram|citalopram|mesh-list
6422525|NCT00296712|Bupropion|bupropion|mesh-list
6422526|NCT00296712|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6422527|NCT00296712|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6422528|NCT00296712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6422529|NCT00296712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422530|NCT00296712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6422531|NCT00296712|Serotonin Agents|serotonin agents|mesh-ancestor
6422532|NCT00296712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422533|NCT00296712|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6422534|NCT00296712|Antidepressive Agents|antidepressive agents|mesh-ancestor
6422535|NCT00296712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6422536|NCT00296712|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6422537|NCT00296712|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6422538|NCT00296712|Parasympatholytics|parasympatholytics|mesh-ancestor
6422539|NCT00296712|Autonomic Agents|autonomic agents|mesh-ancestor
6422540|NCT00296712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6422541|NCT00296712|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6422542|NCT00296712|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6422543|NCT00296712|Cholinergic Agents|cholinergic agents|mesh-ancestor
6422544|NCT00296712|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6422545|NCT00296712|Dopamine Agents|dopamine agents|mesh-ancestor
6422546|NCT00296712|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6422547|NCT00296712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6422548|NCT00296712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6422549|NCT00296751|Fentanyl|fentanyl|mesh-list
6422550|NCT00296751|Meperidine|meperidine|mesh-list
6422551|NCT00296751|Bupivacaine|bupivacaine|mesh-list
6422552|NCT00296751|Anesthetics, Local|anesthetics, local|mesh-ancestor
6422553|NCT00296751|Anesthetics|anesthetics|mesh-ancestor
6422554|NCT00296751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6422555|NCT00296751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422556|NCT00296751|Sensory System Agents|sensory system agents|mesh-ancestor
6422557|NCT00296751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6422558|NCT00296751|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6422559|NCT00296751|Narcotics|narcotics|mesh-ancestor
6422560|NCT00296751|Analgesics|analgesics|mesh-ancestor
6422561|NCT00296751|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6422562|NCT00296751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6422563|NCT00296751|Anesthetics, General|anesthetics, general|mesh-ancestor
6422564|NCT00296777|Citalopram|citalopram|mesh-list
6422565|NCT00296777|Bupropion|bupropion|mesh-list
6422566|NCT00296777|Imipramine|imipramine|mesh-list
6422567|NCT00296777|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6422568|NCT00296777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6422569|NCT00296777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6422570|NCT00296777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422571|NCT00296777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6422572|NCT00296777|Serotonin Agents|serotonin agents|mesh-ancestor
6422573|NCT00296777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422574|NCT00296777|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6422575|NCT00296777|Antidepressive Agents|antidepressive agents|mesh-ancestor
6422576|NCT00296777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6422577|NCT00296777|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6422578|NCT00296777|Dopamine Agents|dopamine agents|mesh-ancestor
6422579|NCT00296777|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6422580|NCT00296777|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6422581|NCT00296777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6422582|NCT00296777|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6422583|NCT00296777|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6422584|NCT00296777|Adrenergic Agents|adrenergic agents|mesh-ancestor
6422585|NCT00296790|Zolpidem|zolpidem|mesh-list
6422586|NCT00296790|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6422587|NCT00296790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6422588|NCT00296790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6422589|NCT00296790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422590|NCT00296790|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6422591|NCT00296790|GABA Agonists|gaba agonists|mesh-ancestor
6422592|NCT00296790|GABA Agents|gaba agents|mesh-ancestor
6422593|NCT00296790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6422594|NCT00296790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422595|NCT00296803|Clopidogrel|clopidogrel|mesh-list
6422596|NCT00296803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6422597|NCT00296803|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6422598|NCT00296803|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6422599|NCT00296803|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6422600|NCT00296803|Purinergic Agents|purinergic agents|mesh-ancestor
6422601|NCT00296803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6422602|NCT00296803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422603|NCT00296803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422604|NCT00296868|Ascorbic Acid|ascorbic acid|mesh-list
6422605|NCT00296868|Vitamins|vitamins|mesh-ancestor
6422606|NCT00296868|Micronutrients|micronutrients|mesh-ancestor
6422607|NCT00296868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422608|NCT00296868|Antioxidants|antioxidants|mesh-ancestor
6422609|NCT00296868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422610|NCT00296868|Protective Agents|protective agents|mesh-ancestor
6422611|NCT00296894|Adalimumab|adalimumab|mesh-list
6422612|NCT00296894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6422613|NCT00296894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6422614|NCT00296933|Citalopram|citalopram|mesh-list
6422615|NCT00296933|Bupropion|bupropion|mesh-list
6422616|NCT00296933|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6422617|NCT00296933|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6422618|NCT00296933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6422619|NCT00296933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422620|NCT00296933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6422621|NCT00296933|Serotonin Agents|serotonin agents|mesh-ancestor
6422622|NCT00296933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422623|NCT00296933|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6422624|NCT00296933|Antidepressive Agents|antidepressive agents|mesh-ancestor
6422625|NCT00296933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6422626|NCT00296933|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6422627|NCT00296933|Dopamine Agents|dopamine agents|mesh-ancestor
6422628|NCT00296933|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6422629|NCT00296933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6422630|NCT00296933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6422631|NCT00296946|Bromides|bromides|mesh-list
6422632|NCT00296946|Ipratropium|ipratropium|mesh-list
6422633|NCT00296946|Anticonvulsants|anticonvulsants|mesh-ancestor
6422634|NCT00296946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6422635|NCT00296946|Autonomic Agents|autonomic agents|mesh-ancestor
6422636|NCT00296946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6422637|NCT00296946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422638|NCT00296946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6422639|NCT00296946|Respiratory System Agents|respiratory system agents|mesh-ancestor
6422640|NCT00296946|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6422641|NCT00296946|Cholinergic Agents|cholinergic agents|mesh-ancestor
6422642|NCT00296946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6422643|NCT00296946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422644|NCT00296959|Topiramate|topiramate|mesh-list
6422645|NCT00296959|Anticonvulsants|anticonvulsants|mesh-ancestor
6422646|NCT00296959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6422647|NCT00296959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422648|NCT00296972|Interferons|interferons|mesh-list
6422649|NCT00296972|Ribavirin|ribavirin|mesh-list
6422650|NCT00296972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6422651|NCT00296972|Antiviral Agents|antiviral agents|mesh-ancestor
6422652|NCT00296972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6422653|NCT00296972|Antimetabolites|antimetabolites|mesh-ancestor
6422654|NCT00296972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422655|NCT00297011|Valacyclovir|valacyclovir|mesh-list
6422656|NCT00297011|Clobetasol|clobetasol|mesh-list
6422657|NCT00297011|Antiviral Agents|antiviral agents|mesh-ancestor
6422658|NCT00297011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6422659|NCT00297011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6422660|NCT00297011|Glucocorticoids|glucocorticoids|mesh-ancestor
6422661|NCT00297011|Hormones|hormones|mesh-ancestor
6422662|NCT00297011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6422663|NCT00297011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422664|NCT00297050|Peramivir|peramivir|mesh-list
6422665|NCT00297050|Antiviral Agents|antiviral agents|mesh-ancestor
6422666|NCT00297050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6422667|NCT00297050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6422668|NCT00297050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422669|NCT00297063|Rosiglitazone|rosiglitazone|mesh-list
6422670|NCT00297063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6422671|NCT00297063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422672|NCT00297076|Aplaviroc|aplaviroc|mesh-list
6422673|NCT00297076|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6422674|NCT00297076|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6422675|NCT00297076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422676|NCT00297076|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6422677|NCT00297076|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6422678|NCT00297076|Antiviral Agents|antiviral agents|mesh-ancestor
6422679|NCT00297076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6422680|NCT00297128|Capecitabine|capecitabine|mesh-list
6422681|NCT00297128|Cetuximab|cetuximab|mesh-list
6422682|NCT00297128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6422683|NCT00297128|Antimetabolites|antimetabolites|mesh-ancestor
6422684|NCT00297128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422685|NCT00297128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6422686|NCT00297128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6422687|NCT00297141|Capecitabine|capecitabine|mesh-list
6422688|NCT00297141|Oxaliplatin|oxaliplatin|mesh-list
6422689|NCT00297141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6422690|NCT00297141|Antimetabolites|antimetabolites|mesh-ancestor
6422691|NCT00297141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422692|NCT00297141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6422693|NCT00297206|Valacyclovir|valacyclovir|mesh-list
6422694|NCT00297206|Antiviral Agents|antiviral agents|mesh-ancestor
6422695|NCT00297206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6422696|NCT00297219|Calcium, Dietary|calcium, dietary|mesh-list
6422697|NCT00297219|Dialysis Solutions|dialysis solutions|mesh-list
6422698|NCT00297219|Calcium|calcium|mesh-list
6422699|NCT00297219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6422700|NCT00297219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422701|NCT00297219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6422702|NCT00297219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6422703|NCT00297284|Modafinil|modafinil|mesh-list
6422704|NCT00297284|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6422705|NCT00297284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422706|NCT00297284|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6422707|NCT00297284|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6422708|NCT00297284|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6422709|NCT00297284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422710|NCT00297323|Topiramate|topiramate|mesh-list
6422711|NCT00297323|Anticonvulsants|anticonvulsants|mesh-ancestor
6422712|NCT00297323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6422713|NCT00297323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422714|NCT00297336|Topiramate|topiramate|mesh-list
6422715|NCT00297336|Anticonvulsants|anticonvulsants|mesh-ancestor
6422716|NCT00297336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6422717|NCT00297336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422718|NCT00297349|Topiramate|topiramate|mesh-list
6422719|NCT00297349|Anticonvulsants|anticonvulsants|mesh-ancestor
6422720|NCT00297349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6422721|NCT00297349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422722|NCT00297362|Galantamine|galantamine|mesh-list
6422723|NCT00297362|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6422724|NCT00297362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6422725|NCT00297362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422726|NCT00297362|Cholinergic Agents|cholinergic agents|mesh-ancestor
6019102|NCT00384865|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6019103|NCT00384865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6019104|NCT00384865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6019105|NCT00384865|Antipyretics|antipyretics|mesh-ancestor
6019106|NCT00384865|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6019107|NCT00384865|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6019108|NCT00384865|Antimetabolites|antimetabolites|mesh-ancestor
6019109|NCT00384865|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6422727|NCT00297362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6422728|NCT00297362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422729|NCT00297362|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6422730|NCT00297362|Autonomic Agents|autonomic agents|mesh-ancestor
6422731|NCT00297362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6422732|NCT00297362|Nootropic Agents|nootropic agents|mesh-ancestor
6422733|NCT00297375|Acetaminophen|acetaminophen|mesh-list
6422734|NCT00297375|Tramadol|tramadol|mesh-list
6422735|NCT00297375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6422736|NCT00297375|Analgesics|analgesics|mesh-ancestor
6422737|NCT00297375|Sensory System Agents|sensory system agents|mesh-ancestor
6422738|NCT00297375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6422739|NCT00297375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019110|NCT00384865|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6019111|NCT00384930|Tadalafil|tadalafil|mesh-list
6019112|NCT00384930|Vasodilator Agents|vasodilator agents|mesh-ancestor
6019113|NCT00384930|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6422740|NCT00297375|Antipyretics|antipyretics|mesh-ancestor
6422741|NCT00297375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6422742|NCT00297375|Narcotics|narcotics|mesh-ancestor
6422743|NCT00297375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6422744|NCT00297388|Risperidone|risperidone|mesh-list
6422745|NCT00297388|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6422746|NCT00297388|Serotonin Agents|serotonin agents|mesh-ancestor
6422747|NCT00297388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6422748|NCT00297388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422749|NCT00297388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422750|NCT00297388|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6422751|NCT00297388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6422752|NCT00297388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6422753|NCT00297388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6422754|NCT00297388|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6422755|NCT00297388|Dopamine Agents|dopamine agents|mesh-ancestor
6422756|NCT00297466|Nicotine|nicotine|mesh-list
6422757|NCT00297466|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6422758|NCT00297466|Autonomic Agents|autonomic agents|mesh-ancestor
6422759|NCT00297466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6422760|NCT00297466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422761|NCT00297466|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6422762|NCT00297466|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6422763|NCT00297466|Cholinergic Agents|cholinergic agents|mesh-ancestor
6422764|NCT00297466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6422765|NCT00297466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422766|NCT00297505|Citalopram|citalopram|mesh-list
6422767|NCT00297505|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6422768|NCT00297505|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6422769|NCT00297505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6422770|NCT00297505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422771|NCT00297505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6422772|NCT00297505|Serotonin Agents|serotonin agents|mesh-ancestor
5501320|NCT04475302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501321|NCT04475614|Vitamin B Complex|vitamin b complex|mesh-list
5501322|NCT04475614|Vitamins|vitamins|mesh-ancestor
5501323|NCT04475614|Micronutrients|micronutrients|mesh-ancestor
5501324|NCT04475614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019114|NCT00384930|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6422773|NCT00297505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422774|NCT00297505|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6422775|NCT00297505|Antidepressive Agents|antidepressive agents|mesh-ancestor
6422776|NCT00297505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6422777|NCT00297544|Sildenafil Citrate|sildenafil citrate|mesh-list
6422778|NCT00297544|Vasodilator Agents|vasodilator agents|mesh-ancestor
6422779|NCT00297544|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6422780|NCT00297544|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6422781|NCT00297544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6422782|NCT00297544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422783|NCT00297544|Urological Agents|urological agents|mesh-ancestor
6422784|NCT00297570|Interferons|interferons|mesh-list
6422785|NCT00297570|Imatinib Mesylate|imatinib mesylate|mesh-list
6422786|NCT00297570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6422787|NCT00297570|Antiviral Agents|antiviral agents|mesh-ancestor
6422788|NCT00297570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6422789|NCT00297570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6422790|NCT00297570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6422791|NCT00297570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422792|NCT00297583|Insulin glulisine|insulin glulisine|mesh-list
6422793|NCT00297583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6422794|NCT00297583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422795|NCT00297661|Sirolimus|sirolimus|mesh-list
6422796|NCT00297661|Paclitaxel|paclitaxel|mesh-list
6422797|NCT00297661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6422798|NCT00297661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6422799|NCT00297661|Tubulin Modulators|tubulin modulators|mesh-ancestor
6422800|NCT00297661|Antimitotic Agents|antimitotic agents|mesh-ancestor
6422801|NCT00297661|Mitosis Modulators|mitosis modulators|mesh-ancestor
6422802|NCT00297661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422803|NCT00297661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6422804|NCT00297661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6422805|NCT00297661|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6422806|NCT00297661|Antifungal Agents|antifungal agents|mesh-ancestor
6422807|NCT00297661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6422808|NCT00297661|Immunologic Factors|immunologic factors|mesh-ancestor
6422809|NCT00297661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422810|NCT00297674|Clarithromycin|clarithromycin|mesh-list
6422811|NCT00297674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6422812|NCT00297674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6422813|NCT00297674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6422814|NCT00297674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6422815|NCT00297674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422816|NCT00297674|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6422817|NCT00297674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6422818|NCT00297739|Risperidone|risperidone|mesh-list
6422819|NCT00297739|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6422820|NCT00297739|Serotonin Agents|serotonin agents|mesh-ancestor
6422821|NCT00297739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6422822|NCT00297739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422823|NCT00297739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422824|NCT00297739|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6422825|NCT00297739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6422826|NCT00297739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6422827|NCT00297739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6422828|NCT00297739|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6422829|NCT00297739|Dopamine Agents|dopamine agents|mesh-ancestor
6019115|NCT00384930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6019116|NCT00384930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019117|NCT00384930|Urological Agents|urological agents|mesh-ancestor
6019118|NCT00384956|Azacitidine|azacitidine|mesh-list
6019119|NCT00384956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6019120|NCT00384956|Antimetabolites|antimetabolites|mesh-ancestor
6422830|NCT00297752|Silver Sulfadiazine|silver sulfadiazine|mesh-list
6422831|NCT00297752|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6422832|NCT00297752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6422833|NCT00297765|Tacrolimus|tacrolimus|mesh-list
6422834|NCT00297765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6422835|NCT00297765|Immunologic Factors|immunologic factors|mesh-ancestor
6422836|NCT00297765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422837|NCT00297765|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6422838|NCT00297765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6422839|NCT00297765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422840|NCT00297804|Paclitaxel|paclitaxel|mesh-list
6422841|NCT00297804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6422842|NCT00297804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6422843|NCT00297804|Tubulin Modulators|tubulin modulators|mesh-ancestor
6422844|NCT00297804|Antimitotic Agents|antimitotic agents|mesh-ancestor
6422845|NCT00297804|Mitosis Modulators|mitosis modulators|mesh-ancestor
6422846|NCT00297804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422847|NCT00297817|Vaccines|vaccines|mesh-list
6422848|NCT00297817|Immunologic Factors|immunologic factors|mesh-ancestor
6422849|NCT00297817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422850|NCT00297947|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6422851|NCT00297947|Antidepressive Agents|antidepressive agents|mesh-ancestor
6422852|NCT00297947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6422853|NCT00297947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6422854|NCT00297947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6422855|NCT00297947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6422856|NCT00297947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422857|NCT00297960|Olanzapine|olanzapine|mesh-list
6422858|NCT00297960|Ziprasidone|ziprasidone|mesh-list
6422859|NCT00297960|Antiemetics|antiemetics|mesh-ancestor
6422860|NCT00297960|Autonomic Agents|autonomic agents|mesh-ancestor
6422861|NCT00297960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6422862|NCT00297960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422863|NCT00297960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6422864|NCT00297960|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6422865|NCT00297960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6422866|NCT00297960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6422867|NCT00297960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6422868|NCT00297960|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6422869|NCT00297960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6422870|NCT00297960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6422871|NCT00297960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422872|NCT00297960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6422873|NCT00297960|Serotonin Agents|serotonin agents|mesh-ancestor
6422874|NCT00297960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6422875|NCT00297960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6422876|NCT00297960|Dopamine Agents|dopamine agents|mesh-ancestor
6422877|NCT00298012|Methotrexate|methotrexate|mesh-list
6422878|NCT00298012|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6422879|NCT00298012|Abortifacient Agents|abortifacient agents|mesh-ancestor
6422880|NCT00298012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6422881|NCT00298012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422882|NCT00298012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6422883|NCT00298012|Antimetabolites|antimetabolites|mesh-ancestor
6422884|NCT00298012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422885|NCT00298012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6422886|NCT00298012|Dermatologic Agents|dermatologic agents|mesh-ancestor
6422887|NCT00298012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6422888|NCT00298012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5501325|NCT04475224|Mitogens|mitogens|mesh-list
6422889|NCT00298012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6422890|NCT00298012|Immunologic Factors|immunologic factors|mesh-ancestor
6422891|NCT00298012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6422892|NCT00298012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6422893|NCT00298025|Cetrorelix|cetrorelix|mesh-list
6422894|NCT00298025|Menotropins|menotropins|mesh-list
6422895|NCT00298025|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6422896|NCT00298025|Hormones|hormones|mesh-list
6422897|NCT00298025|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6422898|NCT00298025|Ganirelix|ganirelix|mesh-list
6422899|NCT00298025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6422900|NCT00298025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422901|NCT00298025|Hormone Antagonists|hormone antagonists|mesh-ancestor
6422902|NCT00298025|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6422903|NCT00298025|Fertility Agents|fertility agents|mesh-ancestor
6422904|NCT00298025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6460357|NCT00449514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6460358|NCT00449527|Budesonide|budesonide|mesh-list
6460359|NCT00449527|Formoterol Fumarate|formoterol fumarate|mesh-list
6460360|NCT00449527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6460361|NCT00449527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6460362|NCT00449527|Autonomic Agents|autonomic agents|mesh-ancestor
6460363|NCT00449527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6460364|NCT00449527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460365|NCT00449527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6460366|NCT00449527|Respiratory System Agents|respiratory system agents|mesh-ancestor
6460367|NCT00449527|Glucocorticoids|glucocorticoids|mesh-ancestor
6460368|NCT00449527|Hormones|hormones|mesh-ancestor
6460369|NCT00449527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6460370|NCT00449527|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6460371|NCT00449527|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6460372|NCT00449527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6460373|NCT00449527|Adrenergic Agents|adrenergic agents|mesh-ancestor
6460374|NCT00449527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6460375|NCT00449527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460376|NCT00449553|Metformin|metformin|mesh-list
6460377|NCT00449553|Pioglitazone|pioglitazone|mesh-list
6460378|NCT00449553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6460379|NCT00449553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460380|NCT00449618|Aspirin|aspirin|mesh-list
6460381|NCT00449618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6460382|NCT00449618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6460383|NCT00449618|Analgesics|analgesics|mesh-ancestor
6460384|NCT00449618|Sensory System Agents|sensory system agents|mesh-ancestor
6460385|NCT00449618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6460386|NCT00449618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460387|NCT00449618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6460388|NCT00449618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6460389|NCT00449618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6460390|NCT00449618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6460391|NCT00449618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460392|NCT00449618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6460393|NCT00449618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6460394|NCT00449618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6460395|NCT00449618|Antipyretics|antipyretics|mesh-ancestor
6460396|NCT00449657|Gemcitabine|gemcitabine|mesh-list
6460397|NCT00449657|Paclitaxel|paclitaxel|mesh-list
6460398|NCT00449657|Carboplatin|carboplatin|mesh-list
6460399|NCT00449657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6460400|NCT00449657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6460401|NCT00449657|Tubulin Modulators|tubulin modulators|mesh-ancestor
6460402|NCT00449657|Antimitotic Agents|antimitotic agents|mesh-ancestor
6460403|NCT00449657|Mitosis Modulators|mitosis modulators|mesh-ancestor
6460404|NCT00449657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460405|NCT00449657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6460406|NCT00449657|Antimetabolites|antimetabolites|mesh-ancestor
6460407|NCT00449657|Antiviral Agents|antiviral agents|mesh-ancestor
6460408|NCT00449657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6460409|NCT00449657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6460410|NCT00449657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6460411|NCT00449657|Immunologic Factors|immunologic factors|mesh-ancestor
6460412|NCT00449657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460413|NCT00449683|Terazosin|terazosin|mesh-list
6460414|NCT00449683|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6460415|NCT00449683|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6538154|NCT00826306|Sunscreening Agents|sunscreening agents|mesh-list
6422905|NCT00298168|polysaccharide-K|polysaccharide-k|mesh-list
6422906|NCT00298168|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6422907|NCT00298168|Immunologic Factors|immunologic factors|mesh-ancestor
6422908|NCT00298168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422909|NCT00298168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6422910|NCT00298168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6422911|NCT00298168|Antiviral Agents|antiviral agents|mesh-ancestor
6422912|NCT00298168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6422913|NCT00298168|Interferon Inducers|interferon inducers|mesh-ancestor
6422914|NCT00298168|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6422915|NCT00298168|Protective Agents|protective agents|mesh-ancestor
6422916|NCT00298181|polysaccharide-K|polysaccharide-k|mesh-list
6422917|NCT00298181|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6422918|NCT00298181|Immunologic Factors|immunologic factors|mesh-ancestor
6422919|NCT00298181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422920|NCT00298181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6422921|NCT00298181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6422922|NCT00298181|Antiviral Agents|antiviral agents|mesh-ancestor
6422923|NCT00298181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6422924|NCT00298181|Interferon Inducers|interferon inducers|mesh-ancestor
6422925|NCT00298181|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6422926|NCT00298181|Protective Agents|protective agents|mesh-ancestor
6422927|NCT00298194|Z 338|z 338|mesh-list
6422928|NCT00298194|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6422929|NCT00298194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6422930|NCT00298194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422931|NCT00298194|Cholinergic Agents|cholinergic agents|mesh-ancestor
6422932|NCT00298194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6422933|NCT00298194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422934|NCT00298194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6422935|NCT00298285|Enoxaparin|enoxaparin|mesh-list
6422936|NCT00298285|Anticoagulants|anticoagulants|mesh-ancestor
6422937|NCT00298285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6422938|NCT00298285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6422939|NCT00298285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422940|NCT00298324|Cyclosporine|cyclosporine|mesh-list
6422941|NCT00298324|Mycophenolic Acid|mycophenolic acid|mesh-list
6422942|NCT00298324|Prednisone|prednisone|mesh-list
6422943|NCT00298324|Cyclosporins|cyclosporins|mesh-list
6422944|NCT00298324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6422945|NCT00298324|Glucocorticoids|glucocorticoids|mesh-ancestor
6422946|NCT00298324|Hormones|hormones|mesh-ancestor
6422947|NCT00298324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6422948|NCT00298324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422949|NCT00298324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6422950|NCT00298324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6422951|NCT00298324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6422952|NCT00298324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422953|NCT00298324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6422954|NCT00298324|Immunologic Factors|immunologic factors|mesh-ancestor
6422955|NCT00298324|Antifungal Agents|antifungal agents|mesh-ancestor
6422956|NCT00298324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6422957|NCT00298324|Dermatologic Agents|dermatologic agents|mesh-ancestor
6422958|NCT00298324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6422959|NCT00298324|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6422960|NCT00298324|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5501326|NCT04475224|Mitosis Modulators|mitosis modulators|mesh-ancestor
6422961|NCT00298324|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6422962|NCT00298324|Antitubercular Agents|antitubercular agents|mesh-ancestor
6422963|NCT00298324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6422964|NCT00298350|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
6422965|NCT00298350|Integrase Inhibitors|integrase inhibitors|mesh-list
6422966|NCT00298350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6422967|NCT00298350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422968|NCT00298350|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6422969|NCT00298350|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6422970|NCT00298350|Antiviral Agents|antiviral agents|mesh-ancestor
6422971|NCT00298350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6422972|NCT00298415|Gemcitabine|gemcitabine|mesh-list
6422973|NCT00298415|Paclitaxel|paclitaxel|mesh-list
6422974|NCT00298415|Vinorelbine|vinorelbine|mesh-list
6422975|NCT00298415|Carboplatin|carboplatin|mesh-list
6422976|NCT00298415|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6422977|NCT00298415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6422978|NCT00298415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6422979|NCT00298415|Tubulin Modulators|tubulin modulators|mesh-ancestor
6422980|NCT00298415|Antimitotic Agents|antimitotic agents|mesh-ancestor
6422981|NCT00298415|Mitosis Modulators|mitosis modulators|mesh-ancestor
6422982|NCT00298415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422983|NCT00298415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6422984|NCT00298415|Antimetabolites|antimetabolites|mesh-ancestor
6422985|NCT00298415|Antiviral Agents|antiviral agents|mesh-ancestor
6422986|NCT00298415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6422987|NCT00298415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6422988|NCT00298415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6422989|NCT00298415|Immunologic Factors|immunologic factors|mesh-ancestor
6422990|NCT00298415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422991|NCT00298415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6422992|NCT00298454|Furosemide|furosemide|mesh-list
6422993|NCT00298454|Diuretics|diuretics|mesh-ancestor
6422994|NCT00298454|Natriuretic Agents|natriuretic agents|mesh-ancestor
6422995|NCT00298454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6422996|NCT00298454|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6422997|NCT00298454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6422998|NCT00298454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6422999|NCT00298506|Mycophenolic Acid|mycophenolic acid|mesh-list
6423000|NCT00298506|Tacrolimus|tacrolimus|mesh-list
6423001|NCT00298506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6423002|NCT00298506|Immunologic Factors|immunologic factors|mesh-ancestor
6423003|NCT00298506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423004|NCT00298506|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6423005|NCT00298506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6423006|NCT00298506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423007|NCT00298506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6423008|NCT00298506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6423009|NCT00298506|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6423010|NCT00298506|Antitubercular Agents|antitubercular agents|mesh-ancestor
6423011|NCT00298506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6423012|NCT00298506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6423013|NCT00298545|Calcitriol|calcitriol|mesh-list
6423014|NCT00298545|Calcium|calcium|mesh-list
6423015|NCT00298545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6423016|NCT00298545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423017|NCT00298545|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6423018|NCT00298545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6423019|NCT00298545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423020|NCT00298545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6423021|NCT00298545|Vitamins|vitamins|mesh-ancestor
6423022|NCT00298545|Micronutrients|micronutrients|mesh-ancestor
6423023|NCT00298545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6423024|NCT00298571|Epinephrine|epinephrine|mesh-list
6423025|NCT00298571|Bupivacaine|bupivacaine|mesh-list
6423026|NCT00298571|Anesthetics, Local|anesthetics, local|mesh-ancestor
6423027|NCT00298571|Anesthetics|anesthetics|mesh-ancestor
6423028|NCT00298571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6423029|NCT00298571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423030|NCT00298571|Sensory System Agents|sensory system agents|mesh-ancestor
6423031|NCT00298571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6423032|NCT00298571|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6423033|NCT00298571|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6423034|NCT00298571|Adrenergic Agents|adrenergic agents|mesh-ancestor
6423035|NCT00298571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6423036|NCT00298571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423037|NCT00298571|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6423038|NCT00298571|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6423039|NCT00298571|Autonomic Agents|autonomic agents|mesh-ancestor
6423040|NCT00298571|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6423041|NCT00298571|Respiratory System Agents|respiratory system agents|mesh-ancestor
6423042|NCT00298571|Mydriatics|mydriatics|mesh-ancestor
6423043|NCT00298571|Sympathomimetics|sympathomimetics|mesh-ancestor
6423044|NCT00298571|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6423045|NCT00298597|Epoetin Alfa|epoetin alfa|mesh-list
6423046|NCT00298597|Sargramostim|sargramostim|mesh-list
6423047|NCT00298597|Immunologic Factors|immunologic factors|mesh-ancestor
6423048|NCT00298597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423049|NCT00298597|Hematinics|hematinics|mesh-ancestor
6423050|NCT00298636|Adenosine|adenosine|mesh-list
6423051|NCT00298636|Analgesics|analgesics|mesh-ancestor
6423052|NCT00298636|Sensory System Agents|sensory system agents|mesh-ancestor
6423053|NCT00298636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6423054|NCT00298636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423055|NCT00298636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6423056|NCT00298636|Vasodilator Agents|vasodilator agents|mesh-ancestor
6423057|NCT00298636|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6423058|NCT00298636|Purinergic Agonists|purinergic agonists|mesh-ancestor
6423059|NCT00298636|Purinergic Agents|purinergic agents|mesh-ancestor
6423060|NCT00298636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6423061|NCT00298636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423062|NCT00298662|Interferons|interferons|mesh-list
6423063|NCT00298662|Interferon-beta|interferon-beta|mesh-list
6423064|NCT00298662|Tacrolimus|tacrolimus|mesh-list
6423065|NCT00298662|Interferon beta-1b|interferon beta-1b|mesh-list
6423066|NCT00298662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6423067|NCT00298662|Antiviral Agents|antiviral agents|mesh-ancestor
6423068|NCT00298662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6423069|NCT00298662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6423070|NCT00298662|Immunologic Factors|immunologic factors|mesh-ancestor
6423071|NCT00298662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423072|NCT00298662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6423073|NCT00298662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6423074|NCT00298662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423075|NCT00298662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6423076|NCT00298675|Irinotecan|irinotecan|mesh-list
6423077|NCT00298675|Iniparib|iniparib|mesh-list
6423078|NCT00298675|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6423079|NCT00298675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6423080|NCT00298675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6423081|NCT00298675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423082|NCT00298675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6423083|NCT00298675|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6423084|NCT00298688|Gefitinib|gefitinib|mesh-list
6423085|NCT00298688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6423086|NCT00298688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6423087|NCT00298688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6423088|NCT00298688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423089|NCT00298714|Losartan|losartan|mesh-list
6423090|NCT00298714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6423091|NCT00298714|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6423092|NCT00298714|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6423093|NCT00298714|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6423094|NCT00298714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423095|NCT00298779|Bortezomib|bortezomib|mesh-list
6423096|NCT00298779|Omeprazole|omeprazole|mesh-list
6423097|NCT00298779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6423098|NCT00298779|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6423099|NCT00298779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6423100|NCT00298779|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6423101|NCT00298779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6423102|NCT00298779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423103|NCT00298857|Valproic Acid|valproic acid|mesh-list
6423104|NCT00298857|Anticonvulsants|anticonvulsants|mesh-ancestor
6423105|NCT00298857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6423106|NCT00298857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423107|NCT00298857|GABA Agents|gaba agents|mesh-ancestor
6423108|NCT00298857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6423109|NCT00298857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423110|NCT00298857|Antimanic Agents|antimanic agents|mesh-ancestor
6423111|NCT00298857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6423112|NCT00298857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6423113|NCT00298857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6423114|NCT00298870|Isoniazid|isoniazid|mesh-list
6423115|NCT00298870|Antitubercular Agents|antitubercular agents|mesh-ancestor
6423116|NCT00298870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6423117|NCT00298870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6423118|NCT00298870|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6423119|NCT00298870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6423120|NCT00298870|Antimetabolites|antimetabolites|mesh-ancestor
6423121|NCT00298870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423122|NCT00298870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6423123|NCT00298883|Mycophenolic Acid|mycophenolic acid|mesh-list
6423124|NCT00298883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6423125|NCT00298883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6423126|NCT00298883|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6423127|NCT00298883|Antitubercular Agents|antitubercular agents|mesh-ancestor
6423128|NCT00298883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6423129|NCT00298883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6423130|NCT00298883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6423131|NCT00298883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423132|NCT00298909|Niacin|niacin|mesh-list
6423133|NCT00298909|Niacinamide|niacinamide|mesh-list
6423134|NCT00298909|Nicotinic Acids|nicotinic acids|mesh-list
6423135|NCT00298909|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6423136|NCT00298909|Antimetabolites|antimetabolites|mesh-ancestor
6423137|NCT00298909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423138|NCT00298909|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6423139|NCT00298909|Vasodilator Agents|vasodilator agents|mesh-ancestor
6423140|NCT00298909|Vitamin B Complex|vitamin b complex|mesh-ancestor
6423141|NCT00298909|Vitamins|vitamins|mesh-ancestor
6423142|NCT00298909|Micronutrients|micronutrients|mesh-ancestor
6423143|NCT00298909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423144|NCT00298922|Azithromycin|azithromycin|mesh-list
6423145|NCT00298922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6423146|NCT00298922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6423147|NCT00298974|Acetaminophen|acetaminophen|mesh-list
6423148|NCT00298974|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
6423149|NCT00298974|Hydrocodone|hydrocodone|mesh-list
6423150|NCT00298974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6423151|NCT00298974|Analgesics|analgesics|mesh-ancestor
6423152|NCT00298974|Sensory System Agents|sensory system agents|mesh-ancestor
6423153|NCT00298974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6538155|NCT00826306|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6423154|NCT00298974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423155|NCT00298974|Antipyretics|antipyretics|mesh-ancestor
6423156|NCT00298974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6423157|NCT00298974|Narcotics|narcotics|mesh-ancestor
6423158|NCT00298974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6423159|NCT00298974|Antitussive Agents|antitussive agents|mesh-ancestor
6423160|NCT00298974|Respiratory System Agents|respiratory system agents|mesh-ancestor
6423161|NCT00298974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6423162|NCT00298974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6423163|NCT00298974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6423164|NCT00299013|Prednisolone|prednisolone|mesh-list
6423165|NCT00299013|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6423166|NCT00299013|Methylprednisolone|methylprednisolone|mesh-list
6423167|NCT00299013|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6423168|NCT00299013|Prednisolone acetate|prednisolone acetate|mesh-list
6423169|NCT00299013|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6423170|NCT00299013|Prednisolone phosphate|prednisolone phosphate|mesh-list
6423171|NCT00299013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6423172|NCT00299013|Glucocorticoids|glucocorticoids|mesh-ancestor
6423173|NCT00299013|Hormones|hormones|mesh-ancestor
6423174|NCT00299013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6423175|NCT00299013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423176|NCT00299013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6423177|NCT00299013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6423178|NCT00299013|Antiemetics|antiemetics|mesh-ancestor
6423179|NCT00299013|Autonomic Agents|autonomic agents|mesh-ancestor
6423180|NCT00299013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6423181|NCT00299013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6423182|NCT00299013|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6423183|NCT00299013|Protective Agents|protective agents|mesh-ancestor
6423184|NCT00299026|Paclitaxel|paclitaxel|mesh-list
6423185|NCT00299026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6423186|NCT00299026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6423187|NCT00299026|Tubulin Modulators|tubulin modulators|mesh-ancestor
6423188|NCT00299026|Antimitotic Agents|antimitotic agents|mesh-ancestor
6423189|NCT00299026|Mitosis Modulators|mitosis modulators|mesh-ancestor
6423190|NCT00299026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538156|NCT00826306|Protective Agents|protective agents|mesh-ancestor
6423191|NCT00299039|Acetaminophen|acetaminophen|mesh-list
6423192|NCT00299039|Ibuprofen|ibuprofen|mesh-list
6423193|NCT00299039|Codeine|codeine|mesh-list
6423194|NCT00299039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6423195|NCT00299039|Analgesics|analgesics|mesh-ancestor
6423196|NCT00299039|Sensory System Agents|sensory system agents|mesh-ancestor
6423197|NCT00299039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6423198|NCT00299039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423199|NCT00299039|Antipyretics|antipyretics|mesh-ancestor
6423200|NCT00299039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6423201|NCT00299039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6423202|NCT00299039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6423203|NCT00299039|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6423204|NCT00299039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6423205|NCT00299039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423206|NCT00299039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6423207|NCT00299039|Narcotics|narcotics|mesh-ancestor
6423208|NCT00299039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6423209|NCT00299039|Antitussive Agents|antitussive agents|mesh-ancestor
6423210|NCT00299039|Respiratory System Agents|respiratory system agents|mesh-ancestor
6423211|NCT00299065|Zileuton|zileuton|mesh-list
6423212|NCT00299065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6423213|NCT00299065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6423214|NCT00299065|Analgesics|analgesics|mesh-ancestor
6423215|NCT00299065|Sensory System Agents|sensory system agents|mesh-ancestor
6423216|NCT00299065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6423217|NCT00299065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423218|NCT00299065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6423219|NCT00299065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6423220|NCT00299065|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6423221|NCT00299065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6423222|NCT00299065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423223|NCT00299065|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6423224|NCT00299065|Hormone Antagonists|hormone antagonists|mesh-ancestor
6423225|NCT00299065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6423226|NCT00299091|Efavirenz|efavirenz|mesh-list
6423227|NCT00299091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6423228|NCT00299091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6423229|NCT00299091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6423230|NCT00299091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423231|NCT00299091|Antiviral Agents|antiviral agents|mesh-ancestor
6423232|NCT00299091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6423233|NCT00299091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6423234|NCT00299091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6423235|NCT00299091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6423236|NCT00299091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6423237|NCT00299091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6423238|NCT00299091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6423239|NCT00299208|Azithromycin|azithromycin|mesh-list
6423240|NCT00299208|Artesunate|artesunate|mesh-list
6423241|NCT00299208|Quinine|quinine|mesh-list
6423242|NCT00299208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6423243|NCT00299208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6423244|NCT00299208|Antimalarials|antimalarials|mesh-ancestor
6423245|NCT00299208|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6423246|NCT00299208|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6423247|NCT00299208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6423248|NCT00299208|Antiviral Agents|antiviral agents|mesh-ancestor
6423249|NCT00299208|Schistosomicides|schistosomicides|mesh-ancestor
6423250|NCT00299208|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6423251|NCT00299208|Anthelmintics|anthelmintics|mesh-ancestor
6423252|NCT00299208|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6423253|NCT00299208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423254|NCT00299208|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6423255|NCT00299208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6423256|NCT00299208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6423257|NCT00299208|Analgesics|analgesics|mesh-ancestor
6423258|NCT00299208|Sensory System Agents|sensory system agents|mesh-ancestor
6423259|NCT00299234|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6423260|NCT00299234|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6423261|NCT00299234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6423262|NCT00299234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6423263|NCT00299234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423264|NCT00299234|Adrenergic Agents|adrenergic agents|mesh-ancestor
6423265|NCT00299234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6423266|NCT00299234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423267|NCT00299247|Pyrimethamine|pyrimethamine|mesh-list
6423268|NCT00299247|Sulfadoxine|sulfadoxine|mesh-list
6423269|NCT00299247|Antimalarials|antimalarials|mesh-ancestor
6423270|NCT00299247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6423271|NCT00299247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6423272|NCT00299247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6423273|NCT00299247|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6423274|NCT00299247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6423275|NCT00299247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423276|NCT00299247|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6423277|NCT00299247|Renal Agents|renal agents|mesh-ancestor
6423278|NCT00299286|Lapatinib|lapatinib|mesh-list
6423279|NCT00299286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6423280|NCT00299286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6423281|NCT00299286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6423282|NCT00299286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423283|NCT00299351|Romidepsin|romidepsin|mesh-list
6423284|NCT00299351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6423285|NCT00299351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6423286|NCT00299364|Tibolone|tibolone|mesh-list
6423287|NCT00299364|Androgen Antagonists|androgen antagonists|mesh-ancestor
6423288|NCT00299364|Hormone Antagonists|hormone antagonists|mesh-ancestor
6423289|NCT00299364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6423290|NCT00299364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423291|NCT00299364|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6423292|NCT00299364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6423293|NCT00299364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6423294|NCT00299364|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6423295|NCT00299364|Anabolic Agents|anabolic agents|mesh-ancestor
6423296|NCT00299364|Hormones|hormones|mesh-ancestor
6423297|NCT00299377|Abciximab|abciximab|mesh-list
6423298|NCT00299377|Anticoagulants|anticoagulants|mesh-ancestor
6423299|NCT00299377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6423300|NCT00299390|Sagopilone|sagopilone|mesh-list
6423301|NCT00299390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6423302|NCT00299455|Amoxicillin|amoxicillin|mesh-list
6423303|NCT00299455|Clavulanic Acid|clavulanic acid|mesh-list
6423304|NCT00299455|Clavulanic Acids|clavulanic acids|mesh-list
6423305|NCT00299455|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6423306|NCT00299455|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6423307|NCT00299455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6423308|NCT00299455|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6423309|NCT00299455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6423310|NCT00299455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423311|NCT00299520|Linezolid|linezolid|mesh-list
6423312|NCT00299520|Iclaprim|iclaprim|mesh-list
6423313|NCT00299520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6423314|NCT00299520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6423315|NCT00299520|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6423316|NCT00299520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6423317|NCT00299520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423318|NCT00299520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6423319|NCT00299559|Camphor|camphor|mesh-list
6423320|NCT00299559|Menthol|menthol|mesh-list
6423321|NCT00299559|Antipruritics|antipruritics|mesh-ancestor
6423322|NCT00299559|Dermatologic Agents|dermatologic agents|mesh-ancestor
6423323|NCT00299559|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6423324|NCT00299559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6423325|NCT00299572|Alendronate|alendronate|mesh-list
6423326|NCT00299572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6423327|NCT00299572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423328|NCT00299598|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6423329|NCT00299598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6423330|NCT00299611|Levetiracetam|levetiracetam|mesh-list
6423331|NCT00299611|Sertraline|sertraline|mesh-list
6423332|NCT00299611|Antidepressive Agents|antidepressive agents|mesh-ancestor
6423333|NCT00299611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6423334|NCT00299611|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6423335|NCT00299611|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6423336|NCT00299611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6423337|NCT00299611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423338|NCT00299611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6423339|NCT00299611|Serotonin Agents|serotonin agents|mesh-ancestor
6423340|NCT00299611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423341|NCT00299611|Anticonvulsants|anticonvulsants|mesh-ancestor
6423342|NCT00299611|Nootropic Agents|nootropic agents|mesh-ancestor
6423343|NCT00299650|Cisatracurium|cisatracurium|mesh-list
6423344|NCT00299650|Atracurium|atracurium|mesh-list
6423345|NCT00299650|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6423346|NCT00299650|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6423347|NCT00299650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6423348|NCT00299650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423349|NCT00299650|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6423350|NCT00299650|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
6423351|NCT00299650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6423352|NCT00299650|Cholinergic Agents|cholinergic agents|mesh-ancestor
6423353|NCT00299650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6423354|NCT00299650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423355|NCT00299676|Galantamine|galantamine|mesh-list
6423356|NCT00299676|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6423357|NCT00299676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6423358|NCT00299676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423359|NCT00299676|Cholinergic Agents|cholinergic agents|mesh-ancestor
6423360|NCT00299676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6423361|NCT00299676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423362|NCT00299676|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6423363|NCT00299676|Autonomic Agents|autonomic agents|mesh-ancestor
6423364|NCT00299676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6423365|NCT00299676|Nootropic Agents|nootropic agents|mesh-ancestor
6423366|NCT00299754|Misoprostol|misoprostol|mesh-list
6423367|NCT00299754|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6423368|NCT00299754|Abortifacient Agents|abortifacient agents|mesh-ancestor
6423369|NCT00299754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6538157|NCT00826306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423370|NCT00299754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423371|NCT00299754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6423372|NCT00299754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6423373|NCT00299754|Oxytocics|oxytocics|mesh-ancestor
6460416|NCT00449683|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6460417|NCT00449683|Adrenergic Agents|adrenergic agents|mesh-ancestor
6460418|NCT00449683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6460419|NCT00449683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460420|NCT00449683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460421|NCT00449683|Urological Agents|urological agents|mesh-ancestor
6460422|NCT00449722|Mesalamine|mesalamine|mesh-list
6460423|NCT00449722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6460424|NCT00449722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6460425|NCT00449722|Analgesics|analgesics|mesh-ancestor
6460426|NCT00449722|Sensory System Agents|sensory system agents|mesh-ancestor
6460427|NCT00449722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6460428|NCT00449722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460429|NCT00449722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6460430|NCT00449722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6460431|NCT00449774|Lamotrigine|lamotrigine|mesh-list
6460432|NCT00449774|Anticonvulsants|anticonvulsants|mesh-list
6460433|NCT00449774|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6460434|NCT00449774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6460435|NCT00449774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460436|NCT00449774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6460437|NCT00449774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460438|NCT00449774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6460439|NCT00449774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6460440|NCT00449774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6460441|NCT00449774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6460442|NCT00449774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6460443|NCT00449800|Ceftriaxone|ceftriaxone|mesh-list
6460444|NCT00449800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6460445|NCT00449800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6460446|NCT00449813|Pantoprazole|pantoprazole|mesh-list
6460447|NCT00449813|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6460448|NCT00449813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6460449|NCT00449813|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6460450|NCT00449813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6460451|NCT00449813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460452|NCT00449839|Insulin|insulin|mesh-list
6460453|NCT00449839|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6460454|NCT00449839|Insulin Aspart|insulin aspart|mesh-list
6460455|NCT00449839|Insulin, Long-Acting|insulin, long-acting|mesh-list
6460456|NCT00449839|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6460457|NCT00449839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6460458|NCT00449839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460459|NCT00450008|Thalidomide|thalidomide|mesh-list
6460460|NCT00450008|Docetaxel|docetaxel|mesh-list
6460461|NCT00450008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6460462|NCT00450008|Tubulin Modulators|tubulin modulators|mesh-ancestor
6460463|NCT00450008|Antimitotic Agents|antimitotic agents|mesh-ancestor
6460464|NCT00450008|Mitosis Modulators|mitosis modulators|mesh-ancestor
6460465|NCT00450008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460466|NCT00450008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6460467|NCT00450008|Immunologic Factors|immunologic factors|mesh-ancestor
6460468|NCT00450008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460469|NCT00450008|Leprostatic Agents|leprostatic agents|mesh-ancestor
6460470|NCT00450008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6460471|NCT00450008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6460472|NCT00450008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6460473|NCT00450008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6460474|NCT00450008|Growth Substances|growth substances|mesh-ancestor
6460475|NCT00450008|Growth Inhibitors|growth inhibitors|mesh-ancestor
6460476|NCT00450086|Budesonide|budesonide|mesh-list
6460477|NCT00450086|Mesalamine|mesalamine|mesh-list
6423374|NCT00299819|Sifalimumab|sifalimumab|mesh-list
6423375|NCT00299819|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6423376|NCT00299819|Immunologic Factors|immunologic factors|mesh-ancestor
6423377|NCT00299819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423378|NCT00299845|Lansoprazole|lansoprazole|mesh-list
6423379|NCT00299845|Dexlansoprazole|dexlansoprazole|mesh-list
6423380|NCT00299845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6423381|NCT00299845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6423382|NCT00299845|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6423383|NCT00299845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6423384|NCT00299845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423385|NCT00299858|Theophylline|theophylline|mesh-list
6423386|NCT00299858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6423387|NCT00299858|Autonomic Agents|autonomic agents|mesh-ancestor
6423388|NCT00299858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6423389|NCT00299858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423390|NCT00299858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6423391|NCT00299858|Respiratory System Agents|respiratory system agents|mesh-ancestor
6423392|NCT00299858|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6423393|NCT00299858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6423394|NCT00299858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423395|NCT00299858|Vasodilator Agents|vasodilator agents|mesh-ancestor
6423396|NCT00299858|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6423397|NCT00299858|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6423398|NCT00299858|Purinergic Agents|purinergic agents|mesh-ancestor
6423399|NCT00299858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6423400|NCT00299871|Lixisenatide|lixisenatide|mesh-list
6423401|NCT00299871|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6423402|NCT00299871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423403|NCT00299884|Atorvastatin|atorvastatin|mesh-list
6423404|NCT00299884|Ezetimibe|ezetimibe|mesh-list
6423405|NCT00299884|Fenofibrate|fenofibrate|mesh-list
6423406|NCT00299884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6423407|NCT00299884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6423408|NCT00299884|Antimetabolites|antimetabolites|mesh-ancestor
6423409|NCT00299884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423410|NCT00299884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6423411|NCT00299884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6423412|NCT00299884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6423413|NCT00299910|Montelukast|montelukast|mesh-list
6423414|NCT00299910|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6423415|NCT00299910|Respiratory System Agents|respiratory system agents|mesh-ancestor
6423416|NCT00299910|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6423417|NCT00299910|Hormone Antagonists|hormone antagonists|mesh-ancestor
6423418|NCT00299910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6423419|NCT00299910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423420|NCT00299910|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6423421|NCT00299910|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6423422|NCT00299910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423423|NCT00299923|Ribavirin|ribavirin|mesh-list
6423424|NCT00299923|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6423425|NCT00299923|Amantadine|amantadine|mesh-list
6423426|NCT00299923|Antimetabolites|antimetabolites|mesh-ancestor
6423427|NCT00299923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423428|NCT00299923|Antiviral Agents|antiviral agents|mesh-ancestor
6423429|NCT00299923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6423430|NCT00299923|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6423431|NCT00299923|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6423432|NCT00299923|Dopamine Agents|dopamine agents|mesh-ancestor
6423433|NCT00299923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6423434|NCT00299923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423435|NCT00299923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6423436|NCT00299923|Analgesics|analgesics|mesh-ancestor
6423437|NCT00299923|Sensory System Agents|sensory system agents|mesh-ancestor
6423438|NCT00299923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6423439|NCT00299936|Ribavirin|ribavirin|mesh-list
6423440|NCT00299936|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6423441|NCT00299936|Antimetabolites|antimetabolites|mesh-ancestor
6423442|NCT00299936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423443|NCT00299936|Antiviral Agents|antiviral agents|mesh-ancestor
6423444|NCT00299936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6423445|NCT00299962|Interferons|interferons|mesh-list
6423446|NCT00299962|Interferon-beta|interferon-beta|mesh-list
6423447|NCT00299962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6423448|NCT00299962|Antiviral Agents|antiviral agents|mesh-ancestor
6423449|NCT00299962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6423450|NCT00299962|Immunologic Factors|immunologic factors|mesh-ancestor
6423451|NCT00299962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423452|NCT00300014|Triamcinolone|triamcinolone|mesh-list
6423453|NCT00300014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6423454|NCT00300014|Glucocorticoids|glucocorticoids|mesh-ancestor
6423455|NCT00300014|Hormones|hormones|mesh-ancestor
6423456|NCT00300014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6423457|NCT00300014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423458|NCT00300040|HBOC 201|hboc 201|mesh-list
6423459|NCT00300040|Blood Substitutes|blood substitutes|mesh-ancestor
6423460|NCT00300079|Brinzolamide|brinzolamide|mesh-list
6423461|NCT00300079|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6423462|NCT00300079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6423463|NCT00300079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423464|NCT00300118|Budesonide|budesonide|mesh-list
6423465|NCT00300118|Mesalamine|mesalamine|mesh-list
6423466|NCT00300118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6423467|NCT00300118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6423468|NCT00300118|Autonomic Agents|autonomic agents|mesh-ancestor
6423469|NCT00300118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6423470|NCT00300118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423471|NCT00300118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6423472|NCT00300118|Respiratory System Agents|respiratory system agents|mesh-ancestor
6423473|NCT00300118|Glucocorticoids|glucocorticoids|mesh-ancestor
6423474|NCT00300118|Hormones|hormones|mesh-ancestor
6538158|NCT00826306|Dermatologic Agents|dermatologic agents|mesh-ancestor
6538159|NCT00826358|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6538160|NCT00826358|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6538161|NCT00826358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6538162|NCT00826358|Antimetabolites|antimetabolites|mesh-ancestor
6538163|NCT00826358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538164|NCT00826358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6538165|NCT00826358|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6538166|NCT00826358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6538167|NCT00826371|Ranibizumab|ranibizumab|mesh-list
6538168|NCT00826371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6538169|NCT00826371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6538170|NCT00826371|Growth Substances|growth substances|mesh-ancestor
6538171|NCT00826371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538172|NCT00826371|Growth Inhibitors|growth inhibitors|mesh-ancestor
6538173|NCT00826371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6538174|NCT00826527|Solifenacin Succinate|solifenacin succinate|mesh-list
6538175|NCT00826527|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6538176|NCT00826527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6538177|NCT00826527|Cholinergic Agents|cholinergic agents|mesh-ancestor
6538178|NCT00826527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6538179|NCT00826527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538180|NCT00826527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538181|NCT00826527|Urological Agents|urological agents|mesh-ancestor
6538182|NCT00826553|Midazolam|midazolam|mesh-list
6538183|NCT00826553|Dexmedetomidine|dexmedetomidine|mesh-list
6538184|NCT00826553|Lorazepam|lorazepam|mesh-list
6538185|NCT00826553|Propofol|propofol|mesh-list
6538186|NCT00826553|GABA Agonists|gaba agonists|mesh-list
6538187|NCT00826553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6538188|NCT00826553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6538189|NCT00826553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538190|NCT00826553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6538191|NCT00826553|Anesthetics, General|anesthetics, general|mesh-ancestor
6538192|NCT00826553|Anesthetics|anesthetics|mesh-ancestor
6423475|NCT00300118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6423476|NCT00300118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6423477|NCT00300118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6423478|NCT00300118|Analgesics|analgesics|mesh-ancestor
6423479|NCT00300118|Sensory System Agents|sensory system agents|mesh-ancestor
6423480|NCT00300118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6423481|NCT00300131|Everolimus|everolimus|mesh-list
6423482|NCT00300131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6423483|NCT00300131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6423484|NCT00300131|Immunologic Factors|immunologic factors|mesh-ancestor
6423485|NCT00300131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423486|NCT00300196|Ancrod|ancrod|mesh-list
6423487|NCT00300196|Anticoagulants|anticoagulants|mesh-ancestor
6423488|NCT00300196|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6423489|NCT00300196|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6423490|NCT00300196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423491|NCT00300222|Capsaicin|capsaicin|mesh-list
6423492|NCT00300222|Antipruritics|antipruritics|mesh-ancestor
6423493|NCT00300222|Dermatologic Agents|dermatologic agents|mesh-ancestor
6423494|NCT00300222|Sensory System Agents|sensory system agents|mesh-ancestor
6423495|NCT00300222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6423496|NCT00300222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423497|NCT00300287|Vildagliptin|vildagliptin|mesh-list
6423498|NCT00300287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6423499|NCT00300287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423500|NCT00300287|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6423501|NCT00300287|Protease Inhibitors|protease inhibitors|mesh-ancestor
6423502|NCT00300287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6423503|NCT00300287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423504|NCT00300313|Citalopram|citalopram|mesh-list
6423505|NCT00300313|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6423506|NCT00300313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6423507|NCT00300313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6423508|NCT00300313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423509|NCT00300313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6423510|NCT00300313|Serotonin Agents|serotonin agents|mesh-ancestor
6423511|NCT00300313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423512|NCT00300313|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6423513|NCT00300313|Antidepressive Agents|antidepressive agents|mesh-ancestor
6423514|NCT00300313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6423515|NCT00300339|Clopidogrel|clopidogrel|mesh-list
6423516|NCT00300339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6423517|NCT00300339|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6423518|NCT00300339|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6423519|NCT00300339|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6423520|NCT00300339|Purinergic Agents|purinergic agents|mesh-ancestor
6423521|NCT00300339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6423522|NCT00300339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423523|NCT00300339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423524|NCT00300352|Folic Acid|folic acid|mesh-list
6423525|NCT00300352|Hematinics|hematinics|mesh-ancestor
6423526|NCT00300352|Vitamin B Complex|vitamin b complex|mesh-ancestor
6423527|NCT00300352|Vitamins|vitamins|mesh-ancestor
6423528|NCT00300352|Micronutrients|micronutrients|mesh-ancestor
6423529|NCT00300352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423530|NCT00300378|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6423531|NCT00300378|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6423532|NCT00300378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6423533|NCT00300378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6423534|NCT00300378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423535|NCT00300378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6423536|NCT00300378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423537|NCT00300378|Antidepressive Agents|antidepressive agents|mesh-ancestor
6423538|NCT00300378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6423539|NCT00300404|Leucovorin|leucovorin|mesh-list
6423540|NCT00300404|Folic Acid|folic acid|mesh-list
6423541|NCT00300404|Pyrimethamine|pyrimethamine|mesh-list
6423542|NCT00300404|Levoleucovorin|levoleucovorin|mesh-list
6423543|NCT00300404|Antidotes|antidotes|mesh-ancestor
6423544|NCT00300404|Protective Agents|protective agents|mesh-ancestor
6423545|NCT00300404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423546|NCT00300404|Vitamin B Complex|vitamin b complex|mesh-ancestor
6423547|NCT00300404|Vitamins|vitamins|mesh-ancestor
6423548|NCT00300404|Micronutrients|micronutrients|mesh-ancestor
6423549|NCT00300404|Hematinics|hematinics|mesh-ancestor
6423550|NCT00300404|Antimalarials|antimalarials|mesh-ancestor
6423551|NCT00300404|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6423552|NCT00300404|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6423553|NCT00300404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6423554|NCT00300404|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6423555|NCT00300404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6423556|NCT00300404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423557|NCT00300443|Bimatoprost|bimatoprost|mesh-list
6423558|NCT00300443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6423559|NCT00300508|Anastrozole|anastrozole|mesh-list
6423560|NCT00300508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6423561|NCT00300508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6423562|NCT00300508|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6423563|NCT00300508|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6423564|NCT00300508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6423565|NCT00300508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423566|NCT00300508|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6423567|NCT00300508|Hormone Antagonists|hormone antagonists|mesh-ancestor
6423568|NCT00300508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6423569|NCT00300508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423570|NCT00300560|Colistin|colistin|mesh-list
6423571|NCT00300560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6423572|NCT00300560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6423573|NCT00300573|Dexelvucitabine|dexelvucitabine|mesh-list
6423574|NCT00300573|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6423575|NCT00300573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6423576|NCT00300573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6423577|NCT00300573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423578|NCT00300573|Antiviral Agents|antiviral agents|mesh-ancestor
6423579|NCT00300573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6423580|NCT00300573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6423581|NCT00300573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6423582|NCT00300586|Gemcitabine|gemcitabine|mesh-list
6423583|NCT00300586|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6423584|NCT00300586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6423585|NCT00300586|Antimetabolites|antimetabolites|mesh-ancestor
6423586|NCT00300586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423587|NCT00300586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6423588|NCT00300586|Antiviral Agents|antiviral agents|mesh-ancestor
6423589|NCT00300586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6423590|NCT00300586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6423591|NCT00300586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6423592|NCT00300586|Immunologic Factors|immunologic factors|mesh-ancestor
6423593|NCT00300586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423594|NCT00300586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6423595|NCT00300664|Hormones|hormones|mesh-list
6423596|NCT00300664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6423597|NCT00300664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423598|NCT00300716|Memantine|memantine|mesh-list
6423599|NCT00300716|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6423600|NCT00300716|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6423601|NCT00300716|Dopamine Agents|dopamine agents|mesh-ancestor
6423602|NCT00300716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6423603|NCT00300716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423604|NCT00300716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423605|NCT00300716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6423606|NCT00300716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6423607|NCT00300729|Celecoxib|celecoxib|mesh-list
6423608|NCT00300729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6423609|NCT00300729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6423610|NCT00300729|Analgesics|analgesics|mesh-ancestor
6423611|NCT00300729|Sensory System Agents|sensory system agents|mesh-ancestor
6423612|NCT00300729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6423613|NCT00300729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423614|NCT00300729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6423615|NCT00300729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6423616|NCT00300729|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6423617|NCT00300729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6423618|NCT00300729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6423619|NCT00300729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423620|NCT00300768|Ivermectin|ivermectin|mesh-list
6423621|NCT00300768|Moxidectin|moxidectin|mesh-list
6423622|NCT00300768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6423623|NCT00300768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6423624|NCT00300768|Anthelmintics|anthelmintics|mesh-ancestor
6423625|NCT00300768|Antinematodal Agents|antinematodal agents|mesh-ancestor
6423626|NCT00300794|Ketamine|ketamine|mesh-list
6423627|NCT00300794|Analgesics|analgesics|mesh-ancestor
6423628|NCT00300794|Sensory System Agents|sensory system agents|mesh-ancestor
6423629|NCT00300794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6423630|NCT00300794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423631|NCT00300794|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6423632|NCT00300794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6423633|NCT00300794|Anesthetics, General|anesthetics, general|mesh-ancestor
6423634|NCT00300794|Anesthetics|anesthetics|mesh-ancestor
6423635|NCT00300794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6423636|NCT00300794|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6423637|NCT00300794|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6423638|NCT00300794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6423639|NCT00300794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423640|NCT00300833|Tirofiban|tirofiban|mesh-list
6423641|NCT00300833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6423642|NCT00300833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6423643|NCT00300833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423644|NCT00300833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6423645|NCT00300846|Aripiprazole|aripiprazole|mesh-list
6423646|NCT00300846|Antidepressive Agents|antidepressive agents|mesh-ancestor
6423647|NCT00300846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6423648|NCT00300846|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6423649|NCT00300846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6423650|NCT00300846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6423651|NCT00300846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423652|NCT00300846|Dopamine Agonists|dopamine agonists|mesh-ancestor
6423653|NCT00300846|Dopamine Agents|dopamine agents|mesh-ancestor
6423654|NCT00300846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6423655|NCT00300846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423656|NCT00300846|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6423657|NCT00300846|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6423658|NCT00300846|Serotonin Agents|serotonin agents|mesh-ancestor
6423659|NCT00300846|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6423660|NCT00300846|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6423661|NCT00300846|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6423662|NCT00300846|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6423663|NCT00300911|Rosiglitazone|rosiglitazone|mesh-list
6423664|NCT00300911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6423665|NCT00300911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423666|NCT00300924|Acetaminophen|acetaminophen|mesh-list
6423667|NCT00300924|Rizatriptan|rizatriptan|mesh-list
6423668|NCT00300924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6423669|NCT00300924|Analgesics|analgesics|mesh-ancestor
6423670|NCT00300924|Sensory System Agents|sensory system agents|mesh-ancestor
6423671|NCT00300924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6423672|NCT00300924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423673|NCT00300924|Antipyretics|antipyretics|mesh-ancestor
6423674|NCT00300924|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6423675|NCT00300924|Serotonin Agents|serotonin agents|mesh-ancestor
6423676|NCT00300924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6423677|NCT00300924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423678|NCT00300937|Ubiquinone|ubiquinone|mesh-list
6423679|NCT00300937|Coenzyme Q10|coenzyme q10|mesh-list
6423680|NCT00300937|Micronutrients|micronutrients|mesh-ancestor
6423681|NCT00300937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423682|NCT00300937|Vitamins|vitamins|mesh-ancestor
6423683|NCT00300950|Gemcitabine|gemcitabine|mesh-list
6423684|NCT00300950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6423685|NCT00300950|Antimetabolites|antimetabolites|mesh-ancestor
6423686|NCT00300950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423687|NCT00300950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6423688|NCT00300950|Antiviral Agents|antiviral agents|mesh-ancestor
6423689|NCT00300950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6423690|NCT00300950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6423691|NCT00300950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6423692|NCT00300950|Immunologic Factors|immunologic factors|mesh-ancestor
6423693|NCT00300950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423694|NCT00301002|Alefacept|alefacept|mesh-list
6423695|NCT00301002|Dermatologic Agents|dermatologic agents|mesh-ancestor
6423696|NCT00301002|Immunologic Factors|immunologic factors|mesh-ancestor
6423697|NCT00301002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423698|NCT00301054|Pyrimethamine|pyrimethamine|mesh-list
6423699|NCT00301054|Sulfadoxine|sulfadoxine|mesh-list
6423700|NCT00301054|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6423701|NCT00301054|Antimalarials|antimalarials|mesh-ancestor
6423702|NCT00301054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6423703|NCT00301054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6423704|NCT00301054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6423705|NCT00301054|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6423706|NCT00301054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6423707|NCT00301054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423708|NCT00301054|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6423709|NCT00301054|Renal Agents|renal agents|mesh-ancestor
6423710|NCT00301093|Imatinib Mesylate|imatinib mesylate|mesh-list
6423711|NCT00301093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6423712|NCT00301093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6423713|NCT00301093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6423714|NCT00301093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423715|NCT00301106|Interleukin-12|interleukin-12|mesh-list
6423716|NCT00301106|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6423717|NCT00301106|Immunologic Factors|immunologic factors|mesh-ancestor
6423718|NCT00301106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423719|NCT00301106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6423720|NCT00301106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6423721|NCT00301106|Growth Substances|growth substances|mesh-ancestor
6423722|NCT00301106|Growth Inhibitors|growth inhibitors|mesh-ancestor
6423723|NCT00301106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6423724|NCT00301145|Varenicline|varenicline|mesh-list
6423725|NCT00301145|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6423726|NCT00301145|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6423727|NCT00301145|Cholinergic Agents|cholinergic agents|mesh-ancestor
6423728|NCT00301145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6423729|NCT00301145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423730|NCT00301145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423731|NCT00301171|Fluticasone|fluticasone|mesh-list
6423732|NCT00301171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6423733|NCT00301171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6423734|NCT00301171|Autonomic Agents|autonomic agents|mesh-ancestor
6423735|NCT00301171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6423736|NCT00301171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423737|NCT00301171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6423738|NCT00301171|Respiratory System Agents|respiratory system agents|mesh-ancestor
6423739|NCT00301171|Dermatologic Agents|dermatologic agents|mesh-ancestor
6423740|NCT00301171|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6423741|NCT00301210|Tramadol|tramadol|mesh-list
6423742|NCT00301210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6423743|NCT00301210|Narcotics|narcotics|mesh-ancestor
6423744|NCT00301210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6423745|NCT00301210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423746|NCT00301210|Analgesics|analgesics|mesh-ancestor
6423747|NCT00301210|Sensory System Agents|sensory system agents|mesh-ancestor
6423748|NCT00301210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6423749|NCT00301223|Pregabalin|pregabalin|mesh-list
6423750|NCT00301223|Analgesics|analgesics|mesh-ancestor
6423751|NCT00301223|Sensory System Agents|sensory system agents|mesh-ancestor
6423752|NCT00301223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6423753|NCT00301223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423754|NCT00301223|Anticonvulsants|anticonvulsants|mesh-ancestor
6423755|NCT00301223|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6423756|NCT00301223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6423757|NCT00301223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423758|NCT00301223|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6423759|NCT00301223|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6423760|NCT00301223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6423761|NCT00301223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6423762|NCT00301223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6423763|NCT00301236|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
6423764|NCT00301236|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6423765|NCT00301236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423766|NCT00301236|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6423767|NCT00301236|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6423768|NCT00301236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6460478|NCT00450086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6423769|NCT00301236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423770|NCT00301236|Dopamine Agents|dopamine agents|mesh-ancestor
6423771|NCT00301236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6423772|NCT00301301|Gemcitabine|gemcitabine|mesh-list
6423773|NCT00301301|Rituximab|rituximab|mesh-list
6423774|NCT00301301|Cisplatin|cisplatin|mesh-list
6423775|NCT00301301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6423776|NCT00301301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6423777|NCT00301301|Immunologic Factors|immunologic factors|mesh-ancestor
6423778|NCT00301301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423779|NCT00301301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6423780|NCT00301301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6423781|NCT00301301|Antimetabolites|antimetabolites|mesh-ancestor
6423782|NCT00301301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423783|NCT00301301|Antiviral Agents|antiviral agents|mesh-ancestor
6423784|NCT00301301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6423785|NCT00301301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6423786|NCT00301301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6423787|NCT00301392|Pitavastatin|pitavastatin|mesh-list
6423788|NCT00301392|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6423789|NCT00301392|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6423790|NCT00301392|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6423791|NCT00301392|Antimetabolites|antimetabolites|mesh-ancestor
6423792|NCT00301392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423793|NCT00301392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6423794|NCT00301392|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6460479|NCT00450086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6460480|NCT00450086|Autonomic Agents|autonomic agents|mesh-ancestor
6460481|NCT00450086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6460482|NCT00450086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460483|NCT00450086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6460484|NCT00450086|Respiratory System Agents|respiratory system agents|mesh-ancestor
6460485|NCT00450086|Glucocorticoids|glucocorticoids|mesh-ancestor
6460486|NCT00450086|Hormones|hormones|mesh-ancestor
6460487|NCT00450086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6460488|NCT00450086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6460489|NCT00450086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6460490|NCT00450086|Analgesics|analgesics|mesh-ancestor
6460491|NCT00450086|Sensory System Agents|sensory system agents|mesh-ancestor
6460492|NCT00450086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6460493|NCT00450099|Bupivacaine|bupivacaine|mesh-list
6460494|NCT00450099|Anesthetics, Local|anesthetics, local|mesh-ancestor
6460495|NCT00450099|Anesthetics|anesthetics|mesh-ancestor
6460496|NCT00450099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6460497|NCT00450099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460498|NCT00450099|Sensory System Agents|sensory system agents|mesh-ancestor
6460499|NCT00450099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6460500|NCT00450138|Cisplatin|cisplatin|mesh-list
6460501|NCT00450138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6460502|NCT00450164|Nadolol|nadolol|mesh-list
6460503|NCT00450164|Prazosin|prazosin|mesh-list
6460504|NCT00450164|Isosorbide|isosorbide|mesh-list
6019121|NCT00384956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019122|NCT00384956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6019123|NCT00384956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6019124|NCT00385008|Naproxen|naproxen|mesh-list
6019125|NCT00385008|Sumatriptan|sumatriptan|mesh-list
6019126|NCT00385008|Eletriptan|eletriptan|mesh-list
6423795|NCT00301405|Thalidomide|thalidomide|mesh-list
6423796|NCT00301405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6423797|NCT00301405|Immunologic Factors|immunologic factors|mesh-ancestor
6423798|NCT00301405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423799|NCT00301405|Leprostatic Agents|leprostatic agents|mesh-ancestor
6423800|NCT00301405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6423801|NCT00301405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6423802|NCT00301405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6423803|NCT00301405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6423804|NCT00301405|Growth Substances|growth substances|mesh-ancestor
6423805|NCT00301405|Growth Inhibitors|growth inhibitors|mesh-ancestor
6423806|NCT00301405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6423807|NCT00301457|Anastrozole|anastrozole|mesh-list
6423808|NCT00301457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6423809|NCT00301457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6423810|NCT00301457|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6423811|NCT00301457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6423812|NCT00301457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6423813|NCT00301457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423814|NCT00301457|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6423815|NCT00301457|Hormone Antagonists|hormone antagonists|mesh-ancestor
6423816|NCT00301457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6423817|NCT00301457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423818|NCT00301483|HBOC 201|hboc 201|mesh-list
6423819|NCT00301483|Blood Substitutes|blood substitutes|mesh-ancestor
6423820|NCT00301509|Ribavirin|ribavirin|mesh-list
6423821|NCT00301509|Antimetabolites|antimetabolites|mesh-ancestor
6423822|NCT00301509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423823|NCT00301509|Antiviral Agents|antiviral agents|mesh-ancestor
6423824|NCT00301509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6423825|NCT00301522|Paclitaxel|paclitaxel|mesh-list
6423826|NCT00301522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6423827|NCT00301522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6423828|NCT00301522|Tubulin Modulators|tubulin modulators|mesh-ancestor
6423829|NCT00301522|Antimitotic Agents|antimitotic agents|mesh-ancestor
6423830|NCT00301522|Mitosis Modulators|mitosis modulators|mesh-ancestor
6423831|NCT00301522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423832|NCT00301535|HBOC 201|hboc 201|mesh-list
6423833|NCT00301535|Blood Substitutes|blood substitutes|mesh-ancestor
6423834|NCT00301574|Galantamine|galantamine|mesh-list
6423835|NCT00301574|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6423836|NCT00301574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6423837|NCT00301574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423838|NCT00301574|Cholinergic Agents|cholinergic agents|mesh-ancestor
6423839|NCT00301574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6423840|NCT00301574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423841|NCT00301574|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6423842|NCT00301574|Autonomic Agents|autonomic agents|mesh-ancestor
6423843|NCT00301574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6423844|NCT00301574|Nootropic Agents|nootropic agents|mesh-ancestor
6423845|NCT00301587|Folic Acid|folic acid|mesh-list
6423846|NCT00301587|Moxifloxacin|moxifloxacin|mesh-list
6423847|NCT00301587|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6423848|NCT00301587|Norgestimate|norgestimate|mesh-list
6423849|NCT00301587|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6423850|NCT00301587|Estradiol|estradiol|mesh-list
6423851|NCT00301587|Estrogens|estrogens|mesh-ancestor
6423852|NCT00301587|Hormones|hormones|mesh-ancestor
6423853|NCT00301587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6423854|NCT00301587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423855|NCT00301587|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6423856|NCT00301587|Contraceptive Agents|contraceptive agents|mesh-ancestor
6423857|NCT00301587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6423858|NCT00301587|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6423859|NCT00301587|Hematinics|hematinics|mesh-ancestor
6423860|NCT00301587|Vitamin B Complex|vitamin b complex|mesh-ancestor
6423861|NCT00301587|Vitamins|vitamins|mesh-ancestor
6423862|NCT00301587|Micronutrients|micronutrients|mesh-ancestor
6460505|NCT00450164|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
6423863|NCT00301587|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6423864|NCT00301587|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6423865|NCT00301587|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6423866|NCT00301587|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6423867|NCT00301587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6423868|NCT00301587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6423869|NCT00301587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6423870|NCT00301587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6423871|NCT00301587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423872|NCT00301587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6423873|NCT00301587|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6423874|NCT00301600|Mycophenolic Acid|mycophenolic acid|mesh-list
6423875|NCT00301600|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6423876|NCT00301600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6423877|NCT00301600|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6423878|NCT00301600|Antitubercular Agents|antitubercular agents|mesh-ancestor
6423879|NCT00301600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6423880|NCT00301600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6423881|NCT00301600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6423882|NCT00301600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423883|NCT00301613|Mycophenolic Acid|mycophenolic acid|mesh-list
6423884|NCT00301613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6423885|NCT00301613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6423886|NCT00301613|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6423887|NCT00301613|Antitubercular Agents|antitubercular agents|mesh-ancestor
6423888|NCT00301613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6423889|NCT00301613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6423890|NCT00301613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6423891|NCT00301613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423892|NCT00301639|Methylphenidate|methylphenidate|mesh-list
6423893|NCT00301639|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6423894|NCT00301639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423895|NCT00301639|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6423896|NCT00301639|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6423897|NCT00301639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6423898|NCT00301639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423899|NCT00301639|Dopamine Agents|dopamine agents|mesh-ancestor
6423900|NCT00301639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6423901|NCT00301652|Mycophenolic Acid|mycophenolic acid|mesh-list
6423902|NCT00301652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6423903|NCT00301652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6423904|NCT00301652|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6423905|NCT00301652|Antitubercular Agents|antitubercular agents|mesh-ancestor
6423906|NCT00301652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6423907|NCT00301652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6423908|NCT00301652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6423909|NCT00301652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423910|NCT00301665|Botulinum Toxins|botulinum toxins|mesh-list
6423911|NCT00301665|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6423912|NCT00301665|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6423913|NCT00301665|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6423914|NCT00301665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6423915|NCT00301665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423916|NCT00301665|Cholinergic Agents|cholinergic agents|mesh-ancestor
6423917|NCT00301665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6423918|NCT00301665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423919|NCT00301665|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6423920|NCT00301665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6423921|NCT00301730|Aldesleukin|aldesleukin|mesh-list
6423922|NCT00301730|Paclitaxel|paclitaxel|mesh-list
6423923|NCT00301730|Trastuzumab|trastuzumab|mesh-list
6423924|NCT00301730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6423925|NCT00301730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6423926|NCT00301730|Tubulin Modulators|tubulin modulators|mesh-ancestor
6423927|NCT00301730|Antimitotic Agents|antimitotic agents|mesh-ancestor
6423928|NCT00301730|Mitosis Modulators|mitosis modulators|mesh-ancestor
6423929|NCT00301730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423930|NCT00301730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6423931|NCT00301730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6423932|NCT00301730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6423933|NCT00301730|Antiviral Agents|antiviral agents|mesh-ancestor
6423934|NCT00301730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6423935|NCT00301782|Carboplatin|carboplatin|mesh-list
6423936|NCT00301782|Etoposide|etoposide|mesh-list
6423937|NCT00301782|Vincristine|vincristine|mesh-list
6423938|NCT00301782|Bleomycin|bleomycin|mesh-list
6423939|NCT00301782|Etoposide phosphate|etoposide phosphate|mesh-list
6423940|NCT00301782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6423941|NCT00301782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6423942|NCT00301782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6423943|NCT00301782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6423944|NCT00301782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6423945|NCT00301782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423946|NCT00301782|Tubulin Modulators|tubulin modulators|mesh-ancestor
6423947|NCT00301782|Antimitotic Agents|antimitotic agents|mesh-ancestor
6423948|NCT00301782|Mitosis Modulators|mitosis modulators|mesh-ancestor
6423949|NCT00301782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6423950|NCT00301795|Rituximab|rituximab|mesh-list
6423951|NCT00301795|Oblimersen|oblimersen|mesh-list
6423952|NCT00301795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6423953|NCT00301795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6423954|NCT00301795|Immunologic Factors|immunologic factors|mesh-ancestor
6423955|NCT00301795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423956|NCT00301795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6423957|NCT00301847|Sorafenib|sorafenib|mesh-list
6423958|NCT00301847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6423959|NCT00301847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6423960|NCT00301847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6423961|NCT00301847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423962|NCT00301860|Cyclosporine|cyclosporine|mesh-list
6423963|NCT00301860|Methotrexate|methotrexate|mesh-list
6423964|NCT00301860|Fludarabine phosphate|fludarabine phosphate|mesh-list
6423965|NCT00301860|Fludarabine|fludarabine|mesh-list
6423966|NCT00301860|Melphalan|melphalan|mesh-list
6423967|NCT00301860|Cyclosporins|cyclosporins|mesh-list
6423968|NCT00301860|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6423969|NCT00301860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6423970|NCT00301860|Abortifacient Agents|abortifacient agents|mesh-ancestor
6423971|NCT00301860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6423972|NCT00301860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423973|NCT00301860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6423974|NCT00301860|Antimetabolites|antimetabolites|mesh-ancestor
6423975|NCT00301860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6423976|NCT00301860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6423977|NCT00301860|Dermatologic Agents|dermatologic agents|mesh-ancestor
6423978|NCT00301860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6423979|NCT00301860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6423980|NCT00301860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6423981|NCT00301860|Immunologic Factors|immunologic factors|mesh-ancestor
6423982|NCT00301860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6423983|NCT00301860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6423984|NCT00301860|Antifungal Agents|antifungal agents|mesh-ancestor
6423985|NCT00301860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6423986|NCT00301860|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6423987|NCT00301860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6423988|NCT00301860|Alkylating Agents|alkylating agents|mesh-ancestor
6423989|NCT00301860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6423990|NCT00301886|Zoledronic Acid|zoledronic acid|mesh-list
6423991|NCT00301886|Ibandronic Acid|ibandronic acid|mesh-list
6423992|NCT00301886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6423993|NCT00301886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6423994|NCT00301899|Trastuzumab|trastuzumab|mesh-list
6423995|NCT00301899|Pertuzumab|pertuzumab|mesh-list
6423996|NCT00301899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6423997|NCT00301899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6423998|NCT00301912|Methotrexate|methotrexate|mesh-list
6423999|NCT00301912|Fludarabine phosphate|fludarabine phosphate|mesh-list
6424000|NCT00301912|Fludarabine|fludarabine|mesh-list
6424001|NCT00301912|Busulfan|busulfan|mesh-list
6424002|NCT00301912|Tacrolimus|tacrolimus|mesh-list
6424003|NCT00301912|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6424004|NCT00301912|Abortifacient Agents|abortifacient agents|mesh-ancestor
6424005|NCT00301912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6424006|NCT00301912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424007|NCT00301912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6424008|NCT00301912|Antimetabolites|antimetabolites|mesh-ancestor
6424009|NCT00301912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424010|NCT00301912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6424011|NCT00301912|Dermatologic Agents|dermatologic agents|mesh-ancestor
6424012|NCT00301912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6424013|NCT00301912|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6424014|NCT00301912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6424015|NCT00301912|Immunologic Factors|immunologic factors|mesh-ancestor
6424016|NCT00301912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6424017|NCT00301912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6424018|NCT00301912|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6424019|NCT00301912|Alkylating Agents|alkylating agents|mesh-ancestor
6424020|NCT00301912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6424021|NCT00301912|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6424022|NCT00301925|Cyclophosphamide|cyclophosphamide|mesh-list
6424023|NCT00301925|Fluorouracil|fluorouracil|mesh-list
6424024|NCT00301925|Capecitabine|capecitabine|mesh-list
6424025|NCT00301925|Methotrexate|methotrexate|mesh-list
6424026|NCT00301925|Epirubicin|epirubicin|mesh-list
6424027|NCT00301925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6424028|NCT00301925|Immunologic Factors|immunologic factors|mesh-ancestor
6424029|NCT00301925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424030|NCT00301925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6424031|NCT00301925|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6424032|NCT00301925|Alkylating Agents|alkylating agents|mesh-ancestor
6424033|NCT00301925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424034|NCT00301925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6424035|NCT00301925|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6424036|NCT00301925|Antimetabolites|antimetabolites|mesh-ancestor
6424037|NCT00301925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6424038|NCT00301925|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6424039|NCT00301925|Abortifacient Agents|abortifacient agents|mesh-ancestor
6424040|NCT00301925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6424041|NCT00301925|Dermatologic Agents|dermatologic agents|mesh-ancestor
6424042|NCT00301925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6424043|NCT00301925|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6424044|NCT00301925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6424045|NCT00301925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6424046|NCT00301925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6424047|NCT00301925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6424048|NCT00301938|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
6424049|NCT00301938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6424050|NCT00301938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6424051|NCT00301938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6424052|NCT00301938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424053|NCT00301951|Mycophenolic Acid|mycophenolic acid|mesh-list
6424054|NCT00301951|Fludarabine|fludarabine|mesh-list
6424055|NCT00301951|Fludarabine phosphate|fludarabine phosphate|mesh-list
6424056|NCT00301951|Busulfan|busulfan|mesh-list
6424057|NCT00301951|Tacrolimus|tacrolimus|mesh-list
6424058|NCT00301951|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6424059|NCT00301951|Sargramostim|sargramostim|mesh-list
6424060|NCT00301951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6424061|NCT00301951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6424062|NCT00301951|Antimetabolites|antimetabolites|mesh-ancestor
6424063|NCT00301951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424064|NCT00301951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6424065|NCT00301951|Immunologic Factors|immunologic factors|mesh-ancestor
6424066|NCT00301951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424067|NCT00301951|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6424068|NCT00301951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6424069|NCT00301951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6424070|NCT00301951|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6424071|NCT00301951|Antitubercular Agents|antitubercular agents|mesh-ancestor
6424072|NCT00301951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6424073|NCT00301951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6424074|NCT00301951|Alkylating Agents|alkylating agents|mesh-ancestor
6424075|NCT00301951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6424076|NCT00301951|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6424077|NCT00301990|Aldesleukin|aldesleukin|mesh-list
6424078|NCT00301990|Bevacizumab|bevacizumab|mesh-list
6424079|NCT00301990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6424080|NCT00301990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6424081|NCT00301990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6424082|NCT00301990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6424083|NCT00301990|Growth Substances|growth substances|mesh-ancestor
6424084|NCT00301990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424085|NCT00301990|Growth Inhibitors|growth inhibitors|mesh-ancestor
6424086|NCT00301990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6424087|NCT00301990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6424088|NCT00301990|Antiviral Agents|antiviral agents|mesh-ancestor
6424089|NCT00301990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6424090|NCT00302224|Ketoconazole|ketoconazole|mesh-list
6424091|NCT00302224|Antifungal Agents|antifungal agents|mesh-ancestor
6424092|NCT00302224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6424093|NCT00302224|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6424094|NCT00302224|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6424095|NCT00302224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6424096|NCT00302224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424097|NCT00302224|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6424098|NCT00302224|Hormone Antagonists|hormone antagonists|mesh-ancestor
6424099|NCT00302224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6424100|NCT00302224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424101|NCT00302224|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6424102|NCT00302289|Caffeine|caffeine|mesh-list
6424103|NCT00302289|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6424104|NCT00302289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424105|NCT00302289|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6424106|NCT00302289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6424107|NCT00302289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424108|NCT00302289|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6424109|NCT00302289|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6424110|NCT00302289|Purinergic Agents|purinergic agents|mesh-ancestor
6424111|NCT00302289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6424112|NCT00302341|Trimethoprim|trimethoprim|mesh-list
6424113|NCT00302341|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6424114|NCT00302341|Sulfamethoxazole|sulfamethoxazole|mesh-list
6424115|NCT00302341|Pafuramidine|pafuramidine|mesh-list
6538193|NCT00826553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6538194|NCT00826553|Analgesics|analgesics|mesh-ancestor
6538195|NCT00826553|Sensory System Agents|sensory system agents|mesh-ancestor
6538196|NCT00826553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6538197|NCT00826553|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6424116|NCT00302341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6424117|NCT00302341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424118|NCT00302341|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6424119|NCT00302341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6424120|NCT00302341|Renal Agents|renal agents|mesh-ancestor
6424121|NCT00302341|Antimalarials|antimalarials|mesh-ancestor
6424122|NCT00302341|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6424123|NCT00302341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6424124|NCT00302341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6424125|NCT00302341|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6424126|NCT00302341|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6424127|NCT00302341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6424128|NCT00302341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6424129|NCT00302341|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6538198|NCT00826553|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6538199|NCT00826553|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6538200|NCT00826553|Adrenergic Agents|adrenergic agents|mesh-ancestor
6538201|NCT00826553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6538202|NCT00826553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538203|NCT00826553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6538204|NCT00826553|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6538205|NCT00826553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6538206|NCT00826553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6538207|NCT00826553|GABA Modulators|gaba modulators|mesh-ancestor
6538208|NCT00826553|GABA Agents|gaba agents|mesh-ancestor
6538209|NCT00826553|Anticonvulsants|anticonvulsants|mesh-ancestor
6538210|NCT00826553|Antiemetics|antiemetics|mesh-ancestor
6538211|NCT00826553|Autonomic Agents|autonomic agents|mesh-ancestor
6538212|NCT00826553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6538213|NCT00826566|Caffeine|caffeine|mesh-list
6538214|NCT00826566|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6538215|NCT00826566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538216|NCT00826566|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6538217|NCT00826566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6538218|NCT00826566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538219|NCT00826566|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6538220|NCT00826566|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6538221|NCT00826566|Purinergic Agents|purinergic agents|mesh-ancestor
6538222|NCT00826566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6538223|NCT00826644|Etoposide|etoposide|mesh-list
6538224|NCT00826644|Belotecan|belotecan|mesh-list
6538225|NCT00826644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6538226|NCT00826644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6538227|NCT00826644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6538228|NCT00826644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6538229|NCT00826644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6538230|NCT00826644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538231|NCT00826644|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6538232|NCT00826657|Vitamin B 12|vitamin b 12|mesh-list
6538233|NCT00826657|Hydroxocobalamin|hydroxocobalamin|mesh-list
6538234|NCT00826657|Vitamins|vitamins|mesh-ancestor
6538235|NCT00826657|Micronutrients|micronutrients|mesh-ancestor
6538236|NCT00826657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538237|NCT00826657|Vitamin B Complex|vitamin b complex|mesh-ancestor
6538238|NCT00826657|Hematinics|hematinics|mesh-ancestor
6538239|NCT00826722|Levetiracetam|levetiracetam|mesh-list
6538240|NCT00826722|Anticonvulsants|anticonvulsants|mesh-ancestor
6538241|NCT00826722|Nootropic Agents|nootropic agents|mesh-ancestor
6538242|NCT00826787|Levetiracetam|levetiracetam|mesh-list
6538243|NCT00826787|Anticonvulsants|anticonvulsants|mesh-ancestor
6538244|NCT00826787|Nootropic Agents|nootropic agents|mesh-ancestor
6538245|NCT00826826|Amiodarone|amiodarone|mesh-list
6538246|NCT00826826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6538247|NCT00826826|Vasodilator Agents|vasodilator agents|mesh-ancestor
6424130|NCT00302354|Methylphenidate|methylphenidate|mesh-list
6424131|NCT00302354|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6424132|NCT00302354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424133|NCT00302354|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6424134|NCT00302354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6424135|NCT00302354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6424136|NCT00302354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424137|NCT00302354|Dopamine Agents|dopamine agents|mesh-ancestor
6424138|NCT00302354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6424139|NCT00302367|Methylphenidate|methylphenidate|mesh-list
6424140|NCT00302367|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6424141|NCT00302367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424142|NCT00302367|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6424143|NCT00302367|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6424144|NCT00302367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6424145|NCT00302367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424146|NCT00302367|Dopamine Agents|dopamine agents|mesh-ancestor
6424147|NCT00302367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6424148|NCT00302393|Methylphenidate|methylphenidate|mesh-list
6424149|NCT00302393|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6424150|NCT00302393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424151|NCT00302393|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6424152|NCT00302393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6424153|NCT00302393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6424154|NCT00302393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424155|NCT00302393|Dopamine Agents|dopamine agents|mesh-ancestor
6424156|NCT00302393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6424157|NCT00302406|Methylphenidate|methylphenidate|mesh-list
6424158|NCT00302406|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6424159|NCT00302406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424160|NCT00302406|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6424161|NCT00302406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6424162|NCT00302406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6424163|NCT00302406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424164|NCT00302406|Dopamine Agents|dopamine agents|mesh-ancestor
6424165|NCT00302406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6424166|NCT00302419|Streptokinase|streptokinase|mesh-list
6424167|NCT00302419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6424168|NCT00302419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6424169|NCT00302419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424170|NCT00302432|Menthol|menthol|mesh-list
6424171|NCT00302432|Antipruritics|antipruritics|mesh-ancestor
6424172|NCT00302432|Dermatologic Agents|dermatologic agents|mesh-ancestor
6424173|NCT00302484|Zoledronic Acid|zoledronic acid|mesh-list
6424174|NCT00302484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6424175|NCT00302484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424176|NCT00302497|Basiliximab|basiliximab|mesh-list
6424177|NCT00302497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6424178|NCT00302497|Immunologic Factors|immunologic factors|mesh-ancestor
6424179|NCT00302497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424180|NCT00302523|Tacrolimus|tacrolimus|mesh-list
6424181|NCT00302523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6424182|NCT00302523|Immunologic Factors|immunologic factors|mesh-ancestor
6424183|NCT00302523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424184|NCT00302523|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6424185|NCT00302523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6424186|NCT00302523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424187|NCT00302536|Tacrolimus|tacrolimus|mesh-list
6424188|NCT00302536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6424189|NCT00302536|Immunologic Factors|immunologic factors|mesh-ancestor
6424190|NCT00302536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424191|NCT00302536|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6424192|NCT00302536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6424193|NCT00302536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424194|NCT00302549|Tacrolimus|tacrolimus|mesh-list
6424195|NCT00302549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6424196|NCT00302549|Immunologic Factors|immunologic factors|mesh-ancestor
6424197|NCT00302549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424198|NCT00302549|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6424199|NCT00302549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6424200|NCT00302549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424201|NCT00302627|Calcium, Dietary|calcium, dietary|mesh-list
6424202|NCT00302627|Vitamin D|vitamin d|mesh-list
6424203|NCT00302627|Ergocalciferols|ergocalciferols|mesh-list
6424204|NCT00302627|Pamidronate|pamidronate|mesh-list
6424205|NCT00302627|Vitamins|vitamins|mesh-list
6424206|NCT00302627|Calcium Carbonate|calcium carbonate|mesh-list
6424207|NCT00302627|Calcium|calcium|mesh-list
6424208|NCT00302627|Micronutrients|micronutrients|mesh-ancestor
6424209|NCT00302627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424210|NCT00302627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6424211|NCT00302627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6424212|NCT00302627|Antacids|antacids|mesh-ancestor
6424213|NCT00302627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424214|NCT00302627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6424215|NCT00302640|Nitazoxanide|nitazoxanide|mesh-list
6424216|NCT00302640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6424217|NCT00302640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6424218|NCT00302653|Rasburicase|rasburicase|mesh-list
6424219|NCT00302653|Gout Suppressants|gout suppressants|mesh-ancestor
6424220|NCT00302653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6424221|NCT00302666|Dienogest|dienogest|mesh-list
6424222|NCT00302666|Nandrolone|nandrolone|mesh-list
6424223|NCT00302666|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6424224|NCT00302666|Contraceptive Agents|contraceptive agents|mesh-ancestor
6424225|NCT00302666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6424226|NCT00302666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424227|NCT00302666|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6424228|NCT00302666|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6424229|NCT00302666|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6424230|NCT00302666|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6424231|NCT00302666|Hormone Antagonists|hormone antagonists|mesh-ancestor
6424232|NCT00302666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6424233|NCT00302666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6424234|NCT00302666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6424235|NCT00302666|Androgens|androgens|mesh-ancestor
6424236|NCT00302666|Hormones|hormones|mesh-ancestor
6424237|NCT00302666|Anabolic Agents|anabolic agents|mesh-ancestor
6424238|NCT00302692|Metoprolol|metoprolol|mesh-list
6424239|NCT00302692|Esmolol|esmolol|mesh-list
6424240|NCT00302692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6424241|NCT00302692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6424242|NCT00302692|Sympatholytics|sympatholytics|mesh-ancestor
6424243|NCT00302692|Autonomic Agents|autonomic agents|mesh-ancestor
6424244|NCT00302692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6424245|NCT00302692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424246|NCT00302692|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6424247|NCT00302692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6424248|NCT00302692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6424249|NCT00302692|Adrenergic Agents|adrenergic agents|mesh-ancestor
6424250|NCT00302692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6424251|NCT00302692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424252|NCT00302705|Valsartan|valsartan|mesh-list
6424253|NCT00302705|Enalapril|enalapril|mesh-list
6424254|NCT00302705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6424255|NCT00302705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6424256|NCT00302705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6424257|NCT00302705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424258|NCT00302705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6424259|NCT00302705|Protease Inhibitors|protease inhibitors|mesh-ancestor
6424260|NCT00302705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6424261|NCT00302744|Psilocybin|psilocybin|mesh-list
6424262|NCT00302744|Hallucinogens|hallucinogens|mesh-ancestor
6424263|NCT00302744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424264|NCT00302744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6424265|NCT00302770|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6424266|NCT00302770|Antidepressive Agents|antidepressive agents|mesh-ancestor
6424267|NCT00302770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6424268|NCT00302770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6424269|NCT00302770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6424270|NCT00302770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6424271|NCT00302770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424272|NCT00302822|Tenofovir|tenofovir|mesh-list
6424273|NCT00302822|Emtricitabine|emtricitabine|mesh-list
6424274|NCT00302822|Efavirenz|efavirenz|mesh-list
6424275|NCT00302822|Lopinavir|lopinavir|mesh-list
6424276|NCT00302822|Enfuvirtide|enfuvirtide|mesh-list
6424277|NCT00302822|Antiviral Agents|antiviral agents|mesh-ancestor
6424278|NCT00302822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6424279|NCT00302822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6424280|NCT00302822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6424281|NCT00302822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6424282|NCT00302822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424283|NCT00302822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6424284|NCT00302822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6424285|NCT00302822|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6424286|NCT00302822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6424287|NCT00302822|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6424288|NCT00302822|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6424289|NCT00302822|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6424290|NCT00302822|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6424291|NCT00302822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6424292|NCT00302822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6424293|NCT00302822|Protease Inhibitors|protease inhibitors|mesh-ancestor
6424294|NCT00302822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6424295|NCT00302822|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6424296|NCT00302822|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6424297|NCT00302835|Analgesics|analgesics|mesh-list
6424298|NCT00302835|Sensory System Agents|sensory system agents|mesh-ancestor
6424299|NCT00302835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6424300|NCT00302835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424301|NCT00302913|Clopidogrel|clopidogrel|mesh-list
6424302|NCT00302913|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6424303|NCT00302913|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6424304|NCT00302913|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6424305|NCT00302913|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6424306|NCT00302913|Purinergic Agents|purinergic agents|mesh-ancestor
6424307|NCT00302913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6424308|NCT00302913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424309|NCT00302913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424310|NCT00303004|Bosentan|bosentan|mesh-list
6424311|NCT00303004|Sildenafil Citrate|sildenafil citrate|mesh-list
6424312|NCT00303004|Vasodilator Agents|vasodilator agents|mesh-ancestor
6424313|NCT00303004|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6424314|NCT00303004|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6424315|NCT00303004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6424316|NCT00303004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538248|NCT00826826|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6538249|NCT00826826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6538250|NCT00826826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424317|NCT00303004|Urological Agents|urological agents|mesh-ancestor
6424318|NCT00303004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6424319|NCT00303004|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6424320|NCT00303017|Naproxen|naproxen|mesh-list
6424321|NCT00303017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6424322|NCT00303017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6424323|NCT00303017|Analgesics|analgesics|mesh-ancestor
6424324|NCT00303017|Sensory System Agents|sensory system agents|mesh-ancestor
6424325|NCT00303017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6424326|NCT00303017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424327|NCT00303017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6424328|NCT00303017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6424329|NCT00303017|Gout Suppressants|gout suppressants|mesh-ancestor
6424330|NCT00303017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6424331|NCT00303017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6424332|NCT00303017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460506|NCT00450164|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
6460507|NCT00450164|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6460508|NCT00450164|Diuretics|diuretics|mesh-ancestor
6460509|NCT00450164|Natriuretic Agents|natriuretic agents|mesh-ancestor
6460510|NCT00450164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460511|NCT00450164|Vasodilator Agents|vasodilator agents|mesh-ancestor
6460512|NCT00450164|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6460513|NCT00450164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460514|NCT00450164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6460515|NCT00450164|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6460516|NCT00450164|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6460517|NCT00450164|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6460518|NCT00450164|Adrenergic Agents|adrenergic agents|mesh-ancestor
6460519|NCT00450164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6460520|NCT00450164|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6460521|NCT00450164|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6460522|NCT00450164|Sympatholytics|sympatholytics|mesh-ancestor
6460523|NCT00450164|Autonomic Agents|autonomic agents|mesh-ancestor
6460524|NCT00450164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6460525|NCT00450203|Bevacizumab|bevacizumab|mesh-list
6460526|NCT00450203|Capecitabine|capecitabine|mesh-list
6460527|NCT00450203|Epirubicin|epirubicin|mesh-list
6460528|NCT00450203|Lapatinib|lapatinib|mesh-list
6460529|NCT00450203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6460530|NCT00450203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6460531|NCT00450203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6460532|NCT00450203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6460533|NCT00450203|Growth Substances|growth substances|mesh-ancestor
6460534|NCT00450203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460535|NCT00450203|Growth Inhibitors|growth inhibitors|mesh-ancestor
6460536|NCT00450203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6460537|NCT00450203|Antimetabolites|antimetabolites|mesh-ancestor
6460538|NCT00450203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460539|NCT00450203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6460540|NCT00450203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6460541|NCT00450203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6460542|NCT00450203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6460543|NCT00450203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6460544|NCT00450229|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
6460545|NCT00450229|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6460546|NCT00450229|Protective Agents|protective agents|mesh-ancestor
6460547|NCT00450229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460548|NCT00450229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6460549|NCT00450281|Antibodies|antibodies|mesh-list
6460550|NCT00450281|Immunologic Factors|immunologic factors|mesh-ancestor
6460551|NCT00450281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460552|NCT00450307|Antibodies|antibodies|mesh-list
6460553|NCT00450307|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6460554|NCT00450307|Sargramostim|sargramostim|mesh-list
6460555|NCT00450307|Immunologic Factors|immunologic factors|mesh-ancestor
6460556|NCT00450307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460557|NCT00450320|Sirolimus|sirolimus|mesh-list
6460558|NCT00450320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6460559|NCT00450320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6460560|NCT00450320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6460561|NCT00450320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6460562|NCT00450320|Antifungal Agents|antifungal agents|mesh-ancestor
6460563|NCT00450320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6424333|NCT00303056|Icatibant|icatibant|mesh-list
6424334|NCT00303056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6424335|NCT00303056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6424336|NCT00303056|Analgesics|analgesics|mesh-ancestor
6424337|NCT00303056|Sensory System Agents|sensory system agents|mesh-ancestor
6424338|NCT00303056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6424339|NCT00303056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424340|NCT00303056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6424341|NCT00303056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6424342|NCT00303056|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
6424343|NCT00303056|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
6424344|NCT00303056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424345|NCT00303056|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6424346|NCT00303056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6424347|NCT00303056|Immunologic Factors|immunologic factors|mesh-ancestor
6424348|NCT00303160|Ascorbic Acid|ascorbic acid|mesh-list
6424349|NCT00303160|Vitamins|vitamins|mesh-ancestor
6424350|NCT00303160|Micronutrients|micronutrients|mesh-ancestor
6424351|NCT00303160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424352|NCT00303160|Antioxidants|antioxidants|mesh-ancestor
6424353|NCT00303160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424354|NCT00303160|Protective Agents|protective agents|mesh-ancestor
6424355|NCT00303264|Esomeprazole|esomeprazole|mesh-list
6424356|NCT00303264|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6424357|NCT00303264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6424358|NCT00303264|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6424359|NCT00303264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6424360|NCT00303264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424361|NCT00303277|Simvastatin|simvastatin|mesh-list
6424362|NCT00303277|Pravastatin|pravastatin|mesh-list
6424363|NCT00303277|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6424364|NCT00303277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6424365|NCT00303277|Antimetabolites|antimetabolites|mesh-ancestor
6424366|NCT00303277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424367|NCT00303277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6424368|NCT00303277|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6424369|NCT00303277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6424370|NCT00303290|Interferons|interferons|mesh-list
6424371|NCT00303290|Cytarabine|cytarabine|mesh-list
6424372|NCT00303290|Interferon-alpha|interferon-alpha|mesh-list
6424373|NCT00303290|Interferon alpha-2|interferon alpha-2|mesh-list
6424374|NCT00303290|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6424375|NCT00303290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6424376|NCT00303290|Antiviral Agents|antiviral agents|mesh-ancestor
6424377|NCT00303290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6424378|NCT00303290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6424379|NCT00303290|Antimetabolites|antimetabolites|mesh-ancestor
6424380|NCT00303290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424381|NCT00303290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6424382|NCT00303290|Immunologic Factors|immunologic factors|mesh-ancestor
6424383|NCT00303290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424384|NCT00303381|Interferons|interferons|mesh-list
6424385|NCT00303381|Interferon-beta|interferon-beta|mesh-list
6424386|NCT00303381|Interferon beta-1a|interferon beta-1a|mesh-list
6424387|NCT00303381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6424388|NCT00303381|Antiviral Agents|antiviral agents|mesh-ancestor
6538251|NCT00826826|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6538252|NCT00826826|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6538253|NCT00826826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6538254|NCT00826826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6538255|NCT00826826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6424389|NCT00303381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6424390|NCT00303381|Immunologic Factors|immunologic factors|mesh-ancestor
6424391|NCT00303381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424392|NCT00303381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6424393|NCT00303394|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6424394|NCT00303394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6424395|NCT00303407|Nadroparin|nadroparin|mesh-list
6424396|NCT00303407|Anticoagulants|anticoagulants|mesh-ancestor
6424397|NCT00303407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6424398|NCT00303407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6424399|NCT00303407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424400|NCT00303420|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6424401|NCT00303420|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6424402|NCT00303420|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6424403|NCT00303420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424404|NCT00303433|Memantine|memantine|mesh-list
6424405|NCT00303433|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6424406|NCT00303433|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6424407|NCT00303433|Dopamine Agents|dopamine agents|mesh-ancestor
6424408|NCT00303433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6424409|NCT00303433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424410|NCT00303433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424411|NCT00303433|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6424412|NCT00303433|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6424413|NCT00303524|Goserelin|goserelin|mesh-list
6424414|NCT00303524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6424415|NCT00303524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6424416|NCT00303537|Metformin|metformin|mesh-list
6424417|NCT00303537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6424418|NCT00303537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424419|NCT00303550|Linezolid|linezolid|mesh-list
6424420|NCT00303550|Iclaprim|iclaprim|mesh-list
6424421|NCT00303550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6424422|NCT00303550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6424423|NCT00303550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6424424|NCT00303550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6424425|NCT00303550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424426|NCT00303550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6424427|NCT00303576|Dapivirine|dapivirine|mesh-list
6424428|NCT00303576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6424429|NCT00303576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6424430|NCT00303576|Antiviral Agents|antiviral agents|mesh-ancestor
6424431|NCT00303576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6424432|NCT00303589|Lactams|lactams|mesh-list
6424433|NCT00303589|beta-Lactams|beta-lactams|mesh-list
6424434|NCT00303589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6424435|NCT00303589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6424436|NCT00303615|Anastrozole|anastrozole|mesh-list
6424437|NCT00303615|Fluoxymesterone|fluoxymesterone|mesh-list
6424438|NCT00303615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6424439|NCT00303615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6424440|NCT00303615|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6424441|NCT00303615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6424442|NCT00303615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6424443|NCT00303615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424444|NCT00303615|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6424445|NCT00303615|Hormone Antagonists|hormone antagonists|mesh-ancestor
6424446|NCT00303615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6424447|NCT00303615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424448|NCT00303615|Anabolic Agents|anabolic agents|mesh-ancestor
6424449|NCT00303615|Hormones|hormones|mesh-ancestor
6424450|NCT00303732|Everolimus|everolimus|mesh-list
6424451|NCT00303732|Vatalanib|vatalanib|mesh-list
6424452|NCT00303732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6424453|NCT00303732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6424454|NCT00303732|Immunologic Factors|immunologic factors|mesh-ancestor
6424455|NCT00303732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424456|NCT00303732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6424457|NCT00303732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6424458|NCT00303732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424459|NCT00303745|Capecitabine|capecitabine|mesh-list
6424460|NCT00303745|Irinotecan|irinotecan|mesh-list
6424461|NCT00303745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6424462|NCT00303745|Antimetabolites|antimetabolites|mesh-ancestor
6424463|NCT00303745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424464|NCT00303745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6424465|NCT00303745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6460564|NCT00450320|Immunologic Factors|immunologic factors|mesh-ancestor
6424466|NCT00303745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6424467|NCT00303745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6424468|NCT00303758|Leucovorin|leucovorin|mesh-list
6424469|NCT00303758|Gemcitabine|gemcitabine|mesh-list
6424470|NCT00303758|Fluorouracil|fluorouracil|mesh-list
6424471|NCT00303758|Calcium|calcium|mesh-list
6424472|NCT00303758|Levoleucovorin|levoleucovorin|mesh-list
6424473|NCT00303758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6424474|NCT00303758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6424475|NCT00303758|Antimetabolites|antimetabolites|mesh-ancestor
6424476|NCT00303758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424477|NCT00303758|Antiviral Agents|antiviral agents|mesh-ancestor
6424478|NCT00303758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6424479|NCT00303758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6424480|NCT00303758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6424481|NCT00303758|Immunologic Factors|immunologic factors|mesh-ancestor
6424482|NCT00303758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424483|NCT00303758|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6424484|NCT00303758|Antidotes|antidotes|mesh-ancestor
6424485|NCT00303758|Protective Agents|protective agents|mesh-ancestor
6424486|NCT00303758|Vitamin B Complex|vitamin b complex|mesh-ancestor
6424487|NCT00303758|Vitamins|vitamins|mesh-ancestor
6424488|NCT00303758|Micronutrients|micronutrients|mesh-ancestor
6424489|NCT00303771|Leucovorin|leucovorin|mesh-list
6424490|NCT00303771|Fluorouracil|fluorouracil|mesh-list
6424491|NCT00303771|Irinotecan|irinotecan|mesh-list
6424492|NCT00303771|Calcium|calcium|mesh-list
6424493|NCT00303771|Levoleucovorin|levoleucovorin|mesh-list
6424494|NCT00303771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6424495|NCT00303771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424496|NCT00303771|Antimetabolites|antimetabolites|mesh-ancestor
6424497|NCT00303771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424498|NCT00303771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6424499|NCT00303771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6424500|NCT00303771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6424501|NCT00303771|Immunologic Factors|immunologic factors|mesh-ancestor
6424502|NCT00303771|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6424503|NCT00303771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6424504|NCT00303771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6424505|NCT00303771|Antidotes|antidotes|mesh-ancestor
6424506|NCT00303771|Protective Agents|protective agents|mesh-ancestor
6424507|NCT00303771|Vitamin B Complex|vitamin b complex|mesh-ancestor
6424508|NCT00303771|Vitamins|vitamins|mesh-ancestor
6424509|NCT00303771|Micronutrients|micronutrients|mesh-ancestor
6424510|NCT00303784|Goserelin|goserelin|mesh-list
6424511|NCT00303784|Estradiol|estradiol|mesh-list
6424512|NCT00303784|Estrogens|estrogens|mesh-ancestor
6424513|NCT00303784|Hormones|hormones|mesh-ancestor
6538256|NCT00826826|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6538257|NCT00826826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6538258|NCT00826839|Leuprolide|leuprolide|mesh-list
6538259|NCT00826839|Contraceptive Agents|contraceptive agents|mesh-list
6538260|NCT00826839|Contraceptives, Oral|contraceptives, oral|mesh-list
6538261|NCT00826839|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
6538262|NCT00826839|Ganirelix|ganirelix|mesh-list
6538263|NCT00826839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6538264|NCT00826839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538265|NCT00826839|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6538266|NCT00826839|Fertility Agents|fertility agents|mesh-ancestor
6538267|NCT00826839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6538268|NCT00826839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6538269|NCT00826839|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6538270|NCT00826839|Hormone Antagonists|hormone antagonists|mesh-ancestor
6538271|NCT00826839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6538272|NCT00826852|Carboplatin|carboplatin|mesh-list
6538273|NCT00826852|Docetaxel|docetaxel|mesh-list
6538274|NCT00826852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6538275|NCT00826852|Tubulin Modulators|tubulin modulators|mesh-ancestor
6538276|NCT00826852|Antimitotic Agents|antimitotic agents|mesh-ancestor
6538277|NCT00826852|Mitosis Modulators|mitosis modulators|mesh-ancestor
6538278|NCT00826852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538279|NCT00826865|Levetiracetam|levetiracetam|mesh-list
6538280|NCT00826865|Anticonvulsants|anticonvulsants|mesh-ancestor
6538281|NCT00826865|Nootropic Agents|nootropic agents|mesh-ancestor
6424514|NCT00303784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6424515|NCT00303784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424516|NCT00303784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6424517|NCT00303784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6424518|NCT00303797|Bortezomib|bortezomib|mesh-list
6424519|NCT00303797|Sorafenib|sorafenib|mesh-list
6424520|NCT00303797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6424521|NCT00303797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6424522|NCT00303797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6424523|NCT00303797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424524|NCT00303810|Cyclophosphamide|cyclophosphamide|mesh-list
6424525|NCT00303810|Thiotepa|thiotepa|mesh-list
6424526|NCT00303810|Lomustine|lomustine|mesh-list
6424527|NCT00303810|Carboplatin|carboplatin|mesh-list
6424528|NCT00303810|Methotrexate|methotrexate|mesh-list
6424529|NCT00303810|Etoposide|etoposide|mesh-list
6424530|NCT00303810|Vincristine|vincristine|mesh-list
6424531|NCT00303810|Etoposide phosphate|etoposide phosphate|mesh-list
6424532|NCT00303810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6424533|NCT00303810|Immunologic Factors|immunologic factors|mesh-ancestor
6424534|NCT00303810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424535|NCT00303810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6424536|NCT00303810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6424537|NCT00303810|Alkylating Agents|alkylating agents|mesh-ancestor
6424538|NCT00303810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424539|NCT00303810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6424540|NCT00303810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6424541|NCT00303810|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6424542|NCT00303810|Abortifacient Agents|abortifacient agents|mesh-ancestor
6424543|NCT00303810|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6424544|NCT00303810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6424545|NCT00303810|Antimetabolites|antimetabolites|mesh-ancestor
6424546|NCT00303810|Dermatologic Agents|dermatologic agents|mesh-ancestor
6424547|NCT00303810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6424548|NCT00303810|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6424549|NCT00303810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6424550|NCT00303810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6424551|NCT00303810|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6538282|NCT00826891|Topotecan|topotecan|mesh-list
6424552|NCT00303810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6424553|NCT00303810|Tubulin Modulators|tubulin modulators|mesh-ancestor
6424554|NCT00303810|Antimitotic Agents|antimitotic agents|mesh-ancestor
6424555|NCT00303810|Mitosis Modulators|mitosis modulators|mesh-ancestor
6424556|NCT00303836|Aldesleukin|aldesleukin|mesh-list
6424557|NCT00303836|Cyclophosphamide|cyclophosphamide|mesh-list
6424558|NCT00303836|Fludarabine|fludarabine|mesh-list
6424559|NCT00303836|Fludarabine phosphate|fludarabine phosphate|mesh-list
6424560|NCT00303836|Interleukin-2|interleukin-2|mesh-list
6424561|NCT00303836|Freund's Adjuvant|freund's adjuvant|mesh-list
6424562|NCT00303836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6424563|NCT00303836|Immunologic Factors|immunologic factors|mesh-ancestor
6424564|NCT00303836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424565|NCT00303836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6424566|NCT00303836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6424567|NCT00303836|Alkylating Agents|alkylating agents|mesh-ancestor
6424568|NCT00303836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424569|NCT00303836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6424570|NCT00303836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6424571|NCT00303836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6424572|NCT00303836|Antimetabolites|antimetabolites|mesh-ancestor
6424573|NCT00303836|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6424574|NCT00303836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6424575|NCT00303836|Analgesics|analgesics|mesh-ancestor
6424576|NCT00303836|Sensory System Agents|sensory system agents|mesh-ancestor
6424577|NCT00303836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6424578|NCT00303836|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6424579|NCT00303836|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6424580|NCT00303836|Antiviral Agents|antiviral agents|mesh-ancestor
6424581|NCT00303836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6424582|NCT00303849|Sodium thiosulfate|sodium thiosulfate|mesh-list
6424583|NCT00303849|Carboplatin|carboplatin|mesh-list
6424584|NCT00303849|Etoposide|etoposide|mesh-list
6424585|NCT00303849|Etoposide phosphate|etoposide phosphate|mesh-list
6424586|NCT00303849|Melphalan|melphalan|mesh-list
6424587|NCT00303849|Mechlorethamine|mechlorethamine|mesh-list
6424588|NCT00303849|Podophyllotoxin|podophyllotoxin|mesh-list
6424589|NCT00303849|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
6424590|NCT00303849|Mannitol|mannitol|mesh-list
6424591|NCT00303849|Antidotes|antidotes|mesh-list
6424592|NCT00303849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6424593|NCT00303849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6424594|NCT00303849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6424595|NCT00303849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6424596|NCT00303849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6424597|NCT00303849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424598|NCT00303849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6424599|NCT00303849|Alkylating Agents|alkylating agents|mesh-ancestor
6424600|NCT00303849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6424601|NCT00303849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6424602|NCT00303849|Immunologic Factors|immunologic factors|mesh-ancestor
6424603|NCT00303849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424604|NCT00303849|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6424605|NCT00303849|Diuretics|diuretics|mesh-ancestor
6424606|NCT00303849|Natriuretic Agents|natriuretic agents|mesh-ancestor
6424607|NCT00303849|Keratolytic Agents|keratolytic agents|mesh-ancestor
6424608|NCT00303849|Dermatologic Agents|dermatologic agents|mesh-ancestor
6424609|NCT00303849|Tubulin Modulators|tubulin modulators|mesh-ancestor
6424610|NCT00303849|Antimitotic Agents|antimitotic agents|mesh-ancestor
6424611|NCT00303849|Mitosis Modulators|mitosis modulators|mesh-ancestor
6424612|NCT00303849|Protective Agents|protective agents|mesh-ancestor
6424613|NCT00303849|Antioxidants|antioxidants|mesh-ancestor
6424614|NCT00303849|Antitubercular Agents|antitubercular agents|mesh-ancestor
6424615|NCT00303849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6424616|NCT00303849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6424617|NCT00303849|Chelating Agents|chelating agents|mesh-ancestor
6424618|NCT00303849|Sequestering Agents|sequestering agents|mesh-ancestor
6424619|NCT00303888|Docetaxel|docetaxel|mesh-list
6424620|NCT00303888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6424621|NCT00303888|Tubulin Modulators|tubulin modulators|mesh-ancestor
6424622|NCT00303888|Antimitotic Agents|antimitotic agents|mesh-ancestor
6424623|NCT00303888|Mitosis Modulators|mitosis modulators|mesh-ancestor
6424624|NCT00303888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424625|NCT00303927|Capecitabine|capecitabine|mesh-list
6424626|NCT00303927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6019127|NCT00385008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6019128|NCT00385008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6424627|NCT00303927|Antimetabolites|antimetabolites|mesh-ancestor
6424628|NCT00303927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424629|NCT00303927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6424630|NCT00303940|Carboplatin|carboplatin|mesh-list
6424631|NCT00303940|Temozolomide|temozolomide|mesh-list
6424632|NCT00303940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6424633|NCT00303940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6424634|NCT00303940|Alkylating Agents|alkylating agents|mesh-ancestor
6424635|NCT00303940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424636|NCT00303992|Trastuzumab|trastuzumab|mesh-list
6424637|NCT00303992|Irinotecan|irinotecan|mesh-list
6424638|NCT00303992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6424639|NCT00303992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6424640|NCT00303992|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6424641|NCT00303992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6424642|NCT00303992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6424643|NCT00303992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424644|NCT00304018|Prednisone|prednisone|mesh-list
6424645|NCT00304018|Fludarabine|fludarabine|mesh-list
6424646|NCT00304018|Fludarabine phosphate|fludarabine phosphate|mesh-list
6424647|NCT00304018|Etoposide|etoposide|mesh-list
6424648|NCT00304018|Busulfan|busulfan|mesh-list
6424649|NCT00304018|Tacrolimus|tacrolimus|mesh-list
6424650|NCT00304018|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6424651|NCT00304018|Sargramostim|sargramostim|mesh-list
6424652|NCT00304018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6424653|NCT00304018|Glucocorticoids|glucocorticoids|mesh-ancestor
6424654|NCT00304018|Hormones|hormones|mesh-ancestor
6424655|NCT00304018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6424656|NCT00304018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424657|NCT00304018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6424658|NCT00304018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6424659|NCT00304018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6424660|NCT00304018|Antimetabolites|antimetabolites|mesh-ancestor
6424661|NCT00304018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424662|NCT00304018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6424663|NCT00304018|Immunologic Factors|immunologic factors|mesh-ancestor
6424664|NCT00304018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6424665|NCT00304018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6424666|NCT00304018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6424667|NCT00304018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6424668|NCT00304018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6424669|NCT00304018|Alkylating Agents|alkylating agents|mesh-ancestor
6424670|NCT00304018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6424671|NCT00304018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6424672|NCT00304135|Gemcitabine|gemcitabine|mesh-list
6424673|NCT00304135|Oxaliplatin|oxaliplatin|mesh-list
6424674|NCT00304135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6424675|NCT00304135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6424676|NCT00304135|Antimetabolites|antimetabolites|mesh-ancestor
6424677|NCT00304135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424678|NCT00304135|Antiviral Agents|antiviral agents|mesh-ancestor
6424679|NCT00304135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6424680|NCT00304135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6424681|NCT00304135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6019129|NCT00385008|Analgesics|analgesics|mesh-ancestor
6424682|NCT00304135|Immunologic Factors|immunologic factors|mesh-ancestor
6424683|NCT00304135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424684|NCT00304200|Temozolomide|temozolomide|mesh-list
6424685|NCT00304200|Sunitinib|sunitinib|mesh-list
6424686|NCT00304200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6424687|NCT00304200|Alkylating Agents|alkylating agents|mesh-ancestor
6424688|NCT00304200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424689|NCT00304200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6424690|NCT00304200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6424691|NCT00304200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6424692|NCT00304200|Growth Substances|growth substances|mesh-ancestor
6424693|NCT00304200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424694|NCT00304200|Growth Inhibitors|growth inhibitors|mesh-ancestor
6424695|NCT00304200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6424696|NCT00304200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6424697|NCT00304213|Testosterone|testosterone|mesh-list
6424698|NCT00304213|Androgens|androgens|mesh-ancestor
6424699|NCT00304213|Hormones|hormones|mesh-ancestor
6424700|NCT00304213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6424701|NCT00304213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424702|NCT00304226|Amlodipine|amlodipine|mesh-list
6424703|NCT00304226|Valsartan|valsartan|mesh-list
6538283|NCT00826891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6538284|NCT00826891|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6019130|NCT00385008|Sensory System Agents|sensory system agents|mesh-ancestor
6019131|NCT00385008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6019132|NCT00385008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019133|NCT00385008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6019134|NCT00385008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6019135|NCT00385008|Gout Suppressants|gout suppressants|mesh-ancestor
6019136|NCT00385008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6019137|NCT00385008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6019138|NCT00385008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424704|NCT00304226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6424705|NCT00304226|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6424706|NCT00304226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6424707|NCT00304226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424708|NCT00304226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6538285|NCT00826891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6538286|NCT00826891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6538287|NCT00826891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424709|NCT00304226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538288|NCT00826930|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
6538289|NCT00826930|Antioxidants|antioxidants|mesh-ancestor
6538290|NCT00826930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538291|NCT00826930|Protective Agents|protective agents|mesh-ancestor
6424710|NCT00304226|Vasodilator Agents|vasodilator agents|mesh-ancestor
6424711|NCT00304226|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6424712|NCT00304226|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6424713|NCT00304239|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6424714|NCT00304239|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
6424715|NCT00304239|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6424716|NCT00304239|Dermatologic Agents|dermatologic agents|mesh-ancestor
6424717|NCT00304252|Interferons|interferons|mesh-list
6424718|NCT00304252|Interferon-beta|interferon-beta|mesh-list
6424719|NCT00304252|Interferon beta-1a|interferon beta-1a|mesh-list
6424720|NCT00304252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6424721|NCT00304252|Antiviral Agents|antiviral agents|mesh-ancestor
6424722|NCT00304252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6424723|NCT00304252|Immunologic Factors|immunologic factors|mesh-ancestor
6424724|NCT00304252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424725|NCT00304252|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6424726|NCT00304291|Mitoxantrone|mitoxantrone|mesh-list
6424727|NCT00304291|Analgesics|analgesics|mesh-ancestor
6424728|NCT00304291|Sensory System Agents|sensory system agents|mesh-ancestor
6424729|NCT00304291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6424730|NCT00304291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424731|NCT00304291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6424732|NCT00304291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6424733|NCT00304291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6424734|NCT00304291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6424735|NCT00304291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424736|NCT00304317|Celecoxib|celecoxib|mesh-list
6424737|NCT00304317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6424738|NCT00304317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6424739|NCT00304317|Analgesics|analgesics|mesh-ancestor
6424740|NCT00304317|Sensory System Agents|sensory system agents|mesh-ancestor
6424741|NCT00304317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6424742|NCT00304317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424743|NCT00304317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6424744|NCT00304317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6424745|NCT00304317|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6424746|NCT00304317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6424747|NCT00304317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6424748|NCT00304317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424749|NCT00304369|Metronidazole|metronidazole|mesh-list
6424750|NCT00304369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6424751|NCT00304369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6424752|NCT00304369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6424753|NCT00304369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6424754|NCT00304382|Vaccines|vaccines|mesh-list
6424755|NCT00304382|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6424756|NCT00304382|Immunologic Factors|immunologic factors|mesh-ancestor
6424757|NCT00304382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424758|NCT00304421|Rabeprazole|rabeprazole|mesh-list
6424759|NCT00304421|Pantoprazole|pantoprazole|mesh-list
6424760|NCT00304421|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6424761|NCT00304421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6424762|NCT00304421|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6424763|NCT00304421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6424764|NCT00304421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424765|NCT00304434|Oseltamivir|oseltamivir|mesh-list
6424766|NCT00304434|Probenecid|probenecid|mesh-list
6424767|NCT00304434|Antiviral Agents|antiviral agents|mesh-ancestor
6424768|NCT00304434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6424769|NCT00304434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6424770|NCT00304434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424771|NCT00304434|Uricosuric Agents|uricosuric agents|mesh-ancestor
6424772|NCT00304434|Gout Suppressants|gout suppressants|mesh-ancestor
6424773|NCT00304434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6424774|NCT00304434|Renal Agents|renal agents|mesh-ancestor
6424775|NCT00304447|Gemtuzumab|gemtuzumab|mesh-list
6424776|NCT00304447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6424777|NCT00304447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6424778|NCT00304460|Aldesleukin|aldesleukin|mesh-list
6424779|NCT00304460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6424780|NCT00304460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6424781|NCT00304460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6424782|NCT00304460|Antiviral Agents|antiviral agents|mesh-ancestor
6424783|NCT00304460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6424784|NCT00304473|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6424785|NCT00304473|Antidepressive Agents|antidepressive agents|mesh-ancestor
6424786|NCT00304473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6424787|NCT00304473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6424788|NCT00304473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6424789|NCT00304473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6424790|NCT00304473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424791|NCT00304499|Oxybutynin|oxybutynin|mesh-list
6424792|NCT00304499|Parasympatholytics|parasympatholytics|mesh-ancestor
6424793|NCT00304499|Autonomic Agents|autonomic agents|mesh-ancestor
6424794|NCT00304499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6424795|NCT00304499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424796|NCT00304499|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6424797|NCT00304499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6424798|NCT00304499|Cholinergic Agents|cholinergic agents|mesh-ancestor
6424799|NCT00304499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6424800|NCT00304499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424801|NCT00304499|Urological Agents|urological agents|mesh-ancestor
6424802|NCT00304538|Glucagon|glucagon|mesh-list
6424803|NCT00304538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6424804|NCT00304538|Hormones|hormones|mesh-ancestor
6424805|NCT00304538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6424806|NCT00304538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424807|NCT00304551|Ribavirin|ribavirin|mesh-list
6424808|NCT00304551|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6424809|NCT00304551|Interferon-alpha|interferon-alpha|mesh-list
6424810|NCT00304551|Antimetabolites|antimetabolites|mesh-ancestor
6424811|NCT00304551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424812|NCT00304551|Antiviral Agents|antiviral agents|mesh-ancestor
6424813|NCT00304551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6424814|NCT00304551|Immunologic Factors|immunologic factors|mesh-ancestor
6424815|NCT00304551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424816|NCT00304616|Olanzapine|olanzapine|mesh-list
6424817|NCT00304616|Risperidone|risperidone|mesh-list
6424818|NCT00304616|Aripiprazole|aripiprazole|mesh-list
6424819|NCT00304616|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6424820|NCT00304616|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6424821|NCT00304616|Serotonin Agents|serotonin agents|mesh-ancestor
6424822|NCT00304616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6424823|NCT00304616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424824|NCT00304616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424825|NCT00304616|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6424826|NCT00304616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6424827|NCT00304616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6424828|NCT00304616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6424829|NCT00304616|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6424830|NCT00304616|Dopamine Agents|dopamine agents|mesh-ancestor
6424831|NCT00304616|Antiemetics|antiemetics|mesh-ancestor
6424832|NCT00304616|Autonomic Agents|autonomic agents|mesh-ancestor
6424833|NCT00304616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6424834|NCT00304616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6424835|NCT00304616|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6424836|NCT00304616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6424837|NCT00304616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6424838|NCT00304616|Antidepressive Agents|antidepressive agents|mesh-ancestor
6424839|NCT00304616|Dopamine Agonists|dopamine agonists|mesh-ancestor
6424840|NCT00304616|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6424841|NCT00304616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6424842|NCT00304616|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6424843|NCT00304616|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6424844|NCT00304629|Galantamine|galantamine|mesh-list
6424845|NCT00304629|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6424846|NCT00304629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6424847|NCT00304629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424848|NCT00304629|Cholinergic Agents|cholinergic agents|mesh-ancestor
6538292|NCT00826930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538293|NCT00826930|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6538294|NCT00826930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6538295|NCT00826969|Ciclesonide|ciclesonide|mesh-list
6538296|NCT00826969|Glucocorticoids|glucocorticoids|mesh-ancestor
6538297|NCT00826969|Hormones|hormones|mesh-ancestor
6538298|NCT00826969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6424849|NCT00304629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6424850|NCT00304629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424851|NCT00304629|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6424852|NCT00304629|Autonomic Agents|autonomic agents|mesh-ancestor
6424853|NCT00304629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6538299|NCT00826969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538300|NCT00826969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6538301|NCT00827021|Epoetin Alfa|epoetin alfa|mesh-list
6538302|NCT00827021|Hematinics|hematinics|mesh-list
6538303|NCT00827034|Warfarin|warfarin|mesh-list
6538304|NCT00827034|Anticoagulants|anticoagulants|mesh-ancestor
6538305|NCT00827138|Rebastinib|rebastinib|mesh-list
6538306|NCT00827138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6538307|NCT00827138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6538308|NCT00827138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6538309|NCT00827138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538310|NCT00827151|Estrogens|estrogens|mesh-list
6538311|NCT00827151|Hormones|hormones|mesh-ancestor
6538312|NCT00827151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6538313|NCT00827151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538314|NCT00827177|Sorafenib|sorafenib|mesh-list
6538315|NCT00827177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6538316|NCT00827177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6538317|NCT00827177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6538318|NCT00827177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538319|NCT00827216|Erythromycin|erythromycin|mesh-list
6538320|NCT00827216|Erythromycin Estolate|erythromycin estolate|mesh-list
6538321|NCT00827216|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
6424854|NCT00304629|Nootropic Agents|nootropic agents|mesh-ancestor
6424855|NCT00304642|Dapivirine|dapivirine|mesh-list
6424856|NCT00304642|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6424857|NCT00304642|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6538322|NCT00827216|Erythromycin stearate|erythromycin stearate|mesh-list
6538323|NCT00827216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6538324|NCT00827216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6538325|NCT00827216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6538326|NCT00827216|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6538327|NCT00827216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6538328|NCT00827216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538329|NCT00827281|Cycloserine|cycloserine|mesh-list
6424858|NCT00304642|Antiviral Agents|antiviral agents|mesh-ancestor
6424859|NCT00304642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6424860|NCT00304655|Aripiprazole|aripiprazole|mesh-list
6424861|NCT00304655|Antidepressive Agents|antidepressive agents|mesh-ancestor
6424862|NCT00304655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6538330|NCT00827281|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6538331|NCT00827281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6538332|NCT00827281|Renal Agents|renal agents|mesh-ancestor
6538333|NCT00827281|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6538334|NCT00827281|Antitubercular Agents|antitubercular agents|mesh-ancestor
6538335|NCT00827281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6424863|NCT00304655|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6424864|NCT00304655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6424865|NCT00304655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6424866|NCT00304655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424867|NCT00304655|Dopamine Agonists|dopamine agonists|mesh-ancestor
6424868|NCT00304655|Dopamine Agents|dopamine agents|mesh-ancestor
6424869|NCT00304655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6424870|NCT00304655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424871|NCT00304655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6424872|NCT00304655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6424873|NCT00304655|Serotonin Agents|serotonin agents|mesh-ancestor
6424874|NCT00304655|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6424875|NCT00304655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6424876|NCT00304655|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6424877|NCT00304655|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6424878|NCT00304668|Dapivirine|dapivirine|mesh-list
6424879|NCT00304668|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6424880|NCT00304668|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6424881|NCT00304668|Antiviral Agents|antiviral agents|mesh-ancestor
6424882|NCT00304668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6424883|NCT00304681|Methylphenidate|methylphenidate|mesh-list
6424884|NCT00304681|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6424885|NCT00304681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424886|NCT00304681|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6424887|NCT00304681|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6424888|NCT00304681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6424889|NCT00304681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424890|NCT00304681|Dopamine Agents|dopamine agents|mesh-ancestor
6424891|NCT00304681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6424892|NCT00304720|Tacrolimus|tacrolimus|mesh-list
6424893|NCT00304720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6424894|NCT00304720|Immunologic Factors|immunologic factors|mesh-ancestor
6424895|NCT00304720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424896|NCT00304720|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6424897|NCT00304720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6424898|NCT00304720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424899|NCT00304772|Fluconazole|fluconazole|mesh-list
6424900|NCT00304772|Micafungin|micafungin|mesh-list
6424901|NCT00304772|Antifungal Agents|antifungal agents|mesh-ancestor
6424902|NCT00304772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6424903|NCT00304772|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6424904|NCT00304772|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6424905|NCT00304772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6424906|NCT00304772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424907|NCT00304772|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6424908|NCT00304772|Hormone Antagonists|hormone antagonists|mesh-ancestor
6424909|NCT00304772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6424910|NCT00304772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424911|NCT00304772|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6424912|NCT00304772|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6424913|NCT00304785|Latanoprost|latanoprost|mesh-list
6424914|NCT00304785|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6424915|NCT00304785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6424916|NCT00304811|Vancomycin|vancomycin|mesh-list
6424917|NCT00304811|Rifampin|rifampin|mesh-list
6424918|NCT00304811|Gentamicins|gentamicins|mesh-list
6424919|NCT00304811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6424920|NCT00304811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6424921|NCT00304811|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6424922|NCT00304811|Antitubercular Agents|antitubercular agents|mesh-ancestor
6424923|NCT00304811|Leprostatic Agents|leprostatic agents|mesh-ancestor
6424924|NCT00304811|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6424925|NCT00304811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6424926|NCT00304811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424927|NCT00304811|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6424928|NCT00304811|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6424929|NCT00304811|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6424930|NCT00304811|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6424931|NCT00304811|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6424932|NCT00304811|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6424933|NCT00304811|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6424934|NCT00304850|Ketamine|ketamine|mesh-list
6424935|NCT00304850|Analgesics|analgesics|mesh-ancestor
6424936|NCT00304850|Sensory System Agents|sensory system agents|mesh-ancestor
6424937|NCT00304850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6424938|NCT00304850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424939|NCT00304850|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6424940|NCT00304850|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6424941|NCT00304850|Anesthetics, General|anesthetics, general|mesh-ancestor
6424942|NCT00304850|Anesthetics|anesthetics|mesh-ancestor
6424943|NCT00304850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6424944|NCT00304850|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6424945|NCT00304850|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6424946|NCT00304850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6424947|NCT00304850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460565|NCT00450320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460566|NCT00450398|polysaccharide-K|polysaccharide-k|mesh-list
6460567|NCT00450398|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6460568|NCT00450398|Immunologic Factors|immunologic factors|mesh-ancestor
6460569|NCT00450398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460570|NCT00450398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6460571|NCT00450398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6460572|NCT00450398|Antiviral Agents|antiviral agents|mesh-ancestor
6460573|NCT00450398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6460574|NCT00450398|Interferon Inducers|interferon inducers|mesh-ancestor
6460575|NCT00450398|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6460576|NCT00450398|Protective Agents|protective agents|mesh-ancestor
6460577|NCT00450515|Capecitabine|capecitabine|mesh-list
6460578|NCT00450515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6460579|NCT00450515|Antimetabolites|antimetabolites|mesh-ancestor
6460580|NCT00450515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460581|NCT00450515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6460582|NCT00450567|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6460583|NCT00450567|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6460584|NCT00450567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460585|NCT00450645|Heparin|heparin|mesh-list
6460586|NCT00450645|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6460587|NCT00450645|Tinzaparin|tinzaparin|mesh-list
6460588|NCT00450645|Dalteparin|dalteparin|mesh-list
6460589|NCT00450645|Anticoagulants|anticoagulants|mesh-ancestor
6460590|NCT00450645|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6460591|NCT00450645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6460592|NCT00450645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460593|NCT00450736|Celecoxib|celecoxib|mesh-list
6460594|NCT00450736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6460595|NCT00450736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6460596|NCT00450736|Analgesics|analgesics|mesh-ancestor
6460597|NCT00450736|Sensory System Agents|sensory system agents|mesh-ancestor
6460598|NCT00450736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6424948|NCT00304980|Lumefantrine|lumefantrine|mesh-list
6424949|NCT00304980|Artemether|artemether|mesh-list
6424950|NCT00304980|Pyrimethamine|pyrimethamine|mesh-list
6424951|NCT00304980|Sulfadoxine|sulfadoxine|mesh-list
6019139|NCT00385008|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6019140|NCT00385008|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6019141|NCT00385008|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6424952|NCT00304980|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6424953|NCT00304980|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6424954|NCT00304980|Antimalarials|antimalarials|mesh-ancestor
6424955|NCT00304980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6424956|NCT00304980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6424957|NCT00304980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6424958|NCT00304980|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6424959|NCT00304980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6424960|NCT00304980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424961|NCT00304980|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6424962|NCT00304980|Renal Agents|renal agents|mesh-ancestor
6424963|NCT00304993|Niacin|niacin|mesh-list
6424964|NCT00304993|Rosiglitazone|rosiglitazone|mesh-list
6424965|NCT00304993|Fenofibrate|fenofibrate|mesh-list
6424966|NCT00304993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6424967|NCT00304993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424968|NCT00304993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6424969|NCT00304993|Antimetabolites|antimetabolites|mesh-ancestor
6424970|NCT00304993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424971|NCT00304993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6424972|NCT00304993|Vasodilator Agents|vasodilator agents|mesh-ancestor
6424973|NCT00304993|Vitamin B Complex|vitamin b complex|mesh-ancestor
6424974|NCT00304993|Vitamins|vitamins|mesh-ancestor
6424975|NCT00304993|Micronutrients|micronutrients|mesh-ancestor
6424976|NCT00305019|Clevudine|clevudine|mesh-list
6424977|NCT00305019|Antiviral Agents|antiviral agents|mesh-ancestor
6424978|NCT00305019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6424979|NCT00305201|Pravastatin|pravastatin|mesh-list
6424980|NCT00305201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6424981|NCT00305201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6424982|NCT00305201|Antimetabolites|antimetabolites|mesh-ancestor
6019142|NCT00385008|Serotonin Agents|serotonin agents|mesh-ancestor
6019143|NCT00385008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6019144|NCT00385138|Clopidogrel|clopidogrel|mesh-list
6019145|NCT00385138|Cangrelor|cangrelor|mesh-list
6019146|NCT00385138|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6424983|NCT00305201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424984|NCT00305201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6424985|NCT00305201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6424986|NCT00305201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6424987|NCT00305266|gamma-Globulins|gamma-globulins|mesh-list
6424988|NCT00305266|Immunologic Factors|immunologic factors|mesh-ancestor
6424989|NCT00305266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424990|NCT00305292|Modafinil|modafinil|mesh-list
6424991|NCT00305292|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6424992|NCT00305292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6424993|NCT00305292|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6424994|NCT00305292|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6424995|NCT00305292|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6424996|NCT00305292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6424997|NCT00305331|Domperidone|domperidone|mesh-list
6424998|NCT00305331|Antiemetics|antiemetics|mesh-ancestor
6424999|NCT00305331|Autonomic Agents|autonomic agents|mesh-ancestor
6425000|NCT00305331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6425001|NCT00305331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425002|NCT00305331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6425003|NCT00305331|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6425004|NCT00305331|Dopamine Agents|dopamine agents|mesh-ancestor
6425005|NCT00305331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6425006|NCT00305331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6425007|NCT00305370|Aripiprazole|aripiprazole|mesh-list
6425008|NCT00305370|Antidepressive Agents|antidepressive agents|mesh-ancestor
6425009|NCT00305370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6425010|NCT00305370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6425011|NCT00305370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6019147|NCT00385138|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6425012|NCT00305370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6425013|NCT00305370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425014|NCT00305370|Dopamine Agonists|dopamine agonists|mesh-ancestor
6019148|NCT00385138|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6019149|NCT00385138|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6019150|NCT00385138|Purinergic Agents|purinergic agents|mesh-ancestor
6019151|NCT00385138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6019152|NCT00385138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019153|NCT00385138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425015|NCT00305370|Dopamine Agents|dopamine agents|mesh-ancestor
6425016|NCT00305370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6425017|NCT00305370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6425018|NCT00305370|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6425019|NCT00305370|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6425020|NCT00305370|Serotonin Agents|serotonin agents|mesh-ancestor
6425021|NCT00305370|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6425022|NCT00305370|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6425023|NCT00305370|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6425024|NCT00305370|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6425025|NCT00305383|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6425026|NCT00305383|Taribavirin|taribavirin|mesh-list
6425027|NCT00305383|Antiviral Agents|antiviral agents|mesh-ancestor
6425028|NCT00305383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6425029|NCT00305396|Sirolimus|sirolimus|mesh-list
6425030|NCT00305396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6425031|NCT00305396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6425032|NCT00305396|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6425033|NCT00305396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6425034|NCT00305396|Antifungal Agents|antifungal agents|mesh-ancestor
6425035|NCT00305396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6425036|NCT00305396|Immunologic Factors|immunologic factors|mesh-ancestor
6425037|NCT00305396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425038|NCT00305409|Sulfalene|sulfalene|mesh-list
6425039|NCT00305409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6425040|NCT00305409|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6425041|NCT00305409|Renal Agents|renal agents|mesh-ancestor
6425042|NCT00305409|Antimalarials|antimalarials|mesh-ancestor
6425043|NCT00305409|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6425044|NCT00305409|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6425045|NCT00305422|Risperidone|risperidone|mesh-list
6425046|NCT00305422|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6425047|NCT00305422|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6425048|NCT00305422|Serotonin Agents|serotonin agents|mesh-ancestor
6425049|NCT00305422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6425050|NCT00305422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6425051|NCT00305422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425052|NCT00305422|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6425053|NCT00305422|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6425054|NCT00305422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6425055|NCT00305422|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6425056|NCT00305422|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6425057|NCT00305422|Dopamine Agents|dopamine agents|mesh-ancestor
6425058|NCT00305422|Antidepressive Agents|antidepressive agents|mesh-ancestor
6425059|NCT00305461|Ciclesonide|ciclesonide|mesh-list
6425060|NCT00305461|Glucocorticoids|glucocorticoids|mesh-ancestor
6425061|NCT00305461|Hormones|hormones|mesh-ancestor
6425062|NCT00305461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6425063|NCT00305461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425064|NCT00305461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6425065|NCT00305474|Risperidone|risperidone|mesh-list
6425066|NCT00305474|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6425067|NCT00305474|Serotonin Agents|serotonin agents|mesh-ancestor
6425068|NCT00305474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6425069|NCT00305474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6425070|NCT00305474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425071|NCT00305474|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6425072|NCT00305474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6425073|NCT00305474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6425074|NCT00305474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6425075|NCT00305474|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6425076|NCT00305474|Dopamine Agents|dopamine agents|mesh-ancestor
6425077|NCT00305487|Ciclesonide|ciclesonide|mesh-list
6425078|NCT00305487|Glucocorticoids|glucocorticoids|mesh-ancestor
6425079|NCT00305487|Hormones|hormones|mesh-ancestor
6425080|NCT00305487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6425081|NCT00305487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425082|NCT00305487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6425083|NCT00305500|Citalopram|citalopram|mesh-list
6425084|NCT00305500|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6425085|NCT00305500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6425086|NCT00305500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6425087|NCT00305500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6425088|NCT00305500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6425089|NCT00305500|Serotonin Agents|serotonin agents|mesh-ancestor
6425090|NCT00305500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425091|NCT00305500|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6425092|NCT00305500|Antidepressive Agents|antidepressive agents|mesh-ancestor
6425093|NCT00305500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6425094|NCT00305513|Caffeine|caffeine|mesh-list
6425095|NCT00305513|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6425096|NCT00305513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425097|NCT00305513|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6425098|NCT00305513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6425099|NCT00305513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538336|NCT00827281|Antimetabolites|antimetabolites|mesh-ancestor
6538337|NCT00827281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538338|NCT00827307|Tamoxifen|tamoxifen|mesh-list
6538339|NCT00827307|Goserelin|goserelin|mesh-list
6538340|NCT00827307|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6538341|NCT00827307|Hormone Antagonists|hormone antagonists|mesh-ancestor
6538342|NCT00827307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6538343|NCT00827307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538344|NCT00827307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6019154|NCT00385203|Cediranib|cediranib|mesh-list
6019155|NCT00385203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6019156|NCT00385203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6019157|NCT00385203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6019158|NCT00385203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019159|NCT00385216|Nicotine|nicotine|mesh-list
6019160|NCT00385216|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6019161|NCT00385216|Autonomic Agents|autonomic agents|mesh-ancestor
6019162|NCT00385216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6019163|NCT00385216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019164|NCT00385216|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6425100|NCT00305513|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6425101|NCT00305513|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6425102|NCT00305513|Purinergic Agents|purinergic agents|mesh-ancestor
6425103|NCT00305513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6425104|NCT00305539|Adalimumab|adalimumab|mesh-list
6425105|NCT00305539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6425106|NCT00305539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6425107|NCT00305552|Thalidomide|thalidomide|mesh-list
6425108|NCT00305552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6425109|NCT00305552|Immunologic Factors|immunologic factors|mesh-ancestor
6425110|NCT00305552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425111|NCT00305552|Leprostatic Agents|leprostatic agents|mesh-ancestor
6425112|NCT00305552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5501327|NCT04475224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501328|NCT04475016|Paclitaxel|paclitaxel|mesh-list
5501329|NCT04475016|Ifosfamide|ifosfamide|mesh-list
5501330|NCT04475016|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5501331|NCT04475016|Nimotuzumab|nimotuzumab|mesh-list
5501332|NCT04475016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6425113|NCT00305552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6425114|NCT00305552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5501333|NCT04475016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5501334|NCT04475016|Tubulin Modulators|tubulin modulators|mesh-ancestor
5501335|NCT04475016|Antimitotic Agents|antimitotic agents|mesh-ancestor
5501336|NCT04475016|Mitosis Modulators|mitosis modulators|mesh-ancestor
5501337|NCT04475016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501338|NCT04475016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5501339|NCT04475016|Alkylating Agents|alkylating agents|mesh-ancestor
5501340|NCT04475016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5501341|NCT04475107|Artesunate|artesunate|mesh-list
5501342|NCT04475107|Pyronaridine|pyronaridine|mesh-list
5501343|NCT04475107|Antimalarials|antimalarials|mesh-ancestor
5501344|NCT04475107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5501345|NCT04475107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5501346|NCT04475107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5501347|NCT04475107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5501348|NCT04475107|Antiviral Agents|antiviral agents|mesh-ancestor
5501349|NCT04475107|Schistosomicides|schistosomicides|mesh-ancestor
5501350|NCT04475107|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5501351|NCT04475107|Anthelmintics|anthelmintics|mesh-ancestor
5501352|NCT04475042|Dapagliflozin|dapagliflozin|mesh-list
5501353|NCT04475042|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5501354|NCT04475042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501355|NCT04475042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5501356|NCT04475042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501357|NCT04475120|Lactoferrin|lactoferrin|mesh-list
5501358|NCT04475120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5501359|NCT04474899|Amlodipine|amlodipine|mesh-list
5501360|NCT04474899|Moxonidine|moxonidine|mesh-list
5501361|NCT04474899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5501362|NCT04474899|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5501363|NCT04474899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5501364|NCT04474899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501365|NCT04474899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5501366|NCT04474899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425115|NCT00305552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6425116|NCT00305552|Growth Substances|growth substances|mesh-ancestor
6425117|NCT00305552|Growth Inhibitors|growth inhibitors|mesh-ancestor
6425118|NCT00305552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6425119|NCT00305591|N-Methylaspartate|n-methylaspartate|mesh-list
6019165|NCT00385216|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6425120|NCT00305591|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
6425121|NCT00305591|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6425122|NCT00305591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6425123|NCT00305591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6425124|NCT00305591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425125|NCT00305617|Antineoplastic Agents|antineoplastic agents|mesh-list
6425126|NCT00305630|Triamcinolone|triamcinolone|mesh-list
6425127|NCT00305630|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6425128|NCT00305630|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6425129|NCT00305630|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6425130|NCT00305630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6425131|NCT00305630|Glucocorticoids|glucocorticoids|mesh-ancestor
6425132|NCT00305630|Hormones|hormones|mesh-ancestor
6425133|NCT00305630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6425134|NCT00305630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425135|NCT00305630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6425136|NCT00305630|Immunologic Factors|immunologic factors|mesh-ancestor
6425137|NCT00305630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6425138|NCT00305630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6425139|NCT00305669|Sargramostim|sargramostim|mesh-list
6425140|NCT00305669|Immunologic Factors|immunologic factors|mesh-ancestor
6425141|NCT00305669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425142|NCT00305708|Fludarabine|fludarabine|mesh-list
6425143|NCT00305708|Fludarabine phosphate|fludarabine phosphate|mesh-list
6425144|NCT00305708|Busulfan|busulfan|mesh-list
6425145|NCT00305708|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6425146|NCT00305708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6425147|NCT00305708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6425148|NCT00305708|Antimetabolites|antimetabolites|mesh-ancestor
6425149|NCT00305708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6425150|NCT00305708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6425151|NCT00305708|Immunologic Factors|immunologic factors|mesh-ancestor
6425152|NCT00305708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425153|NCT00305708|Alkylating Agents|alkylating agents|mesh-ancestor
6425154|NCT00305708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6425155|NCT00305708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6425156|NCT00305734|Gemcitabine|gemcitabine|mesh-list
6425157|NCT00305734|Bortezomib|bortezomib|mesh-list
6425158|NCT00305734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6425159|NCT00305734|Antimetabolites|antimetabolites|mesh-ancestor
6425160|NCT00305734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6425161|NCT00305734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6425162|NCT00305734|Antiviral Agents|antiviral agents|mesh-ancestor
6425163|NCT00305734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6425164|NCT00305734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6425165|NCT00305734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6425166|NCT00305734|Immunologic Factors|immunologic factors|mesh-ancestor
6425167|NCT00305734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425168|NCT00305747|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
6425169|NCT00305747|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6425170|NCT00305747|Protective Agents|protective agents|mesh-ancestor
6425171|NCT00305747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425172|NCT00305747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6425173|NCT00305786|Gemcitabine|gemcitabine|mesh-list
6425174|NCT00305786|Oxaliplatin|oxaliplatin|mesh-list
6425175|NCT00305786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6425176|NCT00305786|Antimetabolites|antimetabolites|mesh-ancestor
6425177|NCT00305786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6425178|NCT00305786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6425179|NCT00305786|Antiviral Agents|antiviral agents|mesh-ancestor
6425180|NCT00305786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6425181|NCT00305786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6425182|NCT00305786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6425183|NCT00305786|Immunologic Factors|immunologic factors|mesh-ancestor
6425184|NCT00305786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425185|NCT00305812|Dexamethasone|dexamethasone|mesh-list
6425186|NCT00305812|Lenalidomide|lenalidomide|mesh-list
6425187|NCT00305812|Melphalan|melphalan|mesh-list
6425188|NCT00305812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6425189|NCT00305812|Antiemetics|antiemetics|mesh-ancestor
6425190|NCT00305812|Autonomic Agents|autonomic agents|mesh-ancestor
6425191|NCT00305812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6425192|NCT00305812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425193|NCT00305812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6425194|NCT00305812|Glucocorticoids|glucocorticoids|mesh-ancestor
6425195|NCT00305812|Hormones|hormones|mesh-ancestor
6425196|NCT00305812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6425197|NCT00305812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6425198|NCT00305812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6425199|NCT00305812|Immunologic Factors|immunologic factors|mesh-ancestor
6425200|NCT00305812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6425201|NCT00305812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6538345|NCT00827307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6538346|NCT00827307|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6538347|NCT00827307|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6538348|NCT00827307|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6538349|NCT00827320|Levetiracetam|levetiracetam|mesh-list
6538350|NCT00827320|Anticonvulsants|anticonvulsants|mesh-ancestor
6538351|NCT00827320|Nootropic Agents|nootropic agents|mesh-ancestor
6538352|NCT00827346|Clopidogrel|clopidogrel|mesh-list
6538353|NCT00827346|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6538354|NCT00827346|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6538355|NCT00827346|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6538356|NCT00827346|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6538357|NCT00827346|Purinergic Agents|purinergic agents|mesh-ancestor
6538358|NCT00827346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6538359|NCT00827346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6425202|NCT00305812|Growth Substances|growth substances|mesh-ancestor
6425203|NCT00305812|Growth Inhibitors|growth inhibitors|mesh-ancestor
6425204|NCT00305812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6425205|NCT00305812|Alkylating Agents|alkylating agents|mesh-ancestor
6425206|NCT00305812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6425207|NCT00305812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6425208|NCT00305812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6425209|NCT00305825|Bevacizumab|bevacizumab|mesh-list
6425210|NCT00305825|Letrozole|letrozole|mesh-list
6425211|NCT00305825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6425212|NCT00305825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6425213|NCT00305825|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6425214|NCT00305825|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6425215|NCT00305825|Growth Substances|growth substances|mesh-ancestor
6425216|NCT00305825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425217|NCT00305825|Growth Inhibitors|growth inhibitors|mesh-ancestor
6425218|NCT00305825|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6425219|NCT00305825|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6425220|NCT00305825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6425221|NCT00305825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6425222|NCT00305825|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6425223|NCT00305825|Hormone Antagonists|hormone antagonists|mesh-ancestor
6425224|NCT00305825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6425225|NCT00305838|Tamoxifen|tamoxifen|mesh-list
6425226|NCT00305838|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6425227|NCT00305838|Hormone Antagonists|hormone antagonists|mesh-ancestor
6425228|NCT00305838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6425229|NCT00305838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425230|NCT00305838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6425231|NCT00305838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6425232|NCT00305838|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6425233|NCT00305838|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6425234|NCT00305838|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6425235|NCT00305903|Memantine|memantine|mesh-list
6425236|NCT00305903|Rivastigmine|rivastigmine|mesh-list
6425237|NCT00305903|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5501367|NCT04474899|Vasodilator Agents|vasodilator agents|mesh-ancestor
6425238|NCT00305903|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6425239|NCT00305903|Dopamine Agents|dopamine agents|mesh-ancestor
6425240|NCT00305903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6425241|NCT00305903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6425242|NCT00305903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425243|NCT00305903|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6425244|NCT00305903|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6425245|NCT00305903|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6425246|NCT00305903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6425247|NCT00305903|Cholinergic Agents|cholinergic agents|mesh-ancestor
6425248|NCT00305903|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6425249|NCT00305903|Protective Agents|protective agents|mesh-ancestor
6425250|NCT00306020|Morphine|morphine|mesh-list
6425251|NCT00306020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6425252|NCT00306020|Narcotics|narcotics|mesh-ancestor
6425253|NCT00306020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6425254|NCT00306020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425255|NCT00306020|Analgesics|analgesics|mesh-ancestor
6425256|NCT00306020|Sensory System Agents|sensory system agents|mesh-ancestor
6425257|NCT00306020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6425258|NCT00306033|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6425259|NCT00306033|gamma-Globulins|gamma-globulins|mesh-list
6425260|NCT00306033|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6425261|NCT00306033|Immunoglobulins|immunoglobulins|mesh-list
6425262|NCT00306033|Immunologic Factors|immunologic factors|mesh-ancestor
6425263|NCT00306033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425264|NCT00306046|Diphosphonates|diphosphonates|mesh-list
6425265|NCT00306046|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6425266|NCT00306046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425267|NCT00306124|Levodopa|levodopa|mesh-list
6425268|NCT00306124|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6425269|NCT00306124|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6538360|NCT00827346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538361|NCT00827411|Aspirin|aspirin|mesh-list
6538362|NCT00827411|Clopidogrel|clopidogrel|mesh-list
6538363|NCT00827411|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6538364|NCT00827411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6538365|NCT00827411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6538366|NCT00827411|Analgesics|analgesics|mesh-ancestor
6538367|NCT00827411|Sensory System Agents|sensory system agents|mesh-ancestor
6538368|NCT00827411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6538369|NCT00827411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538370|NCT00827411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6538371|NCT00827411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6538372|NCT00827411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6538373|NCT00827411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6538374|NCT00827411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538375|NCT00827411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6425270|NCT00306124|Dopamine Agents|dopamine agents|mesh-ancestor
6538376|NCT00827411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6425271|NCT00306124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6425272|NCT00306124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6425273|NCT00306124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425274|NCT00306137|Aprotinin|aprotinin|mesh-list
6425275|NCT00306137|Hemostatics|hemostatics|mesh-ancestor
6425276|NCT00306137|Coagulants|coagulants|mesh-ancestor
6425277|NCT00306137|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6425278|NCT00306137|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6425279|NCT00306137|Protease Inhibitors|protease inhibitors|mesh-ancestor
6425280|NCT00306137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6425281|NCT00306137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6425282|NCT00306150|Aprotinin|aprotinin|mesh-list
6425283|NCT00306150|Hemostatics|hemostatics|mesh-ancestor
6425284|NCT00306150|Coagulants|coagulants|mesh-ancestor
6425285|NCT00306150|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6425286|NCT00306150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6425287|NCT00306150|Protease Inhibitors|protease inhibitors|mesh-ancestor
6425288|NCT00306150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6425289|NCT00306150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6425290|NCT00306176|Rosiglitazone|rosiglitazone|mesh-list
6425291|NCT00306176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6425292|NCT00306176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425293|NCT00306254|Enoxaparin|enoxaparin|mesh-list
6425294|NCT00306254|N-(4-chlorophenyl)-N-(2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl)-4-methoxypyrrolidiine-1,2-dicarboxamide|n-(4-chlorophenyl)-n-(2-fluoro-4-(2-oxopyridin-1(2h)-yl)phenyl)-4-methoxypyrrolidiine-1,2-dicarboxamide|mesh-list
6425295|NCT00306254|Anticoagulants|anticoagulants|mesh-ancestor
6425296|NCT00306254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6425297|NCT00306254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6425298|NCT00306254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6425299|NCT00306254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6425300|NCT00306254|Antithrombins|antithrombins|mesh-ancestor
6425301|NCT00306254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6425302|NCT00306254|Protease Inhibitors|protease inhibitors|mesh-ancestor
6425303|NCT00306254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6425304|NCT00306267|Epoetin Alfa|epoetin alfa|mesh-list
6425305|NCT00306267|Hematinics|hematinics|mesh-ancestor
6425306|NCT00306319|Moxifloxacin|moxifloxacin|mesh-list
6425307|NCT00306319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6425308|NCT00306319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6425309|NCT00306319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6425310|NCT00306319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6425311|NCT00306319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6425312|NCT00306319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6425313|NCT00306319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6425314|NCT00306358|Vitamin B 12|vitamin b 12|mesh-list
6425315|NCT00306358|Hydroxocobalamin|hydroxocobalamin|mesh-list
5501368|NCT04475029|Morphine|morphine|mesh-list
6425316|NCT00306358|Vitamins|vitamins|mesh-ancestor
6425317|NCT00306358|Micronutrients|micronutrients|mesh-ancestor
6425318|NCT00306358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425319|NCT00306358|Vitamin B Complex|vitamin b complex|mesh-ancestor
6425320|NCT00306358|Hematinics|hematinics|mesh-ancestor
6425321|NCT00306397|Sirolimus|sirolimus|mesh-list
6425322|NCT00306397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6425323|NCT00306397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6425324|NCT00306397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6425325|NCT00306397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6425326|NCT00306397|Antifungal Agents|antifungal agents|mesh-ancestor
6425327|NCT00306397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6425328|NCT00306397|Immunologic Factors|immunologic factors|mesh-ancestor
6425329|NCT00306397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425330|NCT00306410|Cholecalciferol|cholecalciferol|mesh-list
6425331|NCT00306410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6425332|NCT00306410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425333|NCT00306410|Vitamins|vitamins|mesh-ancestor
6425334|NCT00306410|Micronutrients|micronutrients|mesh-ancestor
6425335|NCT00306410|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6425336|NCT00306462|Magnesium Sulfate|magnesium sulfate|mesh-list
6425337|NCT00306462|Nifedipine|nifedipine|mesh-list
6425338|NCT00306462|Analgesics|analgesics|mesh-ancestor
6425339|NCT00306462|Sensory System Agents|sensory system agents|mesh-ancestor
6425340|NCT00306462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6425341|NCT00306462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425342|NCT00306462|Anesthetics|anesthetics|mesh-ancestor
6425343|NCT00306462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6425344|NCT00306462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6425345|NCT00306462|Anticonvulsants|anticonvulsants|mesh-ancestor
6425346|NCT00306462|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6425347|NCT00306462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6425348|NCT00306462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6425349|NCT00306462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6425350|NCT00306462|Tocolytic Agents|tocolytic agents|mesh-ancestor
6425351|NCT00306462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6425352|NCT00306462|Vasodilator Agents|vasodilator agents|mesh-ancestor
6425353|NCT00306475|Valproic Acid|valproic acid|mesh-list
6425354|NCT00306475|Anticonvulsants|anticonvulsants|mesh-ancestor
6425355|NCT00306475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6425356|NCT00306475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6425357|NCT00306475|GABA Agents|gaba agents|mesh-ancestor
6425358|NCT00306475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6425359|NCT00306475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425360|NCT00306475|Antimanic Agents|antimanic agents|mesh-ancestor
6425361|NCT00306475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6425362|NCT00306475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6538377|NCT00827411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6538378|NCT00827411|Antipyretics|antipyretics|mesh-ancestor
6538379|NCT00827411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6538380|NCT00827411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6538381|NCT00827411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6538382|NCT00827411|Purinergic Agents|purinergic agents|mesh-ancestor
6538383|NCT00827411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6538384|NCT00827450|Caffeine|caffeine|mesh-list
6538385|NCT00827450|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6538386|NCT00827450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538387|NCT00827450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6538388|NCT00827450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6538389|NCT00827450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538390|NCT00827450|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6538391|NCT00827450|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6538392|NCT00827450|Purinergic Agents|purinergic agents|mesh-ancestor
6538393|NCT00827450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6538394|NCT00827554|Nadroparin|nadroparin|mesh-list
6538395|NCT00827554|Anticoagulants|anticoagulants|mesh-ancestor
6538396|NCT00827554|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6538397|NCT00827554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6538398|NCT00827554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538399|NCT00827580|Eniluracil|eniluracil|mesh-list
6538400|NCT00827580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6538401|NCT00827580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6425363|NCT00306475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6425364|NCT00306540|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6425365|NCT00306540|Antidepressive Agents|antidepressive agents|mesh-ancestor
6538402|NCT00827671|Cetuximab|cetuximab|mesh-list
6425366|NCT00306540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6425367|NCT00306540|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6425368|NCT00306540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6425369|NCT00306540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6425370|NCT00306540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425371|NCT00306618|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
6425372|NCT00306618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6425373|NCT00306618|Tubulin Modulators|tubulin modulators|mesh-ancestor
6425374|NCT00306618|Antimitotic Agents|antimitotic agents|mesh-ancestor
6425375|NCT00306618|Mitosis Modulators|mitosis modulators|mesh-ancestor
6425376|NCT00306618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6425377|NCT00306644|Rosiglitazone|rosiglitazone|mesh-list
6425378|NCT00306644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6425379|NCT00306644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425380|NCT00306683|Diazoxide|diazoxide|mesh-list
6425381|NCT00306683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6425382|NCT00306683|Vasodilator Agents|vasodilator agents|mesh-ancestor
6425383|NCT00306696|Rosiglitazone|rosiglitazone|mesh-list
6425384|NCT00306696|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6425385|NCT00306696|Spironolactone|spironolactone|mesh-list
6425386|NCT00306696|Furosemide|furosemide|mesh-list
6425387|NCT00306696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6425388|NCT00306696|Diuretics|diuretics|mesh-ancestor
6425389|NCT00306696|Natriuretic Agents|natriuretic agents|mesh-ancestor
6425390|NCT00306696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425391|NCT00306696|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6425392|NCT00306696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6425393|NCT00306696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6425394|NCT00306696|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6425395|NCT00306696|Hormone Antagonists|hormone antagonists|mesh-ancestor
6425396|NCT00306696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6425397|NCT00306696|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6425398|NCT00306696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6425399|NCT00306696|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6460599|NCT00450736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460600|NCT00450736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6460601|NCT00450736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6460602|NCT00450736|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6460603|NCT00450736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6460604|NCT00450736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6460605|NCT00450736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460606|NCT00450762|Gemcitabine|gemcitabine|mesh-list
6460607|NCT00450762|Carboplatin|carboplatin|mesh-list
6460608|NCT00450762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6460609|NCT00450762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6460610|NCT00450762|Antimetabolites|antimetabolites|mesh-ancestor
6460611|NCT00450762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460612|NCT00450762|Antiviral Agents|antiviral agents|mesh-ancestor
6460613|NCT00450762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6460614|NCT00450762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6460615|NCT00450762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6460616|NCT00450762|Immunologic Factors|immunologic factors|mesh-ancestor
6460617|NCT00450762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460618|NCT00450827|Bevacizumab|bevacizumab|mesh-list
6460619|NCT00450827|Antibodies|antibodies|mesh-list
6460620|NCT00450827|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6460621|NCT00450827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6460622|NCT00450827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6460623|NCT00450827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6460624|NCT00450827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6460625|NCT00450827|Growth Substances|growth substances|mesh-ancestor
6460626|NCT00450827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460627|NCT00450827|Growth Inhibitors|growth inhibitors|mesh-ancestor
6460628|NCT00450827|Immunologic Factors|immunologic factors|mesh-ancestor
6460629|NCT00450840|Simvastatin|simvastatin|mesh-list
6460630|NCT00450840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6460631|NCT00450840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6460632|NCT00450840|Antimetabolites|antimetabolites|mesh-ancestor
6460633|NCT00450840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460634|NCT00450840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6460635|NCT00450840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6425400|NCT00306722|Fospropofol|fospropofol|mesh-list
6425401|NCT00306722|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6425402|NCT00306722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6425403|NCT00306722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425404|NCT00306735|Palonosetron|palonosetron|mesh-list
6425405|NCT00306735|Antiemetics|antiemetics|mesh-ancestor
6425406|NCT00306735|Autonomic Agents|autonomic agents|mesh-ancestor
6425407|NCT00306735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6425408|NCT00306735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425409|NCT00306735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6425410|NCT00306735|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6425411|NCT00306735|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6425412|NCT00306735|Serotonin Agents|serotonin agents|mesh-ancestor
6425413|NCT00306735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6425414|NCT00306735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6425415|NCT00306748|Linaclotide|linaclotide|mesh-list
6425416|NCT00306748|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
6425417|NCT00306748|Enzyme Activators|enzyme activators|mesh-ancestor
6425418|NCT00306748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6425419|NCT00306748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6425420|NCT00306774|Vitamin D|vitamin d|mesh-list
6425421|NCT00306774|Cholecalciferol|cholecalciferol|mesh-list
6425422|NCT00306774|Vitamins|vitamins|mesh-ancestor
6425423|NCT00306774|Micronutrients|micronutrients|mesh-ancestor
6425424|NCT00306774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425425|NCT00306774|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6425426|NCT00306774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6425427|NCT00306800|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6425428|NCT00306800|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
6425429|NCT00306800|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6425430|NCT00306800|Dermatologic Agents|dermatologic agents|mesh-ancestor
6425431|NCT00306813|Lenalidomide|lenalidomide|mesh-list
6425432|NCT00306813|Immunologic Factors|immunologic factors|mesh-ancestor
6425433|NCT00306813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425434|NCT00306813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6425435|NCT00306813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6425436|NCT00306813|Growth Substances|growth substances|mesh-ancestor
6425437|NCT00306813|Growth Inhibitors|growth inhibitors|mesh-ancestor
6425438|NCT00306813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6425439|NCT00306826|Pioglitazone|pioglitazone|mesh-list
6425440|NCT00306826|Simvastatin|simvastatin|mesh-list
6425441|NCT00306826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6425442|NCT00306826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6425443|NCT00306826|Antimetabolites|antimetabolites|mesh-ancestor
6425444|NCT00306826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6425445|NCT00306826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6425446|NCT00306826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6425447|NCT00306826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6425448|NCT00306826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6425449|NCT00306826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425450|NCT00306878|Abatacept|abatacept|mesh-list
6425451|NCT00306878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6425452|NCT00306878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6425453|NCT00306878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6425454|NCT00306878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6425455|NCT00306878|Immunologic Factors|immunologic factors|mesh-ancestor
6425456|NCT00306878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425457|NCT00306878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6425458|NCT00306969|Bexarotene|bexarotene|mesh-list
6425459|NCT00306969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6425460|NCT00307008|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6425461|NCT00307008|Immunologic Factors|immunologic factors|mesh-ancestor
6425462|NCT00307008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425463|NCT00307099|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6425464|NCT00307099|Meropenem|meropenem|mesh-list
6425465|NCT00307099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6425466|NCT00307138|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
6425467|NCT00307138|Plasma Substitutes|plasma substitutes|mesh-ancestor
6425468|NCT00307138|Blood Substitutes|blood substitutes|mesh-ancestor
6425469|NCT00307177|Vaccines|vaccines|mesh-list
6425470|NCT00307177|Immunologic Factors|immunologic factors|mesh-ancestor
6425471|NCT00307177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425472|NCT00307203|Bupropion|bupropion|mesh-list
6425473|NCT00307203|Nicotine|nicotine|mesh-list
6425474|NCT00307203|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6425475|NCT00307203|Autonomic Agents|autonomic agents|mesh-ancestor
6019166|NCT00385216|Cholinergic Agents|cholinergic agents|mesh-ancestor
6019167|NCT00385216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6019168|NCT00385216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6425476|NCT00307203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6425477|NCT00307203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425478|NCT00307203|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6425479|NCT00307203|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6425480|NCT00307203|Cholinergic Agents|cholinergic agents|mesh-ancestor
6425481|NCT00307203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6425482|NCT00307203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6425483|NCT00307203|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6425484|NCT00307203|Antidepressive Agents|antidepressive agents|mesh-ancestor
6425485|NCT00307203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6425486|NCT00307203|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6425487|NCT00307203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6425488|NCT00307203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6425489|NCT00307203|Dopamine Agents|dopamine agents|mesh-ancestor
6425490|NCT00307203|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6425491|NCT00307203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6425492|NCT00307203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6425493|NCT00307255|Gemcitabine|gemcitabine|mesh-list
6425494|NCT00307255|Paclitaxel|paclitaxel|mesh-list
6425495|NCT00307255|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6425496|NCT00307255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6425497|NCT00307255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6425498|NCT00307255|Tubulin Modulators|tubulin modulators|mesh-ancestor
6425499|NCT00307255|Antimitotic Agents|antimitotic agents|mesh-ancestor
6425500|NCT00307255|Mitosis Modulators|mitosis modulators|mesh-ancestor
6425501|NCT00307255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6425502|NCT00307255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6425503|NCT00307255|Antimetabolites|antimetabolites|mesh-ancestor
6425504|NCT00307255|Antiviral Agents|antiviral agents|mesh-ancestor
6425505|NCT00307255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6425506|NCT00307255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6425507|NCT00307255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6425508|NCT00307255|Immunologic Factors|immunologic factors|mesh-ancestor
6425509|NCT00307255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425510|NCT00307307|Niacin|niacin|mesh-list
6425511|NCT00307307|Simvastatin|simvastatin|mesh-list
6425512|NCT00307307|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6425513|NCT00307307|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6425514|NCT00307307|Antimetabolites|antimetabolites|mesh-ancestor
6425515|NCT00307307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6425516|NCT00307307|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6425517|NCT00307307|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6425518|NCT00307307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6425519|NCT00307307|Vasodilator Agents|vasodilator agents|mesh-ancestor
6425520|NCT00307307|Vitamin B Complex|vitamin b complex|mesh-ancestor
6425521|NCT00307307|Vitamins|vitamins|mesh-ancestor
6425522|NCT00307307|Micronutrients|micronutrients|mesh-ancestor
6425523|NCT00307307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425524|NCT00307411|Hormones|hormones|mesh-list
6425525|NCT00307411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6425526|NCT00307411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425527|NCT00307450|Levetiracetam|levetiracetam|mesh-list
6425528|NCT00307450|Anticonvulsants|anticonvulsants|mesh-ancestor
6425529|NCT00307450|Nootropic Agents|nootropic agents|mesh-ancestor
6425530|NCT00307463|Antihypertensive Agents|antihypertensive agents|mesh-list
6425531|NCT00307502|Ritonavir|ritonavir|mesh-list
6425532|NCT00307502|Lopinavir|lopinavir|mesh-list
6425533|NCT00307502|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6425534|NCT00307502|Darunavir|darunavir|mesh-list
6425535|NCT00307502|Nelfinavir|nelfinavir|mesh-list
6425536|NCT00307502|Indinavir|indinavir|mesh-list
6425537|NCT00307502|Saquinavir|saquinavir|mesh-list
6425538|NCT00307502|Amprenavir|amprenavir|mesh-list
6425539|NCT00307502|Fosamprenavir|fosamprenavir|mesh-list
6019169|NCT00385268|Acamprosate|acamprosate|mesh-list
6425540|NCT00307502|Nevirapine|nevirapine|mesh-list
6425541|NCT00307502|Tipranavir|tipranavir|mesh-list
6425542|NCT00307502|Efavirenz|efavirenz|mesh-list
6425543|NCT00307502|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6425544|NCT00307502|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6425545|NCT00307502|Protease Inhibitors|protease inhibitors|mesh-ancestor
6425546|NCT00307502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6425547|NCT00307502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6425548|NCT00307502|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6425549|NCT00307502|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6425550|NCT00307502|Antiviral Agents|antiviral agents|mesh-ancestor
6425551|NCT00307502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6425552|NCT00307502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6425553|NCT00307502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6425554|NCT00307502|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6425555|NCT00307502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6425556|NCT00307502|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6425557|NCT00307502|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6425558|NCT00307502|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6425559|NCT00307502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6425560|NCT00307502|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6425561|NCT00307502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6425562|NCT00307502|Antitubercular Agents|antitubercular agents|mesh-ancestor
6425563|NCT00307502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6425564|NCT00307515|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6425565|NCT00307515|Hemostatics|hemostatics|mesh-ancestor
6425566|NCT00307515|Coagulants|coagulants|mesh-ancestor
6425567|NCT00307528|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6425568|NCT00307528|Immunologic Factors|immunologic factors|mesh-ancestor
6425569|NCT00307528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425570|NCT00307580|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6425571|NCT00307580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6425572|NCT00307580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6425573|NCT00307580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6425574|NCT00307593|Rituximab|rituximab|mesh-list
6425575|NCT00307593|Infliximab|infliximab|mesh-list
6425576|NCT00307593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6425577|NCT00307593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6538403|NCT00827671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6538404|NCT00827671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6538405|NCT00827684|Sirolimus|sirolimus|mesh-list
6538406|NCT00827684|Irinotecan|irinotecan|mesh-list
6538407|NCT00827684|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6538408|NCT00827684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6538409|NCT00827684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6538410|NCT00827684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538411|NCT00827684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6538412|NCT00827684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6019170|NCT00385268|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6425578|NCT00307593|Immunologic Factors|immunologic factors|mesh-ancestor
6425579|NCT00307593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538413|NCT00827684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6425580|NCT00307593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6425581|NCT00307593|Dermatologic Agents|dermatologic agents|mesh-ancestor
6425582|NCT00307593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6425583|NCT00307606|Methylprednisolone|methylprednisolone|mesh-list
6425584|NCT00307606|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6425585|NCT00307606|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6425586|NCT00307606|Prednisolone|prednisolone|mesh-list
6425587|NCT00307606|Prednisolone acetate|prednisolone acetate|mesh-list
6425588|NCT00307606|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6425589|NCT00307606|Prednisolone phosphate|prednisolone phosphate|mesh-list
6425590|NCT00307606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6425591|NCT00307606|Antiemetics|antiemetics|mesh-ancestor
6425592|NCT00307606|Autonomic Agents|autonomic agents|mesh-ancestor
6425593|NCT00307606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6425594|NCT00307606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425595|NCT00307606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6425596|NCT00307606|Glucocorticoids|glucocorticoids|mesh-ancestor
6425597|NCT00307606|Hormones|hormones|mesh-ancestor
6425598|NCT00307606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6425599|NCT00307606|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6425600|NCT00307606|Protective Agents|protective agents|mesh-ancestor
6425601|NCT00307606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6425602|NCT00307606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6425603|NCT00307619|Topiramate|topiramate|mesh-list
6425604|NCT00307619|Anticonvulsants|anticonvulsants|mesh-ancestor
6425605|NCT00307619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6425606|NCT00307619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425607|NCT00307632|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6425608|NCT00307632|Estradiol|estradiol|mesh-list
6425609|NCT00307632|Estrogens|estrogens|mesh-ancestor
6425610|NCT00307632|Hormones|hormones|mesh-ancestor
6425611|NCT00307632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6425612|NCT00307632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425613|NCT00307632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6425614|NCT00307632|Contraceptive Agents|contraceptive agents|mesh-ancestor
6425615|NCT00307632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6425616|NCT00307632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6425617|NCT00307632|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6425618|NCT00307632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6425619|NCT00307645|Mycophenolic Acid|mycophenolic acid|mesh-list
6425620|NCT00307645|Prednisone|prednisone|mesh-list
6425621|NCT00307645|Methylprednisolone|methylprednisolone|mesh-list
6425622|NCT00307645|Cyclophosphamide|cyclophosphamide|mesh-list
6425623|NCT00307645|Azathioprine|azathioprine|mesh-list
6425624|NCT00307645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6425625|NCT00307645|Immunologic Factors|immunologic factors|mesh-ancestor
6425626|NCT00307645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425627|NCT00307645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6425628|NCT00307645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6425629|NCT00307645|Alkylating Agents|alkylating agents|mesh-ancestor
6460636|NCT00450840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6425630|NCT00307645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6425631|NCT00307645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6425632|NCT00307645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6425633|NCT00307645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6425634|NCT00307645|Glucocorticoids|glucocorticoids|mesh-ancestor
6425635|NCT00307645|Hormones|hormones|mesh-ancestor
6425636|NCT00307645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6425637|NCT00307645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6425638|NCT00307645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6425639|NCT00307645|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6425640|NCT00307645|Antitubercular Agents|antitubercular agents|mesh-ancestor
6019171|NCT00385541|Morphine|morphine|mesh-list
6425641|NCT00307645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6425642|NCT00307645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6425643|NCT00307645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6425644|NCT00307645|Antiemetics|antiemetics|mesh-ancestor
6425645|NCT00307645|Autonomic Agents|autonomic agents|mesh-ancestor
6425646|NCT00307645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6425647|NCT00307645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6425648|NCT00307645|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6425649|NCT00307645|Protective Agents|protective agents|mesh-ancestor
6425650|NCT00307645|Antimetabolites|antimetabolites|mesh-ancestor
6425651|NCT00307645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6425652|NCT00307658|Immunoglobulins|immunoglobulins|mesh-list
6425653|NCT00307658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6425654|NCT00307658|Antibodies|antibodies|mesh-list
6425655|NCT00307658|Immunoglobulin G|immunoglobulin g|mesh-list
6425656|NCT00307658|gamma-Globulins|gamma-globulins|mesh-list
6425657|NCT00307658|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6425658|NCT00307658|Immunologic Factors|immunologic factors|mesh-ancestor
6425659|NCT00307658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425660|NCT00307671|Mycophenolic Acid|mycophenolic acid|mesh-list
6425661|NCT00307671|Prednisone|prednisone|mesh-list
6425662|NCT00307671|Methylprednisolone|methylprednisolone|mesh-list
6425663|NCT00307671|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6425664|NCT00307671|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6425665|NCT00307671|Prednisolone|prednisolone|mesh-list
6425666|NCT00307671|Prednisolone acetate|prednisolone acetate|mesh-list
6425667|NCT00307671|Cyclophosphamide|cyclophosphamide|mesh-list
6425668|NCT00307671|Methotrexate|methotrexate|mesh-list
6425669|NCT00307671|Azathioprine|azathioprine|mesh-list
6425670|NCT00307671|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6425671|NCT00307671|Prednisolone phosphate|prednisolone phosphate|mesh-list
6425672|NCT00307671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6425673|NCT00307671|Immunologic Factors|immunologic factors|mesh-ancestor
6425674|NCT00307671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425675|NCT00307671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6425676|NCT00307671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6425677|NCT00307671|Alkylating Agents|alkylating agents|mesh-ancestor
6425678|NCT00307671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6425679|NCT00307671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6425680|NCT00307671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6425681|NCT00307671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6425682|NCT00307671|Glucocorticoids|glucocorticoids|mesh-ancestor
6425683|NCT00307671|Hormones|hormones|mesh-ancestor
6425684|NCT00307671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6019172|NCT00385541|Hydromorphone|hydromorphone|mesh-list
6425685|NCT00307671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6425686|NCT00307671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6425687|NCT00307671|Abortifacient Agents|abortifacient agents|mesh-ancestor
6425688|NCT00307671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6425689|NCT00307671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6425690|NCT00307671|Antimetabolites|antimetabolites|mesh-ancestor
6425691|NCT00307671|Dermatologic Agents|dermatologic agents|mesh-ancestor
6425692|NCT00307671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6425693|NCT00307671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6425694|NCT00307671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6425695|NCT00307671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6425696|NCT00307671|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6425697|NCT00307671|Antitubercular Agents|antitubercular agents|mesh-ancestor
6425698|NCT00307671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6425699|NCT00307671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6425700|NCT00307671|Antiemetics|antiemetics|mesh-ancestor
6425701|NCT00307671|Autonomic Agents|autonomic agents|mesh-ancestor
6425702|NCT00307671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6425703|NCT00307671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6425704|NCT00307671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6425705|NCT00307671|Protective Agents|protective agents|mesh-ancestor
6425706|NCT00307723|Gemcitabine|gemcitabine|mesh-list
6425707|NCT00307723|Bevacizumab|bevacizumab|mesh-list
6425708|NCT00307723|Fluorouracil|fluorouracil|mesh-list
6425709|NCT00307723|Oxaliplatin|oxaliplatin|mesh-list
6425710|NCT00307723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6425711|NCT00307723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6425712|NCT00307723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6425713|NCT00307723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6425714|NCT00307723|Growth Substances|growth substances|mesh-ancestor
6425715|NCT00307723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425716|NCT00307723|Growth Inhibitors|growth inhibitors|mesh-ancestor
6425717|NCT00307723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6425718|NCT00307723|Antimetabolites|antimetabolites|mesh-ancestor
6425719|NCT00307723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6425720|NCT00307723|Antiviral Agents|antiviral agents|mesh-ancestor
6425721|NCT00307723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6425722|NCT00307723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6425723|NCT00307723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6425724|NCT00307723|Immunologic Factors|immunologic factors|mesh-ancestor
6425725|NCT00307775|Estradiol|estradiol|mesh-list
6425726|NCT00307775|Estrogens|estrogens|mesh-ancestor
6425727|NCT00307775|Hormones|hormones|mesh-ancestor
6538414|NCT00827684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6538415|NCT00827684|Antifungal Agents|antifungal agents|mesh-ancestor
6538416|NCT00827684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6538417|NCT00827684|Immunologic Factors|immunologic factors|mesh-ancestor
6538418|NCT00827684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655346|NCT01463332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6655347|NCT01463332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655348|NCT01463332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6655349|NCT01463332|Analgesics|analgesics|mesh-ancestor
6655350|NCT01463332|Sensory System Agents|sensory system agents|mesh-ancestor
6655351|NCT01463332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6655352|NCT01463332|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6655353|NCT01463332|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6655354|NCT01463332|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6655355|NCT01463332|Adrenergic Agents|adrenergic agents|mesh-ancestor
6655356|NCT01463332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6655357|NCT01463332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655358|NCT01463371|Azithromycin|azithromycin|mesh-list
6655359|NCT01463371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6655360|NCT01463371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6655361|NCT01463592|Iodine|iodine|mesh-list
6425728|NCT00307775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6425729|NCT00307775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655362|NCT01463592|Interferons|interferons|mesh-list
6655363|NCT01463592|Ribavirin|ribavirin|mesh-list
6425730|NCT00307814|Epoetin Alfa|epoetin alfa|mesh-list
6425731|NCT00307814|Hematinics|hematinics|mesh-ancestor
6425732|NCT00307827|Visilizumab|visilizumab|mesh-list
6425733|NCT00307827|Immunologic Factors|immunologic factors|mesh-ancestor
6425734|NCT00307827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425735|NCT00307944|Pantoprazole|pantoprazole|mesh-list
6425736|NCT00307944|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6425737|NCT00307944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6425738|NCT00307944|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6425739|NCT00307944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6425740|NCT00307944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6425741|NCT00307996|Ubiquinone|ubiquinone|mesh-list
6425742|NCT00307996|Coenzyme Q10|coenzyme q10|mesh-list
6425743|NCT00307996|Micronutrients|micronutrients|mesh-ancestor
6425744|NCT00307996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425745|NCT00307996|Vitamins|vitamins|mesh-ancestor
6425746|NCT00308048|Interferons|interferons|mesh-list
6425747|NCT00308048|Ribavirin|ribavirin|mesh-list
6425748|NCT00308048|Interferon-alpha|interferon-alpha|mesh-list
6425749|NCT00308048|Interferon alpha-2|interferon alpha-2|mesh-list
6425750|NCT00308048|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6425751|NCT00308048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6425752|NCT00308048|Antiviral Agents|antiviral agents|mesh-ancestor
6425753|NCT00308048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6425754|NCT00308048|Antimetabolites|antimetabolites|mesh-ancestor
6425755|NCT00308048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6425756|NCT00308048|Immunologic Factors|immunologic factors|mesh-ancestor
6425757|NCT00308048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425758|NCT00308100|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
6425759|NCT00308100|Plasma Substitutes|plasma substitutes|mesh-ancestor
6425760|NCT00308100|Blood Substitutes|blood substitutes|mesh-ancestor
6425761|NCT00308126|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
6425762|NCT00308126|Plasma Substitutes|plasma substitutes|mesh-ancestor
6425763|NCT00308126|Blood Substitutes|blood substitutes|mesh-ancestor
6425764|NCT00308165|Topotecan|topotecan|mesh-list
6425765|NCT00308165|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6425766|NCT00308165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6425767|NCT00308165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6425768|NCT00308165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6425769|NCT00308165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6425770|NCT00308178|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6425771|NCT00308178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6425772|NCT00308191|Bromides|bromides|mesh-list
6425773|NCT00308191|Formoterol Fumarate|formoterol fumarate|mesh-list
6425774|NCT00308191|Tiotropium Bromide|tiotropium bromide|mesh-list
6425775|NCT00308191|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6425776|NCT00308191|Autonomic Agents|autonomic agents|mesh-ancestor
6425777|NCT00308191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6425778|NCT00308191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425779|NCT00308191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6425780|NCT00308191|Respiratory System Agents|respiratory system agents|mesh-ancestor
6425781|NCT00308191|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6425782|NCT00308191|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6425783|NCT00308191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6425784|NCT00308191|Adrenergic Agents|adrenergic agents|mesh-ancestor
6425785|NCT00308191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6460637|NCT00450853|Granisetron|granisetron|mesh-list
6425786|NCT00308191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6425787|NCT00308191|Parasympatholytics|parasympatholytics|mesh-ancestor
6425788|NCT00308191|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6425789|NCT00308191|Cholinergic Agents|cholinergic agents|mesh-ancestor
6425790|NCT00308191|Anticonvulsants|anticonvulsants|mesh-ancestor
6425791|NCT00308269|Folic Acid|folic acid|mesh-list
6425792|NCT00308269|Vinca Alkaloids|vinca alkaloids|mesh-list
6425793|NCT00308269|Hematinics|hematinics|mesh-ancestor
6425794|NCT00308269|Vitamin B Complex|vitamin b complex|mesh-ancestor
6425795|NCT00308269|Vitamins|vitamins|mesh-ancestor
6425796|NCT00308269|Micronutrients|micronutrients|mesh-ancestor
6425797|NCT00308269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425798|NCT00308269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6425799|NCT00308269|Tubulin Modulators|tubulin modulators|mesh-ancestor
6425800|NCT00308269|Antimitotic Agents|antimitotic agents|mesh-ancestor
6425801|NCT00308269|Mitosis Modulators|mitosis modulators|mesh-ancestor
6425802|NCT00308269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6425803|NCT00308321|Prednisolone|prednisolone|mesh-list
6425804|NCT00308321|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6425805|NCT00308321|Methylprednisolone|methylprednisolone|mesh-list
6425806|NCT00308321|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6425807|NCT00308321|Prednisolone acetate|prednisolone acetate|mesh-list
6425808|NCT00308321|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6425809|NCT00308321|Prednisolone phosphate|prednisolone phosphate|mesh-list
6425810|NCT00308321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6425811|NCT00308321|Glucocorticoids|glucocorticoids|mesh-ancestor
6425812|NCT00308321|Hormones|hormones|mesh-ancestor
6425813|NCT00308321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6425814|NCT00308321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425815|NCT00308321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6425816|NCT00308321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6425817|NCT00308321|Antiemetics|antiemetics|mesh-ancestor
6425818|NCT00308321|Autonomic Agents|autonomic agents|mesh-ancestor
6425819|NCT00308321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6425820|NCT00308321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6425821|NCT00308321|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6425822|NCT00308321|Protective Agents|protective agents|mesh-ancestor
6425823|NCT00308334|Domperidone|domperidone|mesh-list
6425824|NCT00308334|Antiemetics|antiemetics|mesh-ancestor
6425825|NCT00308334|Autonomic Agents|autonomic agents|mesh-ancestor
6425826|NCT00308334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6425827|NCT00308334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425828|NCT00308334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6425829|NCT00308334|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6425830|NCT00308334|Dopamine Agents|dopamine agents|mesh-ancestor
6425831|NCT00308334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6425832|NCT00308334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6425833|NCT00308360|Valproic Acid|valproic acid|mesh-list
6425834|NCT00308360|Risperidone|risperidone|mesh-list
6425835|NCT00308360|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6425836|NCT00308360|Serotonin Agents|serotonin agents|mesh-ancestor
6425837|NCT00308360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6425838|NCT00308360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6425839|NCT00308360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425840|NCT00308360|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6425841|NCT00308360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6425842|NCT00308360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6425843|NCT00308360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6425844|NCT00308360|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6425845|NCT00308360|Dopamine Agents|dopamine agents|mesh-ancestor
6425846|NCT00308360|Anticonvulsants|anticonvulsants|mesh-ancestor
6538419|NCT00827814|Dutasteride|dutasteride|mesh-list
6538420|NCT00827814|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6538421|NCT00827814|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6538422|NCT00827814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6538423|NCT00827814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538424|NCT00827814|Hormone Antagonists|hormone antagonists|mesh-ancestor
6425847|NCT00308360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6425848|NCT00308360|GABA Agents|gaba agents|mesh-ancestor
6425849|NCT00308360|Antimanic Agents|antimanic agents|mesh-ancestor
6425850|NCT00308373|Metformin|metformin|mesh-list
6425851|NCT00308373|Pioglitazone|pioglitazone|mesh-list
6425852|NCT00308373|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
6425853|NCT00308373|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6425854|NCT00308373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425855|NCT00308425|Mycophenolic Acid|mycophenolic acid|mesh-list
6425856|NCT00308425|Valsartan|valsartan|mesh-list
6425857|NCT00308425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6425858|NCT00308425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6425859|NCT00308425|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6425860|NCT00308425|Antitubercular Agents|antitubercular agents|mesh-ancestor
6425861|NCT00308425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6425862|NCT00308425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6425863|NCT00308425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6425864|NCT00308425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6425865|NCT00308425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6425866|NCT00308425|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6425867|NCT00308425|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6460638|NCT00450853|Antiemetics|antiemetics|mesh-ancestor
6460639|NCT00450853|Autonomic Agents|autonomic agents|mesh-ancestor
6460640|NCT00450853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6460641|NCT00450853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460642|NCT00450853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6460643|NCT00450853|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6460644|NCT00450853|Serotonin Agents|serotonin agents|mesh-ancestor
6460645|NCT00450853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6460646|NCT00450853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460647|NCT00450892|Docetaxel|docetaxel|mesh-list
6460648|NCT00450892|Trastuzumab|trastuzumab|mesh-list
6460649|NCT00450892|Lapatinib|lapatinib|mesh-list
6460650|NCT00450892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6460651|NCT00450892|Tubulin Modulators|tubulin modulators|mesh-ancestor
6460652|NCT00450892|Antimitotic Agents|antimitotic agents|mesh-ancestor
6460653|NCT00450892|Mitosis Modulators|mitosis modulators|mesh-ancestor
6460654|NCT00450892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460655|NCT00450892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6460656|NCT00450892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6460657|NCT00450892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6462107|NCT00457678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6462108|NCT00457678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6462109|NCT00457678|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6462110|NCT00457678|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6462111|NCT00457678|Growth Substances|growth substances|mesh-ancestor
6462112|NCT00457678|Growth Inhibitors|growth inhibitors|mesh-ancestor
6462113|NCT00457678|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6462114|NCT00457678|Dermatologic Agents|dermatologic agents|mesh-ancestor
6462115|NCT00457717|Atropine|atropine|mesh-list
6462116|NCT00457717|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6462117|NCT00457717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6462118|NCT00457717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6462119|NCT00457717|Autonomic Agents|autonomic agents|mesh-ancestor
6462120|NCT00457717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6462121|NCT00457717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462122|NCT00457717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6462123|NCT00457717|Respiratory System Agents|respiratory system agents|mesh-ancestor
6462124|NCT00457717|Mydriatics|mydriatics|mesh-ancestor
6462125|NCT00457717|Parasympatholytics|parasympatholytics|mesh-ancestor
6462126|NCT00457717|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6462127|NCT00457717|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6462128|NCT00457717|Cholinergic Agents|cholinergic agents|mesh-ancestor
6462129|NCT00457717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6462130|NCT00457717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462131|NCT00457769|Donepezil|donepezil|mesh-list
6462132|NCT00457769|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6462133|NCT00457769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6462134|NCT00457769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462135|NCT00457769|Cholinergic Agents|cholinergic agents|mesh-ancestor
6425868|NCT00308438|Teduglutide|teduglutide|mesh-list
6425869|NCT00308438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6425870|NCT00308438|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6425871|NCT00308438|Protective Agents|protective agents|mesh-ancestor
6425872|NCT00308438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425873|NCT00308451|Chromium|chromium|mesh-list
6425874|NCT00308451|Biotin|biotin|mesh-list
6425875|NCT00308451|Picolinic acid|picolinic acid|mesh-list
6425876|NCT00308451|Trace Elements|trace elements|mesh-ancestor
6425877|NCT00308451|Micronutrients|micronutrients|mesh-ancestor
6425878|NCT00308451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425879|NCT00308451|Vitamin B Complex|vitamin b complex|mesh-ancestor
6655364|NCT01463592|Interferon-alpha|interferon-alpha|mesh-list
6425880|NCT00308451|Vitamins|vitamins|mesh-ancestor
6425881|NCT00308451|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6425882|NCT00308451|Chelating Agents|chelating agents|mesh-ancestor
6425883|NCT00308451|Sequestering Agents|sequestering agents|mesh-ancestor
6425884|NCT00308451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6425885|NCT00308477|Dexamethasone|dexamethasone|mesh-list
6425886|NCT00308477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6425887|NCT00308477|Antiemetics|antiemetics|mesh-ancestor
6425888|NCT00308477|Autonomic Agents|autonomic agents|mesh-ancestor
6425889|NCT00308477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6425890|NCT00308477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425891|NCT00308477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6425892|NCT00308477|Glucocorticoids|glucocorticoids|mesh-ancestor
6425893|NCT00308477|Hormones|hormones|mesh-ancestor
6425894|NCT00308477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6425895|NCT00308477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6425896|NCT00308477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6425897|NCT00308490|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6425898|NCT00308490|Hematinics|hematinics|mesh-ancestor
6425899|NCT00308503|SR 46349B|sr 46349b|mesh-list
6425900|NCT00308503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6425901|NCT00308503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6425902|NCT00308503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6425903|NCT00308503|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6425904|NCT00308503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6425905|NCT00308503|Serotonin Agents|serotonin agents|mesh-ancestor
6425906|NCT00308503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6538425|NCT00827814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6538426|NCT00827814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538427|NCT00827840|Risperidone|risperidone|mesh-list
6538428|NCT00827840|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6538429|NCT00827840|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6538430|NCT00827840|Serotonin Agents|serotonin agents|mesh-ancestor
6538431|NCT00827840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6538432|NCT00827840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538433|NCT00827840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538434|NCT00827840|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6538435|NCT00827840|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6538436|NCT00827840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6538437|NCT00827840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6538438|NCT00827840|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6538439|NCT00827840|Dopamine Agents|dopamine agents|mesh-ancestor
6538440|NCT00827840|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6538441|NCT00827840|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6538442|NCT00827892|Pioglitazone|pioglitazone|mesh-list
6538443|NCT00827892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6538444|NCT00827892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425907|NCT00308503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538445|NCT00827996|Adalimumab|adalimumab|mesh-list
6538446|NCT00827996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6538447|NCT00827996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6538448|NCT00828087|Cobalt|cobalt|mesh-list
6538449|NCT00828087|Chromium|chromium|mesh-list
6538450|NCT00828087|Everolimus|everolimus|mesh-list
6538451|NCT00828087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6538452|NCT00828087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6538453|NCT00828087|Immunologic Factors|immunologic factors|mesh-ancestor
6538454|NCT00828087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538455|NCT00828087|Trace Elements|trace elements|mesh-ancestor
6538456|NCT00828087|Micronutrients|micronutrients|mesh-ancestor
6538457|NCT00828230|Budesonide|budesonide|mesh-list
6538458|NCT00828230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6538459|NCT00828230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6538460|NCT00828230|Autonomic Agents|autonomic agents|mesh-ancestor
6538461|NCT00828230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6538462|NCT00828230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538463|NCT00828230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6538464|NCT00828230|Respiratory System Agents|respiratory system agents|mesh-ancestor
6538465|NCT00828230|Glucocorticoids|glucocorticoids|mesh-ancestor
6538466|NCT00828230|Hormones|hormones|mesh-ancestor
6538467|NCT00828230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6538468|NCT00828282|Simvastatin|simvastatin|mesh-list
6538469|NCT00828282|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6538470|NCT00828282|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6538471|NCT00828282|Antimetabolites|antimetabolites|mesh-ancestor
6538472|NCT00828282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538473|NCT00828282|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6538474|NCT00828282|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6538475|NCT00828282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6538476|NCT00828373|Lidocaine|lidocaine|mesh-list
6538477|NCT00828373|Anesthetics, Local|anesthetics, local|mesh-ancestor
6538478|NCT00828373|Anesthetics|anesthetics|mesh-ancestor
6538479|NCT00828373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6538480|NCT00828373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538481|NCT00828373|Sensory System Agents|sensory system agents|mesh-ancestor
6019173|NCT00385541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6019174|NCT00385541|Narcotics|narcotics|mesh-ancestor
6019175|NCT00385541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6019176|NCT00385541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019177|NCT00385541|Analgesics|analgesics|mesh-ancestor
6425908|NCT00308529|Bevacizumab|bevacizumab|mesh-list
6425909|NCT00308529|Carboplatin|carboplatin|mesh-list
6425910|NCT00308529|Irinotecan|irinotecan|mesh-list
6425911|NCT00308529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6425912|NCT00308529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6425913|NCT00308529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6425914|NCT00308529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6425915|NCT00308529|Growth Substances|growth substances|mesh-ancestor
6425916|NCT00308529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425917|NCT00308529|Growth Inhibitors|growth inhibitors|mesh-ancestor
6425918|NCT00308529|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6425919|NCT00308529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6425920|NCT00308529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6425921|NCT00308529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6425922|NCT00308542|Dexamethasone|dexamethasone|mesh-list
6425923|NCT00308542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6425924|NCT00308542|Antiemetics|antiemetics|mesh-ancestor
6425925|NCT00308542|Autonomic Agents|autonomic agents|mesh-ancestor
6425926|NCT00308542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6425927|NCT00308542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501369|NCT04475029|Methadone|methadone|mesh-list
6425928|NCT00308542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6425929|NCT00308542|Glucocorticoids|glucocorticoids|mesh-ancestor
6425930|NCT00308542|Hormones|hormones|mesh-ancestor
6425931|NCT00308542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6425932|NCT00308542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6425933|NCT00308542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6425934|NCT00308594|Dexamethasone|dexamethasone|mesh-list
6425935|NCT00308594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6425936|NCT00308594|Antiemetics|antiemetics|mesh-ancestor
6425937|NCT00308594|Autonomic Agents|autonomic agents|mesh-ancestor
6425938|NCT00308594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6425939|NCT00308594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425940|NCT00308594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6425941|NCT00308594|Glucocorticoids|glucocorticoids|mesh-ancestor
6425942|NCT00308594|Hormones|hormones|mesh-ancestor
6425943|NCT00308594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6425944|NCT00308594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6425945|NCT00308594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6425946|NCT00308607|Interferons|interferons|mesh-list
6425947|NCT00308607|Interferon-alpha|interferon-alpha|mesh-list
6425948|NCT00308607|Interferon alpha-2|interferon alpha-2|mesh-list
6425949|NCT00308607|Bevacizumab|bevacizumab|mesh-list
6425950|NCT00308607|Dacarbazine|dacarbazine|mesh-list
6425951|NCT00308607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6425952|NCT00308607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6425953|NCT00308607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6425954|NCT00308607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6425955|NCT00308607|Growth Substances|growth substances|mesh-ancestor
6425956|NCT00308607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425957|NCT00308607|Growth Inhibitors|growth inhibitors|mesh-ancestor
6425958|NCT00308607|Antiviral Agents|antiviral agents|mesh-ancestor
6425959|NCT00308607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6425960|NCT00308607|Immunologic Factors|immunologic factors|mesh-ancestor
6425961|NCT00308607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6425962|NCT00308607|Alkylating Agents|alkylating agents|mesh-ancestor
6425963|NCT00308607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6425964|NCT00308763|Bupropion|bupropion|mesh-list
6425965|NCT00308763|Nicotine|nicotine|mesh-list
6425966|NCT00308763|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6425967|NCT00308763|Autonomic Agents|autonomic agents|mesh-ancestor
6425968|NCT00308763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6425969|NCT00308763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425970|NCT00308763|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6425971|NCT00308763|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6425972|NCT00308763|Cholinergic Agents|cholinergic agents|mesh-ancestor
6425973|NCT00308763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6425974|NCT00308763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6425975|NCT00308763|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6425976|NCT00308763|Antidepressive Agents|antidepressive agents|mesh-ancestor
6425977|NCT00308763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6425978|NCT00308763|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6425979|NCT00308763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6425980|NCT00308763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6425981|NCT00308763|Dopamine Agents|dopamine agents|mesh-ancestor
6425982|NCT00308763|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6425983|NCT00308763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6425984|NCT00308763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6425985|NCT00308776|Cholecystokinin|cholecystokinin|mesh-list
6425986|NCT00308776|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6425987|NCT00308776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6425988|NCT00308841|Lidocaine|lidocaine|mesh-list
6425989|NCT00308841|Anesthetics, Local|anesthetics, local|mesh-ancestor
6425990|NCT00308841|Anesthetics|anesthetics|mesh-ancestor
6425991|NCT00308841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6425992|NCT00308841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6425993|NCT00308841|Sensory System Agents|sensory system agents|mesh-ancestor
6425994|NCT00308841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6425995|NCT00308841|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6425996|NCT00308841|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6425997|NCT00308841|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6425998|NCT00308841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6425999|NCT00308841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426000|NCT00308880|Tranexamic Acid|tranexamic acid|mesh-list
6426001|NCT00308880|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6426002|NCT00308880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6426003|NCT00308880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426004|NCT00308880|Hemostatics|hemostatics|mesh-ancestor
6426005|NCT00308880|Coagulants|coagulants|mesh-ancestor
6426006|NCT00308945|Travoprost|travoprost|mesh-list
6426007|NCT00308945|Latanoprost|latanoprost|mesh-list
6426008|NCT00308945|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6426009|NCT00308945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6426010|NCT00308945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6426011|NCT00308971|Vitamin E|vitamin e|mesh-list
6426012|NCT00308971|Tocopherols|tocopherols|mesh-list
6426013|NCT00308971|Tocotrienols|tocotrienols|mesh-list
6426014|NCT00308971|alpha-Tocopherol|alpha-tocopherol|mesh-list
6426015|NCT00308971|Thioctic Acid|thioctic acid|mesh-list
6538482|NCT00828373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6538483|NCT00828373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6538484|NCT00828373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6538485|NCT00828373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6538486|NCT00828373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6538487|NCT00828373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538488|NCT00828477|Nepafenac|nepafenac|mesh-list
6538489|NCT00828477|Bromfenac|bromfenac|mesh-list
6538490|NCT00828477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6538491|NCT00828477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6538492|NCT00828477|Analgesics|analgesics|mesh-ancestor
6538493|NCT00828477|Sensory System Agents|sensory system agents|mesh-ancestor
6538494|NCT00828477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6538495|NCT00828477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538496|NCT00828477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6538497|NCT00828477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6538498|NCT00828503|Valganciclovir|valganciclovir|mesh-list
6538499|NCT00828503|Everolimus|everolimus|mesh-list
6538500|NCT00828503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6538501|NCT00828503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6538502|NCT00828503|Immunologic Factors|immunologic factors|mesh-ancestor
6538503|NCT00828503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538504|NCT00828503|Antiviral Agents|antiviral agents|mesh-ancestor
6538505|NCT00828503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6538506|NCT00828529|Bedaquiline|bedaquiline|mesh-list
6538507|NCT00828529|Antitubercular Agents|antitubercular agents|mesh-ancestor
6538508|NCT00828529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6538509|NCT00828529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6538510|NCT00828555|Vaccines|vaccines|mesh-list
6538511|NCT00828555|Immunologic Factors|immunologic factors|mesh-ancestor
6426016|NCT00308971|Vitamins|vitamins|mesh-ancestor
6426017|NCT00308971|Micronutrients|micronutrients|mesh-ancestor
6426018|NCT00308971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426019|NCT00308971|Antioxidants|antioxidants|mesh-ancestor
6426020|NCT00308971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426021|NCT00308971|Protective Agents|protective agents|mesh-ancestor
6426022|NCT00308971|Vitamin B Complex|vitamin b complex|mesh-ancestor
6426023|NCT00309049|Epothilones|epothilones|mesh-list
6426024|NCT00309049|Tubulin Modulators|tubulin modulators|mesh-ancestor
6426025|NCT00309049|Antimitotic Agents|antimitotic agents|mesh-ancestor
6426026|NCT00309049|Mitosis Modulators|mitosis modulators|mesh-ancestor
6426027|NCT00309049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426028|NCT00309049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6426029|NCT00309088|Tacrolimus|tacrolimus|mesh-list
6426030|NCT00309088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6426031|NCT00309088|Immunologic Factors|immunologic factors|mesh-ancestor
6426032|NCT00309088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426033|NCT00309088|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6426034|NCT00309088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6426035|NCT00309088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426036|NCT00309101|Tacrolimus|tacrolimus|mesh-list
6426037|NCT00309101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6426038|NCT00309101|Immunologic Factors|immunologic factors|mesh-ancestor
6426039|NCT00309101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426040|NCT00309101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6426041|NCT00309101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6426042|NCT00309101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426043|NCT00309192|Triamcinolone|triamcinolone|mesh-list
6426044|NCT00309192|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6426045|NCT00309192|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6426046|NCT00309192|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6426047|NCT00309192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6426048|NCT00309192|Glucocorticoids|glucocorticoids|mesh-ancestor
6426049|NCT00309192|Hormones|hormones|mesh-ancestor
6426050|NCT00309192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6426051|NCT00309192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426052|NCT00309192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6426053|NCT00309192|Immunologic Factors|immunologic factors|mesh-ancestor
6426054|NCT00309192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6426055|NCT00309192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426056|NCT00309205|Dapivirine|dapivirine|mesh-list
6426057|NCT00309205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6426058|NCT00309205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6426059|NCT00309205|Antiviral Agents|antiviral agents|mesh-ancestor
6426060|NCT00309205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6426061|NCT00309218|Methylprednisolone|methylprednisolone|mesh-list
6426062|NCT00309218|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6426063|NCT00309218|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6426064|NCT00309218|Prednisolone|prednisolone|mesh-list
6426065|NCT00309218|Prednisolone acetate|prednisolone acetate|mesh-list
6426066|NCT00309218|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6426067|NCT00309218|Prednisolone phosphate|prednisolone phosphate|mesh-list
6426068|NCT00309218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6426069|NCT00309218|Antiemetics|antiemetics|mesh-ancestor
6426070|NCT00309218|Autonomic Agents|autonomic agents|mesh-ancestor
6538512|NCT00828555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538513|NCT00828594|Sorafenib|sorafenib|mesh-list
6538514|NCT00828594|Everolimus|everolimus|mesh-list
6538515|NCT00828594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6538516|NCT00828594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6538517|NCT00828594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6538518|NCT00828594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538519|NCT00828594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6538520|NCT00828594|Immunologic Factors|immunologic factors|mesh-ancestor
6538521|NCT00828594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538522|NCT00828763|Dolutegravir|dolutegravir|mesh-list
6538523|NCT00828763|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6538524|NCT00828763|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6538525|NCT00828763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6538526|NCT00828763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538527|NCT00828763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6538528|NCT00828763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6538529|NCT00828763|Antiviral Agents|antiviral agents|mesh-ancestor
6538530|NCT00828763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6538531|NCT00828776|Heparin|heparin|mesh-list
6538532|NCT00828776|Calcium heparin|calcium heparin|mesh-list
6538533|NCT00828776|Anticoagulants|anticoagulants|mesh-ancestor
6426071|NCT00309218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6426072|NCT00309218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426073|NCT00309218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6426074|NCT00309218|Glucocorticoids|glucocorticoids|mesh-ancestor
6426075|NCT00309218|Hormones|hormones|mesh-ancestor
6426076|NCT00309218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6426077|NCT00309218|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6426078|NCT00309218|Protective Agents|protective agents|mesh-ancestor
6426079|NCT00309218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6426080|NCT00309218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6426081|NCT00309257|Valsartan|valsartan|mesh-list
6426082|NCT00309257|Benazepril|benazepril|mesh-list
6426083|NCT00309257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6426084|NCT00309257|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6426085|NCT00309257|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6426086|NCT00309257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426087|NCT00309257|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6426088|NCT00309257|Protease Inhibitors|protease inhibitors|mesh-ancestor
6426089|NCT00309257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6426090|NCT00309270|Alemtuzumab|alemtuzumab|mesh-list
6426091|NCT00309270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6426092|NCT00309270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6426093|NCT00309283|Somatostatin|somatostatin|mesh-list
6426094|NCT00309283|Hormones|hormones|mesh-ancestor
6426095|NCT00309283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6426096|NCT00309283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426097|NCT00309309|Rosiglitazone|rosiglitazone|mesh-list
6426098|NCT00309309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6426099|NCT00309309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426100|NCT00309322|Phentolamine|phentolamine|mesh-list
6426101|NCT00309322|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6426102|NCT00309322|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6426103|NCT00309322|Adrenergic Agents|adrenergic agents|mesh-ancestor
6426104|NCT00309322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5501370|NCT04475029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6426105|NCT00309322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426106|NCT00309322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426107|NCT00309322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6426108|NCT00309335|Phentolamine|phentolamine|mesh-list
6426109|NCT00309335|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6426110|NCT00309335|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6426111|NCT00309335|Adrenergic Agents|adrenergic agents|mesh-ancestor
6426112|NCT00309335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6426113|NCT00309335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426114|NCT00309335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426115|NCT00309335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6426116|NCT00309361|Phentolamine|phentolamine|mesh-list
6426117|NCT00309361|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6426118|NCT00309361|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6426119|NCT00309361|Adrenergic Agents|adrenergic agents|mesh-ancestor
6426120|NCT00309361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6426121|NCT00309361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426122|NCT00309361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426123|NCT00309361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6426124|NCT00309374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6426125|NCT00309374|Simvastatin|simvastatin|mesh-list
6426126|NCT00309374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6426127|NCT00309374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6426128|NCT00309374|Antimetabolites|antimetabolites|mesh-ancestor
6426129|NCT00309374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426130|NCT00309374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6426131|NCT00309374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6426132|NCT00309374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6426133|NCT00309413|Cannabidiol|cannabidiol|mesh-list
6019178|NCT00385541|Sensory System Agents|sensory system agents|mesh-ancestor
6019179|NCT00385541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6019180|NCT00385580|Dasatinib|dasatinib|mesh-list
6019181|NCT00385580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6019182|NCT00385580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6019183|NCT00385580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6019184|NCT00385580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019185|NCT00385593|Budesonide|budesonide|mesh-list
6019186|NCT00385593|Formoterol Fumarate|formoterol fumarate|mesh-list
6019187|NCT00385593|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6019188|NCT00385593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6426134|NCT00309413|Anticonvulsants|anticonvulsants|mesh-ancestor
6426135|NCT00309478|Tamoxifen|tamoxifen|mesh-list
6426136|NCT00309478|Cyclophosphamide|cyclophosphamide|mesh-list
6426137|NCT00309478|Fluorouracil|fluorouracil|mesh-list
6426138|NCT00309478|Methotrexate|methotrexate|mesh-list
6426139|NCT00309478|Goserelin|goserelin|mesh-list
6426140|NCT00309478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6426141|NCT00309478|Immunologic Factors|immunologic factors|mesh-ancestor
6426142|NCT00309478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426143|NCT00309478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6426144|NCT00309478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6426145|NCT00309478|Alkylating Agents|alkylating agents|mesh-ancestor
6426146|NCT00309478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426147|NCT00309478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6426148|NCT00309478|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6426149|NCT00309478|Antimetabolites|antimetabolites|mesh-ancestor
6426150|NCT00309478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6426151|NCT00309478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6426152|NCT00309478|Abortifacient Agents|abortifacient agents|mesh-ancestor
6426153|NCT00309478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6426154|NCT00309478|Dermatologic Agents|dermatologic agents|mesh-ancestor
6426155|NCT00309478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6426156|NCT00309478|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6426157|NCT00309478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6426158|NCT00309478|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6426159|NCT00309478|Hormone Antagonists|hormone antagonists|mesh-ancestor
6426160|NCT00309478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6426161|NCT00309478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6426162|NCT00309478|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6426163|NCT00309478|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6426164|NCT00309478|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6426165|NCT00309491|Tamoxifen|tamoxifen|mesh-list
6426166|NCT00309491|Aminoglutethimide|aminoglutethimide|mesh-list
6426167|NCT00309491|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6426168|NCT00309491|Hormone Antagonists|hormone antagonists|mesh-ancestor
6426169|NCT00309491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6426170|NCT00309491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426171|NCT00309491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6426172|NCT00309491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6426173|NCT00309491|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6426174|NCT00309491|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6426175|NCT00309491|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6426176|NCT00309491|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6426177|NCT00309491|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6019189|NCT00385593|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6426178|NCT00309491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6426179|NCT00309491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426180|NCT00309517|Leucovorin|leucovorin|mesh-list
6426181|NCT00309517|Edrecolomab|edrecolomab|mesh-list
6426182|NCT00309517|Antidotes|antidotes|mesh-ancestor
6426183|NCT00309517|Protective Agents|protective agents|mesh-ancestor
6426184|NCT00309517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426185|NCT00309517|Vitamin B Complex|vitamin b complex|mesh-ancestor
6426186|NCT00309517|Vitamins|vitamins|mesh-ancestor
6426187|NCT00309517|Micronutrients|micronutrients|mesh-ancestor
6426188|NCT00309517|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6426189|NCT00309517|Immunologic Factors|immunologic factors|mesh-ancestor
6426190|NCT00309530|Interferons|interferons|mesh-list
6019190|NCT00385593|Autonomic Agents|autonomic agents|mesh-ancestor
6019191|NCT00385593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6019192|NCT00385593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019193|NCT00385593|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6019194|NCT00385593|Respiratory System Agents|respiratory system agents|mesh-ancestor
6426191|NCT00309530|Fluorouracil|fluorouracil|mesh-list
6426192|NCT00309530|Antimetabolites|antimetabolites|mesh-ancestor
6426193|NCT00309530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426194|NCT00309530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6426195|NCT00309530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6426196|NCT00309530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6426197|NCT00309530|Immunologic Factors|immunologic factors|mesh-ancestor
6426198|NCT00309530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426199|NCT00309530|Antiviral Agents|antiviral agents|mesh-ancestor
6426200|NCT00309530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6426201|NCT00309543|Leucovorin|leucovorin|mesh-list
6426202|NCT00309543|Fluorouracil|fluorouracil|mesh-list
6426203|NCT00309543|Antimetabolites|antimetabolites|mesh-ancestor
6426204|NCT00309543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426205|NCT00309543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6426206|NCT00309543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6426207|NCT00309543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6426208|NCT00309543|Immunologic Factors|immunologic factors|mesh-ancestor
6426209|NCT00309543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426210|NCT00309543|Antidotes|antidotes|mesh-ancestor
6426211|NCT00309543|Protective Agents|protective agents|mesh-ancestor
6426212|NCT00309543|Vitamin B Complex|vitamin b complex|mesh-ancestor
6426213|NCT00309543|Vitamins|vitamins|mesh-ancestor
6426214|NCT00309543|Micronutrients|micronutrients|mesh-ancestor
6538534|NCT00828776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6538535|NCT00828776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6538536|NCT00828776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538537|NCT00828789|Tenofovir|tenofovir|mesh-list
6538538|NCT00828789|Efavirenz|efavirenz|mesh-list
6538539|NCT00828789|Antiviral Agents|antiviral agents|mesh-ancestor
6426215|NCT00309556|Docetaxel|docetaxel|mesh-list
6426216|NCT00309556|Capecitabine|capecitabine|mesh-list
6426217|NCT00309556|Trastuzumab|trastuzumab|mesh-list
6426218|NCT00309556|Epirubicin|epirubicin|mesh-list
6426219|NCT00309556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6426220|NCT00309556|Tubulin Modulators|tubulin modulators|mesh-ancestor
6426221|NCT00309556|Antimitotic Agents|antimitotic agents|mesh-ancestor
6426222|NCT00309556|Mitosis Modulators|mitosis modulators|mesh-ancestor
6426223|NCT00309556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426224|NCT00309556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6426225|NCT00309556|Antimetabolites|antimetabolites|mesh-ancestor
6426226|NCT00309556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6426227|NCT00309556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6426228|NCT00309556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6426229|NCT00309556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6426230|NCT00309556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6426231|NCT00309569|Cyclophosphamide|cyclophosphamide|mesh-list
6426232|NCT00309569|Fluorouracil|fluorouracil|mesh-list
6426233|NCT00309569|Methotrexate|methotrexate|mesh-list
6426234|NCT00309569|Epirubicin|epirubicin|mesh-list
6426235|NCT00309569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6426236|NCT00309569|Immunologic Factors|immunologic factors|mesh-ancestor
6426237|NCT00309569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426238|NCT00309569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6426239|NCT00309569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6426240|NCT00309569|Alkylating Agents|alkylating agents|mesh-ancestor
6426241|NCT00309569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426242|NCT00309569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6426243|NCT00309569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6426244|NCT00309569|Antimetabolites|antimetabolites|mesh-ancestor
6426245|NCT00309569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6426246|NCT00309569|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6426247|NCT00309569|Abortifacient Agents|abortifacient agents|mesh-ancestor
6426248|NCT00309569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6426249|NCT00309569|Dermatologic Agents|dermatologic agents|mesh-ancestor
6426250|NCT00309569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6426251|NCT00309569|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6426252|NCT00309569|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6426253|NCT00309569|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6426254|NCT00309569|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6426255|NCT00309569|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6426256|NCT00309621|Alitretinoin|alitretinoin|mesh-list
6426257|NCT00309621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6426258|NCT00309621|Dermatologic Agents|dermatologic agents|mesh-ancestor
6426259|NCT00309634|Vaccines|vaccines|mesh-list
6426260|NCT00309634|Immunologic Factors|immunologic factors|mesh-ancestor
6426261|NCT00309634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426262|NCT00309660|Rosiglitazone|rosiglitazone|mesh-list
6426263|NCT00309660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6426264|NCT00309660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426265|NCT00309673|Lidocaine|lidocaine|mesh-list
6426266|NCT00309673|Prilocaine|prilocaine|mesh-list
6426267|NCT00309673|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
6426268|NCT00309673|Anesthetics, Local|anesthetics, local|mesh-ancestor
6426269|NCT00309673|Anesthetics|anesthetics|mesh-ancestor
6426270|NCT00309673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6426271|NCT00309673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426272|NCT00309673|Sensory System Agents|sensory system agents|mesh-ancestor
6426273|NCT00309673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6426274|NCT00309673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6426275|NCT00309673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6426276|NCT00309673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6426277|NCT00309673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6426278|NCT00309673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426279|NCT00309673|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
6426280|NCT00309686|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6426281|NCT00309686|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6426282|NCT00309686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6426283|NCT00309686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6426284|NCT00309686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426285|NCT00309686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6426286|NCT00309686|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5501371|NCT04475029|Narcotics|narcotics|mesh-ancestor
6426287|NCT00309686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6426288|NCT00309686|Serotonin Agents|serotonin agents|mesh-ancestor
6426289|NCT00309686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6426290|NCT00309686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426291|NCT00309686|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6426292|NCT00309686|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6426293|NCT00309686|Dopamine Agents|dopamine agents|mesh-ancestor
6426294|NCT00309699|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6426295|NCT00309699|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6426296|NCT00309699|Antidepressive Agents|antidepressive agents|mesh-ancestor
6426297|NCT00309699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6426298|NCT00309699|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6426299|NCT00309699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6426300|NCT00309699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6426301|NCT00309699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426302|NCT00309699|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6426303|NCT00309699|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6426304|NCT00309699|Serotonin Agents|serotonin agents|mesh-ancestor
6426305|NCT00309699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6426306|NCT00309699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426307|NCT00309699|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6426308|NCT00309699|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6426309|NCT00309699|Dopamine Agents|dopamine agents|mesh-ancestor
6426310|NCT00309712|Simvastatin|simvastatin|mesh-list
6426311|NCT00309712|Fenofibrate|fenofibrate|mesh-list
6426312|NCT00309712|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6426313|NCT00309712|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6426314|NCT00309712|Antimetabolites|antimetabolites|mesh-ancestor
6426315|NCT00309712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426316|NCT00309712|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6426317|NCT00309712|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6426318|NCT00309712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6426319|NCT00309725|Galantamine|galantamine|mesh-list
6426320|NCT00309725|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6538540|NCT00828789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6538541|NCT00828789|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6538542|NCT00828789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6538543|NCT00828789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6538544|NCT00828789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538545|NCT00828789|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6538546|NCT00828789|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6538547|NCT00828789|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6538548|NCT00828789|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6538549|NCT00828789|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6538550|NCT00828789|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6538551|NCT00828789|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6538552|NCT00828789|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6538553|NCT00828802|Lenalidomide|lenalidomide|mesh-list
6538554|NCT00828802|Decitabine|decitabine|mesh-list
6538555|NCT00828802|Immunologic Factors|immunologic factors|mesh-ancestor
6538556|NCT00828802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426321|NCT00309725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6426322|NCT00309725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426323|NCT00309725|Cholinergic Agents|cholinergic agents|mesh-ancestor
6426324|NCT00309725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6426325|NCT00309725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426326|NCT00309725|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6426327|NCT00309725|Autonomic Agents|autonomic agents|mesh-ancestor
6426328|NCT00309725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6426329|NCT00309725|Nootropic Agents|nootropic agents|mesh-ancestor
6426330|NCT00309790|Sildenafil Citrate|sildenafil citrate|mesh-list
6426331|NCT00309790|Vasodilator Agents|vasodilator agents|mesh-ancestor
6426332|NCT00309790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6426333|NCT00309790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6426334|NCT00309790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6426335|NCT00309790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426336|NCT00309790|Urological Agents|urological agents|mesh-ancestor
6426337|NCT00309816|Sildenafil Citrate|sildenafil citrate|mesh-list
6426338|NCT00309816|Vasodilator Agents|vasodilator agents|mesh-ancestor
6426339|NCT00309816|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6426340|NCT00309816|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6426341|NCT00309816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6426342|NCT00309816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426343|NCT00309816|Urological Agents|urological agents|mesh-ancestor
6426344|NCT00309855|Anastrozole|anastrozole|mesh-list
6426345|NCT00309855|Testosterone|testosterone|mesh-list
6426346|NCT00309855|Dutasteride|dutasteride|mesh-list
6426347|NCT00309855|Androgens|androgens|mesh-ancestor
6426348|NCT00309855|Hormones|hormones|mesh-ancestor
6426349|NCT00309855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6426350|NCT00309855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426351|NCT00309855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6426352|NCT00309855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6426353|NCT00309855|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6426354|NCT00309855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6426355|NCT00309855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6426356|NCT00309855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426357|NCT00309855|Hormone Antagonists|hormone antagonists|mesh-ancestor
6426358|NCT00309855|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6426359|NCT00309855|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6426360|NCT00309881|Prednisone|prednisone|mesh-list
6426361|NCT00309881|Cyclophosphamide|cyclophosphamide|mesh-list
6426362|NCT00309881|Rituximab|rituximab|mesh-list
6426363|NCT00309881|Doxorubicin|doxorubicin|mesh-list
6426364|NCT00309881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6426365|NCT00309881|Vincristine|vincristine|mesh-list
6426366|NCT00309881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6426367|NCT00309881|Immunologic Factors|immunologic factors|mesh-ancestor
6426368|NCT00309881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426369|NCT00309881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6426370|NCT00309881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6426371|NCT00309881|Alkylating Agents|alkylating agents|mesh-ancestor
6426372|NCT00309881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426373|NCT00309881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6426374|NCT00309881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6426375|NCT00309881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6426376|NCT00309881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6426377|NCT00309881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6426378|NCT00309881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6426379|NCT00309881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6426380|NCT00309881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6426381|NCT00309881|Glucocorticoids|glucocorticoids|mesh-ancestor
6426382|NCT00309881|Hormones|hormones|mesh-ancestor
6426383|NCT00309881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6426384|NCT00309881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6426385|NCT00309881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6426386|NCT00309881|Tubulin Modulators|tubulin modulators|mesh-ancestor
6426387|NCT00309881|Antimitotic Agents|antimitotic agents|mesh-ancestor
6426388|NCT00309881|Mitosis Modulators|mitosis modulators|mesh-ancestor
6426389|NCT00309894|Ketoconazole|ketoconazole|mesh-list
6426390|NCT00309894|Hydrocortisone|hydrocortisone|mesh-list
6426391|NCT00309894|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6426392|NCT00309894|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6538557|NCT00828802|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6426393|NCT00309894|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6426394|NCT00309894|Sargramostim|sargramostim|mesh-list
6426395|NCT00309894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6426396|NCT00309894|Immunologic Factors|immunologic factors|mesh-ancestor
6426397|NCT00309894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426398|NCT00309894|Antifungal Agents|antifungal agents|mesh-ancestor
6426399|NCT00309894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6426400|NCT00309894|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6426401|NCT00309894|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6426402|NCT00309894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6426403|NCT00309894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426404|NCT00309894|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6426405|NCT00309894|Hormone Antagonists|hormone antagonists|mesh-ancestor
6426406|NCT00309894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6426407|NCT00309894|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6426408|NCT00309920|Cyclophosphamide|cyclophosphamide|mesh-list
6426409|NCT00309920|Docetaxel|docetaxel|mesh-list
6426410|NCT00309920|Doxorubicin|doxorubicin|mesh-list
6426411|NCT00309920|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6426412|NCT00309920|Fluorouracil|fluorouracil|mesh-list
6426413|NCT00309920|Epirubicin|epirubicin|mesh-list
6426414|NCT00309920|Darbepoetin alfa|darbepoetin alfa|mesh-list
6426415|NCT00309920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6426416|NCT00309920|Immunologic Factors|immunologic factors|mesh-ancestor
6426417|NCT00309920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426418|NCT00309920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6426419|NCT00309920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6426420|NCT00309920|Alkylating Agents|alkylating agents|mesh-ancestor
6426421|NCT00309920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426422|NCT00309920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6426423|NCT00309920|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6426424|NCT00309920|Tubulin Modulators|tubulin modulators|mesh-ancestor
6426425|NCT00309920|Antimitotic Agents|antimitotic agents|mesh-ancestor
6426426|NCT00309920|Mitosis Modulators|mitosis modulators|mesh-ancestor
6426427|NCT00309920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6426428|NCT00309920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6426429|NCT00309920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6426430|NCT00309920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6426431|NCT00309920|Antimetabolites|antimetabolites|mesh-ancestor
6426432|NCT00309920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6426433|NCT00309920|Hematinics|hematinics|mesh-ancestor
6426434|NCT00309998|Bevacizumab|bevacizumab|mesh-list
6426435|NCT00309998|Vinorelbine|vinorelbine|mesh-list
6426436|NCT00309998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6426437|NCT00309998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6426438|NCT00309998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6426439|NCT00309998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6426440|NCT00309998|Growth Substances|growth substances|mesh-ancestor
6426441|NCT00309998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538558|NCT00828802|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6538559|NCT00828802|Growth Substances|growth substances|mesh-ancestor
6538560|NCT00828802|Growth Inhibitors|growth inhibitors|mesh-ancestor
6538561|NCT00828802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6538562|NCT00828802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6538563|NCT00828802|Antimetabolites|antimetabolites|mesh-ancestor
6538564|NCT00828802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538565|NCT00828802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6538566|NCT00828815|Etravirine|etravirine|mesh-list
6538567|NCT00828815|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6538568|NCT00828815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6538569|NCT00828815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6426442|NCT00309998|Growth Inhibitors|growth inhibitors|mesh-ancestor
6426443|NCT00309998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6426444|NCT00309998|Tubulin Modulators|tubulin modulators|mesh-ancestor
6426445|NCT00309998|Antimitotic Agents|antimitotic agents|mesh-ancestor
6426446|NCT00309998|Mitosis Modulators|mitosis modulators|mesh-ancestor
6426447|NCT00309998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426448|NCT00310011|Gemcitabine|gemcitabine|mesh-list
6426449|NCT00310011|Paclitaxel|paclitaxel|mesh-list
6426450|NCT00310011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6426451|NCT00310011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6426452|NCT00310011|Tubulin Modulators|tubulin modulators|mesh-ancestor
6426453|NCT00310011|Antimitotic Agents|antimitotic agents|mesh-ancestor
6426454|NCT00310011|Mitosis Modulators|mitosis modulators|mesh-ancestor
6426455|NCT00310011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426456|NCT00310011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6426457|NCT00310011|Antimetabolites|antimetabolites|mesh-ancestor
6426458|NCT00310011|Antiviral Agents|antiviral agents|mesh-ancestor
6426459|NCT00310011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6426460|NCT00310011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6426461|NCT00310011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6426462|NCT00310011|Immunologic Factors|immunologic factors|mesh-ancestor
6426463|NCT00310011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426464|NCT00310024|Bortezomib|bortezomib|mesh-list
6426465|NCT00310024|Vorinostat|vorinostat|mesh-list
6426466|NCT00310024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6426467|NCT00310024|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6019195|NCT00385593|Glucocorticoids|glucocorticoids|mesh-ancestor
6019196|NCT00385593|Hormones|hormones|mesh-ancestor
6019197|NCT00385593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6426468|NCT00310024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6426469|NCT00310024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426470|NCT00310089|Cyclophosphamide|cyclophosphamide|mesh-list
6426471|NCT00310089|Docetaxel|docetaxel|mesh-list
6426472|NCT00310089|Doxorubicin|doxorubicin|mesh-list
6426473|NCT00310089|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6426474|NCT00310089|Cediranib|cediranib|mesh-list
6426475|NCT00310089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6426476|NCT00310089|Immunologic Factors|immunologic factors|mesh-ancestor
6426477|NCT00310089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426478|NCT00310089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6426479|NCT00310089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6426480|NCT00310089|Alkylating Agents|alkylating agents|mesh-ancestor
6426481|NCT00310089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426482|NCT00310089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6426483|NCT00310089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6426484|NCT00310089|Tubulin Modulators|tubulin modulators|mesh-ancestor
6426485|NCT00310089|Antimitotic Agents|antimitotic agents|mesh-ancestor
6426486|NCT00310089|Mitosis Modulators|mitosis modulators|mesh-ancestor
6426487|NCT00310089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6426488|NCT00310089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6426489|NCT00310089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6019198|NCT00385593|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6019199|NCT00385593|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6019200|NCT00385593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6019201|NCT00385593|Adrenergic Agents|adrenergic agents|mesh-ancestor
6426490|NCT00310089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6426491|NCT00310089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6426492|NCT00310128|Cytarabine|cytarabine|mesh-list
6426493|NCT00310128|Methylprednisolone|methylprednisolone|mesh-list
6426494|NCT00310128|Rituximab|rituximab|mesh-list
6426495|NCT00310128|Etoposide|etoposide|mesh-list
6426496|NCT00310128|Antibodies|antibodies|mesh-list
6426497|NCT00310128|Immunoglobulins|immunoglobulins|mesh-list
6426498|NCT00310128|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6426499|NCT00310128|Immunologic Factors|immunologic factors|mesh-ancestor
6426500|NCT00310128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426501|NCT00310128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6426502|NCT00310128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6426503|NCT00310128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6426504|NCT00310128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6426505|NCT00310128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6426506|NCT00310128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6426507|NCT00310128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6426508|NCT00310128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426509|NCT00310128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6426510|NCT00310128|Antimetabolites|antimetabolites|mesh-ancestor
6426511|NCT00310128|Antiviral Agents|antiviral agents|mesh-ancestor
6426512|NCT00310128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6426513|NCT00310128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6426514|NCT00310128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6426515|NCT00310128|Antiemetics|antiemetics|mesh-ancestor
6426516|NCT00310128|Autonomic Agents|autonomic agents|mesh-ancestor
6426517|NCT00310128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6426518|NCT00310128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6426519|NCT00310128|Glucocorticoids|glucocorticoids|mesh-ancestor
6426520|NCT00310128|Hormones|hormones|mesh-ancestor
6426521|NCT00310128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6426522|NCT00310128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6426523|NCT00310128|Protective Agents|protective agents|mesh-ancestor
6426524|NCT00310141|Nicotine|nicotine|mesh-list
6426525|NCT00310141|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6426526|NCT00310141|Autonomic Agents|autonomic agents|mesh-ancestor
6426527|NCT00310141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6426528|NCT00310141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426529|NCT00310141|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6538570|NCT00828815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538571|NCT00828815|Antiviral Agents|antiviral agents|mesh-ancestor
6538572|NCT00828815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6538573|NCT00828828|Vaccines|vaccines|mesh-list
6538574|NCT00828828|Immunologic Factors|immunologic factors|mesh-ancestor
6538575|NCT00828828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426530|NCT00310141|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6538576|NCT00828854|Entinostat|entinostat|mesh-list
6538577|NCT00828854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6538578|NCT00828854|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6538579|NCT00828854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6538580|NCT00828854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538581|NCT00828919|Axitinib|axitinib|mesh-list
6538582|NCT00828919|Crizotinib|crizotinib|mesh-list
6426531|NCT00310141|Cholinergic Agents|cholinergic agents|mesh-ancestor
6426532|NCT00310141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6426533|NCT00310141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460658|NCT00450944|Immunotoxins|immunotoxins|mesh-list
6460659|NCT00450944|Immunologic Factors|immunologic factors|mesh-ancestor
6460660|NCT00450944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460661|NCT00450957|Lycopene|lycopene|mesh-list
6460662|NCT00450957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6460663|NCT00450957|Antioxidants|antioxidants|mesh-ancestor
6460664|NCT00450957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460665|NCT00450957|Protective Agents|protective agents|mesh-ancestor
6460666|NCT00450957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460667|NCT00450957|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6460668|NCT00450957|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6460669|NCT00450957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6460670|NCT00451061|Tamsulosin|tamsulosin|mesh-list
6460671|NCT00451061|Alfuzosin|alfuzosin|mesh-list
6460672|NCT00451061|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6460673|NCT00451061|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6460674|NCT00451061|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6460675|NCT00451061|Adrenergic Agents|adrenergic agents|mesh-ancestor
6460676|NCT00451061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6460677|NCT00451061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460678|NCT00451061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460679|NCT00451061|Urological Agents|urological agents|mesh-ancestor
6460680|NCT00451074|Gentamicins|gentamicins|mesh-list
6460681|NCT00451074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6460682|NCT00451074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6460683|NCT00451074|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6460684|NCT00451074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6460685|NCT00451074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019202|NCT00385593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6019203|NCT00385593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019204|NCT00385671|Pregabalin|pregabalin|mesh-list
6019205|NCT00385671|Gabapentin|gabapentin|mesh-list
6019206|NCT00385671|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6019207|NCT00385671|Analgesics|analgesics|mesh-ancestor
6019208|NCT00385671|Sensory System Agents|sensory system agents|mesh-ancestor
6019209|NCT00385671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6019210|NCT00385671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019211|NCT00385671|Anticonvulsants|anticonvulsants|mesh-ancestor
6019212|NCT00385671|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6019213|NCT00385671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6460686|NCT00451100|Glycopyrrolate|glycopyrrolate|mesh-list
6460687|NCT00451100|Neostigmine|neostigmine|mesh-list
6460688|NCT00451100|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6460689|NCT00451100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6460690|NCT00451100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460691|NCT00451100|Cholinergic Agents|cholinergic agents|mesh-ancestor
6460692|NCT00451100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6460693|NCT00451100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460694|NCT00451100|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6460695|NCT00451100|Autonomic Agents|autonomic agents|mesh-ancestor
6460696|NCT00451100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6460697|NCT00451100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6460698|NCT00451100|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6460699|NCT00451100|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6460700|NCT00451113|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6460701|NCT00451113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
6460702|NCT00451113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6460703|NCT00451113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426534|NCT00310154|Docetaxel|docetaxel|mesh-list
6426535|NCT00310154|Gefitinib|gefitinib|mesh-list
6426536|NCT00310154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6426537|NCT00310154|Tubulin Modulators|tubulin modulators|mesh-ancestor
6426538|NCT00310154|Antimitotic Agents|antimitotic agents|mesh-ancestor
6426539|NCT00310154|Mitosis Modulators|mitosis modulators|mesh-ancestor
6426540|NCT00310154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426541|NCT00310154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6426542|NCT00310154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6426543|NCT00310206|Vaccines|vaccines|mesh-list
6426544|NCT00310206|Immunologic Factors|immunologic factors|mesh-ancestor
6426545|NCT00310206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426546|NCT00310232|Epoetin Alfa|epoetin alfa|mesh-list
6426547|NCT00310232|Hematinics|hematinics|mesh-ancestor
6426548|NCT00310297|Insulin glulisine|insulin glulisine|mesh-list
6426549|NCT00310297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6426550|NCT00310297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426551|NCT00310323|Dextromethorphan|dextromethorphan|mesh-list
6426552|NCT00310323|Caffeine|caffeine|mesh-list
6538583|NCT00828919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6538584|NCT00828919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6538585|NCT00828919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6538586|NCT00828919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538587|NCT00828958|Risperidone|risperidone|mesh-list
6538588|NCT00828958|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6538589|NCT00828958|Serotonin Agents|serotonin agents|mesh-ancestor
6538590|NCT00828958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6538591|NCT00828958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538592|NCT00828958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538593|NCT00828958|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6538594|NCT00828958|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6426553|NCT00310323|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6426554|NCT00310323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426555|NCT00310323|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6426556|NCT00310323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6426557|NCT00310323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426558|NCT00310323|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6426559|NCT00310323|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6426560|NCT00310323|Purinergic Agents|purinergic agents|mesh-ancestor
6426561|NCT00310323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6426562|NCT00310323|Antitussive Agents|antitussive agents|mesh-ancestor
6426563|NCT00310323|Respiratory System Agents|respiratory system agents|mesh-ancestor
6426564|NCT00310323|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6426565|NCT00310323|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6426566|NCT00310336|Interferons|interferons|mesh-list
6426567|NCT00310336|Ribavirin|ribavirin|mesh-list
6426568|NCT00310336|Interferon-alpha|interferon-alpha|mesh-list
6426569|NCT00310336|Interferon alpha-2|interferon alpha-2|mesh-list
6426570|NCT00310336|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6426571|NCT00310336|Betaine|betaine|mesh-list
6426572|NCT00310336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6426573|NCT00310336|Antiviral Agents|antiviral agents|mesh-ancestor
6426574|NCT00310336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6426575|NCT00310336|Antimetabolites|antimetabolites|mesh-ancestor
6426576|NCT00310336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426577|NCT00310336|Immunologic Factors|immunologic factors|mesh-ancestor
6426578|NCT00310336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019214|NCT00385671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019215|NCT00385671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6019216|NCT00385671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6019217|NCT00385671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6019218|NCT00385671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6019219|NCT00385671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6426579|NCT00310336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6538595|NCT00828958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6538596|NCT00828958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6538597|NCT00828958|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6538598|NCT00828958|Dopamine Agents|dopamine agents|mesh-ancestor
6426580|NCT00310336|Lipotropic Agents|lipotropic agents|mesh-ancestor
6426581|NCT00310336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6426582|NCT00310336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6426583|NCT00310349|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6426584|NCT00310349|Immunologic Factors|immunologic factors|mesh-ancestor
6426585|NCT00310349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426586|NCT00310388|Ezogabine|ezogabine|mesh-list
6426587|NCT00310388|Anticonvulsants|anticonvulsants|mesh-ancestor
6426588|NCT00310388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6426589|NCT00310388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426590|NCT00310505|Amphotericin B|amphotericin b|mesh-list
6426591|NCT00310505|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6426592|NCT00310505|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
6426593|NCT00310505|Deoxycholic Acid|deoxycholic acid|mesh-list
6426594|NCT00310505|Amebicides|amebicides|mesh-ancestor
6426595|NCT00310505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6426596|NCT00310505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6426597|NCT00310505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6426598|NCT00310505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6426599|NCT00310505|Antifungal Agents|antifungal agents|mesh-ancestor
6426600|NCT00310505|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6426601|NCT00310505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6426602|NCT00310518|Beta-lapachone|beta-lapachone|mesh-list
6426603|NCT00310518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6426604|NCT00310518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6426605|NCT00310518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6426606|NCT00310518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6426607|NCT00310518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019220|NCT00385671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6019221|NCT00385671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6019222|NCT00385671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6426608|NCT00310518|Antiviral Agents|antiviral agents|mesh-ancestor
6426609|NCT00310531|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
6426610|NCT00310531|Estradiol|estradiol|mesh-list
6426611|NCT00310531|Estrogens|estrogens|mesh-ancestor
6426612|NCT00310531|Hormones|hormones|mesh-ancestor
6426613|NCT00310531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6426614|NCT00310531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426615|NCT00310531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6426616|NCT00310531|Hormone Antagonists|hormone antagonists|mesh-ancestor
6426617|NCT00310531|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6426618|NCT00310531|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6426619|NCT00310531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6426620|NCT00310583|Pregabalin|pregabalin|mesh-list
6426621|NCT00310583|Analgesics|analgesics|mesh-ancestor
6426622|NCT00310583|Sensory System Agents|sensory system agents|mesh-ancestor
6426623|NCT00310583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6426624|NCT00310583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426625|NCT00310583|Anticonvulsants|anticonvulsants|mesh-ancestor
6426626|NCT00310583|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6426627|NCT00310583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6426628|NCT00310583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426629|NCT00310583|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6426630|NCT00310583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6426631|NCT00310583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6426632|NCT00310583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6426633|NCT00310583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6426634|NCT00310596|Moxifloxacin|moxifloxacin|mesh-list
6426635|NCT00310596|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6426636|NCT00310596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6426637|NCT00310596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6426638|NCT00310596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6538599|NCT00828971|Amoxicillin|amoxicillin|mesh-list
6538600|NCT00828971|Moxifloxacin|moxifloxacin|mesh-list
6538601|NCT00828971|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6538602|NCT00828971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6538603|NCT00828971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6538604|NCT00828971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6538605|NCT00828971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6538606|NCT00828971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6538607|NCT00828971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538608|NCT00828971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6538609|NCT00828971|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6538610|NCT00828971|Contraceptive Agents|contraceptive agents|mesh-ancestor
6538611|NCT00828971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6538612|NCT00828971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538613|NCT00828971|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6538614|NCT00828971|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6538615|NCT00828971|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6538616|NCT00828997|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6538617|NCT00828997|Immunologic Factors|immunologic factors|mesh-ancestor
6538618|NCT00828997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538619|NCT00829023|Ethanol|ethanol|mesh-list
6538620|NCT00829023|Chlorhexidine|chlorhexidine|mesh-list
6538621|NCT00829023|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6538622|NCT00829023|Povidone-Iodine|povidone-iodine|mesh-list
6538623|NCT00829023|Povidone|povidone|mesh-list
6538624|NCT00829023|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6538625|NCT00829023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6538626|NCT00829023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6538627|NCT00829023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538628|NCT00829023|Disinfectants|disinfectants|mesh-ancestor
6538629|NCT00829023|Dermatologic Agents|dermatologic agents|mesh-ancestor
6538630|NCT00829023|Plasma Substitutes|plasma substitutes|mesh-ancestor
6538631|NCT00829023|Blood Substitutes|blood substitutes|mesh-ancestor
6538632|NCT00829114|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6538633|NCT00829114|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6538634|NCT00829114|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6538635|NCT00829114|Estradiol|estradiol|mesh-list
6538636|NCT00829114|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6538637|NCT00829114|Estrogens|estrogens|mesh-ancestor
6538638|NCT00829114|Hormones|hormones|mesh-ancestor
6538639|NCT00829114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6538640|NCT00829114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538641|NCT00829114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6538642|NCT00829114|Contraceptive Agents|contraceptive agents|mesh-ancestor
6538643|NCT00829114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6538644|NCT00829114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6538645|NCT00829114|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6538646|NCT00829114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6538647|NCT00829192|Afamelanotide|afamelanotide|mesh-list
6538648|NCT00829192|Dermatologic Agents|dermatologic agents|mesh-ancestor
6538649|NCT00829205|Rituximab|rituximab|mesh-list
6538650|NCT00829205|Carboplatin|carboplatin|mesh-list
6538651|NCT00829205|Etoposide|etoposide|mesh-list
6538652|NCT00829205|Ifosfamide|ifosfamide|mesh-list
6538653|NCT00829205|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
6538654|NCT00829205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6538655|NCT00829205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6538656|NCT00829205|Immunologic Factors|immunologic factors|mesh-ancestor
6426639|NCT00310596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6426640|NCT00310596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6426641|NCT00310596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426642|NCT00310596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6426643|NCT00310596|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6426644|NCT00310596|Contraceptive Agents|contraceptive agents|mesh-ancestor
6426645|NCT00310596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6426646|NCT00310596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426647|NCT00310596|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6426648|NCT00310596|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6426649|NCT00310596|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6426650|NCT00310765|Pregabalin|pregabalin|mesh-list
6426651|NCT00310765|Gabapentin|gabapentin|mesh-list
6426652|NCT00310765|Analgesics|analgesics|mesh-ancestor
6426653|NCT00310765|Sensory System Agents|sensory system agents|mesh-ancestor
6426654|NCT00310765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6426655|NCT00310765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426656|NCT00310765|Anticonvulsants|anticonvulsants|mesh-ancestor
6426657|NCT00310765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6426658|NCT00310765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6426659|NCT00310765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426660|NCT00310765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6426661|NCT00310765|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6426662|NCT00310765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6426663|NCT00310765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6426664|NCT00310765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6426665|NCT00310765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6426666|NCT00310765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6426667|NCT00310765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6426668|NCT00310765|Antimanic Agents|antimanic agents|mesh-ancestor
6426669|NCT00310778|Atenolol|atenolol|mesh-list
6426670|NCT00310778|Valsartan|valsartan|mesh-list
6426671|NCT00310778|Candesartan|candesartan|mesh-list
6426672|NCT00310778|Ramipril|ramipril|mesh-list
6426673|NCT00310778|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6426674|NCT00310778|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6426675|NCT00310778|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6426676|NCT00310778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426677|NCT00310778|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6426678|NCT00310778|Protease Inhibitors|protease inhibitors|mesh-ancestor
6426679|NCT00310778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6426680|NCT00310778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6426681|NCT00310778|Sympatholytics|sympatholytics|mesh-ancestor
6426682|NCT00310778|Autonomic Agents|autonomic agents|mesh-ancestor
6426683|NCT00310778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6426684|NCT00310778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426685|NCT00310778|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6426686|NCT00310778|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6426687|NCT00310778|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6426688|NCT00310778|Adrenergic Agents|adrenergic agents|mesh-ancestor
6426689|NCT00310778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6426690|NCT00310843|Nevirapine|nevirapine|mesh-list
6426691|NCT00310843|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6426692|NCT00310843|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6426693|NCT00310843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6426694|NCT00310843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426695|NCT00310843|Antiviral Agents|antiviral agents|mesh-ancestor
6426696|NCT00310843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6426697|NCT00310843|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6426698|NCT00310843|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6426699|NCT00310843|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6426700|NCT00310843|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6426701|NCT00310895|Imetelstat|imetelstat|mesh-list
6426702|NCT00310895|Motesanib diphosphate|motesanib diphosphate|mesh-list
6426703|NCT00310895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6426704|NCT00310895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426705|NCT00310895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6426706|NCT00310908|Tramadol|tramadol|mesh-list
6426707|NCT00310908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6426708|NCT00310908|Narcotics|narcotics|mesh-ancestor
6426709|NCT00310908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6426710|NCT00310908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426711|NCT00310908|Analgesics|analgesics|mesh-ancestor
6426712|NCT00310908|Sensory System Agents|sensory system agents|mesh-ancestor
6426713|NCT00310908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6426714|NCT00310921|Misoprostol|misoprostol|mesh-list
6426715|NCT00310921|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6426716|NCT00310921|Abortifacient Agents|abortifacient agents|mesh-ancestor
6426717|NCT00310921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6426718|NCT00310921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426719|NCT00310921|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6426720|NCT00310921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6426721|NCT00310921|Oxytocics|oxytocics|mesh-ancestor
6426722|NCT00310934|Buprenorphine|buprenorphine|mesh-list
6426723|NCT00310934|Methadone|methadone|mesh-list
6426724|NCT00310934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6426725|NCT00310934|Narcotics|narcotics|mesh-ancestor
6426726|NCT00310934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6426727|NCT00310934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426728|NCT00310934|Analgesics|analgesics|mesh-ancestor
6426729|NCT00310934|Sensory System Agents|sensory system agents|mesh-ancestor
6426730|NCT00310934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6426731|NCT00310934|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6426732|NCT00310934|Antitussive Agents|antitussive agents|mesh-ancestor
6426733|NCT00310934|Respiratory System Agents|respiratory system agents|mesh-ancestor
6426734|NCT00311038|Landiolol|landiolol|mesh-list
6426735|NCT00311038|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6426736|NCT00311038|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6426737|NCT00311038|Adrenergic Agents|adrenergic agents|mesh-ancestor
6426738|NCT00311038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6426739|NCT00311038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426740|NCT00311038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426741|NCT00311038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6426742|NCT00311051|Ramatroban|ramatroban|mesh-list
6426743|NCT00311051|Montelukast|montelukast|mesh-list
6426744|NCT00311051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6426745|NCT00311051|Respiratory System Agents|respiratory system agents|mesh-ancestor
6426746|NCT00311051|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6426747|NCT00311051|Hormone Antagonists|hormone antagonists|mesh-ancestor
6426748|NCT00311051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6426749|NCT00311051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426750|NCT00311051|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6426751|NCT00311051|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6426752|NCT00311051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426753|NCT00311051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6426754|NCT00311077|Insulin glulisine|insulin glulisine|mesh-list
6426755|NCT00311077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6426756|NCT00311077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426757|NCT00311116|Vitamin E|vitamin e|mesh-list
6426758|NCT00311116|Vitamins|vitamins|mesh-ancestor
6426759|NCT00311116|Micronutrients|micronutrients|mesh-ancestor
6426760|NCT00311116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426761|NCT00311116|Antioxidants|antioxidants|mesh-ancestor
6426762|NCT00311116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426763|NCT00311116|Protective Agents|protective agents|mesh-ancestor
6426764|NCT00311129|Rituximab|rituximab|mesh-list
6426765|NCT00311129|Fludarabine|fludarabine|mesh-list
6426766|NCT00311129|Fludarabine phosphate|fludarabine phosphate|mesh-list
6426767|NCT00311129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6426768|NCT00311129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6426769|NCT00311129|Immunologic Factors|immunologic factors|mesh-ancestor
6426770|NCT00311129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426771|NCT00311129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6426772|NCT00311129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6426773|NCT00311129|Antimetabolites|antimetabolites|mesh-ancestor
6426774|NCT00311129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426775|NCT00311129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6426776|NCT00311259|Melatonin|melatonin|mesh-list
6426777|NCT00311259|Antioxidants|antioxidants|mesh-ancestor
6426778|NCT00311259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426779|NCT00311259|Protective Agents|protective agents|mesh-ancestor
6426780|NCT00311259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426781|NCT00311259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6426782|NCT00311285|Hydrocortisone|hydrocortisone|mesh-list
6426783|NCT00311285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6426784|NCT00311337|Bortezomib|bortezomib|mesh-list
6426785|NCT00311337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6426786|NCT00311389|Timolol|timolol|mesh-list
6426787|NCT00311389|Travoprost|travoprost|mesh-list
6426788|NCT00311389|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6426789|NCT00311389|Latanoprost|latanoprost|mesh-list
6426790|NCT00311389|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6426791|NCT00311389|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6426792|NCT00311389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6426793|NCT00311389|Adrenergic Agents|adrenergic agents|mesh-ancestor
6426794|NCT00311389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6426795|NCT00311389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426796|NCT00311389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426797|NCT00311389|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6426798|NCT00311389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6426799|NCT00311467|Interferons|interferons|mesh-list
6426800|NCT00311467|Capecitabine|capecitabine|mesh-list
6426801|NCT00311467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6426802|NCT00311467|Antimetabolites|antimetabolites|mesh-ancestor
6426803|NCT00311467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426804|NCT00311467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6426805|NCT00311467|Antiviral Agents|antiviral agents|mesh-ancestor
6426806|NCT00311467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6426807|NCT00311545|Siltuximab|siltuximab|mesh-list
6426808|NCT00311545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6426809|NCT00311558|Interferons|interferons|mesh-list
6426810|NCT00311558|Interferon-alpha|interferon-alpha|mesh-list
6426811|NCT00311558|Interferon alpha-2|interferon alpha-2|mesh-list
6426812|NCT00311558|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
6426813|NCT00311558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6426814|NCT00311558|Antiviral Agents|antiviral agents|mesh-ancestor
6426815|NCT00311558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6426816|NCT00311558|Immunologic Factors|immunologic factors|mesh-ancestor
6019223|NCT00385671|Antimanic Agents|antimanic agents|mesh-ancestor
6019224|NCT00385671|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6426817|NCT00311558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426818|NCT00311558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6426819|NCT00311558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6426820|NCT00311558|Schistosomicides|schistosomicides|mesh-ancestor
6426821|NCT00311558|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6426822|NCT00311558|Anthelmintics|anthelmintics|mesh-ancestor
6426823|NCT00311636|Paclitaxel|paclitaxel|mesh-list
6426824|NCT00311636|Docetaxel|docetaxel|mesh-list
6426825|NCT00311636|Cyclophosphamide|cyclophosphamide|mesh-list
6426826|NCT00311636|Doxorubicin|doxorubicin|mesh-list
6426827|NCT00311636|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6426828|NCT00311636|Fluorouracil|fluorouracil|mesh-list
6426829|NCT00311636|Methotrexate|methotrexate|mesh-list
6426830|NCT00311636|Epirubicin|epirubicin|mesh-list
6426831|NCT00311636|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6426832|NCT00311636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6426833|NCT00311636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6426834|NCT00311636|Tubulin Modulators|tubulin modulators|mesh-ancestor
6426835|NCT00311636|Antimitotic Agents|antimitotic agents|mesh-ancestor
6426836|NCT00311636|Mitosis Modulators|mitosis modulators|mesh-ancestor
6426837|NCT00311636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426838|NCT00311636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6426839|NCT00311636|Immunologic Factors|immunologic factors|mesh-ancestor
6426840|NCT00311636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538657|NCT00829205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538658|NCT00829205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6538659|NCT00829205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6538660|NCT00829205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6538661|NCT00829205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6538662|NCT00829205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6538663|NCT00829205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538664|NCT00829205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6538665|NCT00829205|Alkylating Agents|alkylating agents|mesh-ancestor
6538666|NCT00829205|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6538667|NCT00829205|Protective Agents|protective agents|mesh-ancestor
6538668|NCT00829231|Sorafenib|sorafenib|mesh-list
6538669|NCT00829231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6538670|NCT00829231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6538671|NCT00829231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6538672|NCT00829231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538673|NCT00829257|Fluticasone|fluticasone|mesh-list
6538674|NCT00829257|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6538675|NCT00829257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6538676|NCT00829257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6538677|NCT00829257|Autonomic Agents|autonomic agents|mesh-ancestor
6538678|NCT00829257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6538679|NCT00829257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538680|NCT00829257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6538681|NCT00829257|Respiratory System Agents|respiratory system agents|mesh-ancestor
6538682|NCT00829257|Dermatologic Agents|dermatologic agents|mesh-ancestor
6538683|NCT00829257|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6538684|NCT00829257|Glucocorticoids|glucocorticoids|mesh-ancestor
6538685|NCT00829257|Hormones|hormones|mesh-ancestor
6538686|NCT00829257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6538687|NCT00829257|Sympathomimetics|sympathomimetics|mesh-ancestor
6538688|NCT00829322|Modafinil|modafinil|mesh-list
6538689|NCT00829322|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6538690|NCT00829322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538691|NCT00829322|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6538692|NCT00829322|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6538693|NCT00829322|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6538694|NCT00829322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538695|NCT00829465|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6538696|NCT00829465|Immunologic Factors|immunologic factors|mesh-ancestor
6538697|NCT00829465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538698|NCT00829569|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6538699|NCT00829569|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6655365|NCT01463592|Interferon alpha-2|interferon alpha-2|mesh-list
6426841|NCT00311636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6426842|NCT00311636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6426843|NCT00311636|Alkylating Agents|alkylating agents|mesh-ancestor
6426844|NCT00311636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6426845|NCT00311636|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6426846|NCT00311636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6426847|NCT00311636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6426848|NCT00311636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6426849|NCT00311636|Antimetabolites|antimetabolites|mesh-ancestor
6426850|NCT00311636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6426851|NCT00311636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6426852|NCT00311636|Abortifacient Agents|abortifacient agents|mesh-ancestor
6426853|NCT00311636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6426854|NCT00311636|Dermatologic Agents|dermatologic agents|mesh-ancestor
6426855|NCT00311636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6426856|NCT00311636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6426857|NCT00311636|Luteolytic Agents|luteolytic agents|mesh-ancestor
6426858|NCT00311636|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6426859|NCT00311636|Contraceptive Agents|contraceptive agents|mesh-ancestor
6426860|NCT00311636|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6426861|NCT00311636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6426862|NCT00311688|Interleukin-2|interleukin-2|mesh-list
6426863|NCT00311688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6426864|NCT00311688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6426865|NCT00311688|Analgesics|analgesics|mesh-ancestor
6426866|NCT00311688|Sensory System Agents|sensory system agents|mesh-ancestor
6426867|NCT00311688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6426868|NCT00311688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426869|NCT00311740|Valsartan|valsartan|mesh-list
6426870|NCT00311740|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6426871|NCT00311740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6426872|NCT00311740|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6426873|NCT00311740|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6426874|NCT00311740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426875|NCT00311740|Diuretics|diuretics|mesh-ancestor
6426876|NCT00311740|Natriuretic Agents|natriuretic agents|mesh-ancestor
6426877|NCT00311740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426878|NCT00311740|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6426879|NCT00311740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6426880|NCT00311753|Heparin|heparin|mesh-list
6426881|NCT00311753|Certoparin|certoparin|mesh-list
6426882|NCT00311753|Anticoagulants|anticoagulants|mesh-ancestor
6426883|NCT00311753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6426884|NCT00311753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6426885|NCT00311753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460704|NCT00451113|Incretins|incretins|mesh-ancestor
6460705|NCT00451113|Hormones|hormones|mesh-ancestor
6460706|NCT00451113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6460707|NCT00451113|Protease Inhibitors|protease inhibitors|mesh-ancestor
6460708|NCT00451113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6460709|NCT00451113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460710|NCT00451139|Lumefantrine|lumefantrine|mesh-list
6460711|NCT00451139|Artemether|artemether|mesh-list
6460712|NCT00451139|Quinine|quinine|mesh-list
6460713|NCT00451139|Atovaquone|atovaquone|mesh-list
6460714|NCT00451139|Proguanil|proguanil|mesh-list
6460715|NCT00451139|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6460716|NCT00451139|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
6460717|NCT00451139|Antimalarials|antimalarials|mesh-ancestor
6460718|NCT00451139|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6460719|NCT00451139|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6460720|NCT00451139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6460721|NCT00451139|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6460722|NCT00451139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460723|NCT00451139|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6460724|NCT00451139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6460725|NCT00451139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6460726|NCT00451139|Analgesics|analgesics|mesh-ancestor
6460727|NCT00451139|Sensory System Agents|sensory system agents|mesh-ancestor
6460728|NCT00451139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6460729|NCT00451139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460730|NCT00451139|Antimetabolites|antimetabolites|mesh-ancestor
6460731|NCT00451230|Hydrocortisone|hydrocortisone|mesh-list
6460732|NCT00451230|Cocaine|cocaine|mesh-list
6460733|NCT00451230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6426886|NCT00311818|Insulin Glargine|insulin glargine|mesh-list
6426887|NCT00311818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6426888|NCT00311818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426889|NCT00311857|Cetuximab|cetuximab|mesh-list
6426890|NCT00311857|Temozolomide|temozolomide|mesh-list
6426891|NCT00311857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6426892|NCT00311857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6426893|NCT00311857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6426894|NCT00311857|Alkylating Agents|alkylating agents|mesh-ancestor
6426895|NCT00311857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426896|NCT00311870|Lisinopril|lisinopril|mesh-list
6426897|NCT00311870|Nisoldipine|nisoldipine|mesh-list
6538700|NCT00829569|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6538701|NCT00829569|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6538702|NCT00829595|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6538703|NCT00829595|Immunologic Factors|immunologic factors|mesh-ancestor
6538704|NCT00829595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538705|NCT00829608|Vaccines|vaccines|mesh-list
6538706|NCT00829608|Immunologic Factors|immunologic factors|mesh-ancestor
6538707|NCT00829608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538708|NCT00829634|Methamphetamine|methamphetamine|mesh-list
6538709|NCT00829634|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6538710|NCT00829634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538711|NCT00829634|Sympathomimetics|sympathomimetics|mesh-ancestor
6538712|NCT00829634|Autonomic Agents|autonomic agents|mesh-ancestor
6538713|NCT00829634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6538714|NCT00829634|Dopamine Agents|dopamine agents|mesh-ancestor
6538715|NCT00829634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6538716|NCT00829634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538717|NCT00829634|Adrenergic Agents|adrenergic agents|mesh-ancestor
6538718|NCT00829634|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6538719|NCT00829634|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6538720|NCT00829634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6538721|NCT00829634|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6538722|NCT00829647|Lenalidomide|lenalidomide|mesh-list
6538723|NCT00829647|Dasatinib|dasatinib|mesh-list
6538724|NCT00829647|Immunologic Factors|immunologic factors|mesh-ancestor
6538725|NCT00829647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538726|NCT00829647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6538727|NCT00829647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6538728|NCT00829647|Growth Substances|growth substances|mesh-ancestor
6538729|NCT00829647|Growth Inhibitors|growth inhibitors|mesh-ancestor
6538730|NCT00829647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6538731|NCT00829647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6538732|NCT00829647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6538733|NCT00829647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655366|NCT01463592|Cadexomer iodine|cadexomer iodine|mesh-list
6655367|NCT01463592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6655368|NCT01463592|Antiviral Agents|antiviral agents|mesh-ancestor
6655369|NCT01463592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6655370|NCT01463592|Antimetabolites|antimetabolites|mesh-ancestor
6655371|NCT01463592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655372|NCT01463592|Immunologic Factors|immunologic factors|mesh-ancestor
6655373|NCT01463592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655374|NCT01463592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6655375|NCT01463592|Trace Elements|trace elements|mesh-ancestor
6655376|NCT01463592|Micronutrients|micronutrients|mesh-ancestor
6655377|NCT01463605|Nimotuzumab|nimotuzumab|mesh-list
6655378|NCT01463605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6655379|NCT01463605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6655380|NCT01463670|Lenalidomide|lenalidomide|mesh-list
6655381|NCT01463670|Immunologic Factors|immunologic factors|mesh-ancestor
6655382|NCT01463670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655383|NCT01463670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6655384|NCT01463670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6655385|NCT01463670|Growth Substances|growth substances|mesh-ancestor
6655386|NCT01463670|Growth Inhibitors|growth inhibitors|mesh-ancestor
6655387|NCT01463670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6655388|NCT01463735|Vitamin E|vitamin e|mesh-list
6655389|NCT01463735|Vitamins|vitamins|mesh-ancestor
6655390|NCT01463735|Micronutrients|micronutrients|mesh-ancestor
6655391|NCT01463735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655392|NCT01463735|Antioxidants|antioxidants|mesh-ancestor
6655393|NCT01463735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460734|NCT00451230|Anesthetics, Local|anesthetics, local|mesh-ancestor
6426898|NCT00311870|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6426899|NCT00311870|Protease Inhibitors|protease inhibitors|mesh-ancestor
6426900|NCT00311870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6426901|NCT00311870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426902|NCT00311870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6426903|NCT00311870|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6426904|NCT00311870|Protective Agents|protective agents|mesh-ancestor
6426905|NCT00311870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426906|NCT00311870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6426907|NCT00311870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6426908|NCT00311870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6426909|NCT00311870|Vasodilator Agents|vasodilator agents|mesh-ancestor
6426910|NCT00311883|Hydroxychloroquine|hydroxychloroquine|mesh-list
6426911|NCT00311883|Antimalarials|antimalarials|mesh-ancestor
6426912|NCT00311883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6426913|NCT00311883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6426914|NCT00311883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6426915|NCT00311883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6426916|NCT00311883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426917|NCT00311883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6426918|NCT00311896|Bemiparin|bemiparin|mesh-list
6426919|NCT00311896|Anticoagulants|anticoagulants|mesh-ancestor
6426920|NCT00311961|Prednisolone|prednisolone|mesh-list
6426921|NCT00311961|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6426922|NCT00311961|Methylprednisolone|methylprednisolone|mesh-list
6426923|NCT00311961|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6426924|NCT00311961|Prednisolone acetate|prednisolone acetate|mesh-list
6426925|NCT00311961|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6426926|NCT00311961|Prednisolone phosphate|prednisolone phosphate|mesh-list
6426927|NCT00311961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6426928|NCT00311961|Glucocorticoids|glucocorticoids|mesh-ancestor
6426929|NCT00311961|Hormones|hormones|mesh-ancestor
6426930|NCT00311961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6426931|NCT00311961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426932|NCT00311961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6426933|NCT00311961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6426934|NCT00311961|Antiemetics|antiemetics|mesh-ancestor
6426935|NCT00311961|Autonomic Agents|autonomic agents|mesh-ancestor
6426936|NCT00311961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6426937|NCT00311961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6426938|NCT00311961|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6426939|NCT00311961|Protective Agents|protective agents|mesh-ancestor
6426940|NCT00311974|Dihydralazine|dihydralazine|mesh-list
6426941|NCT00311974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6426942|NCT00311987|3,5-diiodothyropropionic acid|3,5-diiodothyropropionic acid|mesh-list
6426943|NCT00311987|Hormones|hormones|mesh-ancestor
6426944|NCT00311987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6426945|NCT00311987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426946|NCT00312000|Capecitabine|capecitabine|mesh-list
6426947|NCT00312000|Irinotecan|irinotecan|mesh-list
6426948|NCT00312000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6426949|NCT00312000|Antimetabolites|antimetabolites|mesh-ancestor
6426950|NCT00312000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426951|NCT00312000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6426952|NCT00312000|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6426953|NCT00312000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6426954|NCT00312000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6426955|NCT00312013|Nadroparin|nadroparin|mesh-list
6426956|NCT00312013|Anticoagulants|anticoagulants|mesh-ancestor
6426957|NCT00312013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6426958|NCT00312013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6426959|NCT00312013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426960|NCT00312039|Lamivudine|lamivudine|mesh-list
6426961|NCT00312039|Dexelvucitabine|dexelvucitabine|mesh-list
6426962|NCT00312039|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6426963|NCT00312039|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6426964|NCT00312039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6426965|NCT00312039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426966|NCT00312039|Antiviral Agents|antiviral agents|mesh-ancestor
6426967|NCT00312039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6426968|NCT00312039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6426969|NCT00312039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6426970|NCT00312104|Insulin|insulin|mesh-list
6426971|NCT00312104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6426972|NCT00312104|Insulin Glargine|insulin glargine|mesh-list
6426973|NCT00312104|Insulin Aspart|insulin aspart|mesh-list
6426974|NCT00312104|Insulin Detemir|insulin detemir|mesh-list
6426975|NCT00312104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6426976|NCT00312104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426977|NCT00312130|Vildagliptin|vildagliptin|mesh-list
6426978|NCT00312130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6426979|NCT00312130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6426980|NCT00312130|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6426981|NCT00312130|Protease Inhibitors|protease inhibitors|mesh-ancestor
6426982|NCT00312130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6426983|NCT00312130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426984|NCT00312143|Mycophenolic Acid|mycophenolic acid|mesh-list
6426985|NCT00312143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6426986|NCT00312143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6426987|NCT00312143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6426988|NCT00312143|Antitubercular Agents|antitubercular agents|mesh-ancestor
6426989|NCT00312143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6426990|NCT00312143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6426991|NCT00312143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6426992|NCT00312143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6426993|NCT00312156|Insulin|insulin|mesh-list
6426994|NCT00312156|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6426995|NCT00312156|Insulin Aspart|insulin aspart|mesh-list
6426996|NCT00312156|Insulin Detemir|insulin detemir|mesh-list
6426997|NCT00312156|Isophane Insulin, Human|isophane insulin, human|mesh-list
6426998|NCT00312156|Insulin, Isophane|insulin, isophane|mesh-list
6426999|NCT00312156|Isophane insulin, beef|isophane insulin, beef|mesh-list
6427000|NCT00312156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6427001|NCT00312156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427002|NCT00312182|Nelfinavir|nelfinavir|mesh-list
6427003|NCT00312182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6427004|NCT00312182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6427005|NCT00312182|Protease Inhibitors|protease inhibitors|mesh-ancestor
6427006|NCT00312182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6427007|NCT00312182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427008|NCT00312182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6427009|NCT00312182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6427010|NCT00312182|Antiviral Agents|antiviral agents|mesh-ancestor
6427011|NCT00312182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6427012|NCT00312260|Gabapentin|gabapentin|mesh-list
6427013|NCT00312260|Amitriptyline|amitriptyline|mesh-list
6427014|NCT00312260|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6427015|NCT00312260|Analgesics|analgesics|mesh-ancestor
6427016|NCT00312260|Sensory System Agents|sensory system agents|mesh-ancestor
6427017|NCT00312260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6427018|NCT00312260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427019|NCT00312260|Anticonvulsants|anticonvulsants|mesh-ancestor
6427020|NCT00312260|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6427021|NCT00312260|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6427022|NCT00312260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6427023|NCT00312260|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6427024|NCT00312260|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6427025|NCT00312260|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6427026|NCT00312260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6427027|NCT00312260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427028|NCT00312260|Antimanic Agents|antimanic agents|mesh-ancestor
6427029|NCT00312260|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6427030|NCT00312260|Antidepressive Agents|antidepressive agents|mesh-ancestor
6427031|NCT00312260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6427032|NCT00312260|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6427033|NCT00312260|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6427034|NCT00312260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6427035|NCT00312260|Adrenergic Agents|adrenergic agents|mesh-ancestor
6427036|NCT00312260|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6427037|NCT00312273|Aminophylline|aminophylline|mesh-list
6427038|NCT00312273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6427039|NCT00312273|Autonomic Agents|autonomic agents|mesh-ancestor
6427040|NCT00312273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6427041|NCT00312273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427042|NCT00312273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6427043|NCT00312273|Respiratory System Agents|respiratory system agents|mesh-ancestor
6427044|NCT00312273|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6427045|NCT00312273|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6538734|NCT00829660|Acarbose|acarbose|mesh-list
6538735|NCT00829660|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6538736|NCT00829660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6538737|NCT00829660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538738|NCT00829660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6538739|NCT00829660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538740|NCT00829699|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6538741|NCT00829699|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6538742|NCT00829699|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6538743|NCT00829699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6538744|NCT00829777|Naloxone|naloxone|mesh-list
6538745|NCT00829777|Lactulose|lactulose|mesh-list
6538746|NCT00829777|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6538747|NCT00829777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427046|NCT00312273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6427047|NCT00312273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427048|NCT00312273|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6427049|NCT00312273|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6427050|NCT00312273|Purinergic Agents|purinergic agents|mesh-ancestor
6427051|NCT00312273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6427052|NCT00312273|Protective Agents|protective agents|mesh-ancestor
6427053|NCT00312299|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
6427054|NCT00312299|Vasodilator Agents|vasodilator agents|mesh-ancestor
6427055|NCT00312299|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
6427056|NCT00312299|Protective Agents|protective agents|mesh-ancestor
6427057|NCT00312299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427058|NCT00312325|Prednisolone|prednisolone|mesh-list
6427059|NCT00312325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6427060|NCT00312325|Glucocorticoids|glucocorticoids|mesh-ancestor
6427061|NCT00312325|Hormones|hormones|mesh-ancestor
6427062|NCT00312325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6427063|NCT00312325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427064|NCT00312325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6427065|NCT00312325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6427066|NCT00312416|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6427067|NCT00312416|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6427068|NCT00312416|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6427069|NCT00312416|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6427070|NCT00312416|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6427071|NCT00312416|Adrenergic Agents|adrenergic agents|mesh-ancestor
6427072|NCT00312416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6427073|NCT00312416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427074|NCT00312416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427075|NCT00312481|Ascorbic Acid|ascorbic acid|mesh-list
6427076|NCT00312481|Picosulfate sodium|picosulfate sodium|mesh-list
6427077|NCT00312481|Magnesium citrate|magnesium citrate|mesh-list
6427078|NCT00312481|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
6427079|NCT00312481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427080|NCT00312481|Antioxidants|antioxidants|mesh-ancestor
6427081|NCT00312481|Protective Agents|protective agents|mesh-ancestor
6427082|NCT00312481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427083|NCT00312481|Vitamins|vitamins|mesh-ancestor
6427084|NCT00312481|Micronutrients|micronutrients|mesh-ancestor
6427085|NCT00312481|Cathartics|cathartics|mesh-ancestor
6427086|NCT00312481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6427087|NCT00312481|Laxatives|laxatives|mesh-ancestor
6427088|NCT00312507|Pulmonary Surfactants|pulmonary surfactants|mesh-list
6427089|NCT00312507|Respiratory System Agents|respiratory system agents|mesh-ancestor
6427090|NCT00312520|Methylprednisolone|methylprednisolone|mesh-list
6427091|NCT00312520|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6427092|NCT00312520|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6427093|NCT00312520|Prednisolone|prednisolone|mesh-list
6427094|NCT00312520|Prednisolone acetate|prednisolone acetate|mesh-list
6427095|NCT00312520|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6427096|NCT00312520|Prednisolone phosphate|prednisolone phosphate|mesh-list
6427097|NCT00312520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6427098|NCT00312520|Antiemetics|antiemetics|mesh-ancestor
6427099|NCT00312520|Autonomic Agents|autonomic agents|mesh-ancestor
6427100|NCT00312520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6427101|NCT00312520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427102|NCT00312520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6427103|NCT00312520|Glucocorticoids|glucocorticoids|mesh-ancestor
6427104|NCT00312520|Hormones|hormones|mesh-ancestor
6427105|NCT00312520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6427106|NCT00312520|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6427107|NCT00312520|Protective Agents|protective agents|mesh-ancestor
6427108|NCT00312520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6427109|NCT00312520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6427110|NCT00312533|Hylan|hylan|mesh-list
6427111|NCT00312533|Viscosupplements|viscosupplements|mesh-ancestor
6427112|NCT00312533|Protective Agents|protective agents|mesh-ancestor
6427113|NCT00312533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427114|NCT00312546|Enfuvirtide|enfuvirtide|mesh-list
6427115|NCT00312546|Valproic Acid|valproic acid|mesh-list
6427116|NCT00312546|Anticonvulsants|anticonvulsants|mesh-ancestor
6427117|NCT00312546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6427118|NCT00312546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427119|NCT00312546|GABA Agents|gaba agents|mesh-ancestor
6427120|NCT00312546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6427121|NCT00312546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427122|NCT00312546|Antimanic Agents|antimanic agents|mesh-ancestor
6427123|NCT00312546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6427124|NCT00312546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6427125|NCT00312546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6427126|NCT00312546|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6427127|NCT00312546|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6427128|NCT00312546|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6427129|NCT00312546|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6427130|NCT00312546|Antiviral Agents|antiviral agents|mesh-ancestor
6427131|NCT00312546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6427132|NCT00312598|Aripiprazole|aripiprazole|mesh-list
6427133|NCT00312598|Antidepressive Agents|antidepressive agents|mesh-ancestor
6427134|NCT00312598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6427135|NCT00312598|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6427136|NCT00312598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6427137|NCT00312598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6427138|NCT00312598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427139|NCT00312598|Dopamine Agonists|dopamine agonists|mesh-ancestor
6427140|NCT00312598|Dopamine Agents|dopamine agents|mesh-ancestor
6427141|NCT00312598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6427142|NCT00312598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427143|NCT00312598|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6427144|NCT00312598|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6427145|NCT00312598|Serotonin Agents|serotonin agents|mesh-ancestor
6427146|NCT00312598|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6427147|NCT00312598|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6427148|NCT00312598|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6427149|NCT00312598|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6427150|NCT00312650|Gemcitabine|gemcitabine|mesh-list
6427151|NCT00312650|Doxorubicin|doxorubicin|mesh-list
6427152|NCT00312650|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6427153|NCT00312650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6427154|NCT00312650|Antimetabolites|antimetabolites|mesh-ancestor
6427155|NCT00312650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427156|NCT00312650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6427157|NCT00312650|Antiviral Agents|antiviral agents|mesh-ancestor
6427158|NCT00312650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6427159|NCT00312650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6427160|NCT00312650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6427161|NCT00312650|Immunologic Factors|immunologic factors|mesh-ancestor
6427162|NCT00312650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427163|NCT00312650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6427164|NCT00312650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6427165|NCT00312650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6427166|NCT00312754|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6427167|NCT00312754|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6427168|NCT00312754|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6427169|NCT00312754|Protease Inhibitors|protease inhibitors|mesh-ancestor
6427170|NCT00312754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6427171|NCT00312754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427172|NCT00312754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6427173|NCT00312754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6427174|NCT00312754|Antiviral Agents|antiviral agents|mesh-ancestor
6427175|NCT00312754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6427176|NCT00312806|Pantoprazole|pantoprazole|mesh-list
6427177|NCT00312806|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6427178|NCT00312806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6427179|NCT00312806|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6427180|NCT00312806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6427181|NCT00312806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427182|NCT00312819|Disulfiram|disulfiram|mesh-list
6427183|NCT00312819|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6427184|NCT00312819|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
6538748|NCT00829777|Sensory System Agents|sensory system agents|mesh-ancestor
6538749|NCT00829777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6538750|NCT00829777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6538751|NCT00829881|Betahistine|betahistine|mesh-list
6538752|NCT00829881|Vasodilator Agents|vasodilator agents|mesh-ancestor
6538753|NCT00829881|Histamine Agonists|histamine agonists|mesh-ancestor
6538754|NCT00829881|Histamine Agents|histamine agents|mesh-ancestor
6538755|NCT00829881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6538756|NCT00829881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538757|NCT00829881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538758|NCT00829894|Risperidone|risperidone|mesh-list
6538759|NCT00829894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6538760|NCT00829894|Serotonin Agents|serotonin agents|mesh-ancestor
6538761|NCT00829894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6538762|NCT00829894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538763|NCT00829894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538764|NCT00829894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6538765|NCT00829894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6538766|NCT00829894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6538767|NCT00829894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6538768|NCT00829894|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6538769|NCT00829894|Dopamine Agents|dopamine agents|mesh-ancestor
6538770|NCT00830050|Naproxen|naproxen|mesh-list
6538771|NCT00830050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6538772|NCT00830050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6538773|NCT00830050|Analgesics|analgesics|mesh-ancestor
6538774|NCT00830050|Sensory System Agents|sensory system agents|mesh-ancestor
6538775|NCT00830050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6538776|NCT00830050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538777|NCT00830050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6538778|NCT00830050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6538779|NCT00830050|Gout Suppressants|gout suppressants|mesh-ancestor
6538780|NCT00830050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6538781|NCT00830050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6538782|NCT00830050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538783|NCT00830089|Levobupivacaine|levobupivacaine|mesh-list
6538784|NCT00830089|Anesthetics, Local|anesthetics, local|mesh-ancestor
6427185|NCT00312819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6427186|NCT00312819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427187|NCT00312871|Epoetin Alfa|epoetin alfa|mesh-list
6427188|NCT00312871|Hematinics|hematinics|mesh-ancestor
6427189|NCT00312988|Gemcitabine|gemcitabine|mesh-list
6427190|NCT00312988|Topotecan|topotecan|mesh-list
6427191|NCT00312988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6427192|NCT00312988|Antimetabolites|antimetabolites|mesh-ancestor
6427193|NCT00312988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427194|NCT00312988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6427195|NCT00312988|Antiviral Agents|antiviral agents|mesh-ancestor
6427196|NCT00312988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6427197|NCT00312988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6427198|NCT00312988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6427199|NCT00312988|Immunologic Factors|immunologic factors|mesh-ancestor
6427200|NCT00312988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427201|NCT00312988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6427202|NCT00312988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6427203|NCT00313001|Insulin Aspart|insulin aspart|mesh-list
6427204|NCT00313001|Exenatide|exenatide|mesh-list
6427205|NCT00313001|Biphasic Insulins|biphasic insulins|mesh-list
6427206|NCT00313001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6427207|NCT00313001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427208|NCT00313001|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6427209|NCT00313001|Incretins|incretins|mesh-ancestor
6427210|NCT00313001|Hormones|hormones|mesh-ancestor
6427211|NCT00313001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6427212|NCT00313053|Vincristine|vincristine|mesh-list
6427213|NCT00313053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6427214|NCT00313053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6427215|NCT00313053|Tubulin Modulators|tubulin modulators|mesh-ancestor
6427216|NCT00313053|Antimitotic Agents|antimitotic agents|mesh-ancestor
6427217|NCT00313053|Mitosis Modulators|mitosis modulators|mesh-ancestor
6427218|NCT00313053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427219|NCT00313079|Vincristine|vincristine|mesh-list
6427220|NCT00313079|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6427221|NCT00313079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6427222|NCT00313079|Tubulin Modulators|tubulin modulators|mesh-ancestor
6427223|NCT00313079|Antimitotic Agents|antimitotic agents|mesh-ancestor
6427224|NCT00313079|Mitosis Modulators|mitosis modulators|mesh-ancestor
6427225|NCT00313079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427226|NCT00313105|Lobeline|lobeline|mesh-list
6427227|NCT00313105|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6427228|NCT00313105|Autonomic Agents|autonomic agents|mesh-ancestor
6427229|NCT00313105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6427230|NCT00313105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427231|NCT00313105|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6427232|NCT00313105|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6427233|NCT00313105|Cholinergic Agents|cholinergic agents|mesh-ancestor
6427234|NCT00313105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6427235|NCT00313105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427236|NCT00313105|Respiratory System Agents|respiratory system agents|mesh-ancestor
6427237|NCT00313131|Metronidazole|metronidazole|mesh-list
6427238|NCT00313131|Fluconazole|fluconazole|mesh-list
6427239|NCT00313131|Clotrimazole|clotrimazole|mesh-list
6427240|NCT00313131|Miconazole|miconazole|mesh-list
6427241|NCT00313131|Tinidazole|tinidazole|mesh-list
6427242|NCT00313131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6427243|NCT00313131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6427244|NCT00313131|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6538785|NCT00830089|Anesthetics|anesthetics|mesh-ancestor
6538786|NCT00830089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6538787|NCT00830089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538788|NCT00830089|Sensory System Agents|sensory system agents|mesh-ancestor
6538789|NCT00830089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6538790|NCT00830193|Acetylcysteine|acetylcysteine|mesh-list
6538791|NCT00830193|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6538792|NCT00830193|Antiviral Agents|antiviral agents|mesh-ancestor
6538793|NCT00830193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6538794|NCT00830193|Expectorants|expectorants|mesh-ancestor
6538795|NCT00830193|Respiratory System Agents|respiratory system agents|mesh-ancestor
6538796|NCT00830193|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6538797|NCT00830193|Antioxidants|antioxidants|mesh-ancestor
6538798|NCT00830193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427245|NCT00313131|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6427246|NCT00313131|Antifungal Agents|antifungal agents|mesh-ancestor
6427247|NCT00313131|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6427248|NCT00313131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6427249|NCT00313131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6427250|NCT00313131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427251|NCT00313131|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6427252|NCT00313131|Hormone Antagonists|hormone antagonists|mesh-ancestor
6427253|NCT00313131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6427254|NCT00313131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427255|NCT00313131|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6427256|NCT00313131|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6427257|NCT00313131|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6427258|NCT00313131|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6427259|NCT00313131|Alkylating Agents|alkylating agents|mesh-ancestor
6427260|NCT00313131|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
6427261|NCT00313157|Metoprolol|metoprolol|mesh-list
6019225|NCT00385671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6019226|NCT00385671|Antidepressive Agents|antidepressive agents|mesh-ancestor
6019227|NCT00385671|Dopamine Agents|dopamine agents|mesh-ancestor
6019228|NCT00385684|Acetaminophen|acetaminophen|mesh-list
6427262|NCT00313157|Verapamil|verapamil|mesh-list
6427263|NCT00313157|Carvedilol|carvedilol|mesh-list
6427264|NCT00313157|Diltiazem|diltiazem|mesh-list
6427265|NCT00313157|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6427266|NCT00313157|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6427267|NCT00313157|Sympatholytics|sympatholytics|mesh-ancestor
6427268|NCT00313157|Autonomic Agents|autonomic agents|mesh-ancestor
6427269|NCT00313157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6427270|NCT00313157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427271|NCT00313157|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6427272|NCT00313157|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6427273|NCT00313157|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6427274|NCT00313157|Adrenergic Agents|adrenergic agents|mesh-ancestor
6427275|NCT00313157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6427276|NCT00313157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427277|NCT00313157|Antioxidants|antioxidants|mesh-ancestor
6427278|NCT00313157|Protective Agents|protective agents|mesh-ancestor
6427279|NCT00313157|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6427280|NCT00313157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6427281|NCT00313157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6427282|NCT00313157|Vasodilator Agents|vasodilator agents|mesh-ancestor
6427283|NCT00313157|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6427284|NCT00313157|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6427285|NCT00313183|Pramlintide|pramlintide|mesh-list
6427286|NCT00313183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6427287|NCT00313183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427288|NCT00313235|Cyclophosphamide|cyclophosphamide|mesh-list
6427289|NCT00313235|Vaccines|vaccines|mesh-list
6427290|NCT00313235|Immunologic Factors|immunologic factors|mesh-ancestor
6427291|NCT00313235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427292|NCT00313235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6427293|NCT00313235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6427294|NCT00313235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6427295|NCT00313235|Alkylating Agents|alkylating agents|mesh-ancestor
6427296|NCT00313235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427297|NCT00313235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6427298|NCT00313235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6427299|NCT00313261|Clevudine|clevudine|mesh-list
6427300|NCT00313261|Antiviral Agents|antiviral agents|mesh-ancestor
6427301|NCT00313261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6427302|NCT00313274|Clevudine|clevudine|mesh-list
6427303|NCT00313274|Antiviral Agents|antiviral agents|mesh-ancestor
6427304|NCT00313274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6427305|NCT00313287|Clevudine|clevudine|mesh-list
6427306|NCT00313287|Antiviral Agents|antiviral agents|mesh-ancestor
6427307|NCT00313287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6427308|NCT00313391|Risperidone|risperidone|mesh-list
6427309|NCT00313391|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6427310|NCT00313391|Serotonin Agents|serotonin agents|mesh-ancestor
5501372|NCT04475029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6427311|NCT00313391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6427312|NCT00313391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427313|NCT00313391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427314|NCT00313391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6427315|NCT00313391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6427316|NCT00313391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6427317|NCT00313391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6427318|NCT00313391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6427319|NCT00313391|Dopamine Agents|dopamine agents|mesh-ancestor
6427320|NCT00313456|Satraplatin|satraplatin|mesh-list
6427321|NCT00313456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6427322|NCT00313482|Prednisone|prednisone|mesh-list
6427323|NCT00313482|Docetaxel|docetaxel|mesh-list
6427324|NCT00313482|Sargramostim|sargramostim|mesh-list
6427325|NCT00313482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6427326|NCT00313482|Tubulin Modulators|tubulin modulators|mesh-ancestor
6427327|NCT00313482|Antimitotic Agents|antimitotic agents|mesh-ancestor
6427328|NCT00313482|Mitosis Modulators|mitosis modulators|mesh-ancestor
6427329|NCT00313482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427330|NCT00313482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6427331|NCT00313482|Glucocorticoids|glucocorticoids|mesh-ancestor
6427332|NCT00313482|Hormones|hormones|mesh-ancestor
6427333|NCT00313482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6427334|NCT00313482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427335|NCT00313482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6427336|NCT00313482|Immunologic Factors|immunologic factors|mesh-ancestor
6460735|NCT00451230|Anesthetics|anesthetics|mesh-ancestor
6460736|NCT00451230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6460737|NCT00451230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460738|NCT00451230|Sensory System Agents|sensory system agents|mesh-ancestor
6460739|NCT00451230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6460740|NCT00451230|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6460741|NCT00451230|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6460742|NCT00451230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6538799|NCT00830193|Protective Agents|protective agents|mesh-ancestor
6538800|NCT00830193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538801|NCT00830193|Antidotes|antidotes|mesh-ancestor
6538802|NCT00830245|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6538803|NCT00830245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6538804|NCT00830245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6538805|NCT00830245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6538806|NCT00830245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538807|NCT00830297|Isophane Insulin, Human|isophane insulin, human|mesh-list
6538808|NCT00830297|Insulin, Isophane|insulin, isophane|mesh-list
6538809|NCT00830297|Isophane insulin, beef|isophane insulin, beef|mesh-list
6538810|NCT00830297|Insulin, Long-Acting|insulin, long-acting|mesh-list
6538811|NCT00830297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6538812|NCT00830297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538813|NCT00830323|Oseltamivir|oseltamivir|mesh-list
6538814|NCT00830323|Amantadine|amantadine|mesh-list
6538815|NCT00830323|Zanamivir|zanamivir|mesh-list
6538816|NCT00830323|Antiviral Agents|antiviral agents|mesh-ancestor
6427337|NCT00313508|Vidarabine|vidarabine|mesh-list
6427338|NCT00313508|Fludarabine|fludarabine|mesh-list
6427339|NCT00313508|Fludarabine phosphate|fludarabine phosphate|mesh-list
6427340|NCT00313508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6427341|NCT00313508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6427342|NCT00313508|Antimetabolites|antimetabolites|mesh-ancestor
6427343|NCT00313508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427344|NCT00313508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6427345|NCT00313508|Immunologic Factors|immunologic factors|mesh-ancestor
6427346|NCT00313508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427347|NCT00313508|Antiviral Agents|antiviral agents|mesh-ancestor
6427348|NCT00313508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6427349|NCT00313521|Thiotepa|thiotepa|mesh-list
6427350|NCT00313521|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6427351|NCT00313521|Alkylating Agents|alkylating agents|mesh-ancestor
6427352|NCT00313521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427353|NCT00313521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6427354|NCT00313521|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6427355|NCT00313521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6427356|NCT00313521|Immunologic Factors|immunologic factors|mesh-ancestor
6427357|NCT00313521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427358|NCT00313534|Masoprocol|masoprocol|mesh-list
6427359|NCT00313534|Antioxidants|antioxidants|mesh-ancestor
6427360|NCT00313534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427361|NCT00313534|Protective Agents|protective agents|mesh-ancestor
6427362|NCT00313534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427363|NCT00313534|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6427364|NCT00313534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6427365|NCT00313534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6427366|NCT00313534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6427367|NCT00313534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6427368|NCT00313534|Analgesics|analgesics|mesh-ancestor
6427369|NCT00313534|Sensory System Agents|sensory system agents|mesh-ancestor
6427370|NCT00313534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6427371|NCT00313534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6427372|NCT00313534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6427373|NCT00313547|Amlodipine|amlodipine|mesh-list
6427374|NCT00313547|Quinapril|quinapril|mesh-list
6427375|NCT00313547|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6427376|NCT00313547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6427377|NCT00313547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6427378|NCT00313547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427379|NCT00313547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6427380|NCT00313547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427381|NCT00313547|Vasodilator Agents|vasodilator agents|mesh-ancestor
6427382|NCT00313547|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6427383|NCT00313547|Protease Inhibitors|protease inhibitors|mesh-ancestor
6427384|NCT00313547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6427385|NCT00313599|Paclitaxel|paclitaxel|mesh-list
6427386|NCT00313599|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6427387|NCT00313599|Lapatinib|lapatinib|mesh-list
6427388|NCT00313599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6427389|NCT00313599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6427390|NCT00313599|Tubulin Modulators|tubulin modulators|mesh-ancestor
6427391|NCT00313599|Antimitotic Agents|antimitotic agents|mesh-ancestor
6427392|NCT00313599|Mitosis Modulators|mitosis modulators|mesh-ancestor
6427393|NCT00313599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427394|NCT00313599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6427395|NCT00313599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6427396|NCT00313625|Methotrexate|methotrexate|mesh-list
6427397|NCT00313625|Melphalan|melphalan|mesh-list
6427398|NCT00313625|Busulfan|busulfan|mesh-list
6427399|NCT00313625|Tacrolimus|tacrolimus|mesh-list
6427400|NCT00313625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6427401|NCT00313625|Abortifacient Agents|abortifacient agents|mesh-ancestor
6427402|NCT00313625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6427403|NCT00313625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427404|NCT00313625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6427405|NCT00313625|Antimetabolites|antimetabolites|mesh-ancestor
6427406|NCT00313625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427407|NCT00313625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6427408|NCT00313625|Dermatologic Agents|dermatologic agents|mesh-ancestor
6427409|NCT00313625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6427410|NCT00313625|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6427411|NCT00313625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6427412|NCT00313625|Immunologic Factors|immunologic factors|mesh-ancestor
6427413|NCT00313625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6427414|NCT00313625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6427415|NCT00313625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6427416|NCT00313625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6427417|NCT00313625|Alkylating Agents|alkylating agents|mesh-ancestor
6427418|NCT00313625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6427419|NCT00313690|Docetaxel|docetaxel|mesh-list
6427420|NCT00313690|Bortezomib|bortezomib|mesh-list
6427421|NCT00313690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6427422|NCT00313690|Tubulin Modulators|tubulin modulators|mesh-ancestor
6427423|NCT00313690|Antimitotic Agents|antimitotic agents|mesh-ancestor
6427424|NCT00313690|Mitosis Modulators|mitosis modulators|mesh-ancestor
6427425|NCT00313690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427426|NCT00313742|Insulin|insulin|mesh-list
6427427|NCT00313742|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6427428|NCT00313742|Insulin Glargine|insulin glargine|mesh-list
6427429|NCT00313742|Insulin Detemir|insulin detemir|mesh-list
6427430|NCT00313742|Isophane Insulin, Human|isophane insulin, human|mesh-list
6427431|NCT00313742|Insulin, Isophane|insulin, isophane|mesh-list
6427432|NCT00313742|Isophane insulin, beef|isophane insulin, beef|mesh-list
6427433|NCT00313742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6427434|NCT00313742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427435|NCT00313833|Buprenorphine|buprenorphine|mesh-list
6427436|NCT00313833|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6427437|NCT00313833|Narcotics|narcotics|mesh-ancestor
6427438|NCT00313833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6427439|NCT00313833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427440|NCT00313833|Analgesics|analgesics|mesh-ancestor
6427441|NCT00313833|Sensory System Agents|sensory system agents|mesh-ancestor
6427442|NCT00313833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6427443|NCT00313833|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6427444|NCT00313859|Simvastatin|simvastatin|mesh-list
6427445|NCT00313859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6427446|NCT00313859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6427447|NCT00313859|Antimetabolites|antimetabolites|mesh-ancestor
6427448|NCT00313859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427449|NCT00313859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6427450|NCT00313859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6427451|NCT00313859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6538817|NCT00830323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6538818|NCT00830323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6538819|NCT00830323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538820|NCT00830323|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6538821|NCT00830323|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6538822|NCT00830323|Dopamine Agents|dopamine agents|mesh-ancestor
6538823|NCT00830323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6538824|NCT00830323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538825|NCT00830323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6427452|NCT00313885|SR 46349B|sr 46349b|mesh-list
6538826|NCT00830323|Analgesics|analgesics|mesh-ancestor
6538827|NCT00830323|Sensory System Agents|sensory system agents|mesh-ancestor
6427453|NCT00313885|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6427454|NCT00313885|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6427455|NCT00313885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427456|NCT00313885|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6427457|NCT00313885|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6427458|NCT00313885|Serotonin Agents|serotonin agents|mesh-ancestor
6427459|NCT00313885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6427460|NCT00313885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427461|NCT00313898|Sildenafil Citrate|sildenafil citrate|mesh-list
6427462|NCT00313898|Vasodilator Agents|vasodilator agents|mesh-ancestor
6427463|NCT00313898|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6427464|NCT00313898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6427465|NCT00313898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6427466|NCT00313898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427467|NCT00313898|Urological Agents|urological agents|mesh-ancestor
6427468|NCT00313924|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6427469|NCT00313924|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6427470|NCT00313924|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6427471|NCT00313924|Cholinergic Agents|cholinergic agents|mesh-ancestor
6427472|NCT00313924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6427473|NCT00313924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427474|NCT00313924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427475|NCT00313924|Urological Agents|urological agents|mesh-ancestor
6427476|NCT00313937|Insulin Glargine|insulin glargine|mesh-list
6427477|NCT00313937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6427478|NCT00313937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427479|NCT00313950|Vaccines|vaccines|mesh-list
6427480|NCT00313950|Immunologic Factors|immunologic factors|mesh-ancestor
6427481|NCT00313950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427482|NCT00313963|Magnesium Sulfate|magnesium sulfate|mesh-list
6427483|NCT00313963|Analgesics|analgesics|mesh-ancestor
6427484|NCT00313963|Sensory System Agents|sensory system agents|mesh-ancestor
6427485|NCT00313963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6427486|NCT00313963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427487|NCT00313963|Anesthetics|anesthetics|mesh-ancestor
6427488|NCT00313963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6427489|NCT00313963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6427490|NCT00313963|Anticonvulsants|anticonvulsants|mesh-ancestor
6427491|NCT00313963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6427492|NCT00313963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6427493|NCT00313963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427494|NCT00313963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6427495|NCT00313963|Tocolytic Agents|tocolytic agents|mesh-ancestor
6427496|NCT00313963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6427497|NCT00313976|Interferons|interferons|mesh-list
6427498|NCT00313976|Interferon-beta|interferon-beta|mesh-list
6427499|NCT00313976|Interferon beta-1b|interferon beta-1b|mesh-list
6427500|NCT00313976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6427501|NCT00313976|Antiviral Agents|antiviral agents|mesh-ancestor
6427502|NCT00313976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6427503|NCT00313976|Immunologic Factors|immunologic factors|mesh-ancestor
6427504|NCT00313976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427505|NCT00313976|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6427506|NCT00314080|Antitoxins|antitoxins|mesh-list
6427507|NCT00314080|Botulinum Antitoxin|botulinum antitoxin|mesh-list
6427508|NCT00314080|Immunologic Factors|immunologic factors|mesh-ancestor
6427509|NCT00314080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427510|NCT00314158|Timolol|timolol|mesh-list
6427511|NCT00314158|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6427512|NCT00314158|Brinzolamide|brinzolamide|mesh-list
6427513|NCT00314158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6427514|NCT00314158|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6427515|NCT00314158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6427516|NCT00314158|Adrenergic Agents|adrenergic agents|mesh-ancestor
6427517|NCT00314158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6427518|NCT00314158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427519|NCT00314158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427520|NCT00314158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6427521|NCT00314158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6427522|NCT00314158|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6427523|NCT00314158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6427524|NCT00314171|Timolol|timolol|mesh-list
6427525|NCT00314171|Dorzolamide|dorzolamide|mesh-list
6427526|NCT00314171|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6427527|NCT00314171|Brinzolamide|brinzolamide|mesh-list
6427528|NCT00314171|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6427529|NCT00314171|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6427530|NCT00314171|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6427531|NCT00314171|Adrenergic Agents|adrenergic agents|mesh-ancestor
6427532|NCT00314171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6427533|NCT00314171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427534|NCT00314171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427535|NCT00314171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6427536|NCT00314171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6427537|NCT00314171|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6538828|NCT00830323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6538829|NCT00830349|Risperidone|risperidone|mesh-list
6538830|NCT00830349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6538831|NCT00830349|Serotonin Agents|serotonin agents|mesh-ancestor
6538832|NCT00830349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6538833|NCT00830349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538834|NCT00830349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538835|NCT00830349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6538836|NCT00830349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6538837|NCT00830349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6538838|NCT00830349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6538839|NCT00830349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6538840|NCT00830349|Dopamine Agents|dopamine agents|mesh-ancestor
6538841|NCT00830401|Doxycycline|doxycycline|mesh-list
6538842|NCT00830401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6538843|NCT00830401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6538844|NCT00830401|Antimalarials|antimalarials|mesh-ancestor
6538845|NCT00830401|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6538846|NCT00830401|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6538847|NCT00830414|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6538848|NCT00830414|Medroxyprogesterone|medroxyprogesterone|mesh-list
6538849|NCT00830414|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6538850|NCT00830414|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6538851|NCT00830414|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6538852|NCT00830414|Contraceptive Agents|contraceptive agents|mesh-ancestor
6538853|NCT00830414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6538854|NCT00830414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538855|NCT00830414|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6538856|NCT00830414|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6538857|NCT00830414|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6538858|NCT00830414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6538859|NCT00830414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6538860|NCT00830466|Sirolimus|sirolimus|mesh-list
6538861|NCT00830466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6538862|NCT00830466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6538863|NCT00830466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6538864|NCT00830466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6538865|NCT00830466|Antifungal Agents|antifungal agents|mesh-ancestor
6538866|NCT00830466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6538867|NCT00830466|Immunologic Factors|immunologic factors|mesh-ancestor
6538868|NCT00830466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538869|NCT00830492|Clomiphene|clomiphene|mesh-list
6538870|NCT00830492|Enclomiphene|enclomiphene|mesh-list
6538871|NCT00830492|Zuclomiphene|zuclomiphene|mesh-list
6538872|NCT00830492|Buserelin|buserelin|mesh-list
6538873|NCT00830492|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6538874|NCT00830492|Hormone Antagonists|hormone antagonists|mesh-ancestor
6538875|NCT00830492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6538876|NCT00830492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538877|NCT00830492|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6427538|NCT00314171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6538878|NCT00830492|Fertility Agents|fertility agents|mesh-ancestor
6538879|NCT00830492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6427539|NCT00314184|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6427540|NCT00314184|Antidepressive Agents|antidepressive agents|mesh-ancestor
6427541|NCT00314184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6427542|NCT00314184|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6427543|NCT00314184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6427544|NCT00314184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6427545|NCT00314184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427546|NCT00314210|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6427547|NCT00314210|Antidepressive Agents|antidepressive agents|mesh-ancestor
6427548|NCT00314210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6427549|NCT00314210|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6427550|NCT00314210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6427551|NCT00314210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6427552|NCT00314210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427553|NCT00314314|Insulin|insulin|mesh-list
6427554|NCT00314314|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6427555|NCT00314314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427556|NCT00314379|Vitamin E|vitamin e|mesh-list
6427557|NCT00314379|Vitamins|vitamins|mesh-ancestor
6427558|NCT00314379|Micronutrients|micronutrients|mesh-ancestor
6427559|NCT00314379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427560|NCT00314379|Antioxidants|antioxidants|mesh-ancestor
6427561|NCT00314379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427562|NCT00314379|Protective Agents|protective agents|mesh-ancestor
6427563|NCT00314405|Methylene Blue|methylene blue|mesh-list
6427564|NCT00314405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6427565|NCT00314405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427566|NCT00314457|Bupivacaine|bupivacaine|mesh-list
6427567|NCT00314457|Anesthetics, Local|anesthetics, local|mesh-ancestor
6427568|NCT00314457|Anesthetics|anesthetics|mesh-ancestor
6427569|NCT00314457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6427570|NCT00314457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427571|NCT00314457|Sensory System Agents|sensory system agents|mesh-ancestor
6427572|NCT00314457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6427573|NCT00314509|Ciclesonide|ciclesonide|mesh-list
6427574|NCT00314509|Formoterol Fumarate|formoterol fumarate|mesh-list
6427575|NCT00314509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6427576|NCT00314509|Autonomic Agents|autonomic agents|mesh-ancestor
6427577|NCT00314509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6427578|NCT00314509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427579|NCT00314509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6427580|NCT00314509|Respiratory System Agents|respiratory system agents|mesh-ancestor
6427581|NCT00314509|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6427582|NCT00314509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6427583|NCT00314509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6427584|NCT00314509|Adrenergic Agents|adrenergic agents|mesh-ancestor
6427585|NCT00314509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6427586|NCT00314509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427587|NCT00314509|Glucocorticoids|glucocorticoids|mesh-ancestor
6427588|NCT00314509|Hormones|hormones|mesh-ancestor
6427589|NCT00314509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6427590|NCT00314509|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6427591|NCT00314548|Epoprostenol|epoprostenol|mesh-list
6427592|NCT00314548|Alprostadil|alprostadil|mesh-list
6427593|NCT00314548|Tezosentan|tezosentan|mesh-list
6427594|NCT00314548|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6427595|NCT00314548|Vasodilator Agents|vasodilator agents|mesh-ancestor
6427596|NCT00314548|Urological Agents|urological agents|mesh-ancestor
6427597|NCT00314548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6427598|NCT00314561|Pioglitazone|pioglitazone|mesh-list
6427599|NCT00314561|Rosiglitazone|rosiglitazone|mesh-list
6427600|NCT00314561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6427601|NCT00314561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427602|NCT00314613|Risperidone|risperidone|mesh-list
6427603|NCT00314613|Antipsychotic Agents|antipsychotic agents|mesh-list
6427604|NCT00314613|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6427605|NCT00314613|Serotonin Agents|serotonin agents|mesh-ancestor
6427606|NCT00314613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6427607|NCT00314613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427608|NCT00314613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427609|NCT00314613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6427610|NCT00314613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6427611|NCT00314613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6427612|NCT00314613|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6427613|NCT00314613|Dopamine Agents|dopamine agents|mesh-ancestor
6427614|NCT00314626|Lamivudine|lamivudine|mesh-list
6427615|NCT00314626|Efavirenz|efavirenz|mesh-list
6427616|NCT00314626|Abacavir|abacavir|mesh-list
6427617|NCT00314626|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6427618|NCT00314626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6427619|NCT00314626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6427620|NCT00314626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427621|NCT00314626|Antiviral Agents|antiviral agents|mesh-ancestor
6427622|NCT00314626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6427623|NCT00314626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6427624|NCT00314626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6427625|NCT00314626|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6427626|NCT00314626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6427627|NCT00314626|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6538880|NCT00830492|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6538881|NCT00830492|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6538882|NCT00830505|Fluticasone|fluticasone|mesh-list
6538883|NCT00830505|Xhance|xhance|mesh-list
6538884|NCT00830505|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6538885|NCT00830505|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6538886|NCT00830505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6427628|NCT00314626|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6427629|NCT00314626|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6427630|NCT00314626|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6427631|NCT00314639|Modafinil|modafinil|mesh-list
6427632|NCT00314639|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6427633|NCT00314639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427634|NCT00314639|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6427635|NCT00314639|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6427636|NCT00314639|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6427637|NCT00314639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427638|NCT00314652|Buprenorphine|buprenorphine|mesh-list
6427639|NCT00314652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6427640|NCT00314652|Narcotics|narcotics|mesh-ancestor
6427641|NCT00314652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6427642|NCT00314652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427643|NCT00314652|Analgesics|analgesics|mesh-ancestor
6427644|NCT00314652|Sensory System Agents|sensory system agents|mesh-ancestor
6427645|NCT00314652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6427646|NCT00314652|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6427647|NCT00314665|Thalidomide|thalidomide|mesh-list
6427648|NCT00314665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6427649|NCT00314665|Immunologic Factors|immunologic factors|mesh-ancestor
6427650|NCT00314665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427651|NCT00314665|Leprostatic Agents|leprostatic agents|mesh-ancestor
6427652|NCT00314665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6427653|NCT00314665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6427654|NCT00314665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6427655|NCT00314665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6427656|NCT00314665|Growth Substances|growth substances|mesh-ancestor
6427657|NCT00314665|Growth Inhibitors|growth inhibitors|mesh-ancestor
6427658|NCT00314665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6427659|NCT00314678|Paclitaxel|paclitaxel|mesh-list
6427660|NCT00314678|Topotecan|topotecan|mesh-list
6427661|NCT00314678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6427662|NCT00314678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6427663|NCT00314678|Tubulin Modulators|tubulin modulators|mesh-ancestor
6427664|NCT00314678|Antimitotic Agents|antimitotic agents|mesh-ancestor
6427665|NCT00314678|Mitosis Modulators|mitosis modulators|mesh-ancestor
6427666|NCT00314678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427667|NCT00314678|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6427668|NCT00314678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6427669|NCT00314678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6427670|NCT00314704|Dopamine|dopamine|mesh-list
6427671|NCT00314704|Norepinephrine|norepinephrine|mesh-list
6427672|NCT00314704|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6427673|NCT00314704|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6427674|NCT00314704|Adrenergic Agents|adrenergic agents|mesh-ancestor
6427675|NCT00314704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6427676|NCT00314704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427677|NCT00314704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427678|NCT00314704|Sympathomimetics|sympathomimetics|mesh-ancestor
6427679|NCT00314704|Autonomic Agents|autonomic agents|mesh-ancestor
6427680|NCT00314704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6427681|NCT00314704|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6427682|NCT00314704|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6427683|NCT00314704|Dopamine Agents|dopamine agents|mesh-ancestor
6427684|NCT00314704|Protective Agents|protective agents|mesh-ancestor
6427685|NCT00314743|Dexamethasone|dexamethasone|mesh-list
6427686|NCT00314743|Ondansetron|ondansetron|mesh-list
6427687|NCT00314743|Aprepitant|aprepitant|mesh-list
6427688|NCT00314743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6427689|NCT00314743|Antiemetics|antiemetics|mesh-ancestor
6427690|NCT00314743|Autonomic Agents|autonomic agents|mesh-ancestor
6427691|NCT00314743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6427692|NCT00314743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427693|NCT00314743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6427694|NCT00314743|Glucocorticoids|glucocorticoids|mesh-ancestor
6427695|NCT00314743|Hormones|hormones|mesh-ancestor
6427696|NCT00314743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6427697|NCT00314743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6427698|NCT00314743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6427699|NCT00314743|Antipruritics|antipruritics|mesh-ancestor
6427700|NCT00314743|Dermatologic Agents|dermatologic agents|mesh-ancestor
6427701|NCT00314743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6427702|NCT00314743|Serotonin Agents|serotonin agents|mesh-ancestor
6427703|NCT00314743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6538887|NCT00830505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6538888|NCT00830505|Autonomic Agents|autonomic agents|mesh-ancestor
6538889|NCT00830505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6538890|NCT00830505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427704|NCT00314743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427705|NCT00314743|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6427706|NCT00314743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6427707|NCT00314743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6427708|NCT00314743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6427709|NCT00314743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6427710|NCT00314743|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6427711|NCT00314756|Imiquimod|imiquimod|mesh-list
6427712|NCT00314756|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6427713|NCT00314756|Immunologic Factors|immunologic factors|mesh-ancestor
6427714|NCT00314756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427715|NCT00314756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6427716|NCT00314756|Interferon Inducers|interferon inducers|mesh-ancestor
6427717|NCT00314782|Docetaxel|docetaxel|mesh-list
6427718|NCT00314782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6427719|NCT00314782|Tubulin Modulators|tubulin modulators|mesh-ancestor
6427720|NCT00314782|Antimitotic Agents|antimitotic agents|mesh-ancestor
6427721|NCT00314782|Mitosis Modulators|mitosis modulators|mesh-ancestor
6427722|NCT00314782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427723|NCT00314821|Ropinirole|ropinirole|mesh-list
6427724|NCT00314821|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6427725|NCT00314821|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6427726|NCT00314821|Dopamine Agonists|dopamine agonists|mesh-ancestor
6427727|NCT00314821|Dopamine Agents|dopamine agents|mesh-ancestor
6427728|NCT00314821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6427729|NCT00314821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427730|NCT00314821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427731|NCT00314860|Ropinirole|ropinirole|mesh-list
6427732|NCT00314860|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6427733|NCT00314860|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6427734|NCT00314860|Dopamine Agonists|dopamine agonists|mesh-ancestor
6427735|NCT00314860|Dopamine Agents|dopamine agents|mesh-ancestor
6427736|NCT00314860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6427737|NCT00314860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427738|NCT00314860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427739|NCT00314873|Imatinib Mesylate|imatinib mesylate|mesh-list
6427740|NCT00314873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6427741|NCT00314873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6427742|NCT00314873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6427743|NCT00314873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427744|NCT00314912|Tramiprosate|tramiprosate|mesh-list
6427745|NCT00314912|Anticonvulsants|anticonvulsants|mesh-ancestor
6427746|NCT00314912|GABA Agonists|gaba agonists|mesh-ancestor
6427747|NCT00314912|GABA Agents|gaba agents|mesh-ancestor
6427748|NCT00314912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6427749|NCT00314912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427750|NCT00314912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427751|NCT00314977|Cyclophosphamide|cyclophosphamide|mesh-list
6427752|NCT00314977|Docetaxel|docetaxel|mesh-list
6427753|NCT00314977|Doxorubicin|doxorubicin|mesh-list
6538891|NCT00830505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6538892|NCT00830505|Respiratory System Agents|respiratory system agents|mesh-ancestor
6538893|NCT00830505|Dermatologic Agents|dermatologic agents|mesh-ancestor
6538894|NCT00830505|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6538895|NCT00830505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6019229|NCT00385684|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
6019230|NCT00385684|Hydrocodone|hydrocodone|mesh-list
6019231|NCT00385684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6019232|NCT00385684|Narcotics|narcotics|mesh-ancestor
6019233|NCT00385684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6019234|NCT00385684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019235|NCT00385684|Analgesics|analgesics|mesh-ancestor
6019236|NCT00385684|Sensory System Agents|sensory system agents|mesh-ancestor
6427754|NCT00314977|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6427755|NCT00314977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6427756|NCT00314977|Immunologic Factors|immunologic factors|mesh-ancestor
6427757|NCT00314977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427758|NCT00314977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6427759|NCT00314977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6427760|NCT00314977|Alkylating Agents|alkylating agents|mesh-ancestor
6427761|NCT00314977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427762|NCT00314977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6427763|NCT00314977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6427764|NCT00314977|Tubulin Modulators|tubulin modulators|mesh-ancestor
6427765|NCT00314977|Antimitotic Agents|antimitotic agents|mesh-ancestor
6427766|NCT00314977|Mitosis Modulators|mitosis modulators|mesh-ancestor
6427767|NCT00314977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6427768|NCT00314977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6427769|NCT00314977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6427770|NCT00314977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6427771|NCT00314990|Folic Acid|folic acid|mesh-list
6427772|NCT00314990|Pyridoxine|pyridoxine|mesh-list
6427773|NCT00314990|Vitamin B 12|vitamin b 12|mesh-list
6427774|NCT00314990|Hydroxocobalamin|hydroxocobalamin|mesh-list
6427775|NCT00314990|Hematinics|hematinics|mesh-ancestor
6427776|NCT00314990|Vitamin B Complex|vitamin b complex|mesh-ancestor
6427777|NCT00314990|Vitamins|vitamins|mesh-ancestor
6427778|NCT00314990|Micronutrients|micronutrients|mesh-ancestor
6427779|NCT00314990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427780|NCT00315003|Azithromycin|azithromycin|mesh-list
6427781|NCT00315003|Telithromycin|telithromycin|mesh-list
6427782|NCT00315003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6427783|NCT00315003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6427784|NCT00315016|Eplerenone|eplerenone|mesh-list
6427785|NCT00315016|Fosinopril|fosinopril|mesh-list
6427786|NCT00315016|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6427787|NCT00315016|Hormone Antagonists|hormone antagonists|mesh-ancestor
6427788|NCT00315016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6427789|NCT00315016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427790|NCT00315016|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6427791|NCT00315016|Diuretics|diuretics|mesh-ancestor
6427792|NCT00315016|Natriuretic Agents|natriuretic agents|mesh-ancestor
6427793|NCT00315016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6427794|NCT00315016|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6427795|NCT00315016|Protease Inhibitors|protease inhibitors|mesh-ancestor
6427796|NCT00315016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6427797|NCT00315016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427798|NCT00315042|Penicillins|penicillins|mesh-list
6427799|NCT00315042|Telithromycin|telithromycin|mesh-list
6427800|NCT00315042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6427801|NCT00315042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6427802|NCT00315081|Bromocriptine|bromocriptine|mesh-list
6427803|NCT00315081|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6427804|NCT00315081|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6427805|NCT00315081|Hormone Antagonists|hormone antagonists|mesh-ancestor
6427806|NCT00315081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6427807|NCT00315081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427808|NCT00315081|Dopamine Agonists|dopamine agonists|mesh-ancestor
6427809|NCT00315081|Dopamine Agents|dopamine agents|mesh-ancestor
6427810|NCT00315081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6427811|NCT00315081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427812|NCT00315185|Cetuximab|cetuximab|mesh-list
6427813|NCT00315185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6427814|NCT00315185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6427815|NCT00315211|Docetaxel|docetaxel|mesh-list
6427816|NCT00315211|Topotecan|topotecan|mesh-list
6427817|NCT00315211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6427818|NCT00315211|Tubulin Modulators|tubulin modulators|mesh-ancestor
6427819|NCT00315211|Antimitotic Agents|antimitotic agents|mesh-ancestor
6427820|NCT00315211|Mitosis Modulators|mitosis modulators|mesh-ancestor
6427821|NCT00315211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427822|NCT00315211|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6427823|NCT00315211|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6427824|NCT00315211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6460743|NCT00451230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6460744|NCT00451230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460745|NCT00451230|Dopamine Agents|dopamine agents|mesh-ancestor
6460746|NCT00451230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6460747|NCT00451360|Diacetylrhein|diacetylrhein|mesh-list
6460748|NCT00451360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6460749|NCT00451373|Vancomycin|vancomycin|mesh-list
6460750|NCT00451373|Daptomycin|daptomycin|mesh-list
6460751|NCT00451373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6460752|NCT00451373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6460753|NCT00451386|Ceftriaxone|ceftriaxone|mesh-list
6460754|NCT00451386|Ertapenem|ertapenem|mesh-list
6460755|NCT00451386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6460756|NCT00451386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6460757|NCT00451399|Metformin|metformin|mesh-list
6460758|NCT00451399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6460759|NCT00451399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460760|NCT00451412|Heparin|heparin|mesh-list
6460761|NCT00451412|Calcium heparin|calcium heparin|mesh-list
6460762|NCT00451412|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6460763|NCT00451412|Tinzaparin|tinzaparin|mesh-list
6460764|NCT00451412|Dalteparin|dalteparin|mesh-list
6460765|NCT00451412|Certoparin|certoparin|mesh-list
6460766|NCT00451412|Anticoagulants|anticoagulants|mesh-ancestor
6460767|NCT00451412|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6460768|NCT00451412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6460769|NCT00451412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460770|NCT00451490|S 20098|s 20098|mesh-list
6460771|NCT00451490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6460772|NCT00451490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6460773|NCT00451490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460774|NCT00451568|Metformin|metformin|mesh-list
6460775|NCT00451568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6460776|NCT00451568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460777|NCT00451594|Dexamethasone|dexamethasone|mesh-list
6460778|NCT00451594|Prednisolone|prednisolone|mesh-list
6460779|NCT00451594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6460780|NCT00451594|Antiemetics|antiemetics|mesh-ancestor
6460781|NCT00451594|Autonomic Agents|autonomic agents|mesh-ancestor
6460782|NCT00451594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6460783|NCT00451594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460784|NCT00451594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6460785|NCT00451594|Glucocorticoids|glucocorticoids|mesh-ancestor
6460786|NCT00451594|Hormones|hormones|mesh-ancestor
6460787|NCT00451594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6460788|NCT00451594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6427825|NCT00315276|Modafinil|modafinil|mesh-list
6427826|NCT00315276|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6427827|NCT00315276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427828|NCT00315276|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6427829|NCT00315276|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6427830|NCT00315276|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6427831|NCT00315276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427832|NCT00315367|Donepezil|donepezil|mesh-list
6427833|NCT00315367|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6427834|NCT00315367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6427835|NCT00315367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427836|NCT00315367|Cholinergic Agents|cholinergic agents|mesh-ancestor
6427837|NCT00315367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6427838|NCT00315367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427839|NCT00315367|Nootropic Agents|nootropic agents|mesh-ancestor
6538896|NCT00830505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6538897|NCT00830505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6538898|NCT00830505|Adrenergic Agents|adrenergic agents|mesh-ancestor
6538899|NCT00830505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6538900|NCT00830505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538901|NCT00830505|Glucocorticoids|glucocorticoids|mesh-ancestor
6538902|NCT00830505|Hormones|hormones|mesh-ancestor
6538903|NCT00830505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6538904|NCT00830505|Sympathomimetics|sympathomimetics|mesh-ancestor
6538905|NCT00830531|Bumetanide|bumetanide|mesh-list
6538906|NCT00830531|Diuretics|diuretics|mesh-ancestor
6538907|NCT00830531|Natriuretic Agents|natriuretic agents|mesh-ancestor
6538908|NCT00830531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538909|NCT00830531|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6538910|NCT00830531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6538911|NCT00830531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538912|NCT00830570|Warfarin|warfarin|mesh-list
6538913|NCT00830570|Anticoagulants|anticoagulants|mesh-ancestor
6538914|NCT00830609|Ribavirin|ribavirin|mesh-list
6538915|NCT00830609|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6538916|NCT00830609|Interferon-alpha|interferon-alpha|mesh-list
6538917|NCT00830609|Antimetabolites|antimetabolites|mesh-ancestor
6538918|NCT00830609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538919|NCT00830609|Antiviral Agents|antiviral agents|mesh-ancestor
6538920|NCT00830609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6538921|NCT00830609|Immunologic Factors|immunologic factors|mesh-ancestor
6538922|NCT00830609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538923|NCT00830830|Hyaluronic Acid|hyaluronic acid|mesh-list
6538924|NCT00830830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6538925|NCT00830830|Immunologic Factors|immunologic factors|mesh-ancestor
6538926|NCT00830830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538927|NCT00830830|Viscosupplements|viscosupplements|mesh-ancestor
6538928|NCT00830830|Protective Agents|protective agents|mesh-ancestor
6427840|NCT00315432|Interferons|interferons|mesh-list
6427841|NCT00315432|Ribavirin|ribavirin|mesh-list
6427842|NCT00315432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6427843|NCT00315432|Antiviral Agents|antiviral agents|mesh-ancestor
6427844|NCT00315432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6427845|NCT00315432|Antimetabolites|antimetabolites|mesh-ancestor
6427846|NCT00315432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427847|NCT00315484|Epoetin Alfa|epoetin alfa|mesh-list
6427848|NCT00315484|Darbepoetin alfa|darbepoetin alfa|mesh-list
6427849|NCT00315484|Hematinics|hematinics|mesh-ancestor
6427850|NCT00315510|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6427851|NCT00315510|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6427852|NCT00315510|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6427853|NCT00315510|Antimetabolites|antimetabolites|mesh-ancestor
6427854|NCT00315510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427855|NCT00315510|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6427856|NCT00315510|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6427857|NCT00315510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6427858|NCT00315523|Levocetirizine|levocetirizine|mesh-list
6427859|NCT00315523|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6427860|NCT00315523|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6427861|NCT00315523|Histamine Antagonists|histamine antagonists|mesh-ancestor
6427862|NCT00315523|Histamine Agents|histamine agents|mesh-ancestor
6427863|NCT00315523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6427864|NCT00315523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427865|NCT00315523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427866|NCT00315536|Glycopyrrolate|glycopyrrolate|mesh-list
6427867|NCT00315536|Remifentanil|remifentanil|mesh-list
6427868|NCT00315536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6427869|NCT00315536|Narcotics|narcotics|mesh-ancestor
6427870|NCT00315536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6427871|NCT00315536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427872|NCT00315536|Analgesics|analgesics|mesh-ancestor
6427873|NCT00315536|Sensory System Agents|sensory system agents|mesh-ancestor
6427874|NCT00315536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6427875|NCT00315536|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6427876|NCT00315536|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6427877|NCT00315536|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6427878|NCT00315536|Cholinergic Agents|cholinergic agents|mesh-ancestor
6427879|NCT00315536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6427880|NCT00315536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427881|NCT00315549|Penicillins|penicillins|mesh-list
6427882|NCT00315549|Telithromycin|telithromycin|mesh-list
6427883|NCT00315549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6427884|NCT00315549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6427885|NCT00315601|Azithromycin|azithromycin|mesh-list
6427886|NCT00315601|Telithromycin|telithromycin|mesh-list
6427887|NCT00315601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6427888|NCT00315601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6427889|NCT00315666|Memantine|memantine|mesh-list
6427890|NCT00315666|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6427891|NCT00315666|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6427892|NCT00315666|Dopamine Agents|dopamine agents|mesh-ancestor
6427893|NCT00315666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6427894|NCT00315666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427895|NCT00315666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427896|NCT00315666|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6427897|NCT00315666|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6427898|NCT00315679|Pentoxifylline|pentoxifylline|mesh-list
6427899|NCT00315679|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6427900|NCT00315679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6427901|NCT00315679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427902|NCT00315679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6427903|NCT00315679|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6427904|NCT00315679|Protective Agents|protective agents|mesh-ancestor
6427905|NCT00315679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427906|NCT00315679|Vasodilator Agents|vasodilator agents|mesh-ancestor
6427907|NCT00315679|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6427908|NCT00315679|Antioxidants|antioxidants|mesh-ancestor
6427909|NCT00315744|Fluticasone|fluticasone|mesh-list
6427910|NCT00315744|Xhance|xhance|mesh-list
6427911|NCT00315744|Albuterol|albuterol|mesh-list
6427912|NCT00315744|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6427913|NCT00315744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6427914|NCT00315744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6427915|NCT00315744|Autonomic Agents|autonomic agents|mesh-ancestor
6427916|NCT00315744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6427917|NCT00315744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427918|NCT00315744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6427919|NCT00315744|Respiratory System Agents|respiratory system agents|mesh-ancestor
6427920|NCT00315744|Dermatologic Agents|dermatologic agents|mesh-ancestor
6427921|NCT00315744|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6427922|NCT00315744|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6427923|NCT00315744|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6538929|NCT00830843|Propofol|propofol|mesh-list
6538930|NCT00830843|Isoflurane|isoflurane|mesh-list
6538931|NCT00830843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6538932|NCT00830843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6538933|NCT00830843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538934|NCT00830843|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6538935|NCT00830843|Anesthetics, General|anesthetics, general|mesh-ancestor
6538936|NCT00830843|Anesthetics|anesthetics|mesh-ancestor
6538937|NCT00830843|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6538938|NCT00830856|Lamivudine|lamivudine|mesh-list
6538939|NCT00830856|Nevirapine|nevirapine|mesh-list
6538940|NCT00830856|Stavudine|stavudine|mesh-list
6538941|NCT00830856|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
6538942|NCT00830856|Fluconazole|fluconazole|mesh-list
6538943|NCT00830856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6538944|NCT00830856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6538945|NCT00830856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6538946|NCT00830856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538947|NCT00830856|Antiviral Agents|antiviral agents|mesh-ancestor
6538948|NCT00830856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6538949|NCT00830856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6538950|NCT00830856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6538951|NCT00830856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6538952|NCT00830856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6538953|NCT00830856|Antifungal Agents|antifungal agents|mesh-ancestor
6538954|NCT00830856|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6538955|NCT00830856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6538956|NCT00830856|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6538957|NCT00830856|Hormone Antagonists|hormone antagonists|mesh-ancestor
6538958|NCT00830856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6538959|NCT00830856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538960|NCT00830856|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6538961|NCT00830856|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6538962|NCT00830856|Antimetabolites|antimetabolites|mesh-ancestor
6538963|NCT00830882|Albuterol|albuterol|mesh-list
6538964|NCT00830882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6538965|NCT00830882|Autonomic Agents|autonomic agents|mesh-ancestor
6538966|NCT00830882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6538967|NCT00830882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538968|NCT00830882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6538969|NCT00830882|Respiratory System Agents|respiratory system agents|mesh-ancestor
6538970|NCT00830882|Tocolytic Agents|tocolytic agents|mesh-ancestor
6538971|NCT00830882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6538972|NCT00830882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6538973|NCT00830882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6538974|NCT00830882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6538975|NCT00830882|Adrenergic Agents|adrenergic agents|mesh-ancestor
6538976|NCT00830882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6538977|NCT00830882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538978|NCT00830895|Everolimus|everolimus|mesh-list
6427924|NCT00315744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6427925|NCT00315744|Adrenergic Agents|adrenergic agents|mesh-ancestor
6427926|NCT00315744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6427927|NCT00315744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427928|NCT00315744|Tocolytic Agents|tocolytic agents|mesh-ancestor
6427929|NCT00315744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6427930|NCT00315835|Buprenorphine|buprenorphine|mesh-list
6427931|NCT00315835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6427932|NCT00315835|Narcotics|narcotics|mesh-ancestor
6427933|NCT00315835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6427934|NCT00315835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427935|NCT00315835|Analgesics|analgesics|mesh-ancestor
6427936|NCT00315835|Sensory System Agents|sensory system agents|mesh-ancestor
6427937|NCT00315835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6427938|NCT00315835|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6427939|NCT00315848|Buprenorphine|buprenorphine|mesh-list
6427940|NCT00315848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6427941|NCT00315848|Narcotics|narcotics|mesh-ancestor
6427942|NCT00315848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6427943|NCT00315848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427944|NCT00315848|Analgesics|analgesics|mesh-ancestor
6427945|NCT00315848|Sensory System Agents|sensory system agents|mesh-ancestor
6427946|NCT00315848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6427947|NCT00315848|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6427948|NCT00315861|Pemetrexed|pemetrexed|mesh-list
6427949|NCT00315861|Topotecan|topotecan|mesh-list
6427950|NCT00315861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6427951|NCT00315861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6427952|NCT00315861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427953|NCT00315861|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6427954|NCT00315861|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6427955|NCT00315861|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6427956|NCT00315861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6427957|NCT00315874|Buprenorphine|buprenorphine|mesh-list
6427958|NCT00315874|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6427959|NCT00315874|Narcotics|narcotics|mesh-ancestor
6427960|NCT00315874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6427961|NCT00315874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427962|NCT00315874|Analgesics|analgesics|mesh-ancestor
6427963|NCT00315874|Sensory System Agents|sensory system agents|mesh-ancestor
6427964|NCT00315874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6427965|NCT00315874|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6427966|NCT00315887|Buprenorphine|buprenorphine|mesh-list
6427967|NCT00315887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6427968|NCT00315887|Narcotics|narcotics|mesh-ancestor
6427969|NCT00315887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6427970|NCT00315887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427971|NCT00315887|Analgesics|analgesics|mesh-ancestor
6427972|NCT00315887|Sensory System Agents|sensory system agents|mesh-ancestor
6427973|NCT00315887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6427974|NCT00315887|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6427975|NCT00315900|Valproic Acid|valproic acid|mesh-list
6427976|NCT00315900|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6427977|NCT00315900|Antidepressive Agents|antidepressive agents|mesh-ancestor
6538979|NCT00830895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6538980|NCT00830895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6538981|NCT00830895|Immunologic Factors|immunologic factors|mesh-ancestor
6538982|NCT00830895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538983|NCT00831103|Valacyclovir|valacyclovir|mesh-list
6538984|NCT00831103|Antiviral Agents|antiviral agents|mesh-ancestor
6538985|NCT00831103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6538986|NCT00831155|Nicotine|nicotine|mesh-list
6538987|NCT00831155|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6538988|NCT00831155|Autonomic Agents|autonomic agents|mesh-ancestor
6538989|NCT00831155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6538990|NCT00831155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6538991|NCT00831155|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6538992|NCT00831155|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6538993|NCT00831155|Cholinergic Agents|cholinergic agents|mesh-ancestor
6538994|NCT00831155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6538995|NCT00831155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6538996|NCT00831350|Ranibizumab|ranibizumab|mesh-list
6538997|NCT00831350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6538998|NCT00831350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6538999|NCT00831350|Growth Substances|growth substances|mesh-ancestor
6539000|NCT00831350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539001|NCT00831350|Growth Inhibitors|growth inhibitors|mesh-ancestor
6539002|NCT00831350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6539003|NCT00831376|Albuterol|albuterol|mesh-list
6539004|NCT00831376|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6539005|NCT00831376|Autonomic Agents|autonomic agents|mesh-ancestor
6539006|NCT00831376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6539007|NCT00831376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427978|NCT00315900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6427979|NCT00315900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6427980|NCT00315900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6427981|NCT00315900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6427982|NCT00315900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427983|NCT00315900|Anticonvulsants|anticonvulsants|mesh-ancestor
6427984|NCT00315900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6427985|NCT00315900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427986|NCT00315900|GABA Agents|gaba agents|mesh-ancestor
6427987|NCT00315900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6427988|NCT00315900|Antimanic Agents|antimanic agents|mesh-ancestor
6427989|NCT00315913|Propranolol|propranolol|mesh-list
6427990|NCT00315913|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6427991|NCT00315913|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6427992|NCT00315913|Adrenergic Agents|adrenergic agents|mesh-ancestor
6427993|NCT00315913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6427994|NCT00315913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6427995|NCT00315913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6427996|NCT00315913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6427997|NCT00315913|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6427998|NCT00315913|Vasodilator Agents|vasodilator agents|mesh-ancestor
6427999|NCT00315926|Melatonin|melatonin|mesh-list
6428000|NCT00315926|Antioxidants|antioxidants|mesh-ancestor
6428001|NCT00315926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428002|NCT00315926|Protective Agents|protective agents|mesh-ancestor
6428003|NCT00315926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428004|NCT00315926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6428005|NCT00315965|Nitric Oxide|nitric oxide|mesh-list
6428006|NCT00315965|Carbon Monoxide|carbon monoxide|mesh-list
6428007|NCT00315965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6428008|NCT00315965|Autonomic Agents|autonomic agents|mesh-ancestor
6428009|NCT00315965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6428010|NCT00315965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428011|NCT00315965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6428012|NCT00315965|Respiratory System Agents|respiratory system agents|mesh-ancestor
6539008|NCT00831376|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6539009|NCT00831376|Respiratory System Agents|respiratory system agents|mesh-ancestor
6539010|NCT00831376|Tocolytic Agents|tocolytic agents|mesh-ancestor
6539011|NCT00831376|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6539012|NCT00831376|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6539013|NCT00831376|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6539014|NCT00831376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6539015|NCT00831376|Adrenergic Agents|adrenergic agents|mesh-ancestor
6539016|NCT00831376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6539017|NCT00831376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539018|NCT00831506|Digoxin|digoxin|mesh-list
6539019|NCT00831506|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6539020|NCT00831506|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6539021|NCT00831506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6539022|NCT00831506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539023|NCT00831506|Protective Agents|protective agents|mesh-ancestor
6539024|NCT00831506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539025|NCT00831545|Temozolomide|temozolomide|mesh-list
6539026|NCT00831545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6539027|NCT00831545|Alkylating Agents|alkylating agents|mesh-ancestor
6539028|NCT00831545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539029|NCT00831545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6539030|NCT00831597|Rituximab|rituximab|mesh-list
6539031|NCT00831597|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6539032|NCT00831597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6539033|NCT00831597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6428013|NCT00315965|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6428014|NCT00315965|Antioxidants|antioxidants|mesh-ancestor
6428015|NCT00315965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428016|NCT00315965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6428017|NCT00315965|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6428018|NCT00315965|Vasodilator Agents|vasodilator agents|mesh-ancestor
6428019|NCT00315965|Gasotransmitters|gasotransmitters|mesh-ancestor
6428020|NCT00315965|Protective Agents|protective agents|mesh-ancestor
6428021|NCT00315965|Antimetabolites|antimetabolites|mesh-ancestor
6428022|NCT00316030|Bexarotene|bexarotene|mesh-list
6428023|NCT00316030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6428024|NCT00316095|Telmisartan|telmisartan|mesh-list
6428025|NCT00316095|Simvastatin|simvastatin|mesh-list
6428026|NCT00316095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6428027|NCT00316095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6428028|NCT00316095|Antimetabolites|antimetabolites|mesh-ancestor
6428029|NCT00316095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428030|NCT00316095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6428031|NCT00316095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6428032|NCT00316095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6428033|NCT00316095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6428034|NCT00316095|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6428035|NCT00316095|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6428036|NCT00316160|Bupropion|bupropion|mesh-list
6428037|NCT00316160|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6428038|NCT00316160|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6428039|NCT00316160|Antidepressive Agents|antidepressive agents|mesh-ancestor
6428040|NCT00316160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6428041|NCT00316160|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6428042|NCT00316160|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6428043|NCT00316160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6428044|NCT00316160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428045|NCT00316160|Dopamine Agents|dopamine agents|mesh-ancestor
6428046|NCT00316160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6428047|NCT00316160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428048|NCT00316160|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6428049|NCT00316160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6428050|NCT00316160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6428051|NCT00316160|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6428052|NCT00316212|INS 50589|ins 50589|mesh-list
6428053|NCT00316212|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6428054|NCT00316212|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6428055|NCT00316212|Purinergic Agents|purinergic agents|mesh-ancestor
6428056|NCT00316212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6428057|NCT00316212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428058|NCT00316212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428059|NCT00316238|Olanzapine|olanzapine|mesh-list
6428060|NCT00316238|Antiemetics|antiemetics|mesh-ancestor
6428061|NCT00316238|Autonomic Agents|autonomic agents|mesh-ancestor
6428062|NCT00316238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6539034|NCT00831597|Immunologic Factors|immunologic factors|mesh-ancestor
6539035|NCT00831597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539036|NCT00831597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6539037|NCT00831597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6539038|NCT00831597|Alkylating Agents|alkylating agents|mesh-ancestor
6539039|NCT00831597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539040|NCT00831636|Cytarabine|cytarabine|mesh-list
6539041|NCT00831636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6539042|NCT00831636|Antimetabolites|antimetabolites|mesh-ancestor
6655394|NCT01463735|Protective Agents|protective agents|mesh-ancestor
6428063|NCT00316238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428064|NCT00316238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6428065|NCT00316238|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6428066|NCT00316238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6428067|NCT00316238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6428068|NCT00316238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6428069|NCT00316238|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6428070|NCT00316238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6428071|NCT00316238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6428072|NCT00316238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428073|NCT00316238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6428074|NCT00316238|Serotonin Agents|serotonin agents|mesh-ancestor
6428075|NCT00316329|Artesunate|artesunate|mesh-list
6428076|NCT00316329|Amodiaquine|amodiaquine|mesh-list
6428077|NCT00316329|Antimalarials|antimalarials|mesh-ancestor
6428078|NCT00316329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6428079|NCT00316329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6428080|NCT00316329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6428081|NCT00316329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6428082|NCT00316329|Antiviral Agents|antiviral agents|mesh-ancestor
6428083|NCT00316329|Schistosomicides|schistosomicides|mesh-ancestor
6428084|NCT00316329|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6428085|NCT00316329|Anthelmintics|anthelmintics|mesh-ancestor
6428086|NCT00316407|Paclitaxel|paclitaxel|mesh-list
6428087|NCT00316407|Carboplatin|carboplatin|mesh-list
6428088|NCT00316407|Lapatinib|lapatinib|mesh-list
6428089|NCT00316407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6428090|NCT00316407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6428091|NCT00316407|Tubulin Modulators|tubulin modulators|mesh-ancestor
6428092|NCT00316407|Antimitotic Agents|antimitotic agents|mesh-ancestor
6428093|NCT00316407|Mitosis Modulators|mitosis modulators|mesh-ancestor
6428094|NCT00316407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428095|NCT00316407|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6428096|NCT00316407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6428097|NCT00316420|Gemcitabine|gemcitabine|mesh-list
6428098|NCT00316420|Capecitabine|capecitabine|mesh-list
6428099|NCT00316420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6428100|NCT00316420|Antimetabolites|antimetabolites|mesh-ancestor
6428101|NCT00316420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428102|NCT00316420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6428103|NCT00316420|Antiviral Agents|antiviral agents|mesh-ancestor
6428104|NCT00316420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6428105|NCT00316420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6428106|NCT00316420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6428107|NCT00316420|Immunologic Factors|immunologic factors|mesh-ancestor
6428108|NCT00316420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428109|NCT00316433|Oxaliplatin|oxaliplatin|mesh-list
6428110|NCT00316433|Irinotecan|irinotecan|mesh-list
6428111|NCT00316433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6428112|NCT00316433|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6428113|NCT00316433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6428114|NCT00316433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6428115|NCT00316433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428116|NCT00316472|Niacinamide|niacinamide|mesh-list
6428117|NCT00316472|Niacin|niacin|mesh-list
6428118|NCT00316472|Nicotinic Acids|nicotinic acids|mesh-list
6428119|NCT00316472|Vitamin B Complex|vitamin b complex|mesh-ancestor
6428120|NCT00316472|Vitamins|vitamins|mesh-ancestor
6428121|NCT00316472|Micronutrients|micronutrients|mesh-ancestor
6539043|NCT00831636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539044|NCT00831636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6539045|NCT00831636|Antiviral Agents|antiviral agents|mesh-ancestor
6539046|NCT00831636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6539047|NCT00831636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6539048|NCT00831636|Immunologic Factors|immunologic factors|mesh-ancestor
6539049|NCT00831636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539050|NCT00831649|Natalizumab|natalizumab|mesh-list
6539051|NCT00831649|Immunologic Factors|immunologic factors|mesh-ancestor
6539052|NCT00831649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539053|NCT00831714|Rivaroxaban|rivaroxaban|mesh-list
6539054|NCT00831714|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6539055|NCT00831714|Antithrombins|antithrombins|mesh-ancestor
6539056|NCT00831714|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6539057|NCT00831714|Protease Inhibitors|protease inhibitors|mesh-ancestor
6539058|NCT00831714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6539059|NCT00831714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539060|NCT00831714|Anticoagulants|anticoagulants|mesh-ancestor
6655395|NCT01463774|Metformin|metformin|mesh-list
6655396|NCT01463774|Canagliflozin|canagliflozin|mesh-list
6655397|NCT01463774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6655398|NCT01463774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655399|NCT01463774|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6655400|NCT01463774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655401|NCT01463813|Vitamin D|vitamin d|mesh-list
6655402|NCT01463813|Ergocalciferols|ergocalciferols|mesh-list
6655403|NCT01463813|Cholecalciferol|cholecalciferol|mesh-list
6655404|NCT01463813|Vitamins|vitamins|mesh-list
6655405|NCT01463813|Micronutrients|micronutrients|mesh-ancestor
6655406|NCT01463813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655407|NCT01463813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6655408|NCT01463813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6655409|NCT01463852|Vincristine|vincristine|mesh-list
6655410|NCT01463852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6655411|NCT01463852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6655412|NCT01463852|Tubulin Modulators|tubulin modulators|mesh-ancestor
6655413|NCT01463852|Antimitotic Agents|antimitotic agents|mesh-ancestor
6655414|NCT01463852|Mitosis Modulators|mitosis modulators|mesh-ancestor
6655415|NCT01463852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655416|NCT01463865|Ropivacaine|ropivacaine|mesh-list
6655417|NCT01463865|Anesthetics, Local|anesthetics, local|mesh-ancestor
6655418|NCT01463865|Anesthetics|anesthetics|mesh-ancestor
6655419|NCT01463865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6655420|NCT01463865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655421|NCT01463865|Sensory System Agents|sensory system agents|mesh-ancestor
6655422|NCT01463865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6655423|NCT01463956|Interferons|interferons|mesh-list
6655424|NCT01463956|Ribavirin|ribavirin|mesh-list
6655425|NCT01463956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6655426|NCT01463956|Antiviral Agents|antiviral agents|mesh-ancestor
6655427|NCT01463956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6655428|NCT01463956|Antimetabolites|antimetabolites|mesh-ancestor
6655429|NCT01463956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655430|NCT01464008|Interferons|interferons|mesh-list
6428122|NCT00316472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655431|NCT01464008|Ribavirin|ribavirin|mesh-list
6428123|NCT00316472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6428124|NCT00316472|Antimetabolites|antimetabolites|mesh-ancestor
6428125|NCT00316472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428126|NCT00316472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6428127|NCT00316472|Vasodilator Agents|vasodilator agents|mesh-ancestor
6428128|NCT00316498|Miglustat|miglustat|mesh-list
6428129|NCT00316498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6428130|NCT00316498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428131|NCT00316498|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6428132|NCT00316498|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6428133|NCT00316498|Antiviral Agents|antiviral agents|mesh-ancestor
6428134|NCT00316498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6428135|NCT00316498|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6428136|NCT00316498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6428137|NCT00316498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428138|NCT00316563|Dronabinol|dronabinol|mesh-list
6428139|NCT00316563|Hallucinogens|hallucinogens|mesh-ancestor
6428140|NCT00316563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428141|NCT00316563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6428142|NCT00316563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6428143|NCT00316563|Analgesics|analgesics|mesh-ancestor
6428144|NCT00316563|Sensory System Agents|sensory system agents|mesh-ancestor
6428145|NCT00316563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6428146|NCT00316563|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6428147|NCT00316563|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6428148|NCT00316563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6428149|NCT00316563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428150|NCT00316563|Hormones|hormones|mesh-ancestor
6428151|NCT00316563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6428152|NCT00316680|Vaccines|vaccines|mesh-list
6428153|NCT00316680|Immunologic Factors|immunologic factors|mesh-ancestor
6428154|NCT00316680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428155|NCT00316745|Leucovorin|leucovorin|mesh-list
6428156|NCT00316745|Fluorouracil|fluorouracil|mesh-list
6428157|NCT00316745|Oxaliplatin|oxaliplatin|mesh-list
6428158|NCT00316745|Irinotecan|irinotecan|mesh-list
6428159|NCT00316745|Antimetabolites|antimetabolites|mesh-ancestor
6428160|NCT00316745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428161|NCT00316745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6428162|NCT00316745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6428163|NCT00316745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6428164|NCT00316745|Immunologic Factors|immunologic factors|mesh-ancestor
6428165|NCT00316745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428166|NCT00316745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6428167|NCT00316745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6428168|NCT00316745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6428169|NCT00316745|Antidotes|antidotes|mesh-ancestor
6428170|NCT00316745|Protective Agents|protective agents|mesh-ancestor
6428171|NCT00316745|Vitamin B Complex|vitamin b complex|mesh-ancestor
6428172|NCT00316745|Vitamins|vitamins|mesh-ancestor
6428173|NCT00316745|Micronutrients|micronutrients|mesh-ancestor
6428174|NCT00316758|Metformin|metformin|mesh-list
6428175|NCT00316758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6428176|NCT00316758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428177|NCT00316810|Alemtuzumab|alemtuzumab|mesh-list
6428178|NCT00316810|Thymoglobulin|thymoglobulin|mesh-list
6428179|NCT00316810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6428180|NCT00316810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6428181|NCT00316810|Immunologic Factors|immunologic factors|mesh-ancestor
6428182|NCT00316810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428183|NCT00316810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6428184|NCT00316849|Sirolimus|sirolimus|mesh-list
6428185|NCT00316849|Temozolomide|temozolomide|mesh-list
6428186|NCT00316849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6428187|NCT00316849|Alkylating Agents|alkylating agents|mesh-ancestor
6428188|NCT00316849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428189|NCT00316849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6428190|NCT00316849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6428191|NCT00316849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6428192|NCT00316849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6428193|NCT00316849|Antifungal Agents|antifungal agents|mesh-ancestor
6428194|NCT00316849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6428195|NCT00316849|Immunologic Factors|immunologic factors|mesh-ancestor
6428196|NCT00316849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428197|NCT00316875|Doxorubicin|doxorubicin|mesh-list
6428198|NCT00316875|Lapatinib|lapatinib|mesh-list
6428199|NCT00316875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6428200|NCT00316875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6428201|NCT00316875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6428202|NCT00316875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6428203|NCT00316875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6428204|NCT00316875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428205|NCT00316875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6428206|NCT00316901|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6428207|NCT00316901|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6428208|NCT00316901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428209|NCT00316927|Aspirin|aspirin|mesh-list
6428210|NCT00316927|Dexamethasone|dexamethasone|mesh-list
6428211|NCT00316927|Fosfestrol|fosfestrol|mesh-list
6428212|NCT00316927|Diethylstilbestrol|diethylstilbestrol|mesh-list
6428213|NCT00316927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6428214|NCT00316927|Antiemetics|antiemetics|mesh-ancestor
6428215|NCT00316927|Autonomic Agents|autonomic agents|mesh-ancestor
6428216|NCT00316927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6428217|NCT00316927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428218|NCT00316927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6428219|NCT00316927|Glucocorticoids|glucocorticoids|mesh-ancestor
6428220|NCT00316927|Hormones|hormones|mesh-ancestor
6428221|NCT00316927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6428222|NCT00316927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6428223|NCT00316927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6539061|NCT00831857|Bevacizumab|bevacizumab|mesh-list
6428224|NCT00316927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6428225|NCT00316927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6428226|NCT00316927|Analgesics|analgesics|mesh-ancestor
6428227|NCT00316927|Sensory System Agents|sensory system agents|mesh-ancestor
6428228|NCT00316927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6428229|NCT00316927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6428230|NCT00316927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6428231|NCT00316927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428232|NCT00316927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6428233|NCT00316927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6428234|NCT00316927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6428235|NCT00316927|Antipyretics|antipyretics|mesh-ancestor
6428236|NCT00316927|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6428237|NCT00316927|Estrogens|estrogens|mesh-ancestor
6428238|NCT00316940|Bortezomib|bortezomib|mesh-list
6428239|NCT00316940|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
6428240|NCT00316940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6428241|NCT00316940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6428242|NCT00316940|Analgesics|analgesics|mesh-ancestor
6428243|NCT00316940|Sensory System Agents|sensory system agents|mesh-ancestor
6428244|NCT00316940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6428245|NCT00316940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428246|NCT00316953|Dasatinib|dasatinib|mesh-list
6428247|NCT00316953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6428248|NCT00316953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6428249|NCT00316953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6428250|NCT00316953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460789|NCT00451594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6460790|NCT00451620|Glyburide|glyburide|mesh-list
6460791|NCT00451620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6460792|NCT00451620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460793|NCT00451646|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6460794|NCT00451646|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6460795|NCT00451646|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6460796|NCT00451646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6460797|NCT00451672|Bromocriptine|bromocriptine|mesh-list
6460798|NCT00451672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6460799|NCT00451672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6460800|NCT00451672|Hormone Antagonists|hormone antagonists|mesh-ancestor
6460801|NCT00451672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6460802|NCT00451672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460803|NCT00451672|Dopamine Agonists|dopamine agonists|mesh-ancestor
6539062|NCT00831857|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
6539063|NCT00831857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6539064|NCT00831857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6539065|NCT00831857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6539066|NCT00831857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6539067|NCT00831857|Growth Substances|growth substances|mesh-ancestor
6539068|NCT00831857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539069|NCT00831857|Growth Inhibitors|growth inhibitors|mesh-ancestor
6539070|NCT00831857|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6539071|NCT00831857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539072|NCT00832013|Propofol|propofol|mesh-list
6539073|NCT00832013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6539074|NCT00832013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6539075|NCT00832013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539076|NCT00832013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6428251|NCT00317031|Naltrexone|naltrexone|mesh-list
6428252|NCT00317031|Acamprosate|acamprosate|mesh-list
6428253|NCT00317031|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6428254|NCT00317031|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6428255|NCT00317031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428256|NCT00317031|Sensory System Agents|sensory system agents|mesh-ancestor
6428257|NCT00317031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6428258|NCT00317070|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
6428259|NCT00317070|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6428260|NCT00317070|Protective Agents|protective agents|mesh-ancestor
6428261|NCT00317070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428262|NCT00317070|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6428263|NCT00317070|Antioxidants|antioxidants|mesh-ancestor
6428264|NCT00317070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428265|NCT00317096|Rituximab|rituximab|mesh-list
6428266|NCT00317096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6428267|NCT00317096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6428268|NCT00317096|Immunologic Factors|immunologic factors|mesh-ancestor
6428269|NCT00317096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428270|NCT00317096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6428271|NCT00317135|Vaccines|vaccines|mesh-list
6428272|NCT00317135|Immunologic Factors|immunologic factors|mesh-ancestor
6428273|NCT00317135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428274|NCT00317187|Vaccines|vaccines|mesh-list
6428275|NCT00317187|Immunologic Factors|immunologic factors|mesh-ancestor
6428276|NCT00317187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428277|NCT00317200|Paclitaxel|paclitaxel|mesh-list
6428278|NCT00317200|Bevacizumab|bevacizumab|mesh-list
6428279|NCT00317200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6428280|NCT00317200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6428281|NCT00317200|Tubulin Modulators|tubulin modulators|mesh-ancestor
6428282|NCT00317200|Antimitotic Agents|antimitotic agents|mesh-ancestor
6428283|NCT00317200|Mitosis Modulators|mitosis modulators|mesh-ancestor
6428284|NCT00317200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428285|NCT00317200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6428286|NCT00317200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6428287|NCT00317200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6428288|NCT00317200|Growth Substances|growth substances|mesh-ancestor
6428289|NCT00317200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428290|NCT00317200|Growth Inhibitors|growth inhibitors|mesh-ancestor
6428291|NCT00317252|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6428292|NCT00317252|Protease Inhibitors|protease inhibitors|mesh-ancestor
6428293|NCT00317252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6428294|NCT00317252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428295|NCT00317330|Rifampin|rifampin|mesh-list
6428296|NCT00317330|Isoniazid|isoniazid|mesh-list
6428297|NCT00317330|Pyrazinamide|pyrazinamide|mesh-list
6428298|NCT00317330|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6428299|NCT00317330|Antitubercular Agents|antitubercular agents|mesh-ancestor
6428300|NCT00317330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6428301|NCT00317330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6428302|NCT00317330|Leprostatic Agents|leprostatic agents|mesh-ancestor
6428303|NCT00317330|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6428304|NCT00317330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6428305|NCT00317330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428306|NCT00317330|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6428307|NCT00317330|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6428308|NCT00317330|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6428309|NCT00317330|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6428310|NCT00317330|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6428311|NCT00317330|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6428312|NCT00317330|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6428313|NCT00317330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6428314|NCT00317330|Antimetabolites|antimetabolites|mesh-ancestor
6428315|NCT00317330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6428316|NCT00317343|Anticoagulants|anticoagulants|mesh-list
6428317|NCT00317343|Bivalirudin|bivalirudin|mesh-list
6428318|NCT00317343|Thrombin|thrombin|mesh-list
6428319|NCT00317343|Antithrombins|antithrombins|mesh-ancestor
6428320|NCT00317343|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6428321|NCT00317343|Protease Inhibitors|protease inhibitors|mesh-ancestor
6428322|NCT00317343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6428323|NCT00317343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428324|NCT00317343|Hemostatics|hemostatics|mesh-ancestor
6428325|NCT00317343|Coagulants|coagulants|mesh-ancestor
6428326|NCT00317408|Leucovorin|leucovorin|mesh-list
6428327|NCT00317408|Cytarabine|cytarabine|mesh-list
6428328|NCT00317408|Cyclosporine|cyclosporine|mesh-list
6428329|NCT00317408|Dexamethasone|dexamethasone|mesh-list
6428330|NCT00317408|Prednisolone|prednisolone|mesh-list
6428331|NCT00317408|Carboplatin|carboplatin|mesh-list
6428332|NCT00317408|Methotrexate|methotrexate|mesh-list
6428333|NCT00317408|Etoposide|etoposide|mesh-list
6428334|NCT00317408|Melphalan|melphalan|mesh-list
6428335|NCT00317408|Busulfan|busulfan|mesh-list
6428336|NCT00317408|Ifosfamide|ifosfamide|mesh-list
6428337|NCT00317408|Mitoxantrone|mitoxantrone|mesh-list
6428338|NCT00317408|Thiotepa|thiotepa|mesh-list
6428339|NCT00317408|Idarubicin|idarubicin|mesh-list
6428340|NCT00317408|Carmustine|carmustine|mesh-list
6428341|NCT00317408|Vinblastine|vinblastine|mesh-list
6428342|NCT00317408|Lomustine|lomustine|mesh-list
6428343|NCT00317408|Etoposide phosphate|etoposide phosphate|mesh-list
6428344|NCT00317408|Vindesine|vindesine|mesh-list
6428345|NCT00317408|Cyclosporins|cyclosporins|mesh-list
6428346|NCT00317408|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6539077|NCT00832013|Anesthetics, General|anesthetics, general|mesh-ancestor
6539078|NCT00832013|Anesthetics|anesthetics|mesh-ancestor
6539079|NCT00832039|Selenious Acid|selenious acid|mesh-list
6539080|NCT00832039|Sodium Selenite|sodium selenite|mesh-list
6539081|NCT00832039|Trace Elements|trace elements|mesh-ancestor
6539082|NCT00832039|Micronutrients|micronutrients|mesh-ancestor
6539083|NCT00832039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539084|NCT00832182|Insulin|insulin|mesh-list
6539085|NCT00832182|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6539086|NCT00832182|Insulin Aspart|insulin aspart|mesh-list
6539087|NCT00832182|Isophane Insulin, Human|isophane insulin, human|mesh-list
6539088|NCT00832182|Insulin, Isophane|insulin, isophane|mesh-list
6539089|NCT00832182|Isophane insulin, beef|isophane insulin, beef|mesh-list
6539090|NCT00832182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6539091|NCT00832182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539092|NCT00832208|Amphotericin B|amphotericin b|mesh-list
6539093|NCT00832208|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6539094|NCT00832208|Amebicides|amebicides|mesh-ancestor
6539095|NCT00832208|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6539096|NCT00832208|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6428347|NCT00317408|Levoleucovorin|levoleucovorin|mesh-list
6428348|NCT00317408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6428349|NCT00317408|Antiemetics|antiemetics|mesh-ancestor
6428350|NCT00317408|Autonomic Agents|autonomic agents|mesh-ancestor
6428351|NCT00317408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6428352|NCT00317408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428353|NCT00317408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6428354|NCT00317408|Glucocorticoids|glucocorticoids|mesh-ancestor
6428355|NCT00317408|Hormones|hormones|mesh-ancestor
6539097|NCT00832208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6539098|NCT00832208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6539099|NCT00832208|Antifungal Agents|antifungal agents|mesh-ancestor
6428356|NCT00317408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6428357|NCT00317408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6428358|NCT00317408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6428359|NCT00317408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6428360|NCT00317408|Abortifacient Agents|abortifacient agents|mesh-ancestor
6428361|NCT00317408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6428362|NCT00317408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6428363|NCT00317408|Antimetabolites|antimetabolites|mesh-ancestor
6428364|NCT00317408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428365|NCT00317408|Dermatologic Agents|dermatologic agents|mesh-ancestor
6428366|NCT00317408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6428367|NCT00317408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6428368|NCT00317408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6428369|NCT00317408|Immunologic Factors|immunologic factors|mesh-ancestor
6428370|NCT00317408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6428371|NCT00317408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6428372|NCT00317408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6428373|NCT00317408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6428374|NCT00317408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6428375|NCT00317408|Antiviral Agents|antiviral agents|mesh-ancestor
6428376|NCT00317408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6428377|NCT00317408|Antidotes|antidotes|mesh-ancestor
6428378|NCT00317408|Protective Agents|protective agents|mesh-ancestor
6428379|NCT00317408|Vitamin B Complex|vitamin b complex|mesh-ancestor
6428380|NCT00317408|Vitamins|vitamins|mesh-ancestor
6428381|NCT00317408|Micronutrients|micronutrients|mesh-ancestor
6428382|NCT00317408|Antifungal Agents|antifungal agents|mesh-ancestor
6428383|NCT00317408|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6428384|NCT00317408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6428385|NCT00317408|Alkylating Agents|alkylating agents|mesh-ancestor
6428386|NCT00317408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6428387|NCT00317408|Analgesics|analgesics|mesh-ancestor
6428388|NCT00317408|Sensory System Agents|sensory system agents|mesh-ancestor
6428389|NCT00317408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6428390|NCT00317408|Tubulin Modulators|tubulin modulators|mesh-ancestor
6428391|NCT00317408|Antimitotic Agents|antimitotic agents|mesh-ancestor
6428392|NCT00317408|Mitosis Modulators|mitosis modulators|mesh-ancestor
6428393|NCT00317421|Sildenafil Citrate|sildenafil citrate|mesh-list
6428394|NCT00317421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428395|NCT00317421|Vasodilator Agents|vasodilator agents|mesh-ancestor
6428396|NCT00317421|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6428397|NCT00317421|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6428398|NCT00317421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6428399|NCT00317421|Urological Agents|urological agents|mesh-ancestor
6428400|NCT00317434|Lapatinib|lapatinib|mesh-list
6428401|NCT00317434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6428402|NCT00317434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6428403|NCT00317434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6428404|NCT00317434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428405|NCT00317447|Prednisone|prednisone|mesh-list
6428406|NCT00317447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6428407|NCT00317447|Glucocorticoids|glucocorticoids|mesh-ancestor
6428408|NCT00317447|Hormones|hormones|mesh-ancestor
6428409|NCT00317447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6428410|NCT00317447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428411|NCT00317447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6428412|NCT00317447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6428413|NCT00317499|Etanercept|etanercept|mesh-list
6428414|NCT00317499|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6428415|NCT00317499|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6428416|NCT00317499|Analgesics|analgesics|mesh-ancestor
6428417|NCT00317499|Sensory System Agents|sensory system agents|mesh-ancestor
6428418|NCT00317499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6428419|NCT00317499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428420|NCT00317499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6428421|NCT00317499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6428422|NCT00317499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6428423|NCT00317499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6428424|NCT00317499|Immunologic Factors|immunologic factors|mesh-ancestor
6428425|NCT00317512|HBOC 201|hboc 201|mesh-list
6428426|NCT00317512|Blood Substitutes|blood substitutes|mesh-ancestor
6428427|NCT00317538|Etanercept|etanercept|mesh-list
6428428|NCT00317538|Infliximab|infliximab|mesh-list
6428429|NCT00317538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6428430|NCT00317538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6428431|NCT00317538|Analgesics|analgesics|mesh-ancestor
6428432|NCT00317538|Sensory System Agents|sensory system agents|mesh-ancestor
6428433|NCT00317538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6428434|NCT00317538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428435|NCT00317538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6428436|NCT00317538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6428437|NCT00317538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6428438|NCT00317538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6428439|NCT00317538|Immunologic Factors|immunologic factors|mesh-ancestor
6428440|NCT00317538|Dermatologic Agents|dermatologic agents|mesh-ancestor
6428441|NCT00317577|Timolol|timolol|mesh-list
6428442|NCT00317577|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6428443|NCT00317577|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6428444|NCT00317577|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6428445|NCT00317577|Adrenergic Agents|adrenergic agents|mesh-ancestor
6428446|NCT00317577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6428447|NCT00317577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428448|NCT00317577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428449|NCT00317577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6428450|NCT00317577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6428451|NCT00317577|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6428452|NCT00317577|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6428453|NCT00317577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6428454|NCT00317629|Meglumine Antimoniate|meglumine antimoniate|mesh-list
6428455|NCT00317629|Nitric Oxide|nitric oxide|mesh-list
6428456|NCT00317629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6428457|NCT00317629|Autonomic Agents|autonomic agents|mesh-ancestor
6428458|NCT00317629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6428459|NCT00317629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428460|NCT00317629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6428461|NCT00317629|Respiratory System Agents|respiratory system agents|mesh-ancestor
6428462|NCT00317629|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6428463|NCT00317629|Antioxidants|antioxidants|mesh-ancestor
6428464|NCT00317629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428465|NCT00317629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6428466|NCT00317629|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6428467|NCT00317629|Vasodilator Agents|vasodilator agents|mesh-ancestor
6428468|NCT00317629|Gasotransmitters|gasotransmitters|mesh-ancestor
6428469|NCT00317629|Protective Agents|protective agents|mesh-ancestor
6428470|NCT00317629|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6428471|NCT00317629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6428472|NCT00317629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6428473|NCT00317655|Ibuprofen|ibuprofen|mesh-list
6428474|NCT00317655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6428475|NCT00317655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6428476|NCT00317655|Analgesics|analgesics|mesh-ancestor
6428477|NCT00317655|Sensory System Agents|sensory system agents|mesh-ancestor
6428478|NCT00317655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6428479|NCT00317655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428480|NCT00317655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6428481|NCT00317655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6428482|NCT00317655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6428483|NCT00317655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6428484|NCT00317655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428485|NCT00317681|Tacrolimus|tacrolimus|mesh-list
6428486|NCT00317681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6428487|NCT00317681|Immunologic Factors|immunologic factors|mesh-ancestor
6428488|NCT00317681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428489|NCT00317681|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6428490|NCT00317681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6428491|NCT00317681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428492|NCT00317733|Ketoprofen|ketoprofen|mesh-list
6428493|NCT00317733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6428494|NCT00317733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6428495|NCT00317733|Analgesics|analgesics|mesh-ancestor
6428496|NCT00317733|Sensory System Agents|sensory system agents|mesh-ancestor
6428497|NCT00317733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6428498|NCT00317733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428499|NCT00317733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6428500|NCT00317733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6428501|NCT00317733|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6428502|NCT00317733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6428503|NCT00317733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428504|NCT00317746|Citalopram|citalopram|mesh-list
6428505|NCT00317746|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6428506|NCT00317746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6539100|NCT00832221|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6539101|NCT00832221|Raclopride|raclopride|mesh-list
6539102|NCT00832221|Antidepressive Agents|antidepressive agents|mesh-ancestor
6539103|NCT00832221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6539104|NCT00832221|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6539105|NCT00832221|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6539106|NCT00832221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6539107|NCT00832221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428507|NCT00317746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6428508|NCT00317746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428509|NCT00317746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6428510|NCT00317746|Serotonin Agents|serotonin agents|mesh-ancestor
6428511|NCT00317746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428512|NCT00317746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6428513|NCT00317746|Antidepressive Agents|antidepressive agents|mesh-ancestor
6428514|NCT00317746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6428515|NCT00317759|Fludarabine|fludarabine|mesh-list
6428516|NCT00317759|Fludarabine phosphate|fludarabine phosphate|mesh-list
6428517|NCT00317759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6428518|NCT00317759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6428519|NCT00317759|Antimetabolites|antimetabolites|mesh-ancestor
6428520|NCT00317759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428521|NCT00317759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6428522|NCT00317759|Immunologic Factors|immunologic factors|mesh-ancestor
6428523|NCT00317759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428524|NCT00317785|Cyclosporine|cyclosporine|mesh-list
6428525|NCT00317785|Sirolimus|sirolimus|mesh-list
6428526|NCT00317785|Mycophenolic Acid|mycophenolic acid|mesh-list
6428527|NCT00317785|Cyclophosphamide|cyclophosphamide|mesh-list
6428528|NCT00317785|Methotrexate|methotrexate|mesh-list
6428529|NCT00317785|Tacrolimus|tacrolimus|mesh-list
6428530|NCT00317785|Cyclosporins|cyclosporins|mesh-list
6428531|NCT00317785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6428532|NCT00317785|Immunologic Factors|immunologic factors|mesh-ancestor
6428533|NCT00317785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428534|NCT00317785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6428535|NCT00317785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6428536|NCT00317785|Alkylating Agents|alkylating agents|mesh-ancestor
6428537|NCT00317785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428538|NCT00317785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6428539|NCT00317785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6428540|NCT00317785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6428541|NCT00317785|Abortifacient Agents|abortifacient agents|mesh-ancestor
6428542|NCT00317785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6428543|NCT00317785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6428544|NCT00317785|Antimetabolites|antimetabolites|mesh-ancestor
6428545|NCT00317785|Dermatologic Agents|dermatologic agents|mesh-ancestor
6428546|NCT00317785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6428547|NCT00317785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6428548|NCT00317785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6428549|NCT00317785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6428550|NCT00317785|Antifungal Agents|antifungal agents|mesh-ancestor
6428551|NCT00317785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6428552|NCT00317785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6428553|NCT00317785|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6428554|NCT00317785|Antitubercular Agents|antitubercular agents|mesh-ancestor
6428555|NCT00317785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6428556|NCT00317798|Sirolimus|sirolimus|mesh-list
6428557|NCT00317798|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6428558|NCT00317798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6428559|NCT00317798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6428560|NCT00317798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6428561|NCT00317798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6428562|NCT00317798|Antifungal Agents|antifungal agents|mesh-ancestor
6428563|NCT00317798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6428564|NCT00317798|Immunologic Factors|immunologic factors|mesh-ancestor
6428565|NCT00317798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428566|NCT00317811|Ascorbic Acid|ascorbic acid|mesh-list
6428567|NCT00317811|Bortezomib|bortezomib|mesh-list
6428568|NCT00317811|Melphalan|melphalan|mesh-list
6428569|NCT00317811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6428570|NCT00317811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6428571|NCT00317811|Alkylating Agents|alkylating agents|mesh-ancestor
6428572|NCT00317811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428573|NCT00317811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6428574|NCT00317811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6428575|NCT00317811|Immunologic Factors|immunologic factors|mesh-ancestor
6428576|NCT00317811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428577|NCT00317811|Antioxidants|antioxidants|mesh-ancestor
6428578|NCT00317811|Protective Agents|protective agents|mesh-ancestor
6428579|NCT00317811|Vitamins|vitamins|mesh-ancestor
6428580|NCT00317811|Micronutrients|micronutrients|mesh-ancestor
6428581|NCT00317850|Gabapentin|gabapentin|mesh-list
6428582|NCT00317850|Analgesics|analgesics|mesh-ancestor
6428583|NCT00317850|Sensory System Agents|sensory system agents|mesh-ancestor
6428584|NCT00317850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6428585|NCT00317850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428586|NCT00317850|Anticonvulsants|anticonvulsants|mesh-ancestor
6428587|NCT00317850|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6428588|NCT00317850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6428589|NCT00317850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6428590|NCT00317850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6428591|NCT00317850|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6428592|NCT00317850|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6428593|NCT00317850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6428594|NCT00317850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428595|NCT00317850|Antimanic Agents|antimanic agents|mesh-ancestor
6428596|NCT00317876|Cyclosporine|cyclosporine|mesh-list
6539108|NCT00832221|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6539109|NCT00832221|Dopamine Agents|dopamine agents|mesh-ancestor
6539110|NCT00832221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6539111|NCT00832221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539112|NCT00832234|Dexamethasone|dexamethasone|mesh-list
6539113|NCT00832234|Rituximab|rituximab|mesh-list
6539114|NCT00832234|Bortezomib|bortezomib|mesh-list
6539115|NCT00832234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6539116|NCT00832234|Antiemetics|antiemetics|mesh-ancestor
6539117|NCT00832234|Autonomic Agents|autonomic agents|mesh-ancestor
6539118|NCT00832234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6539119|NCT00832234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539120|NCT00832234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6539121|NCT00832234|Glucocorticoids|glucocorticoids|mesh-ancestor
6428597|NCT00317876|Cyclophosphamide|cyclophosphamide|mesh-list
6428598|NCT00317876|Methotrexate|methotrexate|mesh-list
6428599|NCT00317876|Cyclosporins|cyclosporins|mesh-list
6428600|NCT00317876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6539122|NCT00832234|Hormones|hormones|mesh-ancestor
6428601|NCT00317876|Immunologic Factors|immunologic factors|mesh-ancestor
6428602|NCT00317876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428603|NCT00317876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6428604|NCT00317876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6428605|NCT00317876|Alkylating Agents|alkylating agents|mesh-ancestor
6428606|NCT00317876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428607|NCT00317876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6428608|NCT00317876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6428609|NCT00317876|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6428610|NCT00317876|Abortifacient Agents|abortifacient agents|mesh-ancestor
6428611|NCT00317876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6428612|NCT00317876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6428613|NCT00317876|Antimetabolites|antimetabolites|mesh-ancestor
6428614|NCT00317876|Dermatologic Agents|dermatologic agents|mesh-ancestor
6428615|NCT00317876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6428616|NCT00317876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6428617|NCT00317876|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6428618|NCT00317876|Antifungal Agents|antifungal agents|mesh-ancestor
6428619|NCT00317876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6428620|NCT00317876|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6428621|NCT00317902|Epoetin Alfa|epoetin alfa|mesh-list
6428622|NCT00317902|Hematinics|hematinics|mesh-ancestor
6428623|NCT00317915|Irbesartan|irbesartan|mesh-list
6428624|NCT00317915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6428625|NCT00317915|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6428626|NCT00317915|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6428627|NCT00317915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428628|NCT00317928|Metformin|metformin|mesh-list
6428629|NCT00317928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6428630|NCT00317928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428631|NCT00317954|Spironolactone|spironolactone|mesh-list
6428632|NCT00317954|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6428633|NCT00317954|Hormone Antagonists|hormone antagonists|mesh-ancestor
6428634|NCT00317954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6428635|NCT00317954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428636|NCT00317954|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6428637|NCT00317954|Diuretics|diuretics|mesh-ancestor
6428638|NCT00317954|Natriuretic Agents|natriuretic agents|mesh-ancestor
6428639|NCT00317967|Atorvastatin|atorvastatin|mesh-list
6428640|NCT00317967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6428641|NCT00317967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6428642|NCT00317967|Antimetabolites|antimetabolites|mesh-ancestor
6428643|NCT00317967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428644|NCT00317967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6428645|NCT00317967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6428646|NCT00317967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6428647|NCT00317980|Meglumine Antimoniate|meglumine antimoniate|mesh-list
6428648|NCT00317980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6428649|NCT00317980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6428650|NCT00317980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6428651|NCT00317993|Simvastatin|simvastatin|mesh-list
6428652|NCT00317993|Ezetimibe|ezetimibe|mesh-list
6428653|NCT00317993|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6428654|NCT00317993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6428655|NCT00317993|Antimetabolites|antimetabolites|mesh-ancestor
6428656|NCT00317993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428657|NCT00317993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6428658|NCT00317993|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6428659|NCT00317993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6428660|NCT00318084|Esomeprazole|esomeprazole|mesh-list
6428661|NCT00318084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6428662|NCT00318084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6428663|NCT00318084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6428664|NCT00318084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6428665|NCT00318084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428666|NCT00318162|Naltrexone|naltrexone|mesh-list
6428667|NCT00318162|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6428668|NCT00318162|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6428669|NCT00318162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428670|NCT00318162|Sensory System Agents|sensory system agents|mesh-ancestor
6428671|NCT00318162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6428672|NCT00318175|Bosentan|bosentan|mesh-list
6428673|NCT00318175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6428674|NCT00318175|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6428675|NCT00318175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428676|NCT00318201|Erythromycin|erythromycin|mesh-list
6428677|NCT00318201|Erythromycin Estolate|erythromycin estolate|mesh-list
6428678|NCT00318201|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
6428679|NCT00318201|Erythromycin stearate|erythromycin stearate|mesh-list
6428680|NCT00318201|Diltiazem|diltiazem|mesh-list
6428681|NCT00318201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6428682|NCT00318201|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6428683|NCT00318201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6428684|NCT00318201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428685|NCT00318201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6428686|NCT00318201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428687|NCT00318201|Vasodilator Agents|vasodilator agents|mesh-ancestor
6428688|NCT00318201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6428689|NCT00318201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6428690|NCT00318201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6428691|NCT00318201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6428692|NCT00318201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6428693|NCT00318318|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6428694|NCT00318318|Estrogens|estrogens|mesh-ancestor
6428695|NCT00318318|Hormones|hormones|mesh-ancestor
6428696|NCT00318318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6428697|NCT00318318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428698|NCT00318383|Vaccines|vaccines|mesh-list
6428699|NCT00318383|Immunologic Factors|immunologic factors|mesh-ancestor
6428700|NCT00318383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428701|NCT00318422|Liraglutide|liraglutide|mesh-list
6428702|NCT00318422|Glimepiride|glimepiride|mesh-list
6428703|NCT00318422|Rosiglitazone|rosiglitazone|mesh-list
6428704|NCT00318422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6428705|NCT00318422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428706|NCT00318422|Incretins|incretins|mesh-ancestor
6428707|NCT00318422|Hormones|hormones|mesh-ancestor
6428708|NCT00318422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6428709|NCT00318422|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6428710|NCT00318422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6428711|NCT00318422|Immunologic Factors|immunologic factors|mesh-ancestor
6428712|NCT00318448|Zolpidem|zolpidem|mesh-list
6428713|NCT00318448|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6428714|NCT00318448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6428715|NCT00318448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6428716|NCT00318448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539123|NCT00832234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6539124|NCT00832234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6539125|NCT00832234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6539126|NCT00832234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6539127|NCT00832234|Immunologic Factors|immunologic factors|mesh-ancestor
6539128|NCT00832234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6428717|NCT00318448|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6428718|NCT00318448|GABA Agonists|gaba agonists|mesh-ancestor
6428719|NCT00318448|GABA Agents|gaba agents|mesh-ancestor
6539129|NCT00832286|Ciprofloxacin|ciprofloxacin|mesh-list
6539130|NCT00832286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6539131|NCT00832286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6539132|NCT00832286|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6539133|NCT00832286|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6539134|NCT00832286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6539135|NCT00832286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539136|NCT00832286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6539137|NCT00832286|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6539138|NCT00832286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6539139|NCT00832364|Etanercept|etanercept|mesh-list
6539140|NCT00832364|Acitretin|acitretin|mesh-list
6539141|NCT00832364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6539142|NCT00832364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6539143|NCT00832364|Analgesics|analgesics|mesh-ancestor
6539144|NCT00832364|Sensory System Agents|sensory system agents|mesh-ancestor
6539145|NCT00832364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6539146|NCT00832364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539147|NCT00832364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6539148|NCT00832364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6539149|NCT00832364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6539150|NCT00832364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6539151|NCT00832364|Immunologic Factors|immunologic factors|mesh-ancestor
6539152|NCT00832364|Keratolytic Agents|keratolytic agents|mesh-ancestor
6539153|NCT00832364|Dermatologic Agents|dermatologic agents|mesh-ancestor
6539154|NCT00832429|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
6539155|NCT00832429|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6539156|NCT00832429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539157|NCT00832442|Metoprolol|metoprolol|mesh-list
6428720|NCT00318448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6428721|NCT00318448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428722|NCT00318513|Bevacizumab|bevacizumab|mesh-list
6428723|NCT00318513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6428724|NCT00318513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6428725|NCT00318513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6428726|NCT00318513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6428727|NCT00318513|Growth Substances|growth substances|mesh-ancestor
6019237|NCT00385684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6019238|NCT00385684|Antitussive Agents|antitussive agents|mesh-ancestor
6019239|NCT00385684|Respiratory System Agents|respiratory system agents|mesh-ancestor
6019240|NCT00385684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6019241|NCT00385684|Antipyretics|antipyretics|mesh-ancestor
6019242|NCT00385684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6019243|NCT00385684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6019244|NCT00385684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6019245|NCT00385736|Adalimumab|adalimumab|mesh-list
6019246|NCT00385736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6428728|NCT00318513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428729|NCT00318513|Growth Inhibitors|growth inhibitors|mesh-ancestor
6428730|NCT00318539|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6428731|NCT00318539|Antidepressive Agents|antidepressive agents|mesh-ancestor
6428732|NCT00318539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6428733|NCT00318539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6428734|NCT00318539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6428735|NCT00318539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6428736|NCT00318539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428737|NCT00318552|Meropenem|meropenem|mesh-list
6428738|NCT00318552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6428739|NCT00318552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6428740|NCT00318630|Rosiglitazone|rosiglitazone|mesh-list
6428741|NCT00318630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6428742|NCT00318630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428743|NCT00318669|Paroxetine|paroxetine|mesh-list
6428744|NCT00318669|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6428745|NCT00318669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6428746|NCT00318669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6428747|NCT00318669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428748|NCT00318669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6428749|NCT00318669|Serotonin Agents|serotonin agents|mesh-ancestor
6428750|NCT00318669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428751|NCT00318669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6428752|NCT00318669|Antidepressive Agents|antidepressive agents|mesh-ancestor
6428753|NCT00318669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6428754|NCT00318669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6428755|NCT00318669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6428756|NCT00318669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6460804|NCT00451672|Dopamine Agents|dopamine agents|mesh-ancestor
6460805|NCT00451672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6460806|NCT00451672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460807|NCT00451711|Amphotericin B|amphotericin b|mesh-list
6460808|NCT00451711|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6460809|NCT00451711|Amebicides|amebicides|mesh-ancestor
6460810|NCT00451711|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6460811|NCT00451711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6428757|NCT00318760|Clonidine|clonidine|mesh-list
6428758|NCT00318760|Analgesics|analgesics|mesh-ancestor
6428759|NCT00318760|Sensory System Agents|sensory system agents|mesh-ancestor
6428760|NCT00318760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6428761|NCT00318760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428762|NCT00318760|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6428763|NCT00318760|Sympatholytics|sympatholytics|mesh-ancestor
6428764|NCT00318760|Autonomic Agents|autonomic agents|mesh-ancestor
6428765|NCT00318760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6428766|NCT00318760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6428767|NCT00318760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6428768|NCT00318760|Adrenergic Agents|adrenergic agents|mesh-ancestor
6428769|NCT00318760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6428770|NCT00318760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428771|NCT00318773|Sertraline|sertraline|mesh-list
6428772|NCT00318773|Antidepressive Agents|antidepressive agents|mesh-ancestor
6428773|NCT00318773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6428774|NCT00318773|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6428775|NCT00318773|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6428776|NCT00318773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6428777|NCT00318773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428778|NCT00318773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6428779|NCT00318773|Serotonin Agents|serotonin agents|mesh-ancestor
6428780|NCT00318773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428781|NCT00318786|Insulin Aspart|insulin aspart|mesh-list
6428782|NCT00318786|Biphasic Insulins|biphasic insulins|mesh-list
6428783|NCT00318786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6428784|NCT00318786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428785|NCT00318825|Nitrous Oxide|nitrous oxide|mesh-list
6428786|NCT00318825|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6428787|NCT00318825|Anesthetics, General|anesthetics, general|mesh-ancestor
6428788|NCT00318825|Anesthetics|anesthetics|mesh-ancestor
6428789|NCT00318825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6019247|NCT00385736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6019248|NCT00385762|Paroxetine|paroxetine|mesh-list
6428790|NCT00318825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019249|NCT00385762|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
6428791|NCT00318825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6428792|NCT00318825|Analgesics|analgesics|mesh-ancestor
6428793|NCT00318825|Sensory System Agents|sensory system agents|mesh-ancestor
6428794|NCT00318825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6428795|NCT00318838|Azimilide|azimilide|mesh-list
6428796|NCT00318838|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6428797|NCT00318838|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6428798|NCT00318838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6428799|NCT00318838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428800|NCT00318838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6428801|NCT00318838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428802|NCT00318890|Docetaxel|docetaxel|mesh-list
6428803|NCT00318890|Amifostine|amifostine|mesh-list
6428804|NCT00318890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6428805|NCT00318890|Tubulin Modulators|tubulin modulators|mesh-ancestor
6428806|NCT00318890|Antimitotic Agents|antimitotic agents|mesh-ancestor
6428807|NCT00318890|Mitosis Modulators|mitosis modulators|mesh-ancestor
6428808|NCT00318890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428809|NCT00318890|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6428810|NCT00318890|Protective Agents|protective agents|mesh-ancestor
6428811|NCT00318890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019250|NCT00385762|Serotonin|serotonin|mesh-list
6019251|NCT00385762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6019252|NCT00385762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6019253|NCT00385762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019254|NCT00385762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6019255|NCT00385762|Serotonin Agents|serotonin agents|mesh-ancestor
6019256|NCT00385762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019257|NCT00385762|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6428812|NCT00318903|Docetaxel|docetaxel|mesh-list
6428813|NCT00318903|Irinotecan|irinotecan|mesh-list
6428814|NCT00318903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6428815|NCT00318903|Tubulin Modulators|tubulin modulators|mesh-ancestor
6428816|NCT00318903|Antimitotic Agents|antimitotic agents|mesh-ancestor
6428817|NCT00318903|Mitosis Modulators|mitosis modulators|mesh-ancestor
6019258|NCT00385762|Antidepressive Agents|antidepressive agents|mesh-ancestor
6019259|NCT00385762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6019260|NCT00385762|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6428818|NCT00318903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428819|NCT00318903|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6428820|NCT00318903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6428821|NCT00318903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6428822|NCT00318955|Dexmedetomidine|dexmedetomidine|mesh-list
6428823|NCT00318955|Propofol|propofol|mesh-list
6428824|NCT00318955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6428825|NCT00318955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6428826|NCT00318955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428827|NCT00318955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6428828|NCT00318955|Anesthetics, General|anesthetics, general|mesh-ancestor
6428829|NCT00318955|Anesthetics|anesthetics|mesh-ancestor
6428830|NCT00318955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6428831|NCT00318955|Analgesics|analgesics|mesh-ancestor
6428832|NCT00318955|Sensory System Agents|sensory system agents|mesh-ancestor
6428833|NCT00318955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6428834|NCT00318955|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6428835|NCT00318955|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6019261|NCT00385762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6019262|NCT00385762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6019263|NCT00385762|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6019264|NCT00385788|Gemcitabine|gemcitabine|mesh-list
6019265|NCT00385788|Vidarabine|vidarabine|mesh-list
6019266|NCT00385788|Methotrexate|methotrexate|mesh-list
6019267|NCT00385788|Fludarabine phosphate|fludarabine phosphate|mesh-list
6019268|NCT00385788|Fludarabine|fludarabine|mesh-list
6019269|NCT00385788|Melphalan|melphalan|mesh-list
6019270|NCT00385788|Tacrolimus|tacrolimus|mesh-list
6019271|NCT00385788|Thymoglobulin|thymoglobulin|mesh-list
6019272|NCT00385788|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6428836|NCT00318955|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6428837|NCT00318955|Adrenergic Agents|adrenergic agents|mesh-ancestor
6428838|NCT00318955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6428839|NCT00318955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428840|NCT00318968|Esomeprazole|esomeprazole|mesh-list
6428841|NCT00318968|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6428842|NCT00318968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6428843|NCT00318968|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6019273|NCT00385788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6019274|NCT00385788|Antimetabolites|antimetabolites|mesh-ancestor
6019275|NCT00385788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019276|NCT00385788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6019277|NCT00385788|Antiviral Agents|antiviral agents|mesh-ancestor
6019278|NCT00385788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6019279|NCT00385788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6019280|NCT00385788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6019281|NCT00385788|Immunologic Factors|immunologic factors|mesh-ancestor
6019282|NCT00385788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019283|NCT00385788|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6019284|NCT00385788|Abortifacient Agents|abortifacient agents|mesh-ancestor
6019285|NCT00385788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6019286|NCT00385788|Dermatologic Agents|dermatologic agents|mesh-ancestor
6019287|NCT00385788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6019288|NCT00385788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6019289|NCT00385788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6019290|NCT00385788|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6019291|NCT00385788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6019292|NCT00385788|Alkylating Agents|alkylating agents|mesh-ancestor
6019293|NCT00385788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6019294|NCT00385801|Risperidone|risperidone|mesh-list
6019295|NCT00385801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6019296|NCT00385801|Serotonin Agents|serotonin agents|mesh-ancestor
6019297|NCT00385801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6019298|NCT00385801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019299|NCT00385801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428844|NCT00318968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6428845|NCT00318968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428846|NCT00318981|Methylphenidate|methylphenidate|mesh-list
6428847|NCT00318981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6428848|NCT00318981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428849|NCT00318981|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6428850|NCT00318981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6428851|NCT00318981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6428852|NCT00318981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428853|NCT00318981|Dopamine Agents|dopamine agents|mesh-ancestor
6428854|NCT00318981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6428855|NCT00318994|Meropenem|meropenem|mesh-list
6428856|NCT00318994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6428857|NCT00318994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6428858|NCT00319007|Sulindac|sulindac|mesh-list
6428859|NCT00319007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6428860|NCT00319007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6428861|NCT00319007|Analgesics|analgesics|mesh-ancestor
6428862|NCT00319007|Sensory System Agents|sensory system agents|mesh-ancestor
6428863|NCT00319007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6428864|NCT00319007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428865|NCT00319007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6428866|NCT00319007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6428867|NCT00319007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6428868|NCT00319007|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6428869|NCT00319007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6428870|NCT00319007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428871|NCT00319033|Bosentan|bosentan|mesh-list
6428872|NCT00319033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6428873|NCT00319033|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6428874|NCT00319033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428875|NCT00319059|Annexin A5|annexin a5|mesh-list
6428876|NCT00319059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6428877|NCT00319059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428878|NCT00319072|Hormones|hormones|mesh-list
6428879|NCT00319072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6428880|NCT00319072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428881|NCT00319150|Epoetin Alfa|epoetin alfa|mesh-list
6428882|NCT00319150|Hematinics|hematinics|mesh-ancestor
6428883|NCT00319163|Levonorgestrel|levonorgestrel|mesh-list
6428884|NCT00319163|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6428885|NCT00319163|Estradiol|estradiol|mesh-list
6428886|NCT00319163|Estrogens|estrogens|mesh-ancestor
6428887|NCT00319163|Hormones|hormones|mesh-ancestor
6428888|NCT00319163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6428889|NCT00319163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428890|NCT00319163|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6428891|NCT00319163|Contraceptive Agents|contraceptive agents|mesh-ancestor
6428892|NCT00319163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6428893|NCT00319163|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6428894|NCT00319163|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6428895|NCT00319163|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6428896|NCT00319163|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6428897|NCT00319189|Nateglinide|nateglinide|mesh-list
6428898|NCT00319189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6428899|NCT00319189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428900|NCT00319202|Candesartan|candesartan|mesh-list
6428901|NCT00319202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6428902|NCT00319202|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6428903|NCT00319202|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6428904|NCT00319202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428905|NCT00319215|Zopiclone|zopiclone|mesh-list
6428906|NCT00319215|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6428907|NCT00319215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6428908|NCT00319215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428909|NCT00319267|Bosentan|bosentan|mesh-list
6428910|NCT00319267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6428911|NCT00319267|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6428912|NCT00319267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428913|NCT00319293|Metformin|metformin|mesh-list
6428914|NCT00319293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6428915|NCT00319293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428916|NCT00319306|Budesonide|budesonide|mesh-list
6428917|NCT00319306|Formoterol Fumarate|formoterol fumarate|mesh-list
6428918|NCT00319306|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6428919|NCT00319306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6428920|NCT00319306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6428921|NCT00319306|Autonomic Agents|autonomic agents|mesh-ancestor
6428922|NCT00319306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6428923|NCT00319306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428924|NCT00319306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6428925|NCT00319306|Respiratory System Agents|respiratory system agents|mesh-ancestor
6428926|NCT00319306|Glucocorticoids|glucocorticoids|mesh-ancestor
6428927|NCT00319306|Hormones|hormones|mesh-ancestor
6428928|NCT00319306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6428929|NCT00319306|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6428930|NCT00319306|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6428931|NCT00319306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6428932|NCT00319306|Adrenergic Agents|adrenergic agents|mesh-ancestor
6428933|NCT00319306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6428934|NCT00319306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428935|NCT00319319|Mecamylamine|mecamylamine|mesh-list
6428936|NCT00319319|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6428937|NCT00319319|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
6428938|NCT00319319|Autonomic Agents|autonomic agents|mesh-ancestor
6428939|NCT00319319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6428940|NCT00319319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428941|NCT00319319|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
6428942|NCT00319319|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6428943|NCT00319319|Cholinergic Agents|cholinergic agents|mesh-ancestor
6428944|NCT00319319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6428945|NCT00319319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428946|NCT00319332|Tositumomab I-131|tositumomab i-131|mesh-list
6428947|NCT00319332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6428948|NCT00319345|Mannitol|mannitol|mesh-list
6428949|NCT00319345|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6428950|NCT00319345|Diuretics|diuretics|mesh-ancestor
6428951|NCT00319345|Natriuretic Agents|natriuretic agents|mesh-ancestor
6428952|NCT00319345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428953|NCT00319358|Antioxidants|antioxidants|mesh-list
6539158|NCT00832442|Carvedilol|carvedilol|mesh-list
6428954|NCT00319358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428955|NCT00319358|Protective Agents|protective agents|mesh-ancestor
6428956|NCT00319358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428957|NCT00319488|Budesonide|budesonide|mesh-list
6428958|NCT00319488|Albuterol|albuterol|mesh-list
6428959|NCT00319488|Montelukast|montelukast|mesh-list
6428960|NCT00319488|Leukotriene Antagonists|leukotriene antagonists|mesh-list
6428961|NCT00319488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6428962|NCT00319488|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6428963|NCT00319488|Autonomic Agents|autonomic agents|mesh-ancestor
6428964|NCT00319488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6428965|NCT00319488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428966|NCT00319488|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6428967|NCT00319488|Respiratory System Agents|respiratory system agents|mesh-ancestor
6428968|NCT00319488|Glucocorticoids|glucocorticoids|mesh-ancestor
6428969|NCT00319488|Hormones|hormones|mesh-ancestor
6428970|NCT00319488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6428971|NCT00319488|Hormone Antagonists|hormone antagonists|mesh-ancestor
6428972|NCT00319488|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6428973|NCT00319488|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6460812|NCT00451711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6428974|NCT00319488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428975|NCT00319488|Tocolytic Agents|tocolytic agents|mesh-ancestor
6428976|NCT00319488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6428977|NCT00319488|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6428978|NCT00319488|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6428979|NCT00319488|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6428980|NCT00319488|Adrenergic Agents|adrenergic agents|mesh-ancestor
6428981|NCT00319488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6428982|NCT00319514|Docetaxel|docetaxel|mesh-list
6428983|NCT00319514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6428984|NCT00319514|Tubulin Modulators|tubulin modulators|mesh-ancestor
6428985|NCT00319514|Antimitotic Agents|antimitotic agents|mesh-ancestor
6428986|NCT00319514|Mitosis Modulators|mitosis modulators|mesh-ancestor
6428987|NCT00319514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6428988|NCT00319566|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6428989|NCT00319566|Medroxyprogesterone|medroxyprogesterone|mesh-list
6428990|NCT00319566|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6428991|NCT00319566|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6539159|NCT00832442|Nebivolol|nebivolol|mesh-list
6539160|NCT00832442|Bisoprolol|bisoprolol|mesh-list
6539161|NCT00832442|Bucindolol|bucindolol|mesh-list
6428992|NCT00319566|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6428993|NCT00319566|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6428994|NCT00319566|Contraceptive Agents|contraceptive agents|mesh-ancestor
6428995|NCT00319566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6428996|NCT00319566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6428997|NCT00319566|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6428998|NCT00319566|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6428999|NCT00319566|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6429000|NCT00319566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6429001|NCT00319566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6429002|NCT00319566|Estrogens|estrogens|mesh-ancestor
6429003|NCT00319566|Hormones|hormones|mesh-ancestor
6429004|NCT00319566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6429005|NCT00319605|Levetiracetam|levetiracetam|mesh-list
6429006|NCT00319605|Anticonvulsants|anticonvulsants|mesh-ancestor
6429007|NCT00319605|Nootropic Agents|nootropic agents|mesh-ancestor
6429008|NCT00319618|Docetaxel|docetaxel|mesh-list
6429009|NCT00319618|Gefitinib|gefitinib|mesh-list
6429010|NCT00319618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6429011|NCT00319618|Tubulin Modulators|tubulin modulators|mesh-ancestor
6429012|NCT00319618|Antimitotic Agents|antimitotic agents|mesh-ancestor
6429013|NCT00319618|Mitosis Modulators|mitosis modulators|mesh-ancestor
6429014|NCT00319618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429015|NCT00319618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6429016|NCT00319618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6429017|NCT00319670|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
6429018|NCT00319670|Laxatives|laxatives|mesh-ancestor
6429019|NCT00319670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6429020|NCT00319683|Eniluracil|eniluracil|mesh-list
6429021|NCT00319683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6429022|NCT00319683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429023|NCT00319709|Amibegron|amibegron|mesh-list
6429024|NCT00319709|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6429025|NCT00319709|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6429026|NCT00319709|Adrenergic Agents|adrenergic agents|mesh-ancestor
6429027|NCT00319709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6429028|NCT00319709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429029|NCT00319709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429030|NCT00319761|Calcitriol|calcitriol|mesh-list
6429031|NCT00319761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6429032|NCT00319761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429033|NCT00319761|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6429034|NCT00319761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6460813|NCT00451711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5501373|NCT04475029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429035|NCT00319761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429036|NCT00319761|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6429037|NCT00319761|Vitamins|vitamins|mesh-ancestor
6429038|NCT00319761|Micronutrients|micronutrients|mesh-ancestor
6429039|NCT00319761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6429040|NCT00319787|Gefitinib|gefitinib|mesh-list
6429041|NCT00319787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6429042|NCT00319787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6429043|NCT00319787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6429044|NCT00319787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429045|NCT00319800|Irinotecan|irinotecan|mesh-list
6429046|NCT00319800|Gefitinib|gefitinib|mesh-list
6429047|NCT00319800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6429048|NCT00319800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6429049|NCT00319800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6429050|NCT00319800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429051|NCT00319800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6429052|NCT00319800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6429053|NCT00319852|Vaccines|vaccines|mesh-list
6429054|NCT00319852|Immunologic Factors|immunologic factors|mesh-ancestor
6429055|NCT00319852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429056|NCT00319865|Thalidomide|thalidomide|mesh-list
6429057|NCT00319865|Dexamethasone|dexamethasone|mesh-list
6429058|NCT00319865|Doxorubicin|doxorubicin|mesh-list
6429059|NCT00319865|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6539162|NCT00832442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
6539163|NCT00832442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6539164|NCT00832442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6429060|NCT00319865|Bortezomib|bortezomib|mesh-list
6429061|NCT00319865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6429062|NCT00319865|Antiemetics|antiemetics|mesh-ancestor
6429063|NCT00319865|Autonomic Agents|autonomic agents|mesh-ancestor
6429064|NCT00319865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6429065|NCT00319865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429066|NCT00319865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6429067|NCT00319865|Glucocorticoids|glucocorticoids|mesh-ancestor
6429068|NCT00319865|Hormones|hormones|mesh-ancestor
6429069|NCT00319865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6429070|NCT00319865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6429071|NCT00319865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6429072|NCT00319865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6429073|NCT00319865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6429074|NCT00319865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6429075|NCT00319865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6429076|NCT00319865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429077|NCT00319865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6429078|NCT00319865|Immunologic Factors|immunologic factors|mesh-ancestor
6429079|NCT00319865|Leprostatic Agents|leprostatic agents|mesh-ancestor
6429080|NCT00319865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6429081|NCT00319865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6429082|NCT00319865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6429083|NCT00319865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6429084|NCT00319865|Growth Substances|growth substances|mesh-ancestor
6429085|NCT00319865|Growth Inhibitors|growth inhibitors|mesh-ancestor
6429086|NCT00319878|Cyclosporine|cyclosporine|mesh-list
6429087|NCT00319878|Sirolimus|sirolimus|mesh-list
6429088|NCT00319878|Cyclosporins|cyclosporins|mesh-list
6429089|NCT00319878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6429090|NCT00319878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429091|NCT00319878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6429092|NCT00319878|Immunologic Factors|immunologic factors|mesh-ancestor
6429093|NCT00319878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429094|NCT00319878|Antifungal Agents|antifungal agents|mesh-ancestor
6429095|NCT00319878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6429096|NCT00319878|Dermatologic Agents|dermatologic agents|mesh-ancestor
6429097|NCT00319878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6429098|NCT00319878|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6429099|NCT00319878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6429100|NCT00319878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6429101|NCT00319878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6429102|NCT00319917|Tacrolimus|tacrolimus|mesh-list
6429103|NCT00319917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6429104|NCT00319917|Immunologic Factors|immunologic factors|mesh-ancestor
6429105|NCT00319917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429106|NCT00319917|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6429107|NCT00319917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6429108|NCT00319917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429109|NCT00320021|Pyridoxamine|pyridoxamine|mesh-list
6429110|NCT00320021|Vitamin B Complex|vitamin b complex|mesh-ancestor
6429111|NCT00320021|Vitamins|vitamins|mesh-ancestor
6429112|NCT00320021|Micronutrients|micronutrients|mesh-ancestor
6429113|NCT00320021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429114|NCT00320034|Albuterol|albuterol|mesh-list
6429115|NCT00320034|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6429116|NCT00320034|Autonomic Agents|autonomic agents|mesh-ancestor
6429117|NCT00320034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6429118|NCT00320034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429119|NCT00320034|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6429120|NCT00320034|Respiratory System Agents|respiratory system agents|mesh-ancestor
6429121|NCT00320034|Tocolytic Agents|tocolytic agents|mesh-ancestor
6429122|NCT00320034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6429123|NCT00320034|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6429124|NCT00320034|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6429125|NCT00320034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6429126|NCT00320034|Adrenergic Agents|adrenergic agents|mesh-ancestor
6429127|NCT00320034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6429128|NCT00320034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429129|NCT00320047|Baclofen|baclofen|mesh-list
6429130|NCT00320047|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6429131|NCT00320047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429132|NCT00320047|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6429133|NCT00320047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6429134|NCT00320047|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6429135|NCT00320047|GABA Agonists|gaba agonists|mesh-ancestor
6429136|NCT00320047|GABA Agents|gaba agents|mesh-ancestor
6429137|NCT00320047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6429138|NCT00320047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429139|NCT00320060|Pyridoxamine|pyridoxamine|mesh-list
6429140|NCT00320060|Vitamin B Complex|vitamin b complex|mesh-ancestor
6429141|NCT00320060|Vitamins|vitamins|mesh-ancestor
6429142|NCT00320060|Micronutrients|micronutrients|mesh-ancestor
6429143|NCT00320060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429144|NCT00320073|Pemetrexed|pemetrexed|mesh-list
6429145|NCT00320073|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6429146|NCT00320073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6429147|NCT00320073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6429148|NCT00320073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429149|NCT00320073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6429150|NCT00320073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6429151|NCT00320073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6429152|NCT00320099|Insulin|insulin|mesh-list
6429153|NCT00320099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6429154|NCT00320099|Hydrocortisone|hydrocortisone|mesh-list
6429155|NCT00320099|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6429156|NCT00320099|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6429157|NCT00320099|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6429158|NCT00320099|Fludrocortisone|fludrocortisone|mesh-list
6429159|NCT00320099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6429160|NCT00320099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429161|NCT00320099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6429162|NCT00320125|Calcium|calcium|mesh-list
6429163|NCT00320125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6429164|NCT00320125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429165|NCT00320229|Abciximab|abciximab|mesh-list
6429166|NCT00320229|Anticoagulants|anticoagulants|mesh-ancestor
6429167|NCT00320229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6429168|NCT00320268|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6429169|NCT00320268|Antidepressive Agents|antidepressive agents|mesh-ancestor
6429170|NCT00320268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6429171|NCT00320268|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6429172|NCT00320268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6429173|NCT00320268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6539165|NCT00832442|Sympatholytics|sympatholytics|mesh-ancestor
6539166|NCT00832442|Autonomic Agents|autonomic agents|mesh-ancestor
6539167|NCT00832442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6539168|NCT00832442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539169|NCT00832442|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6539170|NCT00832442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6539171|NCT00832442|Adrenergic Agents|adrenergic agents|mesh-ancestor
6539172|NCT00832442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6539173|NCT00832442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539174|NCT00832442|Antioxidants|antioxidants|mesh-ancestor
6539175|NCT00832442|Protective Agents|protective agents|mesh-ancestor
6539176|NCT00832442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6539177|NCT00832442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6539178|NCT00832442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6539179|NCT00832442|Vasodilator Agents|vasodilator agents|mesh-ancestor
6539180|NCT00832442|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6539181|NCT00832442|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6539182|NCT00832442|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6539183|NCT00832442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6539184|NCT00832442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6539185|NCT00832442|Sympathomimetics|sympathomimetics|mesh-ancestor
6539186|NCT00832481|Metformin|metformin|mesh-list
6539187|NCT00832481|Repaglinide|repaglinide|mesh-list
6539188|NCT00832481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6539189|NCT00832481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539190|NCT00832494|Paclitaxel|paclitaxel|mesh-list
6539191|NCT00832494|Carboplatin|carboplatin|mesh-list
6539192|NCT00832494|Vadimezan|vadimezan|mesh-list
6429174|NCT00320268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429175|NCT00320294|Irinotecan|irinotecan|mesh-list
6429176|NCT00320294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6429177|NCT00320294|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6429178|NCT00320294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6539193|NCT00832494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6539194|NCT00832494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6539195|NCT00832494|Tubulin Modulators|tubulin modulators|mesh-ancestor
6539196|NCT00832494|Antimitotic Agents|antimitotic agents|mesh-ancestor
6429179|NCT00320294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6429180|NCT00320294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429181|NCT00320307|Abacavir|abacavir|mesh-list
6429182|NCT00320307|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6429183|NCT00320307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6429184|NCT00320307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6429185|NCT00320307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429186|NCT00320307|Antiviral Agents|antiviral agents|mesh-ancestor
6429187|NCT00320307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6429188|NCT00320307|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6429189|NCT00320307|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6429190|NCT00320320|Irinotecan|irinotecan|mesh-list
6429191|NCT00320320|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6429192|NCT00320320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6429193|NCT00320320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6429194|NCT00320320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429195|NCT00320320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6429196|NCT00320359|Cisplatin|cisplatin|mesh-list
6429197|NCT00320359|Etoposide|etoposide|mesh-list
6429198|NCT00320359|Topotecan|topotecan|mesh-list
6429199|NCT00320359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6429200|NCT00320359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6429201|NCT00320359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6429202|NCT00320359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6429203|NCT00320359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6429204|NCT00320359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429205|NCT00320359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6429206|NCT00320476|Bortezomib|bortezomib|mesh-list
6429207|NCT00320476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6460814|NCT00451711|Antifungal Agents|antifungal agents|mesh-ancestor
6460815|NCT00451724|Ketamine|ketamine|mesh-list
6460816|NCT00451724|Analgesics|analgesics|mesh-ancestor
6460817|NCT00451724|Sensory System Agents|sensory system agents|mesh-ancestor
6460818|NCT00451724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6460819|NCT00451724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460820|NCT00451724|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6460821|NCT00451724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6460822|NCT00451724|Anesthetics, General|anesthetics, general|mesh-ancestor
6460823|NCT00451724|Anesthetics|anesthetics|mesh-ancestor
6460824|NCT00451724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6460825|NCT00451724|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6460826|NCT00451724|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6460827|NCT00451724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6539197|NCT00832494|Mitosis Modulators|mitosis modulators|mesh-ancestor
6539198|NCT00832494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539199|NCT00832689|Gemcitabine|gemcitabine|mesh-list
6539200|NCT00832689|Irinotecan|irinotecan|mesh-list
6539201|NCT00832689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6539202|NCT00832689|Antimetabolites|antimetabolites|mesh-ancestor
6539203|NCT00832689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539204|NCT00832689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6539205|NCT00832689|Antiviral Agents|antiviral agents|mesh-ancestor
6539206|NCT00832689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6539207|NCT00832689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6539208|NCT00832689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6539209|NCT00832689|Immunologic Factors|immunologic factors|mesh-ancestor
6539210|NCT00832689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539211|NCT00832689|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6539212|NCT00832689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6539213|NCT00832806|Varenicline|varenicline|mesh-list
6539214|NCT00832806|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6539215|NCT00832806|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6539216|NCT00832806|Cholinergic Agents|cholinergic agents|mesh-ancestor
6539217|NCT00832806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6429208|NCT00320567|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6429209|NCT00320567|Norgestimate|norgestimate|mesh-list
6429210|NCT00320567|Estradiol|estradiol|mesh-list
6429211|NCT00320567|Estrogens|estrogens|mesh-ancestor
6429212|NCT00320567|Hormones|hormones|mesh-ancestor
6429213|NCT00320567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6429214|NCT00320567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429215|NCT00320567|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6019300|NCT00385801|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6429216|NCT00320567|Contraceptive Agents|contraceptive agents|mesh-ancestor
6429217|NCT00320567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6429218|NCT00320567|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6429219|NCT00320567|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6429220|NCT00320567|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6429221|NCT00320567|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6429222|NCT00320580|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6429223|NCT00320580|Norelgestromin|norelgestromin|mesh-list
6429224|NCT00320580|Estradiol|estradiol|mesh-list
6429225|NCT00320580|Estrogens|estrogens|mesh-ancestor
6429226|NCT00320580|Hormones|hormones|mesh-ancestor
6429227|NCT00320580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6429228|NCT00320580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429229|NCT00320580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6429230|NCT00320580|Contraceptive Agents|contraceptive agents|mesh-ancestor
6429231|NCT00320580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6429232|NCT00320580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6429233|NCT00320580|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6429234|NCT00320580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6429235|NCT00320619|Aminocaproic Acid|aminocaproic acid|mesh-list
6429236|NCT00320619|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6429237|NCT00320619|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6429238|NCT00320619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429239|NCT00320619|Hemostatics|hemostatics|mesh-ancestor
6429240|NCT00320619|Coagulants|coagulants|mesh-ancestor
6429241|NCT00320632|Desipramine|desipramine|mesh-list
6429242|NCT00320632|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6429243|NCT00320632|Antidepressive Agents|antidepressive agents|mesh-ancestor
6429244|NCT00320632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6429245|NCT00320632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6429246|NCT00320632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429247|NCT00320632|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6429248|NCT00320632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6429249|NCT00320632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6429250|NCT00320632|Adrenergic Agents|adrenergic agents|mesh-ancestor
6429251|NCT00320632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6429252|NCT00320632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429253|NCT00320658|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6429254|NCT00320658|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6429255|NCT00320658|Immunologic Factors|immunologic factors|mesh-ancestor
6429256|NCT00320658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429257|NCT00320658|Antacids|antacids|mesh-ancestor
6019301|NCT00385801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6019302|NCT00385801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6019303|NCT00385801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6019304|NCT00385801|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6429258|NCT00320658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429259|NCT00320658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6429260|NCT00320697|Bupropion|bupropion|mesh-list
6429261|NCT00320697|Nicotine|nicotine|mesh-list
6429262|NCT00320697|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6429263|NCT00320697|Autonomic Agents|autonomic agents|mesh-ancestor
6429264|NCT00320697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6429265|NCT00320697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429266|NCT00320697|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6429267|NCT00320697|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6429268|NCT00320697|Cholinergic Agents|cholinergic agents|mesh-ancestor
6429269|NCT00320697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6429270|NCT00320697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429271|NCT00320697|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6429272|NCT00320697|Antidepressive Agents|antidepressive agents|mesh-ancestor
6539218|NCT00832806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539219|NCT00832806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539220|NCT00832884|Lacosamide|lacosamide|mesh-list
6539221|NCT00832884|Anticonvulsants|anticonvulsants|mesh-ancestor
6539222|NCT00832884|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6539223|NCT00832884|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6539224|NCT00832884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6539225|NCT00832884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539226|NCT00833079|Tacrolimus|tacrolimus|mesh-list
6539227|NCT00833079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6539228|NCT00833079|Immunologic Factors|immunologic factors|mesh-ancestor
6539229|NCT00833079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539230|NCT00833079|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6539231|NCT00833079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6539232|NCT00833079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539233|NCT00833157|Ibuprofen|ibuprofen|mesh-list
6539234|NCT00833157|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6539235|NCT00833157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6539236|NCT00833157|Analgesics|analgesics|mesh-ancestor
6539237|NCT00833157|Sensory System Agents|sensory system agents|mesh-ancestor
6539238|NCT00833157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6539239|NCT00833157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539240|NCT00833157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6539241|NCT00833157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6539242|NCT00833157|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6539243|NCT00833157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6539244|NCT00833157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539245|NCT00833235|Lubricant Eye Drops|lubricant eye drops|mesh-list
6539246|NCT00833235|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6539247|NCT00833235|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6539248|NCT00833300|Haloperidol|haloperidol|mesh-list
6429273|NCT00320697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6429274|NCT00320697|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6429275|NCT00320697|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6429276|NCT00320697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6429277|NCT00320697|Dopamine Agents|dopamine agents|mesh-ancestor
6429278|NCT00320697|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6429279|NCT00320697|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6429280|NCT00320697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6429281|NCT00320723|Bupropion|bupropion|mesh-list
6429282|NCT00320723|Nicotine|nicotine|mesh-list
6429283|NCT00320723|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6429284|NCT00320723|Autonomic Agents|autonomic agents|mesh-ancestor
6429285|NCT00320723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6429286|NCT00320723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429287|NCT00320723|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6429288|NCT00320723|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6429289|NCT00320723|Cholinergic Agents|cholinergic agents|mesh-ancestor
6429290|NCT00320723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6429291|NCT00320723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429292|NCT00320723|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6429293|NCT00320723|Antidepressive Agents|antidepressive agents|mesh-ancestor
6429294|NCT00320723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6429295|NCT00320723|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6429296|NCT00320723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6429297|NCT00320723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6429298|NCT00320723|Dopamine Agents|dopamine agents|mesh-ancestor
6429299|NCT00320723|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6429300|NCT00320723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6429301|NCT00320723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6429302|NCT00320736|Galantamine|galantamine|mesh-list
6429303|NCT00320736|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6429304|NCT00320736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6429305|NCT00320736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429306|NCT00320736|Cholinergic Agents|cholinergic agents|mesh-ancestor
6429307|NCT00320736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6429308|NCT00320736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429309|NCT00320736|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6429310|NCT00320736|Autonomic Agents|autonomic agents|mesh-ancestor
6429311|NCT00320736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6429312|NCT00320736|Nootropic Agents|nootropic agents|mesh-ancestor
6429313|NCT00320775|Aflibercept|aflibercept|mesh-list
6429314|NCT00320775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6429315|NCT00320775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6429316|NCT00320775|Growth Substances|growth substances|mesh-ancestor
6429317|NCT00320775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429318|NCT00320775|Growth Inhibitors|growth inhibitors|mesh-ancestor
6429319|NCT00320775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6429320|NCT00320814|Aflibercept|aflibercept|mesh-list
6429321|NCT00320814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6429322|NCT00320814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6429323|NCT00320814|Growth Substances|growth substances|mesh-ancestor
6429324|NCT00320814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429325|NCT00320814|Growth Inhibitors|growth inhibitors|mesh-ancestor
6429326|NCT00320814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6429327|NCT00320827|Antibodies|antibodies|mesh-list
6429328|NCT00320827|Immunologic Factors|immunologic factors|mesh-ancestor
6429329|NCT00320827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429330|NCT00320853|Vitamin D|vitamin d|mesh-list
6429331|NCT00320853|Vitamins|vitamins|mesh-ancestor
6429332|NCT00320853|Micronutrients|micronutrients|mesh-ancestor
6429333|NCT00320853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539249|NCT00833300|Olanzapine|olanzapine|mesh-list
6539250|NCT00833300|Haloperidol decanoate|haloperidol decanoate|mesh-list
6429334|NCT00320853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6429335|NCT00320879|Irbesartan|irbesartan|mesh-list
6429336|NCT00320879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6429337|NCT00320879|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6429338|NCT00320879|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6429339|NCT00320879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429340|NCT00320892|Atropine|atropine|mesh-list
6429341|NCT00320892|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6429342|NCT00320892|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6429343|NCT00320892|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6429344|NCT00320892|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6429345|NCT00320892|Autonomic Agents|autonomic agents|mesh-ancestor
6429346|NCT00320892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6429347|NCT00320892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429348|NCT00320892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6429349|NCT00320892|Respiratory System Agents|respiratory system agents|mesh-ancestor
6429350|NCT00320892|Mydriatics|mydriatics|mesh-ancestor
6429351|NCT00320892|Parasympatholytics|parasympatholytics|mesh-ancestor
6429352|NCT00320892|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6429353|NCT00320892|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6429354|NCT00320892|Cholinergic Agents|cholinergic agents|mesh-ancestor
6429355|NCT00320892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6429356|NCT00320892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429357|NCT00320892|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6429358|NCT00320970|Candesartan|candesartan|mesh-list
6429359|NCT00320970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6429360|NCT00320970|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6429361|NCT00320970|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6429362|NCT00320970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429363|NCT00320983|Topotecan|topotecan|mesh-list
6429364|NCT00320983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6429365|NCT00320983|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6429366|NCT00320983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6429367|NCT00320983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6429368|NCT00320983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429369|NCT00321009|Enoxaparin|enoxaparin|mesh-list
6429370|NCT00321009|Anticoagulants|anticoagulants|mesh-ancestor
6429371|NCT00321009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6429372|NCT00321009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6429373|NCT00321009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429374|NCT00321074|Tacrolimus|tacrolimus|mesh-list
6429375|NCT00321074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6429376|NCT00321074|Immunologic Factors|immunologic factors|mesh-ancestor
6429377|NCT00321074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429378|NCT00321074|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6429379|NCT00321074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6429380|NCT00321074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539251|NCT00833300|Antiemetics|antiemetics|mesh-ancestor
6539252|NCT00833300|Autonomic Agents|autonomic agents|mesh-ancestor
6539253|NCT00833300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6539254|NCT00833300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539255|NCT00833300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6539256|NCT00833300|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6539257|NCT00833300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6539258|NCT00833300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6429381|NCT00321113|Mycophenolic Acid|mycophenolic acid|mesh-list
6429382|NCT00321113|Tacrolimus|tacrolimus|mesh-list
6429383|NCT00321113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6429384|NCT00321113|Immunologic Factors|immunologic factors|mesh-ancestor
6429385|NCT00321113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429386|NCT00321113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6429387|NCT00321113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6429388|NCT00321113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429389|NCT00321113|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6429390|NCT00321113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6429391|NCT00321113|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6429392|NCT00321113|Antitubercular Agents|antitubercular agents|mesh-ancestor
6429393|NCT00321113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6429394|NCT00321113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6429395|NCT00321126|Zinc|zinc|mesh-list
6429396|NCT00321126|Trace Elements|trace elements|mesh-ancestor
6429397|NCT00321126|Micronutrients|micronutrients|mesh-ancestor
6429398|NCT00321126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429399|NCT00321165|Taurolidine|taurolidine|mesh-list
6429400|NCT00321165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6429401|NCT00321165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6429402|NCT00321165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6429403|NCT00321178|Clarithromycin|clarithromycin|mesh-list
6429404|NCT00321178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6429405|NCT00321178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6429406|NCT00321178|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6429407|NCT00321178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6429408|NCT00321178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429409|NCT00321178|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6429410|NCT00321178|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6429411|NCT00321191|Nitrous Oxide|nitrous oxide|mesh-list
6429412|NCT00321191|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6429413|NCT00321191|Anesthetics, General|anesthetics, general|mesh-ancestor
6429414|NCT00321191|Anesthetics|anesthetics|mesh-ancestor
6429415|NCT00321191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6429416|NCT00321191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429417|NCT00321191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6429418|NCT00321191|Analgesics|analgesics|mesh-ancestor
6429419|NCT00321191|Sensory System Agents|sensory system agents|mesh-ancestor
6429420|NCT00321191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6429421|NCT00321230|Ascorbic Acid|ascorbic acid|mesh-list
6429422|NCT00321230|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
6429423|NCT00321230|Antioxidants|antioxidants|mesh-ancestor
6429424|NCT00321230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429425|NCT00321230|Protective Agents|protective agents|mesh-ancestor
6429426|NCT00321230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429427|NCT00321230|Vitamins|vitamins|mesh-ancestor
6429428|NCT00321230|Micronutrients|micronutrients|mesh-ancestor
6429429|NCT00321230|Laxatives|laxatives|mesh-ancestor
6429430|NCT00321230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6429431|NCT00321347|Lidocaine|lidocaine|mesh-list
6429432|NCT00321347|Anesthetics, Local|anesthetics, local|mesh-ancestor
6429433|NCT00321347|Anesthetics|anesthetics|mesh-ancestor
6429434|NCT00321347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6429435|NCT00321347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429436|NCT00321347|Sensory System Agents|sensory system agents|mesh-ancestor
6429437|NCT00321347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6429438|NCT00321347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6429439|NCT00321347|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6429440|NCT00321347|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6429441|NCT00321347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6429442|NCT00321347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429443|NCT00321360|Propofol|propofol|mesh-list
6429444|NCT00321360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6429445|NCT00321360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6429446|NCT00321360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429447|NCT00321360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6429448|NCT00321360|Anesthetics, General|anesthetics, general|mesh-ancestor
6429449|NCT00321360|Anesthetics|anesthetics|mesh-ancestor
6429450|NCT00321477|Casopitant|casopitant|mesh-list
6429451|NCT00321477|Antiemetics|antiemetics|mesh-ancestor
6429452|NCT00321477|Autonomic Agents|autonomic agents|mesh-ancestor
6429453|NCT00321477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6429454|NCT00321477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429455|NCT00321477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6539259|NCT00833300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6429456|NCT00321477|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6429457|NCT00321477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6429458|NCT00321477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429459|NCT00321490|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6429460|NCT00321490|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6429461|NCT00321490|Antidepressive Agents|antidepressive agents|mesh-ancestor
6539260|NCT00833300|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6429462|NCT00321490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6429463|NCT00321490|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6429464|NCT00321490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6429465|NCT00321490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6429466|NCT00321490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429467|NCT00321490|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6429468|NCT00321490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6429469|NCT00321490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6429470|NCT00321490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429471|NCT00321490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6429472|NCT00321490|Analgesics|analgesics|mesh-ancestor
6429473|NCT00321490|Sensory System Agents|sensory system agents|mesh-ancestor
6429474|NCT00321490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6429475|NCT00321490|Dopamine Agents|dopamine agents|mesh-ancestor
6429476|NCT00321516|Aripiprazole|aripiprazole|mesh-list
6429477|NCT00321516|Antidepressive Agents|antidepressive agents|mesh-ancestor
6429478|NCT00321516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6429479|NCT00321516|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6429480|NCT00321516|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6429481|NCT00321516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6429482|NCT00321516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429483|NCT00321516|Dopamine Agonists|dopamine agonists|mesh-ancestor
6429484|NCT00321516|Dopamine Agents|dopamine agents|mesh-ancestor
6429485|NCT00321516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6429486|NCT00321516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429487|NCT00321516|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6429488|NCT00321516|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6429489|NCT00321516|Serotonin Agents|serotonin agents|mesh-ancestor
6429490|NCT00321516|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6429491|NCT00321516|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6429492|NCT00321516|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6429493|NCT00321516|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6429494|NCT00321581|Cediranib|cediranib|mesh-list
6429495|NCT00321581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6429496|NCT00321581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6429497|NCT00321581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6429498|NCT00321581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429499|NCT00321633|Carboplatin|carboplatin|mesh-list
6429500|NCT00321633|Docetaxel|docetaxel|mesh-list
6429501|NCT00321633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6429502|NCT00321633|Tubulin Modulators|tubulin modulators|mesh-ancestor
6429503|NCT00321633|Antimitotic Agents|antimitotic agents|mesh-ancestor
6429504|NCT00321633|Mitosis Modulators|mitosis modulators|mesh-ancestor
6429505|NCT00321633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429506|NCT00321724|Cediranib|cediranib|mesh-list
6429507|NCT00321724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6429508|NCT00321724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429509|NCT00321724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6429510|NCT00321724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6429511|NCT00321750|Pimecrolimus|pimecrolimus|mesh-list
6429512|NCT00321750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6429513|NCT00321750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6429514|NCT00321750|Analgesics|analgesics|mesh-ancestor
6019305|NCT00385801|Dopamine Agents|dopamine agents|mesh-ancestor
6019306|NCT00385827|Prednisone|prednisone|mesh-list
6019307|NCT00385827|Mitoxantrone|mitoxantrone|mesh-list
6429515|NCT00321750|Sensory System Agents|sensory system agents|mesh-ancestor
6429516|NCT00321750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6429517|NCT00321750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429518|NCT00321750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6429519|NCT00321750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6429520|NCT00321750|Dermatologic Agents|dermatologic agents|mesh-ancestor
6429521|NCT00321750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6429522|NCT00321750|Immunologic Factors|immunologic factors|mesh-ancestor
6429523|NCT00321750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6429524|NCT00321750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6429525|NCT00321750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429526|NCT00321802|Simvastatin|simvastatin|mesh-list
6429527|NCT00321802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6429528|NCT00321802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6429529|NCT00321802|Antimetabolites|antimetabolites|mesh-ancestor
6429530|NCT00321802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429531|NCT00321802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6429532|NCT00321802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6429533|NCT00321802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6429534|NCT00321945|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6429535|NCT00321945|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
6429536|NCT00321945|Protease Inhibitors|protease inhibitors|mesh-ancestor
6429537|NCT00321945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6429538|NCT00321945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429539|NCT00322036|Flurbiprofen|flurbiprofen|mesh-list
6429540|NCT00322036|Analgesics|analgesics|mesh-ancestor
6429541|NCT00322036|Sensory System Agents|sensory system agents|mesh-ancestor
6429542|NCT00322036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6429543|NCT00322036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429544|NCT00322036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6429545|NCT00322036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6429546|NCT00322036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6429547|NCT00322036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6429548|NCT00322036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6429549|NCT00322036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6429550|NCT00322036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539261|NCT00833300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6539262|NCT00833300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6539263|NCT00833300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539264|NCT00833300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6539265|NCT00833300|Serotonin Agents|serotonin agents|mesh-ancestor
6539266|NCT00833300|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6539267|NCT00833300|Dopamine Agents|dopamine agents|mesh-ancestor
6539268|NCT00833300|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6539269|NCT00833326|Docetaxel|docetaxel|mesh-list
6539270|NCT00833326|Antimitotic Agents|antimitotic agents|mesh-list
6539271|NCT00833326|Mitogens|mitogens|mesh-list
6539272|NCT00833326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6539273|NCT00833326|Tubulin Modulators|tubulin modulators|mesh-ancestor
6539274|NCT00833326|Mitosis Modulators|mitosis modulators|mesh-ancestor
6539275|NCT00833326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019308|NCT00385827|Siltuximab|siltuximab|mesh-list
6429551|NCT00322062|Ascorbic Acid|ascorbic acid|mesh-list
6429552|NCT00322062|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
6429553|NCT00322062|Antioxidants|antioxidants|mesh-ancestor
6429554|NCT00322062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429555|NCT00322062|Protective Agents|protective agents|mesh-ancestor
6429556|NCT00322062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429557|NCT00322062|Vitamins|vitamins|mesh-ancestor
6429558|NCT00322062|Micronutrients|micronutrients|mesh-ancestor
6429559|NCT00322062|Laxatives|laxatives|mesh-ancestor
6429560|NCT00322062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6429561|NCT00322075|Insulin Glargine|insulin glargine|mesh-list
6429562|NCT00322075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6429563|NCT00322075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429564|NCT00322114|Lycopene|lycopene|mesh-list
6429565|NCT00322114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6429566|NCT00322114|Antioxidants|antioxidants|mesh-ancestor
6429567|NCT00322114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429568|NCT00322114|Protective Agents|protective agents|mesh-ancestor
6429569|NCT00322114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429570|NCT00322114|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6429571|NCT00322114|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6429572|NCT00322114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6429573|NCT00322127|Plerixafor|plerixafor|mesh-list
6429574|NCT00322127|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6429575|NCT00322127|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6429576|NCT00322127|Antiviral Agents|antiviral agents|mesh-ancestor
6429577|NCT00322127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6429578|NCT00322166|Calcium|calcium|mesh-list
6539276|NCT00833339|Mifepristone|mifepristone|mesh-list
6019309|NCT00385827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6019310|NCT00385827|Glucocorticoids|glucocorticoids|mesh-ancestor
6019311|NCT00385827|Hormones|hormones|mesh-ancestor
6019312|NCT00385827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6019313|NCT00385827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019314|NCT00385827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6019315|NCT00385827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6019316|NCT00385827|Analgesics|analgesics|mesh-ancestor
6019317|NCT00385827|Sensory System Agents|sensory system agents|mesh-ancestor
6019318|NCT00385827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6019319|NCT00385827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6019320|NCT00385827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6019321|NCT00385827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6019322|NCT00385827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053211|NCT00593606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6053212|NCT00593606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053213|NCT00593606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053214|NCT00593645|Cytarabine|cytarabine|mesh-list
6053215|NCT00593645|Clofarabine|clofarabine|mesh-list
6053216|NCT00593645|Thymoglobulin|thymoglobulin|mesh-list
6053217|NCT00593645|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6053218|NCT00593645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6053219|NCT00593645|Antimetabolites|antimetabolites|mesh-ancestor
6053220|NCT00593645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462136|NCT00457769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6429579|NCT00322166|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6429580|NCT00322166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429581|NCT00322296|Bexarotene|bexarotene|mesh-list
6429582|NCT00322296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6429583|NCT00322400|Paclitaxel|paclitaxel|mesh-list
6429584|NCT00322400|Docetaxel|docetaxel|mesh-list
6429585|NCT00322400|Motesanib diphosphate|motesanib diphosphate|mesh-list
6429586|NCT00322400|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6429587|NCT00322400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6429588|NCT00322400|Tubulin Modulators|tubulin modulators|mesh-ancestor
6429589|NCT00322400|Antimitotic Agents|antimitotic agents|mesh-ancestor
6019323|NCT00385944|Clopidogrel|clopidogrel|mesh-list
6019324|NCT00385944|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6019325|NCT00385944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6429590|NCT00322400|Mitosis Modulators|mitosis modulators|mesh-ancestor
6429591|NCT00322400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019326|NCT00385944|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6019327|NCT00385944|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6019328|NCT00385944|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6019329|NCT00385944|Purinergic Agents|purinergic agents|mesh-ancestor
6429592|NCT00322400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6429593|NCT00322400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6429594|NCT00322413|Epoetin Alfa|epoetin alfa|mesh-list
6429595|NCT00322413|Hematinics|hematinics|mesh-ancestor
6429596|NCT00322543|Pimecrolimus|pimecrolimus|mesh-list
6429597|NCT00322543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6429598|NCT00322543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6429599|NCT00322543|Analgesics|analgesics|mesh-ancestor
6429600|NCT00322543|Sensory System Agents|sensory system agents|mesh-ancestor
6429601|NCT00322543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6429602|NCT00322543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429603|NCT00322543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6429604|NCT00322543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6429605|NCT00322543|Dermatologic Agents|dermatologic agents|mesh-ancestor
6429606|NCT00322543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6429607|NCT00322543|Immunologic Factors|immunologic factors|mesh-ancestor
6429608|NCT00322543|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6429609|NCT00322543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6429610|NCT00322543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429611|NCT00322569|Pimecrolimus|pimecrolimus|mesh-list
6429612|NCT00322569|Paclitaxel|paclitaxel|mesh-list
6429613|NCT00322569|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6429614|NCT00322569|Tacrolimus|tacrolimus|mesh-list
6429615|NCT00322569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6429616|NCT00322569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6429617|NCT00322569|Tubulin Modulators|tubulin modulators|mesh-ancestor
6429618|NCT00322569|Antimitotic Agents|antimitotic agents|mesh-ancestor
6429619|NCT00322569|Mitosis Modulators|mitosis modulators|mesh-ancestor
6429620|NCT00322569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429621|NCT00322569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6429622|NCT00322569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6429623|NCT00322569|Analgesics|analgesics|mesh-ancestor
6429624|NCT00322569|Sensory System Agents|sensory system agents|mesh-ancestor
6429625|NCT00322569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6019330|NCT00385944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6019331|NCT00385944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019332|NCT00385944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429626|NCT00322569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429627|NCT00322569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6429628|NCT00322569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6429629|NCT00322569|Dermatologic Agents|dermatologic agents|mesh-ancestor
6429630|NCT00322569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6429631|NCT00322569|Immunologic Factors|immunologic factors|mesh-ancestor
6429632|NCT00322569|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6429633|NCT00322569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6429634|NCT00322595|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6539277|NCT00833339|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6539278|NCT00833339|Abortifacient Agents|abortifacient agents|mesh-ancestor
6539279|NCT00833339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6539280|NCT00833339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539281|NCT00833339|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6539282|NCT00833339|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6539283|NCT00833339|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6539284|NCT00833339|Contraceptive Agents|contraceptive agents|mesh-ancestor
6539285|NCT00833339|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6539286|NCT00833339|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6539287|NCT00833339|Hormone Antagonists|hormone antagonists|mesh-ancestor
6539288|NCT00833339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6539289|NCT00833339|Luteolytic Agents|luteolytic agents|mesh-ancestor
6539290|NCT00833339|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6539291|NCT00833339|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6539292|NCT00833378|Ritonavir|ritonavir|mesh-list
6539293|NCT00833378|Lopinavir|lopinavir|mesh-list
6539294|NCT00833378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6539295|NCT00833378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6539296|NCT00833378|Protease Inhibitors|protease inhibitors|mesh-ancestor
6539297|NCT00833378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6539298|NCT00833378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539299|NCT00833378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6539300|NCT00833378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6019333|NCT00385996|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6019334|NCT00385996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6019335|NCT00385996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6019336|NCT00385996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6019337|NCT00385996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019338|NCT00386009|Tadalafil|tadalafil|mesh-list
6019339|NCT00386009|Vasodilator Agents|vasodilator agents|mesh-ancestor
6019340|NCT00386009|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6019341|NCT00386009|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6019342|NCT00386009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6019343|NCT00386009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019344|NCT00386009|Urological Agents|urological agents|mesh-ancestor
6539301|NCT00833378|Antiviral Agents|antiviral agents|mesh-ancestor
6539302|NCT00833378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6539303|NCT00833378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6539304|NCT00833378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6539305|NCT00833404|Nicotine|nicotine|mesh-list
6539306|NCT00833404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6539307|NCT00833404|Autonomic Agents|autonomic agents|mesh-ancestor
6539308|NCT00833404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6539309|NCT00833404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539310|NCT00833404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6539311|NCT00833404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6539312|NCT00833404|Cholinergic Agents|cholinergic agents|mesh-ancestor
6429635|NCT00322595|Paroxetine|paroxetine|mesh-list
6429636|NCT00322595|Antidepressive Agents|antidepressive agents|mesh-ancestor
6429637|NCT00322595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6429638|NCT00322595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6429639|NCT00322595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6429640|NCT00322595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6429641|NCT00322595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429642|NCT00322595|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6429643|NCT00322595|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6429644|NCT00322595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6429645|NCT00322595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429646|NCT00322595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6429647|NCT00322595|Serotonin Agents|serotonin agents|mesh-ancestor
6429648|NCT00322595|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6429649|NCT00322595|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6429650|NCT00322595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6429651|NCT00322595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6460828|NCT00451724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460829|NCT00451750|Hydrocortisone|hydrocortisone|mesh-list
6460830|NCT00451750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6460831|NCT00451763|Bevacizumab|bevacizumab|mesh-list
6460832|NCT00451763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6460833|NCT00451763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6460834|NCT00451763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6460835|NCT00451763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6460836|NCT00451763|Growth Substances|growth substances|mesh-ancestor
6460837|NCT00451763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460838|NCT00451763|Growth Inhibitors|growth inhibitors|mesh-ancestor
6460839|NCT00451776|Propofol|propofol|mesh-list
6460840|NCT00451776|Etomidate|etomidate|mesh-list
6460841|NCT00451776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6460842|NCT00451776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6460843|NCT00451776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460844|NCT00451776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6460845|NCT00451776|Anesthetics, General|anesthetics, general|mesh-ancestor
6460846|NCT00451776|Anesthetics|anesthetics|mesh-ancestor
6460847|NCT00451815|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
6460848|NCT00451815|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
6460849|NCT00451815|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6460850|NCT00451815|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6460851|NCT00451815|Purinergic Agents|purinergic agents|mesh-ancestor
6460852|NCT00451815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6460853|NCT00451815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460854|NCT00451815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460855|NCT00451828|Simvastatin|simvastatin|mesh-list
6460856|NCT00451828|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6460857|NCT00451828|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6460858|NCT00451828|Antimetabolites|antimetabolites|mesh-ancestor
6460859|NCT00451828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460860|NCT00451828|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6460861|NCT00451828|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6460862|NCT00451828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6460863|NCT00451867|Mycophenolic Acid|mycophenolic acid|mesh-list
6460864|NCT00451867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6460865|NCT00451867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6460866|NCT00451867|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6429652|NCT00322660|Epinephrine|epinephrine|mesh-list
6429653|NCT00322660|Racepinephrine|racepinephrine|mesh-list
6429654|NCT00322660|Epinephryl borate|epinephryl borate|mesh-list
6429655|NCT00322660|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6429656|NCT00322660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6429657|NCT00322660|Adrenergic Agents|adrenergic agents|mesh-ancestor
6429658|NCT00322660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6429659|NCT00322660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429660|NCT00322660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429661|NCT00322660|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6429662|NCT00322660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6429663|NCT00322660|Autonomic Agents|autonomic agents|mesh-ancestor
6429664|NCT00322660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6429665|NCT00322660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6429666|NCT00322660|Respiratory System Agents|respiratory system agents|mesh-ancestor
6429667|NCT00322660|Mydriatics|mydriatics|mesh-ancestor
6429668|NCT00322660|Sympathomimetics|sympathomimetics|mesh-ancestor
6429669|NCT00322660|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6429670|NCT00322699|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
6539313|NCT00833404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6539314|NCT00833404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539315|NCT00833534|Rituximab|rituximab|mesh-list
6539316|NCT00833534|Lenalidomide|lenalidomide|mesh-list
6539317|NCT00833534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6539318|NCT00833534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6539319|NCT00833534|Immunologic Factors|immunologic factors|mesh-ancestor
6539320|NCT00833534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539321|NCT00833534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6539322|NCT00833534|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6539323|NCT00833534|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6539324|NCT00833534|Growth Substances|growth substances|mesh-ancestor
6539325|NCT00833534|Growth Inhibitors|growth inhibitors|mesh-ancestor
6539326|NCT00833729|Etanercept|etanercept|mesh-list
6539327|NCT00833729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6539328|NCT00833729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6539329|NCT00833729|Analgesics|analgesics|mesh-ancestor
6539330|NCT00833729|Sensory System Agents|sensory system agents|mesh-ancestor
6539331|NCT00833729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6539332|NCT00833729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539333|NCT00833729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6539334|NCT00833729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6539335|NCT00833729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6539336|NCT00833729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6539337|NCT00833729|Immunologic Factors|immunologic factors|mesh-ancestor
6539338|NCT00833768|Sevelamer|sevelamer|mesh-list
6539339|NCT00833768|Chelating Agents|chelating agents|mesh-ancestor
6539340|NCT00833768|Sequestering Agents|sequestering agents|mesh-ancestor
6539341|NCT00833768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655432|NCT01464008|Interferon-alpha|interferon-alpha|mesh-list
6655433|NCT01464008|Interferon alpha-2|interferon alpha-2|mesh-list
6655434|NCT01464008|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6655435|NCT01464008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6655436|NCT01464008|Antiviral Agents|antiviral agents|mesh-ancestor
6655437|NCT01464008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6655438|NCT01464008|Antimetabolites|antimetabolites|mesh-ancestor
6655439|NCT01464008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655440|NCT01464008|Immunologic Factors|immunologic factors|mesh-ancestor
6655441|NCT01464008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429671|NCT00322699|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
6429672|NCT00322699|Trioxsalen|trioxsalen|mesh-list
6429673|NCT00322699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6429674|NCT00322699|Dermatologic Agents|dermatologic agents|mesh-ancestor
6429675|NCT00322699|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6429676|NCT00322751|Topotecan|topotecan|mesh-list
6429677|NCT00322751|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6429678|NCT00322751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6429679|NCT00322751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6429680|NCT00322751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429681|NCT00322751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6429682|NCT00322803|1-(4-chlorophenyl)-4-piperidin-1-yl-1,5-dihydroimidazol-2-one|1-(4-chlorophenyl)-4-piperidin-1-yl-1,5-dihydroimidazol-2-one|mesh-list
6429683|NCT00322803|Anticonvulsants|anticonvulsants|mesh-ancestor
6429684|NCT00322803|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6429685|NCT00322803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6655442|NCT01464034|Dexamethasone|dexamethasone|mesh-list
6429686|NCT00322803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6429687|NCT00322803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429688|NCT00322803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6429689|NCT00322803|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6429690|NCT00322803|GABA Agonists|gaba agonists|mesh-ancestor
6429691|NCT00322803|GABA Agents|gaba agents|mesh-ancestor
6429692|NCT00322803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6429693|NCT00322803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429694|NCT00322907|Mefloquine|mefloquine|mesh-list
6429695|NCT00322907|Quinine|quinine|mesh-list
6429696|NCT00322907|Antimalarials|antimalarials|mesh-ancestor
6429697|NCT00322907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6429698|NCT00322907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6429699|NCT00322907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6429700|NCT00322907|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6429701|NCT00322907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429702|NCT00322907|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6429703|NCT00322907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6429704|NCT00322907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6429705|NCT00322907|Analgesics|analgesics|mesh-ancestor
6429706|NCT00322907|Sensory System Agents|sensory system agents|mesh-ancestor
6429707|NCT00322920|Topotecan|topotecan|mesh-list
6429708|NCT00322920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6429709|NCT00322920|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6429710|NCT00322920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6429711|NCT00322920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6429712|NCT00322920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429713|NCT00322972|Azithromycin|azithromycin|mesh-list
6429714|NCT00322972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6429715|NCT00322972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6429716|NCT00322985|Lenalidomide|lenalidomide|mesh-list
6429717|NCT00322985|Immunologic Factors|immunologic factors|mesh-ancestor
6429718|NCT00322985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429719|NCT00322985|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6429720|NCT00322985|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6429721|NCT00322985|Growth Substances|growth substances|mesh-ancestor
6429722|NCT00322985|Growth Inhibitors|growth inhibitors|mesh-ancestor
6539342|NCT00833807|Paclitaxel|paclitaxel|mesh-list
6429723|NCT00322985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6429724|NCT00323011|Leucovorin|leucovorin|mesh-list
6429725|NCT00323011|Folic Acid|folic acid|mesh-list
6429726|NCT00323011|Bevacizumab|bevacizumab|mesh-list
6429727|NCT00323011|Fluorouracil|fluorouracil|mesh-list
6429728|NCT00323011|Irinotecan|irinotecan|mesh-list
6429729|NCT00323011|Dalteparin|dalteparin|mesh-list
6429730|NCT00323011|Levoleucovorin|levoleucovorin|mesh-list
6429731|NCT00323011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6429732|NCT00323011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6429733|NCT00323011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6429734|NCT00323011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6429735|NCT00323011|Growth Substances|growth substances|mesh-ancestor
6429736|NCT00323011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429737|NCT00323011|Growth Inhibitors|growth inhibitors|mesh-ancestor
6429738|NCT00323011|Antimetabolites|antimetabolites|mesh-ancestor
6429739|NCT00323011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429740|NCT00323011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6429741|NCT00323011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6429742|NCT00323011|Immunologic Factors|immunologic factors|mesh-ancestor
6429743|NCT00323011|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6429744|NCT00323011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6429745|NCT00323011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6429746|NCT00323011|Antidotes|antidotes|mesh-ancestor
6429747|NCT00323011|Protective Agents|protective agents|mesh-ancestor
6429748|NCT00323011|Vitamin B Complex|vitamin b complex|mesh-ancestor
6429749|NCT00323011|Vitamins|vitamins|mesh-ancestor
6429750|NCT00323011|Micronutrients|micronutrients|mesh-ancestor
6429751|NCT00323011|Hematinics|hematinics|mesh-ancestor
6429752|NCT00323011|Anticoagulants|anticoagulants|mesh-ancestor
6429753|NCT00323011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6429754|NCT00323011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6429755|NCT00323076|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
6429756|NCT00323076|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6429757|NCT00323076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429758|NCT00323154|Nalbuphine|nalbuphine|mesh-list
6429759|NCT00323154|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6429760|NCT00323154|Narcotics|narcotics|mesh-ancestor
6429761|NCT00323154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6429762|NCT00323154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429763|NCT00323154|Analgesics|analgesics|mesh-ancestor
6429764|NCT00323154|Sensory System Agents|sensory system agents|mesh-ancestor
6429765|NCT00323154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6429766|NCT00323206|Interleukin-12|interleukin-12|mesh-list
6429767|NCT00323206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6429768|NCT00323206|Immunologic Factors|immunologic factors|mesh-ancestor
6429769|NCT00323206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429770|NCT00323206|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6429771|NCT00323206|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6429772|NCT00323206|Growth Substances|growth substances|mesh-ancestor
6429773|NCT00323206|Growth Inhibitors|growth inhibitors|mesh-ancestor
6429774|NCT00323206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6429775|NCT00323219|Moxifloxacin|moxifloxacin|mesh-list
6429776|NCT00323219|Cefazolin|cefazolin|mesh-list
6429777|NCT00323219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6429778|NCT00323219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6429779|NCT00323219|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6429780|NCT00323219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6429781|NCT00323219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6429782|NCT00323219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429783|NCT00323219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6429784|NCT00323323|Prednisone|prednisone|mesh-list
6429785|NCT00323323|Cyclophosphamide|cyclophosphamide|mesh-list
6429786|NCT00323323|Doxorubicin|doxorubicin|mesh-list
6429787|NCT00323323|Vincristine|vincristine|mesh-list
6429788|NCT00323323|Alemtuzumab|alemtuzumab|mesh-list
6429789|NCT00323323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6429790|NCT00323323|Immunologic Factors|immunologic factors|mesh-ancestor
6429791|NCT00323323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429792|NCT00323323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6429793|NCT00323323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6429794|NCT00323323|Alkylating Agents|alkylating agents|mesh-ancestor
6539343|NCT00833807|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6539344|NCT00833807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6539345|NCT00833807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6539346|NCT00833807|Tubulin Modulators|tubulin modulators|mesh-ancestor
6539347|NCT00833807|Antimitotic Agents|antimitotic agents|mesh-ancestor
6539348|NCT00833807|Mitosis Modulators|mitosis modulators|mesh-ancestor
6539349|NCT00833807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429795|NCT00323323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429796|NCT00323323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6429797|NCT00323323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6429798|NCT00323323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6429799|NCT00323323|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6429800|NCT00323323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6429801|NCT00323323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6429802|NCT00323323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6429803|NCT00323323|Glucocorticoids|glucocorticoids|mesh-ancestor
6429804|NCT00323323|Hormones|hormones|mesh-ancestor
6539350|NCT00833963|Trastuzumab|trastuzumab|mesh-list
6429805|NCT00323323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6429806|NCT00323323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6429807|NCT00323323|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6429808|NCT00323323|Tubulin Modulators|tubulin modulators|mesh-ancestor
6429809|NCT00323323|Antimitotic Agents|antimitotic agents|mesh-ancestor
6429810|NCT00323323|Mitosis Modulators|mitosis modulators|mesh-ancestor
6429811|NCT00323323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6429812|NCT00323375|Chloroquine|chloroquine|mesh-list
6429813|NCT00323375|Amebicides|amebicides|mesh-ancestor
6429814|NCT00323375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6429815|NCT00323375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6429816|NCT00323375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6429817|NCT00323375|Antimalarials|antimalarials|mesh-ancestor
6429818|NCT00323375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6429819|NCT00323505|Interferons|interferons|mesh-list
6429820|NCT00323505|Interferon-alpha|interferon-alpha|mesh-list
6429821|NCT00323505|Interferon alpha-2|interferon alpha-2|mesh-list
6429822|NCT00323505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6429823|NCT00323505|Antiviral Agents|antiviral agents|mesh-ancestor
6429824|NCT00323505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6429825|NCT00323505|Immunologic Factors|immunologic factors|mesh-ancestor
6429826|NCT00323505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429827|NCT00323544|Tenofovir|tenofovir|mesh-list
6429828|NCT00323544|Lamivudine|lamivudine|mesh-list
6429829|NCT00323544|Zidovudine|zidovudine|mesh-list
6429830|NCT00323544|Emtricitabine|emtricitabine|mesh-list
6429831|NCT00323544|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6429832|NCT00323544|Antiviral Agents|antiviral agents|mesh-ancestor
6429833|NCT00323544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6429834|NCT00323544|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6429835|NCT00323544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6429836|NCT00323544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6429837|NCT00323544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429838|NCT00323544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6429839|NCT00323544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6429840|NCT00323544|Antimetabolites|antimetabolites|mesh-ancestor
6429841|NCT00323583|Leucovorin|leucovorin|mesh-list
6429842|NCT00323583|Paclitaxel|paclitaxel|mesh-list
6429843|NCT00323583|Fluorouracil|fluorouracil|mesh-list
6429844|NCT00323583|Oxaliplatin|oxaliplatin|mesh-list
6429845|NCT00323583|Calcium|calcium|mesh-list
6429846|NCT00323583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6429847|NCT00323583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6429848|NCT00323583|Tubulin Modulators|tubulin modulators|mesh-ancestor
6429849|NCT00323583|Antimitotic Agents|antimitotic agents|mesh-ancestor
6429850|NCT00323583|Mitosis Modulators|mitosis modulators|mesh-ancestor
6429851|NCT00323583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429852|NCT00323583|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6429853|NCT00323583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429854|NCT00323583|Antimetabolites|antimetabolites|mesh-ancestor
6429855|NCT00323583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6429856|NCT00323583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6429857|NCT00323583|Immunologic Factors|immunologic factors|mesh-ancestor
6429858|NCT00323583|Antidotes|antidotes|mesh-ancestor
6429859|NCT00323583|Protective Agents|protective agents|mesh-ancestor
6429860|NCT00323583|Vitamin B Complex|vitamin b complex|mesh-ancestor
6429861|NCT00323583|Vitamins|vitamins|mesh-ancestor
6429862|NCT00323583|Micronutrients|micronutrients|mesh-ancestor
6429863|NCT00323648|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6429864|NCT00323648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6429865|NCT00323687|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6429866|NCT00323687|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6429867|NCT00323687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6429868|NCT00323687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6429869|NCT00323687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429870|NCT00323687|Antiviral Agents|antiviral agents|mesh-ancestor
6429871|NCT00323687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6429872|NCT00323687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6429873|NCT00323687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6429874|NCT00323778|Hyaluronic Acid|hyaluronic acid|mesh-list
6429875|NCT00323778|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6429876|NCT00323778|Immunologic Factors|immunologic factors|mesh-ancestor
6429877|NCT00323778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429878|NCT00323778|Viscosupplements|viscosupplements|mesh-ancestor
6429879|NCT00323778|Protective Agents|protective agents|mesh-ancestor
6429880|NCT00323791|Gemcitabine|gemcitabine|mesh-list
6429881|NCT00323791|Imatinib Mesylate|imatinib mesylate|mesh-list
6429882|NCT00323791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6429883|NCT00323791|Antimetabolites|antimetabolites|mesh-ancestor
6429884|NCT00323791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429885|NCT00323791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6429886|NCT00323791|Antiviral Agents|antiviral agents|mesh-ancestor
6429887|NCT00323791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6429888|NCT00323791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6539351|NCT00833963|Pertuzumab|pertuzumab|mesh-list
6539352|NCT00833963|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
6539353|NCT00833963|Maytansine|maytansine|mesh-list
6539354|NCT00833963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6539355|NCT00833963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6539356|NCT00833963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6539357|NCT00833963|Tubulin Modulators|tubulin modulators|mesh-ancestor
6539358|NCT00833963|Antimitotic Agents|antimitotic agents|mesh-ancestor
6539359|NCT00833963|Mitosis Modulators|mitosis modulators|mesh-ancestor
6539360|NCT00833963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539361|NCT00834093|Vaccines|vaccines|mesh-list
6539362|NCT00834093|Immunologic Factors|immunologic factors|mesh-ancestor
6539363|NCT00834093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539364|NCT00834184|Nikkomycin|nikkomycin|mesh-list
6539365|NCT00834184|Antifungal Agents|antifungal agents|mesh-ancestor
6539366|NCT00834184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6539367|NCT00834184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6539368|NCT00834184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539369|NCT00834262|Insulin|insulin|mesh-list
6539370|NCT00834262|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6539371|NCT00834262|Insulin Aspart|insulin aspart|mesh-list
6539372|NCT00834262|Insulin, Long-Acting|insulin, long-acting|mesh-list
6539373|NCT00834262|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6539374|NCT00834262|Biphasic Insulins|biphasic insulins|mesh-list
6539375|NCT00834262|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6539376|NCT00834262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6539377|NCT00834262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539378|NCT00834379|Pravastatin|pravastatin|mesh-list
6539379|NCT00834379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6539380|NCT00834379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6539381|NCT00834379|Antimetabolites|antimetabolites|mesh-ancestor
6539382|NCT00834379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539383|NCT00834379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6539384|NCT00834379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6539385|NCT00834379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6539386|NCT00834457|Ritonavir|ritonavir|mesh-list
6429889|NCT00323791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6539387|NCT00834457|Lopinavir|lopinavir|mesh-list
6539388|NCT00834457|Zidovudine|zidovudine|mesh-list
6429890|NCT00323791|Immunologic Factors|immunologic factors|mesh-ancestor
6429891|NCT00323791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429892|NCT00323791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6429893|NCT00323804|Ribavirin|ribavirin|mesh-list
6429894|NCT00323804|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6429895|NCT00323804|Antimetabolites|antimetabolites|mesh-ancestor
6429896|NCT00323804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429897|NCT00323804|Antiviral Agents|antiviral agents|mesh-ancestor
6429898|NCT00323804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6429899|NCT00323817|Z 338|z 338|mesh-list
6429900|NCT00323817|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6429901|NCT00323817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6429902|NCT00323817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429903|NCT00323817|Cholinergic Agents|cholinergic agents|mesh-ancestor
6429904|NCT00323817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6429905|NCT00323817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429906|NCT00323817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6429907|NCT00323830|Capecitabine|capecitabine|mesh-list
6429908|NCT00323830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6429909|NCT00323830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6429910|NCT00323830|Antimetabolites|antimetabolites|mesh-ancestor
6429911|NCT00323830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429912|NCT00323843|Isoproterenol|isoproterenol|mesh-list
6429913|NCT00323843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6429914|NCT00323843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6429915|NCT00323843|Adrenergic Agents|adrenergic agents|mesh-ancestor
6429916|NCT00323843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6429917|NCT00323843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429918|NCT00323843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429919|NCT00323843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6429920|NCT00323843|Autonomic Agents|autonomic agents|mesh-ancestor
6429921|NCT00323843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6429922|NCT00323843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6429923|NCT00323843|Respiratory System Agents|respiratory system agents|mesh-ancestor
6429924|NCT00323843|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6429925|NCT00323843|Sympathomimetics|sympathomimetics|mesh-ancestor
6429926|NCT00323843|Protective Agents|protective agents|mesh-ancestor
6429927|NCT00323856|Factor VIII|factor viii|mesh-list
6429928|NCT00323856|Coagulants|coagulants|mesh-ancestor
6429929|NCT00323921|Dermatologic Agents|dermatologic agents|mesh-list
6429930|NCT00323934|Mocetinostat|mocetinostat|mesh-list
6429931|NCT00323934|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6429932|NCT00323934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5501374|NCT04475029|Analgesics|analgesics|mesh-ancestor
6539389|NCT00834457|Lamivudine|lamivudine|mesh-list
6429933|NCT00323934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429934|NCT00323947|Methylphenidate|methylphenidate|mesh-list
6429935|NCT00323947|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6429936|NCT00323947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429937|NCT00323947|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6429938|NCT00323947|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6429939|NCT00323947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6429940|NCT00323947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429941|NCT00323947|Dopamine Agents|dopamine agents|mesh-ancestor
6429942|NCT00323947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6429943|NCT00323973|Bisoprolol|bisoprolol|mesh-list
6429944|NCT00323973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6429945|NCT00323973|Sympatholytics|sympatholytics|mesh-ancestor
6429946|NCT00323973|Autonomic Agents|autonomic agents|mesh-ancestor
6429947|NCT00323973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6429948|NCT00323973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429949|NCT00323973|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6429950|NCT00323973|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6429951|NCT00323973|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6429952|NCT00323973|Adrenergic Agents|adrenergic agents|mesh-ancestor
6429953|NCT00323973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6429954|NCT00323973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429955|NCT00323986|Azithromycin|azithromycin|mesh-list
6429956|NCT00323986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6429957|NCT00323986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6429958|NCT00324012|Docetaxel|docetaxel|mesh-list
6429959|NCT00324012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6429960|NCT00324012|Tubulin Modulators|tubulin modulators|mesh-ancestor
6429961|NCT00324012|Antimitotic Agents|antimitotic agents|mesh-ancestor
6429962|NCT00324012|Mitosis Modulators|mitosis modulators|mesh-ancestor
6429963|NCT00324012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429964|NCT00324025|Efungumab|efungumab|mesh-list
6429965|NCT00324025|Antifungal Agents|antifungal agents|mesh-ancestor
6429966|NCT00324025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6429967|NCT00324051|Olanzapine|olanzapine|mesh-list
6429968|NCT00324051|Antiemetics|antiemetics|mesh-ancestor
6429969|NCT00324051|Autonomic Agents|autonomic agents|mesh-ancestor
6429970|NCT00324051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6429971|NCT00324051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6429972|NCT00324051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6429973|NCT00324051|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6429974|NCT00324051|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6429975|NCT00324051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6429976|NCT00324051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6429977|NCT00324051|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6429978|NCT00324051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6429979|NCT00324051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6429980|NCT00324051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429981|NCT00324051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6429982|NCT00324051|Serotonin Agents|serotonin agents|mesh-ancestor
6429983|NCT00324077|Imatinib Mesylate|imatinib mesylate|mesh-list
6429984|NCT00324077|Dasatinib|dasatinib|mesh-list
6429985|NCT00324077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6429986|NCT00324077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6429987|NCT00324077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6429988|NCT00324077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429989|NCT00324129|Mocetinostat|mocetinostat|mesh-list
6429990|NCT00324129|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6429991|NCT00324129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6429992|NCT00324129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429993|NCT00324142|Tinidazole|tinidazole|mesh-list
6429994|NCT00324142|Alkylating Agents|alkylating agents|mesh-ancestor
6429995|NCT00324142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6429996|NCT00324142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6429997|NCT00324142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6429998|NCT00324142|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
6429999|NCT00324142|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6430000|NCT00324142|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6430001|NCT00324194|Mocetinostat|mocetinostat|mesh-list
6430002|NCT00324194|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6430003|NCT00324194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6430004|NCT00324194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430005|NCT00324298|Etoposide|etoposide|mesh-list
6430006|NCT00324298|Bleomycin|bleomycin|mesh-list
6430007|NCT00324298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6430008|NCT00324298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6430009|NCT00324298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6430010|NCT00324298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6430011|NCT00324298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6430012|NCT00324298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430013|NCT00324298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6430014|NCT00324324|Moxifloxacin|moxifloxacin|mesh-list
6430015|NCT00324324|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6430016|NCT00324324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6430017|NCT00324324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6539390|NCT00834457|Abacavir|abacavir|mesh-list
6539391|NCT00834457|Dideoxynucleosides|dideoxynucleosides|mesh-list
6539392|NCT00834457|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6539393|NCT00834457|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6539394|NCT00834457|Protease Inhibitors|protease inhibitors|mesh-ancestor
6539395|NCT00834457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6539396|NCT00834457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539397|NCT00834457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6539398|NCT00834457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6539399|NCT00834457|Antiviral Agents|antiviral agents|mesh-ancestor
6539400|NCT00834457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6539401|NCT00834457|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6539402|NCT00834457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6539403|NCT00834457|Antimetabolites|antimetabolites|mesh-ancestor
6539404|NCT00834457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6539405|NCT00834457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6539406|NCT00834470|Atropine|atropine|mesh-list
6539407|NCT00834470|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6539408|NCT00834470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6539409|NCT00834470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6539410|NCT00834470|Autonomic Agents|autonomic agents|mesh-ancestor
6539411|NCT00834470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6539412|NCT00834470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539413|NCT00834470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6539414|NCT00834470|Respiratory System Agents|respiratory system agents|mesh-ancestor
6539415|NCT00834470|Mydriatics|mydriatics|mesh-ancestor
6539416|NCT00834470|Parasympatholytics|parasympatholytics|mesh-ancestor
6539417|NCT00834470|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6539418|NCT00834470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6539419|NCT00834470|Cholinergic Agents|cholinergic agents|mesh-ancestor
6539420|NCT00834470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6539421|NCT00834470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539422|NCT00834600|Amlodipine|amlodipine|mesh-list
6539423|NCT00834600|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6539424|NCT00834600|Olmesartan|olmesartan|mesh-list
6539425|NCT00834600|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6539426|NCT00834600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6539427|NCT00834600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6539428|NCT00834600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6430018|NCT00324324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6430019|NCT00324324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6430020|NCT00324324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6430021|NCT00324324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430022|NCT00324324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6430023|NCT00324324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6430024|NCT00324324|Contraceptive Agents|contraceptive agents|mesh-ancestor
6430025|NCT00324324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6430026|NCT00324324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430027|NCT00324324|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6430028|NCT00324324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6430029|NCT00324324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6430030|NCT00324363|Exenatide|exenatide|mesh-list
6430031|NCT00324363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6430032|NCT00324363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430033|NCT00324363|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6430034|NCT00324363|Incretins|incretins|mesh-ancestor
6430035|NCT00324363|Hormones|hormones|mesh-ancestor
6430036|NCT00324363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6430037|NCT00324376|Sevelamer|sevelamer|mesh-list
6430038|NCT00324376|Chelating Agents|chelating agents|mesh-ancestor
6430039|NCT00324376|Sequestering Agents|sequestering agents|mesh-ancestor
6430040|NCT00324376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430041|NCT00324389|Interferons|interferons|mesh-list
6430042|NCT00324389|Interferon-alpha|interferon-alpha|mesh-list
6430043|NCT00324389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6430044|NCT00324389|Antiviral Agents|antiviral agents|mesh-ancestor
6430045|NCT00324389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6430046|NCT00324389|Immunologic Factors|immunologic factors|mesh-ancestor
6430047|NCT00324389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430048|NCT00324454|Levetiracetam|levetiracetam|mesh-list
6430049|NCT00324454|Anticonvulsants|anticonvulsants|mesh-ancestor
6430050|NCT00324454|Nootropic Agents|nootropic agents|mesh-ancestor
6430051|NCT00324467|Acetaminophen|acetaminophen|mesh-list
6430052|NCT00324467|Diphenhydramine|diphenhydramine|mesh-list
6430053|NCT00324467|Promethazine|promethazine|mesh-list
6430054|NCT00324467|Dexamethasone|dexamethasone|mesh-list
6430055|NCT00324467|Dexamethasone acetate|dexamethasone acetate|mesh-list
6430056|NCT00324467|Prednisone|prednisone|mesh-list
6430057|NCT00324467|Cyclophosphamide|cyclophosphamide|mesh-list
6430058|NCT00324467|Ifosfamide|ifosfamide|mesh-list
6430059|NCT00324467|Rituximab|rituximab|mesh-list
6430060|NCT00324467|Carboplatin|carboplatin|mesh-list
6430061|NCT00324467|Doxorubicin|doxorubicin|mesh-list
6430062|NCT00324467|Etoposide|etoposide|mesh-list
6430063|NCT00324467|Vincristine|vincristine|mesh-list
6430064|NCT00324467|Ondansetron|ondansetron|mesh-list
6430065|NCT00324467|BB 1101|bb 1101|mesh-list
6430066|NCT00324467|Mesna|mesna|mesh-list
6430067|NCT00324467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6430068|NCT00324467|Immunologic Factors|immunologic factors|mesh-ancestor
6430069|NCT00324467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430070|NCT00324467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6430071|NCT00324467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6430072|NCT00324467|Alkylating Agents|alkylating agents|mesh-ancestor
6430073|NCT00324467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430074|NCT00324467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6430075|NCT00324467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6430076|NCT00324467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6430077|NCT00324467|Antiemetics|antiemetics|mesh-ancestor
6430078|NCT00324467|Autonomic Agents|autonomic agents|mesh-ancestor
6539429|NCT00834600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539430|NCT00834600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6539431|NCT00834600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539432|NCT00834600|Vasodilator Agents|vasodilator agents|mesh-ancestor
6539433|NCT00834600|Diuretics|diuretics|mesh-ancestor
6539434|NCT00834600|Natriuretic Agents|natriuretic agents|mesh-ancestor
6539435|NCT00834600|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6539436|NCT00834600|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6539437|NCT00834600|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6539438|NCT00834665|Molgramostim|molgramostim|mesh-list
6539439|NCT00834665|Sargramostim|sargramostim|mesh-list
6539440|NCT00834665|Immunologic Factors|immunologic factors|mesh-ancestor
6539441|NCT00834665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539442|NCT00834665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6539443|NCT00834730|Ketamine|ketamine|mesh-list
6539444|NCT00834730|Analgesics|analgesics|mesh-ancestor
6539445|NCT00834730|Sensory System Agents|sensory system agents|mesh-ancestor
6539446|NCT00834730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6539447|NCT00834730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539448|NCT00834730|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6539449|NCT00834730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6539450|NCT00834730|Anesthetics, General|anesthetics, general|mesh-ancestor
6539451|NCT00834730|Anesthetics|anesthetics|mesh-ancestor
6539452|NCT00834730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6539453|NCT00834730|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6539454|NCT00834730|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6539455|NCT00834730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6539456|NCT00834730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539457|NCT00834847|Pravastatin|pravastatin|mesh-list
6539458|NCT00834847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6539459|NCT00834847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6539460|NCT00834847|Antimetabolites|antimetabolites|mesh-ancestor
6539461|NCT00834847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539462|NCT00834847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6539463|NCT00834847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6539464|NCT00834847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6539465|NCT00834860|Ribavirin|ribavirin|mesh-list
6539466|NCT00834860|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6539467|NCT00834860|Antimetabolites|antimetabolites|mesh-ancestor
6539468|NCT00834860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539469|NCT00834860|Antiviral Agents|antiviral agents|mesh-ancestor
6539470|NCT00834860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6539471|NCT00834925|Diltiazem|diltiazem|mesh-list
6539472|NCT00834925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6539473|NCT00834925|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6539474|NCT00834925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6539475|NCT00834925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539476|NCT00834925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6539477|NCT00834925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539478|NCT00834925|Vasodilator Agents|vasodilator agents|mesh-ancestor
6539479|NCT00835029|Clotrimazole|clotrimazole|mesh-list
6539480|NCT00835029|Miconazole|miconazole|mesh-list
6539481|NCT00835029|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6539482|NCT00835029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6539483|NCT00835029|Antifungal Agents|antifungal agents|mesh-ancestor
6539484|NCT00835029|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6539485|NCT00835029|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6539486|NCT00835029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6539487|NCT00835029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539488|NCT00835029|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6539489|NCT00835029|Hormone Antagonists|hormone antagonists|mesh-ancestor
6539490|NCT00835029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6539491|NCT00835029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655443|NCT01464034|Pomalidomide|pomalidomide|mesh-list
6430079|NCT00324467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6430080|NCT00324467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6430081|NCT00324467|Glucocorticoids|glucocorticoids|mesh-ancestor
6430082|NCT00324467|Hormones|hormones|mesh-ancestor
6430083|NCT00324467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6430084|NCT00324467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6430085|NCT00324467|Protease Inhibitors|protease inhibitors|mesh-ancestor
6430086|NCT00324467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6430087|NCT00324467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6430088|NCT00324467|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6430089|NCT00324467|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6430090|NCT00324467|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6430091|NCT00324467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6430092|NCT00324467|Tubulin Modulators|tubulin modulators|mesh-ancestor
6430093|NCT00324467|Antimitotic Agents|antimitotic agents|mesh-ancestor
6430094|NCT00324467|Mitosis Modulators|mitosis modulators|mesh-ancestor
6430095|NCT00324467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6430096|NCT00324467|Analgesics|analgesics|mesh-ancestor
6430097|NCT00324467|Sensory System Agents|sensory system agents|mesh-ancestor
6430098|NCT00324467|Antipyretics|antipyretics|mesh-ancestor
6430099|NCT00324467|Antipruritics|antipruritics|mesh-ancestor
6430100|NCT00324467|Dermatologic Agents|dermatologic agents|mesh-ancestor
6430101|NCT00324467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6430102|NCT00324467|Serotonin Agents|serotonin agents|mesh-ancestor
6430103|NCT00324467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6430104|NCT00324467|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6430105|NCT00324467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6430106|NCT00324467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6430107|NCT00324467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6430108|NCT00324467|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6430109|NCT00324467|Protective Agents|protective agents|mesh-ancestor
6430110|NCT00324467|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6430111|NCT00324467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6430112|NCT00324467|Anesthetics, Local|anesthetics, local|mesh-ancestor
6430113|NCT00324467|Anesthetics|anesthetics|mesh-ancestor
6430114|NCT00324467|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6430115|NCT00324467|Histamine Antagonists|histamine antagonists|mesh-ancestor
6430116|NCT00324467|Histamine Agents|histamine agents|mesh-ancestor
6430117|NCT00324467|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6430118|NCT00324480|Vorinostat|vorinostat|mesh-list
6430119|NCT00324480|Alvocidib|alvocidib|mesh-list
6430120|NCT00324480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6430121|NCT00324480|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6430122|NCT00324480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6430123|NCT00324480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430124|NCT00324480|Growth Inhibitors|growth inhibitors|mesh-ancestor
6430125|NCT00324480|Growth Substances|growth substances|mesh-ancestor
6430126|NCT00324480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430127|NCT00324480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6539492|NCT00835029|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6539493|NCT00835029|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6539494|NCT00835107|Ziprasidone|ziprasidone|mesh-list
6539495|NCT00835107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6539496|NCT00835107|Serotonin Agents|serotonin agents|mesh-ancestor
6539497|NCT00835107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6539498|NCT00835107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539499|NCT00835107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539500|NCT00835107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6539501|NCT00835107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6539502|NCT00835107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6539503|NCT00835107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6539504|NCT00835107|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6539505|NCT00835107|Dopamine Agents|dopamine agents|mesh-ancestor
6539506|NCT00835393|Pantoprazole|pantoprazole|mesh-list
6539507|NCT00835393|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6539508|NCT00835393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6539509|NCT00835393|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6539510|NCT00835393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6539511|NCT00835393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539512|NCT00835471|Docetaxel|docetaxel|mesh-list
6539513|NCT00835471|Pemetrexed|pemetrexed|mesh-list
6539514|NCT00835471|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6539515|NCT00835471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6539516|NCT00835471|Tubulin Modulators|tubulin modulators|mesh-ancestor
6539517|NCT00835471|Antimitotic Agents|antimitotic agents|mesh-ancestor
6460867|NCT00451867|Antitubercular Agents|antitubercular agents|mesh-ancestor
6460868|NCT00451867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6430128|NCT00324506|Mycophenolic Acid|mycophenolic acid|mesh-list
6430129|NCT00324506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6430130|NCT00324506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6430131|NCT00324506|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6430132|NCT00324506|Antitubercular Agents|antitubercular agents|mesh-ancestor
6430133|NCT00324506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6430134|NCT00324506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6430135|NCT00324506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6430136|NCT00324506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430137|NCT00324519|Misoprostol|misoprostol|mesh-list
6430138|NCT00324519|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6430139|NCT00324519|Abortifacient Agents|abortifacient agents|mesh-ancestor
6430140|NCT00324519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6430141|NCT00324519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430142|NCT00324519|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6430143|NCT00324519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6430144|NCT00324519|Oxytocics|oxytocics|mesh-ancestor
6430145|NCT00324558|Bemiparin|bemiparin|mesh-list
6430146|NCT00324558|Anticoagulants|anticoagulants|mesh-ancestor
6430147|NCT00324571|Calcium|calcium|mesh-list
6430148|NCT00324571|Sevelamer|sevelamer|mesh-list
6430149|NCT00324571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6430150|NCT00324571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430151|NCT00324571|Chelating Agents|chelating agents|mesh-ancestor
6430152|NCT00324571|Sequestering Agents|sequestering agents|mesh-ancestor
6430153|NCT00324571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430154|NCT00324597|Gemcitabine|gemcitabine|mesh-list
6430155|NCT00324597|Motesanib diphosphate|motesanib diphosphate|mesh-list
6430156|NCT00324597|Imetelstat|imetelstat|mesh-list
6430157|NCT00324597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6430158|NCT00324597|Antimetabolites|antimetabolites|mesh-ancestor
6430159|NCT00324597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430160|NCT00324597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6430161|NCT00324597|Antiviral Agents|antiviral agents|mesh-ancestor
6430162|NCT00324597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6430163|NCT00324597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6430164|NCT00324597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6430165|NCT00324597|Immunologic Factors|immunologic factors|mesh-ancestor
6430166|NCT00324597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430167|NCT00324597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6430168|NCT00324610|Capecitabine|capecitabine|mesh-list
6430169|NCT00324610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6430170|NCT00324610|Antimetabolites|antimetabolites|mesh-ancestor
6430171|NCT00324610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430172|NCT00324610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6430173|NCT00324623|Cyclophosphamide|cyclophosphamide|mesh-list
6430174|NCT00324623|Fludarabine|fludarabine|mesh-list
6430175|NCT00324623|Fludarabine phosphate|fludarabine phosphate|mesh-list
6430176|NCT00324623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6430177|NCT00324623|Immunologic Factors|immunologic factors|mesh-ancestor
6430178|NCT00324623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430179|NCT00324623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6430180|NCT00324623|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6430181|NCT00324623|Alkylating Agents|alkylating agents|mesh-ancestor
6430182|NCT00324623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430183|NCT00324623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6430184|NCT00324623|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6430185|NCT00324623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6430186|NCT00324623|Antimetabolites|antimetabolites|mesh-ancestor
6430187|NCT00324688|Tenofovir|tenofovir|mesh-list
6430188|NCT00324688|Antiviral Agents|antiviral agents|mesh-ancestor
6430189|NCT00324688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6430190|NCT00324688|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6430191|NCT00324688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6430192|NCT00324688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6430193|NCT00324688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430194|NCT00324688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6430195|NCT00324688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6430196|NCT00324714|Risedronic Acid|risedronic acid|mesh-list
6430197|NCT00324714|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6430198|NCT00324714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6430199|NCT00324714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430200|NCT00324714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6430201|NCT00324714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430202|NCT00324714|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6430203|NCT00324727|Melphalan|melphalan|mesh-list
6430204|NCT00324727|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6430205|NCT00324727|Alkylating Agents|alkylating agents|mesh-ancestor
6430206|NCT00324727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430207|NCT00324727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6430208|NCT00324727|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6430209|NCT00324727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6430210|NCT00324727|Immunologic Factors|immunologic factors|mesh-ancestor
6430211|NCT00324727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430212|NCT00324766|Simendan|simendan|mesh-list
6430213|NCT00324766|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6430214|NCT00324766|Vasodilator Agents|vasodilator agents|mesh-ancestor
6430215|NCT00324766|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6430216|NCT00324766|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6430217|NCT00324766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6430218|NCT00324766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430219|NCT00324766|Protective Agents|protective agents|mesh-ancestor
6430220|NCT00324766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430221|NCT00324779|Rituximab|rituximab|mesh-list
6430222|NCT00324779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6430223|NCT00324779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6430224|NCT00324779|Immunologic Factors|immunologic factors|mesh-ancestor
6430225|NCT00324779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430226|NCT00324779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6430227|NCT00324792|Insulin|insulin|mesh-list
6539518|NCT00835471|Mitosis Modulators|mitosis modulators|mesh-ancestor
6539519|NCT00835471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539520|NCT00835471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6539521|NCT00835471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6539522|NCT00835471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6539523|NCT00835471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6539524|NCT00835627|Sertraline|sertraline|mesh-list
6539525|NCT00835627|Antidepressive Agents|antidepressive agents|mesh-ancestor
6539526|NCT00835627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6539527|NCT00835627|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6539528|NCT00835627|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6539529|NCT00835627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6539530|NCT00835627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539531|NCT00835627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6539532|NCT00835627|Serotonin Agents|serotonin agents|mesh-ancestor
6539533|NCT00835627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539534|NCT00835744|Clomiphene|clomiphene|mesh-list
6539535|NCT00835744|Enclomiphene|enclomiphene|mesh-list
6539536|NCT00835744|Zuclomiphene|zuclomiphene|mesh-list
6539537|NCT00835744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6539538|NCT00835744|Hormone Antagonists|hormone antagonists|mesh-ancestor
6539539|NCT00835744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6539540|NCT00835744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539541|NCT00835744|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6539542|NCT00835744|Fertility Agents|fertility agents|mesh-ancestor
6539543|NCT00835744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6539544|NCT00835744|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6539545|NCT00835744|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6539546|NCT00835848|Exenatide|exenatide|mesh-list
6539547|NCT00835848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6539548|NCT00835848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539549|NCT00835848|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6539550|NCT00835848|Incretins|incretins|mesh-ancestor
6539551|NCT00835848|Hormones|hormones|mesh-ancestor
6539552|NCT00835848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6539553|NCT00835939|Lidocaine|lidocaine|mesh-list
6539554|NCT00835939|Anesthetics, Local|anesthetics, local|mesh-ancestor
6539555|NCT00835939|Anesthetics|anesthetics|mesh-ancestor
6539556|NCT00835939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6539557|NCT00835939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430228|NCT00324792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6430229|NCT00324792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430230|NCT00324818|Azithromycin|azithromycin|mesh-list
6430231|NCT00324818|Metronidazole|metronidazole|mesh-list
6430232|NCT00324818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6430233|NCT00324818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6430234|NCT00324818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6430235|NCT00324818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6430236|NCT00324831|Prednisone|prednisone|mesh-list
6430237|NCT00324831|Cyclophosphamide|cyclophosphamide|mesh-list
6430238|NCT00324831|Rituximab|rituximab|mesh-list
6430239|NCT00324831|Doxorubicin|doxorubicin|mesh-list
6430240|NCT00324831|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6430241|NCT00324831|Vincristine|vincristine|mesh-list
6430242|NCT00324831|Vaccines|vaccines|mesh-list
6430243|NCT00324831|Antibodies|antibodies|mesh-list
6430244|NCT00324831|Immunoglobulins|immunoglobulins|mesh-list
6430245|NCT00324831|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6430246|NCT00324831|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6430247|NCT00324831|Sargramostim|sargramostim|mesh-list
6430248|NCT00324831|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
6430249|NCT00324831|Immunologic Factors|immunologic factors|mesh-ancestor
6430250|NCT00324831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430251|NCT00324831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6430252|NCT00324831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6430253|NCT00324831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6430254|NCT00324831|Alkylating Agents|alkylating agents|mesh-ancestor
6430255|NCT00324831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430256|NCT00324831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6430257|NCT00324831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6430258|NCT00324831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6430259|NCT00324831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6430260|NCT00324831|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6430261|NCT00324831|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6430262|NCT00324831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6430263|NCT00324831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6430264|NCT00324831|Glucocorticoids|glucocorticoids|mesh-ancestor
6430265|NCT00324831|Hormones|hormones|mesh-ancestor
6430266|NCT00324831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6430267|NCT00324831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6430268|NCT00324831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6430269|NCT00324831|Tubulin Modulators|tubulin modulators|mesh-ancestor
6430270|NCT00324831|Antimitotic Agents|antimitotic agents|mesh-ancestor
6430271|NCT00324831|Mitosis Modulators|mitosis modulators|mesh-ancestor
6430272|NCT00324922|Vancomycin|vancomycin|mesh-list
6430273|NCT00324922|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6430274|NCT00324922|Trimethoprim|trimethoprim|mesh-list
6430275|NCT00324922|Sulfamethoxazole|sulfamethoxazole|mesh-list
6430276|NCT00324922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6430277|NCT00324922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6430278|NCT00324922|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6430279|NCT00324922|Renal Agents|renal agents|mesh-ancestor
6430280|NCT00324922|Antimalarials|antimalarials|mesh-ancestor
6430281|NCT00324922|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6430282|NCT00324922|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6430283|NCT00324922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6430284|NCT00324922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6460869|NCT00451867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6430285|NCT00324922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430286|NCT00324922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6430287|NCT00324922|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6430288|NCT00324922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6430289|NCT00324948|Alprostadil|alprostadil|mesh-list
6430290|NCT00324948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6430291|NCT00324948|Vasodilator Agents|vasodilator agents|mesh-ancestor
6430292|NCT00324948|Urological Agents|urological agents|mesh-ancestor
6430293|NCT00324974|Lansoprazole|lansoprazole|mesh-list
6430294|NCT00324974|Dexlansoprazole|dexlansoprazole|mesh-list
6430295|NCT00324974|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6430296|NCT00324974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6430297|NCT00324974|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6430298|NCT00324974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6430299|NCT00324974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430300|NCT00325000|Amitriptyline|amitriptyline|mesh-list
6430301|NCT00325000|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6430302|NCT00325000|Sertraline|sertraline|mesh-list
6430303|NCT00325000|Antidepressive Agents|antidepressive agents|mesh-ancestor
6430304|NCT00325000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6430305|NCT00325000|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6430306|NCT00325000|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6430307|NCT00325000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6430308|NCT00325000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430309|NCT00325000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6430310|NCT00325000|Serotonin Agents|serotonin agents|mesh-ancestor
6430311|NCT00325000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430312|NCT00325000|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6430313|NCT00325000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6430314|NCT00325000|Analgesics|analgesics|mesh-ancestor
6430315|NCT00325000|Sensory System Agents|sensory system agents|mesh-ancestor
6430316|NCT00325000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6430317|NCT00325000|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6430318|NCT00325000|Adrenergic Agents|adrenergic agents|mesh-ancestor
6430319|NCT00325000|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6430320|NCT00325000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6430321|NCT00325000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6430322|NCT00325026|Misoprostol|misoprostol|mesh-list
6430323|NCT00325026|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6430324|NCT00325026|Abortifacient Agents|abortifacient agents|mesh-ancestor
6430325|NCT00325026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6430326|NCT00325026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430327|NCT00325026|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6430328|NCT00325026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6430329|NCT00325026|Oxytocics|oxytocics|mesh-ancestor
6430330|NCT00325104|Calcium|calcium|mesh-list
6430331|NCT00325104|Parathyroid Hormone|parathyroid hormone|mesh-list
6430332|NCT00325104|Hormones|hormones|mesh-list
6430333|NCT00325104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6430334|NCT00325104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430335|NCT00325104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6430336|NCT00325117|Vildagliptin|vildagliptin|mesh-list
6430337|NCT00325117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6430338|NCT00325117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430339|NCT00325117|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6430340|NCT00325117|Protease Inhibitors|protease inhibitors|mesh-ancestor
6430341|NCT00325117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6430342|NCT00325117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430343|NCT00325169|Tiotropium Bromide|tiotropium bromide|mesh-list
6430344|NCT00325169|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6430345|NCT00325169|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6430346|NCT00325169|Autonomic Agents|autonomic agents|mesh-ancestor
6430347|NCT00325169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6430348|NCT00325169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430349|NCT00325169|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5501375|NCT04475029|Sensory System Agents|sensory system agents|mesh-ancestor
6430350|NCT00325169|Respiratory System Agents|respiratory system agents|mesh-ancestor
6430351|NCT00325169|Parasympatholytics|parasympatholytics|mesh-ancestor
6539558|NCT00835939|Sensory System Agents|sensory system agents|mesh-ancestor
6539559|NCT00835939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6539560|NCT00835939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6539561|NCT00835939|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6539562|NCT00835939|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6539563|NCT00835939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6539564|NCT00835939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539565|NCT00835965|Dexamethasone|dexamethasone|mesh-list
6539566|NCT00835965|Dexamethasone acetate|dexamethasone acetate|mesh-list
6539567|NCT00835965|Aprepitant|aprepitant|mesh-list
6539568|NCT00835965|Fosaprepitant|fosaprepitant|mesh-list
6539569|NCT00835965|BB 1101|bb 1101|mesh-list
6539570|NCT00835965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6539571|NCT00835965|Antiemetics|antiemetics|mesh-ancestor
6539572|NCT00835965|Autonomic Agents|autonomic agents|mesh-ancestor
6539573|NCT00835965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6539574|NCT00835965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539575|NCT00835965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6539576|NCT00835965|Glucocorticoids|glucocorticoids|mesh-ancestor
6539577|NCT00835965|Hormones|hormones|mesh-ancestor
6539578|NCT00835965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6539579|NCT00835965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6539580|NCT00835965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6430352|NCT00325169|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6430353|NCT00325169|Cholinergic Agents|cholinergic agents|mesh-ancestor
6430354|NCT00325169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6430355|NCT00325169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430356|NCT00325169|Glucocorticoids|glucocorticoids|mesh-ancestor
6430357|NCT00325169|Hormones|hormones|mesh-ancestor
6430358|NCT00325169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6430359|NCT00325169|Sympathomimetics|sympathomimetics|mesh-ancestor
6430360|NCT00325182|Levetiracetam|levetiracetam|mesh-list
6430361|NCT00325182|Anticonvulsants|anticonvulsants|mesh-ancestor
6430362|NCT00325182|Nootropic Agents|nootropic agents|mesh-ancestor
6430363|NCT00325286|Carbamazepine|carbamazepine|mesh-list
6430364|NCT00325286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6430365|NCT00325286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430366|NCT00325286|Antimanic Agents|antimanic agents|mesh-ancestor
6430367|NCT00325286|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6430368|NCT00325286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6430369|NCT00325286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430370|NCT00325286|Anticonvulsants|anticonvulsants|mesh-ancestor
6430371|NCT00325286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6430372|NCT00325286|Analgesics|analgesics|mesh-ancestor
6430373|NCT00325286|Sensory System Agents|sensory system agents|mesh-ancestor
6430374|NCT00325286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6430375|NCT00325286|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6430376|NCT00325286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6430377|NCT00325286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6430378|NCT00325286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6430379|NCT00325325|Everolimus|everolimus|mesh-list
6430380|NCT00325325|Tacrolimus|tacrolimus|mesh-list
6430381|NCT00325325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6430382|NCT00325325|Immunologic Factors|immunologic factors|mesh-ancestor
6430383|NCT00325325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430384|NCT00325325|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6430385|NCT00325325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6430386|NCT00325325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430387|NCT00325325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6430388|NCT00325351|Carboplatin|carboplatin|mesh-list
6430389|NCT00325351|Sagopilone|sagopilone|mesh-list
6430390|NCT00325351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6430391|NCT00325390|Clopidogrel|clopidogrel|mesh-list
6430392|NCT00325390|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6430393|NCT00325390|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6430394|NCT00325390|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6430395|NCT00325390|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6430396|NCT00325390|Purinergic Agents|purinergic agents|mesh-ancestor
6430397|NCT00325390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6430398|NCT00325390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430399|NCT00325390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430400|NCT00325429|Vildagliptin|vildagliptin|mesh-list
6430401|NCT00325429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6430402|NCT00325429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430403|NCT00325429|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6430404|NCT00325429|Protease Inhibitors|protease inhibitors|mesh-ancestor
6430405|NCT00325429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6430406|NCT00325429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430407|NCT00325455|Anacetrapib|anacetrapib|mesh-list
6430408|NCT00325455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6430409|NCT00325455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6430410|NCT00325455|Antimetabolites|antimetabolites|mesh-ancestor
6430411|NCT00325455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430412|NCT00325455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6430413|NCT00325546|Rimonabant|rimonabant|mesh-list
6430414|NCT00325546|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6430415|NCT00325546|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
6430416|NCT00325546|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6430417|NCT00325546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6430418|NCT00325546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430419|NCT00325546|Hormones|hormones|mesh-ancestor
6430420|NCT00325546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6430421|NCT00325546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430422|NCT00325637|Losartan|losartan|mesh-list
6430423|NCT00325637|Cilnidipine|cilnidipine|mesh-list
6430424|NCT00325637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6430425|NCT00325637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6430426|NCT00325637|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6430427|NCT00325637|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6430428|NCT00325637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430429|NCT00325637|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6430430|NCT00325637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6430431|NCT00325637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6430432|NCT00325637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430433|NCT00325676|Pantoprazole|pantoprazole|mesh-list
6430434|NCT00325676|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6430435|NCT00325676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6430436|NCT00325676|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6430437|NCT00325676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6430438|NCT00325676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430439|NCT00325689|Risperidone|risperidone|mesh-list
6430440|NCT00325689|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6430441|NCT00325689|Aripiprazole|aripiprazole|mesh-list
6430442|NCT00325689|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6430443|NCT00325689|Serotonin Agents|serotonin agents|mesh-ancestor
6430444|NCT00325689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5501376|NCT04475029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6430445|NCT00325689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430446|NCT00325689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430447|NCT00325689|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6430448|NCT00325689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6430449|NCT00325689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6430450|NCT00325689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6430451|NCT00325689|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6539581|NCT00835965|Protease Inhibitors|protease inhibitors|mesh-ancestor
6539582|NCT00835965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6539583|NCT00835965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539584|NCT00835965|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6539585|NCT00835965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6019345|NCT00386022|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
6019346|NCT00386022|Estrogens|estrogens|mesh-list
6019347|NCT00386022|LHRH, N-Ac-2-Nal(1)-4-Cl-Phe(2)-3-Pal(3)-Arg(5)-Glu(6)-AlaNH2(10)-|lhrh, n-ac-2-nal(1)-4-cl-phe(2)-3-pal(3)-arg(5)-glu(6)-alanh2(10)-|mesh-list
6019348|NCT00386022|Hormones|hormones|mesh-ancestor
6019349|NCT00386022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6539586|NCT00836043|Alemtuzumab|alemtuzumab|mesh-list
6539587|NCT00836043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6539588|NCT00836043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6539589|NCT00836134|Bupivacaine|bupivacaine|mesh-list
6539590|NCT00836134|Anesthetics, Local|anesthetics, local|mesh-list
6539591|NCT00836134|Anesthetics|anesthetics|mesh-list
6539592|NCT00836134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6539593|NCT00836134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539594|NCT00836134|Sensory System Agents|sensory system agents|mesh-ancestor
6539595|NCT00836134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6539596|NCT00836199|Vaccines|vaccines|mesh-list
6539597|NCT00836199|Immunologic Factors|immunologic factors|mesh-ancestor
6539598|NCT00836199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539599|NCT00836212|Efavirenz|efavirenz|mesh-list
6539600|NCT00836212|Lopinavir|lopinavir|mesh-list
6539601|NCT00836212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6539602|NCT00836212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6539603|NCT00836212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6539604|NCT00836212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539605|NCT00836212|Antiviral Agents|antiviral agents|mesh-ancestor
6539606|NCT00836212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6539607|NCT00836212|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6539608|NCT00836212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6539609|NCT00836212|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6539610|NCT00836212|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6539611|NCT00836212|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6539612|NCT00836212|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6539613|NCT00836212|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6539614|NCT00836212|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6539615|NCT00836212|Protease Inhibitors|protease inhibitors|mesh-ancestor
6539616|NCT00836212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6539617|NCT00836212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6539618|NCT00836212|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6539619|NCT00836316|Levobupivacaine|levobupivacaine|mesh-list
6539620|NCT00836316|Anesthetics, Local|anesthetics, local|mesh-ancestor
6539621|NCT00836316|Anesthetics|anesthetics|mesh-ancestor
6539622|NCT00836316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6539623|NCT00836316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539624|NCT00836316|Sensory System Agents|sensory system agents|mesh-ancestor
6539625|NCT00836316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6539626|NCT00836368|Vitamin E|vitamin e|mesh-list
6539627|NCT00836368|Tocopherols|tocopherols|mesh-list
6539628|NCT00836368|Tocotrienols|tocotrienols|mesh-list
6539629|NCT00836368|alpha-Tocopherol|alpha-tocopherol|mesh-list
6539630|NCT00836368|gamma-Tocopherol|gamma-tocopherol|mesh-list
6539631|NCT00836368|Vitamins|vitamins|mesh-ancestor
6539632|NCT00836368|Micronutrients|micronutrients|mesh-ancestor
6539633|NCT00836368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539634|NCT00836368|Antioxidants|antioxidants|mesh-ancestor
6539635|NCT00836368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539636|NCT00836368|Protective Agents|protective agents|mesh-ancestor
6539637|NCT00836381|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6539638|NCT00836381|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6539639|NCT00836381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6539640|NCT00836381|Cholinergic Agents|cholinergic agents|mesh-ancestor
6539641|NCT00836381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6430452|NCT00325689|Dopamine Agents|dopamine agents|mesh-ancestor
6430453|NCT00325689|Antidepressive Agents|antidepressive agents|mesh-ancestor
6430454|NCT00325689|Dopamine Agonists|dopamine agonists|mesh-ancestor
6430455|NCT00325689|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6430456|NCT00325689|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6430457|NCT00325689|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6430458|NCT00325689|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6430459|NCT00325715|Esomeprazole|esomeprazole|mesh-list
6430460|NCT00325715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6430461|NCT00325715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6430462|NCT00325715|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6430463|NCT00325715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6430464|NCT00325715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430465|NCT00325767|Albuterol|albuterol|mesh-list
6430466|NCT00325767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6430467|NCT00325767|Autonomic Agents|autonomic agents|mesh-ancestor
6430468|NCT00325767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6430469|NCT00325767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430470|NCT00325767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6430471|NCT00325767|Respiratory System Agents|respiratory system agents|mesh-ancestor
6430472|NCT00325767|Tocolytic Agents|tocolytic agents|mesh-ancestor
6430473|NCT00325767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6430474|NCT00325767|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6430475|NCT00325767|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6430476|NCT00325767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6430477|NCT00325767|Adrenergic Agents|adrenergic agents|mesh-ancestor
6430478|NCT00325767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6430479|NCT00325767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430480|NCT00325793|Nicardipine|nicardipine|mesh-list
6430481|NCT00325793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6430482|NCT00325793|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6430483|NCT00325793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6019350|NCT00386022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019351|NCT00386022|Hormone Antagonists|hormone antagonists|mesh-ancestor
6019352|NCT00386100|Metformin|metformin|mesh-list
6019353|NCT00386100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6430484|NCT00325793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430485|NCT00325793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6430486|NCT00325793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430487|NCT00325793|Vasodilator Agents|vasodilator agents|mesh-ancestor
6430488|NCT00325806|Ramipril|ramipril|mesh-list
6430489|NCT00325806|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6430490|NCT00325806|Protease Inhibitors|protease inhibitors|mesh-ancestor
6430491|NCT00325806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6430492|NCT00325806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430493|NCT00325806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6430494|NCT00325845|Hylan|hylan|mesh-list
6430495|NCT00325845|Viscosupplements|viscosupplements|mesh-ancestor
6430496|NCT00325845|Protective Agents|protective agents|mesh-ancestor
6430497|NCT00325845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430498|NCT00325858|Tramadol|tramadol|mesh-list
6430499|NCT00325858|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6430500|NCT00325858|Narcotics|narcotics|mesh-ancestor
6430501|NCT00325858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6430502|NCT00325858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430503|NCT00325858|Analgesics|analgesics|mesh-ancestor
6430504|NCT00325858|Sensory System Agents|sensory system agents|mesh-ancestor
6430505|NCT00325858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6430506|NCT00325910|Metformin|metformin|mesh-list
6430507|NCT00325910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6430508|NCT00325910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430509|NCT00325936|Cilnidipine|cilnidipine|mesh-list
6430510|NCT00325936|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6430511|NCT00325936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6430512|NCT00325936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430513|NCT00325936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6430514|NCT00325936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430515|NCT00325949|Acetaminophen|acetaminophen|mesh-list
6430516|NCT00325949|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
6430517|NCT00325949|Hydrocodone|hydrocodone|mesh-list
6430518|NCT00325949|Oxycodone|oxycodone|mesh-list
6430519|NCT00325949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6430520|NCT00325949|Analgesics|analgesics|mesh-ancestor
6539642|NCT00836381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430521|NCT00325949|Sensory System Agents|sensory system agents|mesh-ancestor
6430522|NCT00325949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6430523|NCT00325949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430524|NCT00325949|Antipyretics|antipyretics|mesh-ancestor
6430525|NCT00325949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6430526|NCT00325949|Narcotics|narcotics|mesh-ancestor
6430527|NCT00325949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6430528|NCT00325949|Antitussive Agents|antitussive agents|mesh-ancestor
6430529|NCT00325949|Respiratory System Agents|respiratory system agents|mesh-ancestor
6430530|NCT00325949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6430531|NCT00325949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6430532|NCT00325949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6430533|NCT00325962|Verapamil|verapamil|mesh-list
6430534|NCT00325962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6430535|NCT00325962|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6430536|NCT00325962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6430537|NCT00325962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430538|NCT00325962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6430539|NCT00325962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430540|NCT00325962|Vasodilator Agents|vasodilator agents|mesh-ancestor
6430541|NCT00326027|Pantoprazole|pantoprazole|mesh-list
6430542|NCT00326027|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6430543|NCT00326027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6430544|NCT00326027|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6430545|NCT00326027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6430546|NCT00326027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430547|NCT00326053|Budesonide|budesonide|mesh-list
6430548|NCT00326053|Formoterol Fumarate|formoterol fumarate|mesh-list
6430549|NCT00326053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6430550|NCT00326053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6430551|NCT00326053|Autonomic Agents|autonomic agents|mesh-ancestor
6430552|NCT00326053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6430553|NCT00326053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430554|NCT00326053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6430555|NCT00326053|Respiratory System Agents|respiratory system agents|mesh-ancestor
6430556|NCT00326053|Glucocorticoids|glucocorticoids|mesh-ancestor
6430557|NCT00326053|Hormones|hormones|mesh-ancestor
6430558|NCT00326053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6430559|NCT00326053|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6430560|NCT00326053|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6430561|NCT00326053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6430562|NCT00326053|Adrenergic Agents|adrenergic agents|mesh-ancestor
6430563|NCT00326053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6430564|NCT00326053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430565|NCT00326092|Timolol|timolol|mesh-list
6430566|NCT00326092|Brinzolamide|brinzolamide|mesh-list
6430567|NCT00326092|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6430568|NCT00326092|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6430569|NCT00326092|Adrenergic Agents|adrenergic agents|mesh-ancestor
6430570|NCT00326092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6430571|NCT00326092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430572|NCT00326092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430573|NCT00326092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6430574|NCT00326092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6430575|NCT00326092|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6430576|NCT00326092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6539643|NCT00836381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539644|NCT00836381|Urological Agents|urological agents|mesh-ancestor
6539645|NCT00836485|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
6539646|NCT00836485|Ketotifen|ketotifen|mesh-list
6539647|NCT00836485|Lubricant Eye Drops|lubricant eye drops|mesh-list
6539648|NCT00836485|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6539649|NCT00836485|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6430577|NCT00326105|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6430578|NCT00326105|Antidepressive Agents|antidepressive agents|mesh-ancestor
6430579|NCT00326105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6430580|NCT00326105|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6430581|NCT00326105|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6430582|NCT00326105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6430583|NCT00326105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430584|NCT00326131|Taxane|taxane|mesh-list
6430585|NCT00326131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6430586|NCT00326144|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6430587|NCT00326144|Antidepressive Agents|antidepressive agents|mesh-ancestor
6430588|NCT00326144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6430589|NCT00326144|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6430590|NCT00326144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6430591|NCT00326144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6430592|NCT00326144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430593|NCT00326157|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6430594|NCT00326157|Antifungal Agents|antifungal agents|mesh-ancestor
6430595|NCT00326157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6430596|NCT00326157|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6430597|NCT00326157|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6430598|NCT00326235|Buspirone|buspirone|mesh-list
6430599|NCT00326235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6430600|NCT00326235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6430601|NCT00326235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6430602|NCT00326235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430603|NCT00326235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6430604|NCT00326235|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6430605|NCT00326235|Serotonin Agents|serotonin agents|mesh-ancestor
6430606|NCT00326235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6430607|NCT00326235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430608|NCT00326248|Casopitant|casopitant|mesh-list
6430609|NCT00326248|Antiemetics|antiemetics|mesh-ancestor
6430610|NCT00326248|Autonomic Agents|autonomic agents|mesh-ancestor
6430611|NCT00326248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6430612|NCT00326248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430613|NCT00326248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6019354|NCT00386100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019355|NCT00386152|Epoetin Alfa|epoetin alfa|mesh-list
6019356|NCT00386152|Darbepoetin alfa|darbepoetin alfa|mesh-list
6430614|NCT00326248|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6430615|NCT00326248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6430616|NCT00326248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430617|NCT00326300|Methylphenidate|methylphenidate|mesh-list
6430618|NCT00326300|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6430619|NCT00326300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430620|NCT00326300|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6430621|NCT00326300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6430622|NCT00326300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6430623|NCT00326300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430624|NCT00326300|Dopamine Agents|dopamine agents|mesh-ancestor
6430625|NCT00326300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6460870|NCT00451867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6460871|NCT00451867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460872|NCT00451880|Famotidine|famotidine|mesh-list
6460873|NCT00451880|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6460874|NCT00451880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6460875|NCT00451880|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6460876|NCT00451880|Histamine Antagonists|histamine antagonists|mesh-ancestor
6460877|NCT00451880|Histamine Agents|histamine agents|mesh-ancestor
6460878|NCT00451880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6460879|NCT00451880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460880|NCT00451880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460881|NCT00451971|Leflunomide|leflunomide|mesh-list
6460882|NCT00451971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6462137|NCT00457769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430626|NCT00326352|Remifentanil|remifentanil|mesh-list
6430627|NCT00326352|Propofol|propofol|mesh-list
6430628|NCT00326352|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6430629|NCT00326352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6430630|NCT00326352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430631|NCT00326352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6430632|NCT00326352|Anesthetics, General|anesthetics, general|mesh-ancestor
6430633|NCT00326352|Anesthetics|anesthetics|mesh-ancestor
6430634|NCT00326352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6430635|NCT00326352|Narcotics|narcotics|mesh-ancestor
6430636|NCT00326352|Analgesics|analgesics|mesh-ancestor
6430637|NCT00326352|Sensory System Agents|sensory system agents|mesh-ancestor
6430638|NCT00326352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6430639|NCT00326378|Docetaxel|docetaxel|mesh-list
6430640|NCT00326378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6430641|NCT00326378|Tubulin Modulators|tubulin modulators|mesh-ancestor
6430642|NCT00326378|Antimitotic Agents|antimitotic agents|mesh-ancestor
6430643|NCT00326378|Mitosis Modulators|mitosis modulators|mesh-ancestor
6430644|NCT00326378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430645|NCT00326391|Methylphenidate|methylphenidate|mesh-list
6430646|NCT00326391|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6430647|NCT00326391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430648|NCT00326391|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6430649|NCT00326391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6430650|NCT00326391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6430651|NCT00326391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430652|NCT00326391|Dopamine Agents|dopamine agents|mesh-ancestor
6430653|NCT00326391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6430654|NCT00326404|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6430655|NCT00326404|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6430656|NCT00326404|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6430657|NCT00326404|Desogestrel|desogestrel|mesh-list
6430658|NCT00326404|Estradiol|estradiol|mesh-list
6430659|NCT00326404|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6430660|NCT00326404|Estrogens|estrogens|mesh-ancestor
6430661|NCT00326404|Hormones|hormones|mesh-ancestor
6430662|NCT00326404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6430663|NCT00326404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430664|NCT00326404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6430665|NCT00326404|Contraceptive Agents|contraceptive agents|mesh-ancestor
6539650|NCT00836485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6539651|NCT00836485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5501377|NCT04475029|Antitussive Agents|antitussive agents|mesh-ancestor
6019357|NCT00386152|Hematinics|hematinics|mesh-ancestor
6430666|NCT00326404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6430667|NCT00326404|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6430668|NCT00326404|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6430669|NCT00326404|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6430670|NCT00326404|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6430671|NCT00326404|Progestins|progestins|mesh-ancestor
6430672|NCT00326456|Paclitaxel|paclitaxel|mesh-list
6430673|NCT00326456|Carboplatin|carboplatin|mesh-list
6430674|NCT00326456|Doxorubicin|doxorubicin|mesh-list
6430675|NCT00326456|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6430676|NCT00326456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6430677|NCT00326456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6430678|NCT00326456|Tubulin Modulators|tubulin modulators|mesh-ancestor
6430679|NCT00326456|Antimitotic Agents|antimitotic agents|mesh-ancestor
6430680|NCT00326456|Mitosis Modulators|mitosis modulators|mesh-ancestor
6430681|NCT00326456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462138|NCT00457769|Nootropic Agents|nootropic agents|mesh-ancestor
6430682|NCT00326456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6430683|NCT00326456|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6430684|NCT00326456|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6430685|NCT00326456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6430686|NCT00326469|Lanreotide|lanreotide|mesh-list
6430687|NCT00326469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6430688|NCT00326508|Daclizumab|daclizumab|mesh-list
6430689|NCT00326508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6430690|NCT00326508|Immunologic Factors|immunologic factors|mesh-ancestor
6430691|NCT00326508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430692|NCT00326586|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
6430693|NCT00326586|Androgen Antagonists|androgen antagonists|mesh-ancestor
6430694|NCT00326586|Hormone Antagonists|hormone antagonists|mesh-ancestor
6430695|NCT00326586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6430696|NCT00326586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430697|NCT00326664|Cediranib|cediranib|mesh-list
6430698|NCT00326664|Maleic acid|maleic acid|mesh-list
6430699|NCT00326664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6430700|NCT00326664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430701|NCT00326664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6430702|NCT00326664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6430703|NCT00326768|Telmisartan|telmisartan|mesh-list
6430704|NCT00326768|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6430705|NCT00326768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6430706|NCT00326768|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6430707|NCT00326768|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6430708|NCT00326768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430709|NCT00326768|Diuretics|diuretics|mesh-ancestor
6430710|NCT00326768|Natriuretic Agents|natriuretic agents|mesh-ancestor
6430711|NCT00326768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430712|NCT00326768|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6430713|NCT00326768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6430714|NCT00326807|Naltrexone|naltrexone|mesh-list
6430715|NCT00326807|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6430716|NCT00326807|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6430717|NCT00326807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430718|NCT00326807|Sensory System Agents|sensory system agents|mesh-ancestor
6430719|NCT00326807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6430720|NCT00326820|Zoledronic Acid|zoledronic acid|mesh-list
6430721|NCT00326820|Ibandronic Acid|ibandronic acid|mesh-list
6430722|NCT00326820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6430723|NCT00326820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430724|NCT00326833|Vitamin B 12|vitamin b 12|mesh-list
6430725|NCT00326833|Hydroxocobalamin|hydroxocobalamin|mesh-list
6430726|NCT00326833|Vitamins|vitamins|mesh-ancestor
6430727|NCT00326833|Micronutrients|micronutrients|mesh-ancestor
6430728|NCT00326833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430729|NCT00326833|Vitamin B Complex|vitamin b complex|mesh-ancestor
6430730|NCT00326833|Hematinics|hematinics|mesh-ancestor
6430731|NCT00326859|Remifentanil|remifentanil|mesh-list
6430732|NCT00326859|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6430733|NCT00326859|Narcotics|narcotics|mesh-ancestor
6430734|NCT00326859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6430735|NCT00326859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430736|NCT00326859|Analgesics|analgesics|mesh-ancestor
6430737|NCT00326859|Sensory System Agents|sensory system agents|mesh-ancestor
6430738|NCT00326859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6430739|NCT00327080|Acetylcholine|acetylcholine|mesh-list
6430740|NCT00327080|Vasodilator Agents|vasodilator agents|mesh-ancestor
6430741|NCT00327080|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6430742|NCT00327080|Cholinergic Agents|cholinergic agents|mesh-ancestor
6430743|NCT00327080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6430744|NCT00327080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430745|NCT00327080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430746|NCT00327093|Bevacizumab|bevacizumab|mesh-list
6430747|NCT00327093|Cetuximab|cetuximab|mesh-list
6430748|NCT00327093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6430749|NCT00327093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6430750|NCT00327093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6430751|NCT00327093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6430752|NCT00327093|Growth Substances|growth substances|mesh-ancestor
6430753|NCT00327093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430754|NCT00327093|Growth Inhibitors|growth inhibitors|mesh-ancestor
6430755|NCT00327106|Tranexamic Acid|tranexamic acid|mesh-list
6430756|NCT00327106|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6430757|NCT00327106|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6430758|NCT00327106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430759|NCT00327106|Hemostatics|hemostatics|mesh-ancestor
6430760|NCT00327106|Coagulants|coagulants|mesh-ancestor
6430761|NCT00327119|Panitumumab|panitumumab|mesh-list
6430762|NCT00327119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6430763|NCT00327119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6430764|NCT00327132|Amoxicillin|amoxicillin|mesh-list
6430765|NCT00327132|Clarithromycin|clarithromycin|mesh-list
6430766|NCT00327132|Omeprazole|omeprazole|mesh-list
6430767|NCT00327132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6430768|NCT00327132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6430769|NCT00327132|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6430770|NCT00327132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6430771|NCT00327132|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6430772|NCT00327132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6539652|NCT00836485|Analgesics|analgesics|mesh-ancestor
6539653|NCT00836485|Sensory System Agents|sensory system agents|mesh-ancestor
6539654|NCT00836485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6539655|NCT00836485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539656|NCT00836485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6539657|NCT00836485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6539658|NCT00836485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6539659|NCT00836485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6539660|NCT00836485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6539661|NCT00836485|Histamine Antagonists|histamine antagonists|mesh-ancestor
6539662|NCT00836485|Histamine Agents|histamine agents|mesh-ancestor
6539663|NCT00836485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6539664|NCT00836485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539665|NCT00836485|Antipruritics|antipruritics|mesh-ancestor
6539666|NCT00836485|Dermatologic Agents|dermatologic agents|mesh-ancestor
6655444|NCT01464034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6655445|NCT01464034|Antiemetics|antiemetics|mesh-ancestor
6655446|NCT01464034|Autonomic Agents|autonomic agents|mesh-ancestor
6655447|NCT01464034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6655448|NCT01464034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655449|NCT01464034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6655450|NCT01464034|Glucocorticoids|glucocorticoids|mesh-ancestor
6655451|NCT01464034|Hormones|hormones|mesh-ancestor
6655452|NCT01464034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6655453|NCT01464034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6655454|NCT01464034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6655455|NCT01464034|Immunologic Factors|immunologic factors|mesh-ancestor
6655456|NCT01464034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6655457|NCT01464034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6019358|NCT00386243|Analgesics, Opioid|analgesics, opioid|mesh-list
6019359|NCT00386243|Analgesics|analgesics|mesh-list
6019360|NCT00386243|Narcotics|narcotics|mesh-ancestor
6019361|NCT00386243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6430773|NCT00327132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430774|NCT00327132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6430775|NCT00327132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6019362|NCT00386243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019363|NCT00386243|Sensory System Agents|sensory system agents|mesh-ancestor
6430776|NCT00327132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6430777|NCT00327145|Amlodipine|amlodipine|mesh-list
6430778|NCT00327145|Valsartan|valsartan|mesh-list
6430779|NCT00327145|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6655458|NCT01464034|Growth Substances|growth substances|mesh-ancestor
6655459|NCT01464034|Growth Inhibitors|growth inhibitors|mesh-ancestor
6655460|NCT01464060|Amoxicillin|amoxicillin|mesh-list
6655461|NCT01464060|Metronidazole|metronidazole|mesh-list
6655462|NCT01464060|Clarithromycin|clarithromycin|mesh-list
6655463|NCT01464060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6655464|NCT01464060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6655465|NCT01464060|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6655466|NCT01464060|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6655467|NCT01464060|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6655468|NCT01464060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6655469|NCT01464060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655470|NCT01464060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6655471|NCT01464060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6655472|NCT01464099|Insulin|insulin|mesh-list
6655473|NCT01464099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6019364|NCT00386243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6430780|NCT00327145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6655474|NCT01464099|Insulin Aspart|insulin aspart|mesh-list
6430781|NCT00327145|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6430782|NCT00327145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6430783|NCT00327145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430784|NCT00327145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6430785|NCT00327145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430786|NCT00327145|Vasodilator Agents|vasodilator agents|mesh-ancestor
6430787|NCT00327145|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6430788|NCT00327145|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6430789|NCT00327145|Diuretics|diuretics|mesh-ancestor
6430790|NCT00327145|Natriuretic Agents|natriuretic agents|mesh-ancestor
6430791|NCT00327145|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6430792|NCT00327184|PENTA|penta|mesh-list
6430793|NCT00327184|Anticoagulants|anticoagulants|mesh-ancestor
6430794|NCT00327184|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6430795|NCT00327184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6430796|NCT00327184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430797|NCT00327197|Prednisolone|prednisolone|mesh-list
6430798|NCT00327197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6430799|NCT00327197|Glucocorticoids|glucocorticoids|mesh-ancestor
6430800|NCT00327197|Hormones|hormones|mesh-ancestor
6430801|NCT00327197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6430802|NCT00327197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430803|NCT00327197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6430804|NCT00327197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6430805|NCT00327262|Imatinib Mesylate|imatinib mesylate|mesh-list
6430806|NCT00327262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6430807|NCT00327262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6430808|NCT00327262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6430809|NCT00327262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430810|NCT00327288|Docetaxel|docetaxel|mesh-list
6430811|NCT00327288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6430812|NCT00327288|Tubulin Modulators|tubulin modulators|mesh-ancestor
6430813|NCT00327288|Antimitotic Agents|antimitotic agents|mesh-ancestor
6430814|NCT00327288|Mitosis Modulators|mitosis modulators|mesh-ancestor
6430815|NCT00327288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430816|NCT00327327|Gemcitabine|gemcitabine|mesh-list
6430817|NCT00327327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6430818|NCT00327327|Antimetabolites|antimetabolites|mesh-ancestor
6430819|NCT00327327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430820|NCT00327327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6430821|NCT00327327|Antiviral Agents|antiviral agents|mesh-ancestor
6430822|NCT00327327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6430823|NCT00327327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6430824|NCT00327327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6430825|NCT00327327|Immunologic Factors|immunologic factors|mesh-ancestor
6430826|NCT00327327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430827|NCT00327353|Formoterol Fumarate|formoterol fumarate|mesh-list
6430828|NCT00327353|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6430829|NCT00327353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6430830|NCT00327353|Autonomic Agents|autonomic agents|mesh-ancestor
6539667|NCT00836537|Benazepril|benazepril|mesh-list
6539668|NCT00836537|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6539669|NCT00836537|Protease Inhibitors|protease inhibitors|mesh-ancestor
6539670|NCT00836537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6539671|NCT00836537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539672|NCT00836537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6539673|NCT00836576|Benazepril|benazepril|mesh-list
6539674|NCT00836576|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6539675|NCT00836576|Protease Inhibitors|protease inhibitors|mesh-ancestor
6539676|NCT00836576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6539677|NCT00836576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539678|NCT00836576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6539679|NCT00836628|Busulfan|busulfan|mesh-list
6539680|NCT00836628|Alkylating Agents|alkylating agents|mesh-ancestor
6019365|NCT00386308|Tranexamic Acid|tranexamic acid|mesh-list
6430831|NCT00327353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6430832|NCT00327353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430833|NCT00327353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6430834|NCT00327353|Respiratory System Agents|respiratory system agents|mesh-ancestor
6430835|NCT00327353|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6430836|NCT00327353|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6430837|NCT00327353|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6430838|NCT00327353|Adrenergic Agents|adrenergic agents|mesh-ancestor
6430839|NCT00327353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6430840|NCT00327353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430841|NCT00327379|Aprotinin|aprotinin|mesh-list
6430842|NCT00327379|Hemostatics|hemostatics|mesh-ancestor
6430843|NCT00327379|Coagulants|coagulants|mesh-ancestor
6430844|NCT00327379|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6430845|NCT00327379|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6430846|NCT00327379|Protease Inhibitors|protease inhibitors|mesh-ancestor
6430847|NCT00327379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6430848|NCT00327379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430849|NCT00327418|Atorvastatin|atorvastatin|mesh-list
6430850|NCT00327418|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6430851|NCT00327418|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6430852|NCT00327418|Antimetabolites|antimetabolites|mesh-ancestor
6430853|NCT00327418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430854|NCT00327418|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6430855|NCT00327418|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6430856|NCT00327418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6430857|NCT00327522|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6430858|NCT00327522|Immunologic Factors|immunologic factors|mesh-ancestor
6430859|NCT00327522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430860|NCT00327535|Epoetin Alfa|epoetin alfa|mesh-list
6430861|NCT00327535|Darbepoetin alfa|darbepoetin alfa|mesh-list
6430862|NCT00327535|Hematinics|hematinics|mesh-ancestor
6430863|NCT00327587|Amlodipine|amlodipine|mesh-list
6430864|NCT00327587|Valsartan|valsartan|mesh-list
6430865|NCT00327587|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6430866|NCT00327587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6430867|NCT00327587|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6430868|NCT00327587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6430869|NCT00327587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430870|NCT00327587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6430871|NCT00327587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430872|NCT00327587|Vasodilator Agents|vasodilator agents|mesh-ancestor
6430873|NCT00327587|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6430874|NCT00327587|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6430875|NCT00327587|Diuretics|diuretics|mesh-ancestor
6430876|NCT00327587|Natriuretic Agents|natriuretic agents|mesh-ancestor
6430877|NCT00327587|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6430878|NCT00327665|Vaccines|vaccines|mesh-list
6430879|NCT00327665|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6430880|NCT00327665|Immunologic Factors|immunologic factors|mesh-ancestor
6430881|NCT00327665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430882|NCT00327678|Rituximab|rituximab|mesh-list
6430883|NCT00327678|Imatinib Mesylate|imatinib mesylate|mesh-list
6430884|NCT00327678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6430885|NCT00327678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6430886|NCT00327678|Immunologic Factors|immunologic factors|mesh-ancestor
6430887|NCT00327678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430888|NCT00327678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6430889|NCT00327678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6430890|NCT00327678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6430891|NCT00327678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430892|NCT00327691|Atorvastatin|atorvastatin|mesh-list
6430893|NCT00327691|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6430894|NCT00327691|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6430895|NCT00327691|Antimetabolites|antimetabolites|mesh-ancestor
6430896|NCT00327691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430897|NCT00327691|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6430898|NCT00327691|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6430899|NCT00327691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6430900|NCT00327730|Eperisone|eperisone|mesh-list
6430901|NCT00327730|Anticonvulsants|anticonvulsants|mesh-ancestor
6430902|NCT00327730|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6430903|NCT00327730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6430904|NCT00327730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430905|NCT00327730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6430906|NCT00327730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430907|NCT00327730|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6430908|NCT00327730|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6430909|NCT00327730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6430910|NCT00327730|Parasympatholytics|parasympatholytics|mesh-ancestor
6430911|NCT00327730|Autonomic Agents|autonomic agents|mesh-ancestor
6430912|NCT00327730|Vasodilator Agents|vasodilator agents|mesh-ancestor
6430913|NCT00327756|Ubiquinone|ubiquinone|mesh-list
6430914|NCT00327756|Coenzyme Q10|coenzyme q10|mesh-list
6430915|NCT00327756|Micronutrients|micronutrients|mesh-ancestor
6430916|NCT00327756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430917|NCT00327756|Vitamins|vitamins|mesh-ancestor
6430918|NCT00327769|Fulvestrant|fulvestrant|mesh-list
6430919|NCT00327769|Anastrozole|anastrozole|mesh-list
6539681|NCT00836628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539682|NCT00836628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6539683|NCT00836628|Immunologic Factors|immunologic factors|mesh-ancestor
6539684|NCT00836628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539685|NCT00836628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6539686|NCT00836628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6539687|NCT00836628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6539688|NCT00836654|Catumaxomab|catumaxomab|mesh-list
6539689|NCT00836654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6539690|NCT00836667|Sertraline|sertraline|mesh-list
6539691|NCT00836667|Antidepressive Agents|antidepressive agents|mesh-ancestor
6539692|NCT00836667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6539693|NCT00836667|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6539694|NCT00836667|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6539695|NCT00836667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6539696|NCT00836667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539697|NCT00836667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6539698|NCT00836667|Serotonin Agents|serotonin agents|mesh-ancestor
6539699|NCT00836667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539700|NCT00836823|Alfuzosin|alfuzosin|mesh-list
6539701|NCT00836823|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6539702|NCT00836823|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6539703|NCT00836823|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6539704|NCT00836823|Adrenergic Agents|adrenergic agents|mesh-ancestor
6539705|NCT00836823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6539706|NCT00836823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539707|NCT00836823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539708|NCT00836823|Urological Agents|urological agents|mesh-ancestor
6539709|NCT00836849|Sertraline|sertraline|mesh-list
6539710|NCT00836849|Antidepressive Agents|antidepressive agents|mesh-ancestor
6539711|NCT00836849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6430920|NCT00327769|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6430921|NCT00327769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6430922|NCT00327769|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6430923|NCT00327769|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6430924|NCT00327769|Hormone Antagonists|hormone antagonists|mesh-ancestor
6430925|NCT00327769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6430926|NCT00327769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430927|NCT00327769|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6430928|NCT00327769|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6430929|NCT00327769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6430930|NCT00327769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430931|NCT00327808|Budesonide|budesonide|mesh-list
6430932|NCT00327808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6430933|NCT00327808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6430934|NCT00327808|Autonomic Agents|autonomic agents|mesh-ancestor
6430935|NCT00327808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6430936|NCT00327808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430937|NCT00327808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6430938|NCT00327808|Respiratory System Agents|respiratory system agents|mesh-ancestor
6430939|NCT00327808|Glucocorticoids|glucocorticoids|mesh-ancestor
6430940|NCT00327808|Hormones|hormones|mesh-ancestor
6430941|NCT00327808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6430942|NCT00327834|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6430943|NCT00327834|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6430944|NCT00327834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6430945|NCT00327834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6430946|NCT00327834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430947|NCT00327834|Adrenergic Agents|adrenergic agents|mesh-ancestor
6430948|NCT00327834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6430949|NCT00327834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430950|NCT00327847|Vitamin D|vitamin d|mesh-list
6430951|NCT00327847|Vitamins|vitamins|mesh-ancestor
6430952|NCT00327847|Micronutrients|micronutrients|mesh-ancestor
6430953|NCT00327847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430954|NCT00327847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6430955|NCT00327925|Antibodies|antibodies|mesh-list
6430956|NCT00327925|Immunologic Factors|immunologic factors|mesh-ancestor
6430957|NCT00327925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460883|NCT00451971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460884|NCT00451971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6460885|NCT00451971|Immunologic Factors|immunologic factors|mesh-ancestor
6460886|NCT00451971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460887|NCT00451984|Interleukin-2|interleukin-2|mesh-list
6460888|NCT00451984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6460889|NCT00451984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6460890|NCT00451984|Analgesics|analgesics|mesh-ancestor
6460891|NCT00451984|Sensory System Agents|sensory system agents|mesh-ancestor
6460892|NCT00451984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6460893|NCT00451984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460894|NCT00451997|Cytarabine|cytarabine|mesh-list
6460895|NCT00451997|Imatinib Mesylate|imatinib mesylate|mesh-list
6460896|NCT00451997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6460897|NCT00451997|Antimetabolites|antimetabolites|mesh-ancestor
6460898|NCT00451997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460899|NCT00451997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6460900|NCT00451997|Antiviral Agents|antiviral agents|mesh-ancestor
6460901|NCT00451997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6460902|NCT00451997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6460903|NCT00451997|Immunologic Factors|immunologic factors|mesh-ancestor
6460904|NCT00451997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460905|NCT00451997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6460906|NCT00451997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6460907|NCT00452062|Dexamethasone|dexamethasone|mesh-list
6460908|NCT00452062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6460909|NCT00452062|Antiemetics|antiemetics|mesh-ancestor
6460910|NCT00452062|Autonomic Agents|autonomic agents|mesh-ancestor
6460911|NCT00452062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6460912|NCT00452062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460913|NCT00452062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6460914|NCT00452062|Glucocorticoids|glucocorticoids|mesh-ancestor
6460915|NCT00452062|Hormones|hormones|mesh-ancestor
6460916|NCT00452062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6460917|NCT00452062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6460918|NCT00452062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6460919|NCT00452075|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6460920|NCT00452075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6460921|NCT00452075|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6460922|NCT00452075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6460923|NCT00452075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460924|NCT00452166|Rosiglitazone|rosiglitazone|mesh-list
6460925|NCT00452166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6460926|NCT00452166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460927|NCT00452192|Telmisartan|telmisartan|mesh-list
6460928|NCT00452192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6462139|NCT00457808|Sirolimus|sirolimus|mesh-list
6430958|NCT00327990|Alendronate|alendronate|mesh-list
6430959|NCT00327990|Ibandronic Acid|ibandronic acid|mesh-list
6430960|NCT00327990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6430961|NCT00327990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430962|NCT00328029|Busulfan|busulfan|mesh-list
6430963|NCT00328029|Alkylating Agents|alkylating agents|mesh-ancestor
6430964|NCT00328029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430965|NCT00328029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6430966|NCT00328029|Immunologic Factors|immunologic factors|mesh-ancestor
6430967|NCT00328029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430968|NCT00328029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6430969|NCT00328029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6430970|NCT00328029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6430971|NCT00328107|Hemagglutinins|hemagglutinins|mesh-list
6430972|NCT00328107|Agglutinins|agglutinins|mesh-ancestor
6430973|NCT00328107|Immunologic Factors|immunologic factors|mesh-ancestor
6430974|NCT00328107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430975|NCT00328120|Fulvestrant|fulvestrant|mesh-list
6430976|NCT00328120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6430977|NCT00328120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6430978|NCT00328120|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6430979|NCT00328120|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6430980|NCT00328120|Hormone Antagonists|hormone antagonists|mesh-ancestor
6430981|NCT00328120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6430982|NCT00328120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430983|NCT00328211|Bile Acids and Salts|bile acids and salts|mesh-list
6430984|NCT00328211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6430985|NCT00328302|Candesartan|candesartan|mesh-list
6430986|NCT00328302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6430987|NCT00328302|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6430988|NCT00328302|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6430989|NCT00328302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6430990|NCT00328367|Aripiprazole|aripiprazole|mesh-list
6430991|NCT00328367|Antidepressive Agents|antidepressive agents|mesh-ancestor
6539712|NCT00836849|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6539713|NCT00836849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6539714|NCT00836849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6539715|NCT00836849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539716|NCT00836849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6539717|NCT00836849|Serotonin Agents|serotonin agents|mesh-ancestor
6539718|NCT00836849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539719|NCT00836914|Idelalisib|idelalisib|mesh-list
6539720|NCT00836914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6539721|NCT00836914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6539722|NCT00836914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539723|NCT00837044|Naproxen|naproxen|mesh-list
6539724|NCT00837044|Sumatriptan|sumatriptan|mesh-list
6539725|NCT00837044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6539726|NCT00837044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6539727|NCT00837044|Analgesics|analgesics|mesh-ancestor
6539728|NCT00837044|Sensory System Agents|sensory system agents|mesh-ancestor
6539729|NCT00837044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6539730|NCT00837044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539731|NCT00837044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6430992|NCT00328367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6430993|NCT00328367|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6539732|NCT00837044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6539733|NCT00837044|Gout Suppressants|gout suppressants|mesh-ancestor
6539734|NCT00837044|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6539735|NCT00837044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6539736|NCT00837044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539737|NCT00837044|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6539738|NCT00837044|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6539739|NCT00837044|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6539740|NCT00837044|Serotonin Agents|serotonin agents|mesh-ancestor
6539741|NCT00837044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6539742|NCT00837135|Vaccines|vaccines|mesh-list
6539743|NCT00837135|Immunologic Factors|immunologic factors|mesh-ancestor
6430994|NCT00328367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6430995|NCT00328367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6430996|NCT00328367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6430997|NCT00328367|Dopamine Agonists|dopamine agonists|mesh-ancestor
6430998|NCT00328367|Dopamine Agents|dopamine agents|mesh-ancestor
6430999|NCT00328367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6431000|NCT00328367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6431001|NCT00328367|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6431002|NCT00328367|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6431003|NCT00328367|Serotonin Agents|serotonin agents|mesh-ancestor
6431004|NCT00328367|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6431005|NCT00328367|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6431006|NCT00328367|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6431007|NCT00328367|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6431008|NCT00328380|Rifaximin|rifaximin|mesh-list
6431009|NCT00328380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6431010|NCT00328380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6431011|NCT00328380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6431012|NCT00328393|Pioglitazone|pioglitazone|mesh-list
6431013|NCT00328393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6431014|NCT00328393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431015|NCT00328432|Celecoxib|celecoxib|mesh-list
6431016|NCT00328432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6431017|NCT00328432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6431018|NCT00328432|Analgesics|analgesics|mesh-ancestor
6431019|NCT00328432|Sensory System Agents|sensory system agents|mesh-ancestor
6431020|NCT00328432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6431021|NCT00328432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431022|NCT00328432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6431023|NCT00328432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6431024|NCT00328432|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6431025|NCT00328432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6431026|NCT00328432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6431027|NCT00328432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6431028|NCT00328458|Epothilones|epothilones|mesh-list
6431029|NCT00328458|Epothilone B|epothilone b|mesh-list
6431030|NCT00328458|Tubulin Modulators|tubulin modulators|mesh-ancestor
6431031|NCT00328458|Antimitotic Agents|antimitotic agents|mesh-ancestor
6431032|NCT00328458|Mitosis Modulators|mitosis modulators|mesh-ancestor
6431033|NCT00328458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6431034|NCT00328458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6431035|NCT00328497|Bevacizumab|bevacizumab|mesh-list
6431036|NCT00328497|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
6431037|NCT00328497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6431038|NCT00328497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6431039|NCT00328497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6431040|NCT00328497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6431041|NCT00328497|Growth Substances|growth substances|mesh-ancestor
6431042|NCT00328497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431043|NCT00328497|Growth Inhibitors|growth inhibitors|mesh-ancestor
6431044|NCT00328497|Tubulin Modulators|tubulin modulators|mesh-ancestor
6431045|NCT00328497|Antimitotic Agents|antimitotic agents|mesh-ancestor
6431046|NCT00328497|Mitosis Modulators|mitosis modulators|mesh-ancestor
6431047|NCT00328497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6431048|NCT00328549|Interferons|interferons|mesh-list
6431049|NCT00328549|Ribavirin|ribavirin|mesh-list
6431050|NCT00328549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6655475|NCT01464099|Insulin, Long-Acting|insulin, long-acting|mesh-list
6431051|NCT00328549|Antiviral Agents|antiviral agents|mesh-ancestor
6431052|NCT00328549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6431053|NCT00328549|Antimetabolites|antimetabolites|mesh-ancestor
6431054|NCT00328549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6431055|NCT00328692|Rolofylline|rolofylline|mesh-list
6431056|NCT00328692|Diuretics|diuretics|mesh-ancestor
6431057|NCT00328692|Natriuretic Agents|natriuretic agents|mesh-ancestor
6431058|NCT00328692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431059|NCT00328718|Fluticasone|fluticasone|mesh-list
6431060|NCT00328718|Xhance|xhance|mesh-list
6431061|NCT00328718|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6431062|NCT00328718|Montelukast|montelukast|mesh-list
6431063|NCT00328718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6431064|NCT00328718|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6431065|NCT00328718|Autonomic Agents|autonomic agents|mesh-ancestor
6431066|NCT00328718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6431067|NCT00328718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431068|NCT00328718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6431069|NCT00328718|Respiratory System Agents|respiratory system agents|mesh-ancestor
6431070|NCT00328718|Dermatologic Agents|dermatologic agents|mesh-ancestor
6431071|NCT00328718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6431072|NCT00328718|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6431073|NCT00328718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6431074|NCT00328718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6431075|NCT00328718|Adrenergic Agents|adrenergic agents|mesh-ancestor
6431076|NCT00328718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6431077|NCT00328718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6431078|NCT00328718|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6431079|NCT00328718|Hormone Antagonists|hormone antagonists|mesh-ancestor
6431080|NCT00328718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6431081|NCT00328718|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6431082|NCT00328718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6431083|NCT00328796|Lidocaine|lidocaine|mesh-list
6431084|NCT00328796|Anesthetics, Local|anesthetics, local|mesh-ancestor
6431085|NCT00328796|Anesthetics|anesthetics|mesh-ancestor
6431086|NCT00328796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6431087|NCT00328796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431088|NCT00328796|Sensory System Agents|sensory system agents|mesh-ancestor
6431089|NCT00328796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6431090|NCT00328796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6431091|NCT00328796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6539744|NCT00837135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539745|NCT00837174|Bortezomib|bortezomib|mesh-list
6539746|NCT00837174|Vorinostat|vorinostat|mesh-list
6539747|NCT00837174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6539748|NCT00837174|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6539749|NCT00837174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6539750|NCT00837174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539751|NCT00837187|Dexmedetomidine|dexmedetomidine|mesh-list
6539752|NCT00837187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6539753|NCT00837187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6539754|NCT00837187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539755|NCT00837187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6539756|NCT00837187|Analgesics|analgesics|mesh-ancestor
6539757|NCT00837187|Sensory System Agents|sensory system agents|mesh-ancestor
6539758|NCT00837187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6539759|NCT00837187|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6539760|NCT00837187|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6539761|NCT00837187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6539762|NCT00837187|Adrenergic Agents|adrenergic agents|mesh-ancestor
6539763|NCT00837187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6539764|NCT00837187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539765|NCT00837239|Gemcitabine|gemcitabine|mesh-list
6431092|NCT00328796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6431093|NCT00328796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6431094|NCT00328796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6431095|NCT00328809|Spironolactone|spironolactone|mesh-list
6431096|NCT00328809|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6431097|NCT00328809|Hormone Antagonists|hormone antagonists|mesh-ancestor
6431098|NCT00328809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6431099|NCT00328809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431100|NCT00328809|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6431101|NCT00328809|Diuretics|diuretics|mesh-ancestor
6431102|NCT00328809|Natriuretic Agents|natriuretic agents|mesh-ancestor
6431103|NCT00328822|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6431104|NCT00328822|Antidepressive Agents|antidepressive agents|mesh-ancestor
6431105|NCT00328822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6431106|NCT00328822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6431107|NCT00328822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6431108|NCT00328822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6431109|NCT00328822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431110|NCT00328874|Ubiquinone|ubiquinone|mesh-list
6431111|NCT00328874|Coenzyme Q10|coenzyme q10|mesh-list
6019366|NCT00386308|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6019367|NCT00386308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6019368|NCT00386308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019369|NCT00386308|Hemostatics|hemostatics|mesh-ancestor
6019370|NCT00386308|Coagulants|coagulants|mesh-ancestor
6019371|NCT00386334|Eszopiclone|eszopiclone|mesh-list
6019372|NCT00386334|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6431112|NCT00328874|Micronutrients|micronutrients|mesh-ancestor
6431113|NCT00328874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431114|NCT00328874|Vitamins|vitamins|mesh-ancestor
6431115|NCT00328900|Atropine|atropine|mesh-list
6431116|NCT00328900|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6431117|NCT00328900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6431118|NCT00328900|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6019373|NCT00386334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6431119|NCT00328900|Autonomic Agents|autonomic agents|mesh-ancestor
6431120|NCT00328900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6431121|NCT00328900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431122|NCT00328900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6431123|NCT00328900|Respiratory System Agents|respiratory system agents|mesh-ancestor
6431124|NCT00328900|Mydriatics|mydriatics|mesh-ancestor
6431125|NCT00328900|Parasympatholytics|parasympatholytics|mesh-ancestor
6431126|NCT00328900|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6431127|NCT00328900|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6431128|NCT00328900|Cholinergic Agents|cholinergic agents|mesh-ancestor
6431129|NCT00328900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6431130|NCT00328900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6431131|NCT00328913|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
6431132|NCT00328913|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6431133|NCT00328913|Antidepressive Agents|antidepressive agents|mesh-ancestor
6431134|NCT00328913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6431135|NCT00328939|Enoxaparin|enoxaparin|mesh-list
6431136|NCT00328939|PENTA|penta|mesh-list
6431137|NCT00328939|Fondaparinux|fondaparinux|mesh-list
6431138|NCT00328939|Anticoagulants|anticoagulants|mesh-ancestor
6431139|NCT00328939|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6431140|NCT00328939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6431141|NCT00328939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6431142|NCT00328939|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6431143|NCT00328939|Antithrombins|antithrombins|mesh-ancestor
6431144|NCT00328939|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6431145|NCT00328939|Protease Inhibitors|protease inhibitors|mesh-ancestor
6431146|NCT00328939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6431147|NCT00328965|Lacidipine|lacidipine|mesh-list
6431148|NCT00328965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6431149|NCT00328965|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6431150|NCT00328965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6431151|NCT00328965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6431152|NCT00328965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6431153|NCT00328965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431154|NCT00328978|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6431155|NCT00328978|Antidepressive Agents|antidepressive agents|mesh-ancestor
6431156|NCT00328978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6431157|NCT00328978|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6431158|NCT00328978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6019374|NCT00386334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019375|NCT00386360|Risedronic Acid|risedronic acid|mesh-list
6019376|NCT00386360|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6019377|NCT00386360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6431159|NCT00328978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6431160|NCT00328978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431161|NCT00329043|Sunitinib|sunitinib|mesh-list
6431162|NCT00329043|Leuprolide|leuprolide|mesh-list
6431163|NCT00329043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6431164|NCT00329043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6431165|NCT00329043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6431166|NCT00329043|Growth Substances|growth substances|mesh-ancestor
6431167|NCT00329043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431168|NCT00329043|Growth Inhibitors|growth inhibitors|mesh-ancestor
6431169|NCT00329043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6431170|NCT00329043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6431171|NCT00329043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6431172|NCT00329043|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6431173|NCT00329043|Fertility Agents|fertility agents|mesh-ancestor
6431174|NCT00329043|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6431175|NCT00329043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6431176|NCT00329069|Atorvastatin|atorvastatin|mesh-list
6431177|NCT00329069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6431178|NCT00329069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6431179|NCT00329069|Antimetabolites|antimetabolites|mesh-ancestor
6431180|NCT00329069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6431181|NCT00329069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6431182|NCT00329069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6431183|NCT00329069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6431184|NCT00329095|Bimatoprost|bimatoprost|mesh-list
6539766|NCT00837239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6539767|NCT00837239|Antimetabolites|antimetabolites|mesh-ancestor
6539768|NCT00837239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539769|NCT00837239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6539770|NCT00837239|Antiviral Agents|antiviral agents|mesh-ancestor
6539771|NCT00837239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6539772|NCT00837239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6539773|NCT00837239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6539774|NCT00837239|Immunologic Factors|immunologic factors|mesh-ancestor
6539775|NCT00837239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539776|NCT00837317|Phenol|phenol|mesh-list
6539777|NCT00837317|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6539778|NCT00837317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6539779|NCT00837317|Disinfectants|disinfectants|mesh-ancestor
6539780|NCT00837317|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
6431185|NCT00329095|Travoprost|travoprost|mesh-list
6431186|NCT00329095|Antihypertensive Agents|antihypertensive agents|mesh-list
6431187|NCT00329095|Latanoprost|latanoprost|mesh-list
6431188|NCT00329095|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6431189|NCT00329095|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6431190|NCT00329134|Quinine|quinine|mesh-list
6431191|NCT00329134|Antimalarials|antimalarials|mesh-ancestor
6431192|NCT00329134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6431193|NCT00329134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6539781|NCT00837317|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6431194|NCT00329134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6431195|NCT00329134|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6431196|NCT00329134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431197|NCT00329134|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6431198|NCT00329134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6431199|NCT00329134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6431200|NCT00329134|Analgesics|analgesics|mesh-ancestor
6431201|NCT00329134|Sensory System Agents|sensory system agents|mesh-ancestor
6431202|NCT00329147|Paroxetine|paroxetine|mesh-list
6431203|NCT00329147|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6431204|NCT00329147|Desipramine|desipramine|mesh-list
6431205|NCT00329147|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6431206|NCT00329147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6431207|NCT00329147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6431208|NCT00329147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6431209|NCT00329147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6431210|NCT00329147|Serotonin Agents|serotonin agents|mesh-ancestor
6431211|NCT00329147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431212|NCT00329147|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6431213|NCT00329147|Antidepressive Agents|antidepressive agents|mesh-ancestor
6431214|NCT00329147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6431215|NCT00329147|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6431216|NCT00329147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6431217|NCT00329147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6431218|NCT00329147|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6431219|NCT00329147|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6431220|NCT00329147|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6431221|NCT00329147|Adrenergic Agents|adrenergic agents|mesh-ancestor
6431222|NCT00329173|Atorvastatin|atorvastatin|mesh-list
6431223|NCT00329173|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6431224|NCT00329173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6431225|NCT00329173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6431226|NCT00329173|Antimetabolites|antimetabolites|mesh-ancestor
6431227|NCT00329173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6431228|NCT00329173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6431229|NCT00329173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6431230|NCT00329173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6431231|NCT00329186|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6431232|NCT00329186|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6431233|NCT00329186|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6431234|NCT00329186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6431235|NCT00329186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6431236|NCT00329186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6431237|NCT00329186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6431238|NCT00329186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431239|NCT00329186|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6431240|NCT00329186|Antidepressive Agents|antidepressive agents|mesh-ancestor
6431241|NCT00329186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6431242|NCT00329225|Rosiglitazone|rosiglitazone|mesh-list
6431243|NCT00329225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6431244|NCT00329225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431245|NCT00329264|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6431246|NCT00329264|Antidepressive Agents|antidepressive agents|mesh-ancestor
6431247|NCT00329264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6431248|NCT00329264|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6431249|NCT00329264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6431250|NCT00329264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6431251|NCT00329264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431252|NCT00329316|Progesterone|progesterone|mesh-list
6431253|NCT00329316|Progestins|progestins|mesh-ancestor
6431254|NCT00329316|Hormones|hormones|mesh-ancestor
6431255|NCT00329316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6431256|NCT00329316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431257|NCT00329329|Capecitabine|capecitabine|mesh-list
6431258|NCT00329329|Satraplatin|satraplatin|mesh-list
6431259|NCT00329329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6431260|NCT00329329|Antimetabolites|antimetabolites|mesh-ancestor
6431261|NCT00329329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6431262|NCT00329329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6431263|NCT00329355|Naproxen|naproxen|mesh-list
6431264|NCT00329355|Sumatriptan|sumatriptan|mesh-list
6431265|NCT00329355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6539782|NCT00837343|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6539783|NCT00837343|Antidepressive Agents|antidepressive agents|mesh-ancestor
6539784|NCT00837343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6539785|NCT00837343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6539786|NCT00837343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6539787|NCT00837343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6539788|NCT00837343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539789|NCT00837369|Regadenoson|regadenoson|mesh-list
6539790|NCT00837369|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
6539791|NCT00837369|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6539792|NCT00837369|Purinergic Agonists|purinergic agonists|mesh-ancestor
6539793|NCT00837369|Purinergic Agents|purinergic agents|mesh-ancestor
6539794|NCT00837369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6539795|NCT00837369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539796|NCT00837369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539797|NCT00837564|Citalopram|citalopram|mesh-list
6539798|NCT00837564|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6539799|NCT00837564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6539800|NCT00837564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6539801|NCT00837564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539802|NCT00837564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6539803|NCT00837564|Serotonin Agents|serotonin agents|mesh-ancestor
6539804|NCT00837564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539805|NCT00837564|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6539806|NCT00837564|Antidepressive Agents|antidepressive agents|mesh-ancestor
6539807|NCT00837564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6539808|NCT00837655|Calcium Carbonate|calcium carbonate|mesh-list
6539809|NCT00837655|Calcium|calcium|mesh-list
6539810|NCT00837655|Sevelamer|sevelamer|mesh-list
6539811|NCT00837655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6539812|NCT00837655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539813|NCT00837655|Antacids|antacids|mesh-ancestor
6539814|NCT00837655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539815|NCT00837655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6539816|NCT00837655|Chelating Agents|chelating agents|mesh-ancestor
6539817|NCT00837655|Sequestering Agents|sequestering agents|mesh-ancestor
6539818|NCT00837707|Aripiprazole|aripiprazole|mesh-list
6539819|NCT00837707|Antidepressive Agents|antidepressive agents|mesh-ancestor
6539820|NCT00837707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6539821|NCT00837707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6539822|NCT00837707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6539823|NCT00837707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6539824|NCT00837707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539825|NCT00837707|Dopamine Agonists|dopamine agonists|mesh-ancestor
6539826|NCT00837707|Dopamine Agents|dopamine agents|mesh-ancestor
6431266|NCT00329355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6431267|NCT00329355|Analgesics|analgesics|mesh-ancestor
6431268|NCT00329355|Sensory System Agents|sensory system agents|mesh-ancestor
6431269|NCT00329355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6431270|NCT00329355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431271|NCT00329355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6431272|NCT00329355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6431273|NCT00329355|Gout Suppressants|gout suppressants|mesh-ancestor
6431274|NCT00329355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6431275|NCT00329355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6431276|NCT00329355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6431277|NCT00329355|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6431278|NCT00329355|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6431279|NCT00329355|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6431280|NCT00329355|Serotonin Agents|serotonin agents|mesh-ancestor
6431281|NCT00329355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6431282|NCT00329368|Folic Acid|folic acid|mesh-list
6431283|NCT00329368|Vitamin B Complex|vitamin b complex|mesh-list
6431284|NCT00329368|Interferons|interferons|mesh-list
6431285|NCT00329368|Interferon-alpha|interferon-alpha|mesh-list
6431286|NCT00329368|Interleukin-2|interleukin-2|mesh-list
6431287|NCT00329368|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
6431288|NCT00329368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6431289|NCT00329368|Antiviral Agents|antiviral agents|mesh-ancestor
6431290|NCT00329368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6431291|NCT00329368|Immunologic Factors|immunologic factors|mesh-ancestor
6431292|NCT00329368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431293|NCT00329368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6431294|NCT00329368|Analgesics|analgesics|mesh-ancestor
6431295|NCT00329368|Sensory System Agents|sensory system agents|mesh-ancestor
6431296|NCT00329368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6431297|NCT00329368|Hematinics|hematinics|mesh-ancestor
6431298|NCT00329368|Vitamins|vitamins|mesh-ancestor
6431299|NCT00329368|Micronutrients|micronutrients|mesh-ancestor
6431300|NCT00329368|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6431301|NCT00329381|Omalizumab|omalizumab|mesh-list
6431302|NCT00329381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6431303|NCT00329381|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6431304|NCT00329381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6431305|NCT00329381|Respiratory System Agents|respiratory system agents|mesh-ancestor
6431306|NCT00329381|Immunologic Factors|immunologic factors|mesh-ancestor
6431307|NCT00329381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431308|NCT00329394|Ketamine|ketamine|mesh-list
6431309|NCT00329394|Analgesics|analgesics|mesh-ancestor
6431310|NCT00329394|Sensory System Agents|sensory system agents|mesh-ancestor
6431311|NCT00329394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6431312|NCT00329394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431313|NCT00329394|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6431314|NCT00329394|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6431315|NCT00329394|Anesthetics, General|anesthetics, general|mesh-ancestor
6431316|NCT00329394|Anesthetics|anesthetics|mesh-ancestor
6431317|NCT00329394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6431318|NCT00329394|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6431319|NCT00329394|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6431320|NCT00329394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6431321|NCT00329394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6431322|NCT00329446|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6431323|NCT00329446|Citalopram|citalopram|mesh-list
6431324|NCT00329446|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6431325|NCT00329446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6431326|NCT00329446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6431327|NCT00329446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6431328|NCT00329446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6431329|NCT00329446|Serotonin Agents|serotonin agents|mesh-ancestor
6539827|NCT00837707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6431330|NCT00329446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431331|NCT00329446|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6431332|NCT00329446|Antidepressive Agents|antidepressive agents|mesh-ancestor
6539828|NCT00837707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539829|NCT00837707|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6539830|NCT00837707|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6539831|NCT00837707|Serotonin Agents|serotonin agents|mesh-ancestor
6539832|NCT00837707|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6539833|NCT00837707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6539834|NCT00837707|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6539835|NCT00837707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6539836|NCT00837746|Risedronic Acid|risedronic acid|mesh-list
5724713|NCT03185403|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6431333|NCT00329446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6431334|NCT00329446|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6431335|NCT00329446|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6431336|NCT00329446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6431337|NCT00329459|Naproxen|naproxen|mesh-list
6431338|NCT00329459|Sumatriptan|sumatriptan|mesh-list
6431339|NCT00329459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6431340|NCT00329459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6431341|NCT00329459|Analgesics|analgesics|mesh-ancestor
6431342|NCT00329459|Sensory System Agents|sensory system agents|mesh-ancestor
6431343|NCT00329459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6431344|NCT00329459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431345|NCT00329459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6431346|NCT00329459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6431347|NCT00329459|Gout Suppressants|gout suppressants|mesh-ancestor
6431348|NCT00329459|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6431349|NCT00329459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6431350|NCT00329459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6431351|NCT00329459|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6431352|NCT00329459|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6431353|NCT00329459|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6431354|NCT00329459|Serotonin Agents|serotonin agents|mesh-ancestor
6431355|NCT00329459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6431356|NCT00329472|Gemcitabine|gemcitabine|mesh-list
6431357|NCT00329472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6431358|NCT00329472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6431359|NCT00329472|Antimetabolites|antimetabolites|mesh-ancestor
6431360|NCT00329472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6431361|NCT00329472|Antiviral Agents|antiviral agents|mesh-ancestor
6431362|NCT00329472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6431363|NCT00329472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6431364|NCT00329472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6431365|NCT00329472|Immunologic Factors|immunologic factors|mesh-ancestor
6539837|NCT00837746|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6539838|NCT00837746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6539839|NCT00837746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539840|NCT00837746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6539841|NCT00837746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539842|NCT00837746|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6539843|NCT00837785|Dimethyl Fumarate|dimethyl fumarate|mesh-list
6539844|NCT00837785|Dermatologic Agents|dermatologic agents|mesh-ancestor
6539845|NCT00837785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6539846|NCT00837785|Immunologic Factors|immunologic factors|mesh-ancestor
6539847|NCT00837785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539848|NCT00837837|Chlorpheniramine|chlorpheniramine|mesh-list
6539849|NCT00837837|Antipruritics|antipruritics|mesh-ancestor
6539850|NCT00837837|Dermatologic Agents|dermatologic agents|mesh-ancestor
6539851|NCT00837837|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6539852|NCT00837837|Histamine Antagonists|histamine antagonists|mesh-ancestor
6539853|NCT00837837|Histamine Agents|histamine agents|mesh-ancestor
6539854|NCT00837837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6539855|NCT00837837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539856|NCT00837837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539857|NCT00837837|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6539858|NCT00837850|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
6539859|NCT00837850|Vasodilator Agents|vasodilator agents|mesh-ancestor
6539860|NCT00837850|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
6539861|NCT00837850|Protective Agents|protective agents|mesh-ancestor
6539862|NCT00837850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539863|NCT00837889|Diuretics|diuretics|mesh-list
6539864|NCT00837889|Natriuretic Agents|natriuretic agents|mesh-ancestor
6431366|NCT00329472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431367|NCT00329498|Ascorbic Acid|ascorbic acid|mesh-list
6431368|NCT00329498|Antioxidants|antioxidants|mesh-ancestor
6431369|NCT00329498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6431370|NCT00329498|Protective Agents|protective agents|mesh-ancestor
6431371|NCT00329498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431372|NCT00329498|Vitamins|vitamins|mesh-ancestor
6431373|NCT00329498|Micronutrients|micronutrients|mesh-ancestor
6431374|NCT00329511|Clonidine|clonidine|mesh-list
6431375|NCT00329511|Methyldopa|methyldopa|mesh-list
6431376|NCT00329511|Analgesics|analgesics|mesh-ancestor
6431377|NCT00329511|Sensory System Agents|sensory system agents|mesh-ancestor
6431378|NCT00329511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6431379|NCT00329511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431380|NCT00329511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6431381|NCT00329511|Sympatholytics|sympatholytics|mesh-ancestor
6431382|NCT00329511|Autonomic Agents|autonomic agents|mesh-ancestor
6431383|NCT00329511|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6431384|NCT00329511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6431385|NCT00329511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6431386|NCT00329511|Adrenergic Agents|adrenergic agents|mesh-ancestor
6431387|NCT00329511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6431388|NCT00329511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539865|NCT00837889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539866|NCT00837915|Loratadine|loratadine|mesh-list
6539867|NCT00837915|Pseudoephedrine|pseudoephedrine|mesh-list
6539868|NCT00837915|Ephedrine|ephedrine|mesh-list
6539869|NCT00837915|Antipruritics|antipruritics|mesh-ancestor
6539870|NCT00837915|Dermatologic Agents|dermatologic agents|mesh-ancestor
6539871|NCT00837915|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6539872|NCT00837915|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6539873|NCT00837915|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6539874|NCT00837915|Histamine Antagonists|histamine antagonists|mesh-ancestor
6539875|NCT00837915|Histamine Agents|histamine agents|mesh-ancestor
6539876|NCT00837915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6539877|NCT00837915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539878|NCT00837915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539879|NCT00837915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6539880|NCT00837915|Autonomic Agents|autonomic agents|mesh-ancestor
6539881|NCT00837915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6539882|NCT00837915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6539883|NCT00837915|Respiratory System Agents|respiratory system agents|mesh-ancestor
6539884|NCT00837915|Nasal Decongestants|nasal decongestants|mesh-ancestor
6539885|NCT00837915|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6539886|NCT00837915|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6539887|NCT00837915|Sympathomimetics|sympathomimetics|mesh-ancestor
6539888|NCT00837915|Adrenergic Agents|adrenergic agents|mesh-ancestor
6539889|NCT00837928|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6539890|NCT00837928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6539891|NCT00837928|Alkylating Agents|alkylating agents|mesh-ancestor
6539892|NCT00837928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539893|NCT00837928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6539894|NCT00837941|Diphenhydramine|diphenhydramine|mesh-list
5501378|NCT04475029|Respiratory System Agents|respiratory system agents|mesh-ancestor
5724714|NCT03185403|Anesthetics, General|anesthetics, general|mesh-ancestor
6431389|NCT00329537|Sargramostim|sargramostim|mesh-list
6539895|NCT00837941|Promethazine|promethazine|mesh-list
6539896|NCT00837941|Pregabalin|pregabalin|mesh-list
6431390|NCT00329537|Immunologic Factors|immunologic factors|mesh-ancestor
6431391|NCT00329537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431392|NCT00329589|Bortezomib|bortezomib|mesh-list
6431393|NCT00329589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6431394|NCT00329615|Isophane Insulin, Human|isophane insulin, human|mesh-list
6431395|NCT00329615|Insulin, Isophane|insulin, isophane|mesh-list
6431396|NCT00329615|Isophane insulin, beef|isophane insulin, beef|mesh-list
6431397|NCT00329615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6431398|NCT00329615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431399|NCT00329628|Enoxaparin|enoxaparin|mesh-list
6431400|NCT00329628|Rivaroxaban|rivaroxaban|mesh-list
6431401|NCT00329628|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6431402|NCT00329628|Antithrombins|antithrombins|mesh-ancestor
6431403|NCT00329628|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6431404|NCT00329628|Protease Inhibitors|protease inhibitors|mesh-ancestor
6431405|NCT00329628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6431406|NCT00329628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6431407|NCT00329628|Anticoagulants|anticoagulants|mesh-ancestor
6431408|NCT00329628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6431409|NCT00329628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6431410|NCT00329680|Evening primrose oil|evening primrose oil|mesh-list
6431411|NCT00329680|Antioxidants|antioxidants|mesh-list
6431412|NCT00329680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431413|NCT00329680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6431414|NCT00329680|Protective Agents|protective agents|mesh-ancestor
6431415|NCT00329680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6431416|NCT00329680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6431417|NCT00329680|Analgesics|analgesics|mesh-ancestor
6431418|NCT00329680|Sensory System Agents|sensory system agents|mesh-ancestor
6431419|NCT00329680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6431420|NCT00329680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6431421|NCT00329680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6431422|NCT00329680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6431423|NCT00329680|Antimetabolites|antimetabolites|mesh-ancestor
6431424|NCT00329680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6431425|NCT00329680|Dermatologic Agents|dermatologic agents|mesh-ancestor
6431426|NCT00329693|Quinagolide|quinagolide|mesh-list
6431427|NCT00329693|Dopamine Agonists|dopamine agonists|mesh-ancestor
6431428|NCT00329693|Dopamine Agents|dopamine agents|mesh-ancestor
6431429|NCT00329693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6431430|NCT00329693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6431431|NCT00329693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460929|NCT00452192|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6460930|NCT00452192|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6460931|NCT00452192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460932|NCT00452218|Sorafenib|sorafenib|mesh-list
6460933|NCT00452218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6460934|NCT00452218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6460935|NCT00452218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6460936|NCT00452218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460937|NCT00452231|Cycloserine|cycloserine|mesh-list
6460938|NCT00452231|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6460939|NCT00452231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6460940|NCT00452231|Renal Agents|renal agents|mesh-ancestor
6460941|NCT00452231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6460942|NCT00452231|Antitubercular Agents|antitubercular agents|mesh-ancestor
6460943|NCT00452231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6460944|NCT00452231|Antimetabolites|antimetabolites|mesh-ancestor
5501379|NCT04474938|Dexamethasone|dexamethasone|mesh-list
6460945|NCT00452231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460946|NCT00452244|Gefitinib|gefitinib|mesh-list
6460947|NCT00452244|Simvastatin|simvastatin|mesh-list
6460948|NCT00452244|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6460949|NCT00452244|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6460950|NCT00452244|Antimetabolites|antimetabolites|mesh-ancestor
6460951|NCT00452244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539897|NCT00837941|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6539898|NCT00837941|Analgesics|analgesics|mesh-ancestor
6539899|NCT00837941|Sensory System Agents|sensory system agents|mesh-ancestor
6539900|NCT00837941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6539901|NCT00837941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539902|NCT00837941|Anticonvulsants|anticonvulsants|mesh-ancestor
6539903|NCT00837941|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6539904|NCT00837941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6539905|NCT00837941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6431432|NCT00329758|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6431433|NCT00329758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6431434|NCT00329758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6431435|NCT00329758|Antimetabolites|antimetabolites|mesh-ancestor
6431436|NCT00329758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6431437|NCT00329758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6431438|NCT00329758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6431439|NCT00329758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6431440|NCT00329810|Aripiprazole|aripiprazole|mesh-list
6431441|NCT00329810|Antidepressive Agents|antidepressive agents|mesh-ancestor
6431442|NCT00329810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6431443|NCT00329810|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6431444|NCT00329810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6431445|NCT00329810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6431446|NCT00329810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431447|NCT00329810|Dopamine Agonists|dopamine agonists|mesh-ancestor
6431448|NCT00329810|Dopamine Agents|dopamine agents|mesh-ancestor
6431449|NCT00329810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6431450|NCT00329810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6431451|NCT00329810|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6431452|NCT00329810|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6431453|NCT00329810|Serotonin Agents|serotonin agents|mesh-ancestor
6431454|NCT00329810|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6431455|NCT00329810|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6431456|NCT00329810|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6431457|NCT00329810|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6431458|NCT00329823|Etanercept|etanercept|mesh-list
6431459|NCT00329823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6431460|NCT00329823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6431461|NCT00329823|Analgesics|analgesics|mesh-ancestor
6431462|NCT00329823|Sensory System Agents|sensory system agents|mesh-ancestor
6431463|NCT00329823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6431464|NCT00329823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431465|NCT00329823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6431466|NCT00329823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6431467|NCT00329823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6431468|NCT00329823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6431469|NCT00329823|Immunologic Factors|immunologic factors|mesh-ancestor
6431470|NCT00329914|Progesterone|progesterone|mesh-list
6431471|NCT00329914|Progestins|progestins|mesh-ancestor
6431472|NCT00329914|Hormones|hormones|mesh-ancestor
6431473|NCT00329914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6539906|NCT00837941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6539907|NCT00837941|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6431474|NCT00329914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431475|NCT00329940|Letrozole|letrozole|mesh-list
6431476|NCT00329940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6431477|NCT00329940|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6431478|NCT00329940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6431479|NCT00329940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6431480|NCT00329940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6431481|NCT00329940|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6431482|NCT00329940|Hormone Antagonists|hormone antagonists|mesh-ancestor
6431483|NCT00329940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6019378|NCT00386360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019379|NCT00386360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6019380|NCT00386360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019381|NCT00386360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6019382|NCT00386425|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
6019383|NCT00386425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6431484|NCT00329940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431485|NCT00330018|Valganciclovir|valganciclovir|mesh-list
6431486|NCT00330018|Acyclovir|acyclovir|mesh-list
6431487|NCT00330018|Antiviral Agents|antiviral agents|mesh-ancestor
6431488|NCT00330018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6431489|NCT00330044|Carboplatin|carboplatin|mesh-list
6431490|NCT00330044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6431491|NCT00330135|Hyaluronic Acid|hyaluronic acid|mesh-list
6431492|NCT00330135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6431493|NCT00330135|Immunologic Factors|immunologic factors|mesh-ancestor
6431494|NCT00330135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539908|NCT00837941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6539909|NCT00837941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6539910|NCT00837941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6539911|NCT00837941|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6539912|NCT00837941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6539913|NCT00837941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6539914|NCT00837941|Antidepressive Agents|antidepressive agents|mesh-ancestor
6539915|NCT00837941|Dopamine Agents|dopamine agents|mesh-ancestor
6539916|NCT00837941|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6539917|NCT00837941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6539918|NCT00837941|Anesthetics, Local|anesthetics, local|mesh-ancestor
6539919|NCT00837941|Anesthetics|anesthetics|mesh-ancestor
6539920|NCT00837941|Antiemetics|antiemetics|mesh-ancestor
6539921|NCT00837941|Autonomic Agents|autonomic agents|mesh-ancestor
6539922|NCT00837941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6539923|NCT00837941|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6539924|NCT00837941|Histamine Antagonists|histamine antagonists|mesh-ancestor
6539925|NCT00837941|Histamine Agents|histamine agents|mesh-ancestor
6539926|NCT00837941|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6539927|NCT00837941|Antipruritics|antipruritics|mesh-ancestor
6539928|NCT00837941|Dermatologic Agents|dermatologic agents|mesh-ancestor
6539929|NCT00837954|Cellulose, Oxidized|cellulose, oxidized|mesh-list
6539930|NCT00837954|Hemostatics|hemostatics|mesh-ancestor
6539931|NCT00837954|Coagulants|coagulants|mesh-ancestor
6019384|NCT00386477|Povidone-Iodine|povidone-iodine|mesh-list
6431495|NCT00330135|Viscosupplements|viscosupplements|mesh-ancestor
6431496|NCT00330135|Protective Agents|protective agents|mesh-ancestor
6539932|NCT00838032|Haloperidol|haloperidol|mesh-list
6539933|NCT00838032|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6431497|NCT00330148|Eflornithine|eflornithine|mesh-list
6431498|NCT00330148|Nifurtimox|nifurtimox|mesh-list
6431499|NCT00330148|Melarsoprol|melarsoprol|mesh-list
6431500|NCT00330148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6431501|NCT00330148|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6431502|NCT00330148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6431503|NCT00330148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6431504|NCT00330148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6431505|NCT00330148|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
6431506|NCT00330148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6431507|NCT00330148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6431508|NCT00330239|Paroxetine|paroxetine|mesh-list
6431509|NCT00330239|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6431510|NCT00330239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6431511|NCT00330239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6431512|NCT00330239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6431513|NCT00330239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6431514|NCT00330239|Serotonin Agents|serotonin agents|mesh-ancestor
6431515|NCT00330239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431516|NCT00330239|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6431517|NCT00330239|Antidepressive Agents|antidepressive agents|mesh-ancestor
6431518|NCT00330239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6431519|NCT00330239|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6431520|NCT00330239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6431521|NCT00330239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6431522|NCT00330252|Rituximab|rituximab|mesh-list
6431523|NCT00330252|Alemtuzumab|alemtuzumab|mesh-list
6431524|NCT00330252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6431525|NCT00330252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6431526|NCT00330252|Immunologic Factors|immunologic factors|mesh-ancestor
6431527|NCT00330252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431528|NCT00330252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6431529|NCT00330278|Cefazolin|cefazolin|mesh-list
6431530|NCT00330278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6431531|NCT00330278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6431532|NCT00330304|Isoniazid|isoniazid|mesh-list
6431533|NCT00330304|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6431534|NCT00330304|Antitubercular Agents|antitubercular agents|mesh-ancestor
6431535|NCT00330304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6431536|NCT00330304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6431537|NCT00330304|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6431538|NCT00330304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6431539|NCT00330304|Antimetabolites|antimetabolites|mesh-ancestor
6431540|NCT00330304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6431541|NCT00330304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6431542|NCT00330304|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6431543|NCT00330304|Renal Agents|renal agents|mesh-ancestor
6431544|NCT00330304|Antimalarials|antimalarials|mesh-ancestor
6431545|NCT00330304|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6431546|NCT00330304|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6431547|NCT00330317|Letrozole|letrozole|mesh-list
6431548|NCT00330317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6431549|NCT00330317|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6431550|NCT00330317|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6431551|NCT00330317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6431552|NCT00330317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6431553|NCT00330317|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6431554|NCT00330317|Hormone Antagonists|hormone antagonists|mesh-ancestor
6431555|NCT00330317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6431556|NCT00330317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431557|NCT00330395|Caspofungin|caspofungin|mesh-list
6431558|NCT00330395|Antifungal Agents|antifungal agents|mesh-ancestor
6431559|NCT00330395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6431560|NCT00330395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6431561|NCT00330395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6431562|NCT00330486|Acamprosate|acamprosate|mesh-list
6431563|NCT00330486|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6431564|NCT00330499|Cisplatin|cisplatin|mesh-list
6431565|NCT00330499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6431566|NCT00330525|Sibutramine|sibutramine|mesh-list
6431567|NCT00330525|Antidepressive Agents|antidepressive agents|mesh-ancestor
6431568|NCT00330525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6431569|NCT00330525|Appetite Depressants|appetite depressants|mesh-ancestor
6431570|NCT00330525|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6431571|NCT00330577|Timolol|timolol|mesh-list
6431572|NCT00330577|Latanoprost|latanoprost|mesh-list
6431573|NCT00330577|Lubricant Eye Drops|lubricant eye drops|mesh-list
6431574|NCT00330577|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6431575|NCT00330577|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6431576|NCT00330577|Adrenergic Agents|adrenergic agents|mesh-ancestor
6431577|NCT00330577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6431578|NCT00330577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6431579|NCT00330577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431580|NCT00330577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6431581|NCT00330577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6431582|NCT00330577|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6431583|NCT00330577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6431584|NCT00330655|Memantine|memantine|mesh-list
6431585|NCT00330655|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6431586|NCT00330655|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6431587|NCT00330655|Dopamine Agents|dopamine agents|mesh-ancestor
6431588|NCT00330655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6431589|NCT00330655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6431590|NCT00330655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431591|NCT00330655|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6431592|NCT00330655|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6431593|NCT00330707|Interferons|interferons|mesh-list
6431594|NCT00330707|Interferon-alpha|interferon-alpha|mesh-list
6431595|NCT00330707|BCG Vaccine|bcg vaccine|mesh-list
6431596|NCT00330707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6431597|NCT00330707|Antiviral Agents|antiviral agents|mesh-ancestor
6431598|NCT00330707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6431599|NCT00330707|Immunologic Factors|immunologic factors|mesh-ancestor
6431600|NCT00330707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431601|NCT00330707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6431602|NCT00330746|Gemcitabine|gemcitabine|mesh-list
6431603|NCT00330746|Cetuximab|cetuximab|mesh-list
6431604|NCT00330746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6431605|NCT00330746|Antimetabolites|antimetabolites|mesh-ancestor
6431606|NCT00330746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6431607|NCT00330746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6431608|NCT00330746|Antiviral Agents|antiviral agents|mesh-ancestor
6431609|NCT00330746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6431610|NCT00330746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6431611|NCT00330746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6431612|NCT00330746|Immunologic Factors|immunologic factors|mesh-ancestor
6431613|NCT00330746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431614|NCT00330746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6431615|NCT00330772|Aspirin|aspirin|mesh-list
6431616|NCT00330772|Clopidogrel|clopidogrel|mesh-list
6431617|NCT00330772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6431618|NCT00330772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6539934|NCT00838032|Haloperidol decanoate|haloperidol decanoate|mesh-list
6431619|NCT00330772|Analgesics|analgesics|mesh-ancestor
6431620|NCT00330772|Sensory System Agents|sensory system agents|mesh-ancestor
6431621|NCT00330772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6431622|NCT00330772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431623|NCT00330772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6431624|NCT00330772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6539935|NCT00838032|Antidepressive Agents|antidepressive agents|mesh-ancestor
6539936|NCT00838032|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6539937|NCT00838032|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6539938|NCT00838032|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6539939|NCT00838032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6539940|NCT00838032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539941|NCT00838032|Antiemetics|antiemetics|mesh-ancestor
6539942|NCT00838032|Autonomic Agents|autonomic agents|mesh-ancestor
6539943|NCT00838032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6539944|NCT00838032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6539945|NCT00838032|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6539946|NCT00838032|Dopamine Agents|dopamine agents|mesh-ancestor
6539947|NCT00838032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6539948|NCT00838032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539949|NCT00838032|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6539950|NCT00838071|Immunoglobulins|immunoglobulins|mesh-list
6539951|NCT00838071|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6539952|NCT00838071|Antibodies|antibodies|mesh-list
6539953|NCT00838071|Immunologic Factors|immunologic factors|mesh-ancestor
6539954|NCT00838071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539955|NCT00838214|Prednisone|prednisone|mesh-list
6539956|NCT00838214|Budesonide|budesonide|mesh-list
6539957|NCT00838214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6539958|NCT00838214|Glucocorticoids|glucocorticoids|mesh-ancestor
6539959|NCT00838214|Hormones|hormones|mesh-ancestor
6539960|NCT00838214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6539961|NCT00838214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539962|NCT00838214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6539963|NCT00838214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6539964|NCT00838214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6539965|NCT00838214|Autonomic Agents|autonomic agents|mesh-ancestor
6539966|NCT00838214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6539967|NCT00838214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6539968|NCT00838214|Respiratory System Agents|respiratory system agents|mesh-ancestor
6539969|NCT00838227|Modafinil|modafinil|mesh-list
6539970|NCT00838227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6539971|NCT00838227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539972|NCT00838227|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6539973|NCT00838227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6539974|NCT00838227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6539975|NCT00838227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539976|NCT00838240|Cytarabine|cytarabine|mesh-list
6539977|NCT00838240|Clofarabine|clofarabine|mesh-list
6539978|NCT00838240|Idarubicin|idarubicin|mesh-list
6539979|NCT00838240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6431625|NCT00330772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6431626|NCT00330772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6431627|NCT00330772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539980|NCT00838240|Antimetabolites|antimetabolites|mesh-ancestor
6539981|NCT00838240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539982|NCT00838240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6539983|NCT00838240|Antiviral Agents|antiviral agents|mesh-ancestor
6539984|NCT00838240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6539985|NCT00838240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6539986|NCT00838240|Immunologic Factors|immunologic factors|mesh-ancestor
6539987|NCT00838240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539988|NCT00838240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6539989|NCT00838240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6539990|NCT00838240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6431628|NCT00330772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6431629|NCT00330772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6431630|NCT00330772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6431631|NCT00330772|Antipyretics|antipyretics|mesh-ancestor
6431632|NCT00330772|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6431633|NCT00330772|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6431634|NCT00330772|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6431635|NCT00330772|Purinergic Agents|purinergic agents|mesh-ancestor
6539991|NCT00838240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6431636|NCT00330772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6431637|NCT00330785|Amlodipine|amlodipine|mesh-list
6431638|NCT00330785|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
6431639|NCT00330785|Atorvastatin|atorvastatin|mesh-list
6431640|NCT00330785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6431641|NCT00330785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6431642|NCT00330785|Antimetabolites|antimetabolites|mesh-ancestor
6431643|NCT00330785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6431644|NCT00330785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6431645|NCT00330785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6431646|NCT00330785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6431647|NCT00330785|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6431648|NCT00330785|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6431649|NCT00330785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6431650|NCT00330785|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6431651|NCT00330785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431652|NCT00330785|Vasodilator Agents|vasodilator agents|mesh-ancestor
6431653|NCT00330798|Ketorolac|ketorolac|mesh-list
6431654|NCT00330798|Nepafenac|nepafenac|mesh-list
6431655|NCT00330798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6431656|NCT00330798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6431657|NCT00330798|Analgesics|analgesics|mesh-ancestor
6431658|NCT00330798|Sensory System Agents|sensory system agents|mesh-ancestor
6431659|NCT00330798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6431660|NCT00330798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431661|NCT00330798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6431662|NCT00330798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6431663|NCT00330798|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6431664|NCT00330798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6019385|NCT00386477|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6019386|NCT00386477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6019387|NCT00386607|Valsartan|valsartan|mesh-list
6431665|NCT00330798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6431666|NCT00330824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6431667|NCT00330824|Moxifloxacin|moxifloxacin|mesh-list
6431668|NCT00330824|Dexamethasone|dexamethasone|mesh-list
6431669|NCT00330824|Dexamethasone acetate|dexamethasone acetate|mesh-list
6431670|NCT00330824|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6431671|NCT00330824|BB 1101|bb 1101|mesh-list
6431672|NCT00330824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6431673|NCT00330824|Antiemetics|antiemetics|mesh-ancestor
6431674|NCT00330824|Autonomic Agents|autonomic agents|mesh-ancestor
6431675|NCT00330824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6431676|NCT00330824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431677|NCT00330824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6431678|NCT00330824|Glucocorticoids|glucocorticoids|mesh-ancestor
6431679|NCT00330824|Hormones|hormones|mesh-ancestor
6431680|NCT00330824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6431681|NCT00330824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6431682|NCT00330824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6431683|NCT00330824|Protease Inhibitors|protease inhibitors|mesh-ancestor
6431684|NCT00330824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6431685|NCT00330824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6431686|NCT00330824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6431687|NCT00330824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6431688|NCT00330824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6431689|NCT00330824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6431690|NCT00330824|Contraceptive Agents|contraceptive agents|mesh-ancestor
6431691|NCT00330824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6431692|NCT00330824|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6431693|NCT00330824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5501380|NCT04474938|Bortezomib|bortezomib|mesh-list
6431694|NCT00330824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6431695|NCT00330902|Artesunate|artesunate|mesh-list
6431696|NCT00330902|Pyrimethamine|pyrimethamine|mesh-list
6431697|NCT00330902|Primaquine|primaquine|mesh-list
6431698|NCT00330902|Sulfadoxine|sulfadoxine|mesh-list
6431699|NCT00330902|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6431700|NCT00330902|Antimalarials|antimalarials|mesh-ancestor
6431701|NCT00330902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6431702|NCT00330902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6431703|NCT00330902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6431704|NCT00330902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6431705|NCT00330902|Antiviral Agents|antiviral agents|mesh-ancestor
6431706|NCT00330902|Schistosomicides|schistosomicides|mesh-ancestor
6431707|NCT00330902|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6431708|NCT00330902|Anthelmintics|anthelmintics|mesh-ancestor
6431709|NCT00330902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6431710|NCT00330902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6431711|NCT00330902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6431712|NCT00330902|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6431713|NCT00330902|Renal Agents|renal agents|mesh-ancestor
6431714|NCT00330941|Lidocaine|lidocaine|mesh-list
6431715|NCT00330941|Anesthetics, Local|anesthetics, local|mesh-ancestor
6431716|NCT00330941|Anesthetics|anesthetics|mesh-ancestor
6431717|NCT00330941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6431718|NCT00330941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431719|NCT00330941|Sensory System Agents|sensory system agents|mesh-ancestor
6431720|NCT00330941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6431721|NCT00330941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6431722|NCT00330941|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6431723|NCT00330941|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6431724|NCT00330941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6431725|NCT00330941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6431726|NCT00330980|Simvastatin|simvastatin|mesh-list
6431727|NCT00330980|Pravastatin|pravastatin|mesh-list
6431728|NCT00330980|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6431729|NCT00330980|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6431730|NCT00330980|Antimetabolites|antimetabolites|mesh-ancestor
6431731|NCT00330980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6431732|NCT00330980|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6431733|NCT00330980|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6431734|NCT00330980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6431735|NCT00330993|Misoprostol|misoprostol|mesh-list
6431736|NCT00330993|Mifepristone|mifepristone|mesh-list
6431737|NCT00330993|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6019388|NCT00386607|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6019389|NCT00386607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6019390|NCT00386607|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6019391|NCT00386607|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6431738|NCT00330993|Abortifacient Agents|abortifacient agents|mesh-ancestor
6431739|NCT00330993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6431740|NCT00330993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539992|NCT00838266|Grape Seed Extract|grape seed extract|mesh-list
6539993|NCT00838266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6539994|NCT00838266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6539995|NCT00838266|Antioxidants|antioxidants|mesh-ancestor
6539996|NCT00838266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6539997|NCT00838266|Protective Agents|protective agents|mesh-ancestor
6539998|NCT00838266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6539999|NCT00838305|Citalopram|citalopram|mesh-list
6540000|NCT00838305|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6540001|NCT00838305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6540002|NCT00838305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6540003|NCT00838305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6540004|NCT00838305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6540005|NCT00838305|Serotonin Agents|serotonin agents|mesh-ancestor
6540006|NCT00838305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540007|NCT00838305|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6540008|NCT00838305|Antidepressive Agents|antidepressive agents|mesh-ancestor
6540009|NCT00838305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6540010|NCT00838357|Plerixafor|plerixafor|mesh-list
6540011|NCT00838357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6540012|NCT00838357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6540013|NCT00838357|Antiviral Agents|antiviral agents|mesh-ancestor
6540014|NCT00838357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6431741|NCT00330993|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6431742|NCT00330993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6431743|NCT00330993|Oxytocics|oxytocics|mesh-ancestor
6431744|NCT00330993|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6431745|NCT00330993|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6431746|NCT00330993|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6431747|NCT00330993|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6431748|NCT00330993|Contraceptive Agents|contraceptive agents|mesh-ancestor
6431749|NCT00330993|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6431750|NCT00330993|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6431751|NCT00330993|Hormone Antagonists|hormone antagonists|mesh-ancestor
6431752|NCT00330993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6431753|NCT00330993|Luteolytic Agents|luteolytic agents|mesh-ancestor
6431754|NCT00330993|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6431755|NCT00330993|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6431756|NCT00331045|Alvimopan|alvimopan|mesh-list
6431757|NCT00331045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6431758|NCT00331058|Prednisolone|prednisolone|mesh-list
6431759|NCT00331058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6431760|NCT00331058|Glucocorticoids|glucocorticoids|mesh-ancestor
6431761|NCT00331058|Hormones|hormones|mesh-ancestor
6431762|NCT00331058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6431763|NCT00331058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431764|NCT00331058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6431765|NCT00331058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6431766|NCT00331071|Contraceptive Agents|contraceptive agents|mesh-list
6431767|NCT00331071|Ortho Evra|ortho evra|mesh-list
6431768|NCT00331071|Contraceptives, Oral|contraceptives, oral|mesh-list
6431769|NCT00331071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6431770|NCT00331071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431771|NCT00331071|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6431772|NCT00331071|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6431773|NCT00331084|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6431774|NCT00331084|Moxifloxacin|moxifloxacin|mesh-list
6431775|NCT00331084|Dexamethasone|dexamethasone|mesh-list
6431776|NCT00331084|Dexamethasone acetate|dexamethasone acetate|mesh-list
6431777|NCT00331084|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6431778|NCT00331084|BB 1101|bb 1101|mesh-list
6431779|NCT00331084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6431780|NCT00331084|Antiemetics|antiemetics|mesh-ancestor
6431781|NCT00331084|Autonomic Agents|autonomic agents|mesh-ancestor
6431782|NCT00331084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6431783|NCT00331084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431784|NCT00331084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6431785|NCT00331084|Glucocorticoids|glucocorticoids|mesh-ancestor
6431786|NCT00331084|Hormones|hormones|mesh-ancestor
6431787|NCT00331084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6431788|NCT00331084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6431789|NCT00331084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6431790|NCT00331084|Protease Inhibitors|protease inhibitors|mesh-ancestor
6431791|NCT00331084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6431792|NCT00331084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6431793|NCT00331084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6431794|NCT00331084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6431795|NCT00331084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6431796|NCT00331084|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6431797|NCT00331084|Contraceptive Agents|contraceptive agents|mesh-ancestor
6431798|NCT00331084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6431799|NCT00331084|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6431800|NCT00331084|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6431801|NCT00331084|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6431802|NCT00331097|Cyclophosphamide|cyclophosphamide|mesh-list
6431803|NCT00331097|Docetaxel|docetaxel|mesh-list
6431804|NCT00331097|Fluorouracil|fluorouracil|mesh-list
6431805|NCT00331097|Methotrexate|methotrexate|mesh-list
6431806|NCT00331097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6431807|NCT00331097|Immunologic Factors|immunologic factors|mesh-ancestor
6431808|NCT00331097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431809|NCT00331097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6431810|NCT00331097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6431811|NCT00331097|Alkylating Agents|alkylating agents|mesh-ancestor
6431812|NCT00331097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6431813|NCT00331097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6431814|NCT00331097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6431815|NCT00331097|Tubulin Modulators|tubulin modulators|mesh-ancestor
6431816|NCT00331097|Antimitotic Agents|antimitotic agents|mesh-ancestor
6431817|NCT00331097|Mitosis Modulators|mitosis modulators|mesh-ancestor
6431818|NCT00331097|Antimetabolites|antimetabolites|mesh-ancestor
6431819|NCT00331097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6431820|NCT00331097|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6431821|NCT00331097|Abortifacient Agents|abortifacient agents|mesh-ancestor
6431822|NCT00331097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6431823|NCT00331097|Dermatologic Agents|dermatologic agents|mesh-ancestor
6431824|NCT00331097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6431825|NCT00331097|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6431826|NCT00331097|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6431827|NCT00331123|Testosterone|testosterone|mesh-list
6540015|NCT00838370|Fluorouracil|fluorouracil|mesh-list
6540016|NCT00838370|Capecitabine|capecitabine|mesh-list
6540017|NCT00838370|Antimetabolites|antimetabolites|mesh-ancestor
6540018|NCT00838370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6540019|NCT00838370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6540020|NCT00838370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6540021|NCT00838370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6540022|NCT00838370|Immunologic Factors|immunologic factors|mesh-ancestor
6540023|NCT00838370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540024|NCT00838396|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
6540025|NCT00838396|Baclofen|baclofen|mesh-list
6540026|NCT00838396|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6540027|NCT00838396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540028|NCT00838396|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6540029|NCT00838396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6540030|NCT00838396|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6540031|NCT00838396|GABA Agonists|gaba agonists|mesh-ancestor
6540032|NCT00838396|GABA Agents|gaba agents|mesh-ancestor
6540033|NCT00838396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6540034|NCT00838396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655476|NCT01464099|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6655477|NCT01464099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6655478|NCT01464099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655479|NCT01464112|Dexamethasone|dexamethasone|mesh-list
6655480|NCT01464112|Bortezomib|bortezomib|mesh-list
6655481|NCT01464112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6655482|NCT01464112|Antiemetics|antiemetics|mesh-ancestor
6655483|NCT01464112|Autonomic Agents|autonomic agents|mesh-ancestor
6655484|NCT01464112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6655485|NCT01464112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655486|NCT01464112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6655487|NCT01464112|Glucocorticoids|glucocorticoids|mesh-ancestor
6655488|NCT01464112|Hormones|hormones|mesh-ancestor
6655489|NCT01464112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6655490|NCT01464112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6655491|NCT01464112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6655492|NCT01464125|Azithromycin|azithromycin|mesh-list
6655493|NCT01464125|Fosmidomycin|fosmidomycin|mesh-list
6655494|NCT01464125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6655495|NCT01464125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6655496|NCT01464138|Clindamycin|clindamycin|mesh-list
6655497|NCT01464138|Clindamycin palmitate|clindamycin palmitate|mesh-list
6655498|NCT01464138|Clindamycin phosphate|clindamycin phosphate|mesh-list
6655499|NCT01464138|Fosmidomycin|fosmidomycin|mesh-list
6655500|NCT01464138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6655501|NCT01464138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6655502|NCT01464138|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6655503|NCT01464138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6655504|NCT01464138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6664658|NCT01513187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6664659|NCT01513187|Immunologic Factors|immunologic factors|mesh-ancestor
6664660|NCT01513187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664661|NCT01513200|Heparin|heparin|mesh-list
6664662|NCT01513200|Calcium heparin|calcium heparin|mesh-list
6664663|NCT01513200|Anticoagulants|anticoagulants|mesh-ancestor
6664664|NCT01513200|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6664665|NCT01513200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6664666|NCT01513200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6664667|NCT01513499|Oxytocin|oxytocin|mesh-list
6664668|NCT01513499|Oxytocics|oxytocics|mesh-ancestor
6664669|NCT01513499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6664670|NCT01513499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664671|NCT01513525|Liraglutide|liraglutide|mesh-list
6431828|NCT00331123|Androgens|androgens|mesh-ancestor
6431829|NCT00331123|Hormones|hormones|mesh-ancestor
6431830|NCT00331123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6431831|NCT00331123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431832|NCT00331149|Ropinirole|ropinirole|mesh-list
6431833|NCT00331149|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6431834|NCT00331149|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6431835|NCT00331149|Dopamine Agonists|dopamine agonists|mesh-ancestor
6431836|NCT00331149|Dopamine Agents|dopamine agents|mesh-ancestor
6431837|NCT00331149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6431838|NCT00331149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6431839|NCT00331149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431840|NCT00331188|Vapreotide|vapreotide|mesh-list
6431841|NCT00331188|Analgesics|analgesics|mesh-ancestor
6431842|NCT00331188|Sensory System Agents|sensory system agents|mesh-ancestor
6431843|NCT00331188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6431844|NCT00331188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431845|NCT00331188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6431846|NCT00331214|Testosterone|testosterone|mesh-list
6431847|NCT00331214|Androgens|androgens|mesh-ancestor
6431848|NCT00331214|Hormones|hormones|mesh-ancestor
6431849|NCT00331214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6431850|NCT00331214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431851|NCT00331240|Timolol|timolol|mesh-list
6431852|NCT00331240|Travoprost|travoprost|mesh-list
6431853|NCT00331240|Lubricant Eye Drops|lubricant eye drops|mesh-list
6431854|NCT00331240|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6431855|NCT00331240|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6431856|NCT00331240|Adrenergic Agents|adrenergic agents|mesh-ancestor
6431857|NCT00331240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6431858|NCT00331240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6431859|NCT00331240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431860|NCT00331240|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6431861|NCT00331240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6431862|NCT00331240|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6431863|NCT00331240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6431864|NCT00331305|Sertraline|sertraline|mesh-list
6431865|NCT00331305|Antidepressive Agents|antidepressive agents|mesh-ancestor
6431866|NCT00331305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6431867|NCT00331305|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6431868|NCT00331305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6431869|NCT00331305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6431870|NCT00331305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6431871|NCT00331305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6431872|NCT00331305|Serotonin Agents|serotonin agents|mesh-ancestor
6431873|NCT00331305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431874|NCT00331435|Verteporfin|verteporfin|mesh-list
6431875|NCT00331435|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6431876|NCT00331435|Dermatologic Agents|dermatologic agents|mesh-ancestor
6431877|NCT00331487|Pioglitazone|pioglitazone|mesh-list
6431878|NCT00331487|Rosiglitazone|rosiglitazone|mesh-list
6431879|NCT00331487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6431880|NCT00331487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431881|NCT00331500|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
6431882|NCT00331500|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6431883|NCT00331500|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6431884|NCT00331500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6431885|NCT00331500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6431886|NCT00331500|Analgesics|analgesics|mesh-ancestor
6431887|NCT00331500|Sensory System Agents|sensory system agents|mesh-ancestor
6431888|NCT00331500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6431889|NCT00331500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431890|NCT00331500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6431891|NCT00331500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6431892|NCT00331500|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6431893|NCT00331500|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6431894|NCT00331500|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6431895|NCT00331500|Histamine Antagonists|histamine antagonists|mesh-ancestor
6431896|NCT00331500|Histamine Agents|histamine agents|mesh-ancestor
6431897|NCT00331500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6431898|NCT00331500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6431899|NCT00331513|Vorinostat|vorinostat|mesh-list
6431900|NCT00331513|Idarubicin|idarubicin|mesh-list
6431901|NCT00331513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6431902|NCT00331513|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6431903|NCT00331513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6431904|NCT00331513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6431905|NCT00331513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6431906|NCT00331513|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6431907|NCT00331513|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6431908|NCT00331526|Aldesleukin|aldesleukin|mesh-list
6431909|NCT00331526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6431910|NCT00331526|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6431911|NCT00331526|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6431912|NCT00331526|Antiviral Agents|antiviral agents|mesh-ancestor
6431913|NCT00331526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6431914|NCT00331604|Insulin|insulin|mesh-list
6431915|NCT00331604|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6540035|NCT00838656|Gemcitabine|gemcitabine|mesh-list
6540036|NCT00838656|Paclitaxel|paclitaxel|mesh-list
6540037|NCT00838656|Carboplatin|carboplatin|mesh-list
6540038|NCT00838656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6540039|NCT00838656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6540040|NCT00838656|Tubulin Modulators|tubulin modulators|mesh-ancestor
6540041|NCT00838656|Antimitotic Agents|antimitotic agents|mesh-ancestor
6540042|NCT00838656|Mitosis Modulators|mitosis modulators|mesh-ancestor
6540043|NCT00838656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6540044|NCT00838656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6540045|NCT00838656|Antimetabolites|antimetabolites|mesh-ancestor
6540046|NCT00838656|Antiviral Agents|antiviral agents|mesh-ancestor
6540047|NCT00838656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6540048|NCT00838656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6540049|NCT00838656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6540050|NCT00838656|Immunologic Factors|immunologic factors|mesh-ancestor
6540051|NCT00838656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540052|NCT00838669|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6540053|NCT00838669|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6540054|NCT00838669|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6540055|NCT00838669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6540056|NCT00838669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540057|NCT00838669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6540058|NCT00838669|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6540059|NCT00838669|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6540060|NCT00838669|Serotonin Agents|serotonin agents|mesh-ancestor
6540061|NCT00838669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6540062|NCT00838669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6540063|NCT00838669|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6540064|NCT00838669|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6431916|NCT00331604|Insulin Aspart|insulin aspart|mesh-list
6431917|NCT00331604|Insulin, Long-Acting|insulin, long-acting|mesh-list
6431918|NCT00331604|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6431919|NCT00331604|Insulin Detemir|insulin detemir|mesh-list
6431920|NCT00331604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6431921|NCT00331604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431922|NCT00331643|Epothilones|epothilones|mesh-list
6431923|NCT00331643|Epothilone B|epothilone b|mesh-list
6431924|NCT00331643|Tubulin Modulators|tubulin modulators|mesh-ancestor
6431925|NCT00331643|Antimitotic Agents|antimitotic agents|mesh-ancestor
6431926|NCT00331643|Mitosis Modulators|mitosis modulators|mesh-ancestor
6431927|NCT00331643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6431928|NCT00331643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6460952|NCT00452244|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6460953|NCT00452244|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6460954|NCT00452244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6460955|NCT00452244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6460956|NCT00452244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6460957|NCT00452270|Xylometazoline|xylometazoline|mesh-list
6460958|NCT00452270|Nasal Decongestants|nasal decongestants|mesh-ancestor
6460959|NCT00452270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6460960|NCT00452270|Respiratory System Agents|respiratory system agents|mesh-ancestor
6460961|NCT00452296|Insulin|insulin|mesh-list
6460962|NCT00452296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6460963|NCT00452296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460964|NCT00452322|Methyltestosterone|methyltestosterone|mesh-list
6460965|NCT00452322|Testosterone|testosterone|mesh-list
6460966|NCT00452322|Testosterone undecanoate|testosterone undecanoate|mesh-list
6460967|NCT00452322|Testosterone enanthate|testosterone enanthate|mesh-list
6460968|NCT00452322|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6460969|NCT00452322|Androgens|androgens|mesh-ancestor
6460970|NCT00452322|Hormones|hormones|mesh-ancestor
6460971|NCT00452322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6460972|NCT00452322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460973|NCT00452322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6460974|NCT00452322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6460975|NCT00452322|Anabolic Agents|anabolic agents|mesh-ancestor
6460976|NCT00452556|Docetaxel|docetaxel|mesh-list
6460977|NCT00452556|Leuprolide|leuprolide|mesh-list
6460978|NCT00452556|Androgens|androgens|mesh-list
6460979|NCT00452556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6460980|NCT00452556|Tubulin Modulators|tubulin modulators|mesh-ancestor
6460981|NCT00452556|Antimitotic Agents|antimitotic agents|mesh-ancestor
6460982|NCT00452556|Mitosis Modulators|mitosis modulators|mesh-ancestor
6460983|NCT00452556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6460984|NCT00452556|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6460985|NCT00452556|Fertility Agents|fertility agents|mesh-ancestor
6460986|NCT00452556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6460987|NCT00452556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460988|NCT00452556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6460989|NCT00452556|Hormones|hormones|mesh-ancestor
6460990|NCT00452556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6431929|NCT00331695|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
6431930|NCT00331695|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
6431931|NCT00331695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6431932|NCT00331695|Hormone Antagonists|hormone antagonists|mesh-ancestor
6431933|NCT00331695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6431934|NCT00331695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431935|NCT00331695|Progestins|progestins|mesh-ancestor
6431936|NCT00331695|Hormones|hormones|mesh-ancestor
6431937|NCT00331708|Artesunate|artesunate|mesh-list
6431938|NCT00331708|Pyrimethamine|pyrimethamine|mesh-list
6431939|NCT00331708|Sulfadoxine|sulfadoxine|mesh-list
6431940|NCT00331708|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6019392|NCT00386607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019393|NCT00386607|Diuretics|diuretics|mesh-ancestor
6019394|NCT00386607|Natriuretic Agents|natriuretic agents|mesh-ancestor
6431941|NCT00331708|Antimalarials|antimalarials|mesh-ancestor
6431942|NCT00331708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6431943|NCT00331708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6431944|NCT00331708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6431945|NCT00331708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6431946|NCT00331708|Antiviral Agents|antiviral agents|mesh-ancestor
6431947|NCT00331708|Schistosomicides|schistosomicides|mesh-ancestor
6431948|NCT00331708|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6431949|NCT00331708|Anthelmintics|anthelmintics|mesh-ancestor
6431950|NCT00331708|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6431951|NCT00331708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6431952|NCT00331708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6431953|NCT00331708|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6431954|NCT00331708|Renal Agents|renal agents|mesh-ancestor
6431955|NCT00331747|Glatiramer Acetate|glatiramer acetate|mesh-list
6431956|NCT00331747|(T,G)-A-L|(t,g)-a-l|mesh-list
6431957|NCT00331747|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6431958|NCT00331747|Immunologic Factors|immunologic factors|mesh-ancestor
6431959|NCT00331747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431960|NCT00331747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6431961|NCT00331747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6431962|NCT00331786|Aspirin|aspirin|mesh-list
6431963|NCT00331786|Nitroaspirin|nitroaspirin|mesh-list
6431964|NCT00331786|Nitric Oxide|nitric oxide|mesh-list
6431965|NCT00331786|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6431966|NCT00331786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6431967|NCT00331786|Analgesics|analgesics|mesh-ancestor
6431968|NCT00331786|Sensory System Agents|sensory system agents|mesh-ancestor
6540065|NCT00838669|Dopamine Agents|dopamine agents|mesh-ancestor
6540066|NCT00838760|Darunavir|darunavir|mesh-list
6540067|NCT00838760|TMC-310911|tmc-310911|mesh-list
6540068|NCT00838760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6540069|NCT00838760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6540070|NCT00838760|Protease Inhibitors|protease inhibitors|mesh-ancestor
6540071|NCT00838760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6540072|NCT00838760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6540073|NCT00838760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6540074|NCT00838760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6540075|NCT00838760|Antiviral Agents|antiviral agents|mesh-ancestor
6540076|NCT00838760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6540077|NCT00838838|Methyltestosterone|methyltestosterone|mesh-list
6540078|NCT00838838|Testosterone|testosterone|mesh-list
6540079|NCT00838838|Testosterone undecanoate|testosterone undecanoate|mesh-list
6540080|NCT00838838|Testosterone enanthate|testosterone enanthate|mesh-list
6540081|NCT00838838|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6540082|NCT00838838|Androgens|androgens|mesh-ancestor
6540083|NCT00838838|Hormones|hormones|mesh-ancestor
6540084|NCT00838838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6540085|NCT00838838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540086|NCT00838838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6540087|NCT00838838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6540088|NCT00838838|Anabolic Agents|anabolic agents|mesh-ancestor
6540089|NCT00838864|Ceftriaxone|ceftriaxone|mesh-list
6540090|NCT00838864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6540091|NCT00838864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6540092|NCT00838955|Sirolimus|sirolimus|mesh-list
6540093|NCT00838955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6540094|NCT00838955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6540095|NCT00838955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6431969|NCT00331786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6431970|NCT00331786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6431971|NCT00331786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6540096|NCT00838955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6431972|NCT00331786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6431973|NCT00331786|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6431974|NCT00331786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6431975|NCT00331786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6431976|NCT00331786|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6431977|NCT00331786|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6431978|NCT00331786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6431979|NCT00331786|Antipyretics|antipyretics|mesh-ancestor
6431980|NCT00331786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6431981|NCT00331786|Autonomic Agents|autonomic agents|mesh-ancestor
6431982|NCT00331786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6431983|NCT00331786|Respiratory System Agents|respiratory system agents|mesh-ancestor
6431984|NCT00331786|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6431985|NCT00331786|Antioxidants|antioxidants|mesh-ancestor
6431986|NCT00331786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6431987|NCT00331786|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6431988|NCT00331786|Vasodilator Agents|vasodilator agents|mesh-ancestor
6431989|NCT00331786|Gasotransmitters|gasotransmitters|mesh-ancestor
6431990|NCT00331786|Protective Agents|protective agents|mesh-ancestor
6431991|NCT00331786|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
6431992|NCT00331786|Protease Inhibitors|protease inhibitors|mesh-ancestor
6431993|NCT00331825|Olanzapine|olanzapine|mesh-list
6431994|NCT00331825|Risperidone|risperidone|mesh-list
6431995|NCT00331825|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6431996|NCT00331825|Serotonin Agents|serotonin agents|mesh-ancestor
6431997|NCT00331825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6431998|NCT00331825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6431999|NCT00331825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432000|NCT00331825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6432001|NCT00331825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6432002|NCT00331825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6432003|NCT00331825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6432004|NCT00331825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6432005|NCT00331825|Dopamine Agents|dopamine agents|mesh-ancestor
6432006|NCT00331825|Antiemetics|antiemetics|mesh-ancestor
6432007|NCT00331825|Autonomic Agents|autonomic agents|mesh-ancestor
6432008|NCT00331825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6432009|NCT00331825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6432010|NCT00331825|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6019395|NCT00386607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432011|NCT00331825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6432012|NCT00331825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6432013|NCT00331838|Enoxaparin|enoxaparin|mesh-list
6432014|NCT00331838|Semuloparin|semuloparin|mesh-list
6432015|NCT00331838|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6432016|NCT00331838|Enoxaparin sodium|enoxaparin sodium|mesh-list
6432017|NCT00331838|Anticoagulants|anticoagulants|mesh-ancestor
6432018|NCT00331838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6432019|NCT00331838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6432020|NCT00331838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432021|NCT00331851|Metformin|metformin|mesh-list
6432022|NCT00331851|Insulin Glargine|insulin glargine|mesh-list
6432023|NCT00331851|Liraglutide|liraglutide|mesh-list
6432024|NCT00331851|Glimepiride|glimepiride|mesh-list
6432025|NCT00331851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6432026|NCT00331851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432027|NCT00331851|Incretins|incretins|mesh-ancestor
6432028|NCT00331851|Hormones|hormones|mesh-ancestor
6432029|NCT00331851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6432030|NCT00331851|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6432031|NCT00331851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6432032|NCT00331851|Immunologic Factors|immunologic factors|mesh-ancestor
6432033|NCT00331890|Choline|choline|mesh-list
6432034|NCT00331890|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
6432035|NCT00331890|Lipotropic Agents|lipotropic agents|mesh-ancestor
6432036|NCT00331890|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6432037|NCT00331890|Antimetabolites|antimetabolites|mesh-ancestor
6432038|NCT00331890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432039|NCT00331890|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6432040|NCT00331890|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6432041|NCT00331890|Nootropic Agents|nootropic agents|mesh-ancestor
6432042|NCT00331955|Doxorubicin|doxorubicin|mesh-list
6432043|NCT00331955|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6432044|NCT00331955|Vorinostat|vorinostat|mesh-list
6432045|NCT00331955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6432046|NCT00331955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6432047|NCT00331955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6432048|NCT00331955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6432049|NCT00331955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6432050|NCT00331955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432051|NCT00331955|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6432052|NCT00331981|Amisulpride|amisulpride|mesh-list
6432053|NCT00331981|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6432054|NCT00331981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6432055|NCT00331981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6432056|NCT00331981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432057|NCT00331981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6432058|NCT00331981|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6432059|NCT00331981|Dopamine Agents|dopamine agents|mesh-ancestor
6432060|NCT00331981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6432061|NCT00331981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432062|NCT00331981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6432063|NCT00331981|Antidepressive Agents|antidepressive agents|mesh-ancestor
6432064|NCT00331994|Metronidazole|metronidazole|mesh-list
6432065|NCT00331994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6432066|NCT00331994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6432067|NCT00331994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6432068|NCT00331994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6432069|NCT00332020|Enoxaparin|enoxaparin|mesh-list
6432070|NCT00332020|Rivaroxaban|rivaroxaban|mesh-list
6432071|NCT00332020|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6432072|NCT00332020|Antithrombins|antithrombins|mesh-ancestor
6432073|NCT00332020|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6432074|NCT00332020|Protease Inhibitors|protease inhibitors|mesh-ancestor
6432075|NCT00332020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6432076|NCT00332020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432077|NCT00332020|Anticoagulants|anticoagulants|mesh-ancestor
6432078|NCT00332020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6432079|NCT00332020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6432080|NCT00332033|Pirfenidone|pirfenidone|mesh-list
6432081|NCT00332033|Analgesics|analgesics|mesh-ancestor
6432082|NCT00332033|Sensory System Agents|sensory system agents|mesh-ancestor
6432083|NCT00332033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6432084|NCT00332033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432085|NCT00332033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6432086|NCT00332033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6432087|NCT00332033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6432088|NCT00332033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6432089|NCT00332033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6432090|NCT00332046|Casopitant|casopitant|mesh-list
6432091|NCT00332046|Antiemetics|antiemetics|mesh-ancestor
6432092|NCT00332046|Autonomic Agents|autonomic agents|mesh-ancestor
6432093|NCT00332046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6432094|NCT00332046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432095|NCT00332046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6432096|NCT00332046|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6432097|NCT00332046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6432098|NCT00332046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432099|NCT00332059|Timolol|timolol|mesh-list
6432100|NCT00332059|Bimatoprost|bimatoprost|mesh-list
6540097|NCT00838955|Antifungal Agents|antifungal agents|mesh-ancestor
6540098|NCT00838955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6019396|NCT00386607|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6019397|NCT00386607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6019398|NCT00387010|Fentanyl|fentanyl|mesh-list
6019399|NCT00387010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6019400|NCT00387010|Narcotics|narcotics|mesh-ancestor
6019401|NCT00387010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6019402|NCT00387010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019403|NCT00387010|Analgesics|analgesics|mesh-ancestor
6432101|NCT00332059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6432102|NCT00332059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6432103|NCT00332059|Adrenergic Agents|adrenergic agents|mesh-ancestor
6432104|NCT00332059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6432105|NCT00332059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432106|NCT00332059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432107|NCT00332059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6432108|NCT00332059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6432109|NCT00332072|Timolol|timolol|mesh-list
6432110|NCT00332072|Bimatoprost|bimatoprost|mesh-list
6432111|NCT00332072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6432112|NCT00332072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6432113|NCT00332072|Adrenergic Agents|adrenergic agents|mesh-ancestor
6432114|NCT00332072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6432115|NCT00332072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432116|NCT00332072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432117|NCT00332072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6432118|NCT00332072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6432119|NCT00332085|Chromium|chromium|mesh-list
6432120|NCT00332085|Picolinic acid|picolinic acid|mesh-list
6432121|NCT00332085|Trace Elements|trace elements|mesh-ancestor
6432122|NCT00332085|Micronutrients|micronutrients|mesh-ancestor
6432123|NCT00332085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019404|NCT00387010|Sensory System Agents|sensory system agents|mesh-ancestor
6432124|NCT00332085|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6432125|NCT00332085|Chelating Agents|chelating agents|mesh-ancestor
6432126|NCT00332085|Sequestering Agents|sequestering agents|mesh-ancestor
6432127|NCT00332085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432128|NCT00332124|Choline|choline|mesh-list
6432129|NCT00332124|Lipotropic Agents|lipotropic agents|mesh-ancestor
6019405|NCT00387010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6019406|NCT00387010|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6019407|NCT00387010|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6019408|NCT00387010|Anesthetics, General|anesthetics, general|mesh-ancestor
6019409|NCT00387010|Anesthetics|anesthetics|mesh-ancestor
6019410|NCT00387023|Rituximab|rituximab|mesh-list
6432130|NCT00332124|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6432131|NCT00332124|Antimetabolites|antimetabolites|mesh-ancestor
6432132|NCT00332124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432133|NCT00332124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6432134|NCT00332124|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6432135|NCT00332124|Nootropic Agents|nootropic agents|mesh-ancestor
6432136|NCT00332137|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6432137|NCT00332137|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6432138|NCT00332137|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6540099|NCT00838955|Immunologic Factors|immunologic factors|mesh-ancestor
6540100|NCT00838955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540101|NCT00838968|Interferons|interferons|mesh-list
6540102|NCT00838968|Interferon-alpha|interferon-alpha|mesh-list
6540103|NCT00838968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6540104|NCT00838968|Antiviral Agents|antiviral agents|mesh-ancestor
6540105|NCT00838968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6540106|NCT00838968|Immunologic Factors|immunologic factors|mesh-ancestor
6540107|NCT00838968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540108|NCT00839059|Lenalidomide|lenalidomide|mesh-list
6540109|NCT00839059|Immunologic Factors|immunologic factors|mesh-ancestor
6540110|NCT00839059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540111|NCT00839059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6540112|NCT00839059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6540113|NCT00839059|Growth Substances|growth substances|mesh-ancestor
6540114|NCT00839059|Growth Inhibitors|growth inhibitors|mesh-ancestor
6540115|NCT00839059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6540116|NCT00839085|Ascorbic Acid|ascorbic acid|mesh-list
6540117|NCT00839085|Grape Seed Extract|grape seed extract|mesh-list
6540118|NCT00839085|Antioxidants|antioxidants|mesh-ancestor
6540119|NCT00839085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6540120|NCT00839085|Protective Agents|protective agents|mesh-ancestor
6540121|NCT00839085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540122|NCT00839085|Vitamins|vitamins|mesh-ancestor
6540123|NCT00839085|Micronutrients|micronutrients|mesh-ancestor
6540124|NCT00839085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6540125|NCT00839085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6540126|NCT00839111|Irinotecan|irinotecan|mesh-list
6540127|NCT00839111|Sorafenib|sorafenib|mesh-list
6540128|NCT00839111|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6540129|NCT00839111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6540130|NCT00839111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6540131|NCT00839111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6540132|NCT00839111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6540133|NCT00839111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6540134|NCT00839163|Vitamin K|vitamin k|mesh-list
6540135|NCT00839163|Enoxaparin|enoxaparin|mesh-list
6540136|NCT00839163|Rivaroxaban|rivaroxaban|mesh-list
6540137|NCT00839163|Vitamins|vitamins|mesh-ancestor
6540138|NCT00839163|Micronutrients|micronutrients|mesh-ancestor
6540139|NCT00839163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540140|NCT00839163|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6540141|NCT00839163|Antithrombins|antithrombins|mesh-ancestor
6540142|NCT00839163|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6540143|NCT00839163|Protease Inhibitors|protease inhibitors|mesh-ancestor
6540144|NCT00839163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6540145|NCT00839163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6540146|NCT00839163|Anticoagulants|anticoagulants|mesh-ancestor
6540147|NCT00839163|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6540148|NCT00839163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6540149|NCT00839163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6540150|NCT00839163|Hemostatics|hemostatics|mesh-ancestor
6432139|NCT00332137|Cholinergic Agents|cholinergic agents|mesh-ancestor
6432140|NCT00332137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6432141|NCT00332137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432142|NCT00332137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432143|NCT00332137|Urological Agents|urological agents|mesh-ancestor
6432144|NCT00332176|Ribavirin|ribavirin|mesh-list
6432145|NCT00332176|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6432146|NCT00332176|Antimetabolites|antimetabolites|mesh-ancestor
6432147|NCT00332176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432148|NCT00332176|Antiviral Agents|antiviral agents|mesh-ancestor
6432149|NCT00332176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6432150|NCT00332228|Naltrexone|naltrexone|mesh-list
6432151|NCT00332228|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6540151|NCT00839163|Coagulants|coagulants|mesh-ancestor
6540152|NCT00839228|Perhexiline|perhexiline|mesh-list
6540153|NCT00839228|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6655505|NCT01464242|Meglumine Antimoniate|meglumine antimoniate|mesh-list
6432152|NCT00332228|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6432153|NCT00332228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432154|NCT00332228|Sensory System Agents|sensory system agents|mesh-ancestor
6432155|NCT00332228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6432156|NCT00332254|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6432157|NCT00332254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6432158|NCT00332293|Moxifloxacin|moxifloxacin|mesh-list
6432159|NCT00332293|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6432160|NCT00332293|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6432161|NCT00332293|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6432162|NCT00332293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6432163|NCT00332293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6432164|NCT00332293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6432165|NCT00332293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6432166|NCT00332293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6432167|NCT00332293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432168|NCT00332293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6432169|NCT00332293|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6432170|NCT00332293|Contraceptive Agents|contraceptive agents|mesh-ancestor
6432171|NCT00332293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6432172|NCT00332293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432173|NCT00332293|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6432174|NCT00332293|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6432175|NCT00332293|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6432176|NCT00332306|Lamivudine|lamivudine|mesh-list
6432177|NCT00332306|Efavirenz|efavirenz|mesh-list
6432178|NCT00332306|Nevirapine|nevirapine|mesh-list
6432179|NCT00332306|Didanosine|didanosine|mesh-list
6432180|NCT00332306|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6432181|NCT00332306|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6432182|NCT00332306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6432183|NCT00332306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432184|NCT00332306|Antiviral Agents|antiviral agents|mesh-ancestor
6432185|NCT00332306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6432186|NCT00332306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6432187|NCT00332306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6432188|NCT00332306|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6432189|NCT00332306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6432190|NCT00332306|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6432191|NCT00332306|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6432192|NCT00332306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6432193|NCT00332306|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6432194|NCT00332306|Antimetabolites|antimetabolites|mesh-ancestor
6432195|NCT00332319|Casopitant|casopitant|mesh-list
6432196|NCT00332319|Antiemetics|antiemetics|mesh-ancestor
6432197|NCT00332319|Autonomic Agents|autonomic agents|mesh-ancestor
6432198|NCT00332319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6432199|NCT00332319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432200|NCT00332319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6432201|NCT00332319|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6432202|NCT00332319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6432203|NCT00332319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432204|NCT00332345|Timolol|timolol|mesh-list
6432205|NCT00332345|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6432206|NCT00332345|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6432207|NCT00332345|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6540154|NCT00839228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6540155|NCT00839228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6540156|NCT00839228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6540157|NCT00839228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540158|NCT00839228|Vasodilator Agents|vasodilator agents|mesh-ancestor
6540159|NCT00839280|Pantothenic Acid|pantothenic acid|mesh-list
6540160|NCT00839280|Vitamin B Complex|vitamin b complex|mesh-ancestor
6540161|NCT00839280|Vitamins|vitamins|mesh-ancestor
6540162|NCT00839280|Micronutrients|micronutrients|mesh-ancestor
6540163|NCT00839280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540164|NCT00839293|Fenofibric acid|fenofibric acid|mesh-list
6540165|NCT00839293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6540166|NCT00839293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6540167|NCT00839293|Antimetabolites|antimetabolites|mesh-ancestor
6540168|NCT00839293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432208|NCT00332345|Adrenergic Agents|adrenergic agents|mesh-ancestor
6432209|NCT00332345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6432210|NCT00332345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432211|NCT00332345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432212|NCT00332345|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6432213|NCT00332345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6432214|NCT00332345|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6432215|NCT00332345|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6432216|NCT00332345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6432217|NCT00332384|Timolol|timolol|mesh-list
6432218|NCT00332384|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6432219|NCT00332384|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6432220|NCT00332384|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6432221|NCT00332384|Adrenergic Agents|adrenergic agents|mesh-ancestor
6432222|NCT00332384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6432223|NCT00332384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432224|NCT00332384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432225|NCT00332384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6432226|NCT00332384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6432227|NCT00332384|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6432228|NCT00332384|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6432229|NCT00332384|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6432230|NCT00332397|Sirolimus|sirolimus|mesh-list
6432231|NCT00332397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6432232|NCT00332397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6432233|NCT00332397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6432234|NCT00332397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6432235|NCT00332397|Antifungal Agents|antifungal agents|mesh-ancestor
6432236|NCT00332397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6432237|NCT00332397|Immunologic Factors|immunologic factors|mesh-ancestor
6432238|NCT00332397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432239|NCT00332436|Timolol|timolol|mesh-list
6432240|NCT00332436|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6432241|NCT00332436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6432242|NCT00332436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6432243|NCT00332436|Adrenergic Agents|adrenergic agents|mesh-ancestor
6432244|NCT00332436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6432245|NCT00332436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432246|NCT00332436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432247|NCT00332436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6432248|NCT00332436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6432249|NCT00332436|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6432250|NCT00332436|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6432251|NCT00332436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6432252|NCT00332540|Timolol|timolol|mesh-list
6432253|NCT00332540|Bimatoprost|bimatoprost|mesh-list
6432254|NCT00332540|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6432255|NCT00332540|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6432256|NCT00332540|Adrenergic Agents|adrenergic agents|mesh-ancestor
6432257|NCT00332540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6432258|NCT00332540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019411|NCT00387023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6019412|NCT00387023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6019413|NCT00387023|Immunologic Factors|immunologic factors|mesh-ancestor
6019414|NCT00387023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019415|NCT00387023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6019416|NCT00387036|Fluticasone|fluticasone|mesh-list
6432259|NCT00332540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432260|NCT00332540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6432261|NCT00332540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6019417|NCT00387036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5501381|NCT04474938|Daratumumab|daratumumab|mesh-list
6432262|NCT00332553|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
6432263|NCT00332553|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6432264|NCT00332553|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6432265|NCT00332553|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6432266|NCT00332553|Medroxyprogesterone|medroxyprogesterone|mesh-list
6432267|NCT00332553|Estradiol|estradiol|mesh-list
6432268|NCT00332553|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6432269|NCT00332553|Estrogens|estrogens|mesh-list
6432270|NCT00332553|Hormones|hormones|mesh-ancestor
6432271|NCT00332553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6432272|NCT00332553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432273|NCT00332553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6432274|NCT00332553|Contraceptive Agents|contraceptive agents|mesh-ancestor
6432275|NCT00332553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6432276|NCT00332553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6432277|NCT00332553|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6432278|NCT00332553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6432279|NCT00332553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6432280|NCT00332553|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6432281|NCT00332553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6432282|NCT00332553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6432283|NCT00332553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6540169|NCT00839293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6540170|NCT00839345|Clopidogrel|clopidogrel|mesh-list
6540171|NCT00839345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6540172|NCT00839345|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6540173|NCT00839345|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6540174|NCT00839345|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6540175|NCT00839345|Purinergic Agents|purinergic agents|mesh-ancestor
6540176|NCT00839345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6540177|NCT00839345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6540178|NCT00839345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540179|NCT00839358|Midodrine|midodrine|mesh-list
6540180|NCT00839358|Sympathomimetics|sympathomimetics|mesh-ancestor
6540181|NCT00839358|Autonomic Agents|autonomic agents|mesh-ancestor
6540182|NCT00839358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6540183|NCT00839358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540184|NCT00839358|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6540185|NCT00839358|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6540186|NCT00839358|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6540187|NCT00839358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6540188|NCT00839358|Adrenergic Agents|adrenergic agents|mesh-ancestor
6540189|NCT00839358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6540190|NCT00839358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6540191|NCT00839371|Midazolam|midazolam|mesh-list
6540192|NCT00839371|Propofol|propofol|mesh-list
6540193|NCT00839371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6540194|NCT00839371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6540195|NCT00839371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540196|NCT00839371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6540197|NCT00839371|Anesthetics, General|anesthetics, general|mesh-ancestor
6540198|NCT00839371|Anesthetics|anesthetics|mesh-ancestor
6540199|NCT00839371|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6540200|NCT00839371|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6432284|NCT00332553|Hormone Antagonists|hormone antagonists|mesh-ancestor
6432285|NCT00332553|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6432286|NCT00332553|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6432287|NCT00332553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6432288|NCT00332618|Glycerol|glycerol|mesh-list
6432289|NCT00332618|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6432290|NCT00332618|Protective Agents|protective agents|mesh-ancestor
6432291|NCT00332618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432292|NCT00332631|Acetylcysteine|acetylcysteine|mesh-list
6432293|NCT00332631|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6432294|NCT00332631|Antiviral Agents|antiviral agents|mesh-ancestor
6432295|NCT00332631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6432296|NCT00332631|Expectorants|expectorants|mesh-ancestor
6432297|NCT00332631|Respiratory System Agents|respiratory system agents|mesh-ancestor
6432298|NCT00332631|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6432299|NCT00332631|Antioxidants|antioxidants|mesh-ancestor
6432300|NCT00332631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432301|NCT00332631|Protective Agents|protective agents|mesh-ancestor
6432302|NCT00332631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432303|NCT00332631|Antidotes|antidotes|mesh-ancestor
6432304|NCT00332735|Bupivacaine|bupivacaine|mesh-list
6432305|NCT00332735|Carticaine|carticaine|mesh-list
6432306|NCT00332735|Anesthetics, Local|anesthetics, local|mesh-ancestor
6432307|NCT00332735|Anesthetics|anesthetics|mesh-ancestor
6432308|NCT00332735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6432309|NCT00332735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432310|NCT00332735|Sensory System Agents|sensory system agents|mesh-ancestor
6432311|NCT00332735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6432312|NCT00332761|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
6432313|NCT00332761|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6432314|NCT00332761|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6432315|NCT00332761|Antimetabolites|antimetabolites|mesh-ancestor
6432316|NCT00332761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432317|NCT00332761|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6432318|NCT00332761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6432319|NCT00332761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6432320|NCT00332761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6432321|NCT00332761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6432322|NCT00332761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432323|NCT00332761|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6432324|NCT00332761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6432325|NCT00332774|Ketorolac|ketorolac|mesh-list
6432326|NCT00332774|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6432327|NCT00332774|Nepafenac|nepafenac|mesh-list
6432328|NCT00332774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6432329|NCT00332774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6432330|NCT00332774|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6540201|NCT00839371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6540202|NCT00839371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6540203|NCT00839371|GABA Modulators|gaba modulators|mesh-ancestor
6540204|NCT00839371|GABA Agents|gaba agents|mesh-ancestor
6540205|NCT00839371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6540206|NCT00839371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6540207|NCT00839397|Paroxetine|paroxetine|mesh-list
6540208|NCT00839397|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6540209|NCT00839397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6540210|NCT00839397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6540211|NCT00839397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6540212|NCT00839397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6540213|NCT00839397|Serotonin Agents|serotonin agents|mesh-ancestor
6540214|NCT00839397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540215|NCT00839397|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6540216|NCT00839397|Antidepressive Agents|antidepressive agents|mesh-ancestor
6540217|NCT00839397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6540218|NCT00839397|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6540219|NCT00839397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6540220|NCT00839397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6540221|NCT00839449|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
6540222|NCT00839449|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6540223|NCT00839449|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6432331|NCT00332774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6432332|NCT00332774|Analgesics|analgesics|mesh-ancestor
6432333|NCT00332774|Sensory System Agents|sensory system agents|mesh-ancestor
6432334|NCT00332774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6432335|NCT00332774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432336|NCT00332774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6432337|NCT00332774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6432338|NCT00332774|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6432339|NCT00332774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6432340|NCT00332774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432341|NCT00332787|Fluoxetine|fluoxetine|mesh-list
6432342|NCT00332787|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6432343|NCT00332787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6432344|NCT00332787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6432345|NCT00332787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432346|NCT00332787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6432347|NCT00332787|Serotonin Agents|serotonin agents|mesh-ancestor
6432348|NCT00332787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432349|NCT00332787|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6432350|NCT00332787|Antidepressive Agents|antidepressive agents|mesh-ancestor
6432351|NCT00332787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6432352|NCT00332787|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6432353|NCT00332787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6432354|NCT00332787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6432355|NCT00332826|Insulin|insulin|mesh-list
6432356|NCT00332826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6432357|NCT00332826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432358|NCT00332852|Letrozole|letrozole|mesh-list
6432359|NCT00332852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6432360|NCT00332852|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6432361|NCT00332852|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6432362|NCT00332852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6432363|NCT00332852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432364|NCT00332852|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6432365|NCT00332852|Hormone Antagonists|hormone antagonists|mesh-ancestor
6432366|NCT00332852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6432367|NCT00332852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432368|NCT00332891|Amibegron|amibegron|mesh-list
6432369|NCT00332891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6432370|NCT00332891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6432371|NCT00332891|Adrenergic Agents|adrenergic agents|mesh-ancestor
6432372|NCT00332891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6432373|NCT00332891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432374|NCT00332891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432375|NCT00332904|Propranolol|propranolol|mesh-list
6432376|NCT00332904|Spironolactone|spironolactone|mesh-list
6432377|NCT00332904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6432378|NCT00332904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6432379|NCT00332904|Adrenergic Agents|adrenergic agents|mesh-ancestor
6432380|NCT00332904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6432381|NCT00332904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432382|NCT00332904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432383|NCT00332904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6432384|NCT00332904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6432385|NCT00332904|Vasodilator Agents|vasodilator agents|mesh-ancestor
6432386|NCT00332904|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6432387|NCT00332904|Hormone Antagonists|hormone antagonists|mesh-ancestor
6432388|NCT00332904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6432389|NCT00332904|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6432390|NCT00332904|Diuretics|diuretics|mesh-ancestor
6432391|NCT00332904|Natriuretic Agents|natriuretic agents|mesh-ancestor
6432392|NCT00332930|Interferons|interferons|mesh-list
6432393|NCT00332930|Interferon-gamma|interferon-gamma|mesh-list
6432394|NCT00332930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6432395|NCT00332930|Antiviral Agents|antiviral agents|mesh-ancestor
6432396|NCT00332930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6432397|NCT00332969|Octreotide|octreotide|mesh-list
6540224|NCT00839462|Pantothenic Acid|pantothenic acid|mesh-list
6540225|NCT00839462|Vitamin B Complex|vitamin b complex|mesh-ancestor
6540226|NCT00839462|Vitamins|vitamins|mesh-ancestor
6540227|NCT00839462|Micronutrients|micronutrients|mesh-ancestor
6540228|NCT00839462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540229|NCT00839488|Pantoprazole|pantoprazole|mesh-list
6540230|NCT00839488|Famotidine|famotidine|mesh-list
6540231|NCT00839488|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6540232|NCT00839488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6540233|NCT00839488|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6540234|NCT00839488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6540235|NCT00839488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6540236|NCT00839488|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6540237|NCT00839488|Histamine Antagonists|histamine antagonists|mesh-ancestor
6540238|NCT00839488|Histamine Agents|histamine agents|mesh-ancestor
6540239|NCT00839488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6540240|NCT00839488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540241|NCT00839501|Acetazolamide|acetazolamide|mesh-list
6540242|NCT00839501|Anticonvulsants|anticonvulsants|mesh-ancestor
6540243|NCT00839501|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6540244|NCT00839501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5724715|NCT03185793|Benzbromarone|benzbromarone|mesh-list
6540245|NCT00839501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6540246|NCT00839501|Diuretics|diuretics|mesh-ancestor
6540247|NCT00839501|Natriuretic Agents|natriuretic agents|mesh-ancestor
6540248|NCT00839501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540249|NCT00839553|Minocycline|minocycline|mesh-list
6540250|NCT00839553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6540251|NCT00839553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6540252|NCT00839605|Dexmedetomidine|dexmedetomidine|mesh-list
6540253|NCT00839605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6432398|NCT00332969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6460991|NCT00452569|Thalidomide|thalidomide|mesh-list
6540254|NCT00839605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6432399|NCT00332969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6432400|NCT00332969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6432401|NCT00332995|Dapivirine|dapivirine|mesh-list
6432402|NCT00332995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6432403|NCT00332995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6432404|NCT00332995|Antiviral Agents|antiviral agents|mesh-ancestor
6432405|NCT00332995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6432406|NCT00333008|Prednisone|prednisone|mesh-list
6432407|NCT00333008|Cyclophosphamide|cyclophosphamide|mesh-list
6432408|NCT00333008|Rituximab|rituximab|mesh-list
6432409|NCT00333008|Vincristine|vincristine|mesh-list
6432410|NCT00333008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6432411|NCT00333008|Immunologic Factors|immunologic factors|mesh-ancestor
6432412|NCT00333008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432413|NCT00333008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6432414|NCT00333008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6432415|NCT00333008|Alkylating Agents|alkylating agents|mesh-ancestor
6432416|NCT00333008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432417|NCT00333008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6432418|NCT00333008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6432419|NCT00333008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6432420|NCT00333008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6432421|NCT00333008|Glucocorticoids|glucocorticoids|mesh-ancestor
6432422|NCT00333008|Hormones|hormones|mesh-ancestor
6432423|NCT00333008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6432424|NCT00333008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6432425|NCT00333008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6432426|NCT00333008|Tubulin Modulators|tubulin modulators|mesh-ancestor
6432427|NCT00333008|Antimitotic Agents|antimitotic agents|mesh-ancestor
6432428|NCT00333008|Mitosis Modulators|mitosis modulators|mesh-ancestor
6432429|NCT00333021|PENTA|penta|mesh-list
6432430|NCT00333021|Fondaparinux|fondaparinux|mesh-list
6432431|NCT00333021|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6432432|NCT00333021|Antithrombins|antithrombins|mesh-ancestor
6432433|NCT00333021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6432434|NCT00333021|Protease Inhibitors|protease inhibitors|mesh-ancestor
6432435|NCT00333021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6432436|NCT00333021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432437|NCT00333021|Anticoagulants|anticoagulants|mesh-ancestor
6432438|NCT00333021|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6432439|NCT00333021|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6432440|NCT00333034|Etanercept|etanercept|mesh-list
6432441|NCT00333034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6432442|NCT00333034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6432443|NCT00333034|Analgesics|analgesics|mesh-ancestor
6432444|NCT00333034|Sensory System Agents|sensory system agents|mesh-ancestor
6432445|NCT00333034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6432446|NCT00333034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432447|NCT00333034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6432448|NCT00333034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6432449|NCT00333034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6432450|NCT00333034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6432451|NCT00333034|Immunologic Factors|immunologic factors|mesh-ancestor
6432452|NCT00333047|Letrozole|letrozole|mesh-list
6432453|NCT00333047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6432454|NCT00333047|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6432455|NCT00333047|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6432456|NCT00333047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6432457|NCT00333047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432458|NCT00333047|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6432459|NCT00333047|Hormone Antagonists|hormone antagonists|mesh-ancestor
6432460|NCT00333047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6432461|NCT00333047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432462|NCT00333060|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6432463|NCT00333060|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6432464|NCT00333086|Letrozole|letrozole|mesh-list
6432465|NCT00333086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6540255|NCT00839605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540256|NCT00839605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6540257|NCT00839605|Analgesics|analgesics|mesh-ancestor
6540258|NCT00839605|Sensory System Agents|sensory system agents|mesh-ancestor
6540259|NCT00839605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6432466|NCT00333086|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6655506|NCT01464242|Pentoxifylline|pentoxifylline|mesh-list
6432467|NCT00333086|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6432468|NCT00333086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6432469|NCT00333086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432470|NCT00333086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6432471|NCT00333086|Hormone Antagonists|hormone antagonists|mesh-ancestor
6432472|NCT00333086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6432473|NCT00333086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432474|NCT00333112|Tamsulosin|tamsulosin|mesh-list
6432475|NCT00333112|Solifenacin Succinate|solifenacin succinate|mesh-list
6432476|NCT00333112|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6432477|NCT00333112|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6432478|NCT00333112|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6432479|NCT00333112|Adrenergic Agents|adrenergic agents|mesh-ancestor
6432480|NCT00333112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6432481|NCT00333112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432482|NCT00333112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432483|NCT00333112|Urological Agents|urological agents|mesh-ancestor
6432484|NCT00333112|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6432485|NCT00333112|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6432486|NCT00333112|Cholinergic Agents|cholinergic agents|mesh-ancestor
6432487|NCT00333125|Timolol|timolol|mesh-list
6432488|NCT00333125|Travoprost|travoprost|mesh-list
6432489|NCT00333125|Dorzolamide|dorzolamide|mesh-list
6432490|NCT00333125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6432491|NCT00333125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6432492|NCT00333125|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6432493|NCT00333125|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6432494|NCT00333125|Adrenergic Agents|adrenergic agents|mesh-ancestor
6432495|NCT00333125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6432496|NCT00333125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432497|NCT00333125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432498|NCT00333125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6432499|NCT00333125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6432500|NCT00333125|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6432501|NCT00333125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6432502|NCT00333151|Metformin|metformin|mesh-list
6432503|NCT00333151|Liraglutide|liraglutide|mesh-list
6432504|NCT00333151|Rosiglitazone|rosiglitazone|mesh-list
5724716|NCT03185793|Uricosuric Agents|uricosuric agents|mesh-ancestor
5724717|NCT03185793|Gout Suppressants|gout suppressants|mesh-ancestor
5724718|NCT03185793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5724719|NCT03185793|Renal Agents|renal agents|mesh-ancestor
6432505|NCT00333151|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6432506|NCT00333151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432507|NCT00333151|Incretins|incretins|mesh-ancestor
6432508|NCT00333151|Hormones|hormones|mesh-ancestor
6432509|NCT00333151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6432510|NCT00333164|Cilostazol|cilostazol|mesh-list
6432511|NCT00333164|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6432512|NCT00333164|Autonomic Agents|autonomic agents|mesh-ancestor
6432513|NCT00333164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6432514|NCT00333164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432515|NCT00333164|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6432516|NCT00333164|Respiratory System Agents|respiratory system agents|mesh-ancestor
6432517|NCT00333164|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6432518|NCT00333164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6432519|NCT00333164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432520|NCT00333164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6432521|NCT00333164|Vasodilator Agents|vasodilator agents|mesh-ancestor
6432522|NCT00333164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6432523|NCT00333164|Protective Agents|protective agents|mesh-ancestor
6432524|NCT00333164|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6432525|NCT00333164|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6432526|NCT00333164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6432527|NCT00333242|Dextromethorphan|dextromethorphan|mesh-list
6432528|NCT00333242|Antitussive Agents|antitussive agents|mesh-ancestor
6432529|NCT00333242|Respiratory System Agents|respiratory system agents|mesh-ancestor
6432530|NCT00333242|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6432531|NCT00333242|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6432532|NCT00333242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6432533|NCT00333242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432534|NCT00333242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432535|NCT00333255|Nepafenac|nepafenac|mesh-list
6432536|NCT00333255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6432537|NCT00333255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6432538|NCT00333255|Analgesics|analgesics|mesh-ancestor
6432539|NCT00333255|Sensory System Agents|sensory system agents|mesh-ancestor
6432540|NCT00333255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6432541|NCT00333255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432542|NCT00333255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6432543|NCT00333255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6432544|NCT00333281|Tadalafil|tadalafil|mesh-list
6432545|NCT00333281|Vasodilator Agents|vasodilator agents|mesh-ancestor
6432546|NCT00333281|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6432547|NCT00333281|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6432548|NCT00333281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6432549|NCT00333281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432550|NCT00333281|Urological Agents|urological agents|mesh-ancestor
6432551|NCT00333294|Vinorelbine|vinorelbine|mesh-list
6432552|NCT00333294|Gefitinib|gefitinib|mesh-list
6432553|NCT00333294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6432554|NCT00333294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6432555|NCT00333294|Tubulin Modulators|tubulin modulators|mesh-ancestor
6432556|NCT00333294|Antimitotic Agents|antimitotic agents|mesh-ancestor
6432557|NCT00333294|Mitosis Modulators|mitosis modulators|mesh-ancestor
6432558|NCT00333294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432559|NCT00333294|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6432560|NCT00333294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6432561|NCT00333307|Methocarbamol|methocarbamol|mesh-list
6432562|NCT00333307|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6432563|NCT00333307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432564|NCT00333307|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6432565|NCT00333307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6432566|NCT00333346|Tramadol|tramadol|mesh-list
6432567|NCT00333346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6432568|NCT00333346|Narcotics|narcotics|mesh-ancestor
6432569|NCT00333346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6432570|NCT00333346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432571|NCT00333346|Analgesics|analgesics|mesh-ancestor
6019418|NCT00387036|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6019419|NCT00387036|Autonomic Agents|autonomic agents|mesh-ancestor
6019420|NCT00387036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6432572|NCT00333346|Sensory System Agents|sensory system agents|mesh-ancestor
6432573|NCT00333346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6432574|NCT00333372|Z 338|z 338|mesh-list
6432575|NCT00333372|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6432576|NCT00333372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6432577|NCT00333372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019421|NCT00387036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432578|NCT00333372|Cholinergic Agents|cholinergic agents|mesh-ancestor
6540260|NCT00839605|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6540261|NCT00839605|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6540262|NCT00839605|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6540263|NCT00839605|Adrenergic Agents|adrenergic agents|mesh-ancestor
6540264|NCT00839605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6540265|NCT00839605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6540266|NCT00839657|Warfarin|warfarin|mesh-list
6540267|NCT00839657|Anticoagulants|anticoagulants|mesh-ancestor
6540268|NCT00839683|Dapagliflozin|dapagliflozin|mesh-list
6540269|NCT00839683|Valsartan|valsartan|mesh-list
6540270|NCT00839683|Simvastatin|simvastatin|mesh-list
6540271|NCT00839683|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6540272|NCT00839683|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6540273|NCT00839683|Antimetabolites|antimetabolites|mesh-ancestor
6540274|NCT00839683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6540275|NCT00839683|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6540276|NCT00839683|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6540277|NCT00839683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6540278|NCT00839683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6540279|NCT00839683|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6540280|NCT00839683|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6540281|NCT00839683|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6540282|NCT00839683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6540283|NCT00839683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501382|NCT04474938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5501383|NCT04474938|Antiemetics|antiemetics|mesh-ancestor
5501384|NCT04474938|Autonomic Agents|autonomic agents|mesh-ancestor
5501385|NCT04474938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5501386|NCT04474938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540284|NCT00839761|Iron|iron|mesh-list
6540285|NCT00839761|Trace Elements|trace elements|mesh-ancestor
6540286|NCT00839761|Micronutrients|micronutrients|mesh-ancestor
6540287|NCT00839761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540288|NCT00839787|Morphine|morphine|mesh-list
6540289|NCT00839787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6540290|NCT00839787|Narcotics|narcotics|mesh-ancestor
6540291|NCT00839787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5501387|NCT04474938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5501388|NCT04474938|Glucocorticoids|glucocorticoids|mesh-ancestor
5501389|NCT04474938|Hormones|hormones|mesh-ancestor
5501390|NCT04474938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5501391|NCT04474938|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5501392|NCT04474938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5501393|NCT04474600|Propofol|propofol|mesh-list
6432579|NCT00333372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6432580|NCT00333372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432581|NCT00333372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6432582|NCT00333385|Ceftazidime|ceftazidime|mesh-list
6432583|NCT00333385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6432584|NCT00333385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6432585|NCT00333398|Vaccines|vaccines|mesh-list
6432586|NCT00333398|Immunologic Factors|immunologic factors|mesh-ancestor
6432587|NCT00333398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460992|NCT00452569|Dexamethasone|dexamethasone|mesh-list
6540292|NCT00839787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540293|NCT00839787|Analgesics|analgesics|mesh-ancestor
5501394|NCT04474600|Desflurane|desflurane|mesh-list
6540294|NCT00839787|Sensory System Agents|sensory system agents|mesh-ancestor
6432588|NCT00333424|Vaccines|vaccines|mesh-list
6432589|NCT00333424|Immunologic Factors|immunologic factors|mesh-ancestor
6432590|NCT00333424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432591|NCT00333450|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6432592|NCT00333450|Immunologic Factors|immunologic factors|mesh-ancestor
6432593|NCT00333450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432594|NCT00333476|Squalamine|squalamine|mesh-list
6432595|NCT00333476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6432596|NCT00333476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6432597|NCT00333476|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6432598|NCT00333476|Protective Agents|protective agents|mesh-ancestor
6432599|NCT00333476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432600|NCT00333476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6432601|NCT00333476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6432602|NCT00333476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6432603|NCT00333476|Growth Substances|growth substances|mesh-ancestor
6432604|NCT00333476|Growth Inhibitors|growth inhibitors|mesh-ancestor
6432605|NCT00333489|Valsartan|valsartan|mesh-list
6432606|NCT00333489|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6432607|NCT00333489|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6432608|NCT00333489|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6432609|NCT00333489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432610|NCT00333567|Lumiracoxib|lumiracoxib|mesh-list
6432611|NCT00333567|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6432612|NCT00333567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6432613|NCT00333567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6432614|NCT00333567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432615|NCT00333567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6432616|NCT00333567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6432617|NCT00333567|Analgesics|analgesics|mesh-ancestor
6432618|NCT00333567|Sensory System Agents|sensory system agents|mesh-ancestor
6432619|NCT00333567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6432620|NCT00333567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432621|NCT00333567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6432622|NCT00333567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6432623|NCT00333632|Fentanyl|fentanyl|mesh-list
6432624|NCT00333632|Midazolam|midazolam|mesh-list
6432625|NCT00333632|Dexmedetomidine|dexmedetomidine|mesh-list
6432626|NCT00333632|Propofol|propofol|mesh-list
6432627|NCT00333632|Isoflurane|isoflurane|mesh-list
6540295|NCT00839787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6540296|NCT00839826|Enoxaparin|enoxaparin|mesh-list
6019422|NCT00387036|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6019423|NCT00387036|Respiratory System Agents|respiratory system agents|mesh-ancestor
6019424|NCT00387036|Dermatologic Agents|dermatologic agents|mesh-ancestor
6019425|NCT00387036|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6019426|NCT00387088|Tiotropium Bromide|tiotropium bromide|mesh-list
6019427|NCT00387088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6019428|NCT00387088|Autonomic Agents|autonomic agents|mesh-ancestor
6019429|NCT00387088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6540297|NCT00839826|Rivaroxaban|rivaroxaban|mesh-list
6540298|NCT00839826|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6540299|NCT00839826|Antithrombins|antithrombins|mesh-ancestor
6540300|NCT00839826|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6540301|NCT00839826|Protease Inhibitors|protease inhibitors|mesh-ancestor
6540302|NCT00839826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6540303|NCT00839826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6540304|NCT00839826|Anticoagulants|anticoagulants|mesh-ancestor
6540305|NCT00839826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6540306|NCT00839826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6540307|NCT00840112|Vitamin E|vitamin e|mesh-list
6540308|NCT00840112|Tocopherols|tocopherols|mesh-list
6540309|NCT00840112|alpha-Tocopherol|alpha-tocopherol|mesh-list
6540310|NCT00840112|Vitamins|vitamins|mesh-ancestor
6540311|NCT00840112|Micronutrients|micronutrients|mesh-ancestor
6540312|NCT00840112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540313|NCT00840112|Antioxidants|antioxidants|mesh-ancestor
6540314|NCT00840112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6540315|NCT00840112|Protective Agents|protective agents|mesh-ancestor
6540316|NCT00840125|Docetaxel|docetaxel|mesh-list
6540317|NCT00840125|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6540318|NCT00840125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6540319|NCT00840125|Tubulin Modulators|tubulin modulators|mesh-ancestor
6432628|NCT00333632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6540320|NCT00840125|Antimitotic Agents|antimitotic agents|mesh-ancestor
6540321|NCT00840125|Mitosis Modulators|mitosis modulators|mesh-ancestor
6540322|NCT00840125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432629|NCT00333632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6432630|NCT00333632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432631|NCT00333632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6432632|NCT00333632|Anesthetics, General|anesthetics, general|mesh-ancestor
6432633|NCT00333632|Anesthetics|anesthetics|mesh-ancestor
6432634|NCT00333632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6432635|NCT00333632|Analgesics|analgesics|mesh-ancestor
6432636|NCT00333632|Sensory System Agents|sensory system agents|mesh-ancestor
6432637|NCT00333632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6432638|NCT00333632|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6432639|NCT00333632|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6432640|NCT00333632|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6432641|NCT00333632|Adrenergic Agents|adrenergic agents|mesh-ancestor
6432642|NCT00333632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6432643|NCT00333632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432644|NCT00333632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6432645|NCT00333632|Narcotics|narcotics|mesh-ancestor
6432646|NCT00333632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6432647|NCT00333632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6432648|NCT00333632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6432649|NCT00333632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6432650|NCT00333632|GABA Modulators|gaba modulators|mesh-ancestor
6432651|NCT00333632|GABA Agents|gaba agents|mesh-ancestor
6432652|NCT00333632|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6432653|NCT00333645|Caspofungin|caspofungin|mesh-list
6432654|NCT00333645|Antifungal Agents|antifungal agents|mesh-ancestor
6432655|NCT00333645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6432656|NCT00333645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6432657|NCT00333645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432658|NCT00333671|Glycerol|glycerol|mesh-list
6432659|NCT00333671|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6432660|NCT00333671|Protective Agents|protective agents|mesh-ancestor
6432661|NCT00333671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432662|NCT00333723|Rosiglitazone|rosiglitazone|mesh-list
6432663|NCT00333723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6432664|NCT00333723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432665|NCT00333918|Bromfenac|bromfenac|mesh-list
6432666|NCT00333918|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6432667|NCT00333918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6432668|NCT00333918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6432669|NCT00333918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6432670|NCT00333918|Analgesics|analgesics|mesh-ancestor
6432671|NCT00333918|Sensory System Agents|sensory system agents|mesh-ancestor
6432672|NCT00333918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6432673|NCT00333918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432674|NCT00333918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6432675|NCT00333918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6432676|NCT00333931|Phenytoin|phenytoin|mesh-list
6432677|NCT00333931|Anticonvulsants|anticonvulsants|mesh-ancestor
6432678|NCT00333931|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6432679|NCT00333931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6432680|NCT00333931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6432681|NCT00333931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432682|NCT00333931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6432683|NCT00333931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6432684|NCT00333944|Pralidoxime|pralidoxime|mesh-list
6432685|NCT00333944|Antidotes|antidotes|mesh-ancestor
6432686|NCT00333944|Protective Agents|protective agents|mesh-ancestor
6432687|NCT00333944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432688|NCT00333944|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
6432689|NCT00333944|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
6432690|NCT00333944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432691|NCT00333944|Cholinergic Agents|cholinergic agents|mesh-ancestor
6432692|NCT00333944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6432693|NCT00333996|Dexamethasone|dexamethasone|mesh-list
6432694|NCT00333996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6432695|NCT00333996|Antiemetics|antiemetics|mesh-ancestor
6432696|NCT00333996|Autonomic Agents|autonomic agents|mesh-ancestor
6432697|NCT00333996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6432698|NCT00333996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432699|NCT00333996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6432700|NCT00333996|Glucocorticoids|glucocorticoids|mesh-ancestor
6432701|NCT00333996|Hormones|hormones|mesh-ancestor
6432702|NCT00333996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6432703|NCT00333996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6432704|NCT00333996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6432705|NCT00334022|Enfuvirtide|enfuvirtide|mesh-list
6432706|NCT00334022|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6432707|NCT00334022|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6432708|NCT00334022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432709|NCT00334022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6432710|NCT00334022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6432711|NCT00334022|Antiviral Agents|antiviral agents|mesh-ancestor
6432712|NCT00334022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6432713|NCT00334035|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6432714|NCT00334035|Antidepressive Agents|antidepressive agents|mesh-ancestor
6432715|NCT00334035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6432716|NCT00334035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6432717|NCT00334035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6432718|NCT00334035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6432719|NCT00334035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432720|NCT00334048|Ropinirole|ropinirole|mesh-list
6432721|NCT00334048|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6432722|NCT00334048|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6432723|NCT00334048|Dopamine Agonists|dopamine agonists|mesh-ancestor
6432724|NCT00334048|Dopamine Agents|dopamine agents|mesh-ancestor
6432725|NCT00334048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6432726|NCT00334048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6540323|NCT00840125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6540324|NCT00840125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6540325|NCT00840229|Triamcinolone|triamcinolone|mesh-list
6540326|NCT00840229|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6540327|NCT00840229|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6540328|NCT00840229|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6540329|NCT00840229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6540330|NCT00840229|Glucocorticoids|glucocorticoids|mesh-ancestor
6540331|NCT00840229|Hormones|hormones|mesh-ancestor
6540332|NCT00840229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6432727|NCT00334048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540333|NCT00840229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540334|NCT00840229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6540335|NCT00840229|Immunologic Factors|immunologic factors|mesh-ancestor
6540336|NCT00840229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6540337|NCT00840229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6540338|NCT00840242|Nicotine|nicotine|mesh-list
6540339|NCT00840242|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6540340|NCT00840242|Autonomic Agents|autonomic agents|mesh-ancestor
6540341|NCT00840242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6540342|NCT00840242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540343|NCT00840242|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6540344|NCT00840242|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6540345|NCT00840242|Cholinergic Agents|cholinergic agents|mesh-ancestor
6540346|NCT00840242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6540347|NCT00840242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6540348|NCT00840333|Levofloxacin|levofloxacin|mesh-list
6540349|NCT00840333|Ofloxacin|ofloxacin|mesh-list
6540350|NCT00840333|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6540351|NCT00840333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6540352|NCT00840333|Renal Agents|renal agents|mesh-ancestor
6540353|NCT00840333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6540354|NCT00840333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6540355|NCT00840333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6540356|NCT00840333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6540357|NCT00840333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6540358|NCT00840333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6540359|NCT00840333|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6540360|NCT00840333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6540361|NCT00840346|Panobinostat|panobinostat|mesh-list
6540362|NCT00840346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6540363|NCT00840346|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6540364|NCT00840346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6540365|NCT00840346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6540366|NCT00840385|Vidarabine|vidarabine|mesh-list
6540367|NCT00840385|Fludarabine|fludarabine|mesh-list
6540368|NCT00840385|Fludarabine phosphate|fludarabine phosphate|mesh-list
6540369|NCT00840385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6540370|NCT00840385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6540371|NCT00840385|Antimetabolites|antimetabolites|mesh-ancestor
6540372|NCT00840385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432728|NCT00334126|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6432729|NCT00334126|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6432730|NCT00334126|Antidepressive Agents|antidepressive agents|mesh-ancestor
6432731|NCT00334126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6432732|NCT00334126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6432733|NCT00334126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6432734|NCT00334126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6432735|NCT00334126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432736|NCT00334126|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6432737|NCT00334126|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6432738|NCT00334126|Serotonin Agents|serotonin agents|mesh-ancestor
6432739|NCT00334126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6432740|NCT00334126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432741|NCT00334126|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6432742|NCT00334126|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6432743|NCT00334126|Dopamine Agents|dopamine agents|mesh-ancestor
6432744|NCT00334139|Zoledronic Acid|zoledronic acid|mesh-list
6432745|NCT00334139|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6432746|NCT00334139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432747|NCT00334152|Casopitant|casopitant|mesh-list
6432748|NCT00334152|Antiemetics|antiemetics|mesh-ancestor
6432749|NCT00334152|Autonomic Agents|autonomic agents|mesh-ancestor
6432750|NCT00334152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6432751|NCT00334152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432752|NCT00334152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6432753|NCT00334152|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6432754|NCT00334152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6432755|NCT00334152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432756|NCT00334256|Tenofovir|tenofovir|mesh-list
6432757|NCT00334256|Emtricitabine|emtricitabine|mesh-list
6432758|NCT00334256|Antiviral Agents|antiviral agents|mesh-ancestor
6432759|NCT00334256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6432760|NCT00334256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6432761|NCT00334256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6432762|NCT00334256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6432763|NCT00334256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432764|NCT00334256|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6432765|NCT00334256|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6432766|NCT00334308|Caseins|caseins|mesh-list
6432767|NCT00334308|Chelating Agents|chelating agents|mesh-ancestor
6432768|NCT00334308|Sequestering Agents|sequestering agents|mesh-ancestor
6432769|NCT00334308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432770|NCT00334321|Paclitaxel|paclitaxel|mesh-list
6432771|NCT00334321|Carboplatin|carboplatin|mesh-list
6432772|NCT00334321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6432773|NCT00334321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6432774|NCT00334321|Tubulin Modulators|tubulin modulators|mesh-ancestor
6432775|NCT00334321|Antimitotic Agents|antimitotic agents|mesh-ancestor
6432776|NCT00334321|Mitosis Modulators|mitosis modulators|mesh-ancestor
6432777|NCT00334321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432778|NCT00334347|Valproic Acid|valproic acid|mesh-list
6432779|NCT00334347|Anticonvulsants|anticonvulsants|mesh-ancestor
6432780|NCT00334347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6432781|NCT00334347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432782|NCT00334347|GABA Agents|gaba agents|mesh-ancestor
6432783|NCT00334347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6432784|NCT00334347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432785|NCT00334347|Antimanic Agents|antimanic agents|mesh-ancestor
6432786|NCT00334347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6432787|NCT00334347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6432788|NCT00334347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6432789|NCT00334360|Dexmedetomidine|dexmedetomidine|mesh-list
6432790|NCT00334360|Buspirone|buspirone|mesh-list
6432791|NCT00334360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6432792|NCT00334360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6432793|NCT00334360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432794|NCT00334360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6432795|NCT00334360|Analgesics|analgesics|mesh-ancestor
6432796|NCT00334360|Sensory System Agents|sensory system agents|mesh-ancestor
6432797|NCT00334360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6432798|NCT00334360|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6432799|NCT00334360|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6432800|NCT00334360|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6432801|NCT00334360|Adrenergic Agents|adrenergic agents|mesh-ancestor
6432802|NCT00334360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6432803|NCT00334360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432804|NCT00334360|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6432805|NCT00334360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6432806|NCT00334360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6432807|NCT00334360|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6432808|NCT00334360|Serotonin Agents|serotonin agents|mesh-ancestor
6432809|NCT00334386|Torsemide|torsemide|mesh-list
6432810|NCT00334386|Diuretics|diuretics|mesh-list
6432811|NCT00334386|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
6432812|NCT00334386|Natriuretic Agents|natriuretic agents|mesh-ancestor
6432813|NCT00334386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432814|NCT00334386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6432815|NCT00334386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432816|NCT00334386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6432817|NCT00334399|Miglitol|miglitol|mesh-list
6432818|NCT00334399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6432819|NCT00334399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432820|NCT00334399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6432821|NCT00334399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432822|NCT00334399|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6432823|NCT00334412|Caspofungin|caspofungin|mesh-list
6432824|NCT00334412|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6432825|NCT00334412|Antifungal Agents|antifungal agents|mesh-ancestor
6432826|NCT00334412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6432827|NCT00334412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6432828|NCT00334412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432829|NCT00334412|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6432830|NCT00334412|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6432831|NCT00334425|Menotropins|menotropins|mesh-list
6432832|NCT00334425|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6432833|NCT00334425|Fertility Agents|fertility agents|mesh-ancestor
6540373|NCT00840385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6540374|NCT00840385|Immunologic Factors|immunologic factors|mesh-ancestor
6540375|NCT00840385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540376|NCT00840385|Antiviral Agents|antiviral agents|mesh-ancestor
6540377|NCT00840385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6540378|NCT00840398|Buspirone|buspirone|mesh-list
6540379|NCT00840398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6540380|NCT00840398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6540381|NCT00840398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6540382|NCT00840398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540383|NCT00840398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6540384|NCT00840398|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6540385|NCT00840398|Serotonin Agents|serotonin agents|mesh-ancestor
6540386|NCT00840398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6540387|NCT00840398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655507|NCT01464242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6655508|NCT01464242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6655509|NCT01464242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655510|NCT01464242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6655511|NCT01464242|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6655512|NCT01464242|Protective Agents|protective agents|mesh-ancestor
6655513|NCT01464242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655514|NCT01464242|Vasodilator Agents|vasodilator agents|mesh-ancestor
6655515|NCT01464242|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6655516|NCT01464242|Antioxidants|antioxidants|mesh-ancestor
6655517|NCT01464242|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6655518|NCT01464242|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6655519|NCT01464242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6655520|NCT01464268|Riboflavin|riboflavin|mesh-list
6655521|NCT01464268|Dextrans|dextrans|mesh-list
6432834|NCT00334425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6432835|NCT00334425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432836|NCT00334438|Rituximab|rituximab|mesh-list
6432837|NCT00334438|Bortezomib|bortezomib|mesh-list
6432838|NCT00334438|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6432839|NCT00334438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6432840|NCT00334438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6432841|NCT00334438|Immunologic Factors|immunologic factors|mesh-ancestor
6432842|NCT00334438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432843|NCT00334438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6432844|NCT00334464|Warfarin|warfarin|mesh-list
6432845|NCT00334464|Anticoagulants|anticoagulants|mesh-ancestor
6432846|NCT00334477|Tadalafil|tadalafil|mesh-list
6432847|NCT00334477|Vasodilator Agents|vasodilator agents|mesh-ancestor
6432848|NCT00334477|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6432849|NCT00334477|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6432850|NCT00334477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6432851|NCT00334477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432852|NCT00334477|Urological Agents|urological agents|mesh-ancestor
6432853|NCT00334490|Sildenafil Citrate|sildenafil citrate|mesh-list
6432854|NCT00334490|Vasodilator Agents|vasodilator agents|mesh-ancestor
6432855|NCT00334490|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6432856|NCT00334490|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6432857|NCT00334490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6432858|NCT00334490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432859|NCT00334490|Urological Agents|urological agents|mesh-ancestor
6432860|NCT00334503|Miglitol|miglitol|mesh-list
6432861|NCT00334503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6432862|NCT00334503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432863|NCT00334503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6432864|NCT00334503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432865|NCT00334503|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6432866|NCT00334529|Oseltamivir|oseltamivir|mesh-list
6432867|NCT00334529|Antiviral Agents|antiviral agents|mesh-ancestor
6432868|NCT00334529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6432869|NCT00334529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6432870|NCT00334529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432871|NCT00334568|Rosiglitazone|rosiglitazone|mesh-list
6432872|NCT00334568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6432873|NCT00334568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432874|NCT00334581|Irbesartan|irbesartan|mesh-list
6432875|NCT00334581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6432876|NCT00334581|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6432877|NCT00334581|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6432878|NCT00334581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432879|NCT00334594|Pemetrexed|pemetrexed|mesh-list
6432880|NCT00334594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6432881|NCT00334594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6432882|NCT00334594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432883|NCT00334594|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6432884|NCT00334594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6432885|NCT00334646|Cyclophosphamide|cyclophosphamide|mesh-list
6432886|NCT00334646|Casopitant|casopitant|mesh-list
6432887|NCT00334646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6432888|NCT00334646|Immunologic Factors|immunologic factors|mesh-ancestor
6432889|NCT00334646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432890|NCT00334646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6432891|NCT00334646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6432892|NCT00334646|Alkylating Agents|alkylating agents|mesh-ancestor
6432893|NCT00334646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432894|NCT00334646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6432895|NCT00334646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6432896|NCT00334646|Antiemetics|antiemetics|mesh-ancestor
6432897|NCT00334646|Autonomic Agents|autonomic agents|mesh-ancestor
6432898|NCT00334646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6432899|NCT00334646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6432900|NCT00334646|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6432901|NCT00334646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6432902|NCT00334672|Cyclosporine|cyclosporine|mesh-list
6432903|NCT00334672|Mycophenolic Acid|mycophenolic acid|mesh-list
6432904|NCT00334672|Dexamethasone|dexamethasone|mesh-list
6432905|NCT00334672|Hydrocortisone|hydrocortisone|mesh-list
6432906|NCT00334672|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6432907|NCT00334672|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6432908|NCT00334672|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6432909|NCT00334672|Cyclophosphamide|cyclophosphamide|mesh-list
6432910|NCT00334672|Busulfan|busulfan|mesh-list
6432911|NCT00334672|Methotrexate|methotrexate|mesh-list
6432912|NCT00334672|Etoposide|etoposide|mesh-list
6432913|NCT00334672|Cyclosporins|cyclosporins|mesh-list
6432914|NCT00334672|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6432915|NCT00334672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6432916|NCT00334672|Immunologic Factors|immunologic factors|mesh-ancestor
6432917|NCT00334672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540388|NCT00840489|Ribavirin|ribavirin|mesh-list
6540389|NCT00840489|Colchicine|colchicine|mesh-list
6540390|NCT00840489|Antimetabolites|antimetabolites|mesh-ancestor
6540391|NCT00840489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6540392|NCT00840489|Antiviral Agents|antiviral agents|mesh-ancestor
6540393|NCT00840489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6540394|NCT00840489|Gout Suppressants|gout suppressants|mesh-ancestor
6540395|NCT00840489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6540396|NCT00840489|Tubulin Modulators|tubulin modulators|mesh-ancestor
6540397|NCT00840489|Antimitotic Agents|antimitotic agents|mesh-ancestor
6540398|NCT00840489|Mitosis Modulators|mitosis modulators|mesh-ancestor
6540399|NCT00840489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6540400|NCT00840580|Moxifloxacin|moxifloxacin|mesh-list
6540401|NCT00840580|Levofloxacin|levofloxacin|mesh-list
6540402|NCT00840580|Ofloxacin|ofloxacin|mesh-list
6540403|NCT00840580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6540404|NCT00840580|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6540405|NCT00840580|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6540406|NCT00840580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6540407|NCT00840580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6540408|NCT00840580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6540409|NCT00840580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6540410|NCT00840580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6540411|NCT00840580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6540412|NCT00840580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6432918|NCT00334672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6432919|NCT00334672|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6432920|NCT00334672|Alkylating Agents|alkylating agents|mesh-ancestor
6540413|NCT00840580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6432921|NCT00334672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432922|NCT00334672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6432923|NCT00334672|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6432924|NCT00334672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6432925|NCT00334672|Antiemetics|antiemetics|mesh-ancestor
6432926|NCT00334672|Autonomic Agents|autonomic agents|mesh-ancestor
6432927|NCT00334672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6432928|NCT00334672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6432929|NCT00334672|Glucocorticoids|glucocorticoids|mesh-ancestor
6432930|NCT00334672|Hormones|hormones|mesh-ancestor
6432931|NCT00334672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6432932|NCT00334672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6432933|NCT00334672|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6432934|NCT00334672|Abortifacient Agents|abortifacient agents|mesh-ancestor
6432935|NCT00334672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6432936|NCT00334672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6432937|NCT00334672|Antimetabolites|antimetabolites|mesh-ancestor
6432938|NCT00334672|Dermatologic Agents|dermatologic agents|mesh-ancestor
6432939|NCT00334672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6432940|NCT00334672|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6432941|NCT00334672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6432942|NCT00334672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6432943|NCT00334672|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6432944|NCT00334672|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6432945|NCT00334672|Antifungal Agents|antifungal agents|mesh-ancestor
6432946|NCT00334672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6432947|NCT00334672|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6432948|NCT00334672|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6432949|NCT00334672|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6432950|NCT00334672|Antitubercular Agents|antitubercular agents|mesh-ancestor
6432951|NCT00334672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6432952|NCT00334685|Pregabalin|pregabalin|mesh-list
6432953|NCT00334685|Reboxetine|reboxetine|mesh-list
6432954|NCT00334685|Analgesics|analgesics|mesh-ancestor
6432955|NCT00334685|Sensory System Agents|sensory system agents|mesh-ancestor
6432956|NCT00334685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6432957|NCT00334685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540414|NCT00840580|Contraceptive Agents|contraceptive agents|mesh-ancestor
6540415|NCT00840580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6540416|NCT00840580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540417|NCT00840580|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6540418|NCT00840580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6540419|NCT00840580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6540420|NCT00840580|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6540421|NCT00840580|Renal Agents|renal agents|mesh-ancestor
6540422|NCT00840580|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6540423|NCT00840580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6540424|NCT00840606|Buspirone|buspirone|mesh-list
6540425|NCT00840606|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6540426|NCT00840606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6540427|NCT00840606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6540428|NCT00840606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540429|NCT00840606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6540430|NCT00840606|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6540431|NCT00840606|Serotonin Agents|serotonin agents|mesh-ancestor
6540432|NCT00840606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6540433|NCT00840606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6540434|NCT00840645|Mirabegron|mirabegron|mesh-list
6540435|NCT00840645|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6540436|NCT00840645|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6540437|NCT00840645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6540438|NCT00840645|Adrenergic Agents|adrenergic agents|mesh-ancestor
6540439|NCT00840645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6540440|NCT00840645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6540441|NCT00840645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540442|NCT00840645|Urological Agents|urological agents|mesh-ancestor
6540443|NCT00840671|Cerebrolysin|cerebrolysin|mesh-list
6540444|NCT00840671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6540445|NCT00840671|Protective Agents|protective agents|mesh-ancestor
6540446|NCT00840671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540447|NCT00840671|Nootropic Agents|nootropic agents|mesh-ancestor
6540448|NCT00840684|Cytarabine|cytarabine|mesh-list
6540449|NCT00840684|Melphalan|melphalan|mesh-list
6432958|NCT00334685|Anticonvulsants|anticonvulsants|mesh-ancestor
6432959|NCT00334685|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6432960|NCT00334685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6432961|NCT00334685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432962|NCT00334685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6432963|NCT00334685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6432964|NCT00334685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6432965|NCT00334685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6432966|NCT00334685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6432967|NCT00334685|Antidepressive Agents|antidepressive agents|mesh-ancestor
6432968|NCT00334685|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6432969|NCT00334685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6432970|NCT00334685|Adrenergic Agents|adrenergic agents|mesh-ancestor
6432971|NCT00334685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6432972|NCT00334698|Cetirizine|cetirizine|mesh-list
6432973|NCT00334698|Pseudoephedrine|pseudoephedrine|mesh-list
6432974|NCT00334698|Ephedrine|ephedrine|mesh-list
6432975|NCT00334698|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6432976|NCT00334698|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6432977|NCT00334698|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6432978|NCT00334698|Histamine Antagonists|histamine antagonists|mesh-ancestor
6432979|NCT00334698|Histamine Agents|histamine agents|mesh-ancestor
6432980|NCT00334698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6432981|NCT00334698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6432982|NCT00334698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6432983|NCT00334698|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6432984|NCT00334698|Autonomic Agents|autonomic agents|mesh-ancestor
6432985|NCT00334698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6432986|NCT00334698|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6432987|NCT00334698|Respiratory System Agents|respiratory system agents|mesh-ancestor
6432988|NCT00334698|Nasal Decongestants|nasal decongestants|mesh-ancestor
6432989|NCT00334698|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6432990|NCT00334698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6432991|NCT00334698|Sympathomimetics|sympathomimetics|mesh-ancestor
6432992|NCT00334698|Adrenergic Agents|adrenergic agents|mesh-ancestor
6432993|NCT00334763|Paclitaxel|paclitaxel|mesh-list
6432994|NCT00334763|Bevacizumab|bevacizumab|mesh-list
6432995|NCT00334763|Carboplatin|carboplatin|mesh-list
6432996|NCT00334763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6432997|NCT00334763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6432998|NCT00334763|Tubulin Modulators|tubulin modulators|mesh-ancestor
6432999|NCT00334763|Antimitotic Agents|antimitotic agents|mesh-ancestor
6433000|NCT00334763|Mitosis Modulators|mitosis modulators|mesh-ancestor
6433001|NCT00334763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433002|NCT00334763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6433003|NCT00334763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6433004|NCT00334763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6433005|NCT00334763|Growth Substances|growth substances|mesh-ancestor
6433006|NCT00334763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433007|NCT00334763|Growth Inhibitors|growth inhibitors|mesh-ancestor
6433008|NCT00334789|Vitamin A|vitamin a|mesh-list
6433009|NCT00334789|Tretinoin|tretinoin|mesh-list
6433010|NCT00334789|Belinostat|belinostat|mesh-list
6433011|NCT00334789|Isotretinoin|isotretinoin|mesh-list
6433012|NCT00334789|Vitamins|vitamins|mesh-ancestor
6433013|NCT00334789|Micronutrients|micronutrients|mesh-ancestor
6433014|NCT00334789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540450|NCT00840684|Busulfan|busulfan|mesh-list
6540451|NCT00840684|Daunorubicin|daunorubicin|mesh-list
6540452|NCT00840684|Mitoxantrone|mitoxantrone|mesh-list
6540453|NCT00840684|Amsacrine|amsacrine|mesh-list
6540454|NCT00840684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6540455|NCT00840684|Antimetabolites|antimetabolites|mesh-ancestor
6540456|NCT00840684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6540457|NCT00840684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6540458|NCT00840684|Antiviral Agents|antiviral agents|mesh-ancestor
6540459|NCT00840684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6540460|NCT00840684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6540461|NCT00840684|Immunologic Factors|immunologic factors|mesh-ancestor
6540462|NCT00840684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540463|NCT00840684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6540464|NCT00840684|Alkylating Agents|alkylating agents|mesh-ancestor
6540465|NCT00840684|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6540466|NCT00840684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6540467|NCT00840684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6540468|NCT00840684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6540469|NCT00840684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6540470|NCT00840684|Analgesics|analgesics|mesh-ancestor
6540471|NCT00840684|Sensory System Agents|sensory system agents|mesh-ancestor
6540472|NCT00840684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6540473|NCT00840801|Vaccines|vaccines|mesh-list
6540474|NCT00840801|Immunologic Factors|immunologic factors|mesh-ancestor
6540475|NCT00840801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540476|NCT00840853|Acetaminophen|acetaminophen|mesh-list
6540477|NCT00840853|Diphenhydramine|diphenhydramine|mesh-list
6433015|NCT00334789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433016|NCT00334789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6433017|NCT00334789|Keratolytic Agents|keratolytic agents|mesh-ancestor
6019430|NCT00387088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019431|NCT00387088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6019432|NCT00387088|Respiratory System Agents|respiratory system agents|mesh-ancestor
6433018|NCT00334789|Dermatologic Agents|dermatologic agents|mesh-ancestor
6433019|NCT00334789|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6433020|NCT00334789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6433021|NCT00334854|Doxorubicin|doxorubicin|mesh-list
6433022|NCT00334854|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6433023|NCT00334854|Ifosfamide|ifosfamide|mesh-list
6433024|NCT00334854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6433025|NCT00334854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6433026|NCT00334854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6433027|NCT00334854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6433028|NCT00334854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6433029|NCT00334854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433030|NCT00334854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6433031|NCT00334854|Alkylating Agents|alkylating agents|mesh-ancestor
6433032|NCT00334867|Cyclophosphamide|cyclophosphamide|mesh-list
6433033|NCT00334867|Ifosfamide|ifosfamide|mesh-list
6433034|NCT00334867|Doxorubicin|doxorubicin|mesh-list
6433035|NCT00334867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6433036|NCT00334867|Etoposide|etoposide|mesh-list
6433037|NCT00334867|Vincristine|vincristine|mesh-list
6433038|NCT00334867|Topotecan|topotecan|mesh-list
6433039|NCT00334867|Dexrazoxane|dexrazoxane|mesh-list
6433040|NCT00334867|Razoxane|razoxane|mesh-list
6433041|NCT00334867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6433042|NCT00334867|Immunologic Factors|immunologic factors|mesh-ancestor
6433043|NCT00334867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433044|NCT00334867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6433045|NCT00334867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6433046|NCT00334867|Alkylating Agents|alkylating agents|mesh-ancestor
6433047|NCT00334867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433048|NCT00334867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6433049|NCT00334867|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6433050|NCT00334867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6433051|NCT00334867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6433052|NCT00334867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6433053|NCT00334867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6433054|NCT00334867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6433055|NCT00334867|Tubulin Modulators|tubulin modulators|mesh-ancestor
6433056|NCT00334867|Antimitotic Agents|antimitotic agents|mesh-ancestor
6433057|NCT00334867|Mitosis Modulators|mitosis modulators|mesh-ancestor
6433058|NCT00334867|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6433059|NCT00334867|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6433060|NCT00334867|Protective Agents|protective agents|mesh-ancestor
6433061|NCT00334880|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6019433|NCT00387088|Parasympatholytics|parasympatholytics|mesh-ancestor
6019434|NCT00387088|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6433062|NCT00334880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6433063|NCT00334880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433064|NCT00334880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6433065|NCT00334880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6433066|NCT00334880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6433067|NCT00334880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433068|NCT00334880|Dopamine Agents|dopamine agents|mesh-ancestor
6433069|NCT00334880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6433070|NCT00334906|Memantine|memantine|mesh-list
6433071|NCT00334906|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6433072|NCT00334906|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6433073|NCT00334906|Dopamine Agents|dopamine agents|mesh-ancestor
6433074|NCT00334906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6433075|NCT00334906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433076|NCT00334906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433077|NCT00334906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6433078|NCT00334906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6433079|NCT00334919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
6433080|NCT00334932|Doxorubicin|doxorubicin|mesh-list
6433081|NCT00334932|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6433082|NCT00334932|Bortezomib|bortezomib|mesh-list
6433083|NCT00334932|Melphalan|melphalan|mesh-list
6433084|NCT00334932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6433085|NCT00334932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6433086|NCT00334932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6433087|NCT00334932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6433088|NCT00334932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6433089|NCT00334932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433090|NCT00334932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6433091|NCT00334932|Alkylating Agents|alkylating agents|mesh-ancestor
6433092|NCT00334932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6433093|NCT00334932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6433094|NCT00334932|Immunologic Factors|immunologic factors|mesh-ancestor
6433095|NCT00334932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433096|NCT00335010|Nitroglycerin|nitroglycerin|mesh-list
6433097|NCT00335010|Vasodilator Agents|vasodilator agents|mesh-ancestor
6433098|NCT00335075|Temozolomide|temozolomide|mesh-list
6433099|NCT00335075|Semustine|semustine|mesh-list
6433100|NCT00335075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6433101|NCT00335075|Alkylating Agents|alkylating agents|mesh-ancestor
6433102|NCT00335075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433103|NCT00335075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6433104|NCT00335088|Iodine|iodine|mesh-list
6433105|NCT00335088|Moxifloxacin|moxifloxacin|mesh-list
6433106|NCT00335088|Povidone-Iodine|povidone-iodine|mesh-list
6433107|NCT00335088|Povidone|povidone|mesh-list
6433108|NCT00335088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6433109|NCT00335088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6433110|NCT00335088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6433111|NCT00335088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6433112|NCT00335088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6433113|NCT00335088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433114|NCT00335088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6433115|NCT00335088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433116|NCT00335088|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6433117|NCT00335088|Trace Elements|trace elements|mesh-ancestor
6433118|NCT00335088|Micronutrients|micronutrients|mesh-ancestor
6433119|NCT00335088|Plasma Substitutes|plasma substitutes|mesh-ancestor
6433120|NCT00335088|Blood Substitutes|blood substitutes|mesh-ancestor
6460993|NCT00452569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6460994|NCT00452569|Antiemetics|antiemetics|mesh-ancestor
6460995|NCT00452569|Autonomic Agents|autonomic agents|mesh-ancestor
6460996|NCT00452569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6460997|NCT00452569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6460998|NCT00452569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6460999|NCT00452569|Glucocorticoids|glucocorticoids|mesh-ancestor
6461000|NCT00452569|Hormones|hormones|mesh-ancestor
6461001|NCT00452569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6461002|NCT00452569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6461003|NCT00452569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6461004|NCT00452569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6461005|NCT00452569|Immunologic Factors|immunologic factors|mesh-ancestor
6461006|NCT00452569|Leprostatic Agents|leprostatic agents|mesh-ancestor
6461007|NCT00452569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6461008|NCT00452569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6461009|NCT00452569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6461010|NCT00452569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6461011|NCT00452569|Growth Substances|growth substances|mesh-ancestor
6461012|NCT00452569|Growth Inhibitors|growth inhibitors|mesh-ancestor
6461013|NCT00452582|Sildenafil Citrate|sildenafil citrate|mesh-list
6461014|NCT00452582|Vasodilator Agents|vasodilator agents|mesh-ancestor
6461015|NCT00452582|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6540478|NCT00840853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6540479|NCT00840853|Analgesics|analgesics|mesh-ancestor
6540480|NCT00840853|Sensory System Agents|sensory system agents|mesh-ancestor
6540481|NCT00840853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6540482|NCT00840853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540483|NCT00840853|Antipyretics|antipyretics|mesh-ancestor
6540484|NCT00840853|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6461016|NCT00452582|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6461017|NCT00452582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6433121|NCT00335114|Cyclosporine|cyclosporine|mesh-list
6433122|NCT00335114|Cyclosporins|cyclosporins|mesh-list
6433123|NCT00335114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6433124|NCT00335114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433125|NCT00335114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6433126|NCT00335114|Immunologic Factors|immunologic factors|mesh-ancestor
6433127|NCT00335114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433128|NCT00335114|Antifungal Agents|antifungal agents|mesh-ancestor
6433129|NCT00335114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6433130|NCT00335114|Dermatologic Agents|dermatologic agents|mesh-ancestor
6433131|NCT00335114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6433132|NCT00335114|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6433133|NCT00335166|Pramipexole|pramipexole|mesh-list
6433134|NCT00335166|Antioxidants|antioxidants|mesh-ancestor
6433135|NCT00335166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433136|NCT00335166|Protective Agents|protective agents|mesh-ancestor
6433137|NCT00335166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433138|NCT00335166|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6433139|NCT00335166|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6433140|NCT00335166|Dopamine Agonists|dopamine agonists|mesh-ancestor
6433141|NCT00335166|Dopamine Agents|dopamine agents|mesh-ancestor
6433142|NCT00335166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6433143|NCT00335179|Imiquimod|imiquimod|mesh-list
6433144|NCT00335179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6433145|NCT00335179|Immunologic Factors|immunologic factors|mesh-ancestor
6433146|NCT00335179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433147|NCT00335179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6433148|NCT00335179|Interferon Inducers|interferon inducers|mesh-ancestor
6433149|NCT00335192|Tenofovir|tenofovir|mesh-list
6433150|NCT00335192|Lamivudine|lamivudine|mesh-list
6433151|NCT00335192|Lopinavir|lopinavir|mesh-list
6433152|NCT00335192|Abacavir|abacavir|mesh-list
6433153|NCT00335192|Antiviral Agents|antiviral agents|mesh-ancestor
6433154|NCT00335192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6433155|NCT00335192|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6433156|NCT00335192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6433157|NCT00335192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6433158|NCT00335192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433159|NCT00335192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6433160|NCT00335192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6433161|NCT00335192|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6433162|NCT00335192|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6433163|NCT00335192|Protease Inhibitors|protease inhibitors|mesh-ancestor
6433164|NCT00335192|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6433165|NCT00335192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6433166|NCT00335205|Ropinirole|ropinirole|mesh-list
6433167|NCT00335205|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6433168|NCT00335205|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6433169|NCT00335205|Dopamine Agonists|dopamine agonists|mesh-ancestor
6433170|NCT00335205|Dopamine Agents|dopamine agents|mesh-ancestor
6433171|NCT00335205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6433172|NCT00335205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433173|NCT00335205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433174|NCT00335231|Gatifloxacin|gatifloxacin|mesh-list
6433175|NCT00335231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6433176|NCT00335231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6433177|NCT00335231|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6433178|NCT00335231|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6433179|NCT00335231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6433180|NCT00335231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6433181|NCT00335231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6433182|NCT00335231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433183|NCT00335231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6433184|NCT00335270|Ritonavir|ritonavir|mesh-list
6433185|NCT00335270|Amprenavir|amprenavir|mesh-list
6433186|NCT00335270|Fosamprenavir|fosamprenavir|mesh-list
6433187|NCT00335270|Lamivudine|lamivudine|mesh-list
6433188|NCT00335270|Abacavir|abacavir|mesh-list
6433189|NCT00335270|Calcium|calcium|mesh-list
6433190|NCT00335270|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6433191|NCT00335270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433192|NCT00335270|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6433193|NCT00335270|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6433194|NCT00335270|Protease Inhibitors|protease inhibitors|mesh-ancestor
6433195|NCT00335270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6433196|NCT00335270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433197|NCT00335270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6433198|NCT00335270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6433199|NCT00335270|Antiviral Agents|antiviral agents|mesh-ancestor
6433200|NCT00335270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6433201|NCT00335270|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6433202|NCT00335270|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6433203|NCT00335270|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6433204|NCT00335270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6433205|NCT00335270|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6433206|NCT00335270|Antitubercular Agents|antitubercular agents|mesh-ancestor
6433207|NCT00335270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6433208|NCT00335309|Amoxicillin|amoxicillin|mesh-list
6433209|NCT00335309|Clavulanic Acid|clavulanic acid|mesh-list
6433210|NCT00335309|Clavulanic Acids|clavulanic acids|mesh-list
6433211|NCT00335309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6433212|NCT00335309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6433213|NCT00335309|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6433214|NCT00335309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6433215|NCT00335309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433216|NCT00335348|Dexamethasone|dexamethasone|mesh-list
6433217|NCT00335348|Bortezomib|bortezomib|mesh-list
6433218|NCT00335348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6433219|NCT00335348|Antiemetics|antiemetics|mesh-ancestor
6433220|NCT00335348|Autonomic Agents|autonomic agents|mesh-ancestor
6433221|NCT00335348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6433222|NCT00335348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433223|NCT00335348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6433224|NCT00335348|Glucocorticoids|glucocorticoids|mesh-ancestor
6433225|NCT00335348|Hormones|hormones|mesh-ancestor
6433226|NCT00335348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6433227|NCT00335348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6433228|NCT00335348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6433229|NCT00335400|Anesthetics|anesthetics|mesh-list
6433230|NCT00335400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6433231|NCT00335400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433232|NCT00335413|Spironolactone|spironolactone|mesh-list
6433233|NCT00335413|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6433234|NCT00335413|Hormone Antagonists|hormone antagonists|mesh-ancestor
6433235|NCT00335413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6433236|NCT00335413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433237|NCT00335413|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6433238|NCT00335413|Diuretics|diuretics|mesh-ancestor
6433239|NCT00335413|Natriuretic Agents|natriuretic agents|mesh-ancestor
6433240|NCT00335439|Ketorolac|ketorolac|mesh-list
6433241|NCT00335439|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6433242|NCT00335439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6433243|NCT00335439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6433244|NCT00335439|Analgesics|analgesics|mesh-ancestor
6433245|NCT00335439|Sensory System Agents|sensory system agents|mesh-ancestor
6433246|NCT00335439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6433247|NCT00335439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433248|NCT00335439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6433249|NCT00335439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6433250|NCT00335439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6433251|NCT00335439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6433252|NCT00335439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433253|NCT00335465|Insulin Glargine|insulin glargine|mesh-list
6433254|NCT00335465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6540485|NCT00840853|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6540486|NCT00840853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6540487|NCT00840853|Anesthetics, Local|anesthetics, local|mesh-ancestor
6540488|NCT00840853|Anesthetics|anesthetics|mesh-ancestor
6540489|NCT00840853|Antiemetics|antiemetics|mesh-ancestor
6540490|NCT00840853|Autonomic Agents|autonomic agents|mesh-ancestor
6540491|NCT00840853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6540492|NCT00840853|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6540493|NCT00840853|Histamine Antagonists|histamine antagonists|mesh-ancestor
6540494|NCT00840853|Histamine Agents|histamine agents|mesh-ancestor
6540495|NCT00840853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6540496|NCT00840853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6540497|NCT00840853|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6433255|NCT00335465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433256|NCT00335543|Gemcitabine|gemcitabine|mesh-list
6433257|NCT00335543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6433258|NCT00335543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6433259|NCT00335543|Antimetabolites|antimetabolites|mesh-ancestor
6433260|NCT00335543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433261|NCT00335543|Antiviral Agents|antiviral agents|mesh-ancestor
6433262|NCT00335543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6433263|NCT00335543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6433264|NCT00335543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6433265|NCT00335543|Immunologic Factors|immunologic factors|mesh-ancestor
6433266|NCT00335543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433267|NCT00335582|Clonidine|clonidine|mesh-list
6433268|NCT00335582|Analgesics|analgesics|mesh-ancestor
6433269|NCT00335582|Sensory System Agents|sensory system agents|mesh-ancestor
6433270|NCT00335582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6433271|NCT00335582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433272|NCT00335582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6433273|NCT00335582|Sympatholytics|sympatholytics|mesh-ancestor
6433274|NCT00335582|Autonomic Agents|autonomic agents|mesh-ancestor
6433275|NCT00335582|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6433276|NCT00335582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6433277|NCT00335582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6433278|NCT00335582|Adrenergic Agents|adrenergic agents|mesh-ancestor
6433279|NCT00335582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6433280|NCT00335582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433281|NCT00335621|Tiotropium Bromide|tiotropium bromide|mesh-list
6433282|NCT00335621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6433283|NCT00335621|Autonomic Agents|autonomic agents|mesh-ancestor
6433284|NCT00335621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6433285|NCT00335621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433286|NCT00335621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6433287|NCT00335621|Respiratory System Agents|respiratory system agents|mesh-ancestor
6433288|NCT00335621|Parasympatholytics|parasympatholytics|mesh-ancestor
6433289|NCT00335621|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6433290|NCT00335621|Cholinergic Agents|cholinergic agents|mesh-ancestor
6433291|NCT00335621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6433292|NCT00335621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433293|NCT00335647|Fluphenazine|fluphenazine|mesh-list
6433294|NCT00335647|Fluphenazine depot|fluphenazine depot|mesh-list
6433295|NCT00335647|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
6433296|NCT00335647|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6433297|NCT00335647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6433298|NCT00335647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6433299|NCT00335647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433300|NCT00335647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6433301|NCT00335647|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6433302|NCT00335647|Dopamine Agents|dopamine agents|mesh-ancestor
6433303|NCT00335647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6433304|NCT00335647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433305|NCT00335673|Irbesartan|irbesartan|mesh-list
6433306|NCT00335673|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6433307|NCT00335673|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6433308|NCT00335673|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6433309|NCT00335673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433310|NCT00335686|Lopinavir|lopinavir|mesh-list
6433311|NCT00335686|Nevirapine|nevirapine|mesh-list
6433312|NCT00335686|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6433313|NCT00335686|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6433314|NCT00335686|Protease Inhibitors|protease inhibitors|mesh-ancestor
6433315|NCT00335686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6433316|NCT00335686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433317|NCT00335686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6433318|NCT00335686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6433319|NCT00335686|Antiviral Agents|antiviral agents|mesh-ancestor
6433320|NCT00335686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6433321|NCT00335686|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6433322|NCT00335686|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6433323|NCT00335686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6433324|NCT00335686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6433325|NCT00335686|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6433326|NCT00335686|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6433327|NCT00335699|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6433328|NCT00335699|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6433329|NCT00335699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6433330|NCT00335699|Antimetabolites|antimetabolites|mesh-ancestor
6433331|NCT00335699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433332|NCT00335699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6433333|NCT00335699|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6433334|NCT00335699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6433335|NCT00335907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
6433336|NCT00335920|Dexamethasone|dexamethasone|mesh-list
6433337|NCT00335920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6433338|NCT00335920|Antiemetics|antiemetics|mesh-ancestor
6433339|NCT00335920|Autonomic Agents|autonomic agents|mesh-ancestor
6433340|NCT00335920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6433341|NCT00335920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433342|NCT00335920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6433343|NCT00335920|Glucocorticoids|glucocorticoids|mesh-ancestor
6433344|NCT00335920|Hormones|hormones|mesh-ancestor
6433345|NCT00335920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6433346|NCT00335920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6433347|NCT00335920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6433348|NCT00335933|Gabapentin|gabapentin|mesh-list
6433349|NCT00335933|Analgesics|analgesics|mesh-ancestor
6433350|NCT00335933|Sensory System Agents|sensory system agents|mesh-ancestor
6433351|NCT00335933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6433352|NCT00335933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433353|NCT00335933|Anticonvulsants|anticonvulsants|mesh-ancestor
6433354|NCT00335933|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6433355|NCT00335933|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6433356|NCT00335933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6433357|NCT00335933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6433358|NCT00335933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6433359|NCT00335933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6433360|NCT00335933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6433361|NCT00335933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433362|NCT00335933|Antimanic Agents|antimanic agents|mesh-ancestor
6433363|NCT00335985|Immunoglobulins|immunoglobulins|mesh-list
6433364|NCT00335985|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6433365|NCT00335985|gamma-Globulins|gamma-globulins|mesh-list
6433366|NCT00335985|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6433367|NCT00335985|Immunologic Factors|immunologic factors|mesh-ancestor
6433368|NCT00335985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433369|NCT00335998|Cisplatin|cisplatin|mesh-list
6433370|NCT00335998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6433371|NCT00336141|Vorinostat|vorinostat|mesh-list
6433372|NCT00336141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6433373|NCT00336141|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6433374|NCT00336141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6433375|NCT00336141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433376|NCT00336154|Tetracycline|tetracycline|mesh-list
6433377|NCT00336154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6433378|NCT00336154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6433379|NCT00336154|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6433380|NCT00336154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6433381|NCT00336154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433382|NCT00336167|Bezafibrate|bezafibrate|mesh-list
6433383|NCT00336167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6433384|NCT00336167|Antimetabolites|antimetabolites|mesh-ancestor
6433385|NCT00336167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433386|NCT00336167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6433387|NCT00336206|Alemtuzumab|alemtuzumab|mesh-list
6433388|NCT00336206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6433389|NCT00336206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6433390|NCT00336219|Pantoprazole|pantoprazole|mesh-list
6433391|NCT00336219|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6433392|NCT00336219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6433393|NCT00336219|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6433394|NCT00336219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6433395|NCT00336219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433396|NCT00336245|Copper|copper|mesh-list
6433397|NCT00336245|Contraceptive Agents|contraceptive agents|mesh-list
6433398|NCT00336245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6433399|NCT00336245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433400|NCT00336245|Trace Elements|trace elements|mesh-ancestor
6433401|NCT00336245|Micronutrients|micronutrients|mesh-ancestor
6433402|NCT00336310|Repaglinide|repaglinide|mesh-list
6433403|NCT00336310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6433404|NCT00336310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433405|NCT00336336|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6433406|NCT00336336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6540498|NCT00840918|Lidocaine|lidocaine|mesh-list
6540499|NCT00840918|Anesthetics, Local|anesthetics, local|mesh-ancestor
6540500|NCT00840918|Anesthetics|anesthetics|mesh-ancestor
6540501|NCT00840918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6540502|NCT00840918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540503|NCT00840918|Sensory System Agents|sensory system agents|mesh-ancestor
6540504|NCT00840918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6540505|NCT00840918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6540506|NCT00840918|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6540507|NCT00840918|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6540508|NCT00840918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6433407|NCT00336336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6433408|NCT00336336|Antimetabolites|antimetabolites|mesh-ancestor
6433409|NCT00336336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433410|NCT00336336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6433411|NCT00336336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6433412|NCT00336336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6433413|NCT00336349|Botulinum Toxins|botulinum toxins|mesh-list
6433414|NCT00336349|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6433415|NCT00336349|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6433416|NCT00336349|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6433417|NCT00336349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6433418|NCT00336349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433419|NCT00336349|Cholinergic Agents|cholinergic agents|mesh-ancestor
6433420|NCT00336349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6433421|NCT00336349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433422|NCT00336349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6433423|NCT00336349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6433424|NCT00336362|Hydroxyurea|hydroxyurea|mesh-list
6433425|NCT00336362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6433426|NCT00336362|Antisickling Agents|antisickling agents|mesh-ancestor
6433427|NCT00336362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6433428|NCT00336362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433429|NCT00336362|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6433430|NCT00336375|Lumefantrine|lumefantrine|mesh-list
6433431|NCT00336375|Artemether|artemether|mesh-list
6433432|NCT00336375|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6433433|NCT00336375|Antimalarials|antimalarials|mesh-ancestor
6433434|NCT00336375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6433435|NCT00336375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6433436|NCT00336375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6433437|NCT00336401|Propofol|propofol|mesh-list
6433438|NCT00336401|Sevoflurane|sevoflurane|mesh-list
6433439|NCT00336401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6433440|NCT00336401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6433441|NCT00336401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433442|NCT00336401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6433443|NCT00336401|Anesthetics, General|anesthetics, general|mesh-ancestor
6433444|NCT00336401|Anesthetics|anesthetics|mesh-ancestor
6433445|NCT00336401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6433446|NCT00336401|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6433447|NCT00336414|Prednisone|prednisone|mesh-list
6433448|NCT00336414|Cyclophosphamide|cyclophosphamide|mesh-list
6433449|NCT00336414|Azathioprine|azathioprine|mesh-list
6433450|NCT00336414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6433451|NCT00336414|Immunologic Factors|immunologic factors|mesh-ancestor
6433452|NCT00336414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433453|NCT00336414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6433454|NCT00336414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6433455|NCT00336414|Alkylating Agents|alkylating agents|mesh-ancestor
6433456|NCT00336414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433457|NCT00336414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6433458|NCT00336414|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6433459|NCT00336414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6433460|NCT00336414|Glucocorticoids|glucocorticoids|mesh-ancestor
6433461|NCT00336414|Hormones|hormones|mesh-ancestor
6433462|NCT00336414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6433463|NCT00336414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6433464|NCT00336414|Antimetabolites|antimetabolites|mesh-ancestor
6433465|NCT00336414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6433466|NCT00336453|Vaccines|vaccines|mesh-list
6540509|NCT00840918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6540510|NCT00840931|Lenalidomide|lenalidomide|mesh-list
6540511|NCT00840931|Immunologic Factors|immunologic factors|mesh-ancestor
6540512|NCT00840931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540513|NCT00840931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6540514|NCT00840931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6540515|NCT00840931|Growth Substances|growth substances|mesh-ancestor
6433467|NCT00336453|Hemagglutinins|hemagglutinins|mesh-list
6433468|NCT00336453|Immunologic Factors|immunologic factors|mesh-ancestor
6433469|NCT00336453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433470|NCT00336453|Agglutinins|agglutinins|mesh-ancestor
6433471|NCT00336466|Epoetin Alfa|epoetin alfa|mesh-list
6433472|NCT00336466|Hematinics|hematinics|mesh-ancestor
6433473|NCT00336518|Ribavirin|ribavirin|mesh-list
6433474|NCT00336518|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6433475|NCT00336518|Antimetabolites|antimetabolites|mesh-ancestor
6433476|NCT00336518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433477|NCT00336518|Antiviral Agents|antiviral agents|mesh-ancestor
6433478|NCT00336518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6433479|NCT00336531|Itraconazole|itraconazole|mesh-list
6433480|NCT00336531|Antifungal Agents|antifungal agents|mesh-ancestor
6433481|NCT00336531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6433482|NCT00336531|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6433483|NCT00336531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6433484|NCT00336531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6433485|NCT00336531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433486|NCT00336531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6433487|NCT00336531|Hormone Antagonists|hormone antagonists|mesh-ancestor
6433488|NCT00336531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6433489|NCT00336531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433490|NCT00336531|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6433491|NCT00336648|Gemcitabine|gemcitabine|mesh-list
6433492|NCT00336648|Bevacizumab|bevacizumab|mesh-list
6433493|NCT00336648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6433494|NCT00336648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6433495|NCT00336648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6433496|NCT00336648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6433497|NCT00336648|Growth Substances|growth substances|mesh-ancestor
6433498|NCT00336648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433499|NCT00336648|Growth Inhibitors|growth inhibitors|mesh-ancestor
6433500|NCT00336648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6433501|NCT00336648|Antimetabolites|antimetabolites|mesh-ancestor
6433502|NCT00336648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433503|NCT00336648|Antiviral Agents|antiviral agents|mesh-ancestor
6433504|NCT00336648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6433505|NCT00336648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6433506|NCT00336648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6433507|NCT00336648|Immunologic Factors|immunologic factors|mesh-ancestor
6433508|NCT00336674|Insulin|insulin|mesh-list
6433509|NCT00336674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6433510|NCT00336674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433511|NCT00336739|Cinacalcet|cinacalcet|mesh-list
6433512|NCT00336739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6433513|NCT00336739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433514|NCT00336739|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6433515|NCT00336739|Hormone Antagonists|hormone antagonists|mesh-ancestor
6433516|NCT00336739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6433517|NCT00336765|XL647|xl647|mesh-list
6433518|NCT00336765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6433519|NCT00336765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6433520|NCT00336765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6433521|NCT00336765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433522|NCT00336791|Paclitaxel|paclitaxel|mesh-list
6433523|NCT00336791|Cyclophosphamide|cyclophosphamide|mesh-list
6433524|NCT00336791|Doxorubicin|doxorubicin|mesh-list
6433525|NCT00336791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6433526|NCT00336791|Fluorouracil|fluorouracil|mesh-list
6433527|NCT00336791|Epirubicin|epirubicin|mesh-list
6433528|NCT00336791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6433529|NCT00336791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6433530|NCT00336791|Tubulin Modulators|tubulin modulators|mesh-ancestor
6433531|NCT00336791|Antimitotic Agents|antimitotic agents|mesh-ancestor
6433532|NCT00336791|Mitosis Modulators|mitosis modulators|mesh-ancestor
6433533|NCT00336791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433534|NCT00336791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6433535|NCT00336791|Immunologic Factors|immunologic factors|mesh-ancestor
6433536|NCT00336791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433537|NCT00336791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6433538|NCT00336791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6433539|NCT00336791|Alkylating Agents|alkylating agents|mesh-ancestor
6433540|NCT00336791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6433541|NCT00336791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6433542|NCT00336791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6433543|NCT00336791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6433544|NCT00336791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6433545|NCT00336791|Antimetabolites|antimetabolites|mesh-ancestor
6433546|NCT00336791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6433547|NCT00336882|Midazolam|midazolam|mesh-list
6433548|NCT00336882|Propofol|propofol|mesh-list
6433549|NCT00336882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6433550|NCT00336882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6433551|NCT00336882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433552|NCT00336882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6433553|NCT00336882|Anesthetics, General|anesthetics, general|mesh-ancestor
6433554|NCT00336882|Anesthetics|anesthetics|mesh-ancestor
6433555|NCT00336882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6433556|NCT00336882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6433557|NCT00336882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6433558|NCT00336882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6433559|NCT00336882|GABA Modulators|gaba modulators|mesh-ancestor
6433560|NCT00336882|GABA Agents|gaba agents|mesh-ancestor
6433561|NCT00336882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6433562|NCT00336882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433563|NCT00336921|Alfuzosin|alfuzosin|mesh-list
6433564|NCT00336921|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6433565|NCT00336921|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6433566|NCT00336921|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6433567|NCT00336921|Adrenergic Agents|adrenergic agents|mesh-ancestor
6433568|NCT00336921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6433569|NCT00336921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433570|NCT00336921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433571|NCT00336921|Urological Agents|urological agents|mesh-ancestor
6433572|NCT00336947|Tegafur|tegafur|mesh-list
6433573|NCT00336947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6433574|NCT00336947|Antimetabolites|antimetabolites|mesh-ancestor
6462140|NCT00457808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6540516|NCT00840931|Growth Inhibitors|growth inhibitors|mesh-ancestor
6540517|NCT00840931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6540518|NCT00840944|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6540519|NCT00840944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540520|NCT00840944|Luteolytic Agents|luteolytic agents|mesh-ancestor
6540521|NCT00840944|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6540522|NCT00840944|Contraceptive Agents|contraceptive agents|mesh-ancestor
6540523|NCT00840944|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6540524|NCT00840944|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6540525|NCT00840944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6540526|NCT00840944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6540527|NCT00840957|Infliximab|infliximab|mesh-list
6540528|NCT00840957|Dermatologic Agents|dermatologic agents|mesh-ancestor
6540529|NCT00840957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6540530|NCT00840957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6540531|NCT00841061|Ferrous fumarate|ferrous fumarate|mesh-list
6433575|NCT00336947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433576|NCT00336947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6461018|NCT00452582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461019|NCT00452582|Urological Agents|urological agents|mesh-ancestor
6461020|NCT00452595|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6461021|NCT00452595|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6461022|NCT00452595|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6461023|NCT00452595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6461024|NCT00452595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461025|NCT00452595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6461026|NCT00452595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461027|NCT00452595|Antidepressive Agents|antidepressive agents|mesh-ancestor
6461028|NCT00452595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6461029|NCT00452608|Atorvastatin|atorvastatin|mesh-list
6461030|NCT00452608|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6461031|NCT00452608|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6461032|NCT00452608|Antimetabolites|antimetabolites|mesh-ancestor
6461033|NCT00452608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461034|NCT00452608|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6461035|NCT00452608|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6461036|NCT00452608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6461037|NCT00452634|Irinotecan|irinotecan|mesh-list
6461038|NCT00452634|Simvastatin|simvastatin|mesh-list
6461039|NCT00452634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6461040|NCT00452634|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6461041|NCT00452634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6461042|NCT00452634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6461043|NCT00452634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461044|NCT00452634|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6461045|NCT00452634|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6540532|NCT00841061|Trace Elements|trace elements|mesh-ancestor
6540533|NCT00841061|Micronutrients|micronutrients|mesh-ancestor
6540534|NCT00841061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540535|NCT00841074|Chlorhexidine|chlorhexidine|mesh-list
6540536|NCT00841074|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6540537|NCT00841074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6540538|NCT00841074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6540539|NCT00841074|Disinfectants|disinfectants|mesh-ancestor
6540540|NCT00841074|Dermatologic Agents|dermatologic agents|mesh-ancestor
6540541|NCT00841113|Goserelin|goserelin|mesh-list
6540542|NCT00841113|Bicalutamide|bicalutamide|mesh-list
6540543|NCT00841113|Abarelix|abarelix|mesh-list
6540544|NCT00841113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6540545|NCT00841113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6540546|NCT00841113|Androgen Antagonists|androgen antagonists|mesh-ancestor
6540547|NCT00841113|Hormone Antagonists|hormone antagonists|mesh-ancestor
6540548|NCT00841113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6540549|NCT00841113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540550|NCT00841126|Iron|iron|mesh-list
6540551|NCT00841126|Trace Elements|trace elements|mesh-ancestor
6540552|NCT00841126|Micronutrients|micronutrients|mesh-ancestor
6540553|NCT00841126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540554|NCT00841139|Perhexiline|perhexiline|mesh-list
6540555|NCT00841139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6540556|NCT00841139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6540557|NCT00841139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6540558|NCT00841139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6540559|NCT00841139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540560|NCT00841139|Vasodilator Agents|vasodilator agents|mesh-ancestor
6540561|NCT00841191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6540562|NCT00841191|Siltuximab|siltuximab|mesh-list
6540563|NCT00841191|Antibodies|antibodies|mesh-list
6540564|NCT00841191|Immunoglobulins|immunoglobulins|mesh-list
6540565|NCT00841191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6540566|NCT00841191|Immunologic Factors|immunologic factors|mesh-ancestor
6540567|NCT00841191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540568|NCT00841191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6540569|NCT00841256|Glycerol|glycerol|mesh-list
6540570|NCT00841256|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6540571|NCT00841256|Protective Agents|protective agents|mesh-ancestor
6540572|NCT00841256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540573|NCT00841373|Ranibizumab|ranibizumab|mesh-list
6540574|NCT00841373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6540575|NCT00841373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6433577|NCT00336960|Celecoxib|celecoxib|mesh-list
6433578|NCT00336960|Fluorouracil|fluorouracil|mesh-list
6433579|NCT00336960|Antimetabolites|antimetabolites|mesh-ancestor
6433580|NCT00336960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433581|NCT00336960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6433582|NCT00336960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6433583|NCT00336960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6433584|NCT00336960|Immunologic Factors|immunologic factors|mesh-ancestor
6433585|NCT00336960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433586|NCT00336960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6433587|NCT00336960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6433588|NCT00336960|Analgesics|analgesics|mesh-ancestor
6433589|NCT00336960|Sensory System Agents|sensory system agents|mesh-ancestor
6433590|NCT00336960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6433591|NCT00336960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6433592|NCT00336960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6433593|NCT00336960|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6433594|NCT00336960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6433595|NCT00336960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6433596|NCT00337051|Propofol|propofol|mesh-list
6433597|NCT00337051|Sevoflurane|sevoflurane|mesh-list
6433598|NCT00337051|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6433599|NCT00337051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6433600|NCT00337051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433601|NCT00337051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6433602|NCT00337051|Anesthetics, General|anesthetics, general|mesh-ancestor
6433603|NCT00337051|Anesthetics|anesthetics|mesh-ancestor
6433604|NCT00337051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6433605|NCT00337051|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6433606|NCT00337090|Mirabegron|mirabegron|mesh-list
6433607|NCT00337090|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6433608|NCT00337090|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6433609|NCT00337090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6433610|NCT00337090|Adrenergic Agents|adrenergic agents|mesh-ancestor
6433611|NCT00337090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6433612|NCT00337090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433613|NCT00337090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540576|NCT00841373|Growth Substances|growth substances|mesh-ancestor
6540577|NCT00841373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540578|NCT00841373|Growth Inhibitors|growth inhibitors|mesh-ancestor
6540579|NCT00841373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6540580|NCT00841386|Riboflavin|riboflavin|mesh-list
6540581|NCT00841386|Flavin Mononucleotide|flavin mononucleotide|mesh-list
6540582|NCT00841386|Vitamin B Complex|vitamin b complex|mesh-ancestor
6540583|NCT00841386|Vitamins|vitamins|mesh-ancestor
6540584|NCT00841386|Micronutrients|micronutrients|mesh-ancestor
6540585|NCT00841386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540586|NCT00841386|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6540587|NCT00841386|Dermatologic Agents|dermatologic agents|mesh-ancestor
6540588|NCT00841438|Abciximab|abciximab|mesh-list
6540589|NCT00841438|Anticoagulants|anticoagulants|mesh-ancestor
6540590|NCT00841438|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6540591|NCT00841477|Vaccines|vaccines|mesh-list
6540592|NCT00841477|Immunologic Factors|immunologic factors|mesh-ancestor
6540593|NCT00841477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540594|NCT00841581|Ranibizumab|ranibizumab|mesh-list
6540595|NCT00841581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6540596|NCT00841581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6540597|NCT00841581|Growth Substances|growth substances|mesh-ancestor
6540598|NCT00841581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540599|NCT00841581|Growth Inhibitors|growth inhibitors|mesh-ancestor
6540600|NCT00841581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6540601|NCT00841594|Nitroglycerin|nitroglycerin|mesh-list
6540602|NCT00841594|Vasodilator Agents|vasodilator agents|mesh-ancestor
6540603|NCT00841633|Norepinephrine|norepinephrine|mesh-list
6540604|NCT00841633|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6540605|NCT00841633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6540606|NCT00841633|Adrenergic Agents|adrenergic agents|mesh-ancestor
6540607|NCT00841633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6540608|NCT00841633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6540609|NCT00841633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540610|NCT00841633|Sympathomimetics|sympathomimetics|mesh-ancestor
6540611|NCT00841633|Autonomic Agents|autonomic agents|mesh-ancestor
6540612|NCT00841633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6540613|NCT00841633|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6540614|NCT00841724|Fludarabine|fludarabine|mesh-list
6540615|NCT00841724|Busulfan|busulfan|mesh-list
6433614|NCT00337090|Urological Agents|urological agents|mesh-ancestor
6433615|NCT00337155|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
6433616|NCT00337155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6433617|NCT00337246|Cyclophosphamide|cyclophosphamide|mesh-list
6433618|NCT00337246|Rituximab|rituximab|mesh-list
6433619|NCT00337246|Fludarabine|fludarabine|mesh-list
6019435|NCT00387088|Cholinergic Agents|cholinergic agents|mesh-ancestor
6019436|NCT00387088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6019437|NCT00387088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019438|NCT00387127|Lapatinib|lapatinib|mesh-list
6019439|NCT00387127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6433620|NCT00337246|Fludarabine phosphate|fludarabine phosphate|mesh-list
6433621|NCT00337246|Mitoxantrone|mitoxantrone|mesh-list
6433622|NCT00337246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6433623|NCT00337246|Immunologic Factors|immunologic factors|mesh-ancestor
6433624|NCT00337246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433625|NCT00337246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6433626|NCT00337246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6433627|NCT00337246|Alkylating Agents|alkylating agents|mesh-ancestor
6433628|NCT00337246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433629|NCT00337246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6433630|NCT00337246|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6433631|NCT00337246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6433632|NCT00337246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6433633|NCT00337246|Antimetabolites|antimetabolites|mesh-ancestor
6433634|NCT00337246|Analgesics|analgesics|mesh-ancestor
6433635|NCT00337246|Sensory System Agents|sensory system agents|mesh-ancestor
6433636|NCT00337246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6433637|NCT00337246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6433638|NCT00337246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6019440|NCT00387127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6019441|NCT00387127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6019442|NCT00387127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019443|NCT00387335|Sunitinib|sunitinib|mesh-list
6019444|NCT00387335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6019445|NCT00387335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6433639|NCT00337246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6433640|NCT00337259|Gemcitabine|gemcitabine|mesh-list
6433641|NCT00337259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6433642|NCT00337259|Antimetabolites|antimetabolites|mesh-ancestor
6433643|NCT00337259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433644|NCT00337259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6433645|NCT00337259|Antiviral Agents|antiviral agents|mesh-ancestor
6433646|NCT00337259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6433647|NCT00337259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6433648|NCT00337259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6433649|NCT00337259|Immunologic Factors|immunologic factors|mesh-ancestor
6433650|NCT00337259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433651|NCT00337298|Amlodipine|amlodipine|mesh-list
6433652|NCT00337298|Lisinopril|lisinopril|mesh-list
6433653|NCT00337298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6433654|NCT00337298|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6019446|NCT00387335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6433655|NCT00337298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6433656|NCT00337298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433657|NCT00337298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6433658|NCT00337298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433659|NCT00337298|Vasodilator Agents|vasodilator agents|mesh-ancestor
6433660|NCT00337298|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6433661|NCT00337298|Protease Inhibitors|protease inhibitors|mesh-ancestor
6540616|NCT00841724|Thymoglobulin|thymoglobulin|mesh-list
6540617|NCT00841724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6540618|NCT00841724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433662|NCT00337298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6433663|NCT00337298|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6433664|NCT00337298|Protective Agents|protective agents|mesh-ancestor
6433665|NCT00337376|Sirolimus|sirolimus|mesh-list
6433666|NCT00337376|Paclitaxel|paclitaxel|mesh-list
6433667|NCT00337376|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6433668|NCT00337376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6433669|NCT00337376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6433670|NCT00337376|Tubulin Modulators|tubulin modulators|mesh-ancestor
6433671|NCT00337376|Antimitotic Agents|antimitotic agents|mesh-ancestor
6433672|NCT00337376|Mitosis Modulators|mitosis modulators|mesh-ancestor
6433673|NCT00337376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433674|NCT00337376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6433675|NCT00337376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6433676|NCT00337376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6433677|NCT00337376|Antifungal Agents|antifungal agents|mesh-ancestor
6433678|NCT00337376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6433679|NCT00337376|Immunologic Factors|immunologic factors|mesh-ancestor
6540619|NCT00841724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6540620|NCT00841724|Immunologic Factors|immunologic factors|mesh-ancestor
6540621|NCT00841724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540622|NCT00841724|Alkylating Agents|alkylating agents|mesh-ancestor
6540623|NCT00841724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6540624|NCT00841724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6540625|NCT00841789|Etanercept|etanercept|mesh-list
6540626|NCT00841789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6540627|NCT00841789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6540628|NCT00841789|Analgesics|analgesics|mesh-ancestor
6540629|NCT00841789|Sensory System Agents|sensory system agents|mesh-ancestor
6540630|NCT00841789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6540631|NCT00841789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540632|NCT00841789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6540633|NCT00841789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6540634|NCT00841789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6540635|NCT00841789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6540636|NCT00841789|Immunologic Factors|immunologic factors|mesh-ancestor
6540637|NCT00841802|Prednisone|prednisone|mesh-list
6540638|NCT00841802|Glucocorticoids|glucocorticoids|mesh-list
6540639|NCT00841802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6540640|NCT00841802|Hormones|hormones|mesh-ancestor
6540641|NCT00841802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6540642|NCT00841802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540643|NCT00841802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6540644|NCT00841802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6540645|NCT00841841|Acetaminophen|acetaminophen|mesh-list
6540646|NCT00841841|Dipyrone|dipyrone|mesh-list
6540647|NCT00841841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6540648|NCT00841841|Analgesics|analgesics|mesh-ancestor
6540649|NCT00841841|Sensory System Agents|sensory system agents|mesh-ancestor
6540650|NCT00841841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6540651|NCT00841841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540652|NCT00841841|Antipyretics|antipyretics|mesh-ancestor
6540653|NCT00841841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6540654|NCT00841841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6540655|NCT00841841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6540656|NCT00841854|Metronidazole|metronidazole|mesh-list
6540657|NCT00841854|Tetracycline|tetracycline|mesh-list
6540658|NCT00841854|Pantoprazole|pantoprazole|mesh-list
6540659|NCT00841854|Bismuth|bismuth|mesh-list
6540660|NCT00841854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6540661|NCT00841854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6540662|NCT00841854|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6433680|NCT00337376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540663|NCT00841854|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6540664|NCT00841854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6433681|NCT00337389|Leucovorin|leucovorin|mesh-list
6433682|NCT00337389|Bevacizumab|bevacizumab|mesh-list
6433683|NCT00337389|Fluorouracil|fluorouracil|mesh-list
6433684|NCT00337389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6433685|NCT00337389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6433686|NCT00337389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6433687|NCT00337389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6433688|NCT00337389|Growth Substances|growth substances|mesh-ancestor
6433689|NCT00337389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433690|NCT00337389|Growth Inhibitors|growth inhibitors|mesh-ancestor
6433691|NCT00337389|Antimetabolites|antimetabolites|mesh-ancestor
6433692|NCT00337389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433693|NCT00337389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6433694|NCT00337389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6433695|NCT00337389|Immunologic Factors|immunologic factors|mesh-ancestor
6433696|NCT00337389|Antidotes|antidotes|mesh-ancestor
6433697|NCT00337389|Protective Agents|protective agents|mesh-ancestor
6433698|NCT00337389|Vitamin B Complex|vitamin b complex|mesh-ancestor
6433699|NCT00337389|Vitamins|vitamins|mesh-ancestor
6433700|NCT00337389|Micronutrients|micronutrients|mesh-ancestor
6433701|NCT00337441|Epoetin Alfa|epoetin alfa|mesh-list
6433702|NCT00337441|Hematinics|hematinics|mesh-ancestor
6433703|NCT00337493|Cyclosporine|cyclosporine|mesh-list
6433704|NCT00337493|Mycophenolic Acid|mycophenolic acid|mesh-list
6433705|NCT00337493|Tacrolimus|tacrolimus|mesh-list
6433706|NCT00337493|Cyclosporins|cyclosporins|mesh-list
6433707|NCT00337493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6433708|NCT00337493|Immunologic Factors|immunologic factors|mesh-ancestor
6433709|NCT00337493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433710|NCT00337493|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6433711|NCT00337493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6433712|NCT00337493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433713|NCT00337493|Antifungal Agents|antifungal agents|mesh-ancestor
6433714|NCT00337493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6433715|NCT00337493|Dermatologic Agents|dermatologic agents|mesh-ancestor
6433716|NCT00337493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6433717|NCT00337493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6433718|NCT00337493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6433719|NCT00337493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6433720|NCT00337493|Antitubercular Agents|antitubercular agents|mesh-ancestor
6433721|NCT00337493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6433722|NCT00337506|Dexamethasone|dexamethasone|mesh-list
6433723|NCT00337506|Bortezomib|bortezomib|mesh-list
6433724|NCT00337506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6433725|NCT00337506|Antiemetics|antiemetics|mesh-ancestor
6433726|NCT00337506|Autonomic Agents|autonomic agents|mesh-ancestor
6433727|NCT00337506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6433728|NCT00337506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433729|NCT00337506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6433730|NCT00337506|Glucocorticoids|glucocorticoids|mesh-ancestor
6433731|NCT00337506|Hormones|hormones|mesh-ancestor
6433732|NCT00337506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6433733|NCT00337506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6433734|NCT00337506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6433735|NCT00337519|Alemtuzumab|alemtuzumab|mesh-list
6433736|NCT00337519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6433737|NCT00337519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6433738|NCT00337545|Everolimus|everolimus|mesh-list
6433739|NCT00337545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6433740|NCT00337545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6433741|NCT00337545|Immunologic Factors|immunologic factors|mesh-ancestor
6433742|NCT00337545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433743|NCT00337558|Solifenacin Succinate|solifenacin succinate|mesh-list
6433744|NCT00337558|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6433745|NCT00337558|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6433746|NCT00337558|Cholinergic Agents|cholinergic agents|mesh-ancestor
6433747|NCT00337558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6433748|NCT00337558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433749|NCT00337558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433750|NCT00337558|Urological Agents|urological agents|mesh-ancestor
6433751|NCT00337623|Prednisolone|prednisolone|mesh-list
6433752|NCT00337623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6433753|NCT00337623|Glucocorticoids|glucocorticoids|mesh-ancestor
6433754|NCT00337623|Hormones|hormones|mesh-ancestor
6433755|NCT00337623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6433756|NCT00337623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433757|NCT00337623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6433758|NCT00337623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6433759|NCT00337649|Trastuzumab|trastuzumab|mesh-list
6433760|NCT00337649|Epothilones|epothilones|mesh-list
6433761|NCT00337649|Desoxyepothilone B|desoxyepothilone b|mesh-list
6433762|NCT00337649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6433763|NCT00337649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6433764|NCT00337649|Tubulin Modulators|tubulin modulators|mesh-ancestor
6433765|NCT00337649|Antimitotic Agents|antimitotic agents|mesh-ancestor
6433766|NCT00337649|Mitosis Modulators|mitosis modulators|mesh-ancestor
6433767|NCT00337649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433768|NCT00337701|Enfuvirtide|enfuvirtide|mesh-list
6433769|NCT00337701|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6433770|NCT00337701|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6433771|NCT00337701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433772|NCT00337701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6433773|NCT00337701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6433774|NCT00337701|Antiviral Agents|antiviral agents|mesh-ancestor
6433775|NCT00337701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6433776|NCT00337740|Propranolol|propranolol|mesh-list
6433777|NCT00337740|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6433778|NCT00337740|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6433779|NCT00337740|Adrenergic Agents|adrenergic agents|mesh-ancestor
6433780|NCT00337740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6433781|NCT00337740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433782|NCT00337740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433783|NCT00337740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6433784|NCT00337740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6433785|NCT00337740|Vasodilator Agents|vasodilator agents|mesh-ancestor
6433786|NCT00337766|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
6433787|NCT00337766|Hemostatics|hemostatics|mesh-ancestor
6433788|NCT00337766|Coagulants|coagulants|mesh-ancestor
6433789|NCT00337766|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6433790|NCT00337766|Natriuretic Agents|natriuretic agents|mesh-ancestor
6433791|NCT00337766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433792|NCT00337792|Fentanyl|fentanyl|mesh-list
6433793|NCT00337792|Midazolam|midazolam|mesh-list
6433794|NCT00337792|Oxycodone|oxycodone|mesh-list
6433795|NCT00337792|Lorazepam|lorazepam|mesh-list
6433796|NCT00337792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6433797|NCT00337792|Narcotics|narcotics|mesh-ancestor
6433798|NCT00337792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6433799|NCT00337792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433800|NCT00337792|Analgesics|analgesics|mesh-ancestor
6433801|NCT00337792|Sensory System Agents|sensory system agents|mesh-ancestor
6433802|NCT00337792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6433803|NCT00337792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6433804|NCT00337792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6433805|NCT00337792|Anesthetics, General|anesthetics, general|mesh-ancestor
6433806|NCT00337792|Anesthetics|anesthetics|mesh-ancestor
6433807|NCT00337792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6433808|NCT00337792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6433809|NCT00337792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6433810|NCT00337792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6433811|NCT00337792|GABA Modulators|gaba modulators|mesh-ancestor
6433812|NCT00337792|GABA Agents|gaba agents|mesh-ancestor
6433813|NCT00337792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6433814|NCT00337792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433815|NCT00337792|Anticonvulsants|anticonvulsants|mesh-ancestor
6433816|NCT00337792|Antiemetics|antiemetics|mesh-ancestor
6433817|NCT00337792|Autonomic Agents|autonomic agents|mesh-ancestor
6433818|NCT00337792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6433819|NCT00337805|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
6433820|NCT00337805|Plasma Substitutes|plasma substitutes|mesh-ancestor
6433821|NCT00337805|Blood Substitutes|blood substitutes|mesh-ancestor
6433822|NCT00337883|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6433823|NCT00337883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6433824|NCT00337883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6433825|NCT00337883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6433826|NCT00337883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433827|NCT00337922|Lamivudine|lamivudine|mesh-list
6433828|NCT00337922|Abacavir|abacavir|mesh-list
6433829|NCT00337922|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6433830|NCT00337922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6433831|NCT00337922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6433832|NCT00337922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433833|NCT00337922|Antiviral Agents|antiviral agents|mesh-ancestor
6433834|NCT00337922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6433835|NCT00337922|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6433836|NCT00337922|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6433837|NCT00337948|Epoetin Alfa|epoetin alfa|mesh-list
6433838|NCT00337948|Hematinics|hematinics|mesh-ancestor
6433839|NCT00338000|Epoetin Alfa|epoetin alfa|mesh-list
6433840|NCT00338000|Hematinics|hematinics|mesh-ancestor
6433841|NCT00338052|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6433842|NCT00338052|Norethindrone|norethindrone|mesh-list
6433843|NCT00338052|Norethindrone Acetate|norethindrone acetate|mesh-list
6433844|NCT00338052|Estradiol|estradiol|mesh-list
6433845|NCT00338052|Estrogens|estrogens|mesh-ancestor
6433846|NCT00338052|Hormones|hormones|mesh-ancestor
6433847|NCT00338052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6433848|NCT00338052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433849|NCT00338052|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6433850|NCT00338052|Contraceptive Agents|contraceptive agents|mesh-ancestor
6433851|NCT00338052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6433852|NCT00338052|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6433853|NCT00338052|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6433854|NCT00338052|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6433855|NCT00338052|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6540665|NCT00841854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6540666|NCT00841854|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6540667|NCT00841854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6540668|NCT00841854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6540669|NCT00841854|Antacids|antacids|mesh-ancestor
6540670|NCT00841854|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6540671|NCT00841880|Felodipine|felodipine|mesh-list
6540672|NCT00841880|Ramipril|ramipril|mesh-list
6540673|NCT00841880|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6540674|NCT00841880|Protease Inhibitors|protease inhibitors|mesh-ancestor
6540675|NCT00841880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6540676|NCT00841880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6540677|NCT00841880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6540678|NCT00841880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6433856|NCT00338091|Losartan|losartan|mesh-list
6433857|NCT00338091|Benazepril|benazepril|mesh-list
6433858|NCT00338091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6540679|NCT00841880|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6540680|NCT00841880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6540681|NCT00841880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6540682|NCT00841880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540683|NCT00841880|Vasodilator Agents|vasodilator agents|mesh-ancestor
6540684|NCT00841893|Mechlorethamine|mechlorethamine|mesh-list
6540685|NCT00841893|Alkylating Agents|alkylating agents|mesh-ancestor
6540686|NCT00841893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6540687|NCT00841893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6540688|NCT00841893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6540689|NCT00841919|Insulin|insulin|mesh-list
6540690|NCT00841919|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6540691|NCT00841919|Insulin Glargine|insulin glargine|mesh-list
6540692|NCT00841919|Insulin, Isophane|insulin, isophane|mesh-list
6433859|NCT00338091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6433860|NCT00338091|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6433861|NCT00338091|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6433862|NCT00338091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433863|NCT00338091|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6433864|NCT00338091|Protease Inhibitors|protease inhibitors|mesh-ancestor
6433865|NCT00338091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6433866|NCT00338117|Galantamine|galantamine|mesh-list
6433867|NCT00338117|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6433868|NCT00338117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6433869|NCT00338117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433870|NCT00338117|Cholinergic Agents|cholinergic agents|mesh-ancestor
6433871|NCT00338117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6433872|NCT00338117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433873|NCT00338117|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6433874|NCT00338117|Autonomic Agents|autonomic agents|mesh-ancestor
6433875|NCT00338117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6433876|NCT00338117|Nootropic Agents|nootropic agents|mesh-ancestor
6433877|NCT00338130|Temozolomide|temozolomide|mesh-list
6433878|NCT00338130|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6433879|NCT00338130|Alkylating Agents|alkylating agents|mesh-ancestor
6433880|NCT00338130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433881|NCT00338130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6433882|NCT00338195|Caffeine|caffeine|mesh-list
6433883|NCT00338195|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6433884|NCT00338195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433885|NCT00338195|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6433886|NCT00338195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6433887|NCT00338195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433888|NCT00338195|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6433889|NCT00338195|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6433890|NCT00338195|Purinergic Agents|purinergic agents|mesh-ancestor
6433891|NCT00338195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6433892|NCT00338221|Glycine|glycine|mesh-list
6433893|NCT00338221|Glycine Agents|glycine agents|mesh-ancestor
6433894|NCT00338221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6433895|NCT00338221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433896|NCT00338221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433897|NCT00338247|Capecitabine|capecitabine|mesh-list
6433898|NCT00338247|Lapatinib|lapatinib|mesh-list
6433899|NCT00338247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6433900|NCT00338247|Antimetabolites|antimetabolites|mesh-ancestor
6433901|NCT00338247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433902|NCT00338247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6433903|NCT00338247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6433904|NCT00338247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6433905|NCT00338273|Aripiprazole|aripiprazole|mesh-list
6433906|NCT00338273|Antidepressive Agents|antidepressive agents|mesh-ancestor
6433907|NCT00338273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6433908|NCT00338273|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6433909|NCT00338273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6433910|NCT00338273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6433911|NCT00338273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433912|NCT00338273|Dopamine Agonists|dopamine agonists|mesh-ancestor
6433913|NCT00338273|Dopamine Agents|dopamine agents|mesh-ancestor
6433914|NCT00338273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6433915|NCT00338273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433916|NCT00338273|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6433917|NCT00338273|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6433918|NCT00338273|Serotonin Agents|serotonin agents|mesh-ancestor
6433919|NCT00338273|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6433920|NCT00338273|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6433921|NCT00338273|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6433922|NCT00338273|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6433923|NCT00338299|Epoetin Alfa|epoetin alfa|mesh-list
6433924|NCT00338299|Hematinics|hematinics|mesh-ancestor
6433925|NCT00338312|Testosterone|testosterone|mesh-list
6433926|NCT00338312|Androgens|androgens|mesh-ancestor
6433927|NCT00338312|Hormones|hormones|mesh-ancestor
6433928|NCT00338312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6433929|NCT00338312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433930|NCT00338338|Amlodipine|amlodipine|mesh-list
6433931|NCT00338338|Lacidipine|lacidipine|mesh-list
6433932|NCT00338338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6019447|NCT00387335|Growth Substances|growth substances|mesh-ancestor
6019448|NCT00387335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019449|NCT00387335|Growth Inhibitors|growth inhibitors|mesh-ancestor
6019450|NCT00387335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6019451|NCT00387335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6433933|NCT00338338|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6433934|NCT00338338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6433935|NCT00338338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433936|NCT00338338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6433937|NCT00338338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433938|NCT00338338|Vasodilator Agents|vasodilator agents|mesh-ancestor
6433939|NCT00338377|Vidarabine|vidarabine|mesh-list
6433940|NCT00338377|Cyclophosphamide|cyclophosphamide|mesh-list
6433941|NCT00338377|Fludarabine|fludarabine|mesh-list
6433942|NCT00338377|Fludarabine phosphate|fludarabine phosphate|mesh-list
6433943|NCT00338377|Interleukin-2|interleukin-2|mesh-list
6433944|NCT00338377|Vaccines|vaccines|mesh-list
6433945|NCT00338377|Mesna|mesna|mesh-list
6433946|NCT00338377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6433947|NCT00338377|Immunologic Factors|immunologic factors|mesh-ancestor
6433948|NCT00338377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433949|NCT00338377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6433950|NCT00338377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6433951|NCT00338377|Alkylating Agents|alkylating agents|mesh-ancestor
6433952|NCT00338377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433953|NCT00338377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6433954|NCT00338377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6433955|NCT00338377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6433956|NCT00338377|Antimetabolites|antimetabolites|mesh-ancestor
6433957|NCT00338377|Antiviral Agents|antiviral agents|mesh-ancestor
6433958|NCT00338377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6433959|NCT00338377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6433960|NCT00338377|Analgesics|analgesics|mesh-ancestor
6433961|NCT00338377|Sensory System Agents|sensory system agents|mesh-ancestor
6433962|NCT00338377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6433963|NCT00338377|Protective Agents|protective agents|mesh-ancestor
6433964|NCT00338390|Lamivudine|lamivudine|mesh-list
6433965|NCT00338390|Abacavir|abacavir|mesh-list
6433966|NCT00338390|Dideoxynucleosides|dideoxynucleosides|mesh-list
6433967|NCT00338390|Didanosine|didanosine|mesh-list
6433968|NCT00338390|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6433969|NCT00338390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6433970|NCT00338390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6433971|NCT00338390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433972|NCT00338390|Antiviral Agents|antiviral agents|mesh-ancestor
6433973|NCT00338390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6433974|NCT00338390|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6433975|NCT00338390|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6433976|NCT00338390|Antimetabolites|antimetabolites|mesh-ancestor
6433977|NCT00338416|Epoetin Alfa|epoetin alfa|mesh-list
6433978|NCT00338416|Hematinics|hematinics|mesh-ancestor
6433979|NCT00338468|Epoetin Alfa|epoetin alfa|mesh-list
6433980|NCT00338468|Hematinics|hematinics|mesh-ancestor
6433981|NCT00338481|Morphine|morphine|mesh-list
6433982|NCT00338481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6433983|NCT00338481|Narcotics|narcotics|mesh-ancestor
6433984|NCT00338481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6433985|NCT00338481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6433986|NCT00338481|Analgesics|analgesics|mesh-ancestor
6433987|NCT00338481|Sensory System Agents|sensory system agents|mesh-ancestor
6433988|NCT00338481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6433989|NCT00338494|Clofarabine|clofarabine|mesh-list
6433990|NCT00338494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6433991|NCT00338494|Antimetabolites|antimetabolites|mesh-ancestor
6433992|NCT00338494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6433993|NCT00338494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6433994|NCT00338507|Erdosteine|erdosteine|mesh-list
6433995|NCT00338507|Expectorants|expectorants|mesh-ancestor
6433996|NCT00338507|Respiratory System Agents|respiratory system agents|mesh-ancestor
6433997|NCT00338546|Cocaine|cocaine|mesh-list
6433998|NCT00338546|Dexmedetomidine|dexmedetomidine|mesh-list
6433999|NCT00338546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6434000|NCT00338546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6434001|NCT00338546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434002|NCT00338546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6434003|NCT00338546|Analgesics|analgesics|mesh-ancestor
6434004|NCT00338546|Sensory System Agents|sensory system agents|mesh-ancestor
6434005|NCT00338546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6434006|NCT00338546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6434007|NCT00338546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6434008|NCT00338546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6434009|NCT00338546|Adrenergic Agents|adrenergic agents|mesh-ancestor
6434010|NCT00338546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6434011|NCT00338546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434012|NCT00338546|Anesthetics, Local|anesthetics, local|mesh-ancestor
6434013|NCT00338546|Anesthetics|anesthetics|mesh-ancestor
6434014|NCT00338546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6434015|NCT00338546|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6434016|NCT00338546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6434017|NCT00338546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6434018|NCT00338546|Dopamine Agents|dopamine agents|mesh-ancestor
6434019|NCT00338624|Oxybutynin|oxybutynin|mesh-list
6434020|NCT00338624|Parasympatholytics|parasympatholytics|mesh-ancestor
6434021|NCT00338624|Autonomic Agents|autonomic agents|mesh-ancestor
6434022|NCT00338624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6434023|NCT00338624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434024|NCT00338624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6540693|NCT00841919|Isophane Insulin, Human|isophane insulin, human|mesh-list
6540694|NCT00841919|Isophane insulin, beef|isophane insulin, beef|mesh-list
6540695|NCT00841919|Insulin Lispro|insulin lispro|mesh-list
6540696|NCT00841919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6540697|NCT00841919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540698|NCT00841945|Prednisone|prednisone|mesh-list
6540699|NCT00841945|Rituximab|rituximab|mesh-list
6540700|NCT00841945|Doxorubicin|doxorubicin|mesh-list
6540701|NCT00841945|Vincristine|vincristine|mesh-list
6540702|NCT00841945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6540703|NCT00841945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6540704|NCT00841945|Immunologic Factors|immunologic factors|mesh-ancestor
6540705|NCT00841945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434025|NCT00338624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6540706|NCT00841945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6434026|NCT00338624|Cholinergic Agents|cholinergic agents|mesh-ancestor
6434027|NCT00338624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6434028|NCT00338624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434029|NCT00338624|Urological Agents|urological agents|mesh-ancestor
6434030|NCT00338650|Adalimumab|adalimumab|mesh-list
6434031|NCT00338650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6434032|NCT00338650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6434033|NCT00338754|Adalimumab|adalimumab|mesh-list
6434034|NCT00338754|Antibodies|antibodies|mesh-list
6434035|NCT00338754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6434036|NCT00338754|Immunologic Factors|immunologic factors|mesh-ancestor
6434037|NCT00338754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434038|NCT00338754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6434039|NCT00338754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6461046|NCT00452634|Antimetabolites|antimetabolites|mesh-ancestor
6461047|NCT00452634|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6461048|NCT00452634|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6461049|NCT00452660|Deferasirox|deferasirox|mesh-list
6461050|NCT00452660|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6461051|NCT00452660|Chelating Agents|chelating agents|mesh-ancestor
6461052|NCT00452660|Sequestering Agents|sequestering agents|mesh-ancestor
6461053|NCT00452660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462141|NCT00457808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6462142|NCT00457808|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6462143|NCT00457808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6462144|NCT00457808|Antifungal Agents|antifungal agents|mesh-ancestor
6462145|NCT00457808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6462146|NCT00457808|Immunologic Factors|immunologic factors|mesh-ancestor
6462147|NCT00457808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462148|NCT00457860|Immunotoxin HA22|immunotoxin ha22|mesh-list
6462149|NCT00457860|Immunotoxins|immunotoxins|mesh-list
6462150|NCT00457860|Immunologic Factors|immunologic factors|mesh-ancestor
6462151|NCT00457860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462152|NCT00457860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6462153|NCT00457899|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6462154|NCT00457899|Antidepressive Agents|antidepressive agents|mesh-ancestor
6462155|NCT00457899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6462156|NCT00457899|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6462157|NCT00457899|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6462158|NCT00457899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6462159|NCT00457899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462160|NCT00457964|Everolimus|everolimus|mesh-list
6462161|NCT00457964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6462162|NCT00457964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6462163|NCT00457964|Immunologic Factors|immunologic factors|mesh-ancestor
6462164|NCT00457964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462165|NCT00458003|Phenylephrine|phenylephrine|mesh-list
6462166|NCT00458003|Oxymetazoline|oxymetazoline|mesh-list
6462167|NCT00458003|Ephedrine|ephedrine|mesh-list
6462168|NCT00458003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6462169|NCT00458003|Mydriatics|mydriatics|mesh-ancestor
6462170|NCT00458003|Autonomic Agents|autonomic agents|mesh-ancestor
6462171|NCT00458003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6462172|NCT00458003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462173|NCT00458003|Sympathomimetics|sympathomimetics|mesh-ancestor
6462174|NCT00458003|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6462175|NCT00458003|Nasal Decongestants|nasal decongestants|mesh-ancestor
6462176|NCT00458003|Respiratory System Agents|respiratory system agents|mesh-ancestor
6540707|NCT00841945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6462177|NCT00458003|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6462178|NCT00458003|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6462179|NCT00458003|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6462180|NCT00458003|Adrenergic Agents|adrenergic agents|mesh-ancestor
6462181|NCT00458003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6462182|NCT00458003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462183|NCT00458003|Protective Agents|protective agents|mesh-ancestor
6462184|NCT00458003|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6434040|NCT00338767|Fluoxetine|fluoxetine|mesh-list
6434041|NCT00338767|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6434042|NCT00338767|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6434043|NCT00338767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6434044|NCT00338767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434045|NCT00338767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6434046|NCT00338767|Serotonin Agents|serotonin agents|mesh-ancestor
6434047|NCT00338767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434048|NCT00338767|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6434049|NCT00338767|Antidepressive Agents|antidepressive agents|mesh-ancestor
6434050|NCT00338767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6434051|NCT00338767|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6434052|NCT00338767|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6434053|NCT00338767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6434054|NCT00338780|Lamivudine|lamivudine|mesh-list
6434055|NCT00338780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6434056|NCT00338780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6434057|NCT00338780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6434058|NCT00338780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434059|NCT00338780|Antiviral Agents|antiviral agents|mesh-ancestor
6434060|NCT00338780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6434061|NCT00338780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6434062|NCT00338780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6434063|NCT00338793|Prednisolone|prednisolone|mesh-list
6434064|NCT00338793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6434065|NCT00338793|Glucocorticoids|glucocorticoids|mesh-ancestor
6434066|NCT00338793|Hormones|hormones|mesh-ancestor
6434067|NCT00338793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6540708|NCT00841945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6540709|NCT00841945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6540710|NCT00841945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6540711|NCT00841945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6540712|NCT00841945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6540713|NCT00841945|Glucocorticoids|glucocorticoids|mesh-ancestor
6540714|NCT00841945|Hormones|hormones|mesh-ancestor
6540715|NCT00841945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6540716|NCT00841945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6540717|NCT00841945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6540718|NCT00841945|Tubulin Modulators|tubulin modulators|mesh-ancestor
6540719|NCT00841945|Antimitotic Agents|antimitotic agents|mesh-ancestor
6540720|NCT00841945|Mitosis Modulators|mitosis modulators|mesh-ancestor
6540721|NCT00842114|Interferons|interferons|mesh-list
6540722|NCT00842114|Prednisone|prednisone|mesh-list
6540723|NCT00842114|Cyclophosphamide|cyclophosphamide|mesh-list
6434068|NCT00338793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434069|NCT00338793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6434070|NCT00338793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6434071|NCT00338910|Metronidazole|metronidazole|mesh-list
6434072|NCT00338910|Budesonide|budesonide|mesh-list
6434073|NCT00338910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6434074|NCT00338910|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6434075|NCT00338910|Autonomic Agents|autonomic agents|mesh-ancestor
6434076|NCT00338910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6434077|NCT00338910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434078|NCT00338910|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6434079|NCT00338910|Respiratory System Agents|respiratory system agents|mesh-ancestor
6434080|NCT00338910|Glucocorticoids|glucocorticoids|mesh-ancestor
6434081|NCT00338910|Hormones|hormones|mesh-ancestor
6434082|NCT00338910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6434083|NCT00338910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6434084|NCT00338910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6434085|NCT00338910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6434086|NCT00338910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6434087|NCT00338936|Valsartan|valsartan|mesh-list
6434088|NCT00338936|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6434089|NCT00338936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6434090|NCT00338936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6434091|NCT00338936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6434092|NCT00338936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434093|NCT00338936|Diuretics|diuretics|mesh-ancestor
6434094|NCT00338936|Natriuretic Agents|natriuretic agents|mesh-ancestor
6434095|NCT00338936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434096|NCT00338936|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6434097|NCT00338936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6434098|NCT00339001|Epoetin Alfa|epoetin alfa|mesh-list
6434099|NCT00339001|Hematinics|hematinics|mesh-ancestor
6434100|NCT00339014|Zonisamide|zonisamide|mesh-list
6434101|NCT00339014|Bupropion|bupropion|mesh-list
6434102|NCT00339014|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6434103|NCT00339014|Antidepressive Agents|antidepressive agents|mesh-ancestor
6434104|NCT00339014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6434105|NCT00339014|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6434106|NCT00339014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6434107|NCT00339014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6434108|NCT00339014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434109|NCT00339014|Dopamine Agents|dopamine agents|mesh-ancestor
6434110|NCT00339014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6434111|NCT00339014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434112|NCT00339014|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6434113|NCT00339014|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6434114|NCT00339014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6434115|NCT00339014|Anticonvulsants|anticonvulsants|mesh-ancestor
6434116|NCT00339014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6434117|NCT00339014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6434118|NCT00339066|Sertraline|sertraline|mesh-list
6434119|NCT00339066|Antidepressive Agents|antidepressive agents|mesh-ancestor
6434120|NCT00339066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6434121|NCT00339066|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6434122|NCT00339066|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6434123|NCT00339066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6434124|NCT00339066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434125|NCT00339066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6434126|NCT00339066|Serotonin Agents|serotonin agents|mesh-ancestor
6434127|NCT00339066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434128|NCT00339118|Doxorubicin|doxorubicin|mesh-list
6434129|NCT00339118|Cyclophosphamide|cyclophosphamide|mesh-list
6434130|NCT00339118|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6434131|NCT00339118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6434132|NCT00339118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6434133|NCT00339118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6434134|NCT00339118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6434135|NCT00339118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434136|NCT00339118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6434137|NCT00339118|Immunologic Factors|immunologic factors|mesh-ancestor
6434138|NCT00339118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434139|NCT00339118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6434140|NCT00339118|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6434141|NCT00339118|Alkylating Agents|alkylating agents|mesh-ancestor
6434142|NCT00339118|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6434143|NCT00339131|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
6434144|NCT00339131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6434145|NCT00339131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6434146|NCT00339131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434147|NCT00339131|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6434148|NCT00339157|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6434149|NCT00339157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6434150|NCT00339196|Azacitidine|azacitidine|mesh-list
6434151|NCT00339196|Tretinoin|tretinoin|mesh-list
6434152|NCT00339196|Valproic Acid|valproic acid|mesh-list
6434153|NCT00339196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6434154|NCT00339196|Antimetabolites|antimetabolites|mesh-ancestor
6434155|NCT00339196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434156|NCT00339196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6434157|NCT00339196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6434158|NCT00339196|Keratolytic Agents|keratolytic agents|mesh-ancestor
6434159|NCT00339196|Dermatologic Agents|dermatologic agents|mesh-ancestor
6434160|NCT00339196|Anticonvulsants|anticonvulsants|mesh-ancestor
6434161|NCT00339196|GABA Agents|gaba agents|mesh-ancestor
6434162|NCT00339196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6434163|NCT00339196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434164|NCT00339196|Antimanic Agents|antimanic agents|mesh-ancestor
6434165|NCT00339196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6434166|NCT00339196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6434167|NCT00339196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6434168|NCT00339417|Ivermectin|ivermectin|mesh-list
6434169|NCT00339417|Albendazole|albendazole|mesh-list
6434170|NCT00339417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6434171|NCT00339417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6434172|NCT00339417|Anthelmintics|anthelmintics|mesh-ancestor
6434173|NCT00339417|Anticestodal Agents|anticestodal agents|mesh-ancestor
6434174|NCT00339417|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6434175|NCT00339417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6434176|NCT00339417|Tubulin Modulators|tubulin modulators|mesh-ancestor
6434177|NCT00339417|Antimitotic Agents|antimitotic agents|mesh-ancestor
6434178|NCT00339417|Mitosis Modulators|mitosis modulators|mesh-ancestor
6434179|NCT00339417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434180|NCT00339417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6434181|NCT00339586|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6434182|NCT00339586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6434183|NCT00339586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6434184|NCT00339586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6434185|NCT00339586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434186|NCT00339768|Amoxicillin|amoxicillin|mesh-list
6434187|NCT00339768|Omeprazole|omeprazole|mesh-list
6434188|NCT00339768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6434189|NCT00339768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6434190|NCT00339768|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6434191|NCT00339768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6434192|NCT00339768|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6434193|NCT00339768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6019452|NCT00387335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019453|NCT00387348|Dexetimide|dexetimide|mesh-list
6019454|NCT00387348|Citalopram|citalopram|mesh-list
6434194|NCT00339768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434195|NCT00340080|Abacavir|abacavir|mesh-list
6434196|NCT00340080|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6434197|NCT00340080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6434198|NCT00340080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6434199|NCT00340080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434200|NCT00340080|Antiviral Agents|antiviral agents|mesh-ancestor
6434201|NCT00340080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6434202|NCT00340080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6434203|NCT00340080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6434204|NCT00340184|Paclitaxel|paclitaxel|mesh-list
6434205|NCT00340184|Carboplatin|carboplatin|mesh-list
6434206|NCT00340184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6434207|NCT00340184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6434208|NCT00340184|Tubulin Modulators|tubulin modulators|mesh-ancestor
6434209|NCT00340184|Antimitotic Agents|antimitotic agents|mesh-ancestor
6434210|NCT00340184|Mitosis Modulators|mitosis modulators|mesh-ancestor
6434211|NCT00340184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434212|NCT00340314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
6461054|NCT00452725|Hormones|hormones|mesh-list
6461055|NCT00452725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6461056|NCT00452725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461057|NCT00452829|Folic Acid|folic acid|mesh-list
6461058|NCT00452829|Vitamin B Complex|vitamin b complex|mesh-list
6461059|NCT00452829|Inositol|inositol|mesh-list
6461060|NCT00452829|Hematinics|hematinics|mesh-ancestor
6461061|NCT00452829|Vitamins|vitamins|mesh-ancestor
6461062|NCT00452829|Micronutrients|micronutrients|mesh-ancestor
6461063|NCT00452829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461064|NCT00452855|Remifentanil|remifentanil|mesh-list
6461065|NCT00452855|Sevoflurane|sevoflurane|mesh-list
6540724|NCT00842114|Vincristine|vincristine|mesh-list
6540725|NCT00842114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6540726|NCT00842114|Immunologic Factors|immunologic factors|mesh-ancestor
6540727|NCT00842114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540728|NCT00842114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6540729|NCT00842114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6540730|NCT00842114|Alkylating Agents|alkylating agents|mesh-ancestor
6540731|NCT00842114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6540732|NCT00842114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6540733|NCT00842114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6540734|NCT00842114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6540735|NCT00842114|Glucocorticoids|glucocorticoids|mesh-ancestor
6540736|NCT00842114|Hormones|hormones|mesh-ancestor
6540737|NCT00842114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6540738|NCT00842114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6540739|NCT00842114|Antiviral Agents|antiviral agents|mesh-ancestor
6540740|NCT00842114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6540741|NCT00842114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6540742|NCT00842114|Tubulin Modulators|tubulin modulators|mesh-ancestor
6540743|NCT00842114|Antimitotic Agents|antimitotic agents|mesh-ancestor
6540744|NCT00842114|Mitosis Modulators|mitosis modulators|mesh-ancestor
6540745|NCT00842127|Methylphenidate|methylphenidate|mesh-list
6540746|NCT00842127|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6540747|NCT00842127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540748|NCT00842127|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6461066|NCT00452855|Anesthetics|anesthetics|mesh-ancestor
6461067|NCT00452855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6461068|NCT00452855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434213|NCT00340574|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6434214|NCT00340574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6434215|NCT00340574|Immunologic Factors|immunologic factors|mesh-ancestor
6434216|NCT00340574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434217|NCT00340574|Antacids|antacids|mesh-ancestor
6434218|NCT00340574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434219|NCT00340574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6434220|NCT00340613|Insulin Glargine|insulin glargine|mesh-list
6434221|NCT00340613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6434222|NCT00340613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434223|NCT00340691|Doxycycline|doxycycline|mesh-list
6434224|NCT00340691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6434225|NCT00340691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6434226|NCT00340691|Antimalarials|antimalarials|mesh-ancestor
6434227|NCT00340691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6434228|NCT00340691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6434229|NCT00341055|Epoetin Alfa|epoetin alfa|mesh-list
6434230|NCT00341055|Hematinics|hematinics|mesh-ancestor
6434231|NCT00341250|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6434232|NCT00341250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6434233|NCT00341250|Immunologic Factors|immunologic factors|mesh-ancestor
6434234|NCT00341250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434235|NCT00341250|Antacids|antacids|mesh-ancestor
6434236|NCT00341250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434237|NCT00341250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6434238|NCT00341432|Nicotine|nicotine|mesh-list
6434239|NCT00341432|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6434240|NCT00341432|Autonomic Agents|autonomic agents|mesh-ancestor
6434241|NCT00341432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6434242|NCT00341432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434243|NCT00341432|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6434244|NCT00341432|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6434245|NCT00341432|Cholinergic Agents|cholinergic agents|mesh-ancestor
6434246|NCT00341432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6461069|NCT00452855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6434247|NCT00341432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461070|NCT00452855|Narcotics|narcotics|mesh-ancestor
6461071|NCT00452855|Analgesics|analgesics|mesh-ancestor
6461072|NCT00452855|Sensory System Agents|sensory system agents|mesh-ancestor
6461073|NCT00452855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6461074|NCT00452855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6461075|NCT00452855|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6461076|NCT00452855|Anesthetics, General|anesthetics, general|mesh-ancestor
6461077|NCT00452881|Gemcitabine|gemcitabine|mesh-list
6461078|NCT00452881|Oxaliplatin|oxaliplatin|mesh-list
6461079|NCT00452881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6461080|NCT00452881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6461081|NCT00452881|Antimetabolites|antimetabolites|mesh-ancestor
6461082|NCT00452881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461083|NCT00452881|Antiviral Agents|antiviral agents|mesh-ancestor
6461084|NCT00452881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6461085|NCT00452881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6461086|NCT00452881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6461087|NCT00452881|Immunologic Factors|immunologic factors|mesh-ancestor
6461088|NCT00452881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461089|NCT00452894|Varenicline|varenicline|mesh-list
6461090|NCT00452894|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6461091|NCT00452894|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6461092|NCT00452894|Cholinergic Agents|cholinergic agents|mesh-ancestor
6461093|NCT00452894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6461094|NCT00452894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461095|NCT00452894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461096|NCT00452907|Artesunate|artesunate|mesh-list
6461097|NCT00452907|Lumefantrine|lumefantrine|mesh-list
6461098|NCT00452907|Pyrimethamine|pyrimethamine|mesh-list
6461099|NCT00452907|Sulfadoxine|sulfadoxine|mesh-list
6461100|NCT00452907|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6461101|NCT00452907|Antimalarials|antimalarials|mesh-ancestor
6461102|NCT00452907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6461103|NCT00452907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6461104|NCT00452907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6461105|NCT00452907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6461106|NCT00452907|Antiviral Agents|antiviral agents|mesh-ancestor
6461107|NCT00452907|Schistosomicides|schistosomicides|mesh-ancestor
6461108|NCT00452907|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6461109|NCT00452907|Anthelmintics|anthelmintics|mesh-ancestor
6461110|NCT00452907|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6461111|NCT00452907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6461112|NCT00452907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461113|NCT00452907|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6461114|NCT00452907|Renal Agents|renal agents|mesh-ancestor
6461115|NCT00452920|Docetaxel|docetaxel|mesh-list
6461116|NCT00452920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6461117|NCT00452920|Tubulin Modulators|tubulin modulators|mesh-ancestor
6461118|NCT00452920|Antimitotic Agents|antimitotic agents|mesh-ancestor
6461119|NCT00452920|Mitosis Modulators|mitosis modulators|mesh-ancestor
6461120|NCT00452920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461121|NCT00452972|Anesthetics|anesthetics|mesh-list
6461122|NCT00452972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6461123|NCT00452972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461124|NCT00452985|Carboplatin|carboplatin|mesh-list
6461125|NCT00452985|Docetaxel|docetaxel|mesh-list
6461126|NCT00452985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6461127|NCT00452985|Tubulin Modulators|tubulin modulators|mesh-ancestor
6461128|NCT00452985|Antimitotic Agents|antimitotic agents|mesh-ancestor
6461129|NCT00452985|Mitosis Modulators|mitosis modulators|mesh-ancestor
6461130|NCT00452985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461131|NCT00453050|Imiquimod|imiquimod|mesh-list
6461132|NCT00453050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6461133|NCT00453050|Immunologic Factors|immunologic factors|mesh-ancestor
6461134|NCT00453050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461135|NCT00453050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6461136|NCT00453050|Interferon Inducers|interferon inducers|mesh-ancestor
6461137|NCT00453076|Paclitaxel|paclitaxel|mesh-list
6461138|NCT00453076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6461139|NCT00453076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6461140|NCT00453076|Tubulin Modulators|tubulin modulators|mesh-ancestor
6461141|NCT00453076|Antimitotic Agents|antimitotic agents|mesh-ancestor
6461142|NCT00453076|Mitosis Modulators|mitosis modulators|mesh-ancestor
6434248|NCT00342381|Amifampridine|amifampridine|mesh-list
6434249|NCT00342381|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6434250|NCT00342381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6434251|NCT00342381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434252|NCT00342381|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6434253|NCT00342381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6434254|NCT00342381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434255|NCT00342849|Succimer|succimer|mesh-list
6434256|NCT00342849|Antidotes|antidotes|mesh-ancestor
6434257|NCT00342849|Protective Agents|protective agents|mesh-ancestor
6434258|NCT00342849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434259|NCT00342849|Chelating Agents|chelating agents|mesh-ancestor
6434260|NCT00342849|Sequestering Agents|sequestering agents|mesh-ancestor
6434261|NCT00342849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434262|NCT00342862|Alefacept|alefacept|mesh-list
6434263|NCT00342862|Dermatologic Agents|dermatologic agents|mesh-ancestor
6434264|NCT00342862|Immunologic Factors|immunologic factors|mesh-ancestor
6434265|NCT00342862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434266|NCT00343005|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6434267|NCT00343005|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6434268|NCT00343005|Immunologic Factors|immunologic factors|mesh-ancestor
6434269|NCT00343005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434270|NCT00343005|Antacids|antacids|mesh-ancestor
6434271|NCT00343005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434272|NCT00343005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6434273|NCT00343070|Citalopram|citalopram|mesh-list
6434274|NCT00343070|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6434275|NCT00343070|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6434276|NCT00343070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6434277|NCT00343070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434278|NCT00343070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6434279|NCT00343070|Serotonin Agents|serotonin agents|mesh-ancestor
6434280|NCT00343070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434281|NCT00343070|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6434282|NCT00343070|Antidepressive Agents|antidepressive agents|mesh-ancestor
6434283|NCT00343070|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6434284|NCT00343096|Lorazepam|lorazepam|mesh-list
6434285|NCT00343096|Anticonvulsants|anticonvulsants|mesh-ancestor
6434286|NCT00343096|Antiemetics|antiemetics|mesh-ancestor
6434287|NCT00343096|Autonomic Agents|autonomic agents|mesh-ancestor
6434288|NCT00343096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6434289|NCT00343096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434290|NCT00343096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6434291|NCT00343096|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6434292|NCT00343096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6434293|NCT00343096|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6434294|NCT00343096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6434295|NCT00343096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6434296|NCT00343096|GABA Modulators|gaba modulators|mesh-ancestor
6434297|NCT00343096|GABA Agents|gaba agents|mesh-ancestor
6434298|NCT00343096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6434299|NCT00343096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434300|NCT00343135|Amoxicillin|amoxicillin|mesh-list
6434301|NCT00343135|Clavulanic Acid|clavulanic acid|mesh-list
6434302|NCT00343135|Clavulanic Acids|clavulanic acids|mesh-list
6434303|NCT00343135|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6434304|NCT00343135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6434305|NCT00343135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6434306|NCT00343135|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6434307|NCT00343135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6434308|NCT00343135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434309|NCT00343161|Esomeprazole|esomeprazole|mesh-list
6434310|NCT00343161|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6434311|NCT00343161|Magnesium trisilicate|magnesium trisilicate|mesh-list
6434312|NCT00343161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6434313|NCT00343161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6434314|NCT00343161|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6434315|NCT00343161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6434316|NCT00343161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434317|NCT00343161|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6434318|NCT00343161|Immunologic Factors|immunologic factors|mesh-ancestor
6434319|NCT00343161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434320|NCT00343161|Antacids|antacids|mesh-ancestor
6434321|NCT00343174|Ancrod|ancrod|mesh-list
6434322|NCT00343174|Anticoagulants|anticoagulants|mesh-ancestor
6434323|NCT00343174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6434324|NCT00343174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6434325|NCT00343174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434326|NCT00343187|Dapsone|dapsone|mesh-list
6434327|NCT00343187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6434328|NCT00343187|Antimalarials|antimalarials|mesh-ancestor
6434329|NCT00343187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6434330|NCT00343187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6434331|NCT00343187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6434332|NCT00343187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6434333|NCT00343187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434334|NCT00343187|Leprostatic Agents|leprostatic agents|mesh-ancestor
6434335|NCT00343187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6434336|NCT00343200|Sildenafil Citrate|sildenafil citrate|mesh-list
6434337|NCT00343200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434338|NCT00343200|Vasodilator Agents|vasodilator agents|mesh-ancestor
6434339|NCT00343200|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6434340|NCT00343200|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6434341|NCT00343200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6434342|NCT00343200|Urological Agents|urological agents|mesh-ancestor
6434343|NCT00343226|Basiliximab|basiliximab|mesh-list
6434344|NCT00343226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6434345|NCT00343226|Immunologic Factors|immunologic factors|mesh-ancestor
6434346|NCT00343226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434347|NCT00343239|Docetaxel|docetaxel|mesh-list
6434348|NCT00343239|Fluorouracil|fluorouracil|mesh-list
6434349|NCT00343239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6434350|NCT00343239|Tubulin Modulators|tubulin modulators|mesh-ancestor
6434351|NCT00343239|Antimitotic Agents|antimitotic agents|mesh-ancestor
6540749|NCT00842127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6540750|NCT00842127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6540751|NCT00842127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6540752|NCT00842127|Dopamine Agents|dopamine agents|mesh-ancestor
6540753|NCT00842127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6540754|NCT00842140|Metformin|metformin|mesh-list
6540755|NCT00842140|Spironolactone|spironolactone|mesh-list
6540756|NCT00842140|Contraceptive Agents|contraceptive agents|mesh-list
6540757|NCT00842140|Contraceptives, Oral|contraceptives, oral|mesh-list
6540758|NCT00842140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6540759|NCT00842140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540760|NCT00842140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6540761|NCT00842140|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6540762|NCT00842140|Hormone Antagonists|hormone antagonists|mesh-ancestor
6540763|NCT00842140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6540764|NCT00842140|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6540765|NCT00842140|Diuretics|diuretics|mesh-ancestor
6540766|NCT00842140|Natriuretic Agents|natriuretic agents|mesh-ancestor
6540767|NCT00842140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6540768|NCT00842192|Insulin Detemir|insulin detemir|mesh-list
6434352|NCT00343239|Mitosis Modulators|mitosis modulators|mesh-ancestor
6434353|NCT00343239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434354|NCT00343239|Antimetabolites|antimetabolites|mesh-ancestor
6434355|NCT00343239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6434356|NCT00343239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6434357|NCT00343239|Immunologic Factors|immunologic factors|mesh-ancestor
6434358|NCT00343239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434359|NCT00343265|Progesterone|progesterone|mesh-list
6434360|NCT00343265|Progestins|progestins|mesh-ancestor
6434361|NCT00343265|Hormones|hormones|mesh-ancestor
6434362|NCT00343265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6434363|NCT00343265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434364|NCT00343278|Valacyclovir|valacyclovir|mesh-list
6434365|NCT00343278|Antiviral Agents|antiviral agents|mesh-ancestor
6434366|NCT00343278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6434367|NCT00343317|Cefoxitin|cefoxitin|mesh-list
6434368|NCT00343317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6434369|NCT00343317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6434370|NCT00343369|Cytarabine|cytarabine|mesh-list
6434371|NCT00343369|Dexamethasone|dexamethasone|mesh-list
6434372|NCT00343369|Prednisolone|prednisolone|mesh-list
6434373|NCT00343369|Cyclophosphamide|cyclophosphamide|mesh-list
6434374|NCT00343369|Doxorubicin|doxorubicin|mesh-list
6434375|NCT00343369|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6434376|NCT00343369|Methotrexate|methotrexate|mesh-list
6434377|NCT00343369|Vincristine|vincristine|mesh-list
6434378|NCT00343369|Daunorubicin|daunorubicin|mesh-list
6434379|NCT00343369|Asparaginase|asparaginase|mesh-list
6434380|NCT00343369|Mercaptopurine|mercaptopurine|mesh-list
6434381|NCT00343369|Pegaspargase|pegaspargase|mesh-list
6434382|NCT00343369|Thioguanine|thioguanine|mesh-list
6434383|NCT00343369|Teniposide|teniposide|mesh-list
6434384|NCT00343369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6434385|NCT00343369|Immunologic Factors|immunologic factors|mesh-ancestor
6540769|NCT00842192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6540770|NCT00842192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540771|NCT00842205|Interferons|interferons|mesh-list
6540772|NCT00842205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6540773|NCT00842205|Antiviral Agents|antiviral agents|mesh-ancestor
6540774|NCT00842205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6655522|NCT01464268|Vitamin B Complex|vitamin b complex|mesh-ancestor
6655523|NCT01464268|Vitamins|vitamins|mesh-ancestor
6655524|NCT01464268|Micronutrients|micronutrients|mesh-ancestor
6655525|NCT01464268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655526|NCT01464268|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6655527|NCT01464268|Dermatologic Agents|dermatologic agents|mesh-ancestor
6655528|NCT01464268|Anticoagulants|anticoagulants|mesh-ancestor
6655529|NCT01464268|Plasma Substitutes|plasma substitutes|mesh-ancestor
6655530|NCT01464268|Blood Substitutes|blood substitutes|mesh-ancestor
6434386|NCT00343369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434387|NCT00343369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6434388|NCT00343369|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6434389|NCT00343369|Alkylating Agents|alkylating agents|mesh-ancestor
6655531|NCT01464281|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6434390|NCT00343369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434391|NCT00343369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6434392|NCT00343369|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6434393|NCT00343369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6434394|NCT00343369|Antiemetics|antiemetics|mesh-ancestor
6434395|NCT00343369|Autonomic Agents|autonomic agents|mesh-ancestor
6434396|NCT00343369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6434397|NCT00343369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6434398|NCT00343369|Glucocorticoids|glucocorticoids|mesh-ancestor
6434399|NCT00343369|Hormones|hormones|mesh-ancestor
6434400|NCT00343369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6434401|NCT00343369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6434402|NCT00343369|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6434403|NCT00343369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6434404|NCT00343369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6434405|NCT00343369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6434406|NCT00343369|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6434407|NCT00343369|Abortifacient Agents|abortifacient agents|mesh-ancestor
6434408|NCT00343369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6434409|NCT00343369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6434410|NCT00343369|Antimetabolites|antimetabolites|mesh-ancestor
6434411|NCT00343369|Dermatologic Agents|dermatologic agents|mesh-ancestor
6434412|NCT00343369|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6434413|NCT00343369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6434414|NCT00343369|Antiviral Agents|antiviral agents|mesh-ancestor
6434415|NCT00343369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6434416|NCT00343369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6434417|NCT00343369|Tubulin Modulators|tubulin modulators|mesh-ancestor
6434418|NCT00343369|Antimitotic Agents|antimitotic agents|mesh-ancestor
6434419|NCT00343369|Mitosis Modulators|mitosis modulators|mesh-ancestor
6434420|NCT00343408|Leucovorin|leucovorin|mesh-list
6434421|NCT00343408|Gemcitabine|gemcitabine|mesh-list
6434422|NCT00343408|Fluorouracil|fluorouracil|mesh-list
6434423|NCT00343408|Oxaliplatin|oxaliplatin|mesh-list
6434424|NCT00343408|Cediranib|cediranib|mesh-list
6434425|NCT00343408|Calcium|calcium|mesh-list
6434426|NCT00343408|Levoleucovorin|levoleucovorin|mesh-list
6434427|NCT00343408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6434428|NCT00343408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6434429|NCT00343408|Antimetabolites|antimetabolites|mesh-ancestor
6434430|NCT00343408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434431|NCT00343408|Antiviral Agents|antiviral agents|mesh-ancestor
6434432|NCT00343408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6434433|NCT00343408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6434434|NCT00343408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6434435|NCT00343408|Immunologic Factors|immunologic factors|mesh-ancestor
6434436|NCT00343408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434437|NCT00343408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6434438|NCT00343408|Antidotes|antidotes|mesh-ancestor
6434439|NCT00343408|Protective Agents|protective agents|mesh-ancestor
6434440|NCT00343408|Vitamin B Complex|vitamin b complex|mesh-ancestor
6434441|NCT00343408|Vitamins|vitamins|mesh-ancestor
6434442|NCT00343408|Micronutrients|micronutrients|mesh-ancestor
6434443|NCT00343408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6434444|NCT00343421|Vaccines|vaccines|mesh-list
6434445|NCT00343421|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6434446|NCT00343421|Immunologic Factors|immunologic factors|mesh-ancestor
6434447|NCT00343421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434448|NCT00343447|Cyclophosphamide|cyclophosphamide|mesh-list
6434449|NCT00343447|Rituximab|rituximab|mesh-list
6434450|NCT00343447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6434451|NCT00343447|Immunologic Factors|immunologic factors|mesh-ancestor
6434452|NCT00343447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434453|NCT00343447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6434454|NCT00343447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6434455|NCT00343447|Alkylating Agents|alkylating agents|mesh-ancestor
6434456|NCT00343447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434457|NCT00343447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6434458|NCT00343447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6434459|NCT00343447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6434460|NCT00343486|Solabegron|solabegron|mesh-list
6434461|NCT00343486|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6434462|NCT00343486|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6434463|NCT00343486|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6434464|NCT00343486|Adrenergic Agents|adrenergic agents|mesh-ancestor
6434465|NCT00343486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6434466|NCT00343486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434467|NCT00343486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434468|NCT00343499|Valsartan|valsartan|mesh-list
6434469|NCT00343499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6434470|NCT00343499|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6434471|NCT00343499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6434472|NCT00343499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434473|NCT00343525|Bavituximab|bavituximab|mesh-list
6434474|NCT00343525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6434475|NCT00343525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6434476|NCT00343629|Sulindac|sulindac|mesh-list
6434477|NCT00343629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6434478|NCT00343629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6434479|NCT00343629|Analgesics|analgesics|mesh-ancestor
6434480|NCT00343629|Sensory System Agents|sensory system agents|mesh-ancestor
6434481|NCT00343629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6434482|NCT00343629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434483|NCT00343629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6434484|NCT00343629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6434485|NCT00343629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6434486|NCT00343629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6434487|NCT00343629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6434488|NCT00343629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434489|NCT00343655|Atorvastatin|atorvastatin|mesh-list
6434490|NCT00343655|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6434491|NCT00343655|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6434492|NCT00343655|Antimetabolites|antimetabolites|mesh-ancestor
6434493|NCT00343655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434494|NCT00343655|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6434495|NCT00343655|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6434496|NCT00343655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6434497|NCT00343668|Irinotecan|irinotecan|mesh-list
6434498|NCT00343668|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6434499|NCT00343668|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6434500|NCT00343668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6434501|NCT00343668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434502|NCT00343668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6434503|NCT00343707|Paroxetine|paroxetine|mesh-list
6434504|NCT00343707|Vestipitant|vestipitant|mesh-list
6434505|NCT00343707|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6434506|NCT00343707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6434507|NCT00343707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6434508|NCT00343707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434509|NCT00343707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6434510|NCT00343707|Serotonin Agents|serotonin agents|mesh-ancestor
6434511|NCT00343707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434512|NCT00343707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6434513|NCT00343707|Antidepressive Agents|antidepressive agents|mesh-ancestor
6434514|NCT00343707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6434515|NCT00343707|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6434516|NCT00343707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6434517|NCT00343707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6434518|NCT00343707|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6434519|NCT00343720|Bortezomib|bortezomib|mesh-list
6434520|NCT00343720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6540775|NCT00842400|Metformin|metformin|mesh-list
6540776|NCT00842400|Probenecid|probenecid|mesh-list
6540777|NCT00842400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6540778|NCT00842400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540779|NCT00842400|Uricosuric Agents|uricosuric agents|mesh-ancestor
6540780|NCT00842400|Gout Suppressants|gout suppressants|mesh-ancestor
6540781|NCT00842400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6540782|NCT00842400|Renal Agents|renal agents|mesh-ancestor
6540783|NCT00842452|Topotecan|topotecan|mesh-list
6655532|NCT01464281|Antiviral Agents|antiviral agents|mesh-ancestor
6434521|NCT00343733|Fentanyl|fentanyl|mesh-list
6434522|NCT00343733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6434523|NCT00343733|Narcotics|narcotics|mesh-ancestor
6434524|NCT00343733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6434525|NCT00343733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434526|NCT00343733|Analgesics|analgesics|mesh-ancestor
6434527|NCT00343733|Sensory System Agents|sensory system agents|mesh-ancestor
6434528|NCT00343733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6434529|NCT00343733|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6434530|NCT00343733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6434531|NCT00343733|Anesthetics, General|anesthetics, general|mesh-ancestor
6434532|NCT00343733|Anesthetics|anesthetics|mesh-ancestor
6434533|NCT00343759|Lapatinib|lapatinib|mesh-list
6434534|NCT00343759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6434535|NCT00343759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6434536|NCT00343759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6434537|NCT00343759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434538|NCT00343798|Cyclosporine|cyclosporine|mesh-list
6434539|NCT00343798|Mycophenolic Acid|mycophenolic acid|mesh-list
6434540|NCT00343798|Cyclophosphamide|cyclophosphamide|mesh-list
6434541|NCT00343798|Fludarabine|fludarabine|mesh-list
6434542|NCT00343798|Fludarabine phosphate|fludarabine phosphate|mesh-list
6434543|NCT00343798|Cyclosporins|cyclosporins|mesh-list
6434544|NCT00343798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6019455|NCT00387348|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6434545|NCT00343798|Immunologic Factors|immunologic factors|mesh-ancestor
6434546|NCT00343798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434547|NCT00343798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6434548|NCT00343798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6434549|NCT00343798|Alkylating Agents|alkylating agents|mesh-ancestor
6434550|NCT00343798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434551|NCT00343798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6434552|NCT00343798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6434553|NCT00343798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6434554|NCT00343798|Antimetabolites|antimetabolites|mesh-ancestor
6434555|NCT00343798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6434556|NCT00343798|Antifungal Agents|antifungal agents|mesh-ancestor
6434557|NCT00343798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6434558|NCT00343798|Dermatologic Agents|dermatologic agents|mesh-ancestor
6434559|NCT00343798|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6434560|NCT00343798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6434561|NCT00343798|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6434562|NCT00343798|Antitubercular Agents|antitubercular agents|mesh-ancestor
6434563|NCT00343798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6434564|NCT00343811|Modafinil|modafinil|mesh-list
6434565|NCT00343811|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6434566|NCT00343811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434567|NCT00343811|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6434568|NCT00343811|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6434569|NCT00343811|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6434570|NCT00343811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434571|NCT00343824|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6434572|NCT00343824|Laxatives|laxatives|mesh-ancestor
6434573|NCT00343824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6434574|NCT00343850|Mesalamine|mesalamine|mesh-list
6434575|NCT00343850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6434576|NCT00343850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6434577|NCT00343850|Analgesics|analgesics|mesh-ancestor
6434578|NCT00343850|Sensory System Agents|sensory system agents|mesh-ancestor
6434579|NCT00343850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6434580|NCT00343850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434581|NCT00343850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6434582|NCT00343850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6434583|NCT00343876|Aspirin|aspirin|mesh-list
6434584|NCT00343876|Clopidogrel|clopidogrel|mesh-list
6434585|NCT00343876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6434586|NCT00343876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6434587|NCT00343876|Analgesics|analgesics|mesh-ancestor
6434588|NCT00343876|Sensory System Agents|sensory system agents|mesh-ancestor
6434589|NCT00343876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6434590|NCT00343876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434591|NCT00343876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6434592|NCT00343876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6434593|NCT00343876|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6434594|NCT00343876|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6434595|NCT00343876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434596|NCT00343876|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6434597|NCT00343876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6434598|NCT00343876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6434599|NCT00343876|Antipyretics|antipyretics|mesh-ancestor
6434600|NCT00343876|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6019456|NCT00387348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6019457|NCT00387348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6019458|NCT00387348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434601|NCT00343876|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6434602|NCT00343876|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6434603|NCT00343876|Purinergic Agents|purinergic agents|mesh-ancestor
6434604|NCT00343876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6434605|NCT00343980|Insulin|insulin|mesh-list
6434606|NCT00343980|Glimepiride|glimepiride|mesh-list
6434607|NCT00343980|Rosiglitazone|rosiglitazone|mesh-list
6434608|NCT00343980|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6434609|NCT00343980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6434610|NCT00343980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019459|NCT00387348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6019460|NCT00387348|Serotonin Agents|serotonin agents|mesh-ancestor
6019461|NCT00387348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434611|NCT00343980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6434612|NCT00343980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6434613|NCT00343980|Immunologic Factors|immunologic factors|mesh-ancestor
6434614|NCT00344006|Artesunate|artesunate|mesh-list
6434615|NCT00344006|Lumefantrine|lumefantrine|mesh-list
6434616|NCT00344006|Artemether|artemether|mesh-list
6434617|NCT00344006|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6434618|NCT00344006|Dapsone|dapsone|mesh-list
6434619|NCT00344006|Chlorproguanil|chlorproguanil|mesh-list
6434620|NCT00344006|Proguanil|proguanil|mesh-list
6434621|NCT00344006|Antimalarials|antimalarials|mesh-ancestor
6434622|NCT00344006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6434623|NCT00344006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6434624|NCT00344006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6434625|NCT00344006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6434626|NCT00344006|Antiviral Agents|antiviral agents|mesh-ancestor
6434627|NCT00344006|Schistosomicides|schistosomicides|mesh-ancestor
6434628|NCT00344006|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6434629|NCT00344006|Anthelmintics|anthelmintics|mesh-ancestor
6434630|NCT00344006|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6434631|NCT00344006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6434632|NCT00344006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434633|NCT00344006|Leprostatic Agents|leprostatic agents|mesh-ancestor
6434634|NCT00344006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6434635|NCT00344006|Antimetabolites|antimetabolites|mesh-ancestor
6434636|NCT00344058|Magnesium Sulfate|magnesium sulfate|mesh-list
6434637|NCT00344058|Analgesics|analgesics|mesh-ancestor
6434638|NCT00344058|Sensory System Agents|sensory system agents|mesh-ancestor
6434639|NCT00344058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6434640|NCT00344058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434641|NCT00344058|Anesthetics|anesthetics|mesh-ancestor
6434642|NCT00344058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6434643|NCT00344058|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6434644|NCT00344058|Anticonvulsants|anticonvulsants|mesh-ancestor
6540784|NCT00842452|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6540785|NCT00842452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6540786|NCT00842452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6540787|NCT00842452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6540788|NCT00842452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6540789|NCT00842491|Cisplatin|cisplatin|mesh-list
6540790|NCT00842491|Capecitabine|capecitabine|mesh-list
6540791|NCT00842491|Endostar protein|endostar protein|mesh-list
6540792|NCT00842491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6540793|NCT00842491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6540794|NCT00842491|Antimetabolites|antimetabolites|mesh-ancestor
6540795|NCT00842491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6540796|NCT00842491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6540797|NCT00842491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6540798|NCT00842491|Growth Substances|growth substances|mesh-ancestor
6540799|NCT00842491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540800|NCT00842491|Growth Inhibitors|growth inhibitors|mesh-ancestor
6540801|NCT00842504|Micafungin|micafungin|mesh-list
6540802|NCT00842504|Antifungal Agents|antifungal agents|mesh-ancestor
6540803|NCT00842504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6540804|NCT00842556|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6540805|NCT00842556|Dapagliflozin|dapagliflozin|mesh-list
6540806|NCT00842556|Glimepiride|glimepiride|mesh-list
6540807|NCT00842556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6540808|NCT00842556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540809|NCT00842556|Incretins|incretins|mesh-ancestor
6540810|NCT00842556|Hormones|hormones|mesh-ancestor
6434645|NCT00344058|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6540811|NCT00842556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6540812|NCT00842556|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6540813|NCT00842556|Protease Inhibitors|protease inhibitors|mesh-ancestor
6540814|NCT00842556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6540815|NCT00842556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6540816|NCT00842556|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6540817|NCT00842556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6540818|NCT00842556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6540819|NCT00842556|Immunologic Factors|immunologic factors|mesh-ancestor
6540820|NCT00842582|Azacitidine|azacitidine|mesh-list
6540821|NCT00842582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6434646|NCT00344058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6434647|NCT00344058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434648|NCT00344058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6434649|NCT00344058|Tocolytic Agents|tocolytic agents|mesh-ancestor
6434650|NCT00344058|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6434651|NCT00344123|Ritonavir|ritonavir|mesh-list
6434652|NCT00344123|Tipranavir|tipranavir|mesh-list
6434653|NCT00344123|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6434654|NCT00344123|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6434655|NCT00344123|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6434656|NCT00344123|Protease Inhibitors|protease inhibitors|mesh-ancestor
6434657|NCT00344123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6434658|NCT00344123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434659|NCT00344123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6434660|NCT00344123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6434661|NCT00344123|Antiviral Agents|antiviral agents|mesh-ancestor
6434662|NCT00344123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6434663|NCT00344123|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6434664|NCT00344123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6434665|NCT00344123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6434666|NCT00344123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6434667|NCT00344123|Antimetabolites|antimetabolites|mesh-ancestor
6434668|NCT00344123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6434669|NCT00344123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6434670|NCT00344149|Rituximab|rituximab|mesh-list
6434671|NCT00344149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6434672|NCT00344149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6434673|NCT00344149|Immunologic Factors|immunologic factors|mesh-ancestor
6434674|NCT00344149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434675|NCT00344149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6434676|NCT00344201|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6434677|NCT00344201|Hemostatics|hemostatics|mesh-ancestor
6434678|NCT00344201|Coagulants|coagulants|mesh-ancestor
6434679|NCT00344227|Ranibizumab|ranibizumab|mesh-list
6434680|NCT00344227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6434681|NCT00344227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6434682|NCT00344227|Growth Substances|growth substances|mesh-ancestor
6434683|NCT00344227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434684|NCT00344227|Growth Inhibitors|growth inhibitors|mesh-ancestor
6434685|NCT00344227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6434686|NCT00344253|Interferons|interferons|mesh-list
6434687|NCT00344253|Interferon-beta|interferon-beta|mesh-list
6434688|NCT00344253|Methotrexate|methotrexate|mesh-list
6434689|NCT00344253|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6434690|NCT00344253|Abortifacient Agents|abortifacient agents|mesh-ancestor
6434691|NCT00344253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6434692|NCT00344253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434693|NCT00344253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6434694|NCT00344253|Antimetabolites|antimetabolites|mesh-ancestor
6434695|NCT00344253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434696|NCT00344253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6434697|NCT00344253|Dermatologic Agents|dermatologic agents|mesh-ancestor
6434698|NCT00344253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6434699|NCT00344253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6434700|NCT00344253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6434701|NCT00344253|Immunologic Factors|immunologic factors|mesh-ancestor
6434702|NCT00344253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6434703|NCT00344253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6434704|NCT00344253|Antiviral Agents|antiviral agents|mesh-ancestor
6434705|NCT00344253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6434706|NCT00344383|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6434707|NCT00344383|Norgestimate|norgestimate|mesh-list
6434708|NCT00344383|Estradiol|estradiol|mesh-list
6434709|NCT00344383|Estrogens|estrogens|mesh-ancestor
6434710|NCT00344383|Hormones|hormones|mesh-ancestor
6434711|NCT00344383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6434712|NCT00344383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434713|NCT00344383|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6434714|NCT00344383|Contraceptive Agents|contraceptive agents|mesh-ancestor
6434715|NCT00344383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6434716|NCT00344383|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6434717|NCT00344383|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6434718|NCT00344383|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6434719|NCT00344383|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6019462|NCT00387348|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6019463|NCT00387348|Antidepressive Agents|antidepressive agents|mesh-ancestor
6019464|NCT00387348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6019465|NCT00387348|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6019466|NCT00387348|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6019467|NCT00387348|Parasympatholytics|parasympatholytics|mesh-ancestor
6019468|NCT00387348|Autonomic Agents|autonomic agents|mesh-ancestor
6019469|NCT00387348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6019470|NCT00387348|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6019471|NCT00387348|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6019472|NCT00387348|Cholinergic Agents|cholinergic agents|mesh-ancestor
6019473|NCT00387426|Sunitinib|sunitinib|mesh-list
6434720|NCT00344409|Darbepoetin alfa|darbepoetin alfa|mesh-list
6434721|NCT00344409|Hematinics|hematinics|mesh-ancestor
6434722|NCT00344422|Dexamethasone|dexamethasone|mesh-list
6434723|NCT00344422|Dexamethasone acetate|dexamethasone acetate|mesh-list
6434724|NCT00344422|Doxorubicin|doxorubicin|mesh-list
6434725|NCT00344422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6434726|NCT00344422|Vincristine|vincristine|mesh-list
6434727|NCT00344422|BB 1101|bb 1101|mesh-list
6434728|NCT00344422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6434729|NCT00344422|Antiemetics|antiemetics|mesh-ancestor
6434730|NCT00344422|Autonomic Agents|autonomic agents|mesh-ancestor
6434731|NCT00344422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6434732|NCT00344422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434733|NCT00344422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6434734|NCT00344422|Glucocorticoids|glucocorticoids|mesh-ancestor
6434735|NCT00344422|Hormones|hormones|mesh-ancestor
6434736|NCT00344422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6434737|NCT00344422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6434738|NCT00344422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6434739|NCT00344422|Protease Inhibitors|protease inhibitors|mesh-ancestor
6434740|NCT00344422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6540822|NCT00842582|Antimetabolites|antimetabolites|mesh-ancestor
6540823|NCT00842582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6540824|NCT00842582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6540825|NCT00842582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6540826|NCT00842595|Prednisone|prednisone|mesh-list
6540827|NCT00842595|Rituximab|rituximab|mesh-list
6540828|NCT00842595|Vinorelbine|vinorelbine|mesh-list
6540829|NCT00842595|Ifosfamide|ifosfamide|mesh-list
6540830|NCT00842595|Mitoxantrone|mitoxantrone|mesh-list
6540831|NCT00842595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6540832|NCT00842595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6540833|NCT00842595|Immunologic Factors|immunologic factors|mesh-ancestor
6540834|NCT00842595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540835|NCT00842595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6540836|NCT00842595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6540837|NCT00842595|Glucocorticoids|glucocorticoids|mesh-ancestor
6540838|NCT00842595|Hormones|hormones|mesh-ancestor
6540839|NCT00842595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6540840|NCT00842595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6540841|NCT00842595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6540842|NCT00842595|Tubulin Modulators|tubulin modulators|mesh-ancestor
6540843|NCT00842595|Antimitotic Agents|antimitotic agents|mesh-ancestor
6540844|NCT00842595|Mitosis Modulators|mitosis modulators|mesh-ancestor
6540845|NCT00842595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6540846|NCT00842595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6540847|NCT00842595|Alkylating Agents|alkylating agents|mesh-ancestor
6540848|NCT00842595|Analgesics|analgesics|mesh-ancestor
6540849|NCT00842595|Sensory System Agents|sensory system agents|mesh-ancestor
6540850|NCT00842595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6540851|NCT00842595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6540852|NCT00842595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6540853|NCT00842595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6540854|NCT00842660|Gemcitabine|gemcitabine|mesh-list
6540855|NCT00842660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6540856|NCT00842660|Antimetabolites|antimetabolites|mesh-ancestor
6019474|NCT00387426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6434741|NCT00344422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434742|NCT00344422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6434743|NCT00344422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6434744|NCT00344422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6434745|NCT00344422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6434746|NCT00344422|Tubulin Modulators|tubulin modulators|mesh-ancestor
6664672|NCT01513525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6434747|NCT00344422|Antimitotic Agents|antimitotic agents|mesh-ancestor
6434748|NCT00344422|Mitosis Modulators|mitosis modulators|mesh-ancestor
6434749|NCT00344513|Carvedilol|carvedilol|mesh-list
6434750|NCT00344513|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
6434751|NCT00344513|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6434752|NCT00344513|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6434753|NCT00344513|Adrenergic Agents|adrenergic agents|mesh-ancestor
6434754|NCT00344513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6434755|NCT00344513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434756|NCT00344513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434757|NCT00344513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6434758|NCT00344513|Antioxidants|antioxidants|mesh-ancestor
6434759|NCT00344513|Protective Agents|protective agents|mesh-ancestor
6434760|NCT00344513|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6434761|NCT00344513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6434762|NCT00344513|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6434763|NCT00344513|Vasodilator Agents|vasodilator agents|mesh-ancestor
6434764|NCT00344513|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6434765|NCT00344513|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6434766|NCT00344513|Protease Inhibitors|protease inhibitors|mesh-ancestor
6434767|NCT00344513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6434768|NCT00344526|Dexamethasone|dexamethasone|mesh-list
6434769|NCT00344526|Melphalan|melphalan|mesh-list
6434770|NCT00344526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6434771|NCT00344526|Antiemetics|antiemetics|mesh-ancestor
6019475|NCT00387426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6434772|NCT00344526|Autonomic Agents|autonomic agents|mesh-ancestor
6434773|NCT00344526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6434774|NCT00344526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434775|NCT00344526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6434776|NCT00344526|Glucocorticoids|glucocorticoids|mesh-ancestor
6434777|NCT00344526|Hormones|hormones|mesh-ancestor
6434778|NCT00344526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6434779|NCT00344526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6434780|NCT00344526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6434781|NCT00344526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6434782|NCT00344526|Alkylating Agents|alkylating agents|mesh-ancestor
6434783|NCT00344526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434784|NCT00344526|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6434785|NCT00344526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6434786|NCT00344526|Immunologic Factors|immunologic factors|mesh-ancestor
6434787|NCT00344539|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6434788|NCT00344539|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6434789|NCT00344539|Immunologic Factors|immunologic factors|mesh-ancestor
6434790|NCT00344539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434791|NCT00344539|Antacids|antacids|mesh-ancestor
6434792|NCT00344539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434793|NCT00344539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6434794|NCT00344552|Paclitaxel|paclitaxel|mesh-list
6434795|NCT00344552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6434796|NCT00344552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6019476|NCT00387426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6019477|NCT00387426|Growth Substances|growth substances|mesh-ancestor
6019478|NCT00387426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019479|NCT00387426|Growth Inhibitors|growth inhibitors|mesh-ancestor
6019480|NCT00387426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6019481|NCT00387426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6434797|NCT00344552|Tubulin Modulators|tubulin modulators|mesh-ancestor
6434798|NCT00344552|Antimitotic Agents|antimitotic agents|mesh-ancestor
6434799|NCT00344552|Mitosis Modulators|mitosis modulators|mesh-ancestor
6434800|NCT00344552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434801|NCT00344565|Modafinil|modafinil|mesh-list
6434802|NCT00344565|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6434803|NCT00344565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434804|NCT00344565|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6434805|NCT00344565|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6434806|NCT00344565|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6434807|NCT00344565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434808|NCT00344617|Bevacizumab|bevacizumab|mesh-list
6434809|NCT00344617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6434810|NCT00344617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6434811|NCT00344617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6434812|NCT00344617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6434813|NCT00344617|Growth Substances|growth substances|mesh-ancestor
6434814|NCT00344617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434815|NCT00344617|Growth Inhibitors|growth inhibitors|mesh-ancestor
6434816|NCT00344669|Albendazole|albendazole|mesh-list
6434817|NCT00344669|Anthelmintics|anthelmintics|mesh-ancestor
6434818|NCT00344669|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6434819|NCT00344669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6434820|NCT00344669|Anticestodal Agents|anticestodal agents|mesh-ancestor
6434821|NCT00344669|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6434822|NCT00344669|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6434823|NCT00344669|Tubulin Modulators|tubulin modulators|mesh-ancestor
6434824|NCT00344669|Antimitotic Agents|antimitotic agents|mesh-ancestor
6434825|NCT00344669|Mitosis Modulators|mitosis modulators|mesh-ancestor
6434826|NCT00344669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434827|NCT00344669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6434828|NCT00344695|Bupropion|bupropion|mesh-list
6434829|NCT00344695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6434830|NCT00344695|Antidepressive Agents|antidepressive agents|mesh-ancestor
6434831|NCT00344695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6434832|NCT00344695|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6434833|NCT00344695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6434834|NCT00344695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6434835|NCT00344695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434836|NCT00344695|Dopamine Agents|dopamine agents|mesh-ancestor
6434837|NCT00344695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6434838|NCT00344695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434839|NCT00344695|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6434840|NCT00344695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6434841|NCT00344695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6434842|NCT00344734|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
6434843|NCT00344734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6434844|NCT00344734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434845|NCT00344760|Tenofovir|tenofovir|mesh-list
6434846|NCT00344760|Lamivudine|lamivudine|mesh-list
6434847|NCT00344760|Efavirenz|efavirenz|mesh-list
6434848|NCT00344760|Enfuvirtide|enfuvirtide|mesh-list
6434849|NCT00344760|Antiviral Agents|antiviral agents|mesh-ancestor
6434850|NCT00344760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6434851|NCT00344760|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6434852|NCT00344760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6434853|NCT00344760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6434854|NCT00344760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434855|NCT00344760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6434856|NCT00344760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6434857|NCT00344760|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6434858|NCT00344760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6434859|NCT00344760|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6434860|NCT00344760|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6434861|NCT00344760|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6434862|NCT00344760|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6434863|NCT00344760|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6434864|NCT00344760|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6434865|NCT00344812|Buprenorphine|buprenorphine|mesh-list
6434866|NCT00344812|Methadone|methadone|mesh-list
6434867|NCT00344812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6434868|NCT00344812|Narcotics|narcotics|mesh-ancestor
6434869|NCT00344812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6462185|NCT00458042|Treprostinil|treprostinil|mesh-list
6540857|NCT00842660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6540858|NCT00842660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6540859|NCT00842660|Antiviral Agents|antiviral agents|mesh-ancestor
6540860|NCT00842660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6540861|NCT00842660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6540862|NCT00842660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6540863|NCT00842660|Immunologic Factors|immunologic factors|mesh-ancestor
6540864|NCT00842660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540865|NCT00842686|Bevacizumab|bevacizumab|mesh-list
6540866|NCT00842686|Capecitabine|capecitabine|mesh-list
6540867|NCT00842686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6540868|NCT00842686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6540869|NCT00842686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6540870|NCT00842686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6540871|NCT00842686|Growth Substances|growth substances|mesh-ancestor
6540872|NCT00842686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540873|NCT00842686|Growth Inhibitors|growth inhibitors|mesh-ancestor
6540874|NCT00842686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6540875|NCT00842686|Antimetabolites|antimetabolites|mesh-ancestor
6540876|NCT00842686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6540877|NCT00842894|Insulin|insulin|mesh-list
6540878|NCT00842894|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6540879|NCT00842894|Insulin Aspart|insulin aspart|mesh-list
6540880|NCT00842894|Insulin Detemir|insulin detemir|mesh-list
6540881|NCT00842894|Biphasic Insulins|biphasic insulins|mesh-list
6540882|NCT00842894|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6540883|NCT00842894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6540884|NCT00842894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540885|NCT00842907|Tretinoin|tretinoin|mesh-list
6540886|NCT00842907|Isotretinoin|isotretinoin|mesh-list
6540887|NCT00842907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6540888|NCT00842907|Keratolytic Agents|keratolytic agents|mesh-ancestor
6540889|NCT00842907|Dermatologic Agents|dermatologic agents|mesh-ancestor
6540890|NCT00842920|Simvastatin|simvastatin|mesh-list
6540891|NCT00842920|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6540892|NCT00842920|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6540893|NCT00842920|Antimetabolites|antimetabolites|mesh-ancestor
6540894|NCT00842920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6540895|NCT00842920|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6540896|NCT00842920|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6540897|NCT00842920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6540898|NCT00842933|Prednisone|prednisone|mesh-list
6540899|NCT00842933|Methylprednisolone|methylprednisolone|mesh-list
6540900|NCT00842933|Hydrocortisone|hydrocortisone|mesh-list
6540901|NCT00842933|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6540902|NCT00842933|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6540903|NCT00842933|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6540904|NCT00842933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6540905|NCT00842933|Glucocorticoids|glucocorticoids|mesh-ancestor
6540906|NCT00842933|Hormones|hormones|mesh-ancestor
6540907|NCT00842933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6540908|NCT00842933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540909|NCT00842933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6540910|NCT00842933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6540911|NCT00842933|Antiemetics|antiemetics|mesh-ancestor
6540912|NCT00842933|Autonomic Agents|autonomic agents|mesh-ancestor
6540913|NCT00842933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6540914|NCT00842933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6540915|NCT00842933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6540916|NCT00842933|Protective Agents|protective agents|mesh-ancestor
6540917|NCT00842998|Trastuzumab|trastuzumab|mesh-list
6434870|NCT00344812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434871|NCT00344812|Analgesics|analgesics|mesh-ancestor
6434872|NCT00344812|Sensory System Agents|sensory system agents|mesh-ancestor
6434873|NCT00344812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6434874|NCT00344812|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6434875|NCT00344812|Antitussive Agents|antitussive agents|mesh-ancestor
6434876|NCT00344812|Respiratory System Agents|respiratory system agents|mesh-ancestor
6434877|NCT00344825|Fludarabine|fludarabine|mesh-list
6434878|NCT00344825|Fludarabine phosphate|fludarabine phosphate|mesh-list
6434879|NCT00344825|Alemtuzumab|alemtuzumab|mesh-list
6434880|NCT00344825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6434881|NCT00344825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6434882|NCT00344825|Antimetabolites|antimetabolites|mesh-ancestor
6434883|NCT00344825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434884|NCT00344825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6434885|NCT00344825|Immunologic Factors|immunologic factors|mesh-ancestor
6434886|NCT00344825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434887|NCT00344825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6434888|NCT00344851|Metformin|metformin|mesh-list
6434889|NCT00344851|Exenatide|exenatide|mesh-list
6434890|NCT00344851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6434891|NCT00344851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434892|NCT00344851|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6434893|NCT00344851|Incretins|incretins|mesh-ancestor
6434894|NCT00344851|Hormones|hormones|mesh-ancestor
6434895|NCT00344851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6434896|NCT00344916|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
6434897|NCT00344916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6434898|NCT00344916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434899|NCT00344942|Triamcinolone|triamcinolone|mesh-list
6434900|NCT00344942|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6434901|NCT00344942|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6434902|NCT00344942|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6434903|NCT00344942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6434904|NCT00344942|Glucocorticoids|glucocorticoids|mesh-ancestor
6434905|NCT00344942|Hormones|hormones|mesh-ancestor
6434906|NCT00344942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6434907|NCT00344942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434908|NCT00344942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6434909|NCT00344942|Immunologic Factors|immunologic factors|mesh-ancestor
6434910|NCT00344942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6434911|NCT00344942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434912|NCT00344955|Atorvastatin|atorvastatin|mesh-list
6434913|NCT00344955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6434914|NCT00344955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6434915|NCT00344955|Antimetabolites|antimetabolites|mesh-ancestor
6434916|NCT00344955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434917|NCT00344955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6019482|NCT00387426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019483|NCT00387465|Azacitidine|azacitidine|mesh-list
6019484|NCT00387465|Entinostat|entinostat|mesh-list
6019485|NCT00387465|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
6019486|NCT00387465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6434918|NCT00344955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6434919|NCT00344955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6434920|NCT00344981|Tenofovir|tenofovir|mesh-list
6434921|NCT00344981|Hydroxyurea|hydroxyurea|mesh-list
6434922|NCT00344981|Antiviral Agents|antiviral agents|mesh-ancestor
6434923|NCT00344981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6434924|NCT00344981|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6434925|NCT00344981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6434926|NCT00344981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6434927|NCT00344981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434928|NCT00344981|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6434929|NCT00344981|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6434930|NCT00344981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6434931|NCT00344981|Antisickling Agents|antisickling agents|mesh-ancestor
6434932|NCT00344994|Pramipexole|pramipexole|mesh-list
6434933|NCT00344994|Antioxidants|antioxidants|mesh-ancestor
6434934|NCT00344994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434935|NCT00344994|Protective Agents|protective agents|mesh-ancestor
6434936|NCT00344994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019487|NCT00387465|Antimetabolites|antimetabolites|mesh-ancestor
6434937|NCT00344994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6434938|NCT00344994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6434939|NCT00344994|Dopamine Agonists|dopamine agonists|mesh-ancestor
6434940|NCT00344994|Dopamine Agents|dopamine agents|mesh-ancestor
6434941|NCT00344994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6434942|NCT00345059|Gemcitabine|gemcitabine|mesh-list
6434943|NCT00345059|Capecitabine|capecitabine|mesh-list
6434944|NCT00345059|Docetaxel|docetaxel|mesh-list
6434945|NCT00345059|Vinorelbine|vinorelbine|mesh-list
6434946|NCT00345059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6434947|NCT00345059|Antimetabolites|antimetabolites|mesh-ancestor
6434948|NCT00345059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434949|NCT00345059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6434950|NCT00345059|Antiviral Agents|antiviral agents|mesh-ancestor
6434951|NCT00345059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6434952|NCT00345059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6434953|NCT00345059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6434954|NCT00345059|Immunologic Factors|immunologic factors|mesh-ancestor
6434955|NCT00345059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434956|NCT00345059|Tubulin Modulators|tubulin modulators|mesh-ancestor
6434957|NCT00345059|Antimitotic Agents|antimitotic agents|mesh-ancestor
6434958|NCT00345059|Mitosis Modulators|mitosis modulators|mesh-ancestor
6434959|NCT00345059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6434960|NCT00345098|Amibegron|amibegron|mesh-list
6434961|NCT00345098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6434962|NCT00345098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6434963|NCT00345098|Adrenergic Agents|adrenergic agents|mesh-ancestor
6434964|NCT00345098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6434965|NCT00345098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434966|NCT00345098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434967|NCT00345137|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
6434968|NCT00345137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6540918|NCT00842998|Lapatinib|lapatinib|mesh-list
6540919|NCT00842998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6540920|NCT00842998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6540921|NCT00842998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6540922|NCT00842998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6540923|NCT00842998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6540924|NCT00843063|Pantoprazole|pantoprazole|mesh-list
6540925|NCT00843063|Famotidine|famotidine|mesh-list
6540926|NCT00843063|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6540927|NCT00843063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6540928|NCT00843063|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6540929|NCT00843063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6540930|NCT00843063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6540931|NCT00843063|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6540932|NCT00843063|Histamine Antagonists|histamine antagonists|mesh-ancestor
6540933|NCT00843063|Histamine Agents|histamine agents|mesh-ancestor
6434969|NCT00345137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434970|NCT00345150|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
6434971|NCT00345150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6540934|NCT00843063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6540935|NCT00843063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540936|NCT00843154|Candesartan|candesartan|mesh-list
6540937|NCT00843154|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6540938|NCT00843154|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6540939|NCT00843154|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6540940|NCT00843154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6540941|NCT00843323|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
6540942|NCT00843323|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6434972|NCT00345150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434973|NCT00345163|Bevacizumab|bevacizumab|mesh-list
6434974|NCT00345163|Irinotecan|irinotecan|mesh-list
6434975|NCT00345163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6434976|NCT00345163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6434977|NCT00345163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6434978|NCT00345163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6434979|NCT00345163|Growth Substances|growth substances|mesh-ancestor
6434980|NCT00345163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434981|NCT00345163|Growth Inhibitors|growth inhibitors|mesh-ancestor
6434982|NCT00345163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6434983|NCT00345163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6434984|NCT00345163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6434985|NCT00345163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434986|NCT00345202|Atorvastatin|atorvastatin|mesh-list
6434987|NCT00345202|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6434988|NCT00345202|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6434989|NCT00345202|Antimetabolites|antimetabolites|mesh-ancestor
6434990|NCT00345202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6434991|NCT00345202|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6434992|NCT00345202|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6434993|NCT00345202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6434994|NCT00345306|Progesterone|progesterone|mesh-list
6434995|NCT00345306|Progestins|progestins|mesh-ancestor
6434996|NCT00345306|Hormones|hormones|mesh-ancestor
6434997|NCT00345306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6434998|NCT00345306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6434999|NCT00345358|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6435000|NCT00345358|Immunologic Factors|immunologic factors|mesh-ancestor
6435001|NCT00345358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435002|NCT00345501|Iloprost|iloprost|mesh-list
6435003|NCT00345501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6435004|NCT00345501|Vasodilator Agents|vasodilator agents|mesh-ancestor
6461143|NCT00453076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461144|NCT00453115|Gemcitabine|gemcitabine|mesh-list
6461145|NCT00453115|Oxaliplatin|oxaliplatin|mesh-list
6461146|NCT00453115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6461147|NCT00453115|Antimetabolites|antimetabolites|mesh-ancestor
6461148|NCT00453115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461149|NCT00453115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6461150|NCT00453115|Antiviral Agents|antiviral agents|mesh-ancestor
6461151|NCT00453115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6461152|NCT00453115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6461153|NCT00453115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6461154|NCT00453115|Immunologic Factors|immunologic factors|mesh-ancestor
6461155|NCT00453115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461156|NCT00453141|Betamethasone|betamethasone|mesh-list
6461157|NCT00453141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6461158|NCT00453141|Glucocorticoids|glucocorticoids|mesh-ancestor
6461159|NCT00453141|Hormones|hormones|mesh-ancestor
6461160|NCT00453141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6461161|NCT00453141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461162|NCT00453141|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6461163|NCT00453141|Respiratory System Agents|respiratory system agents|mesh-ancestor
6461164|NCT00453167|Gemcitabine|gemcitabine|mesh-list
6461165|NCT00453167|Paclitaxel|paclitaxel|mesh-list
6461166|NCT00453167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6461167|NCT00453167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6461168|NCT00453167|Tubulin Modulators|tubulin modulators|mesh-ancestor
6435005|NCT00345644|Risedronic Acid|risedronic acid|mesh-list
6435006|NCT00345644|Etidronic Acid|etidronic acid|mesh-list
6435007|NCT00345644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6435008|NCT00345644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6435009|NCT00345644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435010|NCT00345644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6435011|NCT00345644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435012|NCT00345644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6435013|NCT00345657|Niacin|niacin|mesh-list
6435014|NCT00345657|Lovastatin|lovastatin|mesh-list
6435015|NCT00345657|L 647318|l 647318|mesh-list
6435016|NCT00345657|Dihydromevinolin|dihydromevinolin|mesh-list
6435017|NCT00345657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6435018|NCT00345657|Antimetabolites|antimetabolites|mesh-ancestor
6435019|NCT00345657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435020|NCT00345657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6435021|NCT00345657|Vasodilator Agents|vasodilator agents|mesh-ancestor
6435022|NCT00345657|Vitamin B Complex|vitamin b complex|mesh-ancestor
6435023|NCT00345657|Vitamins|vitamins|mesh-ancestor
6435024|NCT00345657|Micronutrients|micronutrients|mesh-ancestor
6435025|NCT00345657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435026|NCT00345657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6435027|NCT00345657|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6435028|NCT00345657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6435029|NCT00345696|Bevacizumab|bevacizumab|mesh-list
6435030|NCT00345696|Capecitabine|capecitabine|mesh-list
6435031|NCT00345696|Oxaliplatin|oxaliplatin|mesh-list
6435032|NCT00345696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6435033|NCT00345696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6435034|NCT00345696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6435035|NCT00345696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6435036|NCT00345696|Growth Substances|growth substances|mesh-ancestor
6435037|NCT00345696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435038|NCT00345696|Growth Inhibitors|growth inhibitors|mesh-ancestor
6435039|NCT00345696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6435040|NCT00345696|Antimetabolites|antimetabolites|mesh-ancestor
6435041|NCT00345696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435042|NCT00345735|Fentanyl|fentanyl|mesh-list
6435043|NCT00345735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6435044|NCT00345735|Narcotics|narcotics|mesh-ancestor
6435045|NCT00345735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6435046|NCT00345735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435047|NCT00345735|Analgesics|analgesics|mesh-ancestor
6435048|NCT00345735|Sensory System Agents|sensory system agents|mesh-ancestor
6435049|NCT00345735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6435050|NCT00345735|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6435051|NCT00345735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6435052|NCT00345735|Anesthetics, General|anesthetics, general|mesh-ancestor
6435053|NCT00345735|Anesthetics|anesthetics|mesh-ancestor
6435054|NCT00345761|Bevacizumab|bevacizumab|mesh-list
6435055|NCT00345761|Capecitabine|capecitabine|mesh-list
6435056|NCT00345761|Oxaliplatin|oxaliplatin|mesh-list
6435057|NCT00345761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6435058|NCT00345761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6435059|NCT00345761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6435060|NCT00345761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6435061|NCT00345761|Growth Substances|growth substances|mesh-ancestor
6435062|NCT00345761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435063|NCT00345761|Growth Inhibitors|growth inhibitors|mesh-ancestor
6435064|NCT00345761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6435065|NCT00345761|Antimetabolites|antimetabolites|mesh-ancestor
6435066|NCT00345761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435067|NCT00345787|Buprenorphine|buprenorphine|mesh-list
6435068|NCT00345787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6435069|NCT00345787|Narcotics|narcotics|mesh-ancestor
6435070|NCT00345787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6435071|NCT00345787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435072|NCT00345787|Analgesics|analgesics|mesh-ancestor
6435073|NCT00345787|Sensory System Agents|sensory system agents|mesh-ancestor
6435074|NCT00345787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6435075|NCT00345787|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6435076|NCT00345800|Sodium Oxybate|sodium oxybate|mesh-list
6435077|NCT00345800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6435078|NCT00345800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6435079|NCT00345800|Anesthetics, General|anesthetics, general|mesh-ancestor
6435080|NCT00345800|Anesthetics|anesthetics|mesh-ancestor
6435081|NCT00345800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6435082|NCT00345800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435083|NCT00345826|Dasatinib|dasatinib|mesh-list
6435084|NCT00345826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6435085|NCT00345826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6435086|NCT00345826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6435087|NCT00345826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435088|NCT00345982|Sertindole|sertindole|mesh-list
6435089|NCT00345982|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6435090|NCT00345982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6435091|NCT00345982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6435092|NCT00345982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435093|NCT00345982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6435094|NCT00346047|Buprenorphine|buprenorphine|mesh-list
6435095|NCT00346047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6435096|NCT00346047|Narcotics|narcotics|mesh-ancestor
6435097|NCT00346047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6435098|NCT00346047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435099|NCT00346047|Analgesics|analgesics|mesh-ancestor
6435100|NCT00346047|Sensory System Agents|sensory system agents|mesh-ancestor
6435101|NCT00346047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6435102|NCT00346047|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6435103|NCT00346099|Capecitabine|capecitabine|mesh-list
6435104|NCT00346099|Oxaliplatin|oxaliplatin|mesh-list
6540943|NCT00843323|Dermatologic Agents|dermatologic agents|mesh-ancestor
6540944|NCT00843362|Dinoprostone|dinoprostone|mesh-list
6540945|NCT00843362|Oxytocics|oxytocics|mesh-ancestor
6540946|NCT00843362|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6540947|NCT00843362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540948|NCT00843440|Bevacizumab|bevacizumab|mesh-list
6540949|NCT00843440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6540950|NCT00843440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6540951|NCT00843440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6540952|NCT00843440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6540953|NCT00843440|Growth Substances|growth substances|mesh-ancestor
6540954|NCT00843440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540955|NCT00843440|Growth Inhibitors|growth inhibitors|mesh-ancestor
6540956|NCT00843453|Vitamin B 12|vitamin b 12|mesh-list
6540957|NCT00843453|Hydroxocobalamin|hydroxocobalamin|mesh-list
6540958|NCT00843453|Vitamin B Complex|vitamin b complex|mesh-ancestor
6540959|NCT00843453|Vitamins|vitamins|mesh-ancestor
6540960|NCT00843453|Micronutrients|micronutrients|mesh-ancestor
6540961|NCT00843453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540962|NCT00843453|Hematinics|hematinics|mesh-ancestor
6540963|NCT00843570|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6540964|NCT00843570|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6540965|NCT00843570|Nafarelin|nafarelin|mesh-list
6540966|NCT00843570|Estradiol|estradiol|mesh-list
6540967|NCT00843570|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6540968|NCT00843570|Progesterone|progesterone|mesh-list
6540969|NCT00843570|Estrogens|estrogens|mesh-ancestor
6540970|NCT00843570|Hormones|hormones|mesh-ancestor
6540971|NCT00843570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6540972|NCT00843570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540973|NCT00843570|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6540974|NCT00843570|Contraceptive Agents|contraceptive agents|mesh-ancestor
6540975|NCT00843570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6540976|NCT00843570|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6540977|NCT00843570|Progestins|progestins|mesh-ancestor
6540978|NCT00843570|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6435105|NCT00346099|Panitumumab|panitumumab|mesh-list
6435106|NCT00346099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6540979|NCT00843570|Fertility Agents|fertility agents|mesh-ancestor
6540980|NCT00843661|Ezetimibe|ezetimibe|mesh-list
6540981|NCT00843661|Pravastatin|pravastatin|mesh-list
6540982|NCT00843661|Fenofibrate|fenofibrate|mesh-list
6435107|NCT00346099|Antimetabolites|antimetabolites|mesh-ancestor
6435108|NCT00346099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435109|NCT00346099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6435110|NCT00346099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6435111|NCT00346125|Doxorubicin|doxorubicin|mesh-list
6435112|NCT00346125|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6435113|NCT00346125|Ifosfamide|ifosfamide|mesh-list
6435114|NCT00346125|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6435115|NCT00346125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6435116|NCT00346125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6435117|NCT00346125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6435118|NCT00346125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6435119|NCT00346125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6435120|NCT00346125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435121|NCT00346125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6435122|NCT00346125|Alkylating Agents|alkylating agents|mesh-ancestor
6435123|NCT00346125|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6435124|NCT00346190|Alendronate|alendronate|mesh-list
6435125|NCT00346190|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6435126|NCT00346190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435127|NCT00346229|Doxorubicin|doxorubicin|mesh-list
6435128|NCT00346229|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6435129|NCT00346229|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6435130|NCT00346229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6435131|NCT00346229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6435132|NCT00346229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6435133|NCT00346229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6435134|NCT00346229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435135|NCT00346242|Zoledronic Acid|zoledronic acid|mesh-list
6435136|NCT00346242|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6435137|NCT00346242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435138|NCT00346255|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
6435139|NCT00346255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6435140|NCT00346255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6435141|NCT00346255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6435142|NCT00346294|Etanercept|etanercept|mesh-list
6435143|NCT00346294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6435144|NCT00346294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6435145|NCT00346294|Analgesics|analgesics|mesh-ancestor
6435146|NCT00346294|Sensory System Agents|sensory system agents|mesh-ancestor
6435147|NCT00346294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6435148|NCT00346294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435149|NCT00346294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6435150|NCT00346294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6435151|NCT00346294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6435152|NCT00346294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6435153|NCT00346294|Immunologic Factors|immunologic factors|mesh-ancestor
6435154|NCT00346359|Methotrexate|methotrexate|mesh-list
6435155|NCT00346359|Fludarabine phosphate|fludarabine phosphate|mesh-list
6435156|NCT00346359|Fludarabine|fludarabine|mesh-list
6435157|NCT00346359|Busulfan|busulfan|mesh-list
6435158|NCT00346359|Tacrolimus|tacrolimus|mesh-list
6435159|NCT00346359|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6435160|NCT00346359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6435161|NCT00346359|Abortifacient Agents|abortifacient agents|mesh-ancestor
6435162|NCT00346359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6435163|NCT00346359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435164|NCT00346359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6435165|NCT00346359|Antimetabolites|antimetabolites|mesh-ancestor
6435166|NCT00346359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435167|NCT00346359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6435168|NCT00346359|Dermatologic Agents|dermatologic agents|mesh-ancestor
6435169|NCT00346359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6435170|NCT00346359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6435171|NCT00346359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6435172|NCT00346359|Immunologic Factors|immunologic factors|mesh-ancestor
6435173|NCT00346359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6435174|NCT00346359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6435175|NCT00346359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6435176|NCT00346359|Alkylating Agents|alkylating agents|mesh-ancestor
6435177|NCT00346359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6435178|NCT00346359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6435179|NCT00346385|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
6435180|NCT00346385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6435181|NCT00346385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6435182|NCT00346385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6435183|NCT00346463|Allopurinol|allopurinol|mesh-list
6435184|NCT00346463|Antimetabolites|antimetabolites|mesh-ancestor
6435185|NCT00346463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435186|NCT00346463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6435187|NCT00346463|Gout Suppressants|gout suppressants|mesh-ancestor
6435188|NCT00346463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6435189|NCT00346463|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6435190|NCT00346463|Antioxidants|antioxidants|mesh-ancestor
6435191|NCT00346463|Protective Agents|protective agents|mesh-ancestor
6435192|NCT00346463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435193|NCT00346489|Fluorouracil|fluorouracil|mesh-list
6435194|NCT00346489|Mitomycins|mitomycins|mesh-list
6435195|NCT00346489|Mitomycin|mitomycin|mesh-list
6435196|NCT00346489|Antimetabolites|antimetabolites|mesh-ancestor
6435197|NCT00346489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435198|NCT00346489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6435199|NCT00346489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6435200|NCT00346489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6435201|NCT00346489|Immunologic Factors|immunologic factors|mesh-ancestor
6435202|NCT00346489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435203|NCT00346489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6435204|NCT00346489|Alkylating Agents|alkylating agents|mesh-ancestor
6435205|NCT00346489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6435206|NCT00346489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6435207|NCT00346502|Betulinic acid|betulinic acid|mesh-list
6435208|NCT00346502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6435209|NCT00346502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6435210|NCT00346502|Analgesics|analgesics|mesh-ancestor
6435211|NCT00346502|Sensory System Agents|sensory system agents|mesh-ancestor
6435212|NCT00346502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6435213|NCT00346502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435214|NCT00346502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6435215|NCT00346502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6435216|NCT00346502|Antimalarials|antimalarials|mesh-ancestor
6435217|NCT00346502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6435218|NCT00346502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6435219|NCT00346502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6435220|NCT00346502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6435221|NCT00346502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6435222|NCT00346502|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
6435223|NCT00346502|Hormone Antagonists|hormone antagonists|mesh-ancestor
6435224|NCT00346502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6435225|NCT00346502|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6435226|NCT00346502|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6435227|NCT00346502|Antiviral Agents|antiviral agents|mesh-ancestor
6435228|NCT00346567|Tenofovir|tenofovir|mesh-list
6435229|NCT00346567|Lamivudine|lamivudine|mesh-list
6435230|NCT00346567|Zidovudine|zidovudine|mesh-list
6435231|NCT00346567|Emtricitabine|emtricitabine|mesh-list
6435232|NCT00346567|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6435233|NCT00346567|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6435234|NCT00346567|Antiviral Agents|antiviral agents|mesh-ancestor
6435235|NCT00346567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6435236|NCT00346567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6435237|NCT00346567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6435238|NCT00346567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6435239|NCT00346567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435240|NCT00346567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6435241|NCT00346567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6435242|NCT00346567|Antimetabolites|antimetabolites|mesh-ancestor
6435243|NCT00346580|Nelfinavir|nelfinavir|mesh-list
6435244|NCT00346580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6435245|NCT00346580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6435246|NCT00346580|Protease Inhibitors|protease inhibitors|mesh-ancestor
6435247|NCT00346580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6435248|NCT00346580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435249|NCT00346580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6435250|NCT00346580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6435251|NCT00346580|Antiviral Agents|antiviral agents|mesh-ancestor
6435252|NCT00346580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6435253|NCT00346619|Nelfinavir|nelfinavir|mesh-list
6435254|NCT00346619|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6435255|NCT00346619|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6435256|NCT00346619|Protease Inhibitors|protease inhibitors|mesh-ancestor
6435257|NCT00346619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6435258|NCT00346619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435259|NCT00346619|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6435260|NCT00346619|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6435261|NCT00346619|Antiviral Agents|antiviral agents|mesh-ancestor
6435262|NCT00346619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6435263|NCT00346645|Bortezomib|bortezomib|mesh-list
6435264|NCT00346645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6435265|NCT00346684|Rituximab|rituximab|mesh-list
6435266|NCT00346684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6435267|NCT00346684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6435268|NCT00346684|Immunologic Factors|immunologic factors|mesh-ancestor
6435269|NCT00346684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435270|NCT00346684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6435271|NCT00346749|Fluticasone|fluticasone|mesh-list
6435272|NCT00346749|Xhance|xhance|mesh-list
6435273|NCT00346749|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6435274|NCT00346749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6435275|NCT00346749|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6435276|NCT00346749|Autonomic Agents|autonomic agents|mesh-ancestor
6435277|NCT00346749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6435278|NCT00346749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435279|NCT00346749|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6435280|NCT00346749|Respiratory System Agents|respiratory system agents|mesh-ancestor
6435281|NCT00346749|Dermatologic Agents|dermatologic agents|mesh-ancestor
6435282|NCT00346749|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6435283|NCT00346749|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6435284|NCT00346749|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6435285|NCT00346749|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6435286|NCT00346749|Adrenergic Agents|adrenergic agents|mesh-ancestor
6435287|NCT00346749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6435288|NCT00346749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435289|NCT00346801|Celecoxib|celecoxib|mesh-list
6435290|NCT00346801|Cisplatin|cisplatin|mesh-list
6435291|NCT00346801|Irinotecan|irinotecan|mesh-list
6435292|NCT00346801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6435293|NCT00346801|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6435294|NCT00346801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6435295|NCT00346801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6435296|NCT00346801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435297|NCT00346801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6435298|NCT00346801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6435299|NCT00346801|Analgesics|analgesics|mesh-ancestor
6435300|NCT00346801|Sensory System Agents|sensory system agents|mesh-ancestor
6435301|NCT00346801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6435302|NCT00346801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435303|NCT00346801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6435304|NCT00346801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6435305|NCT00346801|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6435306|NCT00346801|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6435307|NCT00346827|Apomorphine|apomorphine|mesh-list
6435308|NCT00346827|Emetics|emetics|mesh-ancestor
6435309|NCT00346827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435310|NCT00346827|Autonomic Agents|autonomic agents|mesh-ancestor
6540983|NCT00843661|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6540984|NCT00843661|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6540985|NCT00843661|Antimetabolites|antimetabolites|mesh-ancestor
6540986|NCT00843661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6540987|NCT00843661|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6540988|NCT00843661|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6540989|NCT00843661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6540990|NCT00843791|Pioglitazone|pioglitazone|mesh-list
6540991|NCT00843791|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
6540992|NCT00843791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6540993|NCT00843791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540994|NCT00843895|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6540995|NCT00843895|Immunologic Factors|immunologic factors|mesh-ancestor
6540996|NCT00843895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6540997|NCT00843908|Imidacloprid|imidacloprid|mesh-list
6540998|NCT00843908|Cholinergic Agents|cholinergic agents|mesh-ancestor
6540999|NCT00843908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6541000|NCT00843908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541001|NCT00843908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541002|NCT00843934|Epirubicin|epirubicin|mesh-list
6541003|NCT00843934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6541004|NCT00843934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6541005|NCT00843934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6541006|NCT00843934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6541007|NCT00843934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6541008|NCT00843934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541009|NCT00844012|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6541010|NCT00844012|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6541011|NCT00844012|Estradiol|estradiol|mesh-list
6541012|NCT00844012|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6541013|NCT00844012|Estrogens|estrogens|mesh-ancestor
6541014|NCT00844012|Hormones|hormones|mesh-ancestor
6541015|NCT00844012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6541016|NCT00844012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541017|NCT00844012|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6541018|NCT00844012|Contraceptive Agents|contraceptive agents|mesh-ancestor
6541019|NCT00844012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6541020|NCT00844012|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6541021|NCT00844064|Trabedersen|trabedersen|mesh-list
6541022|NCT00844064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6541023|NCT00844142|Sulfasalazine|sulfasalazine|mesh-list
6541024|NCT00844142|Etanercept|etanercept|mesh-list
6541025|NCT00844142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6541026|NCT00844142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6541027|NCT00844142|Analgesics|analgesics|mesh-ancestor
6541028|NCT00844142|Sensory System Agents|sensory system agents|mesh-ancestor
6541029|NCT00844142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6541030|NCT00844142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541031|NCT00844142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6541032|NCT00844142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6541033|NCT00844142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6541034|NCT00844142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6541035|NCT00844142|Immunologic Factors|immunologic factors|mesh-ancestor
6541036|NCT00844142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6541037|NCT00844155|Oseltamivir|oseltamivir|mesh-list
6541038|NCT00844155|Antiviral Agents|antiviral agents|mesh-ancestor
6541039|NCT00844155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6541040|NCT00844155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6541041|NCT00844155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435311|NCT00346827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6435312|NCT00346827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6435313|NCT00346827|Dopamine Agonists|dopamine agonists|mesh-ancestor
6435314|NCT00346827|Dopamine Agents|dopamine agents|mesh-ancestor
6435315|NCT00346827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6435316|NCT00346827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435317|NCT00346840|Misoprostol|misoprostol|mesh-list
6435318|NCT00346840|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6435319|NCT00346840|Abortifacient Agents|abortifacient agents|mesh-ancestor
6435320|NCT00346840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6435321|NCT00346840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435322|NCT00346840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6435323|NCT00346840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6435324|NCT00346840|Oxytocics|oxytocics|mesh-ancestor
6435325|NCT00346853|Fomepizole|fomepizole|mesh-list
6435326|NCT00346853|Antidotes|antidotes|mesh-ancestor
6435327|NCT00346853|Protective Agents|protective agents|mesh-ancestor
6435328|NCT00346853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435329|NCT00346853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6435330|NCT00346853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435331|NCT00346866|Anecortave|anecortave|mesh-list
6435332|NCT00346866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6435333|NCT00346866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6435334|NCT00346866|Growth Substances|growth substances|mesh-ancestor
6435335|NCT00346866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435336|NCT00346866|Growth Inhibitors|growth inhibitors|mesh-ancestor
6435337|NCT00346866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6435338|NCT00346879|PENTA|penta|mesh-list
6435339|NCT00346879|Fondaparinux|fondaparinux|mesh-list
6435340|NCT00346879|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6435341|NCT00346879|Antithrombins|antithrombins|mesh-ancestor
6435342|NCT00346879|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6435343|NCT00346879|Protease Inhibitors|protease inhibitors|mesh-ancestor
6435344|NCT00346879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6435345|NCT00346879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435346|NCT00346879|Anticoagulants|anticoagulants|mesh-ancestor
6435347|NCT00346879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6435348|NCT00346879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6435349|NCT00346918|Sirolimus|sirolimus|mesh-list
6435350|NCT00346918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6435351|NCT00346918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6435352|NCT00346918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6435353|NCT00346918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6435354|NCT00346918|Antifungal Agents|antifungal agents|mesh-ancestor
6435355|NCT00346918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6435356|NCT00346918|Immunologic Factors|immunologic factors|mesh-ancestor
6435357|NCT00346918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435358|NCT00346957|Hydrocortisone|hydrocortisone|mesh-list
6435359|NCT00346957|Anecortave|anecortave|mesh-list
6435360|NCT00346957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6435361|NCT00346957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6435362|NCT00346957|Growth Substances|growth substances|mesh-ancestor
6435363|NCT00346957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435364|NCT00346957|Growth Inhibitors|growth inhibitors|mesh-ancestor
6435365|NCT00346957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6435366|NCT00346957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6435367|NCT00346970|Niacin|niacin|mesh-list
6435368|NCT00346970|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6435369|NCT00346970|Antimetabolites|antimetabolites|mesh-ancestor
6435370|NCT00346970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435371|NCT00346970|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6435372|NCT00346970|Vasodilator Agents|vasodilator agents|mesh-ancestor
6435373|NCT00346970|Vitamin B Complex|vitamin b complex|mesh-ancestor
6435374|NCT00346970|Vitamins|vitamins|mesh-ancestor
6435375|NCT00346970|Micronutrients|micronutrients|mesh-ancestor
6435376|NCT00346970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435377|NCT00346996|Insulin|insulin|mesh-list
6435378|NCT00346996|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6435379|NCT00346996|Insulin Detemir|insulin detemir|mesh-list
6435380|NCT00346996|Isophane Insulin, Human|isophane insulin, human|mesh-list
6435381|NCT00346996|Insulin, Isophane|insulin, isophane|mesh-list
6435382|NCT00346996|Isophane insulin, beef|isophane insulin, beef|mesh-list
6435383|NCT00346996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6435384|NCT00346996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435385|NCT00347035|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6435386|NCT00347035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6435387|NCT00347035|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6435388|NCT00347035|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6435389|NCT00347035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6435390|NCT00347035|Adrenergic Agents|adrenergic agents|mesh-ancestor
6435391|NCT00347035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6435392|NCT00347035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435393|NCT00347035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435394|NCT00347048|Tacrolimus|tacrolimus|mesh-list
6435395|NCT00347048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6435396|NCT00347048|Immunologic Factors|immunologic factors|mesh-ancestor
6435397|NCT00347048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435398|NCT00347048|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6435399|NCT00347048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6435400|NCT00347048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435401|NCT00347087|Irbesartan|irbesartan|mesh-list
6435402|NCT00347087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6435403|NCT00347087|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6435404|NCT00347087|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6461169|NCT00453167|Antimitotic Agents|antimitotic agents|mesh-ancestor
6541042|NCT00844168|Sorafenib|sorafenib|mesh-list
6541043|NCT00844168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6541044|NCT00844168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6541045|NCT00844168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6541046|NCT00844168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541047|NCT00844207|Azithromycin|azithromycin|mesh-list
6541048|NCT00844207|Chloroquine|chloroquine|mesh-list
6541049|NCT00844207|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
6541050|NCT00844207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6541051|NCT00844207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6541052|NCT00844207|Amebicides|amebicides|mesh-ancestor
6541053|NCT00844207|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6541054|NCT00844207|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6541055|NCT00844207|Antimalarials|antimalarials|mesh-ancestor
6541056|NCT00844207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6541057|NCT00844207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6541058|NCT00844207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6541059|NCT00844207|Analgesics|analgesics|mesh-ancestor
6541060|NCT00844207|Sensory System Agents|sensory system agents|mesh-ancestor
6541061|NCT00844207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6541062|NCT00844207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541063|NCT00844207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6541064|NCT00844207|Filaricides|filaricides|mesh-ancestor
6541065|NCT00844207|Antinematodal Agents|antinematodal agents|mesh-ancestor
6541066|NCT00844207|Anthelmintics|anthelmintics|mesh-ancestor
6541067|NCT00844233|Irinotecan|irinotecan|mesh-list
6541068|NCT00844233|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6541069|NCT00844233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6541070|NCT00844233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6435405|NCT00347087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435406|NCT00347100|Metformin|metformin|mesh-list
6435407|NCT00347100|Insulin Glargine|insulin glargine|mesh-list
6435408|NCT00347100|Glyburide|glyburide|mesh-list
6435409|NCT00347100|Glipizide|glipizide|mesh-list
6435410|NCT00347100|Gliclazide|gliclazide|mesh-list
6435411|NCT00347100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6435412|NCT00347100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435413|NCT00347113|Albendazole|albendazole|mesh-list
6435414|NCT00347113|Praziquantel|praziquantel|mesh-list
6435415|NCT00347113|Anthelmintics|anthelmintics|mesh-ancestor
6435416|NCT00347113|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6435417|NCT00347113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6435418|NCT00347113|Anticestodal Agents|anticestodal agents|mesh-ancestor
6435419|NCT00347113|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6435420|NCT00347113|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6435421|NCT00347113|Tubulin Modulators|tubulin modulators|mesh-ancestor
6435422|NCT00347113|Antimitotic Agents|antimitotic agents|mesh-ancestor
6435423|NCT00347113|Mitosis Modulators|mitosis modulators|mesh-ancestor
6435424|NCT00347113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435425|NCT00347113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6435426|NCT00347139|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6435427|NCT00347139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6435428|NCT00347139|Autonomic Agents|autonomic agents|mesh-ancestor
6435429|NCT00347139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6435430|NCT00347139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435431|NCT00347139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6435432|NCT00347139|Respiratory System Agents|respiratory system agents|mesh-ancestor
6435433|NCT00347139|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6435434|NCT00347139|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6435435|NCT00347139|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6435436|NCT00347139|Adrenergic Agents|adrenergic agents|mesh-ancestor
6435437|NCT00347139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6435438|NCT00347139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435439|NCT00347152|Valproic Acid|valproic acid|mesh-list
6435440|NCT00347152|Anticonvulsants|anticonvulsants|mesh-ancestor
6435441|NCT00347152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6435442|NCT00347152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435443|NCT00347152|GABA Agents|gaba agents|mesh-ancestor
6435444|NCT00347152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6435445|NCT00347152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435446|NCT00347152|Antimanic Agents|antimanic agents|mesh-ancestor
6435447|NCT00347152|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6435448|NCT00347152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6435449|NCT00347152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6435450|NCT00347165|Bevacizumab|bevacizumab|mesh-list
6435451|NCT00347165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6435452|NCT00347165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6435453|NCT00347165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6435454|NCT00347165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6435455|NCT00347165|Growth Substances|growth substances|mesh-ancestor
6435456|NCT00347165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435457|NCT00347165|Growth Inhibitors|growth inhibitors|mesh-ancestor
6435458|NCT00347204|Ketorolac|ketorolac|mesh-list
6435459|NCT00347204|Nepafenac|nepafenac|mesh-list
6435460|NCT00347204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6435461|NCT00347204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6435462|NCT00347204|Analgesics|analgesics|mesh-ancestor
6435463|NCT00347204|Sensory System Agents|sensory system agents|mesh-ancestor
6435464|NCT00347204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6435465|NCT00347204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435466|NCT00347204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6435467|NCT00347204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6435468|NCT00347204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6435469|NCT00347204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6461170|NCT00453167|Mitosis Modulators|mitosis modulators|mesh-ancestor
6435470|NCT00347204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461171|NCT00453167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461172|NCT00453167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6461173|NCT00453167|Antimetabolites|antimetabolites|mesh-ancestor
6461174|NCT00453167|Antiviral Agents|antiviral agents|mesh-ancestor
6461175|NCT00453167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6461176|NCT00453167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6461177|NCT00453167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6461178|NCT00453167|Immunologic Factors|immunologic factors|mesh-ancestor
6461179|NCT00453167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461180|NCT00453232|Etoposide|etoposide|mesh-list
6461181|NCT00453232|Bleomycin|bleomycin|mesh-list
6461182|NCT00453232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6461183|NCT00453232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6461184|NCT00453232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6461185|NCT00453232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6461186|NCT00453232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6461187|NCT00453232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541071|NCT00844233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541072|NCT00844233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6541073|NCT00844285|Certolizumab Pegol|certolizumab pegol|mesh-list
6541074|NCT00844285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6541075|NCT00844285|Immunologic Factors|immunologic factors|mesh-ancestor
6541076|NCT00844285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541077|NCT00844285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6541078|NCT00844311|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6541079|NCT00844311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6541080|NCT00844311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541081|NCT00844324|Candesartan|candesartan|mesh-list
6541082|NCT00844324|Candesartan cilexetil|candesartan cilexetil|mesh-list
6541083|NCT00844324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6541084|NCT00844324|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6541085|NCT00844324|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6541086|NCT00844324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541087|NCT00844337|Amoxicillin|amoxicillin|mesh-list
6541088|NCT00844337|Gentamicins|gentamicins|mesh-list
6541089|NCT00844337|Penicillins|penicillins|mesh-list
6541090|NCT00844337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6541091|NCT00844337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6541092|NCT00844337|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6541093|NCT00844337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6541094|NCT00844337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541095|NCT00844350|Letrozole|letrozole|mesh-list
6541096|NCT00844350|Oxytocin|oxytocin|mesh-list
6541097|NCT00844350|Clomiphene|clomiphene|mesh-list
6541098|NCT00844350|Enclomiphene|enclomiphene|mesh-list
6541099|NCT00844350|Zuclomiphene|zuclomiphene|mesh-list
6541100|NCT00844350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541101|NCT00844350|Oxytocics|oxytocics|mesh-ancestor
6541102|NCT00844350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6541103|NCT00844350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541104|NCT00844350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6541105|NCT00844350|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6541106|NCT00844350|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6541107|NCT00844350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6541108|NCT00844350|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6541109|NCT00844350|Hormone Antagonists|hormone antagonists|mesh-ancestor
6541110|NCT00844350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6541111|NCT00844350|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6541112|NCT00844350|Fertility Agents|fertility agents|mesh-ancestor
6541113|NCT00844350|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6541114|NCT00844350|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6541115|NCT00844402|Atorvastatin|atorvastatin|mesh-list
6541116|NCT00844402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6435471|NCT00347256|Cisplatin|cisplatin|mesh-list
6435472|NCT00347256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6435473|NCT00347295|Estazolam|estazolam|mesh-list
6435474|NCT00347295|Brotizolam|brotizolam|mesh-list
6435475|NCT00347295|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6435476|NCT00347295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6435477|NCT00347295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435478|NCT00347295|Anticonvulsants|anticonvulsants|mesh-ancestor
6435479|NCT00347295|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6435480|NCT00347295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6435481|NCT00347295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6435482|NCT00347295|GABA Modulators|gaba modulators|mesh-ancestor
6435483|NCT00347295|GABA Agents|gaba agents|mesh-ancestor
6435484|NCT00347295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6435485|NCT00347295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435486|NCT00347386|Zinc Sulfate|zinc sulfate|mesh-list
6435487|NCT00347386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435488|NCT00347386|Astringents|astringents|mesh-ancestor
6435489|NCT00347386|Dermatologic Agents|dermatologic agents|mesh-ancestor
6435490|NCT00347399|Bevacizumab|bevacizumab|mesh-list
6435491|NCT00347399|Verteporfin|verteporfin|mesh-list
6435492|NCT00347399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6435493|NCT00347399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6435494|NCT00347399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6435495|NCT00347399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6435496|NCT00347399|Growth Substances|growth substances|mesh-ancestor
6435497|NCT00347399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435498|NCT00347399|Growth Inhibitors|growth inhibitors|mesh-ancestor
6435499|NCT00347399|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6435500|NCT00347399|Dermatologic Agents|dermatologic agents|mesh-ancestor
6435501|NCT00347412|Paclitaxel|paclitaxel|mesh-list
6435502|NCT00347412|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6435503|NCT00347412|Carboplatin|carboplatin|mesh-list
6435504|NCT00347412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6435505|NCT00347412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6435506|NCT00347412|Tubulin Modulators|tubulin modulators|mesh-ancestor
6435507|NCT00347412|Antimitotic Agents|antimitotic agents|mesh-ancestor
6435508|NCT00347412|Mitosis Modulators|mitosis modulators|mesh-ancestor
6541117|NCT00844402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6541118|NCT00844402|Antimetabolites|antimetabolites|mesh-ancestor
6541119|NCT00844402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541120|NCT00844402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6541121|NCT00844402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6541122|NCT00844402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6541123|NCT00844454|Ethanol|ethanol|mesh-list
6541124|NCT00844454|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6541125|NCT00844454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6541126|NCT00844454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6541127|NCT00844454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541128|NCT00844480|Zoledronic Acid|zoledronic acid|mesh-list
6541129|NCT00844480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6541130|NCT00844480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541131|NCT00844506|Cyclophosphamide|cyclophosphamide|mesh-list
6541132|NCT00844506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6541133|NCT00844506|Immunologic Factors|immunologic factors|mesh-ancestor
6541134|NCT00844506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541135|NCT00844506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6541136|NCT00844506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6541137|NCT00844506|Alkylating Agents|alkylating agents|mesh-ancestor
6541138|NCT00844506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541139|NCT00844506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6541140|NCT00844506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6541141|NCT00844662|Sevelamer|sevelamer|mesh-list
6541142|NCT00844662|Chelating Agents|chelating agents|mesh-ancestor
6541143|NCT00844662|Sequestering Agents|sequestering agents|mesh-ancestor
6541144|NCT00844662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541145|NCT00844675|Rabeprazole|rabeprazole|mesh-list
6541146|NCT00844675|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6541147|NCT00844675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6541148|NCT00844675|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6435509|NCT00347412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541149|NCT00844675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6435510|NCT00347425|Olanzapine|olanzapine|mesh-list
6435511|NCT00347425|Risperidone|risperidone|mesh-list
6435512|NCT00347425|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6435513|NCT00347425|Aripiprazole|aripiprazole|mesh-list
6435514|NCT00347425|Ziprasidone|ziprasidone|mesh-list
6435515|NCT00347425|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6435516|NCT00347425|Serotonin Agents|serotonin agents|mesh-ancestor
6435517|NCT00347425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6435518|NCT00347425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435519|NCT00347425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435520|NCT00347425|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6435521|NCT00347425|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6435522|NCT00347425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6435523|NCT00347425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6435524|NCT00347425|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6435525|NCT00347425|Dopamine Agents|dopamine agents|mesh-ancestor
6435526|NCT00347425|Antiemetics|antiemetics|mesh-ancestor
6435527|NCT00347425|Autonomic Agents|autonomic agents|mesh-ancestor
6435528|NCT00347425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6435529|NCT00347425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6435530|NCT00347425|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6435531|NCT00347425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6435532|NCT00347425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6435533|NCT00347425|Antidepressive Agents|antidepressive agents|mesh-ancestor
6435534|NCT00347425|Dopamine Agonists|dopamine agonists|mesh-ancestor
6435535|NCT00347425|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6435536|NCT00347425|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6435537|NCT00347425|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6435538|NCT00347425|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6435539|NCT00347490|Enoxaparin|enoxaparin|mesh-list
6435540|NCT00347490|Anticoagulants|anticoagulants|mesh-ancestor
6435541|NCT00347490|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6435542|NCT00347490|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6541150|NCT00844675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541151|NCT00844688|Gemcitabine|gemcitabine|mesh-list
6541152|NCT00844688|Sorafenib|sorafenib|mesh-list
6541153|NCT00844688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6541154|NCT00844688|Antimetabolites|antimetabolites|mesh-ancestor
6541155|NCT00844688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541156|NCT00844688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6541157|NCT00844688|Antiviral Agents|antiviral agents|mesh-ancestor
6541158|NCT00844688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6541159|NCT00844688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6541160|NCT00844688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6541161|NCT00844688|Immunologic Factors|immunologic factors|mesh-ancestor
6541162|NCT00844688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541163|NCT00844688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6541164|NCT00844727|Rofecoxib|rofecoxib|mesh-list
6541165|NCT00844727|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6541166|NCT00844727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6541167|NCT00844727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6541168|NCT00844727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541169|NCT00844727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6541170|NCT00844727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6541171|NCT00844727|Analgesics|analgesics|mesh-ancestor
6541172|NCT00844727|Sensory System Agents|sensory system agents|mesh-ancestor
6541173|NCT00844727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6541174|NCT00844727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541175|NCT00844727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6435543|NCT00347490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435544|NCT00347503|Ketorolac|ketorolac|mesh-list
6435545|NCT00347503|Bromfenac|bromfenac|mesh-list
6435546|NCT00347503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6435547|NCT00347503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6435548|NCT00347503|Analgesics|analgesics|mesh-ancestor
6435549|NCT00347503|Sensory System Agents|sensory system agents|mesh-ancestor
6435550|NCT00347503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6435551|NCT00347503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435552|NCT00347503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6435553|NCT00347503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6435554|NCT00347503|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6435555|NCT00347503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6435556|NCT00347503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435557|NCT00347542|Vitamin D|vitamin d|mesh-list
6435558|NCT00347542|Vitamins|vitamins|mesh-ancestor
6435559|NCT00347542|Micronutrients|micronutrients|mesh-ancestor
6435560|NCT00347542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435561|NCT00347542|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6435562|NCT00347555|Aluminum phosphate|aluminum phosphate|mesh-list
6435563|NCT00347555|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6435564|NCT00347555|Immunologic Factors|immunologic factors|mesh-ancestor
6435565|NCT00347555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435566|NCT00347555|Antacids|antacids|mesh-ancestor
6435567|NCT00347555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435568|NCT00347555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6435569|NCT00347581|Methamphetamine|methamphetamine|mesh-list
6435570|NCT00347581|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6435571|NCT00347581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435572|NCT00347581|Sympathomimetics|sympathomimetics|mesh-ancestor
6435573|NCT00347581|Autonomic Agents|autonomic agents|mesh-ancestor
6435574|NCT00347581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6435575|NCT00347581|Dopamine Agents|dopamine agents|mesh-ancestor
6435576|NCT00347581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6435577|NCT00347581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435578|NCT00347581|Adrenergic Agents|adrenergic agents|mesh-ancestor
6435579|NCT00347581|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6435580|NCT00347581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6435581|NCT00347581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6435582|NCT00347581|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6435583|NCT00347646|Fibrinolysin|fibrinolysin|mesh-list
6435584|NCT00347646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6435585|NCT00347646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6435586|NCT00347646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435587|NCT00347685|Tramadol|tramadol|mesh-list
6435588|NCT00347685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6435589|NCT00347685|Narcotics|narcotics|mesh-ancestor
6435590|NCT00347685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6435591|NCT00347685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435592|NCT00347685|Analgesics|analgesics|mesh-ancestor
6435593|NCT00347685|Sensory System Agents|sensory system agents|mesh-ancestor
6435594|NCT00347685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6435595|NCT00347698|Bevacizumab|bevacizumab|mesh-list
6435596|NCT00347698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6541176|NCT00844727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6435597|NCT00347698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6435598|NCT00347698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6435599|NCT00347698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6435600|NCT00347698|Growth Substances|growth substances|mesh-ancestor
6435601|NCT00347698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435602|NCT00347698|Growth Inhibitors|growth inhibitors|mesh-ancestor
6435603|NCT00347724|Tramadol|tramadol|mesh-list
6435604|NCT00347724|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6435605|NCT00347724|Narcotics|narcotics|mesh-ancestor
6435606|NCT00347724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6435607|NCT00347724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435608|NCT00347724|Analgesics|analgesics|mesh-ancestor
6435609|NCT00347724|Sensory System Agents|sensory system agents|mesh-ancestor
6435610|NCT00347724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6435611|NCT00347737|Teriparatide|teriparatide|mesh-list
6435612|NCT00347737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6435613|NCT00347737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435614|NCT00347737|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6435615|NCT00347750|Lopinavir|lopinavir|mesh-list
6435616|NCT00347750|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6435617|NCT00347750|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6435618|NCT00347750|Protease Inhibitors|protease inhibitors|mesh-ancestor
6435619|NCT00347750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6435620|NCT00347750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435621|NCT00347750|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6435622|NCT00347750|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6435623|NCT00347750|Antiviral Agents|antiviral agents|mesh-ancestor
6435624|NCT00347750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6435625|NCT00347750|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6435626|NCT00347750|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6435627|NCT00347763|Permethrin|permethrin|mesh-list
6435628|NCT00347763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6435629|NCT00347763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435630|NCT00347802|Bimatoprost|bimatoprost|mesh-list
6435631|NCT00347802|Travoprost|travoprost|mesh-list
6435632|NCT00347802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6435633|NCT00347815|Buprenorphine|buprenorphine|mesh-list
6541177|NCT00844740|Cinacalcet|cinacalcet|mesh-list
6541178|NCT00844740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6541179|NCT00844740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541180|NCT00844740|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6541181|NCT00844740|Hormone Antagonists|hormone antagonists|mesh-ancestor
6541182|NCT00844740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6541183|NCT00844792|Vitamin D|vitamin d|mesh-list
6541184|NCT00844792|Cholecalciferol|cholecalciferol|mesh-list
6541185|NCT00844792|Vitamins|vitamins|mesh-list
6541186|NCT00844792|Vitamin E|vitamin e|mesh-list
6541187|NCT00844792|Selenium|selenium|mesh-list
6541188|NCT00844792|Lycopene|lycopene|mesh-list
6541189|NCT00844792|Micronutrients|micronutrients|mesh-ancestor
6541190|NCT00844792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541191|NCT00844792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6541192|NCT00844792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6541193|NCT00844792|Antioxidants|antioxidants|mesh-ancestor
6541194|NCT00844792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541195|NCT00844792|Protective Agents|protective agents|mesh-ancestor
6541196|NCT00844792|Trace Elements|trace elements|mesh-ancestor
6541197|NCT00844792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6541198|NCT00844792|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6435634|NCT00347815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6435635|NCT00347815|Narcotics|narcotics|mesh-ancestor
6435636|NCT00347815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6541199|NCT00844792|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6541200|NCT00844792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6541201|NCT00845104|Bevacizumab|bevacizumab|mesh-list
6541202|NCT00845104|Rituximab|rituximab|mesh-list
6541203|NCT00845104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6541204|NCT00845104|Fludarabine|fludarabine|mesh-list
6541205|NCT00845104|Fludarabine phosphate|fludarabine phosphate|mesh-list
6541206|NCT00845104|Antibodies|antibodies|mesh-list
6541207|NCT00845104|Immunoglobulins|immunoglobulins|mesh-list
6541208|NCT00845104|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6541209|NCT00845104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6541210|NCT00845104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6541211|NCT00845104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6541212|NCT00845104|Growth Substances|growth substances|mesh-ancestor
6541213|NCT00845104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541214|NCT00845104|Growth Inhibitors|growth inhibitors|mesh-ancestor
6541215|NCT00845104|Immunologic Factors|immunologic factors|mesh-ancestor
6541216|NCT00845104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6541217|NCT00845104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6541218|NCT00845104|Antimetabolites|antimetabolites|mesh-ancestor
6541219|NCT00845104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541220|NCT00845104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6541221|NCT00845156|Thioctic Acid|thioctic acid|mesh-list
6541222|NCT00845156|Antioxidants|antioxidants|mesh-ancestor
6541223|NCT00845156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541224|NCT00845156|Protective Agents|protective agents|mesh-ancestor
6541225|NCT00845156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541226|NCT00845156|Vitamin B Complex|vitamin b complex|mesh-ancestor
6435637|NCT00347815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435638|NCT00347815|Analgesics|analgesics|mesh-ancestor
6435639|NCT00347815|Sensory System Agents|sensory system agents|mesh-ancestor
6435640|NCT00347815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6435641|NCT00347815|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6435642|NCT00347828|Moxifloxacin|moxifloxacin|mesh-list
6435643|NCT00347828|Gatifloxacin|gatifloxacin|mesh-list
6541227|NCT00845156|Vitamins|vitamins|mesh-ancestor
6541228|NCT00845156|Micronutrients|micronutrients|mesh-ancestor
6541229|NCT00845221|Imatinib Mesylate|imatinib mesylate|mesh-list
6541230|NCT00845221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6435644|NCT00347828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6435645|NCT00347828|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6435646|NCT00347828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6435647|NCT00347828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6435648|NCT00347828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6435649|NCT00347828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6435650|NCT00347828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6435651|NCT00347828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435652|NCT00347828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6435653|NCT00347841|Bimatoprost|bimatoprost|mesh-list
6435654|NCT00347841|Latanoprost|latanoprost|mesh-list
6435655|NCT00347841|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6435656|NCT00347841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6435657|NCT00347841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6435658|NCT00347854|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6435659|NCT00347854|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6435660|NCT00347854|Lubricant Eye Drops|lubricant eye drops|mesh-list
6435661|NCT00347854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6435662|NCT00347854|Laxatives|laxatives|mesh-ancestor
6435663|NCT00347854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6435664|NCT00347867|Sildenafil Citrate|sildenafil citrate|mesh-list
6435665|NCT00347867|Vasodilator Agents|vasodilator agents|mesh-ancestor
6435666|NCT00347867|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6435667|NCT00347867|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6435668|NCT00347867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6435669|NCT00347867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435670|NCT00347867|Urological Agents|urological agents|mesh-ancestor
6435671|NCT00347971|Rituximab|rituximab|mesh-list
6435672|NCT00347971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6435673|NCT00347971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6435674|NCT00347971|Immunologic Factors|immunologic factors|mesh-ancestor
6541231|NCT00845221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6435675|NCT00347971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435676|NCT00347971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6435677|NCT00347984|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6435678|NCT00347984|Lubricant Eye Drops|lubricant eye drops|mesh-list
6435679|NCT00347984|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6435680|NCT00348010|Tramadol|tramadol|mesh-list
6435681|NCT00348010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6435682|NCT00348010|Narcotics|narcotics|mesh-ancestor
6019488|NCT00387465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019489|NCT00387465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6019490|NCT00387465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6019491|NCT00387621|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6435683|NCT00348010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6435684|NCT00348010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435685|NCT00348010|Analgesics|analgesics|mesh-ancestor
6435686|NCT00348010|Sensory System Agents|sensory system agents|mesh-ancestor
6435687|NCT00348010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6435688|NCT00348023|Timolol|timolol|mesh-list
6435689|NCT00348023|Bimatoprost|bimatoprost|mesh-list
6435690|NCT00348023|Travoprost|travoprost|mesh-list
6435691|NCT00348023|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6435692|NCT00348023|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6435693|NCT00348023|Adrenergic Agents|adrenergic agents|mesh-ancestor
6435694|NCT00348023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6019492|NCT00387621|Natriuretic Agents|natriuretic agents|mesh-ancestor
6435695|NCT00348023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435696|NCT00348023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435697|NCT00348023|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6435698|NCT00348023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6435699|NCT00348062|Bimatoprost|bimatoprost|mesh-list
6435700|NCT00348062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6435701|NCT00348101|Enoximone|enoximone|mesh-list
6435702|NCT00348101|Esmolol|esmolol|mesh-list
6435703|NCT00348101|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6435704|NCT00348101|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6435705|NCT00348101|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6435706|NCT00348101|Adrenergic Agents|adrenergic agents|mesh-ancestor
6435707|NCT00348101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6435708|NCT00348101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435709|NCT00348101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435710|NCT00348101|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6435711|NCT00348101|Vasodilator Agents|vasodilator agents|mesh-ancestor
6435712|NCT00348101|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6435713|NCT00348101|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6435714|NCT00348101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6435715|NCT00348101|Protective Agents|protective agents|mesh-ancestor
6435716|NCT00348153|Adalimumab|adalimumab|mesh-list
6435717|NCT00348153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6435718|NCT00348153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6435719|NCT00348166|Cyclopentolate|cyclopentolate|mesh-list
6435720|NCT00348166|Mydriatics|mydriatics|mesh-ancestor
6435721|NCT00348166|Autonomic Agents|autonomic agents|mesh-ancestor
6435722|NCT00348166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6435723|NCT00348166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435724|NCT00348166|Parasympatholytics|parasympatholytics|mesh-ancestor
6541232|NCT00845221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6541233|NCT00845221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541234|NCT00845338|Darifenacin|darifenacin|mesh-list
6541235|NCT00845338|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6541236|NCT00845338|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6541237|NCT00845338|Cholinergic Agents|cholinergic agents|mesh-ancestor
6541238|NCT00845338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6541239|NCT00845338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541240|NCT00845338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541241|NCT00845338|Urological Agents|urological agents|mesh-ancestor
6435725|NCT00348166|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6435726|NCT00348166|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6435727|NCT00348166|Cholinergic Agents|cholinergic agents|mesh-ancestor
6435728|NCT00348166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6435729|NCT00348166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435730|NCT00348192|Donepezil|donepezil|mesh-list
6435731|NCT00348192|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6435732|NCT00348192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6435733|NCT00348192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435734|NCT00348192|Cholinergic Agents|cholinergic agents|mesh-ancestor
6435735|NCT00348192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6435736|NCT00348192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435737|NCT00348192|Nootropic Agents|nootropic agents|mesh-ancestor
6435738|NCT00348231|Insulin|insulin|mesh-list
6435739|NCT00348231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6435740|NCT00348231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435741|NCT00348244|Prednisolone|prednisolone|mesh-list
6435742|NCT00348244|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6435743|NCT00348244|Methylprednisolone|methylprednisolone|mesh-list
6435744|NCT00348244|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6435745|NCT00348244|Prednisolone acetate|prednisolone acetate|mesh-list
6435746|NCT00348244|Ketorolac|ketorolac|mesh-list
6435747|NCT00348244|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6435748|NCT00348244|Prednisolone phosphate|prednisolone phosphate|mesh-list
6435749|NCT00348244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6435750|NCT00348244|Glucocorticoids|glucocorticoids|mesh-ancestor
6435751|NCT00348244|Hormones|hormones|mesh-ancestor
6435752|NCT00348244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6435753|NCT00348244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435754|NCT00348244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6435755|NCT00348244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6435756|NCT00348244|Antiemetics|antiemetics|mesh-ancestor
6435757|NCT00348244|Autonomic Agents|autonomic agents|mesh-ancestor
6435758|NCT00348244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6435759|NCT00348244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6435760|NCT00348244|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6435761|NCT00348244|Protective Agents|protective agents|mesh-ancestor
6435762|NCT00348244|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6435763|NCT00348244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6435764|NCT00348244|Analgesics|analgesics|mesh-ancestor
6435765|NCT00348244|Sensory System Agents|sensory system agents|mesh-ancestor
6435766|NCT00348244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6435767|NCT00348244|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6435768|NCT00348244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6435769|NCT00348244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435770|NCT00348296|Immunoglobulins|immunoglobulins|mesh-list
6435771|NCT00348296|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6435772|NCT00348296|Antibodies|antibodies|mesh-list
6435773|NCT00348296|gamma-Globulins|gamma-globulins|mesh-list
6435774|NCT00348296|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6435775|NCT00348296|Immunologic Factors|immunologic factors|mesh-ancestor
6435776|NCT00348296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435777|NCT00348322|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6435778|NCT00348322|Lubricant Eye Drops|lubricant eye drops|mesh-list
6435779|NCT00348322|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6435780|NCT00348335|Cyclosporine|cyclosporine|mesh-list
6435781|NCT00348335|Cyclosporins|cyclosporins|mesh-list
6435782|NCT00348335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6435783|NCT00348335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435784|NCT00348335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6435785|NCT00348335|Immunologic Factors|immunologic factors|mesh-ancestor
6435786|NCT00348335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435787|NCT00348335|Antifungal Agents|antifungal agents|mesh-ancestor
6435788|NCT00348335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6435789|NCT00348335|Dermatologic Agents|dermatologic agents|mesh-ancestor
6435790|NCT00348335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6541242|NCT00845351|Bexarotene|bexarotene|mesh-list
6541243|NCT00845351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6541244|NCT00845364|Perhexiline|perhexiline|mesh-list
6541245|NCT00845364|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6541246|NCT00845364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6541247|NCT00845364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541248|NCT00845364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6541249|NCT00845364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541250|NCT00845364|Vasodilator Agents|vasodilator agents|mesh-ancestor
6541251|NCT00845533|Piperaquine|piperaquine|mesh-list
6541252|NCT00845533|Artenimol|artenimol|mesh-list
6541253|NCT00845533|Antimalarials|antimalarials|mesh-ancestor
6541254|NCT00845533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6541255|NCT00845533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6541256|NCT00845533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6541257|NCT00845546|Loratadine|loratadine|mesh-list
6541258|NCT00845546|Pseudoephedrine|pseudoephedrine|mesh-list
6541259|NCT00845546|Ephedrine|ephedrine|mesh-list
6541260|NCT00845546|Antipruritics|antipruritics|mesh-ancestor
6541261|NCT00845546|Dermatologic Agents|dermatologic agents|mesh-ancestor
6541262|NCT00845546|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6541263|NCT00845546|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6541264|NCT00845546|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6541265|NCT00845546|Histamine Antagonists|histamine antagonists|mesh-ancestor
6541266|NCT00845546|Histamine Agents|histamine agents|mesh-ancestor
6541267|NCT00845546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6541268|NCT00845546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541269|NCT00845546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541270|NCT00845546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6541271|NCT00845546|Autonomic Agents|autonomic agents|mesh-ancestor
6541272|NCT00845546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6541273|NCT00845546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6541274|NCT00845546|Respiratory System Agents|respiratory system agents|mesh-ancestor
6541275|NCT00845546|Nasal Decongestants|nasal decongestants|mesh-ancestor
6541276|NCT00845546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6541277|NCT00845546|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6541278|NCT00845546|Sympathomimetics|sympathomimetics|mesh-ancestor
6541279|NCT00845546|Adrenergic Agents|adrenergic agents|mesh-ancestor
6541280|NCT00845559|Exenatide|exenatide|mesh-list
6541281|NCT00845559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6541282|NCT00845559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541283|NCT00845559|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6541284|NCT00845559|Incretins|incretins|mesh-ancestor
6541285|NCT00845559|Hormones|hormones|mesh-ancestor
6541286|NCT00845559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6541287|NCT00845572|Risperidone|risperidone|mesh-list
6541288|NCT00845572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6541289|NCT00845572|Serotonin Agents|serotonin agents|mesh-ancestor
6541290|NCT00845572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6541291|NCT00845572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541292|NCT00845572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435791|NCT00348335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6435792|NCT00348361|Fluticasone|fluticasone|mesh-list
6435793|NCT00348361|Xhance|xhance|mesh-list
6435794|NCT00348361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6435795|NCT00348361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6435796|NCT00348361|Autonomic Agents|autonomic agents|mesh-ancestor
6435797|NCT00348361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6435798|NCT00348361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435799|NCT00348361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6435800|NCT00348361|Respiratory System Agents|respiratory system agents|mesh-ancestor
6435801|NCT00348361|Dermatologic Agents|dermatologic agents|mesh-ancestor
6435802|NCT00348361|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6435803|NCT00348387|Vaccines|vaccines|mesh-list
6435804|NCT00348387|Immunologic Factors|immunologic factors|mesh-ancestor
6435805|NCT00348387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435806|NCT00348400|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6435807|NCT00348400|Dorzolamide|dorzolamide|mesh-list
6435808|NCT00348400|Latanoprost|latanoprost|mesh-list
6435809|NCT00348400|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6435810|NCT00348400|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6435811|NCT00348400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6435812|NCT00348400|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6435813|NCT00348400|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6435814|NCT00348400|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6435815|NCT00348400|Adrenergic Agents|adrenergic agents|mesh-ancestor
6435816|NCT00348400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6435817|NCT00348400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435818|NCT00348400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435819|NCT00348400|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6435820|NCT00348400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6435821|NCT00348413|Methylprednisolone|methylprednisolone|mesh-list
6435822|NCT00348413|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6435823|NCT00348413|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6435824|NCT00348413|Prednisolone|prednisolone|mesh-list
6435825|NCT00348413|Prednisolone acetate|prednisolone acetate|mesh-list
6435826|NCT00348413|Methotrexate|methotrexate|mesh-list
6435827|NCT00348413|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6435828|NCT00348413|Prednisolone phosphate|prednisolone phosphate|mesh-list
6435829|NCT00348413|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6435830|NCT00348413|Abortifacient Agents|abortifacient agents|mesh-ancestor
6435831|NCT00348413|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6435832|NCT00348413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435833|NCT00348413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6435834|NCT00348413|Antimetabolites|antimetabolites|mesh-ancestor
6435835|NCT00348413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435836|NCT00348413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6435837|NCT00348413|Dermatologic Agents|dermatologic agents|mesh-ancestor
6435838|NCT00348413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6435839|NCT00348413|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6435840|NCT00348413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6435841|NCT00348413|Immunologic Factors|immunologic factors|mesh-ancestor
6435842|NCT00348413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6435843|NCT00348413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6435844|NCT00348413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6435845|NCT00348413|Antiemetics|antiemetics|mesh-ancestor
6435846|NCT00348413|Autonomic Agents|autonomic agents|mesh-ancestor
6435847|NCT00348413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6435848|NCT00348413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6435849|NCT00348413|Glucocorticoids|glucocorticoids|mesh-ancestor
6435850|NCT00348413|Hormones|hormones|mesh-ancestor
6435851|NCT00348413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6435852|NCT00348413|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6435853|NCT00348413|Protective Agents|protective agents|mesh-ancestor
6435854|NCT00348413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6435855|NCT00348426|Antitoxins|antitoxins|mesh-list
6435856|NCT00348426|Botulinum Antitoxin|botulinum antitoxin|mesh-list
6435857|NCT00348426|Immunologic Factors|immunologic factors|mesh-ancestor
6435858|NCT00348426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435859|NCT00348439|Fibrinolysin|fibrinolysin|mesh-list
6435860|NCT00348439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6435861|NCT00348439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6435862|NCT00348439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435863|NCT00348452|Celecoxib|celecoxib|mesh-list
6435864|NCT00348452|Tramadol|tramadol|mesh-list
6435865|NCT00348452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6435866|NCT00348452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6019493|NCT00387621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435867|NCT00348452|Analgesics|analgesics|mesh-ancestor
6435868|NCT00348452|Sensory System Agents|sensory system agents|mesh-ancestor
6435869|NCT00348452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6435870|NCT00348452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435871|NCT00348452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6435872|NCT00348452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6435873|NCT00348452|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6435874|NCT00348452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6435875|NCT00348452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6435876|NCT00348452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435877|NCT00348452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6435878|NCT00348452|Narcotics|narcotics|mesh-ancestor
6435879|NCT00348452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6435880|NCT00348491|Lumiracoxib|lumiracoxib|mesh-list
6435881|NCT00348491|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6435882|NCT00348491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6435883|NCT00348491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6435884|NCT00348491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435885|NCT00348491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6435886|NCT00348491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6435887|NCT00348491|Analgesics|analgesics|mesh-ancestor
6435888|NCT00348491|Sensory System Agents|sensory system agents|mesh-ancestor
6435889|NCT00348491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6435890|NCT00348491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435891|NCT00348491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6435892|NCT00348491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6435893|NCT00348504|Simendan|simendan|mesh-list
6435894|NCT00348504|Dobutamine|dobutamine|mesh-list
6435895|NCT00348504|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6435896|NCT00348504|Vasodilator Agents|vasodilator agents|mesh-ancestor
6435897|NCT00348504|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6435898|NCT00348504|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6435899|NCT00348504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6435900|NCT00348504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435901|NCT00348504|Protective Agents|protective agents|mesh-ancestor
6435902|NCT00348504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435903|NCT00348504|Sympathomimetics|sympathomimetics|mesh-ancestor
6435904|NCT00348504|Autonomic Agents|autonomic agents|mesh-ancestor
6435905|NCT00348504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6435906|NCT00348504|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6435907|NCT00348504|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6435908|NCT00348504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6435909|NCT00348504|Adrenergic Agents|adrenergic agents|mesh-ancestor
6435910|NCT00348504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6435911|NCT00348517|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6435912|NCT00348517|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6435913|NCT00348517|Lubricant Eye Drops|lubricant eye drops|mesh-list
6435914|NCT00348517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6435915|NCT00348517|Laxatives|laxatives|mesh-ancestor
6435916|NCT00348517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6435917|NCT00348530|Verapamil|verapamil|mesh-list
6435918|NCT00348530|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6435919|NCT00348530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6435920|NCT00348530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6435921|NCT00348530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435922|NCT00348530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6435923|NCT00348530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435924|NCT00348530|Vasodilator Agents|vasodilator agents|mesh-ancestor
6435925|NCT00348582|Ketorolac|ketorolac|mesh-list
6435926|NCT00348582|Nepafenac|nepafenac|mesh-list
6435927|NCT00348582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6435928|NCT00348582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6435929|NCT00348582|Analgesics|analgesics|mesh-ancestor
6435930|NCT00348582|Sensory System Agents|sensory system agents|mesh-ancestor
6435931|NCT00348582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6435932|NCT00348582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435933|NCT00348582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6435934|NCT00348582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6435935|NCT00348582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6435936|NCT00348582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6435937|NCT00348582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435938|NCT00348634|Tegaserod|tegaserod|mesh-list
6435939|NCT00348634|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6435940|NCT00348634|Serotonin Agents|serotonin agents|mesh-ancestor
6435941|NCT00348634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6435942|NCT00348634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435943|NCT00348634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435944|NCT00348712|Insulin|insulin|mesh-list
6435945|NCT00348712|Metformin|metformin|mesh-list
6435946|NCT00348712|Rosiglitazone|rosiglitazone|mesh-list
6435947|NCT00348712|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6435948|NCT00348712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6435949|NCT00348712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435950|NCT00348725|Metformin|metformin|mesh-list
6435951|NCT00348725|Fenofibrate|fenofibrate|mesh-list
6435952|NCT00348725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6435953|NCT00348725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435954|NCT00348725|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6435955|NCT00348725|Antimetabolites|antimetabolites|mesh-ancestor
6435956|NCT00348725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435957|NCT00348725|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6435958|NCT00348738|Epoetin Alfa|epoetin alfa|mesh-list
6435959|NCT00348738|Hematinics|hematinics|mesh-ancestor
6461188|NCT00453232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6461189|NCT00453323|Paclitaxel|paclitaxel|mesh-list
6461190|NCT00453323|Capecitabine|capecitabine|mesh-list
6461191|NCT00453323|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6461192|NCT00453323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6461193|NCT00453323|Tubulin Modulators|tubulin modulators|mesh-ancestor
6461194|NCT00453323|Antimitotic Agents|antimitotic agents|mesh-ancestor
6461195|NCT00453323|Mitosis Modulators|mitosis modulators|mesh-ancestor
6461196|NCT00453323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461197|NCT00453323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6461198|NCT00453323|Antimetabolites|antimetabolites|mesh-ancestor
6461199|NCT00453375|Butylated Hydroxytoluene|butylated hydroxytoluene|mesh-list
6461200|NCT00453375|Antioxidants|antioxidants|mesh-ancestor
6461201|NCT00453375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461202|NCT00453375|Protective Agents|protective agents|mesh-ancestor
6461203|NCT00453375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461204|NCT00453401|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
6461205|NCT00453401|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
6461206|NCT00453401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6541293|NCT00845572|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6541294|NCT00845572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6541295|NCT00845572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6541296|NCT00845572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6541297|NCT00845572|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6541298|NCT00845572|Dopamine Agents|dopamine agents|mesh-ancestor
6541299|NCT00845598|Fluticasone|fluticasone|mesh-list
6541300|NCT00845598|Xhance|xhance|mesh-list
6541301|NCT00845598|Azelastine|azelastine|mesh-list
6541302|NCT00845598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6541303|NCT00845598|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6541304|NCT00845598|Autonomic Agents|autonomic agents|mesh-ancestor
6541305|NCT00845598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6541306|NCT00845598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541307|NCT00845598|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6541308|NCT00845598|Respiratory System Agents|respiratory system agents|mesh-ancestor
6541309|NCT00845598|Dermatologic Agents|dermatologic agents|mesh-ancestor
6541310|NCT00845598|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6541311|NCT00845598|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6541312|NCT00845598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6462186|NCT00458042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6435960|NCT00348764|Polidocanol|polidocanol|mesh-list
6435961|NCT00348764|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
6435962|NCT00348764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6435963|NCT00348894|Reboxetine|reboxetine|mesh-list
6435964|NCT00348894|Antidepressive Agents|antidepressive agents|mesh-ancestor
6435965|NCT00348894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6435966|NCT00348894|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6435967|NCT00348894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6435968|NCT00348894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6435969|NCT00348894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435970|NCT00348894|Adrenergic Agents|adrenergic agents|mesh-ancestor
6435971|NCT00348894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6435972|NCT00348894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435973|NCT00348920|Bupivacaine|bupivacaine|mesh-list
6435974|NCT00348920|Anesthetics, Local|anesthetics, local|mesh-ancestor
6435975|NCT00348920|Anesthetics|anesthetics|mesh-ancestor
6435976|NCT00348920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6435977|NCT00348920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435978|NCT00348920|Sensory System Agents|sensory system agents|mesh-ancestor
6435979|NCT00348920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6435980|NCT00348972|Insulin Glargine|insulin glargine|mesh-list
6435981|NCT00348972|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6435982|NCT00348972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435983|NCT00348985|Bortezomib|bortezomib|mesh-list
6435984|NCT00348985|Belinostat|belinostat|mesh-list
6435985|NCT00348985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6435986|NCT00348985|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6435987|NCT00348985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6435988|NCT00348985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6435989|NCT00348998|Bevacizumab|bevacizumab|mesh-list
6435990|NCT00348998|Goserelin|goserelin|mesh-list
6435991|NCT00348998|Bicalutamide|bicalutamide|mesh-list
6435992|NCT00348998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6435993|NCT00348998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6435994|NCT00348998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6435995|NCT00348998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6435996|NCT00348998|Growth Substances|growth substances|mesh-ancestor
6435997|NCT00348998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6435998|NCT00348998|Growth Inhibitors|growth inhibitors|mesh-ancestor
6435999|NCT00348998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6436000|NCT00348998|Androgen Antagonists|androgen antagonists|mesh-ancestor
6436001|NCT00348998|Hormone Antagonists|hormone antagonists|mesh-ancestor
6436002|NCT00348998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6436003|NCT00349024|Povidone|povidone|mesh-list
6436004|NCT00349024|Hyaluronic Acid|hyaluronic acid|mesh-list
6436005|NCT00349024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6436006|NCT00349024|Immunologic Factors|immunologic factors|mesh-ancestor
6436007|NCT00349024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436008|NCT00349024|Viscosupplements|viscosupplements|mesh-ancestor
6436009|NCT00349024|Protective Agents|protective agents|mesh-ancestor
6436010|NCT00349024|Plasma Substitutes|plasma substitutes|mesh-ancestor
6541313|NCT00845598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541314|NCT00845598|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6541315|NCT00845598|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6541316|NCT00845598|Histamine Antagonists|histamine antagonists|mesh-ancestor
6541317|NCT00845598|Histamine Agents|histamine agents|mesh-ancestor
6541318|NCT00845598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6541319|NCT00845689|Adenosine|adenosine|mesh-list
6541320|NCT00845689|Analgesics|analgesics|mesh-ancestor
6541321|NCT00845689|Sensory System Agents|sensory system agents|mesh-ancestor
6541322|NCT00845689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6541323|NCT00845689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541324|NCT00845689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6541325|NCT00845689|Vasodilator Agents|vasodilator agents|mesh-ancestor
6541326|NCT00845689|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6541327|NCT00845689|Purinergic Agonists|purinergic agonists|mesh-ancestor
6436011|NCT00349024|Blood Substitutes|blood substitutes|mesh-ancestor
6436012|NCT00349076|Oxaliplatin|oxaliplatin|mesh-list
6436013|NCT00349076|Fluorouracil|fluorouracil|mesh-list
6436014|NCT00349076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6436015|NCT00349076|Antimetabolites|antimetabolites|mesh-ancestor
6436016|NCT00349076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436017|NCT00349076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6436018|NCT00349076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6436019|NCT00349076|Immunologic Factors|immunologic factors|mesh-ancestor
6436020|NCT00349076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436021|NCT00349089|Pemetrexed|pemetrexed|mesh-list
6436022|NCT00349089|Vinorelbine|vinorelbine|mesh-list
6436023|NCT00349089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6436024|NCT00349089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6436025|NCT00349089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436026|NCT00349089|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6436027|NCT00349089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6436028|NCT00349089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6436029|NCT00349089|Tubulin Modulators|tubulin modulators|mesh-ancestor
6436030|NCT00349089|Antimitotic Agents|antimitotic agents|mesh-ancestor
6436031|NCT00349089|Mitosis Modulators|mitosis modulators|mesh-ancestor
6436032|NCT00349115|Thalidomide|thalidomide|mesh-list
6436033|NCT00349115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6436034|NCT00349115|Immunologic Factors|immunologic factors|mesh-ancestor
6436035|NCT00349115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436036|NCT00349115|Leprostatic Agents|leprostatic agents|mesh-ancestor
6436037|NCT00349115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6436038|NCT00349115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6436039|NCT00349115|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6436040|NCT00349115|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6436041|NCT00349115|Growth Substances|growth substances|mesh-ancestor
6436042|NCT00349115|Growth Inhibitors|growth inhibitors|mesh-ancestor
6436043|NCT00349115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6436044|NCT00349128|Metformin|metformin|mesh-list
6436045|NCT00349128|Fenofibrate|fenofibrate|mesh-list
6436046|NCT00349128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6436047|NCT00349128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436048|NCT00349128|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6436049|NCT00349128|Antimetabolites|antimetabolites|mesh-ancestor
6436050|NCT00349128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436051|NCT00349128|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6436052|NCT00349180|Enoxaparin|enoxaparin|mesh-list
6436053|NCT00349180|Enoxaparin sodium|enoxaparin sodium|mesh-list
6436054|NCT00349180|Anticoagulants|anticoagulants|mesh-ancestor
6436055|NCT00349180|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6436056|NCT00349180|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6436057|NCT00349180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436058|NCT00349206|Sirolimus|sirolimus|mesh-list
6436059|NCT00349206|Sorafenib|sorafenib|mesh-list
6436060|NCT00349206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6436061|NCT00349206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6436062|NCT00349206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6541328|NCT00845689|Purinergic Agents|purinergic agents|mesh-ancestor
6541329|NCT00845689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6541330|NCT00845689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541331|NCT00845754|Ketorolac|ketorolac|mesh-list
6541332|NCT00845754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6541333|NCT00845754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6541334|NCT00845754|Analgesics|analgesics|mesh-ancestor
6541335|NCT00845754|Sensory System Agents|sensory system agents|mesh-ancestor
6541336|NCT00845754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6541337|NCT00845754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541338|NCT00845754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6541339|NCT00845754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6541340|NCT00845754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6541341|NCT00845754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6541342|NCT00845754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436063|NCT00349206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436064|NCT00349206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6436065|NCT00349206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6436066|NCT00349206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6436067|NCT00349206|Antifungal Agents|antifungal agents|mesh-ancestor
6436068|NCT00349206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6436069|NCT00349206|Immunologic Factors|immunologic factors|mesh-ancestor
6436070|NCT00349206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436071|NCT00349219|Gemcitabine|gemcitabine|mesh-list
6436072|NCT00349219|Cisplatin|cisplatin|mesh-list
6436073|NCT00349219|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6436074|NCT00349219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6436075|NCT00349219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6436076|NCT00349219|Antimetabolites|antimetabolites|mesh-ancestor
6436077|NCT00349219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436078|NCT00349219|Antiviral Agents|antiviral agents|mesh-ancestor
6436079|NCT00349219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6436080|NCT00349219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6436081|NCT00349219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6436082|NCT00349219|Immunologic Factors|immunologic factors|mesh-ancestor
6436083|NCT00349219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436084|NCT00349219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6436085|NCT00349245|Dexmedetomidine|dexmedetomidine|mesh-list
6436086|NCT00349245|Remifentanil|remifentanil|mesh-list
6436087|NCT00349245|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6436088|NCT00349245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6436089|NCT00349245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436090|NCT00349245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6436091|NCT00349245|Analgesics|analgesics|mesh-ancestor
6436092|NCT00349245|Sensory System Agents|sensory system agents|mesh-ancestor
6436093|NCT00349245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6436094|NCT00349245|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6436095|NCT00349245|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6436096|NCT00349245|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6436097|NCT00349245|Adrenergic Agents|adrenergic agents|mesh-ancestor
6436098|NCT00349245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6436099|NCT00349245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436100|NCT00349245|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6436101|NCT00349245|Narcotics|narcotics|mesh-ancestor
6436102|NCT00349258|Leuprolide|leuprolide|mesh-list
6436103|NCT00349258|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6436104|NCT00349258|Fertility Agents|fertility agents|mesh-ancestor
6436105|NCT00349258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6436106|NCT00349258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436107|NCT00349258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6436108|NCT00349258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6436109|NCT00349284|Ezetimibe|ezetimibe|mesh-list
6436110|NCT00349284|Fenofibrate|fenofibrate|mesh-list
6436111|NCT00349284|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6436112|NCT00349284|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6436113|NCT00349284|Antimetabolites|antimetabolites|mesh-ancestor
6436114|NCT00349284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436115|NCT00349284|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6436116|NCT00349310|Pramipexole|pramipexole|mesh-list
6436117|NCT00349310|Antioxidants|antioxidants|mesh-ancestor
6436118|NCT00349310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436119|NCT00349310|Protective Agents|protective agents|mesh-ancestor
6436120|NCT00349310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436121|NCT00349310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6436122|NCT00349310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6436123|NCT00349310|Dopamine Agonists|dopamine agonists|mesh-ancestor
6436124|NCT00349310|Dopamine Agents|dopamine agents|mesh-ancestor
6436125|NCT00349310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6436126|NCT00349362|Testosterone|testosterone|mesh-list
6436127|NCT00349362|Androgens|androgens|mesh-ancestor
6436128|NCT00349362|Hormones|hormones|mesh-ancestor
6436129|NCT00349362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6436130|NCT00349362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436131|NCT00349375|Simvastatin|simvastatin|mesh-list
6436132|NCT00349375|Fenofibrate|fenofibrate|mesh-list
6436133|NCT00349375|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6436134|NCT00349375|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6436135|NCT00349375|Antimetabolites|antimetabolites|mesh-ancestor
6436136|NCT00349375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436137|NCT00349375|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6436138|NCT00349375|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6436139|NCT00349375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6436140|NCT00349401|Ketorolac|ketorolac|mesh-list
6541343|NCT00845780|Amiodarone|amiodarone|mesh-list
6541344|NCT00845780|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6541345|NCT00845780|Vasodilator Agents|vasodilator agents|mesh-ancestor
6541346|NCT00845780|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6541347|NCT00845780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6541348|NCT00845780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541349|NCT00845780|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6541350|NCT00845780|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6541351|NCT00845780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6541352|NCT00845780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6541353|NCT00845780|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6541354|NCT00845780|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6541355|NCT00845780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6541356|NCT00845819|Iodine|iodine|mesh-list
6541357|NCT00845819|Chlorhexidine|chlorhexidine|mesh-list
6541358|NCT00845819|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6541359|NCT00845819|Cadexomer iodine|cadexomer iodine|mesh-list
6541360|NCT00845819|Povidone-Iodine|povidone-iodine|mesh-list
6541361|NCT00845819|Nystatin|nystatin|mesh-list
6541362|NCT00845819|Povidone|povidone|mesh-list
6541363|NCT00845819|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6436141|NCT00349401|Morphine|morphine|mesh-list
6436142|NCT00349401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6436143|NCT00349401|Narcotics|narcotics|mesh-ancestor
6436144|NCT00349401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6436145|NCT00349401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436146|NCT00349401|Analgesics|analgesics|mesh-ancestor
6436147|NCT00349401|Sensory System Agents|sensory system agents|mesh-ancestor
6436148|NCT00349401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6436149|NCT00349401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6436150|NCT00349401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6436151|NCT00349401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6436152|NCT00349401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6436153|NCT00349401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6436154|NCT00349401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6436155|NCT00349401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436156|NCT00349427|Rosiglitazone|rosiglitazone|mesh-list
6436157|NCT00349427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6436158|NCT00349427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436159|NCT00349440|Cyclosporine|cyclosporine|mesh-list
6436160|NCT00349440|Cyclosporins|cyclosporins|mesh-list
6436161|NCT00349440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6436162|NCT00349440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436163|NCT00349440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6436164|NCT00349440|Immunologic Factors|immunologic factors|mesh-ancestor
6436165|NCT00349440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436166|NCT00349440|Antifungal Agents|antifungal agents|mesh-ancestor
6436167|NCT00349440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6436168|NCT00349440|Dermatologic Agents|dermatologic agents|mesh-ancestor
6436169|NCT00349440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6436170|NCT00349440|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6436171|NCT00349453|Deferiprone|deferiprone|mesh-list
6436172|NCT00349453|Deferoxamine|deferoxamine|mesh-list
6436173|NCT00349453|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6436174|NCT00349453|Chelating Agents|chelating agents|mesh-ancestor
6436175|NCT00349453|Sequestering Agents|sequestering agents|mesh-ancestor
6436176|NCT00349453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436177|NCT00349453|Siderophores|siderophores|mesh-ancestor
6436178|NCT00349492|Cisplatin|cisplatin|mesh-list
6436179|NCT00349492|Irinotecan|irinotecan|mesh-list
6436180|NCT00349492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6436181|NCT00349492|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6436182|NCT00349492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6436183|NCT00349492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6436184|NCT00349492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436185|NCT00349518|Dasatinib|dasatinib|mesh-list
6436186|NCT00349518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6436187|NCT00349518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6436188|NCT00349518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6436189|NCT00349518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436190|NCT00349531|Pramipexole|pramipexole|mesh-list
6436191|NCT00349531|Antioxidants|antioxidants|mesh-ancestor
6436192|NCT00349531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436193|NCT00349531|Protective Agents|protective agents|mesh-ancestor
6436194|NCT00349531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436195|NCT00349531|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6436196|NCT00349531|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6436197|NCT00349531|Dopamine Agonists|dopamine agonists|mesh-ancestor
6436198|NCT00349531|Dopamine Agents|dopamine agents|mesh-ancestor
6436199|NCT00349531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6436200|NCT00349557|Bevacizumab|bevacizumab|mesh-list
6436201|NCT00349557|Goserelin|goserelin|mesh-list
6436202|NCT00349557|Bicalutamide|bicalutamide|mesh-list
6436203|NCT00349557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6436204|NCT00349557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6436205|NCT00349557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6436206|NCT00349557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6436207|NCT00349557|Growth Substances|growth substances|mesh-ancestor
6436208|NCT00349557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436209|NCT00349557|Growth Inhibitors|growth inhibitors|mesh-ancestor
6436210|NCT00349557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6436211|NCT00349557|Androgen Antagonists|androgen antagonists|mesh-ancestor
6436212|NCT00349557|Hormone Antagonists|hormone antagonists|mesh-ancestor
6436213|NCT00349557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6436214|NCT00349583|Cyclosporine|cyclosporine|mesh-list
6436215|NCT00349583|Cyclosporins|cyclosporins|mesh-list
6436216|NCT00349583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6436217|NCT00349583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436218|NCT00349583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6436219|NCT00349583|Immunologic Factors|immunologic factors|mesh-ancestor
6436220|NCT00349583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436221|NCT00349583|Antifungal Agents|antifungal agents|mesh-ancestor
6436222|NCT00349583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6436223|NCT00349583|Dermatologic Agents|dermatologic agents|mesh-ancestor
6436224|NCT00349583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6436225|NCT00349583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6436226|NCT00349596|Decitabine|decitabine|mesh-list
6436227|NCT00349596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6436228|NCT00349596|Antimetabolites|antimetabolites|mesh-ancestor
6436229|NCT00349596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436230|NCT00349596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6436231|NCT00349596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6436232|NCT00349635|Metformin|metformin|mesh-list
6436233|NCT00349635|Fenofibrate|fenofibrate|mesh-list
6436234|NCT00349635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6436235|NCT00349635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436236|NCT00349635|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6436237|NCT00349635|Antimetabolites|antimetabolites|mesh-ancestor
6436238|NCT00349635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436239|NCT00349635|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6436240|NCT00349674|Methotrexate|methotrexate|mesh-list
6436241|NCT00349674|Azathioprine|azathioprine|mesh-list
6436242|NCT00349674|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6436243|NCT00349674|Abortifacient Agents|abortifacient agents|mesh-ancestor
6436244|NCT00349674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6436245|NCT00349674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436246|NCT00349674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6436247|NCT00349674|Antimetabolites|antimetabolites|mesh-ancestor
6541364|NCT00845819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6541365|NCT00845819|Disinfectants|disinfectants|mesh-ancestor
6541366|NCT00845819|Dermatologic Agents|dermatologic agents|mesh-ancestor
6541367|NCT00845819|Trace Elements|trace elements|mesh-ancestor
6541368|NCT00845819|Micronutrients|micronutrients|mesh-ancestor
6541369|NCT00845819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541370|NCT00845819|Plasma Substitutes|plasma substitutes|mesh-ancestor
6541371|NCT00845819|Blood Substitutes|blood substitutes|mesh-ancestor
6541372|NCT00845819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6541373|NCT00845819|Antifungal Agents|antifungal agents|mesh-ancestor
6541374|NCT00845819|Ionophores|ionophores|mesh-ancestor
6541375|NCT00845819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6436248|NCT00349674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462187|NCT00458055|Niacin|niacin|mesh-list
6541376|NCT00845819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541377|NCT00845884|Bevacizumab|bevacizumab|mesh-list
6541378|NCT00845884|Cisplatin|cisplatin|mesh-list
6541379|NCT00845884|Docetaxel|docetaxel|mesh-list
6541380|NCT00845884|Capecitabine|capecitabine|mesh-list
6541381|NCT00845884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6541382|NCT00845884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6541383|NCT00845884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6541384|NCT00845884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6541385|NCT00845884|Growth Substances|growth substances|mesh-ancestor
6541386|NCT00845884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541387|NCT00845884|Growth Inhibitors|growth inhibitors|mesh-ancestor
6541388|NCT00845884|Tubulin Modulators|tubulin modulators|mesh-ancestor
6541389|NCT00845884|Antimitotic Agents|antimitotic agents|mesh-ancestor
6541390|NCT00845884|Mitosis Modulators|mitosis modulators|mesh-ancestor
6541391|NCT00845884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436249|NCT00349674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6436250|NCT00349674|Dermatologic Agents|dermatologic agents|mesh-ancestor
6436251|NCT00349674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6436252|NCT00349674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6436253|NCT00349674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6436254|NCT00349674|Immunologic Factors|immunologic factors|mesh-ancestor
6436255|NCT00349674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6436256|NCT00349674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6436257|NCT00349726|Inositol|inositol|mesh-list
6436258|NCT00349726|Vitamin B Complex|vitamin b complex|mesh-ancestor
6436259|NCT00349726|Vitamins|vitamins|mesh-ancestor
6436260|NCT00349726|Micronutrients|micronutrients|mesh-ancestor
6436261|NCT00349726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436262|NCT00349739|Anecortave|anecortave|mesh-list
6436263|NCT00349739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6436264|NCT00349739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6436265|NCT00349739|Growth Substances|growth substances|mesh-ancestor
6436266|NCT00349739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436267|NCT00349739|Growth Inhibitors|growth inhibitors|mesh-ancestor
6436268|NCT00349739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6436269|NCT00349791|Testosterone|testosterone|mesh-list
6436270|NCT00349791|Androgens|androgens|mesh-ancestor
6436271|NCT00349791|Hormones|hormones|mesh-ancestor
6436272|NCT00349791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6436273|NCT00349791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436274|NCT00349986|Insulin Glargine|insulin glargine|mesh-list
6436275|NCT00349986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6436276|NCT00349986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436277|NCT00350038|Irbesartan|irbesartan|mesh-list
6436278|NCT00350038|Ciprofibrate|ciprofibrate|mesh-list
6436279|NCT00350038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6436280|NCT00350038|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6436281|NCT00350038|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6436282|NCT00350038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436283|NCT00350038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6436284|NCT00350038|Antimetabolites|antimetabolites|mesh-ancestor
6436285|NCT00350038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6436286|NCT00350051|Prednisone|prednisone|mesh-list
6436287|NCT00350051|Sagopilone|sagopilone|mesh-list
6436288|NCT00350051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6436289|NCT00350051|Glucocorticoids|glucocorticoids|mesh-ancestor
6436290|NCT00350051|Hormones|hormones|mesh-ancestor
6436291|NCT00350051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6436292|NCT00350051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436293|NCT00350051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6436294|NCT00350051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6436295|NCT00350077|Vitamins|vitamins|mesh-list
6436296|NCT00350077|Ascorbic Acid|ascorbic acid|mesh-list
6436297|NCT00350077|Micronutrients|micronutrients|mesh-ancestor
6436298|NCT00350077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436299|NCT00350077|Antioxidants|antioxidants|mesh-ancestor
6436300|NCT00350077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436301|NCT00350077|Protective Agents|protective agents|mesh-ancestor
6436302|NCT00350090|Epoetin Alfa|epoetin alfa|mesh-list
6436303|NCT00350090|Hematinics|hematinics|mesh-ancestor
6436304|NCT00350116|Vitamin B 12|vitamin b 12|mesh-list
6436305|NCT00350116|Hydroxocobalamin|hydroxocobalamin|mesh-list
6436306|NCT00350116|Vitamins|vitamins|mesh-ancestor
6436307|NCT00350116|Micronutrients|micronutrients|mesh-ancestor
6436308|NCT00350116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436309|NCT00350116|Vitamin B Complex|vitamin b complex|mesh-ancestor
6436310|NCT00350116|Hematinics|hematinics|mesh-ancestor
6436311|NCT00350155|Lumiracoxib|lumiracoxib|mesh-list
6436312|NCT00350155|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6436313|NCT00350155|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6436314|NCT00350155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6436315|NCT00350155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436316|NCT00350155|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6436317|NCT00350155|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6436318|NCT00350155|Analgesics|analgesics|mesh-ancestor
6436319|NCT00350155|Sensory System Agents|sensory system agents|mesh-ancestor
6436320|NCT00350155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6436321|NCT00350155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436322|NCT00350155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6436323|NCT00350155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6436324|NCT00350168|Amlodipine|amlodipine|mesh-list
6436325|NCT00350168|Valsartan|valsartan|mesh-list
6436326|NCT00350168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6436327|NCT00350168|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6436328|NCT00350168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6436329|NCT00350168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436330|NCT00350168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6436331|NCT00350168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436332|NCT00350168|Vasodilator Agents|vasodilator agents|mesh-ancestor
6436333|NCT00350168|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6436334|NCT00350168|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6436335|NCT00350181|Mycophenolic Acid|mycophenolic acid|mesh-list
6019494|NCT00387647|Azacitidine|azacitidine|mesh-list
6019495|NCT00387647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6019496|NCT00387647|Antimetabolites|antimetabolites|mesh-ancestor
6436336|NCT00350181|Sirolimus|sirolimus|mesh-list
6436337|NCT00350181|Cyclophosphamide|cyclophosphamide|mesh-list
6436338|NCT00350181|Busulfan|busulfan|mesh-list
6436339|NCT00350181|Carmustine|carmustine|mesh-list
6436340|NCT00350181|Etoposide|etoposide|mesh-list
6436341|NCT00350181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6436342|NCT00350181|Immunologic Factors|immunologic factors|mesh-ancestor
6436343|NCT00350181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436344|NCT00350181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6436345|NCT00350181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6436346|NCT00350181|Alkylating Agents|alkylating agents|mesh-ancestor
6436347|NCT00350181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436348|NCT00350181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6436349|NCT00350181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6436350|NCT00350181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6436351|NCT00350181|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6436352|NCT00350181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6436353|NCT00350181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6436354|NCT00350181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6436355|NCT00350181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6436356|NCT00350181|Antitubercular Agents|antitubercular agents|mesh-ancestor
6436357|NCT00350181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6541392|NCT00845884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6541393|NCT00845884|Antimetabolites|antimetabolites|mesh-ancestor
6541394|NCT00845910|Bevacizumab|bevacizumab|mesh-list
6541395|NCT00845910|Docetaxel|docetaxel|mesh-list
6541396|NCT00845910|Capecitabine|capecitabine|mesh-list
6541397|NCT00845910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6541398|NCT00845910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6541399|NCT00845910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6541400|NCT00845910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6541401|NCT00845910|Growth Substances|growth substances|mesh-ancestor
6541402|NCT00845910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541403|NCT00845910|Growth Inhibitors|growth inhibitors|mesh-ancestor
6541404|NCT00845910|Tubulin Modulators|tubulin modulators|mesh-ancestor
6541405|NCT00845910|Antimitotic Agents|antimitotic agents|mesh-ancestor
6436358|NCT00350181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6436359|NCT00350181|Antifungal Agents|antifungal agents|mesh-ancestor
6436360|NCT00350311|Nicotine|nicotine|mesh-list
6436361|NCT00350311|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6436362|NCT00350311|Autonomic Agents|autonomic agents|mesh-ancestor
6436363|NCT00350311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6436364|NCT00350311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436365|NCT00350311|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6436366|NCT00350311|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6436367|NCT00350311|Cholinergic Agents|cholinergic agents|mesh-ancestor
6436368|NCT00350311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6541406|NCT00845910|Mitosis Modulators|mitosis modulators|mesh-ancestor
6541407|NCT00845910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541408|NCT00845910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6541409|NCT00845910|Antimetabolites|antimetabolites|mesh-ancestor
6541410|NCT00845936|Metformin|metformin|mesh-list
6541411|NCT00845936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6541412|NCT00845936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541413|NCT00845962|Bupivacaine|bupivacaine|mesh-list
6541414|NCT00845962|Chloroprocaine|chloroprocaine|mesh-list
6541415|NCT00845962|Anesthetics, Local|anesthetics, local|mesh-ancestor
6541416|NCT00845962|Anesthetics|anesthetics|mesh-ancestor
6541417|NCT00845962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6541418|NCT00845962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541419|NCT00845962|Sensory System Agents|sensory system agents|mesh-ancestor
6541420|NCT00845962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6541421|NCT00845988|Aripiprazole|aripiprazole|mesh-list
6541422|NCT00845988|Antidepressive Agents|antidepressive agents|mesh-ancestor
6541423|NCT00845988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6541424|NCT00845988|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6541425|NCT00845988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6541426|NCT00845988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6541427|NCT00845988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541428|NCT00845988|Dopamine Agonists|dopamine agonists|mesh-ancestor
6541429|NCT00845988|Dopamine Agents|dopamine agents|mesh-ancestor
6541430|NCT00845988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6541431|NCT00845988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541432|NCT00845988|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6541433|NCT00845988|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6541434|NCT00845988|Serotonin Agents|serotonin agents|mesh-ancestor
6541435|NCT00845988|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6541436|NCT00845988|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6436369|NCT00350311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436370|NCT00350415|Mesalamine|mesalamine|mesh-list
6436371|NCT00350415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6436372|NCT00350415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6436373|NCT00350415|Analgesics|analgesics|mesh-ancestor
6436374|NCT00350415|Sensory System Agents|sensory system agents|mesh-ancestor
6436375|NCT00350415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6436376|NCT00350415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436377|NCT00350415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6436378|NCT00350415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6461207|NCT00453401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461208|NCT00453414|Iloprost|iloprost|mesh-list
6461209|NCT00453414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6461210|NCT00453414|Vasodilator Agents|vasodilator agents|mesh-ancestor
6461211|NCT00453427|Alemtuzumab|alemtuzumab|mesh-list
6461212|NCT00453427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6461213|NCT00453427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6461214|NCT00453453|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6461215|NCT00453453|Natriuretic Agents|natriuretic agents|mesh-ancestor
6461216|NCT00453453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461217|NCT00453492|Risedronic Acid|risedronic acid|mesh-list
6461218|NCT00453492|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6461219|NCT00453492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6461220|NCT00453492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461221|NCT00453492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6461222|NCT00453492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461223|NCT00453492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6461224|NCT00453609|Naltrexone|naltrexone|mesh-list
6461225|NCT00453609|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6461226|NCT00453609|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6461227|NCT00453609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461228|NCT00453609|Sensory System Agents|sensory system agents|mesh-ancestor
6461229|NCT00453609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6461230|NCT00453635|Carboplatin|carboplatin|mesh-list
6541437|NCT00845988|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6541438|NCT00845988|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6541439|NCT00846079|Regadenoson|regadenoson|mesh-list
6541440|NCT00846079|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
6541441|NCT00846079|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6541442|NCT00846079|Purinergic Agonists|purinergic agonists|mesh-ancestor
6541443|NCT00846079|Purinergic Agents|purinergic agents|mesh-ancestor
6541444|NCT00846079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6541445|NCT00846079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541446|NCT00846079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655533|NCT01464281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6655534|NCT01464450|Rivaroxaban|rivaroxaban|mesh-list
6655535|NCT01464450|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6655536|NCT01464450|Antithrombins|antithrombins|mesh-ancestor
6655537|NCT01464450|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6655538|NCT01464450|Protease Inhibitors|protease inhibitors|mesh-ancestor
6655539|NCT01464450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6655540|NCT01464450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655541|NCT01464450|Anticoagulants|anticoagulants|mesh-ancestor
6655542|NCT01464476|Azimilide|azimilide|mesh-list
6655543|NCT01464476|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6655544|NCT01464476|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6655545|NCT01464476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6655546|NCT01464476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655547|NCT01464476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6655548|NCT01464476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655549|NCT01464489|Atropine|atropine|mesh-list
6655550|NCT01464489|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6655551|NCT01464489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6655552|NCT01464489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6655553|NCT01464489|Autonomic Agents|autonomic agents|mesh-ancestor
6461231|NCT00453635|Docetaxel|docetaxel|mesh-list
6436379|NCT00350441|Sildenafil Citrate|sildenafil citrate|mesh-list
6436380|NCT00350441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436381|NCT00350441|Vasodilator Agents|vasodilator agents|mesh-ancestor
6436382|NCT00350441|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6436383|NCT00350441|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6436384|NCT00350441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6436385|NCT00350441|Urological Agents|urological agents|mesh-ancestor
6436386|NCT00350454|Sirolimus|sirolimus|mesh-list
6436387|NCT00350454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6436388|NCT00350454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6436389|NCT00350454|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5724720|NCT03185351|Midazolam|midazolam|mesh-list
5724721|NCT03185351|Bupivacaine|bupivacaine|mesh-list
5724722|NCT03185351|Anesthetics, Local|anesthetics, local|mesh-ancestor
5724723|NCT03185351|Anesthetics|anesthetics|mesh-ancestor
5724724|NCT03185351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6436390|NCT00350454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6436391|NCT00350454|Antifungal Agents|antifungal agents|mesh-ancestor
6436392|NCT00350454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6436393|NCT00350454|Immunologic Factors|immunologic factors|mesh-ancestor
6436394|NCT00350454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436395|NCT00350467|Olanzapine|olanzapine|mesh-list
6436396|NCT00350467|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6436397|NCT00350467|Antiemetics|antiemetics|mesh-ancestor
6436398|NCT00350467|Autonomic Agents|autonomic agents|mesh-ancestor
6436399|NCT00350467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6436400|NCT00350467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436401|NCT00350467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6436402|NCT00350467|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6436403|NCT00350467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6436404|NCT00350467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6436405|NCT00350467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6436406|NCT00350467|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6436407|NCT00350467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6436408|NCT00350467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6436409|NCT00350467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436410|NCT00350467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6436411|NCT00350467|Serotonin Agents|serotonin agents|mesh-ancestor
6436412|NCT00350467|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6436413|NCT00350467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6436414|NCT00350467|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6436415|NCT00350467|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6436416|NCT00350467|Dopamine Agents|dopamine agents|mesh-ancestor
6436417|NCT00350480|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6436418|NCT00350480|Contraceptives, Oral|contraceptives, oral|mesh-list
6436419|NCT00350480|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
6436420|NCT00350480|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6436421|NCT00350480|Contraceptive Agents|contraceptive agents|mesh-ancestor
6436422|NCT00350480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6436423|NCT00350480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436424|NCT00350480|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6436425|NCT00350480|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6436426|NCT00350480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6436427|NCT00350480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6436428|NCT00350597|Molgramostim|molgramostim|mesh-list
6436429|NCT00350597|Sargramostim|sargramostim|mesh-list
6436430|NCT00350597|Immunologic Factors|immunologic factors|mesh-ancestor
6436431|NCT00350597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436432|NCT00350597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6436433|NCT00350662|Deferiprone|deferiprone|mesh-list
6436434|NCT00350662|Deferoxamine|deferoxamine|mesh-list
6436435|NCT00350662|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6436436|NCT00350662|Chelating Agents|chelating agents|mesh-ancestor
6436437|NCT00350662|Sequestering Agents|sequestering agents|mesh-ancestor
6436438|NCT00350662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436439|NCT00350662|Siderophores|siderophores|mesh-ancestor
6541447|NCT00846118|Pitavastatin|pitavastatin|mesh-list
6541448|NCT00846118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6541449|NCT00846118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6541450|NCT00846118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6541451|NCT00846118|Antimetabolites|antimetabolites|mesh-ancestor
6541452|NCT00846118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541453|NCT00846118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6541454|NCT00846118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6541455|NCT00846131|Sorafenib|sorafenib|mesh-list
6541456|NCT00846131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6541457|NCT00846131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6541458|NCT00846131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6541459|NCT00846131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541460|NCT00846144|Copper|copper|mesh-list
6541461|NCT00846144|Copper Sulfate|copper sulfate|mesh-list
6541462|NCT00846144|Trace Elements|trace elements|mesh-ancestor
6541463|NCT00846144|Micronutrients|micronutrients|mesh-ancestor
6541464|NCT00846144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541465|NCT00846144|Antidotes|antidotes|mesh-ancestor
6541466|NCT00846144|Protective Agents|protective agents|mesh-ancestor
6541467|NCT00846144|Emetics|emetics|mesh-ancestor
6541468|NCT00846144|Autonomic Agents|autonomic agents|mesh-ancestor
6541469|NCT00846144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6541470|NCT00846144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6541471|NCT00846196|Risedronic Acid|risedronic acid|mesh-list
6541472|NCT00846196|Etidronic Acid|etidronic acid|mesh-list
6541473|NCT00846196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6541474|NCT00846196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6541475|NCT00846196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541476|NCT00846196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6541477|NCT00846196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541478|NCT00846196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6541479|NCT00846235|Glycerol|glycerol|mesh-list
6541480|NCT00846235|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6541481|NCT00846235|Protective Agents|protective agents|mesh-ancestor
6541482|NCT00846235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541483|NCT00846248|Chromium|chromium|mesh-list
6541484|NCT00846248|Trace Elements|trace elements|mesh-ancestor
6541485|NCT00846248|Micronutrients|micronutrients|mesh-ancestor
6541486|NCT00846248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541487|NCT00846274|Antithrombins|antithrombins|mesh-list
6541488|NCT00846274|Antithrombin III|antithrombin iii|mesh-list
6541489|NCT00846274|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6541490|NCT00846274|Protease Inhibitors|protease inhibitors|mesh-ancestor
6541491|NCT00846274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6541492|NCT00846274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541493|NCT00846274|Anticoagulants|anticoagulants|mesh-ancestor
6541494|NCT00846326|Fluticasone|fluticasone|mesh-list
6541495|NCT00846326|Xhance|xhance|mesh-list
6541496|NCT00846326|Phenylephrine|phenylephrine|mesh-list
6541497|NCT00846326|Oxymetazoline|oxymetazoline|mesh-list
6541498|NCT00846326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6541499|NCT00846326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6541500|NCT00846326|Autonomic Agents|autonomic agents|mesh-ancestor
6541501|NCT00846326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6436440|NCT00350753|Bevacizumab|bevacizumab|mesh-list
6436441|NCT00350753|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6541502|NCT00846326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541503|NCT00846326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6436442|NCT00350753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6436443|NCT00350753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6436444|NCT00350753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6436445|NCT00350753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6436446|NCT00350753|Growth Substances|growth substances|mesh-ancestor
6436447|NCT00350753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436448|NCT00350753|Growth Inhibitors|growth inhibitors|mesh-ancestor
6436449|NCT00350753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6436450|NCT00350753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6436451|NCT00350753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436452|NCT00350818|Azacitidine|azacitidine|mesh-list
6436453|NCT00350818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6436454|NCT00350818|Antimetabolites|antimetabolites|mesh-ancestor
6436455|NCT00350818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436456|NCT00350818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6436457|NCT00350818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6436458|NCT00350857|Carbamazepine|carbamazepine|mesh-list
6436459|NCT00350857|Anticonvulsants|anticonvulsants|mesh-ancestor
6436460|NCT00350857|Antimanic Agents|antimanic agents|mesh-ancestor
6436461|NCT00350857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6436462|NCT00350857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6436463|NCT00350857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436464|NCT00350857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6436465|NCT00350857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6436466|NCT00350857|Analgesics|analgesics|mesh-ancestor
6436467|NCT00350857|Sensory System Agents|sensory system agents|mesh-ancestor
6436468|NCT00350857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6436469|NCT00350857|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6436470|NCT00350857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6436471|NCT00350857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436472|NCT00350857|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6436473|NCT00350857|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6436474|NCT00350948|Doxorubicin|doxorubicin|mesh-list
6436475|NCT00350948|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6436476|NCT00350948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6436477|NCT00350948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6436478|NCT00350948|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6436479|NCT00350948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6436480|NCT00350948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6436481|NCT00350948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436482|NCT00350961|Gemcitabine|gemcitabine|mesh-list
6436483|NCT00350961|Capecitabine|capecitabine|mesh-list
6436484|NCT00350961|Oxaliplatin|oxaliplatin|mesh-list
6436485|NCT00350961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6436486|NCT00350961|Antimetabolites|antimetabolites|mesh-ancestor
6436487|NCT00350961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436488|NCT00350961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6436489|NCT00350961|Antiviral Agents|antiviral agents|mesh-ancestor
6436490|NCT00350961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6436491|NCT00350961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6436492|NCT00350961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6436493|NCT00350961|Immunologic Factors|immunologic factors|mesh-ancestor
6436494|NCT00350961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436495|NCT00351026|Methadone|methadone|mesh-list
6436496|NCT00351026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6436497|NCT00351026|Narcotics|narcotics|mesh-ancestor
6436498|NCT00351026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6436499|NCT00351026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436500|NCT00351026|Analgesics|analgesics|mesh-ancestor
6436501|NCT00351026|Sensory System Agents|sensory system agents|mesh-ancestor
6436502|NCT00351026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6436503|NCT00351026|Antitussive Agents|antitussive agents|mesh-ancestor
6436504|NCT00351026|Respiratory System Agents|respiratory system agents|mesh-ancestor
6436505|NCT00351052|Pimecrolimus|pimecrolimus|mesh-list
6436506|NCT00351052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6436507|NCT00351052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6436508|NCT00351052|Analgesics|analgesics|mesh-ancestor
6436509|NCT00351052|Sensory System Agents|sensory system agents|mesh-ancestor
6436510|NCT00351052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6436511|NCT00351052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436512|NCT00351052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6436513|NCT00351052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6436514|NCT00351052|Dermatologic Agents|dermatologic agents|mesh-ancestor
6436515|NCT00351052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6436516|NCT00351052|Immunologic Factors|immunologic factors|mesh-ancestor
6436517|NCT00351052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6436518|NCT00351052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6436519|NCT00351052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436520|NCT00351091|Risedronic Acid|risedronic acid|mesh-list
6436521|NCT00351091|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6436522|NCT00351091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6436523|NCT00351091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436524|NCT00351091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6436525|NCT00351091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436526|NCT00351091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6436527|NCT00351104|Ketoprofen|ketoprofen|mesh-list
6436528|NCT00351104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6436529|NCT00351104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6436530|NCT00351104|Analgesics|analgesics|mesh-ancestor
6541504|NCT00846326|Respiratory System Agents|respiratory system agents|mesh-ancestor
6541505|NCT00846326|Dermatologic Agents|dermatologic agents|mesh-ancestor
6541506|NCT00846326|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6541507|NCT00846326|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6541508|NCT00846326|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6541509|NCT00846326|Adrenergic Agents|adrenergic agents|mesh-ancestor
6541510|NCT00846326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6541511|NCT00846326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541512|NCT00846326|Sympathomimetics|sympathomimetics|mesh-ancestor
6541513|NCT00846326|Nasal Decongestants|nasal decongestants|mesh-ancestor
6541514|NCT00846326|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6541515|NCT00846326|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6541516|NCT00846326|Mydriatics|mydriatics|mesh-ancestor
6541517|NCT00846326|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6541518|NCT00846326|Protective Agents|protective agents|mesh-ancestor
6541519|NCT00846339|Bupropion|bupropion|mesh-list
6541520|NCT00846339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6541521|NCT00846339|Antidepressive Agents|antidepressive agents|mesh-ancestor
6541522|NCT00846339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6541523|NCT00846339|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6541524|NCT00846339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6541525|NCT00846339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6541526|NCT00846339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541527|NCT00846339|Dopamine Agents|dopamine agents|mesh-ancestor
6541528|NCT00846339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6541529|NCT00846339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541530|NCT00846339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6541531|NCT00846339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6541532|NCT00846339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6541533|NCT00846430|Interferons|interferons|mesh-list
6541534|NCT00846430|Interferon-alpha|interferon-alpha|mesh-list
6541535|NCT00846430|Interferon alpha-2|interferon alpha-2|mesh-list
6541536|NCT00846430|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6541537|NCT00846430|Celecoxib|celecoxib|mesh-list
6541538|NCT00846430|Vincristine|vincristine|mesh-list
6541539|NCT00846430|Temozolomide|temozolomide|mesh-list
6436531|NCT00351104|Sensory System Agents|sensory system agents|mesh-ancestor
6436532|NCT00351104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6436533|NCT00351104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436534|NCT00351104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6436535|NCT00351104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6436536|NCT00351104|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6436537|NCT00351104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6436538|NCT00351104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436539|NCT00351130|Amlodipine|amlodipine|mesh-list
6436540|NCT00351130|Valsartan|valsartan|mesh-list
6436541|NCT00351130|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6436542|NCT00351130|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6436543|NCT00351130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6436544|NCT00351130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436545|NCT00351130|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6436546|NCT00351130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436547|NCT00351130|Vasodilator Agents|vasodilator agents|mesh-ancestor
6436548|NCT00351130|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6436549|NCT00351130|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6436550|NCT00351143|Fluticasone|fluticasone|mesh-list
6436551|NCT00351143|Xhance|xhance|mesh-list
6436552|NCT00351143|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6436553|NCT00351143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6436554|NCT00351143|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6436555|NCT00351143|Autonomic Agents|autonomic agents|mesh-ancestor
6436556|NCT00351143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6436557|NCT00351143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436558|NCT00351143|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6436559|NCT00351143|Respiratory System Agents|respiratory system agents|mesh-ancestor
6436560|NCT00351143|Dermatologic Agents|dermatologic agents|mesh-ancestor
6436561|NCT00351143|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6436562|NCT00351143|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6436563|NCT00351143|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6436564|NCT00351143|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6436565|NCT00351143|Adrenergic Agents|adrenergic agents|mesh-ancestor
6436566|NCT00351143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6436567|NCT00351143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436568|NCT00351169|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6436569|NCT00351169|Citalopram|citalopram|mesh-list
6436570|NCT00351169|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6436571|NCT00351169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6436572|NCT00351169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6436573|NCT00351169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436574|NCT00351169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6436575|NCT00351169|Serotonin Agents|serotonin agents|mesh-ancestor
6436576|NCT00351169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436577|NCT00351169|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6436578|NCT00351169|Antidepressive Agents|antidepressive agents|mesh-ancestor
6436579|NCT00351169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6436580|NCT00351169|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6436581|NCT00351169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6436582|NCT00351169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6541540|NCT00846430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6541541|NCT00846430|Antiviral Agents|antiviral agents|mesh-ancestor
6541542|NCT00846430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6541543|NCT00846430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6541544|NCT00846430|Tubulin Modulators|tubulin modulators|mesh-ancestor
6541545|NCT00846430|Antimitotic Agents|antimitotic agents|mesh-ancestor
6541546|NCT00846430|Mitosis Modulators|mitosis modulators|mesh-ancestor
6541547|NCT00846430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541548|NCT00846430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6541549|NCT00846430|Alkylating Agents|alkylating agents|mesh-ancestor
6541550|NCT00846430|Immunologic Factors|immunologic factors|mesh-ancestor
6541551|NCT00846430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541552|NCT00846430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6541553|NCT00846430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6541554|NCT00846430|Analgesics|analgesics|mesh-ancestor
6541555|NCT00846430|Sensory System Agents|sensory system agents|mesh-ancestor
6541556|NCT00846430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6541557|NCT00846430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6541558|NCT00846430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6436583|NCT00351182|Doxycycline|doxycycline|mesh-list
6436584|NCT00351182|Telithromycin|telithromycin|mesh-list
6436585|NCT00351182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6436586|NCT00351182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6436587|NCT00351182|Antimalarials|antimalarials|mesh-ancestor
6436588|NCT00351182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6436589|NCT00351182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6436590|NCT00351195|Capecitabine|capecitabine|mesh-list
6436591|NCT00351195|Oxaliplatin|oxaliplatin|mesh-list
6436592|NCT00351195|Etoposide|etoposide|mesh-list
6436593|NCT00351195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6436594|NCT00351195|Antimetabolites|antimetabolites|mesh-ancestor
6436595|NCT00351195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436596|NCT00351195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6436597|NCT00351195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6436598|NCT00351195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6436599|NCT00351195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6436600|NCT00351195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6436601|NCT00351221|Mecasermin|mecasermin|mesh-list
6436602|NCT00351221|Growth Substances|growth substances|mesh-ancestor
6436603|NCT00351221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436604|NCT00351286|Simvastatin|simvastatin|mesh-list
6436605|NCT00351286|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6436606|NCT00351286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6436607|NCT00351286|Antimetabolites|antimetabolites|mesh-ancestor
6436608|NCT00351286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436609|NCT00351286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6436610|NCT00351286|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6436611|NCT00351286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6436612|NCT00351364|Montelukast|montelukast|mesh-list
6436613|NCT00351364|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6436614|NCT00351364|Respiratory System Agents|respiratory system agents|mesh-ancestor
6436615|NCT00351364|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6436616|NCT00351364|Hormone Antagonists|hormone antagonists|mesh-ancestor
6436617|NCT00351364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6436618|NCT00351364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436619|NCT00351364|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6436620|NCT00351364|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6436621|NCT00351364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436622|NCT00351403|Ribavirin|ribavirin|mesh-list
6436623|NCT00351403|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6436624|NCT00351403|Antimetabolites|antimetabolites|mesh-ancestor
6436625|NCT00351403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436626|NCT00351403|Antiviral Agents|antiviral agents|mesh-ancestor
6436627|NCT00351403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6436628|NCT00351507|Vildagliptin|vildagliptin|mesh-list
6436629|NCT00351507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6436630|NCT00351507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436631|NCT00351507|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6436632|NCT00351507|Protease Inhibitors|protease inhibitors|mesh-ancestor
6436633|NCT00351507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6436634|NCT00351507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436635|NCT00351546|Vildagliptin|vildagliptin|mesh-list
6436636|NCT00351546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6436637|NCT00351546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436638|NCT00351546|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6436639|NCT00351546|Protease Inhibitors|protease inhibitors|mesh-ancestor
6436640|NCT00351546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6436641|NCT00351546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436642|NCT00351585|Vildagliptin|vildagliptin|mesh-list
6436643|NCT00351585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6436644|NCT00351585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436645|NCT00351585|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6436646|NCT00351585|Protease Inhibitors|protease inhibitors|mesh-ancestor
6436647|NCT00351585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6461232|NCT00453635|Trastuzumab|trastuzumab|mesh-list
6541559|NCT00846430|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6541560|NCT00846430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6541561|NCT00846430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6436648|NCT00351585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436649|NCT00351637|Methadone|methadone|mesh-list
6436650|NCT00351637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6436651|NCT00351637|Narcotics|narcotics|mesh-ancestor
6436652|NCT00351637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6436653|NCT00351637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436654|NCT00351637|Analgesics|analgesics|mesh-ancestor
6436655|NCT00351637|Sensory System Agents|sensory system agents|mesh-ancestor
6436656|NCT00351637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6436657|NCT00351637|Antitussive Agents|antitussive agents|mesh-ancestor
6436658|NCT00351637|Respiratory System Agents|respiratory system agents|mesh-ancestor
6436659|NCT00351663|Enoxaparin|enoxaparin|mesh-list
6436660|NCT00351663|Anticoagulants|anticoagulants|mesh-ancestor
6436661|NCT00351663|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6436662|NCT00351663|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6436663|NCT00351663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436664|NCT00351702|Isoniazid|isoniazid|mesh-list
6436665|NCT00351702|Ethambutol|ethambutol|mesh-list
6436666|NCT00351702|Antitubercular Agents|antitubercular agents|mesh-ancestor
6436667|NCT00351702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6436668|NCT00351702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6436669|NCT00351702|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6436670|NCT00351702|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6436671|NCT00351702|Antimetabolites|antimetabolites|mesh-ancestor
6436672|NCT00351702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436673|NCT00351702|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6436674|NCT00351715|Methadone|methadone|mesh-list
6436675|NCT00351715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6436676|NCT00351715|Narcotics|narcotics|mesh-ancestor
6436677|NCT00351715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6436678|NCT00351715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436679|NCT00351715|Analgesics|analgesics|mesh-ancestor
6436680|NCT00351715|Sensory System Agents|sensory system agents|mesh-ancestor
6436681|NCT00351715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6436682|NCT00351715|Antitussive Agents|antitussive agents|mesh-ancestor
6436683|NCT00351715|Respiratory System Agents|respiratory system agents|mesh-ancestor
6436684|NCT00351832|Vildagliptin|vildagliptin|mesh-list
6436685|NCT00351832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6436686|NCT00351832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541562|NCT00846443|Cisplatin|cisplatin|mesh-list
6541563|NCT00846443|Pemetrexed|pemetrexed|mesh-list
6541564|NCT00846443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6541565|NCT00846443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6541566|NCT00846443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541567|NCT00846443|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6541568|NCT00846443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6541569|NCT00846508|Cisplatin|cisplatin|mesh-list
6541570|NCT00846508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6541571|NCT00846612|Bevacizumab|bevacizumab|mesh-list
6541572|NCT00846612|Doxorubicin|doxorubicin|mesh-list
6541573|NCT00846612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6541574|NCT00846612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6541575|NCT00846612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6541576|NCT00846612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6541577|NCT00846612|Growth Substances|growth substances|mesh-ancestor
6541578|NCT00846612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541579|NCT00846612|Growth Inhibitors|growth inhibitors|mesh-ancestor
6541580|NCT00846612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6541581|NCT00846612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6541582|NCT00846612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6541583|NCT00846612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6541584|NCT00846612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541585|NCT00846625|Triamcinolone|triamcinolone|mesh-list
6541586|NCT00846625|Ranibizumab|ranibizumab|mesh-list
6541587|NCT00846625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6541588|NCT00846625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6541589|NCT00846625|Growth Substances|growth substances|mesh-ancestor
6541590|NCT00846625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541591|NCT00846625|Growth Inhibitors|growth inhibitors|mesh-ancestor
6541592|NCT00846625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6541593|NCT00846625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6541594|NCT00846625|Glucocorticoids|glucocorticoids|mesh-ancestor
6436687|NCT00351832|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6436688|NCT00351832|Protease Inhibitors|protease inhibitors|mesh-ancestor
6436689|NCT00351832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6461233|NCT00453635|Vinorelbine|vinorelbine|mesh-list
6436690|NCT00351832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436691|NCT00351871|Ribavirin|ribavirin|mesh-list
6436692|NCT00351871|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6436693|NCT00351871|Antimetabolites|antimetabolites|mesh-ancestor
6436694|NCT00351871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436695|NCT00351871|Antiviral Agents|antiviral agents|mesh-ancestor
6436696|NCT00351871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6436697|NCT00351884|Vildagliptin|vildagliptin|mesh-list
6436698|NCT00351884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6436699|NCT00351884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436700|NCT00351884|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6436701|NCT00351884|Protease Inhibitors|protease inhibitors|mesh-ancestor
6436702|NCT00351884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6436703|NCT00351884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436704|NCT00351910|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6436705|NCT00351910|Amitriptyline|amitriptyline|mesh-list
6436706|NCT00351910|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6436707|NCT00351910|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6436708|NCT00351910|Citalopram|citalopram|mesh-list
6436709|NCT00351910|Bupropion|bupropion|mesh-list
6436710|NCT00351910|Fluoxetine|fluoxetine|mesh-list
6436711|NCT00351910|Paroxetine|paroxetine|mesh-list
6436712|NCT00351910|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6436713|NCT00351910|Sertraline|sertraline|mesh-list
6436714|NCT00351910|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6436715|NCT00351910|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6436716|NCT00351910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6436717|NCT00351910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436718|NCT00351910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6436719|NCT00351910|Serotonin Agents|serotonin agents|mesh-ancestor
6436720|NCT00351910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436721|NCT00351910|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6436722|NCT00351910|Antidepressive Agents|antidepressive agents|mesh-ancestor
6436723|NCT00351910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6436724|NCT00351910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6436725|NCT00351910|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6436726|NCT00351910|Dopamine Agents|dopamine agents|mesh-ancestor
6436727|NCT00351910|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6436728|NCT00351910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6436729|NCT00351910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6436730|NCT00351910|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6436731|NCT00351910|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6436732|NCT00351910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6436733|NCT00351910|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6436734|NCT00351910|Analgesics|analgesics|mesh-ancestor
6436735|NCT00351910|Sensory System Agents|sensory system agents|mesh-ancestor
6436736|NCT00351910|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6436737|NCT00351910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6436738|NCT00351910|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6436739|NCT00351910|Adrenergic Agents|adrenergic agents|mesh-ancestor
6436740|NCT00351975|Azacitidine|azacitidine|mesh-list
6436741|NCT00351975|Belinostat|belinostat|mesh-list
6436742|NCT00351975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6436743|NCT00351975|Antimetabolites|antimetabolites|mesh-ancestor
6436744|NCT00351975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436745|NCT00351975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6436746|NCT00351975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6436747|NCT00351975|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6436748|NCT00352079|Gefitinib|gefitinib|mesh-list
6436749|NCT00352079|BCG Vaccine|bcg vaccine|mesh-list
6436750|NCT00352079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6436751|NCT00352079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6436752|NCT00352079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6436753|NCT00352079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436754|NCT00352079|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6436755|NCT00352079|Immunologic Factors|immunologic factors|mesh-ancestor
6436756|NCT00352079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436757|NCT00352092|Mycophenolic Acid|mycophenolic acid|mesh-list
6436758|NCT00352092|Sirolimus|sirolimus|mesh-list
6436759|NCT00352092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
6436760|NCT00352092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6436761|NCT00352092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6436762|NCT00352092|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6436763|NCT00352092|Antitubercular Agents|antitubercular agents|mesh-ancestor
6436764|NCT00352092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6436765|NCT00352092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6436766|NCT00352092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6436767|NCT00352092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436768|NCT00352092|Antifungal Agents|antifungal agents|mesh-ancestor
6436769|NCT00352092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6436770|NCT00352092|Immunologic Factors|immunologic factors|mesh-ancestor
6436771|NCT00352092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436772|NCT00352144|Eszopiclone|eszopiclone|mesh-list
6436773|NCT00352144|Zopiclone|zopiclone|mesh-list
6436774|NCT00352144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6436775|NCT00352144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6436776|NCT00352144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436777|NCT00352170|Calcium, Dietary|calcium, dietary|mesh-list
6541595|NCT00846625|Hormones|hormones|mesh-ancestor
6541596|NCT00846625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6541597|NCT00846677|Vitamin D|vitamin d|mesh-list
6541598|NCT00846677|Ergocalciferols|ergocalciferols|mesh-list
6541599|NCT00846677|Cholecalciferol|cholecalciferol|mesh-list
6541600|NCT00846677|Vitamins|vitamins|mesh-list
6541601|NCT00846677|Micronutrients|micronutrients|mesh-ancestor
6541602|NCT00846677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541603|NCT00846677|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6541604|NCT00846677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6541605|NCT00846690|Lidocaine|lidocaine|mesh-list
6541606|NCT00846690|Phenylephrine|phenylephrine|mesh-list
6541607|NCT00846690|Benzocaine|benzocaine|mesh-list
6541608|NCT00846690|Tetracaine|tetracaine|mesh-list
6541609|NCT00846690|Anesthetics, Local|anesthetics, local|mesh-ancestor
6541610|NCT00846690|Anesthetics|anesthetics|mesh-ancestor
6541611|NCT00846690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6541612|NCT00846690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541613|NCT00846690|Sensory System Agents|sensory system agents|mesh-ancestor
6541614|NCT00846690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6541615|NCT00846690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6541616|NCT00846690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6541617|NCT00846690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6541618|NCT00846690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6541619|NCT00846690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541620|NCT00846690|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6541621|NCT00846690|Mydriatics|mydriatics|mesh-ancestor
6541622|NCT00846690|Autonomic Agents|autonomic agents|mesh-ancestor
6541623|NCT00846690|Sympathomimetics|sympathomimetics|mesh-ancestor
6541624|NCT00846690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6541625|NCT00846690|Nasal Decongestants|nasal decongestants|mesh-ancestor
6541626|NCT00846690|Respiratory System Agents|respiratory system agents|mesh-ancestor
6541627|NCT00846690|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6541628|NCT00846690|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6541629|NCT00846690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6541630|NCT00846690|Adrenergic Agents|adrenergic agents|mesh-ancestor
6541631|NCT00846690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6541632|NCT00846690|Protective Agents|protective agents|mesh-ancestor
6541633|NCT00846703|Dexamethasone|dexamethasone|mesh-list
6541634|NCT00846703|Methotrexate|methotrexate|mesh-list
6541635|NCT00846703|Vincristine|vincristine|mesh-list
6436778|NCT00352170|Vitamin D|vitamin d|mesh-list
6436779|NCT00352170|Cholecalciferol|cholecalciferol|mesh-list
6436780|NCT00352170|Calcium|calcium|mesh-list
6541636|NCT00846703|Mercaptopurine|mercaptopurine|mesh-list
6436781|NCT00352170|Vitamins|vitamins|mesh-ancestor
6436782|NCT00352170|Micronutrients|micronutrients|mesh-ancestor
6436783|NCT00352170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436784|NCT00352170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6436785|NCT00352170|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6461234|NCT00453635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6461235|NCT00453635|Tubulin Modulators|tubulin modulators|mesh-ancestor
6461236|NCT00453635|Antimitotic Agents|antimitotic agents|mesh-ancestor
6461237|NCT00453635|Mitosis Modulators|mitosis modulators|mesh-ancestor
6461238|NCT00453635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461239|NCT00453635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6461240|NCT00453635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6461241|NCT00453648|Vitamin A|vitamin a|mesh-list
6461242|NCT00453648|Retinol palmitate|retinol palmitate|mesh-list
6461243|NCT00453648|Antioxidants|antioxidants|mesh-ancestor
6461244|NCT00453648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461245|NCT00453648|Protective Agents|protective agents|mesh-ancestor
6461246|NCT00453648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461247|NCT00453648|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6461248|NCT00453648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6461249|NCT00453648|Vitamins|vitamins|mesh-ancestor
6461250|NCT00453648|Micronutrients|micronutrients|mesh-ancestor
6461251|NCT00453765|Montelukast|montelukast|mesh-list
6461252|NCT00453765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6461253|NCT00453765|Respiratory System Agents|respiratory system agents|mesh-ancestor
6461254|NCT00453765|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6461255|NCT00453765|Hormone Antagonists|hormone antagonists|mesh-ancestor
6461256|NCT00453765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6461257|NCT00453765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461258|NCT00453765|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6461259|NCT00453765|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6461260|NCT00453765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461261|NCT00453778|Fluticasone|fluticasone|mesh-list
6461262|NCT00453778|Xhance|xhance|mesh-list
6461263|NCT00453778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6461264|NCT00453778|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6461265|NCT00453778|Autonomic Agents|autonomic agents|mesh-ancestor
6461266|NCT00453778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6461267|NCT00453778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461268|NCT00453778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6461269|NCT00453778|Respiratory System Agents|respiratory system agents|mesh-ancestor
6461270|NCT00453778|Dermatologic Agents|dermatologic agents|mesh-ancestor
6461271|NCT00453778|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6461272|NCT00453804|Naltrexone|naltrexone|mesh-list
6461273|NCT00453804|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6461274|NCT00453804|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6461275|NCT00453804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461276|NCT00453804|Sensory System Agents|sensory system agents|mesh-ancestor
6461277|NCT00453804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6461278|NCT00453856|Pyrimethamine|pyrimethamine|mesh-list
6461279|NCT00453856|Sulfadoxine|sulfadoxine|mesh-list
6461280|NCT00453856|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6461281|NCT00453856|Antimalarials|antimalarials|mesh-ancestor
6461282|NCT00453856|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6461283|NCT00453856|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6461284|NCT00453856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6461285|NCT00453856|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6461286|NCT00453856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6436786|NCT00352183|Simvastatin|simvastatin|mesh-list
6436787|NCT00352183|Fenofibrate|fenofibrate|mesh-list
6436788|NCT00352183|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6436789|NCT00352183|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6436790|NCT00352183|Antimetabolites|antimetabolites|mesh-ancestor
6436791|NCT00352183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436792|NCT00352183|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6436793|NCT00352183|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6436794|NCT00352183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6436795|NCT00352196|Risperidone|risperidone|mesh-list
6436796|NCT00352196|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6436797|NCT00352196|Serotonin Agents|serotonin agents|mesh-ancestor
6436798|NCT00352196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6436799|NCT00352196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436800|NCT00352196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436801|NCT00352196|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6436802|NCT00352196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6436803|NCT00352196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6436804|NCT00352196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6436805|NCT00352196|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6436806|NCT00352196|Dopamine Agents|dopamine agents|mesh-ancestor
6436807|NCT00352235|KRN 7000|krn 7000|mesh-list
6436808|NCT00352235|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6436809|NCT00352235|Immunologic Factors|immunologic factors|mesh-ancestor
6436810|NCT00352235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436811|NCT00352235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6436812|NCT00352261|Esomeprazole|esomeprazole|mesh-list
6436813|NCT00352261|Lansoprazole|lansoprazole|mesh-list
6436814|NCT00352261|Dexlansoprazole|dexlansoprazole|mesh-list
6436815|NCT00352261|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6436816|NCT00352261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6436817|NCT00352261|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6436818|NCT00352261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6436819|NCT00352261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436820|NCT00352287|Pioglitazone|pioglitazone|mesh-list
6436821|NCT00352287|Hormones|hormones|mesh-list
6436822|NCT00352287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6436823|NCT00352287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436824|NCT00352287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6436825|NCT00352300|Paclitaxel|paclitaxel|mesh-list
6436826|NCT00352300|Carboplatin|carboplatin|mesh-list
6436827|NCT00352300|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6436828|NCT00352300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6436829|NCT00352300|Tubulin Modulators|tubulin modulators|mesh-ancestor
6436830|NCT00352300|Antimitotic Agents|antimitotic agents|mesh-ancestor
6436831|NCT00352300|Mitosis Modulators|mitosis modulators|mesh-ancestor
6436832|NCT00352300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436833|NCT00352313|Carboplatin|carboplatin|mesh-list
6436834|NCT00352313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6436835|NCT00352339|Aripiprazole|aripiprazole|mesh-list
6436836|NCT00352339|Antidepressive Agents|antidepressive agents|mesh-ancestor
6436837|NCT00352339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6436838|NCT00352339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6436839|NCT00352339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6436840|NCT00352339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6436841|NCT00352339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436842|NCT00352339|Dopamine Agonists|dopamine agonists|mesh-ancestor
6436843|NCT00352339|Dopamine Agents|dopamine agents|mesh-ancestor
6436844|NCT00352339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6541637|NCT00846703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6541638|NCT00846703|Antiemetics|antiemetics|mesh-ancestor
6541639|NCT00846703|Autonomic Agents|autonomic agents|mesh-ancestor
6541640|NCT00846703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6541641|NCT00846703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541642|NCT00846703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6541643|NCT00846703|Glucocorticoids|glucocorticoids|mesh-ancestor
6541644|NCT00846703|Hormones|hormones|mesh-ancestor
6541645|NCT00846703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6541646|NCT00846703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6541647|NCT00846703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6541648|NCT00846703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6541649|NCT00846703|Abortifacient Agents|abortifacient agents|mesh-ancestor
6541650|NCT00846703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6541651|NCT00846703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6541652|NCT00846703|Antimetabolites|antimetabolites|mesh-ancestor
6541653|NCT00846703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541654|NCT00846703|Dermatologic Agents|dermatologic agents|mesh-ancestor
6541655|NCT00846703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6541656|NCT00846703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6541657|NCT00846703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6541658|NCT00846703|Immunologic Factors|immunologic factors|mesh-ancestor
6541659|NCT00846703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6541660|NCT00846703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6541661|NCT00846703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6541662|NCT00846703|Tubulin Modulators|tubulin modulators|mesh-ancestor
6541663|NCT00846703|Antimitotic Agents|antimitotic agents|mesh-ancestor
6541664|NCT00846703|Mitosis Modulators|mitosis modulators|mesh-ancestor
6541665|NCT00846716|Pioglitazone|pioglitazone|mesh-list
6541666|NCT00846716|Biguanides|biguanides|mesh-list
6541667|NCT00846716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6541668|NCT00846716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541669|NCT00846755|Propylthiouracil|propylthiouracil|mesh-list
6541670|NCT00846755|Antimetabolites|antimetabolites|mesh-ancestor
6541671|NCT00846755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541672|NCT00846755|Antithyroid Agents|antithyroid agents|mesh-ancestor
6541673|NCT00846755|Hormone Antagonists|hormone antagonists|mesh-ancestor
6541674|NCT00846755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6541675|NCT00846755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541676|NCT00846859|Varenicline|varenicline|mesh-list
6541677|NCT00846859|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6541678|NCT00846859|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6541679|NCT00846859|Cholinergic Agents|cholinergic agents|mesh-ancestor
6541680|NCT00846859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6541681|NCT00846859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541682|NCT00846859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541683|NCT00846872|Mannitol|mannitol|mesh-list
6541684|NCT00846872|Hormones|hormones|mesh-list
6541685|NCT00846872|Secretagogues|secretagogues|mesh-list
6541686|NCT00846872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6541687|NCT00846872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541688|NCT00846872|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6541689|NCT00846872|Diuretics|diuretics|mesh-ancestor
6541690|NCT00846872|Natriuretic Agents|natriuretic agents|mesh-ancestor
6541691|NCT00846911|Moxifloxacin|moxifloxacin|mesh-list
6541692|NCT00846911|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6541693|NCT00846911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6541694|NCT00846911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6541695|NCT00846911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6541696|NCT00846911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6541697|NCT00846911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6541698|NCT00846911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541699|NCT00846911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6541700|NCT00846911|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6541701|NCT00846911|Contraceptive Agents|contraceptive agents|mesh-ancestor
6436845|NCT00352339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436846|NCT00352339|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6436847|NCT00352339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6436848|NCT00352339|Serotonin Agents|serotonin agents|mesh-ancestor
6436849|NCT00352339|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6436850|NCT00352339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6436851|NCT00352339|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6436852|NCT00352339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6436853|NCT00352378|Cyclophosphamide|cyclophosphamide|mesh-list
6436854|NCT00352378|Docetaxel|docetaxel|mesh-list
6436855|NCT00352378|Doxorubicin|doxorubicin|mesh-list
6436856|NCT00352378|Capecitabine|capecitabine|mesh-list
6436857|NCT00352378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6436858|NCT00352378|Immunologic Factors|immunologic factors|mesh-ancestor
6436859|NCT00352378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436860|NCT00352378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6436861|NCT00352378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6436862|NCT00352378|Alkylating Agents|alkylating agents|mesh-ancestor
6436863|NCT00352378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436864|NCT00352378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6436865|NCT00352378|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6436866|NCT00352378|Tubulin Modulators|tubulin modulators|mesh-ancestor
6436867|NCT00352378|Antimitotic Agents|antimitotic agents|mesh-ancestor
6436868|NCT00352378|Mitosis Modulators|mitosis modulators|mesh-ancestor
6436869|NCT00352378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6436870|NCT00352378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6436871|NCT00352378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6436872|NCT00352378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6436873|NCT00352378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6436874|NCT00352378|Antimetabolites|antimetabolites|mesh-ancestor
6436875|NCT00352430|Nitric Oxide|nitric oxide|mesh-list
6436876|NCT00352430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6436877|NCT00352430|Autonomic Agents|autonomic agents|mesh-ancestor
6436878|NCT00352430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6436879|NCT00352430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436880|NCT00352430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6436881|NCT00352430|Respiratory System Agents|respiratory system agents|mesh-ancestor
6436882|NCT00352430|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6436883|NCT00352430|Antioxidants|antioxidants|mesh-ancestor
6436884|NCT00352430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436885|NCT00352430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6436886|NCT00352430|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6436887|NCT00352430|Vasodilator Agents|vasodilator agents|mesh-ancestor
6436888|NCT00352430|Gasotransmitters|gasotransmitters|mesh-ancestor
6436889|NCT00352430|Protective Agents|protective agents|mesh-ancestor
6436890|NCT00352443|Everolimus|everolimus|mesh-list
6436891|NCT00352443|Lapatinib|lapatinib|mesh-list
6436892|NCT00352443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6436893|NCT00352443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6436894|NCT00352443|Immunologic Factors|immunologic factors|mesh-ancestor
6436895|NCT00352443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436896|NCT00352443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6436897|NCT00352443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6436898|NCT00352443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436899|NCT00352469|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6436900|NCT00352469|Antidepressive Agents|antidepressive agents|mesh-ancestor
6436901|NCT00352469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6436902|NCT00352469|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6436903|NCT00352469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6436904|NCT00352469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6436905|NCT00352469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436906|NCT00352482|Sildenafil Citrate|sildenafil citrate|mesh-list
6436907|NCT00352482|Vasodilator Agents|vasodilator agents|mesh-ancestor
6436908|NCT00352482|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6436909|NCT00352482|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6436910|NCT00352482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6436911|NCT00352482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436912|NCT00352482|Urological Agents|urological agents|mesh-ancestor
6436913|NCT00352495|Carboplatin|carboplatin|mesh-list
6436914|NCT00352495|Vinblastine|vinblastine|mesh-list
6436915|NCT00352495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6436916|NCT00352495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6436917|NCT00352495|Tubulin Modulators|tubulin modulators|mesh-ancestor
6436918|NCT00352495|Antimitotic Agents|antimitotic agents|mesh-ancestor
6436919|NCT00352495|Mitosis Modulators|mitosis modulators|mesh-ancestor
6436920|NCT00352495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436921|NCT00352521|Bevacizumab|bevacizumab|mesh-list
6436922|NCT00352521|Irinotecan|irinotecan|mesh-list
6436923|NCT00352521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6436924|NCT00352521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6436925|NCT00352521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6436926|NCT00352521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6436927|NCT00352521|Growth Substances|growth substances|mesh-ancestor
6436928|NCT00352521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436929|NCT00352521|Growth Inhibitors|growth inhibitors|mesh-ancestor
6436930|NCT00352521|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6436931|NCT00352521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6436932|NCT00352521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6436933|NCT00352521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436934|NCT00352599|Lovastatin|lovastatin|mesh-list
6436935|NCT00352599|L 647318|l 647318|mesh-list
6436936|NCT00352599|Dihydromevinolin|dihydromevinolin|mesh-list
6436937|NCT00352599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6436938|NCT00352599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6436939|NCT00352599|Antimetabolites|antimetabolites|mesh-ancestor
6436940|NCT00352599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436941|NCT00352599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6436942|NCT00352599|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6436943|NCT00352599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6436944|NCT00352625|Ketoprofen|ketoprofen|mesh-list
6436945|NCT00352625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6436946|NCT00352625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6436947|NCT00352625|Analgesics|analgesics|mesh-ancestor
6436948|NCT00352625|Sensory System Agents|sensory system agents|mesh-ancestor
6436949|NCT00352625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6436950|NCT00352625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436951|NCT00352625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6541702|NCT00846911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6541703|NCT00846911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541704|NCT00846911|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6541705|NCT00846911|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6541706|NCT00846911|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6541707|NCT00846950|Lorazepam|lorazepam|mesh-list
6541708|NCT00846950|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
6436952|NCT00352625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6436953|NCT00352625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6436954|NCT00352625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6436955|NCT00352625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436956|NCT00352651|Pregabalin|pregabalin|mesh-list
6436957|NCT00352651|Analgesics|analgesics|mesh-ancestor
6436958|NCT00352651|Sensory System Agents|sensory system agents|mesh-ancestor
6436959|NCT00352651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6436960|NCT00352651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436961|NCT00352651|Anticonvulsants|anticonvulsants|mesh-ancestor
6436962|NCT00352651|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6436963|NCT00352651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6436964|NCT00352651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436965|NCT00352651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6436966|NCT00352651|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6436967|NCT00352651|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6436968|NCT00352651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6436969|NCT00352651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6436970|NCT00352677|Bafetinib|bafetinib|mesh-list
6436971|NCT00352677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6436972|NCT00352677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6436973|NCT00352677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436974|NCT00352742|Bortezomib|bortezomib|mesh-list
6436975|NCT00352742|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
6436976|NCT00352742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6436977|NCT00352742|Chelating Agents|chelating agents|mesh-ancestor
6436978|NCT00352742|Sequestering Agents|sequestering agents|mesh-ancestor
6436979|NCT00352742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436980|NCT00352742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6436981|NCT00352742|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6436982|NCT00352742|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6436983|NCT00352742|Growth Substances|growth substances|mesh-ancestor
6436984|NCT00352742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436985|NCT00352742|Growth Inhibitors|growth inhibitors|mesh-ancestor
6436986|NCT00352768|Fluvoxamine|fluvoxamine|mesh-list
6436987|NCT00352768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6436988|NCT00352768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6436989|NCT00352768|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6436990|NCT00352768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6436991|NCT00352768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6436992|NCT00352768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6436993|NCT00352768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6436994|NCT00352768|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6436995|NCT00352768|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6436996|NCT00352768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6436997|NCT00352768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6436998|NCT00352768|Serotonin Agents|serotonin agents|mesh-ancestor
6436999|NCT00352768|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6437000|NCT00352768|Antidepressive Agents|antidepressive agents|mesh-ancestor
6437001|NCT00352768|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6462188|NCT00458055|Atorvastatin|atorvastatin|mesh-list
6437002|NCT00352768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6437003|NCT00352768|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6437004|NCT00352807|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6437005|NCT00352807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6437006|NCT00352807|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6437007|NCT00352807|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6437008|NCT00352807|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6437009|NCT00352807|Adrenergic Agents|adrenergic agents|mesh-ancestor
6437010|NCT00352807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6437011|NCT00352807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437012|NCT00352807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437013|NCT00352833|Catumaxomab|catumaxomab|mesh-list
6437014|NCT00352833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6437015|NCT00352859|Gemcitabine|gemcitabine|mesh-list
6437016|NCT00352859|Interferons|interferons|mesh-list
6437017|NCT00352859|Sorafenib|sorafenib|mesh-list
6437018|NCT00352859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6437019|NCT00352859|Antimetabolites|antimetabolites|mesh-ancestor
6437020|NCT00352859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437021|NCT00352859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6437022|NCT00352859|Antiviral Agents|antiviral agents|mesh-ancestor
6437023|NCT00352859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6437024|NCT00352859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6437025|NCT00352859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6437026|NCT00352859|Immunologic Factors|immunologic factors|mesh-ancestor
6437027|NCT00352859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437028|NCT00352859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6437029|NCT00352950|Panitumumab|panitumumab|mesh-list
6437030|NCT00352950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6437031|NCT00352950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6437032|NCT00353002|Lidocaine|lidocaine|mesh-list
6437033|NCT00353002|Tetracaine|tetracaine|mesh-list
6437034|NCT00353002|Anesthetics, Local|anesthetics, local|mesh-ancestor
6437035|NCT00353002|Anesthetics|anesthetics|mesh-ancestor
6437036|NCT00353002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6437037|NCT00353002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437038|NCT00353002|Sensory System Agents|sensory system agents|mesh-ancestor
6437039|NCT00353002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6437040|NCT00353002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6437041|NCT00353002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6437042|NCT00353002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6437043|NCT00353002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6437044|NCT00353002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437045|NCT00353015|Cisplatin|cisplatin|mesh-list
6437046|NCT00353015|Irinotecan|irinotecan|mesh-list
6437047|NCT00353015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6437048|NCT00353015|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6437049|NCT00353015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6541709|NCT00846950|Anticonvulsants|anticonvulsants|mesh-ancestor
6541710|NCT00846950|Antiemetics|antiemetics|mesh-ancestor
6541711|NCT00846950|Autonomic Agents|autonomic agents|mesh-ancestor
6541712|NCT00846950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6541713|NCT00846950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541714|NCT00846950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6541715|NCT00846950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6541716|NCT00846950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6541717|NCT00846950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6541718|NCT00846950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6437050|NCT00353015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6541719|NCT00846950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6541720|NCT00846950|GABA Modulators|gaba modulators|mesh-ancestor
6541721|NCT00846950|GABA Agents|gaba agents|mesh-ancestor
6541722|NCT00846950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6437051|NCT00353015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437052|NCT00353028|Fluvoxamine|fluvoxamine|mesh-list
6437053|NCT00353028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6437054|NCT00353028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437055|NCT00353028|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6437056|NCT00353028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6437057|NCT00353028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6437058|NCT00353028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437059|NCT00353028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6437060|NCT00353028|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6437061|NCT00353028|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6437062|NCT00353028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6437063|NCT00353028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6437064|NCT00353028|Serotonin Agents|serotonin agents|mesh-ancestor
6437065|NCT00353028|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6437066|NCT00353028|Antidepressive Agents|antidepressive agents|mesh-ancestor
6437067|NCT00353028|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6437068|NCT00353028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6437069|NCT00353028|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6437070|NCT00353041|Lidocaine|lidocaine|mesh-list
6437071|NCT00353041|Anesthetics, Local|anesthetics, local|mesh-ancestor
6437072|NCT00353041|Anesthetics|anesthetics|mesh-ancestor
6437073|NCT00353041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6437074|NCT00353041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437075|NCT00353041|Sensory System Agents|sensory system agents|mesh-ancestor
6437076|NCT00353041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6437077|NCT00353041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6437078|NCT00353041|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6437079|NCT00353041|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6437080|NCT00353041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6437081|NCT00353041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437082|NCT00353054|Calcium Carbonate|calcium carbonate|mesh-list
6437083|NCT00353054|Antacids|antacids|mesh-ancestor
6437084|NCT00353054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437085|NCT00353054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6437086|NCT00353067|2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid|2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid|mesh-list
6437087|NCT00353067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6437088|NCT00353067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6437089|NCT00353067|Analgesics|analgesics|mesh-ancestor
6437090|NCT00353067|Sensory System Agents|sensory system agents|mesh-ancestor
6437091|NCT00353067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6437092|NCT00353067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437093|NCT00353067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6437094|NCT00353067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6437095|NCT00353067|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6437096|NCT00353067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6437097|NCT00353067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437098|NCT00353080|Risedronic Acid|risedronic acid|mesh-list
6437099|NCT00353080|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6437100|NCT00353080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6437101|NCT00353080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437102|NCT00353080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6437103|NCT00353080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437104|NCT00353080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6437105|NCT00353145|Gemcitabine|gemcitabine|mesh-list
6437106|NCT00353145|Oxaliplatin|oxaliplatin|mesh-list
6437107|NCT00353145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6437108|NCT00353145|Antimetabolites|antimetabolites|mesh-ancestor
6437109|NCT00353145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437110|NCT00353145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6437111|NCT00353145|Antiviral Agents|antiviral agents|mesh-ancestor
6437112|NCT00353145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6437113|NCT00353145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6437114|NCT00353145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6437115|NCT00353145|Immunologic Factors|immunologic factors|mesh-ancestor
6437116|NCT00353145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437117|NCT00353184|Montelukast|montelukast|mesh-list
6437118|NCT00353184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6437119|NCT00353184|Respiratory System Agents|respiratory system agents|mesh-ancestor
6437120|NCT00353184|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6437121|NCT00353184|Hormone Antagonists|hormone antagonists|mesh-ancestor
6437122|NCT00353184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6437123|NCT00353184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437124|NCT00353184|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6437125|NCT00353184|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6437126|NCT00353184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437127|NCT00353340|Acetylcysteine|acetylcysteine|mesh-list
6437128|NCT00353340|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6437129|NCT00353340|Antiviral Agents|antiviral agents|mesh-ancestor
6437130|NCT00353340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6437131|NCT00353340|Expectorants|expectorants|mesh-ancestor
6437132|NCT00353340|Respiratory System Agents|respiratory system agents|mesh-ancestor
6437133|NCT00353340|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6437134|NCT00353340|Antioxidants|antioxidants|mesh-ancestor
6437135|NCT00353340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437136|NCT00353340|Protective Agents|protective agents|mesh-ancestor
6437137|NCT00353340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437138|NCT00353340|Antidotes|antidotes|mesh-ancestor
6437139|NCT00353379|Guanfacine|guanfacine|mesh-list
6437140|NCT00353379|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6437141|NCT00353379|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6437142|NCT00353379|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6437143|NCT00353379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6437144|NCT00353379|Adrenergic Agents|adrenergic agents|mesh-ancestor
6437145|NCT00353379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6437146|NCT00353379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437147|NCT00353379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437148|NCT00353561|Fluconazole|fluconazole|mesh-list
6437149|NCT00353561|Antifungal Agents|antifungal agents|mesh-ancestor
6437150|NCT00353561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6437151|NCT00353561|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6437152|NCT00353561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6437153|NCT00353561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6437154|NCT00353561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437155|NCT00353561|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6437156|NCT00353561|Hormone Antagonists|hormone antagonists|mesh-ancestor
6437157|NCT00353561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6437158|NCT00353561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437159|NCT00353561|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6437160|NCT00353561|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6437161|NCT00353665|Riluzole|riluzole|mesh-list
6437162|NCT00353665|Memantine|memantine|mesh-list
6437163|NCT00353665|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6541723|NCT00846950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541724|NCT00846950|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6541725|NCT00846950|Histamine Antagonists|histamine antagonists|mesh-ancestor
6541726|NCT00846950|Histamine Agents|histamine agents|mesh-ancestor
6541727|NCT00846963|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
6541728|NCT00846963|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6541729|NCT00846963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6541730|NCT00846976|Bicalutamide|bicalutamide|mesh-list
6541731|NCT00846976|Androgen Antagonists|androgen antagonists|mesh-ancestor
6541732|NCT00846976|Hormone Antagonists|hormone antagonists|mesh-ancestor
6541733|NCT00846976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6541734|NCT00846976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541735|NCT00846976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6541736|NCT00847054|Antibodies|antibodies|mesh-list
6541737|NCT00847054|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6541738|NCT00847054|Immunologic Factors|immunologic factors|mesh-ancestor
6437164|NCT00353665|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6437165|NCT00353665|Dopamine Agents|dopamine agents|mesh-ancestor
6437166|NCT00353665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6437167|NCT00353665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541739|NCT00847054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541740|NCT00847080|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6541741|NCT00847080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6541742|NCT00847080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541743|NCT00847080|Incretins|incretins|mesh-ancestor
6541744|NCT00847080|Hormones|hormones|mesh-ancestor
6541745|NCT00847080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6541746|NCT00847080|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6541747|NCT00847080|Protease Inhibitors|protease inhibitors|mesh-ancestor
6541748|NCT00847080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6541749|NCT00847080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541750|NCT00847093|Lidocaine|lidocaine|mesh-list
6541751|NCT00847093|Anesthetics, Local|anesthetics, local|mesh-ancestor
6541752|NCT00847093|Anesthetics|anesthetics|mesh-ancestor
6541753|NCT00847093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6541754|NCT00847093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541755|NCT00847093|Sensory System Agents|sensory system agents|mesh-ancestor
6541756|NCT00847093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6541757|NCT00847093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6541758|NCT00847093|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6541759|NCT00847093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6541760|NCT00847093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6541761|NCT00847093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541762|NCT00847106|Daclizumab|daclizumab|mesh-list
6541763|NCT00847106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6541764|NCT00847106|Immunologic Factors|immunologic factors|mesh-ancestor
6541765|NCT00847106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541766|NCT00847119|Bevacizumab|bevacizumab|mesh-list
6541767|NCT00847119|Capecitabine|capecitabine|mesh-list
6541768|NCT00847119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6541769|NCT00847119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6541770|NCT00847119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6541771|NCT00847119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6541772|NCT00847119|Growth Substances|growth substances|mesh-ancestor
6541773|NCT00847119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541774|NCT00847119|Growth Inhibitors|growth inhibitors|mesh-ancestor
6541775|NCT00847119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6541776|NCT00847119|Antimetabolites|antimetabolites|mesh-ancestor
6541777|NCT00847119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541778|NCT00847223|Tipifarnib|tipifarnib|mesh-list
6541779|NCT00847223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6541780|NCT00847262|Amlodipine|amlodipine|mesh-list
6541781|NCT00847262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6437168|NCT00353665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437169|NCT00353665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6437170|NCT00353665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6437171|NCT00353665|Anticonvulsants|anticonvulsants|mesh-ancestor
6437172|NCT00353665|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6437173|NCT00353665|Protective Agents|protective agents|mesh-ancestor
6437174|NCT00353678|Darexaban|darexaban|mesh-list
6437175|NCT00353678|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6437176|NCT00353678|Antithrombins|antithrombins|mesh-ancestor
6437177|NCT00353678|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6437178|NCT00353678|Protease Inhibitors|protease inhibitors|mesh-ancestor
6437179|NCT00353678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6437180|NCT00353678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437181|NCT00353678|Anticoagulants|anticoagulants|mesh-ancestor
6437182|NCT00353691|Metformin|metformin|mesh-list
6437183|NCT00353691|Glimepiride|glimepiride|mesh-list
6437184|NCT00353691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6437185|NCT00353691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437186|NCT00353691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6437187|NCT00353691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6437188|NCT00353691|Immunologic Factors|immunologic factors|mesh-ancestor
6437189|NCT00353717|Paclitaxel|paclitaxel|mesh-list
6437190|NCT00353717|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6437191|NCT00353717|Cetuximab|cetuximab|mesh-list
6437192|NCT00353717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6437193|NCT00353717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6437194|NCT00353717|Tubulin Modulators|tubulin modulators|mesh-ancestor
6437195|NCT00353717|Antimitotic Agents|antimitotic agents|mesh-ancestor
6437196|NCT00353717|Mitosis Modulators|mitosis modulators|mesh-ancestor
6437197|NCT00353717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437198|NCT00353717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6437199|NCT00353743|Metronidazole|metronidazole|mesh-list
6437200|NCT00353743|Doxycycline|doxycycline|mesh-list
6437201|NCT00353743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6437202|NCT00353743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6437203|NCT00353743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6437204|NCT00353743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6437205|NCT00353743|Antimalarials|antimalarials|mesh-ancestor
6437206|NCT00353808|Reboxetine|reboxetine|mesh-list
6437207|NCT00353808|Antidepressive Agents|antidepressive agents|mesh-ancestor
6437208|NCT00353808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6437209|NCT00353808|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6437210|NCT00353808|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6437211|NCT00353808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6437212|NCT00353808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437213|NCT00353808|Adrenergic Agents|adrenergic agents|mesh-ancestor
6437214|NCT00353808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6437215|NCT00353808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437216|NCT00353912|Amlodipine|amlodipine|mesh-list
6437217|NCT00353912|Valsartan|valsartan|mesh-list
6437218|NCT00353912|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6437219|NCT00353912|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6437220|NCT00353912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6437221|NCT00353912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437222|NCT00353912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6437223|NCT00353912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437224|NCT00353912|Vasodilator Agents|vasodilator agents|mesh-ancestor
6437225|NCT00353912|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6437226|NCT00353912|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6437227|NCT00353990|Insulin Aspart|insulin aspart|mesh-list
6437228|NCT00353990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6437229|NCT00353990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461287|NCT00453856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461288|NCT00453856|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6461289|NCT00453856|Renal Agents|renal agents|mesh-ancestor
6461290|NCT00453908|Alfuzosin|alfuzosin|mesh-list
6461291|NCT00453908|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6461292|NCT00453908|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6461293|NCT00453908|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6461294|NCT00453908|Adrenergic Agents|adrenergic agents|mesh-ancestor
6461295|NCT00453908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6437230|NCT00354068|Temozolomide|temozolomide|mesh-list
6437231|NCT00354068|Imatinib Mesylate|imatinib mesylate|mesh-list
6437232|NCT00354068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6437233|NCT00354068|Alkylating Agents|alkylating agents|mesh-ancestor
6437234|NCT00354068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437235|NCT00354068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6437236|NCT00354068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6437237|NCT00354068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6541782|NCT00847262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6541783|NCT00847262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6541784|NCT00847262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541785|NCT00847262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6541786|NCT00847262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541787|NCT00847262|Vasodilator Agents|vasodilator agents|mesh-ancestor
6541788|NCT00847314|Methyltestosterone|methyltestosterone|mesh-list
6541789|NCT00847314|Testosterone|testosterone|mesh-list
6541790|NCT00847314|Testosterone undecanoate|testosterone undecanoate|mesh-list
6541791|NCT00847314|Testosterone enanthate|testosterone enanthate|mesh-list
6541792|NCT00847314|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6541793|NCT00847314|Androgens|androgens|mesh-ancestor
6541794|NCT00847314|Hormones|hormones|mesh-ancestor
6541795|NCT00847314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6541796|NCT00847314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541797|NCT00847314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6541798|NCT00847314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6541799|NCT00847314|Anabolic Agents|anabolic agents|mesh-ancestor
6541800|NCT00847418|Esketamine|esketamine|mesh-list
6541801|NCT00847418|Antidepressive Agents|antidepressive agents|mesh-ancestor
6541802|NCT00847418|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6541803|NCT00847483|Bimatoprost|bimatoprost|mesh-list
6541804|NCT00847483|Travoprost|travoprost|mesh-list
6541805|NCT00847483|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6541806|NCT00847483|Latanoprost|latanoprost|mesh-list
6541807|NCT00847483|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6541808|NCT00847483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6541809|NCT00847639|Lenalidomide|lenalidomide|mesh-list
6541810|NCT00847639|Immunologic Factors|immunologic factors|mesh-ancestor
6541811|NCT00847639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541812|NCT00847639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6541813|NCT00847639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6541814|NCT00847639|Growth Substances|growth substances|mesh-ancestor
6541815|NCT00847639|Growth Inhibitors|growth inhibitors|mesh-ancestor
6541816|NCT00847639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6541817|NCT00847678|Amphotericin B|amphotericin b|mesh-list
6541818|NCT00847678|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6541819|NCT00847678|Flucytosine|flucytosine|mesh-list
6541820|NCT00847678|Efungumab|efungumab|mesh-list
6541821|NCT00847678|Amebicides|amebicides|mesh-ancestor
6541822|NCT00847678|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6541823|NCT00847678|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6541824|NCT00847678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6541825|NCT00847678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6541826|NCT00847678|Antifungal Agents|antifungal agents|mesh-ancestor
6541827|NCT00847678|Antimetabolites|antimetabolites|mesh-ancestor
6541828|NCT00847678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541829|NCT00847821|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
6541830|NCT00847821|Bazedoxifene|bazedoxifene|mesh-list
6541831|NCT00847821|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6541832|NCT00847821|Hormone Antagonists|hormone antagonists|mesh-ancestor
6541833|NCT00847821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6541834|NCT00847821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541835|NCT00847821|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6541836|NCT00847821|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6541837|NCT00847821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6541838|NCT00847834|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6541839|NCT00847834|Irbesartan|irbesartan|mesh-list
6541840|NCT00847834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6437238|NCT00354081|Vitamins|vitamins|mesh-list
6437239|NCT00354081|Folic Acid|folic acid|mesh-list
6437240|NCT00354081|Hydroxocobalamin|hydroxocobalamin|mesh-list
6437241|NCT00354081|Vitamin B 12|vitamin b 12|mesh-list
6437242|NCT00354081|Pyridoxine|pyridoxine|mesh-list
6437243|NCT00354081|Pyridoxal|pyridoxal|mesh-list
6541841|NCT00847834|Diuretics|diuretics|mesh-ancestor
6541842|NCT00847834|Natriuretic Agents|natriuretic agents|mesh-ancestor
6541843|NCT00847834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541844|NCT00847834|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6437244|NCT00354081|Vitamin B 6|vitamin b 6|mesh-list
6437245|NCT00354081|Vitamin B Complex|vitamin b complex|mesh-list
6437246|NCT00354081|Micronutrients|micronutrients|mesh-ancestor
6437247|NCT00354081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437248|NCT00354081|Hematinics|hematinics|mesh-ancestor
6437249|NCT00354094|Reboxetine|reboxetine|mesh-list
6437250|NCT00354094|Antidepressive Agents|antidepressive agents|mesh-ancestor
6437251|NCT00354094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6437252|NCT00354094|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6437253|NCT00354094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6437254|NCT00354094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6437255|NCT00354094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437256|NCT00354094|Adrenergic Agents|adrenergic agents|mesh-ancestor
6437257|NCT00354094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6437258|NCT00354094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437259|NCT00354146|Tipifarnib|tipifarnib|mesh-list
6437260|NCT00354146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6437261|NCT00354185|Belinostat|belinostat|mesh-list
6437262|NCT00354185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6437263|NCT00354185|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6437264|NCT00354185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6437265|NCT00354185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437266|NCT00354198|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6437267|NCT00354198|Pentoxifylline|pentoxifylline|mesh-list
6437268|NCT00354198|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6437269|NCT00354198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6437270|NCT00354198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437271|NCT00354198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6437272|NCT00354198|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6437273|NCT00354198|Protective Agents|protective agents|mesh-ancestor
6437274|NCT00354198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437275|NCT00354198|Vasodilator Agents|vasodilator agents|mesh-ancestor
6437276|NCT00354198|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6437277|NCT00354198|Antioxidants|antioxidants|mesh-ancestor
6437278|NCT00354198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6437279|NCT00354198|Glucocorticoids|glucocorticoids|mesh-ancestor
6437280|NCT00354198|Hormones|hormones|mesh-ancestor
6437281|NCT00354198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6437282|NCT00354198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6437283|NCT00354198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6437284|NCT00354198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6437285|NCT00354237|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6437286|NCT00354237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437287|NCT00354276|Cytarabine|cytarabine|mesh-list
6437288|NCT00354276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6437289|NCT00354276|Antimetabolites|antimetabolites|mesh-ancestor
6437290|NCT00354276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437291|NCT00354276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6437292|NCT00354276|Antiviral Agents|antiviral agents|mesh-ancestor
6437293|NCT00354276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6437294|NCT00354276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6437295|NCT00354276|Immunologic Factors|immunologic factors|mesh-ancestor
6437296|NCT00354276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437297|NCT00354302|Calcium, Dietary|calcium, dietary|mesh-list
6437298|NCT00354302|Cholecalciferol|cholecalciferol|mesh-list
6437299|NCT00354302|Alendronate|alendronate|mesh-list
6437300|NCT00354302|Risedronic Acid|risedronic acid|mesh-list
6437301|NCT00354302|Calcium Carbonate|calcium carbonate|mesh-list
6437302|NCT00354302|Calcium|calcium|mesh-list
6437303|NCT00354302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6437304|NCT00354302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437305|NCT00354302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6437306|NCT00354302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437307|NCT00354302|Vitamins|vitamins|mesh-ancestor
6437308|NCT00354302|Micronutrients|micronutrients|mesh-ancestor
6437309|NCT00354302|Antacids|antacids|mesh-ancestor
6437310|NCT00354302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6437311|NCT00354302|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6437312|NCT00354302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6437313|NCT00354354|Ipratropium|ipratropium|mesh-list
6437314|NCT00354354|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6437315|NCT00354354|Autonomic Agents|autonomic agents|mesh-ancestor
6437316|NCT00354354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6437317|NCT00354354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437318|NCT00354354|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6437319|NCT00354354|Respiratory System Agents|respiratory system agents|mesh-ancestor
6437320|NCT00354354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6437321|NCT00354354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437322|NCT00354354|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6437323|NCT00354354|Cholinergic Agents|cholinergic agents|mesh-ancestor
6437324|NCT00354367|Certolizumab Pegol|certolizumab pegol|mesh-list
6437325|NCT00354367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6437326|NCT00354367|Immunologic Factors|immunologic factors|mesh-ancestor
6437327|NCT00354367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437328|NCT00354367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6437329|NCT00354380|Artesunate|artesunate|mesh-list
6437330|NCT00354380|Amodiaquine|amodiaquine|mesh-list
6437331|NCT00354380|Methylene Blue|methylene blue|mesh-list
6437332|NCT00354380|Antimalarials|antimalarials|mesh-ancestor
6437333|NCT00354380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6437334|NCT00354380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6437335|NCT00354380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6437336|NCT00354380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6437337|NCT00354380|Antiviral Agents|antiviral agents|mesh-ancestor
6437338|NCT00354380|Schistosomicides|schistosomicides|mesh-ancestor
6437339|NCT00354380|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6437340|NCT00354380|Anthelmintics|anthelmintics|mesh-ancestor
6437341|NCT00354380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6437342|NCT00354380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437343|NCT00354393|Methotrexate|methotrexate|mesh-list
6437344|NCT00354393|Vinorelbine|vinorelbine|mesh-list
6437345|NCT00354393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6437346|NCT00354393|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6437347|NCT00354393|Abortifacient Agents|abortifacient agents|mesh-ancestor
6437348|NCT00354393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6437349|NCT00354393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437350|NCT00354393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6437351|NCT00354393|Antimetabolites|antimetabolites|mesh-ancestor
6437352|NCT00354393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437353|NCT00354393|Dermatologic Agents|dermatologic agents|mesh-ancestor
6437354|NCT00354393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6437355|NCT00354393|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6437356|NCT00354393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6437357|NCT00354393|Immunologic Factors|immunologic factors|mesh-ancestor
6437358|NCT00354393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6437359|NCT00354393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6437360|NCT00354393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6437361|NCT00354393|Tubulin Modulators|tubulin modulators|mesh-ancestor
6437362|NCT00354393|Antimitotic Agents|antimitotic agents|mesh-ancestor
6437363|NCT00354393|Mitosis Modulators|mitosis modulators|mesh-ancestor
6437364|NCT00354406|Abciximab|abciximab|mesh-list
6437365|NCT00354406|Anticoagulants|anticoagulants|mesh-ancestor
6437366|NCT00354406|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6541845|NCT00847834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6541846|NCT00847834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541847|NCT00847834|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6541848|NCT00847834|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6541849|NCT00847860|Aspirin|aspirin|mesh-list
6541850|NCT00847860|Cilostazol|cilostazol|mesh-list
6541851|NCT00847860|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6541852|NCT00847860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6541853|NCT00847860|Analgesics|analgesics|mesh-ancestor
6541854|NCT00847860|Sensory System Agents|sensory system agents|mesh-ancestor
6541855|NCT00847860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6541856|NCT00847860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541857|NCT00847860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6541858|NCT00847860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6541859|NCT00847860|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6541860|NCT00847860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6541861|NCT00847860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541862|NCT00847860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6541863|NCT00847860|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6541864|NCT00847860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6541865|NCT00847860|Antipyretics|antipyretics|mesh-ancestor
6541866|NCT00847860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6541867|NCT00847860|Autonomic Agents|autonomic agents|mesh-ancestor
6541868|NCT00847860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6541869|NCT00847860|Respiratory System Agents|respiratory system agents|mesh-ancestor
6541870|NCT00847860|Vasodilator Agents|vasodilator agents|mesh-ancestor
6541871|NCT00847860|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6541872|NCT00847860|Protective Agents|protective agents|mesh-ancestor
6541873|NCT00847860|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6541874|NCT00847860|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6541875|NCT00847899|1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea|1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea|mesh-list
6541876|NCT00847899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6541877|NCT00847899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6541878|NCT00847899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655554|NCT01464489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6655555|NCT01464489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437367|NCT00354419|Cyclosporine|cyclosporine|mesh-list
6437368|NCT00354419|Mycophenolic Acid|mycophenolic acid|mesh-list
6437369|NCT00354419|Cyclophosphamide|cyclophosphamide|mesh-list
6437370|NCT00354419|Cyclosporins|cyclosporins|mesh-list
6437371|NCT00354419|Thymoglobulin|thymoglobulin|mesh-list
6437372|NCT00354419|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6437373|NCT00354419|Lenograstim|lenograstim|mesh-list
6437374|NCT00354419|Sargramostim|sargramostim|mesh-list
6437375|NCT00354419|Immunoglobulins|immunoglobulins|mesh-list
6437376|NCT00354419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6437377|NCT00354419|Immunologic Factors|immunologic factors|mesh-ancestor
6437378|NCT00354419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437379|NCT00354419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6437380|NCT00354419|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6437381|NCT00354419|Alkylating Agents|alkylating agents|mesh-ancestor
6437382|NCT00354419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437383|NCT00354419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6437384|NCT00354419|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6437385|NCT00354419|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6437386|NCT00354419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6437387|NCT00354419|Antifungal Agents|antifungal agents|mesh-ancestor
6437388|NCT00354419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6437389|NCT00354419|Dermatologic Agents|dermatologic agents|mesh-ancestor
6437390|NCT00354419|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6437391|NCT00354419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6437392|NCT00354419|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6437393|NCT00354419|Antitubercular Agents|antitubercular agents|mesh-ancestor
6437394|NCT00354419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6437395|NCT00354458|Rolofylline|rolofylline|mesh-list
6437396|NCT00354458|Diuretics|diuretics|mesh-ancestor
6437397|NCT00354458|Natriuretic Agents|natriuretic agents|mesh-ancestor
6437398|NCT00354458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437399|NCT00354523|Capecitabine|capecitabine|mesh-list
6437400|NCT00354523|Imatinib Mesylate|imatinib mesylate|mesh-list
6437401|NCT00354523|Dacarbazine|dacarbazine|mesh-list
6437402|NCT00354523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6437403|NCT00354523|Antimetabolites|antimetabolites|mesh-ancestor
6437404|NCT00354523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437405|NCT00354523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6437406|NCT00354523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6437407|NCT00354523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6437408|NCT00354523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6437409|NCT00354523|Alkylating Agents|alkylating agents|mesh-ancestor
6437410|NCT00354549|Gemcitabine|gemcitabine|mesh-list
6437411|NCT00354549|Bevacizumab|bevacizumab|mesh-list
6437412|NCT00354549|Carboplatin|carboplatin|mesh-list
6437413|NCT00354549|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6437414|NCT00354549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6437415|NCT00354549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6437416|NCT00354549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6437417|NCT00354549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6437418|NCT00354549|Growth Substances|growth substances|mesh-ancestor
6437419|NCT00354549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437420|NCT00354549|Growth Inhibitors|growth inhibitors|mesh-ancestor
6437421|NCT00354549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6437422|NCT00354549|Antimetabolites|antimetabolites|mesh-ancestor
6437423|NCT00354549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437424|NCT00354549|Antiviral Agents|antiviral agents|mesh-ancestor
6437425|NCT00354549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6437426|NCT00354549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6437427|NCT00354549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6437428|NCT00354549|Immunologic Factors|immunologic factors|mesh-ancestor
6437429|NCT00354549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6437430|NCT00354562|Docetaxel|docetaxel|mesh-list
6437431|NCT00354562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6437432|NCT00354562|Tubulin Modulators|tubulin modulators|mesh-ancestor
6437433|NCT00354562|Antimitotic Agents|antimitotic agents|mesh-ancestor
6437434|NCT00354562|Mitosis Modulators|mitosis modulators|mesh-ancestor
6437435|NCT00354562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437436|NCT00354627|Etravirine|etravirine|mesh-list
6437437|NCT00354627|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6437438|NCT00354627|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6437439|NCT00354627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6437440|NCT00354627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437441|NCT00354627|Antiviral Agents|antiviral agents|mesh-ancestor
6437442|NCT00354627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6437443|NCT00354653|Lamivudine|lamivudine|mesh-list
6437444|NCT00354653|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6437445|NCT00354653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6437446|NCT00354653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6437447|NCT00354653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437448|NCT00354653|Antiviral Agents|antiviral agents|mesh-ancestor
6437449|NCT00354653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6541879|NCT00848068|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6437450|NCT00354653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6437451|NCT00354653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6437452|NCT00354692|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6437453|NCT00354692|Ferric gluconate|ferric gluconate|mesh-list
6437454|NCT00354692|Hematinics|hematinics|mesh-ancestor
6437455|NCT00354731|Pentoxifylline|pentoxifylline|mesh-list
6541880|NCT00848068|Lubricant Eye Drops|lubricant eye drops|mesh-list
6541881|NCT00848068|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6541882|NCT00848302|Nitric Oxide|nitric oxide|mesh-list
6541883|NCT00848302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6541884|NCT00848302|Autonomic Agents|autonomic agents|mesh-ancestor
6541885|NCT00848302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6541886|NCT00848302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541887|NCT00848302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6541888|NCT00848302|Respiratory System Agents|respiratory system agents|mesh-ancestor
6541889|NCT00848302|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6541890|NCT00848302|Antioxidants|antioxidants|mesh-ancestor
6541891|NCT00848302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541892|NCT00848302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6541893|NCT00848302|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6541894|NCT00848302|Vasodilator Agents|vasodilator agents|mesh-ancestor
6541895|NCT00848302|Gasotransmitters|gasotransmitters|mesh-ancestor
6541896|NCT00848302|Protective Agents|protective agents|mesh-ancestor
6541897|NCT00848432|Risperidone|risperidone|mesh-list
6541898|NCT00848432|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6541899|NCT00848432|Serotonin Agents|serotonin agents|mesh-ancestor
6541900|NCT00848432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6437456|NCT00354731|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6541901|NCT00848432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541902|NCT00848432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541903|NCT00848432|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6541904|NCT00848432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6541905|NCT00848432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6541906|NCT00848432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6541907|NCT00848432|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6437457|NCT00354731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6437458|NCT00354731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437459|NCT00354731|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6541908|NCT00848432|Dopamine Agents|dopamine agents|mesh-ancestor
6541909|NCT00848458|Azelaic acid|azelaic acid|mesh-list
6541910|NCT00848458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6541911|NCT00848458|Dermatologic Agents|dermatologic agents|mesh-ancestor
6437460|NCT00354731|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6541912|NCT00848523|Panobinostat|panobinostat|mesh-list
6541913|NCT00848523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6541914|NCT00848523|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6541915|NCT00848523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6437461|NCT00354731|Protective Agents|protective agents|mesh-ancestor
6437462|NCT00354731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437463|NCT00354731|Vasodilator Agents|vasodilator agents|mesh-ancestor
6437464|NCT00354731|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6437465|NCT00354731|Antioxidants|antioxidants|mesh-ancestor
6437466|NCT00354757|Rabeprazole|rabeprazole|mesh-list
6437467|NCT00354757|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6437468|NCT00354757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6437469|NCT00354757|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6437470|NCT00354757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6437471|NCT00354757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437472|NCT00354809|Casopitant|casopitant|mesh-list
6437473|NCT00354809|Antiemetics|antiemetics|mesh-ancestor
6437474|NCT00354809|Autonomic Agents|autonomic agents|mesh-ancestor
6437475|NCT00354809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6437476|NCT00354809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437477|NCT00354809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6437478|NCT00354809|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6437479|NCT00354809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6437480|NCT00354809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437481|NCT00354861|Aluminum sulfate|aluminum sulfate|mesh-list
6437482|NCT00354861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6437483|NCT00354861|Immunologic Factors|immunologic factors|mesh-ancestor
6437484|NCT00354861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437485|NCT00354874|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6437486|NCT00354874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6437487|NCT00354874|Autonomic Agents|autonomic agents|mesh-ancestor
6437488|NCT00354874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6437489|NCT00354874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437490|NCT00354874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6437491|NCT00354874|Respiratory System Agents|respiratory system agents|mesh-ancestor
6437492|NCT00354874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6437493|NCT00354874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6437494|NCT00354874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6437495|NCT00354874|Adrenergic Agents|adrenergic agents|mesh-ancestor
6437496|NCT00354874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6437497|NCT00354874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437498|NCT00354900|Aprotinin|aprotinin|mesh-list
6437499|NCT00354900|Hemostatics|hemostatics|mesh-ancestor
6437500|NCT00354900|Coagulants|coagulants|mesh-ancestor
6437501|NCT00354900|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6437502|NCT00354900|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6437503|NCT00354900|Protease Inhibitors|protease inhibitors|mesh-ancestor
6437504|NCT00354900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6437505|NCT00354900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437506|NCT00354939|Insulin Glargine|insulin glargine|mesh-list
6437507|NCT00354939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6437508|NCT00354939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437509|NCT00354952|Azithromycin|azithromycin|mesh-list
6437510|NCT00354952|Clarithromycin|clarithromycin|mesh-list
6437511|NCT00354952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6437512|NCT00354952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6437513|NCT00354952|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6437514|NCT00354952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6437515|NCT00354952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437516|NCT00354952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6437517|NCT00354952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6437518|NCT00354965|Amoxicillin|amoxicillin|mesh-list
6437519|NCT00354965|Clavulanic Acid|clavulanic acid|mesh-list
6437520|NCT00354965|Clavulanic Acids|clavulanic acids|mesh-list
6437521|NCT00354965|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6437522|NCT00354965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6437523|NCT00354965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6437524|NCT00354965|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6437525|NCT00354965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6437526|NCT00354965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437527|NCT00354991|Losartan|losartan|mesh-list
6437528|NCT00354991|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6437529|NCT00354991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6437530|NCT00354991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6437531|NCT00354991|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6437532|NCT00354991|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6437533|NCT00354991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437534|NCT00354991|Diuretics|diuretics|mesh-ancestor
6437535|NCT00354991|Natriuretic Agents|natriuretic agents|mesh-ancestor
6437536|NCT00354991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437537|NCT00354991|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6437538|NCT00354991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6437539|NCT00355043|Zinc Sulfate|zinc sulfate|mesh-list
6437540|NCT00355043|Astringents|astringents|mesh-ancestor
6437541|NCT00355043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437542|NCT00355043|Dermatologic Agents|dermatologic agents|mesh-ancestor
6437543|NCT00355095|Epoetin Alfa|epoetin alfa|mesh-list
6437544|NCT00355095|Hematinics|hematinics|mesh-ancestor
6437545|NCT00355108|Tranexamic Acid|tranexamic acid|mesh-list
6437546|NCT00355108|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6437547|NCT00355108|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6437548|NCT00355108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437549|NCT00355108|Hemostatics|hemostatics|mesh-ancestor
6437550|NCT00355108|Coagulants|coagulants|mesh-ancestor
6437551|NCT00355251|Atorvastatin|atorvastatin|mesh-list
6437552|NCT00355251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6437553|NCT00355251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6437554|NCT00355251|Antimetabolites|antimetabolites|mesh-ancestor
6437555|NCT00355251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437556|NCT00355251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6437557|NCT00355251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6541916|NCT00848523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541917|NCT00848562|Nicorandil|nicorandil|mesh-list
6541918|NCT00848562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6541919|NCT00848562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6437558|NCT00355251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6437559|NCT00355277|Amitriptyline|amitriptyline|mesh-list
6437560|NCT00355277|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6437561|NCT00355277|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6437562|NCT00355277|Antidepressive Agents|antidepressive agents|mesh-ancestor
6437563|NCT00355277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6437564|NCT00355277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6437565|NCT00355277|Analgesics|analgesics|mesh-ancestor
6437566|NCT00355277|Sensory System Agents|sensory system agents|mesh-ancestor
6437567|NCT00355277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6437568|NCT00355277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437569|NCT00355277|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6437570|NCT00355277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6437571|NCT00355277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6437572|NCT00355277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437573|NCT00355277|Adrenergic Agents|adrenergic agents|mesh-ancestor
6437574|NCT00355277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6437575|NCT00355277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6437576|NCT00355277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6437577|NCT00355277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6437578|NCT00355290|Vitamin K|vitamin k|mesh-list
6437579|NCT00355290|Vitamins|vitamins|mesh-ancestor
6437580|NCT00355290|Micronutrients|micronutrients|mesh-ancestor
6437581|NCT00355290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437582|NCT00355290|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6437583|NCT00355290|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6437584|NCT00355290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437585|NCT00355290|Hemostatics|hemostatics|mesh-ancestor
6437586|NCT00355290|Coagulants|coagulants|mesh-ancestor
6437587|NCT00355303|Misoprostol|misoprostol|mesh-list
6437588|NCT00355303|Dinoprostone|dinoprostone|mesh-list
6437589|NCT00355303|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6437590|NCT00355303|Abortifacient Agents|abortifacient agents|mesh-ancestor
6437591|NCT00355303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6437592|NCT00355303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437593|NCT00355303|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6437594|NCT00355303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6437595|NCT00355303|Oxytocics|oxytocics|mesh-ancestor
6437596|NCT00355407|Darbepoetin alfa|darbepoetin alfa|mesh-list
6437597|NCT00355407|Hematinics|hematinics|mesh-ancestor
6437598|NCT00355446|Bimatoprost|bimatoprost|mesh-list
6437599|NCT00355446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6437600|NCT00355459|Doxycycline|doxycycline|mesh-list
6437601|NCT00355459|Tetracycline|tetracycline|mesh-list
6437602|NCT00355459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6437603|NCT00355459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6437604|NCT00355459|Antimalarials|antimalarials|mesh-ancestor
6437605|NCT00355459|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6437606|NCT00355459|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6437607|NCT00355459|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6437608|NCT00355459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6437609|NCT00355459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437610|NCT00355524|Ritonavir|ritonavir|mesh-list
6437611|NCT00355524|Darunavir|darunavir|mesh-list
6437612|NCT00355524|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6437613|NCT00355524|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6437614|NCT00355524|Protease Inhibitors|protease inhibitors|mesh-ancestor
6437615|NCT00355524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6437616|NCT00355524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437617|NCT00355524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6437618|NCT00355524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6437619|NCT00355524|Antiviral Agents|antiviral agents|mesh-ancestor
6437620|NCT00355524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6437621|NCT00355524|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6437622|NCT00355524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6437623|NCT00355537|Testosterone|testosterone|mesh-list
6437624|NCT00355537|Androgens|androgens|mesh-ancestor
6437625|NCT00355537|Hormones|hormones|mesh-ancestor
6437626|NCT00355537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6437627|NCT00355537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437628|NCT00355576|Minocycline|minocycline|mesh-list
6437629|NCT00355576|Celecoxib|celecoxib|mesh-list
6437630|NCT00355576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6437631|NCT00355576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6437632|NCT00355576|Analgesics|analgesics|mesh-ancestor
6437633|NCT00355576|Sensory System Agents|sensory system agents|mesh-ancestor
6437634|NCT00355576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6437635|NCT00355576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437636|NCT00355576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6437637|NCT00355576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6437638|NCT00355576|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6437639|NCT00355576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6437640|NCT00355576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6437641|NCT00355576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437642|NCT00355576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6437643|NCT00355576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6437644|NCT00355589|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6437645|NCT00355589|Ramipril|ramipril|mesh-list
6437646|NCT00355589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6437647|NCT00355589|Diuretics|diuretics|mesh-ancestor
6437648|NCT00355589|Natriuretic Agents|natriuretic agents|mesh-ancestor
6437649|NCT00355589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437650|NCT00355589|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6437651|NCT00355589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6462189|NCT00458055|Fenofibrate|fenofibrate|mesh-list
6437652|NCT00355589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437653|NCT00355589|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6437654|NCT00355589|Protease Inhibitors|protease inhibitors|mesh-ancestor
6437655|NCT00355589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6437656|NCT00355602|Metronidazole|metronidazole|mesh-list
6437657|NCT00355602|Vancomycin|vancomycin|mesh-list
6437658|NCT00355602|Clarithromycin|clarithromycin|mesh-list
6437659|NCT00355602|Doxycycline|doxycycline|mesh-list
6437660|NCT00355602|Ciprofloxacin|ciprofloxacin|mesh-list
6437661|NCT00355602|Rifaximin|rifaximin|mesh-list
6437662|NCT00355602|Cefuroxime|cefuroxime|mesh-list
6437663|NCT00355602|Neomycin|neomycin|mesh-list
6437664|NCT00355602|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6437665|NCT00355602|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6437666|NCT00355602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6437667|NCT00355602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6437668|NCT00355602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6437669|NCT00355602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6437670|NCT00355602|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6437671|NCT00355602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6437672|NCT00355602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437673|NCT00355602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6437674|NCT00355602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6437675|NCT00355602|Antimalarials|antimalarials|mesh-ancestor
6437676|NCT00355602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6437677|NCT00355602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6437678|NCT00355602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6437679|NCT00355602|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6437680|NCT00355602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6437681|NCT00355602|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6437682|NCT00355602|Renal Agents|renal agents|mesh-ancestor
6437683|NCT00355602|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6437684|NCT00355628|Fentanyl|fentanyl|mesh-list
6437685|NCT00355628|Citric Acid|citric acid|mesh-list
6437686|NCT00355628|Sodium Citrate|sodium citrate|mesh-list
6437687|NCT00355628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6437688|NCT00355628|Narcotics|narcotics|mesh-ancestor
6437689|NCT00355628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6437690|NCT00355628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437691|NCT00355628|Analgesics|analgesics|mesh-ancestor
6437692|NCT00355628|Sensory System Agents|sensory system agents|mesh-ancestor
6019497|NCT00387647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019498|NCT00387647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6019499|NCT00387647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6019500|NCT00387660|Carboplatin|carboplatin|mesh-list
6019501|NCT00387660|Irinotecan|irinotecan|mesh-list
6019502|NCT00387660|Camptothecin|camptothecin|mesh-list
6437693|NCT00355628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6437694|NCT00355628|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6437695|NCT00355628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6437696|NCT00355628|Anesthetics, General|anesthetics, general|mesh-ancestor
6437697|NCT00355628|Anesthetics|anesthetics|mesh-ancestor
6437698|NCT00355628|Anticoagulants|anticoagulants|mesh-ancestor
6437699|NCT00355628|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6437700|NCT00355628|Chelating Agents|chelating agents|mesh-ancestor
6437701|NCT00355628|Sequestering Agents|sequestering agents|mesh-ancestor
6437702|NCT00355628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437703|NCT00355641|Ropinirole|ropinirole|mesh-list
6437704|NCT00355641|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6437705|NCT00355641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6437706|NCT00355641|Dopamine Agonists|dopamine agonists|mesh-ancestor
6019503|NCT00387660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6437707|NCT00355641|Dopamine Agents|dopamine agents|mesh-ancestor
6437708|NCT00355641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6437709|NCT00355641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437710|NCT00355641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437711|NCT00355667|Furosemide|furosemide|mesh-list
6437712|NCT00355667|Azosemide|azosemide|mesh-list
6437713|NCT00355667|Diuretics|diuretics|mesh-ancestor
6437714|NCT00355667|Natriuretic Agents|natriuretic agents|mesh-ancestor
6437715|NCT00355667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437716|NCT00355667|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6541920|NCT00848562|Vasodilator Agents|vasodilator agents|mesh-ancestor
6019504|NCT00387660|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6019505|NCT00387660|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6019506|NCT00387660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6019507|NCT00387660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019508|NCT00387660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6019509|NCT00387751|Bevacizumab|bevacizumab|mesh-list
6019510|NCT00387751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6019511|NCT00387751|Sorafenib|sorafenib|mesh-list
6019512|NCT00387751|Endothelial Growth Factors|endothelial growth factors|mesh-list
6019513|NCT00387751|Antibodies|antibodies|mesh-list
6019514|NCT00387751|Immunoglobulins|immunoglobulins|mesh-list
6019515|NCT00387751|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6019516|NCT00387751|Immunoglobulin G|immunoglobulin g|mesh-list
6019517|NCT00387751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6019518|NCT00387751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6019519|NCT00387751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6019520|NCT00387751|Growth Substances|growth substances|mesh-ancestor
6019521|NCT00387751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019522|NCT00387751|Growth Inhibitors|growth inhibitors|mesh-ancestor
6019523|NCT00387751|Immunologic Factors|immunologic factors|mesh-ancestor
6019524|NCT00387751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6019525|NCT00387751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6437717|NCT00355667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6541921|NCT00848562|Vitamin B Complex|vitamin b complex|mesh-ancestor
6541922|NCT00848562|Vitamins|vitamins|mesh-ancestor
6541923|NCT00848562|Micronutrients|micronutrients|mesh-ancestor
6437718|NCT00355667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437719|NCT00355693|Propofol|propofol|mesh-list
6437720|NCT00355693|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6437721|NCT00355693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6437722|NCT00355693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437723|NCT00355693|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6437724|NCT00355693|Anesthetics, General|anesthetics, general|mesh-ancestor
6437725|NCT00355693|Anesthetics|anesthetics|mesh-ancestor
6437726|NCT00355719|Ritonavir|ritonavir|mesh-list
6437727|NCT00355719|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6437728|NCT00355719|Nevirapine|nevirapine|mesh-list
6437729|NCT00355719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6437730|NCT00355719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6437731|NCT00355719|Protease Inhibitors|protease inhibitors|mesh-ancestor
6437732|NCT00355719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6437733|NCT00355719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437734|NCT00355719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6437735|NCT00355719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6437736|NCT00355719|Antiviral Agents|antiviral agents|mesh-ancestor
6437737|NCT00355719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6437738|NCT00355719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6437739|NCT00355719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6541924|NCT00848562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437740|NCT00355719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6437741|NCT00355719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6437742|NCT00355719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6437743|NCT00355719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6437744|NCT00355771|Levocetirizine|levocetirizine|mesh-list
6437745|NCT00355771|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6437746|NCT00355771|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6437747|NCT00355771|Histamine Antagonists|histamine antagonists|mesh-ancestor
6437748|NCT00355771|Histamine Agents|histamine agents|mesh-ancestor
6437749|NCT00355771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6437750|NCT00355771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437751|NCT00355771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461296|NCT00453908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461297|NCT00453908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461298|NCT00453908|Urological Agents|urological agents|mesh-ancestor
6461299|NCT00453960|Norethindrone|norethindrone|mesh-list
6461300|NCT00453960|Norethindrone Acetate|norethindrone acetate|mesh-list
6461301|NCT00453960|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6461302|NCT00453960|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6461303|NCT00453960|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6461304|NCT00453960|Contraceptive Agents|contraceptive agents|mesh-ancestor
6461305|NCT00453960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6461306|NCT00453960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461307|NCT00453960|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6461308|NCT00453960|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6461309|NCT00454168|Sargramostim|sargramostim|mesh-list
6461310|NCT00454168|Immunologic Factors|immunologic factors|mesh-ancestor
6461311|NCT00454168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461312|NCT00454233|Metformin|metformin|mesh-list
6461313|NCT00454233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6461314|NCT00454233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461315|NCT00454259|Fentanyl|fentanyl|mesh-list
6461316|NCT00454259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6461317|NCT00454259|Narcotics|narcotics|mesh-ancestor
6461318|NCT00454259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6461319|NCT00454259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461320|NCT00454259|Analgesics|analgesics|mesh-ancestor
6461321|NCT00454259|Sensory System Agents|sensory system agents|mesh-ancestor
6461322|NCT00454259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6461323|NCT00454259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6461324|NCT00454259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6461325|NCT00454259|Anesthetics, General|anesthetics, general|mesh-ancestor
6461326|NCT00454259|Anesthetics|anesthetics|mesh-ancestor
6461327|NCT00454272|Vancomycin|vancomycin|mesh-list
6461328|NCT00454272|Teicoplanin|teicoplanin|mesh-list
6461329|NCT00454272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6461330|NCT00454272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6461331|NCT00454285|Amoxicillin|amoxicillin|mesh-list
6461332|NCT00454285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6461333|NCT00454285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6461334|NCT00454337|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6461335|NCT00454337|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6461336|NCT00454337|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6461337|NCT00454337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6461338|NCT00454337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461339|NCT00454337|Antiviral Agents|antiviral agents|mesh-ancestor
6461340|NCT00454337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6461341|NCT00454337|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6461342|NCT00454337|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6461343|NCT00454350|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
6461344|NCT00454350|Vitamins|vitamins|mesh-ancestor
6461345|NCT00454350|Micronutrients|micronutrients|mesh-ancestor
6461346|NCT00454350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461347|NCT00454350|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6461348|NCT00454389|Ranibizumab|ranibizumab|mesh-list
6461349|NCT00454389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6461350|NCT00454389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6461351|NCT00454389|Growth Substances|growth substances|mesh-ancestor
6461352|NCT00454389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461353|NCT00454389|Growth Inhibitors|growth inhibitors|mesh-ancestor
6461354|NCT00454389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6461355|NCT00454402|Alfuzosin|alfuzosin|mesh-list
6461356|NCT00454402|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6461357|NCT00454402|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6437752|NCT00355862|Cyclosporine|cyclosporine|mesh-list
6437753|NCT00355862|Sirolimus|sirolimus|mesh-list
6437754|NCT00355862|Prednisolone|prednisolone|mesh-list
6437755|NCT00355862|Azathioprine|azathioprine|mesh-list
6437756|NCT00355862|Tacrolimus|tacrolimus|mesh-list
6437757|NCT00355862|Cyclosporins|cyclosporins|mesh-list
6437758|NCT00355862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6437759|NCT00355862|Immunologic Factors|immunologic factors|mesh-ancestor
6437760|NCT00355862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437761|NCT00355862|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6437762|NCT00355862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6437763|NCT00355862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437764|NCT00355862|Antifungal Agents|antifungal agents|mesh-ancestor
6437765|NCT00355862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6437766|NCT00355862|Dermatologic Agents|dermatologic agents|mesh-ancestor
6437767|NCT00355862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6437768|NCT00355862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6437769|NCT00355862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6437770|NCT00355862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6437771|NCT00355862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6437772|NCT00355862|Glucocorticoids|glucocorticoids|mesh-ancestor
6437773|NCT00355862|Hormones|hormones|mesh-ancestor
6437774|NCT00355862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6437775|NCT00355862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6437776|NCT00355862|Antimetabolites|antimetabolites|mesh-ancestor
6437777|NCT00355862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6437778|NCT00355901|Visilizumab|visilizumab|mesh-list
6437779|NCT00355901|Immunologic Factors|immunologic factors|mesh-ancestor
6437780|NCT00355901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437781|NCT00355927|Propofol|propofol|mesh-list
6437782|NCT00355927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6437783|NCT00355927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6437784|NCT00355927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437785|NCT00355927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6437786|NCT00355927|Anesthetics, General|anesthetics, general|mesh-ancestor
6437787|NCT00355927|Anesthetics|anesthetics|mesh-ancestor
6437788|NCT00355953|Genistein|genistein|mesh-list
6437789|NCT00355953|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6437790|NCT00355953|Protective Agents|protective agents|mesh-ancestor
6437791|NCT00355953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437792|NCT00355953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6437793|NCT00355953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6437794|NCT00355953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6437795|NCT00355953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437796|NCT00355953|Phytoestrogens|phytoestrogens|mesh-ancestor
6437797|NCT00355953|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6437798|NCT00355953|Estrogens|estrogens|mesh-ancestor
6437799|NCT00355953|Hormones|hormones|mesh-ancestor
6437800|NCT00355953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6437801|NCT00355966|Misoprostol|misoprostol|mesh-list
6437802|NCT00355966|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6437803|NCT00355966|Abortifacient Agents|abortifacient agents|mesh-ancestor
6437804|NCT00355966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6541925|NCT00848640|Sorafenib|sorafenib|mesh-list
6541926|NCT00848640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6541927|NCT00848640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6541928|NCT00848640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6541929|NCT00848640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541930|NCT00848679|Lidocaine|lidocaine|mesh-list
6541931|NCT00848679|Anesthetics, Local|anesthetics, local|mesh-ancestor
6541932|NCT00848679|Anesthetics|anesthetics|mesh-ancestor
6541933|NCT00848679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6541934|NCT00848679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541935|NCT00848679|Sensory System Agents|sensory system agents|mesh-ancestor
6541936|NCT00848679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6541937|NCT00848679|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6541938|NCT00848679|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6541939|NCT00848679|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6541940|NCT00848679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6541941|NCT00848679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541942|NCT00848692|Rituximab|rituximab|mesh-list
6541943|NCT00848692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6541944|NCT00848692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6541945|NCT00848692|Immunologic Factors|immunologic factors|mesh-ancestor
6437805|NCT00355966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437806|NCT00355966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6437807|NCT00355966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6437808|NCT00355966|Oxytocics|oxytocics|mesh-ancestor
6437809|NCT00356005|Azithromycin|azithromycin|mesh-list
6437810|NCT00356005|Artesunate|artesunate|mesh-list
6437811|NCT00356005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6437812|NCT00356005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6437813|NCT00356005|Antimalarials|antimalarials|mesh-ancestor
6437814|NCT00356005|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6437815|NCT00356005|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6437816|NCT00356005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6437817|NCT00356005|Antiviral Agents|antiviral agents|mesh-ancestor
6437818|NCT00356005|Schistosomicides|schistosomicides|mesh-ancestor
6437819|NCT00356005|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6437820|NCT00356005|Anthelmintics|anthelmintics|mesh-ancestor
6437821|NCT00356070|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6437822|NCT00356070|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6437823|NCT00356070|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6437824|NCT00356070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6437825|NCT00356070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437826|NCT00356070|Adrenergic Agents|adrenergic agents|mesh-ancestor
6437827|NCT00356070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6437828|NCT00356070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437829|NCT00356083|Methadone|methadone|mesh-list
6437830|NCT00356083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6437831|NCT00356083|Narcotics|narcotics|mesh-ancestor
6437832|NCT00356083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6437833|NCT00356083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437834|NCT00356083|Analgesics|analgesics|mesh-ancestor
6437835|NCT00356083|Sensory System Agents|sensory system agents|mesh-ancestor
6437836|NCT00356083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6437837|NCT00356083|Antitussive Agents|antitussive agents|mesh-ancestor
6437838|NCT00356083|Respiratory System Agents|respiratory system agents|mesh-ancestor
6437839|NCT00356096|Pramipexole|pramipexole|mesh-list
6437840|NCT00356096|Antioxidants|antioxidants|mesh-ancestor
6437841|NCT00356096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437842|NCT00356096|Protective Agents|protective agents|mesh-ancestor
6437843|NCT00356096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437844|NCT00356096|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6437845|NCT00356096|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6437846|NCT00356096|Dopamine Agonists|dopamine agonists|mesh-ancestor
6437847|NCT00356096|Dopamine Agents|dopamine agents|mesh-ancestor
6437848|NCT00356096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6437849|NCT00356226|Clonidine|clonidine|mesh-list
6437850|NCT00356226|Analgesics|analgesics|mesh-ancestor
6437851|NCT00356226|Sensory System Agents|sensory system agents|mesh-ancestor
6437852|NCT00356226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6437853|NCT00356226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437854|NCT00356226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6437855|NCT00356226|Sympatholytics|sympatholytics|mesh-ancestor
6437856|NCT00356226|Autonomic Agents|autonomic agents|mesh-ancestor
6437857|NCT00356226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6437858|NCT00356226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6437859|NCT00356226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6437860|NCT00356226|Adrenergic Agents|adrenergic agents|mesh-ancestor
6437861|NCT00356226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6437862|NCT00356226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437863|NCT00356252|Carotenoids|carotenoids|mesh-list
6437864|NCT00356252|Antioxidants|antioxidants|mesh-ancestor
6437865|NCT00356252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437866|NCT00356252|Protective Agents|protective agents|mesh-ancestor
6437867|NCT00356252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437868|NCT00356356|Etanercept|etanercept|mesh-list
6437869|NCT00356356|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6437870|NCT00356356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6437871|NCT00356356|Analgesics|analgesics|mesh-ancestor
6437872|NCT00356356|Sensory System Agents|sensory system agents|mesh-ancestor
6437873|NCT00356356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6437874|NCT00356356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437875|NCT00356356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6437876|NCT00356356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6437877|NCT00356356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6437878|NCT00356356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6437879|NCT00356356|Immunologic Factors|immunologic factors|mesh-ancestor
6437880|NCT00356395|Candesartan|candesartan|mesh-list
6437881|NCT00356395|Ramipril|ramipril|mesh-list
6437882|NCT00356395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6437883|NCT00356395|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6437884|NCT00356395|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6437885|NCT00356395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437886|NCT00356395|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6437887|NCT00356395|Protease Inhibitors|protease inhibitors|mesh-ancestor
6541946|NCT00848692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541947|NCT00848692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6541948|NCT00848731|Nitric Oxide|nitric oxide|mesh-list
6541949|NCT00848731|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6541950|NCT00848731|Autonomic Agents|autonomic agents|mesh-ancestor
6541951|NCT00848731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6541952|NCT00848731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541953|NCT00848731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6541954|NCT00848731|Respiratory System Agents|respiratory system agents|mesh-ancestor
6541955|NCT00848731|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6541956|NCT00848731|Antioxidants|antioxidants|mesh-ancestor
6541957|NCT00848731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541958|NCT00848731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6541959|NCT00848731|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6541960|NCT00848731|Vasodilator Agents|vasodilator agents|mesh-ancestor
6541961|NCT00848731|Gasotransmitters|gasotransmitters|mesh-ancestor
6541962|NCT00848731|Protective Agents|protective agents|mesh-ancestor
6541963|NCT00848770|Norepinephrine|norepinephrine|mesh-list
6541964|NCT00848770|Esmolol|esmolol|mesh-list
6541965|NCT00848770|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6541966|NCT00848770|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6541967|NCT00848770|Adrenergic Agents|adrenergic agents|mesh-ancestor
6541968|NCT00848770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6541969|NCT00848770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541970|NCT00848770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541971|NCT00848770|Sympathomimetics|sympathomimetics|mesh-ancestor
6541972|NCT00848770|Autonomic Agents|autonomic agents|mesh-ancestor
6541973|NCT00848770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6541974|NCT00848770|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6541975|NCT00848770|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6541976|NCT00848770|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6541977|NCT00848770|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6541978|NCT00848796|Heparin|heparin|mesh-list
6541979|NCT00848796|Calcium heparin|calcium heparin|mesh-list
6437888|NCT00356395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6437889|NCT00356447|Estradiol|estradiol|mesh-list
6437890|NCT00356447|Estrogens|estrogens|mesh-ancestor
6437891|NCT00356447|Hormones|hormones|mesh-ancestor
6437892|NCT00356447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6437893|NCT00356447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437894|NCT00356460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6437895|NCT00356460|Antibodies|antibodies|mesh-list
6437896|NCT00356460|Immunoglobulins|immunoglobulins|mesh-list
6437897|NCT00356460|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6437898|NCT00356460|Mitogens|mitogens|mesh-list
6437899|NCT00356460|Immunologic Factors|immunologic factors|mesh-ancestor
6437900|NCT00356460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437901|NCT00356460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6437902|NCT00356460|Mitosis Modulators|mitosis modulators|mesh-ancestor
6437903|NCT00356460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437904|NCT00356473|Atorvastatin|atorvastatin|mesh-list
6437905|NCT00356473|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6437906|NCT00356473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6437907|NCT00356473|Antimetabolites|antimetabolites|mesh-ancestor
6437908|NCT00356473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437909|NCT00356473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6437910|NCT00356473|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6437911|NCT00356473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6437912|NCT00356486|Ribavirin|ribavirin|mesh-list
6437913|NCT00356486|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6437914|NCT00356486|Interferon-alpha|interferon-alpha|mesh-list
6437915|NCT00356486|Antimetabolites|antimetabolites|mesh-ancestor
6437916|NCT00356486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437917|NCT00356486|Antiviral Agents|antiviral agents|mesh-ancestor
6437918|NCT00356486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6437919|NCT00356486|Immunologic Factors|immunologic factors|mesh-ancestor
6437920|NCT00356486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437921|NCT00356616|Tenofovir|tenofovir|mesh-list
6437922|NCT00356616|Abacavir|abacavir|mesh-list
6437923|NCT00356616|Antiviral Agents|antiviral agents|mesh-ancestor
6437924|NCT00356616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6437925|NCT00356616|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6437926|NCT00356616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6437927|NCT00356616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6437928|NCT00356616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437929|NCT00356616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6437930|NCT00356616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6541980|NCT00848796|Anticoagulants|anticoagulants|mesh-ancestor
6541981|NCT00848796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6541982|NCT00848796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6541983|NCT00848796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6541984|NCT00848809|Vancomycin|vancomycin|mesh-list
6437931|NCT00356720|Azithromycin|azithromycin|mesh-list
6437932|NCT00356720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6437933|NCT00356720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6437934|NCT00356733|Epoetin Alfa|epoetin alfa|mesh-list
6437935|NCT00356733|Hematinics|hematinics|mesh-ancestor
6437936|NCT00356772|Azithromycin|azithromycin|mesh-list
6437937|NCT00356772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6437938|NCT00356772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6437939|NCT00356824|Artesunate|artesunate|mesh-list
6437940|NCT00356824|Amodiaquine|amodiaquine|mesh-list
6437941|NCT00356824|Antimalarials|antimalarials|mesh-ancestor
6437942|NCT00356824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6437943|NCT00356824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6437944|NCT00356824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6437945|NCT00356824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6437946|NCT00356824|Antiviral Agents|antiviral agents|mesh-ancestor
6437947|NCT00356824|Schistosomicides|schistosomicides|mesh-ancestor
6437948|NCT00356824|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6437949|NCT00356824|Anthelmintics|anthelmintics|mesh-ancestor
6437950|NCT00356850|Azithromycin|azithromycin|mesh-list
6437951|NCT00356850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6437952|NCT00356850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6437953|NCT00356928|Cyclophosphamide|cyclophosphamide|mesh-list
6437954|NCT00356928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6437955|NCT00356928|Immunologic Factors|immunologic factors|mesh-ancestor
6437956|NCT00356928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437957|NCT00356928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6437958|NCT00356928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6437959|NCT00356928|Alkylating Agents|alkylating agents|mesh-ancestor
6437960|NCT00356928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437961|NCT00356928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6437962|NCT00356928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6437963|NCT00356941|Docetaxel|docetaxel|mesh-list
6437964|NCT00356941|Oxaliplatin|oxaliplatin|mesh-list
6437965|NCT00356941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6437966|NCT00356941|Tubulin Modulators|tubulin modulators|mesh-ancestor
6437967|NCT00356941|Antimitotic Agents|antimitotic agents|mesh-ancestor
6437968|NCT00356941|Mitosis Modulators|mitosis modulators|mesh-ancestor
6437969|NCT00356941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437970|NCT00356954|Ascorbic Acid|ascorbic acid|mesh-list
6541985|NCT00848809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6541986|NCT00848809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6541987|NCT00848848|Vaccines|vaccines|mesh-list
6541988|NCT00848848|Immunologic Factors|immunologic factors|mesh-ancestor
6541989|NCT00848848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541990|NCT00848861|Midazolam|midazolam|mesh-list
6541991|NCT00848861|Meperidine|meperidine|mesh-list
6541992|NCT00848861|Propofol|propofol|mesh-list
6541993|NCT00848861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6541994|NCT00848861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6541995|NCT00848861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6541996|NCT00848861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6541997|NCT00848861|Anesthetics, General|anesthetics, general|mesh-ancestor
6541998|NCT00848861|Anesthetics|anesthetics|mesh-ancestor
6541999|NCT00848861|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6542000|NCT00848861|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6542001|NCT00848861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6542002|NCT00848861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6542003|NCT00848861|GABA Modulators|gaba modulators|mesh-ancestor
6542004|NCT00848861|GABA Agents|gaba agents|mesh-ancestor
6542005|NCT00848861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6542006|NCT00848861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542007|NCT00848861|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6542008|NCT00848861|Narcotics|narcotics|mesh-ancestor
6542009|NCT00848861|Analgesics|analgesics|mesh-ancestor
6542010|NCT00848861|Sensory System Agents|sensory system agents|mesh-ancestor
6542011|NCT00848861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6542012|NCT00848939|Treprostinil|treprostinil|mesh-list
6542013|NCT00848939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6542014|NCT00848991|Dexmedetomidine|dexmedetomidine|mesh-list
6542015|NCT00848991|Propofol|propofol|mesh-list
6542016|NCT00848991|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6542017|NCT00848991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6542018|NCT00848991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437971|NCT00356954|Antioxidants|antioxidants|mesh-ancestor
6437972|NCT00356954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437973|NCT00356954|Protective Agents|protective agents|mesh-ancestor
6437974|NCT00356954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542019|NCT00848991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6542020|NCT00848991|Anesthetics, General|anesthetics, general|mesh-ancestor
6437975|NCT00356954|Vitamins|vitamins|mesh-ancestor
6437976|NCT00356954|Micronutrients|micronutrients|mesh-ancestor
6437977|NCT00357019|Isospaglumic acid|isospaglumic acid|mesh-list
6437978|NCT00357019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6437979|NCT00357019|Autonomic Agents|autonomic agents|mesh-ancestor
6437980|NCT00357019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6437981|NCT00357019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6437982|NCT00357019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6437983|NCT00357019|Respiratory System Agents|respiratory system agents|mesh-ancestor
6437984|NCT00357019|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6437985|NCT00357019|Histamine Antagonists|histamine antagonists|mesh-ancestor
6437986|NCT00357019|Histamine Agents|histamine agents|mesh-ancestor
6437987|NCT00357019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6437988|NCT00357019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437989|NCT00357019|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6437990|NCT00357019|Protective Agents|protective agents|mesh-ancestor
6437991|NCT00357019|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6437992|NCT00357045|Paroxetine|paroxetine|mesh-list
6437993|NCT00357045|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6437994|NCT00357045|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6437995|NCT00357045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6437996|NCT00357045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6437997|NCT00357045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6437998|NCT00357045|Serotonin Agents|serotonin agents|mesh-ancestor
6437999|NCT00357045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438000|NCT00357045|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6438001|NCT00357045|Antidepressive Agents|antidepressive agents|mesh-ancestor
6438002|NCT00357045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6542021|NCT00848991|Anesthetics|anesthetics|mesh-ancestor
6542022|NCT00848991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6542023|NCT00848991|Analgesics|analgesics|mesh-ancestor
6542024|NCT00848991|Sensory System Agents|sensory system agents|mesh-ancestor
6542025|NCT00848991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6542026|NCT00848991|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6542027|NCT00848991|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6542028|NCT00848991|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6542029|NCT00848991|Adrenergic Agents|adrenergic agents|mesh-ancestor
6019526|NCT00387751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542030|NCT00848991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6542031|NCT00848991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438003|NCT00357045|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6438004|NCT00357045|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6438005|NCT00357045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6438006|NCT00357084|Prednisone|prednisone|mesh-list
6438007|NCT00357084|Methylprednisolone|methylprednisolone|mesh-list
6438008|NCT00357084|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6438009|NCT00357084|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6438010|NCT00357084|Prednisolone|prednisolone|mesh-list
6438011|NCT00357084|Prednisolone acetate|prednisolone acetate|mesh-list
6438012|NCT00357084|Methotrexate|methotrexate|mesh-list
6438013|NCT00357084|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6438014|NCT00357084|Prednisolone phosphate|prednisolone phosphate|mesh-list
6438015|NCT00357084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6438016|NCT00357084|Glucocorticoids|glucocorticoids|mesh-ancestor
6438017|NCT00357084|Hormones|hormones|mesh-ancestor
6438018|NCT00357084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6438019|NCT00357084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438020|NCT00357084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6438021|NCT00357084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6438022|NCT00357084|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6438023|NCT00357084|Abortifacient Agents|abortifacient agents|mesh-ancestor
6438024|NCT00357084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6438025|NCT00357084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6438026|NCT00357084|Antimetabolites|antimetabolites|mesh-ancestor
6438027|NCT00357084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438028|NCT00357084|Dermatologic Agents|dermatologic agents|mesh-ancestor
6438029|NCT00357084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6438030|NCT00357084|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6438031|NCT00357084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6438032|NCT00357084|Immunologic Factors|immunologic factors|mesh-ancestor
6438033|NCT00357084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6438034|NCT00357084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6438035|NCT00357084|Antiemetics|antiemetics|mesh-ancestor
6438036|NCT00357084|Autonomic Agents|autonomic agents|mesh-ancestor
6438037|NCT00357084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6438038|NCT00357084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6438039|NCT00357084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6438040|NCT00357084|Protective Agents|protective agents|mesh-ancestor
6438041|NCT00357123|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6438042|NCT00357123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6438043|NCT00357123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6438044|NCT00357123|Antimetabolites|antimetabolites|mesh-ancestor
6438045|NCT00357123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438046|NCT00357123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6438047|NCT00357123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6438048|NCT00357123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6438049|NCT00357149|Cisplatin|cisplatin|mesh-list
6438050|NCT00357149|Docetaxel|docetaxel|mesh-list
6438051|NCT00357149|Fluorouracil|fluorouracil|mesh-list
6438052|NCT00357149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6438053|NCT00357149|Tubulin Modulators|tubulin modulators|mesh-ancestor
6438054|NCT00357149|Antimitotic Agents|antimitotic agents|mesh-ancestor
6438055|NCT00357149|Mitosis Modulators|mitosis modulators|mesh-ancestor
6438056|NCT00357149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438057|NCT00357149|Antimetabolites|antimetabolites|mesh-ancestor
6438058|NCT00357149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6438059|NCT00357149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6438060|NCT00357149|Immunologic Factors|immunologic factors|mesh-ancestor
6438061|NCT00357149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438062|NCT00357188|Ritonavir|ritonavir|mesh-list
6438063|NCT00357188|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6438064|NCT00357188|Efavirenz|efavirenz|mesh-list
6438065|NCT00357188|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6438066|NCT00357188|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6438067|NCT00357188|Protease Inhibitors|protease inhibitors|mesh-ancestor
6438068|NCT00357188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6438069|NCT00357188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438070|NCT00357188|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6438071|NCT00357188|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6438072|NCT00357188|Antiviral Agents|antiviral agents|mesh-ancestor
6438073|NCT00357188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6438074|NCT00357188|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6438075|NCT00357188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6438076|NCT00357188|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6438077|NCT00357188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6438078|NCT00357188|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6438079|NCT00357188|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6438080|NCT00357188|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6438081|NCT00357188|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6438082|NCT00357188|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6438083|NCT00357240|Ritonavir|ritonavir|mesh-list
6438084|NCT00357240|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6542032|NCT00849030|Tamoxifen|tamoxifen|mesh-list
6542033|NCT00849030|Anastrozole|anastrozole|mesh-list
6542034|NCT00849030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6542035|NCT00849030|Hormone Antagonists|hormone antagonists|mesh-ancestor
6542036|NCT00849030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6542037|NCT00849030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542038|NCT00849030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6542039|NCT00849030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6542040|NCT00849030|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6542041|NCT00849030|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6542042|NCT00849030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6542043|NCT00849030|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6438085|NCT00357240|Omeprazole|omeprazole|mesh-list
6438086|NCT00357240|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6438087|NCT00357240|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6438088|NCT00357240|Protease Inhibitors|protease inhibitors|mesh-ancestor
6542044|NCT00849030|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6542045|NCT00849030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6542046|NCT00849030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542047|NCT00849082|Goserelin|goserelin|mesh-list
6542048|NCT00849082|Cyproterone Acetate|cyproterone acetate|mesh-list
6542049|NCT00849082|Cyproterone|cyproterone|mesh-list
6542050|NCT00849082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6542051|NCT00849082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6542052|NCT00849082|Androgen Antagonists|androgen antagonists|mesh-ancestor
6542053|NCT00849082|Hormone Antagonists|hormone antagonists|mesh-ancestor
6542054|NCT00849082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6542055|NCT00849082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542056|NCT00849082|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6542057|NCT00849082|Contraceptive Agents|contraceptive agents|mesh-ancestor
6542058|NCT00849082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6542059|NCT00849095|Budesonide|budesonide|mesh-list
6542060|NCT00849095|Terbutaline|terbutaline|mesh-list
6542061|NCT00849095|Formoterol Fumarate|formoterol fumarate|mesh-list
6542062|NCT00849095|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6542063|NCT00849095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6542064|NCT00849095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6542065|NCT00849095|Autonomic Agents|autonomic agents|mesh-ancestor
6542066|NCT00849095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6542067|NCT00849095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542068|NCT00849095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6542069|NCT00849095|Respiratory System Agents|respiratory system agents|mesh-ancestor
6542070|NCT00849095|Glucocorticoids|glucocorticoids|mesh-ancestor
6438089|NCT00357240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6438090|NCT00357240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438091|NCT00357240|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6438092|NCT00357240|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6438093|NCT00357240|Antiviral Agents|antiviral agents|mesh-ancestor
6438094|NCT00357240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6438095|NCT00357240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6438096|NCT00357240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6438097|NCT00357240|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6438098|NCT00357240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6438099|NCT00357240|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6438100|NCT00357253|Capecitabine|capecitabine|mesh-list
6438101|NCT00357253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6438102|NCT00357253|Antimetabolites|antimetabolites|mesh-ancestor
6438103|NCT00357253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438104|NCT00357253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6438105|NCT00357292|Azithromycin|azithromycin|mesh-list
6438106|NCT00357292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6438107|NCT00357292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6438108|NCT00357305|Cytarabine|cytarabine|mesh-list
6438109|NCT00357305|Etoposide|etoposide|mesh-list
6438110|NCT00357305|Etoposide phosphate|etoposide phosphate|mesh-list
6438111|NCT00357305|Vorinostat|vorinostat|mesh-list
6438112|NCT00357305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6438113|NCT00357305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6438114|NCT00357305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6438115|NCT00357305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6438116|NCT00357305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6438117|NCT00357305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438118|NCT00357305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6438119|NCT00357305|Antimetabolites|antimetabolites|mesh-ancestor
6438120|NCT00357305|Antiviral Agents|antiviral agents|mesh-ancestor
6438121|NCT00357305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6438122|NCT00357305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6438123|NCT00357305|Immunologic Factors|immunologic factors|mesh-ancestor
6438124|NCT00357305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438125|NCT00357305|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6438126|NCT00357318|Bevacizumab|bevacizumab|mesh-list
6438127|NCT00357318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6438128|NCT00357318|Sunitinib|sunitinib|mesh-list
6438129|NCT00357318|Antibodies|antibodies|mesh-list
6438130|NCT00357318|Immunoglobulins|immunoglobulins|mesh-list
6438131|NCT00357318|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6438132|NCT00357318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6438133|NCT00357318|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6438134|NCT00357318|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6438135|NCT00357318|Growth Substances|growth substances|mesh-ancestor
6438136|NCT00357318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438137|NCT00357318|Growth Inhibitors|growth inhibitors|mesh-ancestor
6438138|NCT00357318|Immunologic Factors|immunologic factors|mesh-ancestor
6438139|NCT00357318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6438140|NCT00357318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6438141|NCT00357318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438142|NCT00357383|Azithromycin|azithromycin|mesh-list
6438143|NCT00357383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6438144|NCT00357383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6438145|NCT00357422|Ethanol|ethanol|mesh-list
6438146|NCT00357422|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6438147|NCT00357422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6438148|NCT00357422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6542071|NCT00849095|Hormones|hormones|mesh-ancestor
6542072|NCT00849095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6542073|NCT00849095|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6542074|NCT00849095|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6542075|NCT00849095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6542076|NCT00849095|Adrenergic Agents|adrenergic agents|mesh-ancestor
6542077|NCT00849095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6542078|NCT00849095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542079|NCT00849095|Sympathomimetics|sympathomimetics|mesh-ancestor
6542080|NCT00849095|Tocolytic Agents|tocolytic agents|mesh-ancestor
6542081|NCT00849095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6542082|NCT00849160|Darunavir|darunavir|mesh-list
6542083|NCT00849160|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6542084|NCT00849160|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6542085|NCT00849160|Protease Inhibitors|protease inhibitors|mesh-ancestor
6542086|NCT00849160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6542087|NCT00849160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542088|NCT00849160|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6542089|NCT00849160|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6542090|NCT00849160|Antiviral Agents|antiviral agents|mesh-ancestor
6542091|NCT00849160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6542092|NCT00849238|Mycophenolic Acid|mycophenolic acid|mesh-list
6542093|NCT00849238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6542094|NCT00849238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6542095|NCT00849238|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6542096|NCT00849238|Antitubercular Agents|antitubercular agents|mesh-ancestor
6542097|NCT00849238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6542098|NCT00849238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6542099|NCT00849238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6542100|NCT00849238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542101|NCT00849264|Fluorouracil|fluorouracil|mesh-list
6542102|NCT00849264|Endostar protein|endostar protein|mesh-list
6542103|NCT00849264|Antimetabolites|antimetabolites|mesh-ancestor
6542104|NCT00849264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542105|NCT00849264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6542106|NCT00849264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6542107|NCT00849264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6542108|NCT00849264|Immunologic Factors|immunologic factors|mesh-ancestor
6542109|NCT00849264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542110|NCT00849264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6542111|NCT00849264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6542112|NCT00849264|Growth Substances|growth substances|mesh-ancestor
6542113|NCT00849264|Growth Inhibitors|growth inhibitors|mesh-ancestor
6542114|NCT00849316|Insulin Aspart|insulin aspart|mesh-list
6542115|NCT00849316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6542116|NCT00849316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542117|NCT00849329|Lapatinib|lapatinib|mesh-list
6542118|NCT00849329|Esomeprazole|esomeprazole|mesh-list
6542119|NCT00849329|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6542120|NCT00849329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6542121|NCT00849329|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6542122|NCT00849329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6542123|NCT00849329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542124|NCT00849329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6542125|NCT00849329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6542126|NCT00849342|Insulin Detemir|insulin detemir|mesh-list
6542127|NCT00849342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6542128|NCT00849342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542129|NCT00849355|Rituximab|rituximab|mesh-list
6542130|NCT00849355|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6542131|NCT00849355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6542132|NCT00849355|Immunologic Factors|immunologic factors|mesh-ancestor
6542133|NCT00849355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542134|NCT00849355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6438149|NCT00357422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438150|NCT00357448|Interleukin-2|interleukin-2|mesh-list
6438151|NCT00357448|Denileukin diftitox|denileukin diftitox|mesh-list
6438152|NCT00357448|Immunotoxins|immunotoxins|mesh-list
6438153|NCT00357448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6438154|NCT00357448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6438155|NCT00357448|Analgesics|analgesics|mesh-ancestor
6542135|NCT00849368|Azathioprine|azathioprine|mesh-list
6438156|NCT00357448|Sensory System Agents|sensory system agents|mesh-ancestor
6438157|NCT00357448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6438158|NCT00357448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438159|NCT00357448|Immunologic Factors|immunologic factors|mesh-ancestor
6438160|NCT00357461|Ipilimumab|ipilimumab|mesh-list
6438161|NCT00357461|Vaccines|vaccines|mesh-list
6438162|NCT00357461|Freund's Adjuvant|freund's adjuvant|mesh-list
6438163|NCT00357461|Immunologic Factors|immunologic factors|mesh-ancestor
6438164|NCT00357461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438165|NCT00357461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6438166|NCT00357461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6438167|NCT00357461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6438168|NCT00357461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438169|NCT00357461|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6438170|NCT00357474|Ethanol|ethanol|mesh-list
6438171|NCT00357474|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6438172|NCT00357474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6438173|NCT00357474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6438174|NCT00357474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438175|NCT00357539|Azithromycin|azithromycin|mesh-list
6438176|NCT00357539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6438177|NCT00357539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6438178|NCT00357604|Ritonavir|ritonavir|mesh-list
6438179|NCT00357604|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6438180|NCT00357604|Moxifloxacin|moxifloxacin|mesh-list
6438181|NCT00357604|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6438182|NCT00357604|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6438183|NCT00357604|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6438184|NCT00357604|Norgestimate|norgestimate|mesh-list
6438185|NCT00357604|Norgestrel|norgestrel|mesh-list
6438186|NCT00357604|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6438187|NCT00357604|Estradiol|estradiol|mesh-list
6438188|NCT00357604|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6438189|NCT00357604|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6438190|NCT00357604|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6438191|NCT00357604|Protease Inhibitors|protease inhibitors|mesh-ancestor
6438192|NCT00357604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6438193|NCT00357604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438194|NCT00357604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6438195|NCT00357604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6438196|NCT00357604|Antiviral Agents|antiviral agents|mesh-ancestor
6438197|NCT00357604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6438198|NCT00357604|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6438199|NCT00357604|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6438200|NCT00357604|Estrogens|estrogens|mesh-ancestor
6438201|NCT00357604|Hormones|hormones|mesh-ancestor
6438202|NCT00357604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6438203|NCT00357604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438204|NCT00357604|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6438205|NCT00357604|Contraceptive Agents|contraceptive agents|mesh-ancestor
6438206|NCT00357604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6438207|NCT00357604|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6438208|NCT00357604|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6438209|NCT00357604|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6438210|NCT00357604|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6438211|NCT00357604|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6438212|NCT00357604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6438213|NCT00357604|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6438214|NCT00357604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6438215|NCT00357604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6438216|NCT00357617|Celecoxib|celecoxib|mesh-list
6438217|NCT00357617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6438218|NCT00357617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6438219|NCT00357617|Analgesics|analgesics|mesh-ancestor
6438220|NCT00357617|Sensory System Agents|sensory system agents|mesh-ancestor
6438221|NCT00357617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6438222|NCT00357617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438223|NCT00357617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6438224|NCT00357617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6438225|NCT00357617|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6438226|NCT00357617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6438227|NCT00357617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6438228|NCT00357617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438229|NCT00357630|Gemcitabine|gemcitabine|mesh-list
6438230|NCT00357630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6438231|NCT00357630|Antimetabolites|antimetabolites|mesh-ancestor
6438232|NCT00357630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438233|NCT00357630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6438234|NCT00357630|Antiviral Agents|antiviral agents|mesh-ancestor
6438235|NCT00357630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6438236|NCT00357630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6438237|NCT00357630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6438238|NCT00357630|Immunologic Factors|immunologic factors|mesh-ancestor
6438239|NCT00357630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438240|NCT00357643|Vitamin D|vitamin d|mesh-list
6438241|NCT00357643|Calcium|calcium|mesh-list
6438242|NCT00357643|Vitamins|vitamins|mesh-ancestor
6438243|NCT00357643|Micronutrients|micronutrients|mesh-ancestor
6438244|NCT00357643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438245|NCT00357643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6438246|NCT00357643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6438247|NCT00357669|Brivaracetam|brivaracetam|mesh-list
6438248|NCT00357669|Anticonvulsants|anticonvulsants|mesh-ancestor
6438249|NCT00357682|Aspirin|aspirin|mesh-list
6438250|NCT00357682|Esomeprazole|esomeprazole|mesh-list
6438251|NCT00357682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6438252|NCT00357682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6438253|NCT00357682|Analgesics|analgesics|mesh-ancestor
6542136|NCT00849368|Allopurinol|allopurinol|mesh-list
6542137|NCT00849368|Antimetabolites|antimetabolites|mesh-ancestor
6542138|NCT00849368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542139|NCT00849368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6542140|NCT00849368|Gout Suppressants|gout suppressants|mesh-ancestor
6542141|NCT00849368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6542142|NCT00849368|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6542143|NCT00849368|Antioxidants|antioxidants|mesh-ancestor
6542144|NCT00849368|Protective Agents|protective agents|mesh-ancestor
6542145|NCT00849368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542146|NCT00849368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6542147|NCT00849368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6542148|NCT00849368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6542149|NCT00849368|Immunologic Factors|immunologic factors|mesh-ancestor
6542150|NCT00849459|Interleukin-12|interleukin-12|mesh-list
6542151|NCT00849459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6542152|NCT00849459|Immunologic Factors|immunologic factors|mesh-ancestor
6542153|NCT00849459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542154|NCT00849459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6542155|NCT00849459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6542156|NCT00849459|Growth Substances|growth substances|mesh-ancestor
6542157|NCT00849459|Growth Inhibitors|growth inhibitors|mesh-ancestor
6542158|NCT00849459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6542159|NCT00849511|Melatonin|melatonin|mesh-list
6542160|NCT00849511|Antioxidants|antioxidants|mesh-ancestor
6542161|NCT00849511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542162|NCT00849511|Protective Agents|protective agents|mesh-ancestor
6542163|NCT00849511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542164|NCT00849511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6542165|NCT00849537|Triamcinolone|triamcinolone|mesh-list
6542166|NCT00849537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6542167|NCT00849537|Glucocorticoids|glucocorticoids|mesh-ancestor
6542168|NCT00849537|Hormones|hormones|mesh-ancestor
6438254|NCT00357682|Sensory System Agents|sensory system agents|mesh-ancestor
6438255|NCT00357682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6438256|NCT00357682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438257|NCT00357682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6438258|NCT00357682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6438259|NCT00357682|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6438260|NCT00357682|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6438261|NCT00357682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438262|NCT00357682|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6438263|NCT00357682|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6438264|NCT00357682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6438265|NCT00357682|Antipyretics|antipyretics|mesh-ancestor
6438266|NCT00357682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6438267|NCT00357682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6438268|NCT00357682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6438269|NCT00357708|Decitabine|decitabine|mesh-list
6438270|NCT00357708|Azacitidine|azacitidine|mesh-list
6438271|NCT00357708|Vorinostat|vorinostat|mesh-list
6438272|NCT00357708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6438273|NCT00357708|Antimetabolites|antimetabolites|mesh-ancestor
6438274|NCT00357708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438275|NCT00357708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6438276|NCT00357708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6438277|NCT00357708|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6438278|NCT00357721|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6438279|NCT00357721|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6438280|NCT00357721|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6438281|NCT00357721|Protease Inhibitors|protease inhibitors|mesh-ancestor
6438282|NCT00357721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6438283|NCT00357721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438284|NCT00357721|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6438285|NCT00357721|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6438286|NCT00357721|Antiviral Agents|antiviral agents|mesh-ancestor
6438287|NCT00357721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6461358|NCT00454402|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6461359|NCT00454402|Adrenergic Agents|adrenergic agents|mesh-ancestor
6461360|NCT00454402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6461361|NCT00454402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461362|NCT00454402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461363|NCT00454402|Urological Agents|urological agents|mesh-ancestor
6542169|NCT00849537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6542170|NCT00849537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542171|NCT00849550|Bevacizumab|bevacizumab|mesh-list
6542172|NCT00849550|Capecitabine|capecitabine|mesh-list
6542173|NCT00849550|Oxaliplatin|oxaliplatin|mesh-list
6542174|NCT00849550|Everolimus|everolimus|mesh-list
6542175|NCT00849550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6542176|NCT00849550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6542177|NCT00849550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6542178|NCT00849550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6542179|NCT00849550|Growth Substances|growth substances|mesh-ancestor
6542180|NCT00849550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542181|NCT00849550|Growth Inhibitors|growth inhibitors|mesh-ancestor
6542182|NCT00849550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6542183|NCT00849550|Antimetabolites|antimetabolites|mesh-ancestor
6542184|NCT00849550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542185|NCT00849550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6542186|NCT00849550|Immunologic Factors|immunologic factors|mesh-ancestor
6542187|NCT00849602|Chloroquine|chloroquine|mesh-list
6542188|NCT00849602|Amebicides|amebicides|mesh-ancestor
6542189|NCT00849602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6542190|NCT00849602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6542191|NCT00849602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6542192|NCT00849602|Antimalarials|antimalarials|mesh-ancestor
6542193|NCT00849602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6542194|NCT00849615|Leucovorin|leucovorin|mesh-list
6542195|NCT00849615|Folic Acid|folic acid|mesh-list
6542196|NCT00849615|Docetaxel|docetaxel|mesh-list
6542197|NCT00849615|Fluorouracil|fluorouracil|mesh-list
6542198|NCT00849615|Oxaliplatin|oxaliplatin|mesh-list
6438288|NCT00357747|Docetaxel|docetaxel|mesh-list
6438289|NCT00357747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6438290|NCT00357747|Tubulin Modulators|tubulin modulators|mesh-ancestor
6438291|NCT00357747|Antimitotic Agents|antimitotic agents|mesh-ancestor
6438292|NCT00357747|Mitosis Modulators|mitosis modulators|mesh-ancestor
6438293|NCT00357747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438294|NCT00357773|Azithromycin|azithromycin|mesh-list
6438295|NCT00357773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6438296|NCT00357773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6438297|NCT00357825|Reboxetine|reboxetine|mesh-list
6438298|NCT00357825|Antidepressive Agents|antidepressive agents|mesh-ancestor
6438299|NCT00357825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6438300|NCT00357825|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6438301|NCT00357825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6438302|NCT00357825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6438303|NCT00357825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438304|NCT00357825|Adrenergic Agents|adrenergic agents|mesh-ancestor
6438305|NCT00357825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6438306|NCT00357825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438307|NCT00357851|Aprotinin|aprotinin|mesh-list
6438308|NCT00357851|Hemostatics|hemostatics|mesh-ancestor
6438309|NCT00357851|Coagulants|coagulants|mesh-ancestor
6438310|NCT00357851|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6438311|NCT00357851|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6438312|NCT00357851|Protease Inhibitors|protease inhibitors|mesh-ancestor
6438313|NCT00357851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6438314|NCT00357851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438315|NCT00357864|Carbachol|carbachol|mesh-list
6438316|NCT00357864|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6438317|NCT00357864|Miotics|miotics|mesh-ancestor
6438318|NCT00357864|Autonomic Agents|autonomic agents|mesh-ancestor
6438319|NCT00357864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6438320|NCT00357864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438321|NCT00357864|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6438322|NCT00357864|Cholinergic Agents|cholinergic agents|mesh-ancestor
6438323|NCT00357864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6438324|NCT00357864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438325|NCT00357864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6438326|NCT00357864|Analgesics|analgesics|mesh-ancestor
6438327|NCT00357864|Sensory System Agents|sensory system agents|mesh-ancestor
6438328|NCT00357864|Protective Agents|protective agents|mesh-ancestor
6438329|NCT00357890|Insulin Glargine|insulin glargine|mesh-list
6438330|NCT00357890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6438331|NCT00357890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438332|NCT00357942|Morphine|morphine|mesh-list
6438333|NCT00357942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6438334|NCT00357942|Narcotics|narcotics|mesh-ancestor
6438335|NCT00357942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6438336|NCT00357942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438337|NCT00357942|Analgesics|analgesics|mesh-ancestor
6438338|NCT00357942|Sensory System Agents|sensory system agents|mesh-ancestor
6438339|NCT00357942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6438340|NCT00357981|Contraceptive Agents|contraceptive agents|mesh-list
6438341|NCT00357981|Ortho Evra|ortho evra|mesh-list
6438342|NCT00357981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6438343|NCT00357981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438344|NCT00357981|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6438345|NCT00358020|Thalidomide|thalidomide|mesh-list
6438346|NCT00358020|Bortezomib|bortezomib|mesh-list
6438347|NCT00358020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6438348|NCT00358020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6438349|NCT00358020|Immunologic Factors|immunologic factors|mesh-ancestor
6438350|NCT00358020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438351|NCT00358020|Leprostatic Agents|leprostatic agents|mesh-ancestor
6438352|NCT00358020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6438353|NCT00358020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6542199|NCT00849615|Levoleucovorin|levoleucovorin|mesh-list
6542200|NCT00849615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6542201|NCT00849615|Tubulin Modulators|tubulin modulators|mesh-ancestor
6542202|NCT00849615|Antimitotic Agents|antimitotic agents|mesh-ancestor
6542203|NCT00849615|Mitosis Modulators|mitosis modulators|mesh-ancestor
6542204|NCT00849615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542205|NCT00849615|Antimetabolites|antimetabolites|mesh-ancestor
6542206|NCT00849615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6542207|NCT00849615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6542208|NCT00849615|Immunologic Factors|immunologic factors|mesh-ancestor
6542209|NCT00849615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542210|NCT00849615|Antidotes|antidotes|mesh-ancestor
6542211|NCT00849615|Protective Agents|protective agents|mesh-ancestor
6542212|NCT00849615|Vitamin B Complex|vitamin b complex|mesh-ancestor
6542213|NCT00849615|Vitamins|vitamins|mesh-ancestor
6542214|NCT00849615|Micronutrients|micronutrients|mesh-ancestor
6542215|NCT00849615|Hematinics|hematinics|mesh-ancestor
6542216|NCT00849745|Alemtuzumab|alemtuzumab|mesh-list
6542217|NCT00849745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6542218|NCT00849745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6655556|NCT01464489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6655557|NCT01464489|Respiratory System Agents|respiratory system agents|mesh-ancestor
6655558|NCT01464489|Mydriatics|mydriatics|mesh-ancestor
6655559|NCT01464489|Parasympatholytics|parasympatholytics|mesh-ancestor
6655560|NCT01464489|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6655561|NCT01464489|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6655562|NCT01464489|Cholinergic Agents|cholinergic agents|mesh-ancestor
6655563|NCT01464489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6655564|NCT01464489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655565|NCT01464528|Hyaluronic Acid|hyaluronic acid|mesh-list
6655566|NCT01464528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6655567|NCT01464528|Immunologic Factors|immunologic factors|mesh-ancestor
6655568|NCT01464528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655569|NCT01464528|Viscosupplements|viscosupplements|mesh-ancestor
6655570|NCT01464528|Protective Agents|protective agents|mesh-ancestor
6655571|NCT01464593|Doxorubicin|doxorubicin|mesh-list
6655572|NCT01464593|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6655573|NCT01464593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6655574|NCT01464593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6655575|NCT01464593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6655576|NCT01464593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6655577|NCT01464593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6655578|NCT01464593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655579|NCT01464606|Dactinomycin|dactinomycin|mesh-list
6019527|NCT00387790|Motexafin gadolinium|motexafin gadolinium|mesh-list
6438354|NCT00358020|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6438355|NCT00358020|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6438356|NCT00358020|Growth Substances|growth substances|mesh-ancestor
6438357|NCT00358020|Growth Inhibitors|growth inhibitors|mesh-ancestor
6438358|NCT00358124|Metformin|metformin|mesh-list
6438359|NCT00358124|Insulin Glargine|insulin glargine|mesh-list
6438360|NCT00358124|Rosiglitazone|rosiglitazone|mesh-list
6438361|NCT00358124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6655580|NCT01464606|Cyclophosphamide|cyclophosphamide|mesh-list
6438362|NCT00358124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438363|NCT00358163|Paclitaxel|paclitaxel|mesh-list
6438364|NCT00358163|Vatalanib|vatalanib|mesh-list
6438365|NCT00358163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6438366|NCT00358163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6438367|NCT00358163|Tubulin Modulators|tubulin modulators|mesh-ancestor
6438368|NCT00358163|Antimitotic Agents|antimitotic agents|mesh-ancestor
6438369|NCT00358163|Mitosis Modulators|mitosis modulators|mesh-ancestor
6438370|NCT00358163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438371|NCT00358163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6438372|NCT00358163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6438373|NCT00358176|Risedronic Acid|risedronic acid|mesh-list
6438374|NCT00358176|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6438375|NCT00358176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6438376|NCT00358176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438377|NCT00358176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6438378|NCT00358176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438379|NCT00358176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6438380|NCT00358202|Ceftriaxone|ceftriaxone|mesh-list
6438381|NCT00358202|Cefepime|cefepime|mesh-list
6438382|NCT00358202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6438383|NCT00358202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6438384|NCT00358228|Rimonabant|rimonabant|mesh-list
6438385|NCT00358228|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6438386|NCT00358228|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
6438387|NCT00358228|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6438388|NCT00358228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6438389|NCT00358228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438390|NCT00358228|Hormones|hormones|mesh-ancestor
6438391|NCT00358228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6438392|NCT00358228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438393|NCT00358280|Bupivacaine|bupivacaine|mesh-list
6438394|NCT00358280|Ropivacaine|ropivacaine|mesh-list
6438395|NCT00358280|Anesthetics, Local|anesthetics, local|mesh-ancestor
6438396|NCT00358280|Anesthetics|anesthetics|mesh-ancestor
6438397|NCT00358280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6438398|NCT00358280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438399|NCT00358280|Sensory System Agents|sensory system agents|mesh-ancestor
6438400|NCT00358280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6438401|NCT00358293|Tizanidine|tizanidine|mesh-list
6438402|NCT00358293|Analgesics|analgesics|mesh-ancestor
6438403|NCT00358293|Sensory System Agents|sensory system agents|mesh-ancestor
6438404|NCT00358293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6438405|NCT00358293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438406|NCT00358293|Anticonvulsants|anticonvulsants|mesh-ancestor
6438407|NCT00358293|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6438408|NCT00358293|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6438409|NCT00358293|Parasympatholytics|parasympatholytics|mesh-ancestor
6438410|NCT00358293|Autonomic Agents|autonomic agents|mesh-ancestor
6438411|NCT00358293|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6438412|NCT00358293|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6438413|NCT00358293|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6438414|NCT00358293|Adrenergic Agents|adrenergic agents|mesh-ancestor
6438415|NCT00358293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6438416|NCT00358293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438417|NCT00358319|Valproic Acid|valproic acid|mesh-list
6438418|NCT00358319|Anticonvulsants|anticonvulsants|mesh-ancestor
6438419|NCT00358319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6438420|NCT00358319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438421|NCT00358319|GABA Agents|gaba agents|mesh-ancestor
6438422|NCT00358319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6438423|NCT00358319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438424|NCT00358319|Antimanic Agents|antimanic agents|mesh-ancestor
6438425|NCT00358319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6438426|NCT00358319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6438427|NCT00358319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6438428|NCT00358358|Fluticasone|fluticasone|mesh-list
6438429|NCT00358358|Xhance|xhance|mesh-list
6438430|NCT00358358|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6438431|NCT00358358|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6438432|NCT00358358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6438433|NCT00358358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6438434|NCT00358358|Autonomic Agents|autonomic agents|mesh-ancestor
6438435|NCT00358358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6438436|NCT00358358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438437|NCT00358358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6438438|NCT00358358|Respiratory System Agents|respiratory system agents|mesh-ancestor
6438439|NCT00358358|Dermatologic Agents|dermatologic agents|mesh-ancestor
6438440|NCT00358358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6438441|NCT00358358|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6542219|NCT00849966|Celecoxib|celecoxib|mesh-list
6542220|NCT00849966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6542221|NCT00849966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6542222|NCT00849966|Analgesics|analgesics|mesh-ancestor
6542223|NCT00849966|Sensory System Agents|sensory system agents|mesh-ancestor
6542224|NCT00849966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6542225|NCT00849966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542226|NCT00849966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6542227|NCT00849966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6542228|NCT00849966|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6542229|NCT00849966|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6542230|NCT00849966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6542231|NCT00849966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542232|NCT00849992|Imiquimod|imiquimod|mesh-list
6438442|NCT00358358|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6438443|NCT00358358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6438444|NCT00358358|Adrenergic Agents|adrenergic agents|mesh-ancestor
6438445|NCT00358358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6542233|NCT00849992|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6542234|NCT00849992|Immunologic Factors|immunologic factors|mesh-ancestor
6542235|NCT00849992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542236|NCT00849992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6542237|NCT00849992|Interferon Inducers|interferon inducers|mesh-ancestor
6542238|NCT00850005|Immunoglobulins|immunoglobulins|mesh-list
6542239|NCT00850005|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6542240|NCT00850005|Antibodies|antibodies|mesh-list
6542241|NCT00850005|gamma-Globulins|gamma-globulins|mesh-list
6542242|NCT00850005|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6542243|NCT00850005|Immunologic Factors|immunologic factors|mesh-ancestor
6542244|NCT00850005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542245|NCT00850044|Ritonavir|ritonavir|mesh-list
6542246|NCT00850044|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6542247|NCT00850044|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6542248|NCT00850044|Protease Inhibitors|protease inhibitors|mesh-ancestor
6542249|NCT00850044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6542250|NCT00850044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542251|NCT00850044|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6542252|NCT00850044|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6542253|NCT00850044|Antiviral Agents|antiviral agents|mesh-ancestor
6542254|NCT00850044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6542255|NCT00850044|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6542256|NCT00850044|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6542257|NCT00850122|Cefazolin|cefazolin|mesh-list
6542258|NCT00850122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6542259|NCT00850122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6542260|NCT00850161|Insulin|insulin|mesh-list
6542261|NCT00850161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6542262|NCT00850161|Insulin Aspart|insulin aspart|mesh-list
6542263|NCT00850161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6542264|NCT00850161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542265|NCT00850304|Arsenic Trioxide|arsenic trioxide|mesh-list
6461364|NCT00454480|Cytarabine|cytarabine|mesh-list
6542266|NCT00850304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6542267|NCT00850382|Cytarabine|cytarabine|mesh-list
6438446|NCT00358358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438447|NCT00358358|Glucocorticoids|glucocorticoids|mesh-ancestor
6438448|NCT00358358|Hormones|hormones|mesh-ancestor
6438449|NCT00358358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6438450|NCT00358358|Sympathomimetics|sympathomimetics|mesh-ancestor
6438451|NCT00358371|Floxacillin|floxacillin|mesh-list
6438452|NCT00358371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6438453|NCT00358371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6438454|NCT00358384|Betamethasone|betamethasone|mesh-list
6438455|NCT00358384|Betamethasone Valerate|betamethasone valerate|mesh-list
6438456|NCT00358384|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
6438457|NCT00358384|Betamethasone benzoate|betamethasone benzoate|mesh-list
6438458|NCT00358384|Calcipotriene|calcipotriene|mesh-list
6438459|NCT00358384|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
6438460|NCT00358384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6438461|NCT00358384|Glucocorticoids|glucocorticoids|mesh-ancestor
6438462|NCT00358384|Hormones|hormones|mesh-ancestor
6438463|NCT00358384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6438464|NCT00358384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438465|NCT00358384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6438466|NCT00358384|Respiratory System Agents|respiratory system agents|mesh-ancestor
6438467|NCT00358384|Dermatologic Agents|dermatologic agents|mesh-ancestor
6438468|NCT00358410|Casopitant|casopitant|mesh-list
6438469|NCT00358410|Antiemetics|antiemetics|mesh-ancestor
6438470|NCT00358410|Autonomic Agents|autonomic agents|mesh-ancestor
6438471|NCT00358410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6438472|NCT00358410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438473|NCT00358410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6438474|NCT00358410|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6438475|NCT00358410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6438476|NCT00358410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438477|NCT00358488|Albuterol|albuterol|mesh-list
6438478|NCT00358488|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6438479|NCT00358488|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6438480|NCT00358488|Autonomic Agents|autonomic agents|mesh-ancestor
6438481|NCT00358488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6461365|NCT00454480|Fludarabine|fludarabine|mesh-list
6542268|NCT00850382|Daunorubicin|daunorubicin|mesh-list
6542269|NCT00850382|Dasatinib|dasatinib|mesh-list
6542270|NCT00850382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6542271|NCT00850382|Antimetabolites|antimetabolites|mesh-ancestor
6542272|NCT00850382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542273|NCT00850382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6542274|NCT00850382|Antiviral Agents|antiviral agents|mesh-ancestor
6542275|NCT00850382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6542276|NCT00850382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6542277|NCT00850382|Immunologic Factors|immunologic factors|mesh-ancestor
6542278|NCT00850382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542279|NCT00850382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6542280|NCT00850382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6542281|NCT00850382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6542282|NCT00850382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6542283|NCT00850382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6542284|NCT00850668|Hypoxanthine arabinoside|hypoxanthine arabinoside|mesh-list
6542285|NCT00850668|Antiviral Agents|antiviral agents|mesh-ancestor
6542286|NCT00850668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6542287|NCT00850746|Moxifloxacin|moxifloxacin|mesh-list
6542288|NCT00850746|Z 338|z 338|mesh-list
6542289|NCT00850746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6438482|NCT00358488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438483|NCT00358488|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6438484|NCT00358488|Respiratory System Agents|respiratory system agents|mesh-ancestor
6438485|NCT00358488|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6438486|NCT00358488|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6438487|NCT00358488|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6438488|NCT00358488|Adrenergic Agents|adrenergic agents|mesh-ancestor
6438489|NCT00358488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6438490|NCT00358488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438491|NCT00358488|Tocolytic Agents|tocolytic agents|mesh-ancestor
6438492|NCT00358488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6438493|NCT00358553|Insulin|insulin|mesh-list
6438494|NCT00358553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6438495|NCT00358553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438496|NCT00358566|Gemcitabine|gemcitabine|mesh-list
6438497|NCT00358566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6438498|NCT00358566|Antimetabolites|antimetabolites|mesh-ancestor
6438499|NCT00358566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438500|NCT00358566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6438501|NCT00358566|Antiviral Agents|antiviral agents|mesh-ancestor
6438502|NCT00358566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6019528|NCT00387790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6019529|NCT00387790|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6019530|NCT00387790|Dermatologic Agents|dermatologic agents|mesh-ancestor
6019531|NCT00387829|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6019532|NCT00387829|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6019533|NCT00387829|Estradiol|estradiol|mesh-list
6019534|NCT00387829|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6019535|NCT00387829|Estrogens|estrogens|mesh-ancestor
6019536|NCT00387829|Hormones|hormones|mesh-ancestor
6019537|NCT00387829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6438503|NCT00358566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6438504|NCT00358566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6438505|NCT00358566|Immunologic Factors|immunologic factors|mesh-ancestor
6438506|NCT00358566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438507|NCT00358618|Propofol|propofol|mesh-list
6438508|NCT00358618|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6438509|NCT00358618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6438510|NCT00358618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438511|NCT00358618|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6438512|NCT00358618|Anesthetics, General|anesthetics, general|mesh-ancestor
6438513|NCT00358618|Anesthetics|anesthetics|mesh-ancestor
6438514|NCT00358683|Certolizumab Pegol|certolizumab pegol|mesh-list
6438515|NCT00358683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6438516|NCT00358683|Immunologic Factors|immunologic factors|mesh-ancestor
6438517|NCT00358683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438518|NCT00358683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6438519|NCT00358696|Tenofovir|tenofovir|mesh-list
6438520|NCT00358696|Antiviral Agents|antiviral agents|mesh-ancestor
6438521|NCT00358696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6438522|NCT00358696|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6438523|NCT00358696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6438524|NCT00358696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6438525|NCT00358696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438526|NCT00358696|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6438527|NCT00358696|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6438528|NCT00358748|Hydrocortisone|hydrocortisone|mesh-list
6438529|NCT00358748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6438530|NCT00358813|Casopitant|casopitant|mesh-list
6438531|NCT00358813|Antiemetics|antiemetics|mesh-ancestor
6438532|NCT00358813|Autonomic Agents|autonomic agents|mesh-ancestor
6438533|NCT00358813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6438534|NCT00358813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438535|NCT00358813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6438536|NCT00358813|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6438537|NCT00358813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6438538|NCT00358813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438539|NCT00358930|Beta-lapachone|beta-lapachone|mesh-list
6438540|NCT00358930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6438541|NCT00358930|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6438542|NCT00358930|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6438543|NCT00358930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6438544|NCT00358930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438545|NCT00358930|Antiviral Agents|antiviral agents|mesh-ancestor
6438546|NCT00358969|Guanfacine|guanfacine|mesh-list
6438547|NCT00358969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6438548|NCT00358969|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6438549|NCT00358969|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6438550|NCT00358969|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6438551|NCT00358969|Adrenergic Agents|adrenergic agents|mesh-ancestor
6438552|NCT00358969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6438553|NCT00358969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438554|NCT00358969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438555|NCT00359112|Metformin|metformin|mesh-list
6438556|NCT00359112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6438557|NCT00359112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438558|NCT00359125|Mifepristone|mifepristone|mesh-list
6438559|NCT00359125|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6438560|NCT00359125|Abortifacient Agents|abortifacient agents|mesh-ancestor
6438561|NCT00359125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6438562|NCT00359125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438563|NCT00359125|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6438564|NCT00359125|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6438565|NCT00359125|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6438566|NCT00359125|Contraceptive Agents|contraceptive agents|mesh-ancestor
6438567|NCT00359125|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6438568|NCT00359125|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6438569|NCT00359125|Hormone Antagonists|hormone antagonists|mesh-ancestor
6438570|NCT00359125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6438571|NCT00359125|Luteolytic Agents|luteolytic agents|mesh-ancestor
6438572|NCT00359125|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6438573|NCT00359125|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6438574|NCT00359151|Celecoxib|celecoxib|mesh-list
6438575|NCT00359151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6438576|NCT00359151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6438577|NCT00359151|Analgesics|analgesics|mesh-ancestor
6438578|NCT00359151|Sensory System Agents|sensory system agents|mesh-ancestor
6438579|NCT00359151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6438580|NCT00359151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438581|NCT00359151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6438582|NCT00359151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6438583|NCT00359151|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6438584|NCT00359151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6438585|NCT00359151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6438586|NCT00359151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438587|NCT00359164|Bevacizumab|bevacizumab|mesh-list
6438588|NCT00359164|Verteporfin|verteporfin|mesh-list
6438589|NCT00359164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6438590|NCT00359164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6438591|NCT00359164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6438592|NCT00359164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6438593|NCT00359164|Growth Substances|growth substances|mesh-ancestor
6438594|NCT00359164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438595|NCT00359164|Growth Inhibitors|growth inhibitors|mesh-ancestor
6438596|NCT00359164|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6438597|NCT00359164|Dermatologic Agents|dermatologic agents|mesh-ancestor
6438598|NCT00359177|Casopitant|casopitant|mesh-list
6438599|NCT00359177|Antiemetics|antiemetics|mesh-ancestor
6438600|NCT00359177|Autonomic Agents|autonomic agents|mesh-ancestor
6438601|NCT00359177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6438602|NCT00359177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438603|NCT00359177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6438604|NCT00359177|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6438605|NCT00359177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6438606|NCT00359177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438607|NCT00359190|Lapatinib|lapatinib|mesh-list
6438608|NCT00359190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6438609|NCT00359190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6438610|NCT00359190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6438611|NCT00359190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438612|NCT00359229|Zolpidem|zolpidem|mesh-list
6438613|NCT00359229|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6438614|NCT00359229|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6438615|NCT00359229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6438616|NCT00359229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438617|NCT00359229|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6438618|NCT00359229|GABA Agonists|gaba agonists|mesh-ancestor
6438619|NCT00359229|GABA Agents|gaba agents|mesh-ancestor
6438620|NCT00359229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6438621|NCT00359229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438622|NCT00359333|Gemcitabine|gemcitabine|mesh-list
6438623|NCT00359333|Docetaxel|docetaxel|mesh-list
6438624|NCT00359333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6438625|NCT00359333|Antimetabolites|antimetabolites|mesh-ancestor
6438626|NCT00359333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438627|NCT00359333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6438628|NCT00359333|Antiviral Agents|antiviral agents|mesh-ancestor
6438629|NCT00359333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6438630|NCT00359333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6438631|NCT00359333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6438632|NCT00359333|Immunologic Factors|immunologic factors|mesh-ancestor
6438633|NCT00359333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438634|NCT00359333|Tubulin Modulators|tubulin modulators|mesh-ancestor
6438635|NCT00359333|Antimitotic Agents|antimitotic agents|mesh-ancestor
6438636|NCT00359333|Mitosis Modulators|mitosis modulators|mesh-ancestor
6438637|NCT00359359|Sagopilone|sagopilone|mesh-list
6542290|NCT00850746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6542291|NCT00850746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6542292|NCT00850746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6542293|NCT00850746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6542294|NCT00850746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542295|NCT00850746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6542296|NCT00850746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542297|NCT00850746|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6542298|NCT00850746|Cholinergic Agents|cholinergic agents|mesh-ancestor
6542299|NCT00850746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6542300|NCT00850746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6542301|NCT00850850|Physostigmine|physostigmine|mesh-list
6542302|NCT00850850|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6542303|NCT00850850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6542304|NCT00850850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542305|NCT00850850|Cholinergic Agents|cholinergic agents|mesh-ancestor
6542306|NCT00850850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6542307|NCT00850850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542308|NCT00850850|Miotics|miotics|mesh-ancestor
6542309|NCT00850850|Autonomic Agents|autonomic agents|mesh-ancestor
6542310|NCT00850850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6542311|NCT00851136|Bevacizumab|bevacizumab|mesh-list
6542312|NCT00851136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6542313|NCT00851136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6542314|NCT00851136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6542315|NCT00851136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6542316|NCT00851136|Growth Substances|growth substances|mesh-ancestor
6542317|NCT00851136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542318|NCT00851136|Growth Inhibitors|growth inhibitors|mesh-ancestor
6542319|NCT00851175|Caffeine|caffeine|mesh-list
5724725|NCT03185351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724726|NCT03185351|Sensory System Agents|sensory system agents|mesh-ancestor
5724727|NCT03185351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5724728|NCT03185351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5724729|NCT03185351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5724730|NCT03185351|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5724731|NCT03185351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6438638|NCT00359359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6438639|NCT00359385|Alendronate|alendronate|mesh-list
6438640|NCT00359385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6438641|NCT00359385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438642|NCT00359567|Palonosetron|palonosetron|mesh-list
6438643|NCT00359567|Granisetron|granisetron|mesh-list
6438644|NCT00359567|Antiemetics|antiemetics|mesh-ancestor
6438645|NCT00359567|Autonomic Agents|autonomic agents|mesh-ancestor
6438646|NCT00359567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6438647|NCT00359567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438648|NCT00359567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6438649|NCT00359567|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6438650|NCT00359567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6438651|NCT00359567|Serotonin Agents|serotonin agents|mesh-ancestor
6438652|NCT00359567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6438653|NCT00359567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461366|NCT00454480|Fludarabine phosphate|fludarabine phosphate|mesh-list
6461367|NCT00454480|Azacitidine|azacitidine|mesh-list
6461368|NCT00454480|Melphalan|melphalan|mesh-list
6461369|NCT00454480|Busulfan|busulfan|mesh-list
6461370|NCT00454480|Daunorubicin|daunorubicin|mesh-list
6461371|NCT00454480|Alemtuzumab|alemtuzumab|mesh-list
6461372|NCT00454480|Clofarabine|clofarabine|mesh-list
6461373|NCT00454480|Arsenic Trioxide|arsenic trioxide|mesh-list
6461374|NCT00454480|Gemtuzumab|gemtuzumab|mesh-list
6461375|NCT00454480|Tipifarnib|tipifarnib|mesh-list
6461376|NCT00454480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6461377|NCT00454480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6461378|NCT00454480|Antimetabolites|antimetabolites|mesh-ancestor
6461379|NCT00454480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461380|NCT00454480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6461381|NCT00454480|Immunologic Factors|immunologic factors|mesh-ancestor
6461382|NCT00454480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461383|NCT00454480|Antiviral Agents|antiviral agents|mesh-ancestor
6461384|NCT00454480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6461385|NCT00454480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6461386|NCT00454480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6461387|NCT00454480|Alkylating Agents|alkylating agents|mesh-ancestor
6461388|NCT00454480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6461389|NCT00454480|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6461390|NCT00454480|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6461391|NCT00454480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6461392|NCT00454480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6461393|NCT00454519|Mitomycins|mitomycins|mesh-list
6461394|NCT00454519|Mitomycin|mitomycin|mesh-list
6461395|NCT00454519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6461396|NCT00454519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6461397|NCT00454519|Alkylating Agents|alkylating agents|mesh-ancestor
6461398|NCT00454519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461399|NCT00454519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6461400|NCT00454519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6461401|NCT00454545|Atorvastatin|atorvastatin|mesh-list
6461402|NCT00454545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6461403|NCT00454545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6461404|NCT00454545|Antimetabolites|antimetabolites|mesh-ancestor
6461405|NCT00454545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461406|NCT00454545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6461407|NCT00454545|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6461408|NCT00454545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6461409|NCT00454558|Riociguat|riociguat|mesh-list
6461410|NCT00454558|Enzyme Activators|enzyme activators|mesh-ancestor
6461411|NCT00454558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461412|NCT00454662|Amlodipine|amlodipine|mesh-list
6461413|NCT00454662|Olmesartan|olmesartan|mesh-list
6461414|NCT00454662|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6461415|NCT00454662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6461416|NCT00454662|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5724732|NCT03185351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6542320|NCT00851175|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6438654|NCT00359606|Tetrahydrouridine|tetrahydrouridine|mesh-list
6438655|NCT00359606|Antimetabolites|antimetabolites|mesh-ancestor
6438656|NCT00359606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438657|NCT00359658|Cyclosporine|cyclosporine|mesh-list
6438658|NCT00359658|Prednisolone|prednisolone|mesh-list
6438659|NCT00359658|Cyclosporins|cyclosporins|mesh-list
6438660|NCT00359658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6438661|NCT00359658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542321|NCT00851175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6542322|NCT00851175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6542323|NCT00851175|Antimetabolites|antimetabolites|mesh-ancestor
6542324|NCT00851175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542325|NCT00851175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6542326|NCT00851175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6542327|NCT00851175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6542328|NCT00851175|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6542329|NCT00851175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542330|NCT00851175|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6542331|NCT00851175|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6542332|NCT00851175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6542333|NCT00851175|Purinergic Agents|purinergic agents|mesh-ancestor
6542334|NCT00851175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6542335|NCT00851227|Conivaptan|conivaptan|mesh-list
6542336|NCT00851227|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6542337|NCT00851227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542338|NCT00851227|Natriuretic Agents|natriuretic agents|mesh-ancestor
6542339|NCT00851227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542340|NCT00851344|Cetirizine|cetirizine|mesh-list
6542341|NCT00851344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6542342|NCT00851344|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6542343|NCT00851344|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6438662|NCT00359658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6438663|NCT00359658|Immunologic Factors|immunologic factors|mesh-ancestor
6438664|NCT00359658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438665|NCT00359658|Antifungal Agents|antifungal agents|mesh-ancestor
6542344|NCT00851344|Histamine Antagonists|histamine antagonists|mesh-ancestor
6542345|NCT00851344|Histamine Agents|histamine agents|mesh-ancestor
6542346|NCT00851344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6542347|NCT00851344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542348|NCT00851344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438666|NCT00359658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6438667|NCT00359658|Dermatologic Agents|dermatologic agents|mesh-ancestor
6438668|NCT00359658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6542349|NCT00851370|Omalizumab|omalizumab|mesh-list
6542350|NCT00851370|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6542351|NCT00851370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6438669|NCT00359658|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6438670|NCT00359658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6438671|NCT00359658|Glucocorticoids|glucocorticoids|mesh-ancestor
6438672|NCT00359658|Hormones|hormones|mesh-ancestor
6438673|NCT00359658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6438674|NCT00359658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6438675|NCT00359658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6438676|NCT00359671|Docetaxel|docetaxel|mesh-list
6438677|NCT00359671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6438678|NCT00359671|Tubulin Modulators|tubulin modulators|mesh-ancestor
6438679|NCT00359671|Antimitotic Agents|antimitotic agents|mesh-ancestor
6438680|NCT00359671|Mitosis Modulators|mitosis modulators|mesh-ancestor
6438681|NCT00359671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438682|NCT00359697|Mannitol|mannitol|mesh-list
6438683|NCT00359697|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6438684|NCT00359697|Diuretics|diuretics|mesh-ancestor
6438685|NCT00359697|Natriuretic Agents|natriuretic agents|mesh-ancestor
6438686|NCT00359697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438687|NCT00359723|Methylphenidate|methylphenidate|mesh-list
6438688|NCT00359723|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6438689|NCT00359723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438690|NCT00359723|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6438691|NCT00359723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6438692|NCT00359723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6438693|NCT00359723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438694|NCT00359723|Dopamine Agents|dopamine agents|mesh-ancestor
6438695|NCT00359723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6438696|NCT00359814|Cyclosporine|cyclosporine|mesh-list
6438697|NCT00359814|Cyclosporins|cyclosporins|mesh-list
6438698|NCT00359814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6438699|NCT00359814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438700|NCT00359814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6438701|NCT00359814|Immunologic Factors|immunologic factors|mesh-ancestor
6438702|NCT00359814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438703|NCT00359814|Antifungal Agents|antifungal agents|mesh-ancestor
6438704|NCT00359814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6438705|NCT00359814|Dermatologic Agents|dermatologic agents|mesh-ancestor
6438706|NCT00359814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6438707|NCT00359814|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6438708|NCT00359840|Darbepoetin alfa|darbepoetin alfa|mesh-list
6438709|NCT00359840|Hematinics|hematinics|mesh-ancestor
6438710|NCT00359853|Norfloxacin|norfloxacin|mesh-list
6438711|NCT00359853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6438712|NCT00359853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6438713|NCT00359853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6438714|NCT00359853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6438715|NCT00359853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6438716|NCT00359853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438717|NCT00359853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6438718|NCT00359853|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6438719|NCT00359853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5724733|NCT03185351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6438720|NCT00359879|Exenatide|exenatide|mesh-list
6438721|NCT00359879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6438722|NCT00359879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438723|NCT00359879|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6438724|NCT00359879|Incretins|incretins|mesh-ancestor
6438725|NCT00359879|Hormones|hormones|mesh-ancestor
6438726|NCT00359879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6438727|NCT00359892|Obatoclax|obatoclax|mesh-list
6438728|NCT00359892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6438729|NCT00359892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438730|NCT00359905|Tamsulosin|tamsulosin|mesh-list
6438731|NCT00359905|Silodosin|silodosin|mesh-list
5724734|NCT03185351|Anesthetics, General|anesthetics, general|mesh-ancestor
6438732|NCT00359905|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6438733|NCT00359905|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6438734|NCT00359905|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6438735|NCT00359905|Adrenergic Agents|adrenergic agents|mesh-ancestor
6438736|NCT00359905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6438737|NCT00359905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438738|NCT00359905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438739|NCT00359905|Urological Agents|urological agents|mesh-ancestor
6438740|NCT00359970|Azithromycin|azithromycin|mesh-list
6438741|NCT00359970|Loperamide|loperamide|mesh-list
6438742|NCT00359970|Antidiarrheals|antidiarrheals|mesh-list
6438743|NCT00359970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6438744|NCT00359970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6438745|NCT00359970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6438746|NCT00360048|Oxytocin|oxytocin|mesh-list
6438747|NCT00360048|Oxytocics|oxytocics|mesh-ancestor
6438748|NCT00360048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6438749|NCT00360048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438750|NCT00360087|Bosentan|bosentan|mesh-list
6438751|NCT00360087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6438752|NCT00360087|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6438753|NCT00360087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438754|NCT00360178|Amlodipine|amlodipine|mesh-list
6438755|NCT00360178|Valsartan|valsartan|mesh-list
6438756|NCT00360178|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6438757|NCT00360178|Candesartan|candesartan|mesh-list
6438758|NCT00360178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6438759|NCT00360178|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6542352|NCT00851370|Respiratory System Agents|respiratory system agents|mesh-ancestor
6542353|NCT00851461|Goserelin|goserelin|mesh-list
6542354|NCT00851461|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6542355|NCT00851461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6542356|NCT00851487|Amoxicillin|amoxicillin|mesh-list
6542357|NCT00851487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6542358|NCT00851487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6542359|NCT00851513|Lidocaine|lidocaine|mesh-list
6542360|NCT00851513|Anesthetics, Local|anesthetics, local|mesh-ancestor
6542361|NCT00851513|Anesthetics|anesthetics|mesh-ancestor
6542362|NCT00851513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6542363|NCT00851513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542364|NCT00851513|Sensory System Agents|sensory system agents|mesh-ancestor
6542365|NCT00851513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6542366|NCT00851513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6542367|NCT00851513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6542368|NCT00851513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6542369|NCT00851513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6542370|NCT00851513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542371|NCT00851565|Infliximab|infliximab|mesh-list
6542372|NCT00851565|Antibodies|antibodies|mesh-list
6542373|NCT00851565|Immunologic Factors|immunologic factors|mesh-ancestor
6542374|NCT00851565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542375|NCT00851565|Dermatologic Agents|dermatologic agents|mesh-ancestor
6542376|NCT00851565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6542377|NCT00851565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6542378|NCT00851708|Acetylcysteine|acetylcysteine|mesh-list
6542379|NCT00851708|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6438760|NCT00360178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6438761|NCT00360178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438762|NCT00360178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6438763|NCT00360178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438764|NCT00360178|Vasodilator Agents|vasodilator agents|mesh-ancestor
6438765|NCT00360178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6438766|NCT00360178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6438767|NCT00360178|Diuretics|diuretics|mesh-ancestor
6438768|NCT00360178|Natriuretic Agents|natriuretic agents|mesh-ancestor
6438769|NCT00360178|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6438770|NCT00360191|Buspirone|buspirone|mesh-list
6438771|NCT00360191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6438772|NCT00360191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6438773|NCT00360191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6438774|NCT00360191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438775|NCT00360191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6438776|NCT00360191|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6438777|NCT00360191|Serotonin Agents|serotonin agents|mesh-ancestor
6438778|NCT00360191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6438779|NCT00360191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438780|NCT00360295|Azithromycin|azithromycin|mesh-list
6438781|NCT00360295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6438782|NCT00360295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6438783|NCT00360386|Clopidogrel|clopidogrel|mesh-list
6438784|NCT00360386|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6438785|NCT00360386|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6438786|NCT00360386|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6438787|NCT00360386|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6438788|NCT00360386|Purinergic Agents|purinergic agents|mesh-ancestor
6438789|NCT00360386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6438790|NCT00360386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438791|NCT00360386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438792|NCT00360425|Moxifloxacin|moxifloxacin|mesh-list
6438793|NCT00360425|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
6438794|NCT00360425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6438795|NCT00360425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6438796|NCT00360425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6438797|NCT00360425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6438798|NCT00360425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6438799|NCT00360425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438800|NCT00360425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6438801|NCT00360425|Hematinics|hematinics|mesh-ancestor
6438802|NCT00360425|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6438803|NCT00360425|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6438804|NCT00360438|Rasburicase|rasburicase|mesh-list
6438805|NCT00360438|Gout Suppressants|gout suppressants|mesh-ancestor
6438806|NCT00360438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6438807|NCT00360464|Azithromycin|azithromycin|mesh-list
6438808|NCT00360464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6438809|NCT00360464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6438810|NCT00360594|Acamprosate|acamprosate|mesh-list
6438811|NCT00360594|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6438812|NCT00360607|Metronidazole|metronidazole|mesh-list
6438813|NCT00360607|Amikacin|amikacin|mesh-list
6438814|NCT00360607|Ceftazidime|ceftazidime|mesh-list
6438815|NCT00360607|Sulbactam|sulbactam|mesh-list
6438816|NCT00360607|Cefoperazone|cefoperazone|mesh-list
6438817|NCT00360607|Sulperazone|sulperazone|mesh-list
6438818|NCT00360607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6438819|NCT00360607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6438820|NCT00360607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6438821|NCT00360607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6438822|NCT00360607|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6438823|NCT00360607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6438824|NCT00360607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438825|NCT00360607|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6438826|NCT00360607|Renal Agents|renal agents|mesh-ancestor
6438827|NCT00360737|Antitoxins|antitoxins|mesh-list
6438828|NCT00360737|Botulinum Antitoxin|botulinum antitoxin|mesh-list
6438829|NCT00360737|Immunologic Factors|immunologic factors|mesh-ancestor
6438830|NCT00360737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438831|NCT00360750|Cytarabine|cytarabine|mesh-list
6438832|NCT00360750|Carboplatin|carboplatin|mesh-list
6438833|NCT00360750|Etoposide|etoposide|mesh-list
6438834|NCT00360750|Vincristine|vincristine|mesh-list
6438835|NCT00360750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6438836|NCT00360750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6438837|NCT00360750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6438838|NCT00360750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6438839|NCT00360750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6438840|NCT00360750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438841|NCT00360750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6438842|NCT00360750|Antimetabolites|antimetabolites|mesh-ancestor
6438843|NCT00360750|Antiviral Agents|antiviral agents|mesh-ancestor
6438844|NCT00360750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6438845|NCT00360750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6438846|NCT00360750|Immunologic Factors|immunologic factors|mesh-ancestor
6438847|NCT00360750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438848|NCT00360750|Tubulin Modulators|tubulin modulators|mesh-ancestor
6438849|NCT00360750|Antimitotic Agents|antimitotic agents|mesh-ancestor
6438850|NCT00360750|Mitosis Modulators|mitosis modulators|mesh-ancestor
6438851|NCT00360763|Candesartan|candesartan|mesh-list
6438852|NCT00360763|Candesartan cilexetil|candesartan cilexetil|mesh-list
6438853|NCT00360763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6438854|NCT00360763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6438855|NCT00360763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6438856|NCT00360763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438857|NCT00360776|Tipifarnib|tipifarnib|mesh-list
6438858|NCT00360776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6438859|NCT00360815|Insulin|insulin|mesh-list
6438860|NCT00360815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6438861|NCT00360815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542380|NCT00851708|Antiviral Agents|antiviral agents|mesh-ancestor
6542381|NCT00851708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6542382|NCT00851708|Expectorants|expectorants|mesh-ancestor
6542383|NCT00851708|Respiratory System Agents|respiratory system agents|mesh-ancestor
6542384|NCT00851708|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6542385|NCT00851708|Antioxidants|antioxidants|mesh-ancestor
6542386|NCT00851708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542387|NCT00851708|Protective Agents|protective agents|mesh-ancestor
6542388|NCT00851708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542389|NCT00851708|Antidotes|antidotes|mesh-ancestor
6542390|NCT00851734|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6542391|NCT00851734|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6655581|NCT01464606|Ifosfamide|ifosfamide|mesh-list
6655582|NCT01464606|Doxorubicin|doxorubicin|mesh-list
6655583|NCT01464606|Vincristine|vincristine|mesh-list
6655584|NCT01464606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6655585|NCT01464606|Immunologic Factors|immunologic factors|mesh-ancestor
6655586|NCT01464606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655587|NCT01464606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6655588|NCT01464606|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6655589|NCT01464606|Alkylating Agents|alkylating agents|mesh-ancestor
6438862|NCT00360854|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6438863|NCT00360854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6438864|NCT00360854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6438865|NCT00360854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6438866|NCT00360854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438867|NCT00360945|Temozolomide|temozolomide|mesh-list
6438868|NCT00360945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6438869|NCT00360945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6438870|NCT00360945|Alkylating Agents|alkylating agents|mesh-ancestor
6438871|NCT00360945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438872|NCT00360984|Insulin|insulin|mesh-list
6438873|NCT00360984|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6438874|NCT00360984|Insulin Glargine|insulin glargine|mesh-list
6438875|NCT00360984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6438876|NCT00360984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438877|NCT00361010|Levetiracetam|levetiracetam|mesh-list
6438878|NCT00361010|Anticonvulsants|anticonvulsants|mesh-ancestor
6438879|NCT00361010|Nootropic Agents|nootropic agents|mesh-ancestor
6438880|NCT00361023|Losartan|losartan|mesh-list
6438881|NCT00361023|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6438882|NCT00361023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6438883|NCT00361023|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6438884|NCT00361023|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6438885|NCT00361023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438886|NCT00361075|Estradiol|estradiol|mesh-list
6438887|NCT00361075|Estrogens|estrogens|mesh-list
6438888|NCT00361075|Progesterone|progesterone|mesh-list
6438889|NCT00361075|Hormones|hormones|mesh-ancestor
6438890|NCT00361075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6438891|NCT00361075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438892|NCT00361075|Progestins|progestins|mesh-ancestor
6438893|NCT00361088|Bortezomib|bortezomib|mesh-list
6438894|NCT00361088|Tipifarnib|tipifarnib|mesh-list
6438895|NCT00361088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6438896|NCT00361114|Pyrimethamine|pyrimethamine|mesh-list
6438897|NCT00361114|Sulfadoxine|sulfadoxine|mesh-list
6438898|NCT00361114|Dapsone|dapsone|mesh-list
6438899|NCT00361114|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6438900|NCT00361114|Chlorproguanil|chlorproguanil|mesh-list
6438901|NCT00361114|Antimalarials|antimalarials|mesh-ancestor
6438902|NCT00361114|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6438903|NCT00361114|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6438904|NCT00361114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6438905|NCT00361114|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6542392|NCT00851864|Tinzaparin|tinzaparin|mesh-list
6542393|NCT00851864|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6542394|NCT00851864|Dalteparin|dalteparin|mesh-list
6542395|NCT00851864|Anticoagulants|anticoagulants|mesh-ancestor
6542396|NCT00851864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6542397|NCT00851864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6542398|NCT00851864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542399|NCT00851929|Ambrisentan|ambrisentan|mesh-list
6542400|NCT00851929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6542401|NCT00851942|Cosyntropin|cosyntropin|mesh-list
6542402|NCT00851942|Hormones|hormones|mesh-ancestor
6542403|NCT00851942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6542404|NCT00851942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542405|NCT00852046|Dexmedetomidine|dexmedetomidine|mesh-list
6542406|NCT00852046|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6542407|NCT00852046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6542408|NCT00852046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542409|NCT00852046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6542410|NCT00852046|Analgesics|analgesics|mesh-ancestor
6542411|NCT00852046|Sensory System Agents|sensory system agents|mesh-ancestor
6542412|NCT00852046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6542413|NCT00852046|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6542414|NCT00852046|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6542415|NCT00852046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6542416|NCT00852046|Adrenergic Agents|adrenergic agents|mesh-ancestor
6542417|NCT00852046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6542418|NCT00852046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019538|NCT00387829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438906|NCT00361114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6438907|NCT00361114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438908|NCT00361114|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6438909|NCT00361114|Renal Agents|renal agents|mesh-ancestor
6438910|NCT00361114|Leprostatic Agents|leprostatic agents|mesh-ancestor
6438911|NCT00361114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6438912|NCT00361153|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
6438913|NCT00361153|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6438914|NCT00361153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6438915|NCT00361153|Antimetabolites|antimetabolites|mesh-ancestor
6438916|NCT00361153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438917|NCT00361153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6438918|NCT00361166|Pimavanserin|pimavanserin|mesh-list
6438919|NCT00361166|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6438920|NCT00361166|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6438921|NCT00361166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6438922|NCT00361166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6438923|NCT00361166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6438924|NCT00361166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438925|NCT00361166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6438926|NCT00361166|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6438927|NCT00361166|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6438928|NCT00361166|Serotonin Agents|serotonin agents|mesh-ancestor
6438929|NCT00361166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6438930|NCT00361166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438931|NCT00361244|Irinotecan|irinotecan|mesh-list
6438932|NCT00361244|Cetuximab|cetuximab|mesh-list
6438933|NCT00361244|Sunitinib|sunitinib|mesh-list
6438934|NCT00361244|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6438935|NCT00361244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6438936|NCT00361244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6438937|NCT00361244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438938|NCT00361244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6438939|NCT00361244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6438940|NCT00361244|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6438941|NCT00361244|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6438942|NCT00361244|Growth Substances|growth substances|mesh-ancestor
6438943|NCT00361244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438944|NCT00361244|Growth Inhibitors|growth inhibitors|mesh-ancestor
6438945|NCT00361244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6438946|NCT00361309|Sunitinib|sunitinib|mesh-list
6438947|NCT00361309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6438948|NCT00361309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6438949|NCT00361309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6438950|NCT00361309|Growth Substances|growth substances|mesh-ancestor
6438951|NCT00361309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438952|NCT00361309|Growth Inhibitors|growth inhibitors|mesh-ancestor
6438953|NCT00361309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6438954|NCT00361309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6438955|NCT00361309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438956|NCT00361322|Clindamycin|clindamycin|mesh-list
6438957|NCT00361322|Clindamycin palmitate|clindamycin palmitate|mesh-list
6438958|NCT00361322|Clindamycin phosphate|clindamycin phosphate|mesh-list
6438959|NCT00361322|Salicylic Acid|salicylic acid|mesh-list
6438960|NCT00361322|Salicylates|salicylates|mesh-list
6438961|NCT00361322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6438962|NCT00361322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6542419|NCT00852059|Methylphenidate|methylphenidate|mesh-list
6542420|NCT00852059|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6542421|NCT00852059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542422|NCT00852059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6438963|NCT00361322|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6438964|NCT00361322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6438965|NCT00361322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438966|NCT00361322|Antifungal Agents|antifungal agents|mesh-ancestor
6438967|NCT00361322|Keratolytic Agents|keratolytic agents|mesh-ancestor
6438968|NCT00361322|Dermatologic Agents|dermatologic agents|mesh-ancestor
6438969|NCT00361322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6438970|NCT00361322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6438971|NCT00361322|Analgesics|analgesics|mesh-ancestor
6438972|NCT00361322|Sensory System Agents|sensory system agents|mesh-ancestor
6438973|NCT00361322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6438974|NCT00361322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438975|NCT00361322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6438976|NCT00361322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6438977|NCT00361322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6438978|NCT00361348|Heparin|heparin|mesh-list
6438979|NCT00361348|Anticoagulants|anticoagulants|mesh-ancestor
6438980|NCT00361348|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6438981|NCT00361348|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6438982|NCT00361348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438983|NCT00361387|Methylphenidate|methylphenidate|mesh-list
6438984|NCT00361387|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6438985|NCT00361387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438986|NCT00361387|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6438987|NCT00361387|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6438988|NCT00361387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6438989|NCT00361387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6438990|NCT00361387|Dopamine Agents|dopamine agents|mesh-ancestor
6438991|NCT00361387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6438992|NCT00361413|Alefacept|alefacept|mesh-list
6438993|NCT00361413|Dermatologic Agents|dermatologic agents|mesh-ancestor
6438994|NCT00361413|Immunologic Factors|immunologic factors|mesh-ancestor
6438995|NCT00361413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6438996|NCT00361452|Epinephrine|epinephrine|mesh-list
6438997|NCT00361452|Albuterol|albuterol|mesh-list
6438998|NCT00361452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6438999|NCT00361452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6439000|NCT00361452|Adrenergic Agents|adrenergic agents|mesh-ancestor
6439001|NCT00361452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6439002|NCT00361452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439003|NCT00361452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439004|NCT00361452|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6439005|NCT00361452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6439006|NCT00361452|Autonomic Agents|autonomic agents|mesh-ancestor
6439007|NCT00361452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6439008|NCT00361452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6439009|NCT00361452|Respiratory System Agents|respiratory system agents|mesh-ancestor
6439010|NCT00361452|Mydriatics|mydriatics|mesh-ancestor
6439011|NCT00361452|Sympathomimetics|sympathomimetics|mesh-ancestor
6439012|NCT00361452|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6439013|NCT00361452|Tocolytic Agents|tocolytic agents|mesh-ancestor
6439014|NCT00361452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6439015|NCT00361452|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6439016|NCT00361517|Amphotericin B|amphotericin b|mesh-list
6439017|NCT00361517|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6439018|NCT00361517|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
6439019|NCT00361517|Deoxycholic Acid|deoxycholic acid|mesh-list
6439020|NCT00361517|Amebicides|amebicides|mesh-ancestor
6439021|NCT00361517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6439022|NCT00361517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6439023|NCT00361517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6439024|NCT00361517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6439025|NCT00361517|Antifungal Agents|antifungal agents|mesh-ancestor
6439026|NCT00361517|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6439027|NCT00361517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6439028|NCT00361543|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
6439029|NCT00361543|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6439030|NCT00361543|Hormone Antagonists|hormone antagonists|mesh-ancestor
6439031|NCT00361543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6439032|NCT00361543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439033|NCT00361543|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6439034|NCT00361543|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6439035|NCT00361543|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6461417|NCT00454662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6461418|NCT00454662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461419|NCT00454662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6542423|NCT00852059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6542424|NCT00852059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6542425|NCT00852059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542426|NCT00852059|Dopamine Agents|dopamine agents|mesh-ancestor
6542427|NCT00852059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6542428|NCT00852163|Busulfan|busulfan|mesh-list
6542429|NCT00852163|Clofarabine|clofarabine|mesh-list
6542430|NCT00852163|Alkylating Agents|alkylating agents|mesh-ancestor
6542431|NCT00852163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542432|NCT00852163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6542433|NCT00852163|Immunologic Factors|immunologic factors|mesh-ancestor
6542434|NCT00852163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542435|NCT00852163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6542436|NCT00852163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6542437|NCT00852163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6542438|NCT00852163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6542439|NCT00852163|Antimetabolites|antimetabolites|mesh-ancestor
6542440|NCT00852189|Folic Acid|folic acid|mesh-list
6542441|NCT00852189|Vitamin B Complex|vitamin b complex|mesh-list
6542442|NCT00852189|Vinca Alkaloids|vinca alkaloids|mesh-list
6542443|NCT00852189|Hematinics|hematinics|mesh-ancestor
6542444|NCT00852189|Vitamins|vitamins|mesh-ancestor
6542445|NCT00852189|Micronutrients|micronutrients|mesh-ancestor
6542446|NCT00852189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542447|NCT00852189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6542448|NCT00852189|Tubulin Modulators|tubulin modulators|mesh-ancestor
6542449|NCT00852189|Antimitotic Agents|antimitotic agents|mesh-ancestor
6542450|NCT00852189|Mitosis Modulators|mitosis modulators|mesh-ancestor
6542451|NCT00852189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542452|NCT00852228|Cetuximab|cetuximab|mesh-list
6542453|NCT00852228|Oxaliplatin|oxaliplatin|mesh-list
6542454|NCT00852228|Irinotecan|irinotecan|mesh-list
6542455|NCT00852228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6542456|NCT00852228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6542457|NCT00852228|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6542458|NCT00852228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6542459|NCT00852228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6542460|NCT00852228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542461|NCT00852332|Curcumin|curcumin|mesh-list
6542462|NCT00852332|Docetaxel|docetaxel|mesh-list
6542463|NCT00852332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6542464|NCT00852332|Tubulin Modulators|tubulin modulators|mesh-ancestor
6542465|NCT00852332|Antimitotic Agents|antimitotic agents|mesh-ancestor
6542466|NCT00852332|Mitosis Modulators|mitosis modulators|mesh-ancestor
6542467|NCT00852332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542468|NCT00852332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6542469|NCT00852332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6542470|NCT00852332|Analgesics|analgesics|mesh-ancestor
6542471|NCT00852332|Sensory System Agents|sensory system agents|mesh-ancestor
6542472|NCT00852332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6542473|NCT00852332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542474|NCT00852332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6542475|NCT00852332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6542476|NCT00852332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6542477|NCT00852345|Clofazimine|clofazimine|mesh-list
6542478|NCT00852345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6542479|NCT00852345|Leprostatic Agents|leprostatic agents|mesh-ancestor
6439036|NCT00361621|Prednisone|prednisone|mesh-list
6439037|NCT00361621|Cyclophosphamide|cyclophosphamide|mesh-list
6439038|NCT00361621|Rituximab|rituximab|mesh-list
6439039|NCT00361621|Doxorubicin|doxorubicin|mesh-list
6439040|NCT00361621|Vincristine|vincristine|mesh-list
6439041|NCT00361621|Bortezomib|bortezomib|mesh-list
6439042|NCT00361621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6439043|NCT00361621|Immunologic Factors|immunologic factors|mesh-ancestor
6439044|NCT00361621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439045|NCT00361621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6439046|NCT00361621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6439047|NCT00361621|Alkylating Agents|alkylating agents|mesh-ancestor
6439048|NCT00361621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439049|NCT00361621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6439050|NCT00361621|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6439051|NCT00361621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6439052|NCT00361621|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6439053|NCT00361621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6439054|NCT00361621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6439055|NCT00361621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6439056|NCT00361621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6439057|NCT00361621|Glucocorticoids|glucocorticoids|mesh-ancestor
6439058|NCT00361621|Hormones|hormones|mesh-ancestor
6439059|NCT00361621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6439060|NCT00361621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6439061|NCT00361621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6439062|NCT00361621|Tubulin Modulators|tubulin modulators|mesh-ancestor
6439063|NCT00361621|Antimitotic Agents|antimitotic agents|mesh-ancestor
6439064|NCT00361621|Mitosis Modulators|mitosis modulators|mesh-ancestor
6439065|NCT00361686|Tramadol|tramadol|mesh-list
6439066|NCT00361686|Remifentanil|remifentanil|mesh-list
6439067|NCT00361686|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6439068|NCT00361686|Narcotics|narcotics|mesh-ancestor
6439069|NCT00361686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6439070|NCT00361686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439071|NCT00361686|Analgesics|analgesics|mesh-ancestor
6439072|NCT00361686|Sensory System Agents|sensory system agents|mesh-ancestor
6439073|NCT00361686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6439074|NCT00361751|Fenofibrate|fenofibrate|mesh-list
6439075|NCT00361751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6439076|NCT00361751|Antimetabolites|antimetabolites|mesh-ancestor
6439077|NCT00361751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439078|NCT00361751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6439079|NCT00361790|Aripiprazole|aripiprazole|mesh-list
6439080|NCT00361790|Citalopram|citalopram|mesh-list
6439081|NCT00361790|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6439082|NCT00361790|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6439083|NCT00361790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6439084|NCT00361790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439085|NCT00361790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6439086|NCT00361790|Serotonin Agents|serotonin agents|mesh-ancestor
6439087|NCT00361790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439088|NCT00361790|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6439089|NCT00361790|Antidepressive Agents|antidepressive agents|mesh-ancestor
6439090|NCT00361790|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6439091|NCT00361790|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6439092|NCT00361790|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6439093|NCT00361790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6439094|NCT00361790|Dopamine Agonists|dopamine agonists|mesh-ancestor
6439095|NCT00361790|Dopamine Agents|dopamine agents|mesh-ancestor
6439096|NCT00361790|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6439097|NCT00361790|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6439098|NCT00361790|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6439099|NCT00361790|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6439100|NCT00361790|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6439101|NCT00361790|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6439102|NCT00361803|Topotecan|topotecan|mesh-list
6439103|NCT00361803|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6439104|NCT00361803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6439105|NCT00361803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6542480|NCT00852345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6439106|NCT00361803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439107|NCT00361803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6439108|NCT00361868|Metformin|metformin|mesh-list
6439109|NCT00361868|Rosiglitazone|rosiglitazone|mesh-list
6439110|NCT00361868|Fenofibrate|fenofibrate|mesh-list
6439111|NCT00361868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6439112|NCT00361868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439113|NCT00361868|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6439114|NCT00361868|Antimetabolites|antimetabolites|mesh-ancestor
6439115|NCT00361868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439116|NCT00361868|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6439117|NCT00361881|Acyclovir|acyclovir|mesh-list
6439118|NCT00361881|Hydrocortisone|hydrocortisone|mesh-list
6439119|NCT00361881|Antiviral Agents|antiviral agents|mesh-ancestor
6439120|NCT00361881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6439121|NCT00361881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6439122|NCT00361894|Enoxaparin|enoxaparin|mesh-list
6439123|NCT00361894|Rivaroxaban|rivaroxaban|mesh-list
6439124|NCT00361894|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6439125|NCT00361894|Antithrombins|antithrombins|mesh-ancestor
6542481|NCT00852345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6542482|NCT00852371|Pyrimethamine|pyrimethamine|mesh-list
6542483|NCT00852371|Piperaquine|piperaquine|mesh-list
6542484|NCT00852371|Sulfadoxine|sulfadoxine|mesh-list
6542485|NCT00852371|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6542486|NCT00852371|Amodiaquine|amodiaquine|mesh-list
6542487|NCT00852371|Artenimol|artenimol|mesh-list
6542488|NCT00852371|Antimalarials|antimalarials|mesh-ancestor
6542489|NCT00852371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6542490|NCT00852371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6542491|NCT00852371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6542492|NCT00852371|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6542493|NCT00852371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6542494|NCT00852371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542495|NCT00852371|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6542496|NCT00852371|Renal Agents|renal agents|mesh-ancestor
6542497|NCT00852410|Lidocaine|lidocaine|mesh-list
6542498|NCT00852410|Epinephrine|epinephrine|mesh-list
6542499|NCT00852410|Racepinephrine|racepinephrine|mesh-list
6542500|NCT00852410|Epinephryl borate|epinephryl borate|mesh-list
6542501|NCT00852410|Anesthetics, Local|anesthetics, local|mesh-ancestor
6542502|NCT00852410|Anesthetics|anesthetics|mesh-ancestor
6542503|NCT00852410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6542504|NCT00852410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542505|NCT00852410|Sensory System Agents|sensory system agents|mesh-ancestor
6542506|NCT00852410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6542507|NCT00852410|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6542508|NCT00852410|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6542509|NCT00852410|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6542510|NCT00852410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6542511|NCT00852410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542512|NCT00852410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6542513|NCT00852410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6542514|NCT00852410|Adrenergic Agents|adrenergic agents|mesh-ancestor
6542515|NCT00852410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6542516|NCT00852410|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6542517|NCT00852410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6542518|NCT00852410|Autonomic Agents|autonomic agents|mesh-ancestor
6542519|NCT00852410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6542520|NCT00852410|Respiratory System Agents|respiratory system agents|mesh-ancestor
6542521|NCT00852410|Mydriatics|mydriatics|mesh-ancestor
6439126|NCT00361894|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6542522|NCT00852410|Sympathomimetics|sympathomimetics|mesh-ancestor
6439127|NCT00361894|Protease Inhibitors|protease inhibitors|mesh-ancestor
6542523|NCT00852410|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6439128|NCT00361894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6439129|NCT00361894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439130|NCT00361894|Anticoagulants|anticoagulants|mesh-ancestor
6439131|NCT00361894|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6439132|NCT00361894|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6439133|NCT00361907|Insulin|insulin|mesh-list
6439134|NCT00361907|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6439135|NCT00361907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6439136|NCT00361907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439137|NCT00361920|Prednisone|prednisone|mesh-list
6439138|NCT00361920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6439139|NCT00361920|Glucocorticoids|glucocorticoids|mesh-ancestor
6439140|NCT00361920|Hormones|hormones|mesh-ancestor
6439141|NCT00361920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6439142|NCT00361920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439143|NCT00361920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6439144|NCT00361920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6439145|NCT00361933|Valganciclovir|valganciclovir|mesh-list
6439146|NCT00361933|Antiviral Agents|antiviral agents|mesh-ancestor
6439147|NCT00361933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6439148|NCT00361959|Fluticasone|fluticasone|mesh-list
6439149|NCT00361959|Xhance|xhance|mesh-list
6439150|NCT00361959|Bromides|bromides|mesh-list
6439151|NCT00361959|Tiotropium Bromide|tiotropium bromide|mesh-list
6439152|NCT00361959|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6439153|NCT00361959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6439154|NCT00361959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6439155|NCT00361959|Autonomic Agents|autonomic agents|mesh-ancestor
6439156|NCT00361959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6439157|NCT00361959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439158|NCT00361959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6439159|NCT00361959|Respiratory System Agents|respiratory system agents|mesh-ancestor
6439160|NCT00361959|Dermatologic Agents|dermatologic agents|mesh-ancestor
6439161|NCT00361959|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6439162|NCT00361959|Parasympatholytics|parasympatholytics|mesh-ancestor
6439163|NCT00361959|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6439164|NCT00361959|Cholinergic Agents|cholinergic agents|mesh-ancestor
6439165|NCT00361959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6439166|NCT00361959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439167|NCT00361959|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6439168|NCT00361959|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6439169|NCT00361959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6439170|NCT00361959|Adrenergic Agents|adrenergic agents|mesh-ancestor
6439171|NCT00361959|Anticonvulsants|anticonvulsants|mesh-ancestor
6439172|NCT00361985|Esomeprazole|esomeprazole|mesh-list
6439173|NCT00361985|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6439174|NCT00361985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6439175|NCT00361985|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6439176|NCT00361985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6439177|NCT00361985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439178|NCT00361998|Nitrofurantoin|nitrofurantoin|mesh-list
6439179|NCT00361998|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6439180|NCT00361998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6439181|NCT00361998|Renal Agents|renal agents|mesh-ancestor
6439182|NCT00361998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6439183|NCT00362037|Irbesartan|irbesartan|mesh-list
6439184|NCT00362037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6439185|NCT00362037|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6439186|NCT00362037|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6439187|NCT00362037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439188|NCT00362063|Hormones|hormones|mesh-list
6461420|NCT00454662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439189|NCT00362063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6439190|NCT00362063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439191|NCT00362089|Dronabinol|dronabinol|mesh-list
6439192|NCT00362089|Hallucinogens|hallucinogens|mesh-ancestor
6439193|NCT00362089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439194|NCT00362089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6439195|NCT00362089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6439196|NCT00362089|Analgesics|analgesics|mesh-ancestor
6439197|NCT00362089|Sensory System Agents|sensory system agents|mesh-ancestor
6439198|NCT00362089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6439199|NCT00362089|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6439200|NCT00362089|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6439201|NCT00362089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6439202|NCT00362089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439203|NCT00362089|Hormones|hormones|mesh-ancestor
6439204|NCT00362089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6439205|NCT00362102|Cetuximab|cetuximab|mesh-list
6439206|NCT00362102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6439207|NCT00362102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6439208|NCT00362141|Levetiracetam|levetiracetam|mesh-list
6439209|NCT00362141|Anticonvulsants|anticonvulsants|mesh-ancestor
6439210|NCT00362141|Nootropic Agents|nootropic agents|mesh-ancestor
6542524|NCT00852423|Artesunate|artesunate|mesh-list
6542525|NCT00852423|Lumefantrine|lumefantrine|mesh-list
6542526|NCT00852423|Artemether|artemether|mesh-list
6542527|NCT00852423|Piperaquine|piperaquine|mesh-list
6542528|NCT00852423|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6542529|NCT00852423|Amodiaquine|amodiaquine|mesh-list
6542530|NCT00852423|Artenimol|artenimol|mesh-list
6542531|NCT00852423|Mefloquine|mefloquine|mesh-list
6542532|NCT00852423|Antimalarials|antimalarials|mesh-ancestor
6542533|NCT00852423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6542534|NCT00852423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6542535|NCT00852423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6542536|NCT00852423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6542537|NCT00852423|Antiviral Agents|antiviral agents|mesh-ancestor
6542538|NCT00852423|Schistosomicides|schistosomicides|mesh-ancestor
6542539|NCT00852423|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6542540|NCT00852423|Anthelmintics|anthelmintics|mesh-ancestor
6542541|NCT00852436|Pregabalin|pregabalin|mesh-list
6542542|NCT00852436|Analgesics|analgesics|mesh-ancestor
6542543|NCT00852436|Sensory System Agents|sensory system agents|mesh-ancestor
6542544|NCT00852436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6542545|NCT00852436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542546|NCT00852436|Anticonvulsants|anticonvulsants|mesh-ancestor
6542547|NCT00852436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6542548|NCT00852436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6542549|NCT00852436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542550|NCT00852436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6542551|NCT00852436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6542552|NCT00852436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6542553|NCT00852436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6542554|NCT00852436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6542555|NCT00852566|Imatinib Mesylate|imatinib mesylate|mesh-list
6542556|NCT00852566|Dasatinib|dasatinib|mesh-list
6542557|NCT00852566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6439211|NCT00362206|Simvastatin|simvastatin|mesh-list
6439212|NCT00362206|Pravastatin|pravastatin|mesh-list
6439213|NCT00362206|Fenofibrate|fenofibrate|mesh-list
6439214|NCT00362206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6439215|NCT00362206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6439216|NCT00362206|Antimetabolites|antimetabolites|mesh-ancestor
6439217|NCT00362206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439218|NCT00362206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6439219|NCT00362206|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6439220|NCT00362206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6439221|NCT00362219|Morphine|morphine|mesh-list
6439222|NCT00362219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6439223|NCT00362219|Narcotics|narcotics|mesh-ancestor
6439224|NCT00362219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6439225|NCT00362219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439226|NCT00362219|Analgesics|analgesics|mesh-ancestor
6439227|NCT00362219|Sensory System Agents|sensory system agents|mesh-ancestor
6439228|NCT00362219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6439229|NCT00362245|Amikacin|amikacin|mesh-list
6439230|NCT00362245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6439231|NCT00362245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6439232|NCT00362258|Irbesartan|irbesartan|mesh-list
6439233|NCT00362258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6439234|NCT00362258|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6439235|NCT00362258|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6439236|NCT00362258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439237|NCT00362271|Aripiprazole|aripiprazole|mesh-list
6439238|NCT00362271|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6439239|NCT00362271|Antidepressive Agents|antidepressive agents|mesh-ancestor
6439240|NCT00362271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6439241|NCT00362271|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6439242|NCT00362271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6439243|NCT00362271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6439244|NCT00362271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439245|NCT00362271|Dopamine Agonists|dopamine agonists|mesh-ancestor
6439246|NCT00362271|Dopamine Agents|dopamine agents|mesh-ancestor
6439247|NCT00362271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6439248|NCT00362271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439249|NCT00362271|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6439250|NCT00362271|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6439251|NCT00362271|Serotonin Agents|serotonin agents|mesh-ancestor
6439252|NCT00362271|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6439253|NCT00362271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6439254|NCT00362271|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6439255|NCT00362271|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6439256|NCT00362271|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6439257|NCT00362271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6439258|NCT00362271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6439259|NCT00362271|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6439260|NCT00362310|Indinavir|indinavir|mesh-list
6439261|NCT00362310|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6439262|NCT00362310|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6439263|NCT00362310|Protease Inhibitors|protease inhibitors|mesh-ancestor
6439264|NCT00362310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6439265|NCT00362310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439266|NCT00362310|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6439267|NCT00362310|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6439268|NCT00362310|Antiviral Agents|antiviral agents|mesh-ancestor
6439269|NCT00362310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6439270|NCT00362323|Metformin|metformin|mesh-list
6439271|NCT00362323|Fenofibrate|fenofibrate|mesh-list
6439272|NCT00362323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6439273|NCT00362323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439274|NCT00362323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6439275|NCT00362323|Antimetabolites|antimetabolites|mesh-ancestor
6439276|NCT00362323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439277|NCT00362323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6439278|NCT00362505|Clevudine|clevudine|mesh-list
6439279|NCT00362505|Antiviral Agents|antiviral agents|mesh-ancestor
6439280|NCT00362505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6439281|NCT00362531|Prednisone|prednisone|mesh-list
6439282|NCT00362531|Tacrolimus|tacrolimus|mesh-list
6439283|NCT00362531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6439284|NCT00362531|Glucocorticoids|glucocorticoids|mesh-ancestor
6439285|NCT00362531|Hormones|hormones|mesh-ancestor
6439286|NCT00362531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6439287|NCT00362531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439288|NCT00362531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6439289|NCT00362531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6439290|NCT00362531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6439291|NCT00362531|Immunologic Factors|immunologic factors|mesh-ancestor
6439292|NCT00362531|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6439293|NCT00362531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6439294|NCT00362531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439295|NCT00362544|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6439296|NCT00362544|Antifungal Agents|antifungal agents|mesh-ancestor
6439297|NCT00362544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6439298|NCT00362544|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6439299|NCT00362544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6439300|NCT00362570|Temozolomide|temozolomide|mesh-list
6439301|NCT00362570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6439302|NCT00362570|Alkylating Agents|alkylating agents|mesh-ancestor
6439303|NCT00362570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439304|NCT00362570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6439305|NCT00362583|Fentanyl|fentanyl|mesh-list
6542558|NCT00852566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6542559|NCT00852566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6542560|NCT00852566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542561|NCT00852579|Azithromycin|azithromycin|mesh-list
6542562|NCT00852579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6542563|NCT00852579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6542564|NCT00852670|Ponesimod|ponesimod|mesh-list
6542565|NCT00852670|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6542566|NCT00852670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542567|NCT00852670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6542568|NCT00852670|Immunologic Factors|immunologic factors|mesh-ancestor
6542569|NCT00852670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542570|NCT00852683|Pregabalin|pregabalin|mesh-list
6542571|NCT00852683|Analgesics|analgesics|mesh-ancestor
6542572|NCT00852683|Sensory System Agents|sensory system agents|mesh-ancestor
6542573|NCT00852683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6542574|NCT00852683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542575|NCT00852683|Anticonvulsants|anticonvulsants|mesh-ancestor
6542576|NCT00852683|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6542577|NCT00852683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6542578|NCT00852683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542579|NCT00852683|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6542580|NCT00852683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6542581|NCT00852683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6542582|NCT00852683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6542583|NCT00852683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6542584|NCT00852696|Solifenacin Succinate|solifenacin succinate|mesh-list
6542585|NCT00852696|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6542586|NCT00852696|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6542587|NCT00852696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6542588|NCT00852696|Cholinergic Agents|cholinergic agents|mesh-ancestor
6542589|NCT00852696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6542590|NCT00852696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439306|NCT00362583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6439307|NCT00362583|Narcotics|narcotics|mesh-ancestor
6439308|NCT00362583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6439309|NCT00362583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439310|NCT00362583|Analgesics|analgesics|mesh-ancestor
6439311|NCT00362583|Sensory System Agents|sensory system agents|mesh-ancestor
6439312|NCT00362583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6439313|NCT00362583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6439314|NCT00362583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6439315|NCT00362583|Anesthetics, General|anesthetics, general|mesh-ancestor
6439316|NCT00362583|Anesthetics|anesthetics|mesh-ancestor
6439317|NCT00362596|Acyclovir|acyclovir|mesh-list
6439318|NCT00362596|Antiviral Agents|antiviral agents|mesh-ancestor
6439319|NCT00362596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6439320|NCT00362635|Clevudine|clevudine|mesh-list
6439321|NCT00362635|Antiviral Agents|antiviral agents|mesh-ancestor
6439322|NCT00362635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6439323|NCT00362661|Hydrocortisone|hydrocortisone|mesh-list
6439324|NCT00362661|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6439325|NCT00362661|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6439326|NCT00362661|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6439327|NCT00362661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6439328|NCT00362687|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6439329|NCT00362687|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6439330|NCT00362687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6439331|NCT00362687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6439332|NCT00362687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439333|NCT00362687|Antiviral Agents|antiviral agents|mesh-ancestor
6439334|NCT00362687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6439335|NCT00362687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6439336|NCT00362687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6439337|NCT00362700|Clevudine|clevudine|mesh-list
6439338|NCT00362700|Antiviral Agents|antiviral agents|mesh-ancestor
6439339|NCT00362700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6439340|NCT00362713|Ipilimumab|ipilimumab|mesh-list
6439341|NCT00362713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6439342|NCT00362713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6439343|NCT00362713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6439344|NCT00362713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439345|NCT00362726|Rosiglitazone|rosiglitazone|mesh-list
6439346|NCT00362726|Ritonavir|ritonavir|mesh-list
6439347|NCT00362726|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6439348|NCT00362726|Maleic acid|maleic acid|mesh-list
6439349|NCT00362726|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6439350|NCT00362726|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6439351|NCT00362726|Protease Inhibitors|protease inhibitors|mesh-ancestor
6439352|NCT00362726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6439353|NCT00362726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439354|NCT00362726|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6439355|NCT00362726|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6439356|NCT00362726|Antiviral Agents|antiviral agents|mesh-ancestor
6439357|NCT00362726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6439358|NCT00362726|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6439359|NCT00362726|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6439360|NCT00362726|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6439361|NCT00362726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439362|NCT00362752|Norfloxacin|norfloxacin|mesh-list
6439363|NCT00362752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6439364|NCT00362752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6439365|NCT00362752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6439366|NCT00362752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6439367|NCT00362752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6439368|NCT00362752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439369|NCT00362752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6439370|NCT00362752|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6439371|NCT00362752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6439372|NCT00362765|Metformin|metformin|mesh-list
6439373|NCT00362765|Fenofibrate|fenofibrate|mesh-list
6439374|NCT00362765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6439375|NCT00362765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439376|NCT00362765|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6439377|NCT00362765|Antimetabolites|antimetabolites|mesh-ancestor
6439378|NCT00362765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439379|NCT00362765|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6439380|NCT00362778|Insulin|insulin|mesh-list
6439381|NCT00362778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6439382|NCT00362778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439383|NCT00362804|Tetrabenazine|tetrabenazine|mesh-list
6439384|NCT00362804|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6439385|NCT00362804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6439386|NCT00362804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6439387|NCT00362804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439388|NCT00362804|Adrenergic Agents|adrenergic agents|mesh-ancestor
6439389|NCT00362804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6439390|NCT00362804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439391|NCT00362869|Levofloxacin|levofloxacin|mesh-list
6439392|NCT00362869|Ofloxacin|ofloxacin|mesh-list
6439393|NCT00362869|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6439394|NCT00362869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6439395|NCT00362869|Renal Agents|renal agents|mesh-ancestor
6439396|NCT00362869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6439397|NCT00362869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6439398|NCT00362869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6439399|NCT00362869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6439400|NCT00362869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439401|NCT00362869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6439402|NCT00362869|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6439403|NCT00362869|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6439404|NCT00362895|Tobramycin|tobramycin|mesh-list
6439405|NCT00362895|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
6439406|NCT00362895|Dexamethasone|dexamethasone|mesh-list
6439407|NCT00362895|Dexamethasone acetate|dexamethasone acetate|mesh-list
6439408|NCT00362895|BB 1101|bb 1101|mesh-list
6439409|NCT00362895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6439410|NCT00362895|Antiemetics|antiemetics|mesh-ancestor
6019539|NCT00387829|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6019540|NCT00387829|Contraceptive Agents|contraceptive agents|mesh-ancestor
6019541|NCT00387829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6019542|NCT00387829|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6439411|NCT00362895|Autonomic Agents|autonomic agents|mesh-ancestor
6439412|NCT00362895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6439413|NCT00362895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439414|NCT00362895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6439415|NCT00362895|Glucocorticoids|glucocorticoids|mesh-ancestor
6439416|NCT00362895|Hormones|hormones|mesh-ancestor
6439417|NCT00362895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6439418|NCT00362895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6439419|NCT00362895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6542591|NCT00852696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542592|NCT00852696|Urological Agents|urological agents|mesh-ancestor
6542593|NCT00852709|Cyclophosphamide|cyclophosphamide|mesh-list
6542594|NCT00852709|Clofarabine|clofarabine|mesh-list
6542595|NCT00852709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6542596|NCT00852709|Immunologic Factors|immunologic factors|mesh-ancestor
6542597|NCT00852709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542598|NCT00852709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6542599|NCT00852709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6542600|NCT00852709|Alkylating Agents|alkylating agents|mesh-ancestor
6542601|NCT00852709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542602|NCT00852709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6542603|NCT00852709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6542604|NCT00852709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6542605|NCT00852709|Antimetabolites|antimetabolites|mesh-ancestor
6542606|NCT00852787|Digoxin|digoxin|mesh-list
6542607|NCT00852787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6542608|NCT00852787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6542609|NCT00852787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6542610|NCT00852787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542611|NCT00852787|Protective Agents|protective agents|mesh-ancestor
6542612|NCT00852787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542613|NCT00852800|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6542614|NCT00852956|Betahistine|betahistine|mesh-list
6542615|NCT00852956|Vasodilator Agents|vasodilator agents|mesh-ancestor
6542616|NCT00852956|Histamine Agonists|histamine agonists|mesh-ancestor
6542617|NCT00852956|Histamine Agents|histamine agents|mesh-ancestor
6542618|NCT00852956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6542619|NCT00852956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542620|NCT00852956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542621|NCT00853008|Cytarabine|cytarabine|mesh-list
6542622|NCT00853008|Dexamethasone|dexamethasone|mesh-list
6542623|NCT00853008|Prednisone|prednisone|mesh-list
6542624|NCT00853008|Hydrocortisone|hydrocortisone|mesh-list
6542625|NCT00853008|Methotrexate|methotrexate|mesh-list
6542626|NCT00853008|Vincristine|vincristine|mesh-list
6542627|NCT00853008|Daunorubicin|daunorubicin|mesh-list
6542628|NCT00853008|Mercaptopurine|mercaptopurine|mesh-list
6542629|NCT00853008|Mitoxantrone|mitoxantrone|mesh-list
6542630|NCT00853008|Teniposide|teniposide|mesh-list
6542631|NCT00853008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6542632|NCT00853008|Antiemetics|antiemetics|mesh-ancestor
6542633|NCT00853008|Autonomic Agents|autonomic agents|mesh-ancestor
6542634|NCT00853008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6542635|NCT00853008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542636|NCT00853008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6542637|NCT00853008|Glucocorticoids|glucocorticoids|mesh-ancestor
6542638|NCT00853008|Hormones|hormones|mesh-ancestor
6542639|NCT00853008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6542640|NCT00853008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6542641|NCT00853008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6542642|NCT00853008|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6542643|NCT00853008|Abortifacient Agents|abortifacient agents|mesh-ancestor
6542644|NCT00853008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6542645|NCT00853008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6542646|NCT00853008|Antimetabolites|antimetabolites|mesh-ancestor
6542647|NCT00853008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542648|NCT00853008|Dermatologic Agents|dermatologic agents|mesh-ancestor
6542649|NCT00853008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6542650|NCT00853008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6542651|NCT00853008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6542652|NCT00853008|Immunologic Factors|immunologic factors|mesh-ancestor
6542653|NCT00853008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6439420|NCT00362895|Protease Inhibitors|protease inhibitors|mesh-ancestor
6439421|NCT00362895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6439422|NCT00362895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439423|NCT00362895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6439424|NCT00362895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6439425|NCT00362895|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6439426|NCT00362895|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6439427|NCT00362921|Carmustine|carmustine|mesh-list
6439428|NCT00362921|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
6439429|NCT00362921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6439430|NCT00362921|Alkylating Agents|alkylating agents|mesh-ancestor
6439431|NCT00362921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439432|NCT00362921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6439433|NCT00362921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6439434|NCT00362934|Atorvastatin|atorvastatin|mesh-list
6439435|NCT00362934|Simvastatin|simvastatin|mesh-list
6439436|NCT00362934|Fenofibrate|fenofibrate|mesh-list
6439437|NCT00362934|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6439438|NCT00362934|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6439439|NCT00362934|Antimetabolites|antimetabolites|mesh-ancestor
6439440|NCT00362934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439441|NCT00362934|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6439442|NCT00362934|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6439443|NCT00362934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6439444|NCT00362947|Parnaparin|parnaparin|mesh-list
6439445|NCT00362947|Anticoagulants|anticoagulants|mesh-ancestor
6439446|NCT00362947|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6439447|NCT00362947|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6439448|NCT00362947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439449|NCT00362960|Losartan|losartan|mesh-list
6439450|NCT00362960|Olmesartan|olmesartan|mesh-list
6439451|NCT00362960|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6439452|NCT00362960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6439453|NCT00362960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6439454|NCT00362960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6439455|NCT00362960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6439456|NCT00362960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439457|NCT00362973|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6439458|NCT00362973|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6439459|NCT00362973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439460|NCT00362986|Sunscreening Agents|sunscreening agents|mesh-list
6439461|NCT00362986|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6439462|NCT00362986|Protective Agents|protective agents|mesh-ancestor
6439463|NCT00362986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439464|NCT00362986|Dermatologic Agents|dermatologic agents|mesh-ancestor
6439465|NCT00363025|Daunorubicin|daunorubicin|mesh-list
6439466|NCT00363025|Idarubicin|idarubicin|mesh-list
6439467|NCT00363025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6439468|NCT00363025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6439469|NCT00363025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6439470|NCT00363025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6439471|NCT00363025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6439472|NCT00363025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439473|NCT00363090|Prednisone|prednisone|mesh-list
6439474|NCT00363090|Cyclophosphamide|cyclophosphamide|mesh-list
6439475|NCT00363090|Doxorubicin|doxorubicin|mesh-list
6439476|NCT00363090|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6439477|NCT00363090|Vincristine|vincristine|mesh-list
6439478|NCT00363090|Alemtuzumab|alemtuzumab|mesh-list
6439479|NCT00363090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6439480|NCT00363090|Immunologic Factors|immunologic factors|mesh-ancestor
6439481|NCT00363090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439482|NCT00363090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6439483|NCT00363090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6439484|NCT00363090|Alkylating Agents|alkylating agents|mesh-ancestor
6439485|NCT00363090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439486|NCT00363090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6439487|NCT00363090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6439488|NCT00363090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6439489|NCT00363090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6439490|NCT00363090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6439491|NCT00363090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6542654|NCT00853008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5724735|NCT03185351|GABA Modulators|gaba modulators|mesh-ancestor
6439492|NCT00363090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6439493|NCT00363090|Glucocorticoids|glucocorticoids|mesh-ancestor
6439494|NCT00363090|Hormones|hormones|mesh-ancestor
6439495|NCT00363090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6439496|NCT00363090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6439497|NCT00363090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6439498|NCT00363090|Tubulin Modulators|tubulin modulators|mesh-ancestor
6542655|NCT00853008|Antiviral Agents|antiviral agents|mesh-ancestor
6542656|NCT00853008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6542657|NCT00853008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6542658|NCT00853008|Tubulin Modulators|tubulin modulators|mesh-ancestor
6542659|NCT00853008|Antimitotic Agents|antimitotic agents|mesh-ancestor
6542660|NCT00853008|Mitosis Modulators|mitosis modulators|mesh-ancestor
6542661|NCT00853008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6542662|NCT00853008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6542663|NCT00853008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6542664|NCT00853008|Analgesics|analgesics|mesh-ancestor
6542665|NCT00853008|Sensory System Agents|sensory system agents|mesh-ancestor
6542666|NCT00853177|Lidocaine|lidocaine|mesh-list
6542667|NCT00853177|Anesthetics|anesthetics|mesh-ancestor
5724736|NCT03185351|GABA Agents|gaba agents|mesh-ancestor
6439499|NCT00363090|Antimitotic Agents|antimitotic agents|mesh-ancestor
6439500|NCT00363090|Mitosis Modulators|mitosis modulators|mesh-ancestor
6439501|NCT00363090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6439502|NCT00363116|Daclizumab|daclizumab|mesh-list
6439503|NCT00363116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6439504|NCT00363116|Immunologic Factors|immunologic factors|mesh-ancestor
6439505|NCT00363116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439506|NCT00363155|KRN 7000|krn 7000|mesh-list
6439507|NCT00363155|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6439508|NCT00363155|Immunologic Factors|immunologic factors|mesh-ancestor
6439509|NCT00363155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439510|NCT00363155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6439511|NCT00363259|Ribavirin|ribavirin|mesh-list
6439512|NCT00363259|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6439513|NCT00363259|Antimetabolites|antimetabolites|mesh-ancestor
6542668|NCT00853177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6542669|NCT00853177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439514|NCT00363259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439515|NCT00363259|Antiviral Agents|antiviral agents|mesh-ancestor
6439516|NCT00363259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6439517|NCT00363285|Cyproterone Acetate|cyproterone acetate|mesh-list
6439518|NCT00363285|Hormones|hormones|mesh-list
6439519|NCT00363285|Cyproterone|cyproterone|mesh-list
6439520|NCT00363285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6439521|NCT00363285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439522|NCT00363285|Androgen Antagonists|androgen antagonists|mesh-ancestor
6439523|NCT00363285|Hormone Antagonists|hormone antagonists|mesh-ancestor
6439524|NCT00363285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6439525|NCT00363285|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6439526|NCT00363285|Contraceptive Agents|contraceptive agents|mesh-ancestor
6439527|NCT00363285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6439528|NCT00363337|Aripiprazole|aripiprazole|mesh-list
6439529|NCT00363337|Antidepressive Agents|antidepressive agents|mesh-ancestor
6439530|NCT00363337|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6439531|NCT00363337|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6439532|NCT00363337|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6439533|NCT00363337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6439534|NCT00363337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439535|NCT00363337|Dopamine Agonists|dopamine agonists|mesh-ancestor
6439536|NCT00363337|Dopamine Agents|dopamine agents|mesh-ancestor
6439537|NCT00363337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6439538|NCT00363337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439539|NCT00363337|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6439540|NCT00363337|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6439541|NCT00363337|Serotonin Agents|serotonin agents|mesh-ancestor
6439542|NCT00363337|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6439543|NCT00363337|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6439544|NCT00363337|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6439545|NCT00363337|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6439546|NCT00363350|Rituximab|rituximab|mesh-list
6439547|NCT00363350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6439548|NCT00363350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6439549|NCT00363350|Immunologic Factors|immunologic factors|mesh-ancestor
6439550|NCT00363350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439551|NCT00363350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6461421|NCT00454662|Vasodilator Agents|vasodilator agents|mesh-ancestor
6461422|NCT00454662|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6461423|NCT00454662|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6461424|NCT00454701|Alefacept|alefacept|mesh-list
6461425|NCT00454701|Dermatologic Agents|dermatologic agents|mesh-ancestor
6461426|NCT00454701|Immunologic Factors|immunologic factors|mesh-ancestor
6461427|NCT00454701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461428|NCT00454714|Sildenafil Citrate|sildenafil citrate|mesh-list
6461429|NCT00454714|Vasodilator Agents|vasodilator agents|mesh-ancestor
6461430|NCT00454714|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6461431|NCT00454714|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6461432|NCT00454714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6542670|NCT00853177|Anesthetics, Local|anesthetics, local|mesh-ancestor
6542671|NCT00853177|Sensory System Agents|sensory system agents|mesh-ancestor
6542672|NCT00853177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6542673|NCT00853177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6542674|NCT00853177|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6542675|NCT00853177|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6461433|NCT00454714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461434|NCT00454714|Urological Agents|urological agents|mesh-ancestor
6461435|NCT00454740|Solifenacin Succinate|solifenacin succinate|mesh-list
6461436|NCT00454740|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6461437|NCT00454740|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6461438|NCT00454740|Cholinergic Agents|cholinergic agents|mesh-ancestor
6461439|NCT00454740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6461440|NCT00454740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461441|NCT00454740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461442|NCT00454740|Urological Agents|urological agents|mesh-ancestor
6461443|NCT00454831|Chitosan|chitosan|mesh-list
6461444|NCT00454831|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6439552|NCT00363376|Zonisamide|zonisamide|mesh-list
6439553|NCT00363376|Olanzapine|olanzapine|mesh-list
6439554|NCT00363376|Antiemetics|antiemetics|mesh-ancestor
6439555|NCT00363376|Autonomic Agents|autonomic agents|mesh-ancestor
6439556|NCT00363376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6439557|NCT00363376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439558|NCT00363376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6439559|NCT00363376|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6439560|NCT00363376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6439561|NCT00363376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6439562|NCT00363376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6439563|NCT00363376|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6439564|NCT00363376|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6439565|NCT00363376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6439566|NCT00363376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439567|NCT00363376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6439568|NCT00363376|Serotonin Agents|serotonin agents|mesh-ancestor
6439569|NCT00363376|Anticonvulsants|anticonvulsants|mesh-ancestor
6439570|NCT00363376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6439571|NCT00363376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6439572|NCT00363389|Misoprostol|misoprostol|mesh-list
6439573|NCT00363389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6439574|NCT00363389|Abortifacient Agents|abortifacient agents|mesh-ancestor
6439575|NCT00363389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6439576|NCT00363389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439577|NCT00363389|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6439578|NCT00363389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6439579|NCT00363389|Oxytocics|oxytocics|mesh-ancestor
6439580|NCT00363519|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6439581|NCT00363519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6439582|NCT00363519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439583|NCT00363519|Incretins|incretins|mesh-ancestor
6439584|NCT00363519|Hormones|hormones|mesh-ancestor
6439585|NCT00363519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6439586|NCT00363519|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6439587|NCT00363519|Protease Inhibitors|protease inhibitors|mesh-ancestor
6439588|NCT00363519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6439589|NCT00363519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439590|NCT00363532|Calcitonin|calcitonin|mesh-list
6439591|NCT00363532|Salmon calcitonin|salmon calcitonin|mesh-list
6439592|NCT00363532|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
6439593|NCT00363532|Katacalcin|katacalcin|mesh-list
6439594|NCT00363532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6439595|NCT00363532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439596|NCT00363532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6439597|NCT00363532|Vasodilator Agents|vasodilator agents|mesh-ancestor
6439598|NCT00363571|Acetazolamide|acetazolamide|mesh-list
6439599|NCT00363571|Anticonvulsants|anticonvulsants|mesh-ancestor
6439600|NCT00363571|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6439601|NCT00363571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6439602|NCT00363571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439603|NCT00363571|Diuretics|diuretics|mesh-ancestor
6439604|NCT00363571|Natriuretic Agents|natriuretic agents|mesh-ancestor
6439605|NCT00363571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542676|NCT00853177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6542677|NCT00853177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542678|NCT00853190|Chlorpheniramine|chlorpheniramine|mesh-list
6542679|NCT00853190|Hydrocodone|hydrocodone|mesh-list
6542680|NCT00853190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439606|NCT00363584|Capecitabine|capecitabine|mesh-list
6439607|NCT00363584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6439608|NCT00363584|Antimetabolites|antimetabolites|mesh-ancestor
6439609|NCT00363584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439610|NCT00363584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6439611|NCT00363610|Pegaspargase|pegaspargase|mesh-list
6439612|NCT00363610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6439613|NCT00363688|Penicillins|penicillins|mesh-list
6439614|NCT00363688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6439615|NCT00363688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6439616|NCT00363701|Esomeprazole|esomeprazole|mesh-list
6439617|NCT00363701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6439618|NCT00363701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6439619|NCT00363701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6439620|NCT00363701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6439621|NCT00363701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439622|NCT00363727|Ropinirole|ropinirole|mesh-list
6439623|NCT00363727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6439624|NCT00363727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6439625|NCT00363727|Dopamine Agonists|dopamine agonists|mesh-ancestor
6439626|NCT00363727|Dopamine Agents|dopamine agents|mesh-ancestor
6439627|NCT00363727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6439628|NCT00363727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439629|NCT00363727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439630|NCT00363753|Aspirin|aspirin|mesh-list
6439631|NCT00363753|Clopidogrel|clopidogrel|mesh-list
6439632|NCT00363753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6439633|NCT00363753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6439634|NCT00363753|Analgesics|analgesics|mesh-ancestor
6439635|NCT00363753|Sensory System Agents|sensory system agents|mesh-ancestor
6439636|NCT00363753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6439637|NCT00363753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439638|NCT00363753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6439639|NCT00363753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6439640|NCT00363753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6439641|NCT00363753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6439642|NCT00363753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439643|NCT00363753|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6439644|NCT00363753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6439645|NCT00363753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6439646|NCT00363753|Antipyretics|antipyretics|mesh-ancestor
6439647|NCT00363753|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6439648|NCT00363753|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6439649|NCT00363753|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6439650|NCT00363753|Purinergic Agents|purinergic agents|mesh-ancestor
6439651|NCT00363753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6439652|NCT00363792|Nitroglycerin|nitroglycerin|mesh-list
6439653|NCT00363792|Vasodilator Agents|vasodilator agents|mesh-ancestor
6439654|NCT00363831|Oxaliplatin|oxaliplatin|mesh-list
6439655|NCT00363831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6439656|NCT00363844|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6439657|NCT00363844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6439658|NCT00363844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439659|NCT00363844|Incretins|incretins|mesh-ancestor
6439660|NCT00363844|Hormones|hormones|mesh-ancestor
6439661|NCT00363844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6439662|NCT00363844|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6439663|NCT00363844|Protease Inhibitors|protease inhibitors|mesh-ancestor
6439664|NCT00363844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6542681|NCT00853190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6439665|NCT00363844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439666|NCT00363857|Ropinirole|ropinirole|mesh-list
6439667|NCT00363857|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6439668|NCT00363857|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6439669|NCT00363857|Dopamine Agonists|dopamine agonists|mesh-ancestor
6439670|NCT00363857|Dopamine Agents|dopamine agents|mesh-ancestor
6439671|NCT00363857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6439672|NCT00363857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439673|NCT00363857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439674|NCT00363909|Dexetimide|dexetimide|mesh-list
6439675|NCT00363909|Citalopram|citalopram|mesh-list
6439676|NCT00363909|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6439677|NCT00363909|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6439678|NCT00363909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6439679|NCT00363909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439680|NCT00363909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6439681|NCT00363909|Serotonin Agents|serotonin agents|mesh-ancestor
6439682|NCT00363909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439683|NCT00363909|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6439684|NCT00363909|Antidepressive Agents|antidepressive agents|mesh-ancestor
6439685|NCT00363909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6439686|NCT00363909|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6439687|NCT00363909|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6439688|NCT00363909|Parasympatholytics|parasympatholytics|mesh-ancestor
6439689|NCT00363909|Autonomic Agents|autonomic agents|mesh-ancestor
6439690|NCT00363909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6439691|NCT00363909|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6439692|NCT00363909|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6439693|NCT00363909|Cholinergic Agents|cholinergic agents|mesh-ancestor
6439694|NCT00363935|Dexmedetomidine|dexmedetomidine|mesh-list
6439695|NCT00363935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6439696|NCT00363935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6439697|NCT00363935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439698|NCT00363935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6439699|NCT00363935|Analgesics|analgesics|mesh-ancestor
6439700|NCT00363935|Sensory System Agents|sensory system agents|mesh-ancestor
6439701|NCT00363935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6439702|NCT00363935|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6439703|NCT00363935|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6439704|NCT00363935|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6439705|NCT00363935|Adrenergic Agents|adrenergic agents|mesh-ancestor
6439706|NCT00363935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6439707|NCT00363935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439708|NCT00363948|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6439709|NCT00363948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6439710|NCT00363948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439711|NCT00363948|Incretins|incretins|mesh-ancestor
6439712|NCT00363948|Hormones|hormones|mesh-ancestor
6439713|NCT00363948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6439714|NCT00363948|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6439715|NCT00363948|Protease Inhibitors|protease inhibitors|mesh-ancestor
6439716|NCT00363948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6439717|NCT00363948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439718|NCT00364000|Calcium|calcium|mesh-list
6439719|NCT00364000|Sevelamer|sevelamer|mesh-list
6439720|NCT00364000|Calcium acetate|calcium acetate|mesh-list
6439721|NCT00364000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6439722|NCT00364000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439723|NCT00364000|Chelating Agents|chelating agents|mesh-ancestor
6542682|NCT00853190|Narcotics|narcotics|mesh-ancestor
6542683|NCT00853190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6542684|NCT00853190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542685|NCT00853190|Analgesics|analgesics|mesh-ancestor
6542686|NCT00853190|Sensory System Agents|sensory system agents|mesh-ancestor
6542687|NCT00853190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6542688|NCT00853190|Antitussive Agents|antitussive agents|mesh-ancestor
6542689|NCT00853190|Respiratory System Agents|respiratory system agents|mesh-ancestor
6542690|NCT00853190|Antipruritics|antipruritics|mesh-ancestor
6542691|NCT00853190|Dermatologic Agents|dermatologic agents|mesh-ancestor
6542692|NCT00853190|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6542693|NCT00853190|Histamine Antagonists|histamine antagonists|mesh-ancestor
6542694|NCT00853190|Histamine Agents|histamine agents|mesh-ancestor
6542695|NCT00853190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6542696|NCT00853190|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6439724|NCT00364000|Sequestering Agents|sequestering agents|mesh-ancestor
6439725|NCT00364000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439726|NCT00364026|Darusentan|darusentan|mesh-list
6439727|NCT00364026|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6439728|NCT00364026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439729|NCT00364052|Valganciclovir|valganciclovir|mesh-list
6439730|NCT00364052|Ganciclovir|ganciclovir|mesh-list
6439731|NCT00364052|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6439732|NCT00364052|Antiviral Agents|antiviral agents|mesh-ancestor
6439733|NCT00364052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6439734|NCT00364052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6439735|NCT00364052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6439736|NCT00364052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439737|NCT00364091|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6439738|NCT00364091|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6439739|NCT00364143|Irinotecan|irinotecan|mesh-list
6439740|NCT00364143|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6439741|NCT00364143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6439742|NCT00364143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6439743|NCT00364143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439744|NCT00364143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6439745|NCT00364195|Tesmilifene|tesmilifene|mesh-list
6439746|NCT00364195|Histamine Antagonists|histamine antagonists|mesh-ancestor
6439747|NCT00364195|Histamine Agents|histamine agents|mesh-ancestor
6439748|NCT00364195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6439749|NCT00364195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439750|NCT00364195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439751|NCT00364195|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6439752|NCT00364221|Rosiglitazone|rosiglitazone|mesh-list
6439753|NCT00364221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6439754|NCT00364221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439755|NCT00364260|Epoetin Alfa|epoetin alfa|mesh-list
6439756|NCT00364260|Hematinics|hematinics|mesh-ancestor
6439757|NCT00364273|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6439758|NCT00364273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6439759|NCT00364273|Autonomic Agents|autonomic agents|mesh-ancestor
6439760|NCT00364273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6439761|NCT00364273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439762|NCT00364273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6439763|NCT00364273|Respiratory System Agents|respiratory system agents|mesh-ancestor
6439764|NCT00364273|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6542697|NCT00853216|Oxycodone|oxycodone|mesh-list
6542698|NCT00853216|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6542699|NCT00853216|Narcotics|narcotics|mesh-ancestor
6542700|NCT00853216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6542701|NCT00853216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542702|NCT00853216|Analgesics|analgesics|mesh-ancestor
6542703|NCT00853216|Sensory System Agents|sensory system agents|mesh-ancestor
6542704|NCT00853216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6542705|NCT00853268|Oxycodone|oxycodone|mesh-list
6542706|NCT00853268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6542707|NCT00853268|Narcotics|narcotics|mesh-ancestor
6542708|NCT00853268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6542709|NCT00853268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542710|NCT00853268|Analgesics|analgesics|mesh-ancestor
6542711|NCT00853268|Sensory System Agents|sensory system agents|mesh-ancestor
6542712|NCT00853268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6542713|NCT00853294|Chlorpheniramine|chlorpheniramine|mesh-list
6542714|NCT00853294|Hydrocodone|hydrocodone|mesh-list
6542715|NCT00853294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542716|NCT00853294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6542717|NCT00853294|Narcotics|narcotics|mesh-ancestor
6542718|NCT00853294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6542719|NCT00853294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542720|NCT00853294|Analgesics|analgesics|mesh-ancestor
6542721|NCT00853294|Sensory System Agents|sensory system agents|mesh-ancestor
6542722|NCT00853294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6542723|NCT00853294|Antitussive Agents|antitussive agents|mesh-ancestor
6542724|NCT00853294|Respiratory System Agents|respiratory system agents|mesh-ancestor
6542725|NCT00853294|Antipruritics|antipruritics|mesh-ancestor
6542726|NCT00853294|Dermatologic Agents|dermatologic agents|mesh-ancestor
6542727|NCT00853294|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6542728|NCT00853294|Histamine Antagonists|histamine antagonists|mesh-ancestor
6542729|NCT00853294|Histamine Agents|histamine agents|mesh-ancestor
6542730|NCT00853294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6542731|NCT00853294|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6542732|NCT00853320|Oxycodone|oxycodone|mesh-list
6542733|NCT00853320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6542734|NCT00853320|Narcotics|narcotics|mesh-ancestor
6542735|NCT00853320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6542736|NCT00853320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542737|NCT00853320|Analgesics|analgesics|mesh-ancestor
6439765|NCT00364273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6439766|NCT00364273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6439767|NCT00364273|Adrenergic Agents|adrenergic agents|mesh-ancestor
6439768|NCT00364273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6439769|NCT00364273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439770|NCT00364429|Lorazepam|lorazepam|mesh-list
6439771|NCT00364429|Risperidone|risperidone|mesh-list
6439772|NCT00364429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6439773|NCT00364429|Serotonin Agents|serotonin agents|mesh-ancestor
6439774|NCT00364429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6439775|NCT00364429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439776|NCT00364429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439777|NCT00364429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6439778|NCT00364429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6439779|NCT00364429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6439780|NCT00364429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6439781|NCT00364429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6542738|NCT00853320|Sensory System Agents|sensory system agents|mesh-ancestor
6542739|NCT00853320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6542740|NCT00853411|Prednisone|prednisone|mesh-list
6542741|NCT00853411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6439782|NCT00364429|Dopamine Agents|dopamine agents|mesh-ancestor
6439783|NCT00364429|Anticonvulsants|anticonvulsants|mesh-ancestor
6439784|NCT00364429|Antiemetics|antiemetics|mesh-ancestor
6439785|NCT00364429|Autonomic Agents|autonomic agents|mesh-ancestor
6439786|NCT00364429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6439787|NCT00364429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6439788|NCT00364429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6439789|NCT00364429|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6439790|NCT00364429|GABA Modulators|gaba modulators|mesh-ancestor
6439791|NCT00364429|GABA Agents|gaba agents|mesh-ancestor
6439792|NCT00364442|Fluticasone|fluticasone|mesh-list
6439793|NCT00364442|Xhance|xhance|mesh-list
6439794|NCT00364442|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6439795|NCT00364442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6439796|NCT00364442|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6439797|NCT00364442|Autonomic Agents|autonomic agents|mesh-ancestor
6439798|NCT00364442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6439799|NCT00364442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439800|NCT00364442|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6439801|NCT00364442|Respiratory System Agents|respiratory system agents|mesh-ancestor
6439802|NCT00364442|Dermatologic Agents|dermatologic agents|mesh-ancestor
6439803|NCT00364442|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6439804|NCT00364442|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6439805|NCT00364442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6439806|NCT00364442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6439807|NCT00364442|Adrenergic Agents|adrenergic agents|mesh-ancestor
6439808|NCT00364442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6439809|NCT00364442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439810|NCT00364455|Epoetin Alfa|epoetin alfa|mesh-list
6439811|NCT00364455|Hematinics|hematinics|mesh-ancestor
6439812|NCT00364481|Omeprazole|omeprazole|mesh-list
6439813|NCT00364481|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6439814|NCT00364481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6439815|NCT00364481|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6439816|NCT00364481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6439817|NCT00364481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439818|NCT00364559|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6439819|NCT00364559|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6439820|NCT00364559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6439821|NCT00364559|Antimetabolites|antimetabolites|mesh-ancestor
6439822|NCT00364559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439823|NCT00364559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6439824|NCT00364559|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6439825|NCT00364559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6439826|NCT00364572|Etanercept|etanercept|mesh-list
6439827|NCT00364572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6439828|NCT00364572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6439829|NCT00364572|Analgesics|analgesics|mesh-ancestor
6439830|NCT00364572|Sensory System Agents|sensory system agents|mesh-ancestor
6439831|NCT00364572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6439832|NCT00364572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439833|NCT00364572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6439834|NCT00364572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6439835|NCT00364572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6439836|NCT00364572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6439837|NCT00364572|Immunologic Factors|immunologic factors|mesh-ancestor
6439838|NCT00364702|Methylphenidate|methylphenidate|mesh-list
6439839|NCT00364702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6439840|NCT00364702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439841|NCT00364702|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6439842|NCT00364702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6439843|NCT00364702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6439844|NCT00364702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439845|NCT00364702|Dopamine Agents|dopamine agents|mesh-ancestor
6439846|NCT00364702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6439847|NCT00364754|Tesmilifene|tesmilifene|mesh-list
6439848|NCT00364754|Histamine Antagonists|histamine antagonists|mesh-ancestor
6439849|NCT00364754|Histamine Agents|histamine agents|mesh-ancestor
6439850|NCT00364754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6439851|NCT00364754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439852|NCT00364754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439853|NCT00364754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6439854|NCT00364806|Metoclopramide|metoclopramide|mesh-list
6439855|NCT00364806|Prochlorperazine|prochlorperazine|mesh-list
6439856|NCT00364806|Antiemetics|antiemetics|mesh-ancestor
6439857|NCT00364806|Autonomic Agents|autonomic agents|mesh-ancestor
6439858|NCT00364806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6439859|NCT00364806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439860|NCT00364806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6439861|NCT00364806|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6439862|NCT00364806|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6439863|NCT00364806|Dopamine Agents|dopamine agents|mesh-ancestor
6439864|NCT00364806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6542742|NCT00853411|Glucocorticoids|glucocorticoids|mesh-ancestor
6542743|NCT00853411|Hormones|hormones|mesh-ancestor
6542744|NCT00853411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6542745|NCT00853411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542746|NCT00853411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6542747|NCT00853411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6542748|NCT00853450|Clopidogrel|clopidogrel|mesh-list
6542749|NCT00853450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6542750|NCT00853450|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6542751|NCT00853450|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6542752|NCT00853450|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6542753|NCT00853450|Purinergic Agents|purinergic agents|mesh-ancestor
6542754|NCT00853450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6542755|NCT00853450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542756|NCT00853450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542757|NCT00853502|Methyltestosterone|methyltestosterone|mesh-list
6542758|NCT00853502|Testosterone|testosterone|mesh-list
6542759|NCT00853502|Testosterone undecanoate|testosterone undecanoate|mesh-list
6542760|NCT00853502|Testosterone enanthate|testosterone enanthate|mesh-list
6542761|NCT00853502|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6542762|NCT00853502|Androgens|androgens|mesh-ancestor
6542763|NCT00853502|Hormones|hormones|mesh-ancestor
6019543|NCT00387881|Naproxen|naproxen|mesh-list
6019544|NCT00387881|Sumatriptan|sumatriptan|mesh-list
6019545|NCT00387881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6019546|NCT00387881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6019547|NCT00387881|Analgesics|analgesics|mesh-ancestor
6019548|NCT00387881|Sensory System Agents|sensory system agents|mesh-ancestor
6019549|NCT00387881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6439865|NCT00364806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019550|NCT00387881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439866|NCT00364806|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6439867|NCT00364806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6439868|NCT00364806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6439869|NCT00364806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6439870|NCT00364871|Naltrexone|naltrexone|mesh-list
6439871|NCT00364871|Bupropion|bupropion|mesh-list
6439872|NCT00364871|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6439873|NCT00364871|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6439874|NCT00364871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439875|NCT00364871|Sensory System Agents|sensory system agents|mesh-ancestor
6439876|NCT00364871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6439877|NCT00364871|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6664673|NCT01513525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019551|NCT00387881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6019552|NCT00387881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6019553|NCT00387881|Gout Suppressants|gout suppressants|mesh-ancestor
6019554|NCT00387881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6019555|NCT00387881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6019556|NCT00387881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019557|NCT00387881|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6019558|NCT00387881|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6019559|NCT00387881|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6019560|NCT00387881|Serotonin Agents|serotonin agents|mesh-ancestor
6019561|NCT00387881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6439878|NCT00364871|Antidepressive Agents|antidepressive agents|mesh-ancestor
6439879|NCT00364871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6439880|NCT00364871|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6439881|NCT00364871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6439882|NCT00364871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6439883|NCT00364871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439884|NCT00364871|Dopamine Agents|dopamine agents|mesh-ancestor
6439885|NCT00364871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6439886|NCT00364871|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6439887|NCT00364871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6439888|NCT00364871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6439889|NCT00364988|Pioglitazone|pioglitazone|mesh-list
6439890|NCT00364988|Losartan|losartan|mesh-list
6439891|NCT00364988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6439892|NCT00364988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439893|NCT00364988|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6439894|NCT00364988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6439895|NCT00364988|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6439896|NCT00364988|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6439897|NCT00364988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439898|NCT00365001|Methotrexate|methotrexate|mesh-list
6439899|NCT00365001|Simvastatin|simvastatin|mesh-list
6439900|NCT00365001|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6439901|NCT00365001|Abortifacient Agents|abortifacient agents|mesh-ancestor
6439902|NCT00365001|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6439903|NCT00365001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439904|NCT00365001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6439905|NCT00365001|Antimetabolites|antimetabolites|mesh-ancestor
6439906|NCT00365001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439907|NCT00365001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6439908|NCT00365001|Dermatologic Agents|dermatologic agents|mesh-ancestor
6439909|NCT00365001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6439910|NCT00365001|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6439911|NCT00365001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6439912|NCT00365001|Immunologic Factors|immunologic factors|mesh-ancestor
6439913|NCT00365001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6439914|NCT00365001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6439915|NCT00365001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6439916|NCT00365001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6439917|NCT00365001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6439918|NCT00365001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6439919|NCT00365040|Mitomycins|mitomycins|mesh-list
6439920|NCT00365040|Mitomycin|mitomycin|mesh-list
6439921|NCT00365040|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6439922|NCT00365040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6439923|NCT00365040|Alkylating Agents|alkylating agents|mesh-ancestor
6439924|NCT00365040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439925|NCT00365040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6439926|NCT00365040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6439927|NCT00365170|Insulin|insulin|mesh-list
6439928|NCT00365170|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6439929|NCT00365170|Insulin Aspart|insulin aspart|mesh-list
6439930|NCT00365170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6439931|NCT00365170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439932|NCT00365183|Pemetrexed|pemetrexed|mesh-list
6439933|NCT00365183|Motexafin gadolinium|motexafin gadolinium|mesh-list
6439934|NCT00365183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6439935|NCT00365183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6439936|NCT00365183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439937|NCT00365183|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6439938|NCT00365183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6542764|NCT00853502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6542765|NCT00853502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542766|NCT00853502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6542767|NCT00853502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6439939|NCT00365183|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6439940|NCT00365183|Dermatologic Agents|dermatologic agents|mesh-ancestor
6439941|NCT00365222|Temozolomide|temozolomide|mesh-list
6439942|NCT00365222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6439943|NCT00365222|Alkylating Agents|alkylating agents|mesh-ancestor
6439944|NCT00365222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439945|NCT00365222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6461445|NCT00454831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6461446|NCT00454831|Antimetabolites|antimetabolites|mesh-ancestor
6461447|NCT00454831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461448|NCT00454831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6542768|NCT00853502|Anabolic Agents|anabolic agents|mesh-ancestor
6542769|NCT00853554|Hydromorphone|hydromorphone|mesh-list
6542770|NCT00853554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6542771|NCT00853554|Narcotics|narcotics|mesh-ancestor
6542772|NCT00853554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6542773|NCT00853554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542774|NCT00853554|Analgesics|analgesics|mesh-ancestor
6542775|NCT00853554|Sensory System Agents|sensory system agents|mesh-ancestor
6542776|NCT00853554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6542777|NCT00853684|Capecitabine|capecitabine|mesh-list
6542778|NCT00853684|Endostar protein|endostar protein|mesh-list
6542779|NCT00853684|Endostatins|endostatins|mesh-list
6542780|NCT00853684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6542781|NCT00853684|Antimetabolites|antimetabolites|mesh-ancestor
6542782|NCT00853684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542783|NCT00853684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6542784|NCT00853684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6542785|NCT00853684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6542786|NCT00853684|Growth Substances|growth substances|mesh-ancestor
6542787|NCT00853684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542788|NCT00853684|Growth Inhibitors|growth inhibitors|mesh-ancestor
6655590|NCT01464606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655591|NCT01464606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6655592|NCT01464606|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6655593|NCT01464606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6655594|NCT01464606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6655595|NCT01464606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6461449|NCT00454831|Chelating Agents|chelating agents|mesh-ancestor
6439946|NCT00365287|Cyclosporine|cyclosporine|mesh-list
6439947|NCT00365287|Mycophenolic Acid|mycophenolic acid|mesh-list
6439948|NCT00365287|Cyclophosphamide|cyclophosphamide|mesh-list
6439949|NCT00365287|Fludarabine|fludarabine|mesh-list
6439950|NCT00365287|Fludarabine phosphate|fludarabine phosphate|mesh-list
6439951|NCT00365287|Cyclosporins|cyclosporins|mesh-list
6439952|NCT00365287|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6439953|NCT00365287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6439954|NCT00365287|Immunologic Factors|immunologic factors|mesh-ancestor
6439955|NCT00365287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439956|NCT00365287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6439957|NCT00365287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6439958|NCT00365287|Alkylating Agents|alkylating agents|mesh-ancestor
6439959|NCT00365287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439960|NCT00365287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6439961|NCT00365287|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6439962|NCT00365287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6439963|NCT00365287|Antimetabolites|antimetabolites|mesh-ancestor
6439964|NCT00365287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6439965|NCT00365287|Antifungal Agents|antifungal agents|mesh-ancestor
6439966|NCT00365287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6439967|NCT00365287|Dermatologic Agents|dermatologic agents|mesh-ancestor
6439968|NCT00365287|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6439969|NCT00365287|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6439970|NCT00365287|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6439971|NCT00365287|Antitubercular Agents|antitubercular agents|mesh-ancestor
6439972|NCT00365287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6439973|NCT00365313|Celecoxib|celecoxib|mesh-list
6439974|NCT00365313|Esomeprazole|esomeprazole|mesh-list
6439975|NCT00365313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6439976|NCT00365313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6439977|NCT00365313|Analgesics|analgesics|mesh-ancestor
6439978|NCT00365313|Sensory System Agents|sensory system agents|mesh-ancestor
6439979|NCT00365313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6439980|NCT00365313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6439981|NCT00365313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6439982|NCT00365313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6439983|NCT00365313|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6439984|NCT00365313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6439985|NCT00365313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6439986|NCT00365313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6439987|NCT00365313|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6439988|NCT00365313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6439989|NCT00365313|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6439990|NCT00365339|Ritonavir|ritonavir|mesh-list
6439991|NCT00365339|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6439992|NCT00365339|Tenofovir|tenofovir|mesh-list
6439993|NCT00365339|Aripiprazole|aripiprazole|mesh-list
6439994|NCT00365339|Famotidine|famotidine|mesh-list
6439995|NCT00365339|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6439996|NCT00365339|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6439997|NCT00365339|Protease Inhibitors|protease inhibitors|mesh-ancestor
6439998|NCT00365339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6439999|NCT00365339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6440000|NCT00365339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6440001|NCT00365339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6440002|NCT00365339|Antiviral Agents|antiviral agents|mesh-ancestor
6440003|NCT00365339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6440004|NCT00365339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6440005|NCT00365339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6440006|NCT00365339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6440007|NCT00365339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6440008|NCT00365339|Antidepressive Agents|antidepressive agents|mesh-ancestor
6440009|NCT00365339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6440010|NCT00365339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6440011|NCT00365339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6440012|NCT00365339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6440013|NCT00365339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440014|NCT00365339|Dopamine Agonists|dopamine agonists|mesh-ancestor
6440015|NCT00365339|Dopamine Agents|dopamine agents|mesh-ancestor
6440016|NCT00365339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6440017|NCT00365339|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6440018|NCT00365339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6440019|NCT00365339|Serotonin Agents|serotonin agents|mesh-ancestor
6440020|NCT00365339|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6440021|NCT00365339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6440022|NCT00365339|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6440023|NCT00365339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6440024|NCT00365339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6440025|NCT00365339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6440026|NCT00365339|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6440027|NCT00365339|Histamine Antagonists|histamine antagonists|mesh-ancestor
6440028|NCT00365339|Histamine Agents|histamine agents|mesh-ancestor
6440029|NCT00365560|Tiotropium Bromide|tiotropium bromide|mesh-list
6440030|NCT00365560|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6440031|NCT00365560|Autonomic Agents|autonomic agents|mesh-ancestor
6440032|NCT00365560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6440033|NCT00365560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440034|NCT00365560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6440035|NCT00365560|Respiratory System Agents|respiratory system agents|mesh-ancestor
6440036|NCT00365560|Parasympatholytics|parasympatholytics|mesh-ancestor
6440037|NCT00365560|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6440038|NCT00365560|Cholinergic Agents|cholinergic agents|mesh-ancestor
6440039|NCT00365560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6440040|NCT00365560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6440041|NCT00365586|Ketoprofen|ketoprofen|mesh-list
6440042|NCT00365586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6542789|NCT00853697|Methyltestosterone|methyltestosterone|mesh-list
6542790|NCT00853697|Testosterone|testosterone|mesh-list
6542791|NCT00853697|Testosterone undecanoate|testosterone undecanoate|mesh-list
6542792|NCT00853697|Testosterone enanthate|testosterone enanthate|mesh-list
6542793|NCT00853697|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6542794|NCT00853697|Dutasteride|dutasteride|mesh-list
6542795|NCT00853697|Androgens|androgens|mesh-ancestor
6542796|NCT00853697|Hormones|hormones|mesh-ancestor
6542797|NCT00853697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6542798|NCT00853697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542799|NCT00853697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6542800|NCT00853697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6542801|NCT00853697|Anabolic Agents|anabolic agents|mesh-ancestor
6542802|NCT00853697|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6542803|NCT00853697|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6542804|NCT00853697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6542805|NCT00853697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542806|NCT00853697|Hormone Antagonists|hormone antagonists|mesh-ancestor
6542807|NCT00853736|Oxycodone|oxycodone|mesh-list
6542808|NCT00853736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6542809|NCT00853736|Narcotics|narcotics|mesh-ancestor
6542810|NCT00853736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6542811|NCT00853736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542812|NCT00853736|Analgesics|analgesics|mesh-ancestor
6542813|NCT00853736|Sensory System Agents|sensory system agents|mesh-ancestor
6542814|NCT00853736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6542815|NCT00853866|Reboxetine|reboxetine|mesh-list
6542816|NCT00853866|Antidepressive Agents|antidepressive agents|mesh-ancestor
6542817|NCT00853866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6542818|NCT00853866|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6542819|NCT00853866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6542820|NCT00853866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6542821|NCT00853866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542822|NCT00853866|Adrenergic Agents|adrenergic agents|mesh-ancestor
6542823|NCT00853866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6542824|NCT00853866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440043|NCT00365586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6440044|NCT00365586|Analgesics|analgesics|mesh-ancestor
6440045|NCT00365586|Sensory System Agents|sensory system agents|mesh-ancestor
6440046|NCT00365586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6440047|NCT00365586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440048|NCT00365586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6440049|NCT00365586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6440050|NCT00365586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6440051|NCT00365586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6440052|NCT00365586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6440053|NCT00365612|Tenofovir|tenofovir|mesh-list
6440054|NCT00365612|Emtricitabine|emtricitabine|mesh-list
6440055|NCT00365612|Efavirenz|efavirenz|mesh-list
6440056|NCT00365612|Antiviral Agents|antiviral agents|mesh-ancestor
6440057|NCT00365612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6440058|NCT00365612|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6440059|NCT00365612|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6440060|NCT00365612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6440061|NCT00365612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6440062|NCT00365612|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6440063|NCT00365612|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6440064|NCT00365612|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6440065|NCT00365612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6440066|NCT00365612|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6440067|NCT00365612|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6440068|NCT00365612|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6440069|NCT00365612|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6440070|NCT00365638|Simvastatin|simvastatin|mesh-list
6440071|NCT00365638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6440072|NCT00365638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6440073|NCT00365638|Antimetabolites|antimetabolites|mesh-ancestor
6440074|NCT00365638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6440075|NCT00365638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6440076|NCT00365638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6440077|NCT00365638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6440078|NCT00365742|Simvastatin|simvastatin|mesh-list
6440079|NCT00365742|Red yeast rice|red yeast rice|mesh-list
6440080|NCT00365742|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6440081|NCT00365742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6440082|NCT00365742|Antimetabolites|antimetabolites|mesh-ancestor
6440083|NCT00365742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6440084|NCT00365742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6440085|NCT00365742|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6440086|NCT00365742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6440087|NCT00365755|Cyclophosphamide|cyclophosphamide|mesh-list
6440088|NCT00365755|Melphalan|melphalan|mesh-list
6440089|NCT00365755|Carboplatin|carboplatin|mesh-list
6440090|NCT00365755|Etoposide|etoposide|mesh-list
6440091|NCT00365755|Vincristine|vincristine|mesh-list
6440092|NCT00365755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6440093|NCT00365755|Immunologic Factors|immunologic factors|mesh-ancestor
6440094|NCT00365755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440095|NCT00365755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6440096|NCT00365755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6440097|NCT00365755|Alkylating Agents|alkylating agents|mesh-ancestor
6440098|NCT00365755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6440099|NCT00365755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6440100|NCT00365755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6440101|NCT00365755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6440102|NCT00365755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6440103|NCT00365755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6440104|NCT00365755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6440105|NCT00365755|Tubulin Modulators|tubulin modulators|mesh-ancestor
6440106|NCT00365755|Antimitotic Agents|antimitotic agents|mesh-ancestor
6440107|NCT00365755|Mitosis Modulators|mitosis modulators|mesh-ancestor
6440108|NCT00365820|Tegaserod|tegaserod|mesh-list
6440109|NCT00365820|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6440110|NCT00365820|Serotonin Agents|serotonin agents|mesh-ancestor
6440111|NCT00365820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6440112|NCT00365820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6440113|NCT00365820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440114|NCT00365898|Hydromorphone|hydromorphone|mesh-list
6440115|NCT00365898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6440116|NCT00365898|Narcotics|narcotics|mesh-ancestor
6440117|NCT00365898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6440118|NCT00365898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440119|NCT00365898|Analgesics|analgesics|mesh-ancestor
6440120|NCT00365898|Sensory System Agents|sensory system agents|mesh-ancestor
6440121|NCT00365898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6440122|NCT00365924|Teriparatide|teriparatide|mesh-list
6440123|NCT00365924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6440124|NCT00365924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440125|NCT00365924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6440126|NCT00365937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
6440127|NCT00365937|Immunologic Factors|immunologic factors|mesh-ancestor
6440128|NCT00365937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440129|NCT00365950|Warfarin|warfarin|mesh-list
6440130|NCT00365950|Anticoagulants|anticoagulants|mesh-ancestor
6440131|NCT00366002|Darifenacin|darifenacin|mesh-list
6440132|NCT00366002|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6440133|NCT00366002|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6440134|NCT00366002|Cholinergic Agents|cholinergic agents|mesh-ancestor
6440135|NCT00366002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6440136|NCT00366002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6440137|NCT00366002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440138|NCT00366002|Urological Agents|urological agents|mesh-ancestor
6542825|NCT00853879|Vitamins|vitamins|mesh-list
6542826|NCT00853879|Folic Acid|folic acid|mesh-list
6542827|NCT00853879|Hydroxocobalamin|hydroxocobalamin|mesh-list
6542828|NCT00853879|Vitamin B 12|vitamin b 12|mesh-list
6542829|NCT00853879|Vitamin B 6|vitamin b 6|mesh-list
6542830|NCT00853879|Pyridoxal|pyridoxal|mesh-list
6542831|NCT00853879|Pyridoxine|pyridoxine|mesh-list
6542832|NCT00853879|Vitamin B Complex|vitamin b complex|mesh-list
6542833|NCT00853879|Micronutrients|micronutrients|mesh-ancestor
6542834|NCT00853879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542835|NCT00853879|Hematinics|hematinics|mesh-ancestor
6542836|NCT00853892|Oxycodone|oxycodone|mesh-list
6542837|NCT00853892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6542838|NCT00853892|Narcotics|narcotics|mesh-ancestor
6542839|NCT00853892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6542840|NCT00853892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542841|NCT00853892|Analgesics|analgesics|mesh-ancestor
6542842|NCT00853892|Sensory System Agents|sensory system agents|mesh-ancestor
6542843|NCT00853892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6542844|NCT00853931|Panitumumab|panitumumab|mesh-list
6542845|NCT00853931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6542846|NCT00853931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6542847|NCT00853944|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6542848|NCT00853944|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
6542849|NCT00853944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6542850|NCT00853944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542851|NCT00853944|Incretins|incretins|mesh-ancestor
6542852|NCT00853944|Hormones|hormones|mesh-ancestor
6542853|NCT00853944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6542854|NCT00853944|Protease Inhibitors|protease inhibitors|mesh-ancestor
6542855|NCT00853944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6542856|NCT00853944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542857|NCT00853983|Saracatinib|saracatinib|mesh-list
6542858|NCT00853983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6542859|NCT00853983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6542860|NCT00853983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542861|NCT00854009|BLI-489|bli-489|mesh-list
6542862|NCT00854009|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6542863|NCT00854009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6542864|NCT00854009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542865|NCT00854009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6542866|NCT00854009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6542867|NCT00854035|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6542868|NCT00854035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6542869|NCT00854035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542870|NCT00854035|Incretins|incretins|mesh-ancestor
6542871|NCT00854035|Hormones|hormones|mesh-ancestor
6542872|NCT00854035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6542873|NCT00854035|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6542874|NCT00854035|Protease Inhibitors|protease inhibitors|mesh-ancestor
6542875|NCT00854035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6440139|NCT00366067|Phenytoin|phenytoin|mesh-list
6655596|NCT01464606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6440140|NCT00366067|Anticonvulsants|anticonvulsants|mesh-ancestor
6440141|NCT00366067|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6440142|NCT00366067|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6440143|NCT00366067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6440144|NCT00366067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6440145|NCT00366067|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6440146|NCT00366067|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6440147|NCT00366093|Eszopiclone|eszopiclone|mesh-list
6440148|NCT00366093|Zopiclone|zopiclone|mesh-list
6440149|NCT00366093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6440150|NCT00366093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6440151|NCT00366093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440152|NCT00366119|Ramipril|ramipril|mesh-list
6440153|NCT00366119|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6440154|NCT00366119|Protease Inhibitors|protease inhibitors|mesh-ancestor
6440155|NCT00366119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6440156|NCT00366119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6440157|NCT00366119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6440158|NCT00366236|Nitazoxanide|nitazoxanide|mesh-list
6440159|NCT00366236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6440160|NCT00366236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6440161|NCT00366262|Naproxen|naproxen|mesh-list
6440162|NCT00366262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6440163|NCT00366262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6440164|NCT00366262|Analgesics|analgesics|mesh-ancestor
6440165|NCT00366262|Sensory System Agents|sensory system agents|mesh-ancestor
6440166|NCT00366262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6440167|NCT00366262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440168|NCT00366262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6440169|NCT00366262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6440170|NCT00366262|Gout Suppressants|gout suppressants|mesh-ancestor
6440171|NCT00366262|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6440172|NCT00366262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6440173|NCT00366262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6440174|NCT00366418|Rituximab|rituximab|mesh-list
6440175|NCT00366418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6440176|NCT00366418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6440177|NCT00366418|Immunologic Factors|immunologic factors|mesh-ancestor
6440178|NCT00366418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440179|NCT00366418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6440180|NCT00366470|Cholecalciferol|cholecalciferol|mesh-list
6440181|NCT00366470|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6440182|NCT00366470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440183|NCT00366470|Vitamins|vitamins|mesh-ancestor
6440184|NCT00366470|Micronutrients|micronutrients|mesh-ancestor
6440185|NCT00366470|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6440186|NCT00366652|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6440187|NCT00366652|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6440188|NCT00366652|Desipramine|desipramine|mesh-list
6440189|NCT00366652|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6440190|NCT00366652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6440191|NCT00366652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6440192|NCT00366652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6440193|NCT00366652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6440194|NCT00366652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440195|NCT00366652|Analgesics|analgesics|mesh-ancestor
6440196|NCT00366652|Sensory System Agents|sensory system agents|mesh-ancestor
6440197|NCT00366652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6440198|NCT00366652|Antidepressive Agents|antidepressive agents|mesh-ancestor
6440199|NCT00366652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6440200|NCT00366652|Dopamine Agents|dopamine agents|mesh-ancestor
6440201|NCT00366652|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6440202|NCT00366652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6440203|NCT00366652|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6440204|NCT00366652|Adrenergic Agents|adrenergic agents|mesh-ancestor
6440205|NCT00366691|Loteprednol Etabonate|loteprednol etabonate|mesh-list
6440206|NCT00366691|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6440207|NCT00366730|Nitazoxanide|nitazoxanide|mesh-list
6440208|NCT00366730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6440209|NCT00366730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6440210|NCT00366834|Dexamethasone|dexamethasone|mesh-list
6440211|NCT00366834|Dexamethasone acetate|dexamethasone acetate|mesh-list
6440212|NCT00366834|Ondansetron|ondansetron|mesh-list
6440213|NCT00366834|Casopitant|casopitant|mesh-list
6440214|NCT00366834|BB 1101|bb 1101|mesh-list
6440215|NCT00366834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6440216|NCT00366834|Antiemetics|antiemetics|mesh-ancestor
6440217|NCT00366834|Autonomic Agents|autonomic agents|mesh-ancestor
6440218|NCT00366834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6440219|NCT00366834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440220|NCT00366834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6440221|NCT00366834|Glucocorticoids|glucocorticoids|mesh-ancestor
6440222|NCT00366834|Hormones|hormones|mesh-ancestor
6440223|NCT00366834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6440224|NCT00366834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6440225|NCT00366834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6440226|NCT00366834|Protease Inhibitors|protease inhibitors|mesh-ancestor
6440227|NCT00366834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6440228|NCT00366834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6440229|NCT00366834|Antipruritics|antipruritics|mesh-ancestor
6440230|NCT00366834|Dermatologic Agents|dermatologic agents|mesh-ancestor
6440231|NCT00366834|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6440232|NCT00366834|Serotonin Agents|serotonin agents|mesh-ancestor
6440233|NCT00366834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6440234|NCT00366834|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6440235|NCT00366834|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6440236|NCT00366834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6440237|NCT00366834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6440238|NCT00366834|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6440239|NCT00366834|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6440240|NCT00366873|Calcium|calcium|mesh-list
6440241|NCT00366873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6440242|NCT00366873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440243|NCT00366938|Lumiracoxib|lumiracoxib|mesh-list
6440244|NCT00366938|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6440245|NCT00366938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6440246|NCT00366938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6440247|NCT00366938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6440248|NCT00366938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6440249|NCT00366938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6440250|NCT00366938|Analgesics|analgesics|mesh-ancestor
6542876|NCT00854035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542877|NCT00854139|Cyclosporine|cyclosporine|mesh-list
6542878|NCT00854139|Cyclophosphamide|cyclophosphamide|mesh-list
6440251|NCT00366938|Sensory System Agents|sensory system agents|mesh-ancestor
6440252|NCT00366938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6461450|NCT00454831|Sequestering Agents|sequestering agents|mesh-ancestor
6440253|NCT00366938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440254|NCT00366938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6440255|NCT00366938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6440256|NCT00367068|Baclofen|baclofen|mesh-list
6440257|NCT00367068|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6440258|NCT00367068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440259|NCT00367068|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6440260|NCT00367068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6440261|NCT00367068|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6440262|NCT00367068|GABA Agonists|gaba agonists|mesh-ancestor
6440263|NCT00367068|GABA Agents|gaba agents|mesh-ancestor
6440264|NCT00367068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6440265|NCT00367068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6440266|NCT00367081|Pyrimethamine|pyrimethamine|mesh-list
6440267|NCT00367081|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6440268|NCT00367081|Sulfadiazine|sulfadiazine|mesh-list
6440269|NCT00367081|Antimalarials|antimalarials|mesh-ancestor
6440270|NCT00367081|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6440271|NCT00367081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6440272|NCT00367081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6440273|NCT00367081|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6440274|NCT00367081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6440275|NCT00367081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6440276|NCT00367081|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6440277|NCT00367081|Renal Agents|renal agents|mesh-ancestor
6440278|NCT00367081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6440279|NCT00367081|Coccidiostats|coccidiostats|mesh-ancestor
6461451|NCT00454831|Hemostatics|hemostatics|mesh-ancestor
6461452|NCT00454831|Coagulants|coagulants|mesh-ancestor
6461453|NCT00454883|Ziprasidone|ziprasidone|mesh-list
6461454|NCT00454883|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6461455|NCT00454883|Serotonin Agents|serotonin agents|mesh-ancestor
6461456|NCT00454883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6461457|NCT00454883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461458|NCT00454883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461459|NCT00454883|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6461460|NCT00454883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6461461|NCT00454883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6461462|NCT00454883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6461463|NCT00454883|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6461464|NCT00454883|Dopamine Agents|dopamine agents|mesh-ancestor
6461465|NCT00454896|Solifenacin Succinate|solifenacin succinate|mesh-list
6461466|NCT00454896|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6461467|NCT00454896|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6461468|NCT00454896|Cholinergic Agents|cholinergic agents|mesh-ancestor
6461469|NCT00454896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6461470|NCT00454896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461471|NCT00454896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461472|NCT00454896|Urological Agents|urological agents|mesh-ancestor
6461473|NCT00454961|Lumefantrine|lumefantrine|mesh-list
6461474|NCT00454961|Artemether|artemether|mesh-list
6461475|NCT00454961|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6461476|NCT00454961|Antimalarials|antimalarials|mesh-ancestor
6461477|NCT00454961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6461478|NCT00454961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6461479|NCT00454961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6461480|NCT00455026|Remifentanil|remifentanil|mesh-list
6461481|NCT00455026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6461482|NCT00455026|Narcotics|narcotics|mesh-ancestor
6461483|NCT00455026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6461484|NCT00455026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461485|NCT00455026|Analgesics|analgesics|mesh-ancestor
6461486|NCT00455026|Sensory System Agents|sensory system agents|mesh-ancestor
6461487|NCT00455026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6461488|NCT00455039|Lapatinib|lapatinib|mesh-list
6461489|NCT00455039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6461490|NCT00455039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6461491|NCT00455039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6461492|NCT00455039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461493|NCT00455091|Lamivudine|lamivudine|mesh-list
6461494|NCT00455091|Adefovir|adefovir|mesh-list
6542879|NCT00854139|Cyclosporins|cyclosporins|mesh-list
6542880|NCT00854139|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6440280|NCT00367094|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6440281|NCT00367094|Benazepril|benazepril|mesh-list
6440282|NCT00367094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6440283|NCT00367094|Diuretics|diuretics|mesh-ancestor
6440284|NCT00367094|Natriuretic Agents|natriuretic agents|mesh-ancestor
6440285|NCT00367094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440286|NCT00367094|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6440287|NCT00367094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6440288|NCT00367094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6440289|NCT00367094|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6440290|NCT00367094|Protease Inhibitors|protease inhibitors|mesh-ancestor
6440291|NCT00367094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6440292|NCT00367120|Amoxicillin|amoxicillin|mesh-list
6440293|NCT00367120|Azithromycin|azithromycin|mesh-list
6440294|NCT00367120|Clavulanic Acid|clavulanic acid|mesh-list
6440295|NCT00367120|Clavulanic Acids|clavulanic acids|mesh-list
6440296|NCT00367120|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6440297|NCT00367120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6440298|NCT00367120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6440299|NCT00367120|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6440300|NCT00367120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6542881|NCT00854139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6542882|NCT00854139|Immunologic Factors|immunologic factors|mesh-ancestor
6542883|NCT00854139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542884|NCT00854139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6542885|NCT00854139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6542886|NCT00854139|Alkylating Agents|alkylating agents|mesh-ancestor
6542887|NCT00854139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542888|NCT00854139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6542889|NCT00854139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6542890|NCT00854139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6542891|NCT00854139|Antifungal Agents|antifungal agents|mesh-ancestor
6542892|NCT00854139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6542893|NCT00854139|Dermatologic Agents|dermatologic agents|mesh-ancestor
6542894|NCT00854139|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6542895|NCT00854178|Anesthetics|anesthetics|mesh-list
6542896|NCT00854178|Isoflurane|isoflurane|mesh-list
6542897|NCT00854178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6542898|NCT00854178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542899|NCT00854178|Anesthetics, General|anesthetics, general|mesh-ancestor
6542900|NCT00854178|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6542901|NCT00854204|Darunavir|darunavir|mesh-list
6542902|NCT00854204|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6542903|NCT00854204|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6542904|NCT00854204|Protease Inhibitors|protease inhibitors|mesh-ancestor
6542905|NCT00854204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6542906|NCT00854204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542907|NCT00854204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6542908|NCT00854204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6542909|NCT00854204|Antiviral Agents|antiviral agents|mesh-ancestor
6542910|NCT00854204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6542911|NCT00854230|Naltrexone|naltrexone|mesh-list
6542912|NCT00854230|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6542913|NCT00854230|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6542914|NCT00854230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542915|NCT00854230|Sensory System Agents|sensory system agents|mesh-ancestor
6542916|NCT00854230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6542917|NCT00854256|Mitomycins|mitomycins|mesh-list
6542918|NCT00854256|Mitomycin|mitomycin|mesh-list
6542919|NCT00854256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6542920|NCT00854256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6542921|NCT00854256|Alkylating Agents|alkylating agents|mesh-ancestor
6542922|NCT00854256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542923|NCT00854256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6542924|NCT00854256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6542925|NCT00854321|Rituximab|rituximab|mesh-list
6440301|NCT00367120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6440302|NCT00367172|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6440303|NCT00367172|Antiviral Agents|antiviral agents|mesh-ancestor
6440304|NCT00367172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6440305|NCT00367185|Thalidomide|thalidomide|mesh-list
6440306|NCT00367185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6440307|NCT00367185|Immunologic Factors|immunologic factors|mesh-ancestor
6440308|NCT00367185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440309|NCT00367185|Leprostatic Agents|leprostatic agents|mesh-ancestor
6440310|NCT00367185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6440311|NCT00367185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6440312|NCT00367185|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6440313|NCT00367185|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6440314|NCT00367185|Growth Substances|growth substances|mesh-ancestor
6440315|NCT00367185|Growth Inhibitors|growth inhibitors|mesh-ancestor
6440316|NCT00367185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6440317|NCT00367211|Naproxen|naproxen|mesh-list
6440318|NCT00367211|Omeprazole|omeprazole|mesh-list
6440319|NCT00367211|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6440320|NCT00367211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6440321|NCT00367211|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6440322|NCT00367211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6440323|NCT00367211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6440324|NCT00367211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6440325|NCT00367211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6440326|NCT00367211|Analgesics|analgesics|mesh-ancestor
6440327|NCT00367211|Sensory System Agents|sensory system agents|mesh-ancestor
6440328|NCT00367211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6440329|NCT00367211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440330|NCT00367211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6440331|NCT00367211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6440332|NCT00367211|Gout Suppressants|gout suppressants|mesh-ancestor
6440333|NCT00367211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6440334|NCT00367250|Trastuzumab|trastuzumab|mesh-list
6440335|NCT00367250|Cetuximab|cetuximab|mesh-list
6440336|NCT00367250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6440337|NCT00367250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6440338|NCT00367263|Ciclesonide|ciclesonide|mesh-list
6440339|NCT00367263|Glucocorticoids|glucocorticoids|mesh-ancestor
6440340|NCT00367263|Hormones|hormones|mesh-ancestor
6440341|NCT00367263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6440342|NCT00367263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440343|NCT00367263|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6440344|NCT00367276|Drospirenone|drospirenone|mesh-list
6440345|NCT00367276|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6440346|NCT00367276|Hormone Antagonists|hormone antagonists|mesh-ancestor
6440347|NCT00367276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6440348|NCT00367276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440349|NCT00367276|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6440350|NCT00367276|Diuretics|diuretics|mesh-ancestor
6440351|NCT00367276|Natriuretic Agents|natriuretic agents|mesh-ancestor
6440352|NCT00367302|Buprenorphine|buprenorphine|mesh-list
6440353|NCT00367302|Methadone|methadone|mesh-list
6440354|NCT00367302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6440355|NCT00367302|Narcotics|narcotics|mesh-ancestor
6440356|NCT00367302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6440357|NCT00367302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440358|NCT00367302|Analgesics|analgesics|mesh-ancestor
6440359|NCT00367302|Sensory System Agents|sensory system agents|mesh-ancestor
6440360|NCT00367302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6440361|NCT00367302|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6440362|NCT00367302|Antitussive Agents|antitussive agents|mesh-ancestor
6440363|NCT00367302|Respiratory System Agents|respiratory system agents|mesh-ancestor
6440364|NCT00367315|Lumiracoxib|lumiracoxib|mesh-list
6440365|NCT00367315|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6440366|NCT00367315|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6440367|NCT00367315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6440368|NCT00367315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6440369|NCT00367315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6440370|NCT00367315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6440371|NCT00367315|Analgesics|analgesics|mesh-ancestor
6440372|NCT00367315|Sensory System Agents|sensory system agents|mesh-ancestor
6440373|NCT00367315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6440374|NCT00367315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440375|NCT00367315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6440376|NCT00367315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6440377|NCT00367393|Pimecrolimus|pimecrolimus|mesh-list
6440378|NCT00367393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6440379|NCT00367393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6440380|NCT00367393|Analgesics|analgesics|mesh-ancestor
6440381|NCT00367393|Sensory System Agents|sensory system agents|mesh-ancestor
6440382|NCT00367393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6440383|NCT00367393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440384|NCT00367393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6019562|NCT00387894|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6019563|NCT00387894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6542926|NCT00854321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6542927|NCT00854321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6542928|NCT00854321|Immunologic Factors|immunologic factors|mesh-ancestor
6542929|NCT00854321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542930|NCT00854321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6542931|NCT00854425|Asparaginase|asparaginase|mesh-list
6542932|NCT00854425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6542933|NCT00854451|Amoxicillin|amoxicillin|mesh-list
6542934|NCT00854451|Omeprazole|omeprazole|mesh-list
6542935|NCT00854451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6542936|NCT00854451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6542937|NCT00854451|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6542938|NCT00854451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6542939|NCT00854451|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6542940|NCT00854451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6542941|NCT00854451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542942|NCT00854477|Capecitabine|capecitabine|mesh-list
6542943|NCT00854477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6542944|NCT00854477|Antimetabolites|antimetabolites|mesh-ancestor
6542945|NCT00854477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542946|NCT00854477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6542947|NCT00854503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6542948|NCT00854503|Simvastatin|simvastatin|mesh-list
6542949|NCT00854503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6542950|NCT00854503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6542951|NCT00854503|Antimetabolites|antimetabolites|mesh-ancestor
6542952|NCT00854503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542953|NCT00854503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6542954|NCT00854503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6542955|NCT00854503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6542956|NCT00854529|Bevacizumab|bevacizumab|mesh-list
6542957|NCT00854529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6542958|NCT00854529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6542959|NCT00854529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6542960|NCT00854529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6542961|NCT00854529|Growth Substances|growth substances|mesh-ancestor
6542962|NCT00854529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542963|NCT00854529|Growth Inhibitors|growth inhibitors|mesh-ancestor
6542964|NCT00854633|Lactoferrin|lactoferrin|mesh-list
6542965|NCT00854633|Talactoferrin alfa|talactoferrin alfa|mesh-list
6542966|NCT00854633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6542967|NCT00854633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6542968|NCT00854646|ON 01910|on 01910|mesh-list
6542969|NCT00854646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6542970|NCT00854646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6542971|NCT00854646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6542972|NCT00854646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019564|NCT00387894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6440385|NCT00367393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6440386|NCT00367393|Dermatologic Agents|dermatologic agents|mesh-ancestor
6440387|NCT00367393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6440388|NCT00367393|Immunologic Factors|immunologic factors|mesh-ancestor
6440389|NCT00367393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6440390|NCT00367393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6440391|NCT00367393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6440392|NCT00367419|Erythromycin|erythromycin|mesh-list
6440393|NCT00367419|Erythromycin Estolate|erythromycin estolate|mesh-list
6440394|NCT00367419|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
6440395|NCT00367419|Erythromycin stearate|erythromycin stearate|mesh-list
6440396|NCT00367419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6440397|NCT00367419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6440398|NCT00367419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6440399|NCT00367419|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6440400|NCT00367419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6440401|NCT00367419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6440402|NCT00367445|Insulin|insulin|mesh-list
6440403|NCT00367445|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6440404|NCT00367445|Insulin Glargine|insulin glargine|mesh-list
6440405|NCT00367445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6440406|NCT00367445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440407|NCT00367471|Paclitaxel|paclitaxel|mesh-list
6440408|NCT00367471|Carboplatin|carboplatin|mesh-list
6440409|NCT00367471|Trastuzumab|trastuzumab|mesh-list
6440410|NCT00367471|Lapatinib|lapatinib|mesh-list
6440411|NCT00367471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6440412|NCT00367471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6440413|NCT00367471|Tubulin Modulators|tubulin modulators|mesh-ancestor
6440414|NCT00367471|Antimitotic Agents|antimitotic agents|mesh-ancestor
6440415|NCT00367471|Mitosis Modulators|mitosis modulators|mesh-ancestor
6440416|NCT00367471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6440417|NCT00367471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6440418|NCT00367471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6440419|NCT00367471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6440420|NCT00367497|Cytarabine|cytarabine|mesh-list
6440421|NCT00367497|Methylprednisolone|methylprednisolone|mesh-list
6440422|NCT00367497|Rituximab|rituximab|mesh-list
6440423|NCT00367497|Etoposide|etoposide|mesh-list
6440424|NCT00367497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6440425|NCT00367497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6440426|NCT00367497|Immunologic Factors|immunologic factors|mesh-ancestor
6440427|NCT00367497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440428|NCT00367497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6440429|NCT00367497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6440430|NCT00367497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6440431|NCT00367497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6440432|NCT00367497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6440433|NCT00367497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6440434|NCT00367497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6440435|NCT00367497|Antimetabolites|antimetabolites|mesh-ancestor
6440436|NCT00367497|Antiviral Agents|antiviral agents|mesh-ancestor
6440437|NCT00367497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6440438|NCT00367497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6440439|NCT00367497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6440440|NCT00367497|Antiemetics|antiemetics|mesh-ancestor
6440441|NCT00367497|Autonomic Agents|autonomic agents|mesh-ancestor
6440442|NCT00367497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6440443|NCT00367497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6440444|NCT00367497|Glucocorticoids|glucocorticoids|mesh-ancestor
6440445|NCT00367497|Hormones|hormones|mesh-ancestor
6440446|NCT00367497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6440447|NCT00367497|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6440448|NCT00367497|Protective Agents|protective agents|mesh-ancestor
6440449|NCT00367536|Bazedoxifene|bazedoxifene|mesh-list
6440450|NCT00367536|Estrogens|estrogens|mesh-list
6440451|NCT00367536|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6440452|NCT00367536|Hormones|hormones|mesh-ancestor
6440453|NCT00367536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6440454|NCT00367536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440455|NCT00367536|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6440456|NCT00367536|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6440457|NCT00367536|Hormone Antagonists|hormone antagonists|mesh-ancestor
6440458|NCT00367536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6440459|NCT00367562|Valsartan|valsartan|mesh-list
6440460|NCT00367562|Enalapril|enalapril|mesh-list
6440461|NCT00367562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6440462|NCT00367562|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6440463|NCT00367562|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6440464|NCT00367562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6440465|NCT00367562|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6440466|NCT00367562|Protease Inhibitors|protease inhibitors|mesh-ancestor
6440467|NCT00367562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6440468|NCT00367614|Pantoprazole|pantoprazole|mesh-list
6440469|NCT00367614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6440470|NCT00367614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6440471|NCT00367614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6440472|NCT00367614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6440473|NCT00367614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6440474|NCT00367627|Albendazole|albendazole|mesh-list
6440475|NCT00367627|Anthelmintics|anthelmintics|mesh-ancestor
6440476|NCT00367627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6440477|NCT00367627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6440478|NCT00367627|Anticestodal Agents|anticestodal agents|mesh-ancestor
6440479|NCT00367627|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6440480|NCT00367627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6542973|NCT00854711|Nitric Oxide|nitric oxide|mesh-list
6542974|NCT00854711|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6542975|NCT00854711|Autonomic Agents|autonomic agents|mesh-ancestor
6542976|NCT00854711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6542977|NCT00854711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542978|NCT00854711|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6542979|NCT00854711|Respiratory System Agents|respiratory system agents|mesh-ancestor
6542980|NCT00854711|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6542981|NCT00854711|Antioxidants|antioxidants|mesh-ancestor
6542982|NCT00854711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542983|NCT00854711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6542984|NCT00854711|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6542985|NCT00854711|Vasodilator Agents|vasodilator agents|mesh-ancestor
6542986|NCT00854711|Gasotransmitters|gasotransmitters|mesh-ancestor
6542987|NCT00854711|Protective Agents|protective agents|mesh-ancestor
6542988|NCT00854750|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6542989|NCT00854750|Hormones|hormones|mesh-ancestor
6542990|NCT00854750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6542991|NCT00854750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6542992|NCT00854763|Olmesartan|olmesartan|mesh-list
6542993|NCT00854763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6542994|NCT00854763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6542995|NCT00854763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6542996|NCT00854763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6542997|NCT00854776|Lansoprazole|lansoprazole|mesh-list
6542998|NCT00854776|Dexlansoprazole|dexlansoprazole|mesh-list
6542999|NCT00854776|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6543000|NCT00854776|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6543001|NCT00854776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6543002|NCT00854776|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6543003|NCT00854776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6543004|NCT00854776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543005|NCT00854776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6543006|NCT00854776|Immunologic Factors|immunologic factors|mesh-ancestor
6543007|NCT00854776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543008|NCT00854776|Antacids|antacids|mesh-ancestor
6543009|NCT00854802|Ribavirin|ribavirin|mesh-list
6543010|NCT00854802|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6543011|NCT00854802|Cyclosporine|cyclosporine|mesh-list
6543012|NCT00854802|Antimetabolites|antimetabolites|mesh-ancestor
6543013|NCT00854802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543014|NCT00854802|Antiviral Agents|antiviral agents|mesh-ancestor
6543015|NCT00854802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6543016|NCT00854802|Antifungal Agents|antifungal agents|mesh-ancestor
6543017|NCT00854802|Dermatologic Agents|dermatologic agents|mesh-ancestor
6543018|NCT00854802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6543019|NCT00854802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6543020|NCT00854802|Immunologic Factors|immunologic factors|mesh-ancestor
6543021|NCT00854802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543022|NCT00854802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6019565|NCT00387894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6019566|NCT00387894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019567|NCT00387959|Cyclosporine|cyclosporine|mesh-list
6019568|NCT00387959|Mycophenolic Acid|mycophenolic acid|mesh-list
6440481|NCT00367627|Tubulin Modulators|tubulin modulators|mesh-ancestor
6440482|NCT00367627|Antimitotic Agents|antimitotic agents|mesh-ancestor
6440483|NCT00367627|Mitosis Modulators|mitosis modulators|mesh-ancestor
6440484|NCT00367627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6440485|NCT00367627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6440486|NCT00367653|Azithromycin|azithromycin|mesh-list
6440487|NCT00367653|Chloroquine|chloroquine|mesh-list
6440488|NCT00367653|Mefloquine|mefloquine|mesh-list
6440489|NCT00367653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6440490|NCT00367653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6440491|NCT00367653|Amebicides|amebicides|mesh-ancestor
6440492|NCT00367653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6440493|NCT00367653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6440494|NCT00367653|Antimalarials|antimalarials|mesh-ancestor
6440495|NCT00367653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6440496|NCT00367718|Bortezomib|bortezomib|mesh-list
6440497|NCT00367718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6440498|NCT00367731|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6440499|NCT00367731|Antiviral Agents|antiviral agents|mesh-ancestor
6440500|NCT00367731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6440501|NCT00367822|Ropinirole|ropinirole|mesh-list
6440502|NCT00367822|Lisuride|lisuride|mesh-list
6440503|NCT00367822|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6440504|NCT00367822|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6440505|NCT00367822|Dopamine Agonists|dopamine agonists|mesh-ancestor
6440506|NCT00367822|Dopamine Agents|dopamine agents|mesh-ancestor
6440507|NCT00367822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6440508|NCT00367822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6440509|NCT00367822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440510|NCT00367822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6440511|NCT00367822|Serotonin Agents|serotonin agents|mesh-ancestor
6440512|NCT00367861|Imatinib Mesylate|imatinib mesylate|mesh-list
6440513|NCT00367861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6440514|NCT00367861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6440515|NCT00367861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6440516|NCT00367861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6440517|NCT00367874|Buprenorphine|buprenorphine|mesh-list
6440518|NCT00367874|Valproic Acid|valproic acid|mesh-list
6440519|NCT00367874|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6440520|NCT00367874|Narcotics|narcotics|mesh-ancestor
6440521|NCT00367874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6440522|NCT00367874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440523|NCT00367874|Analgesics|analgesics|mesh-ancestor
6440524|NCT00367874|Sensory System Agents|sensory system agents|mesh-ancestor
6440525|NCT00367874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6440526|NCT00367874|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6440527|NCT00367874|Anticonvulsants|anticonvulsants|mesh-ancestor
6440528|NCT00367874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6440529|NCT00367874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543023|NCT00854802|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6543024|NCT00854841|Imatinib Mesylate|imatinib mesylate|mesh-list
6543025|NCT00854841|Dasatinib|dasatinib|mesh-list
6440530|NCT00367874|GABA Agents|gaba agents|mesh-ancestor
6440531|NCT00367874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6440532|NCT00367874|Antimanic Agents|antimanic agents|mesh-ancestor
6440533|NCT00367874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6440534|NCT00367874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6440535|NCT00367913|Clarithromycin|clarithromycin|mesh-list
6440536|NCT00367913|Ciprofloxacin|ciprofloxacin|mesh-list
6440537|NCT00367913|Rifampin|rifampin|mesh-list
6440538|NCT00367913|Ethambutol|ethambutol|mesh-list
6440539|NCT00367913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6440540|NCT00367913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6440541|NCT00367913|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6440542|NCT00367913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6440543|NCT00367913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6440544|NCT00367913|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6440545|NCT00367913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6440546|NCT00367913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6440547|NCT00367913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6440548|NCT00367913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6440549|NCT00367913|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6440550|NCT00367913|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6440551|NCT00367913|Antitubercular Agents|antitubercular agents|mesh-ancestor
6440552|NCT00367913|Leprostatic Agents|leprostatic agents|mesh-ancestor
6440553|NCT00367913|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6440554|NCT00367913|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6440555|NCT00367913|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6440556|NCT00367913|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6440557|NCT00367913|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6440558|NCT00367913|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6440559|NCT00367913|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6440560|NCT00367939|Amlodipine|amlodipine|mesh-list
6440561|NCT00367939|Valsartan|valsartan|mesh-list
6440562|NCT00367939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6440563|NCT00367939|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6440564|NCT00367939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6440565|NCT00367939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6440566|NCT00367939|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6440567|NCT00367939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440568|NCT00367939|Vasodilator Agents|vasodilator agents|mesh-ancestor
6440569|NCT00367939|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6440570|NCT00367939|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6440571|NCT00367965|Eszopiclone|eszopiclone|mesh-list
6440572|NCT00367965|Zopiclone|zopiclone|mesh-list
6440573|NCT00367965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6440574|NCT00367965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6440575|NCT00367965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440576|NCT00367978|Amlodipine|amlodipine|mesh-list
6440577|NCT00367978|Benazepril|benazepril|mesh-list
6440578|NCT00367978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6440579|NCT00367978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6440580|NCT00367978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6440581|NCT00367978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6440582|NCT00367978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6440583|NCT00367978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440584|NCT00367978|Vasodilator Agents|vasodilator agents|mesh-ancestor
6440585|NCT00367978|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6440586|NCT00367978|Protease Inhibitors|protease inhibitors|mesh-ancestor
6440587|NCT00367978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6440588|NCT00368017|Pioglitazone|pioglitazone|mesh-list
6440589|NCT00368017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6440590|NCT00368017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440591|NCT00368030|Eszopiclone|eszopiclone|mesh-list
6440592|NCT00368030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6440593|NCT00368030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6440594|NCT00368030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440595|NCT00368056|Eszopiclone|eszopiclone|mesh-list
6440596|NCT00368056|Zopiclone|zopiclone|mesh-list
6440597|NCT00368056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6440598|NCT00368056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6440599|NCT00368056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440600|NCT00368121|Dexamethasone|dexamethasone|mesh-list
6440601|NCT00368121|Cetuximab|cetuximab|mesh-list
6440602|NCT00368121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6440603|NCT00368121|Antiemetics|antiemetics|mesh-ancestor
6440604|NCT00368121|Autonomic Agents|autonomic agents|mesh-ancestor
6440605|NCT00368121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6543026|NCT00854841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6543027|NCT00854841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6543028|NCT00854841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6543029|NCT00854841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543030|NCT00854919|Antipsychotic Agents|antipsychotic agents|mesh-list
6543031|NCT00854919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6543032|NCT00854919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6440606|NCT00368121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543033|NCT00854919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543034|NCT00854919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6543035|NCT00854932|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6543036|NCT00854932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6543037|NCT00855049|Acetaminophen|acetaminophen|mesh-list
6543038|NCT00855049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6543039|NCT00855049|Analgesics|analgesics|mesh-ancestor
6440607|NCT00368121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6440608|NCT00368121|Glucocorticoids|glucocorticoids|mesh-ancestor
6440609|NCT00368121|Hormones|hormones|mesh-ancestor
6440610|NCT00368121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6440611|NCT00368121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6440612|NCT00368121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6440613|NCT00368121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6440614|NCT00368134|Vildagliptin|vildagliptin|mesh-list
6440615|NCT00368134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6440616|NCT00368134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440617|NCT00368134|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6440618|NCT00368134|Protease Inhibitors|protease inhibitors|mesh-ancestor
6440619|NCT00368134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6440620|NCT00368134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6440621|NCT00368160|Eszopiclone|eszopiclone|mesh-list
6440622|NCT00368160|Zopiclone|zopiclone|mesh-list
6440623|NCT00368160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6440624|NCT00368160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6440625|NCT00368160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440626|NCT00368238|Aspirin|aspirin|mesh-list
6440627|NCT00368238|Epoetin Alfa|epoetin alfa|mesh-list
6440628|NCT00368238|Clopidogrel|clopidogrel|mesh-list
6440629|NCT00368238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6440630|NCT00368238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6440631|NCT00368238|Analgesics|analgesics|mesh-ancestor
6440632|NCT00368238|Sensory System Agents|sensory system agents|mesh-ancestor
6440633|NCT00368238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6440634|NCT00368238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440635|NCT00368238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6440636|NCT00368238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6440637|NCT00368238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6440638|NCT00368238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6440639|NCT00368238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6440640|NCT00368238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6440641|NCT00368238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6440642|NCT00368238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6440643|NCT00368238|Antipyretics|antipyretics|mesh-ancestor
6440644|NCT00368238|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6440645|NCT00368238|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6440646|NCT00368238|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6440647|NCT00368238|Purinergic Agents|purinergic agents|mesh-ancestor
6440648|NCT00368238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6440649|NCT00368238|Hematinics|hematinics|mesh-ancestor
6440650|NCT00368264|Infliximab|infliximab|mesh-list
6440651|NCT00368264|Dermatologic Agents|dermatologic agents|mesh-ancestor
6440652|NCT00368264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6440653|NCT00368264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6440654|NCT00368303|Paroxetine|paroxetine|mesh-list
6440655|NCT00368303|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6440656|NCT00368303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6440657|NCT00368303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6440658|NCT00368303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6440659|NCT00368303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6440660|NCT00368303|Serotonin Agents|serotonin agents|mesh-ancestor
6440661|NCT00368303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440662|NCT00368303|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6440663|NCT00368303|Antidepressive Agents|antidepressive agents|mesh-ancestor
6440664|NCT00368303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6440665|NCT00368303|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6440666|NCT00368303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6019569|NCT00387959|Cyclophosphamide|cyclophosphamide|mesh-list
6440667|NCT00368303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6440668|NCT00368329|Carboplatin|carboplatin|mesh-list
6440669|NCT00368329|Fluorouracil|fluorouracil|mesh-list
6440670|NCT00368329|Capecitabine|capecitabine|mesh-list
6440671|NCT00368329|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6440672|NCT00368329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6440673|NCT00368329|Antimetabolites|antimetabolites|mesh-ancestor
6440674|NCT00368329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6440675|NCT00368329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6440676|NCT00368329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6440677|NCT00368329|Immunologic Factors|immunologic factors|mesh-ancestor
6440678|NCT00368329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440679|NCT00368329|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6440680|NCT00368342|Azithromycin|azithromycin|mesh-list
6440681|NCT00368342|Clarithromycin|clarithromycin|mesh-list
6440682|NCT00368342|Erythromycin|erythromycin|mesh-list
6440683|NCT00368342|Erythromycin Estolate|erythromycin estolate|mesh-list
6440684|NCT00368342|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
6440685|NCT00368342|Erythromycin stearate|erythromycin stearate|mesh-list
6440686|NCT00368342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6440687|NCT00368342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6440688|NCT00368342|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6440689|NCT00368342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6440690|NCT00368342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543040|NCT00855049|Sensory System Agents|sensory system agents|mesh-ancestor
6543041|NCT00855049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6543042|NCT00855049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543043|NCT00855049|Antipyretics|antipyretics|mesh-ancestor
6543044|NCT00855088|Ritonavir|ritonavir|mesh-list
6543045|NCT00855088|Darunavir|darunavir|mesh-list
6543046|NCT00855088|Etravirine|etravirine|mesh-list
6543047|NCT00855088|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6543048|NCT00855088|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6543049|NCT00855088|Protease Inhibitors|protease inhibitors|mesh-ancestor
6543050|NCT00855088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6543051|NCT00855088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543052|NCT00855088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6543053|NCT00855088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6543054|NCT00855088|Antiviral Agents|antiviral agents|mesh-ancestor
6543055|NCT00855088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6543056|NCT00855088|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6543057|NCT00855088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6543058|NCT00855088|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6543059|NCT00855088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6543060|NCT00855101|Voriconazole|voriconazole|mesh-list
6543061|NCT00855101|Antifungal Agents|antifungal agents|mesh-ancestor
6543062|NCT00855101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6543063|NCT00855101|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6543064|NCT00855101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6543065|NCT00855101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6543066|NCT00855101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543067|NCT00855101|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6543068|NCT00855101|Hormone Antagonists|hormone antagonists|mesh-ancestor
6543069|NCT00855101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6543070|NCT00855101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543071|NCT00855101|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6543072|NCT00855114|Everolimus|everolimus|mesh-list
6543073|NCT00855114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6543074|NCT00855114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6543075|NCT00855114|Immunologic Factors|immunologic factors|mesh-ancestor
6543076|NCT00855114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543077|NCT00855153|Cycloserine|cycloserine|mesh-list
6543078|NCT00855153|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6543079|NCT00855153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6543080|NCT00855153|Renal Agents|renal agents|mesh-ancestor
6461495|NCT00455091|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6543081|NCT00855153|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6440691|NCT00368342|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6440692|NCT00368342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6440693|NCT00368342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6440694|NCT00368381|Hydrocortisone|hydrocortisone|mesh-list
6440695|NCT00368381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6440696|NCT00368394|Insulin glulisine|insulin glulisine|mesh-list
6440697|NCT00368394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6440698|NCT00368394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440699|NCT00368498|Teicoplanin|teicoplanin|mesh-list
6440700|NCT00368498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6440701|NCT00368498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6440702|NCT00368589|Atorvastatin|atorvastatin|mesh-list
6440703|NCT00368589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6440704|NCT00368589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6440705|NCT00368589|Antimetabolites|antimetabolites|mesh-ancestor
6440706|NCT00368589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6440707|NCT00368589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6440708|NCT00368589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6440709|NCT00368589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6440710|NCT00368602|Timolol|timolol|mesh-list
6440711|NCT00368602|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
6440712|NCT00368602|Adrenergic Antagonists|adrenergic antagonists|mesh-list
6440713|NCT00368602|Adrenergic Agents|adrenergic agents|mesh-ancestor
6440714|NCT00368602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6440715|NCT00368602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6440716|NCT00368602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440717|NCT00368602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6440718|NCT00368602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6440719|NCT00368706|Solifenacin Succinate|solifenacin succinate|mesh-list
6440720|NCT00368706|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6440721|NCT00368706|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6440722|NCT00368706|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6440723|NCT00368706|Cholinergic Agents|cholinergic agents|mesh-ancestor
6440724|NCT00368706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6440725|NCT00368706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6440726|NCT00368706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440727|NCT00368706|Urological Agents|urological agents|mesh-ancestor
6440728|NCT00368719|Tacrolimus|tacrolimus|mesh-list
6440729|NCT00368719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6440730|NCT00368719|Immunologic Factors|immunologic factors|mesh-ancestor
6440731|NCT00368719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440732|NCT00368719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6440733|NCT00368719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6440734|NCT00368719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461496|NCT00455091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6461497|NCT00455091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6461498|NCT00455091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6461499|NCT00455091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461500|NCT00455091|Antiviral Agents|antiviral agents|mesh-ancestor
6461501|NCT00455091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6461502|NCT00455091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6461503|NCT00455091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6461504|NCT00455117|Parecoxib|parecoxib|mesh-list
6461505|NCT00455117|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6461506|NCT00455117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6461507|NCT00455117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6461508|NCT00455117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461509|NCT00455117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6461510|NCT00455117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6461511|NCT00455117|Analgesics|analgesics|mesh-ancestor
6461512|NCT00455117|Sensory System Agents|sensory system agents|mesh-ancestor
6461513|NCT00455117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6461514|NCT00455117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461515|NCT00455117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6461516|NCT00455117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6461517|NCT00455130|Mannitol|mannitol|mesh-list
6461518|NCT00455130|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6461519|NCT00455130|Diuretics|diuretics|mesh-ancestor
6461520|NCT00455130|Natriuretic Agents|natriuretic agents|mesh-ancestor
6461521|NCT00455130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461522|NCT00455234|Promethazine|promethazine|mesh-list
6461523|NCT00455234|Diphenhydramine|diphenhydramine|mesh-list
6461524|NCT00455234|Haloperidol|haloperidol|mesh-list
6461525|NCT00455234|Haloperidol decanoate|haloperidol decanoate|mesh-list
6461526|NCT00455234|Antiemetics|antiemetics|mesh-ancestor
6543082|NCT00855153|Antitubercular Agents|antitubercular agents|mesh-ancestor
6543083|NCT00855153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6543084|NCT00855153|Antimetabolites|antimetabolites|mesh-ancestor
6655597|NCT01464606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6440735|NCT00368862|Memantine|memantine|mesh-list
6440736|NCT00368862|Citalopram|citalopram|mesh-list
6440737|NCT00368862|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6440738|NCT00368862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6440739|NCT00368862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6440740|NCT00368862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019570|NCT00387959|Rituximab|rituximab|mesh-list
6019571|NCT00387959|Fludarabine|fludarabine|mesh-list
6019572|NCT00387959|Fludarabine phosphate|fludarabine phosphate|mesh-list
6019573|NCT00387959|Cyclosporins|cyclosporins|mesh-list
6019574|NCT00387959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6440741|NCT00368862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6440742|NCT00368862|Serotonin Agents|serotonin agents|mesh-ancestor
6440743|NCT00368862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440744|NCT00368862|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6440745|NCT00368862|Antidepressive Agents|antidepressive agents|mesh-ancestor
6440746|NCT00368862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6440747|NCT00368862|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6440748|NCT00368862|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6440749|NCT00368862|Dopamine Agents|dopamine agents|mesh-ancestor
6440750|NCT00368862|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6440751|NCT00368862|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6440752|NCT00368901|Darbepoetin alfa|darbepoetin alfa|mesh-list
6440753|NCT00368901|Hematinics|hematinics|mesh-ancestor
6440754|NCT00368914|Sirolimus|sirolimus|mesh-list
6440755|NCT00368914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6440756|NCT00368914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6440757|NCT00368914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6440758|NCT00368914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6440759|NCT00368914|Antifungal Agents|antifungal agents|mesh-ancestor
6440760|NCT00368914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6440761|NCT00368914|Immunologic Factors|immunologic factors|mesh-ancestor
6440762|NCT00368914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440763|NCT00369018|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6440764|NCT00369018|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
6440765|NCT00369018|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6440766|NCT00369018|Dermatologic Agents|dermatologic agents|mesh-ancestor
6440767|NCT00369031|polysaccharide-K|polysaccharide-k|mesh-list
6440768|NCT00369031|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6440769|NCT00369031|Immunologic Factors|immunologic factors|mesh-ancestor
6440770|NCT00369031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440771|NCT00369031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6440772|NCT00369031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6440773|NCT00369031|Antiviral Agents|antiviral agents|mesh-ancestor
6440774|NCT00369031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6440775|NCT00369031|Interferon Inducers|interferon inducers|mesh-ancestor
6440776|NCT00369031|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6440777|NCT00369031|Protective Agents|protective agents|mesh-ancestor
6440778|NCT00369044|Prednisone|prednisone|mesh-list
6440779|NCT00369044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6440780|NCT00369044|Glucocorticoids|glucocorticoids|mesh-ancestor
6440781|NCT00369044|Hormones|hormones|mesh-ancestor
6440782|NCT00369044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6440783|NCT00369044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440784|NCT00369044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6440785|NCT00369044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6440786|NCT00369096|Bemiparin|bemiparin|mesh-list
6440787|NCT00369096|Anticoagulants|anticoagulants|mesh-ancestor
6543085|NCT00855153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543086|NCT00855205|Rituximab|rituximab|mesh-list
6543087|NCT00855205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6543088|NCT00855205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6543089|NCT00855205|Immunologic Factors|immunologic factors|mesh-ancestor
6543090|NCT00855205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543091|NCT00855205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6543092|NCT00855270|Hydrocortisone|hydrocortisone|mesh-list
6543093|NCT00855270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6543094|NCT00855283|Glycopyrrolate|glycopyrrolate|mesh-list
6543095|NCT00855283|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6543096|NCT00855283|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6543097|NCT00855283|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6019575|NCT00387959|Immunologic Factors|immunologic factors|mesh-ancestor
6440788|NCT00369148|Nateglinide|nateglinide|mesh-list
6440789|NCT00369148|Mitiglinide|mitiglinide|mesh-list
6440790|NCT00369148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6461527|NCT00455234|Autonomic Agents|autonomic agents|mesh-ancestor
6543098|NCT00855283|Cholinergic Agents|cholinergic agents|mesh-ancestor
6543099|NCT00855283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6440791|NCT00369148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440792|NCT00369174|Rosiglitazone|rosiglitazone|mesh-list
6440793|NCT00369174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6440794|NCT00369174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440795|NCT00369239|Risperidone|risperidone|mesh-list
6440796|NCT00369239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6440797|NCT00369239|Serotonin Agents|serotonin agents|mesh-ancestor
6440798|NCT00369239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6440799|NCT00369239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6440800|NCT00369239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440801|NCT00369239|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6440802|NCT00369239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6440803|NCT00369239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6440804|NCT00369239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6440805|NCT00369239|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6440806|NCT00369239|Dopamine Agents|dopamine agents|mesh-ancestor
6440807|NCT00369252|Nimotuzumab|nimotuzumab|mesh-list
6440808|NCT00369252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6440809|NCT00369252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6440810|NCT00369291|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
6440811|NCT00369291|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6440812|NCT00369291|Immunologic Factors|immunologic factors|mesh-ancestor
6440813|NCT00369291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440814|NCT00369356|Prednisone|prednisone|mesh-list
6440815|NCT00369356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6440816|NCT00369356|Glucocorticoids|glucocorticoids|mesh-ancestor
6440817|NCT00369356|Hormones|hormones|mesh-ancestor
6440818|NCT00369356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6440819|NCT00369356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440820|NCT00369356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6440821|NCT00369356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6440822|NCT00369395|Volociximab|volociximab|mesh-list
6440823|NCT00369395|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6440824|NCT00369395|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6440825|NCT00369395|Growth Substances|growth substances|mesh-ancestor
6440826|NCT00369395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440827|NCT00369395|Growth Inhibitors|growth inhibitors|mesh-ancestor
6440828|NCT00369395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6440829|NCT00369408|Naltrexone|naltrexone|mesh-list
6440830|NCT00369408|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6440831|NCT00369408|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6440832|NCT00369408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440833|NCT00369408|Sensory System Agents|sensory system agents|mesh-ancestor
6440834|NCT00369408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6440835|NCT00369434|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6440836|NCT00369434|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6440837|NCT00369434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6440838|NCT00369434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6440839|NCT00369434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6440840|NCT00369434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6440841|NCT00369434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440842|NCT00369434|Antidepressive Agents|antidepressive agents|mesh-ancestor
6440843|NCT00369434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6440844|NCT00369447|Nimotuzumab|nimotuzumab|mesh-list
6440845|NCT00369447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6440846|NCT00369447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6440847|NCT00369538|Losartan|losartan|mesh-list
6440848|NCT00369538|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6440849|NCT00369538|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6440850|NCT00369538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6440851|NCT00369538|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6440852|NCT00369538|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6440853|NCT00369538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6440854|NCT00369538|Diuretics|diuretics|mesh-ancestor
6440855|NCT00369538|Natriuretic Agents|natriuretic agents|mesh-ancestor
6440856|NCT00369538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440857|NCT00369538|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6440858|NCT00369538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6440859|NCT00369551|Paclitaxel|paclitaxel|mesh-list
6440860|NCT00369551|Bevacizumab|bevacizumab|mesh-list
6440861|NCT00369551|Carboplatin|carboplatin|mesh-list
6440862|NCT00369551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6440863|NCT00369551|Antibodies|antibodies|mesh-list
6440864|NCT00369551|Immunoglobulins|immunoglobulins|mesh-list
6440865|NCT00369551|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6440866|NCT00369551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6440867|NCT00369551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6440868|NCT00369551|Tubulin Modulators|tubulin modulators|mesh-ancestor
6440869|NCT00369551|Antimitotic Agents|antimitotic agents|mesh-ancestor
6440870|NCT00369551|Mitosis Modulators|mitosis modulators|mesh-ancestor
6440871|NCT00369551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6440872|NCT00369551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6440873|NCT00369551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6440874|NCT00369551|Growth Substances|growth substances|mesh-ancestor
6440875|NCT00369551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440876|NCT00369551|Growth Inhibitors|growth inhibitors|mesh-ancestor
6440877|NCT00369551|Immunologic Factors|immunologic factors|mesh-ancestor
6440878|NCT00369603|Donepezil|donepezil|mesh-list
6440879|NCT00369603|Galantamine|galantamine|mesh-list
6440880|NCT00369603|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6440881|NCT00369603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6440882|NCT00369603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6440883|NCT00369603|Cholinergic Agents|cholinergic agents|mesh-ancestor
6440884|NCT00369603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6440885|NCT00369603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440886|NCT00369603|Nootropic Agents|nootropic agents|mesh-ancestor
6440887|NCT00369603|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6440888|NCT00369603|Autonomic Agents|autonomic agents|mesh-ancestor
6440889|NCT00369603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6440890|NCT00369694|Terlipressin|terlipressin|mesh-list
6440891|NCT00369694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6440892|NCT00369694|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6440893|NCT00369733|Darbepoetin alfa|darbepoetin alfa|mesh-list
6440894|NCT00369733|Hematinics|hematinics|mesh-ancestor
6440895|NCT00369772|Darbepoetin alfa|darbepoetin alfa|mesh-list
6440896|NCT00369772|Hematinics|hematinics|mesh-ancestor
6440897|NCT00369798|Rolipram|rolipram|mesh-list
6440898|NCT00369798|Antidepressive Agents|antidepressive agents|mesh-ancestor
6440899|NCT00369798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6440900|NCT00369798|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6440901|NCT00369798|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6440902|NCT00369798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6440903|NCT00369798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6440904|NCT00369811|Fentanyl|fentanyl|mesh-list
6440905|NCT00369811|Oxycodone|oxycodone|mesh-list
6440906|NCT00369811|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6440907|NCT00369811|Narcotics|narcotics|mesh-ancestor
6440908|NCT00369811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6440909|NCT00369811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440910|NCT00369811|Analgesics|analgesics|mesh-ancestor
6440911|NCT00369811|Sensory System Agents|sensory system agents|mesh-ancestor
6440912|NCT00369811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6440913|NCT00369811|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6440914|NCT00369811|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6440915|NCT00369811|Anesthetics, General|anesthetics, general|mesh-ancestor
6440916|NCT00369811|Anesthetics|anesthetics|mesh-ancestor
6440917|NCT00369837|Clevidipine|clevidipine|mesh-list
6440918|NCT00369837|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6655598|NCT01464606|Tubulin Modulators|tubulin modulators|mesh-ancestor
6440919|NCT00369837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6440920|NCT00369837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6440921|NCT00369837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6440922|NCT00369837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440923|NCT00369863|Triamcinolone|triamcinolone|mesh-list
6440924|NCT00369863|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6440925|NCT00369863|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6440926|NCT00369863|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6440927|NCT00369863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6440928|NCT00369863|Glucocorticoids|glucocorticoids|mesh-ancestor
6440929|NCT00369863|Hormones|hormones|mesh-ancestor
6440930|NCT00369863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6440931|NCT00369863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440932|NCT00369863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6440933|NCT00369863|Immunologic Factors|immunologic factors|mesh-ancestor
6440934|NCT00369863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6440935|NCT00369863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6440936|NCT00369889|Bevacizumab|bevacizumab|mesh-list
6440937|NCT00369889|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6440938|NCT00369889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6440939|NCT00369889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6440940|NCT00369889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6440941|NCT00369889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6440942|NCT00369889|Growth Substances|growth substances|mesh-ancestor
6440943|NCT00369889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440944|NCT00369889|Growth Inhibitors|growth inhibitors|mesh-ancestor
6440945|NCT00369889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6440946|NCT00369889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6440947|NCT00369889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6440948|NCT00369954|Gemcitabine|gemcitabine|mesh-list
6440949|NCT00369954|Carboplatin|carboplatin|mesh-list
6440950|NCT00369954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6440951|NCT00369954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6440952|NCT00369954|Antimetabolites|antimetabolites|mesh-ancestor
6440953|NCT00369954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6440954|NCT00369954|Antiviral Agents|antiviral agents|mesh-ancestor
6440955|NCT00369954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6440956|NCT00369954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6440957|NCT00369954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6440958|NCT00369954|Immunologic Factors|immunologic factors|mesh-ancestor
6440959|NCT00369954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440960|NCT00369993|Fluticasone|fluticasone|mesh-list
6440961|NCT00369993|Xhance|xhance|mesh-list
6440962|NCT00369993|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6440963|NCT00369993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6440964|NCT00369993|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6440965|NCT00369993|Autonomic Agents|autonomic agents|mesh-ancestor
6440966|NCT00369993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6440967|NCT00369993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440968|NCT00369993|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6440969|NCT00369993|Respiratory System Agents|respiratory system agents|mesh-ancestor
6440970|NCT00369993|Dermatologic Agents|dermatologic agents|mesh-ancestor
6440971|NCT00369993|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6440972|NCT00369993|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6440973|NCT00369993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6440974|NCT00369993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6440975|NCT00369993|Adrenergic Agents|adrenergic agents|mesh-ancestor
6440976|NCT00369993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6440977|NCT00369993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6440978|NCT00370019|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6440979|NCT00370019|Medroxyprogesterone|medroxyprogesterone|mesh-list
6440980|NCT00370019|Estradiol|estradiol|mesh-list
6440981|NCT00370019|Estrogens|estrogens|mesh-ancestor
6440982|NCT00370019|Hormones|hormones|mesh-ancestor
6440983|NCT00370019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6440984|NCT00370019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6440985|NCT00370019|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6440986|NCT00370019|Contraceptive Agents|contraceptive agents|mesh-ancestor
6440987|NCT00370019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6440988|NCT00370019|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6440989|NCT00370019|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6440990|NCT00370019|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6440991|NCT00370019|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6440992|NCT00370019|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6440993|NCT00370019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6440994|NCT00370019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6440995|NCT00370045|Bivalirudin|bivalirudin|mesh-list
6440996|NCT00370045|Eptifibatide|eptifibatide|mesh-list
6440997|NCT00370045|Antithrombins|antithrombins|mesh-ancestor
6440998|NCT00370045|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6543100|NCT00855283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6440999|NCT00370045|Protease Inhibitors|protease inhibitors|mesh-ancestor
6441000|NCT00370045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6441001|NCT00370045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441002|NCT00370045|Anticoagulants|anticoagulants|mesh-ancestor
6441003|NCT00370045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6441004|NCT00370097|Fluticasone|fluticasone|mesh-list
6441005|NCT00370097|Xhance|xhance|mesh-list
6441006|NCT00370097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6441007|NCT00370097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6441008|NCT00370097|Autonomic Agents|autonomic agents|mesh-ancestor
6441009|NCT00370097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6441010|NCT00370097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441011|NCT00370097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6543101|NCT00855283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543102|NCT00855361|Rabeprazole|rabeprazole|mesh-list
6543103|NCT00855361|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6543104|NCT00855361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6543105|NCT00855361|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6543106|NCT00855361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6543107|NCT00855361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543108|NCT00855387|Pancrelipase|pancrelipase|mesh-list
6543109|NCT00855387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6655599|NCT01464606|Antimitotic Agents|antimitotic agents|mesh-ancestor
6655600|NCT01464606|Mitosis Modulators|mitosis modulators|mesh-ancestor
6655601|NCT01464606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6655602|NCT01464606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6655603|NCT01464606|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6441012|NCT00370097|Respiratory System Agents|respiratory system agents|mesh-ancestor
6441013|NCT00370097|Dermatologic Agents|dermatologic agents|mesh-ancestor
6441014|NCT00370097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6441015|NCT00370188|Topiramate|topiramate|mesh-list
6441016|NCT00370188|Anticonvulsants|anticonvulsants|mesh-ancestor
6441017|NCT00370188|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6441018|NCT00370188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441019|NCT00370201|Colchicine|colchicine|mesh-list
6441020|NCT00370201|Gout Suppressants|gout suppressants|mesh-ancestor
6441021|NCT00370201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6441022|NCT00370201|Tubulin Modulators|tubulin modulators|mesh-ancestor
6441023|NCT00370201|Antimitotic Agents|antimitotic agents|mesh-ancestor
6441024|NCT00370201|Mitosis Modulators|mitosis modulators|mesh-ancestor
6441025|NCT00370201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441026|NCT00370201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6441027|NCT00370240|Ropivacaine|ropivacaine|mesh-list
6441028|NCT00370240|Anesthetics, Local|anesthetics, local|mesh-ancestor
6441029|NCT00370240|Anesthetics|anesthetics|mesh-ancestor
6441030|NCT00370240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6441031|NCT00370240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441032|NCT00370240|Sensory System Agents|sensory system agents|mesh-ancestor
6441033|NCT00370240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6441034|NCT00370253|Terlipressin|terlipressin|mesh-list
6441035|NCT00370253|Norepinephrine|norepinephrine|mesh-list
6441036|NCT00370253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6441037|NCT00370253|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6441038|NCT00370253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6441039|NCT00370253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6441040|NCT00370253|Adrenergic Agents|adrenergic agents|mesh-ancestor
6441041|NCT00370253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6441042|NCT00370253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441043|NCT00370253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441044|NCT00370253|Sympathomimetics|sympathomimetics|mesh-ancestor
6441045|NCT00370253|Autonomic Agents|autonomic agents|mesh-ancestor
6441046|NCT00370253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6441047|NCT00370266|Triamcinolone|triamcinolone|mesh-list
6441048|NCT00370266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6441049|NCT00370266|Glucocorticoids|glucocorticoids|mesh-ancestor
6441050|NCT00370266|Hormones|hormones|mesh-ancestor
6441051|NCT00370266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6441052|NCT00370266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441053|NCT00370305|Rosiglitazone|rosiglitazone|mesh-list
6441054|NCT00370305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6441055|NCT00370305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441056|NCT00370318|Acetaminophen|acetaminophen|mesh-list
6441057|NCT00370318|Vaccines|vaccines|mesh-list
6441058|NCT00370318|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6441059|NCT00370318|Immunologic Factors|immunologic factors|mesh-ancestor
6441060|NCT00370318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441061|NCT00370318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6441062|NCT00370318|Analgesics|analgesics|mesh-ancestor
6441063|NCT00370318|Sensory System Agents|sensory system agents|mesh-ancestor
6441064|NCT00370318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6441065|NCT00370318|Antipyretics|antipyretics|mesh-ancestor
6441066|NCT00370370|Triamcinolone|triamcinolone|mesh-list
6441067|NCT00370370|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6441068|NCT00370370|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6441069|NCT00370370|Bevacizumab|bevacizumab|mesh-list
6441070|NCT00370370|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6441071|NCT00370370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6441072|NCT00370370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6441073|NCT00370370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6441074|NCT00370370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6441075|NCT00370370|Growth Substances|growth substances|mesh-ancestor
6441076|NCT00370370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441077|NCT00370370|Growth Inhibitors|growth inhibitors|mesh-ancestor
6441078|NCT00370370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6441079|NCT00370370|Glucocorticoids|glucocorticoids|mesh-ancestor
6441080|NCT00370370|Hormones|hormones|mesh-ancestor
6441081|NCT00370370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6441082|NCT00370370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6441083|NCT00370370|Immunologic Factors|immunologic factors|mesh-ancestor
6441084|NCT00370370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6441085|NCT00370370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441086|NCT00370422|Triamcinolone|triamcinolone|mesh-list
6441087|NCT00370422|Bevacizumab|bevacizumab|mesh-list
6441088|NCT00370422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6441089|NCT00370422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6441090|NCT00370422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6441091|NCT00370422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6441092|NCT00370422|Growth Substances|growth substances|mesh-ancestor
6441093|NCT00370422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441094|NCT00370422|Growth Inhibitors|growth inhibitors|mesh-ancestor
6441095|NCT00370422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6441096|NCT00370422|Glucocorticoids|glucocorticoids|mesh-ancestor
6441097|NCT00370422|Hormones|hormones|mesh-ancestor
6441098|NCT00370422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6441099|NCT00370500|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6441100|NCT00370500|Antidepressive Agents|antidepressive agents|mesh-ancestor
6441101|NCT00370500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6441102|NCT00370500|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6441103|NCT00370500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6441104|NCT00370500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6441105|NCT00370500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441106|NCT00370539|Triamcinolone|triamcinolone|mesh-list
6441107|NCT00370539|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6441108|NCT00370539|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6441109|NCT00370539|Bevacizumab|bevacizumab|mesh-list
6441110|NCT00370539|Verteporfin|verteporfin|mesh-list
6441111|NCT00370539|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6441112|NCT00370539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6441113|NCT00370539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6441114|NCT00370539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6441115|NCT00370539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6441116|NCT00370539|Growth Substances|growth substances|mesh-ancestor
6441117|NCT00370539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441118|NCT00370539|Growth Inhibitors|growth inhibitors|mesh-ancestor
6441119|NCT00370539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6441120|NCT00370539|Glucocorticoids|glucocorticoids|mesh-ancestor
6441121|NCT00370539|Hormones|hormones|mesh-ancestor
6441122|NCT00370539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6441123|NCT00370539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6441124|NCT00370539|Immunologic Factors|immunologic factors|mesh-ancestor
6441125|NCT00370539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6441126|NCT00370539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441127|NCT00370539|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6441128|NCT00370539|Dermatologic Agents|dermatologic agents|mesh-ancestor
6441129|NCT00370565|Insulin|insulin|mesh-list
6441130|NCT00370565|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6441131|NCT00370565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6441132|NCT00370565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441133|NCT00370591|Fluticasone|fluticasone|mesh-list
6441134|NCT00370591|Xhance|xhance|mesh-list
6441135|NCT00370591|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6543110|NCT00855517|Latanoprost|latanoprost|mesh-list
6543111|NCT00855517|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6543112|NCT00855517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6543113|NCT00855530|Amibegron|amibegron|mesh-list
6441136|NCT00370591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6543114|NCT00855530|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6543115|NCT00855530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6543116|NCT00855530|Adrenergic Agents|adrenergic agents|mesh-ancestor
6543117|NCT00855530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6543118|NCT00855530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543119|NCT00855530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543120|NCT00855608|Adalimumab|adalimumab|mesh-list
6543121|NCT00855608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6543122|NCT00855608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6441137|NCT00370591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6441138|NCT00370591|Autonomic Agents|autonomic agents|mesh-ancestor
6441139|NCT00370591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6441140|NCT00370591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441141|NCT00370591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6441142|NCT00370591|Respiratory System Agents|respiratory system agents|mesh-ancestor
6441143|NCT00370591|Dermatologic Agents|dermatologic agents|mesh-ancestor
6441144|NCT00370591|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6441145|NCT00370591|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6441146|NCT00370591|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6019576|NCT00387959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019577|NCT00387959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6019578|NCT00387959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6019579|NCT00387959|Alkylating Agents|alkylating agents|mesh-ancestor
6019580|NCT00387959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019581|NCT00387959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6019582|NCT00387959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6019583|NCT00387959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6019584|NCT00387959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6019585|NCT00387959|Antimetabolites|antimetabolites|mesh-ancestor
6019586|NCT00387959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6019587|NCT00387959|Antifungal Agents|antifungal agents|mesh-ancestor
6019588|NCT00387959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6019589|NCT00387959|Dermatologic Agents|dermatologic agents|mesh-ancestor
6019590|NCT00387959|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6019591|NCT00387959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6441147|NCT00370591|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6441148|NCT00370591|Adrenergic Agents|adrenergic agents|mesh-ancestor
6441149|NCT00370591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6441150|NCT00370591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441151|NCT00370617|Metformin|metformin|mesh-list
6441152|NCT00370617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6441153|NCT00370617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441154|NCT00370630|Triamcinolone|triamcinolone|mesh-list
6441155|NCT00370630|Bevacizumab|bevacizumab|mesh-list
6441156|NCT00370630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6441157|NCT00370630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6441158|NCT00370630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6441159|NCT00370630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6441160|NCT00370630|Growth Substances|growth substances|mesh-ancestor
6441161|NCT00370630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441162|NCT00370630|Growth Inhibitors|growth inhibitors|mesh-ancestor
6441163|NCT00370630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6441164|NCT00370630|Glucocorticoids|glucocorticoids|mesh-ancestor
6441165|NCT00370630|Hormones|hormones|mesh-ancestor
6441166|NCT00370630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6441167|NCT00370643|Insulin|insulin|mesh-list
6441168|NCT00370643|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6441169|NCT00370643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6441170|NCT00370643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441171|NCT00370656|Pregabalin|pregabalin|mesh-list
6441172|NCT00370656|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6441173|NCT00370656|Amitriptyline|amitriptyline|mesh-list
6441174|NCT00370656|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6441175|NCT00370656|Analgesics|analgesics|mesh-ancestor
6441176|NCT00370656|Sensory System Agents|sensory system agents|mesh-ancestor
6441177|NCT00370656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6441178|NCT00370656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441179|NCT00370656|Anticonvulsants|anticonvulsants|mesh-ancestor
6441180|NCT00370656|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6441181|NCT00370656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6441182|NCT00370656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441183|NCT00370656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6441184|NCT00370656|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6441185|NCT00370656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6441186|NCT00370656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6441187|NCT00370656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6441188|NCT00370656|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6441189|NCT00370656|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6441190|NCT00370656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6441191|NCT00370656|Antidepressive Agents|antidepressive agents|mesh-ancestor
6441192|NCT00370656|Dopamine Agents|dopamine agents|mesh-ancestor
6441193|NCT00370656|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6441194|NCT00370656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6441195|NCT00370656|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6543123|NCT00855660|Riociguat|riociguat|mesh-list
6543124|NCT00855660|Enzyme Activators|enzyme activators|mesh-ancestor
6543125|NCT00855660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543126|NCT00855686|Memantine|memantine|mesh-list
6543127|NCT00855686|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6543128|NCT00855686|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6543129|NCT00855686|Dopamine Agents|dopamine agents|mesh-ancestor
6543130|NCT00855686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6543131|NCT00855686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543132|NCT00855686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543133|NCT00855686|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6543134|NCT00855686|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6543135|NCT00855699|Acamprosate|acamprosate|mesh-list
6543136|NCT00855699|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6543137|NCT00855777|Ibuprofen|ibuprofen|mesh-list
6543138|NCT00855777|Etoricoxib|etoricoxib|mesh-list
6543139|NCT00855777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6543140|NCT00855777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6543141|NCT00855777|Analgesics|analgesics|mesh-ancestor
6543142|NCT00855777|Sensory System Agents|sensory system agents|mesh-ancestor
6543143|NCT00855777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6543144|NCT00855777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543145|NCT00855777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6543146|NCT00855777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6543147|NCT00855777|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6543148|NCT00855777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6543149|NCT00855777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543150|NCT00855777|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6543151|NCT00855881|Tegafur|tegafur|mesh-list
6543152|NCT00855881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6543153|NCT00855881|Antimetabolites|antimetabolites|mesh-ancestor
6543154|NCT00855881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543155|NCT00855881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6543156|NCT00855972|Naltrexone|naltrexone|mesh-list
6543157|NCT00855972|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6543158|NCT00855972|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6543159|NCT00855972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543160|NCT00855972|Sensory System Agents|sensory system agents|mesh-ancestor
6543161|NCT00855972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6543162|NCT00856037|Doxorubicin|doxorubicin|mesh-list
6543163|NCT00856037|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6543164|NCT00856037|Topotecan|topotecan|mesh-list
6543165|NCT00856037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6441196|NCT00370656|Adrenergic Agents|adrenergic agents|mesh-ancestor
6441197|NCT00370656|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6441198|NCT00370669|Triamcinolone|triamcinolone|mesh-list
6441199|NCT00370669|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6441200|NCT00370669|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6441201|NCT00370669|Bevacizumab|bevacizumab|mesh-list
6441202|NCT00370669|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6441203|NCT00370669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6441204|NCT00370669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6441205|NCT00370669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6441206|NCT00370669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6441207|NCT00370669|Growth Substances|growth substances|mesh-ancestor
6441208|NCT00370669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441209|NCT00370669|Growth Inhibitors|growth inhibitors|mesh-ancestor
6441210|NCT00370669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6441211|NCT00370669|Glucocorticoids|glucocorticoids|mesh-ancestor
6441212|NCT00370669|Hormones|hormones|mesh-ancestor
6441213|NCT00370669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6441214|NCT00370669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6441215|NCT00370669|Immunologic Factors|immunologic factors|mesh-ancestor
6441216|NCT00370669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6441217|NCT00370669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441218|NCT00370721|Bevacizumab|bevacizumab|mesh-list
6441219|NCT00370721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6441220|NCT00370721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6441221|NCT00370721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6441222|NCT00370721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6441223|NCT00370721|Growth Substances|growth substances|mesh-ancestor
6441224|NCT00370721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441225|NCT00370721|Growth Inhibitors|growth inhibitors|mesh-ancestor
6441226|NCT00370734|Botulinum Toxins|botulinum toxins|mesh-list
6441227|NCT00370734|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6441228|NCT00370734|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6441229|NCT00370734|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6441230|NCT00370734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6441231|NCT00370734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441232|NCT00370734|Cholinergic Agents|cholinergic agents|mesh-ancestor
6441233|NCT00370734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6441234|NCT00370734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441235|NCT00370734|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6441236|NCT00370734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6441237|NCT00370747|Ecabet|ecabet|mesh-list
6441238|NCT00370747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6441239|NCT00370747|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6441240|NCT00370747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6441241|NCT00370747|Protease Inhibitors|protease inhibitors|mesh-ancestor
6441242|NCT00370747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6441243|NCT00370747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441244|NCT00370747|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6441245|NCT00370747|Protective Agents|protective agents|mesh-ancestor
6441246|NCT00370747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441247|NCT00370747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6461528|NCT00455234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6461529|NCT00455234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461530|NCT00455234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6461531|NCT00455234|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6461532|NCT00455234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6461533|NCT00455234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6461534|NCT00455234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6441248|NCT00370760|Dexamethasone|dexamethasone|mesh-list
6441249|NCT00370760|Colchicine|colchicine|mesh-list
6441250|NCT00370760|Heparin|heparin|mesh-list
6441251|NCT00370760|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6441252|NCT00370760|Tinzaparin|tinzaparin|mesh-list
6441253|NCT00370760|Dalteparin|dalteparin|mesh-list
6441254|NCT00370760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6441255|NCT00370760|Antiemetics|antiemetics|mesh-ancestor
6441256|NCT00370760|Autonomic Agents|autonomic agents|mesh-ancestor
6441257|NCT00370760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6441258|NCT00370760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441259|NCT00370760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6441260|NCT00370760|Glucocorticoids|glucocorticoids|mesh-ancestor
6441261|NCT00370760|Hormones|hormones|mesh-ancestor
6441262|NCT00370760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6441263|NCT00370760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6441264|NCT00370760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6441265|NCT00370760|Anticoagulants|anticoagulants|mesh-ancestor
6441266|NCT00370760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6441267|NCT00370760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6441268|NCT00370760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441269|NCT00370760|Gout Suppressants|gout suppressants|mesh-ancestor
6441270|NCT00370760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6441271|NCT00370760|Tubulin Modulators|tubulin modulators|mesh-ancestor
6441272|NCT00370760|Antimitotic Agents|antimitotic agents|mesh-ancestor
6441273|NCT00370760|Mitosis Modulators|mitosis modulators|mesh-ancestor
6441274|NCT00370786|Bevacizumab|bevacizumab|mesh-list
6441275|NCT00370786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6543166|NCT00856037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6543167|NCT00856037|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6543168|NCT00856037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6543169|NCT00856037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6543170|NCT00856037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543171|NCT00856037|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6543172|NCT00856063|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6441276|NCT00370786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6441277|NCT00370786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6441278|NCT00370786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6441279|NCT00370786|Growth Substances|growth substances|mesh-ancestor
6441280|NCT00370786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441281|NCT00370786|Growth Inhibitors|growth inhibitors|mesh-ancestor
6441282|NCT00370799|Betamethasone|betamethasone|mesh-list
6441283|NCT00370799|Betamethasone Valerate|betamethasone valerate|mesh-list
6441284|NCT00370799|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
6441285|NCT00370799|Betamethasone benzoate|betamethasone benzoate|mesh-list
6441286|NCT00370799|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6441287|NCT00370799|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
6441288|NCT00370799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6441289|NCT00370799|Glucocorticoids|glucocorticoids|mesh-ancestor
6441290|NCT00370799|Hormones|hormones|mesh-ancestor
6441291|NCT00370799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6441292|NCT00370799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441293|NCT00370799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6441294|NCT00370799|Respiratory System Agents|respiratory system agents|mesh-ancestor
6441295|NCT00370825|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6441296|NCT00370825|Miltefosine|miltefosine|mesh-list
6441297|NCT00370825|Antifungal Agents|antifungal agents|mesh-ancestor
6441298|NCT00370825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6441299|NCT00370825|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6441300|NCT00370825|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6441301|NCT00370825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6441302|NCT00370851|Bevacizumab|bevacizumab|mesh-list
6441303|NCT00370851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6441304|NCT00370851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6441305|NCT00370851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6441306|NCT00370851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6441307|NCT00370851|Growth Substances|growth substances|mesh-ancestor
6441308|NCT00370851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441309|NCT00370851|Growth Inhibitors|growth inhibitors|mesh-ancestor
6441310|NCT00370968|Zinc Sulfate|zinc sulfate|mesh-list
6441311|NCT00370968|Astringents|astringents|mesh-ancestor
6441312|NCT00370968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441313|NCT00370968|Dermatologic Agents|dermatologic agents|mesh-ancestor
6441314|NCT00371007|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6441315|NCT00371007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6441316|NCT00371007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441317|NCT00371007|Incretins|incretins|mesh-ancestor
6441318|NCT00371007|Hormones|hormones|mesh-ancestor
6441319|NCT00371007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6441320|NCT00371007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6441321|NCT00371007|Protease Inhibitors|protease inhibitors|mesh-ancestor
6441322|NCT00371007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6441323|NCT00371007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441324|NCT00371020|Heparin|heparin|mesh-list
6441325|NCT00371020|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6441326|NCT00371020|Tinzaparin|tinzaparin|mesh-list
6441327|NCT00371020|Dalteparin|dalteparin|mesh-list
6441328|NCT00371020|Anticoagulants|anticoagulants|mesh-ancestor
6441329|NCT00371020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6441330|NCT00371020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6441331|NCT00371020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441332|NCT00371033|Pregabalin|pregabalin|mesh-list
6441333|NCT00371033|Analgesics|analgesics|mesh-ancestor
6441334|NCT00371033|Sensory System Agents|sensory system agents|mesh-ancestor
6441335|NCT00371033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6441336|NCT00371033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441337|NCT00371033|Anticonvulsants|anticonvulsants|mesh-ancestor
6441338|NCT00371033|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6441339|NCT00371033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6441340|NCT00371033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441341|NCT00371033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6441342|NCT00371033|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6441343|NCT00371033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6441344|NCT00371033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6441345|NCT00371033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6441346|NCT00371059|Memantine|memantine|mesh-list
6441347|NCT00371059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6441348|NCT00371059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6441349|NCT00371059|Dopamine Agents|dopamine agents|mesh-ancestor
6441350|NCT00371059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6461535|NCT00455234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6664674|NCT01513525|Incretins|incretins|mesh-ancestor
6441351|NCT00371059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441352|NCT00371059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441353|NCT00371059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6441354|NCT00371059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6441355|NCT00371072|Mitomycins|mitomycins|mesh-list
6441356|NCT00371072|Mitomycin|mitomycin|mesh-list
6441357|NCT00371072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6441358|NCT00371072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6019592|NCT00387959|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6019593|NCT00387959|Antitubercular Agents|antitubercular agents|mesh-ancestor
6019594|NCT00387959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6019595|NCT00388037|Sunitinib|sunitinib|mesh-list
6019596|NCT00388037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6019597|NCT00388037|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6019598|NCT00388037|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6019599|NCT00388037|Growth Substances|growth substances|mesh-ancestor
6019600|NCT00388037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019601|NCT00388037|Growth Inhibitors|growth inhibitors|mesh-ancestor
6019602|NCT00388037|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6441359|NCT00371072|Alkylating Agents|alkylating agents|mesh-ancestor
6441360|NCT00371072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441361|NCT00371072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6441362|NCT00371072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6441363|NCT00371098|Vaccines|vaccines|mesh-list
6441364|NCT00371098|Immunologic Factors|immunologic factors|mesh-ancestor
6441365|NCT00371098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441366|NCT00371111|Triamcinolone|triamcinolone|mesh-list
6441367|NCT00371111|Bevacizumab|bevacizumab|mesh-list
6441368|NCT00371111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6441369|NCT00371111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6441370|NCT00371111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6441371|NCT00371111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6441372|NCT00371111|Growth Substances|growth substances|mesh-ancestor
6441373|NCT00371111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441374|NCT00371111|Growth Inhibitors|growth inhibitors|mesh-ancestor
6441375|NCT00371111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6441376|NCT00371111|Glucocorticoids|glucocorticoids|mesh-ancestor
6441377|NCT00371111|Hormones|hormones|mesh-ancestor
6441378|NCT00371111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6441379|NCT00371124|Atropine|atropine|mesh-list
6441380|NCT00371124|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6441381|NCT00371124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6441382|NCT00371124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6441383|NCT00371124|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6441384|NCT00371124|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6441385|NCT00371124|Autonomic Agents|autonomic agents|mesh-ancestor
6441386|NCT00371124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6441387|NCT00371124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441388|NCT00371124|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6441389|NCT00371124|Respiratory System Agents|respiratory system agents|mesh-ancestor
6441390|NCT00371124|Mydriatics|mydriatics|mesh-ancestor
6441391|NCT00371124|Parasympatholytics|parasympatholytics|mesh-ancestor
6441392|NCT00371124|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6441393|NCT00371124|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6441394|NCT00371124|Cholinergic Agents|cholinergic agents|mesh-ancestor
6441395|NCT00371124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6441396|NCT00371124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441397|NCT00371306|Metformin|metformin|mesh-list
6441398|NCT00371306|Glyburide|glyburide|mesh-list
6441399|NCT00371306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6441400|NCT00371306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441401|NCT00371319|Mycophenolic Acid|mycophenolic acid|mesh-list
6441402|NCT00371319|Tacrolimus|tacrolimus|mesh-list
6441403|NCT00371319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6441404|NCT00371319|Immunologic Factors|immunologic factors|mesh-ancestor
6441405|NCT00371319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441406|NCT00371319|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6441407|NCT00371319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6019603|NCT00388037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6461536|NCT00455234|Dopamine Agents|dopamine agents|mesh-ancestor
6441408|NCT00371319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441409|NCT00371319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6441410|NCT00371319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6441411|NCT00371319|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6543173|NCT00856063|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6543174|NCT00856063|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6543175|NCT00856063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6543176|NCT00856063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543177|NCT00856063|Adrenergic Agents|adrenergic agents|mesh-ancestor
6543178|NCT00856063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6543179|NCT00856063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543180|NCT00856089|Retapamulin|retapamulin|mesh-list
6543181|NCT00856089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6543182|NCT00856089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6543183|NCT00856271|Losartan|losartan|mesh-list
6543184|NCT00856271|Olmesartan|olmesartan|mesh-list
6543185|NCT00856271|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6543186|NCT00856271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6543187|NCT00856271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6543188|NCT00856271|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6543189|NCT00856271|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6543190|NCT00856271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543191|NCT00856310|Fasinumab|fasinumab|mesh-list
6441412|NCT00371319|Antitubercular Agents|antitubercular agents|mesh-ancestor
6441413|NCT00371319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6441414|NCT00371319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6441415|NCT00371332|Minocycline|minocycline|mesh-list
6441416|NCT00371332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6441417|NCT00371332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6441418|NCT00371410|Triamcinolone|triamcinolone|mesh-list
6441419|NCT00371410|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6441420|NCT00371410|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6441421|NCT00371410|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6441422|NCT00371410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6441423|NCT00371410|Glucocorticoids|glucocorticoids|mesh-ancestor
6441424|NCT00371410|Hormones|hormones|mesh-ancestor
6441425|NCT00371410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6441426|NCT00371410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441427|NCT00371410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6441428|NCT00371410|Immunologic Factors|immunologic factors|mesh-ancestor
6441429|NCT00371410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6441430|NCT00371410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441431|NCT00371488|Lapatinib|lapatinib|mesh-list
6441432|NCT00371488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6543192|NCT00856310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6441433|NCT00371488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6441434|NCT00371488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6441435|NCT00371488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441436|NCT00371501|Aspirin|aspirin|mesh-list
6441437|NCT00371501|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6441438|NCT00371501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6441439|NCT00371501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6441440|NCT00371501|Analgesics|analgesics|mesh-ancestor
6441441|NCT00371501|Sensory System Agents|sensory system agents|mesh-ancestor
6543193|NCT00856310|Analgesics|analgesics|mesh-ancestor
6543194|NCT00856310|Sensory System Agents|sensory system agents|mesh-ancestor
6543195|NCT00856310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6543196|NCT00856310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543197|NCT00856362|Moxidectin|moxidectin|mesh-list
6543198|NCT00856362|Midazolam|midazolam|mesh-list
6543199|NCT00856362|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6543200|NCT00856362|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6543201|NCT00856362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6543202|NCT00856362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543203|NCT00856362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6543204|NCT00856362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6543205|NCT00856362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6543206|NCT00856362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6543207|NCT00856362|Anesthetics, General|anesthetics, general|mesh-ancestor
6543208|NCT00856362|Anesthetics|anesthetics|mesh-ancestor
6441442|NCT00371501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6543209|NCT00856362|GABA Modulators|gaba modulators|mesh-ancestor
6441443|NCT00371501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441444|NCT00371501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6441445|NCT00371501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6441446|NCT00371501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6441447|NCT00371501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6441448|NCT00371501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441449|NCT00371501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6441450|NCT00371501|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6441451|NCT00371501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6441452|NCT00371501|Antipyretics|antipyretics|mesh-ancestor
6441453|NCT00371501|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6441454|NCT00371501|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6441455|NCT00371501|Antimetabolites|antimetabolites|mesh-ancestor
6441456|NCT00371501|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6441457|NCT00371501|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6441458|NCT00371527|Ipratropium|ipratropium|mesh-list
6441459|NCT00371527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6441460|NCT00371527|Autonomic Agents|autonomic agents|mesh-ancestor
6441461|NCT00371527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6441462|NCT00371527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441463|NCT00371527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6441464|NCT00371527|Respiratory System Agents|respiratory system agents|mesh-ancestor
6441465|NCT00371527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6441466|NCT00371527|Cholinergic Agents|cholinergic agents|mesh-ancestor
6441467|NCT00371527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6441468|NCT00371527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441469|NCT00371553|Sunitinib|sunitinib|mesh-list
6441470|NCT00371553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6441471|NCT00371553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6441472|NCT00371553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6441473|NCT00371553|Growth Substances|growth substances|mesh-ancestor
6441474|NCT00371553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441475|NCT00371553|Growth Inhibitors|growth inhibitors|mesh-ancestor
6441476|NCT00371553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6441477|NCT00371553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6441478|NCT00371553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441479|NCT00371579|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6441480|NCT00371579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6441481|NCT00371579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6441482|NCT00371579|Antimetabolites|antimetabolites|mesh-ancestor
6441483|NCT00371579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441484|NCT00371579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6441485|NCT00371579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6441486|NCT00371579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6441487|NCT00371592|Acyclovir|acyclovir|mesh-list
6441488|NCT00371592|Antiviral Agents|antiviral agents|mesh-ancestor
6441489|NCT00371592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6441490|NCT00371696|Acetaminophen|acetaminophen|mesh-list
6441491|NCT00371696|Diclofenac|diclofenac|mesh-list
6441492|NCT00371696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6441493|NCT00371696|Analgesics|analgesics|mesh-ancestor
6441494|NCT00371696|Sensory System Agents|sensory system agents|mesh-ancestor
6441495|NCT00371696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6441496|NCT00371696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441497|NCT00371696|Antipyretics|antipyretics|mesh-ancestor
6441498|NCT00371696|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6441499|NCT00371696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6441500|NCT00371696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6441501|NCT00371696|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6441502|NCT00371696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6543210|NCT00856362|GABA Agents|gaba agents|mesh-ancestor
6441503|NCT00371696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441504|NCT00371735|Artesunate|artesunate|mesh-list
6441505|NCT00371735|Dapsone|dapsone|mesh-list
6441506|NCT00371735|Chlorproguanil|chlorproguanil|mesh-list
6441507|NCT00371735|Proguanil|proguanil|mesh-list
6441508|NCT00371735|Antimalarials|antimalarials|mesh-ancestor
6441509|NCT00371735|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6441510|NCT00371735|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6441511|NCT00371735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6441512|NCT00371735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6441513|NCT00371735|Antiviral Agents|antiviral agents|mesh-ancestor
6441514|NCT00371735|Schistosomicides|schistosomicides|mesh-ancestor
6441515|NCT00371735|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6441516|NCT00371735|Anthelmintics|anthelmintics|mesh-ancestor
6441517|NCT00371735|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6441518|NCT00371735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6441519|NCT00371735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441520|NCT00371735|Leprostatic Agents|leprostatic agents|mesh-ancestor
6543211|NCT00856362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6543212|NCT00856362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543213|NCT00856362|Anthelmintics|anthelmintics|mesh-ancestor
6543214|NCT00856362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6543215|NCT00856362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6543216|NCT00856362|Antinematodal Agents|antinematodal agents|mesh-ancestor
6543217|NCT00856401|Parathyroid Hormone|parathyroid hormone|mesh-list
6543218|NCT00856401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543219|NCT00856401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6543220|NCT00856505|Mycophenolic Acid|mycophenolic acid|mesh-list
6543221|NCT00856505|Everolimus|everolimus|mesh-list
6543222|NCT00856505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6543223|NCT00856505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6543224|NCT00856505|Immunologic Factors|immunologic factors|mesh-ancestor
6543225|NCT00856505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543226|NCT00856505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6543227|NCT00856505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6543228|NCT00856505|Antitubercular Agents|antitubercular agents|mesh-ancestor
6543229|NCT00856505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6543230|NCT00856505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6543231|NCT00856505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6543232|NCT00856505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543233|NCT00856570|Warfarin|warfarin|mesh-list
6543234|NCT00856570|Mirabegron|mirabegron|mesh-list
6543235|NCT00856570|Anticoagulants|anticoagulants|mesh-ancestor
6543236|NCT00856570|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6543237|NCT00856570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6543238|NCT00856570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6543239|NCT00856570|Adrenergic Agents|adrenergic agents|mesh-ancestor
6543240|NCT00856570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6543241|NCT00856570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543242|NCT00856570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543243|NCT00856570|Urological Agents|urological agents|mesh-ancestor
6543244|NCT00856596|Sertaconazole|sertaconazole|mesh-list
6543245|NCT00856596|Antifungal Agents|antifungal agents|mesh-ancestor
6543246|NCT00856596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6543247|NCT00856622|Timolol|timolol|mesh-list
6543248|NCT00856622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6543249|NCT00856622|Latanoprost|latanoprost|mesh-list
6543250|NCT00856622|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6543251|NCT00856622|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6543252|NCT00856622|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6543253|NCT00856622|Adrenergic Agents|adrenergic agents|mesh-ancestor
6543254|NCT00856622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6543255|NCT00856622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543256|NCT00856622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543257|NCT00856622|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6543258|NCT00856622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6543259|NCT00856687|Montelukast|montelukast|mesh-list
6543260|NCT00856687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6543261|NCT00856687|Respiratory System Agents|respiratory system agents|mesh-ancestor
6543262|NCT00856687|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6543263|NCT00856687|Hormone Antagonists|hormone antagonists|mesh-ancestor
6543264|NCT00856687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6543265|NCT00856687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441521|NCT00371735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6441522|NCT00371735|Antimetabolites|antimetabolites|mesh-ancestor
6441523|NCT00371813|Varenicline|varenicline|mesh-list
6441524|NCT00371813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6441525|NCT00371813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6441526|NCT00371813|Cholinergic Agents|cholinergic agents|mesh-ancestor
6441527|NCT00371813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6441528|NCT00371813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441529|NCT00371813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441530|NCT00371878|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6441531|NCT00371878|Immunologic Factors|immunologic factors|mesh-ancestor
6441532|NCT00371878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441533|NCT00371904|Rituximab|rituximab|mesh-list
6441534|NCT00371904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6441535|NCT00371904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6441536|NCT00371904|Immunologic Factors|immunologic factors|mesh-ancestor
6441537|NCT00371904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441538|NCT00371904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6441539|NCT00371956|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
6441540|NCT00371956|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6441541|NCT00371956|Hormone Antagonists|hormone antagonists|mesh-ancestor
6441542|NCT00371956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6441543|NCT00371956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441544|NCT00371956|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6441545|NCT00371956|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6441546|NCT00371956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6441547|NCT00371995|Amphotericin B|amphotericin b|mesh-list
6441548|NCT00371995|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6441549|NCT00371995|Miltefosine|miltefosine|mesh-list
6441550|NCT00371995|Amebicides|amebicides|mesh-ancestor
6441551|NCT00371995|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6441552|NCT00371995|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6441553|NCT00371995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6441554|NCT00371995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6441555|NCT00371995|Antifungal Agents|antifungal agents|mesh-ancestor
6441556|NCT00371995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6441557|NCT00372008|Testosterone|testosterone|mesh-list
6441558|NCT00372008|Androgens|androgens|mesh-ancestor
6441559|NCT00372008|Hormones|hormones|mesh-ancestor
6441560|NCT00372008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6441561|NCT00372008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441562|NCT00372086|Rosiglitazone|rosiglitazone|mesh-list
6441563|NCT00372086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6441564|NCT00372086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441565|NCT00372099|Calcitonin|calcitonin|mesh-list
6441566|NCT00372099|Salmon calcitonin|salmon calcitonin|mesh-list
6441567|NCT00372099|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
6441568|NCT00372099|Katacalcin|katacalcin|mesh-list
6441569|NCT00372099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6441570|NCT00372099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441571|NCT00372099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6441572|NCT00372099|Vasodilator Agents|vasodilator agents|mesh-ancestor
6441573|NCT00372138|Thrombin|thrombin|mesh-list
6441574|NCT00372138|Hemostatics|hemostatics|mesh-ancestor
6441575|NCT00372138|Coagulants|coagulants|mesh-ancestor
6441576|NCT00372177|Immunoglobulin Fab Fragments|immunoglobulin fab fragments|mesh-list
6441577|NCT00372177|Immunologic Factors|immunologic factors|mesh-ancestor
6441578|NCT00372177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441579|NCT00372216|Clopidogrel|clopidogrel|mesh-list
6441580|NCT00372216|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6441581|NCT00372216|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6441582|NCT00372216|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6441583|NCT00372216|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6441584|NCT00372216|Purinergic Agents|purinergic agents|mesh-ancestor
6441585|NCT00372216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6441586|NCT00372216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441587|NCT00372216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441588|NCT00372229|Valganciclovir|valganciclovir|mesh-list
6441589|NCT00372229|Ganciclovir|ganciclovir|mesh-list
6441590|NCT00372229|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6441591|NCT00372229|Antiviral Agents|antiviral agents|mesh-ancestor
6441592|NCT00372229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6441593|NCT00372229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6441594|NCT00372229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6441595|NCT00372229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441596|NCT00372294|Clindamycin|clindamycin|mesh-list
6441597|NCT00372294|Clindamycin palmitate|clindamycin palmitate|mesh-list
6441598|NCT00372294|Clindamycin phosphate|clindamycin phosphate|mesh-list
6441599|NCT00372294|Sulfadiazine|sulfadiazine|mesh-list
6441600|NCT00372294|Pyrimethamine|pyrimethamine|mesh-list
6441601|NCT00372294|Dexamethasone|dexamethasone|mesh-list
6441602|NCT00372294|Prednisolone|prednisolone|mesh-list
6441603|NCT00372294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6441604|NCT00372294|Antiemetics|antiemetics|mesh-ancestor
6441605|NCT00372294|Autonomic Agents|autonomic agents|mesh-ancestor
6441606|NCT00372294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6441607|NCT00372294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441608|NCT00372294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6543266|NCT00856687|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6543267|NCT00856687|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6543268|NCT00856687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543269|NCT00856700|Incretins|incretins|mesh-list
6543270|NCT00856700|Hormones|hormones|mesh-ancestor
6543271|NCT00856700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6543272|NCT00856700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543273|NCT00856804|Ribavirin|ribavirin|mesh-list
6543274|NCT00856804|Thalidomide|thalidomide|mesh-list
6543275|NCT00856804|Antimetabolites|antimetabolites|mesh-ancestor
6543276|NCT00856804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543277|NCT00856804|Antiviral Agents|antiviral agents|mesh-ancestor
6543278|NCT00856804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6543279|NCT00856804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6543280|NCT00856804|Immunologic Factors|immunologic factors|mesh-ancestor
6543281|NCT00856804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543282|NCT00856804|Leprostatic Agents|leprostatic agents|mesh-ancestor
6543283|NCT00856804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6543284|NCT00856804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6543285|NCT00856804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6543286|NCT00856804|Growth Substances|growth substances|mesh-ancestor
6543287|NCT00856804|Growth Inhibitors|growth inhibitors|mesh-ancestor
6543288|NCT00856804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6543289|NCT00856882|Caseins|caseins|mesh-list
6543290|NCT00856882|Chelating Agents|chelating agents|mesh-ancestor
6543291|NCT00856882|Sequestering Agents|sequestering agents|mesh-ancestor
6543292|NCT00856882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543293|NCT00856947|Vitamin D|vitamin d|mesh-list
6543294|NCT00856947|Cholecalciferol|cholecalciferol|mesh-list
6543295|NCT00856947|Vitamins|vitamins|mesh-ancestor
6543296|NCT00856947|Micronutrients|micronutrients|mesh-ancestor
6543297|NCT00856947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543298|NCT00856947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6543299|NCT00856947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6543300|NCT00856960|Losartan|losartan|mesh-list
6543301|NCT00856960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6543302|NCT00856960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6441609|NCT00372294|Glucocorticoids|glucocorticoids|mesh-ancestor
6441610|NCT00372294|Hormones|hormones|mesh-ancestor
6441611|NCT00372294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6441612|NCT00372294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6543303|NCT00856960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6543304|NCT00856960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6543305|NCT00856960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441613|NCT00372294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6441614|NCT00372294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6441615|NCT00372294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6441616|NCT00372294|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6441617|NCT00372294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6441618|NCT00372294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441619|NCT00372294|Antimalarials|antimalarials|mesh-ancestor
6441620|NCT00372294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6441621|NCT00372294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6441622|NCT00372294|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6441623|NCT00372294|Coccidiostats|coccidiostats|mesh-ancestor
6441624|NCT00372307|Pimecrolimus|pimecrolimus|mesh-list
6441625|NCT00372307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6441626|NCT00372307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6441627|NCT00372307|Analgesics|analgesics|mesh-ancestor
6441628|NCT00372307|Sensory System Agents|sensory system agents|mesh-ancestor
6441629|NCT00372307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6441630|NCT00372307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441631|NCT00372307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6441632|NCT00372307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6441633|NCT00372307|Dermatologic Agents|dermatologic agents|mesh-ancestor
6441634|NCT00372307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6441635|NCT00372307|Immunologic Factors|immunologic factors|mesh-ancestor
6441636|NCT00372307|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6441637|NCT00372307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6441638|NCT00372307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441639|NCT00372372|Risedronic Acid|risedronic acid|mesh-list
6441640|NCT00372372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6441641|NCT00372372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6441642|NCT00372372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441643|NCT00372372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6441644|NCT00372372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441645|NCT00372372|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6441646|NCT00372476|Imatinib Mesylate|imatinib mesylate|mesh-list
6441647|NCT00372476|Vinorelbine|vinorelbine|mesh-list
6441648|NCT00372476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6441649|NCT00372476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6441650|NCT00372476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6441651|NCT00372476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441652|NCT00372476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6441653|NCT00372476|Tubulin Modulators|tubulin modulators|mesh-ancestor
6441654|NCT00372476|Antimitotic Agents|antimitotic agents|mesh-ancestor
6441655|NCT00372476|Mitosis Modulators|mitosis modulators|mesh-ancestor
6441656|NCT00372515|Gefitinib|gefitinib|mesh-list
6441657|NCT00372515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6441658|NCT00372515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6441659|NCT00372515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6441660|NCT00372515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441661|NCT00372541|Ceftriaxone|ceftriaxone|mesh-list
6441662|NCT00372541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6441663|NCT00372541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6461537|NCT00455234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6461538|NCT00455234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461539|NCT00455234|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6441664|NCT00372632|Pyrimethamine|pyrimethamine|mesh-list
6441665|NCT00372632|Sulfadoxine|sulfadoxine|mesh-list
6441666|NCT00372632|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6441667|NCT00372632|Antimalarials|antimalarials|mesh-ancestor
6441668|NCT00372632|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6441669|NCT00372632|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6441670|NCT00372632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6441671|NCT00372632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6441672|NCT00372632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6441673|NCT00372632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441674|NCT00372632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6441675|NCT00372632|Renal Agents|renal agents|mesh-ancestor
6441676|NCT00372645|Folic Acid|folic acid|mesh-list
6441677|NCT00372645|Hematinics|hematinics|mesh-ancestor
6441678|NCT00372645|Vitamin B Complex|vitamin b complex|mesh-ancestor
6441679|NCT00372645|Vitamins|vitamins|mesh-ancestor
6441680|NCT00372645|Micronutrients|micronutrients|mesh-ancestor
6441681|NCT00372645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441682|NCT00372658|Lidocaine|lidocaine|mesh-list
6441683|NCT00372658|Anesthetics, Local|anesthetics, local|mesh-ancestor
6441684|NCT00372658|Anesthetics|anesthetics|mesh-ancestor
6441685|NCT00372658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6441686|NCT00372658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441687|NCT00372658|Sensory System Agents|sensory system agents|mesh-ancestor
6441688|NCT00372658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6441689|NCT00372658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6441690|NCT00372658|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6441691|NCT00372658|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6441692|NCT00372658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6441693|NCT00372658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441694|NCT00372710|Zoledronic Acid|zoledronic acid|mesh-list
6441695|NCT00372710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6441696|NCT00372710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441697|NCT00372723|Infliximab|infliximab|mesh-list
6441698|NCT00372723|Dermatologic Agents|dermatologic agents|mesh-ancestor
6441699|NCT00372723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6441700|NCT00372723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6441701|NCT00372736|Docetaxel|docetaxel|mesh-list
6441702|NCT00372736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6543306|NCT00857038|Doxycycline|doxycycline|mesh-list
6543307|NCT00857038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6543308|NCT00857038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6543309|NCT00857038|Antimalarials|antimalarials|mesh-ancestor
6543310|NCT00857038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6543311|NCT00857038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6543312|NCT00857077|Pyrimethamine|pyrimethamine|mesh-list
6543313|NCT00857077|Sulfadoxine|sulfadoxine|mesh-list
6543314|NCT00857077|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6441703|NCT00372736|Tubulin Modulators|tubulin modulators|mesh-ancestor
6441704|NCT00372736|Antimitotic Agents|antimitotic agents|mesh-ancestor
6441705|NCT00372736|Mitosis Modulators|mitosis modulators|mesh-ancestor
6441706|NCT00372736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441707|NCT00372762|Furosemide|furosemide|mesh-list
6441708|NCT00372762|Bumetanide|bumetanide|mesh-list
6441709|NCT00372762|Diuretics|diuretics|mesh-ancestor
6441710|NCT00372762|Natriuretic Agents|natriuretic agents|mesh-ancestor
6441711|NCT00372762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441712|NCT00372762|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6441713|NCT00372762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6441714|NCT00372762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441715|NCT00372788|Pemetrexed|pemetrexed|mesh-list
6441716|NCT00372788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6441717|NCT00372788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6441718|NCT00372788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441719|NCT00372788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6441720|NCT00372788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6441721|NCT00372801|Ibuprofen|ibuprofen|mesh-list
6441722|NCT00372801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6543315|NCT00857077|Antimalarials|antimalarials|mesh-ancestor
6441723|NCT00372801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6441724|NCT00372801|Analgesics|analgesics|mesh-ancestor
6441725|NCT00372801|Sensory System Agents|sensory system agents|mesh-ancestor
6441726|NCT00372801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6441727|NCT00372801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441728|NCT00372801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6441729|NCT00372801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6441730|NCT00372801|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6441731|NCT00372801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6441732|NCT00372801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441733|NCT00372827|Travoprost|travoprost|mesh-list
6441734|NCT00372827|Brinzolamide|brinzolamide|mesh-list
6441735|NCT00372827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6441736|NCT00372827|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6441737|NCT00372827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6441738|NCT00372827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441739|NCT00372853|Tremelimumab|tremelimumab|mesh-list
6441740|NCT00372853|Ipilimumab|ipilimumab|mesh-list
6441741|NCT00372853|Sunitinib|sunitinib|mesh-list
6441742|NCT00372853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6441743|NCT00372853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6441744|NCT00372853|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6441745|NCT00372853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441746|NCT00372853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6441747|NCT00372853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6441748|NCT00372853|Growth Substances|growth substances|mesh-ancestor
6441749|NCT00372853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441750|NCT00372853|Growth Inhibitors|growth inhibitors|mesh-ancestor
6441751|NCT00372853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6441752|NCT00372853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6441753|NCT00372879|Vitamin E|vitamin e|mesh-list
6441754|NCT00372879|Vitamins|vitamins|mesh-ancestor
6441755|NCT00372879|Micronutrients|micronutrients|mesh-ancestor
6441756|NCT00372879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441757|NCT00372879|Antioxidants|antioxidants|mesh-ancestor
6441758|NCT00372879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441759|NCT00372879|Protective Agents|protective agents|mesh-ancestor
6441760|NCT00372892|Rituximab|rituximab|mesh-list
6441761|NCT00372892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6441762|NCT00372892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6441763|NCT00372892|Immunologic Factors|immunologic factors|mesh-ancestor
6441764|NCT00372892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441765|NCT00372892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6441766|NCT00373048|Mefloquine|mefloquine|mesh-list
6441767|NCT00373048|Antimalarials|antimalarials|mesh-ancestor
6441768|NCT00373048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6441769|NCT00373048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6441770|NCT00373048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6441771|NCT00373061|Omalizumab|omalizumab|mesh-list
6441772|NCT00373061|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6441773|NCT00373061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6441774|NCT00373061|Respiratory System Agents|respiratory system agents|mesh-ancestor
6441775|NCT00373087|Entacapone|entacapone|mesh-list
6441776|NCT00373087|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6441777|NCT00373087|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6441778|NCT00373087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441779|NCT00373087|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6441780|NCT00373087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6441781|NCT00373126|Nicotine|nicotine|mesh-list
6441782|NCT00373126|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6441783|NCT00373126|Autonomic Agents|autonomic agents|mesh-ancestor
6441784|NCT00373126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6441785|NCT00373126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441786|NCT00373126|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6441787|NCT00373126|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6441788|NCT00373126|Cholinergic Agents|cholinergic agents|mesh-ancestor
6441789|NCT00373126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6441790|NCT00373126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441791|NCT00373165|Ganciclovir|ganciclovir|mesh-list
6441792|NCT00373165|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6441793|NCT00373165|Antiviral Agents|antiviral agents|mesh-ancestor
6441794|NCT00373165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6441795|NCT00373165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6441796|NCT00373165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6441797|NCT00373165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441798|NCT00373178|Metformin|metformin|mesh-list
6441799|NCT00373178|Rosiglitazone|rosiglitazone|mesh-list
6441800|NCT00373178|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6461540|NCT00455234|Antipruritics|antipruritics|mesh-ancestor
6543316|NCT00857077|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6543317|NCT00857077|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6543318|NCT00857077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6543319|NCT00857077|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6543320|NCT00857077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6543321|NCT00857077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543322|NCT00857077|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6543323|NCT00857077|Renal Agents|renal agents|mesh-ancestor
6543324|NCT00857116|Albendazole|albendazole|mesh-list
6543325|NCT00857116|Anthelmintics|anthelmintics|mesh-ancestor
6543326|NCT00857116|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6543327|NCT00857116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6543328|NCT00857116|Anticestodal Agents|anticestodal agents|mesh-ancestor
6543329|NCT00857116|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6543330|NCT00857116|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6543331|NCT00857116|Tubulin Modulators|tubulin modulators|mesh-ancestor
6543332|NCT00857116|Antimitotic Agents|antimitotic agents|mesh-ancestor
6543333|NCT00857116|Mitosis Modulators|mitosis modulators|mesh-ancestor
6543334|NCT00857116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543335|NCT00857116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6543336|NCT00857142|Oxymorphone|oxymorphone|mesh-list
6543337|NCT00857142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6543338|NCT00857142|Narcotics|narcotics|mesh-ancestor
6543339|NCT00857142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6543340|NCT00857142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543341|NCT00857142|Analgesics|analgesics|mesh-ancestor
6543342|NCT00857142|Sensory System Agents|sensory system agents|mesh-ancestor
6543343|NCT00857142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6543344|NCT00857142|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6543345|NCT00857155|Clopidogrel|clopidogrel|mesh-list
6543346|NCT00857155|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6543347|NCT00857155|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6543348|NCT00857155|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6543349|NCT00857155|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6543350|NCT00857155|Purinergic Agents|purinergic agents|mesh-ancestor
6543351|NCT00857155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6543352|NCT00857155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543353|NCT00857155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543354|NCT00857168|Testosterone|testosterone|mesh-list
6543355|NCT00857168|Androgens|androgens|mesh-ancestor
6543356|NCT00857168|Hormones|hormones|mesh-ancestor
6543357|NCT00857168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6543358|NCT00857168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543359|NCT00857324|Vorinostat|vorinostat|mesh-list
6543360|NCT00857324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6543361|NCT00857324|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6543362|NCT00857324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6543363|NCT00857324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543364|NCT00857376|Thioctic Acid|thioctic acid|mesh-list
6543365|NCT00857376|Antioxidants|antioxidants|mesh-ancestor
6543366|NCT00857376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543367|NCT00857376|Protective Agents|protective agents|mesh-ancestor
6543368|NCT00857376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543369|NCT00857376|Vitamin B Complex|vitamin b complex|mesh-ancestor
6543370|NCT00857376|Vitamins|vitamins|mesh-ancestor
6441801|NCT00373178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441802|NCT00373204|Motexafin gadolinium|motexafin gadolinium|mesh-list
6441803|NCT00373204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6441804|NCT00373204|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6441805|NCT00373204|Dermatologic Agents|dermatologic agents|mesh-ancestor
6441806|NCT00373217|Paclitaxel|paclitaxel|mesh-list
6441807|NCT00373217|Carboplatin|carboplatin|mesh-list
6441808|NCT00373217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6441809|NCT00373217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6441810|NCT00373217|Tubulin Modulators|tubulin modulators|mesh-ancestor
6441811|NCT00373217|Antimitotic Agents|antimitotic agents|mesh-ancestor
6441812|NCT00373217|Mitosis Modulators|mitosis modulators|mesh-ancestor
6441813|NCT00373217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441814|NCT00373282|Triamcinolone|triamcinolone|mesh-list
6441815|NCT00373282|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6441816|NCT00373282|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6441817|NCT00373282|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6441818|NCT00373282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6441819|NCT00373282|Glucocorticoids|glucocorticoids|mesh-ancestor
6441820|NCT00373282|Hormones|hormones|mesh-ancestor
6441821|NCT00373282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6441822|NCT00373282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441823|NCT00373282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6441824|NCT00373282|Immunologic Factors|immunologic factors|mesh-ancestor
6441825|NCT00373282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6441826|NCT00373282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441827|NCT00373373|Sorafenib|sorafenib|mesh-list
6441828|NCT00373373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6441829|NCT00373373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6441830|NCT00373373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6441831|NCT00373373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441832|NCT00373412|Vaccines|vaccines|mesh-list
6441833|NCT00373412|Immunologic Factors|immunologic factors|mesh-ancestor
6441834|NCT00373412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441835|NCT00373451|Heparin|heparin|mesh-list
6441836|NCT00373451|Calcium heparin|calcium heparin|mesh-list
6441837|NCT00373451|Bivalirudin|bivalirudin|mesh-list
6441838|NCT00373451|Abciximab|abciximab|mesh-list
6441839|NCT00373451|Anticoagulants|anticoagulants|mesh-ancestor
6441840|NCT00373451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6441841|NCT00373451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6441842|NCT00373451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441843|NCT00373451|Antithrombins|antithrombins|mesh-ancestor
6441844|NCT00373451|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6441845|NCT00373451|Protease Inhibitors|protease inhibitors|mesh-ancestor
6441846|NCT00373451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6441847|NCT00373451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6441848|NCT00373464|Etoricoxib|etoricoxib|mesh-list
6441849|NCT00373464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6441850|NCT00373464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6441851|NCT00373464|Analgesics|analgesics|mesh-ancestor
6441852|NCT00373464|Sensory System Agents|sensory system agents|mesh-ancestor
6441853|NCT00373464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6441854|NCT00373464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441855|NCT00373464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6441856|NCT00373464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6441857|NCT00373464|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6441858|NCT00373464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6441859|NCT00373464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6441860|NCT00373464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441861|NCT00373503|Lofexidine|lofexidine|mesh-list
6441862|NCT00373503|Dronabinol|dronabinol|mesh-list
6543371|NCT00857376|Micronutrients|micronutrients|mesh-ancestor
6543372|NCT00857428|Oxymorphone|oxymorphone|mesh-list
6543373|NCT00857428|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6543374|NCT00857428|Narcotics|narcotics|mesh-ancestor
6543375|NCT00857428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6543376|NCT00857428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441863|NCT00373503|Hallucinogens|hallucinogens|mesh-ancestor
6441864|NCT00373503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441865|NCT00373503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6441866|NCT00373503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6441867|NCT00373503|Analgesics|analgesics|mesh-ancestor
6441868|NCT00373503|Sensory System Agents|sensory system agents|mesh-ancestor
6441869|NCT00373503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6441870|NCT00373503|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6441871|NCT00373503|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6441872|NCT00373503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6441873|NCT00373503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441874|NCT00373503|Hormones|hormones|mesh-ancestor
6441875|NCT00373503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6441876|NCT00373503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6441877|NCT00373503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6441878|NCT00373503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6441879|NCT00373503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6441880|NCT00373503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6441881|NCT00373503|Adrenergic Agents|adrenergic agents|mesh-ancestor
6441882|NCT00373542|Ropinirole|ropinirole|mesh-list
6441883|NCT00373542|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6441884|NCT00373542|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6441885|NCT00373542|Dopamine Agonists|dopamine agonists|mesh-ancestor
6441886|NCT00373542|Dopamine Agents|dopamine agents|mesh-ancestor
6441887|NCT00373542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6441888|NCT00373542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441889|NCT00373542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441890|NCT00373568|Miltefosine|miltefosine|mesh-list
6441891|NCT00373568|Antifungal Agents|antifungal agents|mesh-ancestor
6441892|NCT00373568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6441893|NCT00373568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6441894|NCT00373568|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6441895|NCT00373568|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6441896|NCT00373581|Cocaine|cocaine|mesh-list
6441897|NCT00373581|Vigabatrin|vigabatrin|mesh-list
6441898|NCT00373581|Anesthetics, Local|anesthetics, local|mesh-ancestor
6441899|NCT00373581|Anesthetics|anesthetics|mesh-ancestor
6441900|NCT00373581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6441901|NCT00373581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441902|NCT00373581|Sensory System Agents|sensory system agents|mesh-ancestor
6441903|NCT00373581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6441904|NCT00373581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6441905|NCT00373581|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6441906|NCT00373581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6441907|NCT00373581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6441908|NCT00373581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441909|NCT00373581|Dopamine Agents|dopamine agents|mesh-ancestor
6441910|NCT00373581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6441911|NCT00373581|Anticonvulsants|anticonvulsants|mesh-ancestor
6441912|NCT00373581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6441913|NCT00373581|GABA Agents|gaba agents|mesh-ancestor
6441914|NCT00373594|Rituximab|rituximab|mesh-list
6441915|NCT00373594|Fludarabine|fludarabine|mesh-list
6441916|NCT00373594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6441917|NCT00373594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6441918|NCT00373594|Immunologic Factors|immunologic factors|mesh-ancestor
6441919|NCT00373594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441920|NCT00373594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6441921|NCT00373607|Artesunate|artesunate|mesh-list
6441922|NCT00373607|Piperaquine|piperaquine|mesh-list
6441923|NCT00373607|Mefloquine|mefloquine|mesh-list
6441924|NCT00373607|Antimalarials|antimalarials|mesh-ancestor
6441925|NCT00373607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6441926|NCT00373607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6441927|NCT00373607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6441928|NCT00373607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6441929|NCT00373607|Antiviral Agents|antiviral agents|mesh-ancestor
6441930|NCT00373607|Schistosomicides|schistosomicides|mesh-ancestor
6441931|NCT00373607|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6441932|NCT00373607|Anthelmintics|anthelmintics|mesh-ancestor
6441933|NCT00373620|Paclitaxel|paclitaxel|mesh-list
6441934|NCT00373620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6441935|NCT00373620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6441936|NCT00373620|Tubulin Modulators|tubulin modulators|mesh-ancestor
6441937|NCT00373620|Antimitotic Agents|antimitotic agents|mesh-ancestor
6441938|NCT00373620|Mitosis Modulators|mitosis modulators|mesh-ancestor
6441939|NCT00373620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441940|NCT00373646|Thalidomide|thalidomide|mesh-list
6441941|NCT00373646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6543377|NCT00857428|Analgesics|analgesics|mesh-ancestor
6543378|NCT00857428|Sensory System Agents|sensory system agents|mesh-ancestor
6543379|NCT00857428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6543380|NCT00857428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6543381|NCT00857519|Carboplatin|carboplatin|mesh-list
6543382|NCT00857519|Melphalan|melphalan|mesh-list
6543383|NCT00857519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6543384|NCT00857519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6543385|NCT00857519|Alkylating Agents|alkylating agents|mesh-ancestor
6543386|NCT00857519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543387|NCT00857519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6543388|NCT00857519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6543389|NCT00857519|Immunologic Factors|immunologic factors|mesh-ancestor
6543390|NCT00857519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543391|NCT00857558|Saxagliptin|saxagliptin|mesh-list
6543392|NCT00857558|Incretins|incretins|mesh-ancestor
6543393|NCT00857558|Hormones|hormones|mesh-ancestor
6543394|NCT00857558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6543395|NCT00857558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543396|NCT00857558|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6543397|NCT00857558|Protease Inhibitors|protease inhibitors|mesh-ancestor
6543398|NCT00857558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6543399|NCT00857558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441942|NCT00373646|Immunologic Factors|immunologic factors|mesh-ancestor
6441943|NCT00373646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441944|NCT00373646|Leprostatic Agents|leprostatic agents|mesh-ancestor
6441945|NCT00373646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6441946|NCT00373646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6441947|NCT00373646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6441948|NCT00373646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6441949|NCT00373646|Growth Substances|growth substances|mesh-ancestor
6441950|NCT00373646|Growth Inhibitors|growth inhibitors|mesh-ancestor
6441951|NCT00373646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6441952|NCT00373659|Ranibizumab|ranibizumab|mesh-list
6441953|NCT00373659|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6441954|NCT00373659|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6441955|NCT00373659|Growth Substances|growth substances|mesh-ancestor
6441956|NCT00373659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441957|NCT00373659|Growth Inhibitors|growth inhibitors|mesh-ancestor
6441958|NCT00373659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6441959|NCT00373672|Modafinil|modafinil|mesh-list
6441960|NCT00373672|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6441961|NCT00373672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441962|NCT00373672|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6441963|NCT00373672|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6441964|NCT00373672|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6441965|NCT00373672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441966|NCT00373711|Iodine|iodine|mesh-list
6441967|NCT00373711|Cadexomer iodine|cadexomer iodine|mesh-list
6441968|NCT00373711|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6441969|NCT00373711|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6441970|NCT00373711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6441971|NCT00373711|Trace Elements|trace elements|mesh-ancestor
6441972|NCT00373711|Micronutrients|micronutrients|mesh-ancestor
6441973|NCT00373711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441974|NCT00373711|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6441975|NCT00373711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441976|NCT00373776|Miltefosine|miltefosine|mesh-list
6441977|NCT00373776|Antifungal Agents|antifungal agents|mesh-ancestor
6441978|NCT00373776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6441979|NCT00373776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6441980|NCT00373776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6441981|NCT00373776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6441982|NCT00373789|Botulinum Toxins|botulinum toxins|mesh-list
6441983|NCT00373789|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6441984|NCT00373789|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6441985|NCT00373789|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6441986|NCT00373789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6441987|NCT00373789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6441988|NCT00373789|Cholinergic Agents|cholinergic agents|mesh-ancestor
6441989|NCT00373789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6441990|NCT00373789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6441991|NCT00373789|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6441992|NCT00373789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6441993|NCT00373802|Phenylephrine|phenylephrine|mesh-list
6441994|NCT00373802|Oxymetazoline|oxymetazoline|mesh-list
6441995|NCT00373802|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6441996|NCT00373802|Mydriatics|mydriatics|mesh-ancestor
6441997|NCT00373802|Autonomic Agents|autonomic agents|mesh-ancestor
6441998|NCT00373802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6441999|NCT00373802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442000|NCT00373802|Sympathomimetics|sympathomimetics|mesh-ancestor
6442001|NCT00373802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6442002|NCT00373802|Nasal Decongestants|nasal decongestants|mesh-ancestor
6442003|NCT00373802|Respiratory System Agents|respiratory system agents|mesh-ancestor
6442004|NCT00373802|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6442005|NCT00373802|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6442006|NCT00373802|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6442007|NCT00373802|Adrenergic Agents|adrenergic agents|mesh-ancestor
6019604|NCT00388037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019605|NCT00388154|Gemcitabine|gemcitabine|mesh-list
6019606|NCT00388154|Cisplatin|cisplatin|mesh-list
6019607|NCT00388154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6019608|NCT00388154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6019609|NCT00388154|Antimetabolites|antimetabolites|mesh-ancestor
6019610|NCT00388154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019611|NCT00388154|Antiviral Agents|antiviral agents|mesh-ancestor
6019612|NCT00388154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6019613|NCT00388154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6019614|NCT00388154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6019615|NCT00388154|Immunologic Factors|immunologic factors|mesh-ancestor
6019616|NCT00388154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019617|NCT00388349|Gemcitabine|gemcitabine|mesh-list
6019618|NCT00388349|Cyclophosphamide|cyclophosphamide|mesh-list
6019619|NCT00388349|Carmustine|carmustine|mesh-list
6019620|NCT00388349|Etoposide|etoposide|mesh-list
6543400|NCT00857558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6543401|NCT00857597|Esomeprazole|esomeprazole|mesh-list
6543402|NCT00857597|Omeprazole|omeprazole|mesh-list
6543403|NCT00857597|Rabeprazole|rabeprazole|mesh-list
6543404|NCT00857597|Pantoprazole|pantoprazole|mesh-list
6543405|NCT00857597|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
6543406|NCT00857597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6543407|NCT00857597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6543408|NCT00857597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6543409|NCT00857597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655604|NCT01464606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6655605|NCT01464671|Heparin|heparin|mesh-list
6655606|NCT01464671|Bivalirudin|bivalirudin|mesh-list
6655607|NCT01464671|Anticoagulants|anticoagulants|mesh-ancestor
6655608|NCT01464671|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6655609|NCT01464671|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6655610|NCT01464671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655611|NCT01464671|Antithrombins|antithrombins|mesh-ancestor
6655612|NCT01464671|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6655613|NCT01464671|Protease Inhibitors|protease inhibitors|mesh-ancestor
6655614|NCT01464671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6655615|NCT01464762|Bedaquiline|bedaquiline|mesh-list
6655616|NCT01464762|Antitubercular Agents|antitubercular agents|mesh-ancestor
6655617|NCT01464762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6655618|NCT01464762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6655619|NCT01464801|Resveratrol|resveratrol|mesh-list
6655620|NCT01464801|Antioxidants|antioxidants|mesh-ancestor
6655621|NCT01464801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655622|NCT01464801|Protective Agents|protective agents|mesh-ancestor
6442008|NCT00373802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6442009|NCT00373802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442010|NCT00373802|Protective Agents|protective agents|mesh-ancestor
6442011|NCT00373815|Everolimus|everolimus|mesh-list
6442012|NCT00373815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6442013|NCT00373815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6442014|NCT00373815|Immunologic Factors|immunologic factors|mesh-ancestor
6442015|NCT00373815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442016|NCT00373893|Lidocaine|lidocaine|mesh-list
6442017|NCT00373893|Anesthetics, Local|anesthetics, local|mesh-ancestor
6442018|NCT00373893|Anesthetics|anesthetics|mesh-ancestor
6442019|NCT00373893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6442020|NCT00373893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442021|NCT00373893|Sensory System Agents|sensory system agents|mesh-ancestor
6442022|NCT00373893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6442023|NCT00373893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6442024|NCT00373893|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6442025|NCT00373893|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6442026|NCT00373893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6442027|NCT00373893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442028|NCT00373906|Bortezomib|bortezomib|mesh-list
6442029|NCT00373906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6442030|NCT00373919|Erythromycin|erythromycin|mesh-list
6442031|NCT00373919|Erythromycin Estolate|erythromycin estolate|mesh-list
6442032|NCT00373919|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
6442033|NCT00373919|Erythromycin stearate|erythromycin stearate|mesh-list
6442034|NCT00373919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6442035|NCT00373919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6442036|NCT00373919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6442037|NCT00373919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6442038|NCT00373919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6442039|NCT00373919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442040|NCT00374023|Vitamin A|vitamin a|mesh-list
6442041|NCT00374023|Vitamins|vitamins|mesh-ancestor
6442042|NCT00374023|Micronutrients|micronutrients|mesh-ancestor
6442043|NCT00374023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442044|NCT00374075|Valproic Acid|valproic acid|mesh-list
6442045|NCT00374075|Anticonvulsants|anticonvulsants|mesh-ancestor
6442046|NCT00374075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6442047|NCT00374075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442048|NCT00374075|GABA Agents|gaba agents|mesh-ancestor
6442049|NCT00374075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6442050|NCT00374075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442051|NCT00374075|Antimanic Agents|antimanic agents|mesh-ancestor
6442052|NCT00374075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6442053|NCT00374075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6442054|NCT00374075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6442055|NCT00374101|Omeprazole|omeprazole|mesh-list
6442056|NCT00374101|Pantoprazole|pantoprazole|mesh-list
6442057|NCT00374101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6442058|NCT00374101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6442059|NCT00374101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6442060|NCT00374101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6442061|NCT00374101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442062|NCT00374192|Eszopiclone|eszopiclone|mesh-list
6442063|NCT00374192|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6442064|NCT00374192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6442065|NCT00374192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442066|NCT00374205|Artesunate|artesunate|mesh-list
6442067|NCT00374205|Lumefantrine|lumefantrine|mesh-list
6442068|NCT00374205|Artemether|artemether|mesh-list
6442069|NCT00374205|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6442070|NCT00374205|Amodiaquine|amodiaquine|mesh-list
6442071|NCT00374205|Antimalarials|antimalarials|mesh-ancestor
6442072|NCT00374205|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6442073|NCT00374205|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6442074|NCT00374205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6442075|NCT00374205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6442076|NCT00374205|Antiviral Agents|antiviral agents|mesh-ancestor
6442077|NCT00374205|Schistosomicides|schistosomicides|mesh-ancestor
6442078|NCT00374205|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6442079|NCT00374205|Anthelmintics|anthelmintics|mesh-ancestor
6442080|NCT00374348|Aripiprazole|aripiprazole|mesh-list
6442081|NCT00374348|Antidepressive Agents|antidepressive agents|mesh-ancestor
6442082|NCT00374348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6442083|NCT00374348|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6442084|NCT00374348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6442085|NCT00374348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6442086|NCT00374348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442087|NCT00374348|Dopamine Agonists|dopamine agonists|mesh-ancestor
6442088|NCT00374348|Dopamine Agents|dopamine agents|mesh-ancestor
6442089|NCT00374348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6442090|NCT00374348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442091|NCT00374348|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6442092|NCT00374348|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6543410|NCT00857753|Fentanyl|fentanyl|mesh-list
6543411|NCT00857753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6543412|NCT00857753|Narcotics|narcotics|mesh-ancestor
6543413|NCT00857753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6543414|NCT00857753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543415|NCT00857753|Analgesics|analgesics|mesh-ancestor
6543416|NCT00857753|Sensory System Agents|sensory system agents|mesh-ancestor
6442093|NCT00374348|Serotonin Agents|serotonin agents|mesh-ancestor
6019621|NCT00388349|Vinorelbine|vinorelbine|mesh-list
6442094|NCT00374348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6442095|NCT00374348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6543417|NCT00857753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6442096|NCT00374348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6442097|NCT00374348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6461541|NCT00455234|Dermatologic Agents|dermatologic agents|mesh-ancestor
6461542|NCT00455234|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6461543|NCT00455234|Histamine Antagonists|histamine antagonists|mesh-ancestor
6461544|NCT00455234|Histamine Agents|histamine agents|mesh-ancestor
6461545|NCT00455234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6461546|NCT00455234|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6461547|NCT00455234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6461548|NCT00455234|Anesthetics, Local|anesthetics, local|mesh-ancestor
6461549|NCT00455234|Anesthetics|anesthetics|mesh-ancestor
6461550|NCT00455234|Sensory System Agents|sensory system agents|mesh-ancestor
6461551|NCT00455286|Methylprednisolone|methylprednisolone|mesh-list
6461552|NCT00455286|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6461553|NCT00455286|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6461554|NCT00455286|Prednisolone|prednisolone|mesh-list
6461555|NCT00455286|Prednisolone acetate|prednisolone acetate|mesh-list
6461556|NCT00455286|Methotrexate|methotrexate|mesh-list
6461557|NCT00455286|Temozolomide|temozolomide|mesh-list
6461558|NCT00455286|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6461559|NCT00455286|Prednisolone phosphate|prednisolone phosphate|mesh-list
6461560|NCT00455286|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6461561|NCT00455286|Abortifacient Agents|abortifacient agents|mesh-ancestor
6461562|NCT00455286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6461563|NCT00455286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461564|NCT00455286|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6461565|NCT00455286|Antimetabolites|antimetabolites|mesh-ancestor
6461566|NCT00455286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461567|NCT00455286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6461568|NCT00455286|Dermatologic Agents|dermatologic agents|mesh-ancestor
6461569|NCT00455286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6461570|NCT00455286|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6461571|NCT00455286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6461572|NCT00455286|Immunologic Factors|immunologic factors|mesh-ancestor
6461573|NCT00455286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6461574|NCT00455286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6461575|NCT00455286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6461576|NCT00455286|Alkylating Agents|alkylating agents|mesh-ancestor
6461577|NCT00455286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6461578|NCT00455286|Antiemetics|antiemetics|mesh-ancestor
6461579|NCT00455286|Autonomic Agents|autonomic agents|mesh-ancestor
6461580|NCT00455286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6461581|NCT00455286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6461582|NCT00455286|Glucocorticoids|glucocorticoids|mesh-ancestor
6461583|NCT00455286|Hormones|hormones|mesh-ancestor
6461584|NCT00455286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6461585|NCT00455286|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6461586|NCT00455286|Protective Agents|protective agents|mesh-ancestor
6461587|NCT00455286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6461588|NCT00455325|Chloroquine|chloroquine|mesh-list
6461589|NCT00455325|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
6461590|NCT00455325|Amebicides|amebicides|mesh-ancestor
6461591|NCT00455325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6461592|NCT00455325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6461593|NCT00455325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6461594|NCT00455325|Antimalarials|antimalarials|mesh-ancestor
6461595|NCT00455325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6461596|NCT00455325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6543418|NCT00857753|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6543419|NCT00857753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6543420|NCT00857753|Anesthetics, General|anesthetics, general|mesh-ancestor
6543421|NCT00857753|Anesthetics|anesthetics|mesh-ancestor
6543422|NCT00857831|Vitamin D|vitamin d|mesh-list
6543423|NCT00857831|Calcium|calcium|mesh-list
6543424|NCT00857831|Vitamins|vitamins|mesh-ancestor
6543425|NCT00857831|Micronutrients|micronutrients|mesh-ancestor
6543426|NCT00857831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543427|NCT00857831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6543428|NCT00857831|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6543429|NCT00857870|Metformin|metformin|mesh-list
6543430|NCT00857870|Insulin Glargine|insulin glargine|mesh-list
6543431|NCT00857870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6543432|NCT00857870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543433|NCT00857909|Amiloride|amiloride|mesh-list
6543434|NCT00857909|Spironolactone|spironolactone|mesh-list
6543435|NCT00857909|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6461597|NCT00455325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6442098|NCT00374387|NuvaRing|nuvaring|mesh-list
6442099|NCT00374387|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6442100|NCT00374387|Contraceptive Agents|contraceptive agents|mesh-ancestor
6442101|NCT00374387|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6442102|NCT00374387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442103|NCT00374426|Sertraline|sertraline|mesh-list
6442104|NCT00374426|Antidepressive Agents|antidepressive agents|mesh-ancestor
6442105|NCT00374426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6442106|NCT00374426|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6442107|NCT00374426|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6442108|NCT00374426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6442109|NCT00374426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442110|NCT00374426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6442111|NCT00374426|Serotonin Agents|serotonin agents|mesh-ancestor
6442112|NCT00374426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442113|NCT00374465|Verapamil|verapamil|mesh-list
6442114|NCT00374465|Carvedilol|carvedilol|mesh-list
6442115|NCT00374465|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6543436|NCT00857909|Hormone Antagonists|hormone antagonists|mesh-ancestor
6543437|NCT00857909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6543438|NCT00857909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543439|NCT00857909|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6543440|NCT00857909|Diuretics|diuretics|mesh-ancestor
6543441|NCT00857909|Natriuretic Agents|natriuretic agents|mesh-ancestor
6543442|NCT00857909|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
6543443|NCT00857909|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6543444|NCT00857909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6543445|NCT00857909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543446|NCT00857909|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
6543447|NCT00857935|Permethrin|permethrin|mesh-list
6543448|NCT00857935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6543449|NCT00857935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543450|NCT00857987|Expectorants|expectorants|mesh-list
6543451|NCT00857987|Respiratory System Agents|respiratory system agents|mesh-ancestor
6543452|NCT00858182|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6543453|NCT00858195|Indomethacin|indomethacin|mesh-list
6543454|NCT00858195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6543455|NCT00858195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6543456|NCT00858195|Analgesics|analgesics|mesh-ancestor
6019622|NCT00388349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6019623|NCT00388349|Immunologic Factors|immunologic factors|mesh-ancestor
6019624|NCT00388349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019625|NCT00388349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6019626|NCT00388349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6019627|NCT00388349|Alkylating Agents|alkylating agents|mesh-ancestor
6019628|NCT00388349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019629|NCT00388349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6019630|NCT00388349|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6019631|NCT00388349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6019632|NCT00388349|Antimetabolites|antimetabolites|mesh-ancestor
6442116|NCT00374465|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6442117|NCT00374465|Adrenergic Agents|adrenergic agents|mesh-ancestor
6442118|NCT00374465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6442119|NCT00374465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442120|NCT00374465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442121|NCT00374465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6442122|NCT00374465|Antioxidants|antioxidants|mesh-ancestor
6442123|NCT00374465|Protective Agents|protective agents|mesh-ancestor
6442124|NCT00374465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6442125|NCT00374465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6442126|NCT00374465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6442127|NCT00374465|Vasodilator Agents|vasodilator agents|mesh-ancestor
6442128|NCT00374465|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6442129|NCT00374465|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6442130|NCT00374465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6442131|NCT00374478|Scopolamine|scopolamine|mesh-list
6442132|NCT00374478|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
6442133|NCT00374478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6442134|NCT00374478|Antiemetics|antiemetics|mesh-ancestor
6442135|NCT00374478|Autonomic Agents|autonomic agents|mesh-ancestor
6442136|NCT00374478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6442137|NCT00374478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442138|NCT00374478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6442139|NCT00374478|Mydriatics|mydriatics|mesh-ancestor
6543457|NCT00858195|Sensory System Agents|sensory system agents|mesh-ancestor
6543458|NCT00858195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6543459|NCT00858195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543460|NCT00858195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6543461|NCT00858195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6543462|NCT00858195|Gout Suppressants|gout suppressants|mesh-ancestor
6442140|NCT00374478|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6543463|NCT00858195|Tocolytic Agents|tocolytic agents|mesh-ancestor
6543464|NCT00858195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6543465|NCT00858195|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6543466|NCT00858195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6543467|NCT00858195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543468|NCT00858273|Insulin|insulin|mesh-list
6543469|NCT00858273|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6543470|NCT00858273|Antioxidants|antioxidants|mesh-list
6543471|NCT00858273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6543472|NCT00858273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543473|NCT00858273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543474|NCT00858273|Protective Agents|protective agents|mesh-ancestor
6543475|NCT00858299|Valsartan|valsartan|mesh-list
6543476|NCT00858299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6543477|NCT00858299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6543478|NCT00858299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6543479|NCT00858299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543480|NCT00858325|Daptomycin|daptomycin|mesh-list
6543481|NCT00858325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6543482|NCT00858325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6543483|NCT00858338|Floxuridine|floxuridine|mesh-list
6543484|NCT00858338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6442141|NCT00374478|Cholinergic Agents|cholinergic agents|mesh-ancestor
6442142|NCT00374478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6442143|NCT00374478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442144|NCT00374478|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6442145|NCT00374478|Parasympatholytics|parasympatholytics|mesh-ancestor
6442146|NCT00374621|Isosorbide|isosorbide|mesh-list
6543485|NCT00858338|Antimetabolites|antimetabolites|mesh-ancestor
6543486|NCT00858338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543487|NCT00858338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6543488|NCT00858377|Complement Factor H|complement factor h|mesh-list
6543489|NCT00858377|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6543490|NCT00858377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6543491|NCT00858377|Immunologic Factors|immunologic factors|mesh-ancestor
6543492|NCT00858377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543493|NCT00858429|Capecitabine|capecitabine|mesh-list
6543494|NCT00858429|Doxifluridine|doxifluridine|mesh-list
6543495|NCT00858429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6543496|NCT00858429|Antimetabolites|antimetabolites|mesh-ancestor
6543497|NCT00858429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543498|NCT00858429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6543499|NCT00858429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6543500|NCT00858429|Immunologic Factors|immunologic factors|mesh-ancestor
6543501|NCT00858429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543502|NCT00858429|Appetite Stimulants|appetite stimulants|mesh-ancestor
6543503|NCT00858429|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6543504|NCT00858455|Dolutegravir|dolutegravir|mesh-list
6543505|NCT00858455|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6543506|NCT00858455|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6543507|NCT00858455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6543508|NCT00858455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543509|NCT00858455|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6543510|NCT00858455|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6543511|NCT00858455|Antiviral Agents|antiviral agents|mesh-ancestor
6543512|NCT00858455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6543513|NCT00858624|Ketamine|ketamine|mesh-list
6543514|NCT00858624|Analgesics|analgesics|mesh-ancestor
6543515|NCT00858624|Sensory System Agents|sensory system agents|mesh-ancestor
6543516|NCT00858624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6543517|NCT00858624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543518|NCT00858624|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6543519|NCT00858624|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6543520|NCT00858624|Anesthetics, General|anesthetics, general|mesh-ancestor
6543521|NCT00858624|Anesthetics|anesthetics|mesh-ancestor
6543522|NCT00858624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6543523|NCT00858624|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6543524|NCT00858624|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6543525|NCT00858624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6543526|NCT00858624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543527|NCT00858663|Everolimus|everolimus|mesh-list
6543528|NCT00858663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6543529|NCT00858663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6543530|NCT00858663|Immunologic Factors|immunologic factors|mesh-ancestor
6543531|NCT00858663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543532|NCT00858676|Acarbose|acarbose|mesh-list
6543533|NCT00858676|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6543534|NCT00858676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6442147|NCT00374621|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
6543535|NCT00858676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543536|NCT00858676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6543537|NCT00858676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543538|NCT00858715|Aspirin|aspirin|mesh-list
6543539|NCT00858715|Clopidogrel|clopidogrel|mesh-list
6543540|NCT00858715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6543541|NCT00858715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6543542|NCT00858715|Analgesics|analgesics|mesh-ancestor
6543543|NCT00858715|Sensory System Agents|sensory system agents|mesh-ancestor
6543544|NCT00858715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6543545|NCT00858715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543546|NCT00858715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6543547|NCT00858715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6543548|NCT00858715|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6543549|NCT00858715|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6543550|NCT00858715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543551|NCT00858715|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6543552|NCT00858715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6543553|NCT00858715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6543554|NCT00858715|Antipyretics|antipyretics|mesh-ancestor
6543555|NCT00858715|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6543556|NCT00858715|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6543557|NCT00858715|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6543558|NCT00858715|Purinergic Agents|purinergic agents|mesh-ancestor
6543559|NCT00858715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6442148|NCT00374621|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
6442149|NCT00374621|Misoprostol|misoprostol|mesh-list
6442150|NCT00374621|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6442151|NCT00374621|Abortifacient Agents|abortifacient agents|mesh-ancestor
6442152|NCT00374621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6442153|NCT00374621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442154|NCT00374621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6442155|NCT00374621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6543560|NCT00858754|Methylnaltrexone|methylnaltrexone|mesh-list
6543561|NCT00858754|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6543562|NCT00858754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543563|NCT00858754|Sensory System Agents|sensory system agents|mesh-ancestor
6543564|NCT00858754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6543565|NCT00858767|Vitamin K 2|vitamin k 2|mesh-list
6543566|NCT00858767|Vitamin K|vitamin k|mesh-list
6543567|NCT00858767|Vitamin MK 7|vitamin mk 7|mesh-list
6543568|NCT00858767|Caseins|caseins|mesh-list
6543569|NCT00858767|Chelating Agents|chelating agents|mesh-ancestor
6543570|NCT00858767|Sequestering Agents|sequestering agents|mesh-ancestor
6543571|NCT00858767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543572|NCT00858767|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6543573|NCT00858767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6543574|NCT00858767|Hemostatics|hemostatics|mesh-ancestor
6543575|NCT00858767|Coagulants|coagulants|mesh-ancestor
6543576|NCT00858767|Vitamins|vitamins|mesh-ancestor
6543577|NCT00858767|Micronutrients|micronutrients|mesh-ancestor
6543578|NCT00858767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543579|NCT00858806|Imatinib Mesylate|imatinib mesylate|mesh-list
6543580|NCT00858806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6543581|NCT00858806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6543582|NCT00858806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6543583|NCT00858806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543584|NCT00858897|Insulin|insulin|mesh-list
6543585|NCT00858897|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6543586|NCT00858897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6543587|NCT00858897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543588|NCT00859079|Insulin|insulin|mesh-list
6543589|NCT00859079|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6543590|NCT00859079|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6543591|NCT00859079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6543592|NCT00859079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543593|NCT00859079|Incretins|incretins|mesh-ancestor
6543594|NCT00859079|Hormones|hormones|mesh-ancestor
6543595|NCT00859079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6543596|NCT00859105|Imiquimod|imiquimod|mesh-list
6543597|NCT00859105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6543598|NCT00859105|Immunologic Factors|immunologic factors|mesh-ancestor
6543599|NCT00859105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543600|NCT00859105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6543601|NCT00859105|Interferon Inducers|interferon inducers|mesh-ancestor
6543602|NCT00859118|Axitinib|axitinib|mesh-list
6543603|NCT00859118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6543604|NCT00859118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6543605|NCT00859118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5724737|NCT03185351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6543606|NCT00859118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543607|NCT00859183|Sirolimus|sirolimus|mesh-list
6543608|NCT00859183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6543609|NCT00859183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6543610|NCT00859183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6543611|NCT00859183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6543612|NCT00859183|Antifungal Agents|antifungal agents|mesh-ancestor
6543613|NCT00859183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6543614|NCT00859183|Immunologic Factors|immunologic factors|mesh-ancestor
6543615|NCT00859183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543616|NCT00859235|Chlorhexidine|chlorhexidine|mesh-list
6543617|NCT00859235|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6543618|NCT00859235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6543619|NCT00859235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6543620|NCT00859235|Disinfectants|disinfectants|mesh-ancestor
6543621|NCT00859235|Dermatologic Agents|dermatologic agents|mesh-ancestor
6543622|NCT00859274|Budesonide|budesonide|mesh-list
6442156|NCT00374621|Oxytocics|oxytocics|mesh-ancestor
6442157|NCT00374621|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6442158|NCT00374621|Diuretics|diuretics|mesh-ancestor
6442159|NCT00374621|Natriuretic Agents|natriuretic agents|mesh-ancestor
6442160|NCT00374621|Vasodilator Agents|vasodilator agents|mesh-ancestor
6442161|NCT00374621|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6442162|NCT00374621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442163|NCT00374647|Mycophenolic Acid|mycophenolic acid|mesh-list
6442164|NCT00374647|Sirolimus|sirolimus|mesh-list
6442165|NCT00374647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6442166|NCT00374647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6442167|NCT00374647|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6442168|NCT00374647|Antitubercular Agents|antitubercular agents|mesh-ancestor
6442169|NCT00374647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6442170|NCT00374647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6442171|NCT00374647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6442172|NCT00374647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442173|NCT00374647|Antifungal Agents|antifungal agents|mesh-ancestor
6442174|NCT00374647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6442175|NCT00374647|Immunologic Factors|immunologic factors|mesh-ancestor
6442176|NCT00374647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442177|NCT00374686|Valganciclovir|valganciclovir|mesh-list
6442178|NCT00374686|Antiviral Agents|antiviral agents|mesh-ancestor
6442179|NCT00374686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6442180|NCT00374699|Bortezomib|bortezomib|mesh-list
6442181|NCT00374699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6442182|NCT00374764|Risperidone|risperidone|mesh-list
6442183|NCT00374764|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6543623|NCT00859274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6442184|NCT00374764|Serotonin Agents|serotonin agents|mesh-ancestor
6543624|NCT00859274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6442185|NCT00374764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6461598|NCT00455325|Analgesics|analgesics|mesh-ancestor
6442186|NCT00374764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442187|NCT00374764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442188|NCT00374764|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6442189|NCT00374764|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6543625|NCT00859274|Autonomic Agents|autonomic agents|mesh-ancestor
6543626|NCT00859274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6543627|NCT00859274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543628|NCT00859274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6543629|NCT00859274|Respiratory System Agents|respiratory system agents|mesh-ancestor
6543630|NCT00859274|Glucocorticoids|glucocorticoids|mesh-ancestor
6543631|NCT00859274|Hormones|hormones|mesh-ancestor
6543632|NCT00859274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6543633|NCT00859352|Midazolam|midazolam|mesh-list
6543634|NCT00859352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6543635|NCT00859352|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6543636|NCT00859352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6543637|NCT00859352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543638|NCT00859352|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6543639|NCT00859352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6543640|NCT00859352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6543641|NCT00859352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6543642|NCT00859352|Anesthetics, General|anesthetics, general|mesh-ancestor
6543643|NCT00859352|Anesthetics|anesthetics|mesh-ancestor
6543644|NCT00859352|GABA Modulators|gaba modulators|mesh-ancestor
6543645|NCT00859352|GABA Agents|gaba agents|mesh-ancestor
6543646|NCT00859352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6543647|NCT00859352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543648|NCT00859534|Afamelanotide|afamelanotide|mesh-list
6543649|NCT00859534|Dermatologic Agents|dermatologic agents|mesh-ancestor
6655623|NCT01464801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655624|NCT01464801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6655625|NCT01464801|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6655626|NCT01464944|Aspirin|aspirin|mesh-list
6655627|NCT01464944|Acetaminophen|acetaminophen|mesh-list
6655628|NCT01464944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6655629|NCT01464944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6655630|NCT01464944|Analgesics|analgesics|mesh-ancestor
6019633|NCT00388349|Antiviral Agents|antiviral agents|mesh-ancestor
6019634|NCT00388349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6019635|NCT00388349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6019636|NCT00388349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6019637|NCT00388349|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6019638|NCT00388349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6019639|NCT00388349|Tubulin Modulators|tubulin modulators|mesh-ancestor
6019640|NCT00388349|Antimitotic Agents|antimitotic agents|mesh-ancestor
6019641|NCT00388349|Mitosis Modulators|mitosis modulators|mesh-ancestor
6019642|NCT00388362|Sirolimus|sirolimus|mesh-list
6019643|NCT00388362|Prednisone|prednisone|mesh-list
6019644|NCT00388362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6019645|NCT00388362|Glucocorticoids|glucocorticoids|mesh-ancestor
6019646|NCT00388362|Hormones|hormones|mesh-ancestor
6019647|NCT00388362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6019648|NCT00388362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019649|NCT00388362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6019650|NCT00388362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6655631|NCT01464944|Sensory System Agents|sensory system agents|mesh-ancestor
6655632|NCT01464944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6655633|NCT01464944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655634|NCT01464944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6655635|NCT01464944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6655636|NCT01464944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6655637|NCT01464944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6655638|NCT01464944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655639|NCT01464944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6655640|NCT01464944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6655641|NCT01464944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6019651|NCT00388362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6442190|NCT00374764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6442191|NCT00374764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6442192|NCT00374764|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6442193|NCT00374764|Dopamine Agents|dopamine agents|mesh-ancestor
6442194|NCT00374777|Nitrazepam|nitrazepam|mesh-list
6442195|NCT00374777|Zolpidem|zolpidem|mesh-list
6655642|NCT01464944|Antipyretics|antipyretics|mesh-ancestor
6655643|NCT01464983|Aspirin|aspirin|mesh-list
6655644|NCT01464983|Ibuprofen|ibuprofen|mesh-list
6543650|NCT00859703|Risedronic Acid|risedronic acid|mesh-list
6543651|NCT00859703|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6543652|NCT00859703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6543653|NCT00859703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543654|NCT00859703|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6543655|NCT00859703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543656|NCT00859703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6543657|NCT00859781|Ketoconazole|ketoconazole|mesh-list
6543658|NCT00859781|Hydrocortisone|hydrocortisone|mesh-list
6543659|NCT00859781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6543660|NCT00859781|Antifungal Agents|antifungal agents|mesh-ancestor
6543661|NCT00859781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6543662|NCT00859781|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6543663|NCT00859781|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6543664|NCT00859781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6543665|NCT00859781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543666|NCT00859781|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6543667|NCT00859781|Hormone Antagonists|hormone antagonists|mesh-ancestor
6543668|NCT00859781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6543669|NCT00859781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543670|NCT00859781|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6543671|NCT00859807|Amodiaquine|amodiaquine|mesh-list
6543672|NCT00859807|Antimalarials|antimalarials|mesh-ancestor
6543673|NCT00859807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6543674|NCT00859807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6543675|NCT00859807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6543676|NCT00859872|Haloperidol|haloperidol|mesh-list
6543677|NCT00859872|Risperidone|risperidone|mesh-list
6543678|NCT00859872|Haloperidol decanoate|haloperidol decanoate|mesh-list
6543679|NCT00859872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6543680|NCT00859872|Serotonin Agents|serotonin agents|mesh-ancestor
6543681|NCT00859872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6543682|NCT00859872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543683|NCT00859872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543684|NCT00859872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6543685|NCT00859872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6543686|NCT00859872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6543687|NCT00859872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6543688|NCT00859872|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6543689|NCT00859872|Dopamine Agents|dopamine agents|mesh-ancestor
6543690|NCT00859872|Antiemetics|antiemetics|mesh-ancestor
6543691|NCT00859872|Autonomic Agents|autonomic agents|mesh-ancestor
6543692|NCT00859872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6543693|NCT00859872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6543694|NCT00859872|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6543695|NCT00859885|Aspirin|aspirin|mesh-list
6543696|NCT00859885|Clopidogrel|clopidogrel|mesh-list
6543697|NCT00859885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6543698|NCT00859885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6543699|NCT00859885|Analgesics|analgesics|mesh-ancestor
6543700|NCT00859885|Sensory System Agents|sensory system agents|mesh-ancestor
6543701|NCT00859885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6543702|NCT00859885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543703|NCT00859885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6543704|NCT00859885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6543705|NCT00859885|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6543706|NCT00859885|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6543707|NCT00859885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543708|NCT00859885|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6543709|NCT00859885|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6543710|NCT00859885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6543711|NCT00859885|Antipyretics|antipyretics|mesh-ancestor
6543712|NCT00859885|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6543713|NCT00859885|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6543714|NCT00859885|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6543715|NCT00859885|Purinergic Agents|purinergic agents|mesh-ancestor
6543716|NCT00859885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6543717|NCT00859911|Micronutrients|micronutrients|mesh-list
6543718|NCT00859911|Trace Elements|trace elements|mesh-list
6543719|NCT00859911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543720|NCT00860119|Alprazolam|alprazolam|mesh-list
6543721|NCT00860119|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6543722|NCT00860119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6543723|NCT00860119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543724|NCT00860119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6543725|NCT00860119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6543726|NCT00860119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6543727|NCT00860119|GABA Modulators|gaba modulators|mesh-ancestor
6543728|NCT00860119|GABA Agents|gaba agents|mesh-ancestor
6543729|NCT00860119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6543730|NCT00860119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543731|NCT00860223|Digoxin|digoxin|mesh-list
6543732|NCT00860223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6543733|NCT00860223|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6543734|NCT00860223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6543735|NCT00860223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543736|NCT00860223|Protective Agents|protective agents|mesh-ancestor
6543737|NCT00860223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543738|NCT00860275|Fluconazole|fluconazole|mesh-list
6543739|NCT00860275|Ketoconazole|ketoconazole|mesh-list
6543740|NCT00860275|Antifungal Agents|antifungal agents|mesh-ancestor
6543741|NCT00860275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6543742|NCT00860275|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6543743|NCT00860275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6543744|NCT00860275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6543745|NCT00860275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543746|NCT00860275|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6543747|NCT00860275|Hormone Antagonists|hormone antagonists|mesh-ancestor
6543748|NCT00860275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6543749|NCT00860275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543750|NCT00860275|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6543751|NCT00860275|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6543752|NCT00860275|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6543753|NCT00860340|Spironolactone|spironolactone|mesh-list
6543754|NCT00860340|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6543755|NCT00860340|Hormone Antagonists|hormone antagonists|mesh-ancestor
6543756|NCT00860340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6543757|NCT00860340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543758|NCT00860340|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6543759|NCT00860340|Diuretics|diuretics|mesh-ancestor
6543760|NCT00860340|Natriuretic Agents|natriuretic agents|mesh-ancestor
6543761|NCT00860366|Uric Acid|uric acid|mesh-list
6543762|NCT00860366|Antioxidants|antioxidants|mesh-ancestor
6543763|NCT00860366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543764|NCT00860366|Protective Agents|protective agents|mesh-ancestor
6543765|NCT00860366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543766|NCT00860496|Cyclosporine|cyclosporine|mesh-list
6543767|NCT00860496|Tacrolimus|tacrolimus|mesh-list
6543768|NCT00860496|Cyclosporins|cyclosporins|mesh-list
6543769|NCT00860496|Tofacitinib|tofacitinib|mesh-list
6543770|NCT00860496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6543771|NCT00860496|Immunologic Factors|immunologic factors|mesh-ancestor
6543772|NCT00860496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543773|NCT00860496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6543774|NCT00860496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6543775|NCT00860496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543776|NCT00860496|Antifungal Agents|antifungal agents|mesh-ancestor
6543777|NCT00860496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6543778|NCT00860496|Dermatologic Agents|dermatologic agents|mesh-ancestor
6543779|NCT00860496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6543780|NCT00860496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6543781|NCT00860626|Interferons|interferons|mesh-list
6543782|NCT00860626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6543783|NCT00860626|Antiviral Agents|antiviral agents|mesh-ancestor
6543784|NCT00860626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6543785|NCT00860639|Gemtuzumab|gemtuzumab|mesh-list
6543786|NCT00860639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6543787|NCT00860639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6543788|NCT00860899|Clonidine|clonidine|mesh-list
6543789|NCT00860899|Levobupivacaine|levobupivacaine|mesh-list
6543790|NCT00860899|Anesthetics, Local|anesthetics, local|mesh-ancestor
6543791|NCT00860899|Anesthetics|anesthetics|mesh-ancestor
6543792|NCT00860899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6543793|NCT00860899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543794|NCT00860899|Sensory System Agents|sensory system agents|mesh-ancestor
6019652|NCT00388362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6442196|NCT00374777|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6442197|NCT00374777|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6442198|NCT00374777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6442199|NCT00374777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442200|NCT00374777|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6442201|NCT00374777|GABA Agonists|gaba agonists|mesh-ancestor
6543795|NCT00860899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6543796|NCT00860899|Analgesics|analgesics|mesh-ancestor
6543797|NCT00860899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6543798|NCT00860899|Sympatholytics|sympatholytics|mesh-ancestor
6543799|NCT00860899|Autonomic Agents|autonomic agents|mesh-ancestor
6543800|NCT00860899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6543801|NCT00860899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6543802|NCT00860899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6543803|NCT00860899|Adrenergic Agents|adrenergic agents|mesh-ancestor
6543804|NCT00860899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6543805|NCT00860899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543806|NCT00860925|Clonidine|clonidine|mesh-list
6543807|NCT00860925|Analgesics|analgesics|mesh-ancestor
6543808|NCT00860925|Sensory System Agents|sensory system agents|mesh-ancestor
6543809|NCT00860925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6543810|NCT00860925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543811|NCT00860925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6543812|NCT00860925|Sympatholytics|sympatholytics|mesh-ancestor
6543813|NCT00860925|Autonomic Agents|autonomic agents|mesh-ancestor
6543814|NCT00860925|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6543815|NCT00860925|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6543816|NCT00860925|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6543817|NCT00860925|Adrenergic Agents|adrenergic agents|mesh-ancestor
6543818|NCT00860925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6442202|NCT00374777|GABA Agents|gaba agents|mesh-ancestor
6543819|NCT00860925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543820|NCT00860964|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6019653|NCT00388362|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6543821|NCT00860964|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6543822|NCT00860964|Estradiol|estradiol|mesh-list
6543823|NCT00860964|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6543824|NCT00860964|Estrogens|estrogens|mesh-ancestor
6543825|NCT00860964|Hormones|hormones|mesh-ancestor
6543826|NCT00860964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6543827|NCT00860964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543828|NCT00860964|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6543829|NCT00860964|Contraceptive Agents|contraceptive agents|mesh-ancestor
6543830|NCT00860964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6543831|NCT00860964|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6543832|NCT00860977|Valacyclovir|valacyclovir|mesh-list
6543833|NCT00860977|Antiviral Agents|antiviral agents|mesh-ancestor
6543834|NCT00860977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6543835|NCT00861016|Metoprolol|metoprolol|mesh-list
6543836|NCT00861016|Felodipine|felodipine|mesh-list
6543837|NCT00861016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6543838|NCT00861016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6543839|NCT00861016|Sympatholytics|sympatholytics|mesh-ancestor
6543840|NCT00861016|Autonomic Agents|autonomic agents|mesh-ancestor
6543841|NCT00861016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6543842|NCT00861016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543843|NCT00861016|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6543844|NCT00861016|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6543845|NCT00861016|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6543846|NCT00861016|Adrenergic Agents|adrenergic agents|mesh-ancestor
6543847|NCT00861016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6543848|NCT00861016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543849|NCT00861016|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6543850|NCT00861016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6543851|NCT00861016|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6543852|NCT00861016|Vasodilator Agents|vasodilator agents|mesh-ancestor
6543853|NCT00861029|Moxifloxacin|moxifloxacin|mesh-list
6543854|NCT00861029|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6543855|NCT00861029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6543856|NCT00861029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6543857|NCT00861029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6543858|NCT00861029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6543859|NCT00861029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6543860|NCT00861029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543861|NCT00861029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6543862|NCT00861029|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6543863|NCT00861029|Contraceptive Agents|contraceptive agents|mesh-ancestor
6543864|NCT00861029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6543865|NCT00861029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543866|NCT00861029|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6543867|NCT00861029|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6543868|NCT00861029|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6543869|NCT00861042|Lacosamide|lacosamide|mesh-list
6543870|NCT00861042|Anticonvulsants|anticonvulsants|mesh-ancestor
6543871|NCT00861042|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6543872|NCT00861042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6543873|NCT00861042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6543874|NCT00861042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543875|NCT00861068|Lacosamide|lacosamide|mesh-list
6543876|NCT00861068|Anticonvulsants|anticonvulsants|mesh-ancestor
6543877|NCT00861068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6543878|NCT00861068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6543879|NCT00861068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6543880|NCT00861068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543881|NCT00861094|Leucovorin|leucovorin|mesh-list
6442203|NCT00374777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6442204|NCT00374777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442205|NCT00374777|Anticonvulsants|anticonvulsants|mesh-ancestor
6442206|NCT00374777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6442207|NCT00374777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6442208|NCT00374777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6442209|NCT00374777|GABA Modulators|gaba modulators|mesh-ancestor
6442210|NCT00374855|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6442211|NCT00374855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6442212|NCT00374855|Diuretics|diuretics|mesh-ancestor
6442213|NCT00374855|Natriuretic Agents|natriuretic agents|mesh-ancestor
6543882|NCT00861094|Folic Acid|folic acid|mesh-list
6543883|NCT00861094|Fluorouracil|fluorouracil|mesh-list
6543884|NCT00861094|Oxaliplatin|oxaliplatin|mesh-list
6543885|NCT00861094|Levoleucovorin|levoleucovorin|mesh-list
6543886|NCT00861094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6543887|NCT00861094|Antimetabolites|antimetabolites|mesh-ancestor
6543888|NCT00861094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543889|NCT00861094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6543890|NCT00861094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6543891|NCT00861094|Immunologic Factors|immunologic factors|mesh-ancestor
6543892|NCT00861094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543893|NCT00861094|Antidotes|antidotes|mesh-ancestor
6543894|NCT00861094|Protective Agents|protective agents|mesh-ancestor
6442214|NCT00374855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442215|NCT00374855|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6442216|NCT00374855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6442217|NCT00374855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442218|NCT00374881|Phenylephrine|phenylephrine|mesh-list
6442219|NCT00374881|Oxymetazoline|oxymetazoline|mesh-list
6442220|NCT00374881|Morphine|morphine|mesh-list
6442221|NCT00374881|Sorbitol|sorbitol|mesh-list
6442222|NCT00374881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6442223|NCT00374881|Narcotics|narcotics|mesh-ancestor
6442224|NCT00374881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6442225|NCT00374881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442226|NCT00374881|Analgesics|analgesics|mesh-ancestor
6442227|NCT00374881|Sensory System Agents|sensory system agents|mesh-ancestor
6442228|NCT00374881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6442229|NCT00374881|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6442230|NCT00374881|Mydriatics|mydriatics|mesh-ancestor
6442231|NCT00374881|Autonomic Agents|autonomic agents|mesh-ancestor
6442232|NCT00374881|Sympathomimetics|sympathomimetics|mesh-ancestor
6442233|NCT00374881|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6442234|NCT00374881|Nasal Decongestants|nasal decongestants|mesh-ancestor
6442235|NCT00374881|Respiratory System Agents|respiratory system agents|mesh-ancestor
6442236|NCT00374881|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6442237|NCT00374881|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6442238|NCT00374881|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6543895|NCT00861094|Vitamin B Complex|vitamin b complex|mesh-ancestor
6543896|NCT00861094|Vitamins|vitamins|mesh-ancestor
6543897|NCT00861094|Micronutrients|micronutrients|mesh-ancestor
6543898|NCT00861094|Hematinics|hematinics|mesh-ancestor
6543899|NCT00861107|Vaccines|vaccines|mesh-list
6543900|NCT00861107|Immunologic Factors|immunologic factors|mesh-ancestor
6543901|NCT00861107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543902|NCT00861120|Doxorubicin|doxorubicin|mesh-list
6543903|NCT00861120|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6543904|NCT00861120|Panitumumab|panitumumab|mesh-list
6543905|NCT00861120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6543906|NCT00861120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6543907|NCT00861120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6543908|NCT00861120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6543909|NCT00861120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6543910|NCT00861120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543911|NCT00861120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6543912|NCT00861250|Dexamethasone|dexamethasone|mesh-list
6543913|NCT00861250|Bortezomib|bortezomib|mesh-list
6442239|NCT00374881|Adrenergic Agents|adrenergic agents|mesh-ancestor
6543914|NCT00861250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6543915|NCT00861250|Antiemetics|antiemetics|mesh-ancestor
6543916|NCT00861250|Autonomic Agents|autonomic agents|mesh-ancestor
6543917|NCT00861250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6543918|NCT00861250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543919|NCT00861250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6543920|NCT00861250|Glucocorticoids|glucocorticoids|mesh-ancestor
6543921|NCT00861250|Hormones|hormones|mesh-ancestor
6543922|NCT00861250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6543923|NCT00861250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6543924|NCT00861250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6543925|NCT00861276|Nicotine|nicotine|mesh-list
6543926|NCT00861276|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6543927|NCT00861276|Autonomic Agents|autonomic agents|mesh-ancestor
6543928|NCT00861276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6543929|NCT00861276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543930|NCT00861276|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6543931|NCT00861276|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6543932|NCT00861276|Cholinergic Agents|cholinergic agents|mesh-ancestor
6543933|NCT00861276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6543934|NCT00861276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543935|NCT00861315|Amikacin|amikacin|mesh-list
6543936|NCT00861315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6543937|NCT00861315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6543938|NCT00861328|Oxaliplatin|oxaliplatin|mesh-list
6543939|NCT00861328|Irinotecan|irinotecan|mesh-list
6543940|NCT00861328|Camptothecin|camptothecin|mesh-list
6543941|NCT00861328|ON 01910|on 01910|mesh-list
6543942|NCT00861328|Glycine|glycine|mesh-list
6543943|NCT00861328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6543944|NCT00861328|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6543945|NCT00861328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6543946|NCT00861328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6543947|NCT00861328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543948|NCT00861328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6543949|NCT00861328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6543950|NCT00861328|Glycine Agents|glycine agents|mesh-ancestor
6543951|NCT00861328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6543952|NCT00861328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543953|NCT00861367|Aspirin|aspirin|mesh-list
6543954|NCT00861367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6543955|NCT00861367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6543956|NCT00861367|Analgesics|analgesics|mesh-ancestor
6543957|NCT00861367|Sensory System Agents|sensory system agents|mesh-ancestor
6543958|NCT00861367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6543959|NCT00861367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442240|NCT00374881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6442241|NCT00374881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442242|NCT00374881|Protective Agents|protective agents|mesh-ancestor
6442243|NCT00374881|Cathartics|cathartics|mesh-ancestor
6442244|NCT00374881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6442245|NCT00374894|Succimer|succimer|mesh-list
6442246|NCT00374894|Antidotes|antidotes|mesh-ancestor
6442247|NCT00374894|Protective Agents|protective agents|mesh-ancestor
6442248|NCT00374894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442249|NCT00374894|Chelating Agents|chelating agents|mesh-ancestor
6442250|NCT00374894|Sequestering Agents|sequestering agents|mesh-ancestor
6442251|NCT00374894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442252|NCT00374959|Ceftriaxone|ceftriaxone|mesh-list
6442253|NCT00374959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6019654|NCT00388362|Antifungal Agents|antifungal agents|mesh-ancestor
6019655|NCT00388362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6019656|NCT00388362|Immunologic Factors|immunologic factors|mesh-ancestor
6442254|NCT00374959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6543960|NCT00861367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6543961|NCT00861367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6543962|NCT00861367|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6442255|NCT00374985|Docetaxel|docetaxel|mesh-list
6442256|NCT00374985|Oxaliplatin|oxaliplatin|mesh-list
6442257|NCT00374985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6543963|NCT00861367|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6543964|NCT00861367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543965|NCT00861367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6543966|NCT00861367|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6543967|NCT00861367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6543968|NCT00861367|Antipyretics|antipyretics|mesh-ancestor
6543969|NCT00861406|Interferons|interferons|mesh-list
6543970|NCT00861406|Interferon-alpha|interferon-alpha|mesh-list
6543971|NCT00861406|Interferon alpha-2|interferon alpha-2|mesh-list
6543972|NCT00861406|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6543973|NCT00861406|Vaccines|vaccines|mesh-list
6543974|NCT00861406|Immunologic Factors|immunologic factors|mesh-ancestor
6543975|NCT00861406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543976|NCT00861406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6543977|NCT00861406|Antiviral Agents|antiviral agents|mesh-ancestor
6543978|NCT00861406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6543979|NCT00861419|Niacinamide|niacinamide|mesh-list
6543980|NCT00861419|Bevacizumab|bevacizumab|mesh-list
6543981|NCT00861419|Sunitinib|sunitinib|mesh-list
6543982|NCT00861419|Trebananib|trebananib|mesh-list
6543983|NCT00861419|Sorafenib|sorafenib|mesh-list
6543984|NCT00861419|Motesanib diphosphate|motesanib diphosphate|mesh-list
6543985|NCT00861419|Imetelstat|imetelstat|mesh-list
6543986|NCT00861419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6543987|NCT00861419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6543988|NCT00861419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6543989|NCT00861419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6543990|NCT00861419|Growth Substances|growth substances|mesh-ancestor
6543991|NCT00861419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6543992|NCT00861419|Growth Inhibitors|growth inhibitors|mesh-ancestor
6543993|NCT00861419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6543994|NCT00861419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6543995|NCT00861419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6543996|NCT00861419|Vitamin B Complex|vitamin b complex|mesh-ancestor
6543997|NCT00861419|Vitamins|vitamins|mesh-ancestor
6543998|NCT00861419|Micronutrients|micronutrients|mesh-ancestor
6543999|NCT00861445|Lacosamide|lacosamide|mesh-list
6544000|NCT00861445|Anticonvulsants|anticonvulsants|mesh-ancestor
6544001|NCT00861445|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6544002|NCT00861445|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6544003|NCT00861445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6544004|NCT00861445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655645|NCT01464983|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6655646|NCT01464983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6655647|NCT01464983|Analgesics|analgesics|mesh-ancestor
6655648|NCT01464983|Sensory System Agents|sensory system agents|mesh-ancestor
6655649|NCT01464983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6655650|NCT01464983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655651|NCT01464983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6655652|NCT01464983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6655653|NCT01464983|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6655654|NCT01464983|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6655655|NCT01464983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655656|NCT01464983|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6655657|NCT01464983|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6655658|NCT01464983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6655659|NCT01464983|Antipyretics|antipyretics|mesh-ancestor
6442258|NCT00374985|Tubulin Modulators|tubulin modulators|mesh-ancestor
6442259|NCT00374985|Antimitotic Agents|antimitotic agents|mesh-ancestor
6442260|NCT00374985|Mitosis Modulators|mitosis modulators|mesh-ancestor
6442261|NCT00374985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442262|NCT00375050|Riluzole|riluzole|mesh-list
6442263|NCT00375050|Anticonvulsants|anticonvulsants|mesh-ancestor
6442264|NCT00375050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6442265|NCT00375050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6442266|NCT00375050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6442267|NCT00375050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442268|NCT00375050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442269|NCT00375050|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6442270|NCT00375050|Protective Agents|protective agents|mesh-ancestor
6442271|NCT00375076|Enoxaparin|enoxaparin|mesh-list
6442272|NCT00375076|Anticoagulants|anticoagulants|mesh-ancestor
6655660|NCT01465009|Aspirin|aspirin|mesh-list
6655661|NCT01465009|Acetaminophen|acetaminophen|mesh-list
6544005|NCT00861510|ON 01910|on 01910|mesh-list
6544006|NCT00861510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6544007|NCT00861510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6544008|NCT00861510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6544009|NCT00861510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544010|NCT00861523|Thiamine|thiamine|mesh-list
6544011|NCT00861523|Promethazine|promethazine|mesh-list
6544012|NCT00861523|Diphenhydramine|diphenhydramine|mesh-list
6544013|NCT00861523|Vitamin B Complex|vitamin b complex|mesh-ancestor
6544014|NCT00861523|Vitamins|vitamins|mesh-ancestor
6544015|NCT00861523|Micronutrients|micronutrients|mesh-ancestor
6544016|NCT00861523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544017|NCT00861523|Antipruritics|antipruritics|mesh-ancestor
6544018|NCT00861523|Dermatologic Agents|dermatologic agents|mesh-ancestor
6544019|NCT00861523|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6544020|NCT00861523|Histamine Antagonists|histamine antagonists|mesh-ancestor
6544021|NCT00861523|Histamine Agents|histamine agents|mesh-ancestor
6544022|NCT00861523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6544023|NCT00861523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544024|NCT00861523|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6544025|NCT00861523|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6544026|NCT00861523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6544027|NCT00861523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6544028|NCT00861523|Anesthetics, Local|anesthetics, local|mesh-ancestor
6544029|NCT00861523|Anesthetics|anesthetics|mesh-ancestor
6544030|NCT00861523|Sensory System Agents|sensory system agents|mesh-ancestor
6544031|NCT00861523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6544032|NCT00861523|Antiemetics|antiemetics|mesh-ancestor
6544033|NCT00861523|Autonomic Agents|autonomic agents|mesh-ancestor
6544034|NCT00861523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6442273|NCT00375076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6442274|NCT00375076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6544035|NCT00861536|Thymoglobulin|thymoglobulin|mesh-list
6544036|NCT00861536|Immunologic Factors|immunologic factors|mesh-ancestor
6544037|NCT00861536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544038|NCT00861536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6544039|NCT00861627|Paclitaxel|paclitaxel|mesh-list
6544040|NCT00861627|Carboplatin|carboplatin|mesh-list
6544041|NCT00861627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6544042|NCT00861627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6544043|NCT00861627|Tubulin Modulators|tubulin modulators|mesh-ancestor
6544044|NCT00861627|Antimitotic Agents|antimitotic agents|mesh-ancestor
6544045|NCT00861627|Mitosis Modulators|mitosis modulators|mesh-ancestor
6544046|NCT00861627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544047|NCT00861640|Omeprazole|omeprazole|mesh-list
6544048|NCT00861640|Rabeprazole|rabeprazole|mesh-list
6544049|NCT00861640|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6544050|NCT00861640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6544051|NCT00861640|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6544052|NCT00861640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6544053|NCT00861640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544054|NCT00861731|Simvastatin|simvastatin|mesh-list
6544055|NCT00861731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6544056|NCT00861731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6544057|NCT00861731|Antimetabolites|antimetabolites|mesh-ancestor
6544058|NCT00861731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544059|NCT00861731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6544060|NCT00861731|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6544061|NCT00861731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6544062|NCT00861783|Oxaliplatin|oxaliplatin|mesh-list
6544063|NCT00861783|Irinotecan|irinotecan|mesh-list
6544064|NCT00861783|Camptothecin|camptothecin|mesh-list
6544065|NCT00861783|ON 01910|on 01910|mesh-list
6544066|NCT00861783|Glycine|glycine|mesh-list
6544067|NCT00861783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6544068|NCT00861783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6544069|NCT00861783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6442275|NCT00375076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442276|NCT00375232|Montelukast|montelukast|mesh-list
6442277|NCT00375232|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6442278|NCT00375232|Respiratory System Agents|respiratory system agents|mesh-ancestor
6442279|NCT00375232|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6442280|NCT00375232|Hormone Antagonists|hormone antagonists|mesh-ancestor
6442281|NCT00375232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6544070|NCT00861783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6544071|NCT00861783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544072|NCT00861783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6544073|NCT00861783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6544074|NCT00861783|Glycine Agents|glycine agents|mesh-ancestor
6544075|NCT00861783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6544076|NCT00861783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544077|NCT00861861|Atorvastatin|atorvastatin|mesh-list
6544078|NCT00861861|Pitavastatin|pitavastatin|mesh-list
6544079|NCT00861861|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6544080|NCT00861861|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6544081|NCT00861861|Antimetabolites|antimetabolites|mesh-ancestor
6544082|NCT00861861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544083|NCT00861861|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6544084|NCT00861861|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6544085|NCT00861861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6544086|NCT00861874|Sirolimus|sirolimus|mesh-list
6544087|NCT00861874|Decitabine|decitabine|mesh-list
6544088|NCT00861874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6544089|NCT00861874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6544090|NCT00861874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6544091|NCT00861874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6544092|NCT00861874|Antifungal Agents|antifungal agents|mesh-ancestor
6544093|NCT00861874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6544094|NCT00861874|Immunologic Factors|immunologic factors|mesh-ancestor
6544095|NCT00861874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544096|NCT00861874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6544097|NCT00861874|Antimetabolites|antimetabolites|mesh-ancestor
6544098|NCT00861874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544099|NCT00861874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6544100|NCT00861887|Vancomycin|vancomycin|mesh-list
6544101|NCT00861887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6544102|NCT00861887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6544103|NCT00861926|Beclomethasone|beclomethasone|mesh-list
6544104|NCT00861926|Albuterol|albuterol|mesh-list
6544105|NCT00861926|Formoterol Fumarate|formoterol fumarate|mesh-list
6544106|NCT00861926|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6544107|NCT00861926|Autonomic Agents|autonomic agents|mesh-ancestor
6544108|NCT00861926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6544109|NCT00861926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544110|NCT00861926|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6544111|NCT00861926|Respiratory System Agents|respiratory system agents|mesh-ancestor
6544112|NCT00861926|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6544113|NCT00861926|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6544114|NCT00861926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6544115|NCT00861926|Adrenergic Agents|adrenergic agents|mesh-ancestor
6544116|NCT00861926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6544117|NCT00861926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544118|NCT00861926|Tocolytic Agents|tocolytic agents|mesh-ancestor
6544119|NCT00861926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6544120|NCT00861926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6544121|NCT00861926|Glucocorticoids|glucocorticoids|mesh-ancestor
6544122|NCT00861926|Hormones|hormones|mesh-ancestor
6544123|NCT00861926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6544124|NCT00861939|Bupropion|bupropion|mesh-list
6544125|NCT00861939|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6544126|NCT00861939|Antidepressive Agents|antidepressive agents|mesh-ancestor
6544127|NCT00861939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6544128|NCT00861939|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6544129|NCT00861939|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6544130|NCT00861939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6544131|NCT00861939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544132|NCT00861939|Dopamine Agents|dopamine agents|mesh-ancestor
6544133|NCT00861939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6544134|NCT00861939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544135|NCT00861939|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6544136|NCT00861939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6544137|NCT00861939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6544138|NCT00861952|Mineral Oil|mineral oil|mesh-list
6544139|NCT00861952|Emollients|emollients|mesh-ancestor
6544140|NCT00861952|Dermatologic Agents|dermatologic agents|mesh-ancestor
6544141|NCT00862043|Sildenafil Citrate|sildenafil citrate|mesh-list
6544142|NCT00862043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544143|NCT00862043|Vasodilator Agents|vasodilator agents|mesh-ancestor
6544144|NCT00862043|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6544145|NCT00862043|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6544146|NCT00862043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6544147|NCT00862043|Urological Agents|urological agents|mesh-ancestor
6544148|NCT00862095|Topiramate|topiramate|mesh-list
6544149|NCT00862095|Propranolol|propranolol|mesh-list
6544150|NCT00862095|Amitriptyline|amitriptyline|mesh-list
6544151|NCT00862095|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6544152|NCT00862095|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6544153|NCT00862095|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6544154|NCT00862095|Adrenergic Agents|adrenergic agents|mesh-ancestor
6544155|NCT00862095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6544156|NCT00862095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544157|NCT00862095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544158|NCT00862095|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6544159|NCT00862095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6544160|NCT00862095|Vasodilator Agents|vasodilator agents|mesh-ancestor
6544161|NCT00862095|Anticonvulsants|anticonvulsants|mesh-ancestor
6544162|NCT00862095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6544163|NCT00862095|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6544164|NCT00862095|Antidepressive Agents|antidepressive agents|mesh-ancestor
6544165|NCT00862095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6544166|NCT00862095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6544167|NCT00862095|Analgesics|analgesics|mesh-ancestor
6544168|NCT00862095|Sensory System Agents|sensory system agents|mesh-ancestor
6544169|NCT00862095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6544170|NCT00862095|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6544171|NCT00862095|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6544172|NCT00862095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6544173|NCT00862095|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6544174|NCT00862095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6544175|NCT00862095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6544176|NCT00862108|Methylphenidate|methylphenidate|mesh-list
6544177|NCT00862108|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6544178|NCT00862108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544179|NCT00862108|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6544180|NCT00862108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6544181|NCT00862108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6544182|NCT00862108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544183|NCT00862108|Dopamine Agents|dopamine agents|mesh-ancestor
6544184|NCT00862108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6544185|NCT00862264|Beclomethasone|beclomethasone|mesh-list
6544186|NCT00862264|Norflurane|norflurane|mesh-list
6544187|NCT00862264|Formoterol Fumarate|formoterol fumarate|mesh-list
6544188|NCT00862264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6544189|NCT00862264|Autonomic Agents|autonomic agents|mesh-ancestor
6544190|NCT00862264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6544191|NCT00862264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544192|NCT00862264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6544193|NCT00862264|Respiratory System Agents|respiratory system agents|mesh-ancestor
6544194|NCT00862264|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6544195|NCT00862264|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6544196|NCT00862264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6544197|NCT00862264|Adrenergic Agents|adrenergic agents|mesh-ancestor
6544198|NCT00862264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6544199|NCT00862264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544200|NCT00862264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6442282|NCT00375232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544201|NCT00862264|Glucocorticoids|glucocorticoids|mesh-ancestor
6544202|NCT00862264|Hormones|hormones|mesh-ancestor
6544203|NCT00862264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6544204|NCT00862264|Anesthetics|anesthetics|mesh-ancestor
6442283|NCT00375232|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6442284|NCT00375232|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6442285|NCT00375232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442286|NCT00375245|Sirolimus|sirolimus|mesh-list
6442287|NCT00375245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6442288|NCT00375245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6442289|NCT00375245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6442290|NCT00375245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6442291|NCT00375245|Antifungal Agents|antifungal agents|mesh-ancestor
6544205|NCT00862264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6544206|NCT00862329|Caseins|caseins|mesh-list
6544207|NCT00862329|Chelating Agents|chelating agents|mesh-ancestor
6544208|NCT00862329|Sequestering Agents|sequestering agents|mesh-ancestor
6544209|NCT00862329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544210|NCT00862342|Bevacizumab|bevacizumab|mesh-list
6544211|NCT00862342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6544212|NCT00862342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6544213|NCT00862342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6544214|NCT00862342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6544215|NCT00862342|Growth Substances|growth substances|mesh-ancestor
6544216|NCT00862342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544217|NCT00862342|Growth Inhibitors|growth inhibitors|mesh-ancestor
6544218|NCT00862381|Hydrocortisone|hydrocortisone|mesh-list
6544219|NCT00862381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6544220|NCT00862394|Formoterol Fumarate|formoterol fumarate|mesh-list
6544221|NCT00862394|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6544222|NCT00862394|Autonomic Agents|autonomic agents|mesh-ancestor
6544223|NCT00862394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6544224|NCT00862394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544225|NCT00862394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6544226|NCT00862394|Respiratory System Agents|respiratory system agents|mesh-ancestor
6544227|NCT00862394|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6544228|NCT00862394|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6544229|NCT00862394|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6544230|NCT00862394|Adrenergic Agents|adrenergic agents|mesh-ancestor
6544231|NCT00862394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6544232|NCT00862394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544233|NCT00862420|Ticlopidine|ticlopidine|mesh-list
6544234|NCT00862420|Clopidogrel|clopidogrel|mesh-list
6442292|NCT00375245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6442293|NCT00375245|Immunologic Factors|immunologic factors|mesh-ancestor
6442294|NCT00375245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442295|NCT00375258|Tranexamic Acid|tranexamic acid|mesh-list
6442296|NCT00375258|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6442297|NCT00375258|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6442298|NCT00375258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442299|NCT00375258|Hemostatics|hemostatics|mesh-ancestor
6442300|NCT00375258|Coagulants|coagulants|mesh-ancestor
6442301|NCT00375284|Pramipexole|pramipexole|mesh-list
6442302|NCT00375284|Antioxidants|antioxidants|mesh-ancestor
6544235|NCT00862420|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6544236|NCT00862420|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6544237|NCT00862420|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6544238|NCT00862420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6544239|NCT00862420|Purinergic Agents|purinergic agents|mesh-ancestor
6544240|NCT00862420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6544241|NCT00862420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544242|NCT00862420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544243|NCT00862420|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6544244|NCT00862420|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6544245|NCT00862420|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6544246|NCT00862420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6544247|NCT00862420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6544248|NCT00862433|Vitamins|vitamins|mesh-list
6544249|NCT00862433|Vitamin E|vitamin e|mesh-list
6544250|NCT00862433|Tocopherols|tocopherols|mesh-list
6544251|NCT00862433|alpha-Tocopherol|alpha-tocopherol|mesh-list
6544252|NCT00862433|Micronutrients|micronutrients|mesh-ancestor
6544253|NCT00862433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544254|NCT00862433|Antioxidants|antioxidants|mesh-ancestor
6544255|NCT00862433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544256|NCT00862433|Protective Agents|protective agents|mesh-ancestor
6544257|NCT00862472|Timolol|timolol|mesh-list
6544258|NCT00862472|Cloprostenol|cloprostenol|mesh-list
6544259|NCT00862472|Luteolytic Agents|luteolytic agents|mesh-ancestor
6544260|NCT00862472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6544261|NCT00862472|Contraceptive Agents|contraceptive agents|mesh-ancestor
6544262|NCT00862472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6544263|NCT00862472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544264|NCT00862472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6544265|NCT00862472|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6544266|NCT00862472|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6544267|NCT00862472|Adrenergic Agents|adrenergic agents|mesh-ancestor
6544268|NCT00862472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6544269|NCT00862472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544270|NCT00862472|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6544271|NCT00862472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6544272|NCT00862628|Rebamipide|rebamipide|mesh-list
6544273|NCT00862628|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6544274|NCT00862628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6544275|NCT00862628|Antioxidants|antioxidants|mesh-ancestor
6544276|NCT00862628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544277|NCT00862628|Protective Agents|protective agents|mesh-ancestor
6544278|NCT00862628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544279|NCT00862628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6544280|NCT00862693|Calcitriol|calcitriol|mesh-list
6544281|NCT00862693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6544282|NCT00862693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544283|NCT00862693|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6544284|NCT00862693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6544285|NCT00862693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544286|NCT00862693|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6544287|NCT00862693|Vitamins|vitamins|mesh-ancestor
6544288|NCT00862693|Micronutrients|micronutrients|mesh-ancestor
6544289|NCT00862693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6544290|NCT00862706|Telbivudine|telbivudine|mesh-list
6544291|NCT00862706|Antiviral Agents|antiviral agents|mesh-ancestor
6544292|NCT00862706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6544293|NCT00862706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6544294|NCT00862706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6544295|NCT00862706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544296|NCT00862875|Insulin|insulin|mesh-list
6544297|NCT00862875|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6544298|NCT00862875|Insulin Detemir|insulin detemir|mesh-list
6544299|NCT00862875|Insulin, Long-Acting|insulin, long-acting|mesh-list
6544300|NCT00862875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6544301|NCT00862875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544302|NCT00862888|Sildenafil Citrate|sildenafil citrate|mesh-list
6544303|NCT00862888|Vasodilator Agents|vasodilator agents|mesh-ancestor
6544304|NCT00862888|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6544305|NCT00862888|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6544306|NCT00862888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6544307|NCT00862888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544308|NCT00862888|Urological Agents|urological agents|mesh-ancestor
6544309|NCT00862966|Heparin|heparin|mesh-list
6544310|NCT00862966|Anticoagulants|anticoagulants|mesh-ancestor
6544311|NCT00862966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544312|NCT00862966|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6544313|NCT00862966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6544314|NCT00863096|Vaccines|vaccines|mesh-list
6544315|NCT00863096|Immunologic Factors|immunologic factors|mesh-ancestor
6544316|NCT00863096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544317|NCT00863148|Busulfan|busulfan|mesh-list
6544318|NCT00863148|Clofarabine|clofarabine|mesh-list
6544319|NCT00863148|Alkylating Agents|alkylating agents|mesh-ancestor
6544320|NCT00863148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544321|NCT00863148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6544322|NCT00863148|Immunologic Factors|immunologic factors|mesh-ancestor
6544323|NCT00863148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544324|NCT00863148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6544325|NCT00863148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6544326|NCT00863148|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6544327|NCT00863148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6544328|NCT00863148|Antimetabolites|antimetabolites|mesh-ancestor
6544329|NCT00863161|Lesogaberan|lesogaberan|mesh-list
6544330|NCT00863161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6544331|NCT00863161|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6544332|NCT00863161|GABA Agonists|gaba agonists|mesh-ancestor
6544333|NCT00863161|GABA Agents|gaba agents|mesh-ancestor
6544334|NCT00863161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6544335|NCT00863161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544336|NCT00863161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544337|NCT00863187|Rituximab|rituximab|mesh-list
6544338|NCT00863187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6544339|NCT00863187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6544340|NCT00863187|Immunologic Factors|immunologic factors|mesh-ancestor
6544341|NCT00863187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544342|NCT00863187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6544343|NCT00863213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
6544344|NCT00863239|Interferons|interferons|mesh-list
6544345|NCT00863239|Ribavirin|ribavirin|mesh-list
6544346|NCT00863239|Interferon-alpha|interferon-alpha|mesh-list
6544347|NCT00863239|Interferon alpha-2|interferon alpha-2|mesh-list
6544348|NCT00863239|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6544349|NCT00863239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6544350|NCT00863239|Antiviral Agents|antiviral agents|mesh-ancestor
6544351|NCT00863239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6544352|NCT00863239|Antimetabolites|antimetabolites|mesh-ancestor
6544353|NCT00863239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544354|NCT00863239|Immunologic Factors|immunologic factors|mesh-ancestor
6544355|NCT00863239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544356|NCT00863252|Mycophenolic Acid|mycophenolic acid|mesh-list
6544357|NCT00863252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6544358|NCT00863252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6544359|NCT00863252|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6544360|NCT00863252|Antitubercular Agents|antitubercular agents|mesh-ancestor
6544361|NCT00863252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6544362|NCT00863252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6544363|NCT00863252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6544364|NCT00863252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655662|NCT01465009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6655663|NCT01465009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6655664|NCT01465009|Analgesics|analgesics|mesh-ancestor
6655665|NCT01465009|Sensory System Agents|sensory system agents|mesh-ancestor
6655666|NCT01465009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6655667|NCT01465009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655668|NCT01465009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6655669|NCT01465009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6655670|NCT01465009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6655671|NCT01465009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6655672|NCT01465009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655673|NCT01465009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6655674|NCT01465009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6655675|NCT01465009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6655676|NCT01465009|Antipyretics|antipyretics|mesh-ancestor
6655677|NCT01465074|Nicotine|nicotine|mesh-list
6655678|NCT01465074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6655679|NCT01465074|Autonomic Agents|autonomic agents|mesh-ancestor
6655680|NCT01465074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6655681|NCT01465074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655682|NCT01465074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6655683|NCT01465074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6655684|NCT01465074|Cholinergic Agents|cholinergic agents|mesh-ancestor
6655685|NCT01465074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6655686|NCT01465074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655687|NCT01465113|Vitamin D|vitamin d|mesh-list
6544365|NCT00863291|Buprenorphine|buprenorphine|mesh-list
6544366|NCT00863291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6544367|NCT00863291|Narcotics|narcotics|mesh-ancestor
6544368|NCT00863291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6544369|NCT00863291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544370|NCT00863291|Analgesics|analgesics|mesh-ancestor
6544371|NCT00863291|Sensory System Agents|sensory system agents|mesh-ancestor
6544372|NCT00863291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6544373|NCT00863291|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6544374|NCT00863369|Gemcitabine|gemcitabine|mesh-list
6544375|NCT00863369|Rituximab|rituximab|mesh-list
6544376|NCT00863369|Bortezomib|bortezomib|mesh-list
6544377|NCT00863369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6544378|NCT00863369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6544379|NCT00863369|Immunologic Factors|immunologic factors|mesh-ancestor
6544380|NCT00863369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544381|NCT00863369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6544382|NCT00863369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6544383|NCT00863369|Antimetabolites|antimetabolites|mesh-ancestor
6544384|NCT00863369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544385|NCT00863369|Antiviral Agents|antiviral agents|mesh-ancestor
6544386|NCT00863369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6544387|NCT00863369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6544388|NCT00863369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6544389|NCT00863395|Lidocaine|lidocaine|mesh-list
6544390|NCT00863395|Anesthetics, Local|anesthetics, local|mesh-ancestor
6544391|NCT00863395|Anesthetics|anesthetics|mesh-ancestor
6544392|NCT00863395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6544393|NCT00863395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544394|NCT00863395|Sensory System Agents|sensory system agents|mesh-ancestor
6544395|NCT00863395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6544396|NCT00863395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6544397|NCT00863395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6544398|NCT00863395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6544399|NCT00863395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6544400|NCT00863395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544401|NCT00863460|Cytarabine|cytarabine|mesh-list
6544402|NCT00863460|Prednisone|prednisone|mesh-list
6544403|NCT00863460|Cyclophosphamide|cyclophosphamide|mesh-list
6544404|NCT00863460|Busulfan|busulfan|mesh-list
6544405|NCT00863460|Thiotepa|thiotepa|mesh-list
6544406|NCT00863460|Carmustine|carmustine|mesh-list
6544407|NCT00863460|Methotrexate|methotrexate|mesh-list
6544408|NCT00863460|Etoposide|etoposide|mesh-list
6544409|NCT00863460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6544410|NCT00863460|Immunologic Factors|immunologic factors|mesh-ancestor
6544411|NCT00863460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544412|NCT00863460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6544413|NCT00863460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6544414|NCT00863460|Alkylating Agents|alkylating agents|mesh-ancestor
6544415|NCT00863460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544416|NCT00863460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6544417|NCT00863460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6544418|NCT00863460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6544419|NCT00863460|Glucocorticoids|glucocorticoids|mesh-ancestor
6544420|NCT00863460|Hormones|hormones|mesh-ancestor
6544421|NCT00863460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6544422|NCT00863460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6544423|NCT00863460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6544424|NCT00863460|Abortifacient Agents|abortifacient agents|mesh-ancestor
6544425|NCT00863460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6544426|NCT00863460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6544427|NCT00863460|Antimetabolites|antimetabolites|mesh-ancestor
6544428|NCT00863460|Dermatologic Agents|dermatologic agents|mesh-ancestor
6544429|NCT00863460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6544430|NCT00863460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6544431|NCT00863460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6544432|NCT00863460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6544433|NCT00863460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6544434|NCT00863460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6544435|NCT00863460|Antiviral Agents|antiviral agents|mesh-ancestor
6544436|NCT00863460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6544437|NCT00863499|Methylphenidate|methylphenidate|mesh-list
6544438|NCT00863499|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6544439|NCT00863499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544440|NCT00863499|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6544441|NCT00863499|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6544442|NCT00863499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6544443|NCT00863499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544444|NCT00863499|Dopamine Agents|dopamine agents|mesh-ancestor
6544445|NCT00863499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6544446|NCT00863577|Bemiparin|bemiparin|mesh-list
6544447|NCT00863577|Anticoagulants|anticoagulants|mesh-ancestor
6544448|NCT00863629|Insulin|insulin|mesh-list
6544449|NCT00863629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6544450|NCT00863629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544451|NCT00863668|Tenofovir|tenofovir|mesh-list
6544452|NCT00863668|Emtricitabine|emtricitabine|mesh-list
6544453|NCT00863668|Efavirenz|efavirenz|mesh-list
6544454|NCT00863668|Raltegravir Potassium|raltegravir potassium|mesh-list
6544455|NCT00863668|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6544456|NCT00863668|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
6544457|NCT00863668|Integrase Inhibitors|integrase inhibitors|mesh-list
6544458|NCT00863668|Antiviral Agents|antiviral agents|mesh-ancestor
6544459|NCT00863668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6544460|NCT00863668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6544461|NCT00863668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6544462|NCT00863668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544463|NCT00863668|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6544464|NCT00863668|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6544465|NCT00863668|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6544466|NCT00863668|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6544467|NCT00863668|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6544468|NCT00863668|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6544469|NCT00863668|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6544470|NCT00863668|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6544471|NCT00863668|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6544472|NCT00863733|Acetic Acid|acetic acid|mesh-list
6544473|NCT00863733|Vadimezan|vadimezan|mesh-list
6544474|NCT00863733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6544475|NCT00863733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6544476|NCT00863733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6544477|NCT00863785|Acetylcysteine|acetylcysteine|mesh-list
6544478|NCT00863785|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6544479|NCT00863785|Antiviral Agents|antiviral agents|mesh-ancestor
6544480|NCT00863785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6544481|NCT00863785|Expectorants|expectorants|mesh-ancestor
6544482|NCT00863785|Respiratory System Agents|respiratory system agents|mesh-ancestor
6544483|NCT00863785|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6544484|NCT00863785|Antioxidants|antioxidants|mesh-ancestor
6544485|NCT00863785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544486|NCT00863785|Protective Agents|protective agents|mesh-ancestor
6544487|NCT00863785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544488|NCT00863785|Antidotes|antidotes|mesh-ancestor
6544489|NCT00863837|Terlipressin|terlipressin|mesh-list
6544490|NCT00863837|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
6544491|NCT00863837|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
6544492|NCT00863837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6544493|NCT00863837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6544494|NCT00863837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544495|NCT00863850|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6544496|NCT00863850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6544497|NCT00863850|Alkylating Agents|alkylating agents|mesh-ancestor
6544498|NCT00863850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544499|NCT00863850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6544500|NCT00863863|Griseofulvin|griseofulvin|mesh-list
6544501|NCT00863863|Antifungal Agents|antifungal agents|mesh-ancestor
6544502|NCT00863863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6544503|NCT00863889|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6544504|NCT00863889|Methylprednisolone|methylprednisolone|mesh-list
6544505|NCT00863889|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6544506|NCT00863889|Prednisolone|prednisolone|mesh-list
6544507|NCT00863889|Prednisolone acetate|prednisolone acetate|mesh-list
6544508|NCT00863889|Lidocaine|lidocaine|mesh-list
6544509|NCT00863889|Bupivacaine|bupivacaine|mesh-list
6544510|NCT00863889|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6544511|NCT00863889|Prednisolone phosphate|prednisolone phosphate|mesh-list
6544512|NCT00863889|Anesthetics, Local|anesthetics, local|mesh-ancestor
6544513|NCT00863889|Anesthetics|anesthetics|mesh-ancestor
6544514|NCT00863889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6544515|NCT00863889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544516|NCT00863889|Sensory System Agents|sensory system agents|mesh-ancestor
6544517|NCT00863889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6544518|NCT00863889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6442303|NCT00375284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544519|NCT00863889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6544520|NCT00863889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6544521|NCT00863889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6544522|NCT00863889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544523|NCT00863889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6544524|NCT00863889|Antiemetics|antiemetics|mesh-ancestor
6544525|NCT00863889|Autonomic Agents|autonomic agents|mesh-ancestor
6544526|NCT00863889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6544527|NCT00863889|Glucocorticoids|glucocorticoids|mesh-ancestor
6544528|NCT00863889|Hormones|hormones|mesh-ancestor
6544529|NCT00863889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6544530|NCT00863889|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6544531|NCT00863889|Protective Agents|protective agents|mesh-ancestor
6544532|NCT00863889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6544533|NCT00863889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6544534|NCT00863902|Cetirizine|cetirizine|mesh-list
6544535|NCT00863902|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6544536|NCT00863902|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6544537|NCT00863902|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6544538|NCT00863902|Histamine Antagonists|histamine antagonists|mesh-ancestor
6544539|NCT00863902|Histamine Agents|histamine agents|mesh-ancestor
6544540|NCT00863902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6544541|NCT00863902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544542|NCT00863902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544543|NCT00863915|Ramipril|ramipril|mesh-list
6544544|NCT00863915|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6544545|NCT00863915|Protease Inhibitors|protease inhibitors|mesh-ancestor
6544546|NCT00863915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6442304|NCT00375284|Protective Agents|protective agents|mesh-ancestor
6442305|NCT00375284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442306|NCT00375284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6442307|NCT00375284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6442308|NCT00375284|Dopamine Agonists|dopamine agonists|mesh-ancestor
6442309|NCT00375284|Dopamine Agents|dopamine agents|mesh-ancestor
6544547|NCT00863915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544548|NCT00863915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6544549|NCT00863941|Bupropion|bupropion|mesh-list
6544550|NCT00863941|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6544551|NCT00863941|Antidepressive Agents|antidepressive agents|mesh-ancestor
6544552|NCT00863941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6544553|NCT00863941|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6544554|NCT00863941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6544555|NCT00863941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6544556|NCT00863941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544557|NCT00863941|Dopamine Agents|dopamine agents|mesh-ancestor
6544558|NCT00863941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6544559|NCT00863941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544560|NCT00863941|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6544561|NCT00863941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6544562|NCT00863941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6544563|NCT00863980|Telmisartan|telmisartan|mesh-list
6544564|NCT00863980|Candesartan|candesartan|mesh-list
6544565|NCT00863980|Candesartan cilexetil|candesartan cilexetil|mesh-list
6544566|NCT00863980|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6544567|NCT00863980|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6544568|NCT00863980|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6544569|NCT00863980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544570|NCT00864006|Valproic Acid|valproic acid|mesh-list
6544571|NCT00864006|Anticonvulsants|anticonvulsants|mesh-ancestor
6544572|NCT00864006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6544573|NCT00864006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544574|NCT00864006|GABA Agents|gaba agents|mesh-ancestor
6544575|NCT00864006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6544576|NCT00864006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544577|NCT00864006|Antimanic Agents|antimanic agents|mesh-ancestor
6544578|NCT00864006|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6544579|NCT00864006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6544580|NCT00864006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6544581|NCT00864019|Sertraline|sertraline|mesh-list
6544582|NCT00864019|Antidepressive Agents|antidepressive agents|mesh-ancestor
6544583|NCT00864019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6544584|NCT00864019|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6544585|NCT00864019|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6544586|NCT00864019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6544587|NCT00864019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544588|NCT00864019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6544589|NCT00864019|Serotonin Agents|serotonin agents|mesh-ancestor
6544590|NCT00864019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544591|NCT00864045|Olanzapine|olanzapine|mesh-list
6544592|NCT00864045|Sertindole|sertindole|mesh-list
6544593|NCT00864045|Antiemetics|antiemetics|mesh-ancestor
6544594|NCT00864045|Autonomic Agents|autonomic agents|mesh-ancestor
6544595|NCT00864045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6544596|NCT00864045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544597|NCT00864045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6544598|NCT00864045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6544599|NCT00864045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6544600|NCT00864045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6544601|NCT00864045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6544602|NCT00864045|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6544603|NCT00864045|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6544604|NCT00864045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6544605|NCT00864045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544606|NCT00864045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6544607|NCT00864045|Serotonin Agents|serotonin agents|mesh-ancestor
6544608|NCT00864058|Gabapentin|gabapentin|mesh-list
6544609|NCT00864058|Analgesics|analgesics|mesh-ancestor
6544610|NCT00864058|Sensory System Agents|sensory system agents|mesh-ancestor
6544611|NCT00864058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6544612|NCT00864058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544613|NCT00864058|Anticonvulsants|anticonvulsants|mesh-ancestor
6544614|NCT00864058|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6544615|NCT00864058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6544616|NCT00864058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6544617|NCT00864058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6544618|NCT00864058|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6442310|NCT00375284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6442311|NCT00375297|Sildenafil Citrate|sildenafil citrate|mesh-list
6442312|NCT00375297|Vasodilator Agents|vasodilator agents|mesh-ancestor
6442313|NCT00375297|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6442314|NCT00375297|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6442315|NCT00375297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6442316|NCT00375297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544619|NCT00864058|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6544620|NCT00864058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6544621|NCT00864058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544622|NCT00864058|Antimanic Agents|antimanic agents|mesh-ancestor
6544623|NCT00864071|Griseofulvin|griseofulvin|mesh-list
6544624|NCT00864071|Antifungal Agents|antifungal agents|mesh-ancestor
6544625|NCT00864071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6544626|NCT00864110|Deoxyglucose|deoxyglucose|mesh-list
6544627|NCT00864110|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6544628|NCT00864110|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6544629|NCT00864110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544630|NCT00864110|Antimetabolites|antimetabolites|mesh-ancestor
6544631|NCT00864110|Antiviral Agents|antiviral agents|mesh-ancestor
6442317|NCT00375297|Urological Agents|urological agents|mesh-ancestor
6442318|NCT00375310|Gemcitabine|gemcitabine|mesh-list
6442319|NCT00375310|Sorafenib|sorafenib|mesh-list
6442320|NCT00375310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6442321|NCT00375310|Antimetabolites|antimetabolites|mesh-ancestor
6442322|NCT00375310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442323|NCT00375310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6544632|NCT00864110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6544633|NCT00864136|Levonorgestrel|levonorgestrel|mesh-list
6544634|NCT00864136|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6544635|NCT00864136|Contraceptive Agents|contraceptive agents|mesh-ancestor
6544636|NCT00864136|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6544637|NCT00864136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544638|NCT00864136|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6544639|NCT00864136|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6544640|NCT00864136|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6544641|NCT00864149|Carvedilol|carvedilol|mesh-list
6544642|NCT00864149|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6544643|NCT00864149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6544644|NCT00864149|Adrenergic Agents|adrenergic agents|mesh-ancestor
6544645|NCT00864149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6544646|NCT00864149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544647|NCT00864149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544648|NCT00864149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6544649|NCT00864149|Antioxidants|antioxidants|mesh-ancestor
6544650|NCT00864149|Protective Agents|protective agents|mesh-ancestor
6544651|NCT00864149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6544652|NCT00864149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6544653|NCT00864149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6544654|NCT00864149|Vasodilator Agents|vasodilator agents|mesh-ancestor
6544655|NCT00864149|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6544656|NCT00864149|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6544657|NCT00864162|Ramipril|ramipril|mesh-list
6544658|NCT00864162|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6544659|NCT00864162|Protease Inhibitors|protease inhibitors|mesh-ancestor
6544660|NCT00864162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6544661|NCT00864162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544662|NCT00864162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6544663|NCT00864188|Beta Carotene|beta carotene|mesh-list
6544664|NCT00864188|Carotenoids|carotenoids|mesh-list
6544665|NCT00864188|Antioxidants|antioxidants|mesh-ancestor
6544666|NCT00864188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544667|NCT00864188|Protective Agents|protective agents|mesh-ancestor
6544668|NCT00864188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544669|NCT00864188|Provitamins|provitamins|mesh-ancestor
6544670|NCT00864188|Vitamins|vitamins|mesh-ancestor
6544671|NCT00864188|Micronutrients|micronutrients|mesh-ancestor
6544672|NCT00864201|Bosentan|bosentan|mesh-list
6544673|NCT00864201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6544674|NCT00864201|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6544675|NCT00864201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544676|NCT00864214|Hormones|hormones|mesh-list
6544677|NCT00864214|Estradiol|estradiol|mesh-list
6544678|NCT00864214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6544679|NCT00864214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544680|NCT00864214|Estrogens|estrogens|mesh-ancestor
6544681|NCT00864240|Clobetasol|clobetasol|mesh-list
6544682|NCT00864240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6544683|NCT00864240|Glucocorticoids|glucocorticoids|mesh-ancestor
6544684|NCT00864240|Hormones|hormones|mesh-ancestor
6544685|NCT00864240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6544686|NCT00864240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544687|NCT00864279|Cetirizine|cetirizine|mesh-list
6544688|NCT00864279|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6544689|NCT00864279|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6544690|NCT00864279|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6544691|NCT00864279|Histamine Antagonists|histamine antagonists|mesh-ancestor
6544692|NCT00864279|Histamine Agents|histamine agents|mesh-ancestor
6544693|NCT00864279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6544694|NCT00864279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544695|NCT00864279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544696|NCT00864305|Gabapentin|gabapentin|mesh-list
6544697|NCT00864305|Analgesics|analgesics|mesh-ancestor
6544698|NCT00864305|Sensory System Agents|sensory system agents|mesh-ancestor
6544699|NCT00864305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6544700|NCT00864305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544701|NCT00864305|Anticonvulsants|anticonvulsants|mesh-ancestor
6544702|NCT00864305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6544703|NCT00864305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6544704|NCT00864305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6544705|NCT00864305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6544706|NCT00864305|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6544707|NCT00864305|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6544708|NCT00864305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6544709|NCT00864305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544710|NCT00864305|Antimanic Agents|antimanic agents|mesh-ancestor
6544711|NCT00864318|Paclitaxel|paclitaxel|mesh-list
6544712|NCT00864318|Etoposide|etoposide|mesh-list
6544713|NCT00864318|Ifosfamide|ifosfamide|mesh-list
6544714|NCT00864318|Carboplatin|carboplatin|mesh-list
6544715|NCT00864318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6544716|NCT00864318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6544717|NCT00864318|Tubulin Modulators|tubulin modulators|mesh-ancestor
6544718|NCT00864318|Antimitotic Agents|antimitotic agents|mesh-ancestor
6544719|NCT00864318|Mitosis Modulators|mitosis modulators|mesh-ancestor
6655688|NCT01465113|Ergocalciferols|ergocalciferols|mesh-list
6544720|NCT00864318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544721|NCT00864318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6544722|NCT00864318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6544723|NCT00864318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6544724|NCT00864318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6544725|NCT00864318|Alkylating Agents|alkylating agents|mesh-ancestor
6544726|NCT00864344|Sertraline|sertraline|mesh-list
6544727|NCT00864344|Antidepressive Agents|antidepressive agents|mesh-ancestor
6544728|NCT00864344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6544729|NCT00864344|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6544730|NCT00864344|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6544731|NCT00864344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6544732|NCT00864344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544733|NCT00864344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6544734|NCT00864344|Serotonin Agents|serotonin agents|mesh-ancestor
6544735|NCT00864344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544736|NCT00864357|Ibuprofen|ibuprofen|mesh-list
6544737|NCT00864357|Oxycodone|oxycodone|mesh-list
6544738|NCT00864357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6544739|NCT00864357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6544740|NCT00864357|Analgesics|analgesics|mesh-ancestor
6544741|NCT00864357|Sensory System Agents|sensory system agents|mesh-ancestor
6544742|NCT00864357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6544743|NCT00864357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544744|NCT00864357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6544745|NCT00864357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6544746|NCT00864357|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6544747|NCT00864357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6544748|NCT00864357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544749|NCT00864357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6544750|NCT00864357|Narcotics|narcotics|mesh-ancestor
6544751|NCT00864357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6544752|NCT00864396|Lansoprazole|lansoprazole|mesh-list
6544753|NCT00864396|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6544754|NCT00864396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6544755|NCT00864396|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6544756|NCT00864396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6544757|NCT00864396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544758|NCT00864409|Ropivacaine|ropivacaine|mesh-list
6544759|NCT00864409|Anesthetics, Local|anesthetics, local|mesh-ancestor
6544760|NCT00864409|Anesthetics|anesthetics|mesh-ancestor
6544761|NCT00864409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6544762|NCT00864409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544763|NCT00864409|Sensory System Agents|sensory system agents|mesh-ancestor
6544764|NCT00864409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6544765|NCT00864435|Carvedilol|carvedilol|mesh-list
6442324|NCT00375310|Antiviral Agents|antiviral agents|mesh-ancestor
6442325|NCT00375310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6442326|NCT00375310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6442327|NCT00375310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6442328|NCT00375310|Immunologic Factors|immunologic factors|mesh-ancestor
6442329|NCT00375310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442330|NCT00375310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6442331|NCT00375362|Nitroglycerin|nitroglycerin|mesh-list
6442332|NCT00375362|Vasodilator Agents|vasodilator agents|mesh-ancestor
6544766|NCT00864435|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6544767|NCT00864435|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6544768|NCT00864435|Adrenergic Agents|adrenergic agents|mesh-ancestor
6544769|NCT00864435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6544770|NCT00864435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544771|NCT00864435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544772|NCT00864435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6544773|NCT00864435|Antioxidants|antioxidants|mesh-ancestor
6544774|NCT00864435|Protective Agents|protective agents|mesh-ancestor
6544775|NCT00864435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6544776|NCT00864435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6544777|NCT00864435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6544778|NCT00864435|Vasodilator Agents|vasodilator agents|mesh-ancestor
6544779|NCT00864435|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6544780|NCT00864435|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6544781|NCT00864448|Ramipril|ramipril|mesh-list
6544782|NCT00864448|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6544783|NCT00864448|Protease Inhibitors|protease inhibitors|mesh-ancestor
6544784|NCT00864448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6544785|NCT00864448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544786|NCT00864448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6544787|NCT00864474|Maraviroc|maraviroc|mesh-list
6544788|NCT00864474|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6544789|NCT00864474|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6544790|NCT00864474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544791|NCT00864474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6544792|NCT00864474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6544793|NCT00864474|Antiviral Agents|antiviral agents|mesh-ancestor
6544794|NCT00864474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6544795|NCT00864474|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6544796|NCT00864500|Clobetasol|clobetasol|mesh-list
6544797|NCT00864500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6544798|NCT00864500|Glucocorticoids|glucocorticoids|mesh-ancestor
6544799|NCT00864500|Hormones|hormones|mesh-ancestor
6544800|NCT00864500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6544801|NCT00864500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544802|NCT00864526|Ibuprofen|ibuprofen|mesh-list
6544803|NCT00864526|Oxycodone|oxycodone|mesh-list
6544804|NCT00864526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6544805|NCT00864526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6544806|NCT00864526|Analgesics|analgesics|mesh-ancestor
6544807|NCT00864526|Sensory System Agents|sensory system agents|mesh-ancestor
6544808|NCT00864526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6544809|NCT00864526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544810|NCT00864526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6544811|NCT00864526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6544812|NCT00864526|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6544813|NCT00864526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6544814|NCT00864526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544815|NCT00864526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6544816|NCT00864526|Narcotics|narcotics|mesh-ancestor
6544817|NCT00864526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6544818|NCT00864552|Factor VIII|factor viii|mesh-list
6544819|NCT00864552|Coagulants|coagulants|mesh-ancestor
6544820|NCT00864565|Fentanyl|fentanyl|mesh-list
6544821|NCT00864565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6544822|NCT00864565|Narcotics|narcotics|mesh-ancestor
6544823|NCT00864565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6544824|NCT00864565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544825|NCT00864565|Analgesics|analgesics|mesh-ancestor
6544826|NCT00864565|Sensory System Agents|sensory system agents|mesh-ancestor
6544827|NCT00864565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6544828|NCT00864565|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6544829|NCT00864565|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6544830|NCT00864565|Anesthetics, General|anesthetics, general|mesh-ancestor
6544831|NCT00864565|Anesthetics|anesthetics|mesh-ancestor
6544832|NCT00864591|Adenosine|adenosine|mesh-list
6544833|NCT00864591|Analgesics|analgesics|mesh-ancestor
6544834|NCT00864591|Sensory System Agents|sensory system agents|mesh-ancestor
6544835|NCT00864591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6544836|NCT00864591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544837|NCT00864591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6544838|NCT00864591|Vasodilator Agents|vasodilator agents|mesh-ancestor
6544839|NCT00864591|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6544840|NCT00864591|Purinergic Agonists|purinergic agonists|mesh-ancestor
6544841|NCT00864591|Purinergic Agents|purinergic agents|mesh-ancestor
6544842|NCT00864591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6544843|NCT00864591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544844|NCT00864604|Nabumetone|nabumetone|mesh-list
6544845|NCT00864604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6544846|NCT00864604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6544847|NCT00864604|Analgesics|analgesics|mesh-ancestor
6544848|NCT00864604|Sensory System Agents|sensory system agents|mesh-ancestor
6544849|NCT00864604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6544850|NCT00864604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544851|NCT00864604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6544852|NCT00864604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6544853|NCT00864604|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6544854|NCT00864604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6544855|NCT00864604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6544856|NCT00864604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544857|NCT00864617|Nifedipine|nifedipine|mesh-list
6544858|NCT00864617|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6544859|NCT00864617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6544860|NCT00864617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544861|NCT00864617|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6544862|NCT00864617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544863|NCT00864617|Vasodilator Agents|vasodilator agents|mesh-ancestor
6544864|NCT00864617|Tocolytic Agents|tocolytic agents|mesh-ancestor
6544865|NCT00864617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6544866|NCT00864643|Atorvastatin|atorvastatin|mesh-list
6544867|NCT00864643|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6544868|NCT00864643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6544869|NCT00864643|Antimetabolites|antimetabolites|mesh-ancestor
6544870|NCT00864643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544871|NCT00864643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6544872|NCT00864643|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6544873|NCT00864643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6544874|NCT00864669|Metformin|metformin|mesh-list
6544875|NCT00864669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6544876|NCT00864669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544877|NCT00864734|Metformin|metformin|mesh-list
6544878|NCT00864734|Glyburide|glyburide|mesh-list
6544879|NCT00864734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6544880|NCT00864734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544881|NCT00864747|Propranolol|propranolol|mesh-list
6544882|NCT00864747|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6544883|NCT00864747|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6544884|NCT00864747|Adrenergic Agents|adrenergic agents|mesh-ancestor
6544885|NCT00864747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6544886|NCT00864747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544887|NCT00864747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544888|NCT00864747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6544889|NCT00864747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6544890|NCT00864747|Vasodilator Agents|vasodilator agents|mesh-ancestor
6544891|NCT00864760|Gabapentin|gabapentin|mesh-list
6544892|NCT00864760|Analgesics|analgesics|mesh-ancestor
6544893|NCT00864760|Sensory System Agents|sensory system agents|mesh-ancestor
6544894|NCT00864760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6544895|NCT00864760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544896|NCT00864760|Anticonvulsants|anticonvulsants|mesh-ancestor
6544897|NCT00864760|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6544898|NCT00864760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6544899|NCT00864760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6544900|NCT00864760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6544901|NCT00864760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6544902|NCT00864760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6544903|NCT00864760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6544904|NCT00864760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544905|NCT00864760|Antimanic Agents|antimanic agents|mesh-ancestor
6544906|NCT00864773|Endothelial Growth Factors|endothelial growth factors|mesh-list
6544907|NCT00864773|Growth Substances|growth substances|mesh-ancestor
6544908|NCT00864773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544909|NCT00864799|Misoprostol|misoprostol|mesh-list
6544910|NCT00864799|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6544911|NCT00864799|Abortifacient Agents|abortifacient agents|mesh-ancestor
6544912|NCT00864799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6544913|NCT00864799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544914|NCT00864799|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6544915|NCT00864799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6544916|NCT00864799|Oxytocics|oxytocics|mesh-ancestor
6544917|NCT00864812|Fluticasone|fluticasone|mesh-list
6544918|NCT00864812|Xhance|xhance|mesh-list
6544919|NCT00864812|Tiotropium Bromide|tiotropium bromide|mesh-list
6544920|NCT00864812|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6544921|NCT00864812|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6544922|NCT00864812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6544923|NCT00864812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6544924|NCT00864812|Autonomic Agents|autonomic agents|mesh-ancestor
6544925|NCT00864812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6544926|NCT00864812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544927|NCT00864812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6544928|NCT00864812|Respiratory System Agents|respiratory system agents|mesh-ancestor
6544929|NCT00864812|Dermatologic Agents|dermatologic agents|mesh-ancestor
6544930|NCT00864812|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6544931|NCT00864812|Parasympatholytics|parasympatholytics|mesh-ancestor
6544932|NCT00864812|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6544933|NCT00864812|Cholinergic Agents|cholinergic agents|mesh-ancestor
6544934|NCT00864812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6544935|NCT00864812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544936|NCT00864812|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6544937|NCT00864812|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6544938|NCT00864812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6544939|NCT00864812|Adrenergic Agents|adrenergic agents|mesh-ancestor
6544940|NCT00864812|Glucocorticoids|glucocorticoids|mesh-ancestor
6544941|NCT00864812|Hormones|hormones|mesh-ancestor
6544942|NCT00864812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6544943|NCT00864812|Sympathomimetics|sympathomimetics|mesh-ancestor
6544944|NCT00864825|Allopurinol|allopurinol|mesh-list
6544945|NCT00864825|Antimetabolites|antimetabolites|mesh-ancestor
6544946|NCT00864825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544947|NCT00864825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6544948|NCT00864825|Gout Suppressants|gout suppressants|mesh-ancestor
6544949|NCT00864825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6544950|NCT00864825|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6544951|NCT00864825|Antioxidants|antioxidants|mesh-ancestor
6544952|NCT00864825|Protective Agents|protective agents|mesh-ancestor
6544953|NCT00864825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544954|NCT00864838|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6544955|NCT00864838|Acetazolamide|acetazolamide|mesh-list
6544956|NCT00864838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6544957|NCT00864838|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6544958|NCT00864838|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6544959|NCT00864838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6544960|NCT00864838|Adrenergic Agents|adrenergic agents|mesh-ancestor
6544961|NCT00864838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6544962|NCT00864838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544963|NCT00864838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544964|NCT00864838|Anticonvulsants|anticonvulsants|mesh-ancestor
6544965|NCT00864838|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6544966|NCT00864838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6544967|NCT00864838|Diuretics|diuretics|mesh-ancestor
6544968|NCT00864838|Natriuretic Agents|natriuretic agents|mesh-ancestor
6544969|NCT00864864|Sunitinib|sunitinib|mesh-list
6544970|NCT00864864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6544971|NCT00864864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6544972|NCT00864864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6442333|NCT00375375|Lactulose|lactulose|mesh-list
6442334|NCT00375375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6442335|NCT00375388|Metformin|metformin|mesh-list
6442336|NCT00375388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6019657|NCT00388414|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6019658|NCT00388414|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6019659|NCT00388414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6019660|NCT00388414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6019661|NCT00388414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442337|NCT00375388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442338|NCT00375440|Tranexamic Acid|tranexamic acid|mesh-list
6442339|NCT00375440|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6544973|NCT00864864|Growth Substances|growth substances|mesh-ancestor
6544974|NCT00864864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6544975|NCT00864864|Growth Inhibitors|growth inhibitors|mesh-ancestor
6544976|NCT00864864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6544977|NCT00864864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6544978|NCT00864864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544979|NCT00864890|Dexetimide|dexetimide|mesh-list
6544980|NCT00864890|Citalopram|citalopram|mesh-list
6544981|NCT00864890|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6544982|NCT00864890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6544983|NCT00864890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6544984|NCT00864890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6544985|NCT00864890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6544986|NCT00864890|Serotonin Agents|serotonin agents|mesh-ancestor
6544987|NCT00864890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442340|NCT00375440|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6442341|NCT00375440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442342|NCT00375440|Hemostatics|hemostatics|mesh-ancestor
6442343|NCT00375440|Coagulants|coagulants|mesh-ancestor
6442344|NCT00375466|Tranexamic Acid|tranexamic acid|mesh-list
6544988|NCT00864890|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6544989|NCT00864890|Antidepressive Agents|antidepressive agents|mesh-ancestor
6544990|NCT00864890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6544991|NCT00864890|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6544992|NCT00864890|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6544993|NCT00864890|Parasympatholytics|parasympatholytics|mesh-ancestor
6544994|NCT00864890|Autonomic Agents|autonomic agents|mesh-ancestor
6544995|NCT00864890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6544996|NCT00864890|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6544997|NCT00864890|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6544998|NCT00864890|Cholinergic Agents|cholinergic agents|mesh-ancestor
6544999|NCT00864942|Lenalidomide|lenalidomide|mesh-list
6545000|NCT00864942|Rituximab|rituximab|mesh-list
6545001|NCT00864942|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6545002|NCT00864942|Immunologic Factors|immunologic factors|mesh-ancestor
6545003|NCT00864942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545004|NCT00864942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6545005|NCT00864942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6545006|NCT00864942|Growth Substances|growth substances|mesh-ancestor
6545007|NCT00864942|Growth Inhibitors|growth inhibitors|mesh-ancestor
6545008|NCT00864942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6545009|NCT00864942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6545010|NCT00864942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6545011|NCT00864942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6545012|NCT00864942|Alkylating Agents|alkylating agents|mesh-ancestor
6545013|NCT00864942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545014|NCT00864968|Nabumetone|nabumetone|mesh-list
6545015|NCT00864968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6545016|NCT00864968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6545017|NCT00864968|Analgesics|analgesics|mesh-ancestor
6545018|NCT00864968|Sensory System Agents|sensory system agents|mesh-ancestor
6545019|NCT00864968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6545020|NCT00864968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545021|NCT00864968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6545022|NCT00864968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6545023|NCT00864968|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6545024|NCT00864968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6545025|NCT00864968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6545026|NCT00864968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655689|NCT01465113|Cholecalciferol|cholecalciferol|mesh-list
6655690|NCT01465113|Vitamins|vitamins|mesh-list
6655691|NCT01465113|Metformin|metformin|mesh-list
6545027|NCT00864981|Bupropion|bupropion|mesh-list
6545028|NCT00864981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6545029|NCT00864981|Antidepressive Agents|antidepressive agents|mesh-ancestor
6545030|NCT00864981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6545031|NCT00864981|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6545032|NCT00864981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6545033|NCT00864981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6545034|NCT00864981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545035|NCT00864981|Dopamine Agents|dopamine agents|mesh-ancestor
6545036|NCT00864981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6545037|NCT00864981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545038|NCT00864981|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6545039|NCT00864981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6545040|NCT00864981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6545041|NCT00865007|Ritonavir|ritonavir|mesh-list
6545042|NCT00865007|Lopinavir|lopinavir|mesh-list
6545043|NCT00865007|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6545044|NCT00865007|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6545045|NCT00865007|Protease Inhibitors|protease inhibitors|mesh-ancestor
6545046|NCT00865007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6545047|NCT00865007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545048|NCT00865007|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6545049|NCT00865007|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6545050|NCT00865007|Antiviral Agents|antiviral agents|mesh-ancestor
6545051|NCT00865007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6545052|NCT00865007|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6545053|NCT00865007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6545054|NCT00865033|Metformin|metformin|mesh-list
6545055|NCT00865033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6545056|NCT00865033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545057|NCT00865059|Gabapentin|gabapentin|mesh-list
6545058|NCT00865059|Analgesics|analgesics|mesh-ancestor
6545059|NCT00865059|Sensory System Agents|sensory system agents|mesh-ancestor
6545060|NCT00865059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6545061|NCT00865059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545062|NCT00865059|Anticonvulsants|anticonvulsants|mesh-ancestor
6545063|NCT00865059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6545064|NCT00865059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6545065|NCT00865059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6545066|NCT00865059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6545067|NCT00865059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6545068|NCT00865059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6545069|NCT00865059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6545070|NCT00865059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545071|NCT00865059|Antimanic Agents|antimanic agents|mesh-ancestor
6545072|NCT00865072|Metformin|metformin|mesh-list
6545073|NCT00865072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6545074|NCT00865072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545075|NCT00865085|Dexetimide|dexetimide|mesh-list
6545076|NCT00865085|Citalopram|citalopram|mesh-list
6545077|NCT00865085|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6545078|NCT00865085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6545079|NCT00865085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6545080|NCT00865085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545081|NCT00865085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6545082|NCT00865085|Serotonin Agents|serotonin agents|mesh-ancestor
6545083|NCT00865085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545084|NCT00865085|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6545085|NCT00865085|Antidepressive Agents|antidepressive agents|mesh-ancestor
6545086|NCT00865085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6545087|NCT00865085|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6545088|NCT00865085|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6545089|NCT00865085|Parasympatholytics|parasympatholytics|mesh-ancestor
6545090|NCT00865085|Autonomic Agents|autonomic agents|mesh-ancestor
6545091|NCT00865085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6545092|NCT00865085|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6545093|NCT00865085|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6545094|NCT00865085|Cholinergic Agents|cholinergic agents|mesh-ancestor
6545095|NCT00865111|Bupropion|bupropion|mesh-list
6545096|NCT00865111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6545097|NCT00865111|Antidepressive Agents|antidepressive agents|mesh-ancestor
6545098|NCT00865111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6545099|NCT00865111|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6545100|NCT00865111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6545101|NCT00865111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6545102|NCT00865111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545103|NCT00865111|Dopamine Agents|dopamine agents|mesh-ancestor
6545104|NCT00865111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6545105|NCT00865111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545106|NCT00865111|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6545107|NCT00865111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6545108|NCT00865111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6545109|NCT00865137|Tacrolimus|tacrolimus|mesh-list
6545110|NCT00865137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6545111|NCT00865137|Immunologic Factors|immunologic factors|mesh-ancestor
6545112|NCT00865137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545113|NCT00865137|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6545114|NCT00865137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6545115|NCT00865137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545116|NCT00865176|Eplerenone|eplerenone|mesh-list
6545117|NCT00865176|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6545118|NCT00865176|Hormone Antagonists|hormone antagonists|mesh-ancestor
6545119|NCT00865176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6545120|NCT00865176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545121|NCT00865176|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6545122|NCT00865176|Diuretics|diuretics|mesh-ancestor
6545123|NCT00865176|Natriuretic Agents|natriuretic agents|mesh-ancestor
6545124|NCT00865176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6545125|NCT00865215|Propranolol|propranolol|mesh-list
6545126|NCT00865215|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6655692|NCT01465113|Omeprazole|omeprazole|mesh-list
6545127|NCT00865215|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6545128|NCT00865215|Adrenergic Agents|adrenergic agents|mesh-ancestor
6545129|NCT00865215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6545130|NCT00865215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545131|NCT00865215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545132|NCT00865215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6545133|NCT00865215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6545134|NCT00865215|Vasodilator Agents|vasodilator agents|mesh-ancestor
6545135|NCT00865241|Metformin|metformin|mesh-list
6545136|NCT00865241|Glyburide|glyburide|mesh-list
6545137|NCT00865241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6545138|NCT00865241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545139|NCT00865267|Halobetasol|halobetasol|mesh-list
6545140|NCT00865267|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6545141|NCT00865319|Deoxyglucose|deoxyglucose|mesh-list
6545142|NCT00865319|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6545143|NCT00865319|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6545144|NCT00865319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545145|NCT00865319|Antimetabolites|antimetabolites|mesh-ancestor
6545146|NCT00865319|Antiviral Agents|antiviral agents|mesh-ancestor
6545147|NCT00865319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6545148|NCT00865371|Bupropion|bupropion|mesh-list
6545149|NCT00865371|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6545150|NCT00865371|Antidepressive Agents|antidepressive agents|mesh-ancestor
6545151|NCT00865371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6545152|NCT00865371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6545153|NCT00865371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6545154|NCT00865371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6545155|NCT00865371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545156|NCT00865371|Dopamine Agents|dopamine agents|mesh-ancestor
6545157|NCT00865371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6545158|NCT00865371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545159|NCT00865371|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6545160|NCT00865371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6545161|NCT00865371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6545162|NCT00865384|Mirtazapine|mirtazapine|mesh-list
6545163|NCT00865384|Antidepressive Agents|antidepressive agents|mesh-ancestor
6545164|NCT00865384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6545165|NCT00865384|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6545166|NCT00865384|Histamine Antagonists|histamine antagonists|mesh-ancestor
6545167|NCT00865384|Histamine Agents|histamine agents|mesh-ancestor
6545168|NCT00865384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6545169|NCT00865384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545170|NCT00865384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545171|NCT00865384|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6545172|NCT00865384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6545173|NCT00865384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6545174|NCT00865384|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6545175|NCT00865384|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6545176|NCT00865384|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6545177|NCT00865384|Adrenergic Agents|adrenergic agents|mesh-ancestor
6545178|NCT00865384|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6545179|NCT00865384|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6545180|NCT00865384|Serotonin Agents|serotonin agents|mesh-ancestor
6545181|NCT00865384|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6545182|NCT00865397|Insulin Detemir|insulin detemir|mesh-list
6545183|NCT00865397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6545184|NCT00865397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545185|NCT00865410|Bupropion|bupropion|mesh-list
6545186|NCT00865410|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6545187|NCT00865410|Antidepressive Agents|antidepressive agents|mesh-ancestor
6545188|NCT00865410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6545189|NCT00865410|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6545190|NCT00865410|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6545191|NCT00865410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6545192|NCT00865410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545193|NCT00865410|Dopamine Agents|dopamine agents|mesh-ancestor
6545194|NCT00865410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6545195|NCT00865410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545196|NCT00865410|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6545197|NCT00865410|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6545198|NCT00865410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6545199|NCT00865423|Gabapentin|gabapentin|mesh-list
6545200|NCT00865423|Analgesics|analgesics|mesh-ancestor
6545201|NCT00865423|Sensory System Agents|sensory system agents|mesh-ancestor
6545202|NCT00865423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6545203|NCT00865423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545204|NCT00865423|Anticonvulsants|anticonvulsants|mesh-ancestor
6545205|NCT00865423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6545206|NCT00865423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6545207|NCT00865423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6545208|NCT00865423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6019662|NCT00388414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6019663|NCT00388414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019664|NCT00388414|Analgesics|analgesics|mesh-ancestor
6019665|NCT00388414|Sensory System Agents|sensory system agents|mesh-ancestor
6019666|NCT00388414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6019667|NCT00388414|Antidepressive Agents|antidepressive agents|mesh-ancestor
6019668|NCT00388414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6019669|NCT00388414|Dopamine Agents|dopamine agents|mesh-ancestor
6019670|NCT00388505|Tobramycin|tobramycin|mesh-list
6019671|NCT00388505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6019672|NCT00388505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6019673|NCT00388583|Vaccines|vaccines|mesh-list
6019674|NCT00388583|Immunologic Factors|immunologic factors|mesh-ancestor
6019675|NCT00388583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019676|NCT00388674|Entecavir|entecavir|mesh-list
6019677|NCT00388674|Antiviral Agents|antiviral agents|mesh-ancestor
6019678|NCT00388674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6019679|NCT00388804|Leuprolide|leuprolide|mesh-list
6019680|NCT00388804|Goserelin|goserelin|mesh-list
6019681|NCT00388804|Flutamide|flutamide|mesh-list
6019682|NCT00388804|Bicalutamide|bicalutamide|mesh-list
6019683|NCT00388804|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6019684|NCT00388804|Fertility Agents|fertility agents|mesh-ancestor
6545209|NCT00865423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6545210|NCT00865423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6545211|NCT00865423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6545212|NCT00865423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545213|NCT00865423|Antimanic Agents|antimanic agents|mesh-ancestor
6545214|NCT00865436|Metformin|metformin|mesh-list
6545215|NCT00865436|Glyburide|glyburide|mesh-list
6545216|NCT00865436|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6019685|NCT00388804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6019686|NCT00388804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019687|NCT00388804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6545217|NCT00865436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545218|NCT00865449|Spironolactone|spironolactone|mesh-list
6545219|NCT00865449|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6545220|NCT00865449|Hormone Antagonists|hormone antagonists|mesh-ancestor
6545221|NCT00865449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6545222|NCT00865449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545223|NCT00865449|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6545224|NCT00865449|Diuretics|diuretics|mesh-ancestor
6545225|NCT00865449|Natriuretic Agents|natriuretic agents|mesh-ancestor
6545226|NCT00865462|Bupropion|bupropion|mesh-list
6545227|NCT00865462|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6545228|NCT00865462|Antidepressive Agents|antidepressive agents|mesh-ancestor
6545229|NCT00865462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6545230|NCT00865462|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6545231|NCT00865462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6545232|NCT00865462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6545233|NCT00865462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545234|NCT00865462|Dopamine Agents|dopamine agents|mesh-ancestor
6545235|NCT00865462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6545236|NCT00865462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545237|NCT00865462|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6545238|NCT00865462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6545239|NCT00865462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6545240|NCT00865475|Lopinavir|lopinavir|mesh-list
6545241|NCT00865475|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6545242|NCT00865475|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6545243|NCT00865475|Protease Inhibitors|protease inhibitors|mesh-ancestor
6545244|NCT00865475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6545245|NCT00865475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545246|NCT00865475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6545247|NCT00865475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6545248|NCT00865475|Antiviral Agents|antiviral agents|mesh-ancestor
6545249|NCT00865475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6545250|NCT00865475|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6545251|NCT00865475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6545252|NCT00865501|Spironolactone|spironolactone|mesh-list
6545253|NCT00865501|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6545254|NCT00865501|Hormone Antagonists|hormone antagonists|mesh-ancestor
6545255|NCT00865501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6545256|NCT00865501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545257|NCT00865501|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6545258|NCT00865501|Diuretics|diuretics|mesh-ancestor
6545259|NCT00865501|Natriuretic Agents|natriuretic agents|mesh-ancestor
6545260|NCT00865540|Prednisolone|prednisolone|mesh-list
6545261|NCT00865540|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6545262|NCT00865540|Methylprednisolone|methylprednisolone|mesh-list
6545263|NCT00865540|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6545264|NCT00865540|Prednisolone acetate|prednisolone acetate|mesh-list
6545265|NCT00865540|Ketorolac|ketorolac|mesh-list
6545266|NCT00865540|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6545267|NCT00865540|Nepafenac|nepafenac|mesh-list
6545268|NCT00865540|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6545269|NCT00865540|Prednisolone phosphate|prednisolone phosphate|mesh-list
6545270|NCT00865540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6545271|NCT00865540|Glucocorticoids|glucocorticoids|mesh-ancestor
6545272|NCT00865540|Hormones|hormones|mesh-ancestor
6545273|NCT00865540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6545274|NCT00865540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545275|NCT00865540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6545276|NCT00865540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6545277|NCT00865540|Antiemetics|antiemetics|mesh-ancestor
6545278|NCT00865540|Autonomic Agents|autonomic agents|mesh-ancestor
6545279|NCT00865540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6545280|NCT00865540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6545281|NCT00865540|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6545282|NCT00865540|Protective Agents|protective agents|mesh-ancestor
6545283|NCT00865540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6545284|NCT00865540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6545285|NCT00865540|Analgesics|analgesics|mesh-ancestor
6545286|NCT00865540|Sensory System Agents|sensory system agents|mesh-ancestor
6545287|NCT00865540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6545288|NCT00865540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6545289|NCT00865540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6545290|NCT00865540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545291|NCT00865605|Clobetasol|clobetasol|mesh-list
6545292|NCT00865605|Halobetasol|halobetasol|mesh-list
6545293|NCT00865605|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6545294|NCT00865605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6545295|NCT00865605|Glucocorticoids|glucocorticoids|mesh-ancestor
6545296|NCT00865605|Hormones|hormones|mesh-ancestor
6545297|NCT00865605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6545298|NCT00865605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545299|NCT00865618|Eplerenone|eplerenone|mesh-list
6545300|NCT00865618|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6545301|NCT00865618|Hormone Antagonists|hormone antagonists|mesh-ancestor
6545302|NCT00865618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6545303|NCT00865618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545304|NCT00865618|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6545305|NCT00865618|Diuretics|diuretics|mesh-ancestor
6545306|NCT00865618|Natriuretic Agents|natriuretic agents|mesh-ancestor
6545307|NCT00865618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6545308|NCT00865631|Gabapentin|gabapentin|mesh-list
6545309|NCT00865631|Analgesics|analgesics|mesh-ancestor
6545310|NCT00865631|Sensory System Agents|sensory system agents|mesh-ancestor
6545311|NCT00865631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6545312|NCT00865631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545313|NCT00865631|Anticonvulsants|anticonvulsants|mesh-ancestor
6545314|NCT00865631|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6545315|NCT00865631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6545316|NCT00865631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6545317|NCT00865631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6545318|NCT00865631|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6545319|NCT00865631|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6545320|NCT00865631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6545321|NCT00865631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545322|NCT00865631|Antimanic Agents|antimanic agents|mesh-ancestor
6545323|NCT00865644|Imiquimod|imiquimod|mesh-list
6545324|NCT00865644|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6545325|NCT00865644|Immunologic Factors|immunologic factors|mesh-ancestor
6545326|NCT00865644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545327|NCT00865644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6545328|NCT00865644|Interferon Inducers|interferon inducers|mesh-ancestor
6545329|NCT00865657|Alprazolam|alprazolam|mesh-list
6545330|NCT00865657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6545331|NCT00865657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6545332|NCT00865657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545333|NCT00865657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6545334|NCT00865657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6545335|NCT00865657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6545336|NCT00865657|GABA Modulators|gaba modulators|mesh-ancestor
6545337|NCT00865657|GABA Agents|gaba agents|mesh-ancestor
6545338|NCT00865657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6545339|NCT00865657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545340|NCT00865670|Azithromycin|azithromycin|mesh-list
6545341|NCT00865670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6545342|NCT00865670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6545343|NCT00865696|Mirtazapine|mirtazapine|mesh-list
6545344|NCT00865696|Antidepressive Agents|antidepressive agents|mesh-ancestor
6545345|NCT00865696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6545346|NCT00865696|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6545347|NCT00865696|Histamine Antagonists|histamine antagonists|mesh-ancestor
6545348|NCT00865696|Histamine Agents|histamine agents|mesh-ancestor
6545349|NCT00865696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6545350|NCT00865696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545351|NCT00865696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545352|NCT00865696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6545353|NCT00865696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6545354|NCT00865696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6545355|NCT00865696|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6545356|NCT00865696|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6545357|NCT00865696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6545358|NCT00865696|Adrenergic Agents|adrenergic agents|mesh-ancestor
6545359|NCT00865696|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6545360|NCT00865696|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6545361|NCT00865696|Serotonin Agents|serotonin agents|mesh-ancestor
6545362|NCT00865696|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6545363|NCT00865748|Metformin|metformin|mesh-list
6545364|NCT00865748|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6545365|NCT00865748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545366|NCT00865761|Alprazolam|alprazolam|mesh-list
6545367|NCT00865761|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6545368|NCT00865761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6545369|NCT00865761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545370|NCT00865761|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6545371|NCT00865761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6545372|NCT00865761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6545373|NCT00865761|GABA Modulators|gaba modulators|mesh-ancestor
6545374|NCT00865761|GABA Agents|gaba agents|mesh-ancestor
6545375|NCT00865761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6545376|NCT00865761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545377|NCT00865839|Metformin|metformin|mesh-list
6545378|NCT00865839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6545379|NCT00865839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545380|NCT00865852|Metformin|metformin|mesh-list
6545381|NCT00865852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6545382|NCT00865852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545383|NCT00865878|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6545384|NCT00865878|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6545385|NCT00865878|Dermatologic Agents|dermatologic agents|mesh-ancestor
6545386|NCT00865891|Nifedipine|nifedipine|mesh-list
6545387|NCT00865891|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6545388|NCT00865891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6545389|NCT00865891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545390|NCT00865891|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6545391|NCT00865891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545392|NCT00865891|Vasodilator Agents|vasodilator agents|mesh-ancestor
6545393|NCT00865891|Tocolytic Agents|tocolytic agents|mesh-ancestor
6545394|NCT00865891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6545395|NCT00865917|Metoprolol|metoprolol|mesh-list
6545396|NCT00865917|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
6545397|NCT00865917|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6545398|NCT00865917|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6545399|NCT00865917|Sympatholytics|sympatholytics|mesh-ancestor
6545400|NCT00865917|Autonomic Agents|autonomic agents|mesh-ancestor
6545401|NCT00865917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6545402|NCT00865917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545403|NCT00865917|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6545404|NCT00865917|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6545405|NCT00865917|Adrenergic Agents|adrenergic agents|mesh-ancestor
6545406|NCT00865917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6545407|NCT00865917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545408|NCT00865943|Dexetimide|dexetimide|mesh-list
6545409|NCT00865943|Citalopram|citalopram|mesh-list
6545410|NCT00865943|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6545411|NCT00865943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6545412|NCT00865943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6545413|NCT00865943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545414|NCT00865943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6545415|NCT00865943|Serotonin Agents|serotonin agents|mesh-ancestor
6545416|NCT00865943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545417|NCT00865943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6545418|NCT00865943|Antidepressive Agents|antidepressive agents|mesh-ancestor
6545419|NCT00865943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6545420|NCT00865943|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6545421|NCT00865943|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6545422|NCT00865943|Parasympatholytics|parasympatholytics|mesh-ancestor
6545423|NCT00865943|Autonomic Agents|autonomic agents|mesh-ancestor
6545424|NCT00865943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6545425|NCT00865943|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6545426|NCT00865943|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6545427|NCT00865943|Cholinergic Agents|cholinergic agents|mesh-ancestor
6545428|NCT00865982|Docetaxel|docetaxel|mesh-list
6545429|NCT00865982|Capecitabine|capecitabine|mesh-list
6545430|NCT00865982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6545431|NCT00865982|Tubulin Modulators|tubulin modulators|mesh-ancestor
6545432|NCT00865982|Antimitotic Agents|antimitotic agents|mesh-ancestor
6545433|NCT00865982|Mitosis Modulators|mitosis modulators|mesh-ancestor
6545434|NCT00865982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545435|NCT00865982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6545436|NCT00865982|Antimetabolites|antimetabolites|mesh-ancestor
6545437|NCT00866008|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6545438|NCT00866008|Ganirelix|ganirelix|mesh-list
6545439|NCT00866008|Luteolytic Agents|luteolytic agents|mesh-ancestor
6545440|NCT00866008|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6545441|NCT00866008|Contraceptive Agents|contraceptive agents|mesh-ancestor
6545442|NCT00866008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6545443|NCT00866008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545444|NCT00866008|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6545445|NCT00866008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6545446|NCT00866008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6545447|NCT00866008|Hormone Antagonists|hormone antagonists|mesh-ancestor
6545448|NCT00866008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6545449|NCT00866021|Ritonavir|ritonavir|mesh-list
6545450|NCT00866021|Lopinavir|lopinavir|mesh-list
6545451|NCT00866021|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6545452|NCT00866021|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6545453|NCT00866021|Protease Inhibitors|protease inhibitors|mesh-ancestor
6545454|NCT00866021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6545455|NCT00866021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545456|NCT00866021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6545457|NCT00866021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6545458|NCT00866021|Antiviral Agents|antiviral agents|mesh-ancestor
6545459|NCT00866021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6545460|NCT00866021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6545461|NCT00866021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6545462|NCT00866060|Memantine|memantine|mesh-list
6545463|NCT00866060|Donepezil|donepezil|mesh-list
6545464|NCT00866060|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6545465|NCT00866060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6545466|NCT00866060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545467|NCT00866060|Cholinergic Agents|cholinergic agents|mesh-ancestor
6545468|NCT00866060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6545469|NCT00866060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545470|NCT00866060|Nootropic Agents|nootropic agents|mesh-ancestor
6545471|NCT00866060|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6545472|NCT00866060|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6545473|NCT00866060|Dopamine Agents|dopamine agents|mesh-ancestor
6545474|NCT00866060|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6545475|NCT00866060|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6545476|NCT00866073|Decitabine|decitabine|mesh-list
6545477|NCT00866073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6545478|NCT00866073|Antimetabolites|antimetabolites|mesh-ancestor
6545479|NCT00866073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545480|NCT00866073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6545481|NCT00866073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6545482|NCT00866216|Azithromycin|azithromycin|mesh-list
6545483|NCT00866216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6545484|NCT00866216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6545485|NCT00866229|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6545486|NCT00866229|Simvastatin|simvastatin|mesh-list
6545487|NCT00866229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6545488|NCT00866229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6545489|NCT00866229|Antimetabolites|antimetabolites|mesh-ancestor
6545490|NCT00866229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442345|NCT00375466|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6442346|NCT00375466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6442347|NCT00375466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442348|NCT00375466|Hemostatics|hemostatics|mesh-ancestor
6442349|NCT00375466|Coagulants|coagulants|mesh-ancestor
6442350|NCT00375557|Valproic Acid|valproic acid|mesh-list
6442351|NCT00375557|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6442352|NCT00375557|Antidepressive Agents|antidepressive agents|mesh-ancestor
6442353|NCT00375557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6442354|NCT00375557|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6442355|NCT00375557|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6442356|NCT00375557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6442357|NCT00375557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545491|NCT00866229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6545492|NCT00866229|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6545493|NCT00866229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6545494|NCT00866437|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6545495|NCT00866437|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6545496|NCT00866437|Estropipate|estropipate|mesh-list
6545497|NCT00866437|Estradiol|estradiol|mesh-list
6545498|NCT00866437|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6545499|NCT00866437|Estrone|estrone|mesh-list
6545500|NCT00866437|Progesterone|progesterone|mesh-list
6545501|NCT00866437|Estrogens|estrogens|mesh-ancestor
6545502|NCT00866437|Hormones|hormones|mesh-ancestor
6545503|NCT00866437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6545504|NCT00866437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545505|NCT00866437|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6545506|NCT00866437|Contraceptive Agents|contraceptive agents|mesh-ancestor
6545507|NCT00866437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6545508|NCT00866437|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6545509|NCT00866437|Progestins|progestins|mesh-ancestor
6545510|NCT00866450|Calcium, Dietary|calcium, dietary|mesh-list
6545511|NCT00866450|Calcium|calcium|mesh-list
6545512|NCT00866450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6545513|NCT00866450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545514|NCT00866450|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6545515|NCT00866463|Sildenafil Citrate|sildenafil citrate|mesh-list
6545516|NCT00866463|Vasodilator Agents|vasodilator agents|mesh-ancestor
6545517|NCT00866463|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6545518|NCT00866463|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6545519|NCT00866463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6545520|NCT00866463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545521|NCT00866463|Urological Agents|urological agents|mesh-ancestor
6545522|NCT00866515|Ketoconazole|ketoconazole|mesh-list
6545523|NCT00866515|Antifungal Agents|antifungal agents|mesh-ancestor
6545524|NCT00866515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6545525|NCT00866515|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6545526|NCT00866515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6545527|NCT00866515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6545528|NCT00866515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545529|NCT00866515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6545530|NCT00866515|Hormone Antagonists|hormone antagonists|mesh-ancestor
6545531|NCT00866515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6545532|NCT00866515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545533|NCT00866515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6545534|NCT00866528|Paclitaxel|paclitaxel|mesh-list
6545535|NCT00866528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6442358|NCT00375557|Anticonvulsants|anticonvulsants|mesh-ancestor
6545536|NCT00866528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6545537|NCT00866528|Tubulin Modulators|tubulin modulators|mesh-ancestor
6545538|NCT00866528|Antimitotic Agents|antimitotic agents|mesh-ancestor
6545539|NCT00866528|Mitosis Modulators|mitosis modulators|mesh-ancestor
6545540|NCT00866528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545541|NCT00866554|Tamoxifen|tamoxifen|mesh-list
6545542|NCT00866554|Bicalutamide|bicalutamide|mesh-list
6545543|NCT00866554|Dutasteride|dutasteride|mesh-list
6545544|NCT00866554|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6545545|NCT00866554|Hormone Antagonists|hormone antagonists|mesh-ancestor
6545546|NCT00866554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6545547|NCT00866554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545548|NCT00866554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6545549|NCT00866554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6545550|NCT00866554|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6545551|NCT00866554|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6545552|NCT00866554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6545553|NCT00866554|Androgen Antagonists|androgen antagonists|mesh-ancestor
6545554|NCT00866554|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6545555|NCT00866554|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6545556|NCT00866554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6545557|NCT00866554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545558|NCT00866593|Dexetimide|dexetimide|mesh-list
6545559|NCT00866593|Citalopram|citalopram|mesh-list
6545560|NCT00866593|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6545561|NCT00866593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6545562|NCT00866593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6545563|NCT00866593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545564|NCT00866593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6545565|NCT00866593|Serotonin Agents|serotonin agents|mesh-ancestor
6545566|NCT00866593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545567|NCT00866593|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6545568|NCT00866593|Antidepressive Agents|antidepressive agents|mesh-ancestor
6545569|NCT00866593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6545570|NCT00866593|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6545571|NCT00866593|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6545572|NCT00866593|Parasympatholytics|parasympatholytics|mesh-ancestor
6545573|NCT00866593|Autonomic Agents|autonomic agents|mesh-ancestor
6545574|NCT00866593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6545575|NCT00866593|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6545576|NCT00866593|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6545577|NCT00866593|Cholinergic Agents|cholinergic agents|mesh-ancestor
6545578|NCT00866645|Haloperidol|haloperidol|mesh-list
6545579|NCT00866645|Haloperidol decanoate|haloperidol decanoate|mesh-list
6545580|NCT00866645|Sulpiride|sulpiride|mesh-list
6545581|NCT00866645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6545582|NCT00866645|Antiemetics|antiemetics|mesh-ancestor
6545583|NCT00866645|Autonomic Agents|autonomic agents|mesh-ancestor
6545584|NCT00866645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6545585|NCT00866645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545586|NCT00866645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6545587|NCT00866645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6545588|NCT00866645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6545589|NCT00866645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6545590|NCT00866645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6545591|NCT00866645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6545592|NCT00866645|Dopamine Agents|dopamine agents|mesh-ancestor
6545593|NCT00866645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6545594|NCT00866645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545595|NCT00866645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6655693|NCT01465113|Micronutrients|micronutrients|mesh-ancestor
6545596|NCT00866645|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6545597|NCT00866645|Antidepressive Agents|antidepressive agents|mesh-ancestor
6655694|NCT01465113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655695|NCT01465113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6655696|NCT01465113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6655697|NCT01465113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6655698|NCT01465113|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6655699|NCT01465113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6655700|NCT01465113|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6655701|NCT01465113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6655702|NCT01465113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655703|NCT01465152|Metformin|metformin|mesh-list
6655704|NCT01465152|Repaglinide|repaglinide|mesh-list
6655705|NCT01465152|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6655706|NCT01465152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655707|NCT01465256|Aspirin|aspirin|mesh-list
6655708|NCT01465256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6655709|NCT01465256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6655710|NCT01465256|Analgesics|analgesics|mesh-ancestor
6655711|NCT01465256|Sensory System Agents|sensory system agents|mesh-ancestor
6655712|NCT01465256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6655713|NCT01465256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655714|NCT01465256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6655715|NCT01465256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6655716|NCT01465256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6655717|NCT01465256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6655718|NCT01465256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655719|NCT01465256|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6655720|NCT01465256|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6655721|NCT01465256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6655722|NCT01465256|Antipyretics|antipyretics|mesh-ancestor
6655723|NCT01465373|Progesterone|progesterone|mesh-list
6655724|NCT01465373|Progestins|progestins|mesh-ancestor
6655725|NCT01465373|Hormones|hormones|mesh-ancestor
6655726|NCT01465373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6655727|NCT01465373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655728|NCT01465399|Mitogens|mitogens|mesh-list
6655729|NCT01465399|Mitosis Modulators|mitosis modulators|mesh-ancestor
6655730|NCT01465399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655731|NCT01465438|Adalimumab|adalimumab|mesh-list
6655732|NCT01465438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6655733|NCT01465438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6655734|NCT01465503|Heparin|heparin|mesh-list
6655735|NCT01465503|Calcium heparin|calcium heparin|mesh-list
6655736|NCT01465503|Hirudins|hirudins|mesh-list
5725039|NCT03183310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6545598|NCT00866684|Cyclosporine|cyclosporine|mesh-list
6545599|NCT00866684|Sirolimus|sirolimus|mesh-list
6545600|NCT00866684|Azathioprine|azathioprine|mesh-list
6545601|NCT00866684|Tacrolimus|tacrolimus|mesh-list
6545602|NCT00866684|Cyclosporins|cyclosporins|mesh-list
6545603|NCT00866684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6545604|NCT00866684|Immunologic Factors|immunologic factors|mesh-ancestor
6545605|NCT00866684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545606|NCT00866684|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6545607|NCT00866684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6545608|NCT00866684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545609|NCT00866684|Antifungal Agents|antifungal agents|mesh-ancestor
6545610|NCT00866684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6545611|NCT00866684|Dermatologic Agents|dermatologic agents|mesh-ancestor
6545612|NCT00866684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6545613|NCT00866684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6545614|NCT00866684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6545615|NCT00866684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6545616|NCT00866684|Antimetabolites|antimetabolites|mesh-ancestor
6545617|NCT00866684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6545618|NCT00866736|Dasatinib|dasatinib|mesh-list
6545619|NCT00866736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6545620|NCT00866736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6545621|NCT00866736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6545622|NCT00866736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545623|NCT00866762|Vorinostat|vorinostat|mesh-list
6545624|NCT00866762|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
6545625|NCT00866762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6545626|NCT00866762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545627|NCT00866762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6545628|NCT00866840|Riluzole|riluzole|mesh-list
6545629|NCT00866840|Anticonvulsants|anticonvulsants|mesh-ancestor
6545630|NCT00866840|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6545631|NCT00866840|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6545632|NCT00866840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6545633|NCT00866840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545634|NCT00866840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545635|NCT00866840|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6545636|NCT00866840|Protective Agents|protective agents|mesh-ancestor
6545637|NCT00866853|Simeprevir|simeprevir|mesh-list
6545638|NCT00866853|Antiviral Agents|antiviral agents|mesh-ancestor
6545639|NCT00866853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6545640|NCT00866853|Protease Inhibitors|protease inhibitors|mesh-ancestor
6545641|NCT00866853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6545642|NCT00866853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545643|NCT00866866|Acetylcysteine|acetylcysteine|mesh-list
6545644|NCT00866866|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6545645|NCT00866866|Antiviral Agents|antiviral agents|mesh-ancestor
6545646|NCT00866866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6545647|NCT00866866|Expectorants|expectorants|mesh-ancestor
6545648|NCT00866866|Respiratory System Agents|respiratory system agents|mesh-ancestor
6545649|NCT00866866|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6545650|NCT00866866|Antioxidants|antioxidants|mesh-ancestor
6545651|NCT00866866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545652|NCT00866866|Protective Agents|protective agents|mesh-ancestor
6545653|NCT00866866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545654|NCT00866866|Antidotes|antidotes|mesh-ancestor
6545655|NCT00866944|Leucovorin|leucovorin|mesh-list
6545656|NCT00866944|Fluorouracil|fluorouracil|mesh-list
6545657|NCT00866944|Oxaliplatin|oxaliplatin|mesh-list
6545658|NCT00866944|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6545659|NCT00866944|Antimetabolites|antimetabolites|mesh-ancestor
6545660|NCT00866944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545661|NCT00866944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6545662|NCT00866944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6545663|NCT00866944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6545664|NCT00866944|Immunologic Factors|immunologic factors|mesh-ancestor
6545665|NCT00866944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545666|NCT00866944|Antidotes|antidotes|mesh-ancestor
6545667|NCT00866944|Protective Agents|protective agents|mesh-ancestor
6545668|NCT00866944|Vitamin B Complex|vitamin b complex|mesh-ancestor
6545669|NCT00866944|Vitamins|vitamins|mesh-ancestor
6545670|NCT00866944|Micronutrients|micronutrients|mesh-ancestor
6545671|NCT00866983|Sildenafil Citrate|sildenafil citrate|mesh-list
6545672|NCT00866983|Vasodilator Agents|vasodilator agents|mesh-ancestor
6545673|NCT00866983|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6545674|NCT00866983|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6545675|NCT00866983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6545676|NCT00866983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545677|NCT00866983|Urological Agents|urological agents|mesh-ancestor
6545678|NCT00866996|Methylphenidate|methylphenidate|mesh-list
6545679|NCT00866996|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6545680|NCT00866996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6545681|NCT00866996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545682|NCT00866996|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6545683|NCT00866996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6545684|NCT00866996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6545685|NCT00866996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545686|NCT00866996|Dopamine Agents|dopamine agents|mesh-ancestor
6545687|NCT00866996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6545688|NCT00866996|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6545689|NCT00866996|Adrenergic Agents|adrenergic agents|mesh-ancestor
6545690|NCT00867061|ON 01910|on 01910|mesh-list
6545691|NCT00867061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6545692|NCT00867061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6545693|NCT00867061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6545694|NCT00867061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545695|NCT00867126|Pioglitazone|pioglitazone|mesh-list
6545696|NCT00867126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6545697|NCT00867126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545698|NCT00867152|Ritonavir|ritonavir|mesh-list
6545699|NCT00867152|Lopinavir|lopinavir|mesh-list
6545700|NCT00867152|Darunavir|darunavir|mesh-list
6545701|NCT00867152|Dolutegravir|dolutegravir|mesh-list
6545702|NCT00867152|Etravirine|etravirine|mesh-list
6545703|NCT00867152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6545704|NCT00867152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6545705|NCT00867152|Protease Inhibitors|protease inhibitors|mesh-ancestor
6545706|NCT00867152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6545707|NCT00867152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545708|NCT00867152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6545709|NCT00867152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6545710|NCT00867152|Antiviral Agents|antiviral agents|mesh-ancestor
6545711|NCT00867152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6545712|NCT00867152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6545713|NCT00867152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6545714|NCT00867152|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6545715|NCT00867152|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6545716|NCT00867152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6545717|NCT00867152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6545718|NCT00867295|Cefazolin|cefazolin|mesh-list
6545719|NCT00867295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6545720|NCT00867295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6545721|NCT00867672|Decitabine|decitabine|mesh-list
6545722|NCT00867672|Tretinoin|tretinoin|mesh-list
6545723|NCT00867672|Valproic Acid|valproic acid|mesh-list
6545724|NCT00867672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6545725|NCT00867672|Antimetabolites|antimetabolites|mesh-ancestor
6545726|NCT00867672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545727|NCT00867672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6545728|NCT00867672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6545729|NCT00867672|Keratolytic Agents|keratolytic agents|mesh-ancestor
6545730|NCT00867672|Dermatologic Agents|dermatologic agents|mesh-ancestor
6545731|NCT00867672|Anticonvulsants|anticonvulsants|mesh-ancestor
6545732|NCT00867672|GABA Agents|gaba agents|mesh-ancestor
6545733|NCT00867672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6545734|NCT00867672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545735|NCT00867672|Antimanic Agents|antimanic agents|mesh-ancestor
6545736|NCT00867672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6545737|NCT00867672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6545738|NCT00867672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6545739|NCT00867737|Fluticasone|fluticasone|mesh-list
6545740|NCT00867737|Budesonide|budesonide|mesh-list
6545741|NCT00867737|Formoterol Fumarate|formoterol fumarate|mesh-list
6545742|NCT00867737|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6545743|NCT00867737|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6545744|NCT00867737|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6545745|NCT00867737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6545746|NCT00867737|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6545747|NCT00867737|Autonomic Agents|autonomic agents|mesh-ancestor
6545748|NCT00867737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6545749|NCT00867737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545750|NCT00867737|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6545751|NCT00867737|Respiratory System Agents|respiratory system agents|mesh-ancestor
6545752|NCT00867737|Dermatologic Agents|dermatologic agents|mesh-ancestor
6545753|NCT00867737|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6545754|NCT00867737|Glucocorticoids|glucocorticoids|mesh-ancestor
6545755|NCT00867737|Hormones|hormones|mesh-ancestor
6545756|NCT00867737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6545757|NCT00867737|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6545758|NCT00867737|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6545759|NCT00867737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6545760|NCT00867737|Adrenergic Agents|adrenergic agents|mesh-ancestor
6545761|NCT00867737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6545762|NCT00867737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545763|NCT00867737|Sympathomimetics|sympathomimetics|mesh-ancestor
6545764|NCT00867867|Ferrous fumarate|ferrous fumarate|mesh-list
6545765|NCT00867867|Trace Elements|trace elements|mesh-ancestor
6545766|NCT00867867|Micronutrients|micronutrients|mesh-ancestor
6545767|NCT00867867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545768|NCT00868010|Donepezil|donepezil|mesh-list
6545769|NCT00868010|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6545770|NCT00868010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6545771|NCT00868010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545772|NCT00868010|Cholinergic Agents|cholinergic agents|mesh-ancestor
6545773|NCT00868010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6545774|NCT00868010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545775|NCT00868010|Nootropic Agents|nootropic agents|mesh-ancestor
6545776|NCT00868023|Formoterol Fumarate|formoterol fumarate|mesh-list
6545777|NCT00868023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6545778|NCT00868023|Autonomic Agents|autonomic agents|mesh-ancestor
6545779|NCT00868023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6545780|NCT00868023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545781|NCT00868023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6545782|NCT00868023|Respiratory System Agents|respiratory system agents|mesh-ancestor
6545783|NCT00868023|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6545784|NCT00868023|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6545785|NCT00868023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6545786|NCT00868023|Adrenergic Agents|adrenergic agents|mesh-ancestor
6545787|NCT00868023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6545788|NCT00868023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545789|NCT00868062|Polygeline|polygeline|mesh-list
6545790|NCT00868062|Plasma Substitutes|plasma substitutes|mesh-ancestor
6545791|NCT00868062|Blood Substitutes|blood substitutes|mesh-ancestor
6545792|NCT00868153|Levonorgestrel|levonorgestrel|mesh-list
6545793|NCT00868153|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6545794|NCT00868153|Contraceptive Agents|contraceptive agents|mesh-ancestor
6545795|NCT00868153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6545796|NCT00868153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545797|NCT00868153|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6545798|NCT00868153|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6545799|NCT00868153|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6545800|NCT00868179|Dabigatran|dabigatran|mesh-list
6545801|NCT00868179|Antithrombins|antithrombins|mesh-ancestor
6545802|NCT00868179|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6545803|NCT00868179|Protease Inhibitors|protease inhibitors|mesh-ancestor
6545804|NCT00868179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6545805|NCT00868179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545806|NCT00868179|Anticoagulants|anticoagulants|mesh-ancestor
6545807|NCT00868283|Cerebrolysin|cerebrolysin|mesh-list
6545808|NCT00868283|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6545809|NCT00868283|Protective Agents|protective agents|mesh-ancestor
6545810|NCT00868283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545811|NCT00868283|Nootropic Agents|nootropic agents|mesh-ancestor
6545812|NCT00868413|Cyclophosphamide|cyclophosphamide|mesh-list
6545813|NCT00868413|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6545814|NCT00868413|Rituximab|rituximab|mesh-list
6545815|NCT00868413|Fludarabine|fludarabine|mesh-list
6545816|NCT00868413|Navitoclax|navitoclax|mesh-list
6545817|NCT00868413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6545818|NCT00868413|Immunologic Factors|immunologic factors|mesh-ancestor
6545819|NCT00868413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545820|NCT00868413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6545821|NCT00868413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6545822|NCT00868413|Alkylating Agents|alkylating agents|mesh-ancestor
6545823|NCT00868413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545824|NCT00868413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6545825|NCT00868413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6545826|NCT00868413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6545827|NCT00868426|Budesonide|budesonide|mesh-list
6545828|NCT00868426|Formoterol Fumarate|formoterol fumarate|mesh-list
6545829|NCT00868426|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6545830|NCT00868426|Charcoal|charcoal|mesh-list
6545831|NCT00868426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6545832|NCT00868426|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6545833|NCT00868426|Autonomic Agents|autonomic agents|mesh-ancestor
6545834|NCT00868426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6545835|NCT00868426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545836|NCT00868426|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6545837|NCT00868426|Respiratory System Agents|respiratory system agents|mesh-ancestor
6545838|NCT00868426|Glucocorticoids|glucocorticoids|mesh-ancestor
6545839|NCT00868426|Hormones|hormones|mesh-ancestor
6545840|NCT00868426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6545841|NCT00868426|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6545842|NCT00868426|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6545843|NCT00868426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6545844|NCT00868426|Adrenergic Agents|adrenergic agents|mesh-ancestor
6545845|NCT00868426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6545846|NCT00868426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545847|NCT00868426|Antidotes|antidotes|mesh-ancestor
6545848|NCT00868426|Protective Agents|protective agents|mesh-ancestor
6545849|NCT00868465|Lumefantrine|lumefantrine|mesh-list
6545850|NCT00868465|Artemether|artemether|mesh-list
6545851|NCT00868465|Piperaquine|piperaquine|mesh-list
6545852|NCT00868465|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6545853|NCT00868465|Artenimol|artenimol|mesh-list
6545854|NCT00868465|Antimalarials|antimalarials|mesh-ancestor
6545855|NCT00868465|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6545856|NCT00868465|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6545857|NCT00868465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6545858|NCT00868491|Cisplatin|cisplatin|mesh-list
6545859|NCT00868491|Docetaxel|docetaxel|mesh-list
6545860|NCT00868491|Fluorouracil|fluorouracil|mesh-list
6545861|NCT00868491|Cetuximab|cetuximab|mesh-list
6545862|NCT00868491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6545863|NCT00868491|Tubulin Modulators|tubulin modulators|mesh-ancestor
6545864|NCT00868491|Antimitotic Agents|antimitotic agents|mesh-ancestor
6545865|NCT00868491|Mitosis Modulators|mitosis modulators|mesh-ancestor
6545866|NCT00868491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545867|NCT00868491|Antimetabolites|antimetabolites|mesh-ancestor
6545868|NCT00868491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6545869|NCT00868491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6545870|NCT00868491|Immunologic Factors|immunologic factors|mesh-ancestor
6545871|NCT00868491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545872|NCT00868491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6545873|NCT00868569|Leucovorin|leucovorin|mesh-list
6545874|NCT00868569|Fluorouracil|fluorouracil|mesh-list
6545875|NCT00868569|Oxaliplatin|oxaliplatin|mesh-list
6545876|NCT00868569|Antimetabolites|antimetabolites|mesh-ancestor
6545877|NCT00868569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545878|NCT00868569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6545879|NCT00868569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6545880|NCT00868569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6545881|NCT00868569|Immunologic Factors|immunologic factors|mesh-ancestor
6545882|NCT00868569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545883|NCT00868569|Antidotes|antidotes|mesh-ancestor
6545884|NCT00868569|Protective Agents|protective agents|mesh-ancestor
6545885|NCT00868569|Vitamin B Complex|vitamin b complex|mesh-ancestor
6545886|NCT00868569|Vitamins|vitamins|mesh-ancestor
6545887|NCT00868569|Micronutrients|micronutrients|mesh-ancestor
6545888|NCT00868634|Bevacizumab|bevacizumab|mesh-list
6545889|NCT00868634|Capecitabine|capecitabine|mesh-list
6545890|NCT00868634|Vinorelbine|vinorelbine|mesh-list
6545891|NCT00868634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6545892|NCT00868634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6545893|NCT00868634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6545894|NCT00868634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6545895|NCT00868634|Growth Substances|growth substances|mesh-ancestor
6545896|NCT00868634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545897|NCT00868634|Growth Inhibitors|growth inhibitors|mesh-ancestor
6545898|NCT00868634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6545899|NCT00868634|Antimetabolites|antimetabolites|mesh-ancestor
6545900|NCT00868634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545901|NCT00868634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6545902|NCT00868634|Tubulin Modulators|tubulin modulators|mesh-ancestor
6545903|NCT00868634|Antimitotic Agents|antimitotic agents|mesh-ancestor
6545904|NCT00868634|Mitosis Modulators|mitosis modulators|mesh-ancestor
6655737|NCT01465503|Bivalirudin|bivalirudin|mesh-list
6655738|NCT01465503|Anticoagulants|anticoagulants|mesh-ancestor
6655739|NCT01465503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6655740|NCT01465503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6545905|NCT00868738|Vitamin D|vitamin d|mesh-list
6545906|NCT00868738|Vitamins|vitamins|mesh-ancestor
6545907|NCT00868738|Micronutrients|micronutrients|mesh-ancestor
6545908|NCT00868738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545909|NCT00868738|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6545910|NCT00868764|Granisetron|granisetron|mesh-list
6545911|NCT00868764|Antiemetics|antiemetics|mesh-ancestor
6545912|NCT00868764|Autonomic Agents|autonomic agents|mesh-ancestor
6545913|NCT00868764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6545914|NCT00868764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545915|NCT00868764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6545916|NCT00868764|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6545917|NCT00868764|Serotonin Agents|serotonin agents|mesh-ancestor
6545918|NCT00868764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6545919|NCT00868764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545920|NCT00868816|Oxaliplatin|oxaliplatin|mesh-list
6545921|NCT00868816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6545922|NCT00868829|Chromium|chromium|mesh-list
6545923|NCT00868829|Sirolimus|sirolimus|mesh-list
6545924|NCT00868829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6545925|NCT00868829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6545926|NCT00868829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6545927|NCT00868829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6545928|NCT00868829|Antifungal Agents|antifungal agents|mesh-ancestor
6545929|NCT00868829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6545930|NCT00868829|Immunologic Factors|immunologic factors|mesh-ancestor
6545931|NCT00868829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545932|NCT00868829|Trace Elements|trace elements|mesh-ancestor
6545933|NCT00868829|Micronutrients|micronutrients|mesh-ancestor
6545934|NCT00868855|Bradykinin|bradykinin|mesh-list
6545935|NCT00868855|Kininogens|kininogens|mesh-list
6545936|NCT00868855|Vasodilator Agents|vasodilator agents|mesh-ancestor
6545937|NCT00868855|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
6545938|NCT00868855|Protease Inhibitors|protease inhibitors|mesh-ancestor
6545939|NCT00868855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6545940|NCT00868855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545941|NCT00868894|Latanoprost|latanoprost|mesh-list
6545942|NCT00868894|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6545943|NCT00868894|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6545944|NCT00868907|Risedronic Acid|risedronic acid|mesh-list
6545945|NCT00868907|Etidronic Acid|etidronic acid|mesh-list
6545946|NCT00868907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6545947|NCT00868907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6545948|NCT00868907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545949|NCT00868907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6545950|NCT00868907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545951|NCT00868907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6545952|NCT00868946|Ribavirin|ribavirin|mesh-list
6545953|NCT00868946|Antimetabolites|antimetabolites|mesh-ancestor
6545954|NCT00868946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545955|NCT00868946|Antiviral Agents|antiviral agents|mesh-ancestor
6545956|NCT00868946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6545957|NCT00868985|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
6545958|NCT00868985|Laxatives|laxatives|mesh-ancestor
6545959|NCT00868985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6545960|NCT00869063|Diclofenac|diclofenac|mesh-list
6545961|NCT00869063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6442359|NCT00375557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6442360|NCT00375557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442361|NCT00375557|GABA Agents|gaba agents|mesh-ancestor
6442362|NCT00375557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6545962|NCT00869063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6545963|NCT00869063|Analgesics|analgesics|mesh-ancestor
6545964|NCT00869063|Sensory System Agents|sensory system agents|mesh-ancestor
6545965|NCT00869063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6545966|NCT00869063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545967|NCT00869063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6442363|NCT00375557|Antimanic Agents|antimanic agents|mesh-ancestor
6442364|NCT00375583|Albendazole|albendazole|mesh-list
6442365|NCT00375583|Anthelmintics|anthelmintics|mesh-ancestor
6442366|NCT00375583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6442367|NCT00375583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6442368|NCT00375583|Anticestodal Agents|anticestodal agents|mesh-ancestor
6442369|NCT00375583|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6442370|NCT00375583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6442371|NCT00375583|Tubulin Modulators|tubulin modulators|mesh-ancestor
6442372|NCT00375583|Antimitotic Agents|antimitotic agents|mesh-ancestor
6442373|NCT00375583|Mitosis Modulators|mitosis modulators|mesh-ancestor
6442374|NCT00375583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545968|NCT00869063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6545969|NCT00869063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6545970|NCT00869063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6545971|NCT00869063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545972|NCT00869180|Diclofenac|diclofenac|mesh-list
6545973|NCT00869180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6545974|NCT00869180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6545975|NCT00869180|Analgesics|analgesics|mesh-ancestor
6545976|NCT00869180|Sensory System Agents|sensory system agents|mesh-ancestor
6545977|NCT00869180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6545978|NCT00869180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545979|NCT00869180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6545980|NCT00869180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6545981|NCT00869180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6545982|NCT00869180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6545983|NCT00869180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545984|NCT00869193|Grape Seed Extract|grape seed extract|mesh-list
6545985|NCT00869193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6545986|NCT00869193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6545987|NCT00869193|Antioxidants|antioxidants|mesh-ancestor
6545988|NCT00869193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6545989|NCT00869193|Protective Agents|protective agents|mesh-ancestor
6545990|NCT00869193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545991|NCT00869219|Nepafenac|nepafenac|mesh-list
6545992|NCT00869219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6545993|NCT00869219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6545994|NCT00869219|Analgesics|analgesics|mesh-ancestor
6545995|NCT00869219|Sensory System Agents|sensory system agents|mesh-ancestor
6545996|NCT00869219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6545997|NCT00869219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6545998|NCT00869219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6545999|NCT00869219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6546000|NCT00869232|Thalidomide|thalidomide|mesh-list
6546001|NCT00869232|Dexamethasone|dexamethasone|mesh-list
6546002|NCT00869232|Cyclophosphamide|cyclophosphamide|mesh-list
6546003|NCT00869232|Melphalan|melphalan|mesh-list
6546004|NCT00869232|Doxorubicin|doxorubicin|mesh-list
6546005|NCT00869232|Etoposide|etoposide|mesh-list
6546006|NCT00869232|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6546007|NCT00869232|Bortezomib|bortezomib|mesh-list
6546008|NCT00869232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6546009|NCT00869232|Immunologic Factors|immunologic factors|mesh-ancestor
6546010|NCT00869232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546011|NCT00869232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6546012|NCT00869232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6546013|NCT00869232|Alkylating Agents|alkylating agents|mesh-ancestor
6546014|NCT00869232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546015|NCT00869232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6546016|NCT00869232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6546017|NCT00869232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6546018|NCT00869232|Antiemetics|antiemetics|mesh-ancestor
6546019|NCT00869232|Autonomic Agents|autonomic agents|mesh-ancestor
6546020|NCT00869232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6546021|NCT00869232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6546022|NCT00869232|Glucocorticoids|glucocorticoids|mesh-ancestor
6546023|NCT00869232|Hormones|hormones|mesh-ancestor
6546024|NCT00869232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6546025|NCT00869232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6546026|NCT00869232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6546027|NCT00869232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6546028|NCT00869232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6546029|NCT00869232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6546030|NCT00869232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6546031|NCT00869232|Leprostatic Agents|leprostatic agents|mesh-ancestor
6546032|NCT00869232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6546033|NCT00869232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6546034|NCT00869232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6546035|NCT00869232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6546036|NCT00869232|Growth Substances|growth substances|mesh-ancestor
6546037|NCT00869232|Growth Inhibitors|growth inhibitors|mesh-ancestor
6546038|NCT00869271|Leucovorin|leucovorin|mesh-list
6546039|NCT00869271|Fluorouracil|fluorouracil|mesh-list
6546040|NCT00869271|Oxaliplatin|oxaliplatin|mesh-list
6546041|NCT00869271|Antimetabolites|antimetabolites|mesh-ancestor
6546042|NCT00869271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546043|NCT00869271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6546044|NCT00869271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6546045|NCT00869271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6546046|NCT00869271|Immunologic Factors|immunologic factors|mesh-ancestor
6546047|NCT00869271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546048|NCT00869271|Antidotes|antidotes|mesh-ancestor
6546049|NCT00869271|Protective Agents|protective agents|mesh-ancestor
6546050|NCT00869271|Vitamin B Complex|vitamin b complex|mesh-ancestor
6546051|NCT00869271|Vitamins|vitamins|mesh-ancestor
6546052|NCT00869271|Micronutrients|micronutrients|mesh-ancestor
6546053|NCT00869310|Dexamethasone|dexamethasone|mesh-list
6546054|NCT00869310|Dexamethasone acetate|dexamethasone acetate|mesh-list
6546055|NCT00869310|Aprepitant|aprepitant|mesh-list
6546056|NCT00869310|Metoclopramide|metoclopramide|mesh-list
6546057|NCT00869310|BB 1101|bb 1101|mesh-list
6546058|NCT00869310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6546059|NCT00869310|Antiemetics|antiemetics|mesh-ancestor
6546060|NCT00869310|Autonomic Agents|autonomic agents|mesh-ancestor
6546061|NCT00869310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6546062|NCT00869310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546063|NCT00869310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6546064|NCT00869310|Glucocorticoids|glucocorticoids|mesh-ancestor
6546065|NCT00869310|Hormones|hormones|mesh-ancestor
6546066|NCT00869310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6442375|NCT00375583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6442376|NCT00375596|Ketotifen|ketotifen|mesh-list
6442377|NCT00375596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
6546067|NCT00869310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6546068|NCT00869310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6546069|NCT00869310|Protease Inhibitors|protease inhibitors|mesh-ancestor
6546070|NCT00869310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6546071|NCT00869310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546072|NCT00869310|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6546073|NCT00869310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6546074|NCT00869310|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6546075|NCT00869310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6546076|NCT00869310|Dopamine Agents|dopamine agents|mesh-ancestor
6546077|NCT00869427|Ascorbic Acid|ascorbic acid|mesh-list
6546078|NCT00869427|Vitamins|vitamins|mesh-ancestor
6546079|NCT00869427|Micronutrients|micronutrients|mesh-ancestor
6546080|NCT00869427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546081|NCT00869427|Antioxidants|antioxidants|mesh-ancestor
6546082|NCT00869427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546083|NCT00869427|Protective Agents|protective agents|mesh-ancestor
6546084|NCT00869492|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6546085|NCT00869492|Dermatologic Agents|dermatologic agents|mesh-ancestor
6546086|NCT00869570|Capecitabine|capecitabine|mesh-list
6546087|NCT00869570|Sorafenib|sorafenib|mesh-list
6546088|NCT00869570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6546089|NCT00869570|Antimetabolites|antimetabolites|mesh-ancestor
6546090|NCT00869570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546091|NCT00869570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6546092|NCT00869570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6546093|NCT00869570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6546094|NCT00869596|Fluticasone|fluticasone|mesh-list
6546095|NCT00869596|Xhance|xhance|mesh-list
6546096|NCT00869596|Albuterol|albuterol|mesh-list
6546097|NCT00869596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6546098|NCT00869596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6546099|NCT00869596|Autonomic Agents|autonomic agents|mesh-ancestor
6546100|NCT00869596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6546101|NCT00869596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546102|NCT00869596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6442378|NCT00375596|Antipruritics|antipruritics|mesh-ancestor
6442379|NCT00375596|Dermatologic Agents|dermatologic agents|mesh-ancestor
6442380|NCT00375596|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6442381|NCT00375596|Histamine Antagonists|histamine antagonists|mesh-ancestor
6442382|NCT00375596|Histamine Agents|histamine agents|mesh-ancestor
6442383|NCT00375596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6546103|NCT00869596|Respiratory System Agents|respiratory system agents|mesh-ancestor
6546104|NCT00869596|Dermatologic Agents|dermatologic agents|mesh-ancestor
6546105|NCT00869596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6546106|NCT00869596|Tocolytic Agents|tocolytic agents|mesh-ancestor
6546107|NCT00869596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6546108|NCT00869596|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6546109|NCT00869596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6546110|NCT00869596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6546111|NCT00869596|Adrenergic Agents|adrenergic agents|mesh-ancestor
6546112|NCT00869596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6546113|NCT00869596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546114|NCT00869700|Lumefantrine|lumefantrine|mesh-list
6546115|NCT00869700|Artemether|artemether|mesh-list
6546116|NCT00869700|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6546117|NCT00869700|Antimalarials|antimalarials|mesh-ancestor
6546118|NCT00869700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6546119|NCT00869700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6546120|NCT00869700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6546121|NCT00869752|Etoposide|etoposide|mesh-list
6546122|NCT00869752|Antibodies|antibodies|mesh-list
6546123|NCT00869752|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6546124|NCT00869752|Immunologic Factors|immunologic factors|mesh-ancestor
6546125|NCT00869752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546126|NCT00869752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6546127|NCT00869752|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6546128|NCT00869752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6546129|NCT00869752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6546130|NCT00869752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6546131|NCT00869752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546132|NCT00869765|Cycloserine|cycloserine|mesh-list
6546133|NCT00869765|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6546134|NCT00869765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6546135|NCT00869765|Renal Agents|renal agents|mesh-ancestor
6546136|NCT00869765|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6546137|NCT00869765|Antitubercular Agents|antitubercular agents|mesh-ancestor
6546138|NCT00869765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6546139|NCT00869765|Antimetabolites|antimetabolites|mesh-ancestor
6546140|NCT00869765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546141|NCT00869856|Epoetin Alfa|epoetin alfa|mesh-list
6546142|NCT00869856|Hematinics|hematinics|mesh-ancestor
6546143|NCT00869869|Melatonin|melatonin|mesh-list
6546144|NCT00869869|Antioxidants|antioxidants|mesh-ancestor
6546145|NCT00869869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546146|NCT00869869|Protective Agents|protective agents|mesh-ancestor
6546147|NCT00869869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546148|NCT00869869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6546149|NCT00869908|Insulin|insulin|mesh-list
6546150|NCT00869908|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6546151|NCT00869908|Insulin Aspart|insulin aspart|mesh-list
6546152|NCT00869908|Insulin, Long-Acting|insulin, long-acting|mesh-list
6546153|NCT00869908|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6442384|NCT00375596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442385|NCT00375596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546154|NCT00869908|Insulin Detemir|insulin detemir|mesh-list
6546155|NCT00869908|Biphasic Insulins|biphasic insulins|mesh-list
6546156|NCT00869908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6546157|NCT00869908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546158|NCT00869973|Dexamethasone|dexamethasone|mesh-list
6546159|NCT00869973|Aprepitant|aprepitant|mesh-list
6546160|NCT00869973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6546161|NCT00869973|Antiemetics|antiemetics|mesh-ancestor
6546162|NCT00869973|Autonomic Agents|autonomic agents|mesh-ancestor
6546163|NCT00869973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6546164|NCT00869973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546165|NCT00869973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6546166|NCT00869973|Glucocorticoids|glucocorticoids|mesh-ancestor
6546167|NCT00869973|Hormones|hormones|mesh-ancestor
6546168|NCT00869973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6546169|NCT00869973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6546170|NCT00869973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6546171|NCT00869973|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6546172|NCT00869973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6546173|NCT00869973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546174|NCT00870025|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6546175|NCT00870025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6546176|NCT00870025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546177|NCT00870038|Paclitaxel|paclitaxel|mesh-list
6546178|NCT00870038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6546179|NCT00870038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6546180|NCT00870038|Tubulin Modulators|tubulin modulators|mesh-ancestor
6546181|NCT00870038|Antimitotic Agents|antimitotic agents|mesh-ancestor
6546182|NCT00870038|Mitosis Modulators|mitosis modulators|mesh-ancestor
6546183|NCT00870038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546184|NCT00870142|Amlodipine|amlodipine|mesh-list
6546185|NCT00870142|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6546186|NCT00870142|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6546187|NCT00870142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6546188|NCT00870142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546189|NCT00870142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6546190|NCT00870142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546191|NCT00870142|Vasodilator Agents|vasodilator agents|mesh-ancestor
6546192|NCT00870220|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6546193|NCT00870220|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6546194|NCT00870220|Estradiol|estradiol|mesh-list
6546195|NCT00870220|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6546196|NCT00870220|Estrogens|estrogens|mesh-ancestor
6546197|NCT00870220|Hormones|hormones|mesh-ancestor
6546198|NCT00870220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6546199|NCT00870220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442386|NCT00375596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6442387|NCT00375622|Tamoxifen|tamoxifen|mesh-list
6442388|NCT00375622|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6442389|NCT00375622|Hormone Antagonists|hormone antagonists|mesh-ancestor
6442390|NCT00375622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6442391|NCT00375622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442392|NCT00375622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6442393|NCT00375622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6442394|NCT00375622|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6442395|NCT00375622|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6442396|NCT00375622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6442397|NCT00375648|Zoledronic Acid|zoledronic acid|mesh-list
6442398|NCT00375648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6442399|NCT00375648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442400|NCT00375661|Interferons|interferons|mesh-list
6442401|NCT00375661|Ribavirin|ribavirin|mesh-list
6442402|NCT00375661|Interferon-alpha|interferon-alpha|mesh-list
6442403|NCT00375661|Interferon alpha-2|interferon alpha-2|mesh-list
6442404|NCT00375661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6546200|NCT00870220|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6546201|NCT00870220|Contraceptive Agents|contraceptive agents|mesh-ancestor
6546202|NCT00870220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6546203|NCT00870220|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6546204|NCT00870272|Misoprostol|misoprostol|mesh-list
6546205|NCT00870272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6546206|NCT00870272|Abortifacient Agents|abortifacient agents|mesh-ancestor
6546207|NCT00870272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6546208|NCT00870272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442405|NCT00375661|Antiviral Agents|antiviral agents|mesh-ancestor
6442406|NCT00375661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6442407|NCT00375661|Antimetabolites|antimetabolites|mesh-ancestor
6442408|NCT00375661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442409|NCT00375661|Immunologic Factors|immunologic factors|mesh-ancestor
6442410|NCT00375661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442411|NCT00375687|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6442412|NCT00375687|Luteolytic Agents|luteolytic agents|mesh-ancestor
6442413|NCT00375687|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6442414|NCT00375687|Contraceptive Agents|contraceptive agents|mesh-ancestor
6442415|NCT00375687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6546209|NCT00870272|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6546210|NCT00870272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6546211|NCT00870272|Oxytocics|oxytocics|mesh-ancestor
6546212|NCT00870298|Trimethoprim|trimethoprim|mesh-list
6546213|NCT00870298|Sulfamethoxazole|sulfamethoxazole|mesh-list
6546214|NCT00870298|Warfarin|warfarin|mesh-list
6546215|NCT00870298|Anticoagulants|anticoagulants|mesh-ancestor
6546216|NCT00870298|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6546217|NCT00870298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6546218|NCT00870298|Renal Agents|renal agents|mesh-ancestor
6546219|NCT00870298|Antimalarials|antimalarials|mesh-ancestor
6546220|NCT00870298|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6546221|NCT00870298|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6546222|NCT00870298|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6546223|NCT00870298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6546224|NCT00870298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546225|NCT00870298|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6546226|NCT00870298|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6546227|NCT00870298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6546228|NCT00870311|Lithium Carbonate|lithium carbonate|mesh-list
6546229|NCT00870311|Antidepressive Agents|antidepressive agents|mesh-ancestor
6546230|NCT00870311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6546231|NCT00870311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6546232|NCT00870311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546233|NCT00870311|Antimanic Agents|antimanic agents|mesh-ancestor
6546234|NCT00870311|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6546235|NCT00870311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6546236|NCT00870311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546237|NCT00870337|Everolimus|everolimus|mesh-list
6546238|NCT00870337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6546239|NCT00870337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6546240|NCT00870337|Immunologic Factors|immunologic factors|mesh-ancestor
6546241|NCT00870337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546242|NCT00870402|Spironolactone|spironolactone|mesh-list
6546243|NCT00870402|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6546244|NCT00870402|Hormone Antagonists|hormone antagonists|mesh-ancestor
6546245|NCT00870402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6546246|NCT00870402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546247|NCT00870402|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6546248|NCT00870402|Diuretics|diuretics|mesh-ancestor
6546249|NCT00870402|Natriuretic Agents|natriuretic agents|mesh-ancestor
6546250|NCT00870441|Valacyclovir|valacyclovir|mesh-list
6546251|NCT00870441|Antiviral Agents|antiviral agents|mesh-ancestor
6546252|NCT00870441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6546253|NCT00870480|Finasteride|finasteride|mesh-list
6546254|NCT00870480|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6546255|NCT00870480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6546256|NCT00870480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6546257|NCT00870480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546258|NCT00870480|Hormone Antagonists|hormone antagonists|mesh-ancestor
6546259|NCT00870480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6546260|NCT00870480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546261|NCT00870480|Urological Agents|urological agents|mesh-ancestor
6546262|NCT00870532|Sorafenib|sorafenib|mesh-list
6546263|NCT00870532|Vinorelbine|vinorelbine|mesh-list
6546264|NCT00870532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6546265|NCT00870532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6546266|NCT00870532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6546267|NCT00870532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546268|NCT00870532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6546269|NCT00870532|Tubulin Modulators|tubulin modulators|mesh-ancestor
6546270|NCT00870532|Antimitotic Agents|antimitotic agents|mesh-ancestor
6546271|NCT00870532|Mitosis Modulators|mitosis modulators|mesh-ancestor
6546272|NCT00870558|Ethiodized Oil|ethiodized oil|mesh-list
6546273|NCT00870558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6546274|NCT00870571|Amlodipine|amlodipine|mesh-list
6546275|NCT00870571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6546276|NCT00870571|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6546277|NCT00870571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6546278|NCT00870571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546279|NCT00870571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6546280|NCT00870571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546281|NCT00870571|Vasodilator Agents|vasodilator agents|mesh-ancestor
6655741|NCT01465503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655742|NCT01465503|Antithrombins|antithrombins|mesh-ancestor
6655743|NCT01465503|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6655744|NCT01465503|Protease Inhibitors|protease inhibitors|mesh-ancestor
6655745|NCT01465503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6655746|NCT01465568|Denosumab|denosumab|mesh-list
6655747|NCT01465568|Diphosphonates|diphosphonates|mesh-list
6655748|NCT01465568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6655749|NCT01465568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655750|NCT01465685|Methylphenidate|methylphenidate|mesh-list
6546282|NCT00870636|Bevacizumab|bevacizumab|mesh-list
6546283|NCT00870636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6546284|NCT00870636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6546285|NCT00870636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6546286|NCT00870636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6546287|NCT00870636|Growth Substances|growth substances|mesh-ancestor
6546288|NCT00870636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546289|NCT00870636|Growth Inhibitors|growth inhibitors|mesh-ancestor
6546290|NCT00870714|Ketoconazole|ketoconazole|mesh-list
6546291|NCT00870714|Docetaxel|docetaxel|mesh-list
6546292|NCT00870714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6546293|NCT00870714|Tubulin Modulators|tubulin modulators|mesh-ancestor
6546294|NCT00870714|Antimitotic Agents|antimitotic agents|mesh-ancestor
6546295|NCT00870714|Mitosis Modulators|mitosis modulators|mesh-ancestor
6546296|NCT00870714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546297|NCT00870714|Antifungal Agents|antifungal agents|mesh-ancestor
6546298|NCT00870714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6546299|NCT00870714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6546300|NCT00870714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6546301|NCT00870714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6546302|NCT00870714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6546303|NCT00870714|Hormone Antagonists|hormone antagonists|mesh-ancestor
6546304|NCT00870714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6546305|NCT00870714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546306|NCT00870714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6546307|NCT00870779|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6546308|NCT00870779|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6546309|NCT00870779|Dermatologic Agents|dermatologic agents|mesh-ancestor
6546310|NCT00870883|Acetylcysteine|acetylcysteine|mesh-list
6546311|NCT00870883|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6546312|NCT00870883|Deferoxamine|deferoxamine|mesh-list
6546313|NCT00870883|Antiviral Agents|antiviral agents|mesh-ancestor
6546314|NCT00870883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6546315|NCT00870883|Expectorants|expectorants|mesh-ancestor
6546316|NCT00870883|Respiratory System Agents|respiratory system agents|mesh-ancestor
6546317|NCT00870883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6546318|NCT00870883|Antioxidants|antioxidants|mesh-ancestor
6546319|NCT00870883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546320|NCT00870883|Protective Agents|protective agents|mesh-ancestor
6546321|NCT00870883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546322|NCT00870883|Antidotes|antidotes|mesh-ancestor
6546323|NCT00870883|Siderophores|siderophores|mesh-ancestor
6546324|NCT00870883|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6546325|NCT00870883|Chelating Agents|chelating agents|mesh-ancestor
6546326|NCT00870883|Sequestering Agents|sequestering agents|mesh-ancestor
6546327|NCT00870961|Cholecalciferol|cholecalciferol|mesh-list
6546328|NCT00870961|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6546329|NCT00870961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546330|NCT00870961|Vitamins|vitamins|mesh-ancestor
6546331|NCT00870961|Micronutrients|micronutrients|mesh-ancestor
6546332|NCT00870961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6546333|NCT00870987|Vaccines|vaccines|mesh-list
6546334|NCT00870987|Immunologic Factors|immunologic factors|mesh-ancestor
6546335|NCT00870987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546336|NCT00871039|Midazolam|midazolam|mesh-list
6546337|NCT00871039|Propofol|propofol|mesh-list
6546338|NCT00871039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6546339|NCT00871039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6546340|NCT00871039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546341|NCT00871039|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6546342|NCT00871039|Anesthetics, General|anesthetics, general|mesh-ancestor
6546343|NCT00871039|Anesthetics|anesthetics|mesh-ancestor
6546344|NCT00871039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6546345|NCT00871039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6546346|NCT00871039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6546347|NCT00871039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6546348|NCT00871039|GABA Modulators|gaba modulators|mesh-ancestor
6546349|NCT00871039|GABA Agents|gaba agents|mesh-ancestor
6546350|NCT00871039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6546351|NCT00871039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546352|NCT00871052|Vitamin D|vitamin d|mesh-list
6546353|NCT00871052|Calcipotriene|calcipotriene|mesh-list
6546354|NCT00871052|Vitamins|vitamins|mesh-ancestor
6546355|NCT00871052|Micronutrients|micronutrients|mesh-ancestor
6546356|NCT00871052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546357|NCT00871052|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6546358|NCT00871052|Dermatologic Agents|dermatologic agents|mesh-ancestor
6546359|NCT00871065|Sildenafil Citrate|sildenafil citrate|mesh-list
6546360|NCT00871065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546361|NCT00871065|Vasodilator Agents|vasodilator agents|mesh-ancestor
6546362|NCT00871065|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6546363|NCT00871065|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6546364|NCT00871065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6546365|NCT00871065|Urological Agents|urological agents|mesh-ancestor
6546366|NCT00871104|Vancomycin|vancomycin|mesh-list
6546367|NCT00871104|Imipenem|imipenem|mesh-list
6546368|NCT00871104|Fosfomycin|fosfomycin|mesh-list
6546369|NCT00871104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6546370|NCT00871104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6546371|NCT00871156|Chloroquine|chloroquine|mesh-list
6546372|NCT00871156|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
6546373|NCT00871156|Tafenoquine|tafenoquine|mesh-list
6546374|NCT00871156|Amebicides|amebicides|mesh-ancestor
6546375|NCT00871156|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6546376|NCT00871156|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6546377|NCT00871156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6546378|NCT00871156|Antimalarials|antimalarials|mesh-ancestor
6546379|NCT00871156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6546380|NCT00871156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6546381|NCT00871156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6546382|NCT00871156|Analgesics|analgesics|mesh-ancestor
6546383|NCT00871156|Sensory System Agents|sensory system agents|mesh-ancestor
6546384|NCT00871156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6546385|NCT00871156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546386|NCT00871156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6546387|NCT00871156|Filaricides|filaricides|mesh-ancestor
6546388|NCT00871156|Antinematodal Agents|antinematodal agents|mesh-ancestor
6546389|NCT00871156|Anthelmintics|anthelmintics|mesh-ancestor
6546390|NCT00871208|Retapamulin|retapamulin|mesh-list
6546391|NCT00871208|Hydrocortisone|hydrocortisone|mesh-list
6546392|NCT00871208|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6546393|NCT00871208|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6546394|NCT00871208|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6546395|NCT00871208|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
6546396|NCT00871208|Dermatologic Agents|dermatologic agents|mesh-ancestor
6546397|NCT00871208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6546398|NCT00871208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6546399|NCT00871208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6546400|NCT00871247|Finasteride|finasteride|mesh-list
6546401|NCT00871247|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6546402|NCT00871247|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6546403|NCT00871247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6546404|NCT00871247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546405|NCT00871247|Hormone Antagonists|hormone antagonists|mesh-ancestor
6546406|NCT00871247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6546407|NCT00871247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546408|NCT00871247|Urological Agents|urological agents|mesh-ancestor
6546409|NCT00871273|Capecitabine|capecitabine|mesh-list
6546410|NCT00871273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6546411|NCT00871273|Antimetabolites|antimetabolites|mesh-ancestor
6546412|NCT00871273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546413|NCT00871273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6546414|NCT00871364|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6546415|NCT00871364|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6546416|NCT00871364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6546417|NCT00871364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6546418|NCT00871364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546419|NCT00871364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6546420|NCT00871364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546421|NCT00871364|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6546422|NCT00871364|Antidepressive Agents|antidepressive agents|mesh-ancestor
6546423|NCT00871364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6546424|NCT00871442|Fentanyl|fentanyl|mesh-list
6546425|NCT00871442|Bupivacaine|bupivacaine|mesh-list
6546426|NCT00871442|Anesthetics|anesthetics|mesh-list
6546427|NCT00871442|Anesthetics, Local|anesthetics, local|mesh-ancestor
6546428|NCT00871442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6546429|NCT00871442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546430|NCT00871442|Sensory System Agents|sensory system agents|mesh-ancestor
6546431|NCT00871442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6546432|NCT00871442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6546433|NCT00871442|Narcotics|narcotics|mesh-ancestor
6546434|NCT00871442|Analgesics|analgesics|mesh-ancestor
6546435|NCT00871442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6546436|NCT00871442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6546437|NCT00871442|Anesthetics, General|anesthetics, general|mesh-ancestor
6546438|NCT00871455|Baclofen|baclofen|mesh-list
6546439|NCT00871455|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6546440|NCT00871455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546441|NCT00871455|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6546442|NCT00871455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6546443|NCT00871455|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6546444|NCT00871455|GABA Agonists|gaba agonists|mesh-ancestor
6546445|NCT00871455|GABA Agents|gaba agents|mesh-ancestor
6546446|NCT00871455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6546447|NCT00871455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546448|NCT00871507|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6546449|NCT00871507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6546450|NCT00871507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546451|NCT00871507|Incretins|incretins|mesh-ancestor
6546452|NCT00871507|Hormones|hormones|mesh-ancestor
6546453|NCT00871507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6546454|NCT00871507|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6546455|NCT00871507|Protease Inhibitors|protease inhibitors|mesh-ancestor
6546456|NCT00871507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6546457|NCT00871507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546458|NCT00871533|Interferon-alpha|interferon-alpha|mesh-list
6546459|NCT00871533|Interferon alpha-2|interferon alpha-2|mesh-list
6546460|NCT00871533|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
6546461|NCT00871533|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6546462|NCT00871533|Antiviral Agents|antiviral agents|mesh-ancestor
6546463|NCT00871533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6546464|NCT00871533|Immunologic Factors|immunologic factors|mesh-ancestor
6546465|NCT00871533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546466|NCT00871533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6546467|NCT00871546|Bortezomib|bortezomib|mesh-list
6546468|NCT00871546|Alemtuzumab|alemtuzumab|mesh-list
6546469|NCT00871546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6546470|NCT00871546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6546471|NCT00871598|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6546472|NCT00871598|Immunologic Factors|immunologic factors|mesh-ancestor
6546473|NCT00871598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546474|NCT00871767|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
6546475|NCT00871767|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6546476|NCT00871767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546477|NCT00871767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6546478|NCT00871767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6546479|NCT00871767|Antiviral Agents|antiviral agents|mesh-ancestor
6546480|NCT00871767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6546481|NCT00871910|Dexamethasone|dexamethasone|mesh-list
6546482|NCT00871910|Ondansetron|ondansetron|mesh-list
6546483|NCT00871910|Aprepitant|aprepitant|mesh-list
6546484|NCT00871910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6546485|NCT00871910|Antiemetics|antiemetics|mesh-ancestor
6546486|NCT00871910|Autonomic Agents|autonomic agents|mesh-ancestor
6546487|NCT00871910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6546488|NCT00871910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546489|NCT00871910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6546490|NCT00871910|Glucocorticoids|glucocorticoids|mesh-ancestor
6546491|NCT00871910|Hormones|hormones|mesh-ancestor
6546492|NCT00871910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6546493|NCT00871910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6546494|NCT00871910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6546495|NCT00871910|Antipruritics|antipruritics|mesh-ancestor
6546496|NCT00871910|Dermatologic Agents|dermatologic agents|mesh-ancestor
6546497|NCT00871910|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6546498|NCT00871910|Serotonin Agents|serotonin agents|mesh-ancestor
6546499|NCT00871910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6546500|NCT00871910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546501|NCT00871910|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6546502|NCT00871910|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6546503|NCT00871910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6546504|NCT00871910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6546505|NCT00871910|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6442416|NCT00375687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442417|NCT00375687|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6442418|NCT00375687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6442419|NCT00375687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6442420|NCT00375765|Dutasteride|dutasteride|mesh-list
6442421|NCT00375765|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6442422|NCT00375765|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6442423|NCT00375765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6442424|NCT00375765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442425|NCT00375765|Hormone Antagonists|hormone antagonists|mesh-ancestor
6442426|NCT00375765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6442427|NCT00375765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546506|NCT00871910|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6546507|NCT00871949|Oxazolidinones|oxazolidinones|mesh-list
6546508|NCT00871949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6546509|NCT00871949|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6546510|NCT00871949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6546511|NCT00871949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546512|NCT00872131|Sertraline|sertraline|mesh-list
6546513|NCT00872131|Antidepressive Agents|antidepressive agents|mesh-ancestor
6546514|NCT00872131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6546515|NCT00872131|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6546516|NCT00872131|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6546517|NCT00872131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6546518|NCT00872131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546519|NCT00872131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6546520|NCT00872131|Serotonin Agents|serotonin agents|mesh-ancestor
6546521|NCT00872131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546522|NCT00872144|Nabiximols|nabiximols|mesh-list
6546523|NCT00872144|Analgesics|analgesics|mesh-ancestor
6546524|NCT00872144|Sensory System Agents|sensory system agents|mesh-ancestor
6546525|NCT00872144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6546526|NCT00872144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546527|NCT00872209|Ciprofloxacin|ciprofloxacin|mesh-list
6546528|NCT00872209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6546529|NCT00872209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6546530|NCT00872209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6546531|NCT00872209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6546532|NCT00872209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6546533|NCT00872209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546534|NCT00872209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6546535|NCT00872209|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6546536|NCT00872209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6546537|NCT00872235|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6546538|NCT00872235|Quinapril|quinapril|mesh-list
6546539|NCT00872235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6546540|NCT00872235|Diuretics|diuretics|mesh-ancestor
6546541|NCT00872235|Natriuretic Agents|natriuretic agents|mesh-ancestor
6546542|NCT00872235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546543|NCT00872235|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6546544|NCT00872235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6546545|NCT00872235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546546|NCT00872235|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6546547|NCT00872235|Protease Inhibitors|protease inhibitors|mesh-ancestor
6546548|NCT00872235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6546549|NCT00872248|Anesthetics|anesthetics|mesh-list
6546550|NCT00872248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6546551|NCT00872248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546552|NCT00872274|Sumatriptan|sumatriptan|mesh-list
6546553|NCT00872274|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6546554|NCT00872274|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6546555|NCT00872274|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6546556|NCT00872274|Serotonin Agents|serotonin agents|mesh-ancestor
6546557|NCT00872274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6546558|NCT00872274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546559|NCT00872274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546560|NCT00872365|Micronutrients|micronutrients|mesh-list
6546561|NCT00872365|Trace Elements|trace elements|mesh-list
6546562|NCT00872365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546563|NCT00872378|Exenatide|exenatide|mesh-list
6546564|NCT00872378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6546565|NCT00872378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546566|NCT00872378|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6442428|NCT00375778|Memantine|memantine|mesh-list
6442429|NCT00375778|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6442430|NCT00375778|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6442431|NCT00375778|Dopamine Agents|dopamine agents|mesh-ancestor
6546567|NCT00872378|Incretins|incretins|mesh-ancestor
6546568|NCT00872378|Hormones|hormones|mesh-ancestor
6546569|NCT00872378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6546570|NCT00872417|Lamivudine|lamivudine|mesh-list
6546571|NCT00872417|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6546572|NCT00872417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6546573|NCT00872417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6546574|NCT00872417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546575|NCT00872417|Antiviral Agents|antiviral agents|mesh-ancestor
6546576|NCT00872417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6546577|NCT00872417|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6546578|NCT00872417|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6546579|NCT00872469|Tranexamic Acid|tranexamic acid|mesh-list
6546580|NCT00872469|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6546581|NCT00872469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6546582|NCT00872469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546583|NCT00872469|Hemostatics|hemostatics|mesh-ancestor
6546584|NCT00872469|Coagulants|coagulants|mesh-ancestor
6546585|NCT00872482|Nimotuzumab|nimotuzumab|mesh-list
6546586|NCT00872482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6546587|NCT00872482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6655751|NCT01465685|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
6655752|NCT01465685|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6655753|NCT01465685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655754|NCT01465685|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6655755|NCT01465685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6655756|NCT01465685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6655757|NCT01465685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655758|NCT01465685|Dopamine Agents|dopamine agents|mesh-ancestor
6655759|NCT01465685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6655760|NCT01465685|Hallucinogens|hallucinogens|mesh-ancestor
6655761|NCT01465685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6655762|NCT01465685|Serotonin Agents|serotonin agents|mesh-ancestor
6655763|NCT01465685|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6655764|NCT01465685|Adrenergic Agents|adrenergic agents|mesh-ancestor
6655765|NCT01465815|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6655766|NCT01465815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6655767|NCT01465815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6655768|NCT01465815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6655769|NCT01465815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655770|NCT01465828|Clopidogrel|clopidogrel|mesh-list
6655771|NCT01465828|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6655772|NCT01465828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6655773|NCT01465828|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6655774|NCT01465828|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6655775|NCT01465828|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6655776|NCT01465828|Purinergic Agents|purinergic agents|mesh-ancestor
6655777|NCT01465828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6655778|NCT01465828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655779|NCT01465828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655780|NCT01465867|Selenium|selenium|mesh-list
6655781|NCT01465867|Antioxidants|antioxidants|mesh-ancestor
6655782|NCT01465867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655783|NCT01465867|Protective Agents|protective agents|mesh-ancestor
6655784|NCT01465867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655785|NCT01465867|Trace Elements|trace elements|mesh-ancestor
6655786|NCT01465867|Micronutrients|micronutrients|mesh-ancestor
6655787|NCT01465893|Vitamin D|vitamin d|mesh-list
6655788|NCT01465893|Ergocalciferols|ergocalciferols|mesh-list
6442432|NCT00375778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6442433|NCT00375778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442434|NCT00375778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442435|NCT00375778|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6442436|NCT00375778|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6442437|NCT00375843|Citalopram|citalopram|mesh-list
6442438|NCT00375843|Sertraline|sertraline|mesh-list
6655789|NCT01465893|Vitamins|vitamins|mesh-list
6655790|NCT01465893|Micronutrients|micronutrients|mesh-ancestor
6655791|NCT01465893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546588|NCT00872586|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6546589|NCT00872586|Olmesartan|olmesartan|mesh-list
6546590|NCT00872586|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6546591|NCT00872586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6546592|NCT00872586|Diuretics|diuretics|mesh-ancestor
6546593|NCT00872586|Natriuretic Agents|natriuretic agents|mesh-ancestor
6546594|NCT00872586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546595|NCT00872586|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6546596|NCT00872586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6546597|NCT00872586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546598|NCT00872586|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6546599|NCT00872586|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6546600|NCT00872625|Cyclophosphamide|cyclophosphamide|mesh-list
6546601|NCT00872625|Docetaxel|docetaxel|mesh-list
6546602|NCT00872625|Fluorouracil|fluorouracil|mesh-list
6546603|NCT00872625|Epirubicin|epirubicin|mesh-list
6546604|NCT00872625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6546605|NCT00872625|Immunologic Factors|immunologic factors|mesh-ancestor
6546606|NCT00872625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546607|NCT00872625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6546608|NCT00872625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6546609|NCT00872625|Alkylating Agents|alkylating agents|mesh-ancestor
6546610|NCT00872625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546611|NCT00872625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6546612|NCT00872625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6546613|NCT00872625|Tubulin Modulators|tubulin modulators|mesh-ancestor
6546614|NCT00872625|Antimitotic Agents|antimitotic agents|mesh-ancestor
6546615|NCT00872625|Mitosis Modulators|mitosis modulators|mesh-ancestor
6546616|NCT00872625|Antimetabolites|antimetabolites|mesh-ancestor
6546617|NCT00872625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6546618|NCT00872625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6546619|NCT00872625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6546620|NCT00872625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6546621|NCT00872625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6546622|NCT00872651|Timolol|timolol|mesh-list
6546623|NCT00872651|Travoprost|travoprost|mesh-list
6546624|NCT00872651|Latanoprost|latanoprost|mesh-list
6546625|NCT00872651|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6546626|NCT00872651|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6546627|NCT00872651|Adrenergic Agents|adrenergic agents|mesh-ancestor
6546628|NCT00872651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6019688|NCT00388804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6019689|NCT00388804|Androgen Antagonists|androgen antagonists|mesh-ancestor
6019690|NCT00388804|Hormone Antagonists|hormone antagonists|mesh-ancestor
6019691|NCT00388804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6546629|NCT00872651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546630|NCT00872651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546631|NCT00872651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6546632|NCT00872651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6546633|NCT00872651|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6546634|NCT00872651|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6546635|NCT00872664|Carotenoids|carotenoids|mesh-list
6546636|NCT00872664|Antioxidants|antioxidants|mesh-ancestor
6546637|NCT00872664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546638|NCT00872664|Protective Agents|protective agents|mesh-ancestor
6546639|NCT00872664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546640|NCT00872716|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6546641|NCT00872716|Antidepressive Agents|antidepressive agents|mesh-ancestor
6546642|NCT00872716|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6546643|NCT00872716|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6546644|NCT00872716|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6546645|NCT00872716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6546646|NCT00872716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546647|NCT00872781|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6546648|NCT00872781|Quinapril|quinapril|mesh-list
6546649|NCT00872781|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6546650|NCT00872781|Diuretics|diuretics|mesh-ancestor
6546651|NCT00872781|Natriuretic Agents|natriuretic agents|mesh-ancestor
6546652|NCT00872781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546653|NCT00872781|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6546654|NCT00872781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6546655|NCT00872781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546656|NCT00872781|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6019692|NCT00388973|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6019693|NCT00388973|Antidepressive Agents|antidepressive agents|mesh-ancestor
6019694|NCT00388973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6019695|NCT00388973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6019696|NCT00388973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6019697|NCT00388973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6019698|NCT00388973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019699|NCT00389064|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6546657|NCT00872781|Protease Inhibitors|protease inhibitors|mesh-ancestor
6546658|NCT00872781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6546659|NCT00872924|Sumatriptan|sumatriptan|mesh-list
6546660|NCT00872924|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6546661|NCT00872924|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6546662|NCT00872924|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6546663|NCT00872924|Serotonin Agents|serotonin agents|mesh-ancestor
6546664|NCT00872924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6546665|NCT00872924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546666|NCT00872924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546667|NCT00872950|Amifampridine|amifampridine|mesh-list
6546668|NCT00872950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6546669|NCT00872950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6546670|NCT00872950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546671|NCT00872950|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6546672|NCT00872950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6546673|NCT00872950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546674|NCT00872963|Vaccines|vaccines|mesh-list
6546675|NCT00872963|Immunologic Factors|immunologic factors|mesh-ancestor
6546676|NCT00872963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546677|NCT00872976|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6546678|NCT00872976|Dasatinib|dasatinib|mesh-list
6546679|NCT00872976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6546680|NCT00872976|Alkylating Agents|alkylating agents|mesh-ancestor
6546681|NCT00872976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546682|NCT00872976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6546683|NCT00872976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6546684|NCT00872976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6546685|NCT00873002|Sorafenib|sorafenib|mesh-list
6546686|NCT00873002|Panobinostat|panobinostat|mesh-list
6546687|NCT00873002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6546688|NCT00873002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6546689|NCT00873002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6546690|NCT00873002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546691|NCT00873002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6546692|NCT00873197|Granisetron|granisetron|mesh-list
6546693|NCT00873197|Antiemetics|antiemetics|mesh-ancestor
6546694|NCT00873197|Autonomic Agents|autonomic agents|mesh-ancestor
6546695|NCT00873197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6546696|NCT00873197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546697|NCT00873197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6546698|NCT00873197|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6546699|NCT00873197|Serotonin Agents|serotonin agents|mesh-ancestor
6546700|NCT00873197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6546701|NCT00873197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546702|NCT00873210|Sunitinib|sunitinib|mesh-list
6546703|NCT00873210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6546704|NCT00873210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6546705|NCT00873210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6546706|NCT00873210|Growth Substances|growth substances|mesh-ancestor
6546707|NCT00873210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546708|NCT00873210|Growth Inhibitors|growth inhibitors|mesh-ancestor
6546709|NCT00873210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6546710|NCT00873210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6546711|NCT00873210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546712|NCT00873223|Liraglutide|liraglutide|mesh-list
6546713|NCT00873223|Insulin Detemir|insulin detemir|mesh-list
6546714|NCT00873223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6546715|NCT00873223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546716|NCT00873223|Incretins|incretins|mesh-ancestor
6546717|NCT00873223|Hormones|hormones|mesh-ancestor
6546718|NCT00873223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6546719|NCT00873236|Interferons|interferons|mesh-list
6546720|NCT00873236|Interferon-alpha|interferon-alpha|mesh-list
6546721|NCT00873236|Interferon alpha-2|interferon alpha-2|mesh-list
6546722|NCT00873236|Bevacizumab|bevacizumab|mesh-list
6546723|NCT00873236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6546724|NCT00873236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6546725|NCT00873236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6546726|NCT00873236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6546727|NCT00873236|Growth Substances|growth substances|mesh-ancestor
6546728|NCT00873236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546729|NCT00873236|Growth Inhibitors|growth inhibitors|mesh-ancestor
6546730|NCT00873236|Antiviral Agents|antiviral agents|mesh-ancestor
6546731|NCT00873236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6546732|NCT00873236|Immunologic Factors|immunologic factors|mesh-ancestor
6546733|NCT00873262|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6546734|NCT00873262|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6546735|NCT00873262|Estropipate|estropipate|mesh-list
6546736|NCT00873262|Estradiol|estradiol|mesh-list
6546737|NCT00873262|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6546738|NCT00873262|Estrone|estrone|mesh-list
6546739|NCT00873262|Progesterone|progesterone|mesh-list
6546740|NCT00873262|Estrogens|estrogens|mesh-ancestor
6546741|NCT00873262|Hormones|hormones|mesh-ancestor
6546742|NCT00873262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6546743|NCT00873262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546744|NCT00873262|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6546745|NCT00873262|Contraceptive Agents|contraceptive agents|mesh-ancestor
6546746|NCT00873262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6546747|NCT00873262|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6546748|NCT00873262|Progestins|progestins|mesh-ancestor
6546749|NCT00873275|Leucovorin|leucovorin|mesh-list
6546750|NCT00873275|Bevacizumab|bevacizumab|mesh-list
6546751|NCT00873275|Fluorouracil|fluorouracil|mesh-list
6546752|NCT00873275|Oxaliplatin|oxaliplatin|mesh-list
6546753|NCT00873275|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
6546754|NCT00873275|Calcium|calcium|mesh-list
6546755|NCT00873275|Levoleucovorin|levoleucovorin|mesh-list
6546756|NCT00873275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6546757|NCT00873275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6546758|NCT00873275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6546759|NCT00873275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6546760|NCT00873275|Growth Substances|growth substances|mesh-ancestor
6546761|NCT00873275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546762|NCT00873275|Growth Inhibitors|growth inhibitors|mesh-ancestor
6546763|NCT00873275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6546764|NCT00873275|Antimetabolites|antimetabolites|mesh-ancestor
6546765|NCT00873275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546766|NCT00873275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6546767|NCT00873275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6546768|NCT00873275|Immunologic Factors|immunologic factors|mesh-ancestor
6546769|NCT00873275|Antidotes|antidotes|mesh-ancestor
6546770|NCT00873275|Protective Agents|protective agents|mesh-ancestor
6546771|NCT00873275|Vitamin B Complex|vitamin b complex|mesh-ancestor
6546772|NCT00873275|Vitamins|vitamins|mesh-ancestor
6546773|NCT00873275|Micronutrients|micronutrients|mesh-ancestor
6546774|NCT00873275|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6546775|NCT00873275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6546776|NCT00873340|Interferons|interferons|mesh-list
6546777|NCT00873340|Interferon beta-1b|interferon beta-1b|mesh-list
6546778|NCT00873340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6546779|NCT00873340|Antiviral Agents|antiviral agents|mesh-ancestor
6546780|NCT00873340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6546781|NCT00873340|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6546782|NCT00873340|Immunologic Factors|immunologic factors|mesh-ancestor
6546783|NCT00873340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546784|NCT00873353|Capecitabine|capecitabine|mesh-list
6546785|NCT00873353|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6546786|NCT00873353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6546787|NCT00873353|Antimetabolites|antimetabolites|mesh-ancestor
6546788|NCT00873353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546789|NCT00873353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6546790|NCT00873353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6546791|NCT00873353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6546792|NCT00873366|Tamoxifen|tamoxifen|mesh-list
6546793|NCT00873366|Dextromethorphan|dextromethorphan|mesh-list
6546794|NCT00873366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546795|NCT00873366|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6546796|NCT00873366|Hormone Antagonists|hormone antagonists|mesh-ancestor
6546797|NCT00873366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6546798|NCT00873366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546799|NCT00873366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6546800|NCT00873366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6546801|NCT00873366|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6546802|NCT00873366|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6546803|NCT00873366|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6546804|NCT00873366|Antitussive Agents|antitussive agents|mesh-ancestor
6546805|NCT00873366|Respiratory System Agents|respiratory system agents|mesh-ancestor
6546806|NCT00873366|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6546807|NCT00873366|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6546808|NCT00873366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6546809|NCT00873379|Melatonin|melatonin|mesh-list
6546810|NCT00873379|Antioxidants|antioxidants|mesh-ancestor
6546811|NCT00873379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546812|NCT00873379|Protective Agents|protective agents|mesh-ancestor
6546813|NCT00873379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546814|NCT00873379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6546815|NCT00873392|Nicotine|nicotine|mesh-list
6546816|NCT00873392|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6546817|NCT00873392|Autonomic Agents|autonomic agents|mesh-ancestor
6546818|NCT00873392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6546819|NCT00873392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546820|NCT00873392|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6546821|NCT00873392|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6546822|NCT00873392|Cholinergic Agents|cholinergic agents|mesh-ancestor
6546823|NCT00873392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6546824|NCT00873392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546825|NCT00873483|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6546826|NCT00873483|Gestodene|gestodene|mesh-list
6546827|NCT00873483|Femovan|femovan|mesh-list
6546828|NCT00873483|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6546829|NCT00873483|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6546830|NCT00873483|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6546831|NCT00873483|Contraceptive Agents|contraceptive agents|mesh-ancestor
6546832|NCT00873483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6546833|NCT00873483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546834|NCT00873483|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6546835|NCT00873483|Estrogens|estrogens|mesh-ancestor
6546836|NCT00873483|Hormones|hormones|mesh-ancestor
6546837|NCT00873483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6546838|NCT00873483|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6546839|NCT00873483|Progestins|progestins|mesh-ancestor
6546840|NCT00873483|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6546841|NCT00873496|Hydroxychloroquine|hydroxychloroquine|mesh-list
6546842|NCT00873496|Antimalarials|antimalarials|mesh-ancestor
6546843|NCT00873496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6546844|NCT00873496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6546845|NCT00873496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6546846|NCT00873496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6546847|NCT00873496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546848|NCT00873496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6546849|NCT00873509|Buspirone|buspirone|mesh-list
6546850|NCT00873509|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6546851|NCT00873509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6546852|NCT00873509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6546853|NCT00873509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546854|NCT00873509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6546855|NCT00873509|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6546856|NCT00873509|Serotonin Agents|serotonin agents|mesh-ancestor
6546857|NCT00873509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6546858|NCT00873509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546859|NCT00873535|Varenicline|varenicline|mesh-list
6546860|NCT00873535|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6546861|NCT00873535|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6546862|NCT00873535|Cholinergic Agents|cholinergic agents|mesh-ancestor
6546863|NCT00873535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6546864|NCT00873535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546865|NCT00873535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546866|NCT00873626|Ciprofloxacin|ciprofloxacin|mesh-list
6546867|NCT00873626|Levofloxacin|levofloxacin|mesh-list
6546868|NCT00873626|Ofloxacin|ofloxacin|mesh-list
6546869|NCT00873626|Fluoroquinolones|fluoroquinolones|mesh-list
6546870|NCT00873626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6546871|NCT00873626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6546872|NCT00873626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6546873|NCT00873626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6546874|NCT00873626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6546875|NCT00873626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546876|NCT00873626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6546877|NCT00873626|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6546878|NCT00873626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6546879|NCT00873626|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6546880|NCT00873626|Renal Agents|renal agents|mesh-ancestor
6546881|NCT00873626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6546882|NCT00873639|Insulin|insulin|mesh-list
6546883|NCT00873639|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6546884|NCT00873639|Insulin Aspart|insulin aspart|mesh-list
6546885|NCT00873639|Insulin Detemir|insulin detemir|mesh-list
6546886|NCT00873639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6546887|NCT00873639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546888|NCT00873652|Vaccines|vaccines|mesh-list
6546889|NCT00873652|Immunologic Factors|immunologic factors|mesh-ancestor
6546890|NCT00873652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546891|NCT00873756|Bevacizumab|bevacizumab|mesh-list
6546892|NCT00873756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6546893|NCT00873756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6546894|NCT00873756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6546895|NCT00873756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6546896|NCT00873756|Growth Substances|growth substances|mesh-ancestor
6546897|NCT00873756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546898|NCT00873756|Growth Inhibitors|growth inhibitors|mesh-ancestor
6546899|NCT00873769|Loxapine|loxapine|mesh-list
6546900|NCT00873769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6546901|NCT00873769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6546902|NCT00873769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6546903|NCT00873769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546904|NCT00873769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6546905|NCT00873769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6546906|NCT00873769|Dopamine Agents|dopamine agents|mesh-ancestor
6546907|NCT00873769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6546908|NCT00873769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546909|NCT00873795|Aripiprazole|aripiprazole|mesh-list
6546910|NCT00873795|Sertraline|sertraline|mesh-list
6546911|NCT00873795|Antidepressive Agents|antidepressive agents|mesh-ancestor
6546912|NCT00873795|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6546913|NCT00873795|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6546914|NCT00873795|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6546915|NCT00873795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6546916|NCT00873795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546917|NCT00873795|Dopamine Agonists|dopamine agonists|mesh-ancestor
6546918|NCT00873795|Dopamine Agents|dopamine agents|mesh-ancestor
6546919|NCT00873795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6546920|NCT00873795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546921|NCT00873795|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6546922|NCT00873795|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6546923|NCT00873795|Serotonin Agents|serotonin agents|mesh-ancestor
6546924|NCT00873795|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6546925|NCT00873795|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6546926|NCT00873795|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6546927|NCT00873795|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6546928|NCT00873795|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6546929|NCT00873795|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6546930|NCT00873795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6546931|NCT00873808|Zoledronic Acid|zoledronic acid|mesh-list
6546932|NCT00873808|Ibandronic Acid|ibandronic acid|mesh-list
6546933|NCT00873808|Clodronic Acid|clodronic acid|mesh-list
6546934|NCT00873808|Tetracycline|tetracycline|mesh-list
6546935|NCT00873808|Demeclocycline|demeclocycline|mesh-list
6546936|NCT00873808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6546937|NCT00873808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546938|NCT00873808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6546939|NCT00873808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6546940|NCT00873808|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6546941|NCT00873808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6546942|NCT00873808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546943|NCT00873834|Fluoxetine|fluoxetine|mesh-list
6546944|NCT00873834|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6546945|NCT00873834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6546946|NCT00873834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6546947|NCT00873834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546948|NCT00873834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6546949|NCT00873834|Serotonin Agents|serotonin agents|mesh-ancestor
6546950|NCT00873834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546951|NCT00873834|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6546952|NCT00873834|Antidepressive Agents|antidepressive agents|mesh-ancestor
6546953|NCT00873834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6546954|NCT00873834|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6546955|NCT00873834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6546956|NCT00873834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6546957|NCT00873886|Oseltamivir|oseltamivir|mesh-list
6546958|NCT00873886|Antiviral Agents|antiviral agents|mesh-ancestor
6546959|NCT00873886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6546960|NCT00873886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6546961|NCT00873886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546962|NCT00873925|Vitamin D|vitamin d|mesh-list
6546963|NCT00873925|Vitamins|vitamins|mesh-ancestor
6546964|NCT00873925|Micronutrients|micronutrients|mesh-ancestor
6546965|NCT00873925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546966|NCT00873925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6546967|NCT00873951|Caseins|caseins|mesh-list
6546968|NCT00873951|Chelating Agents|chelating agents|mesh-ancestor
6546969|NCT00873951|Sequestering Agents|sequestering agents|mesh-ancestor
6664675|NCT01513525|Hormones|hormones|mesh-ancestor
6546970|NCT00873951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546971|NCT00874003|Mirtazapine|mirtazapine|mesh-list
6546972|NCT00874003|Antidepressive Agents|antidepressive agents|mesh-ancestor
6546973|NCT00874003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6546974|NCT00874003|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6546975|NCT00874003|Histamine Antagonists|histamine antagonists|mesh-ancestor
6546976|NCT00874003|Histamine Agents|histamine agents|mesh-ancestor
6546977|NCT00874003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6546978|NCT00874003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546979|NCT00874003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6546980|NCT00874003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6546981|NCT00874003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6546982|NCT00874003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6546983|NCT00874003|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6546984|NCT00874003|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6546985|NCT00874003|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6546986|NCT00874003|Adrenergic Agents|adrenergic agents|mesh-ancestor
6546987|NCT00874003|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6546988|NCT00874003|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6546989|NCT00874003|Serotonin Agents|serotonin agents|mesh-ancestor
6546990|NCT00874003|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6546991|NCT00874042|Gemcitabine|gemcitabine|mesh-list
6546992|NCT00874042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6546993|NCT00874042|Antimetabolites|antimetabolites|mesh-ancestor
6546994|NCT00874042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6546995|NCT00874042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6546996|NCT00874042|Antiviral Agents|antiviral agents|mesh-ancestor
6546997|NCT00874042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6546998|NCT00874042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6546999|NCT00874042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6547000|NCT00874042|Immunologic Factors|immunologic factors|mesh-ancestor
6547001|NCT00874042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547002|NCT00874068|Palmitic Acid|palmitic acid|mesh-list
6547003|NCT00874068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6547004|NCT00874068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547005|NCT00874107|Paclitaxel|paclitaxel|mesh-list
6547006|NCT00874107|Bevacizumab|bevacizumab|mesh-list
6547007|NCT00874107|Carboplatin|carboplatin|mesh-list
6547008|NCT00874107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6547009|NCT00874107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6547010|NCT00874107|Tubulin Modulators|tubulin modulators|mesh-ancestor
6547011|NCT00874107|Antimitotic Agents|antimitotic agents|mesh-ancestor
6547012|NCT00874107|Mitosis Modulators|mitosis modulators|mesh-ancestor
6547013|NCT00874107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547014|NCT00874107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6547015|NCT00874107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6547016|NCT00874107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6547017|NCT00874107|Growth Substances|growth substances|mesh-ancestor
6547018|NCT00874107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547019|NCT00874107|Growth Inhibitors|growth inhibitors|mesh-ancestor
6547020|NCT00874133|Domperidone|domperidone|mesh-list
6547021|NCT00874133|Antiemetics|antiemetics|mesh-ancestor
6547022|NCT00874133|Autonomic Agents|autonomic agents|mesh-ancestor
6547023|NCT00874133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6547024|NCT00874133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547025|NCT00874133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6547026|NCT00874133|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6547027|NCT00874133|Dopamine Agents|dopamine agents|mesh-ancestor
6547028|NCT00874133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6547029|NCT00874133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655792|NCT01465893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6655793|NCT01465893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6655794|NCT01465906|Bromides|bromides|mesh-list
6655795|NCT01465906|Tiotropium Bromide|tiotropium bromide|mesh-list
6655796|NCT01465906|Tulobuterol|tulobuterol|mesh-list
6655797|NCT01465906|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6655798|NCT01465906|Autonomic Agents|autonomic agents|mesh-ancestor
6655799|NCT01465906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6655800|NCT01465906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655801|NCT01465906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6655802|NCT01465906|Respiratory System Agents|respiratory system agents|mesh-ancestor
6655803|NCT01465906|Parasympatholytics|parasympatholytics|mesh-ancestor
6655804|NCT01465906|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6655805|NCT01465906|Cholinergic Agents|cholinergic agents|mesh-ancestor
6655806|NCT01465906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6655807|NCT01465906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655808|NCT01465906|Anticonvulsants|anticonvulsants|mesh-ancestor
6655809|NCT01465906|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6655810|NCT01465906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6655811|NCT01465906|Adrenergic Agents|adrenergic agents|mesh-ancestor
6655812|NCT01465919|Mirtazapine|mirtazapine|mesh-list
6655813|NCT01465919|Antidepressive Agents|antidepressive agents|mesh-ancestor
6655814|NCT01465919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6655815|NCT01465919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6655816|NCT01465919|Histamine Antagonists|histamine antagonists|mesh-ancestor
6655817|NCT01465919|Histamine Agents|histamine agents|mesh-ancestor
6655818|NCT01465919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6655819|NCT01465919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655820|NCT01465919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655821|NCT01465919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6655822|NCT01465919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6655823|NCT01465919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6655824|NCT01465919|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6655825|NCT01465919|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6655826|NCT01465919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6655827|NCT01465919|Adrenergic Agents|adrenergic agents|mesh-ancestor
6655828|NCT01465919|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6655829|NCT01465919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6655830|NCT01465919|Serotonin Agents|serotonin agents|mesh-ancestor
6655831|NCT01465919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6664676|NCT01513525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6664677|NCT01513564|Morphine|morphine|mesh-list
6664678|NCT01513564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6664679|NCT01513564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664680|NCT01513564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6664681|NCT01513564|Narcotics|narcotics|mesh-ancestor
6664682|NCT01513564|Analgesics|analgesics|mesh-ancestor
6664683|NCT01513564|Sensory System Agents|sensory system agents|mesh-ancestor
6664684|NCT01513564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6664685|NCT01513603|Cytarabine|cytarabine|mesh-list
6664686|NCT01513603|Mitoxantrone|mitoxantrone|mesh-list
6664687|NCT01513603|Cladribine|cladribine|mesh-list
6664688|NCT01513603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6664689|NCT01513603|Antimetabolites|antimetabolites|mesh-ancestor
6664690|NCT01513603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6664691|NCT01513603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6664692|NCT01513603|Antiviral Agents|antiviral agents|mesh-ancestor
6664693|NCT01513603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6664694|NCT01513603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6664695|NCT01513603|Immunologic Factors|immunologic factors|mesh-ancestor
6664696|NCT01513603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664697|NCT01513603|Analgesics|analgesics|mesh-ancestor
6664698|NCT01513603|Sensory System Agents|sensory system agents|mesh-ancestor
6664699|NCT01513603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6664700|NCT01513603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6664701|NCT01513603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6664702|NCT01513603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6664703|NCT01513668|Acetaminophen|acetaminophen|mesh-list
6664704|NCT01513668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6664705|NCT01513668|Analgesics|analgesics|mesh-ancestor
6547030|NCT00874172|Analgesics|analgesics|mesh-list
6547031|NCT00874172|Sensory System Agents|sensory system agents|mesh-ancestor
6547032|NCT00874172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6547033|NCT00874172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547034|NCT00874315|Cyclosporine|cyclosporine|mesh-list
6547035|NCT00874315|Mycophenolic Acid|mycophenolic acid|mesh-list
6547036|NCT00874315|Fludarabine|fludarabine|mesh-list
6547037|NCT00874315|Fludarabine phosphate|fludarabine phosphate|mesh-list
6547038|NCT00874315|Busulfan|busulfan|mesh-list
6547039|NCT00874315|Tacrolimus|tacrolimus|mesh-list
6547040|NCT00874315|Cyclosporins|cyclosporins|mesh-list
6547041|NCT00874315|Thymoglobulin|thymoglobulin|mesh-list
6547042|NCT00874315|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6547043|NCT00874315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6547044|NCT00874315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6547045|NCT00874315|Antimetabolites|antimetabolites|mesh-ancestor
6547046|NCT00874315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547047|NCT00874315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6547048|NCT00874315|Immunologic Factors|immunologic factors|mesh-ancestor
6547049|NCT00874315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547050|NCT00874315|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6547051|NCT00874315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6547052|NCT00874315|Antifungal Agents|antifungal agents|mesh-ancestor
6547053|NCT00874315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6547054|NCT00874315|Dermatologic Agents|dermatologic agents|mesh-ancestor
6547055|NCT00874315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6547056|NCT00874315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6547057|NCT00874315|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6547058|NCT00874315|Antitubercular Agents|antitubercular agents|mesh-ancestor
6547059|NCT00874315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6547060|NCT00874315|Alkylating Agents|alkylating agents|mesh-ancestor
6547061|NCT00874315|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6547062|NCT00874315|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6547063|NCT00874328|Irinotecan|irinotecan|mesh-list
6547064|NCT00874328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6547065|NCT00874328|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6547066|NCT00874328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6547067|NCT00874328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6547068|NCT00874328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547069|NCT00874393|Hydrocortisone|hydrocortisone|mesh-list
6547070|NCT00874393|Dopamine|dopamine|mesh-list
6547071|NCT00874393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6547072|NCT00874393|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6547073|NCT00874393|Sympathomimetics|sympathomimetics|mesh-ancestor
6547074|NCT00874393|Autonomic Agents|autonomic agents|mesh-ancestor
6547075|NCT00874393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6547076|NCT00874393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547077|NCT00874393|Dopamine Agents|dopamine agents|mesh-ancestor
6547078|NCT00874393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6547079|NCT00874393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547080|NCT00874393|Protective Agents|protective agents|mesh-ancestor
6547081|NCT00874406|Leucovorin|leucovorin|mesh-list
6547082|NCT00874406|Fluorouracil|fluorouracil|mesh-list
6547083|NCT00874406|Oxaliplatin|oxaliplatin|mesh-list
6547084|NCT00874406|Antimetabolites|antimetabolites|mesh-ancestor
6547085|NCT00874406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547086|NCT00874406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6547087|NCT00874406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6547088|NCT00874406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6547089|NCT00874406|Immunologic Factors|immunologic factors|mesh-ancestor
6547090|NCT00874406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547091|NCT00874406|Antidotes|antidotes|mesh-ancestor
6547092|NCT00874406|Protective Agents|protective agents|mesh-ancestor
6547093|NCT00874406|Vitamin B Complex|vitamin b complex|mesh-ancestor
6547094|NCT00874406|Vitamins|vitamins|mesh-ancestor
6547095|NCT00874406|Micronutrients|micronutrients|mesh-ancestor
6547096|NCT00874419|Gemcitabine|gemcitabine|mesh-list
6547097|NCT00874419|Carboplatin|carboplatin|mesh-list
6547098|NCT00874419|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6547099|NCT00874419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6547100|NCT00874419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6547101|NCT00874419|Antimetabolites|antimetabolites|mesh-ancestor
6547102|NCT00874419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547103|NCT00874419|Antiviral Agents|antiviral agents|mesh-ancestor
6547104|NCT00874419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6547105|NCT00874419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6547106|NCT00874419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6547107|NCT00874419|Immunologic Factors|immunologic factors|mesh-ancestor
6547108|NCT00874419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547109|NCT00874419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6547110|NCT00874484|Enoxaparin|enoxaparin|mesh-list
6547111|NCT00874484|Anticoagulants|anticoagulants|mesh-ancestor
6547112|NCT00874484|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6547113|NCT00874484|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6547114|NCT00874484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547115|NCT00874523|Raltegravir Potassium|raltegravir potassium|mesh-list
6547116|NCT00874523|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6547117|NCT00874523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6547118|NCT00874523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6547119|NCT00874523|Antiviral Agents|antiviral agents|mesh-ancestor
6547120|NCT00874523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6547121|NCT00874523|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6547122|NCT00874523|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6547123|NCT00874523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6547124|NCT00874523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547125|NCT00874523|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6547126|NCT00874523|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6547127|NCT00874523|Protease Inhibitors|protease inhibitors|mesh-ancestor
6547128|NCT00874562|Sirolimus|sirolimus|mesh-list
6547129|NCT00874562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6547130|NCT00874562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6547131|NCT00874562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6547132|NCT00874562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6547133|NCT00874562|Antifungal Agents|antifungal agents|mesh-ancestor
6547134|NCT00874562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6547135|NCT00874562|Immunologic Factors|immunologic factors|mesh-ancestor
6547136|NCT00874562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547137|NCT00874575|Vitamin D|vitamin d|mesh-list
6547138|NCT00874575|Ergocalciferols|ergocalciferols|mesh-list
6547139|NCT00874575|Cholecalciferol|cholecalciferol|mesh-list
6547140|NCT00874575|Vitamins|vitamins|mesh-list
6547141|NCT00874575|Micronutrients|micronutrients|mesh-ancestor
6547142|NCT00874575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547143|NCT00874575|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6547144|NCT00874575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6547145|NCT00874601|Valsartan|valsartan|mesh-list
6547146|NCT00874601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6547147|NCT00874601|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6547148|NCT00874601|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6547149|NCT00874601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547150|NCT00874653|Levonorgestrel|levonorgestrel|mesh-list
6442439|NCT00375843|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6442440|NCT00375843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6442441|NCT00375843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6442442|NCT00375843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442443|NCT00375843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6442444|NCT00375843|Serotonin Agents|serotonin agents|mesh-ancestor
6442445|NCT00375843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442446|NCT00375843|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6442447|NCT00375843|Antidepressive Agents|antidepressive agents|mesh-ancestor
6442448|NCT00375843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6442449|NCT00375869|Darbepoetin alfa|darbepoetin alfa|mesh-list
6442450|NCT00375869|Hematinics|hematinics|mesh-ancestor
6442451|NCT00375895|Cyclosporine|cyclosporine|mesh-list
6442452|NCT00375895|Cyclosporins|cyclosporins|mesh-list
6442453|NCT00375895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6442454|NCT00375895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442455|NCT00375895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6442456|NCT00375895|Immunologic Factors|immunologic factors|mesh-ancestor
6442457|NCT00375895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442458|NCT00375895|Antifungal Agents|antifungal agents|mesh-ancestor
6442459|NCT00375895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6442460|NCT00375895|Dermatologic Agents|dermatologic agents|mesh-ancestor
6442461|NCT00375895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6442462|NCT00375895|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6442463|NCT00376012|Rifampin|rifampin|mesh-list
6442464|NCT00376012|Isoniazid|isoniazid|mesh-list
6442465|NCT00376012|Pyrazinamide|pyrazinamide|mesh-list
6442466|NCT00376012|Ethambutol|ethambutol|mesh-list
6442467|NCT00376012|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6442468|NCT00376012|Antitubercular Agents|antitubercular agents|mesh-ancestor
6442469|NCT00376012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6442470|NCT00376012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6442471|NCT00376012|Leprostatic Agents|leprostatic agents|mesh-ancestor
6442472|NCT00376012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6442473|NCT00376012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6442474|NCT00376012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442475|NCT00376012|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6442476|NCT00376012|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6442477|NCT00376012|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6442478|NCT00376012|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6547151|NCT00874653|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6547152|NCT00874653|Contraceptive Agents|contraceptive agents|mesh-ancestor
6547153|NCT00874653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6547154|NCT00874653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547155|NCT00874653|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6547156|NCT00874653|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6547157|NCT00874653|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6547158|NCT00874679|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6547159|NCT00874679|Vasodilator Agents|vasodilator agents|mesh-ancestor
6547160|NCT00874679|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6547161|NCT00874679|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6547162|NCT00874679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6547163|NCT00874679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547164|NCT00874679|Urological Agents|urological agents|mesh-ancestor
6547165|NCT00874744|Triamcinolone|triamcinolone|mesh-list
6547166|NCT00874744|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6547167|NCT00874744|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6547168|NCT00874744|Bevacizumab|bevacizumab|mesh-list
6547169|NCT00874744|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6547170|NCT00874744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6547171|NCT00874744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6547172|NCT00874744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6547173|NCT00874744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6547174|NCT00874744|Growth Substances|growth substances|mesh-ancestor
6547175|NCT00874744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547176|NCT00874744|Growth Inhibitors|growth inhibitors|mesh-ancestor
6547177|NCT00874744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6547178|NCT00874744|Glucocorticoids|glucocorticoids|mesh-ancestor
6547179|NCT00874744|Hormones|hormones|mesh-ancestor
6547180|NCT00874744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6547181|NCT00874744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6547182|NCT00874744|Immunologic Factors|immunologic factors|mesh-ancestor
6547183|NCT00874744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6547184|NCT00874744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547185|NCT00874809|Insulin|insulin|mesh-list
6547186|NCT00874809|Insulin, Short-Acting|insulin, short-acting|mesh-list
6547187|NCT00874809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6547188|NCT00874809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547189|NCT00874861|Poly ICLC|poly iclc|mesh-list
6547190|NCT00874861|Interferon Inducers|interferon inducers|mesh-ancestor
6547191|NCT00874861|Immunologic Factors|immunologic factors|mesh-ancestor
6547192|NCT00874861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547193|NCT00874874|Sorafenib|sorafenib|mesh-list
6547194|NCT00874874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6547195|NCT00874874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6547196|NCT00874874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6442479|NCT00376012|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6442480|NCT00376012|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6442481|NCT00376012|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6442482|NCT00376012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6442483|NCT00376012|Antimetabolites|antimetabolites|mesh-ancestor
6442484|NCT00376012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6461599|NCT00455325|Sensory System Agents|sensory system agents|mesh-ancestor
6461600|NCT00455325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6461601|NCT00455325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461602|NCT00455325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6547197|NCT00874874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547198|NCT00874926|Factor VIII|factor viii|mesh-list
6547199|NCT00874926|Coagulants|coagulants|mesh-ancestor
6547200|NCT00874978|Lenalidomide|lenalidomide|mesh-list
6547201|NCT00874978|Immunologic Factors|immunologic factors|mesh-ancestor
6547202|NCT00874978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547203|NCT00874978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6547204|NCT00874978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6547205|NCT00874978|Growth Substances|growth substances|mesh-ancestor
6547206|NCT00874978|Growth Inhibitors|growth inhibitors|mesh-ancestor
6547207|NCT00874978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6547208|NCT00875004|Epoetin Alfa|epoetin alfa|mesh-list
6547209|NCT00875004|Hematinics|hematinics|mesh-ancestor
6547210|NCT00875030|Artesunate|artesunate|mesh-list
6547211|NCT00875030|Antimalarials|antimalarials|mesh-ancestor
6547212|NCT00875030|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6547213|NCT00875030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6547214|NCT00875030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6547215|NCT00875030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6547216|NCT00875030|Antiviral Agents|antiviral agents|mesh-ancestor
6547217|NCT00875030|Schistosomicides|schistosomicides|mesh-ancestor
6547218|NCT00875030|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6547219|NCT00875030|Anthelmintics|anthelmintics|mesh-ancestor
6547220|NCT00875069|Ethanol|ethanol|mesh-list
6547221|NCT00875069|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6547222|NCT00875069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6547223|NCT00875069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6547224|NCT00875069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547225|NCT00875082|Montelukast|montelukast|mesh-list
6547226|NCT00875082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6547227|NCT00875082|Respiratory System Agents|respiratory system agents|mesh-ancestor
6547228|NCT00875082|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6547229|NCT00875082|Hormone Antagonists|hormone antagonists|mesh-ancestor
6547230|NCT00875082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6547231|NCT00875082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547232|NCT00875082|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6547233|NCT00875082|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6547234|NCT00875082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547235|NCT00875147|Bevacizumab|bevacizumab|mesh-list
6547236|NCT00875147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6547237|NCT00875147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6547238|NCT00875147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6547239|NCT00875147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6547240|NCT00875147|Growth Substances|growth substances|mesh-ancestor
6547241|NCT00875147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547242|NCT00875147|Growth Inhibitors|growth inhibitors|mesh-ancestor
6547243|NCT00875173|Selenium|selenium|mesh-list
6547244|NCT00875173|Antioxidants|antioxidants|mesh-list
6547245|NCT00875173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547246|NCT00875173|Protective Agents|protective agents|mesh-ancestor
6547247|NCT00875173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547248|NCT00875173|Trace Elements|trace elements|mesh-ancestor
6547249|NCT00875173|Micronutrients|micronutrients|mesh-ancestor
6547250|NCT00875238|Doxorubicin|doxorubicin|mesh-list
6547251|NCT00875238|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6547252|NCT00875238|Trastuzumab|trastuzumab|mesh-list
6547253|NCT00875238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6547254|NCT00875238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6547255|NCT00875238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6547256|NCT00875238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6547257|NCT00875238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6547258|NCT00875238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547259|NCT00875238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6547260|NCT00875355|Temozolomide|temozolomide|mesh-list
6547261|NCT00875355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6547262|NCT00875355|Alkylating Agents|alkylating agents|mesh-ancestor
6547263|NCT00875355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547264|NCT00875355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6547265|NCT00875368|Maraviroc|maraviroc|mesh-list
6547266|NCT00875368|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6655832|NCT01465984|Acetaminophen|acetaminophen|mesh-list
6547267|NCT00875368|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6547268|NCT00875368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547269|NCT00875368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6547270|NCT00875368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6547271|NCT00875368|Antiviral Agents|antiviral agents|mesh-ancestor
6547272|NCT00875368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6547273|NCT00875368|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6547274|NCT00875407|3-iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide|3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide|mesh-list
6547275|NCT00875407|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6547276|NCT00875407|Dopamine Agents|dopamine agents|mesh-ancestor
6547277|NCT00875407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6547278|NCT00875407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547279|NCT00875407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547280|NCT00875537|Capsaicin|capsaicin|mesh-list
6547281|NCT00875537|Antipruritics|antipruritics|mesh-ancestor
6547282|NCT00875537|Dermatologic Agents|dermatologic agents|mesh-ancestor
6547283|NCT00875537|Sensory System Agents|sensory system agents|mesh-ancestor
6547284|NCT00875537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6547285|NCT00875537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547286|NCT00875745|Sorafenib|sorafenib|mesh-list
6547287|NCT00875745|Vorinostat|vorinostat|mesh-list
6547288|NCT00875745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6547289|NCT00875745|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6547290|NCT00875745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6547291|NCT00875745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547292|NCT00875745|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6547293|NCT00875771|Bevacizumab|bevacizumab|mesh-list
6547294|NCT00875771|Capecitabine|capecitabine|mesh-list
6547295|NCT00875771|Irinotecan|irinotecan|mesh-list
6547296|NCT00875771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6547297|NCT00875771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6547298|NCT00875771|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6547299|NCT00875771|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6547300|NCT00875771|Growth Substances|growth substances|mesh-ancestor
6547301|NCT00875771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547302|NCT00875771|Growth Inhibitors|growth inhibitors|mesh-ancestor
6547303|NCT00875771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6547304|NCT00875771|Antimetabolites|antimetabolites|mesh-ancestor
6547305|NCT00875771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547306|NCT00875771|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6547307|NCT00875771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6547308|NCT00875771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6547309|NCT00875784|Sumatriptan|sumatriptan|mesh-list
6547310|NCT00875784|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6547311|NCT00875784|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6547312|NCT00875784|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6547313|NCT00875784|Serotonin Agents|serotonin agents|mesh-ancestor
6547314|NCT00875784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6547315|NCT00875784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547316|NCT00875784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547317|NCT00875849|Cetuximab|cetuximab|mesh-list
6547318|NCT00875849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6547319|NCT00875849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6547320|NCT00875875|Rifaximin|rifaximin|mesh-list
6547321|NCT00875875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6547322|NCT00875875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6547323|NCT00875875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6547324|NCT00875927|Zinc|zinc|mesh-list
6547325|NCT00875927|Propolis|propolis|mesh-list
6547326|NCT00875927|Trace Elements|trace elements|mesh-ancestor
6547327|NCT00875927|Micronutrients|micronutrients|mesh-ancestor
6547328|NCT00875927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547329|NCT00875927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6547330|NCT00875966|Azithromycin|azithromycin|mesh-list
6547331|NCT00875966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6547332|NCT00875966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6655833|NCT01465984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6655834|NCT01465984|Analgesics|analgesics|mesh-ancestor
6655835|NCT01465984|Sensory System Agents|sensory system agents|mesh-ancestor
6655836|NCT01465984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6655837|NCT01465984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655838|NCT01465984|Antipyretics|antipyretics|mesh-ancestor
6655839|NCT01466101|Pregabalin|pregabalin|mesh-list
6547333|NCT00876044|Aflibercept|aflibercept|mesh-list
6547334|NCT00876044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6547335|NCT00876044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6547336|NCT00876044|Growth Substances|growth substances|mesh-ancestor
6547337|NCT00876044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547338|NCT00876044|Growth Inhibitors|growth inhibitors|mesh-ancestor
6547339|NCT00876044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6547340|NCT00876135|Albuterol|albuterol|mesh-list
6547341|NCT00876135|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6547342|NCT00876135|Autonomic Agents|autonomic agents|mesh-ancestor
6547343|NCT00876135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6547344|NCT00876135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547345|NCT00876135|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6547346|NCT00876135|Respiratory System Agents|respiratory system agents|mesh-ancestor
6547347|NCT00876135|Tocolytic Agents|tocolytic agents|mesh-ancestor
6547348|NCT00876135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6547349|NCT00876135|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6547350|NCT00876135|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6547351|NCT00876135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6547352|NCT00876135|Adrenergic Agents|adrenergic agents|mesh-ancestor
6547353|NCT00876135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6547354|NCT00876135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547355|NCT00876226|Citalopram|citalopram|mesh-list
6547356|NCT00876226|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6547357|NCT00876226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6547358|NCT00876226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6547359|NCT00876226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547360|NCT00876226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6547361|NCT00876226|Serotonin Agents|serotonin agents|mesh-ancestor
6019700|NCT00389064|Antidepressive Agents|antidepressive agents|mesh-ancestor
6019701|NCT00389064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6019702|NCT00389064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6019703|NCT00389064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6547362|NCT00876226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547363|NCT00876226|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6547364|NCT00876226|Antidepressive Agents|antidepressive agents|mesh-ancestor
6547365|NCT00876226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6547366|NCT00876317|Etoricoxib|etoricoxib|mesh-list
6547367|NCT00876317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6547368|NCT00876317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6547369|NCT00876317|Analgesics|analgesics|mesh-ancestor
6547370|NCT00876317|Sensory System Agents|sensory system agents|mesh-ancestor
6547371|NCT00876317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6547372|NCT00876317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547373|NCT00876317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6547374|NCT00876317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6547375|NCT00876317|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6547376|NCT00876317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6547377|NCT00876317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6547378|NCT00876317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547379|NCT00876330|Antihypertensive Agents|antihypertensive agents|mesh-list
6547380|NCT00876421|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6547381|NCT00876421|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6442485|NCT00376025|Antioxidants|antioxidants|mesh-list
6442486|NCT00376025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442487|NCT00376025|Protective Agents|protective agents|mesh-ancestor
6442488|NCT00376025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442489|NCT00376038|Metformin|metformin|mesh-list
6442490|NCT00376038|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6442491|NCT00376038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442492|NCT00376051|Citalopram|citalopram|mesh-list
6442493|NCT00376051|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6442494|NCT00376051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6442495|NCT00376051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6547382|NCT00876421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6547383|NCT00876421|Cholinergic Agents|cholinergic agents|mesh-ancestor
6547384|NCT00876421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6442496|NCT00376051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547385|NCT00876421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547386|NCT00876421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547387|NCT00876421|Urological Agents|urological agents|mesh-ancestor
6547388|NCT00876434|Sirolimus|sirolimus|mesh-list
6547389|NCT00876434|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6547390|NCT00876434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6547391|NCT00876434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6547392|NCT00876434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6547393|NCT00876434|Antifungal Agents|antifungal agents|mesh-ancestor
6547394|NCT00876434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6547395|NCT00876434|Immunologic Factors|immunologic factors|mesh-ancestor
6547396|NCT00876434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547397|NCT00876577|Moxifloxacin|moxifloxacin|mesh-list
6547398|NCT00876577|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6547399|NCT00876577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6547400|NCT00876577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6547401|NCT00876577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6655840|NCT01466101|Analgesics|analgesics|mesh-ancestor
6547402|NCT00876577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6547403|NCT00876577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6547404|NCT00876577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547405|NCT00876577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6547406|NCT00876577|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6547407|NCT00876577|Contraceptive Agents|contraceptive agents|mesh-ancestor
6547408|NCT00876577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6547409|NCT00876577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547410|NCT00876577|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6547411|NCT00876577|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6547412|NCT00876577|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6547413|NCT00876616|Mycophenolic Acid|mycophenolic acid|mesh-list
6547414|NCT00876616|Cyclophosphamide|cyclophosphamide|mesh-list
6547415|NCT00876616|Tacrolimus|tacrolimus|mesh-list
6547416|NCT00876616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6547417|NCT00876616|Immunologic Factors|immunologic factors|mesh-ancestor
6547418|NCT00876616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547419|NCT00876616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6547420|NCT00876616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6547421|NCT00876616|Alkylating Agents|alkylating agents|mesh-ancestor
6547422|NCT00876616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547423|NCT00876616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6547424|NCT00876616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6547425|NCT00876616|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6547426|NCT00876616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6547427|NCT00876616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6547428|NCT00876616|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6547429|NCT00876616|Antitubercular Agents|antitubercular agents|mesh-ancestor
6547430|NCT00876616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6547431|NCT00876616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6547432|NCT00876655|Tedizolid phosphate|tedizolid phosphate|mesh-list
6547433|NCT00876655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6547434|NCT00876655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6547435|NCT00876772|Olanzapine|olanzapine|mesh-list
6547436|NCT00876772|Antiemetics|antiemetics|mesh-ancestor
6547437|NCT00876772|Autonomic Agents|autonomic agents|mesh-ancestor
6547438|NCT00876772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6547439|NCT00876772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547440|NCT00876772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6547441|NCT00876772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6547442|NCT00876772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6547443|NCT00876772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6547444|NCT00876772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6547445|NCT00876772|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6547446|NCT00876772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6547447|NCT00876772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6547448|NCT00876772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547449|NCT00876772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6547450|NCT00876772|Serotonin Agents|serotonin agents|mesh-ancestor
6547451|NCT00876824|Amphotericin B|amphotericin b|mesh-list
6547452|NCT00876824|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6547453|NCT00876824|Amebicides|amebicides|mesh-ancestor
6547454|NCT00876824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6547455|NCT00876824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6547456|NCT00876824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6547457|NCT00876824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6547458|NCT00876824|Antifungal Agents|antifungal agents|mesh-ancestor
6547459|NCT00876850|Linezolid|linezolid|mesh-list
6547460|NCT00876850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6547461|NCT00876850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6547462|NCT00876850|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6547463|NCT00876850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6547464|NCT00876850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547465|NCT00876889|Riluzole|riluzole|mesh-list
6547466|NCT00876889|Anticonvulsants|anticonvulsants|mesh-ancestor
6547467|NCT00876889|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6547468|NCT00876889|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6547469|NCT00876889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6547470|NCT00876889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547471|NCT00876889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547472|NCT00876889|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6547473|NCT00876889|Protective Agents|protective agents|mesh-ancestor
6547474|NCT00876902|polysaccharide-K|polysaccharide-k|mesh-list
6547475|NCT00876902|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6547476|NCT00876902|Immunologic Factors|immunologic factors|mesh-ancestor
6547477|NCT00876902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547478|NCT00876902|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6547479|NCT00876902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6547480|NCT00876902|Antiviral Agents|antiviral agents|mesh-ancestor
6547481|NCT00876902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6547482|NCT00876902|Interferon Inducers|interferon inducers|mesh-ancestor
6547483|NCT00876902|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6547484|NCT00876902|Protective Agents|protective agents|mesh-ancestor
6547485|NCT00876967|Pyrithione zinc|pyrithione zinc|mesh-list
6547486|NCT00876967|Keratolytic Agents|keratolytic agents|mesh-ancestor
6547487|NCT00876967|Dermatologic Agents|dermatologic agents|mesh-ancestor
6547488|NCT00877097|Clodronic Acid|clodronic acid|mesh-list
6547489|NCT00877097|Trisequens|trisequens|mesh-list
6547490|NCT00877097|Norethindrone|norethindrone|mesh-list
6547491|NCT00877097|Estradiol|estradiol|mesh-list
6547492|NCT00877097|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6547493|NCT00877097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547494|NCT00877097|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6547495|NCT00877097|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6547496|NCT00877097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6547497|NCT00877097|Contraceptive Agents|contraceptive agents|mesh-ancestor
6547498|NCT00877097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6547499|NCT00877097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6547500|NCT00877097|Estrogens|estrogens|mesh-ancestor
6547501|NCT00877097|Hormones|hormones|mesh-ancestor
6547502|NCT00877097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6547503|NCT00877097|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6547504|NCT00877110|Cyclophosphamide|cyclophosphamide|mesh-list
6547505|NCT00877110|Vincristine|vincristine|mesh-list
6547506|NCT00877110|Topotecan|topotecan|mesh-list
6547507|NCT00877110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6547508|NCT00877110|Immunologic Factors|immunologic factors|mesh-ancestor
6547509|NCT00877110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547510|NCT00877110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6547511|NCT00877110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6547512|NCT00877110|Alkylating Agents|alkylating agents|mesh-ancestor
6547513|NCT00877110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547514|NCT00877110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6547515|NCT00877110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6547516|NCT00877110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6547517|NCT00877110|Tubulin Modulators|tubulin modulators|mesh-ancestor
6547518|NCT00877110|Antimitotic Agents|antimitotic agents|mesh-ancestor
6547519|NCT00877110|Mitosis Modulators|mitosis modulators|mesh-ancestor
6547520|NCT00877110|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6547521|NCT00877110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6547522|NCT00877110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6547523|NCT00877123|Vitamin D|vitamin d|mesh-list
6547524|NCT00877123|Vitamins|vitamins|mesh-ancestor
6547525|NCT00877123|Micronutrients|micronutrients|mesh-ancestor
6547526|NCT00877123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547527|NCT00877123|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6547528|NCT00877149|Telbivudine|telbivudine|mesh-list
6547529|NCT00877149|Antiviral Agents|antiviral agents|mesh-ancestor
6547530|NCT00877149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6547531|NCT00877149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6547532|NCT00877149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6547533|NCT00877149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547534|NCT00877175|Phenylephrine|phenylephrine|mesh-list
6547535|NCT00877175|Oxymetazoline|oxymetazoline|mesh-list
6547536|NCT00877175|Tropicamide|tropicamide|mesh-list
6547537|NCT00877175|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6547538|NCT00877175|Mydriatics|mydriatics|mesh-ancestor
6547539|NCT00877175|Autonomic Agents|autonomic agents|mesh-ancestor
6547540|NCT00877175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6547541|NCT00877175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547542|NCT00877175|Sympathomimetics|sympathomimetics|mesh-ancestor
6547543|NCT00877175|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6547544|NCT00877175|Nasal Decongestants|nasal decongestants|mesh-ancestor
6547545|NCT00877175|Respiratory System Agents|respiratory system agents|mesh-ancestor
6547546|NCT00877175|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6547547|NCT00877175|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6547548|NCT00877175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6547549|NCT00877175|Adrenergic Agents|adrenergic agents|mesh-ancestor
6547550|NCT00877175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6547551|NCT00877175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547552|NCT00877175|Protective Agents|protective agents|mesh-ancestor
6547553|NCT00877175|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6547554|NCT00877175|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6547555|NCT00877175|Cholinergic Agents|cholinergic agents|mesh-ancestor
6547556|NCT00877214|Rituximab|rituximab|mesh-list
6547557|NCT00877214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6547558|NCT00877214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6547559|NCT00877214|Immunologic Factors|immunologic factors|mesh-ancestor
6547560|NCT00877214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547561|NCT00877214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6547562|NCT00877227|Leucovorin|leucovorin|mesh-list
6547563|NCT00877227|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
6547564|NCT00877227|Levoleucovorin|levoleucovorin|mesh-list
6547565|NCT00877227|Antidotes|antidotes|mesh-ancestor
6547566|NCT00877227|Protective Agents|protective agents|mesh-ancestor
6547567|NCT00877227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547568|NCT00877227|Vitamin B Complex|vitamin b complex|mesh-ancestor
6547569|NCT00877227|Vitamins|vitamins|mesh-ancestor
6547570|NCT00877227|Micronutrients|micronutrients|mesh-ancestor
6547571|NCT00877253|Carboplatin|carboplatin|mesh-list
6547572|NCT00877253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6547573|NCT00877266|Mepivacaine|mepivacaine|mesh-list
6547574|NCT00877266|Anesthetics, Local|anesthetics, local|mesh-ancestor
6547575|NCT00877266|Anesthetics|anesthetics|mesh-ancestor
6547576|NCT00877266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6547577|NCT00877266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547578|NCT00877266|Sensory System Agents|sensory system agents|mesh-ancestor
6547579|NCT00877266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6547580|NCT00877396|Vaccines|vaccines|mesh-list
6547581|NCT00877396|Immunologic Factors|immunologic factors|mesh-ancestor
6547582|NCT00877396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547583|NCT00877409|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6547584|NCT00877409|Dermatologic Agents|dermatologic agents|mesh-ancestor
6547585|NCT00877422|Vitamin D|vitamin d|mesh-list
6547586|NCT00877422|Cholecalciferol|cholecalciferol|mesh-list
6547587|NCT00877422|Vitamins|vitamins|mesh-ancestor
6547588|NCT00877422|Micronutrients|micronutrients|mesh-ancestor
6547589|NCT00877422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547590|NCT00877422|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6547591|NCT00877422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6547592|NCT00877500|Epothilones|epothilones|mesh-list
6547593|NCT00877500|Epothilone B|epothilone b|mesh-list
6547594|NCT00877500|Tubulin Modulators|tubulin modulators|mesh-ancestor
6547595|NCT00877500|Antimitotic Agents|antimitotic agents|mesh-ancestor
6547596|NCT00877500|Mitosis Modulators|mitosis modulators|mesh-ancestor
6547597|NCT00877500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547598|NCT00877500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6547599|NCT00877539|Fluticasone|fluticasone|mesh-list
6547600|NCT00877539|Xhance|xhance|mesh-list
6547601|NCT00877539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6547602|NCT00877539|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6547603|NCT00877539|Autonomic Agents|autonomic agents|mesh-ancestor
6547604|NCT00877539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6547605|NCT00877539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547606|NCT00877539|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6547607|NCT00877539|Respiratory System Agents|respiratory system agents|mesh-ancestor
6547608|NCT00877539|Dermatologic Agents|dermatologic agents|mesh-ancestor
6547609|NCT00877539|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6547610|NCT00877591|Ritonavir|ritonavir|mesh-list
6547611|NCT00877591|Darunavir|darunavir|mesh-list
6547612|NCT00877591|Fosamprenavir|fosamprenavir|mesh-list
6547613|NCT00877591|Rifampin|rifampin|mesh-list
6547614|NCT00877591|Rifabutin|rifabutin|mesh-list
6547615|NCT00877591|Buprenorphine|buprenorphine|mesh-list
6547616|NCT00877591|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6547617|NCT00877591|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6547618|NCT00877591|Protease Inhibitors|protease inhibitors|mesh-ancestor
6547619|NCT00877591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6547620|NCT00877591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547621|NCT00877591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6547622|NCT00877591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6547623|NCT00877591|Antiviral Agents|antiviral agents|mesh-ancestor
6019704|NCT00389064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6019705|NCT00389064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442497|NCT00376051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6442498|NCT00376051|Serotonin Agents|serotonin agents|mesh-ancestor
6442499|NCT00376051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442500|NCT00376051|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6442501|NCT00376051|Antidepressive Agents|antidepressive agents|mesh-ancestor
6442502|NCT00376051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6442503|NCT00376064|Octreotide|octreotide|mesh-list
6547624|NCT00877591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6547625|NCT00877591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6547626|NCT00877591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6547627|NCT00877591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6547628|NCT00877591|Narcotics|narcotics|mesh-ancestor
6547629|NCT00877591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6547630|NCT00877591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547631|NCT00877591|Analgesics|analgesics|mesh-ancestor
6547632|NCT00877591|Sensory System Agents|sensory system agents|mesh-ancestor
6019706|NCT00389168|Atenolol|atenolol|mesh-list
6442504|NCT00376064|Cabergoline|cabergoline|mesh-list
6442505|NCT00376064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6442506|NCT00376064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6442507|NCT00376064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6547633|NCT00877591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6547634|NCT00877591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6547635|NCT00877591|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6547636|NCT00877591|Antitubercular Agents|antitubercular agents|mesh-ancestor
6547637|NCT00877591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6547638|NCT00877591|Leprostatic Agents|leprostatic agents|mesh-ancestor
6547639|NCT00877591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6547640|NCT00877591|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6547641|NCT00877591|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6547642|NCT00877591|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6547643|NCT00877591|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6547644|NCT00877591|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6547645|NCT00877591|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6547646|NCT00877656|Zanolimumab|zanolimumab|mesh-list
6547647|NCT00877656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6547648|NCT00877656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6655841|NCT01466101|Sensory System Agents|sensory system agents|mesh-ancestor
6655842|NCT01466101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6655843|NCT01466101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655844|NCT01466101|Anticonvulsants|anticonvulsants|mesh-ancestor
6655845|NCT01466101|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6655846|NCT01466101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6655847|NCT01466101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655848|NCT01466101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6655849|NCT01466101|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6655850|NCT01466101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6655851|NCT01466101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6655852|NCT01466101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6655853|NCT01466114|Norethindrone|norethindrone|mesh-list
6655854|NCT01466114|Norethindrone Acetate|norethindrone acetate|mesh-list
6655855|NCT01466114|Progestins|progestins|mesh-list
6655856|NCT01466114|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6655857|NCT01466114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6655858|NCT01466114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6655859|NCT01466114|Contraceptive Agents|contraceptive agents|mesh-ancestor
6655860|NCT01466114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6655861|NCT01466114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655862|NCT01466114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6655863|NCT01466114|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6655864|NCT01466114|Hormones|hormones|mesh-ancestor
6655865|NCT01466114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6655866|NCT01466205|Dihydrexidine|dihydrexidine|mesh-list
6655867|NCT01466205|Dopamine Agonists|dopamine agonists|mesh-ancestor
6655868|NCT01466205|Dopamine Agents|dopamine agents|mesh-ancestor
6655869|NCT01466205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6442508|NCT00376064|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6442509|NCT00376064|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6442510|NCT00376064|Dopamine Agonists|dopamine agonists|mesh-ancestor
6442511|NCT00376064|Dopamine Agents|dopamine agents|mesh-ancestor
6442512|NCT00376064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6442513|NCT00376064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442514|NCT00376064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442515|NCT00376077|Methylprednisolone|methylprednisolone|mesh-list
6442516|NCT00376077|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6442517|NCT00376077|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6547649|NCT00877734|Baclofen|baclofen|mesh-list
6547650|NCT00877734|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6547651|NCT00877734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547652|NCT00877734|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6547653|NCT00877734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6547654|NCT00877734|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6547655|NCT00877734|GABA Agonists|gaba agonists|mesh-ancestor
6547656|NCT00877734|GABA Agents|gaba agents|mesh-ancestor
6547657|NCT00877734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6547658|NCT00877734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547659|NCT00877760|Interferons|interferons|mesh-list
6547660|NCT00877760|Entecavir|entecavir|mesh-list
6547661|NCT00877760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6547662|NCT00877760|Antiviral Agents|antiviral agents|mesh-ancestor
6547663|NCT00877760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6547664|NCT00877812|Glycine|glycine|mesh-list
6547665|NCT00877812|Glycine Agents|glycine agents|mesh-ancestor
6547666|NCT00877812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6547667|NCT00877812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547668|NCT00877812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547669|NCT00877955|Alprazolam|alprazolam|mesh-list
6547670|NCT00877955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6547671|NCT00877955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6547672|NCT00877955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547673|NCT00877955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6547674|NCT00877955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6442518|NCT00376077|gamma-Globulins|gamma-globulins|mesh-list
6442519|NCT00376077|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6442520|NCT00376077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6442521|NCT00376077|Antiemetics|antiemetics|mesh-ancestor
6442522|NCT00376077|Autonomic Agents|autonomic agents|mesh-ancestor
6442523|NCT00376077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6442524|NCT00376077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547675|NCT00877955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6547676|NCT00877955|GABA Modulators|gaba modulators|mesh-ancestor
6547677|NCT00877955|GABA Agents|gaba agents|mesh-ancestor
6547678|NCT00877955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6547679|NCT00877955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547680|NCT00877981|Parathyroid Hormone|parathyroid hormone|mesh-list
6547681|NCT00877981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6547682|NCT00877981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547683|NCT00878124|Ubiquinone|ubiquinone|mesh-list
6547684|NCT00878124|Coenzyme Q10|coenzyme q10|mesh-list
6547685|NCT00878124|Micronutrients|micronutrients|mesh-ancestor
6547686|NCT00878124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547687|NCT00878124|Vitamins|vitamins|mesh-ancestor
6547688|NCT00878163|Gemcitabine|gemcitabine|mesh-list
6547689|NCT00878163|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6547690|NCT00878163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6547691|NCT00878163|Antimetabolites|antimetabolites|mesh-ancestor
6547692|NCT00878163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547693|NCT00878163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6547694|NCT00878163|Antiviral Agents|antiviral agents|mesh-ancestor
6547695|NCT00878163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6547696|NCT00878163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6547697|NCT00878163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6547698|NCT00878163|Immunologic Factors|immunologic factors|mesh-ancestor
6547699|NCT00878163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547700|NCT00878163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6547701|NCT00878254|Leucovorin|leucovorin|mesh-list
6547702|NCT00878254|Cytarabine|cytarabine|mesh-list
6547703|NCT00878254|Cyclophosphamide|cyclophosphamide|mesh-list
6547704|NCT00878254|Ifosfamide|ifosfamide|mesh-list
6547705|NCT00878254|Rituximab|rituximab|mesh-list
6547706|NCT00878254|Doxorubicin|doxorubicin|mesh-list
6442525|NCT00376077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6442526|NCT00376077|Glucocorticoids|glucocorticoids|mesh-ancestor
6442527|NCT00376077|Hormones|hormones|mesh-ancestor
6442528|NCT00376077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6547707|NCT00878254|Methotrexate|methotrexate|mesh-list
6547708|NCT00878254|Etoposide|etoposide|mesh-list
6547709|NCT00878254|Vincristine|vincristine|mesh-list
6547710|NCT00878254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6547711|NCT00878254|Immunologic Factors|immunologic factors|mesh-ancestor
6547712|NCT00878254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547713|NCT00878254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6547714|NCT00878254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6547715|NCT00878254|Alkylating Agents|alkylating agents|mesh-ancestor
6547716|NCT00878254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547717|NCT00878254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6547718|NCT00878254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6547719|NCT00878254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6547720|NCT00878254|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6547721|NCT00878254|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6547722|NCT00878254|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6547723|NCT00878254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6547724|NCT00878254|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6547725|NCT00878254|Abortifacient Agents|abortifacient agents|mesh-ancestor
6547726|NCT00878254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6547727|NCT00878254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6547728|NCT00878254|Antimetabolites|antimetabolites|mesh-ancestor
6547729|NCT00878254|Dermatologic Agents|dermatologic agents|mesh-ancestor
6547730|NCT00878254|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6547731|NCT00878254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6547732|NCT00878254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6547733|NCT00878254|Antiviral Agents|antiviral agents|mesh-ancestor
6547734|NCT00878254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6547735|NCT00878254|Antidotes|antidotes|mesh-ancestor
6547736|NCT00878254|Protective Agents|protective agents|mesh-ancestor
6547737|NCT00878254|Vitamin B Complex|vitamin b complex|mesh-ancestor
6547738|NCT00878254|Vitamins|vitamins|mesh-ancestor
6547739|NCT00878254|Micronutrients|micronutrients|mesh-ancestor
6547740|NCT00878254|Tubulin Modulators|tubulin modulators|mesh-ancestor
6547741|NCT00878254|Antimitotic Agents|antimitotic agents|mesh-ancestor
6547742|NCT00878254|Mitosis Modulators|mitosis modulators|mesh-ancestor
6547743|NCT00878306|Ritonavir|ritonavir|mesh-list
6547744|NCT00878306|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6547745|NCT00878306|Efavirenz|efavirenz|mesh-list
6547746|NCT00878306|Disulfiram|disulfiram|mesh-list
6547747|NCT00878306|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6547748|NCT00878306|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6547749|NCT00878306|Protease Inhibitors|protease inhibitors|mesh-ancestor
6547750|NCT00878306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6547751|NCT00878306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547752|NCT00878306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6547753|NCT00878306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6547754|NCT00878306|Antiviral Agents|antiviral agents|mesh-ancestor
6547755|NCT00878306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6547756|NCT00878306|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6547757|NCT00878306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6547758|NCT00878306|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6547759|NCT00878306|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6547760|NCT00878306|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6547761|NCT00878306|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6547762|NCT00878306|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6547763|NCT00878306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6547764|NCT00878306|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6547765|NCT00878306|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6547766|NCT00878306|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
6547767|NCT00878345|Pentobarbital|pentobarbital|mesh-list
6547768|NCT00878345|Dexmedetomidine|dexmedetomidine|mesh-list
6547769|NCT00878345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6547770|NCT00878345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6547771|NCT00878345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547772|NCT00878345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6547773|NCT00878345|Analgesics|analgesics|mesh-ancestor
6547774|NCT00878345|Sensory System Agents|sensory system agents|mesh-ancestor
6547775|NCT00878345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6547776|NCT00878345|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6547777|NCT00878345|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6547778|NCT00878345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6547779|NCT00878345|Adrenergic Agents|adrenergic agents|mesh-ancestor
6547780|NCT00878345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6547781|NCT00878345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547782|NCT00878345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6547783|NCT00878345|GABA Modulators|gaba modulators|mesh-ancestor
6547784|NCT00878345|GABA Agents|gaba agents|mesh-ancestor
6547785|NCT00878371|Morphine|morphine|mesh-list
6547786|NCT00878371|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6547787|NCT00878371|Narcotics|narcotics|mesh-ancestor
6547788|NCT00878371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6547789|NCT00878371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547790|NCT00878371|Analgesics|analgesics|mesh-ancestor
6547791|NCT00878371|Sensory System Agents|sensory system agents|mesh-ancestor
6547792|NCT00878371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6547793|NCT00878449|Etoposide|etoposide|mesh-list
6547794|NCT00878449|Navitoclax|navitoclax|mesh-list
6547795|NCT00878449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6547796|NCT00878449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6547797|NCT00878449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6547798|NCT00878449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6547799|NCT00878449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6547800|NCT00878449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547801|NCT00878514|Alprazolam|alprazolam|mesh-list
6547802|NCT00878514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6547803|NCT00878514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6547804|NCT00878514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547805|NCT00878514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6547806|NCT00878514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6547807|NCT00878514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6547808|NCT00878514|GABA Modulators|gaba modulators|mesh-ancestor
6547809|NCT00878514|GABA Agents|gaba agents|mesh-ancestor
6547810|NCT00878514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6547811|NCT00878514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547812|NCT00878540|Mirtazapine|mirtazapine|mesh-list
6547813|NCT00878540|Antidepressive Agents|antidepressive agents|mesh-ancestor
6547814|NCT00878540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6547815|NCT00878540|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6547816|NCT00878540|Histamine Antagonists|histamine antagonists|mesh-ancestor
6547817|NCT00878540|Histamine Agents|histamine agents|mesh-ancestor
6547818|NCT00878540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6547819|NCT00878540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547820|NCT00878540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547821|NCT00878540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6547822|NCT00878540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6547823|NCT00878540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6547824|NCT00878540|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6547825|NCT00878540|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6547826|NCT00878540|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6547827|NCT00878540|Adrenergic Agents|adrenergic agents|mesh-ancestor
6547828|NCT00878540|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6547829|NCT00878540|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6547830|NCT00878540|Serotonin Agents|serotonin agents|mesh-ancestor
6547831|NCT00878540|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6547832|NCT00878631|Dextrans|dextrans|mesh-list
6547833|NCT00878631|Anticoagulants|anticoagulants|mesh-ancestor
6547834|NCT00878631|Plasma Substitutes|plasma substitutes|mesh-ancestor
6547835|NCT00878631|Blood Substitutes|blood substitutes|mesh-ancestor
6547836|NCT00878657|Gemcitabine|gemcitabine|mesh-list
6547837|NCT00878657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6547838|NCT00878657|Antimetabolites|antimetabolites|mesh-ancestor
6547839|NCT00878657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547840|NCT00878657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6547841|NCT00878657|Antiviral Agents|antiviral agents|mesh-ancestor
6547842|NCT00878657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6547843|NCT00878657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6547844|NCT00878657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6547845|NCT00878657|Immunologic Factors|immunologic factors|mesh-ancestor
6547846|NCT00878657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547847|NCT00878670|Evening primrose oil|evening primrose oil|mesh-list
6547848|NCT00878670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6547849|NCT00878670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6547850|NCT00878670|Analgesics|analgesics|mesh-ancestor
6547851|NCT00878670|Sensory System Agents|sensory system agents|mesh-ancestor
6547852|NCT00878670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6547853|NCT00878670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547854|NCT00878670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6547855|NCT00878670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6547856|NCT00878670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6547857|NCT00878670|Antimetabolites|antimetabolites|mesh-ancestor
6547858|NCT00878670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547859|NCT00878670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6547860|NCT00878670|Dermatologic Agents|dermatologic agents|mesh-ancestor
6547861|NCT00878748|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6547862|NCT00878748|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6547863|NCT00878748|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6547864|NCT00878748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6547865|NCT00878748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547866|NCT00878748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6547867|NCT00878748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547868|NCT00878748|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6547869|NCT00878748|Antidepressive Agents|antidepressive agents|mesh-ancestor
6547870|NCT00878748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6547871|NCT00878865|Alprazolam|alprazolam|mesh-list
6547872|NCT00878865|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6547873|NCT00878865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6547874|NCT00878865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547875|NCT00878865|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6547876|NCT00878865|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6547877|NCT00878865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6547878|NCT00878865|GABA Modulators|gaba modulators|mesh-ancestor
6547879|NCT00878865|GABA Agents|gaba agents|mesh-ancestor
6547880|NCT00878865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6547881|NCT00878865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547882|NCT00878904|Epirubicin|epirubicin|mesh-list
6547883|NCT00878904|Panobinostat|panobinostat|mesh-list
6547884|NCT00878904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6547885|NCT00878904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6547886|NCT00878904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6547887|NCT00878904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6547888|NCT00878904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6547889|NCT00878904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547890|NCT00878904|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6547891|NCT00878917|Dorzolamide|dorzolamide|mesh-list
6547892|NCT00878917|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6547893|NCT00878917|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6547894|NCT00878917|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6547895|NCT00878917|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6547896|NCT00878917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6547897|NCT00878917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547898|NCT00878943|Sildenafil Citrate|sildenafil citrate|mesh-list
6547899|NCT00878943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547900|NCT00878943|Vasodilator Agents|vasodilator agents|mesh-ancestor
6547901|NCT00878943|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6547902|NCT00878943|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6547903|NCT00878943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6547904|NCT00878943|Urological Agents|urological agents|mesh-ancestor
6547905|NCT00879008|Moxifloxacin|moxifloxacin|mesh-list
6547906|NCT00879008|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6547907|NCT00879008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6547908|NCT00879008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6547909|NCT00879008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6547910|NCT00879008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6547911|NCT00879008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6547912|NCT00879008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547913|NCT00879008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6547914|NCT00879008|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6547915|NCT00879008|Contraceptive Agents|contraceptive agents|mesh-ancestor
6547916|NCT00879008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6547917|NCT00879008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547918|NCT00879008|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6547919|NCT00879008|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6547920|NCT00879008|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6547921|NCT00879021|Pregabalin|pregabalin|mesh-list
6547922|NCT00879021|Analgesics|analgesics|mesh-ancestor
6547923|NCT00879021|Sensory System Agents|sensory system agents|mesh-ancestor
6547924|NCT00879021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6547925|NCT00879021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547926|NCT00879021|Anticonvulsants|anticonvulsants|mesh-ancestor
6547927|NCT00879021|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6547928|NCT00879021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6547929|NCT00879021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547930|NCT00879021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6547931|NCT00879021|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6547932|NCT00879021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6547933|NCT00879021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6547934|NCT00879021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6547935|NCT00879047|Ethanol|ethanol|mesh-list
6547936|NCT00879047|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6547937|NCT00879047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6547938|NCT00879047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6547939|NCT00879047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547940|NCT00879073|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6547941|NCT00879073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6547942|NCT00879073|Alkylating Agents|alkylating agents|mesh-ancestor
6547943|NCT00879073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547944|NCT00879073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6547945|NCT00879099|Timolol|timolol|mesh-list
6547946|NCT00879099|Paroxetine|paroxetine|mesh-list
6547947|NCT00879099|Maleic acid|maleic acid|mesh-list
6547948|NCT00879099|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6547949|NCT00879099|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6547950|NCT00879099|Adrenergic Agents|adrenergic agents|mesh-ancestor
6547951|NCT00879099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6547952|NCT00879099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547953|NCT00879099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547954|NCT00879099|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6547955|NCT00879099|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6547956|NCT00879099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6547957|NCT00879099|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6547958|NCT00879099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6547959|NCT00879099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6547960|NCT00879099|Serotonin Agents|serotonin agents|mesh-ancestor
6547961|NCT00879099|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6547962|NCT00879099|Antidepressive Agents|antidepressive agents|mesh-ancestor
6547963|NCT00879099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6547964|NCT00879099|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6547965|NCT00879099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6547966|NCT00879164|Bupivacaine|bupivacaine|mesh-list
6547967|NCT00879164|Anesthetics, Local|anesthetics, local|mesh-ancestor
6547968|NCT00879164|Anesthetics|anesthetics|mesh-ancestor
6547969|NCT00879164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6547970|NCT00879164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547971|NCT00879164|Sensory System Agents|sensory system agents|mesh-ancestor
6547972|NCT00879164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6547973|NCT00879177|Varenicline|varenicline|mesh-list
6547974|NCT00879177|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6547975|NCT00879177|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6547976|NCT00879177|Cholinergic Agents|cholinergic agents|mesh-ancestor
6547977|NCT00879177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6547978|NCT00879177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547979|NCT00879177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547980|NCT00879242|Deferasirox|deferasirox|mesh-list
6547981|NCT00879242|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6547982|NCT00879242|Chelating Agents|chelating agents|mesh-ancestor
6547983|NCT00879242|Sequestering Agents|sequestering agents|mesh-ancestor
6547984|NCT00879242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6547985|NCT00879268|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6547986|NCT00879307|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6547987|NCT00879307|Antidepressive Agents|antidepressive agents|mesh-ancestor
6547988|NCT00879307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6547989|NCT00879307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6547990|NCT00879307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6547991|NCT00879307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6547992|NCT00879307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6547993|NCT00879372|Tianeptine|tianeptine|mesh-list
6547994|NCT00879372|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6547995|NCT00879372|Antidepressive Agents|antidepressive agents|mesh-ancestor
6547996|NCT00879372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6547997|NCT00879385|Decitabine|decitabine|mesh-list
6547998|NCT00879385|Panitumumab|panitumumab|mesh-list
6547999|NCT00879385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6548000|NCT00879385|Antimetabolites|antimetabolites|mesh-ancestor
6548001|NCT00879385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548002|NCT00879385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6548003|NCT00879385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6548004|NCT00879385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6548005|NCT00879424|Vitamin D|vitamin d|mesh-list
6548006|NCT00879424|Cholecalciferol|cholecalciferol|mesh-list
6548007|NCT00879424|Vitamins|vitamins|mesh-ancestor
6548008|NCT00879424|Micronutrients|micronutrients|mesh-ancestor
6548009|NCT00879424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548010|NCT00879424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6548011|NCT00879424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6655870|NCT01466205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655871|NCT01466205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655872|NCT01466231|Everolimus|everolimus|mesh-list
6655873|NCT01466231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6655874|NCT01466231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6655875|NCT01466231|Immunologic Factors|immunologic factors|mesh-ancestor
6655876|NCT01466231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655877|NCT01466244|Cetuximab|cetuximab|mesh-list
6655878|NCT01466244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6655879|NCT01466244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6655880|NCT01466257|Cetuximab|cetuximab|mesh-list
6655881|NCT01466257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6655882|NCT01466257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6655883|NCT01466452|Aspirin|aspirin|mesh-list
6655884|NCT01466452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6548012|NCT00879476|Ramipril|ramipril|mesh-list
6548013|NCT00879476|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6548014|NCT00879476|Protease Inhibitors|protease inhibitors|mesh-ancestor
6548015|NCT00879476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6548016|NCT00879476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548017|NCT00879476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6548018|NCT00879489|Vaccines|vaccines|mesh-list
6548019|NCT00879489|Immunologic Factors|immunologic factors|mesh-ancestor
6548020|NCT00879489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548021|NCT00879541|Factor VIII|factor viii|mesh-list
6548022|NCT00879541|Coagulants|coagulants|mesh-ancestor
6548023|NCT00879723|Vitamins|vitamins|mesh-list
6548024|NCT00879723|Micronutrients|micronutrients|mesh-ancestor
6548025|NCT00879723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548026|NCT00879788|Ramipril|ramipril|mesh-list
6548027|NCT00879788|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6548028|NCT00879788|Protease Inhibitors|protease inhibitors|mesh-ancestor
6548029|NCT00879788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6548030|NCT00879788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548031|NCT00879788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6548032|NCT00879827|PENTA|penta|mesh-list
6548033|NCT00879827|Anticoagulants|anticoagulants|mesh-ancestor
6548034|NCT00879827|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6548035|NCT00879827|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6548036|NCT00879827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548037|NCT00879892|Xenon|xenon|mesh-list
6548038|NCT00879892|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6548039|NCT00879892|Anesthetics, General|anesthetics, general|mesh-ancestor
6548040|NCT00879892|Anesthetics|anesthetics|mesh-ancestor
6548041|NCT00879892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6548042|NCT00879892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548043|NCT00879918|Nicotine|nicotine|mesh-list
6548044|NCT00879918|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6548045|NCT00879918|Autonomic Agents|autonomic agents|mesh-ancestor
6548046|NCT00879918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6548047|NCT00879918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548048|NCT00879918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6548049|NCT00879918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6548050|NCT00879918|Cholinergic Agents|cholinergic agents|mesh-ancestor
6548051|NCT00879918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6548052|NCT00879918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548053|NCT00879931|Methylprednisolone|methylprednisolone|mesh-list
6548054|NCT00879931|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6548055|NCT00879931|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6548056|NCT00879931|Prednisolone|prednisolone|mesh-list
6548057|NCT00879931|Prednisolone acetate|prednisolone acetate|mesh-list
6548058|NCT00879931|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6548059|NCT00879931|Prednisolone phosphate|prednisolone phosphate|mesh-list
6548060|NCT00879931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6548061|NCT00879931|Antiemetics|antiemetics|mesh-ancestor
6548062|NCT00879931|Autonomic Agents|autonomic agents|mesh-ancestor
6548063|NCT00879931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6548064|NCT00879931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442529|NCT00376077|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6442530|NCT00376077|Protective Agents|protective agents|mesh-ancestor
6442531|NCT00376077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6442532|NCT00376077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6442533|NCT00376077|Immunologic Factors|immunologic factors|mesh-ancestor
6442534|NCT00376103|Temozolomide|temozolomide|mesh-list
6442535|NCT00376103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6442536|NCT00376103|Alkylating Agents|alkylating agents|mesh-ancestor
6442537|NCT00376103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442538|NCT00376103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6442539|NCT00376129|Alefacept|alefacept|mesh-list
6442540|NCT00376129|Dermatologic Agents|dermatologic agents|mesh-ancestor
6548065|NCT00879931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6548066|NCT00879931|Glucocorticoids|glucocorticoids|mesh-ancestor
6548067|NCT00879931|Hormones|hormones|mesh-ancestor
6548068|NCT00879931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6548069|NCT00879931|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6548070|NCT00879931|Protective Agents|protective agents|mesh-ancestor
6548071|NCT00879931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6548072|NCT00879931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6548073|NCT00879957|Heparin|heparin|mesh-list
6548074|NCT00879957|Calcium heparin|calcium heparin|mesh-list
6548075|NCT00879957|Anticoagulants|anticoagulants|mesh-ancestor
6548076|NCT00879957|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6548077|NCT00879957|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6548078|NCT00879957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442541|NCT00376129|Immunologic Factors|immunologic factors|mesh-ancestor
6548079|NCT00879983|Azithromycin|azithromycin|mesh-list
6548080|NCT00879983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6548081|NCT00879983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6548082|NCT00880178|Niacin|niacin|mesh-list
6548083|NCT00880178|Niacinamide|niacinamide|mesh-list
6548084|NCT00880178|Nicotinic Acids|nicotinic acids|mesh-list
6548085|NCT00880178|Simvastatin|simvastatin|mesh-list
6548086|NCT00880178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6548087|NCT00880178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6548088|NCT00880178|Antimetabolites|antimetabolites|mesh-ancestor
6548089|NCT00880178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548090|NCT00880178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6548091|NCT00880178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6548092|NCT00880178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6548093|NCT00880178|Vasodilator Agents|vasodilator agents|mesh-ancestor
6548094|NCT00880178|Vitamin B Complex|vitamin b complex|mesh-ancestor
6548095|NCT00880178|Vitamins|vitamins|mesh-ancestor
6548096|NCT00880178|Micronutrients|micronutrients|mesh-ancestor
6548097|NCT00880178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548098|NCT00880243|Cytarabine|cytarabine|mesh-list
6548099|NCT00880243|Etoposide|etoposide|mesh-list
6548100|NCT00880243|Mitoxantrone|mitoxantrone|mesh-list
6548101|NCT00880243|Daunorubicin|daunorubicin|mesh-list
6548102|NCT00880243|Molgramostim|molgramostim|mesh-list
6548103|NCT00880243|Sargramostim|sargramostim|mesh-list
6548104|NCT00880243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6548105|NCT00880243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6548106|NCT00880243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6548107|NCT00880243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6548108|NCT00880243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6548109|NCT00880243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548110|NCT00880243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6548111|NCT00880243|Antimetabolites|antimetabolites|mesh-ancestor
6548112|NCT00880243|Antiviral Agents|antiviral agents|mesh-ancestor
6548113|NCT00880243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6548114|NCT00880243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6548115|NCT00880243|Immunologic Factors|immunologic factors|mesh-ancestor
6548116|NCT00880243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548117|NCT00880243|Analgesics|analgesics|mesh-ancestor
6548118|NCT00880243|Sensory System Agents|sensory system agents|mesh-ancestor
6548119|NCT00880243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6548120|NCT00880243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6548121|NCT00880282|Sirolimus|sirolimus|mesh-list
6548122|NCT00880282|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6548123|NCT00880282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6548124|NCT00880282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6548125|NCT00880282|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6548126|NCT00880282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6548127|NCT00880282|Antifungal Agents|antifungal agents|mesh-ancestor
6548128|NCT00880282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6548129|NCT00880282|Immunologic Factors|immunologic factors|mesh-ancestor
6548130|NCT00880282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548131|NCT00880321|Dabrafenib|dabrafenib|mesh-list
6548132|NCT00880321|Midazolam|midazolam|mesh-list
6548133|NCT00880321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6548134|NCT00880321|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6548135|NCT00880321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6548136|NCT00880321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548137|NCT00880321|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6548138|NCT00880321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6548139|NCT00880321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6548140|NCT00880321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6548141|NCT00880321|Anesthetics, General|anesthetics, general|mesh-ancestor
6548142|NCT00880321|Anesthetics|anesthetics|mesh-ancestor
6548143|NCT00880321|GABA Modulators|gaba modulators|mesh-ancestor
6548144|NCT00880321|GABA Agents|gaba agents|mesh-ancestor
6548145|NCT00880321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6548146|NCT00880321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548147|NCT00880321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6548148|NCT00880321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6548149|NCT00880321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6548150|NCT00880373|Ibuprofen|ibuprofen|mesh-list
6548151|NCT00880373|Morphine|morphine|mesh-list
6548152|NCT00880373|Heroin|heroin|mesh-list
6548153|NCT00880373|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6548154|NCT00880373|Narcotics|narcotics|mesh-ancestor
6548155|NCT00880373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6548156|NCT00880373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548157|NCT00880373|Analgesics|analgesics|mesh-ancestor
6548158|NCT00880373|Sensory System Agents|sensory system agents|mesh-ancestor
6548159|NCT00880373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6548160|NCT00880373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6548161|NCT00880373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6548162|NCT00880373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6548163|NCT00880373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6548164|NCT00880373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6548165|NCT00880373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6548166|NCT00880373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442542|NCT00376129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442543|NCT00376155|Pyrimethamine|pyrimethamine|mesh-list
6442544|NCT00376155|Sulfadoxine|sulfadoxine|mesh-list
6442545|NCT00376155|Amodiaquine|amodiaquine|mesh-list
6442546|NCT00376155|Antimalarials|antimalarials|mesh-ancestor
6442547|NCT00376155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6442548|NCT00376155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6442549|NCT00376155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6442550|NCT00376155|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6442551|NCT00376155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6442552|NCT00376155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442553|NCT00376155|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6442554|NCT00376155|Renal Agents|renal agents|mesh-ancestor
6442555|NCT00376181|Pioglitazone|pioglitazone|mesh-list
6442556|NCT00376181|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
6442557|NCT00376181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6442558|NCT00376181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442559|NCT00376181|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6442560|NCT00376181|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6442561|NCT00376181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442562|NCT00376272|Valsartan|valsartan|mesh-list
6442563|NCT00376272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6442564|NCT00376272|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6442565|NCT00376272|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6548167|NCT00880386|Losartan|losartan|mesh-list
6548168|NCT00880386|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6548169|NCT00880386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6548170|NCT00880386|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6548171|NCT00880386|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6548172|NCT00880386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548173|NCT00880412|Etazolate|etazolate|mesh-list
6548174|NCT00880412|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6548175|NCT00880412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6548176|NCT00880412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548177|NCT00880412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6548178|NCT00880412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6548179|NCT00880412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6548180|NCT00880412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548181|NCT00880412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6548182|NCT00880477|Edetic Acid|edetic acid|mesh-list
6548183|NCT00880477|Vaccines|vaccines|mesh-list
6548184|NCT00880477|Pentetic Acid|pentetic acid|mesh-list
6548185|NCT00880477|Immunologic Factors|immunologic factors|mesh-ancestor
6548186|NCT00880477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548187|NCT00880477|Antidotes|antidotes|mesh-ancestor
6548188|NCT00880477|Protective Agents|protective agents|mesh-ancestor
6548189|NCT00880477|Chelating Agents|chelating agents|mesh-ancestor
6548190|NCT00880477|Sequestering Agents|sequestering agents|mesh-ancestor
6548191|NCT00880477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548192|NCT00880477|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6548193|NCT00880477|Anticoagulants|anticoagulants|mesh-ancestor
6548194|NCT00880477|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6548195|NCT00880529|Morphine|morphine|mesh-list
6548196|NCT00880529|Bupivacaine|bupivacaine|mesh-list
6548197|NCT00880529|Anesthetics, Local|anesthetics, local|mesh-ancestor
6548198|NCT00880529|Anesthetics|anesthetics|mesh-ancestor
6548199|NCT00880529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6548200|NCT00880529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548201|NCT00880529|Sensory System Agents|sensory system agents|mesh-ancestor
6548202|NCT00880529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6548203|NCT00880529|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6548204|NCT00880529|Narcotics|narcotics|mesh-ancestor
6548205|NCT00880529|Analgesics|analgesics|mesh-ancestor
6548206|NCT00880594|Desipramine|desipramine|mesh-list
6548207|NCT00880594|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6548208|NCT00880594|Antidepressive Agents|antidepressive agents|mesh-ancestor
6548209|NCT00880594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6548210|NCT00880594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6548211|NCT00880594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548212|NCT00880594|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6548213|NCT00880594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6548214|NCT00880594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6548215|NCT00880594|Adrenergic Agents|adrenergic agents|mesh-ancestor
6548216|NCT00880594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6548217|NCT00880594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548218|NCT00880672|Dutasteride|dutasteride|mesh-list
6548219|NCT00880672|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6548220|NCT00880672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6548221|NCT00880672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6548222|NCT00880672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548223|NCT00880672|Hormone Antagonists|hormone antagonists|mesh-ancestor
6548224|NCT00880672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6548225|NCT00880672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548226|NCT00880815|Rituximab|rituximab|mesh-list
6548227|NCT00880815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6548228|NCT00880815|Methotrexate|methotrexate|mesh-list
6548229|NCT00880815|Fludarabine|fludarabine|mesh-list
6548230|NCT00880815|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6548231|NCT00880815|Antibodies|antibodies|mesh-list
6548232|NCT00880815|Immunoglobulins|immunoglobulins|mesh-list
6548233|NCT00880815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6548234|NCT00880815|Lenograstim|lenograstim|mesh-list
6548235|NCT00880815|Tacrolimus|tacrolimus|mesh-list
6548236|NCT00880815|Thymoglobulin|thymoglobulin|mesh-list
6548237|NCT00880815|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6548238|NCT00880815|Immunologic Factors|immunologic factors|mesh-ancestor
6548239|NCT00880815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548240|NCT00880815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6548241|NCT00880815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6548242|NCT00880815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6548243|NCT00880815|Abortifacient Agents|abortifacient agents|mesh-ancestor
6548244|NCT00880815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6548245|NCT00880815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6548246|NCT00880815|Antimetabolites|antimetabolites|mesh-ancestor
6548247|NCT00880815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548248|NCT00880815|Dermatologic Agents|dermatologic agents|mesh-ancestor
6548249|NCT00880815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6548250|NCT00880815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6548251|NCT00880815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6548252|NCT00880815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6548253|NCT00880815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6548254|NCT00880815|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6548255|NCT00880815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6548256|NCT00880815|Alkylating Agents|alkylating agents|mesh-ancestor
6548257|NCT00880828|Acetaminophen|acetaminophen|mesh-list
6548258|NCT00880828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6548259|NCT00880828|Analgesics|analgesics|mesh-ancestor
6548260|NCT00880828|Sensory System Agents|sensory system agents|mesh-ancestor
6548261|NCT00880828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6548262|NCT00880828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548263|NCT00880828|Antipyretics|antipyretics|mesh-ancestor
6548264|NCT00880841|Buprenorphine|buprenorphine|mesh-list
6548265|NCT00880841|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6548266|NCT00880841|Naloxone|naloxone|mesh-list
6548267|NCT00880841|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6548268|NCT00880841|Narcotics|narcotics|mesh-ancestor
6548269|NCT00880841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6548270|NCT00880841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548271|NCT00880841|Analgesics|analgesics|mesh-ancestor
6548272|NCT00880841|Sensory System Agents|sensory system agents|mesh-ancestor
6548273|NCT00880841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6548274|NCT00880841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6548275|NCT00880854|Tremelimumab|tremelimumab|mesh-list
6548276|NCT00880854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6548277|NCT00880867|Poly ICLC|poly iclc|mesh-list
6548278|NCT00880867|Interferon Inducers|interferon inducers|mesh-ancestor
6548279|NCT00880867|Immunologic Factors|immunologic factors|mesh-ancestor
6548280|NCT00880867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548281|NCT00881049|Imatinib Mesylate|imatinib mesylate|mesh-list
6548282|NCT00881049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6548283|NCT00881049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6548284|NCT00881049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6548285|NCT00881049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548286|NCT00881088|PENTA|penta|mesh-list
6548287|NCT00881088|Nadroparin|nadroparin|mesh-list
6548288|NCT00881088|Fondaparinux|fondaparinux|mesh-list
6548289|NCT00881088|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6548290|NCT00881088|Antithrombins|antithrombins|mesh-ancestor
6548291|NCT00881088|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6548292|NCT00881088|Protease Inhibitors|protease inhibitors|mesh-ancestor
6548293|NCT00881088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6548294|NCT00881088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548295|NCT00881088|Anticoagulants|anticoagulants|mesh-ancestor
6548296|NCT00881088|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6548297|NCT00881088|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6548298|NCT00881101|Paclitaxel|paclitaxel|mesh-list
6548299|NCT00881101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6548300|NCT00881101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6548301|NCT00881101|Tubulin Modulators|tubulin modulators|mesh-ancestor
6548302|NCT00881101|Antimitotic Agents|antimitotic agents|mesh-ancestor
6548303|NCT00881101|Mitosis Modulators|mitosis modulators|mesh-ancestor
6548304|NCT00881101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548305|NCT00881114|Cetuximab|cetuximab|mesh-list
6548306|NCT00881114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6548307|NCT00881114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6548308|NCT00881127|Cetirizine|cetirizine|mesh-list
6548309|NCT00881127|Pseudoephedrine|pseudoephedrine|mesh-list
6548310|NCT00881127|Ephedrine|ephedrine|mesh-list
6548311|NCT00881127|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6548312|NCT00881127|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6548313|NCT00881127|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6548314|NCT00881127|Histamine Antagonists|histamine antagonists|mesh-ancestor
6548315|NCT00881127|Histamine Agents|histamine agents|mesh-ancestor
6548316|NCT00881127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6548317|NCT00881127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548318|NCT00881127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548319|NCT00881127|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6548320|NCT00881127|Autonomic Agents|autonomic agents|mesh-ancestor
6548321|NCT00881127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6548322|NCT00881127|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6548323|NCT00881127|Respiratory System Agents|respiratory system agents|mesh-ancestor
6548324|NCT00881127|Nasal Decongestants|nasal decongestants|mesh-ancestor
6548325|NCT00881127|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6548326|NCT00881127|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6548327|NCT00881127|Sympathomimetics|sympathomimetics|mesh-ancestor
6548328|NCT00881127|Adrenergic Agents|adrenergic agents|mesh-ancestor
6548329|NCT00881140|Mifepristone|mifepristone|mesh-list
6548330|NCT00881140|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6548331|NCT00881140|Abortifacient Agents|abortifacient agents|mesh-ancestor
6548332|NCT00881140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6548333|NCT00881140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548334|NCT00881140|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6548335|NCT00881140|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6548336|NCT00881140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6548337|NCT00881140|Contraceptive Agents|contraceptive agents|mesh-ancestor
6548338|NCT00881140|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6548339|NCT00881140|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6548340|NCT00881140|Hormone Antagonists|hormone antagonists|mesh-ancestor
6548341|NCT00881140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6548342|NCT00881140|Luteolytic Agents|luteolytic agents|mesh-ancestor
6548343|NCT00881140|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6548344|NCT00881140|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6548345|NCT00881153|Cefprozil|cefprozil|mesh-list
6548346|NCT00881153|Cephalosporins|cephalosporins|mesh-list
6548347|NCT00881153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6548348|NCT00881153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6548349|NCT00881166|Paclitaxel|paclitaxel|mesh-list
6548350|NCT00881166|Etoposide|etoposide|mesh-list
6548351|NCT00881166|Docetaxel|docetaxel|mesh-list
6548352|NCT00881166|Carboplatin|carboplatin|mesh-list
6548353|NCT00881166|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6548354|NCT00881166|Topotecan|topotecan|mesh-list
6548355|NCT00881166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6548356|NCT00881166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6548357|NCT00881166|Tubulin Modulators|tubulin modulators|mesh-ancestor
6548358|NCT00881166|Antimitotic Agents|antimitotic agents|mesh-ancestor
6548359|NCT00881166|Mitosis Modulators|mitosis modulators|mesh-ancestor
6548360|NCT00881166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548361|NCT00881166|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6548362|NCT00881166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6548363|NCT00881166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6548364|NCT00881166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6548365|NCT00881166|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6548366|NCT00881179|Clarithromycin|clarithromycin|mesh-list
6548367|NCT00881179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6548368|NCT00881179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6548369|NCT00881179|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6548370|NCT00881179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5725040|NCT03183310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6548371|NCT00881179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548372|NCT00881179|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6548373|NCT00881179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6548374|NCT00881218|Regadenoson|regadenoson|mesh-list
6548375|NCT00881218|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
6548376|NCT00881218|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6548377|NCT00881218|Purinergic Agonists|purinergic agonists|mesh-ancestor
6548378|NCT00881218|Purinergic Agents|purinergic agents|mesh-ancestor
6548379|NCT00881218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6548380|NCT00881218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548381|NCT00881218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548382|NCT00881231|Cilostazol|cilostazol|mesh-list
6548383|NCT00881231|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6548384|NCT00881231|Autonomic Agents|autonomic agents|mesh-ancestor
6548385|NCT00881231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6548386|NCT00881231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548387|NCT00881231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6548388|NCT00881231|Respiratory System Agents|respiratory system agents|mesh-ancestor
6548389|NCT00881231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6548390|NCT00881231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6548391|NCT00881231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548392|NCT00881231|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6548393|NCT00881231|Vasodilator Agents|vasodilator agents|mesh-ancestor
6548394|NCT00881231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6548395|NCT00881231|Protective Agents|protective agents|mesh-ancestor
6548396|NCT00881231|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6548397|NCT00881231|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6548398|NCT00881231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6548399|NCT00881296|Gemcitabine|gemcitabine|mesh-list
6548400|NCT00881296|Carboplatin|carboplatin|mesh-list
6548401|NCT00881296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6548402|NCT00881296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6548403|NCT00881296|Antimetabolites|antimetabolites|mesh-ancestor
6548404|NCT00881296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548405|NCT00881296|Antiviral Agents|antiviral agents|mesh-ancestor
6548406|NCT00881296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6548407|NCT00881296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6548408|NCT00881296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6548409|NCT00881296|Immunologic Factors|immunologic factors|mesh-ancestor
6548410|NCT00881296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548411|NCT00881387|Gemcitabine|gemcitabine|mesh-list
6548412|NCT00881387|Rituximab|rituximab|mesh-list
6548413|NCT00881387|Vinorelbine|vinorelbine|mesh-list
6548414|NCT00881387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6548415|NCT00881387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6548416|NCT00881387|Immunologic Factors|immunologic factors|mesh-ancestor
6548417|NCT00881387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548418|NCT00881387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6548419|NCT00881387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6548420|NCT00881387|Antimetabolites|antimetabolites|mesh-ancestor
6548421|NCT00881387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548422|NCT00881387|Antiviral Agents|antiviral agents|mesh-ancestor
6548423|NCT00881387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6548424|NCT00881387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6548425|NCT00881387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6548426|NCT00881387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6548427|NCT00881387|Tubulin Modulators|tubulin modulators|mesh-ancestor
6548428|NCT00881387|Antimitotic Agents|antimitotic agents|mesh-ancestor
6548429|NCT00881387|Mitosis Modulators|mitosis modulators|mesh-ancestor
6548430|NCT00881400|Cefprozil|cefprozil|mesh-list
6548431|NCT00881400|Cephalosporins|cephalosporins|mesh-list
6548432|NCT00881400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6548433|NCT00881400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6655885|NCT01466452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6655886|NCT01466452|Analgesics|analgesics|mesh-ancestor
6655887|NCT01466452|Sensory System Agents|sensory system agents|mesh-ancestor
6655888|NCT01466452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6655889|NCT01466452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655890|NCT01466452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6655891|NCT01466452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6655892|NCT01466452|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6655893|NCT01466452|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6655894|NCT01466452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655895|NCT01466452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6655896|NCT01466452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6655897|NCT01466452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6655898|NCT01466452|Antipyretics|antipyretics|mesh-ancestor
6655899|NCT01466465|Vitamin D|vitamin d|mesh-list
6655900|NCT01466465|Cholecalciferol|cholecalciferol|mesh-list
6655901|NCT01466465|Vitamins|vitamins|mesh-ancestor
6655902|NCT01466465|Micronutrients|micronutrients|mesh-ancestor
6655903|NCT01466465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655904|NCT01466465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6655905|NCT01466465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6655906|NCT01466478|Calcitriol|calcitriol|mesh-list
6655907|NCT01466478|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
6655908|NCT01466478|Calcipotriene|calcipotriene|mesh-list
6655909|NCT01466478|Dermatologic Agents|dermatologic agents|mesh-ancestor
6655910|NCT01466478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6655911|NCT01466478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655912|NCT01466478|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6655913|NCT01466478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6655914|NCT01466478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655915|NCT01466478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6655916|NCT01466478|Vitamins|vitamins|mesh-ancestor
6655917|NCT01466478|Micronutrients|micronutrients|mesh-ancestor
6655918|NCT01466478|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6655919|NCT01466478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6655920|NCT01466517|Ibuprofen|ibuprofen|mesh-list
6655921|NCT01466517|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6655922|NCT01466517|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6655923|NCT01466517|Analgesics|analgesics|mesh-ancestor
6655924|NCT01466517|Sensory System Agents|sensory system agents|mesh-ancestor
6655925|NCT01466517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6655926|NCT01466517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655927|NCT01466517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6655928|NCT01466517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6655929|NCT01466517|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6655930|NCT01466517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6655931|NCT01466517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655932|NCT01466530|Misoprostol|misoprostol|mesh-list
6655933|NCT01466530|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6655934|NCT01466530|Abortifacient Agents|abortifacient agents|mesh-ancestor
6655935|NCT01466530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6655936|NCT01466530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655937|NCT01466530|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6655938|NCT01466530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6655939|NCT01466530|Oxytocics|oxytocics|mesh-ancestor
6655940|NCT01466543|Udenafil|udenafil|mesh-list
6655941|NCT01466543|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6655942|NCT01466543|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6655943|NCT01466543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6655944|NCT01466543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655945|NCT01466608|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6655946|NCT01466608|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6655947|NCT01466608|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6655948|NCT01466608|Antimetabolites|antimetabolites|mesh-ancestor
6548434|NCT00881413|Esomeprazole|esomeprazole|mesh-list
6548435|NCT00881413|Pantoprazole|pantoprazole|mesh-list
6548436|NCT00881413|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6548437|NCT00881413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6548438|NCT00881413|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6548439|NCT00881413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6548440|NCT00881413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548441|NCT00881426|Cefprozil|cefprozil|mesh-list
6548442|NCT00881426|Cephalosporins|cephalosporins|mesh-list
6548443|NCT00881426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6548444|NCT00881426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6548445|NCT00881491|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6548446|NCT00881491|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6548447|NCT00881491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6548448|NCT00881491|Antitubercular Agents|antitubercular agents|mesh-ancestor
6548449|NCT00881517|Immunoglobulins|immunoglobulins|mesh-list
6548450|NCT00881517|Immunologic Factors|immunologic factors|mesh-ancestor
6548451|NCT00881517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548452|NCT00881543|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6548453|NCT00881543|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
6548454|NCT00881543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6548455|NCT00881543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548456|NCT00881543|Incretins|incretins|mesh-ancestor
6548457|NCT00881543|Hormones|hormones|mesh-ancestor
6548458|NCT00881543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6548459|NCT00881543|Protease Inhibitors|protease inhibitors|mesh-ancestor
6548460|NCT00881543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6548461|NCT00881543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548462|NCT00881556|Fludarabine|fludarabine|mesh-list
6548463|NCT00881556|Busulfan|busulfan|mesh-list
6548464|NCT00881556|Alemtuzumab|alemtuzumab|mesh-list
6548465|NCT00881556|Lorazepam|lorazepam|mesh-list
6548466|NCT00881556|Tacrolimus|tacrolimus|mesh-list
6548467|NCT00881556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6548468|NCT00881556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548469|NCT00881556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6548470|NCT00881556|Immunologic Factors|immunologic factors|mesh-ancestor
6548471|NCT00881556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548472|NCT00881556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6548473|NCT00881556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6548474|NCT00881556|Alkylating Agents|alkylating agents|mesh-ancestor
6548475|NCT00881556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6548476|NCT00881556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6548477|NCT00881556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6548478|NCT00881556|Anticonvulsants|anticonvulsants|mesh-ancestor
6548479|NCT00881556|Antiemetics|antiemetics|mesh-ancestor
6548480|NCT00881556|Autonomic Agents|autonomic agents|mesh-ancestor
6548481|NCT00881556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6548482|NCT00881556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6548483|NCT00881556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6548484|NCT00881556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6548485|NCT00881556|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6548486|NCT00881556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6548487|NCT00881556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6548488|NCT00881556|GABA Modulators|gaba modulators|mesh-ancestor
6548489|NCT00881556|GABA Agents|gaba agents|mesh-ancestor
6548490|NCT00881556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6548491|NCT00881582|Interferons|interferons|mesh-list
6548492|NCT00881582|Interferon-alpha|interferon-alpha|mesh-list
6548493|NCT00881582|Interferon alpha-2|interferon alpha-2|mesh-list
6548494|NCT00881582|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6548495|NCT00881582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6548496|NCT00881582|Antiviral Agents|antiviral agents|mesh-ancestor
6548497|NCT00881582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6548498|NCT00881582|Immunologic Factors|immunologic factors|mesh-ancestor
6548499|NCT00881582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548500|NCT00881595|Temozolomide|temozolomide|mesh-list
6548501|NCT00881595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6548502|NCT00881595|Alkylating Agents|alkylating agents|mesh-ancestor
6548503|NCT00881595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548504|NCT00881595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6548505|NCT00881634|Cetirizine|cetirizine|mesh-list
6548506|NCT00881634|Pseudoephedrine|pseudoephedrine|mesh-list
6548507|NCT00881634|Ephedrine|ephedrine|mesh-list
6548508|NCT00881634|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6548509|NCT00881634|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6548510|NCT00881634|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6548511|NCT00881634|Histamine Antagonists|histamine antagonists|mesh-ancestor
6548512|NCT00881634|Histamine Agents|histamine agents|mesh-ancestor
6548513|NCT00881634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6548514|NCT00881634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548515|NCT00881634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548516|NCT00881634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6548517|NCT00881634|Autonomic Agents|autonomic agents|mesh-ancestor
6548518|NCT00881634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6548519|NCT00881634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6548520|NCT00881634|Respiratory System Agents|respiratory system agents|mesh-ancestor
6548521|NCT00881634|Nasal Decongestants|nasal decongestants|mesh-ancestor
6548522|NCT00881634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6548523|NCT00881634|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6548524|NCT00881634|Sympathomimetics|sympathomimetics|mesh-ancestor
6548525|NCT00881634|Adrenergic Agents|adrenergic agents|mesh-ancestor
6548526|NCT00881673|Dexamethasone|dexamethasone|mesh-list
6548527|NCT00881673|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6548528|NCT00881673|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6548529|NCT00881673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6548530|NCT00881673|Antiemetics|antiemetics|mesh-ancestor
6548531|NCT00881673|Autonomic Agents|autonomic agents|mesh-ancestor
6548532|NCT00881673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6548533|NCT00881673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548534|NCT00881673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6548535|NCT00881673|Glucocorticoids|glucocorticoids|mesh-ancestor
6548536|NCT00881673|Hormones|hormones|mesh-ancestor
6548537|NCT00881673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6548538|NCT00881673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6548539|NCT00881673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6548540|NCT00881686|Adenosine|adenosine|mesh-list
6548541|NCT00881686|Analgesics|analgesics|mesh-ancestor
6548542|NCT00881686|Sensory System Agents|sensory system agents|mesh-ancestor
6548543|NCT00881686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6548544|NCT00881686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548545|NCT00881686|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6548546|NCT00881686|Vasodilator Agents|vasodilator agents|mesh-ancestor
6548547|NCT00881686|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6548548|NCT00881686|Purinergic Agonists|purinergic agonists|mesh-ancestor
6548549|NCT00881686|Purinergic Agents|purinergic agents|mesh-ancestor
6548550|NCT00881686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6548551|NCT00881686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548552|NCT00881725|Metformin|metformin|mesh-list
6548553|NCT00881725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6548554|NCT00881725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548555|NCT00881738|Clarithromycin|clarithromycin|mesh-list
6548556|NCT00881738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6548557|NCT00881738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6548558|NCT00881738|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6548559|NCT00881738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6548560|NCT00881738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548561|NCT00881738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6548562|NCT00881738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6548563|NCT00881764|Anesthetics|anesthetics|mesh-list
6548564|NCT00881764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6548565|NCT00881764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548566|NCT00881790|Fluorides|fluorides|mesh-list
6548567|NCT00881790|Fluorides, Topical|fluorides, topical|mesh-list
6548568|NCT00881790|Cariostatic Agents|cariostatic agents|mesh-ancestor
6548569|NCT00881790|Protective Agents|protective agents|mesh-ancestor
6548570|NCT00881790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548571|NCT00881816|Paclitaxel|paclitaxel|mesh-list
6548572|NCT00881816|Capecitabine|capecitabine|mesh-list
6548573|NCT00881816|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6548574|NCT00881816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6548575|NCT00881816|Tubulin Modulators|tubulin modulators|mesh-ancestor
6548576|NCT00881816|Antimitotic Agents|antimitotic agents|mesh-ancestor
6548577|NCT00881816|Mitosis Modulators|mitosis modulators|mesh-ancestor
6548578|NCT00881816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548579|NCT00881816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6548580|NCT00881816|Antimetabolites|antimetabolites|mesh-ancestor
6548581|NCT00881855|Cefprozil|cefprozil|mesh-list
6548582|NCT00881855|Cephalosporins|cephalosporins|mesh-list
6548583|NCT00881855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6548584|NCT00881855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6548585|NCT00881907|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6548586|NCT00881907|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6548587|NCT00881907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6548588|NCT00881907|Antitubercular Agents|antitubercular agents|mesh-ancestor
6548589|NCT00882024|Tranilast|tranilast|mesh-list
6548590|NCT00882024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6548591|NCT00882024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6548592|NCT00882024|Analgesics|analgesics|mesh-ancestor
6548593|NCT00882024|Sensory System Agents|sensory system agents|mesh-ancestor
6548594|NCT00882024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6548595|NCT00882024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548596|NCT00882024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6548597|NCT00882024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6548598|NCT00882024|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6548599|NCT00882024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6548600|NCT00882024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442566|NCT00376272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548601|NCT00882024|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6548602|NCT00882024|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6548603|NCT00882024|Histamine Antagonists|histamine antagonists|mesh-ancestor
6548604|NCT00882024|Histamine Agents|histamine agents|mesh-ancestor
6548605|NCT00882024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6548606|NCT00882024|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6548607|NCT00882024|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6548608|NCT00882076|Etoposide|etoposide|mesh-list
6548609|NCT00882076|Mitoxantrone|mitoxantrone|mesh-list
6548610|NCT00882076|Etoposide phosphate|etoposide phosphate|mesh-list
6548611|NCT00882076|Clofarabine|clofarabine|mesh-list
6548612|NCT00882076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6548613|NCT00882076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6548614|NCT00882076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6548615|NCT00882076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6548616|NCT00882076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6548617|NCT00882076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548618|NCT00882076|Analgesics|analgesics|mesh-ancestor
6548619|NCT00882076|Sensory System Agents|sensory system agents|mesh-ancestor
6548620|NCT00882076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6548621|NCT00882076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548622|NCT00882076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6548623|NCT00882076|Antimetabolites|antimetabolites|mesh-ancestor
6548624|NCT00882154|Cefdinir|cefdinir|mesh-list
6548625|NCT00882154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6548626|NCT00882154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6548627|NCT00882193|Ribavirin|ribavirin|mesh-list
6548628|NCT00882193|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6548629|NCT00882193|Betaine|betaine|mesh-list
6548630|NCT00882193|Antimetabolites|antimetabolites|mesh-ancestor
6548631|NCT00882193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548632|NCT00882193|Antiviral Agents|antiviral agents|mesh-ancestor
6548633|NCT00882193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6442567|NCT00376285|Fenofibrate|fenofibrate|mesh-list
6442568|NCT00376285|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6442569|NCT00376285|Antimetabolites|antimetabolites|mesh-ancestor
6442570|NCT00376285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442571|NCT00376285|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6442572|NCT00376311|Calcitonin|calcitonin|mesh-list
6548634|NCT00882193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6548635|NCT00882193|Lipotropic Agents|lipotropic agents|mesh-ancestor
6442573|NCT00376311|Salmon calcitonin|salmon calcitonin|mesh-list
6548636|NCT00882193|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6548637|NCT00882193|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6548638|NCT00882232|Hyaluronic Acid|hyaluronic acid|mesh-list
6548639|NCT00882232|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6548640|NCT00882232|Immunologic Factors|immunologic factors|mesh-ancestor
6442574|NCT00376311|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
6442575|NCT00376311|Katacalcin|katacalcin|mesh-list
6442576|NCT00376311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6019707|NCT00389168|Irbesartan|irbesartan|mesh-list
6019708|NCT00389168|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6019709|NCT00389168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6019710|NCT00389168|Sympatholytics|sympatholytics|mesh-ancestor
6442577|NCT00376311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548641|NCT00882232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548642|NCT00882232|Viscosupplements|viscosupplements|mesh-ancestor
6548643|NCT00882232|Protective Agents|protective agents|mesh-ancestor
6548644|NCT00882323|Cyclophosphamide|cyclophosphamide|mesh-list
6548645|NCT00882323|Fludarabine|fludarabine|mesh-list
6548646|NCT00882323|Thymoglobulin|thymoglobulin|mesh-list
6548647|NCT00882323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6548648|NCT00882323|Immunologic Factors|immunologic factors|mesh-ancestor
6548649|NCT00882323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548650|NCT00882323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6548651|NCT00882323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6548652|NCT00882323|Alkylating Agents|alkylating agents|mesh-ancestor
6548653|NCT00882323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548654|NCT00882323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6548655|NCT00882323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6548656|NCT00882375|Nicotine|nicotine|mesh-list
6548657|NCT00882375|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6548658|NCT00882375|Autonomic Agents|autonomic agents|mesh-ancestor
6548659|NCT00882375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6548660|NCT00882375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548661|NCT00882375|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6548662|NCT00882375|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6548663|NCT00882375|Cholinergic Agents|cholinergic agents|mesh-ancestor
6548664|NCT00882375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6548665|NCT00882375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548666|NCT00882388|Aspirin|aspirin|mesh-list
6548667|NCT00882388|Celecoxib|celecoxib|mesh-list
6548668|NCT00882388|Clopidogrel|clopidogrel|mesh-list
6548669|NCT00882388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6548670|NCT00882388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6548671|NCT00882388|Analgesics|analgesics|mesh-ancestor
6548672|NCT00882388|Sensory System Agents|sensory system agents|mesh-ancestor
6548673|NCT00882388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6019711|NCT00389168|Autonomic Agents|autonomic agents|mesh-ancestor
6442578|NCT00376311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6442579|NCT00376311|Vasodilator Agents|vasodilator agents|mesh-ancestor
6442580|NCT00376324|Tigecycline|tigecycline|mesh-list
6442581|NCT00376324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6442582|NCT00376324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6442583|NCT00376324|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6548674|NCT00882388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548675|NCT00882388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6548676|NCT00882388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6548677|NCT00882388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6548678|NCT00882388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6548679|NCT00882388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548680|NCT00882388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6548681|NCT00882388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6548682|NCT00882388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6548683|NCT00882388|Antipyretics|antipyretics|mesh-ancestor
6548684|NCT00882388|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6548685|NCT00882388|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6548686|NCT00882388|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6548687|NCT00882388|Purinergic Agents|purinergic agents|mesh-ancestor
6548688|NCT00882388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6548689|NCT00882388|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6442584|NCT00376324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6442585|NCT00376324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442586|NCT00376337|Micafungin|micafungin|mesh-list
6442587|NCT00376337|Antifungal Agents|antifungal agents|mesh-list
6548690|NCT00882401|Vitamin D|vitamin d|mesh-list
6548691|NCT00882401|Ergocalciferols|ergocalciferols|mesh-list
6548692|NCT00882401|Vitamins|vitamins|mesh-ancestor
6548693|NCT00882401|Micronutrients|micronutrients|mesh-ancestor
5501395|NCT04474600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6442588|NCT00376337|Clotrimazole|clotrimazole|mesh-list
6442589|NCT00376337|Miconazole|miconazole|mesh-list
6442590|NCT00376337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6442591|NCT00376337|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6442592|NCT00376337|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6442593|NCT00376337|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6442594|NCT00376337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6548694|NCT00882401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548695|NCT00882401|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6442595|NCT00376337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442596|NCT00376337|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6442597|NCT00376337|Hormone Antagonists|hormone antagonists|mesh-ancestor
6442598|NCT00376337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6019712|NCT00389168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6019713|NCT00389168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442599|NCT00376337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442600|NCT00376337|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6442601|NCT00376337|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6548696|NCT00882401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6548697|NCT00882414|Ferric Compounds|ferric compounds|mesh-list
6548698|NCT00882414|Hematinics|hematinics|mesh-ancestor
6548699|NCT00882453|Interferons|interferons|mesh-list
6548700|NCT00882453|Interferon-beta|interferon-beta|mesh-list
6548701|NCT00882453|Interferon beta-1b|interferon beta-1b|mesh-list
6548702|NCT00882453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6548703|NCT00882453|Antiviral Agents|antiviral agents|mesh-ancestor
6548704|NCT00882453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6548705|NCT00882453|Immunologic Factors|immunologic factors|mesh-ancestor
6548706|NCT00882453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548707|NCT00882453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6548708|NCT00882466|Epoetin Alfa|epoetin alfa|mesh-list
6548709|NCT00882466|Hematinics|hematinics|mesh-ancestor
6548710|NCT00882531|Isotretinoin|isotretinoin|mesh-list
6548711|NCT00882531|Dermatologic Agents|dermatologic agents|mesh-ancestor
6548712|NCT00882570|Cefdinir|cefdinir|mesh-list
6548713|NCT00882570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6548714|NCT00882570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6548715|NCT00882609|Fluorides|fluorides|mesh-list
6548716|NCT00882609|Cariostatic Agents|cariostatic agents|mesh-ancestor
6548717|NCT00882609|Protective Agents|protective agents|mesh-ancestor
6548718|NCT00882609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548719|NCT00882635|Heparin|heparin|mesh-list
6548720|NCT00882635|Enoxaparin|enoxaparin|mesh-list
6548721|NCT00882635|Calcium heparin|calcium heparin|mesh-list
6548722|NCT00882635|Anticoagulants|anticoagulants|mesh-ancestor
6548723|NCT00882635|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6548724|NCT00882635|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6548725|NCT00882635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548726|NCT00882700|Cefdinir|cefdinir|mesh-list
6548727|NCT00882700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6548728|NCT00882700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6548729|NCT00882739|Clopidogrel|clopidogrel|mesh-list
6548730|NCT00882739|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6548731|NCT00882739|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6548732|NCT00882739|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6548733|NCT00882739|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6548734|NCT00882739|Purinergic Agents|purinergic agents|mesh-ancestor
6548735|NCT00882739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6548736|NCT00882739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548737|NCT00882739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548738|NCT00882765|Genistein|genistein|mesh-list
6548739|NCT00882765|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6548740|NCT00882765|Protective Agents|protective agents|mesh-ancestor
6548741|NCT00882765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548742|NCT00882765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6548743|NCT00882765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6548744|NCT00882765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6548745|NCT00882765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548746|NCT00882765|Phytoestrogens|phytoestrogens|mesh-ancestor
6548747|NCT00882765|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6548748|NCT00882765|Estrogens|estrogens|mesh-ancestor
6548749|NCT00882765|Hormones|hormones|mesh-ancestor
6548750|NCT00882765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6548751|NCT00882856|Bisoprolol|bisoprolol|mesh-list
6548752|NCT00882856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6548753|NCT00882856|Sympatholytics|sympatholytics|mesh-ancestor
6548754|NCT00882856|Autonomic Agents|autonomic agents|mesh-ancestor
6548755|NCT00882856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6548756|NCT00882856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548757|NCT00882856|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6548758|NCT00882856|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6548759|NCT00882856|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6548760|NCT00882856|Adrenergic Agents|adrenergic agents|mesh-ancestor
6548761|NCT00882856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6548762|NCT00882856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548763|NCT00882869|Sorafenib|sorafenib|mesh-list
6548764|NCT00882869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6548765|NCT00882869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6548766|NCT00882869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6548767|NCT00882869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548768|NCT00882882|Metformin|metformin|mesh-list
6548769|NCT00882882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6548770|NCT00882882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548771|NCT00882947|Iloprost|iloprost|mesh-list
6548772|NCT00882947|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6548773|NCT00882947|Vasodilator Agents|vasodilator agents|mesh-ancestor
6548774|NCT00882960|Fentanyl|fentanyl|mesh-list
6548775|NCT00882960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6548776|NCT00882960|Narcotics|narcotics|mesh-ancestor
6548777|NCT00882960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6548778|NCT00882960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548779|NCT00882960|Analgesics|analgesics|mesh-ancestor
6548780|NCT00882960|Sensory System Agents|sensory system agents|mesh-ancestor
6548781|NCT00882960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6548782|NCT00882960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6548783|NCT00882960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6548784|NCT00882960|Anesthetics, General|anesthetics, general|mesh-ancestor
6548785|NCT00882960|Anesthetics|anesthetics|mesh-ancestor
6548786|NCT00883064|Lisinopril|lisinopril|mesh-list
6548787|NCT00883064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6548788|NCT00883064|Protease Inhibitors|protease inhibitors|mesh-ancestor
6548789|NCT00883064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6442602|NCT00376376|Levofloxacin|levofloxacin|mesh-list
6442603|NCT00376376|Ofloxacin|ofloxacin|mesh-list
6442604|NCT00376376|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6442605|NCT00376376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6442606|NCT00376376|Renal Agents|renal agents|mesh-ancestor
6442607|NCT00376376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6442608|NCT00376376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6442609|NCT00376376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6442610|NCT00376376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6442611|NCT00376376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442612|NCT00376376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6548790|NCT00883064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548791|NCT00883064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6548792|NCT00883064|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6548793|NCT00883064|Protective Agents|protective agents|mesh-ancestor
6548794|NCT00883064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548795|NCT00883155|Bupropion|bupropion|mesh-list
6548796|NCT00883155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6548797|NCT00883155|Antidepressive Agents|antidepressive agents|mesh-ancestor
6442613|NCT00376376|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6442614|NCT00376376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6442615|NCT00376428|Gentamicins|gentamicins|mesh-list
6442616|NCT00376428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6442617|NCT00376428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6442618|NCT00376428|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6548798|NCT00883155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6548799|NCT00883155|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6548800|NCT00883155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6548801|NCT00883155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6548802|NCT00883155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548803|NCT00883155|Dopamine Agents|dopamine agents|mesh-ancestor
6442619|NCT00376428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6548804|NCT00883155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6442620|NCT00376428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548805|NCT00883155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548806|NCT00883155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6548807|NCT00883155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6548808|NCT00883155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6548809|NCT00883194|Ropivacaine|ropivacaine|mesh-list
6548810|NCT00883194|Anesthetics, Local|anesthetics, local|mesh-ancestor
6548811|NCT00883194|Anesthetics|anesthetics|mesh-ancestor
6548812|NCT00883194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6548813|NCT00883194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548814|NCT00883194|Sensory System Agents|sensory system agents|mesh-ancestor
6548815|NCT00883194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6442621|NCT00376467|Imatinib Mesylate|imatinib mesylate|mesh-list
6442622|NCT00376467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6442623|NCT00376467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6442624|NCT00376467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6442625|NCT00376467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442626|NCT00376480|Methylprednisolone|methylprednisolone|mesh-list
6442627|NCT00376480|Fludarabine|fludarabine|mesh-list
6442628|NCT00376480|Fludarabine phosphate|fludarabine phosphate|mesh-list
6442629|NCT00376480|Thiotepa|thiotepa|mesh-list
6442630|NCT00376480|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6461603|NCT00455325|Filaricides|filaricides|mesh-ancestor
6548816|NCT00883259|Metformin|metformin|mesh-list
6548817|NCT00883259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6548818|NCT00883259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655949|NCT01466608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655950|NCT01466608|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6655951|NCT01466608|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6655952|NCT01466608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6655953|NCT01466686|Temozolomide|temozolomide|mesh-list
6655954|NCT01466686|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6655955|NCT01466686|Alkylating Agents|alkylating agents|mesh-ancestor
6655956|NCT01466686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655957|NCT01466686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6655958|NCT01466712|Beclomethasone|beclomethasone|mesh-list
6655959|NCT01466712|Formoterol Fumarate|formoterol fumarate|mesh-list
6655960|NCT01466712|Tiotropium Bromide|tiotropium bromide|mesh-list
6655961|NCT01466712|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6655962|NCT01466712|Autonomic Agents|autonomic agents|mesh-ancestor
6655963|NCT01466712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6655964|NCT01466712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655965|NCT01466712|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6655966|NCT01466712|Respiratory System Agents|respiratory system agents|mesh-ancestor
6655967|NCT01466712|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6655968|NCT01466712|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6655969|NCT01466712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6655970|NCT01466712|Adrenergic Agents|adrenergic agents|mesh-ancestor
6655971|NCT01466712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6655972|NCT01466712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655973|NCT01466712|Parasympatholytics|parasympatholytics|mesh-ancestor
6655974|NCT01466712|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6655975|NCT01466712|Cholinergic Agents|cholinergic agents|mesh-ancestor
6655976|NCT01466712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6655977|NCT01466712|Glucocorticoids|glucocorticoids|mesh-ancestor
6655978|NCT01466712|Hormones|hormones|mesh-ancestor
6655979|NCT01466712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6655980|NCT01466829|Hormones|hormones|mesh-list
6655981|NCT01466829|Parathyroid Hormone|parathyroid hormone|mesh-list
6655982|NCT01466829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6655983|NCT01466829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655984|NCT01466829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6655985|NCT01466855|Topotecan|topotecan|mesh-list
6655986|NCT01466855|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6655987|NCT01466855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6655988|NCT01466855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6655989|NCT01466855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655990|NCT01466855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6655991|NCT01466959|Acetic Acid|acetic acid|mesh-list
6655992|NCT01466959|Retinol acetate|retinol acetate|mesh-list
6655993|NCT01466959|Citric Acid|citric acid|mesh-list
6655994|NCT01466959|Dialysis Solutions|dialysis solutions|mesh-list
6655995|NCT01466959|Anticoagulants|anticoagulants|mesh-ancestor
6655996|NCT01466959|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6655997|NCT01466959|Chelating Agents|chelating agents|mesh-ancestor
6655998|NCT01466959|Sequestering Agents|sequestering agents|mesh-ancestor
6655999|NCT01466959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656000|NCT01466959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6656001|NCT01466959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6656002|NCT01466959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6656003|NCT01466959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6656004|NCT01466959|Immunologic Factors|immunologic factors|mesh-ancestor
6656005|NCT01466959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656006|NCT01466959|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6656007|NCT01466959|Protective Agents|protective agents|mesh-ancestor
6656008|NCT01466959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6656009|NCT01467011|Mycophenolic Acid|mycophenolic acid|mesh-list
6656010|NCT01467011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6656011|NCT01467011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6548819|NCT00883298|Bevacizumab|bevacizumab|mesh-list
6548820|NCT00883298|Temozolomide|temozolomide|mesh-list
6548821|NCT00883298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5501396|NCT04474600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6548822|NCT00883298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6548823|NCT00883298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6548824|NCT00883298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6548825|NCT00883298|Growth Substances|growth substances|mesh-ancestor
6548826|NCT00883298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548827|NCT00883298|Growth Inhibitors|growth inhibitors|mesh-ancestor
6548828|NCT00883298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6548829|NCT00883298|Alkylating Agents|alkylating agents|mesh-ancestor
6548830|NCT00883298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548831|NCT00883480|Gemcitabine|gemcitabine|mesh-list
6548832|NCT00883480|Cisplatin|cisplatin|mesh-list
6548833|NCT00883480|Docetaxel|docetaxel|mesh-list
6548834|NCT00883480|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6548835|NCT00883480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6548836|NCT00883480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6548837|NCT00883480|Antimetabolites|antimetabolites|mesh-ancestor
6548838|NCT00883480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548839|NCT00883480|Antiviral Agents|antiviral agents|mesh-ancestor
6548840|NCT00883480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6548841|NCT00883480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6548842|NCT00883480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6548843|NCT00883480|Immunologic Factors|immunologic factors|mesh-ancestor
6548844|NCT00883480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548845|NCT00883480|Tubulin Modulators|tubulin modulators|mesh-ancestor
6548846|NCT00883480|Antimitotic Agents|antimitotic agents|mesh-ancestor
6548847|NCT00883480|Mitosis Modulators|mitosis modulators|mesh-ancestor
6548848|NCT00883480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6548849|NCT00883506|Lisinopril|lisinopril|mesh-list
6548850|NCT00883506|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6548851|NCT00883506|Protease Inhibitors|protease inhibitors|mesh-ancestor
6548852|NCT00883506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6548853|NCT00883506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548854|NCT00883506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6548855|NCT00883506|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6548856|NCT00883506|Protective Agents|protective agents|mesh-ancestor
6548857|NCT00883506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548858|NCT00883532|Budesonide|budesonide|mesh-list
6548859|NCT00883532|Pulmonary Surfactants|pulmonary surfactants|mesh-list
6548860|NCT00883532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6548861|NCT00883532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6548862|NCT00883532|Autonomic Agents|autonomic agents|mesh-ancestor
6548863|NCT00883532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6548864|NCT00883532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548865|NCT00883532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6548866|NCT00883532|Respiratory System Agents|respiratory system agents|mesh-ancestor
6548867|NCT00883532|Glucocorticoids|glucocorticoids|mesh-ancestor
6548868|NCT00883532|Hormones|hormones|mesh-ancestor
6548869|NCT00883532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6548870|NCT00883623|Lenalidomide|lenalidomide|mesh-list
6548871|NCT00883623|Immunologic Factors|immunologic factors|mesh-ancestor
6548872|NCT00883623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548873|NCT00883623|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6548874|NCT00883623|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6548875|NCT00883623|Growth Substances|growth substances|mesh-ancestor
6548876|NCT00883623|Growth Inhibitors|growth inhibitors|mesh-ancestor
6548877|NCT00883623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6548878|NCT00883662|Levonorgestrel|levonorgestrel|mesh-list
6548879|NCT00883662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6548880|NCT00883662|Contraceptive Agents|contraceptive agents|mesh-ancestor
6548881|NCT00883662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6548882|NCT00883662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548883|NCT00883662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6548884|NCT00883662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6548885|NCT00883662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6548886|NCT00883727|Plasma-lyte 148|plasma-lyte 148|mesh-list
6548887|NCT00883727|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6548888|NCT00883727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6548889|NCT00883818|Azithromycin|azithromycin|mesh-list
6548890|NCT00883818|Doxycycline|doxycycline|mesh-list
6548891|NCT00883818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6548892|NCT00883818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6548893|NCT00883818|Antimalarials|antimalarials|mesh-ancestor
6548894|NCT00883818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6548895|NCT00883818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6548896|NCT00883870|Plasma-lyte 148|plasma-lyte 148|mesh-list
6548897|NCT00883870|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6548898|NCT00883870|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6548899|NCT00883883|Cefdinir|cefdinir|mesh-list
6548900|NCT00883883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6548901|NCT00883883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6548902|NCT00883909|Dutasteride|dutasteride|mesh-list
6548903|NCT00883909|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6548904|NCT00883909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6548905|NCT00883909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6548906|NCT00883909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548907|NCT00883909|Hormone Antagonists|hormone antagonists|mesh-ancestor
6548908|NCT00883909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6548909|NCT00883909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548910|NCT00883935|Ritonavir|ritonavir|mesh-list
6548911|NCT00883935|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6548912|NCT00883935|Dolutegravir|dolutegravir|mesh-list
6548913|NCT00883935|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6548914|NCT00883935|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6548915|NCT00883935|Protease Inhibitors|protease inhibitors|mesh-ancestor
6548916|NCT00883935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6548917|NCT00883935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548918|NCT00883935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6548919|NCT00883935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6548920|NCT00883935|Antiviral Agents|antiviral agents|mesh-ancestor
5501397|NCT04474600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548921|NCT00883935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6548922|NCT00883935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6548923|NCT00883935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6548924|NCT00883935|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6548925|NCT00883935|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6548926|NCT00884104|Solifenacin Succinate|solifenacin succinate|mesh-list
6548927|NCT00884104|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6548928|NCT00884104|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6548929|NCT00884104|Cholinergic Agents|cholinergic agents|mesh-ancestor
6548930|NCT00884104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6548931|NCT00884104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548932|NCT00884104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548933|NCT00884104|Urological Agents|urological agents|mesh-ancestor
6548934|NCT00884260|Levonorgestrel|levonorgestrel|mesh-list
6548935|NCT00884260|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6548936|NCT00884260|Contraceptive Agents|contraceptive agents|mesh-ancestor
6548937|NCT00884260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6548938|NCT00884260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548939|NCT00884260|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6548940|NCT00884260|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6548941|NCT00884260|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6548942|NCT00884299|Antioxidants|antioxidants|mesh-list
6548943|NCT00884299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548944|NCT00884299|Protective Agents|protective agents|mesh-ancestor
6548945|NCT00884299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548946|NCT00884416|Sorafenib|sorafenib|mesh-list
6548947|NCT00884416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6548948|NCT00884416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6548949|NCT00884416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6548950|NCT00884416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548951|NCT00884442|Nifedipine|nifedipine|mesh-list
6548952|NCT00884442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6548953|NCT00884442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6548954|NCT00884442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548955|NCT00884442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6548956|NCT00884442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548957|NCT00884442|Vasodilator Agents|vasodilator agents|mesh-ancestor
6548958|NCT00884442|Tocolytic Agents|tocolytic agents|mesh-ancestor
6548959|NCT00884442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6548960|NCT00884481|Natalizumab|natalizumab|mesh-list
6548961|NCT00884481|Immunologic Factors|immunologic factors|mesh-ancestor
6548962|NCT00884481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548963|NCT00884494|Insulin|insulin|mesh-list
6548964|NCT00884494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6548965|NCT00884494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548966|NCT00884533|Moxifloxacin|moxifloxacin|mesh-list
6548967|NCT00884533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6548968|NCT00884533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6548969|NCT00884533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6548970|NCT00884533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6548971|NCT00884533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6548972|NCT00884533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6548973|NCT00884533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6548974|NCT00884546|Dexamethasone|dexamethasone|mesh-list
6548975|NCT00884546|Lenalidomide|lenalidomide|mesh-list
6548976|NCT00884546|Bortezomib|bortezomib|mesh-list
6548977|NCT00884546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6548978|NCT00884546|Antiemetics|antiemetics|mesh-ancestor
6548979|NCT00884546|Autonomic Agents|autonomic agents|mesh-ancestor
6548980|NCT00884546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6548981|NCT00884546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6548982|NCT00884546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6548983|NCT00884546|Glucocorticoids|glucocorticoids|mesh-ancestor
6442631|NCT00376480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6442632|NCT00376480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6442633|NCT00376480|Antimetabolites|antimetabolites|mesh-ancestor
6442634|NCT00376480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442635|NCT00376480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6442636|NCT00376480|Immunologic Factors|immunologic factors|mesh-ancestor
6442637|NCT00376480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442638|NCT00376480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6548984|NCT00884546|Hormones|hormones|mesh-ancestor
6656012|NCT01467011|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6548985|NCT00884546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6548986|NCT00884546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6548987|NCT00884546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6548988|NCT00884546|Immunologic Factors|immunologic factors|mesh-ancestor
6548989|NCT00884546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6548990|NCT00884546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6548991|NCT00884546|Growth Substances|growth substances|mesh-ancestor
6548992|NCT00884546|Growth Inhibitors|growth inhibitors|mesh-ancestor
6548993|NCT00884663|Propranolol|propranolol|mesh-list
6548994|NCT00884663|Candesartan|candesartan|mesh-list
6548995|NCT00884663|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6548996|NCT00884663|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6548997|NCT00884663|Adrenergic Agents|adrenergic agents|mesh-ancestor
6548998|NCT00884663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6548999|NCT00884663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549000|NCT00884663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549001|NCT00884663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6549002|NCT00884663|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6549003|NCT00884663|Vasodilator Agents|vasodilator agents|mesh-ancestor
6549004|NCT00884663|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6549005|NCT00884663|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6549006|NCT00884676|Sunitinib|sunitinib|mesh-list
6549007|NCT00884676|Epothilone B|epothilone b|mesh-list
6549008|NCT00884676|Epothilones|epothilones|mesh-list
6549009|NCT00884676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6549010|NCT00884676|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6549011|NCT00884676|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6549012|NCT00884676|Growth Substances|growth substances|mesh-ancestor
6549013|NCT00884676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549014|NCT00884676|Growth Inhibitors|growth inhibitors|mesh-ancestor
6549015|NCT00884676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6549016|NCT00884676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6549017|NCT00884676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549018|NCT00884676|Tubulin Modulators|tubulin modulators|mesh-ancestor
6549019|NCT00884676|Antimitotic Agents|antimitotic agents|mesh-ancestor
6549020|NCT00884676|Mitosis Modulators|mitosis modulators|mesh-ancestor
6549021|NCT00884767|Leucovorin|leucovorin|mesh-list
6549022|NCT00884767|Fluorouracil|fluorouracil|mesh-list
6549023|NCT00884767|Oxaliplatin|oxaliplatin|mesh-list
6549024|NCT00884767|Calcium|calcium|mesh-list
6549025|NCT00884767|Levoleucovorin|levoleucovorin|mesh-list
6549026|NCT00884767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6549027|NCT00884767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549028|NCT00884767|Antimetabolites|antimetabolites|mesh-ancestor
6549029|NCT00884767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549030|NCT00884767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6549031|NCT00884767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6549032|NCT00884767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6549033|NCT00884767|Immunologic Factors|immunologic factors|mesh-ancestor
6549034|NCT00884767|Antidotes|antidotes|mesh-ancestor
6549035|NCT00884767|Protective Agents|protective agents|mesh-ancestor
6549036|NCT00884767|Vitamin B Complex|vitamin b complex|mesh-ancestor
6549037|NCT00884767|Vitamins|vitamins|mesh-ancestor
6549038|NCT00884767|Micronutrients|micronutrients|mesh-ancestor
6549039|NCT00884819|Fenofibrate|fenofibrate|mesh-list
6549040|NCT00884819|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6549041|NCT00884819|Antimetabolites|antimetabolites|mesh-ancestor
6549042|NCT00884819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549043|NCT00884819|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6549044|NCT00884845|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6549045|NCT00884845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5725041|NCT03183310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6549046|NCT00884845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6549047|NCT00884845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6549048|NCT00884845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549049|NCT00884858|Maraviroc|maraviroc|mesh-list
6549050|NCT00884858|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6549051|NCT00884858|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6549052|NCT00884858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549053|NCT00884858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6549054|NCT00884858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6549055|NCT00884858|Antiviral Agents|antiviral agents|mesh-ancestor
6549056|NCT00884858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6549057|NCT00884858|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6549058|NCT00884884|Topiramate|topiramate|mesh-list
6549059|NCT00884884|Aripiprazole|aripiprazole|mesh-list
6549060|NCT00884884|Antidepressive Agents|antidepressive agents|mesh-ancestor
6549061|NCT00884884|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6549062|NCT00884884|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6549063|NCT00884884|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6549064|NCT00884884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6549065|NCT00884884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549066|NCT00884884|Dopamine Agonists|dopamine agonists|mesh-ancestor
6549067|NCT00884884|Dopamine Agents|dopamine agents|mesh-ancestor
6549068|NCT00884884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6549069|NCT00884884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549070|NCT00884884|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6549071|NCT00884884|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6549072|NCT00884884|Serotonin Agents|serotonin agents|mesh-ancestor
6549073|NCT00884884|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6549074|NCT00884884|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6549075|NCT00884884|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6549076|NCT00884884|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6549077|NCT00884884|Anticonvulsants|anticonvulsants|mesh-ancestor
6549078|NCT00884884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6549079|NCT00885066|Gemcitabine|gemcitabine|mesh-list
6549080|NCT00885066|Capecitabine|capecitabine|mesh-list
6549081|NCT00885066|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6549082|NCT00885066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6549083|NCT00885066|Antimetabolites|antimetabolites|mesh-ancestor
6549084|NCT00885066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549085|NCT00885066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6549086|NCT00885066|Antiviral Agents|antiviral agents|mesh-ancestor
6549087|NCT00885066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6549088|NCT00885066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6549089|NCT00885066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6549090|NCT00885066|Immunologic Factors|immunologic factors|mesh-ancestor
6549091|NCT00885066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549092|NCT00885066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6656013|NCT01467011|Antitubercular Agents|antitubercular agents|mesh-ancestor
6656014|NCT01467011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6656015|NCT01467011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6656016|NCT01467011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6656017|NCT01467011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656018|NCT01467115|Leucovorin|leucovorin|mesh-list
6656019|NCT01467115|Docetaxel|docetaxel|mesh-list
6656020|NCT01467115|Fluorouracil|fluorouracil|mesh-list
6656021|NCT01467115|Cetuximab|cetuximab|mesh-list
6656022|NCT01467115|Epoetin Alfa|epoetin alfa|mesh-list
6656023|NCT01467115|Levoleucovorin|levoleucovorin|mesh-list
6656024|NCT01467115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6656025|NCT01467115|Tubulin Modulators|tubulin modulators|mesh-ancestor
6656026|NCT01467115|Antimitotic Agents|antimitotic agents|mesh-ancestor
6656027|NCT01467115|Mitosis Modulators|mitosis modulators|mesh-ancestor
6656028|NCT01467115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656029|NCT01467115|Antimetabolites|antimetabolites|mesh-ancestor
6656030|NCT01467115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6656031|NCT01467115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6656032|NCT01467115|Immunologic Factors|immunologic factors|mesh-ancestor
6656033|NCT01467115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656034|NCT01467115|Antidotes|antidotes|mesh-ancestor
6656035|NCT01467115|Protective Agents|protective agents|mesh-ancestor
6656036|NCT01467115|Vitamin B Complex|vitamin b complex|mesh-ancestor
6656037|NCT01467115|Vitamins|vitamins|mesh-ancestor
6549093|NCT00885274|Magnesium Oxide|magnesium oxide|mesh-list
6549094|NCT00885274|Citric Acid|citric acid|mesh-list
6549095|NCT00885274|Antacids|antacids|mesh-ancestor
6549096|NCT00885274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549097|NCT00885274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6549098|NCT00885274|Anticoagulants|anticoagulants|mesh-ancestor
6549099|NCT00885274|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6549100|NCT00885274|Chelating Agents|chelating agents|mesh-ancestor
6549101|NCT00885274|Sequestering Agents|sequestering agents|mesh-ancestor
6549102|NCT00885287|Lumefantrine|lumefantrine|mesh-list
6549103|NCT00885287|Artemether|artemether|mesh-list
6549104|NCT00885287|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6549105|NCT00885287|Antimalarials|antimalarials|mesh-ancestor
6549106|NCT00885287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6549107|NCT00885287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6549108|NCT00885287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6549109|NCT00885300|Cloxacillin|cloxacillin|mesh-list
6549110|NCT00885300|Heparin|heparin|mesh-list
6549111|NCT00885300|Anticoagulants|anticoagulants|mesh-ancestor
6549112|NCT00885300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6549113|NCT00885300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6549114|NCT00885300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549115|NCT00885300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6549116|NCT00885300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6549117|NCT00885326|Zoledronic Acid|zoledronic acid|mesh-list
6549118|NCT00885326|Cyclophosphamide|cyclophosphamide|mesh-list
6549119|NCT00885326|Bevacizumab|bevacizumab|mesh-list
6549120|NCT00885326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6549121|NCT00885326|Immunologic Factors|immunologic factors|mesh-ancestor
6549122|NCT00885326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549123|NCT00885326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6549124|NCT00885326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6549125|NCT00885326|Alkylating Agents|alkylating agents|mesh-ancestor
6549126|NCT00885326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549127|NCT00885326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6549128|NCT00885326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6549129|NCT00885326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6549130|NCT00885326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6549131|NCT00885326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6549132|NCT00885326|Growth Substances|growth substances|mesh-ancestor
6549133|NCT00885326|Growth Inhibitors|growth inhibitors|mesh-ancestor
6549134|NCT00885326|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6549135|NCT00885404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6549136|NCT00885404|Plasma-lyte 148|plasma-lyte 148|mesh-list
6549137|NCT00885404|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6549138|NCT00885443|Propofol|propofol|mesh-list
6549139|NCT00885443|Sevoflurane|sevoflurane|mesh-list
6549140|NCT00885443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6549141|NCT00885443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6549142|NCT00885443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549143|NCT00885443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6549144|NCT00885443|Anesthetics, General|anesthetics, general|mesh-ancestor
6549145|NCT00885443|Anesthetics|anesthetics|mesh-ancestor
6549146|NCT00885443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6549147|NCT00885443|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6549148|NCT00885508|Lenalidomide|lenalidomide|mesh-list
6549149|NCT00885508|Immunologic Factors|immunologic factors|mesh-ancestor
6549150|NCT00885508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549151|NCT00885508|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6549152|NCT00885508|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6549153|NCT00885508|Growth Substances|growth substances|mesh-ancestor
6549154|NCT00885508|Growth Inhibitors|growth inhibitors|mesh-ancestor
6549155|NCT00885508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6549156|NCT00885586|Gabapentin|gabapentin|mesh-list
6549157|NCT00885586|Analgesics|analgesics|mesh-ancestor
6549158|NCT00885586|Sensory System Agents|sensory system agents|mesh-ancestor
6549159|NCT00885586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6549160|NCT00885586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549161|NCT00885586|Anticonvulsants|anticonvulsants|mesh-ancestor
6549162|NCT00885586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6549163|NCT00885586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6549164|NCT00885586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6549165|NCT00885586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6549166|NCT00885586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6549167|NCT00885586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6549168|NCT00885586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6549169|NCT00885586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549170|NCT00885586|Antimanic Agents|antimanic agents|mesh-ancestor
6549171|NCT00885599|Listerine|listerine|mesh-list
6549172|NCT00885599|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
6549173|NCT00885599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6549174|NCT00885625|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6549175|NCT00885625|Immunologic Factors|immunologic factors|mesh-ancestor
6549176|NCT00885625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549177|NCT00885664|Ritonavir|ritonavir|mesh-list
6549178|NCT00885664|Lopinavir|lopinavir|mesh-list
6549179|NCT00885664|Tenofovir|tenofovir|mesh-list
6549180|NCT00885664|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6549181|NCT00885664|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6549182|NCT00885664|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6549183|NCT00885664|Protease Inhibitors|protease inhibitors|mesh-ancestor
6549184|NCT00885664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6549185|NCT00885664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549186|NCT00885664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6549187|NCT00885664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6549188|NCT00885664|Antiviral Agents|antiviral agents|mesh-ancestor
6549189|NCT00885664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6549190|NCT00885664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6549191|NCT00885664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6549192|NCT00885664|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6549193|NCT00885664|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6549194|NCT00885690|Olanzapine|olanzapine|mesh-list
6549195|NCT00885690|Sertindole|sertindole|mesh-list
6549196|NCT00885690|Antiemetics|antiemetics|mesh-ancestor
6549197|NCT00885690|Autonomic Agents|autonomic agents|mesh-ancestor
6549198|NCT00885690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6549199|NCT00885690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549200|NCT00885690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6549201|NCT00885690|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6549202|NCT00885690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6549203|NCT00885690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6549204|NCT00885690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6549205|NCT00885690|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6549206|NCT00885690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6549207|NCT00885690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6549208|NCT00885690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549209|NCT00885690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6549210|NCT00885690|Serotonin Agents|serotonin agents|mesh-ancestor
6549211|NCT00885781|SMOFlipid|smoflipid|mesh-list
6549212|NCT00885781|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6549213|NCT00885781|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6549214|NCT00885781|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6549215|NCT00885794|Ranibizumab|ranibizumab|mesh-list
6549216|NCT00885794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6549217|NCT00885794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6549218|NCT00885794|Growth Substances|growth substances|mesh-ancestor
6549219|NCT00885794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549220|NCT00885794|Growth Inhibitors|growth inhibitors|mesh-ancestor
6549221|NCT00885794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6549222|NCT00885820|Prednisone|prednisone|mesh-list
6549223|NCT00885820|Methylprednisolone|methylprednisolone|mesh-list
6549224|NCT00885820|Tacrolimus|tacrolimus|mesh-list
6549225|NCT00885820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6549226|NCT00885820|Glucocorticoids|glucocorticoids|mesh-ancestor
6549227|NCT00885820|Hormones|hormones|mesh-ancestor
6549228|NCT00885820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6549229|NCT00885820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549230|NCT00885820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6549231|NCT00885820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6549232|NCT00885820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6549233|NCT00885820|Immunologic Factors|immunologic factors|mesh-ancestor
6549234|NCT00885820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6549235|NCT00885820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6549236|NCT00885820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549237|NCT00885820|Antiemetics|antiemetics|mesh-ancestor
6549238|NCT00885820|Autonomic Agents|autonomic agents|mesh-ancestor
6549239|NCT00885820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6549240|NCT00885820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6549241|NCT00885820|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6549242|NCT00885820|Protective Agents|protective agents|mesh-ancestor
6549243|NCT00885833|Fludarabine|fludarabine|mesh-list
6549244|NCT00885833|Busulfan|busulfan|mesh-list
6549245|NCT00885833|Thymoglobulin|thymoglobulin|mesh-list
6549246|NCT00885833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6549247|NCT00885833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549248|NCT00885833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6549249|NCT00885833|Immunologic Factors|immunologic factors|mesh-ancestor
6549250|NCT00885833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549251|NCT00885833|Alkylating Agents|alkylating agents|mesh-ancestor
6549252|NCT00885833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6549253|NCT00885833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6549254|NCT00885872|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6549255|NCT00885872|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6549256|NCT00885872|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6549257|NCT00885872|Antimetabolites|antimetabolites|mesh-ancestor
6549258|NCT00885872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549259|NCT00885872|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6549260|NCT00885872|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6549261|NCT00885872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6549262|NCT00885885|Panitumumab|panitumumab|mesh-list
6549263|NCT00885885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6549264|NCT00885885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6549265|NCT00885924|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
6442639|NCT00376480|Antiemetics|antiemetics|mesh-ancestor
6442640|NCT00376480|Autonomic Agents|autonomic agents|mesh-ancestor
6442641|NCT00376480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6442642|NCT00376480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6442643|NCT00376480|Glucocorticoids|glucocorticoids|mesh-ancestor
6442644|NCT00376480|Hormones|hormones|mesh-ancestor
6442645|NCT00376480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6442646|NCT00376480|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6442647|NCT00376480|Protective Agents|protective agents|mesh-ancestor
6549266|NCT00885924|Hemostatics|hemostatics|mesh-ancestor
6549267|NCT00885924|Coagulants|coagulants|mesh-ancestor
6549268|NCT00885924|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6549269|NCT00885924|Natriuretic Agents|natriuretic agents|mesh-ancestor
6549270|NCT00885924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549271|NCT00886002|Fentanyl|fentanyl|mesh-list
6549272|NCT00886002|Buprenorphine|buprenorphine|mesh-list
6549273|NCT00886002|Naloxone|naloxone|mesh-list
6549274|NCT00886002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6549275|NCT00886002|Narcotics|narcotics|mesh-ancestor
6549276|NCT00886002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6549277|NCT00886002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549278|NCT00886002|Analgesics|analgesics|mesh-ancestor
6549279|NCT00886002|Sensory System Agents|sensory system agents|mesh-ancestor
6549280|NCT00886002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6549281|NCT00886002|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6549282|NCT00886002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6549283|NCT00886002|Anesthetics, General|anesthetics, general|mesh-ancestor
6549284|NCT00886002|Anesthetics|anesthetics|mesh-ancestor
6549285|NCT00886002|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6549286|NCT00886028|Doxorubicin|doxorubicin|mesh-list
6549287|NCT00886028|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6549288|NCT00886028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6549289|NCT00886028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6549290|NCT00886028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6549291|NCT00886028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6549292|NCT00886028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6549293|NCT00886028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442648|NCT00376480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6442649|NCT00376480|Alkylating Agents|alkylating agents|mesh-ancestor
6549294|NCT00886106|Midazolam|midazolam|mesh-list
6549295|NCT00886106|Remifentanil|remifentanil|mesh-list
6549296|NCT00886106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6549297|NCT00886106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6549298|NCT00886106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6549299|NCT00886106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549300|NCT00886106|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6549301|NCT00886106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6549302|NCT00886106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6549303|NCT00886106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6549304|NCT00886106|Anesthetics, General|anesthetics, general|mesh-ancestor
6549305|NCT00886106|Anesthetics|anesthetics|mesh-ancestor
6549306|NCT00886106|GABA Modulators|gaba modulators|mesh-ancestor
6442650|NCT00376480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6442651|NCT00376493|Metronidazole|metronidazole|mesh-list
6442652|NCT00376493|Doxycycline|doxycycline|mesh-list
6442653|NCT00376493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6442654|NCT00376493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6442655|NCT00376493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6442656|NCT00376493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6442657|NCT00376493|Antimalarials|antimalarials|mesh-ancestor
6442658|NCT00376519|Cyclosporine|cyclosporine|mesh-list
6442659|NCT00376519|Mycophenolic Acid|mycophenolic acid|mesh-list
6442660|NCT00376519|Cyclophosphamide|cyclophosphamide|mesh-list
6442661|NCT00376519|Fludarabine|fludarabine|mesh-list
6442662|NCT00376519|Fludarabine phosphate|fludarabine phosphate|mesh-list
6442663|NCT00376519|Cyclosporins|cyclosporins|mesh-list
6442664|NCT00376519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6442665|NCT00376519|Immunologic Factors|immunologic factors|mesh-ancestor
6442666|NCT00376519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442667|NCT00376519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6442668|NCT00376519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6442669|NCT00376519|Alkylating Agents|alkylating agents|mesh-ancestor
6442670|NCT00376519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442671|NCT00376519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6442672|NCT00376519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6442673|NCT00376519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6442674|NCT00376519|Antimetabolites|antimetabolites|mesh-ancestor
6442675|NCT00376519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6442676|NCT00376519|Antifungal Agents|antifungal agents|mesh-ancestor
6442677|NCT00376519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6442678|NCT00376519|Dermatologic Agents|dermatologic agents|mesh-ancestor
6442679|NCT00376519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6442680|NCT00376519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6442681|NCT00376519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6442682|NCT00376519|Antitubercular Agents|antitubercular agents|mesh-ancestor
6442683|NCT00376519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6442684|NCT00376584|Niacin|niacin|mesh-list
6442685|NCT00376584|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6442686|NCT00376584|Antimetabolites|antimetabolites|mesh-ancestor
6442687|NCT00376584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442688|NCT00376584|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6442689|NCT00376584|Vasodilator Agents|vasodilator agents|mesh-ancestor
6442690|NCT00376584|Vitamin B Complex|vitamin b complex|mesh-ancestor
6442691|NCT00376584|Vitamins|vitamins|mesh-ancestor
6442692|NCT00376584|Micronutrients|micronutrients|mesh-ancestor
6442693|NCT00376584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442694|NCT00376662|Etidronic Acid|etidronic acid|mesh-list
6442695|NCT00376662|Hormones|hormones|mesh-list
6442696|NCT00376662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6442697|NCT00376662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442698|NCT00376662|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6442699|NCT00376701|Bevacizumab|bevacizumab|mesh-list
6442700|NCT00376701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6442701|NCT00376701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6442702|NCT00376701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6442703|NCT00376701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6442704|NCT00376701|Growth Substances|growth substances|mesh-ancestor
6442705|NCT00376701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442706|NCT00376701|Growth Inhibitors|growth inhibitors|mesh-ancestor
6442707|NCT00376727|Cetuximab|cetuximab|mesh-list
6442708|NCT00376727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6442709|NCT00376727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6442710|NCT00376740|Zoledronic Acid|zoledronic acid|mesh-list
6549307|NCT00886106|GABA Agents|gaba agents|mesh-ancestor
6549308|NCT00886106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6549309|NCT00886106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549310|NCT00886106|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6549311|NCT00886106|Narcotics|narcotics|mesh-ancestor
6549312|NCT00886106|Analgesics|analgesics|mesh-ancestor
6549313|NCT00886106|Sensory System Agents|sensory system agents|mesh-ancestor
6549314|NCT00886106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6549315|NCT00886132|Sunitinib|sunitinib|mesh-list
6549316|NCT00886132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6549317|NCT00886132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6549318|NCT00886132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6549319|NCT00886132|Growth Substances|growth substances|mesh-ancestor
6549320|NCT00886132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549321|NCT00886132|Growth Inhibitors|growth inhibitors|mesh-ancestor
6549322|NCT00886132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6549323|NCT00886132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6549324|NCT00886132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549325|NCT00886275|Midazolam|midazolam|mesh-list
6549326|NCT00886275|Dexmedetomidine|dexmedetomidine|mesh-list
6549327|NCT00886275|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6549328|NCT00886275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6549329|NCT00886275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549330|NCT00886275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6549331|NCT00886275|Analgesics|analgesics|mesh-ancestor
6549332|NCT00886275|Sensory System Agents|sensory system agents|mesh-ancestor
6549333|NCT00886275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6549334|NCT00886275|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6549335|NCT00886275|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6549336|NCT00886275|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6549337|NCT00886275|Adrenergic Agents|adrenergic agents|mesh-ancestor
6549338|NCT00886275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6549339|NCT00886275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549340|NCT00886275|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6549341|NCT00886275|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6549342|NCT00886275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6549343|NCT00886275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6549344|NCT00886275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6549345|NCT00886275|Anesthetics, General|anesthetics, general|mesh-ancestor
6549346|NCT00886275|Anesthetics|anesthetics|mesh-ancestor
6549347|NCT00886275|GABA Modulators|gaba modulators|mesh-ancestor
6549348|NCT00886275|GABA Agents|gaba agents|mesh-ancestor
6549349|NCT00886314|Midazolam|midazolam|mesh-list
6549350|NCT00886314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6549351|NCT00886314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6549352|NCT00886314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6549353|NCT00886314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549354|NCT00886314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6549355|NCT00886314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6549356|NCT00886314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5725042|NCT03183310|Dopamine Agents|dopamine agents|mesh-ancestor
6549357|NCT00886314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6549358|NCT00886314|Anesthetics, General|anesthetics, general|mesh-ancestor
6549359|NCT00886314|Anesthetics|anesthetics|mesh-ancestor
6549360|NCT00886314|GABA Modulators|gaba modulators|mesh-ancestor
6549361|NCT00886314|GABA Agents|gaba agents|mesh-ancestor
6549362|NCT00886314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6549363|NCT00886314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549364|NCT00886405|Nitroglycerin|nitroglycerin|mesh-list
6549365|NCT00886405|Vasodilator Agents|vasodilator agents|mesh-ancestor
6549366|NCT00886457|Interferons|interferons|mesh-list
6549367|NCT00886457|Interferon-alpha|interferon-alpha|mesh-list
6549368|NCT00886457|Interferon alpha-2|interferon alpha-2|mesh-list
6549369|NCT00886457|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6549370|NCT00886457|Decitabine|decitabine|mesh-list
6549371|NCT00886457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6549372|NCT00886457|Antiviral Agents|antiviral agents|mesh-ancestor
6549373|NCT00886457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6549374|NCT00886457|Immunologic Factors|immunologic factors|mesh-ancestor
6549375|NCT00886457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549376|NCT00886457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6549377|NCT00886457|Antimetabolites|antimetabolites|mesh-ancestor
6549378|NCT00886457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549379|NCT00886457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6549380|NCT00886496|Lectins|lectins|mesh-list
6549381|NCT00886496|Agglutinins|agglutinins|mesh-ancestor
6549382|NCT00886496|Immunologic Factors|immunologic factors|mesh-ancestor
6549383|NCT00886496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549384|NCT00886496|Coagulants|coagulants|mesh-ancestor
6549385|NCT00886509|Lenograstim|lenograstim|mesh-list
6549386|NCT00886509|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6549387|NCT00886509|Immunologic Factors|immunologic factors|mesh-ancestor
6549388|NCT00886509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549389|NCT00886574|Aspirin|aspirin|mesh-list
6549390|NCT00886574|Cilostazol|cilostazol|mesh-list
6549391|NCT00886574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6549392|NCT00886574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6549393|NCT00886574|Analgesics|analgesics|mesh-ancestor
6549394|NCT00886574|Sensory System Agents|sensory system agents|mesh-ancestor
6549395|NCT00886574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6549396|NCT00886574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549397|NCT00886574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6549398|NCT00886574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6549399|NCT00886574|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6549400|NCT00886574|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6549401|NCT00886574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549402|NCT00886574|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6549403|NCT00886574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6549404|NCT00886574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6549405|NCT00886574|Antipyretics|antipyretics|mesh-ancestor
6549406|NCT00886574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6549407|NCT00886574|Autonomic Agents|autonomic agents|mesh-ancestor
6549408|NCT00886574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6549409|NCT00886574|Respiratory System Agents|respiratory system agents|mesh-ancestor
6549410|NCT00886574|Vasodilator Agents|vasodilator agents|mesh-ancestor
6549411|NCT00886574|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6549412|NCT00886574|Protective Agents|protective agents|mesh-ancestor
6549413|NCT00886574|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6549414|NCT00886574|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6549415|NCT00886678|Carboplatin|carboplatin|mesh-list
6549416|NCT00886678|Pemetrexed|pemetrexed|mesh-list
6549417|NCT00886678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6549418|NCT00886678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6549419|NCT00886678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549420|NCT00886678|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6549421|NCT00886678|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6549422|NCT00886717|Paclitaxel|paclitaxel|mesh-list
6549423|NCT00886717|Carboplatin|carboplatin|mesh-list
6549424|NCT00886717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6549425|NCT00886717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6549426|NCT00886717|Tubulin Modulators|tubulin modulators|mesh-ancestor
6549427|NCT00886717|Antimitotic Agents|antimitotic agents|mesh-ancestor
6549428|NCT00886717|Mitosis Modulators|mitosis modulators|mesh-ancestor
6549429|NCT00886717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549430|NCT00886860|Misoprostol|misoprostol|mesh-list
6549431|NCT00886860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6549432|NCT00886860|Abortifacient Agents|abortifacient agents|mesh-ancestor
6549433|NCT00886860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6549434|NCT00886860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549435|NCT00886860|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6549436|NCT00886860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6549437|NCT00886860|Oxytocics|oxytocics|mesh-ancestor
6549438|NCT00886873|Mifepristone|mifepristone|mesh-list
6549439|NCT00886873|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6549440|NCT00886873|Abortifacient Agents|abortifacient agents|mesh-ancestor
6549441|NCT00886873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6549442|NCT00886873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549443|NCT00886873|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6549444|NCT00886873|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6549445|NCT00886873|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6549446|NCT00886873|Contraceptive Agents|contraceptive agents|mesh-ancestor
6549447|NCT00886873|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6549448|NCT00886873|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6549449|NCT00886873|Hormone Antagonists|hormone antagonists|mesh-ancestor
6549450|NCT00886873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6549451|NCT00886873|Luteolytic Agents|luteolytic agents|mesh-ancestor
6549452|NCT00886873|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6549453|NCT00886873|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6549454|NCT00886886|Reboxetine|reboxetine|mesh-list
6549455|NCT00886886|Antidepressive Agents|antidepressive agents|mesh-ancestor
6549456|NCT00886886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6549457|NCT00886886|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6549458|NCT00886886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6549459|NCT00886886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6549460|NCT00886886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549461|NCT00886886|Adrenergic Agents|adrenergic agents|mesh-ancestor
6549462|NCT00886886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6549463|NCT00886886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549464|NCT00886990|Ritonavir|ritonavir|mesh-list
6549465|NCT00886990|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6549466|NCT00886990|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6549467|NCT00886990|Protease Inhibitors|protease inhibitors|mesh-ancestor
6549468|NCT00886990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6656038|NCT01467115|Micronutrients|micronutrients|mesh-ancestor
6549469|NCT00886990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549470|NCT00886990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6549471|NCT00886990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6549472|NCT00886990|Antiviral Agents|antiviral agents|mesh-ancestor
6549473|NCT00886990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6549474|NCT00886990|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6549475|NCT00886990|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6549476|NCT00887003|Methylprednisolone|methylprednisolone|mesh-list
6549477|NCT00887003|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6549478|NCT00887003|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6549479|NCT00887003|Prednisolone|prednisolone|mesh-list
6549480|NCT00887003|Prednisolone acetate|prednisolone acetate|mesh-list
6549481|NCT00887003|Bupivacaine|bupivacaine|mesh-list
6549482|NCT00887003|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6549483|NCT00887003|Prednisolone phosphate|prednisolone phosphate|mesh-list
6549484|NCT00887003|Anesthetics, Local|anesthetics, local|mesh-ancestor
6549485|NCT00887003|Anesthetics|anesthetics|mesh-ancestor
6549486|NCT00887003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6549487|NCT00887003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549488|NCT00887003|Sensory System Agents|sensory system agents|mesh-ancestor
6549489|NCT00887003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6549490|NCT00887003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6549491|NCT00887003|Antiemetics|antiemetics|mesh-ancestor
6549492|NCT00887003|Autonomic Agents|autonomic agents|mesh-ancestor
6549493|NCT00887003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6549494|NCT00887003|Glucocorticoids|glucocorticoids|mesh-ancestor
6549495|NCT00887003|Hormones|hormones|mesh-ancestor
6549496|NCT00887003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6549497|NCT00887003|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6549498|NCT00887003|Protective Agents|protective agents|mesh-ancestor
6549499|NCT00887003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6549500|NCT00887003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6549501|NCT00887029|Timolol|timolol|mesh-list
6549502|NCT00887029|Travoprost|travoprost|mesh-list
6549503|NCT00887029|Latanoprost|latanoprost|mesh-list
6549504|NCT00887029|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6549505|NCT00887029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6549506|NCT00887029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6549507|NCT00887029|Adrenergic Agents|adrenergic agents|mesh-ancestor
6549508|NCT00887029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6549509|NCT00887029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549510|NCT00887029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549511|NCT00887029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6549512|NCT00887029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6549513|NCT00887029|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6656039|NCT01467115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6656040|NCT01467115|Hematinics|hematinics|mesh-ancestor
6656041|NCT01467141|Insulin|insulin|mesh-list
6656042|NCT01467141|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6656043|NCT01467141|Insulin Aspart|insulin aspart|mesh-list
6656044|NCT01467141|Isophane Insulin, Human|isophane insulin, human|mesh-list
6656045|NCT01467141|Insulin, Isophane|insulin, isophane|mesh-list
6656046|NCT01467141|Isophane insulin, beef|isophane insulin, beef|mesh-list
6656047|NCT01467141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6656048|NCT01467141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656049|NCT01467219|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6656050|NCT01467219|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6656051|NCT01467219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656052|NCT01467232|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6656053|NCT01467258|Amantadine|amantadine|mesh-list
6656054|NCT01467258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6656055|NCT01467258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6656056|NCT01467258|Antiviral Agents|antiviral agents|mesh-ancestor
6656057|NCT01467258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6656058|NCT01467258|Dopamine Agents|dopamine agents|mesh-ancestor
6656059|NCT01467258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6656060|NCT01467258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656061|NCT01467258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656062|NCT01467258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6656063|NCT01467258|Analgesics|analgesics|mesh-ancestor
6656064|NCT01467258|Sensory System Agents|sensory system agents|mesh-ancestor
6656065|NCT01467258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6656066|NCT01467297|Levofloxacin|levofloxacin|mesh-list
6656067|NCT01467297|Ofloxacin|ofloxacin|mesh-list
6656068|NCT01467297|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6656069|NCT01467297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6656070|NCT01467297|Renal Agents|renal agents|mesh-ancestor
6549514|NCT00887042|Fludarabine|fludarabine|mesh-list
6549515|NCT00887042|Busulfan|busulfan|mesh-list
6549516|NCT00887042|Thymoglobulin|thymoglobulin|mesh-list
6549517|NCT00887042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6549518|NCT00887042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549519|NCT00887042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6549520|NCT00887042|Immunologic Factors|immunologic factors|mesh-ancestor
6549521|NCT00887042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549522|NCT00887042|Alkylating Agents|alkylating agents|mesh-ancestor
6549523|NCT00887042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6549524|NCT00887042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6549525|NCT00887081|Ribavirin|ribavirin|mesh-list
6549526|NCT00887081|Interferon-alpha|interferon-alpha|mesh-list
6549527|NCT00887081|Interferon alpha-2|interferon alpha-2|mesh-list
6549528|NCT00887081|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
6549529|NCT00887081|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6549530|NCT00887081|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6549531|NCT00887081|Antimetabolites|antimetabolites|mesh-ancestor
6549532|NCT00887081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549533|NCT00887081|Antiviral Agents|antiviral agents|mesh-ancestor
6549534|NCT00887081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6549535|NCT00887081|Immunologic Factors|immunologic factors|mesh-ancestor
6549536|NCT00887081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549537|NCT00887081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6549538|NCT00887107|Sorafenib|sorafenib|mesh-list
6549539|NCT00887107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6549540|NCT00887107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6549541|NCT00887107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6549542|NCT00887107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549543|NCT00887120|Ritonavir|ritonavir|mesh-list
6549544|NCT00887120|Lopinavir|lopinavir|mesh-list
6549545|NCT00887120|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6549546|NCT00887120|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6549547|NCT00887120|Protease Inhibitors|protease inhibitors|mesh-ancestor
6549548|NCT00887120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6549549|NCT00887120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549550|NCT00887120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6549551|NCT00887120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6549552|NCT00887120|Antiviral Agents|antiviral agents|mesh-ancestor
6549553|NCT00887120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6549554|NCT00887120|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6549555|NCT00887120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6549556|NCT00887211|Sirolimus|sirolimus|mesh-list
6549557|NCT00887211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6549558|NCT00887211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6549559|NCT00887211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6549560|NCT00887211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6549561|NCT00887211|Antifungal Agents|antifungal agents|mesh-ancestor
6549562|NCT00887211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6549563|NCT00887211|Immunologic Factors|immunologic factors|mesh-ancestor
6549564|NCT00887211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549565|NCT00887263|Budesonide|budesonide|mesh-list
6549566|NCT00887263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6549567|NCT00887263|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6549568|NCT00887263|Autonomic Agents|autonomic agents|mesh-ancestor
6549569|NCT00887263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6549570|NCT00887263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549571|NCT00887263|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6549572|NCT00887263|Respiratory System Agents|respiratory system agents|mesh-ancestor
6549573|NCT00887263|Glucocorticoids|glucocorticoids|mesh-ancestor
6549574|NCT00887263|Hormones|hormones|mesh-ancestor
6549575|NCT00887263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6549576|NCT00887276|Amoxicillin|amoxicillin|mesh-list
6549577|NCT00887276|Moxifloxacin|moxifloxacin|mesh-list
6549578|NCT00887276|Ampicillin|ampicillin|mesh-list
6549579|NCT00887276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6549580|NCT00887276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6549581|NCT00887276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6549582|NCT00887276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6549583|NCT00887276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6549584|NCT00887276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549585|NCT00887276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6549586|NCT00887328|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6549587|NCT00887328|Plasminogen|plasminogen|mesh-list
6549588|NCT00887328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6549589|NCT00887328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6549590|NCT00887328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549591|NCT00887367|Ethanol|ethanol|mesh-list
6549592|NCT00887367|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6549593|NCT00887367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6549594|NCT00887367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6549595|NCT00887367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549596|NCT00887380|Anastrozole|anastrozole|mesh-list
6549597|NCT00887380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6549598|NCT00887380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6549599|NCT00887380|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6549600|NCT00887380|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6019714|NCT00389168|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6019715|NCT00389168|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6019716|NCT00389168|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6019717|NCT00389168|Adrenergic Agents|adrenergic agents|mesh-ancestor
6019718|NCT00389168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6019719|NCT00389168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019720|NCT00389168|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6019721|NCT00389168|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6019722|NCT00389207|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6019723|NCT00389207|Nevirapine|nevirapine|mesh-list
6549601|NCT00887380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6549602|NCT00887380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549603|NCT00887380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6549604|NCT00887380|Hormone Antagonists|hormone antagonists|mesh-ancestor
6549605|NCT00887380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6549606|NCT00887380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549607|NCT00887536|Cyclophosphamide|cyclophosphamide|mesh-list
6549608|NCT00887536|Bevacizumab|bevacizumab|mesh-list
6549609|NCT00887536|Docetaxel|docetaxel|mesh-list
6549610|NCT00887536|Doxorubicin|doxorubicin|mesh-list
6549611|NCT00887536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6549612|NCT00887536|Immunologic Factors|immunologic factors|mesh-ancestor
6549613|NCT00887536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549614|NCT00887536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6549615|NCT00887536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6549616|NCT00887536|Alkylating Agents|alkylating agents|mesh-ancestor
6549617|NCT00887536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549618|NCT00887536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6019724|NCT00389207|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6019725|NCT00389207|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6019726|NCT00389207|Protease Inhibitors|protease inhibitors|mesh-ancestor
6549619|NCT00887536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6549620|NCT00887536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6549621|NCT00887536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6549622|NCT00887536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6549623|NCT00887536|Growth Substances|growth substances|mesh-ancestor
6549624|NCT00887536|Growth Inhibitors|growth inhibitors|mesh-ancestor
6549625|NCT00887536|Tubulin Modulators|tubulin modulators|mesh-ancestor
6549626|NCT00887536|Antimitotic Agents|antimitotic agents|mesh-ancestor
6549627|NCT00887536|Mitosis Modulators|mitosis modulators|mesh-ancestor
6549628|NCT00887536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6549629|NCT00887536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6549630|NCT00887536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6549631|NCT00887536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6549632|NCT00887601|Donepezil|donepezil|mesh-list
6549633|NCT00887601|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6549634|NCT00887601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6549635|NCT00887601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549636|NCT00887601|Cholinergic Agents|cholinergic agents|mesh-ancestor
6549637|NCT00887601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6549638|NCT00887601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549639|NCT00887601|Nootropic Agents|nootropic agents|mesh-ancestor
6549640|NCT00887627|Conivaptan|conivaptan|mesh-list
6549641|NCT00887627|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6549642|NCT00887627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549643|NCT00887627|Natriuretic Agents|natriuretic agents|mesh-ancestor
6549644|NCT00887627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549645|NCT00887757|Gemcitabine|gemcitabine|mesh-list
6549646|NCT00887757|Navitoclax|navitoclax|mesh-list
6019727|NCT00389207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6549647|NCT00887757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6549648|NCT00887757|Antimetabolites|antimetabolites|mesh-ancestor
6549649|NCT00887757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549650|NCT00887757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6549651|NCT00887757|Antiviral Agents|antiviral agents|mesh-ancestor
6549652|NCT00887757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6549653|NCT00887757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6549654|NCT00887757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6549655|NCT00887757|Immunologic Factors|immunologic factors|mesh-ancestor
6549656|NCT00887757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549657|NCT00887770|Moxifloxacin|moxifloxacin|mesh-list
6549658|NCT00887770|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
6549659|NCT00887770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6549660|NCT00887770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6549661|NCT00887770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6549662|NCT00887770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6549663|NCT00887770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6549664|NCT00887770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549665|NCT00887770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6549666|NCT00887770|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6549667|NCT00887770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6549668|NCT00887770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6549669|NCT00887770|Antiviral Agents|antiviral agents|mesh-ancestor
6549670|NCT00888043|Bevacizumab|bevacizumab|mesh-list
6549671|NCT00888043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6549672|NCT00888043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6549673|NCT00888043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6549674|NCT00888043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6549675|NCT00888043|Growth Substances|growth substances|mesh-ancestor
6549676|NCT00888043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549677|NCT00888043|Growth Inhibitors|growth inhibitors|mesh-ancestor
6549678|NCT00888082|Goserelin|goserelin|mesh-list
6549679|NCT00888082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6549680|NCT00888082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6549681|NCT00888108|Docetaxel|docetaxel|mesh-list
6549682|NCT00888108|Navitoclax|navitoclax|mesh-list
6549683|NCT00888108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6549684|NCT00888108|Tubulin Modulators|tubulin modulators|mesh-ancestor
6549685|NCT00888108|Antimitotic Agents|antimitotic agents|mesh-ancestor
6549686|NCT00888108|Mitosis Modulators|mitosis modulators|mesh-ancestor
6549687|NCT00888108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549688|NCT00888186|Levodopa|levodopa|mesh-list
6549689|NCT00888186|Carbidopa|carbidopa|mesh-list
6549690|NCT00888186|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6549691|NCT00888186|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6549692|NCT00888186|Dopamine Agents|dopamine agents|mesh-ancestor
6549693|NCT00888186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6549694|NCT00888186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549695|NCT00888186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549696|NCT00888186|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6549697|NCT00888186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6549698|NCT00888303|Dexamethasone|dexamethasone|mesh-list
6549699|NCT00888303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6549700|NCT00888303|Antiemetics|antiemetics|mesh-ancestor
6549701|NCT00888303|Autonomic Agents|autonomic agents|mesh-ancestor
6549702|NCT00888303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6549703|NCT00888303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549704|NCT00888303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6549705|NCT00888303|Glucocorticoids|glucocorticoids|mesh-ancestor
6549706|NCT00888303|Hormones|hormones|mesh-ancestor
6549707|NCT00888303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6549708|NCT00888303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6549709|NCT00888303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6549710|NCT00888342|Ethanol|ethanol|mesh-list
6549711|NCT00888342|Zopiclone|zopiclone|mesh-list
6549712|NCT00888342|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6549713|NCT00888342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6549714|NCT00888342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6549715|NCT00888342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549716|NCT00888342|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6549717|NCT00888394|Imidacloprid|imidacloprid|mesh-list
6549718|NCT00888394|Cholinergic Agents|cholinergic agents|mesh-ancestor
6549719|NCT00888394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6549720|NCT00888394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549721|NCT00888394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549722|NCT00888602|Psyllium|psyllium|mesh-list
6549723|NCT00888602|Calcium polycarbophil|calcium polycarbophil|mesh-list
6549724|NCT00888602|Cathartics|cathartics|mesh-ancestor
6549725|NCT00888602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6549726|NCT00888602|Antidiarrheals|antidiarrheals|mesh-ancestor
6549727|NCT00888732|Insulin|insulin|mesh-list
6549728|NCT00888732|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6549729|NCT00888732|Insulin Aspart|insulin aspart|mesh-list
6549730|NCT00888732|Insulin, Long-Acting|insulin, long-acting|mesh-list
6549731|NCT00888732|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6549732|NCT00888732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6549733|NCT00888732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549734|NCT00888758|Sirolimus|sirolimus|mesh-list
6549735|NCT00888758|Umirolimus|umirolimus|mesh-list
6549736|NCT00888758|Everolimus|everolimus|mesh-list
6549737|NCT00888758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6549738|NCT00888758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6549739|NCT00888758|Immunologic Factors|immunologic factors|mesh-ancestor
6549740|NCT00888758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549741|NCT00888758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6549742|NCT00888758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6549743|NCT00888758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6549744|NCT00888758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6549745|NCT00888758|Antifungal Agents|antifungal agents|mesh-ancestor
6549746|NCT00888784|Propranolol|propranolol|mesh-list
6549747|NCT00888784|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
6549748|NCT00888784|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6549749|NCT00888784|Adrenergic Agents|adrenergic agents|mesh-ancestor
6549750|NCT00888784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6549751|NCT00888784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549752|NCT00888784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549753|NCT00888784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6549754|NCT00888784|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6549755|NCT00888784|Vasodilator Agents|vasodilator agents|mesh-ancestor
6549756|NCT00888797|Etodolac|etodolac|mesh-list
6549757|NCT00888797|Propranolol|propranolol|mesh-list
6549758|NCT00888797|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6549759|NCT00888797|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6549760|NCT00888797|Adrenergic Agents|adrenergic agents|mesh-ancestor
6549761|NCT00888797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6549762|NCT00888797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549763|NCT00888797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549764|NCT00888797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6549765|NCT00888797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6549766|NCT00888797|Vasodilator Agents|vasodilator agents|mesh-ancestor
6549767|NCT00888797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6549768|NCT00888797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6549769|NCT00888797|Analgesics|analgesics|mesh-ancestor
6549770|NCT00888797|Sensory System Agents|sensory system agents|mesh-ancestor
6549771|NCT00888797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6549772|NCT00888797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6549773|NCT00888797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6549774|NCT00888797|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6549775|NCT00888797|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6549776|NCT00888797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6549777|NCT00888810|Topotecan|topotecan|mesh-list
6549778|NCT00888810|Lapatinib|lapatinib|mesh-list
6549779|NCT00888810|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6549780|NCT00888810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6549781|NCT00888810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6549782|NCT00888810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549783|NCT00888810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6549784|NCT00888810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6549785|NCT00888836|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6549786|NCT00888836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549787|NCT00888862|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6549788|NCT00888862|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6549789|NCT00888862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6549790|NCT00888862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6549791|NCT00888862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549792|NCT00888862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6549793|NCT00888862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549794|NCT00888862|Antidepressive Agents|antidepressive agents|mesh-ancestor
6549795|NCT00888862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6549796|NCT00888901|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6549797|NCT00888901|Methylprednisolone|methylprednisolone|mesh-list
6549798|NCT00888901|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6549799|NCT00888901|Prednisolone|prednisolone|mesh-list
6549800|NCT00888901|Prednisolone acetate|prednisolone acetate|mesh-list
6549801|NCT00888901|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6549802|NCT00888901|Prednisolone phosphate|prednisolone phosphate|mesh-list
6549803|NCT00888901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6549804|NCT00888901|Antiemetics|antiemetics|mesh-ancestor
6549805|NCT00888901|Autonomic Agents|autonomic agents|mesh-ancestor
6549806|NCT00888901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6549807|NCT00888901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549808|NCT00888901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6549809|NCT00888901|Glucocorticoids|glucocorticoids|mesh-ancestor
6549810|NCT00888901|Hormones|hormones|mesh-ancestor
6549811|NCT00888901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6549812|NCT00888901|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6549813|NCT00888901|Protective Agents|protective agents|mesh-ancestor
6549814|NCT00888901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6549815|NCT00888901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6656071|NCT01467297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6656072|NCT01467297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6656073|NCT01467297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6656074|NCT01467297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6656075|NCT01467297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656076|NCT01467297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6656077|NCT01467297|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6656078|NCT01467297|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6656079|NCT01467310|Trametinib|trametinib|mesh-list
6656080|NCT01467310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6656081|NCT01467310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6656082|NCT01467310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6656083|NCT01467310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656084|NCT01467323|Insulin|insulin|mesh-list
6656085|NCT01467323|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6656086|NCT01467323|Insulin Aspart|insulin aspart|mesh-list
6656087|NCT01467323|Biphasic Insulins|biphasic insulins|mesh-list
6656088|NCT01467323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6656089|NCT01467323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656090|NCT01467362|Desonide|desonide|mesh-list
6656091|NCT01467362|V0034CR|v0034cr|mesh-list
6656092|NCT01467362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6656093|NCT01467362|Emollients|emollients|mesh-ancestor
6656094|NCT01467362|Dermatologic Agents|dermatologic agents|mesh-ancestor
6656095|NCT01467375|Insulin Aspart|insulin aspart|mesh-list
6656096|NCT01467375|Biphasic Insulins|biphasic insulins|mesh-list
6656097|NCT01467375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6656098|NCT01467375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656099|NCT01467401|Insulin|insulin|mesh-list
6656100|NCT01467401|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6656101|NCT01467401|Insulin Aspart|insulin aspart|mesh-list
5724738|NCT03185351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656102|NCT01467401|Biphasic Insulins|biphasic insulins|mesh-list
6656103|NCT01467401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6549816|NCT00889018|Carboplatin|carboplatin|mesh-list
6019728|NCT00389207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019729|NCT00389207|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6019730|NCT00389207|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6019731|NCT00389207|Antiviral Agents|antiviral agents|mesh-ancestor
6019732|NCT00389207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6442711|NCT00376740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6442712|NCT00376740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442713|NCT00376766|Levetiracetam|levetiracetam|mesh-list
6442714|NCT00376766|Anticonvulsants|anticonvulsants|mesh-ancestor
6442715|NCT00376766|Nootropic Agents|nootropic agents|mesh-ancestor
6442716|NCT00376792|Docetaxel|docetaxel|mesh-list
6442717|NCT00376792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6442718|NCT00376792|Tubulin Modulators|tubulin modulators|mesh-ancestor
6442719|NCT00376792|Antimitotic Agents|antimitotic agents|mesh-ancestor
6442720|NCT00376792|Mitosis Modulators|mitosis modulators|mesh-ancestor
6442721|NCT00376792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442722|NCT00376818|Hormones|hormones|mesh-list
6442723|NCT00376818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6442724|NCT00376818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549817|NCT00889018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5724739|NCT03185104|Fluorides|fluorides|mesh-list
6549818|NCT00889044|Clopidogrel|clopidogrel|mesh-list
6549819|NCT00889044|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6549820|NCT00889044|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6549821|NCT00889044|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5724740|NCT03185104|Cariostatic Agents|cariostatic agents|mesh-ancestor
5724741|NCT03185104|Protective Agents|protective agents|mesh-ancestor
5724742|NCT03185104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724743|NCT03185156|Propofol|propofol|mesh-list
5724744|NCT03185156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5724745|NCT03185156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5724746|NCT03185156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724747|NCT03185156|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6549822|NCT00889044|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6549823|NCT00889044|Purinergic Agents|purinergic agents|mesh-ancestor
6549824|NCT00889044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6549825|NCT00889044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549826|NCT00889044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724748|NCT03185156|Anesthetics, General|anesthetics, general|mesh-ancestor
5724749|NCT03185156|Anesthetics|anesthetics|mesh-ancestor
6549827|NCT00889057|Sorafenib|sorafenib|mesh-list
6549828|NCT00889057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6442725|NCT00376831|Fentanyl|fentanyl|mesh-list
6549829|NCT00889057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6549830|NCT00889057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6549831|NCT00889057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549832|NCT00889096|Propranolol|propranolol|mesh-list
6549833|NCT00889096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6549834|NCT00889096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6549835|NCT00889096|Adrenergic Agents|adrenergic agents|mesh-ancestor
6549836|NCT00889096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6549837|NCT00889096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549838|NCT00889096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549839|NCT00889096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6549840|NCT00889096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6549841|NCT00889096|Vasodilator Agents|vasodilator agents|mesh-ancestor
6549842|NCT00889135|Droxidopa|droxidopa|mesh-list
6549843|NCT00889135|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6549844|NCT00889135|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6549845|NCT00889148|Gabapentin|gabapentin|mesh-list
6549846|NCT00889148|Analgesics|analgesics|mesh-ancestor
6549847|NCT00889148|Sensory System Agents|sensory system agents|mesh-ancestor
6549848|NCT00889148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6549849|NCT00889148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549850|NCT00889148|Anticonvulsants|anticonvulsants|mesh-ancestor
6549851|NCT00889148|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6549852|NCT00889148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6549853|NCT00889148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6549854|NCT00889148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6549855|NCT00889148|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6549856|NCT00889148|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6549857|NCT00889148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6549858|NCT00889148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549859|NCT00889148|Antimanic Agents|antimanic agents|mesh-ancestor
6549860|NCT00889161|Curcumin|curcumin|mesh-list
6549861|NCT00889161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6549862|NCT00889161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6549863|NCT00889161|Analgesics|analgesics|mesh-ancestor
6549864|NCT00889161|Sensory System Agents|sensory system agents|mesh-ancestor
6549865|NCT00889161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5724750|NCT03184844|Thalidomide|thalidomide|mesh-list
6549866|NCT00889161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549867|NCT00889161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6549868|NCT00889161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6549869|NCT00889161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6549870|NCT00889161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6549871|NCT00889161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549872|NCT00889213|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6549873|NCT00889213|Hemostatics|hemostatics|mesh-ancestor
6549874|NCT00889213|Coagulants|coagulants|mesh-ancestor
6549875|NCT00889343|Leucovorin|leucovorin|mesh-list
6549876|NCT00889343|Fluorouracil|fluorouracil|mesh-list
6549877|NCT00889343|Oxaliplatin|oxaliplatin|mesh-list
6549878|NCT00889343|Irinotecan|irinotecan|mesh-list
6549879|NCT00889343|Sorafenib|sorafenib|mesh-list
6549880|NCT00889343|Antimetabolites|antimetabolites|mesh-ancestor
6549881|NCT00889343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442726|NCT00376831|Midazolam|midazolam|mesh-list
6442727|NCT00376831|Ketamine|ketamine|mesh-list
6442728|NCT00376831|Analgesics|analgesics|mesh-ancestor
6442729|NCT00376831|Sensory System Agents|sensory system agents|mesh-ancestor
6442730|NCT00376831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6442731|NCT00376831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442732|NCT00376831|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6442733|NCT00376831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6549882|NCT00889343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6549883|NCT00889343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6549884|NCT00889343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6442734|NCT00376831|Anesthetics, General|anesthetics, general|mesh-ancestor
6442735|NCT00376831|Anesthetics|anesthetics|mesh-ancestor
6442736|NCT00376831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6442737|NCT00376831|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6442738|NCT00376831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6549885|NCT00889343|Immunologic Factors|immunologic factors|mesh-ancestor
6549886|NCT00889343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549887|NCT00889343|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6549888|NCT00889343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6549889|NCT00889343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6549890|NCT00889343|Antidotes|antidotes|mesh-ancestor
6549891|NCT00889343|Protective Agents|protective agents|mesh-ancestor
6549892|NCT00889343|Vitamin B Complex|vitamin b complex|mesh-ancestor
6549893|NCT00889343|Vitamins|vitamins|mesh-ancestor
6549894|NCT00889343|Micronutrients|micronutrients|mesh-ancestor
6549895|NCT00889343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6549896|NCT00889356|Clindamycin|clindamycin|mesh-list
6549897|NCT00889356|Clindamycin palmitate|clindamycin palmitate|mesh-list
6549898|NCT00889356|Clindamycin phosphate|clindamycin phosphate|mesh-list
6549899|NCT00889356|Amphotericin B|amphotericin b|mesh-list
6549900|NCT00889356|Tetracycline|tetracycline|mesh-list
6549901|NCT00889356|Ketoconazole|ketoconazole|mesh-list
6549902|NCT00889356|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6549903|NCT00889356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6549904|NCT00889356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6549905|NCT00889356|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6549906|NCT00889356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6549907|NCT00889356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549908|NCT00889356|Antifungal Agents|antifungal agents|mesh-ancestor
6549909|NCT00889356|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6549910|NCT00889356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6549911|NCT00889356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6549912|NCT00889356|Hormone Antagonists|hormone antagonists|mesh-ancestor
6549913|NCT00889356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6549914|NCT00889356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549915|NCT00889356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6549916|NCT00889356|Amebicides|amebicides|mesh-ancestor
6549917|NCT00889356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6549918|NCT00889356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6549919|NCT00889369|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6549920|NCT00889369|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6549921|NCT00889369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6549922|NCT00889369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6656104|NCT01467401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549923|NCT00889369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549924|NCT00889369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6549925|NCT00889369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549926|NCT00889369|Analgesics|analgesics|mesh-ancestor
6549927|NCT00889369|Sensory System Agents|sensory system agents|mesh-ancestor
6549928|NCT00889369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6549929|NCT00889369|Antidepressive Agents|antidepressive agents|mesh-ancestor
6549930|NCT00889369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6549931|NCT00889369|Dopamine Agents|dopamine agents|mesh-ancestor
6549932|NCT00889434|Tocotrienols|tocotrienols|mesh-list
6549933|NCT00889434|Vitamin E|vitamin e|mesh-list
6549934|NCT00889434|Tocopherols|tocopherols|mesh-list
6549935|NCT00889434|Antioxidants|antioxidants|mesh-ancestor
6549936|NCT00889434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549937|NCT00889434|Protective Agents|protective agents|mesh-ancestor
6549938|NCT00889434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549939|NCT00889434|Vitamins|vitamins|mesh-ancestor
6549940|NCT00889434|Micronutrients|micronutrients|mesh-ancestor
6549941|NCT00889499|Tropisetron|tropisetron|mesh-list
6549942|NCT00889499|Antiemetics|antiemetics|mesh-ancestor
6549943|NCT00889499|Autonomic Agents|autonomic agents|mesh-ancestor
6549944|NCT00889499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6549945|NCT00889499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549946|NCT00889499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6549947|NCT00889499|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6549948|NCT00889499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6549949|NCT00889499|Serotonin Agents|serotonin agents|mesh-ancestor
6549950|NCT00889499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6549951|NCT00889499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549952|NCT00889525|Cabergoline|cabergoline|mesh-list
6549953|NCT00889525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6549954|NCT00889525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6549955|NCT00889525|Dopamine Agonists|dopamine agonists|mesh-ancestor
6442739|NCT00376831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6442740|NCT00376831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442741|NCT00376831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6442742|NCT00376831|Narcotics|narcotics|mesh-ancestor
6442743|NCT00376831|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6442744|NCT00376831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6442745|NCT00376831|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6442746|NCT00376831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6442747|NCT00376831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6442748|NCT00376831|GABA Modulators|gaba modulators|mesh-ancestor
6442749|NCT00376831|GABA Agents|gaba agents|mesh-ancestor
6442750|NCT00376870|Pioglitazone|pioglitazone|mesh-list
6442751|NCT00376870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6549956|NCT00889525|Dopamine Agents|dopamine agents|mesh-ancestor
6442752|NCT00376870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442753|NCT00376883|Pamidronate|pamidronate|mesh-list
6549957|NCT00889525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6549958|NCT00889525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549959|NCT00889525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549960|NCT00889590|Zoledronic Acid|zoledronic acid|mesh-list
6549961|NCT00889590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6549962|NCT00889590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549963|NCT00889616|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6549964|NCT00889616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6549965|NCT00889616|Immunologic Factors|immunologic factors|mesh-ancestor
6549966|NCT00889616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549967|NCT00889616|Antacids|antacids|mesh-ancestor
6549968|NCT00889616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549969|NCT00889616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6549970|NCT00889629|Vitamin D|vitamin d|mesh-list
6549971|NCT00889629|Cholecalciferol|cholecalciferol|mesh-list
6549972|NCT00889629|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
6549973|NCT00889629|Ergocalciferols|ergocalciferols|mesh-list
6549974|NCT00889629|Vitamins|vitamins|mesh-ancestor
6549975|NCT00889629|Micronutrients|micronutrients|mesh-ancestor
6549976|NCT00889629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549977|NCT00889629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6549978|NCT00889629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6442754|NCT00376883|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6442755|NCT00376883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442756|NCT00376987|Zinc Oxide|zinc oxide|mesh-list
6442757|NCT00376987|Dermatologic Agents|dermatologic agents|mesh-ancestor
6442758|NCT00376987|Sunscreening Agents|sunscreening agents|mesh-ancestor
6549979|NCT00889642|Lidocaine|lidocaine|mesh-list
6549980|NCT00889642|Epinephrine|epinephrine|mesh-list
6549981|NCT00889642|Racepinephrine|racepinephrine|mesh-list
6442759|NCT00376987|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6442760|NCT00376987|Protective Agents|protective agents|mesh-ancestor
6442761|NCT00376987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442762|NCT00377000|Clindamycin|clindamycin|mesh-list
6549982|NCT00889642|Epinephryl borate|epinephryl borate|mesh-list
6549983|NCT00889642|Anesthetics, Local|anesthetics, local|mesh-ancestor
6549984|NCT00889642|Anesthetics|anesthetics|mesh-ancestor
6549985|NCT00889642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6549986|NCT00889642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6549987|NCT00889642|Sensory System Agents|sensory system agents|mesh-ancestor
6656105|NCT01467414|Insulin|insulin|mesh-list
6549988|NCT00889642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6549989|NCT00889642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6549990|NCT00889642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6549991|NCT00889642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6549992|NCT00889642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6549993|NCT00889642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6549994|NCT00889642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6549995|NCT00889642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6549996|NCT00889642|Adrenergic Agents|adrenergic agents|mesh-ancestor
6549997|NCT00889642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6549998|NCT00889642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6549999|NCT00889642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6550000|NCT00889642|Autonomic Agents|autonomic agents|mesh-ancestor
6550001|NCT00889642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6550002|NCT00889642|Respiratory System Agents|respiratory system agents|mesh-ancestor
6550003|NCT00889642|Mydriatics|mydriatics|mesh-ancestor
6550004|NCT00889642|Sympathomimetics|sympathomimetics|mesh-ancestor
6550005|NCT00889642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6550006|NCT00889655|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
6550007|NCT00889655|Laxatives|laxatives|mesh-ancestor
6550008|NCT00889655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6550009|NCT00889694|Sulfasalazine|sulfasalazine|mesh-list
6550010|NCT00889694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6550011|NCT00889694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6550012|NCT00889694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6550013|NCT00889694|Analgesics|analgesics|mesh-ancestor
6550014|NCT00889694|Sensory System Agents|sensory system agents|mesh-ancestor
6550015|NCT00889694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6550016|NCT00889694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550017|NCT00889694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6550018|NCT00889694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6550019|NCT00889694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6550020|NCT00889733|Cisplatin|cisplatin|mesh-list
6550021|NCT00889733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6550022|NCT00889837|Loxapine|loxapine|mesh-list
6550023|NCT00889837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6550024|NCT00889837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6550025|NCT00889837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6550026|NCT00889837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550027|NCT00889837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6550028|NCT00889837|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6550029|NCT00889837|Dopamine Agents|dopamine agents|mesh-ancestor
6550030|NCT00889837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6550031|NCT00889837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550032|NCT00889850|Esomeprazole|esomeprazole|mesh-list
6550033|NCT00889850|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6550034|NCT00889850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6550035|NCT00889850|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6550036|NCT00889850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6550037|NCT00889850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550038|NCT00889876|Metformin|metformin|mesh-list
6550039|NCT00889876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6550040|NCT00889876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550041|NCT00890110|Sunitinib|sunitinib|mesh-list
6550042|NCT00890110|Vaccines|vaccines|mesh-list
6550043|NCT00890110|Immunologic Factors|immunologic factors|mesh-ancestor
6550044|NCT00890110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550045|NCT00890110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6550046|NCT00890110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6550047|NCT00890110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6442763|NCT00377000|Clindamycin palmitate|clindamycin palmitate|mesh-list
6442764|NCT00377000|Clindamycin phosphate|clindamycin phosphate|mesh-list
6442765|NCT00377000|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6442766|NCT00377000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6442767|NCT00377000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6442768|NCT00377000|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6442769|NCT00377000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6442770|NCT00377000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442771|NCT00377000|Dermatologic Agents|dermatologic agents|mesh-ancestor
6442772|NCT00377052|Gemcitabine|gemcitabine|mesh-list
6442773|NCT00377052|Bortezomib|bortezomib|mesh-list
6442774|NCT00377052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6442775|NCT00377052|Antimetabolites|antimetabolites|mesh-ancestor
6442776|NCT00377052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442777|NCT00377052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6442778|NCT00377052|Antiviral Agents|antiviral agents|mesh-ancestor
6442779|NCT00377052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6442780|NCT00377052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6442781|NCT00377052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6442782|NCT00377052|Immunologic Factors|immunologic factors|mesh-ancestor
6442783|NCT00377052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442784|NCT00377065|Raltegravir Potassium|raltegravir potassium|mesh-list
6442785|NCT00377065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6442786|NCT00377065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6442787|NCT00377065|Antiviral Agents|antiviral agents|mesh-ancestor
6442788|NCT00377065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6442789|NCT00377065|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6442790|NCT00377065|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6442791|NCT00377065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6442792|NCT00377065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442793|NCT00377078|Lactoferrin|lactoferrin|mesh-list
6442794|NCT00377078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6442795|NCT00377091|PENTA|penta|mesh-list
6442796|NCT00377091|Fondaparinux|fondaparinux|mesh-list
6550048|NCT00890110|Growth Substances|growth substances|mesh-ancestor
6550049|NCT00890110|Growth Inhibitors|growth inhibitors|mesh-ancestor
6550050|NCT00890110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6550051|NCT00890110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6550052|NCT00890110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550053|NCT00890175|Loxapine|loxapine|mesh-list
6550054|NCT00890175|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6550055|NCT00890175|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6550056|NCT00890175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6550057|NCT00890175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550058|NCT00890175|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6550059|NCT00890175|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6550060|NCT00890175|Dopamine Agents|dopamine agents|mesh-ancestor
6550061|NCT00890175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6550062|NCT00890175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550063|NCT00890188|Thalidomide|thalidomide|mesh-list
6550064|NCT00890188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6550065|NCT00890188|Immunologic Factors|immunologic factors|mesh-ancestor
6550066|NCT00890188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550067|NCT00890188|Leprostatic Agents|leprostatic agents|mesh-ancestor
6550068|NCT00890188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6550069|NCT00890188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6550070|NCT00890188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6550071|NCT00890188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6550072|NCT00890188|Growth Substances|growth substances|mesh-ancestor
6550073|NCT00890188|Growth Inhibitors|growth inhibitors|mesh-ancestor
6550074|NCT00890188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6550075|NCT00890214|Epoprostenol|epoprostenol|mesh-list
6550076|NCT00890214|Heparin|heparin|mesh-list
6550077|NCT00890214|Calcium heparin|calcium heparin|mesh-list
6550078|NCT00890214|Tezosentan|tezosentan|mesh-list
6550079|NCT00890214|Anticoagulants|anticoagulants|mesh-ancestor
6550080|NCT00890214|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6550081|NCT00890214|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6550082|NCT00890214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550083|NCT00890214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6550084|NCT00890214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6550085|NCT00890214|Vasodilator Agents|vasodilator agents|mesh-ancestor
6550086|NCT00890253|Mycophenolic Acid|mycophenolic acid|mesh-list
6550087|NCT00890253|Prednisone|prednisone|mesh-list
6550088|NCT00890253|Prednisolone|prednisolone|mesh-list
6550089|NCT00890253|Everolimus|everolimus|mesh-list
6550090|NCT00890253|Basiliximab|basiliximab|mesh-list
6550091|NCT00890253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6550092|NCT00890253|Glucocorticoids|glucocorticoids|mesh-ancestor
6550093|NCT00890253|Hormones|hormones|mesh-ancestor
6550094|NCT00890253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6550095|NCT00890253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550096|NCT00890253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6550097|NCT00890253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6550098|NCT00890253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6550099|NCT00890253|Immunologic Factors|immunologic factors|mesh-ancestor
6550100|NCT00890253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6550101|NCT00890253|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6550102|NCT00890253|Antitubercular Agents|antitubercular agents|mesh-ancestor
6550103|NCT00890253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6550104|NCT00890253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6550105|NCT00890253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6550106|NCT00890253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550107|NCT00890266|Riboflavin|riboflavin|mesh-list
6550108|NCT00890266|Vitamin B Complex|vitamin b complex|mesh-ancestor
6550109|NCT00890266|Vitamins|vitamins|mesh-ancestor
6550110|NCT00890266|Micronutrients|micronutrients|mesh-ancestor
6550111|NCT00890266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550112|NCT00890266|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6550113|NCT00890266|Dermatologic Agents|dermatologic agents|mesh-ancestor
6550114|NCT00890279|Imidapril|imidapril|mesh-list
6550115|NCT00890279|Cilnidipine|cilnidipine|mesh-list
6550116|NCT00890279|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6550117|NCT00890279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6550118|NCT00890279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656106|NCT01467414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6550119|NCT00890279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6550120|NCT00890279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550121|NCT00890279|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6550122|NCT00890279|Protease Inhibitors|protease inhibitors|mesh-ancestor
6550123|NCT00890279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6550124|NCT00890279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6550125|NCT00890318|Ketoconazole|ketoconazole|mesh-list
6550126|NCT00890318|Antifungal Agents|antifungal agents|mesh-ancestor
6550127|NCT00890318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6550128|NCT00890318|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6550129|NCT00890318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6550130|NCT00890318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6550131|NCT00890318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550132|NCT00890318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6550133|NCT00890318|Hormone Antagonists|hormone antagonists|mesh-ancestor
6550134|NCT00890318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6550135|NCT00890318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550136|NCT00890318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6550137|NCT00890383|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
6550138|NCT00890383|Plasma Substitutes|plasma substitutes|mesh-ancestor
6550139|NCT00890383|Blood Substitutes|blood substitutes|mesh-ancestor
6550140|NCT00890422|Vaccines|vaccines|mesh-list
6550141|NCT00890422|Immunologic Factors|immunologic factors|mesh-ancestor
6550142|NCT00890422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550143|NCT00890487|Hyaluronic Acid|hyaluronic acid|mesh-list
6550144|NCT00890487|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6550145|NCT00890487|Immunologic Factors|immunologic factors|mesh-ancestor
6550146|NCT00890487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550147|NCT00890487|Viscosupplements|viscosupplements|mesh-ancestor
6550148|NCT00890487|Protective Agents|protective agents|mesh-ancestor
6550149|NCT00890500|Sirolimus|sirolimus|mesh-list
6550150|NCT00890500|Fludarabine|fludarabine|mesh-list
6550151|NCT00890500|Melphalan|melphalan|mesh-list
6550152|NCT00890500|Tacrolimus|tacrolimus|mesh-list
6550153|NCT00890500|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6550154|NCT00890500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6550155|NCT00890500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550156|NCT00890500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6550157|NCT00890500|Immunologic Factors|immunologic factors|mesh-ancestor
6550158|NCT00890500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550159|NCT00890500|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6550160|NCT00890500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6550161|NCT00890500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6550162|NCT00890500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6550163|NCT00890500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6550164|NCT00890500|Antifungal Agents|antifungal agents|mesh-ancestor
6550165|NCT00890500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6550166|NCT00890500|Alkylating Agents|alkylating agents|mesh-ancestor
6550167|NCT00890500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6550168|NCT00890539|Methacholine Chloride|methacholine chloride|mesh-list
6550169|NCT00890539|Miotics|miotics|mesh-ancestor
6550170|NCT00890539|Autonomic Agents|autonomic agents|mesh-ancestor
6550171|NCT00890539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6550172|NCT00890539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550173|NCT00890539|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6550174|NCT00890539|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
6550175|NCT00890539|Respiratory System Agents|respiratory system agents|mesh-ancestor
6550176|NCT00890539|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6550177|NCT00890539|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6550178|NCT00890539|Cholinergic Agents|cholinergic agents|mesh-ancestor
6550179|NCT00890539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6550180|NCT00890539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550181|NCT00890565|Granisetron|granisetron|mesh-list
6550182|NCT00890565|Antiemetics|antiemetics|mesh-ancestor
6550183|NCT00890565|Autonomic Agents|autonomic agents|mesh-ancestor
6550184|NCT00890565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6550185|NCT00890565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550186|NCT00890565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6550187|NCT00890565|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6550188|NCT00890565|Serotonin Agents|serotonin agents|mesh-ancestor
6550189|NCT00890565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6550190|NCT00890565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550191|NCT00890604|Acetaminophen|acetaminophen|mesh-list
6550192|NCT00890604|Ibuprofen|ibuprofen|mesh-list
6550193|NCT00890604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6550194|NCT00890604|Analgesics|analgesics|mesh-ancestor
6550195|NCT00890604|Sensory System Agents|sensory system agents|mesh-ancestor
6550196|NCT00890604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6550197|NCT00890604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550198|NCT00890604|Antipyretics|antipyretics|mesh-ancestor
6550199|NCT00890604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6550200|NCT00890604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6550201|NCT00890604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6550202|NCT00890604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6550203|NCT00890604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6550204|NCT00890604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550205|NCT00890630|Oxytocin|oxytocin|mesh-list
6550206|NCT00890630|Oxytocics|oxytocics|mesh-ancestor
6550207|NCT00890630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6550208|NCT00890630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550209|NCT00890643|Prazosin|prazosin|mesh-list
6550210|NCT00890643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6550211|NCT00890643|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6550212|NCT00890643|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6550213|NCT00890643|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6550214|NCT00890643|Adrenergic Agents|adrenergic agents|mesh-ancestor
6550215|NCT00890643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6550216|NCT00890643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550217|NCT00890643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550218|NCT00890708|Voriconazole|voriconazole|mesh-list
6550219|NCT00890708|Antifungal Agents|antifungal agents|mesh-ancestor
6550220|NCT00890708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6550221|NCT00890708|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6550222|NCT00890708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6550223|NCT00890708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6656107|NCT01467414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550224|NCT00890708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550225|NCT00890708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6550226|NCT00890708|Hormone Antagonists|hormone antagonists|mesh-ancestor
6550227|NCT00890708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6550228|NCT00890708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550229|NCT00890708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6550230|NCT00890747|Sunitinib|sunitinib|mesh-list
6550231|NCT00890747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6550232|NCT00890747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6550233|NCT00890747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6550234|NCT00890747|Growth Substances|growth substances|mesh-ancestor
6550235|NCT00890747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550236|NCT00890747|Growth Inhibitors|growth inhibitors|mesh-ancestor
6550237|NCT00890747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6550238|NCT00890747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6550239|NCT00890747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550240|NCT00890786|Bevacizumab|bevacizumab|mesh-list
6550241|NCT00890786|Irinotecan|irinotecan|mesh-list
6550242|NCT00890786|Temozolomide|temozolomide|mesh-list
6550243|NCT00890786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6550244|NCT00890786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6550245|NCT00890786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6550246|NCT00890786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6550247|NCT00890786|Growth Substances|growth substances|mesh-ancestor
6550248|NCT00890786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550249|NCT00890786|Growth Inhibitors|growth inhibitors|mesh-ancestor
6550250|NCT00890786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6550251|NCT00890786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6550252|NCT00890786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6550253|NCT00890786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550254|NCT00890786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6550255|NCT00890786|Alkylating Agents|alkylating agents|mesh-ancestor
6656108|NCT01467518|Dolutegravir|dolutegravir|mesh-list
6656109|NCT01467518|Methadone|methadone|mesh-list
6656110|NCT01467518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6656111|NCT01467518|Narcotics|narcotics|mesh-ancestor
6656112|NCT01467518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6656113|NCT01467518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656114|NCT01467518|Analgesics|analgesics|mesh-ancestor
6656115|NCT01467518|Sensory System Agents|sensory system agents|mesh-ancestor
6656116|NCT01467518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6656117|NCT01467518|Antitussive Agents|antitussive agents|mesh-ancestor
6656118|NCT01467518|Respiratory System Agents|respiratory system agents|mesh-ancestor
6656119|NCT01467518|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6656120|NCT01467518|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6656121|NCT01467518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6656122|NCT01467518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656123|NCT01467518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6550256|NCT00890942|Naloxone|naloxone|mesh-list
6550257|NCT00890942|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6550258|NCT00890942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550259|NCT00890942|Sensory System Agents|sensory system agents|mesh-ancestor
6550260|NCT00890942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6550261|NCT00890955|Cyclophosphamide|cyclophosphamide|mesh-list
6550262|NCT00890955|Amrubicin|amrubicin|mesh-list
6550263|NCT00890955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6550264|NCT00890955|Immunologic Factors|immunologic factors|mesh-ancestor
6550265|NCT00890955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550266|NCT00890955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6550267|NCT00890955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6550268|NCT00890955|Alkylating Agents|alkylating agents|mesh-ancestor
6550269|NCT00890955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550270|NCT00890955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6550271|NCT00890955|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6550272|NCT00891033|Bortezomib|bortezomib|mesh-list
6550273|NCT00891033|Panobinostat|panobinostat|mesh-list
6550274|NCT00891033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6550275|NCT00891033|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6550276|NCT00891033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6550277|NCT00891033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550278|NCT00891072|Acetic Acid|acetic acid|mesh-list
6550279|NCT00891072|Paclitaxel|paclitaxel|mesh-list
6550280|NCT00891072|Gossypol acetic acid|gossypol acetic acid|mesh-list
6550281|NCT00891072|Carboplatin|carboplatin|mesh-list
6550282|NCT00891072|Retinol acetate|retinol acetate|mesh-list
6550283|NCT00891072|Gossypol|gossypol|mesh-list
6550284|NCT00891072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6550285|NCT00891072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6550286|NCT00891072|Tubulin Modulators|tubulin modulators|mesh-ancestor
6550287|NCT00891072|Antimitotic Agents|antimitotic agents|mesh-ancestor
6550288|NCT00891072|Mitosis Modulators|mitosis modulators|mesh-ancestor
6550289|NCT00891072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550290|NCT00891072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6550291|NCT00891072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6550292|NCT00891072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6550293|NCT00891072|Immunologic Factors|immunologic factors|mesh-ancestor
6550294|NCT00891072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550295|NCT00891072|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6550296|NCT00891072|Protective Agents|protective agents|mesh-ancestor
6550297|NCT00891072|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6550298|NCT00891072|Contraceptive Agents|contraceptive agents|mesh-ancestor
6550299|NCT00891072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6550300|NCT00891072|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6550301|NCT00891072|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
6550302|NCT00891072|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
6550303|NCT00891150|Oxytocin|oxytocin|mesh-list
6550304|NCT00891150|Oxytocics|oxytocics|mesh-ancestor
6550305|NCT00891150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6550306|NCT00891150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550307|NCT00891163|Lidocaine|lidocaine|mesh-list
6550308|NCT00891163|Tetracaine|tetracaine|mesh-list
6550309|NCT00891163|Anesthetics, Local|anesthetics, local|mesh-ancestor
6550310|NCT00891163|Anesthetics|anesthetics|mesh-ancestor
6442797|NCT00377091|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6442798|NCT00377091|Antithrombins|antithrombins|mesh-ancestor
6442799|NCT00377091|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6442800|NCT00377091|Protease Inhibitors|protease inhibitors|mesh-ancestor
6442801|NCT00377091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6442802|NCT00377091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442803|NCT00377091|Anticoagulants|anticoagulants|mesh-ancestor
6442804|NCT00377091|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6442805|NCT00377091|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6442806|NCT00377104|Alvocidib|alvocidib|mesh-list
6442807|NCT00377104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6550311|NCT00891163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6550312|NCT00891163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550313|NCT00891163|Sensory System Agents|sensory system agents|mesh-ancestor
6550314|NCT00891163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6550315|NCT00891163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6550316|NCT00891163|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6550317|NCT00891163|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6550318|NCT00891163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6550319|NCT00891163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550320|NCT00891267|Amlodipine|amlodipine|mesh-list
6550321|NCT00891267|Olmesartan|olmesartan|mesh-list
6550322|NCT00891267|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6550323|NCT00891267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6550324|NCT00891267|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6550325|NCT00891267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6550326|NCT00891267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550327|NCT00891267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6550328|NCT00891267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550329|NCT00891267|Vasodilator Agents|vasodilator agents|mesh-ancestor
6550330|NCT00891267|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6550331|NCT00891267|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6550332|NCT00891306|Cyclosporine|cyclosporine|mesh-list
6550333|NCT00891306|Mycophenolic Acid|mycophenolic acid|mesh-list
6550334|NCT00891306|Methylprednisolone|methylprednisolone|mesh-list
6550335|NCT00891306|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6550336|NCT00891306|Cyclosporins|cyclosporins|mesh-list
6550337|NCT00891306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6550338|NCT00891306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550339|NCT00891306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6550340|NCT00891306|Immunologic Factors|immunologic factors|mesh-ancestor
6550341|NCT00891306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550342|NCT00891306|Antifungal Agents|antifungal agents|mesh-ancestor
6550343|NCT00891306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6550344|NCT00891306|Dermatologic Agents|dermatologic agents|mesh-ancestor
6550345|NCT00891306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6550346|NCT00891306|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6550347|NCT00891306|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6550348|NCT00891306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6550349|NCT00891306|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6550350|NCT00891306|Antitubercular Agents|antitubercular agents|mesh-ancestor
6550351|NCT00891306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6550352|NCT00891306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6550353|NCT00891306|Antiemetics|antiemetics|mesh-ancestor
6550354|NCT00891306|Autonomic Agents|autonomic agents|mesh-ancestor
6550355|NCT00891306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6550356|NCT00891306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6550357|NCT00891306|Glucocorticoids|glucocorticoids|mesh-ancestor
6550358|NCT00891306|Hormones|hormones|mesh-ancestor
6550359|NCT00891306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6550360|NCT00891306|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6550361|NCT00891306|Protective Agents|protective agents|mesh-ancestor
6550362|NCT00891306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6550363|NCT00891332|Leucovorin|leucovorin|mesh-list
6550364|NCT00891332|Antidotes|antidotes|mesh-ancestor
6550365|NCT00891332|Protective Agents|protective agents|mesh-ancestor
6550366|NCT00891332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550367|NCT00891332|Vitamin B Complex|vitamin b complex|mesh-ancestor
6550368|NCT00891332|Vitamins|vitamins|mesh-ancestor
6550369|NCT00891332|Micronutrients|micronutrients|mesh-ancestor
6550370|NCT00891384|Lenalidomide|lenalidomide|mesh-list
6550371|NCT00891384|Immunologic Factors|immunologic factors|mesh-ancestor
6550372|NCT00891384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550373|NCT00891384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6550374|NCT00891384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6550375|NCT00891384|Growth Substances|growth substances|mesh-ancestor
6550376|NCT00891384|Growth Inhibitors|growth inhibitors|mesh-ancestor
6550377|NCT00891384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6550378|NCT00891397|Pregabalin|pregabalin|mesh-list
6550379|NCT00891397|Analgesics|analgesics|mesh-ancestor
6550380|NCT00891397|Sensory System Agents|sensory system agents|mesh-ancestor
6550381|NCT00891397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6550382|NCT00891397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550383|NCT00891397|Anticonvulsants|anticonvulsants|mesh-ancestor
6550384|NCT00891397|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6550385|NCT00891397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6550386|NCT00891397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550387|NCT00891397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6550388|NCT00891397|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6550389|NCT00891397|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6550390|NCT00891397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6550391|NCT00891397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6550392|NCT00891423|Meropenem|meropenem|mesh-list
6550393|NCT00891423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6550394|NCT00891423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6550395|NCT00891475|Interferons|interferons|mesh-list
6550396|NCT00891475|Interferon-alpha|interferon-alpha|mesh-list
6550397|NCT00891475|Sunitinib|sunitinib|mesh-list
6550398|NCT00891475|Maleic acid|maleic acid|mesh-list
6550399|NCT00891475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6550400|NCT00891475|Antiviral Agents|antiviral agents|mesh-ancestor
6550401|NCT00891475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6550402|NCT00891475|Immunologic Factors|immunologic factors|mesh-ancestor
6550403|NCT00891475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550404|NCT00891475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6550405|NCT00891475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6550406|NCT00891475|Growth Substances|growth substances|mesh-ancestor
6550407|NCT00891475|Growth Inhibitors|growth inhibitors|mesh-ancestor
6550408|NCT00891475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6550409|NCT00891475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6550410|NCT00891475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550411|NCT00891540|Ropivacaine|ropivacaine|mesh-list
6550412|NCT00891540|Anesthetics, Local|anesthetics, local|mesh-ancestor
6550413|NCT00891540|Anesthetics|anesthetics|mesh-ancestor
6550414|NCT00891540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6550415|NCT00891540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550416|NCT00891540|Sensory System Agents|sensory system agents|mesh-ancestor
6550417|NCT00891540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6550418|NCT00891579|Pemetrexed|pemetrexed|mesh-list
6550419|NCT00891579|Gefitinib|gefitinib|mesh-list
6550420|NCT00891579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6550421|NCT00891579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6550422|NCT00891579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550423|NCT00891579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6550424|NCT00891579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6550425|NCT00891579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6550426|NCT00891605|Paclitaxel|paclitaxel|mesh-list
6550427|NCT00891605|Navitoclax|navitoclax|mesh-list
6550428|NCT00891605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6550429|NCT00891605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6550430|NCT00891605|Tubulin Modulators|tubulin modulators|mesh-ancestor
6550431|NCT00891605|Antimitotic Agents|antimitotic agents|mesh-ancestor
6550432|NCT00891605|Mitosis Modulators|mitosis modulators|mesh-ancestor
6550433|NCT00891605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550434|NCT00891670|Aspirin|aspirin|mesh-list
6550435|NCT00891670|Cilostazol|cilostazol|mesh-list
6550436|NCT00891670|Clopidogrel|clopidogrel|mesh-list
6550437|NCT00891670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6550438|NCT00891670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6550439|NCT00891670|Analgesics|analgesics|mesh-ancestor
6550440|NCT00891670|Sensory System Agents|sensory system agents|mesh-ancestor
6550441|NCT00891670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6550442|NCT00891670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550443|NCT00891670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6550444|NCT00891670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6550445|NCT00891670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6550446|NCT00891670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6550447|NCT00891670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550448|NCT00891670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6550449|NCT00891670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6550450|NCT00891670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6550451|NCT00891670|Antipyretics|antipyretics|mesh-ancestor
6550452|NCT00891670|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6550453|NCT00891670|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6550454|NCT00891670|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6550455|NCT00891670|Purinergic Agents|purinergic agents|mesh-ancestor
6550456|NCT00891670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6550457|NCT00891670|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6550458|NCT00891670|Autonomic Agents|autonomic agents|mesh-ancestor
6550459|NCT00891670|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6550460|NCT00891670|Respiratory System Agents|respiratory system agents|mesh-ancestor
6550461|NCT00891670|Vasodilator Agents|vasodilator agents|mesh-ancestor
6550462|NCT00891670|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6550463|NCT00891670|Protective Agents|protective agents|mesh-ancestor
6550464|NCT00891670|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6550465|NCT00891670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6550466|NCT00891696|Sirolimus|sirolimus|mesh-list
6550467|NCT00891696|Nitroprusside|nitroprusside|mesh-list
6550468|NCT00891696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6550469|NCT00891696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6550470|NCT00891696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6550471|NCT00891696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6550472|NCT00891696|Antifungal Agents|antifungal agents|mesh-ancestor
6550473|NCT00891696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6550474|NCT00891696|Immunologic Factors|immunologic factors|mesh-ancestor
6550475|NCT00891696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550476|NCT00891696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6550477|NCT00891696|Vasodilator Agents|vasodilator agents|mesh-ancestor
6550478|NCT00891696|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6550479|NCT00891696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550480|NCT00891761|Dexamethasone|dexamethasone|mesh-list
6550481|NCT00891761|Dexamethasone acetate|dexamethasone acetate|mesh-list
6550482|NCT00891761|Ondansetron|ondansetron|mesh-list
6550483|NCT00891761|Casopitant|casopitant|mesh-list
6550484|NCT00891761|BB 1101|bb 1101|mesh-list
6550485|NCT00891761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6550486|NCT00891761|Antiemetics|antiemetics|mesh-ancestor
6550487|NCT00891761|Autonomic Agents|autonomic agents|mesh-ancestor
6550488|NCT00891761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6550489|NCT00891761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550490|NCT00891761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6550491|NCT00891761|Glucocorticoids|glucocorticoids|mesh-ancestor
6550492|NCT00891761|Hormones|hormones|mesh-ancestor
6550493|NCT00891761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6550494|NCT00891761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6550495|NCT00891761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6550496|NCT00891761|Protease Inhibitors|protease inhibitors|mesh-ancestor
6550497|NCT00891761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6550498|NCT00891761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550499|NCT00891761|Antipruritics|antipruritics|mesh-ancestor
6550500|NCT00891761|Dermatologic Agents|dermatologic agents|mesh-ancestor
6550501|NCT00891761|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6550502|NCT00891761|Serotonin Agents|serotonin agents|mesh-ancestor
6550503|NCT00891761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6550504|NCT00891761|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6550505|NCT00891761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6550506|NCT00891761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6550507|NCT00891761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6550508|NCT00891761|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6550509|NCT00891761|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6550510|NCT00892073|Metformin|metformin|mesh-list
6550511|NCT00892073|Diazoxide|diazoxide|mesh-list
6550512|NCT00892073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6550513|NCT00892073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550514|NCT00892073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6550515|NCT00892073|Vasodilator Agents|vasodilator agents|mesh-ancestor
6550516|NCT00892112|Plasma Substitutes|plasma substitutes|mesh-list
6550517|NCT00892112|Immunoglobulins|immunoglobulins|mesh-list
6550518|NCT00892112|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6550519|NCT00892112|Antibodies|antibodies|mesh-list
6550520|NCT00892112|gamma-Globulins|gamma-globulins|mesh-list
6550521|NCT00892112|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6550522|NCT00892112|Immunologic Factors|immunologic factors|mesh-ancestor
6550523|NCT00892112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550524|NCT00892112|Blood Substitutes|blood substitutes|mesh-ancestor
6550525|NCT00892125|Carbamazepine|carbamazepine|mesh-list
6550526|NCT00892125|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6550527|NCT00892125|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6550528|NCT00892125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6550529|NCT00892125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6550530|NCT00892125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550531|NCT00892125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6550532|NCT00892125|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6550533|NCT00892125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6550534|NCT00892125|Serotonin Agents|serotonin agents|mesh-ancestor
6550535|NCT00892125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6550536|NCT00892125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550537|NCT00892125|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6550538|NCT00892125|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6550539|NCT00892125|Dopamine Agents|dopamine agents|mesh-ancestor
6550540|NCT00892125|Anticonvulsants|anticonvulsants|mesh-ancestor
6550541|NCT00892125|Antimanic Agents|antimanic agents|mesh-ancestor
6550542|NCT00892125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6550543|NCT00892125|Analgesics|analgesics|mesh-ancestor
6550544|NCT00892125|Sensory System Agents|sensory system agents|mesh-ancestor
6550545|NCT00892125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6550546|NCT00892125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6550547|NCT00892125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6550548|NCT00892125|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6550549|NCT00892125|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6550550|NCT00892190|Dasatinib|dasatinib|mesh-list
6550551|NCT00892190|Tretinoin|tretinoin|mesh-list
6550552|NCT00892190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6550553|NCT00892190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6550554|NCT00892190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6550555|NCT00892190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550556|NCT00892190|Keratolytic Agents|keratolytic agents|mesh-ancestor
6550557|NCT00892190|Dermatologic Agents|dermatologic agents|mesh-ancestor
6550558|NCT00892229|Misoprostol|misoprostol|mesh-list
6550559|NCT00892229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6550560|NCT00892229|Abortifacient Agents|abortifacient agents|mesh-ancestor
6550561|NCT00892229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6550562|NCT00892229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550563|NCT00892229|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6550564|NCT00892229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6550565|NCT00892229|Oxytocics|oxytocics|mesh-ancestor
6550566|NCT00892242|Zoledronic Acid|zoledronic acid|mesh-list
6550567|NCT00892242|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6550568|NCT00892242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550569|NCT00892307|Adenosine|adenosine|mesh-list
6550570|NCT00892307|Analgesics|analgesics|mesh-ancestor
6550571|NCT00892307|Sensory System Agents|sensory system agents|mesh-ancestor
6442808|NCT00377104|Growth Inhibitors|growth inhibitors|mesh-ancestor
6442809|NCT00377104|Growth Substances|growth substances|mesh-ancestor
6442810|NCT00377104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442811|NCT00377104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6442812|NCT00377104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6442813|NCT00377104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442814|NCT00377143|Warfarin|warfarin|mesh-list
6442815|NCT00377143|Anticoagulants|anticoagulants|mesh-ancestor
6442816|NCT00377273|Fluorouracil|fluorouracil|mesh-list
6442817|NCT00377273|Antimetabolites|antimetabolites|mesh-ancestor
6442818|NCT00377273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442819|NCT00377273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6550572|NCT00892307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6550573|NCT00892307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550574|NCT00892307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6550575|NCT00892307|Vasodilator Agents|vasodilator agents|mesh-ancestor
6550576|NCT00892307|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6550577|NCT00892307|Purinergic Agonists|purinergic agonists|mesh-ancestor
6550578|NCT00892307|Purinergic Agents|purinergic agents|mesh-ancestor
6550579|NCT00892307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6550580|NCT00892307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550581|NCT00892320|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6550582|NCT00892320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6550583|NCT00892320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6550584|NCT00892320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6550585|NCT00892320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461604|NCT00455325|Antinematodal Agents|antinematodal agents|mesh-ancestor
6550586|NCT00892320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6550587|NCT00892320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6550588|NCT00892320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6550589|NCT00892320|Serotonin Agents|serotonin agents|mesh-ancestor
6550590|NCT00892320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6550591|NCT00892320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550592|NCT00892320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6550593|NCT00892320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6550594|NCT00892320|Dopamine Agents|dopamine agents|mesh-ancestor
6550595|NCT00892346|Thalidomide|thalidomide|mesh-list
6550596|NCT00892346|Melphalan|melphalan|mesh-list
6550597|NCT00892346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6550598|NCT00892346|Alkylating Agents|alkylating agents|mesh-ancestor
6550599|NCT00892346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550600|NCT00892346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6550601|NCT00892346|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6550602|NCT00892346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6550603|NCT00892346|Immunologic Factors|immunologic factors|mesh-ancestor
6550604|NCT00892346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550605|NCT00892346|Leprostatic Agents|leprostatic agents|mesh-ancestor
6550606|NCT00892346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6550607|NCT00892346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6550608|NCT00892346|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6550609|NCT00892346|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6550610|NCT00892346|Growth Substances|growth substances|mesh-ancestor
6550611|NCT00892346|Growth Inhibitors|growth inhibitors|mesh-ancestor
6550612|NCT00892359|Anidulafungin|anidulafungin|mesh-list
6550613|NCT00892359|Antifungal Agents|antifungal agents|mesh-ancestor
6550614|NCT00892359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6550615|NCT00892385|Temozolomide|temozolomide|mesh-list
6550616|NCT00892385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6550617|NCT00892385|Alkylating Agents|alkylating agents|mesh-ancestor
6550618|NCT00892385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550619|NCT00892385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6461605|NCT00455325|Anthelmintics|anthelmintics|mesh-ancestor
6461606|NCT00455351|Vorinostat|vorinostat|mesh-list
6461607|NCT00455351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6461608|NCT00455351|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6461609|NCT00455351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6461610|NCT00455351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461611|NCT00455364|Voriconazole|voriconazole|mesh-list
6461612|NCT00455364|Antifungal Agents|antifungal agents|mesh-ancestor
6461613|NCT00455364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6461614|NCT00455364|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6461615|NCT00455364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6550620|NCT00892398|Ranibizumab|ranibizumab|mesh-list
6550621|NCT00892398|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6550622|NCT00892398|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6550623|NCT00892398|Growth Substances|growth substances|mesh-ancestor
6550624|NCT00892398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550625|NCT00892398|Growth Inhibitors|growth inhibitors|mesh-ancestor
6550626|NCT00892398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6550627|NCT00892424|Sorafenib|sorafenib|mesh-list
6550628|NCT00892424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6550629|NCT00892424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6550630|NCT00892424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6550631|NCT00892424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550632|NCT00892450|Oxybutynin|oxybutynin|mesh-list
6550633|NCT00892450|Darifenacin|darifenacin|mesh-list
6550634|NCT00892450|Parasympatholytics|parasympatholytics|mesh-ancestor
6550635|NCT00892450|Autonomic Agents|autonomic agents|mesh-ancestor
6550636|NCT00892450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6550637|NCT00892450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550638|NCT00892450|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6550639|NCT00892450|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6550640|NCT00892450|Cholinergic Agents|cholinergic agents|mesh-ancestor
6550641|NCT00892450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6550642|NCT00892450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550643|NCT00892450|Urological Agents|urological agents|mesh-ancestor
6550644|NCT00892463|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6550645|NCT00892463|Antidepressive Agents|antidepressive agents|mesh-ancestor
6550646|NCT00892463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6550647|NCT00892463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6550648|NCT00892463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6550649|NCT00892463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6550650|NCT00892463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550651|NCT00892476|Calcium, Dietary|calcium, dietary|mesh-list
6550652|NCT00892476|Calcium|calcium|mesh-list
6550653|NCT00892476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6550654|NCT00892476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550655|NCT00892476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6550656|NCT00892489|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6550657|NCT00892489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6550658|NCT00892489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6550659|NCT00892489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6550660|NCT00892489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550661|NCT00892489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6550662|NCT00892489|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6550663|NCT00892489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6550664|NCT00892489|Serotonin Agents|serotonin agents|mesh-ancestor
6550665|NCT00892489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6550666|NCT00892489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550667|NCT00892489|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6550668|NCT00892489|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6550669|NCT00892489|Dopamine Agents|dopamine agents|mesh-ancestor
6550670|NCT00892502|Bismuth|bismuth|mesh-list
6550671|NCT00892502|Antacids|antacids|mesh-ancestor
6550672|NCT00892502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550673|NCT00892502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6550674|NCT00892541|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6550675|NCT00892541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6550676|NCT00892541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6550677|NCT00892541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6550678|NCT00892541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550679|NCT00892541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6550680|NCT00892541|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6550681|NCT00892541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6550682|NCT00892541|Serotonin Agents|serotonin agents|mesh-ancestor
6550683|NCT00892541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6550684|NCT00892541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550685|NCT00892541|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6550686|NCT00892541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6550687|NCT00892541|Dopamine Agents|dopamine agents|mesh-ancestor
6550688|NCT00892658|Sorafenib|sorafenib|mesh-list
6550689|NCT00892658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6550690|NCT00892658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6550691|NCT00892658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6550692|NCT00892658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656124|NCT01467518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6656125|NCT01467518|Antiviral Agents|antiviral agents|mesh-ancestor
6656126|NCT01467518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6656127|NCT01467531|Dolutegravir|dolutegravir|mesh-list
6656128|NCT01467531|Cabotegravir|cabotegravir|mesh-list
6656129|NCT01467531|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6656130|NCT01467531|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6656131|NCT01467531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6656132|NCT01467531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656133|NCT01467531|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6656134|NCT01467531|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6656135|NCT01467531|Antiviral Agents|antiviral agents|mesh-ancestor
6656136|NCT01467531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6656137|NCT01467596|Lidocaine|lidocaine|mesh-list
6656138|NCT01467596|Levobupivacaine|levobupivacaine|mesh-list
6656139|NCT01467596|Anesthetics, Local|anesthetics, local|mesh-ancestor
6656140|NCT01467596|Anesthetics|anesthetics|mesh-ancestor
6656141|NCT01467596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6656142|NCT01467596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656143|NCT01467596|Sensory System Agents|sensory system agents|mesh-ancestor
6656144|NCT01467596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6656145|NCT01467596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6656146|NCT01467596|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6656147|NCT01467596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6656148|NCT01467596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6656149|NCT01467596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656150|NCT01467648|Doripenem|doripenem|mesh-list
6656151|NCT01467648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6656152|NCT01467648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6656153|NCT01467687|Verapamil|verapamil|mesh-list
6656154|NCT01467687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6656155|NCT01467687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6656156|NCT01467687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6656157|NCT01467687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656158|NCT01467687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6656159|NCT01467687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656160|NCT01467687|Vasodilator Agents|vasodilator agents|mesh-ancestor
6664706|NCT01513668|Sensory System Agents|sensory system agents|mesh-ancestor
6664707|NCT01513668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6664708|NCT01513668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664709|NCT01513668|Antipyretics|antipyretics|mesh-ancestor
6664710|NCT01513681|Lamotrigine|lamotrigine|mesh-list
6664711|NCT01513681|Anticonvulsants|anticonvulsants|mesh-ancestor
6664712|NCT01513681|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6664713|NCT01513681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6664714|NCT01513681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550693|NCT00892736|Veliparib|veliparib|mesh-list
6550694|NCT00892736|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6550695|NCT00892736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6550696|NCT00892736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550697|NCT00892736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6550698|NCT00892801|Everolimus|everolimus|mesh-list
6550699|NCT00892801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6550700|NCT00892801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6550701|NCT00892801|Immunologic Factors|immunologic factors|mesh-ancestor
6550702|NCT00892801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550703|NCT00892827|Rituximab|rituximab|mesh-list
6550704|NCT00892827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6550705|NCT00892827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6550706|NCT00892827|Immunologic Factors|immunologic factors|mesh-ancestor
6550707|NCT00892827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550708|NCT00892827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6550709|NCT00892892|Nitrendipine|nitrendipine|mesh-list
6550710|NCT00892892|Rilmenidine|rilmenidine|mesh-list
6550711|NCT00892892|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6550712|NCT00892892|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6550713|NCT00892892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6550714|NCT00892892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550715|NCT00892892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6550716|NCT00892892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550717|NCT00892892|Vasodilator Agents|vasodilator agents|mesh-ancestor
6550718|NCT00892892|Sympatholytics|sympatholytics|mesh-ancestor
6550719|NCT00892892|Autonomic Agents|autonomic agents|mesh-ancestor
6550720|NCT00892892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6550721|NCT00892892|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6550722|NCT00892892|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6550723|NCT00892892|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6550724|NCT00892892|Adrenergic Agents|adrenergic agents|mesh-ancestor
6550725|NCT00892892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6550726|NCT00892918|Moxifloxacin|moxifloxacin|mesh-list
6550727|NCT00892918|Gatifloxacin|gatifloxacin|mesh-list
6550728|NCT00892918|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6550729|NCT00892918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6550730|NCT00892918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6550731|NCT00892918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6550732|NCT00892918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6550733|NCT00892918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6550734|NCT00892918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6550735|NCT00892918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550736|NCT00892918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6550737|NCT00892996|Dexamethasone|dexamethasone|mesh-list
6550738|NCT00892996|Dexamethasone acetate|dexamethasone acetate|mesh-list
6550739|NCT00892996|BB 1101|bb 1101|mesh-list
6550740|NCT00892996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6550741|NCT00892996|Antiemetics|antiemetics|mesh-ancestor
6550742|NCT00892996|Autonomic Agents|autonomic agents|mesh-ancestor
6550743|NCT00892996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6550744|NCT00892996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550745|NCT00892996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6550746|NCT00892996|Glucocorticoids|glucocorticoids|mesh-ancestor
6550747|NCT00892996|Hormones|hormones|mesh-ancestor
6442820|NCT00377273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6442821|NCT00377273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6442822|NCT00377273|Immunologic Factors|immunologic factors|mesh-ancestor
6442823|NCT00377273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442824|NCT00377325|Cyclosporine|cyclosporine|mesh-list
6442825|NCT00377325|Cyclosporins|cyclosporins|mesh-list
6442826|NCT00377325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6442827|NCT00377325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442828|NCT00377325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6442829|NCT00377325|Immunologic Factors|immunologic factors|mesh-ancestor
6442830|NCT00377325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442831|NCT00377325|Antifungal Agents|antifungal agents|mesh-ancestor
6442832|NCT00377325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6550748|NCT00892996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6550749|NCT00892996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6550750|NCT00892996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6550751|NCT00892996|Protease Inhibitors|protease inhibitors|mesh-ancestor
6550752|NCT00892996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6442833|NCT00377325|Dermatologic Agents|dermatologic agents|mesh-ancestor
6442834|NCT00377325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6550753|NCT00892996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550754|NCT00893009|Theophylline|theophylline|mesh-list
6550755|NCT00893009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6442835|NCT00377325|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6442836|NCT00377390|Omalizumab|omalizumab|mesh-list
6442837|NCT00377390|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6442838|NCT00377390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6442839|NCT00377390|Respiratory System Agents|respiratory system agents|mesh-ancestor
6442840|NCT00377442|Simvastatin|simvastatin|mesh-list
6442841|NCT00377442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6442842|NCT00377442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6442843|NCT00377442|Antimetabolites|antimetabolites|mesh-ancestor
6442844|NCT00377442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442845|NCT00377442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6442846|NCT00377442|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6550756|NCT00893009|Autonomic Agents|autonomic agents|mesh-ancestor
6550757|NCT00893009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6550758|NCT00893009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550759|NCT00893009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6550760|NCT00893009|Respiratory System Agents|respiratory system agents|mesh-ancestor
6550761|NCT00893009|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6550762|NCT00893009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6550763|NCT00893009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550764|NCT00893009|Vasodilator Agents|vasodilator agents|mesh-ancestor
6550765|NCT00893009|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6442847|NCT00377442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6442848|NCT00377468|Dronabinol|dronabinol|mesh-list
6442849|NCT00377468|Hallucinogens|hallucinogens|mesh-ancestor
6442850|NCT00377468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442851|NCT00377468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6442852|NCT00377468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6442853|NCT00377468|Analgesics|analgesics|mesh-ancestor
6442854|NCT00377468|Sensory System Agents|sensory system agents|mesh-ancestor
6442855|NCT00377468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6461616|NCT00455364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6550766|NCT00893009|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6550767|NCT00893009|Purinergic Agents|purinergic agents|mesh-ancestor
6550768|NCT00893009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6550769|NCT00893048|Prednisone|prednisone|mesh-list
6550770|NCT00893048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6550771|NCT00893048|Glucocorticoids|glucocorticoids|mesh-ancestor
6550772|NCT00893048|Hormones|hormones|mesh-ancestor
6550773|NCT00893048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6550774|NCT00893048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550775|NCT00893048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6550776|NCT00893048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6550777|NCT00893061|Tamoxifen|tamoxifen|mesh-list
6550778|NCT00893061|Letrozole|letrozole|mesh-list
6550779|NCT00893061|Anastrozole|anastrozole|mesh-list
6550780|NCT00893061|Exemestane|exemestane|mesh-list
6550781|NCT00893061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550782|NCT00893061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6550783|NCT00893061|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6550784|NCT00893061|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6550785|NCT00893061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6550786|NCT00893061|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6550787|NCT00893061|Hormone Antagonists|hormone antagonists|mesh-ancestor
6550788|NCT00893061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6550789|NCT00893061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550790|NCT00893061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6550791|NCT00893061|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6550792|NCT00893061|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6550793|NCT00893061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6550794|NCT00893100|Diltiazem|diltiazem|mesh-list
6550795|NCT00893100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6550796|NCT00893100|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6550797|NCT00893100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6550798|NCT00893100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550799|NCT00893100|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6550800|NCT00893100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550801|NCT00893100|Vasodilator Agents|vasodilator agents|mesh-ancestor
6550802|NCT00893217|Interferons|interferons|mesh-list
6550803|NCT00893217|Interferon-beta|interferon-beta|mesh-list
6550804|NCT00893217|Interferon beta-1b|interferon beta-1b|mesh-list
6550805|NCT00893217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6550806|NCT00893217|Antiviral Agents|antiviral agents|mesh-ancestor
6550807|NCT00893217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6550808|NCT00893217|Immunologic Factors|immunologic factors|mesh-ancestor
6550809|NCT00893217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550810|NCT00893217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6550811|NCT00893256|Risperidone|risperidone|mesh-list
6550812|NCT00893256|Citalopram|citalopram|mesh-list
6550813|NCT00893256|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6550814|NCT00893256|Serotonin Agents|serotonin agents|mesh-ancestor
6550815|NCT00893256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6550816|NCT00893256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550817|NCT00893256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550818|NCT00893256|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6550819|NCT00893256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6550820|NCT00893256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6550821|NCT00893256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6550822|NCT00893256|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6550823|NCT00893256|Dopamine Agents|dopamine agents|mesh-ancestor
6550824|NCT00893256|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6550825|NCT00893256|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6550826|NCT00893256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6550827|NCT00893256|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6550828|NCT00893256|Antidepressive Agents|antidepressive agents|mesh-ancestor
6550829|NCT00893269|Zolpidem|zolpidem|mesh-list
6550830|NCT00893269|Eszopiclone|eszopiclone|mesh-list
6550831|NCT00893269|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6550832|NCT00893269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6550833|NCT00893269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6550834|NCT00893269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550835|NCT00893269|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6550836|NCT00893269|GABA Agonists|gaba agonists|mesh-ancestor
6550837|NCT00893269|GABA Agents|gaba agents|mesh-ancestor
6550838|NCT00893269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6550839|NCT00893269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550840|NCT00893373|Sorafenib|sorafenib|mesh-list
6550841|NCT00893373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6550842|NCT00893373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6550843|NCT00893373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6550844|NCT00893373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550845|NCT00893399|Gemtuzumab|gemtuzumab|mesh-list
6550846|NCT00893399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6550847|NCT00893399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6550848|NCT00893412|Tramadol|tramadol|mesh-list
6550849|NCT00893412|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6550850|NCT00893412|Narcotics|narcotics|mesh-ancestor
6550851|NCT00893412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6550852|NCT00893412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550853|NCT00893412|Analgesics|analgesics|mesh-ancestor
6550854|NCT00893412|Sensory System Agents|sensory system agents|mesh-ancestor
6550855|NCT00893412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6550856|NCT00893425|Ramipril|ramipril|mesh-list
6550857|NCT00893425|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6550858|NCT00893425|Protease Inhibitors|protease inhibitors|mesh-ancestor
6550859|NCT00893425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6550860|NCT00893425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550861|NCT00893425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6550862|NCT00893451|Vitamin D|vitamin d|mesh-list
6550863|NCT00893451|Cholecalciferol|cholecalciferol|mesh-list
6550864|NCT00893451|Vitamins|vitamins|mesh-ancestor
6550865|NCT00893451|Micronutrients|micronutrients|mesh-ancestor
6550866|NCT00893451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550867|NCT00893451|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6550868|NCT00893451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6550869|NCT00893477|Rituximab|rituximab|mesh-list
6550870|NCT00893477|Sargramostim|sargramostim|mesh-list
6550871|NCT00893477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6550872|NCT00893477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6550873|NCT00893477|Immunologic Factors|immunologic factors|mesh-ancestor
6550874|NCT00893477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550875|NCT00893477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6550876|NCT00893490|Mitomycins|mitomycins|mesh-list
6550877|NCT00893490|Mitomycin|mitomycin|mesh-list
6550878|NCT00893490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6550879|NCT00893490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6550880|NCT00893490|Alkylating Agents|alkylating agents|mesh-ancestor
6550881|NCT00893490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550882|NCT00893490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6550883|NCT00893490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6550884|NCT00893542|Mycophenolic Acid|mycophenolic acid|mesh-list
6550885|NCT00893542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6550886|NCT00893542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6550887|NCT00893542|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6550888|NCT00893542|Antitubercular Agents|antitubercular agents|mesh-ancestor
6550889|NCT00893542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6550890|NCT00893542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6442856|NCT00377468|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6442857|NCT00377468|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6442858|NCT00377468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6442859|NCT00377468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550891|NCT00893542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6550892|NCT00893542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550893|NCT00893555|Voriconazole|voriconazole|mesh-list
6550894|NCT00893555|Antifungal Agents|antifungal agents|mesh-ancestor
6550895|NCT00893555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6550896|NCT00893555|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6550897|NCT00893555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6550898|NCT00893555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6550899|NCT00893555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550900|NCT00893555|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6550901|NCT00893555|Hormone Antagonists|hormone antagonists|mesh-ancestor
6550902|NCT00893555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6550903|NCT00893555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550904|NCT00893555|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6550905|NCT00893581|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6550906|NCT00893581|Antidepressive Agents|antidepressive agents|mesh-ancestor
6550907|NCT00893581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6442860|NCT00377468|Hormones|hormones|mesh-ancestor
6442861|NCT00377468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6550908|NCT00893581|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6550909|NCT00893581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6550910|NCT00893581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6550911|NCT00893581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550912|NCT00893594|Naproxen|naproxen|mesh-list
6550913|NCT00893594|Sumatriptan|sumatriptan|mesh-list
6550914|NCT00893594|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6442862|NCT00377481|Darbepoetin alfa|darbepoetin alfa|mesh-list
6442863|NCT00377481|Hematinics|hematinics|mesh-ancestor
6442864|NCT00377494|Vaccines|vaccines|mesh-list
6442865|NCT00377494|Immunologic Factors|immunologic factors|mesh-ancestor
6442866|NCT00377494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442867|NCT00377546|Ketorolac|ketorolac|mesh-list
6442868|NCT00377546|Nepafenac|nepafenac|mesh-list
6442869|NCT00377546|Bromfenac|bromfenac|mesh-list
6442870|NCT00377546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6442871|NCT00377546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6550915|NCT00893594|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6550916|NCT00893594|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6550917|NCT00893594|Serotonin Agents|serotonin agents|mesh-ancestor
6550918|NCT00893594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6550919|NCT00893594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550920|NCT00893594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550921|NCT00893594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6550922|NCT00893594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6550923|NCT00893594|Analgesics|analgesics|mesh-ancestor
6550924|NCT00893594|Sensory System Agents|sensory system agents|mesh-ancestor
6550925|NCT00893594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6550926|NCT00893594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6550927|NCT00893594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6442872|NCT00377546|Analgesics|analgesics|mesh-ancestor
6442873|NCT00377546|Sensory System Agents|sensory system agents|mesh-ancestor
6442874|NCT00377546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6442875|NCT00377546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442876|NCT00377546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6442877|NCT00377546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6442878|NCT00377546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6442879|NCT00377546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6442880|NCT00377546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442881|NCT00377559|Docetaxel|docetaxel|mesh-list
6442882|NCT00377559|Doxorubicin|doxorubicin|mesh-list
6442883|NCT00377559|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6442884|NCT00377559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6442885|NCT00377559|Tubulin Modulators|tubulin modulators|mesh-ancestor
6442886|NCT00377559|Antimitotic Agents|antimitotic agents|mesh-ancestor
6442887|NCT00377559|Mitosis Modulators|mitosis modulators|mesh-ancestor
6442888|NCT00377559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442889|NCT00377559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6442890|NCT00377559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6442891|NCT00377559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6442892|NCT00377559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6442893|NCT00377624|Hyaluronic Acid|hyaluronic acid|mesh-list
6442894|NCT00377624|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6442895|NCT00377624|Immunologic Factors|immunologic factors|mesh-ancestor
6442896|NCT00377624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442897|NCT00377624|Viscosupplements|viscosupplements|mesh-ancestor
6442898|NCT00377624|Protective Agents|protective agents|mesh-ancestor
6461617|NCT00455364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550928|NCT00893594|Gout Suppressants|gout suppressants|mesh-ancestor
6550929|NCT00893594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6550930|NCT00893594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6550931|NCT00893607|Methoxamine|methoxamine|mesh-list
6550932|NCT00893607|Sympathomimetics|sympathomimetics|mesh-ancestor
6550933|NCT00893607|Autonomic Agents|autonomic agents|mesh-ancestor
6550934|NCT00893607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6550935|NCT00893607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550936|NCT00893607|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6550937|NCT00893607|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6550938|NCT00893607|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6550939|NCT00893607|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6550940|NCT00893607|Adrenergic Agents|adrenergic agents|mesh-ancestor
6550941|NCT00893607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6550942|NCT00893607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550943|NCT00893711|Vitamin D|vitamin d|mesh-list
6550944|NCT00893711|Vitamins|vitamins|mesh-ancestor
6550945|NCT00893711|Micronutrients|micronutrients|mesh-ancestor
6550946|NCT00893711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550947|NCT00893711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6550948|NCT00893724|Tocopherols|tocopherols|mesh-list
6550949|NCT00893724|Vitamin E|vitamin e|mesh-list
6550950|NCT00893724|Tocotrienols|tocotrienols|mesh-list
6550951|NCT00893724|alpha-Tocopherol|alpha-tocopherol|mesh-list
6550952|NCT00893724|Coenzyme Q10|coenzyme q10|mesh-list
6550953|NCT00893724|Niacinamide|niacinamide|mesh-list
6550954|NCT00893724|Niacin|niacin|mesh-list
6550955|NCT00893724|Nicotinic Acids|nicotinic acids|mesh-list
6550956|NCT00893724|Ubiquinone|ubiquinone|mesh-list
6550957|NCT00893724|Minocycline|minocycline|mesh-list
6550958|NCT00893724|Acetylcysteine|acetylcysteine|mesh-list
6550959|NCT00893724|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6550960|NCT00893724|Vitamins|vitamins|mesh-ancestor
6550961|NCT00893724|Micronutrients|micronutrients|mesh-ancestor
6550962|NCT00893724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550963|NCT00893724|Antioxidants|antioxidants|mesh-ancestor
6550964|NCT00893724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550965|NCT00893724|Protective Agents|protective agents|mesh-ancestor
6550966|NCT00893724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6550967|NCT00893724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6550968|NCT00893724|Antiviral Agents|antiviral agents|mesh-ancestor
6550969|NCT00893724|Expectorants|expectorants|mesh-ancestor
6550970|NCT00893724|Respiratory System Agents|respiratory system agents|mesh-ancestor
6550971|NCT00893724|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6550972|NCT00893724|Antidotes|antidotes|mesh-ancestor
6550973|NCT00893724|Vitamin B Complex|vitamin b complex|mesh-ancestor
6550974|NCT00893724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6550975|NCT00893724|Antimetabolites|antimetabolites|mesh-ancestor
6550976|NCT00893724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6550977|NCT00893724|Vasodilator Agents|vasodilator agents|mesh-ancestor
6550978|NCT00893841|Pramipexole|pramipexole|mesh-list
6550979|NCT00893841|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6550980|NCT00893841|Antidepressive Agents|antidepressive agents|mesh-ancestor
6550981|NCT00893841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6550982|NCT00893841|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6550983|NCT00893841|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6550984|NCT00893841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6550985|NCT00893841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6550986|NCT00893841|Antioxidants|antioxidants|mesh-ancestor
6550987|NCT00893841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6550988|NCT00893841|Protective Agents|protective agents|mesh-ancestor
6550989|NCT00893841|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6550990|NCT00893841|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6550991|NCT00893841|Dopamine Agonists|dopamine agonists|mesh-ancestor
6550992|NCT00893841|Dopamine Agents|dopamine agents|mesh-ancestor
6550993|NCT00893841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6550994|NCT00893854|Triamcinolone|triamcinolone|mesh-list
6550995|NCT00893854|Diclofenac|diclofenac|mesh-list
6550996|NCT00893854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6550997|NCT00893854|Glucocorticoids|glucocorticoids|mesh-ancestor
6550998|NCT00893854|Hormones|hormones|mesh-ancestor
6550999|NCT00893854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6551000|NCT00893854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551001|NCT00893854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6551002|NCT00893854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551003|NCT00893854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6551004|NCT00893854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6551005|NCT00893854|Analgesics|analgesics|mesh-ancestor
6551006|NCT00893854|Sensory System Agents|sensory system agents|mesh-ancestor
6551007|NCT00893854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6551008|NCT00893854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6551009|NCT00893854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6551010|NCT00893880|Nitric Oxide|nitric oxide|mesh-list
6551011|NCT00893880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6551012|NCT00893880|Autonomic Agents|autonomic agents|mesh-ancestor
6551013|NCT00893880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6551014|NCT00893880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551015|NCT00893880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6551016|NCT00893880|Respiratory System Agents|respiratory system agents|mesh-ancestor
6551017|NCT00893880|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6551018|NCT00893880|Antioxidants|antioxidants|mesh-ancestor
6551019|NCT00893880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551020|NCT00893880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6551021|NCT00893880|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6551022|NCT00893880|Vasodilator Agents|vasodilator agents|mesh-ancestor
6551023|NCT00893880|Gasotransmitters|gasotransmitters|mesh-ancestor
6551024|NCT00893880|Protective Agents|protective agents|mesh-ancestor
6551025|NCT00893906|Vaccines|vaccines|mesh-list
6551026|NCT00893906|Immunologic Factors|immunologic factors|mesh-ancestor
6551027|NCT00893906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551028|NCT00893919|Mycophenolic Acid|mycophenolic acid|mesh-list
6551029|NCT00893919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6551030|NCT00893919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6551031|NCT00893919|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6551032|NCT00893919|Antitubercular Agents|antitubercular agents|mesh-ancestor
6551033|NCT00893919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6551034|NCT00893919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6551035|NCT00893919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6656161|NCT01467804|Sertraline|sertraline|mesh-list
6551036|NCT00893919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551037|NCT00893958|Mycophenolic Acid|mycophenolic acid|mesh-list
6551038|NCT00893958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6551039|NCT00893958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6551040|NCT00893958|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6551041|NCT00893958|Antitubercular Agents|antitubercular agents|mesh-ancestor
6551042|NCT00893958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6551043|NCT00893958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6551044|NCT00893958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6551045|NCT00893958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551046|NCT00894010|Carbamazepine|carbamazepine|mesh-list
6551047|NCT00894010|Levetiracetam|levetiracetam|mesh-list
6551048|NCT00894010|Anticonvulsants|anticonvulsants|mesh-ancestor
6551049|NCT00894010|Nootropic Agents|nootropic agents|mesh-ancestor
6551050|NCT00894010|Antimanic Agents|antimanic agents|mesh-ancestor
6551051|NCT00894010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6551052|NCT00894010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6551053|NCT00894010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551054|NCT00894010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6551055|NCT00894010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6551056|NCT00894010|Analgesics|analgesics|mesh-ancestor
6551057|NCT00894010|Sensory System Agents|sensory system agents|mesh-ancestor
6551058|NCT00894010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6551059|NCT00894010|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6551060|NCT00894010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6551061|NCT00894010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551062|NCT00894010|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6551063|NCT00894010|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6551064|NCT00894023|Abciximab|abciximab|mesh-list
6551065|NCT00894023|Anticoagulants|anticoagulants|mesh-ancestor
6551066|NCT00894023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6551067|NCT00894062|Everolimus|everolimus|mesh-list
6551068|NCT00894062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6551069|NCT00894062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6551070|NCT00894062|Immunologic Factors|immunologic factors|mesh-ancestor
6551071|NCT00894062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551072|NCT00894088|Mycophenolic Acid|mycophenolic acid|mesh-list
6551073|NCT00894088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6551074|NCT00894088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6551075|NCT00894088|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6551076|NCT00894088|Antitubercular Agents|antitubercular agents|mesh-ancestor
6551077|NCT00894088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6551078|NCT00894088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6551079|NCT00894088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6551080|NCT00894088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551081|NCT00894231|Levocetirizine|levocetirizine|mesh-list
6551082|NCT00894231|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6551083|NCT00894231|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6551084|NCT00894231|Histamine Antagonists|histamine antagonists|mesh-ancestor
6551085|NCT00894231|Histamine Agents|histamine agents|mesh-ancestor
6551086|NCT00894231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6551087|NCT00894231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551088|NCT00894231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551089|NCT00894283|Enoxaparin|enoxaparin|mesh-list
6551090|NCT00894283|PENTA|penta|mesh-list
6551091|NCT00894283|Fondaparinux|fondaparinux|mesh-list
6551092|NCT00894283|Anticoagulants|anticoagulants|mesh-ancestor
6551093|NCT00894283|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6551094|NCT00894283|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6551095|NCT00894283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551096|NCT00894283|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6551097|NCT00894283|Antithrombins|antithrombins|mesh-ancestor
6551098|NCT00894283|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6551099|NCT00894283|Protease Inhibitors|protease inhibitors|mesh-ancestor
6551100|NCT00894283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6656162|NCT01467804|Antidepressive Agents|antidepressive agents|mesh-ancestor
6656163|NCT01467804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6656164|NCT01467804|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6656165|NCT01467804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6656166|NCT01467804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6656167|NCT01467804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656168|NCT01467804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6656169|NCT01467804|Serotonin Agents|serotonin agents|mesh-ancestor
6656170|NCT01467804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656171|NCT01467921|Oxaliplatin|oxaliplatin|mesh-list
6656172|NCT01467921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6656173|NCT01467986|Sirolimus|sirolimus|mesh-list
6656174|NCT01467986|Irinotecan|irinotecan|mesh-list
6656175|NCT01467986|Temozolomide|temozolomide|mesh-list
6656176|NCT01467986|Dasatinib|dasatinib|mesh-list
6656177|NCT01467986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6656178|NCT01467986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6656179|NCT01467986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6656180|NCT01467986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656181|NCT01467986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6656182|NCT01467986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6656183|NCT01467986|Alkylating Agents|alkylating agents|mesh-ancestor
6656184|NCT01467986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6656185|NCT01467986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6656186|NCT01467986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6656187|NCT01467986|Antifungal Agents|antifungal agents|mesh-ancestor
6656188|NCT01467986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6656189|NCT01467986|Immunologic Factors|immunologic factors|mesh-ancestor
6656190|NCT01467986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656191|NCT01467986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6656192|NCT01468025|Naproxen|naproxen|mesh-list
6656193|NCT01468025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6656194|NCT01468025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6656195|NCT01468025|Analgesics|analgesics|mesh-ancestor
6656196|NCT01468025|Sensory System Agents|sensory system agents|mesh-ancestor
6656197|NCT01468025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6656198|NCT01468025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656199|NCT01468025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6656200|NCT01468025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6656201|NCT01468025|Gout Suppressants|gout suppressants|mesh-ancestor
6656202|NCT01468025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6656203|NCT01468025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6656204|NCT01468025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656205|NCT01468038|Trazodone|trazodone|mesh-list
6656206|NCT01468038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6656207|NCT01468038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6656208|NCT01468038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6656209|NCT01468038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656210|NCT01468038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6656211|NCT01468038|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6656212|NCT01468038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6656213|NCT01468038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6656214|NCT01468038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656215|NCT01468038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6551101|NCT00894374|Artesunate|artesunate|mesh-list
6551102|NCT00894374|Antimalarials|antimalarials|mesh-ancestor
6551103|NCT00894374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6551104|NCT00894374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6551105|NCT00894374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6551106|NCT00894374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6551107|NCT00894374|Antiviral Agents|antiviral agents|mesh-ancestor
6551108|NCT00894374|Schistosomicides|schistosomicides|mesh-ancestor
6551109|NCT00894374|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6551110|NCT00894374|Anthelmintics|anthelmintics|mesh-ancestor
6551111|NCT00894439|Piperacillin|piperacillin|mesh-list
6551112|NCT00894439|BLI-489|bli-489|mesh-list
6551113|NCT00894439|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6551114|NCT00894439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6551115|NCT00894439|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6551116|NCT00894439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6551117|NCT00894439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551118|NCT00894569|Paclitaxel|paclitaxel|mesh-list
6551119|NCT00894569|Carboplatin|carboplatin|mesh-list
6551120|NCT00894569|Cetuximab|cetuximab|mesh-list
6551121|NCT00894569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6551122|NCT00894569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6551123|NCT00894569|Tubulin Modulators|tubulin modulators|mesh-ancestor
6551124|NCT00894569|Antimitotic Agents|antimitotic agents|mesh-ancestor
6551125|NCT00894569|Mitosis Modulators|mitosis modulators|mesh-ancestor
6551126|NCT00894569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551127|NCT00894569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6551128|NCT00894608|Letrozole|letrozole|mesh-list
6551129|NCT00894608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6551130|NCT00894608|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6551131|NCT00894608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6551132|NCT00894608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6551133|NCT00894608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551134|NCT00894608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6551135|NCT00894608|Hormone Antagonists|hormone antagonists|mesh-ancestor
6551136|NCT00894608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6551137|NCT00894608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551138|NCT00894621|Norepinephrine|norepinephrine|mesh-list
6551139|NCT00894621|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6551140|NCT00894621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6551141|NCT00894621|Adrenergic Agents|adrenergic agents|mesh-ancestor
6551142|NCT00894621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6551143|NCT00894621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551144|NCT00894621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551145|NCT00894621|Sympathomimetics|sympathomimetics|mesh-ancestor
6551146|NCT00894621|Autonomic Agents|autonomic agents|mesh-ancestor
6551147|NCT00894621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6551148|NCT00894621|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6551149|NCT00894634|Brompheniramine|brompheniramine|mesh-list
6551150|NCT00894634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551151|NCT00894634|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6551152|NCT00894634|Histamine Antagonists|histamine antagonists|mesh-ancestor
6551153|NCT00894634|Histamine Agents|histamine agents|mesh-ancestor
6551154|NCT00894634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6551155|NCT00894634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551156|NCT00894634|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6551157|NCT00894660|Amodiaquine|amodiaquine|mesh-list
6551158|NCT00894660|Antimalarials|antimalarials|mesh-ancestor
6551159|NCT00894660|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6551160|NCT00894660|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6551161|NCT00894660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6551162|NCT00894673|Heparin|heparin|mesh-list
6551163|NCT00894673|Calcium heparin|calcium heparin|mesh-list
6551164|NCT00894673|Anticoagulants|anticoagulants|mesh-ancestor
6551165|NCT00894673|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6551166|NCT00894673|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6551167|NCT00894673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551168|NCT00894712|Sulforaphane|sulforaphane|mesh-list
6551169|NCT00894712|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6551170|NCT00894712|Protective Agents|protective agents|mesh-ancestor
6551171|NCT00894712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551172|NCT00894712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6551173|NCT00894751|Dexmedetomidine|dexmedetomidine|mesh-list
6551174|NCT00894751|Propofol|propofol|mesh-list
6551175|NCT00894751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6551176|NCT00894751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6551177|NCT00894751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551178|NCT00894751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6551179|NCT00894751|Anesthetics, General|anesthetics, general|mesh-ancestor
6551180|NCT00894751|Anesthetics|anesthetics|mesh-ancestor
6551181|NCT00894751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6551182|NCT00894751|Analgesics|analgesics|mesh-ancestor
6551183|NCT00894751|Sensory System Agents|sensory system agents|mesh-ancestor
6551184|NCT00894751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6551185|NCT00894751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6551186|NCT00894751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6551187|NCT00894751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6551188|NCT00894751|Adrenergic Agents|adrenergic agents|mesh-ancestor
6551189|NCT00894751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6551190|NCT00894751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551191|NCT00894829|Heparin|heparin|mesh-list
6551192|NCT00894829|Calcium heparin|calcium heparin|mesh-list
6551193|NCT00894829|Anticoagulants|anticoagulants|mesh-ancestor
6551194|NCT00894829|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6551195|NCT00894829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6551196|NCT00894829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551197|NCT00894920|Biotin|biotin|mesh-list
6551198|NCT00894920|Vitamin B Complex|vitamin b complex|mesh-ancestor
6551199|NCT00894920|Vitamins|vitamins|mesh-ancestor
6551200|NCT00894920|Micronutrients|micronutrients|mesh-ancestor
6551201|NCT00894920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551202|NCT00894946|Ethiodized Oil|ethiodized oil|mesh-list
6551203|NCT00894946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6551204|NCT00894959|Heparin|heparin|mesh-list
6551205|NCT00894959|Calcium heparin|calcium heparin|mesh-list
6551206|NCT00894959|Anticoagulants|anticoagulants|mesh-ancestor
6551207|NCT00894959|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6551208|NCT00894959|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6551209|NCT00894959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551210|NCT00894985|Heparin|heparin|mesh-list
6551211|NCT00894985|Calcium heparin|calcium heparin|mesh-list
6551212|NCT00894985|Anticoagulants|anticoagulants|mesh-ancestor
6019733|NCT00389207|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6019734|NCT00389207|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6019735|NCT00389207|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6442899|NCT00377728|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
6442900|NCT00377728|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6442901|NCT00377728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6442902|NCT00377728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6442903|NCT00377728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461618|NCT00455364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6461619|NCT00455364|Hormone Antagonists|hormone antagonists|mesh-ancestor
6461620|NCT00455364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6461621|NCT00455364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551213|NCT00894985|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6551214|NCT00894985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6551215|NCT00894985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551216|NCT00894998|Heparin|heparin|mesh-list
6461622|NCT00455364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6461623|NCT00455390|Psychotropic Drugs|psychotropic drugs|mesh-list
6461624|NCT00455416|Selenium|selenium|mesh-list
6461625|NCT00455416|Allicin|allicin|mesh-list
6461626|NCT00455416|Resveratrol|resveratrol|mesh-list
6461627|NCT00455416|Quercetin|quercetin|mesh-list
6461628|NCT00455416|Antioxidants|antioxidants|mesh-ancestor
6551217|NCT00894998|Calcium heparin|calcium heparin|mesh-list
6551218|NCT00894998|Anticoagulants|anticoagulants|mesh-ancestor
6551219|NCT00894998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6551220|NCT00894998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6551221|NCT00894998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551222|NCT00895063|Botulinum Toxins|botulinum toxins|mesh-list
6551223|NCT00895063|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6551224|NCT00895063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6551225|NCT00895063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551226|NCT00895063|Cholinergic Agents|cholinergic agents|mesh-ancestor
6551227|NCT00895063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6551228|NCT00895063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551229|NCT00895076|Dexamethasone|dexamethasone|mesh-list
6551230|NCT00895076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6551231|NCT00895076|Antiemetics|antiemetics|mesh-ancestor
6551232|NCT00895076|Autonomic Agents|autonomic agents|mesh-ancestor
6551233|NCT00895076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6551234|NCT00895076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551235|NCT00895076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6551236|NCT00895076|Glucocorticoids|glucocorticoids|mesh-ancestor
6551237|NCT00895076|Hormones|hormones|mesh-ancestor
6551238|NCT00895076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6551239|NCT00895076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6551240|NCT00895076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6551241|NCT00895089|Moxifloxacin|moxifloxacin|mesh-list
6551242|NCT00895089|Ceftriaxone|ceftriaxone|mesh-list
6551243|NCT00895089|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6551244|NCT00895089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6551245|NCT00895089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6551246|NCT00895089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6551247|NCT00895089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6551248|NCT00895089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6551249|NCT00895089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551250|NCT00895089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6551251|NCT00895089|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6551252|NCT00895089|Contraceptive Agents|contraceptive agents|mesh-ancestor
6551253|NCT00895089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6551254|NCT00895089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551255|NCT00895089|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6551256|NCT00895089|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6551257|NCT00895089|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6551258|NCT00895115|Vitamin E|vitamin e|mesh-list
6551259|NCT00895115|Vitamins|vitamins|mesh-ancestor
6551260|NCT00895115|Micronutrients|micronutrients|mesh-ancestor
6551261|NCT00895115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551262|NCT00895115|Antioxidants|antioxidants|mesh-ancestor
6551263|NCT00895115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551264|NCT00895115|Protective Agents|protective agents|mesh-ancestor
6551265|NCT00895128|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6551266|NCT00895128|Dasatinib|dasatinib|mesh-list
6551267|NCT00895128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6551268|NCT00895128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6551269|NCT00895128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6551270|NCT00895128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551271|NCT00895167|Curcumin|curcumin|mesh-list
6442904|NCT00377780|Docetaxel|docetaxel|mesh-list
6442905|NCT00377780|Doxorubicin|doxorubicin|mesh-list
6442906|NCT00377780|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6442907|NCT00377780|Trastuzumab|trastuzumab|mesh-list
6442908|NCT00377780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6551272|NCT00895167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6551273|NCT00895167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6551274|NCT00895167|Analgesics|analgesics|mesh-ancestor
6551275|NCT00895167|Sensory System Agents|sensory system agents|mesh-ancestor
6551276|NCT00895167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6551277|NCT00895167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551278|NCT00895167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6551279|NCT00895167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6551280|NCT00895167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6551281|NCT00895167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6551282|NCT00895167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551283|NCT00895297|Dasatinib|dasatinib|mesh-list
6551284|NCT00895297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6551285|NCT00895297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6551286|NCT00895297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6551287|NCT00895297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551288|NCT00895323|Antibodies|antibodies|mesh-list
6551289|NCT00895323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6551290|NCT00895323|Antibodies, Bispecific|antibodies, bispecific|mesh-list
6551291|NCT00895323|Immunologic Factors|immunologic factors|mesh-ancestor
6551292|NCT00895323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551293|NCT00895362|Cetuximab|cetuximab|mesh-list
6551294|NCT00895362|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6551295|NCT00895362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6551296|NCT00895362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6551297|NCT00895362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6551298|NCT00895362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6551299|NCT00895362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551300|NCT00895505|Warfarin|warfarin|mesh-list
6551301|NCT00895505|Phenprocoumon|phenprocoumon|mesh-list
6551302|NCT00895505|Anticoagulants|anticoagulants|mesh-ancestor
6551303|NCT00895544|Vaccines|vaccines|mesh-list
6551304|NCT00895544|Immunologic Factors|immunologic factors|mesh-ancestor
6551305|NCT00895544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551306|NCT00895557|Varenicline|varenicline|mesh-list
6551307|NCT00895557|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6551308|NCT00895557|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6551309|NCT00895557|Cholinergic Agents|cholinergic agents|mesh-ancestor
6551310|NCT00895557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6551311|NCT00895557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551312|NCT00895557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551313|NCT00895570|Modafinil|modafinil|mesh-list
6551314|NCT00895570|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6551315|NCT00895570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551316|NCT00895570|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6551317|NCT00895570|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6551318|NCT00895570|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6551319|NCT00895570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551320|NCT00895609|Neostigmine|neostigmine|mesh-list
6442909|NCT00377780|Tubulin Modulators|tubulin modulators|mesh-ancestor
6442910|NCT00377780|Antimitotic Agents|antimitotic agents|mesh-ancestor
6442911|NCT00377780|Mitosis Modulators|mitosis modulators|mesh-ancestor
6442912|NCT00377780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442913|NCT00377780|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6442914|NCT00377780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6551321|NCT00895609|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6551322|NCT00895609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6656216|NCT01468038|Serotonin Agents|serotonin agents|mesh-ancestor
6551323|NCT00895609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551324|NCT00895609|Cholinergic Agents|cholinergic agents|mesh-ancestor
6551325|NCT00895609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6551326|NCT00895609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551327|NCT00895609|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6551328|NCT00895609|Autonomic Agents|autonomic agents|mesh-ancestor
6551329|NCT00895609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6551330|NCT00895648|Pemetrexed|pemetrexed|mesh-list
6551331|NCT00895648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6551332|NCT00895648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6551333|NCT00895648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551334|NCT00895648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6551335|NCT00895648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6551336|NCT00895674|Sorafenib|sorafenib|mesh-list
6551337|NCT00895674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6551338|NCT00895674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6551339|NCT00895674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6551340|NCT00895674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551341|NCT00895687|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6551342|NCT00895687|Bortezomib|bortezomib|mesh-list
6551343|NCT00895687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6551344|NCT00895687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6551345|NCT00895687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6551346|NCT00895687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551347|NCT00895713|Immunoglobulins|immunoglobulins|mesh-list
6551348|NCT00895713|Antibodies|antibodies|mesh-list
6551349|NCT00895713|gamma-Globulins|gamma-globulins|mesh-list
6551350|NCT00895713|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6551351|NCT00895713|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6551352|NCT00895713|Immunologic Factors|immunologic factors|mesh-ancestor
6551353|NCT00895713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551354|NCT00895739|Cyclosporine|cyclosporine|mesh-list
6551355|NCT00895739|Alemtuzumab|alemtuzumab|mesh-list
6551356|NCT00895739|Cyclosporins|cyclosporins|mesh-list
6551357|NCT00895739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6551358|NCT00895739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551359|NCT00895739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6551360|NCT00895739|Immunologic Factors|immunologic factors|mesh-ancestor
6551361|NCT00895739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551362|NCT00895739|Antifungal Agents|antifungal agents|mesh-ancestor
6551363|NCT00895739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6551364|NCT00895739|Dermatologic Agents|dermatologic agents|mesh-ancestor
6551365|NCT00895739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6551366|NCT00895739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6551367|NCT00895739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6551368|NCT00895739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6551369|NCT00895778|Rocuronium|rocuronium|mesh-list
6551370|NCT00895778|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6551371|NCT00895778|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6551372|NCT00895778|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6551373|NCT00895778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6551374|NCT00895778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551375|NCT00895791|Umirolimus|umirolimus|mesh-list
6551376|NCT00895791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6551377|NCT00895791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6551378|NCT00895791|Immunologic Factors|immunologic factors|mesh-ancestor
6551379|NCT00895791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551380|NCT00895804|Pindolol|pindolol|mesh-list
6551381|NCT00895804|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6551382|NCT00895804|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6551383|NCT00895804|Adrenergic Agents|adrenergic agents|mesh-ancestor
6551384|NCT00895804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6551385|NCT00895804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551386|NCT00895804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551387|NCT00895804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6551388|NCT00895804|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6551389|NCT00895804|Serotonin Agents|serotonin agents|mesh-ancestor
6551390|NCT00895804|Vasodilator Agents|vasodilator agents|mesh-ancestor
6551391|NCT00895882|Interferons|interferons|mesh-list
6551392|NCT00895882|Ribavirin|ribavirin|mesh-list
6551393|NCT00895882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6551394|NCT00895882|Antiviral Agents|antiviral agents|mesh-ancestor
6551395|NCT00895882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6551396|NCT00895882|Antimetabolites|antimetabolites|mesh-ancestor
6551397|NCT00895882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551398|NCT00895960|Temozolomide|temozolomide|mesh-list
6551399|NCT00895960|Dasatinib|dasatinib|mesh-list
6551400|NCT00895960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6551401|NCT00895960|Alkylating Agents|alkylating agents|mesh-ancestor
6551402|NCT00895960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551403|NCT00895960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6551404|NCT00895960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6551405|NCT00895960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6551406|NCT00896077|Lisofylline|lisofylline|mesh-list
6551407|NCT00896077|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6551408|NCT00896077|Immunologic Factors|immunologic factors|mesh-ancestor
6551409|NCT00896077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551410|NCT00896077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6551411|NCT00896077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6551412|NCT00896077|Analgesics|analgesics|mesh-ancestor
6551413|NCT00896077|Sensory System Agents|sensory system agents|mesh-ancestor
6551414|NCT00896077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6551415|NCT00896077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6551416|NCT00896077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6551417|NCT00896077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6551418|NCT00896155|Tamoxifen|tamoxifen|mesh-list
6551419|NCT00896155|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6551420|NCT00896155|Hormone Antagonists|hormone antagonists|mesh-ancestor
6551421|NCT00896155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6551422|NCT00896155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551423|NCT00896155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6551424|NCT00896155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6551425|NCT00896155|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6551426|NCT00896155|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6551427|NCT00896155|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6551428|NCT00896285|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
6551429|NCT00896285|Analgesics|analgesics|mesh-list
6551430|NCT00896285|Opiate Alkaloids|opiate alkaloids|mesh-list
6551431|NCT00896285|Sensory System Agents|sensory system agents|mesh-ancestor
6551432|NCT00896285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6551433|NCT00896285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551434|NCT00896285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6551435|NCT00896285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6551436|NCT00896285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6551437|NCT00896285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6551438|NCT00896285|Narcotics|narcotics|mesh-ancestor
6551439|NCT00896285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6656217|NCT01468038|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6656218|NCT01468038|Antidepressive Agents|antidepressive agents|mesh-ancestor
6656219|NCT01468051|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6656220|NCT01468051|Vaccines|vaccines|mesh-list
6656221|NCT01468051|Immunologic Factors|immunologic factors|mesh-ancestor
6656222|NCT01468051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656223|NCT01468051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6656224|NCT01468051|Antacids|antacids|mesh-ancestor
6656225|NCT01468051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656226|NCT01468051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6656227|NCT01468155|Dabigatran|dabigatran|mesh-list
6656228|NCT01468155|Antithrombins|antithrombins|mesh-ancestor
6656229|NCT01468155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6656230|NCT01468155|Protease Inhibitors|protease inhibitors|mesh-ancestor
6656231|NCT01468155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6656232|NCT01468155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656233|NCT01468155|Anticoagulants|anticoagulants|mesh-ancestor
6656234|NCT01468259|Droxidopa|droxidopa|mesh-list
6656235|NCT01468259|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6656236|NCT01468259|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6656237|NCT01468272|Beclomethasone|beclomethasone|mesh-list
6656238|NCT01468272|Formoterol Fumarate|formoterol fumarate|mesh-list
6656239|NCT01468272|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6656240|NCT01468272|Autonomic Agents|autonomic agents|mesh-ancestor
6656241|NCT01468272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6656242|NCT01468272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656243|NCT01468272|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6656244|NCT01468272|Respiratory System Agents|respiratory system agents|mesh-ancestor
6656245|NCT01468272|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6656246|NCT01468272|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6656247|NCT01468272|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6656248|NCT01468272|Adrenergic Agents|adrenergic agents|mesh-ancestor
6656249|NCT01468272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6656250|NCT01468272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656251|NCT01468272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6442915|NCT00377780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6019736|NCT00389207|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6019737|NCT00389324|Immunoglobulins|immunoglobulins|mesh-list
6019738|NCT00389324|Antibodies|antibodies|mesh-list
6656252|NCT01468272|Glucocorticoids|glucocorticoids|mesh-ancestor
6442916|NCT00377780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6442917|NCT00377780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6442918|NCT00377793|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6442919|NCT00377793|Vasodilator Agents|vasodilator agents|mesh-ancestor
6442920|NCT00377793|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6442921|NCT00377793|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6656253|NCT01468272|Hormones|hormones|mesh-ancestor
6551440|NCT00896311|Nitroglycerin|nitroglycerin|mesh-list
6551441|NCT00896311|Vasodilator Agents|vasodilator agents|mesh-ancestor
6551442|NCT00896376|Trastuzumab|trastuzumab|mesh-list
6551443|NCT00896376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6551444|NCT00896376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6551445|NCT00896402|Iodine|iodine|mesh-list
6551446|NCT00896402|Chlorhexidine|chlorhexidine|mesh-list
6442922|NCT00377793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6442923|NCT00377793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442924|NCT00377793|Urological Agents|urological agents|mesh-ancestor
6442925|NCT00377806|Diclofenac|diclofenac|mesh-list
6442926|NCT00377806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6442927|NCT00377806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6442928|NCT00377806|Analgesics|analgesics|mesh-ancestor
6551447|NCT00896402|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6551448|NCT00896402|Povidone-Iodine|povidone-iodine|mesh-list
6551449|NCT00896402|Povidone|povidone|mesh-list
6551450|NCT00896402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6551451|NCT00896402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6551452|NCT00896402|Disinfectants|disinfectants|mesh-ancestor
6551453|NCT00896402|Dermatologic Agents|dermatologic agents|mesh-ancestor
6551454|NCT00896402|Trace Elements|trace elements|mesh-ancestor
6551455|NCT00896402|Micronutrients|micronutrients|mesh-ancestor
6551456|NCT00896402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551457|NCT00896402|Plasma Substitutes|plasma substitutes|mesh-ancestor
6551458|NCT00896402|Blood Substitutes|blood substitutes|mesh-ancestor
6551459|NCT00896428|Gallopamil|gallopamil|mesh-list
6551460|NCT00896428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6551461|NCT00896428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6551462|NCT00896428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551463|NCT00896428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6551464|NCT00896428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551465|NCT00896493|Cyclosporine|cyclosporine|mesh-list
6551466|NCT00896493|Cyclosporins|cyclosporins|mesh-list
6551467|NCT00896493|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6551468|NCT00896493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6551469|NCT00896493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551470|NCT00896493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6551471|NCT00896493|Immunologic Factors|immunologic factors|mesh-ancestor
6551472|NCT00896493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551473|NCT00896493|Antifungal Agents|antifungal agents|mesh-ancestor
6551474|NCT00896493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6442929|NCT00377806|Sensory System Agents|sensory system agents|mesh-ancestor
6551475|NCT00896493|Dermatologic Agents|dermatologic agents|mesh-ancestor
6551476|NCT00896493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6551477|NCT00896493|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6551478|NCT00896519|Prednisone|prednisone|mesh-list
6551479|NCT00896519|Cyclophosphamide|cyclophosphamide|mesh-list
6551480|NCT00896519|Rituximab|rituximab|mesh-list
6551481|NCT00896519|Doxorubicin|doxorubicin|mesh-list
6551482|NCT00896519|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6551483|NCT00896519|Vincristine|vincristine|mesh-list
6551484|NCT00896519|Sargramostim|sargramostim|mesh-list
6551485|NCT00896519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6551486|NCT00896519|Immunologic Factors|immunologic factors|mesh-ancestor
6551487|NCT00896519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551488|NCT00896519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6551489|NCT00896519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6551490|NCT00896519|Alkylating Agents|alkylating agents|mesh-ancestor
6551491|NCT00896519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442930|NCT00377806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6442931|NCT00377806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442932|NCT00377806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6442933|NCT00377806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6551492|NCT00896519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6551493|NCT00896519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6551494|NCT00896519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6551495|NCT00896519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6551496|NCT00896519|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6551497|NCT00896519|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6551498|NCT00896519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6551499|NCT00896519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6551500|NCT00896519|Glucocorticoids|glucocorticoids|mesh-ancestor
6551501|NCT00896519|Hormones|hormones|mesh-ancestor
6551502|NCT00896519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6551503|NCT00896519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6551504|NCT00896519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6551505|NCT00896519|Tubulin Modulators|tubulin modulators|mesh-ancestor
6551506|NCT00896519|Antimitotic Agents|antimitotic agents|mesh-ancestor
6551507|NCT00896519|Mitosis Modulators|mitosis modulators|mesh-ancestor
6551508|NCT00896558|Midazolam|midazolam|mesh-list
6551509|NCT00896558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6551510|NCT00896558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6551511|NCT00896558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6551512|NCT00896558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551513|NCT00896558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6551514|NCT00896558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6551515|NCT00896558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6551516|NCT00896558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6551517|NCT00896558|Anesthetics, General|anesthetics, general|mesh-ancestor
6551518|NCT00896558|Anesthetics|anesthetics|mesh-ancestor
6551519|NCT00896558|GABA Modulators|gaba modulators|mesh-ancestor
6551520|NCT00896558|GABA Agents|gaba agents|mesh-ancestor
6551521|NCT00896558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6551522|NCT00896558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551523|NCT00896571|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6551524|NCT00896571|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6551525|NCT00896571|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6551526|NCT00896571|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6551527|NCT00896571|Contraceptive Agents|contraceptive agents|mesh-ancestor
6551528|NCT00896571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6551529|NCT00896571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551530|NCT00896571|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6551531|NCT00896571|Estrogens|estrogens|mesh-ancestor
6551532|NCT00896571|Hormones|hormones|mesh-ancestor
6551533|NCT00896571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6551534|NCT00896714|Anesthetics|anesthetics|mesh-list
6551535|NCT00896714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6551536|NCT00896714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551537|NCT00896727|Antibodies|antibodies|mesh-list
6551538|NCT00896727|Immunologic Factors|immunologic factors|mesh-ancestor
6551539|NCT00896727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551540|NCT00896831|N-Methylaspartate|n-methylaspartate|mesh-list
6551541|NCT00896831|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
6551542|NCT00896831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6551543|NCT00896831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6551544|NCT00896831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551545|NCT00896831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551546|NCT00896948|Antibodies|antibodies|mesh-list
6551547|NCT00896948|Immunologic Factors|immunologic factors|mesh-ancestor
6551548|NCT00896948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551549|NCT00896987|Lamotrigine|lamotrigine|mesh-list
6551550|NCT00896987|Carbamazepine|carbamazepine|mesh-list
6551551|NCT00896987|Anticonvulsants|anticonvulsants|mesh-ancestor
6551552|NCT00896987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6551553|NCT00896987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6551554|NCT00896987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551555|NCT00896987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6551556|NCT00896987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551557|NCT00896987|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6551558|NCT00896987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6551559|NCT00896987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6551560|NCT00896987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6551561|NCT00896987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6551562|NCT00896987|Antimanic Agents|antimanic agents|mesh-ancestor
6551563|NCT00896987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6551564|NCT00896987|Analgesics|analgesics|mesh-ancestor
6551565|NCT00896987|Sensory System Agents|sensory system agents|mesh-ancestor
6551566|NCT00896987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6551567|NCT00896987|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6551568|NCT00896987|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6551569|NCT00897026|Paclitaxel|paclitaxel|mesh-list
6551570|NCT00897026|Cyclophosphamide|cyclophosphamide|mesh-list
6551571|NCT00897026|Doxorubicin|doxorubicin|mesh-list
6551572|NCT00897026|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6551573|NCT00897026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6551574|NCT00897026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6551575|NCT00897026|Tubulin Modulators|tubulin modulators|mesh-ancestor
6551576|NCT00897026|Antimitotic Agents|antimitotic agents|mesh-ancestor
6551577|NCT00897026|Mitosis Modulators|mitosis modulators|mesh-ancestor
6551578|NCT00897026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551579|NCT00897026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6551580|NCT00897026|Immunologic Factors|immunologic factors|mesh-ancestor
6551581|NCT00897026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551582|NCT00897026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6019739|NCT00389324|gamma-Globulins|gamma-globulins|mesh-list
6019740|NCT00389324|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6019741|NCT00389324|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6019742|NCT00389324|Immunoglobulin G|immunoglobulin g|mesh-list
6019743|NCT00389324|Immunologic Factors|immunologic factors|mesh-ancestor
6019744|NCT00389324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019745|NCT00389441|Axitinib|axitinib|mesh-list
6019746|NCT00389441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6019747|NCT00389441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6019748|NCT00389441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6551583|NCT00897026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6551584|NCT00897026|Alkylating Agents|alkylating agents|mesh-ancestor
6551585|NCT00897026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6551586|NCT00897026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6551587|NCT00897026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6551588|NCT00897026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6551589|NCT00897026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6551590|NCT00897065|Antibodies|antibodies|mesh-list
6551591|NCT00897065|Immunologic Factors|immunologic factors|mesh-ancestor
6551592|NCT00897065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551593|NCT00897130|Azacitidine|azacitidine|mesh-list
6551594|NCT00897130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6551595|NCT00897130|Antimetabolites|antimetabolites|mesh-ancestor
6551596|NCT00897130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551597|NCT00897130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6442934|NCT00377806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6442935|NCT00377806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6442936|NCT00377806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442937|NCT00377910|Lidocaine|lidocaine|mesh-list
6442938|NCT00377910|Polidocanol|polidocanol|mesh-list
6442939|NCT00377910|Anesthetics, Local|anesthetics, local|mesh-ancestor
6442940|NCT00377910|Anesthetics|anesthetics|mesh-ancestor
6442941|NCT00377910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6442942|NCT00377910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442943|NCT00377910|Sensory System Agents|sensory system agents|mesh-ancestor
6442944|NCT00377910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6442945|NCT00377910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6442946|NCT00377910|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6442947|NCT00377910|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6551598|NCT00897130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6551599|NCT00897221|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6551600|NCT00897221|Deferiprone|deferiprone|mesh-list
6551601|NCT00897221|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6551602|NCT00897221|Chelating Agents|chelating agents|mesh-ancestor
6551603|NCT00897221|Sequestering Agents|sequestering agents|mesh-ancestor
6551604|NCT00897221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551605|NCT00897312|Interferons|interferons|mesh-list
6551606|NCT00897312|Ribavirin|ribavirin|mesh-list
6551607|NCT00897312|Interferon-alpha|interferon-alpha|mesh-list
6551608|NCT00897312|Tremelimumab|tremelimumab|mesh-list
6551609|NCT00897312|Infliximab|infliximab|mesh-list
6551610|NCT00897312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6551611|NCT00897312|Antiviral Agents|antiviral agents|mesh-ancestor
6551612|NCT00897312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6551613|NCT00897312|Antimetabolites|antimetabolites|mesh-ancestor
6551614|NCT00897312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551615|NCT00897312|Immunologic Factors|immunologic factors|mesh-ancestor
6551616|NCT00897312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551617|NCT00897312|Dermatologic Agents|dermatologic agents|mesh-ancestor
6551618|NCT00897312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6551619|NCT00897312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6551620|NCT00897377|Temozolomide|temozolomide|mesh-list
6551621|NCT00897377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6551622|NCT00897377|Alkylating Agents|alkylating agents|mesh-ancestor
6442948|NCT00377910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6442949|NCT00377910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442950|NCT00377910|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
6442951|NCT00377910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6442952|NCT00377923|Progesterone|progesterone|mesh-list
6442953|NCT00377923|Progestins|progestins|mesh-ancestor
6442954|NCT00377923|Hormones|hormones|mesh-ancestor
6442955|NCT00377923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6442956|NCT00377923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442957|NCT00377936|Gemcitabine|gemcitabine|mesh-list
6442958|NCT00377936|Paclitaxel|paclitaxel|mesh-list
6442959|NCT00377936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6442960|NCT00377936|Antimetabolites|antimetabolites|mesh-ancestor
6442961|NCT00377936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551623|NCT00897377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551624|NCT00897377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6551625|NCT00897520|Interferons|interferons|mesh-list
6551626|NCT00897520|Interferon-alpha|interferon-alpha|mesh-list
6551627|NCT00897520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6551628|NCT00897520|Antiviral Agents|antiviral agents|mesh-ancestor
6551629|NCT00897520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6551630|NCT00897520|Immunologic Factors|immunologic factors|mesh-ancestor
6551631|NCT00897520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551632|NCT00897871|Cyclophosphamide|cyclophosphamide|mesh-list
6551633|NCT00897871|Carboplatin|carboplatin|mesh-list
6551634|NCT00897871|Etoposide|etoposide|mesh-list
6551635|NCT00897871|Etoposide phosphate|etoposide phosphate|mesh-list
6551636|NCT00897871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6551637|NCT00897871|Immunologic Factors|immunologic factors|mesh-ancestor
6551638|NCT00897871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551639|NCT00897871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6551640|NCT00897871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6551641|NCT00897871|Alkylating Agents|alkylating agents|mesh-ancestor
6551642|NCT00897871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551643|NCT00897871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6551644|NCT00897871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6551645|NCT00897871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6551646|NCT00897871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6551647|NCT00897871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6551648|NCT00897871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6551649|NCT00897884|Metformin|metformin|mesh-list
6551650|NCT00897884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6551651|NCT00897884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656254|NCT01468272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6656255|NCT01468285|Betahistine|betahistine|mesh-list
6656256|NCT01468285|Vasodilator Agents|vasodilator agents|mesh-ancestor
6656257|NCT01468285|Histamine Agonists|histamine agonists|mesh-ancestor
6656258|NCT01468285|Histamine Agents|histamine agents|mesh-ancestor
6656259|NCT01468285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6656260|NCT01468285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656261|NCT01468285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656262|NCT01468389|Capecitabine|capecitabine|mesh-list
6551652|NCT00897975|Red yeast rice|red yeast rice|mesh-list
6551653|NCT00897975|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6551654|NCT00897975|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6551655|NCT00897975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6551656|NCT00897975|Antimetabolites|antimetabolites|mesh-ancestor
6551657|NCT00897975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551658|NCT00897975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6551659|NCT00897975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6551660|NCT00898287|Gemcitabine|gemcitabine|mesh-list
6551661|NCT00898287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6551662|NCT00898287|Antimetabolites|antimetabolites|mesh-ancestor
6551663|NCT00898287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551664|NCT00898287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6551665|NCT00898287|Antiviral Agents|antiviral agents|mesh-ancestor
6551666|NCT00898287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6551667|NCT00898287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6551668|NCT00898287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6551669|NCT00898287|Immunologic Factors|immunologic factors|mesh-ancestor
6551670|NCT00898287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551671|NCT00898417|Paclitaxel|paclitaxel|mesh-list
6551672|NCT00898417|Bevacizumab|bevacizumab|mesh-list
6551673|NCT00898417|Carboplatin|carboplatin|mesh-list
6551674|NCT00898417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6551675|NCT00898417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6551676|NCT00898417|Tubulin Modulators|tubulin modulators|mesh-ancestor
6551677|NCT00898417|Antimitotic Agents|antimitotic agents|mesh-ancestor
6551678|NCT00898417|Mitosis Modulators|mitosis modulators|mesh-ancestor
6551679|NCT00898417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551680|NCT00898417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6442962|NCT00377936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6442963|NCT00377936|Antiviral Agents|antiviral agents|mesh-ancestor
6442964|NCT00377936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6442965|NCT00377936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6442966|NCT00377936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6442967|NCT00377936|Immunologic Factors|immunologic factors|mesh-ancestor
6442968|NCT00377936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442969|NCT00377936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6442970|NCT00377936|Tubulin Modulators|tubulin modulators|mesh-ancestor
6442971|NCT00377936|Antimitotic Agents|antimitotic agents|mesh-ancestor
6442972|NCT00377936|Mitosis Modulators|mitosis modulators|mesh-ancestor
6551681|NCT00898417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6551682|NCT00898417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6551683|NCT00898417|Growth Substances|growth substances|mesh-ancestor
6551684|NCT00898417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551685|NCT00898417|Growth Inhibitors|growth inhibitors|mesh-ancestor
6551686|NCT00898508|Antibodies|antibodies|mesh-list
6551687|NCT00898508|Immunologic Factors|immunologic factors|mesh-ancestor
6551688|NCT00898508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551689|NCT00898573|Lapatinib|lapatinib|mesh-list
6551690|NCT00898573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6551691|NCT00898573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6551692|NCT00898573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6551693|NCT00898573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551694|NCT00898794|Bevacizumab|bevacizumab|mesh-list
6551695|NCT00898794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6551696|NCT00898794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6442973|NCT00377975|Pioglitazone|pioglitazone|mesh-list
6442974|NCT00377975|Ephedrine|ephedrine|mesh-list
6442975|NCT00377975|Caffeine|caffeine|mesh-list
6551697|NCT00898794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6551698|NCT00898794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6551699|NCT00898794|Growth Substances|growth substances|mesh-ancestor
6551700|NCT00898794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551701|NCT00898794|Growth Inhibitors|growth inhibitors|mesh-ancestor
6551702|NCT00898846|Tegafur|tegafur|mesh-list
6551703|NCT00898846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6551704|NCT00898846|Antimetabolites|antimetabolites|mesh-ancestor
6551705|NCT00898846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551706|NCT00898846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6551707|NCT00898950|Aspirin|aspirin|mesh-list
6551708|NCT00898950|Salicylic Acid|salicylic acid|mesh-list
6551709|NCT00898950|Salicylates|salicylates|mesh-list
6551710|NCT00898950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6551711|NCT00898950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6551712|NCT00898950|Analgesics|analgesics|mesh-ancestor
6551713|NCT00898950|Sensory System Agents|sensory system agents|mesh-ancestor
6551714|NCT00898950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6551715|NCT00898950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551716|NCT00898950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6551717|NCT00898950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6551718|NCT00898950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6551719|NCT00898950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6551720|NCT00898950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551721|NCT00898950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6551722|NCT00898950|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6551723|NCT00898950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6551724|NCT00898950|Antipyretics|antipyretics|mesh-ancestor
6551725|NCT00898950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6551726|NCT00898950|Antifungal Agents|antifungal agents|mesh-ancestor
6442976|NCT00377975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6442977|NCT00377975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551727|NCT00898950|Keratolytic Agents|keratolytic agents|mesh-ancestor
6551728|NCT00898950|Dermatologic Agents|dermatologic agents|mesh-ancestor
6551729|NCT00899197|Tamoxifen|tamoxifen|mesh-list
6551730|NCT00899197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6551731|NCT00899197|Hormone Antagonists|hormone antagonists|mesh-ancestor
6551732|NCT00899197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6551733|NCT00899197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551734|NCT00899197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6551735|NCT00899197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6551736|NCT00899197|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6551737|NCT00899197|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6551738|NCT00899197|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6551739|NCT00899483|Insulin|insulin|mesh-list
6551740|NCT00899483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6551741|NCT00899483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551742|NCT00899587|Enalapril|enalapril|mesh-list
6551743|NCT00899587|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6551744|NCT00899587|Protease Inhibitors|protease inhibitors|mesh-ancestor
6551745|NCT00899587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6442978|NCT00377975|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6442979|NCT00377975|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6442980|NCT00377975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6551746|NCT00899587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551747|NCT00899587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6656263|NCT01468389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6656264|NCT01468389|Antimetabolites|antimetabolites|mesh-ancestor
6656265|NCT01468389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656266|NCT01468389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6656267|NCT01468415|Phenol|phenol|mesh-list
6656268|NCT01468415|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6656269|NCT01468415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6656270|NCT01468415|Disinfectants|disinfectants|mesh-ancestor
6656271|NCT01468415|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
6656272|NCT01468415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6656273|NCT01468441|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6656274|NCT01468441|Cetrorelix|cetrorelix|mesh-list
6656275|NCT01468441|Luteolytic Agents|luteolytic agents|mesh-ancestor
6656276|NCT01468441|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6656277|NCT01468441|Contraceptive Agents|contraceptive agents|mesh-ancestor
6656278|NCT01468441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6656279|NCT01468441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656280|NCT01468441|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6656281|NCT01468441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6656282|NCT01468441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6656283|NCT01468441|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6656284|NCT01468441|Fertility Agents|fertility agents|mesh-ancestor
6656285|NCT01468441|Hormone Antagonists|hormone antagonists|mesh-ancestor
6656286|NCT01468441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6656287|NCT01468480|Calcium, Dietary|calcium, dietary|mesh-list
6656288|NCT01468480|Calcium|calcium|mesh-list
6656289|NCT01468480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6656290|NCT01468480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656291|NCT01468480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6656292|NCT01468519|Insulin|insulin|mesh-list
6656293|NCT01468519|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6656294|NCT01468519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6656295|NCT01468519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656296|NCT01468545|Iloprost|iloprost|mesh-list
6656297|NCT01468545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6656298|NCT01468545|Vasodilator Agents|vasodilator agents|mesh-ancestor
6656299|NCT01468571|Spironolactone|spironolactone|mesh-list
6656300|NCT01468571|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6656301|NCT01468571|Hormone Antagonists|hormone antagonists|mesh-ancestor
6656302|NCT01468571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6656303|NCT01468571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656304|NCT01468571|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6656305|NCT01468571|Diuretics|diuretics|mesh-ancestor
6656306|NCT01468571|Natriuretic Agents|natriuretic agents|mesh-ancestor
6656307|NCT01468610|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6656308|NCT01468610|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6656309|NCT01468610|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6656310|NCT01468610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6656311|NCT01468610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656312|NCT01468610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6656313|NCT01468610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656314|NCT01468610|Antidepressive Agents|antidepressive agents|mesh-ancestor
6656315|NCT01468610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6656316|NCT01468688|Imatinib Mesylate|imatinib mesylate|mesh-list
6656317|NCT01468688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6656318|NCT01468688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6656319|NCT01468688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6656320|NCT01468688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656321|NCT01468714|Ketoconazole|ketoconazole|mesh-list
6656322|NCT01468714|Antifungal Agents|antifungal agents|mesh-ancestor
6656323|NCT01468714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6656324|NCT01468714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6656325|NCT01468714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6656326|NCT01468714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6656327|NCT01468714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656328|NCT01468714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6656329|NCT01468714|Hormone Antagonists|hormone antagonists|mesh-ancestor
6656330|NCT01468714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6656331|NCT01468714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551748|NCT00899821|Aldesleukin|aldesleukin|mesh-list
6551749|NCT00899821|Interleukin-12|interleukin-12|mesh-list
6551750|NCT00899821|Sargramostim|sargramostim|mesh-list
6551751|NCT00899821|Immunologic Factors|immunologic factors|mesh-ancestor
6551752|NCT00899821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551753|NCT00899821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6551754|NCT00899821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6551755|NCT00899821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6551756|NCT00899821|Antiviral Agents|antiviral agents|mesh-ancestor
6551757|NCT00899821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6442981|NCT00377975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6442982|NCT00377975|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6442983|NCT00377975|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6442984|NCT00377975|Purinergic Agents|purinergic agents|mesh-ancestor
6551758|NCT00899821|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6551759|NCT00899821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6551760|NCT00899821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6551761|NCT00899821|Growth Substances|growth substances|mesh-ancestor
6551762|NCT00899821|Growth Inhibitors|growth inhibitors|mesh-ancestor
6551763|NCT00899951|Fentanyl|fentanyl|mesh-list
6551764|NCT00899951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6551765|NCT00899951|Narcotics|narcotics|mesh-ancestor
6551766|NCT00899951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6551767|NCT00899951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551768|NCT00899951|Analgesics|analgesics|mesh-ancestor
6551769|NCT00899951|Sensory System Agents|sensory system agents|mesh-ancestor
6551770|NCT00899951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6551771|NCT00899951|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6551772|NCT00899951|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6551773|NCT00899951|Anesthetics, General|anesthetics, general|mesh-ancestor
6551774|NCT00899951|Anesthetics|anesthetics|mesh-ancestor
6551775|NCT00900172|Paclitaxel|paclitaxel|mesh-list
6551776|NCT00900172|Bevacizumab|bevacizumab|mesh-list
6551777|NCT00900172|Carboplatin|carboplatin|mesh-list
6551778|NCT00900172|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6551779|NCT00900172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6551780|NCT00900172|Tubulin Modulators|tubulin modulators|mesh-ancestor
6551781|NCT00900172|Antimitotic Agents|antimitotic agents|mesh-ancestor
6551782|NCT00900172|Mitosis Modulators|mitosis modulators|mesh-ancestor
6551783|NCT00900172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551784|NCT00900172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6551785|NCT00900172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6551786|NCT00900172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6551787|NCT00900172|Growth Substances|growth substances|mesh-ancestor
6551788|NCT00900172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551789|NCT00900172|Growth Inhibitors|growth inhibitors|mesh-ancestor
6551790|NCT00900445|Prednisone|prednisone|mesh-list
6442985|NCT00377975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6442986|NCT00377975|Sympathomimetics|sympathomimetics|mesh-ancestor
6442987|NCT00377975|Autonomic Agents|autonomic agents|mesh-ancestor
6442988|NCT00377975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6442989|NCT00377975|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6442990|NCT00377975|Adrenergic Agents|adrenergic agents|mesh-ancestor
6442991|NCT00377988|Contraceptive Agents|contraceptive agents|mesh-list
6442992|NCT00377988|Norgestimate|norgestimate|mesh-list
6442993|NCT00377988|Contraceptives, Oral|contraceptives, oral|mesh-list
6442994|NCT00377988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6442995|NCT00377988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6442996|NCT00377988|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6442997|NCT00377988|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6442998|NCT00377988|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6442999|NCT00378027|PENTA|penta|mesh-list
6443000|NCT00378027|Fondaparinux|fondaparinux|mesh-list
6443001|NCT00378027|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6443002|NCT00378027|Antithrombins|antithrombins|mesh-ancestor
6443003|NCT00378027|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6551791|NCT00900445|Prednisolone|prednisolone|mesh-list
6551792|NCT00900445|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6551793|NCT00900445|Methylprednisolone|methylprednisolone|mesh-list
6551794|NCT00900445|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6551795|NCT00900445|Prednisolone acetate|prednisolone acetate|mesh-list
6551796|NCT00900445|Hydrocortisone|hydrocortisone|mesh-list
6551797|NCT00900445|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6551798|NCT00900445|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6551799|NCT00900445|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6551800|NCT00900445|Cortisone|cortisone|mesh-list
6551801|NCT00900445|Vincristine|vincristine|mesh-list
6551802|NCT00900445|Daunorubicin|daunorubicin|mesh-list
6551803|NCT00900445|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6551804|NCT00900445|Prednisolone phosphate|prednisolone phosphate|mesh-list
6551805|NCT00900445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6551806|NCT00900445|Glucocorticoids|glucocorticoids|mesh-ancestor
6551807|NCT00900445|Hormones|hormones|mesh-ancestor
6551808|NCT00900445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6551809|NCT00900445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551810|NCT00900445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6551811|NCT00900445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6551812|NCT00900445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6551813|NCT00900445|Tubulin Modulators|tubulin modulators|mesh-ancestor
6551814|NCT00900445|Antimitotic Agents|antimitotic agents|mesh-ancestor
6551815|NCT00900445|Mitosis Modulators|mitosis modulators|mesh-ancestor
6551816|NCT00900445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551817|NCT00900445|Antiemetics|antiemetics|mesh-ancestor
6551818|NCT00900445|Autonomic Agents|autonomic agents|mesh-ancestor
6551819|NCT00900445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6551820|NCT00900445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6551821|NCT00900445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6551822|NCT00900445|Protective Agents|protective agents|mesh-ancestor
6551823|NCT00900445|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6551824|NCT00900445|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6551825|NCT00900445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6551826|NCT00900445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6551827|NCT00900510|Trimethoprim|trimethoprim|mesh-list
6551828|NCT00900510|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6551829|NCT00900510|Sulfamethoxazole|sulfamethoxazole|mesh-list
6551830|NCT00900510|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6551831|NCT00900510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6551832|NCT00900510|Renal Agents|renal agents|mesh-ancestor
6551833|NCT00900510|Antimalarials|antimalarials|mesh-ancestor
6551834|NCT00900510|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6551835|NCT00900510|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6551836|NCT00900510|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6551837|NCT00900510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6551838|NCT00900510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551839|NCT00900510|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6551840|NCT00900510|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6551841|NCT00900510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6551842|NCT00900510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6551843|NCT00900744|Tamoxifen|tamoxifen|mesh-list
6551844|NCT00900744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6551845|NCT00900744|Hormone Antagonists|hormone antagonists|mesh-ancestor
6551846|NCT00900744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6551847|NCT00900744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551848|NCT00900744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6551849|NCT00900744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6551850|NCT00900744|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6551851|NCT00900744|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6551852|NCT00900744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6551853|NCT00900874|Albuterol|albuterol|mesh-list
6551854|NCT00900874|Formoterol Fumarate|formoterol fumarate|mesh-list
6551855|NCT00900874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6551856|NCT00900874|Autonomic Agents|autonomic agents|mesh-ancestor
6443004|NCT00378027|Protease Inhibitors|protease inhibitors|mesh-ancestor
6443005|NCT00378027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6443006|NCT00378027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443007|NCT00378027|Anticoagulants|anticoagulants|mesh-ancestor
6551857|NCT00900874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6551858|NCT00900874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551859|NCT00900874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6551860|NCT00900874|Respiratory System Agents|respiratory system agents|mesh-ancestor
6551861|NCT00900874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6551862|NCT00900874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6551863|NCT00900874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6551864|NCT00900874|Adrenergic Agents|adrenergic agents|mesh-ancestor
6551865|NCT00900874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6551866|NCT00900874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551867|NCT00900874|Tocolytic Agents|tocolytic agents|mesh-ancestor
6551868|NCT00900874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6551869|NCT00900887|Ketorolac|ketorolac|mesh-list
6551870|NCT00900887|Nepafenac|nepafenac|mesh-list
6551871|NCT00900887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6551872|NCT00900887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6551873|NCT00900887|Analgesics|analgesics|mesh-ancestor
6551874|NCT00900887|Sensory System Agents|sensory system agents|mesh-ancestor
6551875|NCT00900887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6551876|NCT00900887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551877|NCT00900887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6551878|NCT00900887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6551879|NCT00900887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6551880|NCT00900887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6551881|NCT00900887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551882|NCT00900913|Ropivacaine|ropivacaine|mesh-list
6551883|NCT00900913|Anesthetics, Local|anesthetics, local|mesh-ancestor
6551884|NCT00900913|Anesthetics|anesthetics|mesh-ancestor
6551885|NCT00900913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6551886|NCT00900913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551887|NCT00900913|Sensory System Agents|sensory system agents|mesh-ancestor
6551888|NCT00900913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6551889|NCT00900978|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6551890|NCT00900978|Immunologic Factors|immunologic factors|mesh-ancestor
6551891|NCT00900978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551892|NCT00901069|Cyclophosphamide|cyclophosphamide|mesh-list
6551893|NCT00901069|Rituximab|rituximab|mesh-list
6551894|NCT00901069|Vincristine|vincristine|mesh-list
6551895|NCT00901069|Azacitidine|azacitidine|mesh-list
6551896|NCT00901069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6551897|NCT00901069|Immunologic Factors|immunologic factors|mesh-ancestor
6551898|NCT00901069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551899|NCT00901069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6551900|NCT00901069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6551901|NCT00901069|Alkylating Agents|alkylating agents|mesh-ancestor
6551902|NCT00901069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551903|NCT00901069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6551904|NCT00901069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6551905|NCT00901069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6551906|NCT00901069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6551907|NCT00901069|Tubulin Modulators|tubulin modulators|mesh-ancestor
6551908|NCT00901069|Antimitotic Agents|antimitotic agents|mesh-ancestor
6551909|NCT00901069|Mitosis Modulators|mitosis modulators|mesh-ancestor
6551910|NCT00901069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6551911|NCT00901069|Antimetabolites|antimetabolites|mesh-ancestor
6551912|NCT00901069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6551913|NCT00901147|Bortezomib|bortezomib|mesh-list
6551914|NCT00901147|Panobinostat|panobinostat|mesh-list
6551915|NCT00901147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6443008|NCT00378027|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6443009|NCT00378027|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6443010|NCT00378066|Bevacizumab|bevacizumab|mesh-list
6443011|NCT00378066|Capecitabine|capecitabine|mesh-list
6443012|NCT00378066|Oxaliplatin|oxaliplatin|mesh-list
6443013|NCT00378066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6443014|NCT00378066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6551916|NCT00901147|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6551917|NCT00901147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6551918|NCT00901147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551919|NCT00901290|Contraceptive Agents|contraceptive agents|mesh-list
6551920|NCT00901290|Contraceptives, Oral|contraceptives, oral|mesh-list
6551921|NCT00901290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6551922|NCT00901290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551923|NCT00901290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6551924|NCT00901368|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6551925|NCT00901368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6551926|NCT00901368|Autonomic Agents|autonomic agents|mesh-ancestor
6551927|NCT00901368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6551928|NCT00901368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551929|NCT00901368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6551930|NCT00901368|Respiratory System Agents|respiratory system agents|mesh-ancestor
6551931|NCT00901368|Glucocorticoids|glucocorticoids|mesh-ancestor
6551932|NCT00901368|Hormones|hormones|mesh-ancestor
6551933|NCT00901368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6551934|NCT00901368|Sympathomimetics|sympathomimetics|mesh-ancestor
6551935|NCT00901381|Lenograstim|lenograstim|mesh-list
6551936|NCT00901381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6551937|NCT00901381|Immunologic Factors|immunologic factors|mesh-ancestor
6551938|NCT00901381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551939|NCT00901407|Lamotrigine|lamotrigine|mesh-list
6551940|NCT00901407|Paroxetine|paroxetine|mesh-list
6551941|NCT00901407|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6551942|NCT00901407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6551943|NCT00901407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6551944|NCT00901407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551945|NCT00901407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6551946|NCT00901407|Serotonin Agents|serotonin agents|mesh-ancestor
6551947|NCT00901407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551948|NCT00901407|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6551949|NCT00901407|Antidepressive Agents|antidepressive agents|mesh-ancestor
6551950|NCT00901407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6551951|NCT00901407|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6551952|NCT00901407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6551953|NCT00901407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6551954|NCT00901407|Anticonvulsants|anticonvulsants|mesh-ancestor
6551955|NCT00901407|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6551956|NCT00901407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6551957|NCT00901407|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6551958|NCT00901407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6551959|NCT00901407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6551960|NCT00901407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6656332|NCT01468714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6656333|NCT01468740|Prednisone|prednisone|mesh-list
6656334|NCT01468740|Cyclophosphamide|cyclophosphamide|mesh-list
6656335|NCT01468740|Dacarbazine|dacarbazine|mesh-list
6656336|NCT01468740|Doxorubicin|doxorubicin|mesh-list
6656337|NCT01468740|Etoposide|etoposide|mesh-list
6656338|NCT01468740|Vincristine|vincristine|mesh-list
6656339|NCT01468740|Bleomycin|bleomycin|mesh-list
6656340|NCT01468740|Vinblastine|vinblastine|mesh-list
6656341|NCT01468740|Procarbazine|procarbazine|mesh-list
6656342|NCT01468740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6656343|NCT01468740|Immunologic Factors|immunologic factors|mesh-ancestor
6656344|NCT01468740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656345|NCT01468740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6656346|NCT01468740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6656347|NCT01468740|Alkylating Agents|alkylating agents|mesh-ancestor
6656348|NCT01468740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656349|NCT01468740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6551961|NCT00901511|Molgramostim|molgramostim|mesh-list
6551962|NCT00901511|Sargramostim|sargramostim|mesh-list
6551963|NCT00901511|Immunologic Factors|immunologic factors|mesh-ancestor
6551964|NCT00901511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551965|NCT00901511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6551966|NCT00901524|Interferons|interferons|mesh-list
6551967|NCT00901524|Ribavirin|ribavirin|mesh-list
6551968|NCT00901524|Interferon-alpha|interferon-alpha|mesh-list
6551969|NCT00901524|Interferon alpha-2|interferon alpha-2|mesh-list
6551970|NCT00901524|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6551971|NCT00901524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6551972|NCT00901524|Antiviral Agents|antiviral agents|mesh-ancestor
6551973|NCT00901524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6551974|NCT00901524|Antimetabolites|antimetabolites|mesh-ancestor
6551975|NCT00901524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551976|NCT00901524|Immunologic Factors|immunologic factors|mesh-ancestor
6551977|NCT00901524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501398|NCT04474600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5501399|NCT04474600|Anesthetics, General|anesthetics, general|mesh-ancestor
5501400|NCT04474600|Anesthetics|anesthetics|mesh-ancestor
5501401|NCT04474600|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5501402|NCT04474457|Favipiravir|favipiravir|mesh-list
5501403|NCT04474457|Antiviral Agents|antiviral agents|mesh-ancestor
5501404|NCT04474457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5501405|NCT04474483|Melatonin|melatonin|mesh-list
5501406|NCT04474483|Antioxidants|antioxidants|mesh-ancestor
5501407|NCT04474483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501408|NCT04474483|Protective Agents|protective agents|mesh-ancestor
5501409|NCT04474483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501410|NCT04474483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5501411|NCT04474327|Montelukast|montelukast|mesh-list
5501412|NCT04474327|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6551978|NCT00901537|Azacitidine|azacitidine|mesh-list
6551979|NCT00901537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6551980|NCT00901537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6551981|NCT00901537|Antimetabolites|antimetabolites|mesh-ancestor
6551982|NCT00901537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551983|NCT00901537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6551984|NCT00901550|Methotrexate|methotrexate|mesh-list
6551985|NCT00901550|Infliximab|infliximab|mesh-list
6551986|NCT00901550|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6551987|NCT00901550|Abortifacient Agents|abortifacient agents|mesh-ancestor
6551988|NCT00901550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6551989|NCT00901550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6551990|NCT00901550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6551991|NCT00901550|Antimetabolites|antimetabolites|mesh-ancestor
6551992|NCT00901550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6551993|NCT00901550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6551994|NCT00901550|Dermatologic Agents|dermatologic agents|mesh-ancestor
6551995|NCT00901550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6551996|NCT00901550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6551997|NCT00901550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6551998|NCT00901550|Immunologic Factors|immunologic factors|mesh-ancestor
6551999|NCT00901550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6552000|NCT00901550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6552001|NCT00901550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6552002|NCT00901615|Lenalidomide|lenalidomide|mesh-list
6552003|NCT00901615|Immunologic Factors|immunologic factors|mesh-ancestor
6552004|NCT00901615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552005|NCT00901615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6552006|NCT00901615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6552007|NCT00901615|Growth Substances|growth substances|mesh-ancestor
6552008|NCT00901615|Growth Inhibitors|growth inhibitors|mesh-ancestor
6552009|NCT00901615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6552010|NCT00901654|Vaccines|vaccines|mesh-list
6552011|NCT00901654|Immunologic Factors|immunologic factors|mesh-ancestor
6552012|NCT00901654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552013|NCT00901719|Nitroprusside|nitroprusside|mesh-list
6552014|NCT00901719|Acetylcholine|acetylcholine|mesh-list
6552015|NCT00901719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6552016|NCT00901719|Vasodilator Agents|vasodilator agents|mesh-ancestor
6552017|NCT00901719|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6552018|NCT00901719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552019|NCT00901719|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6552020|NCT00901719|Cholinergic Agents|cholinergic agents|mesh-ancestor
6552021|NCT00901719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6552022|NCT00901719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552023|NCT00901732|Calcium|calcium|mesh-list
6552024|NCT00901732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6552025|NCT00901732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552026|NCT00901745|Angiotensin II|angiotensin ii|mesh-list
6552027|NCT00901745|Giapreza|giapreza|mesh-list
6552028|NCT00901745|Norepinephrine|norepinephrine|mesh-list
6552029|NCT00901745|Angiotensinogen|angiotensinogen|mesh-list
6552030|NCT00901745|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6552031|NCT00901745|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6552032|NCT00901745|Protease Inhibitors|protease inhibitors|mesh-ancestor
6552033|NCT00901745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6552034|NCT00901745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552035|NCT00901745|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6552036|NCT00901745|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6552037|NCT00901745|Adrenergic Agents|adrenergic agents|mesh-ancestor
6552038|NCT00901745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6552039|NCT00901745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552040|NCT00901745|Sympathomimetics|sympathomimetics|mesh-ancestor
6552041|NCT00901745|Autonomic Agents|autonomic agents|mesh-ancestor
6552042|NCT00901745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6552043|NCT00901758|Nitroglycerin|nitroglycerin|mesh-list
6552044|NCT00901758|Vasodilator Agents|vasodilator agents|mesh-ancestor
6552045|NCT00901784|Topiramate|topiramate|mesh-list
6552046|NCT00901784|Anticonvulsants|anticonvulsants|mesh-ancestor
6552047|NCT00901784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6552048|NCT00901784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552049|NCT00901823|Diazoxide|diazoxide|mesh-list
6552050|NCT00901823|Choline|choline|mesh-list
6552051|NCT00901823|Lipotropic Agents|lipotropic agents|mesh-ancestor
6552052|NCT00901823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6552053|NCT00901823|Antimetabolites|antimetabolites|mesh-ancestor
6552054|NCT00901823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552055|NCT00901823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6552056|NCT00901823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6552057|NCT00901823|Nootropic Agents|nootropic agents|mesh-ancestor
6552058|NCT00901823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6552059|NCT00901823|Vasodilator Agents|vasodilator agents|mesh-ancestor
6552060|NCT00901849|Sirolimus|sirolimus|mesh-list
6552061|NCT00901849|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6552062|NCT00901849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6552063|NCT00901849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6552064|NCT00901849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6552065|NCT00901849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6552066|NCT00901849|Antifungal Agents|antifungal agents|mesh-ancestor
6552067|NCT00901849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6552068|NCT00901849|Immunologic Factors|immunologic factors|mesh-ancestor
6552069|NCT00901849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552070|NCT00901849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6552071|NCT00901849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6552072|NCT00901849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552073|NCT00901875|Buprenorphine|buprenorphine|mesh-list
6552074|NCT00901875|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6552075|NCT00901875|Naloxone|naloxone|mesh-list
6552076|NCT00901875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6552077|NCT00901875|Narcotics|narcotics|mesh-ancestor
6552078|NCT00901875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6552079|NCT00901875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552080|NCT00901875|Analgesics|analgesics|mesh-ancestor
6552081|NCT00901875|Sensory System Agents|sensory system agents|mesh-ancestor
6552082|NCT00901875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6552083|NCT00901875|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6552084|NCT00901888|Nitroprusside|nitroprusside|mesh-list
6552085|NCT00901888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6552086|NCT00901888|Vasodilator Agents|vasodilator agents|mesh-ancestor
6552087|NCT00901888|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6552088|NCT00901888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552089|NCT00902031|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
6552090|NCT00902031|Sennosides|sennosides|mesh-list
6552091|NCT00902031|Senna Extract|senna extract|mesh-list
6552092|NCT00902031|Antidiarrheals|antidiarrheals|mesh-ancestor
6552093|NCT00902031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6552094|NCT00902031|Laxatives|laxatives|mesh-ancestor
6552095|NCT00902031|Cathartics|cathartics|mesh-ancestor
6552096|NCT00902057|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
6552097|NCT00902057|Hemostatics|hemostatics|mesh-ancestor
6552098|NCT00902057|Coagulants|coagulants|mesh-ancestor
6552099|NCT00902057|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6552100|NCT00902057|Natriuretic Agents|natriuretic agents|mesh-ancestor
6552101|NCT00902057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552102|NCT00902070|Rocuronium|rocuronium|mesh-list
6552103|NCT00902070|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6552104|NCT00902070|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6552105|NCT00902070|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6552106|NCT00902070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6552107|NCT00902070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552108|NCT00902135|Interferons|interferons|mesh-list
6552109|NCT00902135|Interferon-beta|interferon-beta|mesh-list
6552110|NCT00902135|Interferon beta-1b|interferon beta-1b|mesh-list
6552111|NCT00902135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6552112|NCT00902135|Antiviral Agents|antiviral agents|mesh-ancestor
6552113|NCT00902135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6552114|NCT00902135|Immunologic Factors|immunologic factors|mesh-ancestor
6552115|NCT00902135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552116|NCT00902135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6552117|NCT00902187|Fesoterodine|fesoterodine|mesh-list
6552118|NCT00902187|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6552119|NCT00902187|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6552120|NCT00902187|Cholinergic Agents|cholinergic agents|mesh-ancestor
6552121|NCT00902187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6552122|NCT00902187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552123|NCT00902187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552124|NCT00902187|Urological Agents|urological agents|mesh-ancestor
6552125|NCT00902395|Midazolam|midazolam|mesh-list
6552126|NCT00902395|Ketamine|ketamine|mesh-list
6552127|NCT00902395|Analgesics|analgesics|mesh-ancestor
6552128|NCT00902395|Sensory System Agents|sensory system agents|mesh-ancestor
6552129|NCT00902395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6552130|NCT00902395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552131|NCT00902395|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6552132|NCT00902395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6552133|NCT00902395|Anesthetics, General|anesthetics, general|mesh-ancestor
6552134|NCT00902395|Anesthetics|anesthetics|mesh-ancestor
6552135|NCT00902395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6552136|NCT00902395|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6552137|NCT00902395|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6552138|NCT00902395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6552139|NCT00902395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552140|NCT00902395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6552141|NCT00902395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6552142|NCT00902395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6552143|NCT00902395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6552144|NCT00902395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6552145|NCT00902395|GABA Modulators|gaba modulators|mesh-ancestor
6552146|NCT00902395|GABA Agents|gaba agents|mesh-ancestor
6552147|NCT00902421|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
6552148|NCT00902421|Serotonin|serotonin|mesh-list
6552149|NCT00902421|Muscarinic Antagonists|muscarinic antagonists|mesh-list
6552150|NCT00902421|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6552151|NCT00902421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6552152|NCT00902421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552153|NCT00902421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6552154|NCT00902421|Serotonin Agents|serotonin agents|mesh-ancestor
6552155|NCT00902421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552156|NCT00902421|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6552157|NCT00902421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6552158|NCT00902421|Cholinergic Agents|cholinergic agents|mesh-ancestor
6552159|NCT00902460|Midazolam|midazolam|mesh-list
6552160|NCT00902460|Tofacitinib|tofacitinib|mesh-list
6552161|NCT00902460|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6552162|NCT00902460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6552163|NCT00902460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6552164|NCT00902460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552165|NCT00902460|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6552166|NCT00902460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6552167|NCT00902460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6552168|NCT00902460|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6552169|NCT00902460|Anesthetics, General|anesthetics, general|mesh-ancestor
6552170|NCT00902460|Anesthetics|anesthetics|mesh-ancestor
6552171|NCT00902460|GABA Modulators|gaba modulators|mesh-ancestor
6552172|NCT00902460|GABA Agents|gaba agents|mesh-ancestor
6552173|NCT00902460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6552174|NCT00902460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552175|NCT00902460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6552176|NCT00902460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6552177|NCT00902473|Topiramate|topiramate|mesh-list
6552178|NCT00902473|Anticonvulsants|anticonvulsants|mesh-ancestor
6552179|NCT00902473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6552180|NCT00902473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552181|NCT00902512|Sildenafil Citrate|sildenafil citrate|mesh-list
6552182|NCT00902512|Vasodilator Agents|vasodilator agents|mesh-ancestor
6552183|NCT00902512|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6552184|NCT00902512|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6552185|NCT00902512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6552186|NCT00902512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552187|NCT00902512|Urological Agents|urological agents|mesh-ancestor
6552188|NCT00902525|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6552189|NCT00902525|Immunologic Factors|immunologic factors|mesh-ancestor
6552190|NCT00902525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552191|NCT00902603|Iloprost|iloprost|mesh-list
6552192|NCT00902603|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6552193|NCT00902603|Vasodilator Agents|vasodilator agents|mesh-ancestor
6552194|NCT00902655|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
6552195|NCT00902655|Hemostatics|hemostatics|mesh-ancestor
6552196|NCT00902655|Coagulants|coagulants|mesh-ancestor
6552197|NCT00902655|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6552198|NCT00902655|Natriuretic Agents|natriuretic agents|mesh-ancestor
6552199|NCT00902655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552200|NCT00902681|Fesoterodine|fesoterodine|mesh-list
6552201|NCT00902681|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6552202|NCT00902681|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6552203|NCT00902681|Cholinergic Agents|cholinergic agents|mesh-ancestor
6552204|NCT00902681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6552205|NCT00902681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552206|NCT00902681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552207|NCT00902681|Urological Agents|urological agents|mesh-ancestor
6552208|NCT00902707|Phenylpropanolamine|phenylpropanolamine|mesh-list
6552209|NCT00902707|Guaifenesin|guaifenesin|mesh-list
6552210|NCT00902707|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
6552211|NCT00902707|Expectorants|expectorants|mesh-ancestor
6552212|NCT00902707|Respiratory System Agents|respiratory system agents|mesh-ancestor
6552213|NCT00902707|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6552214|NCT00902707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6552215|NCT00902707|Adrenergic Agents|adrenergic agents|mesh-ancestor
6552216|NCT00902707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6552217|NCT00902707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552218|NCT00902707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552219|NCT00902707|Appetite Depressants|appetite depressants|mesh-ancestor
6552220|NCT00902707|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6552221|NCT00902707|Sympathomimetics|sympathomimetics|mesh-ancestor
6552222|NCT00902707|Autonomic Agents|autonomic agents|mesh-ancestor
6552223|NCT00902707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6552224|NCT00902707|Nasal Decongestants|nasal decongestants|mesh-ancestor
6552225|NCT00902707|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6552226|NCT00902772|Lorazepam|lorazepam|mesh-list
6552227|NCT00902772|Anticonvulsants|anticonvulsants|mesh-ancestor
6552228|NCT00902772|Antiemetics|antiemetics|mesh-ancestor
6552229|NCT00902772|Autonomic Agents|autonomic agents|mesh-ancestor
6552230|NCT00902772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6552231|NCT00902772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552232|NCT00902772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6552233|NCT00902772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6552234|NCT00902772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6552235|NCT00902772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6552236|NCT00902772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6552237|NCT00902772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6552238|NCT00902772|GABA Modulators|gaba modulators|mesh-ancestor
6552239|NCT00902772|GABA Agents|gaba agents|mesh-ancestor
6552240|NCT00902772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6552241|NCT00902772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552242|NCT00902811|Artesunate|artesunate|mesh-list
6552243|NCT00902811|Amodiaquine|amodiaquine|mesh-list
6552244|NCT00902811|Antimalarials|antimalarials|mesh-ancestor
6552245|NCT00902811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6552246|NCT00902811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6552247|NCT00902811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6552248|NCT00902811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6552249|NCT00902811|Antiviral Agents|antiviral agents|mesh-ancestor
6552250|NCT00902811|Schistosomicides|schistosomicides|mesh-ancestor
6552251|NCT00902811|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6552252|NCT00902811|Anthelmintics|anthelmintics|mesh-ancestor
6552253|NCT00902837|Oxycodone|oxycodone|mesh-list
6552254|NCT00902837|Naloxone|naloxone|mesh-list
6552255|NCT00902837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6552256|NCT00902837|Narcotics|narcotics|mesh-ancestor
6552257|NCT00902837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6552258|NCT00902837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552259|NCT00902837|Analgesics|analgesics|mesh-ancestor
6552260|NCT00902837|Sensory System Agents|sensory system agents|mesh-ancestor
6552261|NCT00902837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6552262|NCT00902837|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6552263|NCT00902915|Dexamethasone|dexamethasone|mesh-list
6552264|NCT00902915|Lenalidomide|lenalidomide|mesh-list
6552265|NCT00902915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6552266|NCT00902915|Antiemetics|antiemetics|mesh-ancestor
6552267|NCT00902915|Autonomic Agents|autonomic agents|mesh-ancestor
6552268|NCT00902915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6552269|NCT00902915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443015|NCT00378066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6443016|NCT00378066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6443017|NCT00378066|Growth Substances|growth substances|mesh-ancestor
6443018|NCT00378066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443019|NCT00378066|Growth Inhibitors|growth inhibitors|mesh-ancestor
6552270|NCT00902915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6552271|NCT00902915|Glucocorticoids|glucocorticoids|mesh-ancestor
6552272|NCT00902915|Hormones|hormones|mesh-ancestor
6552273|NCT00902915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6552274|NCT00902915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6552275|NCT00902915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6552276|NCT00902915|Immunologic Factors|immunologic factors|mesh-ancestor
6552277|NCT00902915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6552278|NCT00902915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6552279|NCT00902915|Growth Substances|growth substances|mesh-ancestor
6552280|NCT00902915|Growth Inhibitors|growth inhibitors|mesh-ancestor
6552281|NCT00902941|Rasagiline|rasagiline|mesh-list
6552282|NCT00902941|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6552283|NCT00902941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6552284|NCT00902941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552285|NCT00902941|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6552286|NCT00902941|Protective Agents|protective agents|mesh-ancestor
6552287|NCT00902941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552288|NCT00902954|Letrozole|letrozole|mesh-list
6552289|NCT00902954|Anastrozole|anastrozole|mesh-list
6552290|NCT00902954|Exemestane|exemestane|mesh-list
6552291|NCT00902954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6552292|NCT00902954|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6552293|NCT00902954|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6552294|NCT00902954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6552295|NCT00902954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552296|NCT00902954|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6552297|NCT00902954|Hormone Antagonists|hormone antagonists|mesh-ancestor
6552298|NCT00902954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6552299|NCT00902954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552300|NCT00902954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6552301|NCT00902967|Atorvastatin|atorvastatin|mesh-list
6552302|NCT00902967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6552303|NCT00902967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6552304|NCT00902967|Antimetabolites|antimetabolites|mesh-ancestor
6552305|NCT00902967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552306|NCT00902967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6552307|NCT00902967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6552308|NCT00902967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6552309|NCT00903045|Propiverine|propiverine|mesh-list
6552310|NCT00903045|Parasympatholytics|parasympatholytics|mesh-ancestor
6552311|NCT00903045|Autonomic Agents|autonomic agents|mesh-ancestor
6552312|NCT00903045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6552313|NCT00903045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552314|NCT00903045|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6552315|NCT00903045|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6552316|NCT00903045|Cholinergic Agents|cholinergic agents|mesh-ancestor
6552317|NCT00903045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6443020|NCT00378066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6443021|NCT00378066|Antimetabolites|antimetabolites|mesh-ancestor
6443022|NCT00378066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443023|NCT00378092|Risperidone|risperidone|mesh-list
6443024|NCT00378092|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6443025|NCT00378092|Serotonin Agents|serotonin agents|mesh-ancestor
6443026|NCT00378092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6443027|NCT00378092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443028|NCT00378092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443029|NCT00378092|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6443030|NCT00378092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6443031|NCT00378092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6443032|NCT00378092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6443033|NCT00378092|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6552318|NCT00903045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552319|NCT00903045|Urological Agents|urological agents|mesh-ancestor
6552320|NCT00903084|Tenofovir|tenofovir|mesh-list
6552321|NCT00903084|Antiviral Agents|antiviral agents|mesh-ancestor
6552322|NCT00903084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6552323|NCT00903084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6552324|NCT00903084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6552325|NCT00903084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6552326|NCT00903084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552327|NCT00903084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6552328|NCT00903084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6552329|NCT00903188|Cyclosporine|cyclosporine|mesh-list
6552330|NCT00903188|Mycophenolic Acid|mycophenolic acid|mesh-list
6552331|NCT00903188|Methylprednisolone|methylprednisolone|mesh-list
6552332|NCT00903188|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6552333|NCT00903188|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6552334|NCT00903188|Prednisolone|prednisolone|mesh-list
6552335|NCT00903188|Prednisolone acetate|prednisolone acetate|mesh-list
6552336|NCT00903188|Everolimus|everolimus|mesh-list
6552337|NCT00903188|Cyclosporins|cyclosporins|mesh-list
6552338|NCT00903188|Basiliximab|basiliximab|mesh-list
6552339|NCT00903188|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6552340|NCT00903188|Prednisolone phosphate|prednisolone phosphate|mesh-list
6552341|NCT00903188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6552342|NCT00903188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552343|NCT00903188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6552344|NCT00903188|Immunologic Factors|immunologic factors|mesh-ancestor
6552345|NCT00903188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552346|NCT00903188|Antifungal Agents|antifungal agents|mesh-ancestor
6552347|NCT00903188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6552348|NCT00903188|Dermatologic Agents|dermatologic agents|mesh-ancestor
6552349|NCT00903188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6552350|NCT00903188|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6552351|NCT00903188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6552352|NCT00903188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6552353|NCT00903188|Antiemetics|antiemetics|mesh-ancestor
6552354|NCT00903188|Autonomic Agents|autonomic agents|mesh-ancestor
6552355|NCT00903188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6552356|NCT00903188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6552357|NCT00903188|Glucocorticoids|glucocorticoids|mesh-ancestor
6552358|NCT00903188|Hormones|hormones|mesh-ancestor
6552359|NCT00903188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6552360|NCT00903188|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6552361|NCT00903188|Protective Agents|protective agents|mesh-ancestor
6552362|NCT00903188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6552363|NCT00903188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6552364|NCT00903188|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6552365|NCT00903188|Antitubercular Agents|antitubercular agents|mesh-ancestor
6552366|NCT00903188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6552367|NCT00903214|Riluzole|riluzole|mesh-list
6552368|NCT00903214|Anticonvulsants|anticonvulsants|mesh-ancestor
6552369|NCT00903214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6552370|NCT00903214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6552371|NCT00903214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6552372|NCT00903214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552373|NCT00903214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552374|NCT00903214|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6552375|NCT00903214|Protective Agents|protective agents|mesh-ancestor
6552376|NCT00903227|Fluticasone|fluticasone|mesh-list
6552377|NCT00903227|Xhance|xhance|mesh-list
6552378|NCT00903227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6552379|NCT00903227|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6552380|NCT00903227|Autonomic Agents|autonomic agents|mesh-ancestor
6552381|NCT00903227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6552382|NCT00903227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552383|NCT00903227|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6552384|NCT00903227|Respiratory System Agents|respiratory system agents|mesh-ancestor
6552385|NCT00903227|Dermatologic Agents|dermatologic agents|mesh-ancestor
6552386|NCT00903227|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6552387|NCT00903279|Retapamulin|retapamulin|mesh-list
6552388|NCT00903279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6552389|NCT00903279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6552390|NCT00903292|Pemetrexed|pemetrexed|mesh-list
6552391|NCT00903292|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6552392|NCT00903292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6552393|NCT00903292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6552394|NCT00903292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552395|NCT00903292|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6552396|NCT00903292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6552397|NCT00903292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6552398|NCT00903656|Lapatinib|lapatinib|mesh-list
6552399|NCT00903656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6552400|NCT00903656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6552401|NCT00903656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6552402|NCT00903656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552403|NCT00903734|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6552404|NCT00903734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6552405|NCT00903734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6552406|NCT00903734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6552407|NCT00903734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552408|NCT00903747|Moxifloxacin|moxifloxacin|mesh-list
6552409|NCT00903747|Prucalopride|prucalopride|mesh-list
6552410|NCT00903747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6552411|NCT00903747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6552412|NCT00903747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6552413|NCT00903747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6552414|NCT00903747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6552415|NCT00903747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552416|NCT00903747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6552417|NCT00903747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552418|NCT00903747|Laxatives|laxatives|mesh-ancestor
6552419|NCT00903747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6552420|NCT00903747|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
6552421|NCT00903747|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6552422|NCT00903747|Serotonin Agents|serotonin agents|mesh-ancestor
6552423|NCT00903747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6552424|NCT00903825|Lidocaine|lidocaine|mesh-list
6552425|NCT00903825|Anesthetics, Local|anesthetics, local|mesh-list
6552426|NCT00903825|Anesthetics|anesthetics|mesh-list
6552427|NCT00903825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6552428|NCT00903825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552429|NCT00903825|Sensory System Agents|sensory system agents|mesh-ancestor
6552430|NCT00903825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6552431|NCT00903825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6552432|NCT00903825|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6552433|NCT00903825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6552434|NCT00903825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6552435|NCT00903825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552436|NCT00903838|Pramipexole|pramipexole|mesh-list
6552437|NCT00903838|Antioxidants|antioxidants|mesh-ancestor
6552438|NCT00903838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552439|NCT00903838|Protective Agents|protective agents|mesh-ancestor
6552440|NCT00903838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552441|NCT00903838|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6552442|NCT00903838|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6552443|NCT00903838|Dopamine Agonists|dopamine agonists|mesh-ancestor
6552444|NCT00903838|Dopamine Agents|dopamine agents|mesh-ancestor
6443034|NCT00378092|Dopamine Agents|dopamine agents|mesh-ancestor
6443035|NCT00378118|Antibodies|antibodies|mesh-list
6443036|NCT00378118|Immunoglobulins|immunoglobulins|mesh-list
6443037|NCT00378118|HIV Antibodies|hiv antibodies|mesh-list
6443038|NCT00378118|Immunologic Factors|immunologic factors|mesh-ancestor
6443039|NCT00378118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443040|NCT00378144|Acetaminophen|acetaminophen|mesh-list
6443041|NCT00378144|Pseudoephedrine|pseudoephedrine|mesh-list
6443042|NCT00378144|Ephedrine|ephedrine|mesh-list
6552445|NCT00903838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6552446|NCT00903851|Lidocaine|lidocaine|mesh-list
6552447|NCT00903851|Anesthetics, Local|anesthetics, local|mesh-ancestor
6552448|NCT00903851|Anesthetics|anesthetics|mesh-ancestor
6552449|NCT00903851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6552450|NCT00903851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552451|NCT00903851|Sensory System Agents|sensory system agents|mesh-ancestor
6552452|NCT00903851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6552453|NCT00903851|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6552454|NCT00903851|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6552455|NCT00903851|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6552456|NCT00903851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6552457|NCT00903851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552458|NCT00903942|Paclitaxel|paclitaxel|mesh-list
6552459|NCT00903942|Carboplatin|carboplatin|mesh-list
6552460|NCT00903942|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6552461|NCT00903942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6552462|NCT00903942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6552463|NCT00903942|Tubulin Modulators|tubulin modulators|mesh-ancestor
6552464|NCT00903942|Antimitotic Agents|antimitotic agents|mesh-ancestor
6443043|NCT00378144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6552465|NCT00903942|Mitosis Modulators|mitosis modulators|mesh-ancestor
6552466|NCT00903942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552467|NCT00903994|Ketoprofen|ketoprofen|mesh-list
6552468|NCT00903994|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6552469|NCT00903994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6552470|NCT00903994|Analgesics|analgesics|mesh-ancestor
6552471|NCT00903994|Sensory System Agents|sensory system agents|mesh-ancestor
6552472|NCT00903994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6552473|NCT00903994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552474|NCT00903994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6552475|NCT00903994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6552476|NCT00903994|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6443044|NCT00378144|Analgesics|analgesics|mesh-ancestor
6443045|NCT00378144|Sensory System Agents|sensory system agents|mesh-ancestor
6443046|NCT00378144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6443047|NCT00378144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443048|NCT00378144|Antipyretics|antipyretics|mesh-ancestor
6443049|NCT00378144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6552477|NCT00903994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6552478|NCT00903994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552479|NCT00904020|Lidocaine|lidocaine|mesh-list
6443050|NCT00378144|Autonomic Agents|autonomic agents|mesh-ancestor
6443051|NCT00378144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6552480|NCT00904020|Anesthetics, Local|anesthetics, local|mesh-ancestor
6552481|NCT00904020|Anesthetics|anesthetics|mesh-ancestor
6552482|NCT00904020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6552483|NCT00904020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552484|NCT00904020|Sensory System Agents|sensory system agents|mesh-ancestor
6552485|NCT00904020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6552486|NCT00904020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6552487|NCT00904020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6552488|NCT00904020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6552489|NCT00904020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6552490|NCT00904020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552491|NCT00904059|Asunaprevir|asunaprevir|mesh-list
6552492|NCT00904059|Protease Inhibitors|protease inhibitors|mesh-ancestor
6552493|NCT00904059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6552494|NCT00904059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552495|NCT00904085|Oxymorphone|oxymorphone|mesh-list
6552496|NCT00904085|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6552497|NCT00904085|Narcotics|narcotics|mesh-ancestor
6552498|NCT00904085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6552499|NCT00904085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552500|NCT00904085|Analgesics|analgesics|mesh-ancestor
6552501|NCT00904085|Sensory System Agents|sensory system agents|mesh-ancestor
6552502|NCT00904085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6552503|NCT00904085|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6552504|NCT00904098|Frovatriptan|frovatriptan|mesh-list
6552505|NCT00904098|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6552506|NCT00904098|Serotonin Agents|serotonin agents|mesh-ancestor
6552507|NCT00904098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6552508|NCT00904098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552509|NCT00904098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552510|NCT00904111|Lidocaine|lidocaine|mesh-list
6552511|NCT00904111|Anesthetics, Local|anesthetics, local|mesh-ancestor
6552512|NCT00904111|Anesthetics|anesthetics|mesh-ancestor
6552513|NCT00904111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6552514|NCT00904111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552515|NCT00904111|Sensory System Agents|sensory system agents|mesh-ancestor
6552516|NCT00904111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6552517|NCT00904111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6552518|NCT00904111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6552519|NCT00904111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6552520|NCT00904111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6552521|NCT00904111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552522|NCT00904176|Dapagliflozin|dapagliflozin|mesh-list
6552523|NCT00904176|Digoxin|digoxin|mesh-list
6552524|NCT00904176|Warfarin|warfarin|mesh-list
6552525|NCT00904176|Anticoagulants|anticoagulants|mesh-ancestor
6552526|NCT00904176|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6552527|NCT00904176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552528|NCT00904176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6552529|NCT00904176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552530|NCT00904176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6552531|NCT00904176|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6552532|NCT00904176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6552533|NCT00904176|Protective Agents|protective agents|mesh-ancestor
6552534|NCT00904202|Lidocaine|lidocaine|mesh-list
6552535|NCT00904202|Gabapentin|gabapentin|mesh-list
6552536|NCT00904202|Anesthetics, Local|anesthetics, local|mesh-ancestor
6552537|NCT00904202|Anesthetics|anesthetics|mesh-ancestor
6552538|NCT00904202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6552539|NCT00904202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552540|NCT00904202|Sensory System Agents|sensory system agents|mesh-ancestor
6552541|NCT00904202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6552542|NCT00904202|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6552543|NCT00904202|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6552544|NCT00904202|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6552545|NCT00904202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6552546|NCT00904202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552547|NCT00904202|Analgesics|analgesics|mesh-ancestor
6552548|NCT00904202|Anticonvulsants|anticonvulsants|mesh-ancestor
6552549|NCT00904202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6552550|NCT00904202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6552551|NCT00904202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6552552|NCT00904202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6552553|NCT00904202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6552554|NCT00904202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6552555|NCT00904202|Antimanic Agents|antimanic agents|mesh-ancestor
6552556|NCT00904280|Oxymorphone|oxymorphone|mesh-list
6552557|NCT00904280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6552558|NCT00904280|Narcotics|narcotics|mesh-ancestor
6552559|NCT00904280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6552560|NCT00904280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552561|NCT00904280|Analgesics|analgesics|mesh-ancestor
6552562|NCT00904280|Sensory System Agents|sensory system agents|mesh-ancestor
6552563|NCT00904280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6552564|NCT00904280|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6552565|NCT00904293|Warfarin|warfarin|mesh-list
6552566|NCT00904293|Anticoagulants|anticoagulants|mesh-ancestor
6552567|NCT00904306|Chromium|chromium|mesh-list
6552568|NCT00904306|Picolinic acid|picolinic acid|mesh-list
6552569|NCT00904306|Trace Elements|trace elements|mesh-ancestor
6552570|NCT00904306|Micronutrients|micronutrients|mesh-ancestor
6552571|NCT00904306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552572|NCT00904306|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6552573|NCT00904306|Chelating Agents|chelating agents|mesh-ancestor
6552574|NCT00904306|Sequestering Agents|sequestering agents|mesh-ancestor
6552575|NCT00904306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552576|NCT00904397|Celecoxib|celecoxib|mesh-list
6552577|NCT00904397|Lidocaine|lidocaine|mesh-list
6443052|NCT00378144|Respiratory System Agents|respiratory system agents|mesh-ancestor
6443053|NCT00378144|Nasal Decongestants|nasal decongestants|mesh-ancestor
6443054|NCT00378144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6443055|NCT00378144|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6443056|NCT00378144|Sympathomimetics|sympathomimetics|mesh-ancestor
6443057|NCT00378144|Adrenergic Agents|adrenergic agents|mesh-ancestor
6443058|NCT00378144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6443059|NCT00378144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443060|NCT00378183|Risperidone|risperidone|mesh-list
6443061|NCT00378183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6443062|NCT00378183|Serotonin Agents|serotonin agents|mesh-ancestor
6443063|NCT00378183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6552578|NCT00904397|Anesthetics, Local|anesthetics, local|mesh-ancestor
6552579|NCT00904397|Anesthetics|anesthetics|mesh-ancestor
6552580|NCT00904397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6552581|NCT00904397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552582|NCT00904397|Sensory System Agents|sensory system agents|mesh-ancestor
6552583|NCT00904397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6552584|NCT00904397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6552585|NCT00904397|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6552586|NCT00904397|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6552587|NCT00904397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6552588|NCT00904397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552589|NCT00904397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6552590|NCT00904397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6552591|NCT00904397|Analgesics|analgesics|mesh-ancestor
6552592|NCT00904397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6552593|NCT00904397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6552594|NCT00904397|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6552595|NCT00904397|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6552596|NCT00904397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6552597|NCT00904436|Ipratropium|ipratropium|mesh-list
6552598|NCT00904436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6552599|NCT00904436|Autonomic Agents|autonomic agents|mesh-ancestor
6552600|NCT00904436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6552601|NCT00904436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552602|NCT00904436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6552603|NCT00904436|Respiratory System Agents|respiratory system agents|mesh-ancestor
6552604|NCT00904436|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6552605|NCT00904436|Cholinergic Agents|cholinergic agents|mesh-ancestor
6552606|NCT00904436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6552607|NCT00904436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552608|NCT00904449|Oxymorphone|oxymorphone|mesh-list
6552609|NCT00904449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6552610|NCT00904449|Narcotics|narcotics|mesh-ancestor
6552611|NCT00904449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6552612|NCT00904449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552613|NCT00904449|Analgesics|analgesics|mesh-ancestor
6552614|NCT00904449|Sensory System Agents|sensory system agents|mesh-ancestor
6552615|NCT00904449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6552616|NCT00904449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6552617|NCT00904462|Lidocaine|lidocaine|mesh-list
6552618|NCT00904462|Anesthetics, Local|anesthetics, local|mesh-ancestor
6552619|NCT00904462|Anesthetics|anesthetics|mesh-ancestor
6552620|NCT00904462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6552621|NCT00904462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552622|NCT00904462|Sensory System Agents|sensory system agents|mesh-ancestor
6552623|NCT00904462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6552624|NCT00904462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6552625|NCT00904462|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6552626|NCT00904462|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6443064|NCT00378183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443065|NCT00378183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443066|NCT00378183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6443067|NCT00378183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6443068|NCT00378183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6443069|NCT00378183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6552627|NCT00904462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6552628|NCT00904462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552629|NCT00904475|Lidocaine|lidocaine|mesh-list
6443070|NCT00378183|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6443071|NCT00378183|Dopamine Agents|dopamine agents|mesh-ancestor
6443072|NCT00378196|Ranibizumab|ranibizumab|mesh-list
6552630|NCT00904475|Anesthetics, Local|anesthetics, local|mesh-ancestor
6552631|NCT00904475|Anesthetics|anesthetics|mesh-ancestor
6552632|NCT00904475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6552633|NCT00904475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552634|NCT00904475|Sensory System Agents|sensory system agents|mesh-ancestor
6552635|NCT00904475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6552636|NCT00904475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6552637|NCT00904475|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6552638|NCT00904475|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6552639|NCT00904475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6443073|NCT00378196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6552640|NCT00904475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552641|NCT00904540|Lidocaine|lidocaine|mesh-list
6552642|NCT00904540|Anesthetics, Local|anesthetics, local|mesh-ancestor
6552643|NCT00904540|Anesthetics|anesthetics|mesh-ancestor
6552644|NCT00904540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6552645|NCT00904540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552646|NCT00904540|Sensory System Agents|sensory system agents|mesh-ancestor
6552647|NCT00904540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6552648|NCT00904540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6552649|NCT00904540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6552650|NCT00904540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6552651|NCT00904540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6552652|NCT00904540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552653|NCT00904605|Celecoxib|celecoxib|mesh-list
6552654|NCT00904605|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6552655|NCT00904605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6552656|NCT00904605|Analgesics|analgesics|mesh-ancestor
6552657|NCT00904605|Sensory System Agents|sensory system agents|mesh-ancestor
6552658|NCT00904605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6552659|NCT00904605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552660|NCT00904605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6552661|NCT00904605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6552662|NCT00904605|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6552663|NCT00904605|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6552664|NCT00904605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6552665|NCT00904605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552666|NCT00904631|Salicylic Acid|salicylic acid|mesh-list
6552667|NCT00904631|Salicylates|salicylates|mesh-list
6552668|NCT00904631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6552669|NCT00904631|Antifungal Agents|antifungal agents|mesh-ancestor
6552670|NCT00904631|Keratolytic Agents|keratolytic agents|mesh-ancestor
6552671|NCT00904631|Dermatologic Agents|dermatologic agents|mesh-ancestor
6552672|NCT00904631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6552673|NCT00904631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6552674|NCT00904631|Analgesics|analgesics|mesh-ancestor
6552675|NCT00904631|Sensory System Agents|sensory system agents|mesh-ancestor
6552676|NCT00904631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6552677|NCT00904631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552678|NCT00904631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6552679|NCT00904631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6552680|NCT00904631|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6552681|NCT00904631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6552682|NCT00904631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552683|NCT00904644|Raltegravir Potassium|raltegravir potassium|mesh-list
6552684|NCT00904644|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6552685|NCT00904644|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6552686|NCT00904644|Antiviral Agents|antiviral agents|mesh-ancestor
6552687|NCT00904644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6552688|NCT00904644|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6552689|NCT00904644|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6552690|NCT00904644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6552691|NCT00904644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552692|NCT00904657|Sunitinib|sunitinib|mesh-list
6552693|NCT00904657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6552694|NCT00904657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6552695|NCT00904657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6552696|NCT00904657|Growth Substances|growth substances|mesh-ancestor
6552697|NCT00904657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552698|NCT00904657|Growth Inhibitors|growth inhibitors|mesh-ancestor
6552699|NCT00904657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6552700|NCT00904657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6552701|NCT00904657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552702|NCT00904709|Tranexamic Acid|tranexamic acid|mesh-list
6552703|NCT00904709|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6552704|NCT00904709|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6552705|NCT00904709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552706|NCT00904709|Hemostatics|hemostatics|mesh-ancestor
6552707|NCT00904709|Coagulants|coagulants|mesh-ancestor
6552708|NCT00904735|Imatinib Mesylate|imatinib mesylate|mesh-list
6552709|NCT00904735|Hydroxyurea|hydroxyurea|mesh-list
6552710|NCT00904735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6552711|NCT00904735|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6552712|NCT00904735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6552713|NCT00904735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552714|NCT00904735|Antisickling Agents|antisickling agents|mesh-ancestor
6552715|NCT00904735|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6552716|NCT00904852|Bevacizumab|bevacizumab|mesh-list
6552717|NCT00904852|Temozolomide|temozolomide|mesh-list
6552718|NCT00904852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6552719|NCT00904852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6552720|NCT00904852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6552721|NCT00904852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6552722|NCT00904852|Growth Substances|growth substances|mesh-ancestor
6552723|NCT00904852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552724|NCT00904852|Growth Inhibitors|growth inhibitors|mesh-ancestor
6552725|NCT00904852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6552726|NCT00904852|Alkylating Agents|alkylating agents|mesh-ancestor
6552727|NCT00904852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552728|NCT00904904|Ketorolac|ketorolac|mesh-list
6552729|NCT00904904|Indomethacin|indomethacin|mesh-list
6552730|NCT00904904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6552731|NCT00904904|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6552732|NCT00904904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6552733|NCT00904904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6552734|NCT00904904|Analgesics|analgesics|mesh-ancestor
6552735|NCT00904904|Sensory System Agents|sensory system agents|mesh-ancestor
6552736|NCT00904904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6552737|NCT00904904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552738|NCT00904904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6552739|NCT00904904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6552740|NCT00904904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6552741|NCT00904904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6552742|NCT00904904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552743|NCT00904904|Gout Suppressants|gout suppressants|mesh-ancestor
6552744|NCT00904904|Tocolytic Agents|tocolytic agents|mesh-ancestor
6552745|NCT00904904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6552746|NCT00905047|Leucovorin|leucovorin|mesh-list
6552747|NCT00905047|Folic Acid|folic acid|mesh-list
6552748|NCT00905047|Tegafur|tegafur|mesh-list
6552749|NCT00905047|Levoleucovorin|levoleucovorin|mesh-list
6552750|NCT00905047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6552751|NCT00905047|Antimetabolites|antimetabolites|mesh-ancestor
6552752|NCT00905047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552753|NCT00905047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6552754|NCT00905047|Antidotes|antidotes|mesh-ancestor
6552755|NCT00905047|Protective Agents|protective agents|mesh-ancestor
6552756|NCT00905047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552757|NCT00905047|Vitamin B Complex|vitamin b complex|mesh-ancestor
6552758|NCT00905047|Vitamins|vitamins|mesh-ancestor
6552759|NCT00905047|Micronutrients|micronutrients|mesh-ancestor
6552760|NCT00905047|Hematinics|hematinics|mesh-ancestor
6552761|NCT00905073|Cyclosporine|cyclosporine|mesh-list
6552762|NCT00905073|Methotrexate|methotrexate|mesh-list
6552763|NCT00905073|Cyclosporins|cyclosporins|mesh-list
6552764|NCT00905073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6552765|NCT00905073|Abortifacient Agents|abortifacient agents|mesh-ancestor
6552766|NCT00905073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6552767|NCT00905073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552768|NCT00905073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6552769|NCT00905073|Antimetabolites|antimetabolites|mesh-ancestor
6552770|NCT00905073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552771|NCT00905073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6552772|NCT00905073|Dermatologic Agents|dermatologic agents|mesh-ancestor
6552773|NCT00905073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6552774|NCT00905073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6552775|NCT00905073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6552776|NCT00905073|Immunologic Factors|immunologic factors|mesh-ancestor
6552777|NCT00905073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6552778|NCT00905073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6552779|NCT00905073|Antifungal Agents|antifungal agents|mesh-ancestor
6552780|NCT00905073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6552781|NCT00905073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6552782|NCT00905190|Ondansetron|ondansetron|mesh-list
6552783|NCT00905190|Antiemetics|antiemetics|mesh-ancestor
6552784|NCT00905190|Autonomic Agents|autonomic agents|mesh-ancestor
6552785|NCT00905190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6552786|NCT00905190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552787|NCT00905190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6552788|NCT00905190|Antipruritics|antipruritics|mesh-ancestor
6552789|NCT00905190|Dermatologic Agents|dermatologic agents|mesh-ancestor
6552790|NCT00905190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6552791|NCT00905190|Serotonin Agents|serotonin agents|mesh-ancestor
6552792|NCT00905190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6552793|NCT00905190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552794|NCT00905190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6552795|NCT00905190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6552796|NCT00905190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6552797|NCT00905190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6552798|NCT00905190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6656350|NCT01468740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6656351|NCT01468740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6656352|NCT01468740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6656353|NCT01468740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6656354|NCT01468740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6656355|NCT01468740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6656356|NCT01468740|Glucocorticoids|glucocorticoids|mesh-ancestor
6656357|NCT01468740|Hormones|hormones|mesh-ancestor
6656358|NCT01468740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6656359|NCT01468740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6656360|NCT01468740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6656361|NCT01468740|Tubulin Modulators|tubulin modulators|mesh-ancestor
6656362|NCT01468740|Antimitotic Agents|antimitotic agents|mesh-ancestor
6656363|NCT01468740|Mitosis Modulators|mitosis modulators|mesh-ancestor
6656364|NCT01469143|Insulin|insulin|mesh-list
6656365|NCT01469143|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6656366|NCT01469143|Insulin Aspart|insulin aspart|mesh-list
6656367|NCT01469143|Insulin, Long-Acting|insulin, long-acting|mesh-list
6656368|NCT01469143|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6552799|NCT00905216|Heparin|heparin|mesh-list
6552800|NCT00905216|Calcium heparin|calcium heparin|mesh-list
6552801|NCT00905216|Anticoagulants|anticoagulants|mesh-ancestor
6552802|NCT00905216|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6552803|NCT00905216|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6552804|NCT00905216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552805|NCT00905229|Vitamins|vitamins|mesh-list
6552806|NCT00905229|Vitamin K|vitamin k|mesh-list
6552807|NCT00905229|Vitamin K 1|vitamin k 1|mesh-list
6552808|NCT00905229|Micronutrients|micronutrients|mesh-ancestor
6552809|NCT00905229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552810|NCT00905229|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6552811|NCT00905229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6552812|NCT00905229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552813|NCT00905229|Hemostatics|hemostatics|mesh-ancestor
6552814|NCT00905229|Coagulants|coagulants|mesh-ancestor
6552815|NCT00905333|Felodipine|felodipine|mesh-list
6552816|NCT00905333|Candesartan|candesartan|mesh-list
6552817|NCT00905333|Candesartan cilexetil|candesartan cilexetil|mesh-list
6552818|NCT00905333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6552819|NCT00905333|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6552820|NCT00905333|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6552821|NCT00905333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552822|NCT00905333|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6552823|NCT00905333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6552824|NCT00905333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6552825|NCT00905333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6552826|NCT00905333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552827|NCT00905333|Vasodilator Agents|vasodilator agents|mesh-ancestor
6552828|NCT00905502|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6552829|NCT00905528|Telmisartan|telmisartan|mesh-list
6552830|NCT00905528|Ramipril|ramipril|mesh-list
6552831|NCT00905528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6552832|NCT00905528|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6552833|NCT00905528|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6552834|NCT00905528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552835|NCT00905528|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6552836|NCT00905528|Protease Inhibitors|protease inhibitors|mesh-ancestor
6552837|NCT00905528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6552838|NCT00905541|Simvastatin|simvastatin|mesh-list
6552839|NCT00905541|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6552840|NCT00905541|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6552841|NCT00905541|Antimetabolites|antimetabolites|mesh-ancestor
6552842|NCT00905541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552843|NCT00905541|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6552844|NCT00905541|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6552845|NCT00905541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6552846|NCT00905684|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
6552847|NCT00905684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6552848|NCT00905684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552849|NCT00905723|Estradiol|estradiol|mesh-list
6552850|NCT00905723|Estrogens|estrogens|mesh-ancestor
6552851|NCT00905723|Hormones|hormones|mesh-ancestor
6552852|NCT00905723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6552853|NCT00905723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552854|NCT00905762|Moxifloxacin|moxifloxacin|mesh-list
6552855|NCT00905762|Gatifloxacin|gatifloxacin|mesh-list
6552856|NCT00905762|Besifloxacin|besifloxacin|mesh-list
6552857|NCT00905762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6552858|NCT00905762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6552859|NCT00905762|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6552860|NCT00905762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6552861|NCT00905762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6552862|NCT00905762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552863|NCT00905762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6552864|NCT00905762|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6552865|NCT00905762|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6552866|NCT00905814|Axitinib|axitinib|mesh-list
6552867|NCT00905814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6552868|NCT00905814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6552869|NCT00905814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6552870|NCT00905814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552871|NCT00905853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
6552872|NCT00905853|Amiodarone|amiodarone|mesh-list
6552873|NCT00905853|Vasodilator Agents|vasodilator agents|mesh-ancestor
6552874|NCT00905853|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6552875|NCT00905853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6552876|NCT00905853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552877|NCT00905853|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6552878|NCT00905853|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6552879|NCT00905853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6552880|NCT00905853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6552881|NCT00905853|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6552882|NCT00905853|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6552883|NCT00905853|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6552884|NCT00905905|Simvastatin|simvastatin|mesh-list
6552885|NCT00905905|Ezetimibe|ezetimibe|mesh-list
6552886|NCT00905905|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
6552887|NCT00905905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6552888|NCT00905905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6552889|NCT00905905|Antimetabolites|antimetabolites|mesh-ancestor
6552890|NCT00905905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552891|NCT00905905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6552892|NCT00905905|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6552893|NCT00905905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6552894|NCT00905918|Vitamin E|vitamin e|mesh-list
6552895|NCT00905918|Vitamins|vitamins|mesh-ancestor
6552896|NCT00905918|Micronutrients|micronutrients|mesh-ancestor
6552897|NCT00905918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552898|NCT00905918|Antioxidants|antioxidants|mesh-ancestor
6552899|NCT00905918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552900|NCT00905918|Protective Agents|protective agents|mesh-ancestor
6552901|NCT00905931|Lycopene|lycopene|mesh-list
6552902|NCT00905931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6552903|NCT00905931|Antioxidants|antioxidants|mesh-ancestor
6552904|NCT00905931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552905|NCT00905931|Protective Agents|protective agents|mesh-ancestor
6552906|NCT00905931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552907|NCT00905931|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6552908|NCT00905931|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6552909|NCT00905931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6552910|NCT00905983|Gemcitabine|gemcitabine|mesh-list
6552911|NCT00905983|Docetaxel|docetaxel|mesh-list
6552912|NCT00905983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6443074|NCT00378196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6443075|NCT00378196|Growth Substances|growth substances|mesh-ancestor
6552913|NCT00905983|Antimetabolites|antimetabolites|mesh-ancestor
6552914|NCT00905983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552915|NCT00905983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6552916|NCT00905983|Antiviral Agents|antiviral agents|mesh-ancestor
6552917|NCT00905983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6552918|NCT00905983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6552919|NCT00905983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6552920|NCT00905983|Immunologic Factors|immunologic factors|mesh-ancestor
6552921|NCT00905983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552922|NCT00905983|Tubulin Modulators|tubulin modulators|mesh-ancestor
6552923|NCT00905983|Antimitotic Agents|antimitotic agents|mesh-ancestor
6552924|NCT00905983|Mitosis Modulators|mitosis modulators|mesh-ancestor
6552925|NCT00905996|Propranolol|propranolol|mesh-list
6552926|NCT00905996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
6552927|NCT00905996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6552928|NCT00905996|Adrenergic Agents|adrenergic agents|mesh-ancestor
6552929|NCT00905996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6552930|NCT00905996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552931|NCT00905996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552932|NCT00905996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6552933|NCT00905996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6552934|NCT00905996|Vasodilator Agents|vasodilator agents|mesh-ancestor
6552935|NCT00906048|Levofloxacin|levofloxacin|mesh-list
6552936|NCT00906048|Ofloxacin|ofloxacin|mesh-list
6552937|NCT00906048|Rifampin|rifampin|mesh-list
6552938|NCT00906048|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6552939|NCT00906048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6552940|NCT00906048|Renal Agents|renal agents|mesh-ancestor
6552941|NCT00906048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6552942|NCT00906048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6552943|NCT00906048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6552944|NCT00906048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6552945|NCT00906048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552946|NCT00906048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6552947|NCT00906048|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6552948|NCT00906048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6552949|NCT00906048|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6552950|NCT00906048|Antitubercular Agents|antitubercular agents|mesh-ancestor
6552951|NCT00906048|Leprostatic Agents|leprostatic agents|mesh-ancestor
6552952|NCT00906048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6552953|NCT00906048|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6552954|NCT00906048|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6552955|NCT00906048|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6552956|NCT00906048|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6552957|NCT00906048|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6552958|NCT00906048|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6552959|NCT00906061|Gemcitabine|gemcitabine|mesh-list
6552960|NCT00906061|Docetaxel|docetaxel|mesh-list
6552961|NCT00906061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6552962|NCT00906061|Antimetabolites|antimetabolites|mesh-ancestor
6552963|NCT00906061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552964|NCT00906061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6552965|NCT00906061|Antiviral Agents|antiviral agents|mesh-ancestor
6552966|NCT00906061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6552967|NCT00906061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6552968|NCT00906061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6552969|NCT00906061|Immunologic Factors|immunologic factors|mesh-ancestor
6552970|NCT00906061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552971|NCT00906061|Tubulin Modulators|tubulin modulators|mesh-ancestor
6552972|NCT00906061|Antimitotic Agents|antimitotic agents|mesh-ancestor
6552973|NCT00906061|Mitosis Modulators|mitosis modulators|mesh-ancestor
6443076|NCT00378196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443077|NCT00378196|Growth Inhibitors|growth inhibitors|mesh-ancestor
6443078|NCT00378196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6443079|NCT00378287|Rabeprazole|rabeprazole|mesh-list
6443080|NCT00378287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6443081|NCT00378287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6552974|NCT00906113|Melphalan|melphalan|mesh-list
6552975|NCT00906113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6552976|NCT00906113|Alkylating Agents|alkylating agents|mesh-ancestor
6656369|NCT01469143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6552977|NCT00906113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6552978|NCT00906113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6552979|NCT00906113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6552980|NCT00906113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6552981|NCT00906113|Immunologic Factors|immunologic factors|mesh-ancestor
6552982|NCT00906113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552983|NCT00906126|Misoprostol|misoprostol|mesh-list
6552984|NCT00906126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6552985|NCT00906126|Abortifacient Agents|abortifacient agents|mesh-ancestor
6552986|NCT00906126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6552987|NCT00906126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552988|NCT00906126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6552989|NCT00906126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6552990|NCT00906126|Oxytocics|oxytocics|mesh-ancestor
6552991|NCT00906139|Fentanyl|fentanyl|mesh-list
6552992|NCT00906139|Midazolam|midazolam|mesh-list
6552993|NCT00906139|Propofol|propofol|mesh-list
6552994|NCT00906139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6552995|NCT00906139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6552996|NCT00906139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6552997|NCT00906139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6552998|NCT00906139|Anesthetics, General|anesthetics, general|mesh-ancestor
6552999|NCT00906139|Anesthetics|anesthetics|mesh-ancestor
6553000|NCT00906139|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6553001|NCT00906139|Narcotics|narcotics|mesh-ancestor
6553002|NCT00906139|Analgesics|analgesics|mesh-ancestor
6553003|NCT00906139|Sensory System Agents|sensory system agents|mesh-ancestor
6553004|NCT00906139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6553005|NCT00906139|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6553006|NCT00906139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6553007|NCT00906139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6553008|NCT00906139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6553009|NCT00906139|GABA Modulators|gaba modulators|mesh-ancestor
6553010|NCT00906139|GABA Agents|gaba agents|mesh-ancestor
6553011|NCT00906139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6553012|NCT00906139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553013|NCT00906269|Sildenafil Citrate|sildenafil citrate|mesh-list
6553014|NCT00906269|Vasodilator Agents|vasodilator agents|mesh-ancestor
6553015|NCT00906269|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6553016|NCT00906269|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6553017|NCT00906269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6553018|NCT00906269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553019|NCT00906269|Urological Agents|urological agents|mesh-ancestor
6553020|NCT00906360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6553021|NCT00906360|Cetuximab|cetuximab|mesh-list
6553022|NCT00906360|Sunitinib|sunitinib|mesh-list
6553023|NCT00906360|Antibodies|antibodies|mesh-list
6553024|NCT00906360|Immunoglobulins|immunoglobulins|mesh-list
6553025|NCT00906360|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6553026|NCT00906360|Immunologic Factors|immunologic factors|mesh-ancestor
6553027|NCT00906360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553028|NCT00906360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6553029|NCT00906360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6553030|NCT00906360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6553031|NCT00906360|Growth Substances|growth substances|mesh-ancestor
6553032|NCT00906360|Growth Inhibitors|growth inhibitors|mesh-ancestor
6553033|NCT00906360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6553034|NCT00906360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6553035|NCT00906360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553036|NCT00906386|Varenicline|varenicline|mesh-list
6553037|NCT00906386|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6553038|NCT00906386|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6553039|NCT00906386|Cholinergic Agents|cholinergic agents|mesh-ancestor
6553040|NCT00906386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6553041|NCT00906386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553042|NCT00906386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553043|NCT00906451|Simvastatin|simvastatin|mesh-list
6553044|NCT00906451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6553045|NCT00906451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6553046|NCT00906451|Antimetabolites|antimetabolites|mesh-ancestor
6553047|NCT00906451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553048|NCT00906451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6553049|NCT00906451|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6553050|NCT00906451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6553051|NCT00906516|Bevacizumab|bevacizumab|mesh-list
6553052|NCT00906516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6553053|NCT00906516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6553054|NCT00906516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6553055|NCT00906516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6553056|NCT00906516|Growth Substances|growth substances|mesh-ancestor
6553057|NCT00906516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553058|NCT00906516|Growth Inhibitors|growth inhibitors|mesh-ancestor
6553059|NCT00906529|Insulin Aspart|insulin aspart|mesh-list
6553060|NCT00906529|Insulin Detemir|insulin detemir|mesh-list
6553061|NCT00906529|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6553062|NCT00906529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553063|NCT00906594|Latanoprost|latanoprost|mesh-list
6553064|NCT00906594|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6553065|NCT00906594|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6553066|NCT00906685|Bevacizumab|bevacizumab|mesh-list
6553067|NCT00906685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6553068|NCT00906685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6553069|NCT00906685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6553070|NCT00906685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6553071|NCT00906685|Growth Substances|growth substances|mesh-ancestor
6553072|NCT00906685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553073|NCT00906685|Growth Inhibitors|growth inhibitors|mesh-ancestor
6553074|NCT00906724|Insulin|insulin|mesh-list
6553075|NCT00906724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6553076|NCT00906724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553077|NCT00906828|Levodopa|levodopa|mesh-list
6553078|NCT00906828|Carbidopa|carbidopa|mesh-list
6553079|NCT00906828|Entacapone|entacapone|mesh-list
6553080|NCT00906828|Tolcapone|tolcapone|mesh-list
6553081|NCT00906828|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6553082|NCT00906828|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6553083|NCT00906828|Dopamine Agents|dopamine agents|mesh-ancestor
6553084|NCT00906828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6553085|NCT00906828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553086|NCT00906828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553087|NCT00906828|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6553088|NCT00906828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6553089|NCT00906828|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6553090|NCT00906867|Methacholine Chloride|methacholine chloride|mesh-list
6553091|NCT00906867|Miotics|miotics|mesh-ancestor
6553092|NCT00906867|Autonomic Agents|autonomic agents|mesh-ancestor
6553093|NCT00906867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6553094|NCT00906867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553095|NCT00906867|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6553096|NCT00906867|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
6553097|NCT00906867|Respiratory System Agents|respiratory system agents|mesh-ancestor
6553098|NCT00906867|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6553099|NCT00906867|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6553100|NCT00906867|Cholinergic Agents|cholinergic agents|mesh-ancestor
6553101|NCT00906867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6553102|NCT00906867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553103|NCT00906880|Eflornithine|eflornithine|mesh-list
6553104|NCT00906880|Nifurtimox|nifurtimox|mesh-list
6553105|NCT00906880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6553106|NCT00906880|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6553107|NCT00906880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6553108|NCT00906880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6553109|NCT00906880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6553110|NCT00906880|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
6553111|NCT00906880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6553112|NCT00906880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656370|NCT01469143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656371|NCT01469156|Ranibizumab|ranibizumab|mesh-list
6656372|NCT01469156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6656373|NCT01469156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6656374|NCT01469156|Growth Substances|growth substances|mesh-ancestor
6656375|NCT01469156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656376|NCT01469156|Growth Inhibitors|growth inhibitors|mesh-ancestor
6656377|NCT01469156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6656378|NCT01469169|Iloprost|iloprost|mesh-list
6656379|NCT01469169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6656380|NCT01469169|Vasodilator Agents|vasodilator agents|mesh-ancestor
6656381|NCT01469338|Prednisone|prednisone|mesh-list
6656382|NCT01469338|Octreotide|octreotide|mesh-list
6656383|NCT01469338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6656384|NCT01469338|Glucocorticoids|glucocorticoids|mesh-ancestor
6656385|NCT01469338|Hormones|hormones|mesh-ancestor
6656386|NCT01469338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6443082|NCT00378287|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6443083|NCT00378287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6443084|NCT00378287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443085|NCT00378313|Gemcitabine|gemcitabine|mesh-list
6443086|NCT00378313|Paclitaxel|paclitaxel|mesh-list
6656387|NCT01469338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656388|NCT01469338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6656389|NCT01469338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6656390|NCT01469338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6656391|NCT01469351|Liraglutide|liraglutide|mesh-list
6656392|NCT01469351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6656393|NCT01469351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656394|NCT01469351|Incretins|incretins|mesh-ancestor
6656395|NCT01469351|Hormones|hormones|mesh-ancestor
6656396|NCT01469351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6656397|NCT01469416|Clopidogrel|clopidogrel|mesh-list
6656398|NCT01469416|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6656399|NCT01469416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6656400|NCT01469416|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6656401|NCT01469416|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6656402|NCT01469416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6656403|NCT01469416|Purinergic Agents|purinergic agents|mesh-ancestor
6656404|NCT01469416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6656405|NCT01469416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656406|NCT01469416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656407|NCT01469416|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6656408|NCT01469416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6656409|NCT01469416|Antimetabolites|antimetabolites|mesh-ancestor
6656410|NCT01469416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6656411|NCT01469416|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6656412|NCT01469416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6656413|NCT01469468|Simvastatin|simvastatin|mesh-list
6656414|NCT01469468|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6656415|NCT01469468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6656416|NCT01469468|Antimetabolites|antimetabolites|mesh-ancestor
6656417|NCT01469468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656418|NCT01469468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6656419|NCT01469468|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6656420|NCT01469468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6656421|NCT01469481|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
6656422|NCT01469481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6443087|NCT00378313|Epirubicin|epirubicin|mesh-list
6443088|NCT00378313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6443089|NCT00378313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6443090|NCT00378313|Tubulin Modulators|tubulin modulators|mesh-ancestor
6553113|NCT00907036|Cyclosporine|cyclosporine|mesh-list
6553114|NCT00907036|Fludarabine|fludarabine|mesh-list
6553115|NCT00907036|Fludarabine phosphate|fludarabine phosphate|mesh-list
6553116|NCT00907036|Melphalan|melphalan|mesh-list
6553117|NCT00907036|Alemtuzumab|alemtuzumab|mesh-list
6553118|NCT00907036|Cyclosporins|cyclosporins|mesh-list
6553119|NCT00907036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6553120|NCT00907036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6553121|NCT00907036|Antimetabolites|antimetabolites|mesh-ancestor
6553122|NCT00907036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553123|NCT00907036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6553124|NCT00907036|Immunologic Factors|immunologic factors|mesh-ancestor
6553125|NCT00907036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553126|NCT00907036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6553127|NCT00907036|Antifungal Agents|antifungal agents|mesh-ancestor
6553128|NCT00907036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6553129|NCT00907036|Dermatologic Agents|dermatologic agents|mesh-ancestor
6553130|NCT00907036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6553131|NCT00907036|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6553132|NCT00907036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6553133|NCT00907036|Alkylating Agents|alkylating agents|mesh-ancestor
6553134|NCT00907036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6553135|NCT00907036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6553136|NCT00907114|Ketorolac|ketorolac|mesh-list
6553137|NCT00907114|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6553138|NCT00907114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6553139|NCT00907114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6553140|NCT00907114|Analgesics|analgesics|mesh-ancestor
6553141|NCT00907114|Sensory System Agents|sensory system agents|mesh-ancestor
6553142|NCT00907114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6553143|NCT00907114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553144|NCT00907114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6553145|NCT00907114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6553146|NCT00907114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6553147|NCT00907114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6553148|NCT00907114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553149|NCT00907166|Gemcitabine|gemcitabine|mesh-list
6553150|NCT00907166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6553151|NCT00907166|Antimetabolites|antimetabolites|mesh-ancestor
6553152|NCT00907166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553153|NCT00907166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6553154|NCT00907166|Antiviral Agents|antiviral agents|mesh-ancestor
6553155|NCT00907166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6553156|NCT00907166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6553157|NCT00907166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6553158|NCT00907166|Immunologic Factors|immunologic factors|mesh-ancestor
6553159|NCT00907166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553160|NCT00907179|Pemetrexed|pemetrexed|mesh-list
6553161|NCT00907179|Panobinostat|panobinostat|mesh-list
6553162|NCT00907179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6553163|NCT00907179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6553164|NCT00907179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553165|NCT00907179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6553166|NCT00907179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6553167|NCT00907179|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6553168|NCT00907270|Cholecalciferol|cholecalciferol|mesh-list
6553169|NCT00907270|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6553170|NCT00907270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553171|NCT00907270|Vitamins|vitamins|mesh-ancestor
6553172|NCT00907270|Micronutrients|micronutrients|mesh-ancestor
6553173|NCT00907270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6553174|NCT00907283|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6553175|NCT00907283|Deferiprone|deferiprone|mesh-list
6553176|NCT00907283|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6553177|NCT00907283|Chelating Agents|chelating agents|mesh-ancestor
6553178|NCT00907283|Sequestering Agents|sequestering agents|mesh-ancestor
6553179|NCT00907283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553180|NCT00907400|Naproxen|naproxen|mesh-list
6553181|NCT00907400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6553182|NCT00907400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6553183|NCT00907400|Analgesics|analgesics|mesh-ancestor
6553184|NCT00907400|Sensory System Agents|sensory system agents|mesh-ancestor
6553185|NCT00907400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6553186|NCT00907400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553187|NCT00907400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6553188|NCT00907400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6553189|NCT00907400|Gout Suppressants|gout suppressants|mesh-ancestor
6553190|NCT00907400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6553191|NCT00907400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6553192|NCT00907400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553193|NCT00907452|Thalidomide|thalidomide|mesh-list
6553194|NCT00907452|Dexamethasone|dexamethasone|mesh-list
6443091|NCT00378313|Antimitotic Agents|antimitotic agents|mesh-ancestor
6443092|NCT00378313|Mitosis Modulators|mitosis modulators|mesh-ancestor
6443093|NCT00378313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443094|NCT00378313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6443095|NCT00378313|Antimetabolites|antimetabolites|mesh-ancestor
6443096|NCT00378313|Antiviral Agents|antiviral agents|mesh-ancestor
6443097|NCT00378313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6443098|NCT00378313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6553195|NCT00907452|Prednisone|prednisone|mesh-list
6553196|NCT00907452|Lenalidomide|lenalidomide|mesh-list
6553197|NCT00907452|Melphalan|melphalan|mesh-list
6553198|NCT00907452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6553199|NCT00907452|Antiemetics|antiemetics|mesh-ancestor
6553200|NCT00907452|Autonomic Agents|autonomic agents|mesh-ancestor
6553201|NCT00907452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6553202|NCT00907452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553203|NCT00907452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6553204|NCT00907452|Glucocorticoids|glucocorticoids|mesh-ancestor
6553205|NCT00907452|Hormones|hormones|mesh-ancestor
6553206|NCT00907452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6553207|NCT00907452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6553208|NCT00907452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6553209|NCT00907452|Immunologic Factors|immunologic factors|mesh-ancestor
6443099|NCT00378313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6443100|NCT00378313|Immunologic Factors|immunologic factors|mesh-ancestor
6443101|NCT00378313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443102|NCT00378313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6443103|NCT00378313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6443104|NCT00378313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6443105|NCT00378365|Arsenic Trioxide|arsenic trioxide|mesh-list
6443106|NCT00378365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6443107|NCT00378404|Docetaxel|docetaxel|mesh-list
6443108|NCT00378404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6443109|NCT00378404|Tubulin Modulators|tubulin modulators|mesh-ancestor
6443110|NCT00378404|Antimitotic Agents|antimitotic agents|mesh-ancestor
6443111|NCT00378404|Mitosis Modulators|mitosis modulators|mesh-ancestor
6443112|NCT00378404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443113|NCT00378417|Vaccines|vaccines|mesh-list
6443114|NCT00378417|Immunologic Factors|immunologic factors|mesh-ancestor
6443115|NCT00378417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443116|NCT00378443|Prednisone|prednisone|mesh-list
6443117|NCT00378443|Losartan|losartan|mesh-list
6443118|NCT00378443|Cilazapril|cilazapril|mesh-list
6443119|NCT00378443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6443120|NCT00378443|Glucocorticoids|glucocorticoids|mesh-ancestor
6443121|NCT00378443|Hormones|hormones|mesh-ancestor
6443122|NCT00378443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6443123|NCT00378443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443124|NCT00378443|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6443125|NCT00378443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6443126|NCT00378443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6443127|NCT00378443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6443128|NCT00378443|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6443129|NCT00378443|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6443130|NCT00378443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443131|NCT00378443|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6443132|NCT00378443|Protease Inhibitors|protease inhibitors|mesh-ancestor
6443133|NCT00378443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6443134|NCT00378456|Vitamins|vitamins|mesh-list
6443135|NCT00378456|Leucovorin|leucovorin|mesh-list
6443136|NCT00378456|Folic Acid|folic acid|mesh-list
6443137|NCT00378456|Vitamin A|vitamin a|mesh-list
6443138|NCT00378456|Zinc|zinc|mesh-list
6443139|NCT00378456|Selenium|selenium|mesh-list
6443140|NCT00378456|Retinol palmitate|retinol palmitate|mesh-list
6443141|NCT00378456|Levoleucovorin|levoleucovorin|mesh-list
6553210|NCT00907452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6553211|NCT00907452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6553212|NCT00907452|Growth Substances|growth substances|mesh-ancestor
6553213|NCT00907452|Growth Inhibitors|growth inhibitors|mesh-ancestor
6553214|NCT00907452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6553215|NCT00907452|Alkylating Agents|alkylating agents|mesh-ancestor
6553216|NCT00907452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553217|NCT00907452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6553218|NCT00907452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6553219|NCT00907452|Leprostatic Agents|leprostatic agents|mesh-ancestor
6553220|NCT00907452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6553221|NCT00907452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6553222|NCT00907504|Gemcitabine|gemcitabine|mesh-list
6553223|NCT00907504|Cisplatin|cisplatin|mesh-list
6553224|NCT00907504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6553225|NCT00907504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6553226|NCT00907504|Antimetabolites|antimetabolites|mesh-ancestor
6553227|NCT00907504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553228|NCT00907504|Antiviral Agents|antiviral agents|mesh-ancestor
6553229|NCT00907504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6553230|NCT00907504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6553231|NCT00907504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6553232|NCT00907504|Immunologic Factors|immunologic factors|mesh-ancestor
6553233|NCT00907504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553234|NCT00907608|Darbepoetin alfa|darbepoetin alfa|mesh-list
6553235|NCT00907608|Hematinics|hematinics|mesh-ancestor
6553236|NCT00907751|Rituximab|rituximab|mesh-list
6553237|NCT00907751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6553238|NCT00907751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6553239|NCT00907751|Immunologic Factors|immunologic factors|mesh-ancestor
6553240|NCT00907751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553241|NCT00907751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6553242|NCT00907764|Regadenoson|regadenoson|mesh-list
6553243|NCT00907764|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
6553244|NCT00907764|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6553245|NCT00907764|Purinergic Agonists|purinergic agonists|mesh-ancestor
6553246|NCT00907764|Purinergic Agents|purinergic agents|mesh-ancestor
6553247|NCT00907764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6553248|NCT00907764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553249|NCT00907764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553250|NCT00907829|Lidocaine|lidocaine|mesh-list
6553251|NCT00907829|Anesthetics, Local|anesthetics, local|mesh-ancestor
6553252|NCT00907829|Anesthetics|anesthetics|mesh-ancestor
6553253|NCT00907829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6553254|NCT00907829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553255|NCT00907829|Sensory System Agents|sensory system agents|mesh-ancestor
6553256|NCT00907829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6553257|NCT00907829|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6553258|NCT00907829|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6553259|NCT00907829|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6553260|NCT00907829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6553261|NCT00907829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553262|NCT00907894|Telbivudine|telbivudine|mesh-list
6553263|NCT00907894|Antiviral Agents|antiviral agents|mesh-ancestor
6553264|NCT00907894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6553265|NCT00907894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6553266|NCT00907894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6553267|NCT00907894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553268|NCT00907972|Vitamin D|vitamin d|mesh-list
6553269|NCT00907972|Ergocalciferols|ergocalciferols|mesh-list
6553270|NCT00907972|Cholecalciferol|cholecalciferol|mesh-list
6553271|NCT00907972|Vitamins|vitamins|mesh-list
6553272|NCT00907972|Micronutrients|micronutrients|mesh-ancestor
6553273|NCT00907972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553274|NCT00907972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6553275|NCT00907972|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6553276|NCT00907985|Lamotrigine|lamotrigine|mesh-list
6553277|NCT00907985|Vofopitant|vofopitant|mesh-list
6553278|NCT00907985|Anticonvulsants|anticonvulsants|mesh-ancestor
6553279|NCT00907985|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6553280|NCT00907985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6553281|NCT00907985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553282|NCT00907985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6553283|NCT00907985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553284|NCT00907985|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6553285|NCT00907985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6553286|NCT00907985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6553287|NCT00907985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6553288|NCT00907985|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6553289|NCT00907985|Antiemetics|antiemetics|mesh-ancestor
6553290|NCT00907985|Autonomic Agents|autonomic agents|mesh-ancestor
6553291|NCT00907985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6553292|NCT00907985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6553293|NCT00907985|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6553294|NCT00907985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6553295|NCT00908024|Cetuximab|cetuximab|mesh-list
6553296|NCT00908024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6553297|NCT00908024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6553298|NCT00908050|Botulinum Toxins|botulinum toxins|mesh-list
6553299|NCT00908050|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6553300|NCT00908050|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6553301|NCT00908050|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6553302|NCT00908050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6553303|NCT00908050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553304|NCT00908050|Cholinergic Agents|cholinergic agents|mesh-ancestor
6553305|NCT00908050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6553306|NCT00908050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553307|NCT00908050|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6553308|NCT00908050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6553309|NCT00908089|Sulfasalazine|sulfasalazine|mesh-list
6553310|NCT00908089|Hydroxychloroquine|hydroxychloroquine|mesh-list
6553311|NCT00908089|Prednisolone|prednisolone|mesh-list
6553312|NCT00908089|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6553313|NCT00908089|Methylprednisolone|methylprednisolone|mesh-list
6553314|NCT00908089|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6553315|NCT00908089|Prednisolone acetate|prednisolone acetate|mesh-list
6443142|NCT00378456|Antioxidants|antioxidants|mesh-list
6443143|NCT00378456|Micronutrients|micronutrients|mesh-ancestor
6443144|NCT00378456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443145|NCT00378456|Trace Elements|trace elements|mesh-ancestor
6443146|NCT00378456|Antidotes|antidotes|mesh-ancestor
6553316|NCT00908089|Infliximab|infliximab|mesh-list
6553317|NCT00908089|Naltrexone|naltrexone|mesh-list
6553318|NCT00908089|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6553319|NCT00908089|Prednisolone phosphate|prednisolone phosphate|mesh-list
6553320|NCT00908089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6553321|NCT00908089|Glucocorticoids|glucocorticoids|mesh-ancestor
6553322|NCT00908089|Hormones|hormones|mesh-ancestor
6553323|NCT00908089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6553324|NCT00908089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553325|NCT00908089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6553326|NCT00908089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6553327|NCT00908089|Antiemetics|antiemetics|mesh-ancestor
6553328|NCT00908089|Autonomic Agents|autonomic agents|mesh-ancestor
6553329|NCT00908089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6553330|NCT00908089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6553331|NCT00908089|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6553332|NCT00908089|Protective Agents|protective agents|mesh-ancestor
6553333|NCT00908089|Dermatologic Agents|dermatologic agents|mesh-ancestor
6553334|NCT00908089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6553335|NCT00908089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6553336|NCT00908089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6553337|NCT00908089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6553338|NCT00908089|Analgesics|analgesics|mesh-ancestor
6553339|NCT00908089|Sensory System Agents|sensory system agents|mesh-ancestor
6553340|NCT00908089|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6553341|NCT00908089|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6553342|NCT00908089|Antimalarials|antimalarials|mesh-ancestor
6553343|NCT00908089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6553344|NCT00908089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6553345|NCT00908089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6553346|NCT00908089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553347|NCT00908167|Cytarabine|cytarabine|mesh-list
6553348|NCT00908167|Clofarabine|clofarabine|mesh-list
6553349|NCT00908167|Sorafenib|sorafenib|mesh-list
6553350|NCT00908167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6553351|NCT00908167|Antimetabolites|antimetabolites|mesh-ancestor
6553352|NCT00908167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553353|NCT00908167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6553354|NCT00908167|Antiviral Agents|antiviral agents|mesh-ancestor
6553355|NCT00908167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6443147|NCT00378456|Protective Agents|protective agents|mesh-ancestor
6443148|NCT00378456|Vitamin B Complex|vitamin b complex|mesh-ancestor
6443149|NCT00378456|Hematinics|hematinics|mesh-ancestor
6443150|NCT00378456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443151|NCT00378456|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6553356|NCT00908167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6553357|NCT00908167|Immunologic Factors|immunologic factors|mesh-ancestor
6553358|NCT00908167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553359|NCT00908167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6553360|NCT00908167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6553361|NCT00908180|Cytarabine|cytarabine|mesh-list
6553362|NCT00908180|Cyclosporine|cyclosporine|mesh-list
6553363|NCT00908180|Etoposide|etoposide|mesh-list
6553364|NCT00908180|Melphalan|melphalan|mesh-list
6553365|NCT00908180|Alemtuzumab|alemtuzumab|mesh-list
6443152|NCT00378456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6443153|NCT00378495|Miltefosine|miltefosine|mesh-list
6443154|NCT00378495|Antifungal Agents|antifungal agents|mesh-ancestor
6443155|NCT00378495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6553366|NCT00908180|Carmustine|carmustine|mesh-list
6553367|NCT00908180|Cyclosporins|cyclosporins|mesh-list
6553368|NCT00908180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6553369|NCT00908180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6553370|NCT00908180|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6553371|NCT00908180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6553372|NCT00908180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6553373|NCT00908180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553374|NCT00908180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6553375|NCT00908180|Antimetabolites|antimetabolites|mesh-ancestor
6553376|NCT00908180|Antiviral Agents|antiviral agents|mesh-ancestor
6553377|NCT00908180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6553378|NCT00908180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6553379|NCT00908180|Immunologic Factors|immunologic factors|mesh-ancestor
6553380|NCT00908180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553381|NCT00908180|Antifungal Agents|antifungal agents|mesh-ancestor
6443156|NCT00378495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6443157|NCT00378495|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6443158|NCT00378495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6443159|NCT00378547|Acetaminophen|acetaminophen|mesh-list
6443160|NCT00378547|Dexamethasone|dexamethasone|mesh-list
6443161|NCT00378547|Dexamethasone acetate|dexamethasone acetate|mesh-list
6443162|NCT00378547|Pregabalin|pregabalin|mesh-list
6553382|NCT00908180|Dermatologic Agents|dermatologic agents|mesh-ancestor
6553383|NCT00908180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6553384|NCT00908180|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6553385|NCT00908180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6553386|NCT00908180|Alkylating Agents|alkylating agents|mesh-ancestor
6553387|NCT00908180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6553388|NCT00908180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6553389|NCT00908219|Bevacizumab|bevacizumab|mesh-list
6553390|NCT00908219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6553391|NCT00908219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6553392|NCT00908219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6553393|NCT00908219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6553394|NCT00908219|Growth Substances|growth substances|mesh-ancestor
6553395|NCT00908219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553396|NCT00908219|Growth Inhibitors|growth inhibitors|mesh-ancestor
6553397|NCT00908271|Dapagliflozin|dapagliflozin|mesh-list
6553398|NCT00908271|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6553399|NCT00908271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553400|NCT00908271|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6553401|NCT00908271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553402|NCT00908297|Ubiquinone|ubiquinone|mesh-list
6553403|NCT00908297|Coenzyme Q10|coenzyme q10|mesh-list
6553404|NCT00908297|Micronutrients|micronutrients|mesh-ancestor
6553405|NCT00908297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553406|NCT00908297|Vitamins|vitamins|mesh-ancestor
6553407|NCT00908323|Vaccines|vaccines|mesh-list
6553408|NCT00908323|Immunologic Factors|immunologic factors|mesh-ancestor
6553409|NCT00908323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553410|NCT00908336|Docetaxel|docetaxel|mesh-list
6553411|NCT00908336|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6553412|NCT00908336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6553413|NCT00908336|Tubulin Modulators|tubulin modulators|mesh-ancestor
6443163|NCT00378547|BB 1101|bb 1101|mesh-list
6443164|NCT00378547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6443165|NCT00378547|Antiemetics|antiemetics|mesh-ancestor
6553414|NCT00908336|Antimitotic Agents|antimitotic agents|mesh-ancestor
6443166|NCT00378547|Autonomic Agents|autonomic agents|mesh-ancestor
6443167|NCT00378547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6443168|NCT00378547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443169|NCT00378547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6443170|NCT00378547|Glucocorticoids|glucocorticoids|mesh-ancestor
6443171|NCT00378547|Hormones|hormones|mesh-ancestor
6443172|NCT00378547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6553415|NCT00908336|Mitosis Modulators|mitosis modulators|mesh-ancestor
6553416|NCT00908336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553417|NCT00908336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6553418|NCT00908336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6553419|NCT00908362|Fluticasone|fluticasone|mesh-list
6553420|NCT00908362|Xhance|xhance|mesh-list
6553421|NCT00908362|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6553422|NCT00908362|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6553423|NCT00908362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6553424|NCT00908362|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6553425|NCT00908362|Autonomic Agents|autonomic agents|mesh-ancestor
6553426|NCT00908362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6553427|NCT00908362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553428|NCT00908362|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6553429|NCT00908362|Respiratory System Agents|respiratory system agents|mesh-ancestor
6553430|NCT00908362|Dermatologic Agents|dermatologic agents|mesh-ancestor
6553431|NCT00908362|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6553432|NCT00908362|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6553433|NCT00908362|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6553434|NCT00908362|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6553435|NCT00908362|Adrenergic Agents|adrenergic agents|mesh-ancestor
6553436|NCT00908362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6553437|NCT00908362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553438|NCT00908362|Glucocorticoids|glucocorticoids|mesh-ancestor
6553439|NCT00908362|Hormones|hormones|mesh-ancestor
6553440|NCT00908362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6553441|NCT00908362|Sympathomimetics|sympathomimetics|mesh-ancestor
6553442|NCT00908414|TMC-310911|tmc-310911|mesh-list
6553443|NCT00908414|Protease Inhibitors|protease inhibitors|mesh-ancestor
6553444|NCT00908414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6553445|NCT00908414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553446|NCT00908453|Fosphenytoin|fosphenytoin|mesh-list
6553447|NCT00908453|Anticonvulsants|anticonvulsants|mesh-ancestor
6553448|NCT00908453|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6553449|NCT00908453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6553450|NCT00908453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553451|NCT00908531|Letrozole|letrozole|mesh-list
6553452|NCT00908531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6553453|NCT00908531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6553454|NCT00908531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6553455|NCT00908531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6553456|NCT00908531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553457|NCT00908531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6553458|NCT00908531|Hormone Antagonists|hormone antagonists|mesh-ancestor
6553459|NCT00908531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6553460|NCT00908531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553461|NCT00908661|Cellulose, Oxidized|cellulose, oxidized|mesh-list
6553462|NCT00908661|Hemostatics|hemostatics|mesh-ancestor
6553463|NCT00908661|Coagulants|coagulants|mesh-ancestor
6553464|NCT00908674|Cyproterone Acetate|cyproterone acetate|mesh-list
6553465|NCT00908674|Cyproterone|cyproterone|mesh-list
6553466|NCT00908674|Androgen Antagonists|androgen antagonists|mesh-ancestor
6553467|NCT00908674|Hormone Antagonists|hormone antagonists|mesh-ancestor
6553468|NCT00908674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6553469|NCT00908674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553470|NCT00908674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6443173|NCT00378547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6443174|NCT00378547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6019749|NCT00389441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019750|NCT00389493|Risperidone|risperidone|mesh-list
6019751|NCT00389493|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6019752|NCT00389493|Serotonin Agents|serotonin agents|mesh-ancestor
6019753|NCT00389493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6019754|NCT00389493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019755|NCT00389493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019756|NCT00389493|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6019757|NCT00389493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6443175|NCT00378547|Protease Inhibitors|protease inhibitors|mesh-ancestor
6443176|NCT00378547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6443177|NCT00378547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553471|NCT00908674|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6553472|NCT00908674|Contraceptive Agents|contraceptive agents|mesh-ancestor
6553473|NCT00908674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6553474|NCT00908713|Methylprednisolone|methylprednisolone|mesh-list
6553475|NCT00908713|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6553476|NCT00908713|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6553477|NCT00908713|Prednisolone|prednisolone|mesh-list
6553478|NCT00908713|Prednisolone acetate|prednisolone acetate|mesh-list
6553479|NCT00908713|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6553480|NCT00908713|Prednisolone phosphate|prednisolone phosphate|mesh-list
6553481|NCT00908713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6553482|NCT00908713|Antiemetics|antiemetics|mesh-ancestor
6553483|NCT00908713|Autonomic Agents|autonomic agents|mesh-ancestor
6553484|NCT00908713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6553485|NCT00908713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553486|NCT00908713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6553487|NCT00908713|Glucocorticoids|glucocorticoids|mesh-ancestor
6553488|NCT00908713|Hormones|hormones|mesh-ancestor
6443178|NCT00378547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6443179|NCT00378547|Analgesics|analgesics|mesh-ancestor
6443180|NCT00378547|Sensory System Agents|sensory system agents|mesh-ancestor
6443181|NCT00378547|Antipyretics|antipyretics|mesh-ancestor
6443182|NCT00378547|Anticonvulsants|anticonvulsants|mesh-ancestor
6443183|NCT00378547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6443184|NCT00378547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6443185|NCT00378547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6443186|NCT00378547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6443187|NCT00378547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6443188|NCT00378547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6443189|NCT00378547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6443190|NCT00378612|Sirolimus|sirolimus|mesh-list
6443191|NCT00378612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6443192|NCT00378612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6443193|NCT00378612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6443194|NCT00378612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6443195|NCT00378612|Antifungal Agents|antifungal agents|mesh-ancestor
6443196|NCT00378612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6443197|NCT00378612|Immunologic Factors|immunologic factors|mesh-ancestor
6443198|NCT00378612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443199|NCT00378625|Artesunate|artesunate|mesh-list
6443200|NCT00378625|Antimalarials|antimalarials|mesh-ancestor
6553489|NCT00908713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6553490|NCT00908713|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6553491|NCT00908713|Protective Agents|protective agents|mesh-ancestor
6553492|NCT00908713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6553493|NCT00908713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6553494|NCT00908726|Propofol|propofol|mesh-list
6553495|NCT00908726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6553496|NCT00908726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6553497|NCT00908726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553498|NCT00908726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6553499|NCT00908726|Anesthetics, General|anesthetics, general|mesh-ancestor
6553500|NCT00908726|Anesthetics|anesthetics|mesh-ancestor
6553501|NCT00908817|Chlorhexidine|chlorhexidine|mesh-list
6553502|NCT00908817|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6553503|NCT00908817|Triamcinolone|triamcinolone|mesh-list
6553504|NCT00908817|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6553505|NCT00908817|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6553506|NCT00908817|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6553507|NCT00908817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6553508|NCT00908817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6553509|NCT00908817|Disinfectants|disinfectants|mesh-ancestor
6553510|NCT00908817|Dermatologic Agents|dermatologic agents|mesh-ancestor
6553511|NCT00908817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6553512|NCT00908817|Glucocorticoids|glucocorticoids|mesh-ancestor
6553513|NCT00908817|Hormones|hormones|mesh-ancestor
6553514|NCT00908817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6553515|NCT00908817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553516|NCT00908817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6553517|NCT00908817|Immunologic Factors|immunologic factors|mesh-ancestor
6553518|NCT00908817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6553519|NCT00908817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553520|NCT00908869|Interferons|interferons|mesh-list
6553521|NCT00908869|Interferon-alpha|interferon-alpha|mesh-list
6553522|NCT00908869|Interferon alpha-2|interferon alpha-2|mesh-list
6553523|NCT00908869|Cyclophosphamide|cyclophosphamide|mesh-list
6553524|NCT00908869|Vinorelbine|vinorelbine|mesh-list
6553525|NCT00908869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6553526|NCT00908869|Immunologic Factors|immunologic factors|mesh-ancestor
6553527|NCT00908869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553528|NCT00908869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6553529|NCT00908869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6553530|NCT00908869|Alkylating Agents|alkylating agents|mesh-ancestor
6553531|NCT00908869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553532|NCT00908869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6553533|NCT00908869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6553534|NCT00908869|Antiviral Agents|antiviral agents|mesh-ancestor
6553535|NCT00908869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6553536|NCT00908869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6553537|NCT00908869|Tubulin Modulators|tubulin modulators|mesh-ancestor
6553538|NCT00908869|Antimitotic Agents|antimitotic agents|mesh-ancestor
6553539|NCT00908869|Mitosis Modulators|mitosis modulators|mesh-ancestor
6656423|NCT01469481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656424|NCT01469507|Hyaluronic Acid|hyaluronic acid|mesh-list
6656425|NCT01469507|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6656426|NCT01469507|Immunologic Factors|immunologic factors|mesh-ancestor
6656427|NCT01469507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656428|NCT01469507|Viscosupplements|viscosupplements|mesh-ancestor
6656429|NCT01469507|Protective Agents|protective agents|mesh-ancestor
6656430|NCT01469520|Lamivudine|lamivudine|mesh-list
6656431|NCT01469520|Zidovudine|zidovudine|mesh-list
6656432|NCT01469520|Nevirapine|nevirapine|mesh-list
6553540|NCT00908921|Glimepiride|glimepiride|mesh-list
6553541|NCT00908921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6553542|NCT00908921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6553543|NCT00908921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553544|NCT00908921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6553545|NCT00908921|Immunologic Factors|immunologic factors|mesh-ancestor
6553546|NCT00908986|Rituximab|rituximab|mesh-list
6553547|NCT00908986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6553548|NCT00908986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6553549|NCT00908986|Immunologic Factors|immunologic factors|mesh-ancestor
6553550|NCT00908986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553551|NCT00908986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6553552|NCT00909051|Acarbose|acarbose|mesh-list
6553553|NCT00909051|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6553554|NCT00909051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6553555|NCT00909051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553556|NCT00909051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6553557|NCT00909051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553558|NCT00909077|Dexamethasone|dexamethasone|mesh-list
6553559|NCT00909077|Dexamethasone acetate|dexamethasone acetate|mesh-list
6553560|NCT00909077|Rituximab|rituximab|mesh-list
6553561|NCT00909077|BB 1101|bb 1101|mesh-list
6553562|NCT00909077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6553563|NCT00909077|Antiemetics|antiemetics|mesh-ancestor
6553564|NCT00909077|Autonomic Agents|autonomic agents|mesh-ancestor
6553565|NCT00909077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6553566|NCT00909077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553567|NCT00909077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6553568|NCT00909077|Glucocorticoids|glucocorticoids|mesh-ancestor
6553569|NCT00909077|Hormones|hormones|mesh-ancestor
6553570|NCT00909077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6553571|NCT00909077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6553572|NCT00909077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6553573|NCT00909077|Protease Inhibitors|protease inhibitors|mesh-ancestor
6553574|NCT00909077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6553575|NCT00909077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553576|NCT00909077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6553577|NCT00909077|Immunologic Factors|immunologic factors|mesh-ancestor
6553578|NCT00909077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6553579|NCT00909129|Interferons|interferons|mesh-list
6553580|NCT00909129|Ribavirin|ribavirin|mesh-list
6553581|NCT00909129|Interferon-alpha|interferon-alpha|mesh-list
6553582|NCT00909129|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6553583|NCT00909129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6553584|NCT00909129|Antiviral Agents|antiviral agents|mesh-ancestor
6553585|NCT00909129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6553586|NCT00909129|Antimetabolites|antimetabolites|mesh-ancestor
6553587|NCT00909129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553588|NCT00909129|Immunologic Factors|immunologic factors|mesh-ancestor
6553589|NCT00909129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553590|NCT00909142|Clodronic Acid|clodronic acid|mesh-list
6553591|NCT00909142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6553592|NCT00909142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553593|NCT00909168|Gemtuzumab|gemtuzumab|mesh-list
6553594|NCT00909168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6553595|NCT00909168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6553596|NCT00909233|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6553597|NCT00909233|Vasodilator Agents|vasodilator agents|mesh-ancestor
6553598|NCT00909233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6553599|NCT00909233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6553600|NCT00909233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6553601|NCT00909233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553602|NCT00909233|Urological Agents|urological agents|mesh-ancestor
6553603|NCT00909311|Ritonavir|ritonavir|mesh-list
6553604|NCT00909311|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6553605|NCT00909311|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6553606|NCT00909311|Protease Inhibitors|protease inhibitors|mesh-ancestor
6553607|NCT00909311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6553608|NCT00909311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553609|NCT00909311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6553610|NCT00909311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6553611|NCT00909311|Antiviral Agents|antiviral agents|mesh-ancestor
6553612|NCT00909311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6553613|NCT00909311|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6553614|NCT00909311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6553615|NCT00909337|Bosentan|bosentan|mesh-list
6553616|NCT00909337|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6553617|NCT00909337|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6553618|NCT00909337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553619|NCT00909402|Capecitabine|capecitabine|mesh-list
6553620|NCT00909402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6553621|NCT00909402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6553622|NCT00909402|Antimetabolites|antimetabolites|mesh-ancestor
6553623|NCT00909402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553624|NCT00909454|Vitamin D|vitamin d|mesh-list
6553625|NCT00909454|Ergocalciferols|ergocalciferols|mesh-list
6553626|NCT00909454|Cholecalciferol|cholecalciferol|mesh-list
6553627|NCT00909454|Vitamins|vitamins|mesh-list
6553628|NCT00909454|Micronutrients|micronutrients|mesh-ancestor
6553629|NCT00909454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553630|NCT00909454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6553631|NCT00909454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6553632|NCT00909506|Metformin|metformin|mesh-list
6553633|NCT00909506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6553634|NCT00909506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553635|NCT00909519|Naproxen|naproxen|mesh-list
6553636|NCT00909519|Furosemide|furosemide|mesh-list
6553637|NCT00909519|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
6553638|NCT00909519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6553639|NCT00909519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6553640|NCT00909519|Analgesics|analgesics|mesh-ancestor
6553641|NCT00909519|Sensory System Agents|sensory system agents|mesh-ancestor
6553642|NCT00909519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6553643|NCT00909519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553644|NCT00909519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6553645|NCT00909519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6553646|NCT00909519|Gout Suppressants|gout suppressants|mesh-ancestor
6553647|NCT00909519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6553648|NCT00909519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6553649|NCT00909519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553650|NCT00909519|Diuretics|diuretics|mesh-ancestor
6553651|NCT00909519|Natriuretic Agents|natriuretic agents|mesh-ancestor
6553652|NCT00909519|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6553653|NCT00909519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6553654|NCT00909519|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6553655|NCT00909571|Tacrolimus|tacrolimus|mesh-list
6553656|NCT00909571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6553657|NCT00909571|Immunologic Factors|immunologic factors|mesh-ancestor
6553658|NCT00909571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553659|NCT00909571|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6553660|NCT00909571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6553661|NCT00909571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553662|NCT00909688|BLI-489|bli-489|mesh-list
6553663|NCT00909688|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6553664|NCT00909688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6553665|NCT00909688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553666|NCT00909688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6553667|NCT00909688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6553668|NCT00909831|Hydroxychloroquine|hydroxychloroquine|mesh-list
6553669|NCT00909831|Sirolimus|sirolimus|mesh-list
6553670|NCT00909831|Antimalarials|antimalarials|mesh-ancestor
6553671|NCT00909831|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6553672|NCT00909831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6553673|NCT00909831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6553674|NCT00909831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6553675|NCT00909831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553676|NCT00909831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6553677|NCT00909831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6553678|NCT00909831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6553679|NCT00909831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6553680|NCT00909831|Antifungal Agents|antifungal agents|mesh-ancestor
6553681|NCT00909831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6553682|NCT00909831|Immunologic Factors|immunologic factors|mesh-ancestor
6553683|NCT00909831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553684|NCT00909883|Botulinum Toxins|botulinum toxins|mesh-list
6553685|NCT00909883|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6553686|NCT00909883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6553687|NCT00909883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553688|NCT00909883|Cholinergic Agents|cholinergic agents|mesh-ancestor
6553689|NCT00909883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6553690|NCT00909883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553691|NCT00909935|Dexmedetomidine|dexmedetomidine|mesh-list
6553692|NCT00909935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6553693|NCT00909935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6553694|NCT00909935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553695|NCT00909935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6553696|NCT00909935|Analgesics|analgesics|mesh-ancestor
6553697|NCT00909935|Sensory System Agents|sensory system agents|mesh-ancestor
6553698|NCT00909935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6553699|NCT00909935|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6553700|NCT00909935|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6553701|NCT00909935|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6553702|NCT00909935|Adrenergic Agents|adrenergic agents|mesh-ancestor
6553703|NCT00909935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6553704|NCT00909935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553705|NCT00909948|Fludarabine|fludarabine|mesh-list
6553706|NCT00909948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6553707|NCT00909961|Zoledronic Acid|zoledronic acid|mesh-list
6553708|NCT00909961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6553709|NCT00909961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553710|NCT00909974|Micronutrients|micronutrients|mesh-list
6553711|NCT00909974|Trace Elements|trace elements|mesh-list
6553712|NCT00909974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553713|NCT00909987|Bevacizumab|bevacizumab|mesh-list
6553714|NCT00909987|Capecitabine|capecitabine|mesh-list
6553715|NCT00909987|Oxaliplatin|oxaliplatin|mesh-list
6553716|NCT00909987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6553717|NCT00909987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6553718|NCT00909987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6553719|NCT00909987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6553720|NCT00909987|Growth Substances|growth substances|mesh-ancestor
6553721|NCT00909987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553722|NCT00909987|Growth Inhibitors|growth inhibitors|mesh-ancestor
6553723|NCT00909987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6553724|NCT00909987|Antimetabolites|antimetabolites|mesh-ancestor
6553725|NCT00909987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553726|NCT00910013|Ropivacaine|ropivacaine|mesh-list
6553727|NCT00910013|Anesthetics, Local|anesthetics, local|mesh-ancestor
6553728|NCT00910013|Anesthetics|anesthetics|mesh-ancestor
6553729|NCT00910013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6553730|NCT00910013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553731|NCT00910013|Sensory System Agents|sensory system agents|mesh-ancestor
6553732|NCT00910013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6553733|NCT00910052|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6553734|NCT00910052|Hemostatics|hemostatics|mesh-ancestor
6553735|NCT00910052|Coagulants|coagulants|mesh-ancestor
6553736|NCT00910065|Aspirin|aspirin|mesh-list
6553737|NCT00910065|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
6553738|NCT00910065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6553739|NCT00910065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6553740|NCT00910065|Analgesics|analgesics|mesh-ancestor
6553741|NCT00910065|Sensory System Agents|sensory system agents|mesh-ancestor
6553742|NCT00910065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6553743|NCT00910065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553744|NCT00910065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6553745|NCT00910065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6553746|NCT00910065|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6553747|NCT00910065|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6553748|NCT00910065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553749|NCT00910065|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6553750|NCT00910065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6553751|NCT00910065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6553752|NCT00910065|Antipyretics|antipyretics|mesh-ancestor
6443201|NCT00378625|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6443202|NCT00378625|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6553753|NCT00910117|Nimotuzumab|nimotuzumab|mesh-list
6553754|NCT00910117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6553755|NCT00910117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6553756|NCT00910195|Acetaminophen|acetaminophen|mesh-list
6553757|NCT00910195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6553758|NCT00910195|Analgesics|analgesics|mesh-ancestor
6553759|NCT00910195|Sensory System Agents|sensory system agents|mesh-ancestor
6553760|NCT00910195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6553761|NCT00910195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553762|NCT00910195|Antipyretics|antipyretics|mesh-ancestor
6553763|NCT00910221|Atorvastatin|atorvastatin|mesh-list
6553764|NCT00910221|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6553765|NCT00910221|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6553766|NCT00910221|Antimetabolites|antimetabolites|mesh-ancestor
6553767|NCT00910221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553768|NCT00910221|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6553769|NCT00910221|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6553770|NCT00910221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6553771|NCT00910234|Epoetin Alfa|epoetin alfa|mesh-list
6443203|NCT00378625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6443204|NCT00378625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6443205|NCT00378625|Antiviral Agents|antiviral agents|mesh-ancestor
6443206|NCT00378625|Schistosomicides|schistosomicides|mesh-ancestor
6443207|NCT00378625|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6443208|NCT00378625|Anthelmintics|anthelmintics|mesh-ancestor
6443209|NCT00378638|Bevacizumab|bevacizumab|mesh-list
6443210|NCT00378638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6443211|NCT00378638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6443212|NCT00378638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6443213|NCT00378638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6443214|NCT00378638|Growth Substances|growth substances|mesh-ancestor
6443215|NCT00378638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443216|NCT00378638|Growth Inhibitors|growth inhibitors|mesh-ancestor
6443217|NCT00378677|Cyclosporine|cyclosporine|mesh-list
6443218|NCT00378677|Cyclosporins|cyclosporins|mesh-list
6443219|NCT00378677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6443220|NCT00378677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443221|NCT00378677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6443222|NCT00378677|Immunologic Factors|immunologic factors|mesh-ancestor
6443223|NCT00378677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443224|NCT00378677|Antifungal Agents|antifungal agents|mesh-ancestor
6553772|NCT00910234|Hematinics|hematinics|mesh-ancestor
6553773|NCT00910351|Ciprofloxacin|ciprofloxacin|mesh-list
6553774|NCT00910351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6553775|NCT00910351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6553776|NCT00910351|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6553777|NCT00910351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6553778|NCT00910351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6553779|NCT00910351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553780|NCT00910351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6553781|NCT00910351|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6553782|NCT00910351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6553783|NCT00910390|Ethylene|ethylene|mesh-list
6553784|NCT00910390|Plant Growth Regulators|plant growth regulators|mesh-ancestor
6553785|NCT00910390|Growth Substances|growth substances|mesh-ancestor
6553786|NCT00910390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553787|NCT00910416|Remifentanil|remifentanil|mesh-list
6553788|NCT00910416|Propofol|propofol|mesh-list
6553789|NCT00910416|Sevoflurane|sevoflurane|mesh-list
6553790|NCT00910416|Atracurium|atracurium|mesh-list
6553791|NCT00910416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6553792|NCT00910416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6553793|NCT00910416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553794|NCT00910416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6553795|NCT00910416|Anesthetics, General|anesthetics, general|mesh-ancestor
6553796|NCT00910416|Anesthetics|anesthetics|mesh-ancestor
6553797|NCT00910416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6553798|NCT00910416|Narcotics|narcotics|mesh-ancestor
6553799|NCT00910416|Analgesics|analgesics|mesh-ancestor
6443225|NCT00378677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6443226|NCT00378677|Dermatologic Agents|dermatologic agents|mesh-ancestor
6553800|NCT00910416|Sensory System Agents|sensory system agents|mesh-ancestor
6553801|NCT00910416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6553802|NCT00910416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6553803|NCT00910416|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6553804|NCT00910416|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6553805|NCT00910416|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6553806|NCT00910416|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6553807|NCT00910416|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
6553808|NCT00910416|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6553809|NCT00910416|Cholinergic Agents|cholinergic agents|mesh-ancestor
6553810|NCT00910416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6553811|NCT00910416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553812|NCT00910442|Acetylcysteine|acetylcysteine|mesh-list
6553813|NCT00910442|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6553814|NCT00910442|Antiviral Agents|antiviral agents|mesh-ancestor
6553815|NCT00910442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6553816|NCT00910442|Expectorants|expectorants|mesh-ancestor
6553817|NCT00910442|Respiratory System Agents|respiratory system agents|mesh-ancestor
6553818|NCT00910442|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6553819|NCT00910442|Antioxidants|antioxidants|mesh-ancestor
6553820|NCT00910442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553821|NCT00910442|Protective Agents|protective agents|mesh-ancestor
6553822|NCT00910442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553823|NCT00910442|Antidotes|antidotes|mesh-ancestor
6553824|NCT00910455|SRX246|srx246|mesh-list
6553825|NCT00910455|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6553826|NCT00910455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553827|NCT00910455|Natriuretic Agents|natriuretic agents|mesh-ancestor
6553828|NCT00910455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553829|NCT00910533|Ceftriaxone|ceftriaxone|mesh-list
6553830|NCT00910533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6553831|NCT00910533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6553832|NCT00910598|Glatiramer Acetate|glatiramer acetate|mesh-list
6553833|NCT00910598|(T,G)-A-L|(t,g)-a-l|mesh-list
6553834|NCT00910598|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6553835|NCT00910598|Immunologic Factors|immunologic factors|mesh-ancestor
6553836|NCT00910598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553837|NCT00910598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6553838|NCT00910598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6553839|NCT00910637|Gestodene|gestodene|mesh-list
6553840|NCT00910637|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6553841|NCT00910637|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6553842|NCT00910637|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6553843|NCT00910637|Contraceptive Agents|contraceptive agents|mesh-ancestor
6553844|NCT00910637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6553845|NCT00910637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553846|NCT00910637|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6553847|NCT00910637|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6553848|NCT00910637|Progestins|progestins|mesh-ancestor
6553849|NCT00910637|Hormones|hormones|mesh-ancestor
6553850|NCT00910637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6553851|NCT00910676|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
6553852|NCT00910676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6553853|NCT00910741|Gemcitabine|gemcitabine|mesh-list
6553854|NCT00910741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6553855|NCT00910741|Antimetabolites|antimetabolites|mesh-ancestor
6553856|NCT00910741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553857|NCT00910741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6553858|NCT00910741|Antiviral Agents|antiviral agents|mesh-ancestor
6553859|NCT00910741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6553860|NCT00910741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6553861|NCT00910741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6553862|NCT00910741|Immunologic Factors|immunologic factors|mesh-ancestor
6553863|NCT00910741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553864|NCT00910754|Prednisone|prednisone|mesh-list
6553865|NCT00910754|Abiraterone Acetate|abiraterone acetate|mesh-list
6553866|NCT00910754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6553867|NCT00910754|Glucocorticoids|glucocorticoids|mesh-ancestor
6553868|NCT00910754|Hormones|hormones|mesh-ancestor
6553869|NCT00910754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6553870|NCT00910754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553871|NCT00910754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6553872|NCT00910754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6553873|NCT00910754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6553874|NCT00910754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6553875|NCT00910754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553876|NCT00910754|Hormone Antagonists|hormone antagonists|mesh-ancestor
6553877|NCT00910754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6553878|NCT00910767|Insulin|insulin|mesh-list
6553879|NCT00910767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6553880|NCT00910767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553881|NCT00910780|Olanzapine|olanzapine|mesh-list
6553882|NCT00910780|Aripiprazole|aripiprazole|mesh-list
6553883|NCT00910780|Antidepressive Agents|antidepressive agents|mesh-ancestor
6553884|NCT00910780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6553885|NCT00910780|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6553886|NCT00910780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6553887|NCT00910780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6553888|NCT00910780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553889|NCT00910780|Dopamine Agonists|dopamine agonists|mesh-ancestor
6553890|NCT00910780|Dopamine Agents|dopamine agents|mesh-ancestor
6553891|NCT00910780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6553892|NCT00910780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553893|NCT00910780|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6553894|NCT00910780|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6553895|NCT00910780|Serotonin Agents|serotonin agents|mesh-ancestor
6553896|NCT00910780|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6553897|NCT00910780|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6553898|NCT00910780|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6553899|NCT00910780|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6553900|NCT00910780|Antiemetics|antiemetics|mesh-ancestor
6553901|NCT00910780|Autonomic Agents|autonomic agents|mesh-ancestor
6553902|NCT00910780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6553903|NCT00910780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6553904|NCT00910780|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6443227|NCT00378677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6443228|NCT00378677|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6443229|NCT00378690|Leuprolide|leuprolide|mesh-list
6443230|NCT00378690|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6443231|NCT00378690|Fertility Agents|fertility agents|mesh-ancestor
6443232|NCT00378690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6443233|NCT00378690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443234|NCT00378690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6443235|NCT00378690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6443236|NCT00378716|Leucovorin|leucovorin|mesh-list
6443237|NCT00378716|Fluorouracil|fluorouracil|mesh-list
6443238|NCT00378716|Tegafur|tegafur|mesh-list
6443239|NCT00378716|Calcium|calcium|mesh-list
6443240|NCT00378716|Levoleucovorin|levoleucovorin|mesh-list
6443241|NCT00378716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6443242|NCT00378716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553905|NCT00910780|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6553906|NCT00910780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6553907|NCT00910806|Nevirapine|nevirapine|mesh-list
6553908|NCT00910806|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6553909|NCT00910806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6553910|NCT00910806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6553911|NCT00910806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553912|NCT00910806|Antiviral Agents|antiviral agents|mesh-ancestor
6553913|NCT00910806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6553914|NCT00910806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6443243|NCT00378716|Antimetabolites|antimetabolites|mesh-ancestor
6443244|NCT00378716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553915|NCT00910806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6553916|NCT00910806|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6553917|NCT00910806|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6656433|NCT01469520|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6656434|NCT01469520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6656435|NCT01469520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6656436|NCT01469520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656437|NCT01469520|Antiviral Agents|antiviral agents|mesh-ancestor
6656438|NCT01469520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6656439|NCT01469520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6656440|NCT01469520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6656441|NCT01469520|Antimetabolites|antimetabolites|mesh-ancestor
6656442|NCT01469520|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6656443|NCT01469520|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6656444|NCT01469559|Insulin|insulin|mesh-list
6656445|NCT01469559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6656446|NCT01469559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656447|NCT01469572|Everolimus|everolimus|mesh-list
6656448|NCT01469572|Pasireotide|pasireotide|mesh-list
6656449|NCT01469572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6656450|NCT01469572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6656451|NCT01469572|Immunologic Factors|immunologic factors|mesh-ancestor
6656452|NCT01469572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656453|NCT01469572|Hormones|hormones|mesh-ancestor
6656454|NCT01469572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6656455|NCT01469598|Gemcitabine|gemcitabine|mesh-list
6656456|NCT01469598|Docetaxel|docetaxel|mesh-list
6656457|NCT01469598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6656458|NCT01469598|Antimetabolites|antimetabolites|mesh-ancestor
6656459|NCT01469598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656460|NCT01469598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6656461|NCT01469598|Antiviral Agents|antiviral agents|mesh-ancestor
6656462|NCT01469598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6656463|NCT01469598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6656464|NCT01469598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6656465|NCT01469598|Immunologic Factors|immunologic factors|mesh-ancestor
6443245|NCT00378716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6443246|NCT00378716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6443247|NCT00378716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6443248|NCT00378716|Immunologic Factors|immunologic factors|mesh-ancestor
6656466|NCT01469598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656467|NCT01469598|Tubulin Modulators|tubulin modulators|mesh-ancestor
6656468|NCT01469598|Antimitotic Agents|antimitotic agents|mesh-ancestor
6656469|NCT01469598|Mitosis Modulators|mitosis modulators|mesh-ancestor
6656470|NCT01469624|Pentoxifylline|pentoxifylline|mesh-list
6656471|NCT01469624|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6656472|NCT01469624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6656473|NCT01469624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656474|NCT01469624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6656475|NCT01469624|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6656476|NCT01469624|Protective Agents|protective agents|mesh-ancestor
6656477|NCT01469624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656478|NCT01469624|Vasodilator Agents|vasodilator agents|mesh-ancestor
6656479|NCT01469624|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6656480|NCT01469624|Antioxidants|antioxidants|mesh-ancestor
6656481|NCT01469650|Vitamin D|vitamin d|mesh-list
6656482|NCT01469650|Ergocalciferols|ergocalciferols|mesh-list
6656483|NCT01469650|Cholecalciferol|cholecalciferol|mesh-list
6656484|NCT01469650|Vitamins|vitamins|mesh-list
6656485|NCT01469650|Micronutrients|micronutrients|mesh-ancestor
6656486|NCT01469650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656487|NCT01469650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6656488|NCT01469650|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6664715|NCT01513681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6664716|NCT01513681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664717|NCT01513681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6664718|NCT01513681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6664719|NCT01513681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6664720|NCT01513681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6443249|NCT00378716|Antidotes|antidotes|mesh-ancestor
6443250|NCT00378716|Protective Agents|protective agents|mesh-ancestor
6443251|NCT00378716|Vitamin B Complex|vitamin b complex|mesh-ancestor
6443252|NCT00378716|Vitamins|vitamins|mesh-ancestor
6443253|NCT00378716|Micronutrients|micronutrients|mesh-ancestor
6443254|NCT00378729|Metformin|metformin|mesh-list
6664721|NCT01513681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6553918|NCT00910897|Thalidomide|thalidomide|mesh-list
6553919|NCT00910897|Dexamethasone|dexamethasone|mesh-list
6553920|NCT00910897|Dexamethasone acetate|dexamethasone acetate|mesh-list
6553921|NCT00910897|Bortezomib|bortezomib|mesh-list
6553922|NCT00910897|BB 1101|bb 1101|mesh-list
6553923|NCT00910897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6553924|NCT00910897|Antiemetics|antiemetics|mesh-ancestor
6553925|NCT00910897|Autonomic Agents|autonomic agents|mesh-ancestor
6553926|NCT00910897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6553927|NCT00910897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553928|NCT00910897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6553929|NCT00910897|Glucocorticoids|glucocorticoids|mesh-ancestor
6553930|NCT00910897|Hormones|hormones|mesh-ancestor
6553931|NCT00910897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6553932|NCT00910897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6553933|NCT00910897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6553934|NCT00910897|Protease Inhibitors|protease inhibitors|mesh-ancestor
6553935|NCT00910897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6553936|NCT00910897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553937|NCT00910897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6553938|NCT00910897|Immunologic Factors|immunologic factors|mesh-ancestor
6553939|NCT00910897|Leprostatic Agents|leprostatic agents|mesh-ancestor
6553940|NCT00910897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6553941|NCT00910897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6553942|NCT00910897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6553943|NCT00910897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6553944|NCT00910897|Growth Substances|growth substances|mesh-ancestor
6553945|NCT00910897|Growth Inhibitors|growth inhibitors|mesh-ancestor
6553946|NCT00910975|Interferons|interferons|mesh-list
6553947|NCT00910975|Ribavirin|ribavirin|mesh-list
6553948|NCT00910975|Interferon-alpha|interferon-alpha|mesh-list
6553949|NCT00910975|Interferon alpha-2|interferon alpha-2|mesh-list
6553950|NCT00910975|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6553951|NCT00910975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6553952|NCT00910975|Antiviral Agents|antiviral agents|mesh-ancestor
6553953|NCT00910975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6553954|NCT00910975|Antimetabolites|antimetabolites|mesh-ancestor
6553955|NCT00910975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553956|NCT00910975|Immunologic Factors|immunologic factors|mesh-ancestor
6553957|NCT00910975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553958|NCT00911066|Azacitidine|azacitidine|mesh-list
6553959|NCT00911066|Pevonedistat|pevonedistat|mesh-list
6553960|NCT00911066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6553961|NCT00911066|Antimetabolites|antimetabolites|mesh-ancestor
6553962|NCT00911066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553963|NCT00911066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6553964|NCT00911066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6553965|NCT00911092|Fluorouracil|fluorouracil|mesh-list
6553966|NCT00911092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6553967|NCT00911092|Antimetabolites|antimetabolites|mesh-ancestor
6553968|NCT00911092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553969|NCT00911092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6553970|NCT00911092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6553971|NCT00911092|Immunologic Factors|immunologic factors|mesh-ancestor
6553972|NCT00911092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553973|NCT00911183|Prednisone|prednisone|mesh-list
6553974|NCT00911183|Cyclophosphamide|cyclophosphamide|mesh-list
6553975|NCT00911183|Rituximab|rituximab|mesh-list
6553976|NCT00911183|Doxorubicin|doxorubicin|mesh-list
6553977|NCT00911183|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6553978|NCT00911183|Vincristine|vincristine|mesh-list
6553979|NCT00911183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6553980|NCT00911183|Immunologic Factors|immunologic factors|mesh-ancestor
6553981|NCT00911183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6553982|NCT00911183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6553983|NCT00911183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6553984|NCT00911183|Alkylating Agents|alkylating agents|mesh-ancestor
6553985|NCT00911183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6553986|NCT00911183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6553987|NCT00911183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6553988|NCT00911183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6553989|NCT00911183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6553990|NCT00911183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6553991|NCT00911183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6553992|NCT00911183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6553993|NCT00911183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6553994|NCT00911183|Glucocorticoids|glucocorticoids|mesh-ancestor
6443255|NCT00378729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6443256|NCT00378729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443257|NCT00378755|Bortezomib|bortezomib|mesh-list
6443258|NCT00378755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6443259|NCT00378768|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6443260|NCT00378768|Immunologic Factors|immunologic factors|mesh-ancestor
6443261|NCT00378768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443262|NCT00378768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6443263|NCT00378781|Minocycline|minocycline|mesh-list
6443264|NCT00378781|Heparin|heparin|mesh-list
6443265|NCT00378781|Anticoagulants|anticoagulants|mesh-ancestor
6443266|NCT00378781|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6553995|NCT00911183|Hormones|hormones|mesh-ancestor
6553996|NCT00911183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6553997|NCT00911183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6553998|NCT00911183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6553999|NCT00911183|Tubulin Modulators|tubulin modulators|mesh-ancestor
6554000|NCT00911183|Antimitotic Agents|antimitotic agents|mesh-ancestor
6554001|NCT00911183|Mitosis Modulators|mitosis modulators|mesh-ancestor
6554002|NCT00911235|Fluconazole|fluconazole|mesh-list
6554003|NCT00911235|Fesoterodine|fesoterodine|mesh-list
6554004|NCT00911235|Antifungal Agents|antifungal agents|mesh-ancestor
6554005|NCT00911235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6554006|NCT00911235|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6554007|NCT00911235|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6554008|NCT00911235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6554009|NCT00911235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554010|NCT00911235|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6554011|NCT00911235|Hormone Antagonists|hormone antagonists|mesh-ancestor
6554012|NCT00911235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6554013|NCT00911235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554014|NCT00911235|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6554015|NCT00911235|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6554016|NCT00911235|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6554017|NCT00911235|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6554018|NCT00911235|Cholinergic Agents|cholinergic agents|mesh-ancestor
6554019|NCT00911235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6554020|NCT00911235|Urological Agents|urological agents|mesh-ancestor
6554021|NCT00911261|Oxymorphone|oxymorphone|mesh-list
6554022|NCT00911261|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6554023|NCT00911261|Narcotics|narcotics|mesh-ancestor
6554024|NCT00911261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6554025|NCT00911261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554026|NCT00911261|Analgesics|analgesics|mesh-ancestor
6554027|NCT00911261|Sensory System Agents|sensory system agents|mesh-ancestor
6554028|NCT00911261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6554029|NCT00911261|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6554030|NCT00911287|Oxymorphone|oxymorphone|mesh-list
6554031|NCT00911287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6554032|NCT00911287|Narcotics|narcotics|mesh-ancestor
6554033|NCT00911287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6554034|NCT00911287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554035|NCT00911287|Analgesics|analgesics|mesh-ancestor
6554036|NCT00911287|Sensory System Agents|sensory system agents|mesh-ancestor
6554037|NCT00911287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6554038|NCT00911287|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6554039|NCT00911313|Metformin|metformin|mesh-list
6554040|NCT00911313|Letrozole|letrozole|mesh-list
6554041|NCT00911313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6554042|NCT00911313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554043|NCT00911313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6554044|NCT00911313|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6554045|NCT00911313|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6554046|NCT00911313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6554047|NCT00911313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554048|NCT00911313|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6554049|NCT00911313|Hormone Antagonists|hormone antagonists|mesh-ancestor
6443267|NCT00378781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6554050|NCT00911313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6554051|NCT00911339|Atorvastatin|atorvastatin|mesh-list
6554052|NCT00911339|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6554053|NCT00911339|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6554054|NCT00911339|Antimetabolites|antimetabolites|mesh-ancestor
6554055|NCT00911339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554056|NCT00911339|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6554057|NCT00911339|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6554058|NCT00911339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6554059|NCT00911521|Vaccines|vaccines|mesh-list
6554060|NCT00911521|Immunologic Factors|immunologic factors|mesh-ancestor
6554061|NCT00911521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554062|NCT00911573|Vancomycin|vancomycin|mesh-list
6554063|NCT00911573|Clindamycin|clindamycin|mesh-list
6554064|NCT00911573|Clindamycin palmitate|clindamycin palmitate|mesh-list
6554065|NCT00911573|Clindamycin phosphate|clindamycin phosphate|mesh-list
6554066|NCT00911573|Tigecycline|tigecycline|mesh-list
6554067|NCT00911573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6554068|NCT00911573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6554069|NCT00911573|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6554070|NCT00911573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6554071|NCT00911573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554072|NCT00911651|Bromides|bromides|mesh-list
6554073|NCT00911651|Albuterol|albuterol|mesh-list
6554074|NCT00911651|Ipratropium|ipratropium|mesh-list
6554075|NCT00911651|Anticonvulsants|anticonvulsants|mesh-ancestor
6554076|NCT00911651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6554077|NCT00911651|Autonomic Agents|autonomic agents|mesh-ancestor
6554078|NCT00911651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6554079|NCT00911651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554080|NCT00911651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6554081|NCT00911651|Respiratory System Agents|respiratory system agents|mesh-ancestor
6554082|NCT00911651|Tocolytic Agents|tocolytic agents|mesh-ancestor
6554083|NCT00911651|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6554084|NCT00911651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6554085|NCT00911651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6554086|NCT00911651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6554087|NCT00911651|Adrenergic Agents|adrenergic agents|mesh-ancestor
6554088|NCT00911651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6554089|NCT00911651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554090|NCT00911651|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6554091|NCT00911651|Cholinergic Agents|cholinergic agents|mesh-ancestor
6554092|NCT00911664|Vitamin D|vitamin d|mesh-list
6554093|NCT00911664|Ergocalciferols|ergocalciferols|mesh-list
6554094|NCT00911664|Vitamins|vitamins|mesh-list
6554095|NCT00911664|Micronutrients|micronutrients|mesh-ancestor
6554096|NCT00911664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554097|NCT00911664|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6554098|NCT00911664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6554099|NCT00911716|Cyclophosphamide|cyclophosphamide|mesh-list
6554100|NCT00911716|Bevacizumab|bevacizumab|mesh-list
6554101|NCT00911716|Docetaxel|docetaxel|mesh-list
6554102|NCT00911716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6554103|NCT00911716|Immunologic Factors|immunologic factors|mesh-ancestor
6554104|NCT00911716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554105|NCT00911716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6554106|NCT00911716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6554107|NCT00911716|Alkylating Agents|alkylating agents|mesh-ancestor
6554108|NCT00911716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554109|NCT00911716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6554110|NCT00911716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6554111|NCT00911716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6554112|NCT00911716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6554113|NCT00911716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6554114|NCT00911716|Growth Substances|growth substances|mesh-ancestor
6554115|NCT00911716|Growth Inhibitors|growth inhibitors|mesh-ancestor
6554116|NCT00911716|Tubulin Modulators|tubulin modulators|mesh-ancestor
6554117|NCT00911716|Antimitotic Agents|antimitotic agents|mesh-ancestor
6554118|NCT00911716|Mitosis Modulators|mitosis modulators|mesh-ancestor
6554119|NCT00912119|Aminocaproic Acid|aminocaproic acid|mesh-list
6554120|NCT00912119|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6554121|NCT00912119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6554122|NCT00912119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554123|NCT00912119|Hemostatics|hemostatics|mesh-ancestor
6554124|NCT00912119|Coagulants|coagulants|mesh-ancestor
6554125|NCT00912145|Alprazolam|alprazolam|mesh-list
6554126|NCT00912145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6554127|NCT00912145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6554128|NCT00912145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554129|NCT00912145|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6554130|NCT00912145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6554131|NCT00912145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6554132|NCT00912145|GABA Modulators|gaba modulators|mesh-ancestor
6554133|NCT00912145|GABA Agents|gaba agents|mesh-ancestor
6554134|NCT00912145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6554135|NCT00912145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554136|NCT00912171|Budesonide|budesonide|mesh-list
6554137|NCT00912171|Montelukast|montelukast|mesh-list
6554138|NCT00912171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6554139|NCT00912171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6554140|NCT00912171|Autonomic Agents|autonomic agents|mesh-ancestor
6554141|NCT00912171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6554142|NCT00912171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554143|NCT00912171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6554144|NCT00912171|Respiratory System Agents|respiratory system agents|mesh-ancestor
6554145|NCT00912171|Glucocorticoids|glucocorticoids|mesh-ancestor
6554146|NCT00912171|Hormones|hormones|mesh-ancestor
6554147|NCT00912171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6554148|NCT00912171|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6554149|NCT00912171|Hormone Antagonists|hormone antagonists|mesh-ancestor
6554150|NCT00912171|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6554151|NCT00912171|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6554152|NCT00912171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554153|NCT00912262|Capsaicin|capsaicin|mesh-list
6554154|NCT00912262|Antipruritics|antipruritics|mesh-ancestor
6554155|NCT00912262|Dermatologic Agents|dermatologic agents|mesh-ancestor
6554156|NCT00912262|Sensory System Agents|sensory system agents|mesh-ancestor
6554157|NCT00912262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6554158|NCT00912262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554159|NCT00912275|Vinorelbine|vinorelbine|mesh-list
6554160|NCT00912275|Lapatinib|lapatinib|mesh-list
6554161|NCT00912275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6554162|NCT00912275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6554163|NCT00912275|Tubulin Modulators|tubulin modulators|mesh-ancestor
6554164|NCT00912275|Antimitotic Agents|antimitotic agents|mesh-ancestor
6554165|NCT00912275|Mitosis Modulators|mitosis modulators|mesh-ancestor
6554166|NCT00912275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554167|NCT00912275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6554168|NCT00912275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6554169|NCT00912327|Cetuximab|cetuximab|mesh-list
6554170|NCT00912327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6554171|NCT00912327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6554172|NCT00912392|Carboplatin|carboplatin|mesh-list
6554173|NCT00912392|Etoposide|etoposide|mesh-list
6554174|NCT00912392|Endostar protein|endostar protein|mesh-list
6554175|NCT00912392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6554176|NCT00912392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6554177|NCT00912392|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6554178|NCT00912392|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6554179|NCT00912392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6554180|NCT00912392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554181|NCT00912392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6554182|NCT00912392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6554183|NCT00912392|Growth Substances|growth substances|mesh-ancestor
6554184|NCT00912392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554185|NCT00912392|Growth Inhibitors|growth inhibitors|mesh-ancestor
6554186|NCT00912444|Cyclophosphamide|cyclophosphamide|mesh-list
6554187|NCT00912444|Docetaxel|docetaxel|mesh-list
6554188|NCT00912444|Doxorubicin|doxorubicin|mesh-list
6554189|NCT00912444|Epirubicin|epirubicin|mesh-list
6554190|NCT00912444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6554191|NCT00912444|Immunologic Factors|immunologic factors|mesh-ancestor
6554192|NCT00912444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554193|NCT00912444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6554194|NCT00912444|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6554195|NCT00912444|Alkylating Agents|alkylating agents|mesh-ancestor
6554196|NCT00912444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554197|NCT00912444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6554198|NCT00912444|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6554199|NCT00912444|Tubulin Modulators|tubulin modulators|mesh-ancestor
6554200|NCT00912444|Antimitotic Agents|antimitotic agents|mesh-ancestor
6554201|NCT00912444|Mitosis Modulators|mitosis modulators|mesh-ancestor
6554202|NCT00912444|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6554203|NCT00912444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6554204|NCT00912444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6554205|NCT00912444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6554206|NCT00912457|Donepezil|donepezil|mesh-list
6554207|NCT00912457|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6554208|NCT00912457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6554209|NCT00912457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554210|NCT00912457|Cholinergic Agents|cholinergic agents|mesh-ancestor
6554211|NCT00912457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6554212|NCT00912457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554213|NCT00912457|Nootropic Agents|nootropic agents|mesh-ancestor
6554214|NCT00912483|Heparin|heparin|mesh-list
6554215|NCT00912483|Calcium heparin|calcium heparin|mesh-list
6554216|NCT00912483|Anticoagulants|anticoagulants|mesh-ancestor
6554217|NCT00912483|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6554218|NCT00912483|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6554219|NCT00912483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554220|NCT00912535|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6554221|NCT00912535|Antidepressive Agents|antidepressive agents|mesh-ancestor
6554222|NCT00912535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6554223|NCT00912535|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6554224|NCT00912535|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6554225|NCT00912535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6554226|NCT00912535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554227|NCT00912548|Tamoxifen|tamoxifen|mesh-list
6554228|NCT00912548|Goserelin|goserelin|mesh-list
6554229|NCT00912548|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6554230|NCT00912548|Hormone Antagonists|hormone antagonists|mesh-ancestor
6443268|NCT00378781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443269|NCT00378781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6443270|NCT00378781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6443271|NCT00378820|Caseins|caseins|mesh-list
6443272|NCT00378820|Chelating Agents|chelating agents|mesh-ancestor
6443273|NCT00378820|Sequestering Agents|sequestering agents|mesh-ancestor
6443274|NCT00378820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443275|NCT00378833|Niacin|niacin|mesh-list
6443276|NCT00378833|Niacinamide|niacinamide|mesh-list
6443277|NCT00378833|Nicotinic Acids|nicotinic acids|mesh-list
6443278|NCT00378833|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6443279|NCT00378833|Antimetabolites|antimetabolites|mesh-ancestor
6554231|NCT00912548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6554232|NCT00912548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554233|NCT00912548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6554234|NCT00912548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6554235|NCT00912548|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6554236|NCT00912548|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6554237|NCT00912548|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6554238|NCT00912574|Molgramostim|molgramostim|mesh-list
6554239|NCT00912574|Sargramostim|sargramostim|mesh-list
6554240|NCT00912574|Freund's Adjuvant|freund's adjuvant|mesh-list
6554241|NCT00912574|Immunologic Factors|immunologic factors|mesh-ancestor
6554242|NCT00912574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554243|NCT00912574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6554244|NCT00912574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6554245|NCT00912639|Paclitaxel|paclitaxel|mesh-list
6462190|NCT00458055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6554246|NCT00912639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6554247|NCT00912639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6554248|NCT00912639|Tubulin Modulators|tubulin modulators|mesh-ancestor
6554249|NCT00912639|Antimitotic Agents|antimitotic agents|mesh-ancestor
6554250|NCT00912639|Mitosis Modulators|mitosis modulators|mesh-ancestor
6443280|NCT00378833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443281|NCT00378833|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6443282|NCT00378833|Vasodilator Agents|vasodilator agents|mesh-ancestor
6443283|NCT00378833|Vitamin B Complex|vitamin b complex|mesh-ancestor
6443284|NCT00378833|Vitamins|vitamins|mesh-ancestor
6443285|NCT00378833|Micronutrients|micronutrients|mesh-ancestor
6443286|NCT00378833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443287|NCT00378872|Tranexamic Acid|tranexamic acid|mesh-list
6443288|NCT00378872|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6443289|NCT00378872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6554251|NCT00912639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554252|NCT00912678|Mycophenolic Acid|mycophenolic acid|mesh-list
6554253|NCT00912678|Tacrolimus|tacrolimus|mesh-list
6554254|NCT00912678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6554255|NCT00912678|Immunologic Factors|immunologic factors|mesh-ancestor
6554256|NCT00912678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554257|NCT00912678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6554258|NCT00912678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6554259|NCT00912678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554260|NCT00912678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6554261|NCT00912678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6554262|NCT00912678|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6554263|NCT00912678|Antitubercular Agents|antitubercular agents|mesh-ancestor
6554264|NCT00912678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6554265|NCT00912678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6656489|NCT01469702|Azithromycin|azithromycin|mesh-list
6656490|NCT01469702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6656491|NCT01469702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6656492|NCT01469884|Cyclosporine|cyclosporine|mesh-list
6656493|NCT01469884|Everolimus|everolimus|mesh-list
6656494|NCT01469884|Tacrolimus|tacrolimus|mesh-list
6656495|NCT01469884|Cyclosporins|cyclosporins|mesh-list
6656496|NCT01469884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6656497|NCT01469884|Immunologic Factors|immunologic factors|mesh-ancestor
6656498|NCT01469884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656499|NCT01469884|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6656500|NCT01469884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6656501|NCT01469884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656502|NCT01469884|Antifungal Agents|antifungal agents|mesh-ancestor
6656503|NCT01469884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6656504|NCT01469884|Dermatologic Agents|dermatologic agents|mesh-ancestor
6656505|NCT01469884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6656506|NCT01469884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6656507|NCT01469975|Edetic Acid|edetic acid|mesh-list
6656508|NCT01469975|Pentetic Acid|pentetic acid|mesh-list
6656509|NCT01469975|Antidotes|antidotes|mesh-ancestor
6656510|NCT01469975|Protective Agents|protective agents|mesh-ancestor
6656511|NCT01469975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656512|NCT01469975|Chelating Agents|chelating agents|mesh-ancestor
6656513|NCT01469975|Sequestering Agents|sequestering agents|mesh-ancestor
6656514|NCT01469975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656515|NCT01469975|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6656516|NCT01469975|Anticoagulants|anticoagulants|mesh-ancestor
6656517|NCT01469975|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6656518|NCT01469988|Testosterone|testosterone|mesh-list
6443290|NCT00378872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443291|NCT00378872|Hemostatics|hemostatics|mesh-ancestor
6443292|NCT00378872|Coagulants|coagulants|mesh-ancestor
6443293|NCT00378911|Sunitinib|sunitinib|mesh-list
6443294|NCT00378911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6443295|NCT00378911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6443296|NCT00378911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6443297|NCT00378911|Growth Substances|growth substances|mesh-ancestor
6443298|NCT00378911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443299|NCT00378911|Growth Inhibitors|growth inhibitors|mesh-ancestor
6443300|NCT00378911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6443301|NCT00378911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6554266|NCT00912756|Cilostazol|cilostazol|mesh-list
6554267|NCT00912756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6554268|NCT00912756|Autonomic Agents|autonomic agents|mesh-ancestor
6554269|NCT00912756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6554270|NCT00912756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554271|NCT00912756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6554272|NCT00912756|Respiratory System Agents|respiratory system agents|mesh-ancestor
6554273|NCT00912756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6554274|NCT00912756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6554275|NCT00912756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554276|NCT00912756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6554277|NCT00912756|Vasodilator Agents|vasodilator agents|mesh-ancestor
6554278|NCT00912756|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6554279|NCT00912756|Protective Agents|protective agents|mesh-ancestor
6554280|NCT00912756|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6554281|NCT00912756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6554282|NCT00912756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6554283|NCT00912821|Dialysis Solutions|dialysis solutions|mesh-list
6554284|NCT00912821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6554285|NCT00912860|Interferons|interferons|mesh-list
6554286|NCT00912860|Interferon-beta|interferon-beta|mesh-list
6554287|NCT00912860|Interferon beta-1a|interferon beta-1a|mesh-list
6554288|NCT00912860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6554289|NCT00912860|Antiviral Agents|antiviral agents|mesh-ancestor
6554290|NCT00912860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6554291|NCT00912860|Immunologic Factors|immunologic factors|mesh-ancestor
6554292|NCT00912860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554293|NCT00912860|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6554294|NCT00912899|Noscapine|noscapine|mesh-list
6554295|NCT00912899|Antitussive Agents|antitussive agents|mesh-ancestor
6554296|NCT00912899|Respiratory System Agents|respiratory system agents|mesh-ancestor
6554297|NCT00912938|Zoledronic Acid|zoledronic acid|mesh-list
6554298|NCT00912938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6554299|NCT00912938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554300|NCT00913029|Timolol|timolol|mesh-list
6554301|NCT00913029|Latanoprost|latanoprost|mesh-list
6554302|NCT00913029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6554303|NCT00913029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6554304|NCT00913029|Adrenergic Agents|adrenergic agents|mesh-ancestor
6554305|NCT00913029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6554306|NCT00913029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554307|NCT00913029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554308|NCT00913029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6554309|NCT00913029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6554310|NCT00913029|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6554311|NCT00913029|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6554312|NCT00913055|Octreotide|octreotide|mesh-list
6554313|NCT00913055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6554314|NCT00913055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6554315|NCT00913055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6554316|NCT00913107|Lamotrigine|lamotrigine|mesh-list
6554317|NCT00913107|Carbamazepine|carbamazepine|mesh-list
6554318|NCT00913107|Anticonvulsants|anticonvulsants|mesh-list
6554319|NCT00913107|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6554320|NCT00913107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6554321|NCT00913107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554322|NCT00913107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6554323|NCT00913107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554324|NCT00913107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6554325|NCT00913107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6554326|NCT00913107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6554327|NCT00913107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6554328|NCT00913107|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6554329|NCT00913107|Antimanic Agents|antimanic agents|mesh-ancestor
6554330|NCT00913107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6554331|NCT00913107|Analgesics|analgesics|mesh-ancestor
6554332|NCT00913107|Sensory System Agents|sensory system agents|mesh-ancestor
6554333|NCT00913107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6554334|NCT00913107|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6554335|NCT00913107|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6554336|NCT00913120|Enoxaparin|enoxaparin|mesh-list
6554337|NCT00913120|Anticoagulants|anticoagulants|mesh-ancestor
6554338|NCT00913120|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6554339|NCT00913120|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6554340|NCT00913120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554341|NCT00913224|Diclofenac|diclofenac|mesh-list
6554342|NCT00913224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6554343|NCT00913224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6554344|NCT00913224|Analgesics|analgesics|mesh-ancestor
6554345|NCT00913224|Sensory System Agents|sensory system agents|mesh-ancestor
6554346|NCT00913224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6554347|NCT00913224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554348|NCT00913224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6554349|NCT00913224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6554350|NCT00913224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6554351|NCT00913224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6554352|NCT00913224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554353|NCT00913237|Desipramine|desipramine|mesh-list
6554354|NCT00913237|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6554355|NCT00913237|Antidepressive Agents|antidepressive agents|mesh-ancestor
6554356|NCT00913237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6554357|NCT00913237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6554358|NCT00913237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554359|NCT00913237|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6554360|NCT00913237|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6554361|NCT00913237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6554362|NCT00913237|Adrenergic Agents|adrenergic agents|mesh-ancestor
6554363|NCT00913237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6554364|NCT00913237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554365|NCT00913250|Interferon beta-1a|interferon beta-1a|mesh-list
6554366|NCT00913250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6554367|NCT00913250|Immunologic Factors|immunologic factors|mesh-ancestor
6554368|NCT00913250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554369|NCT00913250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6554370|NCT00913250|Antiviral Agents|antiviral agents|mesh-ancestor
6554371|NCT00913250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6554372|NCT00913276|Propofol|propofol|mesh-list
6554373|NCT00913276|Sevoflurane|sevoflurane|mesh-list
6554374|NCT00913276|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6554375|NCT00913276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6554376|NCT00913276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554377|NCT00913276|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6554378|NCT00913276|Anesthetics, General|anesthetics, general|mesh-ancestor
6554379|NCT00913276|Anesthetics|anesthetics|mesh-ancestor
6554380|NCT00913276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6554381|NCT00913276|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6554382|NCT00913315|Tamsulosin|tamsulosin|mesh-list
6554383|NCT00913315|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6554384|NCT00913315|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6554385|NCT00913315|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6554386|NCT00913315|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6554387|NCT00913315|Adrenergic Agents|adrenergic agents|mesh-ancestor
6554388|NCT00913315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6554389|NCT00913315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554390|NCT00913315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554391|NCT00913315|Urological Agents|urological agents|mesh-ancestor
6554392|NCT00913315|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6554393|NCT00913315|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6554394|NCT00913315|Cholinergic Agents|cholinergic agents|mesh-ancestor
6554395|NCT00913328|Montelukast|montelukast|mesh-list
6554396|NCT00913328|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6554397|NCT00913328|Respiratory System Agents|respiratory system agents|mesh-ancestor
6554398|NCT00913328|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6554399|NCT00913328|Hormone Antagonists|hormone antagonists|mesh-ancestor
6554400|NCT00913328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6554401|NCT00913328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554402|NCT00913328|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6554403|NCT00913328|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6554404|NCT00913328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554405|NCT00913341|Alprazolam|alprazolam|mesh-list
6554406|NCT00913341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6554407|NCT00913341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6554408|NCT00913341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554409|NCT00913341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6554410|NCT00913341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6554411|NCT00913341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6554412|NCT00913341|GABA Modulators|gaba modulators|mesh-ancestor
6554413|NCT00913341|GABA Agents|gaba agents|mesh-ancestor
6554414|NCT00913341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6554415|NCT00913341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554416|NCT00913367|Insulin|insulin|mesh-list
6554417|NCT00913367|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6554418|NCT00913367|Metformin|metformin|mesh-list
6554419|NCT00913367|Insulin Glargine|insulin glargine|mesh-list
6554420|NCT00913367|Glimepiride|glimepiride|mesh-list
6554421|NCT00913367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6554422|NCT00913367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554423|NCT00913367|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6554424|NCT00913367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6554425|NCT00913367|Immunologic Factors|immunologic factors|mesh-ancestor
6554426|NCT00913419|Amitriptyline|amitriptyline|mesh-list
6554427|NCT00913419|Cyclobenzaprine|cyclobenzaprine|mesh-list
6554428|NCT00913419|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6554429|NCT00913419|Antidepressive Agents|antidepressive agents|mesh-ancestor
6554430|NCT00913419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6554431|NCT00913419|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6554432|NCT00913419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554433|NCT00913419|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6554434|NCT00913419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6554435|NCT00913419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6554436|NCT00913419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6554437|NCT00913419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6554438|NCT00913419|Analgesics|analgesics|mesh-ancestor
6554439|NCT00913419|Sensory System Agents|sensory system agents|mesh-ancestor
6554440|NCT00913419|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6554441|NCT00913419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6554442|NCT00913419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6554443|NCT00913419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554444|NCT00913419|Adrenergic Agents|adrenergic agents|mesh-ancestor
6554445|NCT00913419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6554446|NCT00913484|Disulfiram|disulfiram|mesh-list
6554447|NCT00913484|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6554448|NCT00913484|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
6554449|NCT00913484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6554450|NCT00913484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554451|NCT00913497|Insulin|insulin|mesh-list
6554452|NCT00913497|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6554453|NCT00913497|Insulin Aspart|insulin aspart|mesh-list
6554454|NCT00913497|Insulin glulisine|insulin glulisine|mesh-list
6554455|NCT00913497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6554456|NCT00913497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554457|NCT00913549|Clemastine|clemastine|mesh-list
6554458|NCT00913549|Antipruritics|antipruritics|mesh-ancestor
6554459|NCT00913549|Dermatologic Agents|dermatologic agents|mesh-ancestor
6554460|NCT00913549|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6554461|NCT00913549|Histamine Antagonists|histamine antagonists|mesh-ancestor
6554462|NCT00913549|Histamine Agents|histamine agents|mesh-ancestor
6554463|NCT00913549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6554464|NCT00913549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554465|NCT00913549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554466|NCT00913549|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6554467|NCT00913562|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6554468|NCT00913562|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6554469|NCT00913562|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6554470|NCT00913562|Antimetabolites|antimetabolites|mesh-ancestor
6554471|NCT00913562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554472|NCT00913562|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6554473|NCT00913562|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6554474|NCT00913562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6554475|NCT00913588|Fluoxetine|fluoxetine|mesh-list
6554476|NCT00913588|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6554477|NCT00913588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6554478|NCT00913588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6554479|NCT00913588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554480|NCT00913588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6554481|NCT00913588|Serotonin Agents|serotonin agents|mesh-ancestor
6554482|NCT00913588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554483|NCT00913588|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6554484|NCT00913588|Antidepressive Agents|antidepressive agents|mesh-ancestor
6554485|NCT00913588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6554486|NCT00913588|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6554487|NCT00913588|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6554488|NCT00913588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6554489|NCT00913614|SR 46349B|sr 46349b|mesh-list
6554490|NCT00913614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6554491|NCT00913614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6554492|NCT00913614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554493|NCT00913614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6554494|NCT00913614|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6554495|NCT00913614|Serotonin Agents|serotonin agents|mesh-ancestor
6554496|NCT00913614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6554497|NCT00913614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554498|NCT00913653|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
6554499|NCT00913653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6554500|NCT00913653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554501|NCT00913666|Interferons|interferons|mesh-list
6554502|NCT00913666|Interferon-beta|interferon-beta|mesh-list
6554503|NCT00913666|Interferon beta-1a|interferon beta-1a|mesh-list
6554504|NCT00913666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6554505|NCT00913666|Antiviral Agents|antiviral agents|mesh-ancestor
6554506|NCT00913666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6554507|NCT00913666|Immunologic Factors|immunologic factors|mesh-ancestor
6554508|NCT00913666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554509|NCT00913666|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6554510|NCT00913705|Carboplatin|carboplatin|mesh-list
6554511|NCT00913705|Paclitaxel|paclitaxel|mesh-list
6554512|NCT00913705|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6554513|NCT00913705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6554514|NCT00913705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6554515|NCT00913705|Tubulin Modulators|tubulin modulators|mesh-ancestor
6554516|NCT00913705|Antimitotic Agents|antimitotic agents|mesh-ancestor
6554517|NCT00913705|Mitosis Modulators|mitosis modulators|mesh-ancestor
6554518|NCT00913705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554519|NCT00913718|Fluoxetine|fluoxetine|mesh-list
6554520|NCT00913718|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6554521|NCT00913718|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6554522|NCT00913718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6554523|NCT00913718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554524|NCT00913718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6554525|NCT00913718|Serotonin Agents|serotonin agents|mesh-ancestor
6554526|NCT00913718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554527|NCT00913718|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6554528|NCT00913718|Antidepressive Agents|antidepressive agents|mesh-ancestor
6554529|NCT00913718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6554530|NCT00913718|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6554531|NCT00913718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6554532|NCT00913718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6554533|NCT00913783|Clomipramine|clomipramine|mesh-list
6554534|NCT00913783|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6554535|NCT00913783|Antidepressive Agents|antidepressive agents|mesh-ancestor
6554536|NCT00913783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6554537|NCT00913783|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6554538|NCT00913783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6554539|NCT00913783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6554540|NCT00913783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554541|NCT00913783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6554542|NCT00913783|Serotonin Agents|serotonin agents|mesh-ancestor
6554543|NCT00913783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554544|NCT00913796|Potassium Citrate|potassium citrate|mesh-list
6554545|NCT00913796|Diuretics|diuretics|mesh-ancestor
6554546|NCT00913796|Natriuretic Agents|natriuretic agents|mesh-ancestor
6554547|NCT00913796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554548|NCT00913796|Expectorants|expectorants|mesh-ancestor
6554549|NCT00913796|Respiratory System Agents|respiratory system agents|mesh-ancestor
6554550|NCT00913809|Desipramine|desipramine|mesh-list
6554551|NCT00913809|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6554552|NCT00913809|Antidepressive Agents|antidepressive agents|mesh-ancestor
6554553|NCT00913809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6554554|NCT00913809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6554555|NCT00913809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554556|NCT00913809|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6554557|NCT00913809|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6554558|NCT00913809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6554559|NCT00913809|Adrenergic Agents|adrenergic agents|mesh-ancestor
6554560|NCT00913809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6554561|NCT00913809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554562|NCT00913822|Desipramine|desipramine|mesh-list
6554563|NCT00913822|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6554564|NCT00913822|Antidepressive Agents|antidepressive agents|mesh-ancestor
6554565|NCT00913822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6554566|NCT00913822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6554567|NCT00913822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554568|NCT00913822|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6554569|NCT00913822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6554570|NCT00913822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6554571|NCT00913822|Adrenergic Agents|adrenergic agents|mesh-ancestor
6554572|NCT00913822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6554573|NCT00913822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554574|NCT00913848|Valproic Acid|valproic acid|mesh-list
6554575|NCT00913848|Anticonvulsants|anticonvulsants|mesh-ancestor
6554576|NCT00913848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6554577|NCT00913848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554578|NCT00913848|GABA Agents|gaba agents|mesh-ancestor
6554579|NCT00913848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6554580|NCT00913848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554581|NCT00913848|Antimanic Agents|antimanic agents|mesh-ancestor
6554582|NCT00913848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6554583|NCT00913848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6554584|NCT00913848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6554585|NCT00913861|Fentanyl|fentanyl|mesh-list
6554586|NCT00913861|Propofol|propofol|mesh-list
6554587|NCT00913861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6554588|NCT00913861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6554589|NCT00913861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554590|NCT00913861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6554591|NCT00913861|Anesthetics, General|anesthetics, general|mesh-ancestor
6554592|NCT00913861|Anesthetics|anesthetics|mesh-ancestor
6554593|NCT00913861|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6554594|NCT00913861|Narcotics|narcotics|mesh-ancestor
6554595|NCT00913861|Analgesics|analgesics|mesh-ancestor
6554596|NCT00913861|Sensory System Agents|sensory system agents|mesh-ancestor
6554597|NCT00913861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6554598|NCT00913861|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6554599|NCT00913874|Valproic Acid|valproic acid|mesh-list
6554600|NCT00913874|Anticonvulsants|anticonvulsants|mesh-ancestor
6554601|NCT00913874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6554602|NCT00913874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554603|NCT00913874|GABA Agents|gaba agents|mesh-ancestor
6554604|NCT00913874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6554605|NCT00913874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554606|NCT00913874|Antimanic Agents|antimanic agents|mesh-ancestor
6554607|NCT00913874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6554608|NCT00913874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6554609|NCT00913874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6554610|NCT00913887|Diclofenac|diclofenac|mesh-list
6554611|NCT00913887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6554612|NCT00913887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6554613|NCT00913887|Analgesics|analgesics|mesh-ancestor
6554614|NCT00913887|Sensory System Agents|sensory system agents|mesh-ancestor
6554615|NCT00913887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6554616|NCT00913887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554617|NCT00913887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6554618|NCT00913887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6554619|NCT00913887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6554620|NCT00913887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6554621|NCT00913887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554622|NCT00913952|Clomipramine|clomipramine|mesh-list
6554623|NCT00913952|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6554624|NCT00913952|Antidepressive Agents|antidepressive agents|mesh-ancestor
6554625|NCT00913952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6554626|NCT00913952|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6554627|NCT00913952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6554628|NCT00913952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6554629|NCT00913952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554630|NCT00913952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6554631|NCT00913952|Serotonin Agents|serotonin agents|mesh-ancestor
6554632|NCT00913952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554633|NCT00913965|Atenolol|atenolol|mesh-list
6554634|NCT00913965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6554635|NCT00913965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6554636|NCT00913965|Sympatholytics|sympatholytics|mesh-ancestor
6554637|NCT00913965|Autonomic Agents|autonomic agents|mesh-ancestor
6554638|NCT00913965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6554639|NCT00913965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554640|NCT00913965|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6554641|NCT00913965|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6554642|NCT00913965|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6554643|NCT00913965|Adrenergic Agents|adrenergic agents|mesh-ancestor
6554644|NCT00913965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6554645|NCT00913965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554646|NCT00914004|Desipramine|desipramine|mesh-list
6554647|NCT00914004|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6554648|NCT00914004|Antidepressive Agents|antidepressive agents|mesh-ancestor
6554649|NCT00914004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6554650|NCT00914004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6554651|NCT00914004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554652|NCT00914004|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6554653|NCT00914004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6554654|NCT00914004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6554655|NCT00914004|Adrenergic Agents|adrenergic agents|mesh-ancestor
6554656|NCT00914004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6554657|NCT00914004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554658|NCT00914017|Atorvastatin|atorvastatin|mesh-list
6554659|NCT00914017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6554660|NCT00914017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6554661|NCT00914017|Antimetabolites|antimetabolites|mesh-ancestor
6554662|NCT00914017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554663|NCT00914017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6554664|NCT00914017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6554665|NCT00914017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6554666|NCT00914056|Lactulose|lactulose|mesh-list
6554667|NCT00914056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6554668|NCT00914095|Methylphenidate|methylphenidate|mesh-list
6554669|NCT00914095|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6554670|NCT00914095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554671|NCT00914095|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6554672|NCT00914095|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6554673|NCT00914095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6554674|NCT00914095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554675|NCT00914095|Dopamine Agents|dopamine agents|mesh-ancestor
6554676|NCT00914095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6554677|NCT00914121|Moxifloxacin|moxifloxacin|mesh-list
6554678|NCT00914121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6554679|NCT00914121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6554680|NCT00914121|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6554681|NCT00914121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6554682|NCT00914121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6554683|NCT00914121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554684|NCT00914121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6554685|NCT00914134|Levodopa|levodopa|mesh-list
6554686|NCT00914134|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6554687|NCT00914134|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6554688|NCT00914134|Dopamine Agents|dopamine agents|mesh-ancestor
6554689|NCT00914134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6554690|NCT00914134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554691|NCT00914134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554692|NCT00914160|Diclofenac|diclofenac|mesh-list
6554693|NCT00914160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6554694|NCT00914160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6554695|NCT00914160|Analgesics|analgesics|mesh-ancestor
6554696|NCT00914160|Sensory System Agents|sensory system agents|mesh-ancestor
6554697|NCT00914160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6554698|NCT00914160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554699|NCT00914160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6554700|NCT00914160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6554701|NCT00914160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6554702|NCT00914160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6554703|NCT00914160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554704|NCT00914212|Sibutramine|sibutramine|mesh-list
6554705|NCT00914212|Antidepressive Agents|antidepressive agents|mesh-ancestor
6554706|NCT00914212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6554707|NCT00914212|Appetite Depressants|appetite depressants|mesh-ancestor
6554708|NCT00914212|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6554709|NCT00914277|Sildenafil Citrate|sildenafil citrate|mesh-list
6554710|NCT00914277|Vasodilator Agents|vasodilator agents|mesh-ancestor
6554711|NCT00914277|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6554712|NCT00914277|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6554713|NCT00914277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6554714|NCT00914277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554715|NCT00914277|Urological Agents|urological agents|mesh-ancestor
6554716|NCT00914368|Clopidogrel|clopidogrel|mesh-list
6554717|NCT00914368|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6554718|NCT00914368|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6554719|NCT00914368|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6554720|NCT00914368|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6554721|NCT00914368|Purinergic Agents|purinergic agents|mesh-ancestor
6554722|NCT00914368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6554723|NCT00914368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554724|NCT00914368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554725|NCT00914394|Phenylephrine|phenylephrine|mesh-list
6554726|NCT00914394|Oxymetazoline|oxymetazoline|mesh-list
6554727|NCT00914394|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
6554728|NCT00914394|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6554729|NCT00914394|Mydriatics|mydriatics|mesh-ancestor
6554730|NCT00914394|Autonomic Agents|autonomic agents|mesh-ancestor
6554731|NCT00914394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6554732|NCT00914394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554733|NCT00914394|Sympathomimetics|sympathomimetics|mesh-ancestor
6554734|NCT00914394|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6554735|NCT00914394|Nasal Decongestants|nasal decongestants|mesh-ancestor
6554736|NCT00914394|Respiratory System Agents|respiratory system agents|mesh-ancestor
6554737|NCT00914394|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6554738|NCT00914394|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6554739|NCT00914394|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6554740|NCT00914394|Adrenergic Agents|adrenergic agents|mesh-ancestor
6554741|NCT00914394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6554742|NCT00914394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554743|NCT00914394|Protective Agents|protective agents|mesh-ancestor
6554744|NCT00914394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6554745|NCT00914420|Trapidil|trapidil|mesh-list
6554746|NCT00914420|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6554747|NCT00914420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6554748|NCT00914420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554749|NCT00914420|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6554750|NCT00914420|Vasodilator Agents|vasodilator agents|mesh-ancestor
6656519|NCT01469988|Androgens|androgens|mesh-ancestor
6656520|NCT01469988|Hormones|hormones|mesh-ancestor
6656521|NCT01469988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6656522|NCT01469988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656523|NCT01470040|Aspirin|aspirin|mesh-list
6656524|NCT01470040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6656525|NCT01470040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6656526|NCT01470040|Analgesics|analgesics|mesh-ancestor
6656527|NCT01470040|Sensory System Agents|sensory system agents|mesh-ancestor
6656528|NCT01470040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6656529|NCT01470040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656530|NCT01470040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6656531|NCT01470040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6656532|NCT01470040|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6656533|NCT01470040|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6656534|NCT01470040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656535|NCT01470040|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6656536|NCT01470040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6656537|NCT01470040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6656538|NCT01470040|Antipyretics|antipyretics|mesh-ancestor
6656539|NCT01470053|Mometasone Furoate|mometasone furoate|mesh-list
6656540|NCT01470053|Azelastine|azelastine|mesh-list
6656541|NCT01470053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6656542|NCT01470053|Dermatologic Agents|dermatologic agents|mesh-ancestor
6656543|NCT01470053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6554751|NCT00914472|Heparin|heparin|mesh-list
6554752|NCT00914472|Calcium heparin|calcium heparin|mesh-list
6554753|NCT00914472|Anticoagulants|anticoagulants|mesh-ancestor
6554754|NCT00914472|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6554755|NCT00914472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6554756|NCT00914472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554757|NCT00914498|Lidocaine|lidocaine|mesh-list
6554758|NCT00914498|Anesthetics, Local|anesthetics, local|mesh-ancestor
6554759|NCT00914498|Anesthetics|anesthetics|mesh-ancestor
6554760|NCT00914498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6554761|NCT00914498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554762|NCT00914498|Sensory System Agents|sensory system agents|mesh-ancestor
6554763|NCT00914498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6554764|NCT00914498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6554765|NCT00914498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6554766|NCT00914498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6554767|NCT00914498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6554768|NCT00914498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554769|NCT00914524|Olmesartan|olmesartan|mesh-list
6554770|NCT00914524|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6554771|NCT00914524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6554772|NCT00914524|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6554773|NCT00914524|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6554774|NCT00914524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554775|NCT00914563|Lithium Carbonate|lithium carbonate|mesh-list
6554776|NCT00914563|Antidepressive Agents|antidepressive agents|mesh-ancestor
6554777|NCT00914563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6554778|NCT00914563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6554779|NCT00914563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554780|NCT00914563|Antimanic Agents|antimanic agents|mesh-ancestor
6554781|NCT00914563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6554782|NCT00914563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6554783|NCT00914563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554784|NCT00914576|Vitamins|vitamins|mesh-list
6554785|NCT00914576|Micronutrients|micronutrients|mesh-ancestor
6554786|NCT00914576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554787|NCT00914641|Apixaban|apixaban|mesh-list
6554788|NCT00914641|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6554789|NCT00914641|Antithrombins|antithrombins|mesh-ancestor
6554790|NCT00914641|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6554791|NCT00914641|Protease Inhibitors|protease inhibitors|mesh-ancestor
6554792|NCT00914641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6554793|NCT00914641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554794|NCT00914641|Anticoagulants|anticoagulants|mesh-ancestor
6554795|NCT00914654|Formoterol Fumarate|formoterol fumarate|mesh-list
6554796|NCT00914654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6554797|NCT00914654|Autonomic Agents|autonomic agents|mesh-ancestor
6554798|NCT00914654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6554799|NCT00914654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554800|NCT00914654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6554801|NCT00914654|Respiratory System Agents|respiratory system agents|mesh-ancestor
6554802|NCT00914654|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6554803|NCT00914654|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6554804|NCT00914654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6554805|NCT00914654|Adrenergic Agents|adrenergic agents|mesh-ancestor
6554806|NCT00914654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6554807|NCT00914654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554808|NCT00914667|Warfarin|warfarin|mesh-list
6554809|NCT00914667|Fesoterodine|fesoterodine|mesh-list
6554810|NCT00914667|Anticoagulants|anticoagulants|mesh-ancestor
6554811|NCT00914667|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6554812|NCT00914667|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6554813|NCT00914667|Cholinergic Agents|cholinergic agents|mesh-ancestor
6554814|NCT00914667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6554815|NCT00914667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554816|NCT00914667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554817|NCT00914667|Urological Agents|urological agents|mesh-ancestor
6554818|NCT00914693|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6554819|NCT00914693|Gestodene|gestodene|mesh-list
6554820|NCT00914693|Femovan|femovan|mesh-list
6554821|NCT00914693|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6554822|NCT00914693|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6554823|NCT00914693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6554824|NCT00914693|Contraceptive Agents|contraceptive agents|mesh-ancestor
6554825|NCT00914693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6554826|NCT00914693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554827|NCT00914693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6554828|NCT00914693|Estrogens|estrogens|mesh-ancestor
6554829|NCT00914693|Hormones|hormones|mesh-ancestor
6554830|NCT00914693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6554831|NCT00914693|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6554832|NCT00914693|Progestins|progestins|mesh-ancestor
6554833|NCT00914693|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6554834|NCT00914771|Vaccines|vaccines|mesh-list
6554835|NCT00914771|Immunologic Factors|immunologic factors|mesh-ancestor
6554836|NCT00914771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554837|NCT00914797|Terbutaline|terbutaline|mesh-list
6554838|NCT00914797|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6554839|NCT00914797|Autonomic Agents|autonomic agents|mesh-ancestor
6554840|NCT00914797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6554841|NCT00914797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554842|NCT00914797|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6554843|NCT00914797|Respiratory System Agents|respiratory system agents|mesh-ancestor
6554844|NCT00914797|Sympathomimetics|sympathomimetics|mesh-ancestor
6554845|NCT00914797|Tocolytic Agents|tocolytic agents|mesh-ancestor
6554846|NCT00914797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6554847|NCT00914797|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6554848|NCT00914797|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6554849|NCT00914797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6554850|NCT00914797|Adrenergic Agents|adrenergic agents|mesh-ancestor
6554851|NCT00914797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6554852|NCT00914797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554853|NCT00914836|Betamethasone|betamethasone|mesh-list
6554854|NCT00914836|Betamethasone Valerate|betamethasone valerate|mesh-list
6554855|NCT00914836|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
6019758|NCT00389493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6554856|NCT00914836|Betamethasone benzoate|betamethasone benzoate|mesh-list
6554857|NCT00914836|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
6554858|NCT00914836|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
6554859|NCT00914836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6554860|NCT00914836|Glucocorticoids|glucocorticoids|mesh-ancestor
6554861|NCT00914836|Hormones|hormones|mesh-ancestor
6554862|NCT00914836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6554863|NCT00914836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554864|NCT00914836|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6554865|NCT00914836|Respiratory System Agents|respiratory system agents|mesh-ancestor
6554866|NCT00914888|Metronidazole|metronidazole|mesh-list
6554867|NCT00914888|Clarithromycin|clarithromycin|mesh-list
6554868|NCT00914888|Ceftriaxone|ceftriaxone|mesh-list
6554869|NCT00914888|Tigecycline|tigecycline|mesh-list
6554870|NCT00914888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6554871|NCT00914888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6554872|NCT00914888|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6554873|NCT00914888|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6554874|NCT00914888|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6554875|NCT00914888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6554876|NCT00914888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554877|NCT00914888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6554878|NCT00914888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6554879|NCT00914901|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6554880|NCT00914901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6554881|NCT00914901|Autonomic Agents|autonomic agents|mesh-ancestor
6554882|NCT00914901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6554883|NCT00914901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019759|NCT00389493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6554884|NCT00914901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6554885|NCT00914901|Respiratory System Agents|respiratory system agents|mesh-ancestor
6554886|NCT00914901|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6554887|NCT00914901|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6554888|NCT00914901|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6554889|NCT00914901|Adrenergic Agents|adrenergic agents|mesh-ancestor
6554890|NCT00914901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6554891|NCT00914901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554892|NCT00914953|Oxytocin|oxytocin|mesh-list
6554893|NCT00914953|Oxytocics|oxytocics|mesh-ancestor
6554894|NCT00914953|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6554895|NCT00914953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554896|NCT00915070|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
6554897|NCT00915070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6554898|NCT00915070|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6554899|NCT00915070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554900|NCT00915083|Amrubicin|amrubicin|mesh-list
6554901|NCT00915083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6554902|NCT00915200|Acetylcysteine|acetylcysteine|mesh-list
6554903|NCT00915200|Silybin|silybin|mesh-list
6554904|NCT00915200|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6554905|NCT00915200|Antiviral Agents|antiviral agents|mesh-ancestor
6554906|NCT00915200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6554907|NCT00915200|Expectorants|expectorants|mesh-ancestor
6554908|NCT00915200|Respiratory System Agents|respiratory system agents|mesh-ancestor
6554909|NCT00915200|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6554910|NCT00915200|Antioxidants|antioxidants|mesh-ancestor
6554911|NCT00915200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554912|NCT00915200|Protective Agents|protective agents|mesh-ancestor
6554913|NCT00915200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554914|NCT00915200|Antidotes|antidotes|mesh-ancestor
6554915|NCT00915200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6554916|NCT00915200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6554917|NCT00915239|Pantoprazole|pantoprazole|mesh-list
6554918|NCT00915239|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6554919|NCT00915239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6554920|NCT00915239|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6554921|NCT00915239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6554922|NCT00915239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554923|NCT00915252|Cytarabine|cytarabine|mesh-list
6554924|NCT00915252|Azacitidine|azacitidine|mesh-list
6554925|NCT00915252|Daunorubicin|daunorubicin|mesh-list
6554926|NCT00915252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6554927|NCT00915252|Antimetabolites|antimetabolites|mesh-ancestor
6554928|NCT00915252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554929|NCT00915252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6554930|NCT00915252|Antiviral Agents|antiviral agents|mesh-ancestor
6554931|NCT00915252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6554932|NCT00915252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6554933|NCT00915252|Immunologic Factors|immunologic factors|mesh-ancestor
6554934|NCT00915252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554935|NCT00915252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6554936|NCT00915252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6554937|NCT00915252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6554938|NCT00915252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6554939|NCT00915369|Paclitaxel|paclitaxel|mesh-list
6554940|NCT00915369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6554941|NCT00915369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6554942|NCT00915369|Tubulin Modulators|tubulin modulators|mesh-ancestor
6554943|NCT00915369|Antimitotic Agents|antimitotic agents|mesh-ancestor
6554944|NCT00915369|Mitosis Modulators|mitosis modulators|mesh-ancestor
6554945|NCT00915369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554946|NCT00915382|Cisplatin|cisplatin|mesh-list
6554947|NCT00915382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6554948|NCT00915408|Dexamethasone|dexamethasone|mesh-list
6554949|NCT00915408|Cyclophosphamide|cyclophosphamide|mesh-list
6554950|NCT00915408|Lenalidomide|lenalidomide|mesh-list
6554951|NCT00915408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6554952|NCT00915408|Immunologic Factors|immunologic factors|mesh-ancestor
6554953|NCT00915408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554954|NCT00915408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6554955|NCT00915408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6554956|NCT00915408|Alkylating Agents|alkylating agents|mesh-ancestor
6554957|NCT00915408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554958|NCT00915408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6554959|NCT00915408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6554960|NCT00915408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6554961|NCT00915408|Antiemetics|antiemetics|mesh-ancestor
6554962|NCT00915408|Autonomic Agents|autonomic agents|mesh-ancestor
6554963|NCT00915408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6554964|NCT00915408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6554965|NCT00915408|Glucocorticoids|glucocorticoids|mesh-ancestor
6554966|NCT00915408|Hormones|hormones|mesh-ancestor
6554967|NCT00915408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6554968|NCT00915408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6554969|NCT00915408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6554970|NCT00915408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6554971|NCT00915408|Growth Substances|growth substances|mesh-ancestor
6554972|NCT00915408|Growth Inhibitors|growth inhibitors|mesh-ancestor
6554973|NCT00915460|Interferons|interferons|mesh-list
6554974|NCT00915460|Interferon-beta|interferon-beta|mesh-list
6554975|NCT00915460|Interferon beta-1a|interferon beta-1a|mesh-list
6443302|NCT00378911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443303|NCT00378937|Acetaminophen|acetaminophen|mesh-list
6443304|NCT00378937|Morphine|morphine|mesh-list
6554976|NCT00915460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6554977|NCT00915460|Antiviral Agents|antiviral agents|mesh-ancestor
6554978|NCT00915460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6554979|NCT00915460|Immunologic Factors|immunologic factors|mesh-ancestor
6554980|NCT00915460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554981|NCT00915460|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6554982|NCT00915512|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6554983|NCT00915512|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6554984|NCT00915512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6554985|NCT00915512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6554986|NCT00915512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6554987|NCT00915512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6554988|NCT00915512|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6554989|NCT00915512|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6554990|NCT00915512|Serotonin Agents|serotonin agents|mesh-ancestor
6554991|NCT00915512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6554992|NCT00915512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6554993|NCT00915512|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6554994|NCT00915512|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6554995|NCT00915512|Dopamine Agents|dopamine agents|mesh-ancestor
6554996|NCT00915564|Simeprevir|simeprevir|mesh-list
6554997|NCT00915564|Methadone|methadone|mesh-list
6554998|NCT00915564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6554999|NCT00915564|Narcotics|narcotics|mesh-ancestor
6555000|NCT00915564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6443305|NCT00378937|Oxycodone|oxycodone|mesh-list
6443306|NCT00378937|Codeine|codeine|mesh-list
6443307|NCT00378937|Dextropropoxyphene|dextropropoxyphene|mesh-list
6443308|NCT00378937|Levopropoxyphene|levopropoxyphene|mesh-list
6443309|NCT00378937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6443310|NCT00378937|Narcotics|narcotics|mesh-ancestor
6443311|NCT00378937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6443312|NCT00378937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443313|NCT00378937|Analgesics|analgesics|mesh-ancestor
6443314|NCT00378937|Sensory System Agents|sensory system agents|mesh-ancestor
6443315|NCT00378937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6443316|NCT00378937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6443317|NCT00378937|Antipyretics|antipyretics|mesh-ancestor
6443318|NCT00378937|Antitussive Agents|antitussive agents|mesh-ancestor
6555001|NCT00915564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555002|NCT00915564|Analgesics|analgesics|mesh-ancestor
6555003|NCT00915564|Sensory System Agents|sensory system agents|mesh-ancestor
6555004|NCT00915564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6555005|NCT00915564|Antitussive Agents|antitussive agents|mesh-ancestor
6555006|NCT00915564|Respiratory System Agents|respiratory system agents|mesh-ancestor
6555007|NCT00915564|Antiviral Agents|antiviral agents|mesh-ancestor
6555008|NCT00915564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6555009|NCT00915564|Protease Inhibitors|protease inhibitors|mesh-ancestor
6555010|NCT00915564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6555011|NCT00915564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555012|NCT00915577|Interferons|interferons|mesh-list
6555013|NCT00915577|Interferon-beta|interferon-beta|mesh-list
6555014|NCT00915577|Interferon beta-1a|interferon beta-1a|mesh-list
6555015|NCT00915577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6555016|NCT00915577|Antiviral Agents|antiviral agents|mesh-ancestor
6555017|NCT00915577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6555018|NCT00915577|Immunologic Factors|immunologic factors|mesh-ancestor
6555019|NCT00915577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555020|NCT00915577|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6555021|NCT00915616|Melatonin|melatonin|mesh-list
6555022|NCT00915616|Antioxidants|antioxidants|mesh-ancestor
6555023|NCT00915616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555024|NCT00915616|Protective Agents|protective agents|mesh-ancestor
6555025|NCT00915616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555026|NCT00915616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6555027|NCT00915681|Silybin|silybin|mesh-list
6555028|NCT00915681|Protective Agents|protective agents|mesh-ancestor
6555029|NCT00915681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555030|NCT00915681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6555031|NCT00915681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6555032|NCT00915694|Nelfinavir|nelfinavir|mesh-list
6555033|NCT00915694|Temozolomide|temozolomide|mesh-list
6555034|NCT00915694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6555035|NCT00915694|Alkylating Agents|alkylating agents|mesh-ancestor
6555036|NCT00915694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555037|NCT00915694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6555038|NCT00915694|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6555039|NCT00915694|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6555040|NCT00915694|Protease Inhibitors|protease inhibitors|mesh-ancestor
6555041|NCT00915694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6555042|NCT00915694|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6555043|NCT00915694|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6555044|NCT00915694|Antiviral Agents|antiviral agents|mesh-ancestor
6555045|NCT00915694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6555046|NCT00915733|Aspirin|aspirin|mesh-list
6555047|NCT00915733|Cilostazol|cilostazol|mesh-list
6555048|NCT00915733|Clopidogrel|clopidogrel|mesh-list
6555049|NCT00915733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6555050|NCT00915733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6555051|NCT00915733|Analgesics|analgesics|mesh-ancestor
6555052|NCT00915733|Sensory System Agents|sensory system agents|mesh-ancestor
6555053|NCT00915733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6555054|NCT00915733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555055|NCT00915733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6555056|NCT00915733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6555057|NCT00915733|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6555058|NCT00915733|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6555059|NCT00915733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555060|NCT00915733|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6555061|NCT00915733|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6555062|NCT00915733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6555063|NCT00915733|Antipyretics|antipyretics|mesh-ancestor
6555064|NCT00915733|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6555065|NCT00915733|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6555066|NCT00915733|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6555067|NCT00915733|Purinergic Agents|purinergic agents|mesh-ancestor
6555068|NCT00915733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6555069|NCT00915733|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6555070|NCT00915733|Autonomic Agents|autonomic agents|mesh-ancestor
6555071|NCT00915733|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6555072|NCT00915733|Respiratory System Agents|respiratory system agents|mesh-ancestor
6555073|NCT00915733|Vasodilator Agents|vasodilator agents|mesh-ancestor
6555074|NCT00915733|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6555075|NCT00915733|Protective Agents|protective agents|mesh-ancestor
6555076|NCT00915733|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6555077|NCT00915733|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6555078|NCT00915746|Ketoconazole|ketoconazole|mesh-list
6555079|NCT00915746|Antifungal Agents|antifungal agents|mesh-ancestor
6555080|NCT00915746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6555081|NCT00915746|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6555082|NCT00915746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6555083|NCT00915746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6555084|NCT00915746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555085|NCT00915746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6555086|NCT00915746|Hormone Antagonists|hormone antagonists|mesh-ancestor
6555087|NCT00915746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6555088|NCT00915746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555089|NCT00915746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6555090|NCT00915785|Azacitidine|azacitidine|mesh-list
6555091|NCT00915785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6555092|NCT00915785|Antimetabolites|antimetabolites|mesh-ancestor
6555093|NCT00915785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555094|NCT00915785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6555095|NCT00915785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6555096|NCT00915811|Fludarabine|fludarabine|mesh-list
6555097|NCT00915811|Busulfan|busulfan|mesh-list
6555098|NCT00915811|Thymoglobulin|thymoglobulin|mesh-list
6555099|NCT00915811|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6555100|NCT00915811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6555101|NCT00915811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555102|NCT00915811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6555103|NCT00915811|Immunologic Factors|immunologic factors|mesh-ancestor
6555104|NCT00915811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555105|NCT00915811|Alkylating Agents|alkylating agents|mesh-ancestor
6555106|NCT00915811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6555107|NCT00915811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6555108|NCT00915837|Triamcinolone|triamcinolone|mesh-list
6555109|NCT00915837|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6555110|NCT00915837|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6555111|NCT00915837|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6555112|NCT00915837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6555113|NCT00915837|Glucocorticoids|glucocorticoids|mesh-ancestor
6555114|NCT00915837|Hormones|hormones|mesh-ancestor
6555115|NCT00915837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6555116|NCT00915837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555117|NCT00915837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6555118|NCT00915837|Immunologic Factors|immunologic factors|mesh-ancestor
6555119|NCT00915837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6555120|NCT00915837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555121|NCT00915850|Cisplatin|cisplatin|mesh-list
6555122|NCT00915850|Docetaxel|docetaxel|mesh-list
6555123|NCT00915850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6555124|NCT00915850|Tubulin Modulators|tubulin modulators|mesh-ancestor
6555125|NCT00915850|Antimitotic Agents|antimitotic agents|mesh-ancestor
6555126|NCT00915850|Mitosis Modulators|mitosis modulators|mesh-ancestor
6555127|NCT00915850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724751|NCT03184844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6555128|NCT00915915|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6555129|NCT00915915|Gestodene|gestodene|mesh-list
6555130|NCT00915915|Femovan|femovan|mesh-list
6555131|NCT00915915|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6555132|NCT00915915|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6555133|NCT00915915|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6555134|NCT00915915|Contraceptive Agents|contraceptive agents|mesh-ancestor
6555135|NCT00915915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6555136|NCT00915915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555137|NCT00915915|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6555138|NCT00915915|Estrogens|estrogens|mesh-ancestor
6555139|NCT00915915|Hormones|hormones|mesh-ancestor
6555140|NCT00915915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6555141|NCT00915915|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6555142|NCT00915915|Progestins|progestins|mesh-ancestor
6555143|NCT00915915|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6555144|NCT00916045|Vidarabine|vidarabine|mesh-list
6555145|NCT00916045|Cyclosporine|cyclosporine|mesh-list
6555146|NCT00916045|Mycophenolic Acid|mycophenolic acid|mesh-list
6555147|NCT00916045|Cyclophosphamide|cyclophosphamide|mesh-list
6555148|NCT00916045|Melphalan|melphalan|mesh-list
6555149|NCT00916045|Busulfan|busulfan|mesh-list
6555150|NCT00916045|Thiotepa|thiotepa|mesh-list
6555151|NCT00916045|Fludarabine|fludarabine|mesh-list
6555152|NCT00916045|Fludarabine phosphate|fludarabine phosphate|mesh-list
6555153|NCT00916045|Cyclosporins|cyclosporins|mesh-list
6555154|NCT00916045|Thymoglobulin|thymoglobulin|mesh-list
6555155|NCT00916045|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6555156|NCT00916045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6555157|NCT00916045|Immunologic Factors|immunologic factors|mesh-ancestor
6555158|NCT00916045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555159|NCT00916045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6555160|NCT00916045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6555161|NCT00916045|Alkylating Agents|alkylating agents|mesh-ancestor
6555162|NCT00916045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555163|NCT00916045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6555164|NCT00916045|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6555165|NCT00916045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6555166|NCT00916045|Antimetabolites|antimetabolites|mesh-ancestor
6555167|NCT00916045|Antiviral Agents|antiviral agents|mesh-ancestor
6555168|NCT00916045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6555169|NCT00916045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6555170|NCT00916045|Antifungal Agents|antifungal agents|mesh-ancestor
6555171|NCT00916045|Dermatologic Agents|dermatologic agents|mesh-ancestor
6555172|NCT00916045|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6555173|NCT00916045|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6555174|NCT00916045|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6555175|NCT00916045|Antitubercular Agents|antitubercular agents|mesh-ancestor
6555176|NCT00916045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6555177|NCT00916097|Docetaxel|docetaxel|mesh-list
6555178|NCT00916097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6555179|NCT00916097|Tubulin Modulators|tubulin modulators|mesh-ancestor
6555180|NCT00916097|Antimitotic Agents|antimitotic agents|mesh-ancestor
6555181|NCT00916097|Mitosis Modulators|mitosis modulators|mesh-ancestor
6555182|NCT00916097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555183|NCT00916123|Prednisone|prednisone|mesh-list
6555184|NCT00916123|Docetaxel|docetaxel|mesh-list
6555185|NCT00916123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6555186|NCT00916123|Tubulin Modulators|tubulin modulators|mesh-ancestor
6555187|NCT00916123|Antimitotic Agents|antimitotic agents|mesh-ancestor
6555188|NCT00916123|Mitosis Modulators|mitosis modulators|mesh-ancestor
6555189|NCT00916123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555190|NCT00916123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6555191|NCT00916123|Glucocorticoids|glucocorticoids|mesh-ancestor
6555192|NCT00916123|Hormones|hormones|mesh-ancestor
6555193|NCT00916123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6555194|NCT00916123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555195|NCT00916123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6555196|NCT00916201|Cannabidiol|cannabidiol|mesh-list
6555197|NCT00916201|Anticonvulsants|anticonvulsants|mesh-ancestor
6555198|NCT00916253|Modafinil|modafinil|mesh-list
6555199|NCT00916253|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6555200|NCT00916253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555201|NCT00916253|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6555202|NCT00916253|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6555203|NCT00916253|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6555204|NCT00916253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656544|NCT01470053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6656545|NCT01470053|Autonomic Agents|autonomic agents|mesh-ancestor
6656546|NCT01470053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6656547|NCT01470053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443319|NCT00378937|Respiratory System Agents|respiratory system agents|mesh-ancestor
6443320|NCT00378976|Valacyclovir|valacyclovir|mesh-list
6443321|NCT00378976|Antiviral Agents|antiviral agents|mesh-ancestor
6443322|NCT00378976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6443323|NCT00379015|Cyclophosphamide|cyclophosphamide|mesh-list
6443324|NCT00379015|Docetaxel|docetaxel|mesh-list
6443325|NCT00379015|Trastuzumab|trastuzumab|mesh-list
6443326|NCT00379015|Epirubicin|epirubicin|mesh-list
6443327|NCT00379015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6443328|NCT00379015|Immunologic Factors|immunologic factors|mesh-ancestor
6443329|NCT00379015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443330|NCT00379015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6656548|NCT01470053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6656549|NCT01470053|Respiratory System Agents|respiratory system agents|mesh-ancestor
6656550|NCT01470053|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6656551|NCT01470053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6656552|NCT01470053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656553|NCT01470053|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6656554|NCT01470053|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6656555|NCT01470053|Histamine Antagonists|histamine antagonists|mesh-ancestor
6656556|NCT01470053|Histamine Agents|histamine agents|mesh-ancestor
6656557|NCT01470053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6656558|NCT01470092|Tibolone|tibolone|mesh-list
6656559|NCT01470092|Androgen Antagonists|androgen antagonists|mesh-ancestor
6656560|NCT01470092|Hormone Antagonists|hormone antagonists|mesh-ancestor
6656561|NCT01470092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6656562|NCT01470092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656563|NCT01470092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6656564|NCT01470092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6656565|NCT01470092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6656566|NCT01470092|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6656567|NCT01470092|Anabolic Agents|anabolic agents|mesh-ancestor
6656568|NCT01470092|Hormones|hormones|mesh-ancestor
6656569|NCT01470157|Ketamine|ketamine|mesh-list
6656570|NCT01470157|Analgesics|analgesics|mesh-ancestor
6656571|NCT01470157|Sensory System Agents|sensory system agents|mesh-ancestor
6656572|NCT01470157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6656573|NCT01470157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656574|NCT01470157|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6656575|NCT01470157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6656576|NCT01470157|Anesthetics, General|anesthetics, general|mesh-ancestor
6656577|NCT01470157|Anesthetics|anesthetics|mesh-ancestor
6443331|NCT00379015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6443332|NCT00379015|Alkylating Agents|alkylating agents|mesh-ancestor
6555205|NCT00916396|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
6555206|NCT00916396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6555207|NCT00916396|Immunologic Factors|immunologic factors|mesh-ancestor
6555208|NCT00916396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555209|NCT00916409|Temozolomide|temozolomide|mesh-list
6555210|NCT00916409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6555211|NCT00916409|Alkylating Agents|alkylating agents|mesh-ancestor
6555212|NCT00916409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555213|NCT00916409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6555214|NCT00916448|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6555215|NCT00916448|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6555216|NCT00916448|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6555217|NCT00916448|Protease Inhibitors|protease inhibitors|mesh-ancestor
6555218|NCT00916448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6555219|NCT00916448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555220|NCT00916448|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6555221|NCT00916448|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6555222|NCT00916448|Antiviral Agents|antiviral agents|mesh-ancestor
6555223|NCT00916448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6555224|NCT00916461|Minocycline|minocycline|mesh-list
6555225|NCT00916461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6555226|NCT00916461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6555227|NCT00916500|Cisplatin|cisplatin|mesh-list
6555228|NCT00916500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6555229|NCT00916526|Mannitol|mannitol|mesh-list
6555230|NCT00916526|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6555231|NCT00916526|Diuretics|diuretics|mesh-ancestor
6555232|NCT00916526|Natriuretic Agents|natriuretic agents|mesh-ancestor
6555233|NCT00916526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555234|NCT00916552|Epoetin Alfa|epoetin alfa|mesh-list
6555235|NCT00916552|Hematinics|hematinics|mesh-ancestor
6555236|NCT00916630|Pemetrexed|pemetrexed|mesh-list
6555237|NCT00916630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6555238|NCT00916630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6555239|NCT00916630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555240|NCT00916630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6555241|NCT00916630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6555242|NCT00916669|Etoposide|etoposide|mesh-list
6555243|NCT00916669|Enoxaparin|enoxaparin|mesh-list
6555244|NCT00916669|Enoxaparin sodium|enoxaparin sodium|mesh-list
6555245|NCT00916669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6555246|NCT00916669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6555247|NCT00916669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6555248|NCT00916669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6555249|NCT00916669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6555250|NCT00916669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555251|NCT00916669|Anticoagulants|anticoagulants|mesh-ancestor
6555252|NCT00916669|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6555253|NCT00916669|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6555254|NCT00916695|Everolimus|everolimus|mesh-list
6555255|NCT00916695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6555256|NCT00916695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6555257|NCT00916695|Immunologic Factors|immunologic factors|mesh-ancestor
6555258|NCT00916695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555259|NCT00916747|Zoledronic Acid|zoledronic acid|mesh-list
6555260|NCT00916747|Pravastatin|pravastatin|mesh-list
6555261|NCT00916747|Lonafarnib|lonafarnib|mesh-list
6555262|NCT00916747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6555263|NCT00916747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555264|NCT00916747|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6555265|NCT00916747|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6555266|NCT00916747|Antimetabolites|antimetabolites|mesh-ancestor
6555267|NCT00916747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555268|NCT00916747|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6555269|NCT00916747|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6555270|NCT00916747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6555271|NCT00916760|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6555272|NCT00916760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6555273|NCT00916760|Immunologic Factors|immunologic factors|mesh-ancestor
6555274|NCT00916760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555275|NCT00916760|Antacids|antacids|mesh-ancestor
6555276|NCT00916760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555277|NCT00916760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6555278|NCT00916890|Fentanyl|fentanyl|mesh-list
6555279|NCT00916890|Morphine|morphine|mesh-list
6555280|NCT00916890|Oxycodone|oxycodone|mesh-list
6555281|NCT00916890|Buprenorphine|buprenorphine|mesh-list
6555282|NCT00916890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6555283|NCT00916890|Narcotics|narcotics|mesh-ancestor
6555284|NCT00916890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6555285|NCT00916890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555286|NCT00916890|Analgesics|analgesics|mesh-ancestor
6555287|NCT00916890|Sensory System Agents|sensory system agents|mesh-ancestor
6555288|NCT00916890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6555289|NCT00916890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6555290|NCT00916890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6555291|NCT00916890|Anesthetics, General|anesthetics, general|mesh-ancestor
6555292|NCT00916890|Anesthetics|anesthetics|mesh-ancestor
6555293|NCT00916890|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6555294|NCT00916942|Lidocaine|lidocaine|mesh-list
6555295|NCT00916942|Prilocaine|prilocaine|mesh-list
6555296|NCT00916942|Capsaicin|capsaicin|mesh-list
6555297|NCT00916942|Anesthetics, Local|anesthetics, local|mesh-ancestor
6555298|NCT00916942|Anesthetics|anesthetics|mesh-ancestor
6555299|NCT00916942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6555300|NCT00916942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555301|NCT00916942|Sensory System Agents|sensory system agents|mesh-ancestor
6555302|NCT00916942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6555303|NCT00916942|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6555304|NCT00916942|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6555305|NCT00916942|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6555306|NCT00916942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6555307|NCT00916942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555308|NCT00916942|Antipruritics|antipruritics|mesh-ancestor
6555309|NCT00916942|Dermatologic Agents|dermatologic agents|mesh-ancestor
6555310|NCT00917059|Citalopram|citalopram|mesh-list
6555311|NCT00917059|Bupropion|bupropion|mesh-list
6555312|NCT00917059|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6555313|NCT00917059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6555314|NCT00917059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6555315|NCT00917059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555316|NCT00917059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6555317|NCT00917059|Serotonin Agents|serotonin agents|mesh-ancestor
6555318|NCT00917059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555319|NCT00917059|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6555320|NCT00917059|Antidepressive Agents|antidepressive agents|mesh-ancestor
6443333|NCT00379015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443334|NCT00379015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6443335|NCT00379015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6443336|NCT00379015|Tubulin Modulators|tubulin modulators|mesh-ancestor
6443337|NCT00379015|Antimitotic Agents|antimitotic agents|mesh-ancestor
6443338|NCT00379015|Mitosis Modulators|mitosis modulators|mesh-ancestor
6555321|NCT00917059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6555322|NCT00917059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6555323|NCT00917059|Dopamine Agents|dopamine agents|mesh-ancestor
6555324|NCT00917059|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6555325|NCT00917059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6555326|NCT00917059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6555327|NCT00917163|Sirolimus|sirolimus|mesh-list
6555328|NCT00917163|Everolimus|everolimus|mesh-list
6555329|NCT00917163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6555330|NCT00917163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6555331|NCT00917163|Immunologic Factors|immunologic factors|mesh-ancestor
6555332|NCT00917163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555333|NCT00917163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6555334|NCT00917163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6555335|NCT00917163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6555336|NCT00917163|Antifungal Agents|antifungal agents|mesh-ancestor
6555337|NCT00917241|Dexamethasone|dexamethasone|mesh-list
6555338|NCT00917241|Methimazole|methimazole|mesh-list
6555339|NCT00917241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6555340|NCT00917241|Antiemetics|antiemetics|mesh-ancestor
6555341|NCT00917241|Autonomic Agents|autonomic agents|mesh-ancestor
6555342|NCT00917241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6555343|NCT00917241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555344|NCT00917241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6443339|NCT00379015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6443340|NCT00379015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6555345|NCT00917241|Glucocorticoids|glucocorticoids|mesh-ancestor
6555346|NCT00917241|Hormones|hormones|mesh-ancestor
6555347|NCT00917241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6555348|NCT00917241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6555349|NCT00917241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6555350|NCT00917241|Antithyroid Agents|antithyroid agents|mesh-ancestor
6555351|NCT00917241|Hormone Antagonists|hormone antagonists|mesh-ancestor
6555352|NCT00917254|Enoxaparin|enoxaparin|mesh-list
6555353|NCT00917254|Anticoagulants|anticoagulants|mesh-ancestor
6555354|NCT00917254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6555355|NCT00917254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6555356|NCT00917254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555357|NCT00917345|Captopril|captopril|mesh-list
6555358|NCT00917345|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6555359|NCT00917345|Protease Inhibitors|protease inhibitors|mesh-ancestor
6555360|NCT00917345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6555361|NCT00917345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555362|NCT00917345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6555363|NCT00917358|Interferons|interferons|mesh-list
6019760|NCT00389493|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6019761|NCT00389493|Dopamine Agents|dopamine agents|mesh-ancestor
6019762|NCT00389519|Ramipril|ramipril|mesh-list
6019763|NCT00389519|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6019764|NCT00389519|Protease Inhibitors|protease inhibitors|mesh-ancestor
6019765|NCT00389519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6019766|NCT00389519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555364|NCT00917358|Interferon-alpha|interferon-alpha|mesh-list
6555365|NCT00917358|Interferon alpha-2|interferon alpha-2|mesh-list
6555366|NCT00917358|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6555367|NCT00917358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6555368|NCT00917358|Antiviral Agents|antiviral agents|mesh-ancestor
6555369|NCT00917358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6555370|NCT00917358|Immunologic Factors|immunologic factors|mesh-ancestor
6555371|NCT00917358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555372|NCT00917397|Sertraline|sertraline|mesh-list
6555373|NCT00917397|Antidepressive Agents|antidepressive agents|mesh-ancestor
6555374|NCT00917397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6555375|NCT00917397|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6555376|NCT00917397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6555377|NCT00917397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6555378|NCT00917397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555379|NCT00917397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6555380|NCT00917397|Serotonin Agents|serotonin agents|mesh-ancestor
6555381|NCT00917397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555382|NCT00917527|Atorvastatin|atorvastatin|mesh-list
6555383|NCT00917527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6555384|NCT00917527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6555385|NCT00917527|Antimetabolites|antimetabolites|mesh-ancestor
6555386|NCT00917527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555387|NCT00917527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6555388|NCT00917527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6555389|NCT00917527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6555390|NCT00917592|Amoxicillin|amoxicillin|mesh-list
6555391|NCT00917592|Clavulanic Acids|clavulanic acids|mesh-list
6555392|NCT00917592|Clavulanic Acid|clavulanic acid|mesh-list
6555393|NCT00917592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6555394|NCT00917592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6555395|NCT00917592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6555396|NCT00917592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555397|NCT00917592|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6555398|NCT00917748|Docetaxel|docetaxel|mesh-list
6555399|NCT00917748|Modafinil|modafinil|mesh-list
6555400|NCT00917748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6555401|NCT00917748|Tubulin Modulators|tubulin modulators|mesh-ancestor
6555402|NCT00917748|Antimitotic Agents|antimitotic agents|mesh-ancestor
6555403|NCT00917748|Mitosis Modulators|mitosis modulators|mesh-ancestor
6555404|NCT00917748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555405|NCT00917748|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6555406|NCT00917748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555407|NCT00917748|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6555408|NCT00917748|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6555409|NCT00917748|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6555410|NCT00917761|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6555411|NCT00917761|Interferon-alpha|interferon-alpha|mesh-list
6555412|NCT00917761|Entecavir|entecavir|mesh-list
6555413|NCT00917761|Antiviral Agents|antiviral agents|mesh-ancestor
6555414|NCT00917761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6555415|NCT00917761|Immunologic Factors|immunologic factors|mesh-ancestor
6555416|NCT00917761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555417|NCT00917839|Lamotrigine|lamotrigine|mesh-list
6555418|NCT00917839|Anticonvulsants|anticonvulsants|mesh-ancestor
6555419|NCT00917839|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6555420|NCT00917839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6555421|NCT00917839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555422|NCT00917839|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6555423|NCT00917839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555424|NCT00917839|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6555425|NCT00917839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6555426|NCT00917839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6555427|NCT00917839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6555428|NCT00917839|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6555429|NCT00917878|Calcium|calcium|mesh-list
6555430|NCT00917878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6555431|NCT00917878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555432|NCT00917891|Dapivirine|dapivirine|mesh-list
6555433|NCT00917891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6555434|NCT00917891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6555435|NCT00917891|Antiviral Agents|antiviral agents|mesh-ancestor
6555436|NCT00917891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6555437|NCT00917904|Dapivirine|dapivirine|mesh-list
6555438|NCT00917904|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6555439|NCT00917904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6555440|NCT00917904|Antiviral Agents|antiviral agents|mesh-ancestor
6555441|NCT00917904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6656578|NCT01470157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6656579|NCT01470157|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6656580|NCT01470157|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6656581|NCT01470157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6656582|NCT01470157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656583|NCT01470209|Everolimus|everolimus|mesh-list
6656584|NCT01470209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6656585|NCT01470209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6656586|NCT01470209|Immunologic Factors|immunologic factors|mesh-ancestor
6656587|NCT01470209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656588|NCT01470326|Bazedoxifene|bazedoxifene|mesh-list
6656589|NCT01470326|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6656590|NCT01470326|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6656591|NCT01470326|Hormone Antagonists|hormone antagonists|mesh-ancestor
6656592|NCT01470326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6555442|NCT00918021|Olanzapine|olanzapine|mesh-list
6555443|NCT00918021|Antiemetics|antiemetics|mesh-ancestor
6555444|NCT00918021|Autonomic Agents|autonomic agents|mesh-ancestor
6555445|NCT00918021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6555446|NCT00918021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555447|NCT00918021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6555448|NCT00918021|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6555449|NCT00918021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6555450|NCT00918021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6555451|NCT00918021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6555452|NCT00918021|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6555453|NCT00918021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6555454|NCT00918021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6555455|NCT00918021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555456|NCT00918021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6555457|NCT00918021|Serotonin Agents|serotonin agents|mesh-ancestor
6555458|NCT00918034|Talaporfin|talaporfin|mesh-list
6555459|NCT00918034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6555460|NCT00918034|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6555461|NCT00918034|Dermatologic Agents|dermatologic agents|mesh-ancestor
6555462|NCT00918047|Oxcarbazepine|oxcarbazepine|mesh-list
6555463|NCT00918047|Anticonvulsants|anticonvulsants|mesh-ancestor
6555464|NCT00918047|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6555465|NCT00918047|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6555466|NCT00918047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6555467|NCT00918047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555468|NCT00918047|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6555469|NCT00918047|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6555470|NCT00918086|Vitamin D|vitamin d|mesh-list
6555471|NCT00918086|Vitamins|vitamins|mesh-ancestor
6555472|NCT00918086|Micronutrients|micronutrients|mesh-ancestor
6555473|NCT00918086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555474|NCT00918086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6555475|NCT00918177|Levodopa|levodopa|mesh-list
6555476|NCT00918177|Carbidopa|carbidopa|mesh-list
6555477|NCT00918177|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
6555478|NCT00918177|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6555479|NCT00918177|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6443341|NCT00379015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6443342|NCT00379015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6443343|NCT00379015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6443344|NCT00379028|Fluticasone|fluticasone|mesh-list
6443345|NCT00379028|Budesonide|budesonide|mesh-list
6443346|NCT00379028|Formoterol Fumarate|formoterol fumarate|mesh-list
6443347|NCT00379028|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6443348|NCT00379028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6555480|NCT00918177|Dopamine Agents|dopamine agents|mesh-ancestor
6555481|NCT00918177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6555482|NCT00918177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555483|NCT00918177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555484|NCT00918177|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6555485|NCT00918177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6555486|NCT00918177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6555487|NCT00918177|Immunologic Factors|immunologic factors|mesh-ancestor
6555488|NCT00918177|Dopamine Agonists|dopamine agonists|mesh-ancestor
6555489|NCT00918190|Dexamethasone|dexamethasone|mesh-list
6555490|NCT00918190|Dexamethasone acetate|dexamethasone acetate|mesh-list
6555491|NCT00918190|Midazolam|midazolam|mesh-list
6555492|NCT00918190|Ondansetron|ondansetron|mesh-list
6555493|NCT00918190|BB 1101|bb 1101|mesh-list
6555494|NCT00918190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6555495|NCT00918190|Antiemetics|antiemetics|mesh-ancestor
6555496|NCT00918190|Autonomic Agents|autonomic agents|mesh-ancestor
6555497|NCT00918190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6555498|NCT00918190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555499|NCT00918190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6555500|NCT00918190|Glucocorticoids|glucocorticoids|mesh-ancestor
6443349|NCT00379028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6555501|NCT00918190|Hormones|hormones|mesh-ancestor
6443350|NCT00379028|Autonomic Agents|autonomic agents|mesh-ancestor
6555502|NCT00918190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6555503|NCT00918190|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6555504|NCT00918190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6555505|NCT00918190|Protease Inhibitors|protease inhibitors|mesh-ancestor
6555506|NCT00918190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6555507|NCT00918190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555508|NCT00918190|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6555509|NCT00918190|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6555510|NCT00918190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6555511|NCT00918190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6555512|NCT00918190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6555513|NCT00918190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6555514|NCT00918190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6555515|NCT00918190|Anesthetics, General|anesthetics, general|mesh-ancestor
6555516|NCT00918190|Anesthetics|anesthetics|mesh-ancestor
6555517|NCT00918190|GABA Modulators|gaba modulators|mesh-ancestor
6555518|NCT00918190|GABA Agents|gaba agents|mesh-ancestor
6555519|NCT00918190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6555520|NCT00918190|Antipruritics|antipruritics|mesh-ancestor
6555521|NCT00918190|Dermatologic Agents|dermatologic agents|mesh-ancestor
6555522|NCT00918190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6555523|NCT00918190|Serotonin Agents|serotonin agents|mesh-ancestor
6555524|NCT00918190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6555525|NCT00918307|Varenicline|varenicline|mesh-list
6555526|NCT00918307|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6555527|NCT00918307|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6555528|NCT00918307|Cholinergic Agents|cholinergic agents|mesh-ancestor
6555529|NCT00918307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6555530|NCT00918307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555531|NCT00918307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555532|NCT00918320|Temozolomide|temozolomide|mesh-list
6555533|NCT00918320|Topotecan|topotecan|mesh-list
6555534|NCT00918320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6555535|NCT00918320|Alkylating Agents|alkylating agents|mesh-ancestor
6555536|NCT00918320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555537|NCT00918320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6555538|NCT00918320|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6555539|NCT00918320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6555540|NCT00918320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6555541|NCT00918411|Ramosetron|ramosetron|mesh-list
6555542|NCT00918411|Antiemetics|antiemetics|mesh-ancestor
6555543|NCT00918411|Autonomic Agents|autonomic agents|mesh-ancestor
5724752|NCT03184844|Immunologic Factors|immunologic factors|mesh-ancestor
6555544|NCT00918411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6555545|NCT00918411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555546|NCT00918411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6555547|NCT00918411|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6555548|NCT00918411|Serotonin Agents|serotonin agents|mesh-ancestor
6555549|NCT00918411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6555550|NCT00918411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555551|NCT00918424|Oxcarbazepine|oxcarbazepine|mesh-list
6555552|NCT00918424|Anticonvulsants|anticonvulsants|mesh-ancestor
6555553|NCT00918424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6555554|NCT00918424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6555555|NCT00918424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6555556|NCT00918424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555557|NCT00918424|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6555558|NCT00918424|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6555559|NCT00918450|Navitoclax|navitoclax|mesh-list
6555560|NCT00918450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6555561|NCT00918476|Contraceptive Agents|contraceptive agents|mesh-list
6555562|NCT00918476|Contraceptives, Oral|contraceptives, oral|mesh-list
6555563|NCT00918476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6555564|NCT00918476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555565|NCT00918476|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6555566|NCT00918489|Vorinostat|vorinostat|mesh-list
6555567|NCT00918489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6555568|NCT00918489|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6555569|NCT00918489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6555570|NCT00918489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555571|NCT00918528|Mitomycins|mitomycins|mesh-list
6555572|NCT00918528|Mitomycin|mitomycin|mesh-list
6555573|NCT00918528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6555574|NCT00918528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6555575|NCT00918528|Alkylating Agents|alkylating agents|mesh-ancestor
6555576|NCT00918528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555577|NCT00918528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6555578|NCT00918528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6555579|NCT00918554|Methotrexate|methotrexate|mesh-list
6555580|NCT00918554|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6555581|NCT00918554|Abortifacient Agents|abortifacient agents|mesh-ancestor
6555582|NCT00918554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6555583|NCT00918554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555584|NCT00918554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6555585|NCT00918554|Antimetabolites|antimetabolites|mesh-ancestor
6555586|NCT00918554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555587|NCT00918554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6555588|NCT00918554|Dermatologic Agents|dermatologic agents|mesh-ancestor
6555589|NCT00918554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6555590|NCT00918554|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6555591|NCT00918554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6555592|NCT00918554|Immunologic Factors|immunologic factors|mesh-ancestor
6555593|NCT00918554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6555594|NCT00918554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6555595|NCT00918593|Bleomycin|bleomycin|mesh-list
6555596|NCT00918593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6555597|NCT00918593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6555598|NCT00918632|Axitinib|axitinib|mesh-list
6443351|NCT00379028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6443352|NCT00379028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555599|NCT00918632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6555600|NCT00918632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6555601|NCT00918632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6555602|NCT00918632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555603|NCT00918840|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6555604|NCT00918840|Antiviral Agents|antiviral agents|mesh-ancestor
6555605|NCT00918840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6555606|NCT00918853|Pancrelipase|pancrelipase|mesh-list
6555607|NCT00918853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6555608|NCT00919022|Cyproterone Acetate|cyproterone acetate|mesh-list
6555609|NCT00919022|Cyproterone|cyproterone|mesh-list
6555610|NCT00919022|Androgen Antagonists|androgen antagonists|mesh-ancestor
6555611|NCT00919022|Hormone Antagonists|hormone antagonists|mesh-ancestor
6555612|NCT00919022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6555613|NCT00919022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555614|NCT00919022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6555615|NCT00919022|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6555616|NCT00919022|Contraceptive Agents|contraceptive agents|mesh-ancestor
6555617|NCT00919022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6555618|NCT00919178|Vaccines|vaccines|mesh-list
6555619|NCT00919178|Immunologic Factors|immunologic factors|mesh-ancestor
6555620|NCT00919178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555621|NCT00919204|Axitinib|axitinib|mesh-list
6555622|NCT00919204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6555623|NCT00919204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6555624|NCT00919204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6555625|NCT00919204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555626|NCT00919243|Prednisone|prednisone|mesh-list
6555627|NCT00919243|Allopurinol|allopurinol|mesh-list
6555628|NCT00919243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6555629|NCT00919243|Glucocorticoids|glucocorticoids|mesh-ancestor
6555630|NCT00919243|Hormones|hormones|mesh-ancestor
6555631|NCT00919243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6555632|NCT00919243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555633|NCT00919243|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6555634|NCT00919243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6555635|NCT00919243|Antimetabolites|antimetabolites|mesh-ancestor
6555636|NCT00919243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555637|NCT00919243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6555638|NCT00919243|Gout Suppressants|gout suppressants|mesh-ancestor
6555639|NCT00919243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6555640|NCT00919243|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6555641|NCT00919243|Antioxidants|antioxidants|mesh-ancestor
6555642|NCT00919243|Protective Agents|protective agents|mesh-ancestor
6555643|NCT00919282|Leucovorin|leucovorin|mesh-list
6555644|NCT00919282|Folic Acid|folic acid|mesh-list
6555645|NCT00919282|Gemcitabine|gemcitabine|mesh-list
6555646|NCT00919282|Levoleucovorin|levoleucovorin|mesh-list
6555647|NCT00919282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6555648|NCT00919282|Antimetabolites|antimetabolites|mesh-ancestor
6555649|NCT00919282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555650|NCT00919282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6555651|NCT00919282|Antiviral Agents|antiviral agents|mesh-ancestor
6555652|NCT00919282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6555653|NCT00919282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6555654|NCT00919282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6555655|NCT00919282|Immunologic Factors|immunologic factors|mesh-ancestor
6443353|NCT00379028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6443354|NCT00379028|Respiratory System Agents|respiratory system agents|mesh-ancestor
6443355|NCT00379028|Dermatologic Agents|dermatologic agents|mesh-ancestor
6443356|NCT00379028|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6443357|NCT00379028|Glucocorticoids|glucocorticoids|mesh-ancestor
6443358|NCT00379028|Hormones|hormones|mesh-ancestor
6443359|NCT00379028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6443360|NCT00379028|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6443361|NCT00379028|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6443362|NCT00379028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6443363|NCT00379028|Adrenergic Agents|adrenergic agents|mesh-ancestor
6443364|NCT00379028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6443365|NCT00379028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555656|NCT00919282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555657|NCT00919282|Antidotes|antidotes|mesh-ancestor
6555658|NCT00919282|Protective Agents|protective agents|mesh-ancestor
6555659|NCT00919282|Vitamin B Complex|vitamin b complex|mesh-ancestor
6555660|NCT00919282|Vitamins|vitamins|mesh-ancestor
6555661|NCT00919282|Micronutrients|micronutrients|mesh-ancestor
6555662|NCT00919282|Hematinics|hematinics|mesh-ancestor
6555663|NCT00919295|Mirtazapine|mirtazapine|mesh-list
6555664|NCT00919295|Antidepressive Agents|antidepressive agents|mesh-ancestor
6555665|NCT00919295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6555666|NCT00919295|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6555667|NCT00919295|Histamine Antagonists|histamine antagonists|mesh-ancestor
6555668|NCT00919295|Histamine Agents|histamine agents|mesh-ancestor
6555669|NCT00919295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6555670|NCT00919295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555671|NCT00919295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555672|NCT00919295|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6555673|NCT00919295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6555674|NCT00919295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6555675|NCT00919295|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6555676|NCT00919295|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6555677|NCT00919295|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6555678|NCT00919295|Adrenergic Agents|adrenergic agents|mesh-ancestor
6555679|NCT00919295|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6555680|NCT00919295|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6555681|NCT00919295|Serotonin Agents|serotonin agents|mesh-ancestor
6555682|NCT00919295|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6555683|NCT00919321|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6555684|NCT00919321|Immunologic Factors|immunologic factors|mesh-ancestor
6555685|NCT00919321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555686|NCT00919399|Tamoxifen|tamoxifen|mesh-list
6555687|NCT00919399|Exemestane|exemestane|mesh-list
6555688|NCT00919399|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6555689|NCT00919399|Hormone Antagonists|hormone antagonists|mesh-ancestor
6555690|NCT00919399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6555691|NCT00919399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555692|NCT00919399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6555693|NCT00919399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6555694|NCT00919399|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6555695|NCT00919399|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6555696|NCT00919399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6555697|NCT00919399|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6555698|NCT00919399|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6555699|NCT00919399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6555700|NCT00919399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555701|NCT00919438|Diuretics|diuretics|mesh-list
6555702|NCT00919438|Natriuretic Agents|natriuretic agents|mesh-ancestor
6555703|NCT00919438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555704|NCT00919451|Cyclosporine|cyclosporine|mesh-list
6555705|NCT00919451|Cyclosporins|cyclosporins|mesh-list
6555706|NCT00919451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6555707|NCT00919451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555708|NCT00919451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6555709|NCT00919451|Immunologic Factors|immunologic factors|mesh-ancestor
6555710|NCT00919451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555711|NCT00919451|Antifungal Agents|antifungal agents|mesh-ancestor
6555712|NCT00919451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6555713|NCT00919451|Dermatologic Agents|dermatologic agents|mesh-ancestor
6555714|NCT00919451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6555715|NCT00919451|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6555716|NCT00919542|Cyclosporine|cyclosporine|mesh-list
6555717|NCT00919542|Prednisolone|prednisolone|mesh-list
6555718|NCT00919542|Cyclosporins|cyclosporins|mesh-list
6555719|NCT00919542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6555720|NCT00919542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555721|NCT00919542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6555722|NCT00919542|Immunologic Factors|immunologic factors|mesh-ancestor
6555723|NCT00919542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555724|NCT00919542|Antifungal Agents|antifungal agents|mesh-ancestor
6555725|NCT00919542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6555726|NCT00919542|Dermatologic Agents|dermatologic agents|mesh-ancestor
6555727|NCT00919542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6555728|NCT00919542|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6555729|NCT00919542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6555730|NCT00919542|Glucocorticoids|glucocorticoids|mesh-ancestor
6555731|NCT00919542|Hormones|hormones|mesh-ancestor
6555732|NCT00919542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6555733|NCT00919542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6555734|NCT00919542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6555735|NCT00919555|Pioglitazone|pioglitazone|mesh-list
6555736|NCT00919555|Tretinoin|tretinoin|mesh-list
6555737|NCT00919555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6555738|NCT00919555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555739|NCT00919555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6555740|NCT00919555|Keratolytic Agents|keratolytic agents|mesh-ancestor
6555741|NCT00919555|Dermatologic Agents|dermatologic agents|mesh-ancestor
6555742|NCT00919607|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6555743|NCT00919607|Antidepressive Agents|antidepressive agents|mesh-ancestor
6555744|NCT00919607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6555745|NCT00919607|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6555746|NCT00919607|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6555747|NCT00919607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6555748|NCT00919607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555749|NCT00919776|Cyclosporine|cyclosporine|mesh-list
6555750|NCT00919776|Prednisolone|prednisolone|mesh-list
6555751|NCT00919776|Cyclosporins|cyclosporins|mesh-list
6555752|NCT00919776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6555753|NCT00919776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555754|NCT00919776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6555755|NCT00919776|Immunologic Factors|immunologic factors|mesh-ancestor
6555756|NCT00919776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555757|NCT00919776|Antifungal Agents|antifungal agents|mesh-ancestor
6555758|NCT00919776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6555759|NCT00919776|Dermatologic Agents|dermatologic agents|mesh-ancestor
6555760|NCT00919776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6555761|NCT00919776|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6555762|NCT00919776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6555763|NCT00919776|Glucocorticoids|glucocorticoids|mesh-ancestor
6555764|NCT00919776|Hormones|hormones|mesh-ancestor
6555765|NCT00919776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6555766|NCT00919776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6555767|NCT00919776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6555768|NCT00919815|Cyclosporine|cyclosporine|mesh-list
6555769|NCT00919815|Prednisolone|prednisolone|mesh-list
6555770|NCT00919815|Cyclosporins|cyclosporins|mesh-list
6555771|NCT00919815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6555772|NCT00919815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555773|NCT00919815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6555774|NCT00919815|Immunologic Factors|immunologic factors|mesh-ancestor
6555775|NCT00919815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555776|NCT00919815|Antifungal Agents|antifungal agents|mesh-ancestor
6555777|NCT00919815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6555778|NCT00919815|Dermatologic Agents|dermatologic agents|mesh-ancestor
6555779|NCT00919815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6555780|NCT00919815|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6555781|NCT00919815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6555782|NCT00919815|Glucocorticoids|glucocorticoids|mesh-ancestor
6555783|NCT00919815|Hormones|hormones|mesh-ancestor
6555784|NCT00919815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6555785|NCT00919815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6555786|NCT00919815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6656593|NCT01470326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656594|NCT01470326|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6656595|NCT01470339|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6656596|NCT01470339|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6656597|NCT01470339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6656598|NCT01470339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6656599|NCT01470339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656600|NCT01470339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6656601|NCT01470339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656602|NCT01470339|Analgesics|analgesics|mesh-ancestor
6656603|NCT01470339|Sensory System Agents|sensory system agents|mesh-ancestor
6656604|NCT01470339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6656605|NCT01470339|Antidepressive Agents|antidepressive agents|mesh-ancestor
6656606|NCT01470339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6656607|NCT01470339|Dopamine Agents|dopamine agents|mesh-ancestor
6656608|NCT01470352|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6656609|NCT01470352|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6656610|NCT01470352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6656611|NCT01470352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6656612|NCT01470352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656613|NCT01470352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6656614|NCT01470352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656615|NCT01470352|Analgesics|analgesics|mesh-ancestor
6656616|NCT01470352|Sensory System Agents|sensory system agents|mesh-ancestor
6656617|NCT01470352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6656618|NCT01470352|Antidepressive Agents|antidepressive agents|mesh-ancestor
6656619|NCT01470352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6656620|NCT01470352|Dopamine Agents|dopamine agents|mesh-ancestor
6656621|NCT01470443|Oxaliplatin|oxaliplatin|mesh-list
6656622|NCT01470443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6656623|NCT01470456|Rituximab|rituximab|mesh-list
6656624|NCT01470456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6656625|NCT01470456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6656626|NCT01470456|Immunologic Factors|immunologic factors|mesh-ancestor
6443366|NCT00379041|Prednisone|prednisone|mesh-list
6443367|NCT00379041|Doxorubicin|doxorubicin|mesh-list
6555787|NCT00919880|Paclitaxel|paclitaxel|mesh-list
6555788|NCT00919880|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6555789|NCT00919880|Carboplatin|carboplatin|mesh-list
6555790|NCT00919880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6555791|NCT00919880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6555792|NCT00919880|Tubulin Modulators|tubulin modulators|mesh-ancestor
6555793|NCT00919880|Antimitotic Agents|antimitotic agents|mesh-ancestor
6555794|NCT00919880|Mitosis Modulators|mitosis modulators|mesh-ancestor
6555795|NCT00919880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555796|NCT00919919|Progesterone|progesterone|mesh-list
6555797|NCT00919919|Progestins|progestins|mesh-ancestor
6555798|NCT00919919|Hormones|hormones|mesh-ancestor
6555799|NCT00919919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6555800|NCT00919919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555801|NCT00919984|Paclitaxel|paclitaxel|mesh-list
6555802|NCT00919984|Carboplatin|carboplatin|mesh-list
6555803|NCT00919984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6555804|NCT00919984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6555805|NCT00919984|Tubulin Modulators|tubulin modulators|mesh-ancestor
6555806|NCT00919984|Antimitotic Agents|antimitotic agents|mesh-ancestor
6555807|NCT00919984|Mitosis Modulators|mitosis modulators|mesh-ancestor
6555808|NCT00919984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555809|NCT00920088|Ritonavir|ritonavir|mesh-list
6555810|NCT00920088|Lopinavir|lopinavir|mesh-list
6555811|NCT00920088|Darunavir|darunavir|mesh-list
6555812|NCT00920088|Flurbiprofen|flurbiprofen|mesh-list
6555813|NCT00920088|Midazolam|midazolam|mesh-list
6555814|NCT00920088|Dextromethorphan|dextromethorphan|mesh-list
6555815|NCT00920088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6555816|NCT00920088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6555817|NCT00920088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6555818|NCT00920088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555819|NCT00920088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6555820|NCT00920088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6555821|NCT00920088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6555822|NCT00920088|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6555823|NCT00920088|Anesthetics, General|anesthetics, general|mesh-ancestor
6555824|NCT00920088|Anesthetics|anesthetics|mesh-ancestor
6555825|NCT00920088|GABA Modulators|gaba modulators|mesh-ancestor
6555826|NCT00920088|GABA Agents|gaba agents|mesh-ancestor
6555827|NCT00920088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6555828|NCT00920088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555829|NCT00920088|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6555830|NCT00920088|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6555831|NCT00920088|Protease Inhibitors|protease inhibitors|mesh-ancestor
6555832|NCT00920088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6555833|NCT00920088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6555834|NCT00920088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6555835|NCT00920088|Antiviral Agents|antiviral agents|mesh-ancestor
6555836|NCT00920088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6555837|NCT00920088|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6555838|NCT00920088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6555839|NCT00920088|Antitussive Agents|antitussive agents|mesh-ancestor
6555840|NCT00920088|Respiratory System Agents|respiratory system agents|mesh-ancestor
6555841|NCT00920088|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6443368|NCT00379041|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6443369|NCT00379041|Bleomycin|bleomycin|mesh-list
6443370|NCT00379041|Vincristine|vincristine|mesh-list
6443371|NCT00379041|Vinblastine|vinblastine|mesh-list
6443372|NCT00379041|Procarbazine|procarbazine|mesh-list
6443373|NCT00379041|Mechlorethamine|mechlorethamine|mesh-list
6443374|NCT00379041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6443375|NCT00379041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6443376|NCT00379041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6443377|NCT00379041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6443378|NCT00379041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6555842|NCT00920088|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6555843|NCT00920088|Analgesics|analgesics|mesh-ancestor
6555844|NCT00920088|Sensory System Agents|sensory system agents|mesh-ancestor
6555845|NCT00920088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6555846|NCT00920088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6555847|NCT00920088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6555848|NCT00920088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6555849|NCT00920088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6555850|NCT00920088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6555851|NCT00920101|Atorvastatin|atorvastatin|mesh-list
6555852|NCT00920101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6555853|NCT00920101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6555854|NCT00920101|Antimetabolites|antimetabolites|mesh-ancestor
6555855|NCT00920101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555856|NCT00920101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6555857|NCT00920101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6555858|NCT00920101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6555859|NCT00920153|Gemcitabine|gemcitabine|mesh-list
6555860|NCT00920153|Cytarabine|cytarabine|mesh-list
6555861|NCT00920153|Dexamethasone|dexamethasone|mesh-list
6555862|NCT00920153|Methylprednisolone|methylprednisolone|mesh-list
6555863|NCT00920153|Doxorubicin|doxorubicin|mesh-list
6555864|NCT00920153|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6555865|NCT00920153|Etoposide|etoposide|mesh-list
6555866|NCT00920153|Vincristine|vincristine|mesh-list
6555867|NCT00920153|Melphalan|melphalan|mesh-list
6555868|NCT00920153|Vinorelbine|vinorelbine|mesh-list
6555869|NCT00920153|Ifosfamide|ifosfamide|mesh-list
6555870|NCT00920153|Dacarbazine|dacarbazine|mesh-list
6555871|NCT00920153|Carmustine|carmustine|mesh-list
6555872|NCT00920153|Bleomycin|bleomycin|mesh-list
6555873|NCT00920153|Vindesine|vindesine|mesh-list
6555874|NCT00920153|Mitoguazone|mitoguazone|mesh-list
6555875|NCT00920153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6555876|NCT00920153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6555877|NCT00920153|Antiemetics|antiemetics|mesh-ancestor
6555878|NCT00920153|Autonomic Agents|autonomic agents|mesh-ancestor
6555879|NCT00920153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6555880|NCT00920153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555881|NCT00920153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6555882|NCT00920153|Glucocorticoids|glucocorticoids|mesh-ancestor
6555883|NCT00920153|Hormones|hormones|mesh-ancestor
6555884|NCT00920153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6555885|NCT00920153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6555886|NCT00920153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6555887|NCT00920153|Antimetabolites|antimetabolites|mesh-ancestor
6555888|NCT00920153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555889|NCT00920153|Antiviral Agents|antiviral agents|mesh-ancestor
6555890|NCT00920153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6555891|NCT00920153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6555892|NCT00920153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6555893|NCT00920153|Immunologic Factors|immunologic factors|mesh-ancestor
6555894|NCT00920153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6555895|NCT00920153|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6555896|NCT00920153|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6555897|NCT00920153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6555898|NCT00920153|Tubulin Modulators|tubulin modulators|mesh-ancestor
6555899|NCT00920153|Antimitotic Agents|antimitotic agents|mesh-ancestor
6555900|NCT00920153|Mitosis Modulators|mitosis modulators|mesh-ancestor
6555901|NCT00920153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6555902|NCT00920153|Alkylating Agents|alkylating agents|mesh-ancestor
6555903|NCT00920153|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6555904|NCT00920153|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6555905|NCT00920153|Protective Agents|protective agents|mesh-ancestor
6555906|NCT00920244|Atropine|atropine|mesh-list
6555907|NCT00920244|Amiodarone|amiodarone|mesh-list
6555908|NCT00920244|Epinephrine|epinephrine|mesh-list
6555909|NCT00920244|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6555910|NCT00920244|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6555911|NCT00920244|Adrenergic Agents|adrenergic agents|mesh-ancestor
6555912|NCT00920244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6555913|NCT00920244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555914|NCT00920244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555915|NCT00920244|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6555916|NCT00920244|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6555917|NCT00920244|Autonomic Agents|autonomic agents|mesh-ancestor
6555918|NCT00920244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6555919|NCT00920244|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6555920|NCT00920244|Respiratory System Agents|respiratory system agents|mesh-ancestor
6555921|NCT00920244|Mydriatics|mydriatics|mesh-ancestor
6555922|NCT00920244|Sympathomimetics|sympathomimetics|mesh-ancestor
6555923|NCT00920244|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6555924|NCT00920244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6555925|NCT00920244|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6555926|NCT00920244|Parasympatholytics|parasympatholytics|mesh-ancestor
6555927|NCT00920244|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6555928|NCT00920244|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6555929|NCT00920244|Cholinergic Agents|cholinergic agents|mesh-ancestor
6555930|NCT00920244|Vasodilator Agents|vasodilator agents|mesh-ancestor
6555931|NCT00920244|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6555932|NCT00920244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6555933|NCT00920244|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6555934|NCT00920244|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6555935|NCT00920244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6555936|NCT00920244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6555937|NCT00920244|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6555938|NCT00920244|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6555939|NCT00920244|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6555940|NCT00920270|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6555941|NCT00920270|Colistin|colistin|mesh-list
6555942|NCT00920270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6555943|NCT00920283|Cobalt|cobalt|mesh-list
6555944|NCT00920283|Trace Elements|trace elements|mesh-ancestor
6555945|NCT00920283|Micronutrients|micronutrients|mesh-ancestor
6555946|NCT00920283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555947|NCT00920296|Cabotegravir|cabotegravir|mesh-list
6555948|NCT00920296|Etravirine|etravirine|mesh-list
6555949|NCT00920296|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6555950|NCT00920296|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6443379|NCT00379041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443380|NCT00379041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6443381|NCT00379041|Glucocorticoids|glucocorticoids|mesh-ancestor
6443382|NCT00379041|Hormones|hormones|mesh-ancestor
6555951|NCT00920296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6555952|NCT00920296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555953|NCT00920296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6555954|NCT00920296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6555955|NCT00920296|Antiviral Agents|antiviral agents|mesh-ancestor
6555956|NCT00920296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6555957|NCT00920296|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6555958|NCT00920296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6555959|NCT00920413|Ascorbic Acid|ascorbic acid|mesh-list
6555960|NCT00920413|Vitamins|vitamins|mesh-ancestor
6555961|NCT00920413|Micronutrients|micronutrients|mesh-ancestor
6555962|NCT00920413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555963|NCT00920413|Antioxidants|antioxidants|mesh-ancestor
6555964|NCT00920413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555965|NCT00920413|Protective Agents|protective agents|mesh-ancestor
6555966|NCT00920465|Misoprostol|misoprostol|mesh-list
6555967|NCT00920465|Mifepristone|mifepristone|mesh-list
6555968|NCT00920465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6555969|NCT00920465|Abortifacient Agents|abortifacient agents|mesh-ancestor
6555970|NCT00920465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6555971|NCT00920465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555972|NCT00920465|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6555973|NCT00920465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6555974|NCT00920465|Oxytocics|oxytocics|mesh-ancestor
6555975|NCT00920465|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6555976|NCT00920465|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6555977|NCT00920465|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6555978|NCT00920465|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6555979|NCT00920465|Contraceptive Agents|contraceptive agents|mesh-ancestor
6555980|NCT00920465|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6555981|NCT00920465|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6555982|NCT00920465|Hormone Antagonists|hormone antagonists|mesh-ancestor
6555983|NCT00920465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6555984|NCT00920465|Luteolytic Agents|luteolytic agents|mesh-ancestor
6555985|NCT00920465|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6555986|NCT00920465|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6443383|NCT00379041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6443384|NCT00379041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443385|NCT00379041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6443386|NCT00379041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6443387|NCT00379041|Tubulin Modulators|tubulin modulators|mesh-ancestor
6443388|NCT00379041|Antimitotic Agents|antimitotic agents|mesh-ancestor
6443389|NCT00379041|Mitosis Modulators|mitosis modulators|mesh-ancestor
6443390|NCT00379041|Alkylating Agents|alkylating agents|mesh-ancestor
6443391|NCT00379041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6443392|NCT00379067|Tamsulosin|tamsulosin|mesh-list
6443393|NCT00379067|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6443394|NCT00379067|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6443395|NCT00379067|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6443396|NCT00379067|Adrenergic Agents|adrenergic agents|mesh-ancestor
6443397|NCT00379067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6443398|NCT00379067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443399|NCT00379067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443400|NCT00379067|Urological Agents|urological agents|mesh-ancestor
6443401|NCT00379158|Micronutrients|micronutrients|mesh-list
6443402|NCT00379158|Trace Elements|trace elements|mesh-list
6443403|NCT00379158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443404|NCT00379249|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6443405|NCT00379249|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6443406|NCT00379249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6443407|NCT00379249|Antimetabolites|antimetabolites|mesh-ancestor
6443408|NCT00379249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443409|NCT00379249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6443410|NCT00379249|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6443411|NCT00379249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6443412|NCT00379262|Fluorouracil|fluorouracil|mesh-list
6443413|NCT00379262|Capecitabine|capecitabine|mesh-list
6555987|NCT00920608|Methotrexate|methotrexate|mesh-list
6555988|NCT00920608|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6555989|NCT00920608|Abortifacient Agents|abortifacient agents|mesh-ancestor
6555990|NCT00920608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6555991|NCT00920608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6555992|NCT00920608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6555993|NCT00920608|Antimetabolites|antimetabolites|mesh-ancestor
6555994|NCT00920608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6555995|NCT00920608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6555996|NCT00920608|Dermatologic Agents|dermatologic agents|mesh-ancestor
6555997|NCT00920608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6555998|NCT00920608|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6555999|NCT00920608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6556000|NCT00920608|Immunologic Factors|immunologic factors|mesh-ancestor
6556001|NCT00920608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6556002|NCT00920608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6556003|NCT00920660|Prednisolone|prednisolone|mesh-list
6556004|NCT00920660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6556005|NCT00920660|Glucocorticoids|glucocorticoids|mesh-ancestor
6556006|NCT00920660|Hormones|hormones|mesh-ancestor
6556007|NCT00920660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6556008|NCT00920660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556009|NCT00920660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6556010|NCT00920660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6556011|NCT00920725|Insulin|insulin|mesh-list
6556012|NCT00920725|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6556013|NCT00920725|Insulin Aspart|insulin aspart|mesh-list
6556014|NCT00920725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6556015|NCT00920725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556016|NCT00920803|Resveratrol|resveratrol|mesh-list
6556017|NCT00920803|Antioxidants|antioxidants|mesh-ancestor
6556018|NCT00920803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556019|NCT00920803|Protective Agents|protective agents|mesh-ancestor
6556020|NCT00920803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556021|NCT00920803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6556022|NCT00920803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6556023|NCT00920868|Bevacizumab|bevacizumab|mesh-list
6556024|NCT00920868|Capecitabine|capecitabine|mesh-list
6556025|NCT00920868|Oxaliplatin|oxaliplatin|mesh-list
6556026|NCT00920868|Dasatinib|dasatinib|mesh-list
6556027|NCT00920868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6556028|NCT00920868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6556029|NCT00920868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6556030|NCT00920868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6556031|NCT00920868|Growth Substances|growth substances|mesh-ancestor
6556032|NCT00920868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556033|NCT00920868|Growth Inhibitors|growth inhibitors|mesh-ancestor
6556034|NCT00920868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6556035|NCT00920868|Antimetabolites|antimetabolites|mesh-ancestor
6556036|NCT00920868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556037|NCT00920868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6556038|NCT00920868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6556039|NCT00920933|Prednisolone|prednisolone|mesh-list
6556040|NCT00920933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6556041|NCT00920933|Glucocorticoids|glucocorticoids|mesh-ancestor
6556042|NCT00920933|Hormones|hormones|mesh-ancestor
6556043|NCT00920933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6556044|NCT00920933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556045|NCT00920933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6556046|NCT00920933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6556047|NCT00920998|Z 338|z 338|mesh-list
6556048|NCT00920998|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6556049|NCT00920998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6556050|NCT00920998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556051|NCT00920998|Cholinergic Agents|cholinergic agents|mesh-ancestor
6556052|NCT00920998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6556053|NCT00920998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556054|NCT00920998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6556055|NCT00921063|Alprazolam|alprazolam|mesh-list
6556056|NCT00921063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6556057|NCT00921063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6556058|NCT00921063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556059|NCT00921063|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6556060|NCT00921063|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6556061|NCT00921063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6556062|NCT00921063|GABA Modulators|gaba modulators|mesh-ancestor
6556063|NCT00921063|GABA Agents|gaba agents|mesh-ancestor
6556064|NCT00921063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6556065|NCT00921063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556066|NCT00921102|Atropine|atropine|mesh-list
6556067|NCT00921102|Morphine|morphine|mesh-list
6556068|NCT00921102|Bupivacaine|bupivacaine|mesh-list
6556069|NCT00921102|Anesthetics, Local|anesthetics, local|mesh-list
6556070|NCT00921102|Anesthetics|anesthetics|mesh-list
6556071|NCT00921102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6556072|NCT00921102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556073|NCT00921102|Sensory System Agents|sensory system agents|mesh-ancestor
6556074|NCT00921102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6556075|NCT00921102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6556076|NCT00921102|Narcotics|narcotics|mesh-ancestor
6556077|NCT00921102|Analgesics|analgesics|mesh-ancestor
6556078|NCT00921102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6556079|NCT00921102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6556080|NCT00921102|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6556081|NCT00921102|Autonomic Agents|autonomic agents|mesh-ancestor
6556082|NCT00921102|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6556083|NCT00921102|Respiratory System Agents|respiratory system agents|mesh-ancestor
6556084|NCT00921102|Mydriatics|mydriatics|mesh-ancestor
6556085|NCT00921102|Parasympatholytics|parasympatholytics|mesh-ancestor
6556086|NCT00921102|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6556087|NCT00921102|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6556088|NCT00921102|Cholinergic Agents|cholinergic agents|mesh-ancestor
6556089|NCT00921102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6556090|NCT00921102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556091|NCT00921128|Muscimol|muscimol|mesh-list
6556092|NCT00921128|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6556093|NCT00921128|GABA Agonists|gaba agonists|mesh-ancestor
6556094|NCT00921128|GABA Agents|gaba agents|mesh-ancestor
6556095|NCT00921128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6556096|NCT00921128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556097|NCT00921128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556098|NCT00921154|Ivermectin|ivermectin|mesh-list
6556099|NCT00921154|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6556100|NCT00921154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6556101|NCT00921167|Bevacizumab|bevacizumab|mesh-list
6556102|NCT00921167|Irinotecan|irinotecan|mesh-list
6556103|NCT00921167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6556104|NCT00921167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6556105|NCT00921167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6556106|NCT00921167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6556107|NCT00921167|Growth Substances|growth substances|mesh-ancestor
6556108|NCT00921167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556109|NCT00921167|Growth Inhibitors|growth inhibitors|mesh-ancestor
6556110|NCT00921167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6556111|NCT00921167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6556112|NCT00921167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6556113|NCT00921167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556114|NCT00921180|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6556115|NCT00921180|Interferon-alpha|interferon-alpha|mesh-list
6556116|NCT00921180|Entecavir|entecavir|mesh-list
6556117|NCT00921180|Antiviral Agents|antiviral agents|mesh-ancestor
6556118|NCT00921180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6556119|NCT00921180|Immunologic Factors|immunologic factors|mesh-ancestor
6556120|NCT00921180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556121|NCT00921219|Ivermectin|ivermectin|mesh-list
6556122|NCT00921219|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6556123|NCT00921219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6556124|NCT00921245|Darifenacin|darifenacin|mesh-list
6556125|NCT00921245|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6556126|NCT00921245|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6556127|NCT00921245|Cholinergic Agents|cholinergic agents|mesh-ancestor
6556128|NCT00921245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6556129|NCT00921245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556130|NCT00921245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556131|NCT00921245|Urological Agents|urological agents|mesh-ancestor
6556132|NCT00921284|Dexmedetomidine|dexmedetomidine|mesh-list
6556133|NCT00921284|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6556134|NCT00921284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6556135|NCT00921284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556136|NCT00921284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6556137|NCT00921284|Analgesics|analgesics|mesh-ancestor
6556138|NCT00921284|Sensory System Agents|sensory system agents|mesh-ancestor
6556139|NCT00921284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6556140|NCT00921284|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6556141|NCT00921284|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6556142|NCT00921284|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6556143|NCT00921284|Adrenergic Agents|adrenergic agents|mesh-ancestor
6556144|NCT00921284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6556145|NCT00921284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556146|NCT00921349|Nadolol|nadolol|mesh-list
6556147|NCT00921349|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6556148|NCT00921349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6556149|NCT00921349|Adrenergic Agents|adrenergic agents|mesh-ancestor
6556150|NCT00921349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6556151|NCT00921349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556152|NCT00921349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556153|NCT00921349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6556154|NCT00921349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6556155|NCT00921349|Sympatholytics|sympatholytics|mesh-ancestor
6556156|NCT00921349|Autonomic Agents|autonomic agents|mesh-ancestor
6556157|NCT00921349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6556158|NCT00921388|Varenicline|varenicline|mesh-list
6556159|NCT00921388|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6556160|NCT00921388|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6556161|NCT00921388|Cholinergic Agents|cholinergic agents|mesh-ancestor
6556162|NCT00921388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6556163|NCT00921388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556164|NCT00921388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556165|NCT00921414|Rituximab|rituximab|mesh-list
6556166|NCT00921414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6556167|NCT00921414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6556168|NCT00921414|Immunologic Factors|immunologic factors|mesh-ancestor
6556169|NCT00921414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556170|NCT00921414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6556171|NCT00921505|Acetaminophen|acetaminophen|mesh-list
6556172|NCT00921505|Ibuprofen|ibuprofen|mesh-list
6556173|NCT00921505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6556174|NCT00921505|Analgesics|analgesics|mesh-ancestor
6556175|NCT00921505|Sensory System Agents|sensory system agents|mesh-ancestor
6556176|NCT00921505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6556177|NCT00921505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556178|NCT00921505|Antipyretics|antipyretics|mesh-ancestor
6556179|NCT00921505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6556180|NCT00921505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6556181|NCT00921505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6556182|NCT00921505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6556183|NCT00921505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6556184|NCT00921505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556185|NCT00921531|Thalidomide|thalidomide|mesh-list
6556186|NCT00921531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6556187|NCT00921531|Immunologic Factors|immunologic factors|mesh-ancestor
6556188|NCT00921531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556189|NCT00921531|Leprostatic Agents|leprostatic agents|mesh-ancestor
6556190|NCT00921531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6556191|NCT00921531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6556192|NCT00921531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6556193|NCT00921531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6556194|NCT00921531|Growth Substances|growth substances|mesh-ancestor
6556195|NCT00921531|Growth Inhibitors|growth inhibitors|mesh-ancestor
6556196|NCT00921531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6556197|NCT00921570|Amlodipine|amlodipine|mesh-list
6556198|NCT00921570|Valsartan|valsartan|mesh-list
6556199|NCT00921570|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6556200|NCT00921570|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6556201|NCT00921570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6556202|NCT00921570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556203|NCT00921570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6556204|NCT00921570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556205|NCT00921570|Vasodilator Agents|vasodilator agents|mesh-ancestor
6556206|NCT00921570|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6556207|NCT00921570|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6656627|NCT01470456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656628|NCT01470456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6656629|NCT01470495|Sorafenib|sorafenib|mesh-list
6656630|NCT01470495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6656631|NCT01470495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6656632|NCT01470495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6656633|NCT01470495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656634|NCT01470690|Omeprazole|omeprazole|mesh-list
6656635|NCT01470690|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6656636|NCT01470690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6656637|NCT01470690|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6656638|NCT01470690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6656639|NCT01470690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656640|NCT01470716|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6656641|NCT01470716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6656642|NCT01470716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6656643|NCT01470716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6656644|NCT01470716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656645|NCT01470742|Capecitabine|capecitabine|mesh-list
6656646|NCT01470742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6656647|NCT01470742|Antimetabolites|antimetabolites|mesh-ancestor
6656648|NCT01470742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656649|NCT01470742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6656650|NCT01470755|Albuterol|albuterol|mesh-list
6656651|NCT01470755|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6656652|NCT01470755|Autonomic Agents|autonomic agents|mesh-ancestor
6656653|NCT01470755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6656654|NCT01470755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656655|NCT01470755|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6664722|NCT01513720|Lamotrigine|lamotrigine|mesh-list
6556208|NCT00921622|Vitamin D|vitamin d|mesh-list
6556209|NCT00921622|Vitamins|vitamins|mesh-list
6556210|NCT00921622|Ascorbic Acid|ascorbic acid|mesh-list
6556211|NCT00921622|Micronutrients|micronutrients|mesh-ancestor
6556212|NCT00921622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556213|NCT00921622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6556214|NCT00921622|Antioxidants|antioxidants|mesh-ancestor
6556215|NCT00921622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556216|NCT00921622|Protective Agents|protective agents|mesh-ancestor
6556217|NCT00921661|Aflibercept|aflibercept|mesh-list
6556218|NCT00921661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6556219|NCT00921661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6556220|NCT00921661|Growth Substances|growth substances|mesh-ancestor
6556221|NCT00921661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556222|NCT00921661|Growth Inhibitors|growth inhibitors|mesh-ancestor
6556223|NCT00921661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6556224|NCT00921674|Ivermectin|ivermectin|mesh-list
6556225|NCT00921674|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6556226|NCT00921674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6556227|NCT00921700|Acetaminophen|acetaminophen|mesh-list
6556228|NCT00921700|Ibuprofen|ibuprofen|mesh-list
6556229|NCT00921700|Codeine|codeine|mesh-list
6556230|NCT00921700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6556231|NCT00921700|Analgesics|analgesics|mesh-ancestor
6556232|NCT00921700|Sensory System Agents|sensory system agents|mesh-ancestor
6556233|NCT00921700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6556234|NCT00921700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556235|NCT00921700|Antipyretics|antipyretics|mesh-ancestor
6556236|NCT00921700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6556237|NCT00921700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6556238|NCT00921700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6556239|NCT00921700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6556240|NCT00921700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6556241|NCT00921700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556242|NCT00921700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6556243|NCT00921700|Narcotics|narcotics|mesh-ancestor
6556244|NCT00921700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6556245|NCT00921700|Antitussive Agents|antitussive agents|mesh-ancestor
6556246|NCT00921700|Respiratory System Agents|respiratory system agents|mesh-ancestor
6556247|NCT00921726|Oseltamivir|oseltamivir|mesh-list
6556248|NCT00921726|Zanamivir|zanamivir|mesh-list
6556249|NCT00921726|Antiviral Agents|antiviral agents|mesh-ancestor
6556250|NCT00921726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6556251|NCT00921726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6556252|NCT00921726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556253|NCT00921765|Ketamine|ketamine|mesh-list
6556254|NCT00921765|Naloxone|naloxone|mesh-list
6556255|NCT00921765|Analgesics|analgesics|mesh-ancestor
6556256|NCT00921765|Sensory System Agents|sensory system agents|mesh-ancestor
6556257|NCT00921765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6556258|NCT00921765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556259|NCT00921765|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6556260|NCT00921765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6556261|NCT00921765|Anesthetics, General|anesthetics, general|mesh-ancestor
6556262|NCT00921765|Anesthetics|anesthetics|mesh-ancestor
6556263|NCT00921765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6556264|NCT00921765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6556265|NCT00921765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6556266|NCT00921765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6556267|NCT00921765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556268|NCT00921765|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6556269|NCT00921804|Risperidone|risperidone|mesh-list
6556270|NCT00921804|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6556271|NCT00921804|Serotonin Agents|serotonin agents|mesh-ancestor
6556272|NCT00921804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6556273|NCT00921804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556274|NCT00921804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556275|NCT00921804|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6556276|NCT00921804|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6556277|NCT00921804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6556278|NCT00921804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6556279|NCT00921804|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6556280|NCT00921804|Dopamine Agents|dopamine agents|mesh-ancestor
6556281|NCT00921830|Ibuprofen|ibuprofen|mesh-list
6556282|NCT00921830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6556283|NCT00921830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6556284|NCT00921830|Analgesics|analgesics|mesh-ancestor
6556285|NCT00921830|Sensory System Agents|sensory system agents|mesh-ancestor
6556286|NCT00921830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6556287|NCT00921830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556288|NCT00921830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6556289|NCT00921830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6556290|NCT00921830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6556291|NCT00921830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6556292|NCT00921830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556293|NCT00921973|Vaccines|vaccines|mesh-list
6556294|NCT00921973|Immunologic Factors|immunologic factors|mesh-ancestor
6556295|NCT00921973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556296|NCT00922129|Cyclosporine|cyclosporine|mesh-list
6556297|NCT00922129|Sirolimus|sirolimus|mesh-list
6556298|NCT00922129|Tacrolimus|tacrolimus|mesh-list
6556299|NCT00922129|Cyclosporins|cyclosporins|mesh-list
6556300|NCT00922129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6556301|NCT00922129|Immunologic Factors|immunologic factors|mesh-ancestor
6556302|NCT00922129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556303|NCT00922129|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6556304|NCT00922129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6556305|NCT00922129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556306|NCT00922129|Antifungal Agents|antifungal agents|mesh-ancestor
6556307|NCT00922129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6556308|NCT00922129|Dermatologic Agents|dermatologic agents|mesh-ancestor
6556309|NCT00922129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6556310|NCT00922129|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6556311|NCT00922129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6556312|NCT00922129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6556313|NCT00922389|Lenograstim|lenograstim|mesh-list
6556314|NCT00922389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6556315|NCT00922389|Immunologic Factors|immunologic factors|mesh-ancestor
6556316|NCT00922389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556317|NCT00922402|Insulin|insulin|mesh-list
6556318|NCT00922402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6556319|NCT00922402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556320|NCT00922467|Esmolol|esmolol|mesh-list
6556321|NCT00922467|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6556322|NCT00922467|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6556323|NCT00922467|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6556324|NCT00922467|Adrenergic Agents|adrenergic agents|mesh-ancestor
6556325|NCT00922467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6556326|NCT00922467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556327|NCT00922467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556328|NCT00922506|Doxazosin|doxazosin|mesh-list
6556329|NCT00922506|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6556330|NCT00922506|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6556331|NCT00922506|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6556332|NCT00922506|Cholinergic Agents|cholinergic agents|mesh-ancestor
6556333|NCT00922506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6556334|NCT00922506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556335|NCT00922506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556336|NCT00922506|Urological Agents|urological agents|mesh-ancestor
6556337|NCT00922506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6556338|NCT00922506|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6556339|NCT00922506|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6556340|NCT00922506|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6556341|NCT00922506|Adrenergic Agents|adrenergic agents|mesh-ancestor
6556342|NCT00922519|Listerine|listerine|mesh-list
6556343|NCT00922519|Fluorides|fluorides|mesh-list
6556344|NCT00922519|Sodium Fluoride|sodium fluoride|mesh-list
6556345|NCT00922519|Cariostatic Agents|cariostatic agents|mesh-ancestor
6556346|NCT00922519|Protective Agents|protective agents|mesh-ancestor
6556347|NCT00922519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556348|NCT00922519|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6556349|NCT00922519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6556350|NCT00922532|Nitric Oxide|nitric oxide|mesh-list
6556351|NCT00922532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6556352|NCT00922532|Autonomic Agents|autonomic agents|mesh-ancestor
6556353|NCT00922532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6556354|NCT00922532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556355|NCT00922532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6556356|NCT00922532|Respiratory System Agents|respiratory system agents|mesh-ancestor
6556357|NCT00922532|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6556358|NCT00922532|Antioxidants|antioxidants|mesh-ancestor
6556359|NCT00922532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556360|NCT00922532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6556361|NCT00922532|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6556362|NCT00922532|Vasodilator Agents|vasodilator agents|mesh-ancestor
6556363|NCT00922532|Gasotransmitters|gasotransmitters|mesh-ancestor
6556364|NCT00922532|Protective Agents|protective agents|mesh-ancestor
6556365|NCT00922584|Sorafenib|sorafenib|mesh-list
6556366|NCT00922584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6556367|NCT00922584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6556368|NCT00922584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6556369|NCT00922584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556370|NCT00922597|Factor VIII|factor viii|mesh-list
6556371|NCT00922597|Coagulants|coagulants|mesh-ancestor
6556372|NCT00922610|Epoetin Alfa|epoetin alfa|mesh-list
6556373|NCT00922610|Hematinics|hematinics|mesh-ancestor
6556374|NCT00922649|Insulin|insulin|mesh-list
6556375|NCT00922649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6556376|NCT00922649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556377|NCT00922844|Sevoflurane|sevoflurane|mesh-list
6556378|NCT00922844|Isoflurane|isoflurane|mesh-list
6556379|NCT00922844|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6556380|NCT00922844|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6556381|NCT00922844|Anesthetics, General|anesthetics, general|mesh-ancestor
6556382|NCT00922844|Anesthetics|anesthetics|mesh-ancestor
6556383|NCT00922844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6556384|NCT00922844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556385|NCT00922896|Gemcitabine|gemcitabine|mesh-list
6556386|NCT00922896|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6556387|NCT00922896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6556388|NCT00922896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6556389|NCT00922896|Antimetabolites|antimetabolites|mesh-ancestor
6556390|NCT00922896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556391|NCT00922896|Antiviral Agents|antiviral agents|mesh-ancestor
6556392|NCT00922896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6556393|NCT00922896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6556394|NCT00922896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6556395|NCT00922896|Immunologic Factors|immunologic factors|mesh-ancestor
6556396|NCT00922896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556397|NCT00922896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6556398|NCT00923000|Morphine|morphine|mesh-list
6556399|NCT00923000|Nalbuphine|nalbuphine|mesh-list
6556400|NCT00923000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6556401|NCT00923000|Narcotics|narcotics|mesh-ancestor
6556402|NCT00923000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6556403|NCT00923000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556404|NCT00923000|Analgesics|analgesics|mesh-ancestor
6556405|NCT00923000|Sensory System Agents|sensory system agents|mesh-ancestor
6443414|NCT00379262|Antimetabolites|antimetabolites|mesh-ancestor
6443415|NCT00379262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443416|NCT00379262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6443417|NCT00379262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6443418|NCT00379262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6443419|NCT00379262|Immunologic Factors|immunologic factors|mesh-ancestor
6443420|NCT00379262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443421|NCT00379405|Ritonavir|ritonavir|mesh-list
6443422|NCT00379405|Saquinavir|saquinavir|mesh-list
6443423|NCT00379405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6443424|NCT00379405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6443425|NCT00379405|Protease Inhibitors|protease inhibitors|mesh-ancestor
6443426|NCT00379405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6443427|NCT00379405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443428|NCT00379405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6443429|NCT00379405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6443430|NCT00379405|Antiviral Agents|antiviral agents|mesh-ancestor
6443431|NCT00379405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6443432|NCT00379405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6443433|NCT00379405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6443434|NCT00379418|Abciximab|abciximab|mesh-list
6443435|NCT00379418|Anticoagulants|anticoagulants|mesh-ancestor
6443436|NCT00379418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6556406|NCT00923000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6556407|NCT00923169|Mitogens|mitogens|mesh-list
6556408|NCT00923169|Mitosis Modulators|mitosis modulators|mesh-ancestor
6556409|NCT00923169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556410|NCT00923182|Alemtuzumab|alemtuzumab|mesh-list
6556411|NCT00923182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6556412|NCT00923182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6556413|NCT00923234|Lenalidomide|lenalidomide|mesh-list
6556414|NCT00923234|Azacitidine|azacitidine|mesh-list
6556415|NCT00923234|Immunologic Factors|immunologic factors|mesh-ancestor
6556416|NCT00923234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556417|NCT00923234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6556418|NCT00923234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6556419|NCT00923234|Growth Substances|growth substances|mesh-ancestor
6556420|NCT00923234|Growth Inhibitors|growth inhibitors|mesh-ancestor
6556421|NCT00923234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6556422|NCT00923234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6556423|NCT00923234|Antimetabolites|antimetabolites|mesh-ancestor
6556424|NCT00923234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556425|NCT00923234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6556426|NCT00923247|Bortezomib|bortezomib|mesh-list
6556427|NCT00923247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6556428|NCT00923299|Trastuzumab|trastuzumab|mesh-list
6556429|NCT00923299|Cetuximab|cetuximab|mesh-list
6556430|NCT00923299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6556431|NCT00923299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6556432|NCT00923390|Aldesleukin|aldesleukin|mesh-list
6556433|NCT00923390|Cyclophosphamide|cyclophosphamide|mesh-list
6556434|NCT00923390|Fludarabine|fludarabine|mesh-list
6556435|NCT00923390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6556436|NCT00923390|Immunologic Factors|immunologic factors|mesh-ancestor
6556437|NCT00923390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556438|NCT00923390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6556439|NCT00923390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6556440|NCT00923390|Alkylating Agents|alkylating agents|mesh-ancestor
6556441|NCT00923390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556442|NCT00923390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6556443|NCT00923390|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6556444|NCT00923390|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6556445|NCT00923390|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6556446|NCT00923390|Antiviral Agents|antiviral agents|mesh-ancestor
6556447|NCT00923390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6656656|NCT01470755|Respiratory System Agents|respiratory system agents|mesh-ancestor
6656657|NCT01470755|Tocolytic Agents|tocolytic agents|mesh-ancestor
6656658|NCT01470755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6656659|NCT01470755|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6656660|NCT01470755|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6656661|NCT01470755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6656662|NCT01470755|Adrenergic Agents|adrenergic agents|mesh-ancestor
6656663|NCT01470755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6443437|NCT00379431|Methylprednisolone|methylprednisolone|mesh-list
6443438|NCT00379431|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6443439|NCT00379431|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6443440|NCT00379431|Prednisolone|prednisolone|mesh-list
6443441|NCT00379431|Prednisolone acetate|prednisolone acetate|mesh-list
6443442|NCT00379431|Rituximab|rituximab|mesh-list
6443443|NCT00379431|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6443444|NCT00379431|Prednisolone phosphate|prednisolone phosphate|mesh-list
6443445|NCT00379431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6443446|NCT00379431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6443447|NCT00379431|Immunologic Factors|immunologic factors|mesh-ancestor
6443448|NCT00379431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443449|NCT00379431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6443450|NCT00379431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6443451|NCT00379431|Antiemetics|antiemetics|mesh-ancestor
6443452|NCT00379431|Autonomic Agents|autonomic agents|mesh-ancestor
6443453|NCT00379431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6443454|NCT00379431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6443455|NCT00379431|Glucocorticoids|glucocorticoids|mesh-ancestor
6443456|NCT00379431|Hormones|hormones|mesh-ancestor
6443457|NCT00379431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6443458|NCT00379431|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6443459|NCT00379431|Protective Agents|protective agents|mesh-ancestor
6443460|NCT00379431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6462191|NCT00458055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6556448|NCT00923494|Ropivacaine|ropivacaine|mesh-list
6556449|NCT00923494|Anesthetics, Local|anesthetics, local|mesh-ancestor
6556450|NCT00923494|Anesthetics|anesthetics|mesh-ancestor
6556451|NCT00923494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6556452|NCT00923494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556453|NCT00923494|Sensory System Agents|sensory system agents|mesh-ancestor
6556454|NCT00923494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6556455|NCT00923533|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6556456|NCT00923533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6556457|NCT00923533|Diuretics|diuretics|mesh-ancestor
6556458|NCT00923533|Natriuretic Agents|natriuretic agents|mesh-ancestor
6556459|NCT00923533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556460|NCT00923533|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6556461|NCT00923533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6556462|NCT00923533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556463|NCT00923572|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
6556464|NCT00923572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6556465|NCT00923572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556466|NCT00923637|Oxaliplatin|oxaliplatin|mesh-list
6556467|NCT00923637|Pemetrexed|pemetrexed|mesh-list
6556468|NCT00923637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6556469|NCT00923637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6556470|NCT00923637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556471|NCT00923637|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6556472|NCT00923637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6556473|NCT00923663|Lenalidomide|lenalidomide|mesh-list
6556474|NCT00923663|Immunologic Factors|immunologic factors|mesh-ancestor
6556475|NCT00923663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556476|NCT00923663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6556477|NCT00923663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6556478|NCT00923663|Growth Substances|growth substances|mesh-ancestor
6556479|NCT00923663|Growth Inhibitors|growth inhibitors|mesh-ancestor
6556480|NCT00923663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6556481|NCT00923676|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6556482|NCT00923676|Fenofibrate|fenofibrate|mesh-list
6556483|NCT00923676|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6556484|NCT00923676|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6556485|NCT00923676|Antimetabolites|antimetabolites|mesh-ancestor
6556486|NCT00923676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556487|NCT00923676|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6556488|NCT00923676|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6556489|NCT00923676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6556490|NCT00923741|Talactoferrin alfa|talactoferrin alfa|mesh-list
6556491|NCT00923741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6556492|NCT00923806|Aldesleukin|aldesleukin|mesh-list
6556493|NCT00923806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6556494|NCT00923806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6556495|NCT00923806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6556496|NCT00923806|Antiviral Agents|antiviral agents|mesh-ancestor
6556497|NCT00923806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6556498|NCT00923962|Adenosine|adenosine|mesh-list
6556499|NCT00923962|Glucagon|glucagon|mesh-list
6556500|NCT00923962|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6556501|NCT00923962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6556502|NCT00923962|Hormones|hormones|mesh-ancestor
6556503|NCT00923962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6556504|NCT00923962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556505|NCT00923962|Incretins|incretins|mesh-ancestor
6556506|NCT00923962|Analgesics|analgesics|mesh-ancestor
6556507|NCT00923962|Sensory System Agents|sensory system agents|mesh-ancestor
6556508|NCT00923962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6556509|NCT00923962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6556510|NCT00923962|Vasodilator Agents|vasodilator agents|mesh-ancestor
6556511|NCT00923962|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6556512|NCT00923962|Purinergic Agonists|purinergic agonists|mesh-ancestor
6556513|NCT00923962|Purinergic Agents|purinergic agents|mesh-ancestor
6556514|NCT00923962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6556515|NCT00923962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556516|NCT00924014|Furosemide|furosemide|mesh-list
6556517|NCT00924014|Conivaptan|conivaptan|mesh-list
6556518|NCT00924014|Diuretics|diuretics|mesh-ancestor
6556519|NCT00924014|Natriuretic Agents|natriuretic agents|mesh-ancestor
6556520|NCT00924014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556521|NCT00924014|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6556522|NCT00924014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6556523|NCT00924014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556524|NCT00924014|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6556525|NCT00924079|Nalbuphine|nalbuphine|mesh-list
6556526|NCT00924079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6556527|NCT00924079|Narcotics|narcotics|mesh-ancestor
6556528|NCT00924079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6556529|NCT00924079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556530|NCT00924079|Analgesics|analgesics|mesh-ancestor
6556531|NCT00924079|Sensory System Agents|sensory system agents|mesh-ancestor
6556532|NCT00924079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6556533|NCT00924222|Propofol|propofol|mesh-list
6556534|NCT00924222|Sevoflurane|sevoflurane|mesh-list
6556535|NCT00924222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6556536|NCT00924222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6556537|NCT00924222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556538|NCT00924222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6556539|NCT00924222|Anesthetics, General|anesthetics, general|mesh-ancestor
6556540|NCT00924222|Anesthetics|anesthetics|mesh-ancestor
6556541|NCT00924222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6556542|NCT00924222|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6556543|NCT00924430|Simvastatin|simvastatin|mesh-list
6556544|NCT00924430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6556545|NCT00924430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6556546|NCT00924430|Antimetabolites|antimetabolites|mesh-ancestor
6556547|NCT00924430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556548|NCT00924430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6556549|NCT00924430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6556550|NCT00924430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6556551|NCT00924573|Metformin|metformin|mesh-list
6556552|NCT00924573|Glimepiride|glimepiride|mesh-list
6556553|NCT00924573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6556554|NCT00924573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556555|NCT00924573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6556556|NCT00924573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6556557|NCT00924573|Immunologic Factors|immunologic factors|mesh-ancestor
6556558|NCT00924586|Landiolol|landiolol|mesh-list
6556559|NCT00924586|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6556560|NCT00924586|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6556561|NCT00924586|Adrenergic Agents|adrenergic agents|mesh-ancestor
6556562|NCT00924586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6556563|NCT00924586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556564|NCT00924586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556565|NCT00924586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6556566|NCT00924742|Tazobactam|tazobactam|mesh-list
6556567|NCT00924742|Piperacillin|piperacillin|mesh-list
6556568|NCT00924742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6556569|NCT00924742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6556570|NCT00924742|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6556571|NCT00924742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6556572|NCT00924742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556573|NCT00924755|Caffeine|caffeine|mesh-list
6556574|NCT00924755|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6556575|NCT00924755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556576|NCT00924755|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6556577|NCT00924755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6556578|NCT00924755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556579|NCT00924755|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6556580|NCT00924755|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6556581|NCT00924755|Purinergic Agents|purinergic agents|mesh-ancestor
6556582|NCT00924755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6556583|NCT00924963|Lidocaine|lidocaine|mesh-list
6556584|NCT00924963|Anesthetics, Local|anesthetics, local|mesh-ancestor
6556585|NCT00924963|Anesthetics|anesthetics|mesh-ancestor
6556586|NCT00924963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6556587|NCT00924963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556588|NCT00924963|Sensory System Agents|sensory system agents|mesh-ancestor
6556589|NCT00924963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6556590|NCT00924963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6556591|NCT00924963|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6556592|NCT00924963|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6556593|NCT00924963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6556594|NCT00924963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556595|NCT00925028|Warfarin|warfarin|mesh-list
6556596|NCT00925028|Anticoagulants|anticoagulants|mesh-ancestor
6556597|NCT00925093|Vancomycin|vancomycin|mesh-list
6556598|NCT00925093|Linezolid|linezolid|mesh-list
6556599|NCT00925093|Teicoplanin|teicoplanin|mesh-list
6556600|NCT00925093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6556601|NCT00925093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6556602|NCT00925093|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6556603|NCT00925093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6556604|NCT00925093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556605|NCT00925106|Celecoxib|celecoxib|mesh-list
6556606|NCT00925106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6556607|NCT00925106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6556608|NCT00925106|Analgesics|analgesics|mesh-ancestor
6556609|NCT00925106|Sensory System Agents|sensory system agents|mesh-ancestor
6556610|NCT00925106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6556611|NCT00925106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556612|NCT00925106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6556613|NCT00925106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6556614|NCT00925106|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6556615|NCT00925106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6556616|NCT00925106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6556617|NCT00925106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556618|NCT00925314|Vaccines|vaccines|mesh-list
6556619|NCT00925314|Immunologic Factors|immunologic factors|mesh-ancestor
6556620|NCT00925314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556621|NCT00925327|Riboflavin|riboflavin|mesh-list
6556622|NCT00925327|Vitamin B Complex|vitamin b complex|mesh-ancestor
6556623|NCT00925327|Vitamins|vitamins|mesh-ancestor
6556624|NCT00925327|Micronutrients|micronutrients|mesh-ancestor
6556625|NCT00925327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556626|NCT00925327|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6556627|NCT00925327|Dermatologic Agents|dermatologic agents|mesh-ancestor
6556628|NCT00925392|Doripenem|doripenem|mesh-list
6556629|NCT00925392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6556630|NCT00925392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6556631|NCT00925457|Domperidone|domperidone|mesh-list
6556632|NCT00925457|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
6556633|NCT00925457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6556634|NCT00925457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556635|NCT00925457|Antiemetics|antiemetics|mesh-ancestor
6556636|NCT00925457|Autonomic Agents|autonomic agents|mesh-ancestor
6556637|NCT00925457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6556638|NCT00925457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556639|NCT00925457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6556640|NCT00925457|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6556641|NCT00925457|Dopamine Agents|dopamine agents|mesh-ancestor
6556642|NCT00925457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6656664|NCT01470755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656665|NCT01470794|Flucytosine|flucytosine|mesh-list
6656666|NCT01470794|Antifungal Agents|antifungal agents|mesh-ancestor
6656667|NCT01470794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6656668|NCT01470794|Antimetabolites|antimetabolites|mesh-ancestor
6656669|NCT01470794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656670|NCT01470807|Pancrelipase|pancrelipase|mesh-list
6656671|NCT01470807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6656672|NCT01470937|Acarbose|acarbose|mesh-list
6656673|NCT01470937|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6656674|NCT01470937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6656675|NCT01470937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656676|NCT01470937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6656677|NCT01470937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656678|NCT01471067|Mycophenolic Acid|mycophenolic acid|mesh-list
6656679|NCT01471067|Rituximab|rituximab|mesh-list
6656680|NCT01471067|Fludarabine|fludarabine|mesh-list
6656681|NCT01471067|Fludarabine phosphate|fludarabine phosphate|mesh-list
6656682|NCT01471067|Melphalan|melphalan|mesh-list
6656683|NCT01471067|Busulfan|busulfan|mesh-list
6656684|NCT01471067|Clofarabine|clofarabine|mesh-list
6656685|NCT01471067|Tacrolimus|tacrolimus|mesh-list
6656686|NCT01471067|Thymoglobulin|thymoglobulin|mesh-list
6443461|NCT00379457|Dactinomycin|dactinomycin|mesh-list
6443462|NCT00379457|Cyclophosphamide|cyclophosphamide|mesh-list
6443463|NCT00379457|Ifosfamide|ifosfamide|mesh-list
6443464|NCT00379457|Carboplatin|carboplatin|mesh-list
6443465|NCT00379457|Doxorubicin|doxorubicin|mesh-list
6443466|NCT00379457|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6443467|NCT00379457|Etoposide|etoposide|mesh-list
6443468|NCT00379457|Vincristine|vincristine|mesh-list
6443469|NCT00379457|Topotecan|topotecan|mesh-list
6656687|NCT01471067|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6656688|NCT01471067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6656689|NCT01471067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6656690|NCT01471067|Immunologic Factors|immunologic factors|mesh-ancestor
6656691|NCT01471067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656692|NCT01471067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6656693|NCT01471067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6656694|NCT01471067|Antimetabolites|antimetabolites|mesh-ancestor
6656695|NCT01471067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656696|NCT01471067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6656697|NCT01471067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6656698|NCT01471067|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6656699|NCT01471067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6656700|NCT01471067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6656701|NCT01471067|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6656702|NCT01471067|Antitubercular Agents|antitubercular agents|mesh-ancestor
6656703|NCT01471067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6656704|NCT01471067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6656705|NCT01471067|Alkylating Agents|alkylating agents|mesh-ancestor
6656706|NCT01471067|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6443470|NCT00379457|Vinorelbine|vinorelbine|mesh-list
6656707|NCT01471106|Dasatinib|dasatinib|mesh-list
6443471|NCT00379457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6656708|NCT01471106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6443472|NCT00379457|Immunologic Factors|immunologic factors|mesh-ancestor
6556643|NCT00925730|Pimecrolimus|pimecrolimus|mesh-list
6556644|NCT00925730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6556645|NCT00925730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6556646|NCT00925730|Analgesics|analgesics|mesh-ancestor
6556647|NCT00925730|Sensory System Agents|sensory system agents|mesh-ancestor
6556648|NCT00925730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6556649|NCT00925730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556650|NCT00925730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6556651|NCT00925730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6556652|NCT00925730|Dermatologic Agents|dermatologic agents|mesh-ancestor
6556653|NCT00925730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6556654|NCT00925730|Immunologic Factors|immunologic factors|mesh-ancestor
6556655|NCT00925730|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6556656|NCT00925730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6556657|NCT00925730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556658|NCT00925847|Lithium Carbonate|lithium carbonate|mesh-list
6556659|NCT00925847|Antidepressive Agents|antidepressive agents|mesh-ancestor
6556660|NCT00925847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6556661|NCT00925847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6556662|NCT00925847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556663|NCT00925847|Antimanic Agents|antimanic agents|mesh-ancestor
6556664|NCT00925847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6556665|NCT00925847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6556666|NCT00925847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556667|NCT00925873|Vidarabine|vidarabine|mesh-list
6556668|NCT00925873|Fludarabine|fludarabine|mesh-list
6556669|NCT00925873|Fludarabine phosphate|fludarabine phosphate|mesh-list
6556670|NCT00925873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6556671|NCT00925873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6556672|NCT00925873|Antimetabolites|antimetabolites|mesh-ancestor
6556673|NCT00925873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556674|NCT00925873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6556675|NCT00925873|Immunologic Factors|immunologic factors|mesh-ancestor
6556676|NCT00925873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556677|NCT00925873|Antiviral Agents|antiviral agents|mesh-ancestor
6556678|NCT00925873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6556679|NCT00925912|Bupivacaine|bupivacaine|mesh-list
6556680|NCT00925912|Anesthetics, Local|anesthetics, local|mesh-ancestor
6462192|NCT00458055|Antimetabolites|antimetabolites|mesh-ancestor
6462193|NCT00458055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462194|NCT00458055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6462195|NCT00458055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6462196|NCT00458055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6462197|NCT00458055|Vasodilator Agents|vasodilator agents|mesh-ancestor
6462198|NCT00458055|Vitamin B Complex|vitamin b complex|mesh-ancestor
6462199|NCT00458055|Vitamins|vitamins|mesh-ancestor
6462200|NCT00458055|Micronutrients|micronutrients|mesh-ancestor
6462201|NCT00458055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462202|NCT00458081|Rimonabant|rimonabant|mesh-list
6462203|NCT00458081|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6462204|NCT00458081|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
6462205|NCT00458081|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6462206|NCT00458081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6462207|NCT00458081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462208|NCT00458081|Hormones|hormones|mesh-ancestor
6462209|NCT00458081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6462210|NCT00458081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462211|NCT00458185|Etanercept|etanercept|mesh-list
6462212|NCT00458185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6462213|NCT00458185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6462214|NCT00458185|Analgesics|analgesics|mesh-ancestor
6556681|NCT00925912|Anesthetics|anesthetics|mesh-ancestor
6556682|NCT00925912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6556683|NCT00925912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556684|NCT00925912|Sensory System Agents|sensory system agents|mesh-ancestor
6556685|NCT00925912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6556686|NCT00925951|Acetaminophen|acetaminophen|mesh-list
6556687|NCT00925951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6556688|NCT00925951|Analgesics|analgesics|mesh-ancestor
6556689|NCT00925951|Sensory System Agents|sensory system agents|mesh-ancestor
6556690|NCT00925951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6556691|NCT00925951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556692|NCT00925951|Antipyretics|antipyretics|mesh-ancestor
6556693|NCT00925977|Insulin|insulin|mesh-list
6556694|NCT00925977|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6556695|NCT00925977|Insulin Glargine|insulin glargine|mesh-list
6556696|NCT00925977|Insulin glulisine|insulin glulisine|mesh-list
6556697|NCT00925977|Isophane Insulin, Human|isophane insulin, human|mesh-list
6556698|NCT00925977|Insulin, Isophane|insulin, isophane|mesh-list
6556699|NCT00925977|Isophane insulin, beef|isophane insulin, beef|mesh-list
6556700|NCT00925977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6556701|NCT00925977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556702|NCT00926016|Pioglitazone|pioglitazone|mesh-list
6556703|NCT00926016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6556704|NCT00926016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556705|NCT00926055|Simvastatin|simvastatin|mesh-list
6556706|NCT00926055|Ezetimibe|ezetimibe|mesh-list
6556707|NCT00926055|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
6556708|NCT00926055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6556709|NCT00926055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6556710|NCT00926055|Antimetabolites|antimetabolites|mesh-ancestor
6556711|NCT00926055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556712|NCT00926055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6556713|NCT00926055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6556714|NCT00926055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6556715|NCT00926107|Sirolimus|sirolimus|mesh-list
6556716|NCT00926107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6556717|NCT00926107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6556718|NCT00926107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6556719|NCT00926107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6556720|NCT00926107|Antifungal Agents|antifungal agents|mesh-ancestor
6556721|NCT00926107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6556722|NCT00926107|Immunologic Factors|immunologic factors|mesh-ancestor
6556723|NCT00926107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556724|NCT00926302|Levetiracetam|levetiracetam|mesh-list
6556725|NCT00926302|Anticonvulsants|anticonvulsants|mesh-ancestor
6556726|NCT00926302|Nootropic Agents|nootropic agents|mesh-ancestor
6556727|NCT00926315|Calcitriol|calcitriol|mesh-list
6556728|NCT00926315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6556729|NCT00926315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556730|NCT00926315|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6556731|NCT00926315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6556732|NCT00926315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556733|NCT00926315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6556734|NCT00926315|Vitamins|vitamins|mesh-ancestor
6556735|NCT00926315|Micronutrients|micronutrients|mesh-ancestor
6556736|NCT00926315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6556737|NCT00926341|Pioglitazone|pioglitazone|mesh-list
6556738|NCT00926341|Telmisartan|telmisartan|mesh-list
6556739|NCT00926341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6556740|NCT00926341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556741|NCT00926341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6556742|NCT00926341|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6556743|NCT00926341|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6556744|NCT00926341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556745|NCT00926354|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
6556746|NCT00926354|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6556747|NCT00926354|Immunologic Factors|immunologic factors|mesh-ancestor
6556748|NCT00926354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556749|NCT00926354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6443473|NCT00379457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443474|NCT00379457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6443475|NCT00379457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6443476|NCT00379457|Alkylating Agents|alkylating agents|mesh-ancestor
6019767|NCT00389519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6019768|NCT00389532|Vaccines|vaccines|mesh-list
6019769|NCT00389532|Immunologic Factors|immunologic factors|mesh-ancestor
6019770|NCT00389532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019771|NCT00389805|Pemetrexed|pemetrexed|mesh-list
6443477|NCT00379457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443478|NCT00379457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6556750|NCT00926354|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6556751|NCT00926354|Protective Agents|protective agents|mesh-ancestor
6556752|NCT00926354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6556753|NCT00926354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6556754|NCT00926354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6556755|NCT00926354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556756|NCT00926354|Antiviral Agents|antiviral agents|mesh-ancestor
6556757|NCT00926354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6556758|NCT00926419|Vaccines|vaccines|mesh-list
6556759|NCT00926419|Immunologic Factors|immunologic factors|mesh-ancestor
6556760|NCT00926419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556761|NCT00926614|Pioglitazone|pioglitazone|mesh-list
6556762|NCT00926614|Atorvastatin|atorvastatin|mesh-list
6556763|NCT00926614|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6556764|NCT00926614|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6556765|NCT00926614|Antimetabolites|antimetabolites|mesh-ancestor
6556766|NCT00926614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556767|NCT00926614|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6556768|NCT00926614|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6556769|NCT00926614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6556770|NCT00926614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6556771|NCT00926614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556772|NCT00926627|Bosentan|bosentan|mesh-list
6556773|NCT00926627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6019772|NCT00389805|Bortezomib|bortezomib|mesh-list
6443479|NCT00379457|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6443480|NCT00379457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6443481|NCT00379457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6443482|NCT00379457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6443483|NCT00379457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6556774|NCT00926627|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6664723|NCT01513720|Anticonvulsants|anticonvulsants|mesh-ancestor
6556775|NCT00926627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556776|NCT00926640|Etoposide|etoposide|mesh-list
6556777|NCT00926640|Belinostat|belinostat|mesh-list
6556778|NCT00926640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6556779|NCT00926640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6556780|NCT00926640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6556781|NCT00926640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6556782|NCT00926640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6556783|NCT00926640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556784|NCT00926640|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6556785|NCT00926653|Citalopram|citalopram|mesh-list
6556786|NCT00926653|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6556787|NCT00926653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6556788|NCT00926653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6556789|NCT00926653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556790|NCT00926653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6556791|NCT00926653|Serotonin Agents|serotonin agents|mesh-ancestor
6556792|NCT00926653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556793|NCT00926653|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6556794|NCT00926653|Antidepressive Agents|antidepressive agents|mesh-ancestor
6556795|NCT00926653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6556796|NCT00926666|Levobupivacaine|levobupivacaine|mesh-list
6556797|NCT00926666|Anesthetics, Local|anesthetics, local|mesh-ancestor
6556798|NCT00926666|Anesthetics|anesthetics|mesh-ancestor
6556799|NCT00926666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6556800|NCT00926666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556801|NCT00926666|Sensory System Agents|sensory system agents|mesh-ancestor
6556802|NCT00926666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6556803|NCT00926705|Fentanyl|fentanyl|mesh-list
6556804|NCT00926705|Dexmedetomidine|dexmedetomidine|mesh-list
6556805|NCT00926705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6556806|NCT00926705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6556807|NCT00926705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556808|NCT00926705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6556809|NCT00926705|Analgesics|analgesics|mesh-ancestor
6556810|NCT00926705|Sensory System Agents|sensory system agents|mesh-ancestor
6556811|NCT00926705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6556812|NCT00926705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6556813|NCT00926705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6556814|NCT00926705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6556815|NCT00926705|Adrenergic Agents|adrenergic agents|mesh-ancestor
6556816|NCT00926705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6556817|NCT00926705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556818|NCT00926705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6556819|NCT00926705|Narcotics|narcotics|mesh-ancestor
6556820|NCT00926705|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6556821|NCT00926705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6556822|NCT00926705|Anesthetics, General|anesthetics, general|mesh-ancestor
6556823|NCT00926705|Anesthetics|anesthetics|mesh-ancestor
6556824|NCT00926718|Remifentanil|remifentanil|mesh-list
6556825|NCT00926718|Rocuronium|rocuronium|mesh-list
6556826|NCT00926718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6556827|NCT00926718|Narcotics|narcotics|mesh-ancestor
6556828|NCT00926718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6556829|NCT00926718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556830|NCT00926718|Analgesics|analgesics|mesh-ancestor
6556831|NCT00926718|Sensory System Agents|sensory system agents|mesh-ancestor
6556832|NCT00926718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6556833|NCT00926718|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6556834|NCT00926718|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6556835|NCT00926718|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6556836|NCT00926731|Cytarabine|cytarabine|mesh-list
6556837|NCT00926731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6556838|NCT00926731|Antimetabolites|antimetabolites|mesh-ancestor
6556839|NCT00926731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556840|NCT00926731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6556841|NCT00926731|Antiviral Agents|antiviral agents|mesh-ancestor
6556842|NCT00926731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6556843|NCT00926731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6556844|NCT00926731|Immunologic Factors|immunologic factors|mesh-ancestor
6556845|NCT00926731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556846|NCT00926757|Entecavir|entecavir|mesh-list
6556847|NCT00926757|Antiviral Agents|antiviral agents|mesh-ancestor
6556848|NCT00926757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6556849|NCT00926809|Amoxicillin|amoxicillin|mesh-list
6556850|NCT00926809|Clarithromycin|clarithromycin|mesh-list
6556851|NCT00926809|Lansoprazole|lansoprazole|mesh-list
6556852|NCT00926809|Dexlansoprazole|dexlansoprazole|mesh-list
6556853|NCT00926809|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
6556854|NCT00926809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6556855|NCT00926809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6556856|NCT00926809|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6556857|NCT00926809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6556858|NCT00926809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556859|NCT00926809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6556860|NCT00926809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6556861|NCT00926809|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6556862|NCT00926809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6556863|NCT00926835|Lamotrigine|lamotrigine|mesh-list
6556864|NCT00926835|Dexetimide|dexetimide|mesh-list
6556865|NCT00926835|Aripiprazole|aripiprazole|mesh-list
6556866|NCT00926835|Mirtazapine|mirtazapine|mesh-list
6556867|NCT00926835|Citalopram|citalopram|mesh-list
6556868|NCT00926835|Bupropion|bupropion|mesh-list
6556869|NCT00926835|Paroxetine|paroxetine|mesh-list
6556870|NCT00926835|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6556871|NCT00926835|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6556872|NCT00926835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6556873|NCT00926835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6556874|NCT00926835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556875|NCT00926835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6556876|NCT00926835|Serotonin Agents|serotonin agents|mesh-ancestor
6556877|NCT00926835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556878|NCT00926835|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6556879|NCT00926835|Antidepressive Agents|antidepressive agents|mesh-ancestor
6556880|NCT00926835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6556881|NCT00926835|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6556882|NCT00926835|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6556883|NCT00926835|Parasympatholytics|parasympatholytics|mesh-ancestor
6556884|NCT00926835|Autonomic Agents|autonomic agents|mesh-ancestor
6556885|NCT00926835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6556886|NCT00926835|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6556887|NCT00926835|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6556888|NCT00926835|Cholinergic Agents|cholinergic agents|mesh-ancestor
6556889|NCT00926835|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6556890|NCT00926835|Dopamine Agents|dopamine agents|mesh-ancestor
6556891|NCT00926835|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6556892|NCT00926835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6556893|NCT00926835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6556894|NCT00926835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6556895|NCT00926835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6556896|NCT00926835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6556897|NCT00926835|Dopamine Agonists|dopamine agonists|mesh-ancestor
6556898|NCT00926835|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6556899|NCT00926835|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6556900|NCT00926835|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6556901|NCT00926835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6556902|NCT00926835|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6556903|NCT00926835|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6556904|NCT00926835|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6556905|NCT00926835|Anticonvulsants|anticonvulsants|mesh-ancestor
6556906|NCT00926835|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6556907|NCT00926835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6556908|NCT00926835|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6556909|NCT00926835|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6556910|NCT00926835|Histamine Antagonists|histamine antagonists|mesh-ancestor
6556911|NCT00926835|Histamine Agents|histamine agents|mesh-ancestor
6556912|NCT00926835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6556913|NCT00926835|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6556914|NCT00926835|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6556915|NCT00926835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6556916|NCT00926835|Adrenergic Agents|adrenergic agents|mesh-ancestor
6556917|NCT00926835|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6556918|NCT00926900|Cycloserine|cycloserine|mesh-list
6556919|NCT00926900|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6556920|NCT00926900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6556921|NCT00926900|Renal Agents|renal agents|mesh-ancestor
6556922|NCT00926900|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6556923|NCT00926900|Antitubercular Agents|antitubercular agents|mesh-ancestor
6556924|NCT00926900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6556925|NCT00926900|Antimetabolites|antimetabolites|mesh-ancestor
6556926|NCT00926900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556927|NCT00926926|Oxybutynin|oxybutynin|mesh-list
6556928|NCT00926926|Parasympatholytics|parasympatholytics|mesh-ancestor
6556929|NCT00926926|Autonomic Agents|autonomic agents|mesh-ancestor
6556930|NCT00926926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6556931|NCT00926926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556932|NCT00926926|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6556933|NCT00926926|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6556934|NCT00926926|Cholinergic Agents|cholinergic agents|mesh-ancestor
6556935|NCT00926926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6556936|NCT00926926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556937|NCT00926926|Urological Agents|urological agents|mesh-ancestor
6556938|NCT00926965|Olanzapine|olanzapine|mesh-list
6556939|NCT00926965|Antipsychotic Agents|antipsychotic agents|mesh-list
6556940|NCT00926965|Amisulpride|amisulpride|mesh-list
6556941|NCT00926965|Antiemetics|antiemetics|mesh-ancestor
6556942|NCT00926965|Autonomic Agents|autonomic agents|mesh-ancestor
6556943|NCT00926965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6556944|NCT00926965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556945|NCT00926965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6556946|NCT00926965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6556947|NCT00926965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6556948|NCT00926965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6556949|NCT00926965|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6556950|NCT00926965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6556951|NCT00926965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6556952|NCT00926965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556953|NCT00926965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6556954|NCT00926965|Serotonin Agents|serotonin agents|mesh-ancestor
6556955|NCT00926965|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6556956|NCT00926965|Dopamine Agents|dopamine agents|mesh-ancestor
6556957|NCT00926965|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6556958|NCT00926965|Antidepressive Agents|antidepressive agents|mesh-ancestor
6556959|NCT00927004|Etoricoxib|etoricoxib|mesh-list
6556960|NCT00927004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6556961|NCT00927004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6556962|NCT00927004|Analgesics|analgesics|mesh-ancestor
6443484|NCT00379457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6443485|NCT00379457|Tubulin Modulators|tubulin modulators|mesh-ancestor
6443486|NCT00379457|Antimitotic Agents|antimitotic agents|mesh-ancestor
6443487|NCT00379457|Mitosis Modulators|mitosis modulators|mesh-ancestor
6443488|NCT00379457|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6443489|NCT00379457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6443490|NCT00379457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6556963|NCT00927004|Sensory System Agents|sensory system agents|mesh-ancestor
6556964|NCT00927004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6556965|NCT00927004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556966|NCT00927004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6556967|NCT00927004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6556968|NCT00927004|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6443491|NCT00379457|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6556969|NCT00927004|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6556970|NCT00927004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6556971|NCT00927004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556972|NCT00927030|Melatonin|melatonin|mesh-list
6556973|NCT00927030|Antioxidants|antioxidants|mesh-ancestor
6556974|NCT00927030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556975|NCT00927030|Protective Agents|protective agents|mesh-ancestor
6556976|NCT00927030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556977|NCT00927030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6556978|NCT00927147|Cetuximab|cetuximab|mesh-list
6556979|NCT00927147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6556980|NCT00927147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6556981|NCT00927212|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
6556982|NCT00927212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6556983|NCT00927212|Immunologic Factors|immunologic factors|mesh-ancestor
6556984|NCT00927212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556985|NCT00927212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6556986|NCT00927212|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6556987|NCT00927212|Protective Agents|protective agents|mesh-ancestor
6556988|NCT00927212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6556989|NCT00927212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6556990|NCT00927212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6556991|NCT00927212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6556992|NCT00927212|Antiviral Agents|antiviral agents|mesh-ancestor
6556993|NCT00927212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6556994|NCT00927225|Ropivacaine|ropivacaine|mesh-list
6556995|NCT00927225|Anesthetics, Local|anesthetics, local|mesh-ancestor
6556996|NCT00927225|Anesthetics|anesthetics|mesh-ancestor
6556997|NCT00927225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6556998|NCT00927225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6556999|NCT00927225|Sensory System Agents|sensory system agents|mesh-ancestor
6557000|NCT00927225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6557001|NCT00927290|Pioglitazone|pioglitazone|mesh-list
6557002|NCT00927290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6557003|NCT00927290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557004|NCT00927407|Malathion|malathion|mesh-list
6557005|NCT00927407|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6557006|NCT00927407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6557007|NCT00927407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557008|NCT00927407|Cholinergic Agents|cholinergic agents|mesh-ancestor
6557009|NCT00927407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6557010|NCT00927407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656709|NCT01471106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6656710|NCT01471106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6656711|NCT01471106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656712|NCT01471132|Paclitaxel|paclitaxel|mesh-list
6656713|NCT01471132|Oxaliplatin|oxaliplatin|mesh-list
6443492|NCT00379457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6443493|NCT00379483|Deferasirox|deferasirox|mesh-list
6443494|NCT00379483|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6443495|NCT00379483|Chelating Agents|chelating agents|mesh-ancestor
6443496|NCT00379483|Sequestering Agents|sequestering agents|mesh-ancestor
6443497|NCT00379483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443498|NCT00379496|Antidepressive Agents|antidepressive agents|mesh-list
6443499|NCT00379496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6656714|NCT01471132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6656715|NCT01471132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6656716|NCT01471132|Tubulin Modulators|tubulin modulators|mesh-ancestor
6656717|NCT01471132|Antimitotic Agents|antimitotic agents|mesh-ancestor
6656718|NCT01471132|Mitosis Modulators|mitosis modulators|mesh-ancestor
6656719|NCT01471132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656720|NCT01471145|Naltrexone|naltrexone|mesh-list
6656721|NCT01471145|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6656722|NCT01471145|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6656723|NCT01471145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656724|NCT01471145|Sensory System Agents|sensory system agents|mesh-ancestor
6656725|NCT01471145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6656726|NCT01471158|Timolol|timolol|mesh-list
6656727|NCT01471158|Dorzolamide|dorzolamide|mesh-list
6656728|NCT01471158|Maleic acid|maleic acid|mesh-list
6656729|NCT01471158|Brinzolamide|brinzolamide|mesh-list
6656730|NCT01471158|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6443500|NCT00379509|Lapatinib|lapatinib|mesh-list
6443501|NCT00379509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6557011|NCT00927498|Cytarabine|cytarabine|mesh-list
6557012|NCT00927498|Daunorubicin|daunorubicin|mesh-list
6557013|NCT00927498|Gemtuzumab|gemtuzumab|mesh-list
6557014|NCT00927498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6557015|NCT00927498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6557016|NCT00927498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6557017|NCT00927498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6557018|NCT00927498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6557019|NCT00927498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557020|NCT00927498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6557021|NCT00927498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6557022|NCT00927498|Antimetabolites|antimetabolites|mesh-ancestor
6557023|NCT00927498|Antiviral Agents|antiviral agents|mesh-ancestor
6557024|NCT00927498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6557025|NCT00927498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6557026|NCT00927498|Immunologic Factors|immunologic factors|mesh-ancestor
6557027|NCT00927498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557028|NCT00927511|Fulvestrant|fulvestrant|mesh-list
6557029|NCT00927511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6557030|NCT00927511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6557031|NCT00927511|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6557032|NCT00927511|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6557033|NCT00927511|Hormone Antagonists|hormone antagonists|mesh-ancestor
6557034|NCT00927511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6557035|NCT00927511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557036|NCT00927524|Insulin|insulin|mesh-list
6443502|NCT00379509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6443503|NCT00379509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6443504|NCT00379509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443505|NCT00379522|Vasopressins|vasopressins|mesh-list
6443506|NCT00379522|Arginine Vasopressin|arginine vasopressin|mesh-list
6443507|NCT00379522|Hemostatics|hemostatics|mesh-ancestor
6443508|NCT00379522|Coagulants|coagulants|mesh-ancestor
6443509|NCT00379522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6557037|NCT00927524|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6557038|NCT00927524|Insulin glulisine|insulin glulisine|mesh-list
6557039|NCT00927524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6557040|NCT00927524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557041|NCT00927537|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6557042|NCT00927537|Telmisartan|telmisartan|mesh-list
6557043|NCT00927537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6557044|NCT00927537|Diuretics|diuretics|mesh-ancestor
6557045|NCT00927537|Natriuretic Agents|natriuretic agents|mesh-ancestor
6557046|NCT00927537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557047|NCT00927537|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6557048|NCT00927537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6557049|NCT00927537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557050|NCT00927537|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6557051|NCT00927537|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6557052|NCT00927550|Lithium Carbonate|lithium carbonate|mesh-list
6557053|NCT00927550|Antidepressive Agents|antidepressive agents|mesh-ancestor
6557054|NCT00927550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6557055|NCT00927550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6557056|NCT00927550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557057|NCT00927550|Antimanic Agents|antimanic agents|mesh-ancestor
6557058|NCT00927550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6557059|NCT00927550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6557060|NCT00927550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557061|NCT00927602|PENTA|penta|mesh-list
6557062|NCT00927602|Fondaparinux|fondaparinux|mesh-list
6557063|NCT00927602|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6557064|NCT00927602|Antithrombins|antithrombins|mesh-ancestor
6557065|NCT00927602|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6557066|NCT00927602|Protease Inhibitors|protease inhibitors|mesh-ancestor
6557067|NCT00927602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6557068|NCT00927602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557069|NCT00927602|Anticoagulants|anticoagulants|mesh-ancestor
6557070|NCT00927602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6557071|NCT00927602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6557072|NCT00927615|Abciximab|abciximab|mesh-list
6557073|NCT00927615|Anticoagulants|anticoagulants|mesh-ancestor
6557074|NCT00927615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6557075|NCT00927654|Iloprost|iloprost|mesh-list
6557076|NCT00927654|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6557077|NCT00927654|Vasodilator Agents|vasodilator agents|mesh-ancestor
6557078|NCT00927693|Calcium|calcium|mesh-list
6557079|NCT00927693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6557080|NCT00927693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557081|NCT00927732|Quinidine|quinidine|mesh-list
6557082|NCT00927732|Hydroquinidine|hydroquinidine|mesh-list
6557083|NCT00927732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6557084|NCT00927732|Parasympatholytics|parasympatholytics|mesh-ancestor
6557085|NCT00927732|Autonomic Agents|autonomic agents|mesh-ancestor
6557086|NCT00927732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6557087|NCT00927732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557088|NCT00927732|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6557089|NCT00927732|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6557090|NCT00927732|Adrenergic Agents|adrenergic agents|mesh-ancestor
6557091|NCT00927732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6557092|NCT00927732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557093|NCT00927732|Antimalarials|antimalarials|mesh-ancestor
6557094|NCT00927732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6557095|NCT00927732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6557096|NCT00927732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6557097|NCT00927732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6557098|NCT00927732|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6557099|NCT00927732|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6557100|NCT00927732|Cholinergic Agents|cholinergic agents|mesh-ancestor
6557101|NCT00927732|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6557102|NCT00927732|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6557103|NCT00927732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6557104|NCT00927732|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6557105|NCT00927732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6557106|NCT00927771|Azelaic acid|azelaic acid|mesh-list
6557107|NCT00927771|Hydroquinone|hydroquinone|mesh-list
6557108|NCT00927771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6557109|NCT00927771|Dermatologic Agents|dermatologic agents|mesh-ancestor
6557110|NCT00927771|Antioxidants|antioxidants|mesh-ancestor
6557111|NCT00927771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557112|NCT00927771|Protective Agents|protective agents|mesh-ancestor
6557113|NCT00927771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557114|NCT00927771|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6557115|NCT00927797|Cyclophosphamide|cyclophosphamide|mesh-list
6557116|NCT00927797|Rituximab|rituximab|mesh-list
6557117|NCT00927797|Pentostatin|pentostatin|mesh-list
6557118|NCT00927797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6557119|NCT00927797|Immunologic Factors|immunologic factors|mesh-ancestor
6557120|NCT00927797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557121|NCT00927797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6557122|NCT00927797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6557123|NCT00927797|Alkylating Agents|alkylating agents|mesh-ancestor
6557124|NCT00927797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557125|NCT00927797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6557126|NCT00927797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6557127|NCT00927797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6557128|NCT00927797|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
6557129|NCT00927797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6557130|NCT00927836|Lenograstim|lenograstim|mesh-list
6557131|NCT00927836|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6557132|NCT00927836|Immunologic Factors|immunologic factors|mesh-ancestor
6557133|NCT00927836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557134|NCT00927875|Carboplatin|carboplatin|mesh-list
6557135|NCT00927875|Etoposide|etoposide|mesh-list
6557136|NCT00927875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6557137|NCT00927875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6557138|NCT00927875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6557139|NCT00927875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6557140|NCT00927875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6557141|NCT00927875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557142|NCT00927966|Everolimus|everolimus|mesh-list
6557143|NCT00927966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6557144|NCT00927966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6557145|NCT00927966|Immunologic Factors|immunologic factors|mesh-ancestor
6557146|NCT00927966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557147|NCT00927979|Ropivacaine|ropivacaine|mesh-list
6557148|NCT00927979|Anesthetics, Local|anesthetics, local|mesh-ancestor
6557149|NCT00927979|Anesthetics|anesthetics|mesh-ancestor
6557150|NCT00927979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6557151|NCT00927979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557152|NCT00927979|Sensory System Agents|sensory system agents|mesh-ancestor
6557153|NCT00927979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6557154|NCT00928148|Amphetamine|amphetamine|mesh-list
6557155|NCT00928148|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6557156|NCT00928148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557157|NCT00928148|Sympathomimetics|sympathomimetics|mesh-ancestor
6557158|NCT00928148|Autonomic Agents|autonomic agents|mesh-ancestor
6557159|NCT00928148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6557160|NCT00928148|Dopamine Agents|dopamine agents|mesh-ancestor
6557161|NCT00928148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6557162|NCT00928148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557163|NCT00928148|Adrenergic Agents|adrenergic agents|mesh-ancestor
6557164|NCT00928148|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6557165|NCT00928148|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6557166|NCT00928148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6557167|NCT00928148|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6557168|NCT00928161|Dexlansoprazole|dexlansoprazole|mesh-list
6557169|NCT00928161|Lansoprazole|lansoprazole|mesh-list
6557170|NCT00928161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6557171|NCT00928161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6557172|NCT00928161|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6557173|NCT00928161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6557174|NCT00928161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557175|NCT00928213|Heparin|heparin|mesh-list
6557176|NCT00928213|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6557177|NCT00928213|Tinzaparin|tinzaparin|mesh-list
6557178|NCT00928213|Dalteparin|dalteparin|mesh-list
6557179|NCT00928213|Progesterone|progesterone|mesh-list
6557180|NCT00928213|Hormones|hormones|mesh-ancestor
6557181|NCT00928213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6557182|NCT00928213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557183|NCT00928213|Anticoagulants|anticoagulants|mesh-ancestor
6557184|NCT00928213|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6557185|NCT00928213|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6557186|NCT00928213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557187|NCT00928213|Progestins|progestins|mesh-ancestor
6557188|NCT00928291|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6557189|NCT00928291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6557190|NCT00928330|Trastuzumab|trastuzumab|mesh-list
6557191|NCT00928330|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
6557192|NCT00928330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6557193|NCT00928330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6557194|NCT00928330|Tubulin Modulators|tubulin modulators|mesh-ancestor
6557195|NCT00928330|Antimitotic Agents|antimitotic agents|mesh-ancestor
6557196|NCT00928330|Mitosis Modulators|mitosis modulators|mesh-ancestor
6557197|NCT00928330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557198|NCT00928525|Imatinib Mesylate|imatinib mesylate|mesh-list
6443510|NCT00379522|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6443511|NCT00379522|Natriuretic Agents|natriuretic agents|mesh-ancestor
6443512|NCT00379522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443513|NCT00379600|Rosiglitazone|rosiglitazone|mesh-list
6443514|NCT00379600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6443515|NCT00379600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443516|NCT00379626|Hormones|hormones|mesh-list
6443517|NCT00379626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6443518|NCT00379626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443519|NCT00379665|Cisplatin|cisplatin|mesh-list
6443520|NCT00379665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6443521|NCT00379691|Phenylephrine|phenylephrine|mesh-list
6443522|NCT00379691|Oxymetazoline|oxymetazoline|mesh-list
6443523|NCT00379691|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6443524|NCT00379691|Mydriatics|mydriatics|mesh-ancestor
6443525|NCT00379691|Autonomic Agents|autonomic agents|mesh-ancestor
6443526|NCT00379691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6443527|NCT00379691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443528|NCT00379691|Sympathomimetics|sympathomimetics|mesh-ancestor
6443529|NCT00379691|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6443530|NCT00379691|Nasal Decongestants|nasal decongestants|mesh-ancestor
6443531|NCT00379691|Respiratory System Agents|respiratory system agents|mesh-ancestor
6443532|NCT00379691|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6443533|NCT00379691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6443534|NCT00379691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6443535|NCT00379691|Adrenergic Agents|adrenergic agents|mesh-ancestor
6443536|NCT00379691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6443537|NCT00379691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443538|NCT00379691|Protective Agents|protective agents|mesh-ancestor
6443539|NCT00379717|Docetaxel|docetaxel|mesh-list
6443540|NCT00379717|Cisplatin|cisplatin|mesh-list
6443541|NCT00379717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6443542|NCT00379717|Tubulin Modulators|tubulin modulators|mesh-ancestor
6443543|NCT00379717|Antimitotic Agents|antimitotic agents|mesh-ancestor
6443544|NCT00379717|Mitosis Modulators|mitosis modulators|mesh-ancestor
6443545|NCT00379717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443546|NCT00379730|Prednisolone|prednisolone|mesh-list
6443547|NCT00379730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6443548|NCT00379730|Glucocorticoids|glucocorticoids|mesh-ancestor
6443549|NCT00379730|Hormones|hormones|mesh-ancestor
6557199|NCT00928525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6443550|NCT00379730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6557200|NCT00928525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6557201|NCT00928525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6557202|NCT00928525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557203|NCT00928655|Acetazolamide|acetazolamide|mesh-list
6557204|NCT00928655|Anticonvulsants|anticonvulsants|mesh-ancestor
6557205|NCT00928655|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6557206|NCT00928655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6557207|NCT00928655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557208|NCT00928655|Diuretics|diuretics|mesh-ancestor
6557209|NCT00928655|Natriuretic Agents|natriuretic agents|mesh-ancestor
6557210|NCT00928655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557211|NCT00928798|Sirolimus|sirolimus|mesh-list
6557212|NCT00928798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6557213|NCT00928798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6557214|NCT00928798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6557215|NCT00928798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6557216|NCT00928798|Antifungal Agents|antifungal agents|mesh-ancestor
6557217|NCT00928798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6443551|NCT00379730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443552|NCT00379730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6443553|NCT00379730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6443554|NCT00379756|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6443555|NCT00379756|Vasodilator Agents|vasodilator agents|mesh-ancestor
6557218|NCT00928798|Immunologic Factors|immunologic factors|mesh-ancestor
6557219|NCT00928798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557220|NCT00928811|Basiliximab|basiliximab|mesh-list
6557221|NCT00928811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6557222|NCT00928811|Immunologic Factors|immunologic factors|mesh-ancestor
6557223|NCT00928811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557224|NCT00928837|Naproxen|naproxen|mesh-list
6557225|NCT00928837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6557226|NCT00928837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6557227|NCT00928837|Analgesics|analgesics|mesh-ancestor
6557228|NCT00928837|Sensory System Agents|sensory system agents|mesh-ancestor
6557229|NCT00928837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6557230|NCT00928837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557231|NCT00928837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6557232|NCT00928837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6557233|NCT00928837|Gout Suppressants|gout suppressants|mesh-ancestor
6557234|NCT00928837|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6557235|NCT00928837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6557236|NCT00928837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557237|NCT00928876|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6557238|NCT00928876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6557239|NCT00928915|Thrombin|thrombin|mesh-list
6557240|NCT00928915|Hemostatics|hemostatics|mesh-ancestor
6557241|NCT00928915|Coagulants|coagulants|mesh-ancestor
6557242|NCT00928967|Interferons|interferons|mesh-list
6557243|NCT00928967|Interferon-beta|interferon-beta|mesh-list
6557244|NCT00928967|Interferon beta-1b|interferon beta-1b|mesh-list
6443556|NCT00379756|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6443557|NCT00379756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6443558|NCT00379756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6443559|NCT00379756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443560|NCT00379756|Urological Agents|urological agents|mesh-ancestor
6443561|NCT00379847|Conivaptan|conivaptan|mesh-list
6557245|NCT00928967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6557246|NCT00928967|Antiviral Agents|antiviral agents|mesh-ancestor
6557247|NCT00928967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6557248|NCT00928967|Immunologic Factors|immunologic factors|mesh-ancestor
6557249|NCT00928967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557250|NCT00928967|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6557251|NCT00929006|Progesterone|progesterone|mesh-list
6557252|NCT00929006|Progestins|progestins|mesh-ancestor
6557253|NCT00929006|Hormones|hormones|mesh-ancestor
6557254|NCT00929006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6557255|NCT00929006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557256|NCT00929045|Hormones|hormones|mesh-list
6557257|NCT00929045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6557258|NCT00929045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557259|NCT00929058|Bevacizumab|bevacizumab|mesh-list
6557260|NCT00929058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6557261|NCT00929058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6557262|NCT00929058|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6557263|NCT00929058|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6557264|NCT00929058|Growth Substances|growth substances|mesh-ancestor
6557265|NCT00929058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557266|NCT00929058|Growth Inhibitors|growth inhibitors|mesh-ancestor
6557267|NCT00929253|Buprenorphine|buprenorphine|mesh-list
6557268|NCT00929253|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6557269|NCT00929253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6557270|NCT00929253|Narcotics|narcotics|mesh-ancestor
6557271|NCT00929253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6557272|NCT00929253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557273|NCT00929253|Analgesics|analgesics|mesh-ancestor
6557274|NCT00929253|Sensory System Agents|sensory system agents|mesh-ancestor
6557275|NCT00929253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6557276|NCT00929253|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6557277|NCT00929279|Abciximab|abciximab|mesh-list
6557278|NCT00929279|Anticoagulants|anticoagulants|mesh-ancestor
6557279|NCT00929279|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6557280|NCT00929370|Glycine|glycine|mesh-list
6557281|NCT00929370|Glycine Agents|glycine agents|mesh-ancestor
6557282|NCT00929370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6557283|NCT00929370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557284|NCT00929370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557285|NCT00929487|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6557286|NCT00929591|Tamoxifen|tamoxifen|mesh-list
6557287|NCT00929591|Cyclophosphamide|cyclophosphamide|mesh-list
6557288|NCT00929591|Doxorubicin|doxorubicin|mesh-list
6557289|NCT00929591|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6557290|NCT00929591|Fluorouracil|fluorouracil|mesh-list
6557291|NCT00929591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6557292|NCT00929591|Immunologic Factors|immunologic factors|mesh-ancestor
6557293|NCT00929591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557294|NCT00929591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6557295|NCT00929591|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6557296|NCT00929591|Alkylating Agents|alkylating agents|mesh-ancestor
6557297|NCT00929591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557298|NCT00929591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6557299|NCT00929591|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6557300|NCT00929591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6557301|NCT00929591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6557302|NCT00929591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6557303|NCT00929591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6557304|NCT00929591|Antimetabolites|antimetabolites|mesh-ancestor
6443562|NCT00379847|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6443563|NCT00379847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443564|NCT00379847|Natriuretic Agents|natriuretic agents|mesh-ancestor
6443565|NCT00379847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443566|NCT00379886|Thiopental|thiopental|mesh-list
6557305|NCT00929591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6557306|NCT00929591|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6557307|NCT00929591|Hormone Antagonists|hormone antagonists|mesh-ancestor
6557308|NCT00929591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6557309|NCT00929591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6557310|NCT00929591|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6557311|NCT00929591|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6557312|NCT00929591|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6656731|NCT01471158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6656732|NCT01471158|Adrenergic Agents|adrenergic agents|mesh-ancestor
6656733|NCT01471158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6656734|NCT01471158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656735|NCT01471158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656736|NCT01471158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6656737|NCT01471158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6656738|NCT01471158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6656739|NCT01471158|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6656740|NCT01471184|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6443567|NCT00379886|Propofol|propofol|mesh-list
6443568|NCT00379886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6443569|NCT00379886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6656741|NCT01471184|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6656742|NCT01471262|Liver Extracts|liver extracts|mesh-list
6656743|NCT01471262|Hematinics|hematinics|mesh-ancestor
6656744|NCT01471275|Metformin|metformin|mesh-list
6656745|NCT01471275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6656746|NCT01471275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664724|NCT01513720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6664725|NCT01513720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6664726|NCT01513720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557313|NCT00929630|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6557314|NCT00929630|Hemostatics|hemostatics|mesh-ancestor
6557315|NCT00929630|Coagulants|coagulants|mesh-ancestor
6557316|NCT00929799|Hormones|hormones|mesh-list
6557317|NCT00929799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6557318|NCT00929799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557319|NCT00929812|Glucagon|glucagon|mesh-list
6557320|NCT00929812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6557321|NCT00929812|Hormones|hormones|mesh-ancestor
6557322|NCT00929812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6557323|NCT00929812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557324|NCT00929851|Formoterol Fumarate|formoterol fumarate|mesh-list
6557325|NCT00929851|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6557326|NCT00929851|Autonomic Agents|autonomic agents|mesh-ancestor
6557327|NCT00929851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6557328|NCT00929851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557329|NCT00929851|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6557330|NCT00929851|Respiratory System Agents|respiratory system agents|mesh-ancestor
6557331|NCT00929851|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6557332|NCT00929851|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6557333|NCT00929851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6557334|NCT00929851|Adrenergic Agents|adrenergic agents|mesh-ancestor
6557335|NCT00929851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6443570|NCT00379886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443571|NCT00379886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6443572|NCT00379886|Anesthetics, General|anesthetics, general|mesh-ancestor
6443573|NCT00379886|Anesthetics|anesthetics|mesh-ancestor
6443574|NCT00379886|Anticonvulsants|anticonvulsants|mesh-ancestor
6443575|NCT00379886|GABA Modulators|gaba modulators|mesh-ancestor
6443576|NCT00379886|GABA Agents|gaba agents|mesh-ancestor
6557336|NCT00929851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557337|NCT00929877|Ketoprofen|ketoprofen|mesh-list
6557338|NCT00929877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6557339|NCT00929877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6557340|NCT00929877|Analgesics|analgesics|mesh-ancestor
6557341|NCT00929877|Sensory System Agents|sensory system agents|mesh-ancestor
6557342|NCT00929877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6557343|NCT00929877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557344|NCT00929877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6557345|NCT00929877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6557346|NCT00929877|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6557347|NCT00929877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6557348|NCT00929877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557349|NCT00929955|Ondansetron|ondansetron|mesh-list
6557350|NCT00929955|Simvastatin|simvastatin|mesh-list
6557351|NCT00929955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6557352|NCT00929955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6557353|NCT00929955|Antimetabolites|antimetabolites|mesh-ancestor
6557354|NCT00929955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557355|NCT00929955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6557356|NCT00929955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6557357|NCT00929955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6557358|NCT00929955|Antiemetics|antiemetics|mesh-ancestor
6557359|NCT00929955|Autonomic Agents|autonomic agents|mesh-ancestor
6557360|NCT00929955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6557361|NCT00929955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557362|NCT00929955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6557363|NCT00929955|Antipruritics|antipruritics|mesh-ancestor
6557364|NCT00929955|Dermatologic Agents|dermatologic agents|mesh-ancestor
6557365|NCT00929955|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6557366|NCT00929955|Serotonin Agents|serotonin agents|mesh-ancestor
6557367|NCT00929955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6557368|NCT00929955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6557369|NCT00929955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6557370|NCT00929955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6557371|NCT00929955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6557372|NCT00929955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6557373|NCT00930020|Minocycline|minocycline|mesh-list
6656747|NCT01471418|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6443577|NCT00379886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6443578|NCT00379886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443579|NCT00379951|Ertapenem|ertapenem|mesh-list
6557374|NCT00930020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6557375|NCT00930020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6557376|NCT00930033|Sunitinib|sunitinib|mesh-list
6557377|NCT00930033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6557378|NCT00930033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6557379|NCT00930033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6557380|NCT00930033|Growth Substances|growth substances|mesh-ancestor
6557381|NCT00930033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557382|NCT00930033|Growth Inhibitors|growth inhibitors|mesh-ancestor
6557383|NCT00930033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6557384|NCT00930033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6557385|NCT00930033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557386|NCT00930072|Clonidine|clonidine|mesh-list
6557387|NCT00930072|Bupivacaine|bupivacaine|mesh-list
6557388|NCT00930072|Anesthetics, Local|anesthetics, local|mesh-ancestor
6557389|NCT00930072|Anesthetics|anesthetics|mesh-ancestor
6557390|NCT00930072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6557391|NCT00930072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557392|NCT00930072|Sensory System Agents|sensory system agents|mesh-ancestor
6557393|NCT00930072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6557394|NCT00930072|Analgesics|analgesics|mesh-ancestor
6557395|NCT00930072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6557396|NCT00930072|Sympatholytics|sympatholytics|mesh-ancestor
6557397|NCT00930072|Autonomic Agents|autonomic agents|mesh-ancestor
6557398|NCT00930072|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6557399|NCT00930072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6557400|NCT00930072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6557401|NCT00930072|Adrenergic Agents|adrenergic agents|mesh-ancestor
6557402|NCT00930072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6557403|NCT00930072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557404|NCT00930098|Clofarabine|clofarabine|mesh-list
6557405|NCT00930098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6557406|NCT00930098|Antimetabolites|antimetabolites|mesh-ancestor
6557407|NCT00930098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557408|NCT00930098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6557409|NCT00930189|Triamcinolone|triamcinolone|mesh-list
6557410|NCT00930189|Ranibizumab|ranibizumab|mesh-list
6557411|NCT00930189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6557412|NCT00930189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6557413|NCT00930189|Growth Substances|growth substances|mesh-ancestor
6557414|NCT00930189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557415|NCT00930189|Growth Inhibitors|growth inhibitors|mesh-ancestor
6557416|NCT00930189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6557417|NCT00930189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6557418|NCT00930189|Glucocorticoids|glucocorticoids|mesh-ancestor
6557419|NCT00930189|Hormones|hormones|mesh-ancestor
6557420|NCT00930189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6557421|NCT00930202|Conivaptan|conivaptan|mesh-list
6557422|NCT00930202|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6557423|NCT00930202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557424|NCT00930202|Natriuretic Agents|natriuretic agents|mesh-ancestor
6557425|NCT00930202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557426|NCT00930228|Flutamide|flutamide|mesh-list
6557427|NCT00930228|Androgen Antagonists|androgen antagonists|mesh-ancestor
6557428|NCT00930228|Hormone Antagonists|hormone antagonists|mesh-ancestor
6557429|NCT00930228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6557430|NCT00930228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557431|NCT00930228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6557432|NCT00930228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6557433|NCT00930241|Tacrolimus|tacrolimus|mesh-list
6557434|NCT00930241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6557435|NCT00930241|Immunologic Factors|immunologic factors|mesh-ancestor
6557436|NCT00930241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557437|NCT00930241|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6557438|NCT00930241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6557439|NCT00930241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557440|NCT00930306|Tolbutamide|tolbutamide|mesh-list
6557441|NCT00930306|Midazolam|midazolam|mesh-list
6557442|NCT00930306|Caffeine|caffeine|mesh-list
6557443|NCT00930306|Omeprazole|omeprazole|mesh-list
6557444|NCT00930306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6557445|NCT00930306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6557446|NCT00930306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6557447|NCT00930306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557448|NCT00930306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6557449|NCT00930306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6557450|NCT00930306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6557451|NCT00930306|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6557452|NCT00930306|Anesthetics, General|anesthetics, general|mesh-ancestor
6557453|NCT00930306|Anesthetics|anesthetics|mesh-ancestor
6557454|NCT00930306|GABA Modulators|gaba modulators|mesh-ancestor
6557455|NCT00930306|GABA Agents|gaba agents|mesh-ancestor
6557456|NCT00930306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6557457|NCT00930306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557458|NCT00930306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6557459|NCT00930306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6557460|NCT00930306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6557461|NCT00930306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6557462|NCT00930306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6557463|NCT00930306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6557464|NCT00930306|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6557465|NCT00930306|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6557466|NCT00930306|Purinergic Agents|purinergic agents|mesh-ancestor
6557467|NCT00930306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6557468|NCT00930332|Methadone|methadone|mesh-list
6557469|NCT00930332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6557470|NCT00930332|Narcotics|narcotics|mesh-ancestor
6557471|NCT00930332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6557472|NCT00930332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557473|NCT00930332|Analgesics|analgesics|mesh-ancestor
6557474|NCT00930332|Sensory System Agents|sensory system agents|mesh-ancestor
6557475|NCT00930332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6557476|NCT00930332|Antitussive Agents|antitussive agents|mesh-ancestor
6557477|NCT00930332|Respiratory System Agents|respiratory system agents|mesh-ancestor
6557478|NCT00930345|Sunitinib|sunitinib|mesh-list
6557479|NCT00930345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6557480|NCT00930345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6557481|NCT00930345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6557482|NCT00930345|Growth Substances|growth substances|mesh-ancestor
6557483|NCT00930345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557484|NCT00930345|Growth Inhibitors|growth inhibitors|mesh-ancestor
6557485|NCT00930345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6557486|NCT00930345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6557487|NCT00930345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557488|NCT00930358|Anesthetics|anesthetics|mesh-list
6557489|NCT00930358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6557490|NCT00930358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557491|NCT00930475|Carboplatin|carboplatin|mesh-list
6557492|NCT00930475|Everolimus|everolimus|mesh-list
6557493|NCT00930475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6557494|NCT00930475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6557495|NCT00930475|Immunologic Factors|immunologic factors|mesh-ancestor
6557496|NCT00930475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557497|NCT00930488|Moxifloxacin|moxifloxacin|mesh-list
6557498|NCT00930488|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6557499|NCT00930488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6557500|NCT00930488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6557501|NCT00930488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6557502|NCT00930488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6557503|NCT00930488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6557504|NCT00930488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557505|NCT00930488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6557506|NCT00930488|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6557507|NCT00930488|Contraceptive Agents|contraceptive agents|mesh-ancestor
6557508|NCT00930488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6557509|NCT00930488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557510|NCT00930488|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6557511|NCT00930488|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6557512|NCT00930488|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6557513|NCT00930514|Rituximab|rituximab|mesh-list
6656748|NCT01471418|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6557514|NCT00930514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6557515|NCT00930514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6557516|NCT00930514|Immunologic Factors|immunologic factors|mesh-ancestor
6557517|NCT00930514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557518|NCT00930514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6557519|NCT00930566|Methoxsalen|methoxsalen|mesh-list
6557520|NCT00930566|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6557521|NCT00930566|Dermatologic Agents|dermatologic agents|mesh-ancestor
6557522|NCT00930579|Metformin|metformin|mesh-list
6557523|NCT00930579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6557524|NCT00930579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557525|NCT00930605|Alemtuzumab|alemtuzumab|mesh-list
6557526|NCT00930605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6557527|NCT00930605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6557528|NCT00930670|Esomeprazole|esomeprazole|mesh-list
6557529|NCT00930670|Omeprazole|omeprazole|mesh-list
6557530|NCT00930670|Pantoprazole|pantoprazole|mesh-list
6557531|NCT00930670|Ranitidine|ranitidine|mesh-list
6557532|NCT00930670|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
6557533|NCT00930670|Atorvastatin|atorvastatin|mesh-list
6557534|NCT00930670|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6557535|NCT00930670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6557536|NCT00930670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6557537|NCT00930670|Antimetabolites|antimetabolites|mesh-ancestor
6557538|NCT00930670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557539|NCT00930670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6557540|NCT00930670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6557541|NCT00930670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6557542|NCT00930670|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6557543|NCT00930670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6557544|NCT00930670|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6557545|NCT00930670|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6557546|NCT00930670|Histamine Antagonists|histamine antagonists|mesh-ancestor
6557547|NCT00930670|Histamine Agents|histamine agents|mesh-ancestor
6557548|NCT00930670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6557549|NCT00930670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557550|NCT00930683|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6557551|NCT00930683|Immunologic Factors|immunologic factors|mesh-ancestor
6557552|NCT00930683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557553|NCT00930709|Botulinum Toxins|botulinum toxins|mesh-list
6557554|NCT00930709|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6557555|NCT00930709|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6557556|NCT00930709|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6557557|NCT00930709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6557558|NCT00930709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557559|NCT00930709|Cholinergic Agents|cholinergic agents|mesh-ancestor
6557560|NCT00930709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6557561|NCT00930709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557562|NCT00930709|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6557563|NCT00930709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6557564|NCT00930722|Quinapril|quinapril|mesh-list
6557565|NCT00930722|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6557566|NCT00930722|Protease Inhibitors|protease inhibitors|mesh-ancestor
6557567|NCT00930722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6557568|NCT00930722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557569|NCT00930722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6557570|NCT00930839|Aspirin|aspirin|mesh-list
6557571|NCT00930839|Niacin|niacin|mesh-list
6557572|NCT00930839|Nicotinic Acids|nicotinic acids|mesh-list
6557573|NCT00930839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6557574|NCT00930839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6557575|NCT00930839|Analgesics|analgesics|mesh-ancestor
6557576|NCT00930839|Sensory System Agents|sensory system agents|mesh-ancestor
6557577|NCT00930839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6557578|NCT00930839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557579|NCT00930839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6557580|NCT00930839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6557581|NCT00930839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6557582|NCT00930839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6557583|NCT00930839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557584|NCT00930839|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6557585|NCT00930839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6557586|NCT00930839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6557587|NCT00930839|Antipyretics|antipyretics|mesh-ancestor
6557588|NCT00930839|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6557589|NCT00930839|Antimetabolites|antimetabolites|mesh-ancestor
6557590|NCT00930839|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6557591|NCT00930839|Vasodilator Agents|vasodilator agents|mesh-ancestor
6557592|NCT00930839|Vitamin B Complex|vitamin b complex|mesh-ancestor
6557593|NCT00930839|Vitamins|vitamins|mesh-ancestor
6557594|NCT00930839|Micronutrients|micronutrients|mesh-ancestor
6557595|NCT00930865|Dapagliflozin|dapagliflozin|mesh-list
6557596|NCT00930865|Bumetanide|bumetanide|mesh-list
6557597|NCT00930865|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6557598|NCT00930865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557599|NCT00930865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6557600|NCT00930865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557601|NCT00930865|Diuretics|diuretics|mesh-ancestor
6557602|NCT00930865|Natriuretic Agents|natriuretic agents|mesh-ancestor
6557603|NCT00930865|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6557604|NCT00930865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6557605|NCT00930891|Bevacizumab|bevacizumab|mesh-list
6557606|NCT00930891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6557607|NCT00930891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6557608|NCT00930891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6557609|NCT00930891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6557610|NCT00930891|Growth Substances|growth substances|mesh-ancestor
6557611|NCT00930891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557612|NCT00930891|Growth Inhibitors|growth inhibitors|mesh-ancestor
6557613|NCT00930943|Oxymorphone|oxymorphone|mesh-list
6557614|NCT00930943|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6557615|NCT00930943|Narcotics|narcotics|mesh-ancestor
6557616|NCT00930943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6557617|NCT00930943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557618|NCT00930943|Analgesics|analgesics|mesh-ancestor
6557619|NCT00930943|Sensory System Agents|sensory system agents|mesh-ancestor
6557620|NCT00930943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6557621|NCT00930943|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6557622|NCT00930995|Candesartan|candesartan|mesh-list
6557623|NCT00930995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6557624|NCT00930995|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6557625|NCT00930995|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6557626|NCT00930995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557627|NCT00931008|Docetaxel|docetaxel|mesh-list
6557628|NCT00931008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6557629|NCT00931008|Tubulin Modulators|tubulin modulators|mesh-ancestor
6557630|NCT00931008|Antimitotic Agents|antimitotic agents|mesh-ancestor
6557631|NCT00931008|Mitosis Modulators|mitosis modulators|mesh-ancestor
6557632|NCT00931008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557633|NCT00931021|Nicotine|nicotine|mesh-list
6557634|NCT00931021|Varenicline|varenicline|mesh-list
6557635|NCT00931021|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6557636|NCT00931021|Autonomic Agents|autonomic agents|mesh-ancestor
6557637|NCT00931021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6557638|NCT00931021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557639|NCT00931021|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6557640|NCT00931021|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6557641|NCT00931021|Cholinergic Agents|cholinergic agents|mesh-ancestor
6557642|NCT00931021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6557643|NCT00931021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557644|NCT00931073|Ketoconazole|ketoconazole|mesh-list
6557645|NCT00931073|Omeprazole|omeprazole|mesh-list
6557646|NCT00931073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6557647|NCT00931073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6557648|NCT00931073|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6557649|NCT00931073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6557650|NCT00931073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557651|NCT00931073|Antifungal Agents|antifungal agents|mesh-ancestor
6557652|NCT00931073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6557653|NCT00931073|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6557654|NCT00931073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6557655|NCT00931073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6557656|NCT00931073|Hormone Antagonists|hormone antagonists|mesh-ancestor
6557657|NCT00931073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6557658|NCT00931073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557659|NCT00931073|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6557660|NCT00931086|Belimumab|belimumab|mesh-list
6557661|NCT00931086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6557662|NCT00931086|Immunologic Factors|immunologic factors|mesh-ancestor
6557663|NCT00931086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557664|NCT00931125|Ranibizumab|ranibizumab|mesh-list
6557665|NCT00931125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6557666|NCT00931125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6557667|NCT00931125|Growth Substances|growth substances|mesh-ancestor
6557668|NCT00931125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557669|NCT00931125|Growth Inhibitors|growth inhibitors|mesh-ancestor
6557670|NCT00931125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6557671|NCT00931138|Cytarabine|cytarabine|mesh-list
6557672|NCT00931138|Daunorubicin|daunorubicin|mesh-list
6557673|NCT00931138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6557674|NCT00931138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6557675|NCT00931138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6557676|NCT00931138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6557677|NCT00931138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6557678|NCT00931138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557679|NCT00931138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6557680|NCT00931138|Antimetabolites|antimetabolites|mesh-ancestor
6557681|NCT00931138|Antiviral Agents|antiviral agents|mesh-ancestor
6557682|NCT00931138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6557683|NCT00931138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6557684|NCT00931138|Immunologic Factors|immunologic factors|mesh-ancestor
6557685|NCT00931138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557686|NCT00931203|Celecoxib|celecoxib|mesh-list
6557687|NCT00931203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6557688|NCT00931203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6557689|NCT00931203|Analgesics|analgesics|mesh-ancestor
6557690|NCT00931203|Sensory System Agents|sensory system agents|mesh-ancestor
6557691|NCT00931203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6557692|NCT00931203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557693|NCT00931203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6557694|NCT00931203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6557695|NCT00931203|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6557696|NCT00931203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6557697|NCT00931203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6557698|NCT00931203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557699|NCT00931229|Entecavir|entecavir|mesh-list
6557700|NCT00931229|Antiviral Agents|antiviral agents|mesh-ancestor
6557701|NCT00931229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6557702|NCT00931281|Ritonavir|ritonavir|mesh-list
6557703|NCT00931281|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6557704|NCT00931281|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6557705|NCT00931281|Protease Inhibitors|protease inhibitors|mesh-ancestor
6557706|NCT00931281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6557707|NCT00931281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557708|NCT00931281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6557709|NCT00931281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6557710|NCT00931281|Antiviral Agents|antiviral agents|mesh-ancestor
6557711|NCT00931281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6557712|NCT00931281|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6557713|NCT00931281|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6656749|NCT01471418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656750|NCT01471470|Bevacizumab|bevacizumab|mesh-list
6656751|NCT01471470|Docetaxel|docetaxel|mesh-list
6656752|NCT01471470|Capecitabine|capecitabine|mesh-list
6656753|NCT01471470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6656754|NCT01471470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6656755|NCT01471470|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6656756|NCT01471470|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6656757|NCT01471470|Growth Substances|growth substances|mesh-ancestor
6656758|NCT01471470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656759|NCT01471470|Growth Inhibitors|growth inhibitors|mesh-ancestor
6656760|NCT01471470|Tubulin Modulators|tubulin modulators|mesh-ancestor
6656761|NCT01471470|Antimitotic Agents|antimitotic agents|mesh-ancestor
6656762|NCT01471470|Mitosis Modulators|mitosis modulators|mesh-ancestor
6656763|NCT01471470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656764|NCT01471470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6656765|NCT01471470|Antimetabolites|antimetabolites|mesh-ancestor
6557714|NCT00931372|Lixisenatide|lixisenatide|mesh-list
6557715|NCT00931372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6557716|NCT00931372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443580|NCT00379951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6443581|NCT00379951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6443582|NCT00379964|Caspofungin|caspofungin|mesh-list
6443583|NCT00379964|Antifungal Agents|antifungal agents|mesh-ancestor
6443584|NCT00379964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6443585|NCT00379964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6443586|NCT00379964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443587|NCT00379977|Vaccines|vaccines|mesh-list
6443588|NCT00379977|Immunologic Factors|immunologic factors|mesh-ancestor
6443589|NCT00379977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443590|NCT00380120|Warfarin|warfarin|mesh-list
6443591|NCT00380120|Anticoagulants|anticoagulants|mesh-ancestor
6443592|NCT00380133|Prednisolone|prednisolone|mesh-list
6443593|NCT00380133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6443594|NCT00380133|Glucocorticoids|glucocorticoids|mesh-ancestor
6443595|NCT00380133|Hormones|hormones|mesh-ancestor
6443596|NCT00380133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6443597|NCT00380133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443598|NCT00380133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6443599|NCT00380133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6443600|NCT00380146|Pyrimethamine|pyrimethamine|mesh-list
6557717|NCT00931398|Methylphenidate|methylphenidate|mesh-list
6557718|NCT00931398|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6557719|NCT00931398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557720|NCT00931398|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6557721|NCT00931398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6557722|NCT00931398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6557723|NCT00931398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557724|NCT00931398|Dopamine Agents|dopamine agents|mesh-ancestor
6557725|NCT00931398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6557726|NCT00931437|Vitamin K|vitamin k|mesh-list
6557727|NCT00931437|Vitamins|vitamins|mesh-ancestor
6557728|NCT00931437|Micronutrients|micronutrients|mesh-ancestor
6557729|NCT00931437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557730|NCT00931437|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6557731|NCT00931437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6557732|NCT00931437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557733|NCT00931437|Hemostatics|hemostatics|mesh-ancestor
6557734|NCT00931437|Coagulants|coagulants|mesh-ancestor
6557735|NCT00931450|Sunitinib|sunitinib|mesh-list
6557736|NCT00931450|Exemestane|exemestane|mesh-list
6557737|NCT00931450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6557738|NCT00931450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6557739|NCT00931450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6557740|NCT00931450|Growth Substances|growth substances|mesh-ancestor
6557741|NCT00931450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557742|NCT00931450|Growth Inhibitors|growth inhibitors|mesh-ancestor
6557743|NCT00931450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6557744|NCT00931450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6557745|NCT00931450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557746|NCT00931450|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6557747|NCT00931450|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6557748|NCT00931450|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6443601|NCT00380146|Sulfadoxine|sulfadoxine|mesh-list
6443602|NCT00380146|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6557749|NCT00931450|Hormone Antagonists|hormone antagonists|mesh-ancestor
6557750|NCT00931450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6557751|NCT00931580|Vitamin D|vitamin d|mesh-list
6557752|NCT00931580|Cholecalciferol|cholecalciferol|mesh-list
6557753|NCT00931580|Vitamins|vitamins|mesh-ancestor
6557754|NCT00931580|Micronutrients|micronutrients|mesh-ancestor
6557755|NCT00931580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557756|NCT00931580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6557757|NCT00931580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6557758|NCT00931645|Cytarabine|cytarabine|mesh-list
6557759|NCT00931645|Dexamethasone|dexamethasone|mesh-list
6557760|NCT00931645|Cyclophosphamide|cyclophosphamide|mesh-list
6557761|NCT00931645|Cisplatin|cisplatin|mesh-list
6557762|NCT00931645|Fludarabine|fludarabine|mesh-list
6557763|NCT00931645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6557764|NCT00931645|Immunologic Factors|immunologic factors|mesh-ancestor
6557765|NCT00931645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557766|NCT00931645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6557767|NCT00931645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6557768|NCT00931645|Alkylating Agents|alkylating agents|mesh-ancestor
6557769|NCT00931645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557770|NCT00931645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6557771|NCT00931645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6557772|NCT00931645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6557773|NCT00931645|Antiemetics|antiemetics|mesh-ancestor
6557774|NCT00931645|Autonomic Agents|autonomic agents|mesh-ancestor
6557775|NCT00931645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6557776|NCT00931645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6557777|NCT00931645|Glucocorticoids|glucocorticoids|mesh-ancestor
6557778|NCT00931645|Hormones|hormones|mesh-ancestor
6557779|NCT00931645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6557780|NCT00931645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6557781|NCT00931645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6557782|NCT00931645|Antimetabolites|antimetabolites|mesh-ancestor
6557783|NCT00931645|Antiviral Agents|antiviral agents|mesh-ancestor
6557784|NCT00931645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6557785|NCT00931697|Mefloquine|mefloquine|mesh-list
6557786|NCT00931697|Antimalarials|antimalarials|mesh-ancestor
6557787|NCT00931697|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6557788|NCT00931697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6557789|NCT00931697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6557790|NCT00931736|Rifampin|rifampin|mesh-list
6557791|NCT00931736|Isoniazid|isoniazid|mesh-list
6557792|NCT00931736|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6557793|NCT00931736|Antitubercular Agents|antitubercular agents|mesh-ancestor
6557794|NCT00931736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6557795|NCT00931736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6557796|NCT00931736|Leprostatic Agents|leprostatic agents|mesh-ancestor
6557797|NCT00931736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6557798|NCT00931736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6557799|NCT00931736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557800|NCT00931736|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6557801|NCT00931736|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6557802|NCT00931736|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6557803|NCT00931736|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6557804|NCT00931736|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6557805|NCT00931736|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6557806|NCT00931736|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6557807|NCT00931736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6557808|NCT00931736|Antimetabolites|antimetabolites|mesh-ancestor
6557809|NCT00931736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6557810|NCT00931775|Pindolol|pindolol|mesh-list
6557811|NCT00931775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6557812|NCT00931775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6557813|NCT00931775|Adrenergic Agents|adrenergic agents|mesh-ancestor
6557814|NCT00931775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6557815|NCT00931775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557816|NCT00931775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557817|NCT00931775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6557818|NCT00931775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6557819|NCT00931775|Serotonin Agents|serotonin agents|mesh-ancestor
6557820|NCT00931775|Vasodilator Agents|vasodilator agents|mesh-ancestor
6557821|NCT00931788|Antihypertensive Agents|antihypertensive agents|mesh-list
6557822|NCT00931827|Levonorgestrel|levonorgestrel|mesh-list
6557823|NCT00931827|Etonogestrel|etonogestrel|mesh-list
6557824|NCT00931827|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6443603|NCT00380146|Antimalarials|antimalarials|mesh-ancestor
6443604|NCT00380146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6443605|NCT00380146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6443606|NCT00380146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6443607|NCT00380146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6443608|NCT00380146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6443609|NCT00380146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443610|NCT00380146|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6443611|NCT00380146|Renal Agents|renal agents|mesh-ancestor
6443612|NCT00380224|Olanzapine|olanzapine|mesh-list
6443613|NCT00380224|Antiemetics|antiemetics|mesh-ancestor
6557825|NCT00931827|Contraceptive Agents|contraceptive agents|mesh-ancestor
6443614|NCT00380224|Autonomic Agents|autonomic agents|mesh-ancestor
6557826|NCT00931827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6557827|NCT00931827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557828|NCT00931827|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6557829|NCT00931827|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6557830|NCT00931827|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6557831|NCT00931840|Irinotecan|irinotecan|mesh-list
6557832|NCT00931840|Cetuximab|cetuximab|mesh-list
6557833|NCT00931840|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6557834|NCT00931840|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6557835|NCT00931840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6557836|NCT00931840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557837|NCT00931840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6557838|NCT00931840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6557839|NCT00931866|Diclofenac|diclofenac|mesh-list
6557840|NCT00931866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6557841|NCT00931866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6557842|NCT00931866|Analgesics|analgesics|mesh-ancestor
6557843|NCT00931866|Sensory System Agents|sensory system agents|mesh-ancestor
6557844|NCT00931866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6557845|NCT00931866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557846|NCT00931866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6557847|NCT00931866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6557848|NCT00931866|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6557849|NCT00931866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6557850|NCT00931866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557851|NCT00931957|Prednisolone|prednisolone|mesh-list
6557852|NCT00931957|Etanercept|etanercept|mesh-list
6557853|NCT00931957|Methotrexate|methotrexate|mesh-list
6557854|NCT00931957|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6557855|NCT00931957|Abortifacient Agents|abortifacient agents|mesh-ancestor
6443615|NCT00380224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6443616|NCT00380224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443617|NCT00380224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6443618|NCT00380224|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6443619|NCT00380224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6443620|NCT00380224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6443621|NCT00380224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6443622|NCT00380224|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6443623|NCT00380224|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6443624|NCT00380224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6443625|NCT00380224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443626|NCT00380224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6443627|NCT00380224|Serotonin Agents|serotonin agents|mesh-ancestor
6443628|NCT00380263|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
6443629|NCT00380263|Growth Substances|growth substances|mesh-ancestor
6443630|NCT00380263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557856|NCT00931957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6557857|NCT00931957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557858|NCT00931957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6557859|NCT00931957|Antimetabolites|antimetabolites|mesh-ancestor
6557860|NCT00931957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557861|NCT00931957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6557862|NCT00931957|Dermatologic Agents|dermatologic agents|mesh-ancestor
6557863|NCT00931957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6557864|NCT00931957|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6557865|NCT00931957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6557866|NCT00931957|Immunologic Factors|immunologic factors|mesh-ancestor
6557867|NCT00931957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6557868|NCT00931957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6443631|NCT00380263|Vasodilator Agents|vasodilator agents|mesh-ancestor
6443632|NCT00380263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6443633|NCT00380263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443634|NCT00380289|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
6443635|NCT00380289|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6443636|NCT00380289|Adrenergic Agents|adrenergic agents|mesh-ancestor
6557869|NCT00931957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6557870|NCT00931957|Glucocorticoids|glucocorticoids|mesh-ancestor
6557871|NCT00931957|Hormones|hormones|mesh-ancestor
6557872|NCT00931957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6557873|NCT00931957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6557874|NCT00931957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6557875|NCT00931957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6557876|NCT00931957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6557877|NCT00931957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6557878|NCT00931957|Analgesics|analgesics|mesh-ancestor
6557879|NCT00931957|Sensory System Agents|sensory system agents|mesh-ancestor
6557880|NCT00932048|Atorvastatin|atorvastatin|mesh-list
6557881|NCT00932048|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6557882|NCT00932048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6557883|NCT00932048|Antimetabolites|antimetabolites|mesh-ancestor
6557884|NCT00932048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557885|NCT00932048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6557886|NCT00932048|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6557887|NCT00932048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6557888|NCT00932100|Heparin|heparin|mesh-list
6557889|NCT00932100|Calcium heparin|calcium heparin|mesh-list
6557890|NCT00932100|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6557891|NCT00932100|Tinzaparin|tinzaparin|mesh-list
6557892|NCT00932100|Dalteparin|dalteparin|mesh-list
6557893|NCT00932100|Anticoagulants|anticoagulants|mesh-ancestor
6557894|NCT00932100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6557895|NCT00932100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6557896|NCT00932100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557897|NCT00932217|Lenograstim|lenograstim|mesh-list
6557898|NCT00932217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6557899|NCT00932217|Immunologic Factors|immunologic factors|mesh-ancestor
6557900|NCT00932217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557901|NCT00932386|Dexmedetomidine|dexmedetomidine|mesh-list
6557902|NCT00932386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6557903|NCT00932386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6557904|NCT00932386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557905|NCT00932386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6557906|NCT00932386|Analgesics|analgesics|mesh-ancestor
6557907|NCT00932386|Sensory System Agents|sensory system agents|mesh-ancestor
6557908|NCT00932386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6557909|NCT00932386|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6557910|NCT00932386|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6557911|NCT00932386|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6557912|NCT00932386|Adrenergic Agents|adrenergic agents|mesh-ancestor
6557913|NCT00932386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6557914|NCT00932386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557915|NCT00932529|Olanzapine|olanzapine|mesh-list
6557916|NCT00932529|Risperidone|risperidone|mesh-list
6557917|NCT00932529|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6557918|NCT00932529|Ziprasidone|ziprasidone|mesh-list
6557919|NCT00932529|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6557920|NCT00932529|Serotonin Agents|serotonin agents|mesh-ancestor
6557921|NCT00932529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6557922|NCT00932529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557923|NCT00932529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557924|NCT00932529|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6557925|NCT00932529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6557926|NCT00932529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6557927|NCT00932529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6557928|NCT00932529|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6557929|NCT00932529|Dopamine Agents|dopamine agents|mesh-ancestor
6557930|NCT00932529|Antiemetics|antiemetics|mesh-ancestor
6557931|NCT00932529|Autonomic Agents|autonomic agents|mesh-ancestor
6557932|NCT00932529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6557933|NCT00932529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6557934|NCT00932529|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6557935|NCT00932529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6557936|NCT00932529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6557937|NCT00932529|Antidepressive Agents|antidepressive agents|mesh-ancestor
6557938|NCT00932542|Lidocaine|lidocaine|mesh-list
6557939|NCT00932542|Prilocaine|prilocaine|mesh-list
6557940|NCT00932542|Anesthetics, Local|anesthetics, local|mesh-ancestor
6557941|NCT00932542|Anesthetics|anesthetics|mesh-ancestor
6557942|NCT00932542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6557943|NCT00932542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557944|NCT00932542|Sensory System Agents|sensory system agents|mesh-ancestor
6557945|NCT00932542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6557946|NCT00932542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6557947|NCT00932542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6557948|NCT00932542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6557949|NCT00932542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6557950|NCT00932542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557951|NCT00932555|Factor VIII|factor viii|mesh-list
6557952|NCT00932555|Coagulants|coagulants|mesh-ancestor
6557953|NCT00932685|Midazolam|midazolam|mesh-list
6557954|NCT00932685|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6557955|NCT00932685|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6557956|NCT00932685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6557957|NCT00932685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557958|NCT00932685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6557959|NCT00932685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6557960|NCT00932685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6557961|NCT00932685|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6557962|NCT00932685|Anesthetics, General|anesthetics, general|mesh-ancestor
6557963|NCT00932685|Anesthetics|anesthetics|mesh-ancestor
6557964|NCT00932685|GABA Modulators|gaba modulators|mesh-ancestor
6557965|NCT00932685|GABA Agents|gaba agents|mesh-ancestor
6557966|NCT00932685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6557967|NCT00932685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557968|NCT00932763|Amlodipine|amlodipine|mesh-list
6557969|NCT00932763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6557970|NCT00932763|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6557971|NCT00932763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6557972|NCT00932763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557973|NCT00932763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6557974|NCT00932763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557975|NCT00932763|Vasodilator Agents|vasodilator agents|mesh-ancestor
6557976|NCT00932802|Moxifloxacin|moxifloxacin|mesh-list
6557977|NCT00932802|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6557978|NCT00932802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6557979|NCT00932802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6557980|NCT00932802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6557981|NCT00932802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6557982|NCT00932802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6557983|NCT00932802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557984|NCT00932802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6557985|NCT00932802|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6557986|NCT00932802|Contraceptive Agents|contraceptive agents|mesh-ancestor
6557987|NCT00932802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6557988|NCT00932802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6557989|NCT00932802|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6557990|NCT00932802|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6557991|NCT00932802|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6557992|NCT00932867|Telmisartan|telmisartan|mesh-list
6557993|NCT00932867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6557994|NCT00932867|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6557995|NCT00932867|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6656766|NCT01471535|Interferons|interferons|mesh-list
6557996|NCT00932867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6557997|NCT00932880|Amlodipine|amlodipine|mesh-list
6557998|NCT00932880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6557999|NCT00932880|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6558000|NCT00932880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6558001|NCT00932880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558002|NCT00932880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6558003|NCT00932880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558004|NCT00932880|Vasodilator Agents|vasodilator agents|mesh-ancestor
6558005|NCT00932971|Tenofovir|tenofovir|mesh-list
6558006|NCT00932971|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6558007|NCT00932971|Interferon-alpha|interferon-alpha|mesh-list
6558008|NCT00932971|Interferon alpha-2|interferon alpha-2|mesh-list
6558009|NCT00932971|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
6558010|NCT00932971|Antiviral Agents|antiviral agents|mesh-ancestor
6558011|NCT00932971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6558012|NCT00932971|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6558013|NCT00932971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6558014|NCT00932971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6558015|NCT00932971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558016|NCT00932971|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6558017|NCT00932971|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6558018|NCT00932971|Immunologic Factors|immunologic factors|mesh-ancestor
6558019|NCT00932971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558020|NCT00932971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6558021|NCT00933023|Hydrocortisone|hydrocortisone|mesh-list
6558022|NCT00933023|Betamethasone|betamethasone|mesh-list
6558023|NCT00933023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6558024|NCT00933023|Glucocorticoids|glucocorticoids|mesh-ancestor
6558025|NCT00933023|Hormones|hormones|mesh-ancestor
6558026|NCT00933023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6558027|NCT00933023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558028|NCT00933023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6558029|NCT00933023|Respiratory System Agents|respiratory system agents|mesh-ancestor
6558030|NCT00933049|Amoxicillin|amoxicillin|mesh-list
6558031|NCT00933049|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6558032|NCT00933049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6558033|NCT00933049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6558034|NCT00933049|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6558035|NCT00933049|Renal Agents|renal agents|mesh-ancestor
6558036|NCT00933049|Antimalarials|antimalarials|mesh-ancestor
6558037|NCT00933049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6558038|NCT00933049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6558039|NCT00933179|Levonorgestrel|levonorgestrel|mesh-list
6558040|NCT00933179|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
6558041|NCT00933179|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
6558042|NCT00933179|Gestodene|gestodene|mesh-list
6558043|NCT00933179|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6558044|NCT00933179|Contraceptive Agents|contraceptive agents|mesh-ancestor
6558045|NCT00933179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6558046|NCT00933179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558047|NCT00933179|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6558048|NCT00933179|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6558049|NCT00933179|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6558050|NCT00933179|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6558051|NCT00933179|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6558052|NCT00933179|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
6558053|NCT00933179|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6558054|NCT00933179|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6558055|NCT00933179|Progestins|progestins|mesh-ancestor
6558056|NCT00933179|Hormones|hormones|mesh-ancestor
6558057|NCT00933179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6558058|NCT00933205|Tipranavir|tipranavir|mesh-list
6558059|NCT00933205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6558060|NCT00933205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6558061|NCT00933205|Antiviral Agents|antiviral agents|mesh-ancestor
6558062|NCT00933205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6656767|NCT01471535|Interferon-alpha|interferon-alpha|mesh-list
6656768|NCT01471535|Interferon alpha-2|interferon alpha-2|mesh-list
6656769|NCT01471535|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6656770|NCT01471535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6656771|NCT01471535|Antiviral Agents|antiviral agents|mesh-ancestor
6656772|NCT01471535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6656773|NCT01471535|Immunologic Factors|immunologic factors|mesh-ancestor
6558063|NCT00933231|Mycophenolic Acid|mycophenolic acid|mesh-list
6558064|NCT00933231|Prednisone|prednisone|mesh-list
6558065|NCT00933231|Methylprednisolone|methylprednisolone|mesh-list
6558066|NCT00933231|Ramipril|ramipril|mesh-list
6558067|NCT00933231|Irbesartan|irbesartan|mesh-list
6558068|NCT00933231|Tacrolimus|tacrolimus|mesh-list
6558069|NCT00933231|Basiliximab|basiliximab|mesh-list
6558070|NCT00933231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6558071|NCT00933231|Glucocorticoids|glucocorticoids|mesh-ancestor
6558072|NCT00933231|Hormones|hormones|mesh-ancestor
6558073|NCT00933231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6558074|NCT00933231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558075|NCT00933231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6558076|NCT00933231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6558077|NCT00933231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6558078|NCT00933231|Immunologic Factors|immunologic factors|mesh-ancestor
6558079|NCT00933231|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6558080|NCT00933231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6558081|NCT00933231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558082|NCT00933231|Antiemetics|antiemetics|mesh-ancestor
6558083|NCT00933231|Autonomic Agents|autonomic agents|mesh-ancestor
6558084|NCT00933231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6558085|NCT00933231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6558086|NCT00933231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6558087|NCT00933231|Protective Agents|protective agents|mesh-ancestor
6558088|NCT00933231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6558089|NCT00933231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6558090|NCT00933231|Antitubercular Agents|antitubercular agents|mesh-ancestor
6558091|NCT00933231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6558092|NCT00933231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6558093|NCT00933231|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6558094|NCT00933231|Protease Inhibitors|protease inhibitors|mesh-ancestor
6558095|NCT00933231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6558096|NCT00933231|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6558097|NCT00933231|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6558098|NCT00933283|Methadone|methadone|mesh-list
6558099|NCT00933283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6558100|NCT00933283|Narcotics|narcotics|mesh-ancestor
6558101|NCT00933283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6558102|NCT00933283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558103|NCT00933283|Analgesics|analgesics|mesh-ancestor
6558104|NCT00933283|Sensory System Agents|sensory system agents|mesh-ancestor
6558105|NCT00933283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6558106|NCT00933283|Antitussive Agents|antitussive agents|mesh-ancestor
6558107|NCT00933283|Respiratory System Agents|respiratory system agents|mesh-ancestor
6558108|NCT00933309|Metformin|metformin|mesh-list
6558109|NCT00933309|Rosiglitazone|rosiglitazone|mesh-list
6558110|NCT00933309|Exemestane|exemestane|mesh-list
6558111|NCT00933309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6558112|NCT00933309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558113|NCT00933309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6558114|NCT00933309|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6558115|NCT00933309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6558116|NCT00933309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6558117|NCT00933309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558118|NCT00933309|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6558119|NCT00933309|Hormone Antagonists|hormone antagonists|mesh-ancestor
6558120|NCT00933309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6558121|NCT00933374|Paclitaxel|paclitaxel|mesh-list
6558122|NCT00933374|Everolimus|everolimus|mesh-list
6558123|NCT00933374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6558124|NCT00933374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6558125|NCT00933374|Tubulin Modulators|tubulin modulators|mesh-ancestor
6558126|NCT00933374|Antimitotic Agents|antimitotic agents|mesh-ancestor
6558127|NCT00933374|Mitosis Modulators|mitosis modulators|mesh-ancestor
6558128|NCT00933374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558129|NCT00933374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6558130|NCT00933374|Immunologic Factors|immunologic factors|mesh-ancestor
6558131|NCT00933374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558132|NCT00933387|Paclitaxel|paclitaxel|mesh-list
6558133|NCT00933387|Cetuximab|cetuximab|mesh-list
6558134|NCT00933387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6558135|NCT00933387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6558136|NCT00933387|Tubulin Modulators|tubulin modulators|mesh-ancestor
6558137|NCT00933387|Antimitotic Agents|antimitotic agents|mesh-ancestor
6558138|NCT00933387|Mitosis Modulators|mitosis modulators|mesh-ancestor
6558139|NCT00933387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558140|NCT00933387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6558141|NCT00933426|Paclitaxel|paclitaxel|mesh-list
6558142|NCT00933426|Lenalidomide|lenalidomide|mesh-list
6558143|NCT00933426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6558144|NCT00933426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6558145|NCT00933426|Tubulin Modulators|tubulin modulators|mesh-ancestor
6558146|NCT00933426|Antimitotic Agents|antimitotic agents|mesh-ancestor
6558147|NCT00933426|Mitosis Modulators|mitosis modulators|mesh-ancestor
6558148|NCT00933426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558149|NCT00933426|Immunologic Factors|immunologic factors|mesh-ancestor
6558150|NCT00933426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558151|NCT00933426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6558152|NCT00933426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6558153|NCT00933426|Growth Substances|growth substances|mesh-ancestor
6558154|NCT00933426|Growth Inhibitors|growth inhibitors|mesh-ancestor
6558155|NCT00933439|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6558156|NCT00933439|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6558157|NCT00933439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6558158|NCT00933439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6558159|NCT00933439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558160|NCT00933439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6443637|NCT00380289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6443638|NCT00380289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443639|NCT00380289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443640|NCT00380354|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
6443641|NCT00380354|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6443642|NCT00380354|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6443643|NCT00380354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6443644|NCT00380354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443645|NCT00380380|Vildagliptin|vildagliptin|mesh-list
6558161|NCT00933439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558162|NCT00933439|Analgesics|analgesics|mesh-ancestor
6558163|NCT00933439|Sensory System Agents|sensory system agents|mesh-ancestor
6558164|NCT00933439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6558165|NCT00933439|Antidepressive Agents|antidepressive agents|mesh-ancestor
6558166|NCT00933439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6443646|NCT00380380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6443647|NCT00380380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443648|NCT00380380|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6443649|NCT00380380|Protease Inhibitors|protease inhibitors|mesh-ancestor
6443650|NCT00380380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6443651|NCT00380380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443652|NCT00380406|Leuprolide|leuprolide|mesh-list
6443653|NCT00380406|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6558167|NCT00933439|Dopamine Agents|dopamine agents|mesh-ancestor
6558168|NCT00933452|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6558169|NCT00933452|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6558170|NCT00933452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6558171|NCT00933452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6558172|NCT00933452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558173|NCT00933452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6558174|NCT00933452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558175|NCT00933452|Analgesics|analgesics|mesh-ancestor
6558176|NCT00933452|Sensory System Agents|sensory system agents|mesh-ancestor
6558177|NCT00933452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6558178|NCT00933452|Antidepressive Agents|antidepressive agents|mesh-ancestor
6558179|NCT00933452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6558180|NCT00933452|Dopamine Agents|dopamine agents|mesh-ancestor
6558181|NCT00933465|Loperamide|loperamide|mesh-list
6558182|NCT00933465|Antidiarrheals|antidiarrheals|mesh-list
6558183|NCT00933465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6558184|NCT00933517|Cyclophosphamide|cyclophosphamide|mesh-list
6558185|NCT00933517|Docetaxel|docetaxel|mesh-list
6558186|NCT00933517|Panitumumab|panitumumab|mesh-list
6558187|NCT00933517|Epirubicin|epirubicin|mesh-list
6558188|NCT00933517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6558189|NCT00933517|Immunologic Factors|immunologic factors|mesh-ancestor
6558190|NCT00933517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558191|NCT00933517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6558192|NCT00933517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6558193|NCT00933517|Alkylating Agents|alkylating agents|mesh-ancestor
6558194|NCT00933517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558195|NCT00933517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6558196|NCT00933517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6558197|NCT00933517|Tubulin Modulators|tubulin modulators|mesh-ancestor
6558198|NCT00933517|Antimitotic Agents|antimitotic agents|mesh-ancestor
6558199|NCT00933517|Mitosis Modulators|mitosis modulators|mesh-ancestor
6558200|NCT00933517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6558201|NCT00933517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6558202|NCT00933517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6558203|NCT00933517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6558204|NCT00933517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6558205|NCT00933582|Naproxen|naproxen|mesh-list
6558206|NCT00933582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6558207|NCT00933582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6558208|NCT00933582|Analgesics|analgesics|mesh-ancestor
6558209|NCT00933582|Sensory System Agents|sensory system agents|mesh-ancestor
6558210|NCT00933582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6558211|NCT00933582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443654|NCT00380406|Fertility Agents|fertility agents|mesh-ancestor
6558212|NCT00933582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6558213|NCT00933582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6558214|NCT00933582|Gout Suppressants|gout suppressants|mesh-ancestor
6558215|NCT00933582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6558216|NCT00933582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6558217|NCT00933582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558218|NCT00933634|Propafenone|propafenone|mesh-list
6558219|NCT00933634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6558220|NCT00933634|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6558221|NCT00933634|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6558222|NCT00933634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6558223|NCT00933634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558224|NCT00933777|Everolimus|everolimus|mesh-list
6558225|NCT00933777|Sorafenib|sorafenib|mesh-list
6558226|NCT00933777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6558227|NCT00933777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6558228|NCT00933777|Immunologic Factors|immunologic factors|mesh-ancestor
6558229|NCT00933777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558230|NCT00933777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6558231|NCT00933777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6558232|NCT00933777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558233|NCT00933790|Rifampin|rifampin|mesh-list
6558234|NCT00933790|Pyrazinamide|pyrazinamide|mesh-list
6558235|NCT00933790|Ethambutol|ethambutol|mesh-list
6558236|NCT00933790|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6558237|NCT00933790|Antitubercular Agents|antitubercular agents|mesh-ancestor
6558238|NCT00933790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6558239|NCT00933790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6558240|NCT00933790|Leprostatic Agents|leprostatic agents|mesh-ancestor
6558241|NCT00933790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6558242|NCT00933790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6558243|NCT00933790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558244|NCT00933790|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6558245|NCT00933790|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6558246|NCT00933790|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6558247|NCT00933790|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6558248|NCT00933790|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6443655|NCT00380406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6443656|NCT00380406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443657|NCT00380406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6443658|NCT00380406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6443659|NCT00380445|Vildagliptin|vildagliptin|mesh-list
6443660|NCT00380445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6443661|NCT00380445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443662|NCT00380445|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6558249|NCT00933790|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6558250|NCT00933816|Fluorouracil|fluorouracil|mesh-list
6558251|NCT00933816|Sorafenib|sorafenib|mesh-list
6558252|NCT00933816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6558253|NCT00933816|Antimetabolites|antimetabolites|mesh-ancestor
6558254|NCT00933816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558255|NCT00933816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6558256|NCT00933816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6558257|NCT00933816|Immunologic Factors|immunologic factors|mesh-ancestor
6558258|NCT00933816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558259|NCT00933816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6558260|NCT00933816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6558261|NCT00933894|Citalopram|citalopram|mesh-list
6558262|NCT00933894|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6558263|NCT00933894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6558264|NCT00933894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6558265|NCT00933894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558266|NCT00933894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6558267|NCT00933894|Serotonin Agents|serotonin agents|mesh-ancestor
6558268|NCT00933894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558269|NCT00933894|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6558270|NCT00933894|Antidepressive Agents|antidepressive agents|mesh-ancestor
6558271|NCT00933894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6558272|NCT00933985|Doxorubicin|doxorubicin|mesh-list
6558273|NCT00933985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6558274|NCT00933985|Dexrazoxane|dexrazoxane|mesh-list
6558275|NCT00933985|Vincristine|vincristine|mesh-list
6558276|NCT00933985|Razoxane|razoxane|mesh-list
6558277|NCT00933985|Obatoclax|obatoclax|mesh-list
6558278|NCT00933985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6558279|NCT00933985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6558280|NCT00933985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6558281|NCT00933985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6558282|NCT00933985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6558283|NCT00933985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558284|NCT00933985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6558285|NCT00933985|Tubulin Modulators|tubulin modulators|mesh-ancestor
6558286|NCT00933985|Antimitotic Agents|antimitotic agents|mesh-ancestor
6558287|NCT00933985|Mitosis Modulators|mitosis modulators|mesh-ancestor
6558288|NCT00933985|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6558289|NCT00933985|Protective Agents|protective agents|mesh-ancestor
6558290|NCT00933985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558291|NCT00933998|Pyridoxal|pyridoxal|mesh-list
6558292|NCT00933998|Vitamin B 12|vitamin b 12|mesh-list
6558293|NCT00933998|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
6558294|NCT00933998|Vitamin B Complex|vitamin b complex|mesh-ancestor
6558295|NCT00933998|Vitamins|vitamins|mesh-ancestor
6558296|NCT00933998|Micronutrients|micronutrients|mesh-ancestor
6558297|NCT00933998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558298|NCT00934011|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6558299|NCT00934011|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6558300|NCT00934011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6558301|NCT00934011|Antitubercular Agents|antitubercular agents|mesh-ancestor
6558302|NCT00934076|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6558303|NCT00934076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6558304|NCT00934076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6558305|NCT00934076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6558306|NCT00934076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558307|NCT00934154|Thalidomide|thalidomide|mesh-list
6558308|NCT00934154|Prednisolone|prednisolone|mesh-list
6558309|NCT00934154|Melphalan|melphalan|mesh-list
6558310|NCT00934154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6558311|NCT00934154|Alkylating Agents|alkylating agents|mesh-ancestor
6558312|NCT00934154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558313|NCT00934154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6558314|NCT00934154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6558315|NCT00934154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6558316|NCT00934154|Immunologic Factors|immunologic factors|mesh-ancestor
6558317|NCT00934154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558318|NCT00934154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6558319|NCT00934154|Glucocorticoids|glucocorticoids|mesh-ancestor
6558320|NCT00934154|Hormones|hormones|mesh-ancestor
6558321|NCT00934154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6558322|NCT00934154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6558323|NCT00934154|Leprostatic Agents|leprostatic agents|mesh-ancestor
6558324|NCT00934154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6558325|NCT00934154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6558326|NCT00934154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6558327|NCT00934154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6558328|NCT00934154|Growth Substances|growth substances|mesh-ancestor
6558329|NCT00934154|Growth Inhibitors|growth inhibitors|mesh-ancestor
6558330|NCT00934167|Heparin|heparin|mesh-list
6558331|NCT00934167|Calcium heparin|calcium heparin|mesh-list
6558332|NCT00934167|Anticoagulants|anticoagulants|mesh-ancestor
6558333|NCT00934167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6558334|NCT00934167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6558335|NCT00934167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558336|NCT00934193|Gabapentin|gabapentin|mesh-list
6558337|NCT00934193|Analgesics|analgesics|mesh-ancestor
6558338|NCT00934193|Sensory System Agents|sensory system agents|mesh-ancestor
6558339|NCT00934193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6558340|NCT00934193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558341|NCT00934193|Anticonvulsants|anticonvulsants|mesh-ancestor
6558342|NCT00934193|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6558343|NCT00934193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6558344|NCT00934193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6558345|NCT00934193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6558346|NCT00934193|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6558347|NCT00934193|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6558348|NCT00934193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6558349|NCT00934193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558350|NCT00934193|Antimanic Agents|antimanic agents|mesh-ancestor
6558351|NCT00934232|Busulfan|busulfan|mesh-list
6558352|NCT00934232|Alkylating Agents|alkylating agents|mesh-ancestor
6558353|NCT00934232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558354|NCT00934232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6558355|NCT00934232|Immunologic Factors|immunologic factors|mesh-ancestor
6558356|NCT00934232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558357|NCT00934232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6558358|NCT00934232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6558359|NCT00934232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6558360|NCT00934245|Vaccines|vaccines|mesh-list
6558361|NCT00934245|Immunologic Factors|immunologic factors|mesh-ancestor
6558362|NCT00934245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558363|NCT00934258|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6558364|NCT00934258|Fenofibrate|fenofibrate|mesh-list
6558365|NCT00934258|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6558366|NCT00934258|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6558367|NCT00934258|Antimetabolites|antimetabolites|mesh-ancestor
6558368|NCT00934258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558369|NCT00934258|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6443663|NCT00380445|Protease Inhibitors|protease inhibitors|mesh-ancestor
6443664|NCT00380445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6443665|NCT00380445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558370|NCT00934258|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6558371|NCT00934258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6558372|NCT00934323|Metformin|metformin|mesh-list
6443666|NCT00380484|Budesonide|budesonide|mesh-list
6443667|NCT00380484|Montelukast|montelukast|mesh-list
6443668|NCT00380484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6443669|NCT00380484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6443670|NCT00380484|Autonomic Agents|autonomic agents|mesh-ancestor
6443671|NCT00380484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6443672|NCT00380484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443673|NCT00380484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6443674|NCT00380484|Respiratory System Agents|respiratory system agents|mesh-ancestor
6443675|NCT00380484|Glucocorticoids|glucocorticoids|mesh-ancestor
6443676|NCT00380484|Hormones|hormones|mesh-ancestor
6443677|NCT00380484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6443678|NCT00380484|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6443679|NCT00380484|Hormone Antagonists|hormone antagonists|mesh-ancestor
6558373|NCT00934323|Glimepiride|glimepiride|mesh-list
6558374|NCT00934323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6558375|NCT00934323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558376|NCT00934323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6558377|NCT00934323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6558378|NCT00934323|Immunologic Factors|immunologic factors|mesh-ancestor
6558379|NCT00934414|Insulin|insulin|mesh-list
6558380|NCT00934414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6558381|NCT00934414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558382|NCT00934427|Nitroglycerin|nitroglycerin|mesh-list
6558383|NCT00934427|Vasodilator Agents|vasodilator agents|mesh-ancestor
6558384|NCT00934466|Dextromethorphan|dextromethorphan|mesh-list
6558385|NCT00934466|Antitussive Agents|antitussive agents|mesh-ancestor
6558386|NCT00934466|Respiratory System Agents|respiratory system agents|mesh-ancestor
6558387|NCT00934466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6558388|NCT00934466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6558389|NCT00934466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6558390|NCT00934466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443680|NCT00380484|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6443681|NCT00380484|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6443682|NCT00380484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443683|NCT00380575|Conivaptan|conivaptan|mesh-list
6558391|NCT00934466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558392|NCT00934479|Lubiprostone|lubiprostone|mesh-list
6443684|NCT00380575|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6443685|NCT00380575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443686|NCT00380575|Natriuretic Agents|natriuretic agents|mesh-ancestor
6443687|NCT00380575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443688|NCT00380614|Lamivudine|lamivudine|mesh-list
6558393|NCT00934479|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6558394|NCT00934479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6558395|NCT00934479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558396|NCT00934492|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6558397|NCT00934492|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6558398|NCT00934492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6558399|NCT00934492|Renal Agents|renal agents|mesh-ancestor
6558400|NCT00934492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6558401|NCT00934492|Antimalarials|antimalarials|mesh-ancestor
6558402|NCT00934492|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6558403|NCT00934492|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6558404|NCT00934518|Cetuximab|cetuximab|mesh-list
6558405|NCT00934518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6558406|NCT00934518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6558407|NCT00934531|Donepezil|donepezil|mesh-list
6558408|NCT00934531|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6558409|NCT00934531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6558410|NCT00934531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558411|NCT00934531|Cholinergic Agents|cholinergic agents|mesh-ancestor
6558412|NCT00934531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6558413|NCT00934531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558414|NCT00934531|Nootropic Agents|nootropic agents|mesh-ancestor
6558415|NCT00934570|Metformin|metformin|mesh-list
6558416|NCT00934570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6558417|NCT00934570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558418|NCT00934687|Botulinum Toxins|botulinum toxins|mesh-list
6558419|NCT00934687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6558420|NCT00934687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6558421|NCT00934687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6558422|NCT00934687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6558423|NCT00934687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558424|NCT00934687|Cholinergic Agents|cholinergic agents|mesh-ancestor
6558425|NCT00934687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6558426|NCT00934687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558427|NCT00934687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6558428|NCT00934687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6558429|NCT00934700|Xenon|xenon|mesh-list
6558430|NCT00934700|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6558431|NCT00934700|Anesthetics, General|anesthetics, general|mesh-ancestor
6558432|NCT00934700|Anesthetics|anesthetics|mesh-ancestor
6558433|NCT00934700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6558434|NCT00934700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558435|NCT00934713|Montelukast|montelukast|mesh-list
6558436|NCT00934713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6558437|NCT00934713|Respiratory System Agents|respiratory system agents|mesh-ancestor
6558438|NCT00934713|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6558439|NCT00934713|Hormone Antagonists|hormone antagonists|mesh-ancestor
6558440|NCT00934713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6558441|NCT00934713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558442|NCT00934713|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6558443|NCT00934713|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6558444|NCT00934713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558445|NCT00934739|Thalidomide|thalidomide|mesh-list
6558446|NCT00934739|Dexamethasone|dexamethasone|mesh-list
6558447|NCT00934739|Celecoxib|celecoxib|mesh-list
6558448|NCT00934739|Cyclophosphamide|cyclophosphamide|mesh-list
6558449|NCT00934739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6558450|NCT00934739|Immunologic Factors|immunologic factors|mesh-ancestor
6558451|NCT00934739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558452|NCT00934739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6558453|NCT00934739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6558454|NCT00934739|Alkylating Agents|alkylating agents|mesh-ancestor
6558455|NCT00934739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558456|NCT00934739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6558457|NCT00934739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6558458|NCT00934739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6558459|NCT00934739|Antiemetics|antiemetics|mesh-ancestor
6558460|NCT00934739|Autonomic Agents|autonomic agents|mesh-ancestor
6558461|NCT00934739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6558462|NCT00934739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6558463|NCT00934739|Glucocorticoids|glucocorticoids|mesh-ancestor
6558464|NCT00934739|Hormones|hormones|mesh-ancestor
6558465|NCT00934739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6558466|NCT00934739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6558467|NCT00934739|Leprostatic Agents|leprostatic agents|mesh-ancestor
6558468|NCT00934739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6558469|NCT00934739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6558470|NCT00934739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6558471|NCT00934739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6558472|NCT00934739|Growth Substances|growth substances|mesh-ancestor
6558473|NCT00934739|Growth Inhibitors|growth inhibitors|mesh-ancestor
6558474|NCT00934739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6558475|NCT00934739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6558476|NCT00934739|Analgesics|analgesics|mesh-ancestor
6558477|NCT00934739|Sensory System Agents|sensory system agents|mesh-ancestor
6558478|NCT00934739|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6558479|NCT00934739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6558480|NCT00934739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6558481|NCT00934752|Paclitaxel|paclitaxel|mesh-list
6558482|NCT00934752|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6558483|NCT00934752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6558484|NCT00934752|Tubulin Modulators|tubulin modulators|mesh-ancestor
6558485|NCT00934752|Antimitotic Agents|antimitotic agents|mesh-ancestor
6558486|NCT00934752|Mitosis Modulators|mitosis modulators|mesh-ancestor
6558487|NCT00934752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558488|NCT00934817|Metformin|metformin|mesh-list
6558489|NCT00934817|Glimepiride|glimepiride|mesh-list
6558490|NCT00934817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6558491|NCT00934817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558492|NCT00934817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6558493|NCT00934817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6558494|NCT00934817|Immunologic Factors|immunologic factors|mesh-ancestor
6558495|NCT00934830|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6558496|NCT00934830|Amoxicillin|amoxicillin|mesh-list
6558497|NCT00934830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6656774|NCT01471535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656775|NCT01471613|Lithium Carbonate|lithium carbonate|mesh-list
6656776|NCT01471613|Antidepressive Agents|antidepressive agents|mesh-ancestor
6656777|NCT01471613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5724753|NCT03184844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443689|NCT00380614|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6656778|NCT01471613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6656779|NCT01471613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656780|NCT01471613|Antimanic Agents|antimanic agents|mesh-ancestor
6656781|NCT01471613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6443690|NCT00380614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6443691|NCT00380614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6443692|NCT00380614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443693|NCT00380614|Antiviral Agents|antiviral agents|mesh-ancestor
6443694|NCT00380614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6443695|NCT00380614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6443696|NCT00380614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6443697|NCT00380640|Trimethoprim|trimethoprim|mesh-list
6558498|NCT00934895|Paclitaxel|paclitaxel|mesh-list
6558499|NCT00934895|Everolimus|everolimus|mesh-list
6558500|NCT00934895|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6558501|NCT00934895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6558502|NCT00934895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6558503|NCT00934895|Tubulin Modulators|tubulin modulators|mesh-ancestor
6558504|NCT00934895|Antimitotic Agents|antimitotic agents|mesh-ancestor
6558505|NCT00934895|Mitosis Modulators|mitosis modulators|mesh-ancestor
6558506|NCT00934895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558507|NCT00934895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6558508|NCT00934895|Immunologic Factors|immunologic factors|mesh-ancestor
6558509|NCT00934895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558510|NCT00934973|Mebeverine|mebeverine|mesh-list
6558511|NCT00934973|Alverine|alverine|mesh-list
6558512|NCT00934973|Anticonvulsants|anticonvulsants|mesh-ancestor
6558513|NCT00934973|Parasympatholytics|parasympatholytics|mesh-ancestor
6558514|NCT00934973|Autonomic Agents|autonomic agents|mesh-ancestor
6558515|NCT00934973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6558516|NCT00934973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558517|NCT00935116|Etoricoxib|etoricoxib|mesh-list
6558518|NCT00935116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6558519|NCT00935116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6558520|NCT00935116|Analgesics|analgesics|mesh-ancestor
6558521|NCT00935116|Sensory System Agents|sensory system agents|mesh-ancestor
6558522|NCT00935116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6558523|NCT00935116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558524|NCT00935116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6558525|NCT00935116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6558526|NCT00935116|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6558527|NCT00935116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6558528|NCT00935116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6558529|NCT00935116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558530|NCT00935194|Oseltamivir|oseltamivir|mesh-list
6558531|NCT00935194|Antiviral Agents|antiviral agents|mesh-ancestor
6558532|NCT00935194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6558533|NCT00935194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6558534|NCT00935194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558535|NCT00935246|Dexetimide|dexetimide|mesh-list
6019773|NCT00389805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6019774|NCT00389805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6019775|NCT00389805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443698|NCT00380640|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6558536|NCT00935246|Citalopram|citalopram|mesh-list
6443699|NCT00380640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6443700|NCT00380640|Renal Agents|renal agents|mesh-ancestor
6443701|NCT00380640|Antimalarials|antimalarials|mesh-ancestor
6443702|NCT00380640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6443703|NCT00380640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6443704|NCT00380640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6443705|NCT00380640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6443706|NCT00380640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443707|NCT00380640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6443708|NCT00380640|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6443709|NCT00380640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6558537|NCT00935246|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6558538|NCT00935246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6558539|NCT00935246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6558540|NCT00935246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558541|NCT00935246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6558542|NCT00935246|Serotonin Agents|serotonin agents|mesh-ancestor
6443710|NCT00380679|Vaccines|vaccines|mesh-list
6443711|NCT00380679|Immunologic Factors|immunologic factors|mesh-ancestor
6558543|NCT00935246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558544|NCT00935246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6558545|NCT00935246|Antidepressive Agents|antidepressive agents|mesh-ancestor
6558546|NCT00935246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6558547|NCT00935246|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6558548|NCT00935246|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6558549|NCT00935246|Parasympatholytics|parasympatholytics|mesh-ancestor
6558550|NCT00935246|Autonomic Agents|autonomic agents|mesh-ancestor
6558551|NCT00935246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6558552|NCT00935246|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6558553|NCT00935246|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6558554|NCT00935246|Cholinergic Agents|cholinergic agents|mesh-ancestor
6558555|NCT00935298|Tacrolimus|tacrolimus|mesh-list
6558556|NCT00935298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6558557|NCT00935298|Immunologic Factors|immunologic factors|mesh-ancestor
6558558|NCT00935298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558559|NCT00935298|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6558560|NCT00935298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6558561|NCT00935298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558562|NCT00935363|Glyburide|glyburide|mesh-list
6558563|NCT00935363|Rifampin|rifampin|mesh-list
6558564|NCT00935363|Fluconazole|fluconazole|mesh-list
6558565|NCT00935363|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6558566|NCT00935363|Antitubercular Agents|antitubercular agents|mesh-ancestor
6558567|NCT00935363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6558568|NCT00935363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6558569|NCT00935363|Leprostatic Agents|leprostatic agents|mesh-ancestor
6558570|NCT00935363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6558571|NCT00935363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6558572|NCT00935363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558573|NCT00935363|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6558574|NCT00935363|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6558575|NCT00935363|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6558576|NCT00935363|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6558577|NCT00935363|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6558578|NCT00935363|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6558579|NCT00935363|Antifungal Agents|antifungal agents|mesh-ancestor
6558580|NCT00935363|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6558581|NCT00935363|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6558582|NCT00935363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6558583|NCT00935363|Hormone Antagonists|hormone antagonists|mesh-ancestor
6558584|NCT00935363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6558585|NCT00935363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558586|NCT00935363|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6558587|NCT00935363|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6558588|NCT00935363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6558589|NCT00935415|Montelukast|montelukast|mesh-list
6558590|NCT00935415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6558591|NCT00935415|Respiratory System Agents|respiratory system agents|mesh-ancestor
6558592|NCT00935415|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6558593|NCT00935415|Hormone Antagonists|hormone antagonists|mesh-ancestor
6558594|NCT00935415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6558595|NCT00935415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558596|NCT00935415|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6558597|NCT00935415|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6558598|NCT00935415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558599|NCT00935467|Saxagliptin|saxagliptin|mesh-list
6558600|NCT00935467|Incretins|incretins|mesh-ancestor
6558601|NCT00935467|Hormones|hormones|mesh-ancestor
6558602|NCT00935467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6558603|NCT00935467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558604|NCT00935467|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6558605|NCT00935467|Protease Inhibitors|protease inhibitors|mesh-ancestor
6558606|NCT00935467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6558607|NCT00935467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558608|NCT00935467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6558609|NCT00935480|Raltegravir Potassium|raltegravir potassium|mesh-list
6558610|NCT00935480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6558611|NCT00935480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6558612|NCT00935480|Antiviral Agents|antiviral agents|mesh-ancestor
6558613|NCT00935480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6558614|NCT00935480|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6558615|NCT00935480|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6558616|NCT00935480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6558617|NCT00935480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558618|NCT00935506|Aspirin|aspirin|mesh-list
6558619|NCT00935506|Clopidogrel|clopidogrel|mesh-list
6558620|NCT00935506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6558621|NCT00935506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6558622|NCT00935506|Analgesics|analgesics|mesh-ancestor
6558623|NCT00935506|Sensory System Agents|sensory system agents|mesh-ancestor
5724754|NCT03184844|Leprostatic Agents|leprostatic agents|mesh-ancestor
6558624|NCT00935506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6558625|NCT00935506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558626|NCT00935506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6558627|NCT00935506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6558628|NCT00935506|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6558629|NCT00935506|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6558630|NCT00935506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558631|NCT00935506|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5724755|NCT03184844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5724756|NCT03184844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5724757|NCT03184844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5724758|NCT03184844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5724759|NCT03184844|Growth Substances|growth substances|mesh-ancestor
5724760|NCT03184844|Growth Inhibitors|growth inhibitors|mesh-ancestor
5724761|NCT03184844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5724762|NCT03185208|Lithium Carbonate|lithium carbonate|mesh-list
5724763|NCT03185208|Antidepressive Agents|antidepressive agents|mesh-ancestor
5724764|NCT03185208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5724765|NCT03185208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5724766|NCT03185208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724767|NCT03185208|Antimanic Agents|antimanic agents|mesh-ancestor
5724768|NCT03185208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5724769|NCT03185208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5724770|NCT03185208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724771|NCT03185143|Acetaminophen|acetaminophen|mesh-list
5724772|NCT03185143|Sumatriptan|sumatriptan|mesh-list
5724773|NCT03185143|Naltrexone|naltrexone|mesh-list
5724774|NCT03185143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6443712|NCT00380679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443713|NCT00380770|Lamivudine|lamivudine|mesh-list
6443714|NCT00380770|Stavudine|stavudine|mesh-list
6558632|NCT00935506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6558633|NCT00935506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6558634|NCT00935506|Antipyretics|antipyretics|mesh-ancestor
6558635|NCT00935506|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6558636|NCT00935506|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6558637|NCT00935506|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6558638|NCT00935506|Purinergic Agents|purinergic agents|mesh-ancestor
6558639|NCT00935506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6558640|NCT00935558|Interleukin-2|interleukin-2|mesh-list
6558641|NCT00935558|Exemestane|exemestane|mesh-list
6558642|NCT00935558|Anastrozole|anastrozole|mesh-list
6558643|NCT00935558|Letrozole|letrozole|mesh-list
6558644|NCT00935558|Lactitol|lactitol|mesh-list
6558645|NCT00935558|Vaccines|vaccines|mesh-list
6558646|NCT00935558|Aromatase Inhibitors|aromatase inhibitors|mesh-list
6558647|NCT00935558|Immunologic Factors|immunologic factors|mesh-ancestor
6558648|NCT00935558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558649|NCT00935558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6558650|NCT00935558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6558651|NCT00935558|Analgesics|analgesics|mesh-ancestor
6558652|NCT00935558|Sensory System Agents|sensory system agents|mesh-ancestor
6558653|NCT00935558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6558654|NCT00935558|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6558655|NCT00935558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6558656|NCT00935558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558657|NCT00935558|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6558658|NCT00935558|Hormone Antagonists|hormone antagonists|mesh-ancestor
6558659|NCT00935558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6558660|NCT00935558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6558661|NCT00935558|Cathartics|cathartics|mesh-ancestor
6558662|NCT00935558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6558663|NCT00935571|Remifentanil|remifentanil|mesh-list
6558664|NCT00935571|Propofol|propofol|mesh-list
6558665|NCT00935571|Sevoflurane|sevoflurane|mesh-list
6558666|NCT00935571|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6558667|NCT00935571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6558668|NCT00935571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558669|NCT00935571|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6558670|NCT00935571|Anesthetics, General|anesthetics, general|mesh-ancestor
6558671|NCT00935571|Anesthetics|anesthetics|mesh-ancestor
6558672|NCT00935571|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5724775|NCT03185143|Analgesics|analgesics|mesh-ancestor
6443715|NCT00380770|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
6443716|NCT00380770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6443717|NCT00380770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6443718|NCT00380770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6443719|NCT00380770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443720|NCT00380770|Antiviral Agents|antiviral agents|mesh-ancestor
6443721|NCT00380770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6443722|NCT00380770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6443723|NCT00380770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6443724|NCT00380770|Antimetabolites|antimetabolites|mesh-ancestor
6443725|NCT00380822|Miglitol|miglitol|mesh-list
6558673|NCT00935571|Narcotics|narcotics|mesh-ancestor
6019776|NCT00389805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6019777|NCT00389805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5724776|NCT03185143|Sensory System Agents|sensory system agents|mesh-ancestor
6019778|NCT00389818|Prednisone|prednisone|mesh-list
6019779|NCT00389818|Cyclophosphamide|cyclophosphamide|mesh-list
6019780|NCT00389818|Rituximab|rituximab|mesh-list
6019781|NCT00389818|Doxorubicin|doxorubicin|mesh-list
6019782|NCT00389818|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6019783|NCT00389818|Vincristine|vincristine|mesh-list
6019784|NCT00389818|Sargramostim|sargramostim|mesh-list
6019785|NCT00389818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6019786|NCT00389818|Immunologic Factors|immunologic factors|mesh-ancestor
6019787|NCT00389818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019788|NCT00389818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6019789|NCT00389818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6019790|NCT00389818|Alkylating Agents|alkylating agents|mesh-ancestor
6019791|NCT00389818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019792|NCT00389818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6019793|NCT00389818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6019794|NCT00389818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6019795|NCT00389818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6019796|NCT00389818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6019797|NCT00389818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6019798|NCT00389818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6019799|NCT00389818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6558674|NCT00935571|Analgesics|analgesics|mesh-ancestor
6558675|NCT00935571|Sensory System Agents|sensory system agents|mesh-ancestor
6558676|NCT00935571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6558677|NCT00935571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6558678|NCT00935571|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6558679|NCT00935610|Caseins|caseins|mesh-list
6558680|NCT00935610|Chelating Agents|chelating agents|mesh-ancestor
6558681|NCT00935610|Sequestering Agents|sequestering agents|mesh-ancestor
6558682|NCT00935610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558683|NCT00935675|Citalopram|citalopram|mesh-list
6558684|NCT00935675|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6558685|NCT00935675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6558686|NCT00935675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6558687|NCT00935675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558688|NCT00935675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6558689|NCT00935675|Serotonin Agents|serotonin agents|mesh-ancestor
6558690|NCT00935675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558691|NCT00935675|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6558692|NCT00935675|Antidepressive Agents|antidepressive agents|mesh-ancestor
6558693|NCT00935675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6558694|NCT00935805|Insulin|insulin|mesh-list
6558695|NCT00935805|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6558696|NCT00935805|Metformin|metformin|mesh-list
6558697|NCT00935805|Insulin, Isophane|insulin, isophane|mesh-list
6558698|NCT00935805|Isophane Insulin, Human|isophane insulin, human|mesh-list
6558699|NCT00935805|Isophane insulin, beef|isophane insulin, beef|mesh-list
6558700|NCT00935805|Glyburide|glyburide|mesh-list
6558701|NCT00935805|Propranolol|propranolol|mesh-list
6558702|NCT00935805|Amlodipine|amlodipine|mesh-list
5724777|NCT03185143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6019800|NCT00389818|Glucocorticoids|glucocorticoids|mesh-ancestor
6558703|NCT00935805|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6558704|NCT00935805|Captopril|captopril|mesh-list
6558705|NCT00935805|Diuretics|diuretics|mesh-list
6558706|NCT00935805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6558707|NCT00935805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558708|NCT00935805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6558709|NCT00935805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6558710|NCT00935805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6558711|NCT00935805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558712|NCT00935805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6558713|NCT00935805|Vasodilator Agents|vasodilator agents|mesh-ancestor
6558714|NCT00935805|Natriuretic Agents|natriuretic agents|mesh-ancestor
6558715|NCT00935805|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6558716|NCT00935805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6558717|NCT00935805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6558718|NCT00935805|Adrenergic Agents|adrenergic agents|mesh-ancestor
6558719|NCT00935805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6558720|NCT00935805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6558721|NCT00935805|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6558722|NCT00935805|Protease Inhibitors|protease inhibitors|mesh-ancestor
6558723|NCT00935805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6558724|NCT00935961|Docetaxel|docetaxel|mesh-list
6558725|NCT00935961|Everolimus|everolimus|mesh-list
6558726|NCT00935961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6558727|NCT00935961|Tubulin Modulators|tubulin modulators|mesh-ancestor
6558728|NCT00935961|Antimitotic Agents|antimitotic agents|mesh-ancestor
6558729|NCT00935961|Mitosis Modulators|mitosis modulators|mesh-ancestor
6558730|NCT00935961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558731|NCT00935961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6558732|NCT00935961|Immunologic Factors|immunologic factors|mesh-ancestor
6558733|NCT00935961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558734|NCT00936013|Oseltamivir|oseltamivir|mesh-list
6558735|NCT00936013|Antiviral Agents|antiviral agents|mesh-ancestor
6558736|NCT00936013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6558737|NCT00936013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6019801|NCT00389818|Hormones|hormones|mesh-ancestor
6019802|NCT00389818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6019803|NCT00389818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6019804|NCT00389818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6019805|NCT00389818|Tubulin Modulators|tubulin modulators|mesh-ancestor
6443726|NCT00380822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6443727|NCT00380822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443728|NCT00380822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6443729|NCT00380822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443730|NCT00380822|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6443731|NCT00380835|Amrubicin|amrubicin|mesh-list
6443732|NCT00380835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6443733|NCT00380887|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6443734|NCT00380887|Estrogens|estrogens|mesh-ancestor
6443735|NCT00380887|Hormones|hormones|mesh-ancestor
6443736|NCT00380887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6443737|NCT00380887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558738|NCT00936013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558739|NCT00936091|Vitamin A|vitamin a|mesh-list
6558740|NCT00936091|Vitamins|vitamins|mesh-ancestor
6558741|NCT00936091|Micronutrients|micronutrients|mesh-ancestor
6558742|NCT00936091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558743|NCT00936143|Infliximab|infliximab|mesh-list
6558744|NCT00936143|Dermatologic Agents|dermatologic agents|mesh-ancestor
6558745|NCT00936143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6558746|NCT00936143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6558747|NCT00936156|Carboplatin|carboplatin|mesh-list
6558748|NCT00936156|Etoposide|etoposide|mesh-list
6558749|NCT00936156|Thiotepa|thiotepa|mesh-list
6558750|NCT00936156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6558751|NCT00936156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6558752|NCT00936156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6558753|NCT00936156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6558754|NCT00936156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6558755|NCT00936156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558756|NCT00936156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6558757|NCT00936156|Alkylating Agents|alkylating agents|mesh-ancestor
6558758|NCT00936156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6558759|NCT00936156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6558760|NCT00936156|Immunologic Factors|immunologic factors|mesh-ancestor
6558761|NCT00936156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558762|NCT00936182|Fluconazole|fluconazole|mesh-list
6558763|NCT00936182|Antifungal Agents|antifungal agents|mesh-ancestor
6558764|NCT00936182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6558765|NCT00936182|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6558766|NCT00936182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6558767|NCT00936182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6558768|NCT00936182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558769|NCT00936182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6558770|NCT00936182|Hormone Antagonists|hormone antagonists|mesh-ancestor
6558771|NCT00936182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6558772|NCT00936182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558773|NCT00936182|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6558774|NCT00936182|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6558775|NCT00936195|Ritonavir|ritonavir|mesh-list
6558776|NCT00936195|Lopinavir|lopinavir|mesh-list
6558777|NCT00936195|Tenofovir|tenofovir|mesh-list
6558778|NCT00936195|Lamivudine|lamivudine|mesh-list
6558779|NCT00936195|Zidovudine|zidovudine|mesh-list
6558780|NCT00936195|Emtricitabine|emtricitabine|mesh-list
6558781|NCT00936195|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6558782|NCT00936195|Efavirenz|efavirenz|mesh-list
6558783|NCT00936195|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6558784|NCT00936195|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6558785|NCT00936195|Protease Inhibitors|protease inhibitors|mesh-ancestor
6558786|NCT00936195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6558787|NCT00936195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558788|NCT00936195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6558789|NCT00936195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6558790|NCT00936195|Antiviral Agents|antiviral agents|mesh-ancestor
6558791|NCT00936195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6558792|NCT00936195|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6558793|NCT00936195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6558794|NCT00936195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6558795|NCT00936195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6558796|NCT00936195|Antimetabolites|antimetabolites|mesh-ancestor
6558797|NCT00936195|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6558798|NCT00936195|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6558799|NCT00936195|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6558800|NCT00936195|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6558801|NCT00936195|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6558802|NCT00936234|Vildagliptin|vildagliptin|mesh-list
6558803|NCT00936234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6558804|NCT00936234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558805|NCT00936234|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6558806|NCT00936234|Protease Inhibitors|protease inhibitors|mesh-ancestor
6558807|NCT00936234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6558808|NCT00936234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558809|NCT00936247|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6558810|NCT00936260|Alendronate|alendronate|mesh-list
6558811|NCT00936260|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6558812|NCT00936260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558813|NCT00936390|Leuprolide|leuprolide|mesh-list
6558814|NCT00936390|Goserelin|goserelin|mesh-list
6558815|NCT00936390|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6558816|NCT00936390|Flutamide|flutamide|mesh-list
6558817|NCT00936390|Bicalutamide|bicalutamide|mesh-list
6558818|NCT00936390|Buserelin|buserelin|mesh-list
6558819|NCT00936390|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6558820|NCT00936390|Fertility Agents|fertility agents|mesh-ancestor
6558821|NCT00936390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6558822|NCT00936390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558823|NCT00936390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6558824|NCT00936390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6558825|NCT00936390|Androgen Antagonists|androgen antagonists|mesh-ancestor
6558826|NCT00936390|Hormone Antagonists|hormone antagonists|mesh-ancestor
6558827|NCT00936390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6558828|NCT00936390|Luteolytic Agents|luteolytic agents|mesh-ancestor
6558829|NCT00936390|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6558830|NCT00936390|Contraceptive Agents|contraceptive agents|mesh-ancestor
6558831|NCT00936390|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6558832|NCT00936429|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6558833|NCT00936429|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6558834|NCT00936429|Immunologic Factors|immunologic factors|mesh-ancestor
6558835|NCT00936429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558836|NCT00936429|Antacids|antacids|mesh-ancestor
6558837|NCT00936429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558838|NCT00936429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6558839|NCT00936442|Anastrozole|anastrozole|mesh-list
6558840|NCT00936442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6558841|NCT00936442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6558842|NCT00936442|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6558843|NCT00936442|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6558844|NCT00936442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6558845|NCT00936442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558846|NCT00936442|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6558847|NCT00936442|Hormone Antagonists|hormone antagonists|mesh-ancestor
6558848|NCT00936442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6558849|NCT00936442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558850|NCT00936520|Lifitegrast|lifitegrast|mesh-list
6558851|NCT00936520|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6558852|NCT00936520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6558853|NCT00936533|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6558854|NCT00936533|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6558855|NCT00936533|Botulinum Toxins|botulinum toxins|mesh-list
6558856|NCT00936533|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6558857|NCT00936533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6558858|NCT00936533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558859|NCT00936533|Cholinergic Agents|cholinergic agents|mesh-ancestor
6558860|NCT00936533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6019806|NCT00389818|Antimitotic Agents|antimitotic agents|mesh-ancestor
6558861|NCT00936533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558862|NCT00936533|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6558863|NCT00936533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6558864|NCT00936546|Rituximab|rituximab|mesh-list
6558865|NCT00936546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6558866|NCT00936546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6558867|NCT00936546|Immunologic Factors|immunologic factors|mesh-ancestor
6558868|NCT00936546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558869|NCT00936546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6558870|NCT00936624|Montelukast|montelukast|mesh-list
6558871|NCT00936624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6558872|NCT00936624|Respiratory System Agents|respiratory system agents|mesh-ancestor
6558873|NCT00936624|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6558874|NCT00936624|Hormone Antagonists|hormone antagonists|mesh-ancestor
6558875|NCT00936624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6558876|NCT00936624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558877|NCT00936624|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6558878|NCT00936624|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6558879|NCT00936624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558880|NCT00936650|Cinacalcet|cinacalcet|mesh-list
6558881|NCT00936650|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6558882|NCT00936650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558883|NCT00936650|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6558884|NCT00936650|Hormone Antagonists|hormone antagonists|mesh-ancestor
6558885|NCT00936650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6656782|NCT01471613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6656783|NCT01471613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656784|NCT01471678|Tamsulosin|tamsulosin|mesh-list
6656785|NCT01471678|Dutasteride|dutasteride|mesh-list
6656786|NCT01471678|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6656787|NCT01471678|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6656788|NCT01471678|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6656789|NCT01471678|Adrenergic Agents|adrenergic agents|mesh-ancestor
6656790|NCT01471678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6656791|NCT01471678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656792|NCT01471678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656793|NCT01471678|Urological Agents|urological agents|mesh-ancestor
6656794|NCT01471678|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6656795|NCT01471678|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6656796|NCT01471678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6656797|NCT01471678|Hormone Antagonists|hormone antagonists|mesh-ancestor
6656798|NCT01471678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6656799|NCT01471704|Verapamil|verapamil|mesh-list
6656800|NCT01471704|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6656801|NCT01471704|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6656802|NCT01471704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6443738|NCT00380913|Nabilone|nabilone|mesh-list
6443739|NCT00380913|Antiemetics|antiemetics|mesh-ancestor
6443740|NCT00380913|Autonomic Agents|autonomic agents|mesh-ancestor
6443741|NCT00380913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6443742|NCT00380913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443743|NCT00380913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6443744|NCT00380913|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6443745|NCT00380913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6443746|NCT00380913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6443747|NCT00380913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6443748|NCT00380939|Atorvastatin|atorvastatin|mesh-list
6558886|NCT00936676|Rasagiline|rasagiline|mesh-list
6558887|NCT00936676|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6558888|NCT00936676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6558889|NCT00936676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558890|NCT00936676|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6558891|NCT00936676|Protective Agents|protective agents|mesh-ancestor
6558892|NCT00936676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558893|NCT00936689|Doxorubicin|doxorubicin|mesh-list
6558894|NCT00936689|Chlorotrianisene|chlorotrianisene|mesh-list
6558895|NCT00936689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6558896|NCT00936689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6558897|NCT00936689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6558898|NCT00936689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6558899|NCT00936689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6558900|NCT00936689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558901|NCT00936689|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6558902|NCT00936689|Estrogens|estrogens|mesh-ancestor
6558903|NCT00936689|Hormones|hormones|mesh-ancestor
6558904|NCT00936689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6558905|NCT00936689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558906|NCT00936689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6558907|NCT00936767|Artesunate|artesunate|mesh-list
6558908|NCT00936767|Mefloquine|mefloquine|mesh-list
6558909|NCT00936767|Antimalarials|antimalarials|mesh-ancestor
6558910|NCT00936767|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6558911|NCT00936767|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6558912|NCT00936767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6558913|NCT00936767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6558914|NCT00936767|Antiviral Agents|antiviral agents|mesh-ancestor
6558915|NCT00936767|Schistosomicides|schistosomicides|mesh-ancestor
6558916|NCT00936767|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6558917|NCT00936767|Anthelmintics|anthelmintics|mesh-ancestor
6558918|NCT00936780|Paclitaxel|paclitaxel|mesh-list
6558919|NCT00936780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6558920|NCT00936780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6558921|NCT00936780|Tubulin Modulators|tubulin modulators|mesh-ancestor
6558922|NCT00936780|Antimitotic Agents|antimitotic agents|mesh-ancestor
6558923|NCT00936780|Mitosis Modulators|mitosis modulators|mesh-ancestor
6558924|NCT00936780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558925|NCT00936793|Ritonavir|ritonavir|mesh-list
6558926|NCT00936793|Darunavir|darunavir|mesh-list
6558927|NCT00936793|Beclomethasone|beclomethasone|mesh-list
6558928|NCT00936793|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6558929|NCT00936793|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6558930|NCT00936793|Protease Inhibitors|protease inhibitors|mesh-ancestor
6558931|NCT00936793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6558932|NCT00936793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558933|NCT00936793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6558934|NCT00936793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6558935|NCT00936793|Antiviral Agents|antiviral agents|mesh-ancestor
6558936|NCT00936793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6558937|NCT00936793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6558938|NCT00936793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6558939|NCT00936793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6558940|NCT00936793|Glucocorticoids|glucocorticoids|mesh-ancestor
6558941|NCT00936793|Hormones|hormones|mesh-ancestor
6558942|NCT00936793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6558943|NCT00936793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558944|NCT00936793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6558945|NCT00936793|Respiratory System Agents|respiratory system agents|mesh-ancestor
6558946|NCT00936819|Plasma-lyte 148|plasma-lyte 148|mesh-list
6558947|NCT00936819|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6558948|NCT00936819|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6558949|NCT00936832|Leucovorin|leucovorin|mesh-list
6558950|NCT00936832|Fluorouracil|fluorouracil|mesh-list
6558951|NCT00936832|Irinotecan|irinotecan|mesh-list
6558952|NCT00936832|Sunitinib|sunitinib|mesh-list
6558953|NCT00936832|Calcium|calcium|mesh-list
6558954|NCT00936832|Levoleucovorin|levoleucovorin|mesh-list
6558955|NCT00936832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6558956|NCT00936832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558957|NCT00936832|Antimetabolites|antimetabolites|mesh-ancestor
6558958|NCT00936832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558959|NCT00936832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6558960|NCT00936832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6558961|NCT00936832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6558962|NCT00936832|Immunologic Factors|immunologic factors|mesh-ancestor
6558963|NCT00936832|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6558964|NCT00936832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6558965|NCT00936832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6558966|NCT00936832|Antidotes|antidotes|mesh-ancestor
6558967|NCT00936832|Protective Agents|protective agents|mesh-ancestor
6558968|NCT00936832|Vitamin B Complex|vitamin b complex|mesh-ancestor
6558969|NCT00936832|Vitamins|vitamins|mesh-ancestor
6558970|NCT00936832|Micronutrients|micronutrients|mesh-ancestor
6558971|NCT00936832|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6558972|NCT00936832|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6558973|NCT00936832|Growth Substances|growth substances|mesh-ancestor
6558974|NCT00936832|Growth Inhibitors|growth inhibitors|mesh-ancestor
6558975|NCT00936832|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6558976|NCT00936923|Furosemide|furosemide|mesh-list
5724778|NCT03185143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558977|NCT00936923|Diuretics|diuretics|mesh-list
6558978|NCT00936923|Natriuretic Agents|natriuretic agents|mesh-ancestor
6558979|NCT00936923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558980|NCT00936923|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6558981|NCT00936923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6558982|NCT00936923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558983|NCT00936936|Gemcitabine|gemcitabine|mesh-list
6558984|NCT00936936|Carboplatin|carboplatin|mesh-list
6558985|NCT00936936|Docetaxel|docetaxel|mesh-list
6558986|NCT00936936|Etoposide|etoposide|mesh-list
6558987|NCT00936936|Melphalan|melphalan|mesh-list
6558988|NCT00936936|Ifosfamide|ifosfamide|mesh-list
6558989|NCT00936936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6558990|NCT00936936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6558991|NCT00936936|Antimetabolites|antimetabolites|mesh-ancestor
6558992|NCT00936936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6558993|NCT00936936|Antiviral Agents|antiviral agents|mesh-ancestor
6558994|NCT00936936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6558995|NCT00936936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6558996|NCT00936936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6558997|NCT00936936|Immunologic Factors|immunologic factors|mesh-ancestor
6558998|NCT00936936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6558999|NCT00936936|Tubulin Modulators|tubulin modulators|mesh-ancestor
6559000|NCT00936936|Antimitotic Agents|antimitotic agents|mesh-ancestor
6559001|NCT00936936|Mitosis Modulators|mitosis modulators|mesh-ancestor
6559002|NCT00936936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6559003|NCT00936936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6559004|NCT00936936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6559005|NCT00936936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6559006|NCT00936936|Alkylating Agents|alkylating agents|mesh-ancestor
6559007|NCT00936936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6559008|NCT00936962|Vaccines|vaccines|mesh-list
6559009|NCT00936962|Immunologic Factors|immunologic factors|mesh-ancestor
6559010|NCT00936962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559011|NCT00936988|Cinacalcet|cinacalcet|mesh-list
6665109|NCT01515826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6559012|NCT00936988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6559013|NCT00936988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559014|NCT00936988|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6559015|NCT00936988|Hormone Antagonists|hormone antagonists|mesh-ancestor
6559016|NCT00936988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6559017|NCT00937027|Aminopterin|aminopterin|mesh-list
6559018|NCT00937027|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6559019|NCT00937027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6559020|NCT00937027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019807|NCT00389818|Mitosis Modulators|mitosis modulators|mesh-ancestor
6019808|NCT00389831|Rotigotine|rotigotine|mesh-list
6019809|NCT00389831|Dopamine Agonists|dopamine agonists|mesh-ancestor
6019810|NCT00389831|Dopamine Agents|dopamine agents|mesh-ancestor
6019811|NCT00389831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6019812|NCT00389831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019813|NCT00389831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019814|NCT00389857|Vaccines|vaccines|mesh-list
6019815|NCT00389857|Immunologic Factors|immunologic factors|mesh-ancestor
6019816|NCT00389857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019817|NCT00389974|Sunitinib|sunitinib|mesh-list
6019818|NCT00389974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6019819|NCT00389974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6019820|NCT00389974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6019821|NCT00389974|Growth Substances|growth substances|mesh-ancestor
6019822|NCT00389974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019823|NCT00389974|Growth Inhibitors|growth inhibitors|mesh-ancestor
6443749|NCT00380939|Pravastatin|pravastatin|mesh-list
6443750|NCT00380939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6443751|NCT00380939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6443752|NCT00380939|Antimetabolites|antimetabolites|mesh-ancestor
6443753|NCT00380939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443754|NCT00380939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6443755|NCT00380939|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6443756|NCT00380939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6443757|NCT00380965|Nabilone|nabilone|mesh-list
6443758|NCT00380965|Antiemetics|antiemetics|mesh-ancestor
6443759|NCT00380965|Autonomic Agents|autonomic agents|mesh-ancestor
6443760|NCT00380965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6443761|NCT00380965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443762|NCT00380965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6443763|NCT00380965|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6443764|NCT00380965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6559021|NCT00937079|Exenatide|exenatide|mesh-list
6559022|NCT00937079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6559023|NCT00937079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559024|NCT00937079|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6559025|NCT00937079|Incretins|incretins|mesh-ancestor
6559026|NCT00937079|Hormones|hormones|mesh-ancestor
6559027|NCT00937079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6559028|NCT00937092|Dopamine|dopamine|mesh-list
6559029|NCT00937092|Furosemide|furosemide|mesh-list
6559030|NCT00937092|Diuretics|diuretics|mesh-ancestor
6559031|NCT00937092|Natriuretic Agents|natriuretic agents|mesh-ancestor
6559032|NCT00937092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559033|NCT00937092|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6559034|NCT00937092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6559035|NCT00937092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559036|NCT00937092|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6559037|NCT00937092|Sympathomimetics|sympathomimetics|mesh-ancestor
6559038|NCT00937092|Autonomic Agents|autonomic agents|mesh-ancestor
6559039|NCT00937092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6559040|NCT00937092|Dopamine Agents|dopamine agents|mesh-ancestor
6559041|NCT00937092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6559042|NCT00937092|Protective Agents|protective agents|mesh-ancestor
6559043|NCT00937131|Rituximab|rituximab|mesh-list
6559044|NCT00937131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6559045|NCT00937131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6559046|NCT00937131|Immunologic Factors|immunologic factors|mesh-ancestor
6559047|NCT00937131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559048|NCT00937131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6559049|NCT00937144|Sildenafil Citrate|sildenafil citrate|mesh-list
6559050|NCT00937144|Vasodilator Agents|vasodilator agents|mesh-ancestor
6559051|NCT00937144|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6559052|NCT00937144|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6559053|NCT00937144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6559054|NCT00937144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559055|NCT00937144|Urological Agents|urological agents|mesh-ancestor
6559056|NCT00937183|Vaccines|vaccines|mesh-list
6559057|NCT00937183|Immunologic Factors|immunologic factors|mesh-ancestor
6559058|NCT00937183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559059|NCT00937261|Risperidone|risperidone|mesh-list
6559060|NCT00937261|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6559061|NCT00937261|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6559062|NCT00937261|Serotonin Agents|serotonin agents|mesh-ancestor
6559063|NCT00937261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6559064|NCT00937261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559065|NCT00937261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559066|NCT00937261|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6559067|NCT00937261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6559068|NCT00937261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6559069|NCT00937261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6559070|NCT00937261|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6559071|NCT00937261|Dopamine Agents|dopamine agents|mesh-ancestor
6559072|NCT00937261|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6559073|NCT00937261|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6559074|NCT00937300|Vidarabine|vidarabine|mesh-list
6559075|NCT00937300|Cyclophosphamide|cyclophosphamide|mesh-list
6559076|NCT00937300|Fludarabine|fludarabine|mesh-list
6559077|NCT00937300|Fludarabine phosphate|fludarabine phosphate|mesh-list
6559078|NCT00937300|Interleukin-2|interleukin-2|mesh-list
6559079|NCT00937300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6559080|NCT00937300|Immunologic Factors|immunologic factors|mesh-ancestor
6559081|NCT00937300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559082|NCT00937300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6559083|NCT00937300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6559084|NCT00937300|Alkylating Agents|alkylating agents|mesh-ancestor
6559085|NCT00937300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559086|NCT00937300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6559087|NCT00937300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6559088|NCT00937300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6559089|NCT00937300|Antimetabolites|antimetabolites|mesh-ancestor
6559090|NCT00937300|Antiviral Agents|antiviral agents|mesh-ancestor
6559091|NCT00937300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6559092|NCT00937300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6559093|NCT00937300|Analgesics|analgesics|mesh-ancestor
6559094|NCT00937300|Sensory System Agents|sensory system agents|mesh-ancestor
6559095|NCT00937300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6559096|NCT00937417|Docetaxel|docetaxel|mesh-list
6559097|NCT00937417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6559098|NCT00937417|Tubulin Modulators|tubulin modulators|mesh-ancestor
6559099|NCT00937417|Antimitotic Agents|antimitotic agents|mesh-ancestor
6559100|NCT00937417|Mitosis Modulators|mitosis modulators|mesh-ancestor
6559101|NCT00937417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559102|NCT00937482|Cediranib|cediranib|mesh-list
6559103|NCT00937482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6559104|NCT00937482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559105|NCT00937482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6559106|NCT00937482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6559107|NCT00937508|Varenicline|varenicline|mesh-list
6559108|NCT00937508|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6559109|NCT00937508|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6559110|NCT00937508|Cholinergic Agents|cholinergic agents|mesh-ancestor
6559111|NCT00937508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6559112|NCT00937508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559113|NCT00937508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559114|NCT00937625|Vidarabine|vidarabine|mesh-list
6559115|NCT00937625|Cyclophosphamide|cyclophosphamide|mesh-list
6559116|NCT00937625|Fludarabine|fludarabine|mesh-list
6559117|NCT00937625|Fludarabine phosphate|fludarabine phosphate|mesh-list
6559118|NCT00937625|Interleukin-2|interleukin-2|mesh-list
6559119|NCT00937625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6559120|NCT00937625|Immunologic Factors|immunologic factors|mesh-ancestor
6559121|NCT00937625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559122|NCT00937625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6559123|NCT00937625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6559124|NCT00937625|Alkylating Agents|alkylating agents|mesh-ancestor
6559125|NCT00937625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559126|NCT00937625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6559127|NCT00937625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6559128|NCT00937625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6559129|NCT00937625|Antimetabolites|antimetabolites|mesh-ancestor
6559130|NCT00937625|Antiviral Agents|antiviral agents|mesh-ancestor
6559131|NCT00937625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6559132|NCT00937625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6559133|NCT00937625|Analgesics|analgesics|mesh-ancestor
6559134|NCT00937625|Sensory System Agents|sensory system agents|mesh-ancestor
6559135|NCT00937625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6559136|NCT00937664|Gemcitabine|gemcitabine|mesh-list
6559137|NCT00937664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6559138|NCT00937664|Antimetabolites|antimetabolites|mesh-ancestor
6559139|NCT00937664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559140|NCT00937664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6559141|NCT00937664|Antiviral Agents|antiviral agents|mesh-ancestor
6559142|NCT00937664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6559143|NCT00937664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6559144|NCT00937664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6559145|NCT00937664|Immunologic Factors|immunologic factors|mesh-ancestor
6559146|NCT00937664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559147|NCT00937677|Natalizumab|natalizumab|mesh-list
6559148|NCT00937677|Immunologic Factors|immunologic factors|mesh-ancestor
6559149|NCT00937677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559150|NCT00937807|Sevoflurane|sevoflurane|mesh-list
6559151|NCT00937807|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6559152|NCT00937807|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6559153|NCT00937807|Anesthetics, General|anesthetics, general|mesh-ancestor
6559154|NCT00937807|Anesthetics|anesthetics|mesh-ancestor
6443765|NCT00380965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6443766|NCT00380965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6443767|NCT00381017|Interferons|interferons|mesh-list
6443768|NCT00381017|Interferon-alpha|interferon-alpha|mesh-list
6443769|NCT00381017|Interferon alpha-2|interferon alpha-2|mesh-list
6443770|NCT00381017|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6559155|NCT00937807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6559156|NCT00937807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559157|NCT00937820|Darexaban|darexaban|mesh-list
6559158|NCT00937820|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6559159|NCT00937820|Antithrombins|antithrombins|mesh-ancestor
6559160|NCT00937820|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6559161|NCT00937820|Protease Inhibitors|protease inhibitors|mesh-ancestor
6559162|NCT00937820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6559163|NCT00937820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559164|NCT00937820|Anticoagulants|anticoagulants|mesh-ancestor
6443771|NCT00381017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6443772|NCT00381017|Antiviral Agents|antiviral agents|mesh-ancestor
6559165|NCT00937911|Darexaban|darexaban|mesh-list
6559166|NCT00937911|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6559167|NCT00937911|Antithrombins|antithrombins|mesh-ancestor
6559168|NCT00937911|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6559169|NCT00937911|Protease Inhibitors|protease inhibitors|mesh-ancestor
6559170|NCT00937911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6559171|NCT00937911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559172|NCT00937911|Anticoagulants|anticoagulants|mesh-ancestor
6559173|NCT00937924|Diphenhydramine|diphenhydramine|mesh-list
6559174|NCT00937924|Promethazine|promethazine|mesh-list
6559175|NCT00937924|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6559176|NCT00937924|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6559177|NCT00937924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6559178|NCT00937924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559179|NCT00937924|Anesthetics, Local|anesthetics, local|mesh-ancestor
6559180|NCT00937924|Anesthetics|anesthetics|mesh-ancestor
6559181|NCT00937924|Sensory System Agents|sensory system agents|mesh-ancestor
6559182|NCT00937924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6559183|NCT00937924|Antiemetics|antiemetics|mesh-ancestor
6559184|NCT00937924|Autonomic Agents|autonomic agents|mesh-ancestor
6559185|NCT00937924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6559186|NCT00937924|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6559187|NCT00937924|Histamine Antagonists|histamine antagonists|mesh-ancestor
6559188|NCT00937924|Histamine Agents|histamine agents|mesh-ancestor
6559189|NCT00937924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6559190|NCT00937924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559191|NCT00937924|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6559192|NCT00937924|Antipruritics|antipruritics|mesh-ancestor
6559193|NCT00937924|Dermatologic Agents|dermatologic agents|mesh-ancestor
6559194|NCT00938132|Warfarin|warfarin|mesh-list
6559195|NCT00938132|Anticoagulants|anticoagulants|mesh-ancestor
6559196|NCT00938158|rGLP-1 protein|rglp-1 protein|mesh-list
6559197|NCT00938158|Incretins|incretins|mesh-ancestor
6559198|NCT00938158|Hormones|hormones|mesh-ancestor
6559199|NCT00938158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6559200|NCT00938158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559201|NCT00938171|Anesthetics|anesthetics|mesh-list
6559202|NCT00938171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6559203|NCT00938171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559204|NCT00938184|Paroxetine|paroxetine|mesh-list
6559205|NCT00938184|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6443773|NCT00381017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6443774|NCT00381017|Immunologic Factors|immunologic factors|mesh-ancestor
6443775|NCT00381017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443776|NCT00381030|Carvedilol|carvedilol|mesh-list
6443777|NCT00381030|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6443778|NCT00381030|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6443779|NCT00381030|Adrenergic Agents|adrenergic agents|mesh-ancestor
6443780|NCT00381030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6559206|NCT00938184|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6559207|NCT00938184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6559208|NCT00938184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443781|NCT00381030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443782|NCT00381030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443783|NCT00381030|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6443784|NCT00381030|Antioxidants|antioxidants|mesh-ancestor
6443785|NCT00381030|Protective Agents|protective agents|mesh-ancestor
6559209|NCT00938184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6559210|NCT00938184|Serotonin Agents|serotonin agents|mesh-ancestor
6559211|NCT00938184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559212|NCT00938184|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6559213|NCT00938184|Antidepressive Agents|antidepressive agents|mesh-ancestor
6559214|NCT00938184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6559215|NCT00938184|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6559216|NCT00938184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6559217|NCT00938184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6559218|NCT00938197|Amlodipine|amlodipine|mesh-list
6559219|NCT00938197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6559220|NCT00938197|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6559221|NCT00938197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6559222|NCT00938197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559223|NCT00938197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6559224|NCT00938197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559225|NCT00938197|Vasodilator Agents|vasodilator agents|mesh-ancestor
6559226|NCT00938236|Cyclosporine|cyclosporine|mesh-list
6559227|NCT00938236|Cyclosporins|cyclosporins|mesh-list
6559228|NCT00938236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6559229|NCT00938236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559230|NCT00938236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6559231|NCT00938236|Immunologic Factors|immunologic factors|mesh-ancestor
6559232|NCT00938236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559233|NCT00938236|Antifungal Agents|antifungal agents|mesh-ancestor
6559234|NCT00938236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6559235|NCT00938236|Dermatologic Agents|dermatologic agents|mesh-ancestor
6559236|NCT00938236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6559237|NCT00938236|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6559238|NCT00938262|Ketoconazole|ketoconazole|mesh-list
6559239|NCT00938262|Rifampin|rifampin|mesh-list
6559240|NCT00938262|Antifungal Agents|antifungal agents|mesh-ancestor
6559241|NCT00938262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6559242|NCT00938262|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6559243|NCT00938262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6559244|NCT00938262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6559245|NCT00938262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559246|NCT00938262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6559247|NCT00938262|Hormone Antagonists|hormone antagonists|mesh-ancestor
6559248|NCT00938262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6559249|NCT00938262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559250|NCT00938262|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6559251|NCT00938262|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6559252|NCT00938262|Antitubercular Agents|antitubercular agents|mesh-ancestor
6559253|NCT00938262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6559254|NCT00938262|Leprostatic Agents|leprostatic agents|mesh-ancestor
6559255|NCT00938262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6559256|NCT00938262|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6559257|NCT00938262|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6559258|NCT00938262|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6559259|NCT00938262|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6559260|NCT00938262|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6559261|NCT00938262|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6559262|NCT00938353|Beclomethasone|beclomethasone|mesh-list
6559263|NCT00938353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6559264|NCT00938353|Glucocorticoids|glucocorticoids|mesh-ancestor
6559265|NCT00938353|Hormones|hormones|mesh-ancestor
6559266|NCT00938353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6559267|NCT00938353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559268|NCT00938353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6559269|NCT00938353|Respiratory System Agents|respiratory system agents|mesh-ancestor
6559270|NCT00938379|Insect Repellents|insect repellents|mesh-list
6443786|NCT00381030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6443787|NCT00381030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6443788|NCT00381030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6443789|NCT00381030|Vasodilator Agents|vasodilator agents|mesh-ancestor
6443790|NCT00381030|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6443791|NCT00381030|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6443792|NCT00381134|Losartan|losartan|mesh-list
6443793|NCT00381134|Spironolactone|spironolactone|mesh-list
6443794|NCT00381134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6443795|NCT00381134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6443796|NCT00381134|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6443797|NCT00381134|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6443798|NCT00381134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443799|NCT00381134|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6443800|NCT00381134|Hormone Antagonists|hormone antagonists|mesh-ancestor
6443801|NCT00381134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6443802|NCT00381134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443803|NCT00381134|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6443804|NCT00381134|Diuretics|diuretics|mesh-ancestor
6443805|NCT00381134|Natriuretic Agents|natriuretic agents|mesh-ancestor
6443806|NCT00381147|Clarithromycin|clarithromycin|mesh-list
6443807|NCT00381147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6443808|NCT00381147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6443809|NCT00381147|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6443810|NCT00381147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6443811|NCT00381147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443812|NCT00381147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6443813|NCT00381147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6443814|NCT00381173|Cyclophosphamide|cyclophosphamide|mesh-list
6443815|NCT00381173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6443816|NCT00381173|Immunologic Factors|immunologic factors|mesh-ancestor
6443817|NCT00381173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443818|NCT00381173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6443819|NCT00381173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6443820|NCT00381173|Alkylating Agents|alkylating agents|mesh-ancestor
6443821|NCT00381173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443822|NCT00381173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6443823|NCT00381173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6443824|NCT00381199|Amitriptyline|amitriptyline|mesh-list
6443825|NCT00381199|Nabilone|nabilone|mesh-list
6443826|NCT00381199|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6443827|NCT00381199|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6443828|NCT00381199|Antidepressive Agents|antidepressive agents|mesh-ancestor
6443829|NCT00381199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6443830|NCT00381199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6443831|NCT00381199|Analgesics|analgesics|mesh-ancestor
6443832|NCT00381199|Sensory System Agents|sensory system agents|mesh-ancestor
6559271|NCT00938379|Protective Agents|protective agents|mesh-ancestor
6559272|NCT00938379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559273|NCT00938405|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
6559274|NCT00938405|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6559275|NCT00938405|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6559276|NCT00938405|Antimetabolites|antimetabolites|mesh-ancestor
6559277|NCT00938405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559278|NCT00938405|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6656803|NCT01471704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656804|NCT01471704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6656805|NCT01471704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656806|NCT01471704|Vasodilator Agents|vasodilator agents|mesh-ancestor
6656807|NCT01471730|Thrombin|thrombin|mesh-list
6656808|NCT01471730|Hemostatics|hemostatics|mesh-ancestor
6656809|NCT01471730|Coagulants|coagulants|mesh-ancestor
6656810|NCT01471808|Metformin|metformin|mesh-list
6656811|NCT01471808|Pioglitazone|pioglitazone|mesh-list
6656812|NCT01471808|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6656813|NCT01471808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6656814|NCT01471808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656815|NCT01471808|Incretins|incretins|mesh-ancestor
6656816|NCT01471808|Hormones|hormones|mesh-ancestor
6656817|NCT01471808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6656818|NCT01471808|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6656819|NCT01471808|Protease Inhibitors|protease inhibitors|mesh-ancestor
6656820|NCT01471808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6656821|NCT01471808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656822|NCT01471821|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6656823|NCT01471821|Antiviral Agents|antiviral agents|mesh-ancestor
6656824|NCT01471821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6656825|NCT01471847|Capecitabine|capecitabine|mesh-list
6656826|NCT01471847|Trastuzumab|trastuzumab|mesh-list
6656827|NCT01471847|Lapatinib|lapatinib|mesh-list
6656828|NCT01471847|Dactolisib|dactolisib|mesh-list
6656829|NCT01471847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6656830|NCT01471847|Antimetabolites|antimetabolites|mesh-ancestor
6656831|NCT01471847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656832|NCT01471847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6656833|NCT01471847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6656834|NCT01471847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6656835|NCT01471847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6656836|NCT01471886|Ketorolac|ketorolac|mesh-list
6656837|NCT01471886|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6656838|NCT01471886|Naproxen|naproxen|mesh-list
6656839|NCT01471886|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6656840|NCT01471886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6656841|NCT01471886|Analgesics|analgesics|mesh-ancestor
6656842|NCT01471886|Sensory System Agents|sensory system agents|mesh-ancestor
6656843|NCT01471886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6656844|NCT01471886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656845|NCT01471886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6656846|NCT01471886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6656847|NCT01471886|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6656848|NCT01471886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6656849|NCT01471886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656850|NCT01471886|Gout Suppressants|gout suppressants|mesh-ancestor
6656851|NCT01471899|Ketorolac|ketorolac|mesh-list
6656852|NCT01471899|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6656853|NCT01471899|Naproxen|naproxen|mesh-list
6656854|NCT01471899|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6656855|NCT01471899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6656856|NCT01471899|Analgesics|analgesics|mesh-ancestor
6656857|NCT01471899|Sensory System Agents|sensory system agents|mesh-ancestor
6656858|NCT01471899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6656859|NCT01471899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656860|NCT01471899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6656861|NCT01471899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6656862|NCT01471899|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6656863|NCT01471899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6665110|NCT01515826|Antiemetics|antiemetics|mesh-ancestor
6443833|NCT00381199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6443834|NCT00381199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443835|NCT00381199|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6443836|NCT00381199|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6443837|NCT00381199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6443838|NCT00381199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443839|NCT00381199|Adrenergic Agents|adrenergic agents|mesh-ancestor
6443840|NCT00381199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6443841|NCT00381199|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6443842|NCT00381199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6443843|NCT00381199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6443844|NCT00381199|Antiemetics|antiemetics|mesh-ancestor
6443845|NCT00381199|Autonomic Agents|autonomic agents|mesh-ancestor
6443846|NCT00381199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6443847|NCT00381199|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6461629|NCT00455416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461630|NCT00455416|Protective Agents|protective agents|mesh-ancestor
6461631|NCT00455416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461632|NCT00455416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6461633|NCT00455416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6461634|NCT00455416|Trace Elements|trace elements|mesh-ancestor
6461635|NCT00455416|Micronutrients|micronutrients|mesh-ancestor
6461636|NCT00455416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6461637|NCT00455416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6461638|NCT00455416|Antimetabolites|antimetabolites|mesh-ancestor
6461639|NCT00455416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6461640|NCT00455416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6461641|NCT00455416|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6461642|NCT00455442|Mifepristone|mifepristone|mesh-list
6461643|NCT00455442|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6461644|NCT00455442|Abortifacient Agents|abortifacient agents|mesh-ancestor
6461645|NCT00455442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6461646|NCT00455442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461647|NCT00455442|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6461648|NCT00455442|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6461649|NCT00455442|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6461650|NCT00455442|Contraceptive Agents|contraceptive agents|mesh-ancestor
6461651|NCT00455442|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6461652|NCT00455442|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6461653|NCT00455442|Hormone Antagonists|hormone antagonists|mesh-ancestor
6461654|NCT00455442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6461655|NCT00455442|Luteolytic Agents|luteolytic agents|mesh-ancestor
6461656|NCT00455442|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6461657|NCT00455442|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6461658|NCT00455507|Istradefylline|istradefylline|mesh-list
6461659|NCT00455507|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
6461660|NCT00455507|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6461661|NCT00455507|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6461662|NCT00455507|Purinergic Agents|purinergic agents|mesh-ancestor
6461663|NCT00455507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6461664|NCT00455507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461665|NCT00455507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461666|NCT00455572|Vinorelbine|vinorelbine|mesh-list
6461667|NCT00455572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6461668|NCT00455572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6461669|NCT00455572|Tubulin Modulators|tubulin modulators|mesh-ancestor
6461670|NCT00455572|Antimitotic Agents|antimitotic agents|mesh-ancestor
6461671|NCT00455572|Mitosis Modulators|mitosis modulators|mesh-ancestor
6461672|NCT00455572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461673|NCT00455585|Lamivudine|lamivudine|mesh-list
6461674|NCT00455585|Nevirapine|nevirapine|mesh-list
6461675|NCT00455585|Stavudine|stavudine|mesh-list
6559279|NCT00938509|Ibuprofen|ibuprofen|mesh-list
6559280|NCT00938509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6559281|NCT00938509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6559282|NCT00938509|Analgesics|analgesics|mesh-ancestor
6559283|NCT00938509|Sensory System Agents|sensory system agents|mesh-ancestor
6559284|NCT00938509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6559285|NCT00938509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559286|NCT00938509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6559287|NCT00938509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6559288|NCT00938509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6559289|NCT00938509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6559290|NCT00938509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559291|NCT00938522|Cilostazol|cilostazol|mesh-list
6559292|NCT00938522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6559293|NCT00938522|Autonomic Agents|autonomic agents|mesh-ancestor
6559294|NCT00938522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6559295|NCT00938522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559296|NCT00938522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6559297|NCT00938522|Respiratory System Agents|respiratory system agents|mesh-ancestor
6559298|NCT00938522|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6559299|NCT00938522|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6559300|NCT00938522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559301|NCT00938522|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6559302|NCT00938522|Vasodilator Agents|vasodilator agents|mesh-ancestor
6443848|NCT00381251|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6443849|NCT00381251|Estrogens|estrogens|mesh-ancestor
6443850|NCT00381251|Hormones|hormones|mesh-ancestor
6443851|NCT00381251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6443852|NCT00381251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443853|NCT00381264|Nabilone|nabilone|mesh-list
6443854|NCT00381264|Antiemetics|antiemetics|mesh-ancestor
6443855|NCT00381264|Autonomic Agents|autonomic agents|mesh-ancestor
6443856|NCT00381264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6443857|NCT00381264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443858|NCT00381264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6443859|NCT00381264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6443860|NCT00381264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6443861|NCT00381264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6559303|NCT00938522|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6559304|NCT00938522|Protective Agents|protective agents|mesh-ancestor
6559305|NCT00938522|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6559306|NCT00938522|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6559307|NCT00938522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6559308|NCT00938600|Vitamin D|vitamin d|mesh-list
6559309|NCT00938600|Ergocalciferols|ergocalciferols|mesh-list
6559310|NCT00938600|Cholecalciferol|cholecalciferol|mesh-list
6559311|NCT00938600|Vitamins|vitamins|mesh-list
6559312|NCT00938600|Micronutrients|micronutrients|mesh-ancestor
6559313|NCT00938600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559314|NCT00938600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6559315|NCT00938600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6559316|NCT00938613|Budesonide|budesonide|mesh-list
6559317|NCT00938613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6559318|NCT00938613|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6559319|NCT00938613|Autonomic Agents|autonomic agents|mesh-ancestor
6559320|NCT00938613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6559321|NCT00938613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559322|NCT00938613|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6559323|NCT00938613|Respiratory System Agents|respiratory system agents|mesh-ancestor
6559324|NCT00938613|Glucocorticoids|glucocorticoids|mesh-ancestor
6559325|NCT00938613|Hormones|hormones|mesh-ancestor
6665111|NCT01515826|Autonomic Agents|autonomic agents|mesh-ancestor
6559326|NCT00938613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6559327|NCT00938626|Antibodies|antibodies|mesh-list
6559328|NCT00938626|Antibodies, Bispecific|antibodies, bispecific|mesh-list
6559329|NCT00938626|Immunologic Factors|immunologic factors|mesh-ancestor
6559330|NCT00938626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559331|NCT00938730|Warfarin|warfarin|mesh-list
6559332|NCT00938730|Anticoagulants|anticoagulants|mesh-ancestor
6559333|NCT00938743|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6559334|NCT00938743|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6559335|NCT00938743|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6559336|NCT00938743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6559337|NCT00938743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559338|NCT00938743|Adrenergic Agents|adrenergic agents|mesh-ancestor
6559339|NCT00938743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6019824|NCT00389974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6559340|NCT00938743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559341|NCT00938821|Morphine|morphine|mesh-list
6559342|NCT00938821|Bupivacaine|bupivacaine|mesh-list
6559343|NCT00938821|Anesthetics, Local|anesthetics, local|mesh-ancestor
6559344|NCT00938821|Anesthetics|anesthetics|mesh-ancestor
6559345|NCT00938821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6559346|NCT00938821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559347|NCT00938821|Sensory System Agents|sensory system agents|mesh-ancestor
6559348|NCT00938821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6559349|NCT00938821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6559350|NCT00938821|Narcotics|narcotics|mesh-ancestor
6559351|NCT00938821|Analgesics|analgesics|mesh-ancestor
6559352|NCT00938899|Simeprevir|simeprevir|mesh-list
6559353|NCT00938899|Antiviral Agents|antiviral agents|mesh-ancestor
6559354|NCT00938899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6559355|NCT00938899|Protease Inhibitors|protease inhibitors|mesh-ancestor
6559356|NCT00938899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6559357|NCT00938899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443862|NCT00381264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6559358|NCT00938990|Midazolam|midazolam|mesh-list
6559359|NCT00938990|Etomidate|etomidate|mesh-list
6559360|NCT00938990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6559361|NCT00938990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6559362|NCT00938990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6559363|NCT00938990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559364|NCT00938990|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6559365|NCT00938990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6559366|NCT00938990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6559367|NCT00938990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6559368|NCT00938990|Anesthetics, General|anesthetics, general|mesh-ancestor
6559369|NCT00938990|Anesthetics|anesthetics|mesh-ancestor
6559370|NCT00938990|GABA Modulators|gaba modulators|mesh-ancestor
6559371|NCT00938990|GABA Agents|gaba agents|mesh-ancestor
6559372|NCT00938990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6559373|NCT00938990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559374|NCT00939068|Telbivudine|telbivudine|mesh-list
6559375|NCT00939068|Antiviral Agents|antiviral agents|mesh-ancestor
6559376|NCT00939068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6559377|NCT00939068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6559378|NCT00939068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6559379|NCT00939068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559380|NCT00939133|Tretinoin|tretinoin|mesh-list
6443863|NCT00381316|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
6443864|NCT00381316|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6443865|NCT00381316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443866|NCT00381342|Exenatide|exenatide|mesh-list
6443867|NCT00381342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6443868|NCT00381342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443869|NCT00381342|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6559381|NCT00939133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6559382|NCT00939133|Keratolytic Agents|keratolytic agents|mesh-ancestor
6559383|NCT00939133|Dermatologic Agents|dermatologic agents|mesh-ancestor
6559384|NCT00939328|Rituximab|rituximab|mesh-list
6559385|NCT00939328|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6559386|NCT00939328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6559387|NCT00939328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6559388|NCT00939328|Immunologic Factors|immunologic factors|mesh-ancestor
6559389|NCT00939328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559390|NCT00939328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6559391|NCT00939328|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6559392|NCT00939328|Alkylating Agents|alkylating agents|mesh-ancestor
6559393|NCT00939328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559394|NCT00939458|Lamotrigine|lamotrigine|mesh-list
6559395|NCT00939458|Anticonvulsants|anticonvulsants|mesh-ancestor
6559396|NCT00939458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6559397|NCT00939458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6559398|NCT00939458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559399|NCT00939458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6559400|NCT00939458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559401|NCT00939458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6559402|NCT00939458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6443870|NCT00381342|Incretins|incretins|mesh-ancestor
6443871|NCT00381342|Hormones|hormones|mesh-ancestor
6443872|NCT00381342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6443873|NCT00381368|Ibandronic Acid|ibandronic acid|mesh-list
6443874|NCT00381368|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6443875|NCT00381368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443876|NCT00381472|Ropinirole|ropinirole|mesh-list
6443877|NCT00381472|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6443878|NCT00381472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6443879|NCT00381472|Dopamine Agonists|dopamine agonists|mesh-ancestor
6443880|NCT00381472|Dopamine Agents|dopamine agents|mesh-ancestor
6443881|NCT00381472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6443882|NCT00381472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443883|NCT00381472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443884|NCT00381511|Heparin|heparin|mesh-list
6443885|NCT00381511|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6443886|NCT00381511|Tinzaparin|tinzaparin|mesh-list
6559403|NCT00939458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6559404|NCT00939458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6559405|NCT00939458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6559406|NCT00939497|Risperidone|risperidone|mesh-list
6559407|NCT00939497|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6559408|NCT00939497|Serotonin Agents|serotonin agents|mesh-ancestor
6559409|NCT00939497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6559410|NCT00939497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559411|NCT00939497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559412|NCT00939497|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6559413|NCT00939497|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6559414|NCT00939497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6559415|NCT00939497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6559416|NCT00939497|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6559417|NCT00939497|Dopamine Agents|dopamine agents|mesh-ancestor
6559418|NCT00939549|Cyclophosphamide|cyclophosphamide|mesh-list
6559419|NCT00939549|Glatiramer Acetate|glatiramer acetate|mesh-list
6559420|NCT00939549|(T,G)-A-L|(t,g)-a-l|mesh-list
6559421|NCT00939549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6559422|NCT00939549|Immunologic Factors|immunologic factors|mesh-ancestor
6019825|NCT00389974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6019826|NCT00389974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019827|NCT00390013|Gabapentin|gabapentin|mesh-list
6019828|NCT00390013|Analgesics|analgesics|mesh-ancestor
6019829|NCT00390013|Sensory System Agents|sensory system agents|mesh-ancestor
6443887|NCT00381511|Dalteparin|dalteparin|mesh-list
6443888|NCT00381511|Anticoagulants|anticoagulants|mesh-ancestor
6443889|NCT00381511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6443890|NCT00381511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6443891|NCT00381511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443892|NCT00381537|Carbamazepine|carbamazepine|mesh-list
6443893|NCT00381537|Phenobarbital|phenobarbital|mesh-list
6443894|NCT00381537|Anticonvulsants|anticonvulsants|mesh-ancestor
6443895|NCT00381537|Antimanic Agents|antimanic agents|mesh-ancestor
6443896|NCT00381537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6443897|NCT00381537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6443898|NCT00381537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443899|NCT00381537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6443900|NCT00381537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6443901|NCT00381537|Analgesics|analgesics|mesh-ancestor
6443902|NCT00381537|Sensory System Agents|sensory system agents|mesh-ancestor
6443903|NCT00381537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6443904|NCT00381537|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6443905|NCT00381537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6443906|NCT00381537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443907|NCT00381537|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6443908|NCT00381537|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6443909|NCT00381537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6443910|NCT00381537|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6443911|NCT00381537|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6443912|NCT00381537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6443913|NCT00381537|GABA Modulators|gaba modulators|mesh-ancestor
6443914|NCT00381537|GABA Agents|gaba agents|mesh-ancestor
6443915|NCT00381537|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6443916|NCT00381589|Bromides|bromides|mesh-list
6443917|NCT00381589|Ipratropium|ipratropium|mesh-list
6443918|NCT00381589|Anticonvulsants|anticonvulsants|mesh-ancestor
6443919|NCT00381589|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6443920|NCT00381589|Autonomic Agents|autonomic agents|mesh-ancestor
6443921|NCT00381589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6443922|NCT00381589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443923|NCT00381589|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6443924|NCT00381589|Respiratory System Agents|respiratory system agents|mesh-ancestor
6443925|NCT00381589|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6443926|NCT00381589|Cholinergic Agents|cholinergic agents|mesh-ancestor
6443927|NCT00381589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6443928|NCT00381589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443929|NCT00381654|MP 412|mp 412|mesh-list
6443930|NCT00381654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6443931|NCT00381654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6443932|NCT00381654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6443933|NCT00381654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443934|NCT00381732|Tadalafil|tadalafil|mesh-list
6443935|NCT00381732|Vasodilator Agents|vasodilator agents|mesh-ancestor
6443936|NCT00381732|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6443937|NCT00381732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6443938|NCT00381732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6443939|NCT00381732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443940|NCT00381732|Urological Agents|urological agents|mesh-ancestor
6443941|NCT00381758|Methylphenidate|methylphenidate|mesh-list
6443942|NCT00381758|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6443943|NCT00381758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443944|NCT00381758|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6443945|NCT00381758|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6443946|NCT00381758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6443947|NCT00381758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443948|NCT00381758|Dopamine Agents|dopamine agents|mesh-ancestor
6443949|NCT00381758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6443950|NCT00381836|Darbepoetin alfa|darbepoetin alfa|mesh-list
6443951|NCT00381836|Hematinics|hematinics|mesh-ancestor
6443952|NCT00381875|Sargramostim|sargramostim|mesh-list
6019830|NCT00390013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6019831|NCT00390013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019832|NCT00390013|Anticonvulsants|anticonvulsants|mesh-ancestor
6019833|NCT00390013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6019834|NCT00390013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6019835|NCT00390013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6019836|NCT00390013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6019837|NCT00390013|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6019838|NCT00390013|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6019839|NCT00390013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6019840|NCT00390013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019841|NCT00390013|Antimanic Agents|antimanic agents|mesh-ancestor
6019842|NCT00390182|Gemcitabine|gemcitabine|mesh-list
6019843|NCT00390182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6019844|NCT00390182|Antimetabolites|antimetabolites|mesh-ancestor
6019845|NCT00390182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019846|NCT00390182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6019847|NCT00390182|Antiviral Agents|antiviral agents|mesh-ancestor
6019848|NCT00390182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6019849|NCT00390182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6019850|NCT00390182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6019851|NCT00390182|Immunologic Factors|immunologic factors|mesh-ancestor
6019852|NCT00390182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019853|NCT00390221|Daclizumab|daclizumab|mesh-list
6019854|NCT00390221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6019855|NCT00390221|Immunologic Factors|immunologic factors|mesh-ancestor
6019856|NCT00390221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019857|NCT00390234|Aflibercept|aflibercept|mesh-list
6019858|NCT00390234|Endothelial Growth Factors|endothelial growth factors|mesh-list
6019859|NCT00390234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6443953|NCT00381875|Freund's Adjuvant|freund's adjuvant|mesh-list
6559423|NCT00939549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559424|NCT00939549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6559425|NCT00939549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6559426|NCT00939549|Alkylating Agents|alkylating agents|mesh-ancestor
6559427|NCT00939549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559428|NCT00939549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6559429|NCT00939549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6559430|NCT00939549|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6559431|NCT00939588|Valsartan|valsartan|mesh-list
6559432|NCT00939588|Telmisartan|telmisartan|mesh-list
6559433|NCT00939588|Ramipril|ramipril|mesh-list
6559434|NCT00939588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6559435|NCT00939588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6559436|NCT00939588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6559437|NCT00939588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559438|NCT00939588|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6559439|NCT00939588|Protease Inhibitors|protease inhibitors|mesh-ancestor
6559440|NCT00939588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6559441|NCT00939614|Lamotrigine|lamotrigine|mesh-list
6559442|NCT00939614|Anticonvulsants|anticonvulsants|mesh-ancestor
6559443|NCT00939614|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6559444|NCT00939614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6559445|NCT00939614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559446|NCT00939614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6559447|NCT00939614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559448|NCT00939614|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6559449|NCT00939614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6559450|NCT00939614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6559451|NCT00939614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6559452|NCT00939614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6559453|NCT00939718|Vitamin B 12|vitamin b 12|mesh-list
6559454|NCT00939718|Hydroxocobalamin|hydroxocobalamin|mesh-list
6559455|NCT00939718|Vitamins|vitamins|mesh-ancestor
6559456|NCT00939718|Micronutrients|micronutrients|mesh-ancestor
6559457|NCT00939718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559458|NCT00939718|Vitamin B Complex|vitamin b complex|mesh-ancestor
6559459|NCT00939718|Hematinics|hematinics|mesh-ancestor
6559460|NCT00939757|Mirabegron|mirabegron|mesh-list
6559461|NCT00939757|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6559462|NCT00939757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6559463|NCT00939757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6559464|NCT00939757|Adrenergic Agents|adrenergic agents|mesh-ancestor
6559465|NCT00939757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6019860|NCT00390234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6019861|NCT00390234|Growth Substances|growth substances|mesh-ancestor
6019862|NCT00390234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019863|NCT00390234|Growth Inhibitors|growth inhibitors|mesh-ancestor
6019864|NCT00390234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6019865|NCT00390325|Sorafenib|sorafenib|mesh-list
6019866|NCT00390325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6019867|NCT00390325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6019868|NCT00390325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6019869|NCT00390325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019870|NCT00390364|Everolimus|everolimus|mesh-list
6019871|NCT00390364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6019872|NCT00390364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6019873|NCT00390364|Immunologic Factors|immunologic factors|mesh-ancestor
6019874|NCT00390364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019875|NCT00390416|Leucovorin|leucovorin|mesh-list
6019876|NCT00390416|Bevacizumab|bevacizumab|mesh-list
6559466|NCT00939757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559467|NCT00939757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559468|NCT00939757|Urological Agents|urological agents|mesh-ancestor
6559469|NCT00939835|Dexetimide|dexetimide|mesh-list
6559470|NCT00939835|Citalopram|citalopram|mesh-list
6559471|NCT00939835|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6559472|NCT00939835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6443954|NCT00381875|Immunologic Factors|immunologic factors|mesh-ancestor
6443955|NCT00381875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443956|NCT00381875|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6443957|NCT00381901|Trastuzumab|trastuzumab|mesh-list
6443958|NCT00381901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6559473|NCT00939835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6559474|NCT00939835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559475|NCT00939835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6559476|NCT00939835|Serotonin Agents|serotonin agents|mesh-ancestor
6559477|NCT00939835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559478|NCT00939835|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6019877|NCT00390416|Docetaxel|docetaxel|mesh-list
6019878|NCT00390416|Fluorouracil|fluorouracil|mesh-list
6019879|NCT00390416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6019880|NCT00390416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6019881|NCT00390416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6019882|NCT00390416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6019883|NCT00390416|Growth Substances|growth substances|mesh-ancestor
6019884|NCT00390416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019885|NCT00390416|Growth Inhibitors|growth inhibitors|mesh-ancestor
6443959|NCT00381901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6019886|NCT00390416|Tubulin Modulators|tubulin modulators|mesh-ancestor
6443960|NCT00381914|Vitamin D|vitamin d|mesh-list
6559479|NCT00939835|Antidepressive Agents|antidepressive agents|mesh-ancestor
6559480|NCT00939835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6559481|NCT00939835|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6019887|NCT00390416|Antimitotic Agents|antimitotic agents|mesh-ancestor
6019888|NCT00390416|Mitosis Modulators|mitosis modulators|mesh-ancestor
6019889|NCT00390416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019890|NCT00390416|Antimetabolites|antimetabolites|mesh-ancestor
6019891|NCT00390416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6019892|NCT00390416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6443961|NCT00381914|Ergocalciferols|ergocalciferols|mesh-list
6443962|NCT00381914|Vitamins|vitamins|mesh-list
6019893|NCT00390416|Immunologic Factors|immunologic factors|mesh-ancestor
6019894|NCT00390416|Antidotes|antidotes|mesh-ancestor
6019895|NCT00390416|Protective Agents|protective agents|mesh-ancestor
6019896|NCT00390416|Vitamin B Complex|vitamin b complex|mesh-ancestor
6019897|NCT00390416|Vitamins|vitamins|mesh-ancestor
6019898|NCT00390416|Micronutrients|micronutrients|mesh-ancestor
6019899|NCT00390429|Docetaxel|docetaxel|mesh-list
6019900|NCT00390429|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6019901|NCT00390429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6019902|NCT00390429|Tubulin Modulators|tubulin modulators|mesh-ancestor
6019903|NCT00390429|Antimitotic Agents|antimitotic agents|mesh-ancestor
6019904|NCT00390429|Mitosis Modulators|mitosis modulators|mesh-ancestor
6443963|NCT00381914|Micronutrients|micronutrients|mesh-ancestor
6559482|NCT00939835|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6559483|NCT00939835|Parasympatholytics|parasympatholytics|mesh-ancestor
6559484|NCT00939835|Autonomic Agents|autonomic agents|mesh-ancestor
6559485|NCT00939835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6559486|NCT00939835|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6559487|NCT00939835|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6559488|NCT00939835|Cholinergic Agents|cholinergic agents|mesh-ancestor
6559489|NCT00939848|Gemcitabine|gemcitabine|mesh-list
6559490|NCT00939848|Cisplatin|cisplatin|mesh-list
6559491|NCT00939848|Cediranib|cediranib|mesh-list
6559492|NCT00939848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6559493|NCT00939848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6559494|NCT00939848|Antimetabolites|antimetabolites|mesh-ancestor
6559495|NCT00939848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559496|NCT00939848|Antiviral Agents|antiviral agents|mesh-ancestor
6559497|NCT00939848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6559498|NCT00939848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6559499|NCT00939848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6559500|NCT00939848|Immunologic Factors|immunologic factors|mesh-ancestor
6559501|NCT00939848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559502|NCT00939848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6559503|NCT00939926|Risperidone|risperidone|mesh-list
6559504|NCT00939926|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6559505|NCT00939926|Serotonin Agents|serotonin agents|mesh-ancestor
6559506|NCT00939926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6559507|NCT00939926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443964|NCT00381914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443965|NCT00381914|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6443966|NCT00381914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6443967|NCT00381953|Interferons|interferons|mesh-list
6443968|NCT00381953|Ribavirin|ribavirin|mesh-list
6443969|NCT00381953|Interferon-alpha|interferon-alpha|mesh-list
6443970|NCT00381953|Interferon alpha-2|interferon alpha-2|mesh-list
6443971|NCT00381953|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6443972|NCT00381953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6559508|NCT00939926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559509|NCT00939926|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6019905|NCT00390429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559510|NCT00939926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6559511|NCT00939926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6559512|NCT00939926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6559513|NCT00939926|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6559514|NCT00939926|Dopamine Agents|dopamine agents|mesh-ancestor
6559515|NCT00939939|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6559516|NCT00939939|Glimepiride|glimepiride|mesh-list
6559517|NCT00939939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6559518|NCT00939939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559519|NCT00939939|Incretins|incretins|mesh-ancestor
6559520|NCT00939939|Hormones|hormones|mesh-ancestor
6559521|NCT00939939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6559522|NCT00939939|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6559523|NCT00939939|Protease Inhibitors|protease inhibitors|mesh-ancestor
6559524|NCT00939939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6559525|NCT00939939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559526|NCT00939939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6559527|NCT00939939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6559528|NCT00939939|Immunologic Factors|immunologic factors|mesh-ancestor
6559529|NCT00939965|Isotretinoin|isotretinoin|mesh-list
6559530|NCT00939965|Dermatologic Agents|dermatologic agents|mesh-ancestor
6559531|NCT00940004|Vaccines|vaccines|mesh-list
6559532|NCT00940004|Immunologic Factors|immunologic factors|mesh-ancestor
6559533|NCT00940004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559534|NCT00940069|Pemetrexed|pemetrexed|mesh-list
6559535|NCT00940069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6559536|NCT00940069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6559537|NCT00940069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559538|NCT00940069|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6559539|NCT00940069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6559540|NCT00940121|Mirabegron|mirabegron|mesh-list
6559541|NCT00940121|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6559542|NCT00940121|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6559543|NCT00940121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6559544|NCT00940121|Adrenergic Agents|adrenergic agents|mesh-ancestor
6559545|NCT00940121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6559546|NCT00940121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559547|NCT00940121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559548|NCT00940121|Urological Agents|urological agents|mesh-ancestor
6559549|NCT00940238|Dexetimide|dexetimide|mesh-list
6559550|NCT00940238|Citalopram|citalopram|mesh-list
6559551|NCT00940238|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6559552|NCT00940238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6559553|NCT00940238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6559554|NCT00940238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559555|NCT00940238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6559556|NCT00940238|Serotonin Agents|serotonin agents|mesh-ancestor
6559557|NCT00940238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559558|NCT00940238|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6559559|NCT00940238|Antidepressive Agents|antidepressive agents|mesh-ancestor
6559560|NCT00940238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6559561|NCT00940238|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6559562|NCT00940238|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6443973|NCT00381953|Antiviral Agents|antiviral agents|mesh-ancestor
6443974|NCT00381953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6443975|NCT00381953|Antimetabolites|antimetabolites|mesh-ancestor
6443976|NCT00381953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443977|NCT00381953|Immunologic Factors|immunologic factors|mesh-ancestor
6443978|NCT00381953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443979|NCT00382044|Darbepoetin alfa|darbepoetin alfa|mesh-list
6559563|NCT00940238|Parasympatholytics|parasympatholytics|mesh-ancestor
6559564|NCT00940238|Autonomic Agents|autonomic agents|mesh-ancestor
6443980|NCT00382044|Hematinics|hematinics|mesh-ancestor
6559565|NCT00940238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6559566|NCT00940238|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6443981|NCT00382057|Anastrozole|anastrozole|mesh-list
6443982|NCT00382057|Goserelin|goserelin|mesh-list
6559567|NCT00940238|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6559568|NCT00940238|Cholinergic Agents|cholinergic agents|mesh-ancestor
6559569|NCT00940303|Leucovorin|leucovorin|mesh-list
6559570|NCT00940303|Bevacizumab|bevacizumab|mesh-list
6559571|NCT00940303|Oxaliplatin|oxaliplatin|mesh-list
6559572|NCT00940303|Irinotecan|irinotecan|mesh-list
6559573|NCT00940303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6559574|NCT00940303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6559575|NCT00940303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6559576|NCT00940303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6559577|NCT00940303|Growth Substances|growth substances|mesh-ancestor
6559578|NCT00940303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559579|NCT00940303|Growth Inhibitors|growth inhibitors|mesh-ancestor
6559580|NCT00940303|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6559581|NCT00940303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6559582|NCT00940303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6559583|NCT00940303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559584|NCT00940303|Antidotes|antidotes|mesh-ancestor
6559585|NCT00940303|Protective Agents|protective agents|mesh-ancestor
6559586|NCT00940303|Vitamin B Complex|vitamin b complex|mesh-ancestor
6559587|NCT00940303|Vitamins|vitamins|mesh-ancestor
6559588|NCT00940303|Micronutrients|micronutrients|mesh-ancestor
6559589|NCT00940381|Sirolimus|sirolimus|mesh-list
6559590|NCT00940381|Cetuximab|cetuximab|mesh-list
6559591|NCT00940381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6559592|NCT00940381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6559593|NCT00940381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6559594|NCT00940381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6559595|NCT00940381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6559596|NCT00940381|Antifungal Agents|antifungal agents|mesh-ancestor
6559597|NCT00940381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6559598|NCT00940381|Immunologic Factors|immunologic factors|mesh-ancestor
6559599|NCT00940381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559600|NCT00940420|Ribavirin|ribavirin|mesh-list
6559601|NCT00940420|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6559602|NCT00940420|Interferon-alpha|interferon-alpha|mesh-list
6559603|NCT00940420|Antimetabolites|antimetabolites|mesh-ancestor
6559604|NCT00940420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559605|NCT00940420|Antiviral Agents|antiviral agents|mesh-ancestor
6559606|NCT00940420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6559607|NCT00940420|Immunologic Factors|immunologic factors|mesh-ancestor
6559608|NCT00940420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559609|NCT00940472|Metformin|metformin|mesh-list
6559610|NCT00940472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6559611|NCT00940472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559612|NCT00940498|Gedatolisib|gedatolisib|mesh-list
6559613|NCT00940498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6559614|NCT00940498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6559615|NCT00940498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559616|NCT00940524|Cytarabine|cytarabine|mesh-list
6559617|NCT00940524|Cyclophosphamide|cyclophosphamide|mesh-list
6559618|NCT00940524|Methotrexate|methotrexate|mesh-list
6559619|NCT00940524|Etoposide|etoposide|mesh-list
6559620|NCT00940524|Asparaginase|asparaginase|mesh-list
6559621|NCT00940524|Dasatinib|dasatinib|mesh-list
6559622|NCT00940524|Mitoxantrone|mitoxantrone|mesh-list
6559623|NCT00940524|Pegaspargase|pegaspargase|mesh-list
6559624|NCT00940524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6559625|NCT00940524|Immunologic Factors|immunologic factors|mesh-ancestor
6559626|NCT00940524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559627|NCT00940524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6559628|NCT00940524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6559629|NCT00940524|Alkylating Agents|alkylating agents|mesh-ancestor
6559630|NCT00940524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559631|NCT00940524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6559632|NCT00940524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6559633|NCT00940524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6559634|NCT00940524|Abortifacient Agents|abortifacient agents|mesh-ancestor
6559635|NCT00940524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6559636|NCT00940524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6559637|NCT00940524|Antimetabolites|antimetabolites|mesh-ancestor
6559638|NCT00940524|Dermatologic Agents|dermatologic agents|mesh-ancestor
6559639|NCT00940524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6559640|NCT00940524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6559641|NCT00940524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6559642|NCT00940524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6559643|NCT00940524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6559644|NCT00940524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6559645|NCT00940524|Antiviral Agents|antiviral agents|mesh-ancestor
6559646|NCT00940524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6559647|NCT00940524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6559648|NCT00940524|Analgesics|analgesics|mesh-ancestor
6559649|NCT00940524|Sensory System Agents|sensory system agents|mesh-ancestor
6559650|NCT00940524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6656864|NCT01471899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656865|NCT01471899|Gout Suppressants|gout suppressants|mesh-ancestor
6656866|NCT01471925|Esomeprazole|esomeprazole|mesh-list
6656867|NCT01471925|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6656868|NCT01471925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6656869|NCT01471925|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6656870|NCT01471925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6656871|NCT01471925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656872|NCT01471964|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6656873|NCT01471964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6656874|NCT01471964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6656875|NCT01471964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6656876|NCT01471964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656877|NCT01471990|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
6656878|NCT01471990|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
6656879|NCT01471990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6656880|NCT01471990|Vasodilator Agents|vasodilator agents|mesh-ancestor
6656881|NCT01471990|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6656882|NCT01471990|Protective Agents|protective agents|mesh-ancestor
6656883|NCT01471990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656884|NCT01471990|Growth Substances|growth substances|mesh-ancestor
6656885|NCT01471990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6656886|NCT01471990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656887|NCT01472016|Docetaxel|docetaxel|mesh-list
6656888|NCT01472016|Cetuximab|cetuximab|mesh-list
6443983|NCT00382057|Testosterone|testosterone|mesh-list
6443984|NCT00382057|Androgens|androgens|mesh-ancestor
6443985|NCT00382057|Hormones|hormones|mesh-ancestor
6443986|NCT00382057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6443987|NCT00382057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6443988|NCT00382057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6443989|NCT00382057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6443990|NCT00382057|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6443991|NCT00382057|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6656889|NCT01472016|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6656890|NCT01472016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6656891|NCT01472016|Tubulin Modulators|tubulin modulators|mesh-ancestor
6656892|NCT01472016|Antimitotic Agents|antimitotic agents|mesh-ancestor
6656893|NCT01472016|Mitosis Modulators|mitosis modulators|mesh-ancestor
6656894|NCT01472016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656895|NCT01472016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6656896|NCT01472016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6656897|NCT01472016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6656898|NCT01472029|Leucovorin|leucovorin|mesh-list
6656899|NCT01472029|Docetaxel|docetaxel|mesh-list
6656900|NCT01472029|Oxaliplatin|oxaliplatin|mesh-list
6656901|NCT01472029|Trastuzumab|trastuzumab|mesh-list
6656902|NCT01472029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6019906|NCT00390429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6019907|NCT00390429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6019908|NCT00390455|Fulvestrant|fulvestrant|mesh-list
6019909|NCT00390455|Lapatinib|lapatinib|mesh-list
6443992|NCT00382057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6443993|NCT00382057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6443994|NCT00382057|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6443995|NCT00382057|Hormone Antagonists|hormone antagonists|mesh-ancestor
6443996|NCT00382083|Acetaminophen|acetaminophen|mesh-list
6443997|NCT00382083|Ibuprofen|ibuprofen|mesh-list
6443998|NCT00382083|Lidocaine|lidocaine|mesh-list
6559651|NCT00940550|Melatonin|melatonin|mesh-list
6559652|NCT00940550|Zolpidem|zolpidem|mesh-list
6559653|NCT00940550|Temazepam|temazepam|mesh-list
6559654|NCT00940550|Antioxidants|antioxidants|mesh-ancestor
6559655|NCT00940550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559656|NCT00940550|Protective Agents|protective agents|mesh-ancestor
6559657|NCT00940550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559658|NCT00940550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6559659|NCT00940550|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6559660|NCT00940550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6559661|NCT00940550|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6559662|NCT00940550|GABA Agonists|gaba agonists|mesh-ancestor
6559663|NCT00940550|GABA Agents|gaba agents|mesh-ancestor
6559664|NCT00940550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6559665|NCT00940550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6559666|NCT00940550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6559667|NCT00940550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6559668|NCT00940550|GABA Modulators|gaba modulators|mesh-ancestor
6559669|NCT00940563|Imatinib Mesylate|imatinib mesylate|mesh-list
6559670|NCT00940563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6559671|NCT00940563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6559672|NCT00940563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6559673|NCT00940563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559674|NCT00940628|Orlistat|orlistat|mesh-list
6559675|NCT00940628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6559676|NCT00940628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559677|NCT00940628|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6559678|NCT00940628|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6559679|NCT00940654|Acetaminophen|acetaminophen|mesh-list
6559680|NCT00940654|Antipyretics|antipyretics|mesh-list
6559681|NCT00940654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
6559682|NCT00940654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6559683|NCT00940654|Analgesics|analgesics|mesh-ancestor
6559684|NCT00940654|Sensory System Agents|sensory system agents|mesh-ancestor
6559685|NCT00940654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6559686|NCT00940654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559687|NCT00940667|Losartan|losartan|mesh-list
6559688|NCT00940667|Amlodipine|amlodipine|mesh-list
6559689|NCT00940667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6559690|NCT00940667|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6559691|NCT00940667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6559692|NCT00940667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559693|NCT00940667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6559694|NCT00940667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559695|NCT00940667|Vasodilator Agents|vasodilator agents|mesh-ancestor
6559696|NCT00940667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6559697|NCT00940667|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6559698|NCT00940667|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6559699|NCT00940680|Losartan|losartan|mesh-list
6559700|NCT00940680|Amlodipine|amlodipine|mesh-list
6559701|NCT00940680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6559702|NCT00940680|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6559703|NCT00940680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6559704|NCT00940680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559705|NCT00940680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6559706|NCT00940680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559707|NCT00940680|Vasodilator Agents|vasodilator agents|mesh-ancestor
6559708|NCT00940680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6559709|NCT00940680|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6559710|NCT00940680|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6559711|NCT00940693|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6559712|NCT00940693|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6559713|NCT00940693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6559714|NCT00940693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6559715|NCT00940693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559716|NCT00940693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6559717|NCT00940693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559718|NCT00940693|Analgesics|analgesics|mesh-ancestor
6559719|NCT00940693|Sensory System Agents|sensory system agents|mesh-ancestor
6559720|NCT00940693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6559721|NCT00940693|Antidepressive Agents|antidepressive agents|mesh-ancestor
6559722|NCT00940693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6559723|NCT00940693|Dopamine Agents|dopamine agents|mesh-ancestor
6559724|NCT00940719|Vitamin D|vitamin d|mesh-list
6559725|NCT00940719|Cholecalciferol|cholecalciferol|mesh-list
6559726|NCT00940719|Vitamins|vitamins|mesh-ancestor
6559727|NCT00940719|Micronutrients|micronutrients|mesh-ancestor
6559728|NCT00940719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559729|NCT00940719|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6559730|NCT00940719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6559731|NCT00940784|Aspirin|aspirin|mesh-list
6559732|NCT00940784|Clopidogrel|clopidogrel|mesh-list
6559733|NCT00940784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6559734|NCT00940784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6559735|NCT00940784|Analgesics|analgesics|mesh-ancestor
6559736|NCT00940784|Sensory System Agents|sensory system agents|mesh-ancestor
6559737|NCT00940784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6559738|NCT00940784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559739|NCT00940784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6559740|NCT00940784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6559741|NCT00940784|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6559742|NCT00940784|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6559743|NCT00940784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559744|NCT00940784|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6559745|NCT00940784|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6559746|NCT00940784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6559747|NCT00940784|Antipyretics|antipyretics|mesh-ancestor
6559748|NCT00940784|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6559749|NCT00940784|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6559750|NCT00940784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6559751|NCT00940784|Purinergic Agents|purinergic agents|mesh-ancestor
6559752|NCT00940784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6559753|NCT00940836|Acetaminophen|acetaminophen|mesh-list
6559754|NCT00940836|Chlorpheniramine|chlorpheniramine|mesh-list
6559755|NCT00940836|Phenylephrine|phenylephrine|mesh-list
6559756|NCT00940836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6559757|NCT00940836|Analgesics|analgesics|mesh-ancestor
6559758|NCT00940836|Sensory System Agents|sensory system agents|mesh-ancestor
6559759|NCT00940836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6559760|NCT00940836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559761|NCT00940836|Antipyretics|antipyretics|mesh-ancestor
6559762|NCT00940836|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6559763|NCT00940836|Mydriatics|mydriatics|mesh-ancestor
6559764|NCT00940836|Autonomic Agents|autonomic agents|mesh-ancestor
6559765|NCT00940836|Sympathomimetics|sympathomimetics|mesh-ancestor
6559766|NCT00940836|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6559767|NCT00940836|Nasal Decongestants|nasal decongestants|mesh-ancestor
6559768|NCT00940836|Respiratory System Agents|respiratory system agents|mesh-ancestor
6559769|NCT00940836|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6559770|NCT00940836|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6559771|NCT00940836|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6559772|NCT00940836|Adrenergic Agents|adrenergic agents|mesh-ancestor
6559773|NCT00940836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6656903|NCT01472029|Tubulin Modulators|tubulin modulators|mesh-ancestor
6443999|NCT00382083|Anesthetics, Local|anesthetics, local|mesh-ancestor
6559774|NCT00940836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559775|NCT00940836|Protective Agents|protective agents|mesh-ancestor
6559776|NCT00940836|Antipruritics|antipruritics|mesh-ancestor
6559777|NCT00940836|Dermatologic Agents|dermatologic agents|mesh-ancestor
6559778|NCT00940836|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6559779|NCT00940836|Histamine Antagonists|histamine antagonists|mesh-ancestor
6559780|NCT00940836|Histamine Agents|histamine agents|mesh-ancestor
6559781|NCT00940836|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6559782|NCT00940862|Adalimumab|adalimumab|mesh-list
6559783|NCT00940862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6559784|NCT00940862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6559785|NCT00940914|2beta-carbomethoxy-3beta-(4-iodophenyl)tropane|2beta-carbomethoxy-3beta-(4-iodophenyl)tropane|mesh-list
6559786|NCT00940914|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6559787|NCT00940914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559788|NCT00940940|Vaccines|vaccines|mesh-list
6559789|NCT00940940|Immunologic Factors|immunologic factors|mesh-ancestor
6559790|NCT00940940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559791|NCT00940953|Azelastine|azelastine|mesh-list
6559792|NCT00940953|Budesonide|budesonide|mesh-list
6559793|NCT00940953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6559794|NCT00940953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6559795|NCT00940953|Autonomic Agents|autonomic agents|mesh-ancestor
6559796|NCT00940953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6559797|NCT00940953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559798|NCT00940953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6559799|NCT00940953|Respiratory System Agents|respiratory system agents|mesh-ancestor
6559800|NCT00940953|Glucocorticoids|glucocorticoids|mesh-ancestor
6559801|NCT00940953|Hormones|hormones|mesh-ancestor
6559802|NCT00940953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6559803|NCT00940953|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6559804|NCT00940953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6559805|NCT00940953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559806|NCT00940953|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6559807|NCT00940953|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6559808|NCT00940953|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6559809|NCT00940953|Histamine Antagonists|histamine antagonists|mesh-ancestor
6559810|NCT00940953|Histamine Agents|histamine agents|mesh-ancestor
6559811|NCT00940953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6559812|NCT00941057|Calcium, Dietary|calcium, dietary|mesh-list
6559813|NCT00941057|Tetrahydrofolates|tetrahydrofolates|mesh-list
6559814|NCT00941057|Dienogest|dienogest|mesh-list
6559815|NCT00941057|Calcium|calcium|mesh-list
6559816|NCT00941057|Nandrolone|nandrolone|mesh-list
6559817|NCT00941057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6559818|NCT00941057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559819|NCT00941057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6559820|NCT00941057|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6559821|NCT00941057|Contraceptive Agents|contraceptive agents|mesh-ancestor
6559822|NCT00941057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6559823|NCT00941057|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6559824|NCT00941057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6559825|NCT00941057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6444000|NCT00382083|Anesthetics|anesthetics|mesh-ancestor
6444001|NCT00382083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6444002|NCT00382083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444003|NCT00382083|Sensory System Agents|sensory system agents|mesh-ancestor
6444004|NCT00382083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6444005|NCT00382083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6444006|NCT00382083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6444007|NCT00382083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6559826|NCT00941057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6559827|NCT00941057|Hormone Antagonists|hormone antagonists|mesh-ancestor
6559828|NCT00941057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6559829|NCT00941057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6559830|NCT00941057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6559831|NCT00941057|Androgens|androgens|mesh-ancestor
6559832|NCT00941057|Hormones|hormones|mesh-ancestor
6559833|NCT00941057|Anabolic Agents|anabolic agents|mesh-ancestor
6559834|NCT00941057|Vitamin B Complex|vitamin b complex|mesh-ancestor
6559835|NCT00941057|Vitamins|vitamins|mesh-ancestor
6559836|NCT00941057|Micronutrients|micronutrients|mesh-ancestor
6559837|NCT00941083|Raltegravir Potassium|raltegravir potassium|mesh-list
6559838|NCT00941083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6559839|NCT00941083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6559840|NCT00941083|Antiviral Agents|antiviral agents|mesh-ancestor
6559841|NCT00941083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6559842|NCT00941083|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6559843|NCT00941083|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6559844|NCT00941083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6559845|NCT00941083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559846|NCT00941096|Timolol|timolol|mesh-list
6559847|NCT00941096|Bimatoprost|bimatoprost|mesh-list
6559848|NCT00941096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6559849|NCT00941096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6559850|NCT00941096|Adrenergic Agents|adrenergic agents|mesh-ancestor
6559851|NCT00941096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6559852|NCT00941096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559853|NCT00941096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559854|NCT00941096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6559855|NCT00941096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6559856|NCT00941109|Decitabine|decitabine|mesh-list
6559857|NCT00941109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6559858|NCT00941109|Antimetabolites|antimetabolites|mesh-ancestor
6559859|NCT00941109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559860|NCT00941109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6559861|NCT00941109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6559862|NCT00941135|Docetaxel|docetaxel|mesh-list
6559863|NCT00941135|Cetuximab|cetuximab|mesh-list
6559864|NCT00941135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6559865|NCT00941135|Tubulin Modulators|tubulin modulators|mesh-ancestor
6559866|NCT00941135|Antimitotic Agents|antimitotic agents|mesh-ancestor
6559867|NCT00941135|Mitosis Modulators|mitosis modulators|mesh-ancestor
6559868|NCT00941135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559869|NCT00941135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6559870|NCT00941148|Insulin|insulin|mesh-list
6559871|NCT00941148|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6559872|NCT00941148|Metformin|metformin|mesh-list
6559873|NCT00941148|Insulin Detemir|insulin detemir|mesh-list
6559874|NCT00941148|Insulin, Isophane|insulin, isophane|mesh-list
6559875|NCT00941148|Isophane Insulin, Human|isophane insulin, human|mesh-list
6559876|NCT00941148|Isophane insulin, beef|isophane insulin, beef|mesh-list
6559877|NCT00941148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6559878|NCT00941148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559879|NCT00941161|Metformin|metformin|mesh-list
6559880|NCT00941161|Glimepiride|glimepiride|mesh-list
6559881|NCT00941161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6559882|NCT00941161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559883|NCT00941161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6559884|NCT00941161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6559885|NCT00941161|Immunologic Factors|immunologic factors|mesh-ancestor
6559886|NCT00941174|Leucovorin|leucovorin|mesh-list
6559887|NCT00941174|Calcium|calcium|mesh-list
6559888|NCT00941174|Levoleucovorin|levoleucovorin|mesh-list
6559889|NCT00941174|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6559890|NCT00941174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559891|NCT00941174|Antidotes|antidotes|mesh-ancestor
6559892|NCT00941174|Protective Agents|protective agents|mesh-ancestor
6559893|NCT00941174|Vitamin B Complex|vitamin b complex|mesh-ancestor
6559894|NCT00941174|Vitamins|vitamins|mesh-ancestor
6559895|NCT00941174|Micronutrients|micronutrients|mesh-ancestor
6559896|NCT00941239|Metformin|metformin|mesh-list
6559897|NCT00941239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6559898|NCT00941239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559899|NCT00941252|Imiquimod|imiquimod|mesh-list
6559900|NCT00941252|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6559901|NCT00941252|Immunologic Factors|immunologic factors|mesh-ancestor
6559902|NCT00941252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559903|NCT00941252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6559904|NCT00941252|Interferon Inducers|interferon inducers|mesh-ancestor
6559905|NCT00941265|Levodopa|levodopa|mesh-list
6559906|NCT00941265|Benserazide|benserazide|mesh-list
6559907|NCT00941265|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6559908|NCT00941265|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6559909|NCT00941265|Dopamine Agents|dopamine agents|mesh-ancestor
6559910|NCT00941265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6559911|NCT00941265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559912|NCT00941265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559913|NCT00941265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6559914|NCT00941343|Alfuzosin|alfuzosin|mesh-list
6559915|NCT00941343|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6559916|NCT00941343|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6559917|NCT00941343|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6559918|NCT00941343|Adrenergic Agents|adrenergic agents|mesh-ancestor
6559919|NCT00941343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6559920|NCT00941343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559921|NCT00941343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559922|NCT00941343|Urological Agents|urological agents|mesh-ancestor
6559923|NCT00941369|Insulin|insulin|mesh-list
6559924|NCT00941369|Insulin Glargine|insulin glargine|mesh-list
6559925|NCT00941369|Insulin, Isophane|insulin, isophane|mesh-list
6559926|NCT00941369|Isophane Insulin, Human|isophane insulin, human|mesh-list
6559927|NCT00941369|Isophane insulin, beef|isophane insulin, beef|mesh-list
6559928|NCT00941369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6559929|NCT00941369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559930|NCT00941382|Metformin|metformin|mesh-list
6559931|NCT00941382|Sibutramine|sibutramine|mesh-list
6559932|NCT00941382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6559933|NCT00941382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559934|NCT00941382|Antidepressive Agents|antidepressive agents|mesh-ancestor
6559935|NCT00941382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6559936|NCT00941382|Appetite Depressants|appetite depressants|mesh-ancestor
6559937|NCT00941382|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6559938|NCT00941460|Temozolomide|temozolomide|mesh-list
6559939|NCT00941460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6559940|NCT00941460|Alkylating Agents|alkylating agents|mesh-ancestor
6559941|NCT00941460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559942|NCT00941460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6559943|NCT00941473|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6559944|NCT00941473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6559945|NCT00941473|Glucocorticoids|glucocorticoids|mesh-ancestor
6559946|NCT00941473|Hormones|hormones|mesh-ancestor
6559947|NCT00941473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6559948|NCT00941473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559949|NCT00941473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6559950|NCT00941473|Immunologic Factors|immunologic factors|mesh-ancestor
6559951|NCT00941499|Leucovorin|leucovorin|mesh-list
6559952|NCT00941499|Bevacizumab|bevacizumab|mesh-list
6559953|NCT00941499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6559954|NCT00941499|Cetuximab|cetuximab|mesh-list
6019910|NCT00390455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6559955|NCT00941499|Fluorouracil|fluorouracil|mesh-list
6559956|NCT00941499|Oxaliplatin|oxaliplatin|mesh-list
6559957|NCT00941499|Antibodies|antibodies|mesh-list
6559958|NCT00941499|Immunoglobulins|immunoglobulins|mesh-list
6559959|NCT00941499|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6559960|NCT00941499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6559961|NCT00941499|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6559962|NCT00941499|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6559963|NCT00941499|Growth Substances|growth substances|mesh-ancestor
6559964|NCT00941499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559965|NCT00941499|Growth Inhibitors|growth inhibitors|mesh-ancestor
6559966|NCT00941499|Immunologic Factors|immunologic factors|mesh-ancestor
6559967|NCT00941499|Antimetabolites|antimetabolites|mesh-ancestor
6559968|NCT00941499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6559969|NCT00941499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6559970|NCT00941499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6559971|NCT00941499|Antidotes|antidotes|mesh-ancestor
6559972|NCT00941499|Protective Agents|protective agents|mesh-ancestor
6559973|NCT00941499|Vitamin B Complex|vitamin b complex|mesh-ancestor
6559974|NCT00941499|Vitamins|vitamins|mesh-ancestor
6559975|NCT00941499|Micronutrients|micronutrients|mesh-ancestor
6559976|NCT00941525|Latanoprost|latanoprost|mesh-list
6559977|NCT00941525|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6559978|NCT00941525|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6559979|NCT00941616|Factor VIII|factor viii|mesh-list
6559980|NCT00941616|Coagulants|coagulants|mesh-ancestor
6559981|NCT00941785|Amodiaquine|amodiaquine|mesh-list
6559982|NCT00941785|Antimalarials|antimalarials|mesh-ancestor
6559983|NCT00941785|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6559984|NCT00941785|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6559985|NCT00941785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6559986|NCT00941811|Imiquimod|imiquimod|mesh-list
6559987|NCT00941811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6559988|NCT00941811|Immunologic Factors|immunologic factors|mesh-ancestor
6559989|NCT00941811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6559990|NCT00941811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6559991|NCT00941811|Interferon Inducers|interferon inducers|mesh-ancestor
6559992|NCT00941824|Mycophenolic Acid|mycophenolic acid|mesh-list
6559993|NCT00941824|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6559994|NCT00941824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6559995|NCT00941824|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6559996|NCT00941824|Antitubercular Agents|antitubercular agents|mesh-ancestor
6559997|NCT00941824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6559998|NCT00941824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6559999|NCT00941824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6560000|NCT00941824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560001|NCT00941967|Gemcitabine|gemcitabine|mesh-list
6560002|NCT00941967|Oxaliplatin|oxaliplatin|mesh-list
6560003|NCT00941967|Sorafenib|sorafenib|mesh-list
6560004|NCT00941967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6560005|NCT00941967|Antimetabolites|antimetabolites|mesh-ancestor
6560006|NCT00941967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560007|NCT00941967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6560008|NCT00941967|Antiviral Agents|antiviral agents|mesh-ancestor
6560009|NCT00941967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6560010|NCT00941967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6560011|NCT00941967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6560012|NCT00941967|Immunologic Factors|immunologic factors|mesh-ancestor
6560013|NCT00941967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560014|NCT00941967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6560015|NCT00942006|Doxycycline|doxycycline|mesh-list
6560016|NCT00942006|Ceftriaxone|ceftriaxone|mesh-list
6560017|NCT00942006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6560018|NCT00942006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6560019|NCT00942006|Antimalarials|antimalarials|mesh-ancestor
6560020|NCT00942006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6560021|NCT00942006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6560022|NCT00942136|Dolutegravir|dolutegravir|mesh-list
6560023|NCT00942136|Omeprazole|omeprazole|mesh-list
6560024|NCT00942136|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6560025|NCT00942136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6560026|NCT00942136|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6560027|NCT00942136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6560028|NCT00942136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560029|NCT00942136|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6560030|NCT00942136|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6560031|NCT00942136|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6560032|NCT00942136|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6560033|NCT00942136|Antiviral Agents|antiviral agents|mesh-ancestor
6560034|NCT00942136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6560035|NCT00942201|Dexamethasone|dexamethasone|mesh-list
6560036|NCT00942201|Dexamethasone acetate|dexamethasone acetate|mesh-list
6560037|NCT00942201|BB 1101|bb 1101|mesh-list
6560038|NCT00942201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6560039|NCT00942201|Antiemetics|antiemetics|mesh-ancestor
6560040|NCT00942201|Autonomic Agents|autonomic agents|mesh-ancestor
6560041|NCT00942201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6560042|NCT00942201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560043|NCT00942201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6560044|NCT00942201|Glucocorticoids|glucocorticoids|mesh-ancestor
6560045|NCT00942201|Hormones|hormones|mesh-ancestor
6560046|NCT00942201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6560047|NCT00942201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6560048|NCT00942201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6560049|NCT00942201|Protease Inhibitors|protease inhibitors|mesh-ancestor
6560050|NCT00942201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6560051|NCT00942201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560052|NCT00942214|Natalizumab|natalizumab|mesh-list
6560053|NCT00942214|Immunologic Factors|immunologic factors|mesh-ancestor
6560054|NCT00942214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560055|NCT00942253|Dopamine|dopamine|mesh-list
6560056|NCT00942253|Dopamine Agonists|dopamine agonists|mesh-list
6560057|NCT00942253|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6560058|NCT00942253|Sympathomimetics|sympathomimetics|mesh-ancestor
6560059|NCT00942253|Autonomic Agents|autonomic agents|mesh-ancestor
6560060|NCT00942253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6560061|NCT00942253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560062|NCT00942253|Dopamine Agents|dopamine agents|mesh-ancestor
6560063|NCT00942253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6560064|NCT00942253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560065|NCT00942253|Protective Agents|protective agents|mesh-ancestor
6560066|NCT00942318|Insulin|insulin|mesh-list
6560067|NCT00942318|Metformin|metformin|mesh-list
6560068|NCT00942318|Insulin Aspart|insulin aspart|mesh-list
6560069|NCT00942318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6560070|NCT00942318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656904|NCT01472029|Antimitotic Agents|antimitotic agents|mesh-ancestor
6656905|NCT01472029|Mitosis Modulators|mitosis modulators|mesh-ancestor
6656906|NCT01472029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656907|NCT01472029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6656908|NCT01472029|Antidotes|antidotes|mesh-ancestor
6560071|NCT00942344|Losartan|losartan|mesh-list
6560072|NCT00942344|Amlodipine|amlodipine|mesh-list
6560073|NCT00942344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6560074|NCT00942344|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6560075|NCT00942344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6560076|NCT00942344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560077|NCT00942344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6560078|NCT00942344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560079|NCT00942344|Vasodilator Agents|vasodilator agents|mesh-ancestor
6560080|NCT00942344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6560081|NCT00942344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6560082|NCT00942344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6560083|NCT00942435|Darexaban|darexaban|mesh-list
6560084|NCT00942435|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6560085|NCT00942435|Antithrombins|antithrombins|mesh-ancestor
6560086|NCT00942435|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6560087|NCT00942435|Protease Inhibitors|protease inhibitors|mesh-ancestor
6560088|NCT00942435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6560089|NCT00942435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560090|NCT00942435|Anticoagulants|anticoagulants|mesh-ancestor
6560091|NCT00942487|Nebivolol|nebivolol|mesh-list
6560092|NCT00942487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6560093|NCT00942487|Vasodilator Agents|vasodilator agents|mesh-ancestor
6560094|NCT00942487|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6560095|NCT00942487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6560096|NCT00942487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6560097|NCT00942487|Adrenergic Agents|adrenergic agents|mesh-ancestor
6560098|NCT00942487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6560099|NCT00942487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560100|NCT00942487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560101|NCT00942526|Nystatin|nystatin|mesh-list
6560102|NCT00942526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6560103|NCT00942526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6560104|NCT00942526|Antifungal Agents|antifungal agents|mesh-ancestor
6560105|NCT00942526|Ionophores|ionophores|mesh-ancestor
6560106|NCT00942526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6560107|NCT00942526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560108|NCT00942539|Midazolam|midazolam|mesh-list
6560109|NCT00942539|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6560110|NCT00942539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6560111|NCT00942539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6560112|NCT00942539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560113|NCT00942539|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6560114|NCT00942539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6560115|NCT00942539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6560116|NCT00942539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6560117|NCT00942539|Anesthetics, General|anesthetics, general|mesh-ancestor
6560118|NCT00942539|Anesthetics|anesthetics|mesh-ancestor
6560119|NCT00942539|GABA Modulators|gaba modulators|mesh-ancestor
6560120|NCT00942539|GABA Agents|gaba agents|mesh-ancestor
6560121|NCT00942539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6560122|NCT00942539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560123|NCT00942565|Acetaminophen|acetaminophen|mesh-list
6560124|NCT00942565|Tramadol|tramadol|mesh-list
6560125|NCT00942565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6560126|NCT00942565|Analgesics|analgesics|mesh-ancestor
6560127|NCT00942565|Sensory System Agents|sensory system agents|mesh-ancestor
6560128|NCT00942565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6560129|NCT00942565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560130|NCT00942565|Antipyretics|antipyretics|mesh-ancestor
6560131|NCT00942565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6560132|NCT00942565|Narcotics|narcotics|mesh-ancestor
6560133|NCT00942565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6560134|NCT00942591|Interferons|interferons|mesh-list
6560135|NCT00942591|Interferon-beta|interferon-beta|mesh-list
6560136|NCT00942591|Atorvastatin|atorvastatin|mesh-list
6560137|NCT00942591|Interferon beta-1b|interferon beta-1b|mesh-list
6560138|NCT00942591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6560139|NCT00942591|Antiviral Agents|antiviral agents|mesh-ancestor
6560140|NCT00942591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6560141|NCT00942591|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6560142|NCT00942591|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6560143|NCT00942591|Antimetabolites|antimetabolites|mesh-ancestor
6560144|NCT00942591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560145|NCT00942591|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6560146|NCT00942591|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6560147|NCT00942591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6560148|NCT00942591|Immunologic Factors|immunologic factors|mesh-ancestor
6560149|NCT00942591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560150|NCT00942591|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6560151|NCT00942617|Aspirin|aspirin|mesh-list
6560152|NCT00942617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6560153|NCT00942617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6560154|NCT00942617|Analgesics|analgesics|mesh-ancestor
6560155|NCT00942617|Sensory System Agents|sensory system agents|mesh-ancestor
6656909|NCT01472029|Protective Agents|protective agents|mesh-ancestor
6560156|NCT00942617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6560157|NCT00942617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560158|NCT00942617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6560159|NCT00942617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6560160|NCT00942617|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6560161|NCT00942617|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6560162|NCT00942617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560163|NCT00942617|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6560164|NCT00942617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6560165|NCT00942617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6560166|NCT00942617|Antipyretics|antipyretics|mesh-ancestor
6560167|NCT00942682|Sorafenib|sorafenib|mesh-list
6560168|NCT00942682|Everolimus|everolimus|mesh-list
6560169|NCT00942682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6560170|NCT00942682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6560171|NCT00942682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6560172|NCT00942682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560173|NCT00942682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6560174|NCT00942682|Immunologic Factors|immunologic factors|mesh-ancestor
6560175|NCT00942682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560176|NCT00942747|Sirolimus|sirolimus|mesh-list
6560177|NCT00942747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6560178|NCT00942747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6560179|NCT00942747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6560180|NCT00942747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6560181|NCT00942747|Antifungal Agents|antifungal agents|mesh-ancestor
6560182|NCT00942747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6560183|NCT00942747|Immunologic Factors|immunologic factors|mesh-ancestor
6560184|NCT00942747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560185|NCT00942773|Voriconazole|voriconazole|mesh-list
6560186|NCT00942773|Antifungal Agents|antifungal agents|mesh-ancestor
6560187|NCT00942773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6560188|NCT00942773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6560189|NCT00942773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6560190|NCT00942773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6560191|NCT00942773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560192|NCT00942773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6560193|NCT00942773|Hormone Antagonists|hormone antagonists|mesh-ancestor
6560194|NCT00942773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6560195|NCT00942773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560196|NCT00942773|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6560197|NCT00942838|Cisplatin|cisplatin|mesh-list
6560198|NCT00942838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6560199|NCT00942864|Ranibizumab|ranibizumab|mesh-list
6560200|NCT00942864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6560201|NCT00942864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6560202|NCT00942864|Growth Substances|growth substances|mesh-ancestor
6560203|NCT00942864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560204|NCT00942864|Growth Inhibitors|growth inhibitors|mesh-ancestor
6560205|NCT00942864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6560206|NCT00943059|Acipimox|acipimox|mesh-list
6560207|NCT00943059|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6560208|NCT00943059|Antimetabolites|antimetabolites|mesh-ancestor
6560209|NCT00943059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560210|NCT00943059|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6560211|NCT00943137|Fluorouracil|fluorouracil|mesh-list
6560212|NCT00943137|Antimetabolites|antimetabolites|mesh-ancestor
6560213|NCT00943137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560214|NCT00943137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6560215|NCT00943137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6560216|NCT00943137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6560217|NCT00943137|Immunologic Factors|immunologic factors|mesh-ancestor
6560218|NCT00943137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560219|NCT00943176|Modafinil|modafinil|mesh-list
6560220|NCT00943176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6560221|NCT00943176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560222|NCT00943176|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6560223|NCT00943176|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6560224|NCT00943176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6560225|NCT00943176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560226|NCT00943228|Mycophenolic Acid|mycophenolic acid|mesh-list
6560227|NCT00943228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6560228|NCT00943228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6560229|NCT00943228|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6560230|NCT00943228|Antitubercular Agents|antitubercular agents|mesh-ancestor
6560231|NCT00943228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6560232|NCT00943228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6560233|NCT00943228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6560234|NCT00943228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560235|NCT00943267|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
6560236|NCT00943267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6560237|NCT00943293|Fludarabine|fludarabine|mesh-list
6560238|NCT00943293|Melphalan|melphalan|mesh-list
6560239|NCT00943293|Alemtuzumab|alemtuzumab|mesh-list
6560240|NCT00943293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6560241|NCT00943293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560242|NCT00943293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6560243|NCT00943293|Immunologic Factors|immunologic factors|mesh-ancestor
6560244|NCT00943293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560245|NCT00943293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6560246|NCT00943293|Alkylating Agents|alkylating agents|mesh-ancestor
6560247|NCT00943293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6560248|NCT00943293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6560249|NCT00943345|Indomethacin|indomethacin|mesh-list
6560250|NCT00943345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6560251|NCT00943345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6560252|NCT00943345|Analgesics|analgesics|mesh-ancestor
6560253|NCT00943345|Sensory System Agents|sensory system agents|mesh-ancestor
6560254|NCT00943345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6560255|NCT00943345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560256|NCT00943345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6560257|NCT00943345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6560258|NCT00943345|Gout Suppressants|gout suppressants|mesh-ancestor
6560259|NCT00943345|Tocolytic Agents|tocolytic agents|mesh-ancestor
6560260|NCT00943345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6560261|NCT00943345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6560262|NCT00943345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6560263|NCT00943345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560264|NCT00943358|Vaccines|vaccines|mesh-list
6560265|NCT00943358|Immunologic Factors|immunologic factors|mesh-ancestor
6560266|NCT00943358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560267|NCT00943410|Trastuzumab|trastuzumab|mesh-list
6560268|NCT00943410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6560269|NCT00943410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6560270|NCT00943449|Sorafenib|sorafenib|mesh-list
6560271|NCT00943449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6560272|NCT00943449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6560273|NCT00943449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6560274|NCT00943449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560275|NCT00943462|Temozolomide|temozolomide|mesh-list
6560276|NCT00943462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6560277|NCT00943462|Alkylating Agents|alkylating agents|mesh-ancestor
6560278|NCT00943462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560279|NCT00943462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6560280|NCT00943501|Liraglutide|liraglutide|mesh-list
6560281|NCT00943501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6560282|NCT00943501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560283|NCT00943501|Incretins|incretins|mesh-ancestor
6560284|NCT00943501|Hormones|hormones|mesh-ancestor
6560285|NCT00943501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6560286|NCT00943540|Lamivudine|lamivudine|mesh-list
6560287|NCT00943540|Emtricitabine|emtricitabine|mesh-list
6560288|NCT00943540|Raltegravir Potassium|raltegravir potassium|mesh-list
6560289|NCT00943540|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6560290|NCT00943540|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6560291|NCT00943540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6560292|NCT00943540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6560293|NCT00943540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560294|NCT00943540|Antiviral Agents|antiviral agents|mesh-ancestor
6560295|NCT00943540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6560296|NCT00943540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6560297|NCT00943540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6560298|NCT00943540|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6560299|NCT00943540|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6560300|NCT00943540|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6560301|NCT00943540|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6560302|NCT00943540|Protease Inhibitors|protease inhibitors|mesh-ancestor
6560303|NCT00943553|Decitabine|decitabine|mesh-list
6560304|NCT00943553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6560305|NCT00943553|Antimetabolites|antimetabolites|mesh-ancestor
6560306|NCT00943553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560307|NCT00943553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6560308|NCT00943553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6560309|NCT00943566|Sufentanil|sufentanil|mesh-list
6560310|NCT00943566|Morphine|morphine|mesh-list
6560311|NCT00943566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6560312|NCT00943566|Narcotics|narcotics|mesh-ancestor
6560313|NCT00943566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6560314|NCT00943566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560315|NCT00943566|Analgesics|analgesics|mesh-ancestor
6560316|NCT00943566|Sensory System Agents|sensory system agents|mesh-ancestor
6560317|NCT00943566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6560318|NCT00943566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6560319|NCT00943566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6560320|NCT00943566|Anesthetics, General|anesthetics, general|mesh-ancestor
6560321|NCT00943566|Anesthetics|anesthetics|mesh-ancestor
6560322|NCT00943709|Insulin|insulin|mesh-list
6560323|NCT00943709|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6560324|NCT00943709|Insulin Glargine|insulin glargine|mesh-list
6444008|NCT00382083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6444009|NCT00382083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444010|NCT00382083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6444011|NCT00382083|Analgesics|analgesics|mesh-ancestor
6444012|NCT00382083|Antipyretics|antipyretics|mesh-ancestor
6444013|NCT00382083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6444014|NCT00382083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6444015|NCT00382083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6444016|NCT00382083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6444017|NCT00382083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6444018|NCT00382135|Tadalafil|tadalafil|mesh-list
6444019|NCT00382135|Vasodilator Agents|vasodilator agents|mesh-ancestor
6444020|NCT00382135|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6560325|NCT00943709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6560326|NCT00943709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560327|NCT00943748|Deferiprone|deferiprone|mesh-list
6560328|NCT00943748|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6560329|NCT00943748|Chelating Agents|chelating agents|mesh-ancestor
6560330|NCT00943748|Sequestering Agents|sequestering agents|mesh-ancestor
6560331|NCT00943748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560332|NCT00943839|Sunitinib|sunitinib|mesh-list
6560333|NCT00943839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6560334|NCT00943839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6560335|NCT00943839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6560336|NCT00943839|Growth Substances|growth substances|mesh-ancestor
6560337|NCT00943839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560338|NCT00943839|Growth Inhibitors|growth inhibitors|mesh-ancestor
6560339|NCT00943839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6560340|NCT00943839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6560341|NCT00943839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560342|NCT00943930|Dronabinol|dronabinol|mesh-list
6560343|NCT00943930|Amphetamine|amphetamine|mesh-list
6560344|NCT00943930|Dextroamphetamine|dextroamphetamine|mesh-list
6560345|NCT00943930|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6560346|NCT00943930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560347|NCT00943930|Sympathomimetics|sympathomimetics|mesh-ancestor
6560348|NCT00943930|Autonomic Agents|autonomic agents|mesh-ancestor
6560349|NCT00943930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6560350|NCT00943930|Dopamine Agents|dopamine agents|mesh-ancestor
6560351|NCT00943930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6560352|NCT00943930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560353|NCT00943930|Adrenergic Agents|adrenergic agents|mesh-ancestor
6560354|NCT00943930|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6560355|NCT00943930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6560356|NCT00943930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6560357|NCT00943930|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6560358|NCT00943930|Hallucinogens|hallucinogens|mesh-ancestor
6560359|NCT00943930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6560360|NCT00943930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6560361|NCT00943930|Analgesics|analgesics|mesh-ancestor
6560362|NCT00943930|Sensory System Agents|sensory system agents|mesh-ancestor
6560363|NCT00943930|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6560364|NCT00943930|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6560365|NCT00943930|Hormones|hormones|mesh-ancestor
6560366|NCT00943930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6560367|NCT00943943|Plerixafor|plerixafor|mesh-list
6560368|NCT00943943|Sorafenib|sorafenib|mesh-list
6560369|NCT00943943|Lenograstim|lenograstim|mesh-list
6560370|NCT00943943|Sargramostim|sargramostim|mesh-list
6560371|NCT00943943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6560372|NCT00943943|Immunologic Factors|immunologic factors|mesh-ancestor
6560373|NCT00943943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560374|NCT00943943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6560375|NCT00943943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6560376|NCT00943943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6560377|NCT00943943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560378|NCT00943943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6560379|NCT00943943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6560380|NCT00943943|Antiviral Agents|antiviral agents|mesh-ancestor
6560381|NCT00943943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6560382|NCT00943956|Everolimus|everolimus|mesh-list
6560383|NCT00943956|Leuprolide|leuprolide|mesh-list
6560384|NCT00943956|Bicalutamide|bicalutamide|mesh-list
6560385|NCT00943956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6560386|NCT00943956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6560387|NCT00943956|Immunologic Factors|immunologic factors|mesh-ancestor
6560388|NCT00943956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560389|NCT00943956|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6444021|NCT00382135|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6444022|NCT00382135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6444023|NCT00382135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444024|NCT00382135|Urological Agents|urological agents|mesh-ancestor
6444025|NCT00382200|Decitabine|decitabine|mesh-list
6444026|NCT00382200|Tretinoin|tretinoin|mesh-list
6444027|NCT00382200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6444028|NCT00382200|Antimetabolites|antimetabolites|mesh-ancestor
6444029|NCT00382200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444030|NCT00382200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6444031|NCT00382200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6444032|NCT00382200|Keratolytic Agents|keratolytic agents|mesh-ancestor
6444033|NCT00382200|Dermatologic Agents|dermatologic agents|mesh-ancestor
6444034|NCT00382213|Olmesartan|olmesartan|mesh-list
6444035|NCT00382213|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6444036|NCT00382213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6444037|NCT00382213|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6444038|NCT00382213|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6560390|NCT00943956|Fertility Agents|fertility agents|mesh-ancestor
6560391|NCT00943956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6560392|NCT00943956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6560393|NCT00943956|Androgen Antagonists|androgen antagonists|mesh-ancestor
6560394|NCT00943956|Hormone Antagonists|hormone antagonists|mesh-ancestor
6560395|NCT00943956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6560396|NCT00943982|Interferons|interferons|mesh-list
6560397|NCT00943982|Interferon-gamma|interferon-gamma|mesh-list
6560398|NCT00943982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6560399|NCT00943982|Antiviral Agents|antiviral agents|mesh-ancestor
6560400|NCT00943982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6560401|NCT00944177|Metformin|metformin|mesh-list
6560402|NCT00944177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6560403|NCT00944177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560404|NCT00944242|Sertraline|sertraline|mesh-list
6560405|NCT00944242|Antidepressive Agents|antidepressive agents|mesh-ancestor
6560406|NCT00944242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6560407|NCT00944242|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6560408|NCT00944242|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6560409|NCT00944242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6560410|NCT00944242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560411|NCT00944242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6560412|NCT00944242|Serotonin Agents|serotonin agents|mesh-ancestor
6560413|NCT00944242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560414|NCT00944307|Raltegravir Potassium|raltegravir potassium|mesh-list
6560415|NCT00944307|Antacids|antacids|mesh-list
6560416|NCT00944307|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
6560417|NCT00944307|TEMPO|tempo|mesh-list
6560418|NCT00944307|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6560419|NCT00944307|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6560420|NCT00944307|Antiviral Agents|antiviral agents|mesh-ancestor
6560421|NCT00944307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6560422|NCT00944307|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6560423|NCT00944307|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6560424|NCT00944307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6560425|NCT00944307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560426|NCT00944307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6560427|NCT00944307|Antioxidants|antioxidants|mesh-ancestor
6560428|NCT00944307|Protective Agents|protective agents|mesh-ancestor
6560429|NCT00944307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560430|NCT00944333|Clopidogrel|clopidogrel|mesh-list
6560431|NCT00944333|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6560432|NCT00944333|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6560433|NCT00944333|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6560434|NCT00944333|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6560435|NCT00944333|Purinergic Agents|purinergic agents|mesh-ancestor
6560436|NCT00944333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6560437|NCT00944333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560438|NCT00944333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560439|NCT00944346|Metformin|metformin|mesh-list
6560440|NCT00944346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6560441|NCT00944346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560442|NCT00944359|Zinc|zinc|mesh-list
6560443|NCT00944359|Trace Elements|trace elements|mesh-ancestor
6560444|NCT00944359|Micronutrients|micronutrients|mesh-ancestor
6560445|NCT00944359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656910|NCT01472029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656911|NCT01472029|Vitamin B Complex|vitamin b complex|mesh-ancestor
6656912|NCT01472029|Vitamins|vitamins|mesh-ancestor
6656913|NCT01472029|Micronutrients|micronutrients|mesh-ancestor
6656914|NCT01472055|Fludarabine|fludarabine|mesh-list
6656915|NCT01472055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6656916|NCT01472146|Doxorubicin|doxorubicin|mesh-list
6656917|NCT01472146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6656918|NCT01472146|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6560446|NCT00944385|Urinastatin|urinastatin|mesh-list
6560447|NCT00944385|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6560448|NCT00944385|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6560449|NCT00944385|Protease Inhibitors|protease inhibitors|mesh-ancestor
6560450|NCT00944385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6560451|NCT00944385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560452|NCT00944398|Vitamins|vitamins|mesh-list
6560453|NCT00944398|Zinc|zinc|mesh-list
6560454|NCT00944398|Vitamin B Complex|vitamin b complex|mesh-list
6560455|NCT00944398|Zinc Sulfate|zinc sulfate|mesh-list
6560456|NCT00944398|Micronutrients|micronutrients|mesh-ancestor
6560457|NCT00944398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560458|NCT00944398|Trace Elements|trace elements|mesh-ancestor
6560459|NCT00944398|Astringents|astringents|mesh-ancestor
6560460|NCT00944398|Dermatologic Agents|dermatologic agents|mesh-ancestor
6560461|NCT00944424|Vitamin D|vitamin d|mesh-list
6560462|NCT00944424|Ergocalciferols|ergocalciferols|mesh-list
6560463|NCT00944424|Vitamins|vitamins|mesh-list
6560464|NCT00944424|Docetaxel|docetaxel|mesh-list
6560465|NCT00944424|Micronutrients|micronutrients|mesh-ancestor
6560466|NCT00944424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560467|NCT00944424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6560468|NCT00944424|Tubulin Modulators|tubulin modulators|mesh-ancestor
6560469|NCT00944424|Antimitotic Agents|antimitotic agents|mesh-ancestor
6560470|NCT00944424|Mitosis Modulators|mitosis modulators|mesh-ancestor
6560471|NCT00944424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560472|NCT00944424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6560473|NCT00944424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6560474|NCT00944463|Gemcitabine|gemcitabine|mesh-list
6560475|NCT00944463|Simvastatin|simvastatin|mesh-list
6560476|NCT00944463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6560477|NCT00944463|Antimetabolites|antimetabolites|mesh-ancestor
6560478|NCT00944463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560479|NCT00944463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6560480|NCT00944463|Antiviral Agents|antiviral agents|mesh-ancestor
6560481|NCT00944463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6560482|NCT00944463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6560483|NCT00944463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6560484|NCT00944463|Immunologic Factors|immunologic factors|mesh-ancestor
6560485|NCT00944463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560486|NCT00944463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6560487|NCT00944463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6560488|NCT00944463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6560489|NCT00944463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6560490|NCT00944502|Dexamethasone|dexamethasone|mesh-list
6560491|NCT00944502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6560492|NCT00944502|Antiemetics|antiemetics|mesh-ancestor
6560493|NCT00944502|Autonomic Agents|autonomic agents|mesh-ancestor
6560494|NCT00944502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6560495|NCT00944502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560496|NCT00944502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6560497|NCT00944502|Glucocorticoids|glucocorticoids|mesh-ancestor
6560498|NCT00944502|Hormones|hormones|mesh-ancestor
6560499|NCT00944502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6560500|NCT00944502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6560501|NCT00944502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6560502|NCT00944515|Azithromycin|azithromycin|mesh-list
6560503|NCT00944515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6560504|NCT00944515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6560505|NCT00944541|Maraviroc|maraviroc|mesh-list
6560506|NCT00944541|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6560507|NCT00944541|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6560508|NCT00944541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560509|NCT00944541|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6560510|NCT00944541|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6560511|NCT00944541|Antiviral Agents|antiviral agents|mesh-ancestor
6560512|NCT00944541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6560513|NCT00944541|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6560514|NCT00944606|Vitamin D|vitamin d|mesh-list
6560515|NCT00944606|Vitamins|vitamins|mesh-ancestor
6560516|NCT00944606|Micronutrients|micronutrients|mesh-ancestor
6560517|NCT00944606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560518|NCT00944606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6560519|NCT00944619|Insulin|insulin|mesh-list
6560520|NCT00944619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6560521|NCT00944619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560522|NCT00944684|Ribavirin|ribavirin|mesh-list
6560523|NCT00944684|Antimetabolites|antimetabolites|mesh-ancestor
6560524|NCT00944684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560525|NCT00944684|Antiviral Agents|antiviral agents|mesh-ancestor
6560526|NCT00944684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6560527|NCT00944723|Vitamins|vitamins|mesh-list
6560528|NCT00944723|Zinc|zinc|mesh-list
6560529|NCT00944723|Vitamin B Complex|vitamin b complex|mesh-list
6560530|NCT00944723|Zinc Sulfate|zinc sulfate|mesh-list
6560531|NCT00944723|Micronutrients|micronutrients|mesh-ancestor
6560532|NCT00944723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560533|NCT00944723|Trace Elements|trace elements|mesh-ancestor
6560534|NCT00944723|Astringents|astringents|mesh-ancestor
6560535|NCT00944723|Dermatologic Agents|dermatologic agents|mesh-ancestor
6560536|NCT00944801|Doxorubicin|doxorubicin|mesh-list
6560537|NCT00944801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6560538|NCT00944801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6560539|NCT00944801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6560540|NCT00944801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6560541|NCT00944801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6560542|NCT00944801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6560543|NCT00944801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560544|NCT00944814|Zinc|zinc|mesh-list
6560545|NCT00944814|Trace Elements|trace elements|mesh-ancestor
6560546|NCT00944814|Micronutrients|micronutrients|mesh-ancestor
6560547|NCT00944814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560548|NCT00944840|Amodiaquine|amodiaquine|mesh-list
6560549|NCT00944840|Antimalarials|antimalarials|mesh-ancestor
6560550|NCT00944840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6560551|NCT00944840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6560552|NCT00944840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6560553|NCT00944853|Zinc|zinc|mesh-list
6560554|NCT00944853|Trace Elements|trace elements|mesh-ancestor
6560555|NCT00944853|Micronutrients|micronutrients|mesh-ancestor
6560556|NCT00944853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560557|NCT00944918|Fulvestrant|fulvestrant|mesh-list
6560558|NCT00944918|Anastrozole|anastrozole|mesh-list
6560559|NCT00944918|Exemestane|exemestane|mesh-list
6560560|NCT00944918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6560561|NCT00944918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6560562|NCT00944918|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6560563|NCT00944918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6560564|NCT00944918|Hormone Antagonists|hormone antagonists|mesh-ancestor
6560565|NCT00944918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6560566|NCT00944918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560567|NCT00944918|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6560568|NCT00944918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6560569|NCT00944918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6560570|NCT00944918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560571|NCT00944957|Efavirenz|efavirenz|mesh-list
6560572|NCT00944957|Raltegravir Potassium|raltegravir potassium|mesh-list
6560573|NCT00944957|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6560574|NCT00944957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6560575|NCT00944957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6560576|NCT00944957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560577|NCT00944957|Antiviral Agents|antiviral agents|mesh-ancestor
6560578|NCT00944957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6560579|NCT00944957|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6560580|NCT00944957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6560581|NCT00944957|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6560582|NCT00944957|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6560583|NCT00944957|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6560584|NCT00944957|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6560585|NCT00944957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6560586|NCT00944957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6560587|NCT00944957|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6560588|NCT00944957|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6560589|NCT00944996|Citalopram|citalopram|mesh-list
6560590|NCT00944996|Fluoxetine|fluoxetine|mesh-list
6560591|NCT00944996|Paroxetine|paroxetine|mesh-list
6560592|NCT00944996|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6560593|NCT00944996|Sertraline|sertraline|mesh-list
6560594|NCT00944996|Clomipramine|clomipramine|mesh-list
6560595|NCT00944996|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6560596|NCT00944996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6560597|NCT00944996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6560598|NCT00944996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560599|NCT00944996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6560600|NCT00944996|Serotonin Agents|serotonin agents|mesh-ancestor
6560601|NCT00944996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560602|NCT00944996|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6560603|NCT00944996|Antidepressive Agents|antidepressive agents|mesh-ancestor
6560604|NCT00944996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6560605|NCT00944996|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6560606|NCT00944996|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6560607|NCT00944996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6560608|NCT00944996|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6560609|NCT00944996|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6560610|NCT00945022|Anesthetics|anesthetics|mesh-list
6560611|NCT00945022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6560612|NCT00945022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560613|NCT00945152|Vancomycin|vancomycin|mesh-list
6560614|NCT00945152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6560615|NCT00945152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6560616|NCT00945178|Naproxen|naproxen|mesh-list
6560617|NCT00945178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6560618|NCT00945178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6560619|NCT00945178|Analgesics|analgesics|mesh-ancestor
6560620|NCT00945178|Sensory System Agents|sensory system agents|mesh-ancestor
6560621|NCT00945178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6560622|NCT00945178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560623|NCT00945178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6560624|NCT00945178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6560625|NCT00945178|Gout Suppressants|gout suppressants|mesh-ancestor
6560626|NCT00945178|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6560627|NCT00945178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6560628|NCT00945178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560629|NCT00945308|Eptifibatide|eptifibatide|mesh-list
6560630|NCT00945308|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6560631|NCT00945347|Miglustat|miglustat|mesh-list
6560632|NCT00945347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6560633|NCT00945347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560634|NCT00945347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6560635|NCT00945347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6560636|NCT00945347|Antiviral Agents|antiviral agents|mesh-ancestor
6560637|NCT00945347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6560638|NCT00945347|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6560639|NCT00945347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6560640|NCT00945347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560641|NCT00945360|Letrozole|letrozole|mesh-list
6560642|NCT00945360|Aromatase Inhibitors|aromatase inhibitors|mesh-list
6560643|NCT00945360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6560644|NCT00945360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6560645|NCT00945360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6560646|NCT00945360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560647|NCT00945360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6560648|NCT00945360|Hormone Antagonists|hormone antagonists|mesh-ancestor
6560649|NCT00945360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6560650|NCT00945360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560651|NCT00945373|Calcium Dobesilate|calcium dobesilate|mesh-list
6560652|NCT00945373|Calcium|calcium|mesh-list
6560653|NCT00945373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6560654|NCT00945373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560655|NCT00945373|Hemostatics|hemostatics|mesh-ancestor
6560656|NCT00945373|Coagulants|coagulants|mesh-ancestor
6560657|NCT00945438|Vaccines|vaccines|mesh-list
6560658|NCT00945438|Immunologic Factors|immunologic factors|mesh-ancestor
6560659|NCT00945438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560660|NCT00945529|Nitric Oxide|nitric oxide|mesh-list
6560661|NCT00945529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6560662|NCT00945529|Autonomic Agents|autonomic agents|mesh-ancestor
6560663|NCT00945529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6560664|NCT00945529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560665|NCT00945529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6560666|NCT00945529|Respiratory System Agents|respiratory system agents|mesh-ancestor
6560667|NCT00945529|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6560668|NCT00945529|Antioxidants|antioxidants|mesh-ancestor
6560669|NCT00945529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560670|NCT00945529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6560671|NCT00945529|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6560672|NCT00945529|Vasodilator Agents|vasodilator agents|mesh-ancestor
6560673|NCT00945529|Gasotransmitters|gasotransmitters|mesh-ancestor
6560674|NCT00945529|Protective Agents|protective agents|mesh-ancestor
6560675|NCT00945542|Hemostatics|hemostatics|mesh-list
6560676|NCT00945542|Coagulants|coagulants|mesh-ancestor
6560677|NCT00945620|Ropivacaine|ropivacaine|mesh-list
6560678|NCT00945620|Anesthetics, Local|anesthetics, local|mesh-ancestor
6560679|NCT00945620|Anesthetics|anesthetics|mesh-ancestor
6560680|NCT00945620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6560681|NCT00945620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560682|NCT00945620|Sensory System Agents|sensory system agents|mesh-ancestor
6560683|NCT00945620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6560684|NCT00945724|Cytarabine|cytarabine|mesh-list
6560685|NCT00945724|Prednisolone|prednisolone|mesh-list
6560686|NCT00945724|Cyclophosphamide|cyclophosphamide|mesh-list
6560687|NCT00945724|Rituximab|rituximab|mesh-list
6560688|NCT00945724|Doxorubicin|doxorubicin|mesh-list
6560689|NCT00945724|Methotrexate|methotrexate|mesh-list
6560690|NCT00945724|Vincristine|vincristine|mesh-list
6560691|NCT00945724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6560692|NCT00945724|Immunologic Factors|immunologic factors|mesh-ancestor
6560693|NCT00945724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560694|NCT00945724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6560695|NCT00945724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6560696|NCT00945724|Alkylating Agents|alkylating agents|mesh-ancestor
6560697|NCT00945724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560698|NCT00945724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6560699|NCT00945724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6560700|NCT00945724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6560701|NCT00945724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6560702|NCT00945724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6560703|NCT00945724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6560704|NCT00945724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6560705|NCT00945724|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6560706|NCT00945724|Abortifacient Agents|abortifacient agents|mesh-ancestor
6560707|NCT00945724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6560708|NCT00945724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6560709|NCT00945724|Antimetabolites|antimetabolites|mesh-ancestor
6560710|NCT00945724|Dermatologic Agents|dermatologic agents|mesh-ancestor
6560711|NCT00945724|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6560712|NCT00945724|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6560713|NCT00945724|Antiviral Agents|antiviral agents|mesh-ancestor
6560714|NCT00945724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6560715|NCT00945724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6560716|NCT00945724|Tubulin Modulators|tubulin modulators|mesh-ancestor
6560717|NCT00945724|Antimitotic Agents|antimitotic agents|mesh-ancestor
6560718|NCT00945724|Mitosis Modulators|mitosis modulators|mesh-ancestor
6560719|NCT00945724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6560720|NCT00945724|Glucocorticoids|glucocorticoids|mesh-ancestor
6560721|NCT00945724|Hormones|hormones|mesh-ancestor
6560722|NCT00945724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6560723|NCT00945724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6560724|NCT00945789|Nitric Oxide|nitric oxide|mesh-list
6560725|NCT00945789|Epoetin Alfa|epoetin alfa|mesh-list
6560726|NCT00945789|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6560727|NCT00945789|Autonomic Agents|autonomic agents|mesh-ancestor
5724779|NCT03185143|Antipyretics|antipyretics|mesh-ancestor
6560728|NCT00945789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6560729|NCT00945789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560730|NCT00945789|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6560731|NCT00945789|Respiratory System Agents|respiratory system agents|mesh-ancestor
6560732|NCT00945789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6560733|NCT00945789|Antioxidants|antioxidants|mesh-ancestor
6560734|NCT00945789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560735|NCT00945789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6560736|NCT00945789|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6560737|NCT00945789|Vasodilator Agents|vasodilator agents|mesh-ancestor
6560738|NCT00945789|Gasotransmitters|gasotransmitters|mesh-ancestor
6560739|NCT00945789|Protective Agents|protective agents|mesh-ancestor
6560740|NCT00945789|Hematinics|hematinics|mesh-ancestor
6560741|NCT00945919|Oxymorphone|oxymorphone|mesh-list
6560742|NCT00945919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6560743|NCT00945919|Narcotics|narcotics|mesh-ancestor
6560744|NCT00945919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6560745|NCT00945919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560746|NCT00945919|Analgesics|analgesics|mesh-ancestor
6560747|NCT00945919|Sensory System Agents|sensory system agents|mesh-ancestor
6560748|NCT00945919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6560749|NCT00945919|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6560750|NCT00945997|Misoprostol|misoprostol|mesh-list
6560751|NCT00945997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6560752|NCT00945997|Abortifacient Agents|abortifacient agents|mesh-ancestor
6560753|NCT00945997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6560754|NCT00945997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560755|NCT00945997|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6560756|NCT00945997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6560757|NCT00945997|Oxytocics|oxytocics|mesh-ancestor
6560758|NCT00946036|Sertraline|sertraline|mesh-list
6560759|NCT00946036|Antidepressive Agents|antidepressive agents|mesh-ancestor
6560760|NCT00946036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6560761|NCT00946036|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6560762|NCT00946036|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6560763|NCT00946036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6560764|NCT00946036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560765|NCT00946036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6560766|NCT00946036|Serotonin Agents|serotonin agents|mesh-ancestor
6560767|NCT00946036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560768|NCT00946166|Simvastatin|simvastatin|mesh-list
6560769|NCT00946166|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6560770|NCT00946166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6560771|NCT00946166|Antimetabolites|antimetabolites|mesh-ancestor
6560772|NCT00946166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560773|NCT00946166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6560774|NCT00946166|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6560775|NCT00946166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6560776|NCT00946179|Vaccines|vaccines|mesh-list
6560777|NCT00946179|Immunologic Factors|immunologic factors|mesh-ancestor
6560778|NCT00946179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656919|NCT01472146|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6656920|NCT01472146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6656921|NCT01472146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6656922|NCT01472146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656923|NCT01472263|Pentoxifylline|pentoxifylline|mesh-list
6560779|NCT00946335|Temozolomide|temozolomide|mesh-list
6560780|NCT00946335|Veliparib|veliparib|mesh-list
6560781|NCT00946335|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6560782|NCT00946335|Alkylating Agents|alkylating agents|mesh-ancestor
6560783|NCT00946335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560784|NCT00946335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6560785|NCT00946335|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6560786|NCT00946335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6560787|NCT00946374|Cyclosporine|cyclosporine|mesh-list
6560788|NCT00946374|Doxorubicin|doxorubicin|mesh-list
6560789|NCT00946374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6560790|NCT00946374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6560791|NCT00946374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6560792|NCT00946374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6444039|NCT00382213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444040|NCT00382239|Exenatide|exenatide|mesh-list
6560793|NCT00946374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6560794|NCT00946374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560795|NCT00946374|Immunologic Factors|immunologic factors|mesh-ancestor
6560796|NCT00946374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560797|NCT00946374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6560798|NCT00946374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6560799|NCT00946374|Antifungal Agents|antifungal agents|mesh-ancestor
6560800|NCT00946374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6444041|NCT00382239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6444042|NCT00382239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444043|NCT00382239|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6444044|NCT00382239|Incretins|incretins|mesh-ancestor
6560801|NCT00946374|Dermatologic Agents|dermatologic agents|mesh-ancestor
6560802|NCT00946374|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6560803|NCT00946387|Ondansetron|ondansetron|mesh-list
6444045|NCT00382239|Hormones|hormones|mesh-ancestor
6444046|NCT00382239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6444047|NCT00382330|Ciclopirox|ciclopirox|mesh-list
6444048|NCT00382330|Antifungal Agents|antifungal agents|mesh-ancestor
6444049|NCT00382330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6444050|NCT00382343|Trimethoprim|trimethoprim|mesh-list
6444051|NCT00382343|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6560804|NCT00946387|Antiemetics|antiemetics|mesh-ancestor
6560805|NCT00946387|Autonomic Agents|autonomic agents|mesh-ancestor
6560806|NCT00946387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6560807|NCT00946387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560808|NCT00946387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6560809|NCT00946387|Antipruritics|antipruritics|mesh-ancestor
6560810|NCT00946387|Dermatologic Agents|dermatologic agents|mesh-ancestor
6444052|NCT00382343|Sulfamethoxazole|sulfamethoxazole|mesh-list
6444053|NCT00382343|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6444054|NCT00382343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6444055|NCT00382343|Renal Agents|renal agents|mesh-ancestor
6444056|NCT00382343|Antimalarials|antimalarials|mesh-ancestor
6444057|NCT00382343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6444058|NCT00382343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6444059|NCT00382343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6560811|NCT00946387|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6560812|NCT00946387|Serotonin Agents|serotonin agents|mesh-ancestor
6560813|NCT00946387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6560814|NCT00946387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560815|NCT00946387|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6560816|NCT00946387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6560817|NCT00946387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6560818|NCT00946387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6560819|NCT00946387|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6560820|NCT00946465|Ramipril|ramipril|mesh-list
6560821|NCT00946465|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6560822|NCT00946465|Protease Inhibitors|protease inhibitors|mesh-ancestor
6560823|NCT00946465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5501413|NCT04474327|Respiratory System Agents|respiratory system agents|mesh-ancestor
5501414|NCT04474327|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5501415|NCT04474327|Hormone Antagonists|hormone antagonists|mesh-ancestor
5501416|NCT04474327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5501417|NCT04474327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501418|NCT04474327|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5501419|NCT04474327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6444060|NCT00382343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6560824|NCT00946465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560825|NCT00946465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6560826|NCT00946491|Haloperidol|haloperidol|mesh-list
6560827|NCT00946491|Haloperidol decanoate|haloperidol decanoate|mesh-list
6560828|NCT00946491|Antiemetics|antiemetics|mesh-ancestor
6560829|NCT00946491|Autonomic Agents|autonomic agents|mesh-ancestor
6560830|NCT00946491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6560831|NCT00946491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560832|NCT00946491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6560833|NCT00946491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6560834|NCT00946491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6560835|NCT00946491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6560836|NCT00946491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6560837|NCT00946491|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6560838|NCT00946491|Dopamine Agents|dopamine agents|mesh-ancestor
6560839|NCT00946491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6560840|NCT00946491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560841|NCT00946491|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6560842|NCT00946504|Glipizide|glipizide|mesh-list
6560843|NCT00946504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6560844|NCT00946504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560845|NCT00946556|Valacyclovir|valacyclovir|mesh-list
6560846|NCT00946556|Antiviral Agents|antiviral agents|mesh-ancestor
6560847|NCT00946556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6560848|NCT00946595|Ritonavir|ritonavir|mesh-list
6560849|NCT00946595|Lopinavir|lopinavir|mesh-list
6444061|NCT00382343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560850|NCT00946595|Tenofovir|tenofovir|mesh-list
6560851|NCT00946595|Efavirenz|efavirenz|mesh-list
6560852|NCT00946595|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6560853|NCT00946595|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6560854|NCT00946595|Protease Inhibitors|protease inhibitors|mesh-ancestor
6560855|NCT00946595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6560856|NCT00946595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560857|NCT00946595|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6560858|NCT00946595|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6560859|NCT00946595|Antiviral Agents|antiviral agents|mesh-ancestor
6560860|NCT00946595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6560861|NCT00946595|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6560862|NCT00946595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6560863|NCT00946595|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6560864|NCT00946595|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6560865|NCT00946595|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6560866|NCT00946595|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6560867|NCT00946595|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6560868|NCT00946595|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6560869|NCT00946595|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6560870|NCT00946608|Loratadine|loratadine|mesh-list
6560871|NCT00946608|Antipruritics|antipruritics|mesh-ancestor
6560872|NCT00946608|Dermatologic Agents|dermatologic agents|mesh-ancestor
6560873|NCT00946608|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6560874|NCT00946608|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6444062|NCT00382343|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6444063|NCT00382343|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6444064|NCT00382343|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6444065|NCT00382343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6444066|NCT00382356|Dutasteride|dutasteride|mesh-list
6444067|NCT00382356|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6444068|NCT00382356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6444069|NCT00382356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6444070|NCT00382356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444071|NCT00382356|Hormone Antagonists|hormone antagonists|mesh-ancestor
6444072|NCT00382356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6560875|NCT00946608|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6560876|NCT00946608|Histamine Antagonists|histamine antagonists|mesh-ancestor
6560877|NCT00946608|Histamine Agents|histamine agents|mesh-ancestor
6560878|NCT00946608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6560879|NCT00946608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560880|NCT00946608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560881|NCT00946621|Ramipril|ramipril|mesh-list
6560882|NCT00946621|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6560883|NCT00946621|Protease Inhibitors|protease inhibitors|mesh-ancestor
6560884|NCT00946621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6560885|NCT00946621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560886|NCT00946621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6560887|NCT00946673|Vorinostat|vorinostat|mesh-list
6560888|NCT00946673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6560889|NCT00946673|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6560890|NCT00946673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6560891|NCT00946673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560892|NCT00946686|Leflunomide|leflunomide|mesh-list
6560893|NCT00946686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6560894|NCT00946686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560895|NCT00946686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6560896|NCT00946686|Immunologic Factors|immunologic factors|mesh-ancestor
6560897|NCT00946686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560898|NCT00946725|Atenolol|atenolol|mesh-list
6560899|NCT00946725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6560900|NCT00946725|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6560901|NCT00946725|Sympatholytics|sympatholytics|mesh-ancestor
6560902|NCT00946725|Autonomic Agents|autonomic agents|mesh-ancestor
6560903|NCT00946725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6560904|NCT00946725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560905|NCT00946725|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6560906|NCT00946725|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6560907|NCT00946725|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6560908|NCT00946725|Adrenergic Agents|adrenergic agents|mesh-ancestor
6560909|NCT00946725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6560910|NCT00946725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560911|NCT00946751|Levetiracetam|levetiracetam|mesh-list
6560912|NCT00946751|Anticonvulsants|anticonvulsants|mesh-ancestor
6560913|NCT00946751|Nootropic Agents|nootropic agents|mesh-ancestor
6560914|NCT00946764|Imipramine|imipramine|mesh-list
6560915|NCT00946764|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6560916|NCT00946764|Antidepressive Agents|antidepressive agents|mesh-ancestor
6560917|NCT00946764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6560918|NCT00946764|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6560919|NCT00946764|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6560920|NCT00946764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6560921|NCT00946764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560922|NCT00946764|Adrenergic Agents|adrenergic agents|mesh-ancestor
6560923|NCT00946764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6560924|NCT00946764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560925|NCT00946790|Hydroxychloroquine|hydroxychloroquine|mesh-list
6560926|NCT00946790|Antimalarials|antimalarials|mesh-ancestor
6560927|NCT00946790|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6560928|NCT00946790|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6560929|NCT00946790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6560930|NCT00946790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6560931|NCT00946790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560932|NCT00946790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6560933|NCT00946829|Telmisartan|telmisartan|mesh-list
6560934|NCT00946829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6560935|NCT00946829|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6560936|NCT00946829|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6560937|NCT00946829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560938|NCT00946907|Aspirin|aspirin|mesh-list
6560939|NCT00946907|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6560940|NCT00946907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6560941|NCT00946907|Analgesics|analgesics|mesh-ancestor
6560942|NCT00946907|Sensory System Agents|sensory system agents|mesh-ancestor
6560943|NCT00946907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6560944|NCT00946907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560945|NCT00946907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6560946|NCT00946907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6560947|NCT00946907|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6560948|NCT00946907|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6560949|NCT00946907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560950|NCT00946907|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6560951|NCT00946907|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6560952|NCT00946907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6560953|NCT00946907|Antipyretics|antipyretics|mesh-ancestor
6560954|NCT00946946|Mesalamine|mesalamine|mesh-list
6560955|NCT00946946|Azathioprine|azathioprine|mesh-list
6560956|NCT00946946|Antimetabolites|antimetabolites|mesh-ancestor
6560957|NCT00946946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560958|NCT00946946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6560959|NCT00946946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6560960|NCT00946946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6560961|NCT00946946|Immunologic Factors|immunologic factors|mesh-ancestor
6560962|NCT00946946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560963|NCT00946946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6560964|NCT00946946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6560965|NCT00946946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6560966|NCT00946946|Analgesics|analgesics|mesh-ancestor
6560967|NCT00946946|Sensory System Agents|sensory system agents|mesh-ancestor
6560968|NCT00946946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6560969|NCT00946946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6560970|NCT00947024|Glipizide|glipizide|mesh-list
6560971|NCT00947024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6560972|NCT00947024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560973|NCT00947063|Promethazine|promethazine|mesh-list
6560974|NCT00947063|Diphenhydramine|diphenhydramine|mesh-list
6560975|NCT00947063|Antipruritics|antipruritics|mesh-ancestor
6560976|NCT00947063|Dermatologic Agents|dermatologic agents|mesh-ancestor
6560977|NCT00947063|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6560978|NCT00947063|Histamine Antagonists|histamine antagonists|mesh-ancestor
6560979|NCT00947063|Histamine Agents|histamine agents|mesh-ancestor
6444073|NCT00382356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444074|NCT00382421|Aspirin|aspirin|mesh-list
6444075|NCT00382421|Amlodipine|amlodipine|mesh-list
6444076|NCT00382421|Bisoprolol|bisoprolol|mesh-list
6444077|NCT00382421|Molsidomine|molsidomine|mesh-list
6444078|NCT00382421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6444079|NCT00382421|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6444080|NCT00382421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6444081|NCT00382421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444082|NCT00382421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6444083|NCT00382421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444084|NCT00382421|Vasodilator Agents|vasodilator agents|mesh-ancestor
6444085|NCT00382421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6444086|NCT00382421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6444087|NCT00382421|Analgesics|analgesics|mesh-ancestor
6444088|NCT00382421|Sensory System Agents|sensory system agents|mesh-ancestor
6444089|NCT00382421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6444090|NCT00382421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6444091|NCT00382421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6444092|NCT00382421|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6560980|NCT00947063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6560981|NCT00947063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560982|NCT00947063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6560983|NCT00947063|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6560984|NCT00947063|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6560985|NCT00947063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6560986|NCT00947063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6560987|NCT00947063|Anesthetics, Local|anesthetics, local|mesh-ancestor
6560988|NCT00947063|Anesthetics|anesthetics|mesh-ancestor
6560989|NCT00947063|Sensory System Agents|sensory system agents|mesh-ancestor
6560990|NCT00947063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6560991|NCT00947063|Antiemetics|antiemetics|mesh-ancestor
6560992|NCT00947063|Autonomic Agents|autonomic agents|mesh-ancestor
6560993|NCT00947063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6560994|NCT00947076|Fluoxetine|fluoxetine|mesh-list
6560995|NCT00947076|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6560996|NCT00947076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6560997|NCT00947076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6560998|NCT00947076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6560999|NCT00947076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6561000|NCT00947076|Serotonin Agents|serotonin agents|mesh-ancestor
6561001|NCT00947076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561002|NCT00947076|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6561003|NCT00947076|Antidepressive Agents|antidepressive agents|mesh-ancestor
6561004|NCT00947076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6561005|NCT00947076|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6561006|NCT00947076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6561007|NCT00947076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6561008|NCT00947128|Ondansetron|ondansetron|mesh-list
6561009|NCT00947128|Antiemetics|antiemetics|mesh-ancestor
6561010|NCT00947128|Autonomic Agents|autonomic agents|mesh-ancestor
6561011|NCT00947128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6561012|NCT00947128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561013|NCT00947128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6561014|NCT00947128|Antipruritics|antipruritics|mesh-ancestor
6561015|NCT00947128|Dermatologic Agents|dermatologic agents|mesh-ancestor
6561016|NCT00947128|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6561017|NCT00947128|Serotonin Agents|serotonin agents|mesh-ancestor
6561018|NCT00947128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6444093|NCT00382421|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6444094|NCT00382421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6444095|NCT00382421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6561019|NCT00947128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561020|NCT00947128|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6561021|NCT00947128|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6561022|NCT00947128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6561023|NCT00947128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6561024|NCT00947128|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6561025|NCT00947141|Valganciclovir|valganciclovir|mesh-list
6561026|NCT00947141|Ganciclovir|ganciclovir|mesh-list
6561027|NCT00947141|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6561028|NCT00947141|Foscarnet|foscarnet|mesh-list
6561029|NCT00947141|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
6561030|NCT00947141|Antiviral Agents|antiviral agents|mesh-ancestor
6561031|NCT00947141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6561032|NCT00947141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6561033|NCT00947141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6561034|NCT00947141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561035|NCT00947141|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6561036|NCT00947323|Simvastatin|simvastatin|mesh-list
6561037|NCT00947323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6561038|NCT00947323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6561039|NCT00947323|Antimetabolites|antimetabolites|mesh-ancestor
6561040|NCT00947323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561041|NCT00947323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6561042|NCT00947323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6561043|NCT00947323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6561044|NCT00947336|Norfloxacin|norfloxacin|mesh-list
6561045|NCT00947336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6444096|NCT00382421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6444097|NCT00382421|Antipyretics|antipyretics|mesh-ancestor
6444098|NCT00382421|Sympatholytics|sympatholytics|mesh-ancestor
6444099|NCT00382421|Autonomic Agents|autonomic agents|mesh-ancestor
6444100|NCT00382421|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6444101|NCT00382421|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6561046|NCT00947336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6561047|NCT00947336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6561048|NCT00947336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6561049|NCT00947336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6561050|NCT00947336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561051|NCT00947336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6561052|NCT00947336|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6561053|NCT00947336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6561054|NCT00947375|Lamotrigine|lamotrigine|mesh-list
6561055|NCT00947375|Haloperidol|haloperidol|mesh-list
6561056|NCT00947375|Haloperidol decanoate|haloperidol decanoate|mesh-list
6561057|NCT00947375|Antiemetics|antiemetics|mesh-ancestor
6561058|NCT00947375|Autonomic Agents|autonomic agents|mesh-ancestor
6561059|NCT00947375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6561060|NCT00947375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561061|NCT00947375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6561062|NCT00947375|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6561063|NCT00947375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6561064|NCT00947375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6561065|NCT00947375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6561066|NCT00947375|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6561067|NCT00947375|Dopamine Agents|dopamine agents|mesh-ancestor
6561068|NCT00947375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6444102|NCT00382421|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6444103|NCT00382421|Adrenergic Agents|adrenergic agents|mesh-ancestor
6444104|NCT00382421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6444105|NCT00382421|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6444106|NCT00382499|Lidocaine|lidocaine|mesh-list
6444107|NCT00382499|Anesthetics, Local|anesthetics, local|mesh-ancestor
6444108|NCT00382499|Anesthetics|anesthetics|mesh-ancestor
6444109|NCT00382499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6444110|NCT00382499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444111|NCT00382499|Sensory System Agents|sensory system agents|mesh-ancestor
6444112|NCT00382499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6561069|NCT00947375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561070|NCT00947375|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6561071|NCT00947375|Anticonvulsants|anticonvulsants|mesh-ancestor
6561072|NCT00947375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6561073|NCT00947375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6561074|NCT00947375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6561075|NCT00947375|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6561076|NCT00947388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6561077|NCT00947388|Alemtuzumab|alemtuzumab|mesh-list
6561078|NCT00947388|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6561079|NCT00947388|Antibodies|antibodies|mesh-list
6561080|NCT00947388|Immunoglobulins|immunoglobulins|mesh-list
6561081|NCT00947388|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6561082|NCT00947388|Immunologic Factors|immunologic factors|mesh-ancestor
6561083|NCT00947388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561084|NCT00947388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6561085|NCT00947388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6561086|NCT00947388|Alkylating Agents|alkylating agents|mesh-ancestor
6561087|NCT00947388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561088|NCT00947453|Montelukast|montelukast|mesh-list
6561089|NCT00947453|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6561090|NCT00947453|Respiratory System Agents|respiratory system agents|mesh-ancestor
6561091|NCT00947453|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6561092|NCT00947453|Hormone Antagonists|hormone antagonists|mesh-ancestor
6561093|NCT00947453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6561094|NCT00947453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561095|NCT00947453|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6561096|NCT00947453|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6561097|NCT00947453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561098|NCT00947466|Buprenorphine|buprenorphine|mesh-list
6561099|NCT00947466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6561100|NCT00947466|Narcotics|narcotics|mesh-ancestor
6561101|NCT00947466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6561102|NCT00947466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561103|NCT00947466|Analgesics|analgesics|mesh-ancestor
6561104|NCT00947466|Sensory System Agents|sensory system agents|mesh-ancestor
6561105|NCT00947466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6561106|NCT00947466|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6561107|NCT00947596|Atropine|atropine|mesh-list
6561108|NCT00947596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6561109|NCT00947596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6561110|NCT00947596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6561111|NCT00947596|Autonomic Agents|autonomic agents|mesh-ancestor
6561112|NCT00947596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6561113|NCT00947596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561114|NCT00947596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6561115|NCT00947596|Respiratory System Agents|respiratory system agents|mesh-ancestor
6561116|NCT00947596|Mydriatics|mydriatics|mesh-ancestor
6561117|NCT00947596|Parasympatholytics|parasympatholytics|mesh-ancestor
6561118|NCT00947596|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6561119|NCT00947596|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6561120|NCT00947596|Cholinergic Agents|cholinergic agents|mesh-ancestor
6561121|NCT00947596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6561122|NCT00947596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561123|NCT00947713|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6561124|NCT00947713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6561125|NCT00947713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561126|NCT00947739|Camptothecin|camptothecin|mesh-list
6561127|NCT00947739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6561128|NCT00947739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6561129|NCT00947739|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6561130|NCT00947739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6561131|NCT00947739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6561132|NCT00947739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561133|NCT00947843|Aspirin|aspirin|mesh-list
6561134|NCT00947843|Clopidogrel|clopidogrel|mesh-list
6561135|NCT00947843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6561136|NCT00947843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6561137|NCT00947843|Analgesics|analgesics|mesh-ancestor
6561138|NCT00947843|Sensory System Agents|sensory system agents|mesh-ancestor
6561139|NCT00947843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6561140|NCT00947843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561141|NCT00947843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6561142|NCT00947843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6561143|NCT00947843|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6561144|NCT00947843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6561145|NCT00947843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561146|NCT00947843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6561147|NCT00947843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6561148|NCT00947843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6561149|NCT00947843|Antipyretics|antipyretics|mesh-ancestor
6561150|NCT00947843|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6561151|NCT00947843|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6561152|NCT00947843|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6561153|NCT00947843|Purinergic Agents|purinergic agents|mesh-ancestor
6561154|NCT00947843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6561155|NCT00947895|Methylprednisolone|methylprednisolone|mesh-list
6561156|NCT00947895|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6561157|NCT00947895|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6561158|NCT00947895|Prednisolone|prednisolone|mesh-list
6561159|NCT00947895|Prednisolone acetate|prednisolone acetate|mesh-list
6561160|NCT00947895|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6561161|NCT00947895|Prednisolone phosphate|prednisolone phosphate|mesh-list
6561162|NCT00947895|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6561163|NCT00947895|Hormones|hormones|mesh-ancestor
6561164|NCT00947895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6561165|NCT00947895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561166|NCT00947895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6561167|NCT00947895|Antiemetics|antiemetics|mesh-ancestor
6561168|NCT00947895|Autonomic Agents|autonomic agents|mesh-ancestor
6561169|NCT00947895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6561170|NCT00947895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6561171|NCT00947895|Glucocorticoids|glucocorticoids|mesh-ancestor
6561172|NCT00947895|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6561173|NCT00947895|Protective Agents|protective agents|mesh-ancestor
6561174|NCT00947895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6561175|NCT00947895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6656924|NCT01472263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6656925|NCT01472263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6656926|NCT01472263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656927|NCT01472263|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6656928|NCT01472263|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6656929|NCT01472263|Protective Agents|protective agents|mesh-ancestor
6656930|NCT01472263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656931|NCT01472263|Vasodilator Agents|vasodilator agents|mesh-ancestor
6656932|NCT01472263|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6656933|NCT01472263|Antioxidants|antioxidants|mesh-ancestor
6656934|NCT01472315|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6656935|NCT01472315|Medroxyprogesterone|medroxyprogesterone|mesh-list
6656936|NCT01472315|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6656937|NCT01472315|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6656938|NCT01472315|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6656939|NCT01472315|Contraceptive Agents|contraceptive agents|mesh-ancestor
6656940|NCT01472315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6656941|NCT01472315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656942|NCT01472315|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6656943|NCT01472315|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6656944|NCT01472315|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6561176|NCT00948077|Isoniazid, pyrazinamide, rifampin drug combination|isoniazid, pyrazinamide, rifampin drug combination|mesh-list
6561177|NCT00948077|Antitubercular Agents|antitubercular agents|mesh-ancestor
6561178|NCT00948077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6561179|NCT00948077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6561180|NCT00948103|Nitrous Oxide|nitrous oxide|mesh-list
6561181|NCT00948103|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6561182|NCT00948103|Anesthetics, General|anesthetics, general|mesh-ancestor
6561183|NCT00948103|Anesthetics|anesthetics|mesh-ancestor
6561184|NCT00948103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6561185|NCT00948103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561186|NCT00948103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6561187|NCT00948103|Analgesics|analgesics|mesh-ancestor
6561188|NCT00948103|Sensory System Agents|sensory system agents|mesh-ancestor
6561189|NCT00948103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6561190|NCT00948168|Exenatide|exenatide|mesh-list
6561191|NCT00948168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6561192|NCT00948168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561193|NCT00948168|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6561194|NCT00948168|Incretins|incretins|mesh-ancestor
6561195|NCT00948168|Hormones|hormones|mesh-ancestor
6561196|NCT00948168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6561197|NCT00948220|Ribavirin|ribavirin|mesh-list
6561198|NCT00948220|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6561199|NCT00948220|Antimetabolites|antimetabolites|mesh-ancestor
6561200|NCT00948220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561201|NCT00948220|Antiviral Agents|antiviral agents|mesh-ancestor
6561202|NCT00948220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6561203|NCT00948272|Vaccines|vaccines|mesh-list
6561204|NCT00948272|Immunologic Factors|immunologic factors|mesh-ancestor
6561205|NCT00948272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561206|NCT00948402|Metformin|metformin|mesh-list
6561207|NCT00948402|Biguanides|biguanides|mesh-list
6561208|NCT00948402|Contraceptive Agents|contraceptive agents|mesh-list
6561209|NCT00948402|Contraceptives, Oral|contraceptives, oral|mesh-list
6561210|NCT00948402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6561211|NCT00948402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561212|NCT00948402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6561213|NCT00948402|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6561214|NCT00948480|Sargramostim|sargramostim|mesh-list
6561215|NCT00948480|Immunologic Factors|immunologic factors|mesh-ancestor
6561216|NCT00948480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561217|NCT00948493|Insulin|insulin|mesh-list
6561218|NCT00948493|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6561219|NCT00948493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6561220|NCT00948493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561221|NCT00948584|Insulin|insulin|mesh-list
6561222|NCT00948584|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6561223|NCT00948584|Insulin Glargine|insulin glargine|mesh-list
6561224|NCT00948584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6561225|NCT00948584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561226|NCT00948649|Varenicline|varenicline|mesh-list
6561227|NCT00948649|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6561228|NCT00948649|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6561229|NCT00948649|Cholinergic Agents|cholinergic agents|mesh-ancestor
6561230|NCT00948649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6561231|NCT00948649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561232|NCT00948649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561233|NCT00948662|Ketoconazole|ketoconazole|mesh-list
6561234|NCT00948662|Antifungal Agents|antifungal agents|mesh-ancestor
6561235|NCT00948662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6444113|NCT00382499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6444114|NCT00382499|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6444115|NCT00382499|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6444116|NCT00382499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6444117|NCT00382499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444118|NCT00382538|Mifepristone|mifepristone|mesh-list
6561236|NCT00948662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6561237|NCT00948662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6561238|NCT00948662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6561239|NCT00948662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561240|NCT00948662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6561241|NCT00948662|Hormone Antagonists|hormone antagonists|mesh-ancestor
6561242|NCT00948662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6561243|NCT00948662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561244|NCT00948662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6561245|NCT00948727|Cyclosporine|cyclosporine|mesh-list
6561246|NCT00948727|Cyclosporins|cyclosporins|mesh-list
6561247|NCT00948727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6561248|NCT00948727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561249|NCT00948727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6561250|NCT00948727|Immunologic Factors|immunologic factors|mesh-ancestor
6561251|NCT00948727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561252|NCT00948727|Antifungal Agents|antifungal agents|mesh-ancestor
6561253|NCT00948727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6561254|NCT00948727|Dermatologic Agents|dermatologic agents|mesh-ancestor
6561255|NCT00948727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6561256|NCT00948727|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6561257|NCT00948740|Vitamin D|vitamin d|mesh-list
6561258|NCT00948740|Ergocalciferols|ergocalciferols|mesh-list
6561259|NCT00948740|Vitamins|vitamins|mesh-ancestor
6561260|NCT00948740|Micronutrients|micronutrients|mesh-ancestor
6561261|NCT00948740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561262|NCT00948740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6561263|NCT00948740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6561264|NCT00948779|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6561265|NCT00948779|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6561266|NCT00948779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6561267|NCT00948779|Antitubercular Agents|antitubercular agents|mesh-ancestor
6561268|NCT00948805|Goserelin|goserelin|mesh-list
6444119|NCT00382538|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6561269|NCT00948805|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6561270|NCT00948805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6561271|NCT00948805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6561272|NCT00948805|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6561273|NCT00948805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561274|NCT00948987|Aspirin|aspirin|mesh-list
6561275|NCT00948987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6561276|NCT00948987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6561277|NCT00948987|Analgesics|analgesics|mesh-ancestor
6561278|NCT00948987|Sensory System Agents|sensory system agents|mesh-ancestor
6561279|NCT00948987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6561280|NCT00948987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561281|NCT00948987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6561282|NCT00948987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6561283|NCT00948987|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6561284|NCT00948987|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6561285|NCT00948987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561286|NCT00948987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6561287|NCT00948987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6561288|NCT00948987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6561289|NCT00948987|Antipyretics|antipyretics|mesh-ancestor
6561290|NCT00949026|Sirolimus|sirolimus|mesh-list
6561291|NCT00949026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6561292|NCT00949026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6561293|NCT00949026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6561294|NCT00949026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6561295|NCT00949026|Antifungal Agents|antifungal agents|mesh-ancestor
6561296|NCT00949026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6561297|NCT00949026|Immunologic Factors|immunologic factors|mesh-ancestor
6561298|NCT00949026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561299|NCT00949065|Immunoglobulins|immunoglobulins|mesh-list
6561300|NCT00949065|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6561301|NCT00949065|Antibodies|antibodies|mesh-list
6561302|NCT00949065|gamma-Globulins|gamma-globulins|mesh-list
6561303|NCT00949065|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6561304|NCT00949065|Immunologic Factors|immunologic factors|mesh-ancestor
6561305|NCT00949065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561306|NCT00949130|Linezolid|linezolid|mesh-list
6561307|NCT00949130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6561308|NCT00949130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6561309|NCT00949130|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6561310|NCT00949130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6561311|NCT00949130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561312|NCT00949182|Doxorubicin|doxorubicin|mesh-list
6561313|NCT00949182|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6561314|NCT00949182|Mitomycins|mitomycins|mesh-list
6561315|NCT00949182|Mitomycin|mitomycin|mesh-list
6561316|NCT00949182|Sorafenib|sorafenib|mesh-list
6444120|NCT00382538|Abortifacient Agents|abortifacient agents|mesh-ancestor
6444121|NCT00382538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6444122|NCT00382538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444123|NCT00382538|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6444124|NCT00382538|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6444125|NCT00382538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6561317|NCT00949182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6561318|NCT00949182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6561319|NCT00949182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6561320|NCT00949182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6561321|NCT00949182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6561322|NCT00949182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561323|NCT00949182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6561324|NCT00949182|Alkylating Agents|alkylating agents|mesh-ancestor
6561325|NCT00949182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6561326|NCT00949247|Bevacizumab|bevacizumab|mesh-list
6561327|NCT00949247|Trastuzumab|trastuzumab|mesh-list
6561328|NCT00949247|Carboplatin|carboplatin|mesh-list
6561329|NCT00949247|Docetaxel|docetaxel|mesh-list
6561330|NCT00949247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6561331|NCT00949247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6561332|NCT00949247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6561333|NCT00949247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6561334|NCT00949247|Growth Substances|growth substances|mesh-ancestor
6561335|NCT00949247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561336|NCT00949247|Growth Inhibitors|growth inhibitors|mesh-ancestor
6561337|NCT00949247|Tubulin Modulators|tubulin modulators|mesh-ancestor
6561338|NCT00949247|Antimitotic Agents|antimitotic agents|mesh-ancestor
6561339|NCT00949247|Mitosis Modulators|mitosis modulators|mesh-ancestor
6561340|NCT00949247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561341|NCT00949299|Buprenorphine|buprenorphine|mesh-list
6561342|NCT00949299|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6561343|NCT00949299|Narcotics|narcotics|mesh-ancestor
6561344|NCT00949299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6561345|NCT00949299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561346|NCT00949299|Analgesics|analgesics|mesh-ancestor
6561347|NCT00949299|Sensory System Agents|sensory system agents|mesh-ancestor
6444126|NCT00382538|Contraceptive Agents|contraceptive agents|mesh-ancestor
6444127|NCT00382538|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6444128|NCT00382538|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6444129|NCT00382538|Hormone Antagonists|hormone antagonists|mesh-ancestor
6444130|NCT00382538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6444131|NCT00382538|Luteolytic Agents|luteolytic agents|mesh-ancestor
6444132|NCT00382538|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6444133|NCT00382538|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6444134|NCT00382629|Butylated Hydroxytoluene|butylated hydroxytoluene|mesh-list
6444135|NCT00382629|Antioxidants|antioxidants|mesh-ancestor
6561348|NCT00949299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6561349|NCT00949299|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6561350|NCT00949364|Pomalidomide|pomalidomide|mesh-list
6561351|NCT00949364|Immunologic Factors|immunologic factors|mesh-ancestor
6561352|NCT00949364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561353|NCT00949364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6561354|NCT00949364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6561355|NCT00949364|Growth Substances|growth substances|mesh-ancestor
6561356|NCT00949364|Growth Inhibitors|growth inhibitors|mesh-ancestor
6561357|NCT00949364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6561358|NCT00949377|Bromides|bromides|mesh-list
6561359|NCT00949377|Methylnaltrexone|methylnaltrexone|mesh-list
6561360|NCT00949377|Anticonvulsants|anticonvulsants|mesh-ancestor
6561361|NCT00949377|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6561362|NCT00949377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561363|NCT00949377|Sensory System Agents|sensory system agents|mesh-ancestor
6561364|NCT00949377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6561365|NCT00949442|Insulin|insulin|mesh-list
6561366|NCT00949442|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6561367|NCT00949442|Insulin Glargine|insulin glargine|mesh-list
6561368|NCT00949442|Glimepiride|glimepiride|mesh-list
6561369|NCT00949442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6561370|NCT00949442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561371|NCT00949442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6561372|NCT00949442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6561373|NCT00949442|Immunologic Factors|immunologic factors|mesh-ancestor
6561374|NCT00949455|Lapatinib|lapatinib|mesh-list
6561375|NCT00949455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6561376|NCT00949455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6561377|NCT00949455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6561378|NCT00949455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561379|NCT00949494|Hylan|hylan|mesh-list
6561380|NCT00949494|Hyaluronic Acid|hyaluronic acid|mesh-list
6561381|NCT00949494|Viscosupplements|viscosupplements|mesh-ancestor
6561382|NCT00949494|Protective Agents|protective agents|mesh-ancestor
6561383|NCT00949494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561384|NCT00949494|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6561385|NCT00949494|Immunologic Factors|immunologic factors|mesh-ancestor
6561386|NCT00949546|Etanercept|etanercept|mesh-list
6561387|NCT00949546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6561388|NCT00949546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6561389|NCT00949546|Analgesics|analgesics|mesh-ancestor
6561390|NCT00949546|Sensory System Agents|sensory system agents|mesh-ancestor
6561391|NCT00949546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6561392|NCT00949546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561393|NCT00949546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6561394|NCT00949546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6561395|NCT00949546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6561396|NCT00949546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6561397|NCT00949546|Immunologic Factors|immunologic factors|mesh-ancestor
6561398|NCT00949572|Vaccines|vaccines|mesh-list
6561399|NCT00949572|Aluminum sulfate|aluminum sulfate|mesh-list
6561400|NCT00949572|Immunologic Factors|immunologic factors|mesh-ancestor
6561401|NCT00949572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561402|NCT00949572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6561403|NCT00949598|Tamoxifen|tamoxifen|mesh-list
6561404|NCT00949598|Letrozole|letrozole|mesh-list
6561405|NCT00949598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561406|NCT00949598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6561407|NCT00949598|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6561408|NCT00949598|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6561409|NCT00949598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6561410|NCT00949598|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6561411|NCT00949598|Hormone Antagonists|hormone antagonists|mesh-ancestor
6561412|NCT00949598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6561413|NCT00949598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561414|NCT00949598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6444136|NCT00382629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444137|NCT00382629|Protective Agents|protective agents|mesh-ancestor
6444138|NCT00382629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444139|NCT00382642|Ondansetron|ondansetron|mesh-list
6444140|NCT00382642|Antiemetics|antiemetics|mesh-ancestor
6444141|NCT00382642|Autonomic Agents|autonomic agents|mesh-ancestor
6444142|NCT00382642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6444143|NCT00382642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561415|NCT00949598|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6561416|NCT00949598|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6561417|NCT00949598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6561418|NCT00949624|Docetaxel|docetaxel|mesh-list
6561419|NCT00949624|Axitinib|axitinib|mesh-list
6561420|NCT00949624|Crenolanib|crenolanib|mesh-list
6561421|NCT00949624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6561422|NCT00949624|Tubulin Modulators|tubulin modulators|mesh-ancestor
6561423|NCT00949624|Antimitotic Agents|antimitotic agents|mesh-ancestor
6561424|NCT00949624|Mitosis Modulators|mitosis modulators|mesh-ancestor
6561425|NCT00949624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561426|NCT00949624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6561427|NCT00949624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6561428|NCT00949663|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
6561429|NCT00949663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6561430|NCT00949663|Incretins|incretins|mesh-ancestor
6561431|NCT00949663|Hormones|hormones|mesh-ancestor
6561432|NCT00949663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6561433|NCT00949663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561434|NCT00949728|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6561435|NCT00949728|Hemostatics|hemostatics|mesh-ancestor
6561436|NCT00949728|Coagulants|coagulants|mesh-ancestor
6561437|NCT00949780|Chloral Hydrate|chloral hydrate|mesh-list
6561438|NCT00949780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6444144|NCT00382642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6561439|NCT00949780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6561440|NCT00949780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656945|NCT01472315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6656946|NCT01472315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6656947|NCT01472406|Pancrelipase|pancrelipase|mesh-list
6656948|NCT01472406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6656949|NCT01472497|Pioglitazone|pioglitazone|mesh-list
6656950|NCT01472497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6656951|NCT01472497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656952|NCT01472510|Ranibizumab|ranibizumab|mesh-list
6656953|NCT01472510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6656954|NCT01472510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6656955|NCT01472510|Growth Substances|growth substances|mesh-ancestor
6656956|NCT01472510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561441|NCT00949832|Calcium, Dietary|calcium, dietary|mesh-list
6561442|NCT00949832|Vitamin D|vitamin d|mesh-list
6561443|NCT00949832|Ergocalciferols|ergocalciferols|mesh-list
6561444|NCT00949832|Cholecalciferol|cholecalciferol|mesh-list
6561445|NCT00949832|Vitamins|vitamins|mesh-list
6561446|NCT00949832|Calcium|calcium|mesh-list
6561447|NCT00949832|Micronutrients|micronutrients|mesh-ancestor
6561448|NCT00949832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561449|NCT00949832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6561450|NCT00949832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6561451|NCT00949949|Gemcitabine|gemcitabine|mesh-list
6561452|NCT00949949|Everolimus|everolimus|mesh-list
6561453|NCT00949949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6561454|NCT00949949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6561455|NCT00949949|Antimetabolites|antimetabolites|mesh-ancestor
6561456|NCT00949949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561457|NCT00949949|Antiviral Agents|antiviral agents|mesh-ancestor
6561458|NCT00949949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6561459|NCT00949949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6561460|NCT00949949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6561461|NCT00949949|Immunologic Factors|immunologic factors|mesh-ancestor
6561462|NCT00949949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561463|NCT00949962|Leuprolide|leuprolide|mesh-list
6561464|NCT00949962|Androgen Antagonists|androgen antagonists|mesh-list
6561465|NCT00949962|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6561466|NCT00949962|Fertility Agents|fertility agents|mesh-ancestor
6561467|NCT00949962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6561468|NCT00949962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561469|NCT00949962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6561470|NCT00949962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6561471|NCT00949962|Hormone Antagonists|hormone antagonists|mesh-ancestor
6561472|NCT00949962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6561473|NCT00950027|Povidone-Iodine|povidone-iodine|mesh-list
6561474|NCT00950027|Povidone|povidone|mesh-list
6561475|NCT00950027|Plasma Substitutes|plasma substitutes|mesh-ancestor
6561476|NCT00950027|Blood Substitutes|blood substitutes|mesh-ancestor
6561477|NCT00950027|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6561478|NCT00950027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6561479|NCT00950066|Amlodipine|amlodipine|mesh-list
6561480|NCT00950066|Irbesartan|irbesartan|mesh-list
6561481|NCT00950066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6561482|NCT00950066|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6561483|NCT00950066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6561484|NCT00950066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561485|NCT00950066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6561486|NCT00950066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561487|NCT00950066|Vasodilator Agents|vasodilator agents|mesh-ancestor
6561488|NCT00950066|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6561489|NCT00950066|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6561490|NCT00950105|Semapimod|semapimod|mesh-list
6561491|NCT00950105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6561492|NCT00950105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6561493|NCT00950105|Analgesics|analgesics|mesh-ancestor
6561494|NCT00950105|Sensory System Agents|sensory system agents|mesh-ancestor
6561495|NCT00950105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6561496|NCT00950105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561497|NCT00950105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6561498|NCT00950105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6561499|NCT00950105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6561500|NCT00950105|Immunologic Factors|immunologic factors|mesh-ancestor
6561501|NCT00950196|Amantadine|amantadine|mesh-list
6561502|NCT00950196|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6561503|NCT00950196|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6561504|NCT00950196|Antiviral Agents|antiviral agents|mesh-ancestor
6561505|NCT00950196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6561506|NCT00950196|Dopamine Agents|dopamine agents|mesh-ancestor
6561507|NCT00950196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6444145|NCT00382642|Antipruritics|antipruritics|mesh-ancestor
6444146|NCT00382642|Dermatologic Agents|dermatologic agents|mesh-ancestor
6444147|NCT00382642|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6444148|NCT00382642|Serotonin Agents|serotonin agents|mesh-ancestor
6444149|NCT00382642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6444150|NCT00382642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444151|NCT00382642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6444152|NCT00382642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6444153|NCT00382642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6444154|NCT00382642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6444155|NCT00382642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6444156|NCT00382668|Dasatinib|dasatinib|mesh-list
6444157|NCT00382668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6444158|NCT00382668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6444159|NCT00382668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6444160|NCT00382668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444161|NCT00382681|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6444162|NCT00382694|Fludarabine|fludarabine|mesh-list
6444163|NCT00382694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6444164|NCT00382837|Epratuzumab|epratuzumab|mesh-list
6444165|NCT00382837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6444166|NCT00382837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6444167|NCT00382889|Beclomethasone|beclomethasone|mesh-list
6444168|NCT00382889|Albuterol|albuterol|mesh-list
6444169|NCT00382889|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6444170|NCT00382889|Autonomic Agents|autonomic agents|mesh-ancestor
6444171|NCT00382889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6444172|NCT00382889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561508|NCT00950196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561509|NCT00950196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561510|NCT00950196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6561511|NCT00950196|Analgesics|analgesics|mesh-ancestor
6561512|NCT00950196|Sensory System Agents|sensory system agents|mesh-ancestor
6561513|NCT00950196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6561514|NCT00950209|Heparin|heparin|mesh-list
6561515|NCT00950209|Anticoagulants|anticoagulants|mesh-ancestor
6561516|NCT00950209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6561517|NCT00950209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6561518|NCT00950209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561519|NCT00950222|Imipenem|imipenem|mesh-list
6561520|NCT00950222|Amikacin|amikacin|mesh-list
6561521|NCT00950222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6561522|NCT00950222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6561523|NCT00950261|Cisplatin|cisplatin|mesh-list
6561524|NCT00950261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6561525|NCT00950339|Omeprazole|omeprazole|mesh-list
6561526|NCT00950339|Pantoprazole|pantoprazole|mesh-list
6561527|NCT00950339|Famotidine|famotidine|mesh-list
6561528|NCT00950339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6561529|NCT00950339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6444173|NCT00382889|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6561530|NCT00950339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6561531|NCT00950339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6561532|NCT00950339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561533|NCT00950339|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6561534|NCT00950339|Histamine Antagonists|histamine antagonists|mesh-ancestor
6561535|NCT00950339|Histamine Agents|histamine agents|mesh-ancestor
6561536|NCT00950339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6561537|NCT00950339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561538|NCT00950391|Tacrolimus|tacrolimus|mesh-list
6561539|NCT00950391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6561540|NCT00950391|Immunologic Factors|immunologic factors|mesh-ancestor
6561541|NCT00950391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561542|NCT00950391|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6561543|NCT00950391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6561544|NCT00950391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561545|NCT00950404|Sildenafil Citrate|sildenafil citrate|mesh-list
6561546|NCT00950404|Vasodilator Agents|vasodilator agents|mesh-ancestor
6561547|NCT00950404|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6561548|NCT00950404|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6561549|NCT00950404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6561550|NCT00950404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561551|NCT00950404|Urological Agents|urological agents|mesh-ancestor
6561552|NCT00950417|Nimotuzumab|nimotuzumab|mesh-list
6561553|NCT00950417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6561554|NCT00950417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6561555|NCT00950430|Corticosterone|corticosterone|mesh-list
6561556|NCT00950430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6561557|NCT00950534|Insulin Glargine|insulin glargine|mesh-list
6561558|NCT00950534|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6561559|NCT00950534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561560|NCT00950586|Dextromethorphan|dextromethorphan|mesh-list
6561561|NCT00950586|Antitussive Agents|antitussive agents|mesh-ancestor
6561562|NCT00950586|Respiratory System Agents|respiratory system agents|mesh-ancestor
6561563|NCT00950586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6561564|NCT00950586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6561565|NCT00950586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6561566|NCT00950586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561567|NCT00950586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561568|NCT00950625|Lidocaine|lidocaine|mesh-list
6561569|NCT00950625|Anesthetics, Local|anesthetics, local|mesh-ancestor
6561570|NCT00950625|Anesthetics|anesthetics|mesh-ancestor
6561571|NCT00950625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6561572|NCT00950625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561573|NCT00950625|Sensory System Agents|sensory system agents|mesh-ancestor
6561574|NCT00950625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6561575|NCT00950625|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6561576|NCT00950625|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6561577|NCT00950625|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6561578|NCT00950625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6561579|NCT00950625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561580|NCT00950677|Exenatide|exenatide|mesh-list
6561581|NCT00950677|Pramlintide|pramlintide|mesh-list
6561582|NCT00950677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6561583|NCT00950677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561584|NCT00950677|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6561585|NCT00950677|Incretins|incretins|mesh-ancestor
6561586|NCT00950677|Hormones|hormones|mesh-ancestor
6561587|NCT00950677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6561588|NCT00950794|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6561589|NCT00950794|Tulobuterol|tulobuterol|mesh-list
6561590|NCT00950794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6561591|NCT00950794|Autonomic Agents|autonomic agents|mesh-ancestor
6561592|NCT00950794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6561593|NCT00950794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561594|NCT00950794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6561595|NCT00950794|Respiratory System Agents|respiratory system agents|mesh-ancestor
6561596|NCT00950794|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6561597|NCT00950794|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6561598|NCT00950794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6561599|NCT00950794|Adrenergic Agents|adrenergic agents|mesh-ancestor
6561600|NCT00950794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6561601|NCT00950794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561602|NCT00950820|Capecitabine|capecitabine|mesh-list
6561603|NCT00950820|Oxaliplatin|oxaliplatin|mesh-list
6561604|NCT00950820|Panitumumab|panitumumab|mesh-list
6561605|NCT00950820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6561606|NCT00950820|Antimetabolites|antimetabolites|mesh-ancestor
6561607|NCT00950820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561608|NCT00950820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6561609|NCT00950820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6561610|NCT00950898|Caffeine|caffeine|mesh-list
6561611|NCT00950898|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6561612|NCT00950898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561613|NCT00950898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6561614|NCT00950898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6561615|NCT00950898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561616|NCT00950898|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6561617|NCT00950898|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6561618|NCT00950898|Purinergic Agents|purinergic agents|mesh-ancestor
6561619|NCT00950898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6561620|NCT00951106|Pyrimethamine|pyrimethamine|mesh-list
6561621|NCT00951106|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6561622|NCT00951106|Antimalarials|antimalarials|mesh-ancestor
6561623|NCT00951106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6561624|NCT00951106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6561625|NCT00951106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6561626|NCT00951106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6561627|NCT00951106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6561628|NCT00951106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561629|NCT00951132|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6561630|NCT00951132|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6561631|NCT00951132|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6561632|NCT00951132|Antimetabolites|antimetabolites|mesh-ancestor
6561633|NCT00951132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561634|NCT00951132|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6561635|NCT00951132|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6561636|NCT00951132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6561637|NCT00951223|Interferons|interferons|mesh-list
6561638|NCT00951223|Interferon alfacon-1|interferon alfacon-1|mesh-list
6561639|NCT00951223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6561640|NCT00951223|Antiviral Agents|antiviral agents|mesh-ancestor
6561641|NCT00951223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6561642|NCT00951236|Cortisone|cortisone|mesh-list
6561643|NCT00951236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6561644|NCT00951431|Esomeprazole|esomeprazole|mesh-list
6561645|NCT00951431|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6561646|NCT00951431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6561647|NCT00951431|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6561648|NCT00951431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6561649|NCT00951431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561650|NCT00951444|Gemcitabine|gemcitabine|mesh-list
6561651|NCT00951444|Carboplatin|carboplatin|mesh-list
6561652|NCT00951444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6561653|NCT00951444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6561654|NCT00951444|Antimetabolites|antimetabolites|mesh-ancestor
6561655|NCT00951444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561656|NCT00951444|Antiviral Agents|antiviral agents|mesh-ancestor
6561657|NCT00951444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6561658|NCT00951444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6561659|NCT00951444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6561660|NCT00951444|Immunologic Factors|immunologic factors|mesh-ancestor
6561661|NCT00951444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561662|NCT00951457|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6561663|NCT00951457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6561664|NCT00951457|Alkylating Agents|alkylating agents|mesh-ancestor
6561665|NCT00951457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561666|NCT00951457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6561667|NCT00951574|Nadroparin|nadroparin|mesh-list
6561668|NCT00951574|Calcium|calcium|mesh-list
6561669|NCT00951574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6561670|NCT00951574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561671|NCT00951574|Anticoagulants|anticoagulants|mesh-ancestor
6561672|NCT00951574|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6561673|NCT00951574|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6561674|NCT00951574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561675|NCT00951600|Oxcarbazepine|oxcarbazepine|mesh-list
6561676|NCT00951600|Anticonvulsants|anticonvulsants|mesh-ancestor
6561677|NCT00951600|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6561678|NCT00951600|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6561679|NCT00951600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6561680|NCT00951600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561681|NCT00951600|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6561682|NCT00951600|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6656957|NCT01472510|Growth Inhibitors|growth inhibitors|mesh-ancestor
6656958|NCT01472510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6656959|NCT01472640|Liraglutide|liraglutide|mesh-list
6656960|NCT01472640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6656961|NCT01472640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656962|NCT01472640|Incretins|incretins|mesh-ancestor
6656963|NCT01472640|Hormones|hormones|mesh-ancestor
6656964|NCT01472640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6656965|NCT01472653|Cetuximab|cetuximab|mesh-list
6656966|NCT01472653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6656967|NCT01472653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6656968|NCT01472666|Caseins|caseins|mesh-list
6656969|NCT01472666|Chelating Agents|chelating agents|mesh-ancestor
6656970|NCT01472666|Sequestering Agents|sequestering agents|mesh-ancestor
6656971|NCT01472666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656972|NCT01472731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6656973|NCT01472731|Immunologic Factors|immunologic factors|mesh-ancestor
6656974|NCT01472731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656975|NCT01472770|Gemcitabine|gemcitabine|mesh-list
6656976|NCT01472770|Capecitabine|capecitabine|mesh-list
6656977|NCT01472770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6656978|NCT01472770|Antimetabolites|antimetabolites|mesh-ancestor
6656979|NCT01472770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656980|NCT01472770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6656981|NCT01472770|Antiviral Agents|antiviral agents|mesh-ancestor
6656982|NCT01472770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6656983|NCT01472770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6656984|NCT01472770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6561683|NCT00951834|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
6561684|NCT00951834|Antioxidants|antioxidants|mesh-ancestor
6561685|NCT00951834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561686|NCT00951834|Protective Agents|protective agents|mesh-ancestor
6561687|NCT00951834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561688|NCT00951834|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
6561689|NCT00951834|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6561690|NCT00951834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6561691|NCT00951834|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6561692|NCT00951847|Oxcarbazepine|oxcarbazepine|mesh-list
6561693|NCT00951847|Anticonvulsants|anticonvulsants|mesh-ancestor
6561694|NCT00951847|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6561695|NCT00951847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6561696|NCT00951847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6561697|NCT00951847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561698|NCT00951847|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6561699|NCT00951847|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6561700|NCT00952003|Bevacizumab|bevacizumab|mesh-list
6561701|NCT00952003|Docetaxel|docetaxel|mesh-list
6561702|NCT00952003|Oxaliplatin|oxaliplatin|mesh-list
6561703|NCT00952003|Irinotecan|irinotecan|mesh-list
6561704|NCT00952003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6561705|NCT00952003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6561706|NCT00952003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6561707|NCT00952003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6561708|NCT00952003|Growth Substances|growth substances|mesh-ancestor
6561709|NCT00952003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561710|NCT00952003|Growth Inhibitors|growth inhibitors|mesh-ancestor
6561711|NCT00952003|Tubulin Modulators|tubulin modulators|mesh-ancestor
6561712|NCT00952003|Antimitotic Agents|antimitotic agents|mesh-ancestor
6561713|NCT00952003|Mitosis Modulators|mitosis modulators|mesh-ancestor
6561714|NCT00952003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561715|NCT00952003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6561716|NCT00952003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6561717|NCT00952003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6561718|NCT00952016|Methotrexate|methotrexate|mesh-list
6561719|NCT00952016|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6561720|NCT00952016|Abortifacient Agents|abortifacient agents|mesh-ancestor
6561721|NCT00952016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6561722|NCT00952016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561723|NCT00952016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6561724|NCT00952016|Antimetabolites|antimetabolites|mesh-ancestor
6561725|NCT00952016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561726|NCT00952016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6561727|NCT00952016|Dermatologic Agents|dermatologic agents|mesh-ancestor
6561728|NCT00952016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6561729|NCT00952016|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6561730|NCT00952016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6561731|NCT00952016|Immunologic Factors|immunologic factors|mesh-ancestor
6561732|NCT00952016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6561733|NCT00952016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6561734|NCT00952029|Leucovorin|leucovorin|mesh-list
6561735|NCT00952029|Bevacizumab|bevacizumab|mesh-list
6561736|NCT00952029|Fluorouracil|fluorouracil|mesh-list
6561737|NCT00952029|Irinotecan|irinotecan|mesh-list
6561738|NCT00952029|Calcium|calcium|mesh-list
6561739|NCT00952029|Levoleucovorin|levoleucovorin|mesh-list
6561740|NCT00952029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6561741|NCT00952029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6561742|NCT00952029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6561743|NCT00952029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6561744|NCT00952029|Growth Substances|growth substances|mesh-ancestor
6561745|NCT00952029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561746|NCT00952029|Growth Inhibitors|growth inhibitors|mesh-ancestor
6561747|NCT00952029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6561748|NCT00952029|Antimetabolites|antimetabolites|mesh-ancestor
6561749|NCT00952029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561750|NCT00952029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6561751|NCT00952029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6561752|NCT00952029|Immunologic Factors|immunologic factors|mesh-ancestor
6561753|NCT00952029|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6561754|NCT00952029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6561755|NCT00952029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6561756|NCT00952029|Antidotes|antidotes|mesh-ancestor
6561757|NCT00952029|Protective Agents|protective agents|mesh-ancestor
6561758|NCT00952029|Vitamin B Complex|vitamin b complex|mesh-ancestor
6561759|NCT00952029|Vitamins|vitamins|mesh-ancestor
6561760|NCT00952029|Micronutrients|micronutrients|mesh-ancestor
6561761|NCT00952094|Cinacalcet|cinacalcet|mesh-list
6561762|NCT00952094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6561763|NCT00952094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561764|NCT00952094|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6561765|NCT00952094|Hormone Antagonists|hormone antagonists|mesh-ancestor
6561766|NCT00952094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6561767|NCT00952159|Tramadol|tramadol|mesh-list
6561768|NCT00952159|O-demethyltramadol|o-demethyltramadol|mesh-list
6561769|NCT00952159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6561770|NCT00952159|Narcotics|narcotics|mesh-ancestor
6561771|NCT00952159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6561772|NCT00952159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561773|NCT00952159|Analgesics|analgesics|mesh-ancestor
6561774|NCT00952159|Sensory System Agents|sensory system agents|mesh-ancestor
6561775|NCT00952159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6561776|NCT00952185|Antibodies|antibodies|mesh-list
6561777|NCT00952185|Immunologic Factors|immunologic factors|mesh-ancestor
6561778|NCT00952185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561779|NCT00952302|Iron|iron|mesh-list
6561780|NCT00952302|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6561781|NCT00952302|Trace Elements|trace elements|mesh-ancestor
6561782|NCT00952302|Micronutrients|micronutrients|mesh-ancestor
6561783|NCT00952302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561784|NCT00952302|Hematinics|hematinics|mesh-ancestor
6561785|NCT00952432|Carbamazepine|carbamazepine|mesh-list
6561786|NCT00952432|Anticonvulsants|anticonvulsants|mesh-ancestor
6561787|NCT00952432|Antimanic Agents|antimanic agents|mesh-ancestor
6561788|NCT00952432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6561789|NCT00952432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6561790|NCT00952432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561791|NCT00952432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6561792|NCT00952432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6561793|NCT00952432|Analgesics|analgesics|mesh-ancestor
6561794|NCT00952432|Sensory System Agents|sensory system agents|mesh-ancestor
6561795|NCT00952432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6561796|NCT00952432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6561797|NCT00952432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6561798|NCT00952432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561799|NCT00952432|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6561800|NCT00952432|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6561801|NCT00952497|Capecitabine|capecitabine|mesh-list
6561802|NCT00952497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6561803|NCT00952497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6561804|NCT00952497|Antimetabolites|antimetabolites|mesh-ancestor
6561805|NCT00952497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561806|NCT00952562|Cholecalciferol|cholecalciferol|mesh-list
6561807|NCT00952562|Vitamins|vitamins|mesh-ancestor
6561808|NCT00952562|Micronutrients|micronutrients|mesh-ancestor
6561809|NCT00952562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561810|NCT00952562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6561811|NCT00952562|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6561812|NCT00952575|Immunoglobulins|immunoglobulins|mesh-list
6561813|NCT00952575|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6561814|NCT00952575|Antibodies|antibodies|mesh-list
6561815|NCT00952575|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6561816|NCT00952575|gamma-Globulins|gamma-globulins|mesh-list
6561817|NCT00952575|Immunologic Factors|immunologic factors|mesh-ancestor
6561818|NCT00952575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561819|NCT00952627|Pycnogenols|pycnogenols|mesh-list
6561820|NCT00952627|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6561821|NCT00952627|Immunologic Factors|immunologic factors|mesh-ancestor
6561822|NCT00952627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561823|NCT00952627|Antioxidants|antioxidants|mesh-ancestor
6561824|NCT00952627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561825|NCT00952627|Protective Agents|protective agents|mesh-ancestor
6561826|NCT00952627|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6561827|NCT00952640|Vitamin A|vitamin a|mesh-list
6561828|NCT00952640|Vitamins|vitamins|mesh-ancestor
6561829|NCT00952640|Micronutrients|micronutrients|mesh-ancestor
6561830|NCT00952640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561831|NCT00952796|Moxifloxacin|moxifloxacin|mesh-list
6561832|NCT00952796|Ampicillin|ampicillin|mesh-list
6561833|NCT00952796|Sulbactam|sulbactam|mesh-list
6561834|NCT00952796|Sultamicillin|sultamicillin|mesh-list
6561835|NCT00952796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6561836|NCT00952796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6561837|NCT00952796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6561838|NCT00952796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6561839|NCT00952796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6561840|NCT00952796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561841|NCT00952796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6561842|NCT00952796|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6561843|NCT00952861|Doxycycline|doxycycline|mesh-list
6561844|NCT00952861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6561845|NCT00952861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6561846|NCT00952861|Antimalarials|antimalarials|mesh-ancestor
6561847|NCT00952861|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6561848|NCT00952861|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6561849|NCT00952913|Lansoprazole|lansoprazole|mesh-list
6561850|NCT00952913|Dexlansoprazole|dexlansoprazole|mesh-list
6561851|NCT00952913|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6561852|NCT00952913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6561853|NCT00952913|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6561854|NCT00952913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6561855|NCT00952913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561856|NCT00952952|Mesalamine|mesalamine|mesh-list
6561857|NCT00952952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6561858|NCT00952952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6561859|NCT00952952|Analgesics|analgesics|mesh-ancestor
6561860|NCT00952952|Sensory System Agents|sensory system agents|mesh-ancestor
6561861|NCT00952952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6561862|NCT00952952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561863|NCT00952952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6561864|NCT00952952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6561865|NCT00952978|Omeprazole|omeprazole|mesh-list
6561866|NCT00952978|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6561867|NCT00952978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6561868|NCT00952978|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6561869|NCT00952978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6561870|NCT00952978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561871|NCT00952991|Vildagliptin|vildagliptin|mesh-list
6561872|NCT00952991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6561873|NCT00952991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561874|NCT00952991|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6561875|NCT00952991|Protease Inhibitors|protease inhibitors|mesh-ancestor
6561876|NCT00952991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6561877|NCT00952991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561878|NCT00953108|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6561879|NCT00953108|Citalopram|citalopram|mesh-list
6019911|NCT00390455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6019912|NCT00390455|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6561880|NCT00953108|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6561881|NCT00953108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6561882|NCT00953108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6561883|NCT00953108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561884|NCT00953108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6561885|NCT00953108|Serotonin Agents|serotonin agents|mesh-ancestor
6561886|NCT00953108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561887|NCT00953108|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6561888|NCT00953108|Antidepressive Agents|antidepressive agents|mesh-ancestor
6561889|NCT00953108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6561890|NCT00953108|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6561891|NCT00953108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6561892|NCT00953108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6561893|NCT00953134|Folic Acid|folic acid|mesh-list
6561894|NCT00953134|Micronutrients|micronutrients|mesh-list
6561895|NCT00953134|Ferrous fumarate|ferrous fumarate|mesh-list
6561896|NCT00953134|Trace Elements|trace elements|mesh-list
6561897|NCT00953134|Hematinics|hematinics|mesh-ancestor
6561898|NCT00953134|Vitamin B Complex|vitamin b complex|mesh-ancestor
6561899|NCT00953134|Vitamins|vitamins|mesh-ancestor
6561900|NCT00953134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561901|NCT00953303|Dexamethasone|dexamethasone|mesh-list
6561902|NCT00953303|Dexamethasone acetate|dexamethasone acetate|mesh-list
6561903|NCT00953303|Prednisone|prednisone|mesh-list
6561904|NCT00953303|Torsemide|torsemide|mesh-list
6561905|NCT00953303|Dobutamine|dobutamine|mesh-list
6561906|NCT00953303|Dopamine|dopamine|mesh-list
6561907|NCT00953303|Furosemide|furosemide|mesh-list
6561908|NCT00953303|Nitroglycerin|nitroglycerin|mesh-list
6561909|NCT00953303|Glucocorticoids|glucocorticoids|mesh-list
6561910|NCT00953303|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
6561911|NCT00953303|BB 1101|bb 1101|mesh-list
6561912|NCT00953303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6561913|NCT00953303|Antiemetics|antiemetics|mesh-ancestor
6561914|NCT00953303|Autonomic Agents|autonomic agents|mesh-ancestor
6561915|NCT00953303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6561916|NCT00953303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561917|NCT00953303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6561918|NCT00953303|Hormones|hormones|mesh-ancestor
6561919|NCT00953303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6561920|NCT00953303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6561921|NCT00953303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6561922|NCT00953303|Protease Inhibitors|protease inhibitors|mesh-ancestor
6561923|NCT00953303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6561924|NCT00953303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561925|NCT00953303|Diuretics|diuretics|mesh-ancestor
6561926|NCT00953303|Natriuretic Agents|natriuretic agents|mesh-ancestor
6561927|NCT00953303|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6561928|NCT00953303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6561929|NCT00953303|Vasodilator Agents|vasodilator agents|mesh-ancestor
6561930|NCT00953303|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6561931|NCT00953303|Sympathomimetics|sympathomimetics|mesh-ancestor
6561932|NCT00953303|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6561933|NCT00953303|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6561934|NCT00953303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6561935|NCT00953303|Adrenergic Agents|adrenergic agents|mesh-ancestor
6561936|NCT00953303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6561937|NCT00953303|Protective Agents|protective agents|mesh-ancestor
6561938|NCT00953303|Dopamine Agents|dopamine agents|mesh-ancestor
6561939|NCT00953303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6561940|NCT00953355|Metformin|metformin|mesh-list
6561941|NCT00953355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6561942|NCT00953355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561943|NCT00953381|Omeprazole|omeprazole|mesh-list
6561944|NCT00953381|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6561945|NCT00953381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6561946|NCT00953381|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6561947|NCT00953381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6561948|NCT00953381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561949|NCT00953394|Octreotide|octreotide|mesh-list
6561950|NCT00953394|Fluorouracil|fluorouracil|mesh-list
6561951|NCT00953394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6561952|NCT00953394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6561953|NCT00953394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6561954|NCT00953394|Antimetabolites|antimetabolites|mesh-ancestor
6561955|NCT00953394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561956|NCT00953394|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6561957|NCT00953394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6561958|NCT00953394|Immunologic Factors|immunologic factors|mesh-ancestor
6561959|NCT00953394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561960|NCT00953459|Sunitinib|sunitinib|mesh-list
6561961|NCT00953459|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6561962|NCT00953459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6561963|NCT00953459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6561964|NCT00953459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6561965|NCT00953459|Growth Substances|growth substances|mesh-ancestor
6561966|NCT00953459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561967|NCT00953459|Growth Inhibitors|growth inhibitors|mesh-ancestor
6561968|NCT00953459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6561969|NCT00953459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6561970|NCT00953459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561971|NCT00953459|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6561972|NCT00953472|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6561973|NCT00953472|Natriuretic Agents|natriuretic agents|mesh-ancestor
6561974|NCT00953472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561975|NCT00953498|Pioglitazone|pioglitazone|mesh-list
6561976|NCT00953498|Rosiglitazone|rosiglitazone|mesh-list
6561977|NCT00953498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6561978|NCT00953498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561979|NCT00953537|Capecitabine|capecitabine|mesh-list
6561980|NCT00953537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6561981|NCT00953537|Antimetabolites|antimetabolites|mesh-ancestor
6561982|NCT00953537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561983|NCT00953537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6561984|NCT00953550|Rocuronium|rocuronium|mesh-list
6561985|NCT00953550|Succinylcholine|succinylcholine|mesh-list
6561986|NCT00953550|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6444174|NCT00382889|Respiratory System Agents|respiratory system agents|mesh-ancestor
6444175|NCT00382889|Tocolytic Agents|tocolytic agents|mesh-ancestor
6444176|NCT00382889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6444177|NCT00382889|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6444178|NCT00382889|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6561987|NCT00953550|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6561988|NCT00953550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6561989|NCT00953550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6561990|NCT00953550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6561991|NCT00953550|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
6656985|NCT01472770|Immunologic Factors|immunologic factors|mesh-ancestor
6656986|NCT01472770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656987|NCT01472783|Veliparib|veliparib|mesh-list
6656988|NCT01472783|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6656989|NCT01472783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6656990|NCT01472783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656991|NCT01472783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6656992|NCT01472796|Vitamin D|vitamin d|mesh-list
6656993|NCT01472796|Cholecalciferol|cholecalciferol|mesh-list
6656994|NCT01472796|Vitamins|vitamins|mesh-ancestor
6656995|NCT01472796|Micronutrients|micronutrients|mesh-ancestor
6656996|NCT01472796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6656997|NCT01472796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6656998|NCT01472796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6444179|NCT00382889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6444180|NCT00382889|Adrenergic Agents|adrenergic agents|mesh-ancestor
6444181|NCT00382889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6444182|NCT00382889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444183|NCT00382889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6444184|NCT00382889|Glucocorticoids|glucocorticoids|mesh-ancestor
6444185|NCT00382889|Hormones|hormones|mesh-ancestor
6444186|NCT00382889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6444187|NCT00382954|Bortezomib|bortezomib|mesh-list
6444188|NCT00382954|Idarubicin|idarubicin|mesh-list
6444189|NCT00382954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6444190|NCT00382954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6561992|NCT00953589|Ribavirin|ribavirin|mesh-list
6561993|NCT00953589|Antimetabolites|antimetabolites|mesh-ancestor
6561994|NCT00953589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6561995|NCT00953589|Antiviral Agents|antiviral agents|mesh-ancestor
6561996|NCT00953589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6561997|NCT00953628|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6561998|NCT00953628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6561999|NCT00953628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562000|NCT00953641|Misoprostol|misoprostol|mesh-list
6562001|NCT00953641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6562002|NCT00953641|Abortifacient Agents|abortifacient agents|mesh-ancestor
6562003|NCT00953641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6562004|NCT00953641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562005|NCT00953641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6562006|NCT00953641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6562007|NCT00953641|Oxytocics|oxytocics|mesh-ancestor
6562008|NCT00953771|Danazol|danazol|mesh-list
6562009|NCT00953771|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6562010|NCT00953771|Hormone Antagonists|hormone antagonists|mesh-ancestor
6562011|NCT00953771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6562012|NCT00953771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562013|NCT00953914|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
6562014|NCT00953914|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6562015|NCT00953914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6562016|NCT00953914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562017|NCT00953914|Cholinergic Agents|cholinergic agents|mesh-ancestor
6562018|NCT00953914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6562019|NCT00953914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562020|NCT00954005|Gemcitabine|gemcitabine|mesh-list
6562021|NCT00954005|Rituximab|rituximab|mesh-list
6562022|NCT00954005|Oxaliplatin|oxaliplatin|mesh-list
6562023|NCT00954005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6562024|NCT00954005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6562025|NCT00954005|Immunologic Factors|immunologic factors|mesh-ancestor
6562026|NCT00954005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562027|NCT00954005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6562028|NCT00954005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6562029|NCT00954005|Antimetabolites|antimetabolites|mesh-ancestor
6562030|NCT00954005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562031|NCT00954005|Antiviral Agents|antiviral agents|mesh-ancestor
6562032|NCT00954005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6562033|NCT00954005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6562034|NCT00954005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6562035|NCT00954096|Nicotine|nicotine|mesh-list
6562036|NCT00954096|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6562037|NCT00954096|Autonomic Agents|autonomic agents|mesh-ancestor
6562038|NCT00954096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6562039|NCT00954096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562040|NCT00954096|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6562041|NCT00954096|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6562042|NCT00954096|Cholinergic Agents|cholinergic agents|mesh-ancestor
6562043|NCT00954096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6562044|NCT00954096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562045|NCT00954135|Cyclophosphamide|cyclophosphamide|mesh-list
6562046|NCT00954135|Sorafenib|sorafenib|mesh-list
6562047|NCT00954135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6562048|NCT00954135|Immunologic Factors|immunologic factors|mesh-ancestor
6562049|NCT00954135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562050|NCT00954135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6562051|NCT00954135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6562052|NCT00954135|Alkylating Agents|alkylating agents|mesh-ancestor
6562053|NCT00954135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562054|NCT00954135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6562055|NCT00954135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6562056|NCT00954135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6562057|NCT00954135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6562058|NCT00954200|Ibuprofen|ibuprofen|mesh-list
6562059|NCT00954200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6562060|NCT00954200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6562061|NCT00954200|Analgesics|analgesics|mesh-ancestor
6562062|NCT00954200|Sensory System Agents|sensory system agents|mesh-ancestor
6562063|NCT00954200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6562064|NCT00954200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562065|NCT00954200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6562066|NCT00954200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6562067|NCT00954200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6562068|NCT00954200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6562069|NCT00954200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562070|NCT00954252|Flurbiprofen|flurbiprofen|mesh-list
6562071|NCT00954252|Analgesics|analgesics|mesh-ancestor
6562072|NCT00954252|Sensory System Agents|sensory system agents|mesh-ancestor
6562073|NCT00954252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6562074|NCT00954252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562075|NCT00954252|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6562076|NCT00954252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6562077|NCT00954252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6562078|NCT00954252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6562079|NCT00954252|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6562080|NCT00954252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6562081|NCT00954252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562082|NCT00954265|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6562083|NCT00954265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6562084|NCT00954265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562085|NCT00954278|Sorafenib|sorafenib|mesh-list
6562086|NCT00954278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6562087|NCT00954278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6562088|NCT00954278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6562089|NCT00954278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562090|NCT00954304|Loperamide|loperamide|mesh-list
6562091|NCT00954304|Antidiarrheals|antidiarrheals|mesh-list
6562092|NCT00954304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6562093|NCT00954395|Fibrin Fibrinogen Degradation Products|fibrin fibrinogen degradation products|mesh-list
6562094|NCT00954395|Fibrin fragment D|fibrin fragment d|mesh-list
6562095|NCT00954395|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6562096|NCT00954395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6562097|NCT00954395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562098|NCT00954395|Hemostatics|hemostatics|mesh-ancestor
6562099|NCT00954395|Coagulants|coagulants|mesh-ancestor
6562100|NCT00954395|Anticoagulants|anticoagulants|mesh-ancestor
6562101|NCT00954486|Epoetin Alfa|epoetin alfa|mesh-list
6562102|NCT00954486|Hematinics|hematinics|mesh-ancestor
6562103|NCT00954525|Ascorbic Acid|ascorbic acid|mesh-list
6562104|NCT00954525|Gemcitabine|gemcitabine|mesh-list
6562105|NCT00954525|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6562106|NCT00954525|Vitamins|vitamins|mesh-ancestor
6562107|NCT00954525|Micronutrients|micronutrients|mesh-ancestor
6562108|NCT00954525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562109|NCT00954525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6562110|NCT00954525|Antimetabolites|antimetabolites|mesh-ancestor
6562111|NCT00954525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562112|NCT00954525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6562113|NCT00954525|Antiviral Agents|antiviral agents|mesh-ancestor
6562114|NCT00954525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6562115|NCT00954525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6562116|NCT00954525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6562117|NCT00954525|Immunologic Factors|immunologic factors|mesh-ancestor
6562118|NCT00954525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6562119|NCT00954525|Antioxidants|antioxidants|mesh-ancestor
6562120|NCT00954525|Protective Agents|protective agents|mesh-ancestor
6562121|NCT00954564|Aromatase Inhibitors|aromatase inhibitors|mesh-list
6562122|NCT00954564|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6562123|NCT00954564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6562124|NCT00954564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562125|NCT00954564|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6562126|NCT00954564|Hormone Antagonists|hormone antagonists|mesh-ancestor
6562127|NCT00954564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6562128|NCT00954564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562129|NCT00954603|Haloperidol|haloperidol|mesh-list
6562130|NCT00954603|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6562131|NCT00954603|Haloperidol decanoate|haloperidol decanoate|mesh-list
6562132|NCT00954603|Antidepressive Agents|antidepressive agents|mesh-ancestor
6562133|NCT00954603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6562134|NCT00954603|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6562135|NCT00954603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6562136|NCT00954603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6562137|NCT00954603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562138|NCT00954603|Antiemetics|antiemetics|mesh-ancestor
6562139|NCT00954603|Autonomic Agents|autonomic agents|mesh-ancestor
6562140|NCT00954603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6562141|NCT00954603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6562142|NCT00954603|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6562143|NCT00954603|Dopamine Agents|dopamine agents|mesh-ancestor
6562144|NCT00954603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6562145|NCT00954603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562146|NCT00954603|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6562147|NCT00954642|Paclitaxel|paclitaxel|mesh-list
6562148|NCT00954642|Bevacizumab|bevacizumab|mesh-list
6562149|NCT00954642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6562150|NCT00954642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6562151|NCT00954642|Tubulin Modulators|tubulin modulators|mesh-ancestor
6562152|NCT00954642|Antimitotic Agents|antimitotic agents|mesh-ancestor
6562153|NCT00954642|Mitosis Modulators|mitosis modulators|mesh-ancestor
6562154|NCT00954642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562155|NCT00954642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6562156|NCT00954642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6562157|NCT00954642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6562158|NCT00954642|Growth Substances|growth substances|mesh-ancestor
6562159|NCT00954642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562160|NCT00954642|Growth Inhibitors|growth inhibitors|mesh-ancestor
6562161|NCT00954785|Diclofenac|diclofenac|mesh-list
6562162|NCT00954785|Etoricoxib|etoricoxib|mesh-list
6562163|NCT00954785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6562164|NCT00954785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6562165|NCT00954785|Analgesics|analgesics|mesh-ancestor
6562166|NCT00954785|Sensory System Agents|sensory system agents|mesh-ancestor
6562167|NCT00954785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6562168|NCT00954785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562169|NCT00954785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6562170|NCT00954785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6562171|NCT00954785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6562172|NCT00954785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6562173|NCT00954785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019913|NCT00390455|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6019914|NCT00390455|Hormone Antagonists|hormone antagonists|mesh-ancestor
6019915|NCT00390455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6019916|NCT00390455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019917|NCT00390455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6019918|NCT00390455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6019919|NCT00390455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019920|NCT00390546|Propranolol|propranolol|mesh-list
6019921|NCT00390546|Digoxin|digoxin|mesh-list
6444191|NCT00382954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6444192|NCT00382954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6444193|NCT00382954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6444194|NCT00382954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444195|NCT00382980|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6444196|NCT00382980|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6444197|NCT00382980|Immunologic Factors|immunologic factors|mesh-ancestor
6562174|NCT00954785|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6562175|NCT00954798|Vaccines|vaccines|mesh-list
6562176|NCT00954798|Immunologic Factors|immunologic factors|mesh-ancestor
6562177|NCT00954798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562178|NCT00954811|Progesterone|progesterone|mesh-list
6562179|NCT00954811|Progestins|progestins|mesh-ancestor
6562180|NCT00954811|Hormones|hormones|mesh-ancestor
6562181|NCT00954811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6562182|NCT00954811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562183|NCT00954876|Capecitabine|capecitabine|mesh-list
6562184|NCT00954876|Cetuximab|cetuximab|mesh-list
6562185|NCT00954876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6562186|NCT00954876|Antimetabolites|antimetabolites|mesh-ancestor
6562187|NCT00954876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562188|NCT00954876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6562189|NCT00954876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6562190|NCT00954889|Tamsulosin|tamsulosin|mesh-list
6562191|NCT00954889|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6562192|NCT00954889|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6562193|NCT00954889|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6562194|NCT00954889|Adrenergic Agents|adrenergic agents|mesh-ancestor
6562195|NCT00954889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6562196|NCT00954889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562197|NCT00954889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562198|NCT00954889|Urological Agents|urological agents|mesh-ancestor
6562199|NCT00954902|Antioxidants|antioxidants|mesh-list
6562200|NCT00954902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562201|NCT00954902|Protective Agents|protective agents|mesh-ancestor
6562202|NCT00954902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562203|NCT00955045|Istradefylline|istradefylline|mesh-list
6562204|NCT00955045|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
6562205|NCT00955045|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6562206|NCT00955045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6562207|NCT00955045|Purinergic Agents|purinergic agents|mesh-ancestor
6562208|NCT00955045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6562209|NCT00955045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562210|NCT00955045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562211|NCT00955149|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6562212|NCT00955149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6562213|NCT00955149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6562214|NCT00955149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6562215|NCT00955149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444198|NCT00382980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444199|NCT00382980|Antacids|antacids|mesh-ancestor
6562216|NCT00955162|Buprenorphine|buprenorphine|mesh-list
6562217|NCT00955162|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6562218|NCT00955162|Naloxone|naloxone|mesh-list
6562219|NCT00955162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6444200|NCT00382980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444201|NCT00382980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6562220|NCT00955162|Narcotics|narcotics|mesh-ancestor
6562221|NCT00955162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6562222|NCT00955162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562223|NCT00955162|Analgesics|analgesics|mesh-ancestor
6444202|NCT00383032|Mifepristone|mifepristone|mesh-list
6444203|NCT00383032|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6562224|NCT00955162|Sensory System Agents|sensory system agents|mesh-ancestor
6562225|NCT00955162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6562226|NCT00955162|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6562227|NCT00955214|Paclitaxel|paclitaxel|mesh-list
6562228|NCT00955214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6562229|NCT00955214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6562230|NCT00955214|Tubulin Modulators|tubulin modulators|mesh-ancestor
6562231|NCT00955214|Antimitotic Agents|antimitotic agents|mesh-ancestor
6562232|NCT00955214|Mitosis Modulators|mitosis modulators|mesh-ancestor
6562233|NCT00955214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562234|NCT00955227|Ezetimibe|ezetimibe|mesh-list
6562235|NCT00955227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6562236|NCT00955227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6562237|NCT00955227|Antimetabolites|antimetabolites|mesh-ancestor
6562238|NCT00955227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562239|NCT00955227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6562240|NCT00955240|Fluorouracil|fluorouracil|mesh-list
6562241|NCT00955240|Cetuximab|cetuximab|mesh-list
6444204|NCT00383032|Abortifacient Agents|abortifacient agents|mesh-ancestor
6444205|NCT00383032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6444206|NCT00383032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444207|NCT00383032|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6562242|NCT00955240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6562243|NCT00955240|Antimetabolites|antimetabolites|mesh-ancestor
6562244|NCT00955240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562245|NCT00955240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6562246|NCT00955240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6562247|NCT00955240|Immunologic Factors|immunologic factors|mesh-ancestor
6562248|NCT00955240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562249|NCT00955240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6562250|NCT00955318|Apomorphine|apomorphine|mesh-list
6562251|NCT00955318|Emetics|emetics|mesh-ancestor
6562252|NCT00955318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562253|NCT00955318|Autonomic Agents|autonomic agents|mesh-ancestor
6562254|NCT00955318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6562255|NCT00955318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6562256|NCT00955318|Dopamine Agonists|dopamine agonists|mesh-ancestor
6562257|NCT00955318|Dopamine Agents|dopamine agents|mesh-ancestor
6562258|NCT00955318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6562259|NCT00955318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6656999|NCT01472900|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6657000|NCT01472900|Dermatologic Agents|dermatologic agents|mesh-ancestor
6657001|NCT01472913|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6657002|NCT01472913|Hemostatics|hemostatics|mesh-ancestor
6657003|NCT01472913|Coagulants|coagulants|mesh-ancestor
6657004|NCT01472926|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6657005|NCT01472926|Plasminogen|plasminogen|mesh-list
6657006|NCT01472926|Tenecteplase|tenecteplase|mesh-list
6657007|NCT01472926|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6657008|NCT01472926|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6657009|NCT01472926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657010|NCT01472978|Metronidazole|metronidazole|mesh-list
6657011|NCT01472978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6657012|NCT01472978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6657013|NCT01472978|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6657014|NCT01472978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6657015|NCT01473043|Axitinib|axitinib|mesh-list
6657016|NCT01473043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6657017|NCT01473043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6657018|NCT01473043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6657019|NCT01473043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657020|NCT01473069|Ketoconazole|ketoconazole|mesh-list
6657021|NCT01473069|Antifungal Agents|antifungal agents|mesh-ancestor
6657022|NCT01473069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6657023|NCT01473069|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6657024|NCT01473069|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6657025|NCT01473069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6657026|NCT01473069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657027|NCT01473069|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6657028|NCT01473069|Hormone Antagonists|hormone antagonists|mesh-ancestor
6657029|NCT01473069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6657030|NCT01473069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657031|NCT01473069|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6664727|NCT01513720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6664728|NCT01513720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664729|NCT01513720|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6664730|NCT01513720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6664731|NCT01513720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6664732|NCT01513720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6664733|NCT01513720|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6664734|NCT01513772|Dexmedetomidine|dexmedetomidine|mesh-list
6664735|NCT01513772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6664736|NCT01513772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6664737|NCT01513772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664738|NCT01513772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6664739|NCT01513772|Analgesics|analgesics|mesh-ancestor
6664740|NCT01513772|Sensory System Agents|sensory system agents|mesh-ancestor
6664741|NCT01513772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6664742|NCT01513772|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6664743|NCT01513772|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6664744|NCT01513772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6664745|NCT01513772|Adrenergic Agents|adrenergic agents|mesh-ancestor
6664746|NCT01513772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6664747|NCT01513772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562260|NCT00955526|Istradefylline|istradefylline|mesh-list
6444208|NCT00383032|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6444209|NCT00383032|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6444210|NCT00383032|Contraceptive Agents|contraceptive agents|mesh-ancestor
6444211|NCT00383032|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6444212|NCT00383032|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6444213|NCT00383032|Hormone Antagonists|hormone antagonists|mesh-ancestor
6444214|NCT00383032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6444215|NCT00383032|Luteolytic Agents|luteolytic agents|mesh-ancestor
6444216|NCT00383032|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6562261|NCT00955526|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
6562262|NCT00955526|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6562263|NCT00955526|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6562264|NCT00955526|Purinergic Agents|purinergic agents|mesh-ancestor
6562265|NCT00955526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6562266|NCT00955526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562267|NCT00955526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562268|NCT00955604|Rasagiline|rasagiline|mesh-list
6562269|NCT00955604|Antidepressive Agents|antidepressive agents|mesh-list
6562270|NCT00955604|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6562271|NCT00955604|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6562272|NCT00955604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6562273|NCT00955604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562274|NCT00955604|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6562275|NCT00955604|Protective Agents|protective agents|mesh-ancestor
6562276|NCT00955604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562277|NCT00955630|Ranibizumab|ranibizumab|mesh-list
6562278|NCT00955630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6562279|NCT00955630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6562280|NCT00955630|Growth Substances|growth substances|mesh-ancestor
6562281|NCT00955630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562282|NCT00955630|Growth Inhibitors|growth inhibitors|mesh-ancestor
6562283|NCT00955630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6562284|NCT00955695|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6562285|NCT00955695|Gefitinib|gefitinib|mesh-list
6562286|NCT00955695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6562287|NCT00955695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6562288|NCT00955695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6562289|NCT00955695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562290|NCT00955773|Everolimus|everolimus|mesh-list
6562291|NCT00955773|Trametinib|trametinib|mesh-list
6562292|NCT00955773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6562293|NCT00955773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6562294|NCT00955773|Immunologic Factors|immunologic factors|mesh-ancestor
6562295|NCT00955773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562296|NCT00955773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6562297|NCT00955773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6562298|NCT00955773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562299|NCT00955851|Vaccines|vaccines|mesh-list
6562300|NCT00955851|Immunologic Factors|immunologic factors|mesh-ancestor
6562301|NCT00955851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562302|NCT00955890|Dexrazoxane|dexrazoxane|mesh-list
6562303|NCT00955890|Razoxane|razoxane|mesh-list
6562304|NCT00955890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6562305|NCT00955890|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6562306|NCT00955890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6562307|NCT00955890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6562308|NCT00955890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6562309|NCT00955890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562310|NCT00955890|Protective Agents|protective agents|mesh-ancestor
6562311|NCT00955890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562312|NCT00955890|Antimitotic Agents|antimitotic agents|mesh-ancestor
6562313|NCT00955890|Mitosis Modulators|mitosis modulators|mesh-ancestor
6562314|NCT00956007|Cetuximab|cetuximab|mesh-list
6562315|NCT00956007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6562316|NCT00956007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6562317|NCT00956046|Vaccines|vaccines|mesh-list
6562318|NCT00956046|Immunologic Factors|immunologic factors|mesh-ancestor
6562319|NCT00956046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562320|NCT00956059|Prednisone|prednisone|mesh-list
6562321|NCT00956059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6562322|NCT00956059|Glucocorticoids|glucocorticoids|mesh-ancestor
6562323|NCT00956059|Hormones|hormones|mesh-ancestor
6562324|NCT00956059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6562325|NCT00956059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562326|NCT00956059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6562327|NCT00956059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6562328|NCT00956072|Imatinib Mesylate|imatinib mesylate|mesh-list
6562329|NCT00956072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6562330|NCT00956072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6562331|NCT00956072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6562332|NCT00956072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562333|NCT00956098|Oltipraz|oltipraz|mesh-list
6562334|NCT00956098|Antiviral Agents|antiviral agents|mesh-ancestor
6562335|NCT00956098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6562336|NCT00956098|Schistosomicides|schistosomicides|mesh-ancestor
6562337|NCT00956098|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6562338|NCT00956098|Anthelmintics|anthelmintics|mesh-ancestor
6562339|NCT00956098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6562340|NCT00956098|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6562341|NCT00956098|Protective Agents|protective agents|mesh-ancestor
6562342|NCT00956098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562343|NCT00956098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6562344|NCT00956098|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6562345|NCT00956098|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6562346|NCT00956098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6562347|NCT00956098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562348|NCT00956111|Vaccines|vaccines|mesh-list
6562349|NCT00956111|Immunologic Factors|immunologic factors|mesh-ancestor
6562350|NCT00956111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562351|NCT00956150|Rifaximin|rifaximin|mesh-list
6562352|NCT00956150|Lactulose|lactulose|mesh-list
6562353|NCT00956150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6562354|NCT00956150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6562355|NCT00956150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6562356|NCT00956163|Diphosphonates|diphosphonates|mesh-list
6562357|NCT00956163|Methylene diphosphonate|methylene diphosphonate|mesh-list
6562358|NCT00956163|Listerine|listerine|mesh-list
6562359|NCT00956163|Fluorides|fluorides|mesh-list
6562360|NCT00956163|Sodium Fluoride|sodium fluoride|mesh-list
6562361|NCT00956163|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
6562362|NCT00956163|Cariostatic Agents|cariostatic agents|mesh-ancestor
6562363|NCT00956163|Protective Agents|protective agents|mesh-ancestor
6562364|NCT00956163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562365|NCT00956163|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6562366|NCT00956163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6562367|NCT00956163|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6562368|NCT00956163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562369|NCT00956163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6562370|NCT00956176|Cidofovir|cidofovir|mesh-list
6562371|NCT00956176|Antiviral Agents|antiviral agents|mesh-ancestor
6562372|NCT00956176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6562373|NCT00956176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6562374|NCT00956176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562375|NCT00956189|Aripiprazole|aripiprazole|mesh-list
6562376|NCT00956189|Amisulpride|amisulpride|mesh-list
6562377|NCT00956189|Antidepressive Agents|antidepressive agents|mesh-ancestor
6562378|NCT00956189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6562379|NCT00956189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6562380|NCT00956189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6562381|NCT00956189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6562382|NCT00956189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562383|NCT00956189|Dopamine Agonists|dopamine agonists|mesh-ancestor
6562384|NCT00956189|Dopamine Agents|dopamine agents|mesh-ancestor
6562385|NCT00956189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6562386|NCT00956189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562387|NCT00956189|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6562388|NCT00956189|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6562389|NCT00956189|Serotonin Agents|serotonin agents|mesh-ancestor
6562390|NCT00956189|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6562391|NCT00956189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6562392|NCT00956189|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6562393|NCT00956189|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6562394|NCT00956189|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6562395|NCT00956202|Vaccines|vaccines|mesh-list
6562396|NCT00956202|Immunologic Factors|immunologic factors|mesh-ancestor
6562397|NCT00956202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562398|NCT00956215|Aprepitant|aprepitant|mesh-list
6562399|NCT00956215|Fosaprepitant|fosaprepitant|mesh-list
6562400|NCT00956215|Antiemetics|antiemetics|mesh-ancestor
6562401|NCT00956215|Autonomic Agents|autonomic agents|mesh-ancestor
6562402|NCT00956215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6562403|NCT00956215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562404|NCT00956215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6562405|NCT00956215|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6562406|NCT00956215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6562407|NCT00956215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562408|NCT00956267|Letrozole|letrozole|mesh-list
6562409|NCT00956267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6562410|NCT00956267|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6562411|NCT00956267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6562412|NCT00956267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6562413|NCT00956267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562414|NCT00956267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6562415|NCT00956267|Hormone Antagonists|hormone antagonists|mesh-ancestor
6562416|NCT00956267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6562417|NCT00956267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562418|NCT00956306|Udenafil|udenafil|mesh-list
6562419|NCT00956306|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6562420|NCT00956306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6562421|NCT00956306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6562422|NCT00956306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562423|NCT00956319|Estazolam|estazolam|mesh-list
6562424|NCT00956319|Zolpidem|zolpidem|mesh-list
6562425|NCT00956319|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6562426|NCT00956319|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6562427|NCT00956319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6562428|NCT00956319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562429|NCT00956319|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6562430|NCT00956319|GABA Agonists|gaba agonists|mesh-ancestor
6562431|NCT00956319|GABA Agents|gaba agents|mesh-ancestor
6562432|NCT00956319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6562433|NCT00956319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562434|NCT00956319|Anticonvulsants|anticonvulsants|mesh-ancestor
6562435|NCT00956319|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6562436|NCT00956319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6562437|NCT00956319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6562438|NCT00956319|GABA Modulators|gaba modulators|mesh-ancestor
6562439|NCT00956397|Rifaximin|rifaximin|mesh-list
6562440|NCT00956397|Lactulose|lactulose|mesh-list
6562441|NCT00956397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6562442|NCT00956397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6562443|NCT00956397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6562444|NCT00956436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6562445|NCT00956436|Sorafenib|sorafenib|mesh-list
6562446|NCT00956436|Liver Extracts|liver extracts|mesh-list
6562447|NCT00956436|Antibodies|antibodies|mesh-list
6562448|NCT00956436|Immunoglobulins|immunoglobulins|mesh-list
6562449|NCT00956436|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6562450|NCT00956436|Immunologic Factors|immunologic factors|mesh-ancestor
6562451|NCT00956436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562452|NCT00956436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6562453|NCT00956436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6562454|NCT00956436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6562455|NCT00956436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562456|NCT00956436|Hematinics|hematinics|mesh-ancestor
6562457|NCT00956462|Dexamethasone|dexamethasone|mesh-list
6562458|NCT00956462|Ketorolac|ketorolac|mesh-list
6562459|NCT00956462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
6562460|NCT00956462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6562461|NCT00956462|Antiemetics|antiemetics|mesh-ancestor
6562462|NCT00956462|Autonomic Agents|autonomic agents|mesh-ancestor
6562463|NCT00956462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6562464|NCT00956462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562465|NCT00956462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6444217|NCT00383032|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6444218|NCT00383045|Naltrexone|naltrexone|mesh-list
6444219|NCT00383045|Buprenorphine|buprenorphine|mesh-list
6444220|NCT00383045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6444221|NCT00383045|Narcotics|narcotics|mesh-ancestor
6444222|NCT00383045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6444223|NCT00383045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444224|NCT00383045|Analgesics|analgesics|mesh-ancestor
6444225|NCT00383045|Sensory System Agents|sensory system agents|mesh-ancestor
6444226|NCT00383045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6444227|NCT00383045|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6444228|NCT00383045|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6562466|NCT00956462|Glucocorticoids|glucocorticoids|mesh-ancestor
6562467|NCT00956462|Hormones|hormones|mesh-ancestor
6562468|NCT00956462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6562469|NCT00956462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6562470|NCT00956462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6562471|NCT00956462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6562472|NCT00956462|Analgesics|analgesics|mesh-ancestor
6562473|NCT00956462|Sensory System Agents|sensory system agents|mesh-ancestor
6562474|NCT00956462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6562475|NCT00956462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6562476|NCT00956462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6562477|NCT00956462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562478|NCT00956644|Amlodipine|amlodipine|mesh-list
6562479|NCT00956644|Irbesartan|irbesartan|mesh-list
6562480|NCT00956644|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6562481|NCT00956644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6562482|NCT00956644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6562483|NCT00956644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562484|NCT00956644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6562485|NCT00956644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562486|NCT00956644|Vasodilator Agents|vasodilator agents|mesh-ancestor
6562487|NCT00956644|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6562488|NCT00956644|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6562489|NCT00956696|Topiramate|topiramate|mesh-list
6562490|NCT00956696|Anticonvulsants|anticonvulsants|mesh-ancestor
6562491|NCT00956696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6562492|NCT00956696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562493|NCT00956748|Acetylcysteine|acetylcysteine|mesh-list
6562494|NCT00956748|Ciprofloxacin|ciprofloxacin|mesh-list
6562495|NCT00956748|Dexamethasone|dexamethasone|mesh-list
6562496|NCT00956748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6562497|NCT00956748|Antiemetics|antiemetics|mesh-ancestor
6562498|NCT00956748|Autonomic Agents|autonomic agents|mesh-ancestor
6562499|NCT00956748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6562500|NCT00956748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562501|NCT00956748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6562502|NCT00956748|Glucocorticoids|glucocorticoids|mesh-ancestor
6562503|NCT00956748|Hormones|hormones|mesh-ancestor
6562504|NCT00956748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6562505|NCT00956748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6562506|NCT00956748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6562507|NCT00956748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6562508|NCT00956748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562509|NCT00956748|Antiviral Agents|antiviral agents|mesh-ancestor
6562510|NCT00956748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6562511|NCT00956748|Expectorants|expectorants|mesh-ancestor
6562512|NCT00956748|Respiratory System Agents|respiratory system agents|mesh-ancestor
6562513|NCT00956748|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6562514|NCT00956748|Antioxidants|antioxidants|mesh-ancestor
6562515|NCT00956748|Protective Agents|protective agents|mesh-ancestor
6562516|NCT00956748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6562517|NCT00956748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6562518|NCT00956748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6562519|NCT00956748|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6562520|NCT00956748|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6562521|NCT00956787|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
6562522|NCT00956787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6562523|NCT00956787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6562524|NCT00956982|Interferons|interferons|mesh-list
6562525|NCT00956982|Ribavirin|ribavirin|mesh-list
6562526|NCT00956982|Interferon-alpha|interferon-alpha|mesh-list
6562527|NCT00956982|Interferon alpha-2|interferon alpha-2|mesh-list
6562528|NCT00956982|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6562529|NCT00956982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6562530|NCT00956982|Antiviral Agents|antiviral agents|mesh-ancestor
6562531|NCT00956982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6562532|NCT00956982|Antimetabolites|antimetabolites|mesh-ancestor
6562533|NCT00956982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562534|NCT00956982|Immunologic Factors|immunologic factors|mesh-ancestor
6562535|NCT00956982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562536|NCT00957060|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6562537|NCT00957060|Glimepiride|glimepiride|mesh-list
6562538|NCT00957060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6562539|NCT00957060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562540|NCT00957060|Incretins|incretins|mesh-ancestor
6562541|NCT00957060|Hormones|hormones|mesh-ancestor
6562542|NCT00957060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6562543|NCT00957060|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6562544|NCT00957060|Protease Inhibitors|protease inhibitors|mesh-ancestor
6562545|NCT00957060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6562546|NCT00957060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562547|NCT00957060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6562548|NCT00957060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6562549|NCT00957060|Immunologic Factors|immunologic factors|mesh-ancestor
6562550|NCT00957086|Nimotuzumab|nimotuzumab|mesh-list
6562551|NCT00957086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6562552|NCT00957086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6562553|NCT00957125|Bevacizumab|bevacizumab|mesh-list
6562554|NCT00957125|Docetaxel|docetaxel|mesh-list
6562555|NCT00957125|Epirubicin|epirubicin|mesh-list
6562556|NCT00957125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6562557|NCT00957125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6562558|NCT00957125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6562559|NCT00957125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6562560|NCT00957125|Growth Substances|growth substances|mesh-ancestor
6562561|NCT00957125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562562|NCT00957125|Growth Inhibitors|growth inhibitors|mesh-ancestor
6562563|NCT00957125|Tubulin Modulators|tubulin modulators|mesh-ancestor
6562564|NCT00957125|Antimitotic Agents|antimitotic agents|mesh-ancestor
6562565|NCT00957125|Mitosis Modulators|mitosis modulators|mesh-ancestor
6562566|NCT00957125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562567|NCT00957125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5724780|NCT03185143|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6562568|NCT00957125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6562569|NCT00957125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6562570|NCT00957125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6657032|NCT01473147|Exenatide|exenatide|mesh-list
6657033|NCT01473147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6657034|NCT01473147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657035|NCT01473147|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6657036|NCT01473147|Incretins|incretins|mesh-ancestor
6657037|NCT01473147|Hormones|hormones|mesh-ancestor
6657038|NCT01473147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6657039|NCT01473173|Esomeprazole|esomeprazole|mesh-list
6657040|NCT01473173|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6657041|NCT01473173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6657042|NCT01473173|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6657043|NCT01473173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6657044|NCT01473173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657045|NCT01473251|Bevacizumab|bevacizumab|mesh-list
6657046|NCT01473251|Ranibizumab|ranibizumab|mesh-list
6657047|NCT01473251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6657048|NCT01473251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6657049|NCT01473251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6657050|NCT01473251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6657051|NCT01473251|Growth Substances|growth substances|mesh-ancestor
6657052|NCT01473251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657053|NCT01473251|Growth Inhibitors|growth inhibitors|mesh-ancestor
6657054|NCT01473277|Triamcinolone|triamcinolone|mesh-list
6657055|NCT01473277|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6657056|NCT01473277|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6657057|NCT01473277|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6657058|NCT01473277|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6657059|NCT01473277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6657060|NCT01473277|Glucocorticoids|glucocorticoids|mesh-ancestor
6657061|NCT01473277|Hormones|hormones|mesh-ancestor
6657062|NCT01473277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6657063|NCT01473277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657064|NCT01473277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6657065|NCT01473277|Immunologic Factors|immunologic factors|mesh-ancestor
6657066|NCT01473277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6657067|NCT01473277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657068|NCT01473277|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6657069|NCT01473277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6657070|NCT01473277|Cholinergic Agents|cholinergic agents|mesh-ancestor
6657071|NCT01473277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6657072|NCT01473303|Leucovorin|leucovorin|mesh-list
6657073|NCT01473303|Fluorouracil|fluorouracil|mesh-list
6657074|NCT01473303|Oxaliplatin|oxaliplatin|mesh-list
6657075|NCT01473303|Irinotecan|irinotecan|mesh-list
6657076|NCT01473303|Calcium|calcium|mesh-list
6657077|NCT01473303|Levoleucovorin|levoleucovorin|mesh-list
6657078|NCT01473303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6657079|NCT01473303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657080|NCT01473303|Antimetabolites|antimetabolites|mesh-ancestor
6657081|NCT01473303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657082|NCT01473303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6657083|NCT01473303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6657084|NCT01473303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6657085|NCT01473303|Immunologic Factors|immunologic factors|mesh-ancestor
6657086|NCT01473303|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6657087|NCT01473303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6657088|NCT01473303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6657089|NCT01473303|Antidotes|antidotes|mesh-ancestor
6657090|NCT01473303|Protective Agents|protective agents|mesh-ancestor
6657091|NCT01473303|Vitamin B Complex|vitamin b complex|mesh-ancestor
6657092|NCT01473303|Vitamins|vitamins|mesh-ancestor
6657093|NCT01473303|Micronutrients|micronutrients|mesh-ancestor
6657094|NCT01473316|Ketoconazole|ketoconazole|mesh-list
6657095|NCT01473316|Antifungal Agents|antifungal agents|mesh-ancestor
6657096|NCT01473316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6657097|NCT01473316|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6657098|NCT01473316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6657099|NCT01473316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6657100|NCT01473316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657101|NCT01473316|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6657102|NCT01473316|Hormone Antagonists|hormone antagonists|mesh-ancestor
6562571|NCT00957177|Pregabalin|pregabalin|mesh-list
6562572|NCT00957177|Analgesics|analgesics|mesh-ancestor
6562573|NCT00957177|Sensory System Agents|sensory system agents|mesh-ancestor
6562574|NCT00957177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6562575|NCT00957177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562576|NCT00957177|Anticonvulsants|anticonvulsants|mesh-ancestor
6562577|NCT00957177|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6562578|NCT00957177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6562579|NCT00957177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562580|NCT00957177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6562581|NCT00957177|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6562582|NCT00957177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6562583|NCT00957177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6562584|NCT00957177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6562585|NCT00957190|Timolol|timolol|mesh-list
6562586|NCT00957190|Dorzolamide|dorzolamide|mesh-list
6562587|NCT00957190|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6562588|NCT00957190|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6562589|NCT00957190|Adrenergic Agents|adrenergic agents|mesh-ancestor
6562590|NCT00957190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6562591|NCT00957190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562592|NCT00957190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562593|NCT00957190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6562594|NCT00957190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6562595|NCT00957190|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6562596|NCT00957190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6562597|NCT00957203|Istradefylline|istradefylline|mesh-list
6562598|NCT00957203|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
6562599|NCT00957203|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6562600|NCT00957203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6562601|NCT00957203|Purinergic Agents|purinergic agents|mesh-ancestor
6562602|NCT00957203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6562603|NCT00957203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562604|NCT00957203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562605|NCT00957216|Ubiquinone|ubiquinone|mesh-list
6562606|NCT00957216|Coenzyme Q10|coenzyme q10|mesh-list
6562607|NCT00957216|Micronutrients|micronutrients|mesh-ancestor
6562608|NCT00957216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562609|NCT00957216|Vitamins|vitamins|mesh-ancestor
6562610|NCT00957320|Sirolimus|sirolimus|mesh-list
6562611|NCT00957320|Asparaginase|asparaginase|mesh-list
6562612|NCT00957320|Pegaspargase|pegaspargase|mesh-list
6562613|NCT00957320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6562614|NCT00957320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6562615|NCT00957320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6562616|NCT00957320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6562617|NCT00957320|Antifungal Agents|antifungal agents|mesh-ancestor
6562618|NCT00957320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6562619|NCT00957320|Immunologic Factors|immunologic factors|mesh-ancestor
6562620|NCT00957320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562621|NCT00957346|Misoprostol|misoprostol|mesh-list
6562622|NCT00957346|Mifepristone|mifepristone|mesh-list
6562623|NCT00957346|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6562624|NCT00957346|Abortifacient Agents|abortifacient agents|mesh-ancestor
6562625|NCT00957346|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6562626|NCT00957346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562627|NCT00957346|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6562628|NCT00957346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6562629|NCT00957346|Oxytocics|oxytocics|mesh-ancestor
6562630|NCT00957346|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6562631|NCT00957346|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6562632|NCT00957346|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6562633|NCT00957346|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6562634|NCT00957346|Contraceptive Agents|contraceptive agents|mesh-ancestor
6562635|NCT00957346|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6562636|NCT00957346|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6562637|NCT00957346|Hormone Antagonists|hormone antagonists|mesh-ancestor
6562638|NCT00957346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6562639|NCT00957346|Luteolytic Agents|luteolytic agents|mesh-ancestor
6562640|NCT00957346|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6562641|NCT00957346|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6562642|NCT00957385|Lenalidomide|lenalidomide|mesh-list
6562643|NCT00957385|Immunologic Factors|immunologic factors|mesh-ancestor
6562644|NCT00957385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562645|NCT00957385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6562646|NCT00957385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6562647|NCT00957385|Growth Substances|growth substances|mesh-ancestor
6562648|NCT00957385|Growth Inhibitors|growth inhibitors|mesh-ancestor
6562649|NCT00957385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6562650|NCT00957411|Cetuximab|cetuximab|mesh-list
6562651|NCT00957411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6562652|NCT00957411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6562653|NCT00957554|Amlodipine|amlodipine|mesh-list
6562654|NCT00957554|Irbesartan|irbesartan|mesh-list
6562655|NCT00957554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6562656|NCT00957554|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6562657|NCT00957554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6562658|NCT00957554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562659|NCT00957554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6562660|NCT00957554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562661|NCT00957554|Vasodilator Agents|vasodilator agents|mesh-ancestor
6562662|NCT00957554|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6562663|NCT00957554|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6562664|NCT00957866|Interferons|interferons|mesh-list
6562665|NCT00957866|Ribavirin|ribavirin|mesh-list
6562666|NCT00957866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6562667|NCT00957866|Antiviral Agents|antiviral agents|mesh-ancestor
6562668|NCT00957866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6562669|NCT00957866|Antimetabolites|antimetabolites|mesh-ancestor
6562670|NCT00957866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562671|NCT00957879|Calcitriol|calcitriol|mesh-list
6562672|NCT00957879|Ergocalciferols|ergocalciferols|mesh-list
6562673|NCT00957879|Vitamin D|vitamin d|mesh-list
6444229|NCT00383136|Tirofiban|tirofiban|mesh-list
6444230|NCT00383136|Abciximab|abciximab|mesh-list
6444231|NCT00383136|Anticoagulants|anticoagulants|mesh-ancestor
6444232|NCT00383136|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6444233|NCT00383136|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6562674|NCT00957879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6562675|NCT00957879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562676|NCT00957879|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6562677|NCT00957879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6562678|NCT00957879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562679|NCT00957879|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6562680|NCT00957879|Vitamins|vitamins|mesh-ancestor
6562681|NCT00957879|Micronutrients|micronutrients|mesh-ancestor
6562682|NCT00957879|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6444234|NCT00383136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6444235|NCT00383136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461676|NCT00455585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6461677|NCT00455585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6461678|NCT00455585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6461679|NCT00455585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461680|NCT00455585|Antiviral Agents|antiviral agents|mesh-ancestor
6461681|NCT00455585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6461682|NCT00455585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6461683|NCT00455585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6461684|NCT00455585|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6461685|NCT00455585|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6461686|NCT00455585|Antimetabolites|antimetabolites|mesh-ancestor
6461687|NCT00455624|Androgens|androgens|mesh-list
6562683|NCT00958022|Carboplatin|carboplatin|mesh-list
6562684|NCT00958022|Etoposide|etoposide|mesh-list
6562685|NCT00958022|Etoposide phosphate|etoposide phosphate|mesh-list
6562686|NCT00958022|Panobinostat|panobinostat|mesh-list
6562687|NCT00958022|Podophyllotoxin|podophyllotoxin|mesh-list
6562688|NCT00958022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6562689|NCT00958022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6562690|NCT00958022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6562691|NCT00958022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6562692|NCT00958022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6461688|NCT00455624|Hormones|hormones|mesh-ancestor
6562693|NCT00958022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562694|NCT00958022|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6562695|NCT00958022|Keratolytic Agents|keratolytic agents|mesh-ancestor
6562696|NCT00958022|Dermatologic Agents|dermatologic agents|mesh-ancestor
6562697|NCT00958022|Tubulin Modulators|tubulin modulators|mesh-ancestor
6562698|NCT00958022|Antimitotic Agents|antimitotic agents|mesh-ancestor
6562699|NCT00958022|Mitosis Modulators|mitosis modulators|mesh-ancestor
6562700|NCT00958100|Tenofovir|tenofovir|mesh-list
6562701|NCT00958100|Lamivudine|lamivudine|mesh-list
6562702|NCT00958100|Emtricitabine|emtricitabine|mesh-list
6562703|NCT00958100|Raltegravir Potassium|raltegravir potassium|mesh-list
6562704|NCT00958100|Abacavir|abacavir|mesh-list
6562705|NCT00958100|Dideoxynucleosides|dideoxynucleosides|mesh-list
6562706|NCT00958100|Antiviral Agents|antiviral agents|mesh-ancestor
6562707|NCT00958100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6562708|NCT00958100|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6562709|NCT00958100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6562710|NCT00958100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6562711|NCT00958100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562712|NCT00958100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6562713|NCT00958100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6562714|NCT00958100|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6562715|NCT00958100|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6562716|NCT00958100|Antimetabolites|antimetabolites|mesh-ancestor
6562717|NCT00958139|Permethrin|permethrin|mesh-list
6562718|NCT00958139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6562719|NCT00958139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562720|NCT00958204|Fluoxetine|fluoxetine|mesh-list
6562721|NCT00958204|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6562722|NCT00958204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6562723|NCT00958204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6562724|NCT00958204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562725|NCT00958204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6444236|NCT00383214|Epratuzumab|epratuzumab|mesh-list
6444237|NCT00383214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6444238|NCT00383214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6444239|NCT00383357|Zolpidem|zolpidem|mesh-list
6444240|NCT00383357|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6444241|NCT00383357|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6444242|NCT00383357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6444243|NCT00383357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444244|NCT00383357|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6444245|NCT00383357|GABA Agonists|gaba agonists|mesh-ancestor
6444246|NCT00383357|GABA Agents|gaba agents|mesh-ancestor
6444247|NCT00383357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6444248|NCT00383357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444249|NCT00383370|Aflibercept|aflibercept|mesh-list
6444250|NCT00383370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6444251|NCT00383370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6444252|NCT00383370|Growth Substances|growth substances|mesh-ancestor
6562726|NCT00958204|Serotonin Agents|serotonin agents|mesh-ancestor
6562727|NCT00958204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562728|NCT00958204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6562729|NCT00958204|Antidepressive Agents|antidepressive agents|mesh-ancestor
6562730|NCT00958204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6562731|NCT00958204|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6562732|NCT00958204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6562733|NCT00958204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6562734|NCT00958269|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6562735|NCT00958269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6562736|NCT00958269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562737|NCT00958269|Incretins|incretins|mesh-ancestor
6562738|NCT00958269|Hormones|hormones|mesh-ancestor
6562739|NCT00958269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6562740|NCT00958269|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6562741|NCT00958269|Protease Inhibitors|protease inhibitors|mesh-ancestor
6562742|NCT00958269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6562743|NCT00958269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562744|NCT00958321|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6562745|NCT00958321|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6562746|NCT00958321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562747|NCT00958386|Irinotecan|irinotecan|mesh-list
6562748|NCT00958386|Panitumumab|panitumumab|mesh-list
6562749|NCT00958386|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6562750|NCT00958386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6562751|NCT00958386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6562752|NCT00958386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562753|NCT00958386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6562754|NCT00958386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6562755|NCT00958425|Hyaluronic Acid|hyaluronic acid|mesh-list
6562756|NCT00958425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6562757|NCT00958425|Immunologic Factors|immunologic factors|mesh-ancestor
6562758|NCT00958425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562759|NCT00958425|Viscosupplements|viscosupplements|mesh-ancestor
6562760|NCT00958425|Protective Agents|protective agents|mesh-ancestor
6562761|NCT00958451|Ergocalciferols|ergocalciferols|mesh-list
6562762|NCT00958451|Vitamin D|vitamin d|mesh-list
6562763|NCT00958451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6562764|NCT00958451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562765|NCT00958451|Vitamins|vitamins|mesh-ancestor
6562766|NCT00958451|Micronutrients|micronutrients|mesh-ancestor
6562767|NCT00958451|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6562768|NCT00958503|Thiamphenicol|thiamphenicol|mesh-list
6562769|NCT00958503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6562770|NCT00958503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6562771|NCT00958633|Citalopram|citalopram|mesh-list
6562772|NCT00958633|Bupropion|bupropion|mesh-list
5724781|NCT03185143|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6562773|NCT00958633|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6562774|NCT00958633|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6562775|NCT00958633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6562776|NCT00958633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562777|NCT00958633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6562778|NCT00958633|Serotonin Agents|serotonin agents|mesh-ancestor
6562779|NCT00958633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562780|NCT00958633|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6562781|NCT00958633|Antidepressive Agents|antidepressive agents|mesh-ancestor
6562782|NCT00958633|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6562783|NCT00958633|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6562784|NCT00958633|Dopamine Agents|dopamine agents|mesh-ancestor
6562785|NCT00958633|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6562786|NCT00958633|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6562787|NCT00958633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6562788|NCT00958750|Minoxidil|minoxidil|mesh-list
6562789|NCT00958750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6562790|NCT00958750|Vasodilator Agents|vasodilator agents|mesh-ancestor
6562791|NCT00958854|Thalidomide|thalidomide|mesh-list
6562792|NCT00958854|Cyclophosphamide|cyclophosphamide|mesh-list
6562793|NCT00958854|Fludarabine|fludarabine|mesh-list
6562794|NCT00958854|Fludarabine phosphate|fludarabine phosphate|mesh-list
6562795|NCT00958854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6562796|NCT00958854|Immunologic Factors|immunologic factors|mesh-ancestor
6562797|NCT00958854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562798|NCT00958854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6562799|NCT00958854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6562800|NCT00958854|Alkylating Agents|alkylating agents|mesh-ancestor
6562801|NCT00958854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562802|NCT00958854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6562803|NCT00958854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6562804|NCT00958854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6562805|NCT00958854|Antimetabolites|antimetabolites|mesh-ancestor
6562806|NCT00958854|Leprostatic Agents|leprostatic agents|mesh-ancestor
6562807|NCT00958854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6562808|NCT00958854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6562809|NCT00958854|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6562810|NCT00958854|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6562811|NCT00958854|Growth Substances|growth substances|mesh-ancestor
6562812|NCT00958854|Growth Inhibitors|growth inhibitors|mesh-ancestor
6562813|NCT00958906|Infliximab|infliximab|mesh-list
6562814|NCT00958906|Dermatologic Agents|dermatologic agents|mesh-ancestor
6562815|NCT00958906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6562816|NCT00958906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6562817|NCT00959062|Clonidine|clonidine|mesh-list
6562818|NCT00959062|Analgesics|analgesics|mesh-ancestor
6562819|NCT00959062|Sensory System Agents|sensory system agents|mesh-ancestor
6562820|NCT00959062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6562821|NCT00959062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562822|NCT00959062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6562823|NCT00959062|Sympatholytics|sympatholytics|mesh-ancestor
6562824|NCT00959062|Autonomic Agents|autonomic agents|mesh-ancestor
6562825|NCT00959062|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6562826|NCT00959062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6562827|NCT00959062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6562828|NCT00959062|Adrenergic Agents|adrenergic agents|mesh-ancestor
6562829|NCT00959062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6562830|NCT00959062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562831|NCT00959075|Thiamine|thiamine|mesh-list
6562832|NCT00959075|Vitamins|vitamins|mesh-ancestor
6562833|NCT00959075|Micronutrients|micronutrients|mesh-ancestor
6562834|NCT00959075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562835|NCT00959075|Vitamin B Complex|vitamin b complex|mesh-ancestor
6562836|NCT00959101|Metformin|metformin|mesh-list
6562837|NCT00959101|Repaglinide|repaglinide|mesh-list
6562838|NCT00959101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6562839|NCT00959101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562840|NCT00959218|Dronabinol|dronabinol|mesh-list
6562841|NCT00959218|Hallucinogens|hallucinogens|mesh-ancestor
6562842|NCT00959218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562843|NCT00959218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6562844|NCT00959218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6562845|NCT00959218|Analgesics|analgesics|mesh-ancestor
6562846|NCT00959218|Sensory System Agents|sensory system agents|mesh-ancestor
6562847|NCT00959218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6562848|NCT00959218|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6562849|NCT00959218|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6562850|NCT00959218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6562851|NCT00959218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562852|NCT00959218|Hormones|hormones|mesh-ancestor
6562853|NCT00959218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6562854|NCT00959231|Cyclosporine|cyclosporine|mesh-list
6562855|NCT00959231|Mycophenolic Acid|mycophenolic acid|mesh-list
6562856|NCT00959231|Cyclophosphamide|cyclophosphamide|mesh-list
6562857|NCT00959231|Fludarabine|fludarabine|mesh-list
6562858|NCT00959231|Fludarabine phosphate|fludarabine phosphate|mesh-list
6562859|NCT00959231|Cyclosporins|cyclosporins|mesh-list
6562860|NCT00959231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6562861|NCT00959231|Immunologic Factors|immunologic factors|mesh-ancestor
6562862|NCT00959231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562863|NCT00959231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6562864|NCT00959231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6562865|NCT00959231|Alkylating Agents|alkylating agents|mesh-ancestor
6562866|NCT00959231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562867|NCT00959231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6562868|NCT00959231|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6562869|NCT00959231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6562870|NCT00959231|Antimetabolites|antimetabolites|mesh-ancestor
6562871|NCT00959231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6562872|NCT00959231|Antifungal Agents|antifungal agents|mesh-ancestor
6562873|NCT00959231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6562874|NCT00959231|Dermatologic Agents|dermatologic agents|mesh-ancestor
6562875|NCT00959231|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6562876|NCT00959231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6562877|NCT00959231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6562878|NCT00959231|Antitubercular Agents|antitubercular agents|mesh-ancestor
6562879|NCT00959231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6657103|NCT01473316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6657104|NCT01473316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657105|NCT01473316|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6657106|NCT01473472|Tenofovir|tenofovir|mesh-list
6657107|NCT01473472|Emtricitabine|emtricitabine|mesh-list
6657108|NCT01473472|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6657109|NCT01473472|Antiviral Agents|antiviral agents|mesh-ancestor
6657110|NCT01473472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6657111|NCT01473472|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6657112|NCT01473472|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6657113|NCT01473472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6657114|NCT01473472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657115|NCT01473472|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6657116|NCT01473472|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6657117|NCT01473537|Calcium|calcium|mesh-list
6657118|NCT01473537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6657119|NCT01473537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657120|NCT01473628|Rituximab|rituximab|mesh-list
6657121|NCT01473628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6657122|NCT01473628|Antibodies|antibodies|mesh-list
6657123|NCT01473628|Immunoglobulins|immunoglobulins|mesh-list
6657124|NCT01473628|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6657125|NCT01473628|Immunologic Factors|immunologic factors|mesh-ancestor
6657126|NCT01473628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657127|NCT01473628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6657128|NCT01473628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6657129|NCT01473797|Cladribine|cladribine|mesh-list
6657130|NCT01473797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6657131|NCT01473797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6657132|NCT01473797|Immunologic Factors|immunologic factors|mesh-ancestor
6657133|NCT01473797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657134|NCT01473810|Endocine|endocine|mesh-list
6657135|NCT01473810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6657136|NCT01473810|Immunologic Factors|immunologic factors|mesh-ancestor
6657137|NCT01473810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657138|NCT01473901|Temozolomide|temozolomide|mesh-list
6657139|NCT01473901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6657140|NCT01473901|Alkylating Agents|alkylating agents|mesh-ancestor
6657141|NCT01473901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444253|NCT00383370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562880|NCT00959335|Bicalutamide|bicalutamide|mesh-list
6562881|NCT00959335|Androgen Antagonists|androgen antagonists|mesh-ancestor
6562882|NCT00959335|Hormone Antagonists|hormone antagonists|mesh-ancestor
6562883|NCT00959335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6562884|NCT00959335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562885|NCT00959335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6562886|NCT00959387|Paclitaxel|paclitaxel|mesh-list
6562887|NCT00959387|Cisplatin|cisplatin|mesh-list
6562888|NCT00959387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6562889|NCT00959387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6562890|NCT00959387|Tubulin Modulators|tubulin modulators|mesh-ancestor
6562891|NCT00959387|Antimitotic Agents|antimitotic agents|mesh-ancestor
6562892|NCT00959387|Mitosis Modulators|mitosis modulators|mesh-ancestor
6562893|NCT00959387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562894|NCT00959400|Fentanyl|fentanyl|mesh-list
6562895|NCT00959400|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6562896|NCT00959400|Narcotics|narcotics|mesh-ancestor
6562897|NCT00959400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6562898|NCT00959400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562899|NCT00959400|Analgesics|analgesics|mesh-ancestor
6562900|NCT00959400|Sensory System Agents|sensory system agents|mesh-ancestor
6562901|NCT00959400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6562902|NCT00959400|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6562903|NCT00959400|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6562904|NCT00959400|Anesthetics, General|anesthetics, general|mesh-ancestor
6562905|NCT00959400|Anesthetics|anesthetics|mesh-ancestor
6562906|NCT00959439|Naproxen|naproxen|mesh-list
6562907|NCT00959439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6444254|NCT00383370|Growth Inhibitors|growth inhibitors|mesh-ancestor
6444255|NCT00383370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6444256|NCT00383396|Cyclosporine|cyclosporine|mesh-list
6444257|NCT00383396|Cyclosporins|cyclosporins|mesh-list
6444258|NCT00383396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6562908|NCT00959439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6562909|NCT00959439|Analgesics|analgesics|mesh-ancestor
6562910|NCT00959439|Sensory System Agents|sensory system agents|mesh-ancestor
6562911|NCT00959439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6562912|NCT00959439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562913|NCT00959439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6562914|NCT00959439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6562915|NCT00959439|Gout Suppressants|gout suppressants|mesh-ancestor
6562916|NCT00959439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6562917|NCT00959439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6562918|NCT00959439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562919|NCT00959478|Carbon Monoxide|carbon monoxide|mesh-list
6444259|NCT00383396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444260|NCT00383396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6444261|NCT00383396|Immunologic Factors|immunologic factors|mesh-ancestor
6444262|NCT00383396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562920|NCT00959478|Antimetabolites|antimetabolites|mesh-ancestor
6562921|NCT00959478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562922|NCT00959478|Gasotransmitters|gasotransmitters|mesh-ancestor
6562923|NCT00959478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6562924|NCT00959478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562925|NCT00959517|Artesunate|artesunate|mesh-list
6562926|NCT00959517|Chloroquine|chloroquine|mesh-list
6562927|NCT00959517|Pyrimethamine|pyrimethamine|mesh-list
6562928|NCT00959517|Primaquine|primaquine|mesh-list
6562929|NCT00959517|Sulfadoxine|sulfadoxine|mesh-list
6444263|NCT00383396|Antifungal Agents|antifungal agents|mesh-ancestor
6562930|NCT00959517|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6562931|NCT00959517|Antimalarials|antimalarials|mesh-ancestor
6562932|NCT00959517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6562933|NCT00959517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6562934|NCT00959517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6562935|NCT00959517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6562936|NCT00959517|Antiviral Agents|antiviral agents|mesh-ancestor
6562937|NCT00959517|Schistosomicides|schistosomicides|mesh-ancestor
6562938|NCT00959517|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6562939|NCT00959517|Anthelmintics|anthelmintics|mesh-ancestor
6562940|NCT00959517|Amebicides|amebicides|mesh-ancestor
6562941|NCT00959517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6562942|NCT00959517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6562943|NCT00959517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6562944|NCT00959517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562945|NCT00959517|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6562946|NCT00959517|Renal Agents|renal agents|mesh-ancestor
6562947|NCT00959569|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
6562948|NCT00959569|Esmolol|esmolol|mesh-list
6562949|NCT00959569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6562950|NCT00959569|Adrenergic Agents|adrenergic agents|mesh-ancestor
6562951|NCT00959569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6562952|NCT00959569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562953|NCT00959569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562954|NCT00959569|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6562955|NCT00959582|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6562956|NCT00959582|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6562957|NCT00959582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562958|NCT00959595|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
6562959|NCT00959595|Anesthetics, Local|anesthetics, local|mesh-ancestor
6562960|NCT00959595|Anesthetics|anesthetics|mesh-ancestor
6562961|NCT00959595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6562962|NCT00959595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562963|NCT00959595|Sensory System Agents|sensory system agents|mesh-ancestor
6562964|NCT00959595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6562965|NCT00959595|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
6562966|NCT00959621|Aspirin|aspirin|mesh-list
6562967|NCT00959621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6562968|NCT00959621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6562969|NCT00959621|Analgesics|analgesics|mesh-ancestor
6562970|NCT00959621|Sensory System Agents|sensory system agents|mesh-ancestor
6562971|NCT00959621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6562972|NCT00959621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562973|NCT00959621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6562974|NCT00959621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6562975|NCT00959621|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6562976|NCT00959621|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6562977|NCT00959621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562978|NCT00959621|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6562979|NCT00959621|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6562980|NCT00959621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6562981|NCT00959621|Antipyretics|antipyretics|mesh-ancestor
6562982|NCT00959686|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6562983|NCT00959686|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6562984|NCT00959686|Alkylating Agents|alkylating agents|mesh-ancestor
6562985|NCT00959686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562986|NCT00959686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6562987|NCT00959725|Infliximab|infliximab|mesh-list
6562988|NCT00959725|Dermatologic Agents|dermatologic agents|mesh-ancestor
6562989|NCT00959725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6562990|NCT00959725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6562991|NCT00959777|Lenograstim|lenograstim|mesh-list
6562992|NCT00959777|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6562993|NCT00959777|Immunologic Factors|immunologic factors|mesh-ancestor
6562994|NCT00959777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6562995|NCT00959881|Donepezil|donepezil|mesh-list
6562996|NCT00959881|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6562997|NCT00959881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6562998|NCT00959881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6562999|NCT00959881|Cholinergic Agents|cholinergic agents|mesh-ancestor
6563000|NCT00959881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6563001|NCT00959881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563002|NCT00959881|Nootropic Agents|nootropic agents|mesh-ancestor
6563003|NCT00959933|Ribavirin|ribavirin|mesh-list
6563004|NCT00959933|Antimetabolites|antimetabolites|mesh-ancestor
6563005|NCT00959933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563006|NCT00959933|Antiviral Agents|antiviral agents|mesh-ancestor
6563007|NCT00959933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6563008|NCT00959959|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
6563009|NCT00959959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6563010|NCT00959959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563011|NCT00959972|Nicotine|nicotine|mesh-list
6563012|NCT00959972|Varenicline|varenicline|mesh-list
6563013|NCT00959972|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6563014|NCT00959972|Autonomic Agents|autonomic agents|mesh-ancestor
6563015|NCT00959972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6563016|NCT00959972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563017|NCT00959972|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6563018|NCT00959972|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6563019|NCT00959972|Cholinergic Agents|cholinergic agents|mesh-ancestor
6563020|NCT00959972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6563021|NCT00959972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563022|NCT00960037|Vitamin D|vitamin d|mesh-list
6563023|NCT00960037|Cholecalciferol|cholecalciferol|mesh-list
6563024|NCT00960037|Vitamins|vitamins|mesh-ancestor
6563025|NCT00960037|Micronutrients|micronutrients|mesh-ancestor
6563026|NCT00960037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563027|NCT00960037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6563028|NCT00960037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6563029|NCT00960232|Cholecalciferol|cholecalciferol|mesh-list
6563030|NCT00960232|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6563031|NCT00960232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563032|NCT00960232|Vitamins|vitamins|mesh-ancestor
6563033|NCT00960232|Micronutrients|micronutrients|mesh-ancestor
6563034|NCT00960232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6563035|NCT00960245|Nadolol|nadolol|mesh-list
6563036|NCT00960245|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6563037|NCT00960245|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6563038|NCT00960245|Adrenergic Agents|adrenergic agents|mesh-ancestor
6563039|NCT00960245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6563040|NCT00960245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563041|NCT00960245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563042|NCT00960245|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6563043|NCT00960245|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6563044|NCT00960245|Sympatholytics|sympatholytics|mesh-ancestor
6563045|NCT00960245|Autonomic Agents|autonomic agents|mesh-ancestor
6563046|NCT00960245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6563047|NCT00960284|Gemcitabine|gemcitabine|mesh-list
6563048|NCT00960284|Fluorouracil|fluorouracil|mesh-list
6563049|NCT00960284|Capecitabine|capecitabine|mesh-list
6563050|NCT00960284|Epirubicin|epirubicin|mesh-list
6563051|NCT00960284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6563052|NCT00960284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6563053|NCT00960284|Antimetabolites|antimetabolites|mesh-ancestor
6563054|NCT00960284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563055|NCT00960284|Antiviral Agents|antiviral agents|mesh-ancestor
6563056|NCT00960284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6563057|NCT00960284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6563058|NCT00960284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6563059|NCT00960284|Immunologic Factors|immunologic factors|mesh-ancestor
6563060|NCT00960284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563061|NCT00960284|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6563062|NCT00960284|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6563063|NCT00960284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6563064|NCT00960310|Bicalutamide|bicalutamide|mesh-list
6563065|NCT00960310|Androgen Antagonists|androgen antagonists|mesh-ancestor
6563066|NCT00960310|Hormone Antagonists|hormone antagonists|mesh-ancestor
6563067|NCT00960310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6563068|NCT00960310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563069|NCT00960310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6563070|NCT00960336|Doxorubicin|doxorubicin|mesh-list
6563071|NCT00960336|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6563072|NCT00960336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6563073|NCT00960336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6563074|NCT00960336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6563075|NCT00960336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6563076|NCT00960336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6563077|NCT00960336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563078|NCT00960349|Cisplatin|cisplatin|mesh-list
6563079|NCT00960349|Capecitabine|capecitabine|mesh-list
6563080|NCT00960349|Cediranib|cediranib|mesh-list
6563081|NCT00960349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6563082|NCT00960349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6563083|NCT00960349|Antimetabolites|antimetabolites|mesh-ancestor
6563084|NCT00960349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563085|NCT00960349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6563086|NCT00960349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6563087|NCT00960453|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6563088|NCT00960453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6563089|NCT00960453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563090|NCT00960453|Incretins|incretins|mesh-ancestor
6563091|NCT00960453|Hormones|hormones|mesh-ancestor
6563092|NCT00960453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6563093|NCT00960453|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6563094|NCT00960453|Protease Inhibitors|protease inhibitors|mesh-ancestor
6563095|NCT00960453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6563096|NCT00960453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563097|NCT00960479|Ribavirin|ribavirin|mesh-list
6563098|NCT00960479|Antimetabolites|antimetabolites|mesh-ancestor
6563099|NCT00960479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563100|NCT00960479|Antiviral Agents|antiviral agents|mesh-ancestor
6563101|NCT00960479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6563102|NCT00960492|Temozolomide|temozolomide|mesh-list
6563103|NCT00960492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6563104|NCT00960492|Alkylating Agents|alkylating agents|mesh-ancestor
6563105|NCT00960492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563106|NCT00960492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6563107|NCT00960518|Adefovir|adefovir|mesh-list
6563108|NCT00960518|Antiviral Agents|antiviral agents|mesh-ancestor
6563109|NCT00960518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6444264|NCT00383396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6444265|NCT00383396|Dermatologic Agents|dermatologic agents|mesh-ancestor
6444266|NCT00383396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6444267|NCT00383396|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6444268|NCT00383474|Bortezomib|bortezomib|mesh-list
6444269|NCT00383474|Tipifarnib|tipifarnib|mesh-list
6444270|NCT00383474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6444271|NCT00383487|Calcitriol|calcitriol|mesh-list
6444272|NCT00383487|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
6444273|NCT00383487|Naproxen|naproxen|mesh-list
6444274|NCT00383487|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
6444275|NCT00383487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6444276|NCT00383487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6444277|NCT00383487|Analgesics|analgesics|mesh-ancestor
6444278|NCT00383487|Sensory System Agents|sensory system agents|mesh-ancestor
6444279|NCT00383487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6444280|NCT00383487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444281|NCT00383487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6444282|NCT00383487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6444283|NCT00383487|Gout Suppressants|gout suppressants|mesh-ancestor
6444284|NCT00383487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6444285|NCT00383487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6444286|NCT00383487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444287|NCT00383487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6444288|NCT00383487|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6563110|NCT00960518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6563111|NCT00960518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6563112|NCT00960518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6563113|NCT00960518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563114|NCT00960544|Capecitabine|capecitabine|mesh-list
6563115|NCT00960544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6563116|NCT00960544|Antimetabolites|antimetabolites|mesh-ancestor
6563117|NCT00960544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563118|NCT00960544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6563119|NCT00960557|Combretastatin|combretastatin|mesh-list
6563120|NCT00960557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6563121|NCT00960557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6563122|NCT00960557|Tubulin Modulators|tubulin modulators|mesh-ancestor
6563123|NCT00960557|Antimitotic Agents|antimitotic agents|mesh-ancestor
6563124|NCT00960557|Mitosis Modulators|mitosis modulators|mesh-ancestor
6563125|NCT00960557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563126|NCT00960635|Vitamin D|vitamin d|mesh-list
6563127|NCT00960635|Cholecalciferol|cholecalciferol|mesh-list
6563128|NCT00960635|Calcitriol|calcitriol|mesh-list
6563129|NCT00960635|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
6563130|NCT00960635|Vitamins|vitamins|mesh-ancestor
6563131|NCT00960635|Micronutrients|micronutrients|mesh-ancestor
6563132|NCT00960635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563133|NCT00960635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6563134|NCT00960635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6563135|NCT00960635|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6563136|NCT00960635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6563137|NCT00960635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563138|NCT00960635|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6563139|NCT00960713|Rituximab|rituximab|mesh-list
6563140|NCT00960713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6444289|NCT00383487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6563141|NCT00960713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6563142|NCT00960713|Immunologic Factors|immunologic factors|mesh-ancestor
6563143|NCT00960713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563144|NCT00960713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6563145|NCT00960739|Topotecan|topotecan|mesh-list
6563146|NCT00960739|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
6563147|NCT00960739|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6563148|NCT00960739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6563149|NCT00960739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6563150|NCT00960739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563151|NCT00960739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6563152|NCT00960739|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6563153|NCT00960817|Aspirin|aspirin|mesh-list
6563154|NCT00960817|Dipyridamole|dipyridamole|mesh-list
6563155|NCT00960817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6563156|NCT00960817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6563157|NCT00960817|Analgesics|analgesics|mesh-ancestor
6563158|NCT00960817|Sensory System Agents|sensory system agents|mesh-ancestor
6563159|NCT00960817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6563160|NCT00960817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563161|NCT00960817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6563162|NCT00960817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6563163|NCT00960817|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6563164|NCT00960817|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6563165|NCT00960817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563166|NCT00960817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6563167|NCT00960817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6563168|NCT00960817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6563169|NCT00960817|Antipyretics|antipyretics|mesh-ancestor
6563170|NCT00960817|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6563171|NCT00960817|Vasodilator Agents|vasodilator agents|mesh-ancestor
6563172|NCT00960830|Mirtazapine|mirtazapine|mesh-list
6563173|NCT00960830|Antidepressive Agents|antidepressive agents|mesh-ancestor
6563174|NCT00960830|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6563175|NCT00960830|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6563176|NCT00960830|Histamine Antagonists|histamine antagonists|mesh-ancestor
6563177|NCT00960830|Histamine Agents|histamine agents|mesh-ancestor
6563178|NCT00960830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6563179|NCT00960830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563180|NCT00960830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563181|NCT00960830|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6563182|NCT00960830|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6563183|NCT00960830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6563184|NCT00960830|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6563185|NCT00960830|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6563186|NCT00960830|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6563187|NCT00960830|Adrenergic Agents|adrenergic agents|mesh-ancestor
6563188|NCT00960830|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6563189|NCT00960830|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6563190|NCT00960830|Serotonin Agents|serotonin agents|mesh-ancestor
6563191|NCT00960830|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6563192|NCT00960921|Iron|iron|mesh-list
6563193|NCT00960921|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6563194|NCT00960921|Trace Elements|trace elements|mesh-ancestor
6563195|NCT00960921|Micronutrients|micronutrients|mesh-ancestor
6563196|NCT00960921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563197|NCT00960921|Hematinics|hematinics|mesh-ancestor
6563198|NCT00960960|Paclitaxel|paclitaxel|mesh-list
6563199|NCT00960960|Bevacizumab|bevacizumab|mesh-list
6563200|NCT00960960|Trastuzumab|trastuzumab|mesh-list
6563201|NCT00960960|Letrozole|letrozole|mesh-list
6563202|NCT00960960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6563203|NCT00960960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6563204|NCT00960960|Tubulin Modulators|tubulin modulators|mesh-ancestor
6563205|NCT00960960|Antimitotic Agents|antimitotic agents|mesh-ancestor
6563206|NCT00960960|Mitosis Modulators|mitosis modulators|mesh-ancestor
6563207|NCT00960960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563208|NCT00960960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6563209|NCT00960960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6563210|NCT00960960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6563211|NCT00960960|Growth Substances|growth substances|mesh-ancestor
6563212|NCT00960960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563213|NCT00960960|Growth Inhibitors|growth inhibitors|mesh-ancestor
6563214|NCT00960960|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6563215|NCT00960960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6563216|NCT00960960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6563217|NCT00960960|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6563218|NCT00960960|Hormone Antagonists|hormone antagonists|mesh-ancestor
6563219|NCT00960960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6563220|NCT00960973|Menatetrenone|menatetrenone|mesh-list
6563221|NCT00960973|Hemostatics|hemostatics|mesh-ancestor
6563222|NCT00960973|Coagulants|coagulants|mesh-ancestor
6563223|NCT00961038|Ciprofloxacin|ciprofloxacin|mesh-list
6563224|NCT00961038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6563225|NCT00961038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6563226|NCT00961038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6563227|NCT00961038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6563228|NCT00961038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6563229|NCT00961038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563230|NCT00961038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6563231|NCT00961038|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6563232|NCT00961038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6563233|NCT00961077|Oxaliplatin|oxaliplatin|mesh-list
6563234|NCT00961077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6657142|NCT01473901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6657143|NCT01473914|Vitamins|vitamins|mesh-list
6657144|NCT01473914|Vitamin E|vitamin e|mesh-list
6657145|NCT01473914|Tocopherols|tocopherols|mesh-list
6444290|NCT00383487|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6444291|NCT00383487|Vitamins|vitamins|mesh-ancestor
6444292|NCT00383487|Micronutrients|micronutrients|mesh-ancestor
6444293|NCT00383487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6444294|NCT00383487|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6444295|NCT00383526|Vaccines|vaccines|mesh-list
6444296|NCT00383526|Immunologic Factors|immunologic factors|mesh-ancestor
6444297|NCT00383526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444298|NCT00383539|Vaccines|vaccines|mesh-list
6444299|NCT00383539|Immunologic Factors|immunologic factors|mesh-ancestor
6444300|NCT00383539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444301|NCT00383591|Vaccines|vaccines|mesh-list
6444302|NCT00383591|Immunologic Factors|immunologic factors|mesh-ancestor
6444303|NCT00383591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444304|NCT00383656|Hormones|hormones|mesh-list
6444305|NCT00383656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6444306|NCT00383656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444307|NCT00383682|Mexiletine|mexiletine|mesh-list
6444308|NCT00383682|Morphine|morphine|mesh-list
6444309|NCT00383682|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6444310|NCT00383682|Narcotics|narcotics|mesh-ancestor
6444311|NCT00383682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6444312|NCT00383682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444313|NCT00383682|Analgesics|analgesics|mesh-ancestor
6444314|NCT00383682|Sensory System Agents|sensory system agents|mesh-ancestor
6444315|NCT00383682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6444316|NCT00383682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6444317|NCT00383682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6444318|NCT00383682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6444319|NCT00383682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6444320|NCT00383682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444321|NCT00383695|Capecitabine|capecitabine|mesh-list
6444322|NCT00383695|Oxaliplatin|oxaliplatin|mesh-list
6444323|NCT00383695|Cetuximab|cetuximab|mesh-list
6444324|NCT00383695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6444325|NCT00383695|Antimetabolites|antimetabolites|mesh-ancestor
6444326|NCT00383695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444327|NCT00383695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6444328|NCT00383695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6444329|NCT00383708|Lanreotide|lanreotide|mesh-list
6444330|NCT00383708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6657146|NCT01473914|Tocotrienols|tocotrienols|mesh-list
6563235|NCT00961142|Fludarabine|fludarabine|mesh-list
6563236|NCT00961142|Melphalan|melphalan|mesh-list
6563237|NCT00961142|Thiotepa|thiotepa|mesh-list
6563238|NCT00961142|Thymoglobulin|thymoglobulin|mesh-list
6563239|NCT00961142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6563240|NCT00961142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563241|NCT00961142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6563242|NCT00961142|Immunologic Factors|immunologic factors|mesh-ancestor
6563243|NCT00961142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563244|NCT00961142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6563245|NCT00961142|Alkylating Agents|alkylating agents|mesh-ancestor
6563246|NCT00961142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6563247|NCT00961155|Formoterol Fumarate|formoterol fumarate|mesh-list
6563248|NCT00961155|Montelukast|montelukast|mesh-list
6563249|NCT00961155|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6563250|NCT00961155|Autonomic Agents|autonomic agents|mesh-ancestor
6563251|NCT00961155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6563252|NCT00961155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563253|NCT00961155|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6444331|NCT00383799|Amiodarone|amiodarone|mesh-list
6444332|NCT00383799|Procainamide|procainamide|mesh-list
6444333|NCT00383799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6444334|NCT00383799|Vasodilator Agents|vasodilator agents|mesh-ancestor
6444335|NCT00383799|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6444336|NCT00383799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6444337|NCT00383799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444338|NCT00383799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6444339|NCT00383799|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6444340|NCT00383799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6444341|NCT00383799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6444342|NCT00383799|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6444343|NCT00383799|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6444344|NCT00383799|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6444345|NCT00383799|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6563254|NCT00961155|Respiratory System Agents|respiratory system agents|mesh-ancestor
6563255|NCT00961155|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6563256|NCT00961155|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6563257|NCT00961155|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6563258|NCT00961155|Adrenergic Agents|adrenergic agents|mesh-ancestor
6563259|NCT00961155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6563260|NCT00961155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563261|NCT00961155|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6563262|NCT00961155|Hormone Antagonists|hormone antagonists|mesh-ancestor
6563263|NCT00961155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6563264|NCT00961155|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6563265|NCT00961155|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6563266|NCT00961194|Ketamine|ketamine|mesh-list
6563267|NCT00961194|Analgesics|analgesics|mesh-ancestor
6563268|NCT00961194|Sensory System Agents|sensory system agents|mesh-ancestor
6563269|NCT00961194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6563270|NCT00961194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563271|NCT00961194|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6563272|NCT00961194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6563273|NCT00961194|Anesthetics, General|anesthetics, general|mesh-ancestor
6563274|NCT00961194|Anesthetics|anesthetics|mesh-ancestor
6563275|NCT00961194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6563276|NCT00961194|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6563277|NCT00961194|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6563278|NCT00961194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6563279|NCT00961194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563280|NCT00961324|Insulin|insulin|mesh-list
6563281|NCT00961324|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6563282|NCT00961324|Insulin Glargine|insulin glargine|mesh-list
6563283|NCT00961324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6563284|NCT00961324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563285|NCT00961363|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6563286|NCT00961363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6563287|NCT00961363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563288|NCT00961363|Incretins|incretins|mesh-ancestor
6563289|NCT00961363|Hormones|hormones|mesh-ancestor
6563290|NCT00961363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6563291|NCT00961363|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6563292|NCT00961363|Protease Inhibitors|protease inhibitors|mesh-ancestor
6563293|NCT00961363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6563294|NCT00961363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563295|NCT00961467|Thalidomide|thalidomide|mesh-list
6563296|NCT00961467|Prednisone|prednisone|mesh-list
6563297|NCT00961467|Melphalan|melphalan|mesh-list
6563298|NCT00961467|Lenalidomide|lenalidomide|mesh-list
6563299|NCT00961467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6563300|NCT00961467|Glucocorticoids|glucocorticoids|mesh-ancestor
6563301|NCT00961467|Hormones|hormones|mesh-ancestor
6563302|NCT00961467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6563303|NCT00961467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563304|NCT00961467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6563305|NCT00961467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6563306|NCT00961467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6563307|NCT00961467|Alkylating Agents|alkylating agents|mesh-ancestor
6563308|NCT00961467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563309|NCT00961467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6563310|NCT00961467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6563311|NCT00961467|Immunologic Factors|immunologic factors|mesh-ancestor
6563312|NCT00961467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6563313|NCT00961467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6563314|NCT00961467|Growth Substances|growth substances|mesh-ancestor
6563315|NCT00961467|Growth Inhibitors|growth inhibitors|mesh-ancestor
6444346|NCT00383812|Bevacizumab|bevacizumab|mesh-list
6444347|NCT00383812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6444348|NCT00383812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6563316|NCT00961467|Leprostatic Agents|leprostatic agents|mesh-ancestor
6563317|NCT00961467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6563318|NCT00961467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6563319|NCT00961480|Metformin|metformin|mesh-list
6563320|NCT00961480|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6563321|NCT00961480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6563322|NCT00961480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563323|NCT00961480|Incretins|incretins|mesh-ancestor
6563324|NCT00961480|Hormones|hormones|mesh-ancestor
6563325|NCT00961480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6563326|NCT00961480|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6563327|NCT00961480|Protease Inhibitors|protease inhibitors|mesh-ancestor
6563328|NCT00961480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6563329|NCT00961480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563330|NCT00961753|Ibuprofen|ibuprofen|mesh-list
6563331|NCT00961753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6563332|NCT00961753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6563333|NCT00961753|Analgesics|analgesics|mesh-ancestor
6563334|NCT00961753|Sensory System Agents|sensory system agents|mesh-ancestor
6563335|NCT00961753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6563336|NCT00961753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563337|NCT00961753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6563338|NCT00961753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6563339|NCT00961753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6563340|NCT00961753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6563341|NCT00961753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563342|NCT00961844|Temozolomide|temozolomide|mesh-list
6563343|NCT00961844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6563344|NCT00961844|Alkylating Agents|alkylating agents|mesh-ancestor
6563345|NCT00961844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563346|NCT00961844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6563347|NCT00961857|Metformin|metformin|mesh-list
6444349|NCT00383812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6444350|NCT00383812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6444351|NCT00383812|Growth Substances|growth substances|mesh-ancestor
6444352|NCT00383812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444353|NCT00383812|Growth Inhibitors|growth inhibitors|mesh-ancestor
6444354|NCT00383851|Temozolomide|temozolomide|mesh-list
6444355|NCT00383851|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
6444356|NCT00383851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6444357|NCT00383851|Alkylating Agents|alkylating agents|mesh-ancestor
6444358|NCT00383851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444359|NCT00383851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6444360|NCT00383851|Chelating Agents|chelating agents|mesh-ancestor
6444361|NCT00383851|Sequestering Agents|sequestering agents|mesh-ancestor
6444362|NCT00383851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6444363|NCT00383851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6444364|NCT00383851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6563348|NCT00961857|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6563349|NCT00961857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6444365|NCT00383851|Growth Substances|growth substances|mesh-ancestor
6444366|NCT00383851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444367|NCT00383851|Growth Inhibitors|growth inhibitors|mesh-ancestor
6444368|NCT00383864|Interferons|interferons|mesh-list
6444369|NCT00383864|Ribavirin|ribavirin|mesh-list
6444370|NCT00383864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6444371|NCT00383864|Antiviral Agents|antiviral agents|mesh-ancestor
6444372|NCT00383864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6444373|NCT00383864|Antimetabolites|antimetabolites|mesh-ancestor
6444374|NCT00383864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444375|NCT00383877|Insulin|insulin|mesh-list
6444376|NCT00383877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6444377|NCT00383877|Insulin Detemir|insulin detemir|mesh-list
6444378|NCT00383877|Isophane Insulin, Human|isophane insulin, human|mesh-list
6444379|NCT00383877|Insulin, Isophane|insulin, isophane|mesh-list
6444380|NCT00383877|Isophane insulin, beef|isophane insulin, beef|mesh-list
6444381|NCT00383877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6444382|NCT00383877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444383|NCT00383890|Dexmedetomidine|dexmedetomidine|mesh-list
6444384|NCT00383890|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6444385|NCT00383890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6444386|NCT00383890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444387|NCT00383890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6444388|NCT00383890|Analgesics|analgesics|mesh-ancestor
6444389|NCT00383890|Sensory System Agents|sensory system agents|mesh-ancestor
6444390|NCT00383890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6444391|NCT00383890|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6444392|NCT00383890|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6444393|NCT00383890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6444394|NCT00383890|Adrenergic Agents|adrenergic agents|mesh-ancestor
6444395|NCT00383890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6444396|NCT00383890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444397|NCT00383916|Pantoprazole|pantoprazole|mesh-list
6444398|NCT00383916|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6444399|NCT00383916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6444400|NCT00383916|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6444401|NCT00383916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6444402|NCT00383916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444403|NCT00383929|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6444404|NCT00383929|Candesartan|candesartan|mesh-list
6444405|NCT00383929|Candesartan cilexetil|candesartan cilexetil|mesh-list
6444406|NCT00383929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6444407|NCT00383929|Diuretics|diuretics|mesh-ancestor
6444408|NCT00383929|Natriuretic Agents|natriuretic agents|mesh-ancestor
6444409|NCT00383929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444410|NCT00383929|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6444411|NCT00383929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6444412|NCT00383929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444413|NCT00383929|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6444414|NCT00383929|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6444415|NCT00383994|Rituximab|rituximab|mesh-list
6444416|NCT00383994|Sargramostim|sargramostim|mesh-list
6444417|NCT00383994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6444418|NCT00383994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6444419|NCT00383994|Immunologic Factors|immunologic factors|mesh-ancestor
6444420|NCT00383994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444421|NCT00383994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6444422|NCT00384020|Citalopram|citalopram|mesh-list
6444423|NCT00384020|Paroxetine|paroxetine|mesh-list
6444424|NCT00384020|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6444425|NCT00384020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6444426|NCT00384020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6444427|NCT00384020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444428|NCT00384020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6444429|NCT00384020|Serotonin Agents|serotonin agents|mesh-ancestor
6444430|NCT00384020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444431|NCT00384020|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6444432|NCT00384020|Antidepressive Agents|antidepressive agents|mesh-ancestor
6657147|NCT01473914|alpha-Tocopherol|alpha-tocopherol|mesh-list
6563350|NCT00961857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563351|NCT00961857|Incretins|incretins|mesh-ancestor
6444433|NCT00384020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6444434|NCT00384020|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6444435|NCT00384020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6444436|NCT00384020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6444437|NCT00384046|Testosterone|testosterone|mesh-list
6444438|NCT00384046|Androgens|androgens|mesh-ancestor
6444439|NCT00384046|Hormones|hormones|mesh-ancestor
6444440|NCT00384046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6563352|NCT00961857|Hormones|hormones|mesh-ancestor
6019922|NCT00390546|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6019923|NCT00390546|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6019924|NCT00390546|Adrenergic Agents|adrenergic agents|mesh-ancestor
6019925|NCT00390546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6053221|NCT00593645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6563353|NCT00961857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6563354|NCT00961857|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6563355|NCT00961857|Protease Inhibitors|protease inhibitors|mesh-ancestor
6563356|NCT00961857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6563357|NCT00961857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563358|NCT00961909|Metformin|metformin|mesh-list
6563359|NCT00961909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6563360|NCT00961909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563361|NCT00962026|Rilonacept|rilonacept|mesh-list
6563362|NCT00962026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6563363|NCT00962156|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
6563364|NCT00962156|Plasma Substitutes|plasma substitutes|mesh-ancestor
6563365|NCT00962156|Blood Substitutes|blood substitutes|mesh-ancestor
6563366|NCT00962234|Deuterium Oxide|deuterium oxide|mesh-list
6563367|NCT00962234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6563368|NCT00962234|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6563369|NCT00962234|Protective Agents|protective agents|mesh-ancestor
6563370|NCT00962234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563371|NCT00962286|Furosemide|furosemide|mesh-list
6563372|NCT00962286|Diuretics|diuretics|mesh-ancestor
6563373|NCT00962286|Natriuretic Agents|natriuretic agents|mesh-ancestor
6563374|NCT00962286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563375|NCT00962286|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6563376|NCT00962286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6563377|NCT00962286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563378|NCT00962299|Beclomethasone|beclomethasone|mesh-list
6563379|NCT00962299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6563380|NCT00962299|Glucocorticoids|glucocorticoids|mesh-ancestor
6563381|NCT00962299|Hormones|hormones|mesh-ancestor
6563382|NCT00962299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6563383|NCT00962299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563384|NCT00962299|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6563385|NCT00962299|Respiratory System Agents|respiratory system agents|mesh-ancestor
6563386|NCT00962312|Capecitabine|capecitabine|mesh-list
6563387|NCT00962312|Lapatinib|lapatinib|mesh-list
6563388|NCT00962312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6563389|NCT00962312|Antimetabolites|antimetabolites|mesh-ancestor
6563390|NCT00962312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563391|NCT00962312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6563392|NCT00962312|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6563393|NCT00962312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6563394|NCT00962442|Acetylcysteine|acetylcysteine|mesh-list
6563395|NCT00962442|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6563396|NCT00962442|Antiviral Agents|antiviral agents|mesh-ancestor
6563397|NCT00962442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6563398|NCT00962442|Expectorants|expectorants|mesh-ancestor
6563399|NCT00962442|Respiratory System Agents|respiratory system agents|mesh-ancestor
6563400|NCT00962442|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6563401|NCT00962442|Antioxidants|antioxidants|mesh-ancestor
6563402|NCT00962442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563403|NCT00962442|Protective Agents|protective agents|mesh-ancestor
6563404|NCT00962442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563405|NCT00962442|Antidotes|antidotes|mesh-ancestor
6563406|NCT00962507|Everolimus|everolimus|mesh-list
6563407|NCT00962507|Panobinostat|panobinostat|mesh-list
6563408|NCT00962507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6563409|NCT00962507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6563410|NCT00962507|Immunologic Factors|immunologic factors|mesh-ancestor
6563411|NCT00962507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563412|NCT00962507|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6563413|NCT00962507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6563414|NCT00962507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563415|NCT00962533|Telbivudine|telbivudine|mesh-list
6563416|NCT00962533|Antiviral Agents|antiviral agents|mesh-ancestor
6563417|NCT00962533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6563418|NCT00962533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6563419|NCT00962533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6563420|NCT00962533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563421|NCT00962624|Vaccines|vaccines|mesh-list
6563422|NCT00962624|Immunologic Factors|immunologic factors|mesh-ancestor
6563423|NCT00962624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563424|NCT00962637|Citric Acid|citric acid|mesh-list
6563425|NCT00962637|Sodium Citrate|sodium citrate|mesh-list
6563426|NCT00962637|Enclomiphene|enclomiphene|mesh-list
6563427|NCT00962637|Clomiphene|clomiphene|mesh-list
6563428|NCT00962637|Zuclomiphene|zuclomiphene|mesh-list
6563429|NCT00962637|Testosterone|testosterone|mesh-list
6563430|NCT00962637|Anticoagulants|anticoagulants|mesh-ancestor
6563431|NCT00962637|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6563432|NCT00962637|Chelating Agents|chelating agents|mesh-ancestor
6563433|NCT00962637|Sequestering Agents|sequestering agents|mesh-ancestor
6563434|NCT00962637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563435|NCT00962637|Androgens|androgens|mesh-ancestor
6563436|NCT00962637|Hormones|hormones|mesh-ancestor
6563437|NCT00962637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6563438|NCT00962637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563439|NCT00962637|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6563440|NCT00962637|Hormone Antagonists|hormone antagonists|mesh-ancestor
6563441|NCT00962637|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6563442|NCT00962637|Fertility Agents|fertility agents|mesh-ancestor
6563443|NCT00962637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6563444|NCT00962637|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6563445|NCT00962637|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6563446|NCT00962663|Ibuprofen|ibuprofen|mesh-list
6563447|NCT00962663|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6563448|NCT00962663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6563449|NCT00962663|Analgesics|analgesics|mesh-ancestor
6563450|NCT00962663|Sensory System Agents|sensory system agents|mesh-ancestor
6563451|NCT00962663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6563452|NCT00962663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563453|NCT00962663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6563454|NCT00962663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6563455|NCT00962663|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6563456|NCT00962663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6563457|NCT00962663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563458|NCT00962715|Interferons|interferons|mesh-list
6563459|NCT00962715|Interferon-alpha|interferon-alpha|mesh-list
6563460|NCT00962715|Interferon alpha-2|interferon alpha-2|mesh-list
6563461|NCT00962715|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6563462|NCT00962715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6563463|NCT00962715|Antiviral Agents|antiviral agents|mesh-ancestor
6563464|NCT00962715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6563465|NCT00962715|Immunologic Factors|immunologic factors|mesh-ancestor
6563466|NCT00962715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563467|NCT00962767|Gemtuzumab|gemtuzumab|mesh-list
6563468|NCT00962767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6563469|NCT00962767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6563470|NCT00962845|Hydroxychloroquine|hydroxychloroquine|mesh-list
6563471|NCT00962845|Antimalarials|antimalarials|mesh-ancestor
6563472|NCT00962845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6444441|NCT00384046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444442|NCT00384072|Bazedoxifene|bazedoxifene|mesh-list
6444443|NCT00384072|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6444444|NCT00384072|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6444445|NCT00384072|Hormone Antagonists|hormone antagonists|mesh-ancestor
6444446|NCT00384072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6563473|NCT00962845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6563474|NCT00962845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6563475|NCT00962845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6563476|NCT00962845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563477|NCT00962845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6563478|NCT00962936|Pidilizumab|pidilizumab|mesh-list
6563479|NCT00962936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6563480|NCT00962936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6563481|NCT00962975|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6563482|NCT00962975|Antiviral Agents|antiviral agents|mesh-ancestor
6563483|NCT00962975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6563484|NCT00962988|Bupropion|bupropion|mesh-list
6563485|NCT00962988|Nicotine|nicotine|mesh-list
6563486|NCT00962988|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6563487|NCT00962988|Autonomic Agents|autonomic agents|mesh-ancestor
6563488|NCT00962988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6563489|NCT00962988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563490|NCT00962988|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6563491|NCT00962988|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6563492|NCT00962988|Cholinergic Agents|cholinergic agents|mesh-ancestor
6563493|NCT00962988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6563494|NCT00962988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444447|NCT00384072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444448|NCT00384072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6444449|NCT00384124|Imiquimod|imiquimod|mesh-list
6444450|NCT00384124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6444451|NCT00384124|Immunologic Factors|immunologic factors|mesh-ancestor
6444452|NCT00384124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563495|NCT00962988|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6563496|NCT00962988|Antidepressive Agents|antidepressive agents|mesh-ancestor
6563497|NCT00962988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6563498|NCT00962988|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6563499|NCT00962988|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6563500|NCT00962988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6563501|NCT00962988|Dopamine Agents|dopamine agents|mesh-ancestor
6563502|NCT00962988|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6563503|NCT00962988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6563504|NCT00962988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6563505|NCT00963001|Treprostinil|treprostinil|mesh-list
6444453|NCT00384124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6444454|NCT00384124|Interferon Inducers|interferon inducers|mesh-ancestor
6444455|NCT00384137|Tacrolimus|tacrolimus|mesh-list
6444456|NCT00384137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6444457|NCT00384137|Immunologic Factors|immunologic factors|mesh-ancestor
6563506|NCT00963001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6563507|NCT00963027|Treprostinil|treprostinil|mesh-list
6563508|NCT00963027|Esomeprazole|esomeprazole|mesh-list
6563509|NCT00963027|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6563510|NCT00963027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6563511|NCT00963027|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6563512|NCT00963027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6563513|NCT00963027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563514|NCT00963027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6563515|NCT00963040|Oxytocin|oxytocin|mesh-list
6563516|NCT00963040|Oxytocics|oxytocics|mesh-ancestor
6563517|NCT00963040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6563518|NCT00963040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657148|NCT01473914|Zinc|zinc|mesh-list
6657149|NCT01473914|Selenium|selenium|mesh-list
6657150|NCT01473914|Micronutrients|micronutrients|mesh-ancestor
6657151|NCT01473914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657152|NCT01473914|Trace Elements|trace elements|mesh-ancestor
6657153|NCT01473914|Antioxidants|antioxidants|mesh-ancestor
6657154|NCT01473914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657155|NCT01473914|Protective Agents|protective agents|mesh-ancestor
6657156|NCT01474174|Vaccines|vaccines|mesh-list
6657157|NCT01474174|Immunologic Factors|immunologic factors|mesh-ancestor
6657158|NCT01474174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657159|NCT01474187|Capecitabine|capecitabine|mesh-list
6657160|NCT01474187|Irinotecan|irinotecan|mesh-list
6444458|NCT00384137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444459|NCT00384137|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6444460|NCT00384137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6444461|NCT00384137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444462|NCT00384202|Tacrolimus|tacrolimus|mesh-list
6444463|NCT00384202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6444464|NCT00384202|Immunologic Factors|immunologic factors|mesh-ancestor
6444465|NCT00384202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444466|NCT00384202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6444467|NCT00384202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6657161|NCT01474187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6657162|NCT01474187|Antimetabolites|antimetabolites|mesh-ancestor
6019926|NCT00390546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019927|NCT00390546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019928|NCT00390546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6019929|NCT00390546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6019930|NCT00390546|Vasodilator Agents|vasodilator agents|mesh-ancestor
6019931|NCT00390546|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6019932|NCT00390546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6019933|NCT00390546|Protective Agents|protective agents|mesh-ancestor
6019934|NCT00390559|Nicotine|nicotine|mesh-list
6019935|NCT00390559|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6019936|NCT00390559|Autonomic Agents|autonomic agents|mesh-ancestor
6444468|NCT00384202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444469|NCT00384215|Insulin Glargine|insulin glargine|mesh-list
6444470|NCT00384215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6444471|NCT00384215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444472|NCT00384280|Rifampin|rifampin|mesh-list
6444473|NCT00384280|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6444474|NCT00384280|Antitubercular Agents|antitubercular agents|mesh-ancestor
6444475|NCT00384280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6444476|NCT00384280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6444477|NCT00384280|Leprostatic Agents|leprostatic agents|mesh-ancestor
6444478|NCT00384280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6444479|NCT00384280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6444480|NCT00384280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444481|NCT00384280|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6444482|NCT00384280|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6444483|NCT00384280|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6444484|NCT00384280|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6444485|NCT00384280|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6444486|NCT00384280|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6444487|NCT00384306|Prednisolone|prednisolone|mesh-list
6444488|NCT00384306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6444489|NCT00384306|Glucocorticoids|glucocorticoids|mesh-ancestor
6444490|NCT00384306|Hormones|hormones|mesh-ancestor
6444491|NCT00384306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6444492|NCT00384306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444493|NCT00384306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6444494|NCT00384306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6444495|NCT00384371|Botulinum Toxins|botulinum toxins|mesh-list
6444496|NCT00384371|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6444497|NCT00384371|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6563519|NCT00963131|Antioxidants|antioxidants|mesh-list
6563520|NCT00963131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563521|NCT00963131|Protective Agents|protective agents|mesh-ancestor
6563522|NCT00963131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563523|NCT00963209|Tamoxifen|tamoxifen|mesh-list
6563524|NCT00963209|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6563525|NCT00963209|Hormone Antagonists|hormone antagonists|mesh-ancestor
6563526|NCT00963209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6563527|NCT00963209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563528|NCT00963209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6563529|NCT00963209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6563530|NCT00963209|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6563531|NCT00963209|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6563532|NCT00963209|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6563533|NCT00963222|Vitamin A|vitamin a|mesh-list
6563534|NCT00963222|Vitamins|vitamins|mesh-ancestor
6563535|NCT00963222|Micronutrients|micronutrients|mesh-ancestor
6563536|NCT00963222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563537|NCT00963274|Bortezomib|bortezomib|mesh-list
6563538|NCT00963274|Romidepsin|romidepsin|mesh-list
6563539|NCT00963274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6563540|NCT00963274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6563541|NCT00963313|Adalimumab|adalimumab|mesh-list
6563542|NCT00963313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6563543|NCT00963313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6563544|NCT00963443|Aspirin|aspirin|mesh-list
6563545|NCT00963443|Pseudoephedrine|pseudoephedrine|mesh-list
6563546|NCT00963443|Ephedrine|ephedrine|mesh-list
6563547|NCT00963443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6563548|NCT00963443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6563549|NCT00963443|Analgesics|analgesics|mesh-ancestor
6563550|NCT00963443|Sensory System Agents|sensory system agents|mesh-ancestor
6563551|NCT00963443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6563552|NCT00963443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563553|NCT00963443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6563554|NCT00963443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6563555|NCT00963443|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6563556|NCT00963443|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6563557|NCT00963443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563558|NCT00963443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6563559|NCT00963443|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6563560|NCT00963443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6563561|NCT00963443|Antipyretics|antipyretics|mesh-ancestor
6563562|NCT00963443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6563563|NCT00963443|Autonomic Agents|autonomic agents|mesh-ancestor
6563564|NCT00963443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6563565|NCT00963443|Respiratory System Agents|respiratory system agents|mesh-ancestor
6563566|NCT00963443|Nasal Decongestants|nasal decongestants|mesh-ancestor
6563567|NCT00963443|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6563568|NCT00963443|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6563569|NCT00963443|Sympathomimetics|sympathomimetics|mesh-ancestor
6563570|NCT00963443|Adrenergic Agents|adrenergic agents|mesh-ancestor
6563571|NCT00963443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6563572|NCT00963534|Rituximab|rituximab|mesh-list
6563573|NCT00963534|Lenalidomide|lenalidomide|mesh-list
6563574|NCT00963534|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6563575|NCT00963534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6563576|NCT00963534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6563577|NCT00963534|Immunologic Factors|immunologic factors|mesh-ancestor
6563578|NCT00963534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563579|NCT00963534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6563580|NCT00963534|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6563581|NCT00963534|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6563582|NCT00963534|Growth Substances|growth substances|mesh-ancestor
6563583|NCT00963534|Growth Inhibitors|growth inhibitors|mesh-ancestor
6019937|NCT00390559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6019938|NCT00390559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019939|NCT00390559|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6019940|NCT00390559|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6019941|NCT00390559|Cholinergic Agents|cholinergic agents|mesh-ancestor
6019942|NCT00390559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6019943|NCT00390559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019944|NCT00390611|Paclitaxel|paclitaxel|mesh-list
6019945|NCT00390611|Carboplatin|carboplatin|mesh-list
6019946|NCT00390611|Sorafenib|sorafenib|mesh-list
6563584|NCT00963534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6563585|NCT00963534|Alkylating Agents|alkylating agents|mesh-ancestor
6563586|NCT00963534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563587|NCT00963573|Loratadine|loratadine|mesh-list
6563588|NCT00963573|Betamethasone|betamethasone|mesh-list
6563589|NCT00963573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6563590|NCT00963573|Glucocorticoids|glucocorticoids|mesh-ancestor
6563591|NCT00963573|Hormones|hormones|mesh-ancestor
6563592|NCT00963573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6563593|NCT00963573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563594|NCT00963573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6563595|NCT00963573|Respiratory System Agents|respiratory system agents|mesh-ancestor
6563596|NCT00963573|Antipruritics|antipruritics|mesh-ancestor
6563597|NCT00963573|Dermatologic Agents|dermatologic agents|mesh-ancestor
6563598|NCT00963573|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6563599|NCT00963573|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6563600|NCT00963573|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6563601|NCT00963573|Histamine Antagonists|histamine antagonists|mesh-ancestor
6563602|NCT00963573|Histamine Agents|histamine agents|mesh-ancestor
6563603|NCT00963573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6563604|NCT00963573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563605|NCT00963664|Interferons|interferons|mesh-list
6563606|NCT00963664|Interferon-alpha|interferon-alpha|mesh-list
6563607|NCT00963664|Interferon alpha-2|interferon alpha-2|mesh-list
6563608|NCT00963664|Lovastatin|lovastatin|mesh-list
6563609|NCT00963664|L 647318|l 647318|mesh-list
6563610|NCT00963664|Dihydromevinolin|dihydromevinolin|mesh-list
6563611|NCT00963664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6563612|NCT00963664|Antiviral Agents|antiviral agents|mesh-ancestor
6563613|NCT00963664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6563614|NCT00963664|Immunologic Factors|immunologic factors|mesh-ancestor
6563615|NCT00963664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563616|NCT00963664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6563617|NCT00963664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6563618|NCT00963664|Antimetabolites|antimetabolites|mesh-ancestor
6563619|NCT00963664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563620|NCT00963664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6053222|NCT00593645|Antiviral Agents|antiviral agents|mesh-ancestor
6563621|NCT00963664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6563622|NCT00963664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6563623|NCT00963690|Hemostatics|hemostatics|mesh-list
6563624|NCT00963690|Coagulants|coagulants|mesh-ancestor
6563625|NCT00963703|Rituximab|rituximab|mesh-list
6563626|NCT00963703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6563627|NCT00963703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6563628|NCT00963703|Immunologic Factors|immunologic factors|mesh-ancestor
6563629|NCT00963703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563630|NCT00963703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6563631|NCT00963729|Cyclophosphamide|cyclophosphamide|mesh-list
6563632|NCT00963729|Docetaxel|docetaxel|mesh-list
6563633|NCT00963729|Fluorouracil|fluorouracil|mesh-list
6563634|NCT00963729|Letrozole|letrozole|mesh-list
6563635|NCT00963729|Epirubicin|epirubicin|mesh-list
6563636|NCT00963729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6563637|NCT00963729|Immunologic Factors|immunologic factors|mesh-ancestor
6563638|NCT00963729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563639|NCT00963729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6563640|NCT00963729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6563641|NCT00963729|Alkylating Agents|alkylating agents|mesh-ancestor
6563642|NCT00963729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563643|NCT00963729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6563644|NCT00963729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6563645|NCT00963729|Tubulin Modulators|tubulin modulators|mesh-ancestor
6563646|NCT00963729|Antimitotic Agents|antimitotic agents|mesh-ancestor
6563647|NCT00963729|Mitosis Modulators|mitosis modulators|mesh-ancestor
6563648|NCT00963729|Antimetabolites|antimetabolites|mesh-ancestor
6563649|NCT00963729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6563650|NCT00963729|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6563651|NCT00963729|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6563652|NCT00963729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6563653|NCT00963729|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6563654|NCT00963729|Hormone Antagonists|hormone antagonists|mesh-ancestor
6563655|NCT00963729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6563656|NCT00963729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6563657|NCT00963729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6563658|NCT00963729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6563659|NCT00963768|Canagliflozin|canagliflozin|mesh-list
6563660|NCT00963768|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6563661|NCT00963768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563662|NCT00963768|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6563663|NCT00963768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563664|NCT00963833|Interferons|interferons|mesh-list
6563665|NCT00963833|Interferon-beta|interferon-beta|mesh-list
6563666|NCT00963833|Interferon beta-1b|interferon beta-1b|mesh-list
6563667|NCT00963833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6563668|NCT00963833|Antiviral Agents|antiviral agents|mesh-ancestor
6563669|NCT00963833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6563670|NCT00963833|Immunologic Factors|immunologic factors|mesh-ancestor
6563671|NCT00963833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563672|NCT00963833|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6563673|NCT00963846|Huperzine A|huperzine a|mesh-list
6563674|NCT00963846|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6563675|NCT00963846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6563676|NCT00963846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563677|NCT00963846|Cholinergic Agents|cholinergic agents|mesh-ancestor
6563678|NCT00963846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6563679|NCT00963846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563680|NCT00963846|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6563681|NCT00963846|Protective Agents|protective agents|mesh-ancestor
6563682|NCT00963976|Enalapril|enalapril|mesh-list
6563683|NCT00963976|Hydralazine|hydralazine|mesh-list
6563684|NCT00963976|Labetalol|labetalol|mesh-list
6563685|NCT00963976|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6563686|NCT00963976|Protease Inhibitors|protease inhibitors|mesh-ancestor
6563687|NCT00963976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6563688|NCT00963976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563689|NCT00963976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6563690|NCT00963976|Vasodilator Agents|vasodilator agents|mesh-ancestor
6563691|NCT00963976|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6563692|NCT00963976|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6563693|NCT00963976|Adrenergic Agents|adrenergic agents|mesh-ancestor
6563694|NCT00963976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6563695|NCT00963976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563696|NCT00963976|Sympathomimetics|sympathomimetics|mesh-ancestor
6563697|NCT00963976|Autonomic Agents|autonomic agents|mesh-ancestor
6563698|NCT00963976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6563699|NCT00963976|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6563700|NCT00963976|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6563701|NCT00964002|Efavirenz|efavirenz|mesh-list
6563702|NCT00964002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6563703|NCT00964002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6563704|NCT00964002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6563705|NCT00964002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563706|NCT00964002|Antiviral Agents|antiviral agents|mesh-ancestor
6563707|NCT00964002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6019947|NCT00390611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6563708|NCT00964002|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6563709|NCT00964002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6563710|NCT00964002|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6563711|NCT00964002|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6563712|NCT00964002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6563713|NCT00964002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6019948|NCT00390611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6019949|NCT00390611|Tubulin Modulators|tubulin modulators|mesh-ancestor
6019950|NCT00390611|Antimitotic Agents|antimitotic agents|mesh-ancestor
6019951|NCT00390611|Mitosis Modulators|mitosis modulators|mesh-ancestor
6019952|NCT00390611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019953|NCT00390611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6019954|NCT00390611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6019955|NCT00390689|Pramipexole|pramipexole|mesh-list
6019956|NCT00390689|Antioxidants|antioxidants|mesh-ancestor
6563714|NCT00964015|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
6563715|NCT00964015|Plasma Substitutes|plasma substitutes|mesh-ancestor
6563716|NCT00964015|Blood Substitutes|blood substitutes|mesh-ancestor
6563717|NCT00964041|Cycloserine|cycloserine|mesh-list
6563718|NCT00964041|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6563719|NCT00964041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6563720|NCT00964041|Renal Agents|renal agents|mesh-ancestor
6563721|NCT00964041|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6563722|NCT00964041|Antitubercular Agents|antitubercular agents|mesh-ancestor
6563723|NCT00964041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6563724|NCT00964041|Antimetabolites|antimetabolites|mesh-ancestor
6563725|NCT00964041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563726|NCT00964080|Leucovorin|leucovorin|mesh-list
6563727|NCT00964080|Fluorouracil|fluorouracil|mesh-list
6563728|NCT00964080|Oxaliplatin|oxaliplatin|mesh-list
6563729|NCT00964080|Antimetabolites|antimetabolites|mesh-ancestor
6563730|NCT00964080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563731|NCT00964080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6563732|NCT00964080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6563733|NCT00964080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6563734|NCT00964080|Immunologic Factors|immunologic factors|mesh-ancestor
6563735|NCT00964080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563736|NCT00964080|Antidotes|antidotes|mesh-ancestor
6563737|NCT00964080|Protective Agents|protective agents|mesh-ancestor
6563738|NCT00964080|Vitamin B Complex|vitamin b complex|mesh-ancestor
6563739|NCT00964080|Vitamins|vitamins|mesh-ancestor
6563740|NCT00964080|Micronutrients|micronutrients|mesh-ancestor
6563741|NCT00964106|Rosiglitazone|rosiglitazone|mesh-list
6563742|NCT00964106|Rifampin|rifampin|mesh-list
6563743|NCT00964106|Fluconazole|fluconazole|mesh-list
6563744|NCT00964106|Ketoconazole|ketoconazole|mesh-list
6563745|NCT00964106|Flurbiprofen|flurbiprofen|mesh-list
6563746|NCT00964106|Midazolam|midazolam|mesh-list
6563747|NCT00964106|Dextromethorphan|dextromethorphan|mesh-list
6563748|NCT00964106|Caffeine|caffeine|mesh-list
6563749|NCT00964106|Omeprazole|omeprazole|mesh-list
6563750|NCT00964106|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6563751|NCT00964106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6563752|NCT00964106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6563753|NCT00964106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6563754|NCT00964106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563755|NCT00964106|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6563756|NCT00964106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6563757|NCT00964106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6563758|NCT00964106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6563759|NCT00964106|Anesthetics, General|anesthetics, general|mesh-ancestor
6563760|NCT00964106|Anesthetics|anesthetics|mesh-ancestor
6563761|NCT00964106|GABA Modulators|gaba modulators|mesh-ancestor
6563762|NCT00964106|GABA Agents|gaba agents|mesh-ancestor
6563763|NCT00964106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6563764|NCT00964106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563765|NCT00964106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6563766|NCT00964106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6563767|NCT00964106|Antimetabolites|antimetabolites|mesh-ancestor
6563768|NCT00964106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6563769|NCT00964106|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6563770|NCT00964106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6563771|NCT00964106|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6563772|NCT00964106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6563773|NCT00964106|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6563774|NCT00964106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6563775|NCT00964106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6563776|NCT00964106|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6563777|NCT00964106|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6563778|NCT00964106|Purinergic Agents|purinergic agents|mesh-ancestor
6563779|NCT00964106|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6563780|NCT00964106|Antitubercular Agents|antitubercular agents|mesh-ancestor
6563781|NCT00964106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6563782|NCT00964106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6563783|NCT00964106|Leprostatic Agents|leprostatic agents|mesh-ancestor
6563784|NCT00964106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6563785|NCT00964106|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6563786|NCT00964106|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6563787|NCT00964106|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6563788|NCT00964106|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6563789|NCT00964106|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6563790|NCT00964106|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6563791|NCT00964106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6563792|NCT00964106|Antifungal Agents|antifungal agents|mesh-ancestor
6563793|NCT00964106|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6563794|NCT00964106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6563795|NCT00964106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6563796|NCT00964106|Hormone Antagonists|hormone antagonists|mesh-ancestor
6563797|NCT00964106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6563798|NCT00964106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6563799|NCT00964106|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6563800|NCT00964106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6563801|NCT00964106|Antitussive Agents|antitussive agents|mesh-ancestor
6563802|NCT00964106|Respiratory System Agents|respiratory system agents|mesh-ancestor
6563803|NCT00964106|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6563804|NCT00964106|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6563805|NCT00964106|Analgesics|analgesics|mesh-ancestor
6563806|NCT00964106|Sensory System Agents|sensory system agents|mesh-ancestor
6563807|NCT00964106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6563808|NCT00964106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6563809|NCT00964106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6563810|NCT00964106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6563811|NCT00964106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6563812|NCT00964106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6563813|NCT00964171|Efavirenz|efavirenz|mesh-list
6563814|NCT00964171|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6563815|NCT00964171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6563816|NCT00964171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6563817|NCT00964171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563818|NCT00964171|Antiviral Agents|antiviral agents|mesh-ancestor
6563819|NCT00964171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6563820|NCT00964171|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6563821|NCT00964171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6563822|NCT00964171|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6563823|NCT00964171|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6563824|NCT00964171|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6563825|NCT00964171|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6563826|NCT00964184|Metformin|metformin|mesh-list
6563827|NCT00964184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6563828|NCT00964184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563829|NCT00964262|Exenatide|exenatide|mesh-list
6563830|NCT00964262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6563831|NCT00964262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563832|NCT00964262|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6563833|NCT00964262|Incretins|incretins|mesh-ancestor
6563834|NCT00964262|Hormones|hormones|mesh-ancestor
6563835|NCT00964262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6563836|NCT00964275|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6563837|NCT00964275|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6563838|NCT00964275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563839|NCT00964288|Lidocaine|lidocaine|mesh-list
6563840|NCT00964288|Anesthetics, Local|anesthetics, local|mesh-ancestor
6563841|NCT00964288|Anesthetics|anesthetics|mesh-ancestor
6563842|NCT00964288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6563843|NCT00964288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563844|NCT00964288|Sensory System Agents|sensory system agents|mesh-ancestor
6563845|NCT00964288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6563846|NCT00964288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6563847|NCT00964288|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6563848|NCT00964288|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6563849|NCT00964288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6563850|NCT00964288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563851|NCT00964327|Darunavir|darunavir|mesh-list
6563852|NCT00964327|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6563853|NCT00964327|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6563854|NCT00964327|Protease Inhibitors|protease inhibitors|mesh-ancestor
6563855|NCT00964327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6563856|NCT00964327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563857|NCT00964327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6563858|NCT00964327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6563859|NCT00964327|Antiviral Agents|antiviral agents|mesh-ancestor
6563860|NCT00964327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6563861|NCT00964418|Insulin|insulin|mesh-list
6563862|NCT00964418|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6563863|NCT00964418|Insulin Glargine|insulin glargine|mesh-list
6563864|NCT00964418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6563865|NCT00964418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563866|NCT00964457|Cetuximab|cetuximab|mesh-list
6563867|NCT00964457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6563868|NCT00964457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6563869|NCT00964535|Budesonide|budesonide|mesh-list
6563870|NCT00964535|Formoterol Fumarate|formoterol fumarate|mesh-list
6563871|NCT00964535|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6563872|NCT00964535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6563873|NCT00964535|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6563874|NCT00964535|Autonomic Agents|autonomic agents|mesh-ancestor
6563875|NCT00964535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6563876|NCT00964535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563877|NCT00964535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6563878|NCT00964535|Respiratory System Agents|respiratory system agents|mesh-ancestor
6563879|NCT00964535|Glucocorticoids|glucocorticoids|mesh-ancestor
6563880|NCT00964535|Hormones|hormones|mesh-ancestor
6563881|NCT00964535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6563882|NCT00964535|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6563883|NCT00964535|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6563884|NCT00964535|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6563885|NCT00964535|Adrenergic Agents|adrenergic agents|mesh-ancestor
6563886|NCT00964535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6563887|NCT00964535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563888|NCT00964561|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6563889|NCT00964561|Ciprofloxacin|ciprofloxacin|mesh-list
6563890|NCT00964561|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6563891|NCT00964561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6563892|NCT00964561|Antitubercular Agents|antitubercular agents|mesh-ancestor
6563893|NCT00964561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6563894|NCT00964561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6563895|NCT00964561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6563896|NCT00964561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563897|NCT00964561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6563898|NCT00964561|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6563899|NCT00964561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6563900|NCT00964574|Insulin|insulin|mesh-list
6563901|NCT00964574|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6563902|NCT00964574|Insulin Glargine|insulin glargine|mesh-list
6563903|NCT00964574|Insulin glulisine|insulin glulisine|mesh-list
6563904|NCT00964574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6563905|NCT00964574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563906|NCT00964626|Paclitaxel|paclitaxel|mesh-list
6563907|NCT00964626|Cisplatin|cisplatin|mesh-list
6563908|NCT00964626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6563909|NCT00964626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6563910|NCT00964626|Tubulin Modulators|tubulin modulators|mesh-ancestor
6563911|NCT00964626|Antimitotic Agents|antimitotic agents|mesh-ancestor
6563912|NCT00964626|Mitosis Modulators|mitosis modulators|mesh-ancestor
6563913|NCT00964626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563914|NCT00964639|Ropivacaine|ropivacaine|mesh-list
6563915|NCT00964639|Anesthetics, Local|anesthetics, local|mesh-ancestor
6563916|NCT00964639|Anesthetics|anesthetics|mesh-ancestor
6563917|NCT00964639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6563918|NCT00964639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563919|NCT00964639|Sensory System Agents|sensory system agents|mesh-ancestor
6563920|NCT00964639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6563921|NCT00964665|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6563922|NCT00964665|Interferon-alpha|interferon-alpha|mesh-list
6563923|NCT00964665|Antiviral Agents|antiviral agents|mesh-ancestor
6563924|NCT00964665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6563925|NCT00964665|Immunologic Factors|immunologic factors|mesh-ancestor
6563926|NCT00964665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563927|NCT00964691|Chloroquine|chloroquine|mesh-list
6563928|NCT00964691|Pyrimethamine|pyrimethamine|mesh-list
6563929|NCT00964691|Sulfadoxine|sulfadoxine|mesh-list
6563930|NCT00964691|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6563931|NCT00964691|Amebicides|amebicides|mesh-ancestor
6563932|NCT00964691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6563933|NCT00964691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6563934|NCT00964691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6563935|NCT00964691|Antimalarials|antimalarials|mesh-ancestor
6563936|NCT00964691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6563937|NCT00964691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6563938|NCT00964691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6563939|NCT00964691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563940|NCT00964691|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6563941|NCT00964691|Renal Agents|renal agents|mesh-ancestor
6563942|NCT00964704|Bevacizumab|bevacizumab|mesh-list
6563943|NCT00964704|Trastuzumab|trastuzumab|mesh-list
6563944|NCT00964704|Docetaxel|docetaxel|mesh-list
6563945|NCT00964704|Capecitabine|capecitabine|mesh-list
6563946|NCT00964704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6563947|NCT00964704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6563948|NCT00964704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6563949|NCT00964704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6563950|NCT00964704|Growth Substances|growth substances|mesh-ancestor
6563951|NCT00964704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563952|NCT00964704|Growth Inhibitors|growth inhibitors|mesh-ancestor
6563953|NCT00964704|Tubulin Modulators|tubulin modulators|mesh-ancestor
6563954|NCT00964704|Antimitotic Agents|antimitotic agents|mesh-ancestor
6563955|NCT00964704|Mitosis Modulators|mitosis modulators|mesh-ancestor
6563956|NCT00964704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563957|NCT00964704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6563958|NCT00964704|Antimetabolites|antimetabolites|mesh-ancestor
6563959|NCT00964730|Moxifloxacin|moxifloxacin|mesh-list
6563960|NCT00964730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6563961|NCT00964730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6563962|NCT00964730|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6563963|NCT00964730|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6563964|NCT00964730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6563965|NCT00964730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563966|NCT00964730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6563967|NCT00964756|Ganciclovir|ganciclovir|mesh-list
6563968|NCT00964756|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6563969|NCT00964756|Antiviral Agents|antiviral agents|mesh-ancestor
6563970|NCT00964756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6563971|NCT00964756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6563972|NCT00964756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6563973|NCT00964756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6563974|NCT00964769|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6563975|NCT00964769|Immunologic Factors|immunologic factors|mesh-ancestor
6563976|NCT00964769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563977|NCT00964808|Oxycodone|oxycodone|mesh-list
6563978|NCT00964808|Buprenorphine|buprenorphine|mesh-list
6563979|NCT00964808|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6563980|NCT00964808|Narcotics|narcotics|mesh-ancestor
6563981|NCT00964808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6563982|NCT00964808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563983|NCT00964808|Analgesics|analgesics|mesh-ancestor
6563984|NCT00964808|Sensory System Agents|sensory system agents|mesh-ancestor
6563985|NCT00964808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6563986|NCT00964808|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6563987|NCT00964834|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6563988|NCT00964834|Doxycycline|doxycycline|mesh-list
6563989|NCT00964834|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6563990|NCT00964834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6563991|NCT00964834|Antitubercular Agents|antitubercular agents|mesh-ancestor
6563992|NCT00964834|Antimalarials|antimalarials|mesh-ancestor
6563993|NCT00964834|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6563994|NCT00964834|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6657163|NCT01474187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657164|NCT01474187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6657165|NCT01474187|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6657166|NCT01474187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6657167|NCT01474187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6657168|NCT01474265|Varenicline|varenicline|mesh-list
6657169|NCT01474265|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6657170|NCT01474265|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6657171|NCT01474265|Cholinergic Agents|cholinergic agents|mesh-ancestor
6657172|NCT01474265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6657173|NCT01474265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657174|NCT01474265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657175|NCT01474304|Acetaminophen|acetaminophen|mesh-list
6657176|NCT01474304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6657177|NCT01474304|Analgesics|analgesics|mesh-ancestor
6657178|NCT01474304|Sensory System Agents|sensory system agents|mesh-ancestor
6657179|NCT01474304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6657180|NCT01474304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657181|NCT01474304|Antipyretics|antipyretics|mesh-ancestor
6657182|NCT01474330|Pomalidomide|pomalidomide|mesh-list
6657183|NCT01474330|Immunologic Factors|immunologic factors|mesh-ancestor
6657184|NCT01474330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6563995|NCT00964964|Insulin|insulin|mesh-list
6563996|NCT00964964|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6563997|NCT00964964|Insulin, Long-Acting|insulin, long-acting|mesh-list
6563998|NCT00964964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6563999|NCT00964964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564000|NCT00965042|Ceftobiprole|ceftobiprole|mesh-list
6564001|NCT00965042|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
6564002|NCT00965042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6564003|NCT00965042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6564004|NCT00965107|Thiopental|thiopental|mesh-list
6564005|NCT00965107|Propofol|propofol|mesh-list
6564006|NCT00965107|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6564007|NCT00965107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6564008|NCT00965107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564009|NCT00965107|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6564010|NCT00965107|Anesthetics, General|anesthetics, general|mesh-ancestor
6564011|NCT00965107|Anesthetics|anesthetics|mesh-ancestor
6564012|NCT00965107|Anticonvulsants|anticonvulsants|mesh-ancestor
6564013|NCT00965107|GABA Modulators|gaba modulators|mesh-ancestor
6564014|NCT00965107|GABA Agents|gaba agents|mesh-ancestor
6564015|NCT00965107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6564016|NCT00965107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564017|NCT00965120|Bradykinin|bradykinin|mesh-list
6564018|NCT00965120|Kininogens|kininogens|mesh-list
6564019|NCT00965120|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-list
6564020|NCT00965120|Vasodilator Agents|vasodilator agents|mesh-ancestor
6564021|NCT00965120|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
6564022|NCT00965120|Protease Inhibitors|protease inhibitors|mesh-ancestor
6564023|NCT00965120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6564024|NCT00965120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564025|NCT00965172|Calcium|calcium|mesh-list
6564026|NCT00965172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6564027|NCT00965172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564028|NCT00965224|Vaccines|vaccines|mesh-list
6564029|NCT00965224|Immunologic Factors|immunologic factors|mesh-ancestor
6564030|NCT00965224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564031|NCT00965289|Rituximab|rituximab|mesh-list
6564032|NCT00965289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6564033|NCT00965289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6564034|NCT00965289|Immunologic Factors|immunologic factors|mesh-ancestor
6564035|NCT00965289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564036|NCT00965289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6564037|NCT00965315|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6564038|NCT00965315|Fenofibrate|fenofibrate|mesh-list
6564039|NCT00965315|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6564040|NCT00965315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6564041|NCT00965315|Antimetabolites|antimetabolites|mesh-ancestor
6564042|NCT00965315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564043|NCT00965315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6564044|NCT00965315|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6564045|NCT00965315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6564046|NCT00965393|Bradykinin|bradykinin|mesh-list
6564047|NCT00965393|Kininogens|kininogens|mesh-list
6564048|NCT00965393|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-list
6564049|NCT00965393|Vasodilator Agents|vasodilator agents|mesh-ancestor
6564050|NCT00965393|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
6564051|NCT00965393|Protease Inhibitors|protease inhibitors|mesh-ancestor
6564052|NCT00965393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6564053|NCT00965393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564054|NCT00965406|Insulin|insulin|mesh-list
6564055|NCT00965406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6564056|NCT00965406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564057|NCT00965549|Insulin|insulin|mesh-list
6564058|NCT00965549|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6564059|NCT00965549|Insulin Glargine|insulin glargine|mesh-list
6564060|NCT00965549|Insulin Aspart|insulin aspart|mesh-list
6564061|NCT00965549|Insulin glulisine|insulin glulisine|mesh-list
6564062|NCT00965549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6564063|NCT00965549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564064|NCT00965640|Botulinum Toxins|botulinum toxins|mesh-list
6564065|NCT00965640|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6564066|NCT00965640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6564067|NCT00965640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564068|NCT00965640|Cholinergic Agents|cholinergic agents|mesh-ancestor
6564069|NCT00965640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6564070|NCT00965640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564071|NCT00965653|Folic Acid|folic acid|mesh-list
6564072|NCT00965653|Methotrexate|methotrexate|mesh-list
6564073|NCT00965653|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6564074|NCT00965653|Abortifacient Agents|abortifacient agents|mesh-ancestor
6564075|NCT00965653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6564076|NCT00965653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564077|NCT00965653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6564078|NCT00965653|Antimetabolites|antimetabolites|mesh-ancestor
6564079|NCT00965653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564080|NCT00965653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6564081|NCT00965653|Dermatologic Agents|dermatologic agents|mesh-ancestor
6564082|NCT00965653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6564083|NCT00965653|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6564084|NCT00965653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6564085|NCT00965653|Immunologic Factors|immunologic factors|mesh-ancestor
6564086|NCT00965653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6564087|NCT00965653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6564088|NCT00965653|Hematinics|hematinics|mesh-ancestor
6564089|NCT00965653|Vitamin B Complex|vitamin b complex|mesh-ancestor
6564090|NCT00965653|Vitamins|vitamins|mesh-ancestor
6564091|NCT00965653|Micronutrients|micronutrients|mesh-ancestor
6564092|NCT00965666|Etanercept|etanercept|mesh-list
6564093|NCT00965666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6564094|NCT00965666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6564095|NCT00965666|Analgesics|analgesics|mesh-ancestor
6564096|NCT00965666|Sensory System Agents|sensory system agents|mesh-ancestor
6564097|NCT00965666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6564098|NCT00965666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564099|NCT00965666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6564100|NCT00965666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6564101|NCT00965666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6564102|NCT00965666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6564103|NCT00965666|Immunologic Factors|immunologic factors|mesh-ancestor
6564104|NCT00965796|Lidocaine|lidocaine|mesh-list
6564105|NCT00965796|Anesthetics, Local|anesthetics, local|mesh-ancestor
6564106|NCT00965796|Anesthetics|anesthetics|mesh-ancestor
6564107|NCT00965796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6564108|NCT00965796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564109|NCT00965796|Sensory System Agents|sensory system agents|mesh-ancestor
6564110|NCT00965796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6564111|NCT00965796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6564112|NCT00965796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6564113|NCT00965796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6564114|NCT00965796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6564115|NCT00965796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564116|NCT00965809|Dronabinol|dronabinol|mesh-list
6564117|NCT00965809|Hallucinogens|hallucinogens|mesh-ancestor
6564118|NCT00965809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564119|NCT00965809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6564120|NCT00965809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6564121|NCT00965809|Analgesics|analgesics|mesh-ancestor
6564122|NCT00965809|Sensory System Agents|sensory system agents|mesh-ancestor
6564123|NCT00965809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6564124|NCT00965809|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6564125|NCT00965809|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6564126|NCT00965809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6564127|NCT00965809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564128|NCT00965809|Hormones|hormones|mesh-ancestor
6564129|NCT00965809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6564130|NCT00965874|Magnesium Sulfate|magnesium sulfate|mesh-list
6564131|NCT00965874|Analgesics|analgesics|mesh-ancestor
6564132|NCT00965874|Sensory System Agents|sensory system agents|mesh-ancestor
6564133|NCT00965874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6564134|NCT00965874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564135|NCT00965874|Anesthetics|anesthetics|mesh-ancestor
6564136|NCT00965874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6564137|NCT00965874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6564138|NCT00965874|Anticonvulsants|anticonvulsants|mesh-ancestor
6564139|NCT00965874|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6564140|NCT00965874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6564141|NCT00965874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564142|NCT00965874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6564143|NCT00965874|Tocolytic Agents|tocolytic agents|mesh-ancestor
6564144|NCT00965874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6564145|NCT00965900|Propranolol|propranolol|mesh-list
6564146|NCT00965900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
6564147|NCT00965900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6444498|NCT00384371|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6444499|NCT00384371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6444500|NCT00384371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444501|NCT00384371|Cholinergic Agents|cholinergic agents|mesh-ancestor
6444502|NCT00384371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6444503|NCT00384371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444504|NCT00384371|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6444505|NCT00384371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6444506|NCT00384384|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
6019957|NCT00390689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019958|NCT00390689|Protective Agents|protective agents|mesh-ancestor
6444507|NCT00384384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6444508|NCT00384410|Nabilone|nabilone|mesh-list
6444509|NCT00384410|Antiemetics|antiemetics|mesh-ancestor
6564148|NCT00965900|Adrenergic Agents|adrenergic agents|mesh-ancestor
6564149|NCT00965900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6564150|NCT00965900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564151|NCT00965900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564152|NCT00965900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6564153|NCT00965900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6564154|NCT00965900|Vasodilator Agents|vasodilator agents|mesh-ancestor
6564155|NCT00965913|Nicotine|nicotine|mesh-list
6564156|NCT00965913|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6564157|NCT00965913|Autonomic Agents|autonomic agents|mesh-ancestor
6564158|NCT00965913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6564159|NCT00965913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564160|NCT00965913|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6564161|NCT00965913|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6564162|NCT00965913|Cholinergic Agents|cholinergic agents|mesh-ancestor
6444510|NCT00384410|Autonomic Agents|autonomic agents|mesh-ancestor
6444511|NCT00384410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6444512|NCT00384410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444513|NCT00384410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6444514|NCT00384410|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6444515|NCT00384410|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6444516|NCT00384410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6444517|NCT00384410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6444518|NCT00384436|Citalopram|citalopram|mesh-list
6444519|NCT00384436|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6564163|NCT00965913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6564164|NCT00965913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564165|NCT00965926|Mirabegron|mirabegron|mesh-list
6564166|NCT00965926|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6564167|NCT00965926|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6564168|NCT00965926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6564169|NCT00965926|Adrenergic Agents|adrenergic agents|mesh-ancestor
6564170|NCT00965926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6564171|NCT00965926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564172|NCT00965926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564173|NCT00965926|Urological Agents|urological agents|mesh-ancestor
6564174|NCT00965991|Metformin|metformin|mesh-list
6564175|NCT00965991|Glyburide|glyburide|mesh-list
6564176|NCT00965991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6564177|NCT00965991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564178|NCT00966004|Mirabegron|mirabegron|mesh-list
6564179|NCT00966004|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6564180|NCT00966004|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6564181|NCT00966004|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6564182|NCT00966004|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6564183|NCT00966004|Adrenergic Agents|adrenergic agents|mesh-ancestor
6564184|NCT00966004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6564185|NCT00966004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564186|NCT00966004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564187|NCT00966004|Urological Agents|urological agents|mesh-ancestor
6564188|NCT00966004|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6564189|NCT00966004|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6564190|NCT00966004|Cholinergic Agents|cholinergic agents|mesh-ancestor
6564191|NCT00966056|Mitomycins|mitomycins|mesh-list
6564192|NCT00966056|Mitomycin|mitomycin|mesh-list
6564193|NCT00966056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6564194|NCT00966056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6564195|NCT00966056|Alkylating Agents|alkylating agents|mesh-ancestor
6564196|NCT00966056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564197|NCT00966056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6564198|NCT00966056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6564199|NCT00966082|Propranolol|propranolol|mesh-list
6564200|NCT00966082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6564201|NCT00966082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6564202|NCT00966082|Adrenergic Agents|adrenergic agents|mesh-ancestor
6564203|NCT00966082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6564204|NCT00966082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564205|NCT00966082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564206|NCT00966082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6564207|NCT00966082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6564208|NCT00966082|Vasodilator Agents|vasodilator agents|mesh-ancestor
6564209|NCT00966121|Propranolol|propranolol|mesh-list
6564210|NCT00966121|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6564211|NCT00966121|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6564212|NCT00966121|Adrenergic Agents|adrenergic agents|mesh-ancestor
6564213|NCT00966121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6564214|NCT00966121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564215|NCT00966121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564216|NCT00966121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6564217|NCT00966121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6564218|NCT00966121|Vasodilator Agents|vasodilator agents|mesh-ancestor
6564219|NCT00966160|Ritonavir|ritonavir|mesh-list
6564220|NCT00966160|Lopinavir|lopinavir|mesh-list
6564221|NCT00966160|Lamivudine|lamivudine|mesh-list
6564222|NCT00966160|Zidovudine|zidovudine|mesh-list
6564223|NCT00966160|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6564224|NCT00966160|Efavirenz|efavirenz|mesh-list
6564225|NCT00966160|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6564226|NCT00966160|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6564227|NCT00966160|Protease Inhibitors|protease inhibitors|mesh-ancestor
6564228|NCT00966160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6564229|NCT00966160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564230|NCT00966160|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6564231|NCT00966160|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6564232|NCT00966160|Antiviral Agents|antiviral agents|mesh-ancestor
6564233|NCT00966160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6564234|NCT00966160|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6564235|NCT00966160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6564236|NCT00966160|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6564237|NCT00966160|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6564238|NCT00966160|Antimetabolites|antimetabolites|mesh-ancestor
6564239|NCT00966160|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6564240|NCT00966160|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6564241|NCT00966160|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6564242|NCT00966160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6564243|NCT00966160|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6564244|NCT00966199|Antihypertensive Agents|antihypertensive agents|mesh-list
6564245|NCT00966251|Pidilizumab|pidilizumab|mesh-list
6564246|NCT00966251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6564247|NCT00966251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6564248|NCT00966290|Warfarin|warfarin|mesh-list
6564249|NCT00966290|Anticoagulants|anticoagulants|mesh-list
6564250|NCT00966290|Acenocoumarol|acenocoumarol|mesh-list
6564251|NCT00966290|Fluindione|fluindione|mesh-list
6564252|NCT00966290|Phenindione|phenindione|mesh-list
6564253|NCT00966316|Aspirin|aspirin|mesh-list
6564254|NCT00966316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6564255|NCT00966316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6564256|NCT00966316|Analgesics|analgesics|mesh-ancestor
6564257|NCT00966316|Sensory System Agents|sensory system agents|mesh-ancestor
6564258|NCT00966316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6564259|NCT00966316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564260|NCT00966316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6564261|NCT00966316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6564262|NCT00966316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6564263|NCT00966316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6564264|NCT00966316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564265|NCT00966316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6564266|NCT00966316|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6564267|NCT00966316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6564268|NCT00966316|Antipyretics|antipyretics|mesh-ancestor
6564269|NCT00966329|Maraviroc|maraviroc|mesh-list
6564270|NCT00966329|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6564271|NCT00966329|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6564272|NCT00966329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564273|NCT00966329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6564274|NCT00966329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6564275|NCT00966329|Antiviral Agents|antiviral agents|mesh-ancestor
6564276|NCT00966329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6564277|NCT00966329|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6564278|NCT00966368|Insulin|insulin|mesh-list
6564279|NCT00966368|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6019959|NCT00390689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019960|NCT00390689|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6019961|NCT00390689|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6019962|NCT00390689|Dopamine Agonists|dopamine agonists|mesh-ancestor
6564280|NCT00966368|Insulin, Long-Acting|insulin, long-acting|mesh-list
6564281|NCT00966368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6564282|NCT00966368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564283|NCT00966472|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6564284|NCT00966472|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6019963|NCT00390689|Dopamine Agents|dopamine agents|mesh-ancestor
6019964|NCT00390689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6019965|NCT00390780|Clotrimazole|clotrimazole|mesh-list
6019966|NCT00390780|Miconazole|miconazole|mesh-list
6019967|NCT00390780|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6019968|NCT00390780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6019969|NCT00390780|Antifungal Agents|antifungal agents|mesh-ancestor
6019970|NCT00390780|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6019971|NCT00390780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6564285|NCT00966472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6564286|NCT00966472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6564287|NCT00966472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6564288|NCT00966472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564289|NCT00966472|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6564290|NCT00966472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6564291|NCT00966472|Antimetabolites|antimetabolites|mesh-ancestor
6564292|NCT00966472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6564293|NCT00966472|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6564294|NCT00966576|Timolol|timolol|mesh-list
6564295|NCT00966576|Brinzolamide|brinzolamide|mesh-list
6564296|NCT00966576|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6564297|NCT00966576|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6564298|NCT00966576|Adrenergic Agents|adrenergic agents|mesh-ancestor
6564299|NCT00966576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6564300|NCT00966576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564301|NCT00966576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564302|NCT00966576|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6564303|NCT00966576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6564304|NCT00966576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6564305|NCT00966576|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6564306|NCT00966602|Ivacaftor|ivacaftor|mesh-list
6564307|NCT00966602|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6564308|NCT00966602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6564309|NCT00966602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564310|NCT00966615|Dialysis Solutions|dialysis solutions|mesh-list
6564311|NCT00966615|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6657185|NCT01474330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6657186|NCT01474330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6657187|NCT01474330|Growth Substances|growth substances|mesh-ancestor
6657188|NCT01474330|Growth Inhibitors|growth inhibitors|mesh-ancestor
6657189|NCT01474330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6657190|NCT01474382|Phentolamine|phentolamine|mesh-list
6657191|NCT01474382|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6657192|NCT01474382|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6657193|NCT01474382|Adrenergic Agents|adrenergic agents|mesh-ancestor
6564312|NCT00966680|Anesthetics|anesthetics|mesh-list
6564313|NCT00966680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6564314|NCT00966680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564315|NCT00966706|Gemcitabine|gemcitabine|mesh-list
6564316|NCT00966706|Docetaxel|docetaxel|mesh-list
6564317|NCT00966706|Capecitabine|capecitabine|mesh-list
6564318|NCT00966706|Epirubicin|epirubicin|mesh-list
6564319|NCT00966706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6564320|NCT00966706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6564321|NCT00966706|Antimetabolites|antimetabolites|mesh-ancestor
6564322|NCT00966706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564323|NCT00966706|Antiviral Agents|antiviral agents|mesh-ancestor
6564324|NCT00966706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6019972|NCT00390780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6444520|NCT00384436|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6444521|NCT00384436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6444522|NCT00384436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444523|NCT00384436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6444524|NCT00384436|Serotonin Agents|serotonin agents|mesh-ancestor
6444525|NCT00384436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444526|NCT00384436|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6444527|NCT00384436|Antidepressive Agents|antidepressive agents|mesh-ancestor
6444528|NCT00384436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6444529|NCT00384475|Ciclesonide|ciclesonide|mesh-list
6444530|NCT00384475|Glucocorticoids|glucocorticoids|mesh-ancestor
6444531|NCT00384475|Hormones|hormones|mesh-ancestor
6444532|NCT00384475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6444533|NCT00384475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444534|NCT00384475|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6444535|NCT00384527|Vancomycin|vancomycin|mesh-list
6444536|NCT00384527|Nitazoxanide|nitazoxanide|mesh-list
6444537|NCT00384527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6444538|NCT00384527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6564325|NCT00966706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6564326|NCT00966706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6564327|NCT00966706|Immunologic Factors|immunologic factors|mesh-ancestor
6564328|NCT00966706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564329|NCT00966706|Tubulin Modulators|tubulin modulators|mesh-ancestor
6564330|NCT00966706|Antimitotic Agents|antimitotic agents|mesh-ancestor
6564331|NCT00966706|Mitosis Modulators|mitosis modulators|mesh-ancestor
6564332|NCT00966706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6564333|NCT00966706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6564334|NCT00966706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6564335|NCT00966745|Milrinone|milrinone|mesh-list
6564336|NCT00966745|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6564337|NCT00966745|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6564338|NCT00966745|Vasodilator Agents|vasodilator agents|mesh-ancestor
6564339|NCT00966745|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6564340|NCT00966745|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6564341|NCT00966745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6564342|NCT00966745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564343|NCT00966745|Protective Agents|protective agents|mesh-ancestor
6564344|NCT00966745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564345|NCT00966771|Copper|copper|mesh-list
6564346|NCT00966771|Levonorgestrel|levonorgestrel|mesh-list
6564347|NCT00966771|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6564348|NCT00966771|Contraceptive Agents|contraceptive agents|mesh-ancestor
6564349|NCT00966771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6564350|NCT00966771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444539|NCT00384527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6564351|NCT00966771|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6564352|NCT00966771|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6564353|NCT00966771|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6564354|NCT00966771|Trace Elements|trace elements|mesh-ancestor
6564355|NCT00966771|Micronutrients|micronutrients|mesh-ancestor
6564356|NCT00966836|Mycophenolic Acid|mycophenolic acid|mesh-list
6564357|NCT00966836|Valganciclovir|valganciclovir|mesh-list
6564358|NCT00966836|Everolimus|everolimus|mesh-list
6564359|NCT00966836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6564360|NCT00966836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6564361|NCT00966836|Immunologic Factors|immunologic factors|mesh-ancestor
6564362|NCT00966836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564363|NCT00966836|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6564364|NCT00966836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6564365|NCT00966836|Antitubercular Agents|antitubercular agents|mesh-ancestor
6564366|NCT00966836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6564367|NCT00966836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6564368|NCT00966836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6564369|NCT00966836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564370|NCT00966836|Antiviral Agents|antiviral agents|mesh-ancestor
6564371|NCT00966901|Nicotine|nicotine|mesh-list
6564372|NCT00966901|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6564373|NCT00966901|Autonomic Agents|autonomic agents|mesh-ancestor
6564374|NCT00966901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6564375|NCT00966901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564376|NCT00966901|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6564377|NCT00966901|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6564378|NCT00966901|Cholinergic Agents|cholinergic agents|mesh-ancestor
6564379|NCT00966901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6564380|NCT00966901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564381|NCT00966914|Paclitaxel|paclitaxel|mesh-list
6564382|NCT00966914|Docetaxel|docetaxel|mesh-list
6564383|NCT00966914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6564384|NCT00966914|Cisplatin|cisplatin|mesh-list
6564385|NCT00966914|2,2'-dithiodiethanesulfonic acid|2,2'-dithiodiethanesulfonic acid|mesh-list
6564386|NCT00966914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6564387|NCT00966914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6564388|NCT00966914|Tubulin Modulators|tubulin modulators|mesh-ancestor
6564389|NCT00966914|Antimitotic Agents|antimitotic agents|mesh-ancestor
6564390|NCT00966914|Mitosis Modulators|mitosis modulators|mesh-ancestor
6564391|NCT00966914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564392|NCT00966914|Protective Agents|protective agents|mesh-ancestor
6564393|NCT00966914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564394|NCT00966966|Gemfibrozil|gemfibrozil|mesh-list
6564395|NCT00966966|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6564396|NCT00966966|Antimetabolites|antimetabolites|mesh-ancestor
6564397|NCT00966966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564398|NCT00966966|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6564399|NCT00966966|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6564400|NCT00966966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6564401|NCT00966966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6564402|NCT00967031|Capecitabine|capecitabine|mesh-list
6564403|NCT00967031|Lapatinib|lapatinib|mesh-list
6564404|NCT00967031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6564405|NCT00967031|Antimetabolites|antimetabolites|mesh-ancestor
6564406|NCT00967031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564407|NCT00967031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6564408|NCT00967031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6564409|NCT00967031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6564410|NCT00967057|Dexamethasone|dexamethasone|mesh-list
6564411|NCT00967057|Methotrexate|methotrexate|mesh-list
6564412|NCT00967057|Vincristine|vincristine|mesh-list
6564413|NCT00967057|Asparaginase|asparaginase|mesh-list
6564414|NCT00967057|Mitoxantrone|mitoxantrone|mesh-list
6564415|NCT00967057|Idarubicin|idarubicin|mesh-list
6564416|NCT00967057|Pegaspargase|pegaspargase|mesh-list
6564417|NCT00967057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6564418|NCT00967057|Antiemetics|antiemetics|mesh-ancestor
6564419|NCT00967057|Autonomic Agents|autonomic agents|mesh-ancestor
6564420|NCT00967057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6564421|NCT00967057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564422|NCT00967057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6564423|NCT00967057|Glucocorticoids|glucocorticoids|mesh-ancestor
6564424|NCT00967057|Hormones|hormones|mesh-ancestor
6564425|NCT00967057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6564426|NCT00967057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6564427|NCT00967057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6564428|NCT00967057|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6564429|NCT00967057|Abortifacient Agents|abortifacient agents|mesh-ancestor
6564430|NCT00967057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6564431|NCT00967057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6564432|NCT00967057|Antimetabolites|antimetabolites|mesh-ancestor
6564433|NCT00967057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564434|NCT00967057|Dermatologic Agents|dermatologic agents|mesh-ancestor
6564435|NCT00967057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6564436|NCT00967057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6564437|NCT00967057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6564438|NCT00967057|Immunologic Factors|immunologic factors|mesh-ancestor
6564439|NCT00967057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6564440|NCT00967057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6564441|NCT00967057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6564442|NCT00967057|Tubulin Modulators|tubulin modulators|mesh-ancestor
6564443|NCT00967057|Antimitotic Agents|antimitotic agents|mesh-ancestor
6564444|NCT00967057|Mitosis Modulators|mitosis modulators|mesh-ancestor
6564445|NCT00967057|Analgesics|analgesics|mesh-ancestor
6564446|NCT00967057|Sensory System Agents|sensory system agents|mesh-ancestor
6564447|NCT00967057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6564448|NCT00967057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6564449|NCT00967057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6564450|NCT00967070|Nicotine|nicotine|mesh-list
6564451|NCT00967070|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6564452|NCT00967070|Autonomic Agents|autonomic agents|mesh-ancestor
6564453|NCT00967070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6564454|NCT00967070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564455|NCT00967070|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6564456|NCT00967070|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6564457|NCT00967070|Cholinergic Agents|cholinergic agents|mesh-ancestor
6564458|NCT00967070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6564459|NCT00967070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564460|NCT00967096|Rifaximin|rifaximin|mesh-list
6564461|NCT00967096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6564462|NCT00967096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6564463|NCT00967096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6564464|NCT00967135|Pregabalin|pregabalin|mesh-list
6564465|NCT00967135|Analgesics|analgesics|mesh-ancestor
6564466|NCT00967135|Sensory System Agents|sensory system agents|mesh-ancestor
6564467|NCT00967135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6564468|NCT00967135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564469|NCT00967135|Anticonvulsants|anticonvulsants|mesh-ancestor
6564470|NCT00967135|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6564471|NCT00967135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6564472|NCT00967135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564473|NCT00967135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6564474|NCT00967135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6564475|NCT00967135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6564476|NCT00967135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6564477|NCT00967135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6564478|NCT00967148|Tinzaparin|tinzaparin|mesh-list
6564479|NCT00967148|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6564480|NCT00967148|Dalteparin|dalteparin|mesh-list
6564481|NCT00967148|Anticoagulants|anticoagulants|mesh-ancestor
6564482|NCT00967148|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6564483|NCT00967148|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6564484|NCT00967148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564485|NCT00967174|Nicotine|nicotine|mesh-list
6564486|NCT00967174|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6564487|NCT00967174|Autonomic Agents|autonomic agents|mesh-ancestor
6564488|NCT00967174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6564489|NCT00967174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564490|NCT00967174|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6564491|NCT00967174|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6564492|NCT00967174|Cholinergic Agents|cholinergic agents|mesh-ancestor
6564493|NCT00967174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6564494|NCT00967174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564495|NCT00967213|Ranibizumab|ranibizumab|mesh-list
6564496|NCT00967213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6564497|NCT00967213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6564498|NCT00967213|Growth Substances|growth substances|mesh-ancestor
6564499|NCT00967213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564500|NCT00967213|Growth Inhibitors|growth inhibitors|mesh-ancestor
6564501|NCT00967213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6564502|NCT00967252|Atorvastatin|atorvastatin|mesh-list
6564503|NCT00967252|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6564504|NCT00967252|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6564505|NCT00967252|Antimetabolites|antimetabolites|mesh-ancestor
6564506|NCT00967252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564507|NCT00967252|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6564508|NCT00967252|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6564509|NCT00967252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6564510|NCT00967291|Ifosfamide|ifosfamide|mesh-list
6564511|NCT00967291|Mitomycins|mitomycins|mesh-list
6564512|NCT00967291|Mitomycin|mitomycin|mesh-list
6564513|NCT00967291|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6564514|NCT00967291|Alkylating Agents|alkylating agents|mesh-ancestor
6564515|NCT00967291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564516|NCT00967291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6564517|NCT00967291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6664748|NCT01513785|Amoxicillin|amoxicillin|mesh-list
6444540|NCT00384540|Dobutamine|dobutamine|mesh-list
6444541|NCT00384540|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6444542|NCT00384540|Sympathomimetics|sympathomimetics|mesh-ancestor
6444543|NCT00384540|Autonomic Agents|autonomic agents|mesh-ancestor
6444544|NCT00384540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6444545|NCT00384540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444546|NCT00384540|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6444547|NCT00384540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6444548|NCT00384540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6444549|NCT00384540|Adrenergic Agents|adrenergic agents|mesh-ancestor
6444550|NCT00384540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6019973|NCT00390780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019974|NCT00390780|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6019975|NCT00390780|Hormone Antagonists|hormone antagonists|mesh-ancestor
6444551|NCT00384540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444552|NCT00384540|Protective Agents|protective agents|mesh-ancestor
6053223|NCT00593645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6444553|NCT00384553|Rituximab|rituximab|mesh-list
6444554|NCT00384553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6444555|NCT00384553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6444556|NCT00384553|Immunologic Factors|immunologic factors|mesh-ancestor
6444557|NCT00384553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444558|NCT00384553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6444559|NCT00384566|Metoprolol|metoprolol|mesh-list
6444560|NCT00384566|Carvedilol|carvedilol|mesh-list
6444561|NCT00384566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6444562|NCT00384566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6444563|NCT00384566|Sympatholytics|sympatholytics|mesh-ancestor
6444564|NCT00384566|Autonomic Agents|autonomic agents|mesh-ancestor
6444565|NCT00384566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6444566|NCT00384566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444567|NCT00384566|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6444568|NCT00384566|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6444569|NCT00384566|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6444570|NCT00384566|Adrenergic Agents|adrenergic agents|mesh-ancestor
6444571|NCT00384566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6444572|NCT00384566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444573|NCT00384566|Antioxidants|antioxidants|mesh-ancestor
6444574|NCT00384566|Protective Agents|protective agents|mesh-ancestor
6444575|NCT00384566|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6444576|NCT00384566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6444577|NCT00384566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6444578|NCT00384566|Vasodilator Agents|vasodilator agents|mesh-ancestor
6444579|NCT00384566|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6444580|NCT00384566|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6444581|NCT00384579|Botulinum Toxins|botulinum toxins|mesh-list
6444582|NCT00384579|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6444583|NCT00384579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6444584|NCT00384579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444585|NCT00384579|Cholinergic Agents|cholinergic agents|mesh-ancestor
6444586|NCT00384579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6444587|NCT00384579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444588|NCT00384592|Esomeprazole|esomeprazole|mesh-list
6444589|NCT00384592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6444590|NCT00384592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6444591|NCT00384592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6444592|NCT00384592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6444593|NCT00384592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444594|NCT00384605|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
6444595|NCT00384605|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6444596|NCT00384605|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6444597|NCT00384605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6444598|NCT00384605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444599|NCT00384605|Hormones|hormones|mesh-ancestor
6444600|NCT00384605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6444601|NCT00384605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444602|NCT00384618|Vitamin E|vitamin e|mesh-list
6444603|NCT00384618|Pravastatin|pravastatin|mesh-list
6444604|NCT00384618|Vitamins|vitamins|mesh-ancestor
6444605|NCT00384618|Micronutrients|micronutrients|mesh-ancestor
6444606|NCT00384618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444607|NCT00384618|Antioxidants|antioxidants|mesh-ancestor
6444608|NCT00384618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444609|NCT00384618|Protective Agents|protective agents|mesh-ancestor
6444610|NCT00384618|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6444611|NCT00384618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6444612|NCT00384618|Antimetabolites|antimetabolites|mesh-ancestor
6444613|NCT00384618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6664749|NCT01513785|Rabeprazole|rabeprazole|mesh-list
6564518|NCT00967291|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6564519|NCT00967291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6564520|NCT00967382|Dalteparin|dalteparin|mesh-list
6564521|NCT00967382|Tinzaparin|tinzaparin|mesh-list
6564522|NCT00967382|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6564523|NCT00967382|Anticoagulants|anticoagulants|mesh-ancestor
6564524|NCT00967382|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6564525|NCT00967382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6564526|NCT00967382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564527|NCT00967408|Citalopram|citalopram|mesh-list
6564528|NCT00967408|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6564529|NCT00967408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6564530|NCT00967408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6564531|NCT00967408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564532|NCT00967408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6564533|NCT00967408|Serotonin Agents|serotonin agents|mesh-ancestor
6564534|NCT00967408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564535|NCT00967408|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6564536|NCT00967408|Antidepressive Agents|antidepressive agents|mesh-ancestor
6564537|NCT00967408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6564538|NCT00967421|Ethanol|ethanol|mesh-list
6564539|NCT00967421|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6564540|NCT00967421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6564541|NCT00967421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6564542|NCT00967421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564543|NCT00967434|Atorvastatin|atorvastatin|mesh-list
6564544|NCT00967434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6564545|NCT00967434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6564546|NCT00967434|Antimetabolites|antimetabolites|mesh-ancestor
6564547|NCT00967434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564548|NCT00967434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6564549|NCT00967434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6564550|NCT00967434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6564551|NCT00967512|Cytarabine|cytarabine|mesh-list
6564552|NCT00967512|Idarubicin|idarubicin|mesh-list
6564553|NCT00967512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6564554|NCT00967512|Antimetabolites|antimetabolites|mesh-ancestor
6564555|NCT00967512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564556|NCT00967512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6564557|NCT00967512|Antiviral Agents|antiviral agents|mesh-ancestor
6564558|NCT00967512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6564559|NCT00967512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6564560|NCT00967512|Immunologic Factors|immunologic factors|mesh-ancestor
6564561|NCT00967512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564562|NCT00967512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6564563|NCT00967512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6564564|NCT00967512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6564565|NCT00967512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6564566|NCT00967538|Etanercept|etanercept|mesh-list
6564567|NCT00967538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6564568|NCT00967538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6564569|NCT00967538|Analgesics|analgesics|mesh-ancestor
6564570|NCT00967538|Sensory System Agents|sensory system agents|mesh-ancestor
6564571|NCT00967538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6564572|NCT00967538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564573|NCT00967538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6564574|NCT00967538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6564575|NCT00967538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6564576|NCT00967538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6564577|NCT00967538|Immunologic Factors|immunologic factors|mesh-ancestor
6564578|NCT00967603|Sunitinib|sunitinib|mesh-list
6564579|NCT00967603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6564580|NCT00967603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6564581|NCT00967603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6564582|NCT00967603|Growth Substances|growth substances|mesh-ancestor
6564583|NCT00967603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564584|NCT00967603|Growth Inhibitors|growth inhibitors|mesh-ancestor
6564585|NCT00967603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6564586|NCT00967603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6564587|NCT00967603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564588|NCT00967629|Calcium Carbonate|calcium carbonate|mesh-list
6564589|NCT00967629|Calcium|calcium|mesh-list
6564590|NCT00967629|Sevelamer|sevelamer|mesh-list
6564591|NCT00967629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6564592|NCT00967629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564593|NCT00967629|Antacids|antacids|mesh-ancestor
6564594|NCT00967629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564595|NCT00967629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6564596|NCT00967629|Chelating Agents|chelating agents|mesh-ancestor
6564597|NCT00967629|Sequestering Agents|sequestering agents|mesh-ancestor
6564598|NCT00967642|Insulin|insulin|mesh-list
6564599|NCT00967642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6564600|NCT00967642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564601|NCT00967655|Capecitabine|capecitabine|mesh-list
6564602|NCT00967655|Irinotecan|irinotecan|mesh-list
6564603|NCT00967655|Panitumumab|panitumumab|mesh-list
6564604|NCT00967655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6564605|NCT00967655|Antimetabolites|antimetabolites|mesh-ancestor
6564606|NCT00967655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564607|NCT00967655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6564608|NCT00967655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6564609|NCT00967655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6564610|NCT00967655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6564611|NCT00967655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6564612|NCT00967707|Gabapentin|gabapentin|mesh-list
6564613|NCT00967707|Donepezil|donepezil|mesh-list
6564614|NCT00967707|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6564615|NCT00967707|Analgesics|analgesics|mesh-ancestor
6564616|NCT00967707|Sensory System Agents|sensory system agents|mesh-ancestor
6564617|NCT00967707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6564618|NCT00967707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564619|NCT00967707|Anticonvulsants|anticonvulsants|mesh-ancestor
6564620|NCT00967707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6564621|NCT00967707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6564622|NCT00967707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6564623|NCT00967707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6564624|NCT00967707|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6564625|NCT00967707|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6564626|NCT00967707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6564627|NCT00967707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564628|NCT00967707|Antimanic Agents|antimanic agents|mesh-ancestor
6564629|NCT00967707|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6564630|NCT00967707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6564631|NCT00967707|Cholinergic Agents|cholinergic agents|mesh-ancestor
6444614|NCT00384618|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6444615|NCT00384618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6444616|NCT00384631|Bevacizumab|bevacizumab|mesh-list
6444617|NCT00384631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6444618|NCT00384631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6564632|NCT00967707|Nootropic Agents|nootropic agents|mesh-ancestor
6564633|NCT00967707|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6564634|NCT00967707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6564635|NCT00967707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6564636|NCT00967707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6564637|NCT00967707|Antidepressive Agents|antidepressive agents|mesh-ancestor
6564638|NCT00967772|Naftopidil|naftopidil|mesh-list
6564639|NCT00967772|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6564640|NCT00967772|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6564641|NCT00967772|Adrenergic Agents|adrenergic agents|mesh-ancestor
6564642|NCT00967772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6564643|NCT00967772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564644|NCT00967772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564645|NCT00967772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6564646|NCT00967772|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6564647|NCT00967772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6564648|NCT00967772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6564649|NCT00967772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6564650|NCT00967837|Insulin|insulin|mesh-list
6564651|NCT00967837|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6564652|NCT00967837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6564653|NCT00967837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444619|NCT00384631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6444620|NCT00384631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6564654|NCT00967850|Verteporfin|verteporfin|mesh-list
6564655|NCT00967850|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6564656|NCT00967850|Dermatologic Agents|dermatologic agents|mesh-ancestor
6564657|NCT00967928|Everolimus|everolimus|mesh-list
6564658|NCT00967928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6564659|NCT00967928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6564660|NCT00967928|Immunologic Factors|immunologic factors|mesh-ancestor
6564661|NCT00967928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564662|NCT00967954|Hormones|hormones|mesh-list
6564663|NCT00967954|Androgen Antagonists|androgen antagonists|mesh-list
6564664|NCT00967954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6564665|NCT00967954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564666|NCT00967954|Hormone Antagonists|hormone antagonists|mesh-ancestor
6564667|NCT00967967|Mometasone Furoate|mometasone furoate|mesh-list
6564668|NCT00967967|Desloratadine|desloratadine|mesh-list
6564669|NCT00967967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6564670|NCT00967967|Dermatologic Agents|dermatologic agents|mesh-ancestor
6564671|NCT00967967|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6564672|NCT00967967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6564673|NCT00967967|Cholinergic Agents|cholinergic agents|mesh-ancestor
6564674|NCT00967967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6564675|NCT00967967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564676|NCT00967967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564677|NCT00967967|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6564678|NCT00967967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6564679|NCT00967967|Histamine Antagonists|histamine antagonists|mesh-ancestor
6564680|NCT00967967|Histamine Agents|histamine agents|mesh-ancestor
6564681|NCT00968006|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6564682|NCT00968006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6564683|NCT00968006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564684|NCT00968006|Incretins|incretins|mesh-ancestor
6564685|NCT00968006|Hormones|hormones|mesh-ancestor
6564686|NCT00968006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6444621|NCT00384631|Growth Substances|growth substances|mesh-ancestor
6444622|NCT00384631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444623|NCT00384631|Growth Inhibitors|growth inhibitors|mesh-ancestor
6564687|NCT00968006|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6564688|NCT00968006|Protease Inhibitors|protease inhibitors|mesh-ancestor
6564689|NCT00968006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6564690|NCT00968006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564691|NCT00968110|Omalizumab|omalizumab|mesh-list
6564692|NCT00968110|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6564693|NCT00968110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6564694|NCT00968110|Respiratory System Agents|respiratory system agents|mesh-ancestor
6564695|NCT00968162|Fludarabine|fludarabine|mesh-list
6564696|NCT00968162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6564697|NCT00968240|Bevacizumab|bevacizumab|mesh-list
6564698|NCT00968240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6564699|NCT00968240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6564700|NCT00968240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6564701|NCT00968240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6564702|NCT00968240|Growth Substances|growth substances|mesh-ancestor
6564703|NCT00968240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564704|NCT00968240|Growth Inhibitors|growth inhibitors|mesh-ancestor
6564705|NCT00968331|Rituximab|rituximab|mesh-list
6564706|NCT00968331|Lenalidomide|lenalidomide|mesh-list
6564707|NCT00968331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6564708|NCT00968331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6564709|NCT00968331|Immunologic Factors|immunologic factors|mesh-ancestor
6564710|NCT00968331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564711|NCT00968331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6564712|NCT00968331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6564713|NCT00968331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6564714|NCT00968331|Growth Substances|growth substances|mesh-ancestor
6564715|NCT00968331|Growth Inhibitors|growth inhibitors|mesh-ancestor
6564716|NCT00968383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
6564717|NCT00968383|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6564718|NCT00968383|Adrenergic Agents|adrenergic agents|mesh-list
6564719|NCT00968383|Adrenergic Antagonists|adrenergic antagonists|mesh-list
6564720|NCT00968383|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
6564721|NCT00968383|Protease Inhibitors|protease inhibitors|mesh-ancestor
6564722|NCT00968383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6564723|NCT00968383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564724|NCT00968383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6564725|NCT00968383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564726|NCT00968396|Melphalan|melphalan|mesh-list
6564727|NCT00968396|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6564728|NCT00968396|Alkylating Agents|alkylating agents|mesh-ancestor
6564729|NCT00968396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564730|NCT00968396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6564731|NCT00968396|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6564732|NCT00968396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6564733|NCT00968396|Immunologic Factors|immunologic factors|mesh-ancestor
6564734|NCT00968396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564735|NCT00968435|Bevacizumab|bevacizumab|mesh-list
6564736|NCT00968435|Cetuximab|cetuximab|mesh-list
6564737|NCT00968435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6564738|NCT00968435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6564739|NCT00968435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6564740|NCT00968435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6564741|NCT00968435|Growth Substances|growth substances|mesh-ancestor
6564742|NCT00968435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564743|NCT00968435|Growth Inhibitors|growth inhibitors|mesh-ancestor
6564744|NCT00968461|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
6444624|NCT00384657|Iron|iron|mesh-list
6564745|NCT00968461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6564746|NCT00968461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564747|NCT00968461|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6564748|NCT00968461|Protective Agents|protective agents|mesh-ancestor
6564749|NCT00968461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564750|NCT00968461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6657194|NCT01474382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6657195|NCT01474382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657196|NCT01474382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657197|NCT01474382|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6657198|NCT01474460|Vitamin K|vitamin k|mesh-list
6657199|NCT01474460|Vitamin K 1|vitamin k 1|mesh-list
6657200|NCT01474460|Vitamins|vitamins|mesh-ancestor
6657201|NCT01474460|Micronutrients|micronutrients|mesh-ancestor
6657202|NCT01474460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657203|NCT01474460|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6657204|NCT01474460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6657205|NCT01474460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657206|NCT01474460|Hemostatics|hemostatics|mesh-ancestor
6657207|NCT01474460|Coagulants|coagulants|mesh-ancestor
6657208|NCT01474473|Calpastatin|calpastatin|mesh-list
6657209|NCT01474473|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
6657210|NCT01474473|Protease Inhibitors|protease inhibitors|mesh-ancestor
6657211|NCT01474473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6657212|NCT01474473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657213|NCT01474499|Sorbitol|sorbitol|mesh-list
6657214|NCT01474499|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
6657215|NCT01474499|Glycerol|glycerol|mesh-list
6657216|NCT01474499|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6657217|NCT01474499|Protective Agents|protective agents|mesh-ancestor
6657218|NCT01474499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657219|NCT01474499|Cathartics|cathartics|mesh-ancestor
6657220|NCT01474499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6657221|NCT01474499|Antidiarrheals|antidiarrheals|mesh-ancestor
6657222|NCT01474642|Capecitabine|capecitabine|mesh-list
6657223|NCT01474642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6657224|NCT01474642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6657225|NCT01474642|Antimetabolites|antimetabolites|mesh-ancestor
6657226|NCT01474642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657227|NCT01474902|Enoxaparin|enoxaparin|mesh-list
6657228|NCT01474902|Anticoagulants|anticoagulants|mesh-ancestor
6657229|NCT01474902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6657230|NCT01474902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6657231|NCT01474902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657232|NCT01474967|Metformin|metformin|mesh-list
6657233|NCT01474967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6657234|NCT01474967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657235|NCT01475019|Orlistat|orlistat|mesh-list
6657236|NCT01475019|Sibutramine|sibutramine|mesh-list
6657237|NCT01475019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6657238|NCT01475019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657239|NCT01475019|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6657240|NCT01475019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6657241|NCT01475019|Antidepressive Agents|antidepressive agents|mesh-ancestor
6657242|NCT01475019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6657243|NCT01475019|Appetite Depressants|appetite depressants|mesh-ancestor
6657244|NCT01475032|Beclomethasone|beclomethasone|mesh-list
6657245|NCT01475032|Formoterol Fumarate|formoterol fumarate|mesh-list
6657246|NCT01475032|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6657247|NCT01475032|Autonomic Agents|autonomic agents|mesh-ancestor
6657248|NCT01475032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6657249|NCT01475032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657250|NCT01475032|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6657251|NCT01475032|Respiratory System Agents|respiratory system agents|mesh-ancestor
6657252|NCT01475032|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6657253|NCT01475032|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6657254|NCT01475032|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6657255|NCT01475032|Adrenergic Agents|adrenergic agents|mesh-ancestor
6657256|NCT01475032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6657257|NCT01475032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657258|NCT01475032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6657259|NCT01475032|Glucocorticoids|glucocorticoids|mesh-ancestor
6657260|NCT01475032|Hormones|hormones|mesh-ancestor
6657261|NCT01475032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6664750|NCT01513785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6564751|NCT00968565|Citric Acid|citric acid|mesh-list
6564752|NCT00968565|Sodium Citrate|sodium citrate|mesh-list
6564753|NCT00968565|Anticoagulants|anticoagulants|mesh-ancestor
6564754|NCT00968565|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6564755|NCT00968565|Chelating Agents|chelating agents|mesh-ancestor
6564756|NCT00968565|Sequestering Agents|sequestering agents|mesh-ancestor
6564757|NCT00968565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564758|NCT00968578|Methylprednisolone|methylprednisolone|mesh-list
6564759|NCT00968578|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6564760|NCT00968578|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6564761|NCT00968578|Prednisolone|prednisolone|mesh-list
6564762|NCT00968578|Prednisolone acetate|prednisolone acetate|mesh-list
6564763|NCT00968578|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6564764|NCT00968578|Prednisolone phosphate|prednisolone phosphate|mesh-list
6564765|NCT00968578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6564766|NCT00968578|Antiemetics|antiemetics|mesh-ancestor
6564767|NCT00968578|Autonomic Agents|autonomic agents|mesh-ancestor
6564768|NCT00968578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6564769|NCT00968578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564770|NCT00968578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6564771|NCT00968578|Glucocorticoids|glucocorticoids|mesh-ancestor
6564772|NCT00968578|Hormones|hormones|mesh-ancestor
6564773|NCT00968578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6564774|NCT00968578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6564775|NCT00968578|Protective Agents|protective agents|mesh-ancestor
6564776|NCT00968578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6564777|NCT00968578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6564778|NCT00968591|Everolimus|everolimus|mesh-list
6564779|NCT00968591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6564780|NCT00968591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6564781|NCT00968591|Immunologic Factors|immunologic factors|mesh-ancestor
6564782|NCT00968591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564783|NCT00968682|Trastuzumab|trastuzumab|mesh-list
6564784|NCT00968682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6564785|NCT00968682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6564786|NCT00968734|Cholecalciferol|cholecalciferol|mesh-list
6564787|NCT00968734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6564788|NCT00968734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564789|NCT00968734|Vitamins|vitamins|mesh-ancestor
6564790|NCT00968734|Micronutrients|micronutrients|mesh-ancestor
6564791|NCT00968734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6564792|NCT00968760|Cytarabine|cytarabine|mesh-list
6564793|NCT00968760|Etoposide|etoposide|mesh-list
6564794|NCT00968760|Melphalan|melphalan|mesh-list
6564795|NCT00968760|Interleukin-2|interleukin-2|mesh-list
6564796|NCT00968760|Carmustine|carmustine|mesh-list
6564797|NCT00968760|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6564798|NCT00968760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6564799|NCT00968760|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6564800|NCT00968760|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6564801|NCT00968760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6564802|NCT00968760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564803|NCT00968760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6564804|NCT00968760|Antimetabolites|antimetabolites|mesh-ancestor
6564805|NCT00968760|Antiviral Agents|antiviral agents|mesh-ancestor
6564806|NCT00968760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6564807|NCT00968760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6564808|NCT00968760|Immunologic Factors|immunologic factors|mesh-ancestor
6564809|NCT00968760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564810|NCT00968760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6564811|NCT00968760|Alkylating Agents|alkylating agents|mesh-ancestor
6564812|NCT00968760|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6564813|NCT00968760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6564814|NCT00968760|Analgesics|analgesics|mesh-ancestor
6564815|NCT00968760|Sensory System Agents|sensory system agents|mesh-ancestor
6564816|NCT00968760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6564817|NCT00968877|Cholecalciferol|cholecalciferol|mesh-list
6564818|NCT00968877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6564819|NCT00968877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564820|NCT00968877|Vitamins|vitamins|mesh-ancestor
6564821|NCT00968877|Micronutrients|micronutrients|mesh-ancestor
6564822|NCT00968877|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6564823|NCT00968903|Methylprednisolone|methylprednisolone|mesh-list
6564824|NCT00968903|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6564825|NCT00968903|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6564826|NCT00968903|Prednisolone|prednisolone|mesh-list
6564827|NCT00968903|Prednisolone acetate|prednisolone acetate|mesh-list
6564828|NCT00968903|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6564829|NCT00968903|Prednisolone phosphate|prednisolone phosphate|mesh-list
6564830|NCT00968903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6564831|NCT00968903|Antiemetics|antiemetics|mesh-ancestor
6564832|NCT00968903|Autonomic Agents|autonomic agents|mesh-ancestor
6564833|NCT00968903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6564834|NCT00968903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564835|NCT00968903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6564836|NCT00968903|Glucocorticoids|glucocorticoids|mesh-ancestor
6564837|NCT00968903|Hormones|hormones|mesh-ancestor
6564838|NCT00968903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6564839|NCT00968903|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6564840|NCT00968903|Protective Agents|protective agents|mesh-ancestor
6564841|NCT00968903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6564842|NCT00968903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6564843|NCT00968929|Streptokinase|streptokinase|mesh-list
6564844|NCT00968929|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6019976|NCT00390780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6019977|NCT00390780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019978|NCT00390780|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6564845|NCT00968929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6564846|NCT00968929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564847|NCT00968955|Ropivacaine|ropivacaine|mesh-list
6564848|NCT00968955|Anesthetics, Local|anesthetics, local|mesh-ancestor
6564849|NCT00968955|Anesthetics|anesthetics|mesh-ancestor
6564850|NCT00968955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6564851|NCT00968955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564852|NCT00968955|Sensory System Agents|sensory system agents|mesh-ancestor
6564853|NCT00968955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6564854|NCT00968994|Petrolatum|petrolatum|mesh-list
6564855|NCT00968994|Emollients|emollients|mesh-ancestor
6564856|NCT00968994|Dermatologic Agents|dermatologic agents|mesh-ancestor
6564857|NCT00969033|Irinotecan|irinotecan|mesh-list
6564858|NCT00969033|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6564859|NCT00969033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6564860|NCT00969033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6564861|NCT00969033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564862|NCT00969033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6564863|NCT00969046|Epothilone B|epothilone b|mesh-list
6564864|NCT00969046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6564865|NCT00969046|Tubulin Modulators|tubulin modulators|mesh-ancestor
6564866|NCT00969046|Antimitotic Agents|antimitotic agents|mesh-ancestor
6564867|NCT00969046|Mitosis Modulators|mitosis modulators|mesh-ancestor
6564868|NCT00969046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564869|NCT00969072|Dutasteride|dutasteride|mesh-list
6564870|NCT00969072|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6564871|NCT00969072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6564872|NCT00969072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6564873|NCT00969072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564874|NCT00969072|Hormone Antagonists|hormone antagonists|mesh-ancestor
6564875|NCT00969072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6564876|NCT00969072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564877|NCT00969085|Curcumin|curcumin|mesh-list
6564878|NCT00969085|Turmeric extract|turmeric extract|mesh-list
6564879|NCT00969085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6564880|NCT00969085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6564881|NCT00969085|Analgesics|analgesics|mesh-ancestor
6564882|NCT00969085|Sensory System Agents|sensory system agents|mesh-ancestor
6564883|NCT00969085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6564884|NCT00969085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444625|NCT00384657|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6444626|NCT00384657|Trace Elements|trace elements|mesh-ancestor
6444627|NCT00384657|Micronutrients|micronutrients|mesh-ancestor
6444628|NCT00384657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444629|NCT00384657|Hematinics|hematinics|mesh-ancestor
6444630|NCT00384696|Nicotine|nicotine|mesh-list
6444631|NCT00384696|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6444632|NCT00384696|Autonomic Agents|autonomic agents|mesh-ancestor
6564885|NCT00969085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6564886|NCT00969085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6564887|NCT00969085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6564888|NCT00969085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6564889|NCT00969085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564890|NCT00969085|Antioxidants|antioxidants|mesh-ancestor
6564891|NCT00969085|Protective Agents|protective agents|mesh-ancestor
6564892|NCT00969137|Nicotine|nicotine|mesh-list
6564893|NCT00969137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6564894|NCT00969137|Autonomic Agents|autonomic agents|mesh-ancestor
6564895|NCT00969137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6564896|NCT00969137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564897|NCT00969137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6564898|NCT00969137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6564899|NCT00969137|Cholinergic Agents|cholinergic agents|mesh-ancestor
6564900|NCT00969137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6564901|NCT00969137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564902|NCT00969163|Testosterone|testosterone|mesh-list
6564903|NCT00969163|Androgens|androgens|mesh-ancestor
6564904|NCT00969163|Hormones|hormones|mesh-ancestor
6564905|NCT00969163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6564906|NCT00969163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564907|NCT00969176|Acetaminophen|acetaminophen|mesh-list
6564908|NCT00969176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6564909|NCT00969176|Analgesics|analgesics|mesh-ancestor
6564910|NCT00969176|Sensory System Agents|sensory system agents|mesh-ancestor
6564911|NCT00969176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6564912|NCT00969176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564913|NCT00969176|Antipyretics|antipyretics|mesh-ancestor
6564914|NCT00969293|Ecallantide|ecallantide|mesh-list
6564915|NCT00969293|Analgesics|analgesics|mesh-ancestor
6564916|NCT00969293|Sensory System Agents|sensory system agents|mesh-ancestor
6564917|NCT00969293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6564918|NCT00969293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564919|NCT00969293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6564920|NCT00969293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6564921|NCT00969293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6564922|NCT00969293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6564923|NCT00969306|Chloroquine|chloroquine|mesh-list
6564924|NCT00969306|Amebicides|amebicides|mesh-ancestor
6564925|NCT00969306|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6564926|NCT00969306|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6564927|NCT00969306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6564928|NCT00969306|Antimalarials|antimalarials|mesh-ancestor
6564929|NCT00969306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6564930|NCT00969319|Factor VIII|factor viii|mesh-list
6564931|NCT00969319|Coagulants|coagulants|mesh-ancestor
6564932|NCT00969397|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
6564933|NCT00969397|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6564934|NCT00969397|Growth Substances|growth substances|mesh-ancestor
6564935|NCT00969397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564936|NCT00969397|Growth Inhibitors|growth inhibitors|mesh-ancestor
6564937|NCT00969397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6564938|NCT00969449|Naproxen|naproxen|mesh-list
6564939|NCT00969449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6564940|NCT00969449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6564941|NCT00969449|Analgesics|analgesics|mesh-ancestor
6564942|NCT00969449|Sensory System Agents|sensory system agents|mesh-ancestor
6564943|NCT00969449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6564944|NCT00969449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564945|NCT00969449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6564946|NCT00969449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6564947|NCT00969449|Gout Suppressants|gout suppressants|mesh-ancestor
6564948|NCT00969449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6564949|NCT00969449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6564950|NCT00969449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564951|NCT00969462|Doxorubicin|doxorubicin|mesh-list
6564952|NCT00969462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6564953|NCT00969462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6564954|NCT00969462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6564955|NCT00969462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6564956|NCT00969462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6564957|NCT00969462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564958|NCT00969566|Metformin|metformin|mesh-list
6564959|NCT00969566|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6564960|NCT00969566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6564961|NCT00969566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564962|NCT00969566|Incretins|incretins|mesh-ancestor
6564963|NCT00969566|Hormones|hormones|mesh-ancestor
6564964|NCT00969566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6564965|NCT00969566|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6564966|NCT00969566|Protease Inhibitors|protease inhibitors|mesh-ancestor
6564967|NCT00969566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6564968|NCT00969566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564969|NCT00969592|Insulin|insulin|mesh-list
6564970|NCT00969592|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6564971|NCT00969592|Insulin Aspart|insulin aspart|mesh-list
6564972|NCT00969592|Insulin, Long-Acting|insulin, long-acting|mesh-list
6564973|NCT00969592|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6564974|NCT00969592|Insulin glulisine|insulin glulisine|mesh-list
6564975|NCT00969592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6564976|NCT00969592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564977|NCT00969631|Metformin|metformin|mesh-list
6564978|NCT00969631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6564979|NCT00969631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564980|NCT00969696|Galantamine|galantamine|mesh-list
6564981|NCT00969696|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6564982|NCT00969696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6564983|NCT00969696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564984|NCT00969696|Cholinergic Agents|cholinergic agents|mesh-ancestor
6564985|NCT00969696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6564986|NCT00969696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6564987|NCT00969696|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6564988|NCT00969696|Autonomic Agents|autonomic agents|mesh-ancestor
6564989|NCT00969696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6564990|NCT00969696|Nootropic Agents|nootropic agents|mesh-ancestor
6564991|NCT00969813|Tofacitinib|tofacitinib|mesh-list
6564992|NCT00969813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6564993|NCT00969813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6564994|NCT00969813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6564995|NCT00969852|Sertraline|sertraline|mesh-list
6564996|NCT00969852|Antidepressive Agents|antidepressive agents|mesh-ancestor
6564997|NCT00969852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6564998|NCT00969852|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6564999|NCT00969852|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6565000|NCT00969852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6565001|NCT00969852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6565002|NCT00969852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6565003|NCT00969852|Serotonin Agents|serotonin agents|mesh-ancestor
6565004|NCT00969852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565005|NCT00969904|Acetylcysteine|acetylcysteine|mesh-list
6565006|NCT00969904|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6565007|NCT00969904|Antiviral Agents|antiviral agents|mesh-ancestor
6565008|NCT00969904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6565009|NCT00969904|Expectorants|expectorants|mesh-ancestor
6565010|NCT00969904|Respiratory System Agents|respiratory system agents|mesh-ancestor
6565011|NCT00969904|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6565012|NCT00969904|Antioxidants|antioxidants|mesh-ancestor
6565013|NCT00969904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6565014|NCT00969904|Protective Agents|protective agents|mesh-ancestor
6565015|NCT00969904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565016|NCT00969904|Antidotes|antidotes|mesh-ancestor
6565017|NCT00969982|Misoprostol|misoprostol|mesh-list
6565018|NCT00969982|Mifepristone|mifepristone|mesh-list
6565019|NCT00969982|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6565020|NCT00969982|Abortifacient Agents|abortifacient agents|mesh-ancestor
6565021|NCT00969982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6565022|NCT00969982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565023|NCT00969982|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6565024|NCT00969982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6565025|NCT00969982|Oxytocics|oxytocics|mesh-ancestor
6565026|NCT00969982|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6565027|NCT00969982|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6565028|NCT00969982|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6565029|NCT00969982|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6565030|NCT00969982|Contraceptive Agents|contraceptive agents|mesh-ancestor
6565031|NCT00969982|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6565032|NCT00969982|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6565033|NCT00969982|Hormone Antagonists|hormone antagonists|mesh-ancestor
6565034|NCT00969982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6565035|NCT00969982|Luteolytic Agents|luteolytic agents|mesh-ancestor
6565036|NCT00969982|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6565037|NCT00969982|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6565038|NCT00970008|CD59 Antigens|cd59 antigens|mesh-list
6565039|NCT00970008|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6565040|NCT00970008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6565041|NCT00970008|Immunologic Factors|immunologic factors|mesh-ancestor
6565042|NCT00970008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565043|NCT00970086|Bupivacaine|bupivacaine|mesh-list
6565044|NCT00970086|Levobupivacaine|levobupivacaine|mesh-list
6565045|NCT00970086|Anesthetics, Local|anesthetics, local|mesh-ancestor
6565046|NCT00970086|Anesthetics|anesthetics|mesh-ancestor
6565047|NCT00970086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6565048|NCT00970086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565049|NCT00970086|Sensory System Agents|sensory system agents|mesh-ancestor
6565050|NCT00970086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6565051|NCT00970138|Apatinib|apatinib|mesh-list
6565052|NCT00970138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6565053|NCT00970138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6565054|NCT00970138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6565055|NCT00970138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657262|NCT01475123|Nicorandil|nicorandil|mesh-list
6657263|NCT01475123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6657264|NCT01475123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6657265|NCT01475123|Vasodilator Agents|vasodilator agents|mesh-ancestor
6657266|NCT01475123|Vitamin B Complex|vitamin b complex|mesh-ancestor
6657267|NCT01475123|Vitamins|vitamins|mesh-ancestor
6657268|NCT01475123|Micronutrients|micronutrients|mesh-ancestor
6657269|NCT01475123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657270|NCT01475227|Zinc|zinc|mesh-list
6657271|NCT01475227|Zinc Sulfate|zinc sulfate|mesh-list
6657272|NCT01475227|Trace Elements|trace elements|mesh-ancestor
6657273|NCT01475227|Micronutrients|micronutrients|mesh-ancestor
6657274|NCT01475227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657275|NCT01475227|Astringents|astringents|mesh-ancestor
6657276|NCT01475227|Dermatologic Agents|dermatologic agents|mesh-ancestor
6657277|NCT01475266|Apaziquone|apaziquone|mesh-list
6657278|NCT01475266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6657279|NCT01475279|Warfarin|warfarin|mesh-list
6657280|NCT01475279|Anticoagulants|anticoagulants|mesh-ancestor
6657281|NCT01475318|Letrozole|letrozole|mesh-list
6657282|NCT01475318|Misoprostol|misoprostol|mesh-list
6657283|NCT01475318|Mifepristone|mifepristone|mesh-list
6657284|NCT01475318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6657285|NCT01475318|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6657286|NCT01475318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6657287|NCT01475318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6565056|NCT00970450|Acetaminophen|acetaminophen|mesh-list
6565057|NCT00970450|Tropisetron|tropisetron|mesh-list
6565058|NCT00970450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6565059|NCT00970450|Analgesics|analgesics|mesh-ancestor
6565060|NCT00970450|Sensory System Agents|sensory system agents|mesh-ancestor
6565061|NCT00970450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6565062|NCT00970450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565063|NCT00970450|Antipyretics|antipyretics|mesh-ancestor
6565064|NCT00970450|Antiemetics|antiemetics|mesh-ancestor
6565065|NCT00970450|Autonomic Agents|autonomic agents|mesh-ancestor
6565066|NCT00970450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6565067|NCT00970450|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6565068|NCT00970450|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6565069|NCT00970450|Serotonin Agents|serotonin agents|mesh-ancestor
6565070|NCT00970450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6565071|NCT00970450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6565072|NCT00970528|Acarbose|acarbose|mesh-list
6565073|NCT00970528|Voglibose|voglibose|mesh-list
6565074|NCT00970528|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6565075|NCT00970528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6565076|NCT00970528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6565077|NCT00970528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6565078|NCT00970528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565079|NCT00970567|Insulin|insulin|mesh-list
6565080|NCT00970567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6565081|NCT00970567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565082|NCT00970580|Paclitaxel|paclitaxel|mesh-list
6565083|NCT00970580|Carboplatin|carboplatin|mesh-list
6565084|NCT00970580|Alkylating Agents|alkylating agents|mesh-list
6565085|NCT00970580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6565086|NCT00970580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6565087|NCT00970580|Tubulin Modulators|tubulin modulators|mesh-ancestor
6565088|NCT00970580|Antimitotic Agents|antimitotic agents|mesh-ancestor
6565089|NCT00970580|Mitosis Modulators|mitosis modulators|mesh-ancestor
6565090|NCT00970580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6565091|NCT00970697|Becaplermin|becaplermin|mesh-list
6565092|NCT00970697|Anticoagulants|anticoagulants|mesh-ancestor
6565093|NCT00970697|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
6565094|NCT00970697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6565095|NCT00970697|Growth Substances|growth substances|mesh-ancestor
6565096|NCT00970697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565097|NCT00970762|Rocuronium|rocuronium|mesh-list
6565098|NCT00970762|Vecuronium Bromide|vecuronium bromide|mesh-list
6565099|NCT00970762|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6565100|NCT00970762|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6565101|NCT00970762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6565102|NCT00970762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6565103|NCT00970762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565104|NCT00970762|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
6565105|NCT00970762|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6565106|NCT00970762|Cholinergic Agents|cholinergic agents|mesh-ancestor
6565107|NCT00970762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6565108|NCT00970762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6565109|NCT00970879|Mefloquine|mefloquine|mesh-list
6565110|NCT00970879|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6565111|NCT00970879|Antimalarials|antimalarials|mesh-ancestor
6565112|NCT00970879|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6565113|NCT00970879|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6565114|NCT00970879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6565115|NCT00970879|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6565116|NCT00970879|Renal Agents|renal agents|mesh-ancestor
6565117|NCT00970879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6565118|NCT00970892|Warfarin|warfarin|mesh-list
6565119|NCT00970892|Anticoagulants|anticoagulants|mesh-ancestor
6565120|NCT00970905|Ondansetron|ondansetron|mesh-list
6565121|NCT00970905|Aprepitant|aprepitant|mesh-list
6565122|NCT00970905|Antiemetics|antiemetics|mesh-ancestor
6565123|NCT00970905|Autonomic Agents|autonomic agents|mesh-ancestor
6565124|NCT00970905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6565125|NCT00970905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565126|NCT00970905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6565127|NCT00970905|Antipruritics|antipruritics|mesh-ancestor
6565128|NCT00970905|Dermatologic Agents|dermatologic agents|mesh-ancestor
6565129|NCT00970905|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6565130|NCT00970905|Serotonin Agents|serotonin agents|mesh-ancestor
6565131|NCT00970905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6565132|NCT00970905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6565133|NCT00970905|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6565134|NCT00970905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6565135|NCT00970905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6565136|NCT00970905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6565137|NCT00970905|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6565138|NCT00970905|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6565139|NCT00970931|Chlorthalidone|chlorthalidone|mesh-list
6565140|NCT00970931|Amiloride|amiloride|mesh-list
6565141|NCT00970931|Diuretics|diuretics|mesh-list
6565142|NCT00970931|Natriuretic Agents|natriuretic agents|mesh-ancestor
6565143|NCT00970931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565144|NCT00970931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6565145|NCT00970931|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6565146|NCT00970931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6565147|NCT00970931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6565148|NCT00970931|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
6565149|NCT00970931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6565150|NCT00970931|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
6565151|NCT00970931|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6565152|NCT00970957|Bevacizumab|bevacizumab|mesh-list
6565153|NCT00970957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6565154|NCT00970957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6565155|NCT00970957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6565156|NCT00970957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6565157|NCT00970957|Growth Substances|growth substances|mesh-ancestor
6565158|NCT00970957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565159|NCT00970957|Growth Inhibitors|growth inhibitors|mesh-ancestor
6565160|NCT00970970|Bevacizumab|bevacizumab|mesh-list
6565161|NCT00970970|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
6565162|NCT00970970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6565163|NCT00970970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6565164|NCT00970970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6565165|NCT00970970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6565166|NCT00970970|Growth Substances|growth substances|mesh-ancestor
6565167|NCT00970970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565168|NCT00970970|Growth Inhibitors|growth inhibitors|mesh-ancestor
6565169|NCT00970970|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6565170|NCT00970970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6565171|NCT00970996|Interferons|interferons|mesh-list
6565172|NCT00970996|Interferon-alpha|interferon-alpha|mesh-list
6565173|NCT00970996|Interferon alpha-2|interferon alpha-2|mesh-list
6565174|NCT00970996|Paclitaxel|paclitaxel|mesh-list
6565175|NCT00970996|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6565176|NCT00970996|Cisplatin|cisplatin|mesh-list
6565177|NCT00970996|Temozolomide|temozolomide|mesh-list
6565178|NCT00970996|Interleukin-2|interleukin-2|mesh-list
6565179|NCT00970996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6565180|NCT00970996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6565181|NCT00970996|Tubulin Modulators|tubulin modulators|mesh-ancestor
6565182|NCT00970996|Antimitotic Agents|antimitotic agents|mesh-ancestor
6565183|NCT00970996|Mitosis Modulators|mitosis modulators|mesh-ancestor
6565184|NCT00970996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6565185|NCT00970996|Antiviral Agents|antiviral agents|mesh-ancestor
6565186|NCT00970996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6565187|NCT00970996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6565188|NCT00970996|Alkylating Agents|alkylating agents|mesh-ancestor
6565189|NCT00970996|Immunologic Factors|immunologic factors|mesh-ancestor
6565190|NCT00970996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565191|NCT00970996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6565192|NCT00970996|Analgesics|analgesics|mesh-ancestor
6565193|NCT00970996|Sensory System Agents|sensory system agents|mesh-ancestor
6565194|NCT00970996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6565195|NCT00971074|Hylan|hylan|mesh-list
6565196|NCT00971074|Viscosupplements|viscosupplements|mesh-ancestor
6565197|NCT00971074|Protective Agents|protective agents|mesh-ancestor
6565198|NCT00971074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565199|NCT00971126|Thalidomide|thalidomide|mesh-list
6565200|NCT00971126|Sorafenib|sorafenib|mesh-list
6565201|NCT00971126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6565202|NCT00971126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6565203|NCT00971126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6565204|NCT00971126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6565205|NCT00971126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6565206|NCT00971126|Immunologic Factors|immunologic factors|mesh-ancestor
6565207|NCT00971126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565208|NCT00971126|Leprostatic Agents|leprostatic agents|mesh-ancestor
6565209|NCT00971126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6565210|NCT00971126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6565211|NCT00971126|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6565212|NCT00971126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6565213|NCT00971126|Growth Substances|growth substances|mesh-ancestor
6565214|NCT00971126|Growth Inhibitors|growth inhibitors|mesh-ancestor
6565215|NCT00971152|Menotropins|menotropins|mesh-list
6565216|NCT00971152|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6565217|NCT00971152|Fertility Agents|fertility agents|mesh-ancestor
6565218|NCT00971152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6565219|NCT00971152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565220|NCT00971165|Losartan|losartan|mesh-list
6565221|NCT00971165|Chlorthalidone|chlorthalidone|mesh-list
6565222|NCT00971165|Amiloride|amiloride|mesh-list
6565223|NCT00971165|Diuretics|diuretics|mesh-list
6565224|NCT00971165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6565225|NCT00971165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6565226|NCT00971165|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6565227|NCT00971165|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6565228|NCT00971165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6565229|NCT00971165|Natriuretic Agents|natriuretic agents|mesh-ancestor
6565230|NCT00971165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565231|NCT00971165|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6565232|NCT00971165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6565233|NCT00971165|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
6565234|NCT00971165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6565235|NCT00971165|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
6565236|NCT00971165|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6565237|NCT00971399|Ondansetron|ondansetron|mesh-list
6565238|NCT00971399|Ramosetron|ramosetron|mesh-list
6565239|NCT00971399|Antiemetics|antiemetics|mesh-ancestor
6565240|NCT00971399|Autonomic Agents|autonomic agents|mesh-ancestor
6565241|NCT00971399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6565242|NCT00971399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565243|NCT00971399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6565244|NCT00971399|Antipruritics|antipruritics|mesh-ancestor
6565245|NCT00971399|Dermatologic Agents|dermatologic agents|mesh-ancestor
6565246|NCT00971399|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6565247|NCT00971399|Serotonin Agents|serotonin agents|mesh-ancestor
6565248|NCT00971399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6565249|NCT00971399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6565250|NCT00971399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6565251|NCT00971399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6565252|NCT00971399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6565253|NCT00971399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6565254|NCT00971399|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6565255|NCT00971581|Ketoprofen|ketoprofen|mesh-list
6565256|NCT00971581|Omeprazole|omeprazole|mesh-list
6565257|NCT00971581|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6565258|NCT00971581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6565259|NCT00971581|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6565260|NCT00971581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6565261|NCT00971581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6565262|NCT00971581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6565263|NCT00971581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6565264|NCT00971581|Analgesics|analgesics|mesh-ancestor
6565265|NCT00971581|Sensory System Agents|sensory system agents|mesh-ancestor
6565266|NCT00971581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6565267|NCT00971581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565268|NCT00971581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6565269|NCT00971581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6565270|NCT00971581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6565271|NCT00971607|Sevoflurane|sevoflurane|mesh-list
6565272|NCT00971607|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6565273|NCT00971607|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6565274|NCT00971607|Anesthetics, General|anesthetics, general|mesh-ancestor
6565275|NCT00971607|Anesthetics|anesthetics|mesh-ancestor
6565276|NCT00971607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6565277|NCT00971607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565278|NCT00971659|Insulin|insulin|mesh-list
6565279|NCT00971659|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6565280|NCT00971659|Metformin|metformin|mesh-list
6565281|NCT00971659|Insulin Glargine|insulin glargine|mesh-list
6565282|NCT00971659|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6565283|NCT00971659|Exenatide|exenatide|mesh-list
6565284|NCT00971659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6565285|NCT00971659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565286|NCT00971659|Incretins|incretins|mesh-ancestor
6565287|NCT00971659|Hormones|hormones|mesh-ancestor
6565288|NCT00971659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6565289|NCT00971659|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6565290|NCT00971659|Protease Inhibitors|protease inhibitors|mesh-ancestor
6565291|NCT00971659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6565292|NCT00971659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6565293|NCT00971659|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6565294|NCT00971685|Dexamethasone|dexamethasone|mesh-list
6565295|NCT00971685|Lenalidomide|lenalidomide|mesh-list
6565296|NCT00971685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6565297|NCT00971685|Antiemetics|antiemetics|mesh-ancestor
6565298|NCT00971685|Autonomic Agents|autonomic agents|mesh-ancestor
6565299|NCT00971685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6565300|NCT00971685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565301|NCT00971685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6565302|NCT00971685|Glucocorticoids|glucocorticoids|mesh-ancestor
6565303|NCT00971685|Hormones|hormones|mesh-ancestor
6565304|NCT00971685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6565305|NCT00971685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6565306|NCT00971685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6565307|NCT00971685|Immunologic Factors|immunologic factors|mesh-ancestor
6565308|NCT00971685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6565309|NCT00971685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6565310|NCT00971685|Growth Substances|growth substances|mesh-ancestor
6565311|NCT00971685|Growth Inhibitors|growth inhibitors|mesh-ancestor
6565312|NCT00971724|Prednisolone|prednisolone|mesh-list
6565313|NCT00971724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6565314|NCT00971724|Glucocorticoids|glucocorticoids|mesh-ancestor
6565315|NCT00971724|Hormones|hormones|mesh-ancestor
6565316|NCT00971724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6565317|NCT00971724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565318|NCT00971724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6565319|NCT00971724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6565320|NCT00971763|Gemcitabine|gemcitabine|mesh-list
6565321|NCT00971763|Prednisolone|prednisolone|mesh-list
6565322|NCT00971763|Cyclophosphamide|cyclophosphamide|mesh-list
6565323|NCT00971763|Rituximab|rituximab|mesh-list
6565324|NCT00971763|Vincristine|vincristine|mesh-list
6565325|NCT00971763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6565326|NCT00971763|Immunologic Factors|immunologic factors|mesh-ancestor
6565327|NCT00971763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565328|NCT00971763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6565329|NCT00971763|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6565330|NCT00971763|Alkylating Agents|alkylating agents|mesh-ancestor
6565331|NCT00971763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6565332|NCT00971763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6565333|NCT00971763|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6565334|NCT00971763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6565335|NCT00971763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6565336|NCT00971763|Antimetabolites|antimetabolites|mesh-ancestor
6565337|NCT00971763|Antiviral Agents|antiviral agents|mesh-ancestor
6565338|NCT00971763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6565339|NCT00971763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6565340|NCT00971763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6565341|NCT00971763|Tubulin Modulators|tubulin modulators|mesh-ancestor
6565342|NCT00971763|Antimitotic Agents|antimitotic agents|mesh-ancestor
6565343|NCT00971763|Mitosis Modulators|mitosis modulators|mesh-ancestor
6565344|NCT00971763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6565345|NCT00971763|Glucocorticoids|glucocorticoids|mesh-ancestor
6565346|NCT00971763|Hormones|hormones|mesh-ancestor
6565347|NCT00971763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6565348|NCT00971763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6565349|NCT00971815|Dexetimide|dexetimide|mesh-list
6565350|NCT00971815|Citalopram|citalopram|mesh-list
6565351|NCT00971815|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6565352|NCT00971815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6565353|NCT00971815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6565354|NCT00971815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6565355|NCT00971815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6565356|NCT00971815|Serotonin Agents|serotonin agents|mesh-ancestor
6565357|NCT00971815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565358|NCT00971815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6565359|NCT00971815|Antidepressive Agents|antidepressive agents|mesh-ancestor
6565360|NCT00971815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6565361|NCT00971815|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6565362|NCT00971815|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6565363|NCT00971815|Parasympatholytics|parasympatholytics|mesh-ancestor
6565364|NCT00971815|Autonomic Agents|autonomic agents|mesh-ancestor
6565365|NCT00971815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6565366|NCT00971815|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6565367|NCT00971815|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6565368|NCT00971815|Cholinergic Agents|cholinergic agents|mesh-ancestor
6565369|NCT00971893|Methylprednisolone|methylprednisolone|mesh-list
6565370|NCT00971893|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6565371|NCT00971893|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6565372|NCT00971893|Prednisolone|prednisolone|mesh-list
6565373|NCT00971893|Prednisolone acetate|prednisolone acetate|mesh-list
6565374|NCT00971893|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6565375|NCT00971893|Prednisolone phosphate|prednisolone phosphate|mesh-list
6565376|NCT00971893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6565377|NCT00971893|Antiemetics|antiemetics|mesh-ancestor
6565378|NCT00971893|Autonomic Agents|autonomic agents|mesh-ancestor
6565379|NCT00971893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6565380|NCT00971893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565381|NCT00971893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6565382|NCT00971893|Glucocorticoids|glucocorticoids|mesh-ancestor
6565383|NCT00971893|Hormones|hormones|mesh-ancestor
6565384|NCT00971893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6565385|NCT00971893|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6565386|NCT00971893|Protective Agents|protective agents|mesh-ancestor
6565387|NCT00971893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6565388|NCT00971893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6657288|NCT01475318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657289|NCT01475318|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6657290|NCT01475318|Hormone Antagonists|hormone antagonists|mesh-ancestor
6657291|NCT01475318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6657292|NCT01475318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657293|NCT01475318|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6657294|NCT01475318|Abortifacient Agents|abortifacient agents|mesh-ancestor
6657295|NCT01475318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6657296|NCT01475318|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6657297|NCT01475318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6657298|NCT01475318|Oxytocics|oxytocics|mesh-ancestor
6657299|NCT01475318|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6657300|NCT01475318|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6657301|NCT01475318|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6657302|NCT01475318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6657303|NCT01475318|Contraceptive Agents|contraceptive agents|mesh-ancestor
6657304|NCT01475318|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6657305|NCT01475318|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6657306|NCT01475318|Luteolytic Agents|luteolytic agents|mesh-ancestor
6657307|NCT01475318|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6657308|NCT01475318|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6657309|NCT01475552|Aspirin|aspirin|mesh-list
6657310|NCT01475552|Abciximab|abciximab|mesh-list
6657311|NCT01475552|Clopidogrel|clopidogrel|mesh-list
6657312|NCT01475552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6657313|NCT01475552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6019979|NCT00390780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6019980|NCT00390806|Topotecan|topotecan|mesh-list
6019981|NCT00390806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6019982|NCT00390806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6019983|NCT00390806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6019984|NCT00390806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019985|NCT00390806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6019986|NCT00390858|Deferasirox|deferasirox|mesh-list
6019987|NCT00390858|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6657314|NCT01475552|Analgesics|analgesics|mesh-ancestor
6565389|NCT00972075|Melatonin|melatonin|mesh-list
6565390|NCT00972075|Antioxidants|antioxidants|mesh-ancestor
6565391|NCT00972075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6565392|NCT00972075|Protective Agents|protective agents|mesh-ancestor
6565393|NCT00972075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565394|NCT00972075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6565395|NCT00972101|Mycophenolic Acid|mycophenolic acid|mesh-list
6565396|NCT00972101|Rituximab|rituximab|mesh-list
6565397|NCT00972101|Fludarabine|fludarabine|mesh-list
6565398|NCT00972101|Fludarabine phosphate|fludarabine phosphate|mesh-list
6565399|NCT00972101|Etoposide|etoposide|mesh-list
6565400|NCT00972101|Melphalan|melphalan|mesh-list
6565401|NCT00972101|Thiotepa|thiotepa|mesh-list
6565402|NCT00972101|Tacrolimus|tacrolimus|mesh-list
6565403|NCT00972101|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6565404|NCT00972101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6565405|NCT00972101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6565406|NCT00972101|Immunologic Factors|immunologic factors|mesh-ancestor
6565407|NCT00972101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565408|NCT00972101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6565409|NCT00972101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6565410|NCT00972101|Antimetabolites|antimetabolites|mesh-ancestor
6565411|NCT00972101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6565412|NCT00972101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6565413|NCT00972101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6565414|NCT00972101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6565415|NCT00972101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6565416|NCT00972101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6565417|NCT00972101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6565418|NCT00972101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6565419|NCT00972101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6565420|NCT00972101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6565421|NCT00972101|Antitubercular Agents|antitubercular agents|mesh-ancestor
6565422|NCT00972101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6565423|NCT00972101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6565424|NCT00972101|Alkylating Agents|alkylating agents|mesh-ancestor
6565425|NCT00972101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6565426|NCT00972140|Formoterol Fumarate|formoterol fumarate|mesh-list
6565427|NCT00972140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6565428|NCT00972140|Autonomic Agents|autonomic agents|mesh-ancestor
6444633|NCT00384696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6444634|NCT00384696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444635|NCT00384696|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6444636|NCT00384696|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6444637|NCT00384696|Cholinergic Agents|cholinergic agents|mesh-ancestor
6444638|NCT00384696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6444639|NCT00384696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444640|NCT00384800|Thalidomide|thalidomide|mesh-list
6444641|NCT00384800|Tegafur|tegafur|mesh-list
6444642|NCT00384800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6444643|NCT00384800|Immunologic Factors|immunologic factors|mesh-ancestor
6565429|NCT00972140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6019988|NCT00390858|Chelating Agents|chelating agents|mesh-ancestor
6019989|NCT00390858|Sequestering Agents|sequestering agents|mesh-ancestor
6019990|NCT00390858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6019991|NCT00390884|Vaccines|vaccines|mesh-list
6565430|NCT00972140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565431|NCT00972140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6019992|NCT00390884|Immunologic Factors|immunologic factors|mesh-ancestor
6019993|NCT00390884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565432|NCT00972140|Respiratory System Agents|respiratory system agents|mesh-ancestor
6565433|NCT00972140|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6565434|NCT00972140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6565435|NCT00972140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6565436|NCT00972140|Adrenergic Agents|adrenergic agents|mesh-ancestor
6565437|NCT00972140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6565438|NCT00972140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6565439|NCT00972218|Adalimumab|adalimumab|mesh-list
6565440|NCT00972218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6565441|NCT00972218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6565442|NCT00972257|Timolol|timolol|mesh-list
6565443|NCT00972257|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6565444|NCT00972257|Dorzolamide|dorzolamide|mesh-list
6565445|NCT00972257|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6565446|NCT00972257|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6565447|NCT00972257|Adrenergic Agents|adrenergic agents|mesh-ancestor
6565448|NCT00972257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6565449|NCT00972257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6565450|NCT00972257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565451|NCT00972257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6565452|NCT00972257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6565453|NCT00972257|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6019994|NCT00390910|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6019995|NCT00390910|Immunologic Factors|immunologic factors|mesh-ancestor
6019996|NCT00390910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6019997|NCT00391027|Insulin|insulin|mesh-list
6019998|NCT00391027|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6019999|NCT00391027|Insulin Glargine|insulin glargine|mesh-list
6020000|NCT00391027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6020001|NCT00391027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020002|NCT00391053|Vaccines|vaccines|mesh-list
6020003|NCT00391053|Immunologic Factors|immunologic factors|mesh-ancestor
6020004|NCT00391053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020005|NCT00391079|Nabiximols|nabiximols|mesh-list
6020006|NCT00391079|Analgesics|analgesics|mesh-ancestor
6020007|NCT00391079|Sensory System Agents|sensory system agents|mesh-ancestor
6020008|NCT00391079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6020009|NCT00391079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020010|NCT00391092|Bevacizumab|bevacizumab|mesh-list
6020011|NCT00391092|Trastuzumab|trastuzumab|mesh-list
6020012|NCT00391092|Docetaxel|docetaxel|mesh-list
6020013|NCT00391092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6020014|NCT00391092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6444644|NCT00384800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444645|NCT00384800|Leprostatic Agents|leprostatic agents|mesh-ancestor
6020015|NCT00391092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6444646|NCT00384800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6444647|NCT00384800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6444648|NCT00384800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6444649|NCT00384800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6444650|NCT00384800|Growth Substances|growth substances|mesh-ancestor
6444651|NCT00384800|Growth Inhibitors|growth inhibitors|mesh-ancestor
6444652|NCT00384800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6444653|NCT00384800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6444654|NCT00384800|Antimetabolites|antimetabolites|mesh-ancestor
6444655|NCT00384800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444656|NCT00384826|Paclitaxel|paclitaxel|mesh-list
6444657|NCT00384826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6444658|NCT00384826|Carboplatin|carboplatin|mesh-list
6444659|NCT00384826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6444660|NCT00384826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6444661|NCT00384826|Tubulin Modulators|tubulin modulators|mesh-ancestor
6444662|NCT00384826|Antimitotic Agents|antimitotic agents|mesh-ancestor
6444663|NCT00384826|Mitosis Modulators|mitosis modulators|mesh-ancestor
6444664|NCT00384826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444665|NCT00384826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6444666|NCT00384826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6444667|NCT00384878|Leucovorin|leucovorin|mesh-list
6444668|NCT00384878|Fluorouracil|fluorouracil|mesh-list
6444669|NCT00384878|Cetuximab|cetuximab|mesh-list
6444670|NCT00384878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6444671|NCT00384878|Antimetabolites|antimetabolites|mesh-ancestor
6444672|NCT00384878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444673|NCT00384878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6444674|NCT00384878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6444675|NCT00384878|Immunologic Factors|immunologic factors|mesh-ancestor
6444676|NCT00384878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444677|NCT00384878|Antidotes|antidotes|mesh-ancestor
6444678|NCT00384878|Protective Agents|protective agents|mesh-ancestor
6444679|NCT00384878|Vitamin B Complex|vitamin b complex|mesh-ancestor
6444680|NCT00384878|Vitamins|vitamins|mesh-ancestor
6565454|NCT00972257|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6565455|NCT00972257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6565456|NCT00972257|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6565457|NCT00972257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6565458|NCT00972296|Carbon Fiber|carbon fiber|mesh-list
6565459|NCT00972296|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6565460|NCT00972296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6565461|NCT00972387|Prednisone|prednisone|mesh-list
6565462|NCT00972387|Prednisolone|prednisolone|mesh-list
6565463|NCT00972387|Cyclophosphamide|cyclophosphamide|mesh-list
6565464|NCT00972387|Doxorubicin|doxorubicin|mesh-list
6565465|NCT00972387|Vincristine|vincristine|mesh-list
6565466|NCT00972387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6565467|NCT00972387|Immunologic Factors|immunologic factors|mesh-ancestor
6565468|NCT00972387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565469|NCT00972387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6565470|NCT00972387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6565471|NCT00972387|Alkylating Agents|alkylating agents|mesh-ancestor
6565472|NCT00972387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6565473|NCT00972387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6565474|NCT00972387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6565475|NCT00972387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6565476|NCT00972387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6565477|NCT00972387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6565478|NCT00972387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6565479|NCT00972387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6565480|NCT00972387|Glucocorticoids|glucocorticoids|mesh-ancestor
6565481|NCT00972387|Hormones|hormones|mesh-ancestor
6565482|NCT00972387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6565483|NCT00972387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6565484|NCT00972387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6565485|NCT00972387|Tubulin Modulators|tubulin modulators|mesh-ancestor
6565486|NCT00972387|Antimitotic Agents|antimitotic agents|mesh-ancestor
6565487|NCT00972387|Mitosis Modulators|mitosis modulators|mesh-ancestor
6565488|NCT00972426|Timolol|timolol|mesh-list
6565489|NCT00972426|Carteolol|carteolol|mesh-list
6565490|NCT00972426|Latanoprost|latanoprost|mesh-list
6565491|NCT00972426|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6565492|NCT00972426|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6565493|NCT00972426|Adrenergic Agents|adrenergic agents|mesh-ancestor
6565494|NCT00972426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6565495|NCT00972426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6565496|NCT00972426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565497|NCT00972426|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6565498|NCT00972426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6565499|NCT00972426|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6565500|NCT00972426|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6565501|NCT00972426|Sympatholytics|sympatholytics|mesh-ancestor
6565502|NCT00972426|Autonomic Agents|autonomic agents|mesh-ancestor
6565503|NCT00972426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6565504|NCT00972465|Nimotuzumab|nimotuzumab|mesh-list
6565505|NCT00972465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6565506|NCT00972465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6565507|NCT00972569|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6565508|NCT00972569|Natriuretic Agents|natriuretic agents|mesh-ancestor
6565509|NCT00972569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565510|NCT00972660|Cyclosporine|cyclosporine|mesh-list
6565511|NCT00972660|Mycophenolic Acid|mycophenolic acid|mesh-list
6565512|NCT00972660|Prednisone|prednisone|mesh-list
6565513|NCT00972660|Cyclosporins|cyclosporins|mesh-list
6565514|NCT00972660|Tacrolimus|tacrolimus|mesh-list
6565515|NCT00972660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6565516|NCT00972660|Glucocorticoids|glucocorticoids|mesh-ancestor
6565517|NCT00972660|Hormones|hormones|mesh-ancestor
6565518|NCT00972660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6565519|NCT00972660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565520|NCT00972660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6565521|NCT00972660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6565522|NCT00972660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6565523|NCT00972660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6565524|NCT00972660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6565525|NCT00972660|Immunologic Factors|immunologic factors|mesh-ancestor
6565526|NCT00972660|Antifungal Agents|antifungal agents|mesh-ancestor
6565527|NCT00972660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6565528|NCT00972660|Dermatologic Agents|dermatologic agents|mesh-ancestor
6565529|NCT00972660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6565530|NCT00972660|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6565531|NCT00972660|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6565532|NCT00972660|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6565533|NCT00972660|Antitubercular Agents|antitubercular agents|mesh-ancestor
6565534|NCT00972660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6565535|NCT00972712|Bortezomib|bortezomib|mesh-list
6565536|NCT00972712|Tipifarnib|tipifarnib|mesh-list
6565537|NCT00972712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6565538|NCT00972790|Bupivacaine|bupivacaine|mesh-list
6565539|NCT00972790|Anesthetics, Local|anesthetics, local|mesh-ancestor
6565540|NCT00972790|Anesthetics|anesthetics|mesh-ancestor
6565541|NCT00972790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6565542|NCT00972790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565543|NCT00972790|Sensory System Agents|sensory system agents|mesh-ancestor
6565544|NCT00972790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6565545|NCT00972803|Chlorhexidine|chlorhexidine|mesh-list
6565546|NCT00972803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6444681|NCT00384878|Micronutrients|micronutrients|mesh-ancestor
6444682|NCT00384878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6444683|NCT00384891|BCG Vaccine|bcg vaccine|mesh-list
6444684|NCT00384891|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6444685|NCT00384891|Immunologic Factors|immunologic factors|mesh-ancestor
6444686|NCT00384891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444687|NCT00384917|Ketoconazole|ketoconazole|mesh-list
6444688|NCT00384917|Antifungal Agents|antifungal agents|mesh-ancestor
6444689|NCT00384917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6444690|NCT00384917|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6444691|NCT00384917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6444692|NCT00384917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6444693|NCT00384917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444694|NCT00384917|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6444695|NCT00384917|Hormone Antagonists|hormone antagonists|mesh-ancestor
6444696|NCT00384917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6444697|NCT00384917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565547|NCT00972803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6565548|NCT00972803|Disinfectants|disinfectants|mesh-ancestor
6565549|NCT00972829|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6565550|NCT00972829|Ezetimibe|ezetimibe|mesh-list
6565551|NCT00972829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6565552|NCT00972829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6565553|NCT00972829|Antimetabolites|antimetabolites|mesh-ancestor
6565554|NCT00972829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6565555|NCT00972829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6565556|NCT00972829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6565557|NCT00972829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6565558|NCT00972842|Lenalidomide|lenalidomide|mesh-list
6565559|NCT00972842|Vorinostat|vorinostat|mesh-list
6565560|NCT00972842|Immunologic Factors|immunologic factors|mesh-ancestor
6565561|NCT00972842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565562|NCT00972842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6565563|NCT00972842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6565564|NCT00972842|Growth Substances|growth substances|mesh-ancestor
6565565|NCT00972842|Growth Inhibitors|growth inhibitors|mesh-ancestor
6565566|NCT00972842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6565567|NCT00972842|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6565568|NCT00972842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6565569|NCT00972842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6565570|NCT00972855|Bicalutamide|bicalutamide|mesh-list
6565571|NCT00972855|Androgen Antagonists|androgen antagonists|mesh-ancestor
6565572|NCT00972855|Hormone Antagonists|hormone antagonists|mesh-ancestor
6565573|NCT00972855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6565574|NCT00972855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565575|NCT00972855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6565576|NCT00972881|Capecitabine|capecitabine|mesh-list
6565577|NCT00972881|Irinotecan|irinotecan|mesh-list
6565578|NCT00972881|Cetuximab|cetuximab|mesh-list
6565579|NCT00972881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6565580|NCT00972881|Antimetabolites|antimetabolites|mesh-ancestor
6565581|NCT00972881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6565582|NCT00972881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6565583|NCT00972881|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6565584|NCT00972881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6565585|NCT00972881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6565586|NCT00972881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6565587|NCT00972907|Nifedipine|nifedipine|mesh-list
6565588|NCT00972907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6565589|NCT00972907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6565590|NCT00972907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6565591|NCT00972907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6565592|NCT00972907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565593|NCT00972907|Vasodilator Agents|vasodilator agents|mesh-ancestor
6565594|NCT00972907|Tocolytic Agents|tocolytic agents|mesh-ancestor
6565595|NCT00972907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6565596|NCT00972933|Ipilimumab|ipilimumab|mesh-list
6565597|NCT00972933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6565598|NCT00972933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6565599|NCT00972933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6565600|NCT00972933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6565601|NCT00972946|Dextrans|dextrans|mesh-list
6565602|NCT00972946|Anticoagulants|anticoagulants|mesh-ancestor
6565603|NCT00972946|Plasma Substitutes|plasma substitutes|mesh-ancestor
6565604|NCT00972946|Blood Substitutes|blood substitutes|mesh-ancestor
6565605|NCT00972985|Lorazepam|lorazepam|mesh-list
6565606|NCT00972985|Methylphenidate|methylphenidate|mesh-list
6565607|NCT00972985|Modafinil|modafinil|mesh-list
6565608|NCT00972985|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6565609|NCT00972985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565610|NCT00972985|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6565611|NCT00972985|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6565612|NCT00972985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6565613|NCT00972985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6565614|NCT00972985|Dopamine Agents|dopamine agents|mesh-ancestor
6565615|NCT00972985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6565616|NCT00972985|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6565617|NCT00972985|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6565618|NCT00972985|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6565619|NCT00972985|Anticonvulsants|anticonvulsants|mesh-ancestor
6565620|NCT00972985|Antiemetics|antiemetics|mesh-ancestor
6565621|NCT00972985|Autonomic Agents|autonomic agents|mesh-ancestor
6565622|NCT00972985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6565623|NCT00972985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6565624|NCT00972985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6565625|NCT00972985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6565626|NCT00972985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6565627|NCT00972985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6565628|NCT00972985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6565629|NCT00972985|GABA Modulators|gaba modulators|mesh-ancestor
6565630|NCT00972985|GABA Agents|gaba agents|mesh-ancestor
6565631|NCT00973037|Tamoxifen|tamoxifen|mesh-list
6565632|NCT00973037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6020016|NCT00391092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6020017|NCT00391092|Growth Substances|growth substances|mesh-ancestor
6444698|NCT00384917|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6444699|NCT00384969|Sorafenib|sorafenib|mesh-list
6444700|NCT00384969|Everolimus|everolimus|mesh-list
6444701|NCT00384969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6444702|NCT00384969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6444703|NCT00384969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6444704|NCT00384969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444705|NCT00384969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6444706|NCT00384969|Immunologic Factors|immunologic factors|mesh-ancestor
6444707|NCT00384969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444708|NCT00385021|Leucovorin|leucovorin|mesh-list
6444709|NCT00385021|Fluorouracil|fluorouracil|mesh-list
6565633|NCT00973037|Hormone Antagonists|hormone antagonists|mesh-ancestor
6565634|NCT00973037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6565635|NCT00973037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565636|NCT00973037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6444710|NCT00385021|Oxaliplatin|oxaliplatin|mesh-list
6565637|NCT00973037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6565638|NCT00973037|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6565639|NCT00973037|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6565640|NCT00973037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6565641|NCT00973050|Bicalutamide|bicalutamide|mesh-list
6565642|NCT00973050|Androgen Antagonists|androgen antagonists|mesh-ancestor
6565643|NCT00973050|Hormone Antagonists|hormone antagonists|mesh-ancestor
6565644|NCT00973050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6565645|NCT00973050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565646|NCT00973050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6565647|NCT00973115|Simvastatin|simvastatin|mesh-list
6565648|NCT00973115|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6565649|NCT00973115|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6565650|NCT00973115|Antimetabolites|antimetabolites|mesh-ancestor
6565651|NCT00973115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6565652|NCT00973115|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6565653|NCT00973115|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6565654|NCT00973115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6565655|NCT00973128|Meglumine Antimoniate|meglumine antimoniate|mesh-list
6565656|NCT00973128|Sargramostim|sargramostim|mesh-list
6565657|NCT00973128|Immunologic Factors|immunologic factors|mesh-ancestor
6565658|NCT00973128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565659|NCT00973128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6565660|NCT00973128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6565661|NCT00973128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6565662|NCT00973154|Prednisone|prednisone|mesh-list
6565663|NCT00973154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6565664|NCT00973154|Glucocorticoids|glucocorticoids|mesh-ancestor
6565665|NCT00973154|Hormones|hormones|mesh-ancestor
6444711|NCT00385021|Bevacizumab|bevacizumab|mesh-list
6444712|NCT00385021|Antimetabolites|antimetabolites|mesh-ancestor
6444713|NCT00385021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444714|NCT00385021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6444715|NCT00385021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6444716|NCT00385021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6565666|NCT00973154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6565667|NCT00973154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565668|NCT00973154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6565669|NCT00973154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6565670|NCT00973193|Panitumumab|panitumumab|mesh-list
6565671|NCT00973193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6565672|NCT00973193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6565673|NCT00973219|Interferons|interferons|mesh-list
6444717|NCT00385021|Immunologic Factors|immunologic factors|mesh-ancestor
6444718|NCT00385021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444719|NCT00385021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6444720|NCT00385021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6444721|NCT00385021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6444722|NCT00385021|Growth Substances|growth substances|mesh-ancestor
6444723|NCT00385021|Growth Inhibitors|growth inhibitors|mesh-ancestor
6444724|NCT00385021|Antidotes|antidotes|mesh-ancestor
6444725|NCT00385021|Protective Agents|protective agents|mesh-ancestor
6444726|NCT00385021|Vitamin B Complex|vitamin b complex|mesh-ancestor
6565674|NCT00973219|Tenofovir|tenofovir|mesh-list
6565675|NCT00973219|Interferon-alpha|interferon-alpha|mesh-list
6565676|NCT00973219|Interferon alpha-2|interferon alpha-2|mesh-list
6565677|NCT00973219|Adefovir|adefovir|mesh-list
6565678|NCT00973219|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6565679|NCT00973219|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6565680|NCT00973219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6565681|NCT00973219|Antiviral Agents|antiviral agents|mesh-ancestor
6565682|NCT00973219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6565683|NCT00973219|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6565684|NCT00973219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6565685|NCT00973219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6565686|NCT00973219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6565687|NCT00973219|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6565688|NCT00973219|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6565689|NCT00973219|Immunologic Factors|immunologic factors|mesh-ancestor
6565690|NCT00973219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565691|NCT00973232|Acetaminophen|acetaminophen|mesh-list
6565692|NCT00973232|Tramadol|tramadol|mesh-list
6565693|NCT00973232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6565694|NCT00973232|Analgesics|analgesics|mesh-ancestor
6565695|NCT00973232|Sensory System Agents|sensory system agents|mesh-ancestor
6565696|NCT00973232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6565697|NCT00973232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565698|NCT00973232|Antipyretics|antipyretics|mesh-ancestor
6565699|NCT00973232|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6444727|NCT00385021|Vitamins|vitamins|mesh-ancestor
6565700|NCT00973232|Narcotics|narcotics|mesh-ancestor
6565701|NCT00973232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6565702|NCT00973245|Warfarin|warfarin|mesh-list
6565703|NCT00973245|Rivaroxaban|rivaroxaban|mesh-list
6565704|NCT00973245|Anticoagulants|anticoagulants|mesh-ancestor
6565705|NCT00973245|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6565706|NCT00973245|Antithrombins|antithrombins|mesh-ancestor
6565707|NCT00973245|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6565708|NCT00973245|Protease Inhibitors|protease inhibitors|mesh-ancestor
6565709|NCT00973245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6565710|NCT00973245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6565711|NCT00973271|Atorvastatin|atorvastatin|mesh-list
6565712|NCT00973271|Fenofibric acid|fenofibric acid|mesh-list
6565713|NCT00973271|Fenofibrate|fenofibrate|mesh-list
6565714|NCT00973271|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6565715|NCT00973271|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6565716|NCT00973271|Antimetabolites|antimetabolites|mesh-ancestor
6565717|NCT00973271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6565718|NCT00973271|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6565719|NCT00973271|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6565720|NCT00973271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6565721|NCT00973310|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6565722|NCT00973310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6565723|NCT00973310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6565724|NCT00973310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6565725|NCT00973310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6565726|NCT00973323|Warfarin|warfarin|mesh-list
6565727|NCT00973323|Rivaroxaban|rivaroxaban|mesh-list
6565728|NCT00973323|Anticoagulants|anticoagulants|mesh-ancestor
6565729|NCT00973323|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6565730|NCT00973323|Antithrombins|antithrombins|mesh-ancestor
6565731|NCT00973323|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6565732|NCT00973323|Protease Inhibitors|protease inhibitors|mesh-ancestor
6565733|NCT00973323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6565734|NCT00973323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6565735|NCT00973336|Vitamin D|vitamin d|mesh-list
6565736|NCT00973336|Calcium|calcium|mesh-list
6565737|NCT00973336|Vitamins|vitamins|mesh-ancestor
6565738|NCT00973336|Micronutrients|micronutrients|mesh-ancestor
6565739|NCT00973336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565740|NCT00973336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6565741|NCT00973336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6565742|NCT00973388|Moxifloxacin|moxifloxacin|mesh-list
6565743|NCT00973388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6565744|NCT00973388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6565745|NCT00973388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6565746|NCT00973388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6565747|NCT00973388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6565748|NCT00973388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6565749|NCT00973388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6565750|NCT00973401|Insulin|insulin|mesh-list
6565751|NCT00973401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6565752|NCT00973401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565753|NCT00973453|Immunologic Factors|immunologic factors|mesh-list
6565754|NCT00973453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724782|NCT03185143|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5724783|NCT03185143|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5724784|NCT03185143|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6565755|NCT00973505|Anastrozole|anastrozole|mesh-list
6565756|NCT00973505|Aromatase Inhibitors|aromatase inhibitors|mesh-list
6565757|NCT00973505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6565758|NCT00973505|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6565759|NCT00973505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6565760|NCT00973505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6565761|NCT00973505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6565762|NCT00973505|Hormone Antagonists|hormone antagonists|mesh-ancestor
6565763|NCT00973505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6565764|NCT00973505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565765|NCT00973505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6565766|NCT00973583|Vitamin D|vitamin d|mesh-list
6565767|NCT00973583|Vitamins|vitamins|mesh-ancestor
6565768|NCT00973583|Micronutrients|micronutrients|mesh-ancestor
6565769|NCT00973583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565770|NCT00973583|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6565771|NCT00973609|Folic Acid|folic acid|mesh-list
6565772|NCT00973609|Vitamin B Complex|vitamin b complex|mesh-list
6565773|NCT00973609|Bevacizumab|bevacizumab|mesh-list
6565774|NCT00973609|Fluorouracil|fluorouracil|mesh-list
6565775|NCT00973609|Capecitabine|capecitabine|mesh-list
6565776|NCT00973609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6565777|NCT00973609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6565778|NCT00973609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6565779|NCT00973609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6565780|NCT00973609|Growth Substances|growth substances|mesh-ancestor
6565781|NCT00973609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565782|NCT00973609|Growth Inhibitors|growth inhibitors|mesh-ancestor
6565783|NCT00973609|Antimetabolites|antimetabolites|mesh-ancestor
6565784|NCT00973609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6565785|NCT00973609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6565786|NCT00973609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6565787|NCT00973609|Immunologic Factors|immunologic factors|mesh-ancestor
6565788|NCT00973609|Hematinics|hematinics|mesh-ancestor
6565789|NCT00973609|Vitamins|vitamins|mesh-ancestor
6565790|NCT00973609|Micronutrients|micronutrients|mesh-ancestor
6565791|NCT00973687|Dexamethasone|dexamethasone|mesh-list
6565792|NCT00973687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6565793|NCT00973687|Antiemetics|antiemetics|mesh-ancestor
6565794|NCT00973687|Autonomic Agents|autonomic agents|mesh-ancestor
6565795|NCT00973687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6565796|NCT00973687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565797|NCT00973687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6565798|NCT00973687|Glucocorticoids|glucocorticoids|mesh-ancestor
6565799|NCT00973687|Hormones|hormones|mesh-ancestor
6565800|NCT00973687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6565801|NCT00973687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6565802|NCT00973687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6565803|NCT00973713|Everolimus|everolimus|mesh-list
6565804|NCT00973713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6565805|NCT00973713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6565806|NCT00973713|Immunologic Factors|immunologic factors|mesh-ancestor
6565807|NCT00973713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565808|NCT00973778|Capecitabine|capecitabine|mesh-list
6565809|NCT00973778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6565810|NCT00973778|Antimetabolites|antimetabolites|mesh-ancestor
6444728|NCT00385021|Micronutrients|micronutrients|mesh-ancestor
6461689|NCT00455624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6565811|NCT00973778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6565812|NCT00973778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6565813|NCT00973804|Sirolimus|sirolimus|mesh-list
6565814|NCT00973804|Tacrolimus|tacrolimus|mesh-list
6565815|NCT00973804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6565816|NCT00973804|Immunologic Factors|immunologic factors|mesh-ancestor
6565817|NCT00973804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565818|NCT00973804|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6565819|NCT00973804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6565820|NCT00973804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6565821|NCT00973804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6565822|NCT00973804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6565823|NCT00973804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6565824|NCT00973804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6565825|NCT00973804|Antifungal Agents|antifungal agents|mesh-ancestor
6657315|NCT01475552|Sensory System Agents|sensory system agents|mesh-ancestor
6657316|NCT01475552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6657317|NCT01475552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461690|NCT00455624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461691|NCT00455637|Botulinum Toxins|botulinum toxins|mesh-list
6461692|NCT00455637|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6461693|NCT00455637|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6461694|NCT00455637|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6461695|NCT00455637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6657318|NCT01475552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6565826|NCT00973869|Curcumin|curcumin|mesh-list
6565827|NCT00973869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6565828|NCT00973869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6565829|NCT00973869|Analgesics|analgesics|mesh-ancestor
6565830|NCT00973869|Sensory System Agents|sensory system agents|mesh-ancestor
6565831|NCT00973869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6565832|NCT00973869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444729|NCT00385086|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
6444730|NCT00385086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6444731|NCT00385125|Rituximab|rituximab|mesh-list
6444732|NCT00385125|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6565833|NCT00973869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6565834|NCT00973869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6565835|NCT00973869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6565836|NCT00973869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6565837|NCT00973869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6565838|NCT00973882|Carboplatin|carboplatin|mesh-list
6565839|NCT00973882|Etoposide|etoposide|mesh-list
6565840|NCT00973882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6565841|NCT00973882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6565842|NCT00973882|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6565843|NCT00973882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6565844|NCT00973882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6565845|NCT00973882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6565846|NCT00973986|Atorvastatin|atorvastatin|mesh-list
6565847|NCT00973986|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6444733|NCT00385125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6444734|NCT00385125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6444735|NCT00385125|Immunologic Factors|immunologic factors|mesh-ancestor
6565848|NCT00973986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6565849|NCT00973986|Antimetabolites|antimetabolites|mesh-ancestor
6565850|NCT00973986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6565851|NCT00973986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6565852|NCT00973986|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6565853|NCT00973986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6565854|NCT00973999|Botulinum Toxins|botulinum toxins|mesh-list
6565855|NCT00973999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6565856|NCT00973999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6565857|NCT00973999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6565858|NCT00973999|Cholinergic Agents|cholinergic agents|mesh-ancestor
6565859|NCT00973999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6565860|NCT00973999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565861|NCT00974012|Valproic Acid|valproic acid|mesh-list
6444736|NCT00385125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444737|NCT00385125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6444738|NCT00385125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6444739|NCT00385125|Alkylating Agents|alkylating agents|mesh-ancestor
6565862|NCT00974012|Anticonvulsants|anticonvulsants|mesh-ancestor
6565863|NCT00974012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6565864|NCT00974012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6565865|NCT00974012|GABA Agents|gaba agents|mesh-ancestor
6565866|NCT00974012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6565867|NCT00974012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020018|NCT00391092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020019|NCT00391092|Growth Inhibitors|growth inhibitors|mesh-ancestor
6020020|NCT00391092|Tubulin Modulators|tubulin modulators|mesh-ancestor
6020021|NCT00391092|Antimitotic Agents|antimitotic agents|mesh-ancestor
6020022|NCT00391092|Mitosis Modulators|mitosis modulators|mesh-ancestor
6020023|NCT00391092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020024|NCT00391118|Paclitaxel|paclitaxel|mesh-list
6020025|NCT00391118|Carboplatin|carboplatin|mesh-list
6020026|NCT00391118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6020027|NCT00391118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6020028|NCT00391118|Tubulin Modulators|tubulin modulators|mesh-ancestor
6020029|NCT00391118|Antimitotic Agents|antimitotic agents|mesh-ancestor
6020030|NCT00391118|Mitosis Modulators|mitosis modulators|mesh-ancestor
6020031|NCT00391118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020032|NCT00391222|Olanzapine|olanzapine|mesh-list
6020033|NCT00391222|Risperidone|risperidone|mesh-list
6020034|NCT00391222|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6020035|NCT00391222|Serotonin Agents|serotonin agents|mesh-ancestor
6020036|NCT00391222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6020037|NCT00391222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020038|NCT00391222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020039|NCT00391222|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6020040|NCT00391222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6444740|NCT00385125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444741|NCT00385307|Amibegron|amibegron|mesh-list
6444742|NCT00385307|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6444743|NCT00385307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6444744|NCT00385307|Adrenergic Agents|adrenergic agents|mesh-ancestor
6444745|NCT00385307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6444746|NCT00385307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444747|NCT00385307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444748|NCT00385359|Albuterol|albuterol|mesh-list
6020041|NCT00391222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6020042|NCT00391222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6444749|NCT00385359|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6444750|NCT00385359|Autonomic Agents|autonomic agents|mesh-ancestor
6444751|NCT00385359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6444752|NCT00385359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565868|NCT00974012|Antimanic Agents|antimanic agents|mesh-ancestor
6565869|NCT00974012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6565870|NCT00974012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6565871|NCT00974012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6565872|NCT00974025|Ascorbic Acid|ascorbic acid|mesh-list
6565873|NCT00974025|Vitamins|vitamins|mesh-ancestor
6565874|NCT00974025|Micronutrients|micronutrients|mesh-ancestor
6444753|NCT00385359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6444754|NCT00385359|Respiratory System Agents|respiratory system agents|mesh-ancestor
6444755|NCT00385359|Tocolytic Agents|tocolytic agents|mesh-ancestor
6444756|NCT00385359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6444757|NCT00385359|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6444758|NCT00385359|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6444759|NCT00385359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6444760|NCT00385359|Adrenergic Agents|adrenergic agents|mesh-ancestor
6565875|NCT00974025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565876|NCT00974025|Antioxidants|antioxidants|mesh-ancestor
6565877|NCT00974025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6565878|NCT00974025|Protective Agents|protective agents|mesh-ancestor
6565879|NCT00974155|Dexetimide|dexetimide|mesh-list
6565880|NCT00974155|Citalopram|citalopram|mesh-list
6565881|NCT00974155|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6565882|NCT00974155|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6565883|NCT00974155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6565884|NCT00974155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6565885|NCT00974155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6565886|NCT00974155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6565887|NCT00974155|Serotonin Agents|serotonin agents|mesh-ancestor
6565888|NCT00974155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565889|NCT00974155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6565890|NCT00974155|Antidepressive Agents|antidepressive agents|mesh-ancestor
6565891|NCT00974155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6565892|NCT00974155|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6565893|NCT00974155|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6565894|NCT00974155|Parasympatholytics|parasympatholytics|mesh-ancestor
6565895|NCT00974155|Autonomic Agents|autonomic agents|mesh-ancestor
6565896|NCT00974155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6565897|NCT00974155|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6565898|NCT00974155|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6565899|NCT00974155|Cholinergic Agents|cholinergic agents|mesh-ancestor
6565900|NCT00974155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6565901|NCT00974181|Paclitaxel|paclitaxel|mesh-list
6565902|NCT00974181|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6565903|NCT00974181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6565904|NCT00974181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6565905|NCT00974181|Tubulin Modulators|tubulin modulators|mesh-ancestor
6565906|NCT00974181|Antimitotic Agents|antimitotic agents|mesh-ancestor
6565907|NCT00974181|Mitosis Modulators|mitosis modulators|mesh-ancestor
6565908|NCT00974181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6565909|NCT00974272|Exenatide|exenatide|mesh-list
6565910|NCT00974272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6565911|NCT00974272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565912|NCT00974272|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6565913|NCT00974272|Incretins|incretins|mesh-ancestor
6565914|NCT00974272|Hormones|hormones|mesh-ancestor
6565915|NCT00974272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6565916|NCT00974324|Endostar protein|endostar protein|mesh-list
6565917|NCT00974324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6565918|NCT00974324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6565919|NCT00974324|Growth Substances|growth substances|mesh-ancestor
6565920|NCT00974324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565921|NCT00974324|Growth Inhibitors|growth inhibitors|mesh-ancestor
6565922|NCT00974324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6565923|NCT00974389|Bevacizumab|bevacizumab|mesh-list
6565924|NCT00974389|Tegafur|tegafur|mesh-list
6565925|NCT00974389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6565926|NCT00974389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6565927|NCT00974389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6565928|NCT00974389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6565929|NCT00974389|Growth Substances|growth substances|mesh-ancestor
6565930|NCT00974389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565931|NCT00974389|Growth Inhibitors|growth inhibitors|mesh-ancestor
6565932|NCT00974389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6565933|NCT00974389|Antimetabolites|antimetabolites|mesh-ancestor
6565934|NCT00974389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6565935|NCT00974428|Wobenzym|wobenzym|mesh-list
6565936|NCT00974428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6565937|NCT00974428|Immunologic Factors|immunologic factors|mesh-ancestor
6444761|NCT00385359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6444762|NCT00385359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444763|NCT00385385|KRM 1648|krm 1648|mesh-list
6444764|NCT00385385|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6444765|NCT00385385|Antitubercular Agents|antitubercular agents|mesh-ancestor
6444766|NCT00385385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6444767|NCT00385385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6444768|NCT00385385|Leprostatic Agents|leprostatic agents|mesh-ancestor
6444769|NCT00385398|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6444770|NCT00385398|Temozolomide|temozolomide|mesh-list
6444771|NCT00385398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6444772|NCT00385398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6444773|NCT00385398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6444774|NCT00385398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444775|NCT00385398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6444776|NCT00385398|Alkylating Agents|alkylating agents|mesh-ancestor
6444777|NCT00385411|Valproic Acid|valproic acid|mesh-list
6444778|NCT00385411|Anticonvulsants|anticonvulsants|mesh-ancestor
6444779|NCT00385411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6444780|NCT00385411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444781|NCT00385411|GABA Agents|gaba agents|mesh-ancestor
6444782|NCT00385411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6444783|NCT00385411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444784|NCT00385411|Antimanic Agents|antimanic agents|mesh-ancestor
6657319|NCT01475552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6565938|NCT00974428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565939|NCT00974441|Valproic Acid|valproic acid|mesh-list
6565940|NCT00974441|Anticonvulsants|anticonvulsants|mesh-ancestor
6565941|NCT00974441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6565942|NCT00974441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6565943|NCT00974441|GABA Agents|gaba agents|mesh-ancestor
6565944|NCT00974441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6565945|NCT00974441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565946|NCT00974441|Antimanic Agents|antimanic agents|mesh-ancestor
6565947|NCT00974441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6565948|NCT00974441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6565949|NCT00974441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6565950|NCT00974532|Calcium, Dietary|calcium, dietary|mesh-list
6565951|NCT00974532|Calcium|calcium|mesh-list
6565952|NCT00974532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6565953|NCT00974532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565954|NCT00974532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6565955|NCT00974584|Paclitaxel|paclitaxel|mesh-list
6565956|NCT00974584|Bevacizumab|bevacizumab|mesh-list
6565957|NCT00974584|Carboplatin|carboplatin|mesh-list
6565958|NCT00974584|Pemetrexed|pemetrexed|mesh-list
6565959|NCT00974584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6565960|NCT00974584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6565961|NCT00974584|Tubulin Modulators|tubulin modulators|mesh-ancestor
6565962|NCT00974584|Antimitotic Agents|antimitotic agents|mesh-ancestor
6565963|NCT00974584|Mitosis Modulators|mitosis modulators|mesh-ancestor
6565964|NCT00974584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6565965|NCT00974584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6565966|NCT00974584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6565967|NCT00974584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6565968|NCT00974584|Growth Substances|growth substances|mesh-ancestor
6565969|NCT00974584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565970|NCT00974584|Growth Inhibitors|growth inhibitors|mesh-ancestor
6565971|NCT00974584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6565972|NCT00974584|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6565973|NCT00974584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6565974|NCT00974740|Atorvastatin|atorvastatin|mesh-list
6565975|NCT00974740|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6565976|NCT00974740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6565977|NCT00974740|Antimetabolites|antimetabolites|mesh-ancestor
6565978|NCT00974740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6565979|NCT00974740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6565980|NCT00974740|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6565981|NCT00974740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6565982|NCT00974753|Ketorolac|ketorolac|mesh-list
6565983|NCT00974753|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6565984|NCT00974753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6565985|NCT00974753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6565986|NCT00974753|Analgesics|analgesics|mesh-ancestor
6565987|NCT00974753|Sensory System Agents|sensory system agents|mesh-ancestor
6565988|NCT00974753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6565989|NCT00974753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565990|NCT00974753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6565991|NCT00974753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6565992|NCT00974753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6565993|NCT00974753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6565994|NCT00974753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6565995|NCT00974766|Glucocorticoids|glucocorticoids|mesh-list
6565996|NCT00974766|Hormones|hormones|mesh-ancestor
6565997|NCT00974766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6565998|NCT00974766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6565999|NCT00974792|Leucovorin|leucovorin|mesh-list
6566000|NCT00974792|Cytarabine|cytarabine|mesh-list
6566001|NCT00974792|Cyclophosphamide|cyclophosphamide|mesh-list
6566002|NCT00974792|Ifosfamide|ifosfamide|mesh-list
6566003|NCT00974792|Rituximab|rituximab|mesh-list
6566004|NCT00974792|Doxorubicin|doxorubicin|mesh-list
6566005|NCT00974792|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6566006|NCT00974792|Methotrexate|methotrexate|mesh-list
6566007|NCT00974792|Etoposide|etoposide|mesh-list
6566008|NCT00974792|Vincristine|vincristine|mesh-list
6566009|NCT00974792|Etoposide phosphate|etoposide phosphate|mesh-list
6566010|NCT00974792|Levoleucovorin|levoleucovorin|mesh-list
6566011|NCT00974792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6566012|NCT00974792|Immunologic Factors|immunologic factors|mesh-ancestor
6566013|NCT00974792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566014|NCT00974792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6566015|NCT00974792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6566016|NCT00974792|Alkylating Agents|alkylating agents|mesh-ancestor
6566017|NCT00974792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566018|NCT00974792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6566019|NCT00974792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6566020|NCT00974792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6566021|NCT00974792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6566022|NCT00974792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6566023|NCT00974792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6566024|NCT00974792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6566025|NCT00974792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5724785|NCT03185143|Serotonin Agents|serotonin agents|mesh-ancestor
6566026|NCT00974792|Abortifacient Agents|abortifacient agents|mesh-ancestor
6566027|NCT00974792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6566028|NCT00974792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6566029|NCT00974792|Antimetabolites|antimetabolites|mesh-ancestor
6566030|NCT00974792|Dermatologic Agents|dermatologic agents|mesh-ancestor
6566031|NCT00974792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6566032|NCT00974792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6566033|NCT00974792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6566034|NCT00974792|Antiviral Agents|antiviral agents|mesh-ancestor
6566035|NCT00974792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6566036|NCT00974792|Antidotes|antidotes|mesh-ancestor
6566037|NCT00974792|Protective Agents|protective agents|mesh-ancestor
6566038|NCT00974792|Vitamin B Complex|vitamin b complex|mesh-ancestor
6566039|NCT00974792|Vitamins|vitamins|mesh-ancestor
6566040|NCT00974792|Micronutrients|micronutrients|mesh-ancestor
6566041|NCT00974792|Tubulin Modulators|tubulin modulators|mesh-ancestor
6566042|NCT00974792|Antimitotic Agents|antimitotic agents|mesh-ancestor
6566043|NCT00974792|Mitosis Modulators|mitosis modulators|mesh-ancestor
6566044|NCT00974805|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6566045|NCT00974805|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6566046|NCT00974805|Autonomic Agents|autonomic agents|mesh-ancestor
6566047|NCT00974805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6566048|NCT00974805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566049|NCT00974805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6566050|NCT00974805|Respiratory System Agents|respiratory system agents|mesh-ancestor
6566051|NCT00974805|Glucocorticoids|glucocorticoids|mesh-ancestor
6566052|NCT00974805|Hormones|hormones|mesh-ancestor
6566053|NCT00974805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6566054|NCT00974805|Sympathomimetics|sympathomimetics|mesh-ancestor
6566055|NCT00974935|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6566056|NCT00974935|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6566057|NCT00974935|Immunologic Factors|immunologic factors|mesh-ancestor
6566058|NCT00974935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566059|NCT00974935|Antacids|antacids|mesh-ancestor
6566060|NCT00974935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566061|NCT00974935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6566062|NCT00974961|Bupivacaine|bupivacaine|mesh-list
6566063|NCT00974961|Levobupivacaine|levobupivacaine|mesh-list
6566064|NCT00974961|Anesthetics, Local|anesthetics, local|mesh-ancestor
6566065|NCT00974961|Anesthetics|anesthetics|mesh-ancestor
6566066|NCT00974961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6566067|NCT00974961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566068|NCT00974961|Sensory System Agents|sensory system agents|mesh-ancestor
6566069|NCT00974961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6566070|NCT00974987|Temozolomide|temozolomide|mesh-list
6566071|NCT00974987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6566072|NCT00974987|Alkylating Agents|alkylating agents|mesh-ancestor
6566073|NCT00974987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566074|NCT00974987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6566075|NCT00975052|Metformin|metformin|mesh-list
6566076|NCT00975052|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6566077|NCT00975052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6566078|NCT00975052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566079|NCT00975052|Incretins|incretins|mesh-ancestor
6566080|NCT00975052|Hormones|hormones|mesh-ancestor
6566081|NCT00975052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6566082|NCT00975052|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6566083|NCT00975052|Protease Inhibitors|protease inhibitors|mesh-ancestor
6566084|NCT00975052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6566085|NCT00975052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566086|NCT00975065|Metformin|metformin|mesh-list
6566087|NCT00975065|Vildagliptin|vildagliptin|mesh-list
6566088|NCT00975065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6566089|NCT00975065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566090|NCT00975065|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6566091|NCT00975065|Protease Inhibitors|protease inhibitors|mesh-ancestor
6566092|NCT00975065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6566093|NCT00975065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566094|NCT00975078|Prednisone|prednisone|mesh-list
6566095|NCT00975078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6566096|NCT00975078|Glucocorticoids|glucocorticoids|mesh-ancestor
6566097|NCT00975078|Hormones|hormones|mesh-ancestor
6566098|NCT00975078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6566099|NCT00975078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566100|NCT00975078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6566101|NCT00975078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6566102|NCT00975104|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
6566103|NCT00975104|Immunologic Factors|immunologic factors|mesh-ancestor
6566104|NCT00975104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566105|NCT00975182|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6566106|NCT00975182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6566107|NCT00975182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6566108|NCT00975182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6566109|NCT00975182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566110|NCT00975299|Bombesin|bombesin|mesh-list
6566111|NCT00975299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6566112|NCT00975299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566113|NCT00975299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566114|NCT00975312|Tretinoin|tretinoin|mesh-list
6444785|NCT00385411|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6444786|NCT00385411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6444787|NCT00385411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6566115|NCT00975312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6566116|NCT00975312|Keratolytic Agents|keratolytic agents|mesh-ancestor
6566117|NCT00975312|Dermatologic Agents|dermatologic agents|mesh-ancestor
6566118|NCT00975325|Yohimbine|yohimbine|mesh-list
6566119|NCT00975325|Mydriatics|mydriatics|mesh-ancestor
6566120|NCT00975325|Autonomic Agents|autonomic agents|mesh-ancestor
6566121|NCT00975325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6566122|NCT00975325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566123|NCT00975325|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6566124|NCT00975325|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6566125|NCT00975325|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6566126|NCT00975325|Adrenergic Agents|adrenergic agents|mesh-ancestor
6566127|NCT00975325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6566128|NCT00975325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566129|NCT00975325|Urological Agents|urological agents|mesh-ancestor
6566130|NCT00975351|Tetrahydrofolates|tetrahydrofolates|mesh-list
6566131|NCT00975351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566132|NCT00975351|Vitamin B Complex|vitamin b complex|mesh-ancestor
6566133|NCT00975351|Vitamins|vitamins|mesh-ancestor
6566134|NCT00975351|Micronutrients|micronutrients|mesh-ancestor
6566135|NCT00975390|Caffeine|caffeine|mesh-list
6566136|NCT00975390|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6566137|NCT00975390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566138|NCT00975390|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6566139|NCT00975390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6566140|NCT00975390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566141|NCT00975390|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6566142|NCT00975390|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6566143|NCT00975390|Purinergic Agents|purinergic agents|mesh-ancestor
6566144|NCT00975390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6566145|NCT00975494|Sildenafil Citrate|sildenafil citrate|mesh-list
6566146|NCT00975494|Vasodilator Agents|vasodilator agents|mesh-ancestor
6566147|NCT00975494|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6566148|NCT00975494|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6566149|NCT00975494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6444788|NCT00385437|Mirtazapine|mirtazapine|mesh-list
6444789|NCT00385437|Antidepressive Agents|antidepressive agents|mesh-ancestor
6444790|NCT00385437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6444791|NCT00385437|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6444792|NCT00385437|Histamine Antagonists|histamine antagonists|mesh-ancestor
6444793|NCT00385437|Histamine Agents|histamine agents|mesh-ancestor
6444794|NCT00385437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6444795|NCT00385437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444796|NCT00385437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444797|NCT00385437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6444798|NCT00385437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6444799|NCT00385437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6566150|NCT00975494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566151|NCT00975494|Urological Agents|urological agents|mesh-ancestor
6566152|NCT00975533|Insulin|insulin|mesh-list
6566153|NCT00975533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6566154|NCT00975533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566155|NCT00975572|Vaccines|vaccines|mesh-list
6566156|NCT00975572|Immunologic Factors|immunologic factors|mesh-ancestor
6566157|NCT00975572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566158|NCT00975663|Tacrolimus|tacrolimus|mesh-list
6566159|NCT00975663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6566160|NCT00975663|Immunologic Factors|immunologic factors|mesh-ancestor
6566161|NCT00975663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566162|NCT00975663|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6566163|NCT00975663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6566164|NCT00975663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566165|NCT00975728|Antioxidants|antioxidants|mesh-list
6566166|NCT00975728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566167|NCT00975728|Protective Agents|protective agents|mesh-ancestor
6566168|NCT00975728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657320|NCT01475552|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6657321|NCT01475552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6657322|NCT01475552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657323|NCT01475552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6657324|NCT01475552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6657325|NCT01475552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6657326|NCT01475552|Antipyretics|antipyretics|mesh-ancestor
6657327|NCT01475552|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6657328|NCT01475552|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6657329|NCT01475552|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6657330|NCT01475552|Purinergic Agents|purinergic agents|mesh-ancestor
6657331|NCT01475552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6657332|NCT01475552|Anticoagulants|anticoagulants|mesh-ancestor
6657333|NCT01475578|Ergoloid Mesylates|ergoloid mesylates|mesh-list
6657334|NCT01475578|Dihydroergotoxine|dihydroergotoxine|mesh-list
6657335|NCT01475578|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6657336|NCT01475578|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6657337|NCT01475578|Adrenergic Agents|adrenergic agents|mesh-ancestor
6657338|NCT01475578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6566169|NCT00975741|Mometasone Furoate|mometasone furoate|mesh-list
6566170|NCT00975741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6566171|NCT00975741|Dermatologic Agents|dermatologic agents|mesh-ancestor
6566172|NCT00975741|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6566173|NCT00975754|Budesonide|budesonide|mesh-list
6566174|NCT00975754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6566175|NCT00975754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6566176|NCT00975754|Autonomic Agents|autonomic agents|mesh-ancestor
6566177|NCT00975754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6566178|NCT00975754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566179|NCT00975754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6566180|NCT00975754|Respiratory System Agents|respiratory system agents|mesh-ancestor
6566181|NCT00975754|Glucocorticoids|glucocorticoids|mesh-ancestor
6566182|NCT00975754|Hormones|hormones|mesh-ancestor
6566183|NCT00975754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6566184|NCT00975767|Docetaxel|docetaxel|mesh-list
6566185|NCT00975767|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6566186|NCT00975767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6566187|NCT00975767|Tubulin Modulators|tubulin modulators|mesh-ancestor
6566188|NCT00975767|Antimitotic Agents|antimitotic agents|mesh-ancestor
6566189|NCT00975767|Mitosis Modulators|mitosis modulators|mesh-ancestor
6566190|NCT00975767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566191|NCT00975767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6566192|NCT00975767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6566193|NCT00975819|Sirolimus|sirolimus|mesh-list
6566194|NCT00975819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6566195|NCT00975819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6566196|NCT00975819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6566197|NCT00975819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6566198|NCT00975819|Antifungal Agents|antifungal agents|mesh-ancestor
6566199|NCT00975819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6566200|NCT00975819|Immunologic Factors|immunologic factors|mesh-ancestor
6566201|NCT00975819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566202|NCT00975897|Leucovorin|leucovorin|mesh-list
6566203|NCT00975897|Bevacizumab|bevacizumab|mesh-list
6566204|NCT00975897|Cetuximab|cetuximab|mesh-list
6566205|NCT00975897|Fluorouracil|fluorouracil|mesh-list
6566206|NCT00975897|Oxaliplatin|oxaliplatin|mesh-list
6566207|NCT00975897|Irinotecan|irinotecan|mesh-list
6566208|NCT00975897|Calcium|calcium|mesh-list
6566209|NCT00975897|Levoleucovorin|levoleucovorin|mesh-list
6566210|NCT00975897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6566211|NCT00975897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6566212|NCT00975897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6566213|NCT00975897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6566214|NCT00975897|Growth Substances|growth substances|mesh-ancestor
6566215|NCT00975897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566216|NCT00975897|Growth Inhibitors|growth inhibitors|mesh-ancestor
6566217|NCT00975897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6566218|NCT00975897|Antimetabolites|antimetabolites|mesh-ancestor
6566219|NCT00975897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566220|NCT00975897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6566221|NCT00975897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6566222|NCT00975897|Immunologic Factors|immunologic factors|mesh-ancestor
6566223|NCT00975897|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6566224|NCT00975897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6566225|NCT00975897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6566226|NCT00975897|Antidotes|antidotes|mesh-ancestor
6566227|NCT00975897|Protective Agents|protective agents|mesh-ancestor
6566228|NCT00975897|Vitamin B Complex|vitamin b complex|mesh-ancestor
6566229|NCT00975897|Vitamins|vitamins|mesh-ancestor
6566230|NCT00975897|Micronutrients|micronutrients|mesh-ancestor
6566231|NCT00975910|Lidocaine|lidocaine|mesh-list
6566232|NCT00975910|Anesthetics, Local|anesthetics, local|mesh-ancestor
6566233|NCT00975910|Anesthetics|anesthetics|mesh-ancestor
6566234|NCT00975910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6566235|NCT00975910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566236|NCT00975910|Sensory System Agents|sensory system agents|mesh-ancestor
6566237|NCT00975910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6566238|NCT00975910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6566239|NCT00975910|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6566240|NCT00975910|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6566241|NCT00975910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6566242|NCT00975910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566243|NCT00975936|Ketoconazole|ketoconazole|mesh-list
6566244|NCT00975936|Antifungal Agents|antifungal agents|mesh-ancestor
6566245|NCT00975936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6566246|NCT00975936|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6566247|NCT00975936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6566248|NCT00975936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6566249|NCT00975936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566250|NCT00975936|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6566251|NCT00975936|Hormone Antagonists|hormone antagonists|mesh-ancestor
6566252|NCT00975936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6566253|NCT00975936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566254|NCT00975936|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6566255|NCT00975962|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6566256|NCT00975962|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6566257|NCT00975962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6566258|NCT00975962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566259|NCT00975988|Lapatinib|lapatinib|mesh-list
6566260|NCT00975988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6566261|NCT00975988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6566262|NCT00975988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6566263|NCT00975988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566264|NCT00976040|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6566265|NCT00976040|Antiviral Agents|antiviral agents|mesh-ancestor
6566266|NCT00976040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6566267|NCT00976066|Naltrexone|naltrexone|mesh-list
6566268|NCT00976066|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6566269|NCT00976066|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6566270|NCT00976066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566271|NCT00976066|Sensory System Agents|sensory system agents|mesh-ancestor
6566272|NCT00976066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6566273|NCT00976092|Heparin|heparin|mesh-list
6566274|NCT00976092|Calcium heparin|calcium heparin|mesh-list
6566275|NCT00976092|Bivalirudin|bivalirudin|mesh-list
6566276|NCT00976092|Clopidogrel|clopidogrel|mesh-list
6566277|NCT00976092|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6566278|NCT00976092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6566279|NCT00976092|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6566280|NCT00976092|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6566281|NCT00976092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6566282|NCT00976092|Purinergic Agents|purinergic agents|mesh-ancestor
6566283|NCT00976092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6566284|NCT00976092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566285|NCT00976092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566286|NCT00976092|Anticoagulants|anticoagulants|mesh-ancestor
6566287|NCT00976092|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6566288|NCT00976092|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6566289|NCT00976092|Antithrombins|antithrombins|mesh-ancestor
6566290|NCT00976092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6566291|NCT00976092|Protease Inhibitors|protease inhibitors|mesh-ancestor
6566292|NCT00976092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6566293|NCT00976105|Zolpidem|zolpidem|mesh-list
6566294|NCT00976105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
6566295|NCT00976105|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6566296|NCT00976105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6566297|NCT00976105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566298|NCT00976105|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6566299|NCT00976105|GABA Agonists|gaba agonists|mesh-ancestor
6566300|NCT00976105|GABA Agents|gaba agents|mesh-ancestor
6566301|NCT00976105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6566302|NCT00976105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566303|NCT00976131|Ubiquinone|ubiquinone|mesh-list
6566304|NCT00976131|Coenzyme Q10|coenzyme q10|mesh-list
6566305|NCT00976131|Micronutrients|micronutrients|mesh-ancestor
6566306|NCT00976131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566307|NCT00976131|Vitamins|vitamins|mesh-ancestor
6566308|NCT00976170|Sorafenib|sorafenib|mesh-list
6566309|NCT00976170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6566310|NCT00976170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6566311|NCT00976170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6566312|NCT00976170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566313|NCT00976222|Ranibizumab|ranibizumab|mesh-list
6566314|NCT00976222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6566315|NCT00976222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6566316|NCT00976222|Growth Substances|growth substances|mesh-ancestor
6566317|NCT00976222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566318|NCT00976222|Growth Inhibitors|growth inhibitors|mesh-ancestor
6566319|NCT00976222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6566320|NCT00976261|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6566321|NCT00976261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6566322|NCT00976261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566323|NCT00976261|Incretins|incretins|mesh-ancestor
6566324|NCT00976261|Hormones|hormones|mesh-ancestor
6566325|NCT00976261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6566326|NCT00976261|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6566327|NCT00976261|Protease Inhibitors|protease inhibitors|mesh-ancestor
6566328|NCT00976261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6566329|NCT00976261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566330|NCT00976300|Cyclosporine|cyclosporine|mesh-list
6566331|NCT00976300|Cyclophosphamide|cyclophosphamide|mesh-list
6566332|NCT00976300|Cyclosporins|cyclosporins|mesh-list
6566333|NCT00976300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6566334|NCT00976300|Immunologic Factors|immunologic factors|mesh-ancestor
6566335|NCT00976300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566336|NCT00976300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6566337|NCT00976300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6566338|NCT00976300|Alkylating Agents|alkylating agents|mesh-ancestor
6566339|NCT00976300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566340|NCT00976300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6566341|NCT00976300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6566342|NCT00976300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6566343|NCT00976300|Antifungal Agents|antifungal agents|mesh-ancestor
6566344|NCT00976300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6566345|NCT00976300|Dermatologic Agents|dermatologic agents|mesh-ancestor
6566346|NCT00976300|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6566347|NCT00976326|Insulin|insulin|mesh-list
6566348|NCT00976326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6566349|NCT00976326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566350|NCT00976469|Vaccines|vaccines|mesh-list
6566351|NCT00976469|Immunologic Factors|immunologic factors|mesh-ancestor
6566352|NCT00976469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566353|NCT00976651|Menotropins|menotropins|mesh-list
6566354|NCT00976651|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6566355|NCT00976651|Fertility Agents|fertility agents|mesh-ancestor
6566356|NCT00976651|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6566357|NCT00976651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566358|NCT00976690|Mesalamine|mesalamine|mesh-list
6566359|NCT00976690|Azathioprine|azathioprine|mesh-list
6566360|NCT00976690|Antimetabolites|antimetabolites|mesh-ancestor
6566361|NCT00976690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566362|NCT00976690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6566363|NCT00976690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6566364|NCT00976690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6566365|NCT00976690|Immunologic Factors|immunologic factors|mesh-ancestor
6566366|NCT00976690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566367|NCT00976690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6566368|NCT00976690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6566369|NCT00976690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6566370|NCT00976690|Analgesics|analgesics|mesh-ancestor
6566371|NCT00976690|Sensory System Agents|sensory system agents|mesh-ancestor
6566372|NCT00976690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6566373|NCT00976690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6566374|NCT00976755|Everolimus|everolimus|mesh-list
6566375|NCT00976755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6566376|NCT00976755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6566377|NCT00976755|Immunologic Factors|immunologic factors|mesh-ancestor
6566378|NCT00976755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566379|NCT00976768|Fluorouracil|fluorouracil|mesh-list
6566380|NCT00976768|Oxaliplatin|oxaliplatin|mesh-list
6566381|NCT00976768|Antimetabolites|antimetabolites|mesh-ancestor
6444800|NCT00385437|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6444801|NCT00385437|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6444802|NCT00385437|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6444803|NCT00385437|Adrenergic Agents|adrenergic agents|mesh-ancestor
6444804|NCT00385437|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6444805|NCT00385437|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6444806|NCT00385437|Serotonin Agents|serotonin agents|mesh-ancestor
6444807|NCT00385437|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6444808|NCT00385450|Nelfinavir|nelfinavir|mesh-list
6444809|NCT00385450|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6444810|NCT00385450|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6444811|NCT00385450|Protease Inhibitors|protease inhibitors|mesh-ancestor
6444812|NCT00385450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6444813|NCT00385450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444814|NCT00385450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6444815|NCT00385450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6444816|NCT00385450|Antiviral Agents|antiviral agents|mesh-ancestor
6444817|NCT00385450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6444818|NCT00385463|Montelukast|montelukast|mesh-list
6444819|NCT00385463|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6444820|NCT00385463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6444821|NCT00385463|Respiratory System Agents|respiratory system agents|mesh-ancestor
6444822|NCT00385463|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6566382|NCT00976768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566383|NCT00976768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6566384|NCT00976768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6566385|NCT00976768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6566386|NCT00976768|Immunologic Factors|immunologic factors|mesh-ancestor
6566387|NCT00976768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566388|NCT00976794|Carbamazepine|carbamazepine|mesh-list
6566389|NCT00976794|Valproic Acid|valproic acid|mesh-list
6566390|NCT00976794|Lithium Carbonate|lithium carbonate|mesh-list
6566391|NCT00976794|Antidepressive Agents|antidepressive agents|mesh-ancestor
6566392|NCT00976794|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6566393|NCT00976794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6566394|NCT00976794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566395|NCT00976794|Antimanic Agents|antimanic agents|mesh-ancestor
6566396|NCT00976794|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6566397|NCT00976794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6566398|NCT00976794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566399|NCT00976794|Anticonvulsants|anticonvulsants|mesh-ancestor
6566400|NCT00976794|GABA Agents|gaba agents|mesh-ancestor
6566401|NCT00976794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6566402|NCT00976794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6566403|NCT00976794|Analgesics|analgesics|mesh-ancestor
6566404|NCT00976794|Sensory System Agents|sensory system agents|mesh-ancestor
6566405|NCT00976794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6566406|NCT00976794|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6566407|NCT00976794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6566408|NCT00976794|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6566409|NCT00976794|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6566410|NCT00976963|Fosfomycin|fosfomycin|mesh-list
6566411|NCT00976963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6566412|NCT00976963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6566413|NCT00976976|Cisplatin|cisplatin|mesh-list
6566414|NCT00976976|Docetaxel|docetaxel|mesh-list
6566415|NCT00976976|Capecitabine|capecitabine|mesh-list
6566416|NCT00976976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6566417|NCT00976976|Tubulin Modulators|tubulin modulators|mesh-ancestor
6566418|NCT00976976|Antimitotic Agents|antimitotic agents|mesh-ancestor
6566419|NCT00976976|Mitosis Modulators|mitosis modulators|mesh-ancestor
6566420|NCT00976976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566421|NCT00976976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6566422|NCT00976976|Antimetabolites|antimetabolites|mesh-ancestor
6566423|NCT00977028|Lidocaine|lidocaine|mesh-list
6566424|NCT00977028|Epinephrine|epinephrine|mesh-list
6566425|NCT00977028|Racepinephrine|racepinephrine|mesh-list
6566426|NCT00977028|Anesthetics|anesthetics|mesh-list
6566427|NCT00977028|Epinephryl borate|epinephryl borate|mesh-list
6566428|NCT00977028|Anesthetics, Local|anesthetics, local|mesh-ancestor
6566429|NCT00977028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6566430|NCT00977028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566431|NCT00977028|Sensory System Agents|sensory system agents|mesh-ancestor
6566432|NCT00977028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6566433|NCT00977028|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6566434|NCT00977028|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6566435|NCT00977028|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6566436|NCT00977028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6566437|NCT00977028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566438|NCT00977028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6566439|NCT00977028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6566440|NCT00977028|Adrenergic Agents|adrenergic agents|mesh-ancestor
6566441|NCT00977028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6566442|NCT00977028|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6566443|NCT00977028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6566444|NCT00977028|Autonomic Agents|autonomic agents|mesh-ancestor
6566445|NCT00977028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6566446|NCT00977028|Respiratory System Agents|respiratory system agents|mesh-ancestor
6566447|NCT00977028|Mydriatics|mydriatics|mesh-ancestor
6566448|NCT00977028|Sympathomimetics|sympathomimetics|mesh-ancestor
6566449|NCT00977028|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6566450|NCT00977054|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6566451|NCT00977054|Interferon-alpha|interferon-alpha|mesh-list
6566452|NCT00977054|Ribavirin|ribavirin|mesh-list
6566453|NCT00977054|Interferon alpha-2|interferon alpha-2|mesh-list
6566454|NCT00977054|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
6566455|NCT00977054|Antiviral Agents|antiviral agents|mesh-ancestor
6566456|NCT00977054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6566457|NCT00977054|Immunologic Factors|immunologic factors|mesh-ancestor
6566458|NCT00977054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566459|NCT00977054|Antimetabolites|antimetabolites|mesh-ancestor
6566460|NCT00977054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566461|NCT00977054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6566462|NCT00977093|Pentetic Acid|pentetic acid|mesh-list
6566463|NCT00977093|Antidotes|antidotes|mesh-ancestor
6566464|NCT00977093|Protective Agents|protective agents|mesh-ancestor
6566465|NCT00977093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566466|NCT00977093|Chelating Agents|chelating agents|mesh-ancestor
6566467|NCT00977093|Sequestering Agents|sequestering agents|mesh-ancestor
6566468|NCT00977093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566469|NCT00977093|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6566470|NCT00977132|Lenalidomide|lenalidomide|mesh-list
6566471|NCT00977132|Immunologic Factors|immunologic factors|mesh-ancestor
6566472|NCT00977132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566473|NCT00977132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6566474|NCT00977132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6566475|NCT00977132|Growth Substances|growth substances|mesh-ancestor
6566476|NCT00977132|Growth Inhibitors|growth inhibitors|mesh-ancestor
6566477|NCT00977132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6566478|NCT00977145|Interferon-gamma|interferon-gamma|mesh-list
6566479|NCT00977145|Vaccines|vaccines|mesh-list
6566480|NCT00977145|Immunologic Factors|immunologic factors|mesh-ancestor
6566481|NCT00977145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566482|NCT00977145|Antiviral Agents|antiviral agents|mesh-ancestor
6566483|NCT00977145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6566484|NCT00977223|Aprepitant|aprepitant|mesh-list
6566485|NCT00977223|Fosaprepitant|fosaprepitant|mesh-list
6566486|NCT00977223|Antiemetics|antiemetics|mesh-ancestor
6566487|NCT00977223|Autonomic Agents|autonomic agents|mesh-ancestor
6566488|NCT00977223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6566489|NCT00977223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566490|NCT00977223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6566491|NCT00977223|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6566492|NCT00977223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6566493|NCT00977223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566494|NCT00977249|Varenicline|varenicline|mesh-list
6566495|NCT00977249|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6566496|NCT00977249|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6566497|NCT00977249|Cholinergic Agents|cholinergic agents|mesh-ancestor
6566498|NCT00977249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6566499|NCT00977249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566500|NCT00977249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566501|NCT00977288|Atorvastatin|atorvastatin|mesh-list
6566502|NCT00977288|Anacetrapib|anacetrapib|mesh-list
6566503|NCT00977288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6566504|NCT00977288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6566505|NCT00977288|Antimetabolites|antimetabolites|mesh-ancestor
6566506|NCT00977288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566507|NCT00977288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6566508|NCT00977288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6566509|NCT00977288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6566510|NCT00977301|Ritonavir|ritonavir|mesh-list
6566511|NCT00977301|Fosamprenavir|fosamprenavir|mesh-list
6566512|NCT00977301|Olanzapine|olanzapine|mesh-list
6566513|NCT00977301|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6566514|NCT00977301|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6566515|NCT00977301|Protease Inhibitors|protease inhibitors|mesh-ancestor
6566516|NCT00977301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6566517|NCT00977301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566518|NCT00977301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6566519|NCT00977301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6566520|NCT00977301|Antiviral Agents|antiviral agents|mesh-ancestor
6566521|NCT00977301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6566522|NCT00977301|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6566523|NCT00977301|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6566524|NCT00977301|Antiemetics|antiemetics|mesh-ancestor
6566525|NCT00977301|Autonomic Agents|autonomic agents|mesh-ancestor
6566526|NCT00977301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6566527|NCT00977301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566528|NCT00977301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6566529|NCT00977301|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6566530|NCT00977301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6566531|NCT00977301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6566532|NCT00977301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6566533|NCT00977301|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6566534|NCT00977301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6566535|NCT00977301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6566536|NCT00977301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6566537|NCT00977301|Serotonin Agents|serotonin agents|mesh-ancestor
6566538|NCT00977353|Citalopram|citalopram|mesh-list
6566539|NCT00977353|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6566540|NCT00977353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6566541|NCT00977353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6566542|NCT00977353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566543|NCT00977353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6566544|NCT00977353|Serotonin Agents|serotonin agents|mesh-ancestor
6566545|NCT00977353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566546|NCT00977353|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6566547|NCT00977353|Antidepressive Agents|antidepressive agents|mesh-ancestor
6566548|NCT00977353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6566549|NCT00977405|Gentamicins|gentamicins|mesh-list
6444823|NCT00385463|Hormone Antagonists|hormone antagonists|mesh-ancestor
6444824|NCT00385463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6444825|NCT00385463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444826|NCT00385463|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6444827|NCT00385463|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6444828|NCT00385463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444829|NCT00385463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6444830|NCT00385463|Autonomic Agents|autonomic agents|mesh-ancestor
6444831|NCT00385463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6444832|NCT00385463|Glucocorticoids|glucocorticoids|mesh-ancestor
6566550|NCT00977405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6566551|NCT00977405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6566552|NCT00977405|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6566553|NCT00977405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6566554|NCT00977405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566555|NCT00977444|Prednisolone|prednisolone|mesh-list
6566556|NCT00977444|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6566557|NCT00977444|Methylprednisolone|methylprednisolone|mesh-list
6566558|NCT00977444|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6566559|NCT00977444|Prednisolone acetate|prednisolone acetate|mesh-list
6566560|NCT00977444|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6566561|NCT00977444|Prednisolone phosphate|prednisolone phosphate|mesh-list
6566562|NCT00977444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6566563|NCT00977444|Glucocorticoids|glucocorticoids|mesh-ancestor
6566564|NCT00977444|Hormones|hormones|mesh-ancestor
6566565|NCT00977444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6566566|NCT00977444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566567|NCT00977444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6566568|NCT00977444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6566569|NCT00977444|Antiemetics|antiemetics|mesh-ancestor
6566570|NCT00977444|Autonomic Agents|autonomic agents|mesh-ancestor
6566571|NCT00977444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6566572|NCT00977444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6566573|NCT00977444|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6566574|NCT00977444|Protective Agents|protective agents|mesh-ancestor
6566575|NCT00977600|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
6566576|NCT00977600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6657339|NCT01475578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657340|NCT01475578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657341|NCT01475578|Vasodilator Agents|vasodilator agents|mesh-ancestor
6657342|NCT01475578|Nootropic Agents|nootropic agents|mesh-ancestor
6657343|NCT01475578|Dopamine Agonists|dopamine agonists|mesh-ancestor
6657344|NCT01475578|Dopamine Agents|dopamine agents|mesh-ancestor
6657345|NCT01475617|Calcium, Dietary|calcium, dietary|mesh-list
6657346|NCT01475617|Vitamin B 12|vitamin b 12|mesh-list
6657347|NCT01475617|Hydroxocobalamin|hydroxocobalamin|mesh-list
6657348|NCT01475617|Calcium|calcium|mesh-list
6657349|NCT01475617|Vitamins|vitamins|mesh-ancestor
6657350|NCT01475617|Micronutrients|micronutrients|mesh-ancestor
6657351|NCT01475617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657352|NCT01475617|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6657353|NCT01475617|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6657354|NCT01475617|Vitamin B Complex|vitamin b complex|mesh-ancestor
6657355|NCT01475617|Hematinics|hematinics|mesh-ancestor
6657356|NCT01475656|Levetiracetam|levetiracetam|mesh-list
6657357|NCT01475656|Anticonvulsants|anticonvulsants|mesh-ancestor
6657358|NCT01475656|Nootropic Agents|nootropic agents|mesh-ancestor
6657359|NCT01475708|Doxycycline|doxycycline|mesh-list
6657360|NCT01475708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6657361|NCT01475708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6657362|NCT01475708|Antimalarials|antimalarials|mesh-ancestor
6657363|NCT01475708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6566577|NCT00977756|Ritonavir|ritonavir|mesh-list
6566578|NCT00977756|Lopinavir|lopinavir|mesh-list
6566579|NCT00977756|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6566580|NCT00977756|Darunavir|darunavir|mesh-list
6566581|NCT00977756|Tenofovir|tenofovir|mesh-list
6566582|NCT00977756|Raltegravir Potassium|raltegravir potassium|mesh-list
6566583|NCT00977756|Maraviroc|maraviroc|mesh-list
6566584|NCT00977756|Etravirine|etravirine|mesh-list
6566585|NCT00977756|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6566586|NCT00977756|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6566587|NCT00977756|Protease Inhibitors|protease inhibitors|mesh-ancestor
6566588|NCT00977756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6566589|NCT00977756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566590|NCT00977756|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6566591|NCT00977756|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6566592|NCT00977756|Antiviral Agents|antiviral agents|mesh-ancestor
6566593|NCT00977756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6566594|NCT00977756|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6566595|NCT00977756|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6566596|NCT00977756|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6566597|NCT00977756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6566598|NCT00977756|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6566599|NCT00977756|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6566600|NCT00977756|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6566601|NCT00977756|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6566602|NCT00977756|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6566603|NCT00977795|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6566604|NCT00977795|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6566605|NCT00977795|Dermatologic Agents|dermatologic agents|mesh-ancestor
6566606|NCT00977873|Cholecalciferol|cholecalciferol|mesh-list
6566607|NCT00977873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6566608|NCT00977873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566609|NCT00977873|Vitamins|vitamins|mesh-ancestor
6566610|NCT00977873|Micronutrients|micronutrients|mesh-ancestor
6566611|NCT00977873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6566612|NCT00977964|Caseins|caseins|mesh-list
6566613|NCT00977964|Chelating Agents|chelating agents|mesh-ancestor
6566614|NCT00977964|Sequestering Agents|sequestering agents|mesh-ancestor
6566615|NCT00977964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566616|NCT00978081|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6566617|NCT00978081|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6566618|NCT00978081|Dermatologic Agents|dermatologic agents|mesh-ancestor
6566619|NCT00978107|Flucytosine|flucytosine|mesh-list
6566620|NCT00978107|Antifungal Agents|antifungal agents|mesh-ancestor
6566621|NCT00978107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6566622|NCT00978107|Antimetabolites|antimetabolites|mesh-ancestor
6566623|NCT00978107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566624|NCT00978146|Hydroxyurea|hydroxyurea|mesh-list
6566625|NCT00978146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6566626|NCT00978146|Antisickling Agents|antisickling agents|mesh-ancestor
6566627|NCT00978146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6566628|NCT00978146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566629|NCT00978146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6566630|NCT00978159|Esomeprazole|esomeprazole|mesh-list
6566631|NCT00978159|Famotidine|famotidine|mesh-list
6566632|NCT00978159|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6566633|NCT00978159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6566634|NCT00978159|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6566635|NCT00978159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6566636|NCT00978159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566637|NCT00978159|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6566638|NCT00978159|Histamine Antagonists|histamine antagonists|mesh-ancestor
6566639|NCT00978159|Histamine Agents|histamine agents|mesh-ancestor
6566640|NCT00978159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6566641|NCT00978159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566642|NCT00978172|Artesunate|artesunate|mesh-list
6566643|NCT00978172|Mefloquine|mefloquine|mesh-list
6566644|NCT00978172|Antimalarials|antimalarials|mesh-ancestor
6566645|NCT00978172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6566646|NCT00978172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6566647|NCT00978172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6566648|NCT00978172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6566649|NCT00978172|Antiviral Agents|antiviral agents|mesh-ancestor
6566650|NCT00978172|Schistosomicides|schistosomicides|mesh-ancestor
6566651|NCT00978172|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6566652|NCT00978172|Anthelmintics|anthelmintics|mesh-ancestor
6566653|NCT00978211|Octreotide|octreotide|mesh-list
6566654|NCT00978211|Somatostatin|somatostatin|mesh-list
6566655|NCT00978211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6566656|NCT00978211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6566657|NCT00978211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6566658|NCT00978211|Hormones|hormones|mesh-ancestor
6566659|NCT00978211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6566660|NCT00978211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566661|NCT00978263|Metformin|metformin|mesh-list
6566662|NCT00978263|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6566663|NCT00978263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566664|NCT00978315|Cholecalciferol|cholecalciferol|mesh-list
6566665|NCT00978315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6566666|NCT00978315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566667|NCT00978315|Vitamins|vitamins|mesh-ancestor
6566668|NCT00978315|Micronutrients|micronutrients|mesh-ancestor
6566669|NCT00978315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6566670|NCT00978328|Oxycodone|oxycodone|mesh-list
6566671|NCT00978328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6566672|NCT00978328|Narcotics|narcotics|mesh-ancestor
6566673|NCT00978328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6566674|NCT00978328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566675|NCT00978328|Analgesics|analgesics|mesh-ancestor
6566676|NCT00978328|Sensory System Agents|sensory system agents|mesh-ancestor
6566677|NCT00978328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6566678|NCT00978354|Furosemide|furosemide|mesh-list
6566679|NCT00978354|Diuretics|diuretics|mesh-ancestor
6566680|NCT00978354|Natriuretic Agents|natriuretic agents|mesh-ancestor
6566681|NCT00978354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566682|NCT00978354|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6566683|NCT00978354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6566684|NCT00978354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566685|NCT00978393|Liraglutide|liraglutide|mesh-list
6566686|NCT00978393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6566687|NCT00978393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566688|NCT00978393|Incretins|incretins|mesh-ancestor
6566689|NCT00978393|Hormones|hormones|mesh-ancestor
6566690|NCT00978393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6566691|NCT00978471|Thiotepa|thiotepa|mesh-list
6566692|NCT00978471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6566693|NCT00978471|Alkylating Agents|alkylating agents|mesh-ancestor
6566694|NCT00978471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566695|NCT00978471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6566696|NCT00978471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6566697|NCT00978471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6566698|NCT00978471|Immunologic Factors|immunologic factors|mesh-ancestor
6566699|NCT00978471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566700|NCT00978549|Docetaxel|docetaxel|mesh-list
6566701|NCT00978549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6566702|NCT00978549|Tubulin Modulators|tubulin modulators|mesh-ancestor
6566703|NCT00978549|Antimitotic Agents|antimitotic agents|mesh-ancestor
6566704|NCT00978549|Mitosis Modulators|mitosis modulators|mesh-ancestor
6566705|NCT00978549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566706|NCT00978588|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
6566707|NCT00978588|Plasma Substitutes|plasma substitutes|mesh-ancestor
6566708|NCT00978588|Blood Substitutes|blood substitutes|mesh-ancestor
6566709|NCT00978601|Analgesics|analgesics|mesh-list
6566710|NCT00978601|Sensory System Agents|sensory system agents|mesh-ancestor
6566711|NCT00978601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6566712|NCT00978601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566713|NCT00978653|Allopurinol|allopurinol|mesh-list
6444833|NCT00385463|Hormones|hormones|mesh-ancestor
6444834|NCT00385463|Sympathomimetics|sympathomimetics|mesh-ancestor
6566714|NCT00978653|Antimetabolites|antimetabolites|mesh-ancestor
6566715|NCT00978653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566716|NCT00978653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6566717|NCT00978653|Gout Suppressants|gout suppressants|mesh-ancestor
6566718|NCT00978653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6566719|NCT00978653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6566720|NCT00978653|Antioxidants|antioxidants|mesh-ancestor
6566721|NCT00978653|Protective Agents|protective agents|mesh-ancestor
6566722|NCT00978653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566723|NCT00978718|Selenium|selenium|mesh-list
6566724|NCT00978718|Antioxidants|antioxidants|mesh-ancestor
6566725|NCT00978718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566726|NCT00978718|Protective Agents|protective agents|mesh-ancestor
6566727|NCT00978718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566728|NCT00978718|Trace Elements|trace elements|mesh-ancestor
6566729|NCT00978718|Micronutrients|micronutrients|mesh-ancestor
6566730|NCT00978796|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6566731|NCT00978796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6566732|NCT00978796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566733|NCT00978796|Incretins|incretins|mesh-ancestor
6566734|NCT00978796|Hormones|hormones|mesh-ancestor
6566735|NCT00978796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6566736|NCT00978796|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6566737|NCT00978796|Protease Inhibitors|protease inhibitors|mesh-ancestor
6566738|NCT00978796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6566739|NCT00978796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566740|NCT00978822|Clevidipine|clevidipine|mesh-list
6566741|NCT00978822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6566742|NCT00978822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6566743|NCT00978822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566744|NCT00978822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6566745|NCT00978822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566746|NCT00978861|Hydrogen Peroxide|hydrogen peroxide|mesh-list
6566747|NCT00978861|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6566748|NCT00978861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6566749|NCT00978913|Cyclophosphamide|cyclophosphamide|mesh-list
6566750|NCT00978913|Vaccines|vaccines|mesh-list
6566751|NCT00978913|Immunologic Factors|immunologic factors|mesh-ancestor
6566752|NCT00978913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566753|NCT00978913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6566754|NCT00978913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6566755|NCT00978913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6566756|NCT00978913|Alkylating Agents|alkylating agents|mesh-ancestor
6566757|NCT00978913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566758|NCT00978913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6566759|NCT00978913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6566760|NCT00978978|Fentanyl|fentanyl|mesh-list
6566761|NCT00978978|Midazolam|midazolam|mesh-list
6566762|NCT00978978|Propofol|propofol|mesh-list
6566763|NCT00978978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6566764|NCT00978978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6566765|NCT00978978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566766|NCT00978978|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6566767|NCT00978978|Anesthetics, General|anesthetics, general|mesh-ancestor
6566768|NCT00978978|Anesthetics|anesthetics|mesh-ancestor
6566769|NCT00978978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6566770|NCT00978978|Narcotics|narcotics|mesh-ancestor
6566771|NCT00978978|Analgesics|analgesics|mesh-ancestor
6566772|NCT00978978|Sensory System Agents|sensory system agents|mesh-ancestor
6566773|NCT00978978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6444835|NCT00385502|Econazole|econazole|mesh-list
6444836|NCT00385502|Antifungal Agents|antifungal agents|mesh-ancestor
6444837|NCT00385502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6444838|NCT00385502|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6444839|NCT00385502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6444840|NCT00385502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6566774|NCT00978978|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6566775|NCT00978978|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6566776|NCT00978978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6566777|NCT00978978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6566778|NCT00978978|GABA Modulators|gaba modulators|mesh-ancestor
6566779|NCT00978978|GABA Agents|gaba agents|mesh-ancestor
6566780|NCT00978978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6566781|NCT00978978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566782|NCT00979056|Rifaximin|rifaximin|mesh-list
6566783|NCT00979056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6566784|NCT00979056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6566785|NCT00979056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6566786|NCT00979160|Dasatinib|dasatinib|mesh-list
6566787|NCT00979160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6566788|NCT00979160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6566789|NCT00979160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6566790|NCT00979160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566791|NCT00979186|Hemostatics|hemostatics|mesh-list
6566792|NCT00979186|Coagulants|coagulants|mesh-ancestor
6566793|NCT00979316|Moxifloxacin|moxifloxacin|mesh-list
6444841|NCT00385502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444842|NCT00385502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6444843|NCT00385502|Hormone Antagonists|hormone antagonists|mesh-ancestor
6444844|NCT00385502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6444845|NCT00385502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444846|NCT00385554|UC-781|uc-781|mesh-list
6444847|NCT00385554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6444848|NCT00385554|Antiviral Agents|antiviral agents|mesh-ancestor
6444849|NCT00385554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6444850|NCT00385606|Gemcitabine|gemcitabine|mesh-list
6444851|NCT00385606|Rofecoxib|rofecoxib|mesh-list
6444852|NCT00385606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6444853|NCT00385606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6444854|NCT00385606|Antimetabolites|antimetabolites|mesh-ancestor
6444855|NCT00385606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566794|NCT00979316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6566795|NCT00979316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6566796|NCT00979316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6566797|NCT00979316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6566798|NCT00979316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6566799|NCT00979316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566800|NCT00979316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6566801|NCT00979472|Solifenacin Succinate|solifenacin succinate|mesh-list
6566802|NCT00979472|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6566803|NCT00979472|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6566804|NCT00979472|Cholinergic Agents|cholinergic agents|mesh-ancestor
6566805|NCT00979472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6566806|NCT00979472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566807|NCT00979472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566808|NCT00979472|Urological Agents|urological agents|mesh-ancestor
6657364|NCT01475708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6444856|NCT00385606|Antiviral Agents|antiviral agents|mesh-ancestor
6444857|NCT00385606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6444858|NCT00385606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6444859|NCT00385606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6657365|NCT01475760|Chitosan|chitosan|mesh-list
6657366|NCT01475760|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6657367|NCT01475760|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6657368|NCT01475760|Antimetabolites|antimetabolites|mesh-ancestor
6657369|NCT01475760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657370|NCT01475760|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6657371|NCT01475760|Chelating Agents|chelating agents|mesh-ancestor
6657372|NCT01475760|Sequestering Agents|sequestering agents|mesh-ancestor
6657373|NCT01475760|Hemostatics|hemostatics|mesh-ancestor
6657374|NCT01475760|Coagulants|coagulants|mesh-ancestor
6657375|NCT01475877|Bromfenac|bromfenac|mesh-list
6566809|NCT00979537|Nisoldipine|nisoldipine|mesh-list
6566810|NCT00979537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6566811|NCT00979537|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6566812|NCT00979537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6566813|NCT00979537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566814|NCT00979537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6566815|NCT00979537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566816|NCT00979537|Vasodilator Agents|vasodilator agents|mesh-ancestor
6566817|NCT00979563|Irinotecan|irinotecan|mesh-list
6566818|NCT00979563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6566819|NCT00979563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6566820|NCT00979563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6566821|NCT00979563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566822|NCT00979563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6566823|NCT00979589|Aspirin|aspirin|mesh-list
6566824|NCT00979589|Clopidogrel|clopidogrel|mesh-list
6566825|NCT00979589|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6566826|NCT00979589|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6566827|NCT00979589|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6566828|NCT00979589|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6566829|NCT00979589|Purinergic Agents|purinergic agents|mesh-ancestor
6566830|NCT00979589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6566831|NCT00979589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566832|NCT00979589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566833|NCT00979589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6566834|NCT00979589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6566835|NCT00979589|Analgesics|analgesics|mesh-ancestor
6566836|NCT00979589|Sensory System Agents|sensory system agents|mesh-ancestor
6566837|NCT00979589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6566838|NCT00979589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6566839|NCT00979589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6566840|NCT00979589|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6566841|NCT00979589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6566842|NCT00979589|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6566843|NCT00979589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6566844|NCT00979589|Antipyretics|antipyretics|mesh-ancestor
6566845|NCT00979641|Docetaxel|docetaxel|mesh-list
6566846|NCT00979641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6566847|NCT00979641|Tubulin Modulators|tubulin modulators|mesh-ancestor
6566848|NCT00979641|Antimitotic Agents|antimitotic agents|mesh-ancestor
6566849|NCT00979641|Mitosis Modulators|mitosis modulators|mesh-ancestor
6566850|NCT00979641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566851|NCT00979667|Oseltamivir|oseltamivir|mesh-list
6566852|NCT00979667|Zanamivir|zanamivir|mesh-list
6566853|NCT00979667|Antiviral Agents|antiviral agents|mesh-ancestor
6566854|NCT00979667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6566855|NCT00979667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6566856|NCT00979667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566857|NCT00979693|Psilocybin|psilocybin|mesh-list
6566858|NCT00979693|Hallucinogens|hallucinogens|mesh-ancestor
6566859|NCT00979693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566860|NCT00979693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6566861|NCT00979706|Cyclosporine|cyclosporine|mesh-list
6566862|NCT00979706|Interleukin-2|interleukin-2|mesh-list
6566863|NCT00979706|Cyclosporins|cyclosporins|mesh-list
6566864|NCT00979706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6566865|NCT00979706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566866|NCT00979706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6566867|NCT00979706|Immunologic Factors|immunologic factors|mesh-ancestor
6566868|NCT00979706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566869|NCT00979706|Antifungal Agents|antifungal agents|mesh-ancestor
6566870|NCT00979706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6566871|NCT00979706|Dermatologic Agents|dermatologic agents|mesh-ancestor
6566872|NCT00979706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6566873|NCT00979706|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6566874|NCT00979706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6566875|NCT00979706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6566876|NCT00979706|Analgesics|analgesics|mesh-ancestor
6020043|NCT00391222|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6566877|NCT00979706|Sensory System Agents|sensory system agents|mesh-ancestor
6566878|NCT00979706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6566879|NCT00979758|Atorvastatin|atorvastatin|mesh-list
6566880|NCT00979758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6566881|NCT00979758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6566882|NCT00979758|Antimetabolites|antimetabolites|mesh-ancestor
6566883|NCT00979758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566884|NCT00979758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6566885|NCT00979758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6566886|NCT00979758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6566887|NCT00979836|Calcium Dobesilate|calcium dobesilate|mesh-list
6566888|NCT00979836|Calcium|calcium|mesh-list
6566889|NCT00979836|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6566890|NCT00979836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566891|NCT00979836|Hemostatics|hemostatics|mesh-ancestor
6566892|NCT00979836|Coagulants|coagulants|mesh-ancestor
6566893|NCT00979862|Cediranib|cediranib|mesh-list
6566894|NCT00979862|Maleic acid|maleic acid|mesh-list
6566895|NCT00979862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6566896|NCT00979862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566897|NCT00979862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6566898|NCT00979862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6566899|NCT00979966|Sirolimus|sirolimus|mesh-list
6566900|NCT00979966|Sunitinib|sunitinib|mesh-list
6566901|NCT00979966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6566902|NCT00979966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6566903|NCT00979966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6566904|NCT00979966|Growth Substances|growth substances|mesh-ancestor
6566905|NCT00979966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566906|NCT00979966|Growth Inhibitors|growth inhibitors|mesh-ancestor
6566907|NCT00979966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6566908|NCT00979966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6566909|NCT00979966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566910|NCT00979966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6566911|NCT00979966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6566912|NCT00979966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6566913|NCT00979966|Antifungal Agents|antifungal agents|mesh-ancestor
6566914|NCT00979966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6566915|NCT00979966|Immunologic Factors|immunologic factors|mesh-ancestor
6566916|NCT00980031|Eplerenone|eplerenone|mesh-list
6566917|NCT00980031|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6566918|NCT00980031|Hormone Antagonists|hormone antagonists|mesh-ancestor
6566919|NCT00980031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6566920|NCT00980031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566921|NCT00980031|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6566922|NCT00980031|Diuretics|diuretics|mesh-ancestor
6566923|NCT00980031|Natriuretic Agents|natriuretic agents|mesh-ancestor
6566924|NCT00980031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6566925|NCT00980109|Oseltamivir|oseltamivir|mesh-list
6566926|NCT00980109|Zanamivir|zanamivir|mesh-list
6566927|NCT00980109|Antiviral Agents|antiviral agents|mesh-ancestor
6566928|NCT00980109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6566929|NCT00980109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6566930|NCT00980109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566931|NCT00980135|Hydrocortisone|hydrocortisone|mesh-list
6566932|NCT00980135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6566933|NCT00980187|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6566934|NCT00980187|Indapamide|indapamide|mesh-list
6566935|NCT00980187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6566936|NCT00980187|Diuretics|diuretics|mesh-ancestor
6566937|NCT00980187|Natriuretic Agents|natriuretic agents|mesh-ancestor
6566938|NCT00980187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566939|NCT00980187|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6566940|NCT00980187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6566941|NCT00980187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566942|NCT00980213|Sunitinib|sunitinib|mesh-list
6566943|NCT00980213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6566944|NCT00980213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6566945|NCT00980213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6566946|NCT00980213|Growth Substances|growth substances|mesh-ancestor
6566947|NCT00980213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566948|NCT00980213|Growth Inhibitors|growth inhibitors|mesh-ancestor
6566949|NCT00980213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6566950|NCT00980213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6566951|NCT00980213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566952|NCT00980239|Bevacizumab|bevacizumab|mesh-list
6566953|NCT00980239|Cetuximab|cetuximab|mesh-list
6566954|NCT00980239|Oxaliplatin|oxaliplatin|mesh-list
6566955|NCT00980239|Irinotecan|irinotecan|mesh-list
6566956|NCT00980239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6566957|NCT00980239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6566958|NCT00980239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6566959|NCT00980239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6566960|NCT00980239|Growth Substances|growth substances|mesh-ancestor
6566961|NCT00980239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566962|NCT00980239|Growth Inhibitors|growth inhibitors|mesh-ancestor
6566963|NCT00980239|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6566964|NCT00980239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6566965|NCT00980239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6566966|NCT00980239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566967|NCT00980304|Rituximab|rituximab|mesh-list
6566968|NCT00980304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6566969|NCT00980304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6566970|NCT00980304|Immunologic Factors|immunologic factors|mesh-ancestor
6566971|NCT00980304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566972|NCT00980304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6566973|NCT00980356|Vildagliptin|vildagliptin|mesh-list
6566974|NCT00980356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6566975|NCT00980356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566976|NCT00980356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6566977|NCT00980356|Protease Inhibitors|protease inhibitors|mesh-ancestor
6566978|NCT00980356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6566979|NCT00980356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566980|NCT00980382|Docetaxel|docetaxel|mesh-list
6566981|NCT00980382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6566982|NCT00980382|Tubulin Modulators|tubulin modulators|mesh-ancestor
6566983|NCT00980382|Antimitotic Agents|antimitotic agents|mesh-ancestor
6566984|NCT00980382|Mitosis Modulators|mitosis modulators|mesh-ancestor
6566985|NCT00980382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566986|NCT00980408|Cycloserine|cycloserine|mesh-list
6566987|NCT00980408|Memantine|memantine|mesh-list
6566988|NCT00980408|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6566989|NCT00980408|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6566990|NCT00980408|Dopamine Agents|dopamine agents|mesh-ancestor
6566991|NCT00980408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6566992|NCT00980408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6566993|NCT00980408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6566994|NCT00980408|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6566995|NCT00980408|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6566996|NCT00980408|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6566997|NCT00980408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6566998|NCT00980408|Renal Agents|renal agents|mesh-ancestor
6566999|NCT00980408|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6567000|NCT00980408|Antitubercular Agents|antitubercular agents|mesh-ancestor
6567001|NCT00980408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6567002|NCT00980408|Antimetabolites|antimetabolites|mesh-ancestor
6567003|NCT00980473|Timolol|timolol|mesh-list
6567004|NCT00980473|Travoprost|travoprost|mesh-list
6567005|NCT00980473|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6567006|NCT00980473|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6567007|NCT00980473|Adrenergic Agents|adrenergic agents|mesh-ancestor
6567008|NCT00980473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6567009|NCT00980473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567010|NCT00980473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567011|NCT00980473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6567012|NCT00980473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6567013|NCT00980551|Carboplatin|carboplatin|mesh-list
6567014|NCT00980551|Vincristine|vincristine|mesh-list
6567015|NCT00980551|Topotecan|topotecan|mesh-list
6567016|NCT00980551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6567017|NCT00980551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6567018|NCT00980551|Tubulin Modulators|tubulin modulators|mesh-ancestor
6567019|NCT00980551|Antimitotic Agents|antimitotic agents|mesh-ancestor
6567020|NCT00980551|Mitosis Modulators|mitosis modulators|mesh-ancestor
6567021|NCT00980551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567022|NCT00980551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6567023|NCT00980551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6567024|NCT00980551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6567025|NCT00980603|Docetaxel|docetaxel|mesh-list
6567026|NCT00980603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6567027|NCT00980603|Tubulin Modulators|tubulin modulators|mesh-ancestor
6567028|NCT00980603|Antimitotic Agents|antimitotic agents|mesh-ancestor
6567029|NCT00980603|Mitosis Modulators|mitosis modulators|mesh-ancestor
6567030|NCT00980603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567031|NCT00980616|Ropivacaine|ropivacaine|mesh-list
6567032|NCT00980616|Anesthetics, Local|anesthetics, local|mesh-ancestor
6567033|NCT00980616|Anesthetics|anesthetics|mesh-ancestor
6567034|NCT00980616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6567035|NCT00980616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567036|NCT00980616|Sensory System Agents|sensory system agents|mesh-ancestor
6567037|NCT00980616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6567038|NCT00980707|Fluticasone|fluticasone|mesh-list
6444860|NCT00385606|Immunologic Factors|immunologic factors|mesh-ancestor
6444861|NCT00385606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444862|NCT00385606|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6444863|NCT00385606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6444864|NCT00385606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6020044|NCT00391222|Dopamine Agents|dopamine agents|mesh-ancestor
6444865|NCT00385606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6444866|NCT00385606|Analgesics|analgesics|mesh-ancestor
6444867|NCT00385606|Sensory System Agents|sensory system agents|mesh-ancestor
6444868|NCT00385606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6444869|NCT00385606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6444870|NCT00385606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6444871|NCT00385632|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6444872|NCT00385632|Antiviral Agents|antiviral agents|mesh-ancestor
6444873|NCT00385632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6444874|NCT00385645|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6444875|NCT00385645|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6444876|NCT00385645|Zidovudine|zidovudine|mesh-list
6444877|NCT00385645|Lamivudine|lamivudine|mesh-list
6444878|NCT00385645|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6020045|NCT00391222|Antiemetics|antiemetics|mesh-ancestor
6020046|NCT00391222|Autonomic Agents|autonomic agents|mesh-ancestor
6020047|NCT00391222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6020048|NCT00391222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6444879|NCT00385645|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6444880|NCT00385645|Protease Inhibitors|protease inhibitors|mesh-ancestor
6444881|NCT00385645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6444882|NCT00385645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567039|NCT00980707|Xhance|xhance|mesh-list
6567040|NCT00980707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6567041|NCT00980707|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6444883|NCT00385645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6444884|NCT00385645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6444885|NCT00385645|Antiviral Agents|antiviral agents|mesh-ancestor
6444886|NCT00385645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6444887|NCT00385645|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6444888|NCT00385645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6444889|NCT00385645|Antimetabolites|antimetabolites|mesh-ancestor
6444890|NCT00385658|Simvastatin|simvastatin|mesh-list
6444891|NCT00385658|Ezetimibe|ezetimibe|mesh-list
6567042|NCT00980707|Autonomic Agents|autonomic agents|mesh-ancestor
6567043|NCT00980707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6567044|NCT00980707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567045|NCT00980707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6567046|NCT00980707|Respiratory System Agents|respiratory system agents|mesh-ancestor
6567047|NCT00980707|Dermatologic Agents|dermatologic agents|mesh-ancestor
6567048|NCT00980707|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6567049|NCT00980850|Vaccines|vaccines|mesh-list
6567050|NCT00980850|Immunologic Factors|immunologic factors|mesh-ancestor
6567051|NCT00980850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567052|NCT00980876|Ciprofloxacin|ciprofloxacin|mesh-list
6567053|NCT00980876|Hydrocortisone|hydrocortisone|mesh-list
6567054|NCT00980876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6567055|NCT00980876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6567056|NCT00980876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6567057|NCT00980876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6567058|NCT00980876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6567059|NCT00980876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6567060|NCT00980876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444892|NCT00385658|Fenofibrate|fenofibrate|mesh-list
6567061|NCT00980876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6567062|NCT00980876|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6567063|NCT00980876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6567064|NCT00981006|Mitogens|mitogens|mesh-list
6567065|NCT00981006|Mitosis Modulators|mitosis modulators|mesh-ancestor
6567066|NCT00981006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567067|NCT00981162|Everolimus|everolimus|mesh-list
6567068|NCT00981162|Sorafenib|sorafenib|mesh-list
6567069|NCT00981162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6567070|NCT00981162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6567071|NCT00981162|Immunologic Factors|immunologic factors|mesh-ancestor
6567072|NCT00981162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567073|NCT00981162|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6567074|NCT00981162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6567075|NCT00981162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567076|NCT00981201|Celecoxib|celecoxib|mesh-list
6567077|NCT00981201|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6567078|NCT00981201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6567079|NCT00981201|Analgesics|analgesics|mesh-ancestor
6567080|NCT00981201|Sensory System Agents|sensory system agents|mesh-ancestor
6567081|NCT00981201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6567082|NCT00981201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567083|NCT00981201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6444893|NCT00385658|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6444894|NCT00385658|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6567084|NCT00981201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6567085|NCT00981201|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6567086|NCT00981201|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6567087|NCT00981201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6567088|NCT00981201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567089|NCT00981318|Ritonavir|ritonavir|mesh-list
6567090|NCT00981318|Lopinavir|lopinavir|mesh-list
6567091|NCT00981318|Maraviroc|maraviroc|mesh-list
6567092|NCT00981318|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6567093|NCT00981318|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6567094|NCT00981318|Protease Inhibitors|protease inhibitors|mesh-ancestor
6567095|NCT00981318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6567096|NCT00981318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567097|NCT00981318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6567098|NCT00981318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6567099|NCT00981318|Antiviral Agents|antiviral agents|mesh-ancestor
6567100|NCT00981318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6567101|NCT00981318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6567102|NCT00981318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6567103|NCT00981318|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6567104|NCT00981318|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6567105|NCT00981318|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6567106|NCT00981487|Ondansetron|ondansetron|mesh-list
6567107|NCT00981487|Antiemetics|antiemetics|mesh-ancestor
6567108|NCT00981487|Autonomic Agents|autonomic agents|mesh-ancestor
6567109|NCT00981487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6567110|NCT00981487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567111|NCT00981487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6567112|NCT00981487|Antipruritics|antipruritics|mesh-ancestor
6567113|NCT00981487|Dermatologic Agents|dermatologic agents|mesh-ancestor
6567114|NCT00981487|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6567115|NCT00981487|Serotonin Agents|serotonin agents|mesh-ancestor
6567116|NCT00981487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6567117|NCT00981487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567118|NCT00981487|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6567119|NCT00981487|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6567120|NCT00981487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6567121|NCT00981487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6567122|NCT00981487|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6567123|NCT00981513|Vaccines|vaccines|mesh-list
6567124|NCT00981513|Immunologic Factors|immunologic factors|mesh-ancestor
6567125|NCT00981513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567126|NCT00981591|Iloprost|iloprost|mesh-list
6567127|NCT00981591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6567128|NCT00981591|Vasodilator Agents|vasodilator agents|mesh-ancestor
6567129|NCT00981656|Fluorouracil|fluorouracil|mesh-list
6567130|NCT00981656|Mitomycins|mitomycins|mesh-list
6567131|NCT00981656|Mitomycin|mitomycin|mesh-list
6567132|NCT00981656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6567133|NCT00981656|Antimetabolites|antimetabolites|mesh-ancestor
6567134|NCT00981656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567135|NCT00981656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6567136|NCT00981656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6567137|NCT00981656|Immunologic Factors|immunologic factors|mesh-ancestor
6567138|NCT00981656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567139|NCT00981656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6567140|NCT00981656|Alkylating Agents|alkylating agents|mesh-ancestor
6567141|NCT00981656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6020049|NCT00391222|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6020050|NCT00391222|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6020051|NCT00391222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6567142|NCT00981656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6567143|NCT00981708|Dexamethasone|dexamethasone|mesh-list
6567144|NCT00981708|Dexamethasone acetate|dexamethasone acetate|mesh-list
6567145|NCT00981708|Cyclophosphamide|cyclophosphamide|mesh-list
6567146|NCT00981708|Lenalidomide|lenalidomide|mesh-list
6567147|NCT00981708|BB 1101|bb 1101|mesh-list
6567148|NCT00981708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6567149|NCT00981708|Immunologic Factors|immunologic factors|mesh-ancestor
6567150|NCT00981708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567151|NCT00981708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6567152|NCT00981708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6567153|NCT00981708|Alkylating Agents|alkylating agents|mesh-ancestor
6567154|NCT00981708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567155|NCT00981708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6567156|NCT00981708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6567157|NCT00981708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6567158|NCT00981708|Antiemetics|antiemetics|mesh-ancestor
6567159|NCT00981708|Autonomic Agents|autonomic agents|mesh-ancestor
6567160|NCT00981708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6567161|NCT00981708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6567162|NCT00981708|Glucocorticoids|glucocorticoids|mesh-ancestor
6567163|NCT00981708|Hormones|hormones|mesh-ancestor
6020052|NCT00391274|Docetaxel|docetaxel|mesh-list
6020053|NCT00391274|Pemetrexed|pemetrexed|mesh-list
6020054|NCT00391274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6020055|NCT00391274|Tubulin Modulators|tubulin modulators|mesh-ancestor
6020056|NCT00391274|Antimitotic Agents|antimitotic agents|mesh-ancestor
6020057|NCT00391274|Mitosis Modulators|mitosis modulators|mesh-ancestor
6020058|NCT00391274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567164|NCT00981708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6567165|NCT00981708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6567166|NCT00981708|Protease Inhibitors|protease inhibitors|mesh-ancestor
6567167|NCT00981708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6567168|NCT00981708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6567169|NCT00981708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6567170|NCT00981708|Growth Substances|growth substances|mesh-ancestor
6567171|NCT00981708|Growth Inhibitors|growth inhibitors|mesh-ancestor
6567172|NCT00981721|Cediranib|cediranib|mesh-list
6567173|NCT00981721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6567174|NCT00981721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6567175|NCT00981721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6567176|NCT00981721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567177|NCT00981773|Maraviroc|maraviroc|mesh-list
6567178|NCT00981773|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6567179|NCT00981773|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6567180|NCT00981773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567181|NCT00981773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6567182|NCT00981773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6567183|NCT00981773|Antiviral Agents|antiviral agents|mesh-ancestor
6567184|NCT00981773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6567185|NCT00981773|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6567186|NCT00981786|Timolol|timolol|mesh-list
6567187|NCT00981786|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6567188|NCT00981786|Travoprost|travoprost|mesh-list
6567189|NCT00981786|Brinzolamide|brinzolamide|mesh-list
6567190|NCT00981786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6567191|NCT00981786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6567192|NCT00981786|Adrenergic Agents|adrenergic agents|mesh-ancestor
6567193|NCT00981786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6567194|NCT00981786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567195|NCT00981786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567196|NCT00981786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6567197|NCT00981786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6567198|NCT00981786|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6567199|NCT00981786|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6567200|NCT00981786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6567201|NCT00981786|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6567202|NCT00981786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6657376|NCT01475877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6657377|NCT01475877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6657378|NCT01475877|Analgesics|analgesics|mesh-ancestor
6657379|NCT01475877|Sensory System Agents|sensory system agents|mesh-ancestor
6657380|NCT01475877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6657381|NCT01475877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657382|NCT01475877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6657383|NCT01475877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6657384|NCT01475890|Vitamin D|vitamin d|mesh-list
6657385|NCT01475890|Cholecalciferol|cholecalciferol|mesh-list
6657386|NCT01475890|Vitamins|vitamins|mesh-ancestor
6657387|NCT01475890|Micronutrients|micronutrients|mesh-ancestor
6657388|NCT01475890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657389|NCT01475890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6657390|NCT01475890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6657391|NCT01476007|Vitamins|vitamins|mesh-list
6657392|NCT01476007|Hydroxocobalamin|hydroxocobalamin|mesh-list
6657393|NCT01476007|Vitamin B 12|vitamin b 12|mesh-list
6657394|NCT01476007|Vitamin B Complex|vitamin b complex|mesh-list
6657395|NCT01476007|Micronutrients|micronutrients|mesh-ancestor
6657396|NCT01476007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657397|NCT01476007|Hematinics|hematinics|mesh-ancestor
6657398|NCT01476124|Morphine|morphine|mesh-list
6657399|NCT01476124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6657400|NCT01476124|Narcotics|narcotics|mesh-ancestor
6657401|NCT01476124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6657402|NCT01476124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657403|NCT01476124|Analgesics|analgesics|mesh-ancestor
6657404|NCT01476124|Sensory System Agents|sensory system agents|mesh-ancestor
6657405|NCT01476124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6657406|NCT01476137|Trametinib|trametinib|mesh-list
6657407|NCT01476137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6657408|NCT01476137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6657409|NCT01476137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6657410|NCT01476137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657411|NCT01476176|Acetaminophen|acetaminophen|mesh-list
6657412|NCT01476176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6567203|NCT00981838|Rituximab|rituximab|mesh-list
6567204|NCT00981838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6567205|NCT00981838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6567206|NCT00981838|Immunologic Factors|immunologic factors|mesh-ancestor
6567207|NCT00981838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567208|NCT00981838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6567209|NCT00981851|Albuterol|albuterol|mesh-list
6567210|NCT00981851|Tiotropium Bromide|tiotropium bromide|mesh-list
6567211|NCT00981851|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6567212|NCT00981851|Autonomic Agents|autonomic agents|mesh-ancestor
6567213|NCT00981851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6567214|NCT00981851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567215|NCT00981851|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6567216|NCT00981851|Respiratory System Agents|respiratory system agents|mesh-ancestor
6567217|NCT00981851|Parasympatholytics|parasympatholytics|mesh-ancestor
6567218|NCT00981851|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6567219|NCT00981851|Cholinergic Agents|cholinergic agents|mesh-ancestor
6567220|NCT00981851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6567221|NCT00981851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567222|NCT00981851|Tocolytic Agents|tocolytic agents|mesh-ancestor
6567223|NCT00981851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6567224|NCT00981851|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6567225|NCT00981851|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6567226|NCT00981851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6567227|NCT00981851|Adrenergic Agents|adrenergic agents|mesh-ancestor
6567228|NCT00981890|Sunitinib|sunitinib|mesh-list
6567229|NCT00981890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6567230|NCT00981890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6567231|NCT00981890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6567232|NCT00981890|Growth Substances|growth substances|mesh-ancestor
6567233|NCT00981890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567234|NCT00981890|Growth Inhibitors|growth inhibitors|mesh-ancestor
6567235|NCT00981890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6567236|NCT00981890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6567237|NCT00981890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567238|NCT00981903|Tinzaparin|tinzaparin|mesh-list
6567239|NCT00981903|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6567240|NCT00981903|Dalteparin|dalteparin|mesh-list
6567241|NCT00981903|Anticoagulants|anticoagulants|mesh-ancestor
6567242|NCT00981903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6567243|NCT00981903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6567244|NCT00981903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567245|NCT00981929|Losartan|losartan|mesh-list
6567246|NCT00981929|Tramadol|tramadol|mesh-list
6567247|NCT00981929|Caffeine|caffeine|mesh-list
6567248|NCT00981929|Omeprazole|omeprazole|mesh-list
6567249|NCT00981929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6567250|NCT00981929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6567251|NCT00981929|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6567252|NCT00981929|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6567253|NCT00981929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567254|NCT00981929|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6567255|NCT00981929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6567256|NCT00981929|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6567257|NCT00981929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6567258|NCT00981929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6567259|NCT00981929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567260|NCT00981929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6567261|NCT00981929|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6567262|NCT00981929|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6567263|NCT00981929|Purinergic Agents|purinergic agents|mesh-ancestor
6567264|NCT00981929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6567265|NCT00981929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6567266|NCT00981929|Narcotics|narcotics|mesh-ancestor
6567267|NCT00981929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6567268|NCT00981929|Analgesics|analgesics|mesh-ancestor
6567269|NCT00981929|Sensory System Agents|sensory system agents|mesh-ancestor
6567270|NCT00981929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6567271|NCT00981942|Imatinib Mesylate|imatinib mesylate|mesh-list
6567272|NCT00981942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6567273|NCT00981942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6567274|NCT00981942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6567275|NCT00981942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567276|NCT00981955|Caffeine|caffeine|mesh-list
6567277|NCT00981955|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6567278|NCT00981955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567279|NCT00981955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6567280|NCT00981955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6567281|NCT00981955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567282|NCT00981955|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6567283|NCT00981955|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6567284|NCT00981955|Purinergic Agents|purinergic agents|mesh-ancestor
6567285|NCT00981955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6567286|NCT00981968|Sitaxsentan|sitaxsentan|mesh-list
6567287|NCT00981968|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6567288|NCT00981968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567289|NCT00982046|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6567290|NCT00982124|Zoledronic Acid|zoledronic acid|mesh-list
6567291|NCT00982124|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6567292|NCT00982124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567293|NCT00982202|Pioglitazone|pioglitazone|mesh-list
6567294|NCT00982202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6567295|NCT00982202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567296|NCT00982215|Acetaminophen|acetaminophen|mesh-list
6567297|NCT00982215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6567298|NCT00982215|Analgesics|analgesics|mesh-ancestor
6567299|NCT00982215|Sensory System Agents|sensory system agents|mesh-ancestor
6567300|NCT00982215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6567301|NCT00982215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567302|NCT00982215|Antipyretics|antipyretics|mesh-ancestor
6567303|NCT00982254|Insulin|insulin|mesh-list
6567304|NCT00982254|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6567305|NCT00982254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6567306|NCT00982254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567307|NCT00982332|Betamethasone|betamethasone|mesh-list
6567308|NCT00982332|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
6567309|NCT00982332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6567310|NCT00982332|Glucocorticoids|glucocorticoids|mesh-ancestor
6567311|NCT00982332|Hormones|hormones|mesh-ancestor
6567312|NCT00982332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6567313|NCT00982332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567314|NCT00982332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6567315|NCT00982332|Respiratory System Agents|respiratory system agents|mesh-ancestor
6567316|NCT00982358|Valsartan|valsartan|mesh-list
6567317|NCT00982358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6567318|NCT00982358|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6567319|NCT00982358|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6567320|NCT00982358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567321|NCT00982436|Carboplatin|carboplatin|mesh-list
6567322|NCT00982436|Docetaxel|docetaxel|mesh-list
6567323|NCT00982436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6567324|NCT00982436|Tubulin Modulators|tubulin modulators|mesh-ancestor
6567325|NCT00982436|Antimitotic Agents|antimitotic agents|mesh-ancestor
6567326|NCT00982436|Mitosis Modulators|mitosis modulators|mesh-ancestor
6567327|NCT00982436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567328|NCT00982449|Fialuridine|fialuridine|mesh-list
6567329|NCT00982449|Antiviral Agents|antiviral agents|mesh-ancestor
6567330|NCT00982449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6567331|NCT00982449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6567332|NCT00982449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6567333|NCT00982449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567334|NCT00982527|Fenoldopam|fenoldopam|mesh-list
6567335|NCT00982527|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6567336|NCT00982527|Vasodilator Agents|vasodilator agents|mesh-ancestor
6567337|NCT00982527|Dopamine Agonists|dopamine agonists|mesh-ancestor
6567338|NCT00982527|Dopamine Agents|dopamine agents|mesh-ancestor
6567339|NCT00982527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6567340|NCT00982527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567341|NCT00982527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567342|NCT00982540|Caspofungin|caspofungin|mesh-list
6567343|NCT00982540|Antifungal Agents|antifungal agents|mesh-list
6567344|NCT00982540|Clotrimazole|clotrimazole|mesh-list
6567345|NCT00982540|Miconazole|miconazole|mesh-list
6567346|NCT00982540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6567347|NCT00982540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6567348|NCT00982540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567349|NCT00982540|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6567350|NCT00982540|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6567351|NCT00982540|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6567352|NCT00982540|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6567353|NCT00982540|Hormone Antagonists|hormone antagonists|mesh-ancestor
6567354|NCT00982540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6567355|NCT00982540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567356|NCT00982540|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6567357|NCT00982540|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6567358|NCT00982566|Navitoclax|navitoclax|mesh-list
6567359|NCT00982566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6567360|NCT00982618|Lidocaine|lidocaine|mesh-list
6567361|NCT00982618|Morphine|morphine|mesh-list
6567362|NCT00982618|Anesthetics, Local|anesthetics, local|mesh-list
6567363|NCT00982618|Anesthetics|anesthetics|mesh-list
6567364|NCT00982618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6567365|NCT00982618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567366|NCT00982618|Sensory System Agents|sensory system agents|mesh-ancestor
6567367|NCT00982618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6567368|NCT00982618|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6567369|NCT00982618|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6567370|NCT00982618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6567371|NCT00982618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6567372|NCT00982618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567373|NCT00982618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6567374|NCT00982618|Narcotics|narcotics|mesh-ancestor
6567375|NCT00982618|Analgesics|analgesics|mesh-ancestor
6567376|NCT00982631|Sirolimus|sirolimus|mesh-list
6567377|NCT00982631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6567378|NCT00982631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6567379|NCT00982631|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6567380|NCT00982631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6567381|NCT00982631|Antifungal Agents|antifungal agents|mesh-ancestor
6567382|NCT00982631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6567383|NCT00982631|Immunologic Factors|immunologic factors|mesh-ancestor
6444895|NCT00385658|Antimetabolites|antimetabolites|mesh-ancestor
6444896|NCT00385658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444897|NCT00385658|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6444898|NCT00385658|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6444899|NCT00385658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6444900|NCT00385710|Valproic Acid|valproic acid|mesh-list
6444901|NCT00385710|Anticonvulsants|anticonvulsants|mesh-ancestor
6444902|NCT00385710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6444903|NCT00385710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444904|NCT00385710|GABA Agents|gaba agents|mesh-ancestor
6444905|NCT00385710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6444906|NCT00385710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444907|NCT00385710|Antimanic Agents|antimanic agents|mesh-ancestor
6444908|NCT00385710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6444909|NCT00385710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6444910|NCT00385710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6444911|NCT00385853|Temozolomide|temozolomide|mesh-list
6444912|NCT00385853|Vatalanib|vatalanib|mesh-list
6444913|NCT00385853|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6444914|NCT00385853|Alkylating Agents|alkylating agents|mesh-ancestor
6444915|NCT00385853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444916|NCT00385853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6567384|NCT00982631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567385|NCT00982722|Calcium, Dietary|calcium, dietary|mesh-list
6567386|NCT00982722|Cholecalciferol|cholecalciferol|mesh-list
6567387|NCT00982722|Calcium Carbonate|calcium carbonate|mesh-list
6567388|NCT00982722|Calcium|calcium|mesh-list
6567389|NCT00982722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6567390|NCT00982722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567391|NCT00982722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6567392|NCT00982722|Vitamins|vitamins|mesh-ancestor
6567393|NCT00982722|Micronutrients|micronutrients|mesh-ancestor
6567394|NCT00982722|Antacids|antacids|mesh-ancestor
6567395|NCT00982722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567396|NCT00982722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6567397|NCT00982800|Gabapentin|gabapentin|mesh-list
6567398|NCT00982800|Analgesics|analgesics|mesh-ancestor
6567399|NCT00982800|Sensory System Agents|sensory system agents|mesh-ancestor
6567400|NCT00982800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6567401|NCT00982800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567402|NCT00982800|Anticonvulsants|anticonvulsants|mesh-ancestor
6567403|NCT00982800|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6567404|NCT00982800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6567405|NCT00982800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6567406|NCT00982800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6567407|NCT00982800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6657413|NCT01476176|Analgesics|analgesics|mesh-ancestor
6567408|NCT00982800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6567409|NCT00982800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6567410|NCT00982800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567411|NCT00982800|Antimanic Agents|antimanic agents|mesh-ancestor
6567412|NCT00982891|Morphine|morphine|mesh-list
6567413|NCT00982891|Hydromorphone|hydromorphone|mesh-list
6567414|NCT00982891|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6567415|NCT00982891|Narcotics|narcotics|mesh-ancestor
6567416|NCT00982891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6567417|NCT00982891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567418|NCT00982891|Analgesics|analgesics|mesh-ancestor
6567419|NCT00982891|Sensory System Agents|sensory system agents|mesh-ancestor
6567420|NCT00982891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6567421|NCT00983021|Insulin|insulin|mesh-list
6567422|NCT00983021|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6567423|NCT00983021|Liraglutide|liraglutide|mesh-list
6567424|NCT00983021|Insulin, Long-Acting|insulin, long-acting|mesh-list
6567425|NCT00983021|Xultophy|xultophy|mesh-list
6567426|NCT00983021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6567427|NCT00983021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567428|NCT00983021|Incretins|incretins|mesh-ancestor
6567429|NCT00983021|Hormones|hormones|mesh-ancestor
6567430|NCT00983021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6567431|NCT00983034|Amoxicillin|amoxicillin|mesh-list
6567432|NCT00983034|Clarithromycin|clarithromycin|mesh-list
6567433|NCT00983034|Lansoprazole|lansoprazole|mesh-list
6567434|NCT00983034|Dexlansoprazole|dexlansoprazole|mesh-list
6567435|NCT00983034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6567436|NCT00983034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6567437|NCT00983034|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6567438|NCT00983034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6567439|NCT00983034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567440|NCT00983034|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6567441|NCT00983034|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6567442|NCT00983034|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6567443|NCT00983034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6567444|NCT00983034|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6567445|NCT00983047|Docetaxel|docetaxel|mesh-list
6567446|NCT00983047|Nimotuzumab|nimotuzumab|mesh-list
6567447|NCT00983047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6567448|NCT00983047|Tubulin Modulators|tubulin modulators|mesh-ancestor
6567449|NCT00983047|Antimitotic Agents|antimitotic agents|mesh-ancestor
6567450|NCT00983047|Mitosis Modulators|mitosis modulators|mesh-ancestor
6567451|NCT00983047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567452|NCT00983047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6567453|NCT00983112|Thrombin|thrombin|mesh-list
6567454|NCT00983112|Hemostatics|hemostatics|mesh-ancestor
6567455|NCT00983112|Coagulants|coagulants|mesh-ancestor
6567456|NCT00983125|Clonidine|clonidine|mesh-list
6567457|NCT00983125|Analgesics|analgesics|mesh-ancestor
6567458|NCT00983125|Sensory System Agents|sensory system agents|mesh-ancestor
6567459|NCT00983125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6567460|NCT00983125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567461|NCT00983125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6567462|NCT00983125|Sympatholytics|sympatholytics|mesh-ancestor
6567463|NCT00983125|Autonomic Agents|autonomic agents|mesh-ancestor
6567464|NCT00983125|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6567465|NCT00983125|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6567466|NCT00983125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6567467|NCT00983125|Adrenergic Agents|adrenergic agents|mesh-ancestor
6567468|NCT00983125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6567469|NCT00983125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567470|NCT00983138|Asparaginase|asparaginase|mesh-list
6567471|NCT00983138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6567472|NCT00983151|Tramadol|tramadol|mesh-list
6567473|NCT00983151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6567474|NCT00983151|Narcotics|narcotics|mesh-ancestor
6567475|NCT00983151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6567476|NCT00983151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567477|NCT00983151|Analgesics|analgesics|mesh-ancestor
6567478|NCT00983151|Sensory System Agents|sensory system agents|mesh-ancestor
6567479|NCT00983151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6567480|NCT00983164|Antioxidants|antioxidants|mesh-list
6567481|NCT00983164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567482|NCT00983164|Protective Agents|protective agents|mesh-ancestor
6567483|NCT00983164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567484|NCT00983177|Colchicine|colchicine|mesh-list
6567485|NCT00983177|Gout Suppressants|gout suppressants|mesh-ancestor
6567486|NCT00983177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6567487|NCT00983177|Tubulin Modulators|tubulin modulators|mesh-ancestor
6567488|NCT00983177|Antimitotic Agents|antimitotic agents|mesh-ancestor
6567489|NCT00983177|Mitosis Modulators|mitosis modulators|mesh-ancestor
6567490|NCT00983177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567491|NCT00983177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6567492|NCT00983203|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6567493|NCT00983203|Lubricant Eye Drops|lubricant eye drops|mesh-list
6567494|NCT00983203|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6567495|NCT00983255|Tedizolid phosphate|tedizolid phosphate|mesh-list
6567496|NCT00983255|Tedizolid|tedizolid|mesh-list
6567497|NCT00983255|Oxazolidinones|oxazolidinones|mesh-list
6567498|NCT00983255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6567499|NCT00983255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6567500|NCT00983255|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6567501|NCT00983255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6567502|NCT00983255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567503|NCT00983268|Capecitabine|capecitabine|mesh-list
6567504|NCT00983268|Vorinostat|vorinostat|mesh-list
6567505|NCT00983268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6567506|NCT00983268|Antimetabolites|antimetabolites|mesh-ancestor
6567507|NCT00983268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567508|NCT00983268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6567509|NCT00983268|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6567510|NCT00983268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6567511|NCT00983320|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6567512|NCT00983320|Antidepressive Agents|antidepressive agents|mesh-ancestor
6567513|NCT00983320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6567514|NCT00983320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6567515|NCT00983320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6567516|NCT00983320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6567517|NCT00983320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567518|NCT00983398|Sodium thiosulfate|sodium thiosulfate|mesh-list
6567519|NCT00983398|Carboplatin|carboplatin|mesh-list
6567520|NCT00983398|Melphalan|melphalan|mesh-list
6567521|NCT00983398|Mechlorethamine|mechlorethamine|mesh-list
6567522|NCT00983398|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
6567523|NCT00983398|Mannitol|mannitol|mesh-list
6567524|NCT00983398|Antidotes|antidotes|mesh-list
6567525|NCT00983398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6567526|NCT00983398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6567527|NCT00983398|Alkylating Agents|alkylating agents|mesh-ancestor
6567528|NCT00983398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567529|NCT00983398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6567530|NCT00983398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6567531|NCT00983398|Immunologic Factors|immunologic factors|mesh-ancestor
6567532|NCT00983398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567533|NCT00983398|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6567534|NCT00983398|Diuretics|diuretics|mesh-ancestor
6567535|NCT00983398|Natriuretic Agents|natriuretic agents|mesh-ancestor
6567536|NCT00983398|Protective Agents|protective agents|mesh-ancestor
6567537|NCT00983398|Antioxidants|antioxidants|mesh-ancestor
6567538|NCT00983398|Antitubercular Agents|antitubercular agents|mesh-ancestor
6567539|NCT00983398|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6567540|NCT00983398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6567541|NCT00983398|Chelating Agents|chelating agents|mesh-ancestor
6567542|NCT00983398|Sequestering Agents|sequestering agents|mesh-ancestor
6567543|NCT00983424|Cyclosporine|cyclosporine|mesh-list
6567544|NCT00983424|Paclitaxel|paclitaxel|mesh-list
5503681|NCT04456777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6567545|NCT00983424|Cyclosporins|cyclosporins|mesh-list
6567546|NCT00983424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6567547|NCT00983424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6567548|NCT00983424|Tubulin Modulators|tubulin modulators|mesh-ancestor
6567549|NCT00983424|Antimitotic Agents|antimitotic agents|mesh-ancestor
6567550|NCT00983424|Mitosis Modulators|mitosis modulators|mesh-ancestor
6567551|NCT00983424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567552|NCT00983424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6567553|NCT00983424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6567554|NCT00983424|Immunologic Factors|immunologic factors|mesh-ancestor
6567555|NCT00983424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567556|NCT00983424|Antifungal Agents|antifungal agents|mesh-ancestor
6567557|NCT00983424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6567558|NCT00983424|Dermatologic Agents|dermatologic agents|mesh-ancestor
6567559|NCT00983424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6567560|NCT00983424|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6567561|NCT00983450|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6567562|NCT00983450|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
6567563|NCT00983450|beta-Endorphin|beta-endorphin|mesh-list
6567564|NCT00983450|Hormones|hormones|mesh-ancestor
6567565|NCT00983450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6567566|NCT00983450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567567|NCT00983450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6567568|NCT00983450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567569|NCT00983554|Anastrozole|anastrozole|mesh-list
6567570|NCT00983554|Testosterone|testosterone|mesh-list
6567571|NCT00983554|Dutasteride|dutasteride|mesh-list
6567572|NCT00983554|Androgens|androgens|mesh-ancestor
6567573|NCT00983554|Hormones|hormones|mesh-ancestor
6567574|NCT00983554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6567575|NCT00983554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567576|NCT00983554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6567577|NCT00983554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6567578|NCT00983554|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6567579|NCT00983554|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6567580|NCT00983554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6567581|NCT00983554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567582|NCT00983554|Hormone Antagonists|hormone antagonists|mesh-ancestor
6567583|NCT00983554|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6567584|NCT00983554|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6567585|NCT00983697|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6567586|NCT00983697|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6567587|NCT00983697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657414|NCT01476176|Sensory System Agents|sensory system agents|mesh-ancestor
6657415|NCT01476176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6657416|NCT01476176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657417|NCT01476176|Antipyretics|antipyretics|mesh-ancestor
6657418|NCT01476189|Acetaminophen|acetaminophen|mesh-list
6657419|NCT01476189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6657420|NCT01476189|Analgesics|analgesics|mesh-ancestor
6657421|NCT01476189|Sensory System Agents|sensory system agents|mesh-ancestor
6657422|NCT01476189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6657423|NCT01476189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657424|NCT01476189|Antipyretics|antipyretics|mesh-ancestor
6657425|NCT01476215|Acetaminophen|acetaminophen|mesh-list
6657426|NCT01476215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6657427|NCT01476215|Analgesics|analgesics|mesh-ancestor
6657428|NCT01476215|Sensory System Agents|sensory system agents|mesh-ancestor
6657429|NCT01476215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6657430|NCT01476215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657431|NCT01476215|Antipyretics|antipyretics|mesh-ancestor
6657432|NCT01476280|Palonosetron|palonosetron|mesh-list
6657433|NCT01476280|Ramosetron|ramosetron|mesh-list
6657434|NCT01476280|Antiemetics|antiemetics|mesh-ancestor
6657435|NCT01476280|Autonomic Agents|autonomic agents|mesh-ancestor
6657436|NCT01476280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6657437|NCT01476280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657438|NCT01476280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6657439|NCT01476280|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6657440|NCT01476280|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6657441|NCT01476280|Serotonin Agents|serotonin agents|mesh-ancestor
6657442|NCT01476280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6657443|NCT01476280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657444|NCT01476332|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6444917|NCT00385853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6444918|NCT00385853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6444919|NCT00385931|Valsartan|valsartan|mesh-list
6444920|NCT00385931|Simvastatin|simvastatin|mesh-list
6444921|NCT00385931|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6444922|NCT00385931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6444923|NCT00385931|Antimetabolites|antimetabolites|mesh-ancestor
6444924|NCT00385931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444925|NCT00385931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6444926|NCT00385931|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6444927|NCT00385931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6444928|NCT00385931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6444929|NCT00385931|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6444930|NCT00385931|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6444931|NCT00385957|Lamivudine|lamivudine|mesh-list
6444932|NCT00385957|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6444933|NCT00385957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6444934|NCT00385957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6657445|NCT01476332|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6657446|NCT01476358|Vitamin A|vitamin a|mesh-list
6657447|NCT01476358|Retinol palmitate|retinol palmitate|mesh-list
6657448|NCT01476358|Vitamins|vitamins|mesh-ancestor
6657449|NCT01476358|Micronutrients|micronutrients|mesh-ancestor
6657450|NCT01476358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657451|NCT01476358|Antioxidants|antioxidants|mesh-ancestor
6657452|NCT01476358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657453|NCT01476358|Protective Agents|protective agents|mesh-ancestor
6657454|NCT01476358|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6657455|NCT01476358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6657456|NCT01476410|Doxorubicin|doxorubicin|mesh-list
6657457|NCT01476410|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6657458|NCT01476410|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6657459|NCT01476410|Dacarbazine|dacarbazine|mesh-list
6657460|NCT01476410|Vinblastine|vinblastine|mesh-list
6657461|NCT01476410|Antibodies|antibodies|mesh-list
6657462|NCT01476410|Immunoglobulins|immunoglobulins|mesh-list
6657463|NCT01476410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6657464|NCT01476410|Immunoconjugates|immunoconjugates|mesh-list
6567588|NCT00983736|Tramadol|tramadol|mesh-list
6567589|NCT00983736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6567590|NCT00983736|Narcotics|narcotics|mesh-ancestor
6567591|NCT00983736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6567592|NCT00983736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567593|NCT00983736|Analgesics|analgesics|mesh-ancestor
6567594|NCT00983736|Sensory System Agents|sensory system agents|mesh-ancestor
6567595|NCT00983736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6567596|NCT00983788|Bezafibrate|bezafibrate|mesh-list
6567597|NCT00983788|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6567598|NCT00983788|Antimetabolites|antimetabolites|mesh-ancestor
6567599|NCT00983788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567600|NCT00983788|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6567601|NCT00983944|Prednisone|prednisone|mesh-list
6567602|NCT00983944|Cyclophosphamide|cyclophosphamide|mesh-list
6567603|NCT00983944|Rituximab|rituximab|mesh-list
6567604|NCT00983944|Doxorubicin|doxorubicin|mesh-list
6567605|NCT00983944|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6567606|NCT00983944|Etoposide|etoposide|mesh-list
6567607|NCT00983944|Vincristine|vincristine|mesh-list
6567608|NCT00983944|Bleomycin|bleomycin|mesh-list
6567609|NCT00983944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6567610|NCT00983944|Immunologic Factors|immunologic factors|mesh-ancestor
6567611|NCT00983944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567612|NCT00983944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6567613|NCT00983944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6567614|NCT00983944|Alkylating Agents|alkylating agents|mesh-ancestor
6567615|NCT00983944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567616|NCT00983944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6567617|NCT00983944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6567618|NCT00983944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6567619|NCT00983944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6567620|NCT00983944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6567621|NCT00983944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6567622|NCT00983944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6567623|NCT00983944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6567624|NCT00983944|Glucocorticoids|glucocorticoids|mesh-ancestor
6567625|NCT00983944|Hormones|hormones|mesh-ancestor
6567626|NCT00983944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6567627|NCT00983944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6444935|NCT00385957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444936|NCT00385957|Antiviral Agents|antiviral agents|mesh-ancestor
6444937|NCT00385957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6567628|NCT00983944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6567629|NCT00983944|Tubulin Modulators|tubulin modulators|mesh-ancestor
6567630|NCT00983944|Antimitotic Agents|antimitotic agents|mesh-ancestor
6567631|NCT00983944|Mitosis Modulators|mitosis modulators|mesh-ancestor
6567632|NCT00983996|Alendronate|alendronate|mesh-list
6567633|NCT00983996|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6567634|NCT00983996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567635|NCT00984152|Efavirenz|efavirenz|mesh-list
6567636|NCT00984152|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6567637|NCT00984152|Raltegravir Potassium|raltegravir potassium|mesh-list
6567638|NCT00984152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6567639|NCT00984152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6567640|NCT00984152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6567641|NCT00984152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567642|NCT00984152|Antiviral Agents|antiviral agents|mesh-ancestor
6567643|NCT00984152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6567644|NCT00984152|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6567645|NCT00984152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6567646|NCT00984152|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6567647|NCT00984152|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6567648|NCT00984152|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6567649|NCT00984152|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6567650|NCT00984152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6567651|NCT00984152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6444938|NCT00385957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6444939|NCT00385957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6444940|NCT00385970|Leucovorin|leucovorin|mesh-list
6444941|NCT00385970|polysaccharide-K|polysaccharide-k|mesh-list
6444942|NCT00385970|Tegafur|tegafur|mesh-list
6444943|NCT00385970|Calcium|calcium|mesh-list
6444944|NCT00385970|Levoleucovorin|levoleucovorin|mesh-list
6567652|NCT00984152|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6567653|NCT00984152|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6567654|NCT00984178|Sargramostim|sargramostim|mesh-list
6567655|NCT00984178|Immunologic Factors|immunologic factors|mesh-ancestor
6567656|NCT00984178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567657|NCT00984217|Panitumumab|panitumumab|mesh-list
6567658|NCT00984217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6567659|NCT00984217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6567660|NCT00984230|Lactoferrin|lactoferrin|mesh-list
6567661|NCT00984230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6567662|NCT00984347|Oxytocin|oxytocin|mesh-list
6567663|NCT00984347|Oxytocics|oxytocics|mesh-ancestor
6567664|NCT00984347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6567665|NCT00984347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567666|NCT00984360|Naltrexone|naltrexone|mesh-list
6567667|NCT00984360|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6567668|NCT00984360|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6567669|NCT00984360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567670|NCT00984360|Sensory System Agents|sensory system agents|mesh-ancestor
6567671|NCT00984360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6567672|NCT00984386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6567673|NCT00984386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6567674|NCT00984386|Estradiol|estradiol|mesh-list
6567675|NCT00984386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6567676|NCT00984386|Estrogens|estrogens|mesh-ancestor
6567677|NCT00984386|Hormones|hormones|mesh-ancestor
6567678|NCT00984386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6567679|NCT00984386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567680|NCT00984386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6567681|NCT00984386|Contraceptive Agents|contraceptive agents|mesh-ancestor
6567682|NCT00984386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6567683|NCT00984386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6567684|NCT00984399|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6567685|NCT00984399|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6567686|NCT00984399|Estradiol|estradiol|mesh-list
6567687|NCT00984399|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6567688|NCT00984399|Estrogens|estrogens|mesh-ancestor
6567689|NCT00984399|Hormones|hormones|mesh-ancestor
6567690|NCT00984399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6567691|NCT00984399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567692|NCT00984399|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6567693|NCT00984399|Contraceptive Agents|contraceptive agents|mesh-ancestor
6567694|NCT00984399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6567695|NCT00984399|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6567696|NCT00984425|Sorafenib|sorafenib|mesh-list
6567697|NCT00984425|Lapatinib|lapatinib|mesh-list
6567698|NCT00984425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6567699|NCT00984425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6567700|NCT00984425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6567701|NCT00984425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567702|NCT00984438|Bevacizumab|bevacizumab|mesh-list
6567703|NCT00984438|Irinotecan|irinotecan|mesh-list
6567704|NCT00984438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6567705|NCT00984438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6567706|NCT00984438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6567707|NCT00984438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6567708|NCT00984438|Growth Substances|growth substances|mesh-ancestor
6567709|NCT00984438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567710|NCT00984438|Growth Inhibitors|growth inhibitors|mesh-ancestor
6567711|NCT00984438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6567712|NCT00984438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6567713|NCT00984438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6567714|NCT00984438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567715|NCT00984451|Vaccines|vaccines|mesh-list
6567716|NCT00984451|Immunologic Factors|immunologic factors|mesh-ancestor
6567717|NCT00984451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567718|NCT00984464|Paclitaxel|paclitaxel|mesh-list
6567719|NCT00984464|Carboplatin|carboplatin|mesh-list
6567720|NCT00984464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6567721|NCT00984464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6567722|NCT00984464|Tubulin Modulators|tubulin modulators|mesh-ancestor
6567723|NCT00984464|Antimitotic Agents|antimitotic agents|mesh-ancestor
6567724|NCT00984464|Mitosis Modulators|mitosis modulators|mesh-ancestor
6567725|NCT00984464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567726|NCT00984633|Bromides|bromides|mesh-list
6567727|NCT00984633|Propofol|propofol|mesh-list
6567728|NCT00984633|Sevoflurane|sevoflurane|mesh-list
6567729|NCT00984633|Rocuronium|rocuronium|mesh-list
6567730|NCT00984633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6567731|NCT00984633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6567732|NCT00984633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567733|NCT00984633|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6567734|NCT00984633|Anesthetics, General|anesthetics, general|mesh-ancestor
6567735|NCT00984633|Anesthetics|anesthetics|mesh-ancestor
6567736|NCT00984633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6567737|NCT00984633|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6567738|NCT00984633|Anticonvulsants|anticonvulsants|mesh-ancestor
6567739|NCT00984633|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6567740|NCT00984633|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6567741|NCT00984633|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6567742|NCT00984633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6567743|NCT00984724|Nicotine|nicotine|mesh-list
6567744|NCT00984724|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6567745|NCT00984724|Autonomic Agents|autonomic agents|mesh-ancestor
6567746|NCT00984724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6567747|NCT00984724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567748|NCT00984724|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6567749|NCT00984724|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6567750|NCT00984724|Cholinergic Agents|cholinergic agents|mesh-ancestor
6567751|NCT00984724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6567752|NCT00984724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567753|NCT00984737|Insulin|insulin|mesh-list
6567754|NCT00984737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6657465|NCT01476410|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6020059|NCT00391274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6020060|NCT00391274|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6020061|NCT00391274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6444945|NCT00385970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6444946|NCT00385970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444947|NCT00385970|Antidotes|antidotes|mesh-ancestor
6444948|NCT00385970|Protective Agents|protective agents|mesh-ancestor
6444949|NCT00385970|Vitamin B Complex|vitamin b complex|mesh-ancestor
6444950|NCT00385970|Vitamins|vitamins|mesh-ancestor
6444951|NCT00385970|Micronutrients|micronutrients|mesh-ancestor
6444952|NCT00385970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6444953|NCT00385970|Antimetabolites|antimetabolites|mesh-ancestor
6444954|NCT00385970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444955|NCT00385970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6444956|NCT00385970|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6444957|NCT00385970|Immunologic Factors|immunologic factors|mesh-ancestor
6444958|NCT00385970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6444959|NCT00385970|Antiviral Agents|antiviral agents|mesh-ancestor
6444960|NCT00385970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6444961|NCT00385970|Interferon Inducers|interferon inducers|mesh-ancestor
6567755|NCT00984737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567756|NCT00984750|Acetylcarnitine|acetylcarnitine|mesh-list
6567757|NCT00984750|Simvastatin|simvastatin|mesh-list
6567758|NCT00984750|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6567759|NCT00984750|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6567760|NCT00984750|Antimetabolites|antimetabolites|mesh-ancestor
6567761|NCT00984750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567762|NCT00984750|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6567763|NCT00984750|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6567764|NCT00984750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6567765|NCT00984750|Vitamin B Complex|vitamin b complex|mesh-ancestor
6567766|NCT00984750|Vitamins|vitamins|mesh-ancestor
6567767|NCT00984750|Micronutrients|micronutrients|mesh-ancestor
6567768|NCT00984750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567769|NCT00984750|Nootropic Agents|nootropic agents|mesh-ancestor
6567770|NCT00984763|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6567771|NCT00984763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6567772|NCT00984763|Immunologic Factors|immunologic factors|mesh-ancestor
6567773|NCT00984763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567774|NCT00984763|Antacids|antacids|mesh-ancestor
6567775|NCT00984763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567776|NCT00984763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6567777|NCT00984789|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6567778|NCT00984789|Gestodene|gestodene|mesh-list
6567779|NCT00984789|Norelgestromin|norelgestromin|mesh-list
6567780|NCT00984789|Femovan|femovan|mesh-list
6444962|NCT00385970|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6567781|NCT00984789|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6444963|NCT00386061|Rimonabant|rimonabant|mesh-list
6444964|NCT00386061|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6444965|NCT00386061|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
6444966|NCT00386061|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6444967|NCT00386061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6444968|NCT00386061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444969|NCT00386061|Hormones|hormones|mesh-ancestor
6444970|NCT00386061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6567782|NCT00984789|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6567783|NCT00984789|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6567784|NCT00984789|Contraceptive Agents|contraceptive agents|mesh-ancestor
6567785|NCT00984789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6567786|NCT00984789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567787|NCT00984789|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6567788|NCT00984789|Estrogens|estrogens|mesh-ancestor
6567789|NCT00984789|Hormones|hormones|mesh-ancestor
6567790|NCT00984789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6567791|NCT00984789|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6567792|NCT00984789|Progestins|progestins|mesh-ancestor
6567793|NCT00984789|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6567794|NCT00984828|Bortezomib|bortezomib|mesh-list
6567795|NCT00984828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6567796|NCT00984893|Zoledronic Acid|zoledronic acid|mesh-list
6567797|NCT00984893|Diphosphonates|diphosphonates|mesh-list
6567798|NCT00984893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6567799|NCT00984893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567800|NCT00984932|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6567801|NCT00984932|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6567802|NCT00984932|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6567803|NCT00984932|Antimetabolites|antimetabolites|mesh-ancestor
6567804|NCT00984932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567805|NCT00984932|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6567806|NCT00984932|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6567807|NCT00984932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6567808|NCT00984945|Vaccines|vaccines|mesh-list
6567809|NCT00984945|Immunologic Factors|immunologic factors|mesh-ancestor
6567810|NCT00984945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567811|NCT00984971|Tenofovir|tenofovir|mesh-list
6567812|NCT00984971|Antiviral Agents|antiviral agents|mesh-ancestor
6567813|NCT00984971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6567814|NCT00984971|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6567815|NCT00984971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6567816|NCT00984971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6567817|NCT00984971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567818|NCT00984971|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6567819|NCT00984971|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6567820|NCT00984984|Methylprednisolone|methylprednisolone|mesh-list
6567821|NCT00984984|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6567822|NCT00984984|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6567823|NCT00984984|Prednisolone|prednisolone|mesh-list
6567824|NCT00984984|Prednisolone acetate|prednisolone acetate|mesh-list
6567825|NCT00984984|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6567826|NCT00984984|Prednisolone phosphate|prednisolone phosphate|mesh-list
6567827|NCT00984984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6567828|NCT00984984|Antiemetics|antiemetics|mesh-ancestor
6567829|NCT00984984|Autonomic Agents|autonomic agents|mesh-ancestor
6567830|NCT00984984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6567831|NCT00984984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567832|NCT00984984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6567833|NCT00984984|Glucocorticoids|glucocorticoids|mesh-ancestor
6567834|NCT00984984|Hormones|hormones|mesh-ancestor
6567835|NCT00984984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6567836|NCT00984984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6567837|NCT00984984|Protective Agents|protective agents|mesh-ancestor
6567838|NCT00984984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6567839|NCT00984984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6567840|NCT00984997|Etoposide|etoposide|mesh-list
6567841|NCT00984997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6567842|NCT00984997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6567843|NCT00984997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6567844|NCT00984997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6567845|NCT00984997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6657466|NCT01476410|Immunologic Factors|immunologic factors|mesh-ancestor
6567846|NCT00984997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567847|NCT00985244|Azithromycin|azithromycin|mesh-list
6567848|NCT00985244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6567849|NCT00985244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6567850|NCT00985270|Rifampin|rifampin|mesh-list
6567851|NCT00985270|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6567852|NCT00985270|Antitubercular Agents|antitubercular agents|mesh-ancestor
6567853|NCT00985270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6567854|NCT00985270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6567855|NCT00985270|Leprostatic Agents|leprostatic agents|mesh-ancestor
6567856|NCT00985270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6567857|NCT00985270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6567858|NCT00985270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567859|NCT00985270|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6567860|NCT00985270|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6567861|NCT00985270|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6567862|NCT00985270|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6567863|NCT00985270|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6567864|NCT00985270|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6567865|NCT00985322|Ramipril|ramipril|mesh-list
6567866|NCT00985322|Antihypertensive Agents|antihypertensive agents|mesh-list
6567867|NCT00985322|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6567868|NCT00985322|Protease Inhibitors|protease inhibitors|mesh-ancestor
6567869|NCT00985322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6567870|NCT00985322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567871|NCT00985348|Levetiracetam|levetiracetam|mesh-list
6567872|NCT00985348|Anticonvulsants|anticonvulsants|mesh-ancestor
6567873|NCT00985348|Nootropic Agents|nootropic agents|mesh-ancestor
6567874|NCT00985361|Vitamin D|vitamin d|mesh-list
6567875|NCT00985361|Cholecalciferol|cholecalciferol|mesh-list
6567876|NCT00985361|Vitamins|vitamins|mesh-list
6567877|NCT00985361|Ascorbic Acid|ascorbic acid|mesh-list
6567878|NCT00985361|Micronutrients|micronutrients|mesh-ancestor
6567879|NCT00985361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567880|NCT00985361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6567881|NCT00985361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6567882|NCT00985361|Antioxidants|antioxidants|mesh-ancestor
6567883|NCT00985361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567884|NCT00985361|Protective Agents|protective agents|mesh-ancestor
6567885|NCT00985374|Everolimus|everolimus|mesh-list
6567886|NCT00985374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6567887|NCT00985374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6567888|NCT00985374|Immunologic Factors|immunologic factors|mesh-ancestor
6567889|NCT00985374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567890|NCT00985387|Solifenacin Succinate|solifenacin succinate|mesh-list
6567891|NCT00985387|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6567892|NCT00985387|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6567893|NCT00985387|Cholinergic Agents|cholinergic agents|mesh-ancestor
6567894|NCT00985387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6567895|NCT00985387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567896|NCT00985387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567897|NCT00985387|Urological Agents|urological agents|mesh-ancestor
6567898|NCT00985530|Arsenic Trioxide|arsenic trioxide|mesh-list
6567899|NCT00985530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6567900|NCT00985556|Capecitabine|capecitabine|mesh-list
6567901|NCT00985556|Tegafur|tegafur|mesh-list
6567902|NCT00985556|Oxaliplatin|oxaliplatin|mesh-list
6567903|NCT00985556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6567904|NCT00985556|Antimetabolites|antimetabolites|mesh-ancestor
6567905|NCT00985556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567906|NCT00985556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6567907|NCT00985608|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6567908|NCT00985608|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6567909|NCT00985608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6567910|NCT00985608|Antitubercular Agents|antitubercular agents|mesh-ancestor
6567911|NCT00985647|Lamivudine|lamivudine|mesh-list
6567912|NCT00985647|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6567913|NCT00985647|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6567914|NCT00985647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6567915|NCT00985647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567916|NCT00985647|Antiviral Agents|antiviral agents|mesh-ancestor
6567917|NCT00985647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6567918|NCT00985647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6567919|NCT00985647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6567920|NCT00985660|Nisoldipine|nisoldipine|mesh-list
6567921|NCT00985660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6567922|NCT00985660|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6567923|NCT00985660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6567924|NCT00985660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567925|NCT00985660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6567926|NCT00985660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567927|NCT00985660|Vasodilator Agents|vasodilator agents|mesh-ancestor
6567928|NCT00985777|Vitamin E|vitamin e|mesh-list
6567929|NCT00985777|Tocopherols|tocopherols|mesh-list
6567930|NCT00985777|Tocotrienols|tocotrienols|mesh-list
6567931|NCT00985777|Vitamins|vitamins|mesh-ancestor
6567932|NCT00985777|Micronutrients|micronutrients|mesh-ancestor
6567933|NCT00985777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567934|NCT00985777|Antioxidants|antioxidants|mesh-ancestor
6567935|NCT00985777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567936|NCT00985777|Protective Agents|protective agents|mesh-ancestor
6657467|NCT01476410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657468|NCT01476410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6657469|NCT01476410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6657470|NCT01476410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6657471|NCT01476410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6657472|NCT01476410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6657473|NCT01476410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657474|NCT01476410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6657475|NCT01476410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6657476|NCT01476410|Alkylating Agents|alkylating agents|mesh-ancestor
6657477|NCT01476410|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6657478|NCT01476410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6657479|NCT01476410|Tubulin Modulators|tubulin modulators|mesh-ancestor
6657480|NCT01476410|Antimitotic Agents|antimitotic agents|mesh-ancestor
6657481|NCT01476410|Mitosis Modulators|mitosis modulators|mesh-ancestor
6657482|NCT01476488|Tacrolimus|tacrolimus|mesh-list
6657483|NCT01476488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6657484|NCT01476488|Immunologic Factors|immunologic factors|mesh-ancestor
6657485|NCT01476488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657486|NCT01476488|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6657487|NCT01476488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6657488|NCT01476488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657489|NCT01476501|Vitamin D|vitamin d|mesh-list
6657490|NCT01476501|Cholecalciferol|cholecalciferol|mesh-list
6657491|NCT01476501|Vitamins|vitamins|mesh-ancestor
6657492|NCT01476501|Micronutrients|micronutrients|mesh-ancestor
6657493|NCT01476501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657494|NCT01476501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6567937|NCT00985855|Etoposide|etoposide|mesh-list
6567938|NCT00985855|Cetuximab|cetuximab|mesh-list
6567939|NCT00985855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6567940|NCT00985855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6567941|NCT00985855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6567942|NCT00985855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6567943|NCT00985855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6567944|NCT00985855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567945|NCT00985855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6567946|NCT00985920|Tranexamic Acid|tranexamic acid|mesh-list
6567947|NCT00985920|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6567948|NCT00985920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6567949|NCT00985920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567950|NCT00985920|Hemostatics|hemostatics|mesh-ancestor
6567951|NCT00985920|Coagulants|coagulants|mesh-ancestor
6567952|NCT00985998|Nimotuzumab|nimotuzumab|mesh-list
6567953|NCT00985998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6567954|NCT00985998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6567955|NCT00986037|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6567956|NCT00986037|Immunologic Factors|immunologic factors|mesh-ancestor
6567957|NCT00986037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567958|NCT00986050|Sirolimus|sirolimus|mesh-list
6567959|NCT00986050|Abciximab|abciximab|mesh-list
6567960|NCT00986050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6567961|NCT00986050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6567962|NCT00986050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6567963|NCT00986050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6567964|NCT00986050|Antifungal Agents|antifungal agents|mesh-ancestor
6567965|NCT00986050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6567966|NCT00986050|Immunologic Factors|immunologic factors|mesh-ancestor
6567967|NCT00986050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567968|NCT00986050|Anticoagulants|anticoagulants|mesh-ancestor
6567969|NCT00986050|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6567970|NCT00986076|Enoxaparin|enoxaparin|mesh-list
6567971|NCT00986076|Anticoagulants|anticoagulants|mesh-ancestor
6567972|NCT00986076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6567973|NCT00986076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6567974|NCT00986076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567975|NCT00986115|Memantine|memantine|mesh-list
6567976|NCT00986115|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6567977|NCT00986115|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6567978|NCT00986115|Dopamine Agents|dopamine agents|mesh-ancestor
6567979|NCT00986115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6567980|NCT00986115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6567981|NCT00986115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567982|NCT00986115|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6567983|NCT00986115|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6567984|NCT00986128|Topiramate|topiramate|mesh-list
6567985|NCT00986128|Anticonvulsants|anticonvulsants|mesh-ancestor
5724786|NCT03185143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6444971|NCT00386061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444972|NCT00386074|Fe(III)-EDTA|fe(iii)-edta|mesh-list
6444973|NCT00386074|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6444974|NCT00386074|Chelating Agents|chelating agents|mesh-ancestor
6444975|NCT00386074|Sequestering Agents|sequestering agents|mesh-ancestor
6444976|NCT00386074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444977|NCT00386126|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6444978|NCT00386126|Hematinics|hematinics|mesh-ancestor
6444979|NCT00386178|Vitamin E|vitamin e|mesh-list
6444980|NCT00386178|Tocopherols|tocopherols|mesh-list
6444981|NCT00386178|Tocotrienols|tocotrienols|mesh-list
6444982|NCT00386178|alpha-Tocopherol|alpha-tocopherol|mesh-list
6444983|NCT00386178|gamma-Tocopherol|gamma-tocopherol|mesh-list
6444984|NCT00386178|Vitamins|vitamins|mesh-ancestor
6567986|NCT00986128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6567987|NCT00986128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567988|NCT00986167|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6567989|NCT00986167|Antidepressive Agents|antidepressive agents|mesh-ancestor
6567990|NCT00986167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6567991|NCT00986167|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6567992|NCT00986167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6567993|NCT00986167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6567994|NCT00986167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6567995|NCT00986284|Gefitinib|gefitinib|mesh-list
6567996|NCT00986284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6567997|NCT00986284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6567998|NCT00986284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6567999|NCT00986284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568000|NCT00986336|Topiramate|topiramate|mesh-list
6568001|NCT00986336|Risperidone|risperidone|mesh-list
6568002|NCT00986336|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6568003|NCT00986336|Serotonin Agents|serotonin agents|mesh-ancestor
6568004|NCT00986336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6568005|NCT00986336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568006|NCT00986336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568007|NCT00986336|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6568008|NCT00986336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6568009|NCT00986336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6568010|NCT00986336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6568011|NCT00986336|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6568012|NCT00986336|Dopamine Agents|dopamine agents|mesh-ancestor
6568013|NCT00986336|Anticonvulsants|anticonvulsants|mesh-ancestor
6568014|NCT00986336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6568015|NCT00986466|Vitamin D|vitamin d|mesh-list
6568016|NCT00986466|Ergocalciferols|ergocalciferols|mesh-list
6568017|NCT00986466|Vitamins|vitamins|mesh-list
6568018|NCT00986466|Micronutrients|micronutrients|mesh-ancestor
6568019|NCT00986466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568020|NCT00986466|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6568021|NCT00986466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6568022|NCT00986505|Lidocaine|lidocaine|mesh-list
6568023|NCT00986505|Anesthetics, Local|anesthetics, local|mesh-ancestor
6568024|NCT00986505|Anesthetics|anesthetics|mesh-ancestor
6568025|NCT00986505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6568026|NCT00986505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568027|NCT00986505|Sensory System Agents|sensory system agents|mesh-ancestor
6568028|NCT00986505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6568029|NCT00986505|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6568030|NCT00986505|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6568031|NCT00986505|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6568032|NCT00986505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6568033|NCT00986505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568034|NCT00986557|Ganciclovir|ganciclovir|mesh-list
6568035|NCT00986557|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6568036|NCT00986557|Foscarnet|foscarnet|mesh-list
6568037|NCT00986557|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
6568038|NCT00986557|Alemtuzumab|alemtuzumab|mesh-list
6568039|NCT00986557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6568040|NCT00986557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6568041|NCT00986557|Antiviral Agents|antiviral agents|mesh-ancestor
6568042|NCT00986557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6568043|NCT00986557|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6568044|NCT00986557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6568045|NCT00986557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568046|NCT00986557|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6568047|NCT00986596|Vitamin D|vitamin d|mesh-list
6568048|NCT00986596|Cholecalciferol|cholecalciferol|mesh-list
6568049|NCT00986596|Vitamins|vitamins|mesh-ancestor
6568050|NCT00986596|Micronutrients|micronutrients|mesh-ancestor
6568051|NCT00986596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568052|NCT00986596|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6568053|NCT00986596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6568054|NCT00986609|Poly I-C|poly i-c|mesh-list
6568055|NCT00986609|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6568056|NCT00986609|Vaccines|vaccines|mesh-list
6568057|NCT00986609|Poly ICLC|poly iclc|mesh-list
6568058|NCT00986609|Immunologic Factors|immunologic factors|mesh-ancestor
6568059|NCT00986609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568060|NCT00986609|Interferon Inducers|interferon inducers|mesh-ancestor
6568061|NCT00986609|Laxatives|laxatives|mesh-ancestor
6568062|NCT00986609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6568063|NCT00986609|Antiviral Agents|antiviral agents|mesh-ancestor
6444985|NCT00386178|Micronutrients|micronutrients|mesh-ancestor
6444986|NCT00386178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444987|NCT00386178|Antioxidants|antioxidants|mesh-ancestor
6444988|NCT00386178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444989|NCT00386178|Protective Agents|protective agents|mesh-ancestor
6444990|NCT00386191|Clopidogrel|clopidogrel|mesh-list
6444991|NCT00386191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6444992|NCT00386191|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6444993|NCT00386191|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6444994|NCT00386191|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6568064|NCT00986609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6568065|NCT00986713|Amphotericin B|amphotericin b|mesh-list
6568066|NCT00986713|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6568067|NCT00986713|Amebicides|amebicides|mesh-ancestor
6568068|NCT00986713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6568069|NCT00986713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6568070|NCT00986713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6444995|NCT00386191|Purinergic Agents|purinergic agents|mesh-ancestor
6444996|NCT00386191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6444997|NCT00386191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6444998|NCT00386191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6444999|NCT00386230|Zidovudine|zidovudine|mesh-list
6568071|NCT00986713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6568072|NCT00986713|Antifungal Agents|antifungal agents|mesh-ancestor
6568073|NCT00986765|Aspirin|aspirin|mesh-list
6568074|NCT00986765|Enoxaparin|enoxaparin|mesh-list
6568075|NCT00986765|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6568076|NCT00986765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6568077|NCT00986765|Analgesics|analgesics|mesh-ancestor
6568078|NCT00986765|Sensory System Agents|sensory system agents|mesh-ancestor
6568079|NCT00986765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6568080|NCT00986765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568081|NCT00986765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6568082|NCT00986765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6568083|NCT00986765|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6568084|NCT00986765|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6568085|NCT00986765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568086|NCT00986765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6568087|NCT00986765|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6568088|NCT00986765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6568089|NCT00986765|Antipyretics|antipyretics|mesh-ancestor
6568090|NCT00986765|Anticoagulants|anticoagulants|mesh-ancestor
6568091|NCT00986778|Lamivudine|lamivudine|mesh-list
6568092|NCT00986778|Adefovir|adefovir|mesh-list
6568093|NCT00986778|Entecavir|entecavir|mesh-list
6568094|NCT00986778|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6568095|NCT00986778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6568096|NCT00986778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6568097|NCT00986778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568098|NCT00986778|Antiviral Agents|antiviral agents|mesh-ancestor
6568099|NCT00986778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6568100|NCT00986778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6568101|NCT00986778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6568102|NCT00986804|Decitabine|decitabine|mesh-list
6568103|NCT00986804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6568104|NCT00986804|Antimetabolites|antimetabolites|mesh-ancestor
6568105|NCT00986804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568106|NCT00986804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6568107|NCT00986804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6568108|NCT00986817|Terlipressin|terlipressin|mesh-list
6568109|NCT00986817|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6568110|NCT00986817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6568111|NCT00986843|Irinotecan|irinotecan|mesh-list
6568112|NCT00986843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6568113|NCT00986843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6568114|NCT00986843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6568115|NCT00986843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568116|NCT00986843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6568117|NCT00986960|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6568118|NCT00986960|Hormones|hormones|mesh-ancestor
6568119|NCT00986960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6568120|NCT00986960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568121|NCT00987038|Midazolam|midazolam|mesh-list
6568122|NCT00987038|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6568123|NCT00987038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6568124|NCT00987038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6568125|NCT00987038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568126|NCT00987038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6568127|NCT00987038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6568128|NCT00987038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6568129|NCT00987038|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6568130|NCT00987038|Anesthetics, General|anesthetics, general|mesh-ancestor
6568131|NCT00987038|Anesthetics|anesthetics|mesh-ancestor
6568132|NCT00987038|GABA Modulators|gaba modulators|mesh-ancestor
6568133|NCT00987038|GABA Agents|gaba agents|mesh-ancestor
6568134|NCT00987038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6568135|NCT00987038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568136|NCT00987103|Tacrolimus|tacrolimus|mesh-list
6568137|NCT00987103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6568138|NCT00987103|Immunologic Factors|immunologic factors|mesh-ancestor
6568139|NCT00987103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568140|NCT00987103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6568141|NCT00987103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6568142|NCT00987103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568143|NCT00987116|Prednisone|prednisone|mesh-list
6568144|NCT00987116|Azathioprine|azathioprine|mesh-list
6568145|NCT00987116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6568146|NCT00987116|Glucocorticoids|glucocorticoids|mesh-ancestor
6568147|NCT00987116|Hormones|hormones|mesh-ancestor
6568148|NCT00987116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6568149|NCT00987116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568150|NCT00987116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6568151|NCT00987116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6568152|NCT00987116|Antimetabolites|antimetabolites|mesh-ancestor
6568153|NCT00987116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568154|NCT00987116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6568155|NCT00987116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6568156|NCT00987116|Immunologic Factors|immunologic factors|mesh-ancestor
6568157|NCT00987116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6568158|NCT00987168|Octreotide|octreotide|mesh-list
6568159|NCT00987168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6568160|NCT00987168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6568161|NCT00987168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6568162|NCT00987207|Cyclosporine|cyclosporine|mesh-list
6568163|NCT00987207|Cyclosporins|cyclosporins|mesh-list
6568164|NCT00987207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6568165|NCT00987207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568166|NCT00987207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6568167|NCT00987207|Immunologic Factors|immunologic factors|mesh-ancestor
6568168|NCT00987207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568169|NCT00987207|Antifungal Agents|antifungal agents|mesh-ancestor
6568170|NCT00987207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6568171|NCT00987207|Dermatologic Agents|dermatologic agents|mesh-ancestor
6568172|NCT00987207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6568173|NCT00987207|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6568174|NCT00987220|Donepezil|donepezil|mesh-list
6568175|NCT00987220|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6568176|NCT00987220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6568177|NCT00987220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568178|NCT00987220|Cholinergic Agents|cholinergic agents|mesh-ancestor
6568179|NCT00987220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6568180|NCT00987220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568181|NCT00987220|Nootropic Agents|nootropic agents|mesh-ancestor
6568182|NCT00987233|Triamcinolone|triamcinolone|mesh-list
6568183|NCT00987233|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6568184|NCT00987233|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6568185|NCT00987233|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6568186|NCT00987233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6568187|NCT00987233|Glucocorticoids|glucocorticoids|mesh-ancestor
6568188|NCT00987233|Hormones|hormones|mesh-ancestor
6568189|NCT00987233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6568190|NCT00987233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568191|NCT00987233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6568192|NCT00987233|Immunologic Factors|immunologic factors|mesh-ancestor
6568193|NCT00987233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6568194|NCT00987233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568195|NCT00987376|Choline|choline|mesh-list
6568196|NCT00987376|Lipotropic Agents|lipotropic agents|mesh-ancestor
6568197|NCT00987376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6568198|NCT00987376|Antimetabolites|antimetabolites|mesh-ancestor
6568199|NCT00987376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568200|NCT00987376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6568201|NCT00987376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6568202|NCT00987376|Nootropic Agents|nootropic agents|mesh-ancestor
6568203|NCT00987441|Sufentanil|sufentanil|mesh-list
6568204|NCT00987441|Dsuvia|dsuvia|mesh-list
6568205|NCT00987441|Ropivacaine|ropivacaine|mesh-list
6568206|NCT00987441|Anesthetics, Local|anesthetics, local|mesh-ancestor
6568207|NCT00987441|Anesthetics|anesthetics|mesh-ancestor
6568208|NCT00987441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6568209|NCT00987441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568210|NCT00987441|Sensory System Agents|sensory system agents|mesh-ancestor
6568211|NCT00987441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6568212|NCT00987441|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6568213|NCT00987441|Narcotics|narcotics|mesh-ancestor
6568214|NCT00987441|Analgesics|analgesics|mesh-ancestor
6568215|NCT00987441|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6568216|NCT00987441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6568217|NCT00987441|Anesthetics, General|anesthetics, general|mesh-ancestor
6568218|NCT00987454|Epoetin Alfa|epoetin alfa|mesh-list
6568219|NCT00987454|Hematinics|hematinics|mesh-ancestor
6568220|NCT00987493|Rituximab|rituximab|mesh-list
6568221|NCT00987493|Lenalidomide|lenalidomide|mesh-list
6568222|NCT00987493|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6568223|NCT00987493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6568224|NCT00987493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6568225|NCT00987493|Immunologic Factors|immunologic factors|mesh-ancestor
6568226|NCT00987493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568227|NCT00987493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6568228|NCT00987493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6568229|NCT00987493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6568230|NCT00987493|Growth Substances|growth substances|mesh-ancestor
6568231|NCT00987493|Growth Inhibitors|growth inhibitors|mesh-ancestor
6568232|NCT00987493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6568233|NCT00987493|Alkylating Agents|alkylating agents|mesh-ancestor
6568234|NCT00987493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568235|NCT00987636|Zoledronic Acid|zoledronic acid|mesh-list
6568236|NCT00987636|Diphosphonates|diphosphonates|mesh-list
6568237|NCT00987636|Busulfan|busulfan|mesh-list
6568238|NCT00987636|Treosulfan|treosulfan|mesh-list
6568239|NCT00987636|Alkylating Agents|alkylating agents|mesh-ancestor
6568240|NCT00987636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568241|NCT00987636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6568242|NCT00987636|Immunologic Factors|immunologic factors|mesh-ancestor
6568243|NCT00987636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568244|NCT00987636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6568245|NCT00987636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6568246|NCT00987636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6568247|NCT00987636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6568248|NCT00987662|Amlodipine|amlodipine|mesh-list
6568249|NCT00987662|Irbesartan|irbesartan|mesh-list
6568250|NCT00987662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6568251|NCT00987662|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6568252|NCT00987662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6568253|NCT00987662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568254|NCT00987662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6568255|NCT00987662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568256|NCT00987662|Vasodilator Agents|vasodilator agents|mesh-ancestor
6568257|NCT00987662|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6568258|NCT00987662|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6657495|NCT01476501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6657496|NCT01476592|Resveratrol|resveratrol|mesh-list
6657497|NCT01476592|Antioxidants|antioxidants|mesh-ancestor
6568259|NCT00987766|Gemcitabine|gemcitabine|mesh-list
6568260|NCT00987766|Oxaliplatin|oxaliplatin|mesh-list
6568261|NCT00987766|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6568262|NCT00987766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6568263|NCT00987766|Antimetabolites|antimetabolites|mesh-ancestor
6568264|NCT00987766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568265|NCT00987766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6568266|NCT00987766|Antiviral Agents|antiviral agents|mesh-ancestor
6568267|NCT00987766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6568268|NCT00987766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6568269|NCT00987766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6568270|NCT00987766|Immunologic Factors|immunologic factors|mesh-ancestor
6568271|NCT00987766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568272|NCT00987766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6568273|NCT00987779|Gabapentin|gabapentin|mesh-list
6568274|NCT00987779|Analgesics|analgesics|mesh-ancestor
6568275|NCT00987779|Sensory System Agents|sensory system agents|mesh-ancestor
6445000|NCT00386230|Antimetabolites|antimetabolites|mesh-ancestor
6568276|NCT00987779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6568277|NCT00987779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568278|NCT00987779|Anticonvulsants|anticonvulsants|mesh-ancestor
6568279|NCT00987779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6568280|NCT00987779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6568281|NCT00987779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6568282|NCT00987779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6568283|NCT00987779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6568284|NCT00987779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6568285|NCT00987779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6568286|NCT00987779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568287|NCT00987779|Antimanic Agents|antimanic agents|mesh-ancestor
6568288|NCT00987792|Moxifloxacin|moxifloxacin|mesh-list
6568289|NCT00987792|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6568290|NCT00987792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6568291|NCT00987792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6568292|NCT00987792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6568293|NCT00987792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6568294|NCT00987792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6568295|NCT00987792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568296|NCT00987792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6568297|NCT00987792|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6568298|NCT00987792|Contraceptive Agents|contraceptive agents|mesh-ancestor
6568299|NCT00987792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6568300|NCT00987792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568301|NCT00987792|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6568302|NCT00987792|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6568303|NCT00987792|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6568304|NCT00987844|Prucalopride|prucalopride|mesh-list
6568305|NCT00987844|Laxatives|laxatives|mesh-ancestor
6568306|NCT00987844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6568307|NCT00987844|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
6568308|NCT00987844|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6568309|NCT00987844|Serotonin Agents|serotonin agents|mesh-ancestor
6568310|NCT00987844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6568311|NCT00987844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568312|NCT00987844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445001|NCT00386230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445002|NCT00386230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6445003|NCT00386230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6445004|NCT00386230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6445005|NCT00386230|Antiviral Agents|antiviral agents|mesh-ancestor
6445006|NCT00386230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6445007|NCT00386230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6445008|NCT00386230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6445009|NCT00386269|Codeine|codeine|mesh-list
6445010|NCT00386269|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6445011|NCT00386269|Narcotics|narcotics|mesh-ancestor
6568313|NCT00987870|Betamethasone|betamethasone|mesh-list
6568314|NCT00987870|Calcipotriene|calcipotriene|mesh-list
6568315|NCT00987870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6568316|NCT00987870|Glucocorticoids|glucocorticoids|mesh-ancestor
6568317|NCT00987870|Hormones|hormones|mesh-ancestor
6568318|NCT00987870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6568319|NCT00987870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568320|NCT00987870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6568321|NCT00987870|Respiratory System Agents|respiratory system agents|mesh-ancestor
6568322|NCT00987870|Dermatologic Agents|dermatologic agents|mesh-ancestor
6568323|NCT00987909|Immunologic Factors|immunologic factors|mesh-list
6568324|NCT00987909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568325|NCT00987974|Atorvastatin|atorvastatin|mesh-list
6568326|NCT00987974|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6568327|NCT00987974|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6568328|NCT00987974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6568329|NCT00987974|Antimetabolites|antimetabolites|mesh-ancestor
6568330|NCT00987974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568331|NCT00987974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6568332|NCT00987974|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6568333|NCT00987974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6568334|NCT00988026|Minocycline|minocycline|mesh-list
6568335|NCT00988026|Lymecycline|lymecycline|mesh-list
6568336|NCT00988026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6568337|NCT00988026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6568338|NCT00988039|Raltegravir Potassium|raltegravir potassium|mesh-list
6568339|NCT00988039|Lopinavir|lopinavir|mesh-list
6568340|NCT00988039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6568341|NCT00988039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6568342|NCT00988039|Antiviral Agents|antiviral agents|mesh-ancestor
6568343|NCT00988039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6568344|NCT00988039|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6568345|NCT00988039|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6568346|NCT00988039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6568347|NCT00988039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020062|NCT00391391|Vaccines|vaccines|mesh-list
6445012|NCT00386269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6445013|NCT00386269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445014|NCT00386269|Analgesics|analgesics|mesh-ancestor
6445015|NCT00386269|Sensory System Agents|sensory system agents|mesh-ancestor
6445016|NCT00386269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6445017|NCT00386269|Antitussive Agents|antitussive agents|mesh-ancestor
6445018|NCT00386269|Respiratory System Agents|respiratory system agents|mesh-ancestor
6445019|NCT00386282|Misoprostol|misoprostol|mesh-list
6445020|NCT00386282|Mifepristone|mifepristone|mesh-list
6445021|NCT00386282|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6445022|NCT00386282|Abortifacient Agents|abortifacient agents|mesh-ancestor
6445023|NCT00386282|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6445024|NCT00386282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445025|NCT00386282|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6445026|NCT00386282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6445027|NCT00386282|Oxytocics|oxytocics|mesh-ancestor
6445028|NCT00386282|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6568348|NCT00988039|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6020063|NCT00391391|Immunologic Factors|immunologic factors|mesh-ancestor
6020064|NCT00391391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020065|NCT00391443|Bosentan|bosentan|mesh-list
6020066|NCT00391443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6445029|NCT00386282|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6445030|NCT00386282|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6445031|NCT00386282|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6445032|NCT00386282|Contraceptive Agents|contraceptive agents|mesh-ancestor
6445033|NCT00386282|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6445034|NCT00386282|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6445035|NCT00386282|Hormone Antagonists|hormone antagonists|mesh-ancestor
6445036|NCT00386282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6445037|NCT00386282|Luteolytic Agents|luteolytic agents|mesh-ancestor
6445038|NCT00386282|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6445039|NCT00386282|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6445040|NCT00386373|Imatinib Mesylate|imatinib mesylate|mesh-list
6445041|NCT00386373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6445042|NCT00386373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6445043|NCT00386373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6445044|NCT00386373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445045|NCT00386399|Mitomycins|mitomycins|mesh-list
6445046|NCT00386399|Mitomycin|mitomycin|mesh-list
6445047|NCT00386399|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6445048|NCT00386399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6445049|NCT00386399|Alkylating Agents|alkylating agents|mesh-ancestor
6445050|NCT00386399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445051|NCT00386399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6445052|NCT00386399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6445053|NCT00386412|Valganciclovir|valganciclovir|mesh-list
6445054|NCT00386412|Antiviral Agents|antiviral agents|mesh-ancestor
6445055|NCT00386412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6445056|NCT00386503|Artesunate|artesunate|mesh-list
6445057|NCT00386503|Amodiaquine|amodiaquine|mesh-list
6445058|NCT00386503|Antimalarials|antimalarials|mesh-ancestor
6445059|NCT00386503|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6445060|NCT00386503|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6445061|NCT00386503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6445062|NCT00386503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6445063|NCT00386503|Antiviral Agents|antiviral agents|mesh-ancestor
6445064|NCT00386503|Schistosomicides|schistosomicides|mesh-ancestor
6445065|NCT00386503|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6445066|NCT00386503|Anthelmintics|anthelmintics|mesh-ancestor
6445067|NCT00386516|Fluorouracil|fluorouracil|mesh-list
6445068|NCT00386516|Antimetabolites|antimetabolites|mesh-ancestor
6445069|NCT00386516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445070|NCT00386516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6445071|NCT00386516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6445072|NCT00386516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6445073|NCT00386516|Immunologic Factors|immunologic factors|mesh-ancestor
6445074|NCT00386516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445075|NCT00386529|Aspirin|aspirin|mesh-list
6445076|NCT00386529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6445077|NCT00386529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6445078|NCT00386529|Analgesics|analgesics|mesh-ancestor
6445079|NCT00386529|Sensory System Agents|sensory system agents|mesh-ancestor
6445080|NCT00386529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6445081|NCT00386529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445082|NCT00386529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6445083|NCT00386529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6445084|NCT00386529|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6445085|NCT00386529|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6568349|NCT00988039|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6568350|NCT00988039|Protease Inhibitors|protease inhibitors|mesh-ancestor
6568351|NCT00988039|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6568352|NCT00988039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6568353|NCT00988078|Metformin|metformin|mesh-list
6568354|NCT00988078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6568355|NCT00988078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568356|NCT00988195|Doxorubicin|doxorubicin|mesh-list
6568357|NCT00988195|BCT-100|bct-100|mesh-list
6568358|NCT00988195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6568359|NCT00988195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6568360|NCT00988195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6568361|NCT00988195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6568362|NCT00988195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6568363|NCT00988195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568364|NCT00988312|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
6568365|NCT00988312|Immunologic Factors|immunologic factors|mesh-ancestor
6568366|NCT00988312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568367|NCT00988364|Simvastatin|simvastatin|mesh-list
6568368|NCT00988364|Ezetimibe|ezetimibe|mesh-list
6568369|NCT00988364|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
6568370|NCT00988364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6568371|NCT00988364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6568372|NCT00988364|Antimetabolites|antimetabolites|mesh-ancestor
6568373|NCT00988364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568374|NCT00988364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6568375|NCT00988364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6568376|NCT00988364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6568377|NCT00988403|Levan|levan|mesh-list
6568378|NCT00988403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6568379|NCT00988481|Topiramate|topiramate|mesh-list
6568380|NCT00988481|Anticonvulsants|anticonvulsants|mesh-ancestor
6568381|NCT00988481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6568382|NCT00988481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568383|NCT00988494|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6568384|NCT00988494|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6568385|NCT00988507|Artesunate|artesunate|mesh-list
6445086|NCT00386529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445087|NCT00386529|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6445088|NCT00386529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6445089|NCT00386529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6445090|NCT00386529|Antipyretics|antipyretics|mesh-ancestor
6445091|NCT00386555|Docetaxel|docetaxel|mesh-list
6445092|NCT00386555|Axitinib|axitinib|mesh-list
6445093|NCT00386555|Crenolanib|crenolanib|mesh-list
6445094|NCT00386555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6445095|NCT00386555|Tubulin Modulators|tubulin modulators|mesh-ancestor
6445096|NCT00386555|Antimitotic Agents|antimitotic agents|mesh-ancestor
6445097|NCT00386555|Mitosis Modulators|mitosis modulators|mesh-ancestor
6445098|NCT00386555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445099|NCT00386555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6445100|NCT00386555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6445101|NCT00386581|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6445102|NCT00386581|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6445103|NCT00386581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6445104|NCT00386581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6445105|NCT00386581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445106|NCT00386581|Adrenergic Agents|adrenergic agents|mesh-ancestor
6445107|NCT00386581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6445108|NCT00386581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445109|NCT00386646|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6445110|NCT00386646|Laxatives|laxatives|mesh-ancestor
6445111|NCT00386646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6445112|NCT00386659|Ritonavir|ritonavir|mesh-list
6445113|NCT00386659|Lopinavir|lopinavir|mesh-list
6445114|NCT00386659|Tenofovir|tenofovir|mesh-list
6445115|NCT00386659|Abacavir|abacavir|mesh-list
6445116|NCT00386659|Efavirenz|efavirenz|mesh-list
6445117|NCT00386659|Dideoxynucleosides|dideoxynucleosides|mesh-list
6445118|NCT00386659|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6445119|NCT00386659|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6445120|NCT00386659|Protease Inhibitors|protease inhibitors|mesh-ancestor
6445121|NCT00386659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6445122|NCT00386659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445123|NCT00386659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6568386|NCT00988507|Ferroquine|ferroquine|mesh-list
6568387|NCT00988507|Antimalarials|antimalarials|mesh-ancestor
6568388|NCT00988507|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6568389|NCT00988507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6568390|NCT00988507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6568391|NCT00988507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6568392|NCT00988507|Antiviral Agents|antiviral agents|mesh-ancestor
6568393|NCT00988507|Schistosomicides|schistosomicides|mesh-ancestor
6445124|NCT00386659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6445125|NCT00386659|Antiviral Agents|antiviral agents|mesh-ancestor
6445126|NCT00386659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6568394|NCT00988507|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6568395|NCT00988507|Anthelmintics|anthelmintics|mesh-ancestor
6568396|NCT00988520|Bromides|bromides|mesh-list
6568397|NCT00988520|Propofol|propofol|mesh-list
6568398|NCT00988520|Sevoflurane|sevoflurane|mesh-list
6568399|NCT00988520|Rocuronium|rocuronium|mesh-list
6568400|NCT00988520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6445127|NCT00386659|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6445128|NCT00386659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6445129|NCT00386659|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6445130|NCT00386659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6568401|NCT00988520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6568402|NCT00988520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568403|NCT00988520|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6568404|NCT00988520|Anesthetics, General|anesthetics, general|mesh-ancestor
6568405|NCT00988520|Anesthetics|anesthetics|mesh-ancestor
6568406|NCT00988520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6568407|NCT00988520|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6568408|NCT00988520|Anticonvulsants|anticonvulsants|mesh-ancestor
6568409|NCT00988520|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6445131|NCT00386659|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6445132|NCT00386659|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6568410|NCT00988520|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6568411|NCT00988520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6568412|NCT00988520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6568413|NCT00988663|Memantine|memantine|mesh-list
6568414|NCT00988663|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6568415|NCT00988663|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6568416|NCT00988663|Dopamine Agents|dopamine agents|mesh-ancestor
6568417|NCT00988663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6568418|NCT00988663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568419|NCT00988663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568420|NCT00988663|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6568421|NCT00988663|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6568422|NCT00988715|Cyclosporine|cyclosporine|mesh-list
6568423|NCT00988715|Mycophenolic Acid|mycophenolic acid|mesh-list
6568424|NCT00988715|Fludarabine|fludarabine|mesh-list
6568425|NCT00988715|Fludarabine phosphate|fludarabine phosphate|mesh-list
6568426|NCT00988715|Cyclosporins|cyclosporins|mesh-list
6568427|NCT00988715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6568428|NCT00988715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6568429|NCT00988715|Antimetabolites|antimetabolites|mesh-ancestor
6568430|NCT00988715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568431|NCT00988715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6568432|NCT00988715|Immunologic Factors|immunologic factors|mesh-ancestor
6568433|NCT00988715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568434|NCT00988715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6568435|NCT00988715|Antifungal Agents|antifungal agents|mesh-ancestor
6568436|NCT00988715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6568437|NCT00988715|Dermatologic Agents|dermatologic agents|mesh-ancestor
6568438|NCT00988715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6568439|NCT00988715|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6568440|NCT00988715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6568441|NCT00988715|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6568442|NCT00988715|Antitubercular Agents|antitubercular agents|mesh-ancestor
6568443|NCT00988715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6568444|NCT00988728|Olanzapine|olanzapine|mesh-list
6568445|NCT00988728|Antiemetics|antiemetics|mesh-ancestor
6568446|NCT00988728|Autonomic Agents|autonomic agents|mesh-ancestor
6568447|NCT00988728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6568448|NCT00988728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568449|NCT00988728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6568450|NCT00988728|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6568451|NCT00988728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6568452|NCT00988728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6568453|NCT00988728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6568454|NCT00988728|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6568455|NCT00988728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6568456|NCT00988728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6568457|NCT00988728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568458|NCT00988728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6568459|NCT00988728|Serotonin Agents|serotonin agents|mesh-ancestor
6568460|NCT00988780|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6568461|NCT00988780|Efavirenz|efavirenz|mesh-list
6568462|NCT00988780|Maraviroc|maraviroc|mesh-list
6568463|NCT00988780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6568464|NCT00988780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6568465|NCT00988780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6568466|NCT00988780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568467|NCT00988780|Antiviral Agents|antiviral agents|mesh-ancestor
6568468|NCT00988780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6568469|NCT00988780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6568470|NCT00988780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6568471|NCT00988780|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6568472|NCT00988780|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6568473|NCT00988780|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6568474|NCT00988780|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6568475|NCT00988780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6568476|NCT00988780|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6568477|NCT00988780|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6568478|NCT00988780|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6568479|NCT00988780|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6568480|NCT00988806|Simendan|simendan|mesh-list
6568481|NCT00988806|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6568482|NCT00988806|Vasodilator Agents|vasodilator agents|mesh-ancestor
6445133|NCT00386659|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6445134|NCT00386659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6568483|NCT00988806|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6568484|NCT00988806|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6568485|NCT00988806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6568486|NCT00988806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568487|NCT00988806|Protective Agents|protective agents|mesh-ancestor
6568488|NCT00988806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568489|NCT00988845|Indole-3-carbinol|indole-3-carbinol|mesh-list
6568490|NCT00988845|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6568491|NCT00988845|Protective Agents|protective agents|mesh-ancestor
6568492|NCT00988845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568493|NCT00988845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6568494|NCT00988897|Leucovorin|leucovorin|mesh-list
6568495|NCT00988897|Bevacizumab|bevacizumab|mesh-list
6568496|NCT00988897|Fluorouracil|fluorouracil|mesh-list
6568497|NCT00988897|Oxaliplatin|oxaliplatin|mesh-list
6568498|NCT00988897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6568499|NCT00988897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6568500|NCT00988897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6568501|NCT00988897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6568502|NCT00988897|Growth Substances|growth substances|mesh-ancestor
6568503|NCT00988897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568504|NCT00988897|Growth Inhibitors|growth inhibitors|mesh-ancestor
6568505|NCT00988897|Antimetabolites|antimetabolites|mesh-ancestor
6568506|NCT00988897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568507|NCT00988897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6568508|NCT00988897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6568509|NCT00988897|Immunologic Factors|immunologic factors|mesh-ancestor
6568510|NCT00988897|Antidotes|antidotes|mesh-ancestor
6568511|NCT00988897|Protective Agents|protective agents|mesh-ancestor
6568512|NCT00988897|Vitamin B Complex|vitamin b complex|mesh-ancestor
6568513|NCT00988897|Vitamins|vitamins|mesh-ancestor
6568514|NCT00988897|Micronutrients|micronutrients|mesh-ancestor
6568515|NCT00988910|Contraceptive Agents|contraceptive agents|mesh-list
6568516|NCT00988910|Contraceptives, Oral|contraceptives, oral|mesh-list
6568517|NCT00988910|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
6445135|NCT00386659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6445136|NCT00386659|Antimetabolites|antimetabolites|mesh-ancestor
6445137|NCT00386672|Calcium, Dietary|calcium, dietary|mesh-list
6445138|NCT00386672|Vitamin D|vitamin d|mesh-list
6445139|NCT00386672|Ergocalciferols|ergocalciferols|mesh-list
6445140|NCT00386672|Vitamins|vitamins|mesh-list
6445141|NCT00386672|Calcium|calcium|mesh-list
6445142|NCT00386672|Micronutrients|micronutrients|mesh-ancestor
6445143|NCT00386672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445144|NCT00386672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6445145|NCT00386672|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6445146|NCT00386685|Trastuzumab|trastuzumab|mesh-list
6445147|NCT00386685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6445148|NCT00386685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6445149|NCT00386750|Lumefantrine|lumefantrine|mesh-list
6445150|NCT00386750|Artemether|artemether|mesh-list
6445151|NCT00386750|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6445152|NCT00386750|Antimalarials|antimalarials|mesh-ancestor
6445153|NCT00386750|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6445154|NCT00386750|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6445155|NCT00386750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6445156|NCT00386763|Lumefantrine|lumefantrine|mesh-list
6445157|NCT00386763|Artemether|artemether|mesh-list
6445158|NCT00386763|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6445159|NCT00386763|Antimalarials|antimalarials|mesh-ancestor
6445160|NCT00386763|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6568518|NCT00988910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6568519|NCT00988910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568520|NCT00988910|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6568521|NCT00988949|Spiradoline|spiradoline|mesh-list
6568522|NCT00988949|Analgesics|analgesics|mesh-ancestor
6568523|NCT00988949|Sensory System Agents|sensory system agents|mesh-ancestor
6568524|NCT00988949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6568525|NCT00988949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568526|NCT00988949|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6568527|NCT00988949|Diuretics|diuretics|mesh-ancestor
6568528|NCT00988949|Natriuretic Agents|natriuretic agents|mesh-ancestor
6568529|NCT00989027|Oxytocin|oxytocin|mesh-list
6568530|NCT00989027|Ergonovine|ergonovine|mesh-list
6568531|NCT00989027|Carboprost tromethamine|carboprost tromethamine|mesh-list
6568532|NCT00989027|Carboprost|carboprost|mesh-list
6568533|NCT00989027|Oxytocics|oxytocics|mesh-ancestor
6568534|NCT00989027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6568535|NCT00989027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568536|NCT00989027|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6568537|NCT00989027|Abortifacient Agents|abortifacient agents|mesh-ancestor
6568538|NCT00989053|Citalopram|citalopram|mesh-list
6568539|NCT00989053|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6568540|NCT00989053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6568541|NCT00989053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6568542|NCT00989053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568543|NCT00989053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6568544|NCT00989053|Serotonin Agents|serotonin agents|mesh-ancestor
6568545|NCT00989053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568546|NCT00989053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6568547|NCT00989053|Antidepressive Agents|antidepressive agents|mesh-ancestor
6445161|NCT00386763|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6445162|NCT00386763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6445163|NCT00386802|Antifungal Agents|antifungal agents|mesh-list
6445164|NCT00386802|Clotrimazole|clotrimazole|mesh-list
6445165|NCT00386802|Miconazole|miconazole|mesh-list
6445166|NCT00386802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6445167|NCT00386802|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6445168|NCT00386802|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6445169|NCT00386802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6445170|NCT00386802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6445171|NCT00386802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445172|NCT00386802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6445173|NCT00386802|Hormone Antagonists|hormone antagonists|mesh-ancestor
6445174|NCT00386802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6445175|NCT00386802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445176|NCT00386802|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6445177|NCT00386802|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6445178|NCT00386815|Pemetrexed|pemetrexed|mesh-list
6445179|NCT00386815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6568548|NCT00989053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6568549|NCT00989079|Ertugliflozin|ertugliflozin|mesh-list
6568550|NCT00989079|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6568551|NCT00989079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568552|NCT00989079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6568553|NCT00989079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568554|NCT00989209|Botulinum Toxins|botulinum toxins|mesh-list
6445180|NCT00386815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6445181|NCT00386815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445182|NCT00386815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6445183|NCT00386815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6445184|NCT00386828|Bevacizumab|bevacizumab|mesh-list
6445185|NCT00386828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6445186|NCT00386828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6445187|NCT00386828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6445188|NCT00386828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6445189|NCT00386828|Growth Substances|growth substances|mesh-ancestor
6445190|NCT00386828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445191|NCT00386828|Growth Inhibitors|growth inhibitors|mesh-ancestor
6445192|NCT00386841|Citalopram|citalopram|mesh-list
6445193|NCT00386841|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6445194|NCT00386841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6445195|NCT00386841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6445196|NCT00386841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445197|NCT00386841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6445198|NCT00386841|Serotonin Agents|serotonin agents|mesh-ancestor
6445199|NCT00386841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445200|NCT00386841|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6445201|NCT00386841|Antidepressive Agents|antidepressive agents|mesh-ancestor
6445202|NCT00386841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6445203|NCT00386867|Misoprostol|misoprostol|mesh-list
6445204|NCT00386867|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6445205|NCT00386867|Abortifacient Agents|abortifacient agents|mesh-ancestor
6445206|NCT00386867|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6445207|NCT00386867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445208|NCT00386867|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6445209|NCT00386867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6445210|NCT00386867|Oxytocics|oxytocics|mesh-ancestor
6461696|NCT00455637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461697|NCT00455637|Cholinergic Agents|cholinergic agents|mesh-ancestor
6461698|NCT00455637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6461699|NCT00455637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461700|NCT00455637|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6461701|NCT00455637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6461702|NCT00455715|Sildenafil Citrate|sildenafil citrate|mesh-list
6461703|NCT00455715|Vasodilator Agents|vasodilator agents|mesh-ancestor
6461704|NCT00455715|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6461705|NCT00455715|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6461706|NCT00455715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6461707|NCT00455715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461708|NCT00455715|Urological Agents|urological agents|mesh-ancestor
6461709|NCT00455754|Esomeprazole|esomeprazole|mesh-list
6461710|NCT00455754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6461711|NCT00455754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6461712|NCT00455754|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6461713|NCT00455754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6461714|NCT00455754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461715|NCT00455806|Amoxicillin|amoxicillin|mesh-list
6461716|NCT00455806|Moxifloxacin|moxifloxacin|mesh-list
6461717|NCT00455806|Esomeprazole|esomeprazole|mesh-list
6461718|NCT00455806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6461719|NCT00455806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6461720|NCT00455806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6461721|NCT00455806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6568555|NCT00989209|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6568556|NCT00989209|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6568557|NCT00989209|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6568558|NCT00989209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6568559|NCT00989209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568560|NCT00989209|Cholinergic Agents|cholinergic agents|mesh-ancestor
6568561|NCT00989209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6568562|NCT00989209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568563|NCT00989209|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6568564|NCT00989209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6568565|NCT00989274|Vaccines|vaccines|mesh-list
6568566|NCT00989274|Immunologic Factors|immunologic factors|mesh-ancestor
6568567|NCT00989274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568568|NCT00989300|Omeprazole|omeprazole|mesh-list
6568569|NCT00989300|Rabeprazole|rabeprazole|mesh-list
6568570|NCT00989300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6568571|NCT00989300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6568572|NCT00989300|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6568573|NCT00989300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6568574|NCT00989300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568575|NCT00989352|Rituximab|rituximab|mesh-list
6568576|NCT00989352|Methotrexate|methotrexate|mesh-list
6568577|NCT00989352|Lomustine|lomustine|mesh-list
6568578|NCT00989352|Procarbazine|procarbazine|mesh-list
6568579|NCT00989352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6568580|NCT00989352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6568581|NCT00989352|Immunologic Factors|immunologic factors|mesh-ancestor
6568582|NCT00989352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568583|NCT00989352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6568584|NCT00989352|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6568585|NCT00989352|Abortifacient Agents|abortifacient agents|mesh-ancestor
6568586|NCT00989352|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6568587|NCT00989352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6568588|NCT00989352|Antimetabolites|antimetabolites|mesh-ancestor
6568589|NCT00989352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568590|NCT00989352|Dermatologic Agents|dermatologic agents|mesh-ancestor
6568591|NCT00989352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6568592|NCT00989352|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6568593|NCT00989352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6568594|NCT00989352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6568595|NCT00989352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6568596|NCT00989352|Alkylating Agents|alkylating agents|mesh-ancestor
6568597|NCT00989404|Zanamivir|zanamivir|mesh-list
6568598|NCT00989404|Antiviral Agents|antiviral agents|mesh-ancestor
6568599|NCT00989404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6568600|NCT00989404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6568601|NCT00989404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568602|NCT00989443|Cidofovir|cidofovir|mesh-list
6568603|NCT00989443|Antiviral Agents|antiviral agents|mesh-ancestor
6568604|NCT00989443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6568605|NCT00989443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6568606|NCT00989443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657498|NCT01476592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657499|NCT01476592|Protective Agents|protective agents|mesh-ancestor
6657500|NCT01476592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657501|NCT01476592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6657502|NCT01476592|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6657503|NCT01476605|Sodium Morrhuate|sodium morrhuate|mesh-list
6657504|NCT01476605|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
6657505|NCT01476605|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6657506|NCT01476683|Racecadotril|racecadotril|mesh-list
6657507|NCT01476683|Thiorphan|thiorphan|mesh-list
6657508|NCT01476683|Antidiarrheals|antidiarrheals|mesh-ancestor
6657509|NCT01476683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6657510|NCT01476683|Protease Inhibitors|protease inhibitors|mesh-ancestor
6657511|NCT01476683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6657512|NCT01476683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657513|NCT01476774|Buprenorphine|buprenorphine|mesh-list
6657514|NCT01476774|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6657515|NCT01476774|Narcotics|narcotics|mesh-ancestor
6657516|NCT01476774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6657517|NCT01476774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657518|NCT01476774|Analgesics|analgesics|mesh-ancestor
6657519|NCT01476774|Sensory System Agents|sensory system agents|mesh-ancestor
6657520|NCT01476774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6657521|NCT01476774|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6657522|NCT01476787|Rituximab|rituximab|mesh-list
6657523|NCT01476787|Lenalidomide|lenalidomide|mesh-list
6657524|NCT01476787|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6657525|NCT01476787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6657526|NCT01476787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6657527|NCT01476787|Immunologic Factors|immunologic factors|mesh-ancestor
6657528|NCT01476787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657529|NCT01476787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6657530|NCT01476787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6657531|NCT01476787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6657532|NCT01476787|Growth Substances|growth substances|mesh-ancestor
6657533|NCT01476787|Growth Inhibitors|growth inhibitors|mesh-ancestor
6445211|NCT00386958|Povidone-Iodine|povidone-iodine|mesh-list
6445212|NCT00386958|Povidone|povidone|mesh-list
6445213|NCT00386958|Plasma Substitutes|plasma substitutes|mesh-ancestor
6445214|NCT00386958|Blood Substitutes|blood substitutes|mesh-ancestor
6445215|NCT00386958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6445216|NCT00386958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6445217|NCT00386984|Octreotide|octreotide|mesh-list
6445218|NCT00386984|Somatostatin|somatostatin|mesh-list
6445219|NCT00386984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6445220|NCT00386984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6445221|NCT00386984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6445222|NCT00386984|Hormones|hormones|mesh-ancestor
6445223|NCT00386984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6445224|NCT00386984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445225|NCT00386997|Amphotericin B|amphotericin b|mesh-list
6445226|NCT00386997|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6445227|NCT00386997|Amebicides|amebicides|mesh-ancestor
6445228|NCT00386997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6445229|NCT00386997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6445230|NCT00386997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6568607|NCT00989469|Irinotecan|irinotecan|mesh-list
6568608|NCT00989469|Sorafenib|sorafenib|mesh-list
6568609|NCT00989469|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6568610|NCT00989469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6568611|NCT00989469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6568612|NCT00989469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568613|NCT00989469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6568614|NCT00989469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6568615|NCT00989508|Perhexiline|perhexiline|mesh-list
6568616|NCT00989508|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6568617|NCT00989508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6568618|NCT00989508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568619|NCT00989508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6568620|NCT00989508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568621|NCT00989508|Vasodilator Agents|vasodilator agents|mesh-ancestor
6568622|NCT00989625|Naproxen|naproxen|mesh-list
6568623|NCT00989625|Sumatriptan|sumatriptan|mesh-list
6568624|NCT00989625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6568625|NCT00989625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6568626|NCT00989625|Analgesics|analgesics|mesh-ancestor
6568627|NCT00989625|Sensory System Agents|sensory system agents|mesh-ancestor
6568628|NCT00989625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6568629|NCT00989625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568630|NCT00989625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6568631|NCT00989625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6568632|NCT00989625|Gout Suppressants|gout suppressants|mesh-ancestor
6568633|NCT00989625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6568634|NCT00989625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6568635|NCT00989625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568636|NCT00989625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6568637|NCT00989625|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6568638|NCT00989625|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6568639|NCT00989625|Serotonin Agents|serotonin agents|mesh-ancestor
6568640|NCT00989625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6568641|NCT00989651|Paclitaxel|paclitaxel|mesh-list
6568642|NCT00989651|Bevacizumab|bevacizumab|mesh-list
6568643|NCT00989651|Cisplatin|cisplatin|mesh-list
6568644|NCT00989651|Carboplatin|carboplatin|mesh-list
6568645|NCT00989651|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6568646|NCT00989651|Veliparib|veliparib|mesh-list
6568647|NCT00989651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6568648|NCT00989651|Endothelial Growth Factors|endothelial growth factors|mesh-list
6568649|NCT00989651|Antibodies|antibodies|mesh-list
6568650|NCT00989651|Immunoglobulins|immunoglobulins|mesh-list
6568651|NCT00989651|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6568652|NCT00989651|Immunoglobulin G|immunoglobulin g|mesh-list
6568653|NCT00989651|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6568654|NCT00989651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6568655|NCT00989651|Tubulin Modulators|tubulin modulators|mesh-ancestor
6568656|NCT00989651|Antimitotic Agents|antimitotic agents|mesh-ancestor
6568657|NCT00989651|Mitosis Modulators|mitosis modulators|mesh-ancestor
6568658|NCT00989651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568659|NCT00989651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6568660|NCT00989651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6568661|NCT00989651|Growth Substances|growth substances|mesh-ancestor
6568662|NCT00989651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568663|NCT00989651|Growth Inhibitors|growth inhibitors|mesh-ancestor
6568664|NCT00989651|Immunologic Factors|immunologic factors|mesh-ancestor
6568665|NCT00989651|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6568666|NCT00989651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6568667|NCT00989690|Docetaxel|docetaxel|mesh-list
6568668|NCT00989690|Pemetrexed|pemetrexed|mesh-list
6568669|NCT00989690|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6568670|NCT00989690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6568671|NCT00989690|Tubulin Modulators|tubulin modulators|mesh-ancestor
6568672|NCT00989690|Antimitotic Agents|antimitotic agents|mesh-ancestor
6568673|NCT00989690|Mitosis Modulators|mitosis modulators|mesh-ancestor
6568674|NCT00989690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568675|NCT00989690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5503685|NCT04456777|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6568676|NCT00989690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6568677|NCT00989690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6568678|NCT00989690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6568679|NCT00989703|Methotrexate|methotrexate|mesh-list
6568680|NCT00989703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6568681|NCT00989703|Abortifacient Agents|abortifacient agents|mesh-ancestor
6568682|NCT00989703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6568683|NCT00989703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568684|NCT00989703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6568685|NCT00989703|Antimetabolites|antimetabolites|mesh-ancestor
6568686|NCT00989703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568687|NCT00989703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6568688|NCT00989703|Dermatologic Agents|dermatologic agents|mesh-ancestor
6568689|NCT00989703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6568690|NCT00989703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6568691|NCT00989703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6568692|NCT00989703|Immunologic Factors|immunologic factors|mesh-ancestor
6568693|NCT00989703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6568694|NCT00989703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6568695|NCT00989716|Antihypertensive Agents|antihypertensive agents|mesh-list
6568696|NCT00989716|Nitroglycerin|nitroglycerin|mesh-list
6568697|NCT00989716|Vasodilator Agents|vasodilator agents|mesh-ancestor
6568698|NCT00989729|Methylprednisolone|methylprednisolone|mesh-list
6568699|NCT00989729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6568700|NCT00989729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6568701|NCT00989729|Prednisolone|prednisolone|mesh-list
6568702|NCT00989729|Prednisolone acetate|prednisolone acetate|mesh-list
6568703|NCT00989729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6568704|NCT00989729|Prednisolone phosphate|prednisolone phosphate|mesh-list
6568705|NCT00989729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6568706|NCT00989729|Antiemetics|antiemetics|mesh-ancestor
6568707|NCT00989729|Autonomic Agents|autonomic agents|mesh-ancestor
6568708|NCT00989729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6568709|NCT00989729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568710|NCT00989729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6568711|NCT00989729|Glucocorticoids|glucocorticoids|mesh-ancestor
6568712|NCT00989729|Hormones|hormones|mesh-ancestor
6568713|NCT00989729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6568714|NCT00989729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6568715|NCT00989729|Protective Agents|protective agents|mesh-ancestor
6568716|NCT00989729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6568717|NCT00989729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6568718|NCT00989742|Doxycycline|doxycycline|mesh-list
6568719|NCT00989742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6568720|NCT00989742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6568721|NCT00989742|Antimalarials|antimalarials|mesh-ancestor
6568722|NCT00989742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6568723|NCT00989742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6568724|NCT00989807|Aztreonam|aztreonam|mesh-list
6568725|NCT00989807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6568726|NCT00989807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6568727|NCT00989820|Coal Tar|coal tar|mesh-list
6568728|NCT00989820|Keratolytic Agents|keratolytic agents|mesh-ancestor
6568729|NCT00989820|Dermatologic Agents|dermatologic agents|mesh-ancestor
6568730|NCT00989898|Insulin|insulin|mesh-list
6568731|NCT00989898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6568732|NCT00989898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568733|NCT00990028|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6568734|NCT00990028|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6568735|NCT00990028|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6568736|NCT00990028|Antimetabolites|antimetabolites|mesh-ancestor
6568737|NCT00990028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568738|NCT00990028|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6568739|NCT00990028|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6568740|NCT00990028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6568741|NCT00990054|Plerixafor|plerixafor|mesh-list
6568742|NCT00990054|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6568743|NCT00990054|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6568744|NCT00990054|Antiviral Agents|antiviral agents|mesh-ancestor
6445231|NCT00386997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6445232|NCT00386997|Antifungal Agents|antifungal agents|mesh-ancestor
6568745|NCT00990054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6568746|NCT00990067|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6568747|NCT00990067|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
6568748|NCT00990067|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6568749|NCT00990067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6568750|NCT00990067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6568751|NCT00990067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568752|NCT00990067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6568753|NCT00990067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568754|NCT00990067|Analgesics|analgesics|mesh-ancestor
6020067|NCT00391443|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6020068|NCT00391443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053224|NCT00593645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6053225|NCT00593645|Immunologic Factors|immunologic factors|mesh-ancestor
6053226|NCT00593645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053227|NCT00593827|Epothilones|epothilones|mesh-list
6445233|NCT00387114|Ascorbic Acid|ascorbic acid|mesh-list
6445234|NCT00387114|Vitamins|vitamins|mesh-ancestor
6445235|NCT00387114|Micronutrients|micronutrients|mesh-ancestor
6445236|NCT00387114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445237|NCT00387114|Antioxidants|antioxidants|mesh-ancestor
6445238|NCT00387114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445239|NCT00387114|Protective Agents|protective agents|mesh-ancestor
6445240|NCT00387179|Melatonin|melatonin|mesh-list
6445241|NCT00387179|Antioxidants|antioxidants|mesh-ancestor
6445242|NCT00387179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445243|NCT00387179|Protective Agents|protective agents|mesh-ancestor
6445244|NCT00387179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445245|NCT00387179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6445246|NCT00387309|Methylnaltrexone|methylnaltrexone|mesh-list
5501420|NCT04474327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501421|NCT04474366|Ropivacaine|ropivacaine|mesh-list
5501422|NCT04474366|Anesthetics, Local|anesthetics, local|mesh-ancestor
5501423|NCT04474366|Anesthetics|anesthetics|mesh-ancestor
5501424|NCT04474366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6568755|NCT00990067|Sensory System Agents|sensory system agents|mesh-ancestor
6568756|NCT00990067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6568757|NCT00990067|Antidepressive Agents|antidepressive agents|mesh-ancestor
6568758|NCT00990067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6568759|NCT00990067|Dopamine Agents|dopamine agents|mesh-ancestor
6568760|NCT00990067|Hallucinogens|hallucinogens|mesh-ancestor
6568761|NCT00990067|Serotonin Agents|serotonin agents|mesh-ancestor
6568762|NCT00990067|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6568763|NCT00990067|Adrenergic Agents|adrenergic agents|mesh-ancestor
6568764|NCT00990158|Vitamin K|vitamin k|mesh-list
6568765|NCT00990158|Vitamin K 1|vitamin k 1|mesh-list
6568766|NCT00990158|Vitamins|vitamins|mesh-ancestor
6568767|NCT00990158|Micronutrients|micronutrients|mesh-ancestor
6568768|NCT00990158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568769|NCT00990158|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6568770|NCT00990158|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6568771|NCT00990158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568772|NCT00990158|Hemostatics|hemostatics|mesh-ancestor
6445247|NCT00387309|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6445248|NCT00387309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445249|NCT00387309|Sensory System Agents|sensory system agents|mesh-ancestor
6568773|NCT00990158|Coagulants|coagulants|mesh-ancestor
6568774|NCT00990197|Nicotine|nicotine|mesh-list
6568775|NCT00990197|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6568776|NCT00990197|Autonomic Agents|autonomic agents|mesh-ancestor
6568777|NCT00990197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6568778|NCT00990197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568779|NCT00990197|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6568780|NCT00990197|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6568781|NCT00990197|Cholinergic Agents|cholinergic agents|mesh-ancestor
6568782|NCT00990197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6568783|NCT00990197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568784|NCT00990223|Eplerenone|eplerenone|mesh-list
6568785|NCT00990223|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6568786|NCT00990223|Hormone Antagonists|hormone antagonists|mesh-ancestor
6568787|NCT00990223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6568788|NCT00990223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568789|NCT00990223|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6568790|NCT00990223|Diuretics|diuretics|mesh-ancestor
6568791|NCT00990223|Natriuretic Agents|natriuretic agents|mesh-ancestor
6568792|NCT00990223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6568793|NCT00990275|Ethanol|ethanol|mesh-list
6568794|NCT00990275|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6568795|NCT00990275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6445250|NCT00387309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6445251|NCT00387322|Pemetrexed|pemetrexed|mesh-list
6445252|NCT00387322|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6445253|NCT00387322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6445254|NCT00387322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6445255|NCT00387322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445256|NCT00387322|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6445257|NCT00387322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6445258|NCT00387322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6445259|NCT00387374|Paclitaxel|paclitaxel|mesh-list
6445260|NCT00387374|Bevacizumab|bevacizumab|mesh-list
6445261|NCT00387374|Carboplatin|carboplatin|mesh-list
6445262|NCT00387374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6445263|NCT00387374|Antibodies|antibodies|mesh-list
6445264|NCT00387374|Immunoglobulins|immunoglobulins|mesh-list
6445265|NCT00387374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6445266|NCT00387374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6445267|NCT00387374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6568796|NCT00990275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6568797|NCT00990275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568798|NCT00990301|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6568799|NCT00990301|Moexipril|moexipril|mesh-list
6568800|NCT00990301|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6568801|NCT00990301|Diuretics|diuretics|mesh-ancestor
6568802|NCT00990301|Natriuretic Agents|natriuretic agents|mesh-ancestor
6568803|NCT00990301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568804|NCT00990301|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6568805|NCT00990301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6568806|NCT00990301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568807|NCT00990301|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6568808|NCT00990301|Protease Inhibitors|protease inhibitors|mesh-ancestor
6568809|NCT00990301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6568810|NCT00990392|Polymyxins|polymyxins|mesh-list
6568811|NCT00990392|Bacitracin|bacitracin|mesh-list
6568812|NCT00990392|Polymyxin B|polymyxin b|mesh-list
6568813|NCT00990392|Gramicidin|gramicidin|mesh-list
6568814|NCT00990392|Petrolatum|petrolatum|mesh-list
6568815|NCT00990392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6568816|NCT00990392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6568817|NCT00990392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6568818|NCT00990392|Emollients|emollients|mesh-ancestor
6568819|NCT00990392|Dermatologic Agents|dermatologic agents|mesh-ancestor
6568820|NCT00990405|Amoxicillin|amoxicillin|mesh-list
6568821|NCT00990405|Clarithromycin|clarithromycin|mesh-list
6568822|NCT00990405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6568823|NCT00990405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6568824|NCT00990405|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6568825|NCT00990405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6568826|NCT00990405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568827|NCT00990405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6568828|NCT00990405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6568829|NCT00990418|Fentanyl|fentanyl|mesh-list
6568830|NCT00990418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6568831|NCT00990418|Narcotics|narcotics|mesh-ancestor
6568832|NCT00990418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6568833|NCT00990418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568834|NCT00990418|Analgesics|analgesics|mesh-ancestor
6568835|NCT00990418|Sensory System Agents|sensory system agents|mesh-ancestor
6568836|NCT00990418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6568837|NCT00990418|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6568838|NCT00990418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6568839|NCT00990418|Anesthetics, General|anesthetics, general|mesh-ancestor
6568840|NCT00990418|Anesthetics|anesthetics|mesh-ancestor
6568841|NCT00990444|Insulin|insulin|mesh-list
6568842|NCT00990444|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6568843|NCT00990444|Dextrans|dextrans|mesh-list
6568844|NCT00990444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6568845|NCT00990444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568846|NCT00990444|Anticoagulants|anticoagulants|mesh-ancestor
6568847|NCT00990444|Plasma Substitutes|plasma substitutes|mesh-ancestor
6568848|NCT00990444|Blood Substitutes|blood substitutes|mesh-ancestor
6568849|NCT00990496|Cyclophosphamide|cyclophosphamide|mesh-list
6568850|NCT00990496|Fludarabine|fludarabine|mesh-list
6568851|NCT00990496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6568852|NCT00990496|Immunologic Factors|immunologic factors|mesh-ancestor
6568853|NCT00990496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568854|NCT00990496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6568855|NCT00990496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6568856|NCT00990496|Alkylating Agents|alkylating agents|mesh-ancestor
6568857|NCT00990496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568858|NCT00990496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6568859|NCT00990496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6568860|NCT00990535|Octreotide|octreotide|mesh-list
6568861|NCT00990535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6568862|NCT00990535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6568863|NCT00990535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6568864|NCT00990574|Anesthetics|anesthetics|mesh-list
6568865|NCT00990574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6568866|NCT00990574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568867|NCT00990587|Ciclopirox|ciclopirox|mesh-list
6568868|NCT00990587|Antifungal Agents|antifungal agents|mesh-ancestor
6568869|NCT00990587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6568870|NCT00990600|Tenofovir|tenofovir|mesh-list
6568871|NCT00990600|Emtricitabine|emtricitabine|mesh-list
6568872|NCT00990600|Efavirenz|efavirenz|mesh-list
6568873|NCT00990600|Antiviral Agents|antiviral agents|mesh-ancestor
6568874|NCT00990600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6568875|NCT00990600|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6568876|NCT00990600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6568877|NCT00990600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6568878|NCT00990600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568879|NCT00990600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6568880|NCT00990600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6568881|NCT00990600|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6568882|NCT00990600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6568883|NCT00990600|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6568884|NCT00990600|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6568885|NCT00990600|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6568886|NCT00990600|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6568887|NCT00990639|Candesartan|candesartan|mesh-list
6568888|NCT00990639|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6568889|NCT00990639|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6568890|NCT00990639|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6568891|NCT00990639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568892|NCT00990678|Vitamin D|vitamin d|mesh-list
6568893|NCT00990678|Calcitriol|calcitriol|mesh-list
6568894|NCT00990678|Calcium|calcium|mesh-list
6568895|NCT00990678|Vitamins|vitamins|mesh-ancestor
6568896|NCT00990678|Micronutrients|micronutrients|mesh-ancestor
6568897|NCT00990678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568898|NCT00990678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6568899|NCT00990678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6568900|NCT00990678|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6568901|NCT00990678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6568902|NCT00990678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568903|NCT00990678|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6568904|NCT00990691|Desipramine|desipramine|mesh-list
6568905|NCT00990691|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6568906|NCT00990691|Antidepressive Agents|antidepressive agents|mesh-ancestor
6568907|NCT00990691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6568908|NCT00990691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6568909|NCT00990691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568910|NCT00990691|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6568911|NCT00990691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6568912|NCT00990691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6568913|NCT00990691|Adrenergic Agents|adrenergic agents|mesh-ancestor
6568914|NCT00990691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6568915|NCT00990691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568916|NCT00990795|Cyclosporine|cyclosporine|mesh-list
6568917|NCT00990795|Cyclosporins|cyclosporins|mesh-list
6568918|NCT00990795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6568919|NCT00990795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568920|NCT00990795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6568921|NCT00990795|Immunologic Factors|immunologic factors|mesh-ancestor
6568922|NCT00990795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568923|NCT00990795|Antifungal Agents|antifungal agents|mesh-ancestor
6568924|NCT00990795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6568925|NCT00990795|Dermatologic Agents|dermatologic agents|mesh-ancestor
6568926|NCT00990795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6568927|NCT00990795|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6568928|NCT00990808|Atorvastatin|atorvastatin|mesh-list
6568929|NCT00990808|Anacetrapib|anacetrapib|mesh-list
6568930|NCT00990808|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6568931|NCT00990808|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6568932|NCT00990808|Antimetabolites|antimetabolites|mesh-ancestor
6568933|NCT00990808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568934|NCT00990808|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6568935|NCT00990808|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6568936|NCT00990808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6568937|NCT00990834|Simvastatin|simvastatin|mesh-list
6445268|NCT00387374|Tubulin Modulators|tubulin modulators|mesh-ancestor
6568938|NCT00990834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6568939|NCT00990834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6568940|NCT00990834|Antimetabolites|antimetabolites|mesh-ancestor
6568941|NCT00990834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568942|NCT00990834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6568943|NCT00990834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6568944|NCT00990834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6568945|NCT00990847|Procaterol|procaterol|mesh-list
6568946|NCT00990847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6568947|NCT00990847|Autonomic Agents|autonomic agents|mesh-ancestor
6568948|NCT00990847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6568949|NCT00990847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568950|NCT00990847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6568951|NCT00990847|Respiratory System Agents|respiratory system agents|mesh-ancestor
6568952|NCT00990847|Sympathomimetics|sympathomimetics|mesh-ancestor
6445269|NCT00387374|Antimitotic Agents|antimitotic agents|mesh-ancestor
6445270|NCT00387374|Mitosis Modulators|mitosis modulators|mesh-ancestor
6445271|NCT00387374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445272|NCT00387374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6445273|NCT00387374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6445274|NCT00387374|Growth Substances|growth substances|mesh-ancestor
6445275|NCT00387374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445276|NCT00387374|Growth Inhibitors|growth inhibitors|mesh-ancestor
6445277|NCT00387374|Immunologic Factors|immunologic factors|mesh-ancestor
6568953|NCT00990847|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6568954|NCT00990847|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6568955|NCT00990847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6568956|NCT00990847|Adrenergic Agents|adrenergic agents|mesh-ancestor
6568957|NCT00990847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6568958|NCT00990847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568959|NCT00990860|Doxorubicin|doxorubicin|mesh-list
6568960|NCT00990860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6568961|NCT00990860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6568962|NCT00990860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6568963|NCT00990860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6568964|NCT00990860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6568965|NCT00990860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568966|NCT00990886|Oxybutynin|oxybutynin|mesh-list
6568967|NCT00990886|Parasympatholytics|parasympatholytics|mesh-ancestor
6568968|NCT00990886|Autonomic Agents|autonomic agents|mesh-ancestor
6568969|NCT00990886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6568970|NCT00990886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568971|NCT00990886|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6568972|NCT00990886|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6568973|NCT00990886|Cholinergic Agents|cholinergic agents|mesh-ancestor
6568974|NCT00990886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6568975|NCT00990886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568976|NCT00990886|Urological Agents|urological agents|mesh-ancestor
6568977|NCT00990990|Linezolid|linezolid|mesh-list
6568978|NCT00990990|Oxazolidinones|oxazolidinones|mesh-list
6568979|NCT00990990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6568980|NCT00990990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6568981|NCT00990990|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6568982|NCT00990990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6568983|NCT00990990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568984|NCT00991055|Pioglitazone|pioglitazone|mesh-list
6568985|NCT00991055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6568986|NCT00991055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6568987|NCT00991133|Clofarabine|clofarabine|mesh-list
6568988|NCT00991133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6568989|NCT00991133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568990|NCT00991133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6568991|NCT00991133|Antimetabolites|antimetabolites|mesh-ancestor
6568992|NCT00991159|Bococizumab|bococizumab|mesh-list
6568993|NCT00991159|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6568994|NCT00991159|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6568995|NCT00991159|Antimetabolites|antimetabolites|mesh-ancestor
6568996|NCT00991159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6568997|NCT00991159|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6568998|NCT00991211|Cyclophosphamide|cyclophosphamide|mesh-list
6568999|NCT00991211|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6569000|NCT00991211|Doxorubicin|doxorubicin|mesh-list
6569001|NCT00991211|Vincristine|vincristine|mesh-list
6569002|NCT00991211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6569003|NCT00991211|Immunologic Factors|immunologic factors|mesh-ancestor
6569004|NCT00991211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569005|NCT00991211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6569006|NCT00991211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6569007|NCT00991211|Alkylating Agents|alkylating agents|mesh-ancestor
6569008|NCT00991211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569009|NCT00991211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6569010|NCT00991211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6569011|NCT00991211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6569012|NCT00991211|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6569013|NCT00991211|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6569014|NCT00991211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6569015|NCT00991211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6569016|NCT00991211|Tubulin Modulators|tubulin modulators|mesh-ancestor
6569017|NCT00991211|Antimitotic Agents|antimitotic agents|mesh-ancestor
6569018|NCT00991211|Mitosis Modulators|mitosis modulators|mesh-ancestor
6657534|NCT01476787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6657535|NCT01476787|Alkylating Agents|alkylating agents|mesh-ancestor
6657536|NCT01476787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657537|NCT01476800|Ketoconazole|ketoconazole|mesh-list
6657538|NCT01476800|Mirabegron|mirabegron|mesh-list
6657539|NCT01476800|Antifungal Agents|antifungal agents|mesh-ancestor
6657540|NCT01476800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6657541|NCT01476800|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6657542|NCT01476800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6657543|NCT01476800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6657544|NCT01476800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020069|NCT00391586|Gemcitabine|gemcitabine|mesh-list
6020070|NCT00391586|Paclitaxel|paclitaxel|mesh-list
6020071|NCT00391586|Etoposide|etoposide|mesh-list
6020072|NCT00391586|Vinorelbine|vinorelbine|mesh-list
6020073|NCT00391586|Docetaxel|docetaxel|mesh-list
6020074|NCT00391586|Irinotecan|irinotecan|mesh-list
6020075|NCT00391586|Pemetrexed|pemetrexed|mesh-list
6569019|NCT00991250|Temozolomide|temozolomide|mesh-list
6569020|NCT00991250|Dacarbazine|dacarbazine|mesh-list
6569021|NCT00991250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6569022|NCT00991250|Alkylating Agents|alkylating agents|mesh-ancestor
6569023|NCT00991250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569024|NCT00991250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6569025|NCT00991562|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
6569026|NCT00991562|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
6569027|NCT00991562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6569028|NCT00991562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6569029|NCT00991562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6569030|NCT00991562|Tubulin Modulators|tubulin modulators|mesh-ancestor
6569031|NCT00991562|Antimitotic Agents|antimitotic agents|mesh-ancestor
6569032|NCT00991562|Mitosis Modulators|mitosis modulators|mesh-ancestor
6569033|NCT00991562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569034|NCT00991627|Atropine|atropine|mesh-list
6569035|NCT00991627|Ephedrine|ephedrine|mesh-list
6569036|NCT00991627|Pseudoephedrine|pseudoephedrine|mesh-list
6569037|NCT00991627|Morphine|morphine|mesh-list
6569038|NCT00991627|Bupivacaine|bupivacaine|mesh-list
6569039|NCT00991627|Anesthetics, Local|anesthetics, local|mesh-list
6569040|NCT00991627|Anesthetics|anesthetics|mesh-list
6569041|NCT00991627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6569042|NCT00991627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569043|NCT00991627|Sensory System Agents|sensory system agents|mesh-ancestor
6569044|NCT00991627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6569045|NCT00991627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6569046|NCT00991627|Narcotics|narcotics|mesh-ancestor
6569047|NCT00991627|Analgesics|analgesics|mesh-ancestor
6569048|NCT00991627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6569049|NCT00991627|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6569050|NCT00991627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6569051|NCT00991627|Autonomic Agents|autonomic agents|mesh-ancestor
6569052|NCT00991627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6569053|NCT00991627|Respiratory System Agents|respiratory system agents|mesh-ancestor
6569054|NCT00991627|Mydriatics|mydriatics|mesh-ancestor
6569055|NCT00991627|Parasympatholytics|parasympatholytics|mesh-ancestor
6569056|NCT00991627|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6569057|NCT00991627|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6569058|NCT00991627|Cholinergic Agents|cholinergic agents|mesh-ancestor
6569059|NCT00991627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6569060|NCT00991627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569061|NCT00991627|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6569062|NCT00991627|Sympathomimetics|sympathomimetics|mesh-ancestor
6569063|NCT00991627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6569064|NCT00991627|Adrenergic Agents|adrenergic agents|mesh-ancestor
6569065|NCT00991627|Nasal Decongestants|nasal decongestants|mesh-ancestor
6569066|NCT00991705|Atorvastatin|atorvastatin|mesh-list
6569067|NCT00991705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6569068|NCT00991705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6569069|NCT00991705|Antimetabolites|antimetabolites|mesh-ancestor
6569070|NCT00991705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569071|NCT00991705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6569072|NCT00991705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6569073|NCT00991705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6569074|NCT00991744|Cytarabine|cytarabine|mesh-list
6569075|NCT00991744|Cortisone|cortisone|mesh-list
6569076|NCT00991744|Prednisolone|prednisolone|mesh-list
6569077|NCT00991744|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6569078|NCT00991744|Methylprednisolone|methylprednisolone|mesh-list
6569079|NCT00991744|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6569080|NCT00991744|Prednisolone acetate|prednisolone acetate|mesh-list
6569081|NCT00991744|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6569082|NCT00991744|Prednisolone phosphate|prednisolone phosphate|mesh-list
6569083|NCT00991744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6569084|NCT00991744|Antimetabolites|antimetabolites|mesh-ancestor
6569085|NCT00991744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445278|NCT00387400|Everolimus|everolimus|mesh-list
6445279|NCT00387400|Temozolomide|temozolomide|mesh-list
6445280|NCT00387400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6445281|NCT00387400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6445282|NCT00387400|Immunologic Factors|immunologic factors|mesh-ancestor
6445283|NCT00387400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445284|NCT00387400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6445285|NCT00387400|Alkylating Agents|alkylating agents|mesh-ancestor
6445286|NCT00387400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445287|NCT00387413|Niacinamide|niacinamide|mesh-list
6445288|NCT00387413|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6569086|NCT00991744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6569087|NCT00991744|Antiviral Agents|antiviral agents|mesh-ancestor
6569088|NCT00991744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6569089|NCT00991744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6569090|NCT00991744|Immunologic Factors|immunologic factors|mesh-ancestor
6569091|NCT00991744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569092|NCT00991744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6569093|NCT00991744|Glucocorticoids|glucocorticoids|mesh-ancestor
6569094|NCT00991744|Hormones|hormones|mesh-ancestor
6569095|NCT00991744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6569096|NCT00991744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6569097|NCT00991744|Antiemetics|antiemetics|mesh-ancestor
6569098|NCT00991744|Autonomic Agents|autonomic agents|mesh-ancestor
6569099|NCT00991744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6569100|NCT00991744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6569101|NCT00991744|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6569102|NCT00991744|Protective Agents|protective agents|mesh-ancestor
6569103|NCT00991783|Digoxin|digoxin|mesh-list
6569104|NCT00991783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6569105|NCT00991783|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6569106|NCT00991783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6569107|NCT00991783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569108|NCT00991783|Protective Agents|protective agents|mesh-ancestor
6569109|NCT00991783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569110|NCT00991796|Paclitaxel|paclitaxel|mesh-list
6569111|NCT00991796|Carboplatin|carboplatin|mesh-list
6569112|NCT00991796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6569113|NCT00991796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6569114|NCT00991796|Tubulin Modulators|tubulin modulators|mesh-ancestor
6569115|NCT00991796|Antimitotic Agents|antimitotic agents|mesh-ancestor
6569116|NCT00991796|Mitosis Modulators|mitosis modulators|mesh-ancestor
6569117|NCT00991796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569118|NCT00991822|Timolol|timolol|mesh-list
6569119|NCT00991822|Dorzolamide|dorzolamide|mesh-list
6569120|NCT00991822|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6569121|NCT00991822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6569122|NCT00991822|Adrenergic Agents|adrenergic agents|mesh-ancestor
6569123|NCT00991822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6569124|NCT00991822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569125|NCT00991822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569126|NCT00991822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6569127|NCT00991822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6569128|NCT00991822|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6569129|NCT00991822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6569130|NCT00991848|Lidocaine|lidocaine|mesh-list
6569131|NCT00991848|Anesthetics, Local|anesthetics, local|mesh-ancestor
6569132|NCT00991848|Anesthetics|anesthetics|mesh-ancestor
6569133|NCT00991848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6569134|NCT00991848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569135|NCT00991848|Sensory System Agents|sensory system agents|mesh-ancestor
6569136|NCT00991848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6569137|NCT00991848|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6569138|NCT00991848|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6569139|NCT00991848|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6569140|NCT00991848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6569141|NCT00991848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569142|NCT00991926|Orlistat|orlistat|mesh-list
6569143|NCT00991926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6569144|NCT00991926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569145|NCT00991926|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6569146|NCT00991926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6569147|NCT00991978|Bevacizumab|bevacizumab|mesh-list
6569148|NCT00991978|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
6569149|NCT00991978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6569150|NCT00991978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6569151|NCT00991978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6569152|NCT00991978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6569153|NCT00991978|Growth Substances|growth substances|mesh-ancestor
6445289|NCT00387413|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6445290|NCT00387413|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6569154|NCT00991978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569155|NCT00991978|Growth Inhibitors|growth inhibitors|mesh-ancestor
6569156|NCT00991978|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6569157|NCT00991978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569158|NCT00992004|Turmeric extract|turmeric extract|mesh-list
6569159|NCT00992004|Antioxidants|antioxidants|mesh-ancestor
6569160|NCT00992004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569161|NCT00992004|Protective Agents|protective agents|mesh-ancestor
6569162|NCT00992004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569163|NCT00992030|Rituximab|rituximab|mesh-list
6569164|NCT00992030|Doxorubicin|doxorubicin|mesh-list
6445291|NCT00387413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6445292|NCT00387413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445293|NCT00387413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6445294|NCT00387413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445295|NCT00387413|Analgesics|analgesics|mesh-ancestor
6445296|NCT00387413|Sensory System Agents|sensory system agents|mesh-ancestor
6445297|NCT00387413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6445298|NCT00387413|Antidepressive Agents|antidepressive agents|mesh-ancestor
6445299|NCT00387413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6445300|NCT00387413|Dopamine Agents|dopamine agents|mesh-ancestor
6445301|NCT00387413|Vitamin B Complex|vitamin b complex|mesh-ancestor
6445302|NCT00387413|Vitamins|vitamins|mesh-ancestor
6445303|NCT00387413|Micronutrients|micronutrients|mesh-ancestor
6445304|NCT00387504|Fenretinide|fenretinide|mesh-list
6445305|NCT00387504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6445306|NCT00387504|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6445307|NCT00387504|Protective Agents|protective agents|mesh-ancestor
6445308|NCT00387504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445309|NCT00387530|Valganciclovir|valganciclovir|mesh-list
6445310|NCT00387530|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
6445311|NCT00387530|Antiviral Agents|antiviral agents|mesh-ancestor
6445312|NCT00387530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6445313|NCT00387530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6445314|NCT00387556|Ondansetron|ondansetron|mesh-list
6445315|NCT00387556|Antiemetics|antiemetics|mesh-ancestor
6445316|NCT00387556|Autonomic Agents|autonomic agents|mesh-ancestor
6445317|NCT00387556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6445318|NCT00387556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445319|NCT00387556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6445320|NCT00387556|Antipruritics|antipruritics|mesh-ancestor
6445321|NCT00387556|Dermatologic Agents|dermatologic agents|mesh-ancestor
6445322|NCT00387556|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6445323|NCT00387556|Serotonin Agents|serotonin agents|mesh-ancestor
6445324|NCT00387556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6445325|NCT00387556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445326|NCT00387556|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6445327|NCT00387556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6445328|NCT00387556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6445329|NCT00387556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6445330|NCT00387556|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6445331|NCT00387569|Vaccines|vaccines|mesh-list
6445332|NCT00387569|Immunologic Factors|immunologic factors|mesh-ancestor
6445333|NCT00387569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445334|NCT00387582|Ranibizumab|ranibizumab|mesh-list
6445335|NCT00387582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6445336|NCT00387582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6445337|NCT00387582|Growth Substances|growth substances|mesh-ancestor
6445338|NCT00387582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445339|NCT00387582|Growth Inhibitors|growth inhibitors|mesh-ancestor
6445340|NCT00387582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6445341|NCT00387608|Veliparib|veliparib|mesh-list
6445342|NCT00387608|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6445343|NCT00387608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6445344|NCT00387608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445345|NCT00387608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6445346|NCT00387699|Bevacizumab|bevacizumab|mesh-list
6445347|NCT00387699|Etoposide|etoposide|mesh-list
6445348|NCT00387699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6445349|NCT00387699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6445350|NCT00387699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6445351|NCT00387699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6445352|NCT00387699|Growth Substances|growth substances|mesh-ancestor
6445353|NCT00387699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445354|NCT00387699|Growth Inhibitors|growth inhibitors|mesh-ancestor
6445355|NCT00387699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6445356|NCT00387699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6445357|NCT00387699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6445358|NCT00387699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6445359|NCT00387699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445360|NCT00387738|Histamine|histamine|mesh-list
6569165|NCT00992030|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6569166|NCT00992030|Dacarbazine|dacarbazine|mesh-list
6569167|NCT00992030|Bleomycin|bleomycin|mesh-list
6569168|NCT00992030|Vinblastine|vinblastine|mesh-list
6569169|NCT00992030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6569170|NCT00992030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6569171|NCT00992030|Immunologic Factors|immunologic factors|mesh-ancestor
6569172|NCT00992030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569173|NCT00992030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6569174|NCT00992030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6569175|NCT00992030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6569176|NCT00992030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6569177|NCT00992030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6569178|NCT00992030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569179|NCT00992030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6569180|NCT00992030|Alkylating Agents|alkylating agents|mesh-ancestor
6569181|NCT00992030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6569182|NCT00992030|Tubulin Modulators|tubulin modulators|mesh-ancestor
6569183|NCT00992030|Antimitotic Agents|antimitotic agents|mesh-ancestor
6569184|NCT00992030|Mitosis Modulators|mitosis modulators|mesh-ancestor
6569185|NCT00992069|Efavirenz|efavirenz|mesh-list
6569186|NCT00992069|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6569187|NCT00992069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6569188|NCT00992069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6569189|NCT00992069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569190|NCT00992069|Antiviral Agents|antiviral agents|mesh-ancestor
6569191|NCT00992069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6569192|NCT00992069|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6569193|NCT00992069|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6569194|NCT00992069|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6569195|NCT00992069|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6569196|NCT00992069|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6569197|NCT00992069|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6569198|NCT00992082|Ketorolac|ketorolac|mesh-list
6569199|NCT00992082|Epinephrine|epinephrine|mesh-list
6569200|NCT00992082|Morphine|morphine|mesh-list
6569201|NCT00992082|Ropivacaine|ropivacaine|mesh-list
6569202|NCT00992082|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6569203|NCT00992082|Narcotics|narcotics|mesh-ancestor
6569204|NCT00992082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6569205|NCT00992082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569206|NCT00992082|Analgesics|analgesics|mesh-ancestor
6569207|NCT00992082|Sensory System Agents|sensory system agents|mesh-ancestor
6569208|NCT00992082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6569209|NCT00992082|Anesthetics, Local|anesthetics, local|mesh-ancestor
6569210|NCT00992082|Anesthetics|anesthetics|mesh-ancestor
6569211|NCT00992082|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6569212|NCT00992082|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6569213|NCT00992082|Adrenergic Agents|adrenergic agents|mesh-ancestor
6569214|NCT00992082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6569215|NCT00992082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569216|NCT00992082|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6569217|NCT00992082|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6569218|NCT00992082|Autonomic Agents|autonomic agents|mesh-ancestor
6569219|NCT00992082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6569220|NCT00992082|Respiratory System Agents|respiratory system agents|mesh-ancestor
6569221|NCT00992082|Mydriatics|mydriatics|mesh-ancestor
6569222|NCT00992082|Sympathomimetics|sympathomimetics|mesh-ancestor
6569223|NCT00992082|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6569224|NCT00992082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6569225|NCT00992082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6569226|NCT00992082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6569227|NCT00992082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6569228|NCT00992082|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6569229|NCT00992082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6569230|NCT00992095|Buprenorphine|buprenorphine|mesh-list
6569231|NCT00992095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6569232|NCT00992095|Narcotics|narcotics|mesh-ancestor
6569233|NCT00992095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6569234|NCT00992095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569235|NCT00992095|Analgesics|analgesics|mesh-ancestor
6569236|NCT00992095|Sensory System Agents|sensory system agents|mesh-ancestor
6569237|NCT00992095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6569238|NCT00992095|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6569239|NCT00992121|Bevacizumab|bevacizumab|mesh-list
6569240|NCT00992121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6569241|NCT00992121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6569242|NCT00992121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6569243|NCT00992121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6569244|NCT00992121|Growth Substances|growth substances|mesh-ancestor
6569245|NCT00992121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569246|NCT00992121|Growth Inhibitors|growth inhibitors|mesh-ancestor
6569247|NCT00992134|Cytarabine|cytarabine|mesh-list
6569248|NCT00992134|Rituximab|rituximab|mesh-list
6569249|NCT00992134|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6569250|NCT00992134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6569251|NCT00992134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6569252|NCT00992134|Immunologic Factors|immunologic factors|mesh-ancestor
6569253|NCT00992134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569254|NCT00992134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6569255|NCT00992134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6569256|NCT00992134|Antimetabolites|antimetabolites|mesh-ancestor
6569257|NCT00992134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569258|NCT00992134|Antiviral Agents|antiviral agents|mesh-ancestor
6569259|NCT00992134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6569260|NCT00992134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6569261|NCT00992134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6569262|NCT00992134|Alkylating Agents|alkylating agents|mesh-ancestor
6569263|NCT00992160|Vestipitant|vestipitant|mesh-list
6569264|NCT00992160|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6569265|NCT00992160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6569266|NCT00992160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569267|NCT00992160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569268|NCT00992173|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
6569269|NCT00992173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6569270|NCT00992173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6569271|NCT00992173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569272|NCT00992173|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6569273|NCT00992199|Fluorouracil|fluorouracil|mesh-list
6569274|NCT00992199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6569275|NCT00992199|Antimetabolites|antimetabolites|mesh-ancestor
6569276|NCT00992199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569277|NCT00992199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6569278|NCT00992199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6569279|NCT00992199|Immunologic Factors|immunologic factors|mesh-ancestor
6569280|NCT00992199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569281|NCT00992238|Flavoxate|flavoxate|mesh-list
6569282|NCT00992238|Parasympatholytics|parasympatholytics|mesh-ancestor
6569283|NCT00992238|Autonomic Agents|autonomic agents|mesh-ancestor
6569284|NCT00992238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6569285|NCT00992238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569286|NCT00992238|Urological Agents|urological agents|mesh-ancestor
6569287|NCT00992329|Ciprofloxacin|ciprofloxacin|mesh-list
6569288|NCT00992329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6569289|NCT00992329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6569290|NCT00992329|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6569291|NCT00992329|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6569292|NCT00992329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6569293|NCT00992329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569294|NCT00992329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6569295|NCT00992329|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6569296|NCT00992329|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6569297|NCT00992355|Tobramycin|tobramycin|mesh-list
6569298|NCT00992355|Dexamethasone|dexamethasone|mesh-list
6569299|NCT00992355|Dexamethasone acetate|dexamethasone acetate|mesh-list
6569300|NCT00992355|Ketorolac|ketorolac|mesh-list
6569301|NCT00992355|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6569302|NCT00992355|BB 1101|bb 1101|mesh-list
6569303|NCT00992355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6569304|NCT00992355|Antiemetics|antiemetics|mesh-ancestor
6569305|NCT00992355|Autonomic Agents|autonomic agents|mesh-ancestor
6569306|NCT00992355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6569307|NCT00992355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569308|NCT00992355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6569309|NCT00992355|Glucocorticoids|glucocorticoids|mesh-ancestor
6569310|NCT00992355|Hormones|hormones|mesh-ancestor
6569311|NCT00992355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6569312|NCT00992355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6569313|NCT00992355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6569314|NCT00992355|Protease Inhibitors|protease inhibitors|mesh-ancestor
6569315|NCT00992355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6569316|NCT00992355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569317|NCT00992355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6569318|NCT00992355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6569319|NCT00992355|Analgesics|analgesics|mesh-ancestor
6569320|NCT00992355|Sensory System Agents|sensory system agents|mesh-ancestor
6569321|NCT00992355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6445361|NCT00387738|Histamine Agonists|histamine agonists|mesh-ancestor
6445362|NCT00387738|Histamine Agents|histamine agents|mesh-ancestor
6445363|NCT00387738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6445364|NCT00387738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445365|NCT00387738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445366|NCT00387777|Buprenorphine|buprenorphine|mesh-list
6445367|NCT00387777|Analgesics|analgesics|mesh-list
6445368|NCT00387777|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6445369|NCT00387777|Narcotics|narcotics|mesh-ancestor
6445370|NCT00387777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6445371|NCT00387777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569322|NCT00992355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6569323|NCT00992355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6569324|NCT00992355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6569325|NCT00992381|Naproxen|naproxen|mesh-list
6569326|NCT00992381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6445372|NCT00387777|Sensory System Agents|sensory system agents|mesh-ancestor
6445373|NCT00387777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6445374|NCT00387777|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6445375|NCT00387868|Etoposide|etoposide|mesh-list
6445376|NCT00387868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6569327|NCT00992381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6569328|NCT00992381|Analgesics|analgesics|mesh-ancestor
6569329|NCT00992381|Sensory System Agents|sensory system agents|mesh-ancestor
6569330|NCT00992381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6569331|NCT00992381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569332|NCT00992381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6569333|NCT00992381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6569334|NCT00992381|Gout Suppressants|gout suppressants|mesh-ancestor
6569335|NCT00992381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6569336|NCT00992381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6569337|NCT00992381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569338|NCT00992472|Prochlorperazine|prochlorperazine|mesh-list
6569339|NCT00992472|Antiemetics|antiemetics|mesh-ancestor
6569340|NCT00992472|Autonomic Agents|autonomic agents|mesh-ancestor
6569341|NCT00992472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6569342|NCT00992472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569343|NCT00992472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6569344|NCT00992472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6569345|NCT00992472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6569346|NCT00992472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6569347|NCT00992472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6569348|NCT00992472|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6569349|NCT00992472|Dopamine Agents|dopamine agents|mesh-ancestor
6053228|NCT00593827|Tubulin Modulators|tubulin modulators|mesh-ancestor
6569350|NCT00992472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6569351|NCT00992472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569352|NCT00992524|Misoprostol|misoprostol|mesh-list
6569353|NCT00992524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6569354|NCT00992524|Abortifacient Agents|abortifacient agents|mesh-ancestor
6569355|NCT00992524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6569356|NCT00992524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569357|NCT00992524|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6569358|NCT00992524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6569359|NCT00992524|Oxytocics|oxytocics|mesh-ancestor
6569360|NCT00992537|Insulin|insulin|mesh-list
6569361|NCT00992537|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6569362|NCT00992537|Insulin Aspart|insulin aspart|mesh-list
6569363|NCT00992537|Insulin, Long-Acting|insulin, long-acting|mesh-list
6569364|NCT00992537|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6569365|NCT00992537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6569366|NCT00992537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569367|NCT00992576|Hydromorphone|hydromorphone|mesh-list
6569368|NCT00992576|Naloxone|naloxone|mesh-list
6569369|NCT00992576|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6569370|NCT00992576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569371|NCT00992576|Sensory System Agents|sensory system agents|mesh-ancestor
6569372|NCT00992576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6569373|NCT00992576|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6569374|NCT00992576|Narcotics|narcotics|mesh-ancestor
6569375|NCT00992576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6569376|NCT00992576|Analgesics|analgesics|mesh-ancestor
6569377|NCT00992654|Maraviroc|maraviroc|mesh-list
6569378|NCT00992654|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6569379|NCT00992654|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6569380|NCT00992654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569381|NCT00992654|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6569382|NCT00992654|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6569383|NCT00992654|Antiviral Agents|antiviral agents|mesh-ancestor
6569384|NCT00992654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6569385|NCT00992654|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6569386|NCT00992667|Acetovanillone|acetovanillone|mesh-list
6569387|NCT00992667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6569388|NCT00992667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6569389|NCT00992667|Analgesics|analgesics|mesh-ancestor
6569390|NCT00992667|Sensory System Agents|sensory system agents|mesh-ancestor
6569391|NCT00992667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6569392|NCT00992667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569393|NCT00992667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6569394|NCT00992667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6569395|NCT00992667|Antioxidants|antioxidants|mesh-ancestor
6569396|NCT00992667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569397|NCT00992667|Protective Agents|protective agents|mesh-ancestor
6569398|NCT00992667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6569399|NCT00992693|Ribavirin|ribavirin|mesh-list
6569400|NCT00992693|Antimetabolites|antimetabolites|mesh-ancestor
6569401|NCT00992693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569402|NCT00992693|Antiviral Agents|antiviral agents|mesh-ancestor
6569403|NCT00992693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6569404|NCT00992706|Doxorubicin|doxorubicin|mesh-list
6569405|NCT00992706|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6569406|NCT00992706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6569407|NCT00992706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6569408|NCT00992706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6569409|NCT00992706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6569410|NCT00992706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6569411|NCT00992706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569412|NCT00992758|Tositumomab I-131|tositumomab i-131|mesh-list
6569413|NCT00992758|Antibodies|antibodies|mesh-list
6569414|NCT00992758|Immunologic Factors|immunologic factors|mesh-ancestor
6569415|NCT00992758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569416|NCT00992758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6569417|NCT00992771|Varenicline|varenicline|mesh-list
6569418|NCT00992771|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6569419|NCT00992771|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6569420|NCT00992771|Cholinergic Agents|cholinergic agents|mesh-ancestor
6569421|NCT00992771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6569422|NCT00992771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569423|NCT00992771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569424|NCT00992797|Vitamin D|vitamin d|mesh-list
6569425|NCT00992797|Cholecalciferol|cholecalciferol|mesh-list
6569426|NCT00992797|Vitamins|vitamins|mesh-ancestor
6569427|NCT00992797|Micronutrients|micronutrients|mesh-ancestor
6569428|NCT00992797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569429|NCT00992797|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6569430|NCT00992797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6569431|NCT00992823|Iron|iron|mesh-list
6569432|NCT00992823|Trace Elements|trace elements|mesh-ancestor
6569433|NCT00992823|Micronutrients|micronutrients|mesh-ancestor
6569434|NCT00992823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569435|NCT00992849|Bevacizumab|bevacizumab|mesh-list
6569436|NCT00992849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6569437|NCT00992849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6569438|NCT00992849|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6569439|NCT00992849|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6569440|NCT00992849|Growth Substances|growth substances|mesh-ancestor
6569441|NCT00992849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569442|NCT00992849|Growth Inhibitors|growth inhibitors|mesh-ancestor
6569443|NCT00992862|Moexipril|moexipril|mesh-list
6569444|NCT00992862|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6569445|NCT00992862|Protease Inhibitors|protease inhibitors|mesh-ancestor
6569446|NCT00992862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6569447|NCT00992862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569448|NCT00992862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6569449|NCT00992901|Atropine|atropine|mesh-list
6569450|NCT00992901|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6569451|NCT00992901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6569452|NCT00992901|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6569453|NCT00992901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6569454|NCT00992901|Autonomic Agents|autonomic agents|mesh-ancestor
6569455|NCT00992901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6569456|NCT00992901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569457|NCT00992901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6569458|NCT00992901|Respiratory System Agents|respiratory system agents|mesh-ancestor
6569459|NCT00992901|Mydriatics|mydriatics|mesh-ancestor
6569460|NCT00992901|Parasympatholytics|parasympatholytics|mesh-ancestor
6569461|NCT00992901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6569462|NCT00992901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6569463|NCT00992901|Cholinergic Agents|cholinergic agents|mesh-ancestor
6569464|NCT00992901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6569465|NCT00992901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569466|NCT00992901|Incretins|incretins|mesh-ancestor
6569467|NCT00992901|Hormones|hormones|mesh-ancestor
6569468|NCT00992901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6569469|NCT00992914|Lidocaine|lidocaine|mesh-list
6569470|NCT00992914|Anesthetics, Local|anesthetics, local|mesh-ancestor
6569471|NCT00992914|Anesthetics|anesthetics|mesh-ancestor
6569472|NCT00992914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6569473|NCT00992914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569474|NCT00992914|Sensory System Agents|sensory system agents|mesh-ancestor
6569475|NCT00992914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6569476|NCT00992914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6569477|NCT00992914|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6569478|NCT00992914|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6569479|NCT00992914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6569480|NCT00992914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724787|NCT03185143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724788|NCT03185195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5724789|NCT03184870|Leucovorin|leucovorin|mesh-list
6445377|NCT00387868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6445378|NCT00387868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6657545|NCT01476800|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6657546|NCT01476800|Hormone Antagonists|hormone antagonists|mesh-ancestor
6657547|NCT01476800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6657548|NCT01476800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657549|NCT01476800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6657550|NCT01476800|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6657551|NCT01476800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6657552|NCT01476800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6657553|NCT01476800|Adrenergic Agents|adrenergic agents|mesh-ancestor
6657554|NCT01476800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6657555|NCT01476800|Urological Agents|urological agents|mesh-ancestor
6664751|NCT01513785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6664752|NCT01513785|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6664753|NCT01513785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6664754|NCT01513785|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6664755|NCT01513785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6664756|NCT01513785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6664757|NCT01513811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6665112|NCT01515826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6665113|NCT01515826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665114|NCT01515826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6665115|NCT01515826|Glucocorticoids|glucocorticoids|mesh-ancestor
6665116|NCT01515826|Hormones|hormones|mesh-ancestor
6665117|NCT01515826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6445379|NCT00387868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6445380|NCT00387868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6445381|NCT00387868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445382|NCT00387920|Sunitinib|sunitinib|mesh-list
6445383|NCT00387920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6445384|NCT00387920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6445385|NCT00387920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6445386|NCT00387920|Growth Substances|growth substances|mesh-ancestor
6445387|NCT00387920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445388|NCT00387920|Growth Inhibitors|growth inhibitors|mesh-ancestor
6445389|NCT00387920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6445390|NCT00387920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6445391|NCT00387920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445392|NCT00387933|Imatinib Mesylate|imatinib mesylate|mesh-list
6445393|NCT00387933|Hydroxyurea|hydroxyurea|mesh-list
6445394|NCT00387933|Vatalanib|vatalanib|mesh-list
6445395|NCT00387933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6445396|NCT00387933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6569481|NCT00993057|Insulin|insulin|mesh-list
6569482|NCT00993057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6569483|NCT00993057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569484|NCT00993070|Capsaicin|capsaicin|mesh-list
6569485|NCT00993070|Antipruritics|antipruritics|mesh-ancestor
6569486|NCT00993070|Dermatologic Agents|dermatologic agents|mesh-ancestor
6569487|NCT00993070|Sensory System Agents|sensory system agents|mesh-ancestor
6569488|NCT00993070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6569489|NCT00993070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569490|NCT00993096|Insulin|insulin|mesh-list
6569491|NCT00993096|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6569492|NCT00993096|Insulin Aspart|insulin aspart|mesh-list
6569493|NCT00993096|Insulin, Long-Acting|insulin, long-acting|mesh-list
6569494|NCT00993096|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6569495|NCT00993096|Biphasic Insulins|biphasic insulins|mesh-list
6569496|NCT00993096|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6569497|NCT00993096|Insulin, Isophane|insulin, isophane|mesh-list
6569498|NCT00993096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6569499|NCT00993096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569500|NCT00993109|Valsartan|valsartan|mesh-list
6569501|NCT00993109|Nifedipine|nifedipine|mesh-list
6569502|NCT00993109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6569503|NCT00993109|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6569504|NCT00993109|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6569505|NCT00993109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569506|NCT00993109|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6569507|NCT00993109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6569508|NCT00993109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6569509|NCT00993109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569510|NCT00993109|Vasodilator Agents|vasodilator agents|mesh-ancestor
6569511|NCT00993109|Tocolytic Agents|tocolytic agents|mesh-ancestor
6569512|NCT00993109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6569513|NCT00993122|Ribavirin|ribavirin|mesh-list
6569514|NCT00993122|Antimetabolites|antimetabolites|mesh-ancestor
6569515|NCT00993122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569516|NCT00993122|Antiviral Agents|antiviral agents|mesh-ancestor
6569517|NCT00993122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6445397|NCT00387933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6445398|NCT00387933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445399|NCT00387933|Antisickling Agents|antisickling agents|mesh-ancestor
6445400|NCT00387933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6445401|NCT00388011|Morphine|morphine|mesh-list
6569518|NCT00993135|Methotrexate|methotrexate|mesh-list
6569519|NCT00993135|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6569520|NCT00993135|Abortifacient Agents|abortifacient agents|mesh-ancestor
6569521|NCT00993135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6569522|NCT00993135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569523|NCT00993135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6569524|NCT00993135|Antimetabolites|antimetabolites|mesh-ancestor
6569525|NCT00993135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569526|NCT00993135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6569527|NCT00993135|Dermatologic Agents|dermatologic agents|mesh-ancestor
6569528|NCT00993135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6569529|NCT00993135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6569530|NCT00993135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6569531|NCT00993135|Immunologic Factors|immunologic factors|mesh-ancestor
6569532|NCT00993135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6569533|NCT00993135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6569534|NCT00993304|Liraglutide|liraglutide|mesh-list
6569535|NCT00993304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6569536|NCT00993304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569537|NCT00993304|Incretins|incretins|mesh-ancestor
6569538|NCT00993304|Hormones|hormones|mesh-ancestor
6569539|NCT00993304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6569540|NCT00993343|Cyclosporine|cyclosporine|mesh-list
6569541|NCT00993343|Sirolimus|sirolimus|mesh-list
6569542|NCT00993343|Methotrexate|methotrexate|mesh-list
6569543|NCT00993343|Tacrolimus|tacrolimus|mesh-list
6569544|NCT00993343|Cyclosporins|cyclosporins|mesh-list
6569545|NCT00993343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6569546|NCT00993343|Abortifacient Agents|abortifacient agents|mesh-ancestor
6569547|NCT00993343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6569548|NCT00993343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569549|NCT00993343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6569550|NCT00993343|Antimetabolites|antimetabolites|mesh-ancestor
6569551|NCT00993343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569552|NCT00993343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6569553|NCT00993343|Dermatologic Agents|dermatologic agents|mesh-ancestor
5724790|NCT03184870|Gemcitabine|gemcitabine|mesh-list
6445402|NCT00388011|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6445403|NCT00388011|Narcotics|narcotics|mesh-ancestor
6445404|NCT00388011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6445405|NCT00388011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445406|NCT00388011|Analgesics|analgesics|mesh-ancestor
6445407|NCT00388011|Sensory System Agents|sensory system agents|mesh-ancestor
6445408|NCT00388011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6445409|NCT00388076|Paclitaxel|paclitaxel|mesh-list
6445410|NCT00388076|Carboplatin|carboplatin|mesh-list
6445411|NCT00388076|Lapatinib|lapatinib|mesh-list
6445412|NCT00388076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6445413|NCT00388076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6445414|NCT00388076|Tubulin Modulators|tubulin modulators|mesh-ancestor
6445415|NCT00388076|Antimitotic Agents|antimitotic agents|mesh-ancestor
6445416|NCT00388076|Mitosis Modulators|mitosis modulators|mesh-ancestor
6445417|NCT00388076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445418|NCT00388076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6445419|NCT00388076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6445420|NCT00388089|Bortezomib|bortezomib|mesh-list
6445421|NCT00388089|Topotecan|topotecan|mesh-list
6445422|NCT00388089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6445423|NCT00388089|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6445424|NCT00388089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6445425|NCT00388089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6445426|NCT00388089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445427|NCT00388128|Caffeine|caffeine|mesh-list
6445428|NCT00388128|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6445429|NCT00388128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569554|NCT00993343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6569555|NCT00993343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6569556|NCT00993343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6569557|NCT00993343|Immunologic Factors|immunologic factors|mesh-ancestor
6020076|NCT00391586|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6020077|NCT00391586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6020078|NCT00391586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6569558|NCT00993343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6569559|NCT00993343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6569560|NCT00993343|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6569561|NCT00993343|Antifungal Agents|antifungal agents|mesh-ancestor
6569562|NCT00993343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6569563|NCT00993343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6569564|NCT00993343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6569565|NCT00993356|Lanreotide|lanreotide|mesh-list
6569566|NCT00993356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6569567|NCT00993408|Selexipag|selexipag|mesh-list
6569568|NCT00993408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6569569|NCT00993512|Bleomycin|bleomycin|mesh-list
6569570|NCT00993512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6569571|NCT00993512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6569572|NCT00993525|Ranibizumab|ranibizumab|mesh-list
6569573|NCT00993525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6569574|NCT00993525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6569575|NCT00993525|Growth Substances|growth substances|mesh-ancestor
6569576|NCT00993525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569577|NCT00993525|Growth Inhibitors|growth inhibitors|mesh-ancestor
6569578|NCT00993525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6569579|NCT00993642|Panobinostat|panobinostat|mesh-list
6445430|NCT00388128|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6569580|NCT00993642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6569581|NCT00993642|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6569582|NCT00993642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6569583|NCT00993642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569584|NCT00993681|Vaccines|vaccines|mesh-list
6569585|NCT00993681|Immunologic Factors|immunologic factors|mesh-ancestor
6569586|NCT00993681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569587|NCT00993694|Dapsone|dapsone|mesh-list
6569588|NCT00993694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6569589|NCT00993694|Antimalarials|antimalarials|mesh-ancestor
6569590|NCT00993694|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6569591|NCT00993694|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6569592|NCT00993694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6569593|NCT00993694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6569594|NCT00993694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569595|NCT00993694|Leprostatic Agents|leprostatic agents|mesh-ancestor
6569596|NCT00993694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6569597|NCT00993707|Hyaluronic Acid|hyaluronic acid|mesh-list
6569598|NCT00993707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6569599|NCT00993707|Immunologic Factors|immunologic factors|mesh-ancestor
6569600|NCT00993707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569601|NCT00993707|Viscosupplements|viscosupplements|mesh-ancestor
6569602|NCT00993707|Protective Agents|protective agents|mesh-ancestor
6569603|NCT00993720|Liraglutide|liraglutide|mesh-list
6569604|NCT00993720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5724791|NCT03184870|Paclitaxel|paclitaxel|mesh-list
6445431|NCT00388128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6445432|NCT00388128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445433|NCT00388128|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6445434|NCT00388128|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6445435|NCT00388128|Purinergic Agents|purinergic agents|mesh-ancestor
6445436|NCT00388128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6445437|NCT00388167|Caspofungin|caspofungin|mesh-list
6445438|NCT00388167|Antifungal Agents|antifungal agents|mesh-ancestor
6445439|NCT00388167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6445440|NCT00388167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6445441|NCT00388167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445442|NCT00388193|Rituximab|rituximab|mesh-list
6445443|NCT00388193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6569605|NCT00993720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569606|NCT00993720|Incretins|incretins|mesh-ancestor
6569607|NCT00993720|Hormones|hormones|mesh-ancestor
6569608|NCT00993720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6569609|NCT00993733|Dialysis Solutions|dialysis solutions|mesh-list
6569610|NCT00993733|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6569611|NCT00993746|Lidocaine|lidocaine|mesh-list
6569612|NCT00993746|Bupivacaine|bupivacaine|mesh-list
6569613|NCT00993746|Anesthetics, Local|anesthetics, local|mesh-ancestor
6569614|NCT00993746|Anesthetics|anesthetics|mesh-ancestor
6569615|NCT00993746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6569616|NCT00993746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569617|NCT00993746|Sensory System Agents|sensory system agents|mesh-ancestor
6569618|NCT00993746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6569619|NCT00993746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6569620|NCT00993746|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6569621|NCT00993746|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6569622|NCT00993746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6569623|NCT00993746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569624|NCT00993863|Ibuprofen|ibuprofen|mesh-list
6569625|NCT00993863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6569626|NCT00993863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6569627|NCT00993863|Analgesics|analgesics|mesh-ancestor
6569628|NCT00993863|Sensory System Agents|sensory system agents|mesh-ancestor
6569629|NCT00993863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6569630|NCT00993863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569631|NCT00993863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6569632|NCT00993863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6569633|NCT00993863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6569634|NCT00993863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6569635|NCT00993863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569636|NCT00993876|Citalopram|citalopram|mesh-list
6569637|NCT00993876|Reboxetine|reboxetine|mesh-list
6569638|NCT00993876|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6569639|NCT00993876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6569640|NCT00993876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6569641|NCT00993876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569642|NCT00993876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6569643|NCT00993876|Serotonin Agents|serotonin agents|mesh-ancestor
6569644|NCT00993876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569645|NCT00993876|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6569646|NCT00993876|Antidepressive Agents|antidepressive agents|mesh-ancestor
6569647|NCT00993876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6569648|NCT00993876|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6569649|NCT00993876|Adrenergic Agents|adrenergic agents|mesh-ancestor
6569650|NCT00994006|Magnesium citrate|magnesium citrate|mesh-list
6569651|NCT00994006|Magnesium Oxide|magnesium oxide|mesh-list
6569652|NCT00994006|Levulinic acid|levulinic acid|mesh-list
6569653|NCT00994006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569654|NCT00994006|Cathartics|cathartics|mesh-ancestor
6569655|NCT00994006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6569656|NCT00994006|Antacids|antacids|mesh-ancestor
6569657|NCT00994006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6445444|NCT00388193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6445445|NCT00388193|Immunologic Factors|immunologic factors|mesh-ancestor
6445446|NCT00388193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445447|NCT00388193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6445448|NCT00388219|Buprenorphine|buprenorphine|mesh-list
6445449|NCT00388219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6569658|NCT00994071|Temozolomide|temozolomide|mesh-list
6445450|NCT00388219|Narcotics|narcotics|mesh-ancestor
6445451|NCT00388219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6445452|NCT00388219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569659|NCT00994071|Veliparib|veliparib|mesh-list
6569660|NCT00994071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6569661|NCT00994071|Alkylating Agents|alkylating agents|mesh-ancestor
6569662|NCT00994071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569663|NCT00994071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6569664|NCT00994071|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6569665|NCT00994071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6569666|NCT00994097|Gemcitabine|gemcitabine|mesh-list
6569667|NCT00994097|Pemetrexed|pemetrexed|mesh-list
6569668|NCT00994097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6569669|NCT00994097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6569670|NCT00994097|Antimetabolites|antimetabolites|mesh-ancestor
6569671|NCT00994097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569672|NCT00994097|Antiviral Agents|antiviral agents|mesh-ancestor
6569673|NCT00994097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6445453|NCT00388219|Analgesics|analgesics|mesh-ancestor
6445454|NCT00388219|Sensory System Agents|sensory system agents|mesh-ancestor
6445455|NCT00388219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6445456|NCT00388219|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6445457|NCT00388258|Alvimopan|alvimopan|mesh-list
6445458|NCT00388258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6445459|NCT00388271|Alfuzosin|alfuzosin|mesh-list
6445460|NCT00388271|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6445461|NCT00388271|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6445462|NCT00388271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6445463|NCT00388271|Adrenergic Agents|adrenergic agents|mesh-ancestor
6445464|NCT00388271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6445465|NCT00388271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445466|NCT00388271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445467|NCT00388271|Urological Agents|urological agents|mesh-ancestor
6445468|NCT00388336|Epoetin Alfa|epoetin alfa|mesh-list
6569674|NCT00994097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6569675|NCT00994097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6569676|NCT00994097|Immunologic Factors|immunologic factors|mesh-ancestor
6569677|NCT00994097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569678|NCT00994097|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6569679|NCT00994097|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6569680|NCT00994149|Diazoxide|diazoxide|mesh-list
6569681|NCT00994149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6569682|NCT00994149|Vasodilator Agents|vasodilator agents|mesh-ancestor
6569683|NCT00994253|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6569684|NCT00994253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6569685|NCT00994253|Diuretics|diuretics|mesh-ancestor
6569686|NCT00994253|Natriuretic Agents|natriuretic agents|mesh-ancestor
6569687|NCT00994253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569688|NCT00994253|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6569689|NCT00994253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6569690|NCT00994253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569691|NCT00994305|Acetylcysteine|acetylcysteine|mesh-list
6569692|NCT00994305|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6569693|NCT00994305|Antiviral Agents|antiviral agents|mesh-ancestor
6569694|NCT00994305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6569695|NCT00994305|Expectorants|expectorants|mesh-ancestor
6569696|NCT00994305|Respiratory System Agents|respiratory system agents|mesh-ancestor
6569697|NCT00994305|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6569698|NCT00994305|Antioxidants|antioxidants|mesh-ancestor
6569699|NCT00994305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569700|NCT00994305|Protective Agents|protective agents|mesh-ancestor
6569701|NCT00994305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569702|NCT00994305|Antidotes|antidotes|mesh-ancestor
6569703|NCT00994344|Ritonavir|ritonavir|mesh-list
6569704|NCT00994344|Lopinavir|lopinavir|mesh-list
6569705|NCT00994344|Darunavir|darunavir|mesh-list
6569706|NCT00994344|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6569707|NCT00994344|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6569708|NCT00994344|Protease Inhibitors|protease inhibitors|mesh-ancestor
6569709|NCT00994344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6569710|NCT00994344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569711|NCT00994344|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6569712|NCT00994344|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6569713|NCT00994344|Antiviral Agents|antiviral agents|mesh-ancestor
6569714|NCT00994344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6569715|NCT00994344|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6569716|NCT00994344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6569717|NCT00994383|Morphine|morphine|mesh-list
6445469|NCT00388336|Hematinics|hematinics|mesh-ancestor
6569718|NCT00994383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6569719|NCT00994383|Narcotics|narcotics|mesh-ancestor
6569720|NCT00994383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6569721|NCT00994383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569722|NCT00994383|Analgesics|analgesics|mesh-ancestor
6569723|NCT00994383|Sensory System Agents|sensory system agents|mesh-ancestor
6569724|NCT00994383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6569725|NCT00994396|Vitamin D|vitamin d|mesh-list
6569726|NCT00994396|Cholecalciferol|cholecalciferol|mesh-list
6569727|NCT00994396|Vitamins|vitamins|mesh-ancestor
6569728|NCT00994396|Micronutrients|micronutrients|mesh-ancestor
6569729|NCT00994396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569730|NCT00994396|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6569731|NCT00994396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6569732|NCT00994500|Bortezomib|bortezomib|mesh-list
6569733|NCT00994500|Vorinostat|vorinostat|mesh-list
6445470|NCT00388388|Losartan|losartan|mesh-list
6445471|NCT00388388|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6445472|NCT00388388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6445473|NCT00388388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6569734|NCT00994500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6569735|NCT00994500|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6569736|NCT00994500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6569737|NCT00994500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569738|NCT00994513|Thioctic Acid|thioctic acid|mesh-list
6569739|NCT00994513|Antioxidants|antioxidants|mesh-ancestor
6569740|NCT00994513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569741|NCT00994513|Protective Agents|protective agents|mesh-ancestor
6569742|NCT00994513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569743|NCT00994513|Vitamin B Complex|vitamin b complex|mesh-ancestor
6569744|NCT00994513|Vitamins|vitamins|mesh-ancestor
6569745|NCT00994513|Micronutrients|micronutrients|mesh-ancestor
6569746|NCT00994526|Vitamin E|vitamin e|mesh-list
6569747|NCT00994526|Calcium|calcium|mesh-list
6569748|NCT00994526|Vitamins|vitamins|mesh-ancestor
6569749|NCT00994526|Micronutrients|micronutrients|mesh-ancestor
6569750|NCT00994526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569751|NCT00994526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6569752|NCT00994526|Antioxidants|antioxidants|mesh-ancestor
6569753|NCT00994526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569754|NCT00994526|Protective Agents|protective agents|mesh-ancestor
6569755|NCT00994539|Morphine|morphine|mesh-list
6569756|NCT00994539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6569757|NCT00994539|Narcotics|narcotics|mesh-ancestor
6569758|NCT00994539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6445474|NCT00388388|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6445475|NCT00388388|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6445476|NCT00388388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445477|NCT00388388|Diuretics|diuretics|mesh-ancestor
6445478|NCT00388388|Natriuretic Agents|natriuretic agents|mesh-ancestor
6445479|NCT00388388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445480|NCT00388388|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6445481|NCT00388388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6445482|NCT00388401|Alvimopan|alvimopan|mesh-list
6445483|NCT00388401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6445484|NCT00388427|Cetuximab|cetuximab|mesh-list
6569759|NCT00994539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569760|NCT00994539|Analgesics|analgesics|mesh-ancestor
6569761|NCT00994539|Sensory System Agents|sensory system agents|mesh-ancestor
6569762|NCT00994539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6569763|NCT00994617|Losartan|losartan|mesh-list
6569764|NCT00994617|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6569765|NCT00994617|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6569766|NCT00994617|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6569767|NCT00994617|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6569768|NCT00994617|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6569769|NCT00994617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569770|NCT00994617|Diuretics|diuretics|mesh-ancestor
6569771|NCT00994617|Natriuretic Agents|natriuretic agents|mesh-ancestor
6569772|NCT00994617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569773|NCT00994617|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6569774|NCT00994617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6569775|NCT00994695|Vaccines|vaccines|mesh-list
6569776|NCT00994695|Immunologic Factors|immunologic factors|mesh-ancestor
6569777|NCT00994695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569778|NCT00994708|Esomeprazole|esomeprazole|mesh-list
6569779|NCT00994708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6569780|NCT00994708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6569781|NCT00994708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6569782|NCT00994708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6569783|NCT00994708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569784|NCT00994734|Mifepristone|mifepristone|mesh-list
6569785|NCT00994734|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6569786|NCT00994734|Abortifacient Agents|abortifacient agents|mesh-ancestor
6569787|NCT00994734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6569788|NCT00994734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569789|NCT00994734|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6569790|NCT00994734|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6569791|NCT00994734|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6569792|NCT00994734|Contraceptive Agents|contraceptive agents|mesh-ancestor
6569793|NCT00994734|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6569794|NCT00994734|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6569795|NCT00994734|Hormone Antagonists|hormone antagonists|mesh-ancestor
6569796|NCT00994734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6569797|NCT00994734|Luteolytic Agents|luteolytic agents|mesh-ancestor
6569798|NCT00994734|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6569799|NCT00994734|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6569800|NCT00994773|Tenofovir|tenofovir|mesh-list
6569801|NCT00994773|Entecavir|entecavir|mesh-list
6569802|NCT00994773|Simvastatin|simvastatin|mesh-list
6569803|NCT00994773|Antiviral Agents|antiviral agents|mesh-ancestor
6569804|NCT00994773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6569805|NCT00994773|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6569806|NCT00994773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6569807|NCT00994773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6569808|NCT00994773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569809|NCT00994773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5724792|NCT03184870|Fluorouracil|fluorouracil|mesh-list
6569810|NCT00994773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6569811|NCT00994773|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6569812|NCT00994773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6569813|NCT00994773|Antimetabolites|antimetabolites|mesh-ancestor
6569814|NCT00994773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6569815|NCT00994773|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6569816|NCT00994786|Pregabalin|pregabalin|mesh-list
6569817|NCT00994786|Analgesics|analgesics|mesh-ancestor
6569818|NCT00994786|Sensory System Agents|sensory system agents|mesh-ancestor
6569819|NCT00994786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6569820|NCT00994786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569821|NCT00994786|Anticonvulsants|anticonvulsants|mesh-ancestor
6569822|NCT00994786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6569823|NCT00994786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6569824|NCT00994786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569825|NCT00994786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6569826|NCT00994786|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6569827|NCT00994786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6569828|NCT00994786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6569829|NCT00994786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6657556|NCT01476813|Glycopyrrolate|glycopyrrolate|mesh-list
6657557|NCT01476813|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6657558|NCT01476813|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6657559|NCT01476813|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6657560|NCT01476813|Cholinergic Agents|cholinergic agents|mesh-ancestor
6657561|NCT01476813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6657562|NCT01476813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657563|NCT01476813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657564|NCT01476839|Cytarabine|cytarabine|mesh-list
6657565|NCT01476839|Etoposide|etoposide|mesh-list
6657566|NCT01476839|Etoposide phosphate|etoposide phosphate|mesh-list
6657567|NCT01476839|Melphalan|melphalan|mesh-list
6657568|NCT01476839|Carmustine|carmustine|mesh-list
6657569|NCT01476839|Basiliximab|basiliximab|mesh-list
6657570|NCT01476839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6657571|NCT01476839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6657572|NCT01476839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6657573|NCT01476839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6657574|NCT01476839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6657575|NCT01476839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657576|NCT01476839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6657577|NCT01476839|Antimetabolites|antimetabolites|mesh-ancestor
6657578|NCT01476839|Antiviral Agents|antiviral agents|mesh-ancestor
6657579|NCT01476839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6657580|NCT01476839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6657581|NCT01476839|Immunologic Factors|immunologic factors|mesh-ancestor
6657582|NCT01476839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569830|NCT00994799|Ranibizumab|ranibizumab|mesh-list
6569831|NCT00994799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6569832|NCT00994799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6569833|NCT00994799|Growth Substances|growth substances|mesh-ancestor
6569834|NCT00994799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569835|NCT00994799|Growth Inhibitors|growth inhibitors|mesh-ancestor
6569836|NCT00994799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6569837|NCT00994812|Metformin|metformin|mesh-list
6569838|NCT00994812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6569839|NCT00994812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569840|NCT00994825|Simendan|simendan|mesh-list
6569841|NCT00994825|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6569842|NCT00994825|Vasodilator Agents|vasodilator agents|mesh-ancestor
6569843|NCT00994825|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6569844|NCT00994825|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6569845|NCT00994825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6569846|NCT00994825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569847|NCT00994825|Protective Agents|protective agents|mesh-ancestor
6569848|NCT00994825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569849|NCT00994903|Simvastatin|simvastatin|mesh-list
6569850|NCT00994903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6569851|NCT00994903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6569852|NCT00994903|Antimetabolites|antimetabolites|mesh-ancestor
6569853|NCT00994903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569854|NCT00994903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6569855|NCT00994903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6569856|NCT00994903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6569857|NCT00994916|Amifampridine|amifampridine|mesh-list
6569858|NCT00994916|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6569859|NCT00994916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6569860|NCT00994916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569861|NCT00994916|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6569862|NCT00994916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6569863|NCT00994916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569864|NCT00994942|Morphine|morphine|mesh-list
6569865|NCT00994942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6569866|NCT00994942|Narcotics|narcotics|mesh-ancestor
6569867|NCT00994942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6569868|NCT00994942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569869|NCT00994942|Analgesics|analgesics|mesh-ancestor
6569870|NCT00994942|Sensory System Agents|sensory system agents|mesh-ancestor
6569871|NCT00994942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6569872|NCT00994968|Cyclophosphamide|cyclophosphamide|mesh-list
6569873|NCT00994968|Docetaxel|docetaxel|mesh-list
6569874|NCT00994968|Doxorubicin|doxorubicin|mesh-list
6569875|NCT00994968|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6569876|NCT00994968|Tegafur|tegafur|mesh-list
6569877|NCT00994968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6569878|NCT00994968|Immunologic Factors|immunologic factors|mesh-ancestor
6569879|NCT00994968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569880|NCT00994968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6569881|NCT00994968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6569882|NCT00994968|Alkylating Agents|alkylating agents|mesh-ancestor
6569883|NCT00994968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569884|NCT00994968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6569885|NCT00994968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6569886|NCT00994968|Tubulin Modulators|tubulin modulators|mesh-ancestor
6569887|NCT00994968|Antimitotic Agents|antimitotic agents|mesh-ancestor
6569888|NCT00994968|Mitosis Modulators|mitosis modulators|mesh-ancestor
6569889|NCT00994968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6569890|NCT00994968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6569891|NCT00994968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6569892|NCT00994968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6569893|NCT00994968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6569894|NCT00994968|Antimetabolites|antimetabolites|mesh-ancestor
6569895|NCT00994981|Magnesium Sulfate|magnesium sulfate|mesh-list
6569896|NCT00994981|Analgesics|analgesics|mesh-ancestor
6569897|NCT00994981|Sensory System Agents|sensory system agents|mesh-ancestor
6569898|NCT00994981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6569899|NCT00994981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569900|NCT00994981|Anesthetics|anesthetics|mesh-ancestor
6569901|NCT00994981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6569902|NCT00994981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6569903|NCT00994981|Anticonvulsants|anticonvulsants|mesh-ancestor
6569904|NCT00994981|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6569905|NCT00994981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6569906|NCT00994981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569907|NCT00994981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6569908|NCT00994981|Tocolytic Agents|tocolytic agents|mesh-ancestor
6569909|NCT00994981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6569910|NCT00994994|Tranylcypromine|tranylcypromine|mesh-list
6569911|NCT00994994|Tranexamic Acid|tranexamic acid|mesh-list
6569912|NCT00994994|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
6569913|NCT00994994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6569914|NCT00994994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569915|NCT00994994|Hemostatics|hemostatics|mesh-ancestor
6569916|NCT00994994|Coagulants|coagulants|mesh-ancestor
6569917|NCT00994994|Antidepressive Agents|antidepressive agents|mesh-ancestor
6569918|NCT00994994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6569919|NCT00994994|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6569920|NCT00994994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6569921|NCT00994994|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6020079|NCT00391586|Tubulin Modulators|tubulin modulators|mesh-ancestor
6569922|NCT00994994|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6569923|NCT00994994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6569924|NCT00994994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569925|NCT00995033|Varenicline|varenicline|mesh-list
6569926|NCT00995033|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6569927|NCT00995033|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6569928|NCT00995033|Cholinergic Agents|cholinergic agents|mesh-ancestor
6569929|NCT00995033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6569930|NCT00995033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569931|NCT00995033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569932|NCT00995046|Factor VIII|factor viii|mesh-list
6569933|NCT00995046|Coagulants|coagulants|mesh-ancestor
6569934|NCT00995059|Sirolimus|sirolimus|mesh-list
6569935|NCT00995059|Bortezomib|bortezomib|mesh-list
6569936|NCT00995059|Melphalan|melphalan|mesh-list
6569937|NCT00995059|Tacrolimus|tacrolimus|mesh-list
6569938|NCT00995059|Thymoglobulin|thymoglobulin|mesh-list
6569939|NCT00995059|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6569940|NCT00995059|Immunoglobulins|immunoglobulins|mesh-list
6569941|NCT00995059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6569942|NCT00995059|Immunologic Factors|immunologic factors|mesh-ancestor
6569943|NCT00995059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569944|NCT00995059|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6569945|NCT00995059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6569946|NCT00995059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569947|NCT00995059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6569948|NCT00995059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6569949|NCT00995059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6569950|NCT00995059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6569951|NCT00995059|Antifungal Agents|antifungal agents|mesh-ancestor
6569952|NCT00995059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6020080|NCT00391586|Antimitotic Agents|antimitotic agents|mesh-ancestor
6020081|NCT00391586|Mitosis Modulators|mitosis modulators|mesh-ancestor
6020082|NCT00391586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569953|NCT00995059|Alkylating Agents|alkylating agents|mesh-ancestor
6569954|NCT00995059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6569955|NCT00995124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6569956|NCT00995150|Levonorgestrel|levonorgestrel|mesh-list
6569957|NCT00995150|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6569958|NCT00995150|Contraceptive Agents|contraceptive agents|mesh-ancestor
6569959|NCT00995150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6569960|NCT00995150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569961|NCT00995150|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6569962|NCT00995150|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6569963|NCT00995150|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6569964|NCT00995241|Raltegravir Potassium|raltegravir potassium|mesh-list
6569965|NCT00995241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6569966|NCT00995241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6569967|NCT00995241|Antiviral Agents|antiviral agents|mesh-ancestor
6569968|NCT00995241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6569969|NCT00995241|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6569970|NCT00995241|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6569971|NCT00995241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6569972|NCT00995241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569973|NCT00995293|Docetaxel|docetaxel|mesh-list
6569974|NCT00995293|Fluorouracil|fluorouracil|mesh-list
6569975|NCT00995293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6569976|NCT00995293|Tubulin Modulators|tubulin modulators|mesh-ancestor
6569977|NCT00995293|Antimitotic Agents|antimitotic agents|mesh-ancestor
6569978|NCT00995293|Mitosis Modulators|mitosis modulators|mesh-ancestor
6569979|NCT00995293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569980|NCT00995293|Antimetabolites|antimetabolites|mesh-ancestor
6569981|NCT00995293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6569982|NCT00995293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5501425|NCT04474366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501426|NCT04474366|Sensory System Agents|sensory system agents|mesh-ancestor
5501427|NCT04474366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5501428|NCT04474262|Midodrine|midodrine|mesh-list
5501429|NCT04474262|Sympathomimetics|sympathomimetics|mesh-ancestor
5501430|NCT04474262|Autonomic Agents|autonomic agents|mesh-ancestor
5501431|NCT04474262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5501432|NCT04474262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501433|NCT04474262|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6020083|NCT00391586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6445485|NCT00388427|Dasatinib|dasatinib|mesh-list
6445486|NCT00388427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6445487|NCT00388427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6445488|NCT00388427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6445489|NCT00388427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6445490|NCT00388427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445491|NCT00388479|Alvimopan|alvimopan|mesh-list
6445492|NCT00388479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6445493|NCT00388557|Ketoconazole|ketoconazole|mesh-list
6445494|NCT00388557|Antifungal Agents|antifungal agents|mesh-ancestor
6445495|NCT00388557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6445496|NCT00388557|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6445497|NCT00388557|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6445498|NCT00388557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6445499|NCT00388557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445500|NCT00388557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6445501|NCT00388557|Hormone Antagonists|hormone antagonists|mesh-ancestor
6461722|NCT00455806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6569983|NCT00995293|Immunologic Factors|immunologic factors|mesh-ancestor
6569984|NCT00995293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569985|NCT00995306|Capsaicin|capsaicin|mesh-list
6569986|NCT00995306|Antipruritics|antipruritics|mesh-ancestor
6569987|NCT00995306|Dermatologic Agents|dermatologic agents|mesh-ancestor
6569988|NCT00995306|Sensory System Agents|sensory system agents|mesh-ancestor
6569989|NCT00995306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6569990|NCT00995306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6569991|NCT00995332|Cytarabine|cytarabine|mesh-list
6569992|NCT00995332|Tretinoin|tretinoin|mesh-list
6569993|NCT00995332|Valproic Acid|valproic acid|mesh-list
6569994|NCT00995332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6569995|NCT00995332|Antimetabolites|antimetabolites|mesh-ancestor
6569996|NCT00995332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6569997|NCT00995332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6569998|NCT00995332|Antiviral Agents|antiviral agents|mesh-ancestor
6569999|NCT00995332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6570000|NCT00995332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6570001|NCT00995332|Immunologic Factors|immunologic factors|mesh-ancestor
6570002|NCT00995332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570003|NCT00995332|Keratolytic Agents|keratolytic agents|mesh-ancestor
6570004|NCT00995332|Dermatologic Agents|dermatologic agents|mesh-ancestor
6570005|NCT00995332|Anticonvulsants|anticonvulsants|mesh-ancestor
6570006|NCT00995332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6570007|NCT00995332|GABA Agents|gaba agents|mesh-ancestor
6570008|NCT00995332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6570009|NCT00995332|Antimanic Agents|antimanic agents|mesh-ancestor
6570010|NCT00995332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6570011|NCT00995332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6570012|NCT00995332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6570013|NCT00995397|Chlorpheniramine|chlorpheniramine|mesh-list
6570014|NCT00995397|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
6570015|NCT00995397|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6570016|NCT00995397|Histamine Antagonists|histamine antagonists|mesh-ancestor
6570017|NCT00995397|Histamine Agents|histamine agents|mesh-ancestor
6570018|NCT00995397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6570019|NCT00995397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570020|NCT00995397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570021|NCT00995397|Antipruritics|antipruritics|mesh-ancestor
6570022|NCT00995397|Dermatologic Agents|dermatologic agents|mesh-ancestor
6570023|NCT00995397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6570024|NCT00995423|Paclitaxel|paclitaxel|mesh-list
6570025|NCT00995423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6570026|NCT00995423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6570027|NCT00995423|Tubulin Modulators|tubulin modulators|mesh-ancestor
6570028|NCT00995423|Antimitotic Agents|antimitotic agents|mesh-ancestor
6570029|NCT00995423|Mitosis Modulators|mitosis modulators|mesh-ancestor
6570030|NCT00995423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570031|NCT00995618|Tranilast|tranilast|mesh-list
6570032|NCT00995618|Febuxostat|febuxostat|mesh-list
6570033|NCT00995618|Gout Suppressants|gout suppressants|mesh-ancestor
6570034|NCT00995618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6570035|NCT00995618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6570036|NCT00995618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6570037|NCT00995618|Analgesics|analgesics|mesh-ancestor
6570038|NCT00995618|Sensory System Agents|sensory system agents|mesh-ancestor
6570039|NCT00995618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6570040|NCT00995618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570041|NCT00995618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6570042|NCT00995618|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6570043|NCT00995618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6570044|NCT00995618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570045|NCT00995618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6570046|NCT00995618|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6570047|NCT00995618|Histamine Antagonists|histamine antagonists|mesh-ancestor
6570048|NCT00995618|Histamine Agents|histamine agents|mesh-ancestor
6570049|NCT00995618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6570050|NCT00995618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5724793|NCT03184870|Nivolumab|nivolumab|mesh-list
6570051|NCT00995618|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6570052|NCT00995657|Fluticasone|fluticasone|mesh-list
6570053|NCT00995657|Xhance|xhance|mesh-list
6570054|NCT00995657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6570055|NCT00995657|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6570056|NCT00995657|Autonomic Agents|autonomic agents|mesh-ancestor
6570057|NCT00995657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6570058|NCT00995657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570059|NCT00995657|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6570060|NCT00995657|Respiratory System Agents|respiratory system agents|mesh-ancestor
6570061|NCT00995657|Dermatologic Agents|dermatologic agents|mesh-ancestor
6570062|NCT00995657|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6570063|NCT00995800|Fluticasone|fluticasone|mesh-list
6570064|NCT00995800|Xhance|xhance|mesh-list
6570065|NCT00995800|Formoterol Fumarate|formoterol fumarate|mesh-list
6570066|NCT00995800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6570067|NCT00995800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6570068|NCT00995800|Autonomic Agents|autonomic agents|mesh-ancestor
6570069|NCT00995800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6570070|NCT00995800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570071|NCT00995800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6020084|NCT00391586|Antimetabolites|antimetabolites|mesh-ancestor
6020085|NCT00391586|Antiviral Agents|antiviral agents|mesh-ancestor
6020086|NCT00391586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6570072|NCT00995800|Respiratory System Agents|respiratory system agents|mesh-ancestor
6570073|NCT00995800|Dermatologic Agents|dermatologic agents|mesh-ancestor
6570074|NCT00995800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6570075|NCT00995800|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6570076|NCT00995800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6570077|NCT00995800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6570078|NCT00995800|Adrenergic Agents|adrenergic agents|mesh-ancestor
6570079|NCT00995800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6570080|NCT00995800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570081|NCT00995826|Laninamivir|laninamivir|mesh-list
6570082|NCT00995826|Antiviral Agents|antiviral agents|mesh-ancestor
6570083|NCT00995826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6570084|NCT00995839|Terlipressin|terlipressin|mesh-list
6570085|NCT00995839|Vasopressins|vasopressins|mesh-list
6570086|NCT00995839|Arginine Vasopressin|arginine vasopressin|mesh-list
6570087|NCT00995839|Hemostatics|hemostatics|mesh-ancestor
6570088|NCT00995839|Coagulants|coagulants|mesh-ancestor
6570089|NCT00995839|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6570090|NCT00995839|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6570091|NCT00995839|Natriuretic Agents|natriuretic agents|mesh-ancestor
6570092|NCT00995839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570093|NCT00995839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6445502|NCT00388557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6445503|NCT00388557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445504|NCT00388557|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6445505|NCT00388635|Prednisone|prednisone|mesh-list
6445506|NCT00388635|Melphalan|melphalan|mesh-list
6570094|NCT00995917|Vitamin K|vitamin k|mesh-list
6570095|NCT00995917|Vitamins|vitamins|mesh-ancestor
6570096|NCT00995917|Micronutrients|micronutrients|mesh-ancestor
6570097|NCT00995917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570098|NCT00995917|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6570099|NCT00995917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6570100|NCT00995917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570101|NCT00995917|Hemostatics|hemostatics|mesh-ancestor
6570102|NCT00995917|Coagulants|coagulants|mesh-ancestor
6570103|NCT00995995|Rosiglitazone|rosiglitazone|mesh-list
6570104|NCT00995995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6570105|NCT00995995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570106|NCT00996021|Moxifloxacin|moxifloxacin|mesh-list
6570107|NCT00996021|Dolutegravir|dolutegravir|mesh-list
6570108|NCT00996021|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6570109|NCT00996021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6570110|NCT00996021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6570111|NCT00996021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6570112|NCT00996021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6570113|NCT00996021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6570114|NCT00996021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570115|NCT00996021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6570116|NCT00996021|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6570117|NCT00996021|Contraceptive Agents|contraceptive agents|mesh-ancestor
6570118|NCT00996021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6570119|NCT00996021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570120|NCT00996021|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6570121|NCT00996021|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6570122|NCT00996021|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6570123|NCT00996021|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6570124|NCT00996021|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6570125|NCT00996021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6570126|NCT00996021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6445507|NCT00388635|Bortezomib|bortezomib|mesh-list
6570127|NCT00996021|Antiviral Agents|antiviral agents|mesh-ancestor
6570128|NCT00996060|Hydralazine|hydralazine|mesh-list
6570129|NCT00996060|Valproic Acid|valproic acid|mesh-list
6570130|NCT00996060|Anticonvulsants|anticonvulsants|mesh-ancestor
6570131|NCT00996060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6570132|NCT00996060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570133|NCT00996060|GABA Agents|gaba agents|mesh-ancestor
6570134|NCT00996060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6570135|NCT00996060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570136|NCT00996060|Antimanic Agents|antimanic agents|mesh-ancestor
6570137|NCT00996060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6570138|NCT00996060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6570139|NCT00996060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6570140|NCT00996060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6570141|NCT00996060|Vasodilator Agents|vasodilator agents|mesh-ancestor
6570142|NCT00996099|Insulin|insulin|mesh-list
6570143|NCT00996099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6570144|NCT00996099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6570145|NCT00996099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445508|NCT00388635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6445509|NCT00388635|Glucocorticoids|glucocorticoids|mesh-ancestor
6445510|NCT00388635|Hormones|hormones|mesh-ancestor
6445511|NCT00388635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6445512|NCT00388635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445513|NCT00388635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6445514|NCT00388635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6570146|NCT00996151|Testosterone|testosterone|mesh-list
6570147|NCT00996151|Androgens|androgens|mesh-ancestor
6570148|NCT00996151|Hormones|hormones|mesh-ancestor
6570149|NCT00996151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6570150|NCT00996151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570151|NCT00996177|Fentanyl|fentanyl|mesh-list
6570152|NCT00996177|Morphine|morphine|mesh-list
6570153|NCT00996177|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6570154|NCT00996177|Narcotics|narcotics|mesh-ancestor
6570155|NCT00996177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6570156|NCT00996177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570157|NCT00996177|Analgesics|analgesics|mesh-ancestor
6570158|NCT00996177|Sensory System Agents|sensory system agents|mesh-ancestor
6570159|NCT00996177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6570160|NCT00996177|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6570161|NCT00996177|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6570162|NCT00996177|Anesthetics, General|anesthetics, general|mesh-ancestor
6570163|NCT00996177|Anesthetics|anesthetics|mesh-ancestor
6570164|NCT00996190|Phenylephrine|phenylephrine|mesh-list
6570165|NCT00996190|Oxymetazoline|oxymetazoline|mesh-list
6570166|NCT00996190|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6570167|NCT00996190|Mydriatics|mydriatics|mesh-ancestor
6570168|NCT00996190|Autonomic Agents|autonomic agents|mesh-ancestor
6570169|NCT00996190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6570170|NCT00996190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570171|NCT00996190|Sympathomimetics|sympathomimetics|mesh-ancestor
6570172|NCT00996190|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6570173|NCT00996190|Nasal Decongestants|nasal decongestants|mesh-ancestor
6570174|NCT00996190|Respiratory System Agents|respiratory system agents|mesh-ancestor
6570175|NCT00996190|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6570176|NCT00996190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6570177|NCT00996190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6570178|NCT00996190|Adrenergic Agents|adrenergic agents|mesh-ancestor
6570179|NCT00996190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6664758|NCT01513863|Metronidazole|metronidazole|mesh-list
6570180|NCT00996190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570181|NCT00996190|Protective Agents|protective agents|mesh-ancestor
6570182|NCT00996229|Resveratrol|resveratrol|mesh-list
6570183|NCT00996229|Antioxidants|antioxidants|mesh-ancestor
6570184|NCT00996229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570185|NCT00996229|Protective Agents|protective agents|mesh-ancestor
6445515|NCT00388635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6445516|NCT00388635|Alkylating Agents|alkylating agents|mesh-ancestor
6445517|NCT00388635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445518|NCT00388635|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6445519|NCT00388635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6445520|NCT00388635|Immunologic Factors|immunologic factors|mesh-ancestor
6445521|NCT00388661|Melatonin|melatonin|mesh-list
6445522|NCT00388661|Antioxidants|antioxidants|mesh-ancestor
6445523|NCT00388661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445524|NCT00388661|Protective Agents|protective agents|mesh-ancestor
6570186|NCT00996229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445525|NCT00388661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445526|NCT00388661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6445527|NCT00388687|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
6445528|NCT00388687|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6445529|NCT00388687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445530|NCT00388700|Leucovorin|leucovorin|mesh-list
6445531|NCT00388700|Bevacizumab|bevacizumab|mesh-list
6445532|NCT00388700|Fluorouracil|fluorouracil|mesh-list
6445533|NCT00388700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6445534|NCT00388700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6445535|NCT00388700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6445536|NCT00388700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6445537|NCT00388700|Growth Substances|growth substances|mesh-ancestor
6570187|NCT00996229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6570188|NCT00996229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6570189|NCT00996385|Oxaliplatin|oxaliplatin|mesh-list
6570190|NCT00996385|Bortezomib|bortezomib|mesh-list
6570191|NCT00996385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6570192|NCT00996411|Salvinorin A|salvinorin a|mesh-list
6570193|NCT00996411|Hallucinogens|hallucinogens|mesh-ancestor
6570194|NCT00996411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570195|NCT00996411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6570196|NCT00996424|Acetylcysteine|acetylcysteine|mesh-list
6570197|NCT00996424|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6570198|NCT00996424|Antiviral Agents|antiviral agents|mesh-ancestor
6570199|NCT00996424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6570200|NCT00996424|Expectorants|expectorants|mesh-ancestor
6570201|NCT00996424|Respiratory System Agents|respiratory system agents|mesh-ancestor
6570202|NCT00996424|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6570203|NCT00996424|Antioxidants|antioxidants|mesh-ancestor
6570204|NCT00996424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570205|NCT00996424|Protective Agents|protective agents|mesh-ancestor
6570206|NCT00996424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570207|NCT00996424|Antidotes|antidotes|mesh-ancestor
6570208|NCT00996463|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
6570209|NCT00996463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6570210|NCT00996463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6570211|NCT00996463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6570212|NCT00996463|Schistosomicides|schistosomicides|mesh-ancestor
6570213|NCT00996463|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6570214|NCT00996463|Anthelmintics|anthelmintics|mesh-ancestor
6570215|NCT00996515|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6570216|NCT00996515|Azacitidine|azacitidine|mesh-list
6570217|NCT00996515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6570218|NCT00996515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6570219|NCT00996515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6570220|NCT00996515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570221|NCT00996515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6570222|NCT00996515|Antimetabolites|antimetabolites|mesh-ancestor
6570223|NCT00996567|Cetuximab|cetuximab|mesh-list
6570224|NCT00996567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6570225|NCT00996567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6570226|NCT00996684|Plasminogen|plasminogen|mesh-list
6570227|NCT00996684|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6570228|NCT00996684|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6570229|NCT00996684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570230|NCT00996697|Budesonide|budesonide|mesh-list
6570231|NCT00996697|Formoterol Fumarate|formoterol fumarate|mesh-list
6570232|NCT00996697|Tiotropium Bromide|tiotropium bromide|mesh-list
6570233|NCT00996697|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6570234|NCT00996697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6570235|NCT00996697|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6570236|NCT00996697|Autonomic Agents|autonomic agents|mesh-ancestor
6570237|NCT00996697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6020087|NCT00391586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6445538|NCT00388700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445539|NCT00388700|Growth Inhibitors|growth inhibitors|mesh-ancestor
6445540|NCT00388700|Antimetabolites|antimetabolites|mesh-ancestor
6445541|NCT00388700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445542|NCT00388700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6445543|NCT00388700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6445544|NCT00388700|Immunologic Factors|immunologic factors|mesh-ancestor
6445545|NCT00388700|Antidotes|antidotes|mesh-ancestor
6445546|NCT00388700|Protective Agents|protective agents|mesh-ancestor
6570238|NCT00996697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570239|NCT00996697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6570240|NCT00996697|Respiratory System Agents|respiratory system agents|mesh-ancestor
6570241|NCT00996697|Glucocorticoids|glucocorticoids|mesh-ancestor
6570242|NCT00996697|Hormones|hormones|mesh-ancestor
6570243|NCT00996697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6570244|NCT00996697|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6570245|NCT00996697|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6570246|NCT00996697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6570247|NCT00996697|Adrenergic Agents|adrenergic agents|mesh-ancestor
6570248|NCT00996697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6570249|NCT00996697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570250|NCT00996697|Parasympatholytics|parasympatholytics|mesh-ancestor
6570251|NCT00996697|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6570252|NCT00996697|Cholinergic Agents|cholinergic agents|mesh-ancestor
6657583|NCT01476839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6657584|NCT01476839|Alkylating Agents|alkylating agents|mesh-ancestor
6657585|NCT01476839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6657586|NCT01477021|Cyclophosphamide|cyclophosphamide|mesh-list
6657587|NCT01477021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6657588|NCT01477021|Immunologic Factors|immunologic factors|mesh-ancestor
6657589|NCT01477021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657590|NCT01477021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6657591|NCT01477021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6657592|NCT01477021|Alkylating Agents|alkylating agents|mesh-ancestor
6657593|NCT01477021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657594|NCT01477021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6657595|NCT01477021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6657596|NCT01477034|Vitamin D|vitamin d|mesh-list
6657597|NCT01477034|Ergocalciferols|ergocalciferols|mesh-list
6657598|NCT01477034|Cholecalciferol|cholecalciferol|mesh-list
6657599|NCT01477034|Vitamins|vitamins|mesh-list
6657600|NCT01477034|Micronutrients|micronutrients|mesh-ancestor
6657601|NCT01477034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657602|NCT01477034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6657603|NCT01477034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6657604|NCT01477060|Metformin|metformin|mesh-list
6657605|NCT01477060|Lapatinib|lapatinib|mesh-list
6657606|NCT01477060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6657607|NCT01477060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657608|NCT01477060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6657609|NCT01477060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6657610|NCT01477060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6657611|NCT01477060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657612|NCT01477073|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6657613|NCT01477073|Hormones|hormones|mesh-ancestor
6657614|NCT01477073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6657615|NCT01477073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657616|NCT01477112|Beta Carotene|beta carotene|mesh-list
6657617|NCT01477112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657618|NCT01477112|Provitamins|provitamins|mesh-ancestor
6657619|NCT01477112|Vitamins|vitamins|mesh-ancestor
6657620|NCT01477112|Micronutrients|micronutrients|mesh-ancestor
6657621|NCT01477151|Anesthetics|anesthetics|mesh-list
6570253|NCT00996723|Dasatinib|dasatinib|mesh-list
6570254|NCT00996723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6570255|NCT00996723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6570256|NCT00996723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6570257|NCT00996723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570258|NCT00996762|Lapatinib|lapatinib|mesh-list
6570259|NCT00996762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6570260|NCT00996762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6570261|NCT00996762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6570262|NCT00996762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570263|NCT00996788|Rebamipide|rebamipide|mesh-list
6570264|NCT00996788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6570265|NCT00996788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6570266|NCT00996788|Antioxidants|antioxidants|mesh-ancestor
6570267|NCT00996788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570268|NCT00996788|Protective Agents|protective agents|mesh-ancestor
6570269|NCT00996788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570270|NCT00996788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6570271|NCT00996866|Vitamin D|vitamin d|mesh-list
6570272|NCT00996866|Cholecalciferol|cholecalciferol|mesh-list
6570273|NCT00996866|Vitamins|vitamins|mesh-ancestor
6570274|NCT00996866|Micronutrients|micronutrients|mesh-ancestor
6570275|NCT00996866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570276|NCT00996866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6570277|NCT00996866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6570278|NCT00996879|Midazolam|midazolam|mesh-list
6570279|NCT00996879|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6570280|NCT00996879|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6570281|NCT00996879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6570282|NCT00996879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570283|NCT00996879|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6570284|NCT00996879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6570285|NCT00996879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6570286|NCT00996879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6570287|NCT00996879|Anesthetics, General|anesthetics, general|mesh-ancestor
6570288|NCT00996879|Anesthetics|anesthetics|mesh-ancestor
6570289|NCT00996879|GABA Modulators|gaba modulators|mesh-ancestor
6570290|NCT00996879|GABA Agents|gaba agents|mesh-ancestor
6570291|NCT00996879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6570292|NCT00996879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570293|NCT00996983|Ziconotide|ziconotide|mesh-list
6570294|NCT00996983|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6570295|NCT00996983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6570296|NCT00996983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570297|NCT00996983|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6570298|NCT00996983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570299|NCT00996983|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6570300|NCT00996983|Protective Agents|protective agents|mesh-ancestor
6570301|NCT00996983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6570302|NCT00996983|Analgesics|analgesics|mesh-ancestor
6570303|NCT00996983|Sensory System Agents|sensory system agents|mesh-ancestor
6570304|NCT00996983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6570305|NCT00997009|Paclitaxel|paclitaxel|mesh-list
6570306|NCT00997009|Carboplatin|carboplatin|mesh-list
6570307|NCT00997009|Cetuximab|cetuximab|mesh-list
6570308|NCT00997009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6570309|NCT00997009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6570310|NCT00997009|Tubulin Modulators|tubulin modulators|mesh-ancestor
6570311|NCT00997009|Antimitotic Agents|antimitotic agents|mesh-ancestor
6570312|NCT00997009|Mitosis Modulators|mitosis modulators|mesh-ancestor
6570313|NCT00997009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570314|NCT00997009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6570315|NCT00997022|Sorafenib|sorafenib|mesh-list
6570316|NCT00997022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6570317|NCT00997022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6570318|NCT00997022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6570319|NCT00997022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570320|NCT00997061|Topotecan|topotecan|mesh-list
6570321|NCT00997061|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6570322|NCT00997061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6570323|NCT00997061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6570324|NCT00997061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570325|NCT00997061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6570326|NCT00997074|Ibuprofen|ibuprofen|mesh-list
6570327|NCT00997074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
6570328|NCT00997074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
6570329|NCT00997074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6570330|NCT00997074|Analgesics|analgesics|mesh-ancestor
6570331|NCT00997074|Sensory System Agents|sensory system agents|mesh-ancestor
6570332|NCT00997074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6570333|NCT00997074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570334|NCT00997074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6570335|NCT00997074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6570336|NCT00997074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6570337|NCT00997074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570338|NCT00997087|Flumazenil|flumazenil|mesh-list
6570339|NCT00997087|Antidotes|antidotes|mesh-ancestor
6570340|NCT00997087|Protective Agents|protective agents|mesh-ancestor
6570341|NCT00997087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570342|NCT00997087|GABA Modulators|gaba modulators|mesh-ancestor
6570343|NCT00997087|GABA Agents|gaba agents|mesh-ancestor
6570344|NCT00997087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6570345|NCT00997087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570346|NCT00997191|Triamcinolone|triamcinolone|mesh-list
6570347|NCT00997191|Bevacizumab|bevacizumab|mesh-list
6570348|NCT00997191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6570349|NCT00997191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6570350|NCT00997191|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6570351|NCT00997191|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6570352|NCT00997191|Growth Substances|growth substances|mesh-ancestor
6570353|NCT00997191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570354|NCT00997191|Growth Inhibitors|growth inhibitors|mesh-ancestor
6570355|NCT00997191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6570356|NCT00997191|Glucocorticoids|glucocorticoids|mesh-ancestor
6570357|NCT00997191|Hormones|hormones|mesh-ancestor
6570358|NCT00997191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6570359|NCT00997269|Ubiquinone|ubiquinone|mesh-list
6570360|NCT00997269|Coenzyme Q10|coenzyme q10|mesh-list
6570361|NCT00997269|Micronutrients|micronutrients|mesh-ancestor
6020088|NCT00391586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6020089|NCT00391586|Immunologic Factors|immunologic factors|mesh-ancestor
6020090|NCT00391586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570362|NCT00997269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570363|NCT00997269|Vitamins|vitamins|mesh-ancestor
6570364|NCT00997347|Misoprostol|misoprostol|mesh-list
6570365|NCT00997347|Mifepristone|mifepristone|mesh-list
6570366|NCT00997347|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6570367|NCT00997347|Abortifacient Agents|abortifacient agents|mesh-ancestor
6570368|NCT00997347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6570369|NCT00997347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570370|NCT00997347|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6570371|NCT00997347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6570372|NCT00997347|Oxytocics|oxytocics|mesh-ancestor
6570373|NCT00997347|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6570374|NCT00997347|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6570375|NCT00997347|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6570376|NCT00997347|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6570377|NCT00997347|Contraceptive Agents|contraceptive agents|mesh-ancestor
6570378|NCT00997347|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6570379|NCT00997347|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6570380|NCT00997347|Hormone Antagonists|hormone antagonists|mesh-ancestor
6570381|NCT00997347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6570382|NCT00997347|Luteolytic Agents|luteolytic agents|mesh-ancestor
6570383|NCT00997347|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6570384|NCT00997347|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6570385|NCT00997399|Panobinostat|panobinostat|mesh-list
6570386|NCT00997399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6570387|NCT00997399|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6570388|NCT00997399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6570389|NCT00997399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570390|NCT00997412|Mycophenolic Acid|mycophenolic acid|mesh-list
6570391|NCT00997412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6570392|NCT00997412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6570393|NCT00997412|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6570394|NCT00997412|Antitubercular Agents|antitubercular agents|mesh-ancestor
6570395|NCT00997412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6570396|NCT00997412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6570397|NCT00997412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6570398|NCT00997412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570399|NCT00997477|Budesonide|budesonide|mesh-list
6570400|NCT00997477|Formoterol Fumarate|formoterol fumarate|mesh-list
6570401|NCT00997477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6570402|NCT00997477|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6570403|NCT00997477|Autonomic Agents|autonomic agents|mesh-ancestor
6570404|NCT00997477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6570405|NCT00997477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570406|NCT00997477|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6570407|NCT00997477|Respiratory System Agents|respiratory system agents|mesh-ancestor
6570408|NCT00997477|Glucocorticoids|glucocorticoids|mesh-ancestor
6570409|NCT00997477|Hormones|hormones|mesh-ancestor
6570410|NCT00997477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6570411|NCT00997477|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6570412|NCT00997477|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6570413|NCT00997477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6570414|NCT00997477|Adrenergic Agents|adrenergic agents|mesh-ancestor
6570415|NCT00997477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6570416|NCT00997477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570417|NCT00997542|Allopurinol|allopurinol|mesh-list
6570418|NCT00997542|Antimetabolites|antimetabolites|mesh-ancestor
6570419|NCT00997542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570420|NCT00997542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6570421|NCT00997542|Gout Suppressants|gout suppressants|mesh-ancestor
6570422|NCT00997542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6570423|NCT00997542|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6570424|NCT00997542|Antioxidants|antioxidants|mesh-ancestor
6570425|NCT00997542|Protective Agents|protective agents|mesh-ancestor
6570426|NCT00997542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570427|NCT00997581|Apremilast|apremilast|mesh-list
6570428|NCT00997581|Indomethacin|indomethacin|mesh-list
6570429|NCT00997581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6570430|NCT00997581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6570431|NCT00997581|Analgesics|analgesics|mesh-ancestor
6570432|NCT00997581|Sensory System Agents|sensory system agents|mesh-ancestor
6570433|NCT00997581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6570434|NCT00997581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570435|NCT00997581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6570436|NCT00997581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6570437|NCT00997581|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6570438|NCT00997581|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6570439|NCT00997581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6570440|NCT00997581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570441|NCT00997581|Gout Suppressants|gout suppressants|mesh-ancestor
6570442|NCT00997581|Tocolytic Agents|tocolytic agents|mesh-ancestor
6570443|NCT00997581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6570444|NCT00997581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6570445|NCT00997607|Vaccines|vaccines|mesh-list
6570446|NCT00997607|Immunologic Factors|immunologic factors|mesh-ancestor
6570447|NCT00997607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570448|NCT00997659|Chromium|chromium|mesh-list
6570449|NCT00997659|Picolinic acid|picolinic acid|mesh-list
6570450|NCT00997659|Trace Elements|trace elements|mesh-ancestor
6570451|NCT00997659|Micronutrients|micronutrients|mesh-ancestor
6570452|NCT00997659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570453|NCT00997659|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6570454|NCT00997659|Chelating Agents|chelating agents|mesh-ancestor
6570455|NCT00997659|Sequestering Agents|sequestering agents|mesh-ancestor
6570456|NCT00997659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570457|NCT00997685|Capecitabine|capecitabine|mesh-list
6570458|NCT00997685|Oxaliplatin|oxaliplatin|mesh-list
6570459|NCT00997685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6570460|NCT00997685|Antimetabolites|antimetabolites|mesh-ancestor
6570461|NCT00997685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570462|NCT00997685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6570463|NCT00997711|Sirolimus|sirolimus|mesh-list
6570464|NCT00997711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6570465|NCT00997711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6570466|NCT00997711|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6570467|NCT00997711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6570468|NCT00997711|Antifungal Agents|antifungal agents|mesh-ancestor
6570469|NCT00997711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6570470|NCT00997711|Immunologic Factors|immunologic factors|mesh-ancestor
6570471|NCT00997711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570472|NCT00997750|Lornoxicam|lornoxicam|mesh-list
6570473|NCT00997750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6570474|NCT00997750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6570475|NCT00997750|Analgesics|analgesics|mesh-ancestor
6570476|NCT00997750|Sensory System Agents|sensory system agents|mesh-ancestor
6570477|NCT00997750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6570478|NCT00997750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570479|NCT00997750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6570480|NCT00997750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6570481|NCT00997815|Botulinum Toxins|botulinum toxins|mesh-list
6570482|NCT00997815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6570483|NCT00997815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6570484|NCT00997815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6570485|NCT00997815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6570486|NCT00997815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570487|NCT00997815|Cholinergic Agents|cholinergic agents|mesh-ancestor
6570488|NCT00997815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6570489|NCT00997815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570490|NCT00997815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6570491|NCT00997815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6570492|NCT00997828|Everolimus|everolimus|mesh-list
6570493|NCT00997828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6570494|NCT00997828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6570495|NCT00997828|Immunologic Factors|immunologic factors|mesh-ancestor
6570496|NCT00997828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570497|NCT00997880|Calcium, Dietary|calcium, dietary|mesh-list
6570498|NCT00997880|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6570499|NCT00997880|Calcium|calcium|mesh-list
6570500|NCT00997880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6570501|NCT00997880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570502|NCT00997880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6570503|NCT00997880|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6570504|NCT00997880|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6570505|NCT00997880|Antimetabolites|antimetabolites|mesh-ancestor
6570506|NCT00997880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570507|NCT00997880|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6570508|NCT00997880|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6570509|NCT00997880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6570510|NCT00997906|Gemcitabine|gemcitabine|mesh-list
6570511|NCT00997906|Paclitaxel|paclitaxel|mesh-list
6570512|NCT00997906|Carboplatin|carboplatin|mesh-list
6570513|NCT00997906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6570514|NCT00997906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6570515|NCT00997906|Tubulin Modulators|tubulin modulators|mesh-ancestor
6570516|NCT00997906|Antimitotic Agents|antimitotic agents|mesh-ancestor
6570517|NCT00997906|Mitosis Modulators|mitosis modulators|mesh-ancestor
6570518|NCT00997906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570519|NCT00997906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6570520|NCT00997906|Antimetabolites|antimetabolites|mesh-ancestor
6570521|NCT00997906|Antiviral Agents|antiviral agents|mesh-ancestor
6570522|NCT00997906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6570523|NCT00997906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6570524|NCT00997906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6570525|NCT00997906|Immunologic Factors|immunologic factors|mesh-ancestor
6570526|NCT00997906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570527|NCT00997919|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6570528|NCT00997919|Immunologic Factors|immunologic factors|mesh-ancestor
6570529|NCT00997919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570530|NCT00997958|Mycophenolic Acid|mycophenolic acid|mesh-list
6570531|NCT00997958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6570532|NCT00997958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6570533|NCT00997958|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6570534|NCT00997958|Antitubercular Agents|antitubercular agents|mesh-ancestor
6570535|NCT00997958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6570536|NCT00997958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6570537|NCT00997958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6570538|NCT00997958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570539|NCT00997997|Moxifloxacin|moxifloxacin|mesh-list
6570540|NCT00997997|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6570541|NCT00997997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6570542|NCT00997997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6570543|NCT00997997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6570544|NCT00997997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6570545|NCT00997997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6570546|NCT00997997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570547|NCT00997997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6570548|NCT00997997|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6570549|NCT00997997|Contraceptive Agents|contraceptive agents|mesh-ancestor
6570550|NCT00997997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6570551|NCT00997997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570552|NCT00997997|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6570553|NCT00997997|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6570554|NCT00997997|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6570555|NCT00998036|Sirolimus|sirolimus|mesh-list
6570556|NCT00998036|Cisplatin|cisplatin|mesh-list
6570557|NCT00998036|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5724794|NCT03184870|Irinotecan|irinotecan|mesh-list
6570558|NCT00998036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6570559|NCT00998036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6570560|NCT00998036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6570561|NCT00998036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570562|NCT00998036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6570563|NCT00998036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6570564|NCT00998036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6570565|NCT00998036|Antifungal Agents|antifungal agents|mesh-ancestor
6570566|NCT00998036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6570567|NCT00998036|Immunologic Factors|immunologic factors|mesh-ancestor
6570568|NCT00998036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570569|NCT00998075|Aspirin|aspirin|mesh-list
6570570|NCT00998075|Esomeprazole|esomeprazole|mesh-list
6570571|NCT00998075|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6570572|NCT00998075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6570573|NCT00998075|Analgesics|analgesics|mesh-ancestor
6570574|NCT00998075|Sensory System Agents|sensory system agents|mesh-ancestor
6570575|NCT00998075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6570576|NCT00998075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570577|NCT00998075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6570578|NCT00998075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6570579|NCT00998075|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6570580|NCT00998075|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6570581|NCT00998075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570582|NCT00998075|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6570583|NCT00998075|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6570584|NCT00998075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6570585|NCT00998075|Antipyretics|antipyretics|mesh-ancestor
6570586|NCT00998075|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6570587|NCT00998075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6570588|NCT00998075|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6570589|NCT00998088|Epoetin Alfa|epoetin alfa|mesh-list
6570590|NCT00998088|Hematinics|hematinics|mesh-ancestor
6570591|NCT00998101|Carboplatin|carboplatin|mesh-list
6570592|NCT00998101|Cetuximab|cetuximab|mesh-list
6570593|NCT00998101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6570594|NCT00998101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6570595|NCT00998166|Bevacizumab|bevacizumab|mesh-list
6570596|NCT00998166|Pemetrexed|pemetrexed|mesh-list
6570597|NCT00998166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6570598|NCT00998166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6570599|NCT00998166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6570600|NCT00998166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6570601|NCT00998166|Growth Substances|growth substances|mesh-ancestor
6570602|NCT00998166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570603|NCT00998166|Growth Inhibitors|growth inhibitors|mesh-ancestor
6570604|NCT00998166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6570605|NCT00998166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570606|NCT00998166|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6570607|NCT00998166|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6570608|NCT00998192|Paclitaxel|paclitaxel|mesh-list
6570609|NCT00998192|Carboplatin|carboplatin|mesh-list
6570610|NCT00998192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6570611|NCT00998192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6570612|NCT00998192|Tubulin Modulators|tubulin modulators|mesh-ancestor
6570613|NCT00998192|Antimitotic Agents|antimitotic agents|mesh-ancestor
6570614|NCT00998192|Mitosis Modulators|mitosis modulators|mesh-ancestor
6570615|NCT00998192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570616|NCT00998218|Ranolazine|ranolazine|mesh-list
6570617|NCT00998218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6570618|NCT00998218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6570619|NCT00998218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570620|NCT00998283|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
6570621|NCT00998283|Immunologic Factors|immunologic factors|mesh-ancestor
6570622|NCT00998283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570623|NCT00998322|Gemcitabine|gemcitabine|mesh-list
6570624|NCT00998322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6570625|NCT00998322|Antimetabolites|antimetabolites|mesh-ancestor
6570626|NCT00998322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570627|NCT00998322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6570628|NCT00998322|Antiviral Agents|antiviral agents|mesh-ancestor
6570629|NCT00998322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6570630|NCT00998322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6570631|NCT00998322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6570632|NCT00998322|Immunologic Factors|immunologic factors|mesh-ancestor
6570633|NCT00998322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570634|NCT00998439|Paclitaxel|paclitaxel|mesh-list
6570635|NCT00998439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6570636|NCT00998439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6570637|NCT00998439|Tubulin Modulators|tubulin modulators|mesh-ancestor
6570638|NCT00998439|Antimitotic Agents|antimitotic agents|mesh-ancestor
6570639|NCT00998439|Mitosis Modulators|mitosis modulators|mesh-ancestor
6570640|NCT00998439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570641|NCT00998504|Resveratrol|resveratrol|mesh-list
6570642|NCT00998504|Antioxidants|antioxidants|mesh-ancestor
6570643|NCT00998504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570644|NCT00998504|Protective Agents|protective agents|mesh-ancestor
6570645|NCT00998504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570646|NCT00998504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6570647|NCT00998504|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6570648|NCT00998556|Bromocriptine|bromocriptine|mesh-list
6570649|NCT00998556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6570650|NCT00998556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6570651|NCT00998556|Hormone Antagonists|hormone antagonists|mesh-ancestor
6570652|NCT00998556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6570653|NCT00998556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570654|NCT00998556|Dopamine Agonists|dopamine agonists|mesh-ancestor
6570655|NCT00998556|Dopamine Agents|dopamine agents|mesh-ancestor
6570656|NCT00998556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6570657|NCT00998556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657622|NCT01477151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6657623|NCT01477151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657624|NCT01477190|Morphine|morphine|mesh-list
6657625|NCT01477190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6657626|NCT01477190|Narcotics|narcotics|mesh-ancestor
6657627|NCT01477190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6657628|NCT01477190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657629|NCT01477190|Analgesics|analgesics|mesh-ancestor
6657630|NCT01477190|Sensory System Agents|sensory system agents|mesh-ancestor
6657631|NCT01477190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6657632|NCT01477203|Citalopram|citalopram|mesh-list
6657633|NCT01477203|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6657634|NCT01477203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6657635|NCT01477203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6657636|NCT01477203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657637|NCT01477203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6657638|NCT01477203|Serotonin Agents|serotonin agents|mesh-ancestor
6657639|NCT01477203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657640|NCT01477203|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6657641|NCT01477203|Antidepressive Agents|antidepressive agents|mesh-ancestor
6657642|NCT01477203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6657643|NCT01477242|Ondansetron|ondansetron|mesh-list
6657644|NCT01477242|Antiemetics|antiemetics|mesh-ancestor
6657645|NCT01477242|Autonomic Agents|autonomic agents|mesh-ancestor
6657646|NCT01477242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6657647|NCT01477242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657648|NCT01477242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6657649|NCT01477242|Antipruritics|antipruritics|mesh-ancestor
6657650|NCT01477242|Dermatologic Agents|dermatologic agents|mesh-ancestor
6657651|NCT01477242|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6657652|NCT01477242|Serotonin Agents|serotonin agents|mesh-ancestor
6657653|NCT01477242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6657654|NCT01477242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657655|NCT01477242|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6657656|NCT01477242|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6657657|NCT01477242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6657658|NCT01477242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6657659|NCT01477242|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6657660|NCT01477268|Sertraline|sertraline|mesh-list
6657661|NCT01477268|Antidepressive Agents|antidepressive agents|mesh-list
6570658|NCT00998608|Risperidone|risperidone|mesh-list
6570659|NCT00998608|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6570660|NCT00998608|Serotonin Agents|serotonin agents|mesh-ancestor
6570661|NCT00998608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6570662|NCT00998608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570663|NCT00998608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570664|NCT00998608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6570665|NCT00998608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6570666|NCT00998608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6570667|NCT00998608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6570668|NCT00998608|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6570669|NCT00998608|Dopamine Agents|dopamine agents|mesh-ancestor
6570670|NCT00998634|Lithium Carbonate|lithium carbonate|mesh-list
6570671|NCT00998634|Antidepressive Agents|antidepressive agents|mesh-ancestor
6570672|NCT00998634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6570673|NCT00998634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6570674|NCT00998634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570675|NCT00998634|Antimanic Agents|antimanic agents|mesh-ancestor
6570676|NCT00998634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6570677|NCT00998634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6570678|NCT00998634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570679|NCT00998686|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6570680|NCT00998686|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6570681|NCT00998686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570682|NCT00998686|Incretins|incretins|mesh-ancestor
6570683|NCT00998686|Hormones|hormones|mesh-ancestor
6570684|NCT00998686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6570685|NCT00998686|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6570686|NCT00998686|Protease Inhibitors|protease inhibitors|mesh-ancestor
6570687|NCT00998686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6570688|NCT00998686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570689|NCT00998816|Pregabalin|pregabalin|mesh-list
6570690|NCT00998816|Analgesics|analgesics|mesh-ancestor
6570691|NCT00998816|Sensory System Agents|sensory system agents|mesh-ancestor
6570692|NCT00998816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6570693|NCT00998816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570694|NCT00998816|Anticonvulsants|anticonvulsants|mesh-ancestor
6570695|NCT00998816|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6570696|NCT00998816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6570697|NCT00998816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570698|NCT00998816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6570699|NCT00998816|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6570700|NCT00998816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6570701|NCT00998816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6020091|NCT00391586|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6570702|NCT00998816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6570703|NCT00998920|Equol|equol|mesh-list
6570704|NCT00998920|Phytoestrogens|phytoestrogens|mesh-ancestor
6570705|NCT00998920|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6570706|NCT00998920|Estrogens|estrogens|mesh-ancestor
6570707|NCT00998920|Hormones|hormones|mesh-ancestor
6570708|NCT00998920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6570709|NCT00998920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570710|NCT00998933|Testosterone|testosterone|mesh-list
6570711|NCT00998933|Androgens|androgens|mesh-ancestor
6570712|NCT00998933|Hormones|hormones|mesh-ancestor
6570713|NCT00998933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6570714|NCT00998933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570715|NCT00998972|Acetylcysteine|acetylcysteine|mesh-list
6570716|NCT00998972|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6570717|NCT00998972|Antiviral Agents|antiviral agents|mesh-ancestor
6570718|NCT00998972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6570719|NCT00998972|Expectorants|expectorants|mesh-ancestor
6570720|NCT00998972|Respiratory System Agents|respiratory system agents|mesh-ancestor
6570721|NCT00998972|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6570722|NCT00998972|Antioxidants|antioxidants|mesh-ancestor
6570723|NCT00998972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570724|NCT00998972|Protective Agents|protective agents|mesh-ancestor
6570725|NCT00998972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570726|NCT00998972|Antidotes|antidotes|mesh-ancestor
6570727|NCT00999128|Rabeprazole|rabeprazole|mesh-list
6570728|NCT00999128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6570729|NCT00999128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6570730|NCT00999128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6570731|NCT00999128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6570732|NCT00999128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570733|NCT00999180|Botulinum Toxins|botulinum toxins|mesh-list
6570734|NCT00999180|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6570735|NCT00999180|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6570736|NCT00999180|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6570737|NCT00999180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6570738|NCT00999180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570739|NCT00999180|Cholinergic Agents|cholinergic agents|mesh-ancestor
6570740|NCT00999180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6570741|NCT00999180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020092|NCT00391586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6020093|NCT00391586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6570742|NCT00999180|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6570743|NCT00999180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6570744|NCT00999206|Vaccines|vaccines|mesh-list
6570745|NCT00999206|Immunologic Factors|immunologic factors|mesh-ancestor
6570746|NCT00999206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570747|NCT00999219|Zolpidem|zolpidem|mesh-list
6570748|NCT00999219|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6570749|NCT00999219|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6570750|NCT00999219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6570751|NCT00999219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570752|NCT00999219|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6570753|NCT00999219|GABA Agonists|gaba agonists|mesh-ancestor
6570754|NCT00999219|GABA Agents|gaba agents|mesh-ancestor
6570755|NCT00999219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6570756|NCT00999219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570757|NCT00999232|Erythromycin|erythromycin|mesh-list
6570758|NCT00999232|Erythromycin Estolate|erythromycin estolate|mesh-list
6570759|NCT00999232|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
6570760|NCT00999232|Erythromycin stearate|erythromycin stearate|mesh-list
6570761|NCT00999232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6570762|NCT00999232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6570763|NCT00999232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6570764|NCT00999232|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6570765|NCT00999232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6570766|NCT00999232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570767|NCT00999258|Sirolimus|sirolimus|mesh-list
6570768|NCT00999258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6570769|NCT00999258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6570770|NCT00999258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6570771|NCT00999258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6570772|NCT00999258|Antifungal Agents|antifungal agents|mesh-ancestor
6020094|NCT00391586|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6020095|NCT00391586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6020096|NCT00391586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6020097|NCT00391716|Gabapentin|gabapentin|mesh-list
6020098|NCT00391716|Analgesics|analgesics|mesh-ancestor
6020099|NCT00391716|Sensory System Agents|sensory system agents|mesh-ancestor
6020100|NCT00391716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6020101|NCT00391716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570773|NCT00999258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6570774|NCT00999258|Immunologic Factors|immunologic factors|mesh-ancestor
6570775|NCT00999258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570776|NCT00999271|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
6570777|NCT00999271|Hormones|hormones|mesh-list
6570778|NCT00999271|Incretins|incretins|mesh-list
6570779|NCT00999271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6570780|NCT00999271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570781|NCT00999271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6570782|NCT00999297|Capsaicin|capsaicin|mesh-list
6570783|NCT00999297|Antipruritics|antipruritics|mesh-ancestor
6570784|NCT00999297|Dermatologic Agents|dermatologic agents|mesh-ancestor
6570785|NCT00999297|Sensory System Agents|sensory system agents|mesh-ancestor
6570786|NCT00999297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6570787|NCT00999297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570788|NCT00999336|Betrixaban|betrixaban|mesh-list
6570789|NCT00999336|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6570790|NCT00999336|Antithrombins|antithrombins|mesh-ancestor
6570791|NCT00999336|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6570792|NCT00999336|Protease Inhibitors|protease inhibitors|mesh-ancestor
6570793|NCT00999336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6570794|NCT00999336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570795|NCT00999336|Anticoagulants|anticoagulants|mesh-ancestor
6570796|NCT00999349|Silymarin|silymarin|mesh-list
6570797|NCT00999349|Antioxidants|antioxidants|mesh-ancestor
6570798|NCT00999349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570799|NCT00999349|Protective Agents|protective agents|mesh-ancestor
6570800|NCT00999349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570801|NCT00999427|Povidone-Iodine|povidone-iodine|mesh-list
6570802|NCT00999427|Povidone|povidone|mesh-list
6570803|NCT00999427|Plasma Substitutes|plasma substitutes|mesh-ancestor
6570804|NCT00999427|Blood Substitutes|blood substitutes|mesh-ancestor
6570805|NCT00999427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6570806|NCT00999427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6570807|NCT00999440|Methadone|methadone|mesh-list
6570808|NCT00999440|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6570809|NCT00999440|Narcotics|narcotics|mesh-ancestor
6570810|NCT00999440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6570811|NCT00999440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570812|NCT00999440|Analgesics|analgesics|mesh-ancestor
6570813|NCT00999440|Sensory System Agents|sensory system agents|mesh-ancestor
6570814|NCT00999440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6570815|NCT00999440|Antitussive Agents|antitussive agents|mesh-ancestor
6570816|NCT00999440|Respiratory System Agents|respiratory system agents|mesh-ancestor
6570817|NCT00999479|Ferrous fumarate|ferrous fumarate|mesh-list
6570818|NCT00999479|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6570819|NCT00999479|Norethindrone|norethindrone|mesh-list
6570820|NCT00999479|Norethindrone Acetate|norethindrone acetate|mesh-list
6020102|NCT00391716|Anticonvulsants|anticonvulsants|mesh-ancestor
6020103|NCT00391716|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6570821|NCT00999479|Estradiol|estradiol|mesh-list
6570822|NCT00999479|Estrogens|estrogens|mesh-ancestor
6570823|NCT00999479|Hormones|hormones|mesh-ancestor
6570824|NCT00999479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6570825|NCT00999479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570826|NCT00999479|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6570827|NCT00999479|Contraceptive Agents|contraceptive agents|mesh-ancestor
6570828|NCT00999479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6570829|NCT00999479|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6570830|NCT00999479|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6570831|NCT00999479|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6570832|NCT00999479|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6570833|NCT00999479|Trace Elements|trace elements|mesh-ancestor
6570834|NCT00999479|Micronutrients|micronutrients|mesh-ancestor
6570835|NCT00999505|Amantadine|amantadine|mesh-list
6570836|NCT00999505|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6020104|NCT00391716|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6020105|NCT00391716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6020106|NCT00391716|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6020107|NCT00391716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6020108|NCT00391716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6570837|NCT00999505|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6570838|NCT00999505|Antiviral Agents|antiviral agents|mesh-ancestor
6570839|NCT00999505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6570840|NCT00999505|Dopamine Agents|dopamine agents|mesh-ancestor
6570841|NCT00999505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6570842|NCT00999505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570843|NCT00999505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570844|NCT00999505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6570845|NCT00999505|Analgesics|analgesics|mesh-ancestor
6570846|NCT00999505|Sensory System Agents|sensory system agents|mesh-ancestor
6570847|NCT00999505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6570848|NCT00999557|Bimatoprost|bimatoprost|mesh-list
6570849|NCT00999557|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6570850|NCT00999557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6570851|NCT00999557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6570852|NCT00999700|Cisplatin|cisplatin|mesh-list
6570853|NCT00999700|Docetaxel|docetaxel|mesh-list
6570854|NCT00999700|Fluorouracil|fluorouracil|mesh-list
6570855|NCT00999700|Cetuximab|cetuximab|mesh-list
6570856|NCT00999700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6570857|NCT00999700|Tubulin Modulators|tubulin modulators|mesh-ancestor
6570858|NCT00999700|Antimitotic Agents|antimitotic agents|mesh-ancestor
6570859|NCT00999700|Mitosis Modulators|mitosis modulators|mesh-ancestor
6570860|NCT00999700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570861|NCT00999700|Antimetabolites|antimetabolites|mesh-ancestor
6570862|NCT00999700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6570863|NCT00999700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6570864|NCT00999700|Immunologic Factors|immunologic factors|mesh-ancestor
6570865|NCT00999700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570866|NCT00999700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6570867|NCT00999739|Vaccines|vaccines|mesh-list
6570868|NCT00999739|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6570869|NCT00999739|Immunologic Factors|immunologic factors|mesh-ancestor
6570870|NCT00999739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570871|NCT00999752|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6570872|NCT00999752|Nebivolol|nebivolol|mesh-list
6570873|NCT00999752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6570874|NCT00999752|Diuretics|diuretics|mesh-ancestor
6570875|NCT00999752|Natriuretic Agents|natriuretic agents|mesh-ancestor
6570876|NCT00999752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570877|NCT00999752|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6020109|NCT00391716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6570878|NCT00999752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6570879|NCT00999752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570880|NCT00999752|Vasodilator Agents|vasodilator agents|mesh-ancestor
6570881|NCT00999752|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6570882|NCT00999752|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6570883|NCT00999752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6570884|NCT00999752|Adrenergic Agents|adrenergic agents|mesh-ancestor
6570885|NCT00999752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6570886|NCT00999791|Diclofenac|diclofenac|mesh-list
6570887|NCT00999791|Bevacizumab|bevacizumab|mesh-list
6570888|NCT00999791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6570889|NCT00999791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6570890|NCT00999791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6570891|NCT00999791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6570892|NCT00999791|Growth Substances|growth substances|mesh-ancestor
6570893|NCT00999791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570894|NCT00999791|Growth Inhibitors|growth inhibitors|mesh-ancestor
6570895|NCT00999791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6570896|NCT00999791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6570897|NCT00999791|Analgesics|analgesics|mesh-ancestor
6570898|NCT00999791|Sensory System Agents|sensory system agents|mesh-ancestor
6570899|NCT00999791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6570900|NCT00999791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6445547|NCT00388700|Vitamin B Complex|vitamin b complex|mesh-ancestor
6445548|NCT00388700|Vitamins|vitamins|mesh-ancestor
6445549|NCT00388700|Micronutrients|micronutrients|mesh-ancestor
6445550|NCT00388739|Prednisolone|prednisolone|mesh-list
6445551|NCT00388739|Budesonide|budesonide|mesh-list
6445552|NCT00388739|Albuterol|albuterol|mesh-list
6445553|NCT00388739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6445554|NCT00388739|Glucocorticoids|glucocorticoids|mesh-ancestor
6445555|NCT00388739|Hormones|hormones|mesh-ancestor
6570901|NCT00999791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6570902|NCT00999791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6570903|NCT00999791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6570904|NCT00999791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570905|NCT00999817|Dextromethorphan|dextromethorphan|mesh-list
6570906|NCT00999817|Antitussive Agents|antitussive agents|mesh-ancestor
6570907|NCT00999817|Respiratory System Agents|respiratory system agents|mesh-ancestor
6570908|NCT00999817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6570909|NCT00999817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6570910|NCT00999817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6570911|NCT00999817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570912|NCT00999817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570913|NCT00999843|Sorafenib|sorafenib|mesh-list
6570914|NCT00999843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6570915|NCT00999843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6570916|NCT00999843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6570917|NCT00999843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570918|NCT00999869|Triamcinolone|triamcinolone|mesh-list
6570919|NCT00999869|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6570920|NCT00999869|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6570921|NCT00999869|Botulinum Toxins|botulinum toxins|mesh-list
6570922|NCT00999869|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6570923|NCT00999869|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6570924|NCT00999869|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6570925|NCT00999869|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6570926|NCT00999869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6570927|NCT00999869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570928|NCT00999869|Cholinergic Agents|cholinergic agents|mesh-ancestor
6570929|NCT00999869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6570930|NCT00999869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570931|NCT00999869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6570932|NCT00999869|Glucocorticoids|glucocorticoids|mesh-ancestor
6570933|NCT00999869|Hormones|hormones|mesh-ancestor
6570934|NCT00999869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6570935|NCT00999869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6570936|NCT00999869|Immunologic Factors|immunologic factors|mesh-ancestor
6570937|NCT00999869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6570938|NCT00999869|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6570939|NCT00999869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6570940|NCT00999973|Mitomycins|mitomycins|mesh-list
6445556|NCT00388739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6445557|NCT00388739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570941|NCT00999973|Mitomycin|mitomycin|mesh-list
6570942|NCT00999973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6570943|NCT00999973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6570944|NCT00999973|Alkylating Agents|alkylating agents|mesh-ancestor
6570945|NCT00999973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570946|NCT00999973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6570947|NCT00999973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6570948|NCT00999986|Cyclophosphamide|cyclophosphamide|mesh-list
6570949|NCT00999986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6570950|NCT00999986|Immunologic Factors|immunologic factors|mesh-ancestor
6570951|NCT00999986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570952|NCT00999986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6570953|NCT00999986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6570954|NCT00999986|Alkylating Agents|alkylating agents|mesh-ancestor
6570955|NCT00999986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570956|NCT00999986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6570957|NCT00999986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6570958|NCT01000116|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6570959|NCT01000116|Hemostatics|hemostatics|mesh-ancestor
6445558|NCT00388739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6445559|NCT00388739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6445560|NCT00388739|Autonomic Agents|autonomic agents|mesh-ancestor
6445561|NCT00388739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6445562|NCT00388739|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6445563|NCT00388739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6445564|NCT00388739|Respiratory System Agents|respiratory system agents|mesh-ancestor
6445565|NCT00388739|Tocolytic Agents|tocolytic agents|mesh-ancestor
6445566|NCT00388739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6445567|NCT00388739|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6445568|NCT00388739|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6445569|NCT00388739|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6445570|NCT00388739|Adrenergic Agents|adrenergic agents|mesh-ancestor
6445571|NCT00388739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6445572|NCT00388739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461723|NCT00455806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461724|NCT00455806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6461725|NCT00455806|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6461726|NCT00455806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6461727|NCT00455806|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6461728|NCT00455832|Ribavirin|ribavirin|mesh-list
6570960|NCT01000116|Coagulants|coagulants|mesh-ancestor
6570961|NCT01000220|Omeprazole|omeprazole|mesh-list
6570962|NCT01000220|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6570963|NCT01000220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6570964|NCT01000220|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6570965|NCT01000220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6570966|NCT01000220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570967|NCT01000233|Inositol|inositol|mesh-list
6570968|NCT01000233|Vitamin B Complex|vitamin b complex|mesh-ancestor
6570969|NCT01000233|Vitamins|vitamins|mesh-ancestor
6570970|NCT01000233|Micronutrients|micronutrients|mesh-ancestor
6570971|NCT01000233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657662|NCT01477268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6657663|NCT01477268|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6657664|NCT01477268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6657665|NCT01477268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6657666|NCT01477268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657667|NCT01477268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6657668|NCT01477268|Serotonin Agents|serotonin agents|mesh-ancestor
6657669|NCT01477268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657670|NCT01477294|Caffeine|caffeine|mesh-list
6657671|NCT01477294|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6657672|NCT01477294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657673|NCT01477294|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6657674|NCT01477294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6657675|NCT01477294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657676|NCT01477294|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6657677|NCT01477294|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6657678|NCT01477294|Purinergic Agents|purinergic agents|mesh-ancestor
6657679|NCT01477294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6657680|NCT01477385|Fluorides|fluorides|mesh-list
6657681|NCT01477385|Cariostatic Agents|cariostatic agents|mesh-ancestor
6657682|NCT01477385|Protective Agents|protective agents|mesh-ancestor
6570972|NCT01000298|Amoxicillin|amoxicillin|mesh-list
6570973|NCT01000298|Cefdinir|cefdinir|mesh-list
6570974|NCT01000298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6570975|NCT01000298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6570976|NCT01000415|Cisplatin|cisplatin|mesh-list
6570977|NCT01000415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6570978|NCT01000441|Adalimumab|adalimumab|mesh-list
6570979|NCT01000441|Etanercept|etanercept|mesh-list
6570980|NCT01000441|Rituximab|rituximab|mesh-list
6570981|NCT01000441|Abatacept|abatacept|mesh-list
6570982|NCT01000441|Infliximab|infliximab|mesh-list
6570983|NCT01000441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6570984|NCT01000441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6570985|NCT01000441|Immunologic Factors|immunologic factors|mesh-ancestor
6570986|NCT01000441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6570987|NCT01000441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6570988|NCT01000441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6570989|NCT01000441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6570990|NCT01000441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6570991|NCT01000441|Analgesics|analgesics|mesh-ancestor
6570992|NCT01000441|Sensory System Agents|sensory system agents|mesh-ancestor
6570993|NCT01000441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6570994|NCT01000441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6570995|NCT01000441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6570996|NCT01000441|Dermatologic Agents|dermatologic agents|mesh-ancestor
5501434|NCT04474262|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5501435|NCT04474262|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5501436|NCT04474262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5501437|NCT04474262|Adrenergic Agents|adrenergic agents|mesh-ancestor
6445573|NCT00388778|Doxycycline|doxycycline|mesh-list
6445574|NCT00388778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6445575|NCT00388778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6445576|NCT00388778|Antimalarials|antimalarials|mesh-ancestor
6445577|NCT00388778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6445578|NCT00388778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6445579|NCT00388856|Ascorbic Acid|ascorbic acid|mesh-list
6445580|NCT00388856|Vitamins|vitamins|mesh-ancestor
6445581|NCT00388856|Micronutrients|micronutrients|mesh-ancestor
6445582|NCT00388856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445583|NCT00388856|Antioxidants|antioxidants|mesh-ancestor
6445584|NCT00388856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445585|NCT00388856|Protective Agents|protective agents|mesh-ancestor
6445586|NCT00388882|Bromides|bromides|mesh-list
6445587|NCT00388882|Albuterol|albuterol|mesh-list
6445588|NCT00388882|Tiotropium Bromide|tiotropium bromide|mesh-list
6445589|NCT00388882|Ipratropium|ipratropium|mesh-list
6445590|NCT00388882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6445591|NCT00388882|Autonomic Agents|autonomic agents|mesh-ancestor
6445592|NCT00388882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6445593|NCT00388882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445594|NCT00388882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6445595|NCT00388882|Respiratory System Agents|respiratory system agents|mesh-ancestor
6445596|NCT00388882|Parasympatholytics|parasympatholytics|mesh-ancestor
6445597|NCT00388882|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6445598|NCT00388882|Cholinergic Agents|cholinergic agents|mesh-ancestor
6445599|NCT00388882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6461729|NCT00455832|Antimetabolites|antimetabolites|mesh-ancestor
6570997|NCT01000441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6570998|NCT01000441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6570999|NCT01000467|Probucol|probucol|mesh-list
6571000|NCT01000467|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6571001|NCT01000467|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6571002|NCT01000467|Antimetabolites|antimetabolites|mesh-ancestor
6571003|NCT01000467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571004|NCT01000467|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6571005|NCT01000467|Antioxidants|antioxidants|mesh-ancestor
6571006|NCT01000467|Protective Agents|protective agents|mesh-ancestor
6445600|NCT00388882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445601|NCT00388882|Anticonvulsants|anticonvulsants|mesh-ancestor
6571007|NCT01000467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571008|NCT01000545|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
6571009|NCT01000545|Anticoagulants|anticoagulants|mesh-ancestor
6571010|NCT01000545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6571011|NCT01000545|Antimetabolites|antimetabolites|mesh-ancestor
6571012|NCT01000545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571013|NCT01000545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6571014|NCT01000545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6571015|NCT01000545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6571016|NCT01000545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6571017|NCT01000545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571018|NCT01000597|Fluticasone|fluticasone|mesh-list
6571019|NCT01000597|Xhance|xhance|mesh-list
6571020|NCT01000597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6571021|NCT01000597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6571022|NCT01000597|Autonomic Agents|autonomic agents|mesh-ancestor
6571023|NCT01000597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6571024|NCT01000597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571025|NCT01000597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6571026|NCT01000597|Respiratory System Agents|respiratory system agents|mesh-ancestor
6571027|NCT01000597|Dermatologic Agents|dermatologic agents|mesh-ancestor
6571028|NCT01000597|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6571029|NCT01000623|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6571030|NCT01000623|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6571031|NCT01000623|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6571032|NCT01000623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6571033|NCT01000623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571034|NCT01000623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6571035|NCT01000623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571036|NCT01000623|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6571037|NCT01000623|Antidepressive Agents|antidepressive agents|mesh-ancestor
6571038|NCT01000623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6571039|NCT01000688|Vildagliptin|vildagliptin|mesh-list
6571040|NCT01000688|Acarbose|acarbose|mesh-list
6571041|NCT01000688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6571042|NCT01000688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571043|NCT01000688|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6571044|NCT01000688|Protease Inhibitors|protease inhibitors|mesh-ancestor
6571045|NCT01000688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6445602|NCT00388882|Tocolytic Agents|tocolytic agents|mesh-ancestor
6445603|NCT00388882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6445604|NCT00388882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6445605|NCT00388882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6445606|NCT00388882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6445607|NCT00388882|Adrenergic Agents|adrenergic agents|mesh-ancestor
6445608|NCT00388895|Imatinib Mesylate|imatinib mesylate|mesh-list
6445609|NCT00388895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6445610|NCT00388895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6445611|NCT00388895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6657683|NCT01477385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571046|NCT01000688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571047|NCT01000688|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6571048|NCT01000779|Propranolol|propranolol|mesh-list
6571049|NCT01000779|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6571050|NCT01000779|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6571051|NCT01000779|Adrenergic Agents|adrenergic agents|mesh-ancestor
6571052|NCT01000779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6571053|NCT01000779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571054|NCT01000779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571055|NCT01000779|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6571056|NCT01000779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6571057|NCT01000779|Vasodilator Agents|vasodilator agents|mesh-ancestor
6571058|NCT01000792|Cetirizine|cetirizine|mesh-list
6571059|NCT01000792|Levocetirizine|levocetirizine|mesh-list
6571060|NCT01000792|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6571061|NCT01000792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6571062|NCT01000792|Histamine Antagonists|histamine antagonists|mesh-ancestor
6571063|NCT01000792|Histamine Agents|histamine agents|mesh-ancestor
6571064|NCT01000792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6571065|NCT01000792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571066|NCT01000792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571067|NCT01000792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6571068|NCT01000831|Vaccines|vaccines|mesh-list
6571069|NCT01000831|Immunologic Factors|immunologic factors|mesh-ancestor
6571070|NCT01000831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571071|NCT01000857|Paroxetine|paroxetine|mesh-list
6571072|NCT01000857|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6571073|NCT01000857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6571074|NCT01000857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6571075|NCT01000857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571076|NCT01000857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6571077|NCT01000857|Serotonin Agents|serotonin agents|mesh-ancestor
6571078|NCT01000857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571079|NCT01000857|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6571080|NCT01000857|Antidepressive Agents|antidepressive agents|mesh-ancestor
6571081|NCT01000857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6571082|NCT01000857|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6571083|NCT01000857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6571084|NCT01000857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6571085|NCT01000896|Paclitaxel|paclitaxel|mesh-list
6571086|NCT01000896|Carboplatin|carboplatin|mesh-list
6571087|NCT01000896|Saracatinib|saracatinib|mesh-list
6571088|NCT01000896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6571089|NCT01000896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6571090|NCT01000896|Tubulin Modulators|tubulin modulators|mesh-ancestor
6571091|NCT01000896|Antimitotic Agents|antimitotic agents|mesh-ancestor
6571092|NCT01000896|Mitosis Modulators|mitosis modulators|mesh-ancestor
6571093|NCT01000896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571094|NCT01000896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6571095|NCT01001013|Pioglitazone|pioglitazone|mesh-list
6571096|NCT01001013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6571097|NCT01001013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571098|NCT01001130|Fluticasone|fluticasone|mesh-list
6571099|NCT01001130|Xhance|xhance|mesh-list
6571100|NCT01001130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6571101|NCT01001130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6571102|NCT01001130|Autonomic Agents|autonomic agents|mesh-ancestor
6571103|NCT01001130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6571104|NCT01001130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571105|NCT01001130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6571106|NCT01001130|Respiratory System Agents|respiratory system agents|mesh-ancestor
6571107|NCT01001130|Dermatologic Agents|dermatologic agents|mesh-ancestor
6571108|NCT01001130|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6571109|NCT01001143|Decitabine|decitabine|mesh-list
6571110|NCT01001143|Bexarotene|bexarotene|mesh-list
6571111|NCT01001143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6571112|NCT01001143|Antimetabolites|antimetabolites|mesh-ancestor
6571113|NCT01001143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571114|NCT01001143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6571115|NCT01001143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6571116|NCT01001247|Rilpivirine|rilpivirine|mesh-list
6571117|NCT01001247|Omeprazole|omeprazole|mesh-list
6571118|NCT01001247|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6571119|NCT01001247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6571120|NCT01001247|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6571121|NCT01001247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6571122|NCT01001247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571123|NCT01001247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6571124|NCT01001247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6571125|NCT01001247|Antiviral Agents|antiviral agents|mesh-ancestor
6571126|NCT01001247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6571127|NCT01001247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6571128|NCT01001247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6571129|NCT01001260|Aspirin|aspirin|mesh-list
6571130|NCT01001260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6571131|NCT01001260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6571132|NCT01001260|Analgesics|analgesics|mesh-ancestor
6571133|NCT01001260|Sensory System Agents|sensory system agents|mesh-ancestor
6571134|NCT01001260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6571135|NCT01001260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571136|NCT01001260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5501438|NCT04474262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6571137|NCT01001260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6571138|NCT01001260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6571139|NCT01001260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6571140|NCT01001260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571141|NCT01001260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6571142|NCT01001260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6571143|NCT01001260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6571144|NCT01001260|Antipyretics|antipyretics|mesh-ancestor
6571145|NCT01001364|Budesonide|budesonide|mesh-list
6571146|NCT01001364|Formoterol Fumarate|formoterol fumarate|mesh-list
6571147|NCT01001364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6571148|NCT01001364|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6571149|NCT01001364|Autonomic Agents|autonomic agents|mesh-ancestor
6571150|NCT01001364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6571151|NCT01001364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571152|NCT01001364|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6571153|NCT01001364|Respiratory System Agents|respiratory system agents|mesh-ancestor
6571154|NCT01001364|Glucocorticoids|glucocorticoids|mesh-ancestor
6571155|NCT01001364|Hormones|hormones|mesh-ancestor
6571156|NCT01001364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6571157|NCT01001364|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6571158|NCT01001364|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6571159|NCT01001364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6571160|NCT01001364|Adrenergic Agents|adrenergic agents|mesh-ancestor
6571161|NCT01001364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6571162|NCT01001364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571163|NCT01001585|Sevoflurane|sevoflurane|mesh-list
6571164|NCT01001585|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6571165|NCT01001585|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6571166|NCT01001585|Anesthetics, General|anesthetics, general|mesh-ancestor
6571167|NCT01001585|Anesthetics|anesthetics|mesh-ancestor
6571168|NCT01001585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6571169|NCT01001585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571170|NCT01001624|Hydroquinone|hydroquinone|mesh-list
6571171|NCT01001624|Antioxidants|antioxidants|mesh-ancestor
6571172|NCT01001624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571173|NCT01001624|Protective Agents|protective agents|mesh-ancestor
6571174|NCT01001624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571175|NCT01001624|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6571176|NCT01001637|Curcumin|curcumin|mesh-list
6571177|NCT01001637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6571178|NCT01001637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6571179|NCT01001637|Analgesics|analgesics|mesh-ancestor
6571180|NCT01001637|Sensory System Agents|sensory system agents|mesh-ancestor
6571181|NCT01001637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6571182|NCT01001637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571183|NCT01001637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6571184|NCT01001637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6571185|NCT01001637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6571186|NCT01001637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6571187|NCT01001637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571188|NCT01001676|Paclitaxel|paclitaxel|mesh-list
6571189|NCT01001676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6571190|NCT01001676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6571191|NCT01001676|Tubulin Modulators|tubulin modulators|mesh-ancestor
6571192|NCT01001676|Antimitotic Agents|antimitotic agents|mesh-ancestor
6571193|NCT01001676|Mitosis Modulators|mitosis modulators|mesh-ancestor
6571194|NCT01001676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571195|NCT01001754|Ribavirin|ribavirin|mesh-list
6571196|NCT01001754|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6571197|NCT01001754|Antimetabolites|antimetabolites|mesh-ancestor
6571198|NCT01001754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571199|NCT01001754|Antiviral Agents|antiviral agents|mesh-ancestor
6571200|NCT01001754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6571201|NCT01001780|Cyclophosphamide|cyclophosphamide|mesh-list
6571202|NCT01001780|Rituximab|rituximab|mesh-list
6571203|NCT01001780|Pentostatin|pentostatin|mesh-list
6571204|NCT01001780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6571205|NCT01001780|Immunologic Factors|immunologic factors|mesh-ancestor
6571206|NCT01001780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571207|NCT01001780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6571208|NCT01001780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6571209|NCT01001780|Alkylating Agents|alkylating agents|mesh-ancestor
6657684|NCT01477411|Digoxin|digoxin|mesh-list
6053229|NCT00593827|Antimitotic Agents|antimitotic agents|mesh-ancestor
6571210|NCT01001780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571211|NCT01001780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6571212|NCT01001780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6571213|NCT01001780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6571214|NCT01001780|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
6571215|NCT01001780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6571216|NCT01001845|Vitamin E|vitamin e|mesh-list
6571217|NCT01001845|alpha-Tocopherol|alpha-tocopherol|mesh-list
6571218|NCT01001845|Tocopherols|tocopherols|mesh-list
6571219|NCT01001845|Antioxidants|antioxidants|mesh-ancestor
6571220|NCT01001845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571221|NCT01001845|Protective Agents|protective agents|mesh-ancestor
6571222|NCT01001845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571223|NCT01001845|Vitamins|vitamins|mesh-ancestor
6571224|NCT01001845|Micronutrients|micronutrients|mesh-ancestor
6571225|NCT01001871|Vitamins|vitamins|mesh-list
6571226|NCT01001871|Micronutrients|micronutrients|mesh-ancestor
6571227|NCT01001871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571228|NCT01001897|Misoprostol|misoprostol|mesh-list
6571229|NCT01001897|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6571230|NCT01001897|Abortifacient Agents|abortifacient agents|mesh-ancestor
6571231|NCT01001897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6571232|NCT01001897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571233|NCT01001897|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6571234|NCT01001897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6571235|NCT01001897|Oxytocics|oxytocics|mesh-ancestor
6571236|NCT01001962|Metformin|metformin|mesh-list
6571237|NCT01001962|Empagliflozin|empagliflozin|mesh-list
6571238|NCT01001962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6571239|NCT01001962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571240|NCT01001962|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6571241|NCT01001962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571242|NCT01002079|Rifampin|rifampin|mesh-list
6571243|NCT01002079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6571244|NCT01002079|Antitubercular Agents|antitubercular agents|mesh-ancestor
6571245|NCT01002079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6571246|NCT01002079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6571247|NCT01002079|Leprostatic Agents|leprostatic agents|mesh-ancestor
6571248|NCT01002079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6571249|NCT01002079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6571250|NCT01002079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571251|NCT01002079|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6571252|NCT01002079|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6571253|NCT01002079|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6571254|NCT01002079|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6571255|NCT01002079|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6571256|NCT01002079|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6571257|NCT01002092|Endostar protein|endostar protein|mesh-list
6571258|NCT01002092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6571259|NCT01002092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6571260|NCT01002092|Growth Substances|growth substances|mesh-ancestor
6571261|NCT01002092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571262|NCT01002092|Growth Inhibitors|growth inhibitors|mesh-ancestor
6571263|NCT01002092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6571264|NCT01002157|Vitamin K|vitamin k|mesh-list
6571265|NCT01002157|Vitamin K 2|vitamin k 2|mesh-list
6571266|NCT01002157|Vitamin MK 7|vitamin mk 7|mesh-list
6571267|NCT01002157|Vitamins|vitamins|mesh-ancestor
6571268|NCT01002157|Micronutrients|micronutrients|mesh-ancestor
6571269|NCT01002157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571270|NCT01002157|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6571271|NCT01002157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6571272|NCT01002157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571273|NCT01002157|Hemostatics|hemostatics|mesh-ancestor
6571274|NCT01002157|Coagulants|coagulants|mesh-ancestor
6571275|NCT01002183|Fosmidomycin|fosmidomycin|mesh-list
6571276|NCT01002183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6571277|NCT01002183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6571278|NCT01002300|Oxytocin|oxytocin|mesh-list
6571279|NCT01002300|Oxytocics|oxytocics|mesh-ancestor
6571280|NCT01002300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6571281|NCT01002300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020110|NCT00391716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020111|NCT00391716|Antimanic Agents|antimanic agents|mesh-ancestor
6020112|NCT00391768|Oseltamivir|oseltamivir|mesh-list
6020113|NCT00391768|Antiviral Agents|antiviral agents|mesh-ancestor
6020114|NCT00391768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6020115|NCT00391768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6020116|NCT00391768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020117|NCT00391807|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6020118|NCT00391807|Norethindrone|norethindrone|mesh-list
6020119|NCT00391807|Norethindrone Acetate|norethindrone acetate|mesh-list
6020120|NCT00391807|Estradiol|estradiol|mesh-list
6020121|NCT00391807|Estrogens|estrogens|mesh-ancestor
6020122|NCT00391807|Hormones|hormones|mesh-ancestor
6020123|NCT00391807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6020124|NCT00391807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020125|NCT00391807|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6020126|NCT00391807|Contraceptive Agents|contraceptive agents|mesh-ancestor
6020127|NCT00391807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6020128|NCT00391807|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6020129|NCT00391807|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6020130|NCT00391807|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6020131|NCT00391807|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6020132|NCT00391846|Metoprolol|metoprolol|mesh-list
6020133|NCT00391846|Valsartan|valsartan|mesh-list
6020134|NCT00391846|Carvedilol|carvedilol|mesh-list
6020135|NCT00391846|Candesartan|candesartan|mesh-list
6020136|NCT00391846|Ramipril|ramipril|mesh-list
6020137|NCT00391846|Enalapril|enalapril|mesh-list
6020138|NCT00391846|Lisinopril|lisinopril|mesh-list
6020139|NCT00391846|Eplerenone|eplerenone|mesh-list
6020140|NCT00391846|Bisoprolol|bisoprolol|mesh-list
6020141|NCT00391846|Captopril|captopril|mesh-list
6020142|NCT00391846|Trandolapril|trandolapril|mesh-list
6020143|NCT00391846|Spironolactone|spironolactone|mesh-list
6657685|NCT01477411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6657686|NCT01477411|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6657687|NCT01477411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6657688|NCT01477411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657689|NCT01477411|Protective Agents|protective agents|mesh-ancestor
6657690|NCT01477411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657691|NCT01477424|Warfarin|warfarin|mesh-list
6657692|NCT01477424|Anticoagulants|anticoagulants|mesh-ancestor
6657693|NCT01477476|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6657694|NCT01477476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6657695|NCT01477489|Veliparib|veliparib|mesh-list
6657696|NCT01477489|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6657697|NCT01477489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6657698|NCT01477489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657699|NCT01477489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6657700|NCT01477580|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6657701|NCT01477580|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6657702|NCT01477580|Immunologic Factors|immunologic factors|mesh-ancestor
6657703|NCT01477580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657704|NCT01477580|Antacids|antacids|mesh-ancestor
6657705|NCT01477580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020144|NCT00391846|Diuretics|diuretics|mesh-list
6020145|NCT00391846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6020146|NCT00391846|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6571282|NCT01002534|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6571283|NCT01002534|Vasodilator Agents|vasodilator agents|mesh-ancestor
6571284|NCT01002534|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6571285|NCT01002534|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6571286|NCT01002534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6571287|NCT01002534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571288|NCT01002534|Urological Agents|urological agents|mesh-ancestor
6571289|NCT01002690|Etoricoxib|etoricoxib|mesh-list
6571290|NCT01002690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6571291|NCT01002690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6571292|NCT01002690|Analgesics|analgesics|mesh-ancestor
6571293|NCT01002690|Sensory System Agents|sensory system agents|mesh-ancestor
6571294|NCT01002690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6571295|NCT01002690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571296|NCT01002690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6571297|NCT01002690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6571298|NCT01002690|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6571299|NCT01002690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6571300|NCT01002690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6571301|NCT01002690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571302|NCT01002703|Prednisone|prednisone|mesh-list
6571303|NCT01002703|Lenalidomide|lenalidomide|mesh-list
6571304|NCT01002703|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6571305|NCT01002703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6571306|NCT01002703|Glucocorticoids|glucocorticoids|mesh-ancestor
6571307|NCT01002703|Hormones|hormones|mesh-ancestor
6571308|NCT01002703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6571309|NCT01002703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571310|NCT01002703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6571311|NCT01002703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6571312|NCT01002703|Immunologic Factors|immunologic factors|mesh-ancestor
6571313|NCT01002703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6571314|NCT01002703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6571315|NCT01002703|Growth Substances|growth substances|mesh-ancestor
6571316|NCT01002703|Growth Inhibitors|growth inhibitors|mesh-ancestor
6571317|NCT01002703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6571318|NCT01002703|Alkylating Agents|alkylating agents|mesh-ancestor
6571319|NCT01002703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571320|NCT01002716|Vaccines|vaccines|mesh-list
6571321|NCT01002716|Immunologic Factors|immunologic factors|mesh-ancestor
6571322|NCT01002716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571323|NCT01002729|Oseltamivir|oseltamivir|mesh-list
6571324|NCT01002729|Antiviral Agents|antiviral agents|mesh-ancestor
6571325|NCT01002729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6571326|NCT01002729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6571327|NCT01002729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571328|NCT01002768|Insulin|insulin|mesh-list
6571329|NCT01002768|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6571330|NCT01002768|Insulin Glargine|insulin glargine|mesh-list
6571331|NCT01002768|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6571332|NCT01002768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571333|NCT01002807|Metformin|metformin|mesh-list
6571334|NCT01002807|Dapagliflozin|dapagliflozin|mesh-list
6571335|NCT01002807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6571336|NCT01002807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571337|NCT01002807|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6571338|NCT01002807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571339|NCT01002898|Ritonavir|ritonavir|mesh-list
6571340|NCT01002898|Lopinavir|lopinavir|mesh-list
6571341|NCT01002898|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6571342|NCT01002898|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6571343|NCT01002898|Protease Inhibitors|protease inhibitors|mesh-ancestor
6571344|NCT01002898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6571345|NCT01002898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571346|NCT01002898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6571347|NCT01002898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6571348|NCT01002898|Antiviral Agents|antiviral agents|mesh-ancestor
6571349|NCT01002898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6571350|NCT01002898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6571351|NCT01002898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6571352|NCT01002911|Cefazolin|cefazolin|mesh-list
6571353|NCT01002911|Cephalexin|cephalexin|mesh-list
6571354|NCT01002911|Bacitracin|bacitracin|mesh-list
6053230|NCT00593827|Mitosis Modulators|mitosis modulators|mesh-ancestor
6571355|NCT01002911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6571356|NCT01002911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6571357|NCT01002911|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6571358|NCT01003002|Levodopa|levodopa|mesh-list
6571359|NCT01003002|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6571360|NCT01003002|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6571361|NCT01003002|Dopamine Agents|dopamine agents|mesh-ancestor
6571362|NCT01003002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6571363|NCT01003002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571364|NCT01003002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571365|NCT01003028|Remifentanil|remifentanil|mesh-list
6571366|NCT01003028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6571367|NCT01003028|Narcotics|narcotics|mesh-ancestor
6571368|NCT01003028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6571369|NCT01003028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571370|NCT01003028|Analgesics|analgesics|mesh-ancestor
6571371|NCT01003028|Sensory System Agents|sensory system agents|mesh-ancestor
6571372|NCT01003028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6571373|NCT01003054|Cyclophosphamide|cyclophosphamide|mesh-list
6571374|NCT01003054|Busulfan|busulfan|mesh-list
6571375|NCT01003054|Imatinib Mesylate|imatinib mesylate|mesh-list
6571376|NCT01003054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6571377|NCT01003054|Immunologic Factors|immunologic factors|mesh-ancestor
6571378|NCT01003054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571379|NCT01003054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6571380|NCT01003054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6571381|NCT01003054|Alkylating Agents|alkylating agents|mesh-ancestor
6571382|NCT01003054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571383|NCT01003054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6571384|NCT01003054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6571385|NCT01003054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6571386|NCT01003054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6571387|NCT01003158|Paclitaxel|paclitaxel|mesh-list
6571388|NCT01003158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6571389|NCT01003158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6571390|NCT01003158|Tubulin Modulators|tubulin modulators|mesh-ancestor
6571391|NCT01003158|Antimitotic Agents|antimitotic agents|mesh-ancestor
6571392|NCT01003158|Mitosis Modulators|mitosis modulators|mesh-ancestor
6445612|NCT00388895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445613|NCT00388986|Glyburide|glyburide|mesh-list
6445614|NCT00388986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6445615|NCT00388986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445616|NCT00388999|Lectins|lectins|mesh-list
6445617|NCT00388999|Agglutinins|agglutinins|mesh-ancestor
6445618|NCT00388999|Immunologic Factors|immunologic factors|mesh-ancestor
6445619|NCT00388999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445620|NCT00388999|Coagulants|coagulants|mesh-ancestor
6445621|NCT00389025|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
6445622|NCT00389025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6445623|NCT00389025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6445624|NCT00389025|Analgesics|analgesics|mesh-ancestor
6445625|NCT00389025|Sensory System Agents|sensory system agents|mesh-ancestor
6445626|NCT00389025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6445627|NCT00389025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445628|NCT00389025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6445629|NCT00389025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6445630|NCT00389025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6445631|NCT00389025|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6445632|NCT00389025|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6445633|NCT00389025|Histamine Antagonists|histamine antagonists|mesh-ancestor
6445634|NCT00389025|Histamine Agents|histamine agents|mesh-ancestor
6445635|NCT00389025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6445636|NCT00389025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445637|NCT00389038|Amitriptyline|amitriptyline|mesh-list
6445638|NCT00389038|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6445639|NCT00389038|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6445640|NCT00389038|Antidepressive Agents|antidepressive agents|mesh-ancestor
6445641|NCT00389038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6571393|NCT01003158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571394|NCT01003314|Vaccines|vaccines|mesh-list
6571395|NCT01003314|Immunologic Factors|immunologic factors|mesh-ancestor
6571396|NCT01003314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571397|NCT01003483|Orlistat|orlistat|mesh-list
6571398|NCT01003483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6571399|NCT01003483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571400|NCT01003483|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6571401|NCT01003483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6571402|NCT01003522|Anesthetics|anesthetics|mesh-list
6571403|NCT01003522|Anesthetics, General|anesthetics, general|mesh-list
6571404|NCT01003522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6571405|NCT01003522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571406|NCT01003561|Anesthetics|anesthetics|mesh-list
6571407|NCT01003561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6571408|NCT01003561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571409|NCT01003613|Tranilast|tranilast|mesh-list
6571410|NCT01003613|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6571411|NCT01003613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6571412|NCT01003613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6571413|NCT01003613|Analgesics|analgesics|mesh-ancestor
6571414|NCT01003613|Sensory System Agents|sensory system agents|mesh-ancestor
6571415|NCT01003613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6571416|NCT01003613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571417|NCT01003613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6571418|NCT01003613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6571419|NCT01003613|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6571420|NCT01003613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6571421|NCT01003613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571422|NCT01003613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6571423|NCT01003613|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6571424|NCT01003613|Histamine Antagonists|histamine antagonists|mesh-ancestor
6571425|NCT01003613|Histamine Agents|histamine agents|mesh-ancestor
6571426|NCT01003613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6571427|NCT01003613|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6571428|NCT01003613|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6571429|NCT01003613|Hemostatics|hemostatics|mesh-ancestor
6571430|NCT01003613|Coagulants|coagulants|mesh-ancestor
6571431|NCT01003678|Clofarabine|clofarabine|mesh-list
6571432|NCT01003678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6571433|NCT01003678|Antimetabolites|antimetabolites|mesh-ancestor
6571434|NCT01003678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571435|NCT01003678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6571436|NCT01003847|Fenofibrate|fenofibrate|mesh-list
6571437|NCT01003847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6571438|NCT01003847|Antimetabolites|antimetabolites|mesh-ancestor
6571439|NCT01003847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571440|NCT01003847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6571441|NCT01003964|Gemcitabine|gemcitabine|mesh-list
6571442|NCT01003964|Docetaxel|docetaxel|mesh-list
6571443|NCT01003964|Irinotecan|irinotecan|mesh-list
6571444|NCT01003964|Pemetrexed|pemetrexed|mesh-list
6571445|NCT01003964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6571446|NCT01003964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6571447|NCT01003964|Antimetabolites|antimetabolites|mesh-ancestor
6571448|NCT01003964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571449|NCT01003964|Antiviral Agents|antiviral agents|mesh-ancestor
6571450|NCT01003964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6571451|NCT01003964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6571452|NCT01003964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6571453|NCT01003964|Immunologic Factors|immunologic factors|mesh-ancestor
6571454|NCT01003964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571455|NCT01003964|Tubulin Modulators|tubulin modulators|mesh-ancestor
6571456|NCT01003964|Antimitotic Agents|antimitotic agents|mesh-ancestor
6571457|NCT01003964|Mitosis Modulators|mitosis modulators|mesh-ancestor
6571458|NCT01003964|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6571459|NCT01003964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6571460|NCT01003964|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6571461|NCT01003964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6657706|NCT01477580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6657707|NCT01477606|Cytarabine|cytarabine|mesh-list
6657708|NCT01477606|Daunorubicin|daunorubicin|mesh-list
6657709|NCT01477606|Midostaurin|midostaurin|mesh-list
6657710|NCT01477606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6657711|NCT01477606|Antimetabolites|antimetabolites|mesh-ancestor
6657712|NCT01477606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657713|NCT01477606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6657714|NCT01477606|Antiviral Agents|antiviral agents|mesh-ancestor
6657715|NCT01477606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6657716|NCT01477606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6657717|NCT01477606|Immunologic Factors|immunologic factors|mesh-ancestor
6657718|NCT01477606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657719|NCT01477606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6657720|NCT01477606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6657721|NCT01477606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6657722|NCT01477606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6657723|NCT01477606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6657724|NCT01477632|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6657725|NCT01477632|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6657726|NCT01477632|Norethindrone|norethindrone|mesh-list
6657727|NCT01477632|Norethindrone Acetate|norethindrone acetate|mesh-list
6657728|NCT01477632|Estradiol|estradiol|mesh-list
6657729|NCT01477632|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6657730|NCT01477632|Estrogens|estrogens|mesh-ancestor
6657731|NCT01477632|Hormones|hormones|mesh-ancestor
6657732|NCT01477632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6657733|NCT01477632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657734|NCT01477632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6657735|NCT01477632|Contraceptive Agents|contraceptive agents|mesh-ancestor
6657736|NCT01477632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6657737|NCT01477632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6657738|NCT01477632|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6657739|NCT01477632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6657740|NCT01477632|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6657741|NCT01477736|Oxybutynin|oxybutynin|mesh-list
6657742|NCT01477736|Botulinum Toxins|botulinum toxins|mesh-list
6657743|NCT01477736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6657744|NCT01477736|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6657745|NCT01477736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6657746|NCT01477736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6657747|NCT01477736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657748|NCT01477736|Cholinergic Agents|cholinergic agents|mesh-ancestor
6657749|NCT01477736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6657750|NCT01477736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657751|NCT01477736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6657752|NCT01477736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6657753|NCT01477736|Parasympatholytics|parasympatholytics|mesh-ancestor
6657754|NCT01477736|Autonomic Agents|autonomic agents|mesh-ancestor
6657755|NCT01477736|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6657756|NCT01477736|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6657757|NCT01477736|Urological Agents|urological agents|mesh-ancestor
6657758|NCT01477801|Cholecalciferol|cholecalciferol|mesh-list
6657759|NCT01477801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6657760|NCT01477801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445642|NCT00389038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6445643|NCT00389038|Analgesics|analgesics|mesh-ancestor
6445644|NCT00389038|Sensory System Agents|sensory system agents|mesh-ancestor
6445645|NCT00389038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6445646|NCT00389038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445647|NCT00389038|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6445648|NCT00389038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6445649|NCT00389038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6462215|NCT00458185|Sensory System Agents|sensory system agents|mesh-ancestor
6571462|NCT01004055|Anti-Infective Agents|anti-infective agents|mesh-list
6571463|NCT01004055|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6571464|NCT01004068|Clomiphene|clomiphene|mesh-list
6571465|NCT01004068|Enclomiphene|enclomiphene|mesh-list
6571466|NCT01004068|Zuclomiphene|zuclomiphene|mesh-list
6571467|NCT01004068|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6571468|NCT01004068|Hormone Antagonists|hormone antagonists|mesh-ancestor
6571469|NCT01004068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6571470|NCT01004068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571471|NCT01004068|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6571472|NCT01004068|Fertility Agents|fertility agents|mesh-ancestor
6571473|NCT01004068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6571474|NCT01004068|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6571475|NCT01004068|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6571476|NCT01004198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6571477|NCT01004224|Infigratinib|infigratinib|mesh-list
6571478|NCT01004224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6571479|NCT01004237|Valsartan|valsartan|mesh-list
6571480|NCT01004237|Pravastatin|pravastatin|mesh-list
6571481|NCT01004237|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6571482|NCT01004237|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6571483|NCT01004237|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6571484|NCT01004237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571485|NCT01004237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6571486|NCT01004237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6571487|NCT01004237|Antimetabolites|antimetabolites|mesh-ancestor
6571488|NCT01004237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6571489|NCT01004237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6571490|NCT01004237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6571491|NCT01004315|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6571492|NCT01004315|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6571493|NCT01004315|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6571494|NCT01004315|Cholinergic Agents|cholinergic agents|mesh-ancestor
6571495|NCT01004315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6571496|NCT01004315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571497|NCT01004315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571498|NCT01004315|Urological Agents|urological agents|mesh-ancestor
6571499|NCT01004380|Carboplatin|carboplatin|mesh-list
6571500|NCT01004380|Farletuzumab|farletuzumab|mesh-list
6571501|NCT01004380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6571502|NCT01004419|Fulvestrant|fulvestrant|mesh-list
6571503|NCT01004419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6571504|NCT01004419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6571505|NCT01004419|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6571506|NCT01004419|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6571507|NCT01004419|Hormone Antagonists|hormone antagonists|mesh-ancestor
6571508|NCT01004419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6571509|NCT01004419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571510|NCT01004445|Amikacin|amikacin|mesh-list
6571511|NCT01004445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6571512|NCT01004445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6571513|NCT01004497|Cytarabine|cytarabine|mesh-list
6571514|NCT01004497|Dexamethasone|dexamethasone|mesh-list
6571515|NCT01004497|Dexamethasone acetate|dexamethasone acetate|mesh-list
6571516|NCT01004497|Cyclophosphamide|cyclophosphamide|mesh-list
6571517|NCT01004497|Vincristine|vincristine|mesh-list
6571518|NCT01004497|Daunorubicin|daunorubicin|mesh-list
6571519|NCT01004497|Dasatinib|dasatinib|mesh-list
6571520|NCT01004497|Mitoxantrone|mitoxantrone|mesh-list
6571521|NCT01004497|BB 1101|bb 1101|mesh-list
6571522|NCT01004497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6571523|NCT01004497|Immunologic Factors|immunologic factors|mesh-ancestor
6571524|NCT01004497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571525|NCT01004497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6571526|NCT01004497|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6571527|NCT01004497|Alkylating Agents|alkylating agents|mesh-ancestor
6571528|NCT01004497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571529|NCT01004497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6571530|NCT01004497|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6571531|NCT01004497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6571532|NCT01004497|Antiemetics|antiemetics|mesh-ancestor
6571533|NCT01004497|Autonomic Agents|autonomic agents|mesh-ancestor
6571534|NCT01004497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6571535|NCT01004497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6571536|NCT01004497|Glucocorticoids|glucocorticoids|mesh-ancestor
6571537|NCT01004497|Hormones|hormones|mesh-ancestor
6571538|NCT01004497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6571539|NCT01004497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6571540|NCT01004497|Protease Inhibitors|protease inhibitors|mesh-ancestor
6571541|NCT01004497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6571542|NCT01004497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6571543|NCT01004497|Antimetabolites|antimetabolites|mesh-ancestor
6571544|NCT01004497|Antiviral Agents|antiviral agents|mesh-ancestor
6571545|NCT01004497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6571546|NCT01004497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6571547|NCT01004497|Tubulin Modulators|tubulin modulators|mesh-ancestor
6571548|NCT01004497|Antimitotic Agents|antimitotic agents|mesh-ancestor
6571549|NCT01004497|Mitosis Modulators|mitosis modulators|mesh-ancestor
6571550|NCT01004497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6571551|NCT01004497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6571552|NCT01004497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6571553|NCT01004497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6571554|NCT01004497|Analgesics|analgesics|mesh-ancestor
6571555|NCT01004497|Sensory System Agents|sensory system agents|mesh-ancestor
6571556|NCT01004575|Cobalt|cobalt|mesh-list
6571557|NCT01004575|Chromium|chromium|mesh-list
6571558|NCT01004575|Trace Elements|trace elements|mesh-ancestor
6571559|NCT01004575|Micronutrients|micronutrients|mesh-ancestor
6571560|NCT01004575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571561|NCT01004601|Docetaxel|docetaxel|mesh-list
6571562|NCT01004601|Pemetrexed|pemetrexed|mesh-list
6571563|NCT01004601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6571564|NCT01004601|Tubulin Modulators|tubulin modulators|mesh-ancestor
6571565|NCT01004601|Antimitotic Agents|antimitotic agents|mesh-ancestor
6571566|NCT01004601|Mitosis Modulators|mitosis modulators|mesh-ancestor
6571567|NCT01004601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571568|NCT01004601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6571569|NCT01004601|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6571570|NCT01004601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6571571|NCT01004692|Salicylic Acid|salicylic acid|mesh-list
6571572|NCT01004692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6571573|NCT01004692|Antifungal Agents|antifungal agents|mesh-ancestor
6571574|NCT01004692|Keratolytic Agents|keratolytic agents|mesh-ancestor
6571575|NCT01004692|Dermatologic Agents|dermatologic agents|mesh-ancestor
6571576|NCT01004731|Gemcitabine|gemcitabine|mesh-list
6571577|NCT01004731|Carboplatin|carboplatin|mesh-list
6571578|NCT01004731|Cetuximab|cetuximab|mesh-list
6571579|NCT01004731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6571580|NCT01004731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6571581|NCT01004731|Antimetabolites|antimetabolites|mesh-ancestor
6571582|NCT01004731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571583|NCT01004731|Antiviral Agents|antiviral agents|mesh-ancestor
6571584|NCT01004731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6571585|NCT01004731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6571586|NCT01004731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6571587|NCT01004731|Immunologic Factors|immunologic factors|mesh-ancestor
6571588|NCT01004731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571589|NCT01004731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6571590|NCT01004809|Dutasteride|dutasteride|mesh-list
6571591|NCT01004809|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6571592|NCT01004809|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6571593|NCT01004809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6571594|NCT01004809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571595|NCT01004809|Hormone Antagonists|hormone antagonists|mesh-ancestor
6571596|NCT01004809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6571597|NCT01004809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571598|NCT01004900|Timolol|timolol|mesh-list
6571599|NCT01004900|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6571600|NCT01004900|Travoprost|travoprost|mesh-list
6571601|NCT01004900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6571602|NCT01004900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6571603|NCT01004900|Adrenergic Agents|adrenergic agents|mesh-ancestor
6571604|NCT01004900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6571605|NCT01004900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571606|NCT01004900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571607|NCT01004900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6571608|NCT01004900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6571609|NCT01004900|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6571610|NCT01004900|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6571611|NCT01004900|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6571612|NCT01004978|Cisplatin|cisplatin|mesh-list
6571613|NCT01004978|Doxorubicin|doxorubicin|mesh-list
6571614|NCT01004978|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6571615|NCT01004978|Sorafenib|sorafenib|mesh-list
6571616|NCT01004978|Mitomycins|mitomycins|mesh-list
6571617|NCT01004978|Mitomycin|mitomycin|mesh-list
6571618|NCT01004978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6571619|NCT01004978|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6571620|NCT01004978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6571621|NCT01004978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6571622|NCT01004978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6571623|NCT01004978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571624|NCT01004978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6571625|NCT01004978|Alkylating Agents|alkylating agents|mesh-ancestor
6571626|NCT01004978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6571627|NCT01005095|Vitamin D|vitamin d|mesh-list
6571628|NCT01005095|Ergocalciferols|ergocalciferols|mesh-list
6571629|NCT01005095|Cholecalciferol|cholecalciferol|mesh-list
6571630|NCT01005095|Vitamins|vitamins|mesh-list
6571631|NCT01005095|Micronutrients|micronutrients|mesh-ancestor
6571632|NCT01005095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571633|NCT01005095|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6571634|NCT01005095|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6571635|NCT01005121|Colchicine|colchicine|mesh-list
6571636|NCT01005121|Gout Suppressants|gout suppressants|mesh-ancestor
6571637|NCT01005121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6571638|NCT01005121|Tubulin Modulators|tubulin modulators|mesh-ancestor
6571639|NCT01005121|Antimitotic Agents|antimitotic agents|mesh-ancestor
6571640|NCT01005121|Mitosis Modulators|mitosis modulators|mesh-ancestor
6571641|NCT01005121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571642|NCT01005121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6571643|NCT01005147|Tranexamic Acid|tranexamic acid|mesh-list
6571644|NCT01005147|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6571645|NCT01005147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6571646|NCT01005147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571647|NCT01005147|Hemostatics|hemostatics|mesh-ancestor
6571648|NCT01005147|Coagulants|coagulants|mesh-ancestor
6571649|NCT01005160|Metformin|metformin|mesh-list
6571650|NCT01005160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6571651|NCT01005160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571652|NCT01005199|Everolimus|everolimus|mesh-list
6571653|NCT01005199|Sorafenib|sorafenib|mesh-list
6571654|NCT01005199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6571655|NCT01005199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6571656|NCT01005199|Immunologic Factors|immunologic factors|mesh-ancestor
6571657|NCT01005199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571658|NCT01005199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6571659|NCT01005199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6571660|NCT01005199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571661|NCT01005238|Lamivudine|lamivudine|mesh-list
6571662|NCT01005238|Telbivudine|telbivudine|mesh-list
6571663|NCT01005238|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6571664|NCT01005238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6571665|NCT01005238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6571666|NCT01005238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571667|NCT01005238|Antiviral Agents|antiviral agents|mesh-ancestor
6571668|NCT01005238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6571669|NCT01005238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6571670|NCT01005238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6571671|NCT01005303|Vitamin D|vitamin d|mesh-list
6571672|NCT01005303|Cholecalciferol|cholecalciferol|mesh-list
6571673|NCT01005303|Vitamins|vitamins|mesh-ancestor
6571674|NCT01005303|Micronutrients|micronutrients|mesh-ancestor
6571675|NCT01005303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571676|NCT01005303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6571677|NCT01005303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6571678|NCT01005381|Calcium, Dietary|calcium, dietary|mesh-list
6571679|NCT01005381|Vitamin D|vitamin d|mesh-list
6571680|NCT01005381|Calcium Carbonate|calcium carbonate|mesh-list
6571681|NCT01005381|Calcium|calcium|mesh-list
6571682|NCT01005381|Vitamins|vitamins|mesh-ancestor
6571683|NCT01005381|Micronutrients|micronutrients|mesh-ancestor
6657761|NCT01477801|Vitamins|vitamins|mesh-ancestor
6571684|NCT01005381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571685|NCT01005381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6571686|NCT01005381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6571687|NCT01005381|Antacids|antacids|mesh-ancestor
6571688|NCT01005381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571689|NCT01005381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6571690|NCT01005433|Dexmedetomidine|dexmedetomidine|mesh-list
6571691|NCT01005433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6571692|NCT01005433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6571693|NCT01005433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571694|NCT01005433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6571695|NCT01005433|Analgesics|analgesics|mesh-ancestor
6571696|NCT01005433|Sensory System Agents|sensory system agents|mesh-ancestor
6571697|NCT01005433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6571698|NCT01005433|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6571699|NCT01005433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6571700|NCT01005433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6571701|NCT01005433|Adrenergic Agents|adrenergic agents|mesh-ancestor
6571702|NCT01005433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6571703|NCT01005433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571704|NCT01005472|Temozolomide|temozolomide|mesh-list
6571705|NCT01005472|Sunitinib|sunitinib|mesh-list
6571706|NCT01005472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6571707|NCT01005472|Alkylating Agents|alkylating agents|mesh-ancestor
6571708|NCT01005472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571709|NCT01005472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6571710|NCT01005472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6571711|NCT01005472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6571712|NCT01005472|Growth Substances|growth substances|mesh-ancestor
6571713|NCT01005472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571714|NCT01005472|Growth Inhibitors|growth inhibitors|mesh-ancestor
6571715|NCT01005472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6571716|NCT01005472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6571717|NCT01005537|Aldesleukin|aldesleukin|mesh-list
6571718|NCT01005537|Cyclophosphamide|cyclophosphamide|mesh-list
6571719|NCT01005537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6571720|NCT01005537|Immunologic Factors|immunologic factors|mesh-ancestor
6571721|NCT01005537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571722|NCT01005537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6571723|NCT01005537|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6571724|NCT01005537|Alkylating Agents|alkylating agents|mesh-ancestor
6571725|NCT01005537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571726|NCT01005537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6571727|NCT01005537|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6571728|NCT01005537|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6571729|NCT01005537|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6571730|NCT01005537|Antiviral Agents|antiviral agents|mesh-ancestor
6571731|NCT01005537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6571732|NCT01005550|Ropivacaine|ropivacaine|mesh-list
6571733|NCT01005550|Anesthetics, Local|anesthetics, local|mesh-ancestor
6571734|NCT01005550|Anesthetics|anesthetics|mesh-ancestor
6571735|NCT01005550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6571736|NCT01005550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571737|NCT01005550|Sensory System Agents|sensory system agents|mesh-ancestor
6571738|NCT01005550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6571739|NCT01005628|Bortezomib|bortezomib|mesh-list
6571740|NCT01005628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6571741|NCT01005641|Lapatinib|lapatinib|mesh-list
6571742|NCT01005641|Exemestane|exemestane|mesh-list
6571743|NCT01005641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6571744|NCT01005641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6571745|NCT01005641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6571746|NCT01005641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571747|NCT01005641|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6571748|NCT01005641|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6571749|NCT01005641|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6571750|NCT01005641|Hormone Antagonists|hormone antagonists|mesh-ancestor
6571751|NCT01005641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6571752|NCT01005641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571753|NCT01005758|Cytarabine|cytarabine|mesh-list
6571754|NCT01005758|Dexamethasone|dexamethasone|mesh-list
6571755|NCT01005758|Prednisone|prednisone|mesh-list
6571756|NCT01005758|Methylprednisolone|methylprednisolone|mesh-list
6571757|NCT01005758|Prednisolone|prednisolone|mesh-list
6571758|NCT01005758|Hydrocortisone|hydrocortisone|mesh-list
6571759|NCT01005758|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6571760|NCT01005758|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6571761|NCT01005758|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6571762|NCT01005758|Cyclophosphamide|cyclophosphamide|mesh-list
6571763|NCT01005758|Doxorubicin|doxorubicin|mesh-list
6571764|NCT01005758|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6571765|NCT01005758|Methotrexate|methotrexate|mesh-list
6571766|NCT01005758|Etoposide|etoposide|mesh-list
6571767|NCT01005758|Vincristine|vincristine|mesh-list
6571768|NCT01005758|Imatinib Mesylate|imatinib mesylate|mesh-list
6571769|NCT01005758|Mercaptopurine|mercaptopurine|mesh-list
6571770|NCT01005758|Pegaspargase|pegaspargase|mesh-list
6571771|NCT01005758|Etoposide phosphate|etoposide phosphate|mesh-list
6571772|NCT01005758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6571773|NCT01005758|Immunologic Factors|immunologic factors|mesh-ancestor
6571774|NCT01005758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571775|NCT01005758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6571776|NCT01005758|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6571777|NCT01005758|Alkylating Agents|alkylating agents|mesh-ancestor
6571778|NCT01005758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571779|NCT01005758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6571780|NCT01005758|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6571781|NCT01005758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6571782|NCT01005758|Antiemetics|antiemetics|mesh-ancestor
6571783|NCT01005758|Autonomic Agents|autonomic agents|mesh-ancestor
6571784|NCT01005758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6571785|NCT01005758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6571786|NCT01005758|Glucocorticoids|glucocorticoids|mesh-ancestor
6571787|NCT01005758|Hormones|hormones|mesh-ancestor
6571788|NCT01005758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6571789|NCT01005758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6571790|NCT01005758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6571791|NCT01005758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6571792|NCT01005758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6571793|NCT01005758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6571794|NCT01005758|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6571795|NCT01005758|Abortifacient Agents|abortifacient agents|mesh-ancestor
6571796|NCT01005758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6571797|NCT01005758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6571798|NCT01005758|Antimetabolites|antimetabolites|mesh-ancestor
6571799|NCT01005758|Dermatologic Agents|dermatologic agents|mesh-ancestor
6571800|NCT01005758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6571801|NCT01005758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6571802|NCT01005758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6571803|NCT01005758|Antiviral Agents|antiviral agents|mesh-ancestor
6571804|NCT01005758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6571805|NCT01005758|Tubulin Modulators|tubulin modulators|mesh-ancestor
6571806|NCT01005758|Antimitotic Agents|antimitotic agents|mesh-ancestor
6571807|NCT01005758|Mitosis Modulators|mitosis modulators|mesh-ancestor
6571808|NCT01005758|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6571809|NCT01005758|Protective Agents|protective agents|mesh-ancestor
6571810|NCT01005758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6571811|NCT01005784|Cetrorelix|cetrorelix|mesh-list
6571812|NCT01005784|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6571813|NCT01005784|Fertility Agents|fertility agents|mesh-ancestor
6571814|NCT01005784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6571815|NCT01005784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571816|NCT01005784|Hormone Antagonists|hormone antagonists|mesh-ancestor
6571817|NCT01005784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6571818|NCT01005797|Sorafenib|sorafenib|mesh-list
6571819|NCT01005797|Panobinostat|panobinostat|mesh-list
6571820|NCT01005797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6571821|NCT01005797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6571822|NCT01005797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6571823|NCT01005797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571824|NCT01005797|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6571825|NCT01005927|Calcium|calcium|mesh-list
6571826|NCT01005927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6571827|NCT01005927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571828|NCT01005979|Cyclophosphamide|cyclophosphamide|mesh-list
6571829|NCT01005979|Rituximab|rituximab|mesh-list
6571830|NCT01005979|Lenalidomide|lenalidomide|mesh-list
6571831|NCT01005979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6571832|NCT01005979|Immunologic Factors|immunologic factors|mesh-ancestor
6571833|NCT01005979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571834|NCT01005979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6571835|NCT01005979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6571836|NCT01005979|Alkylating Agents|alkylating agents|mesh-ancestor
6571837|NCT01005979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571838|NCT01005979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6571839|NCT01005979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6571840|NCT01005979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6571841|NCT01005979|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6571842|NCT01005979|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6571843|NCT01005979|Growth Substances|growth substances|mesh-ancestor
6571844|NCT01005979|Growth Inhibitors|growth inhibitors|mesh-ancestor
6571845|NCT01006031|Interferons|interferons|mesh-list
6571846|NCT01006031|Ribavirin|ribavirin|mesh-list
6571847|NCT01006031|Interferon-alpha|interferon-alpha|mesh-list
6571848|NCT01006031|Interferon alpha-2|interferon alpha-2|mesh-list
6571849|NCT01006031|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6571850|NCT01006031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6571851|NCT01006031|Antiviral Agents|antiviral agents|mesh-ancestor
6571852|NCT01006031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6571853|NCT01006031|Antimetabolites|antimetabolites|mesh-ancestor
6571854|NCT01006031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571855|NCT01006031|Immunologic Factors|immunologic factors|mesh-ancestor
6571856|NCT01006031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657762|NCT01477801|Micronutrients|micronutrients|mesh-ancestor
6657763|NCT01477801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6657764|NCT01477840|Misoprostol|misoprostol|mesh-list
6657765|NCT01477840|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6657766|NCT01477840|Abortifacient Agents|abortifacient agents|mesh-ancestor
6657767|NCT01477840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6657768|NCT01477840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657769|NCT01477840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6657770|NCT01477840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6657771|NCT01477840|Oxytocics|oxytocics|mesh-ancestor
6657772|NCT01477931|Bupropion|bupropion|mesh-list
6657773|NCT01477931|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6657774|NCT01477931|Antidepressive Agents|antidepressive agents|mesh-ancestor
6657775|NCT01477931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6657776|NCT01477931|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6657777|NCT01477931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6657778|NCT01477931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6657779|NCT01477931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657780|NCT01477931|Dopamine Agents|dopamine agents|mesh-ancestor
6657781|NCT01477931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6657782|NCT01477931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657783|NCT01477931|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6657784|NCT01477931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6657785|NCT01477931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6657786|NCT01477983|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
6657787|NCT01477983|Flecainide|flecainide|mesh-list
6571857|NCT01006057|Insulin|insulin|mesh-list
6571858|NCT01006057|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6571859|NCT01006057|Insulin, Long-Acting|insulin, long-acting|mesh-list
6571860|NCT01006057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6571861|NCT01006057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571862|NCT01006096|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6571863|NCT01006096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6571864|NCT01006096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6571865|NCT01006096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6571866|NCT01006096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571867|NCT01006187|Lidocaine|lidocaine|mesh-list
6571868|NCT01006187|Anesthetics, Local|anesthetics, local|mesh-ancestor
6571869|NCT01006187|Anesthetics|anesthetics|mesh-ancestor
6571870|NCT01006187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6571871|NCT01006187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571872|NCT01006187|Sensory System Agents|sensory system agents|mesh-ancestor
6571873|NCT01006187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6571874|NCT01006187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6571875|NCT01006187|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6571876|NCT01006187|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6571877|NCT01006187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6571878|NCT01006187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571879|NCT01006395|Zoledronic Acid|zoledronic acid|mesh-list
6571880|NCT01006395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6571881|NCT01006395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571882|NCT01006499|Pentoxifylline|pentoxifylline|mesh-list
6571883|NCT01006499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6571884|NCT01006499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6571885|NCT01006499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571886|NCT01006499|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6571887|NCT01006499|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6571888|NCT01006499|Protective Agents|protective agents|mesh-ancestor
6571889|NCT01006499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571890|NCT01006499|Vasodilator Agents|vasodilator agents|mesh-ancestor
6571891|NCT01006499|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6571892|NCT01006499|Antioxidants|antioxidants|mesh-ancestor
6571893|NCT01006525|Zolpidem|zolpidem|mesh-list
6571894|NCT01006525|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6571895|NCT01006525|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6571896|NCT01006525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6571897|NCT01006525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571898|NCT01006525|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6571899|NCT01006525|GABA Agonists|gaba agonists|mesh-ancestor
6571900|NCT01006525|GABA Agents|gaba agents|mesh-ancestor
6571901|NCT01006525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6571902|NCT01006525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571903|NCT01006551|Ziprasidone|ziprasidone|mesh-list
6571904|NCT01006551|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6571905|NCT01006551|Serotonin Agents|serotonin agents|mesh-ancestor
6571906|NCT01006551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6571907|NCT01006551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571908|NCT01006551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571909|NCT01006551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6571910|NCT01006551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6571911|NCT01006551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6571912|NCT01006551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6571913|NCT01006551|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6571914|NCT01006551|Dopamine Agents|dopamine agents|mesh-ancestor
6571915|NCT01006668|Propofol|propofol|mesh-list
6571916|NCT01006668|Sevoflurane|sevoflurane|mesh-list
6571917|NCT01006668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6571918|NCT01006668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6571919|NCT01006668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445650|NCT00389038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445651|NCT00389038|Adrenergic Agents|adrenergic agents|mesh-ancestor
6571920|NCT01006668|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6571921|NCT01006668|Anesthetics, General|anesthetics, general|mesh-ancestor
6571922|NCT01006668|Anesthetics|anesthetics|mesh-ancestor
6571923|NCT01006668|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6571924|NCT01006668|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6571925|NCT01006681|Vaccines|vaccines|mesh-list
6571926|NCT01006681|MF59 oil emulsion|mf59 oil emulsion|mesh-list
6571927|NCT01006681|Immunologic Factors|immunologic factors|mesh-ancestor
6571928|NCT01006681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571929|NCT01006681|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6571930|NCT01006694|Antidepressive Agents|antidepressive agents|mesh-list
6571931|NCT01006694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6571932|NCT01006720|Neostigmine|neostigmine|mesh-list
6571933|NCT01006720|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6571934|NCT01006720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6571935|NCT01006720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571936|NCT01006720|Cholinergic Agents|cholinergic agents|mesh-ancestor
6445652|NCT00389038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6445653|NCT00389038|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6445654|NCT00389038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6445655|NCT00389038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6445656|NCT00389051|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6445657|NCT00389051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6445658|NCT00389051|Alkylating Agents|alkylating agents|mesh-ancestor
6445659|NCT00389051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445660|NCT00389051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6445661|NCT00389090|Temozolomide|temozolomide|mesh-list
6445662|NCT00389090|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
6445663|NCT00389090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6445664|NCT00389090|Alkylating Agents|alkylating agents|mesh-ancestor
6445665|NCT00389090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445666|NCT00389090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6445667|NCT00389090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6445668|NCT00389129|Aspirin|aspirin|mesh-list
6445669|NCT00389129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6445670|NCT00389129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6445671|NCT00389129|Analgesics|analgesics|mesh-ancestor
6445672|NCT00389129|Sensory System Agents|sensory system agents|mesh-ancestor
6445673|NCT00389129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6445674|NCT00389129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445675|NCT00389129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6445676|NCT00389129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6445677|NCT00389129|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6445678|NCT00389129|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6445679|NCT00389129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571937|NCT01006720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6571938|NCT01006720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571939|NCT01006720|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6571940|NCT01006720|Autonomic Agents|autonomic agents|mesh-ancestor
6571941|NCT01006720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6571942|NCT01006798|Vaccines|vaccines|mesh-list
6571943|NCT01006798|Immunologic Factors|immunologic factors|mesh-ancestor
6571944|NCT01006798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571945|NCT01006863|Phenylephrine|phenylephrine|mesh-list
6571946|NCT01006863|Oxymetazoline|oxymetazoline|mesh-list
6571947|NCT01006863|Ephedrine|ephedrine|mesh-list
6571948|NCT01006863|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6571949|NCT01006863|Mydriatics|mydriatics|mesh-ancestor
6571950|NCT01006863|Autonomic Agents|autonomic agents|mesh-ancestor
6571951|NCT01006863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6571952|NCT01006863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571953|NCT01006863|Sympathomimetics|sympathomimetics|mesh-ancestor
6571954|NCT01006863|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6571955|NCT01006863|Nasal Decongestants|nasal decongestants|mesh-ancestor
6571956|NCT01006863|Respiratory System Agents|respiratory system agents|mesh-ancestor
6571957|NCT01006863|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6571958|NCT01006863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6571959|NCT01006863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6571960|NCT01006863|Adrenergic Agents|adrenergic agents|mesh-ancestor
6571961|NCT01006863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6571962|NCT01006863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571963|NCT01006863|Protective Agents|protective agents|mesh-ancestor
6571964|NCT01006863|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6571965|NCT01006876|Warfarin|warfarin|mesh-list
6571966|NCT01006876|Anticoagulants|anticoagulants|mesh-ancestor
6571967|NCT01007019|Esomeprazole|esomeprazole|mesh-list
6571968|NCT01007019|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6571969|NCT01007019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6571970|NCT01007019|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6571971|NCT01007019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6571972|NCT01007019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571973|NCT01007084|Propranolol|propranolol|mesh-list
6571974|NCT01007084|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6571975|NCT01007084|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6571976|NCT01007084|Adrenergic Agents|adrenergic agents|mesh-ancestor
6571977|NCT01007084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6571978|NCT01007084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020147|NCT00391846|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6020148|NCT00391846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020149|NCT00391846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6020150|NCT00391846|Sympatholytics|sympatholytics|mesh-ancestor
6445680|NCT00389129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6445681|NCT00389129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6445682|NCT00389129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6445683|NCT00389129|Antipyretics|antipyretics|mesh-ancestor
6445684|NCT00389233|Ascorbic Acid|ascorbic acid|mesh-list
6445685|NCT00389233|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
6445686|NCT00389233|Antioxidants|antioxidants|mesh-ancestor
6445687|NCT00389233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445688|NCT00389233|Protective Agents|protective agents|mesh-ancestor
6445689|NCT00389233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445690|NCT00389233|Vitamins|vitamins|mesh-ancestor
6445691|NCT00389233|Micronutrients|micronutrients|mesh-ancestor
6445692|NCT00389233|Laxatives|laxatives|mesh-ancestor
6445693|NCT00389233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6445694|NCT00389272|Acetaminophen|acetaminophen|mesh-list
6445695|NCT00389272|Ibuprofen|ibuprofen|mesh-list
6571979|NCT01007084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571980|NCT01007084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6445696|NCT00389272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6445697|NCT00389272|Analgesics|analgesics|mesh-ancestor
6571981|NCT01007084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6571982|NCT01007084|Vasodilator Agents|vasodilator agents|mesh-ancestor
6571983|NCT01007279|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6571984|NCT01007279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6571985|NCT01007279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6571986|NCT01007279|Antimetabolites|antimetabolites|mesh-ancestor
6571987|NCT01007279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6571988|NCT01007279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6571989|NCT01007279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6571990|NCT01007279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6571991|NCT01007500|Dexamethasone|dexamethasone|mesh-list
6571992|NCT01007500|Ondansetron|ondansetron|mesh-list
6571993|NCT01007500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6571994|NCT01007500|Antiemetics|antiemetics|mesh-ancestor
6571995|NCT01007500|Autonomic Agents|autonomic agents|mesh-ancestor
6571996|NCT01007500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6571997|NCT01007500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6571998|NCT01007500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6571999|NCT01007500|Glucocorticoids|glucocorticoids|mesh-ancestor
6572000|NCT01007500|Hormones|hormones|mesh-ancestor
6572001|NCT01007500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6572002|NCT01007500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6572003|NCT01007500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6572004|NCT01007500|Antipruritics|antipruritics|mesh-ancestor
6572005|NCT01007500|Dermatologic Agents|dermatologic agents|mesh-ancestor
6572006|NCT01007500|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6572007|NCT01007500|Serotonin Agents|serotonin agents|mesh-ancestor
6572008|NCT01007500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6572009|NCT01007500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572010|NCT01007500|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6572011|NCT01007500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6572012|NCT01007500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6572013|NCT01007500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6572014|NCT01007500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6572015|NCT01007539|Choline|choline|mesh-list
6572016|NCT01007539|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
6572017|NCT01007539|Lipotropic Agents|lipotropic agents|mesh-ancestor
6572018|NCT01007539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6572019|NCT01007539|Antimetabolites|antimetabolites|mesh-ancestor
6572020|NCT01007539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572021|NCT01007539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6572022|NCT01007539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6572023|NCT01007539|Nootropic Agents|nootropic agents|mesh-ancestor
6572024|NCT01007565|Anesthetics|anesthetics|mesh-list
6572025|NCT01007565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6572026|NCT01007565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572027|NCT01007578|Paclitaxel|paclitaxel|mesh-list
6572028|NCT01007578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6572029|NCT01007578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6572030|NCT01007578|Tubulin Modulators|tubulin modulators|mesh-ancestor
6572031|NCT01007578|Antimitotic Agents|antimitotic agents|mesh-ancestor
6572032|NCT01007578|Mitosis Modulators|mitosis modulators|mesh-ancestor
6572033|NCT01007578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572034|NCT01007630|Rasagiline|rasagiline|mesh-list
6572035|NCT01007630|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6572036|NCT01007630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6572037|NCT01007630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572038|NCT01007630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6572039|NCT01007630|Protective Agents|protective agents|mesh-ancestor
6572040|NCT01007630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572041|NCT01007695|Valproic Acid|valproic acid|mesh-list
6572042|NCT01007695|Anticonvulsants|anticonvulsants|mesh-ancestor
6572043|NCT01007695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6572044|NCT01007695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572045|NCT01007695|GABA Agents|gaba agents|mesh-ancestor
6572046|NCT01007695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6572047|NCT01007695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572048|NCT01007695|Antimanic Agents|antimanic agents|mesh-ancestor
6572049|NCT01007695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6572050|NCT01007695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6572051|NCT01007695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6572052|NCT01007773|Fentanyl|fentanyl|mesh-list
6572053|NCT01007773|Dexmedetomidine|dexmedetomidine|mesh-list
6572054|NCT01007773|Propofol|propofol|mesh-list
6572055|NCT01007773|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6445698|NCT00389272|Sensory System Agents|sensory system agents|mesh-ancestor
6445699|NCT00389272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6445700|NCT00389272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445701|NCT00389272|Antipyretics|antipyretics|mesh-ancestor
6445702|NCT00389272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6445703|NCT00389272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6445704|NCT00389272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6445705|NCT00389272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6445706|NCT00389272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6572056|NCT01007773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6572057|NCT01007773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572058|NCT01007773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6572059|NCT01007773|Anesthetics, General|anesthetics, general|mesh-ancestor
6572060|NCT01007773|Anesthetics|anesthetics|mesh-ancestor
6572061|NCT01007773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6572062|NCT01007773|Analgesics|analgesics|mesh-ancestor
6572063|NCT01007773|Sensory System Agents|sensory system agents|mesh-ancestor
6572064|NCT01007773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6572065|NCT01007773|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6572066|NCT01007773|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6572067|NCT01007773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6572068|NCT01007773|Adrenergic Agents|adrenergic agents|mesh-ancestor
6572069|NCT01007773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6572070|NCT01007773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572071|NCT01007773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6572072|NCT01007773|Narcotics|narcotics|mesh-ancestor
6572073|NCT01007773|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6572074|NCT01007799|Vitamin D|vitamin d|mesh-list
6572075|NCT01007799|Ergocalciferols|ergocalciferols|mesh-list
6572076|NCT01007799|Vitamins|vitamins|mesh-list
6572077|NCT01007799|Micronutrients|micronutrients|mesh-ancestor
6572078|NCT01007799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572079|NCT01007799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6572080|NCT01007799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6572081|NCT01007851|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6572082|NCT01007851|Luteolytic Agents|luteolytic agents|mesh-ancestor
6572083|NCT01007851|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6572084|NCT01007851|Contraceptive Agents|contraceptive agents|mesh-ancestor
6572085|NCT01007851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6572086|NCT01007851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445707|NCT00389272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572087|NCT01007851|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6572088|NCT01007851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6572089|NCT01007851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6445708|NCT00389285|Sorafenib|sorafenib|mesh-list
6445709|NCT00389285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6445710|NCT00389285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6657788|NCT01477983|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6657789|NCT01477983|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6657790|NCT01477983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6657791|NCT01477983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657792|NCT01478022|Ibuprofen|ibuprofen|mesh-list
6657793|NCT01478022|Isosorbide|isosorbide|mesh-list
6657794|NCT01478022|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
6657795|NCT01478022|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
6657796|NCT01478022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6657797|NCT01478022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6657798|NCT01478022|Analgesics|analgesics|mesh-ancestor
6657799|NCT01478022|Sensory System Agents|sensory system agents|mesh-ancestor
6657800|NCT01478022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5724795|NCT03184870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6572090|NCT01007864|Pramipexole|pramipexole|mesh-list
6572091|NCT01007864|Ropinirole|ropinirole|mesh-list
6572092|NCT01007864|Piribedil|piribedil|mesh-list
6572093|NCT01007864|Antioxidants|antioxidants|mesh-ancestor
6572094|NCT01007864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572095|NCT01007864|Protective Agents|protective agents|mesh-ancestor
6572096|NCT01007864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572097|NCT01007864|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6572098|NCT01007864|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6572099|NCT01007864|Dopamine Agonists|dopamine agonists|mesh-ancestor
6572100|NCT01007864|Dopamine Agents|dopamine agents|mesh-ancestor
6572101|NCT01007864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6572102|NCT01007968|Panobinostat|panobinostat|mesh-list
6572103|NCT01007968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6572104|NCT01007968|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6572105|NCT01007968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6572106|NCT01007968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572107|NCT01008020|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
6572108|NCT01008020|Antioxidants|antioxidants|mesh-ancestor
6572109|NCT01008020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572110|NCT01008020|Protective Agents|protective agents|mesh-ancestor
6572111|NCT01008020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572112|NCT01008020|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
6572113|NCT01008020|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6572114|NCT01008020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6572115|NCT01008020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6572116|NCT01008046|Metformin|metformin|mesh-list
6572117|NCT01008046|Acetylcysteine|acetylcysteine|mesh-list
6572118|NCT01008046|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6572119|NCT01008046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6572120|NCT01008046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572121|NCT01008046|Antiviral Agents|antiviral agents|mesh-ancestor
6572122|NCT01008046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6572123|NCT01008046|Expectorants|expectorants|mesh-ancestor
6572124|NCT01008046|Respiratory System Agents|respiratory system agents|mesh-ancestor
6572125|NCT01008046|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6572126|NCT01008046|Antioxidants|antioxidants|mesh-ancestor
6572127|NCT01008046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572128|NCT01008046|Protective Agents|protective agents|mesh-ancestor
6572129|NCT01008046|Antidotes|antidotes|mesh-ancestor
6572130|NCT01008098|Citalopram|citalopram|mesh-list
6572131|NCT01008098|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6572132|NCT01008098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6572133|NCT01008098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6572134|NCT01008098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572135|NCT01008098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6572136|NCT01008098|Serotonin Agents|serotonin agents|mesh-ancestor
6572137|NCT01008098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572138|NCT01008098|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6572139|NCT01008098|Antidepressive Agents|antidepressive agents|mesh-ancestor
6572140|NCT01008098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6572141|NCT01008111|Hydrogen Peroxide|hydrogen peroxide|mesh-list
6572142|NCT01008111|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6572143|NCT01008111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6572144|NCT01008137|Vaccines|vaccines|mesh-list
6572145|NCT01008137|Immunologic Factors|immunologic factors|mesh-ancestor
6572146|NCT01008137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572147|NCT01008293|Lactulose|lactulose|mesh-list
6572148|NCT01008293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6572149|NCT01008345|Ezetimibe|ezetimibe|mesh-list
6572150|NCT01008345|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6572151|NCT01008345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6572152|NCT01008345|Antimetabolites|antimetabolites|mesh-ancestor
6572153|NCT01008345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572154|NCT01008345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6572155|NCT01008358|Tremelimumab|tremelimumab|mesh-list
6572156|NCT01008358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6572157|NCT01008384|Vitamin D|vitamin d|mesh-list
6572158|NCT01008384|Cholecalciferol|cholecalciferol|mesh-list
6572159|NCT01008384|Vitamins|vitamins|mesh-ancestor
6572160|NCT01008384|Micronutrients|micronutrients|mesh-ancestor
6572161|NCT01008384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572162|NCT01008384|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6572163|NCT01008384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6572164|NCT01008488|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6572165|NCT01008488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6572166|NCT01008527|Poly ICLC|poly iclc|mesh-list
6572167|NCT01008527|Interferon Inducers|interferon inducers|mesh-ancestor
6572168|NCT01008527|Immunologic Factors|immunologic factors|mesh-ancestor
6572169|NCT01008527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572170|NCT01008566|Sorafenib|sorafenib|mesh-list
6572171|NCT01008566|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6572172|NCT01008566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6572173|NCT01008566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6572174|NCT01008566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6572175|NCT01008566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572176|NCT01008566|Immunologic Factors|immunologic factors|mesh-ancestor
6572177|NCT01008566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572178|NCT01008592|Levocetirizine|levocetirizine|mesh-list
6572179|NCT01008592|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6572180|NCT01008592|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6572181|NCT01008592|Histamine Antagonists|histamine antagonists|mesh-ancestor
6572182|NCT01008592|Histamine Agents|histamine agents|mesh-ancestor
6572183|NCT01008592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6572184|NCT01008592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572185|NCT01008592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572186|NCT01008631|Sodium thiosulfate|sodium thiosulfate|mesh-list
6572187|NCT01008631|Antidotes|antidotes|mesh-ancestor
6572188|NCT01008631|Protective Agents|protective agents|mesh-ancestor
6572189|NCT01008631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572190|NCT01008631|Antioxidants|antioxidants|mesh-ancestor
6572191|NCT01008631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572192|NCT01008631|Antitubercular Agents|antitubercular agents|mesh-ancestor
6572193|NCT01008631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6572194|NCT01008631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6572195|NCT01008631|Chelating Agents|chelating agents|mesh-ancestor
6572196|NCT01008631|Sequestering Agents|sequestering agents|mesh-ancestor
6572197|NCT01008709|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6572198|NCT01008709|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
6572199|NCT01008709|beta-Endorphin|beta-endorphin|mesh-list
6572200|NCT01008709|Hormones|hormones|mesh-ancestor
6572201|NCT01008709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6572202|NCT01008709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572203|NCT01008709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6572204|NCT01008709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572205|NCT01008761|Azithromycin|azithromycin|mesh-list
6572206|NCT01008761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6572207|NCT01008761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6572208|NCT01008813|Vaccines|vaccines|mesh-list
6572209|NCT01008813|Immunologic Factors|immunologic factors|mesh-ancestor
6572210|NCT01008813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572211|NCT01008917|Sirolimus|sirolimus|mesh-list
6572212|NCT01008917|Sorafenib|sorafenib|mesh-list
6572213|NCT01008917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6572214|NCT01008917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6572215|NCT01008917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6572216|NCT01008917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572217|NCT01008917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6572218|NCT01008917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6572219|NCT01008917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6572220|NCT01008917|Antifungal Agents|antifungal agents|mesh-ancestor
6572221|NCT01008917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6572222|NCT01008917|Immunologic Factors|immunologic factors|mesh-ancestor
6572223|NCT01008917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572224|NCT01008982|Belimumab|belimumab|mesh-list
6572225|NCT01008982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6572226|NCT01008982|Immunologic Factors|immunologic factors|mesh-ancestor
6572227|NCT01008982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572228|NCT01009021|Diclofenac|diclofenac|mesh-list
6572229|NCT01009021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6572230|NCT01009021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6572231|NCT01009021|Analgesics|analgesics|mesh-ancestor
6572232|NCT01009021|Sensory System Agents|sensory system agents|mesh-ancestor
6572233|NCT01009021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6572234|NCT01009021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572235|NCT01009021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6572236|NCT01009021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6572237|NCT01009021|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6572238|NCT01009021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6572239|NCT01009021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572240|NCT01009073|Irinotecan|irinotecan|mesh-list
6572241|NCT01009073|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6572242|NCT01009073|Navitoclax|navitoclax|mesh-list
6572243|NCT01009073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6572244|NCT01009073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6572245|NCT01009073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6572246|NCT01009073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572247|NCT01009073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6572248|NCT01009073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6572249|NCT01009177|Bosentan|bosentan|mesh-list
6572250|NCT01009177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6572251|NCT01009177|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6572252|NCT01009177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572253|NCT01009190|Carboplatin|carboplatin|mesh-list
6572254|NCT01009190|Rucaparib|rucaparib|mesh-list
6572255|NCT01009190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6572256|NCT01009190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6572257|NCT01009190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6572258|NCT01009190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572259|NCT01009437|Ritonavir|ritonavir|mesh-list
6572260|NCT01009437|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6572261|NCT01009437|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6572262|NCT01009437|Protease Inhibitors|protease inhibitors|mesh-ancestor
6572263|NCT01009437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6572264|NCT01009437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572265|NCT01009437|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6572266|NCT01009437|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6572267|NCT01009437|Antiviral Agents|antiviral agents|mesh-ancestor
6572268|NCT01009437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6572269|NCT01009437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6572270|NCT01009437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6572271|NCT01009476|Nicergoline|nicergoline|mesh-list
6572272|NCT01009476|Piracetam|piracetam|mesh-list
6572273|NCT01009476|Galantamine|galantamine|mesh-list
6572274|NCT01009476|Nootropic Agents|nootropic agents|mesh-list
6572275|NCT01009476|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6572276|NCT01009476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6572277|NCT01009476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572278|NCT01009476|Cholinergic Agents|cholinergic agents|mesh-ancestor
6572279|NCT01009476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6572280|NCT01009476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572281|NCT01009476|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6572282|NCT01009476|Autonomic Agents|autonomic agents|mesh-ancestor
6572283|NCT01009476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6572284|NCT01009476|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6572285|NCT01009476|Protective Agents|protective agents|mesh-ancestor
6572286|NCT01009476|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6572287|NCT01009476|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6572288|NCT01009476|Adrenergic Agents|adrenergic agents|mesh-ancestor
6572289|NCT01009476|Vasodilator Agents|vasodilator agents|mesh-ancestor
6572290|NCT01009502|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
6572291|NCT01009502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6572292|NCT01009502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6572293|NCT01009502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6572294|NCT01009502|Schistosomicides|schistosomicides|mesh-ancestor
6572295|NCT01009502|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6572296|NCT01009502|Anthelmintics|anthelmintics|mesh-ancestor
6572297|NCT01009541|Pregabalin|pregabalin|mesh-list
6572298|NCT01009541|Analgesics|analgesics|mesh-ancestor
6572299|NCT01009541|Sensory System Agents|sensory system agents|mesh-ancestor
6572300|NCT01009541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6572301|NCT01009541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572302|NCT01009541|Anticonvulsants|anticonvulsants|mesh-ancestor
6572303|NCT01009541|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6572304|NCT01009541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6572305|NCT01009541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572306|NCT01009541|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6572307|NCT01009541|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6572308|NCT01009541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6572309|NCT01009541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6572310|NCT01009541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6572311|NCT01009567|Cabergoline|cabergoline|mesh-list
6572312|NCT01009567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6572313|NCT01009567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6572314|NCT01009567|Dopamine Agonists|dopamine agonists|mesh-ancestor
6572315|NCT01009567|Dopamine Agents|dopamine agents|mesh-ancestor
6572316|NCT01009567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6572317|NCT01009567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572318|NCT01009567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572319|NCT01009593|Sorafenib|sorafenib|mesh-list
6572320|NCT01009593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6572321|NCT01009593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6572322|NCT01009593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6572323|NCT01009593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572324|NCT01009697|Codeine|codeine|mesh-list
6572325|NCT01009697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6572326|NCT01009697|Narcotics|narcotics|mesh-ancestor
6572327|NCT01009697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6572328|NCT01009697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572329|NCT01009697|Analgesics|analgesics|mesh-ancestor
6572330|NCT01009697|Sensory System Agents|sensory system agents|mesh-ancestor
6572331|NCT01009697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6572332|NCT01009697|Antitussive Agents|antitussive agents|mesh-ancestor
6572333|NCT01009697|Respiratory System Agents|respiratory system agents|mesh-ancestor
6657801|NCT01478022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657802|NCT01478022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6657803|NCT01478022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6657804|NCT01478022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6657805|NCT01478022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6657806|NCT01478022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657807|NCT01478022|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6657808|NCT01478022|Diuretics|diuretics|mesh-ancestor
6657809|NCT01478022|Natriuretic Agents|natriuretic agents|mesh-ancestor
6657810|NCT01478022|Vasodilator Agents|vasodilator agents|mesh-ancestor
6657811|NCT01478022|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6657812|NCT01478035|Phenytoin|phenytoin|mesh-list
6657813|NCT01478035|Anticonvulsants|anticonvulsants|mesh-ancestor
6657814|NCT01478035|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6657815|NCT01478035|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6657816|NCT01478035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6657817|NCT01478035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657818|NCT01478035|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6657819|NCT01478035|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6657820|NCT01478074|Cytarabine|cytarabine|mesh-list
6657821|NCT01478074|Fludarabine|fludarabine|mesh-list
6657822|NCT01478074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6657823|NCT01478074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6657824|NCT01478074|Antimetabolites|antimetabolites|mesh-ancestor
6657825|NCT01478074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657826|NCT01478074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6657827|NCT01478074|Immunologic Factors|immunologic factors|mesh-ancestor
6657828|NCT01478074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657829|NCT01478074|Antiviral Agents|antiviral agents|mesh-ancestor
6657830|NCT01478074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6657831|NCT01478165|Palonosetron|palonosetron|mesh-list
6657832|NCT01478165|Anesthetics|anesthetics|mesh-list
6657833|NCT01478165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6657834|NCT01478165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657835|NCT01478165|Antiemetics|antiemetics|mesh-ancestor
6657836|NCT01478165|Autonomic Agents|autonomic agents|mesh-ancestor
6657837|NCT01478165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6657838|NCT01478165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6657839|NCT01478165|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6657840|NCT01478165|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6657841|NCT01478165|Serotonin Agents|serotonin agents|mesh-ancestor
6657842|NCT01478165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6657843|NCT01478165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657844|NCT01478230|Nicotine|nicotine|mesh-list
6657845|NCT01478230|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6657846|NCT01478230|Autonomic Agents|autonomic agents|mesh-ancestor
6657847|NCT01478230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6572334|NCT01009788|Temozolomide|temozolomide|mesh-list
6572335|NCT01009788|Veliparib|veliparib|mesh-list
6572336|NCT01009788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6572337|NCT01009788|Alkylating Agents|alkylating agents|mesh-ancestor
6572338|NCT01009788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572339|NCT01009788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6572340|NCT01009788|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6572341|NCT01009788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6572342|NCT01009801|Doxorubicin|doxorubicin|mesh-list
6572343|NCT01009801|Everolimus|everolimus|mesh-list
6572344|NCT01009801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6572345|NCT01009801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6572346|NCT01009801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6572347|NCT01009801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6572348|NCT01009801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6572349|NCT01009801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572350|NCT01009801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6572351|NCT01009801|Immunologic Factors|immunologic factors|mesh-ancestor
6572352|NCT01009801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572353|NCT01009853|Codeine|codeine|mesh-list
6572354|NCT01009853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6572355|NCT01009853|Narcotics|narcotics|mesh-ancestor
6572356|NCT01009853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6572357|NCT01009853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572358|NCT01009853|Analgesics|analgesics|mesh-ancestor
6572359|NCT01009853|Sensory System Agents|sensory system agents|mesh-ancestor
6572360|NCT01009853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6572361|NCT01009853|Antitussive Agents|antitussive agents|mesh-ancestor
6572362|NCT01009853|Respiratory System Agents|respiratory system agents|mesh-ancestor
6572363|NCT01009879|Etanercept|etanercept|mesh-list
6572364|NCT01009879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6572365|NCT01009879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6572366|NCT01009879|Analgesics|analgesics|mesh-ancestor
6572367|NCT01009879|Sensory System Agents|sensory system agents|mesh-ancestor
6572368|NCT01009879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6572369|NCT01009879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572370|NCT01009879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6572371|NCT01009879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6572372|NCT01009879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6572373|NCT01009879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6572374|NCT01009879|Immunologic Factors|immunologic factors|mesh-ancestor
6572375|NCT01009892|Codeine|codeine|mesh-list
6572376|NCT01009892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6572377|NCT01009892|Narcotics|narcotics|mesh-ancestor
6572378|NCT01009892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6572379|NCT01009892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572380|NCT01009892|Analgesics|analgesics|mesh-ancestor
6572381|NCT01009892|Sensory System Agents|sensory system agents|mesh-ancestor
6572382|NCT01009892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6572383|NCT01009892|Antitussive Agents|antitussive agents|mesh-ancestor
6572384|NCT01009892|Respiratory System Agents|respiratory system agents|mesh-ancestor
6572385|NCT01009944|Atenolol|atenolol|mesh-list
6572386|NCT01009944|Lisinopril|lisinopril|mesh-list
6572387|NCT01009944|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6572388|NCT01009944|Protease Inhibitors|protease inhibitors|mesh-ancestor
6572389|NCT01009944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6572390|NCT01009944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572391|NCT01009944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6572392|NCT01009944|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6572393|NCT01009944|Protective Agents|protective agents|mesh-ancestor
6572394|NCT01009944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572395|NCT01009944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6572396|NCT01009944|Sympatholytics|sympatholytics|mesh-ancestor
6572397|NCT01009944|Autonomic Agents|autonomic agents|mesh-ancestor
6572398|NCT01009944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6572399|NCT01009944|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6572400|NCT01009944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6445711|NCT00389285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6445712|NCT00389285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445713|NCT00389311|Nonoxynol|nonoxynol|mesh-list
6445714|NCT00389311|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
6445715|NCT00389311|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
6445716|NCT00389311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445717|NCT00389311|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6445718|NCT00389311|Contraceptive Agents|contraceptive agents|mesh-ancestor
6572401|NCT01009944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6572402|NCT01009944|Adrenergic Agents|adrenergic agents|mesh-ancestor
6572403|NCT01009944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6572404|NCT01009957|Everolimus|everolimus|mesh-list
6572405|NCT01009957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6572406|NCT01009957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6572407|NCT01009957|Immunologic Factors|immunologic factors|mesh-ancestor
6572408|NCT01009957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572409|NCT01009970|Prednisone|prednisone|mesh-list
6572410|NCT01009970|Cyclophosphamide|cyclophosphamide|mesh-list
6572411|NCT01009970|Rituximab|rituximab|mesh-list
6572412|NCT01009970|Doxorubicin|doxorubicin|mesh-list
6572413|NCT01009970|Vincristine|vincristine|mesh-list
6572414|NCT01009970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6572415|NCT01009970|Immunologic Factors|immunologic factors|mesh-ancestor
6572416|NCT01009970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572417|NCT01009970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6572418|NCT01009970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6572419|NCT01009970|Alkylating Agents|alkylating agents|mesh-ancestor
6572420|NCT01009970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572421|NCT01009970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6572422|NCT01009970|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6572423|NCT01009970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6572424|NCT01009970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6572425|NCT01009970|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6572426|NCT01009970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6572427|NCT01009970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6572428|NCT01009970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6572429|NCT01009970|Glucocorticoids|glucocorticoids|mesh-ancestor
6572430|NCT01009970|Hormones|hormones|mesh-ancestor
6572431|NCT01009970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6572432|NCT01009970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6572433|NCT01009970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6572434|NCT01009970|Tubulin Modulators|tubulin modulators|mesh-ancestor
6572435|NCT01009970|Antimitotic Agents|antimitotic agents|mesh-ancestor
6572436|NCT01009970|Mitosis Modulators|mitosis modulators|mesh-ancestor
6572437|NCT01010022|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
6572438|NCT01010022|Plasma Substitutes|plasma substitutes|mesh-ancestor
6572439|NCT01010022|Blood Substitutes|blood substitutes|mesh-ancestor
6572440|NCT01010048|Nifedipine|nifedipine|mesh-list
6572441|NCT01010048|Bromides|bromides|mesh-list
6572442|NCT01010048|Propantheline|propantheline|mesh-list
6572443|NCT01010048|Tamsulosin|tamsulosin|mesh-list
6572444|NCT01010048|Progesterone|progesterone|mesh-list
6572445|NCT01010048|Progestins|progestins|mesh-ancestor
6572446|NCT01010048|Hormones|hormones|mesh-ancestor
6572447|NCT01010048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6572448|NCT01010048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572449|NCT01010048|Anticonvulsants|anticonvulsants|mesh-ancestor
6572450|NCT01010048|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6572451|NCT01010048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6572452|NCT01010048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6572453|NCT01010048|Adrenergic Agents|adrenergic agents|mesh-ancestor
6572454|NCT01010048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6572455|NCT01010048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572456|NCT01010048|Urological Agents|urological agents|mesh-ancestor
6572457|NCT01010048|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6572458|NCT01010048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6572459|NCT01010048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6572460|NCT01010048|Vasodilator Agents|vasodilator agents|mesh-ancestor
6572461|NCT01010048|Tocolytic Agents|tocolytic agents|mesh-ancestor
6572462|NCT01010048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6572463|NCT01010048|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6572464|NCT01010048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6572465|NCT01010048|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6572466|NCT01010048|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6572467|NCT01010048|Cholinergic Agents|cholinergic agents|mesh-ancestor
6572468|NCT01010087|Oseltamivir|oseltamivir|mesh-list
6572469|NCT01010087|Antiviral Agents|antiviral agents|mesh-ancestor
6572470|NCT01010087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6572471|NCT01010087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6572472|NCT01010087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572473|NCT01010100|Acarbose|acarbose|mesh-list
6572474|NCT01010100|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6572475|NCT01010100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6572476|NCT01010100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572477|NCT01010100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6572478|NCT01010100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572479|NCT01010139|Codeine|codeine|mesh-list
6572480|NCT01010139|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6572481|NCT01010139|Narcotics|narcotics|mesh-ancestor
6572482|NCT01010139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6572483|NCT01010139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572484|NCT01010139|Analgesics|analgesics|mesh-ancestor
6572485|NCT01010139|Sensory System Agents|sensory system agents|mesh-ancestor
6572486|NCT01010139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6572487|NCT01010139|Antitussive Agents|antitussive agents|mesh-ancestor
6572488|NCT01010139|Respiratory System Agents|respiratory system agents|mesh-ancestor
6572489|NCT01010152|Codeine|codeine|mesh-list
6572490|NCT01010152|Analgesics|analgesics|mesh-ancestor
6572491|NCT01010152|Sensory System Agents|sensory system agents|mesh-ancestor
6572492|NCT01010152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6572493|NCT01010152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572494|NCT01010152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6572495|NCT01010152|Narcotics|narcotics|mesh-ancestor
6572496|NCT01010152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6572497|NCT01010152|Antitussive Agents|antitussive agents|mesh-ancestor
6572498|NCT01010152|Respiratory System Agents|respiratory system agents|mesh-ancestor
6572499|NCT01010178|Theophylline|theophylline|mesh-list
6572500|NCT01010178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6572501|NCT01010178|Autonomic Agents|autonomic agents|mesh-ancestor
6572502|NCT01010178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6572503|NCT01010178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572504|NCT01010178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6572505|NCT01010178|Respiratory System Agents|respiratory system agents|mesh-ancestor
6572506|NCT01010178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6572507|NCT01010178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6572508|NCT01010178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572509|NCT01010178|Vasodilator Agents|vasodilator agents|mesh-ancestor
6572510|NCT01010178|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6572511|NCT01010178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6572512|NCT01010178|Purinergic Agents|purinergic agents|mesh-ancestor
6572513|NCT01010178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6572514|NCT01010243|Pioglitazone|pioglitazone|mesh-list
6572515|NCT01010243|Dexamethasone|dexamethasone|mesh-list
6572516|NCT01010243|Lenalidomide|lenalidomide|mesh-list
6572517|NCT01010243|Treosulfan|treosulfan|mesh-list
6572518|NCT01010243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6572519|NCT01010243|Antiemetics|antiemetics|mesh-ancestor
6572520|NCT01010243|Autonomic Agents|autonomic agents|mesh-ancestor
6572521|NCT01010243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6572522|NCT01010243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572523|NCT01010243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6572524|NCT01010243|Glucocorticoids|glucocorticoids|mesh-ancestor
6572525|NCT01010243|Hormones|hormones|mesh-ancestor
6572526|NCT01010243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6572527|NCT01010243|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6572528|NCT01010243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6572529|NCT01010243|Immunologic Factors|immunologic factors|mesh-ancestor
6572530|NCT01010243|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6572531|NCT01010243|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6572532|NCT01010243|Growth Substances|growth substances|mesh-ancestor
6572533|NCT01010243|Growth Inhibitors|growth inhibitors|mesh-ancestor
6572534|NCT01010243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6572535|NCT01010243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6572536|NCT01010243|Alkylating Agents|alkylating agents|mesh-ancestor
6572537|NCT01010243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572538|NCT01010295|Doxycycline|doxycycline|mesh-list
6572539|NCT01010295|Tetracycline|tetracycline|mesh-list
6572540|NCT01010295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6572541|NCT01010295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6572542|NCT01010295|Antimalarials|antimalarials|mesh-ancestor
6572543|NCT01010295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6572544|NCT01010295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6572545|NCT01010295|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6572546|NCT01010295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6572547|NCT01010295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572548|NCT01010308|Nadolol|nadolol|mesh-list
6572549|NCT01010308|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6572550|NCT01010308|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6445719|NCT00389311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6572551|NCT01010308|Adrenergic Agents|adrenergic agents|mesh-ancestor
6572552|NCT01010308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6572553|NCT01010308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572554|NCT01010308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572555|NCT01010308|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6572556|NCT01010308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6572557|NCT01010308|Sympatholytics|sympatholytics|mesh-ancestor
6572558|NCT01010308|Autonomic Agents|autonomic agents|mesh-ancestor
6572559|NCT01010308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6572560|NCT01010373|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
6572561|NCT01010373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6572562|NCT01010373|Immunologic Factors|immunologic factors|mesh-ancestor
6445720|NCT00389311|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6445721|NCT00389376|Silymarin|silymarin|mesh-list
6445722|NCT00389376|Antioxidants|antioxidants|mesh-ancestor
6445723|NCT00389376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445724|NCT00389376|Protective Agents|protective agents|mesh-ancestor
6445725|NCT00389376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445726|NCT00389402|Ritonavir|ritonavir|mesh-list
6445727|NCT00389402|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6445728|NCT00389402|Saquinavir|saquinavir|mesh-list
6445729|NCT00389402|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6572563|NCT01010373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572564|NCT01010373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6572565|NCT01010373|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6572566|NCT01010373|Protective Agents|protective agents|mesh-ancestor
6572567|NCT01010373|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6572568|NCT01010373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6572569|NCT01010373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6572570|NCT01010373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572571|NCT01010373|Antiviral Agents|antiviral agents|mesh-ancestor
6572572|NCT01010373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6572573|NCT01010425|Hormones|hormones|mesh-list
6572574|NCT01010425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6572575|NCT01010425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572576|NCT01010451|Anti-Infective Agents|anti-infective agents|mesh-list
6572577|NCT01010451|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6572578|NCT01010451|Calcium|calcium|mesh-list
6572579|NCT01010451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6572580|NCT01010451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445730|NCT00389402|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6445731|NCT00389402|Protease Inhibitors|protease inhibitors|mesh-ancestor
6445732|NCT00389402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6445733|NCT00389402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445734|NCT00389402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6445735|NCT00389402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6445736|NCT00389402|Antiviral Agents|antiviral agents|mesh-ancestor
6572581|NCT01010490|Dipivefrin|dipivefrin|mesh-list
6572582|NCT01010490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6572583|NCT01010490|Adrenergic Agents|adrenergic agents|mesh-ancestor
6572584|NCT01010490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6572585|NCT01010490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572586|NCT01010490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572587|NCT01010516|Niacin|niacin|mesh-list
6572588|NCT01010516|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6572589|NCT01010516|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
6572590|NCT01010516|Fenofibrate|fenofibrate|mesh-list
6572591|NCT01010516|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6572592|NCT01010516|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6572593|NCT01010516|Antimetabolites|antimetabolites|mesh-ancestor
6572594|NCT01010516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572595|NCT01010516|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6572596|NCT01010516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6572597|NCT01010516|Vasodilator Agents|vasodilator agents|mesh-ancestor
6572598|NCT01010516|Vitamin B Complex|vitamin b complex|mesh-ancestor
6572599|NCT01010516|Vitamins|vitamins|mesh-ancestor
6572600|NCT01010516|Micronutrients|micronutrients|mesh-ancestor
6572601|NCT01010516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572602|NCT01010581|Folic Acid|folic acid|mesh-list
6572603|NCT01010581|Methotrexate|methotrexate|mesh-list
6572604|NCT01010581|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6572605|NCT01010581|Abortifacient Agents|abortifacient agents|mesh-ancestor
6572606|NCT01010581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6572607|NCT01010581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572608|NCT01010581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5501439|NCT04474262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501440|NCT04474288|Antibodies|antibodies|mesh-list
5501441|NCT04474288|Immunologic Factors|immunologic factors|mesh-ancestor
5501442|NCT04474288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501443|NCT04474093|Lithium Carbonate|lithium carbonate|mesh-list
6445737|NCT00389402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6445738|NCT00389402|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6445739|NCT00389402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6445740|NCT00389415|Vildagliptin|vildagliptin|mesh-list
6445741|NCT00389415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6445742|NCT00389415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445743|NCT00389415|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6445744|NCT00389415|Protease Inhibitors|protease inhibitors|mesh-ancestor
6445745|NCT00389415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6445746|NCT00389415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445747|NCT00389428|Cytarabine|cytarabine|mesh-list
6572609|NCT01010581|Antimetabolites|antimetabolites|mesh-ancestor
6572610|NCT01010581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572611|NCT01010581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6572612|NCT01010581|Dermatologic Agents|dermatologic agents|mesh-ancestor
6572613|NCT01010581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6572614|NCT01010581|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6572615|NCT01010581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6572616|NCT01010581|Immunologic Factors|immunologic factors|mesh-ancestor
6572617|NCT01010581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6572618|NCT01010581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6572619|NCT01010581|Hematinics|hematinics|mesh-ancestor
6572620|NCT01010581|Vitamin B Complex|vitamin b complex|mesh-ancestor
6572621|NCT01010581|Vitamins|vitamins|mesh-ancestor
6572622|NCT01010581|Micronutrients|micronutrients|mesh-ancestor
6572623|NCT01010646|Ribavirin|ribavirin|mesh-list
6572624|NCT01010646|Interferon-alpha|interferon-alpha|mesh-list
6572625|NCT01010646|Interferon alpha-2|interferon alpha-2|mesh-list
6572626|NCT01010646|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
6572627|NCT01010646|Antimetabolites|antimetabolites|mesh-ancestor
6572628|NCT01010646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572629|NCT01010646|Antiviral Agents|antiviral agents|mesh-ancestor
6572630|NCT01010646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6572631|NCT01010646|Immunologic Factors|immunologic factors|mesh-ancestor
6572632|NCT01010646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572633|NCT01010646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6572634|NCT01010672|Sirolimus|sirolimus|mesh-list
6572635|NCT01010672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6572636|NCT01010672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6572637|NCT01010672|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6572638|NCT01010672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6572639|NCT01010672|Antifungal Agents|antifungal agents|mesh-ancestor
6572640|NCT01010672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6572641|NCT01010672|Immunologic Factors|immunologic factors|mesh-ancestor
6572642|NCT01010672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572643|NCT01010698|Acyclovir|acyclovir|mesh-list
6572644|NCT01010698|Cimetidine|cimetidine|mesh-list
6572645|NCT01010698|Antiviral Agents|antiviral agents|mesh-ancestor
6572646|NCT01010698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6572647|NCT01010698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6572648|NCT01010698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6572649|NCT01010698|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6572650|NCT01010698|Histamine Antagonists|histamine antagonists|mesh-ancestor
6572651|NCT01010698|Histamine Agents|histamine agents|mesh-ancestor
6572652|NCT01010698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6572653|NCT01010698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572654|NCT01010698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572655|NCT01010698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6572656|NCT01010698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6572657|NCT01010698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6572658|NCT01010789|Modafinil|modafinil|mesh-list
6572659|NCT01010789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6572660|NCT01010789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572661|NCT01010789|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6572662|NCT01010789|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6572663|NCT01010789|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6572664|NCT01010789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572665|NCT01010802|Epoetin Alfa|epoetin alfa|mesh-list
6572666|NCT01010802|Hematinics|hematinics|mesh-ancestor
6572667|NCT01010893|Vaccines|vaccines|mesh-list
6572668|NCT01010893|Immunologic Factors|immunologic factors|mesh-ancestor
6572669|NCT01010893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572670|NCT01010945|Gemcitabine|gemcitabine|mesh-list
6572671|NCT01010945|Paclitaxel|paclitaxel|mesh-list
6572672|NCT01010945|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6572673|NCT01010945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6572674|NCT01010945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6572675|NCT01010945|Tubulin Modulators|tubulin modulators|mesh-ancestor
6572676|NCT01010945|Antimitotic Agents|antimitotic agents|mesh-ancestor
6572677|NCT01010945|Mitosis Modulators|mitosis modulators|mesh-ancestor
6572678|NCT01010945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572679|NCT01010945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6572680|NCT01010945|Antimetabolites|antimetabolites|mesh-ancestor
6572681|NCT01010945|Antiviral Agents|antiviral agents|mesh-ancestor
6572682|NCT01010945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6572683|NCT01010945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6572684|NCT01010945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6572685|NCT01010945|Immunologic Factors|immunologic factors|mesh-ancestor
6572686|NCT01010945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572687|NCT01010945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6572688|NCT01010958|Valproic Acid|valproic acid|mesh-list
6572689|NCT01010958|Anticonvulsants|anticonvulsants|mesh-ancestor
6572690|NCT01010958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6572691|NCT01010958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572692|NCT01010958|GABA Agents|gaba agents|mesh-ancestor
6572693|NCT01010958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6572694|NCT01010958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572695|NCT01010958|Antimanic Agents|antimanic agents|mesh-ancestor
6572696|NCT01010958|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6572697|NCT01010958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6572698|NCT01010958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6572699|NCT01011010|Doxorubicin|doxorubicin|mesh-list
6572700|NCT01011010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6572701|NCT01011010|Mitomycins|mitomycins|mesh-list
6572702|NCT01011010|Mitomycin|mitomycin|mesh-list
6572703|NCT01011010|Sorafenib|sorafenib|mesh-list
6572704|NCT01011010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6572705|NCT01011010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6572706|NCT01011010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6572707|NCT01011010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6572708|NCT01011010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6572709|NCT01011010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572710|NCT01011010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6572711|NCT01011010|Alkylating Agents|alkylating agents|mesh-ancestor
6572712|NCT01011010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6572713|NCT01011036|Clonazepam|clonazepam|mesh-list
6572714|NCT01011036|Clobazam|clobazam|mesh-list
6572715|NCT01011036|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6572716|NCT01011036|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6572717|NCT01011036|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6572718|NCT01011036|Cholinergic Agents|cholinergic agents|mesh-ancestor
6572719|NCT01011036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6572720|NCT01011036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572721|NCT01011036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572722|NCT01011036|Urological Agents|urological agents|mesh-ancestor
6572723|NCT01011036|Anticonvulsants|anticonvulsants|mesh-ancestor
6572724|NCT01011036|GABA Modulators|gaba modulators|mesh-ancestor
6572725|NCT01011036|GABA Agents|gaba agents|mesh-ancestor
6572726|NCT01011036|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6572727|NCT01011036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6572728|NCT01011036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6572729|NCT01011036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6572730|NCT01011036|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6572731|NCT01011036|GABA Agonists|gaba agonists|mesh-ancestor
6572732|NCT01011062|Losartan|losartan|mesh-list
6572733|NCT01011062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6572734|NCT01011062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6572735|NCT01011062|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6572736|NCT01011062|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6572737|NCT01011062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572738|NCT01011114|Cinacalcet|cinacalcet|mesh-list
6572739|NCT01011114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6572740|NCT01011114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572741|NCT01011114|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6572742|NCT01011114|Hormone Antagonists|hormone antagonists|mesh-ancestor
6572743|NCT01011114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6572744|NCT01011127|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6572745|NCT01011127|Pravastatin|pravastatin|mesh-list
6572746|NCT01011127|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6572747|NCT01011127|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6572748|NCT01011127|Antimetabolites|antimetabolites|mesh-ancestor
6572749|NCT01011127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572750|NCT01011127|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6572751|NCT01011127|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6572752|NCT01011127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6572753|NCT01011166|Ribavirin|ribavirin|mesh-list
6572754|NCT01011166|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6572755|NCT01011166|Antimetabolites|antimetabolites|mesh-ancestor
6572756|NCT01011166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572757|NCT01011166|Antiviral Agents|antiviral agents|mesh-ancestor
6572758|NCT01011166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6572759|NCT01011205|Mycophenolic Acid|mycophenolic acid|mesh-list
6572760|NCT01011205|Methylprednisolone|methylprednisolone|mesh-list
6572761|NCT01011205|Tacrolimus|tacrolimus|mesh-list
6572762|NCT01011205|Basiliximab|basiliximab|mesh-list
6572763|NCT01011205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6572764|NCT01011205|Immunologic Factors|immunologic factors|mesh-ancestor
6572765|NCT01011205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572766|NCT01011205|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6572767|NCT01011205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6572768|NCT01011205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572769|NCT01011205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6572770|NCT01011205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6572771|NCT01011205|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6572772|NCT01011205|Antitubercular Agents|antitubercular agents|mesh-ancestor
6572773|NCT01011205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6572774|NCT01011205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6572775|NCT01011205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6572776|NCT01011205|Antiemetics|antiemetics|mesh-ancestor
6572777|NCT01011205|Autonomic Agents|autonomic agents|mesh-ancestor
6572778|NCT01011205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6572779|NCT01011205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6572780|NCT01011205|Glucocorticoids|glucocorticoids|mesh-ancestor
6572781|NCT01011205|Hormones|hormones|mesh-ancestor
6572782|NCT01011205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6572783|NCT01011205|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6572784|NCT01011205|Protective Agents|protective agents|mesh-ancestor
6572785|NCT01011257|Clopidogrel|clopidogrel|mesh-list
6572786|NCT01011257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6572787|NCT01011257|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6572788|NCT01011257|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6572789|NCT01011257|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6572790|NCT01011257|Purinergic Agents|purinergic agents|mesh-ancestor
6572791|NCT01011257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6572792|NCT01011257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572793|NCT01011257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572794|NCT01011348|Ubiquinone|ubiquinone|mesh-list
6572795|NCT01011348|Coenzyme Q10|coenzyme q10|mesh-list
6572796|NCT01011348|Micronutrients|micronutrients|mesh-ancestor
6572797|NCT01011348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572798|NCT01011348|Vitamins|vitamins|mesh-ancestor
6445748|NCT00389428|Daunorubicin|daunorubicin|mesh-list
6445749|NCT00389428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6445750|NCT00389428|Antimetabolites|antimetabolites|mesh-ancestor
6445751|NCT00389428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445752|NCT00389428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6445753|NCT00389428|Antiviral Agents|antiviral agents|mesh-ancestor
6572799|NCT01011374|Ranibizumab|ranibizumab|mesh-list
6572800|NCT01011374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6572801|NCT01011374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6572802|NCT01011374|Growth Substances|growth substances|mesh-ancestor
6572803|NCT01011374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572804|NCT01011374|Growth Inhibitors|growth inhibitors|mesh-ancestor
6572805|NCT01011374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6572806|NCT01011426|Bisacodyl|bisacodyl|mesh-list
6572807|NCT01011426|Cathartics|cathartics|mesh-ancestor
6572808|NCT01011426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6572809|NCT01011426|Laxatives|laxatives|mesh-ancestor
6572810|NCT01011452|Montelukast|montelukast|mesh-list
5501444|NCT04474093|Methamphetamine|methamphetamine|mesh-list
6445754|NCT00389428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6445755|NCT00389428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6445756|NCT00389428|Immunologic Factors|immunologic factors|mesh-ancestor
6445757|NCT00389428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445758|NCT00389428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6572811|NCT01011452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6445759|NCT00389428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6445760|NCT00389428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6445761|NCT00389428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6445762|NCT00389506|Cyclophosphamide|cyclophosphamide|mesh-list
6445763|NCT00389506|Fludarabine|fludarabine|mesh-list
6445764|NCT00389506|Fludarabine phosphate|fludarabine phosphate|mesh-list
6445765|NCT00389506|Immunotoxins|immunotoxins|mesh-list
6445766|NCT00389506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6445767|NCT00389506|Immunologic Factors|immunologic factors|mesh-ancestor
6445768|NCT00389506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445769|NCT00389506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6445770|NCT00389506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6445771|NCT00389506|Alkylating Agents|alkylating agents|mesh-ancestor
6445772|NCT00389506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445773|NCT00389506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6445774|NCT00389506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6445775|NCT00389506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6572812|NCT01011452|Respiratory System Agents|respiratory system agents|mesh-ancestor
6572813|NCT01011452|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6572814|NCT01011452|Hormone Antagonists|hormone antagonists|mesh-ancestor
6572815|NCT01011452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6572816|NCT01011452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572817|NCT01011452|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6572818|NCT01011452|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6572819|NCT01011452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572820|NCT01011478|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6572821|NCT01011478|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6572822|NCT01011478|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6445776|NCT00389506|Antimetabolites|antimetabolites|mesh-ancestor
6445777|NCT00389558|Amikacin|amikacin|mesh-list
6445778|NCT00389558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6445779|NCT00389558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6445780|NCT00389584|Irinotecan|irinotecan|mesh-list
6572823|NCT01011478|Antimetabolites|antimetabolites|mesh-ancestor
6572824|NCT01011478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572825|NCT01011478|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6572826|NCT01011478|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6572827|NCT01011478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6572828|NCT01011530|Pevonedistat|pevonedistat|mesh-list
6572829|NCT01011530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6572830|NCT01011530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657848|NCT01478230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657849|NCT01478230|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6657850|NCT01478230|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6657851|NCT01478230|Cholinergic Agents|cholinergic agents|mesh-ancestor
6657852|NCT01478230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6657853|NCT01478230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657854|NCT01478282|Rivaroxaban|rivaroxaban|mesh-list
6657855|NCT01478282|Dabigatran|dabigatran|mesh-list
6657856|NCT01478282|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6657857|NCT01478282|Antithrombins|antithrombins|mesh-ancestor
6657858|NCT01478282|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6657859|NCT01478282|Protease Inhibitors|protease inhibitors|mesh-ancestor
6657860|NCT01478282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6657861|NCT01478282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657862|NCT01478282|Anticoagulants|anticoagulants|mesh-ancestor
6657863|NCT01478308|Metformin|metformin|mesh-list
6657864|NCT01478308|Prednisone|prednisone|mesh-list
6657865|NCT01478308|Docetaxel|docetaxel|mesh-list
6657866|NCT01478308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6657867|NCT01478308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657868|NCT01478308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6657869|NCT01478308|Tubulin Modulators|tubulin modulators|mesh-ancestor
6657870|NCT01478308|Antimitotic Agents|antimitotic agents|mesh-ancestor
6657871|NCT01478308|Mitosis Modulators|mitosis modulators|mesh-ancestor
6657872|NCT01478308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657873|NCT01478308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6657874|NCT01478308|Glucocorticoids|glucocorticoids|mesh-ancestor
6657875|NCT01478308|Hormones|hormones|mesh-ancestor
6657876|NCT01478308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6657877|NCT01478308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6657878|NCT01478386|Hyaluronic Acid|hyaluronic acid|mesh-list
6657879|NCT01478386|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6657880|NCT01478386|Immunologic Factors|immunologic factors|mesh-ancestor
6657881|NCT01478386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657882|NCT01478386|Viscosupplements|viscosupplements|mesh-ancestor
6657883|NCT01478386|Protective Agents|protective agents|mesh-ancestor
6664759|NCT01513863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6664760|NCT01513863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6664761|NCT01513863|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6664762|NCT01513863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6664763|NCT01513941|Interferons|interferons|mesh-list
6664764|NCT01513941|Ribavirin|ribavirin|mesh-list
6664765|NCT01513941|Interferon-alpha|interferon-alpha|mesh-list
6664766|NCT01513941|Interferon alpha-2|interferon alpha-2|mesh-list
6664767|NCT01513941|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6664768|NCT01513941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6664769|NCT01513941|Antiviral Agents|antiviral agents|mesh-ancestor
6664770|NCT01513941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6664771|NCT01513941|Antimetabolites|antimetabolites|mesh-ancestor
6664772|NCT01513941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6664773|NCT01513941|Immunologic Factors|immunologic factors|mesh-ancestor
6664774|NCT01513941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572831|NCT01011621|Prednisolone|prednisolone|mesh-list
6572832|NCT01011621|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6572833|NCT01011621|Methylprednisolone|methylprednisolone|mesh-list
6572834|NCT01011621|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6572835|NCT01011621|Prednisolone acetate|prednisolone acetate|mesh-list
6572836|NCT01011621|Betamethasone|betamethasone|mesh-list
6572837|NCT01011621|Betamethasone Valerate|betamethasone valerate|mesh-list
6572838|NCT01011621|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
6572839|NCT01011621|Betamethasone benzoate|betamethasone benzoate|mesh-list
6572840|NCT01011621|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6572841|NCT01011621|Prednisolone phosphate|prednisolone phosphate|mesh-list
6572842|NCT01011621|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
6572843|NCT01011621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6572844|NCT01011621|Glucocorticoids|glucocorticoids|mesh-ancestor
6572845|NCT01011621|Hormones|hormones|mesh-ancestor
6572846|NCT01011621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6572847|NCT01011621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572848|NCT01011621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6572849|NCT01011621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6572850|NCT01011621|Antiemetics|antiemetics|mesh-ancestor
6572851|NCT01011621|Autonomic Agents|autonomic agents|mesh-ancestor
6572852|NCT01011621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6572853|NCT01011621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6572854|NCT01011621|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6572855|NCT01011621|Protective Agents|protective agents|mesh-ancestor
6572856|NCT01011621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6572857|NCT01011621|Respiratory System Agents|respiratory system agents|mesh-ancestor
6572858|NCT01011660|Amlodipine|amlodipine|mesh-list
6572859|NCT01011660|Telmisartan|telmisartan|mesh-list
6572860|NCT01011660|Amiloride|amiloride|mesh-list
6572861|NCT01011660|Simvastatin|simvastatin|mesh-list
6572862|NCT01011660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6572863|NCT01011660|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6572864|NCT01011660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6572865|NCT01011660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572866|NCT01011660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6572867|NCT01011660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572868|NCT01011660|Vasodilator Agents|vasodilator agents|mesh-ancestor
6572869|NCT01011660|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6572870|NCT01011660|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6572871|NCT01011660|Antimetabolites|antimetabolites|mesh-ancestor
6572872|NCT01011660|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6572873|NCT01011660|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6572874|NCT01011660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6572875|NCT01011660|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6572876|NCT01011660|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6572877|NCT01011660|Diuretics|diuretics|mesh-ancestor
6572878|NCT01011660|Natriuretic Agents|natriuretic agents|mesh-ancestor
6572879|NCT01011660|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
6572880|NCT01011660|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6572881|NCT01011660|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
6572882|NCT01011660|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6572883|NCT01011699|Niacinamide|niacinamide|mesh-list
6572884|NCT01011699|Niacin|niacin|mesh-list
6572885|NCT01011699|Nicotinic Acids|nicotinic acids|mesh-list
6572886|NCT01011699|Sevelamer|sevelamer|mesh-list
6572887|NCT01011699|Cinacalcet|cinacalcet|mesh-list
6572888|NCT01011699|Vitamin B Complex|vitamin b complex|mesh-ancestor
6572889|NCT01011699|Vitamins|vitamins|mesh-ancestor
6572890|NCT01011699|Micronutrients|micronutrients|mesh-ancestor
6572891|NCT01011699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572892|NCT01011699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6572893|NCT01011699|Antimetabolites|antimetabolites|mesh-ancestor
6572894|NCT01011699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572895|NCT01011699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6572896|NCT01011699|Vasodilator Agents|vasodilator agents|mesh-ancestor
6572897|NCT01011699|Chelating Agents|chelating agents|mesh-ancestor
6572898|NCT01011699|Sequestering Agents|sequestering agents|mesh-ancestor
6572899|NCT01011699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6572900|NCT01011699|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6572901|NCT01011699|Hormone Antagonists|hormone antagonists|mesh-ancestor
6572902|NCT01011699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6572903|NCT01011751|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6572904|NCT01011751|Leuprolide|leuprolide|mesh-list
6572905|NCT01011751|Flutamide|flutamide|mesh-list
6572906|NCT01011751|Cyproterone Acetate|cyproterone acetate|mesh-list
6572907|NCT01011751|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6572908|NCT01011751|Medroxyprogesterone|medroxyprogesterone|mesh-list
6572909|NCT01011751|Cyproterone|cyproterone|mesh-list
6572910|NCT01011751|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6572911|NCT01011751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6572912|NCT01011751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6572913|NCT01011751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572914|NCT01011751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6572915|NCT01011751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572916|NCT01011751|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6572917|NCT01011751|Antidepressive Agents|antidepressive agents|mesh-ancestor
6572918|NCT01011751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6572919|NCT01011751|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6572920|NCT01011751|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6572921|NCT01011751|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6572922|NCT01011751|Contraceptive Agents|contraceptive agents|mesh-ancestor
6572923|NCT01011751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6572924|NCT01011751|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6572925|NCT01011751|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6572926|NCT01011751|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6572927|NCT01011751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6572928|NCT01011751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6572929|NCT01011751|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6572930|NCT01011751|Fertility Agents|fertility agents|mesh-ancestor
6572931|NCT01011751|Androgen Antagonists|androgen antagonists|mesh-ancestor
6572932|NCT01011751|Hormone Antagonists|hormone antagonists|mesh-ancestor
6572933|NCT01011751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6572934|NCT01011920|Cytarabine|cytarabine|mesh-list
6572935|NCT01011920|Rituximab|rituximab|mesh-list
6572936|NCT01011920|Methotrexate|methotrexate|mesh-list
6572937|NCT01011920|Thiotepa|thiotepa|mesh-list
6572938|NCT01011920|Carmustine|carmustine|mesh-list
6572939|NCT01011920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6572940|NCT01011920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6572941|NCT01011920|Immunologic Factors|immunologic factors|mesh-ancestor
6572942|NCT01011920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572943|NCT01011920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6572944|NCT01011920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6572945|NCT01011920|Abortifacient Agents|abortifacient agents|mesh-ancestor
6572946|NCT01011920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6572947|NCT01011920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6572948|NCT01011920|Antimetabolites|antimetabolites|mesh-ancestor
6572949|NCT01011920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572950|NCT01011920|Dermatologic Agents|dermatologic agents|mesh-ancestor
6572951|NCT01011920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6572952|NCT01011920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6572953|NCT01011920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6572954|NCT01011920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6572955|NCT01011920|Antiviral Agents|antiviral agents|mesh-ancestor
6572956|NCT01011920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6572957|NCT01011920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6572958|NCT01011920|Alkylating Agents|alkylating agents|mesh-ancestor
6572959|NCT01011920|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6572960|NCT01011998|Imatinib Mesylate|imatinib mesylate|mesh-list
6572961|NCT01011998|Valproic Acid|valproic acid|mesh-list
6572962|NCT01011998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6572963|NCT01011998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6572964|NCT01011998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6572965|NCT01011998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572966|NCT01011998|Anticonvulsants|anticonvulsants|mesh-ancestor
6572967|NCT01011998|GABA Agents|gaba agents|mesh-ancestor
6572968|NCT01011998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6572969|NCT01011998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572970|NCT01011998|Antimanic Agents|antimanic agents|mesh-ancestor
6572971|NCT01011998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6572972|NCT01011998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6572973|NCT01011998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6572974|NCT01012011|Sorafenib|sorafenib|mesh-list
6572975|NCT01012011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6572976|NCT01012011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6572977|NCT01012011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6572978|NCT01012011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572979|NCT01012063|Epoetin Alfa|epoetin alfa|mesh-list
6572980|NCT01012063|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6572981|NCT01012063|Hematinics|hematinics|mesh-ancestor
6572982|NCT01012102|Freund's Adjuvant|freund's adjuvant|mesh-list
6572983|NCT01012102|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6572984|NCT01012102|Immunologic Factors|immunologic factors|mesh-ancestor
6572985|NCT01012102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6572986|NCT01012141|Docetaxel|docetaxel|mesh-list
6572987|NCT01012141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6572988|NCT01012141|Tubulin Modulators|tubulin modulators|mesh-ancestor
6572989|NCT01012141|Antimitotic Agents|antimitotic agents|mesh-ancestor
6572990|NCT01012141|Mitosis Modulators|mitosis modulators|mesh-ancestor
6572991|NCT01012141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6572992|NCT01012193|Cilostazol|cilostazol|mesh-list
6572993|NCT01012193|Clopidogrel|clopidogrel|mesh-list
6572994|NCT01012193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6572995|NCT01012193|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6572996|NCT01012193|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6572997|NCT01012193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6572998|NCT01012193|Purinergic Agents|purinergic agents|mesh-ancestor
6572999|NCT01012193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6573000|NCT01012193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573001|NCT01012193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573002|NCT01012193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6573003|NCT01012193|Autonomic Agents|autonomic agents|mesh-ancestor
6573004|NCT01012193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6573005|NCT01012193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6573006|NCT01012193|Respiratory System Agents|respiratory system agents|mesh-ancestor
6573007|NCT01012193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6573008|NCT01012193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6573009|NCT01012193|Vasodilator Agents|vasodilator agents|mesh-ancestor
6573010|NCT01012193|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6573011|NCT01012193|Protective Agents|protective agents|mesh-ancestor
6573012|NCT01012193|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6573013|NCT01012193|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6573014|NCT01012193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6573015|NCT01012232|Ropivacaine|ropivacaine|mesh-list
6573016|NCT01012232|Anesthetics, Local|anesthetics, local|mesh-ancestor
6573017|NCT01012232|Anesthetics|anesthetics|mesh-ancestor
6573018|NCT01012232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6573019|NCT01012232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573020|NCT01012232|Sensory System Agents|sensory system agents|mesh-ancestor
6573021|NCT01012232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6573022|NCT01012284|Bedaquiline|bedaquiline|mesh-list
6573023|NCT01012284|Antitubercular Agents|antitubercular agents|mesh-ancestor
6573024|NCT01012284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6573025|NCT01012284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6573026|NCT01012349|Aspirin|aspirin|mesh-list
6573027|NCT01012349|Citric Acid|citric acid|mesh-list
6573028|NCT01012349|Sodium Citrate|sodium citrate|mesh-list
6573029|NCT01012349|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6573030|NCT01012349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6573031|NCT01012349|Analgesics|analgesics|mesh-ancestor
6573032|NCT01012349|Sensory System Agents|sensory system agents|mesh-ancestor
6573033|NCT01012349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6573034|NCT01012349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573035|NCT01012349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6573036|NCT01012349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6573037|NCT01012349|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6573038|NCT01012349|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6573039|NCT01012349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573040|NCT01012349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6573041|NCT01012349|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6573042|NCT01012349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6573043|NCT01012349|Antipyretics|antipyretics|mesh-ancestor
6573044|NCT01012349|Anticoagulants|anticoagulants|mesh-ancestor
6573045|NCT01012349|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6573046|NCT01012349|Chelating Agents|chelating agents|mesh-ancestor
6573047|NCT01012349|Sequestering Agents|sequestering agents|mesh-ancestor
6573048|NCT01012479|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6573049|NCT01012479|Candesartan|candesartan|mesh-list
6573050|NCT01012479|Candesartan cilexetil|candesartan cilexetil|mesh-list
6573051|NCT01012479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6573052|NCT01012479|Diuretics|diuretics|mesh-ancestor
6573053|NCT01012479|Natriuretic Agents|natriuretic agents|mesh-ancestor
6573054|NCT01012479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573055|NCT01012479|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6573056|NCT01012479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6573057|NCT01012479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573058|NCT01012479|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6573059|NCT01012479|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6573060|NCT01012544|Clopidogrel|clopidogrel|mesh-list
6573061|NCT01012544|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6573062|NCT01012544|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6573063|NCT01012544|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6573064|NCT01012544|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6573065|NCT01012544|Purinergic Agents|purinergic agents|mesh-ancestor
6573066|NCT01012544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6573067|NCT01012544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573068|NCT01012544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573069|NCT01012570|Adalimumab|adalimumab|mesh-list
6573070|NCT01012570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6573071|NCT01012570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6573072|NCT01012687|Perindopril|perindopril|mesh-list
6573073|NCT01012687|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6573074|NCT01012687|Protease Inhibitors|protease inhibitors|mesh-ancestor
6573075|NCT01012687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6573076|NCT01012687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573077|NCT01012687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6573078|NCT01012700|Poly ICLC|poly iclc|mesh-list
6573079|NCT01012700|Interferon Inducers|interferon inducers|mesh-ancestor
6573080|NCT01012700|Immunologic Factors|immunologic factors|mesh-ancestor
6573081|NCT01012700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573082|NCT01012817|Topotecan|topotecan|mesh-list
6573083|NCT01012817|Veliparib|veliparib|mesh-list
6573084|NCT01012817|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6573085|NCT01012817|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6573086|NCT01012817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6573087|NCT01012817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573088|NCT01012817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6573089|NCT01012817|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6573090|NCT01012830|Huperzine A|huperzine a|mesh-list
6573091|NCT01012830|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6573092|NCT01012830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6573093|NCT01012830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573094|NCT01012830|Cholinergic Agents|cholinergic agents|mesh-ancestor
6573095|NCT01012830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6573096|NCT01012830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573097|NCT01012830|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6573098|NCT01012830|Protective Agents|protective agents|mesh-ancestor
6573099|NCT01012843|Amoxicillin|amoxicillin|mesh-list
6573100|NCT01012843|Clavulanic Acid|clavulanic acid|mesh-list
6573101|NCT01012843|Clavulanic Acids|clavulanic acids|mesh-list
6573102|NCT01012843|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6573103|NCT01012843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6573104|NCT01012843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6573105|NCT01012843|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6573106|NCT01012843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6573107|NCT01012843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573108|NCT01012869|Everolimus|everolimus|mesh-list
6573109|NCT01012869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6573110|NCT01012869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6573111|NCT01012869|Immunologic Factors|immunologic factors|mesh-ancestor
6573112|NCT01012869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573113|NCT01012882|Immunologic Factors|immunologic factors|mesh-list
6573114|NCT01012882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573115|NCT01012934|Alendronate|alendronate|mesh-list
6573116|NCT01012934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6573117|NCT01012934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573118|NCT01012960|Methylnaltrexone|methylnaltrexone|mesh-list
6573119|NCT01012960|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6573120|NCT01012960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573121|NCT01012960|Sensory System Agents|sensory system agents|mesh-ancestor
6573122|NCT01012960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6573123|NCT01013012|Dexamethasone|dexamethasone|mesh-list
6573124|NCT01013012|Ramosetron|ramosetron|mesh-list
6573125|NCT01013012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6573126|NCT01013012|Antiemetics|antiemetics|mesh-ancestor
6573127|NCT01013012|Autonomic Agents|autonomic agents|mesh-ancestor
6573128|NCT01013012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6573129|NCT01013012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573130|NCT01013012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6573131|NCT01013012|Glucocorticoids|glucocorticoids|mesh-ancestor
6445781|NCT00389584|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6573132|NCT01013012|Hormones|hormones|mesh-ancestor
6573133|NCT01013012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6573134|NCT01013012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6573135|NCT01013012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6445782|NCT00389584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6445783|NCT00389584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6445784|NCT00389584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445785|NCT00389584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6445786|NCT00389636|Becaplermin|becaplermin|mesh-list
6445787|NCT00389636|Anticoagulants|anticoagulants|mesh-ancestor
6445788|NCT00389636|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
6445789|NCT00389636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6445790|NCT00389636|Growth Substances|growth substances|mesh-ancestor
6445791|NCT00389636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445792|NCT00389688|Pemetrexed|pemetrexed|mesh-list
6445793|NCT00389688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6445794|NCT00389688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6445795|NCT00389688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445796|NCT00389688|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6445797|NCT00389688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6445798|NCT00389701|Dexamethasone|dexamethasone|mesh-list
6445799|NCT00389701|Bortezomib|bortezomib|mesh-list
6445800|NCT00389701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6445801|NCT00389701|Antiemetics|antiemetics|mesh-ancestor
6445802|NCT00389701|Autonomic Agents|autonomic agents|mesh-ancestor
6445803|NCT00389701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6445804|NCT00389701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445805|NCT00389701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6573136|NCT01013012|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6573137|NCT01013012|Serotonin Agents|serotonin agents|mesh-ancestor
6573138|NCT01013012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6573139|NCT01013012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573140|NCT01013103|Atorvastatin|atorvastatin|mesh-list
6573141|NCT01013103|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6573142|NCT01013103|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6573143|NCT01013103|Antimetabolites|antimetabolites|mesh-ancestor
6573144|NCT01013103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573145|NCT01013103|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6445806|NCT00389701|Glucocorticoids|glucocorticoids|mesh-ancestor
6445807|NCT00389701|Hormones|hormones|mesh-ancestor
6445808|NCT00389701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6445809|NCT00389701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6445810|NCT00389701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6445811|NCT00389766|Topotecan|topotecan|mesh-list
6445812|NCT00389766|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
6445813|NCT00389766|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6445814|NCT00389766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6445815|NCT00389766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6445816|NCT00389766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445817|NCT00389766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6445818|NCT00389766|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6445819|NCT00389870|Cyclosporine|cyclosporine|mesh-list
6445820|NCT00389870|Irinotecan|irinotecan|mesh-list
6445821|NCT00389870|Panitumumab|panitumumab|mesh-list
6445822|NCT00389870|Cyclosporins|cyclosporins|mesh-list
6657884|NCT01478490|Metoprolol|metoprolol|mesh-list
6573146|NCT01013103|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6573147|NCT01013103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6573148|NCT01013155|Perindopril|perindopril|mesh-list
6573149|NCT01013155|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6573150|NCT01013155|Protease Inhibitors|protease inhibitors|mesh-ancestor
6573151|NCT01013155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6573152|NCT01013155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573153|NCT01013155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6573154|NCT01013272|Lamivudine|lamivudine|mesh-list
6573155|NCT01013272|Entecavir|entecavir|mesh-list
6573156|NCT01013272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6573157|NCT01013272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6573158|NCT01013272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6573159|NCT01013272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573160|NCT01013272|Antiviral Agents|antiviral agents|mesh-ancestor
6573161|NCT01013272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6573162|NCT01013272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6573163|NCT01013272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6573164|NCT01013402|Insulin|insulin|mesh-list
6573165|NCT01013402|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6573166|NCT01013402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6445823|NCT00389870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6445824|NCT00389870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6445825|NCT00389870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6445826|NCT00389870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501445|NCT04474093|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6445827|NCT00389870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6573167|NCT01013402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573168|NCT01013454|Varenicline|varenicline|mesh-list
6573169|NCT01013454|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6573170|NCT01013454|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6573171|NCT01013454|Cholinergic Agents|cholinergic agents|mesh-ancestor
6573172|NCT01013454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6573173|NCT01013454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573174|NCT01013454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657885|NCT01478490|Mirabegron|mirabegron|mesh-list
6657886|NCT01478490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6657887|NCT01478490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6657888|NCT01478490|Sympatholytics|sympatholytics|mesh-ancestor
6657889|NCT01478490|Autonomic Agents|autonomic agents|mesh-ancestor
6657890|NCT01478490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6657891|NCT01478490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657892|NCT01478490|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6657893|NCT01478490|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6657894|NCT01478490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6657895|NCT01478490|Adrenergic Agents|adrenergic agents|mesh-ancestor
6657896|NCT01478490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6657897|NCT01478490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657898|NCT01478490|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6657899|NCT01478490|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6657900|NCT01478490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6657901|NCT01478490|Urological Agents|urological agents|mesh-ancestor
6657902|NCT01478503|Mirabegron|mirabegron|mesh-list
6657903|NCT01478503|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6657904|NCT01478503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6657905|NCT01478503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6657906|NCT01478503|Adrenergic Agents|adrenergic agents|mesh-ancestor
6657907|NCT01478503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6657908|NCT01478503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657909|NCT01478503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445828|NCT00389870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6445829|NCT00389870|Immunologic Factors|immunologic factors|mesh-ancestor
6445830|NCT00389870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445831|NCT00389870|Antifungal Agents|antifungal agents|mesh-ancestor
6445832|NCT00389870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6445833|NCT00389870|Dermatologic Agents|dermatologic agents|mesh-ancestor
6445834|NCT00389870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6573175|NCT01013480|Baclofen|baclofen|mesh-list
6573176|NCT01013480|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6573177|NCT01013480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573178|NCT01013480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6573179|NCT01013480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6573180|NCT01013480|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6573181|NCT01013480|GABA Agonists|gaba agonists|mesh-ancestor
6573182|NCT01013480|GABA Agents|gaba agents|mesh-ancestor
6573183|NCT01013480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6573184|NCT01013480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573185|NCT01013506|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6573186|NCT01013506|Letrozole|letrozole|mesh-list
6573187|NCT01013506|Goserelin|goserelin|mesh-list
6573188|NCT01013506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6573189|NCT01013506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6573190|NCT01013506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6573191|NCT01013506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573192|NCT01013506|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6573193|NCT01013506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6573194|NCT01013506|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6573195|NCT01013506|Hormone Antagonists|hormone antagonists|mesh-ancestor
6573196|NCT01013506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6573197|NCT01013506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573198|NCT01013506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6573199|NCT01013532|Aspirin|aspirin|mesh-list
6573200|NCT01013532|Cilostazol|cilostazol|mesh-list
6573201|NCT01013532|Probucol|probucol|mesh-list
6573202|NCT01013532|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6573203|NCT01013532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6573204|NCT01013532|Analgesics|analgesics|mesh-ancestor
6573205|NCT01013532|Sensory System Agents|sensory system agents|mesh-ancestor
6573206|NCT01013532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6573207|NCT01013532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573208|NCT01013532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6573209|NCT01013532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6573210|NCT01013532|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6445835|NCT00389870|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6445836|NCT00389870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6020151|NCT00391846|Autonomic Agents|autonomic agents|mesh-ancestor
6020152|NCT00391846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6020153|NCT00391846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020154|NCT00391846|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6020155|NCT00391846|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6020156|NCT00391846|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6445837|NCT00389883|Anesthetics|anesthetics|mesh-list
6445838|NCT00389883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6445839|NCT00389883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445840|NCT00389909|Doxapram|doxapram|mesh-list
6445841|NCT00389909|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6445842|NCT00389909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445843|NCT00389909|Respiratory System Agents|respiratory system agents|mesh-ancestor
6573211|NCT01013532|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6573212|NCT01013532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573213|NCT01013532|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6573214|NCT01013532|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6573215|NCT01013532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6573216|NCT01013532|Antipyretics|antipyretics|mesh-ancestor
6573217|NCT01013532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6573218|NCT01013532|Autonomic Agents|autonomic agents|mesh-ancestor
6573219|NCT01013532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6573220|NCT01013532|Respiratory System Agents|respiratory system agents|mesh-ancestor
6573221|NCT01013532|Vasodilator Agents|vasodilator agents|mesh-ancestor
6573222|NCT01013532|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6573223|NCT01013532|Protective Agents|protective agents|mesh-ancestor
6573224|NCT01013532|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6573225|NCT01013532|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6573226|NCT01013532|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6573227|NCT01013532|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6573228|NCT01013532|Antimetabolites|antimetabolites|mesh-ancestor
6573229|NCT01013532|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6573230|NCT01013532|Antioxidants|antioxidants|mesh-ancestor
6573231|NCT01013558|Remifentanil|remifentanil|mesh-list
6573232|NCT01013558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6573233|NCT01013558|Narcotics|narcotics|mesh-ancestor
6573234|NCT01013558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6573235|NCT01013558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573236|NCT01013558|Analgesics|analgesics|mesh-ancestor
6573237|NCT01013558|Sensory System Agents|sensory system agents|mesh-ancestor
6573238|NCT01013558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6573239|NCT01013571|Insulin|insulin|mesh-list
6573240|NCT01013571|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6573241|NCT01013571|Insulin Glargine|insulin glargine|mesh-list
6573242|NCT01013571|Insulin glulisine|insulin glulisine|mesh-list
6573243|NCT01013571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6573244|NCT01013571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573245|NCT01013584|Cholecalciferol|cholecalciferol|mesh-list
6573246|NCT01013584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6573247|NCT01013584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573248|NCT01013584|Vitamins|vitamins|mesh-ancestor
6573249|NCT01013584|Micronutrients|micronutrients|mesh-ancestor
6573250|NCT01013584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6573251|NCT01013675|Vaccines|vaccines|mesh-list
6573252|NCT01013675|Immunologic Factors|immunologic factors|mesh-ancestor
6573253|NCT01013675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573254|NCT01013727|Technetium Tc 99m bicisate|technetium tc 99m bicisate|mesh-list
6573255|NCT01013727|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6573256|NCT01013727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573257|NCT01013779|Carboplatin|carboplatin|mesh-list
6573258|NCT01013779|Etoposide|etoposide|mesh-list
6573259|NCT01013779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6573260|NCT01013779|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6573261|NCT01013779|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6573262|NCT01013779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6573263|NCT01013779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6573264|NCT01013779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573265|NCT01013805|Leucovorin|leucovorin|mesh-list
6573266|NCT01013805|Fluorouracil|fluorouracil|mesh-list
6573267|NCT01013805|Oxaliplatin|oxaliplatin|mesh-list
6573268|NCT01013805|Antimetabolites|antimetabolites|mesh-ancestor
6573269|NCT01013805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573270|NCT01013805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6573271|NCT01013805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6573272|NCT01013805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6573273|NCT01013805|Immunologic Factors|immunologic factors|mesh-ancestor
6573274|NCT01013805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573275|NCT01013805|Antidotes|antidotes|mesh-ancestor
6573276|NCT01013805|Protective Agents|protective agents|mesh-ancestor
6573277|NCT01013805|Vitamin B Complex|vitamin b complex|mesh-ancestor
6573278|NCT01013805|Vitamins|vitamins|mesh-ancestor
6573279|NCT01013805|Micronutrients|micronutrients|mesh-ancestor
6573280|NCT01013831|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6573281|NCT01013831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6573282|NCT01013831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6573283|NCT01013831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6573284|NCT01013831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573285|NCT01013909|Terbinafine|terbinafine|mesh-list
6573286|NCT01013909|Bifonazole|bifonazole|mesh-list
6573287|NCT01013909|Antifungal Agents|antifungal agents|mesh-ancestor
6573288|NCT01013909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6573289|NCT01013909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6573290|NCT01013909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573291|NCT01013987|Ritonavir|ritonavir|mesh-list
6573292|NCT01013987|Darunavir|darunavir|mesh-list
6573293|NCT01013987|Raltegravir Potassium|raltegravir potassium|mesh-list
6573294|NCT01013987|Maraviroc|maraviroc|mesh-list
6573295|NCT01013987|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6573296|NCT01013987|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6573297|NCT01013987|Protease Inhibitors|protease inhibitors|mesh-ancestor
6573298|NCT01013987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6573299|NCT01013987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573300|NCT01013987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6573301|NCT01013987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6573302|NCT01013987|Antiviral Agents|antiviral agents|mesh-ancestor
6573303|NCT01013987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6573304|NCT01013987|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6573305|NCT01013987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6573306|NCT01013987|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6573307|NCT01013987|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6573308|NCT01013987|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6573309|NCT01013987|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6445844|NCT00389922|Vinorelbine|vinorelbine|mesh-list
6445845|NCT00389922|Lapatinib|lapatinib|mesh-list
6445846|NCT00389922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6445847|NCT00389922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6445848|NCT00389922|Tubulin Modulators|tubulin modulators|mesh-ancestor
6445849|NCT00389922|Antimitotic Agents|antimitotic agents|mesh-ancestor
6445850|NCT00389922|Mitosis Modulators|mitosis modulators|mesh-ancestor
6445851|NCT00389922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445852|NCT00389922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6445853|NCT00389922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6445854|NCT00389935|Thalidomide|thalidomide|mesh-list
6445855|NCT00389935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6445856|NCT00389935|Immunologic Factors|immunologic factors|mesh-ancestor
6445857|NCT00389935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445858|NCT00389935|Leprostatic Agents|leprostatic agents|mesh-ancestor
6573310|NCT01013987|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6573311|NCT01014052|Retinol acetate|retinol acetate|mesh-list
6573312|NCT01014052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6573313|NCT01014052|Immunologic Factors|immunologic factors|mesh-ancestor
6573314|NCT01014052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573315|NCT01014052|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6573316|NCT01014052|Protective Agents|protective agents|mesh-ancestor
6573317|NCT01014052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6573318|NCT01014104|Methylprednisolone|methylprednisolone|mesh-list
6573319|NCT01014104|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6573320|NCT01014104|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6573321|NCT01014104|Prednisolone|prednisolone|mesh-list
6573322|NCT01014104|Prednisolone acetate|prednisolone acetate|mesh-list
6573323|NCT01014104|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6573324|NCT01014104|Prednisolone phosphate|prednisolone phosphate|mesh-list
6573325|NCT01014104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6573326|NCT01014104|Antiemetics|antiemetics|mesh-ancestor
6573327|NCT01014104|Autonomic Agents|autonomic agents|mesh-ancestor
6573328|NCT01014104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6573329|NCT01014104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573330|NCT01014104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6573331|NCT01014104|Glucocorticoids|glucocorticoids|mesh-ancestor
6573332|NCT01014104|Hormones|hormones|mesh-ancestor
6573333|NCT01014104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6573334|NCT01014104|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6573335|NCT01014104|Protective Agents|protective agents|mesh-ancestor
6573336|NCT01014104|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6573337|NCT01014104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6573338|NCT01014156|Epoprostenol|epoprostenol|mesh-list
6573339|NCT01014156|Tezosentan|tezosentan|mesh-list
6573340|NCT01014156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6573341|NCT01014156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6573342|NCT01014156|Vasodilator Agents|vasodilator agents|mesh-ancestor
6573343|NCT01014221|Prednisolone|prednisolone|mesh-list
6573344|NCT01014221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6573345|NCT01014221|Glucocorticoids|glucocorticoids|mesh-ancestor
6573346|NCT01014221|Hormones|hormones|mesh-ancestor
6573347|NCT01014221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6573348|NCT01014221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573349|NCT01014221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6573350|NCT01014221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6573351|NCT01014234|Cyclosporine|cyclosporine|mesh-list
6573352|NCT01014234|Sirolimus|sirolimus|mesh-list
6573353|NCT01014234|Cyclosporins|cyclosporins|mesh-list
6573354|NCT01014234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6657910|NCT01478503|Urological Agents|urological agents|mesh-ancestor
6573355|NCT01014234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573356|NCT01014234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6573357|NCT01014234|Immunologic Factors|immunologic factors|mesh-ancestor
6573358|NCT01014234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573359|NCT01014234|Antifungal Agents|antifungal agents|mesh-ancestor
6573360|NCT01014234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6573361|NCT01014234|Dermatologic Agents|dermatologic agents|mesh-ancestor
6573362|NCT01014234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6573363|NCT01014234|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6573364|NCT01014234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6573365|NCT01014234|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6573366|NCT01014234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6573367|NCT01014247|Moxifloxacin|moxifloxacin|mesh-list
6573368|NCT01014247|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6573369|NCT01014247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6573370|NCT01014247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6573371|NCT01014247|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6573372|NCT01014247|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6573373|NCT01014247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6573374|NCT01014247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573375|NCT01014247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6573376|NCT01014247|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6445859|NCT00389935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6445860|NCT00389935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6445861|NCT00389935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6445862|NCT00389935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6445863|NCT00389935|Growth Substances|growth substances|mesh-ancestor
6445864|NCT00389935|Growth Inhibitors|growth inhibitors|mesh-ancestor
6445865|NCT00389935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6445866|NCT00389987|Tazobactam|tazobactam|mesh-list
6445867|NCT00389987|Piperacillin|piperacillin|mesh-list
6445868|NCT00389987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445869|NCT00389987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6445870|NCT00389987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6445871|NCT00389987|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6445872|NCT00389987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6445873|NCT00390000|Pemetrexed|pemetrexed|mesh-list
6445874|NCT00390000|Vatalanib|vatalanib|mesh-list
6445875|NCT00390000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6445876|NCT00390000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6445877|NCT00390000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445878|NCT00390000|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6445879|NCT00390000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6445880|NCT00390000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6445881|NCT00390026|Bevacizumab|bevacizumab|mesh-list
6445882|NCT00390026|Verteporfin|verteporfin|mesh-list
6445883|NCT00390026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6445884|NCT00390026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6445885|NCT00390026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6445886|NCT00390026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6573377|NCT01014247|Contraceptive Agents|contraceptive agents|mesh-ancestor
6573378|NCT01014247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6573379|NCT01014247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573380|NCT01014247|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6573381|NCT01014247|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6573382|NCT01014247|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6573383|NCT01014260|Doxycycline|doxycycline|mesh-list
6573384|NCT01014260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6573385|NCT01014260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6573386|NCT01014260|Antimalarials|antimalarials|mesh-ancestor
6573387|NCT01014260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6573388|NCT01014260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6573389|NCT01014338|Fosinopril|fosinopril|mesh-list
6573390|NCT01014338|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6573391|NCT01014338|Protease Inhibitors|protease inhibitors|mesh-ancestor
6573392|NCT01014338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6573393|NCT01014338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573394|NCT01014338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6573395|NCT01014364|Hydrocortisone|hydrocortisone|mesh-list
6573396|NCT01014364|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6573397|NCT01014364|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6573398|NCT01014364|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6573399|NCT01014364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6573400|NCT01014416|Tolvaptan|tolvaptan|mesh-list
6573401|NCT01014416|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6573402|NCT01014416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573403|NCT01014416|Natriuretic Agents|natriuretic agents|mesh-ancestor
6573404|NCT01014416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573405|NCT01014468|Bevacizumab|bevacizumab|mesh-list
6573406|NCT01014468|Ranibizumab|ranibizumab|mesh-list
6573407|NCT01014468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6573408|NCT01014468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6573409|NCT01014468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6573410|NCT01014468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6573411|NCT01014468|Growth Substances|growth substances|mesh-ancestor
6573412|NCT01014468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573413|NCT01014468|Growth Inhibitors|growth inhibitors|mesh-ancestor
6573414|NCT01014481|Tenofovir|tenofovir|mesh-list
6573415|NCT01014481|Lamivudine|lamivudine|mesh-list
6573416|NCT01014481|Efavirenz|efavirenz|mesh-list
6573417|NCT01014481|Antiviral Agents|antiviral agents|mesh-ancestor
6573418|NCT01014481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6573419|NCT01014481|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6573420|NCT01014481|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6573421|NCT01014481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6573422|NCT01014481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573423|NCT01014481|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6573424|NCT01014481|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6573425|NCT01014481|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6573426|NCT01014481|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6573427|NCT01014481|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6573428|NCT01014481|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6573429|NCT01014481|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6573430|NCT01014481|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6573431|NCT01014507|Goserelin|goserelin|mesh-list
6573432|NCT01014507|Contraceptive Agents|contraceptive agents|mesh-list
6573433|NCT01014507|Contraceptives, Oral|contraceptives, oral|mesh-list
6573434|NCT01014507|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6573435|NCT01014507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573436|NCT01014507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6573437|NCT01014507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6573438|NCT01014507|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6573439|NCT01014520|Gabapentin|gabapentin|mesh-list
6573440|NCT01014520|Amitriptyline|amitriptyline|mesh-list
6573441|NCT01014520|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6445887|NCT00390026|Growth Substances|growth substances|mesh-ancestor
6445888|NCT00390026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445889|NCT00390026|Growth Inhibitors|growth inhibitors|mesh-ancestor
6573442|NCT01014520|Analgesics|analgesics|mesh-ancestor
6573443|NCT01014520|Sensory System Agents|sensory system agents|mesh-ancestor
6573444|NCT01014520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6445890|NCT00390026|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6445891|NCT00390026|Dermatologic Agents|dermatologic agents|mesh-ancestor
6445892|NCT00390039|Morphine|morphine|mesh-list
6445893|NCT00390039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6445894|NCT00390039|Narcotics|narcotics|mesh-ancestor
6445895|NCT00390039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6445896|NCT00390039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445897|NCT00390039|Analgesics|analgesics|mesh-ancestor
6445898|NCT00390039|Sensory System Agents|sensory system agents|mesh-ancestor
6445899|NCT00390039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6445900|NCT00390065|Nitric Oxide|nitric oxide|mesh-list
6445901|NCT00390065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6445902|NCT00390065|Autonomic Agents|autonomic agents|mesh-ancestor
6445903|NCT00390065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6445904|NCT00390065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445905|NCT00390065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6573445|NCT01014520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573446|NCT01014520|Anticonvulsants|anticonvulsants|mesh-ancestor
6573447|NCT01014520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6573448|NCT01014520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6573449|NCT01014520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6573450|NCT01014520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6573451|NCT01014520|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6573452|NCT01014520|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6573453|NCT01014520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6573454|NCT01014520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573455|NCT01014520|Antimanic Agents|antimanic agents|mesh-ancestor
6573456|NCT01014520|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6573457|NCT01014520|Antidepressive Agents|antidepressive agents|mesh-ancestor
6573458|NCT01014520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6573459|NCT01014520|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6573460|NCT01014520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6573461|NCT01014520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6573462|NCT01014520|Adrenergic Agents|adrenergic agents|mesh-ancestor
6573463|NCT01014520|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6573464|NCT01014546|Vitamins|vitamins|mesh-list
6573465|NCT01014546|Ascorbic Acid|ascorbic acid|mesh-list
6573466|NCT01014546|Arsenic Trioxide|arsenic trioxide|mesh-list
6573467|NCT01014546|Micronutrients|micronutrients|mesh-ancestor
6573468|NCT01014546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573469|NCT01014546|Antioxidants|antioxidants|mesh-ancestor
6573470|NCT01014546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573471|NCT01014546|Protective Agents|protective agents|mesh-ancestor
6573472|NCT01014546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6445906|NCT00390065|Respiratory System Agents|respiratory system agents|mesh-ancestor
6445907|NCT00390065|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6445908|NCT00390065|Antioxidants|antioxidants|mesh-ancestor
6445909|NCT00390065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445910|NCT00390065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6445911|NCT00390065|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6445912|NCT00390065|Vasodilator Agents|vasodilator agents|mesh-ancestor
6445913|NCT00390065|Gasotransmitters|gasotransmitters|mesh-ancestor
6573473|NCT01014559|Oxycodone|oxycodone|mesh-list
6573474|NCT01014559|Naloxone|naloxone|mesh-list
6573475|NCT01014559|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6573476|NCT01014559|Narcotics|narcotics|mesh-ancestor
6573477|NCT01014559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6573478|NCT01014559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573479|NCT01014559|Analgesics|analgesics|mesh-ancestor
6573480|NCT01014559|Sensory System Agents|sensory system agents|mesh-ancestor
6573481|NCT01014559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6573482|NCT01014559|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6573483|NCT01014598|Cisplatin|cisplatin|mesh-list
6573484|NCT01014598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6573485|NCT01014637|Antifungal Agents|antifungal agents|mesh-list
6573486|NCT01014637|Clotrimazole|clotrimazole|mesh-list
6573487|NCT01014637|Miconazole|miconazole|mesh-list
6573488|NCT01014637|Amorolfine|amorolfine|mesh-list
6573489|NCT01014637|Ciclopirox|ciclopirox|mesh-list
6573490|NCT01014637|Keratolytic Agents|keratolytic agents|mesh-list
6573491|NCT01014637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6573492|NCT01014637|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6573493|NCT01014637|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6573494|NCT01014637|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6573495|NCT01014637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6573496|NCT01014637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573497|NCT01014637|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6573498|NCT01014637|Hormone Antagonists|hormone antagonists|mesh-ancestor
6573499|NCT01014637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6573500|NCT01014637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573501|NCT01014637|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6573502|NCT01014637|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6573503|NCT01014637|Dermatologic Agents|dermatologic agents|mesh-ancestor
6573504|NCT01014650|Glycine|glycine|mesh-list
6573505|NCT01014650|Glycine Agents|glycine agents|mesh-ancestor
6573506|NCT01014650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6573507|NCT01014650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573508|NCT01014650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573509|NCT01014793|Cabergoline|cabergoline|mesh-list
6573510|NCT01014793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6573511|NCT01014793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6573512|NCT01014793|Dopamine Agonists|dopamine agonists|mesh-ancestor
6573513|NCT01014793|Dopamine Agents|dopamine agents|mesh-ancestor
6573514|NCT01014793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6573515|NCT01014793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573516|NCT01014793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573517|NCT01014832|Insulin|insulin|mesh-list
6573518|NCT01014832|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6573519|NCT01014832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6573520|NCT01014832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573521|NCT01014845|Vaccines|vaccines|mesh-list
6573522|NCT01014845|Immunologic Factors|immunologic factors|mesh-ancestor
6573523|NCT01014845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445914|NCT00390065|Protective Agents|protective agents|mesh-ancestor
6020157|NCT00391846|Adrenergic Agents|adrenergic agents|mesh-ancestor
6020158|NCT00391846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6020159|NCT00391846|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6020160|NCT00391846|Hormone Antagonists|hormone antagonists|mesh-ancestor
6445915|NCT00390091|Abetimus|abetimus|mesh-list
6573524|NCT01014858|Donepezil|donepezil|mesh-list
6573525|NCT01014858|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6573526|NCT01014858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6573527|NCT01014858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573528|NCT01014858|Cholinergic Agents|cholinergic agents|mesh-ancestor
6573529|NCT01014858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6573530|NCT01014858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573531|NCT01014858|Nootropic Agents|nootropic agents|mesh-ancestor
6445916|NCT00390091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6445917|NCT00390091|Immunologic Factors|immunologic factors|mesh-ancestor
6445918|NCT00390091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445919|NCT00390130|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6445920|NCT00390130|Immunologic Factors|immunologic factors|mesh-ancestor
6445921|NCT00390130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445922|NCT00390156|Cyclophosphamide|cyclophosphamide|mesh-list
6445923|NCT00390156|Bevacizumab|bevacizumab|mesh-list
6445924|NCT00390156|Imatinib Mesylate|imatinib mesylate|mesh-list
6445925|NCT00390156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6445926|NCT00390156|Immunologic Factors|immunologic factors|mesh-ancestor
6445927|NCT00390156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445928|NCT00390156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6445929|NCT00390156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6573532|NCT01015040|Solifenacin Succinate|solifenacin succinate|mesh-list
6573533|NCT01015040|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6573534|NCT01015040|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6573535|NCT01015040|Cholinergic Agents|cholinergic agents|mesh-ancestor
6573536|NCT01015040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6573537|NCT01015040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573538|NCT01015040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020161|NCT00391846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6020162|NCT00391846|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6020163|NCT00391846|Natriuretic Agents|natriuretic agents|mesh-ancestor
6020164|NCT00391846|Antioxidants|antioxidants|mesh-ancestor
6020165|NCT00391846|Protective Agents|protective agents|mesh-ancestor
6020166|NCT00391846|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6573539|NCT01015040|Urological Agents|urological agents|mesh-ancestor
6573540|NCT01015053|Ropivacaine|ropivacaine|mesh-list
6573541|NCT01015053|Anesthetics, Local|anesthetics, local|mesh-ancestor
6573542|NCT01015053|Anesthetics|anesthetics|mesh-ancestor
6573543|NCT01015053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6573544|NCT01015053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573545|NCT01015053|Sensory System Agents|sensory system agents|mesh-ancestor
6573546|NCT01015053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6573547|NCT01015066|Naltrexone|naltrexone|mesh-list
6573548|NCT01015066|Buprenorphine|buprenorphine|mesh-list
6573549|NCT01015066|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6573550|NCT01015066|Naloxone|naloxone|mesh-list
6573551|NCT01015066|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6573552|NCT01015066|Narcotics|narcotics|mesh-ancestor
6573553|NCT01015066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6573554|NCT01015066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573555|NCT01015066|Analgesics|analgesics|mesh-ancestor
6573556|NCT01015066|Sensory System Agents|sensory system agents|mesh-ancestor
6573557|NCT01015066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6573558|NCT01015066|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6573559|NCT01015066|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6573560|NCT01015183|Zinc Sulfate|zinc sulfate|mesh-list
6573561|NCT01015183|Astringents|astringents|mesh-ancestor
6573562|NCT01015183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573563|NCT01015183|Dermatologic Agents|dermatologic agents|mesh-ancestor
6573564|NCT01015196|Daunorubicin|daunorubicin|mesh-list
6573565|NCT01015196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6573566|NCT01015196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6573567|NCT01015196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6573568|NCT01015196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6573569|NCT01015196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6573570|NCT01015196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573571|NCT01015209|Acetylcysteine|acetylcysteine|mesh-list
6573572|NCT01015209|Chitosan|chitosan|mesh-list
6573573|NCT01015209|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6573574|NCT01015209|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6573575|NCT01015209|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6573576|NCT01015209|Antiviral Agents|antiviral agents|mesh-ancestor
6573577|NCT01015209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6573578|NCT01015209|Expectorants|expectorants|mesh-ancestor
6573579|NCT01015209|Respiratory System Agents|respiratory system agents|mesh-ancestor
6573580|NCT01015209|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6573581|NCT01015209|Antioxidants|antioxidants|mesh-ancestor
6573582|NCT01015209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573583|NCT01015209|Protective Agents|protective agents|mesh-ancestor
6573584|NCT01015209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573585|NCT01015209|Antidotes|antidotes|mesh-ancestor
6573586|NCT01015209|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6573587|NCT01015209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6573588|NCT01015209|Antimetabolites|antimetabolites|mesh-ancestor
6573589|NCT01015209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6573590|NCT01015209|Chelating Agents|chelating agents|mesh-ancestor
6573591|NCT01015209|Sequestering Agents|sequestering agents|mesh-ancestor
6573592|NCT01015209|Hemostatics|hemostatics|mesh-ancestor
6573593|NCT01015209|Coagulants|coagulants|mesh-ancestor
6573594|NCT01015222|Paclitaxel|paclitaxel|mesh-list
6573595|NCT01015222|Bevacizumab|bevacizumab|mesh-list
6573596|NCT01015222|Dasatinib|dasatinib|mesh-list
6573597|NCT01015222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6573598|NCT01015222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6573599|NCT01015222|Tubulin Modulators|tubulin modulators|mesh-ancestor
6573600|NCT01015222|Antimitotic Agents|antimitotic agents|mesh-ancestor
6573601|NCT01015222|Mitosis Modulators|mitosis modulators|mesh-ancestor
6573602|NCT01015222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573603|NCT01015222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6573604|NCT01015222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6573605|NCT01015222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6573606|NCT01015222|Growth Substances|growth substances|mesh-ancestor
6573607|NCT01015222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573608|NCT01015222|Growth Inhibitors|growth inhibitors|mesh-ancestor
6573609|NCT01015222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6573610|NCT01015222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6573611|NCT01015235|Ketorolac|ketorolac|mesh-list
6573612|NCT01015235|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6573613|NCT01015235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6573614|NCT01015235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6573615|NCT01015235|Analgesics|analgesics|mesh-ancestor
6573616|NCT01015235|Sensory System Agents|sensory system agents|mesh-ancestor
6573617|NCT01015235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6573618|NCT01015235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573619|NCT01015235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6573620|NCT01015235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6573621|NCT01015235|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6573622|NCT01015235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6573623|NCT01015235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573624|NCT01015248|Rituximab|rituximab|mesh-list
6573625|NCT01015248|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6573626|NCT01015248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6573627|NCT01015248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6573628|NCT01015248|Immunologic Factors|immunologic factors|mesh-ancestor
6573629|NCT01015248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573630|NCT01015248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6573631|NCT01015248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6573632|NCT01015248|Alkylating Agents|alkylating agents|mesh-ancestor
6573633|NCT01015248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657911|NCT01478529|Mirabegron|mirabegron|mesh-list
6657912|NCT01478529|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6657913|NCT01478529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6657914|NCT01478529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6657915|NCT01478529|Adrenergic Agents|adrenergic agents|mesh-ancestor
6657916|NCT01478529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6657917|NCT01478529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657918|NCT01478529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657919|NCT01478529|Urological Agents|urological agents|mesh-ancestor
6657920|NCT01478568|Desipramine|desipramine|mesh-list
6657921|NCT01478568|Mirabegron|mirabegron|mesh-list
6657922|NCT01478568|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6657923|NCT01478568|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6657924|NCT01478568|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5501446|NCT04474093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501447|NCT04474093|Sympathomimetics|sympathomimetics|mesh-ancestor
5501448|NCT04474093|Autonomic Agents|autonomic agents|mesh-ancestor
5501449|NCT04474093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5501450|NCT04474093|Dopamine Agents|dopamine agents|mesh-ancestor
6573634|NCT01015300|Bevacizumab|bevacizumab|mesh-list
6573635|NCT01015300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6573636|NCT01015300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6573637|NCT01015300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6573638|NCT01015300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6573639|NCT01015300|Growth Substances|growth substances|mesh-ancestor
6573640|NCT01015300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573641|NCT01015300|Growth Inhibitors|growth inhibitors|mesh-ancestor
6573642|NCT01015339|Paclitaxel|paclitaxel|mesh-list
6573643|NCT01015339|Capecitabine|capecitabine|mesh-list
6573644|NCT01015339|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6573645|NCT01015339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6573646|NCT01015339|Tubulin Modulators|tubulin modulators|mesh-ancestor
6573647|NCT01015339|Antimitotic Agents|antimitotic agents|mesh-ancestor
6573648|NCT01015339|Mitosis Modulators|mitosis modulators|mesh-ancestor
6573649|NCT01015339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573650|NCT01015339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6573651|NCT01015339|Antimetabolites|antimetabolites|mesh-ancestor
6573652|NCT01015352|Azacitidine|azacitidine|mesh-list
6573653|NCT01015352|Epoetin Alfa|epoetin alfa|mesh-list
6573654|NCT01015352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6573655|NCT01015352|Antimetabolites|antimetabolites|mesh-ancestor
6573656|NCT01015352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573657|NCT01015352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6573658|NCT01015352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6573659|NCT01015352|Hematinics|hematinics|mesh-ancestor
6573660|NCT01015391|Azathioprine|azathioprine|mesh-list
6573661|NCT01015391|Antimetabolites|antimetabolites|mesh-ancestor
6573662|NCT01015391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573663|NCT01015391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6573664|NCT01015391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6573665|NCT01015391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6573666|NCT01015391|Immunologic Factors|immunologic factors|mesh-ancestor
6573667|NCT01015391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573668|NCT01015391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6573669|NCT01015417|Amoxicillin|amoxicillin|mesh-list
6573670|NCT01015417|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6573671|NCT01015417|Clavulanic Acids|clavulanic acids|mesh-list
6573672|NCT01015417|Clavulanic Acid|clavulanic acid|mesh-list
6573673|NCT01015417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6573674|NCT01015417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6573675|NCT01015417|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6573676|NCT01015417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6573677|NCT01015417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573678|NCT01015456|Mycophenolic Acid|mycophenolic acid|mesh-list
6573679|NCT01015456|Cyclophosphamide|cyclophosphamide|mesh-list
6573680|NCT01015456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6573681|NCT01015456|Immunologic Factors|immunologic factors|mesh-ancestor
6573682|NCT01015456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573683|NCT01015456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6573684|NCT01015456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6573685|NCT01015456|Alkylating Agents|alkylating agents|mesh-ancestor
6573686|NCT01015456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573687|NCT01015456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6573688|NCT01015456|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6573689|NCT01015456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6573690|NCT01015456|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6573691|NCT01015456|Antitubercular Agents|antitubercular agents|mesh-ancestor
6573692|NCT01015456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6573693|NCT01015456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6573694|NCT01015456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6573695|NCT01015482|Midazolam|midazolam|mesh-list
6573696|NCT01015482|Remifentanil|remifentanil|mesh-list
6573697|NCT01015482|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6573698|NCT01015482|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6573699|NCT01015482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6573700|NCT01015482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573701|NCT01015482|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6573702|NCT01015482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6573703|NCT01015482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6573704|NCT01015482|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6573705|NCT01015482|Anesthetics, General|anesthetics, general|mesh-ancestor
6573706|NCT01015482|Anesthetics|anesthetics|mesh-ancestor
6573707|NCT01015482|GABA Modulators|gaba modulators|mesh-ancestor
6573708|NCT01015482|GABA Agents|gaba agents|mesh-ancestor
6573709|NCT01015482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6573710|NCT01015482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573711|NCT01015482|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6573712|NCT01015482|Narcotics|narcotics|mesh-ancestor
6573713|NCT01015482|Analgesics|analgesics|mesh-ancestor
6573714|NCT01015482|Sensory System Agents|sensory system agents|mesh-ancestor
6573715|NCT01015482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6573716|NCT01015495|Ranibizumab|ranibizumab|mesh-list
6573717|NCT01015495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6573718|NCT01015495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6573719|NCT01015495|Growth Substances|growth substances|mesh-ancestor
6573720|NCT01015495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573721|NCT01015495|Growth Inhibitors|growth inhibitors|mesh-ancestor
6573722|NCT01015495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6573723|NCT01015547|Sulfasalazine|sulfasalazine|mesh-list
6573724|NCT01015547|Methotrexate|methotrexate|mesh-list
6573725|NCT01015547|Infliximab|infliximab|mesh-list
6573726|NCT01015547|Naltrexone|naltrexone|mesh-list
6573727|NCT01015547|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6573728|NCT01015547|Abortifacient Agents|abortifacient agents|mesh-ancestor
6573729|NCT01015547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6573730|NCT01015547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573731|NCT01015547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6573732|NCT01015547|Antimetabolites|antimetabolites|mesh-ancestor
6573733|NCT01015547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445930|NCT00390156|Alkylating Agents|alkylating agents|mesh-ancestor
6445931|NCT00390156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573734|NCT01015547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6573735|NCT01015547|Dermatologic Agents|dermatologic agents|mesh-ancestor
6573736|NCT01015547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6573737|NCT01015547|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6445932|NCT00390156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6445933|NCT00390156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6445934|NCT00390156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6445935|NCT00390156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6445936|NCT00390156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6445937|NCT00390156|Growth Substances|growth substances|mesh-ancestor
6445938|NCT00390156|Growth Inhibitors|growth inhibitors|mesh-ancestor
6445939|NCT00390156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6445940|NCT00390156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6445941|NCT00390195|Everolimus|everolimus|mesh-list
6445942|NCT00390195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6573738|NCT01015547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6573739|NCT01015547|Immunologic Factors|immunologic factors|mesh-ancestor
6573740|NCT01015547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6573741|NCT01015547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6573742|NCT01015547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6573743|NCT01015547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6573744|NCT01015547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6573745|NCT01015547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6573746|NCT01015547|Analgesics|analgesics|mesh-ancestor
6573747|NCT01015547|Sensory System Agents|sensory system agents|mesh-ancestor
6573748|NCT01015547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6573749|NCT01015547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6573750|NCT01015547|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6573751|NCT01015547|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6573752|NCT01015651|Remifentanil|remifentanil|mesh-list
6573753|NCT01015651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6573754|NCT01015651|Narcotics|narcotics|mesh-ancestor
6573755|NCT01015651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6573756|NCT01015651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573757|NCT01015651|Analgesics|analgesics|mesh-ancestor
6573758|NCT01015651|Sensory System Agents|sensory system agents|mesh-ancestor
6573759|NCT01015651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6573760|NCT01015664|Sirolimus|sirolimus|mesh-list
6573761|NCT01015664|Cetuximab|cetuximab|mesh-list
6573762|NCT01015664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6573763|NCT01015664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6573764|NCT01015664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6573765|NCT01015664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6573766|NCT01015664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6573767|NCT01015664|Antifungal Agents|antifungal agents|mesh-ancestor
6573768|NCT01015664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6573769|NCT01015664|Immunologic Factors|immunologic factors|mesh-ancestor
6573770|NCT01015664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573771|NCT01015729|Aspirin|aspirin|mesh-list
6573772|NCT01015729|Esomeprazole|esomeprazole|mesh-list
6573773|NCT01015729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6573774|NCT01015729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6573775|NCT01015729|Analgesics|analgesics|mesh-ancestor
6573776|NCT01015729|Sensory System Agents|sensory system agents|mesh-ancestor
6573777|NCT01015729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6573778|NCT01015729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573779|NCT01015729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6573780|NCT01015729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6573781|NCT01015729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6573782|NCT01015729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6573783|NCT01015729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573784|NCT01015729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6573785|NCT01015729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6573786|NCT01015729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6573787|NCT01015729|Antipyretics|antipyretics|mesh-ancestor
6573788|NCT01015729|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6573789|NCT01015729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6573790|NCT01015729|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6573791|NCT01015794|Ephedrine|ephedrine|mesh-list
6573792|NCT01015794|Pseudoephedrine|pseudoephedrine|mesh-list
6573793|NCT01015794|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6573794|NCT01015794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573795|NCT01015794|Sympathomimetics|sympathomimetics|mesh-ancestor
6573796|NCT01015794|Autonomic Agents|autonomic agents|mesh-ancestor
6573797|NCT01015794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6573798|NCT01015794|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6573799|NCT01015794|Adrenergic Agents|adrenergic agents|mesh-ancestor
6573800|NCT01015794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6573801|NCT01015794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573802|NCT01015794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6573803|NCT01015794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6573804|NCT01015794|Respiratory System Agents|respiratory system agents|mesh-ancestor
6573805|NCT01015794|Nasal Decongestants|nasal decongestants|mesh-ancestor
6573806|NCT01015937|Losartan|losartan|mesh-list
6573807|NCT01015937|Enalapril|enalapril|mesh-list
6573808|NCT01015937|Angiotensin II|angiotensin ii|mesh-list
6573809|NCT01015937|Giapreza|giapreza|mesh-list
6573810|NCT01015937|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6573811|NCT01015937|Angiotensinogen|angiotensinogen|mesh-list
6573812|NCT01015937|Turmeric extract|turmeric extract|mesh-list
6573813|NCT01015937|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6573814|NCT01015937|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6573815|NCT01015937|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6573816|NCT01015937|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6573817|NCT01015937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573818|NCT01015937|Protease Inhibitors|protease inhibitors|mesh-ancestor
6573819|NCT01015937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6573820|NCT01015937|Antioxidants|antioxidants|mesh-ancestor
6573821|NCT01015937|Protective Agents|protective agents|mesh-ancestor
6573822|NCT01015937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573823|NCT01015937|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6573824|NCT01015937|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6573825|NCT01016002|Temoporfin|temoporfin|mesh-list
6573826|NCT01016002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6573827|NCT01016002|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6573828|NCT01016002|Dermatologic Agents|dermatologic agents|mesh-ancestor
6573829|NCT01016041|Paclitaxel|paclitaxel|mesh-list
6573830|NCT01016041|Everolimus|everolimus|mesh-list
6573831|NCT01016041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6573832|NCT01016041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6573833|NCT01016041|Tubulin Modulators|tubulin modulators|mesh-ancestor
6573834|NCT01016041|Antimitotic Agents|antimitotic agents|mesh-ancestor
6573835|NCT01016041|Mitosis Modulators|mitosis modulators|mesh-ancestor
6573836|NCT01016041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573837|NCT01016041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6573838|NCT01016041|Immunologic Factors|immunologic factors|mesh-ancestor
6573839|NCT01016041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573840|NCT01016054|Gemcitabine|gemcitabine|mesh-list
6573841|NCT01016054|Carboplatin|carboplatin|mesh-list
6573842|NCT01016054|Doxorubicin|doxorubicin|mesh-list
6573843|NCT01016054|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6573844|NCT01016054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6573845|NCT01016054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6573846|NCT01016054|Antimetabolites|antimetabolites|mesh-ancestor
6573847|NCT01016054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573848|NCT01016054|Antiviral Agents|antiviral agents|mesh-ancestor
6573849|NCT01016054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6573850|NCT01016054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6573851|NCT01016054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6573852|NCT01016054|Immunologic Factors|immunologic factors|mesh-ancestor
6573853|NCT01016054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573854|NCT01016054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6573855|NCT01016054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6573856|NCT01016054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6573857|NCT01016093|Zoledronic Acid|zoledronic acid|mesh-list
6573858|NCT01016093|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6573859|NCT01016093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573860|NCT01016145|Antipsychotic Agents|antipsychotic agents|mesh-list
6573861|NCT01016145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6573862|NCT01016145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6573863|NCT01016145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6573864|NCT01016145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573865|NCT01016158|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6573866|NCT01016158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6573867|NCT01016184|Vitamin D|vitamin d|mesh-list
6573868|NCT01016184|Vitamins|vitamins|mesh-ancestor
6573869|NCT01016184|Micronutrients|micronutrients|mesh-ancestor
6573870|NCT01016184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573871|NCT01016184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6573872|NCT01016223|Beclomethasone|beclomethasone|mesh-list
6573873|NCT01016223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6573874|NCT01016223|Glucocorticoids|glucocorticoids|mesh-ancestor
6573875|NCT01016223|Hormones|hormones|mesh-ancestor
6573876|NCT01016223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6573877|NCT01016223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573878|NCT01016223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6573879|NCT01016223|Respiratory System Agents|respiratory system agents|mesh-ancestor
6573880|NCT01016249|Epinephrine|epinephrine|mesh-list
6573881|NCT01016249|Racepinephrine|racepinephrine|mesh-list
6573882|NCT01016249|Epinephryl borate|epinephryl borate|mesh-list
6573883|NCT01016249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6573884|NCT01016249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6573885|NCT01016249|Adrenergic Agents|adrenergic agents|mesh-ancestor
6445943|NCT00390195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6573886|NCT01016249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6573887|NCT01016249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573888|NCT01016249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573889|NCT01016249|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6573890|NCT01016249|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6573891|NCT01016249|Autonomic Agents|autonomic agents|mesh-ancestor
6573892|NCT01016249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6573893|NCT01016249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6573894|NCT01016249|Respiratory System Agents|respiratory system agents|mesh-ancestor
6573895|NCT01016249|Mydriatics|mydriatics|mesh-ancestor
6573896|NCT01016249|Sympathomimetics|sympathomimetics|mesh-ancestor
6573897|NCT01016249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6573898|NCT01016509|Insulin|insulin|mesh-list
6573899|NCT01016509|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6573900|NCT01016509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6573901|NCT01016509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573902|NCT01016626|Mycophenolic Acid|mycophenolic acid|mesh-list
6573903|NCT01016626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6573904|NCT01016626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6573905|NCT01016626|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6573906|NCT01016626|Antitubercular Agents|antitubercular agents|mesh-ancestor
6573907|NCT01016626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6573908|NCT01016626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6573909|NCT01016626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6573910|NCT01016626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573911|NCT01016639|Capecitabine|capecitabine|mesh-list
6573912|NCT01016639|Oxaliplatin|oxaliplatin|mesh-list
6573913|NCT01016639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6573914|NCT01016639|Antimetabolites|antimetabolites|mesh-ancestor
6445944|NCT00390195|Immunologic Factors|immunologic factors|mesh-ancestor
6445945|NCT00390195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445946|NCT00390208|Dexamethasone|dexamethasone|mesh-list
6445947|NCT00390208|Ranibizumab|ranibizumab|mesh-list
6445948|NCT00390208|Verteporfin|verteporfin|mesh-list
6445949|NCT00390208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6445950|NCT00390208|Antiemetics|antiemetics|mesh-ancestor
6445951|NCT00390208|Autonomic Agents|autonomic agents|mesh-ancestor
6445952|NCT00390208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6445953|NCT00390208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445954|NCT00390208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6445955|NCT00390208|Glucocorticoids|glucocorticoids|mesh-ancestor
6445956|NCT00390208|Hormones|hormones|mesh-ancestor
6573915|NCT01016639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573916|NCT01016639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6573917|NCT01016665|Anastrozole|anastrozole|mesh-list
6573918|NCT01016665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6445957|NCT00390208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6445958|NCT00390208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6445959|NCT00390208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6445960|NCT00390208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6445961|NCT00390208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6445962|NCT00390208|Growth Substances|growth substances|mesh-ancestor
6445963|NCT00390208|Growth Inhibitors|growth inhibitors|mesh-ancestor
6573919|NCT01016665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6573920|NCT01016665|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6573921|NCT01016665|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6573922|NCT01016665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6573923|NCT01016665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573924|NCT01016665|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6573925|NCT01016665|Hormone Antagonists|hormone antagonists|mesh-ancestor
6573926|NCT01016665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6573927|NCT01016665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573928|NCT01016717|Omeprazole|omeprazole|mesh-list
6573929|NCT01016717|Pantoprazole|pantoprazole|mesh-list
6573930|NCT01016717|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6573931|NCT01016717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6573932|NCT01016717|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6573933|NCT01016717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6573934|NCT01016717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573935|NCT01016730|Bortezomib|bortezomib|mesh-list
6573936|NCT01016730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6573937|NCT01016795|Lenograstim|lenograstim|mesh-list
6573938|NCT01016795|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6573939|NCT01016795|Immunologic Factors|immunologic factors|mesh-ancestor
6573940|NCT01016795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573941|NCT01016821|Oxycodone|oxycodone|mesh-list
6573942|NCT01016821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6573943|NCT01016821|Narcotics|narcotics|mesh-ancestor
6573944|NCT01016821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6573945|NCT01016821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573946|NCT01016821|Analgesics|analgesics|mesh-ancestor
6573947|NCT01016821|Sensory System Agents|sensory system agents|mesh-ancestor
6573948|NCT01016821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6573949|NCT01016860|Irinotecan|irinotecan|mesh-list
6573950|NCT01016860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6573951|NCT01016860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6573952|NCT01016860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6573953|NCT01016860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573954|NCT01016860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6573955|NCT01016886|Bisoprolol|bisoprolol|mesh-list
6573956|NCT01016886|Perindopril|perindopril|mesh-list
6573957|NCT01016886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6573958|NCT01016886|Sympatholytics|sympatholytics|mesh-ancestor
6573959|NCT01016886|Autonomic Agents|autonomic agents|mesh-ancestor
6573960|NCT01016886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6573961|NCT01016886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573962|NCT01016886|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6573963|NCT01016886|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6573964|NCT01016886|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6573965|NCT01016886|Adrenergic Agents|adrenergic agents|mesh-ancestor
6573966|NCT01016886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6657925|NCT01478568|Adrenergic Agents|adrenergic agents|mesh-ancestor
6445964|NCT00390208|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6445965|NCT00390208|Dermatologic Agents|dermatologic agents|mesh-ancestor
6445966|NCT00390247|Thalidomide|thalidomide|mesh-list
6445967|NCT00390247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6445968|NCT00390247|Immunologic Factors|immunologic factors|mesh-ancestor
6445969|NCT00390247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445970|NCT00390247|Leprostatic Agents|leprostatic agents|mesh-ancestor
6445971|NCT00390247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6573967|NCT01016886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573968|NCT01016886|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6573969|NCT01016886|Protease Inhibitors|protease inhibitors|mesh-ancestor
6573970|NCT01016886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6573971|NCT01016990|Valproic Acid|valproic acid|mesh-list
6573972|NCT01016990|Anticonvulsants|anticonvulsants|mesh-ancestor
6573973|NCT01016990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6573974|NCT01016990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573975|NCT01016990|GABA Agents|gaba agents|mesh-ancestor
6573976|NCT01016990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6573977|NCT01016990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6573978|NCT01016990|Antimanic Agents|antimanic agents|mesh-ancestor
6573979|NCT01016990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6573980|NCT01016990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6573981|NCT01016990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6573982|NCT01017094|Silver Sulfadiazine|silver sulfadiazine|mesh-list
6573983|NCT01017094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6573984|NCT01017094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6573985|NCT01017107|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
6573986|NCT01017107|Protein C|protein c|mesh-list
6573987|NCT01017107|Anticoagulants|anticoagulants|mesh-ancestor
6573988|NCT01017107|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6573989|NCT01017107|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6573990|NCT01017107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573991|NCT01017107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6573992|NCT01017133|Deoxyglucose|deoxyglucose|mesh-list
6573993|NCT01017133|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6573994|NCT01017133|Fluorides|fluorides|mesh-list
6573995|NCT01017133|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6573996|NCT01017133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6573997|NCT01017133|Cariostatic Agents|cariostatic agents|mesh-ancestor
6573998|NCT01017133|Protective Agents|protective agents|mesh-ancestor
6573999|NCT01017133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574000|NCT01017133|Antimetabolites|antimetabolites|mesh-ancestor
6574001|NCT01017133|Antiviral Agents|antiviral agents|mesh-ancestor
6574002|NCT01017133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6574003|NCT01017159|Immunoglobulins|immunoglobulins|mesh-list
6574004|NCT01017159|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6574005|NCT01017159|Antibodies|antibodies|mesh-list
6574006|NCT01017159|Immunologic Factors|immunologic factors|mesh-ancestor
6574007|NCT01017159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574008|NCT01017198|Antacids|antacids|mesh-list
6574009|NCT01017198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574010|NCT01017198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6574011|NCT01017224|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
6574012|NCT01017224|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6574013|NCT01017224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657926|NCT01478568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6657927|NCT01478568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657928|NCT01478568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657929|NCT01478568|Urological Agents|urological agents|mesh-ancestor
6657930|NCT01478568|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6657931|NCT01478568|Antidepressive Agents|antidepressive agents|mesh-ancestor
6657932|NCT01478568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6657933|NCT01478568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6657934|NCT01478568|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6657935|NCT01478568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6657936|NCT01478568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6657937|NCT01478607|Capsaicin|capsaicin|mesh-list
6657938|NCT01478607|Antipruritics|antipruritics|mesh-ancestor
6657939|NCT01478607|Dermatologic Agents|dermatologic agents|mesh-ancestor
6657940|NCT01478607|Sensory System Agents|sensory system agents|mesh-ancestor
6657941|NCT01478607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6657942|NCT01478607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657943|NCT01478633|Galantamine|galantamine|mesh-list
6657944|NCT01478633|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6657945|NCT01478633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6657946|NCT01478633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657947|NCT01478633|Cholinergic Agents|cholinergic agents|mesh-ancestor
6657948|NCT01478633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6657949|NCT01478633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657950|NCT01478633|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6657951|NCT01478633|Autonomic Agents|autonomic agents|mesh-ancestor
6657952|NCT01478633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6574014|NCT01017354|Calcifediol|calcifediol|mesh-list
6574015|NCT01017354|Vitamins|vitamins|mesh-ancestor
6574016|NCT01017354|Micronutrients|micronutrients|mesh-ancestor
6574017|NCT01017354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574018|NCT01017354|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6574019|NCT01017367|Antibodies|antibodies|mesh-list
6574020|NCT01017367|Immunologic Factors|immunologic factors|mesh-ancestor
6574021|NCT01017367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574022|NCT01017380|Celecoxib|celecoxib|mesh-list
6574023|NCT01017380|Etoricoxib|etoricoxib|mesh-list
6574024|NCT01017380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6574025|NCT01017380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6574026|NCT01017380|Analgesics|analgesics|mesh-ancestor
6574027|NCT01017380|Sensory System Agents|sensory system agents|mesh-ancestor
6574028|NCT01017380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6574029|NCT01017380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574030|NCT01017380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6574031|NCT01017380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6574032|NCT01017380|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6574033|NCT01017380|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6574034|NCT01017380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6574035|NCT01017380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574036|NCT01017393|Ketamine|ketamine|mesh-list
6574037|NCT01017393|Analgesics|analgesics|mesh-ancestor
6574038|NCT01017393|Sensory System Agents|sensory system agents|mesh-ancestor
6574039|NCT01017393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6574040|NCT01017393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574041|NCT01017393|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6574042|NCT01017393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6574043|NCT01017393|Anesthetics, General|anesthetics, general|mesh-ancestor
6574044|NCT01017393|Anesthetics|anesthetics|mesh-ancestor
6574045|NCT01017393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6574046|NCT01017393|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6574047|NCT01017393|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6574048|NCT01017393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6574049|NCT01017393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574050|NCT01017458|Methyltestosterone|methyltestosterone|mesh-list
6574051|NCT01017458|Testosterone|testosterone|mesh-list
6574052|NCT01017458|Testosterone undecanoate|testosterone undecanoate|mesh-list
6574053|NCT01017458|Testosterone enanthate|testosterone enanthate|mesh-list
6574054|NCT01017458|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6574055|NCT01017458|Androgens|androgens|mesh-ancestor
6574056|NCT01017458|Hormones|hormones|mesh-ancestor
6574057|NCT01017458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6574058|NCT01017458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574059|NCT01017458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6574060|NCT01017458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6574061|NCT01017458|Anabolic Agents|anabolic agents|mesh-ancestor
6574062|NCT01017640|Mitomycins|mitomycins|mesh-list
6574063|NCT01017640|Mitomycin|mitomycin|mesh-list
6574064|NCT01017640|Veliparib|veliparib|mesh-list
6574065|NCT01017640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6574066|NCT01017640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6574067|NCT01017640|Alkylating Agents|alkylating agents|mesh-ancestor
6574068|NCT01017640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574069|NCT01017640|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6574070|NCT01017640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6574071|NCT01017640|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6574072|NCT01017666|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
6574073|NCT01017666|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
6574074|NCT01017666|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6574075|NCT01017666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6574076|NCT01017666|Purinergic Agents|purinergic agents|mesh-ancestor
6574077|NCT01017666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6574078|NCT01017666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574079|NCT01017666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574080|NCT01017679|Gefitinib|gefitinib|mesh-list
6574081|NCT01017679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6574082|NCT01017679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6574083|NCT01017679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6574084|NCT01017679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574085|NCT01017744|Anesthetics|anesthetics|mesh-list
6574086|NCT01017744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6574087|NCT01017744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574088|NCT01017770|Artesunate|artesunate|mesh-list
6574089|NCT01017770|Lumefantrine|lumefantrine|mesh-list
6574090|NCT01017770|Artemether|artemether|mesh-list
6574091|NCT01017770|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6574092|NCT01017770|Amodiaquine|amodiaquine|mesh-list
6574093|NCT01017770|Antimalarials|antimalarials|mesh-ancestor
6574094|NCT01017770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6574095|NCT01017770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6574096|NCT01017770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6574097|NCT01017770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6574098|NCT01017770|Antiviral Agents|antiviral agents|mesh-ancestor
6574099|NCT01017770|Schistosomicides|schistosomicides|mesh-ancestor
6574100|NCT01017770|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6574101|NCT01017770|Anthelmintics|anthelmintics|mesh-ancestor
6574102|NCT01017796|Ascorbic Acid|ascorbic acid|mesh-list
6574103|NCT01017796|Acetylcysteine|acetylcysteine|mesh-list
6574104|NCT01017796|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6574105|NCT01017796|Antiviral Agents|antiviral agents|mesh-ancestor
6574106|NCT01017796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6574107|NCT01017796|Expectorants|expectorants|mesh-ancestor
6574108|NCT01017796|Respiratory System Agents|respiratory system agents|mesh-ancestor
6574109|NCT01017796|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6574110|NCT01017796|Antioxidants|antioxidants|mesh-ancestor
6574111|NCT01017796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574112|NCT01017796|Protective Agents|protective agents|mesh-ancestor
6574113|NCT01017796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574114|NCT01017796|Antidotes|antidotes|mesh-ancestor
6574115|NCT01017796|Vitamins|vitamins|mesh-ancestor
6574116|NCT01017796|Micronutrients|micronutrients|mesh-ancestor
6574117|NCT01017809|Aprepitant|aprepitant|mesh-list
6574118|NCT01017809|Antiemetics|antiemetics|mesh-ancestor
6020167|NCT00391846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6020168|NCT00391846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6020169|NCT00391846|Vasodilator Agents|vasodilator agents|mesh-ancestor
6020170|NCT00391846|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6020171|NCT00391846|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6020172|NCT00391846|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6020173|NCT00391846|Protease Inhibitors|protease inhibitors|mesh-ancestor
6020174|NCT00391846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6020175|NCT00391846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6020176|NCT00391872|Clopidogrel|clopidogrel|mesh-list
6574119|NCT01017809|Autonomic Agents|autonomic agents|mesh-ancestor
6574120|NCT01017809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6574121|NCT01017809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574122|NCT01017809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6574123|NCT01017809|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6574124|NCT01017809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6574125|NCT01017809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574126|NCT01017822|Gemcitabine|gemcitabine|mesh-list
6574127|NCT01017822|Capecitabine|capecitabine|mesh-list
6574128|NCT01017822|Conatumumab|conatumumab|mesh-list
6574129|NCT01017822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6574130|NCT01017822|Antimetabolites|antimetabolites|mesh-ancestor
6574131|NCT01017822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574132|NCT01017822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6574133|NCT01017822|Antiviral Agents|antiviral agents|mesh-ancestor
6574134|NCT01017822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6574135|NCT01017822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6574136|NCT01017822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6574137|NCT01017822|Immunologic Factors|immunologic factors|mesh-ancestor
6574138|NCT01017822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574139|NCT01017822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6574140|NCT01017926|Triazolam|triazolam|mesh-list
6574141|NCT01017926|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6574142|NCT01017926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6574143|NCT01017926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6574144|NCT01017926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6574145|NCT01017926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574146|NCT01017926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6574147|NCT01017926|GABA Modulators|gaba modulators|mesh-ancestor
6574148|NCT01017926|GABA Agents|gaba agents|mesh-ancestor
6574149|NCT01017926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6574150|NCT01017926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574151|NCT01017939|Prednisone|prednisone|mesh-list
6574152|NCT01017939|Abiraterone Acetate|abiraterone acetate|mesh-list
6574153|NCT01017939|Theophylline|theophylline|mesh-list
6574154|NCT01017939|Dextromethorphan|dextromethorphan|mesh-list
6574155|NCT01017939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6574156|NCT01017939|Glucocorticoids|glucocorticoids|mesh-ancestor
6574157|NCT01017939|Hormones|hormones|mesh-ancestor
6574158|NCT01017939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6574159|NCT01017939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574160|NCT01017939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6574161|NCT01017939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6574162|NCT01017939|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6574163|NCT01017939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6574164|NCT01017939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574165|NCT01017939|Hormone Antagonists|hormone antagonists|mesh-ancestor
6574166|NCT01017939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6574167|NCT01017939|Antitussive Agents|antitussive agents|mesh-ancestor
6574168|NCT01017939|Respiratory System Agents|respiratory system agents|mesh-ancestor
6574169|NCT01017939|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6574170|NCT01017939|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6574171|NCT01017939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6574172|NCT01017939|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6574173|NCT01017939|Autonomic Agents|autonomic agents|mesh-ancestor
6574174|NCT01017939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6574175|NCT01017939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6574176|NCT01017939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6574177|NCT01017939|Vasodilator Agents|vasodilator agents|mesh-ancestor
6574178|NCT01017939|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6574179|NCT01017939|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6574180|NCT01017939|Purinergic Agents|purinergic agents|mesh-ancestor
6574181|NCT01018160|Rabeprazole|rabeprazole|mesh-list
6574182|NCT01018160|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6574183|NCT01018160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6574184|NCT01018160|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6574185|NCT01018160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6574186|NCT01018160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574187|NCT01018225|Darifenacin|darifenacin|mesh-list
6574188|NCT01018225|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6574189|NCT01018225|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6574190|NCT01018225|Cholinergic Agents|cholinergic agents|mesh-ancestor
6574191|NCT01018225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6574192|NCT01018225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574193|NCT01018225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574194|NCT01018225|Urological Agents|urological agents|mesh-ancestor
6574195|NCT01018251|Alovudine|alovudine|mesh-list
6574196|NCT01018251|Antiviral Agents|antiviral agents|mesh-ancestor
6574197|NCT01018251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6574198|NCT01018342|Nitrofurantoin|nitrofurantoin|mesh-list
6574199|NCT01018342|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6574200|NCT01018342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6574201|NCT01018342|Renal Agents|renal agents|mesh-ancestor
6574202|NCT01018342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6574203|NCT01018368|Rifampin|rifampin|mesh-list
6574204|NCT01018368|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6574205|NCT01018368|Antitubercular Agents|antitubercular agents|mesh-ancestor
6574206|NCT01018368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6574207|NCT01018368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6574208|NCT01018368|Leprostatic Agents|leprostatic agents|mesh-ancestor
6574209|NCT01018368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6574210|NCT01018368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6574211|NCT01018368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574212|NCT01018368|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6574213|NCT01018368|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6574214|NCT01018368|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6574215|NCT01018368|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6574216|NCT01018368|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6574217|NCT01018368|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6574218|NCT01018381|Ethanol|ethanol|mesh-list
6574219|NCT01018381|Entecavir|entecavir|mesh-list
6574220|NCT01018381|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6574221|NCT01018381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6574222|NCT01018381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6574223|NCT01018381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574224|NCT01018381|Antiviral Agents|antiviral agents|mesh-ancestor
6574225|NCT01018446|Busulfan|busulfan|mesh-list
6574226|NCT01018446|Alkylating Agents|alkylating agents|mesh-ancestor
6574227|NCT01018446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574228|NCT01018446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6574229|NCT01018446|Immunologic Factors|immunologic factors|mesh-ancestor
6574230|NCT01018446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574231|NCT01018446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6574232|NCT01018446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6574233|NCT01018446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6574234|NCT01018485|Botulinum Toxins|botulinum toxins|mesh-list
6574235|NCT01018485|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6574236|NCT01018485|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6574237|NCT01018485|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6574238|NCT01018485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6574239|NCT01018485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574240|NCT01018485|Cholinergic Agents|cholinergic agents|mesh-ancestor
6574241|NCT01018485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6574242|NCT01018485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574243|NCT01018485|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6574244|NCT01018485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6574245|NCT01018602|Vildagliptin|vildagliptin|mesh-list
6574246|NCT01018602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6574247|NCT01018602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574248|NCT01018602|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6574249|NCT01018602|Protease Inhibitors|protease inhibitors|mesh-ancestor
6574250|NCT01018602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6574251|NCT01018602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574252|NCT01018615|Silymarin|silymarin|mesh-list
6574253|NCT01018615|Antioxidants|antioxidants|mesh-ancestor
6574254|NCT01018615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574255|NCT01018615|Protective Agents|protective agents|mesh-ancestor
6574256|NCT01018615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574257|NCT01018758|Palonosetron|palonosetron|mesh-list
6574258|NCT01018758|Antiemetics|antiemetics|mesh-ancestor
6574259|NCT01018758|Autonomic Agents|autonomic agents|mesh-ancestor
6574260|NCT01018758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6574261|NCT01018758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574262|NCT01018758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6574263|NCT01018758|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6574264|NCT01018758|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6574265|NCT01018758|Serotonin Agents|serotonin agents|mesh-ancestor
6574266|NCT01018758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6574267|NCT01018758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574268|NCT01018823|Ertugliflozin|ertugliflozin|mesh-list
6574269|NCT01018823|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6574270|NCT01018823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574271|NCT01018823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6574272|NCT01018823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574273|NCT01018836|Riluzole|riluzole|mesh-list
6574274|NCT01018836|Anticonvulsants|anticonvulsants|mesh-ancestor
6574275|NCT01018836|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6574276|NCT01018836|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6574277|NCT01018836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6574278|NCT01018836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574279|NCT01018836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574280|NCT01018836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6574281|NCT01018836|Protective Agents|protective agents|mesh-ancestor
6574282|NCT01018849|Vitamin D|vitamin d|mesh-list
6574283|NCT01018849|Cholecalciferol|cholecalciferol|mesh-list
6574284|NCT01018849|Vitamins|vitamins|mesh-ancestor
6574285|NCT01018849|Micronutrients|micronutrients|mesh-ancestor
6574286|NCT01018849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574287|NCT01018849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6574288|NCT01018849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6574289|NCT01018914|Mycophenolic Acid|mycophenolic acid|mesh-list
6574290|NCT01018914|Tacrolimus|tacrolimus|mesh-list
6574291|NCT01018914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6574292|NCT01018914|Immunologic Factors|immunologic factors|mesh-ancestor
6574293|NCT01018914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574294|NCT01018914|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6574295|NCT01018914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6574296|NCT01018914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574297|NCT01018914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6574298|NCT01018914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6574299|NCT01018914|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6574300|NCT01018914|Antitubercular Agents|antitubercular agents|mesh-ancestor
6574301|NCT01018914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6574302|NCT01018914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6657953|NCT01478633|Nootropic Agents|nootropic agents|mesh-ancestor
6657954|NCT01478685|Paclitaxel|paclitaxel|mesh-list
6657955|NCT01478685|Carboplatin|carboplatin|mesh-list
6657956|NCT01478685|Azacitidine|azacitidine|mesh-list
6657957|NCT01478685|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6657958|NCT01478685|Cc-486|cc-486|mesh-list
6657959|NCT01478685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6657960|NCT01478685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6657961|NCT01478685|Tubulin Modulators|tubulin modulators|mesh-ancestor
6657962|NCT01478685|Antimitotic Agents|antimitotic agents|mesh-ancestor
6657963|NCT01478685|Mitosis Modulators|mitosis modulators|mesh-ancestor
6574303|NCT01019070|Asunaprevir|asunaprevir|mesh-list
6574304|NCT01019070|Protease Inhibitors|protease inhibitors|mesh-ancestor
6574305|NCT01019070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6574306|NCT01019070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574307|NCT01019083|Zinc|zinc|mesh-list
6574308|NCT01019083|Albendazole|albendazole|mesh-list
6574309|NCT01019083|Secnidazole|secnidazole|mesh-list
6574310|NCT01019083|Zinc Sulfate|zinc sulfate|mesh-list
6574311|NCT01019083|Trace Elements|trace elements|mesh-ancestor
6574312|NCT01019083|Micronutrients|micronutrients|mesh-ancestor
6574313|NCT01019083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574314|NCT01019083|Anthelmintics|anthelmintics|mesh-ancestor
6574315|NCT01019083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6574316|NCT01019083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6574317|NCT01019083|Anticestodal Agents|anticestodal agents|mesh-ancestor
6574318|NCT01019083|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6574319|NCT01019083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6574320|NCT01019083|Tubulin Modulators|tubulin modulators|mesh-ancestor
6574321|NCT01019083|Antimitotic Agents|antimitotic agents|mesh-ancestor
6574322|NCT01019083|Mitosis Modulators|mitosis modulators|mesh-ancestor
6574323|NCT01019083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574324|NCT01019083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6574325|NCT01019083|Astringents|astringents|mesh-ancestor
6574326|NCT01019083|Dermatologic Agents|dermatologic agents|mesh-ancestor
6574327|NCT01019109|Cobalt|cobalt|mesh-list
6574328|NCT01019109|Trace Elements|trace elements|mesh-ancestor
6574329|NCT01019109|Micronutrients|micronutrients|mesh-ancestor
6574330|NCT01019109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574331|NCT01019174|Cyclophosphamide|cyclophosphamide|mesh-list
6574332|NCT01019174|Lenalidomide|lenalidomide|mesh-list
6574333|NCT01019174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6574334|NCT01019174|Immunologic Factors|immunologic factors|mesh-ancestor
6574335|NCT01019174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574336|NCT01019174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6574337|NCT01019174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6574338|NCT01019174|Alkylating Agents|alkylating agents|mesh-ancestor
6574339|NCT01019174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574340|NCT01019174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6574341|NCT01019174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6574342|NCT01019174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6574343|NCT01019174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6574344|NCT01019174|Growth Substances|growth substances|mesh-ancestor
6574345|NCT01019174|Growth Inhibitors|growth inhibitors|mesh-ancestor
6574346|NCT01019265|Buprenorphine|buprenorphine|mesh-list
6574347|NCT01019265|Tramadol|tramadol|mesh-list
6574348|NCT01019265|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6574349|NCT01019265|Narcotics|narcotics|mesh-ancestor
6574350|NCT01019265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6574351|NCT01019265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574352|NCT01019265|Analgesics|analgesics|mesh-ancestor
6574353|NCT01019265|Sensory System Agents|sensory system agents|mesh-ancestor
6445972|NCT00390247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6445973|NCT00390247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6445974|NCT00390247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6574354|NCT01019265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6574355|NCT01019265|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6574356|NCT01019278|Cisplatin|cisplatin|mesh-list
6574357|NCT01019278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6574358|NCT01019291|Formaldehyde|formaldehyde|mesh-list
6574359|NCT01019291|Disinfectants|disinfectants|mesh-ancestor
6574360|NCT01019291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6574361|NCT01019382|Gemcitabine|gemcitabine|mesh-list
6574362|NCT01019382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6574363|NCT01019382|Antimetabolites|antimetabolites|mesh-ancestor
6574364|NCT01019382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574365|NCT01019382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6574366|NCT01019382|Antiviral Agents|antiviral agents|mesh-ancestor
6574367|NCT01019382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6574368|NCT01019382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6574369|NCT01019382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6574370|NCT01019382|Immunologic Factors|immunologic factors|mesh-ancestor
6574371|NCT01019382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574372|NCT01019395|Daptomycin|daptomycin|mesh-list
6574373|NCT01019395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6574374|NCT01019395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6574375|NCT01019408|Chloroquine|chloroquine|mesh-list
6574376|NCT01019408|Amebicides|amebicides|mesh-ancestor
6574377|NCT01019408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6574378|NCT01019408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6574379|NCT01019408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6574380|NCT01019408|Antimalarials|antimalarials|mesh-ancestor
6574381|NCT01019408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6574382|NCT01019434|Sirolimus|sirolimus|mesh-list
6574383|NCT01019434|Temozolomide|temozolomide|mesh-list
6574384|NCT01019434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6574385|NCT01019434|Alkylating Agents|alkylating agents|mesh-ancestor
6574386|NCT01019434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574387|NCT01019434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6574388|NCT01019434|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6574389|NCT01019434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6574390|NCT01019434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6574391|NCT01019434|Antifungal Agents|antifungal agents|mesh-ancestor
6574392|NCT01019434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6574393|NCT01019434|Immunologic Factors|immunologic factors|mesh-ancestor
6574394|NCT01019434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574395|NCT01019447|Anti-Infective Agents|anti-infective agents|mesh-list
6574396|NCT01019447|Triclosan|triclosan|mesh-list
6574397|NCT01019447|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6574398|NCT01019447|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6574399|NCT01019447|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6574400|NCT01019447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6574401|NCT01019447|Antimetabolites|antimetabolites|mesh-ancestor
6574402|NCT01019447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574403|NCT01019447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6574404|NCT01019590|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6574405|NCT01019590|Olmesartan|olmesartan|mesh-list
6574406|NCT01019590|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6574407|NCT01019590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6574408|NCT01019590|Diuretics|diuretics|mesh-ancestor
6574409|NCT01019590|Natriuretic Agents|natriuretic agents|mesh-ancestor
6574410|NCT01019590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574411|NCT01019590|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6574412|NCT01019590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6574413|NCT01019590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6445975|NCT00390247|Growth Substances|growth substances|mesh-ancestor
6445976|NCT00390247|Growth Inhibitors|growth inhibitors|mesh-ancestor
6445977|NCT00390247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6445978|NCT00390260|Acetaminophen|acetaminophen|mesh-list
6445979|NCT00390260|Rofecoxib|rofecoxib|mesh-list
6445980|NCT00390260|Hydrocodone|hydrocodone|mesh-list
6445981|NCT00390260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6445982|NCT00390260|Analgesics|analgesics|mesh-ancestor
6445983|NCT00390260|Sensory System Agents|sensory system agents|mesh-ancestor
6445984|NCT00390260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6445985|NCT00390260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6445986|NCT00390260|Antipyretics|antipyretics|mesh-ancestor
6462216|NCT00458185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6574414|NCT01019590|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6574415|NCT01019590|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6574416|NCT01019603|Nicotinic Acids|nicotinic acids|mesh-list
6574417|NCT01019603|Tazarotene|tazarotene|mesh-list
6574418|NCT01019603|Dermatologic Agents|dermatologic agents|mesh-ancestor
6574419|NCT01019603|Keratolytic Agents|keratolytic agents|mesh-ancestor
6574420|NCT01019603|Vitamin B Complex|vitamin b complex|mesh-ancestor
6574421|NCT01019603|Vitamins|vitamins|mesh-ancestor
6574422|NCT01019603|Micronutrients|micronutrients|mesh-ancestor
6574423|NCT01019603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574424|NCT01019642|Cholecalciferol|cholecalciferol|mesh-list
6574425|NCT01019642|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6574426|NCT01019642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574427|NCT01019642|Vitamins|vitamins|mesh-ancestor
6574428|NCT01019642|Micronutrients|micronutrients|mesh-ancestor
6574429|NCT01019642|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6574430|NCT01019655|Nadroparin|nadroparin|mesh-list
6574431|NCT01019655|Calcium|calcium|mesh-list
6574432|NCT01019655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6574433|NCT01019655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574434|NCT01019655|Anticoagulants|anticoagulants|mesh-ancestor
6574435|NCT01019655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6574436|NCT01019655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6574437|NCT01019655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574438|NCT01019668|Verteporfin|verteporfin|mesh-list
6574439|NCT01019668|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6574440|NCT01019668|Dermatologic Agents|dermatologic agents|mesh-ancestor
6574441|NCT01019746|Propofol|propofol|mesh-list
6574442|NCT01019746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6574443|NCT01019746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6574444|NCT01019746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574445|NCT01019746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6574446|NCT01019746|Anesthetics, General|anesthetics, general|mesh-ancestor
6574447|NCT01019746|Anesthetics|anesthetics|mesh-ancestor
6574448|NCT01019772|Vaccines|vaccines|mesh-list
6574449|NCT01019772|Immunologic Factors|immunologic factors|mesh-ancestor
6574450|NCT01019772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574451|NCT01019785|Ergocalciferols|ergocalciferols|mesh-list
6574452|NCT01019785|Vitamin D|vitamin d|mesh-list
6574453|NCT01019785|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6574454|NCT01019785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574455|NCT01019785|Vitamins|vitamins|mesh-ancestor
6574456|NCT01019785|Micronutrients|micronutrients|mesh-ancestor
6574457|NCT01019785|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6574458|NCT01019798|Docetaxel|docetaxel|mesh-list
6574459|NCT01019798|Sunitinib|sunitinib|mesh-list
6574460|NCT01019798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6574461|NCT01019798|Tubulin Modulators|tubulin modulators|mesh-ancestor
6574462|NCT01019798|Antimitotic Agents|antimitotic agents|mesh-ancestor
6574463|NCT01019798|Mitosis Modulators|mitosis modulators|mesh-ancestor
6574464|NCT01019798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574465|NCT01019798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6574466|NCT01019798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6574467|NCT01019798|Growth Substances|growth substances|mesh-ancestor
6574468|NCT01019798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574469|NCT01019798|Growth Inhibitors|growth inhibitors|mesh-ancestor
6574470|NCT01019798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6574471|NCT01019798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6574472|NCT01019850|Vorinostat|vorinostat|mesh-list
6574473|NCT01019850|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
6574474|NCT01019850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6574475|NCT01019850|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6574476|NCT01019850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6574477|NCT01019850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574478|NCT01019850|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6574479|NCT01019863|Oxaliplatin|oxaliplatin|mesh-list
6574480|NCT01019863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6574481|NCT01019876|Cyclophosphamide|cyclophosphamide|mesh-list
6574482|NCT01019876|Fludarabine|fludarabine|mesh-list
6574483|NCT01019876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6574484|NCT01019876|Immunologic Factors|immunologic factors|mesh-ancestor
6574485|NCT01019876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574486|NCT01019876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6574487|NCT01019876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6574488|NCT01019876|Alkylating Agents|alkylating agents|mesh-ancestor
6574489|NCT01019876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574490|NCT01019876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6574491|NCT01019876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6574492|NCT01019941|Docetaxel|docetaxel|mesh-list
6574493|NCT01019941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6574494|NCT01019941|Tubulin Modulators|tubulin modulators|mesh-ancestor
6574495|NCT01019941|Antimitotic Agents|antimitotic agents|mesh-ancestor
6574496|NCT01019941|Mitosis Modulators|mitosis modulators|mesh-ancestor
6574497|NCT01019941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574498|NCT01020136|Axitinib|axitinib|mesh-list
6574499|NCT01020136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6574500|NCT01020136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6574501|NCT01020136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6574502|NCT01020136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574503|NCT01020162|Gabapentin|gabapentin|mesh-list
6574504|NCT01020162|Amitriptyline|amitriptyline|mesh-list
6574505|NCT01020162|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6574506|NCT01020162|Analgesics|analgesics|mesh-ancestor
6574507|NCT01020162|Sensory System Agents|sensory system agents|mesh-ancestor
6574508|NCT01020162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6574509|NCT01020162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574510|NCT01020162|Anticonvulsants|anticonvulsants|mesh-ancestor
6574511|NCT01020162|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6574512|NCT01020162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6574513|NCT01020162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6574514|NCT01020162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6574515|NCT01020162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6574516|NCT01020162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6574517|NCT01020162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6574518|NCT01020162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574519|NCT01020162|Antimanic Agents|antimanic agents|mesh-ancestor
6574520|NCT01020162|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6574521|NCT01020162|Antidepressive Agents|antidepressive agents|mesh-ancestor
6574522|NCT01020162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6574523|NCT01020162|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6574524|NCT01020162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6574525|NCT01020162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6574526|NCT01020162|Adrenergic Agents|adrenergic agents|mesh-ancestor
6574527|NCT01020162|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6574528|NCT01020214|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6574529|NCT01020214|Olmesartan|olmesartan|mesh-list
6574530|NCT01020214|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6574531|NCT01020214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6574532|NCT01020214|Diuretics|diuretics|mesh-ancestor
6574533|NCT01020214|Natriuretic Agents|natriuretic agents|mesh-ancestor
6574534|NCT01020214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574535|NCT01020214|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6574536|NCT01020214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6574537|NCT01020214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574538|NCT01020214|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6574539|NCT01020214|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6574540|NCT01020253|Alendronate|alendronate|mesh-list
6574541|NCT01020253|Alfacalcidol|alfacalcidol|mesh-list
6574542|NCT01020253|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
6574543|NCT01020253|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6574544|NCT01020253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574545|NCT01020253|Vitamins|vitamins|mesh-ancestor
6574546|NCT01020253|Micronutrients|micronutrients|mesh-ancestor
6574547|NCT01020279|Celecoxib|celecoxib|mesh-list
6574548|NCT01020279|Ketoprofen|ketoprofen|mesh-list
6574549|NCT01020279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6574550|NCT01020279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6574551|NCT01020279|Analgesics|analgesics|mesh-ancestor
6574552|NCT01020279|Sensory System Agents|sensory system agents|mesh-ancestor
6574553|NCT01020279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6574554|NCT01020279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574555|NCT01020279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6574556|NCT01020279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6574557|NCT01020279|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6574558|NCT01020279|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6574559|NCT01020279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6574560|NCT01020279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574561|NCT01020292|Nelfinavir|nelfinavir|mesh-list
6574562|NCT01020292|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6574563|NCT01020292|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6574564|NCT01020292|Protease Inhibitors|protease inhibitors|mesh-ancestor
6574565|NCT01020292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6445987|NCT00390260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574566|NCT01020292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574567|NCT01020292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6574568|NCT01020292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6574569|NCT01020292|Antiviral Agents|antiviral agents|mesh-ancestor
6574570|NCT01020292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6574571|NCT01020331|Memantine|memantine|mesh-list
6574572|NCT01020331|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6574573|NCT01020331|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6574574|NCT01020331|Dopamine Agents|dopamine agents|mesh-ancestor
6445988|NCT00390260|Respiratory System Agents|respiratory system agents|mesh-ancestor
6445989|NCT00390260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6445990|NCT00390260|Narcotics|narcotics|mesh-ancestor
6445991|NCT00390260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6445992|NCT00390260|Antitussive Agents|antitussive agents|mesh-ancestor
6445993|NCT00390260|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6445994|NCT00390260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6445995|NCT00390260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6445996|NCT00390260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6445997|NCT00390260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6445998|NCT00390260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6445999|NCT00390273|Metformin|metformin|mesh-list
6574575|NCT01020331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6574576|NCT01020331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574577|NCT01020331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574578|NCT01020331|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6574579|NCT01020331|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6574580|NCT01020357|Caffeine|caffeine|mesh-list
6574581|NCT01020357|Caffeine citrate|caffeine citrate|mesh-list
6574582|NCT01020357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574583|NCT01020357|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6574584|NCT01020357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574585|NCT01020357|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6446000|NCT00390273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6574586|NCT01020357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6574587|NCT01020357|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6574588|NCT01020357|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6574589|NCT01020357|Purinergic Agents|purinergic agents|mesh-ancestor
6574590|NCT01020357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6574591|NCT01020383|Abciximab|abciximab|mesh-list
6574592|NCT01020383|Anticoagulants|anticoagulants|mesh-ancestor
6574593|NCT01020383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6574594|NCT01020396|Metronidazole|metronidazole|mesh-list
6574595|NCT01020396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6574596|NCT01020396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6574597|NCT01020396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6574598|NCT01020396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6574599|NCT01020539|Fludarabine|fludarabine|mesh-list
6574600|NCT01020539|Busulfan|busulfan|mesh-list
6574601|NCT01020539|Gemtuzumab|gemtuzumab|mesh-list
6574602|NCT01020539|Isotretinoin|isotretinoin|mesh-list
6574603|NCT01020539|Thymoglobulin|thymoglobulin|mesh-list
6574604|NCT01020539|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6574605|NCT01020539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6574606|NCT01020539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574607|NCT01020539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6574608|NCT01020539|Immunologic Factors|immunologic factors|mesh-ancestor
6574609|NCT01020539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574610|NCT01020539|Alkylating Agents|alkylating agents|mesh-ancestor
6574611|NCT01020539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6574612|NCT01020539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6574613|NCT01020539|Dermatologic Agents|dermatologic agents|mesh-ancestor
6574614|NCT01020539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6574615|NCT01020630|Sunitinib|sunitinib|mesh-list
6574616|NCT01020630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6574617|NCT01020630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6574618|NCT01020630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6574619|NCT01020630|Growth Substances|growth substances|mesh-ancestor
6574620|NCT01020630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574621|NCT01020630|Growth Inhibitors|growth inhibitors|mesh-ancestor
6574622|NCT01020630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6574623|NCT01020630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6574624|NCT01020630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574625|NCT01020643|Propofol|propofol|mesh-list
6574626|NCT01020643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6574627|NCT01020643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6574628|NCT01020643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574629|NCT01020643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6574630|NCT01020643|Anesthetics, General|anesthetics, general|mesh-ancestor
6574631|NCT01020643|Anesthetics|anesthetics|mesh-ancestor
6657964|NCT01478685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657965|NCT01478685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6657966|NCT01478685|Antimetabolites|antimetabolites|mesh-ancestor
6657967|NCT01478685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6657968|NCT01478698|Plasminogen|plasminogen|mesh-list
6657969|NCT01478698|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6657970|NCT01478698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6657971|NCT01478698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6657972|NCT01478698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657973|NCT01478724|Caseins|caseins|mesh-list
6657974|NCT01478724|Chelating Agents|chelating agents|mesh-ancestor
6657975|NCT01478724|Sequestering Agents|sequestering agents|mesh-ancestor
6657976|NCT01478724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657977|NCT01478737|Dexamethasone|dexamethasone|mesh-list
6657978|NCT01478737|Dexamethasone acetate|dexamethasone acetate|mesh-list
6657979|NCT01478737|BB 1101|bb 1101|mesh-list
6657980|NCT01478737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6657981|NCT01478737|Antiemetics|antiemetics|mesh-ancestor
6657982|NCT01478737|Autonomic Agents|autonomic agents|mesh-ancestor
6657983|NCT01478737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6657984|NCT01478737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6657985|NCT01478737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6657986|NCT01478737|Glucocorticoids|glucocorticoids|mesh-ancestor
6574632|NCT01020708|Acetylcysteine|acetylcysteine|mesh-list
6574633|NCT01020708|Aminosalicylic Acid|aminosalicylic acid|mesh-list
6574634|NCT01020708|Mesalamine|mesalamine|mesh-list
6574635|NCT01020708|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6574636|NCT01020708|Antiviral Agents|antiviral agents|mesh-ancestor
6574637|NCT01020708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6574638|NCT01020708|Expectorants|expectorants|mesh-ancestor
6574639|NCT01020708|Respiratory System Agents|respiratory system agents|mesh-ancestor
6574640|NCT01020708|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6574641|NCT01020708|Antioxidants|antioxidants|mesh-ancestor
6574642|NCT01020708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574643|NCT01020708|Protective Agents|protective agents|mesh-ancestor
6574644|NCT01020708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574645|NCT01020708|Antidotes|antidotes|mesh-ancestor
6574646|NCT01020708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6574647|NCT01020708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6574648|NCT01020708|Analgesics|analgesics|mesh-ancestor
6574649|NCT01020708|Sensory System Agents|sensory system agents|mesh-ancestor
6574650|NCT01020708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6574651|NCT01020708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6574652|NCT01020708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6574653|NCT01020708|Antitubercular Agents|antitubercular agents|mesh-ancestor
6574654|NCT01020708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6574655|NCT01020734|Cyclosporine|cyclosporine|mesh-list
6574656|NCT01020734|Cyclophosphamide|cyclophosphamide|mesh-list
6574657|NCT01020734|Busulfan|busulfan|mesh-list
6574658|NCT01020734|Methotrexate|methotrexate|mesh-list
6574659|NCT01020734|Fludarabine|fludarabine|mesh-list
6574660|NCT01020734|Fludarabine phosphate|fludarabine phosphate|mesh-list
6574661|NCT01020734|Cyclosporins|cyclosporins|mesh-list
6574662|NCT01020734|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6574663|NCT01020734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6574664|NCT01020734|Immunologic Factors|immunologic factors|mesh-ancestor
6574665|NCT01020734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574666|NCT01020734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6574667|NCT01020734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6574668|NCT01020734|Alkylating Agents|alkylating agents|mesh-ancestor
6574669|NCT01020734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574670|NCT01020734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6574671|NCT01020734|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6446001|NCT00390273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446002|NCT00390312|Morphine|morphine|mesh-list
6446003|NCT00390312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6446004|NCT00390312|Narcotics|narcotics|mesh-ancestor
6446005|NCT00390312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6446006|NCT00390312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446007|NCT00390312|Analgesics|analgesics|mesh-ancestor
6446008|NCT00390312|Sensory System Agents|sensory system agents|mesh-ancestor
6446009|NCT00390312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6446010|NCT00390390|Lansoprazole|lansoprazole|mesh-list
6446011|NCT00390390|Dexlansoprazole|dexlansoprazole|mesh-list
6574672|NCT01020734|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6574673|NCT01020734|Abortifacient Agents|abortifacient agents|mesh-ancestor
6574674|NCT01020734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6574675|NCT01020734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6574676|NCT01020734|Antimetabolites|antimetabolites|mesh-ancestor
6574677|NCT01020734|Dermatologic Agents|dermatologic agents|mesh-ancestor
6574678|NCT01020734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6574679|NCT01020734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6574680|NCT01020734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6574681|NCT01020734|Antifungal Agents|antifungal agents|mesh-ancestor
6574682|NCT01020734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6574683|NCT01020734|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6574684|NCT01020825|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6574685|NCT01020825|Hemostatics|hemostatics|mesh-ancestor
6574686|NCT01020825|Coagulants|coagulants|mesh-ancestor
6574687|NCT01020864|Carboplatin|carboplatin|mesh-list
6574688|NCT01020864|Cetuximab|cetuximab|mesh-list
6574689|NCT01020864|Vinorelbine|vinorelbine|mesh-list
6574690|NCT01020864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6574691|NCT01020864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6574692|NCT01020864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6574693|NCT01020864|Tubulin Modulators|tubulin modulators|mesh-ancestor
6574694|NCT01020864|Antimitotic Agents|antimitotic agents|mesh-ancestor
6574695|NCT01020864|Mitosis Modulators|mitosis modulators|mesh-ancestor
6574696|NCT01020864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574697|NCT01020955|Mecasermin|mecasermin|mesh-list
6574698|NCT01020955|Growth Substances|growth substances|mesh-ancestor
6574699|NCT01020955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574700|NCT01021150|Cisplatin|cisplatin|mesh-list
6574701|NCT01021150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6574702|NCT01021163|Acetylcysteine|acetylcysteine|mesh-list
6574703|NCT01021163|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6574704|NCT01021163|Antiviral Agents|antiviral agents|mesh-ancestor
6574705|NCT01021163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6446012|NCT00390390|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6446013|NCT00390390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6446014|NCT00390390|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6446015|NCT00390390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6446016|NCT00390390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446017|NCT00390403|Acetic Acid|acetic acid|mesh-list
6446018|NCT00390403|Temozolomide|temozolomide|mesh-list
6446019|NCT00390403|Retinol acetate|retinol acetate|mesh-list
6446020|NCT00390403|Gossypol acetic acid|gossypol acetic acid|mesh-list
6446021|NCT00390403|Gossypol|gossypol|mesh-list
6446022|NCT00390403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6446023|NCT00390403|Alkylating Agents|alkylating agents|mesh-ancestor
6446024|NCT00390403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446025|NCT00390403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6446026|NCT00390403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6574706|NCT01021163|Expectorants|expectorants|mesh-ancestor
6574707|NCT01021163|Respiratory System Agents|respiratory system agents|mesh-ancestor
6574708|NCT01021163|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6574709|NCT01021163|Antioxidants|antioxidants|mesh-ancestor
6574710|NCT01021163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020177|NCT00391872|Ticagrelor|ticagrelor|mesh-list
6446027|NCT00390403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6574711|NCT01021163|Protective Agents|protective agents|mesh-ancestor
6574712|NCT01021163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574713|NCT01021163|Antidotes|antidotes|mesh-ancestor
6574714|NCT01021176|Diltiazem|diltiazem|mesh-list
6574715|NCT01021176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6574716|NCT01021176|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6574717|NCT01021176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6574718|NCT01021176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574719|NCT01021176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6574720|NCT01021176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574721|NCT01021176|Vasodilator Agents|vasodilator agents|mesh-ancestor
6574722|NCT01021267|Saw palmetto extract|saw palmetto extract|mesh-list
6574723|NCT01021267|Urological Agents|urological agents|mesh-ancestor
6574724|NCT01021358|Ketoconazole|ketoconazole|mesh-list
6574725|NCT01021358|Navitoclax|navitoclax|mesh-list
6574726|NCT01021358|Antifungal Agents|antifungal agents|mesh-ancestor
6574727|NCT01021358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6574728|NCT01021358|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6574729|NCT01021358|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6574730|NCT01021358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6574731|NCT01021358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574732|NCT01021358|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6574733|NCT01021358|Hormone Antagonists|hormone antagonists|mesh-ancestor
6574734|NCT01021358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6574735|NCT01021358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574736|NCT01021358|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6574737|NCT01021358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6574738|NCT01021436|Amikacin|amikacin|mesh-list
6574739|NCT01021436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6574740|NCT01021436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6574741|NCT01021475|Domperidone|domperidone|mesh-list
6574742|NCT01021475|Antiemetics|antiemetics|mesh-ancestor
6574743|NCT01021475|Autonomic Agents|autonomic agents|mesh-ancestor
6574744|NCT01021475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6574745|NCT01021475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574746|NCT01021475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6574747|NCT01021475|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6574748|NCT01021475|Dopamine Agents|dopamine agents|mesh-ancestor
6574749|NCT01021475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6574750|NCT01021475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574751|NCT01021488|Enoxaparin|enoxaparin|mesh-list
6574752|NCT01021488|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6574753|NCT01021488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6574754|NCT01021488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6574755|NCT01021488|Antimetabolites|antimetabolites|mesh-ancestor
6574756|NCT01021488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574757|NCT01021488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6574758|NCT01021488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6574759|NCT01021488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6574760|NCT01021488|Anticoagulants|anticoagulants|mesh-ancestor
6574761|NCT01021488|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6574762|NCT01021488|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6574763|NCT01021501|Nifedipine|nifedipine|mesh-list
6574764|NCT01021501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6574765|NCT01021501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6574766|NCT01021501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574767|NCT01021501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6574768|NCT01021501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574769|NCT01021501|Vasodilator Agents|vasodilator agents|mesh-ancestor
6574770|NCT01021501|Tocolytic Agents|tocolytic agents|mesh-ancestor
6574771|NCT01021501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6574772|NCT01021540|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6574773|NCT01021540|Hormones|hormones|mesh-ancestor
6574774|NCT01021540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6574775|NCT01021540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574776|NCT01021566|Methadone|methadone|mesh-list
6574777|NCT01021566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6574778|NCT01021566|Narcotics|narcotics|mesh-ancestor
6574779|NCT01021566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6574780|NCT01021566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574781|NCT01021566|Analgesics|analgesics|mesh-ancestor
6574782|NCT01021566|Sensory System Agents|sensory system agents|mesh-ancestor
6574783|NCT01021566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6574784|NCT01021566|Antitussive Agents|antitussive agents|mesh-ancestor
6574785|NCT01021566|Respiratory System Agents|respiratory system agents|mesh-ancestor
6574786|NCT01021579|Metformin|metformin|mesh-list
6574787|NCT01021579|Simvastatin|simvastatin|mesh-list
6574788|NCT01021579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6574789|NCT01021579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574790|NCT01021579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6574791|NCT01021579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6574792|NCT01021579|Antimetabolites|antimetabolites|mesh-ancestor
6574793|NCT01021579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574794|NCT01021579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6574795|NCT01021579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6574796|NCT01021579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6574797|NCT01021592|Bortezomib|bortezomib|mesh-list
6574798|NCT01021592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6574799|NCT01021696|Acetaminophen|acetaminophen|mesh-list
6574800|NCT01021696|Pregabalin|pregabalin|mesh-list
6574801|NCT01021696|Morphine|morphine|mesh-list
6574802|NCT01021696|Buprenorphine|buprenorphine|mesh-list
6574803|NCT01021696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6574804|NCT01021696|Narcotics|narcotics|mesh-ancestor
6574805|NCT01021696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6574806|NCT01021696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574807|NCT01021696|Analgesics|analgesics|mesh-ancestor
6574808|NCT01021696|Sensory System Agents|sensory system agents|mesh-ancestor
6574809|NCT01021696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6574810|NCT01021696|Anticonvulsants|anticonvulsants|mesh-ancestor
6574811|NCT01021696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6574812|NCT01021696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6574813|NCT01021696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574814|NCT01021696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6574815|NCT01021696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6446028|NCT00390403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6446029|NCT00390403|Immunologic Factors|immunologic factors|mesh-ancestor
6446030|NCT00390403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446031|NCT00390403|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6446032|NCT00390403|Protective Agents|protective agents|mesh-ancestor
6446033|NCT00390403|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6446034|NCT00390403|Contraceptive Agents|contraceptive agents|mesh-ancestor
6446035|NCT00390403|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6446036|NCT00390403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6446037|NCT00390403|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6446038|NCT00390403|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
6446039|NCT00390403|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
6446040|NCT00390520|Vildagliptin|vildagliptin|mesh-list
6446041|NCT00390520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6446042|NCT00390520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574816|NCT01021696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6574817|NCT01021696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6574818|NCT01021696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6020178|NCT00391872|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6446043|NCT00390520|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6446044|NCT00390520|Protease Inhibitors|protease inhibitors|mesh-ancestor
6446045|NCT00390520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6446046|NCT00390520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446047|NCT00390598|Sennosides|sennosides|mesh-list
6446048|NCT00390598|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6446049|NCT00390598|Laxatives|laxatives|mesh-ancestor
6446050|NCT00390598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6446051|NCT00390624|Mannitol|mannitol|mesh-list
6446052|NCT00390624|Ularitide|ularitide|mesh-list
6446053|NCT00390624|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6446054|NCT00390624|Diuretics|diuretics|mesh-ancestor
6446055|NCT00390624|Natriuretic Agents|natriuretic agents|mesh-ancestor
6446056|NCT00390624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446057|NCT00390624|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6446058|NCT00390624|Autonomic Agents|autonomic agents|mesh-ancestor
6446059|NCT00390624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6446060|NCT00390624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6446061|NCT00390624|Respiratory System Agents|respiratory system agents|mesh-ancestor
6446062|NCT00390676|Carboplatin|carboplatin|mesh-list
6446063|NCT00390676|Docetaxel|docetaxel|mesh-list
6446064|NCT00390676|Capecitabine|capecitabine|mesh-list
6446065|NCT00390676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6446066|NCT00390676|Tubulin Modulators|tubulin modulators|mesh-ancestor
6446067|NCT00390676|Antimitotic Agents|antimitotic agents|mesh-ancestor
6446068|NCT00390676|Mitosis Modulators|mitosis modulators|mesh-ancestor
6446069|NCT00390676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446070|NCT00390676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6446071|NCT00390676|Antimetabolites|antimetabolites|mesh-ancestor
6461730|NCT00455832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461731|NCT00455832|Antiviral Agents|antiviral agents|mesh-ancestor
6461732|NCT00455832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6461733|NCT00455845|Levonorgestrel|levonorgestrel|mesh-list
6461734|NCT00455845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6461735|NCT00455845|Contraceptive Agents|contraceptive agents|mesh-ancestor
6461736|NCT00455845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6461737|NCT00455845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461738|NCT00455845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6461739|NCT00455845|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6461740|NCT00455845|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6461741|NCT00455871|Ranibizumab|ranibizumab|mesh-list
6461742|NCT00455871|Verteporfin|verteporfin|mesh-list
6461743|NCT00455871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6461744|NCT00455871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6461745|NCT00455871|Growth Substances|growth substances|mesh-ancestor
6461746|NCT00455871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461747|NCT00455871|Growth Inhibitors|growth inhibitors|mesh-ancestor
6461748|NCT00455871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6461749|NCT00455871|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6461750|NCT00455871|Dermatologic Agents|dermatologic agents|mesh-ancestor
6461751|NCT00455897|Rituximab|rituximab|mesh-list
6461752|NCT00455897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6461753|NCT00455897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6461754|NCT00455897|Immunologic Factors|immunologic factors|mesh-ancestor
6461755|NCT00455897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461756|NCT00455897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6461757|NCT00455910|Thalidomide|thalidomide|mesh-list
6461758|NCT00455910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6461759|NCT00455910|Immunologic Factors|immunologic factors|mesh-ancestor
6461760|NCT00455910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461761|NCT00455910|Leprostatic Agents|leprostatic agents|mesh-ancestor
6574819|NCT01021696|Antipyretics|antipyretics|mesh-ancestor
6574820|NCT01021696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6574821|NCT01021735|Adalimumab|adalimumab|mesh-list
6574822|NCT01021735|Etanercept|etanercept|mesh-list
6446072|NCT00390728|Insulin Glargine|insulin glargine|mesh-list
6446073|NCT00390728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6446074|NCT00390728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446075|NCT00390793|Cytarabine|cytarabine|mesh-list
6446076|NCT00390793|Dexamethasone|dexamethasone|mesh-list
6446077|NCT00390793|Prednisone|prednisone|mesh-list
6446078|NCT00390793|Dexamethasone acetate|dexamethasone acetate|mesh-list
6446079|NCT00390793|Cortisone|cortisone|mesh-list
6446080|NCT00390793|Cyclophosphamide|cyclophosphamide|mesh-list
6446081|NCT00390793|Doxorubicin|doxorubicin|mesh-list
6446082|NCT00390793|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6446083|NCT00390793|Methotrexate|methotrexate|mesh-list
6446084|NCT00390793|Vincristine|vincristine|mesh-list
6446085|NCT00390793|Daunorubicin|daunorubicin|mesh-list
6574823|NCT01021735|Rituximab|rituximab|mesh-list
6574824|NCT01021735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6574825|NCT01021735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6574826|NCT01021735|Immunologic Factors|immunologic factors|mesh-ancestor
6574827|NCT01021735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574828|NCT01021735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6574829|NCT01021735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6574830|NCT01021735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6574831|NCT01021735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6574832|NCT01021735|Analgesics|analgesics|mesh-ancestor
6574833|NCT01021735|Sensory System Agents|sensory system agents|mesh-ancestor
6574834|NCT01021735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6574835|NCT01021735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6574836|NCT01021735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6574837|NCT01021787|Titanium dioxide|titanium dioxide|mesh-list
6574838|NCT01021787|Sunscreening Agents|sunscreening agents|mesh-ancestor
6574839|NCT01021787|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6574840|NCT01021787|Protective Agents|protective agents|mesh-ancestor
6574841|NCT01021787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574842|NCT01021787|Dermatologic Agents|dermatologic agents|mesh-ancestor
6574843|NCT01021787|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6574844|NCT01021865|Glucagon|glucagon|mesh-list
6574845|NCT01021865|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6574846|NCT01021865|Regadenoson|regadenoson|mesh-list
6574847|NCT01021865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6574848|NCT01021865|Hormones|hormones|mesh-ancestor
6574849|NCT01021865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6574850|NCT01021865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574851|NCT01021865|Incretins|incretins|mesh-ancestor
6574852|NCT01021865|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
6574853|NCT01021865|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6574854|NCT01021865|Purinergic Agonists|purinergic agonists|mesh-ancestor
6574855|NCT01021865|Purinergic Agents|purinergic agents|mesh-ancestor
6574856|NCT01021865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6574857|NCT01021865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574858|NCT01021891|Insulin|insulin|mesh-list
6574859|NCT01021891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6574860|NCT01021891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574861|NCT01021930|Sirolimus|sirolimus|mesh-list
6446086|NCT00390793|Dasatinib|dasatinib|mesh-list
6446087|NCT00390793|BB 1101|bb 1101|mesh-list
6446088|NCT00390793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6574862|NCT01021930|Paclitaxel|paclitaxel|mesh-list
6574863|NCT01021930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6574864|NCT01021930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6574865|NCT01021930|Tubulin Modulators|tubulin modulators|mesh-ancestor
6574866|NCT01021930|Antimitotic Agents|antimitotic agents|mesh-ancestor
6574867|NCT01021930|Mitosis Modulators|mitosis modulators|mesh-ancestor
6574868|NCT01021930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574869|NCT01021930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6574870|NCT01021930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6574871|NCT01021930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6574872|NCT01021930|Antifungal Agents|antifungal agents|mesh-ancestor
6574873|NCT01021930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6574874|NCT01021930|Immunologic Factors|immunologic factors|mesh-ancestor
6574875|NCT01021930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574876|NCT01021943|Spironolactone|spironolactone|mesh-list
6574877|NCT01021943|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6574878|NCT01021943|Hormone Antagonists|hormone antagonists|mesh-ancestor
6574879|NCT01021943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6574880|NCT01021943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574881|NCT01021943|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6574882|NCT01021943|Diuretics|diuretics|mesh-ancestor
6446089|NCT00390793|Immunologic Factors|immunologic factors|mesh-ancestor
6446090|NCT00390793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446091|NCT00390793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6446092|NCT00390793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6446093|NCT00390793|Alkylating Agents|alkylating agents|mesh-ancestor
6446094|NCT00390793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446095|NCT00390793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6446096|NCT00390793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6446097|NCT00390793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6446098|NCT00390793|Antiemetics|antiemetics|mesh-ancestor
6574883|NCT01021943|Natriuretic Agents|natriuretic agents|mesh-ancestor
6574884|NCT01022021|Rituximab|rituximab|mesh-list
6574885|NCT01022021|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6574886|NCT01022021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6574887|NCT01022021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6446099|NCT00390793|Autonomic Agents|autonomic agents|mesh-ancestor
6446100|NCT00390793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6446101|NCT00390793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6446102|NCT00390793|Glucocorticoids|glucocorticoids|mesh-ancestor
6446103|NCT00390793|Hormones|hormones|mesh-ancestor
6446104|NCT00390793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6446105|NCT00390793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6020179|NCT00391872|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6020180|NCT00391872|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6020181|NCT00391872|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6020182|NCT00391872|Purinergic Agents|purinergic agents|mesh-ancestor
6020183|NCT00391872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6020184|NCT00391872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020185|NCT00391872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020186|NCT00391898|Levodopa|levodopa|mesh-list
6020187|NCT00391898|Carbidopa|carbidopa|mesh-list
6020188|NCT00391898|Entacapone|entacapone|mesh-list
6446106|NCT00390793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6574888|NCT01022021|Immunologic Factors|immunologic factors|mesh-ancestor
6574889|NCT01022021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574890|NCT01022021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6574891|NCT01022021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6574892|NCT01022021|Alkylating Agents|alkylating agents|mesh-ancestor
6574893|NCT01022021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574894|NCT01022047|Budesonide|budesonide|mesh-list
6574895|NCT01022047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6574896|NCT01022047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6574897|NCT01022047|Autonomic Agents|autonomic agents|mesh-ancestor
6574898|NCT01022047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6574899|NCT01022047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574900|NCT01022047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6574901|NCT01022047|Respiratory System Agents|respiratory system agents|mesh-ancestor
6574902|NCT01022047|Glucocorticoids|glucocorticoids|mesh-ancestor
6574903|NCT01022047|Hormones|hormones|mesh-ancestor
6574904|NCT01022047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6574905|NCT01022125|Simeprevir|simeprevir|mesh-list
6574906|NCT01022125|Antiviral Agents|antiviral agents|mesh-ancestor
6574907|NCT01022125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6574908|NCT01022125|Protease Inhibitors|protease inhibitors|mesh-ancestor
6574909|NCT01022125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6574910|NCT01022125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574911|NCT01022138|Cyclophosphamide|cyclophosphamide|mesh-list
6574912|NCT01022138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6574913|NCT01022138|Immunologic Factors|immunologic factors|mesh-ancestor
6574914|NCT01022138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574915|NCT01022138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6574916|NCT01022138|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6574917|NCT01022138|Alkylating Agents|alkylating agents|mesh-ancestor
6574918|NCT01022138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574919|NCT01022138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6574920|NCT01022138|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6574921|NCT01022151|Aminophylline|aminophylline|mesh-list
6574922|NCT01022151|Doxapram|doxapram|mesh-list
6446107|NCT00390793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6446108|NCT00390793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6446109|NCT00390793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6446110|NCT00390793|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6446111|NCT00390793|Abortifacient Agents|abortifacient agents|mesh-ancestor
6446112|NCT00390793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6446113|NCT00390793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6446114|NCT00390793|Antimetabolites|antimetabolites|mesh-ancestor
6446115|NCT00390793|Dermatologic Agents|dermatologic agents|mesh-ancestor
6446116|NCT00390793|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6446117|NCT00390793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6574923|NCT01022151|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6574924|NCT01022151|Autonomic Agents|autonomic agents|mesh-ancestor
6574925|NCT01022151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6574926|NCT01022151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574927|NCT01022151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6574928|NCT01022151|Respiratory System Agents|respiratory system agents|mesh-ancestor
6574929|NCT01022151|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6574930|NCT01022151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6574931|NCT01022151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6574932|NCT01022151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574933|NCT01022151|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6574934|NCT01022151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6574935|NCT01022151|Purinergic Agents|purinergic agents|mesh-ancestor
6574936|NCT01022151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6574937|NCT01022151|Protective Agents|protective agents|mesh-ancestor
6574938|NCT01022151|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6574939|NCT01022164|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6574940|NCT01022164|Hemostatics|hemostatics|mesh-ancestor
6574941|NCT01022164|Coagulants|coagulants|mesh-ancestor
6574942|NCT01022229|Vitamins|vitamins|mesh-list
6574943|NCT01022229|Vitamin B 6|vitamin b 6|mesh-list
6574944|NCT01022229|Micronutrients|micronutrients|mesh-ancestor
6574945|NCT01022229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574946|NCT01022229|Vitamin B Complex|vitamin b complex|mesh-ancestor
6574947|NCT01022333|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
6574948|NCT01022333|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6574949|NCT01022333|Protective Agents|protective agents|mesh-ancestor
6574950|NCT01022333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574951|NCT01022333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6574952|NCT01022463|Atenolol|atenolol|mesh-list
6574953|NCT01022463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6574954|NCT01022463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6574955|NCT01022463|Sympatholytics|sympatholytics|mesh-ancestor
6574956|NCT01022463|Autonomic Agents|autonomic agents|mesh-ancestor
6574957|NCT01022463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6574958|NCT01022463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574959|NCT01022463|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6574960|NCT01022463|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6574961|NCT01022463|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6574962|NCT01022463|Adrenergic Agents|adrenergic agents|mesh-ancestor
6574963|NCT01022463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6574964|NCT01022463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574965|NCT01022476|Raltegravir Potassium|raltegravir potassium|mesh-list
6574966|NCT01022476|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6574967|NCT01022476|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6574968|NCT01022476|Antiviral Agents|antiviral agents|mesh-ancestor
6574969|NCT01022476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6574970|NCT01022476|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6574971|NCT01022476|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6574972|NCT01022476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6574973|NCT01022476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657987|NCT01478737|Hormones|hormones|mesh-ancestor
6657988|NCT01478737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6657989|NCT01478737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6657990|NCT01478737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6657991|NCT01478737|Protease Inhibitors|protease inhibitors|mesh-ancestor
6657992|NCT01478737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6657993|NCT01478737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6657994|NCT01478997|Acetaminophen|acetaminophen|mesh-list
6657995|NCT01478997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6657996|NCT01478997|Analgesics|analgesics|mesh-ancestor
6657997|NCT01478997|Sensory System Agents|sensory system agents|mesh-ancestor
6657998|NCT01478997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6657999|NCT01478997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658000|NCT01478997|Antipyretics|antipyretics|mesh-ancestor
6658001|NCT01479023|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6658002|NCT01479023|Immunologic Factors|immunologic factors|mesh-ancestor
6658003|NCT01479023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658004|NCT01479036|Docetaxel|docetaxel|mesh-list
6658005|NCT01479036|Epirubicin|epirubicin|mesh-list
6658006|NCT01479036|Endostatins|endostatins|mesh-list
6658007|NCT01479036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6658008|NCT01479036|Tubulin Modulators|tubulin modulators|mesh-ancestor
6658009|NCT01479036|Antimitotic Agents|antimitotic agents|mesh-ancestor
6658010|NCT01479036|Mitosis Modulators|mitosis modulators|mesh-ancestor
6664775|NCT01514019|Acebutolol|acebutolol|mesh-list
5501451|NCT04474093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5501452|NCT04474093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501453|NCT04474093|Adrenergic Agents|adrenergic agents|mesh-ancestor
5501454|NCT04474093|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5501455|NCT04474093|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5501456|NCT04474093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5501457|NCT04474093|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5501458|NCT04474093|Antidepressive Agents|antidepressive agents|mesh-ancestor
5501459|NCT04474093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5501460|NCT04474093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5501461|NCT04474093|Antimanic Agents|antimanic agents|mesh-ancestor
5501462|NCT04474093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5501463|NCT04474093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5501464|NCT04473989|Teriparatide|teriparatide|mesh-list
5501465|NCT04473989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5501466|NCT04473989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501467|NCT04473989|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6020189|NCT00391898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6020190|NCT00391898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6446118|NCT00390793|Antiviral Agents|antiviral agents|mesh-ancestor
6446119|NCT00390793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6446120|NCT00390793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6446121|NCT00390793|Tubulin Modulators|tubulin modulators|mesh-ancestor
6446122|NCT00390793|Antimitotic Agents|antimitotic agents|mesh-ancestor
6446123|NCT00390793|Mitosis Modulators|mitosis modulators|mesh-ancestor
6020191|NCT00391898|Dopamine Agents|dopamine agents|mesh-ancestor
6020192|NCT00391898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6446124|NCT00390793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5501468|NCT04473911|Mycophenolic Acid|mycophenolic acid|mesh-list
5501469|NCT04473911|Sirolimus|sirolimus|mesh-list
5501470|NCT04473911|Cyclophosphamide|cyclophosphamide|mesh-list
5501471|NCT04473911|Melphalan|melphalan|mesh-list
5501472|NCT04473911|Fludarabine|fludarabine|mesh-list
5501473|NCT04473911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6574974|NCT01022528|Dexamethasone|dexamethasone|mesh-list
6574975|NCT01022528|Dexamethasone acetate|dexamethasone acetate|mesh-list
6574976|NCT01022528|BB 1101|bb 1101|mesh-list
6574977|NCT01022528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6574978|NCT01022528|Antiemetics|antiemetics|mesh-ancestor
6574979|NCT01022528|Autonomic Agents|autonomic agents|mesh-ancestor
6574980|NCT01022528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6574981|NCT01022528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6574982|NCT01022528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6574983|NCT01022528|Glucocorticoids|glucocorticoids|mesh-ancestor
6574984|NCT01022528|Hormones|hormones|mesh-ancestor
6574985|NCT01022528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6574986|NCT01022528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6574987|NCT01022528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6574988|NCT01022528|Protease Inhibitors|protease inhibitors|mesh-ancestor
6574989|NCT01022528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6574990|NCT01022528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6574991|NCT01022541|Bevacizumab|bevacizumab|mesh-list
6574992|NCT01022541|Capecitabine|capecitabine|mesh-list
6574993|NCT01022541|Oxaliplatin|oxaliplatin|mesh-list
6574994|NCT01022541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6574995|NCT01022541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6574996|NCT01022541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6574997|NCT01022541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6574998|NCT01022541|Growth Substances|growth substances|mesh-ancestor
6574999|NCT01022541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501474|NCT04473911|Immunologic Factors|immunologic factors|mesh-ancestor
6446125|NCT00390793|Protease Inhibitors|protease inhibitors|mesh-ancestor
6446126|NCT00390832|Epoetin Alfa|epoetin alfa|mesh-list
6446127|NCT00390832|Hematinics|hematinics|mesh-ancestor
6446128|NCT00390871|Fentanyl|fentanyl|mesh-list
6446129|NCT00390871|Dexmedetomidine|dexmedetomidine|mesh-list
6446130|NCT00390871|Propofol|propofol|mesh-list
6446131|NCT00390871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6446132|NCT00390871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6446133|NCT00390871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446134|NCT00390871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6446135|NCT00390871|Anesthetics, General|anesthetics, general|mesh-ancestor
6446136|NCT00390871|Anesthetics|anesthetics|mesh-ancestor
6446137|NCT00390871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6575000|NCT01022541|Growth Inhibitors|growth inhibitors|mesh-ancestor
6575001|NCT01022541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6575002|NCT01022541|Antimetabolites|antimetabolites|mesh-ancestor
6575003|NCT01022541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575004|NCT01022632|Curcumin|curcumin|mesh-list
6575005|NCT01022632|Fluoxetine|fluoxetine|mesh-list
6575006|NCT01022632|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6575007|NCT01022632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6575008|NCT01022632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6575009|NCT01022632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575010|NCT01022632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6575011|NCT01022632|Serotonin Agents|serotonin agents|mesh-ancestor
6575012|NCT01022632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575013|NCT01022632|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6575014|NCT01022632|Antidepressive Agents|antidepressive agents|mesh-ancestor
6575015|NCT01022632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6575016|NCT01022632|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6575017|NCT01022632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6575018|NCT01022632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6575019|NCT01022632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6575020|NCT01022632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6575021|NCT01022632|Analgesics|analgesics|mesh-ancestor
6575022|NCT01022632|Sensory System Agents|sensory system agents|mesh-ancestor
6575023|NCT01022632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6575024|NCT01022632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6575025|NCT01022632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6575026|NCT01022632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6575027|NCT01022645|Copper|copper|mesh-list
6575028|NCT01022645|Levonorgestrel|levonorgestrel|mesh-list
6575029|NCT01022645|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6575030|NCT01022645|Contraceptive Agents|contraceptive agents|mesh-ancestor
6575031|NCT01022645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6575032|NCT01022645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575033|NCT01022645|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6575034|NCT01022645|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6575035|NCT01022645|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6575036|NCT01022645|Trace Elements|trace elements|mesh-ancestor
6575037|NCT01022645|Micronutrients|micronutrients|mesh-ancestor
6575038|NCT01022658|Insulin|insulin|mesh-list
6575039|NCT01022658|Insulin Detemir|insulin detemir|mesh-list
6575040|NCT01022658|Insulin Aspart|insulin aspart|mesh-list
6575041|NCT01022658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6575042|NCT01022658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575043|NCT01022671|Belotecan|belotecan|mesh-list
6575044|NCT01022671|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6575045|NCT01022671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6575046|NCT01022671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6575047|NCT01022671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575048|NCT01022671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6575049|NCT01022736|Gabapentin|gabapentin|mesh-list
6575050|NCT01022736|Analgesics|analgesics|mesh-ancestor
6575051|NCT01022736|Sensory System Agents|sensory system agents|mesh-ancestor
6575052|NCT01022736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6575053|NCT01022736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575054|NCT01022736|Anticonvulsants|anticonvulsants|mesh-ancestor
6575055|NCT01022736|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6575056|NCT01022736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6575057|NCT01022736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6575058|NCT01022736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6575059|NCT01022736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6575060|NCT01022736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6575061|NCT01022736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6575062|NCT01022736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575063|NCT01022736|Antimanic Agents|antimanic agents|mesh-ancestor
6575064|NCT01022749|Vaccines|vaccines|mesh-list
6575065|NCT01022749|Immunologic Factors|immunologic factors|mesh-ancestor
6575066|NCT01022749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575067|NCT01022840|Ketamine|ketamine|mesh-list
6575068|NCT01022840|Esketamine|esketamine|mesh-list
6575069|NCT01022840|Analgesics|analgesics|mesh-ancestor
6575070|NCT01022840|Sensory System Agents|sensory system agents|mesh-ancestor
6575071|NCT01022840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6575072|NCT01022840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575073|NCT01022840|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6575074|NCT01022840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6575075|NCT01022840|Anesthetics, General|anesthetics, general|mesh-ancestor
6575076|NCT01022840|Anesthetics|anesthetics|mesh-ancestor
6575077|NCT01022840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6575078|NCT01022840|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6575079|NCT01022840|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6575080|NCT01022840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6575081|NCT01022840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575082|NCT01022840|Antidepressive Agents|antidepressive agents|mesh-ancestor
6575083|NCT01022840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6575084|NCT01022918|Bevacizumab|bevacizumab|mesh-list
6575085|NCT01022918|Temozolomide|temozolomide|mesh-list
6575086|NCT01022918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6575087|NCT01022918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6575088|NCT01022918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6575089|NCT01022918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6575090|NCT01022918|Growth Substances|growth substances|mesh-ancestor
6575091|NCT01022918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575092|NCT01022918|Growth Inhibitors|growth inhibitors|mesh-ancestor
6575093|NCT01022918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6575094|NCT01022918|Alkylating Agents|alkylating agents|mesh-ancestor
6575095|NCT01022918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575096|NCT01022983|Simendan|simendan|mesh-list
6575097|NCT01022983|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6575098|NCT01022983|Vasodilator Agents|vasodilator agents|mesh-ancestor
6575099|NCT01022983|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6575100|NCT01022983|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6575101|NCT01022983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6575102|NCT01022983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575103|NCT01022983|Protective Agents|protective agents|mesh-ancestor
6575104|NCT01022983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575105|NCT01023087|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6575106|NCT01023087|Colistin|colistin|mesh-list
6575107|NCT01023087|Polymyxins|polymyxins|mesh-list
6575108|NCT01023087|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6575109|NCT01023087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6575110|NCT01023087|Antitubercular Agents|antitubercular agents|mesh-ancestor
6575111|NCT01023100|Tofacitinib|tofacitinib|mesh-list
6575112|NCT01023100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6575113|NCT01023100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6575114|NCT01023100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575115|NCT01023139|Sibutramine|sibutramine|mesh-list
6575116|NCT01023139|Antidepressive Agents|antidepressive agents|mesh-ancestor
6575117|NCT01023139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6575118|NCT01023139|Appetite Depressants|appetite depressants|mesh-ancestor
6575119|NCT01023139|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6575120|NCT01023165|Insulin Lispro|insulin lispro|mesh-list
6575121|NCT01023165|Insulin Aspart|insulin aspart|mesh-list
6575122|NCT01023165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6575123|NCT01023165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575124|NCT01023230|Entecavir|entecavir|mesh-list
6575125|NCT01023230|Antiviral Agents|antiviral agents|mesh-ancestor
6575126|NCT01023230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6575127|NCT01023243|Aspirin|aspirin|mesh-list
6575128|NCT01023243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6575129|NCT01023243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6575130|NCT01023243|Analgesics|analgesics|mesh-ancestor
6575131|NCT01023243|Sensory System Agents|sensory system agents|mesh-ancestor
6575132|NCT01023243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6054328|NCT00602459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6575133|NCT01023243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575134|NCT01023243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6575135|NCT01023243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6575136|NCT01023243|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6575137|NCT01023243|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6575138|NCT01023243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575139|NCT01023243|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6575140|NCT01023243|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6575141|NCT01023243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6575142|NCT01023243|Antipyretics|antipyretics|mesh-ancestor
6575143|NCT01023334|Lidocaine|lidocaine|mesh-list
6575144|NCT01023334|Anesthetics|anesthetics|mesh-list
6575145|NCT01023334|Anesthetics, Local|anesthetics, local|mesh-ancestor
6575146|NCT01023334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6575147|NCT01023334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575148|NCT01023334|Sensory System Agents|sensory system agents|mesh-ancestor
6575149|NCT01023334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6575150|NCT01023334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6575151|NCT01023334|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6575152|NCT01023334|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6575153|NCT01023334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6575154|NCT01023334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575155|NCT01023347|Paclitaxel|paclitaxel|mesh-list
6575156|NCT01023347|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6575157|NCT01023347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6575158|NCT01023347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6575159|NCT01023347|Tubulin Modulators|tubulin modulators|mesh-ancestor
6575160|NCT01023347|Antimitotic Agents|antimitotic agents|mesh-ancestor
6575161|NCT01023347|Mitosis Modulators|mitosis modulators|mesh-ancestor
6575162|NCT01023347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575163|NCT01023360|Esomeprazole|esomeprazole|mesh-list
6575164|NCT01023360|Rabeprazole|rabeprazole|mesh-list
6575165|NCT01023360|Pantoprazole|pantoprazole|mesh-list
6575166|NCT01023360|Clopidogrel|clopidogrel|mesh-list
6575167|NCT01023360|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
6575168|NCT01023360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6575169|NCT01023360|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6575170|NCT01023360|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6575171|NCT01023360|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6575172|NCT01023360|Purinergic Agents|purinergic agents|mesh-ancestor
6575173|NCT01023360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6575174|NCT01023360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575175|NCT01023360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575176|NCT01023360|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6575177|NCT01023360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6575178|NCT01023360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6575179|NCT01023399|Artesunate|artesunate|mesh-list
6575180|NCT01023399|Amodiaquine|amodiaquine|mesh-list
6575181|NCT01023399|Antimalarials|antimalarials|mesh-ancestor
6575182|NCT01023399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6575183|NCT01023399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6575184|NCT01023399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6575185|NCT01023399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6575186|NCT01023399|Antiviral Agents|antiviral agents|mesh-ancestor
6575187|NCT01023399|Schistosomicides|schistosomicides|mesh-ancestor
6575188|NCT01023399|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6575189|NCT01023399|Anthelmintics|anthelmintics|mesh-ancestor
6575190|NCT01023425|Donepezil|donepezil|mesh-list
6575191|NCT01023425|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6575192|NCT01023425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6575193|NCT01023425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575194|NCT01023425|Cholinergic Agents|cholinergic agents|mesh-ancestor
6575195|NCT01023425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6575196|NCT01023425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575197|NCT01023425|Nootropic Agents|nootropic agents|mesh-ancestor
6575198|NCT01023464|Emollients|emollients|mesh-list
6575199|NCT01023464|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6575200|NCT01023464|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6575201|NCT01023464|Dermatologic Agents|dermatologic agents|mesh-ancestor
6575202|NCT01023490|Vitamin D|vitamin d|mesh-list
6575203|NCT01023490|Vitamins|vitamins|mesh-ancestor
6575204|NCT01023490|Micronutrients|micronutrients|mesh-ancestor
6575205|NCT01023490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575206|NCT01023490|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6575207|NCT01023542|Everolimus|everolimus|mesh-list
6575208|NCT01023542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6575209|NCT01023542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6575210|NCT01023542|Immunologic Factors|immunologic factors|mesh-ancestor
6575211|NCT01023542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575212|NCT01023607|Atorvastatin|atorvastatin|mesh-list
6575213|NCT01023607|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6575214|NCT01023607|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6575215|NCT01023607|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6575216|NCT01023607|Antimetabolites|antimetabolites|mesh-ancestor
6575217|NCT01023607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575218|NCT01023607|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6575219|NCT01023607|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6575220|NCT01023607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6575221|NCT01023633|Oxaliplatin|oxaliplatin|mesh-list
6575222|NCT01023633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6575223|NCT01023750|Fenofibrate|fenofibrate|mesh-list
6575224|NCT01023750|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6575225|NCT01023750|Antimetabolites|antimetabolites|mesh-ancestor
6575226|NCT01023750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575227|NCT01023750|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6575228|NCT01023867|Donepezil|donepezil|mesh-list
6575229|NCT01023867|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6575230|NCT01023867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6575231|NCT01023867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575232|NCT01023867|Cholinergic Agents|cholinergic agents|mesh-ancestor
6575233|NCT01023867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6575234|NCT01023867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575235|NCT01023867|Nootropic Agents|nootropic agents|mesh-ancestor
6575236|NCT01023919|Sirolimus|sirolimus|mesh-list
6575237|NCT01023919|Paclitaxel|paclitaxel|mesh-list
6575238|NCT01023919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6575239|NCT01023919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6575240|NCT01023919|Tubulin Modulators|tubulin modulators|mesh-ancestor
6575241|NCT01023919|Antimitotic Agents|antimitotic agents|mesh-ancestor
6575242|NCT01023919|Mitosis Modulators|mitosis modulators|mesh-ancestor
6575243|NCT01023919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575244|NCT01023919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6575245|NCT01023919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6575246|NCT01023919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6575247|NCT01023919|Antifungal Agents|antifungal agents|mesh-ancestor
6575248|NCT01023919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6575249|NCT01023919|Immunologic Factors|immunologic factors|mesh-ancestor
6575250|NCT01023919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575251|NCT01023945|Ipragliflozin|ipragliflozin|mesh-list
6575252|NCT01023945|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6575253|NCT01023945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575254|NCT01023945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6575255|NCT01023945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575256|NCT01024075|Dexamethasone|dexamethasone|mesh-list
6575257|NCT01024075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6575258|NCT01024075|Antiemetics|antiemetics|mesh-ancestor
6575259|NCT01024075|Autonomic Agents|autonomic agents|mesh-ancestor
6575260|NCT01024075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6575261|NCT01024075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575262|NCT01024075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6575263|NCT01024075|Glucocorticoids|glucocorticoids|mesh-ancestor
6575264|NCT01024075|Hormones|hormones|mesh-ancestor
6575265|NCT01024075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6575266|NCT01024075|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6575267|NCT01024075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6575268|NCT01024140|Citalopram|citalopram|mesh-list
6575269|NCT01024140|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6575270|NCT01024140|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6575271|NCT01024140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6575272|NCT01024140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575273|NCT01024140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6575274|NCT01024140|Serotonin Agents|serotonin agents|mesh-ancestor
6575275|NCT01024140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575276|NCT01024140|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6575277|NCT01024140|Antidepressive Agents|antidepressive agents|mesh-ancestor
6575278|NCT01024140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6575279|NCT01024179|Sirolimus|sirolimus|mesh-list
6575280|NCT01024179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6575281|NCT01024179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6575282|NCT01024179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6575283|NCT01024179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6575284|NCT01024179|Antifungal Agents|antifungal agents|mesh-ancestor
6575285|NCT01024179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6575286|NCT01024179|Immunologic Factors|immunologic factors|mesh-ancestor
6575287|NCT01024179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575288|NCT01024192|Zolpidem|zolpidem|mesh-list
6575289|NCT01024192|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6575290|NCT01024192|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6575291|NCT01024192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6575292|NCT01024192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575293|NCT01024192|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6575294|NCT01024192|GABA Agonists|gaba agonists|mesh-ancestor
6575295|NCT01024192|GABA Agents|gaba agents|mesh-ancestor
6575296|NCT01024192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6575297|NCT01024192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575298|NCT01024205|Sunitinib|sunitinib|mesh-list
6575299|NCT01024205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6575300|NCT01024205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6575301|NCT01024205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6575302|NCT01024205|Growth Substances|growth substances|mesh-ancestor
6575303|NCT01024205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575304|NCT01024205|Growth Inhibitors|growth inhibitors|mesh-ancestor
6575305|NCT01024205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6575306|NCT01024205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6575307|NCT01024205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575308|NCT01024270|Misoprostol|misoprostol|mesh-list
6575309|NCT01024270|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6575310|NCT01024270|Abortifacient Agents|abortifacient agents|mesh-ancestor
6575311|NCT01024270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6575312|NCT01024270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575313|NCT01024270|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6575314|NCT01024270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6575315|NCT01024270|Oxytocics|oxytocics|mesh-ancestor
6575316|NCT01024322|Diclofenac|diclofenac|mesh-list
6575317|NCT01024322|Prednisolone acetate|prednisolone acetate|mesh-list
6575318|NCT01024322|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6575319|NCT01024322|Methylprednisolone|methylprednisolone|mesh-list
6575320|NCT01024322|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6575321|NCT01024322|Prednisolone|prednisolone|mesh-list
6575322|NCT01024322|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6575323|NCT01024322|Prednisolone phosphate|prednisolone phosphate|mesh-list
6575324|NCT01024322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6575325|NCT01024322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6575326|NCT01024322|Analgesics|analgesics|mesh-ancestor
6575327|NCT01024322|Sensory System Agents|sensory system agents|mesh-ancestor
6575328|NCT01024322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6575329|NCT01024322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575330|NCT01024322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6575331|NCT01024322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6575332|NCT01024322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6575333|NCT01024322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6575334|NCT01024322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575335|NCT01024322|Antiemetics|antiemetics|mesh-ancestor
6575336|NCT01024322|Autonomic Agents|autonomic agents|mesh-ancestor
6575337|NCT01024322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6575338|NCT01024322|Glucocorticoids|glucocorticoids|mesh-ancestor
6575339|NCT01024322|Hormones|hormones|mesh-ancestor
6575340|NCT01024322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6575341|NCT01024322|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6575342|NCT01024322|Protective Agents|protective agents|mesh-ancestor
6575343|NCT01024322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6575344|NCT01024322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6446138|NCT00390871|Analgesics|analgesics|mesh-ancestor
6446139|NCT00390871|Sensory System Agents|sensory system agents|mesh-ancestor
6446140|NCT00390871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6446141|NCT00390871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6446142|NCT00390871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6446143|NCT00390871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6446144|NCT00390871|Adrenergic Agents|adrenergic agents|mesh-ancestor
6446145|NCT00390871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6575345|NCT01024348|Acetaminophen|acetaminophen|mesh-list
6575346|NCT01024348|Tramadol|tramadol|mesh-list
6575347|NCT01024348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6575348|NCT01024348|Analgesics|analgesics|mesh-ancestor
6575349|NCT01024348|Sensory System Agents|sensory system agents|mesh-ancestor
6575350|NCT01024348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6575351|NCT01024348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575352|NCT01024348|Antipyretics|antipyretics|mesh-ancestor
6575353|NCT01024348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6575354|NCT01024348|Narcotics|narcotics|mesh-ancestor
6575355|NCT01024348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6658011|NCT01479036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658012|NCT01479036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6658013|NCT01479036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6658014|NCT01479036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6658015|NCT01479036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6658016|NCT01479036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6658017|NCT01479036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6658018|NCT01479036|Growth Substances|growth substances|mesh-ancestor
6658019|NCT01479036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658020|NCT01479036|Growth Inhibitors|growth inhibitors|mesh-ancestor
6658021|NCT01479075|Insulin|insulin|mesh-list
6658022|NCT01479075|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6658023|NCT01479075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6658024|NCT01479075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658025|NCT01479088|Cinacalcet|cinacalcet|mesh-list
6658026|NCT01479088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6658027|NCT01479088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658028|NCT01479088|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6658029|NCT01479088|Hormone Antagonists|hormone antagonists|mesh-ancestor
6658030|NCT01479088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6658031|NCT01479114|Sargramostim|sargramostim|mesh-list
6658032|NCT01479114|Lenograstim|lenograstim|mesh-list
6658033|NCT01479114|Immunologic Factors|immunologic factors|mesh-ancestor
6658034|NCT01479114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658035|NCT01479114|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6658036|NCT01479179|Trastuzumab|trastuzumab|mesh-list
6658037|NCT01479179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6658038|NCT01479179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6658039|NCT01479192|Fenretinide|fenretinide|mesh-list
6658040|NCT01479192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6658041|NCT01479192|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6658042|NCT01479192|Protective Agents|protective agents|mesh-ancestor
6658043|NCT01479192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658044|NCT01479231|Dexlansoprazole|dexlansoprazole|mesh-list
6658045|NCT01479231|Lansoprazole|lansoprazole|mesh-list
6658046|NCT01479231|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6658047|NCT01479231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6658048|NCT01479231|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6658049|NCT01479231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6658050|NCT01479231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658051|NCT01479244|Molgramostim|molgramostim|mesh-list
6658052|NCT01479244|Sargramostim|sargramostim|mesh-list
6658053|NCT01479244|Immunologic Factors|immunologic factors|mesh-ancestor
6658054|NCT01479244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658055|NCT01479244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6658056|NCT01479283|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6658057|NCT01479283|Cefazolin|cefazolin|mesh-list
6658058|NCT01479283|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6658059|NCT01479283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6658060|NCT01479283|Antitubercular Agents|antitubercular agents|mesh-ancestor
6658061|NCT01479296|Vaccines|vaccines|mesh-list
6658062|NCT01479296|Immunologic Factors|immunologic factors|mesh-ancestor
6658063|NCT01479296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658064|NCT01479361|Atovaquone|atovaquone|mesh-list
6658065|NCT01479361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6658066|NCT01479361|Antimalarials|antimalarials|mesh-ancestor
6658067|NCT01479361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6658068|NCT01479361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6658069|NCT01479361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6658070|NCT01479361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658071|NCT01479504|Cisplatin|cisplatin|mesh-list
6658072|NCT01479504|Docetaxel|docetaxel|mesh-list
6658073|NCT01479504|Nedaplatin|nedaplatin|mesh-list
6575356|NCT01024413|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6575357|NCT01024413|Gefitinib|gefitinib|mesh-list
6575358|NCT01024413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6575359|NCT01024413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6575360|NCT01024413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6575361|NCT01024413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575362|NCT01024491|Paroxetine|paroxetine|mesh-list
6575363|NCT01024491|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6575364|NCT01024491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6575365|NCT01024491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6575366|NCT01024491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575367|NCT01024491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6575368|NCT01024491|Serotonin Agents|serotonin agents|mesh-ancestor
6575369|NCT01024491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575370|NCT01024491|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6575371|NCT01024491|Antidepressive Agents|antidepressive agents|mesh-ancestor
6575372|NCT01024491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6575373|NCT01024491|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6575374|NCT01024491|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6575375|NCT01024491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6575376|NCT01024504|Bevacizumab|bevacizumab|mesh-list
6575377|NCT01024504|Capecitabine|capecitabine|mesh-list
6575378|NCT01024504|Oxaliplatin|oxaliplatin|mesh-list
6575379|NCT01024504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6575380|NCT01024504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6575381|NCT01024504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6575382|NCT01024504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6575383|NCT01024504|Growth Substances|growth substances|mesh-ancestor
6575384|NCT01024504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575385|NCT01024504|Growth Inhibitors|growth inhibitors|mesh-ancestor
6575386|NCT01024504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6575387|NCT01024504|Antimetabolites|antimetabolites|mesh-ancestor
6575388|NCT01024504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575389|NCT01024543|Phenylephrine|phenylephrine|mesh-list
6575390|NCT01024543|Oxymetazoline|oxymetazoline|mesh-list
6575391|NCT01024543|Angiotensin II|angiotensin ii|mesh-list
6575392|NCT01024543|Giapreza|giapreza|mesh-list
6575393|NCT01024543|Angiotensinogen|angiotensinogen|mesh-list
6575394|NCT01024543|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6575395|NCT01024543|Mydriatics|mydriatics|mesh-ancestor
6575396|NCT01024543|Autonomic Agents|autonomic agents|mesh-ancestor
6575397|NCT01024543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6575398|NCT01024543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575399|NCT01024543|Sympathomimetics|sympathomimetics|mesh-ancestor
6575400|NCT01024543|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6575401|NCT01024543|Nasal Decongestants|nasal decongestants|mesh-ancestor
6575402|NCT01024543|Respiratory System Agents|respiratory system agents|mesh-ancestor
6575403|NCT01024543|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6575404|NCT01024543|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6575405|NCT01024543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6575406|NCT01024543|Adrenergic Agents|adrenergic agents|mesh-ancestor
6575407|NCT01024543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6575408|NCT01024543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575409|NCT01024543|Protective Agents|protective agents|mesh-ancestor
6575410|NCT01024543|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6575411|NCT01024543|Protease Inhibitors|protease inhibitors|mesh-ancestor
6575412|NCT01024543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6575413|NCT01024647|Certolizumab Pegol|certolizumab pegol|mesh-list
6575414|NCT01024647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6575415|NCT01024647|Immunologic Factors|immunologic factors|mesh-ancestor
6575416|NCT01024647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575417|NCT01024647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6575418|NCT01024660|Donepezil|donepezil|mesh-list
6575419|NCT01024660|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6575420|NCT01024660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6575421|NCT01024660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575422|NCT01024660|Cholinergic Agents|cholinergic agents|mesh-ancestor
6575423|NCT01024660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6575424|NCT01024660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575425|NCT01024660|Nootropic Agents|nootropic agents|mesh-ancestor
6575426|NCT01024712|Paclitaxel|paclitaxel|mesh-list
6575427|NCT01024712|Carboplatin|carboplatin|mesh-list
6575428|NCT01024712|Gefitinib|gefitinib|mesh-list
6575429|NCT01024712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6575430|NCT01024712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6575431|NCT01024712|Tubulin Modulators|tubulin modulators|mesh-ancestor
6575432|NCT01024712|Antimitotic Agents|antimitotic agents|mesh-ancestor
6575433|NCT01024712|Mitosis Modulators|mitosis modulators|mesh-ancestor
6575434|NCT01024712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575435|NCT01024712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6575436|NCT01024712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6575437|NCT01024777|Vitamin D|vitamin d|mesh-list
6575438|NCT01024777|Ergocalciferols|ergocalciferols|mesh-list
6575439|NCT01024777|Cholecalciferol|cholecalciferol|mesh-list
6575440|NCT01024777|Vitamins|vitamins|mesh-list
6575441|NCT01024777|Micronutrients|micronutrients|mesh-ancestor
6575442|NCT01024777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575443|NCT01024777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6575444|NCT01024777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6575445|NCT01024868|Ropivacaine|ropivacaine|mesh-list
6575446|NCT01024868|Anesthetics, Local|anesthetics, local|mesh-ancestor
6575447|NCT01024868|Anesthetics|anesthetics|mesh-ancestor
6575448|NCT01024868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6575449|NCT01024868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575450|NCT01024868|Sensory System Agents|sensory system agents|mesh-ancestor
6575451|NCT01024868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6575452|NCT01025089|Cyclophosphamide|cyclophosphamide|mesh-list
6575453|NCT01025089|Doxorubicin|doxorubicin|mesh-list
6575454|NCT01025089|Cetuximab|cetuximab|mesh-list
6575455|NCT01025089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6575456|NCT01025089|Immunologic Factors|immunologic factors|mesh-ancestor
6575457|NCT01025089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575458|NCT01025089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6575459|NCT01025089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6575460|NCT01025089|Alkylating Agents|alkylating agents|mesh-ancestor
6575461|NCT01025089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575462|NCT01025089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6575463|NCT01025089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6575464|NCT01025089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6575465|NCT01025089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6575466|NCT01025089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6575467|NCT01025089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6575468|NCT01025089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6575469|NCT01025102|Sufentanil|sufentanil|mesh-list
6575470|NCT01025102|Ropivacaine|ropivacaine|mesh-list
6575471|NCT01025102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6575472|NCT01025102|Narcotics|narcotics|mesh-ancestor
6575473|NCT01025102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6575474|NCT01025102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575475|NCT01025102|Analgesics|analgesics|mesh-ancestor
6575476|NCT01025102|Sensory System Agents|sensory system agents|mesh-ancestor
6575477|NCT01025102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6575478|NCT01025102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6575479|NCT01025102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6575480|NCT01025102|Anesthetics, General|anesthetics, general|mesh-ancestor
6575481|NCT01025102|Anesthetics|anesthetics|mesh-ancestor
6575482|NCT01025102|Anesthetics, Local|anesthetics, local|mesh-ancestor
6575483|NCT01025128|Vitamin D|vitamin d|mesh-list
6575484|NCT01025128|Vitamins|vitamins|mesh-ancestor
6575485|NCT01025128|Micronutrients|micronutrients|mesh-ancestor
6575486|NCT01025128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575487|NCT01025128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6575488|NCT01025245|Remifentanil|remifentanil|mesh-list
6575489|NCT01025245|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6575490|NCT01025245|Narcotics|narcotics|mesh-ancestor
6575491|NCT01025245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6575492|NCT01025245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575493|NCT01025245|Analgesics|analgesics|mesh-ancestor
6575494|NCT01025245|Sensory System Agents|sensory system agents|mesh-ancestor
6575495|NCT01025245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6575496|NCT01025349|Bevacizumab|bevacizumab|mesh-list
6575497|NCT01025349|Docetaxel|docetaxel|mesh-list
6575498|NCT01025349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6575499|NCT01025349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6575500|NCT01025349|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6575501|NCT01025349|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6575502|NCT01025349|Growth Substances|growth substances|mesh-ancestor
6575503|NCT01025349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575504|NCT01025349|Growth Inhibitors|growth inhibitors|mesh-ancestor
6575505|NCT01025349|Tubulin Modulators|tubulin modulators|mesh-ancestor
6575506|NCT01025349|Antimitotic Agents|antimitotic agents|mesh-ancestor
6575507|NCT01025349|Mitosis Modulators|mitosis modulators|mesh-ancestor
6575508|NCT01025349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575509|NCT01025466|Memantine|memantine|mesh-list
6575510|NCT01025466|Rivastigmine|rivastigmine|mesh-list
6575511|NCT01025466|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6575512|NCT01025466|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6575513|NCT01025466|Dopamine Agents|dopamine agents|mesh-ancestor
6575514|NCT01025466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6575515|NCT01025466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575516|NCT01025466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575517|NCT01025466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6575518|NCT01025466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6575519|NCT01025466|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6575520|NCT01025466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6575521|NCT01025466|Cholinergic Agents|cholinergic agents|mesh-ancestor
6575522|NCT01025466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6575523|NCT01025466|Protective Agents|protective agents|mesh-ancestor
6575524|NCT01025505|Imatinib Mesylate|imatinib mesylate|mesh-list
6575525|NCT01025505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6575526|NCT01025505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6575527|NCT01025505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6575528|NCT01025505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575529|NCT01025544|Vaccines|vaccines|mesh-list
6575530|NCT01025544|Immunologic Factors|immunologic factors|mesh-ancestor
6575531|NCT01025544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575532|NCT01025570|Gemcitabine|gemcitabine|mesh-list
6575533|NCT01025570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6575534|NCT01025570|Antimetabolites|antimetabolites|mesh-ancestor
6575535|NCT01025570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575536|NCT01025570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6575537|NCT01025570|Antiviral Agents|antiviral agents|mesh-ancestor
6575538|NCT01025570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6575539|NCT01025570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6575540|NCT01025570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6575541|NCT01025570|Immunologic Factors|immunologic factors|mesh-ancestor
6575542|NCT01025570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575543|NCT01025583|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6575544|NCT01025700|Nabilone|nabilone|mesh-list
6575545|NCT01025700|Antiemetics|antiemetics|mesh-ancestor
6575546|NCT01025700|Autonomic Agents|autonomic agents|mesh-ancestor
6575547|NCT01025700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6575548|NCT01025700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575549|NCT01025700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6575550|NCT01025700|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6575551|NCT01025700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6575552|NCT01025700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6575553|NCT01025700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6575554|NCT01025765|Metformin|metformin|mesh-list
6575555|NCT01025765|Pioglitazone|pioglitazone|mesh-list
6575556|NCT01025765|Acarbose|acarbose|mesh-list
6575557|NCT01025765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6575558|NCT01025765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575559|NCT01025765|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6575560|NCT01025765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6575561|NCT01025765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575562|NCT01025778|Cyclophosphamide|cyclophosphamide|mesh-list
6575563|NCT01025778|Thiotepa|thiotepa|mesh-list
6575564|NCT01025778|Etoposide|etoposide|mesh-list
6575565|NCT01025778|Clofarabine|clofarabine|mesh-list
6575566|NCT01025778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6575567|NCT01025778|Immunologic Factors|immunologic factors|mesh-ancestor
6575568|NCT01025778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575569|NCT01025778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6575570|NCT01025778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6575571|NCT01025778|Alkylating Agents|alkylating agents|mesh-ancestor
6575572|NCT01025778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575573|NCT01025778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6575574|NCT01025778|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6575575|NCT01025778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6575576|NCT01025778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6575577|NCT01025778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6575578|NCT01025778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6575579|NCT01025778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6575580|NCT01025778|Antimetabolites|antimetabolites|mesh-ancestor
6575581|NCT01025882|Gemcitabine|gemcitabine|mesh-list
6575582|NCT01025882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6575583|NCT01025882|Antimetabolites|antimetabolites|mesh-ancestor
6575584|NCT01025882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575585|NCT01025882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6575586|NCT01025882|Antiviral Agents|antiviral agents|mesh-ancestor
6575587|NCT01025882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6575588|NCT01025882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6575589|NCT01025882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6575590|NCT01025882|Immunologic Factors|immunologic factors|mesh-ancestor
6575591|NCT01025882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575592|NCT01025921|Colistin|colistin|mesh-list
6575593|NCT01025921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6575594|NCT01025921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6575595|NCT01025934|Bevacizumab|bevacizumab|mesh-list
6575596|NCT01025934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6575597|NCT01025934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6575598|NCT01025934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6575599|NCT01025934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6575600|NCT01025934|Growth Substances|growth substances|mesh-ancestor
6575601|NCT01025934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575602|NCT01025934|Growth Inhibitors|growth inhibitors|mesh-ancestor
6575603|NCT01026064|Azithromycin|azithromycin|mesh-list
6575604|NCT01026064|Cantharidin|cantharidin|mesh-list
6575605|NCT01026064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6575606|NCT01026064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6575607|NCT01026064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6575608|NCT01026064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575609|NCT01026090|Dronedarone|dronedarone|mesh-list
6575610|NCT01026090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6575611|NCT01026116|Paclitaxel|paclitaxel|mesh-list
6575612|NCT01026116|Cyclophosphamide|cyclophosphamide|mesh-list
6446146|NCT00390871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446147|NCT00390871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6446148|NCT00390871|Narcotics|narcotics|mesh-ancestor
6575613|NCT01026116|Epirubicin|epirubicin|mesh-list
6575614|NCT01026116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6575615|NCT01026116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6575616|NCT01026116|Tubulin Modulators|tubulin modulators|mesh-ancestor
6575617|NCT01026116|Antimitotic Agents|antimitotic agents|mesh-ancestor
6575618|NCT01026116|Mitosis Modulators|mitosis modulators|mesh-ancestor
6575619|NCT01026116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575620|NCT01026116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6575621|NCT01026116|Immunologic Factors|immunologic factors|mesh-ancestor
6575622|NCT01026116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575623|NCT01026116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6575624|NCT01026116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6575625|NCT01026116|Alkylating Agents|alkylating agents|mesh-ancestor
6575626|NCT01026116|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6575627|NCT01026116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6575628|NCT01026116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6575629|NCT01026116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6575630|NCT01026116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6575631|NCT01026129|Lidocaine|lidocaine|mesh-list
6575632|NCT01026129|Remifentanil|remifentanil|mesh-list
6575633|NCT01026129|Anesthetics, Local|anesthetics, local|mesh-ancestor
6575634|NCT01026129|Anesthetics|anesthetics|mesh-ancestor
6575635|NCT01026129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6575636|NCT01026129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575637|NCT01026129|Sensory System Agents|sensory system agents|mesh-ancestor
6575638|NCT01026129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6575639|NCT01026129|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6575640|NCT01026129|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6575641|NCT01026129|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6575642|NCT01026129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6575643|NCT01026129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575644|NCT01026129|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6575645|NCT01026129|Narcotics|narcotics|mesh-ancestor
6575646|NCT01026129|Analgesics|analgesics|mesh-ancestor
6575647|NCT01026233|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6575648|NCT01026233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6575649|NCT01026233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6658074|NCT01479504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6658075|NCT01479504|Tubulin Modulators|tubulin modulators|mesh-ancestor
6658076|NCT01479504|Antimitotic Agents|antimitotic agents|mesh-ancestor
6658077|NCT01479504|Mitosis Modulators|mitosis modulators|mesh-ancestor
6658078|NCT01479504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446149|NCT00390871|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6446150|NCT00390897|Interferons|interferons|mesh-list
6446151|NCT00390897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6446152|NCT00390897|Antiviral Agents|antiviral agents|mesh-ancestor
6446153|NCT00390897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6446154|NCT00390923|Selegiline|selegiline|mesh-list
6575650|NCT01026285|Risperidone|risperidone|mesh-list
6575651|NCT01026285|Antipsychotic Agents|antipsychotic agents|mesh-list
6575652|NCT01026285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6575653|NCT01026285|Serotonin Agents|serotonin agents|mesh-ancestor
6575654|NCT01026285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6575655|NCT01026285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575656|NCT01026285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575657|NCT01026285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6575658|NCT01026285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6575659|NCT01026285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6575660|NCT01026285|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6575661|NCT01026285|Dopamine Agents|dopamine agents|mesh-ancestor
6575662|NCT01026311|Ubiquinone|ubiquinone|mesh-list
6575663|NCT01026311|Coenzyme Q10|coenzyme q10|mesh-list
6575664|NCT01026311|Micronutrients|micronutrients|mesh-ancestor
6575665|NCT01026311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575666|NCT01026311|Vitamins|vitamins|mesh-ancestor
6575667|NCT01026337|Sunitinib|sunitinib|mesh-list
6575668|NCT01026337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6575669|NCT01026337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6575670|NCT01026337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6575671|NCT01026337|Growth Substances|growth substances|mesh-ancestor
6575672|NCT01026337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575673|NCT01026337|Growth Inhibitors|growth inhibitors|mesh-ancestor
6575674|NCT01026337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6575675|NCT01026337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6575676|NCT01026337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575677|NCT01026350|Antibodies|antibodies|mesh-list
6575678|NCT01026350|Immunologic Factors|immunologic factors|mesh-ancestor
6575679|NCT01026350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575680|NCT01026363|Vitamin D|vitamin d|mesh-list
6575681|NCT01026363|Ergocalciferols|ergocalciferols|mesh-list
6575682|NCT01026363|Calcitriol|calcitriol|mesh-list
6446155|NCT00390923|Nicotine|nicotine|mesh-list
6446156|NCT00390923|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6446157|NCT00390923|Autonomic Agents|autonomic agents|mesh-ancestor
6446158|NCT00390923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6446159|NCT00390923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446160|NCT00390923|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6446161|NCT00390923|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6446162|NCT00390923|Cholinergic Agents|cholinergic agents|mesh-ancestor
6446163|NCT00390923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6446164|NCT00390923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446165|NCT00390923|Antidepressive Agents|antidepressive agents|mesh-ancestor
6446166|NCT00390923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6446167|NCT00390923|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6446168|NCT00390923|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6446169|NCT00390923|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6446170|NCT00390923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6575683|NCT01026363|Vitamins|vitamins|mesh-list
6575684|NCT01026363|Micronutrients|micronutrients|mesh-ancestor
6575685|NCT01026363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575686|NCT01026363|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6575687|NCT01026363|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6575688|NCT01026363|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6575689|NCT01026363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6575690|NCT01026363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575691|NCT01026363|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6575692|NCT01026376|Decitabine|decitabine|mesh-list
6575693|NCT01026376|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6575694|NCT01026376|Antimetabolites|antimetabolites|mesh-ancestor
6575695|NCT01026376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575696|NCT01026376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6575697|NCT01026376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6575698|NCT01026415|Rifampin|rifampin|mesh-list
6575699|NCT01026415|Ketoconazole|ketoconazole|mesh-list
6575700|NCT01026415|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6575701|NCT01026415|Midazolam|midazolam|mesh-list
6575702|NCT01026415|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6575703|NCT01026415|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6575704|NCT01026415|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6575705|NCT01026415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6575706|NCT01026415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575707|NCT01026415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6575708|NCT01026415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6575709|NCT01026415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6575710|NCT01026415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6575711|NCT01026415|Anesthetics, General|anesthetics, general|mesh-ancestor
6575712|NCT01026415|Anesthetics|anesthetics|mesh-ancestor
6575713|NCT01026415|GABA Modulators|gaba modulators|mesh-ancestor
6575714|NCT01026415|GABA Agents|gaba agents|mesh-ancestor
6575715|NCT01026415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6575716|NCT01026415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575717|NCT01026415|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6575718|NCT01026415|Antitubercular Agents|antitubercular agents|mesh-ancestor
6575719|NCT01026415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6575720|NCT01026415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6575721|NCT01026415|Leprostatic Agents|leprostatic agents|mesh-ancestor
6575722|NCT01026415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6575723|NCT01026415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6575724|NCT01026415|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6575725|NCT01026415|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6575726|NCT01026415|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6575727|NCT01026415|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6575728|NCT01026415|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6575729|NCT01026415|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6575730|NCT01026415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6575731|NCT01026415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6575732|NCT01026415|Immunologic Factors|immunologic factors|mesh-ancestor
6575733|NCT01026415|Antifungal Agents|antifungal agents|mesh-ancestor
6575734|NCT01026415|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6575735|NCT01026415|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6575736|NCT01026415|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6575737|NCT01026415|Hormone Antagonists|hormone antagonists|mesh-ancestor
6575738|NCT01026415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6575739|NCT01026415|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6575740|NCT01026428|Levodopa|levodopa|mesh-list
6575741|NCT01026428|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6446171|NCT00390923|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6446172|NCT00390923|Protective Agents|protective agents|mesh-ancestor
6446173|NCT00390975|Tegaserod|tegaserod|mesh-list
6446174|NCT00390975|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6446175|NCT00390975|Serotonin Agents|serotonin agents|mesh-ancestor
6446176|NCT00390975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6446177|NCT00390975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446178|NCT00390975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446179|NCT00391014|Amphotericin B|amphotericin b|mesh-list
6446180|NCT00391014|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6446181|NCT00391014|Amebicides|amebicides|mesh-ancestor
6446182|NCT00391014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6446183|NCT00391014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6446184|NCT00391014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6446185|NCT00391014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6446186|NCT00391014|Antifungal Agents|antifungal agents|mesh-ancestor
6446187|NCT00391105|Remifentanil|remifentanil|mesh-list
6446188|NCT00391105|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6446189|NCT00391105|Narcotics|narcotics|mesh-ancestor
6575742|NCT01026428|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6575743|NCT01026428|Dopamine Agents|dopamine agents|mesh-ancestor
6575744|NCT01026428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6575745|NCT01026428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575746|NCT01026428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575747|NCT01026467|Carboplatin|carboplatin|mesh-list
6575748|NCT01026467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6575749|NCT01026558|Ceftobiprole|ceftobiprole|mesh-list
6575750|NCT01026558|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
6575751|NCT01026558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6575752|NCT01026558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6575753|NCT01026584|Aripiprazole|aripiprazole|mesh-list
6575754|NCT01026584|Antidepressive Agents|antidepressive agents|mesh-ancestor
6575755|NCT01026584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6575756|NCT01026584|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6575757|NCT01026584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6575758|NCT01026584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6575759|NCT01026584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575760|NCT01026584|Dopamine Agonists|dopamine agonists|mesh-ancestor
6575761|NCT01026584|Dopamine Agents|dopamine agents|mesh-ancestor
6575762|NCT01026584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6575763|NCT01026584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575764|NCT01026584|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6575765|NCT01026584|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6575766|NCT01026584|Serotonin Agents|serotonin agents|mesh-ancestor
6575767|NCT01026584|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6575768|NCT01026584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6575769|NCT01026584|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6575770|NCT01026584|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6575771|NCT01026610|Entecavir|entecavir|mesh-list
6575772|NCT01026610|Antiviral Agents|antiviral agents|mesh-ancestor
6575773|NCT01026610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6575774|NCT01026636|Ceftobiprole|ceftobiprole|mesh-list
6575775|NCT01026636|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
6575776|NCT01026636|Cephalosporins|cephalosporins|mesh-list
6575777|NCT01026636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6575778|NCT01026636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6575779|NCT01026701|Bortezomib|bortezomib|mesh-list
6575780|NCT01026701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6575781|NCT01026714|Fluconazole|fluconazole|mesh-list
6575782|NCT01026714|Rifampin|rifampin|mesh-list
6575783|NCT01026714|Flurbiprofen|flurbiprofen|mesh-list
6575784|NCT01026714|Antifungal Agents|antifungal agents|mesh-ancestor
6575785|NCT01026714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6575786|NCT01026714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6575787|NCT01026714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6575788|NCT01026714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6575789|NCT01026714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575790|NCT01026714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6575791|NCT01026714|Hormone Antagonists|hormone antagonists|mesh-ancestor
6658079|NCT01479556|Pregabalin|pregabalin|mesh-list
6658080|NCT01479556|Analgesics|analgesics|mesh-ancestor
6575792|NCT01026714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6575793|NCT01026714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575794|NCT01026714|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6575795|NCT01026714|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6575796|NCT01026714|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6575797|NCT01026714|Antitubercular Agents|antitubercular agents|mesh-ancestor
6575798|NCT01026714|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6575799|NCT01026714|Leprostatic Agents|leprostatic agents|mesh-ancestor
6575800|NCT01026714|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6575801|NCT01026714|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6575802|NCT01026714|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6575803|NCT01026714|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6575804|NCT01026714|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6575805|NCT01026714|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6575806|NCT01026714|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6575807|NCT01026714|Analgesics|analgesics|mesh-ancestor
6575808|NCT01026714|Sensory System Agents|sensory system agents|mesh-ancestor
6575809|NCT01026714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6575810|NCT01026714|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6575811|NCT01026714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6575812|NCT01026714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6575813|NCT01026714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6575814|NCT01026714|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6575815|NCT01026727|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6575816|NCT01026727|Antiviral Agents|antiviral agents|mesh-ancestor
6575817|NCT01026727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6575818|NCT01026740|Ceftobiprole|ceftobiprole|mesh-list
6575819|NCT01026740|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
6575820|NCT01026740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6575821|NCT01026740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6575822|NCT01026961|Acetaminophen|acetaminophen|mesh-list
6575823|NCT01026961|Dimethindene|dimethindene|mesh-list
6575824|NCT01026961|Phenylephrine|phenylephrine|mesh-list
6575825|NCT01026961|Oxymetazoline|oxymetazoline|mesh-list
6575826|NCT01026961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6575827|NCT01026961|Analgesics|analgesics|mesh-ancestor
6575828|NCT01026961|Sensory System Agents|sensory system agents|mesh-ancestor
6575829|NCT01026961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6575830|NCT01026961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575831|NCT01026961|Antipyretics|antipyretics|mesh-ancestor
6575832|NCT01026961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575833|NCT01026961|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6575834|NCT01026961|Mydriatics|mydriatics|mesh-ancestor
6575835|NCT01026961|Autonomic Agents|autonomic agents|mesh-ancestor
6575836|NCT01026961|Sympathomimetics|sympathomimetics|mesh-ancestor
6575837|NCT01026961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6575838|NCT01026961|Nasal Decongestants|nasal decongestants|mesh-ancestor
6575839|NCT01026961|Respiratory System Agents|respiratory system agents|mesh-ancestor
6575840|NCT01026961|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6575841|NCT01026961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6575842|NCT01026961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6575843|NCT01026961|Adrenergic Agents|adrenergic agents|mesh-ancestor
6575844|NCT01026961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6575845|NCT01026961|Protective Agents|protective agents|mesh-ancestor
6575846|NCT01026961|Antipruritics|antipruritics|mesh-ancestor
6575847|NCT01026961|Dermatologic Agents|dermatologic agents|mesh-ancestor
6575848|NCT01026961|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6575849|NCT01026961|Histamine Antagonists|histamine antagonists|mesh-ancestor
6575850|NCT01026961|Histamine Agents|histamine agents|mesh-ancestor
6575851|NCT01026961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6575852|NCT01026987|Plerixafor|plerixafor|mesh-list
6575853|NCT01026987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6575854|NCT01026987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6575855|NCT01026987|Antiviral Agents|antiviral agents|mesh-ancestor
6575856|NCT01026987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6575857|NCT01027065|Tenofovir|tenofovir|mesh-list
6575858|NCT01027065|Entecavir|entecavir|mesh-list
6575859|NCT01027065|Antiviral Agents|antiviral agents|mesh-ancestor
6575860|NCT01027065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6575861|NCT01027065|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6575862|NCT01027065|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6575863|NCT01027065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6575864|NCT01027065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575865|NCT01027065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6575866|NCT01027065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6575867|NCT01027117|Sildenafil Citrate|sildenafil citrate|mesh-list
6575868|NCT01027117|Vasodilator Agents|vasodilator agents|mesh-ancestor
6575869|NCT01027117|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6575870|NCT01027117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6575871|NCT01027117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6575872|NCT01027117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575873|NCT01027117|Urological Agents|urological agents|mesh-ancestor
6575874|NCT01027182|Raltegravir Potassium|raltegravir potassium|mesh-list
6575875|NCT01027182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6575876|NCT01027182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6575877|NCT01027182|Antiviral Agents|antiviral agents|mesh-ancestor
6575878|NCT01027182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6575879|NCT01027182|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6575880|NCT01027182|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6575881|NCT01027182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6575882|NCT01027182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575883|NCT01027377|Factor VIII|factor viii|mesh-list
6575884|NCT01027377|Coagulants|coagulants|mesh-ancestor
6575885|NCT01027429|Amoxicillin|amoxicillin|mesh-list
6575886|NCT01027429|Gentamicins|gentamicins|mesh-list
6575887|NCT01027429|Penicillins|penicillins|mesh-list
6575888|NCT01027429|Penicillin G Procaine|penicillin g procaine|mesh-list
6575889|NCT01027429|Penicillin G|penicillin g|mesh-list
6575890|NCT01027429|Penicillin G Benzathine|penicillin g benzathine|mesh-list
6575891|NCT01027429|Procaine|procaine|mesh-list
6575892|NCT01027429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6575893|NCT01027429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6575894|NCT01027429|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6575895|NCT01027429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6575896|NCT01027429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575897|NCT01027429|Anesthetics, Local|anesthetics, local|mesh-ancestor
6575898|NCT01027429|Anesthetics|anesthetics|mesh-ancestor
6575899|NCT01027429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6575900|NCT01027429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575901|NCT01027429|Sensory System Agents|sensory system agents|mesh-ancestor
6575902|NCT01027429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6575903|NCT01027481|Ranibizumab|ranibizumab|mesh-list
6575904|NCT01027481|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6575905|NCT01027481|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6575906|NCT01027481|Growth Substances|growth substances|mesh-ancestor
6575907|NCT01027481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575908|NCT01027481|Growth Inhibitors|growth inhibitors|mesh-ancestor
6575909|NCT01027481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6575910|NCT01027494|Ciprofloxacin|ciprofloxacin|mesh-list
6575911|NCT01027494|Dexamethasone|dexamethasone|mesh-list
6575912|NCT01027494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6575913|NCT01027494|Antiemetics|antiemetics|mesh-ancestor
6575914|NCT01027494|Autonomic Agents|autonomic agents|mesh-ancestor
6575915|NCT01027494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6575916|NCT01027494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575917|NCT01027494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6575918|NCT01027494|Glucocorticoids|glucocorticoids|mesh-ancestor
6575919|NCT01027494|Hormones|hormones|mesh-ancestor
6575920|NCT01027494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6575921|NCT01027494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6575922|NCT01027494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6575923|NCT01027494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6575924|NCT01027494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6575925|NCT01027494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6575926|NCT01027494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6575927|NCT01027494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6575928|NCT01027494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575929|NCT01027494|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6575930|NCT01027494|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6575931|NCT01027520|Monensin|monensin|mesh-list
6575932|NCT01027520|Antifungal Agents|antifungal agents|mesh-ancestor
6575933|NCT01027520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6575934|NCT01027520|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6575935|NCT01027520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6575936|NCT01027520|Coccidiostats|coccidiostats|mesh-ancestor
6575937|NCT01027520|Proton Ionophores|proton ionophores|mesh-ancestor
6575938|NCT01027520|Uncoupling Agents|uncoupling agents|mesh-ancestor
6575939|NCT01027520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6575940|NCT01027520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575941|NCT01027520|Ionophores|ionophores|mesh-ancestor
6575942|NCT01027520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6575943|NCT01027520|Sodium Ionophores|sodium ionophores|mesh-ancestor
6575944|NCT01027546|Tranexamic Acid|tranexamic acid|mesh-list
6575945|NCT01027546|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6575946|NCT01027546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6575947|NCT01027546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575948|NCT01027546|Hemostatics|hemostatics|mesh-ancestor
6575949|NCT01027546|Coagulants|coagulants|mesh-ancestor
6575950|NCT01027611|Lidocaine|lidocaine|mesh-list
6575951|NCT01027611|Proxymetacaine|proxymetacaine|mesh-list
6575952|NCT01027611|Propoxycaine|propoxycaine|mesh-list
6575953|NCT01027611|Anesthetics, Local|anesthetics, local|mesh-ancestor
6575954|NCT01027611|Anesthetics|anesthetics|mesh-ancestor
6575955|NCT01027611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6575956|NCT01027611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575957|NCT01027611|Sensory System Agents|sensory system agents|mesh-ancestor
6575958|NCT01027611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6575959|NCT01027611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6575960|NCT01027611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6575961|NCT01027611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6575962|NCT01027611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6575963|NCT01027611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575964|NCT01027689|Alprazolam|alprazolam|mesh-list
6575965|NCT01027689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6575966|NCT01027689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6575967|NCT01027689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6575968|NCT01027689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6575969|NCT01027689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6575970|NCT01027689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6575971|NCT01027689|GABA Modulators|gaba modulators|mesh-ancestor
6575972|NCT01027689|GABA Agents|gaba agents|mesh-ancestor
6575973|NCT01027689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6575974|NCT01027689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575975|NCT01027715|Anticonvulsants|anticonvulsants|mesh-list
6575976|NCT01027832|Tazobactam|tazobactam|mesh-list
6575977|NCT01027832|Piperacillin|piperacillin|mesh-list
6575978|NCT01027832|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
6575979|NCT01027832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6575980|NCT01027832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6575981|NCT01027832|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6575982|NCT01027832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6575983|NCT01027832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575984|NCT01027923|Cytarabine|cytarabine|mesh-list
6575985|NCT01027923|Plerixafor|plerixafor|mesh-list
6575986|NCT01027923|Etoposide|etoposide|mesh-list
6575987|NCT01027923|Mitoxantrone|mitoxantrone|mesh-list
6575988|NCT01027923|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6575989|NCT01027923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6575990|NCT01027923|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6575991|NCT01027923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6575992|NCT01027923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6575993|NCT01027923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6575994|NCT01027923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6575995|NCT01027923|Antimetabolites|antimetabolites|mesh-ancestor
6054329|NCT00602459|Antibodies|antibodies|mesh-list
6575996|NCT01027923|Antiviral Agents|antiviral agents|mesh-ancestor
6575997|NCT01027923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6575998|NCT01027923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6575999|NCT01027923|Immunologic Factors|immunologic factors|mesh-ancestor
6576000|NCT01027923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576001|NCT01027923|Analgesics|analgesics|mesh-ancestor
6576002|NCT01027923|Sensory System Agents|sensory system agents|mesh-ancestor
6576003|NCT01027923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6576004|NCT01027923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6576005|NCT01027923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6576006|NCT01028079|Aspirin|aspirin|mesh-list
6576007|NCT01028079|Ibuprofen|ibuprofen|mesh-list
6576008|NCT01028079|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6576009|NCT01028079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6576010|NCT01028079|Analgesics|analgesics|mesh-ancestor
6576011|NCT01028079|Sensory System Agents|sensory system agents|mesh-ancestor
6576012|NCT01028079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6576013|NCT01028079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576014|NCT01028079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6576015|NCT01028079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6576016|NCT01028079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6576017|NCT01028079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6576018|NCT01028079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576019|NCT01028079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6576020|NCT01028079|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6576021|NCT01028079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6576022|NCT01028079|Antipyretics|antipyretics|mesh-ancestor
6576023|NCT01028092|Cyclosporine|cyclosporine|mesh-list
6576024|NCT01028092|Everolimus|everolimus|mesh-list
6576025|NCT01028092|Interleukin-2|interleukin-2|mesh-list
6576026|NCT01028092|Cyclosporins|cyclosporins|mesh-list
6576027|NCT01028092|Thymoglobulin|thymoglobulin|mesh-list
6576028|NCT01028092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6576029|NCT01028092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576030|NCT01028092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6576031|NCT01028092|Immunologic Factors|immunologic factors|mesh-ancestor
6576032|NCT01028092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576033|NCT01028092|Antifungal Agents|antifungal agents|mesh-ancestor
6576034|NCT01028092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6576035|NCT01028092|Dermatologic Agents|dermatologic agents|mesh-ancestor
6576036|NCT01028092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6576037|NCT01028092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6576038|NCT01028092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6576039|NCT01028092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6576040|NCT01028092|Analgesics|analgesics|mesh-ancestor
6576041|NCT01028092|Sensory System Agents|sensory system agents|mesh-ancestor
6576042|NCT01028092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6658081|NCT01479556|Sensory System Agents|sensory system agents|mesh-ancestor
6658082|NCT01479556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6658083|NCT01479556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658084|NCT01479556|Anticonvulsants|anticonvulsants|mesh-ancestor
6658085|NCT01479556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6658086|NCT01479556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6658087|NCT01479556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658088|NCT01479556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6658089|NCT01479556|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6658090|NCT01479556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6576043|NCT01028170|Furosemide|furosemide|mesh-list
6576044|NCT01028170|Diuretics|diuretics|mesh-ancestor
6576045|NCT01028170|Natriuretic Agents|natriuretic agents|mesh-ancestor
6576046|NCT01028170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576047|NCT01028170|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6576048|NCT01028170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6576049|NCT01028170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576050|NCT01028248|Ranibizumab|ranibizumab|mesh-list
6576051|NCT01028248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6576052|NCT01028248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6576053|NCT01028248|Growth Substances|growth substances|mesh-ancestor
6576054|NCT01028248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576055|NCT01028248|Growth Inhibitors|growth inhibitors|mesh-ancestor
6576056|NCT01028248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6576057|NCT01028261|CKD732|ckd732|mesh-list
6576058|NCT01028261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6576059|NCT01028261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6576060|NCT01028261|Growth Substances|growth substances|mesh-ancestor
6576061|NCT01028261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576062|NCT01028261|Growth Inhibitors|growth inhibitors|mesh-ancestor
6576063|NCT01028261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6576064|NCT01028287|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6576065|NCT01028287|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
6576066|NCT01028287|beta-Endorphin|beta-endorphin|mesh-list
6576067|NCT01028287|Hormones|hormones|mesh-ancestor
6576068|NCT01028287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6576069|NCT01028287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576070|NCT01028287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6576071|NCT01028287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576072|NCT01028313|Methylprednisolone|methylprednisolone|mesh-list
6576073|NCT01028313|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6576074|NCT01028313|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6576075|NCT01028313|Prednisolone|prednisolone|mesh-list
6576076|NCT01028313|Prednisolone acetate|prednisolone acetate|mesh-list
6576077|NCT01028313|Panobinostat|panobinostat|mesh-list
6576078|NCT01028313|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6576079|NCT01028313|Prednisolone phosphate|prednisolone phosphate|mesh-list
6576080|NCT01028313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6576081|NCT01028313|Antiemetics|antiemetics|mesh-ancestor
6576082|NCT01028313|Autonomic Agents|autonomic agents|mesh-ancestor
6576083|NCT01028313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6576084|NCT01028313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576085|NCT01028313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6576086|NCT01028313|Glucocorticoids|glucocorticoids|mesh-ancestor
6576087|NCT01028313|Hormones|hormones|mesh-ancestor
6576088|NCT01028313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6576089|NCT01028313|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6576090|NCT01028313|Protective Agents|protective agents|mesh-ancestor
6576091|NCT01028313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6576092|NCT01028313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6576093|NCT01028313|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6576094|NCT01028313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6576095|NCT01028313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576096|NCT01028339|Mannitol|mannitol|mesh-list
6576097|NCT01028339|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6576098|NCT01028339|Diuretics|diuretics|mesh-ancestor
5724796|NCT03184870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6576099|NCT01028339|Natriuretic Agents|natriuretic agents|mesh-ancestor
6576100|NCT01028339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576101|NCT01028404|Insulin|insulin|mesh-list
6576102|NCT01028404|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6576103|NCT01028404|Insulin Aspart|insulin aspart|mesh-list
6576104|NCT01028404|Insulin, Long-Acting|insulin, long-acting|mesh-list
6576105|NCT01028404|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6576106|NCT01028404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6576107|NCT01028404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576108|NCT01028443|Cyclosporine|cyclosporine|mesh-list
6576109|NCT01028443|Antifungal Agents|antifungal agents|mesh-ancestor
6576110|NCT01028443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6576111|NCT01028443|Dermatologic Agents|dermatologic agents|mesh-ancestor
6576112|NCT01028443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6576113|NCT01028443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576114|NCT01028443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6576115|NCT01028443|Immunologic Factors|immunologic factors|mesh-ancestor
6576116|NCT01028443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576117|NCT01028443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6576118|NCT01028443|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6576119|NCT01028482|Sertraline|sertraline|mesh-list
6576120|NCT01028482|Antidepressive Agents|antidepressive agents|mesh-ancestor
6576121|NCT01028482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6576122|NCT01028482|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6576123|NCT01028482|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6576124|NCT01028482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6576125|NCT01028482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576126|NCT01028482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6446190|NCT00391105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6446191|NCT00391105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446192|NCT00391105|Analgesics|analgesics|mesh-ancestor
6446193|NCT00391105|Sensory System Agents|sensory system agents|mesh-ancestor
6446194|NCT00391105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6446195|NCT00391144|Triamcinolone|triamcinolone|mesh-list
6446196|NCT00391144|Bevacizumab|bevacizumab|mesh-list
6446197|NCT00391144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6576127|NCT01028482|Serotonin Agents|serotonin agents|mesh-ancestor
6576128|NCT01028482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576129|NCT01028495|Gemcitabine|gemcitabine|mesh-list
6576130|NCT01028495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6576131|NCT01028495|Antimetabolites|antimetabolites|mesh-ancestor
6576132|NCT01028495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576133|NCT01028495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6576134|NCT01028495|Antiviral Agents|antiviral agents|mesh-ancestor
6576135|NCT01028495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6576136|NCT01028495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6576137|NCT01028495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6576138|NCT01028495|Immunologic Factors|immunologic factors|mesh-ancestor
6576139|NCT01028495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576140|NCT01028508|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6576141|NCT01028508|Antidepressive Agents|antidepressive agents|mesh-ancestor
6576142|NCT01028508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6576143|NCT01028508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576144|NCT01028508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576145|NCT01028508|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6576146|NCT01028508|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6576147|NCT01028508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6576148|NCT01028508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6576149|NCT01028508|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6576150|NCT01028534|Olmesartan|olmesartan|mesh-list
6576151|NCT01028534|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6576152|NCT01028534|Calcium Channel Blockers|calcium channel blockers|mesh-list
6576153|NCT01028534|Angiotensin II|angiotensin ii|mesh-list
6576154|NCT01028534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
6576155|NCT01028534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6576156|NCT01028534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576157|NCT01028534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6446198|NCT00391144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6446199|NCT00391144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6446200|NCT00391144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6576158|NCT01028534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6576159|NCT01028534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576160|NCT01028534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6576161|NCT01028534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6576162|NCT01028547|Dexamethasone|dexamethasone|mesh-list
6576163|NCT01028547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6576164|NCT01028547|Antiemetics|antiemetics|mesh-ancestor
6576165|NCT01028547|Autonomic Agents|autonomic agents|mesh-ancestor
6576166|NCT01028547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6576167|NCT01028547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576168|NCT01028547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6576169|NCT01028547|Glucocorticoids|glucocorticoids|mesh-ancestor
6576170|NCT01028547|Hormones|hormones|mesh-ancestor
6576171|NCT01028547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6576172|NCT01028547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6576173|NCT01028547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6576174|NCT01028573|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
6576175|NCT01028573|Laxatives|laxatives|mesh-ancestor
6576176|NCT01028573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6576177|NCT01028638|Bevacizumab|bevacizumab|mesh-list
6576178|NCT01028638|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
6576179|NCT01028638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6576180|NCT01028638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6576181|NCT01028638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6576182|NCT01028638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6576183|NCT01028638|Growth Substances|growth substances|mesh-ancestor
6576184|NCT01028638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576185|NCT01028638|Growth Inhibitors|growth inhibitors|mesh-ancestor
6576186|NCT01028638|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6576187|NCT01028638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576188|NCT01028729|Gemcitabine|gemcitabine|mesh-list
6576189|NCT01028729|Endostar protein|endostar protein|mesh-list
6576190|NCT01028729|Endostatins|endostatins|mesh-list
6576191|NCT01028729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6576192|NCT01028729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6576193|NCT01028729|Antimetabolites|antimetabolites|mesh-ancestor
6576194|NCT01028729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576195|NCT01028729|Antiviral Agents|antiviral agents|mesh-ancestor
6020193|NCT00391898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020194|NCT00391898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020195|NCT00391898|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6020196|NCT00391898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6576196|NCT01028729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6576197|NCT01028729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6576198|NCT01028729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6576199|NCT01028729|Immunologic Factors|immunologic factors|mesh-ancestor
6576200|NCT01028729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576201|NCT01028729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6576202|NCT01028729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6576203|NCT01028729|Growth Substances|growth substances|mesh-ancestor
6576204|NCT01028729|Growth Inhibitors|growth inhibitors|mesh-ancestor
6576205|NCT01028768|Teduglutide|teduglutide|mesh-list
6576206|NCT01028768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6576207|NCT01028768|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6576208|NCT01028768|Protective Agents|protective agents|mesh-ancestor
6576209|NCT01028768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576210|NCT01028781|Thalidomide|thalidomide|mesh-list
6576211|NCT01028781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6576212|NCT01028781|Immunologic Factors|immunologic factors|mesh-ancestor
6576213|NCT01028781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576214|NCT01028781|Leprostatic Agents|leprostatic agents|mesh-ancestor
6576215|NCT01028781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6576216|NCT01028781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6576217|NCT01028781|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6576218|NCT01028781|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6576219|NCT01028781|Growth Substances|growth substances|mesh-ancestor
6576220|NCT01028781|Growth Inhibitors|growth inhibitors|mesh-ancestor
6576221|NCT01028781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6576222|NCT01028846|Diazoxide|diazoxide|mesh-list
6576223|NCT01028846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6576224|NCT01028846|Vasodilator Agents|vasodilator agents|mesh-ancestor
6576225|NCT01028924|Teduglutide|teduglutide|mesh-list
6576226|NCT01028924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6576227|NCT01028924|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6576228|NCT01028924|Protective Agents|protective agents|mesh-ancestor
6576229|NCT01028924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576230|NCT01028950|Darexaban|darexaban|mesh-list
6576231|NCT01028950|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6576232|NCT01028950|Antithrombins|antithrombins|mesh-ancestor
6576233|NCT01028950|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6576234|NCT01028950|Protease Inhibitors|protease inhibitors|mesh-ancestor
6576235|NCT01028950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6576236|NCT01028950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576237|NCT01028950|Anticoagulants|anticoagulants|mesh-ancestor
6576238|NCT01028963|Pioglitazone|pioglitazone|mesh-list
6576239|NCT01028963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6576240|NCT01028963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576241|NCT01028976|Ascorbic Acid|ascorbic acid|mesh-list
6576242|NCT01028976|Vitamins|vitamins|mesh-ancestor
6576243|NCT01028976|Micronutrients|micronutrients|mesh-ancestor
6576244|NCT01028976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576245|NCT01028976|Antioxidants|antioxidants|mesh-ancestor
6576246|NCT01028976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576247|NCT01028976|Protective Agents|protective agents|mesh-ancestor
6576248|NCT01029002|Vitamin D|vitamin d|mesh-list
6576249|NCT01029002|Vitamins|vitamins|mesh-ancestor
6576250|NCT01029002|Micronutrients|micronutrients|mesh-ancestor
6576251|NCT01029002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576252|NCT01029002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6576253|NCT01029132|Galantamine|galantamine|mesh-list
6576254|NCT01029132|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6576255|NCT01029132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6576256|NCT01029132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576257|NCT01029132|Cholinergic Agents|cholinergic agents|mesh-ancestor
6576258|NCT01029132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6576259|NCT01029132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576260|NCT01029132|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6576261|NCT01029132|Autonomic Agents|autonomic agents|mesh-ancestor
6576262|NCT01029132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6576263|NCT01029132|Nootropic Agents|nootropic agents|mesh-ancestor
6576264|NCT01029223|Metoprolol|metoprolol|mesh-list
6576265|NCT01029223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6576266|NCT01029223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6576267|NCT01029223|Sympatholytics|sympatholytics|mesh-ancestor
6576268|NCT01029223|Autonomic Agents|autonomic agents|mesh-ancestor
6576269|NCT01029223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6576270|NCT01029223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576271|NCT01029223|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6576272|NCT01029223|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6576273|NCT01029223|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6576274|NCT01029223|Adrenergic Agents|adrenergic agents|mesh-ancestor
6576275|NCT01029223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6576276|NCT01029223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576277|NCT01029275|Octreotide|octreotide|mesh-list
6576278|NCT01029275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6576279|NCT01029275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6576280|NCT01029275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6576281|NCT01029288|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6576282|NCT01029288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576283|NCT01029418|Sorafenib|sorafenib|mesh-list
6576284|NCT01029418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6576285|NCT01029418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6576286|NCT01029418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6576287|NCT01029418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576288|NCT01029444|Insulin Aspart|insulin aspart|mesh-list
6576289|NCT01029444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6576290|NCT01029444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576291|NCT01029522|Atorvastatin|atorvastatin|mesh-list
6576292|NCT01029522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6576293|NCT01029522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6576294|NCT01029522|Antimetabolites|antimetabolites|mesh-ancestor
6576295|NCT01029522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576296|NCT01029522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6576297|NCT01029522|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6576298|NCT01029522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6576299|NCT01029613|Adalimumab|adalimumab|mesh-list
6576300|NCT01029613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6576301|NCT01029613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6576302|NCT01029639|Insulin|insulin|mesh-list
6576303|NCT01029639|Insulin Aspart|insulin aspart|mesh-list
6576304|NCT01029639|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6576305|NCT01029639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6576306|NCT01029639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576307|NCT01029678|Vinorelbine|vinorelbine|mesh-list
6576308|NCT01029678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6576309|NCT01029678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6576310|NCT01029678|Tubulin Modulators|tubulin modulators|mesh-ancestor
6576311|NCT01029678|Antimitotic Agents|antimitotic agents|mesh-ancestor
6576312|NCT01029678|Mitosis Modulators|mitosis modulators|mesh-ancestor
6576313|NCT01029678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576314|NCT01029717|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6576315|NCT01029717|Minocycline|minocycline|mesh-list
6576316|NCT01029717|Rifampin|rifampin|mesh-list
6576317|NCT01029717|Heparin|heparin|mesh-list
6576318|NCT01029717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6576319|NCT01029717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6576320|NCT01029717|Antitubercular Agents|antitubercular agents|mesh-ancestor
6576321|NCT01029717|Anticoagulants|anticoagulants|mesh-ancestor
6576322|NCT01029717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6576323|NCT01029717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6576324|NCT01029717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576325|NCT01029717|Leprostatic Agents|leprostatic agents|mesh-ancestor
6576326|NCT01029717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6576327|NCT01029717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6576328|NCT01029717|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6576329|NCT01029717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6576330|NCT01029717|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6576331|NCT01029717|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6576332|NCT01029717|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6576333|NCT01029717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6576334|NCT01029743|Aspirin|aspirin|mesh-list
6576335|NCT01029743|PENTA|penta|mesh-list
6576336|NCT01029743|Rivaroxaban|rivaroxaban|mesh-list
6576337|NCT01029743|Fondaparinux|fondaparinux|mesh-list
6576338|NCT01029743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6576339|NCT01029743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6576340|NCT01029743|Analgesics|analgesics|mesh-ancestor
6576341|NCT01029743|Sensory System Agents|sensory system agents|mesh-ancestor
6576342|NCT01029743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6576343|NCT01029743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576344|NCT01029743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6576345|NCT01029743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6576346|NCT01029743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6576347|NCT01029743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6576348|NCT01029743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576349|NCT01029743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6576350|NCT01029743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6576351|NCT01029743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6576352|NCT01029743|Antipyretics|antipyretics|mesh-ancestor
6576353|NCT01029743|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6576354|NCT01029743|Antithrombins|antithrombins|mesh-ancestor
6576355|NCT01029743|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6576356|NCT01029743|Protease Inhibitors|protease inhibitors|mesh-ancestor
6576357|NCT01029743|Anticoagulants|anticoagulants|mesh-ancestor
6576358|NCT01029769|Olanzapine|olanzapine|mesh-list
6576359|NCT01029769|Amisulpride|amisulpride|mesh-list
6576360|NCT01029769|Antiemetics|antiemetics|mesh-ancestor
6576361|NCT01029769|Autonomic Agents|autonomic agents|mesh-ancestor
6576362|NCT01029769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6576363|NCT01029769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576364|NCT01029769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6576365|NCT01029769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6576366|NCT01029769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6576367|NCT01029769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6576368|NCT01029769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6576369|NCT01029769|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6576370|NCT01029769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6576371|NCT01029769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6576372|NCT01029769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576373|NCT01029769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6576374|NCT01029769|Serotonin Agents|serotonin agents|mesh-ancestor
6576375|NCT01029769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6446201|NCT00391144|Growth Substances|growth substances|mesh-ancestor
6446202|NCT00391144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446203|NCT00391144|Growth Inhibitors|growth inhibitors|mesh-ancestor
6576376|NCT01029769|Dopamine Agents|dopamine agents|mesh-ancestor
6576377|NCT01029769|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6576378|NCT01029769|Antidepressive Agents|antidepressive agents|mesh-ancestor
6658091|NCT01479556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6658092|NCT01479556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6658093|NCT01479634|Efavirenz|efavirenz|mesh-list
6658094|NCT01479634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6658095|NCT01479634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6658096|NCT01479634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6658097|NCT01479634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658098|NCT01479634|Antiviral Agents|antiviral agents|mesh-ancestor
6658099|NCT01479634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6658100|NCT01479634|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6658101|NCT01479634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6658102|NCT01479634|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6658103|NCT01479634|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6658104|NCT01479634|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6658105|NCT01479634|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6658106|NCT01479751|Magnesium Sulfate|magnesium sulfate|mesh-list
6658107|NCT01479751|Ketamine|ketamine|mesh-list
6658108|NCT01479751|Rocuronium|rocuronium|mesh-list
6658109|NCT01479751|Analgesics|analgesics|mesh-ancestor
6020197|NCT00391898|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6446204|NCT00391144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6446205|NCT00391144|Glucocorticoids|glucocorticoids|mesh-ancestor
6446206|NCT00391144|Hormones|hormones|mesh-ancestor
6446207|NCT00391144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6446208|NCT00391157|Dexamethasone|dexamethasone|mesh-list
6446209|NCT00391157|Bortezomib|bortezomib|mesh-list
6446210|NCT00391157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6446211|NCT00391157|Antiemetics|antiemetics|mesh-ancestor
6446212|NCT00391157|Autonomic Agents|autonomic agents|mesh-ancestor
6446213|NCT00391157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6446214|NCT00391157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446215|NCT00391157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6446216|NCT00391157|Glucocorticoids|glucocorticoids|mesh-ancestor
6446217|NCT00391157|Hormones|hormones|mesh-ancestor
6658110|NCT01479751|Sensory System Agents|sensory system agents|mesh-ancestor
6576379|NCT01029821|Heparin|heparin|mesh-list
6576380|NCT01029821|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6576381|NCT01029821|Tinzaparin|tinzaparin|mesh-list
6576382|NCT01029821|Dalteparin|dalteparin|mesh-list
6576383|NCT01029821|Anticoagulants|anticoagulants|mesh-ancestor
6576384|NCT01029821|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6576385|NCT01029821|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6576386|NCT01029821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576387|NCT01029847|Adalimumab|adalimumab|mesh-list
6576388|NCT01029847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6576389|NCT01029847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6576390|NCT01030016|Atenolol|atenolol|mesh-list
6576391|NCT01030016|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6576392|NCT01030016|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6576393|NCT01030016|Adrenergic Agents|adrenergic agents|mesh-ancestor
6576394|NCT01030016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6576395|NCT01030016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576396|NCT01030016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576397|NCT01030016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6576398|NCT01030016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6576399|NCT01030016|Sympatholytics|sympatholytics|mesh-ancestor
6576400|NCT01030016|Autonomic Agents|autonomic agents|mesh-ancestor
6576401|NCT01030016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6576402|NCT01030016|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6576403|NCT01030042|Leucovorin|leucovorin|mesh-list
6576404|NCT01030042|Oxaliplatin|oxaliplatin|mesh-list
6576405|NCT01030042|Irinotecan|irinotecan|mesh-list
6576406|NCT01030042|Cetuximab|cetuximab|mesh-list
6576407|NCT01030042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6576408|NCT01030042|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6576409|NCT01030042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6576410|NCT01030042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6576411|NCT01030042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576412|NCT01030042|Antidotes|antidotes|mesh-ancestor
6576413|NCT01030042|Protective Agents|protective agents|mesh-ancestor
6576414|NCT01030042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576415|NCT01030042|Vitamin B Complex|vitamin b complex|mesh-ancestor
6576416|NCT01030042|Vitamins|vitamins|mesh-ancestor
6576417|NCT01030042|Micronutrients|micronutrients|mesh-ancestor
6576418|NCT01030042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6576419|NCT01030081|Amlodipine|amlodipine|mesh-list
6576420|NCT01030081|Nifedipine|nifedipine|mesh-list
6576421|NCT01030081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6576422|NCT01030081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6576423|NCT01030081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6576424|NCT01030081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576425|NCT01030081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6576426|NCT01030081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576427|NCT01030081|Vasodilator Agents|vasodilator agents|mesh-ancestor
6576428|NCT01030081|Tocolytic Agents|tocolytic agents|mesh-ancestor
6576429|NCT01030081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6576430|NCT01030094|Topiramate|topiramate|mesh-list
6576431|NCT01030094|Carbamazepine|carbamazepine|mesh-list
6576432|NCT01030094|Valproic Acid|valproic acid|mesh-list
6576433|NCT01030094|Anticonvulsants|anticonvulsants|mesh-ancestor
6576434|NCT01030094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6576435|NCT01030094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576436|NCT01030094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6576437|NCT01030094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576438|NCT01030094|GABA Agents|gaba agents|mesh-ancestor
6576439|NCT01030094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6576440|NCT01030094|Antimanic Agents|antimanic agents|mesh-ancestor
6576441|NCT01030094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6576442|NCT01030094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6576443|NCT01030094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6576444|NCT01030094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6576445|NCT01030094|Analgesics|analgesics|mesh-ancestor
6576446|NCT01030094|Sensory System Agents|sensory system agents|mesh-ancestor
6576447|NCT01030094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6576448|NCT01030094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6576449|NCT01030094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6576450|NCT01030094|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6576451|NCT01030094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6576452|NCT01030120|Etanercept|etanercept|mesh-list
6576453|NCT01030120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6576454|NCT01030120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6576455|NCT01030120|Analgesics|analgesics|mesh-ancestor
6576456|NCT01030120|Sensory System Agents|sensory system agents|mesh-ancestor
6576457|NCT01030120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6576458|NCT01030120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576459|NCT01030120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6576460|NCT01030120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6576461|NCT01030120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5501475|NCT04473911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501476|NCT04473911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5501477|NCT04473911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5501478|NCT04473911|Alkylating Agents|alkylating agents|mesh-ancestor
5501479|NCT04473911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501480|NCT04473911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5501481|NCT04473911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5501482|NCT04473911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5501483|NCT04473911|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5501484|NCT04473911|Antitubercular Agents|antitubercular agents|mesh-ancestor
5501485|NCT04473911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5501486|NCT04473911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5501487|NCT04473911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5501488|NCT04473911|Antifungal Agents|antifungal agents|mesh-ancestor
5501489|NCT04473950|Naloxone|naloxone|mesh-list
5501490|NCT04473950|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5501491|NCT04473950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501492|NCT04473950|Sensory System Agents|sensory system agents|mesh-ancestor
6576462|NCT01030120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6576463|NCT01030120|Immunologic Factors|immunologic factors|mesh-ancestor
6576464|NCT01030237|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6576465|NCT01030237|Lubricant Eye Drops|lubricant eye drops|mesh-list
6576466|NCT01030237|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6576467|NCT01030302|Bortezomib|bortezomib|mesh-list
6576468|NCT01030302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6576469|NCT01030328|Fenofibrate|fenofibrate|mesh-list
6576470|NCT01030328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6576471|NCT01030328|Antimetabolites|antimetabolites|mesh-ancestor
6576472|NCT01030328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576473|NCT01030328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6576474|NCT01030393|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6576475|NCT01030393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6576476|NCT01030393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576477|NCT01030510|Rocuronium|rocuronium|mesh-list
6576478|NCT01030510|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6576479|NCT01030510|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6576480|NCT01030510|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6576481|NCT01030510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6576482|NCT01030510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576483|NCT01030601|Dexamethasone|dexamethasone|mesh-list
6576484|NCT01030601|Dexamethasone acetate|dexamethasone acetate|mesh-list
6576485|NCT01030601|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
6576486|NCT01030601|BB 1101|bb 1101|mesh-list
6576487|NCT01030601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6576488|NCT01030601|Antiemetics|antiemetics|mesh-ancestor
6576489|NCT01030601|Autonomic Agents|autonomic agents|mesh-ancestor
5501493|NCT04473950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5501494|NCT04473924|Mycophenolic Acid|mycophenolic acid|mesh-list
5501495|NCT04473924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5501496|NCT04473924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5501497|NCT04473924|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5501498|NCT04473924|Antitubercular Agents|antitubercular agents|mesh-ancestor
5501499|NCT04473924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5501500|NCT04473924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5501501|NCT04473924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5501502|NCT04473924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501503|NCT04473508|Ropivacaine|ropivacaine|mesh-list
5501504|NCT04473508|Anesthetics, Local|anesthetics, local|mesh-ancestor
5501505|NCT04473508|Anesthetics|anesthetics|mesh-ancestor
5501506|NCT04473508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5501507|NCT04473508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501508|NCT04473508|Sensory System Agents|sensory system agents|mesh-ancestor
5724797|NCT03184870|Tubulin Modulators|tubulin modulators|mesh-ancestor
6576490|NCT01030601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6576491|NCT01030601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576492|NCT01030601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6576493|NCT01030601|Glucocorticoids|glucocorticoids|mesh-ancestor
6576494|NCT01030601|Hormones|hormones|mesh-ancestor
6576495|NCT01030601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6576496|NCT01030601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6576497|NCT01030601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6576498|NCT01030601|Protease Inhibitors|protease inhibitors|mesh-ancestor
6576499|NCT01030601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6576500|NCT01030601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576501|NCT01030614|Dexamethasone|dexamethasone|mesh-list
6576502|NCT01030614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6576503|NCT01030614|Antiemetics|antiemetics|mesh-ancestor
6576504|NCT01030614|Autonomic Agents|autonomic agents|mesh-ancestor
6576505|NCT01030614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6576506|NCT01030614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576507|NCT01030614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6576508|NCT01030614|Glucocorticoids|glucocorticoids|mesh-ancestor
6576509|NCT01030614|Hormones|hormones|mesh-ancestor
6576510|NCT01030614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6576511|NCT01030614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6576512|NCT01030614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6576513|NCT01030640|Tanezumab|tanezumab|mesh-list
6576514|NCT01030640|Analgesics|analgesics|mesh-ancestor
6576515|NCT01030640|Sensory System Agents|sensory system agents|mesh-ancestor
6576516|NCT01030640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6576517|NCT01030640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576518|NCT01030692|Rivastigmine|rivastigmine|mesh-list
6576519|NCT01030692|Huperzine A|huperzine a|mesh-list
6576520|NCT01030692|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6576521|NCT01030692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6576522|NCT01030692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576523|NCT01030692|Cholinergic Agents|cholinergic agents|mesh-ancestor
6576524|NCT01030692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6576525|NCT01030692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576526|NCT01030692|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6576527|NCT01030692|Protective Agents|protective agents|mesh-ancestor
6576528|NCT01030731|Ceftobiprole|ceftobiprole|mesh-list
6576529|NCT01030731|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
6576530|NCT01030731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6576531|NCT01030731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6576532|NCT01030770|Ranibizumab|ranibizumab|mesh-list
6576533|NCT01030770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6576534|NCT01030770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6576535|NCT01030770|Growth Substances|growth substances|mesh-ancestor
6576536|NCT01030770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576537|NCT01030770|Growth Inhibitors|growth inhibitors|mesh-ancestor
6576538|NCT01030770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6576539|NCT01030796|Caffeine|caffeine|mesh-list
6576540|NCT01030796|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6576541|NCT01030796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576542|NCT01030796|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6576543|NCT01030796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6576544|NCT01030796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576545|NCT01030796|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6576546|NCT01030796|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6576547|NCT01030796|Purinergic Agents|purinergic agents|mesh-ancestor
6576548|NCT01030796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6576549|NCT01030900|Rituximab|rituximab|mesh-list
6576550|NCT01030900|Alemtuzumab|alemtuzumab|mesh-list
6576551|NCT01030900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6576552|NCT01030900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6576553|NCT01030900|Immunologic Factors|immunologic factors|mesh-ancestor
6576554|NCT01030900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576555|NCT01030900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6576556|NCT01030926|Insulin|insulin|mesh-list
6576557|NCT01030926|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6576558|NCT01030926|Insulin Glargine|insulin glargine|mesh-list
6576559|NCT01030926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6576560|NCT01030926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576561|NCT01031017|Progesterone|progesterone|mesh-list
6576562|NCT01031017|Progestins|progestins|mesh-ancestor
6576563|NCT01031017|Hormones|hormones|mesh-ancestor
6576564|NCT01031017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6576565|NCT01031017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576566|NCT01031030|Cyclophosphamide|cyclophosphamide|mesh-list
6576567|NCT01031030|Fluorouracil|fluorouracil|mesh-list
6576568|NCT01031030|Methotrexate|methotrexate|mesh-list
6576569|NCT01031030|Epirubicin|epirubicin|mesh-list
6576570|NCT01031030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6576571|NCT01031030|Immunologic Factors|immunologic factors|mesh-ancestor
6576572|NCT01031030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576573|NCT01031030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6576574|NCT01031030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6576575|NCT01031030|Alkylating Agents|alkylating agents|mesh-ancestor
6576576|NCT01031030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576577|NCT01031030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6576578|NCT01031030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6576579|NCT01031030|Antimetabolites|antimetabolites|mesh-ancestor
6576580|NCT01031030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6576581|NCT01031030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6576582|NCT01031030|Abortifacient Agents|abortifacient agents|mesh-ancestor
6576583|NCT01031030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6576584|NCT01031030|Dermatologic Agents|dermatologic agents|mesh-ancestor
6576585|NCT01031030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6576586|NCT01031030|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6576587|NCT01031030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6576588|NCT01031030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6576589|NCT01031030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6576590|NCT01031030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6576591|NCT01031212|Acetic Acid|acetic acid|mesh-list
6576592|NCT01031212|Paclitaxel|paclitaxel|mesh-list
6576593|NCT01031212|Carboplatin|carboplatin|mesh-list
6576594|NCT01031212|Cetuximab|cetuximab|mesh-list
6576595|NCT01031212|Vadimezan|vadimezan|mesh-list
6576596|NCT01031212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6576597|NCT01031212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6576598|NCT01031212|Tubulin Modulators|tubulin modulators|mesh-ancestor
6576599|NCT01031212|Antimitotic Agents|antimitotic agents|mesh-ancestor
6576600|NCT01031212|Mitosis Modulators|mitosis modulators|mesh-ancestor
6576601|NCT01031212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576602|NCT01031212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6576603|NCT01031212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6576604|NCT01031212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6576605|NCT01031355|Calcium, Dietary|calcium, dietary|mesh-list
6576606|NCT01031355|Tetrahydrofolates|tetrahydrofolates|mesh-list
6576607|NCT01031355|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6576608|NCT01031355|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6576609|NCT01031355|Calcium|calcium|mesh-list
6576610|NCT01031355|Estradiol|estradiol|mesh-list
6576611|NCT01031355|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6576612|NCT01031355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6576613|NCT01031355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576614|NCT01031355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6576615|NCT01031355|Estrogens|estrogens|mesh-ancestor
6576616|NCT01031355|Hormones|hormones|mesh-ancestor
6446218|NCT00391157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6446219|NCT00391157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6446220|NCT00391157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6446221|NCT00391248|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6446222|NCT00391248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6446223|NCT00391248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6446224|NCT00391248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6446225|NCT00391248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446226|NCT00391261|Metformin|metformin|mesh-list
6446227|NCT00391261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6446228|NCT00391261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446229|NCT00391313|Chloroquine|chloroquine|mesh-list
6446230|NCT00391313|Amebicides|amebicides|mesh-ancestor
6658111|NCT01479751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6576617|NCT01031355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6576618|NCT01031355|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6576619|NCT01031355|Contraceptive Agents|contraceptive agents|mesh-ancestor
6576620|NCT01031355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6576621|NCT01031355|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6576622|NCT01031355|Vitamin B Complex|vitamin b complex|mesh-ancestor
6576623|NCT01031355|Vitamins|vitamins|mesh-ancestor
6576624|NCT01031355|Micronutrients|micronutrients|mesh-ancestor
6576625|NCT01031368|Cytarabine|cytarabine|mesh-list
6576626|NCT01031368|Clofarabine|clofarabine|mesh-list
6576627|NCT01031368|Immunologic Factors|immunologic factors|mesh-ancestor
6576628|NCT01031368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576629|NCT01031368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6576630|NCT01031368|Antimetabolites|antimetabolites|mesh-ancestor
6576631|NCT01031368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576632|NCT01031368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6576633|NCT01031368|Antiviral Agents|antiviral agents|mesh-ancestor
6576634|NCT01031368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6576635|NCT01031368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6576636|NCT01031459|Interferons|interferons|mesh-list
6576637|NCT01031459|Interferon-beta|interferon-beta|mesh-list
6576638|NCT01031459|Interferon beta-1b|interferon beta-1b|mesh-list
6576639|NCT01031459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6576640|NCT01031459|Antiviral Agents|antiviral agents|mesh-ancestor
6576641|NCT01031459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6576642|NCT01031459|Immunologic Factors|immunologic factors|mesh-ancestor
6576643|NCT01031459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576644|NCT01031459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6576645|NCT01031589|Rilpivirine|rilpivirine|mesh-list
6576646|NCT01031589|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6576647|NCT01031589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6576648|NCT01031589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6576649|NCT01031589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576650|NCT01031589|Antiviral Agents|antiviral agents|mesh-ancestor
6576651|NCT01031589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6576652|NCT01031589|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6576653|NCT01031589|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6658112|NCT01479751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658113|NCT01479751|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6658114|NCT01479751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6658115|NCT01479751|Anesthetics, General|anesthetics, general|mesh-ancestor
6658116|NCT01479751|Anesthetics|anesthetics|mesh-ancestor
6658117|NCT01479751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6658118|NCT01479751|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6658119|NCT01479751|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6658120|NCT01479751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6658121|NCT01479751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658122|NCT01479751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6658123|NCT01479751|Anticonvulsants|anticonvulsants|mesh-ancestor
6658124|NCT01479751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6658125|NCT01479751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6658126|NCT01479751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6658127|NCT01479751|Tocolytic Agents|tocolytic agents|mesh-ancestor
6658128|NCT01479751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6658129|NCT01479751|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6658130|NCT01479751|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6658131|NCT01479751|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6658132|NCT01479842|Rituximab|rituximab|mesh-list
6658133|NCT01479842|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6658134|NCT01479842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6658135|NCT01479842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6658136|NCT01479842|Immunologic Factors|immunologic factors|mesh-ancestor
6658137|NCT01479842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658138|NCT01479842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6658139|NCT01479842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6658140|NCT01479842|Alkylating Agents|alkylating agents|mesh-ancestor
6658141|NCT01479842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658142|NCT01479881|Cyclosporine|cyclosporine|mesh-list
6658143|NCT01479881|Simeprevir|simeprevir|mesh-list
6658144|NCT01479881|Tacrolimus|tacrolimus|mesh-list
6658145|NCT01479881|Cyclosporins|cyclosporins|mesh-list
6658146|NCT01479881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6658147|NCT01479881|Immunologic Factors|immunologic factors|mesh-ancestor
6658148|NCT01479881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576654|NCT01031667|Cilostazol|cilostazol|mesh-list
6576655|NCT01031667|Probucol|probucol|mesh-list
6576656|NCT01031667|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6576657|NCT01031667|Autonomic Agents|autonomic agents|mesh-ancestor
6576658|NCT01031667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6576659|NCT01031667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576660|NCT01031667|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6576661|NCT01031667|Respiratory System Agents|respiratory system agents|mesh-ancestor
6576662|NCT01031667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6576663|NCT01031667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6576664|NCT01031667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576665|NCT01031667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6576666|NCT01031667|Vasodilator Agents|vasodilator agents|mesh-ancestor
6576667|NCT01031667|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6576668|NCT01031667|Protective Agents|protective agents|mesh-ancestor
6576669|NCT01031667|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6576670|NCT01031667|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6576671|NCT01031667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6576672|NCT01031667|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6576673|NCT01031667|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6576674|NCT01031667|Antimetabolites|antimetabolites|mesh-ancestor
6576675|NCT01031667|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6576676|NCT01031667|Antioxidants|antioxidants|mesh-ancestor
6576677|NCT01031719|Vaccines|vaccines|mesh-list
6576678|NCT01031719|Immunologic Factors|immunologic factors|mesh-ancestor
6576679|NCT01031719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576680|NCT01031732|Tacrine|tacrine|mesh-list
6576681|NCT01031732|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6576682|NCT01031732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6576683|NCT01031732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576684|NCT01031732|Cholinergic Agents|cholinergic agents|mesh-ancestor
6576685|NCT01031732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6576686|NCT01031732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576687|NCT01031732|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6576688|NCT01031732|Autonomic Agents|autonomic agents|mesh-ancestor
6576689|NCT01031732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6576690|NCT01031732|Nootropic Agents|nootropic agents|mesh-ancestor
6576691|NCT01031849|Lopinavir|lopinavir|mesh-list
6576692|NCT01031849|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6576693|NCT01031849|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6576694|NCT01031849|Protease Inhibitors|protease inhibitors|mesh-ancestor
6576695|NCT01031849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6576696|NCT01031849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576697|NCT01031849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6576698|NCT01031849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6576699|NCT01031849|Antiviral Agents|antiviral agents|mesh-ancestor
6576700|NCT01031849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6576701|NCT01031849|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6576702|NCT01031849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6576703|NCT01031875|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6576704|NCT01031875|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6576705|NCT01031875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576706|NCT01031888|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6576707|NCT01031888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6576708|NCT01031901|Sirolimus|sirolimus|mesh-list
6576709|NCT01031901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6576710|NCT01031901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6576711|NCT01031901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6576712|NCT01031901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6576713|NCT01031901|Antifungal Agents|antifungal agents|mesh-ancestor
6576714|NCT01031901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6576715|NCT01031901|Immunologic Factors|immunologic factors|mesh-ancestor
6576716|NCT01031901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576717|NCT01031927|Glycine|glycine|mesh-list
6576718|NCT01031927|Glycine Agents|glycine agents|mesh-ancestor
6576719|NCT01031927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6576720|NCT01031927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576721|NCT01031927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576722|NCT01031966|Thymalfasin|thymalfasin|mesh-list
6576723|NCT01031966|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6576724|NCT01031966|Immunologic Factors|immunologic factors|mesh-ancestor
6576725|NCT01031966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576726|NCT01031992|Tranexamic Acid|tranexamic acid|mesh-list
6576727|NCT01031992|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6576728|NCT01031992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6576729|NCT01031992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576730|NCT01031992|Hemostatics|hemostatics|mesh-ancestor
6576731|NCT01031992|Coagulants|coagulants|mesh-ancestor
6576732|NCT01032031|Ascorbic Acid|ascorbic acid|mesh-list
6576733|NCT01032031|Vitamins|vitamins|mesh-ancestor
6576734|NCT01032031|Micronutrients|micronutrients|mesh-ancestor
6576735|NCT01032031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576736|NCT01032031|Antioxidants|antioxidants|mesh-ancestor
6576737|NCT01032031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576738|NCT01032031|Protective Agents|protective agents|mesh-ancestor
6576739|NCT01032057|Gemcitabine|gemcitabine|mesh-list
6576740|NCT01032057|Capecitabine|capecitabine|mesh-list
6576741|NCT01032057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6576742|NCT01032057|Antimetabolites|antimetabolites|mesh-ancestor
6576743|NCT01032057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576744|NCT01032057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6576745|NCT01032057|Antiviral Agents|antiviral agents|mesh-ancestor
6576746|NCT01032057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6576747|NCT01032057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6576748|NCT01032057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6576749|NCT01032057|Immunologic Factors|immunologic factors|mesh-ancestor
6576750|NCT01032057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020198|NCT00391976|Tobramycin|tobramycin|mesh-list
6020199|NCT00391976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6020200|NCT00391976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6020201|NCT00391989|Dasatinib|dasatinib|mesh-list
6020202|NCT00391989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6020203|NCT00391989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6020204|NCT00391989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6020205|NCT00391989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020206|NCT00392041|Eszopiclone|eszopiclone|mesh-list
6020207|NCT00392041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6446231|NCT00391313|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6446232|NCT00391313|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6446233|NCT00391313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6446234|NCT00391313|Antimalarials|antimalarials|mesh-ancestor
6446235|NCT00391313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6446236|NCT00391404|Alendronate|alendronate|mesh-list
6446237|NCT00391404|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6446238|NCT00391404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446239|NCT00391417|Estradiol|estradiol|mesh-list
6446240|NCT00391417|Estrogens|estrogens|mesh-ancestor
6446241|NCT00391417|Hormones|hormones|mesh-ancestor
6446242|NCT00391417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6446243|NCT00391417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576751|NCT01032083|Citalopram|citalopram|mesh-list
6576752|NCT01032083|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6576753|NCT01032083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6576754|NCT01032083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6576755|NCT01032083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576756|NCT01032083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6576757|NCT01032083|Serotonin Agents|serotonin agents|mesh-ancestor
6576758|NCT01032083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576759|NCT01032083|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6576760|NCT01032083|Antidepressive Agents|antidepressive agents|mesh-ancestor
6576761|NCT01032083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6576762|NCT01032109|Bevacizumab|bevacizumab|mesh-list
6576763|NCT01032109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6576764|NCT01032109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6576765|NCT01032109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6576766|NCT01032109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6576767|NCT01032109|Growth Substances|growth substances|mesh-ancestor
6576768|NCT01032109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576769|NCT01032109|Growth Inhibitors|growth inhibitors|mesh-ancestor
6576770|NCT01032122|Rituximab|rituximab|mesh-list
6576771|NCT01032122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6576772|NCT01032122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6576773|NCT01032122|Immunologic Factors|immunologic factors|mesh-ancestor
6576774|NCT01032122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576775|NCT01032122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6576776|NCT01032148|Panobinostat|panobinostat|mesh-list
6576777|NCT01032148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6576778|NCT01032148|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6576779|NCT01032148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6576780|NCT01032148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576781|NCT01032187|Amphotericin B|amphotericin b|mesh-list
6576782|NCT01032187|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6576783|NCT01032187|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
6576784|NCT01032187|Meglumine Antimoniate|meglumine antimoniate|mesh-list
6576785|NCT01032187|Deoxycholic Acid|deoxycholic acid|mesh-list
6576786|NCT01032187|Amebicides|amebicides|mesh-ancestor
6576787|NCT01032187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6576788|NCT01032187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6576789|NCT01032187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6576790|NCT01032187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6576791|NCT01032187|Antifungal Agents|antifungal agents|mesh-ancestor
6576792|NCT01032187|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6576793|NCT01032187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6576794|NCT01032213|Magnesium Sulfate|magnesium sulfate|mesh-list
6576795|NCT01032213|Analgesics|analgesics|mesh-ancestor
6576796|NCT01032213|Sensory System Agents|sensory system agents|mesh-ancestor
6576797|NCT01032213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6576798|NCT01032213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576799|NCT01032213|Anesthetics|anesthetics|mesh-ancestor
6576800|NCT01032213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6576801|NCT01032213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6576802|NCT01032213|Anticonvulsants|anticonvulsants|mesh-ancestor
6576803|NCT01032213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6576804|NCT01032213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6576805|NCT01032213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576806|NCT01032213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6576807|NCT01032213|Tocolytic Agents|tocolytic agents|mesh-ancestor
6576808|NCT01032213|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6576809|NCT01032304|Erdosteine|erdosteine|mesh-list
6576810|NCT01032304|Expectorants|expectorants|mesh-ancestor
6576811|NCT01032304|Respiratory System Agents|respiratory system agents|mesh-ancestor
6576812|NCT01032434|Sertraline|sertraline|mesh-list
6576813|NCT01032434|Antidepressive Agents|antidepressive agents|mesh-ancestor
6576814|NCT01032434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6576815|NCT01032434|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6576816|NCT01032434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6576817|NCT01032434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6576818|NCT01032434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576819|NCT01032434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6576820|NCT01032434|Serotonin Agents|serotonin agents|mesh-ancestor
6576821|NCT01032434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576822|NCT01032486|Rasagiline|rasagiline|mesh-list
6576823|NCT01032486|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6576824|NCT01032486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6020208|NCT00392041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6020209|NCT00392041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020210|NCT00392054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
6576825|NCT01032486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576826|NCT01032486|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6576827|NCT01032486|Protective Agents|protective agents|mesh-ancestor
6576828|NCT01032486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576829|NCT01032499|Oxytetracycline|oxytetracycline|mesh-list
6576830|NCT01032499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6576831|NCT01032499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6576832|NCT01032668|Clopidogrel|clopidogrel|mesh-list
6576833|NCT01032668|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6576834|NCT01032668|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6576835|NCT01032668|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6576836|NCT01032668|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6576837|NCT01032668|Purinergic Agents|purinergic agents|mesh-ancestor
6576838|NCT01032668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6576839|NCT01032668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576840|NCT01032668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576841|NCT01032798|Mepivacaine|mepivacaine|mesh-list
6576842|NCT01032798|Anesthetics, Local|anesthetics, local|mesh-ancestor
6576843|NCT01032798|Anesthetics|anesthetics|mesh-ancestor
6576844|NCT01032798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6576845|NCT01032798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576846|NCT01032798|Sensory System Agents|sensory system agents|mesh-ancestor
6576847|NCT01032798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6576848|NCT01033058|Atorvastatin|atorvastatin|mesh-list
6576849|NCT01033058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6576850|NCT01033058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6576851|NCT01033058|Antimetabolites|antimetabolites|mesh-ancestor
6576852|NCT01033058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576853|NCT01033058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6576854|NCT01033058|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6576855|NCT01033058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6576856|NCT01033084|Sertraline|sertraline|mesh-list
6576857|NCT01033084|Antidepressive Agents|antidepressive agents|mesh-ancestor
6576858|NCT01033084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6576859|NCT01033084|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6576860|NCT01033084|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6576861|NCT01033084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6576862|NCT01033084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576863|NCT01033084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6576864|NCT01033084|Serotonin Agents|serotonin agents|mesh-ancestor
6576865|NCT01033084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576866|NCT01033097|Betamethasone|betamethasone|mesh-list
6576867|NCT01033097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6576868|NCT01033097|Glucocorticoids|glucocorticoids|mesh-ancestor
6576869|NCT01033097|Hormones|hormones|mesh-ancestor
6576870|NCT01033097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6576871|NCT01033097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576872|NCT01033097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6576873|NCT01033097|Respiratory System Agents|respiratory system agents|mesh-ancestor
6576874|NCT01033149|Acetylcysteine|acetylcysteine|mesh-list
6576875|NCT01033149|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6576876|NCT01033149|Antiviral Agents|antiviral agents|mesh-ancestor
6576877|NCT01033149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6576878|NCT01033149|Expectorants|expectorants|mesh-ancestor
6576879|NCT01033149|Respiratory System Agents|respiratory system agents|mesh-ancestor
6576880|NCT01033149|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6576881|NCT01033149|Antioxidants|antioxidants|mesh-ancestor
6576882|NCT01033149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576883|NCT01033149|Protective Agents|protective agents|mesh-ancestor
6576884|NCT01033149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576885|NCT01033149|Antidotes|antidotes|mesh-ancestor
6576886|NCT01033279|Warfarin|warfarin|mesh-list
6576887|NCT01033279|Anticoagulants|anticoagulants|mesh-ancestor
6576888|NCT01033305|Cyclosporine|cyclosporine|mesh-list
6576889|NCT01033305|Cyclosporins|cyclosporins|mesh-list
6576890|NCT01033305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6576891|NCT01033305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576892|NCT01033305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6576893|NCT01033305|Immunologic Factors|immunologic factors|mesh-ancestor
6576894|NCT01033305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576895|NCT01033305|Antifungal Agents|antifungal agents|mesh-ancestor
6576896|NCT01033305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6576897|NCT01033305|Dermatologic Agents|dermatologic agents|mesh-ancestor
6576898|NCT01033305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6576899|NCT01033305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6576900|NCT01033318|Losartan|losartan|mesh-list
6576901|NCT01033318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6576902|NCT01033318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6576903|NCT01033318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6576904|NCT01033318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6576905|NCT01033318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576906|NCT01033370|Clevidipine|clevidipine|mesh-list
6576907|NCT01033370|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6576908|NCT01033370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6576909|NCT01033370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576910|NCT01033370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6576911|NCT01033370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576912|NCT01033396|Fexofenadine|fexofenadine|mesh-list
6576913|NCT01033396|Terfenadine|terfenadine|mesh-list
6576914|NCT01033396|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6576915|NCT01033396|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6576916|NCT01033396|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6576917|NCT01033396|Histamine Antagonists|histamine antagonists|mesh-ancestor
6576918|NCT01033396|Histamine Agents|histamine agents|mesh-ancestor
6576919|NCT01033396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6576920|NCT01033396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576921|NCT01033396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576922|NCT01033409|Vaccines|vaccines|mesh-list
6576923|NCT01033409|Immunologic Factors|immunologic factors|mesh-ancestor
6576924|NCT01033409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576925|NCT01033461|Calcium|calcium|mesh-list
6576926|NCT01033461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6576927|NCT01033461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576928|NCT01033500|Abatacept|abatacept|mesh-list
6576929|NCT01033500|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6576930|NCT01033500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576931|NCT01033500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6576932|NCT01033500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6576933|NCT01033500|Immunologic Factors|immunologic factors|mesh-ancestor
6576934|NCT01033500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576935|NCT01033500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6658149|NCT01479881|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6658150|NCT01479881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6658151|NCT01479881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576936|NCT01033526|Aspirin|aspirin|mesh-list
6576937|NCT01033526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6576938|NCT01033526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6576939|NCT01033526|Analgesics|analgesics|mesh-ancestor
6576940|NCT01033526|Sensory System Agents|sensory system agents|mesh-ancestor
6576941|NCT01033526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6576942|NCT01033526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576943|NCT01033526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6576944|NCT01033526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6576945|NCT01033526|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6576946|NCT01033526|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6576947|NCT01033526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576948|NCT01033526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6576949|NCT01033526|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6576950|NCT01033526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6576951|NCT01033526|Antipyretics|antipyretics|mesh-ancestor
6576952|NCT01033552|Cyclosporine|cyclosporine|mesh-list
6576953|NCT01033552|Mycophenolic Acid|mycophenolic acid|mesh-list
6576954|NCT01033552|Cyclophosphamide|cyclophosphamide|mesh-list
6576955|NCT01033552|Fludarabine|fludarabine|mesh-list
6576956|NCT01033552|Cyclosporins|cyclosporins|mesh-list
6576957|NCT01033552|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6576958|NCT01033552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6576959|NCT01033552|Immunologic Factors|immunologic factors|mesh-ancestor
6576960|NCT01033552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576961|NCT01033552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6576962|NCT01033552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6576963|NCT01033552|Alkylating Agents|alkylating agents|mesh-ancestor
6576964|NCT01033552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576965|NCT01033552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6576966|NCT01033552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6576967|NCT01033552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6576968|NCT01033552|Antifungal Agents|antifungal agents|mesh-ancestor
6576969|NCT01033552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6576970|NCT01033552|Dermatologic Agents|dermatologic agents|mesh-ancestor
6576971|NCT01033552|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6576972|NCT01033552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6576973|NCT01033552|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6576974|NCT01033552|Antitubercular Agents|antitubercular agents|mesh-ancestor
6576975|NCT01033552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6576976|NCT01033656|Methotrexate|methotrexate|mesh-list
6576977|NCT01033656|Azathioprine|azathioprine|mesh-list
6576978|NCT01033656|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6576979|NCT01033656|Leflunomide|leflunomide|mesh-list
6576980|NCT01033656|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6576981|NCT01033656|Abortifacient Agents|abortifacient agents|mesh-ancestor
6576982|NCT01033656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6576983|NCT01033656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6576984|NCT01033656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6576985|NCT01033656|Antimetabolites|antimetabolites|mesh-ancestor
6576986|NCT01033656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6576987|NCT01033656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6576988|NCT01033656|Dermatologic Agents|dermatologic agents|mesh-ancestor
6576989|NCT01033656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6576990|NCT01033656|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6576991|NCT01033656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6576992|NCT01033656|Immunologic Factors|immunologic factors|mesh-ancestor
6576993|NCT01033656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6576994|NCT01033656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6576995|NCT01033760|Ritonavir|ritonavir|mesh-list
6576996|NCT01033760|Darunavir|darunavir|mesh-list
6576997|NCT01033760|Tenofovir|tenofovir|mesh-list
6576998|NCT01033760|Emtricitabine|emtricitabine|mesh-list
6576999|NCT01033760|Raltegravir Potassium|raltegravir potassium|mesh-list
6577000|NCT01033760|Maraviroc|maraviroc|mesh-list
6577001|NCT01033760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6577002|NCT01033760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6577003|NCT01033760|Protease Inhibitors|protease inhibitors|mesh-ancestor
6577004|NCT01033760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6577005|NCT01033760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577006|NCT01033760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6577007|NCT01033760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6577008|NCT01033760|Antiviral Agents|antiviral agents|mesh-ancestor
6577009|NCT01033760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6577010|NCT01033760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6577011|NCT01033760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6577012|NCT01033760|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6577013|NCT01033760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6577014|NCT01033760|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6577015|NCT01033760|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6577016|NCT01033760|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6577017|NCT01033760|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6577018|NCT01033760|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6577019|NCT01033877|Vaccines|vaccines|mesh-list
6577020|NCT01033877|Immunologic Factors|immunologic factors|mesh-ancestor
6577021|NCT01033877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577022|NCT01033903|Misoprostol|misoprostol|mesh-list
6577023|NCT01033903|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6577024|NCT01033903|Abortifacient Agents|abortifacient agents|mesh-ancestor
6577025|NCT01033903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6577026|NCT01033903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577027|NCT01033903|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6577028|NCT01033903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6577029|NCT01033903|Oxytocics|oxytocics|mesh-ancestor
6577030|NCT01033955|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6577031|NCT01033955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6577032|NCT01033955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6577033|NCT01033955|Antimetabolites|antimetabolites|mesh-ancestor
6577034|NCT01033955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577035|NCT01033955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6577036|NCT01033955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6577037|NCT01033955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6577038|NCT01033981|Sunitinib|sunitinib|mesh-list
6577039|NCT01033981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6577040|NCT01033981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6577041|NCT01033981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6577042|NCT01033981|Growth Substances|growth substances|mesh-ancestor
6577043|NCT01033981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577044|NCT01033981|Growth Inhibitors|growth inhibitors|mesh-ancestor
6658152|NCT01479881|Antifungal Agents|antifungal agents|mesh-ancestor
6577045|NCT01033981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6577046|NCT01033981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6577047|NCT01033981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577048|NCT01033994|Mitogens|mitogens|mesh-list
6577049|NCT01033994|Mitosis Modulators|mitosis modulators|mesh-ancestor
6577050|NCT01033994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577051|NCT01034020|Nicotine|nicotine|mesh-list
6577052|NCT01034020|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6577053|NCT01034020|Autonomic Agents|autonomic agents|mesh-ancestor
6577054|NCT01034020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6577055|NCT01034020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577056|NCT01034020|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6577057|NCT01034020|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6577058|NCT01034020|Cholinergic Agents|cholinergic agents|mesh-ancestor
6577059|NCT01034020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6577060|NCT01034020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577061|NCT01034124|Vitamin K|vitamin k|mesh-list
6577062|NCT01034124|Midazolam|midazolam|mesh-list
6577063|NCT01034124|Warfarin|warfarin|mesh-list
6577064|NCT01034124|Vitamins|vitamins|mesh-ancestor
6577065|NCT01034124|Micronutrients|micronutrients|mesh-ancestor
6577066|NCT01034124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577067|NCT01034124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6577068|NCT01034124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6577069|NCT01034124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6577070|NCT01034124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6577071|NCT01034124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6577072|NCT01034124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6577073|NCT01034124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6577074|NCT01034124|Anesthetics, General|anesthetics, general|mesh-ancestor
6446244|NCT00391534|Oxcarbazepine|oxcarbazepine|mesh-list
6446245|NCT00391534|Anticonvulsants|anticonvulsants|mesh-ancestor
6446246|NCT00391534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6446247|NCT00391534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6446248|NCT00391534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6446249|NCT00391534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446250|NCT00391534|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6446251|NCT00391534|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6577075|NCT01034124|Anesthetics|anesthetics|mesh-ancestor
6577076|NCT01034124|GABA Modulators|gaba modulators|mesh-ancestor
6577077|NCT01034124|GABA Agents|gaba agents|mesh-ancestor
6577078|NCT01034124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6577079|NCT01034124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577080|NCT01034124|Anticoagulants|anticoagulants|mesh-ancestor
6577081|NCT01034124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6577082|NCT01034124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6577083|NCT01034124|Hemostatics|hemostatics|mesh-ancestor
6577084|NCT01034124|Coagulants|coagulants|mesh-ancestor
6577085|NCT01034189|Paclitaxel|paclitaxel|mesh-list
6577086|NCT01034189|Cetuximab|cetuximab|mesh-list
6577087|NCT01034189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6577088|NCT01034189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6577089|NCT01034189|Tubulin Modulators|tubulin modulators|mesh-ancestor
6577090|NCT01034189|Antimitotic Agents|antimitotic agents|mesh-ancestor
6577091|NCT01034189|Mitosis Modulators|mitosis modulators|mesh-ancestor
6577092|NCT01034189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577093|NCT01034189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6577094|NCT01034345|Sirolimus|sirolimus|mesh-list
6577095|NCT01034345|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
6577096|NCT01034345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6577097|NCT01034345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6577098|NCT01034345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6577099|NCT01034345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6577100|NCT01034345|Antifungal Agents|antifungal agents|mesh-ancestor
6577101|NCT01034345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6446252|NCT00391638|Interferons|interferons|mesh-list
6446253|NCT00391638|Tenofovir|tenofovir|mesh-list
6577102|NCT01034345|Immunologic Factors|immunologic factors|mesh-ancestor
6577103|NCT01034345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577104|NCT01034345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6577105|NCT01034345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577106|NCT01034410|Cytarabine|cytarabine|mesh-list
6577107|NCT01034410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6577108|NCT01034410|Antimetabolites|antimetabolites|mesh-ancestor
6577109|NCT01034410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577110|NCT01034410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6577111|NCT01034410|Antiviral Agents|antiviral agents|mesh-ancestor
6577112|NCT01034410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6577113|NCT01034410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6577114|NCT01034410|Immunologic Factors|immunologic factors|mesh-ancestor
6577115|NCT01034410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446254|NCT00391638|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6020211|NCT00392171|Temozolomide|temozolomide|mesh-list
6020212|NCT00392171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6577116|NCT01034514|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
6577117|NCT01034514|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6577118|NCT01034514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577119|NCT01034683|Leucovorin|leucovorin|mesh-list
6577120|NCT01034683|Antidotes|antidotes|mesh-ancestor
6577121|NCT01034683|Protective Agents|protective agents|mesh-ancestor
6577122|NCT01034683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577123|NCT01034683|Vitamin B Complex|vitamin b complex|mesh-ancestor
6577124|NCT01034683|Vitamins|vitamins|mesh-ancestor
6577125|NCT01034683|Micronutrients|micronutrients|mesh-ancestor
6577126|NCT01034787|Tremelimumab|tremelimumab|mesh-list
6577127|NCT01034787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6577128|NCT01034878|Sunitinib|sunitinib|mesh-list
6577129|NCT01034878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6020213|NCT00392171|Alkylating Agents|alkylating agents|mesh-ancestor
6577130|NCT01034878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6577131|NCT01034878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6577132|NCT01034878|Growth Substances|growth substances|mesh-ancestor
6577133|NCT01034878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577134|NCT01034878|Growth Inhibitors|growth inhibitors|mesh-ancestor
6446255|NCT00391638|Emtricitabine|emtricitabine|mesh-list
6446256|NCT00391638|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6446257|NCT00391638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6446258|NCT00391638|Antiviral Agents|antiviral agents|mesh-ancestor
6446259|NCT00391638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6446260|NCT00391638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6446261|NCT00391638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6446262|NCT00391638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6446263|NCT00391638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446264|NCT00391638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6577135|NCT01034878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6577136|NCT01034878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6577137|NCT01034878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577138|NCT01034917|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6577139|NCT01034917|Etravirine|etravirine|mesh-list
6577140|NCT01034917|Antiviral Agents|antiviral agents|mesh-ancestor
6577141|NCT01034917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6577142|NCT01034917|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6577143|NCT01034917|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6577144|NCT01034917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6577145|NCT01034917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577146|NCT01034956|Calcium|calcium|mesh-list
6577147|NCT01034956|Hyaluronic Acid|hyaluronic acid|mesh-list
6577148|NCT01034956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6577149|NCT01034956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577150|NCT01034956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6577151|NCT01034956|Immunologic Factors|immunologic factors|mesh-ancestor
6577152|NCT01034956|Viscosupplements|viscosupplements|mesh-ancestor
6577153|NCT01034956|Protective Agents|protective agents|mesh-ancestor
6577154|NCT01034995|Citalopram|citalopram|mesh-list
6577155|NCT01034995|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6577156|NCT01034995|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6577157|NCT01034995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6577158|NCT01034995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577159|NCT01034995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6577160|NCT01034995|Serotonin Agents|serotonin agents|mesh-ancestor
6577161|NCT01034995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577162|NCT01034995|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6577163|NCT01034995|Antidepressive Agents|antidepressive agents|mesh-ancestor
6577164|NCT01034995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6577165|NCT01035021|Rocuronium|rocuronium|mesh-list
6577166|NCT01035021|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6577167|NCT01035021|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6577168|NCT01035021|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6577169|NCT01035021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6577170|NCT01035021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577171|NCT01035190|Budesonide|budesonide|mesh-list
6577172|NCT01035190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6577173|NCT01035190|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6577174|NCT01035190|Autonomic Agents|autonomic agents|mesh-ancestor
6577175|NCT01035190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6577176|NCT01035190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577177|NCT01035190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6577178|NCT01035190|Respiratory System Agents|respiratory system agents|mesh-ancestor
6577179|NCT01035190|Glucocorticoids|glucocorticoids|mesh-ancestor
6577180|NCT01035190|Hormones|hormones|mesh-ancestor
6577181|NCT01035190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6577182|NCT01035216|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
6577183|NCT01035216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6577184|NCT01035216|Immunologic Factors|immunologic factors|mesh-ancestor
6577185|NCT01035216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577186|NCT01035281|Nabilone|nabilone|mesh-list
6577187|NCT01035281|Antiemetics|antiemetics|mesh-ancestor
6577188|NCT01035281|Autonomic Agents|autonomic agents|mesh-ancestor
6577189|NCT01035281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6577190|NCT01035281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577191|NCT01035281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6577192|NCT01035281|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6577193|NCT01035281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6577194|NCT01035281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6577195|NCT01035281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6658153|NCT01479881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6658154|NCT01479881|Dermatologic Agents|dermatologic agents|mesh-ancestor
6658155|NCT01479881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6658156|NCT01479881|Antiviral Agents|antiviral agents|mesh-ancestor
6658157|NCT01479881|Protease Inhibitors|protease inhibitors|mesh-ancestor
6658158|NCT01479920|Fluoxetine|fluoxetine|mesh-list
6658159|NCT01479920|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6658160|NCT01479920|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6658161|NCT01479920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6658162|NCT01479920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658163|NCT01479920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6658164|NCT01479920|Serotonin Agents|serotonin agents|mesh-ancestor
6658165|NCT01479920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658166|NCT01479920|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6658167|NCT01479920|Antidepressive Agents|antidepressive agents|mesh-ancestor
6658168|NCT01479920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6658169|NCT01479920|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6658170|NCT01479920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6658171|NCT01479920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6658172|NCT01479933|Vitamin D|vitamin d|mesh-list
6658173|NCT01479933|Ergocalciferols|ergocalciferols|mesh-list
6658174|NCT01479933|Cholecalciferol|cholecalciferol|mesh-list
6658175|NCT01479933|Vitamins|vitamins|mesh-list
6658176|NCT01479933|Micronutrients|micronutrients|mesh-ancestor
6658177|NCT01479933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658178|NCT01479933|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6658179|NCT01479933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6658180|NCT01480050|Temozolomide|temozolomide|mesh-list
6658181|NCT01480050|Mibefradil|mibefradil|mesh-list
6658182|NCT01480050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6658183|NCT01480050|Alkylating Agents|alkylating agents|mesh-ancestor
6658184|NCT01480050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658185|NCT01480050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6658186|NCT01480050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6658187|NCT01480050|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6658188|NCT01480050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6658189|NCT01480050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6658190|NCT01480050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658191|NCT01480050|Vasodilator Agents|vasodilator agents|mesh-ancestor
6658192|NCT01480050|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6658193|NCT01480050|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6658194|NCT01480050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6577196|NCT01035320|Simvastatin|simvastatin|mesh-list
6577197|NCT01035320|Ezetimibe|ezetimibe|mesh-list
6577198|NCT01035320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6577199|NCT01035320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6577200|NCT01035320|Antimetabolites|antimetabolites|mesh-ancestor
6446265|NCT00391638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6446266|NCT00391651|Nitrofurantoin|nitrofurantoin|mesh-list
6446267|NCT00391651|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6446268|NCT00391651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6446269|NCT00391651|Renal Agents|renal agents|mesh-ancestor
6446270|NCT00391651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6577201|NCT01035320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577202|NCT01035320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6577203|NCT01035320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6577204|NCT01035320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6577205|NCT01035450|Sirolimus|sirolimus|mesh-list
6577206|NCT01035450|Everolimus|everolimus|mesh-list
6577207|NCT01035450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6577208|NCT01035450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6577209|NCT01035450|Immunologic Factors|immunologic factors|mesh-ancestor
6577210|NCT01035450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577211|NCT01035450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6577212|NCT01035450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6577213|NCT01035450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6577214|NCT01035450|Antifungal Agents|antifungal agents|mesh-ancestor
6577215|NCT01035515|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
6577216|NCT01035515|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
6577217|NCT01035515|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6577218|NCT01035515|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6577219|NCT01035515|Purinergic Agents|purinergic agents|mesh-ancestor
6577220|NCT01035515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6577221|NCT01035515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577222|NCT01035515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577223|NCT01035528|Metformin|metformin|mesh-list
6577224|NCT01035528|Insulin Glargine|insulin glargine|mesh-list
6577225|NCT01035528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6577226|NCT01035528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577227|NCT01035580|Curcumin|curcumin|mesh-list
6577228|NCT01035580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6577229|NCT01035580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6577230|NCT01035580|Analgesics|analgesics|mesh-ancestor
6577231|NCT01035580|Sensory System Agents|sensory system agents|mesh-ancestor
6577232|NCT01035580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6577233|NCT01035580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577234|NCT01035580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6577235|NCT01035580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6577236|NCT01035580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6577237|NCT01035580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6446271|NCT00391690|Zoledronic Acid|zoledronic acid|mesh-list
6577238|NCT01035580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577239|NCT01035619|Moxidectin|moxidectin|mesh-list
6446272|NCT00391690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6446273|NCT00391690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446274|NCT00391885|Anesthetics|anesthetics|mesh-list
6446275|NCT00391885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6577240|NCT01035619|Anthelmintics|anthelmintics|mesh-ancestor
6577241|NCT01035619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6577242|NCT01035619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6577243|NCT01035619|Antinematodal Agents|antinematodal agents|mesh-ancestor
6577244|NCT01035671|Vitamin E|vitamin e|mesh-list
6577245|NCT01035671|Tocopherylquinone|tocopherylquinone|mesh-list
6577246|NCT01035671|Anticoagulants|anticoagulants|mesh-ancestor
6577247|NCT01035671|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6577248|NCT01035671|Antioxidants|antioxidants|mesh-ancestor
6577249|NCT01035671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577250|NCT01035671|Protective Agents|protective agents|mesh-ancestor
6577251|NCT01035671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577252|NCT01035671|Vitamins|vitamins|mesh-ancestor
6577253|NCT01035671|Micronutrients|micronutrients|mesh-ancestor
6577254|NCT01035801|Insulin Lispro|insulin lispro|mesh-list
6577255|NCT01035801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6577256|NCT01035801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577257|NCT01035853|Colistin|colistin|mesh-list
6577258|NCT01035853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6577259|NCT01035853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6577260|NCT01035983|Frovatriptan|frovatriptan|mesh-list
6577261|NCT01035983|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6577262|NCT01035983|Serotonin Agents|serotonin agents|mesh-ancestor
6577263|NCT01035983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6577264|NCT01035983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577265|NCT01035983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577266|NCT01036035|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6577267|NCT01036035|Pilocarpine|pilocarpine|mesh-list
6577268|NCT01036035|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6577269|NCT01036035|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6577270|NCT01036035|Cholinergic Agents|cholinergic agents|mesh-ancestor
6577271|NCT01036035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6577272|NCT01036035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577273|NCT01036035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577274|NCT01036035|Urological Agents|urological agents|mesh-ancestor
6577275|NCT01036035|Miotics|miotics|mesh-ancestor
6577276|NCT01036035|Autonomic Agents|autonomic agents|mesh-ancestor
6577277|NCT01036035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6577278|NCT01036035|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6577279|NCT01036035|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6577280|NCT01036087|Paclitaxel|paclitaxel|mesh-list
6577281|NCT01036087|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6577282|NCT01036087|Cyclophosphamide|cyclophosphamide|mesh-list
6577283|NCT01036087|Carboplatin|carboplatin|mesh-list
6577284|NCT01036087|Fluorouracil|fluorouracil|mesh-list
6577285|NCT01036087|Epirubicin|epirubicin|mesh-list
6577286|NCT01036087|Panitumumab|panitumumab|mesh-list
6577287|NCT01036087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6577288|NCT01036087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6577289|NCT01036087|Tubulin Modulators|tubulin modulators|mesh-ancestor
6577290|NCT01036087|Antimitotic Agents|antimitotic agents|mesh-ancestor
6577291|NCT01036087|Mitosis Modulators|mitosis modulators|mesh-ancestor
6577292|NCT01036087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577293|NCT01036087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6577294|NCT01036087|Immunologic Factors|immunologic factors|mesh-ancestor
6577295|NCT01036087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577296|NCT01036087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6577297|NCT01036087|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6577298|NCT01036087|Alkylating Agents|alkylating agents|mesh-ancestor
6577299|NCT01036087|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6577300|NCT01036087|Antimetabolites|antimetabolites|mesh-ancestor
6577301|NCT01036087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6577302|NCT01036087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6577303|NCT01036087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6577304|NCT01036087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6577305|NCT01036087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6577306|NCT01036087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6577307|NCT01036399|Lenalidomide|lenalidomide|mesh-list
6577308|NCT01036399|Immunologic Factors|immunologic factors|mesh-ancestor
6577309|NCT01036399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577310|NCT01036399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6577311|NCT01036399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6577312|NCT01036399|Growth Substances|growth substances|mesh-ancestor
6577313|NCT01036399|Growth Inhibitors|growth inhibitors|mesh-ancestor
6577314|NCT01036399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6577315|NCT01036412|Chlorhexidine|chlorhexidine|mesh-list
6577316|NCT01036412|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6658195|NCT01480063|4-Aminopyridine|4-aminopyridine|mesh-list
6577317|NCT01036412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6577318|NCT01036412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6577319|NCT01036412|Disinfectants|disinfectants|mesh-ancestor
6577320|NCT01036412|Dermatologic Agents|dermatologic agents|mesh-ancestor
6577321|NCT01036659|Ecallantide|ecallantide|mesh-list
6577322|NCT01036659|Bradykinin|bradykinin|mesh-list
6577323|NCT01036659|Kallikreins|kallikreins|mesh-list
6577324|NCT01036659|Kininogens|kininogens|mesh-list
6577325|NCT01036659|Vasodilator Agents|vasodilator agents|mesh-ancestor
6577326|NCT01036659|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
6577327|NCT01036659|Protease Inhibitors|protease inhibitors|mesh-ancestor
6577328|NCT01036659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6577329|NCT01036659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577330|NCT01036659|Analgesics|analgesics|mesh-ancestor
6577331|NCT01036659|Sensory System Agents|sensory system agents|mesh-ancestor
6577332|NCT01036659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6577333|NCT01036659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577334|NCT01036659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6577335|NCT01036659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6577336|NCT01036659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6577337|NCT01036659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6577338|NCT01036659|Coagulants|coagulants|mesh-ancestor
6577339|NCT01036659|Fertility Agents, Male|fertility agents, male|mesh-ancestor
6577340|NCT01036659|Fertility Agents|fertility agents|mesh-ancestor
6577341|NCT01036659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6577342|NCT01036841|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
6577343|NCT01036841|Hemostatics|hemostatics|mesh-ancestor
6577344|NCT01036841|Coagulants|coagulants|mesh-ancestor
6577345|NCT01036841|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6577346|NCT01036841|Natriuretic Agents|natriuretic agents|mesh-ancestor
6577347|NCT01036841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577348|NCT01036854|Ondansetron|ondansetron|mesh-list
6577349|NCT01036854|Antiemetics|antiemetics|mesh-ancestor
6577350|NCT01036854|Autonomic Agents|autonomic agents|mesh-ancestor
6577351|NCT01036854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6577352|NCT01036854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577353|NCT01036854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6577354|NCT01036854|Antipruritics|antipruritics|mesh-ancestor
6577355|NCT01036854|Dermatologic Agents|dermatologic agents|mesh-ancestor
6577356|NCT01036854|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6577357|NCT01036854|Serotonin Agents|serotonin agents|mesh-ancestor
6577358|NCT01036854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6577359|NCT01036854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577360|NCT01036854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6577361|NCT01036854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6577362|NCT01036854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6577363|NCT01036854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6577364|NCT01036854|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6577365|NCT01036893|Prucalopride|prucalopride|mesh-list
6577366|NCT01036893|Laxatives|laxatives|mesh-ancestor
6577367|NCT01036893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6577368|NCT01036893|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
6577369|NCT01036893|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6577370|NCT01036893|Serotonin Agents|serotonin agents|mesh-ancestor
6577371|NCT01036893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6577372|NCT01036893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577373|NCT01036893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577374|NCT01036932|Sargramostim|sargramostim|mesh-list
6577375|NCT01036932|Lenograstim|lenograstim|mesh-list
6577376|NCT01036932|Immunologic Factors|immunologic factors|mesh-ancestor
6577377|NCT01036932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577378|NCT01036932|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6577379|NCT01037023|Topotecan|topotecan|mesh-list
6577380|NCT01037023|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6577381|NCT01037023|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6577382|NCT01037023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6577383|NCT01037023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577384|NCT01037023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6577385|NCT01037101|Cycloserine|cycloserine|mesh-list
6577386|NCT01037101|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6577387|NCT01037101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6577388|NCT01037101|Renal Agents|renal agents|mesh-ancestor
6577389|NCT01037101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6577390|NCT01037101|Antitubercular Agents|antitubercular agents|mesh-ancestor
6577391|NCT01037101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6577392|NCT01037101|Antimetabolites|antimetabolites|mesh-ancestor
6577393|NCT01037101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577394|NCT01037140|Vitamin D|vitamin d|mesh-list
6577395|NCT01037140|Cholecalciferol|cholecalciferol|mesh-list
6577396|NCT01037140|Vitamins|vitamins|mesh-ancestor
6577397|NCT01037140|Micronutrients|micronutrients|mesh-ancestor
6577398|NCT01037140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577399|NCT01037140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6577400|NCT01037140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6577401|NCT01037322|Cannabidiol|cannabidiol|mesh-list
6577402|NCT01037322|Anticonvulsants|anticonvulsants|mesh-ancestor
6577403|NCT01037335|Morphine|morphine|mesh-list
6577404|NCT01037335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6577405|NCT01037335|Narcotics|narcotics|mesh-ancestor
6577406|NCT01037335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6577407|NCT01037335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577408|NCT01037335|Analgesics|analgesics|mesh-ancestor
6577409|NCT01037335|Sensory System Agents|sensory system agents|mesh-ancestor
6577410|NCT01037335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6577411|NCT01037348|Ranibizumab|ranibizumab|mesh-list
6577412|NCT01037348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6577413|NCT01037348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6577414|NCT01037348|Growth Substances|growth substances|mesh-ancestor
6577415|NCT01037348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577416|NCT01037348|Growth Inhibitors|growth inhibitors|mesh-ancestor
6577417|NCT01037348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6577418|NCT01037387|Bronchodilator Agents|bronchodilator agents|mesh-list
6577419|NCT01037387|Autonomic Agents|autonomic agents|mesh-ancestor
6577420|NCT01037387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6577421|NCT01037387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577422|NCT01037387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6577423|NCT01037387|Respiratory System Agents|respiratory system agents|mesh-ancestor
6577424|NCT01037465|Acetylcysteine|acetylcysteine|mesh-list
6577425|NCT01037465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6577426|NCT01037465|Antiviral Agents|antiviral agents|mesh-ancestor
6577427|NCT01037465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6577428|NCT01037465|Expectorants|expectorants|mesh-ancestor
6577429|NCT01037465|Respiratory System Agents|respiratory system agents|mesh-ancestor
6577430|NCT01037465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6577431|NCT01037465|Antioxidants|antioxidants|mesh-ancestor
6577432|NCT01037465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577433|NCT01037465|Protective Agents|protective agents|mesh-ancestor
6577434|NCT01037465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577435|NCT01037465|Antidotes|antidotes|mesh-ancestor
6577436|NCT01037491|Aspirin|aspirin|mesh-list
6577437|NCT01037491|Rabeprazole|rabeprazole|mesh-list
6577438|NCT01037491|Clopidogrel|clopidogrel|mesh-list
6577439|NCT01037491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6577440|NCT01037491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6577441|NCT01037491|Analgesics|analgesics|mesh-ancestor
6577442|NCT01037491|Sensory System Agents|sensory system agents|mesh-ancestor
6577443|NCT01037491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6577444|NCT01037491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577445|NCT01037491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6577446|NCT01037491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6577447|NCT01037491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6577448|NCT01037491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6577449|NCT01037491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577450|NCT01037491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6577451|NCT01037491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6577452|NCT01037491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6577453|NCT01037491|Antipyretics|antipyretics|mesh-ancestor
6577454|NCT01037491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6577455|NCT01037491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6577456|NCT01037491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6577457|NCT01037491|Purinergic Agents|purinergic agents|mesh-ancestor
6577458|NCT01037491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6577459|NCT01037491|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6577460|NCT01037491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6577461|NCT01037491|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6577462|NCT01037517|Plerixafor|plerixafor|mesh-list
6577463|NCT01037517|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6577464|NCT01037517|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6577465|NCT01037517|Antiviral Agents|antiviral agents|mesh-ancestor
6577466|NCT01037517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6577467|NCT01037530|Ramipril|ramipril|mesh-list
6577468|NCT01037530|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6577469|NCT01037530|Protease Inhibitors|protease inhibitors|mesh-ancestor
6577470|NCT01037530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6577471|NCT01037530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577472|NCT01037530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6577473|NCT01037595|Turmeric extract|turmeric extract|mesh-list
6577474|NCT01037595|Antioxidants|antioxidants|mesh-ancestor
6577475|NCT01037595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577476|NCT01037595|Protective Agents|protective agents|mesh-ancestor
6577477|NCT01037595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577478|NCT01037608|Nabiximols|nabiximols|mesh-list
6577479|NCT01037608|Analgesics|analgesics|mesh-ancestor
6577480|NCT01037608|Sensory System Agents|sensory system agents|mesh-ancestor
6577481|NCT01037608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6577482|NCT01037608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577483|NCT01037621|Valacyclovir|valacyclovir|mesh-list
6577484|NCT01037621|Antiviral Agents|antiviral agents|mesh-ancestor
6577485|NCT01037621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6577486|NCT01037634|Oseltamivir|oseltamivir|mesh-list
6577487|NCT01037634|Antiviral Agents|antiviral agents|mesh-ancestor
6577488|NCT01037634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6577489|NCT01037634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6577490|NCT01037634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577491|NCT01037660|Metformin|metformin|mesh-list
6577492|NCT01037660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6577493|NCT01037660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577494|NCT01037699|Hormones|hormones|mesh-list
6577495|NCT01037699|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6577496|NCT01037699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6577497|NCT01037699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577498|NCT01037712|Valacyclovir|valacyclovir|mesh-list
6577499|NCT01037712|Antiviral Agents|antiviral agents|mesh-ancestor
6577500|NCT01037712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6577501|NCT01037725|Oxazolidinones|oxazolidinones|mesh-list
6577502|NCT01037725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6577503|NCT01037725|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6577504|NCT01037725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6577505|NCT01037725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658196|NCT01480063|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6658197|NCT01480063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6658198|NCT01480063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6664776|NCT01514019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6664777|NCT01514019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6664778|NCT01514019|Sympathomimetics|sympathomimetics|mesh-ancestor
6664779|NCT01514019|Autonomic Agents|autonomic agents|mesh-ancestor
6664780|NCT01514019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6664781|NCT01514019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664782|NCT01514019|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6664783|NCT01514019|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6664784|NCT01514019|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6664785|NCT01514019|Adrenergic Agents|adrenergic agents|mesh-ancestor
6664786|NCT01514019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6664787|NCT01514019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6664788|NCT01514110|Paclitaxel|paclitaxel|mesh-list
6664789|NCT01514110|Carboplatin|carboplatin|mesh-list
6664790|NCT01514110|Everolimus|everolimus|mesh-list
6664791|NCT01514110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6664792|NCT01514110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6664793|NCT01514110|Tubulin Modulators|tubulin modulators|mesh-ancestor
6664794|NCT01514110|Antimitotic Agents|antimitotic agents|mesh-ancestor
6664795|NCT01514110|Mitosis Modulators|mitosis modulators|mesh-ancestor
6664796|NCT01514110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6664797|NCT01514110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6664798|NCT01514110|Immunologic Factors|immunologic factors|mesh-ancestor
6664799|NCT01514110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020214|NCT00392171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020215|NCT00392171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6020216|NCT00392197|Aripiprazole|aripiprazole|mesh-list
6020217|NCT00392197|Antidepressive Agents|antidepressive agents|mesh-ancestor
6020218|NCT00392197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6020219|NCT00392197|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6020220|NCT00392197|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6020221|NCT00392197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6020222|NCT00392197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020223|NCT00392197|Dopamine Agonists|dopamine agonists|mesh-ancestor
6020224|NCT00392197|Dopamine Agents|dopamine agents|mesh-ancestor
6020225|NCT00392197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6577506|NCT01037842|Mitiglinide|mitiglinide|mesh-list
6577507|NCT01037842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6577508|NCT01037842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577509|NCT01037959|Norfloxacin|norfloxacin|mesh-list
6577510|NCT01037959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6577511|NCT01037959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6577512|NCT01037959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6577513|NCT01037959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6577514|NCT01037959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6577515|NCT01037959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577516|NCT01037959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6577517|NCT01037959|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6577518|NCT01037959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6577519|NCT01037998|Gefitinib|gefitinib|mesh-list
6577520|NCT01037998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6577521|NCT01037998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6577522|NCT01037998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6577523|NCT01037998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577524|NCT01038024|Antioxidants|antioxidants|mesh-list
6577525|NCT01038024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577526|NCT01038024|Protective Agents|protective agents|mesh-ancestor
6577527|NCT01038024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577528|NCT01038037|Carboplatin|carboplatin|mesh-list
6577529|NCT01038037|Vinorelbine|vinorelbine|mesh-list
6577530|NCT01038037|Panitumumab|panitumumab|mesh-list
6577531|NCT01038037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6577532|NCT01038037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6577533|NCT01038037|Tubulin Modulators|tubulin modulators|mesh-ancestor
6577534|NCT01038037|Antimitotic Agents|antimitotic agents|mesh-ancestor
6577535|NCT01038037|Mitosis Modulators|mitosis modulators|mesh-ancestor
6577536|NCT01038037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577537|NCT01038037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6577538|NCT01038063|Lumefantrine|lumefantrine|mesh-list
6577539|NCT01038063|Artemether|artemether|mesh-list
6577540|NCT01038063|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6577541|NCT01038063|Antimalarials|antimalarials|mesh-ancestor
6577542|NCT01038063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6577543|NCT01038063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6577544|NCT01038063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6577545|NCT01038089|Resveratrol|resveratrol|mesh-list
6577546|NCT01038089|Antioxidants|antioxidants|mesh-ancestor
6577547|NCT01038089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577548|NCT01038089|Protective Agents|protective agents|mesh-ancestor
6577549|NCT01038089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577550|NCT01038089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6577551|NCT01038089|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6577552|NCT01038154|Pravastatin|pravastatin|mesh-list
6577553|NCT01038154|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6577554|NCT01038154|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6577555|NCT01038154|Antimetabolites|antimetabolites|mesh-ancestor
6577556|NCT01038154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577557|NCT01038154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6577558|NCT01038154|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6577559|NCT01038154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6577560|NCT01038167|Cyclosporine|cyclosporine|mesh-list
6577561|NCT01038167|Tacrolimus|tacrolimus|mesh-list
6577562|NCT01038167|Cyclosporins|cyclosporins|mesh-list
6577563|NCT01038167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6577564|NCT01038167|Immunologic Factors|immunologic factors|mesh-ancestor
6577565|NCT01038167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577566|NCT01038167|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6577567|NCT01038167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6658199|NCT01480141|Afatinib|afatinib|mesh-list
6577568|NCT01038167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577569|NCT01038167|Antifungal Agents|antifungal agents|mesh-ancestor
6577570|NCT01038167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6577571|NCT01038167|Dermatologic Agents|dermatologic agents|mesh-ancestor
6577572|NCT01038167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6577573|NCT01038349|Methotrexate|methotrexate|mesh-list
6577574|NCT01038349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6577575|NCT01038349|Abortifacient Agents|abortifacient agents|mesh-ancestor
6577576|NCT01038349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6577577|NCT01038349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577578|NCT01038349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6577579|NCT01038349|Antimetabolites|antimetabolites|mesh-ancestor
6577580|NCT01038349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577581|NCT01038349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6577582|NCT01038349|Dermatologic Agents|dermatologic agents|mesh-ancestor
6577583|NCT01038349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6577584|NCT01038349|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6577585|NCT01038349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6577586|NCT01038349|Immunologic Factors|immunologic factors|mesh-ancestor
6577587|NCT01038349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6577588|NCT01038349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6577589|NCT01038388|Dexamethasone|dexamethasone|mesh-list
6577590|NCT01038388|Lenalidomide|lenalidomide|mesh-list
6577591|NCT01038388|Bortezomib|bortezomib|mesh-list
6577592|NCT01038388|Vorinostat|vorinostat|mesh-list
6577593|NCT01038388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6577594|NCT01038388|Antiemetics|antiemetics|mesh-ancestor
6577595|NCT01038388|Autonomic Agents|autonomic agents|mesh-ancestor
6577596|NCT01038388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6577597|NCT01038388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577598|NCT01038388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6577599|NCT01038388|Glucocorticoids|glucocorticoids|mesh-ancestor
6577600|NCT01038388|Hormones|hormones|mesh-ancestor
6577601|NCT01038388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6577602|NCT01038388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6577603|NCT01038388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6577604|NCT01038388|Immunologic Factors|immunologic factors|mesh-ancestor
6577605|NCT01038388|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6577606|NCT01038388|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6577607|NCT01038388|Growth Substances|growth substances|mesh-ancestor
6577608|NCT01038388|Growth Inhibitors|growth inhibitors|mesh-ancestor
6577609|NCT01038388|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6577610|NCT01038388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6577611|NCT01038388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577612|NCT01038453|Vitamin D|vitamin d|mesh-list
6577613|NCT01038453|Cholecalciferol|cholecalciferol|mesh-list
6446276|NCT00391885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446277|NCT00391911|Acetylcysteine|acetylcysteine|mesh-list
6446278|NCT00391911|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6446279|NCT00391911|Antiviral Agents|antiviral agents|mesh-ancestor
6446280|NCT00391911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6446281|NCT00391911|Expectorants|expectorants|mesh-ancestor
6577614|NCT01038453|Vitamins|vitamins|mesh-ancestor
6577615|NCT01038453|Micronutrients|micronutrients|mesh-ancestor
6446282|NCT00391911|Respiratory System Agents|respiratory system agents|mesh-ancestor
6446283|NCT00391911|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6446284|NCT00391911|Antioxidants|antioxidants|mesh-ancestor
6446285|NCT00391911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446286|NCT00391911|Protective Agents|protective agents|mesh-ancestor
6577616|NCT01038453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577617|NCT01038453|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6577618|NCT01038453|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6577619|NCT01038505|Sirolimus|sirolimus|mesh-list
6577620|NCT01038505|Mycophenolic Acid|mycophenolic acid|mesh-list
6577621|NCT01038505|Tacrolimus|tacrolimus|mesh-list
6577622|NCT01038505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6577623|NCT01038505|Immunologic Factors|immunologic factors|mesh-ancestor
6577624|NCT01038505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577625|NCT01038505|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6577626|NCT01038505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6577627|NCT01038505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577628|NCT01038505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6577629|NCT01038505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6577630|NCT01038505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6577631|NCT01038505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6577632|NCT01038505|Antifungal Agents|antifungal agents|mesh-ancestor
6577633|NCT01038505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6577634|NCT01038505|Antitubercular Agents|antitubercular agents|mesh-ancestor
6577635|NCT01038570|Oxytocin|oxytocin|mesh-list
6577636|NCT01038570|Oxytocics|oxytocics|mesh-ancestor
6577637|NCT01038570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6577638|NCT01038570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577639|NCT01038583|Aspirin|aspirin|mesh-list
6577640|NCT01038583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6577641|NCT01038583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6577642|NCT01038583|Analgesics|analgesics|mesh-ancestor
6577643|NCT01038583|Sensory System Agents|sensory system agents|mesh-ancestor
6577644|NCT01038583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6577645|NCT01038583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577646|NCT01038583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6577647|NCT01038583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6577648|NCT01038583|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6577649|NCT01038583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6577650|NCT01038583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577651|NCT01038583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6577652|NCT01038583|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6577653|NCT01038583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6577654|NCT01038583|Antipyretics|antipyretics|mesh-ancestor
6577655|NCT01038648|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6577656|NCT01038648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6577657|NCT01038648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577658|NCT01038648|Incretins|incretins|mesh-ancestor
6577659|NCT01038648|Hormones|hormones|mesh-ancestor
6577660|NCT01038648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6577661|NCT01038648|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6577662|NCT01038648|Protease Inhibitors|protease inhibitors|mesh-ancestor
6577663|NCT01038648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6577664|NCT01038648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577665|NCT01038661|Docetaxel|docetaxel|mesh-list
6577666|NCT01038661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6577667|NCT01038661|Tubulin Modulators|tubulin modulators|mesh-ancestor
6577668|NCT01038661|Antimitotic Agents|antimitotic agents|mesh-ancestor
6577669|NCT01038661|Mitosis Modulators|mitosis modulators|mesh-ancestor
6577670|NCT01038661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577671|NCT01038817|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
6577672|NCT01038817|Cariostatic Agents|cariostatic agents|mesh-ancestor
6577673|NCT01038817|Protective Agents|protective agents|mesh-ancestor
6577674|NCT01038817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577675|NCT01038882|Midazolam|midazolam|mesh-list
6577676|NCT01038882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6577677|NCT01038882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6577678|NCT01038882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6577679|NCT01038882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577680|NCT01038882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6577681|NCT01038882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6577682|NCT01038882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6577683|NCT01038882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6577684|NCT01038882|Anesthetics, General|anesthetics, general|mesh-ancestor
6577685|NCT01038882|Anesthetics|anesthetics|mesh-ancestor
6577686|NCT01038882|GABA Modulators|gaba modulators|mesh-ancestor
6577687|NCT01038882|GABA Agents|gaba agents|mesh-ancestor
6577688|NCT01038882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6577689|NCT01038882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724798|NCT03184870|Antimitotic Agents|antimitotic agents|mesh-ancestor
6577690|NCT01038895|Ramipril|ramipril|mesh-list
6577691|NCT01038895|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6577692|NCT01038895|Protease Inhibitors|protease inhibitors|mesh-ancestor
6577693|NCT01038895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6577694|NCT01038895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577695|NCT01038895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6577696|NCT01039025|Cyclophosphamide|cyclophosphamide|mesh-list
6577697|NCT01039025|Melphalan|melphalan|mesh-list
6577698|NCT01039025|Topotecan|topotecan|mesh-list
6577699|NCT01039025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6577700|NCT01039025|Immunologic Factors|immunologic factors|mesh-ancestor
6577701|NCT01039025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577702|NCT01039025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6577703|NCT01039025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6577704|NCT01039025|Alkylating Agents|alkylating agents|mesh-ancestor
6577705|NCT01039025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577706|NCT01039025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6577707|NCT01039025|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6577708|NCT01039025|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6577709|NCT01039025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6577710|NCT01039025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6577711|NCT01039090|Dopamine|dopamine|mesh-list
6577712|NCT01039090|Apomorphine|apomorphine|mesh-list
6577713|NCT01039090|Dopamine Agonists|dopamine agonists|mesh-list
6577714|NCT01039090|Emetics|emetics|mesh-ancestor
6577715|NCT01039090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577716|NCT01039090|Autonomic Agents|autonomic agents|mesh-ancestor
6577717|NCT01039090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6577718|NCT01039090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6577719|NCT01039090|Dopamine Agents|dopamine agents|mesh-ancestor
6577720|NCT01039090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6577721|NCT01039090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577722|NCT01039090|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6577723|NCT01039090|Sympathomimetics|sympathomimetics|mesh-ancestor
6577724|NCT01039090|Protective Agents|protective agents|mesh-ancestor
6577725|NCT01039103|Methylprednisolone|methylprednisolone|mesh-list
6577726|NCT01039103|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6577727|NCT01039103|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6577728|NCT01039103|Prednisolone|prednisolone|mesh-list
6577729|NCT01039103|Prednisolone acetate|prednisolone acetate|mesh-list
6577730|NCT01039103|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6577731|NCT01039103|Prednisolone phosphate|prednisolone phosphate|mesh-list
6577732|NCT01039103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6577733|NCT01039103|Antiemetics|antiemetics|mesh-ancestor
6577734|NCT01039103|Autonomic Agents|autonomic agents|mesh-ancestor
6577735|NCT01039103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6577736|NCT01039103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577737|NCT01039103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6577738|NCT01039103|Glucocorticoids|glucocorticoids|mesh-ancestor
6577739|NCT01039103|Hormones|hormones|mesh-ancestor
6577740|NCT01039103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6577741|NCT01039103|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6577742|NCT01039103|Protective Agents|protective agents|mesh-ancestor
6664800|NCT01514123|Bevacizumab|bevacizumab|mesh-list
6577743|NCT01039103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6577744|NCT01039103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6577745|NCT01039142|Acitretin|acitretin|mesh-list
6577746|NCT01039142|Keratolytic Agents|keratolytic agents|mesh-ancestor
6577747|NCT01039142|Dermatologic Agents|dermatologic agents|mesh-ancestor
6577748|NCT01039155|Oxaliplatin|oxaliplatin|mesh-list
6577749|NCT01039155|Azacitidine|azacitidine|mesh-list
6577750|NCT01039155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6577751|NCT01039155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6577752|NCT01039155|Antimetabolites|antimetabolites|mesh-ancestor
6577753|NCT01039155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577754|NCT01039155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6577755|NCT01039181|Vitamin D|vitamin d|mesh-list
6577756|NCT01039181|Calcitriol|calcitriol|mesh-list
6577757|NCT01039181|Vitamins|vitamins|mesh-ancestor
6577758|NCT01039181|Micronutrients|micronutrients|mesh-ancestor
6577759|NCT01039181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577760|NCT01039181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6577761|NCT01039181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6577762|NCT01039181|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6577763|NCT01039181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6577764|NCT01039181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577765|NCT01039181|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6577766|NCT01039194|Galantamine|galantamine|mesh-list
6577767|NCT01039194|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6577768|NCT01039194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6577769|NCT01039194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577770|NCT01039194|Cholinergic Agents|cholinergic agents|mesh-ancestor
6577771|NCT01039194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6577772|NCT01039194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577773|NCT01039194|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6577774|NCT01039194|Autonomic Agents|autonomic agents|mesh-ancestor
6577775|NCT01039194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6577776|NCT01039194|Nootropic Agents|nootropic agents|mesh-ancestor
6577777|NCT01039233|Bicalutamide|bicalutamide|mesh-list
6577778|NCT01039233|Androgen Antagonists|androgen antagonists|mesh-ancestor
6577779|NCT01039233|Hormone Antagonists|hormone antagonists|mesh-ancestor
6577780|NCT01039233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6577781|NCT01039233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577782|NCT01039233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6577783|NCT01039285|Poractant alfa|poractant alfa|mesh-list
6577784|NCT01039285|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
6577785|NCT01039285|Respiratory System Agents|respiratory system agents|mesh-ancestor
6577786|NCT01039350|Darbepoetin alfa|darbepoetin alfa|mesh-list
6577787|NCT01039350|Hematinics|hematinics|mesh-ancestor
6577788|NCT01039363|Cytarabine|cytarabine|mesh-list
6577789|NCT01039363|Vorinostat|vorinostat|mesh-list
6577790|NCT01039363|Idarubicin|idarubicin|mesh-list
6577791|NCT01039363|Gemtuzumab|gemtuzumab|mesh-list
6577792|NCT01039363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6577793|NCT01039363|Antimetabolites|antimetabolites|mesh-ancestor
6577794|NCT01039363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577795|NCT01039363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6577796|NCT01039363|Antiviral Agents|antiviral agents|mesh-ancestor
6577797|NCT01039363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6577798|NCT01039363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6577799|NCT01039363|Immunologic Factors|immunologic factors|mesh-ancestor
6577800|NCT01039363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577801|NCT01039363|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6577802|NCT01039363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6577803|NCT01039363|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6577804|NCT01039363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6577805|NCT01039363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6577806|NCT01039363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6658200|NCT01480141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6658201|NCT01480141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6446287|NCT00391911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446288|NCT00391911|Antidotes|antidotes|mesh-ancestor
6446289|NCT00391924|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
6446290|NCT00391924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6446291|NCT00391924|Immunologic Factors|immunologic factors|mesh-ancestor
6446292|NCT00391924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446293|NCT00391950|Zoledronic Acid|zoledronic acid|mesh-list
6446294|NCT00391950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6446295|NCT00391950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724799|NCT03184870|Mitosis Modulators|mitosis modulators|mesh-ancestor
6577807|NCT01039441|Bupivacaine|bupivacaine|mesh-list
6577808|NCT01039441|Anesthetics, Local|anesthetics, local|mesh-ancestor
6577809|NCT01039441|Anesthetics|anesthetics|mesh-ancestor
6577810|NCT01039441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6577811|NCT01039441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577812|NCT01039441|Sensory System Agents|sensory system agents|mesh-ancestor
6577813|NCT01039441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6577814|NCT01039506|Irinotecan|irinotecan|mesh-list
6446296|NCT00392002|Esomeprazole|esomeprazole|mesh-list
6446297|NCT00392002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6446298|NCT00392002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6020226|NCT00392197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020227|NCT00392197|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6446299|NCT00392002|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6577815|NCT01039506|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6577816|NCT01039506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6577817|NCT01039506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6577818|NCT01039506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577819|NCT01039506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6577820|NCT01039545|Norfloxacin|norfloxacin|mesh-list
6577821|NCT01039545|Diclofenac|diclofenac|mesh-list
6577822|NCT01039545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6577823|NCT01039545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6577824|NCT01039545|Analgesics|analgesics|mesh-ancestor
6577825|NCT01039545|Sensory System Agents|sensory system agents|mesh-ancestor
6446300|NCT00392002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6446301|NCT00392002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577826|NCT01039545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6446302|NCT00392028|Ertapenem|ertapenem|mesh-list
6446303|NCT00392028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6446304|NCT00392028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6446305|NCT00392067|Calcipotriene|calcipotriene|mesh-list
6446306|NCT00392067|Dermatologic Agents|dermatologic agents|mesh-ancestor
6446307|NCT00392080|Naproxen|naproxen|mesh-list
6577827|NCT01039545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577828|NCT01039545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6577829|NCT01039545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6577830|NCT01039545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6577831|NCT01039545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6577832|NCT01039545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577833|NCT01039545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6577834|NCT01039545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6577835|NCT01039545|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6577836|NCT01039545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6577837|NCT01039545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6577838|NCT01039545|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6577839|NCT01039545|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6577840|NCT01039558|Ecabet|ecabet|mesh-list
6577841|NCT01039558|Lansoprazole|lansoprazole|mesh-list
6577842|NCT01039558|Dexlansoprazole|dexlansoprazole|mesh-list
6577843|NCT01039558|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6577844|NCT01039558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6577845|NCT01039558|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6577846|NCT01039558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6577847|NCT01039558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577848|NCT01039558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6577849|NCT01039558|Protease Inhibitors|protease inhibitors|mesh-ancestor
6577850|NCT01039558|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6577851|NCT01039558|Protective Agents|protective agents|mesh-ancestor
6577852|NCT01039558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577853|NCT01039558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6577854|NCT01039610|Moxifloxacin|moxifloxacin|mesh-list
6577855|NCT01039610|Linezolid|linezolid|mesh-list
6577856|NCT01039610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6577857|NCT01039610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6577858|NCT01039610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6577859|NCT01039610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6577860|NCT01039610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6577861|NCT01039610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577862|NCT01039610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6577863|NCT01039610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6577864|NCT01039740|Mirtazapine|mirtazapine|mesh-list
6577865|NCT01039740|Antidepressive Agents|antidepressive agents|mesh-ancestor
6577866|NCT01039740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6577867|NCT01039740|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6577868|NCT01039740|Histamine Antagonists|histamine antagonists|mesh-ancestor
6577869|NCT01039740|Histamine Agents|histamine agents|mesh-ancestor
6577870|NCT01039740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6577871|NCT01039740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577872|NCT01039740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577873|NCT01039740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6577874|NCT01039740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6577875|NCT01039740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6577876|NCT01039740|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6577877|NCT01039740|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6446308|NCT00392080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6446309|NCT00392080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6446310|NCT00392080|Analgesics|analgesics|mesh-ancestor
6446311|NCT00392080|Sensory System Agents|sensory system agents|mesh-ancestor
6446312|NCT00392080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6446313|NCT00392080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446314|NCT00392080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6446315|NCT00392080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6446316|NCT00392080|Gout Suppressants|gout suppressants|mesh-ancestor
6446317|NCT00392080|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6446318|NCT00392080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6446319|NCT00392080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446320|NCT00392093|Estrogens|estrogens|mesh-list
6446321|NCT00392093|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6446322|NCT00392093|Hormones|hormones|mesh-ancestor
6577878|NCT01039740|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6577879|NCT01039740|Adrenergic Agents|adrenergic agents|mesh-ancestor
6577880|NCT01039740|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6577881|NCT01039740|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6577882|NCT01039740|Serotonin Agents|serotonin agents|mesh-ancestor
6577883|NCT01039740|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6577884|NCT01039766|Oxytocin|oxytocin|mesh-list
6577885|NCT01039766|Oxytocics|oxytocics|mesh-ancestor
6577886|NCT01039766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6577887|NCT01039766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577888|NCT01039844|Paclitaxel|paclitaxel|mesh-list
6577889|NCT01039844|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6577890|NCT01039844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6577891|NCT01039844|Tubulin Modulators|tubulin modulators|mesh-ancestor
6577892|NCT01039844|Antimitotic Agents|antimitotic agents|mesh-ancestor
6577893|NCT01039844|Mitosis Modulators|mitosis modulators|mesh-ancestor
6577894|NCT01039844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577895|NCT01039883|Albaconazole|albaconazole|mesh-list
6577896|NCT01039883|Antifungal Agents|antifungal agents|mesh-ancestor
6577897|NCT01039883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6577898|NCT01039948|Gefitinib|gefitinib|mesh-list
6577899|NCT01039948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6577900|NCT01039948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6577901|NCT01039948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6577902|NCT01039948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577903|NCT01039974|Ketoconazole|ketoconazole|mesh-list
6577904|NCT01039974|Antifungal Agents|antifungal agents|mesh-ancestor
6577905|NCT01039974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6577906|NCT01039974|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6577907|NCT01039974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6577908|NCT01039974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6577909|NCT01039974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577910|NCT01039974|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6577911|NCT01039974|Hormone Antagonists|hormone antagonists|mesh-ancestor
6577912|NCT01039974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6577913|NCT01039974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577914|NCT01039974|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6577915|NCT01040078|Vaccines|vaccines|mesh-list
6577916|NCT01040078|Immunologic Factors|immunologic factors|mesh-ancestor
6577917|NCT01040078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577918|NCT01040091|Tenofovir|tenofovir|mesh-list
6577919|NCT01040091|Emtricitabine|emtricitabine|mesh-list
6577920|NCT01040091|Efavirenz|efavirenz|mesh-list
6577921|NCT01040091|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6577922|NCT01040091|Antiviral Agents|antiviral agents|mesh-ancestor
6577923|NCT01040091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6577924|NCT01040091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6577925|NCT01040091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6577926|NCT01040091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6577927|NCT01040091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577928|NCT01040091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6020228|NCT00392197|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6020229|NCT00392197|Serotonin Agents|serotonin agents|mesh-ancestor
6020230|NCT00392197|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6020231|NCT00392197|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6020232|NCT00392197|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6446323|NCT00392093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6446324|NCT00392093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446325|NCT00392106|Amiodarone|amiodarone|mesh-list
6446326|NCT00392106|Flecainide|flecainide|mesh-list
6446327|NCT00392106|Propafenone|propafenone|mesh-list
6446328|NCT00392106|Dofetilide|dofetilide|mesh-list
6446329|NCT00392106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6446330|NCT00392106|Vasodilator Agents|vasodilator agents|mesh-ancestor
6446331|NCT00392106|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6577929|NCT01040091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6577930|NCT01040091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6577931|NCT01040091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6577932|NCT01040091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6577933|NCT01040091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6577934|NCT01040091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6577935|NCT01040091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6577936|NCT01040195|Hydroxychloroquine|hydroxychloroquine|mesh-list
6577937|NCT01040195|Methotrexate|methotrexate|mesh-list
6577938|NCT01040195|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6577939|NCT01040195|Abortifacient Agents|abortifacient agents|mesh-ancestor
6577940|NCT01040195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6577941|NCT01040195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577942|NCT01040195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6577943|NCT01040195|Antimetabolites|antimetabolites|mesh-ancestor
6577944|NCT01040195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577945|NCT01040195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6577946|NCT01040195|Dermatologic Agents|dermatologic agents|mesh-ancestor
6577947|NCT01040195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6577948|NCT01040195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6577949|NCT01040195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6577950|NCT01040195|Immunologic Factors|immunologic factors|mesh-ancestor
6577951|NCT01040195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6577952|NCT01040195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6577953|NCT01040195|Antimalarials|antimalarials|mesh-ancestor
6577954|NCT01040195|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6577955|NCT01040195|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6577956|NCT01040195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6577957|NCT01040234|Bupivacaine|bupivacaine|mesh-list
6577958|NCT01040234|Anesthetics, Local|anesthetics, local|mesh-ancestor
6577959|NCT01040234|Anesthetics|anesthetics|mesh-ancestor
6577960|NCT01040234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6577961|NCT01040234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577962|NCT01040234|Sensory System Agents|sensory system agents|mesh-ancestor
6577963|NCT01040234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6577964|NCT01040273|Bupivacaine|bupivacaine|mesh-list
6577965|NCT01040273|Anesthetics, Local|anesthetics, local|mesh-ancestor
6577966|NCT01040273|Anesthetics|anesthetics|mesh-ancestor
6577967|NCT01040273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6577968|NCT01040273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577969|NCT01040273|Sensory System Agents|sensory system agents|mesh-ancestor
6577970|NCT01040273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6577971|NCT01040286|Chlorhexidine|chlorhexidine|mesh-list
6577972|NCT01040286|Flurbiprofen|flurbiprofen|mesh-list
6577973|NCT01040286|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6577974|NCT01040286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6577975|NCT01040286|Disinfectants|disinfectants|mesh-ancestor
6577976|NCT01040286|Analgesics|analgesics|mesh-ancestor
6577977|NCT01040286|Sensory System Agents|sensory system agents|mesh-ancestor
6577978|NCT01040286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5724800|NCT03184870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724801|NCT03184870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6577979|NCT01040286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577980|NCT01040286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6577981|NCT01040286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6577982|NCT01040286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6577983|NCT01040286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6577984|NCT01040286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6577985|NCT01040286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6577986|NCT01040286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6577987|NCT01040312|Cisplatin|cisplatin|mesh-list
6577988|NCT01040312|Carboplatin|carboplatin|mesh-list
6577989|NCT01040312|Nedaplatin|nedaplatin|mesh-list
6577990|NCT01040312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6577991|NCT01040325|Vaccines|vaccines|mesh-list
6577992|NCT01040325|Immunologic Factors|immunologic factors|mesh-ancestor
6577993|NCT01040325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577994|NCT01040338|Nicotine|nicotine|mesh-list
6577995|NCT01040338|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6577996|NCT01040338|Autonomic Agents|autonomic agents|mesh-ancestor
6577997|NCT01040338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6577998|NCT01040338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6577999|NCT01040338|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6578000|NCT01040338|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6578001|NCT01040338|Cholinergic Agents|cholinergic agents|mesh-ancestor
6578002|NCT01040338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6578003|NCT01040338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578004|NCT01040429|Clonidine|clonidine|mesh-list
6578005|NCT01040429|Analgesics|analgesics|mesh-ancestor
6578006|NCT01040429|Sensory System Agents|sensory system agents|mesh-ancestor
6578007|NCT01040429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6578008|NCT01040429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578009|NCT01040429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6578010|NCT01040429|Sympatholytics|sympatholytics|mesh-ancestor
6578011|NCT01040429|Autonomic Agents|autonomic agents|mesh-ancestor
6578012|NCT01040429|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5724802|NCT03184870|Antimetabolites|antimetabolites|mesh-ancestor
6578013|NCT01040429|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6578014|NCT01040429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6578015|NCT01040429|Adrenergic Agents|adrenergic agents|mesh-ancestor
6578016|NCT01040429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6578017|NCT01040429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578018|NCT01040455|Lansoprazole|lansoprazole|mesh-list
6578019|NCT01040455|Dexlansoprazole|dexlansoprazole|mesh-list
6578020|NCT01040455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6578021|NCT01040455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6578022|NCT01040455|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6578023|NCT01040455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6578024|NCT01040455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578025|NCT01040559|Idarubicin|idarubicin|mesh-list
6578026|NCT01040559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6578027|NCT01040559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6578028|NCT01040559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6578029|NCT01040559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6578030|NCT01040559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6578031|NCT01040559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578032|NCT01040585|Linezolid|linezolid|mesh-list
6578033|NCT01040585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6578034|NCT01040585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6578035|NCT01040585|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6578036|NCT01040585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6578037|NCT01040585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578038|NCT01040598|Omalizumab|omalizumab|mesh-list
6578039|NCT01040598|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6578040|NCT01040598|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6578041|NCT01040598|Respiratory System Agents|respiratory system agents|mesh-ancestor
6578042|NCT01040702|Methylphenidate|methylphenidate|mesh-list
6578043|NCT01040702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6578044|NCT01040702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578045|NCT01040702|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6578046|NCT01040702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6578047|NCT01040702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6578048|NCT01040702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578049|NCT01040702|Dopamine Agents|dopamine agents|mesh-ancestor
6578050|NCT01040702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6578051|NCT01040936|Atorvastatin|atorvastatin|mesh-list
6578052|NCT01040936|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6578053|NCT01040936|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6578054|NCT01040936|Antimetabolites|antimetabolites|mesh-ancestor
6578055|NCT01040936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578056|NCT01040936|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6578057|NCT01040936|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5724803|NCT03184870|Antiviral Agents|antiviral agents|mesh-ancestor
6578058|NCT01040936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6578059|NCT01041027|Paclitaxel|paclitaxel|mesh-list
6578060|NCT01041027|Carboplatin|carboplatin|mesh-list
6578061|NCT01041027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6578062|NCT01041027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6578063|NCT01041027|Tubulin Modulators|tubulin modulators|mesh-ancestor
6578064|NCT01041027|Antimitotic Agents|antimitotic agents|mesh-ancestor
6020233|NCT00392197|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6020234|NCT00392223|Azithromycin|azithromycin|mesh-list
6578065|NCT01041027|Mitosis Modulators|mitosis modulators|mesh-ancestor
6578066|NCT01041027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578067|NCT01041040|Gemtuzumab|gemtuzumab|mesh-list
6578068|NCT01041040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6578069|NCT01041040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6020235|NCT00392223|Minocycline|minocycline|mesh-list
6578070|NCT01041066|Labetalol|labetalol|mesh-list
6578071|NCT01041066|Nicardipine|nicardipine|mesh-list
6578072|NCT01041066|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6578073|NCT01041066|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6578074|NCT01041066|Adrenergic Agents|adrenergic agents|mesh-ancestor
6578075|NCT01041066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6578076|NCT01041066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578077|NCT01041066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578078|NCT01041066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6578079|NCT01041066|Sympathomimetics|sympathomimetics|mesh-ancestor
6578080|NCT01041066|Autonomic Agents|autonomic agents|mesh-ancestor
6578081|NCT01041066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6578082|NCT01041066|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6578083|NCT01041066|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6578084|NCT01041066|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6578085|NCT01041066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6578086|NCT01041066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6578087|NCT01041066|Vasodilator Agents|vasodilator agents|mesh-ancestor
6578088|NCT01041092|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
6578089|NCT01041092|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6578090|NCT01041092|Hormone Antagonists|hormone antagonists|mesh-ancestor
6578091|NCT01041092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6578092|NCT01041092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578093|NCT01041092|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6578094|NCT01041092|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6578095|NCT01041092|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6578096|NCT01041170|Rimonabant|rimonabant|mesh-list
6578097|NCT01041170|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6578098|NCT01041170|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
6578099|NCT01041170|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6578100|NCT01041170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6578101|NCT01041170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578102|NCT01041170|Hormones|hormones|mesh-ancestor
6578103|NCT01041170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6578104|NCT01041170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578105|NCT01041183|Ramosetron|ramosetron|mesh-list
6578106|NCT01041183|Antiemetics|antiemetics|mesh-ancestor
6578107|NCT01041183|Autonomic Agents|autonomic agents|mesh-ancestor
6578108|NCT01041183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6578109|NCT01041183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578110|NCT01041183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6578111|NCT01041183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6578112|NCT01041183|Serotonin Agents|serotonin agents|mesh-ancestor
6578113|NCT01041183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6578114|NCT01041183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578115|NCT01041235|Docetaxel|docetaxel|mesh-list
6578116|NCT01041235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6578117|NCT01041235|Tubulin Modulators|tubulin modulators|mesh-ancestor
6578118|NCT01041235|Antimitotic Agents|antimitotic agents|mesh-ancestor
6578119|NCT01041235|Mitosis Modulators|mitosis modulators|mesh-ancestor
6578120|NCT01041235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578121|NCT01041313|Memantine|memantine|mesh-list
6578122|NCT01041313|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6578123|NCT01041313|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6578124|NCT01041313|Dopamine Agents|dopamine agents|mesh-ancestor
6578125|NCT01041313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6578126|NCT01041313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578127|NCT01041313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578128|NCT01041313|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6578129|NCT01041313|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6578130|NCT01041378|Dexamethasone|dexamethasone|mesh-list
6578131|NCT01041378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6578132|NCT01041378|Antiemetics|antiemetics|mesh-ancestor
6578133|NCT01041378|Autonomic Agents|autonomic agents|mesh-ancestor
6578134|NCT01041378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6578135|NCT01041378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578136|NCT01041378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6578137|NCT01041378|Glucocorticoids|glucocorticoids|mesh-ancestor
6578138|NCT01041378|Hormones|hormones|mesh-ancestor
6578139|NCT01041378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6578140|NCT01041378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6578141|NCT01041378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6578142|NCT01041443|Tetrahydrouridine|tetrahydrouridine|mesh-list
6578143|NCT01041443|Antimetabolites|antimetabolites|mesh-ancestor
6578144|NCT01041443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578145|NCT01041482|Sorafenib|sorafenib|mesh-list
6578146|NCT01041482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6578147|NCT01041482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6578148|NCT01041482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6578149|NCT01041482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578150|NCT01041508|Cyclosporine|cyclosporine|mesh-list
6578151|NCT01041508|Mycophenolic Acid|mycophenolic acid|mesh-list
6578152|NCT01041508|Clofarabine|clofarabine|mesh-list
6578153|NCT01041508|Cyclosporins|cyclosporins|mesh-list
6578154|NCT01041508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6578155|NCT01041508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578156|NCT01041508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6578157|NCT01041508|Immunologic Factors|immunologic factors|mesh-ancestor
6578158|NCT01041508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578159|NCT01041508|Antifungal Agents|antifungal agents|mesh-ancestor
6578160|NCT01041508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6578161|NCT01041508|Dermatologic Agents|dermatologic agents|mesh-ancestor
6578162|NCT01041508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6578163|NCT01041508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6578164|NCT01041508|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6578165|NCT01041508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6578166|NCT01041508|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6578167|NCT01041508|Antitubercular Agents|antitubercular agents|mesh-ancestor
6578168|NCT01041508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6578169|NCT01041508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6578170|NCT01041508|Antimetabolites|antimetabolites|mesh-ancestor
6578171|NCT01041625|Apremilast|apremilast|mesh-list
6578172|NCT01041625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6578173|NCT01041625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6578174|NCT01041625|Analgesics|analgesics|mesh-ancestor
6578175|NCT01041625|Sensory System Agents|sensory system agents|mesh-ancestor
6578176|NCT01041625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6578177|NCT01041625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578178|NCT01041625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6578179|NCT01041625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6578180|NCT01041625|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6578181|NCT01041625|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6578182|NCT01041625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6578183|NCT01041625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578184|NCT01041690|Bevacizumab|bevacizumab|mesh-list
6578185|NCT01041690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6578186|NCT01041690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6578187|NCT01041690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6578188|NCT01041690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6578189|NCT01041690|Growth Substances|growth substances|mesh-ancestor
6578190|NCT01041690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578191|NCT01041690|Growth Inhibitors|growth inhibitors|mesh-ancestor
6578192|NCT01041729|Atorvastatin|atorvastatin|mesh-list
6578193|NCT01041729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6578194|NCT01041729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6578195|NCT01041729|Antimetabolites|antimetabolites|mesh-ancestor
6578196|NCT01041729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578197|NCT01041729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6578198|NCT01041729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6578199|NCT01041729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6578200|NCT01041755|N-Methylaspartate|n-methylaspartate|mesh-list
6578201|NCT01041755|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
6578202|NCT01041755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6578203|NCT01041755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6578204|NCT01041755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578205|NCT01041755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578206|NCT01041872|Lidocaine|lidocaine|mesh-list
6578207|NCT01041872|Propofol|propofol|mesh-list
6578208|NCT01041872|Anesthetics, Local|anesthetics, local|mesh-ancestor
6578209|NCT01041872|Anesthetics|anesthetics|mesh-ancestor
6578210|NCT01041872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6578211|NCT01041872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578212|NCT01041872|Sensory System Agents|sensory system agents|mesh-ancestor
6578213|NCT01041872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6578214|NCT01041872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6578215|NCT01041872|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6578216|NCT01041872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6578217|NCT01041872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6578218|NCT01041872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578219|NCT01041872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6578220|NCT01041872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6578221|NCT01041872|Anesthetics, General|anesthetics, general|mesh-ancestor
6578222|NCT01041963|Losartan|losartan|mesh-list
6578223|NCT01041963|Enalapril|enalapril|mesh-list
6578224|NCT01041963|Enalaprilat|enalaprilat|mesh-list
6578225|NCT01041963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6578226|NCT01041963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6578227|NCT01041963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6578228|NCT01041963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6578229|NCT01041963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578230|NCT01041963|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6578231|NCT01041963|Protease Inhibitors|protease inhibitors|mesh-ancestor
6578232|NCT01041963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6578233|NCT01042028|Capecitabine|capecitabine|mesh-list
6578234|NCT01042028|Irinotecan|irinotecan|mesh-list
6578235|NCT01042028|Cetuximab|cetuximab|mesh-list
6578236|NCT01042028|Everolimus|everolimus|mesh-list
6578237|NCT01042028|Oxaliplatin|oxaliplatin|mesh-list
6578238|NCT01042028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6578239|NCT01042028|Antimetabolites|antimetabolites|mesh-ancestor
6578240|NCT01042028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578241|NCT01042028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6578242|NCT01042028|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6578243|NCT01042028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6578244|NCT01042028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6578245|NCT01042028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6578246|NCT01042028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6578247|NCT01042028|Immunologic Factors|immunologic factors|mesh-ancestor
6578248|NCT01042028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578249|NCT01042041|Doxorubicin|doxorubicin|mesh-list
6578250|NCT01042041|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6578251|NCT01042041|Sorafenib|sorafenib|mesh-list
6578252|NCT01042041|Mitomycins|mitomycins|mesh-list
6578253|NCT01042041|Mitomycin|mitomycin|mesh-list
6578254|NCT01042041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6578255|NCT01042041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6578256|NCT01042041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6578257|NCT01042041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6578258|NCT01042041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6578259|NCT01042041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578260|NCT01042041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6578261|NCT01042041|Alkylating Agents|alkylating agents|mesh-ancestor
6578262|NCT01042041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6578263|NCT01042314|Donepezil|donepezil|mesh-list
6578264|NCT01042314|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6578265|NCT01042314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6578266|NCT01042314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578267|NCT01042314|Cholinergic Agents|cholinergic agents|mesh-ancestor
6578268|NCT01042314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6578269|NCT01042314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578270|NCT01042314|Nootropic Agents|nootropic agents|mesh-ancestor
6578271|NCT01042379|Metformin|metformin|mesh-list
6578272|NCT01042379|Paclitaxel|paclitaxel|mesh-list
6578273|NCT01042379|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
6578274|NCT01042379|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6578275|NCT01042379|Carboplatin|carboplatin|mesh-list
6578276|NCT01042379|Doxorubicin|doxorubicin|mesh-list
6578277|NCT01042379|Pembrolizumab|pembrolizumab|mesh-list
6578278|NCT01042379|Trastuzumab|trastuzumab|mesh-list
6578279|NCT01042379|Irinotecan|irinotecan|mesh-list
6578280|NCT01042379|Letrozole|letrozole|mesh-list
6578281|NCT01042379|Durvalumab|durvalumab|mesh-list
6578282|NCT01042379|Olaparib|olaparib|mesh-list
6578283|NCT01042379|Pertuzumab|pertuzumab|mesh-list
6578284|NCT01042379|Veliparib|veliparib|mesh-list
6578285|NCT01042379|Talazoparib|talazoparib|mesh-list
6578286|NCT01042379|Cemiplimab|cemiplimab|mesh-list
6578287|NCT01042379|Trebananib|trebananib|mesh-list
6578288|NCT01042379|Tucatinib|tucatinib|mesh-list
6578289|NCT01042379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6578290|NCT01042379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6578291|NCT01042379|Tubulin Modulators|tubulin modulators|mesh-ancestor
6578292|NCT01042379|Antimitotic Agents|antimitotic agents|mesh-ancestor
6578293|NCT01042379|Mitosis Modulators|mitosis modulators|mesh-ancestor
6578294|NCT01042379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578295|NCT01042379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6578296|NCT01042379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578297|NCT01042379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6578298|NCT01042379|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6578299|NCT01042379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6578300|NCT01042379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6578301|NCT01042379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6578302|NCT01042379|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6578303|NCT01042379|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6578304|NCT01042379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6578305|NCT01042379|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6578306|NCT01042379|Hormone Antagonists|hormone antagonists|mesh-ancestor
6578307|NCT01042379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6578308|NCT01042379|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6578309|NCT01042379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6578310|NCT01042379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6578311|NCT01042379|Growth Substances|growth substances|mesh-ancestor
6578312|NCT01042379|Growth Inhibitors|growth inhibitors|mesh-ancestor
6578313|NCT01042379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6578314|NCT01042457|Mycophenolic Acid|mycophenolic acid|mesh-list
6578315|NCT01042457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6578316|NCT01042457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6578317|NCT01042457|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6578318|NCT01042457|Antitubercular Agents|antitubercular agents|mesh-ancestor
6578319|NCT01042457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6578320|NCT01042457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6578321|NCT01042457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6578322|NCT01042457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578323|NCT01042561|Vitamin D|vitamin d|mesh-list
6578324|NCT01042561|Ergocalciferols|ergocalciferols|mesh-list
6578325|NCT01042561|Cholecalciferol|cholecalciferol|mesh-list
6578326|NCT01042561|Vitamins|vitamins|mesh-list
6578327|NCT01042561|Micronutrients|micronutrients|mesh-ancestor
6578328|NCT01042561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578329|NCT01042561|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6578330|NCT01042561|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6578331|NCT01042574|Clevidipine|clevidipine|mesh-list
6578332|NCT01042574|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6578333|NCT01042574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6578334|NCT01042574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578335|NCT01042574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6578336|NCT01042574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578337|NCT01042652|Raltegravir Potassium|raltegravir potassium|mesh-list
6578338|NCT01042652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6446332|NCT00392106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6446333|NCT00392106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446334|NCT00392106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6446335|NCT00392106|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6446336|NCT00392106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6446337|NCT00392106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6446338|NCT00392106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6446339|NCT00392106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6446340|NCT00392106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6446341|NCT00392106|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6446342|NCT00392158|Anesthetics|anesthetics|mesh-list
6446343|NCT00392158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6578339|NCT01042652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6578340|NCT01042652|Antiviral Agents|antiviral agents|mesh-ancestor
6578341|NCT01042652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6578342|NCT01042652|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6578343|NCT01042652|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6578344|NCT01042652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6578345|NCT01042652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578346|NCT01042665|Latanoprost|latanoprost|mesh-list
6578347|NCT01042665|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6578348|NCT01042665|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6578349|NCT01042691|Oxaliplatin|oxaliplatin|mesh-list
6578350|NCT01042691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6578351|NCT01042704|Aspirin|aspirin|mesh-list
6578352|NCT01042704|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6578353|NCT01042704|Dexamethasone|dexamethasone|mesh-list
6578354|NCT01042704|Lenalidomide|lenalidomide|mesh-list
6578355|NCT01042704|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6578356|NCT01042704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6578357|NCT01042704|Antiemetics|antiemetics|mesh-ancestor
6578358|NCT01042704|Autonomic Agents|autonomic agents|mesh-ancestor
6578359|NCT01042704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6578360|NCT01042704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578361|NCT01042704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6578362|NCT01042704|Glucocorticoids|glucocorticoids|mesh-ancestor
6578363|NCT01042704|Hormones|hormones|mesh-ancestor
6578364|NCT01042704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6578365|NCT01042704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6578366|NCT01042704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6578367|NCT01042704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6578368|NCT01042704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6578369|NCT01042704|Analgesics|analgesics|mesh-ancestor
6578370|NCT01042704|Sensory System Agents|sensory system agents|mesh-ancestor
6578371|NCT01042704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6578372|NCT01042704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6578373|NCT01042704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6578374|NCT01042704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578375|NCT01042704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6578376|NCT01042704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6578377|NCT01042704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6578378|NCT01042704|Antipyretics|antipyretics|mesh-ancestor
6578379|NCT01042704|Immunologic Factors|immunologic factors|mesh-ancestor
6578380|NCT01042704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6578381|NCT01042704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6578382|NCT01042704|Growth Substances|growth substances|mesh-ancestor
6578383|NCT01042704|Growth Inhibitors|growth inhibitors|mesh-ancestor
6578384|NCT01042704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6578385|NCT01042704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6578386|NCT01042704|Alkylating Agents|alkylating agents|mesh-ancestor
6578387|NCT01042717|Plerixafor|plerixafor|mesh-list
6578388|NCT01042717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6578389|NCT01042717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6578390|NCT01042717|Antiviral Agents|antiviral agents|mesh-ancestor
6578391|NCT01042717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6578392|NCT01042730|Pitavastatin|pitavastatin|mesh-list
6578393|NCT01042730|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6578394|NCT01042730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6578395|NCT01042730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6578396|NCT01042730|Antimetabolites|antimetabolites|mesh-ancestor
6578397|NCT01042730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578398|NCT01042730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6578399|NCT01042730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6578400|NCT01042782|Everolimus|everolimus|mesh-list
6578401|NCT01042782|Mitomycin|mitomycin|mesh-list
6578402|NCT01042782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6578403|NCT01042782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6578404|NCT01042782|Immunologic Factors|immunologic factors|mesh-ancestor
6578405|NCT01042782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578406|NCT01042782|Alkylating Agents|alkylating agents|mesh-ancestor
6578407|NCT01042782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578408|NCT01042782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6578409|NCT01042782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6578410|NCT01042782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6658202|NCT01480141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6658203|NCT01480141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658204|NCT01480323|Aldesleukin|aldesleukin|mesh-list
6658205|NCT01480323|Ipilimumab|ipilimumab|mesh-list
6658206|NCT01480323|Interleukin-2|interleukin-2|mesh-list
6658207|NCT01480323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6658208|NCT01480323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6658209|NCT01480323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6658210|NCT01480323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658211|NCT01480323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6658212|NCT01480323|Analgesics|analgesics|mesh-ancestor
6658213|NCT01480323|Sensory System Agents|sensory system agents|mesh-ancestor
6658214|NCT01480323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6658215|NCT01480323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658216|NCT01480323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6658217|NCT01480323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6658218|NCT01480323|Antiviral Agents|antiviral agents|mesh-ancestor
6658219|NCT01480323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6658220|NCT01480336|Amiodarone|amiodarone|mesh-list
6658221|NCT01480336|Ranolazine|ranolazine|mesh-list
6658222|NCT01480336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6658223|NCT01480336|Vasodilator Agents|vasodilator agents|mesh-ancestor
6658224|NCT01480336|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6658225|NCT01480336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6658226|NCT01480336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578411|NCT01042873|Dobutamine|dobutamine|mesh-list
6578412|NCT01042873|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6578413|NCT01042873|Sympathomimetics|sympathomimetics|mesh-ancestor
6578414|NCT01042873|Autonomic Agents|autonomic agents|mesh-ancestor
6578415|NCT01042873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6578416|NCT01042873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578417|NCT01042873|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6578418|NCT01042873|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6578419|NCT01042873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6578420|NCT01042873|Adrenergic Agents|adrenergic agents|mesh-ancestor
6578421|NCT01042873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6578422|NCT01042873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578423|NCT01042873|Protective Agents|protective agents|mesh-ancestor
6578424|NCT01042951|Vaccines|vaccines|mesh-list
6578425|NCT01042951|Immunologic Factors|immunologic factors|mesh-ancestor
6578426|NCT01042951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578427|NCT01043172|Gemcitabine|gemcitabine|mesh-list
6578428|NCT01043172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6578429|NCT01043172|Antimetabolites|antimetabolites|mesh-ancestor
6578430|NCT01043172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578431|NCT01043172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6578432|NCT01043172|Antiviral Agents|antiviral agents|mesh-ancestor
6578433|NCT01043172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6578434|NCT01043172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6578435|NCT01043172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6578436|NCT01043172|Immunologic Factors|immunologic factors|mesh-ancestor
6578437|NCT01043172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578438|NCT01043211|Lidocaine|lidocaine|mesh-list
6578439|NCT01043211|Epinephrine|epinephrine|mesh-list
6578440|NCT01043211|Anesthetics, Local|anesthetics, local|mesh-ancestor
6578441|NCT01043211|Anesthetics|anesthetics|mesh-ancestor
6578442|NCT01043211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6578443|NCT01043211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578444|NCT01043211|Sensory System Agents|sensory system agents|mesh-ancestor
6578445|NCT01043211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6578446|NCT01043211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6578447|NCT01043211|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6578448|NCT01043211|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6578449|NCT01043211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6578450|NCT01043211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578451|NCT01043211|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6578452|NCT01043211|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6578453|NCT01043211|Adrenergic Agents|adrenergic agents|mesh-ancestor
6578454|NCT01043211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6578455|NCT01043211|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6578456|NCT01043211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6578457|NCT01043211|Autonomic Agents|autonomic agents|mesh-ancestor
6578458|NCT01043211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6578459|NCT01043211|Respiratory System Agents|respiratory system agents|mesh-ancestor
6578460|NCT01043211|Mydriatics|mydriatics|mesh-ancestor
6578461|NCT01043211|Sympathomimetics|sympathomimetics|mesh-ancestor
6578462|NCT01043211|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6578463|NCT01043224|Clobetasol|clobetasol|mesh-list
6578464|NCT01043224|Calcipotriene|calcipotriene|mesh-list
6578465|NCT01043224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6578466|NCT01043224|Glucocorticoids|glucocorticoids|mesh-ancestor
6578467|NCT01043224|Hormones|hormones|mesh-ancestor
6578468|NCT01043224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6578469|NCT01043224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578470|NCT01043224|Dermatologic Agents|dermatologic agents|mesh-ancestor
6578471|NCT01043341|Vaccines|vaccines|mesh-list
6578472|NCT01043341|Immunologic Factors|immunologic factors|mesh-ancestor
6578473|NCT01043341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578474|NCT01043380|Atorvastatin|atorvastatin|mesh-list
6578475|NCT01043380|Ezetimibe|ezetimibe|mesh-list
6578476|NCT01043380|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6578477|NCT01043380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6578478|NCT01043380|Antimetabolites|antimetabolites|mesh-ancestor
6578479|NCT01043380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578480|NCT01043380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6578481|NCT01043380|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6578482|NCT01043380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6578483|NCT01043419|Xenon|xenon|mesh-list
6578484|NCT01043419|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6578485|NCT01043419|Anesthetics, General|anesthetics, general|mesh-ancestor
6578486|NCT01043419|Anesthetics|anesthetics|mesh-ancestor
6578487|NCT01043419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6578488|NCT01043419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578489|NCT01043445|Glycerol|glycerol|mesh-list
6578490|NCT01043445|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6578491|NCT01043445|Protective Agents|protective agents|mesh-ancestor
6578492|NCT01043445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578493|NCT01043484|Bevacizumab|bevacizumab|mesh-list
6578494|NCT01043484|Capecitabine|capecitabine|mesh-list
6578495|NCT01043484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6578496|NCT01043484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6578497|NCT01043484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6578498|NCT01043484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6578499|NCT01043484|Growth Substances|growth substances|mesh-ancestor
6578500|NCT01043484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578501|NCT01043484|Growth Inhibitors|growth inhibitors|mesh-ancestor
6578502|NCT01043484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6578503|NCT01043484|Antimetabolites|antimetabolites|mesh-ancestor
6578504|NCT01043484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578505|NCT01043510|Insulin|insulin|mesh-list
6578506|NCT01043510|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6578507|NCT01043510|Insulin Detemir|insulin detemir|mesh-list
6578508|NCT01043510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6578509|NCT01043510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578510|NCT01043536|Temozolomide|temozolomide|mesh-list
6578511|NCT01043536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6578512|NCT01043536|Alkylating Agents|alkylating agents|mesh-ancestor
5501509|NCT04473508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5501510|NCT04473820|Lidocaine|lidocaine|mesh-list
5501511|NCT04473820|Prilocaine|prilocaine|mesh-list
5501512|NCT04473820|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
5501513|NCT04473820|Anesthetics, Local|anesthetics, local|mesh-ancestor
5501514|NCT04473820|Anesthetics|anesthetics|mesh-ancestor
5501515|NCT04473820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5501516|NCT04473820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501517|NCT04473820|Sensory System Agents|sensory system agents|mesh-ancestor
5501518|NCT04473820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5501519|NCT04473820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5501520|NCT04473820|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5501521|NCT04473820|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5501522|NCT04473820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5501523|NCT04473820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501524|NCT04473820|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
5501525|NCT04473846|Anesthetics|anesthetics|mesh-list
5501526|NCT04473846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5501527|NCT04473846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501528|NCT04473417|Dapagliflozin|dapagliflozin|mesh-list
5501529|NCT04473417|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5501530|NCT04473417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501531|NCT04473417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6054330|NCT00602459|Immunoglobulins|immunoglobulins|mesh-list
6578513|NCT01043536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578514|NCT01043536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6578515|NCT01043575|Rifampin|rifampin|mesh-list
6578516|NCT01043575|Rifapentine|rifapentine|mesh-list
6578517|NCT01043575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6578518|NCT01043575|Antitubercular Agents|antitubercular agents|mesh-ancestor
6578519|NCT01043575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6578520|NCT01043575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6578521|NCT01043575|Leprostatic Agents|leprostatic agents|mesh-ancestor
6578522|NCT01043575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6578523|NCT01043575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6578524|NCT01043575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578525|NCT01043575|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6578526|NCT01043575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6578527|NCT01043575|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6578528|NCT01043575|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6578529|NCT01043575|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6578530|NCT01043575|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6578531|NCT01043601|Formoterol Fumarate|formoterol fumarate|mesh-list
6578532|NCT01043601|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6578533|NCT01043601|Autonomic Agents|autonomic agents|mesh-ancestor
6578534|NCT01043601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6578535|NCT01043601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578536|NCT01043601|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6578537|NCT01043601|Respiratory System Agents|respiratory system agents|mesh-ancestor
6578538|NCT01043601|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6578539|NCT01043601|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6578540|NCT01043601|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6578541|NCT01043601|Adrenergic Agents|adrenergic agents|mesh-ancestor
6578542|NCT01043601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6578543|NCT01043601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578544|NCT01043666|Mirabegron|mirabegron|mesh-list
6578545|NCT01043666|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6578546|NCT01043666|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6578547|NCT01043666|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6578548|NCT01043666|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6578549|NCT01043666|Adrenergic Agents|adrenergic agents|mesh-ancestor
6578550|NCT01043666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6578551|NCT01043666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578552|NCT01043666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578553|NCT01043666|Urological Agents|urological agents|mesh-ancestor
6578554|NCT01043666|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6578555|NCT01043666|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6578556|NCT01043666|Cholinergic Agents|cholinergic agents|mesh-ancestor
6578557|NCT01043679|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6578558|NCT01043679|Antidepressive Agents|antidepressive agents|mesh-ancestor
6578559|NCT01043679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6578560|NCT01043679|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6578561|NCT01043679|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6578562|NCT01043679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6578563|NCT01043679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578564|NCT01043744|Lumefantrine|lumefantrine|mesh-list
6578565|NCT01043744|Artemether|artemether|mesh-list
6578566|NCT01043744|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6578567|NCT01043744|Antimalarials|antimalarials|mesh-ancestor
6578568|NCT01043744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6578569|NCT01043744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6578570|NCT01043744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6578571|NCT01043952|Remifentanil|remifentanil|mesh-list
6578572|NCT01043952|Propofol|propofol|mesh-list
6578573|NCT01043952|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6578574|NCT01043952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6578575|NCT01043952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578576|NCT01043952|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6578577|NCT01043952|Anesthetics, General|anesthetics, general|mesh-ancestor
6578578|NCT01043952|Anesthetics|anesthetics|mesh-ancestor
6578579|NCT01043952|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6578580|NCT01043952|Narcotics|narcotics|mesh-ancestor
6578581|NCT01043952|Analgesics|analgesics|mesh-ancestor
6578582|NCT01043952|Sensory System Agents|sensory system agents|mesh-ancestor
6578583|NCT01043952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6578584|NCT01043965|Metformin|metformin|mesh-list
6578585|NCT01043965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6578586|NCT01043965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578587|NCT01043991|Darbepoetin alfa|darbepoetin alfa|mesh-list
6578588|NCT01043991|Hematinics|hematinics|mesh-ancestor
6578589|NCT01044004|Modafinil|modafinil|mesh-list
6578590|NCT01044004|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6578591|NCT01044004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578592|NCT01044004|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6578593|NCT01044004|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6578594|NCT01044004|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6578595|NCT01044004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578596|NCT01044095|Vaccines|vaccines|mesh-list
6578597|NCT01044095|Immunologic Factors|immunologic factors|mesh-ancestor
6578598|NCT01044095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578599|NCT01044186|Deferasirox|deferasirox|mesh-list
6578600|NCT01044186|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6578601|NCT01044186|Chelating Agents|chelating agents|mesh-ancestor
6578602|NCT01044186|Sequestering Agents|sequestering agents|mesh-ancestor
6578603|NCT01044186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578604|NCT01044199|Vaccines|vaccines|mesh-list
6578605|NCT01044199|Immunologic Factors|immunologic factors|mesh-ancestor
6578606|NCT01044199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578607|NCT01044225|Cetuximab|cetuximab|mesh-list
6578608|NCT01044225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6578609|NCT01044225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6578610|NCT01044238|Methylphenidate|methylphenidate|mesh-list
6578611|NCT01044238|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6578612|NCT01044238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578613|NCT01044238|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6578614|NCT01044238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6578615|NCT01044238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6578616|NCT01044238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578617|NCT01044238|Dopamine Agents|dopamine agents|mesh-ancestor
6578618|NCT01044238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6578619|NCT01044251|Frovatriptan|frovatriptan|mesh-list
6578620|NCT01044251|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6578621|NCT01044251|Serotonin Agents|serotonin agents|mesh-ancestor
6578622|NCT01044251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6578623|NCT01044251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578624|NCT01044251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578625|NCT01044329|Triamcinolone|triamcinolone|mesh-list
6578626|NCT01044329|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6578627|NCT01044329|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6578628|NCT01044329|Bevacizumab|bevacizumab|mesh-list
6578629|NCT01044329|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6578630|NCT01044329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6578631|NCT01044329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6578632|NCT01044329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6578633|NCT01044329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6578634|NCT01044329|Growth Substances|growth substances|mesh-ancestor
6578635|NCT01044329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578636|NCT01044329|Growth Inhibitors|growth inhibitors|mesh-ancestor
6578637|NCT01044329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6578638|NCT01044329|Glucocorticoids|glucocorticoids|mesh-ancestor
6578639|NCT01044329|Hormones|hormones|mesh-ancestor
6578640|NCT01044329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6578641|NCT01044329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6578642|NCT01044329|Immunologic Factors|immunologic factors|mesh-ancestor
6578643|NCT01044329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6578644|NCT01044329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578645|NCT01044342|Donepezil|donepezil|mesh-list
6578646|NCT01044342|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6578647|NCT01044342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6578648|NCT01044342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578649|NCT01044342|Cholinergic Agents|cholinergic agents|mesh-ancestor
6578650|NCT01044342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6578651|NCT01044342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578652|NCT01044342|Nootropic Agents|nootropic agents|mesh-ancestor
6578653|NCT01044394|Bisacodyl|bisacodyl|mesh-list
6578654|NCT01044394|Cathartics|cathartics|mesh-ancestor
6578655|NCT01044394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6578656|NCT01044394|Laxatives|laxatives|mesh-ancestor
6578657|NCT01044446|Dialysis Solutions|dialysis solutions|mesh-list
6578658|NCT01044446|Icodextrin|icodextrin|mesh-list
6578659|NCT01044446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6578660|NCT01044485|Docetaxel|docetaxel|mesh-list
6578661|NCT01044485|Lapatinib|lapatinib|mesh-list
6578662|NCT01044485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6578663|NCT01044485|Tubulin Modulators|tubulin modulators|mesh-ancestor
6578664|NCT01044485|Antimitotic Agents|antimitotic agents|mesh-ancestor
6578665|NCT01044485|Mitosis Modulators|mitosis modulators|mesh-ancestor
6578666|NCT01044485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578667|NCT01044485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6578668|NCT01044485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6658227|NCT01480336|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6658228|NCT01480336|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6658229|NCT01480336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6658230|NCT01480336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6658231|NCT01480336|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6658232|NCT01480336|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6658233|NCT01480336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6658234|NCT01480492|Telbivudine|telbivudine|mesh-list
6658235|NCT01480492|Antiviral Agents|antiviral agents|mesh-ancestor
6658236|NCT01480492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6658237|NCT01480492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6658238|NCT01480492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6658239|NCT01480492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658240|NCT01480531|Clevidipine|clevidipine|mesh-list
6658241|NCT01480531|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6658242|NCT01480531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6658243|NCT01480531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658244|NCT01480531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6658245|NCT01480531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658246|NCT01480609|Ezogabine|ezogabine|mesh-list
6658247|NCT01480609|Anticonvulsants|anticonvulsants|mesh-ancestor
6658248|NCT01480609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6658249|NCT01480609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658250|NCT01480687|Ciprofibrate|ciprofibrate|mesh-list
6658251|NCT01480687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6658252|NCT01480687|Antimetabolites|antimetabolites|mesh-ancestor
6658253|NCT01480687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658254|NCT01480687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6658255|NCT01480713|Raltegravir Potassium|raltegravir potassium|mesh-list
6658256|NCT01480713|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6658257|NCT01480713|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6658258|NCT01480713|Antiviral Agents|antiviral agents|mesh-ancestor
6658259|NCT01480713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6658260|NCT01480713|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6658261|NCT01480713|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6658262|NCT01480713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6658263|NCT01480713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658264|NCT01480752|Lornoxicam|lornoxicam|mesh-list
6658265|NCT01480752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6658266|NCT01480752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6658267|NCT01480752|Analgesics|analgesics|mesh-ancestor
6658268|NCT01480752|Sensory System Agents|sensory system agents|mesh-ancestor
6658269|NCT01480752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6658270|NCT01480752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658271|NCT01480752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6658272|NCT01480752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6658273|NCT01480765|Pregabalin|pregabalin|mesh-list
6658274|NCT01480765|Ketamine|ketamine|mesh-list
6658275|NCT01480765|Analgesics|analgesics|mesh-ancestor
6658276|NCT01480765|Sensory System Agents|sensory system agents|mesh-ancestor
6658277|NCT01480765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6658278|NCT01480765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658279|NCT01480765|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6578669|NCT01044719|Meropenem|meropenem|mesh-list
6578670|NCT01044719|Tobramycin|tobramycin|mesh-list
6578671|NCT01044719|Ceftazidime|ceftazidime|mesh-list
6578672|NCT01044719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6578673|NCT01044719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6578674|NCT01044810|Efavirenz|efavirenz|mesh-list
6578675|NCT01044810|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6578676|NCT01044810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6578677|NCT01044810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6578678|NCT01044810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578679|NCT01044810|Antiviral Agents|antiviral agents|mesh-ancestor
6578680|NCT01044810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6578681|NCT01044810|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6578682|NCT01044810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6578683|NCT01044810|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6578684|NCT01044810|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6578685|NCT01044810|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6578686|NCT01044810|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6578687|NCT01044888|Heparin|heparin|mesh-list
6578688|NCT01044888|Anticoagulants|anticoagulants|mesh-ancestor
6578689|NCT01044888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6578690|NCT01044888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6578691|NCT01044888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578692|NCT01044992|Levodopa|levodopa|mesh-list
6578693|NCT01044992|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6578694|NCT01044992|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6578695|NCT01044992|Dopamine Agents|dopamine agents|mesh-ancestor
6578696|NCT01044992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6578697|NCT01044992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578698|NCT01044992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578699|NCT01045018|Mesalamine|mesalamine|mesh-list
6578700|NCT01045018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6578701|NCT01045018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6578702|NCT01045018|Analgesics|analgesics|mesh-ancestor
6578703|NCT01045018|Sensory System Agents|sensory system agents|mesh-ancestor
6578704|NCT01045018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6578705|NCT01045018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578706|NCT01045018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6578707|NCT01045018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6578708|NCT01045083|Methylphenidate|methylphenidate|mesh-list
6578709|NCT01045083|Citalopram|citalopram|mesh-list
6578710|NCT01045083|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6578711|NCT01045083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6578712|NCT01045083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6578713|NCT01045083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578714|NCT01045083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6578715|NCT01045083|Serotonin Agents|serotonin agents|mesh-ancestor
6578716|NCT01045083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578717|NCT01045083|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6578718|NCT01045083|Antidepressive Agents|antidepressive agents|mesh-ancestor
6578719|NCT01045083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6578720|NCT01045083|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6578721|NCT01045083|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6578722|NCT01045083|Dopamine Agents|dopamine agents|mesh-ancestor
6578723|NCT01045109|Vitamin D|vitamin d|mesh-list
6578724|NCT01045109|Ergocalciferols|ergocalciferols|mesh-list
6578725|NCT01045109|Cholecalciferol|cholecalciferol|mesh-list
6578726|NCT01045109|Vitamins|vitamins|mesh-list
6578727|NCT01045109|Micronutrients|micronutrients|mesh-ancestor
6578728|NCT01045109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578729|NCT01045109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6578730|NCT01045109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6578731|NCT01045278|Interferons|interferons|mesh-list
6578732|NCT01045278|Ribavirin|ribavirin|mesh-list
6578733|NCT01045278|Interferon-alpha|interferon-alpha|mesh-list
6578734|NCT01045278|Interferon alpha-2|interferon alpha-2|mesh-list
6578735|NCT01045278|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6578736|NCT01045278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6578737|NCT01045278|Antiviral Agents|antiviral agents|mesh-ancestor
6578738|NCT01045278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6578739|NCT01045278|Antimetabolites|antimetabolites|mesh-ancestor
6578740|NCT01045278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578741|NCT01045278|Immunologic Factors|immunologic factors|mesh-ancestor
6578742|NCT01045278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578743|NCT01045304|Gemcitabine|gemcitabine|mesh-list
6578744|NCT01045304|Carboplatin|carboplatin|mesh-list
6578745|NCT01045304|Iniparib|iniparib|mesh-list
6578746|NCT01045304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6578747|NCT01045304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6578748|NCT01045304|Antimetabolites|antimetabolites|mesh-ancestor
6578749|NCT01045304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578750|NCT01045304|Antiviral Agents|antiviral agents|mesh-ancestor
6578751|NCT01045304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6578752|NCT01045304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6578753|NCT01045304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6578754|NCT01045304|Immunologic Factors|immunologic factors|mesh-ancestor
6578755|NCT01045304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578756|NCT01045304|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6578757|NCT01045369|Etravirine|etravirine|mesh-list
6578758|NCT01045369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6578759|NCT01045369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578760|NCT01045369|Antiviral Agents|antiviral agents|mesh-ancestor
6578761|NCT01045369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6578762|NCT01045369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6578763|NCT01045369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6578764|NCT01045434|Omeprazole|omeprazole|mesh-list
6578765|NCT01045434|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6578766|NCT01045434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6578767|NCT01045434|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6578768|NCT01045434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6578769|NCT01045434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578770|NCT01045538|Capecitabine|capecitabine|mesh-list
6578771|NCT01045538|Vorinostat|vorinostat|mesh-list
6578772|NCT01045538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6578773|NCT01045538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6578774|NCT01045538|Antimetabolites|antimetabolites|mesh-ancestor
6578775|NCT01045538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578776|NCT01045538|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6578777|NCT01045538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6578778|NCT01045642|Omeprazole|omeprazole|mesh-list
6578779|NCT01045642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6578780|NCT01045642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6578781|NCT01045642|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6578782|NCT01045642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6578783|NCT01045642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578784|NCT01045681|Dexamethasone|dexamethasone|mesh-list
6578785|NCT01045681|Dexamethasone acetate|dexamethasone acetate|mesh-list
6578786|NCT01045681|Bortezomib|bortezomib|mesh-list
6578787|NCT01045681|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6578788|NCT01045681|BB 1101|bb 1101|mesh-list
6578789|NCT01045681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6578790|NCT01045681|Antiemetics|antiemetics|mesh-ancestor
6578791|NCT01045681|Autonomic Agents|autonomic agents|mesh-ancestor
6578792|NCT01045681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6578793|NCT01045681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578794|NCT01045681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6578795|NCT01045681|Glucocorticoids|glucocorticoids|mesh-ancestor
6578796|NCT01045681|Hormones|hormones|mesh-ancestor
6578797|NCT01045681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6578798|NCT01045681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6578799|NCT01045681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6578800|NCT01045681|Protease Inhibitors|protease inhibitors|mesh-ancestor
6578801|NCT01045681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6578802|NCT01045681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578803|NCT01045681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6578804|NCT01045681|Alkylating Agents|alkylating agents|mesh-ancestor
6578805|NCT01045772|Rilonacept|rilonacept|mesh-list
6578806|NCT01045772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6578807|NCT01045837|Prednisolone|prednisolone|mesh-list
6578808|NCT01045837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6578809|NCT01045837|Glucocorticoids|glucocorticoids|mesh-ancestor
6578810|NCT01045837|Hormones|hormones|mesh-ancestor
6578811|NCT01045837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6578812|NCT01045837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578813|NCT01045837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6578814|NCT01045837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6578815|NCT01045876|Dexamethasone|dexamethasone|mesh-list
6578816|NCT01045876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6578817|NCT01045876|Antiemetics|antiemetics|mesh-ancestor
6578818|NCT01045876|Autonomic Agents|autonomic agents|mesh-ancestor
6578819|NCT01045876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6578820|NCT01045876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578821|NCT01045876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6578822|NCT01045876|Glucocorticoids|glucocorticoids|mesh-ancestor
6578823|NCT01045876|Hormones|hormones|mesh-ancestor
6578824|NCT01045876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6578825|NCT01045876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6578826|NCT01045876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6578827|NCT01045889|Prednisone|prednisone|mesh-list
6578828|NCT01045889|Cyclophosphamide|cyclophosphamide|mesh-list
6578829|NCT01045889|Melphalan|melphalan|mesh-list
6578830|NCT01045889|Rituximab|rituximab|mesh-list
6578831|NCT01045889|Etoposide|etoposide|mesh-list
6578832|NCT01045889|Vincristine|vincristine|mesh-list
6578833|NCT01045889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6578834|NCT01045889|Immunologic Factors|immunologic factors|mesh-ancestor
6578835|NCT01045889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578836|NCT01045889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6578837|NCT01045889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6578838|NCT01045889|Alkylating Agents|alkylating agents|mesh-ancestor
6578839|NCT01045889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578840|NCT01045889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6578841|NCT01045889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6578842|NCT01045889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6578843|NCT01045889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6578844|NCT01045889|Glucocorticoids|glucocorticoids|mesh-ancestor
6578845|NCT01045889|Hormones|hormones|mesh-ancestor
6578846|NCT01045889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6578847|NCT01045889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6578848|NCT01045889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6578849|NCT01045889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6578850|NCT01045889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6578851|NCT01045889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6578852|NCT01045889|Tubulin Modulators|tubulin modulators|mesh-ancestor
6054331|NCT00602459|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6578853|NCT01045889|Antimitotic Agents|antimitotic agents|mesh-ancestor
6578854|NCT01045889|Mitosis Modulators|mitosis modulators|mesh-ancestor
6578855|NCT01045902|Moxifloxacin|moxifloxacin|mesh-list
6578856|NCT01045902|Ampicillin|ampicillin|mesh-list
6578857|NCT01045902|Sulbactam|sulbactam|mesh-list
6578858|NCT01045902|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6578859|NCT01045902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6578860|NCT01045902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6578861|NCT01045902|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6578862|NCT01045902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6578863|NCT01045902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6578864|NCT01045902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578865|NCT01045902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6578866|NCT01045902|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6578867|NCT01045902|Contraceptive Agents|contraceptive agents|mesh-ancestor
6578868|NCT01045902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6578869|NCT01045902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578870|NCT01045902|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6578871|NCT01045902|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6578872|NCT01045902|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6578873|NCT01045902|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6446344|NCT00392158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446345|NCT00392262|Amlodipine|amlodipine|mesh-list
6446346|NCT00392262|Valsartan|valsartan|mesh-list
6446347|NCT00392262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6446348|NCT00392262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6446349|NCT00392262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6446350|NCT00392262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578874|NCT01045928|Rituximab|rituximab|mesh-list
6578875|NCT01045928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6578876|NCT01045928|Lenalidomide|lenalidomide|mesh-list
6578877|NCT01045928|Antibodies|antibodies|mesh-list
6578878|NCT01045928|Immunoglobulins|immunoglobulins|mesh-list
6578879|NCT01045928|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6578880|NCT01045928|Immunologic Factors|immunologic factors|mesh-ancestor
6578881|NCT01045928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578882|NCT01045928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6578883|NCT01045928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6578884|NCT01045928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6578885|NCT01045928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6578886|NCT01045928|Growth Substances|growth substances|mesh-ancestor
6578887|NCT01045928|Growth Inhibitors|growth inhibitors|mesh-ancestor
6578888|NCT01045941|Gemcitabine|gemcitabine|mesh-list
6578889|NCT01045941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6578890|NCT01045941|Antimetabolites|antimetabolites|mesh-ancestor
6578891|NCT01045941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578892|NCT01045941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6578893|NCT01045941|Antiviral Agents|antiviral agents|mesh-ancestor
6578894|NCT01045941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6578895|NCT01045941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6578896|NCT01045941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6578897|NCT01045941|Immunologic Factors|immunologic factors|mesh-ancestor
6578898|NCT01045941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578899|NCT01045954|Insulin|insulin|mesh-list
6578900|NCT01045954|Insulin Glargine|insulin glargine|mesh-list
6578901|NCT01045954|Insulin Lispro|insulin lispro|mesh-list
6578902|NCT01045954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6578903|NCT01045954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578904|NCT01045980|Vitamin D|vitamin d|mesh-list
6446351|NCT00392262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6446352|NCT00392262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446353|NCT00392262|Vasodilator Agents|vasodilator agents|mesh-ancestor
6446354|NCT00392262|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6446355|NCT00392262|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6446356|NCT00392275|Ciprofloxacin|ciprofloxacin|mesh-list
6446357|NCT00392275|Levofloxacin|levofloxacin|mesh-list
6446358|NCT00392275|Ofloxacin|ofloxacin|mesh-list
6446359|NCT00392275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6446360|NCT00392275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6446361|NCT00392275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6578905|NCT01045980|Ergocalciferols|ergocalciferols|mesh-list
6578906|NCT01045980|Vitamins|vitamins|mesh-list
6578907|NCT01045980|Micronutrients|micronutrients|mesh-ancestor
6578908|NCT01045980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578909|NCT01045980|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6578910|NCT01045980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6578911|NCT01046006|Dexamethasone|dexamethasone|mesh-list
6578912|NCT01046006|Rituximab|rituximab|mesh-list
6578913|NCT01046006|Bortezomib|bortezomib|mesh-list
6578914|NCT01046006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6578915|NCT01046006|Antiemetics|antiemetics|mesh-ancestor
6578916|NCT01046006|Autonomic Agents|autonomic agents|mesh-ancestor
6578917|NCT01046006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6578918|NCT01046006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578919|NCT01046006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6578920|NCT01046006|Glucocorticoids|glucocorticoids|mesh-ancestor
6578921|NCT01046006|Hormones|hormones|mesh-ancestor
6578922|NCT01046006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6578923|NCT01046006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6578924|NCT01046006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6578925|NCT01046006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6578926|NCT01046006|Immunologic Factors|immunologic factors|mesh-ancestor
6578927|NCT01046006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6578928|NCT01046032|Metformin|metformin|mesh-list
6578929|NCT01046032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6578930|NCT01046032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578931|NCT01046045|Everolimus|everolimus|mesh-list
6578932|NCT01046045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6578933|NCT01046045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6578934|NCT01046045|Immunologic Factors|immunologic factors|mesh-ancestor
6578935|NCT01046045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578936|NCT01046058|Simeprevir|simeprevir|mesh-list
6578937|NCT01046058|Antiviral Agents|antiviral agents|mesh-ancestor
6578938|NCT01046058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6578939|NCT01046058|Protease Inhibitors|protease inhibitors|mesh-ancestor
6578940|NCT01046058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6578941|NCT01046058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578942|NCT01046162|Alprazolam|alprazolam|mesh-list
6578943|NCT01046162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6578944|NCT01046162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6578945|NCT01046162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578946|NCT01046162|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6578947|NCT01046162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6578948|NCT01046162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6578949|NCT01046162|GABA Modulators|gaba modulators|mesh-ancestor
6578950|NCT01046162|GABA Agents|gaba agents|mesh-ancestor
6578951|NCT01046162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6578952|NCT01046162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578953|NCT01046214|Bupropion|bupropion|mesh-list
6578954|NCT01046214|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6578955|NCT01046214|Antidepressive Agents|antidepressive agents|mesh-ancestor
6578956|NCT01046214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6578957|NCT01046214|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6578958|NCT01046214|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6578959|NCT01046214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6578960|NCT01046214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578961|NCT01046214|Dopamine Agents|dopamine agents|mesh-ancestor
6578962|NCT01046214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6578963|NCT01046214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578964|NCT01046214|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6578965|NCT01046214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6578966|NCT01046214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6578967|NCT01046227|Vaccines|vaccines|mesh-list
6578968|NCT01046227|Immunologic Factors|immunologic factors|mesh-ancestor
6578969|NCT01046227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578970|NCT01046240|Palonosetron|palonosetron|mesh-list
6578971|NCT01046240|Antiemetics|antiemetics|mesh-ancestor
6578972|NCT01046240|Autonomic Agents|autonomic agents|mesh-ancestor
6578973|NCT01046240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6578974|NCT01046240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578975|NCT01046240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6578976|NCT01046240|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6578977|NCT01046240|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6578978|NCT01046240|Serotonin Agents|serotonin agents|mesh-ancestor
6578979|NCT01046240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6578980|NCT01046240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578981|NCT01046266|Cetuximab|cetuximab|mesh-list
6578982|NCT01046266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6578983|NCT01046266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6578984|NCT01046279|Bevacizumab|bevacizumab|mesh-list
6578985|NCT01046279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6578986|NCT01046279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6578987|NCT01046279|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6578988|NCT01046279|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6578989|NCT01046279|Growth Substances|growth substances|mesh-ancestor
6578990|NCT01046279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6578991|NCT01046279|Growth Inhibitors|growth inhibitors|mesh-ancestor
6658280|NCT01480765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6658281|NCT01480765|Anesthetics, General|anesthetics, general|mesh-ancestor
6658282|NCT01480765|Anesthetics|anesthetics|mesh-ancestor
6446362|NCT00392275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6446363|NCT00392275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6446364|NCT00392275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446365|NCT00392275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6446366|NCT00392275|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6446367|NCT00392275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6446368|NCT00392275|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6446369|NCT00392275|Renal Agents|renal agents|mesh-ancestor
6446370|NCT00392314|Deoxyglucose|deoxyglucose|mesh-list
6446371|NCT00392314|Antimetabolites|antimetabolites|mesh-ancestor
6446372|NCT00392314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446373|NCT00392314|Antiviral Agents|antiviral agents|mesh-ancestor
6446374|NCT00392314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6446375|NCT00392340|Doxorubicin|doxorubicin|mesh-list
6446376|NCT00392340|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6446377|NCT00392340|Vincristine|vincristine|mesh-list
6446378|NCT00392340|Topotecan|topotecan|mesh-list
6446379|NCT00392340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6446380|NCT00392340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6446381|NCT00392340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6446382|NCT00392340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6446383|NCT00392340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6578992|NCT01046383|Caseins|caseins|mesh-list
6578993|NCT01046383|Chelating Agents|chelating agents|mesh-ancestor
6578994|NCT01046383|Sequestering Agents|sequestering agents|mesh-ancestor
6578995|NCT01046383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6578996|NCT01046435|Amoxicillin|amoxicillin|mesh-list
6578997|NCT01046435|Metronidazole|metronidazole|mesh-list
6578998|NCT01046435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6578999|NCT01046435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6579000|NCT01046435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6579001|NCT01046435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6579002|NCT01046461|Dexamethasone|dexamethasone|mesh-list
6579003|NCT01046461|Aprepitant|aprepitant|mesh-list
6579004|NCT01046461|Ramosetron|ramosetron|mesh-list
6579005|NCT01046461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6579006|NCT01046461|Antiemetics|antiemetics|mesh-ancestor
6579007|NCT01046461|Autonomic Agents|autonomic agents|mesh-ancestor
6579008|NCT01046461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6579009|NCT01046461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579010|NCT01046461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6579011|NCT01046461|Glucocorticoids|glucocorticoids|mesh-ancestor
6579012|NCT01046461|Hormones|hormones|mesh-ancestor
6579013|NCT01046461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6579014|NCT01046461|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6579015|NCT01046461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6579016|NCT01046461|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6579017|NCT01046461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6579018|NCT01046461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6579019|NCT01046461|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6579020|NCT01046461|Serotonin Agents|serotonin agents|mesh-ancestor
6579021|NCT01046487|Cyclophosphamide|cyclophosphamide|mesh-list
6579022|NCT01046487|Imatinib Mesylate|imatinib mesylate|mesh-list
6579023|NCT01046487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6579024|NCT01046487|Immunologic Factors|immunologic factors|mesh-ancestor
6579025|NCT01046487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579026|NCT01046487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6579027|NCT01046487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6579028|NCT01046487|Alkylating Agents|alkylating agents|mesh-ancestor
6579029|NCT01046487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6579030|NCT01046487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6579031|NCT01046487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6579032|NCT01046487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6579033|NCT01046487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6579034|NCT01046500|Inositol|inositol|mesh-list
6579035|NCT01046500|Metformin|metformin|mesh-list
6579036|NCT01046500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6579037|NCT01046500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579038|NCT01046500|Vitamin B Complex|vitamin b complex|mesh-ancestor
6579039|NCT01046500|Vitamins|vitamins|mesh-ancestor
6579040|NCT01046500|Micronutrients|micronutrients|mesh-ancestor
6579041|NCT01046539|Buprenorphine|buprenorphine|mesh-list
6579042|NCT01046539|ALKS-33|alks-33|mesh-list
6579043|NCT01046539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6579044|NCT01046539|Narcotics|narcotics|mesh-ancestor
6579045|NCT01046539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6579046|NCT01046539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579047|NCT01046539|Analgesics|analgesics|mesh-ancestor
6579048|NCT01046539|Sensory System Agents|sensory system agents|mesh-ancestor
6579049|NCT01046539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6579050|NCT01046539|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6579051|NCT01046578|Letrozole|letrozole|mesh-list
6579052|NCT01046578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6579053|NCT01046578|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6579054|NCT01046578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6579055|NCT01046578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6579056|NCT01046578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6579057|NCT01046578|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6579058|NCT01046578|Hormone Antagonists|hormone antagonists|mesh-ancestor
6579059|NCT01046578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6579060|NCT01046578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579061|NCT01046630|Ketamine|ketamine|mesh-list
6579062|NCT01046630|Analgesics|analgesics|mesh-ancestor
6579063|NCT01046630|Sensory System Agents|sensory system agents|mesh-ancestor
6579064|NCT01046630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6579065|NCT01046630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579066|NCT01046630|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6579067|NCT01046630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6579068|NCT01046630|Anesthetics, General|anesthetics, general|mesh-ancestor
6579069|NCT01046630|Anesthetics|anesthetics|mesh-ancestor
6579070|NCT01046630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6579071|NCT01046630|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6579072|NCT01046630|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6579073|NCT01046630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6579074|NCT01046630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6579075|NCT01046708|Progesterone|progesterone|mesh-list
6579076|NCT01046708|Progestins|progestins|mesh-ancestor
6579077|NCT01046708|Hormones|hormones|mesh-ancestor
6579078|NCT01046708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6579079|NCT01046708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579080|NCT01046721|Exenatide|exenatide|mesh-list
6579081|NCT01046721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6579082|NCT01046721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579083|NCT01046721|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6579084|NCT01046721|Incretins|incretins|mesh-ancestor
6579085|NCT01046721|Hormones|hormones|mesh-ancestor
6579086|NCT01046721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6579087|NCT01046773|Cholecalciferol|cholecalciferol|mesh-list
6579088|NCT01046773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6579089|NCT01046773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579090|NCT01046773|Vitamins|vitamins|mesh-ancestor
6579091|NCT01046773|Micronutrients|micronutrients|mesh-ancestor
6579092|NCT01046773|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6579093|NCT01046786|Methylprednisolone|methylprednisolone|mesh-list
6579094|NCT01046786|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6579095|NCT01046786|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6579096|NCT01046786|Prednisolone|prednisolone|mesh-list
6579097|NCT01046786|Prednisolone acetate|prednisolone acetate|mesh-list
6579098|NCT01046786|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6579099|NCT01046786|Prednisolone phosphate|prednisolone phosphate|mesh-list
6579100|NCT01046786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6579101|NCT01046786|Antiemetics|antiemetics|mesh-ancestor
6579102|NCT01046786|Autonomic Agents|autonomic agents|mesh-ancestor
6579103|NCT01046786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6579104|NCT01046786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579105|NCT01046786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6579106|NCT01046786|Glucocorticoids|glucocorticoids|mesh-ancestor
6579107|NCT01046786|Hormones|hormones|mesh-ancestor
6579108|NCT01046786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6579109|NCT01046786|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6579110|NCT01046786|Protective Agents|protective agents|mesh-ancestor
6579111|NCT01046786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6579112|NCT01046786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6579113|NCT01046799|Entecavir|entecavir|mesh-list
6579114|NCT01046799|Antiviral Agents|antiviral agents|mesh-ancestor
6579115|NCT01046799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6579116|NCT01046838|Sildenafil Citrate|sildenafil citrate|mesh-list
6579117|NCT01046838|Vasodilator Agents|vasodilator agents|mesh-ancestor
6579118|NCT01046838|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6579119|NCT01046838|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6579120|NCT01046838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6579121|NCT01046838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6579122|NCT01046838|Urological Agents|urological agents|mesh-ancestor
6579123|NCT01046864|Leucovorin|leucovorin|mesh-list
6579124|NCT01046864|Fluorouracil|fluorouracil|mesh-list
6579125|NCT01046864|Irinotecan|irinotecan|mesh-list
6579126|NCT01046864|Antimetabolites|antimetabolites|mesh-ancestor
6658283|NCT01480765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6579127|NCT01046864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6579128|NCT01046864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6579129|NCT01046864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6579130|NCT01046864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6579131|NCT01046864|Immunologic Factors|immunologic factors|mesh-ancestor
6579132|NCT01046864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579133|NCT01046864|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6579134|NCT01046864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6579135|NCT01046864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6579136|NCT01046864|Antidotes|antidotes|mesh-ancestor
6579137|NCT01046864|Protective Agents|protective agents|mesh-ancestor
6579138|NCT01046864|Vitamin B Complex|vitamin b complex|mesh-ancestor
6579139|NCT01046864|Vitamins|vitamins|mesh-ancestor
6579140|NCT01046864|Micronutrients|micronutrients|mesh-ancestor
6579141|NCT01046942|Aspirin|aspirin|mesh-list
6579142|NCT01046942|Clopidogrel|clopidogrel|mesh-list
6579143|NCT01046942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6579144|NCT01046942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6579145|NCT01046942|Analgesics|analgesics|mesh-ancestor
6579146|NCT01046942|Sensory System Agents|sensory system agents|mesh-ancestor
6579147|NCT01046942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6579148|NCT01046942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579149|NCT01046942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6579150|NCT01046942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6579151|NCT01046942|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6579152|NCT01046942|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6579153|NCT01046942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446384|NCT00392340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446385|NCT00392340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6446386|NCT00392340|Tubulin Modulators|tubulin modulators|mesh-ancestor
6446387|NCT00392340|Antimitotic Agents|antimitotic agents|mesh-ancestor
6446388|NCT00392340|Mitosis Modulators|mitosis modulators|mesh-ancestor
6446389|NCT00392340|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6446390|NCT00392418|Micronutrients|micronutrients|mesh-list
6446391|NCT00392418|Trace Elements|trace elements|mesh-list
6446392|NCT00392418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446393|NCT00392431|Amiodarone|amiodarone|mesh-list
6446394|NCT00392431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6446395|NCT00392431|Vasodilator Agents|vasodilator agents|mesh-ancestor
6446396|NCT00392431|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6446397|NCT00392431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6579154|NCT01046942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6579155|NCT01046942|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6579156|NCT01046942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6579157|NCT01046942|Antipyretics|antipyretics|mesh-ancestor
6579158|NCT01046942|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6579159|NCT01046942|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6579160|NCT01046942|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6579161|NCT01046942|Purinergic Agents|purinergic agents|mesh-ancestor
6579162|NCT01046942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6579163|NCT01046955|Alemtuzumab|alemtuzumab|mesh-list
6579164|NCT01046955|Thymoglobulin|thymoglobulin|mesh-list
6579165|NCT01046955|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6579166|NCT01046955|Daclizumab|daclizumab|mesh-list
6579167|NCT01046955|Immunologic Factors|immunologic factors|mesh-ancestor
6579168|NCT01046955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579169|NCT01046955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6579170|NCT01046955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6579171|NCT01046955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6579172|NCT01046981|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6579173|NCT01046981|Metronidazole|metronidazole|mesh-list
6579174|NCT01046981|Cefazolin|cefazolin|mesh-list
6579175|NCT01046981|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6579176|NCT01046981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6579177|NCT01046981|Antitubercular Agents|antitubercular agents|mesh-ancestor
6579178|NCT01046981|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6579179|NCT01046981|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6579180|NCT01046994|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6579181|NCT01046994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579182|NCT01047059|Bevacizumab|bevacizumab|mesh-list
6579183|NCT01047059|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6579184|NCT01047059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6579185|NCT01047059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6579186|NCT01047059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6579187|NCT01047059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6579188|NCT01047059|Growth Substances|growth substances|mesh-ancestor
6579189|NCT01047059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579190|NCT01047059|Growth Inhibitors|growth inhibitors|mesh-ancestor
6579191|NCT01047059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6579192|NCT01047059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6579193|NCT01047059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6579194|NCT01047072|Mycophenolic Acid|mycophenolic acid|mesh-list
6579195|NCT01047072|Cyclophosphamide|cyclophosphamide|mesh-list
6579196|NCT01047072|Rituximab|rituximab|mesh-list
6579197|NCT01047072|Fludarabine|fludarabine|mesh-list
6579198|NCT01047072|Fludarabine phosphate|fludarabine phosphate|mesh-list
6579199|NCT01047072|Tacrolimus|tacrolimus|mesh-list
6579200|NCT01047072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6579201|NCT01047072|Immunologic Factors|immunologic factors|mesh-ancestor
6579202|NCT01047072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579203|NCT01047072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6579204|NCT01047072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6579205|NCT01047072|Alkylating Agents|alkylating agents|mesh-ancestor
6579206|NCT01047072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6579207|NCT01047072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6579208|NCT01047072|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6579209|NCT01047072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6579210|NCT01047072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6579211|NCT01047072|Antimetabolites|antimetabolites|mesh-ancestor
6579212|NCT01047072|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6579213|NCT01047072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6579214|NCT01047072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6579215|NCT01047072|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6579216|NCT01047072|Antitubercular Agents|antitubercular agents|mesh-ancestor
6579217|NCT01047072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6579218|NCT01047072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6579219|NCT01047098|Iron|iron|mesh-list
6579220|NCT01047098|Trace Elements|trace elements|mesh-ancestor
6579221|NCT01047098|Micronutrients|micronutrients|mesh-ancestor
6579222|NCT01047098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579223|NCT01047202|Vaccines|vaccines|mesh-list
6579224|NCT01047202|Immunologic Factors|immunologic factors|mesh-ancestor
6579225|NCT01047202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579226|NCT01047215|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6579227|NCT01047215|Aripiprazole|aripiprazole|mesh-list
6579228|NCT01047215|Antidepressive Agents|antidepressive agents|mesh-ancestor
6579229|NCT01047215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6579230|NCT01047215|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6579231|NCT01047215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6579232|NCT01047215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6579233|NCT01047215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579234|NCT01047215|Dopamine Agonists|dopamine agonists|mesh-ancestor
6579235|NCT01047215|Dopamine Agents|dopamine agents|mesh-ancestor
6579236|NCT01047215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6579237|NCT01047215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6579238|NCT01047215|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6579239|NCT01047215|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6579240|NCT01047215|Serotonin Agents|serotonin agents|mesh-ancestor
6579241|NCT01047215|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6579242|NCT01047215|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6579243|NCT01047215|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6579244|NCT01047215|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6579245|NCT01047423|Simvastatin|simvastatin|mesh-list
6579246|NCT01047423|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6579247|NCT01047423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6579248|NCT01047423|Antimetabolites|antimetabolites|mesh-ancestor
6579249|NCT01047423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6579250|NCT01047423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6579251|NCT01047423|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6579252|NCT01047423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6579253|NCT01047488|Pregabalin|pregabalin|mesh-list
6579254|NCT01047488|Imipramine|imipramine|mesh-list
6579255|NCT01047488|Analgesics|analgesics|mesh-ancestor
6579256|NCT01047488|Sensory System Agents|sensory system agents|mesh-ancestor
6579257|NCT01047488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6579258|NCT01047488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579259|NCT01047488|Anticonvulsants|anticonvulsants|mesh-ancestor
6579260|NCT01047488|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6579261|NCT01047488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6579262|NCT01047488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6579263|NCT01047488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6579264|NCT01047488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6579265|NCT01047488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6579266|NCT01047488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6579267|NCT01047488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6579268|NCT01047488|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6579269|NCT01047488|Antidepressive Agents|antidepressive agents|mesh-ancestor
6579270|NCT01047488|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6579271|NCT01047488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6579272|NCT01047488|Adrenergic Agents|adrenergic agents|mesh-ancestor
6579273|NCT01047488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6579274|NCT01047566|Digoxin|digoxin|mesh-list
6579275|NCT01047566|Dronedarone|dronedarone|mesh-list
6579276|NCT01047566|Calcium Channel Blockers|calcium channel blockers|mesh-list
6579277|NCT01047566|Calcium|calcium|mesh-list
6579278|NCT01047566|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
6579279|NCT01047566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6579280|NCT01047566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579281|NCT01047566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6579282|NCT01047566|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6579283|NCT01047566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6579284|NCT01047566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6579285|NCT01047566|Protective Agents|protective agents|mesh-ancestor
6579286|NCT01047566|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6579287|NCT01047566|Adrenergic Agents|adrenergic agents|mesh-ancestor
6579288|NCT01047566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6579289|NCT01047566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6579290|NCT01047579|Rivastigmine|rivastigmine|mesh-list
6579291|NCT01047579|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6579292|NCT01047579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6579293|NCT01047579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6579294|NCT01047579|Cholinergic Agents|cholinergic agents|mesh-ancestor
6579295|NCT01047579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6579296|NCT01047579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579297|NCT01047579|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6579298|NCT01047579|Protective Agents|protective agents|mesh-ancestor
6579299|NCT01047657|Orlistat|orlistat|mesh-list
6579300|NCT01047657|Sibutramine|sibutramine|mesh-list
6579301|NCT01047657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6579302|NCT01047657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6579303|NCT01047657|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6579304|NCT01047657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6579305|NCT01047657|Antidepressive Agents|antidepressive agents|mesh-ancestor
6579306|NCT01047657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6579307|NCT01047657|Appetite Depressants|appetite depressants|mesh-ancestor
6579308|NCT01047670|Hydrocortisone|hydrocortisone|mesh-list
6579309|NCT01047670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6579310|NCT01047722|Aspirin|aspirin|mesh-list
6579311|NCT01047722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6579312|NCT01047722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6579313|NCT01047722|Analgesics|analgesics|mesh-ancestor
6579314|NCT01047722|Sensory System Agents|sensory system agents|mesh-ancestor
6579315|NCT01047722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6579316|NCT01047722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579317|NCT01047722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6579318|NCT01047722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6579319|NCT01047722|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6579320|NCT01047722|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6579321|NCT01047722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6579322|NCT01047722|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6579323|NCT01047722|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6579324|NCT01047722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6579325|NCT01047722|Antipyretics|antipyretics|mesh-ancestor
6579326|NCT01047748|Digoxin|digoxin|mesh-list
6579327|NCT01047748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6579328|NCT01047748|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6579329|NCT01047748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6579330|NCT01047748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6579331|NCT01047748|Protective Agents|protective agents|mesh-ancestor
6579332|NCT01047748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579333|NCT01047774|Caseins|caseins|mesh-list
6579334|NCT01047774|Chelating Agents|chelating agents|mesh-ancestor
6579335|NCT01047774|Sequestering Agents|sequestering agents|mesh-ancestor
6579336|NCT01047774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6579337|NCT01047891|Sorafenib|sorafenib|mesh-list
6579338|NCT01047891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6579339|NCT01047891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6579340|NCT01047891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6579341|NCT01047891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6579342|NCT01047956|Methadone|methadone|mesh-list
6579343|NCT01047956|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6579344|NCT01047956|Narcotics|narcotics|mesh-ancestor
6579345|NCT01047956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6579346|NCT01047956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579347|NCT01047956|Analgesics|analgesics|mesh-ancestor
6579348|NCT01047956|Sensory System Agents|sensory system agents|mesh-ancestor
6579349|NCT01047956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6579350|NCT01047956|Antitussive Agents|antitussive agents|mesh-ancestor
6579351|NCT01047956|Respiratory System Agents|respiratory system agents|mesh-ancestor
6579352|NCT01047982|Folic Acid|folic acid|mesh-list
6579353|NCT01047982|Inositol|inositol|mesh-list
6579354|NCT01047982|Hematinics|hematinics|mesh-ancestor
6579355|NCT01047982|Vitamin B Complex|vitamin b complex|mesh-ancestor
6579356|NCT01047982|Vitamins|vitamins|mesh-ancestor
6579357|NCT01047982|Micronutrients|micronutrients|mesh-ancestor
6579358|NCT01047982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579359|NCT01047995|Ritonavir|ritonavir|mesh-list
6579360|NCT01047995|Darunavir|darunavir|mesh-list
6579361|NCT01047995|Raltegravir Potassium|raltegravir potassium|mesh-list
6579362|NCT01047995|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6579363|NCT01047995|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6579364|NCT01047995|Protease Inhibitors|protease inhibitors|mesh-ancestor
6579365|NCT01047995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6579366|NCT01047995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6579367|NCT01047995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6579368|NCT01047995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6579369|NCT01047995|Antiviral Agents|antiviral agents|mesh-ancestor
6579370|NCT01047995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6579371|NCT01047995|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6579372|NCT01047995|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6579373|NCT01047995|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6579374|NCT01047995|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6658284|NCT01480765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6658285|NCT01480765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6658286|NCT01480765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6658287|NCT01480765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658288|NCT01480765|Anticonvulsants|anticonvulsants|mesh-ancestor
6658289|NCT01480765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6658290|NCT01480765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6658291|NCT01480765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6658292|NCT01480765|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6658293|NCT01480765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6658294|NCT01480765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6020236|NCT00392223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6020237|NCT00392223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6020238|NCT00392288|Ciclesonide|ciclesonide|mesh-list
6020239|NCT00392288|Glucocorticoids|glucocorticoids|mesh-ancestor
6020240|NCT00392288|Hormones|hormones|mesh-ancestor
6020241|NCT00392288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6579375|NCT01048034|Azacitidine|azacitidine|mesh-list
6579376|NCT01048034|Epoetin Alfa|epoetin alfa|mesh-list
6579377|NCT01048034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6579378|NCT01048034|Antimetabolites|antimetabolites|mesh-ancestor
6579379|NCT01048034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6579380|NCT01048034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6579381|NCT01048034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6579382|NCT01048034|Hematinics|hematinics|mesh-ancestor
6579383|NCT01048047|Amlodipine|amlodipine|mesh-list
6579384|NCT01048047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6579385|NCT01048047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6579386|NCT01048047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6579387|NCT01048047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6579388|NCT01048047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6579389|NCT01048047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579390|NCT01048047|Vasodilator Agents|vasodilator agents|mesh-ancestor
6579391|NCT01048086|Tretinoin|tretinoin|mesh-list
6579392|NCT01048086|Isotretinoin|isotretinoin|mesh-list
6579393|NCT01048086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6579394|NCT01048086|Keratolytic Agents|keratolytic agents|mesh-ancestor
6579395|NCT01048086|Dermatologic Agents|dermatologic agents|mesh-ancestor
6579396|NCT01048138|Biperiden|biperiden|mesh-list
6020242|NCT00392288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020243|NCT00392288|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6020244|NCT00392379|Nicotine|nicotine|mesh-list
6020245|NCT00392379|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6020246|NCT00392379|Autonomic Agents|autonomic agents|mesh-ancestor
6020247|NCT00392379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6020248|NCT00392379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020249|NCT00392379|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6579397|NCT01048138|Biperiden lactate|biperiden lactate|mesh-list
6579398|NCT01048138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6579399|NCT01048138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6579400|NCT01048138|Parasympatholytics|parasympatholytics|mesh-ancestor
6579401|NCT01048138|Autonomic Agents|autonomic agents|mesh-ancestor
6579402|NCT01048138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6579403|NCT01048138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579404|NCT01048138|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6579405|NCT01048138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6579406|NCT01048138|Cholinergic Agents|cholinergic agents|mesh-ancestor
6579407|NCT01048138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6579408|NCT01048138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6579409|NCT01048177|Lidocaine|lidocaine|mesh-list
6579410|NCT01048177|Heparin|heparin|mesh-list
6579411|NCT01048177|Anesthetics, Local|anesthetics, local|mesh-ancestor
6579412|NCT01048177|Anesthetics|anesthetics|mesh-ancestor
6579413|NCT01048177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6579414|NCT01048177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579415|NCT01048177|Sensory System Agents|sensory system agents|mesh-ancestor
6579416|NCT01048177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6579417|NCT01048177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6579418|NCT01048177|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6579419|NCT01048177|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6579420|NCT01048177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6579421|NCT01048177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6579422|NCT01048177|Anticoagulants|anticoagulants|mesh-ancestor
6579423|NCT01048177|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6579424|NCT01048177|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6579425|NCT01048190|Vaccines|vaccines|mesh-list
6579426|NCT01048190|Immunologic Factors|immunologic factors|mesh-ancestor
6579427|NCT01048190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579428|NCT01048229|Pramipexole|pramipexole|mesh-list
6579429|NCT01048229|Rasagiline|rasagiline|mesh-list
6579430|NCT01048229|Antioxidants|antioxidants|mesh-ancestor
6579431|NCT01048229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6579432|NCT01048229|Protective Agents|protective agents|mesh-ancestor
6579433|NCT01048229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579434|NCT01048229|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6579435|NCT01048229|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6579436|NCT01048229|Dopamine Agonists|dopamine agonists|mesh-ancestor
6579437|NCT01048229|Dopamine Agents|dopamine agents|mesh-ancestor
6579438|NCT01048229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5501532|NCT04473417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020250|NCT00392379|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6579439|NCT01048229|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6579440|NCT01048229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6579441|NCT01048229|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6579442|NCT01048268|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
6579443|NCT01048268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6579444|NCT01048268|Incretins|incretins|mesh-ancestor
6579445|NCT01048268|Hormones|hormones|mesh-ancestor
6579446|NCT01048268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6579447|NCT01048268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579448|NCT01048307|Polihexanide|polihexanide|mesh-list
6579449|NCT01048307|Betaine|betaine|mesh-list
6579450|NCT01048307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6579451|NCT01048307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6579452|NCT01048307|Lipotropic Agents|lipotropic agents|mesh-ancestor
6579453|NCT01048307|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6579454|NCT01048307|Antimetabolites|antimetabolites|mesh-ancestor
6579455|NCT01048307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6579456|NCT01048307|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6579457|NCT01048307|Disinfectants|disinfectants|mesh-ancestor
6579458|NCT01048307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6579459|NCT01048320|Gemcitabine|gemcitabine|mesh-list
6579460|NCT01048320|Oxaliplatin|oxaliplatin|mesh-list
6579461|NCT01048320|Imatinib Mesylate|imatinib mesylate|mesh-list
6579462|NCT01048320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6579463|NCT01048320|Antimetabolites|antimetabolites|mesh-ancestor
6579464|NCT01048320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6579465|NCT01048320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6579466|NCT01048320|Antiviral Agents|antiviral agents|mesh-ancestor
6579467|NCT01048320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6579468|NCT01048320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6579469|NCT01048320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6579470|NCT01048320|Immunologic Factors|immunologic factors|mesh-ancestor
6579471|NCT01048320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579472|NCT01048320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6579473|NCT01048385|Ubiquinone|ubiquinone|mesh-list
6579474|NCT01048385|Coenzyme Q10|coenzyme q10|mesh-list
6579475|NCT01048385|Micronutrients|micronutrients|mesh-ancestor
6579476|NCT01048385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579477|NCT01048385|Vitamins|vitamins|mesh-ancestor
6579478|NCT01048398|Acetaminophen|acetaminophen|mesh-list
6579479|NCT01048398|Remifentanil|remifentanil|mesh-list
6579480|NCT01048398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6579481|NCT01048398|Analgesics|analgesics|mesh-ancestor
6579482|NCT01048398|Sensory System Agents|sensory system agents|mesh-ancestor
6579483|NCT01048398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6579484|NCT01048398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579485|NCT01048398|Antipyretics|antipyretics|mesh-ancestor
6579486|NCT01048398|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6579487|NCT01048398|Narcotics|narcotics|mesh-ancestor
6579488|NCT01048398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6579489|NCT01048515|Caffeine|caffeine|mesh-list
6579490|NCT01048515|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6579491|NCT01048515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579492|NCT01048515|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6579493|NCT01048515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6579494|NCT01048515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6579495|NCT01048515|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6579496|NCT01048515|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6579497|NCT01048515|Purinergic Agents|purinergic agents|mesh-ancestor
6579498|NCT01048515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6579499|NCT01048554|Bevacizumab|bevacizumab|mesh-list
6579500|NCT01048554|Temozolomide|temozolomide|mesh-list
6579501|NCT01048554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6579502|NCT01048554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6579503|NCT01048554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6579504|NCT01048554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6579505|NCT01048554|Growth Substances|growth substances|mesh-ancestor
6579506|NCT01048554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579507|NCT01048554|Growth Inhibitors|growth inhibitors|mesh-ancestor
6579508|NCT01048554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6579509|NCT01048554|Alkylating Agents|alkylating agents|mesh-ancestor
6579510|NCT01048554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6579511|NCT01048580|Capecitabine|capecitabine|mesh-list
6579512|NCT01048580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6579513|NCT01048580|Antimetabolites|antimetabolites|mesh-ancestor
6579514|NCT01048580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6579515|NCT01048580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6579516|NCT01048619|ON 01910|on 01910|mesh-list
6579517|NCT01048619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6579518|NCT01048619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6579519|NCT01048619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6579520|NCT01048619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6579521|NCT01048632|Oxandrolone|oxandrolone|mesh-list
6579522|NCT01048632|Androgens|androgens|mesh-ancestor
6579523|NCT01048632|Hormones|hormones|mesh-ancestor
6579524|NCT01048632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6579525|NCT01048632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579526|NCT01048632|Anabolic Agents|anabolic agents|mesh-ancestor
6579527|NCT01048684|Mannitol|mannitol|mesh-list
6579528|NCT01048684|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6579529|NCT01048684|Diuretics|diuretics|mesh-ancestor
6579530|NCT01048684|Natriuretic Agents|natriuretic agents|mesh-ancestor
6579531|NCT01048684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579532|NCT01048827|Busulfan|busulfan|mesh-list
6579533|NCT01048827|Alkylating Agents|alkylating agents|mesh-ancestor
6579534|NCT01048827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6579535|NCT01048827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6579536|NCT01048827|Immunologic Factors|immunologic factors|mesh-ancestor
6579537|NCT01048827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579538|NCT01048827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6579539|NCT01048827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6579540|NCT01048827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6579541|NCT01048892|Cyclophosphamide|cyclophosphamide|mesh-list
6579542|NCT01048892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6579543|NCT01048892|Immunologic Factors|immunologic factors|mesh-ancestor
6579544|NCT01048892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579545|NCT01048892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6579546|NCT01048892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6579547|NCT01048892|Alkylating Agents|alkylating agents|mesh-ancestor
6579548|NCT01048892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6579549|NCT01048892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6579550|NCT01048892|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6579551|NCT01048983|Minocycline|minocycline|mesh-list
6579552|NCT01048983|Curcumin|curcumin|mesh-list
6579553|NCT01048983|Modafinil|modafinil|mesh-list
6579554|NCT01048983|Bupropion|bupropion|mesh-list
6579555|NCT01048983|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6579556|NCT01048983|Antidepressive Agents|antidepressive agents|mesh-ancestor
6446398|NCT00392431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6579557|NCT01048983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6579558|NCT01048983|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6579559|NCT01048983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6579560|NCT01048983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6579561|NCT01048983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6579562|NCT01048983|Dopamine Agents|dopamine agents|mesh-ancestor
6579563|NCT01048983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6579564|NCT01048983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579565|NCT01048983|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6579566|NCT01048983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6579567|NCT01048983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6579568|NCT01048983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6579569|NCT01048983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6579570|NCT01048983|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6579571|NCT01048983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6579572|NCT01048983|Analgesics|analgesics|mesh-ancestor
6579573|NCT01048983|Sensory System Agents|sensory system agents|mesh-ancestor
6579574|NCT01048983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6579575|NCT01048983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6579576|NCT01048983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6579577|NCT01048983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6579578|NCT01048983|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6579579|NCT01048983|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
5501533|NCT04473274|Pioglitazone|pioglitazone|mesh-list
6446399|NCT00392431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6446400|NCT00392431|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6446401|NCT00392431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6446402|NCT00392431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6446403|NCT00392431|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6446404|NCT00392431|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6446405|NCT00392431|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6446406|NCT00392457|Ketoconazole|ketoconazole|mesh-list
6446407|NCT00392457|Hormones|hormones|mesh-list
6446408|NCT00392457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6446409|NCT00392457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446410|NCT00392457|Antifungal Agents|antifungal agents|mesh-ancestor
6579580|NCT01048983|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6579581|NCT01048983|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6579582|NCT01049022|Moxifloxacin|moxifloxacin|mesh-list
6579583|NCT01049022|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6579584|NCT01049022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6579585|NCT01049022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6579586|NCT01049022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6579587|NCT01049022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6579588|NCT01049022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6579589|NCT01049022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6579590|NCT01049022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6579591|NCT01049022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6579592|NCT01049022|Contraceptive Agents|contraceptive agents|mesh-ancestor
6579593|NCT01049022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6579594|NCT01049022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579595|NCT01049022|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6579596|NCT01049022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6579597|NCT01049022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6579598|NCT01049035|Vaccines|vaccines|mesh-list
6579599|NCT01049035|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6579600|NCT01049035|Immunoglobulins|immunoglobulins|mesh-list
6579601|NCT01049035|Immunologic Factors|immunologic factors|mesh-ancestor
6579602|NCT01049035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579603|NCT01049048|Vitamin D|vitamin d|mesh-list
6579604|NCT01049048|Cholecalciferol|cholecalciferol|mesh-list
6579605|NCT01049048|Vitamins|vitamins|mesh-ancestor
6579606|NCT01049048|Micronutrients|micronutrients|mesh-ancestor
6579607|NCT01049048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579608|NCT01049048|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6579609|NCT01049048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6579610|NCT01049061|Farletuzumab|farletuzumab|mesh-list
6579611|NCT01049061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6579612|NCT01049178|Silymarin|silymarin|mesh-list
6579613|NCT01049178|Antioxidants|antioxidants|mesh-ancestor
6579614|NCT01049178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6579615|NCT01049178|Protective Agents|protective agents|mesh-ancestor
6579616|NCT01049178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579617|NCT01049204|Maraviroc|maraviroc|mesh-list
6579618|NCT01049204|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6579619|NCT01049204|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6579620|NCT01049204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446411|NCT00392457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6446412|NCT00392457|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6446413|NCT00392457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6446414|NCT00392457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6446415|NCT00392457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446416|NCT00392457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6446417|NCT00392457|Hormone Antagonists|hormone antagonists|mesh-ancestor
6446418|NCT00392457|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6446419|NCT00392470|Irinotecan|irinotecan|mesh-list
6446420|NCT00392470|Cetuximab|cetuximab|mesh-list
6446421|NCT00392470|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6446422|NCT00392470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6446423|NCT00392470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6446424|NCT00392470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6579621|NCT01049204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6579622|NCT01049204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6579623|NCT01049204|Antiviral Agents|antiviral agents|mesh-ancestor
6579624|NCT01049204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6579625|NCT01049204|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6579626|NCT01049347|Amitriptyline|amitriptyline|mesh-list
6579627|NCT01049347|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6579628|NCT01049347|Paroxetine|paroxetine|mesh-list
6579629|NCT01049347|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6579630|NCT01049347|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6579631|NCT01049347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6579632|NCT01049347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6579633|NCT01049347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6579634|NCT01049347|Serotonin Agents|serotonin agents|mesh-ancestor
6579635|NCT01049347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579636|NCT01049347|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6579637|NCT01049347|Antidepressive Agents|antidepressive agents|mesh-ancestor
6579638|NCT01049347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6579639|NCT01049347|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6579640|NCT01049347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6579641|NCT01049347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6579642|NCT01049347|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6579643|NCT01049347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6579644|NCT01049347|Analgesics|analgesics|mesh-ancestor
6020251|NCT00392379|Cholinergic Agents|cholinergic agents|mesh-ancestor
6579645|NCT01049347|Sensory System Agents|sensory system agents|mesh-ancestor
6579646|NCT01049347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6579647|NCT01049347|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6579648|NCT01049347|Adrenergic Agents|adrenergic agents|mesh-ancestor
6579649|NCT01049347|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6579650|NCT01049347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6579651|NCT01049347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6579652|NCT01049425|Cyclophosphamide|cyclophosphamide|mesh-list
6579653|NCT01049425|Docetaxel|docetaxel|mesh-list
6579654|NCT01049425|Epirubicin|epirubicin|mesh-list
6579655|NCT01049425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6579656|NCT01049425|Immunologic Factors|immunologic factors|mesh-ancestor
6579657|NCT01049425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579658|NCT01049425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6579659|NCT01049425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6579660|NCT01049425|Alkylating Agents|alkylating agents|mesh-ancestor
6579661|NCT01049425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6579662|NCT01049425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6579663|NCT01049425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6579664|NCT01049425|Tubulin Modulators|tubulin modulators|mesh-ancestor
6579665|NCT01049425|Antimitotic Agents|antimitotic agents|mesh-ancestor
6579666|NCT01049425|Mitosis Modulators|mitosis modulators|mesh-ancestor
6579667|NCT01049425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6579668|NCT01049425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6579669|NCT01049425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6579670|NCT01049425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6579671|NCT01049438|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6579672|NCT01049438|Doxycycline|doxycycline|mesh-list
6579673|NCT01049438|Minocycline|minocycline|mesh-list
6579674|NCT01049438|Mupirocin|mupirocin|mesh-list
6579675|NCT01049438|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6579676|NCT01049438|Trimethoprim|trimethoprim|mesh-list
6579677|NCT01049438|Sulfamethoxazole|sulfamethoxazole|mesh-list
6579678|NCT01049438|Hexachlorophene|hexachlorophene|mesh-list
6579679|NCT01049438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6579680|NCT01049438|Antimalarials|antimalarials|mesh-ancestor
6579681|NCT01049438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6579682|NCT01049438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6579683|NCT01049438|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6579684|NCT01049438|Renal Agents|renal agents|mesh-ancestor
6579685|NCT01049438|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6579686|NCT01049438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6664801|NCT01514123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6579687|NCT01049438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6579688|NCT01049438|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6579689|NCT01049438|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6579690|NCT01049438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6579691|NCT01049438|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6579692|NCT01049438|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6579693|NCT01049451|Methylprednisolone|methylprednisolone|mesh-list
6579694|NCT01049451|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6579695|NCT01049451|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6579696|NCT01049451|Prednisolone|prednisolone|mesh-list
6579697|NCT01049451|Prednisolone acetate|prednisolone acetate|mesh-list
6579698|NCT01049451|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6579699|NCT01049451|Prednisolone phosphate|prednisolone phosphate|mesh-list
6579700|NCT01049451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6579701|NCT01049451|Antiemetics|antiemetics|mesh-ancestor
6579702|NCT01049451|Autonomic Agents|autonomic agents|mesh-ancestor
6579703|NCT01049451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6579704|NCT01049451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579705|NCT01049451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6579706|NCT01049451|Glucocorticoids|glucocorticoids|mesh-ancestor
6579707|NCT01049451|Hormones|hormones|mesh-ancestor
6579708|NCT01049451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6579709|NCT01049451|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6579710|NCT01049451|Protective Agents|protective agents|mesh-ancestor
6579711|NCT01049451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6579712|NCT01049451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6579713|NCT01049464|Magnesium Sulfate|magnesium sulfate|mesh-list
6579714|NCT01049464|Analgesics|analgesics|mesh-ancestor
6579715|NCT01049464|Sensory System Agents|sensory system agents|mesh-ancestor
6579716|NCT01049464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6579717|NCT01049464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579718|NCT01049464|Anesthetics|anesthetics|mesh-ancestor
6579719|NCT01049464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6579720|NCT01049464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6579721|NCT01049464|Anticonvulsants|anticonvulsants|mesh-ancestor
6579722|NCT01049464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6579723|NCT01049464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6579724|NCT01049464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6579725|NCT01049464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6579726|NCT01049464|Tocolytic Agents|tocolytic agents|mesh-ancestor
6579727|NCT01049464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6579728|NCT01049542|Astressin|astressin|mesh-list
6579729|NCT01049542|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6579730|NCT01049542|Protective Agents|protective agents|mesh-ancestor
6579731|NCT01049542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579732|NCT01049620|Capecitabine|capecitabine|mesh-list
6579733|NCT01049620|Oxaliplatin|oxaliplatin|mesh-list
6579734|NCT01049620|Everolimus|everolimus|mesh-list
6579735|NCT01049620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6579736|NCT01049620|Antimetabolites|antimetabolites|mesh-ancestor
6579737|NCT01049620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6579738|NCT01049620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6579739|NCT01049620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6579740|NCT01049620|Immunologic Factors|immunologic factors|mesh-ancestor
6579741|NCT01049620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579742|NCT01049633|Aspirin|aspirin|mesh-list
6579743|NCT01049633|Sirolimus|sirolimus|mesh-list
6579744|NCT01049633|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6579745|NCT01049633|Clotrimazole|clotrimazole|mesh-list
6579746|NCT01049633|Miconazole|miconazole|mesh-list
6579747|NCT01049633|Antifungal Agents|antifungal agents|mesh-list
6579748|NCT01049633|Trimethoprim|trimethoprim|mesh-list
6579749|NCT01049633|Sulfamethoxazole|sulfamethoxazole|mesh-list
6579750|NCT01049633|Valganciclovir|valganciclovir|mesh-list
6579751|NCT01049633|Antiviral Agents|antiviral agents|mesh-list
6579752|NCT01049633|Heparin|heparin|mesh-list
6579753|NCT01049633|Enoxaparin|enoxaparin|mesh-list
6579754|NCT01049633|Pentoxifylline|pentoxifylline|mesh-list
6579755|NCT01049633|Tacrolimus|tacrolimus|mesh-list
6579756|NCT01049633|Basiliximab|basiliximab|mesh-list
6579757|NCT01049633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6579758|NCT01049633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6579759|NCT01049633|Analgesics|analgesics|mesh-ancestor
6579760|NCT01049633|Sensory System Agents|sensory system agents|mesh-ancestor
6579761|NCT01049633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6579762|NCT01049633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579763|NCT01049633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6579764|NCT01049633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6579765|NCT01049633|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6579766|NCT01049633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6579767|NCT01049633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6579768|NCT01049633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6579769|NCT01049633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6579770|NCT01049633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6579771|NCT01049633|Antipyretics|antipyretics|mesh-ancestor
6579772|NCT01049633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6579773|NCT01049633|Immunologic Factors|immunologic factors|mesh-ancestor
6579774|NCT01049633|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6579775|NCT01049633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6579776|NCT01049633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6579777|NCT01049633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6579778|NCT01049633|Anticoagulants|anticoagulants|mesh-ancestor
6579779|NCT01049633|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6579780|NCT01049633|Renal Agents|renal agents|mesh-ancestor
6579781|NCT01049633|Antimalarials|antimalarials|mesh-ancestor
6579782|NCT01049633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6579783|NCT01049633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6579784|NCT01049633|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6579785|NCT01049633|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6579786|NCT01049633|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6579787|NCT01049633|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6579788|NCT01049633|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6579789|NCT01049633|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6579790|NCT01049633|Protective Agents|protective agents|mesh-ancestor
6579791|NCT01049633|Vasodilator Agents|vasodilator agents|mesh-ancestor
6579792|NCT01049633|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6579793|NCT01049633|Antioxidants|antioxidants|mesh-ancestor
6579794|NCT01049633|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6579795|NCT01049633|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6579796|NCT01049633|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6579797|NCT01049633|Hormone Antagonists|hormone antagonists|mesh-ancestor
6579798|NCT01049633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6579799|NCT01049633|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6579800|NCT01049633|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6579801|NCT01049646|Angiotensin II|angiotensin ii|mesh-list
6579802|NCT01049646|Giapreza|giapreza|mesh-list
6579803|NCT01049646|Angiotensinogen|angiotensinogen|mesh-list
6579804|NCT01049646|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6579805|NCT01049646|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6579806|NCT01049646|Protease Inhibitors|protease inhibitors|mesh-ancestor
6579807|NCT01049646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6579808|NCT01049646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6579809|NCT01049672|Alfentanil|alfentanil|mesh-list
6579810|NCT01049672|Heroin|heroin|mesh-list
6579811|NCT01049672|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6446425|NCT00392470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6446426|NCT00392470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6446427|NCT00392522|Nitrous Oxide|nitrous oxide|mesh-list
6446428|NCT00392522|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6446429|NCT00392522|Anesthetics, General|anesthetics, general|mesh-ancestor
6579812|NCT01049672|Narcotics|narcotics|mesh-ancestor
6579813|NCT01049672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6579814|NCT01049672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579815|NCT01049672|Analgesics|analgesics|mesh-ancestor
6579816|NCT01049672|Sensory System Agents|sensory system agents|mesh-ancestor
6579817|NCT01049672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6579818|NCT01049672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6579819|NCT01049672|Anesthetics, General|anesthetics, general|mesh-ancestor
6579820|NCT01049672|Anesthetics|anesthetics|mesh-ancestor
6579821|NCT01049685|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6579822|NCT01049685|Antiviral Agents|antiviral agents|mesh-ancestor
6579823|NCT01049685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6658295|NCT01480778|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
6658296|NCT01480778|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6658297|NCT01480778|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6658298|NCT01480778|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6658299|NCT01480778|Contraceptive Agents|contraceptive agents|mesh-ancestor
6658300|NCT01480778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6658301|NCT01480778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658302|NCT01480778|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6658303|NCT01480778|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6658304|NCT01480778|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6658305|NCT01480778|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
6658306|NCT01480778|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6658307|NCT01480778|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6658308|NCT01480791|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6658309|NCT01480791|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6658310|NCT01480791|Diuretics|diuretics|mesh-ancestor
6658311|NCT01480791|Natriuretic Agents|natriuretic agents|mesh-ancestor
6658312|NCT01480791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658313|NCT01480791|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6658314|NCT01480791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6658315|NCT01480791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658316|NCT01480817|Sorafenib|sorafenib|mesh-list
6658317|NCT01480817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6658318|NCT01480817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6658319|NCT01480817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6446430|NCT00392522|Anesthetics|anesthetics|mesh-ancestor
6446431|NCT00392522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6446432|NCT00392522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446433|NCT00392522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6446434|NCT00392522|Analgesics|analgesics|mesh-ancestor
6658320|NCT01480817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658321|NCT01480869|Calcium, Dietary|calcium, dietary|mesh-list
6658322|NCT01480869|Cholecalciferol|cholecalciferol|mesh-list
6658323|NCT01480869|Calcium|calcium|mesh-list
6658324|NCT01480869|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6658325|NCT01480869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658326|NCT01480869|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6658327|NCT01480869|Vitamins|vitamins|mesh-ancestor
6658328|NCT01480869|Micronutrients|micronutrients|mesh-ancestor
6658329|NCT01480986|Irinotecan|irinotecan|mesh-list
6658330|NCT01480986|Octreotide|octreotide|mesh-list
6658331|NCT01480986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6658332|NCT01480986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6658333|NCT01480986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5501534|NCT04473274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6579824|NCT01049711|Epoetin Alfa|epoetin alfa|mesh-list
6579825|NCT01049711|Hematinics|hematinics|mesh-ancestor
6579826|NCT01049763|Oseltamivir|oseltamivir|mesh-list
6579827|NCT01049763|Antiviral Agents|antiviral agents|mesh-ancestor
6579828|NCT01049763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6579829|NCT01049763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6446435|NCT00392522|Sensory System Agents|sensory system agents|mesh-ancestor
6446436|NCT00392522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6579830|NCT01049763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6579831|NCT01049815|Calcium Carbonate|calcium carbonate|mesh-list
6579832|NCT01049815|Calcium|calcium|mesh-list
6579833|NCT01049815|Sevelamer|sevelamer|mesh-list
6579834|NCT01049815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6579835|NCT01049815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579836|NCT01049815|Antacids|antacids|mesh-ancestor
6579837|NCT01049815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6579838|NCT01049815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6579839|NCT01049815|Chelating Agents|chelating agents|mesh-ancestor
6579840|NCT01049815|Sequestering Agents|sequestering agents|mesh-ancestor
6579841|NCT01049841|Sirolimus|sirolimus|mesh-list
6579842|NCT01049841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6579843|NCT01049841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6579844|NCT01049841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6579845|NCT01049841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6579846|NCT01049841|Antifungal Agents|antifungal agents|mesh-ancestor
6579847|NCT01049841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6579848|NCT01049841|Immunologic Factors|immunologic factors|mesh-ancestor
6579849|NCT01049841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579850|NCT01049854|Vidarabine|vidarabine|mesh-list
6579851|NCT01049854|Cyclophosphamide|cyclophosphamide|mesh-list
6579852|NCT01049854|Thiotepa|thiotepa|mesh-list
6579853|NCT01049854|Busulfan|busulfan|mesh-list
6579854|NCT01049854|Fludarabine phosphate|fludarabine phosphate|mesh-list
6579855|NCT01049854|Fludarabine|fludarabine|mesh-list
6579856|NCT01049854|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6579857|NCT01049854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6579858|NCT01049854|Immunologic Factors|immunologic factors|mesh-ancestor
6579859|NCT01049854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579860|NCT01049854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6579861|NCT01049854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6579862|NCT01049854|Alkylating Agents|alkylating agents|mesh-ancestor
6579863|NCT01049854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6579864|NCT01049854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6579865|NCT01049854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6579866|NCT01049854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6446437|NCT00392561|Vitamin E|vitamin e|mesh-list
6446438|NCT00392561|Selenium|selenium|mesh-list
6446439|NCT00392561|Vitamins|vitamins|mesh-ancestor
6446440|NCT00392561|Micronutrients|micronutrients|mesh-ancestor
6446441|NCT00392561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446442|NCT00392561|Antioxidants|antioxidants|mesh-ancestor
6446443|NCT00392561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446444|NCT00392561|Protective Agents|protective agents|mesh-ancestor
6446445|NCT00392561|Trace Elements|trace elements|mesh-ancestor
6446446|NCT00392652|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
6446447|NCT00392652|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6446448|NCT00392652|Protective Agents|protective agents|mesh-ancestor
6446449|NCT00392652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446450|NCT00392652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6446451|NCT00392691|Rituximab|rituximab|mesh-list
6446452|NCT00392691|Melphalan|melphalan|mesh-list
6446453|NCT00392691|Vinorelbine|vinorelbine|mesh-list
6446454|NCT00392691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6446455|NCT00392691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6446456|NCT00392691|Immunologic Factors|immunologic factors|mesh-ancestor
6446457|NCT00392691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446458|NCT00392691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6446459|NCT00392691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6579867|NCT01049854|Antimetabolites|antimetabolites|mesh-ancestor
6579868|NCT01049854|Antiviral Agents|antiviral agents|mesh-ancestor
6579869|NCT01049854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6579870|NCT01049880|Ascorbic Acid|ascorbic acid|mesh-list
6579871|NCT01049880|Gemcitabine|gemcitabine|mesh-list
6579872|NCT01049880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6579873|NCT01049880|Antimetabolites|antimetabolites|mesh-ancestor
6579874|NCT01049880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6579875|NCT01049880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6579876|NCT01049880|Antiviral Agents|antiviral agents|mesh-ancestor
6579877|NCT01049880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6579878|NCT01049880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6579879|NCT01049880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6579880|NCT01049880|Immunologic Factors|immunologic factors|mesh-ancestor
6579881|NCT01049880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579882|NCT01049880|Antioxidants|antioxidants|mesh-ancestor
6579883|NCT01049880|Protective Agents|protective agents|mesh-ancestor
6579884|NCT01049880|Vitamins|vitamins|mesh-ancestor
6579885|NCT01049880|Micronutrients|micronutrients|mesh-ancestor
6579886|NCT01049932|Rilpivirine|rilpivirine|mesh-list
6579887|NCT01049932|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6579888|NCT01049932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6579889|NCT01049932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6579890|NCT01049932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6579891|NCT01049932|Antiviral Agents|antiviral agents|mesh-ancestor
6579892|NCT01049932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6579893|NCT01049932|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6579894|NCT01049932|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6579895|NCT01050036|Busulfan|busulfan|mesh-list
6579896|NCT01050036|Alkylating Agents|alkylating agents|mesh-ancestor
6579897|NCT01050036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6579898|NCT01050036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6579899|NCT01050036|Immunologic Factors|immunologic factors|mesh-ancestor
6579900|NCT01050036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579901|NCT01050036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6579902|NCT01050036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6579903|NCT01050036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6579904|NCT01050088|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6579905|NCT01050114|Oxybutynin|oxybutynin|mesh-list
6579906|NCT01050114|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6579907|NCT01050114|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6579908|NCT01050114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6579909|NCT01050114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579910|NCT01050114|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6579911|NCT01050114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6579912|NCT01050114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6579913|NCT01050114|Cholinergic Agents|cholinergic agents|mesh-ancestor
6579914|NCT01050114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6579915|NCT01050114|Parasympatholytics|parasympatholytics|mesh-ancestor
6579916|NCT01050114|Autonomic Agents|autonomic agents|mesh-ancestor
6579917|NCT01050114|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6579918|NCT01050114|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6579919|NCT01050114|Urological Agents|urological agents|mesh-ancestor
6579920|NCT01050270|Acetylcysteine|acetylcysteine|mesh-list
6579921|NCT01050270|Ondansetron|ondansetron|mesh-list
6579922|NCT01050270|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6579923|NCT01050270|Antiemetics|antiemetics|mesh-ancestor
6579924|NCT01050270|Autonomic Agents|autonomic agents|mesh-ancestor
6579925|NCT01050270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6579926|NCT01050270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579927|NCT01050270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6020252|NCT00392379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6020253|NCT00392379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020254|NCT00392392|Paclitaxel|paclitaxel|mesh-list
6020255|NCT00392392|Bevacizumab|bevacizumab|mesh-list
6020256|NCT00392392|Trastuzumab|trastuzumab|mesh-list
6020257|NCT00392392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6020258|NCT00392392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6020259|NCT00392392|Tubulin Modulators|tubulin modulators|mesh-ancestor
6020260|NCT00392392|Antimitotic Agents|antimitotic agents|mesh-ancestor
6020261|NCT00392392|Mitosis Modulators|mitosis modulators|mesh-ancestor
6020262|NCT00392392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020263|NCT00392392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6020264|NCT00392392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6020265|NCT00392392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6579928|NCT01050270|Antipruritics|antipruritics|mesh-ancestor
6579929|NCT01050270|Dermatologic Agents|dermatologic agents|mesh-ancestor
6579930|NCT01050270|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6579931|NCT01050270|Serotonin Agents|serotonin agents|mesh-ancestor
6579932|NCT01050270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6579933|NCT01050270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6579934|NCT01050270|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6579935|NCT01050270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6579936|NCT01050270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6579937|NCT01050270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6579938|NCT01050270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6579939|NCT01050270|Antiviral Agents|antiviral agents|mesh-ancestor
6579940|NCT01050270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6579941|NCT01050270|Expectorants|expectorants|mesh-ancestor
6579942|NCT01050270|Respiratory System Agents|respiratory system agents|mesh-ancestor
6579943|NCT01050270|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6579944|NCT01050270|Antioxidants|antioxidants|mesh-ancestor
6579945|NCT01050270|Protective Agents|protective agents|mesh-ancestor
6579946|NCT01050270|Antidotes|antidotes|mesh-ancestor
6579947|NCT01050322|Gemcitabine|gemcitabine|mesh-list
6579948|NCT01050322|Capecitabine|capecitabine|mesh-list
6579949|NCT01050322|Vinorelbine|vinorelbine|mesh-list
6579950|NCT01050322|Lapatinib|lapatinib|mesh-list
6579951|NCT01050322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6579952|NCT01050322|Antimetabolites|antimetabolites|mesh-ancestor
6579953|NCT01050322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6579954|NCT01050322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6579955|NCT01050322|Antiviral Agents|antiviral agents|mesh-ancestor
6579956|NCT01050322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6579957|NCT01050322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6579958|NCT01050322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6579959|NCT01050322|Immunologic Factors|immunologic factors|mesh-ancestor
6579960|NCT01050322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579961|NCT01050322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6579962|NCT01050322|Tubulin Modulators|tubulin modulators|mesh-ancestor
6579963|NCT01050322|Antimitotic Agents|antimitotic agents|mesh-ancestor
6579964|NCT01050322|Mitosis Modulators|mitosis modulators|mesh-ancestor
6579965|NCT01050322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6579966|NCT01050348|Atorvastatin|atorvastatin|mesh-list
6579967|NCT01050348|Calcium|calcium|mesh-list
6579968|NCT01050348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6579969|NCT01050348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6579970|NCT01050348|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6579971|NCT01050348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6579972|NCT01050348|Antimetabolites|antimetabolites|mesh-ancestor
6579973|NCT01050348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6579974|NCT01050348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6579975|NCT01050348|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6579976|NCT01050348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6579977|NCT01050374|Albendazole|albendazole|mesh-list
6579978|NCT01050374|Praziquantel|praziquantel|mesh-list
6579979|NCT01050374|Mebendazole|mebendazole|mesh-list
6579980|NCT01050374|Piperazine|piperazine|mesh-list
6579981|NCT01050374|Piperazine citrate|piperazine citrate|mesh-list
6579982|NCT01050374|DMP 777|dmp 777|mesh-list
6579983|NCT01050374|Anthelmintics|anthelmintics|mesh-ancestor
6579984|NCT01050374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6579985|NCT01050374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6579986|NCT01050374|Anticestodal Agents|anticestodal agents|mesh-ancestor
6579987|NCT01050374|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6579988|NCT01050374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6579989|NCT01050374|Tubulin Modulators|tubulin modulators|mesh-ancestor
6579990|NCT01050374|Antimitotic Agents|antimitotic agents|mesh-ancestor
6579991|NCT01050374|Mitosis Modulators|mitosis modulators|mesh-ancestor
6579992|NCT01050374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6579993|NCT01050374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6579994|NCT01050374|Antinematodal Agents|antinematodal agents|mesh-ancestor
6579995|NCT01050374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6579996|NCT01050387|Vitamin D|vitamin d|mesh-list
6579997|NCT01050387|Vitamins|vitamins|mesh-ancestor
6579998|NCT01050387|Micronutrients|micronutrients|mesh-ancestor
6579999|NCT01050387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580000|NCT01050387|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6580001|NCT01050426|Leucovorin|leucovorin|mesh-list
6580002|NCT01050426|Cetuximab|cetuximab|mesh-list
6580003|NCT01050426|Levoleucovorin|levoleucovorin|mesh-list
6580004|NCT01050426|Antidotes|antidotes|mesh-ancestor
6580005|NCT01050426|Protective Agents|protective agents|mesh-ancestor
6580006|NCT01050426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580007|NCT01050426|Vitamin B Complex|vitamin b complex|mesh-ancestor
6580008|NCT01050426|Vitamins|vitamins|mesh-ancestor
6580009|NCT01050426|Micronutrients|micronutrients|mesh-ancestor
6580010|NCT01050426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6580011|NCT01050426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6020266|NCT00392392|Growth Substances|growth substances|mesh-ancestor
6020267|NCT00392392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020268|NCT00392392|Growth Inhibitors|growth inhibitors|mesh-ancestor
6020269|NCT00392444|Sunitinib|sunitinib|mesh-list
6020270|NCT00392444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6020271|NCT00392444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6020272|NCT00392444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6020273|NCT00392444|Growth Substances|growth substances|mesh-ancestor
6020274|NCT00392444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020275|NCT00392444|Growth Inhibitors|growth inhibitors|mesh-ancestor
6020276|NCT00392444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6020277|NCT00392444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6020278|NCT00392444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020279|NCT00392496|Sunitinib|sunitinib|mesh-list
6020280|NCT00392496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6020281|NCT00392496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6446460|NCT00392691|Alkylating Agents|alkylating agents|mesh-ancestor
6446461|NCT00392691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446462|NCT00392691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6446463|NCT00392691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6446464|NCT00392691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6446465|NCT00392691|Tubulin Modulators|tubulin modulators|mesh-ancestor
6446466|NCT00392691|Antimitotic Agents|antimitotic agents|mesh-ancestor
6446467|NCT00392691|Mitosis Modulators|mitosis modulators|mesh-ancestor
6446468|NCT00392717|Atorvastatin|atorvastatin|mesh-list
6580012|NCT01050452|Ivermectin|ivermectin|mesh-list
6580013|NCT01050452|Albendazole|albendazole|mesh-list
6580014|NCT01050452|Mebendazole|mebendazole|mesh-list
6580015|NCT01050452|Piperazine|piperazine|mesh-list
6580016|NCT01050452|Piperazine citrate|piperazine citrate|mesh-list
6580017|NCT01050452|DMP 777|dmp 777|mesh-list
6580018|NCT01050452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6580019|NCT01050452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6446469|NCT00392717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6446470|NCT00392717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6446471|NCT00392717|Antimetabolites|antimetabolites|mesh-ancestor
6446472|NCT00392717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446473|NCT00392717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6446474|NCT00392717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6446475|NCT00392717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6461762|NCT00455910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6461763|NCT00455910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6461764|NCT00455910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6461765|NCT00455910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6461766|NCT00455910|Growth Substances|growth substances|mesh-ancestor
6580020|NCT01050452|Anthelmintics|anthelmintics|mesh-ancestor
6580021|NCT01050452|Anticestodal Agents|anticestodal agents|mesh-ancestor
6580022|NCT01050452|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6580023|NCT01050452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6580024|NCT01050452|Tubulin Modulators|tubulin modulators|mesh-ancestor
6580025|NCT01050452|Antimitotic Agents|antimitotic agents|mesh-ancestor
6580026|NCT01050452|Mitosis Modulators|mitosis modulators|mesh-ancestor
6580027|NCT01050452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6580028|NCT01050452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6580029|NCT01050452|Antinematodal Agents|antinematodal agents|mesh-ancestor
6580030|NCT01050452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6580031|NCT01050478|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6580032|NCT01050478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6580033|NCT01050478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6580034|NCT01050478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6580035|NCT01050478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580036|NCT01050478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6580037|NCT01050478|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6580038|NCT01050478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6580039|NCT01050478|Serotonin Agents|serotonin agents|mesh-ancestor
6580040|NCT01050478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6580041|NCT01050478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6580042|NCT01050478|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6580043|NCT01050478|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6580044|NCT01050478|Dopamine Agents|dopamine agents|mesh-ancestor
6580045|NCT01050491|Sitaxsentan|sitaxsentan|mesh-list
6580046|NCT01050491|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6580047|NCT01050491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6580048|NCT01050517|Ivermectin|ivermectin|mesh-list
6580049|NCT01050517|Albendazole|albendazole|mesh-list
6580050|NCT01050517|Praziquantel|praziquantel|mesh-list
6580051|NCT01050517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6580052|NCT01050517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6580053|NCT01050517|Anthelmintics|anthelmintics|mesh-ancestor
6580054|NCT01050517|Anticestodal Agents|anticestodal agents|mesh-ancestor
6580055|NCT01050517|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6580056|NCT01050517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6580057|NCT01050517|Tubulin Modulators|tubulin modulators|mesh-ancestor
6580058|NCT01050517|Antimitotic Agents|antimitotic agents|mesh-ancestor
6580059|NCT01050517|Mitosis Modulators|mitosis modulators|mesh-ancestor
6580060|NCT01050517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6580061|NCT01050517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6580062|NCT01050556|Folic Acid|folic acid|mesh-list
6580063|NCT01050556|Vitamin B Complex|vitamin b complex|mesh-list
6580064|NCT01050556|Hematinics|hematinics|mesh-ancestor
6580065|NCT01050556|Vitamins|vitamins|mesh-ancestor
6580066|NCT01050556|Micronutrients|micronutrients|mesh-ancestor
6580067|NCT01050556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580068|NCT01050595|Naltrexone|naltrexone|mesh-list
6580069|NCT01050595|Bromides|bromides|mesh-list
6580070|NCT01050595|Methylnaltrexone|methylnaltrexone|mesh-list
6580071|NCT01050595|Anticonvulsants|anticonvulsants|mesh-ancestor
6580072|NCT01050595|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6658334|NCT01480986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6580073|NCT01050595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580074|NCT01050595|Sensory System Agents|sensory system agents|mesh-ancestor
6580075|NCT01050595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6580076|NCT01050595|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6580077|NCT01050608|Ethanol|ethanol|mesh-list
6580078|NCT01050608|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6580079|NCT01050608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6580080|NCT01050608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6580081|NCT01050608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580082|NCT01050621|Ascorbic Acid|ascorbic acid|mesh-list
6580083|NCT01050621|Vitamins|vitamins|mesh-ancestor
6580084|NCT01050621|Micronutrients|micronutrients|mesh-ancestor
6580085|NCT01050621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580086|NCT01050621|Antioxidants|antioxidants|mesh-ancestor
6580087|NCT01050621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6580088|NCT01050621|Protective Agents|protective agents|mesh-ancestor
6580089|NCT01050699|Fentanyl|fentanyl|mesh-list
6580090|NCT01050699|Midazolam|midazolam|mesh-list
6580091|NCT01050699|Dexmedetomidine|dexmedetomidine|mesh-list
6580092|NCT01050699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6580093|NCT01050699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6580094|NCT01050699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580095|NCT01050699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6580096|NCT01050699|Analgesics|analgesics|mesh-ancestor
6580097|NCT01050699|Sensory System Agents|sensory system agents|mesh-ancestor
6580098|NCT01050699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6580099|NCT01050699|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6580100|NCT01050699|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6580101|NCT01050699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6580102|NCT01050699|Adrenergic Agents|adrenergic agents|mesh-ancestor
6580103|NCT01050699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6580104|NCT01050699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020282|NCT00392496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6580105|NCT01050699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6580106|NCT01050699|Narcotics|narcotics|mesh-ancestor
6580107|NCT01050699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6580108|NCT01050699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6580109|NCT01050699|Anesthetics, General|anesthetics, general|mesh-ancestor
6580110|NCT01050699|Anesthetics|anesthetics|mesh-ancestor
6580111|NCT01050699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6020283|NCT00392496|Growth Substances|growth substances|mesh-ancestor
6580112|NCT01050699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6580113|NCT01050699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6580114|NCT01050699|GABA Modulators|gaba modulators|mesh-ancestor
6580115|NCT01050699|GABA Agents|gaba agents|mesh-ancestor
6580116|NCT01050712|Carbon Monoxide|carbon monoxide|mesh-list
6580117|NCT01050712|Antimetabolites|antimetabolites|mesh-ancestor
6580118|NCT01050712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6580119|NCT01050712|Gasotransmitters|gasotransmitters|mesh-ancestor
6580120|NCT01050712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6580121|NCT01050712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580122|NCT01050777|Paromomycin|paromomycin|mesh-list
6580123|NCT01050777|Meglumine Antimoniate|meglumine antimoniate|mesh-list
6580124|NCT01050777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6580125|NCT01050777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6580126|NCT01050777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6580127|NCT01050777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6580128|NCT01050842|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
6580129|NCT01050842|Bicalutamide|bicalutamide|mesh-list
6580130|NCT01050842|Androgen Antagonists|androgen antagonists|mesh-ancestor
6580131|NCT01050842|Hormone Antagonists|hormone antagonists|mesh-ancestor
6580132|NCT01050842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6580133|NCT01050842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580134|NCT01050842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6580135|NCT01050842|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6580136|NCT01050842|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6580137|NCT01050842|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6580138|NCT01050842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6580139|NCT01050855|Busulfan|busulfan|mesh-list
6580140|NCT01050855|Alemtuzumab|alemtuzumab|mesh-list
6580141|NCT01050855|Alkylating Agents|alkylating agents|mesh-ancestor
6580142|NCT01050855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6580143|NCT01050855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6580144|NCT01050855|Immunologic Factors|immunologic factors|mesh-ancestor
6580145|NCT01050855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580146|NCT01050855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6580147|NCT01050855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6580148|NCT01050855|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6580149|NCT01050855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6580150|NCT01050933|Carbon Monoxide|carbon monoxide|mesh-list
6580151|NCT01050933|Antimetabolites|antimetabolites|mesh-ancestor
6580152|NCT01050933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6580153|NCT01050933|Gasotransmitters|gasotransmitters|mesh-ancestor
6580154|NCT01050933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6580155|NCT01050933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580156|NCT01050985|Sirolimus|sirolimus|mesh-list
6580157|NCT01050985|Capecitabine|capecitabine|mesh-list
6580158|NCT01050985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6580159|NCT01050985|Antimetabolites|antimetabolites|mesh-ancestor
6580160|NCT01050985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6580161|NCT01050985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6580162|NCT01050985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6580163|NCT01050985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6580164|NCT01050985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6580165|NCT01050985|Antifungal Agents|antifungal agents|mesh-ancestor
6580166|NCT01050985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6580167|NCT01050985|Immunologic Factors|immunologic factors|mesh-ancestor
6580168|NCT01050985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580169|NCT01051011|Metformin|metformin|mesh-list
6580170|NCT01051011|Insulin Glargine|insulin glargine|mesh-list
6580171|NCT01051011|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6580172|NCT01051011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6580173|NCT01051011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580174|NCT01051011|Incretins|incretins|mesh-ancestor
6580175|NCT01051011|Hormones|hormones|mesh-ancestor
6580176|NCT01051011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6580177|NCT01051102|Insulin|insulin|mesh-list
6580178|NCT01051102|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6580179|NCT01051102|Insulin Aspart|insulin aspart|mesh-list
6580180|NCT01051102|Insulin, Long-Acting|insulin, long-acting|mesh-list
6580181|NCT01051102|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6580182|NCT01051102|Biphasic Insulins|biphasic insulins|mesh-list
6580183|NCT01051102|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6580184|NCT01051102|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6580185|NCT01051102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580186|NCT01051115|Dasatinib|dasatinib|mesh-list
6580187|NCT01051115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6580188|NCT01051115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6580189|NCT01051115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6580190|NCT01051115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6580191|NCT01051167|Cetuximab|cetuximab|mesh-list
6580192|NCT01051167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6580193|NCT01051167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6580194|NCT01051193|Oxcarbazepine|oxcarbazepine|mesh-list
6580195|NCT01051193|Anticonvulsants|anticonvulsants|mesh-ancestor
6580196|NCT01051193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6580197|NCT01051193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6580198|NCT01051193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6580199|NCT01051193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6580200|NCT01051193|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6580201|NCT01051193|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6580202|NCT01051219|Losartan|losartan|mesh-list
6580203|NCT01051219|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6580204|NCT01051219|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6580205|NCT01051219|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6580206|NCT01051219|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6580207|NCT01051219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6580208|NCT01051271|Midazolam|midazolam|mesh-list
6580209|NCT01051271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6580210|NCT01051271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6580211|NCT01051271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6580212|NCT01051271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580213|NCT01051271|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6580214|NCT01051271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6580215|NCT01051271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6580216|NCT01051271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6580217|NCT01051271|Anesthetics, General|anesthetics, general|mesh-ancestor
6580218|NCT01051271|Anesthetics|anesthetics|mesh-ancestor
6580219|NCT01051271|GABA Modulators|gaba modulators|mesh-ancestor
6580220|NCT01051271|GABA Agents|gaba agents|mesh-ancestor
6580221|NCT01051271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6580222|NCT01051271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6580223|NCT01051284|Gemcitabine|gemcitabine|mesh-list
6580224|NCT01051284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6580225|NCT01051284|Antimetabolites|antimetabolites|mesh-ancestor
6580226|NCT01051284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6580227|NCT01051284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6580228|NCT01051284|Antiviral Agents|antiviral agents|mesh-ancestor
6580229|NCT01051284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6580230|NCT01051284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6580231|NCT01051284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6580232|NCT01051284|Immunologic Factors|immunologic factors|mesh-ancestor
6580233|NCT01051284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580234|NCT01051362|Carboplatin|carboplatin|mesh-list
6580235|NCT01051362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6658335|NCT01480986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658336|NCT01480986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6658337|NCT01480986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6658338|NCT01481194|Dexamethasone|dexamethasone|mesh-list
6658339|NCT01481194|Cyclophosphamide|cyclophosphamide|mesh-list
6658340|NCT01481194|Doxorubicin|doxorubicin|mesh-list
6658341|NCT01481194|Lenalidomide|lenalidomide|mesh-list
6658342|NCT01481194|Bortezomib|bortezomib|mesh-list
6658343|NCT01481194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6658344|NCT01481194|Immunologic Factors|immunologic factors|mesh-ancestor
6658345|NCT01481194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658346|NCT01481194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6658347|NCT01481194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6658348|NCT01481194|Alkylating Agents|alkylating agents|mesh-ancestor
6658349|NCT01481194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658350|NCT01481194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6658351|NCT01481194|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6658352|NCT01481194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6658353|NCT01481194|Antiemetics|antiemetics|mesh-ancestor
6658354|NCT01481194|Autonomic Agents|autonomic agents|mesh-ancestor
6658355|NCT01481194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6658356|NCT01481194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6658357|NCT01481194|Glucocorticoids|glucocorticoids|mesh-ancestor
6658358|NCT01481194|Hormones|hormones|mesh-ancestor
6658359|NCT01481194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6658360|NCT01481194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6658361|NCT01481194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6658362|NCT01481194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6658363|NCT01481194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6658364|NCT01481194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6658365|NCT01481194|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6658366|NCT01481194|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6446476|NCT00392756|Hormones|hormones|mesh-list
6446477|NCT00392756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6580236|NCT01051388|Rabeprazole|rabeprazole|mesh-list
6580237|NCT01051388|Gefarnate|gefarnate|mesh-list
6580238|NCT01051388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6580239|NCT01051388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6580240|NCT01051388|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6580241|NCT01051388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6580242|NCT01051388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6580243|NCT01051401|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6580244|NCT01051401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6580245|NCT01051401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6580246|NCT01051401|Antimetabolites|antimetabolites|mesh-ancestor
6580247|NCT01051401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446478|NCT00392756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446479|NCT00392886|Cyclophosphamide|cyclophosphamide|mesh-list
6446480|NCT00392886|Temozolomide|temozolomide|mesh-list
6446481|NCT00392886|Thiotepa|thiotepa|mesh-list
6446482|NCT00392886|Carboplatin|carboplatin|mesh-list
6446483|NCT00392886|Methotrexate|methotrexate|mesh-list
6446484|NCT00392886|Etoposide|etoposide|mesh-list
6446485|NCT00392886|Vincristine|vincristine|mesh-list
6446486|NCT00392886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6446487|NCT00392886|Immunologic Factors|immunologic factors|mesh-ancestor
6446488|NCT00392886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446489|NCT00392886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6446490|NCT00392886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6446491|NCT00392886|Alkylating Agents|alkylating agents|mesh-ancestor
6446492|NCT00392886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446493|NCT00392886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6446494|NCT00392886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6446495|NCT00392886|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6446496|NCT00392886|Abortifacient Agents|abortifacient agents|mesh-ancestor
6580248|NCT01051401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6580249|NCT01051401|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6580250|NCT01051401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6580251|NCT01051427|Hemostatics|hemostatics|mesh-list
6580252|NCT01051427|Surgiflo|surgiflo|mesh-list
6580253|NCT01051427|Coagulants|coagulants|mesh-ancestor
6580254|NCT01051479|Choline|choline|mesh-list
6580255|NCT01051479|Lipotropic Agents|lipotropic agents|mesh-ancestor
6580256|NCT01051479|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6580257|NCT01051479|Antimetabolites|antimetabolites|mesh-ancestor
6446497|NCT00392886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6446498|NCT00392886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6446499|NCT00392886|Antimetabolites|antimetabolites|mesh-ancestor
6446500|NCT00392886|Dermatologic Agents|dermatologic agents|mesh-ancestor
6446501|NCT00392886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6446502|NCT00392886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6446503|NCT00392886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6446504|NCT00392886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6446505|NCT00392886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6446506|NCT00392886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6446507|NCT00392886|Tubulin Modulators|tubulin modulators|mesh-ancestor
6580258|NCT01051479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6580259|NCT01051479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6580260|NCT01051479|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6580261|NCT01051479|Nootropic Agents|nootropic agents|mesh-ancestor
6580262|NCT01051531|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6580263|NCT01051531|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6580264|NCT01051531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6446508|NCT00392886|Antimitotic Agents|antimitotic agents|mesh-ancestor
6580265|NCT01051531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6580266|NCT01051531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580267|NCT01051531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6580268|NCT01051531|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6580269|NCT01051531|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6580270|NCT01051531|Serotonin Agents|serotonin agents|mesh-ancestor
6580271|NCT01051531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6580272|NCT01051531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6580273|NCT01051531|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6580274|NCT01051531|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6580275|NCT01051531|Dopamine Agents|dopamine agents|mesh-ancestor
6580276|NCT01051544|Factor VIII|factor viii|mesh-list
6580277|NCT01051544|Coagulants|coagulants|mesh-ancestor
6580278|NCT01051583|Bevacizumab|bevacizumab|mesh-list
6580279|NCT01051583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6580280|NCT01051583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6580281|NCT01051583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6580282|NCT01051583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6580283|NCT01051583|Growth Substances|growth substances|mesh-ancestor
6580284|NCT01051583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580285|NCT01051583|Growth Inhibitors|growth inhibitors|mesh-ancestor
6580286|NCT01051622|Technetium Tc 99m Exametazime|technetium tc 99m exametazime|mesh-list
6580287|NCT01051622|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6580288|NCT01051622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6580289|NCT01051648|Triamcinolone|triamcinolone|mesh-list
6580290|NCT01051648|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6580291|NCT01051648|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6580292|NCT01051648|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6580293|NCT01051648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6580294|NCT01051648|Glucocorticoids|glucocorticoids|mesh-ancestor
6580295|NCT01051648|Hormones|hormones|mesh-ancestor
6580296|NCT01051648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6580297|NCT01051648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580298|NCT01051648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6580299|NCT01051648|Immunologic Factors|immunologic factors|mesh-ancestor
6580300|NCT01051648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6580301|NCT01051648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6580302|NCT01051687|Botulinum Toxins|botulinum toxins|mesh-list
6580303|NCT01051687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6580304|NCT01051687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6580305|NCT01051687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6580306|NCT01051687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6580307|NCT01051687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6580308|NCT01051687|Cholinergic Agents|cholinergic agents|mesh-ancestor
6580309|NCT01051687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6580310|NCT01051687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580311|NCT01051687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6580312|NCT01051687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6580313|NCT01051765|Irinotecan|irinotecan|mesh-list
6580314|NCT01051765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6580315|NCT01051765|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6580316|NCT01051765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6446509|NCT00392886|Mitosis Modulators|mitosis modulators|mesh-ancestor
6446510|NCT00392899|Tegafur|tegafur|mesh-list
6446511|NCT00392899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6446512|NCT00392899|Antimetabolites|antimetabolites|mesh-ancestor
6446513|NCT00392899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446514|NCT00392899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6446515|NCT00392912|Methyltestosterone|methyltestosterone|mesh-list
6446516|NCT00392912|Testosterone|testosterone|mesh-list
6446517|NCT00392912|Testosterone undecanoate|testosterone undecanoate|mesh-list
6446518|NCT00392912|Testosterone enanthate|testosterone enanthate|mesh-list
6446519|NCT00392912|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6580317|NCT01051765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6580318|NCT01051765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6580319|NCT01051804|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6580320|NCT01051804|Lubricant Eye Drops|lubricant eye drops|mesh-list
6580321|NCT01051804|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6580322|NCT01051934|Paclitaxel|paclitaxel|mesh-list
6580323|NCT01051934|Bevacizumab|bevacizumab|mesh-list
6580324|NCT01051934|Carboplatin|carboplatin|mesh-list
6580325|NCT01051934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6580326|NCT01051934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6580327|NCT01051934|Tubulin Modulators|tubulin modulators|mesh-ancestor
6580328|NCT01051934|Antimitotic Agents|antimitotic agents|mesh-ancestor
6580329|NCT01051934|Mitosis Modulators|mitosis modulators|mesh-ancestor
6580330|NCT01051934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6580331|NCT01051934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6580332|NCT01051934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6580333|NCT01051934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6580334|NCT01051934|Growth Substances|growth substances|mesh-ancestor
6580335|NCT01051934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580336|NCT01051934|Growth Inhibitors|growth inhibitors|mesh-ancestor
6580337|NCT01051947|Metoprolol|metoprolol|mesh-list
6580338|NCT01051947|Nebivolol|nebivolol|mesh-list
6580339|NCT01051947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6580340|NCT01051947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6580341|NCT01051947|Sympatholytics|sympatholytics|mesh-ancestor
6580342|NCT01051947|Autonomic Agents|autonomic agents|mesh-ancestor
6580343|NCT01051947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6580344|NCT01051947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580345|NCT01051947|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6580346|NCT01051947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6580347|NCT01051947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6580348|NCT01051947|Adrenergic Agents|adrenergic agents|mesh-ancestor
6580349|NCT01051947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6580350|NCT01051947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6580351|NCT01051947|Vasodilator Agents|vasodilator agents|mesh-ancestor
6580352|NCT01051947|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6580353|NCT01051947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6580354|NCT01051947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6580355|NCT01052025|Curcumin|curcumin|mesh-list
6580356|NCT01052025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6580357|NCT01052025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6580358|NCT01052025|Analgesics|analgesics|mesh-ancestor
6580359|NCT01052025|Sensory System Agents|sensory system agents|mesh-ancestor
6580360|NCT01052025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6580361|NCT01052025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580362|NCT01052025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6580363|NCT01052025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6580364|NCT01052025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6580365|NCT01052025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6580366|NCT01052025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6580367|NCT01052051|Vitamin D|vitamin d|mesh-list
6580368|NCT01052051|Cholecalciferol|cholecalciferol|mesh-list
6580369|NCT01052051|Calcium Carbonate|calcium carbonate|mesh-list
6580370|NCT01052051|Calcium|calcium|mesh-list
6580371|NCT01052051|Vitamins|vitamins|mesh-ancestor
6580372|NCT01052051|Micronutrients|micronutrients|mesh-ancestor
6580373|NCT01052051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580374|NCT01052051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6580375|NCT01052051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6580376|NCT01052051|Antacids|antacids|mesh-ancestor
6580377|NCT01052051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6580378|NCT01052051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6580379|NCT01052129|Naproxen|naproxen|mesh-list
6580380|NCT01052129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6580381|NCT01052129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6580382|NCT01052129|Analgesics|analgesics|mesh-ancestor
6580383|NCT01052129|Sensory System Agents|sensory system agents|mesh-ancestor
6580384|NCT01052129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6580385|NCT01052129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580386|NCT01052129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6580387|NCT01052129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6580388|NCT01052129|Gout Suppressants|gout suppressants|mesh-ancestor
6580389|NCT01052129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6580390|NCT01052129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6580391|NCT01052129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6580392|NCT01052181|Cholecalciferol|cholecalciferol|mesh-list
6580393|NCT01052181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6580394|NCT01052181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580395|NCT01052181|Vitamins|vitamins|mesh-ancestor
6580396|NCT01052181|Micronutrients|micronutrients|mesh-ancestor
6580397|NCT01052181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6580398|NCT01052246|Clindamycin|clindamycin|mesh-list
6580399|NCT01052246|Clindamycin palmitate|clindamycin palmitate|mesh-list
6580400|NCT01052246|Clindamycin phosphate|clindamycin phosphate|mesh-list
6580401|NCT01052246|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6580402|NCT01052246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6580403|NCT01052246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6580404|NCT01052246|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6580405|NCT01052246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6580406|NCT01052246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6580407|NCT01052246|Dermatologic Agents|dermatologic agents|mesh-ancestor
6580408|NCT01052259|Gusperimus|gusperimus|mesh-list
6580409|NCT01052259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6580410|NCT01052259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6580411|NCT01052259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6580412|NCT01052259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580413|NCT01052259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6580414|NCT01052259|Immunologic Factors|immunologic factors|mesh-ancestor
6580415|NCT01052259|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6580416|NCT01052259|Protective Agents|protective agents|mesh-ancestor
6580417|NCT01052298|Ciprofloxacin|ciprofloxacin|mesh-list
6580418|NCT01052298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6580419|NCT01052298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6580420|NCT01052298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6580421|NCT01052298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6580422|NCT01052298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6580423|NCT01052298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6580424|NCT01052298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6580425|NCT01052298|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6580426|NCT01052298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6580427|NCT01052311|Niacin|niacin|mesh-list
6580428|NCT01052311|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6580429|NCT01052311|Antimetabolites|antimetabolites|mesh-ancestor
6580430|NCT01052311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6580431|NCT01052311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6580432|NCT01052311|Vasodilator Agents|vasodilator agents|mesh-ancestor
6580433|NCT01052311|Vitamin B Complex|vitamin b complex|mesh-ancestor
6580434|NCT01052311|Vitamins|vitamins|mesh-ancestor
6580435|NCT01052311|Micronutrients|micronutrients|mesh-ancestor
6580436|NCT01052311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580437|NCT01052324|Remifentanil|remifentanil|mesh-list
6580438|NCT01052324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6580439|NCT01052324|Narcotics|narcotics|mesh-ancestor
6580440|NCT01052324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6580441|NCT01052324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580442|NCT01052324|Analgesics|analgesics|mesh-ancestor
6580443|NCT01052324|Sensory System Agents|sensory system agents|mesh-ancestor
6580444|NCT01052324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6580445|NCT01052337|Anesthetics|anesthetics|mesh-list
6580446|NCT01052337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6580447|NCT01052337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580448|NCT01052363|Bevacizumab|bevacizumab|mesh-list
6580449|NCT01052363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6580450|NCT01052363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6580451|NCT01052363|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6580452|NCT01052363|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6580453|NCT01052363|Growth Substances|growth substances|mesh-ancestor
6580454|NCT01052363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580455|NCT01052363|Growth Inhibitors|growth inhibitors|mesh-ancestor
6580456|NCT01052389|Haloperidol|haloperidol|mesh-list
6580457|NCT01052389|Olanzapine|olanzapine|mesh-list
6580458|NCT01052389|Aripiprazole|aripiprazole|mesh-list
6580459|NCT01052389|Haloperidol decanoate|haloperidol decanoate|mesh-list
6020284|NCT00392496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020285|NCT00392496|Growth Inhibitors|growth inhibitors|mesh-ancestor
6020286|NCT00392496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6020287|NCT00392496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6020288|NCT00392496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020289|NCT00392665|Sulindac|sulindac|mesh-list
6020290|NCT00392665|Bevacizumab|bevacizumab|mesh-list
6020291|NCT00392665|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6020292|NCT00392665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6446520|NCT00392912|Androgens|androgens|mesh-ancestor
6580460|NCT01052389|Antiemetics|antiemetics|mesh-ancestor
6580461|NCT01052389|Autonomic Agents|autonomic agents|mesh-ancestor
6580462|NCT01052389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6580463|NCT01052389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580464|NCT01052389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6580465|NCT01052389|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6580466|NCT01052389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6580467|NCT01052389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6580468|NCT01052389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6446521|NCT00392912|Hormones|hormones|mesh-ancestor
6446522|NCT00392912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6446523|NCT00392912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446524|NCT00392912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6446525|NCT00392912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6446526|NCT00392912|Anabolic Agents|anabolic agents|mesh-ancestor
6446527|NCT00392938|Docetaxel|docetaxel|mesh-list
6446528|NCT00392938|Androgen Antagonists|androgen antagonists|mesh-list
6446529|NCT00392938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6446530|NCT00392938|Tubulin Modulators|tubulin modulators|mesh-ancestor
6446531|NCT00392938|Antimitotic Agents|antimitotic agents|mesh-ancestor
6446532|NCT00392938|Mitosis Modulators|mitosis modulators|mesh-ancestor
6446533|NCT00392938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446534|NCT00392938|Hormone Antagonists|hormone antagonists|mesh-ancestor
6446535|NCT00392938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6446536|NCT00392938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446537|NCT00393003|Anesthetics|anesthetics|mesh-list
6446538|NCT00393003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6446539|NCT00393003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580469|NCT01052389|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6580470|NCT01052389|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6580471|NCT01052389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6580472|NCT01052389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6580473|NCT01052389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6580474|NCT01052389|Serotonin Agents|serotonin agents|mesh-ancestor
6580475|NCT01052389|Antidepressive Agents|antidepressive agents|mesh-ancestor
6580476|NCT01052389|Dopamine Agonists|dopamine agonists|mesh-ancestor
6580477|NCT01052389|Dopamine Agents|dopamine agents|mesh-ancestor
6580478|NCT01052389|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6580479|NCT01052389|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6020293|NCT00392665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6580480|NCT01052389|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6580481|NCT01052389|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6580482|NCT01052389|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6580483|NCT01052389|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6580484|NCT01052389|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6580485|NCT01052584|Chloroquine|chloroquine|mesh-list
6580486|NCT01052584|Lumefantrine|lumefantrine|mesh-list
6580487|NCT01052584|Artemether|artemether|mesh-list
6580488|NCT01052584|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6580489|NCT01052584|Amebicides|amebicides|mesh-ancestor
6580490|NCT01052584|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6580491|NCT01052584|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6580492|NCT01052584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6580493|NCT01052584|Antimalarials|antimalarials|mesh-ancestor
6580494|NCT01052584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6580495|NCT01052597|Curcumin|curcumin|mesh-list
6580496|NCT01052597|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6580497|NCT01052597|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6580498|NCT01052597|Analgesics|analgesics|mesh-ancestor
6580499|NCT01052597|Sensory System Agents|sensory system agents|mesh-ancestor
6580500|NCT01052597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6580501|NCT01052597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580502|NCT01052597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6580503|NCT01052597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6580504|NCT01052597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6580505|NCT01052597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6580506|NCT01052597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6580507|NCT01052623|Clonidine|clonidine|mesh-list
6580508|NCT01052623|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6580509|NCT01052623|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6580510|NCT01052623|Estradiol|estradiol|mesh-list
6580511|NCT01052623|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6580512|NCT01052623|Hormones|hormones|mesh-ancestor
6580513|NCT01052623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6580514|NCT01052623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580515|NCT01052623|Estrogens|estrogens|mesh-ancestor
6580516|NCT01052623|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6580517|NCT01052623|Contraceptive Agents|contraceptive agents|mesh-ancestor
6580518|NCT01052623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6580519|NCT01052623|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6580520|NCT01052623|Analgesics|analgesics|mesh-ancestor
6580521|NCT01052623|Sensory System Agents|sensory system agents|mesh-ancestor
6580522|NCT01052623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6580523|NCT01052623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6580524|NCT01052623|Sympatholytics|sympatholytics|mesh-ancestor
6580525|NCT01052623|Autonomic Agents|autonomic agents|mesh-ancestor
6580526|NCT01052623|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6580527|NCT01052623|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6580528|NCT01052623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6580529|NCT01052623|Adrenergic Agents|adrenergic agents|mesh-ancestor
6580530|NCT01052623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6580531|NCT01052623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6580532|NCT01052792|Naproxen|naproxen|mesh-list
6580533|NCT01052792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6580534|NCT01052792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6580535|NCT01052792|Analgesics|analgesics|mesh-ancestor
6580536|NCT01052792|Sensory System Agents|sensory system agents|mesh-ancestor
6580537|NCT01052792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6580538|NCT01052792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580539|NCT01052792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6580540|NCT01052792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6580541|NCT01052792|Gout Suppressants|gout suppressants|mesh-ancestor
6580542|NCT01052792|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6580543|NCT01052792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6580544|NCT01052792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6580545|NCT01052870|Finasteride|finasteride|mesh-list
6580546|NCT01052870|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6580547|NCT01052870|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6580548|NCT01052870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6580549|NCT01052870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6580550|NCT01052870|Hormone Antagonists|hormone antagonists|mesh-ancestor
6580551|NCT01052870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6580552|NCT01052870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580553|NCT01052870|Urological Agents|urological agents|mesh-ancestor
6580554|NCT01052896|Gabapentin|gabapentin|mesh-list
6580555|NCT01052896|Analgesics|analgesics|mesh-ancestor
6580556|NCT01052896|Sensory System Agents|sensory system agents|mesh-ancestor
6580557|NCT01052896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6580558|NCT01052896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580559|NCT01052896|Anticonvulsants|anticonvulsants|mesh-ancestor
6580560|NCT01052896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6580561|NCT01052896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6580562|NCT01052896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6580563|NCT01052896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6580564|NCT01052896|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6580565|NCT01052896|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6580566|NCT01052896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6580567|NCT01052896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6580568|NCT01052896|Antimanic Agents|antimanic agents|mesh-ancestor
6580569|NCT01052909|Glimepiride|glimepiride|mesh-list
6580570|NCT01052909|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6580571|NCT01052909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6580572|NCT01052909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580573|NCT01052909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6580574|NCT01052909|Immunologic Factors|immunologic factors|mesh-ancestor
6580575|NCT01052961|Oseltamivir|oseltamivir|mesh-list
6580576|NCT01052961|Antiviral Agents|antiviral agents|mesh-ancestor
6580577|NCT01052961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6580578|NCT01052961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6580579|NCT01052961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6580580|NCT01052974|Ropivacaine|ropivacaine|mesh-list
6580581|NCT01052974|Anesthetics, Local|anesthetics, local|mesh-ancestor
6580582|NCT01052974|Anesthetics|anesthetics|mesh-ancestor
6580583|NCT01052974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6580584|NCT01052974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580585|NCT01052974|Sensory System Agents|sensory system agents|mesh-ancestor
6580586|NCT01052974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6580587|NCT01052987|Tranilast|tranilast|mesh-list
6580588|NCT01052987|Allopurinol|allopurinol|mesh-list
6580589|NCT01052987|Antimetabolites|antimetabolites|mesh-ancestor
6580590|NCT01052987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6580591|NCT01052987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6580592|NCT01052987|Gout Suppressants|gout suppressants|mesh-ancestor
6580593|NCT01052987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6580594|NCT01052987|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6580595|NCT01052987|Antioxidants|antioxidants|mesh-ancestor
6580596|NCT01052987|Protective Agents|protective agents|mesh-ancestor
6580597|NCT01052987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580598|NCT01052987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6580599|NCT01052987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6580600|NCT01052987|Analgesics|analgesics|mesh-ancestor
6580601|NCT01052987|Sensory System Agents|sensory system agents|mesh-ancestor
6580602|NCT01052987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6580603|NCT01052987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6580604|NCT01052987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6580605|NCT01052987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6580606|NCT01052987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6580607|NCT01052987|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6580608|NCT01052987|Histamine Antagonists|histamine antagonists|mesh-ancestor
6580609|NCT01052987|Histamine Agents|histamine agents|mesh-ancestor
6580610|NCT01052987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6580611|NCT01052987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6580612|NCT01052987|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6580613|NCT01053026|Olmesartan|olmesartan|mesh-list
6580614|NCT01053026|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6580615|NCT01053026|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6580616|NCT01053026|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6580617|NCT01053026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6580618|NCT01053039|Morphine|morphine|mesh-list
6580619|NCT01053039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6580620|NCT01053039|Narcotics|narcotics|mesh-ancestor
6580621|NCT01053039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6580622|NCT01053039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580623|NCT01053039|Analgesics|analgesics|mesh-ancestor
6580624|NCT01053039|Sensory System Agents|sensory system agents|mesh-ancestor
6580625|NCT01053039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6580626|NCT01053065|Atorvastatin|atorvastatin|mesh-list
6446540|NCT00393107|Cyclophosphamide|cyclophosphamide|mesh-list
6446541|NCT00393107|Rituximab|rituximab|mesh-list
6446542|NCT00393107|Fludarabine|fludarabine|mesh-list
6446543|NCT00393107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6446544|NCT00393107|Immunologic Factors|immunologic factors|mesh-ancestor
6446545|NCT00393107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446546|NCT00393107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6580627|NCT01053065|Cholestyramine Resin|cholestyramine resin|mesh-list
6580628|NCT01053065|Gamma-sitosterol|gamma-sitosterol|mesh-list
6580629|NCT01053065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6580630|NCT01053065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6580631|NCT01053065|Antimetabolites|antimetabolites|mesh-ancestor
6580632|NCT01053065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6580633|NCT01053065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6580634|NCT01053065|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6580635|NCT01053065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6580636|NCT01053169|Thrombin|thrombin|mesh-list
6580637|NCT01053169|Hemostatics|hemostatics|mesh-ancestor
6580638|NCT01053169|Coagulants|coagulants|mesh-ancestor
6580639|NCT01053208|Diphenhydramine|diphenhydramine|mesh-list
6580640|NCT01053208|Promethazine|promethazine|mesh-list
6580641|NCT01053208|Ibuprofen|ibuprofen|mesh-list
6580642|NCT01053208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6580643|NCT01053208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6580644|NCT01053208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6580645|NCT01053208|Analgesics|analgesics|mesh-ancestor
6580646|NCT01053208|Sensory System Agents|sensory system agents|mesh-ancestor
6580647|NCT01053208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6446547|NCT00393107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6446548|NCT00393107|Alkylating Agents|alkylating agents|mesh-ancestor
6580648|NCT01053208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580649|NCT01053208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6580650|NCT01053208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6580651|NCT01053208|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6580652|NCT01053208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6580653|NCT01053208|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6580654|NCT01053208|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6580655|NCT01053208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6580656|NCT01053208|Anesthetics, Local|anesthetics, local|mesh-ancestor
6580657|NCT01053208|Anesthetics|anesthetics|mesh-ancestor
6580658|NCT01053208|Antiemetics|antiemetics|mesh-ancestor
6580659|NCT01053208|Autonomic Agents|autonomic agents|mesh-ancestor
6580660|NCT01053208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6580661|NCT01053208|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6580662|NCT01053208|Histamine Antagonists|histamine antagonists|mesh-ancestor
6580663|NCT01053208|Histamine Agents|histamine agents|mesh-ancestor
6580664|NCT01053208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6580665|NCT01053208|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6580666|NCT01053208|Antipruritics|antipruritics|mesh-ancestor
6580667|NCT01053208|Dermatologic Agents|dermatologic agents|mesh-ancestor
6658367|NCT01481194|Growth Substances|growth substances|mesh-ancestor
6658368|NCT01481194|Growth Inhibitors|growth inhibitors|mesh-ancestor
6658369|NCT01481233|Colchicine|colchicine|mesh-list
6658370|NCT01481233|Gout Suppressants|gout suppressants|mesh-ancestor
6658371|NCT01481233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6658372|NCT01481233|Tubulin Modulators|tubulin modulators|mesh-ancestor
6658373|NCT01481233|Antimitotic Agents|antimitotic agents|mesh-ancestor
6658374|NCT01481233|Mitosis Modulators|mitosis modulators|mesh-ancestor
6658375|NCT01481233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658376|NCT01481233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6658377|NCT01481259|Pemetrexed|pemetrexed|mesh-list
6658378|NCT01481259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6658379|NCT01481259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6658380|NCT01481259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658381|NCT01481259|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6658382|NCT01481259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6658383|NCT01481311|Bromides|bromides|mesh-list
6658384|NCT01481311|Anticonvulsants|anticonvulsants|mesh-ancestor
6658385|NCT01481350|Sildenafil Citrate|sildenafil citrate|mesh-list
6658386|NCT01481350|Vasodilator Agents|vasodilator agents|mesh-ancestor
6658387|NCT01481350|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6658388|NCT01481350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6658389|NCT01481350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6658390|NCT01481350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658391|NCT01481350|Urological Agents|urological agents|mesh-ancestor
6658392|NCT01481389|Theobromine|theobromine|mesh-list
6658393|NCT01481389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6658394|NCT01481389|Autonomic Agents|autonomic agents|mesh-ancestor
6658395|NCT01481389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6658396|NCT01481389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658397|NCT01481389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6658398|NCT01481389|Respiratory System Agents|respiratory system agents|mesh-ancestor
6658399|NCT01481389|Vasodilator Agents|vasodilator agents|mesh-ancestor
6658400|NCT01481454|Vaccines|vaccines|mesh-list
6658401|NCT01481454|Immunologic Factors|immunologic factors|mesh-ancestor
6658402|NCT01481454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658403|NCT01481467|Vaccines|vaccines|mesh-list
6658404|NCT01481467|Immunologic Factors|immunologic factors|mesh-ancestor
6658405|NCT01481467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658406|NCT01481519|Povidone-Iodine|povidone-iodine|mesh-list
6658407|NCT01481519|Dexamethasone|dexamethasone|mesh-list
6658408|NCT01481519|Dexamethasone acetate|dexamethasone acetate|mesh-list
6658409|NCT01481519|Povidone|povidone|mesh-list
6658410|NCT01481519|Lubricant Eye Drops|lubricant eye drops|mesh-list
6658411|NCT01481519|BB 1101|bb 1101|mesh-list
6658412|NCT01481519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6658413|NCT01481519|Antiemetics|antiemetics|mesh-ancestor
6658414|NCT01481519|Autonomic Agents|autonomic agents|mesh-ancestor
6658415|NCT01481519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6658416|NCT01481519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658417|NCT01481519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6658418|NCT01481519|Glucocorticoids|glucocorticoids|mesh-ancestor
6658419|NCT01481519|Hormones|hormones|mesh-ancestor
6658420|NCT01481519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6658421|NCT01481519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6658422|NCT01481519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6658423|NCT01481519|Protease Inhibitors|protease inhibitors|mesh-ancestor
6658424|NCT01481519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6446549|NCT00393107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446550|NCT00393107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6446551|NCT00393107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6446552|NCT00393107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6446553|NCT00393198|Misoprostol|misoprostol|mesh-list
6446554|NCT00393198|Levonorgestrel|levonorgestrel|mesh-list
6580668|NCT01053325|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6580669|NCT01053325|Antimalarials|antimalarials|mesh-ancestor
6580670|NCT01053325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6580671|NCT01053325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6580672|NCT01053325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6580673|NCT01053325|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6580674|NCT01053325|Renal Agents|renal agents|mesh-ancestor
6580675|NCT01053325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6580676|NCT01053338|Diphenhydramine|diphenhydramine|mesh-list
6580677|NCT01053338|Promethazine|promethazine|mesh-list
6580678|NCT01053338|Ibuprofen|ibuprofen|mesh-list
6580679|NCT01053338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446555|NCT00393198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6580680|NCT01053338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6580681|NCT01053338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6580682|NCT01053338|Analgesics|analgesics|mesh-ancestor
6580683|NCT01053338|Sensory System Agents|sensory system agents|mesh-ancestor
6580684|NCT01053338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6580685|NCT01053338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580686|NCT01053338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6580687|NCT01053338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6580688|NCT01053338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6580689|NCT01053338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6580690|NCT01053338|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6580691|NCT01053338|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6580692|NCT01053338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6580693|NCT01053338|Anesthetics, Local|anesthetics, local|mesh-ancestor
6580694|NCT01053338|Anesthetics|anesthetics|mesh-ancestor
6580695|NCT01053338|Antiemetics|antiemetics|mesh-ancestor
6580696|NCT01053338|Autonomic Agents|autonomic agents|mesh-ancestor
6580697|NCT01053338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6580698|NCT01053338|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6580699|NCT01053338|Histamine Antagonists|histamine antagonists|mesh-ancestor
6580700|NCT01053338|Histamine Agents|histamine agents|mesh-ancestor
6580701|NCT01053338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6580702|NCT01053338|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6580703|NCT01053338|Antipruritics|antipruritics|mesh-ancestor
6580704|NCT01053338|Dermatologic Agents|dermatologic agents|mesh-ancestor
6580705|NCT01053377|Oseltamivir|oseltamivir|mesh-list
6580706|NCT01053377|Antiviral Agents|antiviral agents|mesh-ancestor
6580707|NCT01053377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6580708|NCT01053377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6580709|NCT01053377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6580710|NCT01053390|Leucovorin|leucovorin|mesh-list
6580711|NCT01053390|Fluorouracil|fluorouracil|mesh-list
6580712|NCT01053390|Epirubicin|epirubicin|mesh-list
6580713|NCT01053390|Somatostatin|somatostatin|mesh-list
6446556|NCT00393198|Contraceptive Agents|contraceptive agents|mesh-ancestor
6580714|NCT01053390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6580715|NCT01053390|Antimetabolites|antimetabolites|mesh-ancestor
6580716|NCT01053390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6580717|NCT01053390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6580718|NCT01053390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6580719|NCT01053390|Immunologic Factors|immunologic factors|mesh-ancestor
6580720|NCT01053390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580721|NCT01053390|Antidotes|antidotes|mesh-ancestor
6580722|NCT01053390|Protective Agents|protective agents|mesh-ancestor
6580723|NCT01053390|Vitamin B Complex|vitamin b complex|mesh-ancestor
6580724|NCT01053390|Vitamins|vitamins|mesh-ancestor
6580725|NCT01053390|Micronutrients|micronutrients|mesh-ancestor
6580726|NCT01053390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6580727|NCT01053390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6580728|NCT01053390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6580729|NCT01053390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6580730|NCT01053390|Hormones|hormones|mesh-ancestor
6580731|NCT01053390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6580732|NCT01053403|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
6580733|NCT01053403|Hallucinogens|hallucinogens|mesh-ancestor
6580734|NCT01053403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580735|NCT01053403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6580736|NCT01053403|Serotonin Agents|serotonin agents|mesh-ancestor
6580737|NCT01053403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6580738|NCT01053403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6580739|NCT01053403|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6580740|NCT01053403|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6580741|NCT01053403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6580742|NCT01053403|Adrenergic Agents|adrenergic agents|mesh-ancestor
6580743|NCT01053442|Fe(III)-EDTA|fe(iii)-edta|mesh-list
6580744|NCT01053442|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6580745|NCT01053442|Chelating Agents|chelating agents|mesh-ancestor
6580746|NCT01053442|Sequestering Agents|sequestering agents|mesh-ancestor
6580747|NCT01053442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6580748|NCT01053481|Vitamin D|vitamin d|mesh-list
6580749|NCT01053481|Vitamins|vitamins|mesh-ancestor
6580750|NCT01053481|Micronutrients|micronutrients|mesh-ancestor
6580751|NCT01053481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580752|NCT01053481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6580753|NCT01053520|Navitoclax|navitoclax|mesh-list
6580754|NCT01053520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6580755|NCT01053559|Certolizumab Pegol|certolizumab pegol|mesh-list
6580756|NCT01053559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6580757|NCT01053559|Immunologic Factors|immunologic factors|mesh-ancestor
6580758|NCT01053559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580759|NCT01053559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6580760|NCT01053585|Baclofen|baclofen|mesh-list
6580761|NCT01053585|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6580762|NCT01053585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580763|NCT01053585|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6580764|NCT01053585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6580765|NCT01053585|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6580766|NCT01053585|GABA Agonists|gaba agonists|mesh-ancestor
6580767|NCT01053585|GABA Agents|gaba agents|mesh-ancestor
6580768|NCT01053585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6580769|NCT01053585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6580770|NCT01053611|Remifentanil|remifentanil|mesh-list
6580771|NCT01053611|Propofol|propofol|mesh-list
6580772|NCT01053611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6580773|NCT01053611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6580774|NCT01053611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580775|NCT01053611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6580776|NCT01053611|Anesthetics, General|anesthetics, general|mesh-ancestor
6580777|NCT01053611|Anesthetics|anesthetics|mesh-ancestor
6580778|NCT01053611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6580779|NCT01053611|Narcotics|narcotics|mesh-ancestor
6580780|NCT01053611|Analgesics|analgesics|mesh-ancestor
6580781|NCT01053611|Sensory System Agents|sensory system agents|mesh-ancestor
6580782|NCT01053611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6580783|NCT01053637|Acetaminophen|acetaminophen|mesh-list
6580784|NCT01053637|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
6580785|NCT01053637|Hydrocodone|hydrocodone|mesh-list
6580786|NCT01053637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6461767|NCT00455910|Growth Inhibitors|growth inhibitors|mesh-ancestor
6461768|NCT00455910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6461769|NCT00455936|Gefitinib|gefitinib|mesh-list
6580787|NCT01053637|Analgesics|analgesics|mesh-ancestor
6580788|NCT01053637|Sensory System Agents|sensory system agents|mesh-ancestor
6580789|NCT01053637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6580790|NCT01053637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580791|NCT01053637|Antipyretics|antipyretics|mesh-ancestor
6580792|NCT01053637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6580793|NCT01053637|Narcotics|narcotics|mesh-ancestor
6580794|NCT01053637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6580795|NCT01053637|Antitussive Agents|antitussive agents|mesh-ancestor
6580796|NCT01053637|Respiratory System Agents|respiratory system agents|mesh-ancestor
6580797|NCT01053637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6580798|NCT01053637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6580799|NCT01053637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6580800|NCT01053650|Acetaminophen|acetaminophen|mesh-list
6580801|NCT01053650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6580802|NCT01053650|Analgesics|analgesics|mesh-ancestor
6580803|NCT01053650|Sensory System Agents|sensory system agents|mesh-ancestor
6580804|NCT01053650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6580805|NCT01053650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580806|NCT01053650|Antipyretics|antipyretics|mesh-ancestor
6580807|NCT01053689|Glimepiride|glimepiride|mesh-list
6580808|NCT01053689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6580809|NCT01053689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6580810|NCT01053689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580811|NCT01053689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6580812|NCT01053689|Immunologic Factors|immunologic factors|mesh-ancestor
6580813|NCT01053728|Insulin Glargine|insulin glargine|mesh-list
6580814|NCT01053728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6580815|NCT01053728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580816|NCT01053806|Lenalidomide|lenalidomide|mesh-list
6580817|NCT01053806|Azacitidine|azacitidine|mesh-list
6580818|NCT01053806|Immunologic Factors|immunologic factors|mesh-ancestor
6580819|NCT01053806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580820|NCT01053806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6580821|NCT01053806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6461770|NCT00455936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6461771|NCT00455936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6461772|NCT00455936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6461773|NCT00455936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461774|NCT00456027|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6461775|NCT00456027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6461776|NCT00456027|Immunologic Factors|immunologic factors|mesh-ancestor
6461777|NCT00456027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461778|NCT00456027|Antacids|antacids|mesh-ancestor
6461779|NCT00456027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461780|NCT00456027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6461781|NCT00456144|Hormones|hormones|mesh-list
6461782|NCT00456144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6461783|NCT00456144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461784|NCT00456235|Mycophenolic Acid|mycophenolic acid|mesh-list
6580822|NCT01053806|Growth Substances|growth substances|mesh-ancestor
6580823|NCT01053806|Growth Inhibitors|growth inhibitors|mesh-ancestor
6580824|NCT01053806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6580825|NCT01053806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6580826|NCT01053806|Antimetabolites|antimetabolites|mesh-ancestor
6580827|NCT01053806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6580828|NCT01053806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6580829|NCT01053871|Fentanyl|fentanyl|mesh-list
6580830|NCT01053871|Midazolam|midazolam|mesh-list
6580831|NCT01053871|Propofol|propofol|mesh-list
6580832|NCT01053871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6580833|NCT01053871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6580834|NCT01053871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580835|NCT01053871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6580836|NCT01053871|Anesthetics, General|anesthetics, general|mesh-ancestor
6580837|NCT01053871|Anesthetics|anesthetics|mesh-ancestor
6580838|NCT01053871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6580839|NCT01053871|Narcotics|narcotics|mesh-ancestor
6580840|NCT01053871|Analgesics|analgesics|mesh-ancestor
6580841|NCT01053871|Sensory System Agents|sensory system agents|mesh-ancestor
6580842|NCT01053871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6580843|NCT01053871|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6580844|NCT01053871|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6580845|NCT01053871|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6580846|NCT01053871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6580847|NCT01053871|GABA Modulators|gaba modulators|mesh-ancestor
6580848|NCT01053871|GABA Agents|gaba agents|mesh-ancestor
6580849|NCT01053871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6580850|NCT01053871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6580851|NCT01053884|Anidulafungin|anidulafungin|mesh-list
6580852|NCT01053884|Antifungal Agents|antifungal agents|mesh-ancestor
6580853|NCT01053884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6580854|NCT01053910|Ramipril|ramipril|mesh-list
6580855|NCT01053910|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6580856|NCT01053910|Protease Inhibitors|protease inhibitors|mesh-ancestor
6580857|NCT01053910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6580858|NCT01053910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6580859|NCT01053910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6580860|NCT01053949|Thalidomide|thalidomide|mesh-list
6580861|NCT01053949|Pomalidomide|pomalidomide|mesh-list
6580862|NCT01053949|Immunologic Factors|immunologic factors|mesh-ancestor
6580863|NCT01053949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580864|NCT01053949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6580865|NCT01053949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6580866|NCT01053949|Growth Substances|growth substances|mesh-ancestor
6580867|NCT01053949|Growth Inhibitors|growth inhibitors|mesh-ancestor
6580868|NCT01053949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6580869|NCT01053949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6580870|NCT01053949|Leprostatic Agents|leprostatic agents|mesh-ancestor
6580871|NCT01053949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6580872|NCT01053949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6580873|NCT01054001|Sildenafil Citrate|sildenafil citrate|mesh-list
6580874|NCT01054001|Vasodilator Agents|vasodilator agents|mesh-ancestor
6580875|NCT01054001|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6580876|NCT01054001|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6580877|NCT01054001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6580878|NCT01054001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6580879|NCT01054001|Urological Agents|urological agents|mesh-ancestor
6580880|NCT01054027|Phenylephrine|phenylephrine|mesh-list
6580881|NCT01054027|Oxymetazoline|oxymetazoline|mesh-list
6580882|NCT01054027|Cyclopentolate|cyclopentolate|mesh-list
6580883|NCT01054027|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6580884|NCT01054027|Mydriatics|mydriatics|mesh-ancestor
6580885|NCT01054027|Autonomic Agents|autonomic agents|mesh-ancestor
6580886|NCT01054027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6580887|NCT01054027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580888|NCT01054027|Sympathomimetics|sympathomimetics|mesh-ancestor
6580889|NCT01054027|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6580890|NCT01054027|Nasal Decongestants|nasal decongestants|mesh-ancestor
6580891|NCT01054027|Respiratory System Agents|respiratory system agents|mesh-ancestor
6580892|NCT01054027|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6580893|NCT01054027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6580894|NCT01054027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6580895|NCT01054027|Adrenergic Agents|adrenergic agents|mesh-ancestor
6580896|NCT01054027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6580897|NCT01054027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6580898|NCT01054027|Protective Agents|protective agents|mesh-ancestor
6580899|NCT01054027|Parasympatholytics|parasympatholytics|mesh-ancestor
6580900|NCT01054027|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6580901|NCT01054027|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6580902|NCT01054027|Cholinergic Agents|cholinergic agents|mesh-ancestor
6580903|NCT01054092|Ipragliflozin|ipragliflozin|mesh-list
6580904|NCT01054092|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6580905|NCT01054092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6580906|NCT01054092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6580907|NCT01054092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580908|NCT01054105|Iloprost|iloprost|mesh-list
6580909|NCT01054105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6580910|NCT01054105|Vasodilator Agents|vasodilator agents|mesh-ancestor
6580911|NCT01054118|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6580912|NCT01054118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6580913|NCT01054118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580914|NCT01054118|Incretins|incretins|mesh-ancestor
6580915|NCT01054118|Hormones|hormones|mesh-ancestor
6580916|NCT01054118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6580917|NCT01054118|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6580918|NCT01054118|Protease Inhibitors|protease inhibitors|mesh-ancestor
6580919|NCT01054118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6580920|NCT01054118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6580921|NCT01054196|Lenalidomide|lenalidomide|mesh-list
6580922|NCT01054196|Melphalan|melphalan|mesh-list
6580923|NCT01054196|Immunologic Factors|immunologic factors|mesh-ancestor
6580924|NCT01054196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580925|NCT01054196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6580926|NCT01054196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6580927|NCT01054196|Growth Substances|growth substances|mesh-ancestor
6580928|NCT01054196|Growth Inhibitors|growth inhibitors|mesh-ancestor
6580929|NCT01054196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6580930|NCT01054196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6580931|NCT01054196|Alkylating Agents|alkylating agents|mesh-ancestor
6580932|NCT01054196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6580933|NCT01054196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6580934|NCT01054196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6580935|NCT01054248|Artesunate|artesunate|mesh-list
6580936|NCT01054248|Piperaquine|piperaquine|mesh-list
6580937|NCT01054248|Artenimol|artenimol|mesh-list
6580938|NCT01054248|Mefloquine|mefloquine|mesh-list
6580939|NCT01054248|Antimalarials|antimalarials|mesh-ancestor
6580940|NCT01054248|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6580941|NCT01054248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6580942|NCT01054248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6580943|NCT01054248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6580944|NCT01054248|Antiviral Agents|antiviral agents|mesh-ancestor
6580945|NCT01054248|Schistosomicides|schistosomicides|mesh-ancestor
6580946|NCT01054248|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6580947|NCT01054248|Anthelmintics|anthelmintics|mesh-ancestor
6580948|NCT01054313|Sirolimus|sirolimus|mesh-list
6580949|NCT01054313|Prednisone|prednisone|mesh-list
6580950|NCT01054313|Docetaxel|docetaxel|mesh-list
6580951|NCT01054313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6580952|NCT01054313|Tubulin Modulators|tubulin modulators|mesh-ancestor
6580953|NCT01054313|Antimitotic Agents|antimitotic agents|mesh-ancestor
6580954|NCT01054313|Mitosis Modulators|mitosis modulators|mesh-ancestor
6580955|NCT01054313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6580956|NCT01054313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6580957|NCT01054313|Glucocorticoids|glucocorticoids|mesh-ancestor
6580958|NCT01054313|Hormones|hormones|mesh-ancestor
6580959|NCT01054313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6580960|NCT01054313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580961|NCT01054313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6580962|NCT01054313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6580963|NCT01054313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6580964|NCT01054313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6580965|NCT01054313|Antifungal Agents|antifungal agents|mesh-ancestor
6580966|NCT01054313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6580967|NCT01054313|Immunologic Factors|immunologic factors|mesh-ancestor
6580968|NCT01054469|Ropivacaine|ropivacaine|mesh-list
6580969|NCT01054469|Anesthetics, Local|anesthetics, local|mesh-ancestor
6580970|NCT01054469|Anesthetics|anesthetics|mesh-ancestor
6580971|NCT01054469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6580972|NCT01054469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580973|NCT01054469|Sensory System Agents|sensory system agents|mesh-ancestor
6580974|NCT01054469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6580975|NCT01054508|Nicotinic Acids|nicotinic acids|mesh-list
6580976|NCT01054508|Niacin|niacin|mesh-list
6580977|NCT01054508|Niacinamide|niacinamide|mesh-list
6580978|NCT01054508|Vitamin B Complex|vitamin b complex|mesh-ancestor
6580979|NCT01054508|Vitamins|vitamins|mesh-ancestor
6580980|NCT01054508|Micronutrients|micronutrients|mesh-ancestor
6580981|NCT01054508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580982|NCT01054508|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6580983|NCT01054508|Antimetabolites|antimetabolites|mesh-ancestor
6580984|NCT01054508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6580985|NCT01054508|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6580986|NCT01054508|Vasodilator Agents|vasodilator agents|mesh-ancestor
6580987|NCT01054547|Anesthetics|anesthetics|mesh-list
6580988|NCT01054547|Ropivacaine|ropivacaine|mesh-list
6580989|NCT01054547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6580990|NCT01054547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6580991|NCT01054547|Anesthetics, Local|anesthetics, local|mesh-ancestor
6580992|NCT01054547|Sensory System Agents|sensory system agents|mesh-ancestor
6580993|NCT01054547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6580994|NCT01054651|Artesunate|artesunate|mesh-list
6580995|NCT01054651|Pyrimethamine|pyrimethamine|mesh-list
6580996|NCT01054651|Sulfalene|sulfalene|mesh-list
6580997|NCT01054651|Praziquantel|praziquantel|mesh-list
6580998|NCT01054651|Antimalarials|antimalarials|mesh-ancestor
6580999|NCT01054651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6446557|NCT00393198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6446558|NCT00393198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446559|NCT00393198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6446560|NCT00393198|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6446561|NCT00393198|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6446562|NCT00393198|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6446563|NCT00393198|Abortifacient Agents|abortifacient agents|mesh-ancestor
6446564|NCT00393198|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6581000|NCT01054651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6581001|NCT01054651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6581002|NCT01054651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6581003|NCT01054651|Antiviral Agents|antiviral agents|mesh-ancestor
6581004|NCT01054651|Schistosomicides|schistosomicides|mesh-ancestor
6581005|NCT01054651|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6581006|NCT01054651|Anthelmintics|anthelmintics|mesh-ancestor
6581007|NCT01054651|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6581008|NCT01054651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6581009|NCT01054651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581010|NCT01054651|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6581011|NCT01054651|Renal Agents|renal agents|mesh-ancestor
6581012|NCT01054677|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6581013|NCT01054677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6581014|NCT01054781|Rituximab|rituximab|mesh-list
6581015|NCT01054781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6581016|NCT01054781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6581017|NCT01054781|Immunologic Factors|immunologic factors|mesh-ancestor
6446565|NCT00393198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6446566|NCT00393198|Oxytocics|oxytocics|mesh-ancestor
6446567|NCT00393263|Clobetasol|clobetasol|mesh-list
6446568|NCT00393263|Pimecrolimus|pimecrolimus|mesh-list
6446569|NCT00393263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6446570|NCT00393263|Glucocorticoids|glucocorticoids|mesh-ancestor
6446571|NCT00393263|Hormones|hormones|mesh-ancestor
6461785|NCT00456235|Cyclosporine|cyclosporine|mesh-list
6581018|NCT01054781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581019|NCT01054781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6581020|NCT01054872|Vaccines|vaccines|mesh-list
6581021|NCT01054872|Immunologic Factors|immunologic factors|mesh-ancestor
6581022|NCT01054872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581023|NCT01055041|Budesonide|budesonide|mesh-list
6581024|NCT01055041|Doxofylline|doxofylline|mesh-list
6581025|NCT01055041|Montelukast|montelukast|mesh-list
6581026|NCT01055041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6581027|NCT01055041|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6581028|NCT01055041|Autonomic Agents|autonomic agents|mesh-ancestor
6581029|NCT01055041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6581030|NCT01055041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581031|NCT01055041|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6581032|NCT01055041|Respiratory System Agents|respiratory system agents|mesh-ancestor
6581033|NCT01055041|Glucocorticoids|glucocorticoids|mesh-ancestor
6581034|NCT01055041|Hormones|hormones|mesh-ancestor
6581035|NCT01055041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6581036|NCT01055041|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6581037|NCT01055041|Hormone Antagonists|hormone antagonists|mesh-ancestor
6581038|NCT01055041|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6581039|NCT01055041|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6581040|NCT01055041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581041|NCT01055041|Antitussive Agents|antitussive agents|mesh-ancestor
6581042|NCT01055041|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6581043|NCT01055041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6658425|NCT01481519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658426|NCT01481519|Plasma Substitutes|plasma substitutes|mesh-ancestor
6658427|NCT01481519|Blood Substitutes|blood substitutes|mesh-ancestor
6658428|NCT01481519|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6658429|NCT01481519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6658430|NCT01481519|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6658431|NCT01481519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6658432|NCT01481532|Histamine Antagonists|histamine antagonists|mesh-list
6658433|NCT01481532|Histamine Agents|histamine agents|mesh-ancestor
6658434|NCT01481532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6658435|NCT01481532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658436|NCT01481532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658437|NCT01481610|Diclofenac|diclofenac|mesh-list
6658438|NCT01481610|Lumiracoxib|lumiracoxib|mesh-list
6658439|NCT01481610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6658440|NCT01481610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6658441|NCT01481610|Analgesics|analgesics|mesh-ancestor
6658442|NCT01481610|Sensory System Agents|sensory system agents|mesh-ancestor
6581044|NCT01055145|Moxifloxacin|moxifloxacin|mesh-list
6581045|NCT01055145|Levofloxacin|levofloxacin|mesh-list
6446572|NCT00393263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6446573|NCT00393263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446574|NCT00393263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6446575|NCT00393263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6446576|NCT00393263|Analgesics|analgesics|mesh-ancestor
6446577|NCT00393263|Sensory System Agents|sensory system agents|mesh-ancestor
6446578|NCT00393263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6581046|NCT01055145|Ofloxacin|ofloxacin|mesh-list
6581047|NCT01055145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6581048|NCT01055145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6581049|NCT01055145|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6581050|NCT01055145|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6581051|NCT01055145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6581052|NCT01055145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581053|NCT01055145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6581054|NCT01055145|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6581055|NCT01055145|Renal Agents|renal agents|mesh-ancestor
6581056|NCT01055145|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6581057|NCT01055145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6581058|NCT01055236|Hydroxyzine|hydroxyzine|mesh-list
6581059|NCT01055236|Antipruritics|antipruritics|mesh-ancestor
6581060|NCT01055236|Dermatologic Agents|dermatologic agents|mesh-ancestor
6581061|NCT01055236|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6581062|NCT01055236|Histamine Antagonists|histamine antagonists|mesh-ancestor
6446579|NCT00393263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6581063|NCT01055236|Histamine Agents|histamine agents|mesh-ancestor
6581064|NCT01055236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6581065|NCT01055236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581066|NCT01055236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581067|NCT01055249|Ibuprofen|ibuprofen|mesh-list
6581068|NCT01055249|Hydrocortisone|hydrocortisone|mesh-list
6581069|NCT01055249|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6581070|NCT01055249|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6581071|NCT01055249|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6581072|NCT01055249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6581073|NCT01055249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6581074|NCT01055249|Analgesics|analgesics|mesh-ancestor
6581075|NCT01055249|Sensory System Agents|sensory system agents|mesh-ancestor
6581076|NCT01055249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6581077|NCT01055249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581078|NCT01055249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6581079|NCT01055249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6581080|NCT01055249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6581081|NCT01055249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6581082|NCT01055249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581083|NCT01055301|Thalidomide|thalidomide|mesh-list
6581084|NCT01055301|Dexamethasone|dexamethasone|mesh-list
6581085|NCT01055301|Cyclophosphamide|cyclophosphamide|mesh-list
6581086|NCT01055301|Melphalan|melphalan|mesh-list
6581087|NCT01055301|Doxorubicin|doxorubicin|mesh-list
6581088|NCT01055301|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6581089|NCT01055301|Etoposide|etoposide|mesh-list
6581090|NCT01055301|Lenalidomide|lenalidomide|mesh-list
6581091|NCT01055301|Bortezomib|bortezomib|mesh-list
6581092|NCT01055301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6581093|NCT01055301|Immunologic Factors|immunologic factors|mesh-ancestor
6581094|NCT01055301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581095|NCT01055301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6581096|NCT01055301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6581097|NCT01055301|Alkylating Agents|alkylating agents|mesh-ancestor
6581098|NCT01055301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581099|NCT01055301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6581100|NCT01055301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6581101|NCT01055301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6581102|NCT01055301|Antiemetics|antiemetics|mesh-ancestor
6581103|NCT01055301|Autonomic Agents|autonomic agents|mesh-ancestor
6581104|NCT01055301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6581105|NCT01055301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6581106|NCT01055301|Glucocorticoids|glucocorticoids|mesh-ancestor
6581107|NCT01055301|Hormones|hormones|mesh-ancestor
6581108|NCT01055301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6581109|NCT01055301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6581110|NCT01055301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6581111|NCT01055301|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6581112|NCT01055301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6581113|NCT01055301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6581114|NCT01055301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6581115|NCT01055301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6581116|NCT01055301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6581117|NCT01055301|Growth Substances|growth substances|mesh-ancestor
6581118|NCT01055301|Growth Inhibitors|growth inhibitors|mesh-ancestor
6581119|NCT01055301|Leprostatic Agents|leprostatic agents|mesh-ancestor
6581120|NCT01055301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6581121|NCT01055301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6581122|NCT01055327|Lamotrigine|lamotrigine|mesh-list
6581123|NCT01055327|Anticonvulsants|anticonvulsants|mesh-list
6581124|NCT01055327|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6581125|NCT01055327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6581126|NCT01055327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581127|NCT01055327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6581128|NCT01055327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581129|NCT01055327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6581130|NCT01055327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6581131|NCT01055327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6581132|NCT01055327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6581133|NCT01055327|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6581134|NCT01055379|Rasagiline|rasagiline|mesh-list
6581135|NCT01055379|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6581136|NCT01055379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6581137|NCT01055379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581138|NCT01055379|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6581139|NCT01055379|Protective Agents|protective agents|mesh-ancestor
6581140|NCT01055379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581141|NCT01055392|Lithium Carbonate|lithium carbonate|mesh-list
6581142|NCT01055392|Antidepressive Agents|antidepressive agents|mesh-ancestor
6581143|NCT01055392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6581144|NCT01055392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6581145|NCT01055392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581146|NCT01055392|Antimanic Agents|antimanic agents|mesh-ancestor
6581147|NCT01055392|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6581148|NCT01055392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6581149|NCT01055392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581150|NCT01055405|Sildenafil Citrate|sildenafil citrate|mesh-list
6581151|NCT01055405|Vasodilator Agents|vasodilator agents|mesh-ancestor
6581152|NCT01055405|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6581153|NCT01055405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6581154|NCT01055405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6581155|NCT01055405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581156|NCT01055405|Urological Agents|urological agents|mesh-ancestor
6581157|NCT01055418|Ascorbic Acid|ascorbic acid|mesh-list
6581158|NCT01055418|Vitamins|vitamins|mesh-ancestor
6581159|NCT01055418|Micronutrients|micronutrients|mesh-ancestor
6581160|NCT01055418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581161|NCT01055418|Antioxidants|antioxidants|mesh-ancestor
6581162|NCT01055418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581163|NCT01055418|Protective Agents|protective agents|mesh-ancestor
6446580|NCT00393263|Dermatologic Agents|dermatologic agents|mesh-ancestor
6446581|NCT00393263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6446582|NCT00393263|Immunologic Factors|immunologic factors|mesh-ancestor
6446583|NCT00393263|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6446584|NCT00393263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6446585|NCT00393263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446586|NCT00393289|Calcium|calcium|mesh-list
6446587|NCT00393289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6446588|NCT00393289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581164|NCT01055431|Iron|iron|mesh-list
6581165|NCT01055431|Trace Elements|trace elements|mesh-ancestor
6581166|NCT01055431|Micronutrients|micronutrients|mesh-ancestor
6581167|NCT01055431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581168|NCT01055470|Diclofenac|diclofenac|mesh-list
6581169|NCT01055470|Lornoxicam|lornoxicam|mesh-list
6581170|NCT01055470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6581171|NCT01055470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6581172|NCT01055470|Analgesics|analgesics|mesh-ancestor
6581173|NCT01055470|Sensory System Agents|sensory system agents|mesh-ancestor
6581174|NCT01055470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6581175|NCT01055470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581176|NCT01055470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6581177|NCT01055470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6581178|NCT01055470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6581179|NCT01055470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6581180|NCT01055470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581181|NCT01055483|Panobinostat|panobinostat|mesh-list
6581182|NCT01055483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6581183|NCT01055483|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6581184|NCT01055483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6581185|NCT01055483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581186|NCT01055522|Interleukin-2|interleukin-2|mesh-list
6581187|NCT01055522|Dacarbazine|dacarbazine|mesh-list
6581188|NCT01055522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6581189|NCT01055522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6581190|NCT01055522|Analgesics|analgesics|mesh-ancestor
6581191|NCT01055522|Sensory System Agents|sensory system agents|mesh-ancestor
6581192|NCT01055522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6581193|NCT01055522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581194|NCT01055522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6581195|NCT01055522|Alkylating Agents|alkylating agents|mesh-ancestor
6581196|NCT01055522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581197|NCT01055535|Plasminogen|plasminogen|mesh-list
6581198|NCT01055535|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6581199|NCT01055535|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6581200|NCT01055535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581201|NCT01055652|Dapagliflozin|dapagliflozin|mesh-list
6581202|NCT01055652|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6581203|NCT01055652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446589|NCT00393315|Paclitaxel|paclitaxel|mesh-list
6581204|NCT01055652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6581205|NCT01055652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581206|NCT01055691|Metformin|metformin|mesh-list
5501535|NCT04473274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503589|NCT04457466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503590|NCT04457258|FAPI-46|fapi-46|mesh-list
5503591|NCT04457258|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5503592|NCT04457258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503593|NCT04457050|Ribavirin|ribavirin|mesh-list
5503594|NCT04457050|Sofosbuvir|sofosbuvir|mesh-list
6581207|NCT01055691|Dapagliflozin|dapagliflozin|mesh-list
6581208|NCT01055691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6581209|NCT01055691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581210|NCT01055691|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6581211|NCT01055691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581212|NCT01055743|Fluorouracil|fluorouracil|mesh-list
6581213|NCT01055743|Antimetabolites|antimetabolites|mesh-ancestor
6581214|NCT01055743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581215|NCT01055743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6581216|NCT01055743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6581217|NCT01055743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6581218|NCT01055743|Immunologic Factors|immunologic factors|mesh-ancestor
6581219|NCT01055743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581220|NCT01055756|Loratadine|loratadine|mesh-list
6581221|NCT01055756|Pseudoephedrine|pseudoephedrine|mesh-list
6581222|NCT01055756|Ephedrine|ephedrine|mesh-list
6581223|NCT01055756|Antipruritics|antipruritics|mesh-ancestor
6581224|NCT01055756|Dermatologic Agents|dermatologic agents|mesh-ancestor
6581225|NCT01055756|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6581226|NCT01055756|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6581227|NCT01055756|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6581228|NCT01055756|Histamine Antagonists|histamine antagonists|mesh-ancestor
6581229|NCT01055756|Histamine Agents|histamine agents|mesh-ancestor
6581230|NCT01055756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6581231|NCT01055756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581232|NCT01055756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581233|NCT01055756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6581234|NCT01055756|Autonomic Agents|autonomic agents|mesh-ancestor
6581235|NCT01055756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6581236|NCT01055756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6581237|NCT01055756|Respiratory System Agents|respiratory system agents|mesh-ancestor
6581238|NCT01055756|Nasal Decongestants|nasal decongestants|mesh-ancestor
6581239|NCT01055756|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6581240|NCT01055756|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6581241|NCT01055756|Sympathomimetics|sympathomimetics|mesh-ancestor
6581242|NCT01055756|Adrenergic Agents|adrenergic agents|mesh-ancestor
6581243|NCT01055795|Bevacizumab|bevacizumab|mesh-list
6581244|NCT01055795|Everolimus|everolimus|mesh-list
6581245|NCT01055795|Panobinostat|panobinostat|mesh-list
6581246|NCT01055795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6581247|NCT01055795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6581248|NCT01055795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6581249|NCT01055795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6581250|NCT01055795|Growth Substances|growth substances|mesh-ancestor
6581251|NCT01055795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581252|NCT01055795|Growth Inhibitors|growth inhibitors|mesh-ancestor
6581253|NCT01055795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6581254|NCT01055795|Immunologic Factors|immunologic factors|mesh-ancestor
6581255|NCT01055795|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6581256|NCT01055795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6581257|NCT01055795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581258|NCT01055808|Insulin|insulin|mesh-list
6581259|NCT01055808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6581260|NCT01055808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581261|NCT01055821|Interferons|interferons|mesh-list
6581262|NCT01055821|Ribavirin|ribavirin|mesh-list
6581263|NCT01055821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6581264|NCT01055821|Antiviral Agents|antiviral agents|mesh-ancestor
6581265|NCT01055821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6581266|NCT01055821|Antimetabolites|antimetabolites|mesh-ancestor
6581267|NCT01055821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503595|NCT04457050|Ledipasvir|ledipasvir|mesh-list
6581268|NCT01055847|Aztreonam|aztreonam|mesh-list
6581269|NCT01055847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6581270|NCT01055847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6581271|NCT01055925|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6581272|NCT01055925|Laxatives|laxatives|mesh-ancestor
6581273|NCT01055925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6581274|NCT01055938|Valproic Acid|valproic acid|mesh-list
6581275|NCT01055938|Anticonvulsants|anticonvulsants|mesh-ancestor
6581276|NCT01055938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6581277|NCT01055938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581278|NCT01055938|GABA Agents|gaba agents|mesh-ancestor
6581279|NCT01055938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6581280|NCT01055938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581281|NCT01055938|Antimanic Agents|antimanic agents|mesh-ancestor
6581282|NCT01055938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6581283|NCT01055938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6581284|NCT01055938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6581285|NCT01055964|Tacrolimus|tacrolimus|mesh-list
6581286|NCT01055964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6581287|NCT01055964|Immunologic Factors|immunologic factors|mesh-ancestor
6581288|NCT01055964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581289|NCT01055964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6581290|NCT01055964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6581291|NCT01055964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581292|NCT01056042|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6581293|NCT01056042|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6581294|NCT01056042|Medroxyprogesterone|medroxyprogesterone|mesh-list
6581295|NCT01056042|Gestodene|gestodene|mesh-list
6581296|NCT01056042|Estradiol|estradiol|mesh-list
6581297|NCT01056042|Estrogens|estrogens|mesh-ancestor
6581298|NCT01056042|Hormones|hormones|mesh-ancestor
6581299|NCT01056042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6581300|NCT01056042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581301|NCT01056042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6581302|NCT01056042|Contraceptive Agents|contraceptive agents|mesh-ancestor
6581303|NCT01056042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6581304|NCT01056042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6581305|NCT01056042|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6581306|NCT01056042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6581307|NCT01056042|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6581308|NCT01056042|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6581309|NCT01056042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6581310|NCT01056042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6581311|NCT01056042|Progestins|progestins|mesh-ancestor
6581312|NCT01056172|Ribavirin|ribavirin|mesh-list
6581313|NCT01056172|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6581314|NCT01056172|Interferon-alpha|interferon-alpha|mesh-list
6581315|NCT01056172|Antimetabolites|antimetabolites|mesh-ancestor
6581316|NCT01056172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581317|NCT01056172|Antiviral Agents|antiviral agents|mesh-ancestor
6581318|NCT01056172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6581319|NCT01056172|Immunologic Factors|immunologic factors|mesh-ancestor
6581320|NCT01056172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581321|NCT01056224|Remifentanil|remifentanil|mesh-list
6581322|NCT01056224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6581323|NCT01056224|Narcotics|narcotics|mesh-ancestor
6581324|NCT01056224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6581325|NCT01056224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581326|NCT01056224|Analgesics|analgesics|mesh-ancestor
6581327|NCT01056224|Sensory System Agents|sensory system agents|mesh-ancestor
6581328|NCT01056224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6581329|NCT01056237|Mycophenolic Acid|mycophenolic acid|mesh-list
6581330|NCT01056237|Azathioprine|azathioprine|mesh-list
6581331|NCT01056237|Tacrolimus|tacrolimus|mesh-list
6581332|NCT01056237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6581333|NCT01056237|Immunologic Factors|immunologic factors|mesh-ancestor
6581334|NCT01056237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581335|NCT01056237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6581336|NCT01056237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6581337|NCT01056237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581338|NCT01056237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6581339|NCT01056237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6581340|NCT01056237|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6581341|NCT01056237|Antitubercular Agents|antitubercular agents|mesh-ancestor
6581342|NCT01056237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6581343|NCT01056237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6581344|NCT01056237|Antimetabolites|antimetabolites|mesh-ancestor
6446590|NCT00393315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6446591|NCT00393315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6446592|NCT00393315|Tubulin Modulators|tubulin modulators|mesh-ancestor
6446593|NCT00393315|Antimitotic Agents|antimitotic agents|mesh-ancestor
6446594|NCT00393315|Mitosis Modulators|mitosis modulators|mesh-ancestor
6581345|NCT01056237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6581346|NCT01056237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6581347|NCT01056419|Propylthiouracil|propylthiouracil|mesh-list
6581348|NCT01056419|Antimetabolites|antimetabolites|mesh-ancestor
6581349|NCT01056419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446595|NCT00393315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581350|NCT01056419|Antithyroid Agents|antithyroid agents|mesh-ancestor
6581351|NCT01056419|Hormone Antagonists|hormone antagonists|mesh-ancestor
6581352|NCT01056419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6581353|NCT01056419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581354|NCT01056497|Thioctic Acid|thioctic acid|mesh-list
6581355|NCT01056497|Antioxidants|antioxidants|mesh-ancestor
6581356|NCT01056497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581357|NCT01056497|Protective Agents|protective agents|mesh-ancestor
6581358|NCT01056497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581359|NCT01056497|Vitamin B Complex|vitamin b complex|mesh-ancestor
6581360|NCT01056497|Vitamins|vitamins|mesh-ancestor
6581361|NCT01056497|Micronutrients|micronutrients|mesh-ancestor
6581362|NCT01056549|Exenatide|exenatide|mesh-list
6581363|NCT01056549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6581364|NCT01056549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581365|NCT01056549|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6581366|NCT01056549|Incretins|incretins|mesh-ancestor
6581367|NCT01056549|Hormones|hormones|mesh-ancestor
6581368|NCT01056549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6581369|NCT01056614|Methotrexate|methotrexate|mesh-list
6581370|NCT01056614|Fludarabine phosphate|fludarabine phosphate|mesh-list
6581371|NCT01056614|Fludarabine|fludarabine|mesh-list
6581372|NCT01056614|Busulfan|busulfan|mesh-list
6581373|NCT01056614|Tacrolimus|tacrolimus|mesh-list
6581374|NCT01056614|Thymoglobulin|thymoglobulin|mesh-list
6581375|NCT01056614|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6446596|NCT00393328|Ritonavir|ritonavir|mesh-list
6581376|NCT01056614|Immunoglobulins|immunoglobulins|mesh-list
6581377|NCT01056614|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6581378|NCT01056614|Abortifacient Agents|abortifacient agents|mesh-ancestor
6581379|NCT01056614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6446597|NCT00393328|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6446598|NCT00393328|Aripiprazole|aripiprazole|mesh-list
6461786|NCT00456235|Tacrolimus|tacrolimus|mesh-list
6581380|NCT01056614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581381|NCT01056614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6446599|NCT00393328|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6446600|NCT00393328|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6446601|NCT00393328|Protease Inhibitors|protease inhibitors|mesh-ancestor
6446602|NCT00393328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6581382|NCT01056614|Antimetabolites|antimetabolites|mesh-ancestor
6581383|NCT01056614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581384|NCT01056614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6581385|NCT01056614|Dermatologic Agents|dermatologic agents|mesh-ancestor
6581386|NCT01056614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6581387|NCT01056614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6581388|NCT01056614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6581389|NCT01056614|Immunologic Factors|immunologic factors|mesh-ancestor
6581390|NCT01056614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6581391|NCT01056614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6581392|NCT01056614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6581393|NCT01056614|Alkylating Agents|alkylating agents|mesh-ancestor
6581394|NCT01056614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6581395|NCT01056614|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6581396|NCT01056627|Valproic Acid|valproic acid|mesh-list
6581397|NCT01056627|Anticonvulsants|anticonvulsants|mesh-ancestor
6581398|NCT01056627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6581399|NCT01056627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581400|NCT01056627|GABA Agents|gaba agents|mesh-ancestor
6581401|NCT01056627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6581402|NCT01056627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581403|NCT01056627|Antimanic Agents|antimanic agents|mesh-ancestor
6581404|NCT01056627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6581405|NCT01056627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6581406|NCT01056627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6581407|NCT01056679|Doxorubicin|doxorubicin|mesh-list
6581408|NCT01056679|Lenalidomide|lenalidomide|mesh-list
6581409|NCT01056679|Vinblastine|vinblastine|mesh-list
6581410|NCT01056679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6581411|NCT01056679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6581412|NCT01056679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6581413|NCT01056679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6581414|NCT01056679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6581415|NCT01056679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581416|NCT01056679|Immunologic Factors|immunologic factors|mesh-ancestor
6581417|NCT01056679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581418|NCT01056679|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6581419|NCT01056679|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6581420|NCT01056679|Growth Substances|growth substances|mesh-ancestor
6581421|NCT01056679|Growth Inhibitors|growth inhibitors|mesh-ancestor
5501536|NCT04473261|Iodine|iodine|mesh-list
6446603|NCT00393328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446604|NCT00393328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6446605|NCT00393328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6446606|NCT00393328|Antiviral Agents|antiviral agents|mesh-ancestor
6446607|NCT00393328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6446608|NCT00393328|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6446609|NCT00393328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6446610|NCT00393328|Antidepressive Agents|antidepressive agents|mesh-ancestor
6446611|NCT00393328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6446612|NCT00393328|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6446613|NCT00393328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6446614|NCT00393328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6446615|NCT00393328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446616|NCT00393328|Dopamine Agonists|dopamine agonists|mesh-ancestor
6446617|NCT00393328|Dopamine Agents|dopamine agents|mesh-ancestor
6581422|NCT01056679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6581423|NCT01056679|Tubulin Modulators|tubulin modulators|mesh-ancestor
6581424|NCT01056679|Antimitotic Agents|antimitotic agents|mesh-ancestor
6581425|NCT01056679|Mitosis Modulators|mitosis modulators|mesh-ancestor
6581426|NCT01056705|Vaccines|vaccines|mesh-list
6581427|NCT01056705|Immunologic Factors|immunologic factors|mesh-ancestor
6581428|NCT01056705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581429|NCT01056757|Ribavirin|ribavirin|mesh-list
6581430|NCT01056757|Antimetabolites|antimetabolites|mesh-ancestor
6581431|NCT01056757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581432|NCT01056757|Antiviral Agents|antiviral agents|mesh-ancestor
6581433|NCT01056757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6581434|NCT01056835|Epoprostenol|epoprostenol|mesh-list
6581435|NCT01056835|Tezosentan|tezosentan|mesh-list
6581436|NCT01056835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6581437|NCT01056835|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6581438|NCT01056835|Vasodilator Agents|vasodilator agents|mesh-ancestor
6581439|NCT01056861|Botulinum Toxins|botulinum toxins|mesh-list
6581440|NCT01056861|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6581441|NCT01056861|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6581442|NCT01056861|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6581443|NCT01056861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6581444|NCT01056861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581445|NCT01056861|Cholinergic Agents|cholinergic agents|mesh-ancestor
6581446|NCT01056861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6581447|NCT01056861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581448|NCT01056861|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6581449|NCT01056861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6581450|NCT01056874|Maraviroc|maraviroc|mesh-list
6581451|NCT01056874|Digoxin|digoxin|mesh-list
6581452|NCT01056874|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6581453|NCT01056874|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6581454|NCT01056874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581455|NCT01056874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6581456|NCT01056874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6581457|NCT01056874|Antiviral Agents|antiviral agents|mesh-ancestor
6581458|NCT01056874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6581459|NCT01056874|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6581460|NCT01056874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6581461|NCT01056874|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6581462|NCT01056874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6581463|NCT01056874|Protective Agents|protective agents|mesh-ancestor
6581464|NCT01056874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581465|NCT01056926|Nicotine|nicotine|mesh-list
6581466|NCT01056926|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6581467|NCT01056926|Autonomic Agents|autonomic agents|mesh-ancestor
6581468|NCT01056926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6581469|NCT01056926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581470|NCT01056926|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6581471|NCT01056926|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6581472|NCT01056926|Cholinergic Agents|cholinergic agents|mesh-ancestor
6581473|NCT01056926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6581474|NCT01056926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658443|NCT01481610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6658444|NCT01481610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658445|NCT01481610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6658446|NCT01481610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6658447|NCT01481610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6658448|NCT01481610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6658449|NCT01481610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658450|NCT01481610|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6658451|NCT01481701|Oxaliplatin|oxaliplatin|mesh-list
6446618|NCT00393328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6446619|NCT00393328|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6446620|NCT00393328|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6446621|NCT00393328|Serotonin Agents|serotonin agents|mesh-ancestor
6446622|NCT00393328|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6446623|NCT00393328|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6446624|NCT00393328|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6446625|NCT00393328|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6446626|NCT00393393|Hylan|hylan|mesh-list
6446627|NCT00393393|Viscosupplements|viscosupplements|mesh-ancestor
6446628|NCT00393393|Protective Agents|protective agents|mesh-ancestor
6446629|NCT00393393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446630|NCT00393445|Glucagon|glucagon|mesh-list
6581475|NCT01057069|Paclitaxel|paclitaxel|mesh-list
6581476|NCT01057069|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6581477|NCT01057069|Cyclophosphamide|cyclophosphamide|mesh-list
6581478|NCT01057069|Carboplatin|carboplatin|mesh-list
6581479|NCT01057069|Doxorubicin|doxorubicin|mesh-list
6581480|NCT01057069|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6581481|NCT01057069|Thiotepa|thiotepa|mesh-list
6581482|NCT01057069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6581483|NCT01057069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6581484|NCT01057069|Tubulin Modulators|tubulin modulators|mesh-ancestor
6581485|NCT01057069|Antimitotic Agents|antimitotic agents|mesh-ancestor
6581486|NCT01057069|Mitosis Modulators|mitosis modulators|mesh-ancestor
6581487|NCT01057069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581488|NCT01057069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6581489|NCT01057069|Immunologic Factors|immunologic factors|mesh-ancestor
6581490|NCT01057069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581491|NCT01057069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6581492|NCT01057069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6581493|NCT01057069|Alkylating Agents|alkylating agents|mesh-ancestor
6581494|NCT01057069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6581495|NCT01057069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6581496|NCT01057069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6581497|NCT01057069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6581498|NCT01057069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6581499|NCT01057160|Rizatriptan|rizatriptan|mesh-list
6581500|NCT01057160|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6581501|NCT01057160|Serotonin Agents|serotonin agents|mesh-ancestor
6581502|NCT01057160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6581503|NCT01057160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581504|NCT01057160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581505|NCT01057186|Alfacalcidol|alfacalcidol|mesh-list
6581506|NCT01057186|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
6581507|NCT01057186|Sevelamer|sevelamer|mesh-list
6581508|NCT01057186|Chelating Agents|chelating agents|mesh-ancestor
6581509|NCT01057186|Sequestering Agents|sequestering agents|mesh-ancestor
6581510|NCT01057186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581511|NCT01057186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6581512|NCT01057186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581513|NCT01057186|Vitamins|vitamins|mesh-ancestor
6581514|NCT01057186|Micronutrients|micronutrients|mesh-ancestor
6581515|NCT01057212|Bevacizumab|bevacizumab|mesh-list
6581516|NCT01057212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6581517|NCT01057212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6581518|NCT01057212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6581519|NCT01057212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6581520|NCT01057212|Growth Substances|growth substances|mesh-ancestor
6581521|NCT01057212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581522|NCT01057212|Growth Inhibitors|growth inhibitors|mesh-ancestor
6581523|NCT01057264|Gemcitabine|gemcitabine|mesh-list
6581524|NCT01057264|Paclitaxel|paclitaxel|mesh-list
6581525|NCT01057264|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6581526|NCT01057264|Bevacizumab|bevacizumab|mesh-list
6581527|NCT01057264|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6581528|NCT01057264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6581529|NCT01057264|Tubulin Modulators|tubulin modulators|mesh-ancestor
6581530|NCT01057264|Antimitotic Agents|antimitotic agents|mesh-ancestor
6581531|NCT01057264|Mitosis Modulators|mitosis modulators|mesh-ancestor
6581532|NCT01057264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581533|NCT01057264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6581534|NCT01057264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6581535|NCT01057264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6581536|NCT01057264|Growth Substances|growth substances|mesh-ancestor
6581537|NCT01057264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581538|NCT01057264|Growth Inhibitors|growth inhibitors|mesh-ancestor
6581539|NCT01057264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6581540|NCT01057264|Antimetabolites|antimetabolites|mesh-ancestor
6581541|NCT01057264|Antiviral Agents|antiviral agents|mesh-ancestor
6581542|NCT01057264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6581543|NCT01057264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6581544|NCT01057264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6581545|NCT01057264|Immunologic Factors|immunologic factors|mesh-ancestor
6581546|NCT01057329|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6581547|NCT01057329|Olanzapine|olanzapine|mesh-list
6581548|NCT01057329|Aripiprazole|aripiprazole|mesh-list
6581549|NCT01057329|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6581550|NCT01057329|Antiemetics|antiemetics|mesh-ancestor
6581551|NCT01057329|Autonomic Agents|autonomic agents|mesh-ancestor
6581552|NCT01057329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6581553|NCT01057329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581554|NCT01057329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6581555|NCT01057329|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6581556|NCT01057329|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6581557|NCT01057329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6581558|NCT01057329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6581559|NCT01057329|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6581560|NCT01057329|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6581561|NCT01057329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6581562|NCT01057329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581563|NCT01057329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6581564|NCT01057329|Serotonin Agents|serotonin agents|mesh-ancestor
6581565|NCT01057329|Antidepressive Agents|antidepressive agents|mesh-ancestor
6581566|NCT01057329|Dopamine Agonists|dopamine agonists|mesh-ancestor
6581567|NCT01057329|Dopamine Agents|dopamine agents|mesh-ancestor
6581568|NCT01057329|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6581569|NCT01057329|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6581570|NCT01057329|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6581571|NCT01057329|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6581572|NCT01057329|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6581573|NCT01057329|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6581574|NCT01057329|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6581575|NCT01057329|Analgesics|analgesics|mesh-ancestor
6581576|NCT01057329|Sensory System Agents|sensory system agents|mesh-ancestor
6581577|NCT01057329|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6581578|NCT01057329|Adrenergic Agents|adrenergic agents|mesh-ancestor
6581579|NCT01057342|Paclitaxel|paclitaxel|mesh-list
6581580|NCT01057342|Carboplatin|carboplatin|mesh-list
6581581|NCT01057342|Vadimezan|vadimezan|mesh-list
6581582|NCT01057342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6581583|NCT01057342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6581584|NCT01057342|Tubulin Modulators|tubulin modulators|mesh-ancestor
6581585|NCT01057342|Antimitotic Agents|antimitotic agents|mesh-ancestor
6581586|NCT01057342|Mitosis Modulators|mitosis modulators|mesh-ancestor
6581587|NCT01057342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581588|NCT01057355|Ethanol|ethanol|mesh-list
6581589|NCT01057355|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6581590|NCT01057355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6581591|NCT01057355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6581592|NCT01057355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581593|NCT01057407|Sevelamer|sevelamer|mesh-list
6581594|NCT01057407|Chelating Agents|chelating agents|mesh-ancestor
6581595|NCT01057407|Sequestering Agents|sequestering agents|mesh-ancestor
6581596|NCT01057407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581597|NCT01057498|RNS60|rns60|mesh-list
5501537|NCT04473261|Cadexomer iodine|cadexomer iodine|mesh-list
6581598|NCT01057498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6581599|NCT01057498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6581600|NCT01057498|Analgesics|analgesics|mesh-ancestor
6581601|NCT01057498|Sensory System Agents|sensory system agents|mesh-ancestor
6581602|NCT01057498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6581603|NCT01057498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581604|NCT01057498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6581605|NCT01057498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6581606|NCT01057498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6581607|NCT01057511|Progesterone|progesterone|mesh-list
6581608|NCT01057511|Progestins|progestins|mesh-ancestor
6581609|NCT01057511|Hormones|hormones|mesh-ancestor
6581610|NCT01057511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6581611|NCT01057511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581612|NCT01057563|Paclitaxel|paclitaxel|mesh-list
6581613|NCT01057563|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6581614|NCT01057563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6581615|NCT01057563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6581616|NCT01057563|Tubulin Modulators|tubulin modulators|mesh-ancestor
6581617|NCT01057563|Antimitotic Agents|antimitotic agents|mesh-ancestor
6581618|NCT01057563|Mitosis Modulators|mitosis modulators|mesh-ancestor
6581619|NCT01057563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581620|NCT01057615|Ascorbic Acid|ascorbic acid|mesh-list
6581621|NCT01057615|Vitamins|vitamins|mesh-ancestor
6581622|NCT01057615|Micronutrients|micronutrients|mesh-ancestor
6581623|NCT01057615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581624|NCT01057615|Antioxidants|antioxidants|mesh-ancestor
6581625|NCT01057615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581626|NCT01057615|Protective Agents|protective agents|mesh-ancestor
6581627|NCT01057628|Ipragliflozin|ipragliflozin|mesh-list
6581628|NCT01057628|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6581629|NCT01057628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581630|NCT01057628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6581631|NCT01057628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581632|NCT01057654|Pravastatin|pravastatin|mesh-list
6581633|NCT01057654|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6581634|NCT01057654|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6581635|NCT01057654|Antimetabolites|antimetabolites|mesh-ancestor
6581636|NCT01057654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581637|NCT01057654|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6581638|NCT01057654|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6581639|NCT01057654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6581640|NCT01057758|Simvastatin|simvastatin|mesh-list
6581641|NCT01057758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6581642|NCT01057758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6581643|NCT01057758|Antimetabolites|antimetabolites|mesh-ancestor
6581644|NCT01057758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581645|NCT01057758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6581646|NCT01057758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6581647|NCT01057758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6581648|NCT01057849|Olanzapine|olanzapine|mesh-list
6581649|NCT01057849|Risperidone|risperidone|mesh-list
6581650|NCT01057849|Aripiprazole|aripiprazole|mesh-list
6581651|NCT01057849|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6581652|NCT01057849|Serotonin Agents|serotonin agents|mesh-ancestor
6581653|NCT01057849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6581654|NCT01057849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581655|NCT01057849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581656|NCT01057849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6581657|NCT01057849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6581658|NCT01057849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6581659|NCT01057849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6581660|NCT01057849|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6581661|NCT01057849|Dopamine Agents|dopamine agents|mesh-ancestor
6581662|NCT01057849|Antiemetics|antiemetics|mesh-ancestor
6581663|NCT01057849|Autonomic Agents|autonomic agents|mesh-ancestor
6581664|NCT01057849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6581665|NCT01057849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6581666|NCT01057849|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6581667|NCT01057849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6446631|NCT00393445|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6446632|NCT00393445|Incretins|incretins|mesh-ancestor
6446633|NCT00393445|Hormones|hormones|mesh-ancestor
6446634|NCT00393445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6446635|NCT00393445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446636|NCT00393445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6581668|NCT01057849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6581669|NCT01057849|Antidepressive Agents|antidepressive agents|mesh-ancestor
6581670|NCT01057849|Dopamine Agonists|dopamine agonists|mesh-ancestor
6581671|NCT01057849|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6581672|NCT01057849|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6581673|NCT01057849|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6581674|NCT01057849|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6581675|NCT01057875|Caffeine|caffeine|mesh-list
6581676|NCT01057875|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6581677|NCT01057875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581678|NCT01057875|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6581679|NCT01057875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6581680|NCT01057875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581681|NCT01057875|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6581682|NCT01057875|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6581683|NCT01057875|Purinergic Agents|purinergic agents|mesh-ancestor
6581684|NCT01057875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6581685|NCT01057966|Vitamins|vitamins|mesh-list
6581686|NCT01057966|Micronutrients|micronutrients|mesh-ancestor
6581687|NCT01057966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581688|NCT01058057|Atorvastatin|atorvastatin|mesh-list
6581689|NCT01058057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6581690|NCT01058057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6581691|NCT01058057|Antimetabolites|antimetabolites|mesh-ancestor
6581692|NCT01058057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581693|NCT01058057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6581694|NCT01058057|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6581695|NCT01058057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6581696|NCT01058109|Calcium, Dietary|calcium, dietary|mesh-list
6581697|NCT01058109|Calcium|calcium|mesh-list
6581698|NCT01058109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6581699|NCT01058109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581700|NCT01058109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6581701|NCT01058174|Fluconazole|fluconazole|mesh-list
6581702|NCT01058174|Amphotericin B|amphotericin b|mesh-list
6581703|NCT01058174|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6581704|NCT01058174|Caspofungin|caspofungin|mesh-list
6581705|NCT01058174|Micafungin|micafungin|mesh-list
6581706|NCT01058174|Antifungal Agents|antifungal agents|mesh-ancestor
6581707|NCT01058174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6581708|NCT01058174|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6446637|NCT00393471|Etanercept|etanercept|mesh-list
6446638|NCT00393471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6446639|NCT00393471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6446640|NCT00393471|Analgesics|analgesics|mesh-ancestor
6581709|NCT01058174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6581710|NCT01058174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6581711|NCT01058174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581712|NCT01058174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6581713|NCT01058174|Hormone Antagonists|hormone antagonists|mesh-ancestor
6581714|NCT01058174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6581715|NCT01058174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581716|NCT01058174|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6581717|NCT01058174|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6581718|NCT01058174|Amebicides|amebicides|mesh-ancestor
6581719|NCT01058174|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6581720|NCT01058174|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6581721|NCT01058174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6581722|NCT01058252|Indomethacin|indomethacin|mesh-list
6581723|NCT01058252|Letrozole|letrozole|mesh-list
6581724|NCT01058252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6581725|NCT01058252|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6581726|NCT01058252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6581727|NCT01058252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6581728|NCT01058252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581729|NCT01058252|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6581730|NCT01058252|Hormone Antagonists|hormone antagonists|mesh-ancestor
6581731|NCT01058252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6581732|NCT01058252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581733|NCT01058252|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6581734|NCT01058252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6581735|NCT01058252|Analgesics|analgesics|mesh-ancestor
6581736|NCT01058252|Sensory System Agents|sensory system agents|mesh-ancestor
6581737|NCT01058252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6581738|NCT01058252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6581739|NCT01058252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6581740|NCT01058252|Gout Suppressants|gout suppressants|mesh-ancestor
6581741|NCT01058252|Tocolytic Agents|tocolytic agents|mesh-ancestor
6581742|NCT01058252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6581743|NCT01058252|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6581744|NCT01058291|Apomorphine|apomorphine|mesh-list
6581745|NCT01058291|Emetics|emetics|mesh-ancestor
6581746|NCT01058291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581747|NCT01058291|Autonomic Agents|autonomic agents|mesh-ancestor
6581748|NCT01058291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6581749|NCT01058291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6581750|NCT01058291|Dopamine Agonists|dopamine agonists|mesh-ancestor
6581751|NCT01058291|Dopamine Agents|dopamine agents|mesh-ancestor
6581752|NCT01058291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6581753|NCT01058291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581754|NCT01058317|Propranolol|propranolol|mesh-list
6581755|NCT01058317|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6581756|NCT01058317|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6581757|NCT01058317|Adrenergic Agents|adrenergic agents|mesh-ancestor
6581758|NCT01058317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6581759|NCT01058317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581760|NCT01058317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581761|NCT01058317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6581762|NCT01058317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6581763|NCT01058317|Vasodilator Agents|vasodilator agents|mesh-ancestor
6581764|NCT01058382|Progesterone|progesterone|mesh-list
6581765|NCT01058382|Progestins|progestins|mesh-ancestor
6581766|NCT01058382|Hormones|hormones|mesh-ancestor
6581767|NCT01058382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6581768|NCT01058382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581769|NCT01058408|Cisplatin|cisplatin|mesh-list
6581770|NCT01058408|Everolimus|everolimus|mesh-list
6581771|NCT01058408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6581772|NCT01058408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6581773|NCT01058408|Immunologic Factors|immunologic factors|mesh-ancestor
6581774|NCT01058408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581775|NCT01058577|Somatostatin|somatostatin|mesh-list
6581776|NCT01058577|Hormones|hormones|mesh-ancestor
6581777|NCT01058577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6581778|NCT01058577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658452|NCT01481701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6658453|NCT01481714|Picosulfate sodium|picosulfate sodium|mesh-list
6658454|NCT01481714|Magnesium Oxide|magnesium oxide|mesh-list
6658455|NCT01481714|Sodium Citrate|sodium citrate|mesh-list
6658456|NCT01481714|Citric Acid|citric acid|mesh-list
6658457|NCT01481714|Anticoagulants|anticoagulants|mesh-ancestor
6658458|NCT01481714|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6658459|NCT01481714|Chelating Agents|chelating agents|mesh-ancestor
6658460|NCT01481714|Sequestering Agents|sequestering agents|mesh-ancestor
6658461|NCT01481714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658462|NCT01481714|Cathartics|cathartics|mesh-ancestor
6658463|NCT01481714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6658464|NCT01481714|Antacids|antacids|mesh-ancestor
6664802|NCT01514123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6664803|NCT01514123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6664804|NCT01514123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6664805|NCT01514123|Growth Substances|growth substances|mesh-ancestor
6664806|NCT01514123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664807|NCT01514123|Growth Inhibitors|growth inhibitors|mesh-ancestor
6664808|NCT01514175|Ibuprofen|ibuprofen|mesh-list
6664809|NCT01514175|Ketorolac|ketorolac|mesh-list
6664810|NCT01514175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6664811|NCT01514175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6446641|NCT00393471|Sensory System Agents|sensory system agents|mesh-ancestor
6446642|NCT00393471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6446643|NCT00393471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446644|NCT00393471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6446645|NCT00393471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6446646|NCT00393471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6446647|NCT00393471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6446648|NCT00393471|Immunologic Factors|immunologic factors|mesh-ancestor
6446649|NCT00393497|Bevacizumab|bevacizumab|mesh-list
6446650|NCT00393497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6446651|NCT00393497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6446652|NCT00393497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6446653|NCT00393497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6446654|NCT00393497|Growth Substances|growth substances|mesh-ancestor
6664812|NCT01514175|Analgesics|analgesics|mesh-ancestor
6664813|NCT01514175|Sensory System Agents|sensory system agents|mesh-ancestor
6664814|NCT01514175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6664815|NCT01514175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664816|NCT01514175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6664817|NCT01514175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6664818|NCT01514175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6664819|NCT01514175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6664820|NCT01514175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6664821|NCT01514188|Doxorubicin|doxorubicin|mesh-list
6664822|NCT01514188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6664823|NCT01514188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6664824|NCT01514188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6664825|NCT01514188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6664826|NCT01514188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6664827|NCT01514188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6664828|NCT01514227|Aspirin|aspirin|mesh-list
6664829|NCT01514227|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6664830|NCT01514227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6664831|NCT01514227|Analgesics|analgesics|mesh-ancestor
6664832|NCT01514227|Sensory System Agents|sensory system agents|mesh-ancestor
6664833|NCT01514227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6581779|NCT01058720|Vitamin D|vitamin d|mesh-list
6581780|NCT01058720|Cholecalciferol|cholecalciferol|mesh-list
6581781|NCT01058720|Vitamins|vitamins|mesh-ancestor
6581782|NCT01058720|Micronutrients|micronutrients|mesh-ancestor
6581783|NCT01058720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581784|NCT01058720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6581785|NCT01058720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6581786|NCT01058759|Enoxaparin|enoxaparin|mesh-list
6581787|NCT01058759|Enoxaparin sodium|enoxaparin sodium|mesh-list
6581788|NCT01058759|Anticoagulants|anticoagulants|mesh-ancestor
6581789|NCT01058759|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6581790|NCT01058759|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6581791|NCT01058759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581792|NCT01058824|Lincomycin|lincomycin|mesh-list
6581793|NCT01058824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6581794|NCT01058824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6581795|NCT01058824|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6581796|NCT01058824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6581797|NCT01058824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581798|NCT01058850|Rindopepimut|rindopepimut|mesh-list
6581799|NCT01058850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6581800|NCT01058850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6581801|NCT01058876|Nicotine|nicotine|mesh-list
6581802|NCT01058876|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6581803|NCT01058876|Autonomic Agents|autonomic agents|mesh-ancestor
6581804|NCT01058876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6581805|NCT01058876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581806|NCT01058876|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6581807|NCT01058876|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6581808|NCT01058876|Cholinergic Agents|cholinergic agents|mesh-ancestor
6581809|NCT01058876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6581810|NCT01058876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581811|NCT01058902|Aspirin|aspirin|mesh-list
6581812|NCT01058902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6581813|NCT01058902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6581814|NCT01058902|Analgesics|analgesics|mesh-ancestor
6581815|NCT01058902|Sensory System Agents|sensory system agents|mesh-ancestor
6581816|NCT01058902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6581817|NCT01058902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581818|NCT01058902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6581819|NCT01058902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6581820|NCT01058902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6581821|NCT01058902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6581822|NCT01058902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581823|NCT01058902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6581824|NCT01058902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6581825|NCT01058902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6581826|NCT01058902|Antipyretics|antipyretics|mesh-ancestor
6581827|NCT01058915|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6581828|NCT01058915|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6581829|NCT01058915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6581830|NCT01058915|Antimetabolites|antimetabolites|mesh-ancestor
6581831|NCT01058915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581832|NCT01058915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6581833|NCT01058915|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6581834|NCT01058915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6581835|NCT01059058|Fluorides|fluorides|mesh-list
6581836|NCT01059058|Fluorides, Topical|fluorides, topical|mesh-list
6581837|NCT01059058|Cariostatic Agents|cariostatic agents|mesh-ancestor
6581838|NCT01059058|Protective Agents|protective agents|mesh-ancestor
6581839|NCT01059058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581840|NCT01059084|Valacyclovir|valacyclovir|mesh-list
6581841|NCT01059084|Antiviral Agents|antiviral agents|mesh-ancestor
6581842|NCT01059084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6581843|NCT01059110|Salicylates|salicylates|mesh-list
6581844|NCT01059110|Imiquimod|imiquimod|mesh-list
6581845|NCT01059110|Fluorouracil|fluorouracil|mesh-list
6581846|NCT01059110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6581847|NCT01059110|Immunologic Factors|immunologic factors|mesh-ancestor
6581848|NCT01059110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581849|NCT01059110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6581850|NCT01059110|Interferon Inducers|interferon inducers|mesh-ancestor
6581851|NCT01059110|Antimetabolites|antimetabolites|mesh-ancestor
6581852|NCT01059110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581853|NCT01059110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6581854|NCT01059110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6581855|NCT01059110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6581856|NCT01059110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6446655|NCT00393497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446656|NCT00393497|Growth Inhibitors|growth inhibitors|mesh-ancestor
6581857|NCT01059110|Analgesics|analgesics|mesh-ancestor
6581858|NCT01059110|Sensory System Agents|sensory system agents|mesh-ancestor
6581859|NCT01059110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6581860|NCT01059110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6581861|NCT01059110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6581862|NCT01059110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6581863|NCT01059110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6581864|NCT01059123|Amoxicillin|amoxicillin|mesh-list
6581865|NCT01059123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6581866|NCT01059123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6581867|NCT01059136|Spironolactone|spironolactone|mesh-list
6581868|NCT01059136|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6581869|NCT01059136|Hormone Antagonists|hormone antagonists|mesh-ancestor
6581870|NCT01059136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6581871|NCT01059136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581872|NCT01059136|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6581873|NCT01059136|Diuretics|diuretics|mesh-ancestor
6581874|NCT01059136|Natriuretic Agents|natriuretic agents|mesh-ancestor
6581875|NCT01059331|Pregabalin|pregabalin|mesh-list
6581876|NCT01059331|Analgesics|analgesics|mesh-ancestor
6581877|NCT01059331|Sensory System Agents|sensory system agents|mesh-ancestor
6581878|NCT01059331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6581879|NCT01059331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581880|NCT01059331|Anticonvulsants|anticonvulsants|mesh-ancestor
6581881|NCT01059331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6581882|NCT01059331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6581883|NCT01059331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581884|NCT01059331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6581885|NCT01059331|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6581886|NCT01059331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6581887|NCT01059331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6446657|NCT00393562|Methylphenidate|methylphenidate|mesh-list
6446658|NCT00393562|Modafinil|modafinil|mesh-list
6446659|NCT00393562|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6446660|NCT00393562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446661|NCT00393562|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6581888|NCT01059331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6581889|NCT01059383|Esomeprazole|esomeprazole|mesh-list
6581890|NCT01059383|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6581891|NCT01059383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6581892|NCT01059383|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6581893|NCT01059383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6581894|NCT01059383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581895|NCT01059396|Propranolol|propranolol|mesh-list
6581896|NCT01059396|Carvedilol|carvedilol|mesh-list
6581897|NCT01059396|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6581898|NCT01059396|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6581899|NCT01059396|Adrenergic Agents|adrenergic agents|mesh-ancestor
6581900|NCT01059396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6581901|NCT01059396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581902|NCT01059396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581903|NCT01059396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6581904|NCT01059396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6581905|NCT01059396|Vasodilator Agents|vasodilator agents|mesh-ancestor
6581906|NCT01059396|Antioxidants|antioxidants|mesh-ancestor
6581907|NCT01059396|Protective Agents|protective agents|mesh-ancestor
6581908|NCT01059396|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6581909|NCT01059396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6446662|NCT00393562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6581910|NCT01059396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6581911|NCT01059396|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6581912|NCT01059396|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6581913|NCT01059422|Lamivudine|lamivudine|mesh-list
6581914|NCT01059422|Abacavir|abacavir|mesh-list
6581915|NCT01059422|Raltegravir Potassium|raltegravir potassium|mesh-list
6581916|NCT01059422|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6581917|NCT01059422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6581918|NCT01059422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6581919|NCT01059422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581920|NCT01059422|Antiviral Agents|antiviral agents|mesh-ancestor
6581921|NCT01059422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6581922|NCT01059422|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6581923|NCT01059422|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6581924|NCT01059422|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6581925|NCT01059422|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6581926|NCT01059461|Cerebrolysin|cerebrolysin|mesh-list
6581927|NCT01059461|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6581928|NCT01059461|Protective Agents|protective agents|mesh-ancestor
6581929|NCT01059461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581930|NCT01059461|Nootropic Agents|nootropic agents|mesh-ancestor
6581931|NCT01059552|Vorinostat|vorinostat|mesh-list
6581932|NCT01059552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6581933|NCT01059552|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6581934|NCT01059552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6581935|NCT01059552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581936|NCT01059604|Naproxen|naproxen|mesh-list
6581937|NCT01059604|Sumatriptan|sumatriptan|mesh-list
6581938|NCT01059604|Naratriptan|naratriptan|mesh-list
6581939|NCT01059604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6581940|NCT01059604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6581941|NCT01059604|Analgesics|analgesics|mesh-ancestor
6581942|NCT01059604|Sensory System Agents|sensory system agents|mesh-ancestor
6581943|NCT01059604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6581944|NCT01059604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581945|NCT01059604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6581946|NCT01059604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6581947|NCT01059604|Gout Suppressants|gout suppressants|mesh-ancestor
6581948|NCT01059604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6581949|NCT01059604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6581950|NCT01059604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581951|NCT01059604|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6581952|NCT01059604|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6581953|NCT01059604|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6581954|NCT01059604|Serotonin Agents|serotonin agents|mesh-ancestor
6446663|NCT00393562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6581955|NCT01059604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6581956|NCT01059890|Metronidazole|metronidazole|mesh-list
6581957|NCT01059890|Ciprofloxacin|ciprofloxacin|mesh-list
6581958|NCT01059890|Cefotaxime|cefotaxime|mesh-list
6581959|NCT01059890|Cefoxitin|cefoxitin|mesh-list
6581960|NCT01059890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6581961|NCT01059890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6581962|NCT01059890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6581963|NCT01059890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6581964|NCT01059890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6581965|NCT01059890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6581966|NCT01059890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6581967|NCT01059890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581968|NCT01059890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6581969|NCT01059890|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6581970|NCT01059890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6581971|NCT01059955|Dexamethasone|dexamethasone|mesh-list
6581972|NCT01059955|Dexamethasone acetate|dexamethasone acetate|mesh-list
6581973|NCT01059955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6581974|NCT01059955|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6581975|NCT01059955|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
6581976|NCT01059955|BB 1101|bb 1101|mesh-list
6581977|NCT01059955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6581978|NCT01059955|Antiemetics|antiemetics|mesh-ancestor
6581979|NCT01059955|Autonomic Agents|autonomic agents|mesh-ancestor
6581980|NCT01059955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6581981|NCT01059955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581982|NCT01059955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6581983|NCT01059955|Glucocorticoids|glucocorticoids|mesh-ancestor
6581984|NCT01059955|Hormones|hormones|mesh-ancestor
6581985|NCT01059955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6581986|NCT01059955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6581987|NCT01059955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6581988|NCT01059955|Protease Inhibitors|protease inhibitors|mesh-ancestor
6581989|NCT01059955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6581990|NCT01059955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6581991|NCT01060137|Fentanyl|fentanyl|mesh-list
6581992|NCT01060137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6581993|NCT01060137|Narcotics|narcotics|mesh-ancestor
6581994|NCT01060137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6581995|NCT01060137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6581996|NCT01060137|Analgesics|analgesics|mesh-ancestor
6581997|NCT01060137|Sensory System Agents|sensory system agents|mesh-ancestor
6581998|NCT01060137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6581999|NCT01060137|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6582000|NCT01060137|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6582001|NCT01060137|Anesthetics, General|anesthetics, general|mesh-ancestor
6582002|NCT01060137|Anesthetics|anesthetics|mesh-ancestor
6582003|NCT01060163|Tranexamic Acid|tranexamic acid|mesh-list
6582004|NCT01060163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6582005|NCT01060163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6582006|NCT01060163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582007|NCT01060163|Hemostatics|hemostatics|mesh-ancestor
6582008|NCT01060163|Coagulants|coagulants|mesh-ancestor
6582009|NCT01060176|Tranexamic Acid|tranexamic acid|mesh-list
6582010|NCT01060176|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6582011|NCT01060176|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6582012|NCT01060176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582013|NCT01060176|Hemostatics|hemostatics|mesh-ancestor
6446664|NCT00393562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446665|NCT00393562|Dopamine Agents|dopamine agents|mesh-ancestor
6446666|NCT00393562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6446667|NCT00393562|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6446668|NCT00393562|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6446669|NCT00393562|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6446670|NCT00393614|Levetiracetam|levetiracetam|mesh-list
6446671|NCT00393614|Anticonvulsants|anticonvulsants|mesh-ancestor
6446672|NCT00393614|Nootropic Agents|nootropic agents|mesh-ancestor
6446673|NCT00393679|Artesunate|artesunate|mesh-list
6446674|NCT00393679|Lumefantrine|lumefantrine|mesh-list
6446675|NCT00393679|Artemether|artemether|mesh-list
6446676|NCT00393679|Piperaquine|piperaquine|mesh-list
6446677|NCT00393679|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6446678|NCT00393679|Amodiaquine|amodiaquine|mesh-list
6582014|NCT01060176|Coagulants|coagulants|mesh-ancestor
6582015|NCT01060189|Tranexamic Acid|tranexamic acid|mesh-list
6582016|NCT01060189|Urinastatin|urinastatin|mesh-list
6582017|NCT01060189|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6582018|NCT01060189|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6582019|NCT01060189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582020|NCT01060189|Hemostatics|hemostatics|mesh-ancestor
6582021|NCT01060189|Coagulants|coagulants|mesh-ancestor
6582022|NCT01060189|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6582023|NCT01060189|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6582024|NCT01060189|Protease Inhibitors|protease inhibitors|mesh-ancestor
6582025|NCT01060189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6582026|NCT01060228|Valproic Acid|valproic acid|mesh-list
6582027|NCT01060228|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6582028|NCT01060228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6582029|NCT01060228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6582030|NCT01060228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6582031|NCT01060228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582032|NCT01060228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6582033|NCT01060228|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6582034|NCT01060228|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6582035|NCT01060228|Serotonin Agents|serotonin agents|mesh-ancestor
6582036|NCT01060228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6582037|NCT01060228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582038|NCT01060228|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6582039|NCT01060228|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6582040|NCT01060228|Dopamine Agents|dopamine agents|mesh-ancestor
6582041|NCT01060228|Anticonvulsants|anticonvulsants|mesh-ancestor
6582042|NCT01060228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6582043|NCT01060228|GABA Agents|gaba agents|mesh-ancestor
6582044|NCT01060228|Antimanic Agents|antimanic agents|mesh-ancestor
6582045|NCT01060267|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6582046|NCT01060267|Erythromycin|erythromycin|mesh-list
6582047|NCT01060267|Erythromycin Estolate|erythromycin estolate|mesh-list
6582048|NCT01060267|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
6582049|NCT01060267|Erythromycin stearate|erythromycin stearate|mesh-list
6582050|NCT01060267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6582051|NCT01060267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6582052|NCT01060267|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6582053|NCT01060267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6582054|NCT01060267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446679|NCT00393679|Artenimol|artenimol|mesh-list
6446680|NCT00393679|Dapsone|dapsone|mesh-list
6446681|NCT00393679|Chlorproguanil|chlorproguanil|mesh-list
6446682|NCT00393679|Antimalarials|antimalarials|mesh-ancestor
6446683|NCT00393679|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6446684|NCT00393679|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6446685|NCT00393679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6446686|NCT00393679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6446687|NCT00393679|Antiviral Agents|antiviral agents|mesh-ancestor
6446688|NCT00393679|Schistosomicides|schistosomicides|mesh-ancestor
6461787|NCT00456235|Cyclosporins|cyclosporins|mesh-list
6582055|NCT01060293|Dopamine|dopamine|mesh-list
6582056|NCT01060293|Furosemide|furosemide|mesh-list
6582057|NCT01060293|Diuretics|diuretics|mesh-ancestor
6582058|NCT01060293|Natriuretic Agents|natriuretic agents|mesh-ancestor
6582059|NCT01060293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582060|NCT01060293|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6582061|NCT01060293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6582062|NCT01060293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582063|NCT01060293|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6582064|NCT01060293|Sympathomimetics|sympathomimetics|mesh-ancestor
6582065|NCT01060293|Autonomic Agents|autonomic agents|mesh-ancestor
6582066|NCT01060293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6582067|NCT01060293|Dopamine Agents|dopamine agents|mesh-ancestor
6582068|NCT01060293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6582069|NCT01060293|Protective Agents|protective agents|mesh-ancestor
6582070|NCT01060410|Cyclophosphamide|cyclophosphamide|mesh-list
6582071|NCT01060410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6582072|NCT01060410|Immunologic Factors|immunologic factors|mesh-ancestor
6582073|NCT01060410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582074|NCT01060410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6582075|NCT01060410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6582076|NCT01060410|Alkylating Agents|alkylating agents|mesh-ancestor
6582077|NCT01060410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582078|NCT01060410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6582079|NCT01060410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6582080|NCT01060423|Irinotecan|irinotecan|mesh-list
6582081|NCT01060423|Cetuximab|cetuximab|mesh-list
6582082|NCT01060423|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6582083|NCT01060423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6582084|NCT01060423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6582085|NCT01060423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582086|NCT01060423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6582087|NCT01060423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6582088|NCT01060475|Tacrolimus|tacrolimus|mesh-list
6582089|NCT01060475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6582090|NCT01060475|Immunologic Factors|immunologic factors|mesh-ancestor
6582091|NCT01060475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582092|NCT01060475|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6582093|NCT01060475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6582094|NCT01060475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582095|NCT01060488|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
6582096|NCT01060488|Hormones|hormones|mesh-ancestor
6582097|NCT01060488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6582098|NCT01060488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582099|NCT01060501|Leucovorin|leucovorin|mesh-list
6582100|NCT01060501|Folic Acid|folic acid|mesh-list
6582101|NCT01060501|Interferons|interferons|mesh-list
6582102|NCT01060501|Interferon-alpha|interferon-alpha|mesh-list
6582103|NCT01060501|Levoleucovorin|levoleucovorin|mesh-list
6582104|NCT01060501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6582105|NCT01060501|Antiviral Agents|antiviral agents|mesh-ancestor
6582106|NCT01060501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6582107|NCT01060501|Immunologic Factors|immunologic factors|mesh-ancestor
6582108|NCT01060501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582109|NCT01060501|Antidotes|antidotes|mesh-ancestor
6582110|NCT01060501|Protective Agents|protective agents|mesh-ancestor
6582111|NCT01060501|Vitamin B Complex|vitamin b complex|mesh-ancestor
6582112|NCT01060501|Vitamins|vitamins|mesh-ancestor
6582113|NCT01060501|Micronutrients|micronutrients|mesh-ancestor
6582114|NCT01060501|Hematinics|hematinics|mesh-ancestor
6582115|NCT01060514|Vinorelbine|vinorelbine|mesh-list
6582116|NCT01060514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6582117|NCT01060514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6582118|NCT01060514|Tubulin Modulators|tubulin modulators|mesh-ancestor
6582119|NCT01060514|Antimitotic Agents|antimitotic agents|mesh-ancestor
6582120|NCT01060514|Mitosis Modulators|mitosis modulators|mesh-ancestor
6582121|NCT01060514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582122|NCT01060566|Ivacaftor|ivacaftor|mesh-list
6582123|NCT01060566|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6582124|NCT01060566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6582125|NCT01060566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582126|NCT01060605|Sirolimus|sirolimus|mesh-list
6582127|NCT01060605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6582128|NCT01060605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6582129|NCT01060605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6582130|NCT01060605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6582131|NCT01060605|Antifungal Agents|antifungal agents|mesh-ancestor
6582132|NCT01060605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6582133|NCT01060605|Immunologic Factors|immunologic factors|mesh-ancestor
6582134|NCT01060605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582135|NCT01060618|Maraviroc|maraviroc|mesh-list
6582136|NCT01060618|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6582137|NCT01060618|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6582138|NCT01060618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582139|NCT01060618|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6582140|NCT01060618|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6582141|NCT01060618|Antiviral Agents|antiviral agents|mesh-ancestor
6582142|NCT01060618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6582143|NCT01060618|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6658465|NCT01481831|Palonosetron|palonosetron|mesh-list
6658466|NCT01481831|Antiemetics|antiemetics|mesh-ancestor
6658467|NCT01481831|Autonomic Agents|autonomic agents|mesh-ancestor
6658468|NCT01481831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6658469|NCT01481831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658470|NCT01481831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6658471|NCT01481831|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6658472|NCT01481831|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6658473|NCT01481831|Serotonin Agents|serotonin agents|mesh-ancestor
6658474|NCT01481831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6658475|NCT01481831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658476|NCT01481844|Amoxicillin|amoxicillin|mesh-list
6658477|NCT01481844|Metronidazole|metronidazole|mesh-list
6658478|NCT01481844|Clarithromycin|clarithromycin|mesh-list
6658479|NCT01481844|Tetracycline|tetracycline|mesh-list
6658480|NCT01481844|Tinidazole|tinidazole|mesh-list
6658481|NCT01481844|Lansoprazole|lansoprazole|mesh-list
6658482|NCT01481844|Dexlansoprazole|dexlansoprazole|mesh-list
6658483|NCT01481844|Bismuth|bismuth|mesh-list
6658484|NCT01481844|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
6658485|NCT01481844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6658486|NCT01481844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6658487|NCT01481844|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6658488|NCT01481844|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6658489|NCT01481844|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6658490|NCT01481844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6658491|NCT01481844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658492|NCT01481844|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6658493|NCT01481844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6658494|NCT01481844|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6658495|NCT01481844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6658496|NCT01481844|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6658497|NCT01481844|Antacids|antacids|mesh-ancestor
6658498|NCT01481844|Alkylating Agents|alkylating agents|mesh-ancestor
6658499|NCT01481844|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
6658500|NCT01481844|Antidiarrheals|antidiarrheals|mesh-ancestor
6658501|NCT01481870|Sorafenib|sorafenib|mesh-list
6658502|NCT01481870|Sunitinib|sunitinib|mesh-list
6658503|NCT01481870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6658504|NCT01481870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6658505|NCT01481870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6658506|NCT01481870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658507|NCT01481870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6658508|NCT01481870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6658509|NCT01481870|Growth Substances|growth substances|mesh-ancestor
6658510|NCT01481870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658511|NCT01481870|Growth Inhibitors|growth inhibitors|mesh-ancestor
6658512|NCT01481883|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
6658513|NCT01481883|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6658514|NCT01481883|Hormone Antagonists|hormone antagonists|mesh-ancestor
6658515|NCT01481883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6658516|NCT01481883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658517|NCT01481883|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6582144|NCT01060631|Propofol|propofol|mesh-list
6582145|NCT01060631|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6582146|NCT01060631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6582147|NCT01060631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582148|NCT01060631|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6582149|NCT01060631|Anesthetics, General|anesthetics, general|mesh-ancestor
6582150|NCT01060631|Anesthetics|anesthetics|mesh-ancestor
6582151|NCT01060696|Mefenamic Acid|mefenamic acid|mesh-list
6582152|NCT01060696|Scopolamine|scopolamine|mesh-list
6582153|NCT01060696|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
6582154|NCT01060696|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6582155|NCT01060696|Antiemetics|antiemetics|mesh-ancestor
6582156|NCT01060696|Autonomic Agents|autonomic agents|mesh-ancestor
6582157|NCT01060696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6582158|NCT01060696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582159|NCT01060696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6582160|NCT01060696|Mydriatics|mydriatics|mesh-ancestor
6582161|NCT01060696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6582162|NCT01060696|Cholinergic Agents|cholinergic agents|mesh-ancestor
6582163|NCT01060696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6582164|NCT01060696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446689|NCT00393679|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6582165|NCT01060696|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6582166|NCT01060696|Parasympatholytics|parasympatholytics|mesh-ancestor
6582167|NCT01060696|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6582168|NCT01060696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6582169|NCT01060696|Analgesics|analgesics|mesh-ancestor
6582170|NCT01060696|Sensory System Agents|sensory system agents|mesh-ancestor
6582171|NCT01060696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6582172|NCT01060696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6582173|NCT01060696|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6582174|NCT01060696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6582175|NCT01060735|Vitamin D|vitamin d|mesh-list
6582176|NCT01060735|Vitamins|vitamins|mesh-ancestor
6582177|NCT01060735|Micronutrients|micronutrients|mesh-ancestor
6582178|NCT01060735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582179|NCT01060735|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6582180|NCT01060774|Lidocaine|lidocaine|mesh-list
6582181|NCT01060774|Bupivacaine|bupivacaine|mesh-list
6582182|NCT01060774|Anesthetics, Local|anesthetics, local|mesh-ancestor
6582183|NCT01060774|Anesthetics|anesthetics|mesh-ancestor
6582184|NCT01060774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6582185|NCT01060774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446690|NCT00393679|Anthelmintics|anthelmintics|mesh-ancestor
6446691|NCT00393679|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6582186|NCT01060774|Sensory System Agents|sensory system agents|mesh-ancestor
6582187|NCT01060774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6582188|NCT01060774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6582189|NCT01060774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6446692|NCT00393679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6446693|NCT00393679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446694|NCT00393679|Leprostatic Agents|leprostatic agents|mesh-ancestor
6446695|NCT00393679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6446696|NCT00393731|Misoprostol|misoprostol|mesh-list
6446697|NCT00393731|Oxytocin|oxytocin|mesh-list
6446698|NCT00393731|Oxytocics|oxytocics|mesh-ancestor
6446699|NCT00393731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6446700|NCT00393731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446701|NCT00393731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6582190|NCT01060774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6582191|NCT01060774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6582192|NCT01060774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582193|NCT01060787|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
6582194|NCT01060787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6582195|NCT01060787|Glucocorticoids|glucocorticoids|mesh-ancestor
6582196|NCT01060787|Hormones|hormones|mesh-ancestor
6582197|NCT01060787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6582198|NCT01060787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582199|NCT01060826|Somatostatin|somatostatin|mesh-list
6582200|NCT01060826|Hormones|hormones|mesh-ancestor
6582201|NCT01060826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6582202|NCT01060826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582203|NCT01060891|Colistin|colistin|mesh-list
6582204|NCT01060891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6582205|NCT01060891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6582206|NCT01060904|Doxorubicin|doxorubicin|mesh-list
6582207|NCT01060904|Bleomycin|bleomycin|mesh-list
6582208|NCT01060904|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6582209|NCT01060904|Dacarbazine|dacarbazine|mesh-list
6582210|NCT01060904|Vinblastine|vinblastine|mesh-list
6582211|NCT01060904|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6582212|NCT01060904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6582213|NCT01060904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6582214|NCT01060904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6582215|NCT01060904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6582216|NCT01060904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6582217|NCT01060904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582218|NCT01060904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6582219|NCT01060904|Immunologic Factors|immunologic factors|mesh-ancestor
6582220|NCT01060904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582221|NCT01060904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6582222|NCT01060904|Alkylating Agents|alkylating agents|mesh-ancestor
6582223|NCT01060904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6582224|NCT01060904|Tubulin Modulators|tubulin modulators|mesh-ancestor
6582225|NCT01060904|Antimitotic Agents|antimitotic agents|mesh-ancestor
6582226|NCT01060904|Mitosis Modulators|mitosis modulators|mesh-ancestor
6582227|NCT01060917|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6582228|NCT01060917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582229|NCT01060930|Epinephrine|epinephrine|mesh-list
6582230|NCT01060930|Norepinephrine|norepinephrine|mesh-list
6582231|NCT01060930|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
6582232|NCT01060930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6582233|NCT01060930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6582234|NCT01060930|Adrenergic Agents|adrenergic agents|mesh-ancestor
6582235|NCT01060930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6582236|NCT01060930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582237|NCT01060930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582238|NCT01060930|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6582239|NCT01060930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6582240|NCT01060930|Autonomic Agents|autonomic agents|mesh-ancestor
6582241|NCT01060930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6582242|NCT01060930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6446702|NCT00393731|Abortifacient Agents|abortifacient agents|mesh-ancestor
6446703|NCT00393731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6446704|NCT00393731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6446705|NCT00393744|Amoxicillin|amoxicillin|mesh-list
6446706|NCT00393744|Pristinamycin|pristinamycin|mesh-list
6446707|NCT00393744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6446708|NCT00393744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6446709|NCT00393770|Acetylcarnitine|acetylcarnitine|mesh-list
6446710|NCT00393770|Vitamin B Complex|vitamin b complex|mesh-ancestor
6446711|NCT00393770|Vitamins|vitamins|mesh-ancestor
6446712|NCT00393770|Micronutrients|micronutrients|mesh-ancestor
6446713|NCT00393770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446714|NCT00393770|Nootropic Agents|nootropic agents|mesh-ancestor
6446715|NCT00393783|Trastuzumab|trastuzumab|mesh-list
6446716|NCT00393783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6446717|NCT00393783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6446718|NCT00393835|Azithromycin|azithromycin|mesh-list
6446719|NCT00393835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6446720|NCT00393835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6446721|NCT00394056|Paroxetine|paroxetine|mesh-list
6446722|NCT00394056|Vestipitant|vestipitant|mesh-list
6446723|NCT00394056|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6446724|NCT00394056|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6582243|NCT01060930|Respiratory System Agents|respiratory system agents|mesh-ancestor
6582244|NCT01060930|Mydriatics|mydriatics|mesh-ancestor
6582245|NCT01060930|Sympathomimetics|sympathomimetics|mesh-ancestor
6582246|NCT01060930|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6582247|NCT01060930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6582248|NCT01060969|Acetazolamide|acetazolamide|mesh-list
6582249|NCT01060969|Tadalafil|tadalafil|mesh-list
5503596|NCT04457050|Antimetabolites|antimetabolites|mesh-ancestor
6020294|NCT00392665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6020295|NCT00392665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6020296|NCT00392665|Growth Substances|growth substances|mesh-ancestor
6020297|NCT00392665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020298|NCT00392665|Growth Inhibitors|growth inhibitors|mesh-ancestor
6020299|NCT00392665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6020300|NCT00392665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6446725|NCT00394056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6446726|NCT00394056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446727|NCT00394056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6446728|NCT00394056|Serotonin Agents|serotonin agents|mesh-ancestor
6446729|NCT00394056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446730|NCT00394056|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6446731|NCT00394056|Antidepressive Agents|antidepressive agents|mesh-ancestor
6446732|NCT00394056|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6446733|NCT00394056|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6446734|NCT00394056|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6446735|NCT00394056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6446736|NCT00394056|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6446737|NCT00394147|Gemcitabine|gemcitabine|mesh-list
6446738|NCT00394147|Pemetrexed|pemetrexed|mesh-list
6446739|NCT00394147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6446740|NCT00394147|Antimetabolites|antimetabolites|mesh-ancestor
6446741|NCT00394147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446742|NCT00394147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6582250|NCT01060969|Vasodilator Agents|vasodilator agents|mesh-ancestor
6582251|NCT01060969|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6582252|NCT01060969|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6446743|NCT00394147|Antiviral Agents|antiviral agents|mesh-ancestor
6446744|NCT00394147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6446745|NCT00394147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6446746|NCT00394147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6446747|NCT00394147|Immunologic Factors|immunologic factors|mesh-ancestor
6446748|NCT00394147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446749|NCT00394147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6446750|NCT00394147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6446751|NCT00394186|Solabegron|solabegron|mesh-list
6446752|NCT00394186|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6446753|NCT00394186|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6446754|NCT00394186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6582253|NCT01060969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6582254|NCT01060969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582255|NCT01060969|Urological Agents|urological agents|mesh-ancestor
6582256|NCT01060969|Anticonvulsants|anticonvulsants|mesh-ancestor
6582257|NCT01060969|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6446755|NCT00394186|Adrenergic Agents|adrenergic agents|mesh-ancestor
6582258|NCT01060969|Diuretics|diuretics|mesh-ancestor
6582259|NCT01060969|Natriuretic Agents|natriuretic agents|mesh-ancestor
6582260|NCT01060969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582261|NCT01061060|Epoprostenol|epoprostenol|mesh-list
6582262|NCT01061060|Beraprost|beraprost|mesh-list
6582263|NCT01061060|Tezosentan|tezosentan|mesh-list
6582264|NCT01061060|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6582265|NCT01061060|Vasodilator Agents|vasodilator agents|mesh-ancestor
6582266|NCT01061060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6582267|NCT01061112|Tolbutamide|tolbutamide|mesh-list
6582268|NCT01061112|Fluconazole|fluconazole|mesh-list
6582269|NCT01061112|Ketoprofen|ketoprofen|mesh-list
6582270|NCT01061112|Flurbiprofen|flurbiprofen|mesh-list
6582271|NCT01061112|Antifungal Agents|antifungal agents|mesh-ancestor
6582272|NCT01061112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6582273|NCT01061112|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6582274|NCT01061112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6582275|NCT01061112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6582276|NCT01061112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582277|NCT01061112|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6582278|NCT01061112|Hormone Antagonists|hormone antagonists|mesh-ancestor
6582279|NCT01061112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6582280|NCT01061112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582281|NCT01061112|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6582282|NCT01061112|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6582283|NCT01061112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6582284|NCT01061112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6582285|NCT01061112|Analgesics|analgesics|mesh-ancestor
6582286|NCT01061112|Sensory System Agents|sensory system agents|mesh-ancestor
6582287|NCT01061112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6582288|NCT01061112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6582289|NCT01061112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6582290|NCT01061112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6582291|NCT01061112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6582292|NCT01061190|Propranolol|propranolol|mesh-list
6582293|NCT01061190|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6582294|NCT01061190|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6582295|NCT01061190|Adrenergic Agents|adrenergic agents|mesh-ancestor
6582296|NCT01061190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6582297|NCT01061190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582298|NCT01061190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582299|NCT01061190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6582300|NCT01061190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6582301|NCT01061190|Vasodilator Agents|vasodilator agents|mesh-ancestor
6582302|NCT01061216|Insulin|insulin|mesh-list
6582303|NCT01061216|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6446756|NCT00394186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6446757|NCT00394186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446758|NCT00394186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446759|NCT00394303|Insulin|insulin|mesh-list
6446760|NCT00394303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6446761|NCT00394303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446762|NCT00394368|Fluticasone|fluticasone|mesh-list
6446763|NCT00394368|Xhance|xhance|mesh-list
6446764|NCT00394368|Beclomethasone|beclomethasone|mesh-list
6446765|NCT00394368|Formoterol Fumarate|formoterol fumarate|mesh-list
6446766|NCT00394368|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6446767|NCT00394368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6446768|NCT00394368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6446769|NCT00394368|Autonomic Agents|autonomic agents|mesh-ancestor
6446770|NCT00394368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6446771|NCT00394368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446772|NCT00394368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6446773|NCT00394368|Respiratory System Agents|respiratory system agents|mesh-ancestor
6446774|NCT00394368|Dermatologic Agents|dermatologic agents|mesh-ancestor
6446775|NCT00394368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6582304|NCT01061216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6582305|NCT01061216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582306|NCT01061268|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6582307|NCT01061268|Lubricant Eye Drops|lubricant eye drops|mesh-list
6582308|NCT01061268|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6582309|NCT01061320|Tocopherols|tocopherols|mesh-list
6582310|NCT01061320|Vitamin E|vitamin e|mesh-list
6582311|NCT01061320|Tocotrienols|tocotrienols|mesh-list
6582312|NCT01061320|alpha-Tocopherol|alpha-tocopherol|mesh-list
6582313|NCT01061320|Vitamins|vitamins|mesh-ancestor
6582314|NCT01061320|Micronutrients|micronutrients|mesh-ancestor
6582315|NCT01061320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582316|NCT01061320|Antioxidants|antioxidants|mesh-ancestor
6582317|NCT01061320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582318|NCT01061320|Protective Agents|protective agents|mesh-ancestor
6582319|NCT01061372|Pregabalin|pregabalin|mesh-list
6582320|NCT01061372|Analgesics|analgesics|mesh-ancestor
6582321|NCT01061372|Sensory System Agents|sensory system agents|mesh-ancestor
6582322|NCT01061372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6582323|NCT01061372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582324|NCT01061372|Anticonvulsants|anticonvulsants|mesh-ancestor
5724804|NCT03184870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5724805|NCT03184870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5724806|NCT03184870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5724807|NCT03184870|Immunologic Factors|immunologic factors|mesh-ancestor
5724808|NCT03184870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724809|NCT03184870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5724810|NCT03184870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5724811|NCT03184870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5724812|NCT03184870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5724813|NCT03184870|Antidotes|antidotes|mesh-ancestor
5724814|NCT03184870|Protective Agents|protective agents|mesh-ancestor
5724815|NCT03184870|Vitamin B Complex|vitamin b complex|mesh-ancestor
5724816|NCT03184870|Vitamins|vitamins|mesh-ancestor
5724817|NCT03184870|Micronutrients|micronutrients|mesh-ancestor
5724818|NCT03185130|Diphenhydramine|diphenhydramine|mesh-list
5724819|NCT03185130|Promethazine|promethazine|mesh-list
5724820|NCT03185130|Prochlorperazine|prochlorperazine|mesh-list
6582325|NCT01061372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6582326|NCT01061372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6582327|NCT01061372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582328|NCT01061372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6582329|NCT01061372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6582330|NCT01061372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6582331|NCT01061372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6582332|NCT01061372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6582333|NCT01061411|Sunitinib|sunitinib|mesh-list
6582334|NCT01061411|Dalteparin|dalteparin|mesh-list
6582335|NCT01061411|Tinzaparin|tinzaparin|mesh-list
6582336|NCT01061411|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6582337|NCT01061411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6582338|NCT01061411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6582339|NCT01061411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6582340|NCT01061411|Growth Substances|growth substances|mesh-ancestor
6582341|NCT01061411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582342|NCT01061411|Growth Inhibitors|growth inhibitors|mesh-ancestor
6582343|NCT01061411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6582344|NCT01061411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6582345|NCT01061411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582346|NCT01061411|Anticoagulants|anticoagulants|mesh-ancestor
6582347|NCT01061411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6582348|NCT01061411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6446776|NCT00394368|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6446777|NCT00394368|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6582349|NCT01061437|Lansoprazole|lansoprazole|mesh-list
6582350|NCT01061437|Dexlansoprazole|dexlansoprazole|mesh-list
6582351|NCT01061437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6582352|NCT01061437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6582353|NCT01061437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6582354|NCT01061437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6582355|NCT01061437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582356|NCT01061450|Simvastatin|simvastatin|mesh-list
6582357|NCT01061450|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6582358|NCT01061450|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6582359|NCT01061450|Antimetabolites|antimetabolites|mesh-ancestor
6582360|NCT01061450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582361|NCT01061450|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6582362|NCT01061450|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6582363|NCT01061450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6582364|NCT01061658|Vaccines|vaccines|mesh-list
6582365|NCT01061658|Immunologic Factors|immunologic factors|mesh-ancestor
6582366|NCT01061658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582367|NCT01061697|Pregabalin|pregabalin|mesh-list
6582368|NCT01061697|Analgesics|analgesics|mesh-ancestor
6582369|NCT01061697|Sensory System Agents|sensory system agents|mesh-ancestor
6582370|NCT01061697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6020301|NCT00392665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020302|NCT00392665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6020303|NCT00392665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6446778|NCT00394368|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6446779|NCT00394368|Adrenergic Agents|adrenergic agents|mesh-ancestor
6582371|NCT01061697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446780|NCT00394368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6446781|NCT00394368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446782|NCT00394368|Glucocorticoids|glucocorticoids|mesh-ancestor
6446783|NCT00394368|Hormones|hormones|mesh-ancestor
6446784|NCT00394368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6582372|NCT01061697|Anticonvulsants|anticonvulsants|mesh-ancestor
6582373|NCT01061697|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6582374|NCT01061697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6582375|NCT01061697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582376|NCT01061697|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6582377|NCT01061697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6582378|NCT01061697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6582379|NCT01061697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6582380|NCT01061697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6582381|NCT01061749|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6582382|NCT01061749|Immunologic Factors|immunologic factors|mesh-ancestor
6582383|NCT01061749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582384|NCT01061788|Everolimus|everolimus|mesh-list
6582385|NCT01061788|Panitumumab|panitumumab|mesh-list
6582386|NCT01061788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6582387|NCT01061788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6582388|NCT01061788|Immunologic Factors|immunologic factors|mesh-ancestor
6582389|NCT01061788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582390|NCT01061788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6582391|NCT01061814|Mipomersen|mipomersen|mesh-list
6582392|NCT01061814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6582393|NCT01061814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6582394|NCT01061814|Antimetabolites|antimetabolites|mesh-ancestor
6582395|NCT01061814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582396|NCT01061814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6582397|NCT01061840|Molgramostim|molgramostim|mesh-list
6582398|NCT01061840|Modafinil|modafinil|mesh-list
6582399|NCT01061840|Vaccines|vaccines|mesh-list
6582400|NCT01061840|Sargramostim|sargramostim|mesh-list
6582401|NCT01061840|Immunologic Factors|immunologic factors|mesh-ancestor
6582402|NCT01061840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582403|NCT01061840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6582404|NCT01061840|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6582405|NCT01061840|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6582406|NCT01061840|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6582407|NCT01061840|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6582408|NCT01061840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582409|NCT01061853|Sirolimus|sirolimus|mesh-list
6582410|NCT01061853|Betamethasone|betamethasone|mesh-list
6582411|NCT01061853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6582412|NCT01061853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6582413|NCT01061853|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6582414|NCT01061853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6582415|NCT01061853|Antifungal Agents|antifungal agents|mesh-ancestor
6582416|NCT01061853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6582417|NCT01061853|Immunologic Factors|immunologic factors|mesh-ancestor
6582418|NCT01061853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582419|NCT01061853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6582420|NCT01061853|Glucocorticoids|glucocorticoids|mesh-ancestor
6582421|NCT01061853|Hormones|hormones|mesh-ancestor
6582422|NCT01061853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6582423|NCT01061853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6582424|NCT01061853|Respiratory System Agents|respiratory system agents|mesh-ancestor
6582425|NCT01061996|Basiliximab|basiliximab|mesh-list
6582426|NCT01061996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6582427|NCT01061996|Immunologic Factors|immunologic factors|mesh-ancestor
6582428|NCT01061996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582429|NCT01062048|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6582430|NCT01062048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6582431|NCT01062048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582432|NCT01062048|Incretins|incretins|mesh-ancestor
6582433|NCT01062048|Hormones|hormones|mesh-ancestor
6582434|NCT01062048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6582435|NCT01062048|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6582436|NCT01062048|Protease Inhibitors|protease inhibitors|mesh-ancestor
6582437|NCT01062048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6582438|NCT01062048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582439|NCT01062087|Lidocaine|lidocaine|mesh-list
6582440|NCT01062087|Bupivacaine|bupivacaine|mesh-list
6582441|NCT01062087|Anesthetics, Local|anesthetics, local|mesh-ancestor
6582442|NCT01062087|Anesthetics|anesthetics|mesh-ancestor
6582443|NCT01062087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6582444|NCT01062087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582445|NCT01062087|Sensory System Agents|sensory system agents|mesh-ancestor
6582446|NCT01062087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6582447|NCT01062087|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6582448|NCT01062087|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6582449|NCT01062087|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6582450|NCT01062087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6582451|NCT01062087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582452|NCT01062139|Cetirizine|cetirizine|mesh-list
6582453|NCT01062139|Levocetirizine|levocetirizine|mesh-list
6582454|NCT01062139|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6582455|NCT01062139|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6582456|NCT01062139|Histamine Antagonists|histamine antagonists|mesh-ancestor
6582457|NCT01062139|Histamine Agents|histamine agents|mesh-ancestor
6582458|NCT01062139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6582459|NCT01062139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582460|NCT01062139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582461|NCT01062139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6582462|NCT01062152|Lenalidomide|lenalidomide|mesh-list
6582463|NCT01062152|Immunologic Factors|immunologic factors|mesh-ancestor
6582464|NCT01062152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582465|NCT01062152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6582466|NCT01062152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6582467|NCT01062152|Growth Substances|growth substances|mesh-ancestor
6582468|NCT01062152|Growth Inhibitors|growth inhibitors|mesh-ancestor
6582469|NCT01062152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6582470|NCT01062191|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6582471|NCT01062191|Laxatives|laxatives|mesh-ancestor
6582472|NCT01062191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6582473|NCT01062204|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6582474|NCT01062204|Laxatives|laxatives|mesh-ancestor
6582475|NCT01062204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6582476|NCT01062282|Iloprost|iloprost|mesh-list
6582477|NCT01062282|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6582478|NCT01062282|Vasodilator Agents|vasodilator agents|mesh-ancestor
6658518|NCT01481883|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6658519|NCT01481883|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6658520|NCT01482052|Vaccines|vaccines|mesh-list
6658521|NCT01482052|Immunologic Factors|immunologic factors|mesh-ancestor
6658522|NCT01482052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658523|NCT01482104|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6658524|NCT01482104|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
6658525|NCT01482104|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6658526|NCT01482104|Dermatologic Agents|dermatologic agents|mesh-ancestor
6658527|NCT01482117|Cilostazol|cilostazol|mesh-list
6658528|NCT01482117|Clopidogrel|clopidogrel|mesh-list
6658529|NCT01482117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6658530|NCT01482117|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6658531|NCT01482117|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6658532|NCT01482117|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6658533|NCT01482117|Purinergic Agents|purinergic agents|mesh-ancestor
6020304|NCT00392665|Analgesics|analgesics|mesh-ancestor
6020305|NCT00392665|Sensory System Agents|sensory system agents|mesh-ancestor
6020306|NCT00392665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6020307|NCT00392665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6446785|NCT00394394|Enalapril|enalapril|mesh-list
6446786|NCT00394394|Amiloride|amiloride|mesh-list
6446787|NCT00394394|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6446788|NCT00394394|Protease Inhibitors|protease inhibitors|mesh-ancestor
6446789|NCT00394394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6446790|NCT00394394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446791|NCT00394394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6446792|NCT00394394|Diuretics|diuretics|mesh-ancestor
6446793|NCT00394394|Natriuretic Agents|natriuretic agents|mesh-ancestor
6658534|NCT01482117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6658535|NCT01482117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658536|NCT01482117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658537|NCT01482117|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6658538|NCT01482117|Autonomic Agents|autonomic agents|mesh-ancestor
6658539|NCT01482117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6658540|NCT01482117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6658541|NCT01482117|Respiratory System Agents|respiratory system agents|mesh-ancestor
6658542|NCT01482117|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6658543|NCT01482117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6658544|NCT01482117|Vasodilator Agents|vasodilator agents|mesh-ancestor
6658545|NCT01482117|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6658546|NCT01482117|Protective Agents|protective agents|mesh-ancestor
6658547|NCT01482117|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6658548|NCT01482117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6658549|NCT01482117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6658550|NCT01482156|Everolimus|everolimus|mesh-list
6658551|NCT01482156|Dactolisib|dactolisib|mesh-list
6658552|NCT01482156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6658553|NCT01482156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6020308|NCT00392665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6582479|NCT01062360|Aspirin|aspirin|mesh-list
6582480|NCT01062360|Pseudoephedrine|pseudoephedrine|mesh-list
6582481|NCT01062360|Ephedrine|ephedrine|mesh-list
6582482|NCT01062360|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6582483|NCT01062360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6582484|NCT01062360|Analgesics|analgesics|mesh-ancestor
6582485|NCT01062360|Sensory System Agents|sensory system agents|mesh-ancestor
6582486|NCT01062360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6582487|NCT01062360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582488|NCT01062360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6582489|NCT01062360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6582490|NCT01062360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6582491|NCT01062360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6582492|NCT01062360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582493|NCT01062360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6582494|NCT01062360|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6582495|NCT01062360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6582496|NCT01062360|Antipyretics|antipyretics|mesh-ancestor
6582497|NCT01062360|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6582498|NCT01062360|Autonomic Agents|autonomic agents|mesh-ancestor
6582499|NCT01062360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6582500|NCT01062360|Respiratory System Agents|respiratory system agents|mesh-ancestor
6582501|NCT01062360|Nasal Decongestants|nasal decongestants|mesh-ancestor
6582502|NCT01062360|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6582503|NCT01062360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6582504|NCT01062360|Sympathomimetics|sympathomimetics|mesh-ancestor
6582505|NCT01062360|Adrenergic Agents|adrenergic agents|mesh-ancestor
6582506|NCT01062360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6582507|NCT01062451|Candesartan|candesartan|mesh-list
6582508|NCT01062451|Perindopril|perindopril|mesh-list
6582509|NCT01062451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6582510|NCT01062451|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6582511|NCT01062451|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6582512|NCT01062451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582513|NCT01062451|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6582514|NCT01062451|Protease Inhibitors|protease inhibitors|mesh-ancestor
6582515|NCT01062451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6582516|NCT01062477|Vaccines|vaccines|mesh-list
6582517|NCT01062477|Immunologic Factors|immunologic factors|mesh-ancestor
6582518|NCT01062477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582519|NCT01062490|Treosulfan|treosulfan|mesh-list
6582520|NCT01062490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6582521|NCT01062490|Alkylating Agents|alkylating agents|mesh-ancestor
6582522|NCT01062490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582523|NCT01062490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6582524|NCT01062503|Zoledronic Acid|zoledronic acid|mesh-list
6582525|NCT01062503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6446794|NCT00394394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446795|NCT00394394|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
6446796|NCT00394394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6446797|NCT00394394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6446798|NCT00394394|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
6446799|NCT00394394|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6446800|NCT00394407|Insulin|insulin|mesh-list
6446801|NCT00394407|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6446802|NCT00394407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6446803|NCT00394407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446804|NCT00394459|Anesthetics|anesthetics|mesh-list
6582526|NCT01062503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582527|NCT01062516|Esomeprazole|esomeprazole|mesh-list
6582528|NCT01062516|Famotidine|famotidine|mesh-list
6582529|NCT01062516|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6582530|NCT01062516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6582531|NCT01062516|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6582532|NCT01062516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6582533|NCT01062516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582534|NCT01062516|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6582535|NCT01062516|Histamine Antagonists|histamine antagonists|mesh-ancestor
6582536|NCT01062516|Histamine Agents|histamine agents|mesh-ancestor
6582537|NCT01062516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6582538|NCT01062516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582539|NCT01062529|Somatostatin|somatostatin|mesh-list
6582540|NCT01062529|Hormones|hormones|mesh-ancestor
6582541|NCT01062529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6582542|NCT01062529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582543|NCT01062633|Erythritol|erythritol|mesh-list
6582544|NCT01062633|Sorbitol|sorbitol|mesh-list
6582545|NCT01062633|Vasodilator Agents|vasodilator agents|mesh-ancestor
6582546|NCT01062633|Cathartics|cathartics|mesh-ancestor
6582547|NCT01062633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6582548|NCT01062698|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6582549|NCT01062698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6582550|NCT01062698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6582551|NCT01062698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582552|NCT01062776|Furosemide|furosemide|mesh-list
6582553|NCT01062776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6582554|NCT01062776|Diuretics|diuretics|mesh-ancestor
6582555|NCT01062776|Natriuretic Agents|natriuretic agents|mesh-ancestor
6582556|NCT01062776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582557|NCT01062776|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6582558|NCT01062776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6582559|NCT01062776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582560|NCT01062802|Atorvastatin|atorvastatin|mesh-list
6582561|NCT01062802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6582562|NCT01062802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6582563|NCT01062802|Antimetabolites|antimetabolites|mesh-ancestor
6582564|NCT01062802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582565|NCT01062802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6582566|NCT01062802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6582567|NCT01062802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6582568|NCT01062906|Lidocaine|lidocaine|mesh-list
6582569|NCT01062906|Fentanyl|fentanyl|mesh-list
6582570|NCT01062906|Anesthetics, Local|anesthetics, local|mesh-ancestor
6582571|NCT01062906|Anesthetics|anesthetics|mesh-ancestor
6582572|NCT01062906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6582573|NCT01062906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582574|NCT01062906|Sensory System Agents|sensory system agents|mesh-ancestor
6582575|NCT01062906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6582576|NCT01062906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6582577|NCT01062906|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6582578|NCT01062906|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6582579|NCT01062906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6582580|NCT01062906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582581|NCT01062906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6582582|NCT01062906|Narcotics|narcotics|mesh-ancestor
6582583|NCT01062906|Analgesics|analgesics|mesh-ancestor
6582584|NCT01062906|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6582585|NCT01062906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6582586|NCT01062906|Anesthetics, General|anesthetics, general|mesh-ancestor
6582587|NCT01062932|Cycloserine|cycloserine|mesh-list
6582588|NCT01062932|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6582589|NCT01062932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6582590|NCT01062932|Renal Agents|renal agents|mesh-ancestor
6582591|NCT01062932|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6582592|NCT01062932|Antitubercular Agents|antitubercular agents|mesh-ancestor
6582593|NCT01062932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6582594|NCT01062932|Antimetabolites|antimetabolites|mesh-ancestor
6582595|NCT01062932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582596|NCT01062945|Doxazosin|doxazosin|mesh-list
6582597|NCT01062945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6582598|NCT01062945|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6582599|NCT01062945|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6582600|NCT01062945|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6582601|NCT01062945|Adrenergic Agents|adrenergic agents|mesh-ancestor
6582602|NCT01062945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6582603|NCT01062945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582604|NCT01062945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582605|NCT01062958|Vitamins|vitamins|mesh-list
6582606|NCT01062958|Folic Acid|folic acid|mesh-list
6446805|NCT00394459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6446806|NCT00394459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446807|NCT00394485|Tiotropium Bromide|tiotropium bromide|mesh-list
6446808|NCT00394485|Procaterol|procaterol|mesh-list
6446809|NCT00394485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6446810|NCT00394485|Autonomic Agents|autonomic agents|mesh-ancestor
6446811|NCT00394485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6446812|NCT00394485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446813|NCT00394485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6446814|NCT00394485|Respiratory System Agents|respiratory system agents|mesh-ancestor
6582607|NCT01062958|Vitamin B 12|vitamin b 12|mesh-list
6582608|NCT01062958|Hydroxocobalamin|hydroxocobalamin|mesh-list
6582609|NCT01062958|Micronutrients|micronutrients|mesh-ancestor
6582610|NCT01062958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582611|NCT01062958|Hematinics|hematinics|mesh-ancestor
6582612|NCT01062958|Vitamin B Complex|vitamin b complex|mesh-ancestor
6582613|NCT01063010|Bevacizumab|bevacizumab|mesh-list
6582614|NCT01063010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6582615|NCT01063010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6582616|NCT01063010|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6582617|NCT01063010|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6582618|NCT01063010|Growth Substances|growth substances|mesh-ancestor
6582619|NCT01063010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582620|NCT01063010|Growth Inhibitors|growth inhibitors|mesh-ancestor
6582621|NCT01063023|Moxifloxacin|moxifloxacin|mesh-list
6582622|NCT01063023|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6582623|NCT01063023|Asunaprevir|asunaprevir|mesh-list
6582624|NCT01063023|Protease Inhibitors|protease inhibitors|mesh-ancestor
6582625|NCT01063023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6582626|NCT01063023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582627|NCT01063023|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6582628|NCT01063023|Contraceptive Agents|contraceptive agents|mesh-ancestor
6582629|NCT01063023|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6582630|NCT01063023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582631|NCT01063023|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6582632|NCT01063023|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6582633|NCT01063023|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6582634|NCT01063023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6582635|NCT01063023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6582636|NCT01063023|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6582637|NCT01063023|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6582638|NCT01063023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6582639|NCT01063101|Fucoidan|fucoidan|mesh-list
6582640|NCT01063101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6582641|NCT01063101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6582642|NCT01063101|Anticoagulants|anticoagulants|mesh-ancestor
6582643|NCT01063101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6582644|NCT01063127|Insulin|insulin|mesh-list
6582645|NCT01063127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6582646|NCT01063127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582647|NCT01063140|Vaccines|vaccines|mesh-list
6582648|NCT01063140|Immunologic Factors|immunologic factors|mesh-ancestor
6582649|NCT01063140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446815|NCT00394485|Parasympatholytics|parasympatholytics|mesh-ancestor
6582650|NCT01063179|Thalidomide|thalidomide|mesh-list
6582651|NCT01063179|Prednisone|prednisone|mesh-list
6582652|NCT01063179|Bortezomib|bortezomib|mesh-list
6582653|NCT01063179|Melphalan|melphalan|mesh-list
6582654|NCT01063179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6582655|NCT01063179|Glucocorticoids|glucocorticoids|mesh-ancestor
6582656|NCT01063179|Hormones|hormones|mesh-ancestor
6582657|NCT01063179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6582658|NCT01063179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582659|NCT01063179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6582660|NCT01063179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6582661|NCT01063179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6582662|NCT01063179|Alkylating Agents|alkylating agents|mesh-ancestor
6582663|NCT01063179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582664|NCT01063179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6582665|NCT01063179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6582666|NCT01063179|Immunologic Factors|immunologic factors|mesh-ancestor
6582667|NCT01063179|Leprostatic Agents|leprostatic agents|mesh-ancestor
6582668|NCT01063179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6446816|NCT00394485|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6446817|NCT00394485|Cholinergic Agents|cholinergic agents|mesh-ancestor
6446818|NCT00394485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6446819|NCT00394485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582669|NCT01063179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6582670|NCT01063179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6582671|NCT01063179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6582672|NCT01063179|Growth Substances|growth substances|mesh-ancestor
6582673|NCT01063179|Growth Inhibitors|growth inhibitors|mesh-ancestor
6582674|NCT01063192|Leucovorin|leucovorin|mesh-list
6582675|NCT01063192|Gemcitabine|gemcitabine|mesh-list
6582676|NCT01063192|Fluorouracil|fluorouracil|mesh-list
6582677|NCT01063192|Oxaliplatin|oxaliplatin|mesh-list
6582678|NCT01063192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6582679|NCT01063192|Antimetabolites|antimetabolites|mesh-ancestor
6582680|NCT01063192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582681|NCT01063192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6582682|NCT01063192|Antiviral Agents|antiviral agents|mesh-ancestor
6582683|NCT01063192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6582684|NCT01063192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6582685|NCT01063192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6582686|NCT01063192|Immunologic Factors|immunologic factors|mesh-ancestor
6582687|NCT01063192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582688|NCT01063192|Antidotes|antidotes|mesh-ancestor
6582689|NCT01063192|Protective Agents|protective agents|mesh-ancestor
6582690|NCT01063192|Vitamin B Complex|vitamin b complex|mesh-ancestor
6446820|NCT00394485|Sympathomimetics|sympathomimetics|mesh-ancestor
6446821|NCT00394485|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6446822|NCT00394485|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6446823|NCT00394485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6446824|NCT00394485|Adrenergic Agents|adrenergic agents|mesh-ancestor
6446825|NCT00394498|Sargramostim|sargramostim|mesh-list
6446826|NCT00394498|Lenograstim|lenograstim|mesh-list
6446827|NCT00394498|Immunologic Factors|immunologic factors|mesh-ancestor
6446828|NCT00394498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446829|NCT00394498|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6446830|NCT00394537|Labetalol|labetalol|mesh-list
6582691|NCT01063192|Vitamins|vitamins|mesh-ancestor
6582692|NCT01063192|Micronutrients|micronutrients|mesh-ancestor
6582693|NCT01063205|Acetylcysteine|acetylcysteine|mesh-list
6582694|NCT01063205|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6582695|NCT01063205|Antiviral Agents|antiviral agents|mesh-ancestor
6582696|NCT01063205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6582697|NCT01063205|Expectorants|expectorants|mesh-ancestor
6582698|NCT01063205|Respiratory System Agents|respiratory system agents|mesh-ancestor
6582699|NCT01063205|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6582700|NCT01063205|Antioxidants|antioxidants|mesh-ancestor
6582701|NCT01063205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582702|NCT01063205|Protective Agents|protective agents|mesh-ancestor
6582703|NCT01063205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582704|NCT01063205|Antidotes|antidotes|mesh-ancestor
6582705|NCT01063218|Emollients|emollients|mesh-list
6582706|NCT01063218|Dermatologic Agents|dermatologic agents|mesh-ancestor
6582707|NCT01063257|Clofarabine|clofarabine|mesh-list
6582708|NCT01063257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6582709|NCT01063257|Antimetabolites|antimetabolites|mesh-ancestor
6582710|NCT01063257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582711|NCT01063257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6582712|NCT01063270|Rifampin|rifampin|mesh-list
6582713|NCT01063270|Clindamycin|clindamycin|mesh-list
6582714|NCT01063270|Clindamycin palmitate|clindamycin palmitate|mesh-list
6582715|NCT01063270|Clindamycin phosphate|clindamycin phosphate|mesh-list
6582716|NCT01063270|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6582717|NCT01063270|Antitubercular Agents|antitubercular agents|mesh-ancestor
6582718|NCT01063270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6582719|NCT01063270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6582720|NCT01063270|Leprostatic Agents|leprostatic agents|mesh-ancestor
6582721|NCT01063270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6582722|NCT01063270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6582723|NCT01063270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582724|NCT01063270|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6582725|NCT01063270|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6582726|NCT01063270|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6582727|NCT01063270|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6582728|NCT01063270|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6582729|NCT01063270|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6582730|NCT01063270|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6582731|NCT01063426|Enoxaparin|enoxaparin|mesh-list
6582732|NCT01063426|Enoxaparin sodium|enoxaparin sodium|mesh-list
6582733|NCT01063426|Atorvastatin|atorvastatin|mesh-list
6582734|NCT01063426|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6582735|NCT01063426|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5501538|NCT04473261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5501539|NCT04473261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5501540|NCT04473261|Trace Elements|trace elements|mesh-ancestor
5501541|NCT04473261|Micronutrients|micronutrients|mesh-ancestor
5501542|NCT04473261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501543|NCT04473053|Nafamostat|nafamostat|mesh-list
5501544|NCT04473053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5501545|NCT04473053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5501546|NCT04473053|Analgesics|analgesics|mesh-ancestor
6582736|NCT01063426|Antimetabolites|antimetabolites|mesh-ancestor
6582737|NCT01063426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582738|NCT01063426|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6582739|NCT01063426|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6582740|NCT01063426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5501547|NCT04473053|Sensory System Agents|sensory system agents|mesh-ancestor
5501548|NCT04473053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6020309|NCT00392665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6020310|NCT00392678|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
6582741|NCT01063426|Anticoagulants|anticoagulants|mesh-ancestor
6582742|NCT01063426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6582743|NCT01063426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6582744|NCT01063439|Cytarabine|cytarabine|mesh-list
6582745|NCT01063439|Etoposide|etoposide|mesh-list
6582746|NCT01063439|Melphalan|melphalan|mesh-list
6582747|NCT01063439|Busulfan|busulfan|mesh-list
6582748|NCT01063439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6582749|NCT01063439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6582750|NCT01063439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6582751|NCT01063439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6582752|NCT01063439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6582753|NCT01063439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582754|NCT01063439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6582755|NCT01063439|Antimetabolites|antimetabolites|mesh-ancestor
6582756|NCT01063439|Antiviral Agents|antiviral agents|mesh-ancestor
6446831|NCT00394537|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6446832|NCT00394537|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6446833|NCT00394537|Adrenergic Agents|adrenergic agents|mesh-ancestor
6446834|NCT00394537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6446835|NCT00394537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446836|NCT00394537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446837|NCT00394537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6446838|NCT00394537|Sympathomimetics|sympathomimetics|mesh-ancestor
6446839|NCT00394537|Autonomic Agents|autonomic agents|mesh-ancestor
6446840|NCT00394537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6446841|NCT00394537|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6020311|NCT00392678|Sodium Salicylate|sodium salicylate|mesh-list
6020312|NCT00392678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6020313|NCT00392678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6020314|NCT00392678|Analgesics|analgesics|mesh-ancestor
6020315|NCT00392678|Sensory System Agents|sensory system agents|mesh-ancestor
6020316|NCT00392678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6020317|NCT00392678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020318|NCT00392678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6020319|NCT00392678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6020320|NCT00392678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6020321|NCT00392678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6582757|NCT01063439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6582758|NCT01063439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6582759|NCT01063439|Immunologic Factors|immunologic factors|mesh-ancestor
6582760|NCT01063439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582761|NCT01063439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6582762|NCT01063439|Alkylating Agents|alkylating agents|mesh-ancestor
6582763|NCT01063439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6582764|NCT01063478|Everolimus|everolimus|mesh-list
6582765|NCT01063478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6582766|NCT01063478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6582767|NCT01063478|Immunologic Factors|immunologic factors|mesh-ancestor
6582768|NCT01063478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582769|NCT01063504|Teriparatide|teriparatide|mesh-list
6582770|NCT01063504|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6582771|NCT01063504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582772|NCT01063504|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6582773|NCT01063530|Fluorides|fluorides|mesh-list
6582774|NCT01063530|Cariostatic Agents|cariostatic agents|mesh-ancestor
6582775|NCT01063530|Protective Agents|protective agents|mesh-ancestor
6582776|NCT01063530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582777|NCT01063556|Donepezil|donepezil|mesh-list
6582778|NCT01063556|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6582779|NCT01063556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6582780|NCT01063556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582781|NCT01063556|Cholinergic Agents|cholinergic agents|mesh-ancestor
6582782|NCT01063556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6582783|NCT01063556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582784|NCT01063556|Nootropic Agents|nootropic agents|mesh-ancestor
6582785|NCT01063569|Hydrocortisone|hydrocortisone|mesh-list
6582786|NCT01063569|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6582787|NCT01063569|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6582788|NCT01063569|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6582789|NCT01063569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6582790|NCT01063621|Apomorphine|apomorphine|mesh-list
6582791|NCT01063621|Emetics|emetics|mesh-ancestor
6582792|NCT01063621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582793|NCT01063621|Autonomic Agents|autonomic agents|mesh-ancestor
6582794|NCT01063621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6582795|NCT01063621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6582796|NCT01063621|Dopamine Agonists|dopamine agonists|mesh-ancestor
6582797|NCT01063621|Dopamine Agents|dopamine agents|mesh-ancestor
6582798|NCT01063621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6582799|NCT01063621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582800|NCT01063647|Treosulfan|treosulfan|mesh-list
6582801|NCT01063647|Busulfan|busulfan|mesh-list
6582802|NCT01063647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6582803|NCT01063647|Alkylating Agents|alkylating agents|mesh-ancestor
6582804|NCT01063647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582805|NCT01063647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6582806|NCT01063647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6582807|NCT01063647|Immunologic Factors|immunologic factors|mesh-ancestor
6582808|NCT01063647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582809|NCT01063647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6582810|NCT01063660|Treosulfan|treosulfan|mesh-list
6582811|NCT01063660|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6582812|NCT01063660|Alkylating Agents|alkylating agents|mesh-ancestor
6582813|NCT01063660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582814|NCT01063660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6582815|NCT01063816|Gemcitabine|gemcitabine|mesh-list
6582816|NCT01063816|Carboplatin|carboplatin|mesh-list
6582817|NCT01063816|Veliparib|veliparib|mesh-list
6582818|NCT01063816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6582819|NCT01063816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6582820|NCT01063816|Antimetabolites|antimetabolites|mesh-ancestor
6582821|NCT01063816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582822|NCT01063816|Antiviral Agents|antiviral agents|mesh-ancestor
6582823|NCT01063816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6582824|NCT01063816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6582825|NCT01063816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6582826|NCT01063816|Immunologic Factors|immunologic factors|mesh-ancestor
6582827|NCT01063816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582828|NCT01063816|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6582829|NCT01063842|Acetaminophen|acetaminophen|mesh-list
6582830|NCT01063842|Tramadol|tramadol|mesh-list
6582831|NCT01063842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6582832|NCT01063842|Analgesics|analgesics|mesh-ancestor
6582833|NCT01063842|Sensory System Agents|sensory system agents|mesh-ancestor
6582834|NCT01063842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6582835|NCT01063842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582836|NCT01063842|Antipyretics|antipyretics|mesh-ancestor
6582837|NCT01063842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6582838|NCT01063842|Narcotics|narcotics|mesh-ancestor
6582839|NCT01063842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6582840|NCT01063920|Naproxen|naproxen|mesh-list
6582841|NCT01063920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6582842|NCT01063920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6582843|NCT01063920|Analgesics|analgesics|mesh-ancestor
6582844|NCT01063920|Sensory System Agents|sensory system agents|mesh-ancestor
6582845|NCT01063920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6582846|NCT01063920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582847|NCT01063920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6582848|NCT01063920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6582849|NCT01063920|Gout Suppressants|gout suppressants|mesh-ancestor
6582850|NCT01063920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6582851|NCT01063920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6582852|NCT01063920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582853|NCT01063933|Peramivir|peramivir|mesh-list
6582854|NCT01063933|Antiviral Agents|antiviral agents|mesh-ancestor
6582855|NCT01063933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6582856|NCT01063933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6582857|NCT01063933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658554|NCT01482156|Immunologic Factors|immunologic factors|mesh-ancestor
6658555|NCT01482156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658556|NCT01482286|Metformin|metformin|mesh-list
6658557|NCT01482286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6658558|NCT01482286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658559|NCT01482299|Everolimus|everolimus|mesh-list
6658560|NCT01482299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6658561|NCT01482299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6658562|NCT01482299|Immunologic Factors|immunologic factors|mesh-ancestor
6658563|NCT01482299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658564|NCT01482338|Drospirenone|drospirenone|mesh-list
6658565|NCT01482338|Desogestrel|desogestrel|mesh-list
6658566|NCT01482338|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6658567|NCT01482338|Hormone Antagonists|hormone antagonists|mesh-ancestor
6658568|NCT01482338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6658569|NCT01482338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658570|NCT01482338|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6658571|NCT01482338|Diuretics|diuretics|mesh-ancestor
6658572|NCT01482338|Natriuretic Agents|natriuretic agents|mesh-ancestor
6658573|NCT01482338|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6658574|NCT01482338|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6658575|NCT01482338|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6658576|NCT01482338|Contraceptive Agents|contraceptive agents|mesh-ancestor
6658577|NCT01482338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6658578|NCT01482338|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6658579|NCT01482338|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6658580|NCT01482338|Progestins|progestins|mesh-ancestor
6658581|NCT01482338|Hormones|hormones|mesh-ancestor
6658582|NCT01482377|Cetuximab|cetuximab|mesh-list
6658583|NCT01482377|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6658584|NCT01482377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6658585|NCT01482377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6658586|NCT01482377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6658587|NCT01482377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6658588|NCT01482377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658589|NCT01482416|Estrogens|estrogens|mesh-list
6658590|NCT01482416|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6658591|NCT01482416|Hormones|hormones|mesh-ancestor
6658592|NCT01482416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6582858|NCT01064102|Cetirizine|cetirizine|mesh-list
6582859|NCT01064102|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6582860|NCT01064102|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6582861|NCT01064102|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6582862|NCT01064102|Histamine Antagonists|histamine antagonists|mesh-ancestor
6582863|NCT01064102|Histamine Agents|histamine agents|mesh-ancestor
6582864|NCT01064102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6582865|NCT01064102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582866|NCT01064102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582867|NCT01064115|Cetirizine|cetirizine|mesh-list
6582868|NCT01064115|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6582869|NCT01064115|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6582870|NCT01064115|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6582871|NCT01064115|Histamine Antagonists|histamine antagonists|mesh-ancestor
6582872|NCT01064115|Histamine Agents|histamine agents|mesh-ancestor
6582873|NCT01064115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6582874|NCT01064115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582875|NCT01064115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582876|NCT01064141|Vaccines|vaccines|mesh-list
6582877|NCT01064141|Immunologic Factors|immunologic factors|mesh-ancestor
6582878|NCT01064141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582879|NCT01064154|Carvedilol|carvedilol|mesh-list
6582880|NCT01064154|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6582881|NCT01064154|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6582882|NCT01064154|Adrenergic Agents|adrenergic agents|mesh-ancestor
6582883|NCT01064154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6582884|NCT01064154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582885|NCT01064154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582886|NCT01064154|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6582887|NCT01064154|Antioxidants|antioxidants|mesh-ancestor
6582888|NCT01064154|Protective Agents|protective agents|mesh-ancestor
6582889|NCT01064154|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6582890|NCT01064154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6582891|NCT01064154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6582892|NCT01064154|Vasodilator Agents|vasodilator agents|mesh-ancestor
6582893|NCT01064154|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6582894|NCT01064154|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6582895|NCT01064180|Carvedilol|carvedilol|mesh-list
6582896|NCT01064180|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6582897|NCT01064180|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6582898|NCT01064180|Adrenergic Agents|adrenergic agents|mesh-ancestor
6582899|NCT01064180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6582900|NCT01064180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582901|NCT01064180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582902|NCT01064180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6582903|NCT01064180|Antioxidants|antioxidants|mesh-ancestor
6582904|NCT01064180|Protective Agents|protective agents|mesh-ancestor
6582905|NCT01064180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6582906|NCT01064180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6582907|NCT01064180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6582908|NCT01064180|Vasodilator Agents|vasodilator agents|mesh-ancestor
6582909|NCT01064180|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6582910|NCT01064180|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6582911|NCT01064219|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6582912|NCT01064219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6582913|NCT01064219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582914|NCT01064232|Risperidone|risperidone|mesh-list
6582915|NCT01064232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6582916|NCT01064232|Serotonin Agents|serotonin agents|mesh-ancestor
6582917|NCT01064232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6582918|NCT01064232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582919|NCT01064232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582920|NCT01064232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6582921|NCT01064232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6582922|NCT01064232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6582923|NCT01064232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6582924|NCT01064232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6582925|NCT01064232|Dopamine Agents|dopamine agents|mesh-ancestor
6582943|NCT01064271|Risperidone|risperidone|mesh-list
6582944|NCT01064271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6582945|NCT01064271|Serotonin Agents|serotonin agents|mesh-ancestor
6582946|NCT01064271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6582947|NCT01064271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582948|NCT01064271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582949|NCT01064271|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6582950|NCT01064271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6582951|NCT01064271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6582952|NCT01064271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6582953|NCT01064271|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6582954|NCT01064271|Dopamine Agents|dopamine agents|mesh-ancestor
6582955|NCT01064349|Trastuzumab|trastuzumab|mesh-list
6582956|NCT01064349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6582957|NCT01064349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6582958|NCT01064375|Cyclophosphamide|cyclophosphamide|mesh-list
6582959|NCT01064375|Molgramostim|molgramostim|mesh-list
6582960|NCT01064375|Sargramostim|sargramostim|mesh-list
6582961|NCT01064375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6582962|NCT01064375|Immunologic Factors|immunologic factors|mesh-ancestor
6582963|NCT01064375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582964|NCT01064375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6582965|NCT01064375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6582966|NCT01064375|Alkylating Agents|alkylating agents|mesh-ancestor
6582967|NCT01064375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582968|NCT01064375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6582969|NCT01064375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6582970|NCT01064453|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
6582971|NCT01064453|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6582972|NCT01064453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6582973|NCT01064466|Etoposide|etoposide|mesh-list
6582974|NCT01064466|Etoposide phosphate|etoposide phosphate|mesh-list
6582975|NCT01064466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6582976|NCT01064466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6582977|NCT01064466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6582978|NCT01064466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6582979|NCT01064466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6582980|NCT01064466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582981|NCT01064557|Tretinoin|tretinoin|mesh-list
6582982|NCT01064557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6582983|NCT01064557|Keratolytic Agents|keratolytic agents|mesh-ancestor
6582984|NCT01064557|Dermatologic Agents|dermatologic agents|mesh-ancestor
6582985|NCT01064570|Tretinoin|tretinoin|mesh-list
6582986|NCT01064570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6582987|NCT01064570|Keratolytic Agents|keratolytic agents|mesh-ancestor
6582988|NCT01064570|Dermatologic Agents|dermatologic agents|mesh-ancestor
6582989|NCT01064635|Letrozole|letrozole|mesh-list
6582990|NCT01064635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6582991|NCT01064635|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6582992|NCT01064635|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6582993|NCT01064635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6582994|NCT01064635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6582995|NCT01064635|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6446842|NCT00394537|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6446843|NCT00394628|Temozolomide|temozolomide|mesh-list
6446844|NCT00394628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6446845|NCT00394628|Alkylating Agents|alkylating agents|mesh-ancestor
6446846|NCT00394628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446847|NCT00394628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6446848|NCT00394693|Interferons|interferons|mesh-list
6446849|NCT00394693|Interferon-gamma|interferon-gamma|mesh-list
6446850|NCT00394693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6446851|NCT00394693|Antiviral Agents|antiviral agents|mesh-ancestor
6582996|NCT01064635|Hormone Antagonists|hormone antagonists|mesh-ancestor
6582997|NCT01064635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6582998|NCT01064635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446852|NCT00394693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6446853|NCT00394745|Valsartan|valsartan|mesh-list
6582999|NCT01064726|Fluticasone|fluticasone|mesh-list
6583000|NCT01064726|Xhance|xhance|mesh-list
6583001|NCT01064726|Ibuprofen|ibuprofen|mesh-list
6583002|NCT01064726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6446854|NCT00394745|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6583003|NCT01064726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6583004|NCT01064726|Autonomic Agents|autonomic agents|mesh-ancestor
6583005|NCT01064726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6583006|NCT01064726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583007|NCT01064726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6583008|NCT01064726|Respiratory System Agents|respiratory system agents|mesh-ancestor
6583009|NCT01064726|Dermatologic Agents|dermatologic agents|mesh-ancestor
6583010|NCT01064726|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6583011|NCT01064726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6583012|NCT01064726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6583013|NCT01064726|Analgesics|analgesics|mesh-ancestor
6583014|NCT01064726|Sensory System Agents|sensory system agents|mesh-ancestor
6583015|NCT01064726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6583016|NCT01064726|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6583017|NCT01064726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6583018|NCT01064726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583019|NCT01064752|Minocycline|minocycline|mesh-list
6583020|NCT01064752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6583021|NCT01064752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6583022|NCT01064921|Vorinostat|vorinostat|mesh-list
6583023|NCT01064921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6583024|NCT01064921|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6583025|NCT01064921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6583026|NCT01064921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583027|NCT01064973|Baclofen|baclofen|mesh-list
6446855|NCT00394745|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6446856|NCT00394745|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6446857|NCT00394745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446858|NCT00394810|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
6446859|NCT00394810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6446860|NCT00394810|Tubulin Modulators|tubulin modulators|mesh-ancestor
6446861|NCT00394810|Antimitotic Agents|antimitotic agents|mesh-ancestor
6446862|NCT00394810|Mitosis Modulators|mitosis modulators|mesh-ancestor
6446863|NCT00394810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461788|NCT00456235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6461789|NCT00456235|Immunologic Factors|immunologic factors|mesh-ancestor
6461790|NCT00456235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461791|NCT00456235|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6461792|NCT00456235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6461793|NCT00456235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461794|NCT00456235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6461795|NCT00456235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6583028|NCT01064973|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6583029|NCT01064973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583030|NCT01064973|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6583031|NCT01064973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6583032|NCT01064973|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6583033|NCT01064973|GABA Agonists|gaba agonists|mesh-ancestor
6583034|NCT01064973|GABA Agents|gaba agents|mesh-ancestor
6583035|NCT01064973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6583036|NCT01064973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583037|NCT01064986|Hydrocortisone|hydrocortisone|mesh-list
6583038|NCT01064986|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6583039|NCT01064986|Epinephrine|epinephrine|mesh-list
6583040|NCT01064986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6583041|NCT01064986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6583042|NCT01064986|Adrenergic Agents|adrenergic agents|mesh-ancestor
6583043|NCT01064986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6583044|NCT01064986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583045|NCT01064986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583046|NCT01064986|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6583047|NCT01064986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6583048|NCT01064986|Autonomic Agents|autonomic agents|mesh-ancestor
6583049|NCT01064986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6583050|NCT01064986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6583051|NCT01064986|Respiratory System Agents|respiratory system agents|mesh-ancestor
6583052|NCT01064986|Mydriatics|mydriatics|mesh-ancestor
6583053|NCT01064986|Sympathomimetics|sympathomimetics|mesh-ancestor
6583054|NCT01064986|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6583055|NCT01064986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6583056|NCT01064999|Capecitabine|capecitabine|mesh-list
6583057|NCT01064999|Oxaliplatin|oxaliplatin|mesh-list
6583058|NCT01064999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6583059|NCT01064999|Antimetabolites|antimetabolites|mesh-ancestor
6583060|NCT01064999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583061|NCT01064999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6583062|NCT01065038|Hydroxyurea|hydroxyurea|mesh-list
6583063|NCT01065038|Anagrelide|anagrelide|mesh-list
6583064|NCT01065038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6583065|NCT01065038|Antisickling Agents|antisickling agents|mesh-ancestor
6583066|NCT01065038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6583067|NCT01065038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583068|NCT01065038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6583069|NCT01065038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6583070|NCT01065038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6583071|NCT01065038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6583072|NCT01065116|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6583073|NCT01065116|Antimalarials|antimalarials|mesh-ancestor
6583074|NCT01065116|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6583075|NCT01065116|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6583076|NCT01065116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6583077|NCT01065129|Plerixafor|plerixafor|mesh-list
6583078|NCT01065129|Azacitidine|azacitidine|mesh-list
6583079|NCT01065129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6583080|NCT01065129|Antimetabolites|antimetabolites|mesh-ancestor
6583081|NCT01065129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583082|NCT01065129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6583083|NCT01065129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6583084|NCT01065129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6583085|NCT01065129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6583086|NCT01065129|Antiviral Agents|antiviral agents|mesh-ancestor
6583087|NCT01065129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6583088|NCT01065194|Simendan|simendan|mesh-list
6583089|NCT01065194|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6583090|NCT01065194|Vasodilator Agents|vasodilator agents|mesh-ancestor
6583091|NCT01065194|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6583092|NCT01065194|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6583093|NCT01065194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6583094|NCT01065194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583095|NCT01065194|Protective Agents|protective agents|mesh-ancestor
6583096|NCT01065194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583097|NCT01065220|Cyproterone Acetate|cyproterone acetate|mesh-list
6583098|NCT01065220|Testolactone|testolactone|mesh-list
6583099|NCT01065220|Lynestrenol|lynestrenol|mesh-list
6583100|NCT01065220|Estradiol|estradiol|mesh-list
6583101|NCT01065220|Cyproterone|cyproterone|mesh-list
6583102|NCT01065220|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
6583103|NCT01065220|Estrogens|estrogens|mesh-ancestor
6583104|NCT01065220|Hormones|hormones|mesh-ancestor
6583105|NCT01065220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6583106|NCT01065220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583107|NCT01065220|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6583108|NCT01065220|Contraceptive Agents|contraceptive agents|mesh-ancestor
6583109|NCT01065220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6583110|NCT01065220|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6583111|NCT01065220|Androgen Antagonists|androgen antagonists|mesh-ancestor
6583112|NCT01065220|Hormone Antagonists|hormone antagonists|mesh-ancestor
6583113|NCT01065220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6583114|NCT01065220|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6583115|NCT01065220|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6583116|NCT01065220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6583117|NCT01065220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583118|NCT01065220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6583119|NCT01065220|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6583120|NCT01065220|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6583121|NCT01065220|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6583122|NCT01065246|Catumaxomab|catumaxomab|mesh-list
6583123|NCT01065246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6583124|NCT01065259|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6583125|NCT01065259|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6583126|NCT01065259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6583127|NCT01065259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6583128|NCT01065259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583129|NCT01065259|Adrenergic Agents|adrenergic agents|mesh-ancestor
6583130|NCT01065259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6583131|NCT01065259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583132|NCT01065272|Dexamethasone|dexamethasone|mesh-list
6583133|NCT01065272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6583134|NCT01065272|Antiemetics|antiemetics|mesh-ancestor
6583135|NCT01065272|Autonomic Agents|autonomic agents|mesh-ancestor
6583136|NCT01065272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6583137|NCT01065272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583138|NCT01065272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6583139|NCT01065272|Glucocorticoids|glucocorticoids|mesh-ancestor
6583140|NCT01065272|Hormones|hormones|mesh-ancestor
6020322|NCT00392678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020323|NCT00392704|Paclitaxel|paclitaxel|mesh-list
6583141|NCT01065272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6583142|NCT01065272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6583143|NCT01065272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6583144|NCT01065285|Vaccines|vaccines|mesh-list
6583145|NCT01065285|Immunologic Factors|immunologic factors|mesh-ancestor
6583146|NCT01065285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583147|NCT01065376|Cabergoline|cabergoline|mesh-list
6583148|NCT01065376|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6583149|NCT01065376|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6583150|NCT01065376|Dopamine Agonists|dopamine agonists|mesh-ancestor
6583151|NCT01065376|Dopamine Agents|dopamine agents|mesh-ancestor
6583152|NCT01065376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6583153|NCT01065376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583154|NCT01065376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583155|NCT01065467|Panobinostat|panobinostat|mesh-list
6583156|NCT01065467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6583157|NCT01065467|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6583158|NCT01065467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6583159|NCT01065467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583160|NCT01065519|Umirolimus|umirolimus|mesh-list
6583161|NCT01065519|Everolimus|everolimus|mesh-list
6583162|NCT01065519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6583163|NCT01065519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6583164|NCT01065519|Immunologic Factors|immunologic factors|mesh-ancestor
6583165|NCT01065519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583166|NCT01065519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6583167|NCT01065532|Paclitaxel|paclitaxel|mesh-list
6583168|NCT01065532|Everolimus|everolimus|mesh-list
6583169|NCT01065532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6583170|NCT01065532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6583171|NCT01065532|Tubulin Modulators|tubulin modulators|mesh-ancestor
6583172|NCT01065532|Antimitotic Agents|antimitotic agents|mesh-ancestor
6583173|NCT01065532|Mitosis Modulators|mitosis modulators|mesh-ancestor
6583174|NCT01065532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583175|NCT01065532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6583176|NCT01065532|Immunologic Factors|immunologic factors|mesh-ancestor
6583177|NCT01065532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583178|NCT01065545|Clofarabine|clofarabine|mesh-list
6583179|NCT01065545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6583180|NCT01065545|Antimetabolites|antimetabolites|mesh-ancestor
6583181|NCT01065545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583182|NCT01065545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6583183|NCT01065610|Oxytocin|oxytocin|mesh-list
6583184|NCT01065610|Oxytocics|oxytocics|mesh-ancestor
6583185|NCT01065610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6583186|NCT01065610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583187|NCT01065649|Nortriptyline|nortriptyline|mesh-list
6583188|NCT01065649|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6583189|NCT01065649|Antidepressive Agents|antidepressive agents|mesh-ancestor
6583190|NCT01065649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6583191|NCT01065649|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6583192|NCT01065649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6583193|NCT01065649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6583194|NCT01065649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583195|NCT01065649|Adrenergic Agents|adrenergic agents|mesh-ancestor
6583196|NCT01065649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6583197|NCT01065649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583198|NCT01065662|Sirolimus|sirolimus|mesh-list
6583199|NCT01065662|Cediranib|cediranib|mesh-list
6583200|NCT01065662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6583201|NCT01065662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6583202|NCT01065662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6583203|NCT01065662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6583204|NCT01065662|Antifungal Agents|antifungal agents|mesh-ancestor
6583205|NCT01065662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6583206|NCT01065662|Immunologic Factors|immunologic factors|mesh-ancestor
6583207|NCT01065662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583208|NCT01065662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6583209|NCT01065662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6583210|NCT01065662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583211|NCT01065701|Dexmedetomidine|dexmedetomidine|mesh-list
6583212|NCT01065701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6583213|NCT01065701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6583214|NCT01065701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583215|NCT01065701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6583216|NCT01065701|Analgesics|analgesics|mesh-ancestor
6583217|NCT01065701|Sensory System Agents|sensory system agents|mesh-ancestor
6583218|NCT01065701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6583219|NCT01065701|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6583220|NCT01065701|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6583221|NCT01065701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6583222|NCT01065701|Adrenergic Agents|adrenergic agents|mesh-ancestor
6583223|NCT01065701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6583224|NCT01065701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583225|NCT01065727|Mitoxantrone|mitoxantrone|mesh-list
6583226|NCT01065727|Natalizumab|natalizumab|mesh-list
6583227|NCT01065727|Immunologic Factors|immunologic factors|mesh-list
6583228|NCT01065727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
6583229|NCT01065727|Analgesics|analgesics|mesh-ancestor
6583230|NCT01065727|Sensory System Agents|sensory system agents|mesh-ancestor
6583231|NCT01065727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6583232|NCT01065727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583233|NCT01065727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6583234|NCT01065727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6583235|NCT01065727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6583236|NCT01065727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6583237|NCT01065727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583238|NCT01065805|Alovudine|alovudine|mesh-list
6583239|NCT01065805|Antiviral Agents|antiviral agents|mesh-ancestor
6583240|NCT01065805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6658593|NCT01482416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658594|NCT01482442|Sorafenib|sorafenib|mesh-list
6658595|NCT01482442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6658596|NCT01482442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6658597|NCT01482442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6658598|NCT01482442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658599|NCT01482468|Palonosetron|palonosetron|mesh-list
6658600|NCT01482468|Antiemetics|antiemetics|mesh-ancestor
6658601|NCT01482468|Autonomic Agents|autonomic agents|mesh-ancestor
6658602|NCT01482468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6658603|NCT01482468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658604|NCT01482468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6658605|NCT01482468|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6658606|NCT01482468|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6658607|NCT01482468|Serotonin Agents|serotonin agents|mesh-ancestor
6658608|NCT01482468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6658609|NCT01482468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658610|NCT01482559|Dopamine|dopamine|mesh-list
6658611|NCT01482559|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6658612|NCT01482559|Sympathomimetics|sympathomimetics|mesh-ancestor
6658613|NCT01482559|Autonomic Agents|autonomic agents|mesh-ancestor
6658614|NCT01482559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6658615|NCT01482559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658616|NCT01482559|Dopamine Agents|dopamine agents|mesh-ancestor
6658617|NCT01482559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6664834|NCT01514227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583241|NCT01065857|Picosulfate sodium|picosulfate sodium|mesh-list
6583242|NCT01065857|Sodium sulfate|sodium sulfate|mesh-list
6583243|NCT01065857|Magnesium Oxide|magnesium oxide|mesh-list
6583244|NCT01065857|Citric Acid|citric acid|mesh-list
6583245|NCT01065857|Sodium Citrate|sodium citrate|mesh-list
6583246|NCT01065857|Anticoagulants|anticoagulants|mesh-ancestor
6583247|NCT01065857|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6583248|NCT01065857|Chelating Agents|chelating agents|mesh-ancestor
6583249|NCT01065857|Sequestering Agents|sequestering agents|mesh-ancestor
6583250|NCT01065857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583251|NCT01065857|Cathartics|cathartics|mesh-ancestor
6583252|NCT01065857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6583253|NCT01065857|Antacids|antacids|mesh-ancestor
6583254|NCT01065870|Gemcitabine|gemcitabine|mesh-list
6583255|NCT01065870|Capecitabine|capecitabine|mesh-list
6583256|NCT01065870|Docetaxel|docetaxel|mesh-list
6583257|NCT01065870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6583258|NCT01065870|Antimetabolites|antimetabolites|mesh-ancestor
6583259|NCT01065870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583260|NCT01065870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6583261|NCT01065870|Antiviral Agents|antiviral agents|mesh-ancestor
6583262|NCT01065870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6583263|NCT01065870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6583264|NCT01065870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6583265|NCT01065870|Immunologic Factors|immunologic factors|mesh-ancestor
6583266|NCT01065870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583267|NCT01065870|Tubulin Modulators|tubulin modulators|mesh-ancestor
6583268|NCT01065870|Antimitotic Agents|antimitotic agents|mesh-ancestor
6583269|NCT01065870|Mitosis Modulators|mitosis modulators|mesh-ancestor
6583270|NCT01065961|Dexamethasone|dexamethasone|mesh-list
6583271|NCT01065961|Dexamethasone acetate|dexamethasone acetate|mesh-list
6583272|NCT01065961|BB 1101|bb 1101|mesh-list
6583273|NCT01065961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6583274|NCT01065961|Antiemetics|antiemetics|mesh-ancestor
6583275|NCT01065961|Autonomic Agents|autonomic agents|mesh-ancestor
6583276|NCT01065961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6583277|NCT01065961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583278|NCT01065961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6583279|NCT01065961|Glucocorticoids|glucocorticoids|mesh-ancestor
6583280|NCT01065961|Hormones|hormones|mesh-ancestor
6583281|NCT01065961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6583282|NCT01065961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6583283|NCT01065961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6583284|NCT01065961|Protease Inhibitors|protease inhibitors|mesh-ancestor
6583285|NCT01065961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6583286|NCT01065961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583287|NCT01065987|Tizanidine|tizanidine|mesh-list
6583288|NCT01065987|Analgesics|analgesics|mesh-ancestor
6583289|NCT01065987|Sensory System Agents|sensory system agents|mesh-ancestor
6583290|NCT01065987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6583291|NCT01065987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583292|NCT01065987|Anticonvulsants|anticonvulsants|mesh-ancestor
6583293|NCT01065987|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6583294|NCT01065987|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6583295|NCT01065987|Parasympatholytics|parasympatholytics|mesh-ancestor
6583296|NCT01065987|Autonomic Agents|autonomic agents|mesh-ancestor
6583297|NCT01065987|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6583298|NCT01065987|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6583299|NCT01065987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6583300|NCT01065987|Adrenergic Agents|adrenergic agents|mesh-ancestor
6583301|NCT01065987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6583302|NCT01065987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583303|NCT01066013|Anti-Infective Agents|anti-infective agents|mesh-list
6583304|NCT01066013|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6583305|NCT01066091|Palmitic Acid|palmitic acid|mesh-list
6583306|NCT01066091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6583307|NCT01066091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583308|NCT01066169|Lactitol|lactitol|mesh-list
6583309|NCT01066169|Cathartics|cathartics|mesh-ancestor
6583310|NCT01066169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6583311|NCT01066195|Pemetrexed|pemetrexed|mesh-list
6583312|NCT01066195|Gefitinib|gefitinib|mesh-list
6583313|NCT01066195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6583314|NCT01066195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6583315|NCT01066195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583316|NCT01066195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6583317|NCT01066195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6583318|NCT01066195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6583319|NCT01066247|Midazolam|midazolam|mesh-list
6583320|NCT01066247|Morphine|morphine|mesh-list
6583321|NCT01066247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6583322|NCT01066247|Narcotics|narcotics|mesh-ancestor
6583323|NCT01066247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6583324|NCT01066247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583325|NCT01066247|Analgesics|analgesics|mesh-ancestor
6583326|NCT01066247|Sensory System Agents|sensory system agents|mesh-ancestor
6583327|NCT01066247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6583328|NCT01066247|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6583329|NCT01066247|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6583330|NCT01066247|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6583331|NCT01066247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6583332|NCT01066247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6583333|NCT01066247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6583334|NCT01066247|Anesthetics, General|anesthetics, general|mesh-ancestor
6583335|NCT01066247|Anesthetics|anesthetics|mesh-ancestor
6583336|NCT01066247|GABA Modulators|gaba modulators|mesh-ancestor
6583337|NCT01066247|GABA Agents|gaba agents|mesh-ancestor
6583338|NCT01066247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6583339|NCT01066247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583340|NCT01066299|Oxytocin|oxytocin|mesh-list
6583341|NCT01066299|Oxytocics|oxytocics|mesh-ancestor
6583342|NCT01066299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6020324|NCT00392704|Bevacizumab|bevacizumab|mesh-list
6020325|NCT00392704|Fluorouracil|fluorouracil|mesh-list
6020326|NCT00392704|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6020327|NCT00392704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6020328|NCT00392704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6020329|NCT00392704|Tubulin Modulators|tubulin modulators|mesh-ancestor
6020330|NCT00392704|Antimitotic Agents|antimitotic agents|mesh-ancestor
6583343|NCT01066299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583344|NCT01066351|Epoetin Alfa|epoetin alfa|mesh-list
6583345|NCT01066351|Hematinics|hematinics|mesh-ancestor
6583346|NCT01066377|Sulfalene|sulfalene|mesh-list
6583347|NCT01066377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6583348|NCT01066377|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6583349|NCT01066377|Renal Agents|renal agents|mesh-ancestor
6583350|NCT01066377|Antimalarials|antimalarials|mesh-ancestor
6583351|NCT01066377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6020331|NCT00392704|Mitosis Modulators|mitosis modulators|mesh-ancestor
6583352|NCT01066377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6583353|NCT01066403|Pergolide|pergolide|mesh-list
6583354|NCT01066403|Dopamine Agonists|dopamine agonists|mesh-ancestor
6583355|NCT01066403|Dopamine Agents|dopamine agents|mesh-ancestor
6583356|NCT01066403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6583357|NCT01066403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583358|NCT01066403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583359|NCT01066429|Dexamethasone|dexamethasone|mesh-list
6583360|NCT01066429|Dexamethasone acetate|dexamethasone acetate|mesh-list
6583361|NCT01066429|BB 1101|bb 1101|mesh-list
6583362|NCT01066429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6583363|NCT01066429|Antiemetics|antiemetics|mesh-ancestor
6583364|NCT01066429|Autonomic Agents|autonomic agents|mesh-ancestor
6583365|NCT01066429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6583366|NCT01066429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583367|NCT01066429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6583368|NCT01066429|Glucocorticoids|glucocorticoids|mesh-ancestor
6583369|NCT01066429|Hormones|hormones|mesh-ancestor
6583370|NCT01066429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6583371|NCT01066429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6583372|NCT01066429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6583373|NCT01066429|Protease Inhibitors|protease inhibitors|mesh-ancestor
6583374|NCT01066429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6583375|NCT01066429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583376|NCT01066468|Imatinib Mesylate|imatinib mesylate|mesh-list
6583377|NCT01066468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6583378|NCT01066468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6583379|NCT01066468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6583380|NCT01066468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583381|NCT01066494|Cytarabine|cytarabine|mesh-list
6583382|NCT01066494|Amonafide|amonafide|mesh-list
6583383|NCT01066494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6583384|NCT01066494|Antimetabolites|antimetabolites|mesh-ancestor
6583385|NCT01066494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583386|NCT01066494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6583387|NCT01066494|Antiviral Agents|antiviral agents|mesh-ancestor
6583388|NCT01066494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6583389|NCT01066494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6583390|NCT01066494|Immunologic Factors|immunologic factors|mesh-ancestor
6583391|NCT01066494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583392|NCT01066494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6583393|NCT01066559|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
6583394|NCT01066559|Vasodilator Agents|vasodilator agents|mesh-ancestor
6583395|NCT01066559|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
6583396|NCT01066559|Protective Agents|protective agents|mesh-ancestor
6583397|NCT01066559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583398|NCT01066572|Lisinopril|lisinopril|mesh-list
6583399|NCT01066572|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6583400|NCT01066572|Protease Inhibitors|protease inhibitors|mesh-ancestor
6583401|NCT01066572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6583402|NCT01066572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583403|NCT01066572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6583404|NCT01066572|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6583405|NCT01066572|Protective Agents|protective agents|mesh-ancestor
6583406|NCT01066572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583407|NCT01066598|Rituximab|rituximab|mesh-list
6583408|NCT01066598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6583409|NCT01066598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6583410|NCT01066598|Immunologic Factors|immunologic factors|mesh-ancestor
6583411|NCT01066598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583412|NCT01066598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6583413|NCT01066650|Everolimus|everolimus|mesh-list
6583414|NCT01066650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6583415|NCT01066650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6583416|NCT01066650|Immunologic Factors|immunologic factors|mesh-ancestor
6583417|NCT01066650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583418|NCT01066663|Pyrimethamine|pyrimethamine|mesh-list
6583419|NCT01066663|Antimalarials|antimalarials|mesh-ancestor
6583420|NCT01066663|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6583421|NCT01066663|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6583422|NCT01066663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6583423|NCT01066663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6583424|NCT01066663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6583425|NCT01066663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583426|NCT01066676|Ibuprofen|ibuprofen|mesh-list
6583427|NCT01066676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6583428|NCT01066676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6583429|NCT01066676|Analgesics|analgesics|mesh-ancestor
6583430|NCT01066676|Sensory System Agents|sensory system agents|mesh-ancestor
6583431|NCT01066676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6583432|NCT01066676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583433|NCT01066676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6583434|NCT01066676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6583435|NCT01066676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6583436|NCT01066676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6583437|NCT01066676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583438|NCT01066689|Rituximab|rituximab|mesh-list
6583439|NCT01066689|Citric Acid|citric acid|mesh-list
6583440|NCT01066689|Sodium Citrate|sodium citrate|mesh-list
6583441|NCT01066689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6583442|NCT01066689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6583443|NCT01066689|Immunologic Factors|immunologic factors|mesh-ancestor
6583444|NCT01066689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583445|NCT01066689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6583446|NCT01066689|Anticoagulants|anticoagulants|mesh-ancestor
6583447|NCT01066689|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6583448|NCT01066689|Chelating Agents|chelating agents|mesh-ancestor
6583449|NCT01066689|Sequestering Agents|sequestering agents|mesh-ancestor
6583450|NCT01066689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583451|NCT01066728|Theophylline|theophylline|mesh-list
6583452|NCT01066728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6583453|NCT01066728|Autonomic Agents|autonomic agents|mesh-ancestor
6583454|NCT01066728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6583455|NCT01066728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583456|NCT01066728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6583457|NCT01066728|Respiratory System Agents|respiratory system agents|mesh-ancestor
6583458|NCT01066728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6583459|NCT01066728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6583460|NCT01066728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583461|NCT01066728|Vasodilator Agents|vasodilator agents|mesh-ancestor
6583462|NCT01066728|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6583463|NCT01066728|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6583464|NCT01066728|Purinergic Agents|purinergic agents|mesh-ancestor
6583465|NCT01066728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6583466|NCT01066754|Fexofenadine|fexofenadine|mesh-list
6583467|NCT01066754|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6583468|NCT01066754|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6583469|NCT01066754|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6583470|NCT01066754|Histamine Antagonists|histamine antagonists|mesh-ancestor
6583471|NCT01066754|Histamine Agents|histamine agents|mesh-ancestor
6583472|NCT01066754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6583473|NCT01066754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583474|NCT01066754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583475|NCT01066767|Fexofenadine|fexofenadine|mesh-list
6583476|NCT01066767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6583477|NCT01066767|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6583478|NCT01066767|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6583479|NCT01066767|Histamine Antagonists|histamine antagonists|mesh-ancestor
6583480|NCT01066767|Histamine Agents|histamine agents|mesh-ancestor
6583481|NCT01066767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6583482|NCT01066767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583483|NCT01066767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583484|NCT01066806|Calcium|calcium|mesh-list
6583485|NCT01066806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6583486|NCT01066806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583487|NCT01066832|Paclitaxel|paclitaxel|mesh-list
6583488|NCT01066832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6583489|NCT01066832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6583490|NCT01066832|Tubulin Modulators|tubulin modulators|mesh-ancestor
6583491|NCT01066832|Antimitotic Agents|antimitotic agents|mesh-ancestor
6583492|NCT01066832|Mitosis Modulators|mitosis modulators|mesh-ancestor
6583493|NCT01066832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583494|NCT01066845|Tadalafil|tadalafil|mesh-list
6583495|NCT01066845|Vasodilator Agents|vasodilator agents|mesh-ancestor
6583496|NCT01066845|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6583497|NCT01066845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6583498|NCT01066845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6583499|NCT01066845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446864|NCT00394966|Rolapitant|rolapitant|mesh-list
6446865|NCT00394966|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6446866|NCT00394966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6446867|NCT00394966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446868|NCT00394966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446869|NCT00394992|Bevacizumab|bevacizumab|mesh-list
6446870|NCT00394992|Capecitabine|capecitabine|mesh-list
6446871|NCT00394992|Oxaliplatin|oxaliplatin|mesh-list
6446872|NCT00394992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6446873|NCT00394992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6446874|NCT00394992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6446875|NCT00394992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6446876|NCT00394992|Growth Substances|growth substances|mesh-ancestor
6583500|NCT01066845|Urological Agents|urological agents|mesh-ancestor
6583501|NCT01066858|Tenofovir|tenofovir|mesh-list
6583502|NCT01066858|Antiviral Agents|antiviral agents|mesh-ancestor
6583503|NCT01066858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6583504|NCT01066858|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6583505|NCT01066858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6583506|NCT01066858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6583507|NCT01066858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583508|NCT01066858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6583509|NCT01066858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6583510|NCT01066884|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6583511|NCT01066884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6583512|NCT01066884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6583513|NCT01066884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6583514|NCT01066884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583515|NCT01066962|Ritonavir|ritonavir|mesh-list
6583516|NCT01066962|Darunavir|darunavir|mesh-list
6583517|NCT01066962|Tenofovir|tenofovir|mesh-list
6583518|NCT01066962|Emtricitabine|emtricitabine|mesh-list
6583519|NCT01066962|Raltegravir Potassium|raltegravir potassium|mesh-list
6583520|NCT01066962|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6583521|NCT01066962|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6583522|NCT01066962|Protease Inhibitors|protease inhibitors|mesh-ancestor
6583523|NCT01066962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6583524|NCT01066962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583525|NCT01066962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6583526|NCT01066962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6583527|NCT01066962|Antiviral Agents|antiviral agents|mesh-ancestor
6583528|NCT01066962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6583529|NCT01066962|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6583530|NCT01066962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6583531|NCT01066962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6583532|NCT01066962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6583533|NCT01066962|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6583534|NCT01066962|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6583535|NCT01066988|Emollients|emollients|mesh-list
6583536|NCT01066988|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6583537|NCT01066988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6583538|NCT01066988|Dermatologic Agents|dermatologic agents|mesh-ancestor
6583539|NCT01067053|Bevacizumab|bevacizumab|mesh-list
6583540|NCT01067053|Capecitabine|capecitabine|mesh-list
6583541|NCT01067053|Oxaliplatin|oxaliplatin|mesh-list
6583542|NCT01067053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6583543|NCT01067053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6583544|NCT01067053|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6583545|NCT01067053|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6583546|NCT01067053|Growth Substances|growth substances|mesh-ancestor
6446877|NCT00394992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446878|NCT00394992|Growth Inhibitors|growth inhibitors|mesh-ancestor
6446879|NCT00394992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6446880|NCT00394992|Antimetabolites|antimetabolites|mesh-ancestor
6446881|NCT00394992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446882|NCT00395031|Ziprasidone|ziprasidone|mesh-list
6446883|NCT00395031|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6446884|NCT00395031|Serotonin Agents|serotonin agents|mesh-ancestor
6446885|NCT00395031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6446886|NCT00395031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446887|NCT00395031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446888|NCT00395031|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6446889|NCT00395031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6583547|NCT01067053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583548|NCT01067053|Growth Inhibitors|growth inhibitors|mesh-ancestor
6583549|NCT01067053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6583550|NCT01067053|Antimetabolites|antimetabolites|mesh-ancestor
6583551|NCT01067053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583552|NCT01067066|Temozolomide|temozolomide|mesh-list
6583553|NCT01067066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6583554|NCT01067066|Alkylating Agents|alkylating agents|mesh-ancestor
6583555|NCT01067066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583556|NCT01067066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6583557|NCT01067118|Insulin|insulin|mesh-list
6583558|NCT01067118|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6583559|NCT01067118|Insulin Lispro|insulin lispro|mesh-list
6583560|NCT01067118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6583561|NCT01067118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583562|NCT01067222|Modafinil|modafinil|mesh-list
6583563|NCT01067222|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6583564|NCT01067222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583565|NCT01067222|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6583566|NCT01067222|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6583567|NCT01067222|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6583568|NCT01067222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583569|NCT01067235|Modafinil|modafinil|mesh-list
6583570|NCT01067235|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6583571|NCT01067235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583572|NCT01067235|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6583573|NCT01067235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6583574|NCT01067235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6583575|NCT01067235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583576|NCT01067274|Cytarabine|cytarabine|mesh-list
6583577|NCT01067274|Azacitidine|azacitidine|mesh-list
6583578|NCT01067274|Tretinoin|tretinoin|mesh-list
6583579|NCT01067274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6583580|NCT01067274|Antimetabolites|antimetabolites|mesh-ancestor
6583581|NCT01067274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583582|NCT01067274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6583583|NCT01067274|Antiviral Agents|antiviral agents|mesh-ancestor
6583584|NCT01067274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6583585|NCT01067274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6583586|NCT01067274|Immunologic Factors|immunologic factors|mesh-ancestor
6583587|NCT01067274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583588|NCT01067274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6446890|NCT00395031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6446891|NCT00395031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6446892|NCT00395031|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6446893|NCT00395031|Dopamine Agents|dopamine agents|mesh-ancestor
6583589|NCT01067274|Keratolytic Agents|keratolytic agents|mesh-ancestor
6583590|NCT01067274|Dermatologic Agents|dermatologic agents|mesh-ancestor
6583591|NCT01067287|Pidilizumab|pidilizumab|mesh-list
6583592|NCT01067287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6583593|NCT01067287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6583594|NCT01067365|Citric Acid|citric acid|mesh-list
6583595|NCT01067365|Sodium Citrate|sodium citrate|mesh-list
6583596|NCT01067365|Enclomiphene|enclomiphene|mesh-list
6583597|NCT01067365|Clomiphene|clomiphene|mesh-list
6583598|NCT01067365|Zuclomiphene|zuclomiphene|mesh-list
6583599|NCT01067365|Anticoagulants|anticoagulants|mesh-ancestor
6583600|NCT01067365|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6583601|NCT01067365|Chelating Agents|chelating agents|mesh-ancestor
6583602|NCT01067365|Sequestering Agents|sequestering agents|mesh-ancestor
6583603|NCT01067365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583604|NCT01067365|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6583605|NCT01067365|Hormone Antagonists|hormone antagonists|mesh-ancestor
6583606|NCT01067365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6583607|NCT01067365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583608|NCT01067365|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6583609|NCT01067365|Fertility Agents|fertility agents|mesh-ancestor
6446894|NCT00395070|Temozolomide|temozolomide|mesh-list
6446895|NCT00395070|Dacarbazine|dacarbazine|mesh-list
6446896|NCT00395070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6583610|NCT01067365|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6583611|NCT01067365|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6583612|NCT01067365|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6583613|NCT01067391|Tadalafil|tadalafil|mesh-list
6583614|NCT01067391|Vasodilator Agents|vasodilator agents|mesh-ancestor
6583615|NCT01067391|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6583616|NCT01067391|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6583617|NCT01067391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6583618|NCT01067391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583619|NCT01067391|Urological Agents|urological agents|mesh-ancestor
6446897|NCT00395070|Alkylating Agents|alkylating agents|mesh-ancestor
6583620|NCT01067417|Hydroxychloroquine|hydroxychloroquine|mesh-list
6583621|NCT01067417|Antimalarials|antimalarials|mesh-ancestor
6583622|NCT01067417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6583623|NCT01067417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6583624|NCT01067417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6583625|NCT01067417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6583626|NCT01067417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583627|NCT01067417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6583628|NCT01067430|Diclofenac|diclofenac|mesh-list
6583629|NCT01067430|Etoricoxib|etoricoxib|mesh-list
6583630|NCT01067430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6583631|NCT01067430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6583632|NCT01067430|Analgesics|analgesics|mesh-ancestor
6583633|NCT01067430|Sensory System Agents|sensory system agents|mesh-ancestor
6583634|NCT01067430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6583635|NCT01067430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583636|NCT01067430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6583637|NCT01067430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6446898|NCT00395070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446899|NCT00395070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6446900|NCT00395174|Hemagglutinins|hemagglutinins|mesh-list
6446901|NCT00395174|Immunologic Factors|immunologic factors|mesh-ancestor
6446902|NCT00395174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446903|NCT00395174|Agglutinins|agglutinins|mesh-ancestor
6446904|NCT00395213|Norepinephrine|norepinephrine|mesh-list
6583638|NCT01067430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6583639|NCT01067430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6583640|NCT01067430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583641|NCT01067430|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6583642|NCT01067443|Amphotericin B|amphotericin b|mesh-list
6583643|NCT01067443|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6583644|NCT01067443|Miltefosine|miltefosine|mesh-list
6583645|NCT01067443|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
6583646|NCT01067443|Amebicides|amebicides|mesh-ancestor
6583647|NCT01067443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6446905|NCT00395213|Serotonin|serotonin|mesh-list
6446906|NCT00395213|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
6446907|NCT00395213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6583648|NCT01067443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6583649|NCT01067443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6583650|NCT01067443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6583651|NCT01067443|Antifungal Agents|antifungal agents|mesh-ancestor
6583652|NCT01067443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6583653|NCT01067443|Schistosomicides|schistosomicides|mesh-ancestor
6583654|NCT01067443|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6583655|NCT01067443|Anthelmintics|anthelmintics|mesh-ancestor
6583656|NCT01067534|Albuterol|albuterol|mesh-list
6583657|NCT01067534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6583658|NCT01067534|Autonomic Agents|autonomic agents|mesh-ancestor
6583659|NCT01067534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6583660|NCT01067534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583661|NCT01067534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6583662|NCT01067534|Respiratory System Agents|respiratory system agents|mesh-ancestor
6583663|NCT01067534|Tocolytic Agents|tocolytic agents|mesh-ancestor
6583664|NCT01067534|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6583665|NCT01067534|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6583666|NCT01067534|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6583667|NCT01067534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6583668|NCT01067534|Adrenergic Agents|adrenergic agents|mesh-ancestor
6583669|NCT01067534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6583670|NCT01067534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583671|NCT01067547|Iron|iron|mesh-list
6583672|NCT01067547|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6583673|NCT01067547|Trace Elements|trace elements|mesh-ancestor
6583674|NCT01067547|Micronutrients|micronutrients|mesh-ancestor
6583675|NCT01067547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583676|NCT01067547|Hematinics|hematinics|mesh-ancestor
6658618|NCT01482559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658619|NCT01482559|Protective Agents|protective agents|mesh-ancestor
6658620|NCT01482624|Hyaluronic Acid|hyaluronic acid|mesh-list
6658621|NCT01482624|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6658622|NCT01482624|Immunologic Factors|immunologic factors|mesh-ancestor
6446908|NCT00395213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6446909|NCT00395213|Adrenergic Agents|adrenergic agents|mesh-ancestor
6446910|NCT00395213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6446911|NCT00395213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446912|NCT00395213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446913|NCT00395213|Sympathomimetics|sympathomimetics|mesh-ancestor
6446914|NCT00395213|Autonomic Agents|autonomic agents|mesh-ancestor
6446915|NCT00395213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6658623|NCT01482624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658624|NCT01482624|Viscosupplements|viscosupplements|mesh-ancestor
6658625|NCT01482624|Protective Agents|protective agents|mesh-ancestor
6658626|NCT01482728|Dasatinib|dasatinib|mesh-list
6658627|NCT01482728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6658628|NCT01482728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6658629|NCT01482728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6658630|NCT01482728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658631|NCT01482754|Rituximab|rituximab|mesh-list
6658632|NCT01482754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6658633|NCT01482754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6658634|NCT01482754|Immunologic Factors|immunologic factors|mesh-ancestor
6658635|NCT01482754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658636|NCT01482754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6658637|NCT01482897|Prednisolone|prednisolone|mesh-list
6658638|NCT01482897|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6658639|NCT01482897|Methylprednisolone|methylprednisolone|mesh-list
6658640|NCT01482897|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6658641|NCT01482897|Prednisolone acetate|prednisolone acetate|mesh-list
6020332|NCT00392704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446916|NCT00395213|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6658642|NCT01482897|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6658643|NCT01482897|Prednisolone phosphate|prednisolone phosphate|mesh-list
6583677|NCT01067599|Nicotine|nicotine|mesh-list
6583678|NCT01067599|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6583679|NCT01067599|Autonomic Agents|autonomic agents|mesh-ancestor
6583680|NCT01067599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6583681|NCT01067599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583682|NCT01067599|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6583683|NCT01067599|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6583684|NCT01067599|Cholinergic Agents|cholinergic agents|mesh-ancestor
6583685|NCT01067599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6583686|NCT01067599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583687|NCT01067638|Tranexamic Acid|tranexamic acid|mesh-list
6583688|NCT01067638|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6583689|NCT01067638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6583690|NCT01067638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583691|NCT01067638|Hemostatics|hemostatics|mesh-ancestor
6583692|NCT01067638|Coagulants|coagulants|mesh-ancestor
6583693|NCT01067677|Diphenhydramine|diphenhydramine|mesh-list
6583694|NCT01067677|Promethazine|promethazine|mesh-list
6583695|NCT01067677|Ondansetron|ondansetron|mesh-list
6583696|NCT01067677|Metoclopramide|metoclopramide|mesh-list
6583697|NCT01067677|Antiemetics|antiemetics|mesh-ancestor
6583698|NCT01067677|Autonomic Agents|autonomic agents|mesh-ancestor
6583699|NCT01067677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6583700|NCT01067677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583701|NCT01067677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6583702|NCT01067677|Antipruritics|antipruritics|mesh-ancestor
6583703|NCT01067677|Dermatologic Agents|dermatologic agents|mesh-ancestor
6583704|NCT01067677|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6583705|NCT01067677|Serotonin Agents|serotonin agents|mesh-ancestor
6583706|NCT01067677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6583707|NCT01067677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583708|NCT01067677|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6583709|NCT01067677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6583710|NCT01067677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6583711|NCT01067677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6583712|NCT01067677|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6583713|NCT01067677|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6583714|NCT01067677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6583715|NCT01067677|Anesthetics, Local|anesthetics, local|mesh-ancestor
6583716|NCT01067677|Anesthetics|anesthetics|mesh-ancestor
6583717|NCT01067677|Sensory System Agents|sensory system agents|mesh-ancestor
6583718|NCT01067677|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6583719|NCT01067677|Histamine Antagonists|histamine antagonists|mesh-ancestor
6583720|NCT01067677|Histamine Agents|histamine agents|mesh-ancestor
6583721|NCT01067677|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6583722|NCT01067677|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6583723|NCT01067677|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6583724|NCT01067677|Dopamine Agents|dopamine agents|mesh-ancestor
6583725|NCT01067690|Indinavir|indinavir|mesh-list
6583726|NCT01067690|Bleomycin|bleomycin|mesh-list
6583727|NCT01067690|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6583728|NCT01067690|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6583729|NCT01067690|Protease Inhibitors|protease inhibitors|mesh-ancestor
6583730|NCT01067690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6583731|NCT01067690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583732|NCT01067690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6583733|NCT01067690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6583734|NCT01067690|Antiviral Agents|antiviral agents|mesh-ancestor
6583735|NCT01067690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6583736|NCT01067690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6583737|NCT01067690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6583738|NCT01067898|Vitamin D|vitamin d|mesh-list
6583739|NCT01067898|Ergocalciferols|ergocalciferols|mesh-list
6583740|NCT01067898|Cholecalciferol|cholecalciferol|mesh-list
6583741|NCT01067898|Vitamins|vitamins|mesh-list
6583742|NCT01067898|Calcium Carbonate|calcium carbonate|mesh-list
6583743|NCT01067898|Micronutrients|micronutrients|mesh-ancestor
6583744|NCT01067898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583745|NCT01067898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6583746|NCT01067898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6583747|NCT01067898|Antacids|antacids|mesh-ancestor
6583748|NCT01067898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583749|NCT01067898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6583750|NCT01067950|Pancrelipase|pancrelipase|mesh-list
6583751|NCT01067950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6583752|NCT01067989|Zoledronic Acid|zoledronic acid|mesh-list
6583753|NCT01067989|Pamidronate|pamidronate|mesh-list
6583754|NCT01067989|Celecoxib|celecoxib|mesh-list
6583755|NCT01067989|Cyclophosphamide|cyclophosphamide|mesh-list
6583756|NCT01067989|Capecitabine|capecitabine|mesh-list
6583757|NCT01067989|Methotrexate|methotrexate|mesh-list
6583758|NCT01067989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6583759|NCT01067989|Immunologic Factors|immunologic factors|mesh-ancestor
6583760|NCT01067989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583761|NCT01067989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6583762|NCT01067989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6583763|NCT01067989|Alkylating Agents|alkylating agents|mesh-ancestor
6583764|NCT01067989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583765|NCT01067989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6446917|NCT00395213|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6446918|NCT00395213|Serotonin Agents|serotonin agents|mesh-ancestor
6446919|NCT00395213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6446920|NCT00395213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6446921|NCT00395239|Budesonide|budesonide|mesh-list
6446922|NCT00395239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6446923|NCT00395239|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6446924|NCT00395239|Autonomic Agents|autonomic agents|mesh-ancestor
6446925|NCT00395239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6446926|NCT00395239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446927|NCT00395239|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6446928|NCT00395239|Respiratory System Agents|respiratory system agents|mesh-ancestor
6446929|NCT00395239|Glucocorticoids|glucocorticoids|mesh-ancestor
6446930|NCT00395239|Hormones|hormones|mesh-ancestor
6446931|NCT00395239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5501549|NCT04473053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501550|NCT04473053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5501551|NCT04473053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5501552|NCT04473053|Anticoagulants|anticoagulants|mesh-ancestor
5501553|NCT04473053|Protease Inhibitors|protease inhibitors|mesh-ancestor
5501554|NCT04473053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6583766|NCT01067989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6583767|NCT01067989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6583768|NCT01067989|Antimetabolites|antimetabolites|mesh-ancestor
6583769|NCT01067989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6583770|NCT01067989|Abortifacient Agents|abortifacient agents|mesh-ancestor
6583771|NCT01067989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6583772|NCT01067989|Dermatologic Agents|dermatologic agents|mesh-ancestor
6583773|NCT01067989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6583774|NCT01067989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6583775|NCT01067989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6583776|NCT01067989|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6583777|NCT01067989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6583778|NCT01067989|Analgesics|analgesics|mesh-ancestor
6583779|NCT01067989|Sensory System Agents|sensory system agents|mesh-ancestor
6583780|NCT01067989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6583781|NCT01067989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6583782|NCT01067989|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6583783|NCT01067989|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6583784|NCT01067989|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6583785|NCT01068054|Cyclosporine|cyclosporine|mesh-list
6583786|NCT01068054|Tacrolimus|tacrolimus|mesh-list
6583787|NCT01068054|Cyclosporins|cyclosporins|mesh-list
6583788|NCT01068054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6583789|NCT01068054|Immunologic Factors|immunologic factors|mesh-ancestor
6583790|NCT01068054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583791|NCT01068054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6583792|NCT01068054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5501555|NCT04473053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501556|NCT04473053|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5501557|NCT04473053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5501558|NCT04473053|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5501559|NCT04473053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5501560|NCT04473053|Immunologic Factors|immunologic factors|mesh-ancestor
5501561|NCT04473144|Urinastatin|urinastatin|mesh-list
6583793|NCT01068054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583794|NCT01068054|Antifungal Agents|antifungal agents|mesh-ancestor
6583795|NCT01068054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6583796|NCT01068054|Dermatologic Agents|dermatologic agents|mesh-ancestor
6583797|NCT01068054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6583798|NCT01068067|Tacrolimus|tacrolimus|mesh-list
6583799|NCT01068067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6583800|NCT01068067|Immunologic Factors|immunologic factors|mesh-ancestor
6583801|NCT01068067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583802|NCT01068067|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6583803|NCT01068067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6583804|NCT01068067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583805|NCT01068093|Ezetimibe|ezetimibe|mesh-list
6583806|NCT01068093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6583807|NCT01068093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6583808|NCT01068093|Antimetabolites|antimetabolites|mesh-ancestor
6583809|NCT01068093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583810|NCT01068093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6583811|NCT01068132|Cetuximab|cetuximab|mesh-list
6583812|NCT01068132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6583813|NCT01068132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6583814|NCT01068223|Cetirizine|cetirizine|mesh-list
6583815|NCT01068223|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6583816|NCT01068223|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6583817|NCT01068223|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6583818|NCT01068223|Histamine Antagonists|histamine antagonists|mesh-ancestor
6583819|NCT01068223|Histamine Agents|histamine agents|mesh-ancestor
6583820|NCT01068223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6583821|NCT01068223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583822|NCT01068223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583823|NCT01068249|Everolimus|everolimus|mesh-list
6583824|NCT01068249|Letrozole|letrozole|mesh-list
6583825|NCT01068249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6583826|NCT01068249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6583827|NCT01068249|Immunologic Factors|immunologic factors|mesh-ancestor
6583828|NCT01068249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583829|NCT01068249|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6583830|NCT01068249|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6583831|NCT01068249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6583832|NCT01068249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583833|NCT01068249|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6583834|NCT01068249|Hormone Antagonists|hormone antagonists|mesh-ancestor
6583835|NCT01068249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6583836|NCT01068301|Plerixafor|plerixafor|mesh-list
6583837|NCT01068301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6583838|NCT01068301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6583839|NCT01068301|Antiviral Agents|antiviral agents|mesh-ancestor
6583840|NCT01068301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6583841|NCT01068327|Leucovorin|leucovorin|mesh-list
6583842|NCT01068327|Gemcitabine|gemcitabine|mesh-list
6583843|NCT01068327|Nelfinavir|nelfinavir|mesh-list
6583844|NCT01068327|Fluorouracil|fluorouracil|mesh-list
6583845|NCT01068327|Calcium|calcium|mesh-list
6583846|NCT01068327|Levoleucovorin|levoleucovorin|mesh-list
6583847|NCT01068327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6583848|NCT01068327|Antimetabolites|antimetabolites|mesh-ancestor
6583849|NCT01068327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583850|NCT01068327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6583851|NCT01068327|Antiviral Agents|antiviral agents|mesh-ancestor
6583852|NCT01068327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6583853|NCT01068327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6583854|NCT01068327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6583855|NCT01068327|Immunologic Factors|immunologic factors|mesh-ancestor
6583856|NCT01068327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583857|NCT01068327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6583858|NCT01068327|Antidotes|antidotes|mesh-ancestor
6583859|NCT01068327|Protective Agents|protective agents|mesh-ancestor
6583860|NCT01068327|Vitamin B Complex|vitamin b complex|mesh-ancestor
6583861|NCT01068327|Vitamins|vitamins|mesh-ancestor
6583862|NCT01068327|Micronutrients|micronutrients|mesh-ancestor
6583863|NCT01068327|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6583864|NCT01068327|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6583865|NCT01068327|Protease Inhibitors|protease inhibitors|mesh-ancestor
6583866|NCT01068327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6583867|NCT01068327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6583868|NCT01068353|Etanercept|etanercept|mesh-list
6583869|NCT01068353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6583870|NCT01068353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6583871|NCT01068353|Analgesics|analgesics|mesh-ancestor
6583872|NCT01068353|Sensory System Agents|sensory system agents|mesh-ancestor
6583873|NCT01068353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6583874|NCT01068353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583875|NCT01068353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6583876|NCT01068353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6583877|NCT01068353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6583878|NCT01068353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6583879|NCT01068353|Immunologic Factors|immunologic factors|mesh-ancestor
6583880|NCT01068392|Prednisolone|prednisolone|mesh-list
6583881|NCT01068392|Oxaliplatin|oxaliplatin|mesh-list
6583882|NCT01068392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6583883|NCT01068392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6583884|NCT01068392|Glucocorticoids|glucocorticoids|mesh-ancestor
6583885|NCT01068392|Hormones|hormones|mesh-ancestor
6583886|NCT01068392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6583887|NCT01068392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583888|NCT01068392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6583889|NCT01068405|Methotrexate|methotrexate|mesh-list
6583890|NCT01068405|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6583891|NCT01068405|Abortifacient Agents|abortifacient agents|mesh-ancestor
6583892|NCT01068405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6583893|NCT01068405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583894|NCT01068405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6583895|NCT01068405|Antimetabolites|antimetabolites|mesh-ancestor
6583896|NCT01068405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583897|NCT01068405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6583898|NCT01068405|Dermatologic Agents|dermatologic agents|mesh-ancestor
6583899|NCT01068405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6583900|NCT01068405|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6583901|NCT01068405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6583902|NCT01068405|Immunologic Factors|immunologic factors|mesh-ancestor
6583903|NCT01068405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6583904|NCT01068405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6583905|NCT01068444|Pioglitazone|pioglitazone|mesh-list
6583906|NCT01068444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6583907|NCT01068444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583908|NCT01068587|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6583909|NCT01068587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6583910|NCT01068587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6583911|NCT01068587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6583912|NCT01068587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583913|NCT01068756|Dapagliflozin|dapagliflozin|mesh-list
6583914|NCT01068756|Rifampin|rifampin|mesh-list
6583915|NCT01068756|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6583916|NCT01068756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583917|NCT01068756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6583918|NCT01068756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583919|NCT01068756|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6583920|NCT01068756|Antitubercular Agents|antitubercular agents|mesh-ancestor
6583921|NCT01068756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6583922|NCT01068756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6583923|NCT01068756|Leprostatic Agents|leprostatic agents|mesh-ancestor
6583924|NCT01068756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6583925|NCT01068756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6583926|NCT01068756|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6583927|NCT01068756|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6583928|NCT01068756|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6583929|NCT01068756|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6583930|NCT01068756|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6583931|NCT01068756|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6583932|NCT01068795|Enoxaparin|enoxaparin|mesh-list
6583933|NCT01068795|Anticoagulants|anticoagulants|mesh-ancestor
6583934|NCT01068795|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6583935|NCT01068795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6583936|NCT01068795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583937|NCT01068847|Cycloserine|cycloserine|mesh-list
6583938|NCT01068847|Verapamil|verapamil|mesh-list
6583939|NCT01068847|Nifedipine|nifedipine|mesh-list
6583940|NCT01068847|Tizanidine|tizanidine|mesh-list
6583941|NCT01068847|Naloxone|naloxone|mesh-list
6583942|NCT01068847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6583943|NCT01068847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583944|NCT01068847|Sensory System Agents|sensory system agents|mesh-ancestor
6583945|NCT01068847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6583946|NCT01068847|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6583947|NCT01068847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6583948|NCT01068847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583949|NCT01068847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6583950|NCT01068847|Vasodilator Agents|vasodilator agents|mesh-ancestor
6583951|NCT01068847|Tocolytic Agents|tocolytic agents|mesh-ancestor
6583952|NCT01068847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6583953|NCT01068847|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6583954|NCT01068847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6583955|NCT01068847|Renal Agents|renal agents|mesh-ancestor
6583956|NCT01068847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6583957|NCT01068847|Antitubercular Agents|antitubercular agents|mesh-ancestor
6583958|NCT01068847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6583959|NCT01068847|Antimetabolites|antimetabolites|mesh-ancestor
6583960|NCT01068847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6583961|NCT01068847|Analgesics|analgesics|mesh-ancestor
6583962|NCT01068847|Anticonvulsants|anticonvulsants|mesh-ancestor
6583963|NCT01068847|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6583964|NCT01068847|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6583965|NCT01068847|Parasympatholytics|parasympatholytics|mesh-ancestor
6583966|NCT01068847|Autonomic Agents|autonomic agents|mesh-ancestor
6583967|NCT01068847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6583968|NCT01068847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6583969|NCT01068847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6583970|NCT01068847|Adrenergic Agents|adrenergic agents|mesh-ancestor
6583971|NCT01068847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6583972|NCT01068925|Dolutegravir|dolutegravir|mesh-list
6583973|NCT01068925|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6583974|NCT01068925|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6583975|NCT01068925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6583976|NCT01068925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583977|NCT01068925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6583978|NCT01068925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6583979|NCT01068925|Antiviral Agents|antiviral agents|mesh-ancestor
6583980|NCT01068925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6583981|NCT01068977|Bevacizumab|bevacizumab|mesh-list
6583982|NCT01068977|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6583983|NCT01068977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6583984|NCT01068977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6583985|NCT01068977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6583986|NCT01068977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6583987|NCT01068977|Growth Substances|growth substances|mesh-ancestor
6583988|NCT01068977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6583989|NCT01068977|Growth Inhibitors|growth inhibitors|mesh-ancestor
6583990|NCT01068977|Immunologic Factors|immunologic factors|mesh-ancestor
6583991|NCT01069042|Enalapril|enalapril|mesh-list
6583992|NCT01069042|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6583993|NCT01069042|Protease Inhibitors|protease inhibitors|mesh-ancestor
6583994|NCT01069042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6583995|NCT01069042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6583996|NCT01069042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6583997|NCT01069055|Acetaminophen|acetaminophen|mesh-list
6583998|NCT01069055|Lornoxicam|lornoxicam|mesh-list
6583999|NCT01069055|Piroxicam|piroxicam|mesh-list
6584000|NCT01069055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6584001|NCT01069055|Analgesics|analgesics|mesh-ancestor
6584002|NCT01069055|Sensory System Agents|sensory system agents|mesh-ancestor
6584003|NCT01069055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6584004|NCT01069055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584005|NCT01069055|Antipyretics|antipyretics|mesh-ancestor
6584006|NCT01069055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6584007|NCT01069055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6584008|NCT01069055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6584009|NCT01069055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6584010|NCT01069055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6446932|NCT00395252|Gemcitabine|gemcitabine|mesh-list
6446933|NCT00395252|Cetuximab|cetuximab|mesh-list
6446934|NCT00395252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6446935|NCT00395252|Antimetabolites|antimetabolites|mesh-ancestor
6446936|NCT00395252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446937|NCT00395252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6446938|NCT00395252|Antiviral Agents|antiviral agents|mesh-ancestor
6446939|NCT00395252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6446940|NCT00395252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6584011|NCT01069055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584012|NCT01069081|Cisplatin|cisplatin|mesh-list
6584013|NCT01069081|Docetaxel|docetaxel|mesh-list
6584014|NCT01069081|Esomeprazole|esomeprazole|mesh-list
6584015|NCT01069081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6584016|NCT01069081|Tubulin Modulators|tubulin modulators|mesh-ancestor
6584017|NCT01069081|Antimitotic Agents|antimitotic agents|mesh-ancestor
6584018|NCT01069081|Mitosis Modulators|mitosis modulators|mesh-ancestor
6584019|NCT01069081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584020|NCT01069081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6584021|NCT01069081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6584022|NCT01069081|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6584023|NCT01069081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6584024|NCT01069094|Leuprolide|leuprolide|mesh-list
6584025|NCT01069094|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6584026|NCT01069094|Fertility Agents|fertility agents|mesh-ancestor
6584027|NCT01069094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6584028|NCT01069094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584029|NCT01069094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6584030|NCT01069094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6584031|NCT01069133|Rifaximin|rifaximin|mesh-list
6584032|NCT01069133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6584033|NCT01069133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6584034|NCT01069133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6584035|NCT01069159|Propranolol|propranolol|mesh-list
6584036|NCT01069159|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6584037|NCT01069159|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6584038|NCT01069159|Adrenergic Agents|adrenergic agents|mesh-ancestor
6584039|NCT01069159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6584040|NCT01069159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584041|NCT01069159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584042|NCT01069159|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6584043|NCT01069159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6584044|NCT01069159|Vasodilator Agents|vasodilator agents|mesh-ancestor
6584045|NCT01069198|Vitamin A|vitamin a|mesh-list
6584046|NCT01069198|Albendazole|albendazole|mesh-list
6584047|NCT01069198|Vitamins|vitamins|mesh-ancestor
6584048|NCT01069198|Micronutrients|micronutrients|mesh-ancestor
6584049|NCT01069198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584050|NCT01069198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584051|NCT01069198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6584052|NCT01069198|Anthelmintics|anthelmintics|mesh-ancestor
6584053|NCT01069198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6584054|NCT01069198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6584055|NCT01069198|Anticestodal Agents|anticestodal agents|mesh-ancestor
6584056|NCT01069198|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6584057|NCT01069198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6584058|NCT01069198|Tubulin Modulators|tubulin modulators|mesh-ancestor
6584059|NCT01069198|Antimitotic Agents|antimitotic agents|mesh-ancestor
6584060|NCT01069198|Mitosis Modulators|mitosis modulators|mesh-ancestor
6584061|NCT01069263|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
6584062|NCT01069263|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6584063|NCT01069263|Protective Agents|protective agents|mesh-ancestor
6584064|NCT01069263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584065|NCT01069263|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6584066|NCT01069263|Antioxidants|antioxidants|mesh-ancestor
6584067|NCT01069263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584068|NCT01069302|Clopidogrel|clopidogrel|mesh-list
6584069|NCT01069302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6584070|NCT01069302|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6584071|NCT01069302|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6584072|NCT01069302|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6584073|NCT01069302|Purinergic Agents|purinergic agents|mesh-ancestor
6584074|NCT01069302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6584075|NCT01069302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584076|NCT01069302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658644|NCT01482897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6658645|NCT01482897|Glucocorticoids|glucocorticoids|mesh-ancestor
6658646|NCT01482897|Hormones|hormones|mesh-ancestor
6658647|NCT01482897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6658648|NCT01482897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658649|NCT01482897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6658650|NCT01482897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6658651|NCT01482897|Antiemetics|antiemetics|mesh-ancestor
6658652|NCT01482897|Autonomic Agents|autonomic agents|mesh-ancestor
6658653|NCT01482897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6658654|NCT01482897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6658655|NCT01482897|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6658656|NCT01482897|Protective Agents|protective agents|mesh-ancestor
6658657|NCT01482936|Oxycodone|oxycodone|mesh-list
6658658|NCT01482936|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6658659|NCT01482936|Narcotics|narcotics|mesh-ancestor
6658660|NCT01482936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6658661|NCT01482936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658662|NCT01482936|Analgesics|analgesics|mesh-ancestor
6658663|NCT01482936|Sensory System Agents|sensory system agents|mesh-ancestor
6658664|NCT01482936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6658665|NCT01483014|Imatinib Mesylate|imatinib mesylate|mesh-list
6658666|NCT01483014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6584077|NCT01069328|Paclitaxel|paclitaxel|mesh-list
6584078|NCT01069328|Bevacizumab|bevacizumab|mesh-list
6584079|NCT01069328|Carboplatin|carboplatin|mesh-list
6584080|NCT01069328|Sorafenib|sorafenib|mesh-list
6584081|NCT01069328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6584082|NCT01069328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6584083|NCT01069328|Tubulin Modulators|tubulin modulators|mesh-ancestor
6584084|NCT01069328|Antimitotic Agents|antimitotic agents|mesh-ancestor
6584085|NCT01069328|Mitosis Modulators|mitosis modulators|mesh-ancestor
6584086|NCT01069328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584087|NCT01069328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6584088|NCT01069328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6584089|NCT01069328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6584090|NCT01069328|Growth Substances|growth substances|mesh-ancestor
6584091|NCT01069328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584092|NCT01069328|Growth Inhibitors|growth inhibitors|mesh-ancestor
6584093|NCT01069328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6584094|NCT01069328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6584095|NCT01069536|Metoclopramide|metoclopramide|mesh-list
6584096|NCT01069536|Antiemetics|antiemetics|mesh-ancestor
6584097|NCT01069536|Autonomic Agents|autonomic agents|mesh-ancestor
6584098|NCT01069536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6584099|NCT01069536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584100|NCT01069536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6584101|NCT01069536|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6584102|NCT01069536|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6584103|NCT01069536|Dopamine Agents|dopamine agents|mesh-ancestor
6584104|NCT01069536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6584105|NCT01069536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584106|NCT01069757|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6584107|NCT01069757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6584108|NCT01069757|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6584109|NCT01069757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6584110|NCT01069757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584111|NCT01069770|Sunitinib|sunitinib|mesh-list
6584112|NCT01069770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6584113|NCT01069770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6584114|NCT01069770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6584115|NCT01069770|Growth Substances|growth substances|mesh-ancestor
6584116|NCT01069770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584117|NCT01069770|Growth Inhibitors|growth inhibitors|mesh-ancestor
6584118|NCT01069770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6584119|NCT01069770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6584120|NCT01069770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584121|NCT01069796|Paclitaxel|paclitaxel|mesh-list
6584122|NCT01069796|Bevacizumab|bevacizumab|mesh-list
6584123|NCT01069796|Capecitabine|capecitabine|mesh-list
6584124|NCT01069796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6584125|NCT01069796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6584126|NCT01069796|Tubulin Modulators|tubulin modulators|mesh-ancestor
6584127|NCT01069796|Antimitotic Agents|antimitotic agents|mesh-ancestor
6584128|NCT01069796|Mitosis Modulators|mitosis modulators|mesh-ancestor
6584129|NCT01069796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584130|NCT01069796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6584131|NCT01069796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6584132|NCT01069796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6584133|NCT01069796|Growth Substances|growth substances|mesh-ancestor
6584134|NCT01069796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584135|NCT01069796|Growth Inhibitors|growth inhibitors|mesh-ancestor
6584136|NCT01069796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6584137|NCT01069796|Antimetabolites|antimetabolites|mesh-ancestor
6584138|NCT01069822|Midazolam|midazolam|mesh-list
6584139|NCT01069822|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6584140|NCT01069822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6584141|NCT01069822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6584142|NCT01069822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584143|NCT01069822|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6584144|NCT01069822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6584145|NCT01069822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6584146|NCT01069822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6584147|NCT01069822|Anesthetics, General|anesthetics, general|mesh-ancestor
6584148|NCT01069822|Anesthetics|anesthetics|mesh-ancestor
6584149|NCT01069822|GABA Modulators|gaba modulators|mesh-ancestor
6584150|NCT01069822|GABA Agents|gaba agents|mesh-ancestor
6584151|NCT01069822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6584152|NCT01069822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584153|NCT01069874|Vitamin D|vitamin d|mesh-list
6584154|NCT01069874|Cholecalciferol|cholecalciferol|mesh-list
6584155|NCT01069874|Vitamins|vitamins|mesh-ancestor
6584156|NCT01069874|Micronutrients|micronutrients|mesh-ancestor
6584157|NCT01069874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584158|NCT01069874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6584159|NCT01069874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6584160|NCT01069913|Dimethyl Fumarate|dimethyl fumarate|mesh-list
6584161|NCT01069913|Dermatologic Agents|dermatologic agents|mesh-ancestor
6584162|NCT01069913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6584163|NCT01069913|Immunologic Factors|immunologic factors|mesh-ancestor
6584164|NCT01069913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584165|NCT01069965|BGP 15|bgp 15|mesh-list
6584166|NCT01069965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6584167|NCT01069965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584168|NCT01070030|Amlodipine|amlodipine|mesh-list
6584169|NCT01070030|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6584170|NCT01070030|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6584171|NCT01070030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6584172|NCT01070030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6584173|NCT01070030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584174|NCT01070030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6584175|NCT01070030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584176|NCT01070030|Vasodilator Agents|vasodilator agents|mesh-ancestor
6584177|NCT01070030|Diuretics|diuretics|mesh-ancestor
6584178|NCT01070030|Natriuretic Agents|natriuretic agents|mesh-ancestor
6584179|NCT01070030|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6584180|NCT01070108|Ketamine|ketamine|mesh-list
6584181|NCT01070108|Analgesics|analgesics|mesh-ancestor
6584182|NCT01070108|Sensory System Agents|sensory system agents|mesh-ancestor
6584183|NCT01070108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6584184|NCT01070108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584185|NCT01070108|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6584186|NCT01070108|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6584187|NCT01070108|Anesthetics, General|anesthetics, general|mesh-ancestor
6584188|NCT01070108|Anesthetics|anesthetics|mesh-ancestor
6584189|NCT01070108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6584190|NCT01070108|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6584191|NCT01070108|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6584192|NCT01070108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6584193|NCT01070108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584194|NCT01070160|Metformin|metformin|mesh-list
6584195|NCT01070160|Progesterone|progesterone|mesh-list
6584196|NCT01070160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6584197|NCT01070160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584198|NCT01070160|Progestins|progestins|mesh-ancestor
6584199|NCT01070160|Hormones|hormones|mesh-ancestor
6584200|NCT01070160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6584201|NCT01070186|Sunitinib|sunitinib|mesh-list
6584202|NCT01070186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6584203|NCT01070186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6584204|NCT01070186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6584205|NCT01070186|Growth Substances|growth substances|mesh-ancestor
6584206|NCT01070186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584207|NCT01070186|Growth Inhibitors|growth inhibitors|mesh-ancestor
6584208|NCT01070186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6584209|NCT01070186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6584210|NCT01070186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584211|NCT01070225|Hydrocortisone|hydrocortisone|mesh-list
6584212|NCT01070225|Propranolol|propranolol|mesh-list
6584213|NCT01070225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6584214|NCT01070225|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6584215|NCT01070225|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6584216|NCT01070225|Adrenergic Agents|adrenergic agents|mesh-ancestor
6584217|NCT01070225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6584218|NCT01070225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584219|NCT01070225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584220|NCT01070225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6584221|NCT01070225|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6584222|NCT01070225|Vasodilator Agents|vasodilator agents|mesh-ancestor
6584223|NCT01070277|Albendazole|albendazole|mesh-list
6584224|NCT01070277|Tinidazole|tinidazole|mesh-list
6584225|NCT01070277|Anthelmintics|anthelmintics|mesh-ancestor
6584226|NCT01070277|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6584227|NCT01070277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6584228|NCT01070277|Anticestodal Agents|anticestodal agents|mesh-ancestor
6584229|NCT01070277|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6584230|NCT01070277|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6584231|NCT01070277|Tubulin Modulators|tubulin modulators|mesh-ancestor
6584232|NCT01070277|Antimitotic Agents|antimitotic agents|mesh-ancestor
6584233|NCT01070277|Mitosis Modulators|mitosis modulators|mesh-ancestor
6584234|NCT01070277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584235|NCT01070277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6584236|NCT01070277|Alkylating Agents|alkylating agents|mesh-ancestor
6584237|NCT01070277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6584238|NCT01070277|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
6584239|NCT01070290|Capecitabine|capecitabine|mesh-list
6584240|NCT01070290|Oxaliplatin|oxaliplatin|mesh-list
6584241|NCT01070290|Irinotecan|irinotecan|mesh-list
6584242|NCT01070290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6584243|NCT01070290|Antimetabolites|antimetabolites|mesh-ancestor
6584244|NCT01070290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584245|NCT01070290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6584246|NCT01070290|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6584247|NCT01070290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6584248|NCT01070290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6584249|NCT01070407|Cloricromen|cloricromen|mesh-list
6584250|NCT01070407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6584251|NCT01070446|Choline|choline|mesh-list
6584252|NCT01070446|Lipotropic Agents|lipotropic agents|mesh-ancestor
6584253|NCT01070446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6584254|NCT01070446|Antimetabolites|antimetabolites|mesh-ancestor
6584255|NCT01070446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584256|NCT01070446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6584257|NCT01070446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6584258|NCT01070446|Nootropic Agents|nootropic agents|mesh-ancestor
6584259|NCT01070472|Misoprostol|misoprostol|mesh-list
6584260|NCT01070472|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6584261|NCT01070472|Abortifacient Agents|abortifacient agents|mesh-ancestor
6584262|NCT01070472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6584263|NCT01070472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584264|NCT01070472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6584265|NCT01070472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6584266|NCT01070472|Oxytocics|oxytocics|mesh-ancestor
6584267|NCT01070485|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
6584268|NCT01070485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6584269|NCT01070511|Tadalafil|tadalafil|mesh-list
6584270|NCT01070511|Vasodilator Agents|vasodilator agents|mesh-ancestor
6584271|NCT01070511|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6584272|NCT01070511|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6020333|NCT00392704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6020334|NCT00392704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6020335|NCT00392704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6020336|NCT00392704|Growth Substances|growth substances|mesh-ancestor
6020337|NCT00392704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020338|NCT00392704|Growth Inhibitors|growth inhibitors|mesh-ancestor
6020339|NCT00392704|Antimetabolites|antimetabolites|mesh-ancestor
6020340|NCT00392704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6446941|NCT00395252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6584273|NCT01070511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6584274|NCT01070511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584275|NCT01070511|Urological Agents|urological agents|mesh-ancestor
6584276|NCT01070524|Budesonide|budesonide|mesh-list
6584277|NCT01070524|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6584278|NCT01070524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6584279|NCT01070524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6584280|NCT01070524|Autonomic Agents|autonomic agents|mesh-ancestor
6584281|NCT01070524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6584282|NCT01070524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584283|NCT01070524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6584284|NCT01070524|Respiratory System Agents|respiratory system agents|mesh-ancestor
6584285|NCT01070524|Glucocorticoids|glucocorticoids|mesh-ancestor
6584286|NCT01070524|Hormones|hormones|mesh-ancestor
6584287|NCT01070524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6584288|NCT01070524|Sympathomimetics|sympathomimetics|mesh-ancestor
6446942|NCT00395252|Immunologic Factors|immunologic factors|mesh-ancestor
6446943|NCT00395252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446944|NCT00395252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6446945|NCT00395369|Aprotinin|aprotinin|mesh-list
6446946|NCT00395369|Hemostatics|hemostatics|mesh-ancestor
6446947|NCT00395369|Coagulants|coagulants|mesh-ancestor
6584289|NCT01070615|Prucalopride|prucalopride|mesh-list
6584290|NCT01070615|Laxatives|laxatives|mesh-ancestor
6584291|NCT01070615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6584292|NCT01070615|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
6584293|NCT01070615|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6584294|NCT01070615|Serotonin Agents|serotonin agents|mesh-ancestor
6584295|NCT01070615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6584296|NCT01070615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584297|NCT01070615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584298|NCT01070628|Levodopa|levodopa|mesh-list
6584299|NCT01070628|Carbidopa|carbidopa|mesh-list
6584300|NCT01070628|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
6584301|NCT01070628|Entacapone|entacapone|mesh-list
6584302|NCT01070628|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6584303|NCT01070628|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6584304|NCT01070628|Dopamine Agents|dopamine agents|mesh-ancestor
6584305|NCT01070628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6584306|NCT01070628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584307|NCT01070628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446948|NCT00395369|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6446949|NCT00395369|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6446950|NCT00395369|Protease Inhibitors|protease inhibitors|mesh-ancestor
6446951|NCT00395369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6446952|NCT00395369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446953|NCT00395382|Alendronate|alendronate|mesh-list
6446954|NCT00395382|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6446955|NCT00395382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446956|NCT00395395|Calcitonin|calcitonin|mesh-list
6446957|NCT00395395|Salmon calcitonin|salmon calcitonin|mesh-list
6446958|NCT00395395|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
6446959|NCT00395395|Katacalcin|katacalcin|mesh-list
6446960|NCT00395395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6446961|NCT00395395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446962|NCT00395395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6446963|NCT00395395|Vasodilator Agents|vasodilator agents|mesh-ancestor
6446964|NCT00395421|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6446965|NCT00395421|Antiviral Agents|antiviral agents|mesh-ancestor
6446966|NCT00395421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6446967|NCT00395434|Bevacizumab|bevacizumab|mesh-list
6446968|NCT00395434|Combretastatin|combretastatin|mesh-list
6446969|NCT00395434|Fosbretabulin|fosbretabulin|mesh-list
6446970|NCT00395434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6446971|NCT00395434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6446972|NCT00395434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6584308|NCT01070628|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6584309|NCT01070628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6584310|NCT01070628|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6584311|NCT01070628|Immunologic Factors|immunologic factors|mesh-ancestor
6584312|NCT01070628|Dopamine Agonists|dopamine agonists|mesh-ancestor
6584313|NCT01070628|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6584314|NCT01070641|Carvedilol|carvedilol|mesh-list
6584315|NCT01070641|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6584316|NCT01070641|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6584317|NCT01070641|Adrenergic Agents|adrenergic agents|mesh-ancestor
6584318|NCT01070641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6584319|NCT01070641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584320|NCT01070641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584321|NCT01070641|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6584322|NCT01070641|Antioxidants|antioxidants|mesh-ancestor
6584323|NCT01070641|Protective Agents|protective agents|mesh-ancestor
6584324|NCT01070641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6584325|NCT01070641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6584326|NCT01070641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6584327|NCT01070641|Vasodilator Agents|vasodilator agents|mesh-ancestor
6584328|NCT01070641|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6584329|NCT01070641|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6584330|NCT01070667|Dronedarone|dronedarone|mesh-list
6584331|NCT01070667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6584332|NCT01070680|Dexmedetomidine|dexmedetomidine|mesh-list
6584333|NCT01070680|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6584334|NCT01070680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6584335|NCT01070680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584336|NCT01070680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6584337|NCT01070680|Analgesics|analgesics|mesh-ancestor
6584338|NCT01070680|Sensory System Agents|sensory system agents|mesh-ancestor
6584339|NCT01070680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6584340|NCT01070680|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6584341|NCT01070680|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6584342|NCT01070680|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6584343|NCT01070680|Adrenergic Agents|adrenergic agents|mesh-ancestor
6446973|NCT00395434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6584344|NCT01070680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6584345|NCT01070680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584346|NCT01070706|Gemcitabine|gemcitabine|mesh-list
6584347|NCT01070706|Paclitaxel|paclitaxel|mesh-list
6584348|NCT01070706|Sunitinib|sunitinib|mesh-list
6584349|NCT01070706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6584350|NCT01070706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6584351|NCT01070706|Tubulin Modulators|tubulin modulators|mesh-ancestor
6584352|NCT01070706|Antimitotic Agents|antimitotic agents|mesh-ancestor
6584353|NCT01070706|Mitosis Modulators|mitosis modulators|mesh-ancestor
6584354|NCT01070706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584355|NCT01070706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6584356|NCT01070706|Antimetabolites|antimetabolites|mesh-ancestor
6584357|NCT01070706|Antiviral Agents|antiviral agents|mesh-ancestor
6584358|NCT01070706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6584359|NCT01070706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6584360|NCT01070706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6446974|NCT00395434|Growth Substances|growth substances|mesh-ancestor
6446975|NCT00395434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446976|NCT00395434|Growth Inhibitors|growth inhibitors|mesh-ancestor
6446977|NCT00395434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6446978|NCT00395434|Tubulin Modulators|tubulin modulators|mesh-ancestor
6446979|NCT00395434|Antimitotic Agents|antimitotic agents|mesh-ancestor
6446980|NCT00395434|Mitosis Modulators|mitosis modulators|mesh-ancestor
6446981|NCT00395434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446982|NCT00395499|Risperidone|risperidone|mesh-list
6446983|NCT00395499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6584361|NCT01070706|Immunologic Factors|immunologic factors|mesh-ancestor
6584362|NCT01070706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584363|NCT01070706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6584364|NCT01070706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6584365|NCT01070706|Growth Substances|growth substances|mesh-ancestor
6584366|NCT01070706|Growth Inhibitors|growth inhibitors|mesh-ancestor
6584367|NCT01070706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6584368|NCT01070732|Acetaminophen|acetaminophen|mesh-list
6446984|NCT00395499|Serotonin Agents|serotonin agents|mesh-ancestor
6446985|NCT00395499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6446986|NCT00395499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6446987|NCT00395499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6446988|NCT00395499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6446989|NCT00395499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6446990|NCT00395499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6446991|NCT00395499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6446992|NCT00395499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6446993|NCT00395499|Dopamine Agents|dopamine agents|mesh-ancestor
6446994|NCT00395551|Ranibizumab|ranibizumab|mesh-list
6446995|NCT00395551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6446996|NCT00395551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6446997|NCT00395551|Growth Substances|growth substances|mesh-ancestor
6446998|NCT00395551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584369|NCT01070732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6584370|NCT01070732|Analgesics|analgesics|mesh-ancestor
6584371|NCT01070732|Sensory System Agents|sensory system agents|mesh-ancestor
6584372|NCT01070732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6584373|NCT01070732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584374|NCT01070732|Antipyretics|antipyretics|mesh-ancestor
6584375|NCT01070745|Ibuprofen|ibuprofen|mesh-list
6584376|NCT01070745|Indomethacin|indomethacin|mesh-list
6584377|NCT01070745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6584378|NCT01070745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6584379|NCT01070745|Analgesics|analgesics|mesh-ancestor
6584380|NCT01070745|Sensory System Agents|sensory system agents|mesh-ancestor
6584381|NCT01070745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6584382|NCT01070745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584383|NCT01070745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6584384|NCT01070745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6584385|NCT01070745|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6584386|NCT01070745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6584387|NCT01070745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584388|NCT01070745|Gout Suppressants|gout suppressants|mesh-ancestor
6584389|NCT01070745|Tocolytic Agents|tocolytic agents|mesh-ancestor
6584390|NCT01070745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6584391|NCT01070758|Lanreotide|lanreotide|mesh-list
6584392|NCT01070758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6584393|NCT01070823|Natalizumab|natalizumab|mesh-list
6584394|NCT01070823|Immunologic Factors|immunologic factors|mesh-ancestor
6584395|NCT01070823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584396|NCT01070836|Natalizumab|natalizumab|mesh-list
6584397|NCT01070836|Immunologic Factors|immunologic factors|mesh-ancestor
6584398|NCT01070836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584399|NCT01070862|Thalidomide|thalidomide|mesh-list
6584400|NCT01070862|Dexamethasone|dexamethasone|mesh-list
6584401|NCT01070862|Dexamethasone acetate|dexamethasone acetate|mesh-list
6584402|NCT01070862|Doxorubicin|doxorubicin|mesh-list
6584403|NCT01070862|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6584404|NCT01070862|Melphalan|melphalan|mesh-list
6584405|NCT01070862|Cyclophosphamide|cyclophosphamide|mesh-list
6584406|NCT01070862|Vincristine|vincristine|mesh-list
6584407|NCT01070862|BB 1101|bb 1101|mesh-list
6584408|NCT01070862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6584409|NCT01070862|Antiemetics|antiemetics|mesh-ancestor
6584410|NCT01070862|Autonomic Agents|autonomic agents|mesh-ancestor
6584411|NCT01070862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6584412|NCT01070862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584413|NCT01070862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6584414|NCT01070862|Glucocorticoids|glucocorticoids|mesh-ancestor
6584415|NCT01070862|Hormones|hormones|mesh-ancestor
6584416|NCT01070862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6584417|NCT01070862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6584418|NCT01070862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6584419|NCT01070862|Protease Inhibitors|protease inhibitors|mesh-ancestor
6584420|NCT01070862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6584421|NCT01070862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584422|NCT01070862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6584423|NCT01070862|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6584424|NCT01070862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6584425|NCT01070862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6584426|NCT01070862|Alkylating Agents|alkylating agents|mesh-ancestor
6584427|NCT01070862|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6584428|NCT01070862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6584429|NCT01070862|Immunologic Factors|immunologic factors|mesh-ancestor
6584430|NCT01070862|Leprostatic Agents|leprostatic agents|mesh-ancestor
6584431|NCT01070862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6584432|NCT01070862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6584433|NCT01070862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6584434|NCT01070862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6584435|NCT01070862|Growth Substances|growth substances|mesh-ancestor
6584436|NCT01070862|Growth Inhibitors|growth inhibitors|mesh-ancestor
6584437|NCT01070862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6584438|NCT01070862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6584439|NCT01070862|Tubulin Modulators|tubulin modulators|mesh-ancestor
6584440|NCT01070862|Antimitotic Agents|antimitotic agents|mesh-ancestor
6584441|NCT01070862|Mitosis Modulators|mitosis modulators|mesh-ancestor
6584442|NCT01070875|Heparin|heparin|mesh-list
6584443|NCT01070875|Calcium heparin|calcium heparin|mesh-list
6584444|NCT01070875|Anticoagulants|anticoagulants|mesh-ancestor
6584445|NCT01070875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6584446|NCT01070875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6584447|NCT01070875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584448|NCT01070927|R04929097|r04929097|mesh-list
6584449|NCT01070927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6584450|NCT01070927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584451|NCT01070940|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
6584452|NCT01070940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6584453|NCT01070940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584454|NCT01071005|Leuprolide|leuprolide|mesh-list
6584455|NCT01071005|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6584456|NCT01071005|Fertility Agents|fertility agents|mesh-ancestor
6584457|NCT01071005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6584458|NCT01071005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584459|NCT01071005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6584460|NCT01071005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6584461|NCT01071057|Morphine|morphine|mesh-list
6584462|NCT01071057|Naloxone|naloxone|mesh-list
6584463|NCT01071057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6584464|NCT01071057|Narcotics|narcotics|mesh-ancestor
6584465|NCT01071057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6584466|NCT01071057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584467|NCT01071057|Analgesics|analgesics|mesh-ancestor
6584468|NCT01071057|Sensory System Agents|sensory system agents|mesh-ancestor
6584469|NCT01071057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6584470|NCT01071057|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6658667|NCT01483014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6658668|NCT01483014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6658669|NCT01483014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658670|NCT01483053|S 20098|s 20098|mesh-list
6658671|NCT01483053|Citalopram|citalopram|mesh-list
6658672|NCT01483053|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6658673|NCT01483053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6658674|NCT01483053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6658675|NCT01483053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658676|NCT01483053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6658677|NCT01483053|Serotonin Agents|serotonin agents|mesh-ancestor
6658678|NCT01483053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658679|NCT01483053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6658680|NCT01483053|Antidepressive Agents|antidepressive agents|mesh-ancestor
6658681|NCT01483053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6658682|NCT01483053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6658683|NCT01483053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6658684|NCT01483248|Interferons|interferons|mesh-list
6658685|NCT01483248|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
6658686|NCT01483248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6658687|NCT01483248|Antiviral Agents|antiviral agents|mesh-ancestor
6658688|NCT01483248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6658689|NCT01483248|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6658690|NCT01483248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6658691|NCT01483274|Vaccines|vaccines|mesh-list
6658692|NCT01483274|Immunologic Factors|immunologic factors|mesh-ancestor
6658693|NCT01483274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658694|NCT01483300|Cisplatin|cisplatin|mesh-list
6658695|NCT01483300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6658696|NCT01483365|Progesterone|progesterone|mesh-list
6658697|NCT01483365|Progestins|progestins|mesh-ancestor
6658698|NCT01483365|Hormones|hormones|mesh-ancestor
6658699|NCT01483365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6446999|NCT00395551|Growth Inhibitors|growth inhibitors|mesh-ancestor
6447000|NCT00395551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6584471|NCT01071122|Valsartan|valsartan|mesh-list
6584472|NCT01071122|Nifedipine|nifedipine|mesh-list
6584473|NCT01071122|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6584474|NCT01071122|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6584475|NCT01071122|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6584476|NCT01071122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584477|NCT01071122|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6584478|NCT01071122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6584479|NCT01071122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6584480|NCT01071122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584481|NCT01071122|Vasodilator Agents|vasodilator agents|mesh-ancestor
6584482|NCT01071122|Tocolytic Agents|tocolytic agents|mesh-ancestor
6584483|NCT01071122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6584484|NCT01071135|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6584485|NCT01071135|Antidepressive Agents|antidepressive agents|mesh-ancestor
6584486|NCT01071135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6584487|NCT01071135|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6584488|NCT01071135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6584489|NCT01071135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6584490|NCT01071135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584491|NCT01071161|Azithromycin|azithromycin|mesh-list
6584492|NCT01071161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6584493|NCT01071161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6584494|NCT01071174|Dapivirine|dapivirine|mesh-list
6584495|NCT01071174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6584496|NCT01071174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6584497|NCT01071174|Antiviral Agents|antiviral agents|mesh-ancestor
6584498|NCT01071174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6584499|NCT01071187|Varenicline|varenicline|mesh-list
6584500|NCT01071187|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6584501|NCT01071187|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6584502|NCT01071187|Cholinergic Agents|cholinergic agents|mesh-ancestor
6584503|NCT01071187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6584504|NCT01071187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584505|NCT01071187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584506|NCT01071291|Niacin|niacin|mesh-list
6584507|NCT01071291|Nicotinic Acids|nicotinic acids|mesh-list
6584508|NCT01071291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6584509|NCT01071291|Antimetabolites|antimetabolites|mesh-ancestor
6584510|NCT01071291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584511|NCT01071291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6584512|NCT01071291|Vasodilator Agents|vasodilator agents|mesh-ancestor
6447001|NCT00395655|Hydralazine|hydralazine|mesh-list
6447002|NCT00395655|Valproic Acid|valproic acid|mesh-list
6447003|NCT00395655|Anticonvulsants|anticonvulsants|mesh-ancestor
6447004|NCT00395655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6447005|NCT00395655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447006|NCT00395655|GABA Agents|gaba agents|mesh-ancestor
6584513|NCT01071291|Vitamin B Complex|vitamin b complex|mesh-ancestor
6584514|NCT01071291|Vitamins|vitamins|mesh-ancestor
6584515|NCT01071291|Micronutrients|micronutrients|mesh-ancestor
6584516|NCT01071291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447007|NCT00395655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6447008|NCT00395655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447009|NCT00395655|Antimanic Agents|antimanic agents|mesh-ancestor
6447010|NCT00395655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6447011|NCT00395655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6447012|NCT00395655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6447013|NCT00395655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6447014|NCT00395655|Vasodilator Agents|vasodilator agents|mesh-ancestor
6447015|NCT00395681|Propofol|propofol|mesh-list
6447016|NCT00395681|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6447017|NCT00395681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6447018|NCT00395681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584517|NCT01071304|Midazolam|midazolam|mesh-list
6584518|NCT01071304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6584519|NCT01071304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6584520|NCT01071304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6584521|NCT01071304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584522|NCT01071304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6584523|NCT01071304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6584524|NCT01071304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6584525|NCT01071304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6584526|NCT01071304|Anesthetics, General|anesthetics, general|mesh-ancestor
6584527|NCT01071304|Anesthetics|anesthetics|mesh-ancestor
6584528|NCT01071304|GABA Modulators|gaba modulators|mesh-ancestor
6584529|NCT01071304|GABA Agents|gaba agents|mesh-ancestor
6584530|NCT01071304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6584531|NCT01071304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584532|NCT01071369|Betamethasone|betamethasone|mesh-list
6584533|NCT01071369|Betamethasone Valerate|betamethasone valerate|mesh-list
6584534|NCT01071369|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
6584535|NCT01071369|Betamethasone benzoate|betamethasone benzoate|mesh-list
6584536|NCT01071369|Lidocaine|lidocaine|mesh-list
6584537|NCT01071369|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
6584538|NCT01071369|Anesthetics, Local|anesthetics, local|mesh-ancestor
6584539|NCT01071369|Anesthetics|anesthetics|mesh-ancestor
6584540|NCT01071369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6584541|NCT01071369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584542|NCT01071369|Sensory System Agents|sensory system agents|mesh-ancestor
6584543|NCT01071369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6584544|NCT01071369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6584545|NCT01071369|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6584546|NCT01071369|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6584547|NCT01071369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6584548|NCT01071369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584549|NCT01071369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6584550|NCT01071369|Glucocorticoids|glucocorticoids|mesh-ancestor
6584551|NCT01071369|Hormones|hormones|mesh-ancestor
6584552|NCT01071369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6584553|NCT01071369|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6584554|NCT01071369|Respiratory System Agents|respiratory system agents|mesh-ancestor
6584555|NCT01071499|Morphine|morphine|mesh-list
6584556|NCT01071499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6447019|NCT00395681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6447020|NCT00395681|Anesthetics, General|anesthetics, general|mesh-ancestor
6447021|NCT00395681|Anesthetics|anesthetics|mesh-ancestor
6447022|NCT00395707|Ranibizumab|ranibizumab|mesh-list
6447023|NCT00395707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6447024|NCT00395707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6447025|NCT00395707|Growth Substances|growth substances|mesh-ancestor
6447026|NCT00395707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447027|NCT00395707|Growth Inhibitors|growth inhibitors|mesh-ancestor
6447028|NCT00395707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6447029|NCT00395720|Vaccines|vaccines|mesh-list
6447030|NCT00395720|Immunologic Factors|immunologic factors|mesh-ancestor
6447031|NCT00395720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447032|NCT00395759|Lubricant Eye Drops|lubricant eye drops|mesh-list
6447033|NCT00395759|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6447034|NCT00395759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6447035|NCT00395772|Vitamin K|vitamin k|mesh-list
6447036|NCT00395772|Heparin|heparin|mesh-list
6447037|NCT00395772|Rivaroxaban|rivaroxaban|mesh-list
6447038|NCT00395772|Vitamins|vitamins|mesh-ancestor
6584557|NCT01071499|Narcotics|narcotics|mesh-ancestor
6584558|NCT01071499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6584559|NCT01071499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584560|NCT01071499|Analgesics|analgesics|mesh-ancestor
6584561|NCT01071499|Sensory System Agents|sensory system agents|mesh-ancestor
6584562|NCT01071499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6584563|NCT01071525|Niacin|niacin|mesh-list
6584564|NCT01071525|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6584565|NCT01071525|Antimetabolites|antimetabolites|mesh-ancestor
6584566|NCT01071525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584567|NCT01071525|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6584568|NCT01071525|Vasodilator Agents|vasodilator agents|mesh-ancestor
6584569|NCT01071525|Vitamin B Complex|vitamin b complex|mesh-ancestor
6584570|NCT01071525|Vitamins|vitamins|mesh-ancestor
6584571|NCT01071525|Micronutrients|micronutrients|mesh-ancestor
6584572|NCT01071525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584573|NCT01071564|R04929097|r04929097|mesh-list
6584574|NCT01071564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6447039|NCT00395772|Micronutrients|micronutrients|mesh-ancestor
6447040|NCT00395772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447041|NCT00395772|Anticoagulants|anticoagulants|mesh-ancestor
6447042|NCT00395772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6447043|NCT00395772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6447044|NCT00395772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447045|NCT00395772|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6447046|NCT00395772|Antithrombins|antithrombins|mesh-ancestor
6447047|NCT00395772|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6447048|NCT00395772|Protease Inhibitors|protease inhibitors|mesh-ancestor
6447049|NCT00395772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6447050|NCT00395772|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6447051|NCT00395772|Hemostatics|hemostatics|mesh-ancestor
6447052|NCT00395772|Coagulants|coagulants|mesh-ancestor
6447053|NCT00395902|Cinacalcet|cinacalcet|mesh-list
6447054|NCT00395902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6447055|NCT00395902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447056|NCT00395902|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6447057|NCT00395902|Hormone Antagonists|hormone antagonists|mesh-ancestor
6447058|NCT00395902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6447059|NCT00395915|Aripiprazole|aripiprazole|mesh-list
6447060|NCT00395915|Antidepressive Agents|antidepressive agents|mesh-ancestor
6447061|NCT00395915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6447062|NCT00395915|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6447063|NCT00395915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6584575|NCT01071564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584576|NCT01071655|Fluorouracil|fluorouracil|mesh-list
6584577|NCT01071655|Antimetabolites|antimetabolites|mesh-ancestor
6584578|NCT01071655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584579|NCT01071655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6584580|NCT01071655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6584581|NCT01071655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6584582|NCT01071655|Immunologic Factors|immunologic factors|mesh-ancestor
6584583|NCT01071655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584584|NCT01071681|Telmisartan|telmisartan|mesh-list
6584585|NCT01071681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6584586|NCT01071681|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6584587|NCT01071681|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6584588|NCT01071681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584589|NCT01071694|Interferons|interferons|mesh-list
6584590|NCT01071694|Interferon-beta|interferon-beta|mesh-list
6584591|NCT01071694|Interferon beta-1b|interferon beta-1b|mesh-list
6584592|NCT01071694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6584593|NCT01071694|Antiviral Agents|antiviral agents|mesh-ancestor
6584594|NCT01071694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6584595|NCT01071694|Immunologic Factors|immunologic factors|mesh-ancestor
6584596|NCT01071694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584597|NCT01071694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6584598|NCT01071772|Insulin|insulin|mesh-list
6584599|NCT01071772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6584600|NCT01071772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584601|NCT01071889|Flumazenil|flumazenil|mesh-list
6584602|NCT01071889|Antidotes|antidotes|mesh-ancestor
6584603|NCT01071889|Protective Agents|protective agents|mesh-ancestor
6584604|NCT01071889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584605|NCT01071889|GABA Modulators|gaba modulators|mesh-ancestor
6584606|NCT01071889|GABA Agents|gaba agents|mesh-ancestor
6584607|NCT01071889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6584608|NCT01071889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584609|NCT01071928|Docetaxel|docetaxel|mesh-list
6584610|NCT01071928|Vadimezan|vadimezan|mesh-list
6584611|NCT01071928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6584612|NCT01071928|Tubulin Modulators|tubulin modulators|mesh-ancestor
6584613|NCT01071928|Antimitotic Agents|antimitotic agents|mesh-ancestor
6447064|NCT00395915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6447065|NCT00395915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447066|NCT00395915|Dopamine Agonists|dopamine agonists|mesh-ancestor
6447067|NCT00395915|Dopamine Agents|dopamine agents|mesh-ancestor
6447068|NCT00395915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6447069|NCT00395915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447070|NCT00395915|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6447071|NCT00395915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6447072|NCT00395915|Serotonin Agents|serotonin agents|mesh-ancestor
6447073|NCT00395915|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6447074|NCT00395915|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6447075|NCT00395915|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6447076|NCT00395915|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6447077|NCT00395941|Pioglitazone|pioglitazone|mesh-list
6447078|NCT00395941|Acitretin|acitretin|mesh-list
6447079|NCT00395941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6584614|NCT01071928|Mitosis Modulators|mitosis modulators|mesh-ancestor
6584615|NCT01071928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584616|NCT01072045|Prednisone|prednisone|mesh-list
6584617|NCT01072045|Propranolol|propranolol|mesh-list
6584618|NCT01072045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6584619|NCT01072045|Glucocorticoids|glucocorticoids|mesh-ancestor
6584620|NCT01072045|Hormones|hormones|mesh-ancestor
6584621|NCT01072045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6584622|NCT01072045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584623|NCT01072045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6584624|NCT01072045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6584625|NCT01072045|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6584626|NCT01072045|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6584627|NCT01072045|Adrenergic Agents|adrenergic agents|mesh-ancestor
6584628|NCT01072045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6584629|NCT01072045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584630|NCT01072045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6584631|NCT01072045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6584632|NCT01072045|Vasodilator Agents|vasodilator agents|mesh-ancestor
6584633|NCT01072058|Adalimumab|adalimumab|mesh-list
6584634|NCT01072058|Etanercept|etanercept|mesh-list
6584635|NCT01072058|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
6584636|NCT01072058|Infliximab|infliximab|mesh-list
6584637|NCT01072058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6584638|NCT01072058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6584639|NCT01072058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6584640|NCT01072058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6584641|NCT01072058|Analgesics|analgesics|mesh-ancestor
6584642|NCT01072058|Sensory System Agents|sensory system agents|mesh-ancestor
6584643|NCT01072058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6584644|NCT01072058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584645|NCT01072058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6584646|NCT01072058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6584647|NCT01072058|Immunologic Factors|immunologic factors|mesh-ancestor
6584648|NCT01072058|Dermatologic Agents|dermatologic agents|mesh-ancestor
6584649|NCT01072071|Furosemide|furosemide|mesh-list
6584650|NCT01072071|Diuretics|diuretics|mesh-ancestor
6584651|NCT01072071|Natriuretic Agents|natriuretic agents|mesh-ancestor
6584652|NCT01072071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584653|NCT01072071|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6584654|NCT01072071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6584655|NCT01072071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584656|NCT01072097|Atorvastatin|atorvastatin|mesh-list
6584657|NCT01072097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6584658|NCT01072097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6584659|NCT01072097|Antimetabolites|antimetabolites|mesh-ancestor
6584660|NCT01072097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584661|NCT01072097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6584662|NCT01072097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6584663|NCT01072097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6584664|NCT01072175|Trametinib|trametinib|mesh-list
6584665|NCT01072175|Dabrafenib|dabrafenib|mesh-list
6584666|NCT01072175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6584667|NCT01072175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6584668|NCT01072175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6584669|NCT01072175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584670|NCT01072240|Rituximab|rituximab|mesh-list
6584671|NCT01072240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6584672|NCT01072240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6584673|NCT01072240|Immunologic Factors|immunologic factors|mesh-ancestor
6584674|NCT01072240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584675|NCT01072240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6584676|NCT01072318|Letrozole|letrozole|mesh-list
6584677|NCT01072318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6584678|NCT01072318|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6584679|NCT01072318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6584680|NCT01072318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6584681|NCT01072318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584682|NCT01072318|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6584683|NCT01072318|Hormone Antagonists|hormone antagonists|mesh-ancestor
6584684|NCT01072318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6584685|NCT01072318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584686|NCT01072578|Dapagliflozin|dapagliflozin|mesh-list
6658700|NCT01483365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501562|NCT04473144|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6447080|NCT00395941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447081|NCT00395941|Keratolytic Agents|keratolytic agents|mesh-ancestor
6447082|NCT00395941|Dermatologic Agents|dermatologic agents|mesh-ancestor
6447083|NCT00396045|Lenalidomide|lenalidomide|mesh-list
6447084|NCT00396045|Immunologic Factors|immunologic factors|mesh-ancestor
6447085|NCT00396045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584687|NCT01072578|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6584688|NCT01072578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584689|NCT01072578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6584690|NCT01072578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584691|NCT01072604|Aspirin|aspirin|mesh-list
6584692|NCT01072604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6584693|NCT01072604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6584694|NCT01072604|Analgesics|analgesics|mesh-ancestor
6584695|NCT01072604|Sensory System Agents|sensory system agents|mesh-ancestor
6584696|NCT01072604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6584697|NCT01072604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584698|NCT01072604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6584699|NCT01072604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6584700|NCT01072604|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6584701|NCT01072604|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6584702|NCT01072604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584703|NCT01072604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6584704|NCT01072604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6584705|NCT01072604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6584706|NCT01072604|Antipyretics|antipyretics|mesh-ancestor
6584707|NCT01072695|Ribavirin|ribavirin|mesh-list
6584708|NCT01072695|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6584709|NCT01072695|Antimetabolites|antimetabolites|mesh-ancestor
6584710|NCT01072695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584711|NCT01072695|Antiviral Agents|antiviral agents|mesh-ancestor
6584712|NCT01072695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6584713|NCT01072734|Vaccines|vaccines|mesh-list
6584714|NCT01072734|Immunologic Factors|immunologic factors|mesh-ancestor
6584715|NCT01072734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584716|NCT01072747|Heparin|heparin|mesh-list
6584717|NCT01072747|Calcium heparin|calcium heparin|mesh-list
6584718|NCT01072747|Anticoagulants|anticoagulants|mesh-ancestor
6584719|NCT01072747|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6584720|NCT01072747|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6584721|NCT01072747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584722|NCT01072786|Vaccines|vaccines|mesh-list
6447086|NCT00396045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6447087|NCT00396045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6584723|NCT01072786|Immunologic Factors|immunologic factors|mesh-ancestor
6584724|NCT01072786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584725|NCT01072812|Phenserine|phenserine|mesh-list
6584726|NCT01072812|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6584727|NCT01072812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6584728|NCT01072812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584729|NCT01072812|Cholinergic Agents|cholinergic agents|mesh-ancestor
6584730|NCT01072812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6584731|NCT01072812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584732|NCT01072890|Sirolimus|sirolimus|mesh-list
6584733|NCT01072890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6584734|NCT01072890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6584735|NCT01072890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6584736|NCT01072890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6584737|NCT01072890|Antifungal Agents|antifungal agents|mesh-ancestor
6584738|NCT01072890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6584739|NCT01072890|Immunologic Factors|immunologic factors|mesh-ancestor
6584740|NCT01072890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584741|NCT01072942|Ciprofloxacin|ciprofloxacin|mesh-list
6584742|NCT01072942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6584743|NCT01072942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6584744|NCT01072942|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6584745|NCT01072942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6584746|NCT01072942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6584747|NCT01072942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584748|NCT01072942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6584749|NCT01072942|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6584750|NCT01072942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6584751|NCT01072955|Heparin|heparin|mesh-list
6584752|NCT01072955|Calcium heparin|calcium heparin|mesh-list
6584753|NCT01072955|Anticoagulants|anticoagulants|mesh-ancestor
6584754|NCT01072955|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6584755|NCT01072955|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6584756|NCT01072955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658701|NCT01483508|Proanthocyanidin|proanthocyanidin|mesh-list
6658702|NCT01483508|Procyanidin|procyanidin|mesh-list
6658703|NCT01483508|Antioxidants|antioxidants|mesh-ancestor
6658704|NCT01483508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658705|NCT01483508|Protective Agents|protective agents|mesh-ancestor
6658706|NCT01483508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658707|NCT01483508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6658708|NCT01483508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6658709|NCT01483508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6658710|NCT01483638|Axitinib|axitinib|mesh-list
6658711|NCT01483638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6658712|NCT01483638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6658713|NCT01483638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6658714|NCT01483638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658715|NCT01483729|Ritonavir|ritonavir|mesh-list
6658716|NCT01483729|Lactams|lactams|mesh-list
6658717|NCT01483729|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6658718|NCT01483729|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6658719|NCT01483729|Protease Inhibitors|protease inhibitors|mesh-ancestor
6658720|NCT01483729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6658721|NCT01483729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658722|NCT01483729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6658723|NCT01483729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6658724|NCT01483729|Antiviral Agents|antiviral agents|mesh-ancestor
6658725|NCT01483729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6658726|NCT01483729|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6658727|NCT01483729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6584757|NCT01073007|Simvastatin|simvastatin|mesh-list
6584758|NCT01073007|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6584759|NCT01073007|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6584760|NCT01073007|Antimetabolites|antimetabolites|mesh-ancestor
6584761|NCT01073007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584762|NCT01073007|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6584763|NCT01073007|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6584764|NCT01073007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6584765|NCT01073059|Ertapenem|ertapenem|mesh-list
6584766|NCT01073059|Valproic Acid|valproic acid|mesh-list
6584767|NCT01073059|Anticonvulsants|anticonvulsants|mesh-ancestor
6584768|NCT01073059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6584769|NCT01073059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584770|NCT01073059|GABA Agents|gaba agents|mesh-ancestor
6584771|NCT01073059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6584772|NCT01073059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584773|NCT01073059|Antimanic Agents|antimanic agents|mesh-ancestor
6584774|NCT01073059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6584775|NCT01073059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6584776|NCT01073059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6584777|NCT01073059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6584778|NCT01073059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6584779|NCT01073111|Sirolimus|sirolimus|mesh-list
6584780|NCT01073111|Everolimus|everolimus|mesh-list
6584781|NCT01073111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6584782|NCT01073111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6584783|NCT01073111|Immunologic Factors|immunologic factors|mesh-ancestor
6584784|NCT01073111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584785|NCT01073111|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6584786|NCT01073111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6584787|NCT01073111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6584788|NCT01073111|Antifungal Agents|antifungal agents|mesh-ancestor
6584789|NCT01073150|Tea Tree Oil|tea tree oil|mesh-list
6584790|NCT01073150|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6584791|NCT01073150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6584792|NCT01073189|Fenoldopam|fenoldopam|mesh-list
6584793|NCT01073189|Furosemide|furosemide|mesh-list
6584794|NCT01073189|Diuretics|diuretics|mesh-ancestor
6584795|NCT01073189|Natriuretic Agents|natriuretic agents|mesh-ancestor
6584796|NCT01073189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584797|NCT01073189|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6584798|NCT01073189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6584799|NCT01073189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584800|NCT01073189|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6584801|NCT01073189|Vasodilator Agents|vasodilator agents|mesh-ancestor
6584802|NCT01073189|Dopamine Agonists|dopamine agonists|mesh-ancestor
6584803|NCT01073189|Dopamine Agents|dopamine agents|mesh-ancestor
6584804|NCT01073189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6584805|NCT01073202|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
6584806|NCT01073202|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6584807|NCT01073202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6584808|NCT01073319|Rivastigmine|rivastigmine|mesh-list
6584809|NCT01073319|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6584810|NCT01073319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6584811|NCT01073319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584812|NCT01073319|Cholinergic Agents|cholinergic agents|mesh-ancestor
6584813|NCT01073319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6584814|NCT01073319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584815|NCT01073319|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6584816|NCT01073319|Protective Agents|protective agents|mesh-ancestor
6584817|NCT01073332|Antioxidants|antioxidants|mesh-list
6584818|NCT01073332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584819|NCT01073332|Protective Agents|protective agents|mesh-ancestor
6584820|NCT01073332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584821|NCT01073371|Prilocaine|prilocaine|mesh-list
6584822|NCT01073371|Anesthetics, Local|anesthetics, local|mesh-ancestor
6584823|NCT01073371|Anesthetics|anesthetics|mesh-ancestor
6584824|NCT01073371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6584825|NCT01073371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584826|NCT01073371|Sensory System Agents|sensory system agents|mesh-ancestor
6584827|NCT01073371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6584828|NCT01073384|Beclomethasone|beclomethasone|mesh-list
6584829|NCT01073384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6584830|NCT01073384|Glucocorticoids|glucocorticoids|mesh-ancestor
6584831|NCT01073384|Hormones|hormones|mesh-ancestor
6584832|NCT01073384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6584833|NCT01073384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584834|NCT01073384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6584835|NCT01073384|Respiratory System Agents|respiratory system agents|mesh-ancestor
6584836|NCT01073501|Pregabalin|pregabalin|mesh-list
6584837|NCT01073501|Analgesics|analgesics|mesh-ancestor
6584838|NCT01073501|Sensory System Agents|sensory system agents|mesh-ancestor
6584839|NCT01073501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6584840|NCT01073501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584841|NCT01073501|Anticonvulsants|anticonvulsants|mesh-ancestor
6584842|NCT01073501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6584843|NCT01073501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6584844|NCT01073501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584845|NCT01073501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6584846|NCT01073501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6584847|NCT01073501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6584848|NCT01073501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6584849|NCT01073501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6584850|NCT01073527|Adenosine|adenosine|mesh-list
6584851|NCT01073527|Albuterol|albuterol|mesh-list
6584852|NCT01073527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6584853|NCT01073527|Autonomic Agents|autonomic agents|mesh-ancestor
6584854|NCT01073527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6584855|NCT01073527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584856|NCT01073527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6584857|NCT01073527|Respiratory System Agents|respiratory system agents|mesh-ancestor
6584858|NCT01073527|Tocolytic Agents|tocolytic agents|mesh-ancestor
6584859|NCT01073527|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6584860|NCT01073527|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6584861|NCT01073527|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6584862|NCT01073527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6584863|NCT01073527|Adrenergic Agents|adrenergic agents|mesh-ancestor
6584864|NCT01073527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6584865|NCT01073527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584866|NCT01073527|Analgesics|analgesics|mesh-ancestor
6584867|NCT01073527|Sensory System Agents|sensory system agents|mesh-ancestor
6584868|NCT01073527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6584869|NCT01073527|Vasodilator Agents|vasodilator agents|mesh-ancestor
6584870|NCT01073527|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6584871|NCT01073527|Purinergic Agonists|purinergic agonists|mesh-ancestor
6584872|NCT01073527|Purinergic Agents|purinergic agents|mesh-ancestor
6584873|NCT01073540|Cephalexin|cephalexin|mesh-list
6584874|NCT01073540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6584875|NCT01073540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6584876|NCT01073553|Cephalexin|cephalexin|mesh-list
6584877|NCT01073553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6584878|NCT01073553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6584879|NCT01073579|Vigabatrin|vigabatrin|mesh-list
6584880|NCT01073579|Anticonvulsants|anticonvulsants|mesh-ancestor
6584881|NCT01073579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6584882|NCT01073579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584883|NCT01073579|GABA Agents|gaba agents|mesh-ancestor
6584884|NCT01073579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6584885|NCT01073579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584886|NCT01073644|Sunitinib|sunitinib|mesh-list
6584887|NCT01073644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6584888|NCT01073644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6584889|NCT01073644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6584890|NCT01073644|Growth Substances|growth substances|mesh-ancestor
6584891|NCT01073644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584892|NCT01073644|Growth Inhibitors|growth inhibitors|mesh-ancestor
6584893|NCT01073644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6584894|NCT01073644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6584895|NCT01073644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584896|NCT01073670|Acetaminophen|acetaminophen|mesh-list
6584897|NCT01073670|Indomethacin|indomethacin|mesh-list
6584898|NCT01073670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6584899|NCT01073670|Analgesics|analgesics|mesh-ancestor
6584900|NCT01073670|Sensory System Agents|sensory system agents|mesh-ancestor
6584901|NCT01073670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6584902|NCT01073670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584903|NCT01073670|Antipyretics|antipyretics|mesh-ancestor
6584904|NCT01073670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6584905|NCT01073670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6584906|NCT01073670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6584907|NCT01073670|Gout Suppressants|gout suppressants|mesh-ancestor
6584908|NCT01073670|Tocolytic Agents|tocolytic agents|mesh-ancestor
6584909|NCT01073670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6584910|NCT01073670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6584911|NCT01073670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6584912|NCT01073670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584913|NCT01073683|Docetaxel|docetaxel|mesh-list
6584914|NCT01073683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6584915|NCT01073683|Tubulin Modulators|tubulin modulators|mesh-ancestor
6584916|NCT01073683|Antimitotic Agents|antimitotic agents|mesh-ancestor
6584917|NCT01073683|Mitosis Modulators|mitosis modulators|mesh-ancestor
6584918|NCT01073683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584919|NCT01073696|Granisetron|granisetron|mesh-list
6584920|NCT01073696|Antiemetics|antiemetics|mesh-ancestor
6584921|NCT01073696|Autonomic Agents|autonomic agents|mesh-ancestor
6584922|NCT01073696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6584923|NCT01073696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584924|NCT01073696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6584925|NCT01073696|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6584926|NCT01073696|Serotonin Agents|serotonin agents|mesh-ancestor
6584927|NCT01073696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6584928|NCT01073696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584929|NCT01073709|Acetaminophen|acetaminophen|mesh-list
6584930|NCT01073709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6584931|NCT01073709|Analgesics|analgesics|mesh-ancestor
6584932|NCT01073709|Sensory System Agents|sensory system agents|mesh-ancestor
6584933|NCT01073709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6584934|NCT01073709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584935|NCT01073709|Antipyretics|antipyretics|mesh-ancestor
6584936|NCT01073748|Acetaminophen|acetaminophen|mesh-list
6584937|NCT01073748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6584938|NCT01073748|Analgesics|analgesics|mesh-ancestor
6584939|NCT01073748|Sensory System Agents|sensory system agents|mesh-ancestor
6584940|NCT01073748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6584941|NCT01073748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584942|NCT01073748|Antipyretics|antipyretics|mesh-ancestor
6584943|NCT01073761|Ritonavir|ritonavir|mesh-list
6584944|NCT01073761|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6584945|NCT01073761|Darunavir|darunavir|mesh-list
6584946|NCT01073761|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6584947|NCT01073761|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6584948|NCT01073761|Protease Inhibitors|protease inhibitors|mesh-ancestor
6584949|NCT01073761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6584950|NCT01073761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584951|NCT01073761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6584952|NCT01073761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6584953|NCT01073761|Antiviral Agents|antiviral agents|mesh-ancestor
6584954|NCT01073761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6584955|NCT01073761|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6584956|NCT01073761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6584957|NCT01073800|Atorvastatin|atorvastatin|mesh-list
6584958|NCT01073800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6584959|NCT01073800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6584960|NCT01073800|Antimetabolites|antimetabolites|mesh-ancestor
6584961|NCT01073800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584962|NCT01073800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6584963|NCT01073800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6584964|NCT01073800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6584965|NCT01073813|Minocycline|minocycline|mesh-list
6584966|NCT01073813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6584967|NCT01073813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6584968|NCT01073826|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6584969|NCT01073826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6584970|NCT01073826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584971|NCT01073826|Incretins|incretins|mesh-ancestor
6584972|NCT01073826|Hormones|hormones|mesh-ancestor
6584973|NCT01073826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6584974|NCT01073826|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6584975|NCT01073826|Protease Inhibitors|protease inhibitors|mesh-ancestor
6584976|NCT01073826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6584977|NCT01073826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584978|NCT01073839|Gemcitabine|gemcitabine|mesh-list
6447088|NCT00396045|Growth Substances|growth substances|mesh-ancestor
6447089|NCT00396045|Growth Inhibitors|growth inhibitors|mesh-ancestor
6447090|NCT00396045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6447091|NCT00396058|Methylphenidate|methylphenidate|mesh-list
6447092|NCT00396058|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6447093|NCT00396058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447094|NCT00396058|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6447095|NCT00396058|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6447096|NCT00396058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6584979|NCT01073839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6584980|NCT01073839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6584981|NCT01073839|Antimetabolites|antimetabolites|mesh-ancestor
6584982|NCT01073839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584983|NCT01073839|Antiviral Agents|antiviral agents|mesh-ancestor
6584984|NCT01073839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6584985|NCT01073839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6584986|NCT01073839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6584987|NCT01073839|Immunologic Factors|immunologic factors|mesh-ancestor
6584988|NCT01073839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6584989|NCT01073852|Hydroxychloroquine|hydroxychloroquine|mesh-list
6584990|NCT01073852|Antimalarials|antimalarials|mesh-ancestor
6584991|NCT01073852|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6584992|NCT01073852|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6584993|NCT01073852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6584994|NCT01073852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6584995|NCT01073852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6584996|NCT01073852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6584997|NCT01073891|Moxifloxacin|moxifloxacin|mesh-list
6584998|NCT01073891|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6584999|NCT01073891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6585000|NCT01073891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6585001|NCT01073891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6585002|NCT01073891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6585003|NCT01073891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6585004|NCT01073891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6585005|NCT01073891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6585006|NCT01073891|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6585007|NCT01073891|Contraceptive Agents|contraceptive agents|mesh-ancestor
6585008|NCT01073891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6585009|NCT01073891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585010|NCT01073891|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6585011|NCT01073891|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6585012|NCT01073891|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6585013|NCT01073904|Levonorgestrel|levonorgestrel|mesh-list
6585014|NCT01073904|Norgestrel|norgestrel|mesh-list
6585015|NCT01073904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6585016|NCT01073904|Contraceptive Agents|contraceptive agents|mesh-ancestor
6585017|NCT01073904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6585018|NCT01073904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585019|NCT01073904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6585020|NCT01073904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6585021|NCT01073904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6585022|NCT01073904|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6585023|NCT01073995|Triamcinolone|triamcinolone|mesh-list
6585024|NCT01073995|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6585025|NCT01073995|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6585026|NCT01073995|Bupivacaine|bupivacaine|mesh-list
6585027|NCT01073995|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6585028|NCT01073995|Anesthetics, Local|anesthetics, local|mesh-ancestor
6585029|NCT01073995|Anesthetics|anesthetics|mesh-ancestor
6585030|NCT01073995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6585031|NCT01073995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585032|NCT01073995|Sensory System Agents|sensory system agents|mesh-ancestor
6585033|NCT01073995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6585034|NCT01073995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6585035|NCT01073995|Glucocorticoids|glucocorticoids|mesh-ancestor
6447097|NCT00396058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447098|NCT00396058|Dopamine Agents|dopamine agents|mesh-ancestor
6447099|NCT00396058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6447100|NCT00396071|Vildagliptin|vildagliptin|mesh-list
6585036|NCT01073995|Hormones|hormones|mesh-ancestor
6585037|NCT01073995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6585038|NCT01073995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6585039|NCT01073995|Immunologic Factors|immunologic factors|mesh-ancestor
6585040|NCT01073995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6585041|NCT01073995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6585042|NCT01074021|Nimotuzumab|nimotuzumab|mesh-list
6585043|NCT01074021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6585044|NCT01074021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6585045|NCT01074060|Plerixafor|plerixafor|mesh-list
6585046|NCT01074060|Cyclophosphamide|cyclophosphamide|mesh-list
6585047|NCT01074060|Lenograstim|lenograstim|mesh-list
6585048|NCT01074060|Sargramostim|sargramostim|mesh-list
6585049|NCT01074060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6585050|NCT01074060|Immunologic Factors|immunologic factors|mesh-ancestor
6585051|NCT01074060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585052|NCT01074060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6585053|NCT01074060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6585054|NCT01074060|Alkylating Agents|alkylating agents|mesh-ancestor
6585055|NCT01074060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6585056|NCT01074060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6585057|NCT01074060|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6585058|NCT01074060|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6585059|NCT01074060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6585060|NCT01074060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6585061|NCT01074060|Antiviral Agents|antiviral agents|mesh-ancestor
6585062|NCT01074060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6585063|NCT01074073|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
6585064|NCT01074073|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6585065|NCT01074073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6585066|NCT01074073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6585067|NCT01074073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585068|NCT01074073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6585069|NCT01074073|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6585070|NCT01074073|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6585071|NCT01074073|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6585072|NCT01074073|Adrenergic Agents|adrenergic agents|mesh-ancestor
6585073|NCT01074073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6585074|NCT01074073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6585075|NCT01074073|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6585076|NCT01074073|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6585077|NCT01074073|Serotonin Agents|serotonin agents|mesh-ancestor
6585078|NCT01074073|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6585079|NCT01074073|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6585080|NCT01074073|Dopamine Agents|dopamine agents|mesh-ancestor
6585081|NCT01074086|Everolimus|everolimus|mesh-list
6447101|NCT00396071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6447102|NCT00396071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447103|NCT00396071|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6447104|NCT00396071|Protease Inhibitors|protease inhibitors|mesh-ancestor
6447105|NCT00396071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6585082|NCT01074086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6585083|NCT01074086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6585084|NCT01074086|Immunologic Factors|immunologic factors|mesh-ancestor
6585085|NCT01074086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585086|NCT01074138|Tirbanibulin|tirbanibulin|mesh-list
6585087|NCT01074138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6585088|NCT01074138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6585089|NCT01074151|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6585090|NCT01074151|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6585091|NCT01074151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6585092|NCT01074151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6585093|NCT01074151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6585094|NCT01074151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6585095|NCT01074151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585096|NCT01074151|Analgesics|analgesics|mesh-ancestor
6585097|NCT01074151|Sensory System Agents|sensory system agents|mesh-ancestor
6585098|NCT01074151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6585099|NCT01074151|Antidepressive Agents|antidepressive agents|mesh-ancestor
6585100|NCT01074151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6585101|NCT01074151|Dopamine Agents|dopamine agents|mesh-ancestor
6585102|NCT01074190|Fentanyl|fentanyl|mesh-list
6585103|NCT01074190|Bupivacaine|bupivacaine|mesh-list
6585104|NCT01074190|Anesthetics, Local|anesthetics, local|mesh-ancestor
6585105|NCT01074190|Anesthetics|anesthetics|mesh-ancestor
6585106|NCT01074190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6585107|NCT01074190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585108|NCT01074190|Sensory System Agents|sensory system agents|mesh-ancestor
6585109|NCT01074190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6585110|NCT01074190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6585111|NCT01074190|Narcotics|narcotics|mesh-ancestor
6585112|NCT01074190|Analgesics|analgesics|mesh-ancestor
6585113|NCT01074190|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6585114|NCT01074190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6585115|NCT01074190|Anesthetics, General|anesthetics, general|mesh-ancestor
6585116|NCT01074203|Nitazoxanide|nitazoxanide|mesh-list
6585117|NCT01074203|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6585118|NCT01074203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6585119|NCT01074281|Enalapril|enalapril|mesh-list
6585120|NCT01074281|Enalaprilat|enalaprilat|mesh-list
6585121|NCT01074281|Nitrendipine|nitrendipine|mesh-list
6585122|NCT01074281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6585123|NCT01074281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6585124|NCT01074281|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6585125|NCT01074281|Protease Inhibitors|protease inhibitors|mesh-ancestor
6585126|NCT01074281|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6585127|NCT01074281|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6585128|NCT01074281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6585129|NCT01074281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6585130|NCT01074281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585131|NCT01074281|Vasodilator Agents|vasodilator agents|mesh-ancestor
6585132|NCT01074333|Cetuximab|cetuximab|mesh-list
6585133|NCT01074333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6585134|NCT01074333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6585135|NCT01074346|Interferons|interferons|mesh-list
6585136|NCT01074346|Interferon-beta|interferon-beta|mesh-list
6585137|NCT01074346|Interferon beta-1a|interferon beta-1a|mesh-list
6585138|NCT01074346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6585139|NCT01074346|Antiviral Agents|antiviral agents|mesh-ancestor
6585140|NCT01074346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6585141|NCT01074346|Immunologic Factors|immunologic factors|mesh-ancestor
6585142|NCT01074346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585143|NCT01074346|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6585144|NCT01074359|Tocopherylquinone|tocopherylquinone|mesh-list
6585145|NCT01074359|Anticoagulants|anticoagulants|mesh-ancestor
6585146|NCT01074359|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6585147|NCT01074359|Antioxidants|antioxidants|mesh-ancestor
6585148|NCT01074359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6585149|NCT01074359|Protective Agents|protective agents|mesh-ancestor
6585150|NCT01074359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585151|NCT01074411|Carboplatin|carboplatin|mesh-list
6585152|NCT01074411|Bortezomib|bortezomib|mesh-list
6585153|NCT01074411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6585154|NCT01074567|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
6585155|NCT01074567|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6585156|NCT01074567|Protective Agents|protective agents|mesh-ancestor
6585157|NCT01074567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585158|NCT01074567|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6585159|NCT01074567|Antioxidants|antioxidants|mesh-ancestor
6585160|NCT01074567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6585161|NCT01074593|Interferons|interferons|mesh-list
6585162|NCT01074593|Interferon-beta|interferon-beta|mesh-list
6585163|NCT01074593|Interferon beta-1a|interferon beta-1a|mesh-list
6585164|NCT01074593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6585165|NCT01074593|Antiviral Agents|antiviral agents|mesh-ancestor
6585166|NCT01074593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6585167|NCT01074593|Immunologic Factors|immunologic factors|mesh-ancestor
6585168|NCT01074593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585169|NCT01074593|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6585170|NCT01074619|Memantine|memantine|mesh-list
6585171|NCT01074619|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6585172|NCT01074619|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6585173|NCT01074619|Dopamine Agents|dopamine agents|mesh-ancestor
6585174|NCT01074619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6585175|NCT01074619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6585176|NCT01074619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585177|NCT01074619|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6585178|NCT01074619|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6585179|NCT01074632|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
6585180|NCT01074632|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6585181|NCT01074632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6585182|NCT01074632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6585183|NCT01074632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585184|NCT01074632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6585185|NCT01074632|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6585186|NCT01074632|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6585187|NCT01074632|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6585188|NCT01074632|Adrenergic Agents|adrenergic agents|mesh-ancestor
6585189|NCT01074632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6585190|NCT01074632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6585191|NCT01074632|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6585192|NCT01074632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6585193|NCT01074632|Serotonin Agents|serotonin agents|mesh-ancestor
6585194|NCT01074632|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6585195|NCT01074632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6585196|NCT01074632|Dopamine Agents|dopamine agents|mesh-ancestor
6585197|NCT01074645|Tenofovir|tenofovir|mesh-list
6585198|NCT01074645|Antiviral Agents|antiviral agents|mesh-ancestor
6585199|NCT01074645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6585200|NCT01074645|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6585201|NCT01074645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6585202|NCT01074645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6585203|NCT01074645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6585204|NCT01074645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6585205|NCT01074645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6585206|NCT01074697|Dexamethasone|dexamethasone|mesh-list
6585207|NCT01074697|Palonosetron|palonosetron|mesh-list
6585208|NCT01074697|Fosaprepitant|fosaprepitant|mesh-list
6585209|NCT01074697|Aprepitant|aprepitant|mesh-list
6585210|NCT01074697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6585211|NCT01074697|Antiemetics|antiemetics|mesh-ancestor
6585212|NCT01074697|Autonomic Agents|autonomic agents|mesh-ancestor
6585213|NCT01074697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6585214|NCT01074697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585215|NCT01074697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6585216|NCT01074697|Glucocorticoids|glucocorticoids|mesh-ancestor
6585217|NCT01074697|Hormones|hormones|mesh-ancestor
6585218|NCT01074697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6585219|NCT01074697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6585220|NCT01074697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6585221|NCT01074697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6585222|NCT01074697|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6585223|NCT01074697|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6585224|NCT01074697|Serotonin Agents|serotonin agents|mesh-ancestor
6585225|NCT01074697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6585226|NCT01074697|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6585227|NCT01074723|Carotenoids|carotenoids|mesh-list
6585228|NCT01074723|Antioxidants|antioxidants|mesh-ancestor
6585229|NCT01074723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6585230|NCT01074723|Protective Agents|protective agents|mesh-ancestor
6585231|NCT01074723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658728|NCT01483729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6658729|NCT01483781|Canagliflozin|canagliflozin|mesh-list
6658730|NCT01483781|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6658731|NCT01483781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658732|NCT01483781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6658733|NCT01483781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658734|NCT01483859|Liver Extracts|liver extracts|mesh-list
6658735|NCT01483859|Hematinics|hematinics|mesh-ancestor
6658736|NCT01483911|Gontivimab|gontivimab|mesh-list
6658737|NCT01483911|Antiviral Agents|antiviral agents|mesh-ancestor
6658738|NCT01483911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6658739|NCT01484015|Cefepime|cefepime|mesh-list
6658740|NCT01484015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6658741|NCT01484015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6658742|NCT01484080|Paclitaxel|paclitaxel|mesh-list
6658743|NCT01484080|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6658744|NCT01484080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6658745|NCT01484080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6658746|NCT01484080|Tubulin Modulators|tubulin modulators|mesh-ancestor
6658747|NCT01484080|Antimitotic Agents|antimitotic agents|mesh-ancestor
6658748|NCT01484080|Mitosis Modulators|mitosis modulators|mesh-ancestor
6658749|NCT01484080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658750|NCT01484145|Terbinafine|terbinafine|mesh-list
6658751|NCT01484145|Antifungal Agents|antifungal agents|mesh-ancestor
6658752|NCT01484145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6585232|NCT01074801|Insulin|insulin|mesh-list
6585233|NCT01074801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6585234|NCT01074801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6585235|NCT01074801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585236|NCT01074853|Propranolol|propranolol|mesh-list
6585237|NCT01074853|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6585238|NCT01074853|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6585239|NCT01074853|Adrenergic Agents|adrenergic agents|mesh-ancestor
6447106|NCT00396071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447107|NCT00396214|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6585240|NCT01074853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6585241|NCT01074853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6585242|NCT01074853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585243|NCT01074853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6585244|NCT01074853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6585245|NCT01074853|Vasodilator Agents|vasodilator agents|mesh-ancestor
6585246|NCT01074879|Caseins|caseins|mesh-list
6585247|NCT01074879|Chelating Agents|chelating agents|mesh-ancestor
6585248|NCT01074879|Sequestering Agents|sequestering agents|mesh-ancestor
6585249|NCT01074879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6585250|NCT01074892|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6585251|NCT01074892|Levonorgestrel|levonorgestrel|mesh-list
6585252|NCT01074892|Medroxyprogesterone|medroxyprogesterone|mesh-list
6585253|NCT01074892|Progestins|progestins|mesh-list
6585254|NCT01074892|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6585255|NCT01074892|Contraceptive Agents|contraceptive agents|mesh-ancestor
6585256|NCT01074892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6585257|NCT01074892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585258|NCT01074892|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6585259|NCT01074892|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6585260|NCT01074892|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6585261|NCT01074892|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6585262|NCT01074892|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6447108|NCT00396214|Antidepressive Agents|antidepressive agents|mesh-ancestor
6447109|NCT00396214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6447110|NCT00396214|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6447111|NCT00396214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6585263|NCT01074892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6585264|NCT01074892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6585265|NCT01074892|Hormones|hormones|mesh-ancestor
6585266|NCT01074892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6585267|NCT01074905|Artesunate|artesunate|mesh-list
6585268|NCT01074905|Chloroquine|chloroquine|mesh-list
6585269|NCT01074905|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
6585270|NCT01074905|Primaquine|primaquine|mesh-list
6585271|NCT01074905|Antimalarials|antimalarials|mesh-ancestor
6585272|NCT01074905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6585273|NCT01074905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6585274|NCT01074905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6585275|NCT01074905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6585276|NCT01074905|Antiviral Agents|antiviral agents|mesh-ancestor
6585277|NCT01074905|Schistosomicides|schistosomicides|mesh-ancestor
6585278|NCT01074905|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6447112|NCT00396214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6447113|NCT00396214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447114|NCT00396227|Pioglitazone|pioglitazone|mesh-list
6447115|NCT00396227|Rosiglitazone|rosiglitazone|mesh-list
6447116|NCT00396227|Vildagliptin|vildagliptin|mesh-list
6447117|NCT00396227|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
6585279|NCT01074905|Anthelmintics|anthelmintics|mesh-ancestor
6585280|NCT01074905|Amebicides|amebicides|mesh-ancestor
6585281|NCT01074905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6585282|NCT01074905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6585283|NCT01074905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6585284|NCT01074905|Analgesics|analgesics|mesh-ancestor
6585285|NCT01074905|Sensory System Agents|sensory system agents|mesh-ancestor
6585286|NCT01074905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6585287|NCT01074905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585288|NCT01074905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6585289|NCT01074905|Filaricides|filaricides|mesh-ancestor
6585290|NCT01074905|Antinematodal Agents|antinematodal agents|mesh-ancestor
6585291|NCT01074970|Cisplatin|cisplatin|mesh-list
6585292|NCT01074970|Rucaparib|rucaparib|mesh-list
6585293|NCT01074970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6585294|NCT01074970|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6585295|NCT01074970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6585296|NCT01074970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6585297|NCT01074996|Leucovorin|leucovorin|mesh-list
6447118|NCT00396227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6447119|NCT00396227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447120|NCT00396227|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6447121|NCT00396227|Protease Inhibitors|protease inhibitors|mesh-ancestor
6447122|NCT00396227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6447123|NCT00396227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447124|NCT00396240|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6447125|NCT00396240|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6447126|NCT00396240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6447127|NCT00396240|Antimetabolites|antimetabolites|mesh-ancestor
6447128|NCT00396240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447129|NCT00396240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6447130|NCT00396240|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6447131|NCT00396240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6447132|NCT00396344|Hydrocortisone|hydrocortisone|mesh-list
6447133|NCT00396344|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6447134|NCT00396344|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6447135|NCT00396344|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6585298|NCT01074996|Antidotes|antidotes|mesh-ancestor
6585299|NCT01074996|Protective Agents|protective agents|mesh-ancestor
6585300|NCT01074996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447136|NCT00396344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6585301|NCT01074996|Vitamin B Complex|vitamin b complex|mesh-ancestor
6585302|NCT01074996|Vitamins|vitamins|mesh-ancestor
6585303|NCT01074996|Micronutrients|micronutrients|mesh-ancestor
6585304|NCT01075022|Vitamin D|vitamin d|mesh-list
6585305|NCT01075022|Cholecalciferol|cholecalciferol|mesh-list
6585306|NCT01075022|Vitamins|vitamins|mesh-ancestor
6585307|NCT01075022|Micronutrients|micronutrients|mesh-ancestor
6585308|NCT01075022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585309|NCT01075022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6585310|NCT01075022|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6585311|NCT01075113|Sorafenib|sorafenib|mesh-list
6585312|NCT01075113|Vorinostat|vorinostat|mesh-list
6585313|NCT01075113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6585314|NCT01075113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6585315|NCT01075113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6585316|NCT01075113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6585317|NCT01075113|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6585318|NCT01075126|Valproic Acid|valproic acid|mesh-list
6585319|NCT01075126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6585320|NCT01075126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6585321|NCT01075126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6585322|NCT01075126|Antimanic Agents|antimanic agents|mesh-ancestor
6585323|NCT01075126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6585324|NCT01075126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6585325|NCT01075126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585326|NCT01075126|Anticonvulsants|anticonvulsants|mesh-ancestor
6585327|NCT01075126|GABA Agents|gaba agents|mesh-ancestor
6447137|NCT00396396|Acetylcysteine|acetylcysteine|mesh-list
6447138|NCT00396396|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6585328|NCT01075126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6585329|NCT01075308|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
6585330|NCT01075308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6585331|NCT01075308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6585332|NCT01075425|Bortezomib|bortezomib|mesh-list
6585333|NCT01075425|Belinostat|belinostat|mesh-list
6585334|NCT01075425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6585335|NCT01075425|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6585336|NCT01075425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6585337|NCT01075425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6585338|NCT01075438|Vaccines|vaccines|mesh-list
6585339|NCT01075438|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6585340|NCT01075438|Immunologic Factors|immunologic factors|mesh-ancestor
6585341|NCT01075438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585342|NCT01075464|Paclitaxel|paclitaxel|mesh-list
6585343|NCT01075464|Bevacizumab|bevacizumab|mesh-list
6585344|NCT01075464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6585345|NCT01075464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6585346|NCT01075464|Tubulin Modulators|tubulin modulators|mesh-ancestor
6585347|NCT01075464|Antimitotic Agents|antimitotic agents|mesh-ancestor
6585348|NCT01075464|Mitosis Modulators|mitosis modulators|mesh-ancestor
6585349|NCT01075464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6585350|NCT01075464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6585351|NCT01075464|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6585352|NCT01075464|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6585353|NCT01075464|Growth Substances|growth substances|mesh-ancestor
6585354|NCT01075464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585355|NCT01075464|Growth Inhibitors|growth inhibitors|mesh-ancestor
6585356|NCT01075477|Rituximab|rituximab|mesh-list
6585357|NCT01075477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6585358|NCT01075477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6585359|NCT01075477|Immunologic Factors|immunologic factors|mesh-ancestor
6585360|NCT01075477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585361|NCT01075477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6585362|NCT01075490|Clonidine|clonidine|mesh-list
6585363|NCT01075490|Analgesics|analgesics|mesh-ancestor
6585364|NCT01075490|Sensory System Agents|sensory system agents|mesh-ancestor
6585365|NCT01075490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6585366|NCT01075490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585367|NCT01075490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6585368|NCT01075490|Sympatholytics|sympatholytics|mesh-ancestor
6585369|NCT01075490|Autonomic Agents|autonomic agents|mesh-ancestor
6585370|NCT01075490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6585371|NCT01075490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6585372|NCT01075490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6585373|NCT01075490|Adrenergic Agents|adrenergic agents|mesh-ancestor
6585374|NCT01075490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6585375|NCT01075490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6585376|NCT01075503|Ropivacaine|ropivacaine|mesh-list
6585377|NCT01075503|Anesthetics, Local|anesthetics, local|mesh-ancestor
6585378|NCT01075503|Anesthetics|anesthetics|mesh-ancestor
6585379|NCT01075503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6585380|NCT01075503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585381|NCT01075503|Sensory System Agents|sensory system agents|mesh-ancestor
6585382|NCT01075503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6585383|NCT01075529|Fluoxetine|fluoxetine|mesh-list
6585384|NCT01075529|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6585385|NCT01075529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6585386|NCT01075529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6585387|NCT01075529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6585388|NCT01075529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6585389|NCT01075529|Serotonin Agents|serotonin agents|mesh-ancestor
6585390|NCT01075529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585391|NCT01075529|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6585392|NCT01075529|Antidepressive Agents|antidepressive agents|mesh-ancestor
6585393|NCT01075529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6585394|NCT01075529|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6585395|NCT01075529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6585396|NCT01075529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6585397|NCT01075555|Sorafenib|sorafenib|mesh-list
6585398|NCT01075555|Pravastatin|pravastatin|mesh-list
6585399|NCT01075555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6585400|NCT01075555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6585401|NCT01075555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6585402|NCT01075555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6585403|NCT01075555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6585404|NCT01075555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6585405|NCT01075555|Antimetabolites|antimetabolites|mesh-ancestor
6585406|NCT01075555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6585407|NCT01075555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6585408|NCT01075581|Epinephrine|epinephrine|mesh-list
6585409|NCT01075581|Racepinephrine|racepinephrine|mesh-list
6585410|NCT01075581|Epinephryl borate|epinephryl borate|mesh-list
5501563|NCT04473144|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5501564|NCT04473144|Protease Inhibitors|protease inhibitors|mesh-ancestor
5501565|NCT04473144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5501566|NCT04473144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501567|NCT04472910|Folfirinox|folfirinox|mesh-list
5501568|NCT04472910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6585411|NCT01075581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6585412|NCT01075581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6585413|NCT01075581|Adrenergic Agents|adrenergic agents|mesh-ancestor
6585414|NCT01075581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6585415|NCT01075581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6585416|NCT01075581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585417|NCT01075581|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6585418|NCT01075581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6585419|NCT01075581|Autonomic Agents|autonomic agents|mesh-ancestor
6585420|NCT01075581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6585421|NCT01075581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6585422|NCT01075581|Respiratory System Agents|respiratory system agents|mesh-ancestor
6585423|NCT01075581|Mydriatics|mydriatics|mesh-ancestor
6585424|NCT01075581|Sympathomimetics|sympathomimetics|mesh-ancestor
6585425|NCT01075581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6585426|NCT01075659|Nicotine|nicotine|mesh-list
6585427|NCT01075659|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6585428|NCT01075659|Autonomic Agents|autonomic agents|mesh-ancestor
6585429|NCT01075659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6585430|NCT01075659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585431|NCT01075659|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6585432|NCT01075659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6585433|NCT01075659|Cholinergic Agents|cholinergic agents|mesh-ancestor
6585434|NCT01075659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6585435|NCT01075659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6585436|NCT01075698|Telmisartan|telmisartan|mesh-list
6585437|NCT01075698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6585438|NCT01075698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5501569|NCT04472949|Carboplatin|carboplatin|mesh-list
6447139|NCT00396396|Antiviral Agents|antiviral agents|mesh-ancestor
6447140|NCT00396396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5724821|NCT03185130|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6447141|NCT00396396|Expectorants|expectorants|mesh-ancestor
6447142|NCT00396396|Respiratory System Agents|respiratory system agents|mesh-ancestor
6585439|NCT01075698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6585440|NCT01075698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6585441|NCT01075711|Prednisone|prednisone|mesh-list
6585442|NCT01075711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6585443|NCT01075711|Glucocorticoids|glucocorticoids|mesh-ancestor
6585444|NCT01075711|Hormones|hormones|mesh-ancestor
6585445|NCT01075711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6585446|NCT01075711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585447|NCT01075711|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6585448|NCT01075711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6585449|NCT01075776|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
6585450|NCT01075776|Acetylcholine|acetylcholine|mesh-list
6585451|NCT01075776|Vasodilator Agents|vasodilator agents|mesh-ancestor
6585452|NCT01075776|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6585453|NCT01075776|Cholinergic Agents|cholinergic agents|mesh-ancestor
6585454|NCT01075776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6585455|NCT01075776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6585456|NCT01075776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585457|NCT01075776|Natriuretic Agents|natriuretic agents|mesh-ancestor
6585458|NCT01075789|Lidocaine|lidocaine|mesh-list
6585459|NCT01075789|Anesthetics, Local|anesthetics, local|mesh-ancestor
6585460|NCT01075789|Anesthetics|anesthetics|mesh-ancestor
6585461|NCT01075789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6585462|NCT01075789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585463|NCT01075789|Sensory System Agents|sensory system agents|mesh-ancestor
6585464|NCT01075789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6585465|NCT01075789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6585466|NCT01075789|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6585467|NCT01075789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6585468|NCT01075789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6585469|NCT01075789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6585470|NCT01075802|Tamoxifen|tamoxifen|mesh-list
6585471|NCT01075802|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6585472|NCT01075802|Hormone Antagonists|hormone antagonists|mesh-ancestor
6585473|NCT01075802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6585474|NCT01075802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585475|NCT01075802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6585476|NCT01075802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6447143|NCT00396396|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6447144|NCT00396396|Antioxidants|antioxidants|mesh-ancestor
6447145|NCT00396396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447146|NCT00396396|Protective Agents|protective agents|mesh-ancestor
6447147|NCT00396396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447148|NCT00396396|Antidotes|antidotes|mesh-ancestor
6447149|NCT00396487|Fluorouracil|fluorouracil|mesh-list
6447150|NCT00396487|Capecitabine|capecitabine|mesh-list
6447151|NCT00396487|Irinotecan|irinotecan|mesh-list
6447152|NCT00396487|Antimetabolites|antimetabolites|mesh-ancestor
6447153|NCT00396487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447154|NCT00396487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6447155|NCT00396487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6447156|NCT00396487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6658753|NCT01484145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6447157|NCT00396487|Immunologic Factors|immunologic factors|mesh-ancestor
6585477|NCT01075802|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6585478|NCT01075802|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6585479|NCT01075802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6585480|NCT01075828|Cetuximab|cetuximab|mesh-list
6585481|NCT01075828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6585482|NCT01075828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6585483|NCT01075841|Cetuximab|cetuximab|mesh-list
6585484|NCT01075841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6585485|NCT01075841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6585486|NCT01075854|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6585487|NCT01075854|Hormones|hormones|mesh-ancestor
6585488|NCT01075854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6585489|NCT01075854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585490|NCT01075880|Interferons|interferons|mesh-list
6585491|NCT01075880|Interferon-beta|interferon-beta|mesh-list
6585492|NCT01075880|Interferon beta-1a|interferon beta-1a|mesh-list
6585493|NCT01075880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6585494|NCT01075880|Antiviral Agents|antiviral agents|mesh-ancestor
6585495|NCT01075880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6585496|NCT01075880|Immunologic Factors|immunologic factors|mesh-ancestor
6585497|NCT01075880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585498|NCT01075880|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6585499|NCT01075906|Colchicine|colchicine|mesh-list
6585500|NCT01075906|Gout Suppressants|gout suppressants|mesh-ancestor
6585501|NCT01075906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6585502|NCT01075906|Tubulin Modulators|tubulin modulators|mesh-ancestor
6585503|NCT01075906|Antimitotic Agents|antimitotic agents|mesh-ancestor
6585504|NCT01075906|Mitosis Modulators|mitosis modulators|mesh-ancestor
6585505|NCT01075906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6585506|NCT01075906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6585507|NCT01075945|Lumefantrine|lumefantrine|mesh-list
6585508|NCT01075945|Artemether|artemether|mesh-list
6585509|NCT01075945|Piperaquine|piperaquine|mesh-list
6585510|NCT01075945|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6585511|NCT01075945|Artenimol|artenimol|mesh-list
6585512|NCT01075945|Antimalarials|antimalarials|mesh-ancestor
6585513|NCT01075945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6585514|NCT01075945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6585515|NCT01075945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6585516|NCT01076062|Misoprostol|misoprostol|mesh-list
6585517|NCT01076062|Oxytocin|oxytocin|mesh-list
6585518|NCT01076062|Oxytocics|oxytocics|mesh-ancestor
6585519|NCT01076062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6585520|NCT01076062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585521|NCT01076062|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6585522|NCT01076062|Abortifacient Agents|abortifacient agents|mesh-ancestor
6585523|NCT01076062|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6585524|NCT01076062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6585525|NCT01076140|Lisinopril|lisinopril|mesh-list
6585526|NCT01076140|Nebivolol|nebivolol|mesh-list
6585527|NCT01076140|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6585528|NCT01076140|Protease Inhibitors|protease inhibitors|mesh-ancestor
6585529|NCT01076140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6585530|NCT01076140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6585531|NCT01076140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6585532|NCT01076140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6585533|NCT01076140|Protective Agents|protective agents|mesh-ancestor
6585534|NCT01076140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585535|NCT01076140|Vasodilator Agents|vasodilator agents|mesh-ancestor
6585536|NCT01076140|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6585537|NCT01076140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6585538|NCT01076140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6585539|NCT01076140|Adrenergic Agents|adrenergic agents|mesh-ancestor
6585540|NCT01076140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6585541|NCT01076322|Albuterol|albuterol|mesh-list
6447158|NCT00396487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447159|NCT00396487|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6447160|NCT00396487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6447161|NCT00396487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6447162|NCT00396500|Vitamin A|vitamin a|mesh-list
6447163|NCT00396500|Albendazole|albendazole|mesh-list
6447164|NCT00396500|Vitamins|vitamins|mesh-ancestor
6447165|NCT00396500|Micronutrients|micronutrients|mesh-ancestor
6447166|NCT00396500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447167|NCT00396500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447168|NCT00396500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6447169|NCT00396500|Anthelmintics|anthelmintics|mesh-ancestor
6447170|NCT00396500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6447171|NCT00396500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6447172|NCT00396500|Anticestodal Agents|anticestodal agents|mesh-ancestor
6447173|NCT00396500|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6447174|NCT00396500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6447175|NCT00396500|Tubulin Modulators|tubulin modulators|mesh-ancestor
6447176|NCT00396500|Antimitotic Agents|antimitotic agents|mesh-ancestor
6447177|NCT00396500|Mitosis Modulators|mitosis modulators|mesh-ancestor
6447178|NCT00396513|Metformin|metformin|mesh-list
6447179|NCT00396513|Simvastatin|simvastatin|mesh-list
6585542|NCT01076322|Procaterol|procaterol|mesh-list
6585543|NCT01076322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6585544|NCT01076322|Autonomic Agents|autonomic agents|mesh-ancestor
6585545|NCT01076322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6585546|NCT01076322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585547|NCT01076322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6585548|NCT01076322|Respiratory System Agents|respiratory system agents|mesh-ancestor
6585549|NCT01076322|Tocolytic Agents|tocolytic agents|mesh-ancestor
6585550|NCT01076322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6585551|NCT01076322|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6585552|NCT01076322|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6585553|NCT01076322|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6585554|NCT01076322|Adrenergic Agents|adrenergic agents|mesh-ancestor
6585555|NCT01076322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6585556|NCT01076322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6585557|NCT01076322|Sympathomimetics|sympathomimetics|mesh-ancestor
6585558|NCT01076439|Fluticasone|fluticasone|mesh-list
6585559|NCT01076439|Xhance|xhance|mesh-list
6585560|NCT01076439|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
6585561|NCT01076439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6585562|NCT01076439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6585563|NCT01076439|Autonomic Agents|autonomic agents|mesh-ancestor
6585564|NCT01076439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6585565|NCT01076439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585566|NCT01076439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6585567|NCT01076439|Respiratory System Agents|respiratory system agents|mesh-ancestor
6585568|NCT01076439|Dermatologic Agents|dermatologic agents|mesh-ancestor
6585569|NCT01076439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6585570|NCT01076439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6585571|NCT01076439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6585572|NCT01076439|Analgesics|analgesics|mesh-ancestor
6585573|NCT01076439|Sensory System Agents|sensory system agents|mesh-ancestor
6585574|NCT01076439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6585575|NCT01076439|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6585576|NCT01076439|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6585577|NCT01076439|Histamine Antagonists|histamine antagonists|mesh-ancestor
6585578|NCT01076439|Histamine Agents|histamine agents|mesh-ancestor
6585579|NCT01076439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6585580|NCT01076439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6585581|NCT01076478|Cilostazol|cilostazol|mesh-list
6585582|NCT01076478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6585583|NCT01076478|Autonomic Agents|autonomic agents|mesh-ancestor
6585584|NCT01076478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6585585|NCT01076478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585586|NCT01076478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6585587|NCT01076478|Respiratory System Agents|respiratory system agents|mesh-ancestor
6585588|NCT01076478|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6585589|NCT01076478|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6585590|NCT01076478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6585591|NCT01076478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6585592|NCT01076478|Vasodilator Agents|vasodilator agents|mesh-ancestor
6585593|NCT01076478|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6585594|NCT01076478|Protective Agents|protective agents|mesh-ancestor
6585595|NCT01076478|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6585596|NCT01076478|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6585597|NCT01076478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6585598|NCT01076491|Mannitol|mannitol|mesh-list
6585599|NCT01076491|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6585600|NCT01076491|Diuretics|diuretics|mesh-ancestor
6585601|NCT01076491|Natriuretic Agents|natriuretic agents|mesh-ancestor
6585602|NCT01076491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585603|NCT01076530|Temozolomide|temozolomide|mesh-list
6585604|NCT01076530|Vorinostat|vorinostat|mesh-list
6585605|NCT01076530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6585606|NCT01076530|Alkylating Agents|alkylating agents|mesh-ancestor
6585607|NCT01076530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6585608|NCT01076530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6585609|NCT01076530|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6585610|NCT01076530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6585611|NCT01076556|Cyclophosphamide|cyclophosphamide|mesh-list
6585612|NCT01076556|Rituximab|rituximab|mesh-list
6585613|NCT01076556|Alvocidib|alvocidib|mesh-list
6585614|NCT01076556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6585615|NCT01076556|Antibodies|antibodies|mesh-list
6585616|NCT01076556|Immunoglobulins|immunoglobulins|mesh-list
6585617|NCT01076556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6585618|NCT01076556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6585619|NCT01076556|Immunologic Factors|immunologic factors|mesh-ancestor
6585620|NCT01076556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585621|NCT01076556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6585622|NCT01076556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6585623|NCT01076556|Alkylating Agents|alkylating agents|mesh-ancestor
6447180|NCT00396513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6447181|NCT00396513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447182|NCT00396513|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6447183|NCT00396513|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6447184|NCT00396513|Antimetabolites|antimetabolites|mesh-ancestor
6447185|NCT00396513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447186|NCT00396513|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6447187|NCT00396513|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6447188|NCT00396513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6447189|NCT00396526|Amoxicillin|amoxicillin|mesh-list
6447190|NCT00396526|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6447191|NCT00396526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6447192|NCT00396526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6447193|NCT00396526|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6447194|NCT00396526|Renal Agents|renal agents|mesh-ancestor
6447195|NCT00396526|Antimalarials|antimalarials|mesh-ancestor
6447196|NCT00396526|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6447197|NCT00396526|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6447198|NCT00396578|Vancomycin|vancomycin|mesh-list
6447199|NCT00396578|Gentamicins|gentamicins|mesh-list
6447200|NCT00396578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6447201|NCT00396578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6447202|NCT00396578|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6447203|NCT00396578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6585624|NCT01076556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6585625|NCT01076556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6585626|NCT01076556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6585627|NCT01076556|Growth Inhibitors|growth inhibitors|mesh-ancestor
6585628|NCT01076556|Growth Substances|growth substances|mesh-ancestor
6585629|NCT01076556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6585630|NCT01076556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6585631|NCT01076582|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6585632|NCT01076582|Desogestrel|desogestrel|mesh-list
6585633|NCT01076582|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6585634|NCT01076582|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6585635|NCT01076582|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6585636|NCT01076582|Contraceptive Agents|contraceptive agents|mesh-ancestor
6585637|NCT01076582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6585638|NCT01076582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585639|NCT01076582|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6585640|NCT01076582|Estrogens|estrogens|mesh-ancestor
6585641|NCT01076582|Hormones|hormones|mesh-ancestor
6585642|NCT01076582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6585643|NCT01076582|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6585644|NCT01076582|Progestins|progestins|mesh-ancestor
6585645|NCT01076595|Interferons|interferons|mesh-list
6585646|NCT01076595|Interferon-beta|interferon-beta|mesh-list
6585647|NCT01076595|Interferon beta-1b|interferon beta-1b|mesh-list
6585648|NCT01076595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6585649|NCT01076595|Antiviral Agents|antiviral agents|mesh-ancestor
6585650|NCT01076595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6585651|NCT01076595|Immunologic Factors|immunologic factors|mesh-ancestor
6585652|NCT01076595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585653|NCT01076595|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6585654|NCT01076621|Norethindrone|norethindrone|mesh-list
6585655|NCT01076621|Norethindrone Acetate|norethindrone acetate|mesh-list
6585656|NCT01076621|Estradiol|estradiol|mesh-list
6585657|NCT01076621|Estrogens|estrogens|mesh-ancestor
6585658|NCT01076621|Hormones|hormones|mesh-ancestor
6585659|NCT01076621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6585660|NCT01076621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585661|NCT01076621|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6585662|NCT01076621|Contraceptive Agents|contraceptive agents|mesh-ancestor
6585663|NCT01076621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6585664|NCT01076621|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6585665|NCT01076621|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6585666|NCT01076621|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6585667|NCT01076621|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6585668|NCT01076634|Insulin|insulin|mesh-list
6585669|NCT01076634|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6585670|NCT01076634|Insulin, Long-Acting|insulin, long-acting|mesh-list
6585671|NCT01076634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6585672|NCT01076634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585673|NCT01076673|Hyaluronic Acid|hyaluronic acid|mesh-list
6585674|NCT01076673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6585675|NCT01076673|Immunologic Factors|immunologic factors|mesh-ancestor
6585676|NCT01076673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585677|NCT01076673|Viscosupplements|viscosupplements|mesh-ancestor
6585678|NCT01076673|Protective Agents|protective agents|mesh-ancestor
6658754|NCT01484145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658755|NCT01484171|Idarubicin|idarubicin|mesh-list
6658756|NCT01484171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6658757|NCT01484171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6658758|NCT01484171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6658759|NCT01484171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6585679|NCT01076790|Dexmedetomidine|dexmedetomidine|mesh-list
6585680|NCT01076790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6585681|NCT01076790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6585682|NCT01076790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585683|NCT01076790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6585684|NCT01076790|Analgesics|analgesics|mesh-ancestor
6585685|NCT01076790|Sensory System Agents|sensory system agents|mesh-ancestor
6585686|NCT01076790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6585687|NCT01076790|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6585688|NCT01076790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6585689|NCT01076790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6585690|NCT01076790|Adrenergic Agents|adrenergic agents|mesh-ancestor
6585691|NCT01076790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6585692|NCT01076790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6585693|NCT01076803|Lanreotide|lanreotide|mesh-list
6585694|NCT01076803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6585695|NCT01076816|Dexmedetomidine|dexmedetomidine|mesh-list
6585696|NCT01076816|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6585697|NCT01076816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6585698|NCT01076816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585699|NCT01076816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6585700|NCT01076816|Analgesics|analgesics|mesh-ancestor
6585701|NCT01076816|Sensory System Agents|sensory system agents|mesh-ancestor
6585702|NCT01076816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6585703|NCT01076816|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6585704|NCT01076816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6585705|NCT01076816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6585706|NCT01076816|Adrenergic Agents|adrenergic agents|mesh-ancestor
6585707|NCT01076816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6585708|NCT01076816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6585709|NCT01076842|Insulin|insulin|mesh-list
6585710|NCT01076842|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6585711|NCT01076842|Exenatide|exenatide|mesh-list
6585712|NCT01076842|Insulin Detemir|insulin detemir|mesh-list
6585713|NCT01076842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6585714|NCT01076842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585715|NCT01076842|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6585716|NCT01076842|Incretins|incretins|mesh-ancestor
6585717|NCT01076842|Hormones|hormones|mesh-ancestor
6585718|NCT01076842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6585719|NCT01076868|Primaquine|primaquine|mesh-list
6585720|NCT01076868|Antimalarials|antimalarials|mesh-ancestor
6585721|NCT01076868|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6585722|NCT01076868|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6585723|NCT01076868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6585724|NCT01076894|Anesthetics|anesthetics|mesh-list
6585725|NCT01076894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6585726|NCT01076894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585727|NCT01076998|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6585728|NCT01076998|Lubricant Eye Drops|lubricant eye drops|mesh-list
6585729|NCT01076998|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6447204|NCT00396578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447205|NCT00396604|Maleic acid|maleic acid|mesh-list
6447206|NCT00396604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6447207|NCT00396604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447208|NCT00396669|Bupropion|bupropion|mesh-list
6447209|NCT00396669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6447210|NCT00396669|Antidepressive Agents|antidepressive agents|mesh-ancestor
6447211|NCT00396669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6447212|NCT00396669|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6585730|NCT01077011|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6585731|NCT01077011|Lubricant Eye Drops|lubricant eye drops|mesh-list
6585732|NCT01077011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6585733|NCT01077206|Simvastatin|simvastatin|mesh-list
6585734|NCT01077206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6585735|NCT01077206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6585736|NCT01077206|Antimetabolites|antimetabolites|mesh-ancestor
6585737|NCT01077206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6585738|NCT01077206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6585739|NCT01077206|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6585740|NCT01077206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6585741|NCT01077427|Gemcitabine|gemcitabine|mesh-list
6585742|NCT01077427|Capecitabine|capecitabine|mesh-list
6585743|NCT01077427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6585744|NCT01077427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6585745|NCT01077427|Antimetabolites|antimetabolites|mesh-ancestor
6585746|NCT01077427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6585747|NCT01077427|Antiviral Agents|antiviral agents|mesh-ancestor
6585748|NCT01077427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6585749|NCT01077427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6585750|NCT01077427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6585751|NCT01077427|Immunologic Factors|immunologic factors|mesh-ancestor
6585752|NCT01077427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585753|NCT01077453|Letrozole|letrozole|mesh-list
6585754|NCT01077453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6585755|NCT01077453|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6585756|NCT01077453|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6585757|NCT01077453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6585758|NCT01077453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6585759|NCT01077453|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6585760|NCT01077453|Hormone Antagonists|hormone antagonists|mesh-ancestor
6585761|NCT01077453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6585762|NCT01077453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585763|NCT01077466|Natalizumab|natalizumab|mesh-list
6585764|NCT01077466|Immunologic Factors|immunologic factors|mesh-ancestor
6585765|NCT01077466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585766|NCT01077479|Metformin|metformin|mesh-list
6585767|NCT01077479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6585768|NCT01077479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585769|NCT01077505|Contraceptive Agents|contraceptive agents|mesh-list
6585770|NCT01077505|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
6585771|NCT01077505|Contraceptives, Oral|contraceptives, oral|mesh-list
6585772|NCT01077505|rGLP-1 protein|rglp-1 protein|mesh-list
6585773|NCT01077505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6585774|NCT01077505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585775|NCT01077505|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6585776|NCT01077505|Incretins|incretins|mesh-ancestor
6585777|NCT01077505|Hormones|hormones|mesh-ancestor
6585778|NCT01077505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6585779|NCT01077505|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6585780|NCT01077505|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6585781|NCT01077505|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6585782|NCT01077505|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
6585783|NCT01077505|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6585784|NCT01077557|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6585785|NCT01077557|Antiviral Agents|antiviral agents|mesh-ancestor
6585786|NCT01077557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6585787|NCT01077570|Repaglinide|repaglinide|mesh-list
6585788|NCT01077570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6585789|NCT01077570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585790|NCT01077609|Fluticasone|fluticasone|mesh-list
6585791|NCT01077609|Xhance|xhance|mesh-list
6585792|NCT01077609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6585793|NCT01077609|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6585794|NCT01077609|Autonomic Agents|autonomic agents|mesh-ancestor
6585795|NCT01077609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6585796|NCT01077609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585797|NCT01077609|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6585798|NCT01077609|Respiratory System Agents|respiratory system agents|mesh-ancestor
6585799|NCT01077609|Dermatologic Agents|dermatologic agents|mesh-ancestor
6585800|NCT01077609|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6585801|NCT01077648|Trastuzumab|trastuzumab|mesh-list
6585802|NCT01077648|Lapatinib|lapatinib|mesh-list
6585803|NCT01077648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6585804|NCT01077648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6585805|NCT01077648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6585806|NCT01077648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6585807|NCT01077648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6585808|NCT01077661|Nebivolol|nebivolol|mesh-list
6585809|NCT01077661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6585810|NCT01077661|Vasodilator Agents|vasodilator agents|mesh-ancestor
6585811|NCT01077661|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6585812|NCT01077661|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6585813|NCT01077661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6585814|NCT01077661|Adrenergic Agents|adrenergic agents|mesh-ancestor
6585815|NCT01077661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6585816|NCT01077661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6585817|NCT01077661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585818|NCT01077726|Capecitabine|capecitabine|mesh-list
6585819|NCT01077726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6585820|NCT01077726|Antimetabolites|antimetabolites|mesh-ancestor
6585821|NCT01077726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6585822|NCT01077726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6447213|NCT00396669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6447214|NCT00396669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6447215|NCT00396669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447216|NCT00396669|Dopamine Agents|dopamine agents|mesh-ancestor
6447217|NCT00396669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6447218|NCT00396669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447219|NCT00396669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6447220|NCT00396669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6585823|NCT01077752|Acetaminophen|acetaminophen|mesh-list
6585824|NCT01077752|Lidocaine|lidocaine|mesh-list
6585825|NCT01077752|Morphine|morphine|mesh-list
6585826|NCT01077752|Ropivacaine|ropivacaine|mesh-list
6585827|NCT01077752|Anesthetics, Local|anesthetics, local|mesh-ancestor
6585828|NCT01077752|Anesthetics|anesthetics|mesh-ancestor
6585829|NCT01077752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6585830|NCT01077752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585831|NCT01077752|Sensory System Agents|sensory system agents|mesh-ancestor
6585832|NCT01077752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6585833|NCT01077752|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6585834|NCT01077752|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6585835|NCT01077752|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6585836|NCT01077752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6585837|NCT01077752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6585838|NCT01077752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6585839|NCT01077752|Narcotics|narcotics|mesh-ancestor
6585840|NCT01077752|Analgesics|analgesics|mesh-ancestor
6585841|NCT01077752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6585842|NCT01077752|Antipyretics|antipyretics|mesh-ancestor
6585843|NCT01077908|Antiviral Agents|antiviral agents|mesh-list
6585844|NCT01077908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6585845|NCT01077947|Anesthetics|anesthetics|mesh-list
6585846|NCT01077947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6585847|NCT01077947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585848|NCT01077986|Capecitabine|capecitabine|mesh-list
6585849|NCT01077986|Cetuximab|cetuximab|mesh-list
6585850|NCT01077986|Everolimus|everolimus|mesh-list
6585851|NCT01077986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6585852|NCT01077986|Antimetabolites|antimetabolites|mesh-ancestor
6585853|NCT01077986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6585854|NCT01077986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6585855|NCT01077986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6585856|NCT01077986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6585857|NCT01077986|Immunologic Factors|immunologic factors|mesh-ancestor
6585858|NCT01077986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585859|NCT01077999|Paclitaxel|paclitaxel|mesh-list
6585860|NCT01077999|Carboplatin|carboplatin|mesh-list
6585861|NCT01077999|Panitumumab|panitumumab|mesh-list
6585862|NCT01077999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6585863|NCT01077999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6585864|NCT01077999|Tubulin Modulators|tubulin modulators|mesh-ancestor
6585865|NCT01077999|Antimitotic Agents|antimitotic agents|mesh-ancestor
6585866|NCT01077999|Mitosis Modulators|mitosis modulators|mesh-ancestor
6585867|NCT01077999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6585868|NCT01077999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6447221|NCT00396669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6585869|NCT01078038|Sirolimus|sirolimus|mesh-list
6585870|NCT01078038|Everolimus|everolimus|mesh-list
6585871|NCT01078038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6585872|NCT01078038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6585873|NCT01078038|Immunologic Factors|immunologic factors|mesh-ancestor
6585874|NCT01078038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585875|NCT01078038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6585876|NCT01078038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6585877|NCT01078038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6585878|NCT01078038|Antifungal Agents|antifungal agents|mesh-ancestor
6585879|NCT01078142|Sirolimus|sirolimus|mesh-list
6585880|NCT01078142|Rituximab|rituximab|mesh-list
6585881|NCT01078142|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6585882|NCT01078142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6585883|NCT01078142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6585884|NCT01078142|Immunologic Factors|immunologic factors|mesh-ancestor
6585885|NCT01078142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585886|NCT01078142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6585887|NCT01078142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6585888|NCT01078142|Alkylating Agents|alkylating agents|mesh-ancestor
6585889|NCT01078142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6585890|NCT01078142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6585891|NCT01078142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6585892|NCT01078142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6585893|NCT01078142|Antifungal Agents|antifungal agents|mesh-ancestor
6585894|NCT01078142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6585895|NCT01078428|Petrolatum|petrolatum|mesh-list
6585896|NCT01078428|Emollients|emollients|mesh-ancestor
6585897|NCT01078428|Dermatologic Agents|dermatologic agents|mesh-ancestor
6585898|NCT01078519|Anesthetics|anesthetics|mesh-list
6585899|NCT01078519|Anesthetics, Local|anesthetics, local|mesh-list
6585900|NCT01078519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6585901|NCT01078519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585902|NCT01078519|Sensory System Agents|sensory system agents|mesh-ancestor
6585903|NCT01078519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6585904|NCT01078610|Adalimumab|adalimumab|mesh-list
6585905|NCT01078610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6585906|NCT01078610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6585907|NCT01078714|Bumetanide|bumetanide|mesh-list
6585908|NCT01078714|Diuretics|diuretics|mesh-ancestor
6585909|NCT01078714|Natriuretic Agents|natriuretic agents|mesh-ancestor
6585910|NCT01078714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585911|NCT01078714|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6585912|NCT01078714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6585913|NCT01078714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6585914|NCT01078779|Chloroquine|chloroquine|mesh-list
6585915|NCT01078779|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
6585916|NCT01078779|Amebicides|amebicides|mesh-ancestor
6585917|NCT01078779|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6585918|NCT01078779|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6585919|NCT01078779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6585920|NCT01078779|Antimalarials|antimalarials|mesh-ancestor
6585921|NCT01078779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6585922|NCT01078779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6585923|NCT01078779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6585924|NCT01078779|Analgesics|analgesics|mesh-ancestor
6585925|NCT01078779|Sensory System Agents|sensory system agents|mesh-ancestor
6585926|NCT01078779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6585927|NCT01078779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585928|NCT01078779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6585929|NCT01078779|Filaricides|filaricides|mesh-ancestor
6585930|NCT01078779|Antinematodal Agents|antinematodal agents|mesh-ancestor
6585931|NCT01078779|Anthelmintics|anthelmintics|mesh-ancestor
6658760|NCT01484171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6658761|NCT01484171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658762|NCT01484184|Levodopa|levodopa|mesh-list
6658763|NCT01484184|Buspirone|buspirone|mesh-list
6658764|NCT01484184|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6658765|NCT01484184|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6658766|NCT01484184|Dopamine Agents|dopamine agents|mesh-ancestor
6658767|NCT01484184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6658768|NCT01484184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658769|NCT01484184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658770|NCT01484184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6658771|NCT01484184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6658772|NCT01484184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6658773|NCT01484184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6658774|NCT01484184|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6658775|NCT01484184|Serotonin Agents|serotonin agents|mesh-ancestor
6658776|NCT01484262|Liraglutide|liraglutide|mesh-list
6658777|NCT01484262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6658778|NCT01484262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658779|NCT01484262|Incretins|incretins|mesh-ancestor
6658780|NCT01484262|Hormones|hormones|mesh-ancestor
6658781|NCT01484262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6658782|NCT01484327|Carvedilol|carvedilol|mesh-list
6658783|NCT01484327|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6658784|NCT01484327|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6658785|NCT01484327|Adrenergic Agents|adrenergic agents|mesh-ancestor
6658786|NCT01484327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6658787|NCT01484327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658788|NCT01484327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658789|NCT01484327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6658790|NCT01484327|Antioxidants|antioxidants|mesh-ancestor
6658791|NCT01484327|Protective Agents|protective agents|mesh-ancestor
6658792|NCT01484327|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6658793|NCT01484327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6658794|NCT01484327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6658795|NCT01484327|Vasodilator Agents|vasodilator agents|mesh-ancestor
6658796|NCT01484327|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6658797|NCT01484327|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6658798|NCT01484457|Pancrelipase|pancrelipase|mesh-list
6658799|NCT01484457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6658800|NCT01484600|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6658801|NCT01484600|Immunologic Factors|immunologic factors|mesh-ancestor
6658802|NCT01484600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658803|NCT01484613|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
6658804|NCT01484613|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6658805|NCT01484613|Contraceptive Agents|contraceptive agents|mesh-ancestor
6658806|NCT01484613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6658807|NCT01484613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658808|NCT01484613|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6658809|NCT01484613|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6658810|NCT01484613|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6658811|NCT01484691|Budesonide|budesonide|mesh-list
6658812|NCT01484691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6658813|NCT01484691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5501570|NCT04472949|Etoposide|etoposide|mesh-list
6585932|NCT01078818|Ferrous fumarate|ferrous fumarate|mesh-list
6585933|NCT01078818|Trace Elements|trace elements|mesh-ancestor
6585934|NCT01078818|Micronutrients|micronutrients|mesh-ancestor
6585935|NCT01078818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585936|NCT01078870|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6585937|NCT01078870|Citalopram|citalopram|mesh-list
6585938|NCT01078870|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6585939|NCT01078870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6585940|NCT01078870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6585941|NCT01078870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6585942|NCT01078870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6585943|NCT01078870|Serotonin Agents|serotonin agents|mesh-ancestor
6585944|NCT01078870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585945|NCT01078870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6585946|NCT01078870|Antidepressive Agents|antidepressive agents|mesh-ancestor
6585947|NCT01078870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6585948|NCT01078870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6585949|NCT01078870|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6585950|NCT01078870|Analgesics|analgesics|mesh-ancestor
6585951|NCT01078870|Sensory System Agents|sensory system agents|mesh-ancestor
6585952|NCT01078870|Dopamine Agents|dopamine agents|mesh-ancestor
6585953|NCT01078961|Bortezomib|bortezomib|mesh-list
6585954|NCT01078961|Sorafenib|sorafenib|mesh-list
6585955|NCT01078961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6585956|NCT01078961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6585957|NCT01078961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6585958|NCT01078961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6585959|NCT01079013|Treosulfan|treosulfan|mesh-list
6585960|NCT01079013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6585961|NCT01079013|Alkylating Agents|alkylating agents|mesh-ancestor
6585962|NCT01079013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6585963|NCT01079013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6585964|NCT01079052|Famotidine|famotidine|mesh-list
6585965|NCT01079052|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6585966|NCT01079052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6585967|NCT01079052|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6585968|NCT01079052|Histamine Antagonists|histamine antagonists|mesh-ancestor
6585969|NCT01079052|Histamine Agents|histamine agents|mesh-ancestor
6585970|NCT01079052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6585971|NCT01079052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6585972|NCT01079052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585973|NCT01079065|Famotidine|famotidine|mesh-list
6585974|NCT01079065|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6585975|NCT01079065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6585976|NCT01079065|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6585977|NCT01079065|Histamine Antagonists|histamine antagonists|mesh-ancestor
6585978|NCT01079065|Histamine Agents|histamine agents|mesh-ancestor
6585979|NCT01079065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6585980|NCT01079065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6585981|NCT01079065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585982|NCT01079078|Acetaminophen|acetaminophen|mesh-list
6585983|NCT01079078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6585984|NCT01079078|Analgesics|analgesics|mesh-ancestor
6585985|NCT01079078|Sensory System Agents|sensory system agents|mesh-ancestor
6585986|NCT01079078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6585987|NCT01079078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585988|NCT01079078|Antipyretics|antipyretics|mesh-ancestor
6585989|NCT01079117|Morphine|morphine|mesh-list
6585990|NCT01079117|Methadone|methadone|mesh-list
6585991|NCT01079117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6585992|NCT01079117|Narcotics|narcotics|mesh-ancestor
6585993|NCT01079117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6585994|NCT01079117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6585995|NCT01079117|Analgesics|analgesics|mesh-ancestor
6585996|NCT01079117|Sensory System Agents|sensory system agents|mesh-ancestor
6585997|NCT01079117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6585998|NCT01079117|Antitussive Agents|antitussive agents|mesh-ancestor
6585999|NCT01079117|Respiratory System Agents|respiratory system agents|mesh-ancestor
6586000|NCT01079286|Sirolimus|sirolimus|mesh-list
6586001|NCT01079286|Nelfinavir|nelfinavir|mesh-list
6586002|NCT01079286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6447222|NCT00396682|Cyclophosphamide|cyclophosphamide|mesh-list
6447223|NCT00396682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6447224|NCT00396682|Immunologic Factors|immunologic factors|mesh-ancestor
6447225|NCT00396682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447226|NCT00396682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6447227|NCT00396682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6447228|NCT00396682|Alkylating Agents|alkylating agents|mesh-ancestor
6586003|NCT01079286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6586004|NCT01079286|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6586005|NCT01079286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6586006|NCT01079286|Antifungal Agents|antifungal agents|mesh-ancestor
6586007|NCT01079286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6586008|NCT01079286|Immunologic Factors|immunologic factors|mesh-ancestor
6586009|NCT01079286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586010|NCT01079286|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6586011|NCT01079286|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6586012|NCT01079286|Protease Inhibitors|protease inhibitors|mesh-ancestor
6586013|NCT01079286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6586014|NCT01079286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6586015|NCT01079286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6586016|NCT01079286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6586017|NCT01079286|Antiviral Agents|antiviral agents|mesh-ancestor
6586018|NCT01079312|Fentanyl|fentanyl|mesh-list
6586019|NCT01079312|Remifentanil|remifentanil|mesh-list
6586020|NCT01079312|Propofol|propofol|mesh-list
6586021|NCT01079312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
6586022|NCT01079312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6586023|NCT01079312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586024|NCT01079312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6586025|NCT01079312|Anesthetics, General|anesthetics, general|mesh-ancestor
6586026|NCT01079312|Anesthetics|anesthetics|mesh-ancestor
6586027|NCT01079312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6586028|NCT01079312|Narcotics|narcotics|mesh-ancestor
6586029|NCT01079312|Analgesics|analgesics|mesh-ancestor
6586030|NCT01079312|Sensory System Agents|sensory system agents|mesh-ancestor
6586031|NCT01079312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6586032|NCT01079312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6586033|NCT01079338|Caffeine|caffeine|mesh-list
6586034|NCT01079338|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6586035|NCT01079338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586036|NCT01079338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6586037|NCT01079338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6586038|NCT01079338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6586039|NCT01079338|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6586040|NCT01079338|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6586041|NCT01079338|Purinergic Agents|purinergic agents|mesh-ancestor
6586042|NCT01079338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6586043|NCT01079351|Carbamazepine|carbamazepine|mesh-list
6447229|NCT00396682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6586044|NCT01079351|Anticonvulsants|anticonvulsants|mesh-ancestor
6586045|NCT01079351|Antimanic Agents|antimanic agents|mesh-ancestor
6586046|NCT01079351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6586047|NCT01079351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6586048|NCT01079351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447230|NCT00396682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6447231|NCT00396682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6586049|NCT01079351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6586050|NCT01079351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6586051|NCT01079351|Analgesics|analgesics|mesh-ancestor
6586052|NCT01079351|Sensory System Agents|sensory system agents|mesh-ancestor
6586053|NCT01079351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6586054|NCT01079351|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6586055|NCT01079351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6586056|NCT01079351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6586057|NCT01079351|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6586058|NCT01079351|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6586059|NCT01079364|Insulin|insulin|mesh-list
6586060|NCT01079364|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6586061|NCT01079364|Insulin Glargine|insulin glargine|mesh-list
6586062|NCT01079364|Insulin Aspart|insulin aspart|mesh-list
6586063|NCT01079364|Insulin glulisine|insulin glulisine|mesh-list
6586064|NCT01079364|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6586065|NCT01079364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6586066|NCT01079364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586067|NCT01079455|Corticosterone|corticosterone|mesh-list
6586068|NCT01079455|Bupivacaine|bupivacaine|mesh-list
6586069|NCT01079455|Hyaluronic Acid|hyaluronic acid|mesh-list
6586070|NCT01079455|Anesthetics, Local|anesthetics, local|mesh-ancestor
6586071|NCT01079455|Anesthetics|anesthetics|mesh-ancestor
6586072|NCT01079455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6586073|NCT01079455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586074|NCT01079455|Sensory System Agents|sensory system agents|mesh-ancestor
6586075|NCT01079455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6586076|NCT01079455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6586077|NCT01079455|Immunologic Factors|immunologic factors|mesh-ancestor
6586078|NCT01079455|Viscosupplements|viscosupplements|mesh-ancestor
6586079|NCT01079455|Protective Agents|protective agents|mesh-ancestor
6586080|NCT01079455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6447232|NCT00396721|Sirolimus|sirolimus|mesh-list
6586081|NCT01079481|Everolimus|everolimus|mesh-list
6586082|NCT01079481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6447233|NCT00396721|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
6447234|NCT00396721|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6447235|NCT00396721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6447236|NCT00396721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6447237|NCT00396721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6447238|NCT00396721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6447239|NCT00396721|Antifungal Agents|antifungal agents|mesh-ancestor
6447240|NCT00396721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6447241|NCT00396721|Immunologic Factors|immunologic factors|mesh-ancestor
6586083|NCT01079481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6586084|NCT01079481|Immunologic Factors|immunologic factors|mesh-ancestor
6586085|NCT01079481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586086|NCT01079559|Tobramycin|tobramycin|mesh-list
6586087|NCT01079559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6586088|NCT01079559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6586089|NCT01079624|Glucagon|glucagon|mesh-list
6586090|NCT01079624|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6586091|NCT01079624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6586092|NCT01079624|Hormones|hormones|mesh-ancestor
6586093|NCT01079624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6586094|NCT01079624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586095|NCT01079624|Incretins|incretins|mesh-ancestor
6586096|NCT01079676|Lenograstim|lenograstim|mesh-list
6586097|NCT01079676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6586098|NCT01079676|Immunologic Factors|immunologic factors|mesh-ancestor
6586099|NCT01079676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586100|NCT01079702|Capecitabine|capecitabine|mesh-list
6586101|NCT01079702|Everolimus|everolimus|mesh-list
6586102|NCT01079702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6586103|NCT01079702|Antimetabolites|antimetabolites|mesh-ancestor
6586104|NCT01079702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6586105|NCT01079702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6586106|NCT01079702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6586107|NCT01079702|Immunologic Factors|immunologic factors|mesh-ancestor
6586108|NCT01079702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586109|NCT01079715|Propranolol|propranolol|mesh-list
6586110|NCT01079715|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6586111|NCT01079715|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6586112|NCT01079715|Adrenergic Agents|adrenergic agents|mesh-ancestor
6586113|NCT01079715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6586114|NCT01079715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6586115|NCT01079715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586116|NCT01079715|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6586117|NCT01079715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6586118|NCT01079715|Vasodilator Agents|vasodilator agents|mesh-ancestor
6586119|NCT01079754|Morphine|morphine|mesh-list
6586120|NCT01079754|Analgesics, Opioid|analgesics, opioid|mesh-list
6586121|NCT01079754|Narcotics|narcotics|mesh-ancestor
6586122|NCT01079754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6586123|NCT01079754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586124|NCT01079754|Analgesics|analgesics|mesh-ancestor
6586125|NCT01079754|Sensory System Agents|sensory system agents|mesh-ancestor
6586126|NCT01079754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6586127|NCT01079767|Sirolimus|sirolimus|mesh-list
6586128|NCT01079767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6586129|NCT01079767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6586130|NCT01079767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6586131|NCT01079767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6586132|NCT01079767|Antifungal Agents|antifungal agents|mesh-ancestor
6586133|NCT01079767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6586134|NCT01079767|Immunologic Factors|immunologic factors|mesh-ancestor
6586135|NCT01079767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586136|NCT01079780|Irinotecan|irinotecan|mesh-list
6586137|NCT01079780|Cetuximab|cetuximab|mesh-list
6586138|NCT01079780|Ramucirumab|ramucirumab|mesh-list
6586139|NCT01079780|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6586140|NCT01079780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6586141|NCT01079780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6586142|NCT01079780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447242|NCT00396721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586143|NCT01079780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6586144|NCT01079780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6586145|NCT01079884|Esomeprazole|esomeprazole|mesh-list
6586146|NCT01079884|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6586147|NCT01079884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6586148|NCT01079884|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6586149|NCT01079884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6586150|NCT01079884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6586151|NCT01079897|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
6586152|NCT01079897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6586153|NCT01079910|Fluorides|fluorides|mesh-list
6586154|NCT01079910|Cariostatic Agents|cariostatic agents|mesh-ancestor
6586155|NCT01079910|Protective Agents|protective agents|mesh-ancestor
6586156|NCT01079910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586157|NCT01079923|Vitamin D|vitamin d|mesh-list
6586158|NCT01079923|Ergocalciferols|ergocalciferols|mesh-list
6586159|NCT01079923|Cholecalciferol|cholecalciferol|mesh-list
6586160|NCT01079923|Vitamins|vitamins|mesh-list
6586161|NCT01079923|Micronutrients|micronutrients|mesh-ancestor
6447243|NCT00396721|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6447244|NCT00396721|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6447245|NCT00396721|Antimetabolites|antimetabolites|mesh-ancestor
6586162|NCT01079923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586163|NCT01079923|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6586164|NCT01079923|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6586165|NCT01080027|Interferons|interferons|mesh-list
6586166|NCT01080027|Interferon-beta|interferon-beta|mesh-list
6586167|NCT01080027|Interferon beta-1a|interferon beta-1a|mesh-list
6586168|NCT01080027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6586169|NCT01080027|Antiviral Agents|antiviral agents|mesh-ancestor
6586170|NCT01080027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6586171|NCT01080027|Immunologic Factors|immunologic factors|mesh-ancestor
6586172|NCT01080027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586173|NCT01080027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6586174|NCT01080066|Cetuximab|cetuximab|mesh-list
6586175|NCT01080066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6586176|NCT01080066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6586177|NCT01080079|Terbinafine|terbinafine|mesh-list
6586178|NCT01080079|Antifungal Agents|antifungal agents|mesh-ancestor
6586179|NCT01080079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6586180|NCT01080079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6586181|NCT01080079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6586182|NCT01080352|Ascorbic Acid|ascorbic acid|mesh-list
6586183|NCT01080352|Vitamins|vitamins|mesh-ancestor
6586184|NCT01080352|Micronutrients|micronutrients|mesh-ancestor
6586185|NCT01080352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586186|NCT01080352|Antioxidants|antioxidants|mesh-ancestor
6586187|NCT01080352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6586188|NCT01080352|Protective Agents|protective agents|mesh-ancestor
6586189|NCT01080417|Mycophenolic Acid|mycophenolic acid|mesh-list
6586190|NCT01080417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6586191|NCT01080417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6586192|NCT01080417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6586193|NCT01080417|Antitubercular Agents|antitubercular agents|mesh-ancestor
6586194|NCT01080417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6586195|NCT01080417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6586196|NCT01080417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6586197|NCT01080417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6586198|NCT01080443|Mycophenolic Acid|mycophenolic acid|mesh-list
6586199|NCT01080443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6586200|NCT01080443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6586201|NCT01080443|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6586202|NCT01080443|Antitubercular Agents|antitubercular agents|mesh-ancestor
6447246|NCT00396721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447247|NCT00396721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6447248|NCT00396721|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6447249|NCT00396721|Protease Inhibitors|protease inhibitors|mesh-ancestor
6447250|NCT00396734|Topiramate|topiramate|mesh-list
6447251|NCT00396734|Modafinil|modafinil|mesh-list
6447252|NCT00396734|Anticonvulsants|anticonvulsants|mesh-ancestor
6447253|NCT00396734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6447254|NCT00396734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586203|NCT01080443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6586204|NCT01080443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6586205|NCT01080443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6586206|NCT01080443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6586207|NCT01080456|Tacrolimus|tacrolimus|mesh-list
6586208|NCT01080456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6586209|NCT01080456|Immunologic Factors|immunologic factors|mesh-ancestor
6586210|NCT01080456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586211|NCT01080456|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6586212|NCT01080456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6586213|NCT01080456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6586214|NCT01080469|Tacrolimus|tacrolimus|mesh-list
6586215|NCT01080469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6586216|NCT01080469|Immunologic Factors|immunologic factors|mesh-ancestor
6586217|NCT01080469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586218|NCT01080469|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6586219|NCT01080469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6586220|NCT01080469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6586221|NCT01080482|Tacrolimus|tacrolimus|mesh-list
6586222|NCT01080482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6586223|NCT01080482|Immunologic Factors|immunologic factors|mesh-ancestor
6586224|NCT01080482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586225|NCT01080482|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6586226|NCT01080482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6586227|NCT01080482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6586228|NCT01080534|Tacrolimus|tacrolimus|mesh-list
6586229|NCT01080534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6586230|NCT01080534|Immunologic Factors|immunologic factors|mesh-ancestor
6586231|NCT01080534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586232|NCT01080534|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6586233|NCT01080534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6586234|NCT01080534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6586235|NCT01080547|Capecitabine|capecitabine|mesh-list
6586236|NCT01080547|Oxaliplatin|oxaliplatin|mesh-list
6586237|NCT01080547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6586238|NCT01080547|Antimetabolites|antimetabolites|mesh-ancestor
6586239|NCT01080547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6586240|NCT01080547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6586241|NCT01080560|Cyclosporine|cyclosporine|mesh-list
6586242|NCT01080560|Cyclosporins|cyclosporins|mesh-list
6586243|NCT01080560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6586244|NCT01080560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6586245|NCT01080560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6586246|NCT01080560|Immunologic Factors|immunologic factors|mesh-ancestor
6586247|NCT01080560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586248|NCT01080560|Antifungal Agents|antifungal agents|mesh-ancestor
6586249|NCT01080560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6586250|NCT01080560|Dermatologic Agents|dermatologic agents|mesh-ancestor
6586251|NCT01080560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6586252|NCT01080560|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6586253|NCT01080586|Cyclosporine|cyclosporine|mesh-list
6586254|NCT01080586|Cyclosporins|cyclosporins|mesh-list
6586255|NCT01080586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6586256|NCT01080586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6586257|NCT01080586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6586258|NCT01080586|Immunologic Factors|immunologic factors|mesh-ancestor
6586259|NCT01080586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586260|NCT01080586|Antifungal Agents|antifungal agents|mesh-ancestor
6586261|NCT01080586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6586262|NCT01080586|Dermatologic Agents|dermatologic agents|mesh-ancestor
6586263|NCT01080586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6586264|NCT01080586|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6586265|NCT01080612|Pregabalin|pregabalin|mesh-list
6586266|NCT01080612|Analgesics|analgesics|mesh-ancestor
6586267|NCT01080612|Sensory System Agents|sensory system agents|mesh-ancestor
6586268|NCT01080612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6586269|NCT01080612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586270|NCT01080612|Anticonvulsants|anticonvulsants|mesh-ancestor
6586271|NCT01080612|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6586272|NCT01080612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6586273|NCT01080612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6586274|NCT01080612|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6586275|NCT01080612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6586276|NCT01080612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6586277|NCT01080612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6586278|NCT01080612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6586279|NCT01080638|polysaccharide-K|polysaccharide-k|mesh-list
6586280|NCT01080638|Abciximab|abciximab|mesh-list
6586281|NCT01080638|Anticoagulants|anticoagulants|mesh-ancestor
6586282|NCT01080638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6586283|NCT01080638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6586284|NCT01080638|Immunologic Factors|immunologic factors|mesh-ancestor
6586285|NCT01080638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586286|NCT01080638|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6586287|NCT01080638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6586288|NCT01080638|Antiviral Agents|antiviral agents|mesh-ancestor
6586289|NCT01080638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6586290|NCT01080638|Interferon Inducers|interferon inducers|mesh-ancestor
6586291|NCT01080638|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6586292|NCT01080638|Protective Agents|protective agents|mesh-ancestor
6586293|NCT01080651|Voriconazole|voriconazole|mesh-list
6586294|NCT01080651|Antifungal Agents|antifungal agents|mesh-ancestor
6586295|NCT01080651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6586296|NCT01080651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6586297|NCT01080651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6586298|NCT01080651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6586299|NCT01080651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6586300|NCT01080651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6586301|NCT01080651|Hormone Antagonists|hormone antagonists|mesh-ancestor
6586302|NCT01080651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6586303|NCT01080651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586304|NCT01080651|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6586305|NCT01080729|Hormones|hormones|mesh-list
6586306|NCT01080729|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6586307|NCT01080729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6586308|NCT01080729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586309|NCT01080742|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6586310|NCT01080742|Bisoprolol|bisoprolol|mesh-list
6586311|NCT01080742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6586312|NCT01080742|Diuretics|diuretics|mesh-ancestor
6586313|NCT01080742|Natriuretic Agents|natriuretic agents|mesh-ancestor
6586314|NCT01080742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586315|NCT01080742|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6586316|NCT01080742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6586317|NCT01080742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6586318|NCT01080742|Sympatholytics|sympatholytics|mesh-ancestor
6586319|NCT01080742|Autonomic Agents|autonomic agents|mesh-ancestor
6586320|NCT01080742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6586321|NCT01080742|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6586322|NCT01080742|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6586323|NCT01080742|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6586324|NCT01080742|Adrenergic Agents|adrenergic agents|mesh-ancestor
6586325|NCT01080742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6586326|NCT01080820|Hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|mesh-list
6586327|NCT01080820|Antiviral Agents|antiviral agents|mesh-ancestor
6586328|NCT01080820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6586329|NCT01080820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6586330|NCT01080820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6586331|NCT01080846|Misoprostol|misoprostol|mesh-list
6586332|NCT01080846|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6586333|NCT01080846|Abortifacient Agents|abortifacient agents|mesh-ancestor
6586334|NCT01080846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6586335|NCT01080846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586336|NCT01080846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6586337|NCT01080846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6586338|NCT01080846|Oxytocics|oxytocics|mesh-ancestor
6586339|NCT01080911|Morphine|morphine|mesh-list
6586340|NCT01080911|Analgesics, Opioid|analgesics, opioid|mesh-list
6586341|NCT01080911|Narcotics|narcotics|mesh-ancestor
6586342|NCT01080911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6586343|NCT01080911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586344|NCT01080911|Analgesics|analgesics|mesh-ancestor
6586345|NCT01080911|Sensory System Agents|sensory system agents|mesh-ancestor
6586346|NCT01080911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6586347|NCT01080963|Daptomycin|daptomycin|mesh-list
6586348|NCT01080963|Cefuroxime|cefuroxime|mesh-list
6586349|NCT01080963|Cefuroxime axetil|cefuroxime axetil|mesh-list
6586350|NCT01080963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6586351|NCT01080963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6586352|NCT01081002|Lidocaine|lidocaine|mesh-list
6586353|NCT01081002|Anesthetics, Local|anesthetics, local|mesh-ancestor
6586354|NCT01081002|Anesthetics|anesthetics|mesh-ancestor
6586355|NCT01081002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6586356|NCT01081002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586357|NCT01081002|Sensory System Agents|sensory system agents|mesh-ancestor
6586358|NCT01081002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6586359|NCT01081002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6586360|NCT01081002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6586361|NCT01081002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6586362|NCT01081002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6586363|NCT01081002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6586364|NCT01081158|Ritonavir|ritonavir|mesh-list
5501571|NCT04472949|Durvalumab|durvalumab|mesh-list
5501572|NCT04472949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6586365|NCT01081158|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6586366|NCT01081158|Interferon-alpha|interferon-alpha|mesh-list
6586367|NCT01081158|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6586368|NCT01081158|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6586369|NCT01081158|Protease Inhibitors|protease inhibitors|mesh-ancestor
6586370|NCT01081158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6586371|NCT01081158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6586372|NCT01081158|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6586373|NCT01081158|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5501573|NCT04472949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5501574|NCT04472949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5501575|NCT04472949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5501576|NCT04472949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5501577|NCT04472949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501578|NCT04472949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5501579|NCT04472585|Ivermectin|ivermectin|mesh-list
5501580|NCT04472585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5501581|NCT04472585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5501582|NCT04472806|Endostar protein|endostar protein|mesh-list
5501583|NCT04472806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5501584|NCT04472806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5501585|NCT04472806|Growth Substances|growth substances|mesh-ancestor
5501586|NCT04472806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501587|NCT04472806|Growth Inhibitors|growth inhibitors|mesh-ancestor
5501588|NCT04472806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5501589|NCT04472767|Nivolumab|nivolumab|mesh-list
5501590|NCT04472767|Ipilimumab|ipilimumab|mesh-list
5501591|NCT04472767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6447255|NCT00396734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6447256|NCT00396734|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6447257|NCT00396734|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6447258|NCT00396734|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6447259|NCT00396734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447260|NCT00396747|Methylprednisolone|methylprednisolone|mesh-list
6447261|NCT00396747|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6447262|NCT00396747|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6447263|NCT00396747|Prednisolone|prednisolone|mesh-list
6447264|NCT00396747|Prednisolone acetate|prednisolone acetate|mesh-list
5501592|NCT04472767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6586374|NCT01081158|Antiviral Agents|antiviral agents|mesh-ancestor
6586375|NCT01081158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6586376|NCT01081158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6586377|NCT01081158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6586378|NCT01081158|Immunologic Factors|immunologic factors|mesh-ancestor
6586379|NCT01081158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586380|NCT01081223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
6586381|NCT01081223|Immunologic Factors|immunologic factors|mesh-ancestor
6586382|NCT01081223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586383|NCT01081353|Aspirin|aspirin|mesh-list
6586384|NCT01081353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6586385|NCT01081353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6586386|NCT01081353|Analgesics|analgesics|mesh-ancestor
6586387|NCT01081353|Sensory System Agents|sensory system agents|mesh-ancestor
6586388|NCT01081353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6586389|NCT01081353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586390|NCT01081353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6586391|NCT01081353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6586392|NCT01081353|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6586393|NCT01081353|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6586394|NCT01081353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6586395|NCT01081353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6586396|NCT01081353|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6586397|NCT01081353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6586398|NCT01081353|Antipyretics|antipyretics|mesh-ancestor
6586399|NCT01081431|Lenalidomide|lenalidomide|mesh-list
6586400|NCT01081431|Immunologic Factors|immunologic factors|mesh-ancestor
6586401|NCT01081431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586402|NCT01081431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6586403|NCT01081431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6586404|NCT01081431|Growth Substances|growth substances|mesh-ancestor
6586405|NCT01081431|Growth Inhibitors|growth inhibitors|mesh-ancestor
6586406|NCT01081431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6586407|NCT01081535|Ketorolac|ketorolac|mesh-list
6586408|NCT01081535|Fentanyl|fentanyl|mesh-list
6586409|NCT01081535|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6586410|NCT01081535|Narcotics|narcotics|mesh-ancestor
6586411|NCT01081535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6586412|NCT01081535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586413|NCT01081535|Analgesics|analgesics|mesh-ancestor
6586414|NCT01081535|Sensory System Agents|sensory system agents|mesh-ancestor
6586415|NCT01081535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6586416|NCT01081535|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6586417|NCT01081535|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6586418|NCT01081535|Anesthetics, General|anesthetics, general|mesh-ancestor
6586419|NCT01081535|Anesthetics|anesthetics|mesh-ancestor
6586420|NCT01081535|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6586421|NCT01081535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6586422|NCT01081535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6586423|NCT01081535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6586424|NCT01081535|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6586425|NCT01081535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6586426|NCT01081535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6586427|NCT01081548|Atorvastatin|atorvastatin|mesh-list
6586428|NCT01081548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6586429|NCT01081548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6586430|NCT01081548|Antimetabolites|antimetabolites|mesh-ancestor
6586431|NCT01081548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6586432|NCT01081548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6586433|NCT01081548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6586434|NCT01081548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6586435|NCT01081561|Riboflavin|riboflavin|mesh-list
6447265|NCT00396747|Methotrexate|methotrexate|mesh-list
6447266|NCT00396747|Infliximab|infliximab|mesh-list
6447267|NCT00396747|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6447268|NCT00396747|Prednisolone phosphate|prednisolone phosphate|mesh-list
6447269|NCT00396747|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6447270|NCT00396747|Abortifacient Agents|abortifacient agents|mesh-ancestor
6447271|NCT00396747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6447272|NCT00396747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447273|NCT00396747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6447274|NCT00396747|Antimetabolites|antimetabolites|mesh-ancestor
6447275|NCT00396747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447276|NCT00396747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6586436|NCT01081561|Vitamin B Complex|vitamin b complex|mesh-ancestor
6586437|NCT01081561|Vitamins|vitamins|mesh-ancestor
6586438|NCT01081561|Micronutrients|micronutrients|mesh-ancestor
6586439|NCT01081561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586440|NCT01081561|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6586441|NCT01081561|Dermatologic Agents|dermatologic agents|mesh-ancestor
6586442|NCT01081600|Trastuzumab|trastuzumab|mesh-list
6586443|NCT01081600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6586444|NCT01081600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6586445|NCT01081613|Bevacizumab|bevacizumab|mesh-list
6586446|NCT01081613|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
6586447|NCT01081613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6586448|NCT01081613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6586449|NCT01081613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6586450|NCT01081613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6586451|NCT01081613|Growth Substances|growth substances|mesh-ancestor
6586452|NCT01081613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586453|NCT01081613|Growth Inhibitors|growth inhibitors|mesh-ancestor
6586454|NCT01081613|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6586455|NCT01081613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6586456|NCT01081639|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6586457|NCT01081639|Hormones|hormones|mesh-ancestor
6586458|NCT01081639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6586459|NCT01081639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586460|NCT01081652|Progesterone|progesterone|mesh-list
6586461|NCT01081652|Progestins|progestins|mesh-ancestor
6586462|NCT01081652|Hormones|hormones|mesh-ancestor
6586463|NCT01081652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6586464|NCT01081652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586465|NCT01081691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6586466|NCT01081691|Immunologic Factors|immunologic factors|mesh-ancestor
6586467|NCT01081691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586468|NCT01081704|Ustekinumab|ustekinumab|mesh-list
6586469|NCT01081704|Dermatologic Agents|dermatologic agents|mesh-ancestor
6586470|NCT01081717|Golimumab|golimumab|mesh-list
6586471|NCT01081717|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6586472|NCT01081717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6586473|NCT01081717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6586474|NCT01081717|Immunologic Factors|immunologic factors|mesh-ancestor
6586475|NCT01081717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586476|NCT01081730|Ustekinumab|ustekinumab|mesh-list
6586477|NCT01081730|Dermatologic Agents|dermatologic agents|mesh-ancestor
6586478|NCT01081756|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6586479|NCT01081756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6586480|NCT01081756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586481|NCT01081847|Mannitol|mannitol|mesh-list
6586482|NCT01081847|Freund's Adjuvant|freund's adjuvant|mesh-list
6586483|NCT01081847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6586484|NCT01081847|Immunologic Factors|immunologic factors|mesh-ancestor
6586485|NCT01081847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586486|NCT01081847|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6586487|NCT01081847|Diuretics|diuretics|mesh-ancestor
6586488|NCT01081847|Natriuretic Agents|natriuretic agents|mesh-ancestor
6586489|NCT01081938|Insulin|insulin|mesh-list
6586490|NCT01081938|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6586491|NCT01081938|Insulin Glargine|insulin glargine|mesh-list
6586492|NCT01081938|Insulin glulisine|insulin glulisine|mesh-list
6586493|NCT01081938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6586494|NCT01081938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586495|NCT01081964|Levofloxacin|levofloxacin|mesh-list
6586496|NCT01081964|Ofloxacin|ofloxacin|mesh-list
6586497|NCT01081964|Fluoroquinolones|fluoroquinolones|mesh-list
6586498|NCT01081964|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6586499|NCT01081964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6586500|NCT01081964|Renal Agents|renal agents|mesh-ancestor
6586501|NCT01081964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6586502|NCT01081964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6586503|NCT01081964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6586504|NCT01081964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6586505|NCT01081964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6586506|NCT01081964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6586507|NCT01081964|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6586508|NCT01081964|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6586509|NCT01081964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6586510|NCT01081990|Cyclobenzaprine|cyclobenzaprine|mesh-list
6586511|NCT01081990|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6586512|NCT01081990|Antidepressive Agents|antidepressive agents|mesh-ancestor
6586513|NCT01081990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6586514|NCT01081990|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6586515|NCT01081990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586516|NCT01081990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6586517|NCT01081990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6586518|NCT01081990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6586519|NCT01081990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6586520|NCT01082003|Pentoxifylline|pentoxifylline|mesh-list
6586521|NCT01082003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6586522|NCT01082003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6586523|NCT01082003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6586524|NCT01082003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6586525|NCT01082003|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6586526|NCT01082003|Protective Agents|protective agents|mesh-ancestor
6586527|NCT01082003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586528|NCT01082003|Vasodilator Agents|vasodilator agents|mesh-ancestor
6586529|NCT01082003|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6586530|NCT01082003|Antioxidants|antioxidants|mesh-ancestor
6586531|NCT01082029|Lansoprazole|lansoprazole|mesh-list
6586532|NCT01082029|Dexlansoprazole|dexlansoprazole|mesh-list
6586533|NCT01082029|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6586534|NCT01082029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6586535|NCT01082029|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6586536|NCT01082029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6586537|NCT01082029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6586538|NCT01082120|Pioglitazone|pioglitazone|mesh-list
6586539|NCT01082120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6586540|NCT01082120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586541|NCT01082146|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
6586542|NCT01082146|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6586543|NCT01082146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6586544|NCT01082146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6586545|NCT01082146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586546|NCT01082146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6586547|NCT01082146|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6586548|NCT01082146|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6586549|NCT01082146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6586550|NCT01082146|Adrenergic Agents|adrenergic agents|mesh-ancestor
6586551|NCT01082146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6586552|NCT01082146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6586553|NCT01082146|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6586554|NCT01082146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6586555|NCT01082146|Serotonin Agents|serotonin agents|mesh-ancestor
6586556|NCT01082146|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6586557|NCT01082146|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6586558|NCT01082146|Dopamine Agents|dopamine agents|mesh-ancestor
6586559|NCT01082198|Vaccines|vaccines|mesh-list
6586560|NCT01082198|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
6586561|NCT01082198|Immunologic Factors|immunologic factors|mesh-ancestor
6586562|NCT01082198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586563|NCT01082198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6586564|NCT01082224|Motexafin gadolinium|motexafin gadolinium|mesh-list
6586565|NCT01082224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6586566|NCT01082224|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6586567|NCT01082224|Dermatologic Agents|dermatologic agents|mesh-ancestor
6586568|NCT01082237|Citalopram|citalopram|mesh-list
6586569|NCT01082237|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6586570|NCT01082237|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6586571|NCT01082237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6586572|NCT01082237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6586573|NCT01082237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6586574|NCT01082237|Serotonin Agents|serotonin agents|mesh-ancestor
6586575|NCT01082237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586576|NCT01082237|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6586577|NCT01082237|Antidepressive Agents|antidepressive agents|mesh-ancestor
6586578|NCT01082237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6586579|NCT01082250|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
6586580|NCT01082250|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6586581|NCT01082250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6586582|NCT01082250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6586583|NCT01082250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586584|NCT01082250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6586585|NCT01082250|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6586586|NCT01082250|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6586587|NCT01082250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6586588|NCT01082250|Adrenergic Agents|adrenergic agents|mesh-ancestor
6586589|NCT01082250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6586590|NCT01082250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6586591|NCT01082250|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6586592|NCT01082250|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6586593|NCT01082250|Serotonin Agents|serotonin agents|mesh-ancestor
6586594|NCT01082250|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6586595|NCT01082250|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6586596|NCT01082250|Dopamine Agents|dopamine agents|mesh-ancestor
6586597|NCT01082263|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
6586598|NCT01082263|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6586599|NCT01082263|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6586600|NCT01082263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6586601|NCT01082263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586602|NCT01082263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6586603|NCT01082263|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6586604|NCT01082263|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6586605|NCT01082263|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6586606|NCT01082263|Adrenergic Agents|adrenergic agents|mesh-ancestor
6586607|NCT01082263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6586608|NCT01082263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6586609|NCT01082263|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6586610|NCT01082263|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6586611|NCT01082263|Serotonin Agents|serotonin agents|mesh-ancestor
6586612|NCT01082263|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6586613|NCT01082263|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6586614|NCT01082263|Dopamine Agents|dopamine agents|mesh-ancestor
6586615|NCT01082276|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
6586616|NCT01082276|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6586617|NCT01082276|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6586618|NCT01082276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6586619|NCT01082276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586620|NCT01082276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6586621|NCT01082276|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6586622|NCT01082276|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6586623|NCT01082276|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6586624|NCT01082276|Adrenergic Agents|adrenergic agents|mesh-ancestor
6586625|NCT01082276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6586626|NCT01082276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6586627|NCT01082276|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6586628|NCT01082276|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6586629|NCT01082276|Serotonin Agents|serotonin agents|mesh-ancestor
6586630|NCT01082276|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6586631|NCT01082276|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6586632|NCT01082276|Dopamine Agents|dopamine agents|mesh-ancestor
6586633|NCT01082289|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
6586634|NCT01082289|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6586635|NCT01082289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6586636|NCT01082289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6586637|NCT01082289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586638|NCT01082289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6586639|NCT01082289|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6586640|NCT01082289|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6586641|NCT01082289|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6586642|NCT01082289|Adrenergic Agents|adrenergic agents|mesh-ancestor
6586643|NCT01082289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6586644|NCT01082289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6586645|NCT01082289|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6586646|NCT01082289|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6586647|NCT01082289|Serotonin Agents|serotonin agents|mesh-ancestor
6586648|NCT01082289|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6586649|NCT01082289|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6586650|NCT01082289|Dopamine Agents|dopamine agents|mesh-ancestor
6658814|NCT01484691|Autonomic Agents|autonomic agents|mesh-ancestor
6658815|NCT01484691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6658816|NCT01484691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658817|NCT01484691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6658818|NCT01484691|Respiratory System Agents|respiratory system agents|mesh-ancestor
6658819|NCT01484691|Glucocorticoids|glucocorticoids|mesh-ancestor
6658820|NCT01484691|Hormones|hormones|mesh-ancestor
6658821|NCT01484691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6658822|NCT01484717|Nicotine|nicotine|mesh-list
6658823|NCT01484717|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6658824|NCT01484717|Autonomic Agents|autonomic agents|mesh-ancestor
6658825|NCT01484717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6658826|NCT01484717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658827|NCT01484717|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6658828|NCT01484717|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6658829|NCT01484717|Cholinergic Agents|cholinergic agents|mesh-ancestor
6658830|NCT01484717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6658831|NCT01484717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658832|NCT01484756|Micronutrients|micronutrients|mesh-list
6658833|NCT01484756|Trace Elements|trace elements|mesh-list
6658834|NCT01484756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447277|NCT00396747|Dermatologic Agents|dermatologic agents|mesh-ancestor
6447278|NCT00396747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6447279|NCT00396747|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6447280|NCT00396747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6447281|NCT00396747|Immunologic Factors|immunologic factors|mesh-ancestor
6447282|NCT00396747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6586651|NCT01082315|Cetuximab|cetuximab|mesh-list
6586652|NCT01082315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6586653|NCT01082315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6586654|NCT01082341|Vaccines|vaccines|mesh-list
6586655|NCT01082341|Immunologic Factors|immunologic factors|mesh-ancestor
6586656|NCT01082341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586657|NCT01082393|Mometasone Furoate|mometasone furoate|mesh-list
6586658|NCT01082393|Pimecrolimus|pimecrolimus|mesh-list
6586659|NCT01082393|Tacrolimus|tacrolimus|mesh-list
6586660|NCT01082393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6586661|NCT01082393|Immunologic Factors|immunologic factors|mesh-ancestor
6586662|NCT01082393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586663|NCT01082393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6586664|NCT01082393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6586665|NCT01082393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6586666|NCT01082393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6586667|NCT01082393|Dermatologic Agents|dermatologic agents|mesh-ancestor
6586668|NCT01082393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6586669|NCT01082393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6586670|NCT01082393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6586671|NCT01082393|Analgesics|analgesics|mesh-ancestor
6586672|NCT01082393|Sensory System Agents|sensory system agents|mesh-ancestor
6586673|NCT01082393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6586674|NCT01082393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6586675|NCT01082445|Acetylcysteine|acetylcysteine|mesh-list
6586676|NCT01082445|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6586677|NCT01082445|Antiviral Agents|antiviral agents|mesh-ancestor
6586678|NCT01082445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6586679|NCT01082445|Expectorants|expectorants|mesh-ancestor
6586680|NCT01082445|Respiratory System Agents|respiratory system agents|mesh-ancestor
6586681|NCT01082445|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6586682|NCT01082445|Antioxidants|antioxidants|mesh-ancestor
6586683|NCT01082445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6586684|NCT01082445|Protective Agents|protective agents|mesh-ancestor
6586685|NCT01082445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586686|NCT01082445|Antidotes|antidotes|mesh-ancestor
6586687|NCT01082458|Lidocaine|lidocaine|mesh-list
6586688|NCT01082458|Remifentanil|remifentanil|mesh-list
6586689|NCT01082458|Anesthetics, Local|anesthetics, local|mesh-ancestor
6586690|NCT01082458|Anesthetics|anesthetics|mesh-ancestor
6586691|NCT01082458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6586692|NCT01082458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586693|NCT01082458|Sensory System Agents|sensory system agents|mesh-ancestor
6586694|NCT01082458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6586695|NCT01082458|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6586696|NCT01082458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6447283|NCT00396747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6447284|NCT00396747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6447285|NCT00396747|Antiemetics|antiemetics|mesh-ancestor
6447286|NCT00396747|Autonomic Agents|autonomic agents|mesh-ancestor
6447287|NCT00396747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6586697|NCT01082458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6586698|NCT01082458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6586699|NCT01082458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6586700|NCT01082458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6586701|NCT01082458|Narcotics|narcotics|mesh-ancestor
6586702|NCT01082458|Analgesics|analgesics|mesh-ancestor
6586703|NCT01082471|Morphine|morphine|mesh-list
6586704|NCT01082471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6586705|NCT01082471|Narcotics|narcotics|mesh-ancestor
6586706|NCT01082471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6586707|NCT01082471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586708|NCT01082471|Analgesics|analgesics|mesh-ancestor
6586709|NCT01082471|Sensory System Agents|sensory system agents|mesh-ancestor
6586710|NCT01082471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6586711|NCT01082484|Treprostinil|treprostinil|mesh-list
6586712|NCT01082484|Iloprost|iloprost|mesh-list
6447288|NCT00396747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6447289|NCT00396747|Glucocorticoids|glucocorticoids|mesh-ancestor
6447290|NCT00396747|Hormones|hormones|mesh-ancestor
6447291|NCT00396747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6447292|NCT00396747|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6447293|NCT00396747|Protective Agents|protective agents|mesh-ancestor
6447294|NCT00396747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6586713|NCT01082484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6586714|NCT01082484|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6586715|NCT01082484|Vasodilator Agents|vasodilator agents|mesh-ancestor
6586716|NCT01082510|Tegafur|tegafur|mesh-list
6586717|NCT01082510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6586718|NCT01082510|Antimetabolites|antimetabolites|mesh-ancestor
6586719|NCT01082510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6586720|NCT01082510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6447295|NCT00396760|Tranexamic Acid|tranexamic acid|mesh-list
6447296|NCT00396760|Aprotinin|aprotinin|mesh-list
6586721|NCT01082627|Somatostatin|somatostatin|mesh-list
6586722|NCT01082627|Hormones|hormones|mesh-ancestor
6586723|NCT01082627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6586724|NCT01082627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586725|NCT01082679|Buprenorphine|buprenorphine|mesh-list
6586726|NCT01082679|Methadone|methadone|mesh-list
6586727|NCT01082679|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6586728|NCT01082679|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6586729|NCT01082679|Narcotics|narcotics|mesh-ancestor
6586730|NCT01082679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6586731|NCT01082679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586732|NCT01082679|Analgesics|analgesics|mesh-ancestor
6586733|NCT01082679|Sensory System Agents|sensory system agents|mesh-ancestor
6586734|NCT01082679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6586735|NCT01082679|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6586736|NCT01082679|Antitussive Agents|antitussive agents|mesh-ancestor
6586737|NCT01082679|Respiratory System Agents|respiratory system agents|mesh-ancestor
6586738|NCT01082705|Lumefantrine|lumefantrine|mesh-list
6586739|NCT01082705|Artemether|artemether|mesh-list
6586740|NCT01082705|Piperaquine|piperaquine|mesh-list
6586741|NCT01082705|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6586742|NCT01082705|Artenimol|artenimol|mesh-list
6586743|NCT01082705|Antimalarials|antimalarials|mesh-ancestor
6586744|NCT01082705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6586745|NCT01082705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6586746|NCT01082705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6586747|NCT01082718|Artesunate|artesunate|mesh-list
6447297|NCT00396760|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6586748|NCT01082718|Mefloquine|mefloquine|mesh-list
6586749|NCT01082718|Antimalarials|antimalarials|mesh-ancestor
6586750|NCT01082718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6586751|NCT01082718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6586752|NCT01082718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6586753|NCT01082718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6586754|NCT01082718|Antiviral Agents|antiviral agents|mesh-ancestor
6586755|NCT01082718|Schistosomicides|schistosomicides|mesh-ancestor
6586756|NCT01082718|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6586757|NCT01082718|Anthelmintics|anthelmintics|mesh-ancestor
6586758|NCT01082731|Artesunate|artesunate|mesh-list
6586759|NCT01082731|Lumefantrine|lumefantrine|mesh-list
6586760|NCT01082731|Artemether|artemether|mesh-list
6586761|NCT01082731|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6586762|NCT01082731|Mefloquine|mefloquine|mesh-list
6586763|NCT01082731|Antimalarials|antimalarials|mesh-ancestor
6586764|NCT01082731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6586765|NCT01082731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6586766|NCT01082731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6586767|NCT01082731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6586768|NCT01082731|Antiviral Agents|antiviral agents|mesh-ancestor
6586769|NCT01082731|Schistosomicides|schistosomicides|mesh-ancestor
6586770|NCT01082731|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6586771|NCT01082731|Anthelmintics|anthelmintics|mesh-ancestor
6586772|NCT01082744|Sufentanil|sufentanil|mesh-list
6586773|NCT01082744|Ropivacaine|ropivacaine|mesh-list
6586774|NCT01082744|Anesthetics, Local|anesthetics, local|mesh-ancestor
6586775|NCT01082744|Anesthetics|anesthetics|mesh-ancestor
6586776|NCT01082744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6586777|NCT01082744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586778|NCT01082744|Sensory System Agents|sensory system agents|mesh-ancestor
6586779|NCT01082744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6586780|NCT01082744|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6586781|NCT01082744|Narcotics|narcotics|mesh-ancestor
6586782|NCT01082744|Analgesics|analgesics|mesh-ancestor
6586783|NCT01082744|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6586784|NCT01082744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6586785|NCT01082744|Anesthetics, General|anesthetics, general|mesh-ancestor
6586786|NCT01082796|Glipizide|glipizide|mesh-list
6586787|NCT01082796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6586788|NCT01082796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586789|NCT01082809|Sunitinib|sunitinib|mesh-list
6586790|NCT01082809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6586791|NCT01082809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6586792|NCT01082809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6586793|NCT01082809|Growth Substances|growth substances|mesh-ancestor
6586794|NCT01082809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586795|NCT01082809|Growth Inhibitors|growth inhibitors|mesh-ancestor
6586796|NCT01082809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6586797|NCT01082809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6586798|NCT01082809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6586799|NCT01082848|Aripiprazole|aripiprazole|mesh-list
6586800|NCT01082848|Antidepressive Agents|antidepressive agents|mesh-ancestor
6586801|NCT01082848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6586802|NCT01082848|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6586803|NCT01082848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6586804|NCT01082848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6586805|NCT01082848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586806|NCT01082848|Dopamine Agonists|dopamine agonists|mesh-ancestor
6586807|NCT01082848|Dopamine Agents|dopamine agents|mesh-ancestor
6586808|NCT01082848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6586809|NCT01082848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6586810|NCT01082848|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6586811|NCT01082848|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6586812|NCT01082848|Serotonin Agents|serotonin agents|mesh-ancestor
6586813|NCT01082848|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6586814|NCT01082848|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6586815|NCT01082848|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6586816|NCT01082848|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6586817|NCT01082926|Aldesleukin|aldesleukin|mesh-list
6586818|NCT01082926|Interleukin-2|interleukin-2|mesh-list
6586819|NCT01082926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6586820|NCT01082926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6586821|NCT01082926|Analgesics|analgesics|mesh-ancestor
6586822|NCT01082926|Sensory System Agents|sensory system agents|mesh-ancestor
6586823|NCT01082926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6586824|NCT01082926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586825|NCT01082926|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6586826|NCT01082926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6586827|NCT01082926|Antiviral Agents|antiviral agents|mesh-ancestor
6586828|NCT01082926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6586829|NCT01083017|Chlorthalidone|chlorthalidone|mesh-list
6586830|NCT01083017|Antihypertensive Agents|antihypertensive agents|mesh-list
6586831|NCT01083017|Diuretics|diuretics|mesh-ancestor
6586832|NCT01083017|Natriuretic Agents|natriuretic agents|mesh-ancestor
6586833|NCT01083017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586834|NCT01083017|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6586835|NCT01083017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6586836|NCT01083017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6586837|NCT01083212|Gemfibrozil|gemfibrozil|mesh-list
6586838|NCT01083212|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6586839|NCT01083212|Antimetabolites|antimetabolites|mesh-ancestor
6586840|NCT01083212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6586841|NCT01083212|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6586842|NCT01083212|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6586843|NCT01083212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6586844|NCT01083212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6586845|NCT01083251|Vitamin D|vitamin d|mesh-list
6586846|NCT01083251|Ergocalciferols|ergocalciferols|mesh-list
6586847|NCT01083251|Vitamins|vitamins|mesh-list
6586848|NCT01083251|Entecavir|entecavir|mesh-list
6586849|NCT01083251|Micronutrients|micronutrients|mesh-ancestor
6586850|NCT01083251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586851|NCT01083251|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6586852|NCT01083251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6586853|NCT01083251|Antiviral Agents|antiviral agents|mesh-ancestor
6586854|NCT01083251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6586855|NCT01083264|Gestodene|gestodene|mesh-list
6586856|NCT01083264|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6586857|NCT01083264|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6586858|NCT01083264|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6586859|NCT01083264|Contraceptive Agents|contraceptive agents|mesh-ancestor
6586860|NCT01083264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6586861|NCT01083264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586862|NCT01083264|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6586863|NCT01083264|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6586864|NCT01083264|Progestins|progestins|mesh-ancestor
6586865|NCT01083264|Hormones|hormones|mesh-ancestor
6586866|NCT01083264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6586867|NCT01083290|Spironolactone|spironolactone|mesh-list
6586868|NCT01083290|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6586869|NCT01083290|Hormone Antagonists|hormone antagonists|mesh-ancestor
6586870|NCT01083290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6586871|NCT01083290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586872|NCT01083290|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6586873|NCT01083290|Diuretics|diuretics|mesh-ancestor
6586874|NCT01083290|Natriuretic Agents|natriuretic agents|mesh-ancestor
6586875|NCT01083329|Nicotinic Acids|nicotinic acids|mesh-list
6586876|NCT01083329|Niacin|niacin|mesh-list
6586877|NCT01083329|Niacinamide|niacinamide|mesh-list
6586878|NCT01083329|Vitamin B Complex|vitamin b complex|mesh-ancestor
6586879|NCT01083329|Vitamins|vitamins|mesh-ancestor
6586880|NCT01083329|Micronutrients|micronutrients|mesh-ancestor
6586881|NCT01083329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586882|NCT01083329|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6586883|NCT01083329|Antimetabolites|antimetabolites|mesh-ancestor
6586884|NCT01083329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6586885|NCT01083329|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6586886|NCT01083329|Vasodilator Agents|vasodilator agents|mesh-ancestor
6586887|NCT01083381|Risperidone|risperidone|mesh-list
6586888|NCT01083381|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6586889|NCT01083381|Serotonin Agents|serotonin agents|mesh-ancestor
6586890|NCT01083381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6586891|NCT01083381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6586892|NCT01083381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586893|NCT01083381|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6586894|NCT01083381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6586895|NCT01083381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6586896|NCT01083381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6586897|NCT01083381|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6586898|NCT01083381|Dopamine Agents|dopamine agents|mesh-ancestor
6586899|NCT01083407|Chlorhexidine|chlorhexidine|mesh-list
6586900|NCT01083407|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6586901|NCT01083407|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6586902|NCT01083407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6586903|NCT01083407|Disinfectants|disinfectants|mesh-ancestor
6586904|NCT01083407|Dermatologic Agents|dermatologic agents|mesh-ancestor
6586905|NCT01083420|Minocycline|minocycline|mesh-list
6586906|NCT01083420|Dexamethasone|dexamethasone|mesh-list
6586907|NCT01083420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6586908|NCT01083420|Antiemetics|antiemetics|mesh-ancestor
6586909|NCT01083420|Autonomic Agents|autonomic agents|mesh-ancestor
6586910|NCT01083420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6586911|NCT01083420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586912|NCT01083420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6586913|NCT01083420|Glucocorticoids|glucocorticoids|mesh-ancestor
6586914|NCT01083420|Hormones|hormones|mesh-ancestor
6586915|NCT01083420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6586916|NCT01083420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6586917|NCT01083420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6586918|NCT01083420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6586919|NCT01083420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6586920|NCT01083537|Paclitaxel|paclitaxel|mesh-list
6586921|NCT01083537|Cisplatin|cisplatin|mesh-list
6586922|NCT01083537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6586923|NCT01083537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6586924|NCT01083537|Tubulin Modulators|tubulin modulators|mesh-ancestor
6586925|NCT01083537|Antimitotic Agents|antimitotic agents|mesh-ancestor
6586926|NCT01083537|Mitosis Modulators|mitosis modulators|mesh-ancestor
6586927|NCT01083537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6586928|NCT01083589|Docetaxel|docetaxel|mesh-list
6586929|NCT01083589|Imatinib Mesylate|imatinib mesylate|mesh-list
6586930|NCT01083589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6586931|NCT01083589|Tubulin Modulators|tubulin modulators|mesh-ancestor
6586932|NCT01083589|Antimitotic Agents|antimitotic agents|mesh-ancestor
6586933|NCT01083589|Mitosis Modulators|mitosis modulators|mesh-ancestor
6586934|NCT01083589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6586935|NCT01083589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6586936|NCT01083589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6586937|NCT01083784|Valproic Acid|valproic acid|mesh-list
6586938|NCT01083784|Clonazepam|clonazepam|mesh-list
6586939|NCT01083784|Anticonvulsants|anticonvulsants|mesh-list
6586940|NCT01083784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6586941|NCT01083784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6586942|NCT01083784|GABA Agents|gaba agents|mesh-ancestor
6586943|NCT01083784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6586944|NCT01083784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586945|NCT01083784|Antimanic Agents|antimanic agents|mesh-ancestor
6586946|NCT01083784|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6586947|NCT01083784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6586948|NCT01083784|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6586949|NCT01083784|GABA Modulators|gaba modulators|mesh-ancestor
6586950|NCT01083797|Dexmedetomidine|dexmedetomidine|mesh-list
6586951|NCT01083797|Chloral Hydrate|chloral hydrate|mesh-list
6586952|NCT01083797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6586953|NCT01083797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6586954|NCT01083797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586955|NCT01083797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6586956|NCT01083797|Analgesics|analgesics|mesh-ancestor
6586957|NCT01083797|Sensory System Agents|sensory system agents|mesh-ancestor
6586958|NCT01083797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6586959|NCT01083797|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6586960|NCT01083797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6586961|NCT01083797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6586962|NCT01083797|Adrenergic Agents|adrenergic agents|mesh-ancestor
6586963|NCT01083797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6586964|NCT01083797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6586965|NCT01083875|Amlexanox|amlexanox|mesh-list
6586966|NCT01083875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6586967|NCT01083953|Sevoflurane|sevoflurane|mesh-list
6586968|NCT01083953|Desflurane|desflurane|mesh-list
6586969|NCT01083953|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6586970|NCT01083953|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6586971|NCT01083953|Anesthetics, General|anesthetics, general|mesh-ancestor
6586972|NCT01083953|Anesthetics|anesthetics|mesh-ancestor
6586973|NCT01083953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6586974|NCT01083953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586975|NCT01083966|Bevacizumab|bevacizumab|mesh-list
6586976|NCT01083966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6586977|NCT01083966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6586978|NCT01083966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6586979|NCT01083966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6586980|NCT01083966|Growth Substances|growth substances|mesh-ancestor
6586981|NCT01083966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586982|NCT01083966|Growth Inhibitors|growth inhibitors|mesh-ancestor
6586983|NCT01083992|Vitamin D|vitamin d|mesh-list
6586984|NCT01083992|Vildagliptin|vildagliptin|mesh-list
6586985|NCT01083992|Vitamins|vitamins|mesh-ancestor
6586986|NCT01083992|Micronutrients|micronutrients|mesh-ancestor
6586987|NCT01083992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586988|NCT01083992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6586989|NCT01083992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6586990|NCT01083992|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6586991|NCT01083992|Protease Inhibitors|protease inhibitors|mesh-ancestor
6586992|NCT01083992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6586993|NCT01083992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6586994|NCT01084031|Propofol|propofol|mesh-list
6586995|NCT01084031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6586996|NCT01084031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6586997|NCT01084031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6586998|NCT01084031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6586999|NCT01084031|Anesthetics, General|anesthetics, general|mesh-ancestor
6587000|NCT01084031|Anesthetics|anesthetics|mesh-ancestor
6587001|NCT01084044|Urinastatin|urinastatin|mesh-list
6587002|NCT01084044|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6587003|NCT01084044|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6587004|NCT01084044|Protease Inhibitors|protease inhibitors|mesh-ancestor
6587005|NCT01084044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6587006|NCT01084044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587007|NCT01084057|Vorinostat|vorinostat|mesh-list
6587008|NCT01084057|Epothilone B|epothilone b|mesh-list
6587009|NCT01084057|Epothilones|epothilones|mesh-list
6587010|NCT01084057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6587011|NCT01084057|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6587012|NCT01084057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6587013|NCT01084057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587014|NCT01084057|Tubulin Modulators|tubulin modulators|mesh-ancestor
6587015|NCT01084057|Antimitotic Agents|antimitotic agents|mesh-ancestor
6587016|NCT01084057|Mitosis Modulators|mitosis modulators|mesh-ancestor
6587017|NCT01084122|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6587018|NCT01084122|Hematinics|hematinics|mesh-ancestor
6587019|NCT01084187|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6587020|NCT01084187|Vasodilator Agents|vasodilator agents|mesh-ancestor
6587021|NCT01084187|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6587022|NCT01084187|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6587023|NCT01084187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6587024|NCT01084187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587025|NCT01084187|Urological Agents|urological agents|mesh-ancestor
6587026|NCT01084200|Propofol|propofol|mesh-list
6587027|NCT01084200|Sevoflurane|sevoflurane|mesh-list
6587028|NCT01084200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6587029|NCT01084200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6587030|NCT01084200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587031|NCT01084200|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6587032|NCT01084200|Anesthetics, General|anesthetics, general|mesh-ancestor
6587033|NCT01084200|Anesthetics|anesthetics|mesh-ancestor
6587034|NCT01084200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6587035|NCT01084200|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6658835|NCT01484964|Peficitinib|peficitinib|mesh-list
6447298|NCT00396760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6447299|NCT00396760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447300|NCT00396760|Hemostatics|hemostatics|mesh-ancestor
6447301|NCT00396760|Coagulants|coagulants|mesh-ancestor
6447302|NCT00396760|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6447303|NCT00396760|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6447304|NCT00396760|Protease Inhibitors|protease inhibitors|mesh-ancestor
6447305|NCT00396760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6447306|NCT00396786|Enoxaparin|enoxaparin|mesh-list
6447307|NCT00396786|Rivaroxaban|rivaroxaban|mesh-list
6447308|NCT00396786|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6447309|NCT00396786|Antithrombins|antithrombins|mesh-ancestor
6658836|NCT01484964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6658837|NCT01484964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658838|NCT01484964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6587036|NCT01084213|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6587037|NCT01084213|Antimalarials|antimalarials|mesh-ancestor
6587038|NCT01084213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6587039|NCT01084213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6587040|NCT01084213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6587041|NCT01084291|Vaccines|vaccines|mesh-list
6587042|NCT01084291|Immunologic Factors|immunologic factors|mesh-ancestor
6587043|NCT01084291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587044|NCT01084369|Methyltestosterone|methyltestosterone|mesh-list
6587045|NCT01084369|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6587046|NCT01084369|Testosterone|testosterone|mesh-list
6587047|NCT01084369|Testosterone undecanoate|testosterone undecanoate|mesh-list
6587048|NCT01084369|Testosterone enanthate|testosterone enanthate|mesh-list
6587049|NCT01084369|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6587050|NCT01084369|Androgens|androgens|mesh-ancestor
6587051|NCT01084369|Hormones|hormones|mesh-ancestor
6587052|NCT01084369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6587053|NCT01084369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587054|NCT01084369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6587055|NCT01084369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6587056|NCT01084369|Anabolic Agents|anabolic agents|mesh-ancestor
6587057|NCT01084369|Vasodilator Agents|vasodilator agents|mesh-ancestor
6587058|NCT01084369|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6587059|NCT01084369|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6587060|NCT01084369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6587061|NCT01084369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587062|NCT01084369|Urological Agents|urological agents|mesh-ancestor
6587063|NCT01084408|Paclitaxel|paclitaxel|mesh-list
6587064|NCT01084408|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6587065|NCT01084408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6587066|NCT01084408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6587067|NCT01084408|Tubulin Modulators|tubulin modulators|mesh-ancestor
6587068|NCT01084408|Antimitotic Agents|antimitotic agents|mesh-ancestor
6587069|NCT01084408|Mitosis Modulators|mitosis modulators|mesh-ancestor
6587070|NCT01084408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587071|NCT01084473|Dexmedetomidine|dexmedetomidine|mesh-list
6587072|NCT01084473|Morphine|morphine|mesh-list
6587073|NCT01084473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6587074|NCT01084473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6587075|NCT01084473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587076|NCT01084473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6587077|NCT01084473|Analgesics|analgesics|mesh-ancestor
6587078|NCT01084473|Sensory System Agents|sensory system agents|mesh-ancestor
6587079|NCT01084473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6587080|NCT01084473|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6587081|NCT01084473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6587082|NCT01084473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6587083|NCT01084473|Adrenergic Agents|adrenergic agents|mesh-ancestor
6587084|NCT01084473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6587085|NCT01084473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587086|NCT01084473|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6587087|NCT01084473|Narcotics|narcotics|mesh-ancestor
6587088|NCT01084486|Metformin|metformin|mesh-list
6587089|NCT01084486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6587090|NCT01084486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587091|NCT01084577|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6587092|NCT01084577|Laxatives|laxatives|mesh-ancestor
6587093|NCT01084577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6587094|NCT01084720|V0034CR|v0034cr|mesh-list
6587095|NCT01084720|Emollients|emollients|mesh-ancestor
6587096|NCT01084720|Dermatologic Agents|dermatologic agents|mesh-ancestor
6587097|NCT01084824|Cantharidin|cantharidin|mesh-list
6587098|NCT01084824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6587099|NCT01084824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587100|NCT01084837|Bortezomib|bortezomib|mesh-list
6587101|NCT01084837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6587102|NCT01084863|Paclitaxel|paclitaxel|mesh-list
6587103|NCT01084863|Trastuzumab|trastuzumab|mesh-list
6587104|NCT01084863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6587105|NCT01084863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6587106|NCT01084863|Tubulin Modulators|tubulin modulators|mesh-ancestor
6587107|NCT01084863|Antimitotic Agents|antimitotic agents|mesh-ancestor
6587108|NCT01084863|Mitosis Modulators|mitosis modulators|mesh-ancestor
6587109|NCT01084863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587110|NCT01084863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6587111|NCT01084876|Paclitaxel|paclitaxel|mesh-list
6587112|NCT01084876|Trastuzumab|trastuzumab|mesh-list
6587113|NCT01084876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6587114|NCT01084876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6587115|NCT01084876|Tubulin Modulators|tubulin modulators|mesh-ancestor
6587116|NCT01084876|Antimitotic Agents|antimitotic agents|mesh-ancestor
6587117|NCT01084876|Mitosis Modulators|mitosis modulators|mesh-ancestor
6587118|NCT01084876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587119|NCT01084876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6587120|NCT01084902|Latanoprost|latanoprost|mesh-list
6587121|NCT01084902|Brinzolamide|brinzolamide|mesh-list
6587122|NCT01084902|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6587123|NCT01084902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6587124|NCT01084902|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6587125|NCT01084902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6587126|NCT01084902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587127|NCT01084980|Tacrolimus|tacrolimus|mesh-list
6447310|NCT00396786|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6447311|NCT00396786|Protease Inhibitors|protease inhibitors|mesh-ancestor
6447312|NCT00396786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6447313|NCT00396786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447314|NCT00396786|Anticoagulants|anticoagulants|mesh-ancestor
6587128|NCT01084980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6587129|NCT01084980|Immunologic Factors|immunologic factors|mesh-ancestor
6587130|NCT01084980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587131|NCT01084980|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6587132|NCT01084980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6587133|NCT01084980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587134|NCT01084993|Heparin|heparin|mesh-list
6020341|NCT00392704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6020342|NCT00392704|Immunologic Factors|immunologic factors|mesh-ancestor
6020343|NCT00392704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6020344|NCT00392704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6020345|NCT00392769|Cetuximab|cetuximab|mesh-list
6020346|NCT00392769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6020347|NCT00392769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6020348|NCT00392782|Fludarabine|fludarabine|mesh-list
6020349|NCT00392782|Fludarabine phosphate|fludarabine phosphate|mesh-list
6447315|NCT00396786|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6587135|NCT01084993|Bivalirudin|bivalirudin|mesh-list
6587136|NCT01084993|Anticoagulants|anticoagulants|mesh-ancestor
6587137|NCT01084993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6587138|NCT01084993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6587139|NCT01084993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587140|NCT01084993|Antithrombins|antithrombins|mesh-ancestor
6587141|NCT01084993|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6587142|NCT01084993|Protease Inhibitors|protease inhibitors|mesh-ancestor
6587143|NCT01084993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6587144|NCT01085032|Nicotine|nicotine|mesh-list
6587145|NCT01085032|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6587146|NCT01085032|Autonomic Agents|autonomic agents|mesh-ancestor
6587147|NCT01085032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6587148|NCT01085032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447316|NCT00396786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6447317|NCT00396799|Bazedoxifene|bazedoxifene|mesh-list
6447318|NCT00396799|Estrogens|estrogens|mesh-list
6447319|NCT00396799|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6447320|NCT00396799|Hormones|hormones|mesh-ancestor
6447321|NCT00396799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6447322|NCT00396799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447323|NCT00396799|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6020350|NCT00392782|Thiotepa|thiotepa|mesh-list
6020351|NCT00392782|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6587149|NCT01085032|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6587150|NCT01085032|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6587151|NCT01085032|Cholinergic Agents|cholinergic agents|mesh-ancestor
6587152|NCT01085032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6587153|NCT01085032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587154|NCT01085058|Lenograstim|lenograstim|mesh-list
6587155|NCT01085058|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6587156|NCT01085058|Immunologic Factors|immunologic factors|mesh-ancestor
6587157|NCT01085058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587158|NCT01085149|Simvastatin|simvastatin|mesh-list
6587159|NCT01085149|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6587160|NCT01085149|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6587161|NCT01085149|Antimetabolites|antimetabolites|mesh-ancestor
6587162|NCT01085149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587163|NCT01085149|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6587164|NCT01085149|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6587165|NCT01085149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6587166|NCT01085383|Aripiprazole|aripiprazole|mesh-list
6587167|NCT01085383|Antidepressive Agents|antidepressive agents|mesh-ancestor
6587168|NCT01085383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6587169|NCT01085383|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6587170|NCT01085383|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6587171|NCT01085383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6587172|NCT01085383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587173|NCT01085383|Dopamine Agonists|dopamine agonists|mesh-ancestor
6587174|NCT01085383|Dopamine Agents|dopamine agents|mesh-ancestor
6587175|NCT01085383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6587176|NCT01085383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587177|NCT01085383|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6587178|NCT01085383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6587179|NCT01085383|Serotonin Agents|serotonin agents|mesh-ancestor
6587180|NCT01085383|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6587181|NCT01085383|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6587182|NCT01085383|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6587183|NCT01085383|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6587184|NCT01085422|Temozolomide|temozolomide|mesh-list
6587185|NCT01085422|Veliparib|veliparib|mesh-list
6587186|NCT01085422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6587187|NCT01085422|Alkylating Agents|alkylating agents|mesh-ancestor
6587188|NCT01085422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587189|NCT01085422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6587190|NCT01085422|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6587191|NCT01085422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6587192|NCT01085487|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
6587193|NCT01085487|Levonorgestrel|levonorgestrel|mesh-list
6587194|NCT01085487|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6587195|NCT01085487|Contraceptive Agents|contraceptive agents|mesh-ancestor
6587196|NCT01085487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6587197|NCT01085487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587198|NCT01085487|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6587199|NCT01085487|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6587200|NCT01085487|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6587201|NCT01085487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6587202|NCT01085487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587203|NCT01085487|Hemostatics|hemostatics|mesh-ancestor
6587204|NCT01085487|Coagulants|coagulants|mesh-ancestor
6587205|NCT01085526|Immunologic Factors|immunologic factors|mesh-list
6587206|NCT01085526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587207|NCT01085552|Epoetin Alfa|epoetin alfa|mesh-list
6447324|NCT00396799|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6587208|NCT01085552|Hematinics|hematinics|mesh-ancestor
6587209|NCT01085617|Cytarabine|cytarabine|mesh-list
6587210|NCT01085617|Cyclophosphamide|cyclophosphamide|mesh-list
6587211|NCT01085617|Melphalan|melphalan|mesh-list
6587212|NCT01085617|Rituximab|rituximab|mesh-list
6587213|NCT01085617|Methotrexate|methotrexate|mesh-list
6587214|NCT01085617|Fludarabine|fludarabine|mesh-list
6587215|NCT01085617|Fludarabine phosphate|fludarabine phosphate|mesh-list
6587216|NCT01085617|Etoposide|etoposide|mesh-list
6587217|NCT01085617|Vincristine|vincristine|mesh-list
6587218|NCT01085617|Imatinib Mesylate|imatinib mesylate|mesh-list
6587219|NCT01085617|Daunorubicin|daunorubicin|mesh-list
6587220|NCT01085617|Mercaptopurine|mercaptopurine|mesh-list
6587221|NCT01085617|Pegaspargase|pegaspargase|mesh-list
6587222|NCT01085617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6587223|NCT01085617|Immunologic Factors|immunologic factors|mesh-ancestor
6587224|NCT01085617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587225|NCT01085617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6587226|NCT01085617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6587227|NCT01085617|Alkylating Agents|alkylating agents|mesh-ancestor
6587228|NCT01085617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587229|NCT01085617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6587230|NCT01085617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6587231|NCT01085617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6587232|NCT01085617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6587233|NCT01085617|Abortifacient Agents|abortifacient agents|mesh-ancestor
6587234|NCT01085617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6587235|NCT01085617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6587236|NCT01085617|Antimetabolites|antimetabolites|mesh-ancestor
6587237|NCT01085617|Dermatologic Agents|dermatologic agents|mesh-ancestor
6587238|NCT01085617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6587239|NCT01085617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6587240|NCT01085617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6587241|NCT01085617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6447325|NCT00396799|Hormone Antagonists|hormone antagonists|mesh-ancestor
6447326|NCT00396799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6447327|NCT00396851|Metformin|metformin|mesh-list
6447328|NCT00396851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6447329|NCT00396851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461796|NCT00456235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6461797|NCT00456235|Antitubercular Agents|antitubercular agents|mesh-ancestor
6461798|NCT00456235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6461799|NCT00456235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6461800|NCT00456235|Antifungal Agents|antifungal agents|mesh-ancestor
6461801|NCT00456235|Dermatologic Agents|dermatologic agents|mesh-ancestor
6461802|NCT00456235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6461803|NCT00456248|Ribavirin|ribavirin|mesh-list
6461804|NCT00456248|Interferon alfacon-1|interferon alfacon-1|mesh-list
6461805|NCT00456248|Antimetabolites|antimetabolites|mesh-ancestor
6461806|NCT00456248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461807|NCT00456248|Antiviral Agents|antiviral agents|mesh-ancestor
6461808|NCT00456248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6462217|NCT00458185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587242|NCT01085617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6587243|NCT01085617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6587244|NCT01085617|Antiviral Agents|antiviral agents|mesh-ancestor
6587245|NCT01085617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6587246|NCT01085617|Tubulin Modulators|tubulin modulators|mesh-ancestor
6587247|NCT01085617|Antimitotic Agents|antimitotic agents|mesh-ancestor
6587248|NCT01085617|Mitosis Modulators|mitosis modulators|mesh-ancestor
6587249|NCT01085617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6587250|NCT01085617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6587251|NCT01085656|Combretastatin|combretastatin|mesh-list
6587252|NCT01085656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6587253|NCT01085656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6587254|NCT01085656|Tubulin Modulators|tubulin modulators|mesh-ancestor
6587255|NCT01085656|Antimitotic Agents|antimitotic agents|mesh-ancestor
6587256|NCT01085656|Mitosis Modulators|mitosis modulators|mesh-ancestor
6587257|NCT01085656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587258|NCT01085695|Rabeprazole|rabeprazole|mesh-list
6587259|NCT01085695|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6587260|NCT01085695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6587261|NCT01085695|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6587262|NCT01085695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6587263|NCT01085695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587264|NCT01085708|Rabeprazole|rabeprazole|mesh-list
6587265|NCT01085708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6587266|NCT01085708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6587267|NCT01085708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6587268|NCT01085708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6587269|NCT01085708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587270|NCT01085721|Chlorpheniramine|chlorpheniramine|mesh-list
6587271|NCT01085721|Phenylpropanolamine|phenylpropanolamine|mesh-list
6587272|NCT01085721|Pseudoephedrine|pseudoephedrine|mesh-list
6587273|NCT01085721|Ephedrine|ephedrine|mesh-list
6587274|NCT01085721|Guaifenesin|guaifenesin|mesh-list
6587275|NCT01085721|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
6587276|NCT01085721|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
6587277|NCT01085721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6587278|NCT01085721|Autonomic Agents|autonomic agents|mesh-ancestor
6587279|NCT01085721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6587280|NCT01085721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587281|NCT01085721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6587282|NCT01085721|Respiratory System Agents|respiratory system agents|mesh-ancestor
6587283|NCT01085721|Nasal Decongestants|nasal decongestants|mesh-ancestor
6587284|NCT01085721|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6587285|NCT01085721|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6587286|NCT01085721|Sympathomimetics|sympathomimetics|mesh-ancestor
6587287|NCT01085721|Adrenergic Agents|adrenergic agents|mesh-ancestor
6587288|NCT01085721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6587289|NCT01085721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587290|NCT01085721|Expectorants|expectorants|mesh-ancestor
6587291|NCT01085721|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6587292|NCT01085721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6587293|NCT01085721|Appetite Depressants|appetite depressants|mesh-ancestor
6587294|NCT01085721|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6587295|NCT01085721|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6587296|NCT01085721|Histamine Antagonists|histamine antagonists|mesh-ancestor
6587297|NCT01085721|Histamine Agents|histamine agents|mesh-ancestor
6587298|NCT01085721|Antipruritics|antipruritics|mesh-ancestor
6587299|NCT01085721|Dermatologic Agents|dermatologic agents|mesh-ancestor
6587300|NCT01085721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6587301|NCT01085838|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6587302|NCT01085838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6587303|NCT01085838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6587304|NCT01085838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6658839|NCT01484964|Immunologic Factors|immunologic factors|mesh-ancestor
6587305|NCT01085838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587306|NCT01085851|Chlorpheniramine|chlorpheniramine|mesh-list
6587307|NCT01085851|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
6587308|NCT01085851|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6587309|NCT01085851|Histamine Antagonists|histamine antagonists|mesh-ancestor
6587310|NCT01085851|Histamine Agents|histamine agents|mesh-ancestor
6587311|NCT01085851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6587312|NCT01085851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587313|NCT01085851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587314|NCT01085851|Antipruritics|antipruritics|mesh-ancestor
6587315|NCT01085851|Dermatologic Agents|dermatologic agents|mesh-ancestor
6587316|NCT01085851|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6587317|NCT01085877|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6587318|NCT01085877|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6587319|NCT01085877|Estradiol|estradiol|mesh-list
6587320|NCT01085877|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6587321|NCT01085877|Estrogens|estrogens|mesh-ancestor
6587322|NCT01085877|Hormones|hormones|mesh-ancestor
6587323|NCT01085877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6587324|NCT01085877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587325|NCT01085877|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6587326|NCT01085877|Contraceptive Agents|contraceptive agents|mesh-ancestor
6587327|NCT01085877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6587328|NCT01085877|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6587329|NCT01085981|Niacin|niacin|mesh-list
6587330|NCT01085981|Niacinamide|niacinamide|mesh-list
6587331|NCT01085981|Nicotinic Acids|nicotinic acids|mesh-list
6587332|NCT01085981|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6587333|NCT01085981|Antimetabolites|antimetabolites|mesh-ancestor
6587334|NCT01085981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587335|NCT01085981|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6587336|NCT01085981|Vasodilator Agents|vasodilator agents|mesh-ancestor
6587337|NCT01085981|Vitamin B Complex|vitamin b complex|mesh-ancestor
6587338|NCT01085981|Vitamins|vitamins|mesh-ancestor
6587339|NCT01085981|Micronutrients|micronutrients|mesh-ancestor
6587340|NCT01085981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587341|NCT01086020|Atorvastatin|atorvastatin|mesh-list
6587342|NCT01086020|Ezetimibe|ezetimibe|mesh-list
6587343|NCT01086020|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6587344|NCT01086020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6587345|NCT01086020|Antimetabolites|antimetabolites|mesh-ancestor
6587346|NCT01086020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587347|NCT01086020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6587348|NCT01086020|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6587349|NCT01086020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6587350|NCT01086046|Heparin|heparin|mesh-list
6587351|NCT01086046|Enoxaparin|enoxaparin|mesh-list
6587352|NCT01086046|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6587353|NCT01086046|Tinzaparin|tinzaparin|mesh-list
6587354|NCT01086046|Dalteparin|dalteparin|mesh-list
6587355|NCT01086046|Anticoagulants|anticoagulants|mesh-ancestor
6587356|NCT01086046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6587357|NCT01086046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6587358|NCT01086046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587359|NCT01086085|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6587360|NCT01086085|Interferon-alpha|interferon-alpha|mesh-list
6587361|NCT01086085|Adefovir|adefovir|mesh-list
6587362|NCT01086085|Antiviral Agents|antiviral agents|mesh-ancestor
6587363|NCT01086085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6587364|NCT01086085|Immunologic Factors|immunologic factors|mesh-ancestor
6587365|NCT01086085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587366|NCT01086085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6587367|NCT01086085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6587368|NCT01086085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6587369|NCT01086085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658840|NCT01484964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447330|NCT00396929|Paclitaxel|paclitaxel|mesh-list
6447331|NCT00396929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6447332|NCT00396929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6447333|NCT00396929|Tubulin Modulators|tubulin modulators|mesh-ancestor
6447334|NCT00396929|Antimitotic Agents|antimitotic agents|mesh-ancestor
6447335|NCT00396929|Mitosis Modulators|mitosis modulators|mesh-ancestor
6447336|NCT00396929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447337|NCT00396968|Plerixafor|plerixafor|mesh-list
6658841|NCT01484990|Levodopa|levodopa|mesh-list
6658842|NCT01484990|Carbidopa|carbidopa|mesh-list
6658843|NCT01484990|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
6587370|NCT01086254|Gemcitabine|gemcitabine|mesh-list
6587371|NCT01086254|Iniparib|iniparib|mesh-list
6587372|NCT01086254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6587373|NCT01086254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6587374|NCT01086254|Antimetabolites|antimetabolites|mesh-ancestor
6587375|NCT01086254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587376|NCT01086254|Antiviral Agents|antiviral agents|mesh-ancestor
6587377|NCT01086254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6587378|NCT01086254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6587379|NCT01086254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6587380|NCT01086254|Immunologic Factors|immunologic factors|mesh-ancestor
6587381|NCT01086254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587382|NCT01086254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6587383|NCT01086332|Gemcitabine|gemcitabine|mesh-list
6587384|NCT01086332|Nelfinavir|nelfinavir|mesh-list
6587385|NCT01086332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6587386|NCT01086332|Antimetabolites|antimetabolites|mesh-ancestor
6587387|NCT01086332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587388|NCT01086332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6587389|NCT01086332|Antiviral Agents|antiviral agents|mesh-ancestor
6587390|NCT01086332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6587391|NCT01086332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6587392|NCT01086332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6587393|NCT01086332|Immunologic Factors|immunologic factors|mesh-ancestor
6587394|NCT01086332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587395|NCT01086332|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6587396|NCT01086332|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6587397|NCT01086332|Protease Inhibitors|protease inhibitors|mesh-ancestor
6587398|NCT01086332|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6587399|NCT01086332|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6587400|NCT01086345|Bevacizumab|bevacizumab|mesh-list
6587401|NCT01086345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6587402|NCT01086345|Irinotecan|irinotecan|mesh-list
6587403|NCT01086345|Camptothecin|camptothecin|mesh-list
6587404|NCT01086345|Antibodies|antibodies|mesh-list
6587405|NCT01086345|Immunoglobulins|immunoglobulins|mesh-list
6587406|NCT01086345|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6587407|NCT01086345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6587408|NCT01086345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6587409|NCT01086345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6587410|NCT01086345|Growth Substances|growth substances|mesh-ancestor
6587411|NCT01086345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587412|NCT01086345|Growth Inhibitors|growth inhibitors|mesh-ancestor
6587413|NCT01086345|Immunologic Factors|immunologic factors|mesh-ancestor
6587414|NCT01086345|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6587415|NCT01086345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6587416|NCT01086345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6587417|NCT01086345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587418|NCT01086345|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6587419|NCT01086527|Montelukast|montelukast|mesh-list
6587420|NCT01086527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6587421|NCT01086527|Respiratory System Agents|respiratory system agents|mesh-ancestor
6587422|NCT01086527|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6587423|NCT01086527|Hormone Antagonists|hormone antagonists|mesh-ancestor
6587424|NCT01086527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6587425|NCT01086527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587426|NCT01086527|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6587427|NCT01086527|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6587428|NCT01086527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587429|NCT01086553|Budesonide|budesonide|mesh-list
6587430|NCT01086553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6587431|NCT01086553|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6587432|NCT01086553|Autonomic Agents|autonomic agents|mesh-ancestor
6587433|NCT01086553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6587434|NCT01086553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587435|NCT01086553|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6587436|NCT01086553|Respiratory System Agents|respiratory system agents|mesh-ancestor
6587437|NCT01086553|Glucocorticoids|glucocorticoids|mesh-ancestor
6587438|NCT01086553|Hormones|hormones|mesh-ancestor
6587439|NCT01086553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6587440|NCT01086579|Paclitaxel|paclitaxel|mesh-list
6587441|NCT01086579|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6587442|NCT01086579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6587443|NCT01086579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6587444|NCT01086579|Tubulin Modulators|tubulin modulators|mesh-ancestor
6587445|NCT01086579|Antimitotic Agents|antimitotic agents|mesh-ancestor
6587446|NCT01086579|Mitosis Modulators|mitosis modulators|mesh-ancestor
6587447|NCT01086579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587448|NCT01086631|Rituximab|rituximab|mesh-list
6447338|NCT00396968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6447339|NCT00396968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6447340|NCT00396968|Antiviral Agents|antiviral agents|mesh-ancestor
6447341|NCT00396968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6447342|NCT00397059|Citalopram|citalopram|mesh-list
6447343|NCT00397059|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6447344|NCT00397059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6447345|NCT00397059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6447346|NCT00397059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587449|NCT01086631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6587450|NCT01086631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6587451|NCT01086631|Immunologic Factors|immunologic factors|mesh-ancestor
6587452|NCT01086631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587453|NCT01086631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6587454|NCT01086774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6587455|NCT01086774|Lubricant Eye Drops|lubricant eye drops|mesh-list
6587456|NCT01086774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6587457|NCT01086826|Cisplatin|cisplatin|mesh-list
6587458|NCT01086826|Docetaxel|docetaxel|mesh-list
6587459|NCT01086826|Fluorouracil|fluorouracil|mesh-list
6587460|NCT01086826|Cetuximab|cetuximab|mesh-list
6587461|NCT01086826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6587462|NCT01086826|Tubulin Modulators|tubulin modulators|mesh-ancestor
6587463|NCT01086826|Antimitotic Agents|antimitotic agents|mesh-ancestor
6587464|NCT01086826|Mitosis Modulators|mitosis modulators|mesh-ancestor
6587465|NCT01086826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587466|NCT01086826|Antimetabolites|antimetabolites|mesh-ancestor
6587467|NCT01086826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6587468|NCT01086826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6587469|NCT01086826|Immunologic Factors|immunologic factors|mesh-ancestor
6587470|NCT01086826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587471|NCT01086826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6587472|NCT01086878|Trimethoprim|trimethoprim|mesh-list
6587473|NCT01086878|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6587474|NCT01086878|Sulfamethoxazole|sulfamethoxazole|mesh-list
6587475|NCT01086878|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6587476|NCT01086878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6587477|NCT01086878|Renal Agents|renal agents|mesh-ancestor
6587478|NCT01086878|Antimalarials|antimalarials|mesh-ancestor
6587479|NCT01086878|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6587480|NCT01086878|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6587481|NCT01086878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6587482|NCT01086878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6587483|NCT01086878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587484|NCT01086878|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6587485|NCT01086878|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6587486|NCT01086878|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6587487|NCT01086878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6587488|NCT01086956|Sufentanil|sufentanil|mesh-list
6587489|NCT01086956|Ropivacaine|ropivacaine|mesh-list
6587490|NCT01086956|Anesthetics, Local|anesthetics, local|mesh-ancestor
6587491|NCT01086956|Anesthetics|anesthetics|mesh-ancestor
6587492|NCT01086956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6587493|NCT01086956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587494|NCT01086956|Sensory System Agents|sensory system agents|mesh-ancestor
6587495|NCT01086956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5724822|NCT03185130|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6587496|NCT01086956|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6587497|NCT01086956|Narcotics|narcotics|mesh-ancestor
6587498|NCT01086956|Analgesics|analgesics|mesh-ancestor
6587499|NCT01086956|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6587500|NCT01086956|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6587501|NCT01086956|Anesthetics, General|anesthetics, general|mesh-ancestor
6587502|NCT01086982|Octreotide|octreotide|mesh-list
6587503|NCT01086982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6587504|NCT01086982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6587505|NCT01086982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6587506|NCT01087008|Zoledronic Acid|zoledronic acid|mesh-list
6587507|NCT01087008|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6587508|NCT01087008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587509|NCT01087099|Albendazole|albendazole|mesh-list
6587510|NCT01087099|Anthelmintics|anthelmintics|mesh-ancestor
6587511|NCT01087099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6587512|NCT01087099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6587513|NCT01087099|Anticestodal Agents|anticestodal agents|mesh-ancestor
6587514|NCT01087099|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6587515|NCT01087099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6587516|NCT01087099|Tubulin Modulators|tubulin modulators|mesh-ancestor
6587517|NCT01087099|Antimitotic Agents|antimitotic agents|mesh-ancestor
6587518|NCT01087099|Mitosis Modulators|mitosis modulators|mesh-ancestor
6587519|NCT01087099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587520|NCT01087099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6587521|NCT01087138|Calcium|calcium|mesh-list
6587522|NCT01087138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6587523|NCT01087138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587524|NCT01087190|Isoniazid|isoniazid|mesh-list
6587525|NCT01087190|Antitubercular Agents|antitubercular agents|mesh-ancestor
6587526|NCT01087190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6587527|NCT01087190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6587528|NCT01087190|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6587529|NCT01087190|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6587530|NCT01087190|Antimetabolites|antimetabolites|mesh-ancestor
6587531|NCT01087190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587532|NCT01087190|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6587533|NCT01087203|Tanezumab|tanezumab|mesh-list
6587534|NCT01087203|Analgesics|analgesics|mesh-ancestor
6587535|NCT01087203|Sensory System Agents|sensory system agents|mesh-ancestor
6587536|NCT01087203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6587537|NCT01087203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587538|NCT01087229|Nitrous Oxide|nitrous oxide|mesh-list
6587539|NCT01087229|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6587540|NCT01087229|Anesthetics, General|anesthetics, general|mesh-ancestor
6587541|NCT01087229|Anesthetics|anesthetics|mesh-ancestor
6587542|NCT01087229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6587543|NCT01087229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587544|NCT01087229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6587545|NCT01087229|Analgesics|analgesics|mesh-ancestor
6587546|NCT01087229|Sensory System Agents|sensory system agents|mesh-ancestor
6587547|NCT01087229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6587548|NCT01087359|Melatonin|melatonin|mesh-list
6587549|NCT01087359|Antioxidants|antioxidants|mesh-ancestor
6587550|NCT01087359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587551|NCT01087359|Protective Agents|protective agents|mesh-ancestor
6587552|NCT01087359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587553|NCT01087359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6587554|NCT01087398|Cyclosporine|cyclosporine|mesh-list
6587555|NCT01087398|Cyclophosphamide|cyclophosphamide|mesh-list
6587556|NCT01087398|Busulfan|busulfan|mesh-list
6587557|NCT01087398|Methotrexate|methotrexate|mesh-list
6587558|NCT01087398|Fludarabine|fludarabine|mesh-list
6587559|NCT01087398|Cyclosporins|cyclosporins|mesh-list
6587560|NCT01087398|Thymoglobulin|thymoglobulin|mesh-list
6587561|NCT01087398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6587562|NCT01087398|Immunologic Factors|immunologic factors|mesh-ancestor
6587563|NCT01087398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587564|NCT01087398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6587565|NCT01087398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6587566|NCT01087398|Alkylating Agents|alkylating agents|mesh-ancestor
6587567|NCT01087398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587568|NCT01087398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6587569|NCT01087398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6587570|NCT01087398|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6587571|NCT01087398|Abortifacient Agents|abortifacient agents|mesh-ancestor
6587572|NCT01087398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6587573|NCT01087398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6587574|NCT01087398|Antimetabolites|antimetabolites|mesh-ancestor
6587575|NCT01087398|Dermatologic Agents|dermatologic agents|mesh-ancestor
6587576|NCT01087398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6587577|NCT01087398|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6587578|NCT01087398|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6587579|NCT01087398|Antifungal Agents|antifungal agents|mesh-ancestor
6587580|NCT01087398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6587581|NCT01087398|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6587582|NCT01087437|Calcium|calcium|mesh-list
6587583|NCT01087437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6587584|NCT01087437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587585|NCT01087476|Doxycycline|doxycycline|mesh-list
6587586|NCT01087476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6587587|NCT01087476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6587588|NCT01087476|Antimalarials|antimalarials|mesh-ancestor
6587589|NCT01087476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6587590|NCT01087476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6587591|NCT01087554|Sirolimus|sirolimus|mesh-list
6587592|NCT01087554|Everolimus|everolimus|mesh-list
6587593|NCT01087554|Vorinostat|vorinostat|mesh-list
6587594|NCT01087554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6587595|NCT01087554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6587596|NCT01087554|Immunologic Factors|immunologic factors|mesh-ancestor
6587597|NCT01087554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587598|NCT01087554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6587599|NCT01087554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6587600|NCT01087554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6587601|NCT01087554|Antifungal Agents|antifungal agents|mesh-ancestor
6587602|NCT01087554|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6587603|NCT01087554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6587604|NCT01087554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587605|NCT01087567|Insulin|insulin|mesh-list
6587606|NCT01087567|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6587607|NCT01087567|Metformin|metformin|mesh-list
6587608|NCT01087567|Pioglitazone|pioglitazone|mesh-list
6587609|NCT01087567|Glimepiride|glimepiride|mesh-list
6587610|NCT01087567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6587611|NCT01087567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587612|NCT01087567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6587613|NCT01087567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6587614|NCT01087567|Immunologic Factors|immunologic factors|mesh-ancestor
6587615|NCT01087580|Prednisone|prednisone|mesh-list
6587616|NCT01087580|Docetaxel|docetaxel|mesh-list
6587617|NCT01087580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6587618|NCT01087580|Tubulin Modulators|tubulin modulators|mesh-ancestor
6587619|NCT01087580|Antimitotic Agents|antimitotic agents|mesh-ancestor
6587620|NCT01087580|Mitosis Modulators|mitosis modulators|mesh-ancestor
6587621|NCT01087580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587622|NCT01087580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6587623|NCT01087580|Glucocorticoids|glucocorticoids|mesh-ancestor
6587624|NCT01087580|Hormones|hormones|mesh-ancestor
6587625|NCT01087580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6587626|NCT01087580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587627|NCT01087580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6587628|NCT01087593|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6587629|NCT01087593|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6587630|NCT01087593|Estradiol|estradiol|mesh-list
6587631|NCT01087593|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6587632|NCT01087593|Estrogens|estrogens|mesh-ancestor
6587633|NCT01087593|Hormones|hormones|mesh-ancestor
6587634|NCT01087593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6587635|NCT01087593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587636|NCT01087593|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6587637|NCT01087593|Contraceptive Agents|contraceptive agents|mesh-ancestor
6587638|NCT01087593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6587639|NCT01087593|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6587640|NCT01087632|Folic Acid|folic acid|mesh-list
6587641|NCT01087632|Coenzyme Q10|coenzyme q10|mesh-list
6587642|NCT01087632|Policosanol|policosanol|mesh-list
6587643|NCT01087632|Red yeast rice|red yeast rice|mesh-list
6587644|NCT01087632|Hematinics|hematinics|mesh-ancestor
6587645|NCT01087632|Vitamin B Complex|vitamin b complex|mesh-ancestor
6587646|NCT01087632|Vitamins|vitamins|mesh-ancestor
6587647|NCT01087632|Micronutrients|micronutrients|mesh-ancestor
6587648|NCT01087632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587649|NCT01087632|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6587650|NCT01087632|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6587651|NCT01087632|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6587652|NCT01087632|Antimetabolites|antimetabolites|mesh-ancestor
6587653|NCT01087632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587654|NCT01087632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6587655|NCT01087632|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6587656|NCT01087632|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6587657|NCT01087658|Calcium|calcium|mesh-list
6587658|NCT01087658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6587659|NCT01087658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587660|NCT01087710|Vitamins|vitamins|mesh-list
6587661|NCT01087710|Antioxidants|antioxidants|mesh-list
6587662|NCT01087710|Micronutrients|micronutrients|mesh-ancestor
6587663|NCT01087710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587664|NCT01087710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587665|NCT01087710|Protective Agents|protective agents|mesh-ancestor
6587666|NCT01087749|Losartan|losartan|mesh-list
6587667|NCT01087749|Propranolol|propranolol|mesh-list
6587668|NCT01087749|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6587669|NCT01087749|Eprosartan|eprosartan|mesh-list
6587670|NCT01087749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6587671|NCT01087749|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6587672|NCT01087749|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6587673|NCT01087749|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6587674|NCT01087749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587675|NCT01087749|Diuretics|diuretics|mesh-ancestor
6587676|NCT01087749|Natriuretic Agents|natriuretic agents|mesh-ancestor
6587677|NCT01087749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587678|NCT01087749|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6587679|NCT01087749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6587680|NCT01087749|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6587681|NCT01087749|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6587682|NCT01087749|Adrenergic Agents|adrenergic agents|mesh-ancestor
6587683|NCT01087749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6587684|NCT01087749|Vasodilator Agents|vasodilator agents|mesh-ancestor
6587685|NCT01087749|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
6587686|NCT01087840|Tenofovir|tenofovir|mesh-list
6587687|NCT01087840|Emtricitabine|emtricitabine|mesh-list
6587688|NCT01087840|Raltegravir Potassium|raltegravir potassium|mesh-list
6587689|NCT01087840|Antiviral Agents|antiviral agents|mesh-ancestor
6587690|NCT01087840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6587691|NCT01087840|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6587692|NCT01087840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6587693|NCT01087840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6587694|NCT01087840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587695|NCT01087840|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6587696|NCT01087840|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6587697|NCT01087840|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6587698|NCT01087840|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6587699|NCT01087866|Metformin|metformin|mesh-list
6587700|NCT01087866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6587701|NCT01087866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658844|NCT01484990|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6658845|NCT01484990|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6658846|NCT01484990|Dopamine Agents|dopamine agents|mesh-ancestor
6658847|NCT01484990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6658848|NCT01484990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658849|NCT01484990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658850|NCT01484990|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6658851|NCT01484990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6658852|NCT01484990|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6658853|NCT01484990|Immunologic Factors|immunologic factors|mesh-ancestor
6658854|NCT01484990|Dopamine Agonists|dopamine agonists|mesh-ancestor
6658855|NCT01485003|Natalizumab|natalizumab|mesh-list
6658856|NCT01485003|Immunologic Factors|immunologic factors|mesh-ancestor
5724823|NCT03185130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6447347|NCT00397059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6447348|NCT00397059|Serotonin Agents|serotonin agents|mesh-ancestor
6447349|NCT00397059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447350|NCT00397059|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6447351|NCT00397059|Antidepressive Agents|antidepressive agents|mesh-ancestor
6447352|NCT00397059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6447353|NCT00397072|Sagopilone|sagopilone|mesh-list
6447354|NCT00397072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6447355|NCT00397098|Amibegron|amibegron|mesh-list
6447356|NCT00397098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6447357|NCT00397098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6447358|NCT00397098|Adrenergic Agents|adrenergic agents|mesh-ancestor
6447359|NCT00397098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6658857|NCT01485003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658858|NCT01485068|Paclitaxel|paclitaxel|mesh-list
6658859|NCT01485068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6658860|NCT01485068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6658861|NCT01485068|Tubulin Modulators|tubulin modulators|mesh-ancestor
6658862|NCT01485068|Antimitotic Agents|antimitotic agents|mesh-ancestor
6658863|NCT01485068|Mitosis Modulators|mitosis modulators|mesh-ancestor
6658864|NCT01485068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658865|NCT01485081|Paclitaxel|paclitaxel|mesh-list
6658866|NCT01485081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6658867|NCT01485081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6658868|NCT01485081|Tubulin Modulators|tubulin modulators|mesh-ancestor
6658869|NCT01485081|Antimitotic Agents|antimitotic agents|mesh-ancestor
6658870|NCT01485081|Mitosis Modulators|mitosis modulators|mesh-ancestor
6658871|NCT01485081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658872|NCT01485146|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
6658873|NCT01485146|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6658874|NCT01485146|Antimetabolites|antimetabolites|mesh-ancestor
6658875|NCT01485146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658876|NCT01485146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6658877|NCT01485146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6658878|NCT01485146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6587702|NCT01087879|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6587703|NCT01087879|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6587704|NCT01087879|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6587705|NCT01087879|Etonogestrel|etonogestrel|mesh-list
6587706|NCT01087879|Desogestrel|desogestrel|mesh-list
6587707|NCT01087879|NuvaRing|nuvaring|mesh-list
6587708|NCT01087879|Norelgestromin|norelgestromin|mesh-list
6587709|NCT01087879|Contraceptive Agents|contraceptive agents|mesh-list
6587710|NCT01087879|Estradiol|estradiol|mesh-list
6587711|NCT01087879|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6587712|NCT01087879|Estrogens|estrogens|mesh-ancestor
6587713|NCT01087879|Hormones|hormones|mesh-ancestor
6587714|NCT01087879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6587715|NCT01087879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587716|NCT01087879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6587717|NCT01087879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6587718|NCT01087879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6587719|NCT01087879|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6587720|NCT01087879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6587721|NCT01087879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6587722|NCT01087879|Progestins|progestins|mesh-ancestor
6587723|NCT01087983|Metformin|metformin|mesh-list
6587724|NCT01087983|Sirolimus|sirolimus|mesh-list
6587725|NCT01087983|Lapatinib|lapatinib|mesh-list
6587726|NCT01087983|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6587727|NCT01087983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587728|NCT01087983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6587729|NCT01087983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6587730|NCT01087983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6587731|NCT01087983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6587732|NCT01087983|Antifungal Agents|antifungal agents|mesh-ancestor
6587733|NCT01087983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6587734|NCT01087983|Immunologic Factors|immunologic factors|mesh-ancestor
6587735|NCT01087983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6587736|NCT01087983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6587737|NCT01087983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587738|NCT01088009|Lamivudine|lamivudine|mesh-list
6587739|NCT01088009|Adefovir|adefovir|mesh-list
6587740|NCT01088009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6587741|NCT01088009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6447360|NCT00397098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447361|NCT00397098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587742|NCT01088009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6587743|NCT01088009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587744|NCT01088009|Antiviral Agents|antiviral agents|mesh-ancestor
6587745|NCT01088009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6587746|NCT01088009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6587747|NCT01088009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6587748|NCT01088022|Dexamethasone|dexamethasone|mesh-list
6587749|NCT01088022|Dexamethasone acetate|dexamethasone acetate|mesh-list
6587750|NCT01088022|Aprepitant|aprepitant|mesh-list
6587751|NCT01088022|Palonosetron|palonosetron|mesh-list
6447362|NCT00397176|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6447363|NCT00397176|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6447364|NCT00397176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6447365|NCT00397176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6447366|NCT00397176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447367|NCT00397176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6447368|NCT00397176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447369|NCT00397176|Antidepressive Agents|antidepressive agents|mesh-ancestor
6447370|NCT00397176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6447371|NCT00397241|Timolol|timolol|mesh-list
6447372|NCT00397241|Dorzolamide|dorzolamide|mesh-list
6447373|NCT00397241|Latanoprost|latanoprost|mesh-list
6587752|NCT01088022|BB 1101|bb 1101|mesh-list
6587753|NCT01088022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6587754|NCT01088022|Antiemetics|antiemetics|mesh-ancestor
6587755|NCT01088022|Autonomic Agents|autonomic agents|mesh-ancestor
6587756|NCT01088022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6587757|NCT01088022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587758|NCT01088022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6587759|NCT01088022|Glucocorticoids|glucocorticoids|mesh-ancestor
6587760|NCT01088022|Hormones|hormones|mesh-ancestor
6587761|NCT01088022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6587762|NCT01088022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6587763|NCT01088022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6587764|NCT01088022|Protease Inhibitors|protease inhibitors|mesh-ancestor
6587765|NCT01088022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6587766|NCT01088022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587767|NCT01088022|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6587768|NCT01088022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6587769|NCT01088022|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6587770|NCT01088022|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6587771|NCT01088022|Serotonin Agents|serotonin agents|mesh-ancestor
6587772|NCT01088035|Carboplatin|carboplatin|mesh-list
6587773|NCT01088035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6587774|NCT01088165|Adalimumab|adalimumab|mesh-list
6587775|NCT01088165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6587776|NCT01088165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6587777|NCT01088178|Levonorgestrel|levonorgestrel|mesh-list
6587778|NCT01088178|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6587779|NCT01088178|Contraceptive Agents|contraceptive agents|mesh-ancestor
6587780|NCT01088178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6587781|NCT01088178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587782|NCT01088178|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6587783|NCT01088178|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6587784|NCT01088178|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6587785|NCT01088191|Hyaluronic Acid|hyaluronic acid|mesh-list
6587786|NCT01088191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6587787|NCT01088191|Immunologic Factors|immunologic factors|mesh-ancestor
6587788|NCT01088191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587789|NCT01088191|Viscosupplements|viscosupplements|mesh-ancestor
6587790|NCT01088191|Protective Agents|protective agents|mesh-ancestor
6587791|NCT01088230|Botulinum Toxins|botulinum toxins|mesh-list
6587792|NCT01088230|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6587793|NCT01088230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6587794|NCT01088230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587795|NCT01088230|Cholinergic Agents|cholinergic agents|mesh-ancestor
6587796|NCT01088230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6587797|NCT01088230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587798|NCT01088256|Etoricoxib|etoricoxib|mesh-list
6447374|NCT00397241|Lubricant Eye Drops|lubricant eye drops|mesh-list
6447375|NCT00397241|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6447376|NCT00397241|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6447377|NCT00397241|Adrenergic Agents|adrenergic agents|mesh-ancestor
6447378|NCT00397241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6447379|NCT00397241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447380|NCT00397241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447381|NCT00397241|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6447382|NCT00397241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6447383|NCT00397241|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6447384|NCT00397241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6447385|NCT00397241|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6447386|NCT00397241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6447387|NCT00397319|Hormones|hormones|mesh-list
6447388|NCT00397319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6587799|NCT01088256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6587800|NCT01088256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6587801|NCT01088256|Analgesics|analgesics|mesh-ancestor
6587802|NCT01088256|Sensory System Agents|sensory system agents|mesh-ancestor
6587803|NCT01088256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6587804|NCT01088256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587805|NCT01088256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6587806|NCT01088256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6587807|NCT01088256|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6587808|NCT01088256|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6587809|NCT01088256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6587810|NCT01088256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587811|NCT01088282|Dipivefrin|dipivefrin|mesh-list
6587812|NCT01088282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6587813|NCT01088282|Adrenergic Agents|adrenergic agents|mesh-ancestor
6587814|NCT01088282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6587815|NCT01088282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587816|NCT01088282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587817|NCT01088347|Mapatumumab|mapatumumab|mesh-list
6587818|NCT01088347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6587819|NCT01088373|Lenalidomide|lenalidomide|mesh-list
6587820|NCT01088373|Azacitidine|azacitidine|mesh-list
6587821|NCT01088373|Immunologic Factors|immunologic factors|mesh-ancestor
6587822|NCT01088373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587823|NCT01088373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6587824|NCT01088373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6587825|NCT01088373|Growth Substances|growth substances|mesh-ancestor
6587826|NCT01088373|Growth Inhibitors|growth inhibitors|mesh-ancestor
6587827|NCT01088373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6587828|NCT01088373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6587829|NCT01088373|Antimetabolites|antimetabolites|mesh-ancestor
6587830|NCT01088373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587831|NCT01088373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6587832|NCT01088451|Insulin|insulin|mesh-list
6587833|NCT01088451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6587834|NCT01088451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587835|NCT01088477|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6587836|NCT01088477|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6587837|NCT01088477|Estradiol|estradiol|mesh-list
6587838|NCT01088477|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6587839|NCT01088477|Estrogens|estrogens|mesh-ancestor
6587840|NCT01088477|Hormones|hormones|mesh-ancestor
6587841|NCT01088477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6587842|NCT01088477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587843|NCT01088477|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6587844|NCT01088477|Contraceptive Agents|contraceptive agents|mesh-ancestor
6587845|NCT01088477|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6587846|NCT01088477|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6587847|NCT01088516|Ritonavir|ritonavir|mesh-list
6587848|NCT01088516|Lopinavir|lopinavir|mesh-list
6587849|NCT01088516|Zidovudine|zidovudine|mesh-list
6587850|NCT01088516|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6587851|NCT01088516|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6587852|NCT01088516|Protease Inhibitors|protease inhibitors|mesh-ancestor
6587853|NCT01088516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6587854|NCT01088516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587855|NCT01088516|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6587856|NCT01088516|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6447389|NCT00397319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447390|NCT00397332|Alefacept|alefacept|mesh-list
6447391|NCT00397332|Dermatologic Agents|dermatologic agents|mesh-ancestor
6447392|NCT00397332|Immunologic Factors|immunologic factors|mesh-ancestor
6447393|NCT00397332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447394|NCT00397358|Icodextrin|icodextrin|mesh-list
6447395|NCT00397358|Dialysis Solutions|dialysis solutions|mesh-list
6447396|NCT00397358|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6447397|NCT00397384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6587857|NCT01088516|Antiviral Agents|antiviral agents|mesh-ancestor
6447398|NCT00397384|Cetuximab|cetuximab|mesh-list
6587858|NCT01088516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6587859|NCT01088516|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6587860|NCT01088516|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6587861|NCT01088516|Antimetabolites|antimetabolites|mesh-ancestor
6587862|NCT01088516|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6587863|NCT01088516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6587864|NCT01088555|Sodium thiosulfate|sodium thiosulfate|mesh-list
6587865|NCT01088555|Antidotes|antidotes|mesh-ancestor
6587866|NCT01088555|Protective Agents|protective agents|mesh-ancestor
6587867|NCT01088555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587868|NCT01088555|Antioxidants|antioxidants|mesh-ancestor
6587869|NCT01088555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587870|NCT01088555|Antitubercular Agents|antitubercular agents|mesh-ancestor
6587871|NCT01088555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6587872|NCT01088555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6587873|NCT01088555|Chelating Agents|chelating agents|mesh-ancestor
6587874|NCT01088555|Sequestering Agents|sequestering agents|mesh-ancestor
6587875|NCT01088594|Pioglitazone|pioglitazone|mesh-list
6587876|NCT01088594|Rosiglitazone|rosiglitazone|mesh-list
6587877|NCT01088594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6587878|NCT01088594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587879|NCT01088607|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
6587880|NCT01088607|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6587881|NCT01088607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6587882|NCT01088620|Pemetrexed|pemetrexed|mesh-list
6587883|NCT01088620|Panitumumab|panitumumab|mesh-list
6587884|NCT01088620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6587885|NCT01088620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6587886|NCT01088620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587887|NCT01088620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6587888|NCT01088620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6587889|NCT01088620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6587890|NCT01088659|Tenofovir|tenofovir|mesh-list
6587891|NCT01088659|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6587892|NCT01088659|Antiviral Agents|antiviral agents|mesh-ancestor
6587893|NCT01088659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6587894|NCT01088659|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6587895|NCT01088659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6587896|NCT01088659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6587897|NCT01088659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587898|NCT01088659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6587899|NCT01088659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6587900|NCT01088724|Cyclophosphamide|cyclophosphamide|mesh-list
6587901|NCT01088724|Rituximab|rituximab|mesh-list
6587902|NCT01088724|Doxorubicin|doxorubicin|mesh-list
6587903|NCT01088724|Fludarabine|fludarabine|mesh-list
6587904|NCT01088724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6587905|NCT01088724|Immunologic Factors|immunologic factors|mesh-ancestor
6587906|NCT01088724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587907|NCT01088724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6587908|NCT01088724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6587909|NCT01088724|Alkylating Agents|alkylating agents|mesh-ancestor
6587910|NCT01088724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587911|NCT01088724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6587912|NCT01088724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6587913|NCT01088724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6587914|NCT01088724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6587915|NCT01088724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6587916|NCT01088724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6587917|NCT01088724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6587918|NCT01088737|Imiquimod|imiquimod|mesh-list
6587919|NCT01088737|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6587920|NCT01088737|Immunologic Factors|immunologic factors|mesh-ancestor
6587921|NCT01088737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587922|NCT01088737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6587923|NCT01088737|Interferon Inducers|interferon inducers|mesh-ancestor
6587924|NCT01088750|Prednisolone|prednisolone|mesh-list
6587925|NCT01088750|Cyclophosphamide|cyclophosphamide|mesh-list
6587926|NCT01088750|Vinblastine|vinblastine|mesh-list
6587927|NCT01088750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6587928|NCT01088750|Immunologic Factors|immunologic factors|mesh-ancestor
6587929|NCT01088750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587930|NCT01088750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6587931|NCT01088750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6587932|NCT01088750|Alkylating Agents|alkylating agents|mesh-ancestor
6587933|NCT01088750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587934|NCT01088750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6587935|NCT01088750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6587936|NCT01088750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6587937|NCT01088750|Glucocorticoids|glucocorticoids|mesh-ancestor
6587938|NCT01088750|Hormones|hormones|mesh-ancestor
6587939|NCT01088750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6587940|NCT01088750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6587941|NCT01088750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6587942|NCT01088750|Tubulin Modulators|tubulin modulators|mesh-ancestor
6587943|NCT01088750|Antimitotic Agents|antimitotic agents|mesh-ancestor
6587944|NCT01088750|Mitosis Modulators|mitosis modulators|mesh-ancestor
6587945|NCT01088763|Dexamethasone|dexamethasone|mesh-list
6587946|NCT01088763|R04929097|r04929097|mesh-list
6587947|NCT01088763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6587948|NCT01088763|Antiemetics|antiemetics|mesh-ancestor
6587949|NCT01088763|Autonomic Agents|autonomic agents|mesh-ancestor
6587950|NCT01088763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6587951|NCT01088763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587952|NCT01088763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6587953|NCT01088763|Glucocorticoids|glucocorticoids|mesh-ancestor
6587954|NCT01088763|Hormones|hormones|mesh-ancestor
6587955|NCT01088763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6587956|NCT01088763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6587957|NCT01088763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6587958|NCT01088763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6587959|NCT01088763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587960|NCT01088789|Cyclophosphamide|cyclophosphamide|mesh-list
6587961|NCT01088789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6587962|NCT01088789|Immunologic Factors|immunologic factors|mesh-ancestor
6587963|NCT01088789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587964|NCT01088789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6587965|NCT01088789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6587966|NCT01088789|Alkylating Agents|alkylating agents|mesh-ancestor
6587967|NCT01088789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587968|NCT01088789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6587969|NCT01088789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6587970|NCT01088802|Carboplatin|carboplatin|mesh-list
6587971|NCT01088802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6587972|NCT01088815|Gemcitabine|gemcitabine|mesh-list
6587973|NCT01088815|Paclitaxel|paclitaxel|mesh-list
6587974|NCT01088815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6587975|NCT01088815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6587976|NCT01088815|Tubulin Modulators|tubulin modulators|mesh-ancestor
6587977|NCT01088815|Antimitotic Agents|antimitotic agents|mesh-ancestor
6587978|NCT01088815|Mitosis Modulators|mitosis modulators|mesh-ancestor
6587979|NCT01088815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587980|NCT01088815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6587981|NCT01088815|Antimetabolites|antimetabolites|mesh-ancestor
6587982|NCT01088815|Antiviral Agents|antiviral agents|mesh-ancestor
6587983|NCT01088815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6587984|NCT01088815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6587985|NCT01088815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6587986|NCT01088815|Immunologic Factors|immunologic factors|mesh-ancestor
6587987|NCT01088815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587988|NCT01088893|Everolimus|everolimus|mesh-list
6587989|NCT01088893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6587990|NCT01088893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6587991|NCT01088893|Immunologic Factors|immunologic factors|mesh-ancestor
6587992|NCT01088893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6587993|NCT01088906|Pemetrexed|pemetrexed|mesh-list
6587994|NCT01088906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6587995|NCT01088906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6587996|NCT01088906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6587997|NCT01088906|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6587998|NCT01088906|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6587999|NCT01088919|Pioglitazone|pioglitazone|mesh-list
6588000|NCT01088919|Ipragliflozin|ipragliflozin|mesh-list
6588001|NCT01088919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6588002|NCT01088919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588003|NCT01088919|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6588004|NCT01088919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588005|NCT01088932|SRX246|srx246|mesh-list
6588006|NCT01088932|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6588007|NCT01088932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588008|NCT01088932|Natriuretic Agents|natriuretic agents|mesh-ancestor
6588009|NCT01088932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588010|NCT01088958|Micronutrients|micronutrients|mesh-list
6588011|NCT01088958|Trace Elements|trace elements|mesh-list
6588012|NCT01088958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588013|NCT01089075|Hydrocortisone|hydrocortisone|mesh-list
6588014|NCT01089075|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6588015|NCT01089075|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6588016|NCT01089075|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6588017|NCT01089075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6588018|NCT01089088|Gemcitabine|gemcitabine|mesh-list
6588019|NCT01089088|Sunitinib|sunitinib|mesh-list
6588020|NCT01089088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6588021|NCT01089088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6588022|NCT01089088|Antimetabolites|antimetabolites|mesh-ancestor
6588023|NCT01089088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588024|NCT01089088|Antiviral Agents|antiviral agents|mesh-ancestor
6588025|NCT01089088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6588026|NCT01089088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6588027|NCT01089088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6588028|NCT01089088|Immunologic Factors|immunologic factors|mesh-ancestor
6588029|NCT01089088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588030|NCT01089088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6588031|NCT01089088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6588032|NCT01089088|Growth Substances|growth substances|mesh-ancestor
6588033|NCT01089088|Growth Inhibitors|growth inhibitors|mesh-ancestor
6588034|NCT01089088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6588035|NCT01089140|Tranexamic Acid|tranexamic acid|mesh-list
6588036|NCT01089140|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6588037|NCT01089140|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6588038|NCT01089140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588039|NCT01089140|Hemostatics|hemostatics|mesh-ancestor
6588040|NCT01089140|Coagulants|coagulants|mesh-ancestor
6588041|NCT01089166|Metformin|metformin|mesh-list
6588042|NCT01089166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6588043|NCT01089166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588044|NCT01089179|Metformin|metformin|mesh-list
6588045|NCT01089179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6588046|NCT01089179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588047|NCT01089192|Metformin|metformin|mesh-list
6588048|NCT01089192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6588049|NCT01089192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588050|NCT01089205|Metformin|metformin|mesh-list
6588051|NCT01089205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6588052|NCT01089205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588053|NCT01089218|Amoxicillin|amoxicillin|mesh-list
6588054|NCT01089218|Clavulanic Acid|clavulanic acid|mesh-list
6588055|NCT01089218|Clavulanic Acids|clavulanic acids|mesh-list
6588056|NCT01089218|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6588057|NCT01089218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6588058|NCT01089218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6588059|NCT01089218|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6588060|NCT01089218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6588061|NCT01089218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588062|NCT01089309|Spironolactone|spironolactone|mesh-list
6588063|NCT01089309|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6588064|NCT01089309|Hormone Antagonists|hormone antagonists|mesh-ancestor
6588065|NCT01089309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6588066|NCT01089309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588067|NCT01089309|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6588068|NCT01089309|Diuretics|diuretics|mesh-ancestor
6588069|NCT01089309|Natriuretic Agents|natriuretic agents|mesh-ancestor
6588070|NCT01089348|Metronidazole|metronidazole|mesh-list
6588071|NCT01089348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6588072|NCT01089348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6588073|NCT01089348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6588074|NCT01089348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6588075|NCT01089439|Nitric Oxide|nitric oxide|mesh-list
6588076|NCT01089439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6588077|NCT01089439|Autonomic Agents|autonomic agents|mesh-ancestor
6588078|NCT01089439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6588079|NCT01089439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588080|NCT01089439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6588081|NCT01089439|Respiratory System Agents|respiratory system agents|mesh-ancestor
6588082|NCT01089439|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6588083|NCT01089439|Antioxidants|antioxidants|mesh-ancestor
6588084|NCT01089439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588085|NCT01089439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6588086|NCT01089439|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6588087|NCT01089439|Vasodilator Agents|vasodilator agents|mesh-ancestor
6588088|NCT01089439|Gasotransmitters|gasotransmitters|mesh-ancestor
6588089|NCT01089439|Protective Agents|protective agents|mesh-ancestor
6588090|NCT01089452|Amlodipine|amlodipine|mesh-list
6588091|NCT01089452|Olmesartan|olmesartan|mesh-list
6588092|NCT01089452|Perindopril|perindopril|mesh-list
6588093|NCT01089452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6588094|NCT01089452|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6588095|NCT01089452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6588096|NCT01089452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588097|NCT01089452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6588098|NCT01089452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588099|NCT01089452|Vasodilator Agents|vasodilator agents|mesh-ancestor
6588100|NCT01089452|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6588101|NCT01089452|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6588102|NCT01089452|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6588103|NCT01089452|Protease Inhibitors|protease inhibitors|mesh-ancestor
6588104|NCT01089452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6588105|NCT01089465|Dermatologic Agents|dermatologic agents|mesh-list
6588106|NCT01089621|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6588107|NCT01089621|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6588108|NCT01089621|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6588109|NCT01089621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6588110|NCT01089621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588111|NCT01089621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6588112|NCT01089621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588113|NCT01089621|Analgesics|analgesics|mesh-ancestor
6588114|NCT01089621|Sensory System Agents|sensory system agents|mesh-ancestor
6588115|NCT01089621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6588116|NCT01089621|Antidepressive Agents|antidepressive agents|mesh-ancestor
6588117|NCT01089621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6588118|NCT01089621|Dopamine Agents|dopamine agents|mesh-ancestor
6658879|NCT01485146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658880|NCT01485185|Gabapentin|gabapentin|mesh-list
6658881|NCT01485185|Donepezil|donepezil|mesh-list
6658882|NCT01485185|Analgesics|analgesics|mesh-ancestor
6658883|NCT01485185|Sensory System Agents|sensory system agents|mesh-ancestor
6658884|NCT01485185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6658885|NCT01485185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658886|NCT01485185|Anticonvulsants|anticonvulsants|mesh-ancestor
6447399|NCT00397384|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6447400|NCT00397384|Antibodies|antibodies|mesh-list
6658887|NCT01485185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6658888|NCT01485185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6658889|NCT01485185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6658890|NCT01485185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6658891|NCT01485185|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6658892|NCT01485185|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6658893|NCT01485185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6658894|NCT01485185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658895|NCT01485185|Antimanic Agents|antimanic agents|mesh-ancestor
6658896|NCT01485185|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6658897|NCT01485185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6658898|NCT01485185|Cholinergic Agents|cholinergic agents|mesh-ancestor
6658899|NCT01485185|Nootropic Agents|nootropic agents|mesh-ancestor
6658900|NCT01485198|Acetaminophen|acetaminophen|mesh-list
6658901|NCT01485198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6658902|NCT01485198|Analgesics|analgesics|mesh-ancestor
6658903|NCT01485198|Sensory System Agents|sensory system agents|mesh-ancestor
6658904|NCT01485198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6658905|NCT01485198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658906|NCT01485198|Antipyretics|antipyretics|mesh-ancestor
6658907|NCT01485211|Riboflavin|riboflavin|mesh-list
6658908|NCT01485211|Vitamin B Complex|vitamin b complex|mesh-ancestor
6658909|NCT01485211|Vitamins|vitamins|mesh-ancestor
6658910|NCT01485211|Micronutrients|micronutrients|mesh-ancestor
6658911|NCT01485211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658912|NCT01485211|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6658913|NCT01485211|Dermatologic Agents|dermatologic agents|mesh-ancestor
6664835|NCT01514227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6664836|NCT01514227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6664837|NCT01514227|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6664838|NCT01514227|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6664839|NCT01514227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6664840|NCT01514227|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6664841|NCT01514227|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6664842|NCT01514227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6664843|NCT01514227|Antipyretics|antipyretics|mesh-ancestor
6664844|NCT01514266|Curcumin|curcumin|mesh-list
6664845|NCT01514266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6664846|NCT01514266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6664847|NCT01514266|Analgesics|analgesics|mesh-ancestor
6664848|NCT01514266|Sensory System Agents|sensory system agents|mesh-ancestor
6664849|NCT01514266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6664850|NCT01514266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664851|NCT01514266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6664852|NCT01514266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6664853|NCT01514266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6447401|NCT00397384|Immunoglobulins|immunoglobulins|mesh-list
6447402|NCT00397384|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6447403|NCT00397384|Immunologic Factors|immunologic factors|mesh-ancestor
6447404|NCT00397384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447405|NCT00397384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6447406|NCT00397384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6447407|NCT00397384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6447408|NCT00397384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447409|NCT00397423|Sargramostim|sargramostim|mesh-list
6664854|NCT01514266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6588119|NCT01089660|Vaccines|vaccines|mesh-list
6588120|NCT01089660|Immunologic Factors|immunologic factors|mesh-ancestor
6588121|NCT01089660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588122|NCT01089855|Carbamazepine|carbamazepine|mesh-list
6588123|NCT01089855|Anticonvulsants|anticonvulsants|mesh-ancestor
6588124|NCT01089855|Antimanic Agents|antimanic agents|mesh-ancestor
6588125|NCT01089855|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6588126|NCT01089855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6588127|NCT01089855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588128|NCT01089855|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6588129|NCT01089855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6588130|NCT01089855|Analgesics|analgesics|mesh-ancestor
6588131|NCT01089855|Sensory System Agents|sensory system agents|mesh-ancestor
6588132|NCT01089855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6447410|NCT00397423|Lenograstim|lenograstim|mesh-list
6447411|NCT00397423|Immunologic Factors|immunologic factors|mesh-ancestor
6447412|NCT00397423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447413|NCT00397423|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6447414|NCT00397475|Cholecalciferol|cholecalciferol|mesh-list
6447415|NCT00397475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6447416|NCT00397475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447417|NCT00397475|Vitamins|vitamins|mesh-ancestor
6447418|NCT00397475|Micronutrients|micronutrients|mesh-ancestor
6447419|NCT00397475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6588133|NCT01089855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6588134|NCT01089855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6588135|NCT01089855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588136|NCT01089855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6588137|NCT01089855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6588138|NCT01089933|Anesthetics|anesthetics|mesh-list
6588139|NCT01089933|Anesthetics, Local|anesthetics, local|mesh-list
6588140|NCT01089933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6588141|NCT01089933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588142|NCT01089933|Sensory System Agents|sensory system agents|mesh-ancestor
6588143|NCT01089933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6588144|NCT01089959|Esomeprazole|esomeprazole|mesh-list
6588145|NCT01089959|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6588146|NCT01089959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6588147|NCT01089959|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6588148|NCT01089959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6588149|NCT01089959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588150|NCT01089985|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6588151|NCT01089985|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6588152|NCT01089998|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6588153|NCT01089998|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6588154|NCT01089998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588155|NCT01090037|Epoprostenol|epoprostenol|mesh-list
6588156|NCT01090037|Beraprost|beraprost|mesh-list
6588157|NCT01090037|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6588158|NCT01090037|Vasodilator Agents|vasodilator agents|mesh-ancestor
6588159|NCT01090037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6588160|NCT01090128|Paclitaxel|paclitaxel|mesh-list
6588161|NCT01090128|Cyclophosphamide|cyclophosphamide|mesh-list
6588162|NCT01090128|Doxorubicin|doxorubicin|mesh-list
6588163|NCT01090128|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6588164|NCT01090128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6588165|NCT01090128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6588166|NCT01090128|Tubulin Modulators|tubulin modulators|mesh-ancestor
6588167|NCT01090128|Antimitotic Agents|antimitotic agents|mesh-ancestor
6588168|NCT01090128|Mitosis Modulators|mitosis modulators|mesh-ancestor
6588169|NCT01090128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588170|NCT01090128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6588171|NCT01090128|Immunologic Factors|immunologic factors|mesh-ancestor
6588172|NCT01090128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588173|NCT01090128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6588174|NCT01090128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6588175|NCT01090128|Alkylating Agents|alkylating agents|mesh-ancestor
6588176|NCT01090128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6588177|NCT01090128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6588178|NCT01090128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6588179|NCT01090128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6588180|NCT01090128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6588181|NCT01090167|Clofarabine|clofarabine|mesh-list
6588182|NCT01090167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6588183|NCT01090167|Antimetabolites|antimetabolites|mesh-ancestor
6588184|NCT01090167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588185|NCT01090167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6588186|NCT01090206|Vitamin D|vitamin d|mesh-list
6588187|NCT01090206|Calcium|calcium|mesh-list
6588188|NCT01090206|Vitamins|vitamins|mesh-ancestor
6588189|NCT01090206|Micronutrients|micronutrients|mesh-ancestor
6588190|NCT01090206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588191|NCT01090206|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6588192|NCT01090206|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6588193|NCT01090466|Gemcitabine|gemcitabine|mesh-list
6588194|NCT01090466|Sirolimus|sirolimus|mesh-list
6588195|NCT01090466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6588196|NCT01090466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6588197|NCT01090466|Antimetabolites|antimetabolites|mesh-ancestor
6588198|NCT01090466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588199|NCT01090466|Antiviral Agents|antiviral agents|mesh-ancestor
6588200|NCT01090466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6588201|NCT01090466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6588202|NCT01090466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6588203|NCT01090466|Immunologic Factors|immunologic factors|mesh-ancestor
6588204|NCT01090466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588205|NCT01090466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6588206|NCT01090466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6588207|NCT01090466|Antifungal Agents|antifungal agents|mesh-ancestor
6588208|NCT01090505|Oxaliplatin|oxaliplatin|mesh-list
6588209|NCT01090505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6588210|NCT01090518|Hydrocortisone|hydrocortisone|mesh-list
6588211|NCT01090518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6588212|NCT01090596|Naproxen|naproxen|mesh-list
6588213|NCT01090596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6447420|NCT00397501|Sodium thiosulfate|sodium thiosulfate|mesh-list
6588214|NCT01090596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6588215|NCT01090596|Analgesics|analgesics|mesh-ancestor
6588216|NCT01090596|Sensory System Agents|sensory system agents|mesh-ancestor
6588217|NCT01090596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6588218|NCT01090596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588219|NCT01090596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6588220|NCT01090596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6588221|NCT01090596|Gout Suppressants|gout suppressants|mesh-ancestor
6588222|NCT01090596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6588223|NCT01090596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6588224|NCT01090596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588225|NCT01090648|Etravirine|etravirine|mesh-list
6588226|NCT01090648|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6588227|NCT01090648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6588228|NCT01090648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6588229|NCT01090648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588230|NCT01090648|Antiviral Agents|antiviral agents|mesh-ancestor
6588231|NCT01090648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6588232|NCT01090661|Moxifloxacin|moxifloxacin|mesh-list
6588233|NCT01090661|Mipomersen|mipomersen|mesh-list
6588234|NCT01090661|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6588235|NCT01090661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6588236|NCT01090661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6588237|NCT01090661|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6588238|NCT01090661|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6588239|NCT01090661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6588240|NCT01090661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588241|NCT01090661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6588242|NCT01090661|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6588243|NCT01090661|Contraceptive Agents|contraceptive agents|mesh-ancestor
6588244|NCT01090661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6588245|NCT01090661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588246|NCT01090661|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6588247|NCT01090661|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6588248|NCT01090661|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6588249|NCT01090661|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6588250|NCT01090661|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6588251|NCT01090661|Antimetabolites|antimetabolites|mesh-ancestor
6588252|NCT01090661|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6588253|NCT01090700|Simeprevir|simeprevir|mesh-list
6588254|NCT01090700|Dexetimide|dexetimide|mesh-list
6588255|NCT01090700|Citalopram|citalopram|mesh-list
6588256|NCT01090700|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6588257|NCT01090700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6588258|NCT01090700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6588259|NCT01090700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588260|NCT01090700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6588261|NCT01090700|Serotonin Agents|serotonin agents|mesh-ancestor
6588262|NCT01090700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588263|NCT01090700|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6588264|NCT01090700|Antidepressive Agents|antidepressive agents|mesh-ancestor
6588265|NCT01090700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6588266|NCT01090700|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6588267|NCT01090700|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6588268|NCT01090700|Parasympatholytics|parasympatholytics|mesh-ancestor
6588269|NCT01090700|Autonomic Agents|autonomic agents|mesh-ancestor
6588270|NCT01090700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6588271|NCT01090700|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6588272|NCT01090700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6588273|NCT01090700|Cholinergic Agents|cholinergic agents|mesh-ancestor
6447421|NCT00397501|Carboplatin|carboplatin|mesh-list
6447422|NCT00397501|Methotrexate|methotrexate|mesh-list
6588274|NCT01090700|Antiviral Agents|antiviral agents|mesh-ancestor
6447423|NCT00397501|Trastuzumab|trastuzumab|mesh-list
6447424|NCT00397501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6447425|NCT00397501|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6447426|NCT00397501|Abortifacient Agents|abortifacient agents|mesh-ancestor
6447427|NCT00397501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6447428|NCT00397501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447429|NCT00397501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6447430|NCT00397501|Antimetabolites|antimetabolites|mesh-ancestor
6447431|NCT00397501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447432|NCT00397501|Dermatologic Agents|dermatologic agents|mesh-ancestor
6447433|NCT00397501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6447434|NCT00397501|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6588275|NCT01090700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6588276|NCT01090700|Protease Inhibitors|protease inhibitors|mesh-ancestor
6588277|NCT01090700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6588278|NCT01090713|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6588279|NCT01090713|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6588280|NCT01090713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588281|NCT01090713|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6588282|NCT01090713|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6588283|NCT01090713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6588284|NCT01090713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588285|NCT01090713|Dopamine Agents|dopamine agents|mesh-ancestor
6588286|NCT01090713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6588287|NCT01090778|Hormones|hormones|mesh-list
6588288|NCT01090778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6588289|NCT01090778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588290|NCT01090830|Paclitaxel|paclitaxel|mesh-list
6588291|NCT01090830|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6588292|NCT01090830|Bevacizumab|bevacizumab|mesh-list
6588293|NCT01090830|Carboplatin|carboplatin|mesh-list
6588294|NCT01090830|Belinostat|belinostat|mesh-list
6588295|NCT01090830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6588296|NCT01090830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6588297|NCT01090830|Tubulin Modulators|tubulin modulators|mesh-ancestor
6588298|NCT01090830|Antimitotic Agents|antimitotic agents|mesh-ancestor
6588299|NCT01090830|Mitosis Modulators|mitosis modulators|mesh-ancestor
6588300|NCT01090830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588301|NCT01090830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6588302|NCT01090830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6588303|NCT01090830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6588304|NCT01090830|Growth Substances|growth substances|mesh-ancestor
6588305|NCT01090830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588306|NCT01090830|Growth Inhibitors|growth inhibitors|mesh-ancestor
6588307|NCT01090830|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6588308|NCT01090830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6588309|NCT01090882|Bupivacaine|bupivacaine|mesh-list
6588310|NCT01090882|Anesthetics, Local|anesthetics, local|mesh-ancestor
6588311|NCT01090882|Anesthetics|anesthetics|mesh-ancestor
6588312|NCT01090882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6588313|NCT01090882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588314|NCT01090882|Sensory System Agents|sensory system agents|mesh-ancestor
6447435|NCT00397501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6447436|NCT00397501|Immunologic Factors|immunologic factors|mesh-ancestor
6447437|NCT00397501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6447438|NCT00397501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6447439|NCT00397501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6588315|NCT01090882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6588316|NCT01090895|Ascorbic Acid|ascorbic acid|mesh-list
6588317|NCT01090895|Vitamins|vitamins|mesh-ancestor
6588318|NCT01090895|Micronutrients|micronutrients|mesh-ancestor
6588319|NCT01090895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588320|NCT01090895|Antioxidants|antioxidants|mesh-ancestor
6588321|NCT01090895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588322|NCT01090895|Protective Agents|protective agents|mesh-ancestor
6588323|NCT01090908|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6588324|NCT01090908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6588325|NCT01091012|Sildenafil Citrate|sildenafil citrate|mesh-list
6588326|NCT01091012|Vasodilator Agents|vasodilator agents|mesh-ancestor
6588327|NCT01091012|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6588328|NCT01091012|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6588329|NCT01091012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6588330|NCT01091012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588331|NCT01091012|Urological Agents|urological agents|mesh-ancestor
6588332|NCT01091051|Ustekinumab|ustekinumab|mesh-list
6588333|NCT01091051|Dermatologic Agents|dermatologic agents|mesh-ancestor
6588334|NCT01091077|Naringenin|naringenin|mesh-list
6588335|NCT01091077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6588336|NCT01091077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6588337|NCT01091077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6588338|NCT01091077|Hormone Antagonists|hormone antagonists|mesh-ancestor
6588339|NCT01091077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6588340|NCT01091077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588341|NCT01091207|Sorafenib|sorafenib|mesh-list
6588342|NCT01091207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6588343|NCT01091207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6588344|NCT01091207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6588345|NCT01091207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588346|NCT01091220|Certolizumab Pegol|certolizumab pegol|mesh-list
6588347|NCT01091220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6588348|NCT01091220|Immunologic Factors|immunologic factors|mesh-ancestor
6588349|NCT01091220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588350|NCT01091220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6588351|NCT01091324|Dextromethorphan|dextromethorphan|mesh-list
6588352|NCT01091324|Silymarin|silymarin|mesh-list
6588353|NCT01091324|Antitussive Agents|antitussive agents|mesh-ancestor
6588354|NCT01091324|Respiratory System Agents|respiratory system agents|mesh-ancestor
6588355|NCT01091324|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6588356|NCT01091324|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6588357|NCT01091324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6588358|NCT01091324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588359|NCT01091324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588360|NCT01091324|Antioxidants|antioxidants|mesh-ancestor
6588361|NCT01091324|Protective Agents|protective agents|mesh-ancestor
6588362|NCT01091337|Albuterol|albuterol|mesh-list
6588363|NCT01091337|Procaterol|procaterol|mesh-list
6588364|NCT01091337|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6588365|NCT01091337|Autonomic Agents|autonomic agents|mesh-ancestor
6588366|NCT01091337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6588367|NCT01091337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588368|NCT01091337|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6588369|NCT01091337|Respiratory System Agents|respiratory system agents|mesh-ancestor
6588370|NCT01091337|Tocolytic Agents|tocolytic agents|mesh-ancestor
6588371|NCT01091337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6588372|NCT01091337|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6588373|NCT01091337|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6588374|NCT01091337|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6588375|NCT01091337|Adrenergic Agents|adrenergic agents|mesh-ancestor
6588376|NCT01091337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6588377|NCT01091337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588378|NCT01091337|Sympathomimetics|sympathomimetics|mesh-ancestor
6588379|NCT01091376|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6588380|NCT01091376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6588381|NCT01091376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6588382|NCT01091376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6588383|NCT01091376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658914|NCT01485224|Thalidomide|thalidomide|mesh-list
6658915|NCT01485224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6658916|NCT01485224|Immunologic Factors|immunologic factors|mesh-ancestor
6658917|NCT01485224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658918|NCT01485224|Leprostatic Agents|leprostatic agents|mesh-ancestor
6658919|NCT01485224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6658920|NCT01485224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6658921|NCT01485224|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6658922|NCT01485224|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6658923|NCT01485224|Growth Substances|growth substances|mesh-ancestor
6658924|NCT01485224|Growth Inhibitors|growth inhibitors|mesh-ancestor
6658925|NCT01485224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6658926|NCT01485315|Mannitol|mannitol|mesh-list
6658927|NCT01485315|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6658928|NCT01485315|Diuretics|diuretics|mesh-ancestor
6658929|NCT01485315|Natriuretic Agents|natriuretic agents|mesh-ancestor
6658930|NCT01485315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658931|NCT01485367|Adapalene|adapalene|mesh-list
6658932|NCT01485367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6658933|NCT01485367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6658934|NCT01485367|Analgesics|analgesics|mesh-ancestor
6658935|NCT01485367|Sensory System Agents|sensory system agents|mesh-ancestor
6658936|NCT01485367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6658937|NCT01485367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658938|NCT01485367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6658939|NCT01485367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6658940|NCT01485367|Dermatologic Agents|dermatologic agents|mesh-ancestor
6658941|NCT01485406|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6658942|NCT01485406|Immunologic Factors|immunologic factors|mesh-ancestor
6658943|NCT01485406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658944|NCT01485445|Fluticasone|fluticasone|mesh-list
6658945|NCT01485445|Xhance|xhance|mesh-list
6658946|NCT01485445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6658947|NCT01485445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6658948|NCT01485445|Autonomic Agents|autonomic agents|mesh-ancestor
6658949|NCT01485445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6658950|NCT01485445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658951|NCT01485445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6658952|NCT01485445|Respiratory System Agents|respiratory system agents|mesh-ancestor
6658953|NCT01485445|Dermatologic Agents|dermatologic agents|mesh-ancestor
6658954|NCT01485445|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6658955|NCT01485562|Misoprostol|misoprostol|mesh-list
6658956|NCT01485562|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6658957|NCT01485562|Abortifacient Agents|abortifacient agents|mesh-ancestor
6658958|NCT01485562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6658959|NCT01485562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658960|NCT01485562|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6658961|NCT01485562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6658962|NCT01485562|Oxytocics|oxytocics|mesh-ancestor
6658963|NCT01485653|Mepivacaine|mepivacaine|mesh-list
6658964|NCT01485653|Anesthetics, Local|anesthetics, local|mesh-ancestor
6658965|NCT01485653|Anesthetics|anesthetics|mesh-ancestor
6658966|NCT01485653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6658967|NCT01485653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658968|NCT01485653|Sensory System Agents|sensory system agents|mesh-ancestor
6658969|NCT01485653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6658970|NCT01485679|Deoxyglucose|deoxyglucose|mesh-list
6658971|NCT01485679|Antimetabolites|antimetabolites|mesh-ancestor
6658972|NCT01485679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658973|NCT01485679|Antiviral Agents|antiviral agents|mesh-ancestor
6658974|NCT01485679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6658975|NCT01485692|Promethazine|promethazine|mesh-list
6658976|NCT01485692|Diphenhydramine|diphenhydramine|mesh-list
6658977|NCT01485692|Midazolam|midazolam|mesh-list
6658978|NCT01485692|Haloperidol|haloperidol|mesh-list
6658979|NCT01485692|Olanzapine|olanzapine|mesh-list
6658980|NCT01485692|Haloperidol decanoate|haloperidol decanoate|mesh-list
6658981|NCT01485692|Ziprasidone|ziprasidone|mesh-list
6658982|NCT01485692|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6658983|NCT01485692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6658984|NCT01485692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6658985|NCT01485692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6658986|NCT01485692|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6658987|NCT01485692|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6588384|NCT01091415|Calcium|calcium|mesh-list
6588385|NCT01091415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6588386|NCT01091415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588387|NCT01091493|Moxifloxacin|moxifloxacin|mesh-list
6588388|NCT01091493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6588389|NCT01091493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6588390|NCT01091493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6588391|NCT01091493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6588392|NCT01091493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6588393|NCT01091493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588394|NCT01091493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6588395|NCT01091571|Dipyridamole|dipyridamole|mesh-list
6588396|NCT01091571|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6588397|NCT01091571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6588398|NCT01091571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588399|NCT01091571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6588400|NCT01091571|Vasodilator Agents|vasodilator agents|mesh-ancestor
6588401|NCT01091649|Ritonavir|ritonavir|mesh-list
6588402|NCT01091649|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6588403|NCT01091649|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6588404|NCT01091649|Protease Inhibitors|protease inhibitors|mesh-ancestor
6588405|NCT01091649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6588406|NCT01091649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588407|NCT01091649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6588408|NCT01091649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6588409|NCT01091649|Antiviral Agents|antiviral agents|mesh-ancestor
6588410|NCT01091649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6588411|NCT01091649|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6588412|NCT01091649|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6588413|NCT01091701|Plasma-lyte 148|plasma-lyte 148|mesh-list
6588414|NCT01091701|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6588415|NCT01091701|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6588416|NCT01091727|Botulinum Toxins|botulinum toxins|mesh-list
6588417|NCT01091727|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6588418|NCT01091727|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6588419|NCT01091727|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6588420|NCT01091727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6588421|NCT01091727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588422|NCT01091727|Cholinergic Agents|cholinergic agents|mesh-ancestor
6588423|NCT01091727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6588424|NCT01091727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588425|NCT01091727|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6588426|NCT01091727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6588427|NCT01091753|Amlodipine|amlodipine|mesh-list
6588428|NCT01091753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6588429|NCT01091753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6588430|NCT01091753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6588431|NCT01091753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588432|NCT01091753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6588433|NCT01091753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588434|NCT01091753|Vasodilator Agents|vasodilator agents|mesh-ancestor
6588435|NCT01091766|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6447440|NCT00397501|Antidotes|antidotes|mesh-ancestor
6447441|NCT00397501|Protective Agents|protective agents|mesh-ancestor
6447442|NCT00397501|Antioxidants|antioxidants|mesh-ancestor
6588436|NCT01091792|Bevacizumab|bevacizumab|mesh-list
6588437|NCT01091792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6588438|NCT01091792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6588439|NCT01091792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6588440|NCT01091792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6588441|NCT01091792|Growth Substances|growth substances|mesh-ancestor
6588442|NCT01091792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588443|NCT01091792|Growth Inhibitors|growth inhibitors|mesh-ancestor
6588444|NCT01091818|Midazolam|midazolam|mesh-list
6447443|NCT00397501|Antitubercular Agents|antitubercular agents|mesh-ancestor
6447444|NCT00397501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6447445|NCT00397501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6447446|NCT00397501|Chelating Agents|chelating agents|mesh-ancestor
6447447|NCT00397501|Sequestering Agents|sequestering agents|mesh-ancestor
6447448|NCT00397553|Insulin glulisine|insulin glulisine|mesh-list
6447449|NCT00397553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6447450|NCT00397553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447451|NCT00397566|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
6447452|NCT00397566|BMS-707035|bms-707035|mesh-list
6588445|NCT01091818|Dexmedetomidine|dexmedetomidine|mesh-list
6588446|NCT01091818|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6588447|NCT01091818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6588448|NCT01091818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588449|NCT01091818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6588450|NCT01091818|Analgesics|analgesics|mesh-ancestor
6588451|NCT01091818|Sensory System Agents|sensory system agents|mesh-ancestor
6588452|NCT01091818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6588453|NCT01091818|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6588454|NCT01091818|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6588455|NCT01091818|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6588456|NCT01091818|Adrenergic Agents|adrenergic agents|mesh-ancestor
6588457|NCT01091818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6588458|NCT01091818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588459|NCT01091818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5501593|NCT04472767|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5501594|NCT04472767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588460|NCT01091818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6588461|NCT01091818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6588462|NCT01091818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6588463|NCT01091818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6588464|NCT01091818|Anesthetics, General|anesthetics, general|mesh-ancestor
6588465|NCT01091818|Anesthetics|anesthetics|mesh-ancestor
6588466|NCT01091818|GABA Modulators|gaba modulators|mesh-ancestor
6588467|NCT01091818|GABA Agents|gaba agents|mesh-ancestor
6588468|NCT01091831|Dexamethasone|dexamethasone|mesh-list
6588469|NCT01091831|Cyclophosphamide|cyclophosphamide|mesh-list
6588470|NCT01091831|Melphalan|melphalan|mesh-list
6588471|NCT01091831|Lenalidomide|lenalidomide|mesh-list
6588472|NCT01091831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6588473|NCT01091831|Immunologic Factors|immunologic factors|mesh-ancestor
6588474|NCT01091831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588475|NCT01091831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6588476|NCT01091831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6588477|NCT01091831|Alkylating Agents|alkylating agents|mesh-ancestor
6588478|NCT01091831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588479|NCT01091831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6588480|NCT01091831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6588481|NCT01091831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6588482|NCT01091831|Antiemetics|antiemetics|mesh-ancestor
6588483|NCT01091831|Autonomic Agents|autonomic agents|mesh-ancestor
6588484|NCT01091831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5501595|NCT04472637|Atorvastatin|atorvastatin|mesh-list
5501596|NCT04472637|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5501597|NCT04472637|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5501598|NCT04472637|Antimetabolites|antimetabolites|mesh-ancestor
5501599|NCT04472637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501600|NCT04472637|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5501601|NCT04472637|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5501602|NCT04472637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5501603|NCT04472689|Lidocaine|lidocaine|mesh-list
5501604|NCT04472689|Anesthetics, Local|anesthetics, local|mesh-ancestor
5501605|NCT04472689|Anesthetics|anesthetics|mesh-ancestor
5501606|NCT04472689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6588485|NCT01091831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6588486|NCT01091831|Glucocorticoids|glucocorticoids|mesh-ancestor
6588487|NCT01091831|Hormones|hormones|mesh-ancestor
5501607|NCT04472689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501608|NCT04472689|Sensory System Agents|sensory system agents|mesh-ancestor
5501609|NCT04472689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5501610|NCT04472689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5501611|NCT04472689|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5501612|NCT04472689|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5501613|NCT04472689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6588488|NCT01091831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6588489|NCT01091831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6588490|NCT01091831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6588491|NCT01091831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6588492|NCT01091831|Growth Substances|growth substances|mesh-ancestor
6588493|NCT01091831|Growth Inhibitors|growth inhibitors|mesh-ancestor
6588494|NCT01091870|Sildenafil Citrate|sildenafil citrate|mesh-list
6588495|NCT01091870|Citric Acid|citric acid|mesh-list
6588496|NCT01091870|Sodium Citrate|sodium citrate|mesh-list
6588497|NCT01091870|Anticoagulants|anticoagulants|mesh-ancestor
6588498|NCT01091870|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6588499|NCT01091870|Chelating Agents|chelating agents|mesh-ancestor
6588500|NCT01091870|Sequestering Agents|sequestering agents|mesh-ancestor
6588501|NCT01091870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588502|NCT01091870|Vasodilator Agents|vasodilator agents|mesh-ancestor
6588503|NCT01091870|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6588504|NCT01091870|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6588505|NCT01091870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6588506|NCT01091870|Urological Agents|urological agents|mesh-ancestor
6588507|NCT01091896|Bevacizumab|bevacizumab|mesh-list
6588508|NCT01091896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6588509|NCT01091896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6588510|NCT01091896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6588511|NCT01091896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6588512|NCT01091896|Growth Substances|growth substances|mesh-ancestor
6588513|NCT01091896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588514|NCT01091896|Growth Inhibitors|growth inhibitors|mesh-ancestor
6588515|NCT01092039|Lactoferrin|lactoferrin|mesh-list
6588516|NCT01092039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6588517|NCT01092091|BCT-100|bct-100|mesh-list
6588518|NCT01092091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6588519|NCT01092130|Vitamin D|vitamin d|mesh-list
6588520|NCT01092130|Vitamins|vitamins|mesh-ancestor
6588521|NCT01092130|Micronutrients|micronutrients|mesh-ancestor
6588522|NCT01092130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588523|NCT01092130|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6588524|NCT01092221|Allopurinol|allopurinol|mesh-list
6588525|NCT01092221|Antimetabolites|antimetabolites|mesh-ancestor
6588526|NCT01092221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588527|NCT01092221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6588528|NCT01092221|Gout Suppressants|gout suppressants|mesh-ancestor
6588529|NCT01092221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6588530|NCT01092221|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6588531|NCT01092221|Antioxidants|antioxidants|mesh-ancestor
6588532|NCT01092221|Protective Agents|protective agents|mesh-ancestor
6588533|NCT01092221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588534|NCT01092351|Nitrofurantoin|nitrofurantoin|mesh-list
6588535|NCT01092351|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6588536|NCT01092351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6588537|NCT01092351|Renal Agents|renal agents|mesh-ancestor
6588538|NCT01092351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6588539|NCT01092455|Heparin|heparin|mesh-list
6588540|NCT01092455|Calcium heparin|calcium heparin|mesh-list
6588541|NCT01092455|Anticoagulants|anticoagulants|mesh-ancestor
6588542|NCT01092455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6588543|NCT01092455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6588544|NCT01092455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588545|NCT01092481|Oxaliplatin|oxaliplatin|mesh-list
6588546|NCT01092481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6588547|NCT01092520|Gabapentin|gabapentin|mesh-list
6588548|NCT01092520|Analgesics|analgesics|mesh-ancestor
6588549|NCT01092520|Sensory System Agents|sensory system agents|mesh-ancestor
6588550|NCT01092520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6588551|NCT01092520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588552|NCT01092520|Anticonvulsants|anticonvulsants|mesh-ancestor
6588553|NCT01092520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6588554|NCT01092520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6588555|NCT01092520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6588556|NCT01092520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6588557|NCT01092520|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6588558|NCT01092520|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6588559|NCT01092520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6588560|NCT01092520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588561|NCT01092520|Antimanic Agents|antimanic agents|mesh-ancestor
6588562|NCT01092533|Mycophenolic Acid|mycophenolic acid|mesh-list
6588563|NCT01092533|Prednisolone|prednisolone|mesh-list
6447453|NCT00397566|Integrase Inhibitors|integrase inhibitors|mesh-list
6447454|NCT00397566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6447455|NCT00397566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447456|NCT00397566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6447457|NCT00397566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6447458|NCT00397566|Antiviral Agents|antiviral agents|mesh-ancestor
6447459|NCT00397566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6447460|NCT00397592|Hormones|hormones|mesh-list
6447461|NCT00397592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6447462|NCT00397592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447463|NCT00397657|Niacin|niacin|mesh-list
6447464|NCT00397657|Ezetimibe|ezetimibe|mesh-list
6447465|NCT00397657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6447466|NCT00397657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6447467|NCT00397657|Antimetabolites|antimetabolites|mesh-ancestor
6447468|NCT00397657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447469|NCT00397657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6447470|NCT00397657|Vasodilator Agents|vasodilator agents|mesh-ancestor
6447471|NCT00397657|Vitamin B Complex|vitamin b complex|mesh-ancestor
6447472|NCT00397657|Vitamins|vitamins|mesh-ancestor
6447473|NCT00397657|Micronutrients|micronutrients|mesh-ancestor
6588564|NCT01092533|Prednisone|prednisone|mesh-list
6588565|NCT01092533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6588566|NCT01092533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6588567|NCT01092533|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6588568|NCT01092533|Antitubercular Agents|antitubercular agents|mesh-ancestor
6588569|NCT01092533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6588570|NCT01092533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6588571|NCT01092533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6588572|NCT01092533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588573|NCT01092533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6588574|NCT01092533|Glucocorticoids|glucocorticoids|mesh-ancestor
6588575|NCT01092533|Hormones|hormones|mesh-ancestor
6588576|NCT01092533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6588577|NCT01092533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588578|NCT01092533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6588579|NCT01092572|Simvastatin|simvastatin|mesh-list
6588580|NCT01092572|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6588581|NCT01092572|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6588582|NCT01092572|Antimetabolites|antimetabolites|mesh-ancestor
6588583|NCT01092572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588584|NCT01092572|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6588585|NCT01092572|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6588586|NCT01092572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6588587|NCT01092624|Solifenacin Succinate|solifenacin succinate|mesh-list
6588588|NCT01092624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6588589|NCT01092624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6588590|NCT01092624|Cholinergic Agents|cholinergic agents|mesh-ancestor
6588591|NCT01092624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6588592|NCT01092624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588593|NCT01092624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588594|NCT01092624|Urological Agents|urological agents|mesh-ancestor
6588595|NCT01092741|Imatinib Mesylate|imatinib mesylate|mesh-list
6588596|NCT01092741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6588597|NCT01092741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6588598|NCT01092741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6588599|NCT01092741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588600|NCT01092806|Tacrolimus|tacrolimus|mesh-list
6588601|NCT01092806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6588602|NCT01092806|Immunologic Factors|immunologic factors|mesh-ancestor
6588603|NCT01092806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588604|NCT01092806|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6588605|NCT01092806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6658988|NCT01485692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6588606|NCT01092806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588607|NCT01092858|Methyltestosterone|methyltestosterone|mesh-list
6588608|NCT01092858|Testosterone|testosterone|mesh-list
6588609|NCT01092858|Testosterone undecanoate|testosterone undecanoate|mesh-list
6588610|NCT01092858|Testosterone enanthate|testosterone enanthate|mesh-list
6588611|NCT01092858|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6588612|NCT01092858|Androgens|androgens|mesh-ancestor
6588613|NCT01092858|Hormones|hormones|mesh-ancestor
6588614|NCT01092858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6588615|NCT01092858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588616|NCT01092858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6588617|NCT01092858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6588618|NCT01092858|Anabolic Agents|anabolic agents|mesh-ancestor
6588619|NCT01092962|Mycophenolic Acid|mycophenolic acid|mesh-list
6588620|NCT01092962|Cyclophosphamide|cyclophosphamide|mesh-list
6588621|NCT01092962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6588622|NCT01092962|Immunologic Factors|immunologic factors|mesh-ancestor
6588623|NCT01092962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588624|NCT01092962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6588625|NCT01092962|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6588626|NCT01092962|Alkylating Agents|alkylating agents|mesh-ancestor
6588627|NCT01092962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588628|NCT01092962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6588629|NCT01092962|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6588630|NCT01092962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6588631|NCT01092962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6588632|NCT01092962|Antitubercular Agents|antitubercular agents|mesh-ancestor
6588633|NCT01092962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6588634|NCT01092962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6588635|NCT01092962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6588636|NCT01092975|Phenylephrine|phenylephrine|mesh-list
6588637|NCT01092975|Oxymetazoline|oxymetazoline|mesh-list
6588638|NCT01092975|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6588639|NCT01092975|Mydriatics|mydriatics|mesh-ancestor
6588640|NCT01092975|Autonomic Agents|autonomic agents|mesh-ancestor
6588641|NCT01092975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6588642|NCT01092975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588643|NCT01092975|Sympathomimetics|sympathomimetics|mesh-ancestor
6588644|NCT01092975|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6588645|NCT01092975|Nasal Decongestants|nasal decongestants|mesh-ancestor
6588646|NCT01092975|Respiratory System Agents|respiratory system agents|mesh-ancestor
6588647|NCT01092975|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6588648|NCT01092975|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6588649|NCT01092975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6588650|NCT01092975|Adrenergic Agents|adrenergic agents|mesh-ancestor
6588651|NCT01092975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6588652|NCT01092975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588653|NCT01092975|Protective Agents|protective agents|mesh-ancestor
6588654|NCT01093040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6588655|NCT01093040|Immunologic Factors|immunologic factors|mesh-ancestor
6588656|NCT01093040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588657|NCT01093092|Calcitriol|calcitriol|mesh-list
6588658|NCT01093092|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
6588659|NCT01093092|Gemcitabine|gemcitabine|mesh-list
6588660|NCT01093092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6588661|NCT01093092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6588662|NCT01093092|Antimetabolites|antimetabolites|mesh-ancestor
6588663|NCT01093092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588664|NCT01093092|Antiviral Agents|antiviral agents|mesh-ancestor
6588665|NCT01093092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6588666|NCT01093092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6588667|NCT01093092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6588668|NCT01093092|Immunologic Factors|immunologic factors|mesh-ancestor
6588669|NCT01093092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447474|NCT00397657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447475|NCT00397709|Rifampin|rifampin|mesh-list
6447476|NCT00397709|Isoniazid|isoniazid|mesh-list
6447477|NCT00397709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6447478|NCT00397709|Antitubercular Agents|antitubercular agents|mesh-ancestor
6588670|NCT01093092|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6588671|NCT01093092|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6588672|NCT01093092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6588673|NCT01093092|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6588674|NCT01093092|Vitamins|vitamins|mesh-ancestor
6588675|NCT01093092|Micronutrients|micronutrients|mesh-ancestor
6588676|NCT01093092|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6658989|NCT01485692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6658990|NCT01485692|Anesthetics, General|anesthetics, general|mesh-ancestor
6658991|NCT01485692|Anesthetics|anesthetics|mesh-ancestor
6658992|NCT01485692|GABA Modulators|gaba modulators|mesh-ancestor
6658993|NCT01485692|GABA Agents|gaba agents|mesh-ancestor
6658994|NCT01485692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6658995|NCT01485692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6658996|NCT01485692|Antiemetics|antiemetics|mesh-ancestor
6658997|NCT01485692|Autonomic Agents|autonomic agents|mesh-ancestor
6658998|NCT01485692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6658999|NCT01485692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6447479|NCT00397709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6447480|NCT00397709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6447481|NCT00397709|Leprostatic Agents|leprostatic agents|mesh-ancestor
6447482|NCT00397709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6447483|NCT00397709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6447484|NCT00397709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447485|NCT00397709|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6447486|NCT00397709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6588677|NCT01093157|Hormones|hormones|mesh-list
6588678|NCT01093157|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6588679|NCT01093157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6588680|NCT01093157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588681|NCT01093196|Dexamethasone|dexamethasone|mesh-list
6588682|NCT01093196|Prednisone|prednisone|mesh-list
6588683|NCT01093196|Cyclophosphamide|cyclophosphamide|mesh-list
6588684|NCT01093196|Melphalan|melphalan|mesh-list
6588685|NCT01093196|Lenalidomide|lenalidomide|mesh-list
6588686|NCT01093196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6588687|NCT01093196|Immunologic Factors|immunologic factors|mesh-ancestor
6588688|NCT01093196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588689|NCT01093196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6588690|NCT01093196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6588691|NCT01093196|Alkylating Agents|alkylating agents|mesh-ancestor
6588692|NCT01093196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588693|NCT01093196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6588694|NCT01093196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6588695|NCT01093196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6588696|NCT01093196|Antiemetics|antiemetics|mesh-ancestor
6588697|NCT01093196|Autonomic Agents|autonomic agents|mesh-ancestor
6588698|NCT01093196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6588699|NCT01093196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6588700|NCT01093196|Glucocorticoids|glucocorticoids|mesh-ancestor
6588701|NCT01093196|Hormones|hormones|mesh-ancestor
6588702|NCT01093196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6588703|NCT01093196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6588704|NCT01093196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6588705|NCT01093196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6588706|NCT01093196|Growth Substances|growth substances|mesh-ancestor
6588707|NCT01093196|Growth Inhibitors|growth inhibitors|mesh-ancestor
6588708|NCT01093235|Cyclophosphamide|cyclophosphamide|mesh-list
6588709|NCT01093235|Bevacizumab|bevacizumab|mesh-list
6588710|NCT01093235|Docetaxel|docetaxel|mesh-list
6588711|NCT01093235|Fluorouracil|fluorouracil|mesh-list
6588712|NCT01093235|Epirubicin|epirubicin|mesh-list
6588713|NCT01093235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6588714|NCT01093235|Immunologic Factors|immunologic factors|mesh-ancestor
6588715|NCT01093235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588716|NCT01093235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6588717|NCT01093235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6588718|NCT01093235|Alkylating Agents|alkylating agents|mesh-ancestor
6588719|NCT01093235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588720|NCT01093235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6588721|NCT01093235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6588722|NCT01093235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6588723|NCT01093235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6588724|NCT01093235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6588725|NCT01093235|Growth Substances|growth substances|mesh-ancestor
6588726|NCT01093235|Growth Inhibitors|growth inhibitors|mesh-ancestor
6588727|NCT01093235|Tubulin Modulators|tubulin modulators|mesh-ancestor
6588728|NCT01093235|Antimitotic Agents|antimitotic agents|mesh-ancestor
6588729|NCT01093235|Mitosis Modulators|mitosis modulators|mesh-ancestor
6588730|NCT01093235|Antimetabolites|antimetabolites|mesh-ancestor
6588731|NCT01093235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6588732|NCT01093235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6447487|NCT00397709|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6020352|NCT00392782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6447488|NCT00397709|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6588733|NCT01093235|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6588734|NCT01093235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6588735|NCT01093235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6588736|NCT01093261|Hydrocortisone|hydrocortisone|mesh-list
6588737|NCT01093261|Fludrocortisone|fludrocortisone|mesh-list
6588738|NCT01093261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6588739|NCT01093274|Picosulfate sodium|picosulfate sodium|mesh-list
6588740|NCT01093274|Cathartics|cathartics|mesh-ancestor
6588741|NCT01093274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6588742|NCT01093300|Paclitaxel|paclitaxel|mesh-list
6588743|NCT01093300|Everolimus|everolimus|mesh-list
6588744|NCT01093300|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6588745|NCT01093300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6588746|NCT01093300|Tubulin Modulators|tubulin modulators|mesh-ancestor
6588747|NCT01093300|Antimitotic Agents|antimitotic agents|mesh-ancestor
6588748|NCT01093300|Mitosis Modulators|mitosis modulators|mesh-ancestor
6588749|NCT01093300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588750|NCT01093300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6588751|NCT01093300|Immunologic Factors|immunologic factors|mesh-ancestor
6588752|NCT01093300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588753|NCT01093365|Varenicline|varenicline|mesh-list
6020353|NCT00392782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6447489|NCT00397709|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6447490|NCT00397709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6447491|NCT00397709|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6447492|NCT00397709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6447493|NCT00397709|Antimetabolites|antimetabolites|mesh-ancestor
6447494|NCT00397709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6447495|NCT00397722|Paroxetine|paroxetine|mesh-list
6447496|NCT00397722|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6447497|NCT00397722|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6447498|NCT00397722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6447499|NCT00397722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447500|NCT00397722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6447501|NCT00397722|Serotonin Agents|serotonin agents|mesh-ancestor
6447502|NCT00397722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447503|NCT00397722|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6447504|NCT00397722|Antidepressive Agents|antidepressive agents|mesh-ancestor
6447505|NCT00397722|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6588754|NCT01093365|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6588755|NCT01093365|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6588756|NCT01093365|Cholinergic Agents|cholinergic agents|mesh-ancestor
6588757|NCT01093365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6588758|NCT01093365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588759|NCT01093365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588760|NCT01093612|Copper|copper|mesh-list
6588761|NCT01093612|Trastuzumab|trastuzumab|mesh-list
6588762|NCT01093612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6588763|NCT01093612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6588764|NCT01093612|Trace Elements|trace elements|mesh-ancestor
6588765|NCT01093612|Micronutrients|micronutrients|mesh-ancestor
6588766|NCT01093612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588767|NCT01093638|Insulin|insulin|mesh-list
6588768|NCT01093638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6588769|NCT01093638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588770|NCT01093768|Vasopressins|vasopressins|mesh-list
6588771|NCT01093768|Arginine Vasopressin|arginine vasopressin|mesh-list
6588772|NCT01093768|Oxytocin|oxytocin|mesh-list
6588773|NCT01093768|Oxytocics|oxytocics|mesh-ancestor
6588774|NCT01093768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6588775|NCT01093768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588776|NCT01093768|Hemostatics|hemostatics|mesh-ancestor
6588777|NCT01093768|Coagulants|coagulants|mesh-ancestor
6588778|NCT01093768|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6588779|NCT01093768|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6588780|NCT01093768|Natriuretic Agents|natriuretic agents|mesh-ancestor
6588781|NCT01093807|Enalapril|enalapril|mesh-list
6588782|NCT01093807|Enalaprilat|enalaprilat|mesh-list
6588783|NCT01093807|Lercanidipine|lercanidipine|mesh-list
6588784|NCT01093807|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6588785|NCT01093807|Protease Inhibitors|protease inhibitors|mesh-ancestor
6588786|NCT01093807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6588787|NCT01093807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588788|NCT01093807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6588789|NCT01093807|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6588790|NCT01093807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6588791|NCT01093807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6588792|NCT01093807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588793|NCT01093820|Epoetin Alfa|epoetin alfa|mesh-list
6588794|NCT01093820|Hematinics|hematinics|mesh-ancestor
6588795|NCT01093937|Varenicline|varenicline|mesh-list
6588796|NCT01093937|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6588797|NCT01093937|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6588798|NCT01093937|Cholinergic Agents|cholinergic agents|mesh-ancestor
6588799|NCT01093937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6588800|NCT01093937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588801|NCT01093937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588802|NCT01093963|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6588803|NCT01093963|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6588804|NCT01093963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588805|NCT01093963|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6588806|NCT01093963|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6588807|NCT01093963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6588808|NCT01093963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020354|NCT00392782|Antimetabolites|antimetabolites|mesh-ancestor
6588809|NCT01093963|Dopamine Agents|dopamine agents|mesh-ancestor
6588810|NCT01093963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6588811|NCT01094015|Lidocaine|lidocaine|mesh-list
6588812|NCT01094015|Prilocaine|prilocaine|mesh-list
6588813|NCT01094015|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
6588814|NCT01094015|Anesthetics, Local|anesthetics, local|mesh-ancestor
6588815|NCT01094015|Anesthetics|anesthetics|mesh-ancestor
6588816|NCT01094015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6588817|NCT01094015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588818|NCT01094015|Sensory System Agents|sensory system agents|mesh-ancestor
6588819|NCT01094015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6588820|NCT01094015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6588821|NCT01094015|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6588822|NCT01094015|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6588823|NCT01094015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6588824|NCT01094015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588825|NCT01094015|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
6588826|NCT01094028|Oxytocin|oxytocin|mesh-list
6588827|NCT01094028|Oxytocics|oxytocics|mesh-ancestor
6588828|NCT01094028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6588829|NCT01094028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588830|NCT01094158|Cholic Acids|cholic acids|mesh-list
6588831|NCT01094158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6588832|NCT01094210|Fluorides|fluorides|mesh-list
6588833|NCT01094210|Fluorides, Topical|fluorides, topical|mesh-list
6588834|NCT01094210|Cariostatic Agents|cariostatic agents|mesh-ancestor
6588835|NCT01094210|Protective Agents|protective agents|mesh-ancestor
6588836|NCT01094210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588837|NCT01094249|Valproic Acid|valproic acid|mesh-list
6588838|NCT01094249|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6588839|NCT01094249|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6588840|NCT01094249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6588841|NCT01094249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6588842|NCT01094249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588843|NCT01094249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6588844|NCT01094249|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6588845|NCT01094249|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6588846|NCT01094249|Serotonin Agents|serotonin agents|mesh-ancestor
6588847|NCT01094249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6588848|NCT01094249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588849|NCT01094249|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6588850|NCT01094249|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6588851|NCT01094249|Dopamine Agents|dopamine agents|mesh-ancestor
6588852|NCT01094249|Anticonvulsants|anticonvulsants|mesh-ancestor
6588853|NCT01094249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6588854|NCT01094249|GABA Agents|gaba agents|mesh-ancestor
6588855|NCT01094249|Antimanic Agents|antimanic agents|mesh-ancestor
6588856|NCT01094275|Omeprazole|omeprazole|mesh-list
6588857|NCT01094275|Clopidogrel|clopidogrel|mesh-list
6588858|NCT01094275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6588859|NCT01094275|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6588860|NCT01094275|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6588861|NCT01094275|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6588862|NCT01094275|Purinergic Agents|purinergic agents|mesh-ancestor
6588863|NCT01094275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6588864|NCT01094275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588865|NCT01094275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588866|NCT01094275|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6588867|NCT01094275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6588868|NCT01094275|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6588869|NCT01094275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6588870|NCT01094340|Thalidomide|thalidomide|mesh-list
6588871|NCT01094340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6588872|NCT01094340|Immunologic Factors|immunologic factors|mesh-ancestor
6588873|NCT01094340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588874|NCT01094340|Leprostatic Agents|leprostatic agents|mesh-ancestor
6588875|NCT01094340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6588876|NCT01094340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6588877|NCT01094340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6588878|NCT01094340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6588879|NCT01094340|Growth Substances|growth substances|mesh-ancestor
6588880|NCT01094340|Growth Inhibitors|growth inhibitors|mesh-ancestor
6588881|NCT01094340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6588882|NCT01094444|Vitamin K|vitamin k|mesh-list
6588883|NCT01094444|Vitamin K 3|vitamin k 3|mesh-list
6588884|NCT01094444|Vitamins|vitamins|mesh-ancestor
6588885|NCT01094444|Micronutrients|micronutrients|mesh-ancestor
6588886|NCT01094444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588887|NCT01094444|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6588888|NCT01094444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6588889|NCT01094444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588890|NCT01094444|Hemostatics|hemostatics|mesh-ancestor
6588891|NCT01094444|Coagulants|coagulants|mesh-ancestor
6588892|NCT01094457|Aspirin|aspirin|mesh-list
6588893|NCT01094457|Cilostazol|cilostazol|mesh-list
6588894|NCT01094457|Clopidogrel|clopidogrel|mesh-list
6588895|NCT01094457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6588896|NCT01094457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6588897|NCT01094457|Analgesics|analgesics|mesh-ancestor
6588898|NCT01094457|Sensory System Agents|sensory system agents|mesh-ancestor
6588899|NCT01094457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6588900|NCT01094457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588901|NCT01094457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6588902|NCT01094457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6588903|NCT01094457|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6588904|NCT01094457|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6588905|NCT01094457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588906|NCT01094457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6588907|NCT01094457|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6588908|NCT01094457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6588909|NCT01094457|Antipyretics|antipyretics|mesh-ancestor
6588910|NCT01094457|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6588911|NCT01094457|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6588912|NCT01094457|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6588913|NCT01094457|Purinergic Agents|purinergic agents|mesh-ancestor
6588914|NCT01094457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6588915|NCT01094457|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6588916|NCT01094457|Autonomic Agents|autonomic agents|mesh-ancestor
6588917|NCT01094457|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6588918|NCT01094457|Respiratory System Agents|respiratory system agents|mesh-ancestor
6588919|NCT01094457|Vasodilator Agents|vasodilator agents|mesh-ancestor
6588920|NCT01094457|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6588921|NCT01094457|Protective Agents|protective agents|mesh-ancestor
6588922|NCT01094457|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6588923|NCT01094457|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6588924|NCT01094535|Secretin|secretin|mesh-list
6588925|NCT01094535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6588926|NCT01094535|Hormones|hormones|mesh-ancestor
6588927|NCT01094535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6588928|NCT01094535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588929|NCT01094600|Secretin|secretin|mesh-list
6588930|NCT01094600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6588931|NCT01094600|Hormones|hormones|mesh-ancestor
6588932|NCT01094600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6588933|NCT01094600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588934|NCT01094613|Mercaptopurine|mercaptopurine|mesh-list
6588935|NCT01094613|Antimetabolites|antimetabolites|mesh-ancestor
6588936|NCT01094613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588937|NCT01094613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6588938|NCT01094613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6588939|NCT01094613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6588940|NCT01094613|Immunologic Factors|immunologic factors|mesh-ancestor
6588941|NCT01094613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588942|NCT01094613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6588943|NCT01094613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6588944|NCT01094626|Secretin|secretin|mesh-list
6588945|NCT01094626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6588946|NCT01094626|Hormones|hormones|mesh-ancestor
6588947|NCT01094626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6588948|NCT01094626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588949|NCT01094769|Moxonidine|moxonidine|mesh-list
6588950|NCT01094769|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6588951|NCT01094821|ATI 7505|ati 7505|mesh-list
6588952|NCT01094821|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
6588953|NCT01094821|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6588954|NCT01094821|Serotonin Agents|serotonin agents|mesh-ancestor
6588955|NCT01094821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6588956|NCT01094821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588957|NCT01094821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588958|NCT01094912|Analgesics, Opioid|analgesics, opioid|mesh-list
6588959|NCT01094912|Narcotics|narcotics|mesh-ancestor
6588960|NCT01094912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6588961|NCT01094912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588962|NCT01094912|Analgesics|analgesics|mesh-ancestor
6588963|NCT01094912|Sensory System Agents|sensory system agents|mesh-ancestor
6588964|NCT01094912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6588965|NCT01094925|Gabapentin|gabapentin|mesh-list
6588966|NCT01094925|Analgesics|analgesics|mesh-ancestor
6588967|NCT01094925|Sensory System Agents|sensory system agents|mesh-ancestor
6588968|NCT01094925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6588969|NCT01094925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588970|NCT01094925|Anticonvulsants|anticonvulsants|mesh-ancestor
6588971|NCT01094925|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6588972|NCT01094925|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6588973|NCT01094925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6588974|NCT01094925|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6588975|NCT01094925|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6588976|NCT01094925|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6588977|NCT01094925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6588978|NCT01094925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588979|NCT01094925|Antimanic Agents|antimanic agents|mesh-ancestor
6659000|NCT01485692|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6659001|NCT01485692|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6659002|NCT01485692|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6659003|NCT01485692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6659004|NCT01485692|Serotonin Agents|serotonin agents|mesh-ancestor
6659005|NCT01485692|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6659006|NCT01485692|Dopamine Agents|dopamine agents|mesh-ancestor
6659007|NCT01485692|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6659008|NCT01485692|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6659009|NCT01485692|Antipruritics|antipruritics|mesh-ancestor
6659010|NCT01485692|Dermatologic Agents|dermatologic agents|mesh-ancestor
6659011|NCT01485692|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6659012|NCT01485692|Histamine Antagonists|histamine antagonists|mesh-ancestor
6659013|NCT01485692|Histamine Agents|histamine agents|mesh-ancestor
6659014|NCT01485692|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6659015|NCT01485692|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6659016|NCT01485692|Anesthetics, Local|anesthetics, local|mesh-ancestor
6659017|NCT01485692|Sensory System Agents|sensory system agents|mesh-ancestor
6659018|NCT01485718|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
6659019|NCT01485718|Cathartics|cathartics|mesh-ancestor
6659020|NCT01485718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6659021|NCT01485731|Nelfinavir|nelfinavir|mesh-list
6659022|NCT01485731|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6659023|NCT01485731|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6659024|NCT01485731|Protease Inhibitors|protease inhibitors|mesh-ancestor
6659025|NCT01485731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6659026|NCT01485731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6659027|NCT01485731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6659028|NCT01485731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6659029|NCT01485731|Antiviral Agents|antiviral agents|mesh-ancestor
6659030|NCT01485731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6659031|NCT01485744|Leucovorin|leucovorin|mesh-list
6659032|NCT01485744|Fluorouracil|fluorouracil|mesh-list
6588980|NCT01094964|Interferons|interferons|mesh-list
6588981|NCT01094964|Interferon-alpha|interferon-alpha|mesh-list
6588982|NCT01094964|Epirubicin|epirubicin|mesh-list
6588983|NCT01094964|Mitomycins|mitomycins|mesh-list
6588984|NCT01094964|Mitomycin|mitomycin|mesh-list
6588985|NCT01094964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6588986|NCT01094964|Antiviral Agents|antiviral agents|mesh-ancestor
6588987|NCT01094964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6588988|NCT01094964|Immunologic Factors|immunologic factors|mesh-ancestor
6588989|NCT01094964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6588990|NCT01094964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6588991|NCT01094964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6588992|NCT01094964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6588993|NCT01094964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6588994|NCT01094964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6588995|NCT01094964|Alkylating Agents|alkylating agents|mesh-ancestor
6588996|NCT01094964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6588997|NCT01094977|Tranexamic Acid|tranexamic acid|mesh-list
6588998|NCT01094977|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6588999|NCT01094977|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6589000|NCT01094977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589001|NCT01094977|Hemostatics|hemostatics|mesh-ancestor
6589002|NCT01094977|Coagulants|coagulants|mesh-ancestor
6589003|NCT01094990|Dexamethasone|dexamethasone|mesh-list
6589004|NCT01094990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6589005|NCT01094990|Antiemetics|antiemetics|mesh-ancestor
6589006|NCT01094990|Autonomic Agents|autonomic agents|mesh-ancestor
6589007|NCT01094990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6589008|NCT01094990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589009|NCT01094990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6589010|NCT01094990|Glucocorticoids|glucocorticoids|mesh-ancestor
6589011|NCT01094990|Hormones|hormones|mesh-ancestor
6589012|NCT01094990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6589013|NCT01094990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6589014|NCT01094990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6589015|NCT01095016|Fenoterol|fenoterol|mesh-list
6589016|NCT01095016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6589017|NCT01095016|Autonomic Agents|autonomic agents|mesh-ancestor
6589018|NCT01095016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6589019|NCT01095016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589020|NCT01095016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6589021|NCT01095016|Respiratory System Agents|respiratory system agents|mesh-ancestor
6589022|NCT01095016|Sympathomimetics|sympathomimetics|mesh-ancestor
6447506|NCT00397722|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6447507|NCT00397722|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6589023|NCT01095016|Tocolytic Agents|tocolytic agents|mesh-ancestor
6589024|NCT01095016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6589025|NCT01095016|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6447508|NCT00397722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6447509|NCT00397735|Acetylcysteine|acetylcysteine|mesh-list
6447510|NCT00397735|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6447511|NCT00397735|Antiviral Agents|antiviral agents|mesh-ancestor
6447512|NCT00397735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6447513|NCT00397735|Expectorants|expectorants|mesh-ancestor
6589026|NCT01095016|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6589027|NCT01095016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6589028|NCT01095016|Adrenergic Agents|adrenergic agents|mesh-ancestor
6589029|NCT01095016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6659033|NCT01485744|Oxaliplatin|oxaliplatin|mesh-list
6589030|NCT01095016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589031|NCT01095133|Amiloride|amiloride|mesh-list
6589032|NCT01095133|Diuretics|diuretics|mesh-ancestor
6589033|NCT01095133|Natriuretic Agents|natriuretic agents|mesh-ancestor
6589034|NCT01095133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589035|NCT01095133|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
6589036|NCT01095133|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6589037|NCT01095133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6589038|NCT01095133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589039|NCT01095133|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
6589040|NCT01095133|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6589041|NCT01095172|Prednisolone|prednisolone|mesh-list
6589042|NCT01095172|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6589043|NCT01095172|Methylprednisolone|methylprednisolone|mesh-list
6589044|NCT01095172|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6589045|NCT01095172|Prednisolone acetate|prednisolone acetate|mesh-list
6589046|NCT01095172|Hydrocortisone|hydrocortisone|mesh-list
6589047|NCT01095172|Rituximab|rituximab|mesh-list
6589048|NCT01095172|Tacrolimus|tacrolimus|mesh-list
6589049|NCT01095172|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6589050|NCT01095172|Prednisolone phosphate|prednisolone phosphate|mesh-list
6589051|NCT01095172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6589052|NCT01095172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6589053|NCT01095172|Immunologic Factors|immunologic factors|mesh-ancestor
6589054|NCT01095172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589055|NCT01095172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6589056|NCT01095172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6589057|NCT01095172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5503686|NCT04456777|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6589058|NCT01095172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6589059|NCT01095172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589060|NCT01095172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6589061|NCT01095172|Glucocorticoids|glucocorticoids|mesh-ancestor
6589062|NCT01095172|Hormones|hormones|mesh-ancestor
6589063|NCT01095172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6589064|NCT01095172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6589065|NCT01095172|Antiemetics|antiemetics|mesh-ancestor
6589066|NCT01095172|Autonomic Agents|autonomic agents|mesh-ancestor
6589067|NCT01095172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6589068|NCT01095172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6589069|NCT01095172|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6589070|NCT01095172|Protective Agents|protective agents|mesh-ancestor
6589071|NCT01095185|Simvastatin|simvastatin|mesh-list
6589072|NCT01095185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6589073|NCT01095185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6589074|NCT01095185|Antimetabolites|antimetabolites|mesh-ancestor
6589075|NCT01095185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589076|NCT01095185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6589077|NCT01095185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6589078|NCT01095185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6589079|NCT01095211|Vitamin B Complex|vitamin b complex|mesh-list
6589080|NCT01095211|Vitamins|vitamins|mesh-ancestor
6589081|NCT01095211|Micronutrients|micronutrients|mesh-ancestor
6589082|NCT01095211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589083|NCT01095302|Docetaxel|docetaxel|mesh-list
6589084|NCT01095302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6589085|NCT01095302|Tubulin Modulators|tubulin modulators|mesh-ancestor
6589086|NCT01095302|Antimitotic Agents|antimitotic agents|mesh-ancestor
6589087|NCT01095302|Mitosis Modulators|mitosis modulators|mesh-ancestor
6589088|NCT01095302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589089|NCT01095445|Ribavirin|ribavirin|mesh-list
6589090|NCT01095445|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6589091|NCT01095445|Antimetabolites|antimetabolites|mesh-ancestor
6589092|NCT01095445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589093|NCT01095445|Antiviral Agents|antiviral agents|mesh-ancestor
6589094|NCT01095445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6589095|NCT01095471|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6589096|NCT01095471|Immunologic Factors|immunologic factors|mesh-ancestor
6589097|NCT01095471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589098|NCT01095484|Rotigotine|rotigotine|mesh-list
6589099|NCT01095484|Dopamine Agonists|dopamine agonists|mesh-ancestor
6589100|NCT01095484|Dopamine Agents|dopamine agents|mesh-ancestor
6589101|NCT01095484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6589102|NCT01095484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589103|NCT01095484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589104|NCT01095575|Morphine|morphine|mesh-list
6589105|NCT01095575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6589106|NCT01095575|Narcotics|narcotics|mesh-ancestor
6589107|NCT01095575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6589108|NCT01095575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589109|NCT01095575|Analgesics|analgesics|mesh-ancestor
6589110|NCT01095575|Sensory System Agents|sensory system agents|mesh-ancestor
6589111|NCT01095575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6589112|NCT01095640|Adapalene|adapalene|mesh-list
6589113|NCT01095640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6589114|NCT01095640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6589115|NCT01095640|Analgesics|analgesics|mesh-ancestor
6589116|NCT01095640|Sensory System Agents|sensory system agents|mesh-ancestor
6589117|NCT01095640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6589118|NCT01095640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589119|NCT01095640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6589120|NCT01095640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6589121|NCT01095640|Dermatologic Agents|dermatologic agents|mesh-ancestor
6589122|NCT01095679|Baclofen|baclofen|mesh-list
6589123|NCT01095679|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6589124|NCT01095679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589125|NCT01095679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6589126|NCT01095679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6589127|NCT01095679|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6589128|NCT01095679|GABA Agonists|gaba agonists|mesh-ancestor
6589129|NCT01095679|GABA Agents|gaba agents|mesh-ancestor
6589130|NCT01095679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6589131|NCT01095679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589132|NCT01095731|Acetic Acid|acetic acid|mesh-list
6589133|NCT01095731|Retinol acetate|retinol acetate|mesh-list
6589134|NCT01095731|Glycine|glycine|mesh-list
6589135|NCT01095731|Glycine Agents|glycine agents|mesh-ancestor
6589136|NCT01095731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6589137|NCT01095731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589138|NCT01095731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589139|NCT01095731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6589140|NCT01095731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6589141|NCT01095731|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6589142|NCT01095731|Immunologic Factors|immunologic factors|mesh-ancestor
6589143|NCT01095731|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6589144|NCT01095731|Protective Agents|protective agents|mesh-ancestor
6589145|NCT01095731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6589146|NCT01095809|Triamcinolone|triamcinolone|mesh-list
6589147|NCT01095809|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6589148|NCT01095809|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6589149|NCT01095809|Bevacizumab|bevacizumab|mesh-list
6589150|NCT01095809|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6589151|NCT01095809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6589152|NCT01095809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6589153|NCT01095809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6589154|NCT01095809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6589155|NCT01095809|Growth Substances|growth substances|mesh-ancestor
6589156|NCT01095809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589157|NCT01095809|Growth Inhibitors|growth inhibitors|mesh-ancestor
6589158|NCT01095809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6589159|NCT01095809|Glucocorticoids|glucocorticoids|mesh-ancestor
6589160|NCT01095809|Hormones|hormones|mesh-ancestor
6589161|NCT01095809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6589162|NCT01095809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6589163|NCT01095809|Immunologic Factors|immunologic factors|mesh-ancestor
6589164|NCT01095809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6589165|NCT01095809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589166|NCT01095822|Valsartan|valsartan|mesh-list
6589167|NCT01095822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6589168|NCT01095822|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6589169|NCT01095822|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6589170|NCT01095822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589171|NCT01095900|Botulinum Toxins|botulinum toxins|mesh-list
6589172|NCT01095900|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6589173|NCT01095900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6589174|NCT01095900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589175|NCT01095900|Cholinergic Agents|cholinergic agents|mesh-ancestor
6589176|NCT01095900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6589177|NCT01095900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589178|NCT01095926|Doxorubicin|doxorubicin|mesh-list
6589179|NCT01095926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6589180|NCT01095926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6589181|NCT01095926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6589182|NCT01095926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6589183|NCT01095926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6589184|NCT01095926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589185|NCT01095939|Benazepril|benazepril|mesh-list
6589186|NCT01095939|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6589187|NCT01095939|Protease Inhibitors|protease inhibitors|mesh-ancestor
6589188|NCT01095939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6589189|NCT01095939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589190|NCT01095939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6589191|NCT01095991|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6589192|NCT01095991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6589193|NCT01095991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589194|NCT01095991|Incretins|incretins|mesh-ancestor
6589195|NCT01095991|Hormones|hormones|mesh-ancestor
6589196|NCT01095991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6589197|NCT01095991|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6447514|NCT00397735|Respiratory System Agents|respiratory system agents|mesh-ancestor
6447515|NCT00397735|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6447516|NCT00397735|Antioxidants|antioxidants|mesh-ancestor
6589198|NCT01095991|Protease Inhibitors|protease inhibitors|mesh-ancestor
6589199|NCT01095991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6589200|NCT01095991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589201|NCT01096082|Lithium Carbonate|lithium carbonate|mesh-list
6589202|NCT01096082|Antidepressive Agents|antidepressive agents|mesh-ancestor
6589203|NCT01096082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6589204|NCT01096082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6589205|NCT01096082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589206|NCT01096082|Antimanic Agents|antimanic agents|mesh-ancestor
6589207|NCT01096082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6589208|NCT01096082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6589209|NCT01096082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589210|NCT01096095|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
6589211|NCT01096095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6589212|NCT01096121|Enalapril|enalapril|mesh-list
6589213|NCT01096121|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6589214|NCT01096121|Protease Inhibitors|protease inhibitors|mesh-ancestor
6589215|NCT01096121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6589216|NCT01096121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589217|NCT01096121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6589218|NCT01096199|Cisplatin|cisplatin|mesh-list
6589219|NCT01096199|Everolimus|everolimus|mesh-list
6589220|NCT01096199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6589221|NCT01096199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5724824|NCT03185130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447517|NCT00397735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447518|NCT00397735|Protective Agents|protective agents|mesh-ancestor
6447519|NCT00397735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447520|NCT00397735|Antidotes|antidotes|mesh-ancestor
6447521|NCT00397761|Paclitaxel|paclitaxel|mesh-list
6447522|NCT00397761|Capecitabine|capecitabine|mesh-list
6447523|NCT00397761|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6447524|NCT00397761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6447525|NCT00397761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6589222|NCT01096199|Immunologic Factors|immunologic factors|mesh-ancestor
6589223|NCT01096199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589224|NCT01096212|Sevoflurane|sevoflurane|mesh-list
6589225|NCT01096212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6589226|NCT01096212|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6589227|NCT01096212|Anesthetics, General|anesthetics, general|mesh-ancestor
6589228|NCT01096212|Anesthetics|anesthetics|mesh-ancestor
6589229|NCT01096212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6589230|NCT01096212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589231|NCT01096225|Vaccines|vaccines|mesh-list
6589232|NCT01096225|Immunologic Factors|immunologic factors|mesh-ancestor
6589233|NCT01096225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589234|NCT01096277|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6589235|NCT01096277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6589236|NCT01096277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589237|NCT01096277|Incretins|incretins|mesh-ancestor
6589238|NCT01096277|Hormones|hormones|mesh-ancestor
6589239|NCT01096277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6589240|NCT01096277|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6589241|NCT01096277|Protease Inhibitors|protease inhibitors|mesh-ancestor
6589242|NCT01096277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6589243|NCT01096277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589244|NCT01096329|Methyltestosterone|methyltestosterone|mesh-list
6589245|NCT01096329|Testosterone|testosterone|mesh-list
6589246|NCT01096329|Testosterone undecanoate|testosterone undecanoate|mesh-list
6589247|NCT01096329|Testosterone enanthate|testosterone enanthate|mesh-list
6589248|NCT01096329|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6589249|NCT01096329|Androgens|androgens|mesh-ancestor
6589250|NCT01096329|Hormones|hormones|mesh-ancestor
6589251|NCT01096329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6589252|NCT01096329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589253|NCT01096329|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6589254|NCT01096329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6589255|NCT01096329|Anabolic Agents|anabolic agents|mesh-ancestor
6589256|NCT01096355|R04929097|r04929097|mesh-list
6589257|NCT01096355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6589258|NCT01096355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589259|NCT01096368|Cyclophosphamide|cyclophosphamide|mesh-list
6589260|NCT01096368|Cisplatin|cisplatin|mesh-list
6589261|NCT01096368|Carboplatin|carboplatin|mesh-list
6589262|NCT01096368|Etoposide|etoposide|mesh-list
6589263|NCT01096368|Vincristine|vincristine|mesh-list
6589264|NCT01096368|Etoposide phosphate|etoposide phosphate|mesh-list
6589265|NCT01096368|Podophyllotoxin|podophyllotoxin|mesh-list
6589266|NCT01096368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6589267|NCT01096368|Immunologic Factors|immunologic factors|mesh-ancestor
6589268|NCT01096368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589269|NCT01096368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6589270|NCT01096368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6589271|NCT01096368|Alkylating Agents|alkylating agents|mesh-ancestor
6589272|NCT01096368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589273|NCT01096368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6589274|NCT01096368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6589275|NCT01096368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6589276|NCT01096368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6589277|NCT01096368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6589278|NCT01096368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6589279|NCT01096368|Tubulin Modulators|tubulin modulators|mesh-ancestor
6589280|NCT01096368|Antimitotic Agents|antimitotic agents|mesh-ancestor
6589281|NCT01096368|Mitosis Modulators|mitosis modulators|mesh-ancestor
6589282|NCT01096368|Keratolytic Agents|keratolytic agents|mesh-ancestor
6589283|NCT01096368|Dermatologic Agents|dermatologic agents|mesh-ancestor
6589284|NCT01096420|Topiramate|topiramate|mesh-list
6589285|NCT01096420|Anticonvulsants|anticonvulsants|mesh-ancestor
6589286|NCT01096420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6589287|NCT01096420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589288|NCT01096485|Levonorgestrel|levonorgestrel|mesh-list
6589289|NCT01096485|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6589290|NCT01096485|Contraceptive Agents|contraceptive agents|mesh-ancestor
6589291|NCT01096485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6589292|NCT01096485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589293|NCT01096485|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6589294|NCT01096485|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6589295|NCT01096485|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6589296|NCT01096498|Levonorgestrel|levonorgestrel|mesh-list
6589297|NCT01096498|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6589298|NCT01096498|Contraceptive Agents|contraceptive agents|mesh-ancestor
6589299|NCT01096498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6589300|NCT01096498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589301|NCT01096498|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6589302|NCT01096498|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6589303|NCT01096498|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6659034|NCT01485744|Irinotecan|irinotecan|mesh-list
6659035|NCT01485744|Folfirinox|folfirinox|mesh-list
6659036|NCT01485744|Antimetabolites|antimetabolites|mesh-ancestor
6659037|NCT01485744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6659038|NCT01485744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6659039|NCT01485744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6659040|NCT01485744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6659041|NCT01485744|Immunologic Factors|immunologic factors|mesh-ancestor
6659042|NCT01485744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659043|NCT01485744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6659044|NCT01485744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6659045|NCT01485744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6659046|NCT01485744|Antidotes|antidotes|mesh-ancestor
6659047|NCT01485744|Protective Agents|protective agents|mesh-ancestor
6659048|NCT01485744|Vitamin B Complex|vitamin b complex|mesh-ancestor
6659049|NCT01485744|Vitamins|vitamins|mesh-ancestor
6659050|NCT01485744|Micronutrients|micronutrients|mesh-ancestor
6659051|NCT01485809|Gefitinib|gefitinib|mesh-list
6659052|NCT01485809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6659053|NCT01485809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6659054|NCT01485809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6659055|NCT01485809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447526|NCT00397761|Tubulin Modulators|tubulin modulators|mesh-ancestor
6447527|NCT00397761|Antimitotic Agents|antimitotic agents|mesh-ancestor
6447528|NCT00397761|Mitosis Modulators|mitosis modulators|mesh-ancestor
6447529|NCT00397761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447530|NCT00397761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6447531|NCT00397761|Antimetabolites|antimetabolites|mesh-ancestor
6447532|NCT00397787|Sunitinib|sunitinib|mesh-list
6447533|NCT00397787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6447534|NCT00397787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6447535|NCT00397787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6447536|NCT00397787|Growth Substances|growth substances|mesh-ancestor
6447537|NCT00397787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659056|NCT01485822|Travoprost|travoprost|mesh-list
6659057|NCT01485822|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6659058|NCT01485822|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6659059|NCT01485822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6447538|NCT00397787|Growth Inhibitors|growth inhibitors|mesh-ancestor
6659060|NCT01485835|Dexamethasone|dexamethasone|mesh-list
6589304|NCT01096511|Moxifloxacin|moxifloxacin|mesh-list
6589305|NCT01096511|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6589306|NCT01096511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6589307|NCT01096511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6589308|NCT01096511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6589309|NCT01096511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6589310|NCT01096511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6589311|NCT01096511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589312|NCT01096511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6589313|NCT01096511|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6589314|NCT01096511|Contraceptive Agents|contraceptive agents|mesh-ancestor
6589315|NCT01096511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6589316|NCT01096511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589317|NCT01096511|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6589318|NCT01096511|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6589319|NCT01096511|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6589320|NCT01096654|Epinephrine|epinephrine|mesh-list
6589321|NCT01096654|Racepinephrine|racepinephrine|mesh-list
6589322|NCT01096654|Epinephryl borate|epinephryl borate|mesh-list
6589323|NCT01096654|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6589324|NCT01096654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6589325|NCT01096654|Adrenergic Agents|adrenergic agents|mesh-ancestor
6589326|NCT01096654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6589327|NCT01096654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589328|NCT01096654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589329|NCT01096654|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6589330|NCT01096654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6589331|NCT01096654|Autonomic Agents|autonomic agents|mesh-ancestor
6589332|NCT01096654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6589333|NCT01096654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6589334|NCT01096654|Respiratory System Agents|respiratory system agents|mesh-ancestor
6589335|NCT01096654|Mydriatics|mydriatics|mesh-ancestor
6589336|NCT01096654|Sympathomimetics|sympathomimetics|mesh-ancestor
6589337|NCT01096654|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6589338|NCT01096693|Substance P|substance p|mesh-list
6589339|NCT01096693|Neurokinin A|neurokinin a|mesh-list
6589340|NCT01096693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6589341|NCT01096693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589342|NCT01096693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589343|NCT01096706|Aspirin|aspirin|mesh-list
6589344|NCT01096706|Fluconazole|fluconazole|mesh-list
6589345|NCT01096706|Substance P|substance p|mesh-list
6589346|NCT01096706|Neurokinin A|neurokinin a|mesh-list
6589347|NCT01096706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6589348|NCT01096706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6589349|NCT01096706|Analgesics|analgesics|mesh-ancestor
6589350|NCT01096706|Sensory System Agents|sensory system agents|mesh-ancestor
6589351|NCT01096706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6589352|NCT01096706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589353|NCT01096706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6589354|NCT01096706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6589355|NCT01096706|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6589356|NCT01096706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6589357|NCT01096706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589358|NCT01096706|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6589359|NCT01096706|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6589360|NCT01096706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6589361|NCT01096706|Antipyretics|antipyretics|mesh-ancestor
6589362|NCT01096706|Antifungal Agents|antifungal agents|mesh-ancestor
6589363|NCT01096706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6589364|NCT01096706|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6589365|NCT01096706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6589366|NCT01096706|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6589367|NCT01096706|Hormone Antagonists|hormone antagonists|mesh-ancestor
6589368|NCT01096706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6589369|NCT01096706|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6589370|NCT01096706|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6589371|NCT01096706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6589372|NCT01096745|Gemcitabine|gemcitabine|mesh-list
6589373|NCT01096745|Cisplatin|cisplatin|mesh-list
6589374|NCT01096745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6589375|NCT01096745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6589376|NCT01096745|Antimetabolites|antimetabolites|mesh-ancestor
6659061|NCT01485835|Bortezomib|bortezomib|mesh-list
6589377|NCT01096745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589378|NCT01096745|Antiviral Agents|antiviral agents|mesh-ancestor
6589379|NCT01096745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6589380|NCT01096745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6589381|NCT01096745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6589382|NCT01096745|Immunologic Factors|immunologic factors|mesh-ancestor
6589383|NCT01096745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589384|NCT01096797|Sevoflurane|sevoflurane|mesh-list
6020355|NCT00392782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020356|NCT00392782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6020357|NCT00392782|Immunologic Factors|immunologic factors|mesh-ancestor
6589385|NCT01096797|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6589386|NCT01096797|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6589387|NCT01096797|Anesthetics, General|anesthetics, general|mesh-ancestor
6589388|NCT01096797|Anesthetics|anesthetics|mesh-ancestor
6589389|NCT01096797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6589390|NCT01096797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589391|NCT01096927|Amoxicillin|amoxicillin|mesh-list
6589392|NCT01096927|Clavulanic Acids|clavulanic acids|mesh-list
6589393|NCT01096927|Clavulanic Acid|clavulanic acid|mesh-list
6589394|NCT01096927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6589395|NCT01096927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6589396|NCT01096927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6589397|NCT01096927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589398|NCT01096927|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6589399|NCT01096940|Simvastatin|simvastatin|mesh-list
6589400|NCT01096940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6589401|NCT01096940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6589402|NCT01096940|Antimetabolites|antimetabolites|mesh-ancestor
6589403|NCT01096940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589404|NCT01096940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6589405|NCT01096940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6589406|NCT01096940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6589407|NCT01097148|Atracurium|atracurium|mesh-list
6589408|NCT01097148|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6589409|NCT01097148|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6589410|NCT01097148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6589411|NCT01097148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6589412|NCT01097148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589413|NCT01097148|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
6589414|NCT01097148|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6589415|NCT01097148|Cholinergic Agents|cholinergic agents|mesh-ancestor
6589416|NCT01097148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6589417|NCT01097148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589418|NCT01097213|Ethanol|ethanol|mesh-list
6589419|NCT01097213|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6589420|NCT01097213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6589421|NCT01097213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6589422|NCT01097213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589423|NCT01097252|Cisplatin|cisplatin|mesh-list
6589424|NCT01097252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6589425|NCT01097265|Capecitabine|capecitabine|mesh-list
6589426|NCT01097265|Oxaliplatin|oxaliplatin|mesh-list
6589427|NCT01097265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6589428|NCT01097265|Antimetabolites|antimetabolites|mesh-ancestor
6589429|NCT01097265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589430|NCT01097265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6589431|NCT01097278|Cholecalciferol|cholecalciferol|mesh-list
6589432|NCT01097278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6589433|NCT01097278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589434|NCT01097278|Vitamins|vitamins|mesh-ancestor
6589435|NCT01097278|Micronutrients|micronutrients|mesh-ancestor
6589436|NCT01097278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6589437|NCT01097317|Carboplatin|carboplatin|mesh-list
6589438|NCT01097317|Vinorelbine|vinorelbine|mesh-list
6589439|NCT01097317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6589440|NCT01097317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6589441|NCT01097317|Tubulin Modulators|tubulin modulators|mesh-ancestor
6589442|NCT01097317|Antimitotic Agents|antimitotic agents|mesh-ancestor
6589443|NCT01097317|Mitosis Modulators|mitosis modulators|mesh-ancestor
6589444|NCT01097317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589445|NCT01097382|Zolpidem|zolpidem|mesh-list
6589446|NCT01097382|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6589447|NCT01097382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6589448|NCT01097382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6589449|NCT01097382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589450|NCT01097382|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6589451|NCT01097382|GABA Agonists|gaba agonists|mesh-ancestor
6589452|NCT01097382|GABA Agents|gaba agents|mesh-ancestor
6589453|NCT01097382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6589454|NCT01097382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589455|NCT01097512|Gemcitabine|gemcitabine|mesh-list
6589456|NCT01097512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6589457|NCT01097512|Antimetabolites|antimetabolites|mesh-ancestor
6589458|NCT01097512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589459|NCT01097512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6589460|NCT01097512|Antiviral Agents|antiviral agents|mesh-ancestor
6589461|NCT01097512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6589462|NCT01097512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6589463|NCT01097512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6589464|NCT01097512|Immunologic Factors|immunologic factors|mesh-ancestor
6447539|NCT00397787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6447540|NCT00397787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6447541|NCT00397787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447542|NCT00397800|Cyclophosphamide|cyclophosphamide|mesh-list
6447543|NCT00397800|Rituximab|rituximab|mesh-list
6447544|NCT00397800|Fludarabine|fludarabine|mesh-list
6447545|NCT00397800|Fludarabine phosphate|fludarabine phosphate|mesh-list
6447546|NCT00397800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6447547|NCT00397800|Immunologic Factors|immunologic factors|mesh-ancestor
6447548|NCT00397800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447549|NCT00397800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6447550|NCT00397800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6447551|NCT00397800|Alkylating Agents|alkylating agents|mesh-ancestor
6447552|NCT00397800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447553|NCT00397800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6447554|NCT00397800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6447555|NCT00397800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6447556|NCT00397800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6447557|NCT00397800|Antimetabolites|antimetabolites|mesh-ancestor
6589465|NCT01097512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589466|NCT01097551|Phenylephrine|phenylephrine|mesh-list
6589467|NCT01097551|Acetylcholine|acetylcholine|mesh-list
6589468|NCT01097551|Nitroglycerin|nitroglycerin|mesh-list
6589469|NCT01097551|Vasodilator Agents|vasodilator agents|mesh-ancestor
6589470|NCT01097551|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6589471|NCT01097551|Cholinergic Agents|cholinergic agents|mesh-ancestor
6589472|NCT01097551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6589473|NCT01097551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589474|NCT01097551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589475|NCT01097551|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6589476|NCT01097551|Mydriatics|mydriatics|mesh-ancestor
6589477|NCT01097551|Autonomic Agents|autonomic agents|mesh-ancestor
6589478|NCT01097551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6589479|NCT01097551|Sympathomimetics|sympathomimetics|mesh-ancestor
5501614|NCT04472689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501615|NCT04472611|Colchicine|colchicine|mesh-list
5501616|NCT04472611|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5501617|NCT04472611|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5501618|NCT04472611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5501619|NCT04472611|Antimetabolites|antimetabolites|mesh-ancestor
5501620|NCT04472611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501621|NCT04472611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5501622|NCT04472611|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5501623|NCT04472611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5501624|NCT04472611|Gout Suppressants|gout suppressants|mesh-ancestor
5501625|NCT04472611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5501626|NCT04472611|Tubulin Modulators|tubulin modulators|mesh-ancestor
5724825|NCT03185130|Anesthetics, Local|anesthetics, local|mesh-ancestor
5724826|NCT03185130|Anesthetics|anesthetics|mesh-ancestor
6447558|NCT00397826|Simvastatin|simvastatin|mesh-list
6447559|NCT00397826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6589480|NCT01097551|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6589481|NCT01097551|Nasal Decongestants|nasal decongestants|mesh-ancestor
6589482|NCT01097551|Respiratory System Agents|respiratory system agents|mesh-ancestor
6447560|NCT00397826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6447561|NCT00397826|Antimetabolites|antimetabolites|mesh-ancestor
6447562|NCT00397826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447563|NCT00397826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6447564|NCT00397826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6447565|NCT00397826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6447566|NCT00397917|Folic Acid|folic acid|mesh-list
6447567|NCT00397917|Hematinics|hematinics|mesh-ancestor
6447568|NCT00397917|Vitamin B Complex|vitamin b complex|mesh-ancestor
6447569|NCT00397917|Vitamins|vitamins|mesh-ancestor
6447570|NCT00397917|Micronutrients|micronutrients|mesh-ancestor
6447571|NCT00397917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447572|NCT00397956|Ertapenem|ertapenem|mesh-list
6447573|NCT00397956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6447574|NCT00397956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6447575|NCT00398008|Naltrexone|naltrexone|mesh-list
6447576|NCT00398008|Buprenorphine|buprenorphine|mesh-list
6447577|NCT00398008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5501627|NCT04472611|Antimitotic Agents|antimitotic agents|mesh-ancestor
5501628|NCT04472611|Mitosis Modulators|mitosis modulators|mesh-ancestor
5501629|NCT04472611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6447578|NCT00398008|Narcotics|narcotics|mesh-ancestor
6447579|NCT00398008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6461809|NCT00456313|Fluticasone|fluticasone|mesh-list
6589483|NCT01097551|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6020358|NCT00392782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020359|NCT00392782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6020360|NCT00392782|Alkylating Agents|alkylating agents|mesh-ancestor
6020361|NCT00392782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6020362|NCT00392821|Everolimus|everolimus|mesh-list
6020363|NCT00392821|Sorafenib|sorafenib|mesh-list
6020364|NCT00392821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6020365|NCT00392821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6020366|NCT00392821|Immunologic Factors|immunologic factors|mesh-ancestor
6020367|NCT00392821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020368|NCT00392821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6020369|NCT00392821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6589484|NCT01097551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6589485|NCT01097551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6589486|NCT01097551|Adrenergic Agents|adrenergic agents|mesh-ancestor
6589487|NCT01097551|Protective Agents|protective agents|mesh-ancestor
6589488|NCT01097681|Ipragliflozin|ipragliflozin|mesh-list
6589489|NCT01097681|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6589490|NCT01097681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589491|NCT01097681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6589492|NCT01097681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589493|NCT01097811|Erythromycin|erythromycin|mesh-list
6589494|NCT01097811|Erythromycin Estolate|erythromycin estolate|mesh-list
6589495|NCT01097811|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
6589496|NCT01097811|Erythromycin stearate|erythromycin stearate|mesh-list
6589497|NCT01097811|Neomycin|neomycin|mesh-list
6589498|NCT01097811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6589499|NCT01097811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6589500|NCT01097811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6589501|NCT01097811|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6589502|NCT01097811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6589503|NCT01097811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589504|NCT01097902|Ibuprofen|ibuprofen|mesh-list
6589505|NCT01097902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6589506|NCT01097902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6589507|NCT01097902|Analgesics|analgesics|mesh-ancestor
6589508|NCT01097902|Sensory System Agents|sensory system agents|mesh-ancestor
6589509|NCT01097902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6589510|NCT01097902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589511|NCT01097902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6589512|NCT01097902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6589513|NCT01097902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6589514|NCT01097902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6589515|NCT01097902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589516|NCT01097941|Vaccines|vaccines|mesh-list
6589517|NCT01097941|Immunoglobulins|immunoglobulins|mesh-list
6589518|NCT01097941|Immunologic Factors|immunologic factors|mesh-ancestor
6589519|NCT01097941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589520|NCT01097980|Trazodone|trazodone|mesh-list
6589521|NCT01097980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6589522|NCT01097980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6589523|NCT01097980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6020370|NCT00392821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589524|NCT01097980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589525|NCT01097980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6589526|NCT01097980|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6589527|NCT01097980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6589528|NCT01097980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6589529|NCT01097980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501630|NCT04472481|Ergocalciferols|ergocalciferols|mesh-list
6447580|NCT00398008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447581|NCT00398008|Analgesics|analgesics|mesh-ancestor
6447582|NCT00398008|Sensory System Agents|sensory system agents|mesh-ancestor
6447583|NCT00398008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6447584|NCT00398008|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6447585|NCT00398008|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6447586|NCT00398034|Testosterone|testosterone|mesh-list
6589530|NCT01097980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6589531|NCT01097980|Serotonin Agents|serotonin agents|mesh-ancestor
6589532|NCT01097980|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6589533|NCT01097980|Antidepressive Agents|antidepressive agents|mesh-ancestor
6589534|NCT01098019|Botulinum Toxins|botulinum toxins|mesh-list
6589535|NCT01098019|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6589536|NCT01098019|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
6589537|NCT01098019|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6589538|NCT01098019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6589539|NCT01098019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589540|NCT01098019|Cholinergic Agents|cholinergic agents|mesh-ancestor
6589541|NCT01098019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6589542|NCT01098019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589543|NCT01098019|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6589544|NCT01098019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6589545|NCT01098084|Decitabine|decitabine|mesh-list
6589546|NCT01098084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6589547|NCT01098084|Antimetabolites|antimetabolites|mesh-ancestor
6589548|NCT01098084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589549|NCT01098084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6589550|NCT01098084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6589551|NCT01098201|Certolizumab Pegol|certolizumab pegol|mesh-list
6589552|NCT01098201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6589553|NCT01098201|Immunologic Factors|immunologic factors|mesh-ancestor
6589554|NCT01098201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589555|NCT01098201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6447587|NCT00398034|Androgens|androgens|mesh-ancestor
6447588|NCT00398034|Hormones|hormones|mesh-ancestor
6462218|NCT00458185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6589556|NCT01098344|Gemcitabine|gemcitabine|mesh-list
6589557|NCT01098344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6589558|NCT01098344|Antimetabolites|antimetabolites|mesh-ancestor
6589559|NCT01098344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589560|NCT01098344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6589561|NCT01098344|Antiviral Agents|antiviral agents|mesh-ancestor
6589562|NCT01098344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6589563|NCT01098344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6589564|NCT01098344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6589565|NCT01098344|Immunologic Factors|immunologic factors|mesh-ancestor
6589566|NCT01098344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589567|NCT01098357|Becaplermin|becaplermin|mesh-list
6589568|NCT01098357|Anticoagulants|anticoagulants|mesh-ancestor
6589569|NCT01098357|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
6589570|NCT01098357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6589571|NCT01098357|Growth Substances|growth substances|mesh-ancestor
6589572|NCT01098357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589573|NCT01098383|Acetylcholine|acetylcholine|mesh-list
6589574|NCT01098383|Donepezil|donepezil|mesh-list
6589575|NCT01098383|Choline|choline|mesh-list
6589576|NCT01098383|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6589577|NCT01098383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6589578|NCT01098383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589579|NCT01098383|Cholinergic Agents|cholinergic agents|mesh-ancestor
6589580|NCT01098383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6589581|NCT01098383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589582|NCT01098383|Nootropic Agents|nootropic agents|mesh-ancestor
6589583|NCT01098383|Lipotropic Agents|lipotropic agents|mesh-ancestor
6589584|NCT01098383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6589585|NCT01098383|Antimetabolites|antimetabolites|mesh-ancestor
6589586|NCT01098383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6589587|NCT01098383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6589588|NCT01098383|Vasodilator Agents|vasodilator agents|mesh-ancestor
6589589|NCT01098383|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6589590|NCT01098448|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6589591|NCT01098448|Amoxicillin|amoxicillin|mesh-list
6589592|NCT01098448|Metronidazole|metronidazole|mesh-list
6589593|NCT01098448|Tetracycline|tetracycline|mesh-list
6589594|NCT01098448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6589595|NCT01098448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6589596|NCT01098448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6589597|NCT01098448|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6589598|NCT01098448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6589599|NCT01098448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589600|NCT01098513|Dolutegravir|dolutegravir|mesh-list
6589601|NCT01098513|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6589602|NCT01098513|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6589603|NCT01098513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6589604|NCT01098513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589605|NCT01098513|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6589606|NCT01098513|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6589607|NCT01098513|Antiviral Agents|antiviral agents|mesh-ancestor
5501631|NCT04472481|Vitamin D|vitamin d|mesh-list
6589608|NCT01098513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6589609|NCT01098526|Efavirenz|efavirenz|mesh-list
6589610|NCT01098526|Dolutegravir|dolutegravir|mesh-list
6589611|NCT01098526|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6589612|NCT01098526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6589613|NCT01098526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6589614|NCT01098526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589615|NCT01098526|Antiviral Agents|antiviral agents|mesh-ancestor
6589616|NCT01098526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6589617|NCT01098526|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6589618|NCT01098526|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6589619|NCT01098526|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6589620|NCT01098526|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6589621|NCT01098526|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6589622|NCT01098526|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6589623|NCT01098526|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6589624|NCT01098526|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6589625|NCT01098526|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6589626|NCT01098526|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6659062|NCT01485835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6659063|NCT01485835|Antiemetics|antiemetics|mesh-ancestor
6659064|NCT01485835|Autonomic Agents|autonomic agents|mesh-ancestor
6659065|NCT01485835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6659066|NCT01485835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659067|NCT01485835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6659068|NCT01485835|Glucocorticoids|glucocorticoids|mesh-ancestor
6659069|NCT01485835|Hormones|hormones|mesh-ancestor
6659070|NCT01485835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6659071|NCT01485835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6659072|NCT01485835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6659073|NCT01485848|Paclitaxel|paclitaxel|mesh-list
6659074|NCT01485848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6589627|NCT01098656|Lenalidomide|lenalidomide|mesh-list
6589628|NCT01098656|Immunologic Factors|immunologic factors|mesh-ancestor
6589629|NCT01098656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589630|NCT01098656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6589631|NCT01098656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6589632|NCT01098656|Growth Substances|growth substances|mesh-ancestor
6589633|NCT01098656|Growth Inhibitors|growth inhibitors|mesh-ancestor
6589634|NCT01098656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6589635|NCT01098760|Sorafenib|sorafenib|mesh-list
6589636|NCT01098760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6589637|NCT01098760|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6589638|NCT01098760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6589639|NCT01098760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589640|NCT01098890|Plasminogen|plasminogen|mesh-list
6589641|NCT01098890|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6589642|NCT01098890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6589643|NCT01098890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6589644|NCT01098890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589645|NCT01098955|Varenicline|varenicline|mesh-list
6589646|NCT01098955|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6589647|NCT01098955|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6589648|NCT01098955|Cholinergic Agents|cholinergic agents|mesh-ancestor
6589649|NCT01098955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6589650|NCT01098955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589651|NCT01098955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589652|NCT01098994|Vitamin E|vitamin e|mesh-list
6589653|NCT01098994|Tocopherols|tocopherols|mesh-list
6589654|NCT01098994|alpha-Tocopherol|alpha-tocopherol|mesh-list
6589655|NCT01098994|Vitamins|vitamins|mesh-ancestor
6589656|NCT01098994|Micronutrients|micronutrients|mesh-ancestor
6589657|NCT01098994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589658|NCT01098994|Antioxidants|antioxidants|mesh-ancestor
6589659|NCT01098994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589660|NCT01098994|Protective Agents|protective agents|mesh-ancestor
6589661|NCT01099059|Amantadine|amantadine|mesh-list
6589662|NCT01099059|Methylphenidate|methylphenidate|mesh-list
6589663|NCT01099059|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6589664|NCT01099059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589665|NCT01099059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6589666|NCT01099059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6589667|NCT01099059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6589668|NCT01099059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589669|NCT01099059|Dopamine Agents|dopamine agents|mesh-ancestor
6589670|NCT01099059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6589671|NCT01099059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6589672|NCT01099059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6589673|NCT01099059|Antiviral Agents|antiviral agents|mesh-ancestor
6589674|NCT01099059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6589675|NCT01099059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6589676|NCT01099059|Analgesics|analgesics|mesh-ancestor
6589677|NCT01099059|Sensory System Agents|sensory system agents|mesh-ancestor
6589678|NCT01099059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6589679|NCT01099072|Methylphenidate|methylphenidate|mesh-list
6589680|NCT01099072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6589681|NCT01099072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589682|NCT01099072|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6589683|NCT01099072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6589684|NCT01099072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6589685|NCT01099072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589686|NCT01099072|Dopamine Agents|dopamine agents|mesh-ancestor
6589687|NCT01099072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6589688|NCT01099085|Simvastatin|simvastatin|mesh-list
6589689|NCT01099085|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6589690|NCT01099085|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6589691|NCT01099085|Antimetabolites|antimetabolites|mesh-ancestor
6589692|NCT01099085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589693|NCT01099085|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6589694|NCT01099085|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6589695|NCT01099085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6589696|NCT01099137|Vildagliptin|vildagliptin|mesh-list
6589697|NCT01099137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6589698|NCT01099137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589699|NCT01099137|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6589700|NCT01099137|Protease Inhibitors|protease inhibitors|mesh-ancestor
6589701|NCT01099137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6589702|NCT01099137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589703|NCT01099150|Proanthocyanidin|proanthocyanidin|mesh-list
6589704|NCT01099150|Procyanidin|procyanidin|mesh-list
6589705|NCT01099150|Antioxidants|antioxidants|mesh-ancestor
6589706|NCT01099150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589707|NCT01099150|Protective Agents|protective agents|mesh-ancestor
6589708|NCT01099150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589709|NCT01099150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6589710|NCT01099150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6589711|NCT01099150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6589712|NCT01099228|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
6589713|NCT01099228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6589714|NCT01099228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6589715|NCT01099228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589716|NCT01099228|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6589717|NCT01099436|Zoledronic Acid|zoledronic acid|mesh-list
6589718|NCT01099436|Cyclophosphamide|cyclophosphamide|mesh-list
6589719|NCT01099436|Docetaxel|docetaxel|mesh-list
6589720|NCT01099436|Doxorubicin|doxorubicin|mesh-list
6589721|NCT01099436|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6589722|NCT01099436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6589723|NCT01099436|Immunologic Factors|immunologic factors|mesh-ancestor
6589724|NCT01099436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589725|NCT01099436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6589726|NCT01099436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6589727|NCT01099436|Alkylating Agents|alkylating agents|mesh-ancestor
6589728|NCT01099436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589729|NCT01099436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6589730|NCT01099436|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6589731|NCT01099436|Tubulin Modulators|tubulin modulators|mesh-ancestor
6589732|NCT01099436|Antimitotic Agents|antimitotic agents|mesh-ancestor
6589733|NCT01099436|Mitosis Modulators|mitosis modulators|mesh-ancestor
6589734|NCT01099436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6589735|NCT01099436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6589736|NCT01099436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6589737|NCT01099436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6589738|NCT01099436|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6589739|NCT01099462|Ibuprofen|ibuprofen|mesh-list
6589740|NCT01099462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6589741|NCT01099462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6589742|NCT01099462|Analgesics|analgesics|mesh-ancestor
6589743|NCT01099462|Sensory System Agents|sensory system agents|mesh-ancestor
6589744|NCT01099462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6589745|NCT01099462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589746|NCT01099462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6589747|NCT01099462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6589748|NCT01099462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6589749|NCT01099462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6589750|NCT01099462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589751|NCT01099527|Capecitabine|capecitabine|mesh-list
6589752|NCT01099527|Everolimus|everolimus|mesh-list
6589753|NCT01099527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6589754|NCT01099527|Antimetabolites|antimetabolites|mesh-ancestor
6589755|NCT01099527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589756|NCT01099527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6589757|NCT01099527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6589758|NCT01099527|Immunologic Factors|immunologic factors|mesh-ancestor
6589759|NCT01099527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589760|NCT01099566|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6589761|NCT01099566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6589762|NCT01099592|Citalopram|citalopram|mesh-list
6589763|NCT01099592|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6589764|NCT01099592|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6589765|NCT01099592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6589766|NCT01099592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589767|NCT01099592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6589768|NCT01099592|Serotonin Agents|serotonin agents|mesh-ancestor
6589769|NCT01099592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589770|NCT01099592|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6589771|NCT01099592|Antidepressive Agents|antidepressive agents|mesh-ancestor
6589772|NCT01099592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6589773|NCT01099605|Bupivacaine|bupivacaine|mesh-list
6589774|NCT01099605|Anesthetics, Local|anesthetics, local|mesh-ancestor
6589775|NCT01099605|Anesthetics|anesthetics|mesh-ancestor
6589776|NCT01099605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6589777|NCT01099605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589778|NCT01099605|Sensory System Agents|sensory system agents|mesh-ancestor
6589779|NCT01099605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6589780|NCT01099722|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6589781|NCT01099722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6589782|NCT01099722|Respiratory System Agents|respiratory system agents|mesh-ancestor
6589783|NCT01099748|Methadone|methadone|mesh-list
6589784|NCT01099748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6589785|NCT01099748|Narcotics|narcotics|mesh-ancestor
6589786|NCT01099748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6589787|NCT01099748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589788|NCT01099748|Analgesics|analgesics|mesh-ancestor
6589789|NCT01099748|Sensory System Agents|sensory system agents|mesh-ancestor
6589790|NCT01099748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6589791|NCT01099748|Antitussive Agents|antitussive agents|mesh-ancestor
6589792|NCT01099748|Respiratory System Agents|respiratory system agents|mesh-ancestor
6589793|NCT01099839|Ipragliflozin|ipragliflozin|mesh-list
6589794|NCT01099839|Miglitol|miglitol|mesh-list
6589795|NCT01099839|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6589796|NCT01099839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589797|NCT01099839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6589798|NCT01099839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589799|NCT01099839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6589800|NCT01099839|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6589801|NCT01100021|Doxazosin|doxazosin|mesh-list
6589802|NCT01100021|Tamsulosin|tamsulosin|mesh-list
6589803|NCT01100021|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6589804|NCT01100021|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6589805|NCT01100021|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6589806|NCT01100021|Adrenergic Agents|adrenergic agents|mesh-ancestor
6589807|NCT01100021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6589808|NCT01100021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589809|NCT01100021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589810|NCT01100021|Urological Agents|urological agents|mesh-ancestor
6589811|NCT01100021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6589812|NCT01100060|Azithromycin|azithromycin|mesh-list
6589813|NCT01100060|Chloroquine|chloroquine|mesh-list
6589814|NCT01100060|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
6589815|NCT01100060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6589816|NCT01100060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6589817|NCT01100060|Amebicides|amebicides|mesh-ancestor
6589818|NCT01100060|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6589819|NCT01100060|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6589820|NCT01100060|Antimalarials|antimalarials|mesh-ancestor
6589821|NCT01100060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6589822|NCT01100060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6589823|NCT01100060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6589824|NCT01100060|Analgesics|analgesics|mesh-ancestor
6589825|NCT01100060|Sensory System Agents|sensory system agents|mesh-ancestor
6589826|NCT01100060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6589827|NCT01100060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589828|NCT01100060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6589829|NCT01100060|Filaricides|filaricides|mesh-ancestor
6589830|NCT01100060|Antinematodal Agents|antinematodal agents|mesh-ancestor
6589831|NCT01100060|Anthelmintics|anthelmintics|mesh-ancestor
6589832|NCT01100125|Insulin|insulin|mesh-list
6589833|NCT01100125|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6589834|NCT01100125|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6589835|NCT01100125|Insulin, Long-Acting|insulin, long-acting|mesh-list
6589836|NCT01100125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6589837|NCT01100125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589838|NCT01100125|Incretins|incretins|mesh-ancestor
6589839|NCT01100125|Hormones|hormones|mesh-ancestor
6589840|NCT01100125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6589841|NCT01100125|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6589842|NCT01100125|Protease Inhibitors|protease inhibitors|mesh-ancestor
6589843|NCT01100125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6589844|NCT01100125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589845|NCT01100164|Eszopiclone|eszopiclone|mesh-list
6589846|NCT01100164|Zopiclone|zopiclone|mesh-list
6589847|NCT01100164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6589848|NCT01100164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6589849|NCT01100164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589850|NCT01100177|Sunitinib|sunitinib|mesh-list
6589851|NCT01100177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6589852|NCT01100177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6589853|NCT01100177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6589854|NCT01100177|Growth Substances|growth substances|mesh-ancestor
6589855|NCT01100177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589856|NCT01100177|Growth Inhibitors|growth inhibitors|mesh-ancestor
6589857|NCT01100177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6589858|NCT01100177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6589859|NCT01100177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589860|NCT01100203|Eplerenone|eplerenone|mesh-list
6589861|NCT01100203|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6589862|NCT01100203|Hormone Antagonists|hormone antagonists|mesh-ancestor
6589863|NCT01100203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6589864|NCT01100203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589865|NCT01100203|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6589866|NCT01100203|Diuretics|diuretics|mesh-ancestor
6589867|NCT01100203|Natriuretic Agents|natriuretic agents|mesh-ancestor
6589868|NCT01100203|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6589869|NCT01100216|Nicotine|nicotine|mesh-list
6589870|NCT01100216|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6589871|NCT01100216|Autonomic Agents|autonomic agents|mesh-ancestor
6589872|NCT01100216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6589873|NCT01100216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589874|NCT01100216|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6589875|NCT01100216|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6589876|NCT01100216|Cholinergic Agents|cholinergic agents|mesh-ancestor
6589877|NCT01100216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6589878|NCT01100216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6659075|NCT01485848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6659076|NCT01485848|Tubulin Modulators|tubulin modulators|mesh-ancestor
6659077|NCT01485848|Antimitotic Agents|antimitotic agents|mesh-ancestor
6659078|NCT01485848|Mitosis Modulators|mitosis modulators|mesh-ancestor
6659079|NCT01485848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6659080|NCT01485926|Carboplatin|carboplatin|mesh-list
6659081|NCT01485926|Docetaxel|docetaxel|mesh-list
6589879|NCT01100294|Vaccines|vaccines|mesh-list
6589880|NCT01100294|Immunologic Factors|immunologic factors|mesh-ancestor
6589881|NCT01100294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589882|NCT01100333|Hormones|hormones|mesh-list
6589883|NCT01100333|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6589884|NCT01100333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6589885|NCT01100333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589886|NCT01100346|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6589887|NCT01100346|Hormones|hormones|mesh-ancestor
6589888|NCT01100346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6589889|NCT01100346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589890|NCT01100359|Carboplatin|carboplatin|mesh-list
6589891|NCT01100359|Doxorubicin|doxorubicin|mesh-list
6589892|NCT01100359|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6589893|NCT01100359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6589894|NCT01100359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6589895|NCT01100359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6589896|NCT01100359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6589897|NCT01100359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6589898|NCT01100359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589899|NCT01100372|Gemcitabine|gemcitabine|mesh-list
6589900|NCT01100372|Doxorubicin|doxorubicin|mesh-list
6589901|NCT01100372|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6589902|NCT01100372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6589903|NCT01100372|Antimetabolites|antimetabolites|mesh-ancestor
6589904|NCT01100372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589905|NCT01100372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6589906|NCT01100372|Antiviral Agents|antiviral agents|mesh-ancestor
6589907|NCT01100372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6589908|NCT01100372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6589909|NCT01100372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6589910|NCT01100372|Immunologic Factors|immunologic factors|mesh-ancestor
6589911|NCT01100372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589912|NCT01100372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6589913|NCT01100372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6589914|NCT01100372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6589915|NCT01100619|Rosiglitazone|rosiglitazone|mesh-list
6589916|NCT01100619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6589917|NCT01100619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589918|NCT01100736|Bosentan|bosentan|mesh-list
6589919|NCT01100736|Sitaxsentan|sitaxsentan|mesh-list
6589920|NCT01100736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6589921|NCT01100736|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6589922|NCT01100736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589923|NCT01100775|Galantamine|galantamine|mesh-list
6589924|NCT01100775|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6589925|NCT01100775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6589926|NCT01100775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589927|NCT01100775|Cholinergic Agents|cholinergic agents|mesh-ancestor
6589928|NCT01100775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6589929|NCT01100775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589930|NCT01100775|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6589931|NCT01100775|Autonomic Agents|autonomic agents|mesh-ancestor
6589932|NCT01100775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6589933|NCT01100775|Nootropic Agents|nootropic agents|mesh-ancestor
6589934|NCT01100801|Cisplatin|cisplatin|mesh-list
6589935|NCT01100801|Oxaliplatin|oxaliplatin|mesh-list
6589936|NCT01100801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6589937|NCT01100892|Insulin Detemir|insulin detemir|mesh-list
6589938|NCT01100892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6589939|NCT01100892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589940|NCT01101009|Amlodipine|amlodipine|mesh-list
6589941|NCT01101009|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6589942|NCT01101009|Olmesartan|olmesartan|mesh-list
6589943|NCT01101009|Perindopril|perindopril|mesh-list
6589944|NCT01101009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6589945|NCT01101009|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6589946|NCT01101009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6589947|NCT01101009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589948|NCT01101009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6589949|NCT01101009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589950|NCT01101009|Vasodilator Agents|vasodilator agents|mesh-ancestor
6589951|NCT01101009|Diuretics|diuretics|mesh-ancestor
6589952|NCT01101009|Natriuretic Agents|natriuretic agents|mesh-ancestor
6589953|NCT01101009|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6589954|NCT01101009|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6589955|NCT01101009|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6589956|NCT01101009|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6589957|NCT01101009|Protease Inhibitors|protease inhibitors|mesh-ancestor
6589958|NCT01101009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6589959|NCT01101113|Cinacalcet|cinacalcet|mesh-list
6589960|NCT01101113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6589961|NCT01101113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589962|NCT01101113|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6589963|NCT01101113|Hormone Antagonists|hormone antagonists|mesh-ancestor
6589964|NCT01101113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6589965|NCT01101152|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6589966|NCT01101152|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6589967|NCT01101152|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6589968|NCT01101152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6589969|NCT01101152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589970|NCT01101152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6589971|NCT01101152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589972|NCT01101152|Antidepressive Agents|antidepressive agents|mesh-ancestor
6589973|NCT01101152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6589974|NCT01101204|Metformin|metformin|mesh-list
6589975|NCT01101204|Simvastatin|simvastatin|mesh-list
6589976|NCT01101204|Fenofibrate|fenofibrate|mesh-list
6589977|NCT01101204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6589978|NCT01101204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589979|NCT01101204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6589980|NCT01101204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6589981|NCT01101204|Antimetabolites|antimetabolites|mesh-ancestor
6589982|NCT01101204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589983|NCT01101204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6589984|NCT01101204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6589985|NCT01101204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6589986|NCT01101269|Lisinopril|lisinopril|mesh-list
6589987|NCT01101269|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6589988|NCT01101269|Protease Inhibitors|protease inhibitors|mesh-ancestor
6589989|NCT01101269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6589990|NCT01101269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6589991|NCT01101269|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6589992|NCT01101269|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6589993|NCT01101269|Protective Agents|protective agents|mesh-ancestor
6589994|NCT01101269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6589995|NCT01101386|Voriconazole|voriconazole|mesh-list
6589996|NCT01101386|Antifungal Agents|antifungal agents|mesh-ancestor
6659082|NCT01485926|Trastuzumab|trastuzumab|mesh-list
6020371|NCT00392834|Leucovorin|leucovorin|mesh-list
6589997|NCT01101386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6589998|NCT01101386|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6589999|NCT01101386|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6590000|NCT01101386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6590001|NCT01101386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590002|NCT01101386|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6590003|NCT01101386|Hormone Antagonists|hormone antagonists|mesh-ancestor
6590004|NCT01101386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6590005|NCT01101386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590006|NCT01101386|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6590007|NCT01101412|Calcium, Dietary|calcium, dietary|mesh-list
6590008|NCT01101412|Ethanol|ethanol|mesh-list
6590009|NCT01101412|Trimethoprim|trimethoprim|mesh-list
6590010|NCT01101412|Sulfamethoxazole|sulfamethoxazole|mesh-list
6590011|NCT01101412|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6590012|NCT01101412|Edetic Acid|edetic acid|mesh-list
6590013|NCT01101412|Calcium|calcium|mesh-list
6590014|NCT01101412|Pentetic Acid|pentetic acid|mesh-list
6590015|NCT01101412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6590016|NCT01101412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590017|NCT01101412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6590018|NCT01101412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6590019|NCT01101412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6590020|NCT01101412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6590021|NCT01101412|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6590022|NCT01101412|Renal Agents|renal agents|mesh-ancestor
6590023|NCT01101412|Antimalarials|antimalarials|mesh-ancestor
6590024|NCT01101412|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6590025|NCT01101412|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6590026|NCT01101412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6590027|NCT01101412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6590028|NCT01101412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590029|NCT01101412|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6590030|NCT01101412|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6590031|NCT01101412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6590032|NCT01101412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6590033|NCT01101412|Anticoagulants|anticoagulants|mesh-ancestor
6590034|NCT01101412|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6590035|NCT01101412|Chelating Agents|chelating agents|mesh-ancestor
6590036|NCT01101412|Sequestering Agents|sequestering agents|mesh-ancestor
6590037|NCT01101412|Antidotes|antidotes|mesh-ancestor
6590038|NCT01101412|Protective Agents|protective agents|mesh-ancestor
6590039|NCT01101412|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6590040|NCT01101451|Cisplatin|cisplatin|mesh-list
6590041|NCT01101451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6590042|NCT01101529|Aprepitant|aprepitant|mesh-list
6590043|NCT01101529|Antiemetics|antiemetics|mesh-ancestor
6590044|NCT01101529|Autonomic Agents|autonomic agents|mesh-ancestor
6590045|NCT01101529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6590046|NCT01101529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590047|NCT01101529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6590048|NCT01101529|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6590049|NCT01101529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6590050|NCT01101529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590051|NCT01101568|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6590052|NCT01101568|Simvastatin|simvastatin|mesh-list
6590053|NCT01101568|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6590054|NCT01101568|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6590055|NCT01101568|Antimetabolites|antimetabolites|mesh-ancestor
6590056|NCT01101568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590057|NCT01101568|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6590058|NCT01101568|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6590059|NCT01101568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6590060|NCT01101581|Epratuzumab|epratuzumab|mesh-list
6590061|NCT01101581|Veltuzumab|veltuzumab|mesh-list
6590062|NCT01101581|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
6590063|NCT01101581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6590064|NCT01101581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6590065|NCT01101581|Chelating Agents|chelating agents|mesh-ancestor
6590066|NCT01101581|Sequestering Agents|sequestering agents|mesh-ancestor
6590067|NCT01101581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590068|NCT01101620|Simendan|simendan|mesh-list
6590069|NCT01101620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6590070|NCT01101620|Vasodilator Agents|vasodilator agents|mesh-ancestor
6590071|NCT01101620|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6590072|NCT01101620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6590073|NCT01101620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6590074|NCT01101620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590075|NCT01101620|Protective Agents|protective agents|mesh-ancestor
6590076|NCT01101620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590077|NCT01101646|Rabeprazole|rabeprazole|mesh-list
6590078|NCT01101646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6590079|NCT01101646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6590080|NCT01101646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6590081|NCT01101646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6590082|NCT01101646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590083|NCT01101659|Ketamine|ketamine|mesh-list
6590084|NCT01101659|Analgesics|analgesics|mesh-ancestor
6590085|NCT01101659|Sensory System Agents|sensory system agents|mesh-ancestor
6590086|NCT01101659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6590087|NCT01101659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590088|NCT01101659|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6590089|NCT01101659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6590090|NCT01101659|Anesthetics, General|anesthetics, general|mesh-ancestor
6590091|NCT01101659|Anesthetics|anesthetics|mesh-ancestor
6590092|NCT01101659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6590093|NCT01101659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6590094|NCT01101659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6590095|NCT01101659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6590096|NCT01101659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590097|NCT01101685|Citalopram|citalopram|mesh-list
6590098|NCT01101685|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6590099|NCT01101685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6590100|NCT01101685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6590101|NCT01101685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590102|NCT01101685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6590103|NCT01101685|Serotonin Agents|serotonin agents|mesh-ancestor
6590104|NCT01101685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590105|NCT01101685|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6590106|NCT01101685|Antidepressive Agents|antidepressive agents|mesh-ancestor
6590107|NCT01101685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6590108|NCT01101698|Vitamin D|vitamin d|mesh-list
6590109|NCT01101698|Cholecalciferol|cholecalciferol|mesh-list
6590110|NCT01101698|Vitamins|vitamins|mesh-list
6590111|NCT01101698|Vitamin K|vitamin k|mesh-list
6590112|NCT01101698|Vitamin K 2|vitamin k 2|mesh-list
6590113|NCT01101698|Micronutrients|micronutrients|mesh-ancestor
6590114|NCT01101698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590115|NCT01101698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6590116|NCT01101698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6590117|NCT01101698|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6590118|NCT01101698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6590119|NCT01101698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590120|NCT01101698|Hemostatics|hemostatics|mesh-ancestor
6590121|NCT01101698|Coagulants|coagulants|mesh-ancestor
6590122|NCT01101776|Interferons|interferons|mesh-list
6590123|NCT01101776|Interferon-beta|interferon-beta|mesh-list
6590124|NCT01101776|Interferon beta-1a|interferon beta-1a|mesh-list
6590125|NCT01101776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6590126|NCT01101776|Antiviral Agents|antiviral agents|mesh-ancestor
6590127|NCT01101776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6590128|NCT01101776|Immunologic Factors|immunologic factors|mesh-ancestor
6590129|NCT01101776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590130|NCT01101776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6590131|NCT01101789|Triclosan|triclosan|mesh-list
6590132|NCT01101789|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6590133|NCT01101789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6590134|NCT01101789|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6590135|NCT01101789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6590136|NCT01101789|Antimetabolites|antimetabolites|mesh-ancestor
6590137|NCT01101789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590138|NCT01101789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6590139|NCT01101802|Mycophenolic Acid|mycophenolic acid|mesh-list
6590140|NCT01101802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6590141|NCT01101802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6590142|NCT01101802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6590143|NCT01101802|Antitubercular Agents|antitubercular agents|mesh-ancestor
6590144|NCT01101802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6590145|NCT01101802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6590146|NCT01101802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6590147|NCT01101802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590148|NCT01101815|Naltrexone|naltrexone|mesh-list
6590149|NCT01101815|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6590150|NCT01101815|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6590151|NCT01101815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590152|NCT01101815|Sensory System Agents|sensory system agents|mesh-ancestor
6590153|NCT01101815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6590154|NCT01101893|Raltegravir Potassium|raltegravir potassium|mesh-list
6590155|NCT01101893|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6590156|NCT01101893|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6590157|NCT01101893|Antiviral Agents|antiviral agents|mesh-ancestor
6590158|NCT01101893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6590159|NCT01101893|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6590160|NCT01101893|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6590161|NCT01101893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6590162|NCT01101893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590163|NCT01101919|Tofacitinib|tofacitinib|mesh-list
6590164|NCT01101919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6590165|NCT01101919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6590166|NCT01101919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590167|NCT01101984|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6590168|NCT01101984|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6590169|NCT01101984|Hyaluronic Acid|hyaluronic acid|mesh-list
6590170|NCT01101984|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6447589|NCT00398034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6447590|NCT00398034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447591|NCT00398099|Ertapenem|ertapenem|mesh-list
6447592|NCT00398099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6447593|NCT00398099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6447594|NCT00398229|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6447595|NCT00398229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6447596|NCT00398229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447597|NCT00398281|Dutasteride|dutasteride|mesh-list
6447598|NCT00398281|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6447599|NCT00398281|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6447600|NCT00398281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6447601|NCT00398281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447602|NCT00398281|Hormone Antagonists|hormone antagonists|mesh-ancestor
6447603|NCT00398281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6590171|NCT01101984|Immunologic Factors|immunologic factors|mesh-ancestor
6590172|NCT01101984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590173|NCT01101984|Viscosupplements|viscosupplements|mesh-ancestor
6590174|NCT01101984|Protective Agents|protective agents|mesh-ancestor
6659083|NCT01485926|Lapatinib|lapatinib|mesh-list
6659084|NCT01485926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6659085|NCT01485926|Tubulin Modulators|tubulin modulators|mesh-ancestor
6659086|NCT01485926|Antimitotic Agents|antimitotic agents|mesh-ancestor
6659087|NCT01485926|Mitosis Modulators|mitosis modulators|mesh-ancestor
6659088|NCT01485926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6659089|NCT01485926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6659090|NCT01485926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6659091|NCT01485926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6659092|NCT01485939|Lidocaine|lidocaine|mesh-list
6659093|NCT01485939|Anesthetics, Local|anesthetics, local|mesh-ancestor
6659094|NCT01485939|Anesthetics|anesthetics|mesh-ancestor
6659095|NCT01485939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6659096|NCT01485939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659097|NCT01485939|Sensory System Agents|sensory system agents|mesh-ancestor
6659098|NCT01485939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6659099|NCT01485939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6659100|NCT01485939|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6659101|NCT01485939|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6659102|NCT01485939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6659103|NCT01485939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6659104|NCT01485978|Ramipril|ramipril|mesh-list
6659105|NCT01485978|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6659106|NCT01485978|Protease Inhibitors|protease inhibitors|mesh-ancestor
6659107|NCT01485978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6659108|NCT01485978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6659109|NCT01485978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6659110|NCT01486004|Simeprevir|simeprevir|mesh-list
6659111|NCT01486004|Antiviral Agents|antiviral agents|mesh-ancestor
6659112|NCT01486004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6659113|NCT01486004|Protease Inhibitors|protease inhibitors|mesh-ancestor
6659114|NCT01486004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6659115|NCT01486004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6659116|NCT01486017|Peficitinib|peficitinib|mesh-list
6659117|NCT01486017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6659118|NCT01486017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6659119|NCT01486017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6659120|NCT01486017|Immunologic Factors|immunologic factors|mesh-ancestor
6659121|NCT01486017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659122|NCT01486082|Amoxicillin|amoxicillin|mesh-list
6659123|NCT01486082|Clarithromycin|clarithromycin|mesh-list
6659124|NCT01486082|Omeprazole|omeprazole|mesh-list
6659125|NCT01486082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6659126|NCT01486082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6659127|NCT01486082|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6659128|NCT01486082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6590175|NCT01102101|Remifentanil|remifentanil|mesh-list
6590176|NCT01102101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6590177|NCT01102101|Narcotics|narcotics|mesh-ancestor
6590178|NCT01102101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6590179|NCT01102101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590180|NCT01102101|Analgesics|analgesics|mesh-ancestor
6590181|NCT01102101|Sensory System Agents|sensory system agents|mesh-ancestor
6590182|NCT01102101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6590183|NCT01102114|Vaccines|vaccines|mesh-list
6590184|NCT01102114|Immunologic Factors|immunologic factors|mesh-ancestor
6590185|NCT01102114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590186|NCT01102244|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
6590187|NCT01102244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6590188|NCT01102244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6590189|NCT01102244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6590190|NCT01102244|Glucocorticoids|glucocorticoids|mesh-ancestor
6590191|NCT01102244|Hormones|hormones|mesh-ancestor
6590192|NCT01102244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6590193|NCT01102244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590194|NCT01102244|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6590195|NCT01102244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6590196|NCT01102335|Telbivudine|telbivudine|mesh-list
6590197|NCT01102335|Antiviral Agents|antiviral agents|mesh-ancestor
6590198|NCT01102335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6590199|NCT01102335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6590200|NCT01102335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6590201|NCT01102335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590202|NCT01102439|Aspirin|aspirin|mesh-list
6590203|NCT01102439|Clopidogrel|clopidogrel|mesh-list
6590204|NCT01102439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6590205|NCT01102439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6590206|NCT01102439|Analgesics|analgesics|mesh-ancestor
6590207|NCT01102439|Sensory System Agents|sensory system agents|mesh-ancestor
6590208|NCT01102439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6590209|NCT01102439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590210|NCT01102439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6590211|NCT01102439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6590212|NCT01102439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6590213|NCT01102439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6590214|NCT01102439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590215|NCT01102439|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6590216|NCT01102439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6590217|NCT01102439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6590218|NCT01102439|Antipyretics|antipyretics|mesh-ancestor
6590219|NCT01102439|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6590220|NCT01102439|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6590221|NCT01102439|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6590222|NCT01102439|Purinergic Agents|purinergic agents|mesh-ancestor
6590223|NCT01102439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6590224|NCT01102465|Losartan|losartan|mesh-list
6590225|NCT01102465|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6590226|NCT01102465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6590227|NCT01102465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6590228|NCT01102465|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6590229|NCT01102465|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6590230|NCT01102465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590231|NCT01102465|Diuretics|diuretics|mesh-ancestor
6590232|NCT01102465|Natriuretic Agents|natriuretic agents|mesh-ancestor
6590233|NCT01102465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590234|NCT01102465|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6590235|NCT01102465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6590236|NCT01102478|Losartan|losartan|mesh-list
6590237|NCT01102478|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6590238|NCT01102478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6590239|NCT01102478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6590240|NCT01102478|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6590241|NCT01102478|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6590242|NCT01102478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590243|NCT01102478|Diuretics|diuretics|mesh-ancestor
6590244|NCT01102478|Natriuretic Agents|natriuretic agents|mesh-ancestor
6590245|NCT01102478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590246|NCT01102478|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6590247|NCT01102478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6590248|NCT01102595|Bevacizumab|bevacizumab|mesh-list
6590249|NCT01102595|Temozolomide|temozolomide|mesh-list
6590250|NCT01102595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6590251|NCT01102595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6590252|NCT01102595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6590253|NCT01102595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6590254|NCT01102595|Growth Substances|growth substances|mesh-ancestor
6590255|NCT01102595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590256|NCT01102595|Growth Inhibitors|growth inhibitors|mesh-ancestor
6590257|NCT01102595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6590258|NCT01102595|Alkylating Agents|alkylating agents|mesh-ancestor
6590259|NCT01102595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590260|NCT01102608|Ifosfamide|ifosfamide|mesh-list
6590261|NCT01102608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6590262|NCT01102608|Alkylating Agents|alkylating agents|mesh-ancestor
6590263|NCT01102608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590264|NCT01102608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6590265|NCT01102673|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
6590266|NCT01102673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6590267|NCT01102673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590268|NCT01102686|Leucovorin|leucovorin|mesh-list
6590269|NCT01102686|Pyrimethamine|pyrimethamine|mesh-list
6590270|NCT01102686|Antidotes|antidotes|mesh-ancestor
6590271|NCT01102686|Protective Agents|protective agents|mesh-ancestor
6590272|NCT01102686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590273|NCT01102686|Vitamin B Complex|vitamin b complex|mesh-ancestor
6590274|NCT01102686|Vitamins|vitamins|mesh-ancestor
6590275|NCT01102686|Micronutrients|micronutrients|mesh-ancestor
6590276|NCT01102686|Antimalarials|antimalarials|mesh-ancestor
6590277|NCT01102686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6590278|NCT01102686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6590279|NCT01102686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6590280|NCT01102686|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6590281|NCT01102686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6590282|NCT01102686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590283|NCT01102699|Lenograstim|lenograstim|mesh-list
6590284|NCT01102699|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6590285|NCT01102699|Immunologic Factors|immunologic factors|mesh-ancestor
6590286|NCT01102699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590287|NCT01102946|Ranibizumab|ranibizumab|mesh-list
6590288|NCT01102946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6590289|NCT01102946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6590290|NCT01102946|Growth Substances|growth substances|mesh-ancestor
6590291|NCT01102946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590292|NCT01102946|Growth Inhibitors|growth inhibitors|mesh-ancestor
6590293|NCT01102946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6590294|NCT01103024|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6590295|NCT01103024|Immunologic Factors|immunologic factors|mesh-ancestor
6590296|NCT01103024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590297|NCT01103050|Cetirizine|cetirizine|mesh-list
6590298|NCT01103050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6590299|NCT01103050|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6590300|NCT01103050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6590301|NCT01103050|Histamine Antagonists|histamine antagonists|mesh-ancestor
6590302|NCT01103050|Histamine Agents|histamine agents|mesh-ancestor
6590303|NCT01103050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6590304|NCT01103050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447604|NCT00398281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447605|NCT00398307|Cisplatin|cisplatin|mesh-list
6447606|NCT00398307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6447607|NCT00398372|Rituximab|rituximab|mesh-list
6447608|NCT00398372|Epratuzumab|epratuzumab|mesh-list
6590305|NCT01103050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590306|NCT01103115|Calcium, Dietary|calcium, dietary|mesh-list
6590307|NCT01103115|Vitamin D|vitamin d|mesh-list
6590308|NCT01103115|Calcium Carbonate|calcium carbonate|mesh-list
6590309|NCT01103115|Calcium|calcium|mesh-list
6590310|NCT01103115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6590311|NCT01103115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590312|NCT01103115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6590313|NCT01103115|Vitamins|vitamins|mesh-ancestor
6590314|NCT01103115|Micronutrients|micronutrients|mesh-ancestor
6590315|NCT01103115|Antacids|antacids|mesh-ancestor
6590316|NCT01103115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590317|NCT01103115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6590318|NCT01103154|Nadolol|nadolol|mesh-list
6590319|NCT01103154|Carvedilol|carvedilol|mesh-list
6590320|NCT01103154|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6590321|NCT01103154|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6590322|NCT01103154|Adrenergic Agents|adrenergic agents|mesh-ancestor
6590323|NCT01103154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6590324|NCT01103154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590325|NCT01103154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590326|NCT01103154|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6590327|NCT01103154|Antioxidants|antioxidants|mesh-ancestor
6590328|NCT01103154|Protective Agents|protective agents|mesh-ancestor
6590329|NCT01103154|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6590330|NCT01103154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6590331|NCT01103154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6590332|NCT01103154|Vasodilator Agents|vasodilator agents|mesh-ancestor
6590333|NCT01103154|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6590334|NCT01103154|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6590335|NCT01103154|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6590336|NCT01103154|Sympatholytics|sympatholytics|mesh-ancestor
6590337|NCT01103154|Autonomic Agents|autonomic agents|mesh-ancestor
6590338|NCT01103154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6590339|NCT01103193|Remifentanil|remifentanil|mesh-list
6447609|NCT00398372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6590340|NCT01103193|Sevoflurane|sevoflurane|mesh-list
6590341|NCT01103193|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6590342|NCT01103193|Narcotics|narcotics|mesh-ancestor
6590343|NCT01103193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6590344|NCT01103193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590345|NCT01103193|Analgesics|analgesics|mesh-ancestor
6590346|NCT01103193|Sensory System Agents|sensory system agents|mesh-ancestor
6590347|NCT01103193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6447610|NCT00398372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6447611|NCT00398372|Immunologic Factors|immunologic factors|mesh-ancestor
6447612|NCT00398372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447613|NCT00398372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6447614|NCT00398385|Gemcitabine|gemcitabine|mesh-list
6447615|NCT00398385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6590348|NCT01103193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6590349|NCT01103193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6590350|NCT01103193|Anesthetics, General|anesthetics, general|mesh-ancestor
6590351|NCT01103193|Anesthetics|anesthetics|mesh-ancestor
6590352|NCT01103206|Cinacalcet|cinacalcet|mesh-list
6590353|NCT01103206|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6590354|NCT01103206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590355|NCT01103206|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6590356|NCT01103206|Hormone Antagonists|hormone antagonists|mesh-ancestor
6590357|NCT01103206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6590358|NCT01103336|Nicorandil|nicorandil|mesh-list
6590359|NCT01103336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6590360|NCT01103336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6590361|NCT01103336|Vasodilator Agents|vasodilator agents|mesh-ancestor
6590362|NCT01103336|Vitamin B Complex|vitamin b complex|mesh-ancestor
6590363|NCT01103336|Vitamins|vitamins|mesh-ancestor
6590364|NCT01103336|Micronutrients|micronutrients|mesh-ancestor
6590365|NCT01103336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590366|NCT01103375|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6590367|NCT01103375|Isotretinoin|isotretinoin|mesh-list
6590368|NCT01103375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6590369|NCT01103375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6590370|NCT01103375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6590371|NCT01103375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590372|NCT01103375|Dermatologic Agents|dermatologic agents|mesh-ancestor
6590373|NCT01103388|Rituximab|rituximab|mesh-list
6590374|NCT01103388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6590375|NCT01103388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6590376|NCT01103388|Immunologic Factors|immunologic factors|mesh-ancestor
6590377|NCT01103388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590378|NCT01103388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6590379|NCT01103401|Tobramycin|tobramycin|mesh-list
6590380|NCT01103401|Dexamethasone|dexamethasone|mesh-list
6590381|NCT01103401|Dexamethasone acetate|dexamethasone acetate|mesh-list
6590382|NCT01103401|Ketorolac|ketorolac|mesh-list
6590383|NCT01103401|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6590384|NCT01103401|BB 1101|bb 1101|mesh-list
6590385|NCT01103401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6590386|NCT01103401|Antiemetics|antiemetics|mesh-ancestor
6590387|NCT01103401|Autonomic Agents|autonomic agents|mesh-ancestor
6590388|NCT01103401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6590389|NCT01103401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590390|NCT01103401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6590391|NCT01103401|Glucocorticoids|glucocorticoids|mesh-ancestor
6590392|NCT01103401|Hormones|hormones|mesh-ancestor
6590393|NCT01103401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6590394|NCT01103401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6590395|NCT01103401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6590396|NCT01103401|Protease Inhibitors|protease inhibitors|mesh-ancestor
6590397|NCT01103401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6590398|NCT01103401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590399|NCT01103401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6590400|NCT01103401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6590401|NCT01103401|Analgesics|analgesics|mesh-ancestor
6590402|NCT01103401|Sensory System Agents|sensory system agents|mesh-ancestor
6590403|NCT01103401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6590404|NCT01103401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6590405|NCT01103401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6590406|NCT01103401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6590407|NCT01103518|Cyproterone Acetate|cyproterone acetate|mesh-list
6590408|NCT01103518|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6590409|NCT01103518|Estradiol|estradiol|mesh-list
6590410|NCT01103518|Cyproterone|cyproterone|mesh-list
6590411|NCT01103518|Estrogens|estrogens|mesh-ancestor
6590412|NCT01103518|Hormones|hormones|mesh-ancestor
6590413|NCT01103518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6590414|NCT01103518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590415|NCT01103518|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6590416|NCT01103518|Contraceptive Agents|contraceptive agents|mesh-ancestor
6590417|NCT01103518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6590418|NCT01103518|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6590419|NCT01103518|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6590420|NCT01103518|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6590421|NCT01103518|Androgen Antagonists|androgen antagonists|mesh-ancestor
6590422|NCT01103518|Hormone Antagonists|hormone antagonists|mesh-ancestor
6590423|NCT01103518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6590424|NCT01103518|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6590425|NCT01103583|Hydroxyurea|hydroxyurea|mesh-list
6590426|NCT01103583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6590427|NCT01103583|Antisickling Agents|antisickling agents|mesh-ancestor
6590428|NCT01103583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6590429|NCT01103583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590430|NCT01103583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6590431|NCT01103609|Warfarin|warfarin|mesh-list
6590432|NCT01103609|Anticoagulants|anticoagulants|mesh-ancestor
6590433|NCT01103622|Digoxin|digoxin|mesh-list
6590434|NCT01103622|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6590435|NCT01103622|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6590436|NCT01103622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6590437|NCT01103622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590438|NCT01103622|Protective Agents|protective agents|mesh-ancestor
6590439|NCT01103622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590440|NCT01103635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6590441|NCT01103635|Ipilimumab|ipilimumab|mesh-list
6590442|NCT01103635|Tremelimumab|tremelimumab|mesh-list
6590443|NCT01103635|Antibodies|antibodies|mesh-list
6590444|NCT01103635|Immunoglobulins|immunoglobulins|mesh-list
6590445|NCT01103635|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6590446|NCT01103635|Immunologic Factors|immunologic factors|mesh-ancestor
6590447|NCT01103635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590448|NCT01103635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6590449|NCT01103635|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6590450|NCT01103635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590451|NCT01103648|Simvastatin|simvastatin|mesh-list
6590452|NCT01103648|Ezetimibe|ezetimibe|mesh-list
6590453|NCT01103648|Hypolipidemic Agents|hypolipidemic agents|mesh-list
6590454|NCT01103648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
6590455|NCT01103648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6590456|NCT01103648|Antimetabolites|antimetabolites|mesh-ancestor
6590457|NCT01103648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590458|NCT01103648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6590459|NCT01103648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6590460|NCT01103739|Simvastatin|simvastatin|mesh-list
6590461|NCT01103739|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6590462|NCT01103739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6590463|NCT01103739|Antimetabolites|antimetabolites|mesh-ancestor
6590464|NCT01103739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590465|NCT01103739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6590466|NCT01103739|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6590467|NCT01103739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6590468|NCT01103791|Docetaxel|docetaxel|mesh-list
6590469|NCT01103791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6590470|NCT01103791|Tubulin Modulators|tubulin modulators|mesh-ancestor
6590471|NCT01103791|Antimitotic Agents|antimitotic agents|mesh-ancestor
6590472|NCT01103791|Mitosis Modulators|mitosis modulators|mesh-ancestor
6590473|NCT01103791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590474|NCT01103817|Vitamin D|vitamin d|mesh-list
6590475|NCT01103817|Vitamins|vitamins|mesh-ancestor
6590476|NCT01103817|Micronutrients|micronutrients|mesh-ancestor
6447616|NCT00398385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6447617|NCT00398385|Antimetabolites|antimetabolites|mesh-ancestor
6447618|NCT00398385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447619|NCT00398385|Antiviral Agents|antiviral agents|mesh-ancestor
6447620|NCT00398385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6447621|NCT00398385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6447622|NCT00398385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6590477|NCT01103817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447623|NCT00398385|Immunologic Factors|immunologic factors|mesh-ancestor
6447624|NCT00398385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447625|NCT00398424|Cisplatin|cisplatin|mesh-list
6447626|NCT00398424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6590478|NCT01103817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6659129|NCT01486082|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6659130|NCT01486082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6659131|NCT01486082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6659132|NCT01486082|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6659133|NCT01486082|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6659134|NCT01486082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6659135|NCT01486251|Axitinib|axitinib|mesh-list
6659136|NCT01486251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6659137|NCT01486251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6659138|NCT01486251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6659139|NCT01486251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6659140|NCT01486381|Insulin Aspart|insulin aspart|mesh-list
6659141|NCT01486381|Biphasic Insulins|biphasic insulins|mesh-list
6659142|NCT01486381|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6659143|NCT01486381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6659144|NCT01486381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659145|NCT01486433|Aspirin|aspirin|mesh-list
6659146|NCT01486433|Simvastatin|simvastatin|mesh-list
6659147|NCT01486433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6659148|NCT01486433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6659149|NCT01486433|Analgesics|analgesics|mesh-ancestor
6659150|NCT01486433|Sensory System Agents|sensory system agents|mesh-ancestor
6020372|NCT00392834|Cytarabine|cytarabine|mesh-list
6447627|NCT00398437|Trastuzumab|trastuzumab|mesh-list
6447628|NCT00398437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6447629|NCT00398437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6447630|NCT00398450|Interferons|interferons|mesh-list
6447631|NCT00398450|Interferon-alpha|interferon-alpha|mesh-list
6447632|NCT00398450|Interferon alpha-2|interferon alpha-2|mesh-list
6447633|NCT00398450|Azacitidine|azacitidine|mesh-list
6447634|NCT00398450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6447635|NCT00398450|Antiviral Agents|antiviral agents|mesh-ancestor
6447636|NCT00398450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6447637|NCT00398450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6447638|NCT00398450|Antimetabolites|antimetabolites|mesh-ancestor
6447639|NCT00398450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447640|NCT00398450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6590479|NCT01103830|Moxifloxacin|moxifloxacin|mesh-list
6590480|NCT01103830|Lumefantrine|lumefantrine|mesh-list
6590481|NCT01103830|Artemether|artemether|mesh-list
6590482|NCT01103830|Piperaquine|piperaquine|mesh-list
6590483|NCT01103830|Artenimol|artenimol|mesh-list
6590484|NCT01103830|Artemisinins|artemisinins|mesh-list
6590485|NCT01103830|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6590486|NCT01103830|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6590487|NCT01103830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6590488|NCT01103830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6590489|NCT01103830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6590490|NCT01103830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6590491|NCT01103830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6590492|NCT01103830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590493|NCT01103830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6590494|NCT01103830|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6590495|NCT01103830|Contraceptive Agents|contraceptive agents|mesh-ancestor
6590496|NCT01103830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6590497|NCT01103830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590498|NCT01103830|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6590499|NCT01103830|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6590500|NCT01103830|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6590501|NCT01103830|Antimalarials|antimalarials|mesh-ancestor
6590502|NCT01103830|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6590503|NCT01103830|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6590504|NCT01103843|Clopidogrel|clopidogrel|mesh-list
6590505|NCT01103843|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6590506|NCT01103843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6590507|NCT01103843|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6590508|NCT01103843|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6590509|NCT01103843|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6590510|NCT01103843|Purinergic Agents|purinergic agents|mesh-ancestor
6590511|NCT01103843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6590512|NCT01103843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590513|NCT01103843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590514|NCT01104038|Chlorhexidine|chlorhexidine|mesh-list
6590515|NCT01104038|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6590516|NCT01104038|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6590517|NCT01104038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6590518|NCT01104038|Disinfectants|disinfectants|mesh-ancestor
6590519|NCT01104038|Dermatologic Agents|dermatologic agents|mesh-ancestor
6590520|NCT01104259|Vinorelbine|vinorelbine|mesh-list
6590521|NCT01104259|Veliparib|veliparib|mesh-list
6590522|NCT01104259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6590523|NCT01104259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6590524|NCT01104259|Tubulin Modulators|tubulin modulators|mesh-ancestor
6590525|NCT01104259|Antimitotic Agents|antimitotic agents|mesh-ancestor
6590526|NCT01104259|Mitosis Modulators|mitosis modulators|mesh-ancestor
6590527|NCT01104259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590528|NCT01104259|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6590529|NCT01104259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6590530|NCT01104298|Doxorubicin|doxorubicin|mesh-list
6590531|NCT01104298|Trabectedin|trabectedin|mesh-list
6590532|NCT01104298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6590533|NCT01104298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6590534|NCT01104298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6590535|NCT01104298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6590536|NCT01104298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6590537|NCT01104298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590538|NCT01104298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6590539|NCT01104298|Alkylating Agents|alkylating agents|mesh-ancestor
6590540|NCT01104337|Acetaminophen|acetaminophen|mesh-list
6590541|NCT01104337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6590542|NCT01104337|Analgesics|analgesics|mesh-ancestor
6590543|NCT01104337|Sensory System Agents|sensory system agents|mesh-ancestor
6590544|NCT01104337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6590545|NCT01104337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590546|NCT01104337|Antipyretics|antipyretics|mesh-ancestor
6590547|NCT01104350|Gemcitabine|gemcitabine|mesh-list
6590548|NCT01104350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6590549|NCT01104350|Antimetabolites|antimetabolites|mesh-ancestor
6590550|NCT01104350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590551|NCT01104350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6590552|NCT01104350|Antiviral Agents|antiviral agents|mesh-ancestor
6590553|NCT01104350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6590554|NCT01104350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6590555|NCT01104350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6590556|NCT01104350|Immunologic Factors|immunologic factors|mesh-ancestor
6590557|NCT01104350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590558|NCT01104467|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
6590559|NCT01104467|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6590560|NCT01104467|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6590561|NCT01104467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590562|NCT01104519|Niacin|niacin|mesh-list
6590563|NCT01104519|Nicotinic Acids|nicotinic acids|mesh-list
6590564|NCT01104519|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6590565|NCT01104519|Antimetabolites|antimetabolites|mesh-ancestor
6590566|NCT01104519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590567|NCT01104519|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6590568|NCT01104519|Vasodilator Agents|vasodilator agents|mesh-ancestor
6590569|NCT01104519|Vitamin B Complex|vitamin b complex|mesh-ancestor
6590570|NCT01104519|Vitamins|vitamins|mesh-ancestor
6590571|NCT01104519|Micronutrients|micronutrients|mesh-ancestor
6590572|NCT01104519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590573|NCT01104532|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6590574|NCT01104532|Ipragliflozin|ipragliflozin|mesh-list
6590575|NCT01104532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6590576|NCT01104532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590577|NCT01104532|Incretins|incretins|mesh-ancestor
6590578|NCT01104532|Hormones|hormones|mesh-ancestor
6590579|NCT01104532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6590580|NCT01104532|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6590581|NCT01104532|Protease Inhibitors|protease inhibitors|mesh-ancestor
6590582|NCT01104532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6590583|NCT01104532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590584|NCT01104532|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6590585|NCT01104571|Trastuzumab|trastuzumab|mesh-list
6590586|NCT01104571|Lapatinib|lapatinib|mesh-list
6590587|NCT01104571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6590588|NCT01104571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6590589|NCT01104571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6590590|NCT01104571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6590591|NCT01104571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590592|NCT01104597|Nitroglycerin|nitroglycerin|mesh-list
6590593|NCT01104597|Vasodilator Agents|vasodilator agents|mesh-ancestor
6590594|NCT01104649|Riluzole|riluzole|mesh-list
6590595|NCT01104649|Anticonvulsants|anticonvulsants|mesh-ancestor
6590596|NCT01104649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6590597|NCT01104649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6590598|NCT01104649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6590599|NCT01104649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590600|NCT01104649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590601|NCT01104649|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6590602|NCT01104649|Protective Agents|protective agents|mesh-ancestor
6590603|NCT01104844|Acetaminophen|acetaminophen|mesh-list
6590604|NCT01104844|Ibuprofen|ibuprofen|mesh-list
6590605|NCT01104844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6590606|NCT01104844|Analgesics|analgesics|mesh-ancestor
6590607|NCT01104844|Sensory System Agents|sensory system agents|mesh-ancestor
6590608|NCT01104844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6590609|NCT01104844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590610|NCT01104844|Antipyretics|antipyretics|mesh-ancestor
6590611|NCT01104844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6590612|NCT01104844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6590613|NCT01104844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6590614|NCT01104844|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6590615|NCT01104844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6590616|NCT01104844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590617|NCT01104883|Iodine|iodine|mesh-list
6590618|NCT01104883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6590619|NCT01104883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6590620|NCT01104883|Trace Elements|trace elements|mesh-ancestor
6590621|NCT01104883|Micronutrients|micronutrients|mesh-ancestor
6590622|NCT01104883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590623|NCT01104896|Nicotine|nicotine|mesh-list
6590624|NCT01104896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6590625|NCT01104896|Autonomic Agents|autonomic agents|mesh-ancestor
6590626|NCT01104896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6590627|NCT01104896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590628|NCT01104896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6590629|NCT01104896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6590630|NCT01104896|Cholinergic Agents|cholinergic agents|mesh-ancestor
6590631|NCT01104896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6590632|NCT01104896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590633|NCT01104935|Trastuzumab|trastuzumab|mesh-list
6590634|NCT01104935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6590635|NCT01104935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6590636|NCT01104961|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6590637|NCT01104987|Alendronate|alendronate|mesh-list
6590638|NCT01104987|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6590639|NCT01104987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590640|NCT01105013|Clotrimazole|clotrimazole|mesh-list
6590641|NCT01105013|Miconazole|miconazole|mesh-list
6590642|NCT01105013|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6590643|NCT01105013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6590644|NCT01105013|Antifungal Agents|antifungal agents|mesh-ancestor
6590645|NCT01105013|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6590646|NCT01105013|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6590647|NCT01105013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6590648|NCT01105013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590649|NCT01105013|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6590650|NCT01105013|Hormone Antagonists|hormone antagonists|mesh-ancestor
6590651|NCT01105013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6590652|NCT01105013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590653|NCT01105013|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6590654|NCT01105013|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6590655|NCT01105208|Cephalexin|cephalexin|mesh-list
6590656|NCT01105208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6590657|NCT01105208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6590658|NCT01105234|Vitamin D|vitamin d|mesh-list
6590659|NCT01105234|Calcipotriene|calcipotriene|mesh-list
6590660|NCT01105234|Vitamins|vitamins|mesh-ancestor
6590661|NCT01105234|Micronutrients|micronutrients|mesh-ancestor
6590662|NCT01105234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590663|NCT01105234|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6590664|NCT01105234|Dermatologic Agents|dermatologic agents|mesh-ancestor
6590665|NCT01105273|Cyclophosphamide|cyclophosphamide|mesh-list
6590666|NCT01105273|Fludarabine|fludarabine|mesh-list
6590667|NCT01105273|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6590668|NCT01105273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6590669|NCT01105273|Immunologic Factors|immunologic factors|mesh-ancestor
6590670|NCT01105273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590671|NCT01105273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6590672|NCT01105273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6590673|NCT01105273|Alkylating Agents|alkylating agents|mesh-ancestor
6590674|NCT01105273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590675|NCT01105273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6590676|NCT01105273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6590677|NCT01105286|Vitamin D|vitamin d|mesh-list
6590678|NCT01105286|Calcipotriene|calcipotriene|mesh-list
6590679|NCT01105286|Vitamins|vitamins|mesh-ancestor
6590680|NCT01105286|Micronutrients|micronutrients|mesh-ancestor
6590681|NCT01105286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590682|NCT01105286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6590683|NCT01105286|Dermatologic Agents|dermatologic agents|mesh-ancestor
6590684|NCT01105299|Anastrozole|anastrozole|mesh-list
6590685|NCT01105299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6590686|NCT01105299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6590687|NCT01105299|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6590688|NCT01105299|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6590689|NCT01105299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6590690|NCT01105299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590691|NCT01105299|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6590692|NCT01105299|Hormone Antagonists|hormone antagonists|mesh-ancestor
6590693|NCT01105299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6590694|NCT01105299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590695|NCT01105338|Lycopene|lycopene|mesh-list
6590696|NCT01105338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6590697|NCT01105338|Antioxidants|antioxidants|mesh-ancestor
6590698|NCT01105338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590699|NCT01105338|Protective Agents|protective agents|mesh-ancestor
6590700|NCT01105338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590701|NCT01105338|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6590702|NCT01105338|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6590703|NCT01105338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6590704|NCT01105351|Folic Acid|folic acid|mesh-list
6590705|NCT01105351|Vitamin B Complex|vitamin b complex|mesh-list
6590706|NCT01105351|Hematinics|hematinics|mesh-ancestor
6590707|NCT01105351|Vitamins|vitamins|mesh-ancestor
6590708|NCT01105351|Micronutrients|micronutrients|mesh-ancestor
6590709|NCT01105351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590710|NCT01105390|Pemetrexed|pemetrexed|mesh-list
6590711|NCT01105390|Rilotumumab|rilotumumab|mesh-list
6590712|NCT01105390|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6590713|NCT01105390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6590714|NCT01105390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6590715|NCT01105390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590716|NCT01105390|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6590717|NCT01105390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6590718|NCT01105390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6590719|NCT01105390|Immunologic Factors|immunologic factors|mesh-ancestor
6590720|NCT01105390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590721|NCT01105481|Amisulpride|amisulpride|mesh-list
6590722|NCT01105481|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6590723|NCT01105481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6590724|NCT01105481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6590725|NCT01105481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501632|NCT04472481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5501633|NCT04472481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501634|NCT04472481|Vitamins|vitamins|mesh-ancestor
5501635|NCT04472481|Micronutrients|micronutrients|mesh-ancestor
5501636|NCT04472481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5501637|NCT04472416|Analgesics|analgesics|mesh-list
5501638|NCT04472416|Sensory System Agents|sensory system agents|mesh-ancestor
6020373|NCT00392834|Hydrocortisone|hydrocortisone|mesh-list
6590726|NCT01105481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6590727|NCT01105481|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6590728|NCT01105481|Dopamine Agents|dopamine agents|mesh-ancestor
6590729|NCT01105481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6590730|NCT01105481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590731|NCT01105481|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6590732|NCT01105481|Antidepressive Agents|antidepressive agents|mesh-ancestor
6590733|NCT01105494|Epoetin Alfa|epoetin alfa|mesh-list
6590734|NCT01105494|Hematinics|hematinics|mesh-ancestor
6659151|NCT01486433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6659152|NCT01486433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659153|NCT01486433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6659154|NCT01486433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6659155|NCT01486433|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6659156|NCT01486433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6447641|NCT00398450|Immunologic Factors|immunologic factors|mesh-ancestor
6447642|NCT00398450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447643|NCT00398463|polysaccharide-K|polysaccharide-k|mesh-list
6447644|NCT00398463|Tirofiban|tirofiban|mesh-list
6447645|NCT00398463|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6447646|NCT00398463|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6447647|NCT00398463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447648|NCT00398463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6659157|NCT01486433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6659158|NCT01486433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6659159|NCT01486433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6659160|NCT01486433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6659161|NCT01486433|Antipyretics|antipyretics|mesh-ancestor
6659162|NCT01486433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6659163|NCT01486433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6659164|NCT01486433|Antimetabolites|antimetabolites|mesh-ancestor
6659165|NCT01486433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6659166|NCT01486433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6659167|NCT01486459|Lithium Carbonate|lithium carbonate|mesh-list
6659168|NCT01486459|Antidepressive Agents|antidepressive agents|mesh-ancestor
6659169|NCT01486459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6659170|NCT01486459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6659171|NCT01486459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6659172|NCT01486459|Antimanic Agents|antimanic agents|mesh-ancestor
6659173|NCT01486459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6659174|NCT01486459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6659175|NCT01486459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659176|NCT01486485|Nafamostat|nafamostat|mesh-list
6659177|NCT01486485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6659178|NCT01486485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6659179|NCT01486485|Analgesics|analgesics|mesh-ancestor
6659180|NCT01486485|Sensory System Agents|sensory system agents|mesh-ancestor
6659181|NCT01486485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6590735|NCT01105598|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
6590736|NCT01105598|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6590737|NCT01105598|Antimetabolites|antimetabolites|mesh-ancestor
6590738|NCT01105598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590739|NCT01105598|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6590740|NCT01105598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6590741|NCT01105598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6590742|NCT01105598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590743|NCT01105611|Ritonavir|ritonavir|mesh-list
6590744|NCT01105611|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6590745|NCT01105611|Raltegravir Potassium|raltegravir potassium|mesh-list
6590746|NCT01105611|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6590747|NCT01105611|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6590748|NCT01105611|Protease Inhibitors|protease inhibitors|mesh-ancestor
6590749|NCT01105611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6590750|NCT01105611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590751|NCT01105611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6590752|NCT01105611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6590753|NCT01105611|Antiviral Agents|antiviral agents|mesh-ancestor
6590754|NCT01105611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6590755|NCT01105611|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6590756|NCT01105611|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6590757|NCT01105611|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6590758|NCT01105611|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6590759|NCT01105793|Danazol|danazol|mesh-list
6590760|NCT01105793|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6590761|NCT01105793|Hormone Antagonists|hormone antagonists|mesh-ancestor
6590762|NCT01105793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6590763|NCT01105793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590764|NCT01105819|Chlorhexidine|chlorhexidine|mesh-list
6590765|NCT01105819|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6590766|NCT01105819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6590767|NCT01105819|Disinfectants|disinfectants|mesh-ancestor
6590768|NCT01105832|Teriparatide|teriparatide|mesh-list
6590769|NCT01105832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6590770|NCT01105832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590771|NCT01105832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6590772|NCT01105871|Naloxone|naloxone|mesh-list
6590773|NCT01105871|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6590774|NCT01105871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590775|NCT01105871|Sensory System Agents|sensory system agents|mesh-ancestor
6590776|NCT01105871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6590777|NCT01105910|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6590778|NCT01105910|Lubricant Eye Drops|lubricant eye drops|mesh-list
6590779|NCT01105910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6590780|NCT01106001|Levobupivacaine|levobupivacaine|mesh-list
6590781|NCT01106001|Anesthetics, Local|anesthetics, local|mesh-ancestor
6590782|NCT01106001|Anesthetics|anesthetics|mesh-ancestor
6447649|NCT00398463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6447650|NCT00398463|Immunologic Factors|immunologic factors|mesh-ancestor
6590783|NCT01106001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6590784|NCT01106001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590785|NCT01106001|Sensory System Agents|sensory system agents|mesh-ancestor
6590786|NCT01106001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6590787|NCT01106053|Pramipexole|pramipexole|mesh-list
6590788|NCT01106053|Antioxidants|antioxidants|mesh-ancestor
6590789|NCT01106053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590790|NCT01106053|Protective Agents|protective agents|mesh-ancestor
6590791|NCT01106053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590792|NCT01106053|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6590793|NCT01106053|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6590794|NCT01106053|Dopamine Agonists|dopamine agonists|mesh-ancestor
6590795|NCT01106053|Dopamine Agents|dopamine agents|mesh-ancestor
6590796|NCT01106053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6590797|NCT01106066|Oxaliplatin|oxaliplatin|mesh-list
6590798|NCT01106066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6590799|NCT01106118|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6447651|NCT00398463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447652|NCT00398463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6447653|NCT00398463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6447654|NCT00398463|Antiviral Agents|antiviral agents|mesh-ancestor
6447655|NCT00398463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6447656|NCT00398463|Interferon Inducers|interferon inducers|mesh-ancestor
6590800|NCT01106118|Vasodilator Agents|vasodilator agents|mesh-ancestor
6590801|NCT01106118|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6590802|NCT01106118|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6590803|NCT01106118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6590804|NCT01106118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590805|NCT01106118|Urological Agents|urological agents|mesh-ancestor
6590806|NCT01106131|Pioglitazone|pioglitazone|mesh-list
6590807|NCT01106131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6590808|NCT01106131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590809|NCT01106235|Aldesleukin|aldesleukin|mesh-list
6590810|NCT01106235|Cyclophosphamide|cyclophosphamide|mesh-list
6590811|NCT01106235|Interleukin-2|interleukin-2|mesh-list
6590812|NCT01106235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6590813|NCT01106235|Immunologic Factors|immunologic factors|mesh-ancestor
6590814|NCT01106235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590815|NCT01106235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6590816|NCT01106235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6590817|NCT01106235|Alkylating Agents|alkylating agents|mesh-ancestor
6590818|NCT01106235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590819|NCT01106235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6590820|NCT01106235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6590821|NCT01106235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6590822|NCT01106235|Analgesics|analgesics|mesh-ancestor
6590823|NCT01106235|Sensory System Agents|sensory system agents|mesh-ancestor
6590824|NCT01106235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6590825|NCT01106235|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6590826|NCT01106235|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6590827|NCT01106235|Antiviral Agents|antiviral agents|mesh-ancestor
6590828|NCT01106235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6590829|NCT01106495|Simvastatin|simvastatin|mesh-list
6590830|NCT01106495|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6590831|NCT01106495|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6590832|NCT01106495|Antimetabolites|antimetabolites|mesh-ancestor
6447657|NCT00398463|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6590833|NCT01106495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590834|NCT01106495|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6590835|NCT01106495|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6590836|NCT01106495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6590837|NCT01106547|Methylprednisolone|methylprednisolone|mesh-list
6590838|NCT01106547|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6590839|NCT01106547|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6590840|NCT01106547|Prednisolone|prednisolone|mesh-list
6590841|NCT01106547|Prednisolone acetate|prednisolone acetate|mesh-list
6590842|NCT01106547|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6590843|NCT01106547|Prednisolone phosphate|prednisolone phosphate|mesh-list
6590844|NCT01106547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6590845|NCT01106547|Antiemetics|antiemetics|mesh-ancestor
6590846|NCT01106547|Autonomic Agents|autonomic agents|mesh-ancestor
6590847|NCT01106547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6590848|NCT01106547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590849|NCT01106547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6590850|NCT01106547|Glucocorticoids|glucocorticoids|mesh-ancestor
6590851|NCT01106547|Hormones|hormones|mesh-ancestor
6590852|NCT01106547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6590853|NCT01106547|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6590854|NCT01106547|Protective Agents|protective agents|mesh-ancestor
6590855|NCT01106547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6590856|NCT01106547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6590857|NCT01106716|Lidocaine|lidocaine|mesh-list
6590858|NCT01106716|Anesthetics, Local|anesthetics, local|mesh-ancestor
6590859|NCT01106716|Anesthetics|anesthetics|mesh-ancestor
6590860|NCT01106716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6590861|NCT01106716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590862|NCT01106716|Sensory System Agents|sensory system agents|mesh-ancestor
6590863|NCT01106716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6590864|NCT01106716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6590865|NCT01106716|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6590866|NCT01106716|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6590867|NCT01106716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6590868|NCT01106716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590869|NCT01106872|Gemcitabine|gemcitabine|mesh-list
6590870|NCT01106872|Bevacizumab|bevacizumab|mesh-list
6590871|NCT01106872|Docetaxel|docetaxel|mesh-list
6590872|NCT01106872|Valproic Acid|valproic acid|mesh-list
6590873|NCT01106872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6590874|NCT01106872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6590875|NCT01106872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6590876|NCT01106872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6590877|NCT01106872|Growth Substances|growth substances|mesh-ancestor
6590878|NCT01106872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590879|NCT01106872|Growth Inhibitors|growth inhibitors|mesh-ancestor
6590880|NCT01106872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6590881|NCT01106872|Antimetabolites|antimetabolites|mesh-ancestor
6590882|NCT01106872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590883|NCT01106872|Antiviral Agents|antiviral agents|mesh-ancestor
6590884|NCT01106872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6590885|NCT01106872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6590886|NCT01106872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6590887|NCT01106872|Immunologic Factors|immunologic factors|mesh-ancestor
6590888|NCT01106872|Tubulin Modulators|tubulin modulators|mesh-ancestor
6590889|NCT01106872|Antimitotic Agents|antimitotic agents|mesh-ancestor
6590890|NCT01106872|Mitosis Modulators|mitosis modulators|mesh-ancestor
6590891|NCT01106872|Anticonvulsants|anticonvulsants|mesh-ancestor
6590892|NCT01106872|GABA Agents|gaba agents|mesh-ancestor
6590893|NCT01106872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6590894|NCT01106872|Antimanic Agents|antimanic agents|mesh-ancestor
6590895|NCT01106872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6590896|NCT01106872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6590897|NCT01106872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6590898|NCT01107054|Moxifloxacin|moxifloxacin|mesh-list
6590899|NCT01107054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6590900|NCT01107054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6590901|NCT01107054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6590902|NCT01107054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6590903|NCT01107054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6590904|NCT01107054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590905|NCT01107054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6590906|NCT01107067|Testosterone|testosterone|mesh-list
6590907|NCT01107067|Androgens|androgens|mesh-ancestor
6590908|NCT01107067|Hormones|hormones|mesh-ancestor
6590909|NCT01107067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6590910|NCT01107067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590911|NCT01107093|Ulipristal acetate|ulipristal acetate|mesh-list
6590912|NCT01107093|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6590913|NCT01107093|Contraceptive Agents|contraceptive agents|mesh-ancestor
6590914|NCT01107093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6590915|NCT01107093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590916|NCT01107093|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6590917|NCT01107106|Ulipristal acetate|ulipristal acetate|mesh-list
6590918|NCT01107106|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6590919|NCT01107106|Contraceptive Agents|contraceptive agents|mesh-ancestor
6590920|NCT01107106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6590921|NCT01107106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590922|NCT01107106|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6590923|NCT01107145|Artesunate|artesunate|mesh-list
6590924|NCT01107145|Chloroquine|chloroquine|mesh-list
6590925|NCT01107145|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
6590926|NCT01107145|Lumefantrine|lumefantrine|mesh-list
6590927|NCT01107145|Artemether|artemether|mesh-list
6590928|NCT01107145|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6590929|NCT01107145|Mefloquine|mefloquine|mesh-list
6590930|NCT01107145|Antimalarials|antimalarials|mesh-ancestor
6590931|NCT01107145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6590932|NCT01107145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6590933|NCT01107145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6590934|NCT01107145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6590935|NCT01107145|Antiviral Agents|antiviral agents|mesh-ancestor
6590936|NCT01107145|Schistosomicides|schistosomicides|mesh-ancestor
6590937|NCT01107145|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6590938|NCT01107145|Anthelmintics|anthelmintics|mesh-ancestor
6590939|NCT01107145|Amebicides|amebicides|mesh-ancestor
6590940|NCT01107145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6590941|NCT01107145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6590942|NCT01107145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6590943|NCT01107145|Analgesics|analgesics|mesh-ancestor
6590944|NCT01107145|Sensory System Agents|sensory system agents|mesh-ancestor
6590945|NCT01107145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6590946|NCT01107145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590947|NCT01107145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6590948|NCT01107145|Filaricides|filaricides|mesh-ancestor
6590949|NCT01107145|Antinematodal Agents|antinematodal agents|mesh-ancestor
6590950|NCT01107223|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6590951|NCT01107223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6590952|NCT01107223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6590953|NCT01107223|Antitubercular Agents|antitubercular agents|mesh-ancestor
6590954|NCT01107236|Naproxen|naproxen|mesh-list
6590955|NCT01107236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6590956|NCT01107236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6590957|NCT01107236|Analgesics|analgesics|mesh-ancestor
6590958|NCT01107236|Sensory System Agents|sensory system agents|mesh-ancestor
6590959|NCT01107236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6590960|NCT01107236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590961|NCT01107236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6590962|NCT01107236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6590963|NCT01107236|Gout Suppressants|gout suppressants|mesh-ancestor
6590964|NCT01107236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6590965|NCT01107236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6590966|NCT01107236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590967|NCT01107431|Chromium|chromium|mesh-list
6590968|NCT01107431|Trace Elements|trace elements|mesh-ancestor
6590969|NCT01107431|Micronutrients|micronutrients|mesh-ancestor
6590970|NCT01107431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659182|NCT01486485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659183|NCT01486485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6659184|NCT01486485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6659185|NCT01486485|Anticoagulants|anticoagulants|mesh-ancestor
6659186|NCT01486485|Protease Inhibitors|protease inhibitors|mesh-ancestor
6659187|NCT01486485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6659188|NCT01486485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6659189|NCT01486485|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6659190|NCT01486485|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6659191|NCT01486485|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6659192|NCT01486485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6659193|NCT01486485|Immunologic Factors|immunologic factors|mesh-ancestor
6659194|NCT01486511|Liver Extracts|liver extracts|mesh-list
6659195|NCT01486511|Hematinics|hematinics|mesh-ancestor
6659196|NCT01486550|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
6659197|NCT01486550|Plasma Substitutes|plasma substitutes|mesh-ancestor
6659198|NCT01486550|Blood Substitutes|blood substitutes|mesh-ancestor
6659199|NCT01486563|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
6659200|NCT01486563|Plasma Substitutes|plasma substitutes|mesh-ancestor
6659201|NCT01486563|Blood Substitutes|blood substitutes|mesh-ancestor
6659202|NCT01486576|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
6659203|NCT01486576|Plasma Substitutes|plasma substitutes|mesh-ancestor
6659204|NCT01486576|Blood Substitutes|blood substitutes|mesh-ancestor
6659205|NCT01486602|Paclitaxel|paclitaxel|mesh-list
6659206|NCT01486602|Carboplatin|carboplatin|mesh-list
6590971|NCT01107509|Everolimus|everolimus|mesh-list
6590972|NCT01107509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6590973|NCT01107509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6590974|NCT01107509|Immunologic Factors|immunologic factors|mesh-ancestor
6590975|NCT01107509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590976|NCT01107522|Temozolomide|temozolomide|mesh-list
6590977|NCT01107522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6590978|NCT01107522|Alkylating Agents|alkylating agents|mesh-ancestor
6590979|NCT01107522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590980|NCT01107522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6590981|NCT01107574|Gabapentin|gabapentin|mesh-list
6590982|NCT01107574|Analgesics|analgesics|mesh-ancestor
6590983|NCT01107574|Sensory System Agents|sensory system agents|mesh-ancestor
6590984|NCT01107574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6590985|NCT01107574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6590986|NCT01107574|Anticonvulsants|anticonvulsants|mesh-ancestor
6590987|NCT01107574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6590988|NCT01107574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6590989|NCT01107574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6590990|NCT01107574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6590991|NCT01107574|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6447658|NCT00398463|Protective Agents|protective agents|mesh-ancestor
6447659|NCT00398489|Tamoxifen|tamoxifen|mesh-list
6447660|NCT00398489|Cyclophosphamide|cyclophosphamide|mesh-list
6447661|NCT00398489|Docetaxel|docetaxel|mesh-list
6447662|NCT00398489|Trastuzumab|trastuzumab|mesh-list
6447663|NCT00398489|Epirubicin|epirubicin|mesh-list
6590992|NCT01107574|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6590993|NCT01107574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6447664|NCT00398489|Anastrozole|anastrozole|mesh-list
6447665|NCT00398489|Goserelin|goserelin|mesh-list
6447666|NCT00398489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6447667|NCT00398489|Immunologic Factors|immunologic factors|mesh-ancestor
6590994|NCT01107574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6590995|NCT01107574|Antimanic Agents|antimanic agents|mesh-ancestor
6590996|NCT01107639|Docetaxel|docetaxel|mesh-list
6590997|NCT01107639|Cetuximab|cetuximab|mesh-list
6590998|NCT01107639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6590999|NCT01107639|Tubulin Modulators|tubulin modulators|mesh-ancestor
6591000|NCT01107639|Antimitotic Agents|antimitotic agents|mesh-ancestor
6591001|NCT01107639|Mitosis Modulators|mitosis modulators|mesh-ancestor
6591002|NCT01107639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591003|NCT01107639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6591004|NCT01107717|Metformin|metformin|mesh-list
6591005|NCT01107717|Pioglitazone|pioglitazone|mesh-list
6591006|NCT01107717|Exenatide|exenatide|mesh-list
6591007|NCT01107717|Glyburide|glyburide|mesh-list
6591008|NCT01107717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6591009|NCT01107717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591010|NCT01107717|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6591011|NCT01107717|Incretins|incretins|mesh-ancestor
6591012|NCT01107717|Hormones|hormones|mesh-ancestor
6591013|NCT01107717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6591014|NCT01107756|Lenograstim|lenograstim|mesh-list
6591015|NCT01107756|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6591016|NCT01107756|Immunologic Factors|immunologic factors|mesh-ancestor
6591017|NCT01107756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591018|NCT01107782|Sildenafil Citrate|sildenafil citrate|mesh-list
6591019|NCT01107782|Vasodilator Agents|vasodilator agents|mesh-ancestor
6591020|NCT01107782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6591021|NCT01107782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6591022|NCT01107782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6591023|NCT01107782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591024|NCT01107782|Urological Agents|urological agents|mesh-ancestor
6591025|NCT01107808|Calcium, Dietary|calcium, dietary|mesh-list
6591026|NCT01107808|Vitamin D|vitamin d|mesh-list
6591027|NCT01107808|Ergocalciferols|ergocalciferols|mesh-list
6591028|NCT01107808|Metformin|metformin|mesh-list
6591029|NCT01107808|Calcium|calcium|mesh-list
6591030|NCT01107808|Vitamins|vitamins|mesh-ancestor
6591031|NCT01107808|Micronutrients|micronutrients|mesh-ancestor
6591032|NCT01107808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591033|NCT01107808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6591034|NCT01107808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6591035|NCT01107808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6591036|NCT01107938|Esomeprazole|esomeprazole|mesh-list
6591037|NCT01107938|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6591038|NCT01107938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6591039|NCT01107938|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6591040|NCT01107938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6591041|NCT01107938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591042|NCT01107951|Dexamethasone|dexamethasone|mesh-list
6591043|NCT01107951|Rituximab|rituximab|mesh-list
6591044|NCT01107951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6591045|NCT01107951|Antiemetics|antiemetics|mesh-ancestor
6591046|NCT01107951|Autonomic Agents|autonomic agents|mesh-ancestor
6591047|NCT01107951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6591048|NCT01107951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591049|NCT01107951|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6591050|NCT01107951|Glucocorticoids|glucocorticoids|mesh-ancestor
6591051|NCT01107951|Hormones|hormones|mesh-ancestor
6591052|NCT01107951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6591053|NCT01107951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6591054|NCT01107951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6591055|NCT01107951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6591056|NCT01107951|Immunologic Factors|immunologic factors|mesh-ancestor
6591057|NCT01107951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6591058|NCT01108029|Memantine|memantine|mesh-list
6591059|NCT01108029|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6591060|NCT01108029|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6591061|NCT01108029|Dopamine Agents|dopamine agents|mesh-ancestor
6447668|NCT00398489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447669|NCT00398489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6447670|NCT00398489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6447671|NCT00398489|Alkylating Agents|alkylating agents|mesh-ancestor
6447672|NCT00398489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447673|NCT00398489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6447674|NCT00398489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6447675|NCT00398489|Tubulin Modulators|tubulin modulators|mesh-ancestor
6447676|NCT00398489|Antimitotic Agents|antimitotic agents|mesh-ancestor
6591062|NCT01108029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6591063|NCT01108029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591064|NCT01108029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591065|NCT01108029|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6591066|NCT01108029|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6591067|NCT01108042|Docetaxel|docetaxel|mesh-list
6591068|NCT01108042|Fluorouracil|fluorouracil|mesh-list
6591069|NCT01108042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6591070|NCT01108042|Tubulin Modulators|tubulin modulators|mesh-ancestor
6591071|NCT01108042|Antimitotic Agents|antimitotic agents|mesh-ancestor
6447677|NCT00398489|Mitosis Modulators|mitosis modulators|mesh-ancestor
6447678|NCT00398489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6591072|NCT01108042|Mitosis Modulators|mitosis modulators|mesh-ancestor
6659207|NCT01486602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6447679|NCT00398489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6591073|NCT01108042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591074|NCT01108042|Antimetabolites|antimetabolites|mesh-ancestor
6591075|NCT01108042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6591076|NCT01108042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6591077|NCT01108042|Immunologic Factors|immunologic factors|mesh-ancestor
6591078|NCT01108042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591079|NCT01108055|Paclitaxel|paclitaxel|mesh-list
6591080|NCT01108055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6591081|NCT01108055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6591082|NCT01108055|Tubulin Modulators|tubulin modulators|mesh-ancestor
6591083|NCT01108055|Antimitotic Agents|antimitotic agents|mesh-ancestor
6591084|NCT01108055|Mitosis Modulators|mitosis modulators|mesh-ancestor
6591085|NCT01108055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591086|NCT01108107|Capecitabine|capecitabine|mesh-list
6591087|NCT01108107|Oxaliplatin|oxaliplatin|mesh-list
6591088|NCT01108107|Panitumumab|panitumumab|mesh-list
6591089|NCT01108107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6591090|NCT01108107|Antimetabolites|antimetabolites|mesh-ancestor
6591091|NCT01108107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591092|NCT01108107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6591093|NCT01108107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6591094|NCT01108133|Dexamethasone|dexamethasone|mesh-list
6591095|NCT01108133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6591096|NCT01108133|Antiemetics|antiemetics|mesh-ancestor
6591097|NCT01108133|Autonomic Agents|autonomic agents|mesh-ancestor
6591098|NCT01108133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6591099|NCT01108133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591100|NCT01108133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6591101|NCT01108133|Glucocorticoids|glucocorticoids|mesh-ancestor
6591102|NCT01108133|Hormones|hormones|mesh-ancestor
6591103|NCT01108133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6591104|NCT01108133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6591105|NCT01108133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6591106|NCT01108146|Hydrocortisone|hydrocortisone|mesh-list
6591107|NCT01108146|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6591108|NCT01108146|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6591109|NCT01108146|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6591110|NCT01108146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6591111|NCT01108198|Mometasone Furoate|mometasone furoate|mesh-list
6591112|NCT01108198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6591113|NCT01108198|Dermatologic Agents|dermatologic agents|mesh-ancestor
6591114|NCT01108198|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6591115|NCT01108289|Oxytocin|oxytocin|mesh-list
6591116|NCT01108289|Oxytocics|oxytocics|mesh-ancestor
6591117|NCT01108289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6591118|NCT01108289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591119|NCT01108302|Oxytocin|oxytocin|mesh-list
6591120|NCT01108302|Oxytocics|oxytocics|mesh-ancestor
6591121|NCT01108302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6591122|NCT01108302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591123|NCT01108393|S 20098|s 20098|mesh-list
6591124|NCT01108393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6591125|NCT01108393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6591126|NCT01108393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591127|NCT01108562|Lidocaine|lidocaine|mesh-list
6591128|NCT01108562|Anesthetics, Local|anesthetics, local|mesh-ancestor
6591129|NCT01108562|Anesthetics|anesthetics|mesh-ancestor
6591130|NCT01108562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6591131|NCT01108562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591132|NCT01108562|Sensory System Agents|sensory system agents|mesh-ancestor
6591133|NCT01108562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6591134|NCT01108562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6591135|NCT01108562|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6591136|NCT01108562|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6591137|NCT01108562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6591138|NCT01108562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591139|NCT01108588|Aspirin|aspirin|mesh-list
6591140|NCT01108588|Clopidogrel|clopidogrel|mesh-list
6591141|NCT01108588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6591142|NCT01108588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6591143|NCT01108588|Analgesics|analgesics|mesh-ancestor
6591144|NCT01108588|Sensory System Agents|sensory system agents|mesh-ancestor
6591145|NCT01108588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6591146|NCT01108588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447680|NCT00398489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6447681|NCT00398489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6447682|NCT00398489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6591147|NCT01108588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6591148|NCT01108588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6591149|NCT01108588|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6447683|NCT00398489|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6447684|NCT00398489|Hormone Antagonists|hormone antagonists|mesh-ancestor
6447685|NCT00398489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6447686|NCT00398489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6447687|NCT00398489|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6447688|NCT00398489|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6591150|NCT01108588|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6591151|NCT01108588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591152|NCT01108588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6591153|NCT01108588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6591154|NCT01108588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6591155|NCT01108588|Antipyretics|antipyretics|mesh-ancestor
6591156|NCT01108588|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6591157|NCT01108588|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6591158|NCT01108588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6591159|NCT01108588|Purinergic Agents|purinergic agents|mesh-ancestor
6591160|NCT01108588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6591161|NCT01108601|Ciprofloxacin|ciprofloxacin|mesh-list
6591162|NCT01108601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6591163|NCT01108601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6591164|NCT01108601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6591165|NCT01108601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6591166|NCT01108601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6591167|NCT01108601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591168|NCT01108601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6591169|NCT01108601|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6591170|NCT01108601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6591171|NCT01108627|Formoterol Fumarate|formoterol fumarate|mesh-list
6591172|NCT01108627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6591173|NCT01108627|Autonomic Agents|autonomic agents|mesh-ancestor
6591174|NCT01108627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6591175|NCT01108627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591176|NCT01108627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6591177|NCT01108627|Respiratory System Agents|respiratory system agents|mesh-ancestor
6591178|NCT01108627|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6591179|NCT01108627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6591180|NCT01108627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6591181|NCT01108627|Adrenergic Agents|adrenergic agents|mesh-ancestor
6591182|NCT01108627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6591183|NCT01108627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591184|NCT01108744|Mannitol|mannitol|mesh-list
6591185|NCT01108744|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6591186|NCT01108744|Diuretics|diuretics|mesh-ancestor
6591187|NCT01108744|Natriuretic Agents|natriuretic agents|mesh-ancestor
6591188|NCT01108744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591189|NCT01108783|Desloratadine|desloratadine|mesh-list
6591190|NCT01108783|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6591191|NCT01108783|Cholinergic Agents|cholinergic agents|mesh-ancestor
6591192|NCT01108783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6591193|NCT01108783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591194|NCT01108783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591195|NCT01108783|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6591196|NCT01108783|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6591197|NCT01108783|Histamine Antagonists|histamine antagonists|mesh-ancestor
6591198|NCT01108783|Histamine Agents|histamine agents|mesh-ancestor
6591199|NCT01108848|Complement C1s|complement c1s|mesh-list
6447689|NCT00398489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6447690|NCT00398489|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6447691|NCT00398489|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6447692|NCT00398515|Sirolimus|sirolimus|mesh-list
6447693|NCT00398515|Lenalidomide|lenalidomide|mesh-list
6447694|NCT00398515|Immunologic Factors|immunologic factors|mesh-ancestor
6447695|NCT00398515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447696|NCT00398515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6447697|NCT00398515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6447698|NCT00398515|Growth Substances|growth substances|mesh-ancestor
6447699|NCT00398515|Growth Inhibitors|growth inhibitors|mesh-ancestor
6591200|NCT01108848|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
6447700|NCT00398515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6447701|NCT00398515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6447702|NCT00398515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6447703|NCT00398515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6447704|NCT00398515|Antifungal Agents|antifungal agents|mesh-ancestor
6447705|NCT00398515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6447706|NCT00398528|Glatiramer Acetate|glatiramer acetate|mesh-list
6447707|NCT00398528|(T,G)-A-L|(t,g)-a-l|mesh-list
6447708|NCT00398528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6447709|NCT00398528|Immunologic Factors|immunologic factors|mesh-ancestor
6591201|NCT01108848|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
6591202|NCT01108848|Immunologic Factors|immunologic factors|mesh-ancestor
6591203|NCT01108848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591204|NCT01108848|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6591205|NCT01108848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6591206|NCT01108874|Metaraminol|metaraminol|mesh-list
6591207|NCT01108874|Sympathomimetics|sympathomimetics|mesh-ancestor
6591208|NCT01108874|Autonomic Agents|autonomic agents|mesh-ancestor
6591209|NCT01108874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6591210|NCT01108874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591211|NCT01108874|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6591212|NCT01108874|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6591213|NCT01108874|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6591214|NCT01108874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6591215|NCT01108874|Adrenergic Agents|adrenergic agents|mesh-ancestor
6591216|NCT01108874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6591217|NCT01108874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591218|NCT01108900|Sildenafil Citrate|sildenafil citrate|mesh-list
6447710|NCT00398528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447711|NCT00398528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6447712|NCT00398528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6447713|NCT00398554|Prednisone|prednisone|mesh-list
6447714|NCT00398554|Cyclophosphamide|cyclophosphamide|mesh-list
6447715|NCT00398554|Doxorubicin|doxorubicin|mesh-list
6447716|NCT00398554|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6447717|NCT00398554|Etoposide|etoposide|mesh-list
6591219|NCT01108900|Vasodilator Agents|vasodilator agents|mesh-ancestor
6591220|NCT01108900|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6591221|NCT01108900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6591222|NCT01108900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6591223|NCT01108900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591224|NCT01108900|Urological Agents|urological agents|mesh-ancestor
6591225|NCT01108926|Tenofovir|tenofovir|mesh-list
6591226|NCT01108926|Emtricitabine|emtricitabine|mesh-list
6591227|NCT01108926|Efavirenz|efavirenz|mesh-list
6591228|NCT01108926|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6591229|NCT01108926|Antiviral Agents|antiviral agents|mesh-ancestor
6591230|NCT01108926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6591231|NCT01108926|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6591232|NCT01108926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6591233|NCT01108926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6591234|NCT01108926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591235|NCT01108926|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6591236|NCT01108926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6591237|NCT01108926|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6591238|NCT01108926|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6591239|NCT01108926|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6591240|NCT01108926|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6591241|NCT01108926|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6591242|NCT01108926|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6591243|NCT01108939|Antimalarials|antimalarials|mesh-list
6591244|NCT01108939|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6591245|NCT01108939|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6591246|NCT01108939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6591247|NCT01109030|Pioglitazone|pioglitazone|mesh-list
6591248|NCT01109030|Chlordiazepoxide|chlordiazepoxide|mesh-list
6591249|NCT01109030|Dexetimide|dexetimide|mesh-list
6591250|NCT01109030|Citalopram|citalopram|mesh-list
6591251|NCT01109030|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6591252|NCT01109030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591253|NCT01109030|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6591254|NCT01109030|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6591255|NCT01109030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6591256|NCT01109030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591257|NCT01109030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6591258|NCT01109030|Serotonin Agents|serotonin agents|mesh-ancestor
6591259|NCT01109030|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6591260|NCT01109030|Antidepressive Agents|antidepressive agents|mesh-ancestor
6591261|NCT01109030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6591262|NCT01109030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6591263|NCT01109030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6591264|NCT01109030|Parasympatholytics|parasympatholytics|mesh-ancestor
6591265|NCT01109030|Autonomic Agents|autonomic agents|mesh-ancestor
6591266|NCT01109030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6591267|NCT01109030|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6591268|NCT01109030|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6591269|NCT01109030|Cholinergic Agents|cholinergic agents|mesh-ancestor
6591270|NCT01109030|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6591271|NCT01109030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6591272|NCT01109030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6591273|NCT01109030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6591274|NCT01109030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6591275|NCT01109030|GABA Modulators|gaba modulators|mesh-ancestor
6591276|NCT01109030|GABA Agents|gaba agents|mesh-ancestor
6591277|NCT01109043|Bisoprolol|bisoprolol|mesh-list
6591278|NCT01109043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6591279|NCT01109043|Sympatholytics|sympatholytics|mesh-ancestor
6591280|NCT01109043|Autonomic Agents|autonomic agents|mesh-ancestor
6591281|NCT01109043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6591282|NCT01109043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591283|NCT01109043|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6591284|NCT01109043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6591285|NCT01109043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6591286|NCT01109043|Adrenergic Agents|adrenergic agents|mesh-ancestor
6591287|NCT01109043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6591288|NCT01109043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591289|NCT01109121|Allopurinol|allopurinol|mesh-list
6591290|NCT01109121|Antimetabolites|antimetabolites|mesh-ancestor
6591291|NCT01109121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591292|NCT01109121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6591293|NCT01109121|Gout Suppressants|gout suppressants|mesh-ancestor
6591294|NCT01109121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6591295|NCT01109121|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6591296|NCT01109121|Antioxidants|antioxidants|mesh-ancestor
6591297|NCT01109121|Protective Agents|protective agents|mesh-ancestor
6591298|NCT01109121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591299|NCT01109134|Tirofiban|tirofiban|mesh-list
6591300|NCT01109134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6591301|NCT01109134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6591302|NCT01109134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591303|NCT01109134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6591304|NCT01109160|Azithromycin|azithromycin|mesh-list
6591305|NCT01109160|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6591306|NCT01109160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6591307|NCT01109212|Bindarit|bindarit|mesh-list
6591308|NCT01109212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6591309|NCT01109212|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6591310|NCT01109212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6591311|NCT01109212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591312|NCT01109264|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6591313|NCT01109264|Chlorambucil|chlorambucil|mesh-list
6591314|NCT01109264|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6591315|NCT01109264|Alkylating Agents|alkylating agents|mesh-ancestor
6591316|NCT01109264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591317|NCT01109264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6659208|NCT01486602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6659209|NCT01486602|Tubulin Modulators|tubulin modulators|mesh-ancestor
6659210|NCT01486602|Antimitotic Agents|antimitotic agents|mesh-ancestor
6659211|NCT01486602|Mitosis Modulators|mitosis modulators|mesh-ancestor
6659212|NCT01486602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6659213|NCT01486706|Gabapentin|gabapentin|mesh-list
6659214|NCT01486706|Solifenacin Succinate|solifenacin succinate|mesh-list
6659215|NCT01486706|Analgesics|analgesics|mesh-ancestor
6659216|NCT01486706|Sensory System Agents|sensory system agents|mesh-ancestor
6659217|NCT01486706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6659218|NCT01486706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659219|NCT01486706|Anticonvulsants|anticonvulsants|mesh-ancestor
6659220|NCT01486706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6659221|NCT01486706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6659222|NCT01486706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6659223|NCT01486706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6659224|NCT01486706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6659225|NCT01486706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6659226|NCT01486706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6659227|NCT01486706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6659228|NCT01486706|Antimanic Agents|antimanic agents|mesh-ancestor
6659229|NCT01486706|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6659230|NCT01486706|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6659231|NCT01486706|Cholinergic Agents|cholinergic agents|mesh-ancestor
6659232|NCT01486706|Urological Agents|urological agents|mesh-ancestor
6659233|NCT01486823|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6659234|NCT01486823|Immunologic Factors|immunologic factors|mesh-ancestor
6659235|NCT01486823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664855|NCT01514266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6664856|NCT01514344|Rituximab|rituximab|mesh-list
6591318|NCT01109446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6591319|NCT01109485|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
6591320|NCT01109485|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6591321|NCT01109485|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6591322|NCT01109485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6591323|NCT01109485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6591324|NCT01109485|Analgesics|analgesics|mesh-ancestor
6591325|NCT01109485|Sensory System Agents|sensory system agents|mesh-ancestor
6591326|NCT01109485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6591327|NCT01109485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591328|NCT01109485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6591329|NCT01109485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6591330|NCT01109485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6591331|NCT01109485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6591332|NCT01109485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6591333|NCT01109485|Histamine Antagonists|histamine antagonists|mesh-ancestor
6591334|NCT01109485|Histamine Agents|histamine agents|mesh-ancestor
6591335|NCT01109485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6591336|NCT01109485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591337|NCT01109498|Cyclosporine|cyclosporine|mesh-list
6591338|NCT01109498|Mycophenolic Acid|mycophenolic acid|mesh-list
6591339|NCT01109498|Cyclosporins|cyclosporins|mesh-list
6591340|NCT01109498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6591341|NCT01109498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591342|NCT01109498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6591343|NCT01109498|Immunologic Factors|immunologic factors|mesh-ancestor
6591344|NCT01109498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591345|NCT01109498|Antifungal Agents|antifungal agents|mesh-ancestor
6591346|NCT01109498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6591347|NCT01109498|Dermatologic Agents|dermatologic agents|mesh-ancestor
6591348|NCT01109498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6591349|NCT01109498|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6591350|NCT01109498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6591351|NCT01109498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6591352|NCT01109498|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6591353|NCT01109498|Antitubercular Agents|antitubercular agents|mesh-ancestor
6591354|NCT01109498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6591355|NCT01109511|Oxycodone|oxycodone|mesh-list
6591356|NCT01109511|Naloxone|naloxone|mesh-list
6591357|NCT01109511|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6591358|NCT01109511|Narcotics|narcotics|mesh-ancestor
6591359|NCT01109511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6591360|NCT01109511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591361|NCT01109511|Analgesics|analgesics|mesh-ancestor
6591362|NCT01109511|Sensory System Agents|sensory system agents|mesh-ancestor
6591363|NCT01109511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6591364|NCT01109511|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6591365|NCT01109615|Gemcitabine|gemcitabine|mesh-list
6591366|NCT01109615|Pemetrexed|pemetrexed|mesh-list
6591367|NCT01109615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6591368|NCT01109615|Antimetabolites|antimetabolites|mesh-ancestor
6591369|NCT01109615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591370|NCT01109615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6591371|NCT01109615|Antiviral Agents|antiviral agents|mesh-ancestor
6591372|NCT01109615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6591373|NCT01109615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6591374|NCT01109615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6591375|NCT01109615|Immunologic Factors|immunologic factors|mesh-ancestor
6591376|NCT01109615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591377|NCT01109615|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6591378|NCT01109615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6591379|NCT01109654|Cetrorelix|cetrorelix|mesh-list
6591380|NCT01109654|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6591381|NCT01109654|Hormones|hormones|mesh-ancestor
6591382|NCT01109654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6591383|NCT01109654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591384|NCT01109654|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6591385|NCT01109654|Fertility Agents|fertility agents|mesh-ancestor
6591386|NCT01109654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6591387|NCT01109654|Hormone Antagonists|hormone antagonists|mesh-ancestor
6591388|NCT01109693|Mirtazapine|mirtazapine|mesh-list
6591389|NCT01109693|Sertraline|sertraline|mesh-list
6591390|NCT01109693|Antidepressive Agents|antidepressive agents|mesh-ancestor
6591391|NCT01109693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6591392|NCT01109693|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6591393|NCT01109693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6591394|NCT01109693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6591395|NCT01109693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591396|NCT01109693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6591397|NCT01109693|Serotonin Agents|serotonin agents|mesh-ancestor
6591398|NCT01109693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591399|NCT01109693|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6591400|NCT01109693|Histamine Antagonists|histamine antagonists|mesh-ancestor
6591401|NCT01109693|Histamine Agents|histamine agents|mesh-ancestor
6591402|NCT01109693|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6591403|NCT01109693|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6591404|NCT01109693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6591405|NCT01109693|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6591406|NCT01109693|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6591407|NCT01109693|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6591408|NCT01109693|Adrenergic Agents|adrenergic agents|mesh-ancestor
6591409|NCT01109693|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6591410|NCT01109693|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6591411|NCT01109693|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6591412|NCT01109758|Fenofibrate|fenofibrate|mesh-list
6591413|NCT01109758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6591414|NCT01109758|Antimetabolites|antimetabolites|mesh-ancestor
6591415|NCT01109758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591416|NCT01109758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6591417|NCT01109784|Clopidogrel|clopidogrel|mesh-list
6591418|NCT01109784|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6591419|NCT01109784|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6591420|NCT01109784|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6591421|NCT01109784|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6591422|NCT01109784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6591423|NCT01109784|Purinergic Agents|purinergic agents|mesh-ancestor
6591424|NCT01109784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6591425|NCT01109784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591426|NCT01109784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447718|NCT00398554|Vincristine|vincristine|mesh-list
6591427|NCT01109823|Levofloxacin|levofloxacin|mesh-list
6591428|NCT01109823|Ofloxacin|ofloxacin|mesh-list
6591429|NCT01109823|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6591430|NCT01109823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6591431|NCT01109823|Renal Agents|renal agents|mesh-ancestor
6591432|NCT01109823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6591433|NCT01109823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6591434|NCT01109823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6591435|NCT01109823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6591436|NCT01109823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591437|NCT01109823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6591438|NCT01109823|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6591439|NCT01109823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6591440|NCT01109888|Cetrorelix|cetrorelix|mesh-list
6591441|NCT01109888|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6591442|NCT01109888|Fertility Agents|fertility agents|mesh-ancestor
6591443|NCT01109888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6591444|NCT01109888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591445|NCT01109888|Hormone Antagonists|hormone antagonists|mesh-ancestor
6591446|NCT01109888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6591447|NCT01109927|Insulin|insulin|mesh-list
6591448|NCT01109927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6591449|NCT01109927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591450|NCT01110031|Ofatumumab|ofatumumab|mesh-list
6591451|NCT01110031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6591452|NCT01110226|Cisplatin|cisplatin|mesh-list
6591453|NCT01110226|Sodium arsenite|sodium arsenite|mesh-list
6591454|NCT01110226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6591455|NCT01110226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6591456|NCT01110226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591457|NCT01110291|Docetaxel|docetaxel|mesh-list
6591458|NCT01110291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6591459|NCT01110291|Tubulin Modulators|tubulin modulators|mesh-ancestor
6591460|NCT01110291|Antimitotic Agents|antimitotic agents|mesh-ancestor
6591461|NCT01110291|Mitosis Modulators|mitosis modulators|mesh-ancestor
6591462|NCT01110291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591463|NCT01110304|Analgesics|analgesics|mesh-list
6591464|NCT01110304|Sensory System Agents|sensory system agents|mesh-ancestor
6591465|NCT01110304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6591466|NCT01110304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591467|NCT01110317|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6591468|NCT01110317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6591469|NCT01110317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6591470|NCT01110317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6591471|NCT01110317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591472|NCT01110317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6591473|NCT01110317|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6591474|NCT01110317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6591475|NCT01110317|Serotonin Agents|serotonin agents|mesh-ancestor
6591476|NCT01110317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6591477|NCT01110317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591478|NCT01110317|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6591479|NCT01110317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6591480|NCT01110317|Dopamine Agents|dopamine agents|mesh-ancestor
6591481|NCT01110473|Azacitidine|azacitidine|mesh-list
6591482|NCT01110473|Ilorasertib|ilorasertib|mesh-list
6447719|NCT00398554|Vinblastine|vinblastine|mesh-list
6447720|NCT00398554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6447721|NCT00398554|Immunologic Factors|immunologic factors|mesh-ancestor
6447722|NCT00398554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447723|NCT00398554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6447724|NCT00398554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6447725|NCT00398554|Alkylating Agents|alkylating agents|mesh-ancestor
6447726|NCT00398554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447727|NCT00398554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6447728|NCT00398554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6447729|NCT00398554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6447730|NCT00398554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6447731|NCT00398554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6447732|NCT00398554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6447733|NCT00398554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6447734|NCT00398554|Glucocorticoids|glucocorticoids|mesh-ancestor
6591483|NCT01110473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6447735|NCT00398554|Hormones|hormones|mesh-ancestor
6591484|NCT01110473|Antimetabolites|antimetabolites|mesh-ancestor
6591485|NCT01110473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724827|NCT03185130|Sensory System Agents|sensory system agents|mesh-ancestor
6591486|NCT01110473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6591487|NCT01110473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6591488|NCT01110473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6591489|NCT01110486|Carboplatin|carboplatin|mesh-list
6591490|NCT01110486|Docetaxel|docetaxel|mesh-list
6591491|NCT01110486|Ilorasertib|ilorasertib|mesh-list
6591492|NCT01110486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6591493|NCT01110486|Tubulin Modulators|tubulin modulators|mesh-ancestor
6591494|NCT01110486|Antimitotic Agents|antimitotic agents|mesh-ancestor
6591495|NCT01110486|Mitosis Modulators|mitosis modulators|mesh-ancestor
6591496|NCT01110486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591497|NCT01110486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6591498|NCT01110486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6591499|NCT01110551|Vaccines|vaccines|mesh-list
6591500|NCT01110551|Immunologic Factors|immunologic factors|mesh-ancestor
6591501|NCT01110551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591502|NCT01110590|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6591503|NCT01110590|Vasodilator Agents|vasodilator agents|mesh-ancestor
6591504|NCT01110590|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6591505|NCT01110590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6591506|NCT01110590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6591507|NCT01110590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591508|NCT01110590|Urological Agents|urological agents|mesh-ancestor
6591509|NCT01110603|Paclitaxel|paclitaxel|mesh-list
6591510|NCT01110603|Carboplatin|carboplatin|mesh-list
6591511|NCT01110603|Doxorubicin|doxorubicin|mesh-list
6591512|NCT01110603|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6591513|NCT01110603|Niraparib|niraparib|mesh-list
6591514|NCT01110603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6591515|NCT01110603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6591516|NCT01110603|Tubulin Modulators|tubulin modulators|mesh-ancestor
6591517|NCT01110603|Antimitotic Agents|antimitotic agents|mesh-ancestor
6591518|NCT01110603|Mitosis Modulators|mitosis modulators|mesh-ancestor
6591519|NCT01110603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591520|NCT01110603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6591521|NCT01110603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6591522|NCT01110603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6591523|NCT01110603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6591524|NCT01110603|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6591525|NCT01110616|Lorazepam|lorazepam|mesh-list
6591526|NCT01110616|Anticonvulsants|anticonvulsants|mesh-ancestor
6591527|NCT01110616|Antiemetics|antiemetics|mesh-ancestor
6591528|NCT01110616|Autonomic Agents|autonomic agents|mesh-ancestor
6591529|NCT01110616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6591530|NCT01110616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591531|NCT01110616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6591532|NCT01110616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6591533|NCT01110616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6591534|NCT01110616|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6591535|NCT01110616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6591536|NCT01110616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6591537|NCT01110616|GABA Modulators|gaba modulators|mesh-ancestor
6591538|NCT01110616|GABA Agents|gaba agents|mesh-ancestor
6591539|NCT01110616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6591540|NCT01110616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591541|NCT01110642|Lovastatin|lovastatin|mesh-list
6591542|NCT01110642|L 647318|l 647318|mesh-list
6591543|NCT01110642|Dihydromevinolin|dihydromevinolin|mesh-list
6591544|NCT01110642|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6591545|NCT01110642|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6591546|NCT01110642|Antimetabolites|antimetabolites|mesh-ancestor
6591547|NCT01110642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591548|NCT01110642|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6591549|NCT01110642|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6591550|NCT01110642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6591551|NCT01110785|Panitumumab|panitumumab|mesh-list
6591552|NCT01110785|Simvastatin|simvastatin|mesh-list
6591553|NCT01110785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6591554|NCT01110785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6591555|NCT01110785|Antimetabolites|antimetabolites|mesh-ancestor
6591556|NCT01110785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591557|NCT01110785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6591558|NCT01110785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6591559|NCT01110785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6591560|NCT01110785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6591561|NCT01110785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6591562|NCT01110824|Carvedilol|carvedilol|mesh-list
6591563|NCT01110824|Enalapril|enalapril|mesh-list
6591564|NCT01110824|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6591565|NCT01110824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6591566|NCT01110824|Adrenergic Agents|adrenergic agents|mesh-ancestor
6591567|NCT01110824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6591568|NCT01110824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591569|NCT01110824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591570|NCT01110824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6591571|NCT01110824|Antioxidants|antioxidants|mesh-ancestor
6591572|NCT01110824|Protective Agents|protective agents|mesh-ancestor
6591573|NCT01110824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6591574|NCT01110824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6591575|NCT01110824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6591576|NCT01110824|Vasodilator Agents|vasodilator agents|mesh-ancestor
6591577|NCT01110824|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6591578|NCT01110824|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6591579|NCT01110824|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6591580|NCT01110824|Protease Inhibitors|protease inhibitors|mesh-ancestor
6591581|NCT01110824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6591582|NCT01110941|Leucovorin|leucovorin|mesh-list
6447736|NCT00398554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6447737|NCT00398554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6447738|NCT00398554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6447739|NCT00398554|Tubulin Modulators|tubulin modulators|mesh-ancestor
6447740|NCT00398554|Antimitotic Agents|antimitotic agents|mesh-ancestor
6447741|NCT00398554|Mitosis Modulators|mitosis modulators|mesh-ancestor
6447742|NCT00398580|Methyltestosterone|methyltestosterone|mesh-list
6447743|NCT00398580|Testosterone|testosterone|mesh-list
6447744|NCT00398580|Testosterone undecanoate|testosterone undecanoate|mesh-list
6591583|NCT01110941|Oxaliplatin|oxaliplatin|mesh-list
6591584|NCT01110941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6591585|NCT01110941|Antidotes|antidotes|mesh-ancestor
6591586|NCT01110941|Protective Agents|protective agents|mesh-ancestor
6591587|NCT01110941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591588|NCT01110941|Vitamin B Complex|vitamin b complex|mesh-ancestor
6591589|NCT01110941|Vitamins|vitamins|mesh-ancestor
6591590|NCT01110941|Micronutrients|micronutrients|mesh-ancestor
6591591|NCT01111019|Hormones|hormones|mesh-list
6659236|NCT01486862|Insulin Aspart|insulin aspart|mesh-list
6447745|NCT00398580|Testosterone enanthate|testosterone enanthate|mesh-list
6447746|NCT00398580|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6447747|NCT00398580|Dutasteride|dutasteride|mesh-list
6447748|NCT00398580|Androgens|androgens|mesh-ancestor
6447749|NCT00398580|Hormones|hormones|mesh-ancestor
6447750|NCT00398580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6447751|NCT00398580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447752|NCT00398580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6447753|NCT00398580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6447754|NCT00398580|Anabolic Agents|anabolic agents|mesh-ancestor
6447755|NCT00398580|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6447756|NCT00398580|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6591592|NCT01111019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6591593|NCT01111019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659237|NCT01486862|Biphasic Insulins|biphasic insulins|mesh-list
6659238|NCT01486862|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6659239|NCT01486862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6659240|NCT01486862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659241|NCT01486875|Insulin Aspart|insulin aspart|mesh-list
6659242|NCT01486875|Biphasic Insulins|biphasic insulins|mesh-list
6659243|NCT01486875|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6659244|NCT01486875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6659245|NCT01486875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659246|NCT01486888|Insulin|insulin|mesh-list
6659247|NCT01486888|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6659248|NCT01486888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6659249|NCT01486888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659250|NCT01486901|Insulin|insulin|mesh-list
6659251|NCT01486901|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6659252|NCT01486901|Isophane Insulin, Human|isophane insulin, human|mesh-list
6659253|NCT01486901|Insulin, Isophane|insulin, isophane|mesh-list
6659254|NCT01486901|Isophane insulin, beef|isophane insulin, beef|mesh-list
6659255|NCT01486901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6659256|NCT01486901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659257|NCT01486914|Insulin Aspart|insulin aspart|mesh-list
6659258|NCT01486914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6659259|NCT01486914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659260|NCT01486940|Insulin|insulin|mesh-list
6659261|NCT01486940|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6447757|NCT00398580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6447758|NCT00398580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447759|NCT00398580|Hormone Antagonists|hormone antagonists|mesh-ancestor
6447760|NCT00398658|Clindamycin|clindamycin|mesh-list
6447761|NCT00398658|Clindamycin palmitate|clindamycin palmitate|mesh-list
6447762|NCT00398658|Clindamycin phosphate|clindamycin phosphate|mesh-list
6447763|NCT00398658|Gentamicins|gentamicins|mesh-list
6447764|NCT00398658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6659262|NCT01486940|Insulin Aspart|insulin aspart|mesh-list
6659263|NCT01486940|Insulin Detemir|insulin detemir|mesh-list
6659264|NCT01486940|Isophane Insulin, Human|isophane insulin, human|mesh-list
6659265|NCT01486940|Insulin, Isophane|insulin, isophane|mesh-list
6659266|NCT01486940|Isophane insulin, beef|isophane insulin, beef|mesh-list
6447765|NCT00398658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6659267|NCT01486940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6659268|NCT01486940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447766|NCT00398658|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6447767|NCT00398658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6591594|NCT01111084|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6591595|NCT01111084|Hormones|hormones|mesh-ancestor
6591596|NCT01111084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6591597|NCT01111084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591598|NCT01111188|Bortezomib|bortezomib|mesh-list
6591599|NCT01111188|Palbociclib|palbociclib|mesh-list
6591600|NCT01111188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6591601|NCT01111188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6591602|NCT01111188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6591603|NCT01111188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591604|NCT01111227|Propofol|propofol|mesh-list
6591605|NCT01111227|Isoflurane|isoflurane|mesh-list
6591606|NCT01111227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6591607|NCT01111227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6591608|NCT01111227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591609|NCT01111227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6591610|NCT01111227|Anesthetics, General|anesthetics, general|mesh-ancestor
6591611|NCT01111227|Anesthetics|anesthetics|mesh-ancestor
6591612|NCT01111227|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6591613|NCT01111253|Amoxicillin|amoxicillin|mesh-list
6591614|NCT01111253|Clavulanic Acid|clavulanic acid|mesh-list
6591615|NCT01111253|Clavulanic Acids|clavulanic acids|mesh-list
6591616|NCT01111253|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6591617|NCT01111253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5501639|NCT04472416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5501640|NCT04472416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591618|NCT01111253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6591619|NCT01111253|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6591620|NCT01111253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6591621|NCT01111253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591622|NCT01111383|Tobramycin|tobramycin|mesh-list
5501648|NCT04471922|Rabeprazole|rabeprazole|mesh-list
5501649|NCT04471922|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5501650|NCT04471922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5501651|NCT04471922|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5501652|NCT04471922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5501653|NCT04471922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501654|NCT04471974|Pembrolizumab|pembrolizumab|mesh-list
5501655|NCT04471974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5501656|NCT04471974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5501657|NCT04472143|Granisetron|granisetron|mesh-list
5501658|NCT04472143|Antiemetics|antiemetics|mesh-ancestor
5501659|NCT04472143|Autonomic Agents|autonomic agents|mesh-ancestor
5501660|NCT04472143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5501661|NCT04472143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591623|NCT01111383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6591624|NCT01111383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6591625|NCT01111422|Acetylcysteine|acetylcysteine|mesh-list
6591626|NCT01111422|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6591627|NCT01111422|Antiviral Agents|antiviral agents|mesh-ancestor
6591628|NCT01111422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6591629|NCT01111422|Expectorants|expectorants|mesh-ancestor
6591630|NCT01111422|Respiratory System Agents|respiratory system agents|mesh-ancestor
6591631|NCT01111422|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6591632|NCT01111422|Antioxidants|antioxidants|mesh-ancestor
6591633|NCT01111422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591634|NCT01111422|Protective Agents|protective agents|mesh-ancestor
5501662|NCT04472143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6591635|NCT01111422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591636|NCT01111422|Antidotes|antidotes|mesh-ancestor
6447768|NCT00398658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447769|NCT00398684|Nevirapine|nevirapine|mesh-list
6447770|NCT00398684|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6447771|NCT00398684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6447772|NCT00398684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6447773|NCT00398684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447774|NCT00398684|Antiviral Agents|antiviral agents|mesh-ancestor
6447775|NCT00398684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6591637|NCT01111448|Sirolimus|sirolimus|mesh-list
6591638|NCT01111448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6591639|NCT01111448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6591640|NCT01111448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6591641|NCT01111448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6591642|NCT01111448|Antifungal Agents|antifungal agents|mesh-ancestor
6591643|NCT01111448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6591644|NCT01111448|Immunologic Factors|immunologic factors|mesh-ancestor
6591645|NCT01111448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591646|NCT01111513|Analgesics|analgesics|mesh-list
6591647|NCT01111513|Ropivacaine|ropivacaine|mesh-list
6591648|NCT01111513|Anesthetics, Local|anesthetics, local|mesh-ancestor
6591649|NCT01111513|Anesthetics|anesthetics|mesh-ancestor
6591650|NCT01111513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6591651|NCT01111513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591652|NCT01111513|Sensory System Agents|sensory system agents|mesh-ancestor
6591653|NCT01111513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6591654|NCT01111591|Celecoxib|celecoxib|mesh-list
6591655|NCT01111591|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
6591656|NCT01111591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6591657|NCT01111591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6591658|NCT01111591|Analgesics|analgesics|mesh-ancestor
6591659|NCT01111591|Sensory System Agents|sensory system agents|mesh-ancestor
6591660|NCT01111591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6591661|NCT01111591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591662|NCT01111591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6591663|NCT01111591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6591664|NCT01111591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6591665|NCT01111591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6591666|NCT01111591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591667|NCT01111630|Epoetin Alfa|epoetin alfa|mesh-list
6591668|NCT01111630|Hematinics|hematinics|mesh-ancestor
6591669|NCT01111656|Interferons|interferons|mesh-list
6591670|NCT01111656|Interferon-beta|interferon-beta|mesh-list
6591671|NCT01111656|Atorvastatin|atorvastatin|mesh-list
6591672|NCT01111656|Interferon beta-1b|interferon beta-1b|mesh-list
6591673|NCT01111656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6591674|NCT01111656|Antiviral Agents|antiviral agents|mesh-ancestor
6591675|NCT01111656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6591676|NCT01111656|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6591677|NCT01111656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6591678|NCT01111656|Antimetabolites|antimetabolites|mesh-ancestor
6591679|NCT01111656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591680|NCT01111656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6591681|NCT01111656|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6591682|NCT01111656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6591683|NCT01111656|Immunologic Factors|immunologic factors|mesh-ancestor
6591684|NCT01111656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591685|NCT01111656|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6591686|NCT01111669|Tranexamic Acid|tranexamic acid|mesh-list
6591687|NCT01111669|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6591688|NCT01111669|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6447776|NCT00398684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6447777|NCT00398684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6447778|NCT00398684|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6447779|NCT00398684|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6447780|NCT00398697|Gemcitabine|gemcitabine|mesh-list
6447781|NCT00398697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6447782|NCT00398697|Antimetabolites|antimetabolites|mesh-ancestor
6447783|NCT00398697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447784|NCT00398697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6447785|NCT00398697|Antiviral Agents|antiviral agents|mesh-ancestor
6447786|NCT00398697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6591689|NCT01111669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591690|NCT01111669|Hemostatics|hemostatics|mesh-ancestor
6591691|NCT01111669|Coagulants|coagulants|mesh-ancestor
6591692|NCT01111682|Mannitol|mannitol|mesh-list
6591693|NCT01111682|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6591694|NCT01111682|Diuretics|diuretics|mesh-ancestor
6591695|NCT01111682|Natriuretic Agents|natriuretic agents|mesh-ancestor
6591696|NCT01111682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591697|NCT01111734|Acetylcysteine|acetylcysteine|mesh-list
6591698|NCT01111734|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6591699|NCT01111734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591700|NCT01111734|Antiviral Agents|antiviral agents|mesh-ancestor
6591701|NCT01111734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6591702|NCT01111734|Expectorants|expectorants|mesh-ancestor
6591703|NCT01111734|Respiratory System Agents|respiratory system agents|mesh-ancestor
6591704|NCT01111734|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6591705|NCT01111734|Antioxidants|antioxidants|mesh-ancestor
6591706|NCT01111734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591707|NCT01111734|Protective Agents|protective agents|mesh-ancestor
6591708|NCT01111734|Antidotes|antidotes|mesh-ancestor
6591709|NCT01111747|Mitogens|mitogens|mesh-list
6591710|NCT01111747|Mitosis Modulators|mitosis modulators|mesh-ancestor
6591711|NCT01111747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591712|NCT01111864|Micronutrients|micronutrients|mesh-list
6591713|NCT01111864|Trace Elements|trace elements|mesh-list
6591714|NCT01111864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591715|NCT01111890|Timolol|timolol|mesh-list
6591716|NCT01111890|Dorzolamide|dorzolamide|mesh-list
6591717|NCT01111890|Brinzolamide|brinzolamide|mesh-list
6591718|NCT01111890|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6591719|NCT01111890|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6591720|NCT01111890|Adrenergic Agents|adrenergic agents|mesh-ancestor
6591721|NCT01111890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6591722|NCT01111890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591723|NCT01111890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447787|NCT00398697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6447788|NCT00398697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6447789|NCT00398697|Immunologic Factors|immunologic factors|mesh-ancestor
6447790|NCT00398697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447791|NCT00398749|Epoetin Alfa|epoetin alfa|mesh-list
6447792|NCT00398749|Hematinics|hematinics|mesh-ancestor
6447793|NCT00398775|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6447794|NCT00398775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6447795|NCT00398788|Hydromorphone|hydromorphone|mesh-list
6447796|NCT00398788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6447797|NCT00398788|Narcotics|narcotics|mesh-ancestor
6447798|NCT00398788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6447799|NCT00398788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447800|NCT00398788|Analgesics|analgesics|mesh-ancestor
6447801|NCT00398788|Sensory System Agents|sensory system agents|mesh-ancestor
6447802|NCT00398788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6447803|NCT00398814|Sorafenib|sorafenib|mesh-list
6447804|NCT00398814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6447805|NCT00398814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6447806|NCT00398814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6447807|NCT00398814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447808|NCT00398827|Dexmedetomidine|dexmedetomidine|mesh-list
6591724|NCT01111890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6591725|NCT01111890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6591726|NCT01111890|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6591727|NCT01111890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6591728|NCT01111903|Lenalidomide|lenalidomide|mesh-list
6591729|NCT01111903|Immunologic Factors|immunologic factors|mesh-ancestor
6591730|NCT01111903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591731|NCT01111903|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6591732|NCT01111903|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6591733|NCT01111903|Growth Substances|growth substances|mesh-ancestor
6591734|NCT01111903|Growth Inhibitors|growth inhibitors|mesh-ancestor
6591735|NCT01111903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6591736|NCT01111942|Cisplatin|cisplatin|mesh-list
6591737|NCT01111942|Carboplatin|carboplatin|mesh-list
6591738|NCT01111942|Docetaxel|docetaxel|mesh-list
6591739|NCT01111942|Fluorouracil|fluorouracil|mesh-list
6591740|NCT01111942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6591741|NCT01111942|Tubulin Modulators|tubulin modulators|mesh-ancestor
6591742|NCT01111942|Antimitotic Agents|antimitotic agents|mesh-ancestor
6591743|NCT01111942|Mitosis Modulators|mitosis modulators|mesh-ancestor
6591744|NCT01111942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591745|NCT01111942|Antimetabolites|antimetabolites|mesh-ancestor
6591746|NCT01111942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6591747|NCT01111942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6591748|NCT01111942|Immunologic Factors|immunologic factors|mesh-ancestor
6591749|NCT01111942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591750|NCT01111968|Vaccines|vaccines|mesh-list
6591751|NCT01111968|Immunologic Factors|immunologic factors|mesh-ancestor
6591752|NCT01111968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591753|NCT01111981|Clobetasol|clobetasol|mesh-list
6591754|NCT01111981|Emollients|emollients|mesh-list
6591755|NCT01111981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6591756|NCT01111981|Glucocorticoids|glucocorticoids|mesh-ancestor
6591757|NCT01111981|Hormones|hormones|mesh-ancestor
6591758|NCT01111981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6591759|NCT01111981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591760|NCT01111981|Dermatologic Agents|dermatologic agents|mesh-ancestor
6591761|NCT01111994|Clindamycin|clindamycin|mesh-list
6591762|NCT01111994|Clindamycin palmitate|clindamycin palmitate|mesh-list
6591763|NCT01111994|Clindamycin phosphate|clindamycin phosphate|mesh-list
6591764|NCT01111994|Tretinoin|tretinoin|mesh-list
6591765|NCT01111994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6591766|NCT01111994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6447809|NCT00398827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6447810|NCT00398827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6447811|NCT00398827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447812|NCT00398827|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6447813|NCT00398827|Analgesics|analgesics|mesh-ancestor
6447814|NCT00398827|Sensory System Agents|sensory system agents|mesh-ancestor
6447815|NCT00398827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6447816|NCT00398827|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6447817|NCT00398827|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6447818|NCT00398827|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6447819|NCT00398827|Adrenergic Agents|adrenergic agents|mesh-ancestor
6447820|NCT00398827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6591767|NCT01111994|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6591768|NCT01111994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6591769|NCT01111994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591770|NCT01111994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6591771|NCT01111994|Keratolytic Agents|keratolytic agents|mesh-ancestor
6591772|NCT01111994|Dermatologic Agents|dermatologic agents|mesh-ancestor
6591773|NCT01112072|Riboflavin|riboflavin|mesh-list
6591774|NCT01112072|Vitamin B Complex|vitamin b complex|mesh-ancestor
6591775|NCT01112072|Vitamins|vitamins|mesh-ancestor
6591776|NCT01112072|Micronutrients|micronutrients|mesh-ancestor
6591777|NCT01112072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591778|NCT01112072|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6591779|NCT01112072|Dermatologic Agents|dermatologic agents|mesh-ancestor
6591780|NCT01112085|Ranibizumab|ranibizumab|mesh-list
6591781|NCT01112085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6591782|NCT01112085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6591783|NCT01112085|Growth Substances|growth substances|mesh-ancestor
6591784|NCT01112085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591785|NCT01112085|Growth Inhibitors|growth inhibitors|mesh-ancestor
6591786|NCT01112085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6591787|NCT01112137|Clopidogrel|clopidogrel|mesh-list
6591788|NCT01112137|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6591789|NCT01112137|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6591790|NCT01112137|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6591791|NCT01112137|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6591792|NCT01112137|Purinergic Agents|purinergic agents|mesh-ancestor
6591793|NCT01112137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6591794|NCT01112137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591795|NCT01112137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591796|NCT01112215|Mycophenolic Acid|mycophenolic acid|mesh-list
6591797|NCT01112215|Azathioprine|azathioprine|mesh-list
6591798|NCT01112215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6591799|NCT01112215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6591800|NCT01112215|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6591801|NCT01112215|Antitubercular Agents|antitubercular agents|mesh-ancestor
6591802|NCT01112215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6591803|NCT01112215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6591804|NCT01112215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6591805|NCT01112215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591806|NCT01112215|Antimetabolites|antimetabolites|mesh-ancestor
6591807|NCT01112215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6591808|NCT01112215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6591809|NCT01112215|Immunologic Factors|immunologic factors|mesh-ancestor
6591810|NCT01112215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591811|NCT01112215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6591812|NCT01112449|Selenium|selenium|mesh-list
6591813|NCT01112449|Antioxidants|antioxidants|mesh-ancestor
6591814|NCT01112449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591815|NCT01112449|Protective Agents|protective agents|mesh-ancestor
6591816|NCT01112449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591817|NCT01112449|Trace Elements|trace elements|mesh-ancestor
6591818|NCT01112449|Micronutrients|micronutrients|mesh-ancestor
6591819|NCT01112462|Acetaminophen|acetaminophen|mesh-list
6591820|NCT01112462|Phenylephrine|phenylephrine|mesh-list
6591821|NCT01112462|Oxymetazoline|oxymetazoline|mesh-list
6591822|NCT01112462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6591823|NCT01112462|Analgesics|analgesics|mesh-ancestor
6591824|NCT01112462|Sensory System Agents|sensory system agents|mesh-ancestor
6591825|NCT01112462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6591826|NCT01112462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591827|NCT01112462|Antipyretics|antipyretics|mesh-ancestor
6591828|NCT01112462|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6591829|NCT01112462|Mydriatics|mydriatics|mesh-ancestor
6591830|NCT01112462|Autonomic Agents|autonomic agents|mesh-ancestor
6591831|NCT01112462|Sympathomimetics|sympathomimetics|mesh-ancestor
6591832|NCT01112462|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6591833|NCT01112462|Nasal Decongestants|nasal decongestants|mesh-ancestor
6591834|NCT01112462|Respiratory System Agents|respiratory system agents|mesh-ancestor
6591835|NCT01112462|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6591836|NCT01112462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6591837|NCT01112462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6591838|NCT01112462|Adrenergic Agents|adrenergic agents|mesh-ancestor
6591839|NCT01112462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6591840|NCT01112462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591841|NCT01112462|Protective Agents|protective agents|mesh-ancestor
6591842|NCT01112540|Morphine|morphine|mesh-list
6591843|NCT01112540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6591844|NCT01112540|Narcotics|narcotics|mesh-ancestor
6591845|NCT01112540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6591846|NCT01112540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591847|NCT01112540|Analgesics|analgesics|mesh-ancestor
6591848|NCT01112540|Sensory System Agents|sensory system agents|mesh-ancestor
6591849|NCT01112540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6591850|NCT01112644|Oxycodone|oxycodone|mesh-list
6591851|NCT01112644|Naloxone|naloxone|mesh-list
6591852|NCT01112644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6591853|NCT01112644|Narcotics|narcotics|mesh-ancestor
6591854|NCT01112644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6591855|NCT01112644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591856|NCT01112644|Analgesics|analgesics|mesh-ancestor
6591857|NCT01112644|Sensory System Agents|sensory system agents|mesh-ancestor
6591858|NCT01112644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6591859|NCT01112644|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6591860|NCT01112722|Histamine|histamine|mesh-list
6591861|NCT01112722|Histamine Agonists|histamine agonists|mesh-ancestor
6591862|NCT01112722|Histamine Agents|histamine agents|mesh-ancestor
6591863|NCT01112722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6591864|NCT01112722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591865|NCT01112722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591866|NCT01112748|Lidocaine|lidocaine|mesh-list
6591867|NCT01112748|Anesthetics, Local|anesthetics, local|mesh-ancestor
6591868|NCT01112748|Anesthetics|anesthetics|mesh-ancestor
6591869|NCT01112748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6591870|NCT01112748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591871|NCT01112748|Sensory System Agents|sensory system agents|mesh-ancestor
6591872|NCT01112748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6591873|NCT01112748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6591874|NCT01112748|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6591875|NCT01112748|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6591876|NCT01112748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6591877|NCT01112748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591878|NCT01112787|Tazarotene|tazarotene|mesh-list
6591879|NCT01112787|Dermatologic Agents|dermatologic agents|mesh-ancestor
6591880|NCT01112787|Keratolytic Agents|keratolytic agents|mesh-ancestor
6591881|NCT01112813|Lithium Carbonate|lithium carbonate|mesh-list
6591882|NCT01112813|Antidepressive Agents|antidepressive agents|mesh-ancestor
6591883|NCT01112813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6591884|NCT01112813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6591885|NCT01112813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591886|NCT01112813|Antimanic Agents|antimanic agents|mesh-ancestor
6447821|NCT00398827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447822|NCT00398853|Chromium|chromium|mesh-list
6447823|NCT00398853|Picolinic acid|picolinic acid|mesh-list
6447824|NCT00398853|Trace Elements|trace elements|mesh-ancestor
6447825|NCT00398853|Micronutrients|micronutrients|mesh-ancestor
6447826|NCT00398853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447827|NCT00398853|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6447828|NCT00398853|Chelating Agents|chelating agents|mesh-ancestor
6447829|NCT00398853|Sequestering Agents|sequestering agents|mesh-ancestor
6447830|NCT00398853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447831|NCT00398892|Thioctic Acid|thioctic acid|mesh-list
6447832|NCT00398892|Antioxidants|antioxidants|mesh-ancestor
6447833|NCT00398892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447834|NCT00398892|Protective Agents|protective agents|mesh-ancestor
6591887|NCT01112813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6591888|NCT01112813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6591889|NCT01112813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591890|NCT01112826|Capecitabine|capecitabine|mesh-list
6591891|NCT01112826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6591892|NCT01112826|Antimetabolites|antimetabolites|mesh-ancestor
6591893|NCT01112826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591894|NCT01112826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6659269|NCT01486953|Sevoflurane|sevoflurane|mesh-list
6659270|NCT01486953|Desflurane|desflurane|mesh-list
6659271|NCT01486953|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6659272|NCT01486953|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6659273|NCT01486953|Anesthetics, General|anesthetics, general|mesh-ancestor
6659274|NCT01486953|Anesthetics|anesthetics|mesh-ancestor
6659275|NCT01486953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6659276|NCT01486953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447835|NCT00398892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447836|NCT00398892|Vitamin B Complex|vitamin b complex|mesh-ancestor
6447837|NCT00398892|Vitamins|vitamins|mesh-ancestor
6447838|NCT00398892|Micronutrients|micronutrients|mesh-ancestor
6447839|NCT00398905|Enoxaparin|enoxaparin|mesh-list
6447840|NCT00398905|Rivaroxaban|rivaroxaban|mesh-list
6447841|NCT00398905|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6447842|NCT00398905|Antithrombins|antithrombins|mesh-ancestor
6447843|NCT00398905|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6447844|NCT00398905|Protease Inhibitors|protease inhibitors|mesh-ancestor
6447845|NCT00398905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6447846|NCT00398905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447847|NCT00398905|Anticoagulants|anticoagulants|mesh-ancestor
6659277|NCT01486979|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6659278|NCT01486979|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6659279|NCT01486979|Estradiol|estradiol|mesh-list
6659280|NCT01486979|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6659281|NCT01486979|Estrogens|estrogens|mesh-ancestor
6659282|NCT01486979|Hormones|hormones|mesh-ancestor
6659283|NCT01486979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6659284|NCT01486979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659285|NCT01486979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6659286|NCT01486979|Contraceptive Agents|contraceptive agents|mesh-ancestor
6659287|NCT01486979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6659288|NCT01486979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6659289|NCT01486992|Nimotuzumab|nimotuzumab|mesh-list
6659290|NCT01486992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6659291|NCT01486992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6659292|NCT01487096|Teriflunomide|teriflunomide|mesh-list
6447848|NCT00398905|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6447849|NCT00398905|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6659293|NCT01487096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6659294|NCT01487096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6659295|NCT01487096|Analgesics|analgesics|mesh-ancestor
6659296|NCT01487096|Sensory System Agents|sensory system agents|mesh-ancestor
6659297|NCT01487096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6659298|NCT01487096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659299|NCT01487096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6659300|NCT01487096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6659301|NCT01487096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6659302|NCT01487096|Immunologic Factors|immunologic factors|mesh-ancestor
6659303|NCT01487135|Moxifloxacin|moxifloxacin|mesh-list
6659304|NCT01487135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6659305|NCT01487135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6659306|NCT01487135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6659307|NCT01487135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6659308|NCT01487135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6659309|NCT01487135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6659310|NCT01487135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6659311|NCT01487226|Paclitaxel|paclitaxel|mesh-list
6659312|NCT01487226|Cisplatin|cisplatin|mesh-list
6659313|NCT01487226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6659314|NCT01487226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6659315|NCT01487226|Tubulin Modulators|tubulin modulators|mesh-ancestor
6659316|NCT01487226|Antimitotic Agents|antimitotic agents|mesh-ancestor
6659317|NCT01487226|Mitosis Modulators|mitosis modulators|mesh-ancestor
6659318|NCT01487226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6659319|NCT01487278|Misoprostol|misoprostol|mesh-list
6659320|NCT01487278|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6659321|NCT01487278|Abortifacient Agents|abortifacient agents|mesh-ancestor
6659322|NCT01487278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6461810|NCT00456313|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6461811|NCT00456313|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6591895|NCT01112852|Terlipressin|terlipressin|mesh-list
6591896|NCT01112852|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
6591897|NCT01112852|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
6591898|NCT01112852|Somatostatin|somatostatin|mesh-list
6591899|NCT01112852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6591900|NCT01112852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6591901|NCT01112852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591902|NCT01112852|Hormones|hormones|mesh-ancestor
6591903|NCT01112852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6591904|NCT01112852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447850|NCT00398957|Naltrexone|naltrexone|mesh-list
6447851|NCT00398957|Hydromorphone|hydromorphone|mesh-list
6447852|NCT00398957|Narcotic Antagonists|narcotic antagonists|mesh-list
6447853|NCT00398957|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6447854|NCT00398957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447855|NCT00398957|Sensory System Agents|sensory system agents|mesh-ancestor
6447856|NCT00398957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6447857|NCT00398957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6447858|NCT00398957|Narcotics|narcotics|mesh-ancestor
6447859|NCT00398957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6447860|NCT00398957|Analgesics|analgesics|mesh-ancestor
6447861|NCT00399022|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6447862|NCT00399022|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6447863|NCT00399022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6447864|NCT00399022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6447865|NCT00399022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447866|NCT00399022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6447867|NCT00399022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447868|NCT00399022|Analgesics|analgesics|mesh-ancestor
6447869|NCT00399022|Sensory System Agents|sensory system agents|mesh-ancestor
6447870|NCT00399022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6447871|NCT00399022|Antidepressive Agents|antidepressive agents|mesh-ancestor
6447872|NCT00399022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6447873|NCT00399022|Dopamine Agents|dopamine agents|mesh-ancestor
6447874|NCT00399048|Hydromorphone|hydromorphone|mesh-list
6447875|NCT00399048|Oxycodone|oxycodone|mesh-list
6447876|NCT00399048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6447877|NCT00399048|Narcotics|narcotics|mesh-ancestor
6591905|NCT01112878|Clonidine|clonidine|mesh-list
6591906|NCT01112878|Gabapentin|gabapentin|mesh-list
6591907|NCT01112878|Analgesics|analgesics|mesh-ancestor
6591908|NCT01112878|Sensory System Agents|sensory system agents|mesh-ancestor
6591909|NCT01112878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6591910|NCT01112878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591911|NCT01112878|Anticonvulsants|anticonvulsants|mesh-ancestor
6591912|NCT01112878|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6591913|NCT01112878|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6591914|NCT01112878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6591915|NCT01112878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6591916|NCT01112878|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6591917|NCT01112878|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6591918|NCT01112878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6591919|NCT01112878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591920|NCT01112878|Antimanic Agents|antimanic agents|mesh-ancestor
6591921|NCT01112878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6591922|NCT01112878|Sympatholytics|sympatholytics|mesh-ancestor
6591923|NCT01112878|Autonomic Agents|autonomic agents|mesh-ancestor
6591924|NCT01112878|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6591925|NCT01112878|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6591926|NCT01112878|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6591927|NCT01112878|Adrenergic Agents|adrenergic agents|mesh-ancestor
6591928|NCT01112891|Vitamin D|vitamin d|mesh-list
6447878|NCT00399048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6447879|NCT00399048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447880|NCT00399048|Analgesics|analgesics|mesh-ancestor
6447881|NCT00399048|Sensory System Agents|sensory system agents|mesh-ancestor
6447882|NCT00399048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6447883|NCT00399061|Cyclosporine|cyclosporine|mesh-list
6447884|NCT00399061|Cyclosporins|cyclosporins|mesh-list
6591929|NCT01112891|Ergocalciferols|ergocalciferols|mesh-list
6591930|NCT01112891|Cholecalciferol|cholecalciferol|mesh-list
6591931|NCT01112891|Vitamins|vitamins|mesh-list
6591932|NCT01112891|Micronutrients|micronutrients|mesh-ancestor
6591933|NCT01112891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591934|NCT01112891|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6591935|NCT01112891|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6591936|NCT01113047|Amlodipine|amlodipine|mesh-list
6591937|NCT01113047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6591938|NCT01113047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6591939|NCT01113047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6591940|NCT01113047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591941|NCT01113047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6591942|NCT01113047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591943|NCT01113047|Vasodilator Agents|vasodilator agents|mesh-ancestor
6591944|NCT01113125|Fusidic Acid|fusidic acid|mesh-list
6591945|NCT01113125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6591946|NCT01113125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6591947|NCT01113125|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6591948|NCT01113125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6591949|NCT01113125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591950|NCT01113138|Magnesium Sulfate|magnesium sulfate|mesh-list
6591951|NCT01113138|Analgesics|analgesics|mesh-ancestor
6591952|NCT01113138|Sensory System Agents|sensory system agents|mesh-ancestor
6591953|NCT01113138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6591954|NCT01113138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591955|NCT01113138|Anesthetics|anesthetics|mesh-ancestor
6591956|NCT01113138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6591957|NCT01113138|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6591958|NCT01113138|Anticonvulsants|anticonvulsants|mesh-ancestor
6591959|NCT01113138|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6591960|NCT01113138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6591961|NCT01113138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591962|NCT01113138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6447885|NCT00399061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6447886|NCT00399061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447887|NCT00399061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6591963|NCT01113138|Tocolytic Agents|tocolytic agents|mesh-ancestor
6591964|NCT01113138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6591965|NCT01113164|Ondansetron|ondansetron|mesh-list
6591966|NCT01113164|Sertraline|sertraline|mesh-list
6591967|NCT01113164|Antiemetics|antiemetics|mesh-ancestor
6591968|NCT01113164|Autonomic Agents|autonomic agents|mesh-ancestor
6447888|NCT00399061|Immunologic Factors|immunologic factors|mesh-ancestor
6447889|NCT00399061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447890|NCT00399061|Antifungal Agents|antifungal agents|mesh-ancestor
6447891|NCT00399061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6447892|NCT00399061|Dermatologic Agents|dermatologic agents|mesh-ancestor
6447893|NCT00399061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6447894|NCT00399061|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6447895|NCT00399074|Pyrimethamine|pyrimethamine|mesh-list
6447896|NCT00399074|Sulfadoxine|sulfadoxine|mesh-list
6447897|NCT00399074|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6447898|NCT00399074|Antimalarials|antimalarials|mesh-ancestor
6447899|NCT00399074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6447900|NCT00399074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6447901|NCT00399074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6447902|NCT00399074|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6447903|NCT00399074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6447904|NCT00399074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447905|NCT00399074|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6447906|NCT00399074|Renal Agents|renal agents|mesh-ancestor
6447907|NCT00399087|Prednisone|prednisone|mesh-list
6447908|NCT00399087|Docetaxel|docetaxel|mesh-list
6447909|NCT00399087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6447910|NCT00399087|Tubulin Modulators|tubulin modulators|mesh-ancestor
6447911|NCT00399087|Antimitotic Agents|antimitotic agents|mesh-ancestor
6447912|NCT00399087|Mitosis Modulators|mitosis modulators|mesh-ancestor
6447913|NCT00399087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447914|NCT00399087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6447915|NCT00399087|Glucocorticoids|glucocorticoids|mesh-ancestor
6447916|NCT00399087|Hormones|hormones|mesh-ancestor
6447917|NCT00399087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6447918|NCT00399087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591969|NCT01113164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6591970|NCT01113164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591971|NCT01113164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6591972|NCT01113164|Antipruritics|antipruritics|mesh-ancestor
6591973|NCT01113164|Dermatologic Agents|dermatologic agents|mesh-ancestor
6591974|NCT01113164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6591975|NCT01113164|Serotonin Agents|serotonin agents|mesh-ancestor
6591976|NCT01113164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6591977|NCT01113164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6591978|NCT01113164|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6447919|NCT00399087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6447920|NCT00399126|Paclitaxel|paclitaxel|mesh-list
6447921|NCT00399126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6020374|NCT00392834|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6020375|NCT00392834|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6591979|NCT01113164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6591980|NCT01113164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6591981|NCT01113164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6591982|NCT01113164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6020376|NCT00392834|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6020377|NCT00392834|Cyclophosphamide|cyclophosphamide|mesh-list
6020378|NCT00392834|Ifosfamide|ifosfamide|mesh-list
6020379|NCT00392834|Rituximab|rituximab|mesh-list
6020380|NCT00392834|Doxorubicin|doxorubicin|mesh-list
6020381|NCT00392834|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6020382|NCT00392834|Methotrexate|methotrexate|mesh-list
6020383|NCT00392834|Etoposide|etoposide|mesh-list
6020384|NCT00392834|Vincristine|vincristine|mesh-list
6447922|NCT00399126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6447923|NCT00399126|Tubulin Modulators|tubulin modulators|mesh-ancestor
6447924|NCT00399126|Antimitotic Agents|antimitotic agents|mesh-ancestor
6447925|NCT00399126|Mitosis Modulators|mitosis modulators|mesh-ancestor
6447926|NCT00399126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447927|NCT00399152|Sunitinib|sunitinib|mesh-list
6447928|NCT00399152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6447929|NCT00399152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6447930|NCT00399152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6447931|NCT00399152|Growth Substances|growth substances|mesh-ancestor
6447932|NCT00399152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447933|NCT00399152|Growth Inhibitors|growth inhibitors|mesh-ancestor
6447934|NCT00399152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6447935|NCT00399152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6447936|NCT00399152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447937|NCT00399165|Methyltestosterone|methyltestosterone|mesh-list
6447938|NCT00399165|Testosterone|testosterone|mesh-list
6447939|NCT00399165|Testosterone undecanoate|testosterone undecanoate|mesh-list
6447940|NCT00399165|Testosterone enanthate|testosterone enanthate|mesh-list
6447941|NCT00399165|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6447942|NCT00399165|Dutasteride|dutasteride|mesh-list
6447943|NCT00399165|Androgens|androgens|mesh-ancestor
6447944|NCT00399165|Hormones|hormones|mesh-ancestor
6591983|NCT01113164|Antidepressive Agents|antidepressive agents|mesh-ancestor
6591984|NCT01113164|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6591985|NCT01113164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6591986|NCT01113164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6591987|NCT01113229|Misoprostol|misoprostol|mesh-list
6591988|NCT01113229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6591989|NCT01113229|Abortifacient Agents|abortifacient agents|mesh-ancestor
6591990|NCT01113229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6591991|NCT01113229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591992|NCT01113229|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6591993|NCT01113229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6591994|NCT01113229|Oxytocics|oxytocics|mesh-ancestor
6591995|NCT01113281|Vaccines|vaccines|mesh-list
6591996|NCT01113281|Immunoglobulins|immunoglobulins|mesh-list
6591997|NCT01113281|Immunologic Factors|immunologic factors|mesh-ancestor
6591998|NCT01113281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6591999|NCT01113372|Clopidogrel|clopidogrel|mesh-list
6592000|NCT01113372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6592001|NCT01113372|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6592002|NCT01113372|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6592003|NCT01113372|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6592004|NCT01113372|Purinergic Agents|purinergic agents|mesh-ancestor
6592005|NCT01113372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6592006|NCT01113372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592007|NCT01113372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592008|NCT01113424|Nicotine|nicotine|mesh-list
6592009|NCT01113424|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6592010|NCT01113424|Autonomic Agents|autonomic agents|mesh-ancestor
6592011|NCT01113424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6592012|NCT01113424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592013|NCT01113424|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6592014|NCT01113424|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6592015|NCT01113424|Cholinergic Agents|cholinergic agents|mesh-ancestor
6592016|NCT01113424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6592017|NCT01113424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592018|NCT01113437|Omalizumab|omalizumab|mesh-list
6592019|NCT01113437|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6592020|NCT01113437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6592021|NCT01113437|Respiratory System Agents|respiratory system agents|mesh-ancestor
6592022|NCT01113476|Gemcitabine|gemcitabine|mesh-list
6592023|NCT01113476|Paclitaxel|paclitaxel|mesh-list
6592024|NCT01113476|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6592025|NCT01113476|Bevacizumab|bevacizumab|mesh-list
6592026|NCT01113476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6592027|NCT01113476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6592028|NCT01113476|Tubulin Modulators|tubulin modulators|mesh-ancestor
6447945|NCT00399165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6447946|NCT00399165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447947|NCT00399165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6447948|NCT00399165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6447949|NCT00399165|Anabolic Agents|anabolic agents|mesh-ancestor
6447950|NCT00399165|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6447951|NCT00399165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6447952|NCT00399165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6447953|NCT00399165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447954|NCT00399165|Hormone Antagonists|hormone antagonists|mesh-ancestor
6447955|NCT00399204|Metformin|metformin|mesh-list
6447956|NCT00399204|Pioglitazone|pioglitazone|mesh-list
6447957|NCT00399204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6447958|NCT00399204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447959|NCT00399243|Sumatriptan|sumatriptan|mesh-list
6592029|NCT01113476|Antimitotic Agents|antimitotic agents|mesh-ancestor
6592030|NCT01113476|Mitosis Modulators|mitosis modulators|mesh-ancestor
6592031|NCT01113476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592032|NCT01113476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6592033|NCT01113476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6592034|NCT01113476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6592035|NCT01113476|Growth Substances|growth substances|mesh-ancestor
6592036|NCT01113476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592037|NCT01113476|Growth Inhibitors|growth inhibitors|mesh-ancestor
6592038|NCT01113476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6592039|NCT01113476|Antimetabolites|antimetabolites|mesh-ancestor
6592040|NCT01113476|Antiviral Agents|antiviral agents|mesh-ancestor
6592041|NCT01113476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6592042|NCT01113476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6592043|NCT01113476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6592044|NCT01113476|Immunologic Factors|immunologic factors|mesh-ancestor
6592045|NCT01113489|Beclomethasone|beclomethasone|mesh-list
6592046|NCT01113489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6592047|NCT01113489|Glucocorticoids|glucocorticoids|mesh-ancestor
6592048|NCT01113489|Hormones|hormones|mesh-ancestor
6592049|NCT01113489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6592050|NCT01113489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592051|NCT01113489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6592052|NCT01113489|Respiratory System Agents|respiratory system agents|mesh-ancestor
6592053|NCT01113515|Esmolol|esmolol|mesh-list
6592054|NCT01113515|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6592055|NCT01113515|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6592056|NCT01113515|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6592057|NCT01113515|Adrenergic Agents|adrenergic agents|mesh-ancestor
6592058|NCT01113515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6592059|NCT01113515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592060|NCT01113515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592061|NCT01113528|Aspirin|aspirin|mesh-list
6592062|NCT01113528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6592063|NCT01113528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6592064|NCT01113528|Analgesics|analgesics|mesh-ancestor
6592065|NCT01113528|Sensory System Agents|sensory system agents|mesh-ancestor
6592066|NCT01113528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6592067|NCT01113528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592068|NCT01113528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6592069|NCT01113528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6592070|NCT01113528|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6592071|NCT01113528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6592072|NCT01113528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592073|NCT01113528|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6592074|NCT01113528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6592075|NCT01113528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6592076|NCT01113528|Antipyretics|antipyretics|mesh-ancestor
6592077|NCT01113671|Vitamin E|vitamin e|mesh-list
6592078|NCT01113671|Tocopherols|tocopherols|mesh-list
6592079|NCT01113671|alpha-Tocopherol|alpha-tocopherol|mesh-list
6592080|NCT01113671|Vitamins|vitamins|mesh-ancestor
6592081|NCT01113671|Micronutrients|micronutrients|mesh-ancestor
6592082|NCT01113671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592083|NCT01113671|Antioxidants|antioxidants|mesh-ancestor
6592084|NCT01113671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592085|NCT01113671|Protective Agents|protective agents|mesh-ancestor
6592086|NCT01113762|Cimetidine|cimetidine|mesh-list
6592087|NCT01113762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6592088|NCT01113762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6592089|NCT01113762|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6592090|NCT01113762|Histamine Antagonists|histamine antagonists|mesh-ancestor
6592091|NCT01113762|Histamine Agents|histamine agents|mesh-ancestor
6592092|NCT01113762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6592093|NCT01113762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592094|NCT01113762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592095|NCT01113762|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6592096|NCT01113762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6592097|NCT01113762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6592098|NCT01114048|Thalidomide|thalidomide|mesh-list
6592099|NCT01114048|Dexamethasone|dexamethasone|mesh-list
6592100|NCT01114048|Cyclophosphamide|cyclophosphamide|mesh-list
6592101|NCT01114048|Bortezomib|bortezomib|mesh-list
6592102|NCT01114048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6592103|NCT01114048|Immunologic Factors|immunologic factors|mesh-ancestor
6592104|NCT01114048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592105|NCT01114048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6592106|NCT01114048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6592107|NCT01114048|Alkylating Agents|alkylating agents|mesh-ancestor
6592108|NCT01114048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592109|NCT01114048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6592110|NCT01114048|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6592111|NCT01114048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6592112|NCT01114048|Antiemetics|antiemetics|mesh-ancestor
6592113|NCT01114048|Autonomic Agents|autonomic agents|mesh-ancestor
6592114|NCT01114048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6592115|NCT01114048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6592116|NCT01114048|Glucocorticoids|glucocorticoids|mesh-ancestor
6592117|NCT01114048|Hormones|hormones|mesh-ancestor
6592118|NCT01114048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6592119|NCT01114048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6592120|NCT01114048|Leprostatic Agents|leprostatic agents|mesh-ancestor
6592121|NCT01114048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6592122|NCT01114048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6592123|NCT01114048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6592124|NCT01114048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6592125|NCT01114048|Growth Substances|growth substances|mesh-ancestor
6592126|NCT01114048|Growth Inhibitors|growth inhibitors|mesh-ancestor
6592127|NCT01114087|Imatinib Mesylate|imatinib mesylate|mesh-list
6592128|NCT01114087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6592129|NCT01114087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6592130|NCT01114087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6592131|NCT01114087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592132|NCT01114100|Sertraline|sertraline|mesh-list
6592133|NCT01114100|Antidepressive Agents|antidepressive agents|mesh-ancestor
6592134|NCT01114100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6592135|NCT01114100|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6592136|NCT01114100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6592137|NCT01114100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6592138|NCT01114100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592139|NCT01114100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6592140|NCT01114100|Serotonin Agents|serotonin agents|mesh-ancestor
6592141|NCT01114100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592142|NCT01114191|Ketoconazole|ketoconazole|mesh-list
6592143|NCT01114191|Antifungal Agents|antifungal agents|mesh-ancestor
6592144|NCT01114191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6592145|NCT01114191|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6592146|NCT01114191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6592147|NCT01114191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6592148|NCT01114191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592149|NCT01114191|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6592150|NCT01114191|Hormone Antagonists|hormone antagonists|mesh-ancestor
6592151|NCT01114191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6592152|NCT01114191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592153|NCT01114191|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6592154|NCT01114282|Bortezomib|bortezomib|mesh-list
6592155|NCT01114282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6592156|NCT01114425|Raltegravir Potassium|raltegravir potassium|mesh-list
6592157|NCT01114425|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6592158|NCT01114425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6592159|NCT01114425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6592160|NCT01114425|Antiviral Agents|antiviral agents|mesh-ancestor
6592161|NCT01114425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6592162|NCT01114425|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6592163|NCT01114425|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6592164|NCT01114425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6592165|NCT01114425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592166|NCT01114425|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6592167|NCT01114425|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6592168|NCT01114490|Anacetrapib|anacetrapib|mesh-list
6592169|NCT01114490|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6592170|NCT01114490|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6592171|NCT01114490|Antimetabolites|antimetabolites|mesh-ancestor
6592172|NCT01114490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592173|NCT01114490|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6592174|NCT01114542|Insulin|insulin|mesh-list
6592175|NCT01114542|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6592176|NCT01114542|Insulin Glargine|insulin glargine|mesh-list
6592177|NCT01114542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6592178|NCT01114542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659323|NCT01487278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659324|NCT01487278|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6659325|NCT01487278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6659326|NCT01487278|Oxytocics|oxytocics|mesh-ancestor
6659327|NCT01487304|Hormones|hormones|mesh-list
6659328|NCT01487304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6659329|NCT01487304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659330|NCT01487317|Rivastigmine|rivastigmine|mesh-list
6659331|NCT01487317|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6659332|NCT01487317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6447960|NCT00399243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6447961|NCT00399243|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6447962|NCT00399243|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6447963|NCT00399243|Serotonin Agents|serotonin agents|mesh-ancestor
6447964|NCT00399243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6447965|NCT00399243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447966|NCT00399243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447967|NCT00399256|Acetylcysteine|acetylcysteine|mesh-list
6447968|NCT00399256|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6447969|NCT00399256|Antiviral Agents|antiviral agents|mesh-ancestor
6447970|NCT00399256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6447971|NCT00399256|Expectorants|expectorants|mesh-ancestor
6447972|NCT00399256|Respiratory System Agents|respiratory system agents|mesh-ancestor
6447973|NCT00399256|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6447974|NCT00399256|Antioxidants|antioxidants|mesh-ancestor
6447975|NCT00399256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447976|NCT00399256|Protective Agents|protective agents|mesh-ancestor
6020385|NCT00392834|Levoleucovorin|levoleucovorin|mesh-list
6020386|NCT00392834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6020387|NCT00392834|Immunologic Factors|immunologic factors|mesh-ancestor
6020388|NCT00392834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020389|NCT00392834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6020390|NCT00392834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6020391|NCT00392834|Alkylating Agents|alkylating agents|mesh-ancestor
6020392|NCT00392834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020393|NCT00392834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6020394|NCT00392834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6020395|NCT00392834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6020396|NCT00392834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6592179|NCT01114568|Ertugliflozin|ertugliflozin|mesh-list
6592180|NCT01114568|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6592181|NCT01114568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592182|NCT01114568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6592183|NCT01114568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020397|NCT00392834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6020398|NCT00392834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6020399|NCT00392834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6020400|NCT00392834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6447977|NCT00399256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592184|NCT01114750|Dextrans|dextrans|mesh-list
6592185|NCT01114750|Anticoagulants|anticoagulants|mesh-ancestor
6592186|NCT01114750|Plasma Substitutes|plasma substitutes|mesh-ancestor
6592187|NCT01114750|Blood Substitutes|blood substitutes|mesh-ancestor
6592188|NCT01114841|Tazarotene|tazarotene|mesh-list
6592189|NCT01114841|Dermatologic Agents|dermatologic agents|mesh-ancestor
6592190|NCT01114841|Keratolytic Agents|keratolytic agents|mesh-ancestor
6592191|NCT01114854|Topiramate|topiramate|mesh-list
6592192|NCT01114854|Anticonvulsants|anticonvulsants|mesh-ancestor
6592193|NCT01114854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6592194|NCT01114854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592195|NCT01114958|Cisplatin|cisplatin|mesh-list
6592196|NCT01114958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6592197|NCT01115036|Panobinostat|panobinostat|mesh-list
6592198|NCT01115036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6592199|NCT01115036|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6592200|NCT01115036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6592201|NCT01115036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592202|NCT01115049|Chlorhexidine|chlorhexidine|mesh-list
6592203|NCT01115049|Hexetidine|hexetidine|mesh-list
6592204|NCT01115049|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6592205|NCT01115049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6592206|NCT01115049|Disinfectants|disinfectants|mesh-ancestor
6592207|NCT01115049|Antifungal Agents|antifungal agents|mesh-ancestor
6592208|NCT01115062|Lidocaine|lidocaine|mesh-list
6592209|NCT01115062|Anesthetics, Local|anesthetics, local|mesh-ancestor
6592210|NCT01115062|Anesthetics|anesthetics|mesh-ancestor
6592211|NCT01115062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6592212|NCT01115062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592213|NCT01115062|Sensory System Agents|sensory system agents|mesh-ancestor
6592214|NCT01115062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6592215|NCT01115062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6592216|NCT01115062|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6447978|NCT00399256|Antidotes|antidotes|mesh-ancestor
6447979|NCT00399269|Epoetin Alfa|epoetin alfa|mesh-list
6447980|NCT00399269|Hematinics|hematinics|mesh-ancestor
6447981|NCT00399282|Vitamin E|vitamin e|mesh-list
6447982|NCT00399282|Vitamins|vitamins|mesh-ancestor
6447983|NCT00399282|Micronutrients|micronutrients|mesh-ancestor
6447984|NCT00399282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447985|NCT00399282|Antioxidants|antioxidants|mesh-ancestor
6447986|NCT00399282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6447987|NCT00399282|Protective Agents|protective agents|mesh-ancestor
6447988|NCT00399295|Naltrexone|naltrexone|mesh-list
6447989|NCT00399295|Hydromorphone|hydromorphone|mesh-list
6447990|NCT00399295|Narcotic Antagonists|narcotic antagonists|mesh-list
6447991|NCT00399295|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6447992|NCT00399295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6447993|NCT00399295|Sensory System Agents|sensory system agents|mesh-ancestor
6447994|NCT00399295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6592217|NCT01115062|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6592218|NCT01115062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6020401|NCT00392834|Abortifacient Agents|abortifacient agents|mesh-ancestor
6020402|NCT00392834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6592219|NCT01115062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592220|NCT01115127|Inositol|inositol|mesh-list
6592221|NCT01115127|Melatonin|melatonin|mesh-list
6592222|NCT01115127|Antioxidants|antioxidants|mesh-ancestor
6592223|NCT01115127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592224|NCT01115127|Protective Agents|protective agents|mesh-ancestor
6592225|NCT01115127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592226|NCT01115127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6592227|NCT01115127|Vitamin B Complex|vitamin b complex|mesh-ancestor
6592228|NCT01115127|Vitamins|vitamins|mesh-ancestor
6592229|NCT01115127|Micronutrients|micronutrients|mesh-ancestor
6592230|NCT01115140|Folic Acid|folic acid|mesh-list
6592231|NCT01115140|Vitamin B Complex|vitamin b complex|mesh-list
6592232|NCT01115140|Metformin|metformin|mesh-list
6592233|NCT01115140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6592234|NCT01115140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592235|NCT01115140|Hematinics|hematinics|mesh-ancestor
6592236|NCT01115140|Vitamins|vitamins|mesh-ancestor
6592237|NCT01115140|Micronutrients|micronutrients|mesh-ancestor
6020403|NCT00392834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6447995|NCT00399295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6447996|NCT00399295|Narcotics|narcotics|mesh-ancestor
6447997|NCT00399295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6447998|NCT00399295|Analgesics|analgesics|mesh-ancestor
6447999|NCT00399334|Antipsychotic Agents|antipsychotic agents|mesh-list
6448000|NCT00399334|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6592238|NCT01115179|Propofol|propofol|mesh-list
6592239|NCT01115179|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6592240|NCT01115179|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6592241|NCT01115179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6592242|NCT01115179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592243|NCT01115179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6592244|NCT01115179|Anesthetics, General|anesthetics, general|mesh-ancestor
6592245|NCT01115179|Anesthetics|anesthetics|mesh-ancestor
6592246|NCT01115179|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6592247|NCT01115179|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6592248|NCT01115179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6592249|NCT01115322|Nicotinic Acids|nicotinic acids|mesh-list
6592250|NCT01115322|Tazarotene|tazarotene|mesh-list
6592251|NCT01115322|Dermatologic Agents|dermatologic agents|mesh-ancestor
6592252|NCT01115322|Keratolytic Agents|keratolytic agents|mesh-ancestor
6592253|NCT01115322|Vitamin B Complex|vitamin b complex|mesh-ancestor
6592254|NCT01115322|Vitamins|vitamins|mesh-ancestor
6592255|NCT01115322|Micronutrients|micronutrients|mesh-ancestor
6592256|NCT01115322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448001|NCT00399334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6448002|NCT00399334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448003|NCT00399334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6448004|NCT00399399|Cyclophosphamide|cyclophosphamide|mesh-list
6448005|NCT00399399|Azathioprine|azathioprine|mesh-list
6448006|NCT00399399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6448007|NCT00399399|Immunologic Factors|immunologic factors|mesh-ancestor
6448008|NCT00399399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448009|NCT00399399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6448010|NCT00399399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6448011|NCT00399399|Alkylating Agents|alkylating agents|mesh-ancestor
6448012|NCT00399399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448013|NCT00399399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6448014|NCT00399399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6448015|NCT00399399|Antimetabolites|antimetabolites|mesh-ancestor
6448016|NCT00399399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6448017|NCT00399425|Heparin|heparin|mesh-list
6461812|NCT00456313|Autonomic Agents|autonomic agents|mesh-ancestor
6592257|NCT01115426|Losartan|losartan|mesh-list
6592258|NCT01115426|Ramipril|ramipril|mesh-list
6592259|NCT01115426|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6592260|NCT01115426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6592261|NCT01115426|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6592262|NCT01115426|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6592263|NCT01115426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592264|NCT01115426|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6592265|NCT01115426|Protease Inhibitors|protease inhibitors|mesh-ancestor
6592266|NCT01115426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6592267|NCT01115439|Artesunate|artesunate|mesh-list
6592268|NCT01115439|Pyrimethamine|pyrimethamine|mesh-list
6592269|NCT01115439|Sulfadoxine|sulfadoxine|mesh-list
6592270|NCT01115439|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6592271|NCT01115439|Antimalarials|antimalarials|mesh-ancestor
6592272|NCT01115439|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6592273|NCT01115439|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6592274|NCT01115439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6448018|NCT00399425|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6448019|NCT00399425|Tinzaparin|tinzaparin|mesh-list
6448020|NCT00399425|Dalteparin|dalteparin|mesh-list
6020404|NCT00392834|Antimetabolites|antimetabolites|mesh-ancestor
6448021|NCT00399425|Bemiparin|bemiparin|mesh-list
6448022|NCT00399425|Anticoagulants|anticoagulants|mesh-ancestor
6448023|NCT00399425|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6448024|NCT00399425|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6448025|NCT00399425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448026|NCT00399451|Polidocanol|polidocanol|mesh-list
6448027|NCT00399451|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
6448028|NCT00399451|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6592275|NCT01115439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6592276|NCT01115439|Antiviral Agents|antiviral agents|mesh-ancestor
6592277|NCT01115439|Schistosomicides|schistosomicides|mesh-ancestor
6592278|NCT01115439|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6592279|NCT01115439|Anthelmintics|anthelmintics|mesh-ancestor
6592280|NCT01115439|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6592281|NCT01115439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6448029|NCT00399464|Alfuzosin|alfuzosin|mesh-list
6448030|NCT00399464|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6448031|NCT00399464|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6448032|NCT00399464|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6592282|NCT01115439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592283|NCT01115439|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6592284|NCT01115439|Renal Agents|renal agents|mesh-ancestor
6592285|NCT01115478|Vitamin A|vitamin a|mesh-list
6592286|NCT01115478|Vitamins|vitamins|mesh-ancestor
6592287|NCT01115478|Micronutrients|micronutrients|mesh-ancestor
6592288|NCT01115478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592289|NCT01115504|Thiamine|thiamine|mesh-list
6592290|NCT01115504|Vitamin B Complex|vitamin b complex|mesh-ancestor
6592291|NCT01115504|Vitamins|vitamins|mesh-ancestor
6592292|NCT01115504|Micronutrients|micronutrients|mesh-ancestor
6592293|NCT01115504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592294|NCT01115543|Calcitriol|calcitriol|mesh-list
6592295|NCT01115543|Alfacalcidol|alfacalcidol|mesh-list
6592296|NCT01115543|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
6592297|NCT01115543|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6592298|NCT01115543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592299|NCT01115543|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6592300|NCT01115543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6592301|NCT01115543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448033|NCT00399464|Adrenergic Agents|adrenergic agents|mesh-ancestor
6448034|NCT00399464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6448035|NCT00399464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448036|NCT00399464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448037|NCT00399464|Urological Agents|urological agents|mesh-ancestor
6448038|NCT00399477|Levodopa|levodopa|mesh-list
6448039|NCT00399477|Pramipexole|pramipexole|mesh-list
6592302|NCT01115543|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6592303|NCT01115543|Vitamins|vitamins|mesh-ancestor
6592304|NCT01115543|Micronutrients|micronutrients|mesh-ancestor
6592305|NCT01115543|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6592306|NCT01115712|Pioglitazone|pioglitazone|mesh-list
6592307|NCT01115712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6592308|NCT01115712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592309|NCT01115725|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6592310|NCT01115725|Hormones|hormones|mesh-ancestor
6592311|NCT01115725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6592312|NCT01115725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592313|NCT01115842|Vitamin D|vitamin d|mesh-list
6592314|NCT01115842|Vitamins|vitamins|mesh-ancestor
6592315|NCT01115842|Micronutrients|micronutrients|mesh-ancestor
6592316|NCT01115842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592317|NCT01115842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6592318|NCT01115894|Naltrexone|naltrexone|mesh-list
6592319|NCT01115894|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6592320|NCT01115894|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6592321|NCT01115894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592322|NCT01115894|Sensory System Agents|sensory system agents|mesh-ancestor
6592323|NCT01115894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6592324|NCT01115946|Enalapril|enalapril|mesh-list
6592325|NCT01115946|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6592326|NCT01115946|Protease Inhibitors|protease inhibitors|mesh-ancestor
6592327|NCT01115946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6592328|NCT01115946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592329|NCT01115946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6592330|NCT01115959|Valproic Acid|valproic acid|mesh-list
6592331|NCT01115959|Anticonvulsants|anticonvulsants|mesh-ancestor
6592332|NCT01115959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6592333|NCT01115959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592334|NCT01115959|GABA Agents|gaba agents|mesh-ancestor
6592335|NCT01115959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6592336|NCT01115959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592337|NCT01115959|Antimanic Agents|antimanic agents|mesh-ancestor
6592338|NCT01115959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6592339|NCT01115959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6592340|NCT01115959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6592341|NCT01115972|Valsartan|valsartan|mesh-list
6592342|NCT01115972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6592343|NCT01115972|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6592344|NCT01115972|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6592345|NCT01115972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592346|NCT01115985|Atorvastatin|atorvastatin|mesh-list
6592347|NCT01115985|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6592348|NCT01115985|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6592349|NCT01115985|Antimetabolites|antimetabolites|mesh-ancestor
6592350|NCT01115985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592351|NCT01115985|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6592352|NCT01115985|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6592353|NCT01115985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6592354|NCT01116050|Misoprostol|misoprostol|mesh-list
6592355|NCT01116050|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6592356|NCT01116050|Abortifacient Agents|abortifacient agents|mesh-ancestor
6592357|NCT01116050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6592358|NCT01116050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592359|NCT01116050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6592360|NCT01116050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6592361|NCT01116050|Oxytocics|oxytocics|mesh-ancestor
6592362|NCT01116063|Iloprost|iloprost|mesh-list
6592363|NCT01116063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6592364|NCT01116063|Vasodilator Agents|vasodilator agents|mesh-ancestor
6592365|NCT01116115|Palmitic Acid|palmitic acid|mesh-list
6592366|NCT01116115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6592367|NCT01116115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592368|NCT01116128|Prednisone|prednisone|mesh-list
6592369|NCT01116128|Melphalan|melphalan|mesh-list
6592370|NCT01116128|Dasatinib|dasatinib|mesh-list
6592371|NCT01116128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6592372|NCT01116128|Glucocorticoids|glucocorticoids|mesh-ancestor
6592373|NCT01116128|Hormones|hormones|mesh-ancestor
6592374|NCT01116128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6592375|NCT01116128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592376|NCT01116128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6592377|NCT01116128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6592378|NCT01116128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6592379|NCT01116128|Alkylating Agents|alkylating agents|mesh-ancestor
6592380|NCT01116128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592381|NCT01116128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6592382|NCT01116128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6592383|NCT01116128|Immunologic Factors|immunologic factors|mesh-ancestor
6592384|NCT01116128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6592385|NCT01116128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6592386|NCT01116154|Lenalidomide|lenalidomide|mesh-list
6592387|NCT01116154|Vorinostat|vorinostat|mesh-list
6592388|NCT01116154|Immunologic Factors|immunologic factors|mesh-ancestor
6592389|NCT01116154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592390|NCT01116154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6592391|NCT01116154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6592392|NCT01116154|Growth Substances|growth substances|mesh-ancestor
6592393|NCT01116154|Growth Inhibitors|growth inhibitors|mesh-ancestor
6592394|NCT01116154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6592395|NCT01116154|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6592396|NCT01116154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6592397|NCT01116154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592398|NCT01116167|Letrozole|letrozole|mesh-list
6592399|NCT01116167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6592400|NCT01116167|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6592401|NCT01116167|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6592402|NCT01116167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6592403|NCT01116167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592404|NCT01116167|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6592405|NCT01116167|Hormone Antagonists|hormone antagonists|mesh-ancestor
6592406|NCT01116167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6592407|NCT01116167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592408|NCT01116180|Candesartan|candesartan|mesh-list
6592409|NCT01116180|Angiotensin II|angiotensin ii|mesh-list
6592410|NCT01116180|Giapreza|giapreza|mesh-list
6592411|NCT01116180|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
6592412|NCT01116180|Angiotensinogen|angiotensinogen|mesh-list
6592413|NCT01116180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6592414|NCT01116180|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6592415|NCT01116180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592416|NCT01116180|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6592417|NCT01116180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6592418|NCT01116180|Protease Inhibitors|protease inhibitors|mesh-ancestor
6592419|NCT01116180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6592420|NCT01116193|Dexamethasone|dexamethasone|mesh-list
6592421|NCT01116193|Lenalidomide|lenalidomide|mesh-list
6592422|NCT01116193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6592423|NCT01116193|Antiemetics|antiemetics|mesh-ancestor
6592424|NCT01116193|Autonomic Agents|autonomic agents|mesh-ancestor
6592425|NCT01116193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6592426|NCT01116193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592427|NCT01116193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6592428|NCT01116193|Glucocorticoids|glucocorticoids|mesh-ancestor
6592429|NCT01116193|Hormones|hormones|mesh-ancestor
6592430|NCT01116193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6592431|NCT01116193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6592432|NCT01116193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6592433|NCT01116193|Immunologic Factors|immunologic factors|mesh-ancestor
6592434|NCT01116193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6592435|NCT01116193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6592436|NCT01116193|Growth Substances|growth substances|mesh-ancestor
6592437|NCT01116193|Growth Inhibitors|growth inhibitors|mesh-ancestor
6592438|NCT01116206|Prucalopride|prucalopride|mesh-list
6592439|NCT01116206|Laxatives|laxatives|mesh-ancestor
6592440|NCT01116206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6592441|NCT01116206|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
6592442|NCT01116206|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6592443|NCT01116206|Serotonin Agents|serotonin agents|mesh-ancestor
6592444|NCT01116206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6592445|NCT01116206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592446|NCT01116206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592447|NCT01116219|Bevacizumab|bevacizumab|mesh-list
6592448|NCT01116219|Pemetrexed|pemetrexed|mesh-list
6592449|NCT01116219|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6592450|NCT01116219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6592451|NCT01116219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6592452|NCT01116219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6592453|NCT01116219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6592454|NCT01116219|Growth Substances|growth substances|mesh-ancestor
6592455|NCT01116219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592456|NCT01116219|Growth Inhibitors|growth inhibitors|mesh-ancestor
6592457|NCT01116219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6592458|NCT01116219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592459|NCT01116219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6592460|NCT01116219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6592461|NCT01116219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6592462|NCT01116271|Irinotecan|irinotecan|mesh-list
6592463|NCT01116271|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6592464|NCT01116271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6592465|NCT01116271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6592466|NCT01116271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592467|NCT01116271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6592468|NCT01116310|Glycine|glycine|mesh-list
6592469|NCT01116310|Glycine Agents|glycine agents|mesh-ancestor
6592470|NCT01116310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6592471|NCT01116310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592472|NCT01116310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592473|NCT01116336|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6592474|NCT01116336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6592475|NCT01116336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6592476|NCT01116336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6592477|NCT01116336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6659333|NCT01487317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6659334|NCT01487317|Cholinergic Agents|cholinergic agents|mesh-ancestor
6659335|NCT01487317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6659336|NCT01487317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659337|NCT01487317|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6659338|NCT01487317|Protective Agents|protective agents|mesh-ancestor
6659339|NCT01487369|Insulin Aspart|insulin aspart|mesh-list
6659340|NCT01487369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6659341|NCT01487369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659342|NCT01487382|Insulin Aspart|insulin aspart|mesh-list
6659343|NCT01487382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6659344|NCT01487382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659345|NCT01487395|Donepezil|donepezil|mesh-list
6659346|NCT01487395|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6659347|NCT01487395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6659348|NCT01487395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592478|NCT01116388|Caseins|caseins|mesh-list
6592479|NCT01116388|Chelating Agents|chelating agents|mesh-ancestor
6592480|NCT01116388|Sequestering Agents|sequestering agents|mesh-ancestor
6592481|NCT01116388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592482|NCT01116531|Pregabalin|pregabalin|mesh-list
6592483|NCT01116531|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6592484|NCT01116531|Tramadol|tramadol|mesh-list
6592485|NCT01116531|Analgesics|analgesics|mesh-ancestor
6592486|NCT01116531|Sensory System Agents|sensory system agents|mesh-ancestor
6592487|NCT01116531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6592488|NCT01116531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592489|NCT01116531|Anticonvulsants|anticonvulsants|mesh-ancestor
6592490|NCT01116531|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6592491|NCT01116531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6592492|NCT01116531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592493|NCT01116531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6592494|NCT01116531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6592495|NCT01116531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6592496|NCT01116531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6592497|NCT01116531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6592498|NCT01116531|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6592499|NCT01116531|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6592500|NCT01116531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6592501|NCT01116531|Antidepressive Agents|antidepressive agents|mesh-ancestor
6592502|NCT01116531|Dopamine Agents|dopamine agents|mesh-ancestor
6592503|NCT01116531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6592504|NCT01116531|Narcotics|narcotics|mesh-ancestor
6592505|NCT01116583|Gabapentin|gabapentin|mesh-list
6592506|NCT01116583|Analgesics|analgesics|mesh-ancestor
6592507|NCT01116583|Sensory System Agents|sensory system agents|mesh-ancestor
6592508|NCT01116583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6592509|NCT01116583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592510|NCT01116583|Anticonvulsants|anticonvulsants|mesh-ancestor
6592511|NCT01116583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6592512|NCT01116583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6592513|NCT01116583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6592514|NCT01116583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6592515|NCT01116583|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6592516|NCT01116583|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6592517|NCT01116583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6592518|NCT01116583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592519|NCT01116583|Antimanic Agents|antimanic agents|mesh-ancestor
6592520|NCT01116596|Acetaminophen|acetaminophen|mesh-list
6592521|NCT01116596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6592522|NCT01116596|Analgesics|analgesics|mesh-ancestor
6592523|NCT01116596|Sensory System Agents|sensory system agents|mesh-ancestor
6592524|NCT01116596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6592525|NCT01116596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592526|NCT01116596|Antipyretics|antipyretics|mesh-ancestor
6592527|NCT01116609|Epinephrine|epinephrine|mesh-list
6592528|NCT01116609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6592529|NCT01116609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6592530|NCT01116609|Adrenergic Agents|adrenergic agents|mesh-ancestor
6592531|NCT01116609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6592532|NCT01116609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592533|NCT01116609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448040|NCT00399477|Rasagiline|rasagiline|mesh-list
6448041|NCT00399477|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6448042|NCT00399477|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6448043|NCT00399477|Dopamine Agents|dopamine agents|mesh-ancestor
6448044|NCT00399477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6448045|NCT00399477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448046|NCT00399477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448047|NCT00399477|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6448048|NCT00399477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6448049|NCT00399477|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6448050|NCT00399477|Protective Agents|protective agents|mesh-ancestor
6448051|NCT00399477|Antioxidants|antioxidants|mesh-ancestor
6592534|NCT01116609|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6592535|NCT01116609|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6592536|NCT01116609|Autonomic Agents|autonomic agents|mesh-ancestor
6592537|NCT01116609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6592538|NCT01116609|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6592539|NCT01116609|Respiratory System Agents|respiratory system agents|mesh-ancestor
6592540|NCT01116609|Mydriatics|mydriatics|mesh-ancestor
6592541|NCT01116609|Sympathomimetics|sympathomimetics|mesh-ancestor
6592542|NCT01116609|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6592543|NCT01116622|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6592544|NCT01116622|Bexarotene|bexarotene|mesh-list
6592545|NCT01116622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6592546|NCT01116622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6592547|NCT01116622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6592548|NCT01116622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592549|NCT01116635|Doxorubicin|doxorubicin|mesh-list
6592550|NCT01116635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6592551|NCT01116635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6592552|NCT01116635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6592553|NCT01116635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6592554|NCT01116635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6592555|NCT01116635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592556|NCT01116700|Dexmedetomidine|dexmedetomidine|mesh-list
6592557|NCT01116700|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6592558|NCT01116700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6592559|NCT01116700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592560|NCT01116700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6592561|NCT01116700|Analgesics|analgesics|mesh-ancestor
6448052|NCT00399477|Dopamine Agonists|dopamine agonists|mesh-ancestor
6448053|NCT00399633|Sumatriptan|sumatriptan|mesh-list
6448054|NCT00399633|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6448055|NCT00399633|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6448056|NCT00399633|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6448057|NCT00399633|Serotonin Agents|serotonin agents|mesh-ancestor
6448058|NCT00399633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6592562|NCT01116700|Sensory System Agents|sensory system agents|mesh-ancestor
6592563|NCT01116700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6592564|NCT01116700|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6592565|NCT01116700|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6592566|NCT01116700|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6592567|NCT01116700|Adrenergic Agents|adrenergic agents|mesh-ancestor
6592568|NCT01116700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6592569|NCT01116700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592570|NCT01116713|Dexamethasone|dexamethasone|mesh-list
6592571|NCT01116713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6592572|NCT01116713|Antiemetics|antiemetics|mesh-ancestor
6592573|NCT01116713|Autonomic Agents|autonomic agents|mesh-ancestor
6592574|NCT01116713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6592575|NCT01116713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592576|NCT01116713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6592577|NCT01116713|Glucocorticoids|glucocorticoids|mesh-ancestor
6592578|NCT01116713|Hormones|hormones|mesh-ancestor
6592579|NCT01116713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6592580|NCT01116713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6592581|NCT01116713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6592582|NCT01116791|Cisplatin|cisplatin|mesh-list
6592583|NCT01116791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6592584|NCT01116817|Ritonavir|ritonavir|mesh-list
6592585|NCT01116817|Lopinavir|lopinavir|mesh-list
6592586|NCT01116817|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6592587|NCT01116817|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6592588|NCT01116817|Protease Inhibitors|protease inhibitors|mesh-ancestor
6592589|NCT01116817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6592590|NCT01116817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448059|NCT00399633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448060|NCT00399633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448061|NCT00399659|Tegaserod|tegaserod|mesh-list
6448062|NCT00399659|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6448063|NCT00399659|Serotonin Agents|serotonin agents|mesh-ancestor
6448064|NCT00399659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6592591|NCT01116817|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6592592|NCT01116817|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6592593|NCT01116817|Antiviral Agents|antiviral agents|mesh-ancestor
6592594|NCT01116817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6592595|NCT01116817|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6592596|NCT01116817|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6592597|NCT01116830|Antipsychotic Agents|antipsychotic agents|mesh-list
6592598|NCT01116830|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6592599|NCT01116830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6592600|NCT01116830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592601|NCT01116830|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6592602|NCT01117038|Amlodipine|amlodipine|mesh-list
6592603|NCT01117038|Enalapril|enalapril|mesh-list
6592604|NCT01117038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6592605|NCT01117038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6592606|NCT01117038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6592607|NCT01117038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592608|NCT01117038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6592609|NCT01117038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592610|NCT01117038|Vasodilator Agents|vasodilator agents|mesh-ancestor
6592611|NCT01117038|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6592612|NCT01117038|Protease Inhibitors|protease inhibitors|mesh-ancestor
6592613|NCT01117038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6592614|NCT01117116|Fluticasone|fluticasone|mesh-list
6592615|NCT01117116|Xhance|xhance|mesh-list
6592616|NCT01117116|Budesonide|budesonide|mesh-list
6592617|NCT01117116|Formoterol Fumarate|formoterol fumarate|mesh-list
6592618|NCT01117116|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6592619|NCT01117116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6592620|NCT01117116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6592621|NCT01117116|Autonomic Agents|autonomic agents|mesh-ancestor
6592622|NCT01117116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6592623|NCT01117116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592624|NCT01117116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6592625|NCT01117116|Respiratory System Agents|respiratory system agents|mesh-ancestor
6592626|NCT01117116|Dermatologic Agents|dermatologic agents|mesh-ancestor
6592627|NCT01117116|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6592628|NCT01117116|Glucocorticoids|glucocorticoids|mesh-ancestor
6592629|NCT01117116|Hormones|hormones|mesh-ancestor
6592630|NCT01117116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6592631|NCT01117116|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6592632|NCT01117116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6592633|NCT01117116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6592634|NCT01117116|Adrenergic Agents|adrenergic agents|mesh-ancestor
6592635|NCT01117116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6592636|NCT01117116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592637|NCT01117129|Rituximab|rituximab|mesh-list
6592638|NCT01117129|Methotrexate|methotrexate|mesh-list
6659349|NCT01487395|Cholinergic Agents|cholinergic agents|mesh-ancestor
6448065|NCT00399659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448066|NCT00399659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448067|NCT00399672|Interferons|interferons|mesh-list
6448068|NCT00399672|Ribavirin|ribavirin|mesh-list
6592639|NCT01117129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6592640|NCT01117129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6592641|NCT01117129|Immunologic Factors|immunologic factors|mesh-ancestor
6592642|NCT01117129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592643|NCT01117129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6592644|NCT01117129|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6592645|NCT01117129|Abortifacient Agents|abortifacient agents|mesh-ancestor
6592646|NCT01117129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6592647|NCT01117129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5501663|NCT04472143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5501664|NCT04472143|Serotonin Agents|serotonin agents|mesh-ancestor
5501665|NCT04472143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5501666|NCT04472143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501667|NCT04471818|Ketamine|ketamine|mesh-list
5501668|NCT04471818|Analgesics|analgesics|mesh-ancestor
6592648|NCT01117129|Antimetabolites|antimetabolites|mesh-ancestor
6592649|NCT01117129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592650|NCT01117129|Dermatologic Agents|dermatologic agents|mesh-ancestor
6592651|NCT01117129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6592652|NCT01117129|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6592653|NCT01117129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6592654|NCT01117129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6592655|NCT01117220|Ziprasidone|ziprasidone|mesh-list
6592656|NCT01117220|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6592657|NCT01117220|Serotonin Agents|serotonin agents|mesh-ancestor
6592658|NCT01117220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6592659|NCT01117220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592660|NCT01117220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592661|NCT01117220|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6592662|NCT01117220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6592663|NCT01117220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6592664|NCT01117220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6592665|NCT01117220|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6592666|NCT01117220|Dopamine Agents|dopamine agents|mesh-ancestor
6592667|NCT01117298|Tadalafil|tadalafil|mesh-list
6592668|NCT01117298|Vasodilator Agents|vasodilator agents|mesh-ancestor
6592669|NCT01117298|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6592670|NCT01117298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6592671|NCT01117298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6592672|NCT01117298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592673|NCT01117298|Urological Agents|urological agents|mesh-ancestor
6592674|NCT01117376|Erythromycin|erythromycin|mesh-list
6592675|NCT01117376|Erythromycin Estolate|erythromycin estolate|mesh-list
6592676|NCT01117376|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
6592677|NCT01117376|Erythromycin stearate|erythromycin stearate|mesh-list
6592678|NCT01117376|Methylnaltrexone|methylnaltrexone|mesh-list
6592679|NCT01117376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6592680|NCT01117376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6592681|NCT01117376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6592682|NCT01117376|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6592683|NCT01117376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5501669|NCT04471818|Sensory System Agents|sensory system agents|mesh-ancestor
5501670|NCT04471818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5501671|NCT04471818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448069|NCT00399672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6448070|NCT00399672|Antiviral Agents|antiviral agents|mesh-ancestor
6592684|NCT01117376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592685|NCT01117376|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6448071|NCT00399672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6448072|NCT00399672|Antimetabolites|antimetabolites|mesh-ancestor
6448073|NCT00399672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448074|NCT00399685|Efavirenz|efavirenz|mesh-list
6448075|NCT00399685|Moxifloxacin|moxifloxacin|mesh-list
6448076|NCT00399685|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6020405|NCT00392834|Dermatologic Agents|dermatologic agents|mesh-ancestor
6592686|NCT01117376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592687|NCT01117376|Sensory System Agents|sensory system agents|mesh-ancestor
6592688|NCT01117376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6592689|NCT01117441|Cytarabine|cytarabine|mesh-list
6592690|NCT01117441|Dexamethasone|dexamethasone|mesh-list
6592691|NCT01117441|Prednisone|prednisone|mesh-list
6592692|NCT01117441|Cyclophosphamide|cyclophosphamide|mesh-list
6592693|NCT01117441|Ifosfamide|ifosfamide|mesh-list
6592694|NCT01117441|Doxorubicin|doxorubicin|mesh-list
6592695|NCT01117441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6592696|NCT01117441|Methotrexate|methotrexate|mesh-list
6592697|NCT01117441|Fludarabine|fludarabine|mesh-list
6592698|NCT01117441|Etoposide|etoposide|mesh-list
6592699|NCT01117441|Vincristine|vincristine|mesh-list
6592700|NCT01117441|Daunorubicin|daunorubicin|mesh-list
6592701|NCT01117441|Asparaginase|asparaginase|mesh-list
6592702|NCT01117441|Mercaptopurine|mercaptopurine|mesh-list
6592703|NCT01117441|Thioguanine|thioguanine|mesh-list
6592704|NCT01117441|Pegaspargase|pegaspargase|mesh-list
6592705|NCT01117441|Vindesine|vindesine|mesh-list
6592706|NCT01117441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6592707|NCT01117441|Immunologic Factors|immunologic factors|mesh-ancestor
6592708|NCT01117441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592709|NCT01117441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6592710|NCT01117441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6592711|NCT01117441|Alkylating Agents|alkylating agents|mesh-ancestor
6592712|NCT01117441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592713|NCT01117441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6592714|NCT01117441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6592715|NCT01117441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6592716|NCT01117441|Antiemetics|antiemetics|mesh-ancestor
6592717|NCT01117441|Autonomic Agents|autonomic agents|mesh-ancestor
6592718|NCT01117441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6592719|NCT01117441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6592720|NCT01117441|Glucocorticoids|glucocorticoids|mesh-ancestor
6592721|NCT01117441|Hormones|hormones|mesh-ancestor
6592722|NCT01117441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6592723|NCT01117441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6592724|NCT01117441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6592725|NCT01117441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6592726|NCT01117441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6592727|NCT01117441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6592728|NCT01117441|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6592729|NCT01117441|Abortifacient Agents|abortifacient agents|mesh-ancestor
6592730|NCT01117441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6592731|NCT01117441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6592732|NCT01117441|Antimetabolites|antimetabolites|mesh-ancestor
6592733|NCT01117441|Dermatologic Agents|dermatologic agents|mesh-ancestor
6592734|NCT01117441|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6592735|NCT01117441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6592736|NCT01117441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6592737|NCT01117441|Antiviral Agents|antiviral agents|mesh-ancestor
6592738|NCT01117441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6592739|NCT01117441|Tubulin Modulators|tubulin modulators|mesh-ancestor
6592740|NCT01117441|Antimitotic Agents|antimitotic agents|mesh-ancestor
6592741|NCT01117441|Mitosis Modulators|mitosis modulators|mesh-ancestor
6592742|NCT01117610|Ropivacaine|ropivacaine|mesh-list
6592743|NCT01117610|Anesthetics, Local|anesthetics, local|mesh-ancestor
6592744|NCT01117610|Anesthetics|anesthetics|mesh-ancestor
6592745|NCT01117610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6592746|NCT01117610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592747|NCT01117610|Sensory System Agents|sensory system agents|mesh-ancestor
6592748|NCT01117610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6592749|NCT01117636|Aspirin|aspirin|mesh-list
6592750|NCT01117636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6592751|NCT01117636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6592752|NCT01117636|Analgesics|analgesics|mesh-ancestor
6592753|NCT01117636|Sensory System Agents|sensory system agents|mesh-ancestor
6592754|NCT01117636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6592755|NCT01117636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592756|NCT01117636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6592757|NCT01117636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6592758|NCT01117636|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6592759|NCT01117636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6592760|NCT01117636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592761|NCT01117636|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6592762|NCT01117636|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6592763|NCT01117636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6592764|NCT01117636|Antipyretics|antipyretics|mesh-ancestor
6592765|NCT01117662|Rituximab|rituximab|mesh-list
6592766|NCT01117662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6592767|NCT01117662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6592768|NCT01117662|Immunologic Factors|immunologic factors|mesh-ancestor
6592769|NCT01117662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592770|NCT01117662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6592771|NCT01118039|Sunitinib|sunitinib|mesh-list
6592772|NCT01118039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6592773|NCT01118039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6592774|NCT01118039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6592775|NCT01118039|Growth Substances|growth substances|mesh-ancestor
6592776|NCT01118039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592777|NCT01118039|Growth Inhibitors|growth inhibitors|mesh-ancestor
6592778|NCT01118039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6592779|NCT01118039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6592780|NCT01118039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592781|NCT01118065|Everolimus|everolimus|mesh-list
6592782|NCT01118065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6592783|NCT01118065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6592784|NCT01118065|Immunologic Factors|immunologic factors|mesh-ancestor
6592785|NCT01118065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659350|NCT01487395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6659351|NCT01487395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724828|NCT03185130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6659352|NCT01487395|Nootropic Agents|nootropic agents|mesh-ancestor
6659353|NCT01487408|Insulin Aspart|insulin aspart|mesh-list
6592786|NCT01118234|Rituximab|rituximab|mesh-list
6592787|NCT01118234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6592788|NCT01118234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6592789|NCT01118234|Immunologic Factors|immunologic factors|mesh-ancestor
6592790|NCT01118234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592791|NCT01118234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6592792|NCT01118260|Anesthetics|anesthetics|mesh-list
6592793|NCT01118260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6592794|NCT01118260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592795|NCT01118286|Nifedipine|nifedipine|mesh-list
6592796|NCT01118286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6592797|NCT01118286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6592798|NCT01118286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592799|NCT01118286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6592800|NCT01118286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592801|NCT01118286|Vasodilator Agents|vasodilator agents|mesh-ancestor
6592802|NCT01118286|Tocolytic Agents|tocolytic agents|mesh-ancestor
6592803|NCT01118286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6592804|NCT01118403|Ampicillin|ampicillin|mesh-list
6592805|NCT01118403|Sulbactam|sulbactam|mesh-list
6592806|NCT01118403|Sultamicillin|sultamicillin|mesh-list
6592807|NCT01118403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6592808|NCT01118403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6592809|NCT01118403|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6592810|NCT01118403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6592811|NCT01118403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592812|NCT01118429|Oxybutynin|oxybutynin|mesh-list
6592813|NCT01118429|Parasympatholytics|parasympatholytics|mesh-ancestor
6592814|NCT01118429|Autonomic Agents|autonomic agents|mesh-ancestor
6592815|NCT01118429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6592816|NCT01118429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592817|NCT01118429|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6592818|NCT01118429|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6592819|NCT01118429|Cholinergic Agents|cholinergic agents|mesh-ancestor
6592820|NCT01118429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6592821|NCT01118429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592822|NCT01118429|Urological Agents|urological agents|mesh-ancestor
6592823|NCT01118533|Pyrithione zinc|pyrithione zinc|mesh-list
6592824|NCT01118533|Keratolytic Agents|keratolytic agents|mesh-ancestor
6592825|NCT01118533|Dermatologic Agents|dermatologic agents|mesh-ancestor
6592826|NCT01118559|Darexaban|darexaban|mesh-list
6592827|NCT01118559|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6592828|NCT01118559|Antithrombins|antithrombins|mesh-ancestor
6592829|NCT01118559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6592830|NCT01118559|Protease Inhibitors|protease inhibitors|mesh-ancestor
6592831|NCT01118559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6592832|NCT01118559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592833|NCT01118559|Anticoagulants|anticoagulants|mesh-ancestor
6592834|NCT01118572|Celecoxib|celecoxib|mesh-list
6592835|NCT01118572|Etodolac|etodolac|mesh-list
6592836|NCT01118572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6592837|NCT01118572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6592838|NCT01118572|Analgesics|analgesics|mesh-ancestor
6592839|NCT01118572|Sensory System Agents|sensory system agents|mesh-ancestor
6592840|NCT01118572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6592841|NCT01118572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592842|NCT01118572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6592843|NCT01118572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6592844|NCT01118572|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6592845|NCT01118572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6592846|NCT01118572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6592847|NCT01118572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592848|NCT01118598|Nicotinic Acids|nicotinic acids|mesh-list
6592849|NCT01118598|Niacin|niacin|mesh-list
6592850|NCT01118598|Niacinamide|niacinamide|mesh-list
6592851|NCT01118598|Vitamin B Complex|vitamin b complex|mesh-ancestor
6592852|NCT01118598|Vitamins|vitamins|mesh-ancestor
6592853|NCT01118598|Micronutrients|micronutrients|mesh-ancestor
6592854|NCT01118598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592855|NCT01118598|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6592856|NCT01118598|Antimetabolites|antimetabolites|mesh-ancestor
6659354|NCT01487408|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6592857|NCT01118598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592858|NCT01118598|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6592859|NCT01118598|Vasodilator Agents|vasodilator agents|mesh-ancestor
6592860|NCT01118611|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6592861|NCT01118611|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6592862|NCT01118611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592863|NCT01118702|Methylphenidate|methylphenidate|mesh-list
6592864|NCT01118702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6592865|NCT01118702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592866|NCT01118702|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6592867|NCT01118702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6592868|NCT01118702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6592869|NCT01118702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592870|NCT01118702|Dopamine Agents|dopamine agents|mesh-ancestor
6592871|NCT01118702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6592872|NCT01118793|Clopidogrel|clopidogrel|mesh-list
6592873|NCT01118793|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6592874|NCT01118793|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6592875|NCT01118793|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6592876|NCT01118793|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6592877|NCT01118793|Purinergic Agents|purinergic agents|mesh-ancestor
6592878|NCT01118793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6592879|NCT01118793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592880|NCT01118793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592881|NCT01118871|Ritonavir|ritonavir|mesh-list
6592882|NCT01118871|Darunavir|darunavir|mesh-list
6592883|NCT01118871|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6592884|NCT01118871|Etravirine|etravirine|mesh-list
6592885|NCT01118871|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6592886|NCT01118871|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6592887|NCT01118871|Protease Inhibitors|protease inhibitors|mesh-ancestor
6592888|NCT01118871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6592889|NCT01118871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592890|NCT01118871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6592891|NCT01118871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6592892|NCT01118871|Antiviral Agents|antiviral agents|mesh-ancestor
6592893|NCT01118871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6592894|NCT01118871|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6592895|NCT01118871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6592896|NCT01118871|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6592897|NCT01118871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6592898|NCT01118884|Promethazine|promethazine|mesh-list
6592899|NCT01118884|Diphenhydramine|diphenhydramine|mesh-list
6592900|NCT01118884|Antipruritics|antipruritics|mesh-ancestor
6592901|NCT01118884|Dermatologic Agents|dermatologic agents|mesh-ancestor
6592902|NCT01118884|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6592903|NCT01118884|Histamine Antagonists|histamine antagonists|mesh-ancestor
6592904|NCT01118884|Histamine Agents|histamine agents|mesh-ancestor
6592905|NCT01118884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6592906|NCT01118884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592907|NCT01118884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592908|NCT01118884|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6592909|NCT01118884|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6592910|NCT01118884|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6592911|NCT01118884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6592912|NCT01118884|Anesthetics, Local|anesthetics, local|mesh-ancestor
6592913|NCT01118884|Anesthetics|anesthetics|mesh-ancestor
6592914|NCT01118884|Sensory System Agents|sensory system agents|mesh-ancestor
6592915|NCT01118884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6592916|NCT01118884|Antiemetics|antiemetics|mesh-ancestor
6592917|NCT01118884|Autonomic Agents|autonomic agents|mesh-ancestor
6592918|NCT01118884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6592919|NCT01118923|Magnesium Hydroxide|magnesium hydroxide|mesh-list
6592920|NCT01118923|Antacids|antacids|mesh-ancestor
6592921|NCT01118923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592922|NCT01118923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6592923|NCT01118936|Magnesium Hydroxide|magnesium hydroxide|mesh-list
6592924|NCT01118936|Antacids|antacids|mesh-ancestor
6592925|NCT01118936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592926|NCT01118936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6592927|NCT01119014|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6592928|NCT01119014|Aripiprazole|aripiprazole|mesh-list
6592929|NCT01119014|Antidepressive Agents|antidepressive agents|mesh-ancestor
6592930|NCT01119014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6592931|NCT01119014|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6592932|NCT01119014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6592933|NCT01119014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6592934|NCT01119014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592935|NCT01119014|Dopamine Agonists|dopamine agonists|mesh-ancestor
6592936|NCT01119014|Dopamine Agents|dopamine agents|mesh-ancestor
6592937|NCT01119014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6592938|NCT01119014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592939|NCT01119014|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6592940|NCT01119014|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6592941|NCT01119014|Serotonin Agents|serotonin agents|mesh-ancestor
6592942|NCT01119014|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6592943|NCT01119014|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6592944|NCT01119014|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6592945|NCT01119014|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6592946|NCT01119066|Cyclophosphamide|cyclophosphamide|mesh-list
6592947|NCT01119066|Melphalan|melphalan|mesh-list
6592948|NCT01119066|Busulfan|busulfan|mesh-list
6592949|NCT01119066|Thiotepa|thiotepa|mesh-list
6592950|NCT01119066|Fludarabine|fludarabine|mesh-list
6592951|NCT01119066|Clofarabine|clofarabine|mesh-list
6592952|NCT01119066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6592953|NCT01119066|Immunologic Factors|immunologic factors|mesh-ancestor
6592954|NCT01119066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592955|NCT01119066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6592956|NCT01119066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6592957|NCT01119066|Alkylating Agents|alkylating agents|mesh-ancestor
6592958|NCT01119066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592959|NCT01119066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6592960|NCT01119066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6592961|NCT01119066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6592962|NCT01119066|Antimetabolites|antimetabolites|mesh-ancestor
6592963|NCT01119079|Anesthetics|anesthetics|mesh-list
6592964|NCT01119079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6592965|NCT01119079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592966|NCT01119144|Calcium, Dietary|calcium, dietary|mesh-list
6592967|NCT01119144|Calcium|calcium|mesh-list
6592968|NCT01119144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6592969|NCT01119144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592970|NCT01119144|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6592971|NCT01119157|Vaccines|vaccines|mesh-list
6592972|NCT01119157|Immunologic Factors|immunologic factors|mesh-ancestor
6592973|NCT01119157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592974|NCT01119196|Dialysis Solutions|dialysis solutions|mesh-list
6448077|NCT00399685|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6448078|NCT00399685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6448079|NCT00399685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6448080|NCT00399685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448081|NCT00399685|Antiviral Agents|antiviral agents|mesh-ancestor
6448082|NCT00399685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6448083|NCT00399685|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6448084|NCT00399685|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6448085|NCT00399685|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6448086|NCT00399685|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6448087|NCT00399685|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6448088|NCT00399685|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6448089|NCT00399685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6448090|NCT00399685|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6448091|NCT00399685|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6448092|NCT00399685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6448093|NCT00399685|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6448094|NCT00399685|Contraceptive Agents|contraceptive agents|mesh-ancestor
6448095|NCT00399685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6448096|NCT00399685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448097|NCT00399685|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6448098|NCT00399685|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6448099|NCT00399685|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6448100|NCT00399698|Risperidone|risperidone|mesh-list
6448101|NCT00399698|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6448102|NCT00399698|Serotonin Agents|serotonin agents|mesh-ancestor
6448103|NCT00399698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6448104|NCT00399698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448105|NCT00399698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448106|NCT00399698|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6448107|NCT00399698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6448108|NCT00399698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6448109|NCT00399698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6448110|NCT00399698|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6448111|NCT00399698|Dopamine Agents|dopamine agents|mesh-ancestor
6448112|NCT00399711|Metformin|metformin|mesh-list
6448113|NCT00399711|Rosiglitazone|rosiglitazone|mesh-list
6448114|NCT00399711|Repaglinide|repaglinide|mesh-list
6448115|NCT00399711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6448116|NCT00399711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448117|NCT00399724|Insulin Glargine|insulin glargine|mesh-list
6448118|NCT00399724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6448119|NCT00399724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448120|NCT00399737|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6448121|NCT00399737|Protease Inhibitors|protease inhibitors|mesh-ancestor
6448122|NCT00399737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6448123|NCT00399737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448124|NCT00399750|Bevacizumab|bevacizumab|mesh-list
6448125|NCT00399750|Oxaliplatin|oxaliplatin|mesh-list
6462219|NCT00458185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6592975|NCT01119196|Icodextrin|icodextrin|mesh-list
6592976|NCT01119196|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6592977|NCT01119209|Ropivacaine|ropivacaine|mesh-list
6592978|NCT01119209|Anesthetics, Local|anesthetics, local|mesh-ancestor
6592979|NCT01119209|Anesthetics|anesthetics|mesh-ancestor
6592980|NCT01119209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6592981|NCT01119209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592982|NCT01119209|Sensory System Agents|sensory system agents|mesh-ancestor
6592983|NCT01119209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6592984|NCT01119417|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
6592985|NCT01119417|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6592986|NCT01119417|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6592987|NCT01119417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592988|NCT01119430|Fluoxetine|fluoxetine|mesh-list
6592989|NCT01119430|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6592990|NCT01119430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6592991|NCT01119430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6592992|NCT01119430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6592993|NCT01119430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6592994|NCT01119430|Serotonin Agents|serotonin agents|mesh-ancestor
6592995|NCT01119430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6592996|NCT01119430|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5501672|NCT04471818|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5501673|NCT04471818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5501674|NCT04471818|Anesthetics, General|anesthetics, general|mesh-ancestor
5501675|NCT04471818|Anesthetics|anesthetics|mesh-ancestor
5501676|NCT04471818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5501677|NCT04471818|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5501678|NCT04471818|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6592997|NCT01119430|Antidepressive Agents|antidepressive agents|mesh-ancestor
6592998|NCT01119430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6592999|NCT01119430|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6593000|NCT01119430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6593001|NCT01119430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6593002|NCT01119482|Vaccines|vaccines|mesh-list
6593003|NCT01119482|Immunologic Factors|immunologic factors|mesh-ancestor
6593004|NCT01119482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501679|NCT04471818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5501680|NCT04471818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501681|NCT04472000|Ascorbic Acid|ascorbic acid|mesh-list
5501682|NCT04472000|Vitamins|vitamins|mesh-ancestor
5501683|NCT04472000|Micronutrients|micronutrients|mesh-ancestor
5501684|NCT04472000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501685|NCT04472000|Antioxidants|antioxidants|mesh-ancestor
5501686|NCT04472000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501687|NCT04472000|Protective Agents|protective agents|mesh-ancestor
5501688|NCT04471480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5501689|NCT04471480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501690|NCT04471480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5501691|NCT04471441|Mycophenolic Acid|mycophenolic acid|mesh-list
5501692|NCT04471441|Everolimus|everolimus|mesh-list
5501693|NCT04471441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5501694|NCT04471441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5501695|NCT04471441|Immunologic Factors|immunologic factors|mesh-ancestor
5501696|NCT04471441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501697|NCT04471441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6593005|NCT01119521|Isoniazid|isoniazid|mesh-list
6593006|NCT01119521|Antitubercular Agents|antitubercular agents|mesh-ancestor
6593007|NCT01119521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6593008|NCT01119521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6593009|NCT01119521|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6593010|NCT01119521|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6593011|NCT01119521|Antimetabolites|antimetabolites|mesh-ancestor
6593012|NCT01119521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593013|NCT01119521|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6593014|NCT01119534|Camphor|camphor|mesh-list
6593015|NCT01119534|Eucalyptol|eucalyptol|mesh-list
6593016|NCT01119534|Phenylpropanolamine|phenylpropanolamine|mesh-list
6593017|NCT01119534|Menthol|menthol|mesh-list
6593018|NCT01119534|Guaifenesin|guaifenesin|mesh-list
6593019|NCT01119534|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
6593020|NCT01119534|Antipruritics|antipruritics|mesh-ancestor
6593021|NCT01119534|Dermatologic Agents|dermatologic agents|mesh-ancestor
6593022|NCT01119534|Expectorants|expectorants|mesh-ancestor
6593023|NCT01119534|Respiratory System Agents|respiratory system agents|mesh-ancestor
6593024|NCT01119534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6593025|NCT01119534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6593026|NCT01119534|Adrenergic Agents|adrenergic agents|mesh-ancestor
6593027|NCT01119534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6593028|NCT01119534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593029|NCT01119534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593030|NCT01119534|Appetite Depressants|appetite depressants|mesh-ancestor
6593031|NCT01119534|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6593032|NCT01119534|Sympathomimetics|sympathomimetics|mesh-ancestor
6593033|NCT01119534|Autonomic Agents|autonomic agents|mesh-ancestor
6593034|NCT01119534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6593035|NCT01119534|Nasal Decongestants|nasal decongestants|mesh-ancestor
6593036|NCT01119534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6593037|NCT01119534|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6593038|NCT01119534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6593039|NCT01119534|Antitussive Agents|antitussive agents|mesh-ancestor
6593040|NCT01119534|Insect Repellents|insect repellents|mesh-ancestor
6593041|NCT01119534|Protective Agents|protective agents|mesh-ancestor
6593042|NCT01119599|Temozolomide|temozolomide|mesh-list
6593043|NCT01119599|R04929097|r04929097|mesh-list
6593044|NCT01119599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6593045|NCT01119599|Alkylating Agents|alkylating agents|mesh-ancestor
6593046|NCT01119599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593047|NCT01119599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6593048|NCT01119599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6593049|NCT01119638|Risperidone|risperidone|mesh-list
6593050|NCT01119638|Citalopram|citalopram|mesh-list
6593051|NCT01119638|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6593052|NCT01119638|Serotonin Agents|serotonin agents|mesh-ancestor
6593053|NCT01119638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6593054|NCT01119638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593055|NCT01119638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593056|NCT01119638|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6593057|NCT01119638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6593058|NCT01119638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6593059|NCT01119638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6593060|NCT01119638|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6593061|NCT01119638|Dopamine Agents|dopamine agents|mesh-ancestor
6593062|NCT01119638|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6593063|NCT01119638|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6593064|NCT01119638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6593065|NCT01119638|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6593066|NCT01119638|Antidepressive Agents|antidepressive agents|mesh-ancestor
6593067|NCT01119651|Tazarotene|tazarotene|mesh-list
6593068|NCT01119651|Dermatologic Agents|dermatologic agents|mesh-ancestor
6593069|NCT01119651|Keratolytic Agents|keratolytic agents|mesh-ancestor
6593070|NCT01119677|Interferon beta-1a|interferon beta-1a|mesh-list
6593071|NCT01119677|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6593072|NCT01119677|Immunologic Factors|immunologic factors|mesh-ancestor
6593073|NCT01119677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593074|NCT01119677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6593075|NCT01119677|Antiviral Agents|antiviral agents|mesh-ancestor
6593076|NCT01119677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6593077|NCT01119742|Butenafine|butenafine|mesh-list
6593078|NCT01119742|Antifungal Agents|antifungal agents|mesh-ancestor
6593079|NCT01119742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6593080|NCT01119885|Fentanyl|fentanyl|mesh-list
6593081|NCT01119885|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6593082|NCT01119885|Narcotics|narcotics|mesh-ancestor
6593083|NCT01119885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6593084|NCT01119885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593085|NCT01119885|Analgesics|analgesics|mesh-ancestor
6593086|NCT01119885|Sensory System Agents|sensory system agents|mesh-ancestor
6593087|NCT01119885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6593088|NCT01119885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6593089|NCT01119885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6593090|NCT01119885|Anesthetics, General|anesthetics, general|mesh-ancestor
6593091|NCT01119885|Anesthetics|anesthetics|mesh-ancestor
6593092|NCT01120015|Diacetylrhein|diacetylrhein|mesh-list
6593093|NCT01120015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6593094|NCT01120106|Simendan|simendan|mesh-list
6593095|NCT01120106|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6593096|NCT01120106|Vasodilator Agents|vasodilator agents|mesh-ancestor
6593097|NCT01120106|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6593098|NCT01120106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6593099|NCT01120106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6593100|NCT01120106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593101|NCT01120106|Protective Agents|protective agents|mesh-ancestor
6593102|NCT01120106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593103|NCT01120119|Calcitriol|calcitriol|mesh-list
6593104|NCT01120119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6593105|NCT01120119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593106|NCT01120119|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6593107|NCT01120119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6593108|NCT01120119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593109|NCT01120119|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6593110|NCT01120119|Vitamins|vitamins|mesh-ancestor
6593111|NCT01120119|Micronutrients|micronutrients|mesh-ancestor
6593112|NCT01120119|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6593113|NCT01120158|Paclitaxel|paclitaxel|mesh-list
6593114|NCT01120158|Bevacizumab|bevacizumab|mesh-list
6593115|NCT01120158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6593116|NCT01120158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6593117|NCT01120158|Tubulin Modulators|tubulin modulators|mesh-ancestor
6593118|NCT01120158|Antimitotic Agents|antimitotic agents|mesh-ancestor
6593119|NCT01120158|Mitosis Modulators|mitosis modulators|mesh-ancestor
6593120|NCT01120158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593121|NCT01120158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6593122|NCT01120158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6593123|NCT01120158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6593124|NCT01120158|Growth Substances|growth substances|mesh-ancestor
6593125|NCT01120158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593126|NCT01120158|Growth Inhibitors|growth inhibitors|mesh-ancestor
6659355|NCT01487408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659356|NCT01487421|Insulin|insulin|mesh-list
6659357|NCT01487421|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6659358|NCT01487421|Insulin Aspart|insulin aspart|mesh-list
6659359|NCT01487421|Insulin Detemir|insulin detemir|mesh-list
6659360|NCT01487421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6659361|NCT01487421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659362|NCT01487512|Hydromorphone|hydromorphone|mesh-list
6659363|NCT01487512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6659364|NCT01487512|Narcotics|narcotics|mesh-ancestor
6659365|NCT01487512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6659366|NCT01487512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448126|NCT00399750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6448127|NCT00399750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6448128|NCT00399750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6448129|NCT00399750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6448130|NCT00399750|Growth Substances|growth substances|mesh-ancestor
6448131|NCT00399750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448132|NCT00399750|Growth Inhibitors|growth inhibitors|mesh-ancestor
6448133|NCT00399867|Simvastatin|simvastatin|mesh-list
6448134|NCT00399867|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6659367|NCT01487512|Analgesics|analgesics|mesh-ancestor
6659368|NCT01487512|Sensory System Agents|sensory system agents|mesh-ancestor
6659369|NCT01487512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6659370|NCT01487564|Hydromorphone|hydromorphone|mesh-list
6659371|NCT01487564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6659372|NCT01487564|Narcotics|narcotics|mesh-ancestor
6659373|NCT01487564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6659374|NCT01487564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659375|NCT01487564|Analgesics|analgesics|mesh-ancestor
6659376|NCT01487564|Sensory System Agents|sensory system agents|mesh-ancestor
6593127|NCT01120171|Cyclophosphamide|cyclophosphamide|mesh-list
6593128|NCT01120171|Doxorubicin|doxorubicin|mesh-list
6593129|NCT01120171|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6593130|NCT01120171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6593131|NCT01120171|Immunologic Factors|immunologic factors|mesh-ancestor
6593132|NCT01120171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593133|NCT01120171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6593134|NCT01120171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6593135|NCT01120171|Alkylating Agents|alkylating agents|mesh-ancestor
6593136|NCT01120171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593137|NCT01120171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6593138|NCT01120171|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6593139|NCT01120171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6593140|NCT01120171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6593141|NCT01120171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6593142|NCT01120171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6593143|NCT01120314|Otamixaban|otamixaban|mesh-list
6593144|NCT01120314|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6593145|NCT01120314|Antithrombins|antithrombins|mesh-ancestor
6593146|NCT01120314|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6593147|NCT01120314|Protease Inhibitors|protease inhibitors|mesh-ancestor
6593148|NCT01120314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6593149|NCT01120314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593150|NCT01120314|Anticoagulants|anticoagulants|mesh-ancestor
6593151|NCT01120327|Amlodipine|amlodipine|mesh-list
6593152|NCT01120327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6593153|NCT01120327|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6593154|NCT01120327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6593155|NCT01120327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593156|NCT01120327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6593157|NCT01120327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593158|NCT01120327|Vasodilator Agents|vasodilator agents|mesh-ancestor
6593159|NCT01120340|Mesalamine|mesalamine|mesh-list
6593160|NCT01120340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6593161|NCT01120340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6593162|NCT01120340|Analgesics|analgesics|mesh-ancestor
6593163|NCT01120340|Sensory System Agents|sensory system agents|mesh-ancestor
6593164|NCT01120340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6593165|NCT01120340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593166|NCT01120340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6593167|NCT01120340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6593168|NCT01120366|Methotrexate|methotrexate|mesh-list
6593169|NCT01120366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6593170|NCT01120366|Abortifacient Agents|abortifacient agents|mesh-ancestor
6593171|NCT01120366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6593172|NCT01120366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593173|NCT01120366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6593174|NCT01120366|Antimetabolites|antimetabolites|mesh-ancestor
6593175|NCT01120366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593176|NCT01120366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6593177|NCT01120366|Dermatologic Agents|dermatologic agents|mesh-ancestor
6593178|NCT01120366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6593179|NCT01120366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6593180|NCT01120366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6593181|NCT01120366|Immunologic Factors|immunologic factors|mesh-ancestor
6593182|NCT01120366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6593183|NCT01120366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6593184|NCT01120418|Besifloxacin|besifloxacin|mesh-list
6593185|NCT01120418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6593186|NCT01120418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6593187|NCT01120418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6593188|NCT01120418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6593189|NCT01120418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6593190|NCT01120418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593191|NCT01120418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6593192|NCT01120431|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6593193|NCT01120444|Insulin|insulin|mesh-list
6593194|NCT01120444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6593195|NCT01120444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593196|NCT01120561|Trastuzumab|trastuzumab|mesh-list
6593197|NCT01120561|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
6593198|NCT01120561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6593199|NCT01120561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6593200|NCT01120561|Tubulin Modulators|tubulin modulators|mesh-ancestor
6593201|NCT01120561|Antimitotic Agents|antimitotic agents|mesh-ancestor
6448135|NCT00399867|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6448136|NCT00399867|Antimetabolites|antimetabolites|mesh-ancestor
6448137|NCT00399867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593202|NCT01120561|Mitosis Modulators|mitosis modulators|mesh-ancestor
6593203|NCT01120561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593204|NCT01120665|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6593205|NCT01120665|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6593206|NCT01120665|Estradiol|estradiol|mesh-list
6593207|NCT01120665|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6593208|NCT01120665|Hormones|hormones|mesh-ancestor
6593209|NCT01120665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6593210|NCT01120665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593211|NCT01120665|Estrogens|estrogens|mesh-ancestor
6593212|NCT01120665|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6593213|NCT01120665|Contraceptive Agents|contraceptive agents|mesh-ancestor
6593214|NCT01120665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6593215|NCT01120665|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6593216|NCT01120769|Acetaminophen|acetaminophen|mesh-list
5724829|NCT03185130|Antiemetics|antiemetics|mesh-ancestor
6448138|NCT00399867|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6448139|NCT00399867|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6448140|NCT00399867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6448141|NCT00399945|Tobramycin|tobramycin|mesh-list
6448142|NCT00399945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6448143|NCT00399945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6448144|NCT00399971|Immunologic Factors|immunologic factors|mesh-list
6448145|NCT00399971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448146|NCT00400075|Cyclophosphamide|cyclophosphamide|mesh-list
6448147|NCT00400075|Azathioprine|azathioprine|mesh-list
6448148|NCT00400075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6448149|NCT00400075|Immunologic Factors|immunologic factors|mesh-ancestor
6448150|NCT00400075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448151|NCT00400075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6448152|NCT00400075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6448153|NCT00400075|Alkylating Agents|alkylating agents|mesh-ancestor
6448154|NCT00400075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593217|NCT01120769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6593218|NCT01120769|Analgesics|analgesics|mesh-ancestor
6593219|NCT01120769|Sensory System Agents|sensory system agents|mesh-ancestor
6593220|NCT01120769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6593221|NCT01120769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593222|NCT01120769|Antipyretics|antipyretics|mesh-ancestor
6593223|NCT01120795|Interferons|interferons|mesh-list
6593224|NCT01120795|Ribavirin|ribavirin|mesh-list
6593225|NCT01120795|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6593226|NCT01120795|Interferon-alpha|interferon-alpha|mesh-list
6593227|NCT01120795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6593228|NCT01120795|Antiviral Agents|antiviral agents|mesh-ancestor
6593229|NCT01120795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6593230|NCT01120795|Antimetabolites|antimetabolites|mesh-ancestor
6593231|NCT01120795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593232|NCT01120795|Immunologic Factors|immunologic factors|mesh-ancestor
6593233|NCT01120795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593234|NCT01120821|Imatinib Mesylate|imatinib mesylate|mesh-list
6593235|NCT01120821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6593236|NCT01120821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6593237|NCT01120821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6593238|NCT01120821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593239|NCT01120912|Insulin|insulin|mesh-list
6593240|NCT01120912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6593241|NCT01120912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593242|NCT01121016|Montelukast|montelukast|mesh-list
6593243|NCT01121016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6593244|NCT01121016|Respiratory System Agents|respiratory system agents|mesh-ancestor
6593245|NCT01121016|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6593246|NCT01121016|Hormone Antagonists|hormone antagonists|mesh-ancestor
6593247|NCT01121016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6593248|NCT01121016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593249|NCT01121016|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6593250|NCT01121016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6593251|NCT01121016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593252|NCT01121042|Ondansetron|ondansetron|mesh-list
6593253|NCT01121042|Antiemetics|antiemetics|mesh-ancestor
6593254|NCT01121042|Autonomic Agents|autonomic agents|mesh-ancestor
6593255|NCT01121042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6593256|NCT01121042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593257|NCT01121042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6593258|NCT01121042|Antipruritics|antipruritics|mesh-ancestor
6593259|NCT01121042|Dermatologic Agents|dermatologic agents|mesh-ancestor
6593260|NCT01121042|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6593261|NCT01121042|Serotonin Agents|serotonin agents|mesh-ancestor
6593262|NCT01121042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6593263|NCT01121042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593264|NCT01121042|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6593265|NCT01121042|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6593266|NCT01121042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6593267|NCT01121042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6593268|NCT01121042|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6593269|NCT01121055|Lorazepam|lorazepam|mesh-list
6593270|NCT01121055|Anticonvulsants|anticonvulsants|mesh-ancestor
6593271|NCT01121055|Antiemetics|antiemetics|mesh-ancestor
6593272|NCT01121055|Autonomic Agents|autonomic agents|mesh-ancestor
6593273|NCT01121055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6593274|NCT01121055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593275|NCT01121055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6593276|NCT01121055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6448155|NCT00400075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6448156|NCT00400075|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6448157|NCT00400075|Antimetabolites|antimetabolites|mesh-ancestor
6448158|NCT00400075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6448159|NCT00400088|Lithium Carbonate|lithium carbonate|mesh-list
6448160|NCT00400088|Paroxetine|paroxetine|mesh-list
6448161|NCT00400088|Antidepressive Agents|antidepressive agents|mesh-ancestor
6593277|NCT01121055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6593278|NCT01121055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6593279|NCT01121055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6593280|NCT01121055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6593281|NCT01121055|GABA Modulators|gaba modulators|mesh-ancestor
6448162|NCT00400088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6593282|NCT01121055|GABA Agents|gaba agents|mesh-ancestor
6593283|NCT01121055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6593284|NCT01121055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593285|NCT01121120|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
6593286|NCT01121120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6593287|NCT01121120|Vasodilator Agents|vasodilator agents|mesh-ancestor
6593288|NCT01121133|Rifampin|rifampin|mesh-list
6593289|NCT01121133|Navitoclax|navitoclax|mesh-list
6448163|NCT00400088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6448164|NCT00400088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448165|NCT00400088|Antimanic Agents|antimanic agents|mesh-ancestor
6448166|NCT00400088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6448167|NCT00400088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6593290|NCT01121133|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6593291|NCT01121133|Antitubercular Agents|antitubercular agents|mesh-ancestor
6448168|NCT00400088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448169|NCT00400088|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6448170|NCT00400088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6448171|NCT00400088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6448172|NCT00400088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6593292|NCT01121133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6593293|NCT01121133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6593294|NCT01121133|Leprostatic Agents|leprostatic agents|mesh-ancestor
6593295|NCT01121133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6593296|NCT01121133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6593297|NCT01121133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593298|NCT01121133|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6593299|NCT01121133|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6593300|NCT01121133|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6593301|NCT01121133|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6593302|NCT01121133|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6593303|NCT01121133|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6593304|NCT01121133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6593305|NCT01121198|Ipragliflozin|ipragliflozin|mesh-list
6593306|NCT01121198|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6593307|NCT01121198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593308|NCT01121198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6593309|NCT01121198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593310|NCT01121237|Epoetin Alfa|epoetin alfa|mesh-list
6593311|NCT01121237|Hematinics|hematinics|mesh-ancestor
6448173|NCT00400088|Serotonin Agents|serotonin agents|mesh-ancestor
6593312|NCT01121276|Insulin|insulin|mesh-list
6593313|NCT01121276|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6593314|NCT01121276|Insulin Aspart|insulin aspart|mesh-list
6593315|NCT01121276|Insulin, Long-Acting|insulin, long-acting|mesh-list
6593316|NCT01121276|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6593317|NCT01121276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6593318|NCT01121276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724830|NCT03185130|Autonomic Agents|autonomic agents|mesh-ancestor
6593319|NCT01121289|Insulin Aspart|insulin aspart|mesh-list
6593320|NCT01121289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6593321|NCT01121289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593322|NCT01121354|Cefazolin|cefazolin|mesh-list
6593323|NCT01121354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6593324|NCT01121354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6593325|NCT01121458|Clevidipine|clevidipine|mesh-list
6593326|NCT01121458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6593327|NCT01121458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6448174|NCT00400088|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6448175|NCT00400088|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6448176|NCT00400088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6448177|NCT00400114|Irinotecan|irinotecan|mesh-list
6448178|NCT00400114|Sunitinib|sunitinib|mesh-list
6448179|NCT00400114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6448180|NCT00400114|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6448181|NCT00400114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6448182|NCT00400114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6593328|NCT01121458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593329|NCT01121458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6593330|NCT01121458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593331|NCT01121497|Physostigmine|physostigmine|mesh-list
6593332|NCT01121497|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6593333|NCT01121497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6593334|NCT01121497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593335|NCT01121497|Cholinergic Agents|cholinergic agents|mesh-ancestor
6593336|NCT01121497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6593337|NCT01121497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593338|NCT01121497|Miotics|miotics|mesh-ancestor
6593339|NCT01121497|Autonomic Agents|autonomic agents|mesh-ancestor
6593340|NCT01121497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6593341|NCT01121588|Crizotinib|crizotinib|mesh-list
6593342|NCT01121588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6593343|NCT01121588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6593344|NCT01121588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6593345|NCT01121588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593346|NCT01121705|Interferons|interferons|mesh-list
6593347|NCT01121705|Ribavirin|ribavirin|mesh-list
6593348|NCT01121705|Interferon-alpha|interferon-alpha|mesh-list
6593349|NCT01121705|Interferon alpha-2|interferon alpha-2|mesh-list
6593350|NCT01121705|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6593351|NCT01121705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6593352|NCT01121705|Antiviral Agents|antiviral agents|mesh-ancestor
6593353|NCT01121705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6593354|NCT01121705|Antimetabolites|antimetabolites|mesh-ancestor
6593355|NCT01121705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593356|NCT01121705|Immunologic Factors|immunologic factors|mesh-ancestor
6593357|NCT01121705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593358|NCT01121731|Interferons|interferons|mesh-list
6593359|NCT01121731|Interferon alpha-2|interferon alpha-2|mesh-list
6593360|NCT01121731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6593361|NCT01121731|Antiviral Agents|antiviral agents|mesh-ancestor
6593362|NCT01121731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6593363|NCT01121744|Sirolimus|sirolimus|mesh-list
6593364|NCT01121744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6593365|NCT01121744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6593366|NCT01121744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6593367|NCT01121744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6593368|NCT01121744|Antifungal Agents|antifungal agents|mesh-ancestor
6593369|NCT01121744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6593370|NCT01121744|Immunologic Factors|immunologic factors|mesh-ancestor
6593371|NCT01121744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593372|NCT01121770|PENTA|penta|mesh-list
6593373|NCT01121770|Fondaparinux|fondaparinux|mesh-list
6593374|NCT01121770|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6593375|NCT01121770|Antithrombins|antithrombins|mesh-ancestor
6593376|NCT01121770|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6593377|NCT01121770|Protease Inhibitors|protease inhibitors|mesh-ancestor
6593378|NCT01121770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6593379|NCT01121770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593380|NCT01121770|Anticoagulants|anticoagulants|mesh-ancestor
6593381|NCT01121770|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6593382|NCT01121770|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6593383|NCT01121796|Vitamin D|vitamin d|mesh-list
6593384|NCT01121796|Ergocalciferols|ergocalciferols|mesh-list
6593385|NCT01121796|Vitamins|vitamins|mesh-list
6593386|NCT01121796|Micronutrients|micronutrients|mesh-ancestor
6593387|NCT01121796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593388|NCT01121796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6593389|NCT01121796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6593390|NCT01121809|Raltegravir Potassium|raltegravir potassium|mesh-list
6593391|NCT01121809|Etravirine|etravirine|mesh-list
6593392|NCT01121809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6593393|NCT01121809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6593394|NCT01121809|Antiviral Agents|antiviral agents|mesh-ancestor
6593395|NCT01121809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6593396|NCT01121809|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6593397|NCT01121809|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6593398|NCT01121809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6593399|NCT01121809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593400|NCT01121809|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6593401|NCT01121809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6593402|NCT01121822|Vaccines|vaccines|mesh-list
6593403|NCT01121822|Immunologic Factors|immunologic factors|mesh-ancestor
6593404|NCT01121822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593405|NCT01121835|Insulin|insulin|mesh-list
6593406|NCT01121835|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6593407|NCT01121835|Insulin Glargine|insulin glargine|mesh-list
6593408|NCT01121835|Insulin glulisine|insulin glulisine|mesh-list
6593409|NCT01121835|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6593410|NCT01121835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593411|NCT01121848|Leucovorin|leucovorin|mesh-list
6593412|NCT01121848|Fluorouracil|fluorouracil|mesh-list
6593413|NCT01121848|Oxaliplatin|oxaliplatin|mesh-list
6593414|NCT01121848|Antimetabolites|antimetabolites|mesh-ancestor
6593415|NCT01121848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593416|NCT01121848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6593417|NCT01121848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6593418|NCT01121848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6593419|NCT01121848|Immunologic Factors|immunologic factors|mesh-ancestor
6593420|NCT01121848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593421|NCT01121848|Antidotes|antidotes|mesh-ancestor
6593422|NCT01121848|Protective Agents|protective agents|mesh-ancestor
6593423|NCT01121848|Vitamin B Complex|vitamin b complex|mesh-ancestor
6593424|NCT01121848|Vitamins|vitamins|mesh-ancestor
6593425|NCT01121848|Micronutrients|micronutrients|mesh-ancestor
6593426|NCT01122004|Pregabalin|pregabalin|mesh-list
6593427|NCT01122004|Analgesics|analgesics|mesh-ancestor
6593428|NCT01122004|Sensory System Agents|sensory system agents|mesh-ancestor
6593429|NCT01122004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6593430|NCT01122004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593431|NCT01122004|Anticonvulsants|anticonvulsants|mesh-ancestor
6593432|NCT01122004|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6593433|NCT01122004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6593434|NCT01122004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593435|NCT01122004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6593436|NCT01122004|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6593437|NCT01122004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6593438|NCT01122004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6593439|NCT01122004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6593440|NCT01122056|Interferons|interferons|mesh-list
6593441|NCT01122056|Interferon beta-1b|interferon beta-1b|mesh-list
6593442|NCT01122056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6593443|NCT01122056|Antiviral Agents|antiviral agents|mesh-ancestor
6593444|NCT01122056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6593445|NCT01122056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6593446|NCT01122056|Immunologic Factors|immunologic factors|mesh-ancestor
6593447|NCT01122056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659377|NCT01487564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6659378|NCT01487629|Bevacizumab|bevacizumab|mesh-list
6659379|NCT01487629|Ranibizumab|ranibizumab|mesh-list
6659380|NCT01487629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6659381|NCT01487629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6659382|NCT01487629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6659383|NCT01487629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6659384|NCT01487629|Growth Substances|growth substances|mesh-ancestor
6659385|NCT01487629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659386|NCT01487629|Growth Inhibitors|growth inhibitors|mesh-ancestor
6659387|NCT01487785|Gemcitabine|gemcitabine|mesh-list
6659388|NCT01487785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6659389|NCT01487785|Antimetabolites|antimetabolites|mesh-ancestor
6659390|NCT01487785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6659391|NCT01487785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6659392|NCT01487785|Antiviral Agents|antiviral agents|mesh-ancestor
6659393|NCT01487785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6659394|NCT01487785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6659395|NCT01487785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6659396|NCT01487785|Immunologic Factors|immunologic factors|mesh-ancestor
6659397|NCT01487785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659398|NCT01487798|Insulin|insulin|mesh-list
6659399|NCT01487798|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6659400|NCT01487798|Insulin Aspart|insulin aspart|mesh-list
6659401|NCT01487798|Biphasic Insulins|biphasic insulins|mesh-list
6659402|NCT01487798|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6659403|NCT01487798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6659404|NCT01487798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659405|NCT01487811|Insulin Aspart|insulin aspart|mesh-list
6659406|NCT01487811|Biphasic Insulins|biphasic insulins|mesh-list
6659407|NCT01487811|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6659408|NCT01487811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6659409|NCT01487811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659410|NCT01487993|Metformin|metformin|mesh-list
6659411|NCT01487993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6659412|NCT01487993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659413|NCT01488045|Fentanyl|fentanyl|mesh-list
6659414|NCT01488045|Midazolam|midazolam|mesh-list
6659415|NCT01488045|Propofol|propofol|mesh-list
6659416|NCT01488045|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6659417|NCT01488045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6659418|NCT01488045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659419|NCT01488045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6659420|NCT01488045|Anesthetics, General|anesthetics, general|mesh-ancestor
6659421|NCT01488045|Anesthetics|anesthetics|mesh-ancestor
6659422|NCT01488045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6659423|NCT01488045|Narcotics|narcotics|mesh-ancestor
6659424|NCT01488045|Analgesics|analgesics|mesh-ancestor
6659425|NCT01488045|Sensory System Agents|sensory system agents|mesh-ancestor
6659426|NCT01488045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6659427|NCT01488045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6659428|NCT01488045|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6659429|NCT01488045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6659430|NCT01488045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6593448|NCT01122121|Leuprolide|leuprolide|mesh-list
6593449|NCT01122121|Flutamide|flutamide|mesh-list
6593450|NCT01122121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6593451|NCT01122121|Fertility Agents|fertility agents|mesh-ancestor
6593452|NCT01122121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6593453|NCT01122121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593454|NCT01122121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6593455|NCT01122121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6593456|NCT01122121|Androgen Antagonists|androgen antagonists|mesh-ancestor
6593457|NCT01122121|Hormone Antagonists|hormone antagonists|mesh-ancestor
6593458|NCT01122121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6593459|NCT01122134|Artesunate|artesunate|mesh-list
6593460|NCT01122134|Antimalarials|antimalarials|mesh-ancestor
6593461|NCT01122134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6593462|NCT01122134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6593463|NCT01122134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6593464|NCT01122134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6593465|NCT01122134|Antiviral Agents|antiviral agents|mesh-ancestor
6593466|NCT01122134|Schistosomicides|schistosomicides|mesh-ancestor
6593467|NCT01122134|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6593468|NCT01122134|Anthelmintics|anthelmintics|mesh-ancestor
6593469|NCT01122199|Everolimus|everolimus|mesh-list
6593470|NCT01122199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6593471|NCT01122199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6593472|NCT01122199|Immunologic Factors|immunologic factors|mesh-ancestor
6593473|NCT01122199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593474|NCT01122251|Valsartan|valsartan|mesh-list
6593475|NCT01122251|Lercanidipine|lercanidipine|mesh-list
6593476|NCT01122251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6593477|NCT01122251|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6593478|NCT01122251|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6593479|NCT01122251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593480|NCT01122251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6593481|NCT01122251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6593482|NCT01122251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6593483|NCT01122251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593484|NCT01122342|Methyltestosterone|methyltestosterone|mesh-list
6593485|NCT01122342|Testosterone|testosterone|mesh-list
6593486|NCT01122342|Testosterone undecanoate|testosterone undecanoate|mesh-list
6593487|NCT01122342|Testosterone enanthate|testosterone enanthate|mesh-list
6448183|NCT00400114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448184|NCT00400114|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6593488|NCT01122342|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6593489|NCT01122342|Androgens|androgens|mesh-ancestor
6593490|NCT01122342|Hormones|hormones|mesh-ancestor
6593491|NCT01122342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6593492|NCT01122342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593493|NCT01122342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6593494|NCT01122342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6448185|NCT00400114|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6448186|NCT00400114|Growth Substances|growth substances|mesh-ancestor
6448187|NCT00400114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448188|NCT00400114|Growth Inhibitors|growth inhibitors|mesh-ancestor
6448189|NCT00400114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6448190|NCT00400231|Metformin|metformin|mesh-list
6593495|NCT01122342|Anabolic Agents|anabolic agents|mesh-ancestor
6593496|NCT01122368|Micafungin|micafungin|mesh-list
6593497|NCT01122368|Antifungal Agents|antifungal agents|mesh-ancestor
6593498|NCT01122368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6593499|NCT01122407|Trimethaphan|trimethaphan|mesh-list
6593500|NCT01122407|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
6593501|NCT01122407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593502|NCT01122407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6593503|NCT01122407|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6593504|NCT01122407|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
6593505|NCT01122407|Autonomic Agents|autonomic agents|mesh-ancestor
6593506|NCT01122407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6593507|NCT01122407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593508|NCT01122407|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
6593509|NCT01122407|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6593510|NCT01122407|Cholinergic Agents|cholinergic agents|mesh-ancestor
6593511|NCT01122407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6593512|NCT01122407|Vasodilator Agents|vasodilator agents|mesh-ancestor
6593513|NCT01122472|Lenalidomide|lenalidomide|mesh-list
6593514|NCT01122472|Immunologic Factors|immunologic factors|mesh-ancestor
6593515|NCT01122472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593516|NCT01122472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6593517|NCT01122472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6593518|NCT01122472|Growth Substances|growth substances|mesh-ancestor
6593519|NCT01122472|Growth Inhibitors|growth inhibitors|mesh-ancestor
6593520|NCT01122472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6593521|NCT01122563|Solifenacin Succinate|solifenacin succinate|mesh-list
6593522|NCT01122563|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6593523|NCT01122563|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6593524|NCT01122563|Cholinergic Agents|cholinergic agents|mesh-ancestor
6593525|NCT01122563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6448191|NCT00400231|Fenofibrate|fenofibrate|mesh-list
6448192|NCT00400231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6448193|NCT00400231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448194|NCT00400231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6448195|NCT00400231|Antimetabolites|antimetabolites|mesh-ancestor
6448196|NCT00400231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448197|NCT00400231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6448198|NCT00400322|Valganciclovir|valganciclovir|mesh-list
6448199|NCT00400322|Antiviral Agents|antiviral agents|mesh-ancestor
6448200|NCT00400322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6448201|NCT00400335|Methyltestosterone|methyltestosterone|mesh-list
6448202|NCT00400335|Testosterone|testosterone|mesh-list
6448203|NCT00400335|Testosterone undecanoate|testosterone undecanoate|mesh-list
6448204|NCT00400335|Testosterone enanthate|testosterone enanthate|mesh-list
6448205|NCT00400335|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6448206|NCT00400335|Dutasteride|dutasteride|mesh-list
6448207|NCT00400335|Androgens|androgens|mesh-ancestor
6448208|NCT00400335|Hormones|hormones|mesh-ancestor
6448209|NCT00400335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6448210|NCT00400335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448211|NCT00400335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6448212|NCT00400335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6593526|NCT01122563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593527|NCT01122563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593528|NCT01122563|Urological Agents|urological agents|mesh-ancestor
6593529|NCT01122602|Aspirin|aspirin|mesh-list
6593530|NCT01122602|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6593531|NCT01122602|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6593532|NCT01122602|Analgesics|analgesics|mesh-ancestor
6593533|NCT01122602|Sensory System Agents|sensory system agents|mesh-ancestor
6593534|NCT01122602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6593535|NCT01122602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593536|NCT01122602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6593537|NCT01122602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6593538|NCT01122602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6593539|NCT01122602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6593540|NCT01122602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593541|NCT01122602|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6593542|NCT01122602|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6593543|NCT01122602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6593544|NCT01122602|Antipyretics|antipyretics|mesh-ancestor
6593545|NCT01122615|Sirolimus|sirolimus|mesh-list
6593546|NCT01122615|Sunitinib|sunitinib|mesh-list
6593547|NCT01122615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6593548|NCT01122615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6593549|NCT01122615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6593550|NCT01122615|Growth Substances|growth substances|mesh-ancestor
6593551|NCT01122615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593552|NCT01122615|Growth Inhibitors|growth inhibitors|mesh-ancestor
6593553|NCT01122615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6593554|NCT01122615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6593555|NCT01122615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593556|NCT01122615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6593557|NCT01122615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6593558|NCT01122615|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6593559|NCT01122615|Antifungal Agents|antifungal agents|mesh-ancestor
6593560|NCT01122615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6593561|NCT01122615|Immunologic Factors|immunologic factors|mesh-ancestor
6593562|NCT01122641|Vildagliptin|vildagliptin|mesh-list
6593563|NCT01122641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6593564|NCT01122641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593565|NCT01122641|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6593566|NCT01122641|Protease Inhibitors|protease inhibitors|mesh-ancestor
6593567|NCT01122641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6593568|NCT01122641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593569|NCT01122667|Anacetrapib|anacetrapib|mesh-list
6593570|NCT01122667|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6593571|NCT01122667|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6593572|NCT01122667|Antimetabolites|antimetabolites|mesh-ancestor
6593573|NCT01122667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593574|NCT01122667|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6593575|NCT01122771|Amphotericin B|amphotericin b|mesh-list
6593576|NCT01122771|Paromomycin|paromomycin|mesh-list
6593577|NCT01122771|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6593578|NCT01122771|Miltefosine|miltefosine|mesh-list
6593579|NCT01122771|Amebicides|amebicides|mesh-ancestor
6593580|NCT01122771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6593581|NCT01122771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6593582|NCT01122771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6593583|NCT01122771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6593584|NCT01122771|Antifungal Agents|antifungal agents|mesh-ancestor
6593585|NCT01122771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6593586|NCT01122914|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6593587|NCT01122914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6593588|NCT01122940|Phenytoin|phenytoin|mesh-list
6593589|NCT01122940|Anticonvulsants|anticonvulsants|mesh-ancestor
6593590|NCT01122940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6593591|NCT01122940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6593592|NCT01122940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6593593|NCT01122940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593594|NCT01122940|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6593595|NCT01122940|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6593596|NCT01122953|Phenytoin|phenytoin|mesh-list
6593597|NCT01122953|Anticonvulsants|anticonvulsants|mesh-ancestor
6593598|NCT01122953|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6593599|NCT01122953|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6593600|NCT01122953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6593601|NCT01122953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593602|NCT01122953|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6593603|NCT01122953|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6593604|NCT01122966|Bevacizumab|bevacizumab|mesh-list
6593605|NCT01122966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6593606|NCT01122966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6593607|NCT01122966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6593608|NCT01122966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6593609|NCT01122966|Growth Substances|growth substances|mesh-ancestor
6593610|NCT01122966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593611|NCT01122966|Growth Inhibitors|growth inhibitors|mesh-ancestor
6593612|NCT01122979|Insulin|insulin|mesh-list
6593613|NCT01122979|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6593614|NCT01122979|Insulin Glargine|insulin glargine|mesh-list
6593615|NCT01122979|Insulin glulisine|insulin glulisine|mesh-list
6593616|NCT01122979|Insulin, Isophane|insulin, isophane|mesh-list
6593617|NCT01122979|Isophane Insulin, Human|isophane insulin, human|mesh-list
6593618|NCT01122979|Isophane insulin, beef|isophane insulin, beef|mesh-list
6593619|NCT01122979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6593620|NCT01122979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593621|NCT01123031|Esomeprazole|esomeprazole|mesh-list
6593622|NCT01123031|Lansoprazole|lansoprazole|mesh-list
6593623|NCT01123031|Dexlansoprazole|dexlansoprazole|mesh-list
6593624|NCT01123031|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6593625|NCT01123031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6593626|NCT01123031|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6593627|NCT01123031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6593628|NCT01123031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593629|NCT01123057|Riboflavin|riboflavin|mesh-list
6593630|NCT01123057|Vitamin B Complex|vitamin b complex|mesh-ancestor
6593631|NCT01123057|Vitamins|vitamins|mesh-ancestor
6593632|NCT01123057|Micronutrients|micronutrients|mesh-ancestor
6593633|NCT01123057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593634|NCT01123057|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6593635|NCT01123057|Dermatologic Agents|dermatologic agents|mesh-ancestor
6593636|NCT01123265|Methotrexate|methotrexate|mesh-list
6593637|NCT01123265|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6593638|NCT01123265|Abortifacient Agents|abortifacient agents|mesh-ancestor
6593639|NCT01123265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6593640|NCT01123265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593641|NCT01123265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6593642|NCT01123265|Antimetabolites|antimetabolites|mesh-ancestor
6593643|NCT01123265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593644|NCT01123265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6593645|NCT01123265|Dermatologic Agents|dermatologic agents|mesh-ancestor
6593646|NCT01123265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6593647|NCT01123265|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6593648|NCT01123265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6593649|NCT01123265|Immunologic Factors|immunologic factors|mesh-ancestor
6593650|NCT01123265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6593651|NCT01123265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6593652|NCT01123278|Testosterone|testosterone|mesh-list
6593653|NCT01123278|Androgens|androgens|mesh-ancestor
6593654|NCT01123278|Hormones|hormones|mesh-ancestor
6593655|NCT01123278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6593656|NCT01123278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593657|NCT01123317|Oxytocin|oxytocin|mesh-list
6593658|NCT01123317|Oxytocics|oxytocics|mesh-ancestor
6593659|NCT01123317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6593660|NCT01123317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593661|NCT01123408|Haloperidol|haloperidol|mesh-list
6593662|NCT01123408|Olanzapine|olanzapine|mesh-list
6593663|NCT01123408|Haloperidol decanoate|haloperidol decanoate|mesh-list
6593664|NCT01123408|Clozapine|clozapine|mesh-list
6593665|NCT01123408|Antiemetics|antiemetics|mesh-ancestor
6593666|NCT01123408|Autonomic Agents|autonomic agents|mesh-ancestor
6593667|NCT01123408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6593668|NCT01123408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593669|NCT01123408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6593670|NCT01123408|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6593671|NCT01123408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6593672|NCT01123408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6593673|NCT01123408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6593674|NCT01123408|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6593675|NCT01123408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6593676|NCT01123408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6593677|NCT01123408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593678|NCT01123408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6593679|NCT01123408|Serotonin Agents|serotonin agents|mesh-ancestor
6593680|NCT01123408|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6593681|NCT01123408|Dopamine Agents|dopamine agents|mesh-ancestor
6593682|NCT01123408|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6593683|NCT01123408|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6593684|NCT01123408|GABA Antagonists|gaba antagonists|mesh-ancestor
6593685|NCT01123408|GABA Agents|gaba agents|mesh-ancestor
6593686|NCT01123473|Fluorouracil|fluorouracil|mesh-list
6593687|NCT01123473|Capecitabine|capecitabine|mesh-list
6593688|NCT01123473|Epirubicin|epirubicin|mesh-list
6593689|NCT01123473|Lapatinib|lapatinib|mesh-list
6593690|NCT01123473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6593691|NCT01123473|Antimetabolites|antimetabolites|mesh-ancestor
6593692|NCT01123473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593693|NCT01123473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6593694|NCT01123473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6593695|NCT01123473|Immunologic Factors|immunologic factors|mesh-ancestor
6593696|NCT01123473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593697|NCT01123473|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6593698|NCT01123473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6593699|NCT01123473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6593700|NCT01123473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6593701|NCT01123473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6593702|NCT01123486|Hydromorphone|hydromorphone|mesh-list
6593703|NCT01123486|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6593704|NCT01123486|Narcotics|narcotics|mesh-ancestor
6593705|NCT01123486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6593706|NCT01123486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593707|NCT01123486|Analgesics|analgesics|mesh-ancestor
6593708|NCT01123486|Sensory System Agents|sensory system agents|mesh-ancestor
6593709|NCT01123486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6593710|NCT01123525|Adenosine|adenosine|mesh-list
6593711|NCT01123525|Analgesics|analgesics|mesh-ancestor
6593712|NCT01123525|Sensory System Agents|sensory system agents|mesh-ancestor
6593713|NCT01123525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6593714|NCT01123525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593715|NCT01123525|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6593716|NCT01123525|Vasodilator Agents|vasodilator agents|mesh-ancestor
6593717|NCT01123525|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6593718|NCT01123525|Purinergic Agonists|purinergic agonists|mesh-ancestor
6593719|NCT01123525|Purinergic Agents|purinergic agents|mesh-ancestor
6593720|NCT01123525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6593721|NCT01123525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593722|NCT01123538|Chlormadinone Acetate|chlormadinone acetate|mesh-list
6593723|NCT01123538|Progesterone|progesterone|mesh-list
6593724|NCT01123538|Progestins|progestins|mesh-ancestor
6593725|NCT01123538|Hormones|hormones|mesh-ancestor
6593726|NCT01123538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6593727|NCT01123538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593728|NCT01123538|Androgen Antagonists|androgen antagonists|mesh-ancestor
6593729|NCT01123538|Hormone Antagonists|hormone antagonists|mesh-ancestor
6593730|NCT01123538|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6593731|NCT01123538|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6593732|NCT01123538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6593733|NCT01123538|Contraceptive Agents|contraceptive agents|mesh-ancestor
6593734|NCT01123538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6593735|NCT01123538|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6593736|NCT01123538|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6593737|NCT01123551|Morphine|morphine|mesh-list
6593738|NCT01123551|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6593739|NCT01123551|Narcotics|narcotics|mesh-ancestor
6593740|NCT01123551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6593741|NCT01123551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593742|NCT01123551|Analgesics|analgesics|mesh-ancestor
6593743|NCT01123551|Sensory System Agents|sensory system agents|mesh-ancestor
6593744|NCT01123551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6593745|NCT01123564|Ranibizumab|ranibizumab|mesh-list
6593746|NCT01123564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6593747|NCT01123564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6593748|NCT01123564|Growth Substances|growth substances|mesh-ancestor
6593749|NCT01123564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593750|NCT01123564|Growth Inhibitors|growth inhibitors|mesh-ancestor
6593751|NCT01123564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5501698|NCT04471441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6593752|NCT01123811|Cetuximab|cetuximab|mesh-list
6593753|NCT01123811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6593754|NCT01123811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6593755|NCT01123824|Clopidogrel|clopidogrel|mesh-list
6593756|NCT01123824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6593757|NCT01123824|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6593758|NCT01123824|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6593759|NCT01123824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6593760|NCT01123824|Purinergic Agents|purinergic agents|mesh-ancestor
6593761|NCT01123824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6593762|NCT01123824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593763|NCT01123824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593764|NCT01123876|Veliparib|veliparib|mesh-list
6593765|NCT01123876|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6593766|NCT01123876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6593767|NCT01123876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593768|NCT01123876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6593769|NCT01123915|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
6593770|NCT01123915|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6593771|NCT01123915|Protective Agents|protective agents|mesh-ancestor
6593772|NCT01123915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593773|NCT01123915|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6593774|NCT01123915|Antioxidants|antioxidants|mesh-ancestor
6593775|NCT01123915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593776|NCT01123967|Nicotine|nicotine|mesh-list
6593777|NCT01123967|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6593778|NCT01123967|Autonomic Agents|autonomic agents|mesh-ancestor
6593779|NCT01123967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6593780|NCT01123967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593781|NCT01123967|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6593782|NCT01123967|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6593783|NCT01123967|Cholinergic Agents|cholinergic agents|mesh-ancestor
6593784|NCT01123967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6593785|NCT01123967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593786|NCT01124032|Methylphenidate|methylphenidate|mesh-list
6593787|NCT01124032|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6593788|NCT01124032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593789|NCT01124032|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6593790|NCT01124032|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6593791|NCT01124032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6593792|NCT01124032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593793|NCT01124032|Dopamine Agents|dopamine agents|mesh-ancestor
6593794|NCT01124032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6593795|NCT01124058|Heparin|heparin|mesh-list
6593796|NCT01124058|Calcium heparin|calcium heparin|mesh-list
6593797|NCT01124058|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6593798|NCT01124058|Tinzaparin|tinzaparin|mesh-list
6593799|NCT01124058|Dalteparin|dalteparin|mesh-list
6593800|NCT01124058|Warfarin|warfarin|mesh-list
6593801|NCT01124058|Anticoagulants|anticoagulants|mesh-ancestor
6593802|NCT01124058|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6593803|NCT01124058|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6593804|NCT01124058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593805|NCT01124227|Icodextrin|icodextrin|mesh-list
6593806|NCT01124227|Dialysis Solutions|dialysis solutions|mesh-ancestor
6448213|NCT00400335|Anabolic Agents|anabolic agents|mesh-ancestor
6448214|NCT00400335|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6448215|NCT00400335|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6448216|NCT00400335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6448217|NCT00400335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448218|NCT00400335|Hormone Antagonists|hormone antagonists|mesh-ancestor
6448219|NCT00400348|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
6593807|NCT01124227|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6593808|NCT01124240|Temozolomide|temozolomide|mesh-list
6593809|NCT01124240|Procarbazine|procarbazine|mesh-list
6593810|NCT01124240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6593811|NCT01124240|Alkylating Agents|alkylating agents|mesh-ancestor
6593812|NCT01124240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593813|NCT01124240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6593814|NCT01124253|Endostatins|endostatins|mesh-list
6593815|NCT01124253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6593816|NCT01124253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6593817|NCT01124253|Growth Substances|growth substances|mesh-ancestor
6593818|NCT01124253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593819|NCT01124253|Growth Inhibitors|growth inhibitors|mesh-ancestor
6593820|NCT01124253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6593821|NCT01124318|Lactulose|lactulose|mesh-list
6593822|NCT01124318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6593823|NCT01124383|Lidocaine|lidocaine|mesh-list
6593824|NCT01124383|Ephedrine|ephedrine|mesh-list
6593825|NCT01124383|Midazolam|midazolam|mesh-list
6593826|NCT01124383|Sufentanil|sufentanil|mesh-list
6593827|NCT01124383|Dsuvia|dsuvia|mesh-list
6593828|NCT01124383|Anesthetics|anesthetics|mesh-list
6593829|NCT01124383|Propofol|propofol|mesh-list
6593830|NCT01124383|Sevoflurane|sevoflurane|mesh-list
6593831|NCT01124383|Rocuronium|rocuronium|mesh-list
6593832|NCT01124383|Anesthetics, Local|anesthetics, local|mesh-ancestor
6593833|NCT01124383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6593834|NCT01124383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593835|NCT01124383|Sensory System Agents|sensory system agents|mesh-ancestor
6593836|NCT01124383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6593837|NCT01124383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6593838|NCT01124383|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6020406|NCT00392834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6448220|NCT00400348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6448221|NCT00400348|Tubulin Modulators|tubulin modulators|mesh-ancestor
6448222|NCT00400348|Antimitotic Agents|antimitotic agents|mesh-ancestor
6448223|NCT00400348|Mitosis Modulators|mitosis modulators|mesh-ancestor
6448224|NCT00400348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448225|NCT00400374|Celecoxib|celecoxib|mesh-list
6448226|NCT00400374|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6448227|NCT00400374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6448228|NCT00400374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6020407|NCT00392834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6020408|NCT00392834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6020409|NCT00392834|Antiviral Agents|antiviral agents|mesh-ancestor
6448229|NCT00400374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6593839|NCT01124383|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6593840|NCT01124383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6593841|NCT01124383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593842|NCT01124383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6593843|NCT01124383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6593844|NCT01124383|Anesthetics, General|anesthetics, general|mesh-ancestor
6593845|NCT01124383|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6593846|NCT01124383|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6593847|NCT01124383|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6593848|NCT01124383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6593849|NCT01124383|GABA Modulators|gaba modulators|mesh-ancestor
6593850|NCT01124383|GABA Agents|gaba agents|mesh-ancestor
6593851|NCT01124383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6593852|NCT01124383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6593853|NCT01124383|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6593854|NCT01124383|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6593855|NCT01124383|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6593856|NCT01124383|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6593857|NCT01124383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6593858|NCT01124383|Narcotics|narcotics|mesh-ancestor
6593859|NCT01124383|Analgesics|analgesics|mesh-ancestor
6593860|NCT01124383|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6593861|NCT01124383|Sympathomimetics|sympathomimetics|mesh-ancestor
6593862|NCT01124383|Autonomic Agents|autonomic agents|mesh-ancestor
6593863|NCT01124383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6593864|NCT01124383|Adrenergic Agents|adrenergic agents|mesh-ancestor
6593865|NCT01124435|Celecoxib|celecoxib|mesh-list
6593866|NCT01124435|Carboplatin|carboplatin|mesh-list
6593867|NCT01124435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6593868|NCT01124435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6593869|NCT01124435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6593870|NCT01124435|Analgesics|analgesics|mesh-ancestor
6593871|NCT01124435|Sensory System Agents|sensory system agents|mesh-ancestor
6593872|NCT01124435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6593873|NCT01124435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593874|NCT01124435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6593875|NCT01124435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6593876|NCT01124435|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6593877|NCT01124435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6593878|NCT01124435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6593879|NCT01124435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593880|NCT01124487|Insulin|insulin|mesh-list
6593881|NCT01124487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6593882|NCT01124487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593883|NCT01124500|Methylphenidate|methylphenidate|mesh-list
6593884|NCT01124500|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6593885|NCT01124500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593886|NCT01124500|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6593887|NCT01124500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6593888|NCT01124500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6593889|NCT01124500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593890|NCT01124500|Dopamine Agents|dopamine agents|mesh-ancestor
6593891|NCT01124500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6593892|NCT01124526|Cyclophosphamide|cyclophosphamide|mesh-list
6593893|NCT01124526|Rituximab|rituximab|mesh-list
6593894|NCT01124526|Fludarabine|fludarabine|mesh-list
6593895|NCT01124526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6593896|NCT01124526|Immunologic Factors|immunologic factors|mesh-ancestor
6593897|NCT01124526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593898|NCT01124526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6593899|NCT01124526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6593900|NCT01124526|Alkylating Agents|alkylating agents|mesh-ancestor
6593901|NCT01124526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593902|NCT01124526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6593903|NCT01124526|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6593904|NCT01124526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6593905|NCT01124539|Camptothecin|camptothecin|mesh-list
6593906|NCT01124539|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
6593907|NCT01124539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6593908|NCT01124539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6593909|NCT01124539|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6593910|NCT01124539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6593911|NCT01124539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6593912|NCT01124539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593913|NCT01124630|Leucovorin|leucovorin|mesh-list
6593914|NCT01124630|Fluorouracil|fluorouracil|mesh-list
6593915|NCT01124630|Irinotecan|irinotecan|mesh-list
6593916|NCT01124630|Antimetabolites|antimetabolites|mesh-ancestor
6593917|NCT01124630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593918|NCT01124630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6593919|NCT01124630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6593920|NCT01124630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6593921|NCT01124630|Immunologic Factors|immunologic factors|mesh-ancestor
6593922|NCT01124630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593923|NCT01124630|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6593924|NCT01124630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6593925|NCT01124630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6593926|NCT01124630|Antidotes|antidotes|mesh-ancestor
6593927|NCT01124630|Protective Agents|protective agents|mesh-ancestor
6593928|NCT01124630|Vitamin B Complex|vitamin b complex|mesh-ancestor
6593929|NCT01124630|Vitamins|vitamins|mesh-ancestor
6593930|NCT01124630|Micronutrients|micronutrients|mesh-ancestor
6593931|NCT01124656|Pioglitazone|pioglitazone|mesh-list
6593932|NCT01124656|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
6593933|NCT01124656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6593934|NCT01124656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593935|NCT01124656|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6593936|NCT01124656|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6593937|NCT01124656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593938|NCT01124695|Tamoxifen|tamoxifen|mesh-list
6448230|NCT00400374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448231|NCT00400374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6448232|NCT00400374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6448233|NCT00400374|Analgesics|analgesics|mesh-ancestor
6448234|NCT00400374|Sensory System Agents|sensory system agents|mesh-ancestor
6448235|NCT00400374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6448236|NCT00400374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448237|NCT00400374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6448238|NCT00400374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6448239|NCT00400374|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6448240|NCT00400374|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6448241|NCT00400387|Riboflavin|riboflavin|mesh-list
6593939|NCT01124695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6593940|NCT01124695|Hormone Antagonists|hormone antagonists|mesh-ancestor
6593941|NCT01124695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6593942|NCT01124695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593943|NCT01124695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6593944|NCT01124695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6593945|NCT01124695|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6593946|NCT01124695|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6593947|NCT01124695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6593948|NCT01124760|Ketoconazole|ketoconazole|mesh-list
6593949|NCT01124760|Diltiazem|diltiazem|mesh-list
6593950|NCT01124760|Antifungal Agents|antifungal agents|mesh-ancestor
6593951|NCT01124760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6593952|NCT01124760|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6593953|NCT01124760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6593954|NCT01124760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6593955|NCT01124760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593956|NCT01124760|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6593957|NCT01124760|Hormone Antagonists|hormone antagonists|mesh-ancestor
6659431|NCT01488045|GABA Modulators|gaba modulators|mesh-ancestor
6448242|NCT00400387|Thiamine|thiamine|mesh-list
6593958|NCT01124760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6593959|NCT01124760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593960|NCT01124760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6593961|NCT01124760|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6593962|NCT01124760|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6593963|NCT01124760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6593964|NCT01124760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6593965|NCT01124760|Vasodilator Agents|vasodilator agents|mesh-ancestor
6593966|NCT01124799|Ciprofloxacin|ciprofloxacin|mesh-list
6593967|NCT01124799|Simeprevir|simeprevir|mesh-list
6593968|NCT01124799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6593969|NCT01124799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6593970|NCT01124799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6593971|NCT01124799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5501699|NCT04471441|Antitubercular Agents|antitubercular agents|mesh-ancestor
5501700|NCT04471441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5501701|NCT04471441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5501702|NCT04471441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5501703|NCT04471441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503597|NCT04457050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503598|NCT04457050|Antiviral Agents|antiviral agents|mesh-ancestor
5503599|NCT04457050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5503600|NCT04457180|Repaglinide|repaglinide|mesh-list
6448243|NCT00400387|Pyridoxine|pyridoxine|mesh-list
6448244|NCT00400387|Vitamin B 12|vitamin b 12|mesh-list
6448245|NCT00400387|Folic Acid|folic acid|mesh-list
6448246|NCT00400387|Vitamin B Complex|vitamin b complex|mesh-list
6448247|NCT00400387|Tocopherols|tocopherols|mesh-list
6448248|NCT00400387|Vitamin E|vitamin e|mesh-list
6448249|NCT00400387|Tocotrienols|tocotrienols|mesh-list
6448250|NCT00400387|alpha-Tocopherol|alpha-tocopherol|mesh-list
6593972|NCT01124799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6593973|NCT01124799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593974|NCT01124799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5503601|NCT04457180|Apatinib|apatinib|mesh-list
5503602|NCT04457180|Bupropion|bupropion|mesh-list
5503603|NCT04457180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5503604|NCT04457180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5503605|NCT04457180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6448251|NCT00400387|Heparin|heparin|mesh-list
6593975|NCT01124799|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6593976|NCT01124799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6593977|NCT01124799|Antiviral Agents|antiviral agents|mesh-ancestor
6593978|NCT01124799|Protease Inhibitors|protease inhibitors|mesh-ancestor
6593979|NCT01124877|Ziprasidone|ziprasidone|mesh-list
6593980|NCT01124877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6593981|NCT01124877|Serotonin Agents|serotonin agents|mesh-ancestor
6593982|NCT01124877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6593983|NCT01124877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593984|NCT01124877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6593985|NCT01124877|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6448252|NCT00400387|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6448253|NCT00400387|Tinzaparin|tinzaparin|mesh-list
6448254|NCT00400387|Dalteparin|dalteparin|mesh-list
6593986|NCT01124877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6593987|NCT01124877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6593988|NCT01124877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6593989|NCT01124877|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6593990|NCT01124877|Dopamine Agents|dopamine agents|mesh-ancestor
6593991|NCT01125020|Gemcitabine|gemcitabine|mesh-list
6593992|NCT01125020|Doxorubicin|doxorubicin|mesh-list
6593993|NCT01125020|Oxaliplatin|oxaliplatin|mesh-list
6593994|NCT01125020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6593995|NCT01125020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6593996|NCT01125020|Antimetabolites|antimetabolites|mesh-ancestor
6593997|NCT01125020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6593998|NCT01125020|Antiviral Agents|antiviral agents|mesh-ancestor
6593999|NCT01125020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6594000|NCT01125020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6594001|NCT01125020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6594002|NCT01125020|Immunologic Factors|immunologic factors|mesh-ancestor
6594003|NCT01125020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594004|NCT01125020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6594005|NCT01125020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6594006|NCT01125020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6594007|NCT01125033|Vitamins|vitamins|mesh-list
6594008|NCT01125033|Ascorbic Acid|ascorbic acid|mesh-list
6594009|NCT01125033|Vitamin E|vitamin e|mesh-list
6594010|NCT01125033|Tocopherols|tocopherols|mesh-list
6594011|NCT01125033|Tocotrienols|tocotrienols|mesh-list
6594012|NCT01125033|alpha-Tocopherol|alpha-tocopherol|mesh-list
6594013|NCT01125033|Micronutrients|micronutrients|mesh-ancestor
6594014|NCT01125033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594015|NCT01125033|Antioxidants|antioxidants|mesh-ancestor
6594016|NCT01125033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594017|NCT01125033|Protective Agents|protective agents|mesh-ancestor
6594018|NCT01125059|Methadone|methadone|mesh-list
6594019|NCT01125059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6594020|NCT01125059|Narcotics|narcotics|mesh-ancestor
6594021|NCT01125059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6594022|NCT01125059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594023|NCT01125059|Analgesics|analgesics|mesh-ancestor
6594024|NCT01125059|Sensory System Agents|sensory system agents|mesh-ancestor
6594025|NCT01125059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6594026|NCT01125059|Antitussive Agents|antitussive agents|mesh-ancestor
6594027|NCT01125059|Respiratory System Agents|respiratory system agents|mesh-ancestor
6594028|NCT01125124|Silver Nitrate|silver nitrate|mesh-list
6594029|NCT01125124|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6594030|NCT01125124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6594031|NCT01125150|Metformin|metformin|mesh-list
6594032|NCT01125150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6594033|NCT01125150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594034|NCT01125215|Capsaicin|capsaicin|mesh-list
6594035|NCT01125215|Antipruritics|antipruritics|mesh-ancestor
6594036|NCT01125215|Dermatologic Agents|dermatologic agents|mesh-ancestor
6594037|NCT01125215|Sensory System Agents|sensory system agents|mesh-ancestor
6594038|NCT01125215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6594039|NCT01125215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594040|NCT01125254|Amlodipine|amlodipine|mesh-list
6594041|NCT01125254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6594042|NCT01125254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6594043|NCT01125254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6594044|NCT01125254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594045|NCT01125254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6594046|NCT01125254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594047|NCT01125254|Vasodilator Agents|vasodilator agents|mesh-ancestor
6594048|NCT01125371|Ethanol|ethanol|mesh-list
6594049|NCT01125371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6594050|NCT01125371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6594051|NCT01125371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6594052|NCT01125371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594053|NCT01125410|Clindamycin|clindamycin|mesh-list
6594054|NCT01125410|Clindamycin palmitate|clindamycin palmitate|mesh-list
6594055|NCT01125410|Clindamycin phosphate|clindamycin phosphate|mesh-list
6594056|NCT01125410|Dequalinium|dequalinium|mesh-list
6594057|NCT01125410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6594058|NCT01125410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6594059|NCT01125410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6594060|NCT01125410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6594061|NCT01125410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594062|NCT01125410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6594063|NCT01125423|Milnacipran|milnacipran|mesh-list
6594064|NCT01125423|Levomilnacipran|levomilnacipran|mesh-list
6594065|NCT01125423|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6594066|NCT01125423|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6594067|NCT01125423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6594068|NCT01125423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594069|NCT01125423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6594070|NCT01125423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594071|NCT01125423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6594072|NCT01125423|Analgesics|analgesics|mesh-ancestor
6594073|NCT01125423|Sensory System Agents|sensory system agents|mesh-ancestor
6594074|NCT01125423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6594075|NCT01125423|Antidepressive Agents|antidepressive agents|mesh-ancestor
6594076|NCT01125423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6594077|NCT01125436|Vitamin D|vitamin d|mesh-list
6594078|NCT01125436|Cholecalciferol|cholecalciferol|mesh-list
6594079|NCT01125436|Vitamins|vitamins|mesh-ancestor
6594080|NCT01125436|Micronutrients|micronutrients|mesh-ancestor
6594081|NCT01125436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594082|NCT01125436|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6594083|NCT01125436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6594084|NCT01125449|Ascorbic Acid|ascorbic acid|mesh-list
6594085|NCT01125449|Vitamins|vitamins|mesh-ancestor
6594086|NCT01125449|Micronutrients|micronutrients|mesh-ancestor
6594087|NCT01125449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594088|NCT01125449|Antioxidants|antioxidants|mesh-ancestor
6594089|NCT01125449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594090|NCT01125449|Protective Agents|protective agents|mesh-ancestor
6594091|NCT01125488|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6594092|NCT01125488|Luteolytic Agents|luteolytic agents|mesh-ancestor
6594093|NCT01125488|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6594094|NCT01125488|Contraceptive Agents|contraceptive agents|mesh-ancestor
6594095|NCT01125488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6594096|NCT01125488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594097|NCT01125488|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6594098|NCT01125488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6594099|NCT01125488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6594100|NCT01125527|Vaccines|vaccines|mesh-list
6594101|NCT01125527|Immunologic Factors|immunologic factors|mesh-ancestor
6594102|NCT01125527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594103|NCT01125553|Insulin|insulin|mesh-list
6594104|NCT01125553|Insulin Aspart|insulin aspart|mesh-list
6594105|NCT01125553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6594106|NCT01125553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659432|NCT01488045|GABA Agents|gaba agents|mesh-ancestor
6659433|NCT01488045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6659434|NCT01488045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6659435|NCT01488136|Diazoxide|diazoxide|mesh-list
6659436|NCT01488136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6659437|NCT01488136|Vasodilator Agents|vasodilator agents|mesh-ancestor
6659438|NCT01488201|Brodalumab|brodalumab|mesh-list
6659439|NCT01488201|Dermatologic Agents|dermatologic agents|mesh-ancestor
6659440|NCT01488227|Vitamin D|vitamin d|mesh-list
6659441|NCT01488227|Ergocalciferols|ergocalciferols|mesh-list
6659442|NCT01488227|Vitamins|vitamins|mesh-list
6659443|NCT01488227|Micronutrients|micronutrients|mesh-ancestor
6659444|NCT01488227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659445|NCT01488227|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6659446|NCT01488227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6659447|NCT01488253|Sirolimus|sirolimus|mesh-list
6659448|NCT01488253|Tacrolimus|tacrolimus|mesh-list
6659449|NCT01488253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6659450|NCT01488253|Immunologic Factors|immunologic factors|mesh-ancestor
6659451|NCT01488253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659452|NCT01488253|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6659453|NCT01488253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6659454|NCT01488253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6659455|NCT01488253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6659456|NCT01488253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6659457|NCT01488253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6659458|NCT01488253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6659459|NCT01488253|Antifungal Agents|antifungal agents|mesh-ancestor
6659460|NCT01488266|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6659461|NCT01488266|Milnacipran|milnacipran|mesh-list
6659462|NCT01488266|Aripiprazole|aripiprazole|mesh-list
6659463|NCT01488266|Mirtazapine|mirtazapine|mesh-list
6659464|NCT01488266|Citalopram|citalopram|mesh-list
6659465|NCT01488266|Bupropion|bupropion|mesh-list
6659466|NCT01488266|Fluoxetine|fluoxetine|mesh-list
6659467|NCT01488266|Paroxetine|paroxetine|mesh-list
6659468|NCT01488266|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6659469|NCT01488266|Sertraline|sertraline|mesh-list
6659470|NCT01488266|Antidepressive Agents|antidepressive agents|mesh-list
6659471|NCT01488266|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6659472|NCT01488266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6659473|NCT01488266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6659474|NCT01488266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6659475|NCT01488266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6659476|NCT01488266|Serotonin Agents|serotonin agents|mesh-ancestor
6659477|NCT01488266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659478|NCT01488266|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6659479|NCT01488266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6659480|NCT01488266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6659481|NCT01488266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6659482|NCT01488266|Dopamine Agents|dopamine agents|mesh-ancestor
6659483|NCT01488266|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6659484|NCT01488266|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6659485|NCT01488266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5501704|NCT04471714|Baclofen|baclofen|mesh-list
6659486|NCT01488266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6659487|NCT01488266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6594107|NCT01125657|Darexaban|darexaban|mesh-list
6594108|NCT01125657|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6594109|NCT01125657|Antithrombins|antithrombins|mesh-ancestor
6594110|NCT01125657|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6594111|NCT01125657|Protease Inhibitors|protease inhibitors|mesh-ancestor
6594112|NCT01125657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6594113|NCT01125657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594114|NCT01125657|Anticoagulants|anticoagulants|mesh-ancestor
6594115|NCT01125670|Darexaban|darexaban|mesh-list
6594116|NCT01125670|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6594117|NCT01125670|Antithrombins|antithrombins|mesh-ancestor
6594118|NCT01125670|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6594119|NCT01125670|Protease Inhibitors|protease inhibitors|mesh-ancestor
6594120|NCT01125670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6594121|NCT01125670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594122|NCT01125670|Anticoagulants|anticoagulants|mesh-ancestor
6594123|NCT01125683|Donepezil|donepezil|mesh-list
6594124|NCT01125683|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6594125|NCT01125683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6594126|NCT01125683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594127|NCT01125683|Cholinergic Agents|cholinergic agents|mesh-ancestor
6594128|NCT01125683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6594129|NCT01125683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594130|NCT01125683|Nootropic Agents|nootropic agents|mesh-ancestor
6594131|NCT01125696|Ritonavir|ritonavir|mesh-list
6594132|NCT01125696|Lopinavir|lopinavir|mesh-list
6594133|NCT01125696|Tenofovir|tenofovir|mesh-list
6594134|NCT01125696|Lamivudine|lamivudine|mesh-list
6594135|NCT01125696|Zidovudine|zidovudine|mesh-list
6594136|NCT01125696|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6594137|NCT01125696|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6594138|NCT01125696|Protease Inhibitors|protease inhibitors|mesh-ancestor
6594139|NCT01125696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6594140|NCT01125696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594141|NCT01125696|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6594142|NCT01125696|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6594143|NCT01125696|Antiviral Agents|antiviral agents|mesh-ancestor
6594144|NCT01125696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6594145|NCT01125696|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6594146|NCT01125696|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6594147|NCT01125696|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6594148|NCT01125696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6594149|NCT01125696|Antimetabolites|antimetabolites|mesh-ancestor
6594150|NCT01125761|Clemastine|clemastine|mesh-list
6594151|NCT01125761|Dexamethasone|dexamethasone|mesh-list
6594152|NCT01125761|Dexamethasone acetate|dexamethasone acetate|mesh-list
6594153|NCT01125761|BB 1101|bb 1101|mesh-list
6594154|NCT01125761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6594155|NCT01125761|Antiemetics|antiemetics|mesh-ancestor
6594156|NCT01125761|Autonomic Agents|autonomic agents|mesh-ancestor
6594157|NCT01125761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6594158|NCT01125761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594159|NCT01125761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6594160|NCT01125761|Glucocorticoids|glucocorticoids|mesh-ancestor
6594161|NCT01125761|Hormones|hormones|mesh-ancestor
6594162|NCT01125761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6594163|NCT01125761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6594164|NCT01125761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6594165|NCT01125761|Protease Inhibitors|protease inhibitors|mesh-ancestor
6594166|NCT01125761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6594167|NCT01125761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594168|NCT01125761|Antipruritics|antipruritics|mesh-ancestor
6594169|NCT01125761|Dermatologic Agents|dermatologic agents|mesh-ancestor
6594170|NCT01125761|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6594171|NCT01125761|Histamine Antagonists|histamine antagonists|mesh-ancestor
6594172|NCT01125761|Histamine Agents|histamine agents|mesh-ancestor
6594173|NCT01125761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6594174|NCT01125761|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6594175|NCT01125787|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6594176|NCT01125787|Ofatumumab|ofatumumab|mesh-list
6594177|NCT01125787|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6594178|NCT01125787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6594179|NCT01125787|Alkylating Agents|alkylating agents|mesh-ancestor
6594180|NCT01125787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594181|NCT01125787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6594182|NCT01125787|Immunologic Factors|immunologic factors|mesh-ancestor
6594183|NCT01125787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594184|NCT01125891|Gemcitabine|gemcitabine|mesh-list
6594185|NCT01125891|ON 01910|on 01910|mesh-list
6594186|NCT01125891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6594187|NCT01125891|Antimetabolites|antimetabolites|mesh-ancestor
6594188|NCT01125891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594189|NCT01125891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6594190|NCT01125891|Antiviral Agents|antiviral agents|mesh-ancestor
6594191|NCT01125891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6594192|NCT01125891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6594193|NCT01125891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6594194|NCT01125891|Immunologic Factors|immunologic factors|mesh-ancestor
6594195|NCT01125891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594196|NCT01125891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6594197|NCT01125904|Crizotinib|crizotinib|mesh-list
6594198|NCT01125904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6594199|NCT01125904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6594200|NCT01125904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6594201|NCT01125904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594202|NCT01125943|Bevacizumab|bevacizumab|mesh-list
6594203|NCT01125943|Nitroprusside|nitroprusside|mesh-list
6594204|NCT01125943|Acetylcholine|acetylcholine|mesh-list
6594205|NCT01125943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6594206|NCT01125943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6594207|NCT01125943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6594208|NCT01125943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6594209|NCT01125943|Growth Substances|growth substances|mesh-ancestor
6594210|NCT01125943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594211|NCT01125943|Growth Inhibitors|growth inhibitors|mesh-ancestor
6594212|NCT01125943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6594213|NCT01125943|Vasodilator Agents|vasodilator agents|mesh-ancestor
6594214|NCT01125943|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6594215|NCT01125943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594216|NCT01125943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6594217|NCT01125943|Cholinergic Agents|cholinergic agents|mesh-ancestor
6594218|NCT01125943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6594219|NCT01125982|Propofol|propofol|mesh-list
6594220|NCT01125982|Desflurane|desflurane|mesh-list
6594221|NCT01125982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6594222|NCT01125982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6594223|NCT01125982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594224|NCT01125982|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6594225|NCT01125982|Anesthetics, General|anesthetics, general|mesh-ancestor
6594226|NCT01125982|Anesthetics|anesthetics|mesh-ancestor
6594227|NCT01125982|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6594228|NCT01126008|Docetaxel|docetaxel|mesh-list
6594229|NCT01126008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6594230|NCT01126008|Tubulin Modulators|tubulin modulators|mesh-ancestor
6594231|NCT01126008|Antimitotic Agents|antimitotic agents|mesh-ancestor
6594232|NCT01126008|Mitosis Modulators|mitosis modulators|mesh-ancestor
6594233|NCT01126008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594234|NCT01126073|Niacin|niacin|mesh-list
6594235|NCT01126073|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6594236|NCT01126073|Antimetabolites|antimetabolites|mesh-ancestor
6594237|NCT01126073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594238|NCT01126073|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6594239|NCT01126073|Vasodilator Agents|vasodilator agents|mesh-ancestor
6594240|NCT01126073|Vitamin B Complex|vitamin b complex|mesh-ancestor
6594241|NCT01126073|Vitamins|vitamins|mesh-ancestor
6594242|NCT01126073|Micronutrients|micronutrients|mesh-ancestor
6594243|NCT01126073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594244|NCT01126086|Otamixaban|otamixaban|mesh-list
6594245|NCT01126086|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6594246|NCT01126086|Antithrombins|antithrombins|mesh-ancestor
6594247|NCT01126086|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6594248|NCT01126086|Protease Inhibitors|protease inhibitors|mesh-ancestor
6594249|NCT01126086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6594250|NCT01126086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594251|NCT01126086|Anticoagulants|anticoagulants|mesh-ancestor
6594252|NCT01126112|Panitumumab|panitumumab|mesh-list
6594253|NCT01126112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6594254|NCT01126112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6594255|NCT01126138|Docetaxel|docetaxel|mesh-list
6594256|NCT01126138|Capecitabine|capecitabine|mesh-list
6594257|NCT01126138|Vinorelbine|vinorelbine|mesh-list
6594258|NCT01126138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6594259|NCT01126138|Tubulin Modulators|tubulin modulators|mesh-ancestor
6594260|NCT01126138|Antimitotic Agents|antimitotic agents|mesh-ancestor
6594261|NCT01126138|Mitosis Modulators|mitosis modulators|mesh-ancestor
6594262|NCT01126138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594263|NCT01126138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6594264|NCT01126138|Antimetabolites|antimetabolites|mesh-ancestor
6594265|NCT01126138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6594266|NCT01126177|Interferons|interferons|mesh-list
6594267|NCT01126177|Interferon-beta|interferon-beta|mesh-list
6594268|NCT01126177|Interferon beta-1a|interferon beta-1a|mesh-list
6594269|NCT01126177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6594270|NCT01126177|Antiviral Agents|antiviral agents|mesh-ancestor
6594271|NCT01126177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6594272|NCT01126177|Immunologic Factors|immunologic factors|mesh-ancestor
6594273|NCT01126177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594274|NCT01126177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6594275|NCT01126216|Paclitaxel|paclitaxel|mesh-list
6594276|NCT01126216|Cisplatin|cisplatin|mesh-list
6594277|NCT01126216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6594278|NCT01126216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6594279|NCT01126216|Tubulin Modulators|tubulin modulators|mesh-ancestor
6594280|NCT01126216|Antimitotic Agents|antimitotic agents|mesh-ancestor
6594281|NCT01126216|Mitosis Modulators|mitosis modulators|mesh-ancestor
6594282|NCT01126216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594283|NCT01126229|Resveratrol|resveratrol|mesh-list
6594284|NCT01126229|Antioxidants|antioxidants|mesh-ancestor
6594285|NCT01126229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594286|NCT01126229|Protective Agents|protective agents|mesh-ancestor
6594287|NCT01126229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594288|NCT01126229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6594289|NCT01126229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6594290|NCT01126255|Clobetasol|clobetasol|mesh-list
6594291|NCT01126255|Progesterone|progesterone|mesh-list
6594292|NCT01126255|Progestins|progestins|mesh-ancestor
6594293|NCT01126255|Hormones|hormones|mesh-ancestor
6594294|NCT01126255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6594295|NCT01126255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594296|NCT01126255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6594297|NCT01126255|Glucocorticoids|glucocorticoids|mesh-ancestor
6594298|NCT01126294|Melatonin|melatonin|mesh-list
6594299|NCT01126294|Antioxidants|antioxidants|mesh-ancestor
6594300|NCT01126294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594301|NCT01126294|Protective Agents|protective agents|mesh-ancestor
6594302|NCT01126294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594303|NCT01126294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6594304|NCT01126307|Verapamil|verapamil|mesh-list
6594305|NCT01126307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6594306|NCT01126307|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6594307|NCT01126307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6594308|NCT01126307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594309|NCT01126307|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6594310|NCT01126307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594311|NCT01126307|Vasodilator Agents|vasodilator agents|mesh-ancestor
6594312|NCT01126450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6594313|NCT01126450|Cetuximab|cetuximab|mesh-list
6594314|NCT01126450|Lenalidomide|lenalidomide|mesh-list
6594315|NCT01126450|Antibodies|antibodies|mesh-list
6594316|NCT01126450|Immunoglobulins|immunoglobulins|mesh-list
6594317|NCT01126450|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6594318|NCT01126450|Immunologic Factors|immunologic factors|mesh-ancestor
6594319|NCT01126450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594320|NCT01126450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6594321|NCT01126450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6594322|NCT01126450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6594323|NCT01126450|Growth Substances|growth substances|mesh-ancestor
6594324|NCT01126450|Growth Inhibitors|growth inhibitors|mesh-ancestor
6594325|NCT01126463|Ethiodized Oil|ethiodized oil|mesh-list
6594326|NCT01126463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6594327|NCT01126528|Vitamin D|vitamin d|mesh-list
6594328|NCT01126528|Cholecalciferol|cholecalciferol|mesh-list
6594329|NCT01126528|Vitamins|vitamins|mesh-ancestor
6594330|NCT01126528|Micronutrients|micronutrients|mesh-ancestor
6594331|NCT01126528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594332|NCT01126528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6594333|NCT01126528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6594334|NCT01126606|Glycerol|glycerol|mesh-list
6594335|NCT01126606|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6594336|NCT01126606|Protective Agents|protective agents|mesh-ancestor
6594337|NCT01126606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594338|NCT01126645|Sorafenib|sorafenib|mesh-list
6594339|NCT01126645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6594340|NCT01126645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6594341|NCT01126645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6594342|NCT01126645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594343|NCT01126684|Atorvastatin|atorvastatin|mesh-list
6594344|NCT01126684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6594345|NCT01126684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6594346|NCT01126684|Antimetabolites|antimetabolites|mesh-ancestor
6594347|NCT01126684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594348|NCT01126684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6594349|NCT01126684|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6594350|NCT01126684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6594351|NCT01126697|Ubiquinone|ubiquinone|mesh-list
6594352|NCT01126697|Coenzyme Q10|coenzyme q10|mesh-list
6594353|NCT01126697|Lisinopril|lisinopril|mesh-list
6594354|NCT01126697|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6594355|NCT01126697|Protease Inhibitors|protease inhibitors|mesh-ancestor
6594356|NCT01126697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6594357|NCT01126697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594358|NCT01126697|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6594359|NCT01126697|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6594360|NCT01126697|Protective Agents|protective agents|mesh-ancestor
6594361|NCT01126697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594362|NCT01126697|Micronutrients|micronutrients|mesh-ancestor
6594363|NCT01126697|Vitamins|vitamins|mesh-ancestor
6594364|NCT01126736|Pemetrexed|pemetrexed|mesh-list
6594365|NCT01126736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6594366|NCT01126736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6594367|NCT01126736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594368|NCT01126736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6594369|NCT01126736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6594382|NCT01126814|Imatinib Mesylate|imatinib mesylate|mesh-list
6594383|NCT01126814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6594384|NCT01126814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6594385|NCT01126814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6594386|NCT01126814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594387|NCT01126866|Bevacizumab|bevacizumab|mesh-list
6594388|NCT01126866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6594389|NCT01126866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6594390|NCT01126866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6594391|NCT01126866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6594392|NCT01126866|Growth Substances|growth substances|mesh-ancestor
6594393|NCT01126866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594394|NCT01126866|Growth Inhibitors|growth inhibitors|mesh-ancestor
6594395|NCT01127009|Cytarabine|cytarabine|mesh-list
6594396|NCT01127009|Etoposide|etoposide|mesh-list
6594397|NCT01127009|Podophyllotoxin|podophyllotoxin|mesh-list
6594398|NCT01127009|Mitoxantrone|mitoxantrone|mesh-list
6594399|NCT01127009|Bortezomib|bortezomib|mesh-list
6594400|NCT01127009|Etoposide phosphate|etoposide phosphate|mesh-list
6594401|NCT01127009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6594402|NCT01127009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6594403|NCT01127009|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6594404|NCT01127009|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6594405|NCT01127009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6594406|NCT01127009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594407|NCT01127009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6594408|NCT01127009|Antimetabolites|antimetabolites|mesh-ancestor
6594409|NCT01127009|Antiviral Agents|antiviral agents|mesh-ancestor
6594410|NCT01127009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6594411|NCT01127009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6594412|NCT01127009|Immunologic Factors|immunologic factors|mesh-ancestor
6594413|NCT01127009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594414|NCT01127009|Analgesics|analgesics|mesh-ancestor
6594415|NCT01127009|Sensory System Agents|sensory system agents|mesh-ancestor
6594416|NCT01127009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6594417|NCT01127009|Keratolytic Agents|keratolytic agents|mesh-ancestor
6594418|NCT01127009|Dermatologic Agents|dermatologic agents|mesh-ancestor
6594419|NCT01127009|Tubulin Modulators|tubulin modulators|mesh-ancestor
6594420|NCT01127009|Antimitotic Agents|antimitotic agents|mesh-ancestor
6594421|NCT01127009|Mitosis Modulators|mitosis modulators|mesh-ancestor
6594422|NCT01127022|Choline|choline|mesh-list
6594423|NCT01127022|Lipotropic Agents|lipotropic agents|mesh-ancestor
6594424|NCT01127022|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6594425|NCT01127022|Antimetabolites|antimetabolites|mesh-ancestor
6594426|NCT01127022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594427|NCT01127022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6594428|NCT01127022|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6594429|NCT01127022|Nootropic Agents|nootropic agents|mesh-ancestor
6594430|NCT01127100|Fentanyl|fentanyl|mesh-list
6594431|NCT01127100|Gabapentin|gabapentin|mesh-list
6594432|NCT01127100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6594433|NCT01127100|Narcotics|narcotics|mesh-ancestor
6594434|NCT01127100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6594435|NCT01127100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594436|NCT01127100|Analgesics|analgesics|mesh-ancestor
6594437|NCT01127100|Sensory System Agents|sensory system agents|mesh-ancestor
6594438|NCT01127100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6594439|NCT01127100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6594440|NCT01127100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6594441|NCT01127100|Anesthetics, General|anesthetics, general|mesh-ancestor
6594442|NCT01127100|Anesthetics|anesthetics|mesh-ancestor
6594443|NCT01127100|Anticonvulsants|anticonvulsants|mesh-ancestor
6594444|NCT01127100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6594445|NCT01127100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6594446|NCT01127100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6594447|NCT01127100|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6594448|NCT01127100|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6594449|NCT01127100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6594450|NCT01127100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594451|NCT01127100|Antimanic Agents|antimanic agents|mesh-ancestor
6594452|NCT01127178|10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2H)-one|10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2h)-one|mesh-list
6594453|NCT01127178|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6594454|NCT01127178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6659488|NCT01488266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6594455|NCT01127178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594456|NCT01127178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6594457|NCT01127204|Lamivudine|lamivudine|mesh-list
6594458|NCT01127204|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6594459|NCT01127204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6594460|NCT01127204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6594461|NCT01127204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594462|NCT01127204|Antiviral Agents|antiviral agents|mesh-ancestor
6594463|NCT01127204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6594464|NCT01127204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6594465|NCT01127204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6594466|NCT01127217|Losartan|losartan|mesh-list
6594467|NCT01127217|Amlodipine|amlodipine|mesh-list
6594468|NCT01127217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6594469|NCT01127217|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6594470|NCT01127217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6594471|NCT01127217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594472|NCT01127217|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6594473|NCT01127217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594474|NCT01127217|Vasodilator Agents|vasodilator agents|mesh-ancestor
6594475|NCT01127217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6594476|NCT01127217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6594477|NCT01127217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6594478|NCT01127269|Insulin Glargine|insulin glargine|mesh-list
6594479|NCT01127269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6594480|NCT01127269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594481|NCT01127282|Vitamins|vitamins|mesh-list
6594482|NCT01127282|Vitamin A|vitamin a|mesh-list
6594483|NCT01127282|Micronutrients|micronutrients|mesh-ancestor
6594484|NCT01127282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594485|NCT01127295|Tamoxifen|tamoxifen|mesh-list
6594486|NCT01127295|Letrozole|letrozole|mesh-list
6594487|NCT01127295|Anastrozole|anastrozole|mesh-list
6594488|NCT01127295|Exemestane|exemestane|mesh-list
6594489|NCT01127295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6594490|NCT01127295|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6594491|NCT01127295|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6594492|NCT01127295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6594493|NCT01127295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594494|NCT01127295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6594495|NCT01127295|Hormone Antagonists|hormone antagonists|mesh-ancestor
6594496|NCT01127295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6594497|NCT01127295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594498|NCT01127295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6594499|NCT01127295|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6594500|NCT01127295|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6594501|NCT01127295|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6594502|NCT01127308|Ertugliflozin|ertugliflozin|mesh-list
6594503|NCT01127308|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6594504|NCT01127308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594505|NCT01127308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5501705|NCT04471714|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6594506|NCT01127308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659489|NCT01488266|Dopamine Agonists|dopamine agonists|mesh-ancestor
6659490|NCT01488266|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6659491|NCT01488266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6659492|NCT01488266|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6659493|NCT01488266|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6659494|NCT01488266|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6659495|NCT01488266|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6659496|NCT01488266|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6659497|NCT01488266|Analgesics|analgesics|mesh-ancestor
6659498|NCT01488266|Sensory System Agents|sensory system agents|mesh-ancestor
6659499|NCT01488266|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6659500|NCT01488266|Histamine Antagonists|histamine antagonists|mesh-ancestor
6659501|NCT01488266|Histamine Agents|histamine agents|mesh-ancestor
6659502|NCT01488266|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6659503|NCT01488266|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6659504|NCT01488266|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6659505|NCT01488266|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6659506|NCT01488266|Adrenergic Agents|adrenergic agents|mesh-ancestor
6659507|NCT01488266|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6659508|NCT01488266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6659509|NCT01488305|Micronutrients|micronutrients|mesh-list
6659510|NCT01488305|Trace Elements|trace elements|mesh-list
6659511|NCT01488305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659512|NCT01488344|Nintedanib|nintedanib|mesh-list
6659513|NCT01488344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6659514|NCT01488344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6659515|NCT01488344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6659516|NCT01488344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6659517|NCT01488396|Cyclosporine|cyclosporine|mesh-list
6659518|NCT01488396|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6659519|NCT01488396|Cyclosporins|cyclosporins|mesh-list
6659520|NCT01488396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6659521|NCT01488396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6659522|NCT01488396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6659523|NCT01488396|Immunologic Factors|immunologic factors|mesh-ancestor
6659524|NCT01488396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659525|NCT01488396|Antifungal Agents|antifungal agents|mesh-ancestor
6659526|NCT01488396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6659527|NCT01488396|Dermatologic Agents|dermatologic agents|mesh-ancestor
6659528|NCT01488396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6659529|NCT01488396|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6659530|NCT01488396|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6664857|NCT01514344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6664858|NCT01514344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6664859|NCT01514344|Immunologic Factors|immunologic factors|mesh-ancestor
6664860|NCT01514344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664861|NCT01514344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6664862|NCT01514409|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
6664863|NCT01514409|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6664864|NCT01514409|Antidepressive Agents|antidepressive agents|mesh-ancestor
6664865|NCT01514409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6664866|NCT01514487|Liraglutide|liraglutide|mesh-list
6664867|NCT01514487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6664868|NCT01514487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664869|NCT01514487|Incretins|incretins|mesh-ancestor
6664870|NCT01514487|Hormones|hormones|mesh-ancestor
6664871|NCT01514487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6664872|NCT01514695|Fentanyl|fentanyl|mesh-list
6664873|NCT01514695|Midazolam|midazolam|mesh-list
6664874|NCT01514695|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6664875|NCT01514695|Narcotics|narcotics|mesh-ancestor
6664876|NCT01514695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6664877|NCT01514695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664878|NCT01514695|Analgesics|analgesics|mesh-ancestor
6664879|NCT01514695|Sensory System Agents|sensory system agents|mesh-ancestor
6664880|NCT01514695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6664881|NCT01514695|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6664882|NCT01514695|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6664883|NCT01514695|Anesthetics, General|anesthetics, general|mesh-ancestor
6664884|NCT01514695|Anesthetics|anesthetics|mesh-ancestor
6664885|NCT01514695|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6664886|NCT01514695|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6664887|NCT01514695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6664888|NCT01514695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6594507|NCT01127360|Bevacizumab|bevacizumab|mesh-list
6594508|NCT01127360|Ranibizumab|ranibizumab|mesh-list
6594509|NCT01127360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6594510|NCT01127360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6594511|NCT01127360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6594512|NCT01127360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6594513|NCT01127360|Growth Substances|growth substances|mesh-ancestor
6594514|NCT01127360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594515|NCT01127360|Growth Inhibitors|growth inhibitors|mesh-ancestor
6594516|NCT01127386|Lenalidomide|lenalidomide|mesh-list
6594517|NCT01127386|Immunologic Factors|immunologic factors|mesh-ancestor
6594518|NCT01127386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594519|NCT01127386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6594520|NCT01127386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6594521|NCT01127386|Growth Substances|growth substances|mesh-ancestor
6594522|NCT01127386|Growth Inhibitors|growth inhibitors|mesh-ancestor
6594523|NCT01127386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6594524|NCT01127464|Poly ICLC|poly iclc|mesh-list
6594525|NCT01127464|Interferon Inducers|interferon inducers|mesh-ancestor
6594526|NCT01127464|Immunologic Factors|immunologic factors|mesh-ancestor
6594527|NCT01127464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594528|NCT01127477|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
6594529|NCT01127477|Plasma Substitutes|plasma substitutes|mesh-ancestor
6594530|NCT01127477|Blood Substitutes|blood substitutes|mesh-ancestor
6594531|NCT01127490|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6594532|NCT01127490|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6594533|NCT01127490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6594534|NCT01127490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6594535|NCT01127490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594536|NCT01127490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6594537|NCT01127490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594538|NCT01127490|Analgesics|analgesics|mesh-ancestor
6594539|NCT01127490|Sensory System Agents|sensory system agents|mesh-ancestor
6594540|NCT01127490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6594541|NCT01127490|Antidepressive Agents|antidepressive agents|mesh-ancestor
6594542|NCT01127490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6594543|NCT01127490|Dopamine Agents|dopamine agents|mesh-ancestor
6594544|NCT01127529|Protein C|protein c|mesh-list
6594545|NCT01127529|Anticoagulants|anticoagulants|mesh-ancestor
6594546|NCT01127529|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6594547|NCT01127529|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6594548|NCT01127529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594549|NCT01127542|Lenalidomide|lenalidomide|mesh-list
6594550|NCT01127542|Immunologic Factors|immunologic factors|mesh-ancestor
6594551|NCT01127542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594552|NCT01127542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6594553|NCT01127542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6594554|NCT01127542|Growth Substances|growth substances|mesh-ancestor
6594555|NCT01127542|Growth Inhibitors|growth inhibitors|mesh-ancestor
6594556|NCT01127542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6594557|NCT01127555|Leucovorin|leucovorin|mesh-list
6594558|NCT01127555|Fluorouracil|fluorouracil|mesh-list
6594559|NCT01127555|Oxaliplatin|oxaliplatin|mesh-list
6594560|NCT01127555|Antimetabolites|antimetabolites|mesh-ancestor
6594561|NCT01127555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594562|NCT01127555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6594563|NCT01127555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6594564|NCT01127555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6594565|NCT01127555|Immunologic Factors|immunologic factors|mesh-ancestor
6594566|NCT01127555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594567|NCT01127555|Antidotes|antidotes|mesh-ancestor
6594568|NCT01127555|Protective Agents|protective agents|mesh-ancestor
6594569|NCT01127555|Vitamin B Complex|vitamin b complex|mesh-ancestor
6594570|NCT01127555|Vitamins|vitamins|mesh-ancestor
6594571|NCT01127555|Micronutrients|micronutrients|mesh-ancestor
6594572|NCT01127568|Propranolol|propranolol|mesh-list
6594573|NCT01127568|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6594574|NCT01127568|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6594575|NCT01127568|Adrenergic Agents|adrenergic agents|mesh-ancestor
6594576|NCT01127568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6594577|NCT01127568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594578|NCT01127568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594579|NCT01127568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6594580|NCT01127568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6594581|NCT01127568|Vasodilator Agents|vasodilator agents|mesh-ancestor
6594582|NCT01127594|Temozolomide|temozolomide|mesh-list
6594583|NCT01127594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6594584|NCT01127594|Alkylating Agents|alkylating agents|mesh-ancestor
6594585|NCT01127594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594586|NCT01127594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6594587|NCT01127620|Cetirizine|cetirizine|mesh-list
6594588|NCT01127620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6594589|NCT01127620|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6594590|NCT01127620|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6594591|NCT01127620|Histamine Antagonists|histamine antagonists|mesh-ancestor
6594592|NCT01127620|Histamine Agents|histamine agents|mesh-ancestor
6594593|NCT01127620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6594594|NCT01127620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594595|NCT01127620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594596|NCT01127672|Betamethasone|betamethasone|mesh-list
6594597|NCT01127672|Lidocaine|lidocaine|mesh-list
6594598|NCT01127672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6594599|NCT01127672|Glucocorticoids|glucocorticoids|mesh-ancestor
6594600|NCT01127672|Hormones|hormones|mesh-ancestor
6594601|NCT01127672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6594602|NCT01127672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594603|NCT01127672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6594604|NCT01127672|Respiratory System Agents|respiratory system agents|mesh-ancestor
6594605|NCT01127672|Anesthetics, Local|anesthetics, local|mesh-ancestor
6594606|NCT01127672|Anesthetics|anesthetics|mesh-ancestor
6594607|NCT01127672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6594608|NCT01127672|Sensory System Agents|sensory system agents|mesh-ancestor
6594609|NCT01127672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6594610|NCT01127672|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6594611|NCT01127672|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6594612|NCT01127672|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6594613|NCT01127672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6594614|NCT01127672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594615|NCT01127724|Vitamins|vitamins|mesh-list
6594616|NCT01127724|Vitamin B 12|vitamin b 12|mesh-list
6594617|NCT01127724|Hydroxocobalamin|hydroxocobalamin|mesh-list
6594618|NCT01127724|Vitamin B Complex|vitamin b complex|mesh-list
6594619|NCT01127724|Micronutrients|micronutrients|mesh-ancestor
6594620|NCT01127724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594621|NCT01127724|Hematinics|hematinics|mesh-ancestor
6594622|NCT01127750|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6594623|NCT01127750|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6594624|NCT01127750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594625|NCT01127750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6594626|NCT01127750|Immunologic Factors|immunologic factors|mesh-ancestor
6594627|NCT01127750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594628|NCT01127841|Rituximab|rituximab|mesh-list
6594629|NCT01127841|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6594630|NCT01127841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6594631|NCT01127841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6594632|NCT01127841|Immunologic Factors|immunologic factors|mesh-ancestor
6594633|NCT01127841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594634|NCT01127841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6594635|NCT01127841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6594636|NCT01127841|Alkylating Agents|alkylating agents|mesh-ancestor
6594637|NCT01127841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594638|NCT01127880|Clindamycin|clindamycin|mesh-list
6594639|NCT01127880|Clindamycin palmitate|clindamycin palmitate|mesh-list
6594640|NCT01127880|Clindamycin phosphate|clindamycin phosphate|mesh-list
6594641|NCT01127880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6594642|NCT01127880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6594643|NCT01127880|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6594644|NCT01127880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6594645|NCT01127880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594646|NCT01127906|Oxycodone|oxycodone|mesh-list
6594647|NCT01127906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6594648|NCT01127906|Narcotics|narcotics|mesh-ancestor
6594649|NCT01127906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6594650|NCT01127906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594651|NCT01127906|Analgesics|analgesics|mesh-ancestor
6594652|NCT01127906|Sensory System Agents|sensory system agents|mesh-ancestor
6594653|NCT01127906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6594654|NCT01127984|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6594655|NCT01127984|Hemostatics|hemostatics|mesh-ancestor
6594656|NCT01127984|Coagulants|coagulants|mesh-ancestor
6594657|NCT01128075|Interferon beta-1a|interferon beta-1a|mesh-list
6594658|NCT01128075|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6594659|NCT01128075|Immunologic Factors|immunologic factors|mesh-ancestor
6594660|NCT01128075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594661|NCT01128075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6594662|NCT01128075|Antiviral Agents|antiviral agents|mesh-ancestor
6594663|NCT01128075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6594664|NCT01128101|Spironolactone|spironolactone|mesh-list
6594665|NCT01128101|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6594666|NCT01128101|Hormone Antagonists|hormone antagonists|mesh-ancestor
6594667|NCT01128101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6594668|NCT01128101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594669|NCT01128101|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6594670|NCT01128101|Diuretics|diuretics|mesh-ancestor
6594671|NCT01128101|Natriuretic Agents|natriuretic agents|mesh-ancestor
6594672|NCT01128218|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6594673|NCT01128218|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6594674|NCT01128218|Dermatologic Agents|dermatologic agents|mesh-ancestor
6594675|NCT01128257|Alendronate|alendronate|mesh-list
6594676|NCT01128257|Ibandronic Acid|ibandronic acid|mesh-list
6594677|NCT01128257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6594678|NCT01128257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594679|NCT01128322|Niacin|niacin|mesh-list
6594680|NCT01128322|Amlodipine|amlodipine|mesh-list
6594681|NCT01128322|Telmisartan|telmisartan|mesh-list
6594682|NCT01128322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6594683|NCT01128322|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6594684|NCT01128322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6594685|NCT01128322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594686|NCT01128322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6594687|NCT01128322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594688|NCT01128322|Vasodilator Agents|vasodilator agents|mesh-ancestor
6594689|NCT01128322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6594690|NCT01128322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6594691|NCT01128322|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6448255|NCT00400387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448256|NCT00400387|Anticoagulants|anticoagulants|mesh-ancestor
6448257|NCT00400387|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6448258|NCT00400387|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6448259|NCT00400387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448260|NCT00400387|Vitamins|vitamins|mesh-ancestor
6448261|NCT00400387|Micronutrients|micronutrients|mesh-ancestor
6448262|NCT00400387|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6448263|NCT00400387|Dermatologic Agents|dermatologic agents|mesh-ancestor
6448264|NCT00400387|Antioxidants|antioxidants|mesh-ancestor
6448265|NCT00400387|Protective Agents|protective agents|mesh-ancestor
6448266|NCT00400387|Hematinics|hematinics|mesh-ancestor
6448267|NCT00400478|Rituximab|rituximab|mesh-list
6448268|NCT00400478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6448269|NCT00400478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6448270|NCT00400478|Immunologic Factors|immunologic factors|mesh-ancestor
6448271|NCT00400478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448272|NCT00400478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6448273|NCT00400491|Vitamin D|vitamin d|mesh-list
6448274|NCT00400491|Ergocalciferols|ergocalciferols|mesh-list
6448275|NCT00400491|Cholecalciferol|cholecalciferol|mesh-list
6448276|NCT00400491|Vitamins|vitamins|mesh-list
6448277|NCT00400491|Micronutrients|micronutrients|mesh-ancestor
6448278|NCT00400491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448279|NCT00400491|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6448280|NCT00400491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6448281|NCT00400530|Alendronate|alendronate|mesh-list
6448282|NCT00400530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448283|NCT00400530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6448284|NCT00400556|Lenograstim|lenograstim|mesh-list
6448285|NCT00400556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6448286|NCT00400556|Immunologic Factors|immunologic factors|mesh-ancestor
6448287|NCT00400556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448288|NCT00400582|Candesartan|candesartan|mesh-list
6448289|NCT00400582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6448290|NCT00400582|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6448291|NCT00400582|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6448292|NCT00400582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448293|NCT00400595|Mupirocin|mupirocin|mesh-list
6448294|NCT00400595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6448295|NCT00400595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6448296|NCT00400595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6448297|NCT00400595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6448298|NCT00400595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461813|NCT00456313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6461814|NCT00456313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461815|NCT00456313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6461816|NCT00456313|Respiratory System Agents|respiratory system agents|mesh-ancestor
6461817|NCT00456313|Glucocorticoids|glucocorticoids|mesh-ancestor
6461818|NCT00456313|Hormones|hormones|mesh-ancestor
6461819|NCT00456313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6461820|NCT00456313|Sympathomimetics|sympathomimetics|mesh-ancestor
6461821|NCT00456313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6461822|NCT00456313|Dermatologic Agents|dermatologic agents|mesh-ancestor
6461823|NCT00456313|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6461824|NCT00456339|Amoxicillin|amoxicillin|mesh-list
6461825|NCT00456339|Clavulanic Acid|clavulanic acid|mesh-list
6461826|NCT00456339|Clavulanic Acids|clavulanic acids|mesh-list
6461827|NCT00456339|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6461828|NCT00456339|Prednisolone|prednisolone|mesh-list
6461829|NCT00456339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6461830|NCT00456339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6461831|NCT00456339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6461832|NCT00456339|Glucocorticoids|glucocorticoids|mesh-ancestor
6461833|NCT00456339|Hormones|hormones|mesh-ancestor
6594692|NCT01128322|Antimetabolites|antimetabolites|mesh-ancestor
6594693|NCT01128322|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6594694|NCT01128322|Vitamin B Complex|vitamin b complex|mesh-ancestor
6594695|NCT01128322|Vitamins|vitamins|mesh-ancestor
6594696|NCT01128322|Micronutrients|micronutrients|mesh-ancestor
6594697|NCT01128556|Bepotastine besilate|bepotastine besilate|mesh-list
6594698|NCT01128556|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6594699|NCT01128699|Bevacizumab|bevacizumab|mesh-list
6594700|NCT01128699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6594701|NCT01128699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6594702|NCT01128699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6594703|NCT01128699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6594704|NCT01128699|Growth Substances|growth substances|mesh-ancestor
6594705|NCT01128699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594706|NCT01128699|Growth Inhibitors|growth inhibitors|mesh-ancestor
6594707|NCT01128712|Pregabalin|pregabalin|mesh-list
6594708|NCT01128712|Analgesics|analgesics|mesh-ancestor
6594709|NCT01128712|Sensory System Agents|sensory system agents|mesh-ancestor
6594710|NCT01128712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6594711|NCT01128712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594712|NCT01128712|Anticonvulsants|anticonvulsants|mesh-ancestor
6594713|NCT01128712|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6594714|NCT01128712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6594715|NCT01128712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594716|NCT01128712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6594717|NCT01128712|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6594718|NCT01128712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6594719|NCT01128712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6594720|NCT01128712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6594721|NCT01128985|Canagliflozin|canagliflozin|mesh-list
6594722|NCT01128985|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6594723|NCT01128985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594724|NCT01128985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6594725|NCT01128985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594726|NCT01128998|Sorafenib|sorafenib|mesh-list
6594727|NCT01128998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6594728|NCT01128998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6594729|NCT01128998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6594730|NCT01128998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594731|NCT01129063|Clopidogrel|clopidogrel|mesh-list
6594732|NCT01129063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6594733|NCT01129063|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6594734|NCT01129063|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6594735|NCT01129063|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6594736|NCT01129063|Purinergic Agents|purinergic agents|mesh-ancestor
6594737|NCT01129063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6594738|NCT01129063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594739|NCT01129063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594740|NCT01129089|Micronutrients|micronutrients|mesh-list
6594741|NCT01129089|Trace Elements|trace elements|mesh-list
6594742|NCT01129089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594743|NCT01129154|Panitumumab|panitumumab|mesh-list
6594744|NCT01129154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6594745|NCT01129154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6594746|NCT01129180|Bortezomib|bortezomib|mesh-list
6594747|NCT01129180|Azacitidine|azacitidine|mesh-list
6594748|NCT01129180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6594749|NCT01129180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6594750|NCT01129180|Antimetabolites|antimetabolites|mesh-ancestor
6594751|NCT01129180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594752|NCT01129180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6594753|NCT01129258|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
6594754|NCT01129258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6594755|NCT01129258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594756|NCT01129271|Clopidogrel|clopidogrel|mesh-list
6594757|NCT01129271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6594758|NCT01129271|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6594759|NCT01129271|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6594760|NCT01129271|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6594761|NCT01129271|Purinergic Agents|purinergic agents|mesh-ancestor
6594762|NCT01129271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6594763|NCT01129271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594764|NCT01129271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659531|NCT01488526|Tenofovir|tenofovir|mesh-list
6659532|NCT01488526|Antiviral Agents|antiviral agents|mesh-ancestor
6659533|NCT01488526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6659534|NCT01488526|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6659535|NCT01488526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6659536|NCT01488526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6659537|NCT01488526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6659538|NCT01488526|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6659539|NCT01488526|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6659540|NCT01488552|Metformin|metformin|mesh-list
6659541|NCT01488552|Gemcitabine|gemcitabine|mesh-list
6659542|NCT01488552|Paclitaxel|paclitaxel|mesh-list
6659543|NCT01488552|Folfirinox|folfirinox|mesh-list
6659544|NCT01488552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6659545|NCT01488552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6659546|NCT01488552|Tubulin Modulators|tubulin modulators|mesh-ancestor
6659547|NCT01488552|Antimitotic Agents|antimitotic agents|mesh-ancestor
6659548|NCT01488552|Mitosis Modulators|mitosis modulators|mesh-ancestor
6659549|NCT01488552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6659550|NCT01488552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6659551|NCT01488552|Antimetabolites|antimetabolites|mesh-ancestor
6659552|NCT01488552|Antiviral Agents|antiviral agents|mesh-ancestor
6659553|NCT01488552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6659554|NCT01488552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6659555|NCT01488552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6659556|NCT01488552|Immunologic Factors|immunologic factors|mesh-ancestor
6659557|NCT01488552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659558|NCT01488552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6659559|NCT01488565|Azacitidine|azacitidine|mesh-list
6659560|NCT01488565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6659561|NCT01488565|Antimetabolites|antimetabolites|mesh-ancestor
6659562|NCT01488565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6659563|NCT01488565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6659564|NCT01488565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6594765|NCT01129310|Capecitabine|capecitabine|mesh-list
6594766|NCT01129310|Oxaliplatin|oxaliplatin|mesh-list
6594767|NCT01129310|Irinotecan|irinotecan|mesh-list
6594768|NCT01129310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6594769|NCT01129310|Antimetabolites|antimetabolites|mesh-ancestor
6594770|NCT01129310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594771|NCT01129310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6594772|NCT01129310|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6594773|NCT01129310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6594774|NCT01129310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6594775|NCT01129323|Cyclophosphamide|cyclophosphamide|mesh-list
6594776|NCT01129323|Fludarabine|fludarabine|mesh-list
6594777|NCT01129323|Thymoglobulin|thymoglobulin|mesh-list
6594778|NCT01129323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6594779|NCT01129323|Immunologic Factors|immunologic factors|mesh-ancestor
6594780|NCT01129323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594781|NCT01129323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6594782|NCT01129323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6594783|NCT01129323|Alkylating Agents|alkylating agents|mesh-ancestor
6594784|NCT01129323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594785|NCT01129323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6594786|NCT01129323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6594787|NCT01129375|Omeprazole|omeprazole|mesh-list
6594788|NCT01129375|Clopidogrel|clopidogrel|mesh-list
6594789|NCT01129375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6594790|NCT01129375|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6594791|NCT01129375|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6594792|NCT01129375|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6594793|NCT01129375|Purinergic Agents|purinergic agents|mesh-ancestor
6594794|NCT01129375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6594795|NCT01129375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594796|NCT01129375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594797|NCT01129375|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6594798|NCT01129375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6594799|NCT01129375|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6594800|NCT01129375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6594801|NCT01129388|Omeprazole|omeprazole|mesh-list
6594802|NCT01129388|Clopidogrel|clopidogrel|mesh-list
6594803|NCT01129388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6594804|NCT01129388|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6594805|NCT01129388|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6594806|NCT01129388|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6594807|NCT01129388|Purinergic Agents|purinergic agents|mesh-ancestor
6594808|NCT01129388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6594809|NCT01129388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501706|NCT04471714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501707|NCT04471714|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5501708|NCT04471714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5501709|NCT04471714|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
5501710|NCT04471714|GABA Agonists|gaba agonists|mesh-ancestor
5501711|NCT04471714|GABA Agents|gaba agents|mesh-ancestor
5501712|NCT04471714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6448299|NCT00400608|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6448300|NCT00400608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6448301|NCT00400608|Autonomic Agents|autonomic agents|mesh-ancestor
6448302|NCT00400608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6448303|NCT00400608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448304|NCT00400608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6448305|NCT00400608|Respiratory System Agents|respiratory system agents|mesh-ancestor
6448306|NCT00400608|Glucocorticoids|glucocorticoids|mesh-ancestor
6448307|NCT00400608|Hormones|hormones|mesh-ancestor
6448308|NCT00400608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6448309|NCT00400608|Sympathomimetics|sympathomimetics|mesh-ancestor
6448310|NCT00400621|Acetaminophen|acetaminophen|mesh-list
6594810|NCT01129388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594811|NCT01129388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6594812|NCT01129388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6594813|NCT01129388|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6594814|NCT01129388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6594815|NCT01129414|Omeprazole|omeprazole|mesh-list
6594816|NCT01129414|Clopidogrel|clopidogrel|mesh-list
6594817|NCT01129414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6594818|NCT01129414|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6594819|NCT01129414|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6594820|NCT01129414|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6594821|NCT01129414|Purinergic Agents|purinergic agents|mesh-ancestor
6594822|NCT01129414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6594823|NCT01129414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594824|NCT01129414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594825|NCT01129414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6594826|NCT01129414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6594827|NCT01129414|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6594828|NCT01129414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6594829|NCT01129427|Pantoprazole|pantoprazole|mesh-list
6594830|NCT01129427|Clopidogrel|clopidogrel|mesh-list
6594831|NCT01129427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6594832|NCT01129427|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6594833|NCT01129427|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6594834|NCT01129427|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6594835|NCT01129427|Purinergic Agents|purinergic agents|mesh-ancestor
6594836|NCT01129427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6594837|NCT01129427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594838|NCT01129427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594839|NCT01129427|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6594840|NCT01129427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6594841|NCT01129427|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6594842|NCT01129427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6594843|NCT01129479|Galantamine|galantamine|mesh-list
6594844|NCT01129479|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6594845|NCT01129479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6594846|NCT01129479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594847|NCT01129479|Cholinergic Agents|cholinergic agents|mesh-ancestor
6594848|NCT01129479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6594849|NCT01129479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594850|NCT01129479|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6594851|NCT01129479|Autonomic Agents|autonomic agents|mesh-ancestor
6594852|NCT01129479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6594853|NCT01129479|Nootropic Agents|nootropic agents|mesh-ancestor
6594854|NCT01129518|Vaccines|vaccines|mesh-list
6594855|NCT01129518|Immunologic Factors|immunologic factors|mesh-ancestor
6594856|NCT01129518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594857|NCT01129570|Silybin|silybin|mesh-list
6594858|NCT01129570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6594859|NCT01129570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6594860|NCT01129570|Protective Agents|protective agents|mesh-ancestor
6594861|NCT01129570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594862|NCT01129596|Donepezil|donepezil|mesh-list
6594863|NCT01129596|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6594864|NCT01129596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6594865|NCT01129596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594866|NCT01129596|Cholinergic Agents|cholinergic agents|mesh-ancestor
6594867|NCT01129596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6594868|NCT01129596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594869|NCT01129596|Nootropic Agents|nootropic agents|mesh-ancestor
6594870|NCT01129713|Esomeprazole|esomeprazole|mesh-list
6448311|NCT00400621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6448312|NCT00400621|Analgesics|analgesics|mesh-ancestor
6448313|NCT00400621|Sensory System Agents|sensory system agents|mesh-ancestor
6448314|NCT00400621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6448315|NCT00400621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448316|NCT00400621|Antipyretics|antipyretics|mesh-ancestor
6448317|NCT00400647|Mycophenolic Acid|mycophenolic acid|mesh-list
6448318|NCT00400647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6448319|NCT00400647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6448320|NCT00400647|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6594871|NCT01129713|Omeprazole|omeprazole|mesh-list
6594872|NCT01129713|Lansoprazole|lansoprazole|mesh-list
6594873|NCT01129713|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6594874|NCT01129713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6594875|NCT01129713|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6594876|NCT01129713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6594877|NCT01129713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594878|NCT01129739|Cyclosporine|cyclosporine|mesh-list
6594879|NCT01129739|Cyclosporins|cyclosporins|mesh-list
6594880|NCT01129739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6594881|NCT01129739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594882|NCT01129739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6594883|NCT01129739|Immunologic Factors|immunologic factors|mesh-ancestor
6594884|NCT01129739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594885|NCT01129739|Antifungal Agents|antifungal agents|mesh-ancestor
6594886|NCT01129739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6594887|NCT01129739|Dermatologic Agents|dermatologic agents|mesh-ancestor
6594888|NCT01129739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6594889|NCT01129739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6594890|NCT01129830|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
6594891|NCT01129830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6594892|NCT01129830|Immunologic Factors|immunologic factors|mesh-ancestor
6594893|NCT01129830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594894|NCT01129856|Dexamethasone|dexamethasone|mesh-list
6594895|NCT01129856|Citric Acid|citric acid|mesh-list
6594896|NCT01129856|Sodium Citrate|sodium citrate|mesh-list
6594897|NCT01129856|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6594898|NCT01129856|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6594899|NCT01129856|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
6594900|NCT01129856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6594901|NCT01129856|Antiemetics|antiemetics|mesh-ancestor
6594902|NCT01129856|Autonomic Agents|autonomic agents|mesh-ancestor
6594903|NCT01129856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6594904|NCT01129856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594905|NCT01129856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6594906|NCT01129856|Glucocorticoids|glucocorticoids|mesh-ancestor
6594907|NCT01129856|Hormones|hormones|mesh-ancestor
6594908|NCT01129856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6594909|NCT01129856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6594910|NCT01129856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6594911|NCT01129856|Anticoagulants|anticoagulants|mesh-ancestor
6594912|NCT01129856|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6594913|NCT01129856|Chelating Agents|chelating agents|mesh-ancestor
6594914|NCT01129856|Sequestering Agents|sequestering agents|mesh-ancestor
6594915|NCT01129856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594916|NCT01129934|Promethazine|promethazine|mesh-list
6594917|NCT01129934|Diphenhydramine|diphenhydramine|mesh-list
6594918|NCT01129934|Morphine|morphine|mesh-list
6594919|NCT01129934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6594920|NCT01129934|Narcotics|narcotics|mesh-ancestor
6594921|NCT01129934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6594922|NCT01129934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594923|NCT01129934|Analgesics|analgesics|mesh-ancestor
6594924|NCT01129934|Sensory System Agents|sensory system agents|mesh-ancestor
6594925|NCT01129934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6594926|NCT01129934|Antipruritics|antipruritics|mesh-ancestor
6594927|NCT01129934|Dermatologic Agents|dermatologic agents|mesh-ancestor
6594928|NCT01129934|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6594929|NCT01129934|Histamine Antagonists|histamine antagonists|mesh-ancestor
6594930|NCT01129934|Histamine Agents|histamine agents|mesh-ancestor
6594931|NCT01129934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6594932|NCT01129934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594933|NCT01129934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6594934|NCT01129934|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6594935|NCT01129934|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6594936|NCT01129934|Anesthetics, Local|anesthetics, local|mesh-ancestor
6594937|NCT01129934|Anesthetics|anesthetics|mesh-ancestor
6594938|NCT01129934|Antiemetics|antiemetics|mesh-ancestor
6594939|NCT01129934|Autonomic Agents|autonomic agents|mesh-ancestor
6594940|NCT01129934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6594941|NCT01130025|Tinzaparin|tinzaparin|mesh-list
6594942|NCT01130025|Warfarin|warfarin|mesh-list
6594943|NCT01130025|Anticoagulants|anticoagulants|mesh-ancestor
6594944|NCT01130025|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6594945|NCT01130025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6594946|NCT01130025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594947|NCT01130077|Poly ICLC|poly iclc|mesh-list
6594948|NCT01130077|Interferon Inducers|interferon inducers|mesh-ancestor
6594949|NCT01130077|Immunologic Factors|immunologic factors|mesh-ancestor
6594950|NCT01130077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594951|NCT01130181|Cholecalciferol|cholecalciferol|mesh-list
6594952|NCT01130181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6594953|NCT01130181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594954|NCT01130181|Vitamins|vitamins|mesh-ancestor
6594955|NCT01130181|Micronutrients|micronutrients|mesh-ancestor
6594956|NCT01130181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6594957|NCT01130194|Procarbazine|procarbazine|mesh-list
6594958|NCT01130194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6594959|NCT01130246|Varespladib methyl|varespladib methyl|mesh-list
6594960|NCT01130246|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
6594961|NCT01130246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6594962|NCT01130246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594963|NCT01130259|Iniparib|iniparib|mesh-list
6594964|NCT01130259|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6594965|NCT01130259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6594966|NCT01130259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6594967|NCT01130259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6594968|NCT01130298|Testosterone|testosterone|mesh-list
6594969|NCT01130298|Androgens|androgens|mesh-ancestor
6594970|NCT01130298|Hormones|hormones|mesh-ancestor
6594971|NCT01130298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6594972|NCT01130298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594973|NCT01130311|Vitamin D|vitamin d|mesh-list
6594974|NCT01130311|Cholecalciferol|cholecalciferol|mesh-list
6594975|NCT01130311|Vitamins|vitamins|mesh-ancestor
6594976|NCT01130311|Micronutrients|micronutrients|mesh-ancestor
6594977|NCT01130311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594978|NCT01130311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6594979|NCT01130311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6594980|NCT01130324|Telavancin|telavancin|mesh-list
6594981|NCT01130324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6594982|NCT01130324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6594983|NCT01130376|Aldesleukin|aldesleukin|mesh-list
6594984|NCT01130376|Interleukin-2|interleukin-2|mesh-list
6594985|NCT01130376|Hormones|hormones|mesh-list
6594986|NCT01130376|Sargramostim|sargramostim|mesh-list
6594987|NCT01130376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6594988|NCT01130376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6594989|NCT01130376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6594990|NCT01130376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6594991|NCT01130376|Analgesics|analgesics|mesh-ancestor
6594992|NCT01130376|Sensory System Agents|sensory system agents|mesh-ancestor
6594993|NCT01130376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6594994|NCT01130376|Immunologic Factors|immunologic factors|mesh-ancestor
6594995|NCT01130376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6594996|NCT01130376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6594997|NCT01130376|Antiviral Agents|antiviral agents|mesh-ancestor
6594998|NCT01130376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6594999|NCT01130467|Methylphenidate|methylphenidate|mesh-list
6595000|NCT01130467|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6595001|NCT01130467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6595002|NCT01130467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595003|NCT01130467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6595004|NCT01130467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6595005|NCT01130467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6595006|NCT01130467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595007|NCT01130467|Dopamine Agents|dopamine agents|mesh-ancestor
6595008|NCT01130467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6595009|NCT01130467|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6595010|NCT01130467|Adrenergic Agents|adrenergic agents|mesh-ancestor
6595011|NCT01130506|Cytarabine|cytarabine|mesh-list
6595012|NCT01130506|Decitabine|decitabine|mesh-list
6595013|NCT01130506|Vorinostat|vorinostat|mesh-list
6595014|NCT01130506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6595015|NCT01130506|Antimetabolites|antimetabolites|mesh-ancestor
6595016|NCT01130506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595017|NCT01130506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6595018|NCT01130506|Antiviral Agents|antiviral agents|mesh-ancestor
6595019|NCT01130506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6595020|NCT01130506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6595021|NCT01130506|Immunologic Factors|immunologic factors|mesh-ancestor
6595022|NCT01130506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595023|NCT01130506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6595024|NCT01130506|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6595025|NCT01130636|Oseltamivir|oseltamivir|mesh-list
6595026|NCT01130636|Antiviral Agents|antiviral agents|mesh-ancestor
6595027|NCT01130636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6595028|NCT01130636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6595029|NCT01130636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595030|NCT01130662|Decitabine|decitabine|mesh-list
6595031|NCT01130662|Midostaurin|midostaurin|mesh-list
6595032|NCT01130662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6595033|NCT01130662|Antimetabolites|antimetabolites|mesh-ancestor
6595034|NCT01130662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595035|NCT01130662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6595036|NCT01130662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6595037|NCT01130662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6595038|NCT01130688|Zileuton|zileuton|mesh-list
6595039|NCT01130688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6595040|NCT01130688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6595041|NCT01130688|Analgesics|analgesics|mesh-ancestor
6595042|NCT01130688|Sensory System Agents|sensory system agents|mesh-ancestor
6595043|NCT01130688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6595044|NCT01130688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595045|NCT01130688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6595046|NCT01130688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6595047|NCT01130688|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6595048|NCT01130688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6595049|NCT01130688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595050|NCT01130688|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6595051|NCT01130688|Hormone Antagonists|hormone antagonists|mesh-ancestor
6595052|NCT01130688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6595053|NCT01130701|Capecitabine|capecitabine|mesh-list
6595054|NCT01130701|Panitumumab|panitumumab|mesh-list
6595055|NCT01130701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6595056|NCT01130701|Antimetabolites|antimetabolites|mesh-ancestor
6595057|NCT01130701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595058|NCT01130701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6595059|NCT01130701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6595060|NCT01130753|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6595061|NCT01130753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6595062|NCT01130753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6595063|NCT01130753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6595064|NCT01130753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595065|NCT01130779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6595066|NCT01130779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6595067|NCT01130779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6595068|NCT01130779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6595069|NCT01130779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595070|NCT01130805|Capecitabine|capecitabine|mesh-list
6595071|NCT01130805|Oxaliplatin|oxaliplatin|mesh-list
6595072|NCT01130805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6595073|NCT01130805|Antimetabolites|antimetabolites|mesh-ancestor
6595074|NCT01130805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595075|NCT01130805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6595076|NCT01130909|Ketamine|ketamine|mesh-list
6595077|NCT01130909|Analgesics|analgesics|mesh-ancestor
6595078|NCT01130909|Sensory System Agents|sensory system agents|mesh-ancestor
6595079|NCT01130909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6595080|NCT01130909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595081|NCT01130909|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6595082|NCT01130909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6595083|NCT01130909|Anesthetics, General|anesthetics, general|mesh-ancestor
6595084|NCT01130909|Anesthetics|anesthetics|mesh-ancestor
6595085|NCT01130909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6595086|NCT01130909|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6595087|NCT01130909|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6595088|NCT01130909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6595089|NCT01130909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595090|NCT01130922|Moxifloxacin|moxifloxacin|mesh-list
6595091|NCT01130922|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6595092|NCT01130922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6595093|NCT01130922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6595094|NCT01130922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6595095|NCT01130922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6595096|NCT01130922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6595097|NCT01130922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595098|NCT01130922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6595099|NCT01130922|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6595100|NCT01130922|Contraceptive Agents|contraceptive agents|mesh-ancestor
6595101|NCT01130922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6595102|NCT01130922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595103|NCT01130922|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6595104|NCT01130922|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6595105|NCT01130922|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6595106|NCT01131000|Ibuprofen|ibuprofen|mesh-list
6595107|NCT01131000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6595108|NCT01131000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6595109|NCT01131000|Analgesics|analgesics|mesh-ancestor
6595110|NCT01131000|Sensory System Agents|sensory system agents|mesh-ancestor
6595111|NCT01131000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6595112|NCT01131000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595113|NCT01131000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6595114|NCT01131000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6595115|NCT01131000|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6595116|NCT01131000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6595117|NCT01131000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595118|NCT01131026|Amoxicillin|amoxicillin|mesh-list
6595119|NCT01131026|Levofloxacin|levofloxacin|mesh-list
6595120|NCT01131026|Ofloxacin|ofloxacin|mesh-list
6595121|NCT01131026|Lansoprazole|lansoprazole|mesh-list
6595122|NCT01131026|Dexlansoprazole|dexlansoprazole|mesh-list
6595123|NCT01131026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6595124|NCT01131026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6595125|NCT01131026|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6595126|NCT01131026|Renal Agents|renal agents|mesh-ancestor
6595127|NCT01131026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6595128|NCT01131026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6595129|NCT01131026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6595130|NCT01131026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595131|NCT01131026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6595132|NCT01131026|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6595133|NCT01131026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6595134|NCT01131026|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6595135|NCT01131026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6595136|NCT01131026|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6595137|NCT01131039|Gemcitabine|gemcitabine|mesh-list
6595138|NCT01131039|Bevacizumab|bevacizumab|mesh-list
6595139|NCT01131039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6595140|NCT01131039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6595141|NCT01131039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6595142|NCT01131039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6595143|NCT01131039|Growth Substances|growth substances|mesh-ancestor
6595144|NCT01131039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595145|NCT01131039|Growth Inhibitors|growth inhibitors|mesh-ancestor
6595146|NCT01131039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6595147|NCT01131039|Antimetabolites|antimetabolites|mesh-ancestor
6595148|NCT01131039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595149|NCT01131039|Antiviral Agents|antiviral agents|mesh-ancestor
6595150|NCT01131039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6595151|NCT01131039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6595152|NCT01131039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6595153|NCT01131039|Immunologic Factors|immunologic factors|mesh-ancestor
6659565|NCT01488656|Vitamin D|vitamin d|mesh-list
6659566|NCT01488656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
6659567|NCT01488656|Antioxidants|antioxidants|mesh-list
6659568|NCT01488656|Vitamins|vitamins|mesh-ancestor
6659569|NCT01488656|Micronutrients|micronutrients|mesh-ancestor
6659570|NCT01488656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659571|NCT01488656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6659572|NCT01488656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6659573|NCT01488656|Protective Agents|protective agents|mesh-ancestor
6659574|NCT01488734|Vitamin D|vitamin d|mesh-list
6659575|NCT01488734|Ergocalciferols|ergocalciferols|mesh-list
6659576|NCT01488734|Cholecalciferol|cholecalciferol|mesh-list
6659577|NCT01488734|Vitamins|vitamins|mesh-list
6659578|NCT01488734|Micronutrients|micronutrients|mesh-ancestor
6659579|NCT01488734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659580|NCT01488734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6659581|NCT01488734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6659582|NCT01488773|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6659583|NCT01488773|Montelukast|montelukast|mesh-list
6659584|NCT01488773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6659585|NCT01488773|Autonomic Agents|autonomic agents|mesh-ancestor
6659586|NCT01488773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6659587|NCT01488773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659588|NCT01488773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6659589|NCT01488773|Respiratory System Agents|respiratory system agents|mesh-ancestor
6659590|NCT01488773|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6659591|NCT01488773|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6659592|NCT01488773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6659593|NCT01488773|Adrenergic Agents|adrenergic agents|mesh-ancestor
6659594|NCT01488773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6659595|NCT01488773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6659596|NCT01488773|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6659597|NCT01488773|Hormone Antagonists|hormone antagonists|mesh-ancestor
6659598|NCT01488773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6659599|NCT01488773|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6659600|NCT01488773|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6659601|NCT01488838|Cisplatin|cisplatin|mesh-list
6659602|NCT01488838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6659603|NCT01488955|Fosfomycin|fosfomycin|mesh-list
6659604|NCT01488955|Ibuprofen|ibuprofen|mesh-list
6659605|NCT01488955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6659606|NCT01488955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6659607|NCT01488955|Analgesics|analgesics|mesh-ancestor
6659608|NCT01488955|Sensory System Agents|sensory system agents|mesh-ancestor
6659609|NCT01488955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6659610|NCT01488955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659611|NCT01488955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6659612|NCT01488955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6659613|NCT01488955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6659614|NCT01488955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6448321|NCT00400647|Antitubercular Agents|antitubercular agents|mesh-ancestor
6448322|NCT00400647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6448323|NCT00400647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6448324|NCT00400647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6448325|NCT00400647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448326|NCT00400725|Clobetasol|clobetasol|mesh-list
6448327|NCT00400725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6659615|NCT01488955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448328|NCT00400725|Glucocorticoids|glucocorticoids|mesh-ancestor
6448329|NCT00400725|Hormones|hormones|mesh-ancestor
6448330|NCT00400725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6448331|NCT00400725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448332|NCT00400738|Ritonavir|ritonavir|mesh-list
6448333|NCT00400738|Lopinavir|lopinavir|mesh-list
6448334|NCT00400738|Saquinavir|saquinavir|mesh-list
6448335|NCT00400738|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6448336|NCT00400738|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6448337|NCT00400738|Protease Inhibitors|protease inhibitors|mesh-ancestor
6448338|NCT00400738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6448339|NCT00400738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448340|NCT00400738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6448341|NCT00400738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6448342|NCT00400738|Antiviral Agents|antiviral agents|mesh-ancestor
6448343|NCT00400738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6448344|NCT00400738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6595154|NCT01131195|Paclitaxel|paclitaxel|mesh-list
6595155|NCT01131195|Cyclophosphamide|cyclophosphamide|mesh-list
6595156|NCT01131195|Bevacizumab|bevacizumab|mesh-list
6595157|NCT01131195|Capecitabine|capecitabine|mesh-list
6595158|NCT01131195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6595159|NCT01131195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6595160|NCT01131195|Tubulin Modulators|tubulin modulators|mesh-ancestor
6595161|NCT01131195|Antimitotic Agents|antimitotic agents|mesh-ancestor
6595162|NCT01131195|Mitosis Modulators|mitosis modulators|mesh-ancestor
6595163|NCT01131195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595164|NCT01131195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6595165|NCT01131195|Immunologic Factors|immunologic factors|mesh-ancestor
6595166|NCT01131195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595167|NCT01131195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6595168|NCT01131195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6595169|NCT01131195|Alkylating Agents|alkylating agents|mesh-ancestor
6595170|NCT01131195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6595171|NCT01131195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6595172|NCT01131195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6595173|NCT01131195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6595174|NCT01131195|Growth Substances|growth substances|mesh-ancestor
6595175|NCT01131195|Growth Inhibitors|growth inhibitors|mesh-ancestor
6595176|NCT01131195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6595177|NCT01131195|Antimetabolites|antimetabolites|mesh-ancestor
6595178|NCT01131234|Cediranib|cediranib|mesh-list
6595179|NCT01131234|R04929097|r04929097|mesh-list
6595180|NCT01131234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6595181|NCT01131234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595182|NCT01131234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6595183|NCT01131234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6595184|NCT01131247|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6595185|NCT01131247|Ofatumumab|ofatumumab|mesh-list
6595186|NCT01131247|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6595187|NCT01131247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6595188|NCT01131247|Alkylating Agents|alkylating agents|mesh-ancestor
6595189|NCT01131247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595190|NCT01131247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6595191|NCT01131247|Immunologic Factors|immunologic factors|mesh-ancestor
6595192|NCT01131247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595193|NCT01131273|Buprenorphine|buprenorphine|mesh-list
6595194|NCT01131273|Methadone|methadone|mesh-list
6595195|NCT01131273|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6595196|NCT01131273|Naloxone|naloxone|mesh-list
6595197|NCT01131273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6595198|NCT01131273|Narcotics|narcotics|mesh-ancestor
6595199|NCT01131273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6595200|NCT01131273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595201|NCT01131273|Analgesics|analgesics|mesh-ancestor
6595202|NCT01131273|Sensory System Agents|sensory system agents|mesh-ancestor
6595203|NCT01131273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6595204|NCT01131273|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6595205|NCT01131273|Antitussive Agents|antitussive agents|mesh-ancestor
6595206|NCT01131273|Respiratory System Agents|respiratory system agents|mesh-ancestor
6595207|NCT01131364|Doxorubicin|doxorubicin|mesh-list
6595208|NCT01131364|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6595209|NCT01131364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6595210|NCT01131364|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6595211|NCT01131364|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6595212|NCT01131364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6595213|NCT01131364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595214|NCT01131377|Acetazolamide|acetazolamide|mesh-list
6595215|NCT01131377|Anticonvulsants|anticonvulsants|mesh-ancestor
6595216|NCT01131377|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6595217|NCT01131377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6595218|NCT01131377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595219|NCT01131377|Diuretics|diuretics|mesh-ancestor
6595220|NCT01131377|Natriuretic Agents|natriuretic agents|mesh-ancestor
6595221|NCT01131377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595222|NCT01131429|Cisplatin|cisplatin|mesh-list
6595223|NCT01131429|Docetaxel|docetaxel|mesh-list
6595224|NCT01131429|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6595225|NCT01131429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6595226|NCT01131429|Tubulin Modulators|tubulin modulators|mesh-ancestor
6595227|NCT01131429|Antimitotic Agents|antimitotic agents|mesh-ancestor
6595228|NCT01131429|Mitosis Modulators|mitosis modulators|mesh-ancestor
6595229|NCT01131429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595230|NCT01131429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6595231|NCT01131429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6595232|NCT01131468|Acetylcysteine|acetylcysteine|mesh-list
6595233|NCT01131468|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6595234|NCT01131468|Antiviral Agents|antiviral agents|mesh-ancestor
6595235|NCT01131468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6595236|NCT01131468|Expectorants|expectorants|mesh-ancestor
6595237|NCT01131468|Respiratory System Agents|respiratory system agents|mesh-ancestor
6595238|NCT01131468|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6595239|NCT01131468|Antioxidants|antioxidants|mesh-ancestor
6595240|NCT01131468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595241|NCT01131468|Protective Agents|protective agents|mesh-ancestor
6595242|NCT01131468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595243|NCT01131468|Antidotes|antidotes|mesh-ancestor
6595244|NCT01131546|Amlodipine|amlodipine|mesh-list
6595245|NCT01131546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6595246|NCT01131546|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6595247|NCT01131546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6595248|NCT01131546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595249|NCT01131546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6595250|NCT01131546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595251|NCT01131546|Vasodilator Agents|vasodilator agents|mesh-ancestor
6595252|NCT01131559|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6595253|NCT01131559|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6595254|NCT01131559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595255|NCT01131559|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6595256|NCT01131559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6595257|NCT01131559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6595258|NCT01131559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595259|NCT01131559|Dopamine Agents|dopamine agents|mesh-ancestor
6595260|NCT01131559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6595261|NCT01131572|Acetylcysteine|acetylcysteine|mesh-list
6595262|NCT01131572|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6595263|NCT01131572|Antiviral Agents|antiviral agents|mesh-ancestor
6595264|NCT01131572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6595265|NCT01131572|Expectorants|expectorants|mesh-ancestor
6595266|NCT01131572|Respiratory System Agents|respiratory system agents|mesh-ancestor
6595267|NCT01131572|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6595268|NCT01131572|Antioxidants|antioxidants|mesh-ancestor
6595269|NCT01131572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595270|NCT01131572|Protective Agents|protective agents|mesh-ancestor
6595271|NCT01131572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595272|NCT01131572|Antidotes|antidotes|mesh-ancestor
6595273|NCT01131689|Sorafenib|sorafenib|mesh-list
6595274|NCT01131689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6595275|NCT01131689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6595276|NCT01131689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6595277|NCT01131689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595278|NCT01131702|Ranitidine|ranitidine|mesh-list
6595279|NCT01131702|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
6595280|NCT01131702|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6595281|NCT01131702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6595282|NCT01131702|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6595283|NCT01131702|Histamine Antagonists|histamine antagonists|mesh-ancestor
6595284|NCT01131702|Histamine Agents|histamine agents|mesh-ancestor
6595285|NCT01131702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6595286|NCT01131702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595287|NCT01131702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595288|NCT01131728|Naproxen|naproxen|mesh-list
6595289|NCT01131728|Pseudoephedrine|pseudoephedrine|mesh-list
6595290|NCT01131728|Ephedrine|ephedrine|mesh-list
6595291|NCT01131728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6448345|NCT00400738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6448346|NCT00400777|Amlodipine|amlodipine|mesh-list
6448347|NCT00400777|Valsartan|valsartan|mesh-list
6448348|NCT00400777|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6448349|NCT00400777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6448350|NCT00400777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6448351|NCT00400777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6448352|NCT00400777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448353|NCT00400777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6448354|NCT00400777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448355|NCT00400777|Vasodilator Agents|vasodilator agents|mesh-ancestor
6448356|NCT00400777|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6448357|NCT00400777|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6448358|NCT00400777|Diuretics|diuretics|mesh-ancestor
6448359|NCT00400777|Natriuretic Agents|natriuretic agents|mesh-ancestor
6595292|NCT01131728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6595293|NCT01131728|Analgesics|analgesics|mesh-ancestor
6595294|NCT01131728|Sensory System Agents|sensory system agents|mesh-ancestor
6595295|NCT01131728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6595296|NCT01131728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595297|NCT01131728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6595298|NCT01131728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6595299|NCT01131728|Gout Suppressants|gout suppressants|mesh-ancestor
6595300|NCT01131728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6595301|NCT01131728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6595302|NCT01131728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595303|NCT01131728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6595304|NCT01131728|Autonomic Agents|autonomic agents|mesh-ancestor
6595305|NCT01131728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6595306|NCT01131728|Respiratory System Agents|respiratory system agents|mesh-ancestor
6595307|NCT01131728|Nasal Decongestants|nasal decongestants|mesh-ancestor
6595308|NCT01131728|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6595309|NCT01131728|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6595310|NCT01131728|Sympathomimetics|sympathomimetics|mesh-ancestor
6595311|NCT01131728|Adrenergic Agents|adrenergic agents|mesh-ancestor
6595312|NCT01131728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6595313|NCT01131741|Epinephrine|epinephrine|mesh-list
6595314|NCT01131741|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6595315|NCT01131741|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6595316|NCT01131741|Adrenergic Agents|adrenergic agents|mesh-ancestor
6595317|NCT01131741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6595318|NCT01131741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595319|NCT01131741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595320|NCT01131741|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6595321|NCT01131741|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6595322|NCT01131741|Autonomic Agents|autonomic agents|mesh-ancestor
6595323|NCT01131741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6595324|NCT01131741|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6595325|NCT01131741|Respiratory System Agents|respiratory system agents|mesh-ancestor
6595326|NCT01131741|Mydriatics|mydriatics|mesh-ancestor
6595327|NCT01131741|Sympathomimetics|sympathomimetics|mesh-ancestor
6595328|NCT01131741|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6595329|NCT01131754|Heparin|heparin|mesh-list
6595330|NCT01131754|Anticoagulants|anticoagulants|mesh-ancestor
6595331|NCT01131754|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6595332|NCT01131754|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6595333|NCT01131754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595334|NCT01131767|Naproxen|naproxen|mesh-list
6595335|NCT01131767|Pseudoephedrine|pseudoephedrine|mesh-list
6595336|NCT01131767|Ephedrine|ephedrine|mesh-list
6595337|NCT01131767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6595338|NCT01131767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6595339|NCT01131767|Analgesics|analgesics|mesh-ancestor
6595340|NCT01131767|Sensory System Agents|sensory system agents|mesh-ancestor
6595341|NCT01131767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6595342|NCT01131767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595343|NCT01131767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6595344|NCT01131767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6595345|NCT01131767|Gout Suppressants|gout suppressants|mesh-ancestor
6595346|NCT01131767|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6595347|NCT01131767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6595348|NCT01131767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595349|NCT01131767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6595350|NCT01131767|Autonomic Agents|autonomic agents|mesh-ancestor
6595351|NCT01131767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6595352|NCT01131767|Respiratory System Agents|respiratory system agents|mesh-ancestor
6595353|NCT01131767|Nasal Decongestants|nasal decongestants|mesh-ancestor
6595354|NCT01131767|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6595355|NCT01131767|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6595356|NCT01131767|Sympathomimetics|sympathomimetics|mesh-ancestor
6595357|NCT01131767|Adrenergic Agents|adrenergic agents|mesh-ancestor
6595358|NCT01131767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6595359|NCT01131780|Ibuprofen|ibuprofen|mesh-list
6595360|NCT01131780|Pseudoephedrine|pseudoephedrine|mesh-list
6595361|NCT01131780|Ephedrine|ephedrine|mesh-list
6595362|NCT01131780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6595363|NCT01131780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6595364|NCT01131780|Analgesics|analgesics|mesh-ancestor
6595365|NCT01131780|Sensory System Agents|sensory system agents|mesh-ancestor
6595366|NCT01131780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6595367|NCT01131780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595368|NCT01131780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6595369|NCT01131780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6595370|NCT01131780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6595371|NCT01131780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6595372|NCT01131780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595373|NCT01131780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6595374|NCT01131780|Autonomic Agents|autonomic agents|mesh-ancestor
6595375|NCT01131780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6595376|NCT01131780|Respiratory System Agents|respiratory system agents|mesh-ancestor
6595377|NCT01131780|Nasal Decongestants|nasal decongestants|mesh-ancestor
6595378|NCT01131780|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6595379|NCT01131780|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6595380|NCT01131780|Sympathomimetics|sympathomimetics|mesh-ancestor
6595381|NCT01131780|Adrenergic Agents|adrenergic agents|mesh-ancestor
6595382|NCT01131780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6595383|NCT01131806|Fluticasone|fluticasone|mesh-list
6595384|NCT01131806|Xhance|xhance|mesh-list
6595385|NCT01131806|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6595386|NCT01131806|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6595387|NCT01131806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6595388|NCT01131806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6595389|NCT01131806|Autonomic Agents|autonomic agents|mesh-ancestor
6595390|NCT01131806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6595391|NCT01131806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595392|NCT01131806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6595393|NCT01131806|Respiratory System Agents|respiratory system agents|mesh-ancestor
6595394|NCT01131806|Dermatologic Agents|dermatologic agents|mesh-ancestor
6595395|NCT01131806|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6595396|NCT01131806|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6595397|NCT01131806|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6595398|NCT01131806|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6595399|NCT01131806|Adrenergic Agents|adrenergic agents|mesh-ancestor
6595400|NCT01131806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6595401|NCT01131806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595402|NCT01131806|Glucocorticoids|glucocorticoids|mesh-ancestor
6595403|NCT01131806|Hormones|hormones|mesh-ancestor
6595404|NCT01131806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6595405|NCT01131806|Sympathomimetics|sympathomimetics|mesh-ancestor
6595406|NCT01131845|Treprostinil|treprostinil|mesh-list
6595407|NCT01131845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6595408|NCT01131897|Levetiracetam|levetiracetam|mesh-list
6595409|NCT01131897|Anticonvulsants|anticonvulsants|mesh-ancestor
6595410|NCT01131897|Nootropic Agents|nootropic agents|mesh-ancestor
6595411|NCT01131910|Vaccines|vaccines|mesh-list
6595412|NCT01131910|Immunologic Factors|immunologic factors|mesh-ancestor
6595413|NCT01131910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595414|NCT01131923|Amlodipine|amlodipine|mesh-list
6595415|NCT01131923|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6595416|NCT01131923|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6595417|NCT01131923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6595418|NCT01131923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595419|NCT01131923|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6595420|NCT01131923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595421|NCT01131923|Vasodilator Agents|vasodilator agents|mesh-ancestor
6595422|NCT01131936|Amlodipine|amlodipine|mesh-list
6595423|NCT01131936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6595424|NCT01131936|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6595425|NCT01131936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6595426|NCT01131936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595427|NCT01131936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6595428|NCT01131936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595429|NCT01131936|Vasodilator Agents|vasodilator agents|mesh-ancestor
6595430|NCT01131949|Lamotrigine|lamotrigine|mesh-list
6595431|NCT01131949|Anticonvulsants|anticonvulsants|mesh-ancestor
6595432|NCT01131949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6595433|NCT01131949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6595434|NCT01131949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595435|NCT01131949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6595436|NCT01131949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595437|NCT01131949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6595438|NCT01131949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6595439|NCT01131949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6595440|NCT01131949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6595441|NCT01131949|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6595442|NCT01131962|Sclerosing Solutions|sclerosing solutions|mesh-list
6595443|NCT01131962|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6595444|NCT01131975|Lamotrigine|lamotrigine|mesh-list
6595445|NCT01131975|Anticonvulsants|anticonvulsants|mesh-ancestor
6595446|NCT01131975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6595447|NCT01131975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6664889|NCT01514695|GABA Modulators|gaba modulators|mesh-ancestor
6020410|NCT00392834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6020411|NCT00392834|Antidotes|antidotes|mesh-ancestor
6020412|NCT00392834|Protective Agents|protective agents|mesh-ancestor
6020413|NCT00392834|Vitamin B Complex|vitamin b complex|mesh-ancestor
6020414|NCT00392834|Vitamins|vitamins|mesh-ancestor
6020415|NCT00392834|Micronutrients|micronutrients|mesh-ancestor
6020416|NCT00392834|Tubulin Modulators|tubulin modulators|mesh-ancestor
6020417|NCT00392834|Antimitotic Agents|antimitotic agents|mesh-ancestor
6020418|NCT00392834|Mitosis Modulators|mitosis modulators|mesh-ancestor
6020419|NCT00392834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6020420|NCT00392925|Pramlintide|pramlintide|mesh-list
6020421|NCT00392925|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
6448360|NCT00400777|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6595448|NCT01131975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595449|NCT01131975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6595450|NCT01131975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595451|NCT01131975|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6595452|NCT01131975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6595453|NCT01131975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6595454|NCT01131975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6595455|NCT01131975|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6595456|NCT01131988|Tacrolimus|tacrolimus|mesh-list
6595457|NCT01131988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6595458|NCT01131988|Immunologic Factors|immunologic factors|mesh-ancestor
6595459|NCT01131988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595460|NCT01131988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6595461|NCT01131988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6595462|NCT01131988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595463|NCT01132027|Tacrolimus|tacrolimus|mesh-list
6595464|NCT01132027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6448361|NCT00400790|Propofol|propofol|mesh-list
6448362|NCT00400790|Desflurane|desflurane|mesh-list
6448363|NCT00400790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6448364|NCT00400790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6448365|NCT00400790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595465|NCT01132027|Immunologic Factors|immunologic factors|mesh-ancestor
6595466|NCT01132027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595467|NCT01132027|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6595468|NCT01132027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6595469|NCT01132027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595470|NCT01132040|Primidone|primidone|mesh-list
6595471|NCT01132040|Anticonvulsants|anticonvulsants|mesh-ancestor
6595472|NCT01132040|GABA Modulators|gaba modulators|mesh-ancestor
6595473|NCT01132040|GABA Agents|gaba agents|mesh-ancestor
6595474|NCT01132040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6595475|NCT01132040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595476|NCT01132040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595477|NCT01132157|Propofol|propofol|mesh-list
6595478|NCT01132157|Desflurane|desflurane|mesh-list
6595479|NCT01132157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6595480|NCT01132157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6595481|NCT01132157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595482|NCT01132157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6595483|NCT01132157|Anesthetics, General|anesthetics, general|mesh-ancestor
6595484|NCT01132157|Anesthetics|anesthetics|mesh-ancestor
6595485|NCT01132157|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6595486|NCT01132170|Valproic Acid|valproic acid|mesh-list
6595487|NCT01132170|Anticonvulsants|anticonvulsants|mesh-ancestor
6595488|NCT01132170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6595489|NCT01132170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595490|NCT01132170|GABA Agents|gaba agents|mesh-ancestor
6595491|NCT01132170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6595492|NCT01132170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595493|NCT01132170|Antimanic Agents|antimanic agents|mesh-ancestor
6595494|NCT01132170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6448366|NCT00400790|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6448367|NCT00400790|Anesthetics, General|anesthetics, general|mesh-ancestor
6020422|NCT00392925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6020423|NCT00392925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595495|NCT01132170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6595496|NCT01132170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6595497|NCT01132183|Valproic Acid|valproic acid|mesh-list
6595498|NCT01132183|Anticonvulsants|anticonvulsants|mesh-ancestor
6595499|NCT01132183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6595500|NCT01132183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595501|NCT01132183|GABA Agents|gaba agents|mesh-ancestor
6595502|NCT01132183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6595503|NCT01132183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595504|NCT01132183|Antimanic Agents|antimanic agents|mesh-ancestor
6595505|NCT01132183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6595506|NCT01132183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6595507|NCT01132183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6595508|NCT01132196|Valproic Acid|valproic acid|mesh-list
6595509|NCT01132196|Anticonvulsants|anticonvulsants|mesh-ancestor
6595510|NCT01132196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6595511|NCT01132196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595512|NCT01132196|GABA Agents|gaba agents|mesh-ancestor
6595513|NCT01132196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6595514|NCT01132196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595515|NCT01132196|Antimanic Agents|antimanic agents|mesh-ancestor
6595516|NCT01132196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6595517|NCT01132196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6595518|NCT01132196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6595519|NCT01132222|Ibuprofen|ibuprofen|mesh-list
6595520|NCT01132222|Pseudoephedrine|pseudoephedrine|mesh-list
6595521|NCT01132222|Ephedrine|ephedrine|mesh-list
6595522|NCT01132222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6595523|NCT01132222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6595524|NCT01132222|Analgesics|analgesics|mesh-ancestor
6595525|NCT01132222|Sensory System Agents|sensory system agents|mesh-ancestor
6595526|NCT01132222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6595527|NCT01132222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595528|NCT01132222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6595529|NCT01132222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6595530|NCT01132222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6595531|NCT01132222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6595532|NCT01132222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595533|NCT01132222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6595534|NCT01132222|Autonomic Agents|autonomic agents|mesh-ancestor
6595535|NCT01132222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6595536|NCT01132222|Respiratory System Agents|respiratory system agents|mesh-ancestor
6595537|NCT01132222|Nasal Decongestants|nasal decongestants|mesh-ancestor
6595538|NCT01132222|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6595539|NCT01132222|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6595540|NCT01132222|Sympathomimetics|sympathomimetics|mesh-ancestor
6595541|NCT01132222|Adrenergic Agents|adrenergic agents|mesh-ancestor
6595542|NCT01132222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6595543|NCT01132235|Etanercept|etanercept|mesh-list
6595544|NCT01132235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6595545|NCT01132235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6595546|NCT01132235|Analgesics|analgesics|mesh-ancestor
6595547|NCT01132235|Sensory System Agents|sensory system agents|mesh-ancestor
6595548|NCT01132235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6595549|NCT01132235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595550|NCT01132235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6595551|NCT01132235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6595552|NCT01132235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6595553|NCT01132235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6595554|NCT01132235|Immunologic Factors|immunologic factors|mesh-ancestor
6595555|NCT01132248|Mefloquine|mefloquine|mesh-list
6595556|NCT01132248|Antimalarials|antimalarials|mesh-ancestor
6595557|NCT01132248|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6595558|NCT01132248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6595559|NCT01132248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6595560|NCT01132352|Levetiracetam|levetiracetam|mesh-list
6595561|NCT01132352|Anticonvulsants|anticonvulsants|mesh-ancestor
6595562|NCT01132352|Nootropic Agents|nootropic agents|mesh-ancestor
6595563|NCT01132391|Nitroglycerin|nitroglycerin|mesh-list
6595564|NCT01132391|Vasodilator Agents|vasodilator agents|mesh-ancestor
6595565|NCT01132404|Leuprolide|leuprolide|mesh-list
6595566|NCT01132404|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6595567|NCT01132404|Fertility Agents|fertility agents|mesh-ancestor
6595568|NCT01132404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6595569|NCT01132404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595570|NCT01132404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6595571|NCT01132404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6595572|NCT01132417|Tigecycline|tigecycline|mesh-list
6595573|NCT01132417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6595574|NCT01132417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6595575|NCT01132417|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6595576|NCT01132417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6595577|NCT01132417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595578|NCT01132443|Clindamycin|clindamycin|mesh-list
6595579|NCT01132443|Clindamycin palmitate|clindamycin palmitate|mesh-list
6595580|NCT01132443|Clindamycin phosphate|clindamycin phosphate|mesh-list
6595581|NCT01132443|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6595582|NCT01132443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6595583|NCT01132443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6595584|NCT01132443|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6595585|NCT01132443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6595586|NCT01132443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595587|NCT01132443|Dermatologic Agents|dermatologic agents|mesh-ancestor
6595588|NCT01132521|Urinastatin|urinastatin|mesh-list
6595589|NCT01132521|Trypsin Inhibitors|trypsin inhibitors|mesh-list
6595590|NCT01132521|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6595591|NCT01132521|Protease Inhibitors|protease inhibitors|mesh-ancestor
6595592|NCT01132521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6595593|NCT01132521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595594|NCT01132573|Clofarabine|clofarabine|mesh-list
6595595|NCT01132573|Entinostat|entinostat|mesh-list
6595596|NCT01132573|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
6595597|NCT01132573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6595598|NCT01132573|Antimetabolites|antimetabolites|mesh-ancestor
6595599|NCT01132573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595600|NCT01132573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6595601|NCT01132573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6595602|NCT01132586|Cytarabine|cytarabine|mesh-list
6595603|NCT01132586|Lenalidomide|lenalidomide|mesh-list
6595604|NCT01132586|Idarubicin|idarubicin|mesh-list
6595605|NCT01132586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6595606|NCT01132586|Antimetabolites|antimetabolites|mesh-ancestor
6595607|NCT01132586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595608|NCT01132586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6595609|NCT01132586|Antiviral Agents|antiviral agents|mesh-ancestor
6595610|NCT01132586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6595611|NCT01132586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6595612|NCT01132586|Immunologic Factors|immunologic factors|mesh-ancestor
6595613|NCT01132586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595614|NCT01132586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6595615|NCT01132586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6595616|NCT01132586|Growth Substances|growth substances|mesh-ancestor
6595617|NCT01132586|Growth Inhibitors|growth inhibitors|mesh-ancestor
6595618|NCT01132586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6595619|NCT01132586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6595620|NCT01132586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6595621|NCT01132586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6595622|NCT01132599|Choline|choline|mesh-list
6595623|NCT01132599|Lipotropic Agents|lipotropic agents|mesh-ancestor
6595624|NCT01132599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6595625|NCT01132599|Antimetabolites|antimetabolites|mesh-ancestor
6595626|NCT01132599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595627|NCT01132599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6595628|NCT01132599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6595629|NCT01132599|Nootropic Agents|nootropic agents|mesh-ancestor
6595630|NCT01132638|Esomeprazole|esomeprazole|mesh-list
6595631|NCT01132638|Pantoprazole|pantoprazole|mesh-list
6595632|NCT01132638|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6595633|NCT01132638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6595634|NCT01132638|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6595635|NCT01132638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6595636|NCT01132638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595637|NCT01132677|Methylprednisolone|methylprednisolone|mesh-list
6595638|NCT01132677|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6595639|NCT01132677|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6595640|NCT01132677|Prednisolone|prednisolone|mesh-list
6595641|NCT01132677|Prednisolone acetate|prednisolone acetate|mesh-list
6595642|NCT01132677|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6595643|NCT01132677|Prednisolone phosphate|prednisolone phosphate|mesh-list
6595644|NCT01132677|Hylan|hylan|mesh-list
6595645|NCT01132677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6595646|NCT01132677|Antiemetics|antiemetics|mesh-ancestor
6595647|NCT01132677|Autonomic Agents|autonomic agents|mesh-ancestor
6595648|NCT01132677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6595649|NCT01132677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595650|NCT01132677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6595651|NCT01132677|Glucocorticoids|glucocorticoids|mesh-ancestor
6595652|NCT01132677|Hormones|hormones|mesh-ancestor
6595653|NCT01132677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6020424|NCT00392925|Appetite Depressants|appetite depressants|mesh-ancestor
6595654|NCT01132677|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6595655|NCT01132677|Protective Agents|protective agents|mesh-ancestor
6595656|NCT01132677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6595657|NCT01132677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6595658|NCT01132677|Viscosupplements|viscosupplements|mesh-ancestor
6595659|NCT01132703|Glyburide|glyburide|mesh-list
6595660|NCT01132703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6595661|NCT01132703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595662|NCT01132716|Valacyclovir|valacyclovir|mesh-list
6595663|NCT01132716|Antiviral Agents|antiviral agents|mesh-ancestor
6595664|NCT01132716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6595665|NCT01132729|Valacyclovir|valacyclovir|mesh-list
6595666|NCT01132729|Antiviral Agents|antiviral agents|mesh-ancestor
6595667|NCT01132729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6595668|NCT01132768|Atenolol|atenolol|mesh-list
6595669|NCT01132768|Olmesartan|olmesartan|mesh-list
6595670|NCT01132768|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6595671|NCT01132768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6595672|NCT01132768|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6595673|NCT01132768|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6595674|NCT01132768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595675|NCT01132768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6595676|NCT01132768|Sympatholytics|sympatholytics|mesh-ancestor
6595677|NCT01132768|Autonomic Agents|autonomic agents|mesh-ancestor
6595678|NCT01132768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6595679|NCT01132768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595680|NCT01132768|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6595681|NCT01132768|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6595682|NCT01132768|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6595683|NCT01132768|Adrenergic Agents|adrenergic agents|mesh-ancestor
6595684|NCT01132768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6595685|NCT01132781|Theophylline|theophylline|mesh-list
6595686|NCT01132781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6595687|NCT01132781|Autonomic Agents|autonomic agents|mesh-ancestor
6595688|NCT01132781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6595689|NCT01132781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595690|NCT01132781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5501713|NCT04471714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501714|NCT04471415|Atezolizumab|atezolizumab|mesh-list
5501715|NCT04471415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5501716|NCT04471402|Dexmedetomidine|dexmedetomidine|mesh-list
5501717|NCT04471402|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5501718|NCT04471402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5501719|NCT04471402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501720|NCT04471402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5501721|NCT04471402|Analgesics|analgesics|mesh-ancestor
6448368|NCT00400790|Anesthetics|anesthetics|mesh-ancestor
6448369|NCT00400790|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5501722|NCT04471402|Sensory System Agents|sensory system agents|mesh-ancestor
5501723|NCT04471402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6448370|NCT00400816|Temozolomide|temozolomide|mesh-list
6448371|NCT00400816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6448372|NCT00400816|Alkylating Agents|alkylating agents|mesh-ancestor
6448373|NCT00400816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448374|NCT00400816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6448375|NCT00400855|Fluticasone|fluticasone|mesh-list
6448376|NCT00400855|Xhance|xhance|mesh-list
6448377|NCT00400855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6448378|NCT00400855|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6448379|NCT00400855|Autonomic Agents|autonomic agents|mesh-ancestor
6448380|NCT00400855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6448381|NCT00400855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448382|NCT00400855|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6448383|NCT00400855|Respiratory System Agents|respiratory system agents|mesh-ancestor
6664890|NCT01514695|GABA Agents|gaba agents|mesh-ancestor
6448384|NCT00400855|Dermatologic Agents|dermatologic agents|mesh-ancestor
6448385|NCT00400855|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6595691|NCT01132781|Respiratory System Agents|respiratory system agents|mesh-ancestor
6595692|NCT01132781|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6595693|NCT01132781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6595694|NCT01132781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595695|NCT01132781|Vasodilator Agents|vasodilator agents|mesh-ancestor
6595696|NCT01132781|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6595697|NCT01132781|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6595698|NCT01132781|Purinergic Agents|purinergic agents|mesh-ancestor
6595699|NCT01132781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6595700|NCT01132794|Dexmedetomidine|dexmedetomidine|mesh-list
6595701|NCT01132794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6595702|NCT01132794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6595703|NCT01132794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595704|NCT01132794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6448386|NCT00400998|Fluticasone|fluticasone|mesh-list
6448387|NCT00400998|Xhance|xhance|mesh-list
6595705|NCT01132794|Analgesics|analgesics|mesh-ancestor
6595706|NCT01132794|Sensory System Agents|sensory system agents|mesh-ancestor
6595707|NCT01132794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6595708|NCT01132794|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6448388|NCT00400998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6448389|NCT00400998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6448390|NCT00400998|Autonomic Agents|autonomic agents|mesh-ancestor
6448391|NCT00400998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6448392|NCT00400998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448393|NCT00400998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6448394|NCT00400998|Respiratory System Agents|respiratory system agents|mesh-ancestor
6448395|NCT00400998|Dermatologic Agents|dermatologic agents|mesh-ancestor
6448396|NCT00400998|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6448397|NCT00401024|Imatinib Mesylate|imatinib mesylate|mesh-list
6448398|NCT00401024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6448399|NCT00401024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6595709|NCT01132794|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6595710|NCT01132794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6595711|NCT01132794|Adrenergic Agents|adrenergic agents|mesh-ancestor
6595712|NCT01132794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6595713|NCT01132794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595714|NCT01132911|Bortezomib|bortezomib|mesh-list
6595715|NCT01132911|Vorinostat|vorinostat|mesh-list
6595716|NCT01132911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6595717|NCT01132911|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6595718|NCT01132911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6595719|NCT01132911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6659616|NCT01488955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6659617|NCT01488955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6659618|NCT01489059|Ipilimumab|ipilimumab|mesh-list
6659619|NCT01489059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6659620|NCT01489059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6659621|NCT01489059|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6659622|NCT01489059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448400|NCT00401024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6448401|NCT00401024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448402|NCT00401115|Sirolimus|sirolimus|mesh-list
6448403|NCT00401115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6448404|NCT00401115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6448405|NCT00401115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6448406|NCT00401115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6659623|NCT01489072|Remifentanil|remifentanil|mesh-list
6659624|NCT01489072|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6659625|NCT01489072|Narcotics|narcotics|mesh-ancestor
6659626|NCT01489072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6659627|NCT01489072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659628|NCT01489072|Analgesics|analgesics|mesh-ancestor
6659629|NCT01489072|Sensory System Agents|sensory system agents|mesh-ancestor
6659630|NCT01489072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6659631|NCT01489124|Imipenem|imipenem|mesh-list
6659632|NCT01489124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6659633|NCT01489124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6659634|NCT01489137|Remifentanil|remifentanil|mesh-list
6659635|NCT01489137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6659636|NCT01489137|Narcotics|narcotics|mesh-ancestor
6659637|NCT01489137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6659638|NCT01489137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659639|NCT01489137|Analgesics|analgesics|mesh-ancestor
6659640|NCT01489137|Sensory System Agents|sensory system agents|mesh-ancestor
6659641|NCT01489137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6659642|NCT01489176|Regadenoson|regadenoson|mesh-list
6659643|NCT01489176|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
6659644|NCT01489176|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6659645|NCT01489176|Purinergic Agonists|purinergic agonists|mesh-ancestor
6659646|NCT01489176|Purinergic Agents|purinergic agents|mesh-ancestor
6659647|NCT01489176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6659648|NCT01489176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6659649|NCT01489176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659650|NCT01489202|Cobalt|cobalt|mesh-list
6659651|NCT01489202|Chromium|chromium|mesh-list
6659652|NCT01489202|Everolimus|everolimus|mesh-list
6595720|NCT01132989|Lenalidomide|lenalidomide|mesh-list
6595721|NCT01132989|Immunologic Factors|immunologic factors|mesh-ancestor
6595722|NCT01132989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595723|NCT01132989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6595724|NCT01132989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6595725|NCT01132989|Growth Substances|growth substances|mesh-ancestor
6595726|NCT01132989|Growth Inhibitors|growth inhibitors|mesh-ancestor
6595727|NCT01132989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6595728|NCT01133080|Minocycline|minocycline|mesh-list
6595729|NCT01133080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6595730|NCT01133080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6595731|NCT01133119|Bupivacaine|bupivacaine|mesh-list
6595732|NCT01133119|Anesthetics, Local|anesthetics, local|mesh-ancestor
6595733|NCT01133119|Anesthetics|anesthetics|mesh-ancestor
6595734|NCT01133119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6595735|NCT01133119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595736|NCT01133119|Sensory System Agents|sensory system agents|mesh-ancestor
6595737|NCT01133119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6595738|NCT01133210|Maraviroc|maraviroc|mesh-list
6595739|NCT01133210|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6595740|NCT01133210|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6595741|NCT01133210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595742|NCT01133210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6595743|NCT01133210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6595744|NCT01133210|Antiviral Agents|antiviral agents|mesh-ancestor
6595745|NCT01133210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6595746|NCT01133210|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6595747|NCT01133223|Plasminogen|plasminogen|mesh-list
6595748|NCT01133223|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6595749|NCT01133223|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6595750|NCT01133223|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6595751|NCT01133223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595752|NCT01133301|Naltrexone|naltrexone|mesh-list
6595753|NCT01133301|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6595754|NCT01133301|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6595755|NCT01133301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595756|NCT01133301|Sensory System Agents|sensory system agents|mesh-ancestor
6595757|NCT01133301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6595758|NCT01133353|Tetrabenazine|tetrabenazine|mesh-list
6595759|NCT01133353|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6595760|NCT01133353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6595761|NCT01133353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6595762|NCT01133353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595763|NCT01133353|Adrenergic Agents|adrenergic agents|mesh-ancestor
6595764|NCT01133353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6595765|NCT01133353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595766|NCT01133366|Warfarin|warfarin|mesh-list
6595767|NCT01133366|Mipomersen|mipomersen|mesh-list
6595768|NCT01133366|Anticoagulants|anticoagulants|mesh-ancestor
6595769|NCT01133366|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6595770|NCT01133366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6595771|NCT01133366|Antimetabolites|antimetabolites|mesh-ancestor
6595772|NCT01133366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595773|NCT01133366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6595774|NCT01133431|Glimepiride|glimepiride|mesh-list
6595775|NCT01133431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6595776|NCT01133431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6595777|NCT01133431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595778|NCT01133431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6595779|NCT01133431|Immunologic Factors|immunologic factors|mesh-ancestor
6595780|NCT01133444|Finasteride|finasteride|mesh-list
6595781|NCT01133444|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6595782|NCT01133444|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6595783|NCT01133444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6595784|NCT01133444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595785|NCT01133444|Hormone Antagonists|hormone antagonists|mesh-ancestor
6595786|NCT01133444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6595787|NCT01133444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595788|NCT01133444|Urological Agents|urological agents|mesh-ancestor
6595789|NCT01133457|Finasteride|finasteride|mesh-list
6595790|NCT01133457|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6595791|NCT01133457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6595792|NCT01133457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6595793|NCT01133457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595794|NCT01133457|Hormone Antagonists|hormone antagonists|mesh-ancestor
6595795|NCT01133457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6595796|NCT01133457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595797|NCT01133457|Urological Agents|urological agents|mesh-ancestor
6595798|NCT01133470|Fexofenadine|fexofenadine|mesh-list
6595799|NCT01133470|Pseudoephedrine|pseudoephedrine|mesh-list
6595800|NCT01133470|Ephedrine|ephedrine|mesh-list
6595801|NCT01133470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6595802|NCT01133470|Autonomic Agents|autonomic agents|mesh-ancestor
6595803|NCT01133470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6595804|NCT01133470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595805|NCT01133470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6595806|NCT01133470|Respiratory System Agents|respiratory system agents|mesh-ancestor
6595807|NCT01133470|Nasal Decongestants|nasal decongestants|mesh-ancestor
6595808|NCT01133470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6595809|NCT01133470|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6595810|NCT01133470|Sympathomimetics|sympathomimetics|mesh-ancestor
6595811|NCT01133470|Adrenergic Agents|adrenergic agents|mesh-ancestor
6595812|NCT01133470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6595813|NCT01133470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595814|NCT01133470|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6595815|NCT01133470|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6595816|NCT01133470|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6595817|NCT01133470|Histamine Antagonists|histamine antagonists|mesh-ancestor
6595818|NCT01133470|Histamine Agents|histamine agents|mesh-ancestor
6595819|NCT01133483|Fexofenadine|fexofenadine|mesh-list
6595820|NCT01133483|Pseudoephedrine|pseudoephedrine|mesh-list
6595821|NCT01133483|Ephedrine|ephedrine|mesh-list
6595822|NCT01133483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6595823|NCT01133483|Autonomic Agents|autonomic agents|mesh-ancestor
6595824|NCT01133483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6595825|NCT01133483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595826|NCT01133483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6595827|NCT01133483|Respiratory System Agents|respiratory system agents|mesh-ancestor
6595828|NCT01133483|Nasal Decongestants|nasal decongestants|mesh-ancestor
6595829|NCT01133483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6595830|NCT01133483|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6595831|NCT01133483|Sympathomimetics|sympathomimetics|mesh-ancestor
6595832|NCT01133483|Adrenergic Agents|adrenergic agents|mesh-ancestor
6595833|NCT01133483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6595834|NCT01133483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595835|NCT01133483|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6595836|NCT01133483|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6595837|NCT01133483|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6595838|NCT01133483|Histamine Antagonists|histamine antagonists|mesh-ancestor
6595839|NCT01133483|Histamine Agents|histamine agents|mesh-ancestor
6595840|NCT01133496|Alendronate|alendronate|mesh-list
6595841|NCT01133496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6595842|NCT01133496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595843|NCT01133509|Vaccines|vaccines|mesh-list
6595844|NCT01133509|Immunologic Factors|immunologic factors|mesh-ancestor
6595845|NCT01133509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595846|NCT01133548|Methyltestosterone|methyltestosterone|mesh-list
6595847|NCT01133548|Testosterone|testosterone|mesh-list
6595848|NCT01133548|Testosterone undecanoate|testosterone undecanoate|mesh-list
6595849|NCT01133548|Testosterone enanthate|testosterone enanthate|mesh-list
6595850|NCT01133548|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6595851|NCT01133548|Androgens|androgens|mesh-ancestor
6595852|NCT01133548|Hormones|hormones|mesh-ancestor
6595853|NCT01133548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6595854|NCT01133548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595855|NCT01133548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6595856|NCT01133548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6595857|NCT01133548|Anabolic Agents|anabolic agents|mesh-ancestor
6595858|NCT01133600|Vancomycin|vancomycin|mesh-list
6595859|NCT01133600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6595860|NCT01133600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6595861|NCT01133743|Thalidomide|thalidomide|mesh-list
6448407|NCT00401115|Antifungal Agents|antifungal agents|mesh-ancestor
6448408|NCT00401115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6020425|NCT00392925|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6020426|NCT00392925|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
6448409|NCT00401115|Immunologic Factors|immunologic factors|mesh-ancestor
6448410|NCT00401115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448411|NCT00401128|Gemcitabine|gemcitabine|mesh-list
6448412|NCT00401128|Irinotecan|irinotecan|mesh-list
6448413|NCT00401128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6595862|NCT01133743|Dexamethasone|dexamethasone|mesh-list
6595863|NCT01133743|Lenalidomide|lenalidomide|mesh-list
6595864|NCT01133743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6595865|NCT01133743|Antiemetics|antiemetics|mesh-ancestor
6595866|NCT01133743|Autonomic Agents|autonomic agents|mesh-ancestor
6595867|NCT01133743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6595868|NCT01133743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595869|NCT01133743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6595870|NCT01133743|Glucocorticoids|glucocorticoids|mesh-ancestor
6595871|NCT01133743|Hormones|hormones|mesh-ancestor
6595872|NCT01133743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6595873|NCT01133743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6595874|NCT01133743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6595875|NCT01133743|Immunologic Factors|immunologic factors|mesh-ancestor
6448414|NCT00401128|Antimetabolites|antimetabolites|mesh-ancestor
6448415|NCT00401128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448416|NCT00401128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6448417|NCT00401128|Antiviral Agents|antiviral agents|mesh-ancestor
6448418|NCT00401128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6595876|NCT01133743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6595877|NCT01133743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6595878|NCT01133743|Growth Substances|growth substances|mesh-ancestor
6595879|NCT01133743|Growth Inhibitors|growth inhibitors|mesh-ancestor
6595880|NCT01133743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6595881|NCT01133743|Leprostatic Agents|leprostatic agents|mesh-ancestor
6595882|NCT01133743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6595883|NCT01133743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6595884|NCT01133795|Midodrine|midodrine|mesh-list
6595885|NCT01133795|Sympathomimetics|sympathomimetics|mesh-ancestor
6595886|NCT01133795|Autonomic Agents|autonomic agents|mesh-ancestor
6595887|NCT01133795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6595888|NCT01133795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595889|NCT01133795|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6595890|NCT01133795|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6595891|NCT01133795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6595892|NCT01133795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6595893|NCT01133795|Adrenergic Agents|adrenergic agents|mesh-ancestor
6448419|NCT00401128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6595894|NCT01133795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6659653|NCT01489202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6595895|NCT01133795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595896|NCT01133873|Dextropropoxyphene|dextropropoxyphene|mesh-list
6595897|NCT01133873|Levopropoxyphene|levopropoxyphene|mesh-list
6595898|NCT01133873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6595899|NCT01133873|Narcotics|narcotics|mesh-ancestor
6595900|NCT01133873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6595901|NCT01133873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595902|NCT01133873|Analgesics|analgesics|mesh-ancestor
6595903|NCT01133873|Sensory System Agents|sensory system agents|mesh-ancestor
6595904|NCT01133873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6595905|NCT01133873|Antitussive Agents|antitussive agents|mesh-ancestor
6595906|NCT01133873|Respiratory System Agents|respiratory system agents|mesh-ancestor
6595907|NCT01133886|Decitabine|decitabine|mesh-list
6595908|NCT01133886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6595909|NCT01133886|Antimetabolites|antimetabolites|mesh-ancestor
6595910|NCT01133886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595911|NCT01133886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6595912|NCT01133886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6595913|NCT01133912|Gemcitabine|gemcitabine|mesh-list
6595914|NCT01133912|Paclitaxel|paclitaxel|mesh-list
6595915|NCT01133912|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6595916|NCT01133912|Lapatinib|lapatinib|mesh-list
6595917|NCT01133912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6595918|NCT01133912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6595919|NCT01133912|Tubulin Modulators|tubulin modulators|mesh-ancestor
6595920|NCT01133912|Antimitotic Agents|antimitotic agents|mesh-ancestor
6595921|NCT01133912|Mitosis Modulators|mitosis modulators|mesh-ancestor
6595922|NCT01133912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595923|NCT01133912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6595924|NCT01133912|Antimetabolites|antimetabolites|mesh-ancestor
6595925|NCT01133912|Antiviral Agents|antiviral agents|mesh-ancestor
6595926|NCT01133912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6595927|NCT01133912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6595928|NCT01133912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6595929|NCT01133912|Immunologic Factors|immunologic factors|mesh-ancestor
6595930|NCT01133912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595931|NCT01133912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6595932|NCT01133925|Sirolimus|sirolimus|mesh-list
6595933|NCT01133925|Paclitaxel|paclitaxel|mesh-list
6595934|NCT01133925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6595935|NCT01133925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6595936|NCT01133925|Tubulin Modulators|tubulin modulators|mesh-ancestor
6595937|NCT01133925|Antimitotic Agents|antimitotic agents|mesh-ancestor
6595938|NCT01133925|Mitosis Modulators|mitosis modulators|mesh-ancestor
6595939|NCT01133925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595940|NCT01133925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6595941|NCT01133925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6595942|NCT01133925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6595943|NCT01133925|Antifungal Agents|antifungal agents|mesh-ancestor
6595944|NCT01133925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6595945|NCT01133925|Immunologic Factors|immunologic factors|mesh-ancestor
6595946|NCT01133925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595947|NCT01134185|Prucalopride|prucalopride|mesh-list
6595948|NCT01134185|Laxatives|laxatives|mesh-ancestor
6595949|NCT01134185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6595950|NCT01134185|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
6595951|NCT01134185|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6595952|NCT01134185|Serotonin Agents|serotonin agents|mesh-ancestor
6595953|NCT01134185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6595954|NCT01134185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595955|NCT01134185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595956|NCT01134224|Insulin|insulin|mesh-list
6595957|NCT01134224|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6595958|NCT01134224|Insulin Aspart|insulin aspart|mesh-list
6595959|NCT01134224|Insulin, Long-Acting|insulin, long-acting|mesh-list
6595960|NCT01134224|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6595961|NCT01134224|Biphasic Insulins|biphasic insulins|mesh-list
6595962|NCT01134224|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6595963|NCT01134224|Insulin, Isophane|insulin, isophane|mesh-list
6595964|NCT01134224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6595965|NCT01134224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595966|NCT01134250|Paclitaxel|paclitaxel|mesh-list
6595967|NCT01134250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6595968|NCT01134250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6595969|NCT01134250|Tubulin Modulators|tubulin modulators|mesh-ancestor
6595970|NCT01134250|Antimitotic Agents|antimitotic agents|mesh-ancestor
6595971|NCT01134250|Mitosis Modulators|mitosis modulators|mesh-ancestor
6595972|NCT01134250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595973|NCT01134289|Bupivacaine|bupivacaine|mesh-list
6595974|NCT01134289|Levobupivacaine|levobupivacaine|mesh-list
6595975|NCT01134289|Anesthetics, Local|anesthetics, local|mesh-ancestor
6595976|NCT01134289|Anesthetics|anesthetics|mesh-ancestor
6595977|NCT01134289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6595978|NCT01134289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595979|NCT01134289|Sensory System Agents|sensory system agents|mesh-ancestor
6595980|NCT01134289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6595981|NCT01134341|Vitamins|vitamins|mesh-list
6595982|NCT01134341|Folic Acid|folic acid|mesh-list
6595983|NCT01134341|Vitamin B 12|vitamin b 12|mesh-list
6595984|NCT01134341|Hydroxocobalamin|hydroxocobalamin|mesh-list
6595985|NCT01134341|Vitamin B Complex|vitamin b complex|mesh-list
6595986|NCT01134341|Bexarotene|bexarotene|mesh-list
6595987|NCT01134341|10-deazaaminopterin|10-deazaaminopterin|mesh-list
6595988|NCT01134341|Aminopterin|aminopterin|mesh-list
6595989|NCT01134341|Micronutrients|micronutrients|mesh-ancestor
6595990|NCT01134341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6595991|NCT01134341|Hematinics|hematinics|mesh-ancestor
6595992|NCT01134341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6595993|NCT01134341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6595994|NCT01134341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6595995|NCT01134341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6595996|NCT01134406|Hylan|hylan|mesh-list
6595997|NCT01134406|Viscosupplements|viscosupplements|mesh-ancestor
6595998|NCT01134406|Protective Agents|protective agents|mesh-ancestor
6595999|NCT01134406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596000|NCT01134432|Prednisolone|prednisolone|mesh-list
6596001|NCT01134432|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6596002|NCT01134432|Methylprednisolone|methylprednisolone|mesh-list
6596003|NCT01134432|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6596004|NCT01134432|Prednisolone acetate|prednisolone acetate|mesh-list
6596005|NCT01134432|Rituximab|rituximab|mesh-list
6596006|NCT01134432|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6596007|NCT01134432|Prednisolone phosphate|prednisolone phosphate|mesh-list
6596008|NCT01134432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6596009|NCT01134432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6596010|NCT01134432|Immunologic Factors|immunologic factors|mesh-ancestor
6596011|NCT01134432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596012|NCT01134432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6596013|NCT01134432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6596014|NCT01134432|Glucocorticoids|glucocorticoids|mesh-ancestor
6596015|NCT01134432|Hormones|hormones|mesh-ancestor
6596016|NCT01134432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6596017|NCT01134432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6596018|NCT01134432|Antiemetics|antiemetics|mesh-ancestor
6596019|NCT01134432|Autonomic Agents|autonomic agents|mesh-ancestor
6596020|NCT01134432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6596021|NCT01134432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6596022|NCT01134432|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6596023|NCT01134432|Protective Agents|protective agents|mesh-ancestor
6596024|NCT01134484|Thalidomide|thalidomide|mesh-list
6596025|NCT01134484|Dexamethasone|dexamethasone|mesh-list
6596026|NCT01134484|Bortezomib|bortezomib|mesh-list
6596027|NCT01134484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6596028|NCT01134484|Antiemetics|antiemetics|mesh-ancestor
6596029|NCT01134484|Autonomic Agents|autonomic agents|mesh-ancestor
6596030|NCT01134484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6596031|NCT01134484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596032|NCT01134484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6596033|NCT01134484|Glucocorticoids|glucocorticoids|mesh-ancestor
6596034|NCT01134484|Hormones|hormones|mesh-ancestor
6596035|NCT01134484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6596036|NCT01134484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6596037|NCT01134484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6596038|NCT01134484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6596039|NCT01134484|Immunologic Factors|immunologic factors|mesh-ancestor
6596040|NCT01134484|Leprostatic Agents|leprostatic agents|mesh-ancestor
6596041|NCT01134484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6596042|NCT01134484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6596043|NCT01134484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6596044|NCT01134484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6596045|NCT01134484|Growth Substances|growth substances|mesh-ancestor
6596046|NCT01134484|Growth Inhibitors|growth inhibitors|mesh-ancestor
6596047|NCT01134523|Paclitaxel|paclitaxel|mesh-list
6596048|NCT01134523|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6596049|NCT01134523|Epirubicin|epirubicin|mesh-list
6596050|NCT01134523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6596051|NCT01134523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6596052|NCT01134523|Tubulin Modulators|tubulin modulators|mesh-ancestor
6596053|NCT01134523|Antimitotic Agents|antimitotic agents|mesh-ancestor
6596054|NCT01134523|Mitosis Modulators|mitosis modulators|mesh-ancestor
6596055|NCT01134523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596056|NCT01134523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6596057|NCT01134523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6596058|NCT01134523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6596059|NCT01134523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6596060|NCT01134536|Tapentadol|tapentadol|mesh-list
6596061|NCT01134536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6596062|NCT01134536|Narcotics|narcotics|mesh-ancestor
6596063|NCT01134536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6596064|NCT01134536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596065|NCT01134536|Analgesics|analgesics|mesh-ancestor
6596066|NCT01134536|Sensory System Agents|sensory system agents|mesh-ancestor
6596067|NCT01134536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6596068|NCT01134536|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6596069|NCT01134536|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6596070|NCT01134536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6596071|NCT01134536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596072|NCT01134536|Adrenergic Agents|adrenergic agents|mesh-ancestor
6596073|NCT01134536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6596074|NCT01134666|Cetuximab|cetuximab|mesh-list
6596075|NCT01134666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6596076|NCT01134666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6596077|NCT01134692|Norfloxacin|norfloxacin|mesh-list
6596078|NCT01134692|Propranolol|propranolol|mesh-list
6596079|NCT01134692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6596080|NCT01134692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6596081|NCT01134692|Adrenergic Agents|adrenergic agents|mesh-ancestor
6596082|NCT01134692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6020427|NCT00392925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596083|NCT01134692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596084|NCT01134692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596085|NCT01134692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6596086|NCT01134692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6596087|NCT01134692|Vasodilator Agents|vasodilator agents|mesh-ancestor
6596088|NCT01134692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6020428|NCT00392951|Sirolimus|sirolimus|mesh-list
6020429|NCT00392951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6020430|NCT00392951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6020431|NCT00392951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6020432|NCT00392951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6020433|NCT00392951|Antifungal Agents|antifungal agents|mesh-ancestor
6020434|NCT00392951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6020435|NCT00392951|Immunologic Factors|immunologic factors|mesh-ancestor
6020436|NCT00392951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020437|NCT00392990|Cytarabine|cytarabine|mesh-list
6596089|NCT01134692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6596090|NCT01134692|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6596091|NCT01134692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6596092|NCT01134692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6596093|NCT01134692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6596094|NCT01134692|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6596095|NCT01134692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6596096|NCT01134718|Simeprevir|simeprevir|mesh-list
6596097|NCT01134718|Antiviral Agents|antiviral agents|mesh-ancestor
6596098|NCT01134718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6596099|NCT01134718|Protease Inhibitors|protease inhibitors|mesh-ancestor
6596100|NCT01134718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6596101|NCT01134718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6659654|NCT01489202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6659655|NCT01489202|Immunologic Factors|immunologic factors|mesh-ancestor
6659656|NCT01489202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659657|NCT01489202|Trace Elements|trace elements|mesh-ancestor
6659658|NCT01489202|Micronutrients|micronutrients|mesh-ancestor
6659659|NCT01489228|Benzonidazole|benzonidazole|mesh-list
6659660|NCT01489228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6659661|NCT01489228|Immunologic Factors|immunologic factors|mesh-ancestor
6659662|NCT01489228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659663|NCT01489228|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6659664|NCT01489228|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6659665|NCT01489228|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6659666|NCT01489228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6659667|NCT01489319|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
6659668|NCT01489319|Sodium Salicylate|sodium salicylate|mesh-list
6659669|NCT01489319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6659670|NCT01489319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6659671|NCT01489319|Analgesics|analgesics|mesh-ancestor
6659672|NCT01489319|Sensory System Agents|sensory system agents|mesh-ancestor
6659673|NCT01489319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6659674|NCT01489319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659675|NCT01489319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6659676|NCT01489319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6659677|NCT01489319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6659678|NCT01489319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6659679|NCT01489319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6659680|NCT01489371|Doxorubicin|doxorubicin|mesh-list
6659681|NCT01489371|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6659682|NCT01489371|Interleukin-12|interleukin-12|mesh-list
6659683|NCT01489371|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6659684|NCT01489371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6659685|NCT01489371|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6659686|NCT01489371|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6659687|NCT01489371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6659688|NCT01489371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6659689|NCT01489371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6659690|NCT01489371|Immunologic Factors|immunologic factors|mesh-ancestor
6659691|NCT01489371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659692|NCT01489371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6659693|NCT01489371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6659694|NCT01489371|Growth Substances|growth substances|mesh-ancestor
6659695|NCT01489371|Growth Inhibitors|growth inhibitors|mesh-ancestor
6659696|NCT01489410|Ethanol|ethanol|mesh-list
6659697|NCT01489410|Doxorubicin|doxorubicin|mesh-list
6659698|NCT01489410|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6659699|NCT01489410|Ethiodized Oil|ethiodized oil|mesh-list
6659700|NCT01489410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6659701|NCT01489410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6659702|NCT01489410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6659703|NCT01489410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6659704|NCT01489410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6659705|NCT01489410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6659706|NCT01489410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6596102|NCT01134848|Morphine|morphine|mesh-list
6596103|NCT01134848|Secretin|secretin|mesh-list
6596104|NCT01134848|Neostigmine|neostigmine|mesh-list
6596105|NCT01134848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6596106|NCT01134848|Narcotics|narcotics|mesh-ancestor
6596107|NCT01134848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6596108|NCT01134848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596109|NCT01134848|Analgesics|analgesics|mesh-ancestor
6596110|NCT01134848|Sensory System Agents|sensory system agents|mesh-ancestor
6596111|NCT01134848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6596112|NCT01134848|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6596113|NCT01134848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6596114|NCT01134848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596115|NCT01134848|Cholinergic Agents|cholinergic agents|mesh-ancestor
6596116|NCT01134848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6596117|NCT01134848|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6596118|NCT01134848|Autonomic Agents|autonomic agents|mesh-ancestor
6596119|NCT01134848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6596120|NCT01134848|Hormones|hormones|mesh-ancestor
6596121|NCT01134848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6596122|NCT01134861|Cisplatin|cisplatin|mesh-list
6596123|NCT01134861|Etoposide|etoposide|mesh-list
6596124|NCT01134861|Vinblastine|vinblastine|mesh-list
6596125|NCT01134861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6596126|NCT01134861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6596127|NCT01134861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6596128|NCT01134861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6596129|NCT01134861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6596130|NCT01134861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596131|NCT01134861|Tubulin Modulators|tubulin modulators|mesh-ancestor
6596132|NCT01134861|Antimitotic Agents|antimitotic agents|mesh-ancestor
6596133|NCT01134861|Mitosis Modulators|mitosis modulators|mesh-ancestor
6596134|NCT01134926|Misoprostol|misoprostol|mesh-list
6596135|NCT01134926|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6596136|NCT01134926|Abortifacient Agents|abortifacient agents|mesh-ancestor
6596137|NCT01134926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6596138|NCT01134926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596139|NCT01134926|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6596140|NCT01134926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6596141|NCT01134926|Oxytocics|oxytocics|mesh-ancestor
6596142|NCT01134965|Digoxin|digoxin|mesh-list
6596143|NCT01134965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6596144|NCT01134965|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6596145|NCT01134965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6596146|NCT01134965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596147|NCT01134965|Protective Agents|protective agents|mesh-ancestor
6596148|NCT01134965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596149|NCT01134991|Minocycline|minocycline|mesh-list
6596150|NCT01134991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6596151|NCT01134991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6596152|NCT01135056|Sorafenib|sorafenib|mesh-list
6596153|NCT01135056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6596154|NCT01135056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6596155|NCT01135056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6596156|NCT01135056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596157|NCT01135199|Pomalidomide|pomalidomide|mesh-list
6596158|NCT01135199|Immunologic Factors|immunologic factors|mesh-ancestor
6596159|NCT01135199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596160|NCT01135199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6596161|NCT01135199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6596162|NCT01135199|Growth Substances|growth substances|mesh-ancestor
6596163|NCT01135199|Growth Inhibitors|growth inhibitors|mesh-ancestor
6596164|NCT01135199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6596165|NCT01135212|Candesartan|candesartan|mesh-list
6596166|NCT01135212|Candesartan cilexetil|candesartan cilexetil|mesh-list
6596167|NCT01135212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6596168|NCT01135212|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6596169|NCT01135212|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6596170|NCT01135212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596171|NCT01135290|Petrolatum|petrolatum|mesh-list
6596172|NCT01135290|Emollients|emollients|mesh-ancestor
6596173|NCT01135290|Dermatologic Agents|dermatologic agents|mesh-ancestor
6596174|NCT01135433|Metformin|metformin|mesh-list
6596175|NCT01135433|Ipragliflozin|ipragliflozin|mesh-list
6596176|NCT01135433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6596177|NCT01135433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596178|NCT01135433|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6596179|NCT01135433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596180|NCT01135446|Dapagliflozin|dapagliflozin|mesh-list
6596181|NCT01135446|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6596182|NCT01135446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596183|NCT01135446|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6596184|NCT01135446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596185|NCT01135472|Esomeprazole|esomeprazole|mesh-list
6596186|NCT01135472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6596187|NCT01135472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6596188|NCT01135472|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6596189|NCT01135472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6596190|NCT01135472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596191|NCT01135550|Dexamethasone|dexamethasone|mesh-list
6596192|NCT01135550|Dexamethasone acetate|dexamethasone acetate|mesh-list
6596193|NCT01135550|BB 1101|bb 1101|mesh-list
6596194|NCT01135550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6596195|NCT01135550|Antiemetics|antiemetics|mesh-ancestor
6596196|NCT01135550|Autonomic Agents|autonomic agents|mesh-ancestor
6596197|NCT01135550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6596198|NCT01135550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596199|NCT01135550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6596200|NCT01135550|Glucocorticoids|glucocorticoids|mesh-ancestor
6596201|NCT01135550|Hormones|hormones|mesh-ancestor
6596202|NCT01135550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6596203|NCT01135550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6596204|NCT01135550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6596205|NCT01135550|Protease Inhibitors|protease inhibitors|mesh-ancestor
6596206|NCT01135550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6596207|NCT01135550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596208|NCT01135563|Sirolimus|sirolimus|mesh-list
6596209|NCT01135563|Vinblastine|vinblastine|mesh-list
6596210|NCT01135563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6596211|NCT01135563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6596212|NCT01135563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6596213|NCT01135563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6596214|NCT01135563|Antifungal Agents|antifungal agents|mesh-ancestor
6596215|NCT01135563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6596216|NCT01135563|Immunologic Factors|immunologic factors|mesh-ancestor
6596217|NCT01135563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596218|NCT01135563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6596219|NCT01135563|Tubulin Modulators|tubulin modulators|mesh-ancestor
6596220|NCT01135563|Antimitotic Agents|antimitotic agents|mesh-ancestor
6596221|NCT01135563|Mitosis Modulators|mitosis modulators|mesh-ancestor
6596222|NCT01135563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596223|NCT01135589|Micafungin|micafungin|mesh-list
6448420|NCT00401128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6448421|NCT00401128|Immunologic Factors|immunologic factors|mesh-ancestor
6448422|NCT00401128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448423|NCT00401128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6448424|NCT00401128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6448425|NCT00401167|Memantine|memantine|mesh-list
6448426|NCT00401167|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6448427|NCT00401167|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6448428|NCT00401167|Dopamine Agents|dopamine agents|mesh-ancestor
6448429|NCT00401167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6020438|NCT00392990|Cyclophosphamide|cyclophosphamide|mesh-list
6596224|NCT01135589|Antifungal Agents|antifungal agents|mesh-ancestor
6596225|NCT01135589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6596226|NCT01135602|Topiramate|topiramate|mesh-list
6596227|NCT01135602|Anticonvulsants|anticonvulsants|mesh-ancestor
6596228|NCT01135602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6596229|NCT01135602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596230|NCT01135615|Calcium|calcium|mesh-list
6596231|NCT01135615|Sevelamer|sevelamer|mesh-list
6596232|NCT01135615|Calcium acetate|calcium acetate|mesh-list
6596233|NCT01135615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6596234|NCT01135615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596235|NCT01135615|Chelating Agents|chelating agents|mesh-ancestor
6596236|NCT01135615|Sequestering Agents|sequestering agents|mesh-ancestor
6596237|NCT01135615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596238|NCT01135628|Nitazoxanide|nitazoxanide|mesh-list
6596239|NCT01135628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6596240|NCT01135628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6596241|NCT01135641|Cyclosporine|cyclosporine|mesh-list
6596242|NCT01135641|Rituximab|rituximab|mesh-list
6596243|NCT01135641|Cyclosporins|cyclosporins|mesh-list
6596244|NCT01135641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6596245|NCT01135641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6596246|NCT01135641|Immunologic Factors|immunologic factors|mesh-ancestor
6596247|NCT01135641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596248|NCT01135641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6596249|NCT01135641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6596250|NCT01135641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596251|NCT01135641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6596252|NCT01135641|Antifungal Agents|antifungal agents|mesh-ancestor
6596253|NCT01135641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6596254|NCT01135641|Dermatologic Agents|dermatologic agents|mesh-ancestor
6596255|NCT01135641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6596256|NCT01135667|Clopidogrel|clopidogrel|mesh-list
6596257|NCT01135667|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6596258|NCT01135667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6596259|NCT01135667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6596260|NCT01135667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6596261|NCT01135667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6596262|NCT01135667|Purinergic Agents|purinergic agents|mesh-ancestor
6596263|NCT01135667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6596264|NCT01135667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596265|NCT01135667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596266|NCT01135680|Moxifloxacin|moxifloxacin|mesh-list
6596267|NCT01135680|Glycerol|glycerol|mesh-list
6596268|NCT01135680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6596269|NCT01135680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6596270|NCT01135680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6596271|NCT01135680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6596272|NCT01135680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6596273|NCT01135680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596274|NCT01135680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6596275|NCT01135680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596276|NCT01135680|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6596277|NCT01135680|Protective Agents|protective agents|mesh-ancestor
6596278|NCT01135758|Ketamine|ketamine|mesh-list
6596279|NCT01135758|Analgesics|analgesics|mesh-ancestor
6596280|NCT01135758|Sensory System Agents|sensory system agents|mesh-ancestor
6596281|NCT01135758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6596282|NCT01135758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596283|NCT01135758|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6596284|NCT01135758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6596285|NCT01135758|Anesthetics, General|anesthetics, general|mesh-ancestor
6596286|NCT01135758|Anesthetics|anesthetics|mesh-ancestor
6596287|NCT01135758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6596288|NCT01135758|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6596289|NCT01135758|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6596290|NCT01135758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6596291|NCT01135758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596292|NCT01135771|Insulin|insulin|mesh-list
6596293|NCT01135771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6596294|NCT01135771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596295|NCT01135927|Insulin|insulin|mesh-list
6596296|NCT01135927|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6596297|NCT01135927|Insulin Detemir|insulin detemir|mesh-list
6596298|NCT01135927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6596299|NCT01135927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596300|NCT01135953|Cycloserine|cycloserine|mesh-list
6596301|NCT01135953|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6596302|NCT01135953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6596303|NCT01135953|Renal Agents|renal agents|mesh-ancestor
6596304|NCT01135953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6596305|NCT01135953|Antitubercular Agents|antitubercular agents|mesh-ancestor
6596306|NCT01135953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6596307|NCT01135953|Antimetabolites|antimetabolites|mesh-ancestor
6596308|NCT01135953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596309|NCT01136005|Provitamins|provitamins|mesh-list
6596310|NCT01136005|Vitamins|vitamins|mesh-ancestor
6596311|NCT01136005|Micronutrients|micronutrients|mesh-ancestor
6596312|NCT01136005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596313|NCT01136031|Paclitaxel|paclitaxel|mesh-list
6596314|NCT01136031|Irinotecan|irinotecan|mesh-list
6596315|NCT01136031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6596316|NCT01136031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6596317|NCT01136031|Tubulin Modulators|tubulin modulators|mesh-ancestor
6596318|NCT01136031|Antimitotic Agents|antimitotic agents|mesh-ancestor
6596319|NCT01136031|Mitosis Modulators|mitosis modulators|mesh-ancestor
6596320|NCT01136031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596321|NCT01136031|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6596322|NCT01136031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6596323|NCT01136031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6596324|NCT01136213|Fluoxetine|fluoxetine|mesh-list
6596325|NCT01136213|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6596326|NCT01136213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6596327|NCT01136213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6596328|NCT01136213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596329|NCT01136213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6596330|NCT01136213|Serotonin Agents|serotonin agents|mesh-ancestor
6596331|NCT01136213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596332|NCT01136213|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6596333|NCT01136213|Antidepressive Agents|antidepressive agents|mesh-ancestor
6596334|NCT01136213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6596335|NCT01136213|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6596336|NCT01136213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6596337|NCT01136213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6596338|NCT01136252|Adalimumab|adalimumab|mesh-list
6596339|NCT01136252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6596340|NCT01136252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6596341|NCT01136278|Clonidine|clonidine|mesh-list
6596342|NCT01136278|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
6596343|NCT01136278|Analgesics|analgesics|mesh-ancestor
6596344|NCT01136278|Sensory System Agents|sensory system agents|mesh-ancestor
6596345|NCT01136278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6596346|NCT01136278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596347|NCT01136278|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6596348|NCT01136278|Sympatholytics|sympatholytics|mesh-ancestor
6596349|NCT01136278|Autonomic Agents|autonomic agents|mesh-ancestor
6596350|NCT01136278|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6596351|NCT01136278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6596352|NCT01136278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6596353|NCT01136278|Adrenergic Agents|adrenergic agents|mesh-ancestor
6596354|NCT01136278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6596355|NCT01136278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596356|NCT01136278|Hallucinogens|hallucinogens|mesh-ancestor
6596357|NCT01136278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6596358|NCT01136278|Serotonin Agents|serotonin agents|mesh-ancestor
6596359|NCT01136278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6596360|NCT01136278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6596361|NCT01136278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6596362|NCT01136317|Omeprazole|omeprazole|mesh-list
6596363|NCT01136317|Rabeprazole|rabeprazole|mesh-list
6596364|NCT01136317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6596365|NCT01136317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6596366|NCT01136317|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6596367|NCT01136317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6596368|NCT01136317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596369|NCT01136395|Rituximab|rituximab|mesh-list
6596370|NCT01136395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6596371|NCT01136395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6596372|NCT01136395|Immunologic Factors|immunologic factors|mesh-ancestor
6596373|NCT01136395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596374|NCT01136395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6596375|NCT01136421|Magnesium Sulfate|magnesium sulfate|mesh-list
6596376|NCT01136421|Bromides|bromides|mesh-list
6596377|NCT01136421|Ipratropium|ipratropium|mesh-list
6596378|NCT01136421|Anticonvulsants|anticonvulsants|mesh-ancestor
6596379|NCT01136421|Analgesics|analgesics|mesh-ancestor
6596380|NCT01136421|Sensory System Agents|sensory system agents|mesh-ancestor
6596381|NCT01136421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6596382|NCT01136421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596383|NCT01136421|Anesthetics|anesthetics|mesh-ancestor
6596384|NCT01136421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6596385|NCT01136421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6596386|NCT01136421|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6596387|NCT01136421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6596388|NCT01136421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596389|NCT01136421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6596390|NCT01136421|Tocolytic Agents|tocolytic agents|mesh-ancestor
6596391|NCT01136421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6596392|NCT01136421|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6596393|NCT01136421|Autonomic Agents|autonomic agents|mesh-ancestor
6596394|NCT01136421|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6596395|NCT01136421|Respiratory System Agents|respiratory system agents|mesh-ancestor
6596396|NCT01136421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6596397|NCT01136421|Cholinergic Agents|cholinergic agents|mesh-ancestor
6596398|NCT01136421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6659707|NCT01489410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6659708|NCT01489410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6596399|NCT01136499|Panobinostat|panobinostat|mesh-list
6596400|NCT01136499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6596401|NCT01136499|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6596402|NCT01136499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6596403|NCT01136499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596404|NCT01136525|Valacyclovir|valacyclovir|mesh-list
6596405|NCT01136525|Antiviral Agents|antiviral agents|mesh-ancestor
6596406|NCT01136525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6596407|NCT01136538|Valacyclovir|valacyclovir|mesh-list
6596408|NCT01136538|Antiviral Agents|antiviral agents|mesh-ancestor
6596409|NCT01136538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6596410|NCT01136551|Huperzine A|huperzine a|mesh-list
6596411|NCT01136551|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6596412|NCT01136551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6596413|NCT01136551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596414|NCT01136551|Cholinergic Agents|cholinergic agents|mesh-ancestor
6596415|NCT01136551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6596416|NCT01136551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596417|NCT01136551|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6596418|NCT01136551|Protective Agents|protective agents|mesh-ancestor
6596419|NCT01136590|Tranexamic Acid|tranexamic acid|mesh-list
6596420|NCT01136590|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6596421|NCT01136590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6596422|NCT01136590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596423|NCT01136590|Hemostatics|hemostatics|mesh-ancestor
6596424|NCT01136590|Coagulants|coagulants|mesh-ancestor
6596425|NCT01136642|Nicotine|nicotine|mesh-list
6596426|NCT01136642|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6596427|NCT01136642|Autonomic Agents|autonomic agents|mesh-ancestor
6596428|NCT01136642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6596429|NCT01136642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596430|NCT01136642|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6596431|NCT01136642|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6596432|NCT01136642|Cholinergic Agents|cholinergic agents|mesh-ancestor
6596433|NCT01136642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6596434|NCT01136642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596435|NCT01136759|Tenofovir|tenofovir|mesh-list
6596436|NCT01136759|Antiviral Agents|antiviral agents|mesh-ancestor
6596437|NCT01136759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6596438|NCT01136759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6596439|NCT01136759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6596440|NCT01136759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6596441|NCT01136759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596442|NCT01136759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6020439|NCT00392990|Ifosfamide|ifosfamide|mesh-list
6596443|NCT01136759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6596444|NCT01136850|Azithromycin|azithromycin|mesh-list
6596445|NCT01136850|Chloroquine|chloroquine|mesh-list
6596446|NCT01136850|Pyrimethamine|pyrimethamine|mesh-list
6596447|NCT01136850|Sulfadoxine|sulfadoxine|mesh-list
6596448|NCT01136850|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6596449|NCT01136850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6596450|NCT01136850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6596451|NCT01136850|Amebicides|amebicides|mesh-ancestor
6596452|NCT01136850|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6596453|NCT01136850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6596454|NCT01136850|Antimalarials|antimalarials|mesh-ancestor
6596455|NCT01136850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6596456|NCT01136850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6596457|NCT01136850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6596458|NCT01136850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596459|NCT01136850|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6596460|NCT01136850|Renal Agents|renal agents|mesh-ancestor
6596461|NCT01136863|Felodipine|felodipine|mesh-list
6596462|NCT01136863|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6596463|NCT01136863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6596464|NCT01136863|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6596465|NCT01136863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6596466|NCT01136863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596467|NCT01136863|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6596468|NCT01136863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596469|NCT01136863|Vasodilator Agents|vasodilator agents|mesh-ancestor
6596470|NCT01136941|Zileuton|zileuton|mesh-list
6596471|NCT01136941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6596472|NCT01136941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6596473|NCT01136941|Analgesics|analgesics|mesh-ancestor
6596474|NCT01136941|Sensory System Agents|sensory system agents|mesh-ancestor
6596475|NCT01136941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6596476|NCT01136941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596477|NCT01136941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6596478|NCT01136941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6596479|NCT01136941|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6596480|NCT01136941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6596481|NCT01136941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596482|NCT01136941|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6596483|NCT01136941|Hormone Antagonists|hormone antagonists|mesh-ancestor
6596484|NCT01136941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6596485|NCT01136967|Lenvatinib|lenvatinib|mesh-list
6596486|NCT01136967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6596487|NCT01136967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6596488|NCT01136967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6596489|NCT01136967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596490|NCT01137019|Everolimus|everolimus|mesh-list
6596491|NCT01137019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6596492|NCT01137019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6596493|NCT01137019|Immunologic Factors|immunologic factors|mesh-ancestor
6596494|NCT01137019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596495|NCT01137084|Methylprednisolone|methylprednisolone|mesh-list
6596496|NCT01137084|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6596497|NCT01137084|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6596498|NCT01137084|Prednisolone|prednisolone|mesh-list
6596499|NCT01137084|Prednisolone acetate|prednisolone acetate|mesh-list
6596500|NCT01137084|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6596501|NCT01137084|Prednisolone phosphate|prednisolone phosphate|mesh-list
6596502|NCT01137084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6596503|NCT01137084|Antiemetics|antiemetics|mesh-ancestor
6596504|NCT01137084|Autonomic Agents|autonomic agents|mesh-ancestor
6596505|NCT01137084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6596506|NCT01137084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596507|NCT01137084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6596508|NCT01137084|Glucocorticoids|glucocorticoids|mesh-ancestor
6596509|NCT01137084|Hormones|hormones|mesh-ancestor
6596510|NCT01137084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6596511|NCT01137084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6596512|NCT01137084|Protective Agents|protective agents|mesh-ancestor
6596513|NCT01137084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6596514|NCT01137084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6596515|NCT01137253|Trimethaphan|trimethaphan|mesh-list
6596516|NCT01137253|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
6596517|NCT01137253|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6596518|NCT01137253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6596519|NCT01137253|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
6596520|NCT01137253|Autonomic Agents|autonomic agents|mesh-ancestor
6596521|NCT01137253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6596522|NCT01137253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596523|NCT01137253|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
6596524|NCT01137253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6596525|NCT01137253|Cholinergic Agents|cholinergic agents|mesh-ancestor
6596526|NCT01137253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6596527|NCT01137253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596528|NCT01137253|Vasodilator Agents|vasodilator agents|mesh-ancestor
6596529|NCT01137383|Interferons|interferons|mesh-list
6596530|NCT01137383|Ribavirin|ribavirin|mesh-list
6596531|NCT01137383|Interferon-alpha|interferon-alpha|mesh-list
6596532|NCT01137383|Interferon alpha-2|interferon alpha-2|mesh-list
6596533|NCT01137383|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6596534|NCT01137383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6596535|NCT01137383|Antiviral Agents|antiviral agents|mesh-ancestor
6596536|NCT01137383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6596537|NCT01137383|Antimetabolites|antimetabolites|mesh-ancestor
6596538|NCT01137383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596539|NCT01137383|Immunologic Factors|immunologic factors|mesh-ancestor
6596540|NCT01137383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596541|NCT01137591|Acetaminophen|acetaminophen|mesh-list
6596542|NCT01137591|Acetylcysteine|acetylcysteine|mesh-list
6596543|NCT01137591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6596544|NCT01137591|Analgesics|analgesics|mesh-ancestor
6596545|NCT01137591|Sensory System Agents|sensory system agents|mesh-ancestor
6596546|NCT01137591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6596547|NCT01137591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596548|NCT01137591|Antipyretics|antipyretics|mesh-ancestor
6596549|NCT01137591|Antiviral Agents|antiviral agents|mesh-ancestor
6596550|NCT01137591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6596551|NCT01137591|Expectorants|expectorants|mesh-ancestor
6596552|NCT01137591|Respiratory System Agents|respiratory system agents|mesh-ancestor
6596553|NCT01137591|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6596554|NCT01137591|Antioxidants|antioxidants|mesh-ancestor
6596555|NCT01137591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596556|NCT01137591|Protective Agents|protective agents|mesh-ancestor
6596557|NCT01137656|Acetylcholine|acetylcholine|mesh-list
6596558|NCT01137656|Vasodilator Agents|vasodilator agents|mesh-ancestor
6596559|NCT01137656|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6596560|NCT01137656|Cholinergic Agents|cholinergic agents|mesh-ancestor
6596561|NCT01137656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6596562|NCT01137656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596563|NCT01137656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596564|NCT01137695|Pramlintide|pramlintide|mesh-list
6596565|NCT01137695|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
6596566|NCT01137695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6596567|NCT01137695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596568|NCT01137695|Appetite Depressants|appetite depressants|mesh-ancestor
6596569|NCT01137695|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6596570|NCT01137695|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
6596571|NCT01137695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596572|NCT01137708|Levonorgestrel|levonorgestrel|mesh-list
6596573|NCT01137708|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6596574|NCT01137708|Tofacitinib|tofacitinib|mesh-list
6596575|NCT01137708|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6596576|NCT01137708|Contraceptive Agents|contraceptive agents|mesh-ancestor
6596577|NCT01137708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6596578|NCT01137708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596579|NCT01137708|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6596580|NCT01137708|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6596581|NCT01137708|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6596582|NCT01137708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6596583|NCT01137708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6596584|NCT01137708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596585|NCT01137708|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6596586|NCT01137708|Estrogens|estrogens|mesh-ancestor
6596587|NCT01137708|Hormones|hormones|mesh-ancestor
6596588|NCT01137708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6596589|NCT01137903|Amoxicillin|amoxicillin|mesh-list
6596590|NCT01137903|Ciprofloxacin|ciprofloxacin|mesh-list
6596591|NCT01137903|Clavulanic Acid|clavulanic acid|mesh-list
6596592|NCT01137903|Clavulanic Acids|clavulanic acids|mesh-list
6596593|NCT01137903|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6596594|NCT01137903|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6596595|NCT01137903|Trimethoprim|trimethoprim|mesh-list
6596596|NCT01137903|Sulfamethoxazole|sulfamethoxazole|mesh-list
6596597|NCT01137903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6596598|NCT01137903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6596599|NCT01137903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6596600|NCT01137903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6596601|NCT01137903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6596602|NCT01137903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596603|NCT01137903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6596604|NCT01137903|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6596605|NCT01137903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6596606|NCT01137903|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6596607|NCT01137903|Renal Agents|renal agents|mesh-ancestor
6596608|NCT01137903|Antimalarials|antimalarials|mesh-ancestor
6596609|NCT01137903|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6596610|NCT01137903|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6596611|NCT01137903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6596612|NCT01137903|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6596613|NCT01137903|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6596614|NCT01137903|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6596615|NCT01137916|Imatinib Mesylate|imatinib mesylate|mesh-list
6596616|NCT01137916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6596617|NCT01137916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6596618|NCT01137916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6596619|NCT01137916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596620|NCT01137942|Metronidazole|metronidazole|mesh-list
6596621|NCT01137942|Clarithromycin|clarithromycin|mesh-list
6596622|NCT01137942|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
6596623|NCT01137942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6596624|NCT01137942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6596625|NCT01137942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6596626|NCT01137942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6596627|NCT01137942|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6596628|NCT01137942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6596629|NCT01137942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596630|NCT01137942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6596631|NCT01137942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6596632|NCT01137955|Rifaximin|rifaximin|mesh-list
6596633|NCT01137955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6596634|NCT01137955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6596635|NCT01137955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6596636|NCT01137994|Paclitaxel|paclitaxel|mesh-list
6596637|NCT01137994|Vinorelbine|vinorelbine|mesh-list
6596638|NCT01137994|Docetaxel|docetaxel|mesh-list
6596639|NCT01137994|Trastuzumab|trastuzumab|mesh-list
6596640|NCT01137994|Lapatinib|lapatinib|mesh-list
6596641|NCT01137994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6596642|NCT01137994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6596643|NCT01137994|Tubulin Modulators|tubulin modulators|mesh-ancestor
6596644|NCT01137994|Antimitotic Agents|antimitotic agents|mesh-ancestor
6596645|NCT01137994|Mitosis Modulators|mitosis modulators|mesh-ancestor
6596646|NCT01137994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596647|NCT01137994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6596648|NCT01137994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6596649|NCT01137994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6596650|NCT01138072|Atorvastatin|atorvastatin|mesh-list
6596651|NCT01138072|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6596652|NCT01138072|Simvastatin|simvastatin|mesh-list
6596653|NCT01138072|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6596654|NCT01138072|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6596655|NCT01138072|Antimetabolites|antimetabolites|mesh-ancestor
6596656|NCT01138072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596657|NCT01138072|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6596658|NCT01138072|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6596659|NCT01138072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6596660|NCT01138085|Trametinib|trametinib|mesh-list
6596661|NCT01138085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6596662|NCT01138085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6596663|NCT01138085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6596664|NCT01138085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596665|NCT01138137|Acetylcysteine|acetylcysteine|mesh-list
6596666|NCT01138137|Paclitaxel|paclitaxel|mesh-list
6596667|NCT01138137|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6596668|NCT01138137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6596669|NCT01138137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6596670|NCT01138137|Tubulin Modulators|tubulin modulators|mesh-ancestor
6596671|NCT01138137|Antimitotic Agents|antimitotic agents|mesh-ancestor
6596672|NCT01138137|Mitosis Modulators|mitosis modulators|mesh-ancestor
6596673|NCT01138137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596674|NCT01138137|Antiviral Agents|antiviral agents|mesh-ancestor
6596675|NCT01138137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6596676|NCT01138137|Expectorants|expectorants|mesh-ancestor
6596677|NCT01138137|Respiratory System Agents|respiratory system agents|mesh-ancestor
6596678|NCT01138137|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6596679|NCT01138137|Antioxidants|antioxidants|mesh-ancestor
6596680|NCT01138137|Protective Agents|protective agents|mesh-ancestor
6596681|NCT01138137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596682|NCT01138137|Antidotes|antidotes|mesh-ancestor
6596683|NCT01138215|Vaccines|vaccines|mesh-list
6596684|NCT01138215|Immunologic Factors|immunologic factors|mesh-ancestor
6596685|NCT01138215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659709|NCT01489410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596686|NCT01138384|Lapatinib|lapatinib|mesh-list
6596687|NCT01138384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6596688|NCT01138384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6596689|NCT01138384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6596690|NCT01138384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596691|NCT01138397|Vaccines|vaccines|mesh-list
6596692|NCT01138397|Immunologic Factors|immunologic factors|mesh-ancestor
6596693|NCT01138397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596694|NCT01138423|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6596695|NCT01138423|Moxonidine|moxonidine|mesh-list
6596696|NCT01138423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6596697|NCT01138423|Diuretics|diuretics|mesh-ancestor
6596698|NCT01138423|Natriuretic Agents|natriuretic agents|mesh-ancestor
6596699|NCT01138423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596700|NCT01138423|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6596701|NCT01138423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6596702|NCT01138423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596703|NCT01138449|Vitamin A|vitamin a|mesh-list
6596704|NCT01138449|Vitamins|vitamins|mesh-ancestor
6596705|NCT01138449|Micronutrients|micronutrients|mesh-ancestor
6596706|NCT01138449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596707|NCT01138488|Insulin|insulin|mesh-list
6596708|NCT01138488|Insulin Aspart|insulin aspart|mesh-list
6596709|NCT01138488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6596710|NCT01138488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596711|NCT01138553|Mifepristone|mifepristone|mesh-list
6596712|NCT01138553|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6596713|NCT01138553|Abortifacient Agents|abortifacient agents|mesh-ancestor
6596714|NCT01138553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6596715|NCT01138553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596716|NCT01138553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6596717|NCT01138553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6596718|NCT01138553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6596719|NCT01138553|Contraceptive Agents|contraceptive agents|mesh-ancestor
6596720|NCT01138553|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6596721|NCT01138553|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6596722|NCT01138553|Hormone Antagonists|hormone antagonists|mesh-ancestor
6596723|NCT01138553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6596724|NCT01138553|Luteolytic Agents|luteolytic agents|mesh-ancestor
6596725|NCT01138553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6596726|NCT01138553|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6596727|NCT01138605|Ritonavir|ritonavir|mesh-list
6596728|NCT01138605|Darunavir|darunavir|mesh-list
6596729|NCT01138605|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6596730|NCT01138605|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6596731|NCT01138605|Protease Inhibitors|protease inhibitors|mesh-ancestor
6596732|NCT01138605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6596733|NCT01138605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596734|NCT01138605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6596735|NCT01138605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6596736|NCT01138605|Antiviral Agents|antiviral agents|mesh-ancestor
6596737|NCT01138605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6596738|NCT01138605|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6596739|NCT01138605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6596740|NCT01138683|Diuretics|diuretics|mesh-list
6596741|NCT01138683|Natriuretic Agents|natriuretic agents|mesh-ancestor
6596742|NCT01138683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596743|NCT01138774|Thioctic Acid|thioctic acid|mesh-list
6596744|NCT01138774|Antioxidants|antioxidants|mesh-ancestor
6596745|NCT01138774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596746|NCT01138774|Protective Agents|protective agents|mesh-ancestor
6596747|NCT01138774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596748|NCT01138774|Vitamin B Complex|vitamin b complex|mesh-ancestor
6596749|NCT01138774|Vitamins|vitamins|mesh-ancestor
6596750|NCT01138774|Micronutrients|micronutrients|mesh-ancestor
6596751|NCT01138839|Dexamethasone|dexamethasone|mesh-list
6596752|NCT01138839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6596753|NCT01138839|Antiemetics|antiemetics|mesh-ancestor
6596754|NCT01138839|Autonomic Agents|autonomic agents|mesh-ancestor
6596755|NCT01138839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6596756|NCT01138839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596757|NCT01138839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6596758|NCT01138839|Glucocorticoids|glucocorticoids|mesh-ancestor
6596759|NCT01138839|Hormones|hormones|mesh-ancestor
6596760|NCT01138839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6659710|NCT01489488|Riociguat|riociguat|mesh-list
6596761|NCT01138839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6596762|NCT01138839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6596763|NCT01138852|Ampicillin|ampicillin|mesh-list
6596764|NCT01138852|Cefuroxime|cefuroxime|mesh-list
6596765|NCT01138852|Cefuroxime axetil|cefuroxime axetil|mesh-list
6596766|NCT01138852|Sulbactam|sulbactam|mesh-list
6596767|NCT01138852|Sultamicillin|sultamicillin|mesh-list
6596768|NCT01138852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6596769|NCT01138852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6596770|NCT01138852|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6596771|NCT01138852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6596772|NCT01138852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596773|NCT01138904|Oxaliplatin|oxaliplatin|mesh-list
6596774|NCT01138904|Irinotecan|irinotecan|mesh-list
6596775|NCT01138904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6596776|NCT01138904|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6596777|NCT01138904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6596778|NCT01138904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6596779|NCT01138904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596780|NCT01138956|Acetylcysteine|acetylcysteine|mesh-list
6596781|NCT01138956|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6596782|NCT01138956|Antiviral Agents|antiviral agents|mesh-ancestor
6596783|NCT01138956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6596784|NCT01138956|Expectorants|expectorants|mesh-ancestor
6596785|NCT01138956|Respiratory System Agents|respiratory system agents|mesh-ancestor
6596786|NCT01138956|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6596787|NCT01138956|Antioxidants|antioxidants|mesh-ancestor
6596788|NCT01138956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596789|NCT01138956|Protective Agents|protective agents|mesh-ancestor
6596790|NCT01138956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596791|NCT01138956|Antidotes|antidotes|mesh-ancestor
6596792|NCT01139138|Irinotecan|irinotecan|mesh-list
6596793|NCT01139138|Everolimus|everolimus|mesh-list
6596794|NCT01139138|Panitumumab|panitumumab|mesh-list
6596795|NCT01139138|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6596796|NCT01139138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6596797|NCT01139138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6596798|NCT01139138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596799|NCT01139138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6596800|NCT01139138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6596801|NCT01139138|Immunologic Factors|immunologic factors|mesh-ancestor
6596802|NCT01139138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596803|NCT01139138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6596804|NCT01139151|Cytarabine|cytarabine|mesh-list
6596805|NCT01139151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5501724|NCT04471402|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5501725|NCT04471402|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6596806|NCT01139151|Antimetabolites|antimetabolites|mesh-ancestor
6596807|NCT01139151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596808|NCT01139151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6596809|NCT01139151|Antiviral Agents|antiviral agents|mesh-ancestor
6596810|NCT01139151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6596811|NCT01139151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6596812|NCT01139151|Immunologic Factors|immunologic factors|mesh-ancestor
6596813|NCT01139151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596814|NCT01139203|Lamivudine|lamivudine|mesh-list
6596815|NCT01139203|Adefovir|adefovir|mesh-list
6448430|NCT00401167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448431|NCT00401167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448432|NCT00401167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6448433|NCT00401167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6448434|NCT00401180|Docetaxel|docetaxel|mesh-list
6020440|NCT00392990|Rituximab|rituximab|mesh-list
6020441|NCT00392990|Doxorubicin|doxorubicin|mesh-list
6020442|NCT00392990|Methotrexate|methotrexate|mesh-list
6020443|NCT00392990|Etoposide|etoposide|mesh-list
6020444|NCT00392990|Etoposide phosphate|etoposide phosphate|mesh-list
6020445|NCT00392990|Vincristine|vincristine|mesh-list
6020446|NCT00392990|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6020447|NCT00392990|Podophyllotoxin|podophyllotoxin|mesh-list
6020448|NCT00392990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6020449|NCT00392990|Immunologic Factors|immunologic factors|mesh-ancestor
6448435|NCT00401180|Temozolomide|temozolomide|mesh-list
6448436|NCT00401180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6448437|NCT00401180|Tubulin Modulators|tubulin modulators|mesh-ancestor
6448438|NCT00401180|Antimitotic Agents|antimitotic agents|mesh-ancestor
6448439|NCT00401180|Mitosis Modulators|mitosis modulators|mesh-ancestor
6448440|NCT00401180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448441|NCT00401180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6596816|NCT01139203|Entecavir|entecavir|mesh-list
6596817|NCT01139203|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6596818|NCT01139203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6596819|NCT01139203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6596820|NCT01139203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596821|NCT01139203|Antiviral Agents|antiviral agents|mesh-ancestor
6596822|NCT01139203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6596823|NCT01139203|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6596824|NCT01139203|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6596825|NCT01139372|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6596826|NCT01139372|Lubricant Eye Drops|lubricant eye drops|mesh-list
6596827|NCT01139372|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6596828|NCT01139437|Vaccines|vaccines|mesh-list
6596829|NCT01139437|Immunologic Factors|immunologic factors|mesh-ancestor
6596830|NCT01139437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596831|NCT01139463|Haloperidol|haloperidol|mesh-list
6596832|NCT01139463|Olanzapine|olanzapine|mesh-list
6596833|NCT01139463|Haloperidol decanoate|haloperidol decanoate|mesh-list
6596834|NCT01139463|Antiemetics|antiemetics|mesh-ancestor
6596835|NCT01139463|Autonomic Agents|autonomic agents|mesh-ancestor
6596836|NCT01139463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6448442|NCT00401180|Alkylating Agents|alkylating agents|mesh-ancestor
6448443|NCT00401206|Dexmedetomidine|dexmedetomidine|mesh-list
6596837|NCT01139463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501726|NCT04471402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6020450|NCT00392990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596838|NCT01139463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6596839|NCT01139463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6596840|NCT01139463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6596841|NCT01139463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6596842|NCT01139463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6596843|NCT01139463|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6596844|NCT01139463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6596845|NCT01139463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6596846|NCT01139463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596847|NCT01139463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6596848|NCT01139463|Serotonin Agents|serotonin agents|mesh-ancestor
6596849|NCT01139463|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6596850|NCT01139463|Dopamine Agents|dopamine agents|mesh-ancestor
6596851|NCT01139463|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6596852|NCT01139645|Esomeprazole|esomeprazole|mesh-list
6596853|NCT01139645|Rabeprazole|rabeprazole|mesh-list
6596854|NCT01139645|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6596855|NCT01139645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6596856|NCT01139645|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6596857|NCT01139645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6596858|NCT01139645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596859|NCT01139671|Remifentanil|remifentanil|mesh-list
6596860|NCT01139671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6596861|NCT01139671|Narcotics|narcotics|mesh-ancestor
6596862|NCT01139671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6596863|NCT01139671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596864|NCT01139671|Analgesics|analgesics|mesh-ancestor
6596865|NCT01139671|Sensory System Agents|sensory system agents|mesh-ancestor
6596866|NCT01139671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6596867|NCT01139723|Bevacizumab|bevacizumab|mesh-list
6596868|NCT01139723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6596869|NCT01139723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6596870|NCT01139723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6596871|NCT01139723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6596872|NCT01139723|Growth Substances|growth substances|mesh-ancestor
6596873|NCT01139723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596874|NCT01139723|Growth Inhibitors|growth inhibitors|mesh-ancestor
6596875|NCT01139749|Salicylic Acid|salicylic acid|mesh-list
6596876|NCT01139749|Ciclopirox|ciclopirox|mesh-list
6596877|NCT01139749|Salicylates|salicylates|mesh-list
6596878|NCT01139749|Isotretinoin|isotretinoin|mesh-list
6596879|NCT01139749|Dermatologic Agents|dermatologic agents|mesh-ancestor
6596880|NCT01139749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6596881|NCT01139749|Antifungal Agents|antifungal agents|mesh-ancestor
6596882|NCT01139749|Keratolytic Agents|keratolytic agents|mesh-ancestor
6596883|NCT01139749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6596884|NCT01139749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6596885|NCT01139749|Analgesics|analgesics|mesh-ancestor
6596886|NCT01139749|Sensory System Agents|sensory system agents|mesh-ancestor
6596887|NCT01139749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6596888|NCT01139749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596889|NCT01139749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6448444|NCT00401206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6448445|NCT00401206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6448446|NCT00401206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448447|NCT00401206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6596890|NCT01139749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6596891|NCT01139749|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6596892|NCT01139749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6596893|NCT01139749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596894|NCT01139840|Vitamin D|vitamin d|mesh-list
6596895|NCT01139840|Ergocalciferols|ergocalciferols|mesh-list
6596896|NCT01139840|Cholecalciferol|cholecalciferol|mesh-list
6596897|NCT01139840|Vitamins|vitamins|mesh-list
6596898|NCT01139840|Micronutrients|micronutrients|mesh-ancestor
6596899|NCT01139840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448448|NCT00401206|Analgesics|analgesics|mesh-ancestor
6596900|NCT01139840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6596901|NCT01139840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6596902|NCT01139905|Ritonavir|ritonavir|mesh-list
6596903|NCT01139905|Lopinavir|lopinavir|mesh-list
6596904|NCT01139905|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6596905|NCT01139905|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6596906|NCT01139905|Protease Inhibitors|protease inhibitors|mesh-ancestor
6596907|NCT01139905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6596908|NCT01139905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596909|NCT01139905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6596910|NCT01139905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6596911|NCT01139905|Antiviral Agents|antiviral agents|mesh-ancestor
6596912|NCT01139905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6596913|NCT01139905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6596914|NCT01139905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6596915|NCT01140009|Vaccines|vaccines|mesh-list
6596916|NCT01140009|Immunologic Factors|immunologic factors|mesh-ancestor
6596917|NCT01140009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596918|NCT01140035|Insulin|insulin|mesh-list
6596919|NCT01140035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6596920|NCT01140035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596921|NCT01140074|Zinc Sulfate|zinc sulfate|mesh-list
6596922|NCT01140074|Astringents|astringents|mesh-ancestor
6596923|NCT01140074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596924|NCT01140074|Dermatologic Agents|dermatologic agents|mesh-ancestor
6659711|NCT01489488|Enzyme Activators|enzyme activators|mesh-ancestor
6659712|NCT01489488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6659713|NCT01489566|Fluorouracil|fluorouracil|mesh-list
6659714|NCT01489566|Mitomycins|mitomycins|mesh-list
6659715|NCT01489566|Mitomycin|mitomycin|mesh-list
6659716|NCT01489566|Antimetabolites|antimetabolites|mesh-ancestor
6659717|NCT01489566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6659718|NCT01489566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6659719|NCT01489566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6659720|NCT01489566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6448449|NCT00401206|Sensory System Agents|sensory system agents|mesh-ancestor
6448450|NCT00401206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6448451|NCT00401206|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6659721|NCT01489566|Immunologic Factors|immunologic factors|mesh-ancestor
6659722|NCT01489566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596925|NCT01140100|Thiopental|thiopental|mesh-list
6596926|NCT01140100|Propofol|propofol|mesh-list
6596927|NCT01140100|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6596928|NCT01140100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6596929|NCT01140100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596930|NCT01140100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6596931|NCT01140100|Anesthetics, General|anesthetics, general|mesh-ancestor
6596932|NCT01140100|Anesthetics|anesthetics|mesh-ancestor
6596933|NCT01140100|Anticonvulsants|anticonvulsants|mesh-ancestor
6596934|NCT01140100|GABA Modulators|gaba modulators|mesh-ancestor
6596935|NCT01140100|GABA Agents|gaba agents|mesh-ancestor
6596936|NCT01140100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6596937|NCT01140100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596938|NCT01140126|UB-421|ub-421|mesh-list
6596939|NCT01140126|Antibodies|antibodies|mesh-list
6596940|NCT01140126|Immunologic Factors|immunologic factors|mesh-ancestor
6596941|NCT01140126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596942|NCT01140126|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6596943|NCT01140126|Antiviral Agents|antiviral agents|mesh-ancestor
6596944|NCT01140126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6596945|NCT01140308|Ubiquinone|ubiquinone|mesh-list
6596946|NCT01140308|Coenzyme Q10|coenzyme q10|mesh-list
6596947|NCT01140308|Micronutrients|micronutrients|mesh-ancestor
6596948|NCT01140308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596949|NCT01140308|Vitamins|vitamins|mesh-ancestor
6596950|NCT01140373|Cyclophosphamide|cyclophosphamide|mesh-list
6596951|NCT01140373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6596952|NCT01140373|Immunologic Factors|immunologic factors|mesh-ancestor
6596953|NCT01140373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596954|NCT01140373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6596955|NCT01140373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6596956|NCT01140373|Alkylating Agents|alkylating agents|mesh-ancestor
6596957|NCT01140373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596958|NCT01140373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6596959|NCT01140373|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6596960|NCT01140399|Dopamine|dopamine|mesh-list
6596961|NCT01140399|Furosemide|furosemide|mesh-list
6596962|NCT01140399|Diuretics|diuretics|mesh-ancestor
6596963|NCT01140399|Natriuretic Agents|natriuretic agents|mesh-ancestor
6596964|NCT01140399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6596965|NCT01140399|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6596966|NCT01140399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6596967|NCT01140399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596968|NCT01140399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6596969|NCT01140399|Sympathomimetics|sympathomimetics|mesh-ancestor
6596970|NCT01140399|Autonomic Agents|autonomic agents|mesh-ancestor
6596971|NCT01140399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6596972|NCT01140399|Dopamine Agents|dopamine agents|mesh-ancestor
6596973|NCT01140399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6596974|NCT01140399|Protective Agents|protective agents|mesh-ancestor
6596975|NCT01140412|Ritonavir|ritonavir|mesh-list
6596976|NCT01140412|Fosamprenavir|fosamprenavir|mesh-list
6596977|NCT01140412|Maraviroc|maraviroc|mesh-list
6596978|NCT01140412|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6596979|NCT01140412|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6596980|NCT01140412|Protease Inhibitors|protease inhibitors|mesh-ancestor
6596981|NCT01140412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6596982|NCT01140412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6596983|NCT01140412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6596984|NCT01140412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6596985|NCT01140412|Antiviral Agents|antiviral agents|mesh-ancestor
6448452|NCT00401206|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6448453|NCT00401206|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6448454|NCT00401206|Adrenergic Agents|adrenergic agents|mesh-ancestor
6448455|NCT00401206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6448456|NCT00401206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448457|NCT00401219|Estrogens|estrogens|mesh-list
6448458|NCT00401219|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6448459|NCT00401219|Progestins|progestins|mesh-list
6448460|NCT00401219|Hormones|hormones|mesh-ancestor
6596986|NCT01140412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6596987|NCT01140412|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6448461|NCT00401219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6448462|NCT00401219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448463|NCT00401323|Docetaxel|docetaxel|mesh-list
6596988|NCT01140412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6596989|NCT01140412|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6596990|NCT01140412|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6596991|NCT01140412|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6596992|NCT01140425|Moxifloxacin|moxifloxacin|mesh-list
6596993|NCT01140425|PF 232798|pf 232798|mesh-list
6596994|NCT01140425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6596995|NCT01140425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6596996|NCT01140425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6596997|NCT01140425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6596998|NCT01140425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6596999|NCT01140425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597000|NCT01140425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6597001|NCT01140425|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6597002|NCT01140425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6597003|NCT01140425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6597004|NCT01140425|Antiviral Agents|antiviral agents|mesh-ancestor
6597005|NCT01140438|Metformin|metformin|mesh-list
6597006|NCT01140438|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6597007|NCT01140438|Repaglinide|repaglinide|mesh-list
6597008|NCT01140438|Insulin, Isophane|insulin, isophane|mesh-list
6597009|NCT01140438|Isophane Insulin, Human|isophane insulin, human|mesh-list
6597010|NCT01140438|Isophane insulin, beef|isophane insulin, beef|mesh-list
6597011|NCT01140438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6597012|NCT01140438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597013|NCT01140438|Incretins|incretins|mesh-ancestor
6597014|NCT01140438|Hormones|hormones|mesh-ancestor
6597015|NCT01140438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6597016|NCT01140438|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6597017|NCT01140438|Protease Inhibitors|protease inhibitors|mesh-ancestor
6597018|NCT01140438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6597019|NCT01140438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597020|NCT01140516|Trimethoprim|trimethoprim|mesh-list
6597021|NCT01140516|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6597022|NCT01140516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6597023|NCT01140516|Renal Agents|renal agents|mesh-ancestor
6597024|NCT01140516|Antimalarials|antimalarials|mesh-ancestor
6597025|NCT01140516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6597026|NCT01140516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6597027|NCT01140516|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6597028|NCT01140516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6597029|NCT01140516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597030|NCT01140516|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6597031|NCT01140516|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6597032|NCT01140516|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6597033|NCT01140529|Dexmedetomidine|dexmedetomidine|mesh-list
6597034|NCT01140529|Haloperidol|haloperidol|mesh-list
6597035|NCT01140529|Haloperidol decanoate|haloperidol decanoate|mesh-list
6597036|NCT01140529|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6597037|NCT01140529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6597038|NCT01140529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597039|NCT01140529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6597040|NCT01140529|Analgesics|analgesics|mesh-ancestor
6597041|NCT01140529|Sensory System Agents|sensory system agents|mesh-ancestor
6597042|NCT01140529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6597043|NCT01140529|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6597044|NCT01140529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6597045|NCT01140529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6597046|NCT01140529|Adrenergic Agents|adrenergic agents|mesh-ancestor
6597047|NCT01140529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5501727|NCT04471402|Adrenergic Agents|adrenergic agents|mesh-ancestor
6448464|NCT00401323|Fluorouracil|fluorouracil|mesh-list
6448465|NCT00401323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6448466|NCT00401323|Tubulin Modulators|tubulin modulators|mesh-ancestor
6448467|NCT00401323|Antimitotic Agents|antimitotic agents|mesh-ancestor
6448468|NCT00401323|Mitosis Modulators|mitosis modulators|mesh-ancestor
6448469|NCT00401323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448470|NCT00401323|Antimetabolites|antimetabolites|mesh-ancestor
6597048|NCT01140529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597049|NCT01140529|Antiemetics|antiemetics|mesh-ancestor
6597050|NCT01140529|Autonomic Agents|autonomic agents|mesh-ancestor
6597051|NCT01140529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6597052|NCT01140529|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6597053|NCT01140529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6597054|NCT01140529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6597055|NCT01140529|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6597056|NCT01140529|Dopamine Agents|dopamine agents|mesh-ancestor
6597057|NCT01140529|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6597058|NCT01140581|Dronedarone|dronedarone|mesh-list
6597059|NCT01140581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6597060|NCT01140620|Ketamine|ketamine|mesh-list
6597061|NCT01140620|Risperidone|risperidone|mesh-list
6597062|NCT01140620|Analgesics|analgesics|mesh-ancestor
6597063|NCT01140620|Sensory System Agents|sensory system agents|mesh-ancestor
6597064|NCT01140620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6597065|NCT01140620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597066|NCT01140620|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6597067|NCT01140620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6597068|NCT01140620|Anesthetics, General|anesthetics, general|mesh-ancestor
6597069|NCT01140620|Anesthetics|anesthetics|mesh-ancestor
6597070|NCT01140620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6597071|NCT01140620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6597072|NCT01140620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6597073|NCT01140620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6597074|NCT01140620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597075|NCT01140620|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6597076|NCT01140620|Serotonin Agents|serotonin agents|mesh-ancestor
6597077|NCT01140620|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6597078|NCT01140620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6597079|NCT01140620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6597080|NCT01140620|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6597081|NCT01140620|Dopamine Agents|dopamine agents|mesh-ancestor
6597082|NCT01140737|Axitinib|axitinib|mesh-list
6597083|NCT01140737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6597084|NCT01140737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6597085|NCT01140737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6597086|NCT01140737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597087|NCT01140828|Rabeprazole|rabeprazole|mesh-list
6597088|NCT01140828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6597089|NCT01140828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6597090|NCT01140828|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6597091|NCT01140828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6597092|NCT01140828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597093|NCT01140893|Exenatide|exenatide|mesh-list
6597094|NCT01140893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6597095|NCT01140893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597096|NCT01140893|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6597097|NCT01140893|Incretins|incretins|mesh-ancestor
6597098|NCT01140893|Hormones|hormones|mesh-ancestor
6597099|NCT01140893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6597100|NCT01140932|Prednisolone|prednisolone|mesh-list
6597101|NCT01140932|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6597102|NCT01140932|Methylprednisolone|methylprednisolone|mesh-list
6597103|NCT01140932|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6597104|NCT01140932|Prednisolone acetate|prednisolone acetate|mesh-list
6597105|NCT01140932|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6597106|NCT01140932|Prednisolone phosphate|prednisolone phosphate|mesh-list
6597107|NCT01140932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6597108|NCT01140932|Glucocorticoids|glucocorticoids|mesh-ancestor
6597109|NCT01140932|Hormones|hormones|mesh-ancestor
6597110|NCT01140932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6597111|NCT01140932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597112|NCT01140932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6597113|NCT01140932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6597114|NCT01140932|Antiemetics|antiemetics|mesh-ancestor
6448471|NCT00401323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6448472|NCT00401323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6448473|NCT00401323|Immunologic Factors|immunologic factors|mesh-ancestor
6448474|NCT00401323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448475|NCT00401362|Naltrexone|naltrexone|mesh-list
6448476|NCT00401362|Methylnaltrexone|methylnaltrexone|mesh-list
6448477|NCT00401362|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6448478|NCT00401362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597115|NCT01140932|Autonomic Agents|autonomic agents|mesh-ancestor
6597116|NCT01140932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6597117|NCT01140932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6597118|NCT01140932|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6597119|NCT01140932|Protective Agents|protective agents|mesh-ancestor
6597120|NCT01140971|Misoprostol|misoprostol|mesh-list
6597121|NCT01140971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6597122|NCT01140971|Abortifacient Agents|abortifacient agents|mesh-ancestor
6597123|NCT01140971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6597124|NCT01140971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597125|NCT01140971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6597126|NCT01140971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6597127|NCT01140971|Oxytocics|oxytocics|mesh-ancestor
6597128|NCT01140984|Methylprednisolone|methylprednisolone|mesh-list
6597129|NCT01140984|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6597130|NCT01140984|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6597131|NCT01140984|Prednisolone|prednisolone|mesh-list
6597132|NCT01140984|Prednisolone acetate|prednisolone acetate|mesh-list
6597133|NCT01140984|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6597134|NCT01140984|Prednisolone phosphate|prednisolone phosphate|mesh-list
6597135|NCT01140984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6597136|NCT01140984|Antiemetics|antiemetics|mesh-ancestor
6448479|NCT00401362|Sensory System Agents|sensory system agents|mesh-ancestor
6597137|NCT01140984|Autonomic Agents|autonomic agents|mesh-ancestor
6597138|NCT01140984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6597139|NCT01140984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597140|NCT01140984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6597141|NCT01140984|Glucocorticoids|glucocorticoids|mesh-ancestor
6597142|NCT01140984|Hormones|hormones|mesh-ancestor
6597143|NCT01140984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6597144|NCT01140984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6597145|NCT01140984|Protective Agents|protective agents|mesh-ancestor
6597146|NCT01140984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6597147|NCT01140984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6597148|NCT01140997|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6597149|NCT01140997|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6597150|NCT01140997|Antiviral Agents|antiviral agents|mesh-ancestor
6597151|NCT01140997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6597152|NCT01141036|Midazolam|midazolam|mesh-list
6597153|NCT01141036|Propofol|propofol|mesh-list
6597154|NCT01141036|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6597155|NCT01141036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6597156|NCT01141036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597157|NCT01141036|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6597158|NCT01141036|Anesthetics, General|anesthetics, general|mesh-ancestor
6597159|NCT01141036|Anesthetics|anesthetics|mesh-ancestor
6597160|NCT01141036|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6597161|NCT01141036|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6597162|NCT01141036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6597163|NCT01141036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6597164|NCT01141036|GABA Modulators|gaba modulators|mesh-ancestor
6597165|NCT01141036|GABA Agents|gaba agents|mesh-ancestor
6597166|NCT01141036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6597167|NCT01141036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597168|NCT01141127|Tranexamic Acid|tranexamic acid|mesh-list
6597169|NCT01141127|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6597170|NCT01141127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6597171|NCT01141127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597172|NCT01141127|Hemostatics|hemostatics|mesh-ancestor
6597173|NCT01141127|Coagulants|coagulants|mesh-ancestor
6597174|NCT01141153|Aspirin|aspirin|mesh-list
6597175|NCT01141153|Acenocoumarol|acenocoumarol|mesh-list
6597176|NCT01141153|Clopidogrel|clopidogrel|mesh-list
6597177|NCT01141153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6597178|NCT01141153|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6597179|NCT01141153|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6597180|NCT01141153|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6597181|NCT01141153|Purinergic Agents|purinergic agents|mesh-ancestor
6597182|NCT01141153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6597183|NCT01141153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597184|NCT01141153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597185|NCT01141153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6597186|NCT01141153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6597187|NCT01141153|Analgesics|analgesics|mesh-ancestor
6597188|NCT01141153|Sensory System Agents|sensory system agents|mesh-ancestor
6597189|NCT01141153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6597190|NCT01141153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6597191|NCT01141153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6597192|NCT01141153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6597193|NCT01141153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6597194|NCT01141153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6597195|NCT01141153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6597196|NCT01141153|Antipyretics|antipyretics|mesh-ancestor
6597197|NCT01141153|Anticoagulants|anticoagulants|mesh-ancestor
6597198|NCT01141192|Vitamin D|vitamin d|mesh-list
6597199|NCT01141192|Cholecalciferol|cholecalciferol|mesh-list
6597200|NCT01141192|Vitamins|vitamins|mesh-ancestor
6597201|NCT01141192|Micronutrients|micronutrients|mesh-ancestor
6597202|NCT01141192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597203|NCT01141192|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6597204|NCT01141192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6597205|NCT01141244|Sirolimus|sirolimus|mesh-list
6597206|NCT01141244|Irinotecan|irinotecan|mesh-list
6597207|NCT01141244|Temozolomide|temozolomide|mesh-list
6597208|NCT01141244|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6597209|NCT01141244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6597210|NCT01141244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6597211|NCT01141244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597212|NCT01141244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6597213|NCT01141244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6597214|NCT01141244|Alkylating Agents|alkylating agents|mesh-ancestor
6597215|NCT01141244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6597216|NCT01141244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6597217|NCT01141244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6597218|NCT01141244|Antifungal Agents|antifungal agents|mesh-ancestor
6597219|NCT01141244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6597220|NCT01141244|Immunologic Factors|immunologic factors|mesh-ancestor
6597221|NCT01141244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597222|NCT01141296|Fenofibrate|fenofibrate|mesh-list
6597223|NCT01141296|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6597224|NCT01141296|Antimetabolites|antimetabolites|mesh-ancestor
6597225|NCT01141296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597226|NCT01141296|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6597227|NCT01141309|Everolimus|everolimus|mesh-list
6597228|NCT01141309|Sorafenib|sorafenib|mesh-list
6597229|NCT01141309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6597230|NCT01141309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6597231|NCT01141309|Immunologic Factors|immunologic factors|mesh-ancestor
6597232|NCT01141309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597233|NCT01141309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6597234|NCT01141309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6597235|NCT01141309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597236|NCT01141322|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
6597237|NCT01141322|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6597238|NCT01141322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6597239|NCT01141439|Fluticasone|fluticasone|mesh-list
6597240|NCT01141439|Xhance|xhance|mesh-list
6597241|NCT01141439|Beclomethasone|beclomethasone|mesh-list
6597242|NCT01141439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6597243|NCT01141439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6597244|NCT01141439|Autonomic Agents|autonomic agents|mesh-ancestor
6597245|NCT01141439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6597246|NCT01141439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597247|NCT01141439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6597248|NCT01141439|Respiratory System Agents|respiratory system agents|mesh-ancestor
6597249|NCT01141439|Dermatologic Agents|dermatologic agents|mesh-ancestor
6597250|NCT01141439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6597251|NCT01141439|Glucocorticoids|glucocorticoids|mesh-ancestor
6597252|NCT01141439|Hormones|hormones|mesh-ancestor
6659723|NCT01489566|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6020451|NCT00392990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6597253|NCT01141439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6597254|NCT01141452|Fluticasone|fluticasone|mesh-list
6597255|NCT01141452|Xhance|xhance|mesh-list
6597256|NCT01141452|Beclomethasone|beclomethasone|mesh-list
6597257|NCT01141452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6597258|NCT01141452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6597259|NCT01141452|Autonomic Agents|autonomic agents|mesh-ancestor
6597260|NCT01141452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6597261|NCT01141452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597262|NCT01141452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6597263|NCT01141452|Respiratory System Agents|respiratory system agents|mesh-ancestor
6597264|NCT01141452|Dermatologic Agents|dermatologic agents|mesh-ancestor
6597265|NCT01141452|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6597266|NCT01141452|Glucocorticoids|glucocorticoids|mesh-ancestor
6597267|NCT01141452|Hormones|hormones|mesh-ancestor
6597268|NCT01141452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6597269|NCT01141465|Fluticasone|fluticasone|mesh-list
6597270|NCT01141465|Xhance|xhance|mesh-list
6597271|NCT01141465|Budesonide|budesonide|mesh-list
6597272|NCT01141465|Formoterol Fumarate|formoterol fumarate|mesh-list
6597273|NCT01141465|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6597274|NCT01141465|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6597275|NCT01141465|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6597276|NCT01141465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6597277|NCT01141465|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6597278|NCT01141465|Autonomic Agents|autonomic agents|mesh-ancestor
6597279|NCT01141465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6597280|NCT01141465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597281|NCT01141465|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6597282|NCT01141465|Respiratory System Agents|respiratory system agents|mesh-ancestor
6597283|NCT01141465|Dermatologic Agents|dermatologic agents|mesh-ancestor
6597284|NCT01141465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6597285|NCT01141465|Glucocorticoids|glucocorticoids|mesh-ancestor
6597286|NCT01141465|Hormones|hormones|mesh-ancestor
6597287|NCT01141465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6597288|NCT01141465|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6597289|NCT01141465|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6597290|NCT01141465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6597291|NCT01141465|Adrenergic Agents|adrenergic agents|mesh-ancestor
6597292|NCT01141465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6597293|NCT01141465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597294|NCT01141465|Sympathomimetics|sympathomimetics|mesh-ancestor
6597295|NCT01141543|Plerixafor|plerixafor|mesh-list
6597296|NCT01141543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6597297|NCT01141543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6597298|NCT01141543|Antiviral Agents|antiviral agents|mesh-ancestor
6597299|NCT01141543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6597300|NCT01141556|Selenium|selenium|mesh-list
6597301|NCT01141556|Antioxidants|antioxidants|mesh-ancestor
6597302|NCT01141556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597303|NCT01141556|Protective Agents|protective agents|mesh-ancestor
6597304|NCT01141556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597305|NCT01141556|Trace Elements|trace elements|mesh-ancestor
6597306|NCT01141556|Micronutrients|micronutrients|mesh-ancestor
6659724|NCT01489566|Alkylating Agents|alkylating agents|mesh-ancestor
6659725|NCT01489566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6659726|NCT01489566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6659727|NCT01489592|Turmeric extract|turmeric extract|mesh-list
6659728|NCT01489592|Antioxidants|antioxidants|mesh-ancestor
6659729|NCT01489592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6659730|NCT01489592|Protective Agents|protective agents|mesh-ancestor
6659731|NCT01489592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659732|NCT01489631|Sufentanil|sufentanil|mesh-list
6659733|NCT01489631|Gabapentin|gabapentin|mesh-list
6659734|NCT01489631|Bupivacaine|bupivacaine|mesh-list
6659735|NCT01489631|Ropivacaine|ropivacaine|mesh-list
6659736|NCT01489631|Anesthetics, Local|anesthetics, local|mesh-ancestor
6659737|NCT01489631|Anesthetics|anesthetics|mesh-ancestor
6659738|NCT01489631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6659739|NCT01489631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659740|NCT01489631|Sensory System Agents|sensory system agents|mesh-ancestor
6659741|NCT01489631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6659742|NCT01489631|Analgesics|analgesics|mesh-ancestor
6659743|NCT01489631|Anticonvulsants|anticonvulsants|mesh-ancestor
6659744|NCT01489631|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6659745|NCT01489631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6659746|NCT01489631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6659747|NCT01489631|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6659748|NCT01489631|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6659749|NCT01489631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6659750|NCT01489631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6659751|NCT01489631|Antimanic Agents|antimanic agents|mesh-ancestor
6659752|NCT01489631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6659753|NCT01489631|Narcotics|narcotics|mesh-ancestor
6659754|NCT01489631|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6659755|NCT01489631|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6659756|NCT01489631|Anesthetics, General|anesthetics, general|mesh-ancestor
6659757|NCT01489644|Metformin|metformin|mesh-list
6659758|NCT01489644|Repaglinide|repaglinide|mesh-list
6659759|NCT01489644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6659760|NCT01489644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659761|NCT01489683|Lidocaine|lidocaine|mesh-list
6659762|NCT01489683|Anesthetics, Local|anesthetics, local|mesh-ancestor
6659763|NCT01489683|Anesthetics|anesthetics|mesh-ancestor
6659764|NCT01489683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6659765|NCT01489683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659766|NCT01489683|Sensory System Agents|sensory system agents|mesh-ancestor
6659767|NCT01489683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6659768|NCT01489683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6659769|NCT01489683|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6659770|NCT01489683|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6659771|NCT01489683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6659772|NCT01489683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6659773|NCT01489696|Tamsulosin|tamsulosin|mesh-list
6659774|NCT01489696|Mirabegron|mirabegron|mesh-list
6659775|NCT01489696|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6659776|NCT01489696|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6659777|NCT01489696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6659778|NCT01489696|Adrenergic Agents|adrenergic agents|mesh-ancestor
6659779|NCT01489696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6659780|NCT01489696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6659781|NCT01489696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659782|NCT01489696|Urological Agents|urological agents|mesh-ancestor
6659783|NCT01489696|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6659784|NCT01489696|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6659785|NCT01489696|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6659786|NCT01489709|Solifenacin Succinate|solifenacin succinate|mesh-list
6659787|NCT01489709|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6659788|NCT01489709|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6659789|NCT01489709|Cholinergic Agents|cholinergic agents|mesh-ancestor
6659790|NCT01489709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6659791|NCT01489709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6659792|NCT01489709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659793|NCT01489709|Urological Agents|urological agents|mesh-ancestor
6659794|NCT01489852|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6597307|NCT01141855|Varenicline|varenicline|mesh-list
6597308|NCT01141855|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6597309|NCT01141855|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6597310|NCT01141855|Cholinergic Agents|cholinergic agents|mesh-ancestor
6597311|NCT01141855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6597312|NCT01141855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597313|NCT01141855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597314|NCT01141881|Bevacizumab|bevacizumab|mesh-list
6597315|NCT01141881|Plasminogen|plasminogen|mesh-list
6597316|NCT01141881|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6597317|NCT01141881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6597318|NCT01141881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6597319|NCT01141881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6597320|NCT01141881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6597321|NCT01141881|Growth Substances|growth substances|mesh-ancestor
6597322|NCT01141881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597323|NCT01141881|Growth Inhibitors|growth inhibitors|mesh-ancestor
6597324|NCT01141881|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6597325|NCT01141881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6597326|NCT01141881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597327|NCT01141894|Phenylephrine|phenylephrine|mesh-list
6597328|NCT01141894|Dobutamine|dobutamine|mesh-list
6597329|NCT01141894|Oxymetazoline|oxymetazoline|mesh-list
6597330|NCT01141894|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
6597331|NCT01141894|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6597332|NCT01141894|Mydriatics|mydriatics|mesh-ancestor
6597333|NCT01141894|Autonomic Agents|autonomic agents|mesh-ancestor
6597334|NCT01141894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6597335|NCT01141894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597336|NCT01141894|Sympathomimetics|sympathomimetics|mesh-ancestor
6597337|NCT01141894|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6597338|NCT01141894|Nasal Decongestants|nasal decongestants|mesh-ancestor
6597339|NCT01141894|Respiratory System Agents|respiratory system agents|mesh-ancestor
6597340|NCT01141894|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6597341|NCT01141894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6597342|NCT01141894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6597343|NCT01141894|Adrenergic Agents|adrenergic agents|mesh-ancestor
6597344|NCT01141894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6597345|NCT01141894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597346|NCT01141894|Protective Agents|protective agents|mesh-ancestor
6597347|NCT01141894|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6597348|NCT01141894|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6597349|NCT01141894|Plasma Substitutes|plasma substitutes|mesh-ancestor
6597350|NCT01141894|Blood Substitutes|blood substitutes|mesh-ancestor
6597351|NCT01141972|Vitamin D|vitamin d|mesh-list
6597352|NCT01141972|Vitamins|vitamins|mesh-ancestor
6597353|NCT01141972|Micronutrients|micronutrients|mesh-ancestor
6597354|NCT01141972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597355|NCT01141972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6597356|NCT01141998|Cholecalciferol|cholecalciferol|mesh-list
6597357|NCT01141998|Calcium, Dietary|calcium, dietary|mesh-list
6597358|NCT01141998|Calcium|calcium|mesh-list
6597359|NCT01141998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6597360|NCT01141998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597361|NCT01141998|Vitamins|vitamins|mesh-ancestor
6597362|NCT01141998|Micronutrients|micronutrients|mesh-ancestor
6597363|NCT01141998|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6597364|NCT01142011|Belimumab|belimumab|mesh-list
6597365|NCT01142011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6597366|NCT01142011|Immunologic Factors|immunologic factors|mesh-ancestor
6597367|NCT01142011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597368|NCT01142245|Esomeprazole|esomeprazole|mesh-list
6597369|NCT01142245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6597370|NCT01142245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6597371|NCT01142245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6597372|NCT01142245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6597373|NCT01142245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597374|NCT01142258|Trazodone|trazodone|mesh-list
6597375|NCT01142258|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6597376|NCT01142258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6597377|NCT01142258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6597378|NCT01142258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597379|NCT01142258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6597380|NCT01142258|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6597381|NCT01142258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6597382|NCT01142258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6597383|NCT01142258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597384|NCT01142258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6597385|NCT01142258|Serotonin Agents|serotonin agents|mesh-ancestor
6597386|NCT01142258|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6597387|NCT01142258|Antidepressive Agents|antidepressive agents|mesh-ancestor
6597388|NCT01142284|Cilostazol|cilostazol|mesh-list
6597389|NCT01142284|Probucol|probucol|mesh-list
6597390|NCT01142284|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6597391|NCT01142284|Autonomic Agents|autonomic agents|mesh-ancestor
6597392|NCT01142284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6597393|NCT01142284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597394|NCT01142284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6597395|NCT01142284|Respiratory System Agents|respiratory system agents|mesh-ancestor
6597396|NCT01142284|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6597397|NCT01142284|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6597398|NCT01142284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597399|NCT01142284|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6597400|NCT01142284|Vasodilator Agents|vasodilator agents|mesh-ancestor
6597401|NCT01142284|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6597402|NCT01142284|Protective Agents|protective agents|mesh-ancestor
6597403|NCT01142284|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6597404|NCT01142284|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6597405|NCT01142284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6597406|NCT01142284|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6597407|NCT01142284|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6597408|NCT01142284|Antimetabolites|antimetabolites|mesh-ancestor
6597409|NCT01142284|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6597410|NCT01142284|Antioxidants|antioxidants|mesh-ancestor
6597411|NCT01142401|Bortezomib|bortezomib|mesh-list
6597412|NCT01142401|Fulvestrant|fulvestrant|mesh-list
6597413|NCT01142401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6597414|NCT01142401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6597415|NCT01142401|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6597416|NCT01142401|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6597417|NCT01142401|Hormone Antagonists|hormone antagonists|mesh-ancestor
6597418|NCT01142401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6597419|NCT01142401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597420|NCT01142414|Fluorouracil|fluorouracil|mesh-list
6597421|NCT01142414|Panitumumab|panitumumab|mesh-list
6597422|NCT01142414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6597423|NCT01142414|Antimetabolites|antimetabolites|mesh-ancestor
6597424|NCT01142414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597425|NCT01142414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6597426|NCT01142414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6597427|NCT01142414|Immunologic Factors|immunologic factors|mesh-ancestor
6597428|NCT01142414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597429|NCT01142414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6597430|NCT01142453|Interferons|interferons|mesh-list
6597431|NCT01142453|Interferon-beta|interferon-beta|mesh-list
6597432|NCT01142453|Interferon beta-1a|interferon beta-1a|mesh-list
6597433|NCT01142453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6597434|NCT01142453|Antiviral Agents|antiviral agents|mesh-ancestor
6597435|NCT01142453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6597436|NCT01142453|Immunologic Factors|immunologic factors|mesh-ancestor
6597437|NCT01142453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597438|NCT01142453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6597439|NCT01142492|Interferons|interferons|mesh-list
6597440|NCT01142492|Interferon-beta|interferon-beta|mesh-list
6597441|NCT01142492|Interferon beta-1a|interferon beta-1a|mesh-list
6597442|NCT01142492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6597443|NCT01142492|Antiviral Agents|antiviral agents|mesh-ancestor
6597444|NCT01142492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6597445|NCT01142492|Immunologic Factors|immunologic factors|mesh-ancestor
6597446|NCT01142492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597447|NCT01142492|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6597448|NCT01142505|Mannitol|mannitol|mesh-list
6597449|NCT01142505|Montelukast|montelukast|mesh-list
6597450|NCT01142505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6597451|NCT01142505|Respiratory System Agents|respiratory system agents|mesh-ancestor
6597452|NCT01142505|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6597453|NCT01142505|Hormone Antagonists|hormone antagonists|mesh-ancestor
6597454|NCT01142505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6597455|NCT01142505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597456|NCT01142505|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6597457|NCT01142505|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6597458|NCT01142505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597459|NCT01142505|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6597460|NCT01142505|Diuretics|diuretics|mesh-ancestor
6597461|NCT01142505|Natriuretic Agents|natriuretic agents|mesh-ancestor
6597462|NCT01142518|Interferons|interferons|mesh-list
6597463|NCT01142518|Interferon-beta|interferon-beta|mesh-list
6597464|NCT01142518|Interferon beta-1a|interferon beta-1a|mesh-list
6597465|NCT01142518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6597466|NCT01142518|Antiviral Agents|antiviral agents|mesh-ancestor
6597467|NCT01142518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6597468|NCT01142518|Immunologic Factors|immunologic factors|mesh-ancestor
6597469|NCT01142518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597470|NCT01142518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6597471|NCT01142557|Interferons|interferons|mesh-list
6597472|NCT01142557|Interferon-beta|interferon-beta|mesh-list
6597473|NCT01142557|Interferon beta-1a|interferon beta-1a|mesh-list
6597474|NCT01142557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6597475|NCT01142557|Antiviral Agents|antiviral agents|mesh-ancestor
6597476|NCT01142557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6597477|NCT01142557|Immunologic Factors|immunologic factors|mesh-ancestor
6597478|NCT01142557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597479|NCT01142557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6597480|NCT01142622|Ropivacaine|ropivacaine|mesh-list
6597481|NCT01142622|Anesthetics, Local|anesthetics, local|mesh-ancestor
6597482|NCT01142622|Anesthetics|anesthetics|mesh-ancestor
6597483|NCT01142622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6597484|NCT01142622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597485|NCT01142622|Sensory System Agents|sensory system agents|mesh-ancestor
6597486|NCT01142622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6597487|NCT01142635|Bromides|bromides|mesh-list
6597488|NCT01142635|Rocuronium|rocuronium|mesh-list
6597489|NCT01142635|Anticonvulsants|anticonvulsants|mesh-ancestor
6597490|NCT01142635|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6597491|NCT01142635|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6597492|NCT01142635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6597493|NCT01142635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6597494|NCT01142635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597495|NCT01142648|Glycopyrrolate|glycopyrrolate|mesh-list
6597496|NCT01142648|Neostigmine|neostigmine|mesh-list
6597497|NCT01142648|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6597498|NCT01142648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6597499|NCT01142648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597500|NCT01142648|Cholinergic Agents|cholinergic agents|mesh-ancestor
6597501|NCT01142648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6597502|NCT01142648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597503|NCT01142648|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6597504|NCT01142648|Autonomic Agents|autonomic agents|mesh-ancestor
6597505|NCT01142648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6597506|NCT01142648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6597507|NCT01142648|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6597508|NCT01142648|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6597509|NCT01142700|Ribavirin|ribavirin|mesh-list
6597510|NCT01142700|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6597511|NCT01142700|Antimetabolites|antimetabolites|mesh-ancestor
6597512|NCT01142700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597513|NCT01142700|Antiviral Agents|antiviral agents|mesh-ancestor
6597514|NCT01142700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6597515|NCT01142778|Bevacizumab|bevacizumab|mesh-list
6597516|NCT01142778|Trastuzumab|trastuzumab|mesh-list
6597517|NCT01142778|Docetaxel|docetaxel|mesh-list
6597518|NCT01142778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6597519|NCT01142778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6597520|NCT01142778|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6597521|NCT01142778|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6597522|NCT01142778|Growth Substances|growth substances|mesh-ancestor
6597523|NCT01142778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597524|NCT01142778|Growth Inhibitors|growth inhibitors|mesh-ancestor
6597525|NCT01142778|Tubulin Modulators|tubulin modulators|mesh-ancestor
6597526|NCT01142778|Antimitotic Agents|antimitotic agents|mesh-ancestor
6597527|NCT01142778|Mitosis Modulators|mitosis modulators|mesh-ancestor
6597528|NCT01142778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597529|NCT01142843|Propolis|propolis|mesh-list
6597530|NCT01142843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6597531|NCT01142869|Cetuximab|cetuximab|mesh-list
6597532|NCT01142869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6597533|NCT01142869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6597534|NCT01142934|Chlorhexidine|chlorhexidine|mesh-list
6597535|NCT01142934|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6597536|NCT01142934|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6597537|NCT01142934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6597538|NCT01142934|Disinfectants|disinfectants|mesh-ancestor
6448480|NCT00401362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6448481|NCT00401362|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6448482|NCT00401427|Trastuzumab|trastuzumab|mesh-list
6448483|NCT00401427|Vinorelbine|vinorelbine|mesh-list
6448484|NCT00401427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6448485|NCT00401427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6448486|NCT00401427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6448487|NCT00401427|Tubulin Modulators|tubulin modulators|mesh-ancestor
6448488|NCT00401427|Antimitotic Agents|antimitotic agents|mesh-ancestor
6448489|NCT00401427|Mitosis Modulators|mitosis modulators|mesh-ancestor
6448490|NCT00401427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448491|NCT00401440|Misoprostol|misoprostol|mesh-list
6448492|NCT00401440|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6448493|NCT00401440|Abortifacient Agents|abortifacient agents|mesh-ancestor
6597539|NCT01142934|Dermatologic Agents|dermatologic agents|mesh-ancestor
6597540|NCT01143025|Ropivacaine|ropivacaine|mesh-list
6597541|NCT01143025|Anesthetics, Local|anesthetics, local|mesh-ancestor
6597542|NCT01143025|Anesthetics|anesthetics|mesh-ancestor
6597543|NCT01143025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6597544|NCT01143025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597545|NCT01143025|Sensory System Agents|sensory system agents|mesh-ancestor
6597546|NCT01143025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6448494|NCT00401440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6448495|NCT00401440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448496|NCT00401440|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6448497|NCT00401440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6448498|NCT00401440|Oxytocics|oxytocics|mesh-ancestor
6448499|NCT00401479|Solabegron|solabegron|mesh-list
6448500|NCT00401479|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6448501|NCT00401479|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6448502|NCT00401479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6448503|NCT00401479|Adrenergic Agents|adrenergic agents|mesh-ancestor
6448504|NCT00401479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6597547|NCT01143129|Dexamethasone|dexamethasone|mesh-list
6597548|NCT01143129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6597549|NCT01143129|Antiemetics|antiemetics|mesh-ancestor
6597550|NCT01143129|Autonomic Agents|autonomic agents|mesh-ancestor
6597551|NCT01143129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6597552|NCT01143129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597553|NCT01143129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6597554|NCT01143129|Glucocorticoids|glucocorticoids|mesh-ancestor
6597555|NCT01143129|Hormones|hormones|mesh-ancestor
6597556|NCT01143129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6597557|NCT01143129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6597558|NCT01143129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6597559|NCT01143545|Celecoxib|celecoxib|mesh-list
6597560|NCT01143545|Cyclophosphamide|cyclophosphamide|mesh-list
6597561|NCT01143545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6597562|NCT01143545|Immunologic Factors|immunologic factors|mesh-ancestor
6597563|NCT01143545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597564|NCT01143545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6597565|NCT01143545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6597566|NCT01143545|Alkylating Agents|alkylating agents|mesh-ancestor
6597567|NCT01143545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597568|NCT01143545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6597569|NCT01143545|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6597570|NCT01143545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6597571|NCT01143545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6597572|NCT01143545|Analgesics|analgesics|mesh-ancestor
6597573|NCT01143545|Sensory System Agents|sensory system agents|mesh-ancestor
6597574|NCT01143545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6597575|NCT01143545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6597576|NCT01143545|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6597577|NCT01143545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6597578|NCT01143545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6597579|NCT01143584|Dopamine|dopamine|mesh-list
6597580|NCT01143584|Cabergoline|cabergoline|mesh-list
6597581|NCT01143584|Dopamine Agonists|dopamine agonists|mesh-list
6597582|NCT01143584|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6597583|NCT01143584|Sympathomimetics|sympathomimetics|mesh-ancestor
6597584|NCT01143584|Autonomic Agents|autonomic agents|mesh-ancestor
6597585|NCT01143584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6597586|NCT01143584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597587|NCT01143584|Dopamine Agents|dopamine agents|mesh-ancestor
6597588|NCT01143584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6597589|NCT01143584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597590|NCT01143584|Protective Agents|protective agents|mesh-ancestor
6597591|NCT01143584|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6597592|NCT01143584|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6659795|NCT01489852|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6659796|NCT01489852|Estradiol|estradiol|mesh-list
6659797|NCT01489852|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6659798|NCT01489852|Estrogens|estrogens|mesh-ancestor
6659799|NCT01489852|Hormones|hormones|mesh-ancestor
6659800|NCT01489852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6659801|NCT01489852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659802|NCT01489852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6659803|NCT01489852|Contraceptive Agents|contraceptive agents|mesh-ancestor
6659804|NCT01489852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6659805|NCT01489852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6659806|NCT01489865|Fluorouracil|fluorouracil|mesh-list
6659807|NCT01489865|Veliparib|veliparib|mesh-list
6659808|NCT01489865|Antimetabolites|antimetabolites|mesh-ancestor
6659809|NCT01489865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6659810|NCT01489865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6659811|NCT01489865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6659812|NCT01489865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6659813|NCT01489865|Immunologic Factors|immunologic factors|mesh-ancestor
6659814|NCT01489865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659815|NCT01489865|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6659816|NCT01489865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6659817|NCT01489904|Botulinum Toxins|botulinum toxins|mesh-list
6659818|NCT01489904|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6659819|NCT01489904|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6659820|NCT01489904|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6659821|NCT01489904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6659822|NCT01489904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597593|NCT01143662|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6597594|NCT01143662|Antiviral Agents|antiviral agents|mesh-ancestor
6597595|NCT01143662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5501728|NCT04471402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5501729|NCT04471402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501730|NCT04470908|Rifabutin|rifabutin|mesh-list
5501731|NCT04470908|Zanubrutinib|zanubrutinib|mesh-list
5501732|NCT04470908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5501733|NCT04470908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5501734|NCT04470908|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5501735|NCT04470908|Antitubercular Agents|antitubercular agents|mesh-ancestor
5501736|NCT04470908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5501737|NCT04470908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5501738|NCT04470908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5501739|NCT04470908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501740|NCT04471246|Cephalexin|cephalexin|mesh-list
6597596|NCT01143805|Tofacitinib|tofacitinib|mesh-list
6597597|NCT01143805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6597598|NCT01143805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6597599|NCT01143805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597600|NCT01143831|Vitamins|vitamins|mesh-list
6597601|NCT01143831|Vitamin K|vitamin k|mesh-list
6597602|NCT01143831|Vitamin K 2|vitamin k 2|mesh-list
6597603|NCT01143831|Menatetrenone|menatetrenone|mesh-list
6597604|NCT01143831|Micronutrients|micronutrients|mesh-ancestor
6597605|NCT01143831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597606|NCT01143831|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6597607|NCT01143831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6597608|NCT01143831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597609|NCT01143831|Hemostatics|hemostatics|mesh-ancestor
6597610|NCT01143831|Coagulants|coagulants|mesh-ancestor
6597611|NCT01143857|Varenicline|varenicline|mesh-list
6597612|NCT01143857|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6597613|NCT01143857|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6597614|NCT01143857|Cholinergic Agents|cholinergic agents|mesh-ancestor
6597615|NCT01143857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6597616|NCT01143857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597617|NCT01143857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597618|NCT01143948|Insulin|insulin|mesh-list
6597619|NCT01143948|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6597620|NCT01143948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6597621|NCT01143948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597622|NCT01143974|Pemetrexed|pemetrexed|mesh-list
6597623|NCT01143974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6597624|NCT01143974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6597625|NCT01143974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597626|NCT01143974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6597627|NCT01143974|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6597628|NCT01143987|Cinacalcet|cinacalcet|mesh-list
6597629|NCT01143987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6597630|NCT01143987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597631|NCT01143987|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6597632|NCT01143987|Hormone Antagonists|hormone antagonists|mesh-ancestor
6597633|NCT01143987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6597634|NCT01144000|Daptomycin|daptomycin|mesh-list
6597635|NCT01144000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6597636|NCT01144000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6597637|NCT01144065|Hydrocortisone|hydrocortisone|mesh-list
6597638|NCT01144065|Testosterone|testosterone|mesh-list
6597639|NCT01144065|Androgens|androgens|mesh-ancestor
6597640|NCT01144065|Hormones|hormones|mesh-ancestor
6597641|NCT01144065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6597642|NCT01144065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597643|NCT01144065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6597644|NCT01144091|Pentoxifylline|pentoxifylline|mesh-list
6597645|NCT01144091|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6597646|NCT01144091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6597647|NCT01144091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597648|NCT01144091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6597649|NCT01144091|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6597650|NCT01144091|Protective Agents|protective agents|mesh-ancestor
5501741|NCT04471246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6597651|NCT01144091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597652|NCT01144091|Vasodilator Agents|vasodilator agents|mesh-ancestor
6597653|NCT01144091|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6597654|NCT01144091|Antioxidants|antioxidants|mesh-ancestor
6597655|NCT01144117|Epoetin Alfa|epoetin alfa|mesh-list
6597656|NCT01144117|Hematinics|hematinics|mesh-ancestor
6597657|NCT01144156|Adalimumab|adalimumab|mesh-list
6597658|NCT01144156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6597659|NCT01144156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6597660|NCT01144169|Hydroxychloroquine|hydroxychloroquine|mesh-list
6597661|NCT01144169|Antimalarials|antimalarials|mesh-ancestor
6597662|NCT01144169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6597663|NCT01144169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6597664|NCT01144169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6597665|NCT01144169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6597666|NCT01144169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597667|NCT01144169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6597668|NCT01144195|Panitumumab|panitumumab|mesh-list
6597669|NCT01144195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6597670|NCT01144195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6597671|NCT01144260|Bafetinib|bafetinib|mesh-list
6597672|NCT01144260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6597673|NCT01144260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6597674|NCT01144260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597675|NCT01144312|Fentanyl|fentanyl|mesh-list
6597676|NCT01144312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6597677|NCT01144312|Narcotics|narcotics|mesh-ancestor
6597678|NCT01144312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6597679|NCT01144312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597680|NCT01144312|Analgesics|analgesics|mesh-ancestor
6597681|NCT01144312|Sensory System Agents|sensory system agents|mesh-ancestor
6597682|NCT01144312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6597683|NCT01144312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6597684|NCT01144312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6597685|NCT01144312|Anesthetics, General|anesthetics, general|mesh-ancestor
6597686|NCT01144312|Anesthetics|anesthetics|mesh-ancestor
6597687|NCT01144390|Methadone|methadone|mesh-list
6597688|NCT01144390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6597689|NCT01144390|Narcotics|narcotics|mesh-ancestor
6597690|NCT01144390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6597691|NCT01144390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597692|NCT01144390|Analgesics|analgesics|mesh-ancestor
6597693|NCT01144390|Sensory System Agents|sensory system agents|mesh-ancestor
6597694|NCT01144390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6597695|NCT01144390|Antitussive Agents|antitussive agents|mesh-ancestor
6597696|NCT01144390|Respiratory System Agents|respiratory system agents|mesh-ancestor
6597697|NCT01144533|Hyaluronic Acid|hyaluronic acid|mesh-list
6597698|NCT01144533|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6597699|NCT01144533|Immunologic Factors|immunologic factors|mesh-ancestor
6597700|NCT01144533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597701|NCT01144533|Viscosupplements|viscosupplements|mesh-ancestor
6597702|NCT01144533|Protective Agents|protective agents|mesh-ancestor
6597703|NCT01144650|Dapsone|dapsone|mesh-list
6597704|NCT01144650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6597705|NCT01144650|Antimalarials|antimalarials|mesh-ancestor
6597706|NCT01144650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6597707|NCT01144650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6597708|NCT01144650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6597709|NCT01144650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6597710|NCT01144650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597711|NCT01144650|Leprostatic Agents|leprostatic agents|mesh-ancestor
6597712|NCT01144650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6597713|NCT01144676|Dapivirine|dapivirine|mesh-list
6597714|NCT01144676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6597715|NCT01144676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6597716|NCT01144676|Antiviral Agents|antiviral agents|mesh-ancestor
6597717|NCT01144676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6597718|NCT01144702|Artesunate|artesunate|mesh-list
6597719|NCT01144702|Mefloquine|mefloquine|mesh-list
6597720|NCT01144702|Antimalarials|antimalarials|mesh-ancestor
6597721|NCT01144702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6597722|NCT01144702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6597723|NCT01144702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6659823|NCT01489904|Cholinergic Agents|cholinergic agents|mesh-ancestor
6597724|NCT01144702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6597725|NCT01144702|Antiviral Agents|antiviral agents|mesh-ancestor
6597726|NCT01144702|Schistosomicides|schistosomicides|mesh-ancestor
6597727|NCT01144702|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6597728|NCT01144702|Anthelmintics|anthelmintics|mesh-ancestor
6597729|NCT01144728|Metformin|metformin|mesh-list
6597730|NCT01144728|Glimepiride|glimepiride|mesh-list
6597731|NCT01144728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6597732|NCT01144728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597733|NCT01144728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6597734|NCT01144728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6597735|NCT01144728|Immunologic Factors|immunologic factors|mesh-ancestor
6597736|NCT01144754|Rituximab|rituximab|mesh-list
6597737|NCT01144754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6597738|NCT01144754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6597739|NCT01144754|Immunologic Factors|immunologic factors|mesh-ancestor
6597740|NCT01144754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597741|NCT01144754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6597742|NCT01144832|Ebastine|ebastine|mesh-list
6597743|NCT01144832|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6597744|NCT01144832|Histamine Antagonists|histamine antagonists|mesh-ancestor
6597745|NCT01144832|Histamine Agents|histamine agents|mesh-ancestor
6597746|NCT01144832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6597747|NCT01144832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597748|NCT01144832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597749|NCT01144910|Methacholine Chloride|methacholine chloride|mesh-list
6597750|NCT01144910|Miotics|miotics|mesh-ancestor
6597751|NCT01144910|Autonomic Agents|autonomic agents|mesh-ancestor
6597752|NCT01144910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6597753|NCT01144910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597754|NCT01144910|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6597755|NCT01144910|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
6597756|NCT01144910|Respiratory System Agents|respiratory system agents|mesh-ancestor
6597757|NCT01144910|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6597758|NCT01144910|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6597759|NCT01144910|Cholinergic Agents|cholinergic agents|mesh-ancestor
6597760|NCT01144910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6597761|NCT01144910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597762|NCT01144923|Gabapentin|gabapentin|mesh-list
6597763|NCT01144923|Nortriptyline|nortriptyline|mesh-list
6597764|NCT01144923|Analgesics|analgesics|mesh-ancestor
6597765|NCT01144923|Sensory System Agents|sensory system agents|mesh-ancestor
6597766|NCT01144923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6597767|NCT01144923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597768|NCT01144923|Anticonvulsants|anticonvulsants|mesh-ancestor
6597769|NCT01144923|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6597770|NCT01144923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6597771|NCT01144923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6597772|NCT01144923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6597773|NCT01144923|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6597774|NCT01144923|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6597775|NCT01144923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6597776|NCT01144923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597777|NCT01144923|Antimanic Agents|antimanic agents|mesh-ancestor
6597778|NCT01144923|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6597779|NCT01144923|Antidepressive Agents|antidepressive agents|mesh-ancestor
6597780|NCT01144923|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6597781|NCT01144923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6597782|NCT01144923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6597783|NCT01144923|Adrenergic Agents|adrenergic agents|mesh-ancestor
6597784|NCT01144988|Bevacizumab|bevacizumab|mesh-list
6597785|NCT01144988|Irinotecan|irinotecan|mesh-list
6597786|NCT01144988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6597787|NCT01144988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6597788|NCT01144988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6597789|NCT01144988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6597790|NCT01144988|Growth Substances|growth substances|mesh-ancestor
6597791|NCT01144988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597792|NCT01144988|Growth Inhibitors|growth inhibitors|mesh-ancestor
6597793|NCT01144988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6597794|NCT01144988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6597795|NCT01144988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6597796|NCT01144988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597797|NCT01145079|Sirolimus|sirolimus|mesh-list
6597798|NCT01145079|Everolimus|everolimus|mesh-list
6597799|NCT01145079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6597800|NCT01145079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6597801|NCT01145079|Immunologic Factors|immunologic factors|mesh-ancestor
6597802|NCT01145079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597803|NCT01145079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6597804|NCT01145079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6597805|NCT01145079|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6597806|NCT01145079|Antifungal Agents|antifungal agents|mesh-ancestor
6597807|NCT01145144|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
6597808|NCT01145144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6597809|NCT01145144|Immunologic Factors|immunologic factors|mesh-ancestor
6597810|NCT01145144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597811|NCT01145170|Nimotuzumab|nimotuzumab|mesh-list
6597812|NCT01145170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6597813|NCT01145170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6597814|NCT01145326|Lidocaine|lidocaine|mesh-list
6597815|NCT01145326|Anesthetics, Local|anesthetics, local|mesh-ancestor
6597816|NCT01145326|Anesthetics|anesthetics|mesh-ancestor
6597817|NCT01145326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6597818|NCT01145326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597819|NCT01145326|Sensory System Agents|sensory system agents|mesh-ancestor
6597820|NCT01145326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6597821|NCT01145326|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6597822|NCT01145326|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6597823|NCT01145326|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6597824|NCT01145326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6597825|NCT01145326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597826|NCT01145365|Anesthetics|anesthetics|mesh-list
6597827|NCT01145365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6597828|NCT01145365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597829|NCT01145404|Capecitabine|capecitabine|mesh-list
6597830|NCT01145404|Lapatinib|lapatinib|mesh-list
6597831|NCT01145404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6597832|NCT01145404|Antimetabolites|antimetabolites|mesh-ancestor
6597833|NCT01145404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597834|NCT01145404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6597835|NCT01145404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6597836|NCT01145404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6597837|NCT01145430|Doxorubicin|doxorubicin|mesh-list
6597838|NCT01145430|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6597839|NCT01145430|Veliparib|veliparib|mesh-list
6597840|NCT01145430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6597841|NCT01145430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6597842|NCT01145430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6597843|NCT01145430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6597844|NCT01145430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6597845|NCT01145430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597846|NCT01145430|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6597847|NCT01145456|Gemcitabine|gemcitabine|mesh-list
6597848|NCT01145456|R04929097|r04929097|mesh-list
6597849|NCT01145456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6597850|NCT01145456|Antimetabolites|antimetabolites|mesh-ancestor
6597851|NCT01145456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597852|NCT01145456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6597853|NCT01145456|Antiviral Agents|antiviral agents|mesh-ancestor
6597854|NCT01145456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6597855|NCT01145456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6597856|NCT01145456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6597857|NCT01145456|Immunologic Factors|immunologic factors|mesh-ancestor
6597858|NCT01145456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597859|NCT01145534|Glyburide|glyburide|mesh-list
6597860|NCT01145534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6597861|NCT01145534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597862|NCT01145573|Calcium|calcium|mesh-list
6597863|NCT01145573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6597864|NCT01145573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659824|NCT01489904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6659825|NCT01489904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659826|NCT01489904|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6659827|NCT01489904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6659828|NCT01489917|Heparin|heparin|mesh-list
6659829|NCT01489917|Hemostatics|hemostatics|mesh-list
6659830|NCT01489917|Anticoagulants|anticoagulants|mesh-ancestor
6659831|NCT01489917|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6659832|NCT01489917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6659833|NCT01489917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6659834|NCT01489917|Coagulants|coagulants|mesh-ancestor
6659835|NCT01489943|Pioglitazone|pioglitazone|mesh-list
6659836|NCT01489943|Midazolam|midazolam|mesh-list
6659837|NCT01489943|Omeprazole|omeprazole|mesh-list
6659838|NCT01489943|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6659839|NCT01489943|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6659840|NCT01489943|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6597865|NCT01145612|Losartan|losartan|mesh-list
6597866|NCT01145612|Atenolol|atenolol|mesh-list
6597867|NCT01145612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6597868|NCT01145612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6597869|NCT01145612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6597870|NCT01145612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6597871|NCT01145612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597872|NCT01145612|Sympatholytics|sympatholytics|mesh-ancestor
6597873|NCT01145612|Autonomic Agents|autonomic agents|mesh-ancestor
6597874|NCT01145612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6597875|NCT01145612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597876|NCT01145612|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6597877|NCT01145612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6597878|NCT01145612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6597879|NCT01145612|Adrenergic Agents|adrenergic agents|mesh-ancestor
6597880|NCT01145612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6597881|NCT01145677|Topiramate|topiramate|mesh-list
6597882|NCT01145677|Anticonvulsants|anticonvulsants|mesh-ancestor
6597883|NCT01145677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6597884|NCT01145677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597885|NCT01145703|Vitamin D|vitamin d|mesh-list
6597886|NCT01145703|Ergocalciferols|ergocalciferols|mesh-list
6597887|NCT01145703|Cholecalciferol|cholecalciferol|mesh-list
6597888|NCT01145703|Vitamins|vitamins|mesh-list
6597889|NCT01145703|Micronutrients|micronutrients|mesh-ancestor
6597890|NCT01145703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597891|NCT01145703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6597892|NCT01145703|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6597893|NCT01145807|Terbinafine|terbinafine|mesh-list
6597894|NCT01145807|Antifungal Agents|antifungal agents|mesh-ancestor
6597895|NCT01145807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6597896|NCT01145807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6448505|NCT00401479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597897|NCT01145807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597898|NCT01145846|Cytarabine|cytarabine|mesh-list
6597899|NCT01145846|Daunorubicin|daunorubicin|mesh-list
6597900|NCT01145846|Idarubicin|idarubicin|mesh-list
6597901|NCT01145846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6597902|NCT01145846|Antimetabolites|antimetabolites|mesh-ancestor
6597903|NCT01145846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597904|NCT01145846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6597905|NCT01145846|Antiviral Agents|antiviral agents|mesh-ancestor
6597906|NCT01145846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6597907|NCT01145846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6597908|NCT01145846|Immunologic Factors|immunologic factors|mesh-ancestor
6597909|NCT01145846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597910|NCT01145846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6597911|NCT01145846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6448506|NCT00401479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448507|NCT00401492|Gemcitabine|gemcitabine|mesh-list
6448508|NCT00401492|Vinorelbine|vinorelbine|mesh-list
6448509|NCT00401492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6448510|NCT00401492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6448511|NCT00401492|Antimetabolites|antimetabolites|mesh-ancestor
6448512|NCT00401492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448513|NCT00401492|Antiviral Agents|antiviral agents|mesh-ancestor
6448514|NCT00401492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6448515|NCT00401492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6448516|NCT00401492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6448517|NCT00401492|Immunologic Factors|immunologic factors|mesh-ancestor
6597912|NCT01145846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6597913|NCT01145846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6597914|NCT01145859|Rivaroxaban|rivaroxaban|mesh-list
6597915|NCT01145859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6597916|NCT01145859|Antithrombins|antithrombins|mesh-ancestor
6597917|NCT01145859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6597918|NCT01145859|Protease Inhibitors|protease inhibitors|mesh-ancestor
6597919|NCT01145859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6597920|NCT01145859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597921|NCT01145859|Anticoagulants|anticoagulants|mesh-ancestor
6597922|NCT01145950|Etanercept|etanercept|mesh-list
6597923|NCT01145950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6597924|NCT01145950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6597925|NCT01145950|Analgesics|analgesics|mesh-ancestor
6597926|NCT01145950|Sensory System Agents|sensory system agents|mesh-ancestor
6597927|NCT01145950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6597928|NCT01145950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597929|NCT01145950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6597930|NCT01145950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6597931|NCT01145950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6597932|NCT01145950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6597933|NCT01145950|Immunologic Factors|immunologic factors|mesh-ancestor
6597934|NCT01145976|Cyclophosphamide|cyclophosphamide|mesh-list
6597935|NCT01145976|Fludarabine|fludarabine|mesh-list
6597936|NCT01145976|Thymoglobulin|thymoglobulin|mesh-list
6597937|NCT01145976|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6597938|NCT01145976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6597939|NCT01145976|Immunologic Factors|immunologic factors|mesh-ancestor
6597940|NCT01145976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597941|NCT01145976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6597942|NCT01145976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6597943|NCT01145976|Alkylating Agents|alkylating agents|mesh-ancestor
6597944|NCT01145976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597945|NCT01145976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6597946|NCT01145976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6597947|NCT01146002|Guanfacine|guanfacine|mesh-list
6597948|NCT01146002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6597949|NCT01146002|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6597950|NCT01146002|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6597951|NCT01146002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6597952|NCT01146002|Adrenergic Agents|adrenergic agents|mesh-ancestor
6597953|NCT01146002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6597954|NCT01146002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597955|NCT01146002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597956|NCT01146028|Tizanidine|tizanidine|mesh-list
6597957|NCT01146028|Analgesics|analgesics|mesh-ancestor
6597958|NCT01146028|Sensory System Agents|sensory system agents|mesh-ancestor
6597959|NCT01146028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6597960|NCT01146028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597961|NCT01146028|Anticonvulsants|anticonvulsants|mesh-ancestor
6597962|NCT01146028|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6597963|NCT01146028|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6597964|NCT01146028|Parasympatholytics|parasympatholytics|mesh-ancestor
6597965|NCT01146028|Autonomic Agents|autonomic agents|mesh-ancestor
6597966|NCT01146028|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6597967|NCT01146028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6597968|NCT01146028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6597969|NCT01146028|Adrenergic Agents|adrenergic agents|mesh-ancestor
6597970|NCT01146028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6597971|NCT01146028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597972|NCT01146041|Rivastigmine|rivastigmine|mesh-list
6597973|NCT01146041|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6597974|NCT01146041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6597975|NCT01146041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597976|NCT01146041|Cholinergic Agents|cholinergic agents|mesh-ancestor
6597977|NCT01146041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6597978|NCT01146041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597979|NCT01146041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6597980|NCT01146041|Protective Agents|protective agents|mesh-ancestor
6597981|NCT01146067|Rivastigmine|rivastigmine|mesh-list
6597982|NCT01146067|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6597983|NCT01146067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6597984|NCT01146067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597985|NCT01146067|Cholinergic Agents|cholinergic agents|mesh-ancestor
6597986|NCT01146067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6597987|NCT01146067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6597988|NCT01146067|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6597989|NCT01146067|Protective Agents|protective agents|mesh-ancestor
6597990|NCT01146093|Pravastatin|pravastatin|mesh-list
6597991|NCT01146093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6597992|NCT01146093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6597993|NCT01146093|Antimetabolites|antimetabolites|mesh-ancestor
6597994|NCT01146093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6597995|NCT01146093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6597996|NCT01146093|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6597997|NCT01146093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6597998|NCT01146106|Pravastatin|pravastatin|mesh-list
6597999|NCT01146106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6598000|NCT01146106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6598001|NCT01146106|Antimetabolites|antimetabolites|mesh-ancestor
6598002|NCT01146106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598003|NCT01146106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6598004|NCT01146106|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6598005|NCT01146106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6598006|NCT01146145|Morphine|morphine|mesh-list
6598007|NCT01146145|Ketamine|ketamine|mesh-list
6598008|NCT01146145|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6598009|NCT01146145|Narcotics|narcotics|mesh-ancestor
6598010|NCT01146145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6598011|NCT01146145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598012|NCT01146145|Analgesics|analgesics|mesh-ancestor
6598013|NCT01146145|Sensory System Agents|sensory system agents|mesh-ancestor
6598014|NCT01146145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6598015|NCT01146145|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6598016|NCT01146145|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6598017|NCT01146145|Anesthetics, General|anesthetics, general|mesh-ancestor
6598018|NCT01146145|Anesthetics|anesthetics|mesh-ancestor
6598019|NCT01146145|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6598020|NCT01146145|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6598021|NCT01146145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6598022|NCT01146145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598023|NCT01146301|Clopidogrel|clopidogrel|mesh-list
6598024|NCT01146301|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6598025|NCT01146301|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6598026|NCT01146301|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6598027|NCT01146301|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6598028|NCT01146301|Purinergic Agents|purinergic agents|mesh-ancestor
6598029|NCT01146301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6598030|NCT01146301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598031|NCT01146301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598032|NCT01146431|Anesthetics|anesthetics|mesh-list
6598033|NCT01146431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6598034|NCT01146431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598035|NCT01146483|Pantoprazole|pantoprazole|mesh-list
6598036|NCT01146483|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6598037|NCT01146483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6598038|NCT01146483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6598039|NCT01146483|Antimetabolites|antimetabolites|mesh-ancestor
6598040|NCT01146483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598041|NCT01146483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6598042|NCT01146483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6598043|NCT01146483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6598044|NCT01146483|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6598045|NCT01146483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6598046|NCT01146483|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6598047|NCT01146509|Donepezil|donepezil|mesh-list
6598048|NCT01146509|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6598049|NCT01146509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6598050|NCT01146509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598051|NCT01146509|Cholinergic Agents|cholinergic agents|mesh-ancestor
6598052|NCT01146509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6598053|NCT01146509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598054|NCT01146509|Nootropic Agents|nootropic agents|mesh-ancestor
6598055|NCT01146535|Interferons|interferons|mesh-list
6598056|NCT01146535|Interferon-alpha|interferon-alpha|mesh-list
6598057|NCT01146535|Oseltamivir|oseltamivir|mesh-list
6598058|NCT01146535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6598059|NCT01146535|Antiviral Agents|antiviral agents|mesh-ancestor
6598060|NCT01146535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6598061|NCT01146535|Immunologic Factors|immunologic factors|mesh-ancestor
6598062|NCT01146535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598063|NCT01146535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6598064|NCT01146535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598065|NCT01146548|Fluoxetine|fluoxetine|mesh-list
6598066|NCT01146548|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6598067|NCT01146548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6598068|NCT01146548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6598069|NCT01146548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598070|NCT01146548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6598071|NCT01146548|Serotonin Agents|serotonin agents|mesh-ancestor
6598072|NCT01146548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598073|NCT01146548|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6598074|NCT01146548|Antidepressive Agents|antidepressive agents|mesh-ancestor
6598075|NCT01146548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6598076|NCT01146548|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6598077|NCT01146548|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6598078|NCT01146548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6598079|NCT01146626|Vitamin D|vitamin d|mesh-list
6598080|NCT01146626|Ribavirin|ribavirin|mesh-list
6598081|NCT01146626|Vitamins|vitamins|mesh-ancestor
6598082|NCT01146626|Micronutrients|micronutrients|mesh-ancestor
6598083|NCT01146626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598084|NCT01146626|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6598085|NCT01146626|Antimetabolites|antimetabolites|mesh-ancestor
6598086|NCT01146626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598087|NCT01146626|Antiviral Agents|antiviral agents|mesh-ancestor
6598088|NCT01146626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6598089|NCT01146678|Insulin Glargine|insulin glargine|mesh-list
6598090|NCT01146678|Lixisenatide|lixisenatide|mesh-list
6598091|NCT01146678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6598092|NCT01146678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598093|NCT01146925|Deferiprone|deferiprone|mesh-list
6598094|NCT01146925|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6598095|NCT01146925|Chelating Agents|chelating agents|mesh-ancestor
6598096|NCT01146925|Sequestering Agents|sequestering agents|mesh-ancestor
6598097|NCT01146925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598098|NCT01146977|Cytarabine|cytarabine|mesh-list
6598099|NCT01146977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6598100|NCT01146977|Antimetabolites|antimetabolites|mesh-ancestor
6598101|NCT01146977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598102|NCT01146977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6598103|NCT01146977|Antiviral Agents|antiviral agents|mesh-ancestor
6598104|NCT01146977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6598105|NCT01146977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6598106|NCT01146977|Immunologic Factors|immunologic factors|mesh-ancestor
6598107|NCT01146977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598108|NCT01147016|Paclitaxel|paclitaxel|mesh-list
6598109|NCT01147016|Cyclophosphamide|cyclophosphamide|mesh-list
6598110|NCT01147016|Doxorubicin|doxorubicin|mesh-list
6598111|NCT01147016|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6598112|NCT01147016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6598113|NCT01147016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6598114|NCT01147016|Tubulin Modulators|tubulin modulators|mesh-ancestor
6598115|NCT01147016|Antimitotic Agents|antimitotic agents|mesh-ancestor
6598116|NCT01147016|Mitosis Modulators|mitosis modulators|mesh-ancestor
6598117|NCT01147016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598118|NCT01147016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6598119|NCT01147016|Immunologic Factors|immunologic factors|mesh-ancestor
6598120|NCT01147016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598121|NCT01147016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6598122|NCT01147016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6598123|NCT01147016|Alkylating Agents|alkylating agents|mesh-ancestor
6598124|NCT01147016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6598125|NCT01147016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6598126|NCT01147016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6598127|NCT01147016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6598128|NCT01147016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6598129|NCT01147029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
6598130|NCT01147029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6598131|NCT01147029|Growth Substances|growth substances|mesh-ancestor
6598132|NCT01147029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598133|NCT01147029|Growth Inhibitors|growth inhibitors|mesh-ancestor
6598134|NCT01147029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6598135|NCT01147133|Clopidogrel|clopidogrel|mesh-list
6598136|NCT01147133|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6598137|NCT01147133|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6598138|NCT01147133|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6598139|NCT01147133|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6598140|NCT01147133|Purinergic Agents|purinergic agents|mesh-ancestor
6598141|NCT01147133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6598142|NCT01147133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598143|NCT01147133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598144|NCT01147146|Fentanyl|fentanyl|mesh-list
6598145|NCT01147146|Midazolam|midazolam|mesh-list
6598146|NCT01147146|Bupivacaine|bupivacaine|mesh-list
6598147|NCT01147146|Propofol|propofol|mesh-list
6598148|NCT01147146|Atracurium|atracurium|mesh-list
6598149|NCT01147146|Anesthetics, Local|anesthetics, local|mesh-ancestor
6598150|NCT01147146|Anesthetics|anesthetics|mesh-ancestor
6598151|NCT01147146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6598152|NCT01147146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598153|NCT01147146|Sensory System Agents|sensory system agents|mesh-ancestor
6598154|NCT01147146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6598155|NCT01147146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6598156|NCT01147146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6598157|NCT01147146|Anesthetics, General|anesthetics, general|mesh-ancestor
6598158|NCT01147146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6598159|NCT01147146|Narcotics|narcotics|mesh-ancestor
6598160|NCT01147146|Analgesics|analgesics|mesh-ancestor
6598161|NCT01147146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6598162|NCT01147146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6598163|NCT01147146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6598164|NCT01147146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6598165|NCT01147146|GABA Modulators|gaba modulators|mesh-ancestor
6598166|NCT01147146|GABA Agents|gaba agents|mesh-ancestor
6598167|NCT01147146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6598168|NCT01147146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598169|NCT01147146|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6598170|NCT01147146|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6598171|NCT01147146|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6598172|NCT01147146|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
6598173|NCT01147146|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6598174|NCT01147146|Cholinergic Agents|cholinergic agents|mesh-ancestor
6598175|NCT01147224|Ciclesonide|ciclesonide|mesh-list
6598176|NCT01147224|Glucocorticoids|glucocorticoids|mesh-ancestor
6598177|NCT01147224|Hormones|hormones|mesh-ancestor
6598178|NCT01147224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6598179|NCT01147224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598180|NCT01147224|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6598181|NCT01147276|Vildagliptin|vildagliptin|mesh-list
6598182|NCT01147276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6598183|NCT01147276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598184|NCT01147276|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6598185|NCT01147276|Protease Inhibitors|protease inhibitors|mesh-ancestor
6598186|NCT01147276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6598187|NCT01147276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598188|NCT01147289|Meloxicam|meloxicam|mesh-list
6598189|NCT01147289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6598190|NCT01147289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6598191|NCT01147289|Analgesics|analgesics|mesh-ancestor
6598192|NCT01147289|Sensory System Agents|sensory system agents|mesh-ancestor
6598193|NCT01147289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6598194|NCT01147289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598195|NCT01147289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6598196|NCT01147289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6598197|NCT01147289|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6598198|NCT01147289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6598199|NCT01147289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6598200|NCT01147289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598201|NCT01147354|Selenium|selenium|mesh-list
6598202|NCT01147354|Antioxidants|antioxidants|mesh-ancestor
6598203|NCT01147354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598204|NCT01147354|Protective Agents|protective agents|mesh-ancestor
6598205|NCT01147354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598206|NCT01147354|Trace Elements|trace elements|mesh-ancestor
6598207|NCT01147354|Micronutrients|micronutrients|mesh-ancestor
6659841|NCT01489943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6659842|NCT01489943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659843|NCT01489943|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6659844|NCT01489943|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6659845|NCT01489943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6659846|NCT01489943|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6659847|NCT01489943|Anesthetics, General|anesthetics, general|mesh-ancestor
6659848|NCT01489943|Anesthetics|anesthetics|mesh-ancestor
6659849|NCT01489943|GABA Modulators|gaba modulators|mesh-ancestor
6659850|NCT01489943|GABA Agents|gaba agents|mesh-ancestor
6659851|NCT01489943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6659852|NCT01489943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6659853|NCT01489943|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6659854|NCT01489943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6659855|NCT01489943|Antimetabolites|antimetabolites|mesh-ancestor
6659856|NCT01489943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6659857|NCT01489943|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6659858|NCT01489943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6659859|NCT01489943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6659860|NCT01489943|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6659861|NCT01489943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6659862|NCT01489943|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6659863|NCT01489982|Zopiclone|zopiclone|mesh-list
6659864|NCT01489982|Doxepin|doxepin|mesh-list
6659865|NCT01489982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6659866|NCT01489982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6659867|NCT01489982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659868|NCT01489982|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6659869|NCT01489982|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6659870|NCT01489982|Antidepressive Agents|antidepressive agents|mesh-ancestor
6659871|NCT01489982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6659872|NCT01489982|Histamine Antagonists|histamine antagonists|mesh-ancestor
6659873|NCT01489982|Histamine Agents|histamine agents|mesh-ancestor
6659874|NCT01489982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6659875|NCT01489982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6659876|NCT01489995|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
6659877|NCT01489995|Antiviral Agents|antiviral agents|mesh-ancestor
6659878|NCT01489995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6659879|NCT01489995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6448518|NCT00401492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448519|NCT00401492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6448520|NCT00401492|Tubulin Modulators|tubulin modulators|mesh-ancestor
6020452|NCT00392990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6598208|NCT01147419|Blood Substitutes|blood substitutes|mesh-list
6598209|NCT01147432|Capsaicin|capsaicin|mesh-list
6598210|NCT01147432|Antipruritics|antipruritics|mesh-ancestor
6598211|NCT01147432|Dermatologic Agents|dermatologic agents|mesh-ancestor
6598212|NCT01147432|Sensory System Agents|sensory system agents|mesh-ancestor
6598213|NCT01147432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6598214|NCT01147432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598215|NCT01147510|Montelukast|montelukast|mesh-list
6598216|NCT01147510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6598217|NCT01147510|Respiratory System Agents|respiratory system agents|mesh-ancestor
6598218|NCT01147510|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6598219|NCT01147510|Hormone Antagonists|hormone antagonists|mesh-ancestor
6598220|NCT01147510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6598221|NCT01147510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598222|NCT01147510|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6598223|NCT01147510|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6598224|NCT01147510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598225|NCT01147523|Vitamin E|vitamin e|mesh-list
6598226|NCT01147523|Spironolactone|spironolactone|mesh-list
6598227|NCT01147523|Vitamins|vitamins|mesh-ancestor
6598228|NCT01147523|Micronutrients|micronutrients|mesh-ancestor
6020453|NCT00392990|Alkylating Agents|alkylating agents|mesh-ancestor
6020454|NCT00392990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020455|NCT00392990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6448521|NCT00401492|Antimitotic Agents|antimitotic agents|mesh-ancestor
6598229|NCT01147523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598230|NCT01147523|Antioxidants|antioxidants|mesh-ancestor
6598231|NCT01147523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598232|NCT01147523|Protective Agents|protective agents|mesh-ancestor
6598233|NCT01147523|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6598234|NCT01147523|Hormone Antagonists|hormone antagonists|mesh-ancestor
6598235|NCT01147523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6598236|NCT01147523|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6448522|NCT00401492|Mitosis Modulators|mitosis modulators|mesh-ancestor
6448523|NCT00401596|Omalizumab|omalizumab|mesh-list
6448524|NCT00401596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6448525|NCT00401596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6448526|NCT00401596|Respiratory System Agents|respiratory system agents|mesh-ancestor
6448527|NCT00401609|Gemcitabine|gemcitabine|mesh-list
6448528|NCT00401609|Carboplatin|carboplatin|mesh-list
6448529|NCT00401609|Etoposide|etoposide|mesh-list
6598237|NCT01147523|Diuretics|diuretics|mesh-ancestor
6598238|NCT01147523|Natriuretic Agents|natriuretic agents|mesh-ancestor
6598239|NCT01147588|Esomeprazole|esomeprazole|mesh-list
6598240|NCT01147588|Omeprazole|omeprazole|mesh-list
6598241|NCT01147588|Lansoprazole|lansoprazole|mesh-list
6598242|NCT01147588|Dexlansoprazole|dexlansoprazole|mesh-list
6598243|NCT01147588|Clopidogrel|clopidogrel|mesh-list
6598244|NCT01147588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6598245|NCT01147588|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6598246|NCT01147588|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6598247|NCT01147588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6598248|NCT01147588|Purinergic Agents|purinergic agents|mesh-ancestor
6598249|NCT01147588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6598250|NCT01147588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598251|NCT01147588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598252|NCT01147588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6598253|NCT01147588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6598254|NCT01147588|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6598255|NCT01147588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6598256|NCT01147692|Simvastatin|simvastatin|mesh-list
6598257|NCT01147692|rGLP-1 protein|rglp-1 protein|mesh-list
6598258|NCT01147692|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6598259|NCT01147692|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6598260|NCT01147692|Antimetabolites|antimetabolites|mesh-ancestor
6598261|NCT01147692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598262|NCT01147692|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6598263|NCT01147692|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6598264|NCT01147692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6598265|NCT01147692|Incretins|incretins|mesh-ancestor
6598266|NCT01147692|Hormones|hormones|mesh-ancestor
6598267|NCT01147692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6598268|NCT01147692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598269|NCT01147705|Allopurinol|allopurinol|mesh-list
6598270|NCT01147705|Antimetabolites|antimetabolites|mesh-ancestor
6598271|NCT01147705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598272|NCT01147705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6598273|NCT01147705|Gout Suppressants|gout suppressants|mesh-ancestor
6598274|NCT01147705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6598275|NCT01147705|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6598276|NCT01147705|Antioxidants|antioxidants|mesh-ancestor
6598277|NCT01147705|Protective Agents|protective agents|mesh-ancestor
6598278|NCT01147705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598279|NCT01147718|Digoxin|digoxin|mesh-list
6598280|NCT01147718|rGLP-1 protein|rglp-1 protein|mesh-list
6598281|NCT01147718|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6598282|NCT01147718|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6598283|NCT01147718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6598284|NCT01147718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598285|NCT01147718|Protective Agents|protective agents|mesh-ancestor
6598286|NCT01147718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598287|NCT01147718|Incretins|incretins|mesh-ancestor
6598288|NCT01147718|Hormones|hormones|mesh-ancestor
6598289|NCT01147718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6598290|NCT01147731|Warfarin|warfarin|mesh-list
6598291|NCT01147731|rGLP-1 protein|rglp-1 protein|mesh-list
6598292|NCT01147731|Anticoagulants|anticoagulants|mesh-ancestor
6598293|NCT01147731|Incretins|incretins|mesh-ancestor
6598294|NCT01147731|Hormones|hormones|mesh-ancestor
6598295|NCT01147731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6598296|NCT01147731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598297|NCT01147757|Remifentanil|remifentanil|mesh-list
6598298|NCT01147757|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6598299|NCT01147757|Narcotics|narcotics|mesh-ancestor
6598300|NCT01147757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6598301|NCT01147757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020456|NCT00392990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6020457|NCT00392990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6020458|NCT00392990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6020459|NCT00392990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6020460|NCT00392990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6020461|NCT00392990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6020462|NCT00392990|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6020463|NCT00392990|Abortifacient Agents|abortifacient agents|mesh-ancestor
6598302|NCT01147757|Analgesics|analgesics|mesh-ancestor
6598303|NCT01147757|Sensory System Agents|sensory system agents|mesh-ancestor
6598304|NCT01147757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6598305|NCT01147770|Progesterone|progesterone|mesh-list
6598306|NCT01147770|Progestins|progestins|mesh-ancestor
6598307|NCT01147770|Hormones|hormones|mesh-ancestor
6598308|NCT01147770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6598309|NCT01147770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598310|NCT01148004|Ritonavir|ritonavir|mesh-list
6598311|NCT01148004|Lopinavir|lopinavir|mesh-list
6598312|NCT01148004|Fenofibrate|fenofibrate|mesh-list
6598313|NCT01148004|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6598314|NCT01148004|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6598315|NCT01148004|Protease Inhibitors|protease inhibitors|mesh-ancestor
6598316|NCT01148004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6598317|NCT01148004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598318|NCT01148004|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6598319|NCT01148004|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6598320|NCT01148004|Antiviral Agents|antiviral agents|mesh-ancestor
6598321|NCT01148004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6598322|NCT01148004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6598323|NCT01148004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6598324|NCT01148004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6598325|NCT01148004|Antimetabolites|antimetabolites|mesh-ancestor
6598326|NCT01148004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6598327|NCT01148030|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
6598328|NCT01148030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6598329|NCT01148043|Hydroxychloroquine|hydroxychloroquine|mesh-list
6598330|NCT01148043|Antimalarials|antimalarials|mesh-ancestor
6598331|NCT01148043|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6598332|NCT01148043|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6598333|NCT01148043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6598334|NCT01148043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6598335|NCT01148043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598336|NCT01148043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6598337|NCT01148147|Adenosine|adenosine|mesh-list
6598338|NCT01148147|Analgesics|analgesics|mesh-ancestor
6598339|NCT01148147|Sensory System Agents|sensory system agents|mesh-ancestor
6598340|NCT01148147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6598341|NCT01148147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598342|NCT01148147|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6598343|NCT01148147|Vasodilator Agents|vasodilator agents|mesh-ancestor
6598344|NCT01148147|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6598345|NCT01148147|Purinergic Agonists|purinergic agonists|mesh-ancestor
6598346|NCT01148147|Purinergic Agents|purinergic agents|mesh-ancestor
6598347|NCT01148147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6598348|NCT01148147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598349|NCT01148160|Voriconazole|voriconazole|mesh-list
6598350|NCT01148160|Antifungal Agents|antifungal agents|mesh-ancestor
6598351|NCT01148160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6598352|NCT01148160|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6598353|NCT01148160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6598354|NCT01148160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6598355|NCT01148160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598356|NCT01148160|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6598357|NCT01148160|Hormone Antagonists|hormone antagonists|mesh-ancestor
6664891|NCT01514695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6598358|NCT01148160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6448530|NCT00401609|Vinorelbine|vinorelbine|mesh-list
6598359|NCT01148160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598360|NCT01148160|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6598361|NCT01148173|Ifosfamide|ifosfamide|mesh-list
6598362|NCT01148173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6598363|NCT01148173|Alkylating Agents|alkylating agents|mesh-ancestor
6598364|NCT01148173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598365|NCT01148173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6598366|NCT01148264|Olanzapine|olanzapine|mesh-list
6598367|NCT01148264|Metoclopramide|metoclopramide|mesh-list
6598368|NCT01148264|Antiemetics|antiemetics|mesh-ancestor
6598369|NCT01148264|Autonomic Agents|autonomic agents|mesh-ancestor
6598370|NCT01148264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6598371|NCT01148264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598372|NCT01148264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6598373|NCT01148264|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6598374|NCT01148264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6598375|NCT01148264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6598376|NCT01148264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6598377|NCT01148264|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6598378|NCT01148264|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6598379|NCT01148264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6598380|NCT01148264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598381|NCT01148264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6598382|NCT01148264|Serotonin Agents|serotonin agents|mesh-ancestor
6598383|NCT01148264|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6598384|NCT01148264|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6598385|NCT01148264|Dopamine Agents|dopamine agents|mesh-ancestor
6598386|NCT01148277|Fentanyl|fentanyl|mesh-list
6598387|NCT01148277|Midazolam|midazolam|mesh-list
6598388|NCT01148277|Propofol|propofol|mesh-list
6598389|NCT01148277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6598390|NCT01148277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6598391|NCT01148277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598392|NCT01148277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6598393|NCT01148277|Anesthetics, General|anesthetics, general|mesh-ancestor
6598394|NCT01148277|Anesthetics|anesthetics|mesh-ancestor
6598395|NCT01148277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6598396|NCT01148277|Narcotics|narcotics|mesh-ancestor
6598397|NCT01148277|Analgesics|analgesics|mesh-ancestor
6598398|NCT01148277|Sensory System Agents|sensory system agents|mesh-ancestor
6598399|NCT01148277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6598400|NCT01148277|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6598401|NCT01148277|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6598402|NCT01148277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6598403|NCT01148277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6598404|NCT01148277|GABA Modulators|gaba modulators|mesh-ancestor
6598405|NCT01148277|GABA Agents|gaba agents|mesh-ancestor
6598406|NCT01148277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6598407|NCT01148277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598408|NCT01148303|Etoricoxib|etoricoxib|mesh-list
6598409|NCT01148303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6598410|NCT01148303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6598411|NCT01148303|Analgesics|analgesics|mesh-ancestor
6598412|NCT01148303|Sensory System Agents|sensory system agents|mesh-ancestor
6598413|NCT01148303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6598414|NCT01148303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448531|NCT00401609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6448532|NCT00401609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6448533|NCT00401609|Antimetabolites|antimetabolites|mesh-ancestor
6448534|NCT00401609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448535|NCT00401609|Antiviral Agents|antiviral agents|mesh-ancestor
6448536|NCT00401609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6448537|NCT00401609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6448538|NCT00401609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6448539|NCT00401609|Immunologic Factors|immunologic factors|mesh-ancestor
6448540|NCT00401609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448541|NCT00401609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6598415|NCT01148303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6598416|NCT01148303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6598417|NCT01148303|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6598418|NCT01148303|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6598419|NCT01148303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6598420|NCT01148303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598421|NCT01148316|Fluoxetine|fluoxetine|mesh-list
6598422|NCT01148316|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6598423|NCT01148316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6598424|NCT01148316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6598425|NCT01148316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598426|NCT01148316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6598427|NCT01148316|Serotonin Agents|serotonin agents|mesh-ancestor
6598428|NCT01148316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598429|NCT01148316|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6598430|NCT01148316|Antidepressive Agents|antidepressive agents|mesh-ancestor
6598431|NCT01148316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6598432|NCT01148316|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6598433|NCT01148316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6598434|NCT01148316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6598435|NCT01148342|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
6598436|NCT01148342|Hallucinogens|hallucinogens|mesh-ancestor
6598437|NCT01148342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598438|NCT01148342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6598439|NCT01148342|Serotonin Agents|serotonin agents|mesh-ancestor
6598440|NCT01148342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6598441|NCT01148342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598442|NCT01148342|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6598443|NCT01148342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6598444|NCT01148342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6598445|NCT01148342|Adrenergic Agents|adrenergic agents|mesh-ancestor
6598446|NCT01148446|Prednisone|prednisone|mesh-list
6598447|NCT01148446|Cyclophosphamide|cyclophosphamide|mesh-list
6598448|NCT01148446|Rituximab|rituximab|mesh-list
6598449|NCT01148446|Doxorubicin|doxorubicin|mesh-list
6598450|NCT01148446|Vincristine|vincristine|mesh-list
6598451|NCT01148446|Epirubicin|epirubicin|mesh-list
6598452|NCT01148446|Vinblastine|vinblastine|mesh-list
6598453|NCT01148446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6598454|NCT01148446|Immunologic Factors|immunologic factors|mesh-ancestor
6598455|NCT01148446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598456|NCT01148446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6598457|NCT01148446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6598458|NCT01148446|Alkylating Agents|alkylating agents|mesh-ancestor
6598459|NCT01148446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598460|NCT01148446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6598461|NCT01148446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6598462|NCT01148446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6598463|NCT01148446|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6598464|NCT01148446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6598465|NCT01148446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6598466|NCT01148446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6598467|NCT01148446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6598468|NCT01148446|Glucocorticoids|glucocorticoids|mesh-ancestor
6598469|NCT01148446|Hormones|hormones|mesh-ancestor
6598470|NCT01148446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6598471|NCT01148446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6598472|NCT01148446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6598473|NCT01148446|Tubulin Modulators|tubulin modulators|mesh-ancestor
6598474|NCT01148446|Antimitotic Agents|antimitotic agents|mesh-ancestor
6598475|NCT01148446|Mitosis Modulators|mitosis modulators|mesh-ancestor
6598476|NCT01148472|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6598477|NCT01148472|Citalopram|citalopram|mesh-list
6598478|NCT01148472|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6598479|NCT01148472|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6598480|NCT01148472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6598481|NCT01148472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598482|NCT01148472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6598483|NCT01148472|Serotonin Agents|serotonin agents|mesh-ancestor
6598484|NCT01148472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598485|NCT01148472|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6598486|NCT01148472|Antidepressive Agents|antidepressive agents|mesh-ancestor
6598487|NCT01148472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6598488|NCT01148472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6598489|NCT01148472|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6598490|NCT01148472|Analgesics|analgesics|mesh-ancestor
6598491|NCT01148472|Sensory System Agents|sensory system agents|mesh-ancestor
6598492|NCT01148472|Dopamine Agents|dopamine agents|mesh-ancestor
6598493|NCT01148576|Vitamin E|vitamin e|mesh-list
6598494|NCT01148576|Entecavir|entecavir|mesh-list
6598495|NCT01148576|Essential 303 forte|essential 303 forte|mesh-list
6598496|NCT01148576|Vitamins|vitamins|mesh-ancestor
6598497|NCT01148576|Micronutrients|micronutrients|mesh-ancestor
6598498|NCT01148576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598499|NCT01148576|Antioxidants|antioxidants|mesh-ancestor
6598500|NCT01148576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598501|NCT01148576|Protective Agents|protective agents|mesh-ancestor
6598502|NCT01148576|Antiviral Agents|antiviral agents|mesh-ancestor
6598503|NCT01148576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6598504|NCT01148576|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6598505|NCT01148576|Immunologic Factors|immunologic factors|mesh-ancestor
6598506|NCT01148576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6598507|NCT01148576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6598508|NCT01148576|Antimetabolites|antimetabolites|mesh-ancestor
6598509|NCT01148576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6598510|NCT01148576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6020464|NCT00392990|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6020465|NCT00392990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6020466|NCT00392990|Antimetabolites|antimetabolites|mesh-ancestor
6020467|NCT00392990|Dermatologic Agents|dermatologic agents|mesh-ancestor
6020468|NCT00392990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6020469|NCT00392990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6020470|NCT00392990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6020471|NCT00392990|Antiviral Agents|antiviral agents|mesh-ancestor
6020472|NCT00392990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6448542|NCT00401609|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6448543|NCT00401609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6448544|NCT00401609|Tubulin Modulators|tubulin modulators|mesh-ancestor
6448545|NCT00401609|Antimitotic Agents|antimitotic agents|mesh-ancestor
6448546|NCT00401609|Mitosis Modulators|mitosis modulators|mesh-ancestor
6448547|NCT00401635|Carboplatin|carboplatin|mesh-list
6448548|NCT00401635|Doxorubicin|doxorubicin|mesh-list
6448549|NCT00401635|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6448550|NCT00401635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6448551|NCT00401635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6448552|NCT00401635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6448553|NCT00401635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6448554|NCT00401635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6448555|NCT00401635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448556|NCT00401648|Brivaracetam|brivaracetam|mesh-list
6448557|NCT00401648|Anticonvulsants|anticonvulsants|mesh-ancestor
6448558|NCT00401661|Alfuzosin|alfuzosin|mesh-list
6448559|NCT00401661|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6448560|NCT00401661|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6448561|NCT00401661|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6448562|NCT00401661|Adrenergic Agents|adrenergic agents|mesh-ancestor
6448563|NCT00401661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6448564|NCT00401661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598511|NCT01148576|Antitubercular Agents|antitubercular agents|mesh-ancestor
6598512|NCT01148576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6598513|NCT01148576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6598514|NCT01148615|Docetaxel|docetaxel|mesh-list
6598515|NCT01148615|Aflibercept|aflibercept|mesh-list
6598516|NCT01148615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6598517|NCT01148615|Tubulin Modulators|tubulin modulators|mesh-ancestor
6598518|NCT01148615|Antimitotic Agents|antimitotic agents|mesh-ancestor
6598519|NCT01148615|Mitosis Modulators|mitosis modulators|mesh-ancestor
6598520|NCT01148615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598521|NCT01148615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6598522|NCT01148615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6598523|NCT01148615|Growth Substances|growth substances|mesh-ancestor
6598524|NCT01148615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598525|NCT01148615|Growth Inhibitors|growth inhibitors|mesh-ancestor
6598526|NCT01148628|Everolimus|everolimus|mesh-list
6598527|NCT01148628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6598528|NCT01148628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6598529|NCT01148628|Immunologic Factors|immunologic factors|mesh-ancestor
6598530|NCT01148628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598531|NCT01148667|Caseins|caseins|mesh-list
6598532|NCT01148667|Chelating Agents|chelating agents|mesh-ancestor
6598533|NCT01148667|Sequestering Agents|sequestering agents|mesh-ancestor
6598534|NCT01148667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598535|NCT01148849|Margetuximab|margetuximab|mesh-list
6598536|NCT01148849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6598537|NCT01148901|Infliximab|infliximab|mesh-list
6598538|NCT01148901|Dermatologic Agents|dermatologic agents|mesh-ancestor
6598539|NCT01148901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6448565|NCT00401661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448566|NCT00401661|Urological Agents|urological agents|mesh-ancestor
6448567|NCT00401674|Paclitaxel|paclitaxel|mesh-list
6448568|NCT00401674|Carboplatin|carboplatin|mesh-list
6448569|NCT00401674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6448570|NCT00401674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6448571|NCT00401674|Tubulin Modulators|tubulin modulators|mesh-ancestor
6448572|NCT00401674|Antimitotic Agents|antimitotic agents|mesh-ancestor
6448573|NCT00401674|Mitosis Modulators|mitosis modulators|mesh-ancestor
6448574|NCT00401674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448575|NCT00401765|Docetaxel|docetaxel|mesh-list
6448576|NCT00401765|Siltuximab|siltuximab|mesh-list
6448577|NCT00401765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6448578|NCT00401765|Tubulin Modulators|tubulin modulators|mesh-ancestor
6598540|NCT01148901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6598541|NCT01148966|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6598542|NCT01148966|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6598543|NCT01148966|Dermatologic Agents|dermatologic agents|mesh-ancestor
6598544|NCT01148992|Lofexidine|lofexidine|mesh-list
6598545|NCT01148992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6598546|NCT01148992|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6598547|NCT01148992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598548|NCT01148992|Sensory System Agents|sensory system agents|mesh-ancestor
6598549|NCT01148992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6598550|NCT01148992|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6598551|NCT01148992|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6598552|NCT01148992|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6598553|NCT01148992|Adrenergic Agents|adrenergic agents|mesh-ancestor
6598554|NCT01148992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6598555|NCT01148992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598556|NCT01149005|Insulin|insulin|mesh-list
6598557|NCT01149005|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6598558|NCT01149005|Insulin Lispro|insulin lispro|mesh-list
6598559|NCT01149005|Insulin Aspart|insulin aspart|mesh-list
6598560|NCT01149005|Insulin, Short-Acting|insulin, short-acting|mesh-list
6598561|NCT01149005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6448579|NCT00401765|Antimitotic Agents|antimitotic agents|mesh-ancestor
6448580|NCT00401765|Mitosis Modulators|mitosis modulators|mesh-ancestor
6598562|NCT01149005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598563|NCT01149018|Dronabinol|dronabinol|mesh-list
6598564|NCT01149018|Hallucinogens|hallucinogens|mesh-ancestor
6598565|NCT01149018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598566|NCT01149018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6598567|NCT01149018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6598568|NCT01149018|Analgesics|analgesics|mesh-ancestor
6598569|NCT01149018|Sensory System Agents|sensory system agents|mesh-ancestor
6598570|NCT01149018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6598571|NCT01149018|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6598572|NCT01149018|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6598573|NCT01149018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6598574|NCT01149018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598575|NCT01149018|Hormones|hormones|mesh-ancestor
6598576|NCT01149018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6598577|NCT01149109|Temozolomide|temozolomide|mesh-list
6598578|NCT01149109|Lomustine|lomustine|mesh-list
6598579|NCT01149109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6598580|NCT01149109|Alkylating Agents|alkylating agents|mesh-ancestor
6598581|NCT01149109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598582|NCT01149109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6598583|NCT01149122|Gemcitabine|gemcitabine|mesh-list
6598584|NCT01149122|Oxaliplatin|oxaliplatin|mesh-list
6598585|NCT01149122|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6598586|NCT01149122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6598587|NCT01149122|Antimetabolites|antimetabolites|mesh-ancestor
6598588|NCT01149122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598589|NCT01149122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6598590|NCT01149122|Antiviral Agents|antiviral agents|mesh-ancestor
6598591|NCT01149122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6598592|NCT01149122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6598593|NCT01149122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6598594|NCT01149122|Immunologic Factors|immunologic factors|mesh-ancestor
6598595|NCT01149122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598596|NCT01149122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6598597|NCT01149174|Mitomycins|mitomycins|mesh-list
6598598|NCT01149174|Mitomycin|mitomycin|mesh-list
6598599|NCT01149174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6598600|NCT01149174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6598601|NCT01149174|Alkylating Agents|alkylating agents|mesh-ancestor
6598602|NCT01149174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598603|NCT01149174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6598604|NCT01149174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6598605|NCT01149226|Chloral Hydrate|chloral hydrate|mesh-list
6598606|NCT01149226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6598607|NCT01149226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6598608|NCT01149226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659880|NCT01489995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6664892|NCT01514695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6664893|NCT01514721|Timolol|timolol|mesh-list
6664894|NCT01514721|Travoprost|travoprost|mesh-list
6664895|NCT01514721|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6664896|NCT01514721|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6664897|NCT01514721|Adrenergic Agents|adrenergic agents|mesh-ancestor
6664898|NCT01514721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6664899|NCT01514721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6664900|NCT01514721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664901|NCT01514721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6664902|NCT01514721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6664903|NCT01514812|Digoxin|digoxin|mesh-list
6664904|NCT01514812|Darexaban|darexaban|mesh-list
6664905|NCT01514812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6664906|NCT01514812|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6664907|NCT01514812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6598609|NCT01149278|Benzocaine|benzocaine|mesh-list
6598610|NCT01149278|Anesthetics, Local|anesthetics, local|mesh-ancestor
6598611|NCT01149278|Anesthetics|anesthetics|mesh-ancestor
6598612|NCT01149278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6598613|NCT01149278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598614|NCT01149278|Sensory System Agents|sensory system agents|mesh-ancestor
6598615|NCT01149278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6598616|NCT01149304|Enoxaparin|enoxaparin|mesh-list
6598617|NCT01149304|Pentoxifylline|pentoxifylline|mesh-list
6598618|NCT01149304|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
6598619|NCT01149304|Anticoagulants|anticoagulants|mesh-ancestor
6598620|NCT01149304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6598621|NCT01149304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6598622|NCT01149304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598623|NCT01149304|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6598624|NCT01149304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6598625|NCT01149304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6598626|NCT01149304|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6598627|NCT01149304|Protective Agents|protective agents|mesh-ancestor
6598628|NCT01149304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598629|NCT01149304|Vasodilator Agents|vasodilator agents|mesh-ancestor
6598630|NCT01149304|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6598631|NCT01149304|Antioxidants|antioxidants|mesh-ancestor
6598632|NCT01149304|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6598633|NCT01149304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6598634|NCT01149330|Adapalene|adapalene|mesh-list
6598635|NCT01149330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6598636|NCT01149330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6598637|NCT01149330|Analgesics|analgesics|mesh-ancestor
6598638|NCT01149330|Sensory System Agents|sensory system agents|mesh-ancestor
6598639|NCT01149330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6598640|NCT01149330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598641|NCT01149330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6598642|NCT01149330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6598643|NCT01149330|Dermatologic Agents|dermatologic agents|mesh-ancestor
6598644|NCT01149356|Exemestane|exemestane|mesh-list
6598645|NCT01149356|Goserelin|goserelin|mesh-list
6598646|NCT01149356|R04929097|r04929097|mesh-list
6598647|NCT01149356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6598648|NCT01149356|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6598649|NCT01149356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6598650|NCT01149356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6598651|NCT01149356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598652|NCT01149356|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6598653|NCT01149356|Hormone Antagonists|hormone antagonists|mesh-ancestor
6598654|NCT01149356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6598655|NCT01149356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598656|NCT01149356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6598657|NCT01149395|Dexlansoprazole|dexlansoprazole|mesh-list
6598658|NCT01149395|Lansoprazole|lansoprazole|mesh-list
6598659|NCT01149395|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6598660|NCT01149395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6598661|NCT01149395|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6598662|NCT01149395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6598663|NCT01149395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598664|NCT01149408|Decitabine|decitabine|mesh-list
6598665|NCT01149408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6598666|NCT01149408|Antimetabolites|antimetabolites|mesh-ancestor
6598667|NCT01149408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598668|NCT01149408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6598669|NCT01149408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6598670|NCT01149499|Valacyclovir|valacyclovir|mesh-list
6598671|NCT01149499|Antiviral Agents|antiviral agents|mesh-ancestor
6598672|NCT01149499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6598673|NCT01149564|Ibuprofen|ibuprofen|mesh-list
6598674|NCT01149564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6598675|NCT01149564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6598676|NCT01149564|Analgesics|analgesics|mesh-ancestor
6598677|NCT01149564|Sensory System Agents|sensory system agents|mesh-ancestor
6659881|NCT01490047|Etanercept|etanercept|mesh-list
6598678|NCT01149564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6598679|NCT01149564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598680|NCT01149564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6598681|NCT01149564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6598682|NCT01149564|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6598683|NCT01149564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6598684|NCT01149564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598685|NCT01149577|Olanzapine|olanzapine|mesh-list
6598686|NCT01149577|Antiemetics|antiemetics|mesh-ancestor
6598687|NCT01149577|Autonomic Agents|autonomic agents|mesh-ancestor
6598688|NCT01149577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6598689|NCT01149577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598690|NCT01149577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6598691|NCT01149577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6598692|NCT01149577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6598693|NCT01149577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6598694|NCT01149577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6598695|NCT01149577|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6598696|NCT01149577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6598697|NCT01149577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6598698|NCT01149577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598699|NCT01149577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6598700|NCT01149577|Serotonin Agents|serotonin agents|mesh-ancestor
6598701|NCT01149629|Droxidopa|droxidopa|mesh-list
6598702|NCT01149629|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6598703|NCT01149629|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6598704|NCT01149668|Abexinostat|abexinostat|mesh-list
6598705|NCT01149668|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6598706|NCT01149668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6598707|NCT01149668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598708|NCT01149746|Tamsulosin|tamsulosin|mesh-list
6598709|NCT01149746|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6598710|NCT01149746|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6598711|NCT01149746|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6598712|NCT01149746|Adrenergic Agents|adrenergic agents|mesh-ancestor
6598713|NCT01149746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6598714|NCT01149746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598715|NCT01149746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598716|NCT01149746|Urological Agents|urological agents|mesh-ancestor
6598717|NCT01149798|Cisplatin|cisplatin|mesh-list
6598718|NCT01149798|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6598719|NCT01149798|Paclitaxel|paclitaxel|mesh-list
6598720|NCT01149798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6598721|NCT01149798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6598722|NCT01149798|Tubulin Modulators|tubulin modulators|mesh-ancestor
6598723|NCT01149798|Antimitotic Agents|antimitotic agents|mesh-ancestor
6598724|NCT01149798|Mitosis Modulators|mitosis modulators|mesh-ancestor
6598725|NCT01149798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598726|NCT01149824|Salvinorin A|salvinorin a|mesh-list
6598727|NCT01149824|Hallucinogens|hallucinogens|mesh-ancestor
6598728|NCT01149824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598729|NCT01149824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6598730|NCT01149902|Cyclophosphamide|cyclophosphamide|mesh-list
6598731|NCT01149902|Docetaxel|docetaxel|mesh-list
6598732|NCT01149902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6598733|NCT01149902|Immunologic Factors|immunologic factors|mesh-ancestor
6598734|NCT01149902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598735|NCT01149902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6598736|NCT01149902|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6598737|NCT01149902|Alkylating Agents|alkylating agents|mesh-ancestor
6598738|NCT01149902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598739|NCT01149902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6598740|NCT01149902|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6598741|NCT01149902|Tubulin Modulators|tubulin modulators|mesh-ancestor
6598742|NCT01149902|Antimitotic Agents|antimitotic agents|mesh-ancestor
6598743|NCT01149902|Mitosis Modulators|mitosis modulators|mesh-ancestor
6598744|NCT01149941|Ibuprofen|ibuprofen|mesh-list
6598745|NCT01149941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6598746|NCT01149941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6598747|NCT01149941|Analgesics|analgesics|mesh-ancestor
6598748|NCT01149941|Sensory System Agents|sensory system agents|mesh-ancestor
6659882|NCT01490047|Doxorubicin|doxorubicin|mesh-list
6448581|NCT00401765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448582|NCT00401804|Dexamethasone|dexamethasone|mesh-list
6448583|NCT00401804|Doxorubicin|doxorubicin|mesh-list
6448584|NCT00401804|Bortezomib|bortezomib|mesh-list
6448585|NCT00401804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6448586|NCT00401804|Antiemetics|antiemetics|mesh-ancestor
6448587|NCT00401804|Autonomic Agents|autonomic agents|mesh-ancestor
6598749|NCT01149941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6598750|NCT01149941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598751|NCT01149941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6598752|NCT01149941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6598753|NCT01149941|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6598754|NCT01149941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6598755|NCT01149941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598756|NCT01149954|Ibuprofen|ibuprofen|mesh-list
6598757|NCT01149954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6598758|NCT01149954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6598759|NCT01149954|Analgesics|analgesics|mesh-ancestor
6598760|NCT01149954|Sensory System Agents|sensory system agents|mesh-ancestor
6598761|NCT01149954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6598762|NCT01149954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598763|NCT01149954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6598764|NCT01149954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6598765|NCT01149954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6598766|NCT01149954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6598767|NCT01149954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598768|NCT01149967|Dexetimide|dexetimide|mesh-list
6598769|NCT01149967|Citalopram|citalopram|mesh-list
6598770|NCT01149967|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6598771|NCT01149967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6598772|NCT01149967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6598773|NCT01149967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598774|NCT01149967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6598775|NCT01149967|Serotonin Agents|serotonin agents|mesh-ancestor
6598776|NCT01149967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598777|NCT01149967|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6598778|NCT01149967|Antidepressive Agents|antidepressive agents|mesh-ancestor
6598779|NCT01149967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6598780|NCT01149967|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6598781|NCT01149967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6598782|NCT01149967|Parasympatholytics|parasympatholytics|mesh-ancestor
6598783|NCT01149967|Autonomic Agents|autonomic agents|mesh-ancestor
6598784|NCT01149967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6598785|NCT01149967|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6598786|NCT01149967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6598787|NCT01149967|Cholinergic Agents|cholinergic agents|mesh-ancestor
6598788|NCT01149980|Dexetimide|dexetimide|mesh-list
6598789|NCT01149980|Citalopram|citalopram|mesh-list
6598790|NCT01149980|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6598791|NCT01149980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6598792|NCT01149980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6598793|NCT01149980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598794|NCT01149980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6598795|NCT01149980|Serotonin Agents|serotonin agents|mesh-ancestor
6598796|NCT01149980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598797|NCT01149980|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6598798|NCT01149980|Antidepressive Agents|antidepressive agents|mesh-ancestor
6598799|NCT01149980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6598800|NCT01149980|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6598801|NCT01149980|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6598802|NCT01149980|Parasympatholytics|parasympatholytics|mesh-ancestor
6598803|NCT01149980|Autonomic Agents|autonomic agents|mesh-ancestor
6598804|NCT01149980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6598805|NCT01149980|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6598806|NCT01149980|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6598807|NCT01149980|Cholinergic Agents|cholinergic agents|mesh-ancestor
6598808|NCT01149993|Mycophenolic Acid|mycophenolic acid|mesh-list
6598809|NCT01149993|Thymoglobulin|thymoglobulin|mesh-list
6598810|NCT01149993|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6598811|NCT01149993|Immunologic Factors|immunologic factors|mesh-ancestor
6598812|NCT01149993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501742|NCT04471246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5501743|NCT04470973|Amikacin|amikacin|mesh-list
5501744|NCT04470973|Cefuroxime|cefuroxime|mesh-list
5501745|NCT04470973|Cefuroxime axetil|cefuroxime axetil|mesh-list
5501746|NCT04470973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5501747|NCT04470973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5501748|NCT04470843|Acetazolamide|acetazolamide|mesh-list
5501749|NCT04470843|Anticonvulsants|anticonvulsants|mesh-ancestor
5501750|NCT04470843|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5501751|NCT04470843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5501752|NCT04470843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501753|NCT04470843|Diuretics|diuretics|mesh-ancestor
6598813|NCT01149993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6598814|NCT01149993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6598815|NCT01149993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6598816|NCT01149993|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6598817|NCT01149993|Antitubercular Agents|antitubercular agents|mesh-ancestor
6598818|NCT01149993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6598819|NCT01149993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6598820|NCT01149993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6598821|NCT01149993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598822|NCT01150110|Salicylic Acid|salicylic acid|mesh-list
6598823|NCT01150110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6598824|NCT01150110|Antifungal Agents|antifungal agents|mesh-ancestor
6598825|NCT01150110|Keratolytic Agents|keratolytic agents|mesh-ancestor
6598826|NCT01150110|Dermatologic Agents|dermatologic agents|mesh-ancestor
6598827|NCT01150162|Omeprazole|omeprazole|mesh-list
6598828|NCT01150162|Rebamipide|rebamipide|mesh-list
6598829|NCT01150162|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5501754|NCT04470843|Natriuretic Agents|natriuretic agents|mesh-ancestor
5501755|NCT04470843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501756|NCT04470479|Pilocarpine|pilocarpine|mesh-list
5501757|NCT04470479|Miotics|miotics|mesh-ancestor
5501758|NCT04470479|Autonomic Agents|autonomic agents|mesh-ancestor
5501759|NCT04470479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6598830|NCT01150162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6598831|NCT01150162|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6598832|NCT01150162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6598833|NCT01150162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598834|NCT01150162|Antioxidants|antioxidants|mesh-ancestor
6598835|NCT01150162|Protective Agents|protective agents|mesh-ancestor
6598836|NCT01150162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598837|NCT01150201|Losartan|losartan|mesh-list
6598838|NCT01150201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6598839|NCT01150201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6598840|NCT01150201|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6598841|NCT01150201|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6598842|NCT01150201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598843|NCT01150266|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6598844|NCT01150266|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6598845|NCT01150266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6598846|NCT01150266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598847|NCT01150318|Iodine|iodine|mesh-list
6598848|NCT01150318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6598849|NCT01150318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6598850|NCT01150318|Trace Elements|trace elements|mesh-ancestor
6598851|NCT01150318|Micronutrients|micronutrients|mesh-ancestor
5501760|NCT04470479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501761|NCT04470479|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
5501762|NCT04470479|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5501763|NCT04470479|Cholinergic Agents|cholinergic agents|mesh-ancestor
5501764|NCT04470479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5501765|NCT04470479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501766|NCT04470752|Capsaicin|capsaicin|mesh-list
5501767|NCT04470752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6598852|NCT01150318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598853|NCT01150331|Levetiracetam|levetiracetam|mesh-list
6598854|NCT01150331|Clonazepam|clonazepam|mesh-list
6598855|NCT01150331|Anticonvulsants|anticonvulsants|mesh-list
6598856|NCT01150331|Nootropic Agents|nootropic agents|mesh-ancestor
5501768|NCT04470752|Antipruritics|antipruritics|mesh-ancestor
6598857|NCT01150331|GABA Modulators|gaba modulators|mesh-ancestor
6598858|NCT01150331|GABA Agents|gaba agents|mesh-ancestor
6598859|NCT01150331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6598860|NCT01150331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598861|NCT01150331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598862|NCT01150344|Artemether|artemether|mesh-list
6598863|NCT01150344|Atovaquone|atovaquone|mesh-list
6598864|NCT01150344|Proguanil|proguanil|mesh-list
6598865|NCT01150344|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
6598866|NCT01150344|Antimalarials|antimalarials|mesh-ancestor
6598867|NCT01150344|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6598868|NCT01150344|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6598869|NCT01150344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6598870|NCT01150344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6598871|NCT01150344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598872|NCT01150344|Antimetabolites|antimetabolites|mesh-ancestor
6598873|NCT01150448|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6598874|NCT01150448|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6598875|NCT01150448|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6598876|NCT01150448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6598877|NCT01150448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598878|NCT01150448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6598879|NCT01150448|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6598880|NCT01150448|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6598881|NCT01150448|Serotonin Agents|serotonin agents|mesh-ancestor
6598882|NCT01150448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6598883|NCT01150448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598884|NCT01150448|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6598885|NCT01150448|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6598886|NCT01150448|Dopamine Agents|dopamine agents|mesh-ancestor
6598887|NCT01150617|Insulin|insulin|mesh-list
6598888|NCT01150617|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6598889|NCT01150617|Insulin Glargine|insulin glargine|mesh-list
6598890|NCT01150617|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6598891|NCT01150617|Insulin, Short-Acting|insulin, short-acting|mesh-list
6598892|NCT01150617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598893|NCT01150630|Gemcitabine|gemcitabine|mesh-list
6598894|NCT01150630|Capecitabine|capecitabine|mesh-list
6598895|NCT01150630|Epirubicin|epirubicin|mesh-list
6598896|NCT01150630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6598897|NCT01150630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6598898|NCT01150630|Antimetabolites|antimetabolites|mesh-ancestor
6598899|NCT01150630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598900|NCT01150630|Antiviral Agents|antiviral agents|mesh-ancestor
6598901|NCT01150630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6598902|NCT01150630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6598903|NCT01150630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6598904|NCT01150630|Immunologic Factors|immunologic factors|mesh-ancestor
6598905|NCT01150630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598906|NCT01150630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6598907|NCT01150630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6598908|NCT01150630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6598909|NCT01150747|Azithromycin|azithromycin|mesh-list
6598910|NCT01150747|Ceftriaxone|ceftriaxone|mesh-list
6598911|NCT01150747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6598912|NCT01150747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6598913|NCT01150786|Selenium|selenium|mesh-list
6598914|NCT01150786|Antioxidants|antioxidants|mesh-ancestor
6598915|NCT01150786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598916|NCT01150786|Protective Agents|protective agents|mesh-ancestor
6598917|NCT01150786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598918|NCT01150786|Trace Elements|trace elements|mesh-ancestor
6598919|NCT01150786|Micronutrients|micronutrients|mesh-ancestor
6598920|NCT01150877|Vitamin D|vitamin d|mesh-list
6598921|NCT01150877|Vitamins|vitamins|mesh-ancestor
6598922|NCT01150877|Micronutrients|micronutrients|mesh-ancestor
6598923|NCT01150877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598924|NCT01150877|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6598925|NCT01150955|Resveratrol|resveratrol|mesh-list
6598926|NCT01150955|Antioxidants|antioxidants|mesh-ancestor
6598927|NCT01150955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598928|NCT01150955|Protective Agents|protective agents|mesh-ancestor
6598929|NCT01150955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598930|NCT01150955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6598931|NCT01150955|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6659883|NCT01490047|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6659884|NCT01490047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6659885|NCT01490047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6659886|NCT01490047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6659887|NCT01490047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6659888|NCT01490047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6659889|NCT01490047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6659890|NCT01490047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6659891|NCT01490047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6659892|NCT01490047|Analgesics|analgesics|mesh-ancestor
6659893|NCT01490047|Sensory System Agents|sensory system agents|mesh-ancestor
6659894|NCT01490047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6659895|NCT01490047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659896|NCT01490047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6659897|NCT01490047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6659898|NCT01490047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6659899|NCT01490047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6659900|NCT01490047|Immunologic Factors|immunologic factors|mesh-ancestor
6659901|NCT01490099|Insulin Detemir|insulin detemir|mesh-list
6659902|NCT01490099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6659903|NCT01490099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659904|NCT01490112|Insulin Aspart|insulin aspart|mesh-list
6659905|NCT01490112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6659906|NCT01490112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659907|NCT01490203|Edetic Acid|edetic acid|mesh-list
6659908|NCT01490203|Pentetic Acid|pentetic acid|mesh-list
6659909|NCT01490203|Antidotes|antidotes|mesh-ancestor
6659910|NCT01490203|Protective Agents|protective agents|mesh-ancestor
6659911|NCT01490203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659912|NCT01490203|Chelating Agents|chelating agents|mesh-ancestor
6659913|NCT01490203|Sequestering Agents|sequestering agents|mesh-ancestor
6659914|NCT01490203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6659915|NCT01490203|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6659916|NCT01490203|Anticoagulants|anticoagulants|mesh-ancestor
6659917|NCT01490203|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6659918|NCT01490216|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6659919|NCT01490216|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6659920|NCT01490216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659921|NCT01490216|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6659922|NCT01490216|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6659923|NCT01490216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6659924|NCT01490216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6659925|NCT01490216|Dopamine Agents|dopamine agents|mesh-ancestor
6659926|NCT01490216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6659927|NCT01490229|Ezetimibe|ezetimibe|mesh-list
6659928|NCT01490229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6659929|NCT01490229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6659930|NCT01490229|Antimetabolites|antimetabolites|mesh-ancestor
6659931|NCT01490229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6659932|NCT01490229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6659933|NCT01490255|Amlodipine|amlodipine|mesh-list
6659934|NCT01490255|Ranolazine|ranolazine|mesh-list
6659935|NCT01490255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6659936|NCT01490255|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5501769|NCT04470752|Dermatologic Agents|dermatologic agents|mesh-ancestor
6598932|NCT01151072|Insulin|insulin|mesh-list
6598933|NCT01151072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6598934|NCT01151072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598935|NCT01151176|Insulin|insulin|mesh-list
6598936|NCT01151176|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6598937|NCT01151176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6598938|NCT01151176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598939|NCT01151241|Anesthetics|anesthetics|mesh-list
6598940|NCT01151241|Anesthetics, Local|anesthetics, local|mesh-list
6598941|NCT01151241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6598942|NCT01151241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598943|NCT01151241|Sensory System Agents|sensory system agents|mesh-ancestor
6598944|NCT01151241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6598945|NCT01151254|Propofol|propofol|mesh-list
6598946|NCT01151254|Sevoflurane|sevoflurane|mesh-list
6598947|NCT01151254|Isoflurane|isoflurane|mesh-list
6598948|NCT01151254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6598949|NCT01151254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6598950|NCT01151254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598951|NCT01151254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6598952|NCT01151254|Anesthetics, General|anesthetics, general|mesh-ancestor
6598953|NCT01151254|Anesthetics|anesthetics|mesh-ancestor
6598954|NCT01151254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6598955|NCT01151254|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6598956|NCT01151267|Anesthetics|anesthetics|mesh-list
6598957|NCT01151267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6598958|NCT01151267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598959|NCT01151306|Simvastatin|simvastatin|mesh-list
6598960|NCT01151306|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6598961|NCT01151306|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6598962|NCT01151306|Antimetabolites|antimetabolites|mesh-ancestor
6598963|NCT01151306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598964|NCT01151306|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6598965|NCT01151306|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6598966|NCT01151306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6598967|NCT01151384|Docetaxel|docetaxel|mesh-list
6598968|NCT01151384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6598969|NCT01151384|Tubulin Modulators|tubulin modulators|mesh-ancestor
6598970|NCT01151384|Antimitotic Agents|antimitotic agents|mesh-ancestor
6598971|NCT01151384|Mitosis Modulators|mitosis modulators|mesh-ancestor
6598972|NCT01151384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6598973|NCT01151397|Vitamin D|vitamin d|mesh-list
6598974|NCT01151397|Ribavirin|ribavirin|mesh-list
6598975|NCT01151397|Vitamins|vitamins|mesh-ancestor
6598976|NCT01151397|Micronutrients|micronutrients|mesh-ancestor
6598977|NCT01151397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598978|NCT01151397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6598979|NCT01151397|Antimetabolites|antimetabolites|mesh-ancestor
6598980|NCT01151397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020473|NCT00392990|Tubulin Modulators|tubulin modulators|mesh-ancestor
6020474|NCT00392990|Antimitotic Agents|antimitotic agents|mesh-ancestor
6020475|NCT00392990|Mitosis Modulators|mitosis modulators|mesh-ancestor
6020476|NCT00392990|Keratolytic Agents|keratolytic agents|mesh-ancestor
6020477|NCT00393029|Aldesleukin|aldesleukin|mesh-list
6020478|NCT00393029|Cyclophosphamide|cyclophosphamide|mesh-list
6448588|NCT00401804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6598981|NCT01151397|Antiviral Agents|antiviral agents|mesh-ancestor
6598982|NCT01151397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6598983|NCT01151592|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6598984|NCT01151592|Hematinics|hematinics|mesh-ancestor
6598985|NCT01151605|Insulin|insulin|mesh-list
6598986|NCT01151605|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6598987|NCT01151605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6598988|NCT01151605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598989|NCT01151670|Pioglitazone|pioglitazone|mesh-list
6598990|NCT01151670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6598991|NCT01151670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6598992|NCT01151696|Hydroxyzine|hydroxyzine|mesh-list
6598993|NCT01151696|Antipruritics|antipruritics|mesh-ancestor
6598994|NCT01151696|Dermatologic Agents|dermatologic agents|mesh-ancestor
6598995|NCT01151696|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6598996|NCT01151696|Histamine Antagonists|histamine antagonists|mesh-ancestor
6448589|NCT00401804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448590|NCT00401804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6448591|NCT00401804|Glucocorticoids|glucocorticoids|mesh-ancestor
6448592|NCT00401804|Hormones|hormones|mesh-ancestor
6448593|NCT00401804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6448594|NCT00401804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6598997|NCT01151696|Histamine Agents|histamine agents|mesh-ancestor
6598998|NCT01151696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6598999|NCT01151696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599000|NCT01151696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599001|NCT01151722|Bevacizumab|bevacizumab|mesh-list
6448595|NCT00401804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6448596|NCT00401804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6448597|NCT00401804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6448598|NCT00401804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6448599|NCT00401804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6448600|NCT00401804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448601|NCT00401856|Eplerenone|eplerenone|mesh-list
6448602|NCT00401856|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6448603|NCT00401856|Hormone Antagonists|hormone antagonists|mesh-ancestor
6448604|NCT00401856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6448605|NCT00401856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448606|NCT00401856|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6448607|NCT00401856|Diuretics|diuretics|mesh-ancestor
6448608|NCT00401856|Natriuretic Agents|natriuretic agents|mesh-ancestor
6599002|NCT01151722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6599003|NCT01151722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6599004|NCT01151722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6599005|NCT01151722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6599006|NCT01151722|Growth Substances|growth substances|mesh-ancestor
6599007|NCT01151722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599008|NCT01151722|Growth Inhibitors|growth inhibitors|mesh-ancestor
6599009|NCT01151735|Complement C1s|complement c1s|mesh-list
6599010|NCT01151735|Immunologic Factors|immunologic factors|mesh-ancestor
6599011|NCT01151735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599012|NCT01151787|Amitriptyline|amitriptyline|mesh-list
6599013|NCT01151787|Cyclobenzaprine|cyclobenzaprine|mesh-list
6599014|NCT01151787|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6599015|NCT01151787|Antidepressive Agents|antidepressive agents|mesh-ancestor
6599016|NCT01151787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6599017|NCT01151787|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6599018|NCT01151787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599019|NCT01151787|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6599020|NCT01151787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6599021|NCT01151787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6599022|NCT01151787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6599023|NCT01151787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6599024|NCT01151787|Analgesics|analgesics|mesh-ancestor
6599025|NCT01151787|Sensory System Agents|sensory system agents|mesh-ancestor
6599026|NCT01151787|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6599027|NCT01151787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6599028|NCT01151787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6599029|NCT01151787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599030|NCT01151787|Adrenergic Agents|adrenergic agents|mesh-ancestor
6599031|NCT01151787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6599032|NCT01151800|Benzocaine|benzocaine|mesh-list
6599033|NCT01151800|Anesthetics, Local|anesthetics, local|mesh-ancestor
6599034|NCT01151800|Anesthetics|anesthetics|mesh-ancestor
6599035|NCT01151800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6599036|NCT01151800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599037|NCT01151800|Sensory System Agents|sensory system agents|mesh-ancestor
6599038|NCT01151800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6599039|NCT01151865|Dexmedetomidine|dexmedetomidine|mesh-list
6599040|NCT01151865|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6599041|NCT01151865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6599042|NCT01151865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599043|NCT01151865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6599044|NCT01151865|Analgesics|analgesics|mesh-ancestor
6599045|NCT01151865|Sensory System Agents|sensory system agents|mesh-ancestor
6599046|NCT01151865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6599047|NCT01151865|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6599048|NCT01151865|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6599049|NCT01151865|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6599050|NCT01151865|Adrenergic Agents|adrenergic agents|mesh-ancestor
6599051|NCT01151865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6599052|NCT01151865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599053|NCT01151878|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
6599054|NCT01151878|Cathartics|cathartics|mesh-ancestor
6599055|NCT01151878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6599056|NCT01151943|Anesthetics|anesthetics|mesh-list
6599057|NCT01151943|Anesthetics, Local|anesthetics, local|mesh-list
6599058|NCT01151943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6599059|NCT01151943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599060|NCT01151943|Sensory System Agents|sensory system agents|mesh-ancestor
6599061|NCT01151943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6599062|NCT01152047|Oxytocin|oxytocin|mesh-list
6599063|NCT01152047|Oxytocics|oxytocics|mesh-ancestor
6599064|NCT01152047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6599065|NCT01152047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599066|NCT01152203|Bevacizumab|bevacizumab|mesh-list
6599067|NCT01152203|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6599068|NCT01152203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6599069|NCT01152203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6599070|NCT01152203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6599071|NCT01152203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6599072|NCT01152203|Growth Substances|growth substances|mesh-ancestor
6599073|NCT01152203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599074|NCT01152203|Growth Inhibitors|growth inhibitors|mesh-ancestor
6599075|NCT01152203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6599076|NCT01152203|Alkylating Agents|alkylating agents|mesh-ancestor
6599077|NCT01152203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599078|NCT01152242|Insulin Glargine|insulin glargine|mesh-list
6599079|NCT01152242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6599080|NCT01152242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599081|NCT01152346|Azacitidine|azacitidine|mesh-list
6599082|NCT01152346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6599083|NCT01152346|Antimetabolites|antimetabolites|mesh-ancestor
6599084|NCT01152346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599085|NCT01152346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6599086|NCT01152346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6599087|NCT01152372|Insulin|insulin|mesh-list
6599088|NCT01152372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6599089|NCT01152372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599090|NCT01152476|Remifentanil|remifentanil|mesh-list
6599091|NCT01152476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6599092|NCT01152476|Narcotics|narcotics|mesh-ancestor
6599093|NCT01152476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6599094|NCT01152476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599095|NCT01152476|Analgesics|analgesics|mesh-ancestor
6599096|NCT01152476|Sensory System Agents|sensory system agents|mesh-ancestor
6599097|NCT01152476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6599098|NCT01152541|Riboflavin|riboflavin|mesh-list
6599099|NCT01152541|Dextrans|dextrans|mesh-list
6599100|NCT01152541|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6599101|NCT01152541|Vitamin B Complex|vitamin b complex|mesh-ancestor
6599102|NCT01152541|Vitamins|vitamins|mesh-ancestor
6599103|NCT01152541|Micronutrients|micronutrients|mesh-ancestor
6599104|NCT01152541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599105|NCT01152541|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6599106|NCT01152541|Dermatologic Agents|dermatologic agents|mesh-ancestor
6599107|NCT01152541|Anticoagulants|anticoagulants|mesh-ancestor
6599108|NCT01152541|Plasma Substitutes|plasma substitutes|mesh-ancestor
6599109|NCT01152541|Blood Substitutes|blood substitutes|mesh-ancestor
6599110|NCT01152593|Mupirocin|mupirocin|mesh-list
6599111|NCT01152593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6599112|NCT01152593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6599113|NCT01152593|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6599114|NCT01152593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6599115|NCT01152593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599116|NCT01152606|Trastuzumab|trastuzumab|mesh-list
6599117|NCT01152606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6599118|NCT01152606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6599119|NCT01152710|Capecitabine|capecitabine|mesh-list
6599120|NCT01152710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6599121|NCT01152710|Antimetabolites|antimetabolites|mesh-ancestor
6599122|NCT01152710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599123|NCT01152710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6599124|NCT01152723|Nicotine|nicotine|mesh-list
6599125|NCT01152723|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6599126|NCT01152723|Autonomic Agents|autonomic agents|mesh-ancestor
6599127|NCT01152723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6599128|NCT01152723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599129|NCT01152723|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6599130|NCT01152723|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6599131|NCT01152723|Cholinergic Agents|cholinergic agents|mesh-ancestor
6599132|NCT01152723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6599133|NCT01152723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599134|NCT01152736|Nicotine|nicotine|mesh-list
6599135|NCT01152736|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6599136|NCT01152736|Autonomic Agents|autonomic agents|mesh-ancestor
6599137|NCT01152736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6599138|NCT01152736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599139|NCT01152736|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6599140|NCT01152736|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6599141|NCT01152736|Cholinergic Agents|cholinergic agents|mesh-ancestor
6599142|NCT01152736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6599143|NCT01152736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599144|NCT01152749|Nicotine|nicotine|mesh-list
6599145|NCT01152749|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6599146|NCT01152749|Autonomic Agents|autonomic agents|mesh-ancestor
6599147|NCT01152749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6599148|NCT01152749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599149|NCT01152749|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6599150|NCT01152749|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6599151|NCT01152749|Cholinergic Agents|cholinergic agents|mesh-ancestor
6599152|NCT01152749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6599153|NCT01152749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599154|NCT01152801|Everolimus|everolimus|mesh-list
6599155|NCT01152801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6599156|NCT01152801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6599157|NCT01152801|Immunologic Factors|immunologic factors|mesh-ancestor
6599158|NCT01152801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599159|NCT01152827|Everolimus|everolimus|mesh-list
6599160|NCT01152827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6599161|NCT01152827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6599162|NCT01152827|Immunologic Factors|immunologic factors|mesh-ancestor
6599163|NCT01152827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659937|NCT01490255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6659938|NCT01490255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6659939|NCT01490255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6659940|NCT01490255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659941|NCT01490255|Vasodilator Agents|vasodilator agents|mesh-ancestor
6659942|NCT01490255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6659943|NCT01490268|Sufentanil|sufentanil|mesh-list
6659944|NCT01490268|Dsuvia|dsuvia|mesh-list
6659945|NCT01490268|Hydromorphone|hydromorphone|mesh-list
6659946|NCT01490268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6659947|NCT01490268|Narcotics|narcotics|mesh-ancestor
6659948|NCT01490268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6659949|NCT01490268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659950|NCT01490268|Analgesics|analgesics|mesh-ancestor
6659951|NCT01490268|Sensory System Agents|sensory system agents|mesh-ancestor
6659952|NCT01490268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6659953|NCT01490268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6659954|NCT01490268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6659955|NCT01490268|Anesthetics, General|anesthetics, general|mesh-ancestor
6659956|NCT01490268|Anesthetics|anesthetics|mesh-ancestor
6659957|NCT01490333|Vitamin D|vitamin d|mesh-list
6659958|NCT01490333|Cholecalciferol|cholecalciferol|mesh-list
6659959|NCT01490333|Vitamins|vitamins|mesh-ancestor
6659960|NCT01490333|Micronutrients|micronutrients|mesh-ancestor
6599164|NCT01152840|Everolimus|everolimus|mesh-list
6599165|NCT01152840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6599166|NCT01152840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6599167|NCT01152840|Immunologic Factors|immunologic factors|mesh-ancestor
6599168|NCT01152840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599169|NCT01152866|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6599170|NCT01152866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6599171|NCT01152866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599172|NCT01152931|Vitamins|vitamins|mesh-list
6599173|NCT01152931|Vitamin E|vitamin e|mesh-list
6599174|NCT01152931|Tocopherols|tocopherols|mesh-list
6599175|NCT01152931|Tocotrienols|tocotrienols|mesh-list
6599176|NCT01152931|alpha-Tocopherol|alpha-tocopherol|mesh-list
6599177|NCT01152931|Vitamin A|vitamin a|mesh-list
6599178|NCT01152931|Zinc|zinc|mesh-list
6599179|NCT01152931|Selenium|selenium|mesh-list
6599180|NCT01152931|Artesunate|artesunate|mesh-list
6599181|NCT01152931|Lumefantrine|lumefantrine|mesh-list
6599182|NCT01152931|Artemether|artemether|mesh-list
6599183|NCT01152931|Amodiaquine|amodiaquine|mesh-list
6599184|NCT01152931|Retinol palmitate|retinol palmitate|mesh-list
6599185|NCT01152931|Micronutrients|micronutrients|mesh-ancestor
6599186|NCT01152931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599187|NCT01152931|Trace Elements|trace elements|mesh-ancestor
6599188|NCT01152931|Antioxidants|antioxidants|mesh-ancestor
6599189|NCT01152931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599190|NCT01152931|Protective Agents|protective agents|mesh-ancestor
6599191|NCT01152931|Antimalarials|antimalarials|mesh-ancestor
6599192|NCT01152931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6599193|NCT01152931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6599194|NCT01152931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6599195|NCT01152931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6599196|NCT01152931|Antiviral Agents|antiviral agents|mesh-ancestor
6599197|NCT01152931|Schistosomicides|schistosomicides|mesh-ancestor
6599198|NCT01152931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6599199|NCT01152931|Anthelmintics|anthelmintics|mesh-ancestor
6599200|NCT01152931|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6599201|NCT01153100|Insulin Glargine|insulin glargine|mesh-list
6599202|NCT01153100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6599203|NCT01153100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599204|NCT01153165|Citalopram|citalopram|mesh-list
6599205|NCT01153165|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6599206|NCT01153165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6599207|NCT01153165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6599208|NCT01153165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599209|NCT01153165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6599210|NCT01153165|Serotonin Agents|serotonin agents|mesh-ancestor
6599211|NCT01153165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599212|NCT01153165|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6599213|NCT01153165|Antidepressive Agents|antidepressive agents|mesh-ancestor
6599214|NCT01153165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6599215|NCT01153191|Gentamicins|gentamicins|mesh-list
6599216|NCT01153191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6599217|NCT01153191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6599218|NCT01153191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6599219|NCT01153191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6599220|NCT01153191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599221|NCT01153204|Sildenafil Citrate|sildenafil citrate|mesh-list
6599222|NCT01153204|Citric Acid|citric acid|mesh-list
6599223|NCT01153204|Sodium Citrate|sodium citrate|mesh-list
6599224|NCT01153204|Anticoagulants|anticoagulants|mesh-ancestor
6599225|NCT01153204|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6599226|NCT01153204|Chelating Agents|chelating agents|mesh-ancestor
6599227|NCT01153204|Sequestering Agents|sequestering agents|mesh-ancestor
6448609|NCT00401856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6448610|NCT00401869|Epoetin Alfa|epoetin alfa|mesh-list
6448611|NCT00401869|Hematinics|hematinics|mesh-ancestor
6448612|NCT00401921|Minocycline|minocycline|mesh-list
6599228|NCT01153204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599229|NCT01153204|Vasodilator Agents|vasodilator agents|mesh-ancestor
6599230|NCT01153204|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6599231|NCT01153204|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6599232|NCT01153204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6599233|NCT01153204|Urological Agents|urological agents|mesh-ancestor
6599234|NCT01153217|Tenofovir|tenofovir|mesh-list
6599235|NCT01153217|Abacavir|abacavir|mesh-list
6599236|NCT01153217|Antiviral Agents|antiviral agents|mesh-ancestor
6599237|NCT01153217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6599238|NCT01153217|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6599239|NCT01153217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6599240|NCT01153217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6599241|NCT01153217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448613|NCT00401921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6448614|NCT00401921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6448615|NCT00402012|Pioglitazone|pioglitazone|mesh-list
6448616|NCT00402012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6448617|NCT00402012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448618|NCT00402038|Methylnaltrexone|methylnaltrexone|mesh-list
6448619|NCT00402038|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6448620|NCT00402038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448621|NCT00402038|Sensory System Agents|sensory system agents|mesh-ancestor
6448622|NCT00402038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6448623|NCT00402077|Pramlintide|pramlintide|mesh-list
6448624|NCT00402077|Phentermine|phentermine|mesh-list
6448625|NCT00402077|Sibutramine|sibutramine|mesh-list
6448626|NCT00402077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6448627|NCT00402077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448628|NCT00402077|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6448629|NCT00402077|Appetite Depressants|appetite depressants|mesh-ancestor
6599242|NCT01153217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6599243|NCT01153217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6599244|NCT01153243|Vitamin D|vitamin d|mesh-list
6599245|NCT01153243|Ergocalciferols|ergocalciferols|mesh-list
6599246|NCT01153243|Vitamins|vitamins|mesh-ancestor
6599247|NCT01153243|Micronutrients|micronutrients|mesh-ancestor
6599248|NCT01153243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599249|NCT01153243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6599250|NCT01153243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6599251|NCT01153256|Magnesium Sulfate|magnesium sulfate|mesh-list
6599252|NCT01153256|Analgesics|analgesics|mesh-ancestor
6599253|NCT01153256|Sensory System Agents|sensory system agents|mesh-ancestor
6599254|NCT01153256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6599255|NCT01153256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599256|NCT01153256|Anesthetics|anesthetics|mesh-ancestor
6599257|NCT01153256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6599258|NCT01153256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6599259|NCT01153256|Anticonvulsants|anticonvulsants|mesh-ancestor
6599260|NCT01153256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6599261|NCT01153256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6599262|NCT01153256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599263|NCT01153256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6599264|NCT01153256|Tocolytic Agents|tocolytic agents|mesh-ancestor
6599265|NCT01153256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6599266|NCT01153334|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6599267|NCT01153334|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6599268|NCT01153334|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6599269|NCT01153334|Antimetabolites|antimetabolites|mesh-ancestor
6599270|NCT01153334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599271|NCT01153334|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6599272|NCT01153334|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6599273|NCT01153334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6599274|NCT01153373|Ethanol|ethanol|mesh-list
6599275|NCT01153373|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6599276|NCT01153373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6599277|NCT01153373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6599278|NCT01153373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599279|NCT01153386|Treprostinil|treprostinil|mesh-list
6599280|NCT01153386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6599281|NCT01153542|Ivacaftor|ivacaftor|mesh-list
6448630|NCT00402077|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6448631|NCT00402077|Sympathomimetics|sympathomimetics|mesh-ancestor
6448632|NCT00402077|Autonomic Agents|autonomic agents|mesh-ancestor
6599282|NCT01153542|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6599283|NCT01153542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6599284|NCT01153542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599285|NCT01153568|Vitamin D|vitamin d|mesh-list
6599286|NCT01153568|Cholecalciferol|cholecalciferol|mesh-list
6599287|NCT01153568|Vitamins|vitamins|mesh-ancestor
6599288|NCT01153568|Micronutrients|micronutrients|mesh-ancestor
6599289|NCT01153568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599290|NCT01153568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6599291|NCT01153568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6599292|NCT01153659|Esomeprazole|esomeprazole|mesh-list
6599293|NCT01153659|Rabeprazole|rabeprazole|mesh-list
6599294|NCT01153659|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6599295|NCT01153659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6448633|NCT00402077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6020479|NCT00393029|Fludarabine|fludarabine|mesh-list
6448634|NCT00402077|Adrenergic Agents|adrenergic agents|mesh-ancestor
6448635|NCT00402077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6448636|NCT00402077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448637|NCT00402077|Antidepressive Agents|antidepressive agents|mesh-ancestor
6448638|NCT00402077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6448639|NCT00402142|Vaccines|vaccines|mesh-list
6448640|NCT00402142|Immunologic Factors|immunologic factors|mesh-ancestor
6448641|NCT00402142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448642|NCT00402181|Dexamethasone|dexamethasone|mesh-list
6448643|NCT00402181|Siltuximab|siltuximab|mesh-list
6448644|NCT00402181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6448645|NCT00402181|Antiemetics|antiemetics|mesh-ancestor
6448646|NCT00402181|Autonomic Agents|autonomic agents|mesh-ancestor
6448647|NCT00402181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6448648|NCT00402181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448649|NCT00402181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6448650|NCT00402181|Glucocorticoids|glucocorticoids|mesh-ancestor
6448651|NCT00402181|Hormones|hormones|mesh-ancestor
6448652|NCT00402181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6448653|NCT00402181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6448654|NCT00402181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6448655|NCT00402207|Fluticasone|fluticasone|mesh-list
6448656|NCT00402207|Beclomethasone|beclomethasone|mesh-list
6448657|NCT00402207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6448658|NCT00402207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6448659|NCT00402207|Autonomic Agents|autonomic agents|mesh-ancestor
6448660|NCT00402207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6599296|NCT01153659|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6599297|NCT01153659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6599298|NCT01153659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599299|NCT01153750|Imatinib Mesylate|imatinib mesylate|mesh-list
6599300|NCT01153750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6599301|NCT01153750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6599302|NCT01153750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6599303|NCT01153750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599304|NCT01153802|Dopamine|dopamine|mesh-list
6599305|NCT01153802|Norepinephrine|norepinephrine|mesh-list
6599306|NCT01153802|Serotonin|serotonin|mesh-list
6599307|NCT01153802|Neurotransmitter Agents|neurotransmitter agents|mesh-list
6599308|NCT01153802|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6599309|NCT01153802|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6599310|NCT01153802|Adrenergic Agents|adrenergic agents|mesh-ancestor
6599311|NCT01153802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599312|NCT01153802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599313|NCT01153802|Sympathomimetics|sympathomimetics|mesh-ancestor
6599314|NCT01153802|Autonomic Agents|autonomic agents|mesh-ancestor
6599315|NCT01153802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6599316|NCT01153802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6599317|NCT01153802|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6599318|NCT01153802|Dopamine Agents|dopamine agents|mesh-ancestor
6599319|NCT01153802|Protective Agents|protective agents|mesh-ancestor
6599320|NCT01153802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6599321|NCT01153802|Serotonin Agents|serotonin agents|mesh-ancestor
6599322|NCT01153828|Mupirocin|mupirocin|mesh-list
6599323|NCT01153828|Retapamulin|retapamulin|mesh-list
6599324|NCT01153828|Fusidic Acid|fusidic acid|mesh-list
6599325|NCT01153828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6599326|NCT01153828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6599327|NCT01153828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6599328|NCT01153828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6599329|NCT01153828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599330|NCT01153854|Racecadotril|racecadotril|mesh-list
6599331|NCT01153854|Antidiarrheals|antidiarrheals|mesh-ancestor
6599332|NCT01153854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6599333|NCT01153854|Protease Inhibitors|protease inhibitors|mesh-ancestor
6599334|NCT01153854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6599335|NCT01153854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599336|NCT01153880|Mupirocin|mupirocin|mesh-list
6599337|NCT01153880|Retapamulin|retapamulin|mesh-list
6599338|NCT01153880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6599339|NCT01153880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6448661|NCT00402207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448662|NCT00402207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6448663|NCT00402207|Respiratory System Agents|respiratory system agents|mesh-ancestor
6448664|NCT00402207|Dermatologic Agents|dermatologic agents|mesh-ancestor
6448665|NCT00402207|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6599340|NCT01153880|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6599341|NCT01153880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6599342|NCT01153880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599343|NCT01153919|Interferons|interferons|mesh-list
6599344|NCT01153919|Ribavirin|ribavirin|mesh-list
6599345|NCT01153919|Interferon-alpha|interferon-alpha|mesh-list
6599346|NCT01153919|Interferon alpha-2|interferon alpha-2|mesh-list
6448666|NCT00402207|Glucocorticoids|glucocorticoids|mesh-ancestor
6448667|NCT00402207|Hormones|hormones|mesh-ancestor
6448668|NCT00402207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6448669|NCT00402259|Esomeprazole|esomeprazole|mesh-list
6448670|NCT00402259|Omeprazole|omeprazole|mesh-list
6448671|NCT00402259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6448672|NCT00402259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6448673|NCT00402259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6448674|NCT00402259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6448675|NCT00402259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448676|NCT00402272|Everolimus|everolimus|mesh-list
6448677|NCT00402272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6448678|NCT00402272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6448679|NCT00402272|Immunologic Factors|immunologic factors|mesh-ancestor
6448680|NCT00402272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448681|NCT00402350|Fentanyl|fentanyl|mesh-list
6448682|NCT00402350|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6448683|NCT00402350|Narcotics|narcotics|mesh-ancestor
6448684|NCT00402350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6599347|NCT01153919|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6599348|NCT01153919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6599349|NCT01153919|Antiviral Agents|antiviral agents|mesh-ancestor
6599350|NCT01153919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6599351|NCT01153919|Antimetabolites|antimetabolites|mesh-ancestor
6599352|NCT01153919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599353|NCT01153919|Immunologic Factors|immunologic factors|mesh-ancestor
6599354|NCT01153919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599355|NCT01154114|Darapladib|darapladib|mesh-list
6599356|NCT01154114|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
6599357|NCT01154114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6599358|NCT01154114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599359|NCT01154348|Metformin|metformin|mesh-list
6599360|NCT01154348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6599361|NCT01154348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599362|NCT01154361|Cortisone|cortisone|mesh-list
6599363|NCT01154361|Icatibant|icatibant|mesh-list
6599364|NCT01154361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6599365|NCT01154361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6599366|NCT01154361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6599367|NCT01154361|Analgesics|analgesics|mesh-ancestor
6599368|NCT01154361|Sensory System Agents|sensory system agents|mesh-ancestor
6599369|NCT01154361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6599370|NCT01154361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599371|NCT01154361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6599372|NCT01154361|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
6599373|NCT01154361|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
6599374|NCT01154361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599375|NCT01154361|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6599376|NCT01154361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6599377|NCT01154361|Immunologic Factors|immunologic factors|mesh-ancestor
6599378|NCT01154387|Mycophenolic Acid|mycophenolic acid|mesh-list
6599379|NCT01154387|Tacrolimus|tacrolimus|mesh-list
6599380|NCT01154387|Thymoglobulin|thymoglobulin|mesh-list
6599381|NCT01154387|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6599382|NCT01154387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6599383|NCT01154387|Immunologic Factors|immunologic factors|mesh-ancestor
6599384|NCT01154387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599385|NCT01154387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6599386|NCT01154387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6599387|NCT01154387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599388|NCT01154387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6599389|NCT01154387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6448685|NCT00402350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448686|NCT00402350|Analgesics|analgesics|mesh-ancestor
6448687|NCT00402350|Sensory System Agents|sensory system agents|mesh-ancestor
6448688|NCT00402350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6448689|NCT00402350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6448690|NCT00402350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6448691|NCT00402350|Anesthetics, General|anesthetics, general|mesh-ancestor
6448692|NCT00402350|Anesthetics|anesthetics|mesh-ancestor
6448693|NCT00402376|Carvedilol|carvedilol|mesh-list
6448694|NCT00402376|Perindopril|perindopril|mesh-list
6448695|NCT00402376|Pravastatin|pravastatin|mesh-list
6448696|NCT00402376|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6448697|NCT00402376|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6448698|NCT00402376|Adrenergic Agents|adrenergic agents|mesh-ancestor
6448699|NCT00402376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6599390|NCT01154387|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6599391|NCT01154387|Antitubercular Agents|antitubercular agents|mesh-ancestor
6599392|NCT01154387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6599393|NCT01154387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6599394|NCT01154400|Caseins|caseins|mesh-list
6599395|NCT01154400|Chelating Agents|chelating agents|mesh-ancestor
6599396|NCT01154400|Sequestering Agents|sequestering agents|mesh-ancestor
6599397|NCT01154400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599398|NCT01154426|Gemcitabine|gemcitabine|mesh-list
6599399|NCT01154426|Veliparib|veliparib|mesh-list
6599400|NCT01154426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6599401|NCT01154426|Antimetabolites|antimetabolites|mesh-ancestor
6599402|NCT01154426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599403|NCT01154426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6599404|NCT01154426|Antiviral Agents|antiviral agents|mesh-ancestor
6599405|NCT01154426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6599406|NCT01154426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6599407|NCT01154426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6599408|NCT01154426|Immunologic Factors|immunologic factors|mesh-ancestor
6599409|NCT01154426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599410|NCT01154426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6599411|NCT01154439|Cytarabine|cytarabine|mesh-list
6599412|NCT01154439|Etoposide|etoposide|mesh-list
6599413|NCT01154439|Mitoxantrone|mitoxantrone|mesh-list
6599414|NCT01154439|Idarubicin|idarubicin|mesh-list
6599415|NCT01154439|Etoposide phosphate|etoposide phosphate|mesh-list
6599416|NCT01154439|Everolimus|everolimus|mesh-list
6599417|NCT01154439|Ifosfamide|ifosfamide|mesh-list
6599418|NCT01154439|Carboplatin|carboplatin|mesh-list
6599419|NCT01154439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6599420|NCT01154439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6599421|NCT01154439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6599422|NCT01154439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6599423|NCT01154439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6599424|NCT01154439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599425|NCT01154439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6599426|NCT01154439|Antimetabolites|antimetabolites|mesh-ancestor
6599427|NCT01154439|Antiviral Agents|antiviral agents|mesh-ancestor
6599428|NCT01154439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6599429|NCT01154439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6599430|NCT01154439|Immunologic Factors|immunologic factors|mesh-ancestor
6599431|NCT01154439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599432|NCT01154439|Analgesics|analgesics|mesh-ancestor
6599433|NCT01154439|Sensory System Agents|sensory system agents|mesh-ancestor
6599434|NCT01154439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6599435|NCT01154439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6599436|NCT01154439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6599437|NCT01154439|Alkylating Agents|alkylating agents|mesh-ancestor
6599438|NCT01154465|Povidone-Iodine|povidone-iodine|mesh-list
6448700|NCT00402376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448701|NCT00402376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448702|NCT00402376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6448703|NCT00402376|Antioxidants|antioxidants|mesh-ancestor
6448704|NCT00402376|Protective Agents|protective agents|mesh-ancestor
6448705|NCT00402376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6448706|NCT00402376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6448707|NCT00402376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6448708|NCT00402376|Vasodilator Agents|vasodilator agents|mesh-ancestor
6448709|NCT00402376|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6448710|NCT00402376|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6448711|NCT00402376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6448712|NCT00402376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6448713|NCT00402376|Antimetabolites|antimetabolites|mesh-ancestor
6448714|NCT00402376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6599439|NCT01154465|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6599440|NCT01154465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6599441|NCT01154491|Epoetin Alfa|epoetin alfa|mesh-list
6599442|NCT01154491|Hematinics|hematinics|mesh-ancestor
6599443|NCT01154504|Adrenomedullin|adrenomedullin|mesh-list
6599444|NCT01154504|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6599445|NCT01154504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6599446|NCT01154504|Autonomic Agents|autonomic agents|mesh-ancestor
6599447|NCT01154504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6599448|NCT01154504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599449|NCT01154504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6599450|NCT01154504|Respiratory System Agents|respiratory system agents|mesh-ancestor
6599451|NCT01154504|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6599452|NCT01154504|Vasodilator Agents|vasodilator agents|mesh-ancestor
6599453|NCT01154504|Protective Agents|protective agents|mesh-ancestor
6599454|NCT01154530|Chlorhexidine|chlorhexidine|mesh-list
6599455|NCT01154530|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6599456|NCT01154530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6599457|NCT01154530|Disinfectants|disinfectants|mesh-ancestor
6599458|NCT01154569|Azithromycin|azithromycin|mesh-list
6599459|NCT01154569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6599460|NCT01154569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6599461|NCT01154647|Citalopram|citalopram|mesh-list
6599462|NCT01154647|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6599463|NCT01154647|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6599464|NCT01154647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6599465|NCT01154647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599466|NCT01154647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6599467|NCT01154647|Serotonin Agents|serotonin agents|mesh-ancestor
6599468|NCT01154647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599469|NCT01154647|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6599470|NCT01154647|Antidepressive Agents|antidepressive agents|mesh-ancestor
6599471|NCT01154647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6659961|NCT01490333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659962|NCT01490333|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6659963|NCT01490333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6659964|NCT01490346|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6659965|NCT01490346|Antiviral Agents|antiviral agents|mesh-ancestor
6659966|NCT01490346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6659967|NCT01490398|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6659968|NCT01490398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6659969|NCT01490398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6659970|NCT01490398|Antimetabolites|antimetabolites|mesh-ancestor
6659971|NCT01490398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6659972|NCT01490398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6659973|NCT01490398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6599472|NCT01154738|Lidocaine|lidocaine|mesh-list
6599473|NCT01154738|Anesthetics, Local|anesthetics, local|mesh-ancestor
6599474|NCT01154738|Anesthetics|anesthetics|mesh-ancestor
6599475|NCT01154738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6599476|NCT01154738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599477|NCT01154738|Sensory System Agents|sensory system agents|mesh-ancestor
6599478|NCT01154738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6599479|NCT01154738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6599480|NCT01154738|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6599481|NCT01154738|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6599482|NCT01154738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6599483|NCT01154738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599484|NCT01154764|Ketoconazole|ketoconazole|mesh-list
6599485|NCT01154764|Antifungal Agents|antifungal agents|mesh-ancestor
6599486|NCT01154764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6599487|NCT01154764|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6599488|NCT01154764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6599489|NCT01154764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6599490|NCT01154764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599491|NCT01154764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6599492|NCT01154764|Hormone Antagonists|hormone antagonists|mesh-ancestor
6599493|NCT01154764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6599494|NCT01154764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599495|NCT01154764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6599496|NCT01154790|Naproxen|naproxen|mesh-list
6599497|NCT01154790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6448715|NCT00402376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6448716|NCT00402376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6448717|NCT00402376|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6448718|NCT00402376|Protease Inhibitors|protease inhibitors|mesh-ancestor
6448719|NCT00402415|Sirolimus|sirolimus|mesh-list
6448720|NCT00402415|Sunitinib|sunitinib|mesh-list
6448721|NCT00402415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6599498|NCT01154790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6599499|NCT01154790|Analgesics|analgesics|mesh-ancestor
6599500|NCT01154790|Sensory System Agents|sensory system agents|mesh-ancestor
6599501|NCT01154790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6599502|NCT01154790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599503|NCT01154790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6599504|NCT01154790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6599505|NCT01154790|Gout Suppressants|gout suppressants|mesh-ancestor
6599506|NCT01154790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6599507|NCT01154790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6448722|NCT00402415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6448723|NCT00402415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6448724|NCT00402415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6448725|NCT00402415|Antifungal Agents|antifungal agents|mesh-ancestor
6448726|NCT00402415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6448727|NCT00402415|Immunologic Factors|immunologic factors|mesh-ancestor
6448728|NCT00402415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448729|NCT00402415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6448730|NCT00402415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6448731|NCT00402415|Growth Substances|growth substances|mesh-ancestor
6448732|NCT00402415|Growth Inhibitors|growth inhibitors|mesh-ancestor
6448733|NCT00402415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6448734|NCT00402415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6659974|NCT01490398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6448735|NCT00402415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448736|NCT00402441|Risedronic Acid|risedronic acid|mesh-list
6448737|NCT00402441|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6448738|NCT00402441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6448739|NCT00402441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448740|NCT00402441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6448741|NCT00402441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448742|NCT00402441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6448743|NCT00402454|Rifampin|rifampin|mesh-list
6448744|NCT00402454|Isoniazid|isoniazid|mesh-list
6599508|NCT01154790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599509|NCT01154803|Micronutrients|micronutrients|mesh-list
6599510|NCT01154803|Trace Elements|trace elements|mesh-list
6448745|NCT00402454|Pyrazinamide|pyrazinamide|mesh-list
6448746|NCT00402454|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6448747|NCT00402454|Antitubercular Agents|antitubercular agents|mesh-ancestor
6448748|NCT00402454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6448749|NCT00402454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6599511|NCT01154803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599512|NCT01154829|Aripiprazole|aripiprazole|mesh-list
6599513|NCT01154829|Amisulpride|amisulpride|mesh-list
6599514|NCT01154829|Antidepressive Agents|antidepressive agents|mesh-ancestor
6599515|NCT01154829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6599516|NCT01154829|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6599517|NCT01154829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6599518|NCT01154829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6599519|NCT01154829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599520|NCT01154829|Dopamine Agonists|dopamine agonists|mesh-ancestor
6599521|NCT01154829|Dopamine Agents|dopamine agents|mesh-ancestor
6599522|NCT01154829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6599523|NCT01154829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599524|NCT01154829|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6599525|NCT01154829|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6599526|NCT01154829|Serotonin Agents|serotonin agents|mesh-ancestor
6599527|NCT01154829|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6599528|NCT01154829|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6599529|NCT01154829|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6599530|NCT01154829|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6599531|NCT01154829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6020480|NCT00393029|Fludarabine phosphate|fludarabine phosphate|mesh-list
6020481|NCT00393029|Interleukin-2|interleukin-2|mesh-list
6020482|NCT00393029|Lenograstim|lenograstim|mesh-list
6020483|NCT00393029|Sargramostim|sargramostim|mesh-list
6020484|NCT00393029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6020485|NCT00393029|Immunologic Factors|immunologic factors|mesh-ancestor
6448750|NCT00402454|Leprostatic Agents|leprostatic agents|mesh-ancestor
6448751|NCT00402454|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6448752|NCT00402454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6448753|NCT00402454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448754|NCT00402454|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6448755|NCT00402454|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6448756|NCT00402454|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6448757|NCT00402454|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6448758|NCT00402454|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6448759|NCT00402454|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6448760|NCT00402454|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6020486|NCT00393029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599532|NCT01154881|Insulin|insulin|mesh-list
6599533|NCT01154881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6599534|NCT01154881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599535|NCT01154907|Praziquantel|praziquantel|mesh-list
6599536|NCT01154907|Anthelmintics|anthelmintics|mesh-ancestor
6599537|NCT01154907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6599538|NCT01154907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6599539|NCT01154920|Paclitaxel|paclitaxel|mesh-list
6599540|NCT01154920|Docetaxel|docetaxel|mesh-list
6599541|NCT01154920|Cisplatin|cisplatin|mesh-list
6599542|NCT01154920|Carboplatin|carboplatin|mesh-list
6599543|NCT01154920|Fluorouracil|fluorouracil|mesh-list
6599544|NCT01154920|Cetuximab|cetuximab|mesh-list
6599545|NCT01154920|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6599546|NCT01154920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6599547|NCT01154920|Tubulin Modulators|tubulin modulators|mesh-ancestor
6599548|NCT01154920|Antimitotic Agents|antimitotic agents|mesh-ancestor
6448761|NCT00402454|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6448762|NCT00402454|Antimetabolites|antimetabolites|mesh-ancestor
6448763|NCT00402454|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6448764|NCT00402467|Enoxaparin|enoxaparin|mesh-list
6448765|NCT00402467|Rivaroxaban|rivaroxaban|mesh-list
6599549|NCT01154920|Mitosis Modulators|mitosis modulators|mesh-ancestor
6599550|NCT01154920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599551|NCT01154920|Antimetabolites|antimetabolites|mesh-ancestor
6599552|NCT01154920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6599553|NCT01154920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6599554|NCT01154920|Immunologic Factors|immunologic factors|mesh-ancestor
6599555|NCT01154920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599556|NCT01154920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6599557|NCT01154933|Exenatide|exenatide|mesh-list
6448766|NCT00402467|Enoxaparin sodium|enoxaparin sodium|mesh-list
6448767|NCT00402467|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6448768|NCT00402467|Antithrombins|antithrombins|mesh-ancestor
6448769|NCT00402467|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6448770|NCT00402467|Protease Inhibitors|protease inhibitors|mesh-ancestor
6448771|NCT00402467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6599558|NCT01154933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6599559|NCT01154933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599560|NCT01154933|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6599561|NCT01154933|Incretins|incretins|mesh-ancestor
6599562|NCT01154933|Hormones|hormones|mesh-ancestor
6599563|NCT01154933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6599564|NCT01154959|Moxifloxacin|moxifloxacin|mesh-list
6599565|NCT01154959|Rifampin|rifampin|mesh-list
6599566|NCT01154959|Isoniazid|isoniazid|mesh-list
6599567|NCT01154959|Pyrazinamide|pyrazinamide|mesh-list
6599568|NCT01154959|Ethambutol|ethambutol|mesh-list
6599569|NCT01154959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6599570|NCT01154959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6599571|NCT01154959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6599572|NCT01154959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6599573|NCT01154959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6599574|NCT01154959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599575|NCT01154959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6599576|NCT01154959|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6599577|NCT01154959|Antitubercular Agents|antitubercular agents|mesh-ancestor
6599578|NCT01154959|Leprostatic Agents|leprostatic agents|mesh-ancestor
6599579|NCT01154959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6599580|NCT01154959|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6599581|NCT01154959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6599582|NCT01154959|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6599583|NCT01154959|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6599584|NCT01154959|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6599585|NCT01154959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6599586|NCT01154959|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6599587|NCT01154959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6599588|NCT01154959|Antimetabolites|antimetabolites|mesh-ancestor
6599589|NCT01154959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6599590|NCT01155037|Vaccines|vaccines|mesh-list
6599591|NCT01155037|Immunologic Factors|immunologic factors|mesh-ancestor
6599592|NCT01155037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599593|NCT01155089|Anastrozole|anastrozole|mesh-list
6448772|NCT00402467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448773|NCT00402467|Anticoagulants|anticoagulants|mesh-ancestor
6448774|NCT00402467|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6448775|NCT00402467|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6448776|NCT00402480|Hydroxyurea|hydroxyurea|mesh-list
6448777|NCT00402480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6448778|NCT00402480|Antisickling Agents|antisickling agents|mesh-ancestor
6448779|NCT00402480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6448780|NCT00402480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448781|NCT00402480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6448782|NCT00402493|Ibuprofen|ibuprofen|mesh-list
6448783|NCT00402493|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6448784|NCT00402493|Latanoprost|latanoprost|mesh-list
6599594|NCT01155089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6599595|NCT01155089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6599596|NCT01155089|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6599597|NCT01155089|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6599598|NCT01155089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6599599|NCT01155089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599600|NCT01155089|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6599601|NCT01155089|Hormone Antagonists|hormone antagonists|mesh-ancestor
6599602|NCT01155089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6599603|NCT01155089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599604|NCT01155102|Anastrozole|anastrozole|mesh-list
6599605|NCT01155102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6599606|NCT01155102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6599607|NCT01155102|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6599608|NCT01155102|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6599609|NCT01155102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6599610|NCT01155102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599611|NCT01155102|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6599612|NCT01155102|Hormone Antagonists|hormone antagonists|mesh-ancestor
6599613|NCT01155102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6599614|NCT01155102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599615|NCT01155115|Nitric Oxide|nitric oxide|mesh-list
6599616|NCT01155115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6599617|NCT01155115|Autonomic Agents|autonomic agents|mesh-ancestor
6599618|NCT01155115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6599619|NCT01155115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599620|NCT01155115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6599621|NCT01155115|Respiratory System Agents|respiratory system agents|mesh-ancestor
6599622|NCT01155115|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6599623|NCT01155115|Antioxidants|antioxidants|mesh-ancestor
6599624|NCT01155115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599625|NCT01155115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6599626|NCT01155115|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6599627|NCT01155115|Vasodilator Agents|vasodilator agents|mesh-ancestor
6599628|NCT01155115|Gasotransmitters|gasotransmitters|mesh-ancestor
6599629|NCT01155115|Protective Agents|protective agents|mesh-ancestor
6599630|NCT01155206|Glucagon|glucagon|mesh-list
6599631|NCT01155206|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6599632|NCT01155206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6599633|NCT01155206|Hormones|hormones|mesh-ancestor
6448785|NCT00402493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6448786|NCT00402493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6448787|NCT00402493|Analgesics|analgesics|mesh-ancestor
6448788|NCT00402493|Sensory System Agents|sensory system agents|mesh-ancestor
6448789|NCT00402493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6448790|NCT00402493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448791|NCT00402493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6448792|NCT00402493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6448793|NCT00402493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6448794|NCT00402493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6448795|NCT00402493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599634|NCT01155206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6599635|NCT01155206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599636|NCT01155206|Incretins|incretins|mesh-ancestor
6599637|NCT01155232|Teriparatide|teriparatide|mesh-list
6599638|NCT01155232|Parathyroid Hormone|parathyroid hormone|mesh-list
6599639|NCT01155232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599640|NCT01155232|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6599641|NCT01155232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6599642|NCT01155245|Teriparatide|teriparatide|mesh-list
6599643|NCT01155245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6599644|NCT01155245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599645|NCT01155245|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6599646|NCT01155258|Sirolimus|sirolimus|mesh-list
6599647|NCT01155258|Vinorelbine|vinorelbine|mesh-list
6599648|NCT01155258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6599649|NCT01155258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6599650|NCT01155258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6599651|NCT01155258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6599652|NCT01155258|Antifungal Agents|antifungal agents|mesh-ancestor
6599653|NCT01155258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6599654|NCT01155258|Immunologic Factors|immunologic factors|mesh-ancestor
6599655|NCT01155258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599656|NCT01155258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6599657|NCT01155258|Tubulin Modulators|tubulin modulators|mesh-ancestor
6599658|NCT01155258|Antimitotic Agents|antimitotic agents|mesh-ancestor
6599659|NCT01155258|Mitosis Modulators|mitosis modulators|mesh-ancestor
6599660|NCT01155258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599661|NCT01155440|Lidocaine|lidocaine|mesh-list
6599662|NCT01155440|Anesthetics, Local|anesthetics, local|mesh-ancestor
6599663|NCT01155440|Anesthetics|anesthetics|mesh-ancestor
6599664|NCT01155440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6599665|NCT01155440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599666|NCT01155440|Sensory System Agents|sensory system agents|mesh-ancestor
6599667|NCT01155440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6599668|NCT01155440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6599669|NCT01155440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6599670|NCT01155440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6599671|NCT01155440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6599672|NCT01155440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599673|NCT01155453|Trametinib|trametinib|mesh-list
6599674|NCT01155453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6599675|NCT01155453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6599676|NCT01155453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6599677|NCT01155453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599678|NCT01155505|Lenalidomide|lenalidomide|mesh-list
6599679|NCT01155505|Immunologic Factors|immunologic factors|mesh-ancestor
6599680|NCT01155505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599681|NCT01155505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6599682|NCT01155505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6599683|NCT01155505|Growth Substances|growth substances|mesh-ancestor
6599684|NCT01155505|Growth Inhibitors|growth inhibitors|mesh-ancestor
6599685|NCT01155505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6599686|NCT01155635|Carvedilol|carvedilol|mesh-list
6599687|NCT01155635|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6599688|NCT01155635|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6599689|NCT01155635|Adrenergic Agents|adrenergic agents|mesh-ancestor
6599690|NCT01155635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6599691|NCT01155635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599692|NCT01155635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599693|NCT01155635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6599694|NCT01155635|Antioxidants|antioxidants|mesh-ancestor
6599695|NCT01155635|Protective Agents|protective agents|mesh-ancestor
6599696|NCT01155635|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6599697|NCT01155635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6599698|NCT01155635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6599699|NCT01155635|Vasodilator Agents|vasodilator agents|mesh-ancestor
6599700|NCT01155635|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6599701|NCT01155635|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6599702|NCT01155700|Omalizumab|omalizumab|mesh-list
6599703|NCT01155700|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6599704|NCT01155700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6599705|NCT01155700|Respiratory System Agents|respiratory system agents|mesh-ancestor
6599706|NCT01155765|Clopidogrel|clopidogrel|mesh-list
6599707|NCT01155765|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6599708|NCT01155765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6599709|NCT01155765|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6599710|NCT01155765|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6599711|NCT01155765|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6599712|NCT01155765|Purinergic Agents|purinergic agents|mesh-ancestor
6599713|NCT01155765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6599714|NCT01155765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599715|NCT01155765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599716|NCT01155791|Prednisone|prednisone|mesh-list
6599717|NCT01155791|Docetaxel|docetaxel|mesh-list
6599718|NCT01155791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6599719|NCT01155791|Tubulin Modulators|tubulin modulators|mesh-ancestor
6599720|NCT01155791|Antimitotic Agents|antimitotic agents|mesh-ancestor
6599721|NCT01155791|Mitosis Modulators|mitosis modulators|mesh-ancestor
6599722|NCT01155791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599723|NCT01155791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6599724|NCT01155791|Glucocorticoids|glucocorticoids|mesh-ancestor
6599725|NCT01155791|Hormones|hormones|mesh-ancestor
6599726|NCT01155791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6599727|NCT01155791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599728|NCT01155791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6599729|NCT01155895|Amlodipine|amlodipine|mesh-list
6599730|NCT01155895|Benazepril|benazepril|mesh-list
6599731|NCT01155895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6599732|NCT01155895|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6599733|NCT01155895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6599734|NCT01155895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599735|NCT01155895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6599736|NCT01155895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599737|NCT01155895|Vasodilator Agents|vasodilator agents|mesh-ancestor
6599738|NCT01155895|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6599739|NCT01155895|Protease Inhibitors|protease inhibitors|mesh-ancestor
6599740|NCT01155895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6599741|NCT01155908|Amlodipine|amlodipine|mesh-list
6599742|NCT01155908|Benazepril|benazepril|mesh-list
6599743|NCT01155908|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6599744|NCT01155908|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6599745|NCT01155908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6599746|NCT01155908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599747|NCT01155908|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6599748|NCT01155908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599749|NCT01155908|Vasodilator Agents|vasodilator agents|mesh-ancestor
6599750|NCT01155908|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6599751|NCT01155908|Protease Inhibitors|protease inhibitors|mesh-ancestor
6599752|NCT01155908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6599753|NCT01155921|Risperidone|risperidone|mesh-list
6599754|NCT01155921|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6599755|NCT01155921|Serotonin Agents|serotonin agents|mesh-ancestor
6599756|NCT01155921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6599757|NCT01155921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599758|NCT01155921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599759|NCT01155921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6599760|NCT01155921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6599761|NCT01155921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6599762|NCT01155921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6599763|NCT01155921|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6599764|NCT01155921|Dopamine Agents|dopamine agents|mesh-ancestor
6599765|NCT01155934|Risperidone|risperidone|mesh-list
6599766|NCT01155934|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6448796|NCT00402493|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6448797|NCT00402493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6448798|NCT00402493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6448799|NCT00402493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6448800|NCT00402493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6448801|NCT00402493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6599767|NCT01155934|Serotonin Agents|serotonin agents|mesh-ancestor
6599768|NCT01155934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6599769|NCT01155934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599770|NCT01155934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599771|NCT01155934|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6599772|NCT01155934|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6599773|NCT01155934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6599774|NCT01155934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6599775|NCT01155934|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6599776|NCT01155934|Dopamine Agents|dopamine agents|mesh-ancestor
6448802|NCT00402493|Adrenergic Agents|adrenergic agents|mesh-ancestor
6448803|NCT00402493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6448804|NCT00402506|Pyridoxal|pyridoxal|mesh-list
6448805|NCT00402506|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
6448806|NCT00402506|Vitamin B Complex|vitamin b complex|mesh-ancestor
6448807|NCT00402506|Vitamins|vitamins|mesh-ancestor
6448808|NCT00402506|Micronutrients|micronutrients|mesh-ancestor
6599777|NCT01155947|Anastrozole|anastrozole|mesh-list
6659975|NCT01490411|Immunologic Factors|immunologic factors|mesh-list
6448809|NCT00402506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448810|NCT00402532|Everolimus|everolimus|mesh-list
6599778|NCT01155947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6599779|NCT01155947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6599780|NCT01155947|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6599781|NCT01155947|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6599782|NCT01155947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6599783|NCT01155947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599784|NCT01155947|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6599785|NCT01155947|Hormone Antagonists|hormone antagonists|mesh-ancestor
6599786|NCT01155947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6599787|NCT01155947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599788|NCT01155960|Anastrozole|anastrozole|mesh-list
6599789|NCT01155960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6599790|NCT01155960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6599791|NCT01155960|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6599792|NCT01155960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6599793|NCT01155960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6599794|NCT01155960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599795|NCT01155960|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6599796|NCT01155960|Hormone Antagonists|hormone antagonists|mesh-ancestor
6599797|NCT01155960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6599798|NCT01155960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599799|NCT01155986|Lidocaine|lidocaine|mesh-list
6599800|NCT01155986|Anesthetics, Local|anesthetics, local|mesh-ancestor
6599801|NCT01155986|Anesthetics|anesthetics|mesh-ancestor
6599802|NCT01155986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6599803|NCT01155986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599804|NCT01155986|Sensory System Agents|sensory system agents|mesh-ancestor
6599805|NCT01155986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6599806|NCT01155986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6599807|NCT01155986|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6599808|NCT01155986|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6599809|NCT01155986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6599810|NCT01155986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599811|NCT01156077|Tedizolid phosphate|tedizolid phosphate|mesh-list
6599812|NCT01156077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6599813|NCT01156077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6599814|NCT01156129|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
6599815|NCT01156129|Antidiarrheals|antidiarrheals|mesh-ancestor
6599816|NCT01156129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6599817|NCT01156220|Furosemide|furosemide|mesh-list
6599818|NCT01156220|Diuretics|diuretics|mesh-ancestor
6599819|NCT01156220|Natriuretic Agents|natriuretic agents|mesh-ancestor
6599820|NCT01156220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599821|NCT01156220|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6599822|NCT01156220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6599823|NCT01156220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599824|NCT01156233|Anesthetics|anesthetics|mesh-list
6599825|NCT01156233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6599826|NCT01156233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599827|NCT01156246|Metformin|metformin|mesh-list
6599828|NCT01156246|Dapagliflozin|dapagliflozin|mesh-list
6599829|NCT01156246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6599830|NCT01156246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020487|NCT00393029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6599831|NCT01156246|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6599832|NCT01156246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599833|NCT01156350|Fludarabine|fludarabine|mesh-list
6599834|NCT01156350|Busulfan|busulfan|mesh-list
6599835|NCT01156350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6599836|NCT01156350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599837|NCT01156350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6599838|NCT01156350|Immunologic Factors|immunologic factors|mesh-ancestor
6599839|NCT01156350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599840|NCT01156350|Alkylating Agents|alkylating agents|mesh-ancestor
6599841|NCT01156350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6599842|NCT01156350|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6599843|NCT01156389|Ritonavir|ritonavir|mesh-list
6599844|NCT01156389|Artesunate|artesunate|mesh-list
6599845|NCT01156389|Pyronaridine|pyronaridine|mesh-list
6599846|NCT01156389|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6599847|NCT01156389|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6599848|NCT01156389|Protease Inhibitors|protease inhibitors|mesh-ancestor
6599849|NCT01156389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6599850|NCT01156389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599851|NCT01156389|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6599852|NCT01156389|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6599853|NCT01156389|Antiviral Agents|antiviral agents|mesh-ancestor
6599854|NCT01156389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6599855|NCT01156389|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6599856|NCT01156389|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6599857|NCT01156389|Antimalarials|antimalarials|mesh-ancestor
6599858|NCT01156389|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6599859|NCT01156389|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6599860|NCT01156389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6599861|NCT01156389|Schistosomicides|schistosomicides|mesh-ancestor
6599862|NCT01156389|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6599863|NCT01156389|Anthelmintics|anthelmintics|mesh-ancestor
6599864|NCT01156519|Hydrocortisone|hydrocortisone|mesh-list
6599865|NCT01156519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6599866|NCT01156545|Afatinib|afatinib|mesh-list
6599867|NCT01156545|Simvastatin|simvastatin|mesh-list
6599868|NCT01156545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6599869|NCT01156545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6599870|NCT01156545|Antimetabolites|antimetabolites|mesh-ancestor
6599871|NCT01156545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599872|NCT01156545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6599873|NCT01156545|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6599874|NCT01156545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6599875|NCT01156545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6599876|NCT01156545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6659976|NCT01490411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659977|NCT01490437|Dexamethasone|dexamethasone|mesh-list
6659978|NCT01490437|Pemetrexed|pemetrexed|mesh-list
6659979|NCT01490437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659980|NCT01490437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6659981|NCT01490437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6659982|NCT01490437|Antiemetics|antiemetics|mesh-ancestor
6659983|NCT01490437|Autonomic Agents|autonomic agents|mesh-ancestor
6659984|NCT01490437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6659985|NCT01490437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6659986|NCT01490437|Glucocorticoids|glucocorticoids|mesh-ancestor
6659987|NCT01490437|Hormones|hormones|mesh-ancestor
6659988|NCT01490437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6659989|NCT01490437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6659990|NCT01490437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6599877|NCT01156584|Flucytosine|flucytosine|mesh-list
6599878|NCT01156584|Antifungal Agents|antifungal agents|mesh-ancestor
6599879|NCT01156584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6599880|NCT01156584|Antimetabolites|antimetabolites|mesh-ancestor
6599881|NCT01156584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599882|NCT01156636|Sildenafil Citrate|sildenafil citrate|mesh-list
6599883|NCT01156636|Vasodilator Agents|vasodilator agents|mesh-ancestor
6599884|NCT01156636|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6599885|NCT01156636|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6599886|NCT01156636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6599887|NCT01156636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599888|NCT01156636|Urological Agents|urological agents|mesh-ancestor
6599889|NCT01156649|Acetaminophen|acetaminophen|mesh-list
6599890|NCT01156649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6599891|NCT01156649|Analgesics|analgesics|mesh-ancestor
6599892|NCT01156649|Sensory System Agents|sensory system agents|mesh-ancestor
6599893|NCT01156649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6599894|NCT01156649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599895|NCT01156649|Antipyretics|antipyretics|mesh-ancestor
6599896|NCT01156688|Misoprostol|misoprostol|mesh-list
6599897|NCT01156688|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6599898|NCT01156688|Abortifacient Agents|abortifacient agents|mesh-ancestor
6599899|NCT01156688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6599900|NCT01156688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599901|NCT01156688|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6599902|NCT01156688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6599903|NCT01156688|Oxytocics|oxytocics|mesh-ancestor
6599904|NCT01156740|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6599905|NCT01156740|Amoxicillin|amoxicillin|mesh-list
6599906|NCT01156740|Penicillins|penicillins|mesh-list
6599907|NCT01156740|beta-Lactams|beta-lactams|mesh-list
6599908|NCT01156740|Penicillin G|penicillin g|mesh-list
6599909|NCT01156740|Penicillin G Benzathine|penicillin g benzathine|mesh-list
6599910|NCT01156740|Penicillin G Procaine|penicillin g procaine|mesh-list
6599911|NCT01156740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6599912|NCT01156779|Exenatide|exenatide|mesh-list
6599913|NCT01156779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6599914|NCT01156779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599915|NCT01156779|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6599916|NCT01156779|Incretins|incretins|mesh-ancestor
6599917|NCT01156779|Hormones|hormones|mesh-ancestor
6599918|NCT01156779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6599919|NCT01156857|Ulipristal acetate|ulipristal acetate|mesh-list
6599920|NCT01156857|Progestins|progestins|mesh-list
6599921|NCT01156857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6599922|NCT01156857|Contraceptive Agents|contraceptive agents|mesh-ancestor
6599923|NCT01156857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6599924|NCT01156857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599925|NCT01156857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6599926|NCT01156857|Hormones|hormones|mesh-ancestor
6599927|NCT01156857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6599928|NCT01156883|Cytarabine|cytarabine|mesh-list
6599929|NCT01156883|Dexamethasone|dexamethasone|mesh-list
6599930|NCT01156883|Prednisone|prednisone|mesh-list
6599931|NCT01156883|Methylprednisolone|methylprednisolone|mesh-list
6599932|NCT01156883|Cyclophosphamide|cyclophosphamide|mesh-list
6599933|NCT01156883|Ifosfamide|ifosfamide|mesh-list
6599934|NCT01156883|Doxorubicin|doxorubicin|mesh-list
6599935|NCT01156883|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6599936|NCT01156883|Methotrexate|methotrexate|mesh-list
6599937|NCT01156883|Vincristine|vincristine|mesh-list
6599938|NCT01156883|Daunorubicin|daunorubicin|mesh-list
6599939|NCT01156883|Asparaginase|asparaginase|mesh-list
6599940|NCT01156883|Mercaptopurine|mercaptopurine|mesh-list
6599941|NCT01156883|Thioguanine|thioguanine|mesh-list
6599942|NCT01156883|Vindesine|vindesine|mesh-list
6599943|NCT01156883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6599944|NCT01156883|Immunologic Factors|immunologic factors|mesh-ancestor
6599945|NCT01156883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599946|NCT01156883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6599947|NCT01156883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6599948|NCT01156883|Alkylating Agents|alkylating agents|mesh-ancestor
6599949|NCT01156883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6599950|NCT01156883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6599951|NCT01156883|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6599952|NCT01156883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6599953|NCT01156883|Antiemetics|antiemetics|mesh-ancestor
6599954|NCT01156883|Autonomic Agents|autonomic agents|mesh-ancestor
6599955|NCT01156883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6599956|NCT01156883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6599957|NCT01156883|Glucocorticoids|glucocorticoids|mesh-ancestor
6599958|NCT01156883|Hormones|hormones|mesh-ancestor
6599959|NCT01156883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6599960|NCT01156883|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6599961|NCT01156883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6599962|NCT01156883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6599963|NCT01156883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6599964|NCT01156883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6599965|NCT01156883|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6599966|NCT01156883|Abortifacient Agents|abortifacient agents|mesh-ancestor
6599967|NCT01156883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6599968|NCT01156883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6599969|NCT01156883|Antimetabolites|antimetabolites|mesh-ancestor
6599970|NCT01156883|Dermatologic Agents|dermatologic agents|mesh-ancestor
6599971|NCT01156883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6599972|NCT01156883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6599973|NCT01156883|Antiviral Agents|antiviral agents|mesh-ancestor
6599974|NCT01156883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6599975|NCT01156883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6599976|NCT01156883|Tubulin Modulators|tubulin modulators|mesh-ancestor
6599977|NCT01156883|Antimitotic Agents|antimitotic agents|mesh-ancestor
6599978|NCT01156883|Mitosis Modulators|mitosis modulators|mesh-ancestor
6599979|NCT01156883|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6599980|NCT01156883|Protective Agents|protective agents|mesh-ancestor
6599981|NCT01156909|Rituximab|rituximab|mesh-list
6599982|NCT01156909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6599983|NCT01156909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6599984|NCT01156909|Immunologic Factors|immunologic factors|mesh-ancestor
6599985|NCT01156909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599986|NCT01156909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6599987|NCT01156922|Rituximab|rituximab|mesh-list
6599988|NCT01156922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6599989|NCT01156922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6599990|NCT01156922|Immunologic Factors|immunologic factors|mesh-ancestor
6599991|NCT01156922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599992|NCT01156922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6599993|NCT01156948|Misoprostol|misoprostol|mesh-list
6599994|NCT01156948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6599995|NCT01156948|Abortifacient Agents|abortifacient agents|mesh-ancestor
6599996|NCT01156948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6599997|NCT01156948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6599998|NCT01156948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6599999|NCT01156948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6600000|NCT01156948|Oxytocics|oxytocics|mesh-ancestor
6600001|NCT01156961|Paclitaxel|paclitaxel|mesh-list
6600002|NCT01156961|Bevacizumab|bevacizumab|mesh-list
6600003|NCT01156961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6600004|NCT01156961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6600005|NCT01156961|Tubulin Modulators|tubulin modulators|mesh-ancestor
6600006|NCT01156961|Antimitotic Agents|antimitotic agents|mesh-ancestor
6600007|NCT01156961|Mitosis Modulators|mitosis modulators|mesh-ancestor
6600008|NCT01156961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600009|NCT01156961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6600010|NCT01156961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6600011|NCT01156961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6600012|NCT01156961|Growth Substances|growth substances|mesh-ancestor
6600013|NCT01156961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600014|NCT01156961|Growth Inhibitors|growth inhibitors|mesh-ancestor
6600015|NCT01157000|Canagliflozin|canagliflozin|mesh-list
6600016|NCT01157000|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6600017|NCT01157000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600018|NCT01157000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6600019|NCT01157000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600020|NCT01157013|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6600021|NCT01157013|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6600022|NCT01157013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600023|NCT01157026|Tamoxifen|tamoxifen|mesh-list
6600024|NCT01157026|Tocotrienols|tocotrienols|mesh-list
6600025|NCT01157026|Vitamin E|vitamin e|mesh-list
6600026|NCT01157026|Tocopherols|tocopherols|mesh-list
6600027|NCT01157026|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6600028|NCT01157026|Hormone Antagonists|hormone antagonists|mesh-ancestor
6600029|NCT01157026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6600030|NCT01157026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600031|NCT01157026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6600032|NCT01157026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6600033|NCT01157026|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6600034|NCT01157026|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6600035|NCT01157026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6448811|NCT00402532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6020488|NCT00393029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6020489|NCT00393029|Alkylating Agents|alkylating agents|mesh-ancestor
6020490|NCT00393029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020491|NCT00393029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6020492|NCT00393029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6020493|NCT00393029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6020494|NCT00393029|Antimetabolites|antimetabolites|mesh-ancestor
6020495|NCT00393029|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6020496|NCT00393029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6020497|NCT00393029|Analgesics|analgesics|mesh-ancestor
6020498|NCT00393029|Sensory System Agents|sensory system agents|mesh-ancestor
6020499|NCT00393029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6020500|NCT00393029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6020501|NCT00393029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6600036|NCT01157026|Antioxidants|antioxidants|mesh-ancestor
6600037|NCT01157026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448812|NCT00402532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6448813|NCT00402532|Immunologic Factors|immunologic factors|mesh-ancestor
6448814|NCT00402532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461834|NCT00456339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6461835|NCT00456339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461836|NCT00456339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6461837|NCT00456339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6461838|NCT00456339|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6461839|NCT00456339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6461840|NCT00456339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461841|NCT00456430|Citalopram|citalopram|mesh-list
6600038|NCT01157026|Protective Agents|protective agents|mesh-ancestor
6600039|NCT01157026|Vitamins|vitamins|mesh-ancestor
6600040|NCT01157026|Micronutrients|micronutrients|mesh-ancestor
6600041|NCT01157052|Capecitabine|capecitabine|mesh-list
6600042|NCT01157052|Oxaliplatin|oxaliplatin|mesh-list
6600043|NCT01157052|Calcium|calcium|mesh-list
6600044|NCT01157052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6600045|NCT01157052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600046|NCT01157052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6600047|NCT01157052|Antimetabolites|antimetabolites|mesh-ancestor
6600048|NCT01157052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600049|NCT01157052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6600050|NCT01157247|Fentanyl|fentanyl|mesh-list
6600051|NCT01157247|Anesthetics|anesthetics|mesh-list
6600052|NCT01157247|Anesthetics, Local|anesthetics, local|mesh-list
6600053|NCT01157247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6600054|NCT01157247|Narcotics|narcotics|mesh-ancestor
6600055|NCT01157247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6600056|NCT01157247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600057|NCT01157247|Analgesics|analgesics|mesh-ancestor
6600058|NCT01157247|Sensory System Agents|sensory system agents|mesh-ancestor
6600059|NCT01157247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6600060|NCT01157247|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6600061|NCT01157247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6600062|NCT01157247|Anesthetics, General|anesthetics, general|mesh-ancestor
6600063|NCT01157312|Citric Acid|citric acid|mesh-list
6600064|NCT01157312|Sodium Citrate|sodium citrate|mesh-list
6600065|NCT01157312|Clomiphene|clomiphene|mesh-list
6600066|NCT01157312|Enclomiphene|enclomiphene|mesh-list
6600067|NCT01157312|Zuclomiphene|zuclomiphene|mesh-list
6600068|NCT01157312|Anticoagulants|anticoagulants|mesh-ancestor
6600069|NCT01157312|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6600070|NCT01157312|Chelating Agents|chelating agents|mesh-ancestor
6600071|NCT01157312|Sequestering Agents|sequestering agents|mesh-ancestor
6600072|NCT01157312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600073|NCT01157312|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6600074|NCT01157312|Hormone Antagonists|hormone antagonists|mesh-ancestor
6600075|NCT01157312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6600076|NCT01157312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600077|NCT01157312|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6600078|NCT01157312|Fertility Agents|fertility agents|mesh-ancestor
6600079|NCT01157312|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6600080|NCT01157312|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6600081|NCT01157312|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6600082|NCT01157455|Aspirin|aspirin|mesh-list
6600083|NCT01157455|Everolimus|everolimus|mesh-list
6600084|NCT01157455|Heparin|heparin|mesh-list
6600085|NCT01157455|Bivalirudin|bivalirudin|mesh-list
6600086|NCT01157455|Clopidogrel|clopidogrel|mesh-list
6600087|NCT01157455|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6600088|NCT01157455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6600089|NCT01157455|Analgesics|analgesics|mesh-ancestor
6600090|NCT01157455|Sensory System Agents|sensory system agents|mesh-ancestor
6600091|NCT01157455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6600092|NCT01157455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600093|NCT01157455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6600094|NCT01157455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6600095|NCT01157455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6600096|NCT01157455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6600097|NCT01157455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600098|NCT01157455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6600099|NCT01157455|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6600100|NCT01157455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6600101|NCT01157455|Antipyretics|antipyretics|mesh-ancestor
6600102|NCT01157455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6600103|NCT01157455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6600104|NCT01157455|Immunologic Factors|immunologic factors|mesh-ancestor
6600105|NCT01157455|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6600106|NCT01157455|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6600107|NCT01157455|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6600108|NCT01157455|Purinergic Agents|purinergic agents|mesh-ancestor
6600109|NCT01157455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6600110|NCT01157455|Anticoagulants|anticoagulants|mesh-ancestor
6600111|NCT01157455|Antithrombins|antithrombins|mesh-ancestor
6600112|NCT01157455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6600113|NCT01157455|Protease Inhibitors|protease inhibitors|mesh-ancestor
6600114|NCT01157481|Nifedipine|nifedipine|mesh-list
6600115|NCT01157481|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6600116|NCT01157481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6600117|NCT01157481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600118|NCT01157481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6600119|NCT01157481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600120|NCT01157481|Vasodilator Agents|vasodilator agents|mesh-ancestor
6600121|NCT01157481|Tocolytic Agents|tocolytic agents|mesh-ancestor
6600122|NCT01157481|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6600123|NCT01157507|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6600124|NCT01157507|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6600125|NCT01157507|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6600126|NCT01157507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6600127|NCT01157507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600128|NCT01157507|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6600129|NCT01157507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6600130|NCT01157507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600131|NCT01157507|Cholinergic Agents|cholinergic agents|mesh-ancestor
6600132|NCT01157507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6600133|NCT01157546|Lidocaine|lidocaine|mesh-list
6600134|NCT01157546|Anesthetics, Local|anesthetics, local|mesh-ancestor
6600135|NCT01157546|Anesthetics|anesthetics|mesh-ancestor
6600136|NCT01157546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6600137|NCT01157546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600138|NCT01157546|Sensory System Agents|sensory system agents|mesh-ancestor
6600139|NCT01157546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6600140|NCT01157546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6600141|NCT01157546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6600142|NCT01157546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6600143|NCT01157546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6600144|NCT01157546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600145|NCT01157559|Ziprasidone|ziprasidone|mesh-list
6600146|NCT01157559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6600147|NCT01157559|Serotonin Agents|serotonin agents|mesh-ancestor
6600148|NCT01157559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6600149|NCT01157559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600150|NCT01157559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600151|NCT01157559|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6600152|NCT01157559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6600153|NCT01157559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6600154|NCT01157559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6600155|NCT01157559|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6600156|NCT01157559|Dopamine Agents|dopamine agents|mesh-ancestor
6600157|NCT01157572|Metoprolol|metoprolol|mesh-list
6600158|NCT01157572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6600159|NCT01157572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6600160|NCT01157572|Sympatholytics|sympatholytics|mesh-ancestor
6600161|NCT01157572|Autonomic Agents|autonomic agents|mesh-ancestor
6600162|NCT01157572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6600163|NCT01157572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600164|NCT01157572|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6600165|NCT01157572|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6600166|NCT01157572|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6600167|NCT01157572|Adrenergic Agents|adrenergic agents|mesh-ancestor
6600168|NCT01157572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6600169|NCT01157572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600170|NCT01157585|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6600171|NCT01157585|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6600172|NCT01157585|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6600173|NCT01157585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6600174|NCT01157585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600175|NCT01157585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6600176|NCT01157585|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6600177|NCT01157585|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6600178|NCT01157585|Serotonin Agents|serotonin agents|mesh-ancestor
6600179|NCT01157585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6600180|NCT01157585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600181|NCT01157585|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6600182|NCT01157585|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6600183|NCT01157585|Dopamine Agents|dopamine agents|mesh-ancestor
6600184|NCT01157754|Levonorgestrel|levonorgestrel|mesh-list
6600185|NCT01157754|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6600186|NCT01157754|Contraceptive Agents|contraceptive agents|mesh-ancestor
6600187|NCT01157754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6600188|NCT01157754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600189|NCT01157754|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6600190|NCT01157754|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6600191|NCT01157754|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6600192|NCT01157819|Ciprofloxacin|ciprofloxacin|mesh-list
6600193|NCT01157819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6600194|NCT01157819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6600195|NCT01157819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6600196|NCT01157819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6600197|NCT01157819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6600198|NCT01157819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600199|NCT01157819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6600200|NCT01157819|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6600201|NCT01157819|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6600202|NCT01157858|Everolimus|everolimus|mesh-list
6600203|NCT01157858|Octreotide|octreotide|mesh-list
6600204|NCT01157858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6600205|NCT01157858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6600206|NCT01157858|Immunologic Factors|immunologic factors|mesh-ancestor
6600207|NCT01157858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020502|NCT00393029|Antiviral Agents|antiviral agents|mesh-ancestor
6020503|NCT00393029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6020504|NCT00393042|Amphetamine|amphetamine|mesh-list
6448815|NCT00402545|Docetaxel|docetaxel|mesh-list
6448816|NCT00402545|Fluorouracil|fluorouracil|mesh-list
6448817|NCT00402545|Cetuximab|cetuximab|mesh-list
6448818|NCT00402545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6448819|NCT00402545|Tubulin Modulators|tubulin modulators|mesh-ancestor
6448820|NCT00402545|Antimitotic Agents|antimitotic agents|mesh-ancestor
6600208|NCT01157858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6600209|NCT01157858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6600210|NCT01157936|Allopurinol|allopurinol|mesh-list
6600211|NCT01157936|Antimetabolites|antimetabolites|mesh-ancestor
6448821|NCT00402545|Mitosis Modulators|mitosis modulators|mesh-ancestor
6448822|NCT00402545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600212|NCT01157936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600213|NCT01157936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6600214|NCT01157936|Gout Suppressants|gout suppressants|mesh-ancestor
6600215|NCT01157936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6600216|NCT01157936|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6600217|NCT01157936|Antioxidants|antioxidants|mesh-ancestor
6600218|NCT01157936|Protective Agents|protective agents|mesh-ancestor
6600219|NCT01157936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600220|NCT01157949|Thymoglobulin|thymoglobulin|mesh-list
6600221|NCT01157949|Immunologic Factors|immunologic factors|mesh-ancestor
6600222|NCT01157949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600223|NCT01157949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6600224|NCT01157975|Pioglitazone|pioglitazone|mesh-list
6600225|NCT01157975|Prednisone|prednisone|mesh-list
6600226|NCT01157975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6600227|NCT01157975|Glucocorticoids|glucocorticoids|mesh-ancestor
6020505|NCT00393042|Adderall|adderall|mesh-list
6448823|NCT00402545|Antimetabolites|antimetabolites|mesh-ancestor
6448824|NCT00402545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6448825|NCT00402545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6448826|NCT00402545|Immunologic Factors|immunologic factors|mesh-ancestor
6448827|NCT00402545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600228|NCT01157975|Hormones|hormones|mesh-ancestor
6665118|NCT01515826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6600229|NCT01157975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6600230|NCT01157975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600231|NCT01157975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6600232|NCT01157975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6600233|NCT01157975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6600234|NCT01158014|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6600235|NCT01158014|Hemostatics|hemostatics|mesh-ancestor
6600236|NCT01158014|Coagulants|coagulants|mesh-ancestor
6600237|NCT01158105|Bortezomib|bortezomib|mesh-list
6600238|NCT01158105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6600239|NCT01158144|Paclitaxel|paclitaxel|mesh-list
6600240|NCT01158144|Carboplatin|carboplatin|mesh-list
6600241|NCT01158144|Endostar protein|endostar protein|mesh-list
6600242|NCT01158144|Endostatins|endostatins|mesh-list
6600243|NCT01158144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6600244|NCT01158144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6600245|NCT01158144|Tubulin Modulators|tubulin modulators|mesh-ancestor
5501770|NCT04470752|Sensory System Agents|sensory system agents|mesh-ancestor
6600246|NCT01158144|Antimitotic Agents|antimitotic agents|mesh-ancestor
6600247|NCT01158144|Mitosis Modulators|mitosis modulators|mesh-ancestor
6600248|NCT01158144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600249|NCT01158144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6600250|NCT01158144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6600251|NCT01158144|Growth Substances|growth substances|mesh-ancestor
6600252|NCT01158144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600253|NCT01158144|Growth Inhibitors|growth inhibitors|mesh-ancestor
6600254|NCT01158170|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6600255|NCT01158170|Gefitinib|gefitinib|mesh-list
6600256|NCT01158170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6600257|NCT01158170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6600258|NCT01158170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6600259|NCT01158170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600260|NCT01158183|Interferons|interferons|mesh-list
6600261|NCT01158183|Interferon-beta|interferon-beta|mesh-list
6600262|NCT01158183|Interferon beta-1b|interferon beta-1b|mesh-list
6600263|NCT01158183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6600264|NCT01158183|Antiviral Agents|antiviral agents|mesh-ancestor
6600265|NCT01158183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6600266|NCT01158183|Immunologic Factors|immunologic factors|mesh-ancestor
6600267|NCT01158183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600268|NCT01158183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6659991|NCT01490437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6659992|NCT01490437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6659993|NCT01490437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6659994|NCT01490476|Everolimus|everolimus|mesh-list
6659995|NCT01490476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6659996|NCT01490476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6659997|NCT01490476|Immunologic Factors|immunologic factors|mesh-ancestor
6659998|NCT01490476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501771|NCT04470752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5501772|NCT04470752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6659999|NCT01490502|Vitamin D|vitamin d|mesh-list
6600269|NCT01158248|Panitumumab|panitumumab|mesh-list
6600270|NCT01158248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6600271|NCT01158248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6600272|NCT01158274|Capecitabine|capecitabine|mesh-list
6600273|NCT01158274|R04929097|r04929097|mesh-list
6600274|NCT01158274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6600275|NCT01158274|Antimetabolites|antimetabolites|mesh-ancestor
6600276|NCT01158274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600277|NCT01158274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6600278|NCT01158274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6600279|NCT01158287|Sorafenib|sorafenib|mesh-list
6600280|NCT01158287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6600281|NCT01158287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6600282|NCT01158287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6600283|NCT01158287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600284|NCT01158365|Glycerol|glycerol|mesh-list
6600285|NCT01158365|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6600286|NCT01158365|Protective Agents|protective agents|mesh-ancestor
6600287|NCT01158365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600288|NCT01158417|Resveratrol|resveratrol|mesh-list
6600289|NCT01158417|Antioxidants|antioxidants|mesh-ancestor
6600290|NCT01158417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600291|NCT01158417|Protective Agents|protective agents|mesh-ancestor
6600292|NCT01158417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600293|NCT01158417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6600294|NCT01158417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6600295|NCT01158560|Vitamin D|vitamin d|mesh-list
6600296|NCT01158560|Cholecalciferol|cholecalciferol|mesh-list
6600297|NCT01158560|Vitamins|vitamins|mesh-ancestor
6600298|NCT01158560|Micronutrients|micronutrients|mesh-ancestor
6600299|NCT01158560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600300|NCT01158560|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6600301|NCT01158560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6600302|NCT01158586|Levobupivacaine|levobupivacaine|mesh-list
6600303|NCT01158586|Anesthetics, Local|anesthetics, local|mesh-ancestor
6600304|NCT01158586|Anesthetics|anesthetics|mesh-ancestor
6600305|NCT01158586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6600306|NCT01158586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600307|NCT01158586|Sensory System Agents|sensory system agents|mesh-ancestor
6600308|NCT01158586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6600309|NCT01158612|Hormones|hormones|mesh-list
6600310|NCT01158612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6600311|NCT01158612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600312|NCT01158729|Antithrombins|antithrombins|mesh-list
6600313|NCT01158729|Antithrombin III|antithrombin iii|mesh-list
6600314|NCT01158729|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6600315|NCT01158729|Protease Inhibitors|protease inhibitors|mesh-ancestor
6600316|NCT01158729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6600317|NCT01158729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600318|NCT01158729|Anticoagulants|anticoagulants|mesh-ancestor
6600319|NCT01158755|Moxifloxacin|moxifloxacin|mesh-list
6600320|NCT01158755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6600321|NCT01158755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6600322|NCT01158755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6448828|NCT00402545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6448829|NCT00402558|Aldesleukin|aldesleukin|mesh-list
6448830|NCT00402558|Methotrexate|methotrexate|mesh-list
6448831|NCT00402558|Fludarabine phosphate|fludarabine phosphate|mesh-list
6448832|NCT00402558|Fludarabine|fludarabine|mesh-list
6448833|NCT00402558|Busulfan|busulfan|mesh-list
6448834|NCT00402558|Interleukin-2|interleukin-2|mesh-list
6448835|NCT00402558|Tacrolimus|tacrolimus|mesh-list
6448836|NCT00402558|Thymoglobulin|thymoglobulin|mesh-list
6448837|NCT00402558|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6448838|NCT00402558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6600323|NCT01158755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6020506|NCT00393042|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
6600324|NCT01158755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6600325|NCT01158755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600326|NCT01158755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6600327|NCT01158846|Bivalirudin|bivalirudin|mesh-list
6600328|NCT01158846|Abciximab|abciximab|mesh-list
6600329|NCT01158846|Clopidogrel|clopidogrel|mesh-list
6600330|NCT01158846|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6020507|NCT00393042|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6020508|NCT00393042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600331|NCT01158846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6600332|NCT01158846|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6600333|NCT01158846|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6600334|NCT01158846|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6600335|NCT01158846|Purinergic Agents|purinergic agents|mesh-ancestor
6600336|NCT01158846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6020509|NCT00393042|Sympathomimetics|sympathomimetics|mesh-ancestor
6020510|NCT00393042|Autonomic Agents|autonomic agents|mesh-ancestor
6020511|NCT00393042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6020512|NCT00393042|Dopamine Agents|dopamine agents|mesh-ancestor
6020513|NCT00393042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6020514|NCT00393042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020515|NCT00393042|Adrenergic Agents|adrenergic agents|mesh-ancestor
6448839|NCT00402558|Abortifacient Agents|abortifacient agents|mesh-ancestor
6448840|NCT00402558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6448841|NCT00402558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448842|NCT00402558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6600337|NCT01158846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600338|NCT01158846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600339|NCT01158846|Antithrombins|antithrombins|mesh-ancestor
6600340|NCT01158846|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6600341|NCT01158846|Protease Inhibitors|protease inhibitors|mesh-ancestor
6600342|NCT01158846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6600343|NCT01158846|Anticoagulants|anticoagulants|mesh-ancestor
6600344|NCT01158859|Pregabalin|pregabalin|mesh-list
6600345|NCT01158859|Analgesics|analgesics|mesh-ancestor
6600346|NCT01158859|Sensory System Agents|sensory system agents|mesh-ancestor
6600347|NCT01158859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6600348|NCT01158859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600349|NCT01158859|Anticonvulsants|anticonvulsants|mesh-ancestor
6600350|NCT01158859|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6600351|NCT01158859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6600352|NCT01158859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600353|NCT01158859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6600354|NCT01158859|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6600355|NCT01158859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6600356|NCT01158859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6600357|NCT01158859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6600358|NCT01158937|Meropenem|meropenem|mesh-list
6600359|NCT01158937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6600360|NCT01158937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6600361|NCT01159080|Mycophenolic Acid|mycophenolic acid|mesh-list
6600362|NCT01159080|Tacrolimus|tacrolimus|mesh-list
6600363|NCT01159080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6600364|NCT01159080|Immunologic Factors|immunologic factors|mesh-ancestor
6600365|NCT01159080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600366|NCT01159080|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6600367|NCT01159080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6600368|NCT01159080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600369|NCT01159080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6600370|NCT01159080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6600371|NCT01159080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6600372|NCT01159080|Antitubercular Agents|antitubercular agents|mesh-ancestor
6600373|NCT01159080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6600374|NCT01159080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6600375|NCT01159132|Raltegravir Potassium|raltegravir potassium|mesh-list
6600376|NCT01159132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6600377|NCT01159132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6600378|NCT01159132|Antiviral Agents|antiviral agents|mesh-ancestor
6600379|NCT01159132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6600380|NCT01159132|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6600381|NCT01159132|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6448843|NCT00402558|Antimetabolites|antimetabolites|mesh-ancestor
6448844|NCT00402558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448845|NCT00402558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6448846|NCT00402558|Dermatologic Agents|dermatologic agents|mesh-ancestor
6448847|NCT00402558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6448848|NCT00402558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6600382|NCT01159132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6600383|NCT01159132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600384|NCT01159145|Omeprazole|omeprazole|mesh-list
6600385|NCT01159145|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6600386|NCT01159145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6600387|NCT01159145|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6600388|NCT01159145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6600389|NCT01159145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600390|NCT01159158|Nateglinide|nateglinide|mesh-list
6600391|NCT01159158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6600392|NCT01159158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600393|NCT01159210|Thrombin|thrombin|mesh-list
6600394|NCT01159210|Hemostatics|hemostatics|mesh-ancestor
6600395|NCT01159210|Coagulants|coagulants|mesh-ancestor
6600396|NCT01159236|Paclitaxel|paclitaxel|mesh-list
6600397|NCT01159236|Cyclophosphamide|cyclophosphamide|mesh-list
6600398|NCT01159236|Bevacizumab|bevacizumab|mesh-list
6600399|NCT01159236|Doxorubicin|doxorubicin|mesh-list
6600400|NCT01159236|Fluorouracil|fluorouracil|mesh-list
6600401|NCT01159236|Epirubicin|epirubicin|mesh-list
6600402|NCT01159236|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6600403|NCT01159236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6600404|NCT01159236|Tubulin Modulators|tubulin modulators|mesh-ancestor
6448849|NCT00402558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6448850|NCT00402558|Immunologic Factors|immunologic factors|mesh-ancestor
6448851|NCT00402558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6600405|NCT01159236|Antimitotic Agents|antimitotic agents|mesh-ancestor
6600406|NCT01159236|Mitosis Modulators|mitosis modulators|mesh-ancestor
6600407|NCT01159236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600408|NCT01159236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6600409|NCT01159236|Immunologic Factors|immunologic factors|mesh-ancestor
6600410|NCT01159236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600411|NCT01159236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6600412|NCT01159236|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6600413|NCT01159236|Alkylating Agents|alkylating agents|mesh-ancestor
6600414|NCT01159236|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6600415|NCT01159236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6600416|NCT01159236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6600417|NCT01159236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6600418|NCT01159236|Growth Substances|growth substances|mesh-ancestor
6600419|NCT01159236|Growth Inhibitors|growth inhibitors|mesh-ancestor
6600420|NCT01159236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6600421|NCT01159236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6600422|NCT01159236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6600423|NCT01159236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6600424|NCT01159236|Antimetabolites|antimetabolites|mesh-ancestor
6600425|NCT01159236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6600426|NCT01159275|Lopinavir|lopinavir|mesh-list
6600427|NCT01159275|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6600428|NCT01159275|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6600429|NCT01159275|Protease Inhibitors|protease inhibitors|mesh-ancestor
6600430|NCT01159275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6600431|NCT01159275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600432|NCT01159275|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6600433|NCT01159275|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6600434|NCT01159275|Antiviral Agents|antiviral agents|mesh-ancestor
6600435|NCT01159275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6600436|NCT01159275|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6600437|NCT01159275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6600438|NCT01159301|Sorafenib|sorafenib|mesh-list
6600439|NCT01159301|Entinostat|entinostat|mesh-list
6600440|NCT01159301|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
6600441|NCT01159301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6600442|NCT01159301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6600443|NCT01159301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6600444|NCT01159301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600445|NCT01159327|Sorafenib|sorafenib|mesh-list
6600446|NCT01159327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6600447|NCT01159327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6600448|NCT01159327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6600449|NCT01159327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600450|NCT01159353|Insulin|insulin|mesh-list
6600451|NCT01159353|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6600452|NCT01159353|Insulin Aspart|insulin aspart|mesh-list
6600453|NCT01159353|Insulin glulisine|insulin glulisine|mesh-list
6600454|NCT01159353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6600455|NCT01159353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600456|NCT01159379|Ertapenem|ertapenem|mesh-list
6600457|NCT01159379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6600458|NCT01159379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6600459|NCT01159418|Paclitaxel|paclitaxel|mesh-list
6600460|NCT01159418|Carboplatin|carboplatin|mesh-list
6600461|NCT01159418|Panobinostat|panobinostat|mesh-list
6600462|NCT01159418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6600463|NCT01159418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6600464|NCT01159418|Tubulin Modulators|tubulin modulators|mesh-ancestor
6600465|NCT01159418|Antimitotic Agents|antimitotic agents|mesh-ancestor
6600466|NCT01159418|Mitosis Modulators|mitosis modulators|mesh-ancestor
6600467|NCT01159418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600468|NCT01159418|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6600469|NCT01159418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6600470|NCT01159457|Vaccines|vaccines|mesh-list
6600471|NCT01159457|Immunologic Factors|immunologic factors|mesh-ancestor
6600472|NCT01159457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600473|NCT01159548|Promethazine|promethazine|mesh-list
6600474|NCT01159548|Diphenhydramine|diphenhydramine|mesh-list
6600475|NCT01159548|Antipruritics|antipruritics|mesh-ancestor
6600476|NCT01159548|Dermatologic Agents|dermatologic agents|mesh-ancestor
6600477|NCT01159548|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6600478|NCT01159548|Histamine Antagonists|histamine antagonists|mesh-ancestor
6600479|NCT01159548|Histamine Agents|histamine agents|mesh-ancestor
6600480|NCT01159548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6600481|NCT01159548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600482|NCT01159548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600483|NCT01159548|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6600484|NCT01159548|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6600485|NCT01159548|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6600486|NCT01159548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6600487|NCT01159548|Anesthetics, Local|anesthetics, local|mesh-ancestor
6600488|NCT01159548|Anesthetics|anesthetics|mesh-ancestor
6600489|NCT01159548|Sensory System Agents|sensory system agents|mesh-ancestor
6600490|NCT01159548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6600491|NCT01159548|Antiemetics|antiemetics|mesh-ancestor
6600492|NCT01159548|Autonomic Agents|autonomic agents|mesh-ancestor
6600493|NCT01159548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6600494|NCT01159587|Factor VIII|factor viii|mesh-list
6600495|NCT01159587|Coagulants|coagulants|mesh-ancestor
6600496|NCT01159639|Clopidogrel|clopidogrel|mesh-list
6600497|NCT01159639|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6448852|NCT00402558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6448853|NCT00402558|Antiviral Agents|antiviral agents|mesh-ancestor
6448854|NCT00402558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6448855|NCT00402558|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6448856|NCT00402558|Alkylating Agents|alkylating agents|mesh-ancestor
6448857|NCT00402558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6448858|NCT00402558|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6448859|NCT00402558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6448860|NCT00402558|Analgesics|analgesics|mesh-ancestor
6448861|NCT00402558|Sensory System Agents|sensory system agents|mesh-ancestor
6448862|NCT00402558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6448863|NCT00402558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6600498|NCT01159639|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6600499|NCT01159639|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6600500|NCT01159639|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6600501|NCT01159639|Purinergic Agents|purinergic agents|mesh-ancestor
6600502|NCT01159639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6600503|NCT01159639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600504|NCT01159639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600505|NCT01159652|Zaleplon|zaleplon|mesh-list
6600506|NCT01159652|Zolpidem|zolpidem|mesh-list
6600507|NCT01159652|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6600508|NCT01159652|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6600509|NCT01159652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6600510|NCT01159652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600511|NCT01159652|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6600512|NCT01159652|GABA Agonists|gaba agonists|mesh-ancestor
6600513|NCT01159652|GABA Agents|gaba agents|mesh-ancestor
6600514|NCT01159652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6600515|NCT01159652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600516|NCT01159652|Anticonvulsants|anticonvulsants|mesh-ancestor
6600517|NCT01159652|GABA Modulators|gaba modulators|mesh-ancestor
6600518|NCT01159821|Paroxetine|paroxetine|mesh-list
6600519|NCT01159821|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6600520|NCT01159821|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6600521|NCT01159821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6600522|NCT01159821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600523|NCT01159821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6600524|NCT01159821|Serotonin Agents|serotonin agents|mesh-ancestor
6600525|NCT01159821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600526|NCT01159821|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6600527|NCT01159821|Antidepressive Agents|antidepressive agents|mesh-ancestor
6600528|NCT01159821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6600529|NCT01159821|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6600530|NCT01159821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6600531|NCT01159821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6600532|NCT01159847|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6600533|NCT01159847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6600534|NCT01159847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600535|NCT01159847|Incretins|incretins|mesh-ancestor
6600536|NCT01159847|Hormones|hormones|mesh-ancestor
6600537|NCT01159847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6600538|NCT01159847|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6600539|NCT01159847|Protease Inhibitors|protease inhibitors|mesh-ancestor
6600540|NCT01159847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6600541|NCT01159847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660000|NCT01490502|Cholecalciferol|cholecalciferol|mesh-list
6660001|NCT01490502|Vitamins|vitamins|mesh-ancestor
6660002|NCT01490502|Micronutrients|micronutrients|mesh-ancestor
6660003|NCT01490502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660004|NCT01490502|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6660005|NCT01490502|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6660006|NCT01490567|Donepezil|donepezil|mesh-list
6660007|NCT01490567|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6660008|NCT01490567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6660009|NCT01490567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660010|NCT01490567|Cholinergic Agents|cholinergic agents|mesh-ancestor
6660011|NCT01490567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6660012|NCT01490567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660013|NCT01490567|Nootropic Agents|nootropic agents|mesh-ancestor
6660014|NCT01490658|Metformin|metformin|mesh-list
6660015|NCT01490658|Repaglinide|repaglinide|mesh-list
6660016|NCT01490658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6660017|NCT01490658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660018|NCT01490671|Tenofovir|tenofovir|mesh-list
6660019|NCT01490671|Antiviral Agents|antiviral agents|mesh-ancestor
6660020|NCT01490671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6660021|NCT01490671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6660022|NCT01490671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6660023|NCT01490671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6660024|NCT01490671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660025|NCT01490671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6660026|NCT01490671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6660027|NCT01490749|Carboplatin|carboplatin|mesh-list
6660028|NCT01490749|Capecitabine|capecitabine|mesh-list
6660029|NCT01490749|Oxaliplatin|oxaliplatin|mesh-list
6600542|NCT01160029|Nateglinide|nateglinide|mesh-list
6600543|NCT01160029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6600544|NCT01160029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600545|NCT01160042|Metformin|metformin|mesh-list
6600546|NCT01160042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6600547|NCT01160042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600548|NCT01160068|Metformin|metformin|mesh-list
6600549|NCT01160068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6600550|NCT01160068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600551|NCT01160107|Prednisone|prednisone|mesh-list
6600552|NCT01160107|Melphalan|melphalan|mesh-list
6600553|NCT01160107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6600554|NCT01160107|Glucocorticoids|glucocorticoids|mesh-ancestor
6600555|NCT01160107|Hormones|hormones|mesh-ancestor
6600556|NCT01160107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6600557|NCT01160107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600558|NCT01160107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6600559|NCT01160107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6600560|NCT01160107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6600561|NCT01160107|Alkylating Agents|alkylating agents|mesh-ancestor
6600562|NCT01160107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600563|NCT01160107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6600564|NCT01160107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6600565|NCT01160107|Immunologic Factors|immunologic factors|mesh-ancestor
6600566|NCT01160172|Vaccines|vaccines|mesh-list
6600567|NCT01160172|Immunologic Factors|immunologic factors|mesh-ancestor
6600568|NCT01160172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600569|NCT01160185|Paclitaxel|paclitaxel|mesh-list
6600570|NCT01160185|Topotecan|topotecan|mesh-list
6600571|NCT01160185|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6600572|NCT01160185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6600573|NCT01160185|Tubulin Modulators|tubulin modulators|mesh-ancestor
6600574|NCT01160185|Antimitotic Agents|antimitotic agents|mesh-ancestor
6600575|NCT01160185|Mitosis Modulators|mitosis modulators|mesh-ancestor
6600576|NCT01160185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600577|NCT01160185|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6600578|NCT01160185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6600579|NCT01160185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6600580|NCT01160276|Cyclosporine|cyclosporine|mesh-list
6600581|NCT01160276|Colchicine|colchicine|mesh-list
6600582|NCT01160276|Tacrolimus|tacrolimus|mesh-list
6600583|NCT01160276|Cyclosporins|cyclosporins|mesh-list
6600584|NCT01160276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6600585|NCT01160276|Immunologic Factors|immunologic factors|mesh-ancestor
6600586|NCT01160276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600587|NCT01160276|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6600588|NCT01160276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6600589|NCT01160276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600590|NCT01160276|Antifungal Agents|antifungal agents|mesh-ancestor
6600591|NCT01160276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6600592|NCT01160276|Dermatologic Agents|dermatologic agents|mesh-ancestor
6600593|NCT01160276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6600594|NCT01160276|Gout Suppressants|gout suppressants|mesh-ancestor
6600595|NCT01160276|Tubulin Modulators|tubulin modulators|mesh-ancestor
6600596|NCT01160276|Antimitotic Agents|antimitotic agents|mesh-ancestor
6600597|NCT01160276|Mitosis Modulators|mitosis modulators|mesh-ancestor
6600598|NCT01160276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6600599|NCT01160302|Curcumin|curcumin|mesh-list
6600600|NCT01160302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6600601|NCT01160302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6600602|NCT01160302|Analgesics|analgesics|mesh-ancestor
6600603|NCT01160302|Sensory System Agents|sensory system agents|mesh-ancestor
6600604|NCT01160302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6600605|NCT01160302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600606|NCT01160302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6600607|NCT01160302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6600608|NCT01160302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6600609|NCT01160302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6600610|NCT01160302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600611|NCT01160315|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6600612|NCT01160315|Norethindrone|norethindrone|mesh-list
6600613|NCT01160315|Norethindrone Acetate|norethindrone acetate|mesh-list
6600614|NCT01160315|Luteolytic Agents|luteolytic agents|mesh-ancestor
6600615|NCT01160315|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6600616|NCT01160315|Contraceptive Agents|contraceptive agents|mesh-ancestor
6600617|NCT01160315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6600618|NCT01160315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600619|NCT01160315|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6600620|NCT01160315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6600621|NCT01160315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6600622|NCT01160315|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6600623|NCT01160315|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6600624|NCT01160315|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6600625|NCT01160328|Leuprolide|leuprolide|mesh-list
6600626|NCT01160328|Testosterone|testosterone|mesh-list
6600627|NCT01160328|Androgens|androgens|mesh-ancestor
6600628|NCT01160328|Hormones|hormones|mesh-ancestor
6600629|NCT01160328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6600630|NCT01160328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600631|NCT01160328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6600632|NCT01160328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6600633|NCT01160328|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6600634|NCT01160328|Fertility Agents|fertility agents|mesh-ancestor
6600635|NCT01160328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6600636|NCT01160341|Methyltestosterone|methyltestosterone|mesh-list
6600637|NCT01160341|Testosterone|testosterone|mesh-list
6600638|NCT01160341|Testosterone undecanoate|testosterone undecanoate|mesh-list
6600639|NCT01160341|Testosterone enanthate|testosterone enanthate|mesh-list
6600640|NCT01160341|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6600641|NCT01160341|Androgens|androgens|mesh-ancestor
6600642|NCT01160341|Hormones|hormones|mesh-ancestor
6600643|NCT01160341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6600644|NCT01160341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600645|NCT01160341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6600646|NCT01160341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6600647|NCT01160341|Anabolic Agents|anabolic agents|mesh-ancestor
6600648|NCT01160419|Leucovorin|leucovorin|mesh-list
6600649|NCT01160419|Folic Acid|folic acid|mesh-list
6600650|NCT01160419|Docetaxel|docetaxel|mesh-list
6600651|NCT01160419|Oxaliplatin|oxaliplatin|mesh-list
6600652|NCT01160419|Levoleucovorin|levoleucovorin|mesh-list
6600653|NCT01160419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6600654|NCT01160419|Tubulin Modulators|tubulin modulators|mesh-ancestor
6600655|NCT01160419|Antimitotic Agents|antimitotic agents|mesh-ancestor
6600656|NCT01160419|Mitosis Modulators|mitosis modulators|mesh-ancestor
6600657|NCT01160419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600658|NCT01160419|Antidotes|antidotes|mesh-ancestor
6600659|NCT01160419|Protective Agents|protective agents|mesh-ancestor
6600660|NCT01160419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600661|NCT01160419|Vitamin B Complex|vitamin b complex|mesh-ancestor
6600662|NCT01160419|Vitamins|vitamins|mesh-ancestor
6600663|NCT01160419|Micronutrients|micronutrients|mesh-ancestor
6600664|NCT01160419|Hematinics|hematinics|mesh-ancestor
6600665|NCT01160432|Methadone|methadone|mesh-list
6448864|NCT00402558|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6448865|NCT00402571|Acetaminophen|acetaminophen|mesh-list
6448866|NCT00402571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6448867|NCT00402571|Analgesics|analgesics|mesh-ancestor
6448868|NCT00402571|Sensory System Agents|sensory system agents|mesh-ancestor
6448869|NCT00402571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6448870|NCT00402571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448871|NCT00402571|Antipyretics|antipyretics|mesh-ancestor
6600666|NCT01160432|Naloxone|naloxone|mesh-list
6600667|NCT01160432|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6600668|NCT01160432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600669|NCT01160432|Sensory System Agents|sensory system agents|mesh-ancestor
6600670|NCT01160432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6600671|NCT01160432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6600672|NCT01160432|Narcotics|narcotics|mesh-ancestor
6600673|NCT01160432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6600674|NCT01160432|Analgesics|analgesics|mesh-ancestor
6600675|NCT01160432|Antitussive Agents|antitussive agents|mesh-ancestor
6600676|NCT01160432|Respiratory System Agents|respiratory system agents|mesh-ancestor
6600677|NCT01160588|Sertraline|sertraline|mesh-list
6600678|NCT01160588|Antidepressive Agents|antidepressive agents|mesh-ancestor
6600679|NCT01160588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6600680|NCT01160588|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6600681|NCT01160588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6600682|NCT01160588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6600683|NCT01160588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600684|NCT01160588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6600685|NCT01160588|Serotonin Agents|serotonin agents|mesh-ancestor
6600686|NCT01160588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600687|NCT01160627|Acetylcysteine|acetylcysteine|mesh-list
6600688|NCT01160627|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6600689|NCT01160627|Antiviral Agents|antiviral agents|mesh-ancestor
6600690|NCT01160627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6600691|NCT01160627|Expectorants|expectorants|mesh-ancestor
6600692|NCT01160627|Respiratory System Agents|respiratory system agents|mesh-ancestor
6600693|NCT01160627|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6600694|NCT01160627|Antioxidants|antioxidants|mesh-ancestor
6600695|NCT01160627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600696|NCT01160627|Protective Agents|protective agents|mesh-ancestor
6600697|NCT01160627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600698|NCT01160627|Antidotes|antidotes|mesh-ancestor
6600699|NCT01160666|Belimumab|belimumab|mesh-list
6600700|NCT01160666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6600701|NCT01160666|Immunologic Factors|immunologic factors|mesh-ancestor
6600702|NCT01160666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600703|NCT01160705|Docetaxel|docetaxel|mesh-list
6600704|NCT01160705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6600705|NCT01160705|Tubulin Modulators|tubulin modulators|mesh-ancestor
6600706|NCT01160705|Antimitotic Agents|antimitotic agents|mesh-ancestor
6600707|NCT01160705|Mitosis Modulators|mitosis modulators|mesh-ancestor
6600708|NCT01160705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600709|NCT01160718|Fulvestrant|fulvestrant|mesh-list
6600710|NCT01160718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6600711|NCT01160718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6600712|NCT01160718|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6600713|NCT01160718|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6600714|NCT01160718|Hormone Antagonists|hormone antagonists|mesh-ancestor
6600715|NCT01160718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6600716|NCT01160718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600717|NCT01160731|Etoposide|etoposide|mesh-list
6600718|NCT01160731|Panobinostat|panobinostat|mesh-list
6600719|NCT01160731|Etoposide phosphate|etoposide phosphate|mesh-list
6600720|NCT01160731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6600721|NCT01160731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6600722|NCT01160731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6600723|NCT01160731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6600724|NCT01160731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6600725|NCT01160731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600726|NCT01160731|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6600727|NCT01160900|Bivalirudin|bivalirudin|mesh-list
6600728|NCT01160900|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6600729|NCT01160900|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6600730|NCT01160900|Antithrombins|antithrombins|mesh-ancestor
6600731|NCT01160900|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6600732|NCT01160900|Protease Inhibitors|protease inhibitors|mesh-ancestor
6600733|NCT01160900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6600734|NCT01160900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600735|NCT01160900|Anticoagulants|anticoagulants|mesh-ancestor
6600736|NCT01160926|Cediranib|cediranib|mesh-list
6600737|NCT01160926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6600738|NCT01160926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6600739|NCT01160926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6600740|NCT01160926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600741|NCT01160952|Itraconazole|itraconazole|mesh-list
6600742|NCT01160952|Antifungal Agents|antifungal agents|mesh-ancestor
6600743|NCT01160952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6600744|NCT01160952|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6600745|NCT01160952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6600746|NCT01160952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6600747|NCT01160952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600748|NCT01160952|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6600749|NCT01160952|Hormone Antagonists|hormone antagonists|mesh-ancestor
6600750|NCT01160952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6600751|NCT01160952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600752|NCT01160952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6600753|NCT01160965|Ropivacaine|ropivacaine|mesh-list
6600754|NCT01160965|Levobupivacaine|levobupivacaine|mesh-list
6600755|NCT01160965|Anesthetics, Local|anesthetics, local|mesh-ancestor
6600756|NCT01160965|Anesthetics|anesthetics|mesh-ancestor
6600757|NCT01160965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6600758|NCT01160965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600759|NCT01160965|Sensory System Agents|sensory system agents|mesh-ancestor
6600760|NCT01160965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6600761|NCT01160978|Simvastatin|simvastatin|mesh-list
6600762|NCT01160978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6600763|NCT01160978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6600764|NCT01160978|Antimetabolites|antimetabolites|mesh-ancestor
6600765|NCT01160978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600766|NCT01160978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6600767|NCT01160978|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6600768|NCT01160978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6600769|NCT01160991|Olanzapine|olanzapine|mesh-list
6600770|NCT01160991|Amisulpride|amisulpride|mesh-list
6600771|NCT01160991|Antiemetics|antiemetics|mesh-ancestor
6600772|NCT01160991|Autonomic Agents|autonomic agents|mesh-ancestor
6600773|NCT01160991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6600774|NCT01160991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600775|NCT01160991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6600776|NCT01160991|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6600777|NCT01160991|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6600778|NCT01160991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6600779|NCT01160991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6600780|NCT01160991|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6600781|NCT01160991|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6600782|NCT01160991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6600783|NCT01160991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600784|NCT01160991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6600785|NCT01160991|Serotonin Agents|serotonin agents|mesh-ancestor
6600786|NCT01160991|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6600787|NCT01160991|Dopamine Agents|dopamine agents|mesh-ancestor
6600788|NCT01160991|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6600789|NCT01160991|Antidepressive Agents|antidepressive agents|mesh-ancestor
6600790|NCT01161017|Topiramate|topiramate|mesh-list
6600791|NCT01161017|Amitriptyline|amitriptyline|mesh-list
6600792|NCT01161017|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6600793|NCT01161017|Anticonvulsants|anticonvulsants|mesh-ancestor
6600794|NCT01161017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6600795|NCT01161017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600796|NCT01161017|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6600797|NCT01161017|Antidepressive Agents|antidepressive agents|mesh-ancestor
6600798|NCT01161017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6600799|NCT01161017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6600800|NCT01161017|Analgesics|analgesics|mesh-ancestor
6600801|NCT01161017|Sensory System Agents|sensory system agents|mesh-ancestor
6600802|NCT01161017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6600803|NCT01161017|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6600804|NCT01161017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6600805|NCT01161017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6600806|NCT01161017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600807|NCT01161017|Adrenergic Agents|adrenergic agents|mesh-ancestor
6600808|NCT01161017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6600809|NCT01161017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6600810|NCT01161017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6600811|NCT01161017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6600812|NCT01161069|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1H)-one|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1h)-one|mesh-list
6600813|NCT01161069|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6600814|NCT01161069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6600815|NCT01161069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6600816|NCT01161069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600817|NCT01161108|Melatonin|melatonin|mesh-list
6600818|NCT01161108|Antioxidants|antioxidants|mesh-ancestor
6600819|NCT01161108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448872|NCT00402584|Sibutramine|sibutramine|mesh-list
6600820|NCT01161108|Protective Agents|protective agents|mesh-ancestor
6600821|NCT01161108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600822|NCT01161108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6600823|NCT01161134|Meloxicam|meloxicam|mesh-list
6600824|NCT01161134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6600825|NCT01161134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6600826|NCT01161134|Analgesics|analgesics|mesh-ancestor
6448873|NCT00402584|Antidepressive Agents|antidepressive agents|mesh-ancestor
6448874|NCT00402584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6448875|NCT00402584|Appetite Depressants|appetite depressants|mesh-ancestor
6448876|NCT00402584|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6448877|NCT00402610|Rifampin|rifampin|mesh-list
6448878|NCT00402610|Isoniazid|isoniazid|mesh-list
6448879|NCT00402610|Pyrazinamide|pyrazinamide|mesh-list
6448880|NCT00402610|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6448881|NCT00402610|Antitubercular Agents|antitubercular agents|mesh-ancestor
6448882|NCT00402610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6448883|NCT00402610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6448884|NCT00402610|Leprostatic Agents|leprostatic agents|mesh-ancestor
6448885|NCT00402610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6448886|NCT00402610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6448887|NCT00402610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448888|NCT00402610|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6448889|NCT00402610|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6448890|NCT00402610|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6448891|NCT00402610|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6448892|NCT00402610|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6448893|NCT00402610|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6448894|NCT00402610|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6600827|NCT01161134|Sensory System Agents|sensory system agents|mesh-ancestor
6600828|NCT01161134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6600829|NCT01161134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600830|NCT01161134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6600831|NCT01161134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6600832|NCT01161134|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6600833|NCT01161134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6600834|NCT01161134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6600835|NCT01161134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600836|NCT01161147|Meloxicam|meloxicam|mesh-list
6600837|NCT01161147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6600838|NCT01161147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6600839|NCT01161147|Analgesics|analgesics|mesh-ancestor
6600840|NCT01161147|Sensory System Agents|sensory system agents|mesh-ancestor
6600841|NCT01161147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6600842|NCT01161147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600843|NCT01161147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6600844|NCT01161147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6600845|NCT01161147|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6600846|NCT01161147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6600847|NCT01161147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6600848|NCT01161147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600849|NCT01161186|Gemcitabine|gemcitabine|mesh-list
6600850|NCT01161186|Paclitaxel|paclitaxel|mesh-list
6600851|NCT01161186|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6600852|NCT01161186|Capecitabine|capecitabine|mesh-list
6600853|NCT01161186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6600854|NCT01161186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6600855|NCT01161186|Tubulin Modulators|tubulin modulators|mesh-ancestor
6600856|NCT01161186|Antimitotic Agents|antimitotic agents|mesh-ancestor
6600857|NCT01161186|Mitosis Modulators|mitosis modulators|mesh-ancestor
6600858|NCT01161186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600859|NCT01161186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6600860|NCT01161186|Antimetabolites|antimetabolites|mesh-ancestor
6600861|NCT01161186|Antiviral Agents|antiviral agents|mesh-ancestor
6600862|NCT01161186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6600863|NCT01161186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6600864|NCT01161186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6600865|NCT01161186|Immunologic Factors|immunologic factors|mesh-ancestor
6600866|NCT01161186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600867|NCT01161277|Haloperidol|haloperidol|mesh-list
6600868|NCT01161277|Aripiprazole|aripiprazole|mesh-list
6600869|NCT01161277|Haloperidol decanoate|haloperidol decanoate|mesh-list
6600870|NCT01161277|Antidepressive Agents|antidepressive agents|mesh-ancestor
6600871|NCT01161277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6600872|NCT01161277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6600873|NCT01161277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6600874|NCT01161277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6600875|NCT01161277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600876|NCT01161277|Dopamine Agonists|dopamine agonists|mesh-ancestor
6600877|NCT01161277|Dopamine Agents|dopamine agents|mesh-ancestor
6600878|NCT01161277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6600879|NCT01161277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600880|NCT01161277|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6600881|NCT01161277|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6600882|NCT01161277|Serotonin Agents|serotonin agents|mesh-ancestor
6600883|NCT01161277|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6600884|NCT01161277|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6600885|NCT01161277|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6600886|NCT01161277|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6600887|NCT01161277|Antiemetics|antiemetics|mesh-ancestor
6600888|NCT01161277|Autonomic Agents|autonomic agents|mesh-ancestor
6600889|NCT01161277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6448895|NCT00402610|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6448896|NCT00402610|Antimetabolites|antimetabolites|mesh-ancestor
6448897|NCT00402610|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6448898|NCT00402623|Quercetin|quercetin|mesh-list
6448899|NCT00402623|Antioxidants|antioxidants|mesh-ancestor
6448900|NCT00402623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448901|NCT00402623|Protective Agents|protective agents|mesh-ancestor
6448902|NCT00402623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448903|NCT00402636|Sirolimus|sirolimus|mesh-list
6448904|NCT00402636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6448905|NCT00402636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6600890|NCT01161277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6600891|NCT01161277|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6600892|NCT01161316|Cetuximab|cetuximab|mesh-list
6600893|NCT01161316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6600894|NCT01161316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6600895|NCT01161368|Vinorelbine|vinorelbine|mesh-list
6600896|NCT01161368|Lapatinib|lapatinib|mesh-list
6600897|NCT01161368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6600898|NCT01161368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6600899|NCT01161368|Tubulin Modulators|tubulin modulators|mesh-ancestor
6600900|NCT01161368|Antimitotic Agents|antimitotic agents|mesh-ancestor
6600901|NCT01161368|Mitosis Modulators|mitosis modulators|mesh-ancestor
6600902|NCT01161368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600903|NCT01161368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6600904|NCT01161368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6600905|NCT01161459|Prednisone|prednisone|mesh-list
6600906|NCT01161459|Tacrolimus|tacrolimus|mesh-list
6600907|NCT01161459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6600908|NCT01161459|Glucocorticoids|glucocorticoids|mesh-ancestor
6600909|NCT01161459|Hormones|hormones|mesh-ancestor
6600910|NCT01161459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6600911|NCT01161459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600912|NCT01161459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6448906|NCT00402636|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6448907|NCT00402636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6448908|NCT00402636|Antifungal Agents|antifungal agents|mesh-ancestor
6448909|NCT00402636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6448910|NCT00402636|Immunologic Factors|immunologic factors|mesh-ancestor
6600913|NCT01161459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6600914|NCT01161459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6600915|NCT01161459|Immunologic Factors|immunologic factors|mesh-ancestor
6600916|NCT01161459|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6600917|NCT01161459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6600918|NCT01161459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600919|NCT01161550|Cytarabine|cytarabine|mesh-list
6600920|NCT01161550|Tretinoin|tretinoin|mesh-list
6600921|NCT01161550|Cladribine|cladribine|mesh-list
6600922|NCT01161550|Midostaurin|midostaurin|mesh-list
6600923|NCT01161550|Lenograstim|lenograstim|mesh-list
6600924|NCT01161550|Sargramostim|sargramostim|mesh-list
6600925|NCT01161550|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6600926|NCT01161550|Immunologic Factors|immunologic factors|mesh-ancestor
6600927|NCT01161550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600928|NCT01161550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6600929|NCT01161550|Antimetabolites|antimetabolites|mesh-ancestor
6600930|NCT01161550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600931|NCT01161550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6600932|NCT01161550|Antiviral Agents|antiviral agents|mesh-ancestor
6600933|NCT01161550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6600934|NCT01161550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6600935|NCT01161550|Keratolytic Agents|keratolytic agents|mesh-ancestor
6600936|NCT01161550|Dermatologic Agents|dermatologic agents|mesh-ancestor
6600937|NCT01161550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6600938|NCT01161550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6600939|NCT01161654|Naratriptan|naratriptan|mesh-list
6600940|NCT01161654|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6600941|NCT01161654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6600942|NCT01161654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6600943|NCT01161654|Serotonin Agents|serotonin agents|mesh-ancestor
6600944|NCT01161654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6600945|NCT01161654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600946|NCT01161654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448911|NCT00402636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448912|NCT00402662|Everolimus|everolimus|mesh-list
6448913|NCT00402662|Imatinib Mesylate|imatinib mesylate|mesh-list
6448914|NCT00402662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6448915|NCT00402662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6448916|NCT00402662|Immunologic Factors|immunologic factors|mesh-ancestor
6448917|NCT00402662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448918|NCT00402662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6448919|NCT00402662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6448920|NCT00402662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448921|NCT00402766|Dexamethasone|dexamethasone|mesh-list
6448922|NCT00402766|Cisplatin|cisplatin|mesh-list
6448923|NCT00402766|Pemetrexed|pemetrexed|mesh-list
6600947|NCT01161667|Naratriptan|naratriptan|mesh-list
6600948|NCT01161667|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6448924|NCT00402766|Imatinib Mesylate|imatinib mesylate|mesh-list
6600949|NCT01161667|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6600950|NCT01161667|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6600951|NCT01161667|Serotonin Agents|serotonin agents|mesh-ancestor
6600952|NCT01161667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6600953|NCT01161667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600954|NCT01161667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660030|NCT01490749|Everolimus|everolimus|mesh-list
6660031|NCT01490749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6660032|NCT01490749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6448925|NCT00402766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6448926|NCT00402766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6448927|NCT00402766|Antiemetics|antiemetics|mesh-ancestor
6448928|NCT00402766|Autonomic Agents|autonomic agents|mesh-ancestor
6448929|NCT00402766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6660033|NCT01490749|Antimetabolites|antimetabolites|mesh-ancestor
6660034|NCT01490749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660035|NCT01490749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6660036|NCT01490749|Immunologic Factors|immunologic factors|mesh-ancestor
6660037|NCT01490749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660038|NCT01490762|Insulin|insulin|mesh-list
6660039|NCT01490762|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6660040|NCT01490762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6660041|NCT01490762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660042|NCT01490905|Ibuprofen|ibuprofen|mesh-list
6660043|NCT01490905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6660044|NCT01490905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6660045|NCT01490905|Analgesics|analgesics|mesh-ancestor
6660046|NCT01490905|Sensory System Agents|sensory system agents|mesh-ancestor
6660047|NCT01490905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6660048|NCT01490905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660049|NCT01490905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6660050|NCT01490905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6660051|NCT01490905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6660052|NCT01490905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6660053|NCT01490905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660054|NCT01490944|Iron|iron|mesh-list
6660055|NCT01490944|Folic Acid|folic acid|mesh-list
6660056|NCT01490944|Vitamin B 12|vitamin b 12|mesh-list
6660057|NCT01490944|Hydroxocobalamin|hydroxocobalamin|mesh-list
6660058|NCT01490944|Vitamin B Complex|vitamin b complex|mesh-list
6660059|NCT01490944|Trace Elements|trace elements|mesh-ancestor
6660060|NCT01490944|Micronutrients|micronutrients|mesh-ancestor
6660061|NCT01490944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660062|NCT01490944|Hematinics|hematinics|mesh-ancestor
6660063|NCT01490944|Vitamins|vitamins|mesh-ancestor
6660064|NCT01490996|Curcumin|curcumin|mesh-list
6660065|NCT01490996|Capecitabine|capecitabine|mesh-list
6660066|NCT01490996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6660067|NCT01490996|Antimetabolites|antimetabolites|mesh-ancestor
6660068|NCT01490996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660069|NCT01490996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6660070|NCT01490996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6660071|NCT01490996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6660072|NCT01490996|Analgesics|analgesics|mesh-ancestor
6660073|NCT01490996|Sensory System Agents|sensory system agents|mesh-ancestor
6448930|NCT00402766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448931|NCT00402766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6448932|NCT00402766|Glucocorticoids|glucocorticoids|mesh-ancestor
6448933|NCT00402766|Hormones|hormones|mesh-ancestor
6448934|NCT00402766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6448935|NCT00402766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6448936|NCT00402766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6660074|NCT01490996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6660075|NCT01490996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660076|NCT01490996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6600955|NCT01161836|Iniparib|iniparib|mesh-list
6600956|NCT01161836|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6600957|NCT01161836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6600958|NCT01161836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600959|NCT01161836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6600960|NCT01161888|Imiquimod|imiquimod|mesh-list
6600961|NCT01161888|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6600962|NCT01161888|Immunologic Factors|immunologic factors|mesh-ancestor
6600963|NCT01161888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600964|NCT01161888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6600965|NCT01161888|Interferon Inducers|interferon inducers|mesh-ancestor
6600966|NCT01161927|Nizatidine|nizatidine|mesh-list
6600967|NCT01161927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6600968|NCT01161927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6600969|NCT01161927|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6600970|NCT01161927|Histamine Antagonists|histamine antagonists|mesh-ancestor
6600971|NCT01161927|Histamine Agents|histamine agents|mesh-ancestor
6600972|NCT01161927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6600973|NCT01161927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600974|NCT01161927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448937|NCT00402766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448938|NCT00402766|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6448939|NCT00402766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6448940|NCT00402766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6448941|NCT00402792|Acetaminophen|acetaminophen|mesh-list
6448942|NCT00402792|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
6448943|NCT00402792|Hydrocodone|hydrocodone|mesh-list
6448944|NCT00402792|Oxycodone|oxycodone|mesh-list
6448945|NCT00402792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6448946|NCT00402792|Analgesics|analgesics|mesh-ancestor
6448947|NCT00402792|Sensory System Agents|sensory system agents|mesh-ancestor
6448948|NCT00402792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6448949|NCT00402792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448950|NCT00402792|Antipyretics|antipyretics|mesh-ancestor
6448951|NCT00402792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6448952|NCT00402792|Narcotics|narcotics|mesh-ancestor
6448953|NCT00402792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6448954|NCT00402792|Antitussive Agents|antitussive agents|mesh-ancestor
6448955|NCT00402792|Respiratory System Agents|respiratory system agents|mesh-ancestor
6448956|NCT00402792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6448957|NCT00402792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6448958|NCT00402792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6448959|NCT00402909|Nateglinide|nateglinide|mesh-list
6448960|NCT00402909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6448961|NCT00402909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448962|NCT00402974|Vitamin K 2|vitamin k 2|mesh-list
6448963|NCT00402974|Vitamin K|vitamin k|mesh-list
6448964|NCT00402974|Vitamin MK 7|vitamin mk 7|mesh-list
6448965|NCT00402974|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6448966|NCT00402974|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6600975|NCT01161940|Nizatidine|nizatidine|mesh-list
6600976|NCT01161940|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6600977|NCT01161940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6600978|NCT01161940|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6600979|NCT01161940|Histamine Antagonists|histamine antagonists|mesh-ancestor
6600980|NCT01161940|Histamine Agents|histamine agents|mesh-ancestor
6600981|NCT01161940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6600982|NCT01161940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600983|NCT01161940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600984|NCT01161966|Zonisamide|zonisamide|mesh-list
6600985|NCT01161966|Anticonvulsants|anticonvulsants|mesh-ancestor
6600986|NCT01161966|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6600987|NCT01161966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6600988|NCT01161966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600989|NCT01161966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6600990|NCT01161966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600991|NCT01161979|Zonisamide|zonisamide|mesh-list
6600992|NCT01161979|Anticonvulsants|anticonvulsants|mesh-ancestor
6600993|NCT01161979|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6600994|NCT01161979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6600995|NCT01161979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6600996|NCT01161979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6600997|NCT01161979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6600998|NCT01162031|Bortezomib|bortezomib|mesh-list
6448967|NCT00402974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448968|NCT00402974|Hemostatics|hemostatics|mesh-ancestor
6448969|NCT00402974|Coagulants|coagulants|mesh-ancestor
6448970|NCT00402974|Vitamins|vitamins|mesh-ancestor
6448971|NCT00402974|Micronutrients|micronutrients|mesh-ancestor
6448972|NCT00402974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448973|NCT00403000|Dutasteride|dutasteride|mesh-list
6448974|NCT00403000|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6448975|NCT00403000|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6448976|NCT00403000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6448977|NCT00403000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6448978|NCT00403000|Hormone Antagonists|hormone antagonists|mesh-ancestor
6448979|NCT00403000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6448980|NCT00403000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448981|NCT00403013|Anesthetics|anesthetics|mesh-list
6448982|NCT00403013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6020516|NCT00393042|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6020517|NCT00393042|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6448983|NCT00403013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448984|NCT00403026|Bevacizumab|bevacizumab|mesh-list
6448985|NCT00403026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6448986|NCT00403026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6600999|NCT01162031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6601000|NCT01162109|Zinc Sulfate|zinc sulfate|mesh-list
6601001|NCT01162109|Astringents|astringents|mesh-ancestor
6601002|NCT01162109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601003|NCT01162109|Dermatologic Agents|dermatologic agents|mesh-ancestor
6601004|NCT01162460|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
6601005|NCT01162460|Anticonvulsants|anticonvulsants|mesh-ancestor
6601006|NCT01162460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6601007|NCT01162460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6601008|NCT01162460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6601009|NCT01162460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601010|NCT01162603|Latanoprost|latanoprost|mesh-list
6601011|NCT01162603|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6601012|NCT01162603|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6601013|NCT01162720|Oxymetazoline|oxymetazoline|mesh-list
6601014|NCT01162720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6601015|NCT01162720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6601016|NCT01162720|Adrenergic Agents|adrenergic agents|mesh-ancestor
6601017|NCT01162720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6601018|NCT01162720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601019|NCT01162720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601020|NCT01162720|Sympathomimetics|sympathomimetics|mesh-ancestor
6601021|NCT01162720|Autonomic Agents|autonomic agents|mesh-ancestor
6601022|NCT01162720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6601023|NCT01162720|Nasal Decongestants|nasal decongestants|mesh-ancestor
6601024|NCT01162720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6601025|NCT01162720|Respiratory System Agents|respiratory system agents|mesh-ancestor
6601026|NCT01162746|Dexamethasone|dexamethasone|mesh-list
6601027|NCT01162746|Ranibizumab|ranibizumab|mesh-list
6601028|NCT01162746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6601029|NCT01162746|Antiemetics|antiemetics|mesh-ancestor
6601030|NCT01162746|Autonomic Agents|autonomic agents|mesh-ancestor
6601031|NCT01162746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6601032|NCT01162746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601033|NCT01162746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6601034|NCT01162746|Glucocorticoids|glucocorticoids|mesh-ancestor
6601035|NCT01162746|Hormones|hormones|mesh-ancestor
6601036|NCT01162746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6601037|NCT01162746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6601038|NCT01162746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6601039|NCT01162746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6601040|NCT01162746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6601041|NCT01162746|Growth Substances|growth substances|mesh-ancestor
6601042|NCT01162746|Growth Inhibitors|growth inhibitors|mesh-ancestor
6601043|NCT01162824|Adenosine|adenosine|mesh-list
6601044|NCT01162824|Acetylcholine|acetylcholine|mesh-list
6601045|NCT01162824|Analgesics|analgesics|mesh-ancestor
6601046|NCT01162824|Sensory System Agents|sensory system agents|mesh-ancestor
6601047|NCT01162824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6601048|NCT01162824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601049|NCT01162824|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6601050|NCT01162824|Vasodilator Agents|vasodilator agents|mesh-ancestor
6601051|NCT01162824|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6601052|NCT01162824|Purinergic Agonists|purinergic agonists|mesh-ancestor
6448987|NCT00403026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6448988|NCT00403026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6448989|NCT00403026|Growth Substances|growth substances|mesh-ancestor
6448990|NCT00403026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448991|NCT00403026|Growth Inhibitors|growth inhibitors|mesh-ancestor
6448992|NCT00403039|Ranibizumab|ranibizumab|mesh-list
6448993|NCT00403039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6448994|NCT00403039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6448995|NCT00403039|Growth Substances|growth substances|mesh-ancestor
6448996|NCT00403039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6448997|NCT00403039|Growth Inhibitors|growth inhibitors|mesh-ancestor
6601053|NCT01162824|Purinergic Agents|purinergic agents|mesh-ancestor
6601054|NCT01162824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6601055|NCT01162824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601056|NCT01162824|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6601057|NCT01162824|Cholinergic Agents|cholinergic agents|mesh-ancestor
6601058|NCT01162889|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6601059|NCT01162889|Immunologic Factors|immunologic factors|mesh-ancestor
6601060|NCT01162889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601061|NCT01162902|Candesartan|candesartan|mesh-list
6601062|NCT01162902|Diltiazem|diltiazem|mesh-list
6601063|NCT01162902|Bisoprolol|bisoprolol|mesh-list
6601064|NCT01162902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6601065|NCT01162902|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6601066|NCT01162902|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6601067|NCT01162902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601068|NCT01162902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6601069|NCT01162902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6601070|NCT01162902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6601071|NCT01162902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601072|NCT01162902|Vasodilator Agents|vasodilator agents|mesh-ancestor
6601073|NCT01162902|Sympatholytics|sympatholytics|mesh-ancestor
6601074|NCT01162902|Autonomic Agents|autonomic agents|mesh-ancestor
6601075|NCT01162902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6601076|NCT01162902|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6601077|NCT01162902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6601078|NCT01162902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6601079|NCT01162902|Adrenergic Agents|adrenergic agents|mesh-ancestor
6601080|NCT01162902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6601081|NCT01162941|Prednisolone|prednisolone|mesh-list
6601082|NCT01162941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6601083|NCT01162941|Glucocorticoids|glucocorticoids|mesh-ancestor
6601084|NCT01162941|Hormones|hormones|mesh-ancestor
6601085|NCT01162941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6601086|NCT01162941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601087|NCT01162941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6601088|NCT01162941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6601089|NCT01162967|Posaconazole|posaconazole|mesh-list
6601090|NCT01162967|Benzonidazole|benzonidazole|mesh-list
6601091|NCT01162967|Antifungal Agents|antifungal agents|mesh-ancestor
6601092|NCT01162967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6601093|NCT01162967|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6601094|NCT01162967|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6601095|NCT01162967|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6601096|NCT01162967|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6601097|NCT01162967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6601098|NCT01162967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6601099|NCT01162967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601100|NCT01162967|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6601101|NCT01162967|Hormone Antagonists|hormone antagonists|mesh-ancestor
6601102|NCT01162967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6601103|NCT01162967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601104|NCT01162967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6601105|NCT01162967|Immunologic Factors|immunologic factors|mesh-ancestor
6601106|NCT01163201|Cyclophosphamide|cyclophosphamide|mesh-list
6601107|NCT01163201|Fludarabine|fludarabine|mesh-list
6601108|NCT01163201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6601109|NCT01163201|Immunologic Factors|immunologic factors|mesh-ancestor
6601110|NCT01163201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601111|NCT01163201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6601112|NCT01163201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6601113|NCT01163201|Alkylating Agents|alkylating agents|mesh-ancestor
6601114|NCT01163201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601115|NCT01163201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6601116|NCT01163201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6601117|NCT01163357|Sirolimus|sirolimus|mesh-list
6601118|NCT01163357|Fludarabine|fludarabine|mesh-list
6601119|NCT01163357|Fludarabine phosphate|fludarabine phosphate|mesh-list
6601120|NCT01163357|Bortezomib|bortezomib|mesh-list
6601121|NCT01163357|Melphalan|melphalan|mesh-list
6601122|NCT01163357|Tacrolimus|tacrolimus|mesh-list
6601123|NCT01163357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6601124|NCT01163357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6601125|NCT01163357|Antimetabolites|antimetabolites|mesh-ancestor
6601126|NCT01163357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601127|NCT01163357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6601128|NCT01163357|Immunologic Factors|immunologic factors|mesh-ancestor
6601129|NCT01163357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501773|NCT04470531|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
5501774|NCT04470531|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5501775|NCT04470531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5501776|NCT04470531|Renal Agents|renal agents|mesh-ancestor
5501777|NCT04470531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5501778|NCT04470531|Antimalarials|antimalarials|mesh-ancestor
5501779|NCT04470531|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5501780|NCT04470531|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5501781|NCT04470674|Carboplatin|carboplatin|mesh-list
5501782|NCT04470674|Pemetrexed|pemetrexed|mesh-list
5501783|NCT04470674|Durvalumab|durvalumab|mesh-list
6601130|NCT01163357|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6601131|NCT01163357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6601132|NCT01163357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6601133|NCT01163357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6601134|NCT01163357|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6601135|NCT01163357|Antifungal Agents|antifungal agents|mesh-ancestor
6601136|NCT01163357|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6601137|NCT01163357|Alkylating Agents|alkylating agents|mesh-ancestor
6601138|NCT01163357|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6601139|NCT01163396|Leucovorin|leucovorin|mesh-list
6601140|NCT01163396|Bevacizumab|bevacizumab|mesh-list
6601141|NCT01163396|Fluorouracil|fluorouracil|mesh-list
6601142|NCT01163396|Oxaliplatin|oxaliplatin|mesh-list
6601143|NCT01163396|Irinotecan|irinotecan|mesh-list
6601144|NCT01163396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6601145|NCT01163396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6601146|NCT01163396|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6601147|NCT01163396|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6601148|NCT01163396|Growth Substances|growth substances|mesh-ancestor
6601149|NCT01163396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601150|NCT01163396|Growth Inhibitors|growth inhibitors|mesh-ancestor
6601151|NCT01163396|Antimetabolites|antimetabolites|mesh-ancestor
6601152|NCT01163396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601153|NCT01163396|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6601154|NCT01163396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6601155|NCT01163396|Immunologic Factors|immunologic factors|mesh-ancestor
6601156|NCT01163396|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6601157|NCT01163396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6601158|NCT01163396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6601159|NCT01163396|Antidotes|antidotes|mesh-ancestor
6601160|NCT01163396|Protective Agents|protective agents|mesh-ancestor
6601161|NCT01163396|Vitamin B Complex|vitamin b complex|mesh-ancestor
6601162|NCT01163396|Vitamins|vitamins|mesh-ancestor
6601163|NCT01163396|Micronutrients|micronutrients|mesh-ancestor
6601164|NCT01163435|Clarithromycin|clarithromycin|mesh-list
6601165|NCT01163435|Levofloxacin|levofloxacin|mesh-list
6601166|NCT01163435|Ofloxacin|ofloxacin|mesh-list
6601167|NCT01163435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6601168|NCT01163435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6601169|NCT01163435|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6601170|NCT01163435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6601171|NCT01163435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601172|NCT01163435|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6601173|NCT01163435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6601174|NCT01163435|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6601175|NCT01163435|Renal Agents|renal agents|mesh-ancestor
6601176|NCT01163435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6601177|NCT01163435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5501784|NCT04470674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5501785|NCT04470674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6601178|NCT01163435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6601179|NCT01163435|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6601180|NCT01163500|Ubiquinone|ubiquinone|mesh-list
6601181|NCT01163500|Coenzyme Q10|coenzyme q10|mesh-list
6601182|NCT01163500|Micronutrients|micronutrients|mesh-ancestor
6601183|NCT01163500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601184|NCT01163500|Vitamins|vitamins|mesh-ancestor
6601185|NCT01163630|Esomeprazole|esomeprazole|mesh-list
6601186|NCT01163630|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6601187|NCT01163630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6601188|NCT01163630|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6601189|NCT01163630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6601190|NCT01163630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601191|NCT01163734|Ranolazine|ranolazine|mesh-list
6601192|NCT01163734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6601193|NCT01163734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6601194|NCT01163734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601195|NCT01163799|Alefacept|alefacept|mesh-list
6601196|NCT01163799|Dermatologic Agents|dermatologic agents|mesh-ancestor
6601197|NCT01163799|Immunologic Factors|immunologic factors|mesh-ancestor
6601198|NCT01163799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601199|NCT01163825|Mitogens|mitogens|mesh-list
6601200|NCT01163825|Mitosis Modulators|mitosis modulators|mesh-ancestor
6601201|NCT01163825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601202|NCT01163903|Doxorubicin|doxorubicin|mesh-list
6601203|NCT01163903|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6601204|NCT01163903|Pantoprazole|pantoprazole|mesh-list
6601205|NCT01163903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6601206|NCT01163903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6601207|NCT01163903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6601208|NCT01163903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6601209|NCT01163903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6601210|NCT01163903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601211|NCT01163903|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6601212|NCT01163903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6601213|NCT01163903|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6601214|NCT01163929|Paclitaxel|paclitaxel|mesh-list
6601215|NCT01163929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6601216|NCT01163929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6601217|NCT01163929|Tubulin Modulators|tubulin modulators|mesh-ancestor
6601218|NCT01163929|Antimitotic Agents|antimitotic agents|mesh-ancestor
6601219|NCT01163929|Mitosis Modulators|mitosis modulators|mesh-ancestor
6601220|NCT01163929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601221|NCT01163994|Doxycycline|doxycycline|mesh-list
6601222|NCT01163994|Ceftriaxone|ceftriaxone|mesh-list
6601223|NCT01163994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6601224|NCT01163994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6601225|NCT01163994|Antimalarials|antimalarials|mesh-ancestor
6601226|NCT01163994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6601227|NCT01163994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6601228|NCT01164046|Vitamin K|vitamin k|mesh-list
6601229|NCT01164046|Heparin|heparin|mesh-list
6601230|NCT01164046|Enoxaparin|enoxaparin|mesh-list
6601231|NCT01164046|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6601232|NCT01164046|Tinzaparin|tinzaparin|mesh-list
6601233|NCT01164046|Dalteparin|dalteparin|mesh-list
6601234|NCT01164046|Nadroparin|nadroparin|mesh-list
6601235|NCT01164046|Reviparin|reviparin|mesh-list
6601236|NCT01164046|Warfarin|warfarin|mesh-list
6601237|NCT01164046|Acenocoumarol|acenocoumarol|mesh-list
6601238|NCT01164046|Phenprocoumon|phenprocoumon|mesh-list
6601239|NCT01164046|Bemiparin|bemiparin|mesh-list
6601240|NCT01164046|Certoparin|certoparin|mesh-list
6601241|NCT01164046|Vitamins|vitamins|mesh-ancestor
6601242|NCT01164046|Micronutrients|micronutrients|mesh-ancestor
6601243|NCT01164046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601244|NCT01164046|Anticoagulants|anticoagulants|mesh-ancestor
6601245|NCT01164046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6601246|NCT01164046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6601247|NCT01164046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601248|NCT01164046|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6601249|NCT01164046|Hemostatics|hemostatics|mesh-ancestor
6601250|NCT01164046|Coagulants|coagulants|mesh-ancestor
6601251|NCT01164059|Haloperidol|haloperidol|mesh-list
6601252|NCT01164059|Olanzapine|olanzapine|mesh-list
6601253|NCT01164059|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6601254|NCT01164059|Aripiprazole|aripiprazole|mesh-list
6601255|NCT01164059|Haloperidol decanoate|haloperidol decanoate|mesh-list
6601256|NCT01164059|Flupenthixol|flupenthixol|mesh-list
6601257|NCT01164059|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
6601258|NCT01164059|Antiemetics|antiemetics|mesh-ancestor
6601259|NCT01164059|Autonomic Agents|autonomic agents|mesh-ancestor
6601260|NCT01164059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6601261|NCT01164059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601262|NCT01164059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6601263|NCT01164059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6601264|NCT01164059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6601265|NCT01164059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6601266|NCT01164059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6601267|NCT01164059|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6601268|NCT01164059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6601269|NCT01164059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6601270|NCT01164059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601271|NCT01164059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6601272|NCT01164059|Serotonin Agents|serotonin agents|mesh-ancestor
6601273|NCT01164059|Antidepressive Agents|antidepressive agents|mesh-ancestor
6601274|NCT01164059|Dopamine Agonists|dopamine agonists|mesh-ancestor
6601275|NCT01164059|Dopamine Agents|dopamine agents|mesh-ancestor
6601276|NCT01164059|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6601277|NCT01164059|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6601278|NCT01164059|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6601279|NCT01164059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6601280|NCT01164059|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6601281|NCT01164059|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6601282|NCT01164059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6601283|NCT01164085|Ketorolac|ketorolac|mesh-list
6601284|NCT01164085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6601285|NCT01164085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6601286|NCT01164085|Analgesics|analgesics|mesh-ancestor
6601287|NCT01164085|Sensory System Agents|sensory system agents|mesh-ancestor
6601288|NCT01164085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6601289|NCT01164085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601290|NCT01164085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6601291|NCT01164085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6601292|NCT01164085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6601293|NCT01164085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6601294|NCT01164085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601295|NCT01164176|Everolimus|everolimus|mesh-list
6601296|NCT01164176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6601297|NCT01164176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6601298|NCT01164176|Immunologic Factors|immunologic factors|mesh-ancestor
6601299|NCT01164176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601300|NCT01164189|Bevacizumab|bevacizumab|mesh-list
6601301|NCT01164189|Temozolomide|temozolomide|mesh-list
6601302|NCT01164189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6601303|NCT01164189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6601304|NCT01164189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6601305|NCT01164189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6601306|NCT01164189|Growth Substances|growth substances|mesh-ancestor
6601307|NCT01164189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601308|NCT01164189|Growth Inhibitors|growth inhibitors|mesh-ancestor
6601309|NCT01164189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6601310|NCT01164189|Alkylating Agents|alkylating agents|mesh-ancestor
6601311|NCT01164189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601312|NCT01164202|Sunitinib|sunitinib|mesh-list
6601313|NCT01164202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6601314|NCT01164202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6601315|NCT01164202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6601316|NCT01164202|Growth Substances|growth substances|mesh-ancestor
6601317|NCT01164202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601318|NCT01164202|Growth Inhibitors|growth inhibitors|mesh-ancestor
6601319|NCT01164202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6601320|NCT01164202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6601321|NCT01164202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601322|NCT01164215|Leucovorin|leucovorin|mesh-list
6601323|NCT01164215|Fluorouracil|fluorouracil|mesh-list
6601324|NCT01164215|Oxaliplatin|oxaliplatin|mesh-list
6601325|NCT01164215|Levoleucovorin|levoleucovorin|mesh-list
6601326|NCT01164215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601327|NCT01164215|Antimetabolites|antimetabolites|mesh-ancestor
6601328|NCT01164215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601329|NCT01164215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6601330|NCT01164215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6601331|NCT01164215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6601332|NCT01164215|Immunologic Factors|immunologic factors|mesh-ancestor
6601333|NCT01164215|Antidotes|antidotes|mesh-ancestor
6601334|NCT01164215|Protective Agents|protective agents|mesh-ancestor
6601335|NCT01164215|Vitamin B Complex|vitamin b complex|mesh-ancestor
6601336|NCT01164215|Vitamins|vitamins|mesh-ancestor
6601337|NCT01164215|Micronutrients|micronutrients|mesh-ancestor
6601338|NCT01164267|Everolimus|everolimus|mesh-list
6601339|NCT01164267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6601340|NCT01164267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6601341|NCT01164267|Immunologic Factors|immunologic factors|mesh-ancestor
6601342|NCT01164267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601343|NCT01164306|Nicotine|nicotine|mesh-list
6601344|NCT01164306|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6601345|NCT01164306|Autonomic Agents|autonomic agents|mesh-ancestor
6601346|NCT01164306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6601347|NCT01164306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601348|NCT01164306|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6601349|NCT01164306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6601350|NCT01164306|Cholinergic Agents|cholinergic agents|mesh-ancestor
6601351|NCT01164306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6601352|NCT01164306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601353|NCT01164345|Plerixafor|plerixafor|mesh-list
6601354|NCT01164345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6601355|NCT01164345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6601356|NCT01164345|Antiviral Agents|antiviral agents|mesh-ancestor
6601357|NCT01164345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6601358|NCT01164488|Ritonavir|ritonavir|mesh-list
6601359|NCT01164488|Ketoconazole|ketoconazole|mesh-list
6601360|NCT01164488|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6601361|NCT01164488|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6601362|NCT01164488|Protease Inhibitors|protease inhibitors|mesh-ancestor
6601363|NCT01164488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6601364|NCT01164488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601365|NCT01164488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6601366|NCT01164488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6601367|NCT01164488|Antiviral Agents|antiviral agents|mesh-ancestor
6601368|NCT01164488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6601369|NCT01164488|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6601370|NCT01164488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6601371|NCT01164488|Antifungal Agents|antifungal agents|mesh-ancestor
6601372|NCT01164488|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6601373|NCT01164488|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6601374|NCT01164488|Hormone Antagonists|hormone antagonists|mesh-ancestor
6601375|NCT01164488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6601376|NCT01164488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601377|NCT01164540|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6601378|NCT01164540|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6601379|NCT01164540|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6601380|NCT01164540|Antimetabolites|antimetabolites|mesh-ancestor
6601381|NCT01164540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601382|NCT01164540|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6601383|NCT01164540|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6601384|NCT01164540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6601385|NCT01164605|Raltegravir Potassium|raltegravir potassium|mesh-list
6601386|NCT01164605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6601387|NCT01164605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6601388|NCT01164605|Antiviral Agents|antiviral agents|mesh-ancestor
6601389|NCT01164605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6601390|NCT01164605|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6601391|NCT01164605|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6601392|NCT01164605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6601393|NCT01164605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601394|NCT01164709|Nelfinavir|nelfinavir|mesh-list
6601395|NCT01164709|Bortezomib|bortezomib|mesh-list
6601396|NCT01164709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6601397|NCT01164709|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6601398|NCT01164709|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6601399|NCT01164709|Protease Inhibitors|protease inhibitors|mesh-ancestor
6601400|NCT01164709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6601401|NCT01164709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601402|NCT01164709|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6601403|NCT01164709|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6601404|NCT01164709|Antiviral Agents|antiviral agents|mesh-ancestor
6601405|NCT01164709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6601406|NCT01164761|Ramipril|ramipril|mesh-list
6601407|NCT01164761|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6601408|NCT01164761|Protease Inhibitors|protease inhibitors|mesh-ancestor
6601409|NCT01164761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6601410|NCT01164761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601411|NCT01164761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6601412|NCT01164774|Ramipril|ramipril|mesh-list
6601413|NCT01164774|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6601414|NCT01164774|Protease Inhibitors|protease inhibitors|mesh-ancestor
6601415|NCT01164774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6601416|NCT01164774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601417|NCT01164774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6601418|NCT01164787|Trandolapril|trandolapril|mesh-list
6601419|NCT01164787|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6601420|NCT01164787|Protease Inhibitors|protease inhibitors|mesh-ancestor
6601421|NCT01164787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6601422|NCT01164787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601423|NCT01164787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6601424|NCT01164800|Trandolapril|trandolapril|mesh-list
6601425|NCT01164800|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6601426|NCT01164800|Protease Inhibitors|protease inhibitors|mesh-ancestor
6601427|NCT01164800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6601428|NCT01164800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601429|NCT01164800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6601430|NCT01164813|Nabumetone|nabumetone|mesh-list
6601431|NCT01164813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6601432|NCT01164813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6601433|NCT01164813|Analgesics|analgesics|mesh-ancestor
6601434|NCT01164813|Sensory System Agents|sensory system agents|mesh-ancestor
6601435|NCT01164813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6601436|NCT01164813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601437|NCT01164813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6601438|NCT01164813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6601439|NCT01164813|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6601440|NCT01164813|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6601441|NCT01164813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6601442|NCT01164813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601443|NCT01164826|Nabumetone|nabumetone|mesh-list
6601444|NCT01164826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6601445|NCT01164826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6601446|NCT01164826|Analgesics|analgesics|mesh-ancestor
6601447|NCT01164826|Sensory System Agents|sensory system agents|mesh-ancestor
6601448|NCT01164826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6601449|NCT01164826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601450|NCT01164826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6601451|NCT01164826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6601452|NCT01164826|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6601453|NCT01164826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6601454|NCT01164826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6601455|NCT01164826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601456|NCT01164917|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6601457|NCT01164917|Immunologic Factors|immunologic factors|mesh-ancestor
6601458|NCT01164917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601459|NCT01164969|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6601460|NCT01164969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6601461|NCT01165008|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6601462|NCT01165008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6601463|NCT01165060|Bezafibrate|bezafibrate|mesh-list
6601464|NCT01165060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6601465|NCT01165060|Antimetabolites|antimetabolites|mesh-ancestor
6601466|NCT01165060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601467|NCT01165060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6601468|NCT01165125|Ketoconazole|ketoconazole|mesh-list
6601469|NCT01165125|Antifungal Agents|antifungal agents|mesh-ancestor
6601470|NCT01165125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6601471|NCT01165125|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6601472|NCT01165125|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6601473|NCT01165125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6601474|NCT01165125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601475|NCT01165125|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6601476|NCT01165125|Hormone Antagonists|hormone antagonists|mesh-ancestor
6601477|NCT01165125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6601478|NCT01165125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601479|NCT01165125|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6601480|NCT01165164|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6601481|NCT01165164|Lubricant Eye Drops|lubricant eye drops|mesh-list
6601482|NCT01165164|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6660077|NCT01490996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6660078|NCT01490996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6660079|NCT01491009|Midazolam|midazolam|mesh-list
6660080|NCT01491009|Remifentanil|remifentanil|mesh-list
6660081|NCT01491009|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6660082|NCT01491009|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6660083|NCT01491009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6660084|NCT01491009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660085|NCT01491009|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6660086|NCT01491009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6660087|NCT01491009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6660088|NCT01491009|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6660089|NCT01491009|Anesthetics, General|anesthetics, general|mesh-ancestor
6660090|NCT01491009|Anesthetics|anesthetics|mesh-ancestor
6660091|NCT01491009|GABA Modulators|gaba modulators|mesh-ancestor
6660092|NCT01491009|GABA Agents|gaba agents|mesh-ancestor
6660093|NCT01491009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6660094|NCT01491009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660095|NCT01491009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6660096|NCT01491009|Narcotics|narcotics|mesh-ancestor
6660097|NCT01491009|Analgesics|analgesics|mesh-ancestor
6660098|NCT01491009|Sensory System Agents|sensory system agents|mesh-ancestor
6660099|NCT01491009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6660100|NCT01491048|Tacrine|tacrine|mesh-list
6660101|NCT01491048|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6660102|NCT01491048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6660103|NCT01491048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660104|NCT01491048|Cholinergic Agents|cholinergic agents|mesh-ancestor
6660105|NCT01491048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6660106|NCT01491048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660107|NCT01491048|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6660108|NCT01491048|Autonomic Agents|autonomic agents|mesh-ancestor
6660109|NCT01491048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6660110|NCT01491048|Nootropic Agents|nootropic agents|mesh-ancestor
6660111|NCT01491061|Ranolazine|ranolazine|mesh-list
6601483|NCT01165255|Bupropion|bupropion|mesh-list
6601484|NCT01165255|Antidepressive Agents|antidepressive agents|mesh-list
6601485|NCT01165255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6601486|NCT01165255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6601487|NCT01165255|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6601488|NCT01165255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6601489|NCT01165255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6601490|NCT01165255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601491|NCT01165255|Dopamine Agents|dopamine agents|mesh-ancestor
6601492|NCT01165255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6601493|NCT01165255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601494|NCT01165255|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6601495|NCT01165255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6601496|NCT01165255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6601497|NCT01165268|Dapagliflozin|dapagliflozin|mesh-list
6601498|NCT01165268|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6601499|NCT01165268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601500|NCT01165268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6601501|NCT01165268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601502|NCT01165294|Ketamine|ketamine|mesh-list
6601503|NCT01165294|Analgesics|analgesics|mesh-ancestor
6601504|NCT01165294|Sensory System Agents|sensory system agents|mesh-ancestor
6601505|NCT01165294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6601506|NCT01165294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601507|NCT01165294|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6448998|NCT00403039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6448999|NCT00403052|1018 oligonucleotide|1018 oligonucleotide|mesh-list
6449000|NCT00403052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6449001|NCT00403052|Immunologic Factors|immunologic factors|mesh-ancestor
6449002|NCT00403052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449003|NCT00403065|Dexamethasone|dexamethasone|mesh-list
6449004|NCT00403065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6449005|NCT00403065|Antiemetics|antiemetics|mesh-ancestor
6449006|NCT00403065|Autonomic Agents|autonomic agents|mesh-ancestor
6601508|NCT01165294|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6601509|NCT01165294|Anesthetics, General|anesthetics, general|mesh-ancestor
6601510|NCT01165294|Anesthetics|anesthetics|mesh-ancestor
6601511|NCT01165294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6601512|NCT01165294|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6601513|NCT01165294|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6601514|NCT01165294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6601515|NCT01165294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601516|NCT01165372|Artesunate|artesunate|mesh-list
6601517|NCT01165372|Piperaquine|piperaquine|mesh-list
6601518|NCT01165372|Artenimol|artenimol|mesh-list
6601519|NCT01165372|Antimalarials|antimalarials|mesh-ancestor
6601520|NCT01165372|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6601521|NCT01165372|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6601522|NCT01165372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6601523|NCT01165372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6449007|NCT00403065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6449008|NCT00403065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449009|NCT00403065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6449010|NCT00403065|Glucocorticoids|glucocorticoids|mesh-ancestor
6449011|NCT00403065|Hormones|hormones|mesh-ancestor
6449012|NCT00403065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6449013|NCT00403065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6449014|NCT00403065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6449015|NCT00403156|Ranibizumab|ranibizumab|mesh-list
6449016|NCT00403156|Imatinib Mesylate|imatinib mesylate|mesh-list
6449017|NCT00403156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6449018|NCT00403156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6449019|NCT00403156|Growth Substances|growth substances|mesh-ancestor
6449020|NCT00403156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449021|NCT00403156|Growth Inhibitors|growth inhibitors|mesh-ancestor
6449022|NCT00403156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6449023|NCT00403156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6449024|NCT00403156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6449025|NCT00403156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6449026|NCT00403182|Letrozole|letrozole|mesh-list
6449027|NCT00403182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6601524|NCT01165372|Antiviral Agents|antiviral agents|mesh-ancestor
6601525|NCT01165372|Schistosomicides|schistosomicides|mesh-ancestor
6601526|NCT01165372|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6601527|NCT01165372|Anthelmintics|anthelmintics|mesh-ancestor
6601528|NCT01165385|Cisplatin|cisplatin|mesh-list
6601529|NCT01165385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6601530|NCT01165476|Treprostinil|treprostinil|mesh-list
6601531|NCT01165476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6601532|NCT01165567|Sarpogrelate|sarpogrelate|mesh-list
6601533|NCT01165567|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6601534|NCT01165567|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6601535|NCT01165567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601536|NCT01165567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6601537|NCT01165567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6601538|NCT01165567|Serotonin Agents|serotonin agents|mesh-ancestor
6601539|NCT01165567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6601540|NCT01165567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601541|NCT01165580|Valganciclovir|valganciclovir|mesh-list
6601542|NCT01165580|Antiviral Agents|antiviral agents|mesh-ancestor
6601543|NCT01165580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6601544|NCT01165632|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
6601545|NCT01165632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601546|NCT01165632|Dopamine Agents|dopamine agents|mesh-ancestor
6601547|NCT01165632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6601548|NCT01165632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601549|NCT01165645|Ritonavir|ritonavir|mesh-list
6601550|NCT01165645|Lopinavir|lopinavir|mesh-list
6601551|NCT01165645|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6601552|NCT01165645|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6601553|NCT01165645|Protease Inhibitors|protease inhibitors|mesh-ancestor
6601554|NCT01165645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6601555|NCT01165645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601556|NCT01165645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6601557|NCT01165645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6601558|NCT01165645|Antiviral Agents|antiviral agents|mesh-ancestor
6601559|NCT01165645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6601560|NCT01165645|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6601561|NCT01165645|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6601562|NCT01165814|Naproxen|naproxen|mesh-list
6601563|NCT01165814|Tramadol|tramadol|mesh-list
6601564|NCT01165814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6601565|NCT01165814|Narcotics|narcotics|mesh-ancestor
6601566|NCT01165814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6601567|NCT01165814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449028|NCT00403182|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6449029|NCT00403182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6449030|NCT00403182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6449031|NCT00403182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6449032|NCT00403182|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6449033|NCT00403182|Hormone Antagonists|hormone antagonists|mesh-ancestor
6601568|NCT01165814|Analgesics|analgesics|mesh-ancestor
6601569|NCT01165814|Sensory System Agents|sensory system agents|mesh-ancestor
6601570|NCT01165814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6449034|NCT00403182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6449035|NCT00403182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449036|NCT00403247|Vitamin B 12|vitamin b 12|mesh-list
6449037|NCT00403247|Hydroxocobalamin|hydroxocobalamin|mesh-list
6449038|NCT00403247|Pyridoxine|pyridoxine|mesh-list
6449039|NCT00403247|Vitamins|vitamins|mesh-ancestor
6449040|NCT00403247|Micronutrients|micronutrients|mesh-ancestor
6449041|NCT00403247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449042|NCT00403247|Vitamin B Complex|vitamin b complex|mesh-ancestor
6449043|NCT00403247|Hematinics|hematinics|mesh-ancestor
6449044|NCT00403286|Fluticasone|fluticasone|mesh-list
6449045|NCT00403286|Xhance|xhance|mesh-list
6449046|NCT00403286|Formoterol Fumarate|formoterol fumarate|mesh-list
6449047|NCT00403286|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6449048|NCT00403286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6449049|NCT00403286|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6449050|NCT00403286|Autonomic Agents|autonomic agents|mesh-ancestor
6449051|NCT00403286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6601571|NCT01165814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6601572|NCT01165814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6601573|NCT01165814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6601574|NCT01165814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6601575|NCT01165814|Gout Suppressants|gout suppressants|mesh-ancestor
6601576|NCT01165814|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6601577|NCT01165814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6601578|NCT01165814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601579|NCT01165866|Ondansetron|ondansetron|mesh-list
6601580|NCT01165866|Metoclopramide|metoclopramide|mesh-list
6601581|NCT01165866|Antiemetics|antiemetics|mesh-ancestor
6601582|NCT01165866|Autonomic Agents|autonomic agents|mesh-ancestor
6601583|NCT01165866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6601584|NCT01165866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601585|NCT01165866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6601586|NCT01165866|Antipruritics|antipruritics|mesh-ancestor
6601587|NCT01165866|Dermatologic Agents|dermatologic agents|mesh-ancestor
6601588|NCT01165866|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6601589|NCT01165866|Serotonin Agents|serotonin agents|mesh-ancestor
6601590|NCT01165866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6601591|NCT01165866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601592|NCT01165866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6601593|NCT01165866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6601594|NCT01165866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6601595|NCT01165866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6601596|NCT01165866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6601597|NCT01165866|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6601598|NCT01165866|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6601599|NCT01165866|Dopamine Agents|dopamine agents|mesh-ancestor
6601600|NCT01165905|Gemcitabine|gemcitabine|mesh-list
6601601|NCT01165905|ON 01910|on 01910|mesh-list
6601602|NCT01165905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6601603|NCT01165905|Antimetabolites|antimetabolites|mesh-ancestor
6601604|NCT01165905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601605|NCT01165905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6601606|NCT01165905|Antiviral Agents|antiviral agents|mesh-ancestor
6601607|NCT01165905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6601608|NCT01165905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6601609|NCT01165905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6601610|NCT01165905|Immunologic Factors|immunologic factors|mesh-ancestor
6601611|NCT01165905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601612|NCT01165905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6601613|NCT01165931|Riociguat|riociguat|mesh-list
6601614|NCT01165931|Enzyme Activators|enzyme activators|mesh-ancestor
6601615|NCT01165931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601616|NCT01165944|Pramlintide|pramlintide|mesh-list
6601617|NCT01165944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6601618|NCT01165944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601619|NCT01165970|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6601620|NCT01165970|Laxatives|laxatives|mesh-ancestor
6601621|NCT01165970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6601622|NCT01166035|Lenalidomide|lenalidomide|mesh-list
6601623|NCT01166035|Cetuximab|cetuximab|mesh-list
6601624|NCT01166035|Immunologic Factors|immunologic factors|mesh-ancestor
6601625|NCT01166035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601626|NCT01166035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6601627|NCT01166035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6601628|NCT01166035|Growth Substances|growth substances|mesh-ancestor
6601629|NCT01166035|Growth Inhibitors|growth inhibitors|mesh-ancestor
6601630|NCT01166035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6601631|NCT01166035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6601632|NCT01166048|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6601633|NCT01166048|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6601634|NCT01166048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6601635|NCT01166048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6601636|NCT01166048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601637|NCT01166048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6601638|NCT01166048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601639|NCT01166048|Analgesics|analgesics|mesh-ancestor
6601640|NCT01166048|Sensory System Agents|sensory system agents|mesh-ancestor
6601641|NCT01166048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6601642|NCT01166048|Antidepressive Agents|antidepressive agents|mesh-ancestor
6601643|NCT01166048|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6601644|NCT01166048|Dopamine Agents|dopamine agents|mesh-ancestor
6601645|NCT01166087|Fluoxetine|fluoxetine|mesh-list
6601646|NCT01166087|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6601647|NCT01166087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6601648|NCT01166087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6601649|NCT01166087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601650|NCT01166087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6601651|NCT01166087|Serotonin Agents|serotonin agents|mesh-ancestor
6601652|NCT01166087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601653|NCT01166087|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6449052|NCT00403286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449053|NCT00403286|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6449054|NCT00403286|Respiratory System Agents|respiratory system agents|mesh-ancestor
6449055|NCT00403286|Dermatologic Agents|dermatologic agents|mesh-ancestor
6449056|NCT00403286|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6449057|NCT00403286|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6601654|NCT01166087|Antidepressive Agents|antidepressive agents|mesh-ancestor
6449058|NCT00403286|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6449059|NCT00403286|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6601655|NCT01166087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6601656|NCT01166087|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6601657|NCT01166087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6601658|NCT01166087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6601659|NCT01166100|Fluoxetine|fluoxetine|mesh-list
6601660|NCT01166100|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6601661|NCT01166100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6601662|NCT01166100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6449060|NCT00403286|Adrenergic Agents|adrenergic agents|mesh-ancestor
6449061|NCT00403286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6449062|NCT00403286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6449063|NCT00403312|Nicotine|nicotine|mesh-list
6449064|NCT00403312|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6449065|NCT00403312|Autonomic Agents|autonomic agents|mesh-ancestor
6449066|NCT00403312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6449067|NCT00403312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449068|NCT00403312|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6449069|NCT00403312|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6449070|NCT00403312|Cholinergic Agents|cholinergic agents|mesh-ancestor
6449071|NCT00403312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6449072|NCT00403312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6449073|NCT00403325|Ranibizumab|ranibizumab|mesh-list
6601663|NCT01166100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601664|NCT01166100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6601665|NCT01166100|Serotonin Agents|serotonin agents|mesh-ancestor
6601666|NCT01166100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601667|NCT01166100|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6601668|NCT01166100|Antidepressive Agents|antidepressive agents|mesh-ancestor
6601669|NCT01166100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6601670|NCT01166100|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6601671|NCT01166100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6601672|NCT01166100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6601673|NCT01166113|Prednisone|prednisone|mesh-list
6601674|NCT01166113|Cyclophosphamide|cyclophosphamide|mesh-list
6601675|NCT01166113|Pomalidomide|pomalidomide|mesh-list
6601676|NCT01166113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6601677|NCT01166113|Immunologic Factors|immunologic factors|mesh-ancestor
6601678|NCT01166113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601679|NCT01166113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6601680|NCT01166113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6601681|NCT01166113|Alkylating Agents|alkylating agents|mesh-ancestor
6601682|NCT01166113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601683|NCT01166113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6601684|NCT01166113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6601685|NCT01166113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6601686|NCT01166113|Glucocorticoids|glucocorticoids|mesh-ancestor
6449074|NCT00403325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6449075|NCT00403325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6449076|NCT00403325|Growth Substances|growth substances|mesh-ancestor
6449077|NCT00403325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449078|NCT00403325|Growth Inhibitors|growth inhibitors|mesh-ancestor
6449079|NCT00403325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6601687|NCT01166113|Hormones|hormones|mesh-ancestor
6601688|NCT01166113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6601689|NCT01166113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6601690|NCT01166113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6601691|NCT01166113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6601692|NCT01166113|Growth Substances|growth substances|mesh-ancestor
6601693|NCT01166113|Growth Inhibitors|growth inhibitors|mesh-ancestor
6601694|NCT01166165|Cholecalciferol|cholecalciferol|mesh-list
6601695|NCT01166165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6601696|NCT01166165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601697|NCT01166165|Vitamins|vitamins|mesh-ancestor
6601698|NCT01166165|Micronutrients|micronutrients|mesh-ancestor
6601699|NCT01166165|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6601700|NCT01166425|Lithium Carbonate|lithium carbonate|mesh-list
6601701|NCT01166425|Antidepressive Agents|antidepressive agents|mesh-ancestor
6601702|NCT01166425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6601703|NCT01166425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6601704|NCT01166425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601705|NCT01166425|Antimanic Agents|antimanic agents|mesh-ancestor
6601706|NCT01166425|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6601707|NCT01166425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6601708|NCT01166425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601709|NCT01166451|Iron|iron|mesh-list
6601710|NCT01166451|Trace Elements|trace elements|mesh-ancestor
6601711|NCT01166451|Micronutrients|micronutrients|mesh-ancestor
6601712|NCT01166451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601713|NCT01166477|Ritonavir|ritonavir|mesh-list
6601714|NCT01166477|Lopinavir|lopinavir|mesh-list
6601715|NCT01166477|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6601716|NCT01166477|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6601717|NCT01166477|Protease Inhibitors|protease inhibitors|mesh-ancestor
6601718|NCT01166477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6601719|NCT01166477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601720|NCT01166477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6601721|NCT01166477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6601722|NCT01166477|Antiviral Agents|antiviral agents|mesh-ancestor
6601723|NCT01166477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6601724|NCT01166477|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6601725|NCT01166477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6449080|NCT00403338|Sirolimus|sirolimus|mesh-list
6449081|NCT00403338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6449082|NCT00403338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6449083|NCT00403338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6449084|NCT00403338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6601726|NCT01166542|Paclitaxel|paclitaxel|mesh-list
6601727|NCT01166542|Carboplatin|carboplatin|mesh-list
6601728|NCT01166542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6601729|NCT01166542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6601730|NCT01166542|Tubulin Modulators|tubulin modulators|mesh-ancestor
6601731|NCT01166542|Antimitotic Agents|antimitotic agents|mesh-ancestor
6601732|NCT01166542|Mitosis Modulators|mitosis modulators|mesh-ancestor
6601733|NCT01166542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601734|NCT01166594|Bevacizumab|bevacizumab|mesh-list
6601735|NCT01166594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6601736|NCT01166594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6601737|NCT01166594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6601738|NCT01166594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6601739|NCT01166594|Growth Substances|growth substances|mesh-ancestor
6601740|NCT01166594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601741|NCT01166594|Growth Inhibitors|growth inhibitors|mesh-ancestor
6601742|NCT01166633|Atorvastatin|atorvastatin|mesh-list
6601743|NCT01166633|Pitavastatin|pitavastatin|mesh-list
6601744|NCT01166633|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6601745|NCT01166633|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6601746|NCT01166633|Antimetabolites|antimetabolites|mesh-ancestor
6601747|NCT01166633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601748|NCT01166633|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6601749|NCT01166633|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6601750|NCT01166633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6601751|NCT01166685|Everolimus|everolimus|mesh-list
6601752|NCT01166685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6601753|NCT01166685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6601754|NCT01166685|Immunologic Factors|immunologic factors|mesh-ancestor
6601755|NCT01166685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601756|NCT01166711|Chromium|chromium|mesh-list
6601757|NCT01166711|Paclitaxel|paclitaxel|mesh-list
6601758|NCT01166711|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6601759|NCT01166711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6601760|NCT01166711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6601761|NCT01166711|Tubulin Modulators|tubulin modulators|mesh-ancestor
6601762|NCT01166711|Antimitotic Agents|antimitotic agents|mesh-ancestor
6601763|NCT01166711|Mitosis Modulators|mitosis modulators|mesh-ancestor
6601764|NCT01166711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601765|NCT01166711|Trace Elements|trace elements|mesh-ancestor
6601766|NCT01166711|Micronutrients|micronutrients|mesh-ancestor
6601767|NCT01166711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601768|NCT01166789|Lubiprostone|lubiprostone|mesh-list
6601769|NCT01166789|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6601770|NCT01166789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6601771|NCT01166789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601772|NCT01166815|Zinc Sulfate|zinc sulfate|mesh-list
6601773|NCT01166815|Astringents|astringents|mesh-ancestor
6601774|NCT01166815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601775|NCT01166815|Dermatologic Agents|dermatologic agents|mesh-ancestor
6660112|NCT01491061|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6449085|NCT00403338|Antifungal Agents|antifungal agents|mesh-ancestor
6449086|NCT00403338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6449087|NCT00403338|Immunologic Factors|immunologic factors|mesh-ancestor
6449088|NCT00403338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449089|NCT00403364|Amoxicillin|amoxicillin|mesh-list
6449090|NCT00403364|Clarithromycin|clarithromycin|mesh-list
6449091|NCT00403364|Tinidazole|tinidazole|mesh-list
6449092|NCT00403364|Pantoprazole|pantoprazole|mesh-list
6449093|NCT00403364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6449094|NCT00403364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6601776|NCT01166932|Amoxicillin|amoxicillin|mesh-list
6601777|NCT01166932|Ceftriaxone|ceftriaxone|mesh-list
6601778|NCT01166932|Clavulanic Acids|clavulanic acids|mesh-list
6601779|NCT01166932|Clavulanic Acid|clavulanic acid|mesh-list
6601780|NCT01166932|Oxacillin|oxacillin|mesh-list
6601781|NCT01166932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6601782|NCT01166932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6601783|NCT01166932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6601784|NCT01166932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601785|NCT01166932|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6601786|NCT01167010|Budesonide|budesonide|mesh-list
6601787|NCT01167010|Formoterol Fumarate|formoterol fumarate|mesh-list
6601788|NCT01167010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6601789|NCT01167010|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6601790|NCT01167010|Autonomic Agents|autonomic agents|mesh-ancestor
6601791|NCT01167010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6601792|NCT01167010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601793|NCT01167010|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6601794|NCT01167010|Respiratory System Agents|respiratory system agents|mesh-ancestor
6601795|NCT01167010|Glucocorticoids|glucocorticoids|mesh-ancestor
6601796|NCT01167010|Hormones|hormones|mesh-ancestor
6601797|NCT01167010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6601798|NCT01167010|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6601799|NCT01167010|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6601800|NCT01167010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6601801|NCT01167010|Adrenergic Agents|adrenergic agents|mesh-ancestor
6601802|NCT01167010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6601803|NCT01167010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601804|NCT01167049|Capecitabine|capecitabine|mesh-list
6601805|NCT01167049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6601806|NCT01167049|Antimetabolites|antimetabolites|mesh-ancestor
6601807|NCT01167049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601808|NCT01167049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6601809|NCT01167062|Tamsulosin|tamsulosin|mesh-list
6601810|NCT01167062|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6601811|NCT01167062|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6601812|NCT01167062|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6601813|NCT01167062|Adrenergic Agents|adrenergic agents|mesh-ancestor
6601814|NCT01167062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6601815|NCT01167062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601816|NCT01167062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601817|NCT01167062|Urological Agents|urological agents|mesh-ancestor
6601818|NCT01167101|Pantoprazole|pantoprazole|mesh-list
6601819|NCT01167101|Rebamipide|rebamipide|mesh-list
6601820|NCT01167101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6601821|NCT01167101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6601822|NCT01167101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6601823|NCT01167101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6601824|NCT01167101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601825|NCT01167101|Antioxidants|antioxidants|mesh-ancestor
6601826|NCT01167101|Protective Agents|protective agents|mesh-ancestor
6601827|NCT01167101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601828|NCT01167127|Oxycodone|oxycodone|mesh-list
6601829|NCT01167127|Naloxone|naloxone|mesh-list
6601830|NCT01167127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6601831|NCT01167127|Narcotics|narcotics|mesh-ancestor
6601832|NCT01167127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6601833|NCT01167127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601834|NCT01167127|Analgesics|analgesics|mesh-ancestor
6601835|NCT01167127|Sensory System Agents|sensory system agents|mesh-ancestor
6601836|NCT01167127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6601837|NCT01167127|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6601838|NCT01167231|Acarbose|acarbose|mesh-list
6601839|NCT01167231|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6601840|NCT01167231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6601841|NCT01167231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601842|NCT01167231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6601843|NCT01167231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601844|NCT01167465|Zinc Oxide|zinc oxide|mesh-list
6601845|NCT01167465|Dermatologic Agents|dermatologic agents|mesh-ancestor
6601846|NCT01167465|Sunscreening Agents|sunscreening agents|mesh-ancestor
6601847|NCT01167465|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6601848|NCT01167465|Protective Agents|protective agents|mesh-ancestor
6601849|NCT01167465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601850|NCT01167478|Caffeine|caffeine|mesh-list
6601851|NCT01167478|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6601852|NCT01167478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601853|NCT01167478|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6601854|NCT01167478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6601855|NCT01167478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601856|NCT01167478|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6601857|NCT01167478|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6601858|NCT01167478|Purinergic Agents|purinergic agents|mesh-ancestor
6601859|NCT01167478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6601860|NCT01167530|Everolimus|everolimus|mesh-list
6601861|NCT01167530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6601862|NCT01167530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6601863|NCT01167530|Immunologic Factors|immunologic factors|mesh-ancestor
6449095|NCT00403364|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6449096|NCT00403364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6449097|NCT00403364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6449098|NCT00403364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6601864|NCT01167530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601865|NCT01167699|Oxycodone|oxycodone|mesh-list
6601866|NCT01167699|Naloxone|naloxone|mesh-list
6601867|NCT01167699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6601868|NCT01167699|Narcotics|narcotics|mesh-ancestor
6601869|NCT01167699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6601870|NCT01167699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601871|NCT01167699|Analgesics|analgesics|mesh-ancestor
6601872|NCT01167699|Sensory System Agents|sensory system agents|mesh-ancestor
6601873|NCT01167699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6601874|NCT01167699|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6601875|NCT01167725|Leucovorin|leucovorin|mesh-list
6601876|NCT01167725|Bevacizumab|bevacizumab|mesh-list
6601877|NCT01167725|Cetuximab|cetuximab|mesh-list
6601878|NCT01167725|Fluorouracil|fluorouracil|mesh-list
6601879|NCT01167725|Capecitabine|capecitabine|mesh-list
6601880|NCT01167725|Oxaliplatin|oxaliplatin|mesh-list
6601881|NCT01167725|Irinotecan|irinotecan|mesh-list
6601882|NCT01167725|Mitomycins|mitomycins|mesh-list
6449099|NCT00403364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6449100|NCT00403364|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6449101|NCT00403364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6449102|NCT00403364|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6449103|NCT00403364|Alkylating Agents|alkylating agents|mesh-ancestor
6449104|NCT00403364|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
6449105|NCT00403364|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6449106|NCT00403364|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6449107|NCT00403429|Capecitabine|capecitabine|mesh-list
6449108|NCT00403429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6449109|NCT00403429|Antimetabolites|antimetabolites|mesh-ancestor
6449110|NCT00403429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6449111|NCT00403429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6449112|NCT00403442|Bevacizumab|bevacizumab|mesh-list
6449113|NCT00403442|Verteporfin|verteporfin|mesh-list
6601883|NCT01167725|Mitomycin|mitomycin|mesh-list
6601884|NCT01167725|Levoleucovorin|levoleucovorin|mesh-list
6601885|NCT01167725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6601886|NCT01167725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6601887|NCT01167725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6601888|NCT01167725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6601889|NCT01167725|Growth Substances|growth substances|mesh-ancestor
6601890|NCT01167725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601891|NCT01167725|Growth Inhibitors|growth inhibitors|mesh-ancestor
6601892|NCT01167725|Antimetabolites|antimetabolites|mesh-ancestor
6601893|NCT01167725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601894|NCT01167725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6601895|NCT01167725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6601896|NCT01167725|Immunologic Factors|immunologic factors|mesh-ancestor
6601897|NCT01167725|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6601898|NCT01167725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6601899|NCT01167725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6601900|NCT01167725|Antidotes|antidotes|mesh-ancestor
6601901|NCT01167725|Protective Agents|protective agents|mesh-ancestor
6601902|NCT01167725|Vitamin B Complex|vitamin b complex|mesh-ancestor
6601903|NCT01167725|Vitamins|vitamins|mesh-ancestor
6601904|NCT01167725|Micronutrients|micronutrients|mesh-ancestor
5501786|NCT04470674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501787|NCT04470674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5501788|NCT04470674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5501789|NCT04470674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5501790|NCT04470557|Fibrin fragment D|fibrin fragment d|mesh-list
5501791|NCT04470557|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5501792|NCT04470557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6601905|NCT01167725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6601906|NCT01167725|Alkylating Agents|alkylating agents|mesh-ancestor
6601907|NCT01167725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6601908|NCT01167738|Metformin|metformin|mesh-list
6601909|NCT01167738|Gemcitabine|gemcitabine|mesh-list
6601910|NCT01167738|Capecitabine|capecitabine|mesh-list
6601911|NCT01167738|Epirubicin|epirubicin|mesh-list
6601912|NCT01167738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6601913|NCT01167738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5501793|NCT04470557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601914|NCT01167738|Antimetabolites|antimetabolites|mesh-ancestor
6601915|NCT01167738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601916|NCT01167738|Antiviral Agents|antiviral agents|mesh-ancestor
6601917|NCT01167738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6601918|NCT01167738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6601919|NCT01167738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6601920|NCT01167738|Immunologic Factors|immunologic factors|mesh-ancestor
6601921|NCT01167738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601922|NCT01167738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6601923|NCT01167738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6601924|NCT01167738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6601925|NCT01167738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6601926|NCT01167764|Tranexamic Acid|tranexamic acid|mesh-list
6601927|NCT01167764|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6601928|NCT01167764|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6601929|NCT01167764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601930|NCT01167764|Hemostatics|hemostatics|mesh-ancestor
6601931|NCT01167764|Coagulants|coagulants|mesh-ancestor
6601932|NCT01167803|Desflurane|desflurane|mesh-list
6601933|NCT01167803|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6601934|NCT01167803|Anesthetics, General|anesthetics, general|mesh-ancestor
6601935|NCT01167803|Anesthetics|anesthetics|mesh-ancestor
6601936|NCT01167803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6601937|NCT01167803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601938|NCT01167816|Azacitidine|azacitidine|mesh-list
6601939|NCT01167816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6601940|NCT01167816|Antimetabolites|antimetabolites|mesh-ancestor
6601941|NCT01167816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601942|NCT01167816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6020518|NCT00393042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6601943|NCT01167816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6601944|NCT01167894|Simvastatin|simvastatin|mesh-list
6601945|NCT01167894|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6601946|NCT01167894|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6601947|NCT01167894|Antimetabolites|antimetabolites|mesh-ancestor
6601948|NCT01167894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601949|NCT01167894|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6601950|NCT01167894|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6601951|NCT01167894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6601952|NCT01167920|Calcium Channel Blockers|calcium channel blockers|mesh-list
6020519|NCT00393042|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6020520|NCT00393068|Paclitaxel|paclitaxel|mesh-list
6601953|NCT01167920|Angiotensin II|angiotensin ii|mesh-list
6601954|NCT01167920|Diuretics|diuretics|mesh-list
6601955|NCT01167920|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6601956|NCT01167920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6601957|NCT01167920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601958|NCT01167920|Natriuretic Agents|natriuretic agents|mesh-ancestor
6601959|NCT01167920|Protease Inhibitors|protease inhibitors|mesh-ancestor
6601960|NCT01167920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6601961|NCT01167920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601962|NCT01167920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6601963|NCT01167920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6601964|NCT01167933|Simvastatin|simvastatin|mesh-list
6601965|NCT01167933|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6601966|NCT01167933|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6601967|NCT01167933|Antimetabolites|antimetabolites|mesh-ancestor
6601968|NCT01167933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601969|NCT01167933|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6601970|NCT01167933|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6601971|NCT01167933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6601972|NCT01167946|Methylprednisolone|methylprednisolone|mesh-list
6601973|NCT01167946|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6601974|NCT01167946|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6601975|NCT01167946|Prednisolone|prednisolone|mesh-list
6601976|NCT01167946|Prednisolone acetate|prednisolone acetate|mesh-list
6601977|NCT01167946|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6601978|NCT01167946|Prednisolone phosphate|prednisolone phosphate|mesh-list
6601979|NCT01167946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6601980|NCT01167946|Antiemetics|antiemetics|mesh-ancestor
6601981|NCT01167946|Autonomic Agents|autonomic agents|mesh-ancestor
6601982|NCT01167946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6601983|NCT01167946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6601984|NCT01167946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6601985|NCT01167946|Glucocorticoids|glucocorticoids|mesh-ancestor
6601986|NCT01167946|Hormones|hormones|mesh-ancestor
6601987|NCT01167946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6601988|NCT01167946|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6601989|NCT01167946|Protective Agents|protective agents|mesh-ancestor
6601990|NCT01167946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6601991|NCT01167946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6601992|NCT01168011|ON 01910|on 01910|mesh-list
6601993|NCT01168011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6601994|NCT01168011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6601995|NCT01168011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6601996|NCT01168011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6601997|NCT01168063|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6601998|NCT01168063|Amoxicillin|amoxicillin|mesh-list
6601999|NCT01168063|Metronidazole|metronidazole|mesh-list
6602000|NCT01168063|Clarithromycin|clarithromycin|mesh-list
6602001|NCT01168063|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6602002|NCT01168063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6602003|NCT01168063|Antitubercular Agents|antitubercular agents|mesh-ancestor
6602004|NCT01168063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6602005|NCT01168063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6602006|NCT01168063|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6602007|NCT01168063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6602008|NCT01168063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602009|NCT01168063|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6602010|NCT01168063|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6602011|NCT01168336|Betahistine|betahistine|mesh-list
6602012|NCT01168336|Vasodilator Agents|vasodilator agents|mesh-ancestor
6602013|NCT01168336|Histamine Agonists|histamine agonists|mesh-ancestor
6602014|NCT01168336|Histamine Agents|histamine agents|mesh-ancestor
6602015|NCT01168336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6602016|NCT01168336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602017|NCT01168336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602018|NCT01168375|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6602019|NCT01168375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6602020|NCT01168440|Sunitinib|sunitinib|mesh-list
6602021|NCT01168440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6602022|NCT01168440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6602023|NCT01168440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6602024|NCT01168440|Growth Substances|growth substances|mesh-ancestor
6602025|NCT01168440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602026|NCT01168440|Growth Inhibitors|growth inhibitors|mesh-ancestor
6602027|NCT01168440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6602028|NCT01168440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6602029|NCT01168440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602030|NCT01168492|Ketamine|ketamine|mesh-list
6602031|NCT01168492|Analgesics|analgesics|mesh-ancestor
6602032|NCT01168492|Sensory System Agents|sensory system agents|mesh-ancestor
6602033|NCT01168492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6602034|NCT01168492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602035|NCT01168492|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6602036|NCT01168492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6602037|NCT01168492|Anesthetics, General|anesthetics, general|mesh-ancestor
6602038|NCT01168492|Anesthetics|anesthetics|mesh-ancestor
6602039|NCT01168492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6602040|NCT01168492|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6602041|NCT01168492|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6602042|NCT01168492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6602043|NCT01168492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602044|NCT01168505|Teferrol|teferrol|mesh-list
6602045|NCT01168505|Hematinics|hematinics|mesh-ancestor
6602046|NCT01168531|Dexamethasone|dexamethasone|mesh-list
6602047|NCT01168531|Pregabalin|pregabalin|mesh-list
6602048|NCT01168531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6602049|NCT01168531|Antiemetics|antiemetics|mesh-ancestor
6602050|NCT01168531|Autonomic Agents|autonomic agents|mesh-ancestor
6602051|NCT01168531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6602052|NCT01168531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602053|NCT01168531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6602054|NCT01168531|Glucocorticoids|glucocorticoids|mesh-ancestor
6602055|NCT01168531|Hormones|hormones|mesh-ancestor
6602056|NCT01168531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6602057|NCT01168531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6602058|NCT01168531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6602059|NCT01168531|Analgesics|analgesics|mesh-ancestor
6602060|NCT01168531|Sensory System Agents|sensory system agents|mesh-ancestor
6602061|NCT01168531|Anticonvulsants|anticonvulsants|mesh-ancestor
6602062|NCT01168531|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6602063|NCT01168531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6602064|NCT01168531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602065|NCT01168531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6602066|NCT01168531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6602067|NCT01168531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6602068|NCT01168531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6602069|NCT01168531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6602070|NCT01168544|Vitamin D|vitamin d|mesh-list
6602071|NCT01168544|Ergocalciferols|ergocalciferols|mesh-list
6602072|NCT01168544|Cholecalciferol|cholecalciferol|mesh-list
6602073|NCT01168544|Vitamins|vitamins|mesh-list
6602074|NCT01168544|Micronutrients|micronutrients|mesh-ancestor
6602075|NCT01168544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602076|NCT01168544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6602077|NCT01168544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6602078|NCT01168739|Quercetin|quercetin|mesh-list
6602079|NCT01168739|Antioxidants|antioxidants|mesh-ancestor
6602080|NCT01168739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602081|NCT01168739|Protective Agents|protective agents|mesh-ancestor
6602082|NCT01168739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660113|NCT01491061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6660114|NCT01491061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660115|NCT01491100|Interferons|interferons|mesh-list
6660116|NCT01491100|Interferon-beta|interferon-beta|mesh-list
6660117|NCT01491100|Interferon beta-1b|interferon beta-1b|mesh-list
6660118|NCT01491100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6660119|NCT01491100|Antiviral Agents|antiviral agents|mesh-ancestor
6660120|NCT01491100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6660121|NCT01491100|Immunologic Factors|immunologic factors|mesh-ancestor
6660122|NCT01491100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660123|NCT01491100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6660124|NCT01491139|Olaparib|olaparib|mesh-list
6660125|NCT01491139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6660126|NCT01491139|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6660127|NCT01491139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6660128|NCT01491139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660129|NCT01491191|Palmidrol|palmidrol|mesh-list
6660130|NCT01491191|Analgesics|analgesics|mesh-ancestor
6660131|NCT01491191|Sensory System Agents|sensory system agents|mesh-ancestor
6660132|NCT01491191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6660133|NCT01491191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660134|NCT01491191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6660135|NCT01491191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6660136|NCT01491191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6660137|NCT01491191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6660138|NCT01491191|Antiviral Agents|antiviral agents|mesh-ancestor
6660139|NCT01491191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6660140|NCT01491191|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6660141|NCT01491191|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6660142|NCT01491191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6660143|NCT01491191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660144|NCT01491191|Hormones|hormones|mesh-ancestor
6660145|NCT01491191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6660146|NCT01491204|Paclitaxel|paclitaxel|mesh-list
6602083|NCT01168791|Doxorubicin|doxorubicin|mesh-list
6602084|NCT01168791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6602085|NCT01168791|Isophosphamide mustard|isophosphamide mustard|mesh-list
6602086|NCT01168791|Ifosfamide|ifosfamide|mesh-list
6602087|NCT01168791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6602088|NCT01168791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6602089|NCT01168791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6602090|NCT01168791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6602091|NCT01168791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6602092|NCT01168791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602093|NCT01168791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6602094|NCT01168791|Alkylating Agents|alkylating agents|mesh-ancestor
6602095|NCT01168804|Dexamethasone|dexamethasone|mesh-list
6602096|NCT01168804|Bortezomib|bortezomib|mesh-list
6602097|NCT01168804|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6602098|NCT01168804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6602099|NCT01168804|Antiemetics|antiemetics|mesh-ancestor
6602100|NCT01168804|Autonomic Agents|autonomic agents|mesh-ancestor
6602101|NCT01168804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6602102|NCT01168804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602103|NCT01168804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6602104|NCT01168804|Glucocorticoids|glucocorticoids|mesh-ancestor
6602105|NCT01168804|Hormones|hormones|mesh-ancestor
6602106|NCT01168804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6602107|NCT01168804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6602108|NCT01168804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6602109|NCT01168804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6602110|NCT01168804|Alkylating Agents|alkylating agents|mesh-ancestor
6602111|NCT01168804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602112|NCT01168817|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6602113|NCT01168817|Vasodilator Agents|vasodilator agents|mesh-ancestor
6602114|NCT01168817|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6602115|NCT01168817|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6602116|NCT01168817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6602117|NCT01168817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602118|NCT01168817|Urological Agents|urological agents|mesh-ancestor
6602119|NCT01168895|Ciprofloxacin|ciprofloxacin|mesh-list
6602120|NCT01168895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6602121|NCT01168895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6602122|NCT01168895|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6602123|NCT01168895|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6602124|NCT01168895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6602125|NCT01168895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602126|NCT01168895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6602127|NCT01168895|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6602128|NCT01168895|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6602129|NCT01169012|Clofarabine|clofarabine|mesh-list
5501794|NCT04470557|Hemostatics|hemostatics|mesh-ancestor
6602130|NCT01169012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6602131|NCT01169012|Antimetabolites|antimetabolites|mesh-ancestor
6602132|NCT01169012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602133|NCT01169012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6602134|NCT01169025|Fentanyl|fentanyl|mesh-list
6602135|NCT01169025|Ketamine|ketamine|mesh-list
6602136|NCT01169025|Analgesics|analgesics|mesh-ancestor
6602137|NCT01169025|Sensory System Agents|sensory system agents|mesh-ancestor
6602138|NCT01169025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6602139|NCT01169025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602140|NCT01169025|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6602141|NCT01169025|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6602142|NCT01169025|Anesthetics, General|anesthetics, general|mesh-ancestor
6602143|NCT01169025|Anesthetics|anesthetics|mesh-ancestor
6602144|NCT01169025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6602145|NCT01169025|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6602146|NCT01169025|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6602147|NCT01169025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6602148|NCT01169025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602149|NCT01169025|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6602150|NCT01169025|Narcotics|narcotics|mesh-ancestor
6602151|NCT01169025|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6602152|NCT01169090|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6602153|NCT01169090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6602154|NCT01169090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602155|NCT01169090|Incretins|incretins|mesh-ancestor
6602156|NCT01169090|Hormones|hormones|mesh-ancestor
6602157|NCT01169090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6602158|NCT01169090|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6602159|NCT01169090|Protease Inhibitors|protease inhibitors|mesh-ancestor
6602160|NCT01169090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6602161|NCT01169090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602162|NCT01169142|Vitamin D|vitamin d|mesh-list
6602163|NCT01169142|Ergocalciferols|ergocalciferols|mesh-list
6602164|NCT01169142|Cholecalciferol|cholecalciferol|mesh-list
6602165|NCT01169142|Vitamins|vitamins|mesh-list
6602166|NCT01169142|Micronutrients|micronutrients|mesh-ancestor
6602167|NCT01169142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602168|NCT01169142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6602169|NCT01169142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6602170|NCT01169298|Lenalidomide|lenalidomide|mesh-list
6602171|NCT01169298|Immunologic Factors|immunologic factors|mesh-ancestor
6602172|NCT01169298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602173|NCT01169298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6602174|NCT01169298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6602175|NCT01169298|Growth Substances|growth substances|mesh-ancestor
6602176|NCT01169298|Growth Inhibitors|growth inhibitors|mesh-ancestor
6602177|NCT01169298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6602178|NCT01169389|Bupivacaine|bupivacaine|mesh-list
6602179|NCT01169389|Anesthetics, Local|anesthetics, local|mesh-ancestor
6602180|NCT01169389|Anesthetics|anesthetics|mesh-ancestor
6602181|NCT01169389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6602182|NCT01169389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602183|NCT01169389|Sensory System Agents|sensory system agents|mesh-ancestor
6602184|NCT01169389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6602185|NCT01169402|Fluconazole|fluconazole|mesh-list
6602186|NCT01169402|Antifungal Agents|antifungal agents|mesh-ancestor
6602187|NCT01169402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6602188|NCT01169402|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6602189|NCT01169402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6602190|NCT01169402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6602191|NCT01169402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602192|NCT01169402|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6602193|NCT01169402|Hormone Antagonists|hormone antagonists|mesh-ancestor
6602194|NCT01169402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6602195|NCT01169402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602196|NCT01169402|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6602197|NCT01169402|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6602198|NCT01169415|Dexamethasone|dexamethasone|mesh-list
6602199|NCT01169415|Dexamethasone acetate|dexamethasone acetate|mesh-list
6602200|NCT01169415|BB 1101|bb 1101|mesh-list
6602201|NCT01169415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6602202|NCT01169415|Antiemetics|antiemetics|mesh-ancestor
6602203|NCT01169415|Autonomic Agents|autonomic agents|mesh-ancestor
6602204|NCT01169415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6602205|NCT01169415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602206|NCT01169415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6602207|NCT01169415|Glucocorticoids|glucocorticoids|mesh-ancestor
6602208|NCT01169415|Hormones|hormones|mesh-ancestor
6602209|NCT01169415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6602210|NCT01169415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6602211|NCT01169415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6602212|NCT01169415|Protease Inhibitors|protease inhibitors|mesh-ancestor
6602213|NCT01169415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6602214|NCT01169415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602215|NCT01169506|Silicon|silicon|mesh-list
6602216|NCT01169506|Trace Elements|trace elements|mesh-ancestor
6602217|NCT01169506|Micronutrients|micronutrients|mesh-ancestor
6602218|NCT01169506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602219|NCT01169571|Dexmedetomidine|dexmedetomidine|mesh-list
6602220|NCT01169571|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6602221|NCT01169571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6602222|NCT01169571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602223|NCT01169571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6602224|NCT01169571|Analgesics|analgesics|mesh-ancestor
6602225|NCT01169571|Sensory System Agents|sensory system agents|mesh-ancestor
6602226|NCT01169571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6602227|NCT01169571|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6602228|NCT01169571|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6602229|NCT01169571|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6602230|NCT01169571|Adrenergic Agents|adrenergic agents|mesh-ancestor
6602231|NCT01169571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6602232|NCT01169571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602233|NCT01169584|Molgramostim|molgramostim|mesh-list
6602234|NCT01169584|Sargramostim|sargramostim|mesh-list
6602235|NCT01169584|Immunologic Factors|immunologic factors|mesh-ancestor
6602236|NCT01169584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602237|NCT01169584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6602238|NCT01169597|Prednisone|prednisone|mesh-list
6602239|NCT01169597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6602240|NCT01169597|Glucocorticoids|glucocorticoids|mesh-ancestor
6602241|NCT01169597|Hormones|hormones|mesh-ancestor
6602242|NCT01169597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6602243|NCT01169597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602244|NCT01169597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6602245|NCT01169597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6602246|NCT01169688|Phenylephrine|phenylephrine|mesh-list
6602247|NCT01169688|Oxymetazoline|oxymetazoline|mesh-list
6602248|NCT01169688|Cyclopentolate|cyclopentolate|mesh-list
6602249|NCT01169688|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6602250|NCT01169688|Mydriatics|mydriatics|mesh-ancestor
6602251|NCT01169688|Autonomic Agents|autonomic agents|mesh-ancestor
6602252|NCT01169688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6602253|NCT01169688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602254|NCT01169688|Sympathomimetics|sympathomimetics|mesh-ancestor
6602255|NCT01169688|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6602256|NCT01169688|Nasal Decongestants|nasal decongestants|mesh-ancestor
6602257|NCT01169688|Respiratory System Agents|respiratory system agents|mesh-ancestor
6602258|NCT01169688|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6602259|NCT01169688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6602260|NCT01169688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6602261|NCT01169688|Adrenergic Agents|adrenergic agents|mesh-ancestor
6602262|NCT01169688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6602263|NCT01169688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602264|NCT01169688|Protective Agents|protective agents|mesh-ancestor
6602265|NCT01169688|Parasympatholytics|parasympatholytics|mesh-ancestor
6602266|NCT01169688|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6602267|NCT01169688|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6602268|NCT01169688|Cholinergic Agents|cholinergic agents|mesh-ancestor
6602269|NCT01169740|Bilirubin|bilirubin|mesh-list
6602270|NCT01169740|Antioxidants|antioxidants|mesh-ancestor
6602271|NCT01169740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602272|NCT01169740|Protective Agents|protective agents|mesh-ancestor
6602273|NCT01169740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602274|NCT01169792|Tamoxifen|tamoxifen|mesh-list
6602275|NCT01169792|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6602276|NCT01169792|Hormone Antagonists|hormone antagonists|mesh-ancestor
6602277|NCT01169792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6602278|NCT01169792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602279|NCT01169792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6602280|NCT01169792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6602281|NCT01169792|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6602282|NCT01169792|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6602283|NCT01169792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6602284|NCT01169805|Ondansetron|ondansetron|mesh-list
6602285|NCT01169805|Palonosetron|palonosetron|mesh-list
6602286|NCT01169805|Ramosetron|ramosetron|mesh-list
6602287|NCT01169805|Antiemetics|antiemetics|mesh-ancestor
6602288|NCT01169805|Autonomic Agents|autonomic agents|mesh-ancestor
6602289|NCT01169805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6602290|NCT01169805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602291|NCT01169805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6602292|NCT01169805|Antipruritics|antipruritics|mesh-ancestor
6602293|NCT01169805|Dermatologic Agents|dermatologic agents|mesh-ancestor
6602294|NCT01169805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6602295|NCT01169805|Serotonin Agents|serotonin agents|mesh-ancestor
6602296|NCT01169805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6602297|NCT01169805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602298|NCT01169805|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6602299|NCT01169805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6602300|NCT01169805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6602301|NCT01169805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6602302|NCT01169805|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6602303|NCT01169805|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6602304|NCT01169818|Insulin Glargine|insulin glargine|mesh-list
6602305|NCT01169818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6602306|NCT01169818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602307|NCT01169857|Bortezomib|bortezomib|mesh-list
6602308|NCT01169857|Proteasome Inhibitors|proteasome inhibitors|mesh-list
6602309|NCT01169857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6602310|NCT01169857|Protease Inhibitors|protease inhibitors|mesh-ancestor
6602311|NCT01169857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6602312|NCT01169857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602313|NCT01169870|Paclitaxel|paclitaxel|mesh-list
6602314|NCT01169870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6602315|NCT01169870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6602316|NCT01169870|Tubulin Modulators|tubulin modulators|mesh-ancestor
6602317|NCT01169870|Antimitotic Agents|antimitotic agents|mesh-ancestor
6602318|NCT01169870|Mitosis Modulators|mitosis modulators|mesh-ancestor
6602319|NCT01169870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602320|NCT01169909|Ranibizumab|ranibizumab|mesh-list
6602321|NCT01169909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6602322|NCT01169909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6602323|NCT01169909|Growth Substances|growth substances|mesh-ancestor
6602324|NCT01169909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602325|NCT01169909|Growth Inhibitors|growth inhibitors|mesh-ancestor
6602326|NCT01169909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6602327|NCT01169922|Ethanol|ethanol|mesh-list
6602328|NCT01169922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6602329|NCT01169922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6602330|NCT01169922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6602331|NCT01169922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602332|NCT01169935|Dextrans|dextrans|mesh-list
6602333|NCT01169935|Anticoagulants|anticoagulants|mesh-ancestor
6602334|NCT01169935|Plasma Substitutes|plasma substitutes|mesh-ancestor
6602335|NCT01169935|Blood Substitutes|blood substitutes|mesh-ancestor
6602336|NCT01170052|Sirolimus|sirolimus|mesh-list
6602337|NCT01170052|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6602338|NCT01170052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6602339|NCT01170052|Alkylating Agents|alkylating agents|mesh-ancestor
6602340|NCT01170052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602341|NCT01170052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6602342|NCT01170052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6602343|NCT01170052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6602344|NCT01170052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6602345|NCT01170052|Antifungal Agents|antifungal agents|mesh-ancestor
6602346|NCT01170052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6602347|NCT01170052|Immunologic Factors|immunologic factors|mesh-ancestor
6602348|NCT01170052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602349|NCT01170078|Epoetin Alfa|epoetin alfa|mesh-list
6602350|NCT01170078|Hematinics|hematinics|mesh-ancestor
6602351|NCT01170104|Sorafenib|sorafenib|mesh-list
6602352|NCT01170104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6602353|NCT01170104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6602354|NCT01170104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6602355|NCT01170104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602356|NCT01170130|Lidocaine|lidocaine|mesh-list
6602357|NCT01170130|Anesthetics, Local|anesthetics, local|mesh-ancestor
6602358|NCT01170130|Anesthetics|anesthetics|mesh-ancestor
6602359|NCT01170130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6602360|NCT01170130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602361|NCT01170130|Sensory System Agents|sensory system agents|mesh-ancestor
6602362|NCT01170130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6602363|NCT01170130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6602364|NCT01170130|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6602365|NCT01170130|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6602366|NCT01170130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6602367|NCT01170130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602368|NCT01170143|Trastuzumab|trastuzumab|mesh-list
6602369|NCT01170143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6602370|NCT01170143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6602371|NCT01170169|Omeprazole|omeprazole|mesh-list
6602372|NCT01170169|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6602373|NCT01170169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6602374|NCT01170169|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6602375|NCT01170169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6602376|NCT01170169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602377|NCT01170182|Omeprazole|omeprazole|mesh-list
6602378|NCT01170182|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6602379|NCT01170182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6602380|NCT01170182|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6602381|NCT01170182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6602382|NCT01170182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602383|NCT01170260|Ethanol|ethanol|mesh-list
6602384|NCT01170260|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6602385|NCT01170260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6602386|NCT01170260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6602387|NCT01170260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602388|NCT01170325|Valproic Acid|valproic acid|mesh-list
6602389|NCT01170325|Anticonvulsants|anticonvulsants|mesh-ancestor
6602390|NCT01170325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6602391|NCT01170325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602392|NCT01170325|GABA Agents|gaba agents|mesh-ancestor
6602393|NCT01170325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6602394|NCT01170325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602395|NCT01170325|Antimanic Agents|antimanic agents|mesh-ancestor
6602396|NCT01170325|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6602397|NCT01170325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6602398|NCT01170325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6602399|NCT01170338|Varenicline|varenicline|mesh-list
6602400|NCT01170338|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6602401|NCT01170338|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6602402|NCT01170338|Cholinergic Agents|cholinergic agents|mesh-ancestor
6602403|NCT01170338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6602404|NCT01170338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602405|NCT01170338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602406|NCT01170351|Cyclosporine|cyclosporine|mesh-list
6602407|NCT01170351|Cyclosporins|cyclosporins|mesh-list
6602408|NCT01170351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6602409|NCT01170351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602410|NCT01170351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6602411|NCT01170351|Immunologic Factors|immunologic factors|mesh-ancestor
6602412|NCT01170351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602413|NCT01170351|Antifungal Agents|antifungal agents|mesh-ancestor
6602414|NCT01170351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6602415|NCT01170351|Dermatologic Agents|dermatologic agents|mesh-ancestor
6602416|NCT01170351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6602417|NCT01170351|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6602418|NCT01170429|Procaterol|procaterol|mesh-list
6602419|NCT01170429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6602420|NCT01170429|Autonomic Agents|autonomic agents|mesh-ancestor
6602421|NCT01170429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6602422|NCT01170429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602423|NCT01170429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6602424|NCT01170429|Respiratory System Agents|respiratory system agents|mesh-ancestor
6602425|NCT01170429|Sympathomimetics|sympathomimetics|mesh-ancestor
6602426|NCT01170429|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6602427|NCT01170429|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6602428|NCT01170429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6602429|NCT01170429|Adrenergic Agents|adrenergic agents|mesh-ancestor
6602430|NCT01170429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6602431|NCT01170429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602432|NCT01170442|Vitamin D|vitamin d|mesh-list
6602433|NCT01170442|Ergocalciferols|ergocalciferols|mesh-list
6602434|NCT01170442|Cholecalciferol|cholecalciferol|mesh-list
6602435|NCT01170442|Vitamins|vitamins|mesh-list
6602436|NCT01170442|Micronutrients|micronutrients|mesh-ancestor
6602437|NCT01170442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602438|NCT01170442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6602439|NCT01170442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6602440|NCT01170468|Vitamin D|vitamin d|mesh-list
6449114|NCT00403442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6449115|NCT00403442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6449116|NCT00403442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6449117|NCT00403442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6449118|NCT00403442|Growth Substances|growth substances|mesh-ancestor
6449119|NCT00403442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449120|NCT00403442|Growth Inhibitors|growth inhibitors|mesh-ancestor
6449121|NCT00403442|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6449122|NCT00403442|Dermatologic Agents|dermatologic agents|mesh-ancestor
6449123|NCT00403533|Atorvastatin|atorvastatin|mesh-list
6449124|NCT00403533|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6449125|NCT00403533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6449126|NCT00403533|Antimetabolites|antimetabolites|mesh-ancestor
6602441|NCT01170468|Cholecalciferol|cholecalciferol|mesh-list
6602442|NCT01170468|Vitamins|vitamins|mesh-ancestor
6602443|NCT01170468|Micronutrients|micronutrients|mesh-ancestor
6602444|NCT01170468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602445|NCT01170468|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6602446|NCT01170468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6602447|NCT01170494|Cholecalciferol|cholecalciferol|mesh-list
6602448|NCT01170494|Ergocalciferols|ergocalciferols|mesh-list
6602449|NCT01170494|Vitamin D|vitamin d|mesh-list
6602450|NCT01170494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6602451|NCT01170494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602452|NCT01170494|Vitamins|vitamins|mesh-ancestor
6602453|NCT01170494|Micronutrients|micronutrients|mesh-ancestor
6602454|NCT01170494|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6602455|NCT01170507|Vitamin D|vitamin d|mesh-list
6602456|NCT01170507|Ergocalciferols|ergocalciferols|mesh-list
6602457|NCT01170507|Cholecalciferol|cholecalciferol|mesh-list
6602458|NCT01170507|Vitamins|vitamins|mesh-list
6602459|NCT01170507|Micronutrients|micronutrients|mesh-ancestor
6602460|NCT01170507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602461|NCT01170507|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6602462|NCT01170507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6660147|NCT01491204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6660148|NCT01491204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6660149|NCT01491204|Tubulin Modulators|tubulin modulators|mesh-ancestor
6660150|NCT01491204|Antimitotic Agents|antimitotic agents|mesh-ancestor
6660151|NCT01491204|Mitosis Modulators|mitosis modulators|mesh-ancestor
6660152|NCT01491204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660153|NCT01491217|Paclitaxel|paclitaxel|mesh-list
6660154|NCT01491217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6660155|NCT01491217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6660156|NCT01491217|Tubulin Modulators|tubulin modulators|mesh-ancestor
6660157|NCT01491217|Antimitotic Agents|antimitotic agents|mesh-ancestor
6660158|NCT01491217|Mitosis Modulators|mitosis modulators|mesh-ancestor
6660159|NCT01491217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660160|NCT01491256|Atorvastatin|atorvastatin|mesh-list
6660161|NCT01491256|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6660162|NCT01491256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6660163|NCT01491256|Antimetabolites|antimetabolites|mesh-ancestor
6660164|NCT01491256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660165|NCT01491256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6660166|NCT01491256|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6660167|NCT01491256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6660168|NCT01491295|Tenofovir|tenofovir|mesh-list
6660169|NCT01491295|Lamivudine|lamivudine|mesh-list
6660170|NCT01491295|Adefovir|adefovir|mesh-list
6660171|NCT01491295|Antiviral Agents|antiviral agents|mesh-ancestor
6660172|NCT01491295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6660173|NCT01491295|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6660174|NCT01491295|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6660175|NCT01491295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6660176|NCT01491295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660177|NCT01491295|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6660178|NCT01491295|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6660179|NCT01491321|Loxoprofen|loxoprofen|mesh-list
6660180|NCT01491321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6660181|NCT01491321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6660182|NCT01491321|Analgesics|analgesics|mesh-ancestor
6660183|NCT01491321|Sensory System Agents|sensory system agents|mesh-ancestor
6660184|NCT01491321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6660185|NCT01491321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660186|NCT01491321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6660187|NCT01491321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6020521|NCT00393068|Bevacizumab|bevacizumab|mesh-list
6020522|NCT00393068|Carboplatin|carboplatin|mesh-list
6020523|NCT00393068|Fluorouracil|fluorouracil|mesh-list
6602463|NCT01170585|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6602464|NCT01170585|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6602465|NCT01170585|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6602466|NCT01170585|Antimetabolites|antimetabolites|mesh-ancestor
6602467|NCT01170585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602468|NCT01170585|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6602469|NCT01170585|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6602470|NCT01170585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6602471|NCT01170637|Ibuprofen|ibuprofen|mesh-list
6602472|NCT01170637|Pseudoephedrine|pseudoephedrine|mesh-list
6602473|NCT01170637|Ephedrine|ephedrine|mesh-list
6602474|NCT01170637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6602475|NCT01170637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6602476|NCT01170637|Analgesics|analgesics|mesh-ancestor
6602477|NCT01170637|Sensory System Agents|sensory system agents|mesh-ancestor
6602478|NCT01170637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6602479|NCT01170637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602480|NCT01170637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6602481|NCT01170637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6602482|NCT01170637|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6602483|NCT01170637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6602484|NCT01170637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602485|NCT01170637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6602486|NCT01170637|Autonomic Agents|autonomic agents|mesh-ancestor
6602487|NCT01170637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6602488|NCT01170637|Respiratory System Agents|respiratory system agents|mesh-ancestor
6602489|NCT01170637|Nasal Decongestants|nasal decongestants|mesh-ancestor
6602490|NCT01170637|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6602491|NCT01170637|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6602492|NCT01170637|Sympathomimetics|sympathomimetics|mesh-ancestor
6602493|NCT01170637|Adrenergic Agents|adrenergic agents|mesh-ancestor
6602494|NCT01170637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6602495|NCT01170767|Bevacizumab|bevacizumab|mesh-list
6602496|NCT01170767|Ranibizumab|ranibizumab|mesh-list
6602497|NCT01170767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6602498|NCT01170767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6602499|NCT01170767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6602500|NCT01170767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6602501|NCT01170767|Growth Substances|growth substances|mesh-ancestor
6020524|NCT00393068|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6449127|NCT00403533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6449128|NCT00403533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6449129|NCT00403533|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6449130|NCT00403533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6449131|NCT00403559|Pimecrolimus|pimecrolimus|mesh-list
6449132|NCT00403559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6449133|NCT00403559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6449134|NCT00403559|Analgesics|analgesics|mesh-ancestor
6449135|NCT00403559|Sensory System Agents|sensory system agents|mesh-ancestor
6449136|NCT00403559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6449137|NCT00403559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449138|NCT00403559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6449139|NCT00403559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6602502|NCT01170767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602503|NCT01170767|Growth Inhibitors|growth inhibitors|mesh-ancestor
6602504|NCT01170780|Dexamethasone|dexamethasone|mesh-list
6602505|NCT01170780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6602506|NCT01170780|Antiemetics|antiemetics|mesh-ancestor
6602507|NCT01170780|Autonomic Agents|autonomic agents|mesh-ancestor
6602508|NCT01170780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6602509|NCT01170780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602510|NCT01170780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6602511|NCT01170780|Glucocorticoids|glucocorticoids|mesh-ancestor
6602512|NCT01170780|Hormones|hormones|mesh-ancestor
6602513|NCT01170780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6602514|NCT01170780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6602515|NCT01170780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6602516|NCT01170806|Orlistat|orlistat|mesh-list
6602517|NCT01170806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6602518|NCT01170806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602519|NCT01170806|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6602520|NCT01170806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6602521|NCT01170819|Dinoprostone|dinoprostone|mesh-list
6602522|NCT01170819|Oxytocics|oxytocics|mesh-ancestor
6602523|NCT01170819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6602524|NCT01170819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602525|NCT01170845|Sivelestat|sivelestat|mesh-list
6602526|NCT01170845|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6602527|NCT01170845|Protease Inhibitors|protease inhibitors|mesh-ancestor
6602528|NCT01170845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6602529|NCT01170845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602530|NCT01170858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6602531|NCT01170858|Icodextrin|icodextrin|mesh-list
6602532|NCT01170858|Dialysis Solutions|dialysis solutions|mesh-ancestor
6602533|NCT01170871|Pemetrexed|pemetrexed|mesh-list
6602534|NCT01170871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6602535|NCT01170871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6602536|NCT01170871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6449140|NCT00403559|Dermatologic Agents|dermatologic agents|mesh-ancestor
6449141|NCT00403559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6449142|NCT00403559|Immunologic Factors|immunologic factors|mesh-ancestor
6449143|NCT00403559|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6449144|NCT00403559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6020525|NCT00393068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6020526|NCT00393068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6020527|NCT00393068|Tubulin Modulators|tubulin modulators|mesh-ancestor
6602537|NCT01170871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6602538|NCT01170871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6602539|NCT01171092|Bortezomib|bortezomib|mesh-list
6602540|NCT01171092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6602541|NCT01171170|Paclitaxel|paclitaxel|mesh-list
6602542|NCT01171170|Bevacizumab|bevacizumab|mesh-list
6602543|NCT01171170|Carboplatin|carboplatin|mesh-list
6602544|NCT01171170|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6602545|NCT01171170|Nitroglycerin|nitroglycerin|mesh-list
6602546|NCT01171170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6602547|NCT01171170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6602548|NCT01171170|Tubulin Modulators|tubulin modulators|mesh-ancestor
6602549|NCT01171170|Antimitotic Agents|antimitotic agents|mesh-ancestor
6602550|NCT01171170|Mitosis Modulators|mitosis modulators|mesh-ancestor
6602551|NCT01171170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602552|NCT01171170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6602553|NCT01171170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6602554|NCT01171170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6602555|NCT01171170|Growth Substances|growth substances|mesh-ancestor
6602556|NCT01171170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602557|NCT01171170|Growth Inhibitors|growth inhibitors|mesh-ancestor
6602558|NCT01171170|Vasodilator Agents|vasodilator agents|mesh-ancestor
6602559|NCT01171209|Interferons|interferons|mesh-list
6602560|NCT01171209|Interferon-beta|interferon-beta|mesh-list
6602561|NCT01171209|Interferon-alpha|interferon-alpha|mesh-list
6602562|NCT01171209|Interferon beta-1b|interferon beta-1b|mesh-list
6602563|NCT01171209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6602564|NCT01171209|Antiviral Agents|antiviral agents|mesh-ancestor
6602565|NCT01171209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6602566|NCT01171209|Immunologic Factors|immunologic factors|mesh-ancestor
6602567|NCT01171209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602568|NCT01171209|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6602569|NCT01171300|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6602570|NCT01171300|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6602571|NCT01171300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602572|NCT01171326|Minocycline|minocycline|mesh-list
6020528|NCT00393068|Antimitotic Agents|antimitotic agents|mesh-ancestor
6020529|NCT00393068|Mitosis Modulators|mitosis modulators|mesh-ancestor
6020530|NCT00393068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020531|NCT00393068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6020532|NCT00393068|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6020533|NCT00393068|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6020534|NCT00393068|Growth Substances|growth substances|mesh-ancestor
6020535|NCT00393068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020536|NCT00393068|Growth Inhibitors|growth inhibitors|mesh-ancestor
6020537|NCT00393068|Antimetabolites|antimetabolites|mesh-ancestor
6020538|NCT00393068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6020539|NCT00393068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6602573|NCT01171326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6602574|NCT01171326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6602575|NCT01171365|Ciclesonide|ciclesonide|mesh-list
6602576|NCT01171365|Glucocorticoids|glucocorticoids|mesh-ancestor
6602577|NCT01171365|Hormones|hormones|mesh-ancestor
6602578|NCT01171365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6602579|NCT01171365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602580|NCT01171365|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6602581|NCT01171378|Ofatumumab|ofatumumab|mesh-list
6602582|NCT01171378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6602583|NCT01171456|Metformin|metformin|mesh-list
6602584|NCT01171456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6602585|NCT01171456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602586|NCT01171469|Imiquimod|imiquimod|mesh-list
6602587|NCT01171469|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6602588|NCT01171469|Immunologic Factors|immunologic factors|mesh-ancestor
6602589|NCT01171469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602590|NCT01171469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6602591|NCT01171469|Interferon Inducers|interferon inducers|mesh-ancestor
6602592|NCT01171482|Fluorouracil|fluorouracil|mesh-list
6602593|NCT01171482|Sorafenib|sorafenib|mesh-list
6602594|NCT01171482|Mitomycins|mitomycins|mesh-list
6602595|NCT01171482|Mitomycin|mitomycin|mesh-list
6602596|NCT01171482|Antimetabolites|antimetabolites|mesh-ancestor
6602597|NCT01171482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602598|NCT01171482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6602599|NCT01171482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6602600|NCT01171482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6602601|NCT01171482|Immunologic Factors|immunologic factors|mesh-ancestor
6602602|NCT01171482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602603|NCT01171482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6602604|NCT01171482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6602605|NCT01171482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6602606|NCT01171482|Alkylating Agents|alkylating agents|mesh-ancestor
6602607|NCT01171482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6602608|NCT01171547|Daptomycin|daptomycin|mesh-list
6602609|NCT01171547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6602610|NCT01171547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6602611|NCT01171651|Sorafenib|sorafenib|mesh-list
6602612|NCT01171651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6602613|NCT01171651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6602614|NCT01171651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6602615|NCT01171651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602616|NCT01171755|Gemcitabine|gemcitabine|mesh-list
6602617|NCT01171755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6602618|NCT01171755|Antimetabolites|antimetabolites|mesh-ancestor
6602619|NCT01171755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602620|NCT01171755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6602621|NCT01171755|Antiviral Agents|antiviral agents|mesh-ancestor
6602622|NCT01171755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6602623|NCT01171755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6602624|NCT01171755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6602625|NCT01171755|Immunologic Factors|immunologic factors|mesh-ancestor
6602626|NCT01171755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602627|NCT01171781|Cisplatin|cisplatin|mesh-list
6602628|NCT01171781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6602629|NCT01171807|Dexamethasone|dexamethasone|mesh-list
6602630|NCT01171807|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
6602631|NCT01171807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6602632|NCT01171807|Antiemetics|antiemetics|mesh-ancestor
6602633|NCT01171807|Autonomic Agents|autonomic agents|mesh-ancestor
6602634|NCT01171807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6602635|NCT01171807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602636|NCT01171807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6602637|NCT01171807|Glucocorticoids|glucocorticoids|mesh-ancestor
6602638|NCT01171807|Hormones|hormones|mesh-ancestor
6602639|NCT01171807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6602640|NCT01171807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6602641|NCT01171807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6602642|NCT01171833|Sevoflurane|sevoflurane|mesh-list
6602643|NCT01171833|Desflurane|desflurane|mesh-list
6602644|NCT01171833|Isoflurane|isoflurane|mesh-list
6602645|NCT01171833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6602646|NCT01171833|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6602647|NCT01171833|Anesthetics, General|anesthetics, general|mesh-ancestor
6602648|NCT01171833|Anesthetics|anesthetics|mesh-ancestor
6602649|NCT01171833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6602650|NCT01171833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602651|NCT01171859|Doxycycline|doxycycline|mesh-list
6602652|NCT01171859|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
6602653|NCT01171859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6602654|NCT01171859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6602655|NCT01171859|Antimalarials|antimalarials|mesh-ancestor
6602656|NCT01171859|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6602657|NCT01171859|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6602658|NCT01171859|Antiviral Agents|antiviral agents|mesh-ancestor
6602659|NCT01171859|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6602660|NCT01171859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6602661|NCT01171885|Ropivacaine|ropivacaine|mesh-list
6602662|NCT01171885|Anesthetics, Local|anesthetics, local|mesh-ancestor
6602663|NCT01171885|Anesthetics|anesthetics|mesh-ancestor
6602664|NCT01171885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6602665|NCT01171885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602666|NCT01171885|Sensory System Agents|sensory system agents|mesh-ancestor
6602667|NCT01171885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6602668|NCT01171911|Nicardipine|nicardipine|mesh-list
6602669|NCT01171911|Calcium Channel Blockers|calcium channel blockers|mesh-list
6602670|NCT01171911|Esmolol|esmolol|mesh-list
6602671|NCT01171911|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6602672|NCT01171911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602673|NCT01171911|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6602674|NCT01171911|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6602675|NCT01171911|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6602676|NCT01171911|Adrenergic Agents|adrenergic agents|mesh-ancestor
6602677|NCT01171911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6602678|NCT01171911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602679|NCT01171911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6602680|NCT01171911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6602681|NCT01171911|Vasodilator Agents|vasodilator agents|mesh-ancestor
6602682|NCT01171937|Risperidone|risperidone|mesh-list
6602683|NCT01171937|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6602684|NCT01171937|Serotonin Agents|serotonin agents|mesh-ancestor
6602685|NCT01171937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6602686|NCT01171937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602687|NCT01171937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602688|NCT01171937|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6020540|NCT00393068|Immunologic Factors|immunologic factors|mesh-ancestor
6020541|NCT00393068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6020542|NCT00393068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6020543|NCT00393094|Bevacizumab|bevacizumab|mesh-list
6020544|NCT00393094|Irinotecan|irinotecan|mesh-list
6020545|NCT00393094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6602689|NCT01171937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6602690|NCT01171937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6602691|NCT01171937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6602692|NCT01171937|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6602693|NCT01171937|Dopamine Agents|dopamine agents|mesh-ancestor
6020546|NCT00393094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6602694|NCT01172002|Azathioprine|azathioprine|mesh-list
6602695|NCT01172002|Leflunomide|leflunomide|mesh-list
6602696|NCT01172002|Antimetabolites|antimetabolites|mesh-ancestor
6602697|NCT01172002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602698|NCT01172002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6602699|NCT01172002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6602700|NCT01172002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6602701|NCT01172002|Immunologic Factors|immunologic factors|mesh-ancestor
6602702|NCT01172002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602703|NCT01172002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6602704|NCT01172002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6602705|NCT01172028|Docetaxel|docetaxel|mesh-list
6602706|NCT01172028|Pemetrexed|pemetrexed|mesh-list
6602707|NCT01172028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6602708|NCT01172028|Tubulin Modulators|tubulin modulators|mesh-ancestor
6602709|NCT01172028|Antimitotic Agents|antimitotic agents|mesh-ancestor
6602710|NCT01172028|Mitosis Modulators|mitosis modulators|mesh-ancestor
6602711|NCT01172028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602712|NCT01172028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6602713|NCT01172028|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6602714|NCT01172028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6602715|NCT01172041|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6602716|NCT01172041|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6602717|NCT01172041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020547|NCT00393094|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6602718|NCT01172171|Melatonin|melatonin|mesh-list
6602719|NCT01172171|Antioxidants|antioxidants|mesh-ancestor
6602720|NCT01172171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602721|NCT01172171|Protective Agents|protective agents|mesh-ancestor
6602722|NCT01172171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602723|NCT01172171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6602724|NCT01172223|Paclitaxel|paclitaxel|mesh-list
6602725|NCT01172223|Doxorubicin|doxorubicin|mesh-list
6602726|NCT01172223|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6602727|NCT01172223|Lapatinib|lapatinib|mesh-list
6602728|NCT01172223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6602729|NCT01172223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6602730|NCT01172223|Tubulin Modulators|tubulin modulators|mesh-ancestor
6602731|NCT01172223|Antimitotic Agents|antimitotic agents|mesh-ancestor
6602732|NCT01172223|Mitosis Modulators|mitosis modulators|mesh-ancestor
6602733|NCT01172223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602734|NCT01172223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6602735|NCT01172223|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6602736|NCT01172223|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6602737|NCT01172223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6602738|NCT01172223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6602739|NCT01172236|Lactoferrin|lactoferrin|mesh-list
6602740|NCT01172236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6660188|NCT01491438|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6660189|NCT01491438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6660190|NCT01491438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6660191|NCT01491438|Antitubercular Agents|antitubercular agents|mesh-ancestor
6660192|NCT01491503|Cetirizine|cetirizine|mesh-list
6660193|NCT01491503|Montelukast|montelukast|mesh-list
6660194|NCT01491503|Levocetirizine|levocetirizine|mesh-list
6660195|NCT01491503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6660196|NCT01491503|Respiratory System Agents|respiratory system agents|mesh-ancestor
6660197|NCT01491503|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6660198|NCT01491503|Hormone Antagonists|hormone antagonists|mesh-ancestor
6660199|NCT01491503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6660200|NCT01491503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660201|NCT01491503|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6660202|NCT01491503|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6660203|NCT01491503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660204|NCT01491503|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6660205|NCT01491503|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6660206|NCT01491503|Histamine Antagonists|histamine antagonists|mesh-ancestor
6660207|NCT01491503|Histamine Agents|histamine agents|mesh-ancestor
6660208|NCT01491503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6660209|NCT01491503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6660210|NCT01491711|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6660211|NCT01491711|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
6660212|NCT01491711|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6660213|NCT01491711|Dermatologic Agents|dermatologic agents|mesh-ancestor
6664908|NCT01514812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6664909|NCT01514812|Protective Agents|protective agents|mesh-ancestor
6664910|NCT01514812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664911|NCT01514812|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6664912|NCT01514812|Antithrombins|antithrombins|mesh-ancestor
6664913|NCT01514812|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6664914|NCT01514812|Protease Inhibitors|protease inhibitors|mesh-ancestor
6664915|NCT01514812|Anticoagulants|anticoagulants|mesh-ancestor
6664916|NCT01514825|Darexaban|darexaban|mesh-list
6664917|NCT01514825|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6664918|NCT01514825|Antithrombins|antithrombins|mesh-ancestor
6664919|NCT01514825|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6020548|NCT00393094|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6020549|NCT00393094|Growth Substances|growth substances|mesh-ancestor
6020550|NCT00393094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602741|NCT01172392|Interferons|interferons|mesh-list
6602742|NCT01172392|Interferon-alpha|interferon-alpha|mesh-list
6602743|NCT01172392|Interferon alpha-2|interferon alpha-2|mesh-list
6602744|NCT01172392|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6602745|NCT01172392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6602746|NCT01172392|Antiviral Agents|antiviral agents|mesh-ancestor
6602747|NCT01172392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6602748|NCT01172392|Immunologic Factors|immunologic factors|mesh-ancestor
6602749|NCT01172392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602750|NCT01172405|Ibuprofen|ibuprofen|mesh-list
6602751|NCT01172405|Caffeine|caffeine|mesh-list
6602752|NCT01172405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6602753|NCT01172405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6602754|NCT01172405|Analgesics|analgesics|mesh-ancestor
6602755|NCT01172405|Sensory System Agents|sensory system agents|mesh-ancestor
6602756|NCT01172405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6602757|NCT01172405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602758|NCT01172405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6602759|NCT01172405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6602760|NCT01172405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6602761|NCT01172405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6602762|NCT01172405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602763|NCT01172405|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6602764|NCT01172405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6602765|NCT01172405|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6602766|NCT01172405|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6602767|NCT01172405|Purinergic Agents|purinergic agents|mesh-ancestor
6449145|NCT00403559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6449146|NCT00403611|Praziquantel|praziquantel|mesh-list
6602768|NCT01172405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6602769|NCT01172431|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6602770|NCT01172431|Indapamide|indapamide|mesh-list
6602771|NCT01172431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6602772|NCT01172431|Diuretics|diuretics|mesh-ancestor
6602773|NCT01172431|Natriuretic Agents|natriuretic agents|mesh-ancestor
6602774|NCT01172431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602775|NCT01172431|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6602776|NCT01172431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6602777|NCT01172431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602778|NCT01172444|Mesalamine|mesalamine|mesh-list
6602779|NCT01172444|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6602780|NCT01172444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6602781|NCT01172444|Analgesics|analgesics|mesh-ancestor
6602782|NCT01172444|Sensory System Agents|sensory system agents|mesh-ancestor
6020551|NCT00393094|Growth Inhibitors|growth inhibitors|mesh-ancestor
6020552|NCT00393094|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6020553|NCT00393094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6020554|NCT00393094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6449147|NCT00403611|Anthelmintics|anthelmintics|mesh-ancestor
6449148|NCT00403611|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6449149|NCT00403611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6449150|NCT00403624|Oxaliplatin|oxaliplatin|mesh-list
6449151|NCT00403624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6449152|NCT00403637|Maleic acid|maleic acid|mesh-list
6449153|NCT00403637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6449154|NCT00403637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6449155|NCT00403650|Iloprost|iloprost|mesh-list
6449156|NCT00403650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6449157|NCT00403650|Vasodilator Agents|vasodilator agents|mesh-ancestor
6449158|NCT00403663|Fentanyl|fentanyl|mesh-list
6449159|NCT00403663|Morphine|morphine|mesh-list
6449160|NCT00403663|Bupivacaine|bupivacaine|mesh-list
6449161|NCT00403663|Anesthetics, Local|anesthetics, local|mesh-ancestor
6449162|NCT00403663|Anesthetics|anesthetics|mesh-ancestor
6449163|NCT00403663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6449164|NCT00403663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449165|NCT00403663|Sensory System Agents|sensory system agents|mesh-ancestor
6449166|NCT00403663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6449167|NCT00403663|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6449168|NCT00403663|Narcotics|narcotics|mesh-ancestor
6449169|NCT00403663|Analgesics|analgesics|mesh-ancestor
6449170|NCT00403663|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6449171|NCT00403663|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6449172|NCT00403663|Anesthetics, General|anesthetics, general|mesh-ancestor
6449173|NCT00403715|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6449174|NCT00403715|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6602783|NCT01172444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6602784|NCT01172444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602785|NCT01172444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6602786|NCT01172444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6602787|NCT01172470|Gemcitabine|gemcitabine|mesh-list
6602788|NCT01172470|Carboplatin|carboplatin|mesh-list
6602789|NCT01172470|Pemetrexed|pemetrexed|mesh-list
6602790|NCT01172470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6602791|NCT01172470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6602792|NCT01172470|Antimetabolites|antimetabolites|mesh-ancestor
6602793|NCT01172470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020555|NCT00393094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020556|NCT00393367|Prednisone|prednisone|mesh-list
6020557|NCT00393367|Methylprednisolone|methylprednisolone|mesh-list
6020558|NCT00393367|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6020559|NCT00393367|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5501795|NCT04470557|Coagulants|coagulants|mesh-ancestor
5501796|NCT04470414|Antibodies|antibodies|mesh-list
5501797|NCT04470414|Immunoglobulin G|immunoglobulin g|mesh-list
6602794|NCT01172470|Antiviral Agents|antiviral agents|mesh-ancestor
6602795|NCT01172470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6602796|NCT01172470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6602797|NCT01172470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6602798|NCT01172470|Immunologic Factors|immunologic factors|mesh-ancestor
6602799|NCT01172470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602800|NCT01172470|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6602801|NCT01172470|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6602802|NCT01172496|Treprostinil|treprostinil|mesh-list
6602803|NCT01172496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6602804|NCT01172509|Baclofen|baclofen|mesh-list
6602805|NCT01172509|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6602806|NCT01172509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602807|NCT01172509|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6602808|NCT01172509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6602809|NCT01172509|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6602810|NCT01172509|GABA Agonists|gaba agonists|mesh-ancestor
6602811|NCT01172509|GABA Agents|gaba agents|mesh-ancestor
5501798|NCT04470414|Immunologic Factors|immunologic factors|mesh-ancestor
5501799|NCT04470414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501800|NCT04470544|Camostat|camostat|mesh-list
5501801|NCT04470544|Protease Inhibitors|protease inhibitors|mesh-ancestor
5501802|NCT04470544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5501803|NCT04470544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501804|NCT04470544|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5501805|NCT04470544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5501806|NCT04470791|Antivenins|antivenins|mesh-list
5501807|NCT04470791|Immunologic Factors|immunologic factors|mesh-ancestor
5501808|NCT04470791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602812|NCT01172509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6602813|NCT01172509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602814|NCT01172548|Imatinib Mesylate|imatinib mesylate|mesh-list
6602815|NCT01172548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6602816|NCT01172548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6602817|NCT01172548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6602818|NCT01172548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602819|NCT01172626|Valproic Acid|valproic acid|mesh-list
6602820|NCT01172626|Anticonvulsants|anticonvulsants|mesh-ancestor
6602821|NCT01172626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6602822|NCT01172626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602823|NCT01172626|GABA Agents|gaba agents|mesh-ancestor
6602824|NCT01172626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6602825|NCT01172626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602826|NCT01172626|Antimanic Agents|antimanic agents|mesh-ancestor
6602827|NCT01172626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6602828|NCT01172626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5501809|NCT04470804|Cyclosporine|cyclosporine|mesh-list
5501810|NCT04470804|Sirolimus|sirolimus|mesh-list
5501811|NCT04470804|Cyclosporins|cyclosporins|mesh-list
5501812|NCT04470804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5501813|NCT04470804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501814|NCT04470804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5501815|NCT04470804|Immunologic Factors|immunologic factors|mesh-ancestor
5501816|NCT04470804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501817|NCT04470804|Antifungal Agents|antifungal agents|mesh-ancestor
5501818|NCT04470804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5501819|NCT04470804|Dermatologic Agents|dermatologic agents|mesh-ancestor
6602829|NCT01172626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6602830|NCT01172652|Ziprasidone|ziprasidone|mesh-list
6602831|NCT01172652|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6602832|NCT01172652|Serotonin Agents|serotonin agents|mesh-ancestor
6602833|NCT01172652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6602834|NCT01172652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602835|NCT01172652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602836|NCT01172652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6602837|NCT01172652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6602838|NCT01172652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6602839|NCT01172652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6602840|NCT01172652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6602841|NCT01172652|Dopamine Agents|dopamine agents|mesh-ancestor
6602842|NCT01172691|Nitric Oxide|nitric oxide|mesh-list
6602843|NCT01172691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6602844|NCT01172691|Autonomic Agents|autonomic agents|mesh-ancestor
6602845|NCT01172691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6602846|NCT01172691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602847|NCT01172691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6602848|NCT01172691|Respiratory System Agents|respiratory system agents|mesh-ancestor
6602849|NCT01172691|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6602850|NCT01172691|Antioxidants|antioxidants|mesh-ancestor
6602851|NCT01172691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602852|NCT01172691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6602853|NCT01172691|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6602854|NCT01172691|Vasodilator Agents|vasodilator agents|mesh-ancestor
6602855|NCT01172691|Gasotransmitters|gasotransmitters|mesh-ancestor
6602856|NCT01172691|Protective Agents|protective agents|mesh-ancestor
6602857|NCT01172717|Panitumumab|panitumumab|mesh-list
6602858|NCT01172717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6602859|NCT01172717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6602860|NCT01172756|Riociguat|riociguat|mesh-list
6602861|NCT01172756|Enzyme Activators|enzyme activators|mesh-ancestor
6602862|NCT01172756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602863|NCT01172769|Sirolimus|sirolimus|mesh-list
6602864|NCT01172769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-list
6602865|NCT01172769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6602866|NCT01172769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6602867|NCT01172769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6602868|NCT01172769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6602869|NCT01172769|Antifungal Agents|antifungal agents|mesh-ancestor
6602870|NCT01172769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6602871|NCT01172769|Immunologic Factors|immunologic factors|mesh-ancestor
6602872|NCT01172769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602873|NCT01172769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6660214|NCT01491815|Abatacept|abatacept|mesh-list
5501820|NCT04470804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6602874|NCT01172769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602875|NCT01172782|Hydromorphone|hydromorphone|mesh-list
6602876|NCT01172782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6602877|NCT01172782|Narcotics|narcotics|mesh-ancestor
6602878|NCT01172782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6602879|NCT01172782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602880|NCT01172782|Analgesics|analgesics|mesh-ancestor
6602881|NCT01172782|Sensory System Agents|sensory system agents|mesh-ancestor
6602882|NCT01172782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6602883|NCT01172912|Dexamethasone|dexamethasone|mesh-list
6602884|NCT01172912|Carboplatin|carboplatin|mesh-list
6602885|NCT01172912|Etoposide|etoposide|mesh-list
6602886|NCT01172912|Ifosfamide|ifosfamide|mesh-list
6602887|NCT01172912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6602888|NCT01172912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6602889|NCT01172912|Antiemetics|antiemetics|mesh-ancestor
6602890|NCT01172912|Autonomic Agents|autonomic agents|mesh-ancestor
6602891|NCT01172912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6602892|NCT01172912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602893|NCT01172912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6602894|NCT01172912|Glucocorticoids|glucocorticoids|mesh-ancestor
6602895|NCT01172912|Hormones|hormones|mesh-ancestor
6602896|NCT01172912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6602897|NCT01172912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6602898|NCT01172912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6602899|NCT01172912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6602900|NCT01172912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6602901|NCT01172912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6602902|NCT01172912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602903|NCT01172912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6602904|NCT01172912|Alkylating Agents|alkylating agents|mesh-ancestor
6602905|NCT01172925|Tiotropium Bromide|tiotropium bromide|mesh-list
6602906|NCT01172925|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6602907|NCT01172925|Autonomic Agents|autonomic agents|mesh-ancestor
6602908|NCT01172925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6602909|NCT01172925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602910|NCT01172925|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6602911|NCT01172925|Respiratory System Agents|respiratory system agents|mesh-ancestor
6602912|NCT01172925|Parasympatholytics|parasympatholytics|mesh-ancestor
6602913|NCT01172925|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6602914|NCT01172925|Cholinergic Agents|cholinergic agents|mesh-ancestor
6602915|NCT01172925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6602916|NCT01172925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6449175|NCT00403728|Cyclosporine|cyclosporine|mesh-list
6449176|NCT00403728|Cyclosporins|cyclosporins|mesh-list
6449177|NCT00403728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6449178|NCT00403728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501821|NCT04470804|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6449179|NCT00403728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6449180|NCT00403728|Immunologic Factors|immunologic factors|mesh-ancestor
6449181|NCT00403728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449182|NCT00403728|Antifungal Agents|antifungal agents|mesh-ancestor
6449183|NCT00403728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6449184|NCT00403728|Dermatologic Agents|dermatologic agents|mesh-ancestor
6449185|NCT00403728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6449186|NCT00403728|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6449187|NCT00403780|Pregabalin|pregabalin|mesh-list
6449188|NCT00403780|Analgesics|analgesics|mesh-ancestor
6602917|NCT01172964|Flucytosine|flucytosine|mesh-list
6602918|NCT01172964|Antifungal Agents|antifungal agents|mesh-ancestor
6602919|NCT01172964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6602920|NCT01172964|Antimetabolites|antimetabolites|mesh-ancestor
6602921|NCT01172964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602922|NCT01173003|Misoprostol|misoprostol|mesh-list
6602923|NCT01173003|Mifepristone|mifepristone|mesh-list
6602924|NCT01173003|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6602925|NCT01173003|Abortifacient Agents|abortifacient agents|mesh-ancestor
6602926|NCT01173003|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6602927|NCT01173003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602928|NCT01173003|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6602929|NCT01173003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6602930|NCT01173003|Oxytocics|oxytocics|mesh-ancestor
6602931|NCT01173003|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6602932|NCT01173003|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6602933|NCT01173003|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6602934|NCT01173003|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6602935|NCT01173003|Contraceptive Agents|contraceptive agents|mesh-ancestor
6602936|NCT01173003|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6602937|NCT01173003|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6602938|NCT01173003|Hormone Antagonists|hormone antagonists|mesh-ancestor
6602939|NCT01173003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6602940|NCT01173003|Luteolytic Agents|luteolytic agents|mesh-ancestor
6602941|NCT01173003|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6602942|NCT01173003|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6602943|NCT01173068|Ertapenem|ertapenem|mesh-list
6602944|NCT01173068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6602945|NCT01173068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6449189|NCT00403780|Sensory System Agents|sensory system agents|mesh-ancestor
6449190|NCT00403780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6602946|NCT01173081|Teriparatide|teriparatide|mesh-list
6602947|NCT01173081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6602948|NCT01173081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602949|NCT01173081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6602950|NCT01173107|Colchicine|colchicine|mesh-list
6602951|NCT01173107|Gout Suppressants|gout suppressants|mesh-ancestor
6602952|NCT01173107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6602953|NCT01173107|Tubulin Modulators|tubulin modulators|mesh-ancestor
6602954|NCT01173107|Antimitotic Agents|antimitotic agents|mesh-ancestor
6602955|NCT01173107|Mitosis Modulators|mitosis modulators|mesh-ancestor
6602956|NCT01173107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602957|NCT01173107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6602958|NCT01173172|Boron|boron|mesh-list
6602959|NCT01173172|Trace Elements|trace elements|mesh-ancestor
6602960|NCT01173172|Micronutrients|micronutrients|mesh-ancestor
6602961|NCT01173172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602962|NCT01173237|Pulmonary Surfactants|pulmonary surfactants|mesh-list
6602963|NCT01173237|Respiratory System Agents|respiratory system agents|mesh-ancestor
6602964|NCT01173263|Propofol|propofol|mesh-list
6602965|NCT01173263|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6449191|NCT00403780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449192|NCT00403780|Anticonvulsants|anticonvulsants|mesh-ancestor
6449193|NCT00403780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6449194|NCT00403780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6449195|NCT00403780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602966|NCT01173263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6602967|NCT01173263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602968|NCT01173263|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6602969|NCT01173263|Anesthetics, General|anesthetics, general|mesh-ancestor
6602970|NCT01173263|Anesthetics|anesthetics|mesh-ancestor
6602971|NCT01173315|Vitamins|vitamins|mesh-list
6602972|NCT01173315|Micronutrients|micronutrients|mesh-ancestor
6602973|NCT01173315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6602974|NCT01173510|Raltegravir Potassium|raltegravir potassium|mesh-list
6602975|NCT01173510|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6602976|NCT01173510|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6602977|NCT01173510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6602978|NCT01173510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6602979|NCT01173510|Antiviral Agents|antiviral agents|mesh-ancestor
6602980|NCT01173510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6602981|NCT01173510|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6602982|NCT01173510|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6602983|NCT01173510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6602984|NCT01173510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602985|NCT01173510|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6602986|NCT01173510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6602987|NCT01173536|Moxifloxacin|moxifloxacin|mesh-list
6602988|NCT01173536|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6602989|NCT01173536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6602990|NCT01173536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6602991|NCT01173536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6602992|NCT01173536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6602993|NCT01173536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602994|NCT01173536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6602995|NCT01173549|Canagliflozin|canagliflozin|mesh-list
6602996|NCT01173549|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6602997|NCT01173549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6602998|NCT01173549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6602999|NCT01173549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603000|NCT01173562|Mebendazole|mebendazole|mesh-list
6603001|NCT01173562|Piperazine|piperazine|mesh-list
6603002|NCT01173562|Piperazine citrate|piperazine citrate|mesh-list
6603003|NCT01173562|DMP 777|dmp 777|mesh-list
6449196|NCT00403780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6449197|NCT00403780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6449198|NCT00403780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6449199|NCT00403780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6449200|NCT00403780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6449201|NCT00403806|Dexamethasone|dexamethasone|mesh-list
6449202|NCT00403806|Dexamethasone acetate|dexamethasone acetate|mesh-list
6449203|NCT00403806|BB 1101|bb 1101|mesh-list
6449204|NCT00403806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6449205|NCT00403806|Antiemetics|antiemetics|mesh-ancestor
6449206|NCT00403806|Autonomic Agents|autonomic agents|mesh-ancestor
6449207|NCT00403806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6603004|NCT01173562|Antinematodal Agents|antinematodal agents|mesh-ancestor
6603005|NCT01173562|Anthelmintics|anthelmintics|mesh-ancestor
6603006|NCT01173562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6603007|NCT01173562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6603008|NCT01173562|Tubulin Modulators|tubulin modulators|mesh-ancestor
6603009|NCT01173562|Antimitotic Agents|antimitotic agents|mesh-ancestor
6603010|NCT01173562|Mitosis Modulators|mitosis modulators|mesh-ancestor
6603011|NCT01173562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603012|NCT01173562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6603013|NCT01173562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6603014|NCT01173627|Fentanyl|fentanyl|mesh-list
6603015|NCT01173627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6603016|NCT01173627|Narcotics|narcotics|mesh-ancestor
6603017|NCT01173627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6603018|NCT01173627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603019|NCT01173627|Analgesics|analgesics|mesh-ancestor
6603020|NCT01173627|Sensory System Agents|sensory system agents|mesh-ancestor
6603021|NCT01173627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6603022|NCT01173627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6603023|NCT01173627|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6603024|NCT01173627|Anesthetics, General|anesthetics, general|mesh-ancestor
6603025|NCT01173627|Anesthetics|anesthetics|mesh-ancestor
6603026|NCT01173640|Midazolam|midazolam|mesh-list
6603027|NCT01173640|Resveratrol|resveratrol|mesh-list
6603028|NCT01173640|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6603029|NCT01173640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6603030|NCT01173640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6603031|NCT01173640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603032|NCT01173640|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6603033|NCT01173640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6603034|NCT01173640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6603035|NCT01173640|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6603036|NCT01173640|Anesthetics, General|anesthetics, general|mesh-ancestor
6603037|NCT01173640|Anesthetics|anesthetics|mesh-ancestor
6603038|NCT01173640|GABA Modulators|gaba modulators|mesh-ancestor
6603039|NCT01173640|GABA Agents|gaba agents|mesh-ancestor
6603040|NCT01173640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6603041|NCT01173640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603042|NCT01173640|Antioxidants|antioxidants|mesh-ancestor
6603043|NCT01173640|Protective Agents|protective agents|mesh-ancestor
6603044|NCT01173640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6603045|NCT01173640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6603046|NCT01173809|Amiodarone|amiodarone|mesh-list
6603047|NCT01173809|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6603048|NCT01173809|Vasodilator Agents|vasodilator agents|mesh-ancestor
6603049|NCT01173809|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6603050|NCT01173809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6603051|NCT01173809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603052|NCT01173809|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6603053|NCT01173809|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6603054|NCT01173809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6603055|NCT01173809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6603056|NCT01173809|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6603057|NCT01173809|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6603058|NCT01173809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6603059|NCT01173887|Mogamulizumab|mogamulizumab|mesh-list
6603060|NCT01173887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6603061|NCT01173926|Insulin|insulin|mesh-list
6603062|NCT01173926|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6603063|NCT01173926|Insulin Aspart|insulin aspart|mesh-list
6603064|NCT01173926|Insulin, Long-Acting|insulin, long-acting|mesh-list
6603065|NCT01173926|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6603066|NCT01173926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6603067|NCT01173926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603068|NCT01173939|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6603069|NCT01173939|Pravastatin|pravastatin|mesh-list
6603070|NCT01173939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6603071|NCT01173939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6603072|NCT01173939|Antimetabolites|antimetabolites|mesh-ancestor
6603073|NCT01173939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603074|NCT01173939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6603075|NCT01173939|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6603076|NCT01173939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6660215|NCT01491815|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6660216|NCT01491815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660217|NCT01491815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6660218|NCT01491815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6660219|NCT01491815|Immunologic Factors|immunologic factors|mesh-ancestor
6660220|NCT01491815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660221|NCT01491815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6660222|NCT01491867|Travoprost|travoprost|mesh-list
6660223|NCT01491867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6660224|NCT01492062|Pancrelipase|pancrelipase|mesh-list
6660225|NCT01492062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6660226|NCT01492114|Resveratrol|resveratrol|mesh-list
6660227|NCT01492114|Antioxidants|antioxidants|mesh-ancestor
6660228|NCT01492114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660229|NCT01492114|Protective Agents|protective agents|mesh-ancestor
6660230|NCT01492114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660231|NCT01492114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6660232|NCT01492114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6660233|NCT01492153|Insulin|insulin|mesh-list
6660234|NCT01492153|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6660235|NCT01492153|Isophane Insulin, Human|isophane insulin, human|mesh-list
6660236|NCT01492153|Insulin, Isophane|insulin, isophane|mesh-list
6660237|NCT01492153|Isophane insulin, beef|isophane insulin, beef|mesh-list
6660238|NCT01492153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6660239|NCT01492153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660240|NCT01492166|Insulin|insulin|mesh-list
6660241|NCT01492166|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6660242|NCT01492166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6660243|NCT01492166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660244|NCT01492179|Lidocaine|lidocaine|mesh-list
6660245|NCT01492179|Anesthetics, Local|anesthetics, local|mesh-ancestor
6660246|NCT01492179|Anesthetics|anesthetics|mesh-ancestor
6660247|NCT01492179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6660248|NCT01492179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660249|NCT01492179|Sensory System Agents|sensory system agents|mesh-ancestor
6660250|NCT01492179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6660251|NCT01492179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6660252|NCT01492179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6660253|NCT01492179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6660254|NCT01492179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6660255|NCT01492179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660256|NCT01492205|Insulin|insulin|mesh-list
6660257|NCT01492205|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6660258|NCT01492205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6660259|NCT01492205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660260|NCT01492218|Insulin|insulin|mesh-list
6660261|NCT01492218|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6660262|NCT01492218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6660263|NCT01492218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660264|NCT01492387|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6660265|NCT01492387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6660266|NCT01492504|Asunaprevir|asunaprevir|mesh-list
6660267|NCT01492504|Protease Inhibitors|protease inhibitors|mesh-ancestor
6660268|NCT01492504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6660269|NCT01492504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660270|NCT01492543|Tegafur|tegafur|mesh-list
6660271|NCT01492543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6660272|NCT01492543|Antimetabolites|antimetabolites|mesh-ancestor
6660273|NCT01492543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603077|NCT01173978|Prednisolone|prednisolone|mesh-list
6603078|NCT01173978|Hormones|hormones|mesh-list
6603079|NCT01173978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6603080|NCT01173978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603081|NCT01173978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6603082|NCT01173978|Glucocorticoids|glucocorticoids|mesh-ancestor
6603083|NCT01173978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6603084|NCT01173978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6603085|NCT01174017|Iodine|iodine|mesh-list
6603086|NCT01174017|Cadexomer iodine|cadexomer iodine|mesh-list
6603087|NCT01174017|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6603088|NCT01174017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6603089|NCT01174017|Trace Elements|trace elements|mesh-ancestor
6603090|NCT01174017|Micronutrients|micronutrients|mesh-ancestor
6603091|NCT01174017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603092|NCT01174056|Pioglitazone|pioglitazone|mesh-list
6603093|NCT01174056|Zileuton|zileuton|mesh-list
6603094|NCT01174056|Hydroxyurea|hydroxyurea|mesh-list
6603095|NCT01174056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6603096|NCT01174056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603097|NCT01174056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6603098|NCT01174056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6603099|NCT01174056|Analgesics|analgesics|mesh-ancestor
6603100|NCT01174056|Sensory System Agents|sensory system agents|mesh-ancestor
6603101|NCT01174056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6603102|NCT01174056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6603103|NCT01174056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6603104|NCT01174056|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6603105|NCT01174056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6603106|NCT01174056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603107|NCT01174056|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6603108|NCT01174056|Hormone Antagonists|hormone antagonists|mesh-ancestor
6603109|NCT01174056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6603110|NCT01174056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6603111|NCT01174056|Antisickling Agents|antisickling agents|mesh-ancestor
6603112|NCT01174056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6603113|NCT01174199|Sirolimus|sirolimus|mesh-list
6603114|NCT01174199|Vorinostat|vorinostat|mesh-list
6603115|NCT01174199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6603116|NCT01174199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6603117|NCT01174199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6603118|NCT01174199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6603119|NCT01174199|Antifungal Agents|antifungal agents|mesh-ancestor
6603120|NCT01174199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6603121|NCT01174199|Immunologic Factors|immunologic factors|mesh-ancestor
6603122|NCT01174199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603123|NCT01174199|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6603124|NCT01174199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6603125|NCT01174199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603126|NCT01174212|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6603127|NCT01174212|Vancomycin|vancomycin|mesh-list
6603128|NCT01174212|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6603129|NCT01174212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6603130|NCT01174212|Antitubercular Agents|antitubercular agents|mesh-ancestor
6603131|NCT01174290|Haloperidol|haloperidol|mesh-list
6603132|NCT01174290|Haloperidol decanoate|haloperidol decanoate|mesh-list
6603133|NCT01174290|Antiemetics|antiemetics|mesh-ancestor
6603134|NCT01174290|Autonomic Agents|autonomic agents|mesh-ancestor
6603135|NCT01174290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6603136|NCT01174290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603137|NCT01174290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6603138|NCT01174290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6603139|NCT01174290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6603140|NCT01174290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6603141|NCT01174290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6603142|NCT01174290|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6603143|NCT01174290|Dopamine Agents|dopamine agents|mesh-ancestor
6603144|NCT01174290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6603145|NCT01174290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603146|NCT01174290|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6603147|NCT01174303|Insulin|insulin|mesh-list
6603148|NCT01174303|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6603149|NCT01174303|Insulin Aspart|insulin aspart|mesh-list
6449208|NCT00403806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449209|NCT00403806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6449210|NCT00403806|Glucocorticoids|glucocorticoids|mesh-ancestor
6449211|NCT00403806|Hormones|hormones|mesh-ancestor
6449212|NCT00403806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6449213|NCT00403806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6449214|NCT00403806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6449215|NCT00403806|Protease Inhibitors|protease inhibitors|mesh-ancestor
6603150|NCT01174303|Insulin, Long-Acting|insulin, long-acting|mesh-list
6603151|NCT01174303|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6603152|NCT01174303|Biphasic Insulins|biphasic insulins|mesh-list
6603153|NCT01174303|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6603154|NCT01174303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6603155|NCT01174303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603156|NCT01174394|Fluoxetine|fluoxetine|mesh-list
6603157|NCT01174394|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6603158|NCT01174394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6603159|NCT01174394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6603160|NCT01174394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603161|NCT01174394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6603162|NCT01174394|Serotonin Agents|serotonin agents|mesh-ancestor
6603163|NCT01174394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603164|NCT01174394|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6603165|NCT01174394|Antidepressive Agents|antidepressive agents|mesh-ancestor
6603166|NCT01174394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6603167|NCT01174394|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6603168|NCT01174394|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6603169|NCT01174394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6603170|NCT01174420|Mitomycins|mitomycins|mesh-list
6603171|NCT01174420|Mitomycin|mitomycin|mesh-list
6603172|NCT01174420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6603173|NCT01174420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6603174|NCT01174420|Alkylating Agents|alkylating agents|mesh-ancestor
6603175|NCT01174420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603176|NCT01174420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6603177|NCT01174420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6603178|NCT01174472|Paclitaxel|paclitaxel|mesh-list
6603179|NCT01174472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6603180|NCT01174472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6603181|NCT01174472|Tubulin Modulators|tubulin modulators|mesh-ancestor
6603182|NCT01174472|Antimitotic Agents|antimitotic agents|mesh-ancestor
6603183|NCT01174472|Mitosis Modulators|mitosis modulators|mesh-ancestor
6603184|NCT01174472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603185|NCT01174524|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6603186|NCT01174524|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6603187|NCT01174524|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6603188|NCT01174524|Gestodene|gestodene|mesh-list
6603189|NCT01174524|Femovan|femovan|mesh-list
6603190|NCT01174524|Contraceptive Agents|contraceptive agents|mesh-list
6603191|NCT01174524|Contraceptives, Oral|contraceptives, oral|mesh-list
6603192|NCT01174524|Estradiol|estradiol|mesh-list
6603193|NCT01174524|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6603194|NCT01174524|Estrogens|estrogens|mesh-ancestor
6603195|NCT01174524|Hormones|hormones|mesh-ancestor
6603196|NCT01174524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6603197|NCT01174524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603198|NCT01174524|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6603199|NCT01174524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6603200|NCT01174524|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6603201|NCT01174524|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6664920|NCT01514825|Protease Inhibitors|protease inhibitors|mesh-ancestor
6449216|NCT00403806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6449217|NCT00403806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603202|NCT01174524|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6603203|NCT01174524|Progestins|progestins|mesh-ancestor
6603204|NCT01174524|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6603205|NCT01174563|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6603206|NCT01174563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6603207|NCT01174563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6603208|NCT01174563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6603209|NCT01174563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603210|NCT01174693|Clopidogrel|clopidogrel|mesh-list
6603211|NCT01174693|Triflusal|triflusal|mesh-list
6603212|NCT01174693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6603213|NCT01174693|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6603214|NCT01174693|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6603215|NCT01174693|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6603216|NCT01174693|Purinergic Agents|purinergic agents|mesh-ancestor
6603217|NCT01174693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6603218|NCT01174693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603219|NCT01174693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603220|NCT01174810|Exenatide|exenatide|mesh-list
6603221|NCT01174810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6603222|NCT01174810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603223|NCT01174810|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6603224|NCT01174810|Incretins|incretins|mesh-ancestor
6603225|NCT01174810|Hormones|hormones|mesh-ancestor
6603226|NCT01174810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6603227|NCT01174849|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6603228|NCT01174849|Immunologic Factors|immunologic factors|mesh-ancestor
6603229|NCT01174849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603230|NCT01174888|Cytarabine|cytarabine|mesh-list
6603231|NCT01174888|Etoposide|etoposide|mesh-list
6603232|NCT01174888|Podophyllotoxin|podophyllotoxin|mesh-list
6603233|NCT01174888|Mitoxantrone|mitoxantrone|mesh-list
6603234|NCT01174888|Bortezomib|bortezomib|mesh-list
6603235|NCT01174888|Etoposide phosphate|etoposide phosphate|mesh-list
6603236|NCT01174888|Midostaurin|midostaurin|mesh-list
6603237|NCT01174888|Staurosporine|staurosporine|mesh-list
6603238|NCT01174888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6603239|NCT01174888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6603240|NCT01174888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6603241|NCT01174888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6603242|NCT01174888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6603243|NCT01174888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603244|NCT01174888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6603245|NCT01174888|Antimetabolites|antimetabolites|mesh-ancestor
6603246|NCT01174888|Antiviral Agents|antiviral agents|mesh-ancestor
6603247|NCT01174888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6603248|NCT01174888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6603249|NCT01174888|Immunologic Factors|immunologic factors|mesh-ancestor
6603250|NCT01174888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603251|NCT01174888|Analgesics|analgesics|mesh-ancestor
6603252|NCT01174888|Sensory System Agents|sensory system agents|mesh-ancestor
6603253|NCT01174888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6603254|NCT01174888|Keratolytic Agents|keratolytic agents|mesh-ancestor
6603255|NCT01174888|Dermatologic Agents|dermatologic agents|mesh-ancestor
6603256|NCT01174888|Tubulin Modulators|tubulin modulators|mesh-ancestor
6603257|NCT01174888|Antimitotic Agents|antimitotic agents|mesh-ancestor
6603258|NCT01174888|Mitosis Modulators|mitosis modulators|mesh-ancestor
6603259|NCT01174888|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6603260|NCT01174914|Tenofovir|tenofovir|mesh-list
6603261|NCT01174914|Lamivudine|lamivudine|mesh-list
6603262|NCT01174914|Emtricitabine|emtricitabine|mesh-list
6603263|NCT01174914|Efavirenz|efavirenz|mesh-list
6603264|NCT01174914|Lopinavir|lopinavir|mesh-list
6603265|NCT01174914|Nevirapine|nevirapine|mesh-list
6603266|NCT01174914|Stavudine|stavudine|mesh-list
6603267|NCT01174914|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
6603268|NCT01174914|Naltrexone|naltrexone|mesh-list
6603269|NCT01174914|Antiviral Agents|antiviral agents|mesh-ancestor
6603270|NCT01174914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6603271|NCT01174914|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6603272|NCT01174914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6603273|NCT01174914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6603274|NCT01174914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603275|NCT01174914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6603276|NCT01174914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6603277|NCT01174914|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6603278|NCT01174914|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6603279|NCT01174914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603280|NCT01174914|Sensory System Agents|sensory system agents|mesh-ancestor
6603281|NCT01174914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6603282|NCT01174914|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6603283|NCT01174914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6603284|NCT01174914|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6603285|NCT01174914|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6603286|NCT01174914|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6603287|NCT01174914|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6603288|NCT01174914|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6603289|NCT01174914|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6603290|NCT01174914|Protease Inhibitors|protease inhibitors|mesh-ancestor
6603291|NCT01174914|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6603292|NCT01174914|Antimetabolites|antimetabolites|mesh-ancestor
6603293|NCT01174927|Heroin|heroin|mesh-list
6603294|NCT01174927|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6603295|NCT01174927|Narcotics|narcotics|mesh-ancestor
6449218|NCT00403819|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
6020560|NCT00393367|Prednisolone|prednisolone|mesh-list
6020561|NCT00393367|Prednisolone acetate|prednisolone acetate|mesh-list
6603296|NCT01174927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6603297|NCT01174927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603298|NCT01174927|Analgesics|analgesics|mesh-ancestor
6603299|NCT01174927|Sensory System Agents|sensory system agents|mesh-ancestor
6603300|NCT01174927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6603301|NCT01174953|Finasteride|finasteride|mesh-list
6603302|NCT01174953|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6603303|NCT01174953|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6603304|NCT01174953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6603305|NCT01174953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603306|NCT01174953|Hormone Antagonists|hormone antagonists|mesh-ancestor
6603307|NCT01174953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6603308|NCT01174953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603309|NCT01174953|Urological Agents|urological agents|mesh-ancestor
6603310|NCT01175044|Povidone-Iodine|povidone-iodine|mesh-list
6603311|NCT01175044|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6603312|NCT01175044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6603313|NCT01175096|Everolimus|everolimus|mesh-list
6603314|NCT01175096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6603315|NCT01175096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6603316|NCT01175096|Immunologic Factors|immunologic factors|mesh-ancestor
6603317|NCT01175096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603318|NCT01175109|Imatinib Mesylate|imatinib mesylate|mesh-list
6603319|NCT01175109|Panobinostat|panobinostat|mesh-list
6603320|NCT01175109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6603321|NCT01175109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6603322|NCT01175109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6603323|NCT01175109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603324|NCT01175109|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6603325|NCT01175161|Copper|copper|mesh-list
6603326|NCT01175161|Trace Elements|trace elements|mesh-ancestor
6603327|NCT01175161|Micronutrients|micronutrients|mesh-ancestor
6603328|NCT01175161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603329|NCT01175200|Lansoprazole|lansoprazole|mesh-list
6603330|NCT01175200|Dexlansoprazole|dexlansoprazole|mesh-list
6603331|NCT01175200|Clopidogrel|clopidogrel|mesh-list
6603332|NCT01175200|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6603333|NCT01175200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6603334|NCT01175200|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6603335|NCT01175200|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6020562|NCT00393367|Budesonide|budesonide|mesh-list
6449219|NCT00403819|Laxatives|laxatives|mesh-ancestor
6449220|NCT00403819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6449221|NCT00403858|Lactulose|lactulose|mesh-list
6449222|NCT00403858|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
6449223|NCT00403858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6449224|NCT00403858|Laxatives|laxatives|mesh-ancestor
6449225|NCT00403897|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
6449226|NCT00403897|Laxatives|laxatives|mesh-ancestor
6449227|NCT00403897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6449228|NCT00403910|Canrenone|canrenone|mesh-list
6449229|NCT00403910|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6449230|NCT00403910|Hormone Antagonists|hormone antagonists|mesh-ancestor
6449231|NCT00403910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6449232|NCT00403910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603336|NCT01175200|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6603337|NCT01175200|Purinergic Agents|purinergic agents|mesh-ancestor
6603338|NCT01175200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6603339|NCT01175200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603340|NCT01175200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603341|NCT01175200|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6603342|NCT01175200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6603343|NCT01175200|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6603344|NCT01175200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6603345|NCT01175291|Leucovorin|leucovorin|mesh-list
6603346|NCT01175291|Bevacizumab|bevacizumab|mesh-list
6603347|NCT01175291|Fluorouracil|fluorouracil|mesh-list
6603348|NCT01175291|Oxaliplatin|oxaliplatin|mesh-list
6603349|NCT01175291|Levoleucovorin|levoleucovorin|mesh-list
6603350|NCT01175291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6603351|NCT01175291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5501822|NCT04470804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5501823|NCT04470804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5501824|NCT04470804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5501825|NCT04470609|Vaccines|vaccines|mesh-list
6603352|NCT01175291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6603353|NCT01175291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6603354|NCT01175291|Growth Substances|growth substances|mesh-ancestor
6603355|NCT01175291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603356|NCT01175291|Growth Inhibitors|growth inhibitors|mesh-ancestor
6603357|NCT01175291|Antimetabolites|antimetabolites|mesh-ancestor
6603358|NCT01175291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603359|NCT01175291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6603360|NCT01175291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6603361|NCT01175291|Immunologic Factors|immunologic factors|mesh-ancestor
6603362|NCT01175291|Antidotes|antidotes|mesh-ancestor
6603363|NCT01175291|Protective Agents|protective agents|mesh-ancestor
6603364|NCT01175291|Vitamin B Complex|vitamin b complex|mesh-ancestor
6603365|NCT01175291|Vitamins|vitamins|mesh-ancestor
6603366|NCT01175291|Micronutrients|micronutrients|mesh-ancestor
6603367|NCT01175330|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6603368|NCT01175330|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6603369|NCT01175330|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5501826|NCT04470609|Immunologic Factors|immunologic factors|mesh-ancestor
5501827|NCT04470609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501828|NCT04470401|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5501829|NCT04470401|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5501830|NCT04470401|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5501831|NCT04470401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5501832|NCT04470401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501833|NCT04470401|Cholinergic Agents|cholinergic agents|mesh-ancestor
5501834|NCT04470401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5501835|NCT04470401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501836|NCT04470401|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6020563|NCT00393367|Bromides|bromides|mesh-list
6603370|NCT01175330|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6603371|NCT01175460|Nedaplatin|nedaplatin|mesh-list
6603372|NCT01175460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6603373|NCT01175486|Pioglitazone|pioglitazone|mesh-list
6603374|NCT01175486|Acarbose|acarbose|mesh-list
6603375|NCT01175486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6603376|NCT01175486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603377|NCT01175486|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6603378|NCT01175486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6603379|NCT01175486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603380|NCT01175512|Naltrexone|naltrexone|mesh-list
6603381|NCT01175512|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6603382|NCT01175512|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6603383|NCT01175512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603384|NCT01175512|Sensory System Agents|sensory system agents|mesh-ancestor
6603385|NCT01175512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6603386|NCT01175525|Cromolyn Sodium|cromolyn sodium|mesh-list
6603387|NCT01175525|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
6603388|NCT01175525|Immunologic Factors|immunologic factors|mesh-ancestor
6603389|NCT01175525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603390|NCT01175525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6603391|NCT01175525|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6603392|NCT01175525|Respiratory System Agents|respiratory system agents|mesh-ancestor
6603393|NCT01175538|Lactulose|lactulose|mesh-list
6603394|NCT01175538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6603395|NCT01175577|Carotenoids|carotenoids|mesh-list
6603396|NCT01175577|Antioxidants|antioxidants|mesh-ancestor
6603397|NCT01175577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603398|NCT01175577|Protective Agents|protective agents|mesh-ancestor
6603399|NCT01175577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603400|NCT01175733|Panitumumab|panitumumab|mesh-list
6603401|NCT01175733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6603402|NCT01175733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6603403|NCT01175746|Nicardipine|nicardipine|mesh-list
6603404|NCT01175746|Remifentanil|remifentanil|mesh-list
6603405|NCT01175746|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6603406|NCT01175746|Narcotics|narcotics|mesh-ancestor
6603407|NCT01175746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6603408|NCT01175746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603409|NCT01175746|Analgesics|analgesics|mesh-ancestor
6449233|NCT00403910|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6449234|NCT00403910|Diuretics|diuretics|mesh-ancestor
6449235|NCT00403910|Natriuretic Agents|natriuretic agents|mesh-ancestor
6449236|NCT00403949|Azelaic acid|azelaic acid|mesh-list
6449237|NCT00403949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6449238|NCT00403949|Dermatologic Agents|dermatologic agents|mesh-ancestor
6449239|NCT00403962|Paroxetine|paroxetine|mesh-list
6449240|NCT00403962|Vestipitant|vestipitant|mesh-list
6449241|NCT00403962|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6603410|NCT01175746|Sensory System Agents|sensory system agents|mesh-ancestor
6603411|NCT01175746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6603412|NCT01175746|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6603413|NCT01175746|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6603414|NCT01175746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6603415|NCT01175746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603416|NCT01175746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6449242|NCT00403962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6603417|NCT01175746|Vasodilator Agents|vasodilator agents|mesh-ancestor
6603418|NCT01175772|Celecoxib|celecoxib|mesh-list
6603419|NCT01175772|Methotrexate|methotrexate|mesh-list
6603420|NCT01175772|Cyclophosphamide|cyclophosphamide|mesh-list
6603421|NCT01175772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6603422|NCT01175772|Abortifacient Agents|abortifacient agents|mesh-ancestor
6449243|NCT00403962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6449244|NCT00403962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6449245|NCT00403962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6449246|NCT00403962|Serotonin Agents|serotonin agents|mesh-ancestor
6449247|NCT00403962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449248|NCT00403962|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6449249|NCT00403962|Antidepressive Agents|antidepressive agents|mesh-ancestor
6449250|NCT00403962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6449251|NCT00403962|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6449252|NCT00403962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6449253|NCT00403962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6449254|NCT00403962|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6449255|NCT00403975|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6449256|NCT00403975|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6449257|NCT00403988|Oxaliplatin|oxaliplatin|mesh-list
6449258|NCT00403988|Vinorelbine|vinorelbine|mesh-list
6449259|NCT00403988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6449260|NCT00403988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6449261|NCT00403988|Tubulin Modulators|tubulin modulators|mesh-ancestor
6449262|NCT00403988|Antimitotic Agents|antimitotic agents|mesh-ancestor
6603423|NCT01175772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6603424|NCT01175772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603425|NCT01175772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6603426|NCT01175772|Antimetabolites|antimetabolites|mesh-ancestor
6603427|NCT01175772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603428|NCT01175772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6603429|NCT01175772|Dermatologic Agents|dermatologic agents|mesh-ancestor
6603430|NCT01175772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6603431|NCT01175772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6449263|NCT00403988|Mitosis Modulators|mitosis modulators|mesh-ancestor
6603432|NCT01175772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6603433|NCT01175772|Immunologic Factors|immunologic factors|mesh-ancestor
6603434|NCT01175772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6603435|NCT01175772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6603436|NCT01175772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6603437|NCT01175772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6603438|NCT01175772|Analgesics|analgesics|mesh-ancestor
6603439|NCT01175772|Sensory System Agents|sensory system agents|mesh-ancestor
6603440|NCT01175772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6603441|NCT01175772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6603442|NCT01175772|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6603443|NCT01175772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6603444|NCT01175772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6603445|NCT01175772|Alkylating Agents|alkylating agents|mesh-ancestor
6603446|NCT01175772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6660274|NCT01492543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6660275|NCT01492556|Etoposide|etoposide|mesh-list
6660276|NCT01492556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6660277|NCT01492556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6660278|NCT01492556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6660279|NCT01492556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6660280|NCT01492556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6660281|NCT01492556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660282|NCT01492608|Magnesium Sulfate|magnesium sulfate|mesh-list
6660283|NCT01492608|Analgesics|analgesics|mesh-ancestor
6660284|NCT01492608|Sensory System Agents|sensory system agents|mesh-ancestor
6660285|NCT01492608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6660286|NCT01492608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660287|NCT01492608|Anesthetics|anesthetics|mesh-ancestor
6660288|NCT01492608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6660289|NCT01492608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6660290|NCT01492608|Anticonvulsants|anticonvulsants|mesh-ancestor
6660291|NCT01492608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6660292|NCT01492608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6660293|NCT01492608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660294|NCT01492608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6660295|NCT01492608|Tocolytic Agents|tocolytic agents|mesh-ancestor
6449264|NCT00403988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6449265|NCT00404040|Lactulose|lactulose|mesh-list
6449266|NCT00404040|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
6449267|NCT00404040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6449268|NCT00404040|Laxatives|laxatives|mesh-ancestor
6449269|NCT00404053|Clopidogrel|clopidogrel|mesh-list
6449270|NCT00404053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6449271|NCT00404053|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6449272|NCT00404053|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6449273|NCT00404053|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6449274|NCT00404053|Purinergic Agents|purinergic agents|mesh-ancestor
6449275|NCT00404053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6449276|NCT00404053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6449277|NCT00404053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449278|NCT00404131|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6449279|NCT00404131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6449280|NCT00404157|Rituximab|rituximab|mesh-list
6449281|NCT00404157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6660296|NCT01492608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6660297|NCT01492621|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6660298|NCT01492621|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6660299|NCT01492621|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6660300|NCT01492621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6660301|NCT01492621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660302|NCT01492621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6660303|NCT01492621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660304|NCT01492621|Antidepressive Agents|antidepressive agents|mesh-ancestor
6660305|NCT01492621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6660306|NCT01492712|Propofol|propofol|mesh-list
6660307|NCT01492712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6660308|NCT01492712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6660309|NCT01492712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660310|NCT01492712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6660311|NCT01492712|Anesthetics, General|anesthetics, general|mesh-ancestor
6660312|NCT01492712|Anesthetics|anesthetics|mesh-ancestor
6660313|NCT01492725|Plasminogen|plasminogen|mesh-list
6660314|NCT01492725|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6603447|NCT01175954|Lacosamide|lacosamide|mesh-list
6603448|NCT01175954|Anticonvulsants|anticonvulsants|mesh-ancestor
6603449|NCT01175954|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6603450|NCT01175954|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6603451|NCT01175954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6603452|NCT01175954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603453|NCT01176175|Progesterone|progesterone|mesh-list
6603454|NCT01176175|Progestins|progestins|mesh-ancestor
6603455|NCT01176175|Hormones|hormones|mesh-ancestor
6603456|NCT01176175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6603457|NCT01176175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603458|NCT01176318|Erdosteine|erdosteine|mesh-list
6603459|NCT01176318|Expectorants|expectorants|mesh-ancestor
6603460|NCT01176318|Respiratory System Agents|respiratory system agents|mesh-ancestor
6449282|NCT00404157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6449283|NCT00404157|Immunologic Factors|immunologic factors|mesh-ancestor
6449284|NCT00404157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449285|NCT00404157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6449286|NCT00404183|Acetaminophen|acetaminophen|mesh-list
6449287|NCT00404183|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
6449288|NCT00404183|Hydrocodone|hydrocodone|mesh-list
6449289|NCT00404183|Oxycodone|oxycodone|mesh-list
6449290|NCT00404183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6449291|NCT00404183|Analgesics|analgesics|mesh-ancestor
6449292|NCT00404183|Sensory System Agents|sensory system agents|mesh-ancestor
6449293|NCT00404183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6449294|NCT00404183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449295|NCT00404183|Antipyretics|antipyretics|mesh-ancestor
6449296|NCT00404183|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6449297|NCT00404183|Narcotics|narcotics|mesh-ancestor
6449298|NCT00404183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6449299|NCT00404183|Antitussive Agents|antitussive agents|mesh-ancestor
6449300|NCT00404183|Respiratory System Agents|respiratory system agents|mesh-ancestor
6449301|NCT00404183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6449302|NCT00404183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6449303|NCT00404183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6603461|NCT01176344|Vitamin D|vitamin d|mesh-list
6603462|NCT01176344|Vitamins|vitamins|mesh-ancestor
6603463|NCT01176344|Micronutrients|micronutrients|mesh-ancestor
6603464|NCT01176344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603465|NCT01176344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6603466|NCT01176409|Valacyclovir|valacyclovir|mesh-list
6603467|NCT01176409|Antiviral Agents|antiviral agents|mesh-ancestor
6603468|NCT01176409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6603469|NCT01176552|Interferon-alpha|interferon-alpha|mesh-list
6603470|NCT01176552|Interferon alpha-2|interferon alpha-2|mesh-list
6603471|NCT01176552|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
6603472|NCT01176552|Antiviral Agents|antiviral agents|mesh-ancestor
6603473|NCT01176552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6603474|NCT01176552|Immunologic Factors|immunologic factors|mesh-ancestor
6603475|NCT01176552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603476|NCT01176552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6603477|NCT01176669|Apatinib|apatinib|mesh-list
6603478|NCT01176669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6603479|NCT01176669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6603480|NCT01176669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6603481|NCT01176669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603482|NCT01176708|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
6603483|NCT01176708|Protease Inhibitors|protease inhibitors|mesh-ancestor
6603484|NCT01176708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6603485|NCT01176708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603486|NCT01176708|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6603487|NCT01176708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603488|NCT01176747|Formoterol Fumarate|formoterol fumarate|mesh-list
6603489|NCT01176747|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6603490|NCT01176747|Autonomic Agents|autonomic agents|mesh-ancestor
6603491|NCT01176747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6603492|NCT01176747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603493|NCT01176747|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6020564|NCT00393367|Albuterol|albuterol|mesh-list
6020565|NCT00393367|Ipratropium|ipratropium|mesh-list
6020566|NCT00393367|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6020567|NCT00393367|Prednisolone phosphate|prednisolone phosphate|mesh-list
6603494|NCT01176747|Respiratory System Agents|respiratory system agents|mesh-ancestor
6603495|NCT01176747|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6603496|NCT01176747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6603497|NCT01176747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6603498|NCT01176747|Adrenergic Agents|adrenergic agents|mesh-ancestor
6603499|NCT01176747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6603500|NCT01176747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603501|NCT01176760|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
6603502|NCT01176760|Protease Inhibitors|protease inhibitors|mesh-ancestor
6603503|NCT01176760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6603504|NCT01176760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603505|NCT01176760|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6603506|NCT01176760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603507|NCT01176799|Cyclophosphamide|cyclophosphamide|mesh-list
6603508|NCT01176799|Doxorubicin|doxorubicin|mesh-list
6603509|NCT01176799|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6603510|NCT01176799|Sunitinib|sunitinib|mesh-list
6603511|NCT01176799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6603512|NCT01176799|Immunologic Factors|immunologic factors|mesh-ancestor
6603513|NCT01176799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603514|NCT01176799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6603515|NCT01176799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6603516|NCT01176799|Alkylating Agents|alkylating agents|mesh-ancestor
6603517|NCT01176799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603518|NCT01176799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6603519|NCT01176799|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6603520|NCT01176799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6603521|NCT01176799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6603522|NCT01176799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6603523|NCT01176799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6603524|NCT01176799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6603525|NCT01176799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6603526|NCT01176799|Growth Substances|growth substances|mesh-ancestor
6603527|NCT01176799|Growth Inhibitors|growth inhibitors|mesh-ancestor
6603528|NCT01176799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6603529|NCT01176851|Glycopyrrolate|glycopyrrolate|mesh-list
6603530|NCT01176851|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6603531|NCT01176851|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6603532|NCT01176851|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6603533|NCT01176851|Cholinergic Agents|cholinergic agents|mesh-ancestor
6603534|NCT01176851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6603535|NCT01176851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603536|NCT01176851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603537|NCT01176903|Glycopyrrolate|glycopyrrolate|mesh-list
6603538|NCT01176903|Tiotropium Bromide|tiotropium bromide|mesh-list
6603539|NCT01176903|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6603540|NCT01176903|Autonomic Agents|autonomic agents|mesh-ancestor
6603541|NCT01176903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6603542|NCT01176903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603543|NCT01176903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6603544|NCT01176903|Respiratory System Agents|respiratory system agents|mesh-ancestor
6603545|NCT01176903|Parasympatholytics|parasympatholytics|mesh-ancestor
6603546|NCT01176903|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6603547|NCT01176903|Cholinergic Agents|cholinergic agents|mesh-ancestor
6603548|NCT01176903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6603549|NCT01176903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603550|NCT01176903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6603551|NCT01176903|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6603552|NCT01177176|Bupropion|bupropion|mesh-list
6603553|NCT01177176|Nicotine|nicotine|mesh-list
6603554|NCT01177176|Varenicline|varenicline|mesh-list
6603555|NCT01177176|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6603556|NCT01177176|Autonomic Agents|autonomic agents|mesh-ancestor
6603557|NCT01177176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6603558|NCT01177176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603559|NCT01177176|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6603560|NCT01177176|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6603561|NCT01177176|Cholinergic Agents|cholinergic agents|mesh-ancestor
6603562|NCT01177176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6603563|NCT01177176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603564|NCT01177176|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6603565|NCT01177176|Antidepressive Agents|antidepressive agents|mesh-ancestor
6603566|NCT01177176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6603567|NCT01177176|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6603568|NCT01177176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6603569|NCT01177176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6603570|NCT01177176|Dopamine Agents|dopamine agents|mesh-ancestor
6603571|NCT01177176|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6603572|NCT01177176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6603573|NCT01177176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6603574|NCT01177306|Guanfacine|guanfacine|mesh-list
6603575|NCT01177306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6603576|NCT01177306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6603577|NCT01177306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6603578|NCT01177306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6603579|NCT01177306|Adrenergic Agents|adrenergic agents|mesh-ancestor
6603580|NCT01177306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6603581|NCT01177306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603582|NCT01177306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603583|NCT01177358|Botulinum Toxins|botulinum toxins|mesh-list
6603584|NCT01177358|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6603585|NCT01177358|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6603586|NCT01177358|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6603587|NCT01177358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6603588|NCT01177358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603589|NCT01177358|Cholinergic Agents|cholinergic agents|mesh-ancestor
6603590|NCT01177358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6603591|NCT01177358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603592|NCT01177358|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6603593|NCT01177358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6603594|NCT01177371|Cyclosporine|cyclosporine|mesh-list
6603595|NCT01177371|Methylprednisolone|methylprednisolone|mesh-list
6603596|NCT01177371|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6603597|NCT01177371|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6603598|NCT01177371|Prednisolone|prednisolone|mesh-list
6603599|NCT01177371|Prednisolone acetate|prednisolone acetate|mesh-list
6603600|NCT01177371|Cyclophosphamide|cyclophosphamide|mesh-list
6603601|NCT01177371|Busulfan|busulfan|mesh-list
6603602|NCT01177371|Methotrexate|methotrexate|mesh-list
6603603|NCT01177371|Cyclosporins|cyclosporins|mesh-list
6603604|NCT01177371|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6603605|NCT01177371|Prednisolone phosphate|prednisolone phosphate|mesh-list
6603606|NCT01177371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6603607|NCT01177371|Immunologic Factors|immunologic factors|mesh-ancestor
6603608|NCT01177371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603609|NCT01177371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6603610|NCT01177371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6603611|NCT01177371|Alkylating Agents|alkylating agents|mesh-ancestor
6603612|NCT01177371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603613|NCT01177371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6603614|NCT01177371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6603615|NCT01177371|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6603616|NCT01177371|Abortifacient Agents|abortifacient agents|mesh-ancestor
6603617|NCT01177371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6603618|NCT01177371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6603619|NCT01177371|Antimetabolites|antimetabolites|mesh-ancestor
6603620|NCT01177371|Dermatologic Agents|dermatologic agents|mesh-ancestor
6603621|NCT01177371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6603622|NCT01177371|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6603623|NCT01177371|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6603624|NCT01177371|Antifungal Agents|antifungal agents|mesh-ancestor
6603625|NCT01177371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6603626|NCT01177371|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6603627|NCT01177371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6603628|NCT01177371|Antiemetics|antiemetics|mesh-ancestor
6603629|NCT01177371|Autonomic Agents|autonomic agents|mesh-ancestor
6603630|NCT01177371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6603631|NCT01177371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6603632|NCT01177371|Glucocorticoids|glucocorticoids|mesh-ancestor
6603633|NCT01177371|Hormones|hormones|mesh-ancestor
6603634|NCT01177371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6603635|NCT01177371|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6603636|NCT01177371|Protective Agents|protective agents|mesh-ancestor
6603637|NCT01177371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6603638|NCT01177423|Anesthetics|anesthetics|mesh-list
6603639|NCT01177423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6603640|NCT01177423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603641|NCT01177501|Topotecan|topotecan|mesh-list
6603642|NCT01177501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6603643|NCT01177501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6603644|NCT01177501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6603645|NCT01177501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603646|NCT01177501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6603647|NCT01177514|Gabapentin|gabapentin|mesh-list
6603648|NCT01177514|Analgesics|analgesics|mesh-ancestor
6603649|NCT01177514|Sensory System Agents|sensory system agents|mesh-ancestor
6603650|NCT01177514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6603651|NCT01177514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603652|NCT01177514|Anticonvulsants|anticonvulsants|mesh-ancestor
6603653|NCT01177514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6603654|NCT01177514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6603655|NCT01177514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6603656|NCT01177514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6603657|NCT01177514|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6603658|NCT01177514|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6603659|NCT01177514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6603660|NCT01177514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603661|NCT01177514|Antimanic Agents|antimanic agents|mesh-ancestor
6603662|NCT01177540|Decitabine|decitabine|mesh-list
6603663|NCT01177540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6603664|NCT01177540|Antimetabolites|antimetabolites|mesh-ancestor
6603665|NCT01177540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603666|NCT01177540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6603667|NCT01177540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6603668|NCT01177566|Pimecrolimus|pimecrolimus|mesh-list
6603669|NCT01177566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6603670|NCT01177566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6603671|NCT01177566|Analgesics|analgesics|mesh-ancestor
6603672|NCT01177566|Sensory System Agents|sensory system agents|mesh-ancestor
6603673|NCT01177566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6603674|NCT01177566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603675|NCT01177566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6603676|NCT01177566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6603677|NCT01177566|Dermatologic Agents|dermatologic agents|mesh-ancestor
6603678|NCT01177566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6603679|NCT01177566|Immunologic Factors|immunologic factors|mesh-ancestor
6603680|NCT01177566|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6603681|NCT01177566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6603682|NCT01177566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603683|NCT01177579|Copper|copper|mesh-list
6603684|NCT01177579|Trace Elements|trace elements|mesh-ancestor
6603685|NCT01177579|Micronutrients|micronutrients|mesh-ancestor
6603686|NCT01177579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660315|NCT01492725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6660316|NCT01492725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6660317|NCT01492725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660318|NCT01492881|Doxorubicin|doxorubicin|mesh-list
6660319|NCT01492881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6660320|NCT01492881|Bortezomib|bortezomib|mesh-list
6660321|NCT01492881|Vorinostat|vorinostat|mesh-list
6660322|NCT01492881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6660323|NCT01492881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6660324|NCT01492881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6660325|NCT01492881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6660326|NCT01492881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6660327|NCT01492881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660328|NCT01492881|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6660329|NCT01492894|Cyclosporine|cyclosporine|mesh-list
6660330|NCT01492894|Sirolimus|sirolimus|mesh-list
6660331|NCT01492894|Tacrolimus|tacrolimus|mesh-list
6660332|NCT01492894|Cyclosporins|cyclosporins|mesh-list
6660333|NCT01492894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6603687|NCT01177683|Doxorubicin|doxorubicin|mesh-list
6603688|NCT01177683|Bortezomib|bortezomib|mesh-list
6603689|NCT01177683|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6603690|NCT01177683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6603691|NCT01177683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6603692|NCT01177683|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6603693|NCT01177683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6603694|NCT01177683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6603695|NCT01177683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603696|NCT01177683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6603697|NCT01177683|Alkylating Agents|alkylating agents|mesh-ancestor
6603698|NCT01177696|Psychotropic Drugs|psychotropic drugs|mesh-list
6603699|NCT01177852|Diphenhydramine|diphenhydramine|mesh-list
6603700|NCT01177852|Promethazine|promethazine|mesh-list
6603701|NCT01177852|Brompheniramine|brompheniramine|mesh-list
6603702|NCT01177852|Pseudoephedrine|pseudoephedrine|mesh-list
6603703|NCT01177852|Brompheniramine, pseudoephedrine drug combination|brompheniramine, pseudoephedrine drug combination|mesh-list
6603704|NCT01177852|Ephedrine|ephedrine|mesh-list
6603705|NCT01177852|Dipropizine|dipropizine|mesh-list
6603706|NCT01177852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603707|NCT01177852|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6603708|NCT01177852|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6603709|NCT01177852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6603710|NCT01177852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603711|NCT01177852|Anesthetics, Local|anesthetics, local|mesh-ancestor
6603712|NCT01177852|Anesthetics|anesthetics|mesh-ancestor
6603713|NCT01177852|Sensory System Agents|sensory system agents|mesh-ancestor
6603714|NCT01177852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6603715|NCT01177852|Antiemetics|antiemetics|mesh-ancestor
6603716|NCT01177852|Autonomic Agents|autonomic agents|mesh-ancestor
6603717|NCT01177852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6603718|NCT01177852|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6603719|NCT01177852|Histamine Antagonists|histamine antagonists|mesh-ancestor
6603720|NCT01177852|Histamine Agents|histamine agents|mesh-ancestor
6603721|NCT01177852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6603722|NCT01177852|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6603723|NCT01177852|Antipruritics|antipruritics|mesh-ancestor
6603724|NCT01177852|Dermatologic Agents|dermatologic agents|mesh-ancestor
6603725|NCT01177852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6603726|NCT01177852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6603727|NCT01177852|Respiratory System Agents|respiratory system agents|mesh-ancestor
6603728|NCT01177852|Nasal Decongestants|nasal decongestants|mesh-ancestor
6603729|NCT01177852|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6603730|NCT01177852|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6603731|NCT01177852|Sympathomimetics|sympathomimetics|mesh-ancestor
6603732|NCT01177852|Adrenergic Agents|adrenergic agents|mesh-ancestor
6603733|NCT01177852|Antitussive Agents|antitussive agents|mesh-ancestor
6603734|NCT01177904|Progesterone|progesterone|mesh-list
6603735|NCT01177904|Progestins|progestins|mesh-ancestor
6603736|NCT01177904|Hormones|hormones|mesh-ancestor
6603737|NCT01177904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6603738|NCT01177904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603739|NCT01178021|Chloroquine|chloroquine|mesh-list
6603740|NCT01178021|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
6603741|NCT01178021|Primaquine|primaquine|mesh-list
6603742|NCT01178021|Amebicides|amebicides|mesh-ancestor
6603743|NCT01178021|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6603744|NCT01178021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6603745|NCT01178021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6603746|NCT01178021|Antimalarials|antimalarials|mesh-ancestor
6603747|NCT01178021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6603748|NCT01178021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6603749|NCT01178021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6603750|NCT01178021|Analgesics|analgesics|mesh-ancestor
6603751|NCT01178021|Sensory System Agents|sensory system agents|mesh-ancestor
6603752|NCT01178021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6603753|NCT01178021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603754|NCT01178021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5501837|NCT04470401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6603755|NCT01178021|Filaricides|filaricides|mesh-ancestor
6603756|NCT01178021|Antinematodal Agents|antinematodal agents|mesh-ancestor
6603757|NCT01178021|Anthelmintics|anthelmintics|mesh-ancestor
6603758|NCT01178034|Warfarin|warfarin|mesh-list
6603759|NCT01178034|Anticoagulants|anticoagulants|mesh-ancestor
6603760|NCT01178047|Rasagiline|rasagiline|mesh-list
6603761|NCT01178047|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6603762|NCT01178047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6603763|NCT01178047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603764|NCT01178047|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6603765|NCT01178047|Protective Agents|protective agents|mesh-ancestor
6603766|NCT01178047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603767|NCT01178112|Carboplatin|carboplatin|mesh-list
6603768|NCT01178112|Trientine|trientine|mesh-list
6603769|NCT01178112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6603770|NCT01178112|Chelating Agents|chelating agents|mesh-ancestor
6603771|NCT01178112|Sequestering Agents|sequestering agents|mesh-ancestor
6603772|NCT01178112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603773|NCT01178151|Everolimus|everolimus|mesh-list
6603774|NCT01178151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6603775|NCT01178151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6603776|NCT01178151|Immunologic Factors|immunologic factors|mesh-ancestor
6603777|NCT01178151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603778|NCT01178203|Naproxen|naproxen|mesh-list
6603779|NCT01178203|Tramadol|tramadol|mesh-list
6603780|NCT01178203|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6603781|NCT01178203|Narcotics|narcotics|mesh-ancestor
6603782|NCT01178203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6603783|NCT01178203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603784|NCT01178203|Analgesics|analgesics|mesh-ancestor
6603785|NCT01178203|Sensory System Agents|sensory system agents|mesh-ancestor
6603786|NCT01178203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6603787|NCT01178203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6603788|NCT01178203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6603789|NCT01178203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6603790|NCT01178203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6603791|NCT01178203|Gout Suppressants|gout suppressants|mesh-ancestor
6603792|NCT01178203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6603793|NCT01178203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6603794|NCT01178203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603795|NCT01178320|Niacin|niacin|mesh-list
6603796|NCT01178320|Niacinamide|niacinamide|mesh-list
6603797|NCT01178320|Nicotinic Acids|nicotinic acids|mesh-list
6603798|NCT01178320|Simvastatin|simvastatin|mesh-list
6603799|NCT01178320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6603800|NCT01178320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6603801|NCT01178320|Antimetabolites|antimetabolites|mesh-ancestor
6603802|NCT01178320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603803|NCT01178320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6603804|NCT01178320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6603805|NCT01178320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6603806|NCT01178320|Vasodilator Agents|vasodilator agents|mesh-ancestor
6603807|NCT01178320|Vitamin B Complex|vitamin b complex|mesh-ancestor
6603808|NCT01178320|Vitamins|vitamins|mesh-ancestor
6603809|NCT01178320|Micronutrients|micronutrients|mesh-ancestor
6603810|NCT01178320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603811|NCT01178372|Lactulose|lactulose|mesh-list
6603812|NCT01178372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6603813|NCT01178450|Cinacalcet|cinacalcet|mesh-list
6603814|NCT01178450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6603815|NCT01178450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603816|NCT01178450|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6603817|NCT01178450|Hormone Antagonists|hormone antagonists|mesh-ancestor
6603818|NCT01178450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6603819|NCT01178645|Cytarabine|cytarabine|mesh-list
6603820|NCT01178645|Etoposide|etoposide|mesh-list
6603821|NCT01178645|Melphalan|melphalan|mesh-list
6603822|NCT01178645|Busulfan|busulfan|mesh-list
6603823|NCT01178645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6603824|NCT01178645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6603825|NCT01178645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6603826|NCT01178645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6603827|NCT01178645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6603828|NCT01178645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603829|NCT01178645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6603830|NCT01178645|Antimetabolites|antimetabolites|mesh-ancestor
6603831|NCT01178645|Antiviral Agents|antiviral agents|mesh-ancestor
6603832|NCT01178645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6603833|NCT01178645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6603834|NCT01178645|Immunologic Factors|immunologic factors|mesh-ancestor
6603835|NCT01178645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603836|NCT01178645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6603837|NCT01178645|Alkylating Agents|alkylating agents|mesh-ancestor
6603838|NCT01178645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6603839|NCT01178658|Cytarabine|cytarabine|mesh-list
6603840|NCT01178658|Etoposide|etoposide|mesh-list
6603841|NCT01178658|Melphalan|melphalan|mesh-list
6603842|NCT01178658|Busulfan|busulfan|mesh-list
6603843|NCT01178658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6603844|NCT01178658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6603845|NCT01178658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6603846|NCT01178658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6603847|NCT01178658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6603848|NCT01178658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603849|NCT01178658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6603850|NCT01178658|Antimetabolites|antimetabolites|mesh-ancestor
6603851|NCT01178658|Antiviral Agents|antiviral agents|mesh-ancestor
6603852|NCT01178658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6603853|NCT01178658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6603854|NCT01178658|Immunologic Factors|immunologic factors|mesh-ancestor
6603855|NCT01178658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603856|NCT01178658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6603857|NCT01178658|Alkylating Agents|alkylating agents|mesh-ancestor
6603858|NCT01178658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6603859|NCT01178697|Triamcinolone|triamcinolone|mesh-list
6603860|NCT01178697|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6603861|NCT01178697|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6603862|NCT01178697|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6603863|NCT01178697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6603864|NCT01178697|Glucocorticoids|glucocorticoids|mesh-ancestor
6603865|NCT01178697|Hormones|hormones|mesh-ancestor
6603866|NCT01178697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6603867|NCT01178697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603868|NCT01178697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6603869|NCT01178697|Immunologic Factors|immunologic factors|mesh-ancestor
6603870|NCT01178697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6603871|NCT01178697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603872|NCT01178710|Simvastatin|simvastatin|mesh-list
6603873|NCT01178710|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6603874|NCT01178710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6603875|NCT01178710|Antimetabolites|antimetabolites|mesh-ancestor
6603876|NCT01178710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603877|NCT01178710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6603878|NCT01178710|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6603879|NCT01178710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6603880|NCT01178788|Progesterone|progesterone|mesh-list
6603881|NCT01178788|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
6603882|NCT01178788|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
6603883|NCT01178788|Progestins|progestins|mesh-ancestor
6603884|NCT01178788|Hormones|hormones|mesh-ancestor
6603885|NCT01178788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6603886|NCT01178788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603887|NCT01178788|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6603888|NCT01178788|Hormone Antagonists|hormone antagonists|mesh-ancestor
6603889|NCT01178931|Dydrogesterone|dydrogesterone|mesh-list
6603890|NCT01178931|Progesterone|progesterone|mesh-list
6603891|NCT01178931|Progestins|progestins|mesh-ancestor
6603892|NCT01178931|Hormones|hormones|mesh-ancestor
6603893|NCT01178931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6603894|NCT01178931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603895|NCT01178996|Ribavirin|ribavirin|mesh-list
6603896|NCT01178996|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6603897|NCT01178996|Thymalfasin|thymalfasin|mesh-list
6603898|NCT01178996|Antimetabolites|antimetabolites|mesh-ancestor
6603899|NCT01178996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603900|NCT01178996|Antiviral Agents|antiviral agents|mesh-ancestor
6603901|NCT01178996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6603902|NCT01178996|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6603903|NCT01178996|Immunologic Factors|immunologic factors|mesh-ancestor
6603904|NCT01178996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603905|NCT01179009|Clonidine|clonidine|mesh-list
6603906|NCT01179009|Scopolamine|scopolamine|mesh-list
6603907|NCT01179009|Ketamine|ketamine|mesh-list
6603908|NCT01179009|Lorazepam|lorazepam|mesh-list
6603909|NCT01179009|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
6603910|NCT01179009|Analgesics|analgesics|mesh-ancestor
6603911|NCT01179009|Sensory System Agents|sensory system agents|mesh-ancestor
6603912|NCT01179009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6603913|NCT01179009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603914|NCT01179009|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6603915|NCT01179009|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6603916|NCT01179009|Anesthetics, General|anesthetics, general|mesh-ancestor
6603917|NCT01179009|Anesthetics|anesthetics|mesh-ancestor
6603918|NCT01179009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6603919|NCT01179009|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6603920|NCT01179009|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6603921|NCT01179009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6603922|NCT01179009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603923|NCT01179009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6603924|NCT01179009|Sympatholytics|sympatholytics|mesh-ancestor
6603925|NCT01179009|Autonomic Agents|autonomic agents|mesh-ancestor
6603926|NCT01179009|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6603927|NCT01179009|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6603928|NCT01179009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6603929|NCT01179009|Adrenergic Agents|adrenergic agents|mesh-ancestor
6603930|NCT01179009|Anticonvulsants|anticonvulsants|mesh-ancestor
6603931|NCT01179009|Antiemetics|antiemetics|mesh-ancestor
6603932|NCT01179009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6660334|NCT01492894|Immunologic Factors|immunologic factors|mesh-ancestor
6603933|NCT01179009|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6603934|NCT01179009|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6603935|NCT01179009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6603936|NCT01179009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6603937|NCT01179009|GABA Modulators|gaba modulators|mesh-ancestor
6603938|NCT01179009|GABA Agents|gaba agents|mesh-ancestor
6603939|NCT01179009|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6603940|NCT01179009|Mydriatics|mydriatics|mesh-ancestor
6603941|NCT01179009|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6603942|NCT01179009|Cholinergic Agents|cholinergic agents|mesh-ancestor
6603943|NCT01179009|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6603944|NCT01179009|Parasympatholytics|parasympatholytics|mesh-ancestor
6603945|NCT01179100|Lidocaine|lidocaine|mesh-list
6603946|NCT01179100|Anesthetics, Local|anesthetics, local|mesh-ancestor
6603947|NCT01179100|Anesthetics|anesthetics|mesh-ancestor
6603948|NCT01179100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6603949|NCT01179100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603950|NCT01179100|Sensory System Agents|sensory system agents|mesh-ancestor
6603951|NCT01179100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6603952|NCT01179100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6603953|NCT01179100|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6603954|NCT01179100|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6603955|NCT01179100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6603956|NCT01179100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603957|NCT01179152|Budesonide|budesonide|mesh-list
6603958|NCT01179152|Formoterol Fumarate|formoterol fumarate|mesh-list
6603959|NCT01179152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6603960|NCT01179152|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6603961|NCT01179152|Autonomic Agents|autonomic agents|mesh-ancestor
6603962|NCT01179152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6603963|NCT01179152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603964|NCT01179152|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6603965|NCT01179152|Respiratory System Agents|respiratory system agents|mesh-ancestor
6603966|NCT01179152|Glucocorticoids|glucocorticoids|mesh-ancestor
6603967|NCT01179152|Hormones|hormones|mesh-ancestor
6603968|NCT01179152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6603969|NCT01179152|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6603970|NCT01179152|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6603971|NCT01179152|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6603972|NCT01179152|Adrenergic Agents|adrenergic agents|mesh-ancestor
6603973|NCT01179152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6603974|NCT01179152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603975|NCT01179230|Dipyridamole|dipyridamole|mesh-list
6603976|NCT01179230|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6603977|NCT01179230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6603978|NCT01179230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603979|NCT01179230|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6603980|NCT01179230|Vasodilator Agents|vasodilator agents|mesh-ancestor
6603981|NCT01179256|Curcumin|curcumin|mesh-list
6449304|NCT00404196|Calcipotriene|calcipotriene|mesh-list
6449305|NCT00404196|Dermatologic Agents|dermatologic agents|mesh-ancestor
6603982|NCT01179256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6603983|NCT01179256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6603984|NCT01179256|Analgesics|analgesics|mesh-ancestor
6603985|NCT01179256|Sensory System Agents|sensory system agents|mesh-ancestor
6603986|NCT01179256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6603987|NCT01179256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6603988|NCT01179256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6603989|NCT01179256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6603990|NCT01179256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6603991|NCT01179256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6603992|NCT01179256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6603993|NCT01179269|Paclitaxel|paclitaxel|mesh-list
6603994|NCT01179269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6603995|NCT01179269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6603996|NCT01179269|Tubulin Modulators|tubulin modulators|mesh-ancestor
6603997|NCT01179269|Antimitotic Agents|antimitotic agents|mesh-ancestor
6603998|NCT01179269|Mitosis Modulators|mitosis modulators|mesh-ancestor
6603999|NCT01179269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604000|NCT01179308|Anesthetics|anesthetics|mesh-list
6604001|NCT01179308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6604002|NCT01179308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660335|NCT01492894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660336|NCT01492894|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6660337|NCT01492894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6660338|NCT01492894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660339|NCT01492894|Antifungal Agents|antifungal agents|mesh-ancestor
6660340|NCT01492894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6660341|NCT01492894|Dermatologic Agents|dermatologic agents|mesh-ancestor
6660342|NCT01492894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6660343|NCT01492894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6449306|NCT00404222|Acetaminophen|acetaminophen|mesh-list
6660344|NCT01492894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6660345|NCT01492894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6660346|NCT01492920|Acetylcarnitine|acetylcarnitine|mesh-list
6660347|NCT01492920|Vitamin B Complex|vitamin b complex|mesh-ancestor
6660348|NCT01492920|Vitamins|vitamins|mesh-ancestor
6449307|NCT00404222|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
6449308|NCT00404222|Hydrocodone|hydrocodone|mesh-list
6449309|NCT00404222|Oxycodone|oxycodone|mesh-list
6449310|NCT00404222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6449311|NCT00404222|Analgesics|analgesics|mesh-ancestor
6449312|NCT00404222|Sensory System Agents|sensory system agents|mesh-ancestor
6449313|NCT00404222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6449314|NCT00404222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604003|NCT01179412|Iodine|iodine|mesh-list
6604004|NCT01179412|Cadexomer iodine|cadexomer iodine|mesh-list
6604005|NCT01179412|Povidone-Iodine|povidone-iodine|mesh-list
6604006|NCT01179412|Povidone|povidone|mesh-list
6604007|NCT01179412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6604008|NCT01179412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6604009|NCT01179412|Trace Elements|trace elements|mesh-ancestor
6604010|NCT01179412|Micronutrients|micronutrients|mesh-ancestor
6604011|NCT01179412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604012|NCT01179412|Plasma Substitutes|plasma substitutes|mesh-ancestor
6604013|NCT01179412|Blood Substitutes|blood substitutes|mesh-ancestor
6604014|NCT01179438|Dexmedetomidine|dexmedetomidine|mesh-list
6604015|NCT01179438|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6604016|NCT01179438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6604017|NCT01179438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604018|NCT01179438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6604019|NCT01179438|Analgesics|analgesics|mesh-ancestor
6604020|NCT01179438|Sensory System Agents|sensory system agents|mesh-ancestor
6604021|NCT01179438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6604022|NCT01179438|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6604023|NCT01179438|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6604024|NCT01179438|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6604025|NCT01179438|Adrenergic Agents|adrenergic agents|mesh-ancestor
6604026|NCT01179438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6604027|NCT01179438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604028|NCT01179464|Simvastatin|simvastatin|mesh-list
6604029|NCT01179464|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6604030|NCT01179464|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6604031|NCT01179464|Antimetabolites|antimetabolites|mesh-ancestor
6604032|NCT01179464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604033|NCT01179464|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6604034|NCT01179464|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6604035|NCT01179464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6604036|NCT01179503|Calcium, Dietary|calcium, dietary|mesh-list
6604037|NCT01179503|Vitamin D|vitamin d|mesh-list
6604038|NCT01179503|Calcium|calcium|mesh-list
6604039|NCT01179503|Vitamins|vitamins|mesh-ancestor
6604040|NCT01179503|Micronutrients|micronutrients|mesh-ancestor
6604041|NCT01179503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604042|NCT01179503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6604043|NCT01179503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6604044|NCT01179529|Omalizumab|omalizumab|mesh-list
6604045|NCT01179529|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5501838|NCT04470076|Gemcitabine|gemcitabine|mesh-list
6604046|NCT01179529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6604047|NCT01179529|Respiratory System Agents|respiratory system agents|mesh-ancestor
6604048|NCT01179594|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6604049|NCT01179594|Interferon-alpha|interferon-alpha|mesh-list
6604050|NCT01179594|Entecavir|entecavir|mesh-list
6604051|NCT01179594|Antiviral Agents|antiviral agents|mesh-ancestor
6604052|NCT01179594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6604053|NCT01179594|Immunologic Factors|immunologic factors|mesh-ancestor
6604054|NCT01179594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604055|NCT01179620|Certoparin|certoparin|mesh-list
6604056|NCT01179620|Anticoagulants|anticoagulants|mesh-ancestor
6604057|NCT01179646|Pantoprazole|pantoprazole|mesh-list
6604058|NCT01179646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6604059|NCT01179646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6604060|NCT01179646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6604061|NCT01179646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6604062|NCT01179646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604063|NCT01179659|Pantoprazole|pantoprazole|mesh-list
6604064|NCT01179659|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6604065|NCT01179659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6604066|NCT01179659|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6604067|NCT01179659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6604068|NCT01179659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604069|NCT01179724|Pantoprazole|pantoprazole|mesh-list
6604070|NCT01179724|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
6604071|NCT01179724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6604072|NCT01179724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6604073|NCT01179724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6604074|NCT01179724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604075|NCT01179776|Iloprost|iloprost|mesh-list
6604076|NCT01179776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6604077|NCT01179776|Vasodilator Agents|vasodilator agents|mesh-ancestor
6604078|NCT01179828|Oxycodone|oxycodone|mesh-list
6604079|NCT01179828|Clobazam|clobazam|mesh-list
6604080|NCT01179828|Imipramine|imipramine|mesh-list
6604081|NCT01179828|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6604082|NCT01179828|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6604083|NCT01179828|Narcotics|narcotics|mesh-ancestor
6604084|NCT01179828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6604085|NCT01179828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604086|NCT01179828|Analgesics|analgesics|mesh-ancestor
6604087|NCT01179828|Sensory System Agents|sensory system agents|mesh-ancestor
6604088|NCT01179828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6604089|NCT01179828|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6604090|NCT01179828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6604091|NCT01179828|Cholinergic Agents|cholinergic agents|mesh-ancestor
6604092|NCT01179828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6604093|NCT01179828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604094|NCT01179828|Urological Agents|urological agents|mesh-ancestor
6604095|NCT01179828|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6604096|NCT01179828|Antidepressive Agents|antidepressive agents|mesh-ancestor
6604097|NCT01179828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6604098|NCT01179828|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6604099|NCT01179828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6604100|NCT01179828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6604101|NCT01179828|Adrenergic Agents|adrenergic agents|mesh-ancestor
6604102|NCT01179828|Anticonvulsants|anticonvulsants|mesh-ancestor
6604103|NCT01179828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6604104|NCT01179828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6604105|NCT01179828|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6604106|NCT01179828|GABA Agonists|gaba agonists|mesh-ancestor
6604107|NCT01179828|GABA Agents|gaba agents|mesh-ancestor
6604108|NCT01179971|Evening primrose oil|evening primrose oil|mesh-list
6604109|NCT01179971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6604110|NCT01179971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6604111|NCT01179971|Analgesics|analgesics|mesh-ancestor
6604112|NCT01179971|Sensory System Agents|sensory system agents|mesh-ancestor
6604113|NCT01179971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6604114|NCT01179971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604115|NCT01179971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6604116|NCT01179971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6604117|NCT01179971|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6604118|NCT01179971|Antimetabolites|antimetabolites|mesh-ancestor
6604119|NCT01179971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604120|NCT01179971|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6604121|NCT01179971|Dermatologic Agents|dermatologic agents|mesh-ancestor
6604122|NCT01180062|Latanoprost|latanoprost|mesh-list
6604123|NCT01180062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6604124|NCT01180062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6604125|NCT01180075|Ritonavir|ritonavir|mesh-list
6604126|NCT01180075|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6604127|NCT01180075|Tenofovir|tenofovir|mesh-list
6604128|NCT01180075|Emtricitabine|emtricitabine|mesh-list
6604129|NCT01180075|Efavirenz|efavirenz|mesh-list
6604130|NCT01180075|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6604131|NCT01180075|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6604132|NCT01180075|Protease Inhibitors|protease inhibitors|mesh-ancestor
6604133|NCT01180075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6604134|NCT01180075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604135|NCT01180075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6604136|NCT01180075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6604137|NCT01180075|Antiviral Agents|antiviral agents|mesh-ancestor
6604138|NCT01180075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6604139|NCT01180075|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6604140|NCT01180075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6604141|NCT01180075|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6604142|NCT01180075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6604143|NCT01180075|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6604144|NCT01180075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6604145|NCT01180075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6604146|NCT01180075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6604147|NCT01180075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6604148|NCT01180153|Oxaliplatin|oxaliplatin|mesh-list
6604149|NCT01180153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6604150|NCT01180166|Nimotuzumab|nimotuzumab|mesh-list
6604151|NCT01180166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6604152|NCT01180166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6604153|NCT01180179|Lansoprazole|lansoprazole|mesh-list
6604154|NCT01180179|Dexlansoprazole|dexlansoprazole|mesh-list
6604155|NCT01180179|Famotidine|famotidine|mesh-list
6449315|NCT00404222|Antipyretics|antipyretics|mesh-ancestor
6449316|NCT00404222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6449317|NCT00404222|Narcotics|narcotics|mesh-ancestor
6449318|NCT00404222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6449319|NCT00404222|Antitussive Agents|antitussive agents|mesh-ancestor
6449320|NCT00404222|Respiratory System Agents|respiratory system agents|mesh-ancestor
6449321|NCT00404222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6449322|NCT00404222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6604156|NCT01180179|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6604157|NCT01180179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6604158|NCT01180179|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6604159|NCT01180179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6604160|NCT01180179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604161|NCT01180179|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6604162|NCT01180179|Histamine Antagonists|histamine antagonists|mesh-ancestor
6604163|NCT01180179|Histamine Agents|histamine agents|mesh-ancestor
6604164|NCT01180179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6604165|NCT01180179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604166|NCT01180205|Amlodipine|amlodipine|mesh-list
6604167|NCT01180205|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6604168|NCT01180205|Telmisartan|telmisartan|mesh-list
6604169|NCT01180205|Olmesartan|olmesartan|mesh-list
6604170|NCT01180205|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6604171|NCT01180205|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6604172|NCT01180205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6604173|NCT01180205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6604174|NCT01180205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604175|NCT01180205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6604176|NCT01180205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604177|NCT01180205|Vasodilator Agents|vasodilator agents|mesh-ancestor
6604178|NCT01180205|Diuretics|diuretics|mesh-ancestor
6604179|NCT01180205|Natriuretic Agents|natriuretic agents|mesh-ancestor
6604180|NCT01180205|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6604181|NCT01180205|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6604182|NCT01180205|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6604183|NCT01180231|Moxonidine|moxonidine|mesh-list
6604184|NCT01180231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6604185|NCT01180322|Cytarabine|cytarabine|mesh-list
6604186|NCT01180322|Etoposide|etoposide|mesh-list
6604187|NCT01180322|Idarubicin|idarubicin|mesh-list
6604188|NCT01180322|Azacitidine|azacitidine|mesh-list
6604189|NCT01180322|Lenograstim|lenograstim|mesh-list
6604190|NCT01180322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6604191|NCT01180322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6604192|NCT01180322|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6604193|NCT01180322|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6604194|NCT01180322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6604195|NCT01180322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604196|NCT01180322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6604197|NCT01180322|Antimetabolites|antimetabolites|mesh-ancestor
6604198|NCT01180322|Antiviral Agents|antiviral agents|mesh-ancestor
6604199|NCT01180322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6604200|NCT01180322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5501839|NCT04470076|Carboplatin|carboplatin|mesh-list
5501840|NCT04470076|Pemetrexed|pemetrexed|mesh-list
5501841|NCT04470076|Afatinib|afatinib|mesh-list
5501842|NCT04470076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5501843|NCT04470076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5501844|NCT04470076|Antimetabolites|antimetabolites|mesh-ancestor
5501845|NCT04470076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501846|NCT04470076|Antiviral Agents|antiviral agents|mesh-ancestor
5501847|NCT04470076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5501848|NCT04470076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5501849|NCT04470076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5501850|NCT04470076|Immunologic Factors|immunologic factors|mesh-ancestor
5501851|NCT04470076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501852|NCT04470076|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5501853|NCT04470076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6020568|NCT00393367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6604201|NCT01180322|Immunologic Factors|immunologic factors|mesh-ancestor
6020569|NCT00393367|Glucocorticoids|glucocorticoids|mesh-ancestor
6604202|NCT01180322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604203|NCT01180322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6604204|NCT01180322|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6604205|NCT01180348|Botulinum Toxins|botulinum toxins|mesh-list
6604206|NCT01180348|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6604207|NCT01180348|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6604208|NCT01180348|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6604209|NCT01180348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6604210|NCT01180348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604211|NCT01180348|Cholinergic Agents|cholinergic agents|mesh-ancestor
6604212|NCT01180348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6604213|NCT01180348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604214|NCT01180348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6604215|NCT01180348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6020570|NCT00393367|Hormones|hormones|mesh-ancestor
6604216|NCT01180413|Losartan|losartan|mesh-list
6604217|NCT01180413|Amlodipine|amlodipine|mesh-list
6604218|NCT01180413|Ramipril|ramipril|mesh-list
6604219|NCT01180413|Lercanidipine|lercanidipine|mesh-list
6604220|NCT01180413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6604221|NCT01180413|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6604222|NCT01180413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6604223|NCT01180413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604224|NCT01180413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6604225|NCT01180413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604226|NCT01180413|Vasodilator Agents|vasodilator agents|mesh-ancestor
6604227|NCT01180413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6604228|NCT01180413|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6604229|NCT01180413|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6604230|NCT01180413|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6604231|NCT01180413|Protease Inhibitors|protease inhibitors|mesh-ancestor
6604232|NCT01180413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6604233|NCT01180426|Tosedostat|tosedostat|mesh-list
6604234|NCT01180426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6604235|NCT01180426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604236|NCT01180569|Lenalidomide|lenalidomide|mesh-list
6604237|NCT01180569|Immunologic Factors|immunologic factors|mesh-ancestor
6604238|NCT01180569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604239|NCT01180569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6604240|NCT01180569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6604241|NCT01180569|Growth Substances|growth substances|mesh-ancestor
6604242|NCT01180569|Growth Inhibitors|growth inhibitors|mesh-ancestor
6604243|NCT01180569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6604244|NCT01180621|Vaccines|vaccines|mesh-list
6604245|NCT01180621|Immunologic Factors|immunologic factors|mesh-ancestor
6604246|NCT01180621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604247|NCT01180725|Psyllium|psyllium|mesh-list
6604248|NCT01180725|Cathartics|cathartics|mesh-ancestor
6604249|NCT01180725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6604250|NCT01180751|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6604251|NCT01180751|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6604252|NCT01180751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604253|NCT01180816|Temozolomide|temozolomide|mesh-list
6604254|NCT01180816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6604255|NCT01180816|Alkylating Agents|alkylating agents|mesh-ancestor
6604256|NCT01180816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604257|NCT01180816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6604258|NCT01180933|Folic Acid|folic acid|mesh-list
6604259|NCT01180933|Vitamin B Complex|vitamin b complex|mesh-list
6604260|NCT01180933|Hematinics|hematinics|mesh-ancestor
6604261|NCT01180933|Vitamins|vitamins|mesh-ancestor
6604262|NCT01180933|Micronutrients|micronutrients|mesh-ancestor
6604263|NCT01180933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604264|NCT01180946|Vitamin D|vitamin d|mesh-list
6604265|NCT01180946|Ergocalciferols|ergocalciferols|mesh-list
6604266|NCT01180946|Vitamins|vitamins|mesh-ancestor
6604267|NCT01180946|Micronutrients|micronutrients|mesh-ancestor
6604268|NCT01180946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604269|NCT01180946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6604270|NCT01180946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6604271|NCT01180959|Bevacizumab|bevacizumab|mesh-list
6604272|NCT01180959|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6604273|NCT01180959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6604274|NCT01180959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6604275|NCT01180959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6604276|NCT01180959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6604277|NCT01180959|Growth Substances|growth substances|mesh-ancestor
6604278|NCT01180959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604279|NCT01180959|Growth Inhibitors|growth inhibitors|mesh-ancestor
6604280|NCT01180959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6604281|NCT01180959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6604282|NCT01180959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660349|NCT01492920|Micronutrients|micronutrients|mesh-ancestor
6660350|NCT01492920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660351|NCT01492920|Nootropic Agents|nootropic agents|mesh-ancestor
6660352|NCT01492959|Insulin|insulin|mesh-list
6660353|NCT01492959|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6660354|NCT01492959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6660355|NCT01492959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660356|NCT01492972|Leuprolide|leuprolide|mesh-list
6660357|NCT01492972|Goserelin|goserelin|mesh-list
6660358|NCT01492972|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6660359|NCT01492972|Buserelin|buserelin|mesh-list
6660360|NCT01492972|Androgens|androgens|mesh-list
6660361|NCT01492972|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6660362|NCT01492972|Fertility Agents|fertility agents|mesh-ancestor
6660363|NCT01492972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6660364|NCT01492972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660365|NCT01492972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6660366|NCT01492972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6660367|NCT01492972|Hormones|hormones|mesh-ancestor
6660368|NCT01492972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6660369|NCT01492972|Luteolytic Agents|luteolytic agents|mesh-ancestor
6660370|NCT01492972|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6660371|NCT01492972|Contraceptive Agents|contraceptive agents|mesh-ancestor
6660372|NCT01492972|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6660373|NCT01492985|Vaccines|vaccines|mesh-list
6660374|NCT01492985|Immunologic Factors|immunologic factors|mesh-ancestor
6660375|NCT01492985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660376|NCT01493050|Calcium Carbonate|calcium carbonate|mesh-list
6660377|NCT01493050|Calcium|calcium|mesh-list
6660378|NCT01493050|Sevelamer|sevelamer|mesh-list
6660379|NCT01493050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6660380|NCT01493050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660381|NCT01493050|Antacids|antacids|mesh-ancestor
6660382|NCT01493050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660383|NCT01493050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6660384|NCT01493050|Chelating Agents|chelating agents|mesh-ancestor
6660385|NCT01493050|Sequestering Agents|sequestering agents|mesh-ancestor
6660386|NCT01493102|Vasopressins|vasopressins|mesh-list
6660387|NCT01493102|Arginine Vasopressin|arginine vasopressin|mesh-list
6660388|NCT01493102|Norepinephrine|norepinephrine|mesh-list
6660389|NCT01493102|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6660390|NCT01493102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6660391|NCT01493102|Adrenergic Agents|adrenergic agents|mesh-ancestor
6660392|NCT01493102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6660393|NCT01493102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660394|NCT01493102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604283|NCT01181063|Budesonide|budesonide|mesh-list
6604284|NCT01181063|Formoterol Fumarate|formoterol fumarate|mesh-list
6604285|NCT01181063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6604286|NCT01181063|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6604287|NCT01181063|Autonomic Agents|autonomic agents|mesh-ancestor
6604288|NCT01181063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6604289|NCT01181063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604290|NCT01181063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6604291|NCT01181063|Respiratory System Agents|respiratory system agents|mesh-ancestor
6604292|NCT01181063|Glucocorticoids|glucocorticoids|mesh-ancestor
6604293|NCT01181063|Hormones|hormones|mesh-ancestor
6604294|NCT01181063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6604295|NCT01181063|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6604296|NCT01181063|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6604297|NCT01181063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6604298|NCT01181063|Adrenergic Agents|adrenergic agents|mesh-ancestor
6604299|NCT01181063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6604300|NCT01181063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604301|NCT01181115|Interferon beta-1a|interferon beta-1a|mesh-list
6604302|NCT01181115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6604303|NCT01181115|Immunologic Factors|immunologic factors|mesh-ancestor
6604304|NCT01181115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604305|NCT01181115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6604306|NCT01181115|Antiviral Agents|antiviral agents|mesh-ancestor
6604307|NCT01181115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6604308|NCT01181154|Rituximab|rituximab|mesh-list
6604309|NCT01181154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6604310|NCT01181154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6604311|NCT01181154|Immunologic Factors|immunologic factors|mesh-ancestor
6604312|NCT01181154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604313|NCT01181154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6604314|NCT01181193|Vitamin D|vitamin d|mesh-list
6604315|NCT01181193|Cholecalciferol|cholecalciferol|mesh-list
6604316|NCT01181193|Temozolomide|temozolomide|mesh-list
6604317|NCT01181193|Vitamins|vitamins|mesh-ancestor
6604318|NCT01181193|Micronutrients|micronutrients|mesh-ancestor
6604319|NCT01181193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604320|NCT01181193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6604321|NCT01181193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6604322|NCT01181193|Alkylating Agents|alkylating agents|mesh-ancestor
6604323|NCT01181193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604324|NCT01181193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6604325|NCT01181193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6604326|NCT01181232|Zolpidem|zolpidem|mesh-list
6604327|NCT01181232|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6604328|NCT01181232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6604329|NCT01181232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6604330|NCT01181232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604331|NCT01181232|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6604332|NCT01181232|GABA Agonists|gaba agonists|mesh-ancestor
6604333|NCT01181232|GABA Agents|gaba agents|mesh-ancestor
6604334|NCT01181232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6604335|NCT01181232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604336|NCT01181310|Scopolamine|scopolamine|mesh-list
6604337|NCT01181310|Donepezil|donepezil|mesh-list
6604338|NCT01181310|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
6604339|NCT01181310|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6604340|NCT01181310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6604341|NCT01181310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604342|NCT01181310|Cholinergic Agents|cholinergic agents|mesh-ancestor
6604343|NCT01181310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6604344|NCT01181310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604345|NCT01181310|Nootropic Agents|nootropic agents|mesh-ancestor
6604346|NCT01181310|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6604347|NCT01181310|Antiemetics|antiemetics|mesh-ancestor
6604348|NCT01181310|Autonomic Agents|autonomic agents|mesh-ancestor
6604349|NCT01181310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6604350|NCT01181310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6604351|NCT01181310|Mydriatics|mydriatics|mesh-ancestor
6604352|NCT01181310|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6604353|NCT01181310|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6604354|NCT01181310|Parasympatholytics|parasympatholytics|mesh-ancestor
6604355|NCT01181388|Tirofiban|tirofiban|mesh-list
6604356|NCT01181388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6604357|NCT01181388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6604358|NCT01181388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604359|NCT01181388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6604360|NCT01181401|Cisplatin|cisplatin|mesh-list
6604361|NCT01181401|Docetaxel|docetaxel|mesh-list
6604362|NCT01181401|Cetuximab|cetuximab|mesh-list
6604363|NCT01181401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6604364|NCT01181401|Tubulin Modulators|tubulin modulators|mesh-ancestor
6604365|NCT01181401|Antimitotic Agents|antimitotic agents|mesh-ancestor
6604366|NCT01181401|Mitosis Modulators|mitosis modulators|mesh-ancestor
6604367|NCT01181401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604368|NCT01181401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6604369|NCT01181414|Amiodarone|amiodarone|mesh-list
6604370|NCT01181414|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
6604371|NCT01181414|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6604372|NCT01181414|Vasodilator Agents|vasodilator agents|mesh-ancestor
6604373|NCT01181414|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6604374|NCT01181414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6604375|NCT01181414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604376|NCT01181414|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6604377|NCT01181414|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6604378|NCT01181414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6604379|NCT01181414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6604380|NCT01181414|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6604381|NCT01181414|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6604382|NCT01181414|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6604383|NCT01181414|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6604384|NCT01181414|Adrenergic Agents|adrenergic agents|mesh-ancestor
6604385|NCT01181414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6604386|NCT01181414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604387|NCT01181427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-list
6604388|NCT01181427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6604389|NCT01181427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604390|NCT01181505|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6604391|NCT01181505|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6604392|NCT01181505|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6604393|NCT01181505|Cholinergic Agents|cholinergic agents|mesh-ancestor
6604394|NCT01181505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6604395|NCT01181505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604396|NCT01181505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604397|NCT01181505|Urological Agents|urological agents|mesh-ancestor
6604398|NCT01181544|Heparin|heparin|mesh-list
6604399|NCT01181544|Anticoagulants|anticoagulants|mesh-ancestor
6604400|NCT01181544|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6604401|NCT01181544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6604402|NCT01181544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604403|NCT01181570|Adalimumab|adalimumab|mesh-list
6604404|NCT01181570|Mannitol|mannitol|mesh-list
6604405|NCT01181570|Citric Acid|citric acid|mesh-list
6604406|NCT01181570|Sodium Citrate|sodium citrate|mesh-list
6604407|NCT01181570|Anticoagulants|anticoagulants|mesh-ancestor
6604408|NCT01181570|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6604409|NCT01181570|Chelating Agents|chelating agents|mesh-ancestor
6604410|NCT01181570|Sequestering Agents|sequestering agents|mesh-ancestor
6604411|NCT01181570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604412|NCT01181570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6604413|NCT01181570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6604414|NCT01181570|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6604415|NCT01181570|Diuretics|diuretics|mesh-ancestor
6604416|NCT01181570|Natriuretic Agents|natriuretic agents|mesh-ancestor
6604417|NCT01181570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604418|NCT01181765|Infliximab|infliximab|mesh-list
6604419|NCT01181765|Dermatologic Agents|dermatologic agents|mesh-ancestor
6604420|NCT01181765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6604421|NCT01181765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6604422|NCT01181882|Aspirin|aspirin|mesh-list
6604423|NCT01181882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6604424|NCT01181882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6604425|NCT01181882|Analgesics|analgesics|mesh-ancestor
6604426|NCT01181882|Sensory System Agents|sensory system agents|mesh-ancestor
6604427|NCT01181882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6604428|NCT01181882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604429|NCT01181882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6604430|NCT01181882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6604431|NCT01181882|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6604432|NCT01181882|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6604433|NCT01181882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604434|NCT01181882|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6604435|NCT01181882|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6604436|NCT01181882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6604437|NCT01181882|Antipyretics|antipyretics|mesh-ancestor
6604438|NCT01181934|Nicotine|nicotine|mesh-list
6604439|NCT01181934|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6604440|NCT01181934|Autonomic Agents|autonomic agents|mesh-ancestor
6604441|NCT01181934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6604442|NCT01181934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604443|NCT01181934|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6604444|NCT01181934|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6604445|NCT01181934|Cholinergic Agents|cholinergic agents|mesh-ancestor
6604446|NCT01181934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6604447|NCT01181934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604448|NCT01181960|Risperidone|risperidone|mesh-list
6604449|NCT01181960|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6604450|NCT01181960|Antipsychotic Agents|antipsychotic agents|mesh-list
6604451|NCT01181960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6604452|NCT01181960|Serotonin Agents|serotonin agents|mesh-ancestor
6604453|NCT01181960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6604454|NCT01181960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604455|NCT01181960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604456|NCT01181960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6604457|NCT01181960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6604458|NCT01181960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6604459|NCT01181960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6604460|NCT01181960|Dopamine Agents|dopamine agents|mesh-ancestor
6604461|NCT01181960|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6604462|NCT01181960|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6604463|NCT01181999|Rituximab|rituximab|mesh-list
6604464|NCT01181999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6604465|NCT01181999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6604466|NCT01181999|Immunologic Factors|immunologic factors|mesh-ancestor
6604467|NCT01181999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604468|NCT01181999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6604469|NCT01182077|Midazolam|midazolam|mesh-list
6604470|NCT01182077|Peficitinib|peficitinib|mesh-list
6604471|NCT01182077|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6604472|NCT01182077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6604473|NCT01182077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6604474|NCT01182077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604475|NCT01182077|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6604476|NCT01182077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6604477|NCT01182077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6604478|NCT01182077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6604479|NCT01182077|Anesthetics, General|anesthetics, general|mesh-ancestor
6604480|NCT01182077|Anesthetics|anesthetics|mesh-ancestor
6604481|NCT01182077|GABA Modulators|gaba modulators|mesh-ancestor
6604482|NCT01182077|GABA Agents|gaba agents|mesh-ancestor
6604483|NCT01182077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6604484|NCT01182077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604485|NCT01182077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6604486|NCT01182077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6604487|NCT01182077|Immunologic Factors|immunologic factors|mesh-ancestor
6604488|NCT01182129|Nicotine|nicotine|mesh-list
6604489|NCT01182129|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6604490|NCT01182129|Autonomic Agents|autonomic agents|mesh-ancestor
6604491|NCT01182129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6604492|NCT01182129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604493|NCT01182129|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6604494|NCT01182129|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6604495|NCT01182129|Cholinergic Agents|cholinergic agents|mesh-ancestor
6604496|NCT01182129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6604497|NCT01182129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604498|NCT01182142|Capecitabine|capecitabine|mesh-list
6604499|NCT01182142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6604500|NCT01182142|Antimetabolites|antimetabolites|mesh-ancestor
6604501|NCT01182142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604502|NCT01182142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6604503|NCT01182168|Gemcitabine|gemcitabine|mesh-list
6604504|NCT01182168|Everolimus|everolimus|mesh-list
6604505|NCT01182168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6604506|NCT01182168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6604507|NCT01182168|Antimetabolites|antimetabolites|mesh-ancestor
6604508|NCT01182168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604509|NCT01182168|Antiviral Agents|antiviral agents|mesh-ancestor
6604510|NCT01182168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6604511|NCT01182168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6604512|NCT01182168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6604513|NCT01182168|Immunologic Factors|immunologic factors|mesh-ancestor
6604514|NCT01182168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604515|NCT01182246|Genistein|genistein|mesh-list
6604516|NCT01182246|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6604517|NCT01182246|Protective Agents|protective agents|mesh-ancestor
6604518|NCT01182246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604519|NCT01182246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6604520|NCT01182246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6604521|NCT01182246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6604522|NCT01182246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604523|NCT01182246|Phytoestrogens|phytoestrogens|mesh-ancestor
6604524|NCT01182246|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6604525|NCT01182246|Estrogens|estrogens|mesh-ancestor
6604526|NCT01182246|Hormones|hormones|mesh-ancestor
6604527|NCT01182246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6604528|NCT01182272|Sorafenib|sorafenib|mesh-list
6604529|NCT01182272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6604530|NCT01182272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6604531|NCT01182272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6604532|NCT01182272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604533|NCT01182597|Pantoprazole|pantoprazole|mesh-list
6604534|NCT01182597|Lansoprazole|lansoprazole|mesh-list
6604535|NCT01182597|Dexlansoprazole|dexlansoprazole|mesh-list
6604536|NCT01182597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6604537|NCT01182597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6604538|NCT01182597|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6604539|NCT01182597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6604540|NCT01182597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604541|NCT01182636|Adapalene|adapalene|mesh-list
6604542|NCT01182636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6604543|NCT01182636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6604544|NCT01182636|Analgesics|analgesics|mesh-ancestor
6604545|NCT01182636|Sensory System Agents|sensory system agents|mesh-ancestor
6604546|NCT01182636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6604547|NCT01182636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604548|NCT01182636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6604549|NCT01182636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6604550|NCT01182636|Dermatologic Agents|dermatologic agents|mesh-ancestor
6604551|NCT01182662|Cyclosporine|cyclosporine|mesh-list
6604552|NCT01182662|Cyclosporins|cyclosporins|mesh-list
6604553|NCT01182662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6604554|NCT01182662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604555|NCT01182662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6604556|NCT01182662|Immunologic Factors|immunologic factors|mesh-ancestor
6604557|NCT01182662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604558|NCT01182662|Antifungal Agents|antifungal agents|mesh-ancestor
6604559|NCT01182662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6604560|NCT01182662|Dermatologic Agents|dermatologic agents|mesh-ancestor
6604561|NCT01182662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6604562|NCT01182662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6604563|NCT01182766|Topiramate|topiramate|mesh-list
6604564|NCT01182766|Anticonvulsants|anticonvulsants|mesh-ancestor
6604565|NCT01182766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6604566|NCT01182766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604567|NCT01182792|Ascorbic Acid|ascorbic acid|mesh-list
6604568|NCT01182792|Vitamins|vitamins|mesh-ancestor
6604569|NCT01182792|Micronutrients|micronutrients|mesh-ancestor
6604570|NCT01182792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604571|NCT01182792|Antioxidants|antioxidants|mesh-ancestor
6604572|NCT01182792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604573|NCT01182792|Protective Agents|protective agents|mesh-ancestor
6660395|NCT01493102|Sympathomimetics|sympathomimetics|mesh-ancestor
6449323|NCT00404222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6449324|NCT00404261|Fluticasone|fluticasone|mesh-list
6449325|NCT00404261|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6449326|NCT00404261|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6449327|NCT00404261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6449328|NCT00404261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6449329|NCT00404261|Autonomic Agents|autonomic agents|mesh-ancestor
6449330|NCT00404261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6660396|NCT01493102|Autonomic Agents|autonomic agents|mesh-ancestor
6660397|NCT01493102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6660398|NCT01493102|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6660399|NCT01493102|Hemostatics|hemostatics|mesh-ancestor
6660400|NCT01493102|Coagulants|coagulants|mesh-ancestor
6660401|NCT01493102|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6660402|NCT01493102|Natriuretic Agents|natriuretic agents|mesh-ancestor
6660403|NCT01493115|Insulin|insulin|mesh-list
6660404|NCT01493115|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6660405|NCT01493115|Insulin Glargine|insulin glargine|mesh-list
6660406|NCT01493115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6660407|NCT01493115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660408|NCT01493154|Cyclophosphamide|cyclophosphamide|mesh-list
6660409|NCT01493154|Vaccines|vaccines|mesh-list
6660410|NCT01493154|Immunologic Factors|immunologic factors|mesh-ancestor
6660411|NCT01493154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660412|NCT01493154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6660413|NCT01493154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6660414|NCT01493154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6660415|NCT01493154|Alkylating Agents|alkylating agents|mesh-ancestor
6660416|NCT01493154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660417|NCT01493154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6660418|NCT01493154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6660419|NCT01493310|Paclitaxel|paclitaxel|mesh-list
6660420|NCT01493310|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6660421|NCT01493310|Mifepristone|mifepristone|mesh-list
6660422|NCT01493310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6660423|NCT01493310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6660424|NCT01493310|Tubulin Modulators|tubulin modulators|mesh-ancestor
6660425|NCT01493310|Antimitotic Agents|antimitotic agents|mesh-ancestor
6660426|NCT01493310|Mitosis Modulators|mitosis modulators|mesh-ancestor
6660427|NCT01493310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660428|NCT01493310|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6660429|NCT01493310|Abortifacient Agents|abortifacient agents|mesh-ancestor
6660430|NCT01493310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6660431|NCT01493310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660432|NCT01493310|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6660433|NCT01493310|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6660434|NCT01493310|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6660435|NCT01493310|Contraceptive Agents|contraceptive agents|mesh-ancestor
6660436|NCT01493310|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6660437|NCT01493310|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6660438|NCT01493310|Hormone Antagonists|hormone antagonists|mesh-ancestor
6660439|NCT01493310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6660440|NCT01493310|Luteolytic Agents|luteolytic agents|mesh-ancestor
6660441|NCT01493310|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6660442|NCT01493310|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6660443|NCT01493336|Capecitabine|capecitabine|mesh-list
6660444|NCT01493336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6660445|NCT01493336|Antimetabolites|antimetabolites|mesh-ancestor
6660446|NCT01493336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660447|NCT01493336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6660448|NCT01493388|Insulin|insulin|mesh-list
6660449|NCT01493388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6660450|NCT01493388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660451|NCT01493440|Atosiban|atosiban|mesh-list
6660452|NCT01493440|Hormone Antagonists|hormone antagonists|mesh-ancestor
6664921|NCT01514825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6604574|NCT01182883|Sirolimus|sirolimus|mesh-list
6604575|NCT01182883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6604576|NCT01182883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6604577|NCT01182883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6604578|NCT01182883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6604579|NCT01182883|Antifungal Agents|antifungal agents|mesh-ancestor
6604580|NCT01182883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6604581|NCT01182883|Immunologic Factors|immunologic factors|mesh-ancestor
6604582|NCT01182883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604583|NCT01182974|Acetaminophen|acetaminophen|mesh-list
6604584|NCT01182974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6604585|NCT01182974|Analgesics|analgesics|mesh-ancestor
6604586|NCT01182974|Sensory System Agents|sensory system agents|mesh-ancestor
6604587|NCT01182974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6604588|NCT01182974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604589|NCT01182974|Antipyretics|antipyretics|mesh-ancestor
6604590|NCT01183247|Sirolimus|sirolimus|mesh-list
6604591|NCT01183247|Prednisone|prednisone|mesh-list
6604592|NCT01183247|Everolimus|everolimus|mesh-list
6604593|NCT01183247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6604594|NCT01183247|Glucocorticoids|glucocorticoids|mesh-ancestor
6604595|NCT01183247|Hormones|hormones|mesh-ancestor
6604596|NCT01183247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6604597|NCT01183247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604598|NCT01183247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6604599|NCT01183247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6604600|NCT01183247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6604601|NCT01183247|Immunologic Factors|immunologic factors|mesh-ancestor
6604602|NCT01183247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6604603|NCT01183247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6604604|NCT01183247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6604605|NCT01183247|Antifungal Agents|antifungal agents|mesh-ancestor
6604606|NCT01183364|Docetaxel|docetaxel|mesh-list
6604607|NCT01183364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6604608|NCT01183364|Tubulin Modulators|tubulin modulators|mesh-ancestor
6604609|NCT01183364|Antimitotic Agents|antimitotic agents|mesh-ancestor
6604610|NCT01183364|Mitosis Modulators|mitosis modulators|mesh-ancestor
6604611|NCT01183364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604612|NCT01183442|Vitamin D|vitamin d|mesh-list
6604613|NCT01183442|Ergocalciferols|ergocalciferols|mesh-list
6604614|NCT01183442|Vitamins|vitamins|mesh-list
6604615|NCT01183442|Micronutrients|micronutrients|mesh-ancestor
6604616|NCT01183442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604617|NCT01183442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6604618|NCT01183442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6604619|NCT01183455|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
6604620|NCT01183455|Protease Inhibitors|protease inhibitors|mesh-list
6604621|NCT01183455|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6604622|NCT01183455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6604623|NCT01183455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6604624|NCT01183455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604625|NCT01183494|Irinotecan|irinotecan|mesh-list
6604626|NCT01183494|Bevacizumab|bevacizumab|mesh-list
6604627|NCT01183494|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6604628|NCT01183494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6604629|NCT01183494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6604630|NCT01183494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604631|NCT01183494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6604632|NCT01183494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6604633|NCT01183494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6604634|NCT01183494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6604635|NCT01183494|Growth Substances|growth substances|mesh-ancestor
5724831|NCT03185130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6604636|NCT01183494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604637|NCT01183494|Growth Inhibitors|growth inhibitors|mesh-ancestor
6604638|NCT01183572|Iron|iron|mesh-list
6604639|NCT01183572|Folic Acid|folic acid|mesh-list
6604640|NCT01183572|Vitamin B Complex|vitamin b complex|mesh-list
6604641|NCT01183572|Trace Elements|trace elements|mesh-ancestor
6604642|NCT01183572|Micronutrients|micronutrients|mesh-ancestor
6604643|NCT01183572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604644|NCT01183572|Hematinics|hematinics|mesh-ancestor
6604645|NCT01183572|Vitamins|vitamins|mesh-ancestor
6604646|NCT01183585|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6604647|NCT01183585|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6604648|NCT01183585|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6604649|NCT01183585|Antimetabolites|antimetabolites|mesh-ancestor
6604650|NCT01183585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604651|NCT01183585|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6604652|NCT01183585|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6604653|NCT01183585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6604654|NCT01183611|Vaccines|vaccines|mesh-list
6604655|NCT01183611|Immunologic Factors|immunologic factors|mesh-ancestor
6604656|NCT01183611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604657|NCT01183624|Analgesics|analgesics|mesh-list
6604658|NCT01183624|Sensory System Agents|sensory system agents|mesh-ancestor
6604659|NCT01183624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6604660|NCT01183624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604661|NCT01183663|Leucovorin|leucovorin|mesh-list
6604662|NCT01183663|Sirolimus|sirolimus|mesh-list
6604663|NCT01183663|Bevacizumab|bevacizumab|mesh-list
6604664|NCT01183663|Lenalidomide|lenalidomide|mesh-list
6604665|NCT01183663|Fluorouracil|fluorouracil|mesh-list
6604666|NCT01183663|Oxaliplatin|oxaliplatin|mesh-list
6604667|NCT01183663|Sorafenib|sorafenib|mesh-list
6604668|NCT01183663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6604669|NCT01183663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6604670|NCT01183663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6604671|NCT01183663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6604672|NCT01183663|Growth Substances|growth substances|mesh-ancestor
6604673|NCT01183663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604674|NCT01183663|Growth Inhibitors|growth inhibitors|mesh-ancestor
6604675|NCT01183663|Antimetabolites|antimetabolites|mesh-ancestor
6604676|NCT01183663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604677|NCT01183663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6604678|NCT01183663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6604679|NCT01183663|Immunologic Factors|immunologic factors|mesh-ancestor
6604680|NCT01183663|Antidotes|antidotes|mesh-ancestor
6604681|NCT01183663|Protective Agents|protective agents|mesh-ancestor
6604682|NCT01183663|Vitamin B Complex|vitamin b complex|mesh-ancestor
6604683|NCT01183663|Vitamins|vitamins|mesh-ancestor
6604684|NCT01183663|Micronutrients|micronutrients|mesh-ancestor
6604685|NCT01183663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6604686|NCT01183663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6604687|NCT01183663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6604688|NCT01183663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6604689|NCT01183663|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6604690|NCT01183663|Antifungal Agents|antifungal agents|mesh-ancestor
6604691|NCT01183676|Valproic Acid|valproic acid|mesh-list
6604692|NCT01183676|Anticonvulsants|anticonvulsants|mesh-ancestor
6604693|NCT01183676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6604694|NCT01183676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604695|NCT01183676|GABA Agents|gaba agents|mesh-ancestor
6604696|NCT01183676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6604697|NCT01183676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604698|NCT01183676|Antimanic Agents|antimanic agents|mesh-ancestor
6604699|NCT01183676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6604700|NCT01183676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6604701|NCT01183676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6604702|NCT01183767|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
6604703|NCT01183767|Antioxidants|antioxidants|mesh-ancestor
6604704|NCT01183767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604705|NCT01183767|Protective Agents|protective agents|mesh-ancestor
6604706|NCT01183767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604707|NCT01183767|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
6604708|NCT01183767|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6604709|NCT01183767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6604710|NCT01183767|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6604711|NCT01183806|Rivastigmine|rivastigmine|mesh-list
6604712|NCT01183806|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6604713|NCT01183806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6604714|NCT01183806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604715|NCT01183806|Cholinergic Agents|cholinergic agents|mesh-ancestor
6604716|NCT01183806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6604717|NCT01183806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604718|NCT01183806|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6604719|NCT01183806|Protective Agents|protective agents|mesh-ancestor
6604720|NCT01183910|Calcium Carbonate|calcium carbonate|mesh-list
6604721|NCT01183910|Calcium|calcium|mesh-list
6604722|NCT01183910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6604723|NCT01183910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604724|NCT01183910|Antacids|antacids|mesh-ancestor
6604725|NCT01183910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604726|NCT01183910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6604727|NCT01183962|Vitamin D|vitamin d|mesh-list
6604728|NCT01183962|Vitamins|vitamins|mesh-ancestor
6604729|NCT01183962|Micronutrients|micronutrients|mesh-ancestor
6604730|NCT01183962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604731|NCT01183962|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6604732|NCT01184144|Pioglitazone|pioglitazone|mesh-list
6604733|NCT01184144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6604734|NCT01184144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604735|NCT01184196|Povidone-Iodine|povidone-iodine|mesh-list
6604736|NCT01184196|Povidone|povidone|mesh-list
6604737|NCT01184196|Plasma Substitutes|plasma substitutes|mesh-ancestor
6604738|NCT01184196|Blood Substitutes|blood substitutes|mesh-ancestor
6604739|NCT01184196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6604740|NCT01184196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6604741|NCT01184235|Antipsychotic Agents|antipsychotic agents|mesh-list
6604742|NCT01184235|Antidepressive Agents|antidepressive agents|mesh-list
6604743|NCT01184235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6604744|NCT01184235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6604745|NCT01184235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6604746|NCT01184235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604747|NCT01184287|Ranpirnase|ranpirnase|mesh-list
6604748|NCT01184287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6604749|NCT01184287|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6604750|NCT01184287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6604751|NCT01184287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604752|NCT01184300|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6604753|NCT01184300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6604754|NCT01184378|Caseins|caseins|mesh-list
6604755|NCT01184378|Chelating Agents|chelating agents|mesh-ancestor
6604756|NCT01184378|Sequestering Agents|sequestering agents|mesh-ancestor
6604757|NCT01184378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604758|NCT01184391|Valproic Acid|valproic acid|mesh-list
6604759|NCT01184391|Anticonvulsants|anticonvulsants|mesh-ancestor
6604760|NCT01184391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6604761|NCT01184391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604762|NCT01184391|GABA Agents|gaba agents|mesh-ancestor
6604763|NCT01184391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6604764|NCT01184391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604765|NCT01184391|Antimanic Agents|antimanic agents|mesh-ancestor
6604766|NCT01184391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6604767|NCT01184391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6604768|NCT01184391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6604769|NCT01184404|Bosentan|bosentan|mesh-list
6604770|NCT01184404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6604771|NCT01184404|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6604772|NCT01184404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604773|NCT01184443|Olanzapine|olanzapine|mesh-list
6604774|NCT01184443|Antiemetics|antiemetics|mesh-ancestor
6604775|NCT01184443|Autonomic Agents|autonomic agents|mesh-ancestor
6604776|NCT01184443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6604777|NCT01184443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604778|NCT01184443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6604779|NCT01184443|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6604780|NCT01184443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6604781|NCT01184443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6604782|NCT01184443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6604783|NCT01184443|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6604784|NCT01184443|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6020571|NCT00393367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6020572|NCT00393367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020573|NCT00393367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6020574|NCT00393367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6020575|NCT00393367|Antiemetics|antiemetics|mesh-ancestor
6020576|NCT00393367|Autonomic Agents|autonomic agents|mesh-ancestor
6020577|NCT00393367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6020578|NCT00393367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6020579|NCT00393367|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6020580|NCT00393367|Protective Agents|protective agents|mesh-ancestor
6604785|NCT01184443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6604786|NCT01184443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604787|NCT01184443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6604788|NCT01184443|Serotonin Agents|serotonin agents|mesh-ancestor
6604789|NCT01184482|Cetuximab|cetuximab|mesh-list
6604790|NCT01184482|Lapatinib|lapatinib|mesh-list
6604791|NCT01184482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6020581|NCT00393367|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6604792|NCT01184482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6604793|NCT01184482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6604794|NCT01184482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6604795|NCT01184482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604796|NCT01184495|Epoetin Alfa|epoetin alfa|mesh-list
6604797|NCT01184495|Hematinics|hematinics|mesh-ancestor
6604798|NCT01184560|Orlistat|orlistat|mesh-list
6604799|NCT01184560|Sibutramine|sibutramine|mesh-list
6604800|NCT01184560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6604801|NCT01184560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604802|NCT01184560|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6604803|NCT01184560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6604804|NCT01184560|Antidepressive Agents|antidepressive agents|mesh-ancestor
6604805|NCT01184560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6604806|NCT01184560|Appetite Depressants|appetite depressants|mesh-ancestor
6604807|NCT01184638|Propofol|propofol|mesh-list
6604808|NCT01184638|Sevoflurane|sevoflurane|mesh-list
6604809|NCT01184638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6604810|NCT01184638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6604811|NCT01184638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604812|NCT01184638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6604813|NCT01184638|Anesthetics, General|anesthetics, general|mesh-ancestor
6604814|NCT01184638|Anesthetics|anesthetics|mesh-ancestor
6604815|NCT01184638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6604816|NCT01184638|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6604817|NCT01184664|Nicotine|nicotine|mesh-list
6604818|NCT01184664|Varenicline|varenicline|mesh-list
6604819|NCT01184664|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6604820|NCT01184664|Autonomic Agents|autonomic agents|mesh-ancestor
6604821|NCT01184664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6604822|NCT01184664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604823|NCT01184664|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6604824|NCT01184664|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6604825|NCT01184664|Cholinergic Agents|cholinergic agents|mesh-ancestor
6604826|NCT01184664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6604827|NCT01184664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660453|NCT01493440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6660454|NCT01493440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660455|NCT01493440|Tocolytic Agents|tocolytic agents|mesh-ancestor
6660456|NCT01493440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6660457|NCT01493453|Cyclophosphamide|cyclophosphamide|mesh-list
6660458|NCT01493453|Fludarabine|fludarabine|mesh-list
6660459|NCT01493453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6660460|NCT01493453|Immunologic Factors|immunologic factors|mesh-ancestor
6660461|NCT01493453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660462|NCT01493453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6660463|NCT01493453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6660464|NCT01493453|Alkylating Agents|alkylating agents|mesh-ancestor
6660465|NCT01493453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660466|NCT01493453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6660467|NCT01493453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6664922|NCT01514825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604828|NCT01184716|Vitamin D|vitamin d|mesh-list
6604829|NCT01184716|Vitamins|vitamins|mesh-ancestor
6604830|NCT01184716|Micronutrients|micronutrients|mesh-ancestor
6604831|NCT01184716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604832|NCT01184716|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6604833|NCT01184794|Levobupivacaine|levobupivacaine|mesh-list
6604834|NCT01184794|Anesthetics, Local|anesthetics, local|mesh-ancestor
6604835|NCT01184794|Anesthetics|anesthetics|mesh-ancestor
6604836|NCT01184794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6604837|NCT01184794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604838|NCT01184794|Sensory System Agents|sensory system agents|mesh-ancestor
6604839|NCT01184794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6604840|NCT01184820|Factor VIII|factor viii|mesh-list
6604841|NCT01184820|Coagulants|coagulants|mesh-ancestor
6604842|NCT01184833|Interferons|interferons|mesh-list
6604843|NCT01184833|Interferon-beta|interferon-beta|mesh-list
6604844|NCT01184833|Interferon beta-1b|interferon beta-1b|mesh-list
6604845|NCT01184833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6604846|NCT01184833|Antiviral Agents|antiviral agents|mesh-ancestor
6604847|NCT01184833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6604848|NCT01184833|Immunologic Factors|immunologic factors|mesh-ancestor
6604849|NCT01184833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604850|NCT01184833|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6604851|NCT01184911|Pyrimethamine|pyrimethamine|mesh-list
6604852|NCT01184911|Sulfadoxine|sulfadoxine|mesh-list
6604853|NCT01184911|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6604854|NCT01184911|Antimalarials|antimalarials|mesh-ancestor
6604855|NCT01184911|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6604856|NCT01184911|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6604857|NCT01184911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6604858|NCT01184911|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6604859|NCT01184911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6604860|NCT01184911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604861|NCT01184911|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6604862|NCT01184911|Renal Agents|renal agents|mesh-ancestor
6604863|NCT01185015|Nicorandil|nicorandil|mesh-list
6604864|NCT01185015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6604865|NCT01185015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6604866|NCT01185015|Vasodilator Agents|vasodilator agents|mesh-ancestor
6604867|NCT01185015|Vitamin B Complex|vitamin b complex|mesh-ancestor
6604868|NCT01185015|Vitamins|vitamins|mesh-ancestor
6604869|NCT01185015|Micronutrients|micronutrients|mesh-ancestor
6604870|NCT01185015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604871|NCT01185067|Grape Seed Extract|grape seed extract|mesh-list
6604872|NCT01185067|Resveratrol|resveratrol|mesh-list
6604873|NCT01185067|Antioxidants|antioxidants|mesh-list
6604874|NCT01185067|Quercetin|quercetin|mesh-list
6604875|NCT01185067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604876|NCT01185067|Protective Agents|protective agents|mesh-ancestor
6604877|NCT01185067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604878|NCT01185067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6604879|NCT01185067|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6604880|NCT01185067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6604881|NCT01185067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6604882|NCT01185119|Glucagon|glucagon|mesh-list
6604883|NCT01185119|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6604884|NCT01185119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6604885|NCT01185119|Hormones|hormones|mesh-ancestor
6604886|NCT01185119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6604887|NCT01185119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604888|NCT01185119|Incretins|incretins|mesh-ancestor
6660468|NCT01493479|Rituximab|rituximab|mesh-list
6660469|NCT01493479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6660470|NCT01493479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6660471|NCT01493479|Immunologic Factors|immunologic factors|mesh-ancestor
6660472|NCT01493479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660473|NCT01493479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6660474|NCT01493570|BI 409306|bi 409306|mesh-list
6660475|NCT01493570|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6660476|NCT01493570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6660477|NCT01493570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604889|NCT01185158|Gefitinib|gefitinib|mesh-list
6604890|NCT01185158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6604891|NCT01185158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6604892|NCT01185158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6604893|NCT01185158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604894|NCT01185184|Tofacitinib|tofacitinib|mesh-list
6604895|NCT01185184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6604896|NCT01185184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6604897|NCT01185184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604898|NCT01185197|Mycophenolic Acid|mycophenolic acid|mesh-list
6604899|NCT01185197|Prednisolone|prednisolone|mesh-list
6604900|NCT01185197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6604901|NCT01185197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6604902|NCT01185197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6604903|NCT01185197|Antitubercular Agents|antitubercular agents|mesh-ancestor
6604904|NCT01185197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6604905|NCT01185197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6604906|NCT01185197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6604907|NCT01185197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604908|NCT01185197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6604909|NCT01185197|Glucocorticoids|glucocorticoids|mesh-ancestor
6604910|NCT01185197|Hormones|hormones|mesh-ancestor
6604911|NCT01185197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6604912|NCT01185197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604913|NCT01185197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6604914|NCT01185223|Valganciclovir|valganciclovir|mesh-list
6604915|NCT01185223|Ganciclovir|ganciclovir|mesh-list
6604916|NCT01185223|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6604917|NCT01185223|Antiviral Agents|antiviral agents|mesh-ancestor
6604918|NCT01185223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6604919|NCT01185223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6604920|NCT01185223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6604921|NCT01185223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604922|NCT01185236|Atorvastatin|atorvastatin|mesh-list
6604923|NCT01185236|Simvastatin|simvastatin|mesh-list
6604924|NCT01185236|Ezetimibe|ezetimibe|mesh-list
6604925|NCT01185236|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6604926|NCT01185236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6604927|NCT01185236|Antimetabolites|antimetabolites|mesh-ancestor
6604928|NCT01185236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604929|NCT01185236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6604930|NCT01185236|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6604931|NCT01185236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6604932|NCT01185262|Rituximab|rituximab|mesh-list
6604933|NCT01185262|Lenalidomide|lenalidomide|mesh-list
6604934|NCT01185262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6604935|NCT01185262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6604936|NCT01185262|Immunologic Factors|immunologic factors|mesh-ancestor
6604937|NCT01185262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604938|NCT01185262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6604939|NCT01185262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6604940|NCT01185262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6604941|NCT01185262|Growth Substances|growth substances|mesh-ancestor
6604942|NCT01185262|Growth Inhibitors|growth inhibitors|mesh-ancestor
6604943|NCT01185405|Voriconazole|voriconazole|mesh-list
6604944|NCT01185405|Antifungal Agents|antifungal agents|mesh-ancestor
6604945|NCT01185405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6604946|NCT01185405|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6604947|NCT01185405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6604948|NCT01185405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6604949|NCT01185405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604950|NCT01185405|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6604951|NCT01185405|Hormone Antagonists|hormone antagonists|mesh-ancestor
6604952|NCT01185405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6604953|NCT01185405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604954|NCT01185405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6604955|NCT01185418|Haloperidol|haloperidol|mesh-list
6604956|NCT01185418|Risperidone|risperidone|mesh-list
6604957|NCT01185418|Aripiprazole|aripiprazole|mesh-list
6604958|NCT01185418|Haloperidol decanoate|haloperidol decanoate|mesh-list
6604959|NCT01185418|Amisulpride|amisulpride|mesh-list
6604960|NCT01185418|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6604961|NCT01185418|Serotonin Agents|serotonin agents|mesh-ancestor
6604962|NCT01185418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6604963|NCT01185418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6604964|NCT01185418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604965|NCT01185418|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6604966|NCT01185418|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6604967|NCT01185418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6604968|NCT01185418|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6604969|NCT01185418|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6604970|NCT01185418|Dopamine Agents|dopamine agents|mesh-ancestor
6604971|NCT01185418|Antidepressive Agents|antidepressive agents|mesh-ancestor
6604972|NCT01185418|Dopamine Agonists|dopamine agonists|mesh-ancestor
6604973|NCT01185418|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6604974|NCT01185418|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6604975|NCT01185418|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6604976|NCT01185418|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6604977|NCT01185418|Antiemetics|antiemetics|mesh-ancestor
6604978|NCT01185418|Autonomic Agents|autonomic agents|mesh-ancestor
6604979|NCT01185418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6604980|NCT01185418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6604981|NCT01185418|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6604982|NCT01185418|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6604983|NCT01185444|Hyaluronic Acid|hyaluronic acid|mesh-list
6604984|NCT01185444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6604985|NCT01185444|Immunologic Factors|immunologic factors|mesh-ancestor
6604986|NCT01185444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604987|NCT01185444|Viscosupplements|viscosupplements|mesh-ancestor
6604988|NCT01185444|Protective Agents|protective agents|mesh-ancestor
6604989|NCT01185470|Morphine|morphine|mesh-list
6604990|NCT01185470|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6604991|NCT01185470|Narcotics|narcotics|mesh-ancestor
6604992|NCT01185470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6604993|NCT01185470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6604994|NCT01185470|Analgesics|analgesics|mesh-ancestor
6604995|NCT01185470|Sensory System Agents|sensory system agents|mesh-ancestor
6604996|NCT01185470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6604997|NCT01185535|Anesthetics|anesthetics|mesh-list
6604998|NCT01185535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6604999|NCT01185535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605000|NCT01185574|Vitamin D|vitamin d|mesh-list
6605001|NCT01185574|Vitamins|vitamins|mesh-ancestor
6605002|NCT01185574|Micronutrients|micronutrients|mesh-ancestor
6605003|NCT01185574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605004|NCT01185574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6605005|NCT01185678|Contraceptive Agents|contraceptive agents|mesh-list
6605006|NCT01185678|Desogestrel|desogestrel|mesh-list
6605007|NCT01185678|Contraceptives, Oral|contraceptives, oral|mesh-list
6605008|NCT01185678|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
6605009|NCT01185678|Progestins|progestins|mesh-list
6605010|NCT01185678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6605011|NCT01185678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605012|NCT01185678|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6605013|NCT01185678|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6605014|NCT01185678|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6605015|NCT01185678|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6605016|NCT01185678|Hormones|hormones|mesh-ancestor
6660478|NCT01493622|Minocycline|minocycline|mesh-list
6605017|NCT01185678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6605018|NCT01185743|Olanzapine|olanzapine|mesh-list
6605019|NCT01185743|Ziprasidone|ziprasidone|mesh-list
6605020|NCT01185743|Antiemetics|antiemetics|mesh-ancestor
6605021|NCT01185743|Autonomic Agents|autonomic agents|mesh-ancestor
6605022|NCT01185743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6605023|NCT01185743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605024|NCT01185743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6605025|NCT01185743|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6605026|NCT01185743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6605027|NCT01185743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6605028|NCT01185743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6605029|NCT01185743|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6605030|NCT01185743|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6605031|NCT01185743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6605032|NCT01185743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605033|NCT01185743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6605034|NCT01185743|Serotonin Agents|serotonin agents|mesh-ancestor
6605035|NCT01185743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6605036|NCT01185743|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6605037|NCT01185743|Dopamine Agents|dopamine agents|mesh-ancestor
6605038|NCT01185769|Tocotrienols|tocotrienols|mesh-list
6605039|NCT01185769|Vitamin E|vitamin e|mesh-list
6605040|NCT01185769|Tocopherols|tocopherols|mesh-list
6605041|NCT01185769|Antioxidants|antioxidants|mesh-ancestor
6605042|NCT01185769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605043|NCT01185769|Protective Agents|protective agents|mesh-ancestor
6605044|NCT01185769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605045|NCT01185769|Vitamins|vitamins|mesh-ancestor
6605046|NCT01185769|Micronutrients|micronutrients|mesh-ancestor
6605047|NCT01185808|Vitamin D|vitamin d|mesh-list
6605048|NCT01185808|Ergocalciferols|ergocalciferols|mesh-list
6605049|NCT01185808|Vitamins|vitamins|mesh-list
6605050|NCT01185808|Micronutrients|micronutrients|mesh-ancestor
6605051|NCT01185808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605052|NCT01185808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6605053|NCT01185808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6605054|NCT01185847|Gemcitabine|gemcitabine|mesh-list
6605055|NCT01185847|Pemetrexed|pemetrexed|mesh-list
6605056|NCT01185847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6605057|NCT01185847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6605058|NCT01185847|Antimetabolites|antimetabolites|mesh-ancestor
6605059|NCT01185847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605060|NCT01185847|Antiviral Agents|antiviral agents|mesh-ancestor
6605061|NCT01185847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6605062|NCT01185847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6605063|NCT01185847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6605064|NCT01185847|Immunologic Factors|immunologic factors|mesh-ancestor
6605065|NCT01185847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605066|NCT01185847|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6605067|NCT01185847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6605068|NCT01185860|Ritonavir|ritonavir|mesh-list
6605069|NCT01185860|Ribavirin|ribavirin|mesh-list
6605070|NCT01185860|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6605071|NCT01185860|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6605072|NCT01185860|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6605073|NCT01185860|Protease Inhibitors|protease inhibitors|mesh-ancestor
6605074|NCT01185860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6605075|NCT01185860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605076|NCT01185860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6605077|NCT01185860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6605078|NCT01185860|Antiviral Agents|antiviral agents|mesh-ancestor
6605079|NCT01185860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6605080|NCT01185860|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6605081|NCT01185860|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6605082|NCT01185860|Antimetabolites|antimetabolites|mesh-ancestor
6605083|NCT01185873|Ritonavir|ritonavir|mesh-list
6605084|NCT01185873|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6605085|NCT01185873|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6605086|NCT01185873|Protease Inhibitors|protease inhibitors|mesh-ancestor
6605087|NCT01185873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6605088|NCT01185873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605089|NCT01185873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6605090|NCT01185873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6605091|NCT01185873|Antiviral Agents|antiviral agents|mesh-ancestor
6605092|NCT01185873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6605093|NCT01185873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6605094|NCT01185873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6605095|NCT01185925|Sildenafil Citrate|sildenafil citrate|mesh-list
6605096|NCT01185925|Vasodilator Agents|vasodilator agents|mesh-ancestor
6605097|NCT01185925|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6605098|NCT01185925|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6605099|NCT01185925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6605100|NCT01185925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605101|NCT01185925|Urological Agents|urological agents|mesh-ancestor
6605102|NCT01185938|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6605103|NCT01185938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6605104|NCT01185938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6605105|NCT01185938|Antimetabolites|antimetabolites|mesh-ancestor
6605106|NCT01185938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605107|NCT01185938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6605108|NCT01185938|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6605109|NCT01185938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6605110|NCT01185951|Polidocanol|polidocanol|mesh-list
6605111|NCT01185951|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
6605112|NCT01185951|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6605113|NCT01185977|Fluoxetine|fluoxetine|mesh-list
6605114|NCT01185977|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6605115|NCT01185977|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6605116|NCT01185977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6605117|NCT01185977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605118|NCT01185977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6605119|NCT01185977|Serotonin Agents|serotonin agents|mesh-ancestor
6605120|NCT01185977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605121|NCT01185977|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6605122|NCT01185977|Antidepressive Agents|antidepressive agents|mesh-ancestor
6605123|NCT01185977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6605124|NCT01185977|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6605125|NCT01185977|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6605126|NCT01185977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6605127|NCT01186029|Aprepitant|aprepitant|mesh-list
6605128|NCT01186029|Antiemetics|antiemetics|mesh-ancestor
6605129|NCT01186029|Autonomic Agents|autonomic agents|mesh-ancestor
6605130|NCT01186029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6605131|NCT01186029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605132|NCT01186029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6605133|NCT01186029|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6605134|NCT01186029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6605135|NCT01186029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605136|NCT01186094|Sirolimus|sirolimus|mesh-list
6605137|NCT01186094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6605138|NCT01186094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6605139|NCT01186094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6605140|NCT01186094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6605141|NCT01186094|Antifungal Agents|antifungal agents|mesh-ancestor
6605142|NCT01186094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6605143|NCT01186094|Immunologic Factors|immunologic factors|mesh-ancestor
6605144|NCT01186094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605145|NCT01186120|Umirolimus|umirolimus|mesh-list
6605146|NCT01186120|Everolimus|everolimus|mesh-list
6605147|NCT01186120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6605148|NCT01186120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6605149|NCT01186120|Immunologic Factors|immunologic factors|mesh-ancestor
6605150|NCT01186120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605151|NCT01186120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6605152|NCT01186146|Aspirin|aspirin|mesh-list
6605153|NCT01186146|Clopidogrel|clopidogrel|mesh-list
6605154|NCT01186146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6605155|NCT01186146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6605156|NCT01186146|Analgesics|analgesics|mesh-ancestor
6605157|NCT01186146|Sensory System Agents|sensory system agents|mesh-ancestor
6605158|NCT01186146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6605159|NCT01186146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605160|NCT01186146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6605161|NCT01186146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6605162|NCT01186146|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6605163|NCT01186146|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6605164|NCT01186146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605165|NCT01186146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6605166|NCT01186146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6605167|NCT01186146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6605168|NCT01186146|Antipyretics|antipyretics|mesh-ancestor
6605169|NCT01186146|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6605170|NCT01186146|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6605171|NCT01186146|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6605172|NCT01186146|Purinergic Agents|purinergic agents|mesh-ancestor
6605173|NCT01186146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6605174|NCT01186159|Parecoxib|parecoxib|mesh-list
6605175|NCT01186159|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6605176|NCT01186159|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6605177|NCT01186159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6605178|NCT01186159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605179|NCT01186159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6605180|NCT01186159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6605181|NCT01186159|Analgesics|analgesics|mesh-ancestor
6605182|NCT01186159|Sensory System Agents|sensory system agents|mesh-ancestor
6605183|NCT01186159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6605184|NCT01186159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605185|NCT01186159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6605186|NCT01186159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6605187|NCT01186172|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6605188|NCT01186172|Ethanol|ethanol|mesh-list
6605189|NCT01186172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6605190|NCT01186172|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6605191|NCT01186172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6605192|NCT01186172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605193|NCT01186185|Fludrocortisone|fludrocortisone|mesh-list
6605194|NCT01186185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6605195|NCT01186224|Plerixafor|plerixafor|mesh-list
6605196|NCT01186224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6605197|NCT01186224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6605198|NCT01186224|Antiviral Agents|antiviral agents|mesh-ancestor
6605199|NCT01186224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6605200|NCT01186289|Atorvastatin|atorvastatin|mesh-list
6605201|NCT01186289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6605202|NCT01186289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6605203|NCT01186289|Antimetabolites|antimetabolites|mesh-ancestor
6605204|NCT01186289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605205|NCT01186289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6605206|NCT01186289|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6605207|NCT01186289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6605208|NCT01186445|Morphine|morphine|mesh-list
6605209|NCT01186445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6605210|NCT01186445|Narcotics|narcotics|mesh-ancestor
6605211|NCT01186445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6605212|NCT01186445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605213|NCT01186445|Analgesics|analgesics|mesh-ancestor
6605214|NCT01186445|Sensory System Agents|sensory system agents|mesh-ancestor
6605215|NCT01186445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6605216|NCT01186471|Nicotine|nicotine|mesh-list
6605217|NCT01186471|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6605218|NCT01186471|Autonomic Agents|autonomic agents|mesh-ancestor
6605219|NCT01186471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6605220|NCT01186471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605221|NCT01186471|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6605222|NCT01186471|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6605223|NCT01186471|Cholinergic Agents|cholinergic agents|mesh-ancestor
6605224|NCT01186471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6605225|NCT01186471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605226|NCT01186497|Rabeprazole|rabeprazole|mesh-list
6605227|NCT01186497|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6605228|NCT01186497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6605229|NCT01186497|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6605230|NCT01186497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6605231|NCT01186497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605232|NCT01186549|Lidocaine|lidocaine|mesh-list
6605233|NCT01186549|Ephedrine|ephedrine|mesh-list
6605234|NCT01186549|Pseudoephedrine|pseudoephedrine|mesh-list
6605235|NCT01186549|Anesthetics, Local|anesthetics, local|mesh-ancestor
6605236|NCT01186549|Anesthetics|anesthetics|mesh-ancestor
6605237|NCT01186549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6605238|NCT01186549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605239|NCT01186549|Sensory System Agents|sensory system agents|mesh-ancestor
6605240|NCT01186549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6605241|NCT01186549|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6605242|NCT01186549|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6605243|NCT01186549|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6605244|NCT01186549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6605245|NCT01186549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605246|NCT01186549|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6605247|NCT01186549|Sympathomimetics|sympathomimetics|mesh-ancestor
6605248|NCT01186549|Autonomic Agents|autonomic agents|mesh-ancestor
6605249|NCT01186549|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6605250|NCT01186549|Adrenergic Agents|adrenergic agents|mesh-ancestor
6605251|NCT01186549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6605252|NCT01186549|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6605253|NCT01186549|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6605254|NCT01186549|Respiratory System Agents|respiratory system agents|mesh-ancestor
6605255|NCT01186549|Nasal Decongestants|nasal decongestants|mesh-ancestor
6605256|NCT01186588|Canagliflozin|canagliflozin|mesh-list
6605257|NCT01186588|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6605258|NCT01186588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605259|NCT01186588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6605260|NCT01186588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605261|NCT01186653|Fluticasone|fluticasone|mesh-list
6605262|NCT01186653|Budesonide|budesonide|mesh-list
6605263|NCT01186653|Formoterol Fumarate|formoterol fumarate|mesh-list
6605264|NCT01186653|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6605265|NCT01186653|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6605266|NCT01186653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6605267|NCT01186653|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6605268|NCT01186653|Autonomic Agents|autonomic agents|mesh-ancestor
6605269|NCT01186653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6605270|NCT01186653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605271|NCT01186653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6605272|NCT01186653|Respiratory System Agents|respiratory system agents|mesh-ancestor
6605273|NCT01186653|Dermatologic Agents|dermatologic agents|mesh-ancestor
6605274|NCT01186653|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6605275|NCT01186653|Glucocorticoids|glucocorticoids|mesh-ancestor
6605276|NCT01186653|Hormones|hormones|mesh-ancestor
6605277|NCT01186653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6605278|NCT01186653|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6605279|NCT01186653|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6605280|NCT01186653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6605281|NCT01186653|Adrenergic Agents|adrenergic agents|mesh-ancestor
6605282|NCT01186653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6605283|NCT01186653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605284|NCT01186653|Sympathomimetics|sympathomimetics|mesh-ancestor
6605285|NCT01186731|Docetaxel|docetaxel|mesh-list
6605286|NCT01186731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6605287|NCT01186731|Tubulin Modulators|tubulin modulators|mesh-ancestor
6605288|NCT01186731|Antimitotic Agents|antimitotic agents|mesh-ancestor
6605289|NCT01186731|Mitosis Modulators|mitosis modulators|mesh-ancestor
6605290|NCT01186731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605291|NCT01186835|Botulinum Toxins|botulinum toxins|mesh-list
6605292|NCT01186835|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6605293|NCT01186835|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6605294|NCT01186835|Hyaluronic Acid|hyaluronic acid|mesh-list
6605295|NCT01186835|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6605296|NCT01186835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6605297|NCT01186835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605298|NCT01186835|Cholinergic Agents|cholinergic agents|mesh-ancestor
6605299|NCT01186835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6605300|NCT01186835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605301|NCT01186835|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6605302|NCT01186835|Immunologic Factors|immunologic factors|mesh-ancestor
6605303|NCT01186835|Viscosupplements|viscosupplements|mesh-ancestor
6605304|NCT01186835|Protective Agents|protective agents|mesh-ancestor
6605305|NCT01186835|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6605306|NCT01186835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6605307|NCT01186887|Celecoxib|celecoxib|mesh-list
6605308|NCT01186887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6605309|NCT01186887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6605310|NCT01186887|Analgesics|analgesics|mesh-ancestor
6605311|NCT01186887|Sensory System Agents|sensory system agents|mesh-ancestor
6605312|NCT01186887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6605313|NCT01186887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605314|NCT01186887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6605315|NCT01186887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6605316|NCT01186887|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6605317|NCT01186887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6605318|NCT01186887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6605319|NCT01186887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605320|NCT01187108|Acetylcysteine|acetylcysteine|mesh-list
6605321|NCT01187108|Acetazolamide|acetazolamide|mesh-list
6605322|NCT01187108|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6605323|NCT01187108|Antiviral Agents|antiviral agents|mesh-ancestor
6605324|NCT01187108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6605325|NCT01187108|Expectorants|expectorants|mesh-ancestor
6605326|NCT01187108|Respiratory System Agents|respiratory system agents|mesh-ancestor
6605327|NCT01187108|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6605328|NCT01187108|Antioxidants|antioxidants|mesh-ancestor
6605329|NCT01187108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605330|NCT01187108|Protective Agents|protective agents|mesh-ancestor
6605331|NCT01187108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605332|NCT01187108|Antidotes|antidotes|mesh-ancestor
6605333|NCT01187108|Anticonvulsants|anticonvulsants|mesh-ancestor
6605334|NCT01187108|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6605335|NCT01187108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6605336|NCT01187108|Diuretics|diuretics|mesh-ancestor
6605337|NCT01187108|Natriuretic Agents|natriuretic agents|mesh-ancestor
6605338|NCT01187186|Ipragliflozin|ipragliflozin|mesh-list
6605339|NCT01187186|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6605340|NCT01187186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605341|NCT01187186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6605342|NCT01187186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605343|NCT01187199|Sirolimus|sirolimus|mesh-list
6605344|NCT01187199|Paclitaxel|paclitaxel|mesh-list
6605345|NCT01187199|Bevacizumab|bevacizumab|mesh-list
6605346|NCT01187199|Carboplatin|carboplatin|mesh-list
6605347|NCT01187199|Sorafenib|sorafenib|mesh-list
6605348|NCT01187199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6605349|NCT01187199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6605350|NCT01187199|Tubulin Modulators|tubulin modulators|mesh-ancestor
6605351|NCT01187199|Antimitotic Agents|antimitotic agents|mesh-ancestor
6605352|NCT01187199|Mitosis Modulators|mitosis modulators|mesh-ancestor
6605353|NCT01187199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605354|NCT01187199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6605355|NCT01187199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6605356|NCT01187199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6605357|NCT01187199|Growth Substances|growth substances|mesh-ancestor
6605358|NCT01187199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605359|NCT01187199|Growth Inhibitors|growth inhibitors|mesh-ancestor
6605360|NCT01187199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6605361|NCT01187199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6605362|NCT01187199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6605363|NCT01187199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6605364|NCT01187199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6605365|NCT01187199|Antifungal Agents|antifungal agents|mesh-ancestor
6605366|NCT01187199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6605367|NCT01187199|Immunologic Factors|immunologic factors|mesh-ancestor
6605368|NCT01187212|Cisplatin|cisplatin|mesh-list
6605369|NCT01187212|Capecitabine|capecitabine|mesh-list
6605370|NCT01187212|Sorafenib|sorafenib|mesh-list
6605371|NCT01187212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6605372|NCT01187212|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6605373|NCT01187212|Antimetabolites|antimetabolites|mesh-ancestor
6605374|NCT01187212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605375|NCT01187212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6605376|NCT01187212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6605377|NCT01187238|Cisplatin|cisplatin|mesh-list
6605378|NCT01187238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6605379|NCT01187264|Methotrexate|methotrexate|mesh-list
6605380|NCT01187264|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6605381|NCT01187264|Abortifacient Agents|abortifacient agents|mesh-ancestor
6605382|NCT01187264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6605383|NCT01187264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605384|NCT01187264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6605385|NCT01187264|Antimetabolites|antimetabolites|mesh-ancestor
6605386|NCT01187264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605387|NCT01187264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6605388|NCT01187264|Dermatologic Agents|dermatologic agents|mesh-ancestor
6605389|NCT01187264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6605390|NCT01187264|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6605391|NCT01187264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6605392|NCT01187264|Immunologic Factors|immunologic factors|mesh-ancestor
6605393|NCT01187264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6605394|NCT01187264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6605395|NCT01187303|Ofatumumab|ofatumumab|mesh-list
6605396|NCT01187303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6605397|NCT01187459|Vitamin D|vitamin d|mesh-list
6605398|NCT01187459|Ergocalciferols|ergocalciferols|mesh-list
6605399|NCT01187459|Vitamins|vitamins|mesh-list
6605400|NCT01187459|Micronutrients|micronutrients|mesh-ancestor
6605401|NCT01187459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605402|NCT01187459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6605403|NCT01187459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6605404|NCT01187485|Methyltestosterone|methyltestosterone|mesh-list
6605405|NCT01187485|Testosterone|testosterone|mesh-list
6605406|NCT01187485|Testosterone undecanoate|testosterone undecanoate|mesh-list
6605407|NCT01187485|Testosterone enanthate|testosterone enanthate|mesh-list
6605408|NCT01187485|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6605409|NCT01187485|Androgens|androgens|mesh-ancestor
6605410|NCT01187485|Hormones|hormones|mesh-ancestor
6605411|NCT01187485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6605412|NCT01187485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605413|NCT01187485|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6605414|NCT01187485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6605415|NCT01187485|Anabolic Agents|anabolic agents|mesh-ancestor
6605416|NCT01187537|Bupivacaine|bupivacaine|mesh-list
6605417|NCT01187537|Anesthetics, Local|anesthetics, local|mesh-ancestor
6605418|NCT01187537|Anesthetics|anesthetics|mesh-ancestor
6605419|NCT01187537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6605420|NCT01187537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605421|NCT01187537|Sensory System Agents|sensory system agents|mesh-ancestor
6605422|NCT01187537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6605423|NCT01187589|Albuterol|albuterol|mesh-list
6605424|NCT01187589|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6605425|NCT01187589|Autonomic Agents|autonomic agents|mesh-ancestor
6605426|NCT01187589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6605427|NCT01187589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605428|NCT01187589|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6605429|NCT01187589|Respiratory System Agents|respiratory system agents|mesh-ancestor
6605430|NCT01187589|Tocolytic Agents|tocolytic agents|mesh-ancestor
6605431|NCT01187589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6605432|NCT01187589|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6605433|NCT01187589|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6605434|NCT01187589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6605435|NCT01187589|Adrenergic Agents|adrenergic agents|mesh-ancestor
6605436|NCT01187589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6605437|NCT01187589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605438|NCT01187615|Cisplatin|cisplatin|mesh-list
6605439|NCT01187615|Pemetrexed|pemetrexed|mesh-list
6605440|NCT01187615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6605441|NCT01187615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6605442|NCT01187615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605443|NCT01187615|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6605444|NCT01187615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6605445|NCT01187719|Phenytoin|phenytoin|mesh-list
6605446|NCT01187719|Anticonvulsants|anticonvulsants|mesh-ancestor
6605447|NCT01187719|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6605448|NCT01187719|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6605449|NCT01187719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6605450|NCT01187719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605451|NCT01187719|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6605452|NCT01187719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6605453|NCT01187810|Cytarabine|cytarabine|mesh-list
6605454|NCT01187810|Methotrexate|methotrexate|mesh-list
6605455|NCT01187810|Fenretinide|fenretinide|mesh-list
6605456|NCT01187810|Retinamide|retinamide|mesh-list
6605457|NCT01187810|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6605458|NCT01187810|Abortifacient Agents|abortifacient agents|mesh-ancestor
6605459|NCT01187810|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6605460|NCT01187810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605461|NCT01187810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6605462|NCT01187810|Antimetabolites|antimetabolites|mesh-ancestor
6605463|NCT01187810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605464|NCT01187810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6605465|NCT01187810|Dermatologic Agents|dermatologic agents|mesh-ancestor
6605466|NCT01187810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6605467|NCT01187810|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6605468|NCT01187810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6605469|NCT01187810|Immunologic Factors|immunologic factors|mesh-ancestor
6605470|NCT01187810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6605471|NCT01187810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6605472|NCT01187810|Antiviral Agents|antiviral agents|mesh-ancestor
6605473|NCT01187810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6605474|NCT01187810|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6605475|NCT01187810|Protective Agents|protective agents|mesh-ancestor
6605476|NCT01187849|Metformin|metformin|mesh-list
6605477|NCT01187849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6605478|NCT01187849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605479|NCT01187862|Efavirenz|efavirenz|mesh-list
6449331|NCT00404261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449332|NCT00404261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6449333|NCT00404261|Respiratory System Agents|respiratory system agents|mesh-ancestor
6449334|NCT00404261|Dermatologic Agents|dermatologic agents|mesh-ancestor
6449335|NCT00404261|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6449336|NCT00404261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6449337|NCT00404261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6449338|NCT00404261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6449339|NCT00404261|Adrenergic Agents|adrenergic agents|mesh-ancestor
6449340|NCT00404261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6449341|NCT00404261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6449342|NCT00404261|Glucocorticoids|glucocorticoids|mesh-ancestor
6449343|NCT00404261|Hormones|hormones|mesh-ancestor
6449344|NCT00404261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6449345|NCT00404261|Sympathomimetics|sympathomimetics|mesh-ancestor
6449346|NCT00404274|Casopitant|casopitant|mesh-list
6605480|NCT01187862|Losartan|losartan|mesh-list
6605481|NCT01187862|Metoprolol|metoprolol|mesh-list
6605482|NCT01187862|Midazolam|midazolam|mesh-list
6605483|NCT01187862|Caffeine|caffeine|mesh-list
6605484|NCT01187862|Chlorzoxazone|chlorzoxazone|mesh-list
6605485|NCT01187862|Omeprazole|omeprazole|mesh-list
6605486|NCT01187862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6605487|NCT01187862|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6605488|NCT01187862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6605489|NCT01187862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605490|NCT01187862|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6605491|NCT01187862|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6605492|NCT01187862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6605493|NCT01187862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6605494|NCT01187862|Anesthetics, General|anesthetics, general|mesh-ancestor
6605495|NCT01187862|Anesthetics|anesthetics|mesh-ancestor
6605496|NCT01187862|GABA Modulators|gaba modulators|mesh-ancestor
6605497|NCT01187862|GABA Agents|gaba agents|mesh-ancestor
6605498|NCT01187862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6605499|NCT01187862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605500|NCT01187862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6605501|NCT01187862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6605502|NCT01187862|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6605503|NCT01187862|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6605504|NCT01187862|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6605505|NCT01187862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6605506|NCT01187862|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6605507|NCT01187862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6605508|NCT01187862|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6605509|NCT01187862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6605510|NCT01187862|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6605511|NCT01187862|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6605512|NCT01187862|Purinergic Agents|purinergic agents|mesh-ancestor
6605513|NCT01187862|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6605514|NCT01187862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6605515|NCT01187862|Antiviral Agents|antiviral agents|mesh-ancestor
6605516|NCT01187862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6605517|NCT01187862|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6605518|NCT01187862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6605519|NCT01187862|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6605520|NCT01187862|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6605521|NCT01187862|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6605522|NCT01187862|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6605523|NCT01187862|Sympatholytics|sympatholytics|mesh-ancestor
6605524|NCT01187862|Autonomic Agents|autonomic agents|mesh-ancestor
6605525|NCT01187862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6605526|NCT01187862|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6605527|NCT01187862|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6605528|NCT01187862|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6605529|NCT01187862|Adrenergic Agents|adrenergic agents|mesh-ancestor
6605530|NCT01187862|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6605531|NCT01187862|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6605532|NCT01187888|Rasagiline|rasagiline|mesh-list
6605533|NCT01187888|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6605534|NCT01187888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6605535|NCT01187888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605536|NCT01187888|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6605537|NCT01187888|Protective Agents|protective agents|mesh-ancestor
6605538|NCT01187888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605539|NCT01187992|Atorvastatin|atorvastatin|mesh-list
6605540|NCT01187992|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6605541|NCT01187992|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6605542|NCT01187992|Antimetabolites|antimetabolites|mesh-ancestor
6605543|NCT01187992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605544|NCT01187992|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6605545|NCT01187992|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6605546|NCT01187992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6605547|NCT01188005|Vitamins|vitamins|mesh-list
6605548|NCT01188005|Vitamin E|vitamin e|mesh-list
6605549|NCT01188005|Vitamin A|vitamin a|mesh-list
6605550|NCT01188005|Acetylcysteine|acetylcysteine|mesh-list
6605551|NCT01188005|Allopurinol|allopurinol|mesh-list
6605552|NCT01188005|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6605553|NCT01188005|Micronutrients|micronutrients|mesh-ancestor
6605554|NCT01188005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605555|NCT01188005|Antioxidants|antioxidants|mesh-ancestor
6605556|NCT01188005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605557|NCT01188005|Protective Agents|protective agents|mesh-ancestor
6605558|NCT01188005|Antiviral Agents|antiviral agents|mesh-ancestor
6605559|NCT01188005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6605560|NCT01188005|Expectorants|expectorants|mesh-ancestor
6605561|NCT01188005|Respiratory System Agents|respiratory system agents|mesh-ancestor
6605562|NCT01188005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6605563|NCT01188005|Antidotes|antidotes|mesh-ancestor
6605564|NCT01188005|Antimetabolites|antimetabolites|mesh-ancestor
6605565|NCT01188005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6605566|NCT01188005|Gout Suppressants|gout suppressants|mesh-ancestor
6605567|NCT01188005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6605568|NCT01188031|Alprazolam|alprazolam|mesh-list
6605569|NCT01188031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6605570|NCT01188031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6605571|NCT01188031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605572|NCT01188031|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6605573|NCT01188031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6605574|NCT01188031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6605575|NCT01188031|GABA Modulators|gaba modulators|mesh-ancestor
6605576|NCT01188031|GABA Agents|gaba agents|mesh-ancestor
6605577|NCT01188031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6605578|NCT01188031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605579|NCT01188057|Alprazolam|alprazolam|mesh-list
6605580|NCT01188057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6605581|NCT01188057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6605582|NCT01188057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605583|NCT01188057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6605584|NCT01188057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6605585|NCT01188057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6605586|NCT01188057|GABA Modulators|gaba modulators|mesh-ancestor
6605587|NCT01188057|GABA Agents|gaba agents|mesh-ancestor
6605588|NCT01188057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6605589|NCT01188057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605590|NCT01188148|Memantine|memantine|mesh-list
6605591|NCT01188148|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6605592|NCT01188148|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6605593|NCT01188148|Dopamine Agents|dopamine agents|mesh-ancestor
6605594|NCT01188148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6605595|NCT01188148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605596|NCT01188148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605597|NCT01188148|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6605598|NCT01188148|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6660479|NCT01493622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6660480|NCT01493622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6660481|NCT01493635|Analgesics|analgesics|mesh-list
6660482|NCT01493635|Sensory System Agents|sensory system agents|mesh-ancestor
6660483|NCT01493635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6660484|NCT01493635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660485|NCT01493648|Vitamin D|vitamin d|mesh-list
6660486|NCT01493648|Cholecalciferol|cholecalciferol|mesh-list
6660487|NCT01493648|Vitamins|vitamins|mesh-ancestor
6660488|NCT01493648|Micronutrients|micronutrients|mesh-ancestor
6660489|NCT01493648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660490|NCT01493648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6660491|NCT01493648|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6660492|NCT01493674|Folic Acid|folic acid|mesh-list
6660493|NCT01493674|Vitamin B Complex|vitamin b complex|mesh-list
6660494|NCT01493674|Hematinics|hematinics|mesh-ancestor
6660495|NCT01493674|Vitamins|vitamins|mesh-ancestor
6605599|NCT01188174|Clofarabine|clofarabine|mesh-list
6605600|NCT01188174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6605601|NCT01188174|Antimetabolites|antimetabolites|mesh-ancestor
6605602|NCT01188174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605603|NCT01188174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6605604|NCT01188213|Dimethyl sulfone|dimethyl sulfone|mesh-list
6605605|NCT01188213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6605606|NCT01188265|Valproic Acid|valproic acid|mesh-list
6605607|NCT01188265|Dextromethorphan|dextromethorphan|mesh-list
6605608|NCT01188265|Antitussive Agents|antitussive agents|mesh-ancestor
6605609|NCT01188265|Respiratory System Agents|respiratory system agents|mesh-ancestor
6605610|NCT01188265|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6605611|NCT01188265|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6605612|NCT01188265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6605613|NCT01188265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605614|NCT01188265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605615|NCT01188265|Anticonvulsants|anticonvulsants|mesh-ancestor
6605616|NCT01188265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6605617|NCT01188265|GABA Agents|gaba agents|mesh-ancestor
6605618|NCT01188265|Antimanic Agents|antimanic agents|mesh-ancestor
6605619|NCT01188265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6605620|NCT01188265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6605621|NCT01188265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6605622|NCT01188278|Imatinib Mesylate|imatinib mesylate|mesh-list
6605623|NCT01188278|Dasatinib|dasatinib|mesh-list
6605624|NCT01188278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6605625|NCT01188278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6605626|NCT01188278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6605627|NCT01188278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605628|NCT01188304|Aspirin|aspirin|mesh-list
6605629|NCT01188304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6605630|NCT01188304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6605631|NCT01188304|Analgesics|analgesics|mesh-ancestor
6605632|NCT01188304|Sensory System Agents|sensory system agents|mesh-ancestor
6605633|NCT01188304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6605634|NCT01188304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605635|NCT01188304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6605636|NCT01188304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6605637|NCT01188304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6605638|NCT01188304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6605639|NCT01188304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605640|NCT01188304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6605641|NCT01188304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6605642|NCT01188304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6605643|NCT01188304|Antipyretics|antipyretics|mesh-ancestor
6605644|NCT01188317|Ibuprofen|ibuprofen|mesh-list
6605645|NCT01188317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6605646|NCT01188317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6605647|NCT01188317|Analgesics|analgesics|mesh-ancestor
6605648|NCT01188317|Sensory System Agents|sensory system agents|mesh-ancestor
6605649|NCT01188317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6605650|NCT01188317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605651|NCT01188317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6605652|NCT01188317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6605653|NCT01188317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6605654|NCT01188317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6605655|NCT01188317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6449347|NCT00404274|Warfarin|warfarin|mesh-list
6449348|NCT00404274|Anticoagulants|anticoagulants|mesh-ancestor
6449349|NCT00404274|Antiemetics|antiemetics|mesh-ancestor
6449350|NCT00404274|Autonomic Agents|autonomic agents|mesh-ancestor
6449351|NCT00404274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6449352|NCT00404274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449353|NCT00404274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6449354|NCT00404274|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6449355|NCT00404274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6449356|NCT00404274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461842|NCT00456430|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6605656|NCT01188408|Docetaxel|docetaxel|mesh-list
6605657|NCT01188408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6605658|NCT01188408|Tubulin Modulators|tubulin modulators|mesh-ancestor
6605659|NCT01188408|Antimitotic Agents|antimitotic agents|mesh-ancestor
6605660|NCT01188408|Mitosis Modulators|mitosis modulators|mesh-ancestor
6605661|NCT01188408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605662|NCT01188707|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6605663|NCT01188707|Belinostat|belinostat|mesh-list
6605664|NCT01188707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6605665|NCT01188707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6605666|NCT01188707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6605667|NCT01188707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605668|NCT01188707|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6605669|NCT01188733|Octreotide|octreotide|mesh-list
6605670|NCT01188733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6605671|NCT01188733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6605672|NCT01188733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6605673|NCT01188759|Voriconazole|voriconazole|mesh-list
6605674|NCT01188759|Anidulafungin|anidulafungin|mesh-list
6605675|NCT01188759|Antifungal Agents|antifungal agents|mesh-ancestor
6605676|NCT01188759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6605677|NCT01188759|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6605678|NCT01188759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6605679|NCT01188759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6605680|NCT01188759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605681|NCT01188759|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6605682|NCT01188759|Hormone Antagonists|hormone antagonists|mesh-ancestor
6605683|NCT01188759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6605684|NCT01188759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605685|NCT01188759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6605686|NCT01188824|Cilostazol|cilostazol|mesh-list
6605687|NCT01188824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6605688|NCT01188824|Autonomic Agents|autonomic agents|mesh-ancestor
6605689|NCT01188824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6605690|NCT01188824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605691|NCT01188824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6605692|NCT01188824|Respiratory System Agents|respiratory system agents|mesh-ancestor
6605693|NCT01188824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6605694|NCT01188824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6605695|NCT01188824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605696|NCT01188824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6605697|NCT01188824|Vasodilator Agents|vasodilator agents|mesh-ancestor
6605698|NCT01188824|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6605699|NCT01188824|Protective Agents|protective agents|mesh-ancestor
6605700|NCT01188824|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6605701|NCT01188824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6605702|NCT01188824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6605703|NCT01188863|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
6605704|NCT01188863|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6605705|NCT01188863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605706|NCT01188863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6605707|NCT01188863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605708|NCT01188889|Imatinib Mesylate|imatinib mesylate|mesh-list
6605709|NCT01188889|Everolimus|everolimus|mesh-list
6605710|NCT01188889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6605711|NCT01188889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6605712|NCT01188889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6605713|NCT01188889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605714|NCT01188889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6605715|NCT01188889|Immunologic Factors|immunologic factors|mesh-ancestor
6605716|NCT01188889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605717|NCT01188954|Doxycycline|doxycycline|mesh-list
6605718|NCT01188954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6605719|NCT01188954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6605720|NCT01188954|Antimalarials|antimalarials|mesh-ancestor
6605721|NCT01188954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6605722|NCT01188954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6605723|NCT01189006|Dextromethorphan|dextromethorphan|mesh-list
6605724|NCT01189006|Antitussive Agents|antitussive agents|mesh-ancestor
6605725|NCT01189006|Respiratory System Agents|respiratory system agents|mesh-ancestor
6605726|NCT01189006|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6605727|NCT01189006|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6605728|NCT01189006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6605729|NCT01189006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605730|NCT01189006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605731|NCT01189019|Ranibizumab|ranibizumab|mesh-list
6605732|NCT01189019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6605733|NCT01189019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6605734|NCT01189019|Growth Substances|growth substances|mesh-ancestor
6605735|NCT01189019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605736|NCT01189019|Growth Inhibitors|growth inhibitors|mesh-ancestor
6605737|NCT01189019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6605738|NCT01189097|Dextromethorphan|dextromethorphan|mesh-list
6605739|NCT01189097|Antitussive Agents|antitussive agents|mesh-ancestor
6605740|NCT01189097|Respiratory System Agents|respiratory system agents|mesh-ancestor
6605741|NCT01189097|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6605742|NCT01189097|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6605743|NCT01189097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6605744|NCT01189097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605745|NCT01189097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605746|NCT01189214|Memantine|memantine|mesh-list
6605747|NCT01189214|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6605748|NCT01189214|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6605749|NCT01189214|Dopamine Agents|dopamine agents|mesh-ancestor
6605750|NCT01189214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6449357|NCT00404326|Hydralazine|hydralazine|mesh-list
6449358|NCT00404326|Valproic Acid|valproic acid|mesh-list
6449359|NCT00404326|Anticonvulsants|anticonvulsants|mesh-ancestor
6449360|NCT00404326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6449361|NCT00404326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6449362|NCT00404326|GABA Agents|gaba agents|mesh-ancestor
6449363|NCT00404326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6449364|NCT00404326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449365|NCT00404326|Antimanic Agents|antimanic agents|mesh-ancestor
6605751|NCT01189214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605752|NCT01189214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605753|NCT01189214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6605754|NCT01189214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6605755|NCT01189253|Doxorubicin|doxorubicin|mesh-list
6605756|NCT01189253|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6605757|NCT01189253|Trabectedin|trabectedin|mesh-list
6605758|NCT01189253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6605759|NCT01189253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6605760|NCT01189253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6605761|NCT01189253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6605762|NCT01189253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6605763|NCT01189253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605764|NCT01189253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6605765|NCT01189253|Alkylating Agents|alkylating agents|mesh-ancestor
6605766|NCT01189318|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6605767|NCT01189318|Antidepressive Agents|antidepressive agents|mesh-ancestor
6605768|NCT01189318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6605769|NCT01189318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6605770|NCT01189318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6605771|NCT01189318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6605772|NCT01189318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605773|NCT01189448|Pyrimethamine|pyrimethamine|mesh-list
6605774|NCT01189448|Sulfadiazine|sulfadiazine|mesh-list
6605775|NCT01189448|Spiramycin|spiramycin|mesh-list
6605776|NCT01189448|Antimalarials|antimalarials|mesh-ancestor
6605777|NCT01189448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6605778|NCT01189448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6605779|NCT01189448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6605780|NCT01189448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6605781|NCT01189448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6605782|NCT01189448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605783|NCT01189448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6605784|NCT01189448|Coccidiostats|coccidiostats|mesh-ancestor
6605785|NCT01189526|Ranibizumab|ranibizumab|mesh-list
6605786|NCT01189526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6605787|NCT01189526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6605788|NCT01189526|Growth Substances|growth substances|mesh-ancestor
6605789|NCT01189526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605790|NCT01189526|Growth Inhibitors|growth inhibitors|mesh-ancestor
6605791|NCT01189526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6605792|NCT01189643|Bevacizumab|bevacizumab|mesh-list
6605793|NCT01189643|Irinotecan|irinotecan|mesh-list
6605794|NCT01189643|Temozolomide|temozolomide|mesh-list
6605795|NCT01189643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6605796|NCT01189643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6605797|NCT01189643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6605798|NCT01189643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6605799|NCT01189643|Growth Substances|growth substances|mesh-ancestor
6605800|NCT01189643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605801|NCT01189643|Growth Inhibitors|growth inhibitors|mesh-ancestor
6605802|NCT01189643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6605803|NCT01189643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6605804|NCT01189643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6605805|NCT01189643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605806|NCT01189643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6449366|NCT00404326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6605807|NCT01189643|Alkylating Agents|alkylating agents|mesh-ancestor
6605808|NCT01189656|Vaccines|vaccines|mesh-list
6605809|NCT01189656|Immunologic Factors|immunologic factors|mesh-ancestor
6605810|NCT01189656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605811|NCT01189695|Ritonavir|ritonavir|mesh-list
6605812|NCT01189695|Lopinavir|lopinavir|mesh-list
6605813|NCT01189695|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6605814|NCT01189695|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6605815|NCT01189695|Protease Inhibitors|protease inhibitors|mesh-ancestor
6605816|NCT01189695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6605817|NCT01189695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605818|NCT01189695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6605819|NCT01189695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6605820|NCT01189695|Antiviral Agents|antiviral agents|mesh-ancestor
6605821|NCT01189695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6605822|NCT01189695|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6449367|NCT00404326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6449368|NCT00404326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6449369|NCT00404326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6449370|NCT00404326|Vasodilator Agents|vasodilator agents|mesh-ancestor
6449371|NCT00404378|Ketoconazole|ketoconazole|mesh-list
6449372|NCT00404378|Casopitant|casopitant|mesh-list
6449373|NCT00404378|Antifungal Agents|antifungal agents|mesh-ancestor
6449374|NCT00404378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6449375|NCT00404378|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6449376|NCT00404378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6449377|NCT00404378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6605823|NCT01189695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6605824|NCT01189721|Propofol|propofol|mesh-list
6605825|NCT01189721|Sevoflurane|sevoflurane|mesh-list
6605826|NCT01189721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6605827|NCT01189721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6605828|NCT01189721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605829|NCT01189721|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6605830|NCT01189721|Anesthetics, General|anesthetics, general|mesh-ancestor
6605831|NCT01189721|Anesthetics|anesthetics|mesh-ancestor
6605832|NCT01189721|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6605833|NCT01189721|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6605834|NCT01189773|Ibuprofen|ibuprofen|mesh-list
6449378|NCT00404378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6449379|NCT00404378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6605835|NCT01189773|Codeine|codeine|mesh-list
6605836|NCT01189773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6605837|NCT01189773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6605838|NCT01189773|Analgesics|analgesics|mesh-ancestor
6605839|NCT01189773|Sensory System Agents|sensory system agents|mesh-ancestor
6605840|NCT01189773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6605841|NCT01189773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605842|NCT01189773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6605843|NCT01189773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6605844|NCT01189773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6605845|NCT01189773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6605846|NCT01189773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605847|NCT01189773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6605848|NCT01189773|Narcotics|narcotics|mesh-ancestor
6605849|NCT01189773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6605850|NCT01189773|Antitussive Agents|antitussive agents|mesh-ancestor
6605851|NCT01189773|Respiratory System Agents|respiratory system agents|mesh-ancestor
6605852|NCT01189864|Diclofenac|diclofenac|mesh-list
6605853|NCT01189864|Prednisolone acetate|prednisolone acetate|mesh-list
6605854|NCT01189864|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6605855|NCT01189864|Methylprednisolone|methylprednisolone|mesh-list
6605856|NCT01189864|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6605857|NCT01189864|Prednisolone|prednisolone|mesh-list
6660496|NCT01493674|Micronutrients|micronutrients|mesh-ancestor
6605858|NCT01189864|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6605859|NCT01189864|Prednisolone phosphate|prednisolone phosphate|mesh-list
6605860|NCT01189864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6605861|NCT01189864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6605862|NCT01189864|Analgesics|analgesics|mesh-ancestor
6605863|NCT01189864|Sensory System Agents|sensory system agents|mesh-ancestor
6605864|NCT01189864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6605865|NCT01189864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605866|NCT01189864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6605867|NCT01189864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6605868|NCT01189864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6605869|NCT01189864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6605870|NCT01189864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605871|NCT01189864|Antiemetics|antiemetics|mesh-ancestor
6605872|NCT01189864|Autonomic Agents|autonomic agents|mesh-ancestor
6605873|NCT01189864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6605874|NCT01189864|Glucocorticoids|glucocorticoids|mesh-ancestor
6605875|NCT01189864|Hormones|hormones|mesh-ancestor
6605876|NCT01189864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6605877|NCT01189864|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6605878|NCT01189864|Protective Agents|protective agents|mesh-ancestor
6605879|NCT01189864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6605880|NCT01189864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6605881|NCT01189929|Gemcitabine|gemcitabine|mesh-list
6605882|NCT01189929|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6605883|NCT01189929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6605884|NCT01189929|Antimetabolites|antimetabolites|mesh-ancestor
6605885|NCT01189929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605886|NCT01189929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6605887|NCT01189929|Antiviral Agents|antiviral agents|mesh-ancestor
6605888|NCT01189929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6605889|NCT01189929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6605890|NCT01189929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6605891|NCT01189929|Immunologic Factors|immunologic factors|mesh-ancestor
6605892|NCT01189929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605893|NCT01190137|Cholecalciferol|cholecalciferol|mesh-list
6605894|NCT01190137|Ergocalciferols|ergocalciferols|mesh-list
6605895|NCT01190137|Vitamin D|vitamin d|mesh-list
6605896|NCT01190137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6605897|NCT01190137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605898|NCT01190137|Vitamins|vitamins|mesh-ancestor
6605899|NCT01190137|Micronutrients|micronutrients|mesh-ancestor
6605900|NCT01190137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6605901|NCT01190163|Oxytocin|oxytocin|mesh-list
6605902|NCT01190163|Dinoprostone|dinoprostone|mesh-list
6605903|NCT01190163|Oxytocics|oxytocics|mesh-ancestor
6605904|NCT01190163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6605905|NCT01190163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660497|NCT01493674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660498|NCT01493791|Ulipristal acetate|ulipristal acetate|mesh-list
6660499|NCT01493791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6660500|NCT01493791|Contraceptive Agents|contraceptive agents|mesh-ancestor
6660501|NCT01493791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6660502|NCT01493791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660503|NCT01493791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6660504|NCT01493843|Paclitaxel|paclitaxel|mesh-list
6660505|NCT01493843|Bevacizumab|bevacizumab|mesh-list
6660506|NCT01493843|Carboplatin|carboplatin|mesh-list
6660507|NCT01493843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6660508|NCT01493843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6660509|NCT01493843|Tubulin Modulators|tubulin modulators|mesh-ancestor
6660510|NCT01493843|Antimitotic Agents|antimitotic agents|mesh-ancestor
6660511|NCT01493843|Mitosis Modulators|mitosis modulators|mesh-ancestor
6660512|NCT01493843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660513|NCT01493843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6660514|NCT01493843|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6660515|NCT01493843|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6660516|NCT01493843|Growth Substances|growth substances|mesh-ancestor
6660517|NCT01493843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660518|NCT01493843|Growth Inhibitors|growth inhibitors|mesh-ancestor
6660519|NCT01493856|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6605906|NCT01190241|Everolimus|everolimus|mesh-list
6605907|NCT01190241|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6605908|NCT01190241|Sorafenib|sorafenib|mesh-list
6605909|NCT01190241|Sunitinib|sunitinib|mesh-list
6605910|NCT01190241|Lapatinib|lapatinib|mesh-list
6605911|NCT01190241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6605912|NCT01190241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6605913|NCT01190241|Immunologic Factors|immunologic factors|mesh-ancestor
6605914|NCT01190241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605915|NCT01190241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6605916|NCT01190241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6605917|NCT01190241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605918|NCT01190241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6605919|NCT01190241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6605920|NCT01190241|Growth Substances|growth substances|mesh-ancestor
6605921|NCT01190241|Growth Inhibitors|growth inhibitors|mesh-ancestor
6605922|NCT01190293|Efavirenz|efavirenz|mesh-list
5501854|NCT04470076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5501855|NCT04470310|Pioglitazone|pioglitazone|mesh-list
5501856|NCT04470310|Glimepiride|glimepiride|mesh-list
5501857|NCT04470310|Alogliptin|alogliptin|mesh-list
5501858|NCT04470310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5501859|NCT04470310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501860|NCT04470310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5501861|NCT04470310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5501862|NCT04470310|Immunologic Factors|immunologic factors|mesh-ancestor
5501863|NCT04470310|Incretins|incretins|mesh-ancestor
5501864|NCT04470310|Hormones|hormones|mesh-ancestor
5501865|NCT04470310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5501866|NCT04470310|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5501867|NCT04470310|Protease Inhibitors|protease inhibitors|mesh-ancestor
5501868|NCT04470310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5501869|NCT04470310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501870|NCT04470115|Anesthetics|anesthetics|mesh-list
5501871|NCT04470115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5501872|NCT04470115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501873|NCT04469868|Analgesics, Opioid|analgesics, opioid|mesh-list
5501874|NCT04469868|Narcotics|narcotics|mesh-ancestor
5501875|NCT04469868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5501876|NCT04469868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501877|NCT04469868|Analgesics|analgesics|mesh-ancestor
5501878|NCT04469868|Sensory System Agents|sensory system agents|mesh-ancestor
5501879|NCT04469868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5501880|NCT04470050|Dexmedetomidine|dexmedetomidine|mesh-list
5501881|NCT04470050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5501882|NCT04470050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5501883|NCT04470050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501884|NCT04470050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5501885|NCT04470050|Analgesics|analgesics|mesh-ancestor
5501886|NCT04470050|Sensory System Agents|sensory system agents|mesh-ancestor
5501887|NCT04470050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6449380|NCT00404378|Hormone Antagonists|hormone antagonists|mesh-ancestor
6449381|NCT00404378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6449382|NCT00404378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449383|NCT00404378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6449384|NCT00404378|Antiemetics|antiemetics|mesh-ancestor
6449385|NCT00404378|Autonomic Agents|autonomic agents|mesh-ancestor
6449386|NCT00404378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6449387|NCT00404378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6449388|NCT00404378|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6449389|NCT00404378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6449390|NCT00404391|Acetaminophen|acetaminophen|mesh-list
6449391|NCT00404391|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
6449392|NCT00404391|Hydrocodone|hydrocodone|mesh-list
6449393|NCT00404391|Oxycodone|oxycodone|mesh-list
6449394|NCT00404391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6449395|NCT00404391|Analgesics|analgesics|mesh-ancestor
6449396|NCT00404391|Sensory System Agents|sensory system agents|mesh-ancestor
6449397|NCT00404391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6449398|NCT00404391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605923|NCT01190293|Maraviroc|maraviroc|mesh-list
6605924|NCT01190293|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6605925|NCT01190293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6605926|NCT01190293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6605927|NCT01190293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605928|NCT01190293|Antiviral Agents|antiviral agents|mesh-ancestor
6605929|NCT01190293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6605930|NCT01190293|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6605931|NCT01190293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6605932|NCT01190293|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6605933|NCT01190293|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6605934|NCT01190293|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6605935|NCT01190293|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6605936|NCT01190293|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6605937|NCT01190293|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6605938|NCT01190293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6605939|NCT01190293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6605940|NCT01190293|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6605941|NCT01190345|Bevacizumab|bevacizumab|mesh-list
6605942|NCT01190345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6605943|NCT01190345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6605944|NCT01190345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6605945|NCT01190345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6605946|NCT01190345|Growth Substances|growth substances|mesh-ancestor
6605947|NCT01190345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605948|NCT01190345|Growth Inhibitors|growth inhibitors|mesh-ancestor
6605949|NCT01190358|Grape Seed Extract|grape seed extract|mesh-list
6605950|NCT01190358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6605951|NCT01190358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6605952|NCT01190358|Antioxidants|antioxidants|mesh-ancestor
6605953|NCT01190358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605954|NCT01190358|Protective Agents|protective agents|mesh-ancestor
6605955|NCT01190358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605956|NCT01190371|Artesunate|artesunate|mesh-list
6605957|NCT01190371|Antimalarials|antimalarials|mesh-ancestor
6605958|NCT01190371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6605959|NCT01190371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6605960|NCT01190371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6605961|NCT01190371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6605962|NCT01190371|Antiviral Agents|antiviral agents|mesh-ancestor
6605963|NCT01190371|Schistosomicides|schistosomicides|mesh-ancestor
6605964|NCT01190371|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6605965|NCT01190371|Anthelmintics|anthelmintics|mesh-ancestor
6605966|NCT01190384|Grape Seed Extract|grape seed extract|mesh-list
6605967|NCT01190384|Antioxidants|antioxidants|mesh-list
6605968|NCT01190384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605969|NCT01190384|Protective Agents|protective agents|mesh-ancestor
6605970|NCT01190384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605971|NCT01190384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6605972|NCT01190384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6605973|NCT01190462|Cetuximab|cetuximab|mesh-list
6605974|NCT01190462|Simvastatin|simvastatin|mesh-list
6605975|NCT01190462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6605976|NCT01190462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6605977|NCT01190462|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6605978|NCT01190462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6605979|NCT01190462|Antimetabolites|antimetabolites|mesh-ancestor
6605980|NCT01190462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605981|NCT01190462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6605982|NCT01190462|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6605983|NCT01190462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6605984|NCT01190553|Amantadine|amantadine|mesh-list
6605985|NCT01190553|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6605986|NCT01190553|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6605987|NCT01190553|Antiviral Agents|antiviral agents|mesh-ancestor
6605988|NCT01190553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6605989|NCT01190553|Dopamine Agents|dopamine agents|mesh-ancestor
6605990|NCT01190553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6605991|NCT01190553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6605992|NCT01190553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6605993|NCT01190553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6605994|NCT01190553|Analgesics|analgesics|mesh-ancestor
6605995|NCT01190553|Sensory System Agents|sensory system agents|mesh-ancestor
6664923|NCT01514825|Anticoagulants|anticoagulants|mesh-ancestor
6605996|NCT01190553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6605997|NCT01190670|Tacrolimus|tacrolimus|mesh-list
6605998|NCT01190670|Peficitinib|peficitinib|mesh-list
6605999|NCT01190670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6606000|NCT01190670|Immunologic Factors|immunologic factors|mesh-ancestor
6606001|NCT01190670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606002|NCT01190670|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6606003|NCT01190670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6606004|NCT01190670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606005|NCT01190683|Calcium, Dietary|calcium, dietary|mesh-list
6606006|NCT01190683|Vitamin D|vitamin d|mesh-list
6606007|NCT01190683|Ergocalciferols|ergocalciferols|mesh-list
6606008|NCT01190683|Cholecalciferol|cholecalciferol|mesh-list
6606009|NCT01190683|Vitamins|vitamins|mesh-list
6606010|NCT01190683|Calcium Carbonate|calcium carbonate|mesh-list
6606011|NCT01190683|Calcium|calcium|mesh-list
6606012|NCT01190683|Micronutrients|micronutrients|mesh-ancestor
6606013|NCT01190683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606014|NCT01190683|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6606015|NCT01190683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6606016|NCT01190683|Antacids|antacids|mesh-ancestor
6606017|NCT01190683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606018|NCT01190683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6606019|NCT01190722|Diclofenac|diclofenac|mesh-list
6606020|NCT01190722|Etoricoxib|etoricoxib|mesh-list
6606021|NCT01190722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6606022|NCT01190722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6606023|NCT01190722|Analgesics|analgesics|mesh-ancestor
6606024|NCT01190722|Sensory System Agents|sensory system agents|mesh-ancestor
6606025|NCT01190722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6606026|NCT01190722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606027|NCT01190722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6606028|NCT01190722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6606029|NCT01190722|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6606030|NCT01190722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6606031|NCT01190722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606032|NCT01190722|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6606033|NCT01190735|Caffeine|caffeine|mesh-list
6606034|NCT01190735|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6606035|NCT01190735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606036|NCT01190735|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6606037|NCT01190735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6606038|NCT01190735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606039|NCT01190735|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6606040|NCT01190735|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6606041|NCT01190735|Purinergic Agents|purinergic agents|mesh-ancestor
6606042|NCT01190735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6606043|NCT01190748|Galantamine|galantamine|mesh-list
6606044|NCT01190748|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6606045|NCT01190748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6606046|NCT01190748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606047|NCT01190748|Cholinergic Agents|cholinergic agents|mesh-ancestor
6606048|NCT01190748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6606049|NCT01190748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606050|NCT01190748|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6606051|NCT01190748|Autonomic Agents|autonomic agents|mesh-ancestor
6606052|NCT01190748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6606053|NCT01190748|Nootropic Agents|nootropic agents|mesh-ancestor
6606054|NCT01190761|Galantamine|galantamine|mesh-list
6606055|NCT01190761|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6606056|NCT01190761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6606057|NCT01190761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606058|NCT01190761|Cholinergic Agents|cholinergic agents|mesh-ancestor
6606059|NCT01190761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6606060|NCT01190761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606061|NCT01190761|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6606062|NCT01190761|Autonomic Agents|autonomic agents|mesh-ancestor
6606063|NCT01190761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6606064|NCT01190761|Nootropic Agents|nootropic agents|mesh-ancestor
6606065|NCT01190787|Prednisone|prednisone|mesh-list
6606066|NCT01190787|Cyclophosphamide|cyclophosphamide|mesh-list
6606067|NCT01190787|Melphalan|melphalan|mesh-list
6606068|NCT01190787|Bortezomib|bortezomib|mesh-list
6606069|NCT01190787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6606070|NCT01190787|Immunologic Factors|immunologic factors|mesh-ancestor
6606071|NCT01190787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606072|NCT01190787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6606073|NCT01190787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6606074|NCT01190787|Alkylating Agents|alkylating agents|mesh-ancestor
6606075|NCT01190787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606076|NCT01190787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6606077|NCT01190787|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6606078|NCT01190787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6606079|NCT01190787|Glucocorticoids|glucocorticoids|mesh-ancestor
6606080|NCT01190787|Hormones|hormones|mesh-ancestor
6606081|NCT01190787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6606082|NCT01190787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6606083|NCT01190982|Paclitaxel|paclitaxel|mesh-list
6606084|NCT01190982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6606085|NCT01190982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6606086|NCT01190982|Tubulin Modulators|tubulin modulators|mesh-ancestor
6606087|NCT01190982|Antimitotic Agents|antimitotic agents|mesh-ancestor
6606088|NCT01190982|Mitosis Modulators|mitosis modulators|mesh-ancestor
6606089|NCT01190982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606090|NCT01191021|Propofol|propofol|mesh-list
6606091|NCT01191021|Anesthetics|anesthetics|mesh-ancestor
6606092|NCT01191021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6606093|NCT01191021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606094|NCT01191021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6606095|NCT01191021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6606096|NCT01191021|Anesthetics, General|anesthetics, general|mesh-ancestor
6606097|NCT01191034|Imiquimod|imiquimod|mesh-list
6606098|NCT01191034|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6606099|NCT01191034|Immunologic Factors|immunologic factors|mesh-ancestor
6606100|NCT01191034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606101|NCT01191034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6606102|NCT01191034|Interferon Inducers|interferon inducers|mesh-ancestor
6606103|NCT01191060|Lenalidomide|lenalidomide|mesh-list
6606104|NCT01191060|Bortezomib|bortezomib|mesh-list
6606105|NCT01191060|Immunologic Factors|immunologic factors|mesh-ancestor
6606106|NCT01191060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606107|NCT01191060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6606108|NCT01191060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6606109|NCT01191060|Growth Substances|growth substances|mesh-ancestor
6606110|NCT01191060|Growth Inhibitors|growth inhibitors|mesh-ancestor
6606111|NCT01191060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6606112|NCT01191203|Copper|copper|mesh-list
6606113|NCT01191203|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6606114|NCT01191203|Medroxyprogesterone|medroxyprogesterone|mesh-list
6606115|NCT01191203|Trace Elements|trace elements|mesh-ancestor
6606116|NCT01191203|Micronutrients|micronutrients|mesh-ancestor
6606117|NCT01191203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606118|NCT01191203|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6606119|NCT01191203|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6606120|NCT01191203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6606121|NCT01191203|Contraceptive Agents|contraceptive agents|mesh-ancestor
6606122|NCT01191203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6606123|NCT01191203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6606124|NCT01191203|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6606125|NCT01191203|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6606126|NCT01191203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6606127|NCT01191203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6606128|NCT01191216|Docetaxel|docetaxel|mesh-list
6606129|NCT01191216|Tryptophan|tryptophan|mesh-list
6606130|NCT01191216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6606131|NCT01191216|Tubulin Modulators|tubulin modulators|mesh-ancestor
6606132|NCT01191216|Antimitotic Agents|antimitotic agents|mesh-ancestor
6606133|NCT01191216|Mitosis Modulators|mitosis modulators|mesh-ancestor
6606134|NCT01191216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606135|NCT01191216|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6664924|NCT01514838|Acarbose|acarbose|mesh-list
6449399|NCT00404391|Antipyretics|antipyretics|mesh-ancestor
6449400|NCT00404391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6449401|NCT00404391|Narcotics|narcotics|mesh-ancestor
6449402|NCT00404391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6449403|NCT00404391|Antitussive Agents|antitussive agents|mesh-ancestor
6449404|NCT00404391|Respiratory System Agents|respiratory system agents|mesh-ancestor
6449405|NCT00404391|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6449406|NCT00404391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6449407|NCT00404391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6449408|NCT00404404|Paclitaxel|paclitaxel|mesh-list
6449409|NCT00404404|Bevacizumab|bevacizumab|mesh-list
6449410|NCT00404404|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6449411|NCT00404404|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6449412|NCT00404404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6449413|NCT00404404|Tubulin Modulators|tubulin modulators|mesh-ancestor
6449414|NCT00404404|Antimitotic Agents|antimitotic agents|mesh-ancestor
6449415|NCT00404404|Mitosis Modulators|mitosis modulators|mesh-ancestor
6449416|NCT00404404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6449417|NCT00404404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6449418|NCT00404404|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6449419|NCT00404404|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6449420|NCT00404404|Growth Substances|growth substances|mesh-ancestor
6449421|NCT00404404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449422|NCT00404404|Growth Inhibitors|growth inhibitors|mesh-ancestor
6449423|NCT00404417|Botulinum Toxins|botulinum toxins|mesh-list
6449424|NCT00404417|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6449425|NCT00404417|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6449426|NCT00404417|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6606136|NCT01191216|Antidepressive Agents|antidepressive agents|mesh-ancestor
6606137|NCT01191216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6606138|NCT01191424|Formoterol Fumarate|formoterol fumarate|mesh-list
6606139|NCT01191424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6606140|NCT01191424|Autonomic Agents|autonomic agents|mesh-ancestor
6606141|NCT01191424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6606142|NCT01191424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606143|NCT01191424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6606144|NCT01191424|Respiratory System Agents|respiratory system agents|mesh-ancestor
6606145|NCT01191424|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6606146|NCT01191424|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6606147|NCT01191424|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6606148|NCT01191424|Adrenergic Agents|adrenergic agents|mesh-ancestor
6606149|NCT01191424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6606150|NCT01191424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606151|NCT01191450|Chlorthalidone|chlorthalidone|mesh-list
6606152|NCT01191450|Amiloride|amiloride|mesh-list
6606153|NCT01191450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6606154|NCT01191450|Diuretics|diuretics|mesh-ancestor
6606155|NCT01191450|Natriuretic Agents|natriuretic agents|mesh-ancestor
6606156|NCT01191450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606157|NCT01191450|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6606158|NCT01191450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6606159|NCT01191450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606160|NCT01191450|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
6606161|NCT01191450|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6606162|NCT01191450|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
6606163|NCT01191450|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6606164|NCT01191554|Tranexamic Acid|tranexamic acid|mesh-list
6606165|NCT01191554|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6606166|NCT01191554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6606167|NCT01191554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606168|NCT01191554|Hemostatics|hemostatics|mesh-ancestor
6606169|NCT01191554|Coagulants|coagulants|mesh-ancestor
6606170|NCT01191593|Ropivacaine|ropivacaine|mesh-list
6606171|NCT01191593|Anesthetics, Local|anesthetics, local|mesh-ancestor
6606172|NCT01191593|Anesthetics|anesthetics|mesh-ancestor
6606173|NCT01191593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6606174|NCT01191593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606175|NCT01191593|Sensory System Agents|sensory system agents|mesh-ancestor
6606176|NCT01191593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6606177|NCT01191645|Remifentanil|remifentanil|mesh-list
6606178|NCT01191645|Metoclopramide|metoclopramide|mesh-list
6606179|NCT01191645|Naloxone|naloxone|mesh-list
6606180|NCT01191645|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6606181|NCT01191645|Narcotics|narcotics|mesh-ancestor
6606182|NCT01191645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6606183|NCT01191645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606184|NCT01191645|Analgesics|analgesics|mesh-ancestor
6606185|NCT01191645|Sensory System Agents|sensory system agents|mesh-ancestor
6606186|NCT01191645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6606187|NCT01191645|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6606188|NCT01191645|Antiemetics|antiemetics|mesh-ancestor
6606189|NCT01191645|Autonomic Agents|autonomic agents|mesh-ancestor
6606190|NCT01191645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6606191|NCT01191645|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6606192|NCT01191645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6606193|NCT01191645|Dopamine Agents|dopamine agents|mesh-ancestor
6606194|NCT01191645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6606195|NCT01191645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606196|NCT01191684|Vaccines|vaccines|mesh-list
6606197|NCT01191684|Immunologic Factors|immunologic factors|mesh-ancestor
6606198|NCT01191684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606199|NCT01191697|Bevacizumab|bevacizumab|mesh-list
6606200|NCT01191697|Trastuzumab|trastuzumab|mesh-list
6606201|NCT01191697|Capecitabine|capecitabine|mesh-list
6606202|NCT01191697|Oxaliplatin|oxaliplatin|mesh-list
6606203|NCT01191697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6606204|NCT01191697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6664925|NCT01514838|Ipragliflozin|ipragliflozin|mesh-list
6606205|NCT01191697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6606206|NCT01191697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6606207|NCT01191697|Growth Substances|growth substances|mesh-ancestor
6606208|NCT01191697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606209|NCT01191697|Growth Inhibitors|growth inhibitors|mesh-ancestor
6606210|NCT01191697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6606211|NCT01191697|Antimetabolites|antimetabolites|mesh-ancestor
6606212|NCT01191697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606213|NCT01191710|Progesterone|progesterone|mesh-list
6606214|NCT01191710|Progestins|progestins|mesh-ancestor
6606215|NCT01191710|Hormones|hormones|mesh-ancestor
6606216|NCT01191710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6606217|NCT01191710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606218|NCT01191892|Gemcitabine|gemcitabine|mesh-list
6606219|NCT01191892|Carboplatin|carboplatin|mesh-list
6606220|NCT01191892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6606221|NCT01191892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6606222|NCT01191892|Antimetabolites|antimetabolites|mesh-ancestor
6606223|NCT01191892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606224|NCT01191892|Antiviral Agents|antiviral agents|mesh-ancestor
6606225|NCT01191892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6606226|NCT01191892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6606227|NCT01191892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6606228|NCT01191892|Immunologic Factors|immunologic factors|mesh-ancestor
6606229|NCT01191892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606230|NCT01191918|Lithium Carbonate|lithium carbonate|mesh-list
6606231|NCT01191918|Donepezil|donepezil|mesh-list
6606232|NCT01191918|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6606233|NCT01191918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6606234|NCT01191918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606235|NCT01191918|Cholinergic Agents|cholinergic agents|mesh-ancestor
6606236|NCT01191918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6606237|NCT01191918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606238|NCT01191918|Nootropic Agents|nootropic agents|mesh-ancestor
6606239|NCT01191918|Antidepressive Agents|antidepressive agents|mesh-ancestor
6606240|NCT01191918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6606241|NCT01191918|Antimanic Agents|antimanic agents|mesh-ancestor
6606242|NCT01191918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6606243|NCT01191918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6606244|NCT01191957|Cyclophosphamide|cyclophosphamide|mesh-list
6606245|NCT01191957|Busulfan|busulfan|mesh-list
6606246|NCT01191957|Fludarabine|fludarabine|mesh-list
5724832|NCT03185130|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5724833|NCT03185130|Histamine Antagonists|histamine antagonists|mesh-ancestor
5724834|NCT03185130|Histamine Agents|histamine agents|mesh-ancestor
5724835|NCT03185130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5724836|NCT03185130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724837|NCT03185130|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5724838|NCT03185130|Antipruritics|antipruritics|mesh-ancestor
5724839|NCT03185130|Dermatologic Agents|dermatologic agents|mesh-ancestor
5724840|NCT03185130|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5724841|NCT03185130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5724842|NCT03185130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5724843|NCT03185130|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5724844|NCT03185130|Dopamine Agents|dopamine agents|mesh-ancestor
5724845|NCT03184805|Aspirin|aspirin|mesh-list
5724846|NCT03184805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5724847|NCT03184805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5724848|NCT03184805|Analgesics|analgesics|mesh-ancestor
5724849|NCT03184805|Sensory System Agents|sensory system agents|mesh-ancestor
6606247|NCT01191957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6606248|NCT01191957|Immunologic Factors|immunologic factors|mesh-ancestor
6606249|NCT01191957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606250|NCT01191957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6606251|NCT01191957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6606252|NCT01191957|Alkylating Agents|alkylating agents|mesh-ancestor
6606253|NCT01191957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606254|NCT01191957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6606255|NCT01191957|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6606256|NCT01191983|Epoetin Alfa|epoetin alfa|mesh-list
6606257|NCT01191983|Hematinics|hematinics|mesh-ancestor
6606258|NCT01192087|Cetuximab|cetuximab|mesh-list
6606259|NCT01192087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6606260|NCT01192087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6606261|NCT01192113|Vitamin B 12|vitamin b 12|mesh-list
6606262|NCT01192113|Vitamin B Complex|vitamin b complex|mesh-ancestor
6606263|NCT01192113|Vitamins|vitamins|mesh-ancestor
6606264|NCT01192113|Micronutrients|micronutrients|mesh-ancestor
6606265|NCT01192113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606266|NCT01192165|Paclitaxel|paclitaxel|mesh-list
6606267|NCT01192165|Docetaxel|docetaxel|mesh-list
6606268|NCT01192165|Carboplatin|carboplatin|mesh-list
6606269|NCT01192165|Pemetrexed|pemetrexed|mesh-list
6606270|NCT01192165|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6606271|NCT01192165|Trametinib|trametinib|mesh-list
6606272|NCT01192165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6606273|NCT01192165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6606274|NCT01192165|Tubulin Modulators|tubulin modulators|mesh-ancestor
6606275|NCT01192165|Antimitotic Agents|antimitotic agents|mesh-ancestor
6606276|NCT01192165|Mitosis Modulators|mitosis modulators|mesh-ancestor
6606277|NCT01192165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606278|NCT01192165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6606279|NCT01192165|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6606280|NCT01192165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6606281|NCT01192165|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6606282|NCT01192230|Docetaxel|docetaxel|mesh-list
6606283|NCT01192230|Endostatins|endostatins|mesh-list
6606284|NCT01192230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6606285|NCT01192230|Tubulin Modulators|tubulin modulators|mesh-ancestor
6606286|NCT01192230|Antimitotic Agents|antimitotic agents|mesh-ancestor
6606287|NCT01192230|Mitosis Modulators|mitosis modulators|mesh-ancestor
6606288|NCT01192230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606289|NCT01192230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6606290|NCT01192230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6606291|NCT01192230|Growth Substances|growth substances|mesh-ancestor
6606292|NCT01192230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606293|NCT01192230|Growth Inhibitors|growth inhibitors|mesh-ancestor
6660520|NCT01493856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6660521|NCT01493856|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6660522|NCT01493856|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6660523|NCT01493856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660524|NCT01493973|Epoetin Alfa|epoetin alfa|mesh-list
6660525|NCT01493973|Hematinics|hematinics|mesh-ancestor
6660526|NCT01493986|Ropivacaine|ropivacaine|mesh-list
6660527|NCT01493986|Anesthetics, Local|anesthetics, local|mesh-ancestor
6660528|NCT01493986|Anesthetics|anesthetics|mesh-ancestor
6660529|NCT01493986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6660530|NCT01493986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660531|NCT01493986|Sensory System Agents|sensory system agents|mesh-ancestor
6660532|NCT01493986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6660533|NCT01493999|Clopidogrel|clopidogrel|mesh-list
6660534|NCT01493999|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6660535|NCT01493999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6660536|NCT01493999|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6660537|NCT01493999|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6660538|NCT01493999|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6660539|NCT01493999|Purinergic Agents|purinergic agents|mesh-ancestor
6660540|NCT01493999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6660541|NCT01493999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660542|NCT01493999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660543|NCT01494012|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6660544|NCT01494012|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6660545|NCT01494012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660546|NCT01494090|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6660547|NCT01494090|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6660548|NCT01494090|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6660549|NCT01494090|Antimetabolites|antimetabolites|mesh-ancestor
6660550|NCT01494090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660551|NCT01494090|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6660552|NCT01494090|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6660553|NCT01494090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6660554|NCT01494155|Hydroxychloroquine|hydroxychloroquine|mesh-list
6660555|NCT01494155|Capecitabine|capecitabine|mesh-list
6660556|NCT01494155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6660557|NCT01494155|Antimetabolites|antimetabolites|mesh-ancestor
6660558|NCT01494155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660559|NCT01494155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6660560|NCT01494155|Antimalarials|antimalarials|mesh-ancestor
6660561|NCT01494155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6660562|NCT01494155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6660563|NCT01494155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6660564|NCT01494155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6660565|NCT01494155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6660566|NCT01494259|Epinephrine|epinephrine|mesh-list
6660567|NCT01494259|Bupivacaine|bupivacaine|mesh-list
6660568|NCT01494259|Anesthetics, Local|anesthetics, local|mesh-ancestor
6660569|NCT01494259|Anesthetics|anesthetics|mesh-ancestor
6660570|NCT01494259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6660571|NCT01494259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660572|NCT01494259|Sensory System Agents|sensory system agents|mesh-ancestor
6660573|NCT01494259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6660574|NCT01494259|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6660575|NCT01494259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6660576|NCT01494259|Adrenergic Agents|adrenergic agents|mesh-ancestor
6660577|NCT01494259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6660578|NCT01494259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660579|NCT01494259|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6660580|NCT01494259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6660581|NCT01494259|Autonomic Agents|autonomic agents|mesh-ancestor
6660582|NCT01494259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6606294|NCT01192243|Carboplatin|carboplatin|mesh-list
6606295|NCT01192243|Pemetrexed|pemetrexed|mesh-list
6606296|NCT01192243|Gefitinib|gefitinib|mesh-list
6606297|NCT01192243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6606298|NCT01192243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6606299|NCT01192243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606300|NCT01192243|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6606301|NCT01192243|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6606302|NCT01192243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6606303|NCT01192308|Tamoxifen|tamoxifen|mesh-list
6606304|NCT01192308|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6606305|NCT01192308|Hormone Antagonists|hormone antagonists|mesh-ancestor
6606306|NCT01192308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6606307|NCT01192308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606308|NCT01192308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6606309|NCT01192308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6606310|NCT01192308|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6606311|NCT01192308|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6606312|NCT01192308|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6606313|NCT01192490|Lidocaine|lidocaine|mesh-list
6606314|NCT01192490|Anesthetics, Local|anesthetics, local|mesh-ancestor
6606315|NCT01192490|Anesthetics|anesthetics|mesh-ancestor
6606316|NCT01192490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6606317|NCT01192490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606318|NCT01192490|Sensory System Agents|sensory system agents|mesh-ancestor
6606319|NCT01192490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6606320|NCT01192490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6606321|NCT01192490|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6606322|NCT01192490|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6606323|NCT01192490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6606324|NCT01192490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606325|NCT01192503|Rasagiline|rasagiline|mesh-list
6606326|NCT01192503|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6606327|NCT01192503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6606328|NCT01192503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606329|NCT01192503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6606330|NCT01192503|Protective Agents|protective agents|mesh-ancestor
6606331|NCT01192503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606332|NCT01192529|Phentermine|phentermine|mesh-list
6606333|NCT01192529|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6606334|NCT01192529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606335|NCT01192529|Appetite Depressants|appetite depressants|mesh-ancestor
6606336|NCT01192529|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6606337|NCT01192529|Sympathomimetics|sympathomimetics|mesh-ancestor
6606338|NCT01192529|Autonomic Agents|autonomic agents|mesh-ancestor
6606339|NCT01192529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6606340|NCT01192529|Adrenergic Agents|adrenergic agents|mesh-ancestor
6606341|NCT01192529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6606342|NCT01192529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606343|NCT01192581|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
6606344|NCT01192581|Plasma Substitutes|plasma substitutes|mesh-ancestor
6606345|NCT01192581|Blood Substitutes|blood substitutes|mesh-ancestor
6606346|NCT01192724|Aspirin|aspirin|mesh-list
6606347|NCT01192724|Cilostazol|cilostazol|mesh-list
6606348|NCT01192724|Clopidogrel|clopidogrel|mesh-list
6606349|NCT01192724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6606350|NCT01192724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6606351|NCT01192724|Analgesics|analgesics|mesh-ancestor
6606352|NCT01192724|Sensory System Agents|sensory system agents|mesh-ancestor
6606353|NCT01192724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6606354|NCT01192724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606355|NCT01192724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6606356|NCT01192724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6606357|NCT01192724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6606358|NCT01192724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6606359|NCT01192724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606360|NCT01192724|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6606361|NCT01192724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6606362|NCT01192724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6606363|NCT01192724|Antipyretics|antipyretics|mesh-ancestor
6606364|NCT01192724|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6606365|NCT01192724|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6606366|NCT01192724|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6606367|NCT01192724|Purinergic Agents|purinergic agents|mesh-ancestor
6606368|NCT01192724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6606369|NCT01192724|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6606370|NCT01192724|Autonomic Agents|autonomic agents|mesh-ancestor
6606371|NCT01192724|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6606372|NCT01192724|Respiratory System Agents|respiratory system agents|mesh-ancestor
6606373|NCT01192724|Vasodilator Agents|vasodilator agents|mesh-ancestor
6606374|NCT01192724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6606375|NCT01192724|Protective Agents|protective agents|mesh-ancestor
6606376|NCT01192724|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6606377|NCT01192724|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6606378|NCT01192763|R04929097|r04929097|mesh-list
6606379|NCT01192763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6606380|NCT01192763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606381|NCT01192789|Amoxicillin|amoxicillin|mesh-list
6606382|NCT01192789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6606383|NCT01192789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6606384|NCT01192802|Albendazole|albendazole|mesh-list
6606385|NCT01192802|Anthelmintics|anthelmintics|mesh-ancestor
6606386|NCT01192802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6606387|NCT01192802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6606388|NCT01192802|Anticestodal Agents|anticestodal agents|mesh-ancestor
6606389|NCT01192802|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6606390|NCT01192802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6606391|NCT01192802|Tubulin Modulators|tubulin modulators|mesh-ancestor
6606392|NCT01192802|Antimitotic Agents|antimitotic agents|mesh-ancestor
6606393|NCT01192802|Mitosis Modulators|mitosis modulators|mesh-ancestor
6606394|NCT01192802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606395|NCT01192802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6606396|NCT01192854|Adefovir|adefovir|mesh-list
6606397|NCT01192854|Clevudine|clevudine|mesh-list
6606398|NCT01192854|Antiviral Agents|antiviral agents|mesh-ancestor
6606399|NCT01192854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6606400|NCT01192854|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6606401|NCT01192854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6606402|NCT01192854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6606403|NCT01192854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606404|NCT01192971|Apatinib|apatinib|mesh-list
6606405|NCT01192971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6606406|NCT01192971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6606407|NCT01192971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6606408|NCT01192971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606409|NCT01192984|Mogamulizumab|mogamulizumab|mesh-list
6606410|NCT01192984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6606411|NCT01193166|Olanzapine|olanzapine|mesh-list
6606412|NCT01193166|Risperidone|risperidone|mesh-list
6606413|NCT01193166|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6606414|NCT01193166|Aripiprazole|aripiprazole|mesh-list
6606415|NCT01193166|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6606416|NCT01193166|Perphenazine|perphenazine|mesh-list
6606417|NCT01193166|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6606418|NCT01193166|Serotonin Agents|serotonin agents|mesh-ancestor
6606419|NCT01193166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6606420|NCT01193166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606421|NCT01193166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606422|NCT01193166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6606423|NCT01193166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6606424|NCT01193166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6606425|NCT01193166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6606426|NCT01193166|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6606427|NCT01193166|Dopamine Agents|dopamine agents|mesh-ancestor
6606428|NCT01193166|Antiemetics|antiemetics|mesh-ancestor
6606429|NCT01193166|Autonomic Agents|autonomic agents|mesh-ancestor
6606430|NCT01193166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6606431|NCT01193166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6606432|NCT01193166|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6606433|NCT01193166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6606434|NCT01193166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6606435|NCT01193166|Antidepressive Agents|antidepressive agents|mesh-ancestor
6606436|NCT01193166|Dopamine Agonists|dopamine agonists|mesh-ancestor
6606437|NCT01193166|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6606438|NCT01193166|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6606439|NCT01193166|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6606440|NCT01193166|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6606441|NCT01193192|Vitamins|vitamins|mesh-list
6606442|NCT01193192|Micronutrients|micronutrients|mesh-ancestor
6606443|NCT01193192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606444|NCT01193270|Vitamin E|vitamin e|mesh-list
6606445|NCT01193270|Vitamins|vitamins|mesh-ancestor
6606446|NCT01193270|Micronutrients|micronutrients|mesh-ancestor
6606447|NCT01193270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606448|NCT01193270|Antioxidants|antioxidants|mesh-ancestor
6606449|NCT01193270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606450|NCT01193270|Protective Agents|protective agents|mesh-ancestor
6606451|NCT01193296|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6606452|NCT01193296|Vildagliptin|vildagliptin|mesh-list
6606453|NCT01193296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6606454|NCT01193296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606455|NCT01193296|Incretins|incretins|mesh-ancestor
6606456|NCT01193296|Hormones|hormones|mesh-ancestor
6606457|NCT01193296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6606458|NCT01193296|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6606459|NCT01193296|Protease Inhibitors|protease inhibitors|mesh-ancestor
6606460|NCT01193296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6606461|NCT01193296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606462|NCT01193387|Insulin|insulin|mesh-list
6606463|NCT01193387|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6606464|NCT01193387|Insulin, Long-Acting|insulin, long-acting|mesh-list
6606465|NCT01193387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6606466|NCT01193387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606467|NCT01193400|Cytarabine|cytarabine|mesh-list
6606468|NCT01193400|Clofarabine|clofarabine|mesh-list
6606469|NCT01193400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6606470|NCT01193400|Antimetabolites|antimetabolites|mesh-ancestor
6606471|NCT01193400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606472|NCT01193400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6606473|NCT01193400|Antiviral Agents|antiviral agents|mesh-ancestor
6606474|NCT01193400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6606475|NCT01193400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6606476|NCT01193400|Immunologic Factors|immunologic factors|mesh-ancestor
6606477|NCT01193400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606478|NCT01193452|Leucovorin|leucovorin|mesh-list
6606479|NCT01193452|Fluorouracil|fluorouracil|mesh-list
6606480|NCT01193452|Levoleucovorin|levoleucovorin|mesh-list
6449427|NCT00404417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6449428|NCT00404417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6449429|NCT00404417|Cholinergic Agents|cholinergic agents|mesh-ancestor
6449430|NCT00404417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6449431|NCT00404417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449432|NCT00404417|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6449433|NCT00404417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6449434|NCT00404456|Melatonin|melatonin|mesh-list
6606481|NCT01193452|Antimetabolites|antimetabolites|mesh-ancestor
6660583|NCT01494259|Respiratory System Agents|respiratory system agents|mesh-ancestor
6449435|NCT00404456|Antioxidants|antioxidants|mesh-ancestor
6606482|NCT01193452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606483|NCT01193452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6606484|NCT01193452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6606485|NCT01193452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6606486|NCT01193452|Immunologic Factors|immunologic factors|mesh-ancestor
6606487|NCT01193452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606488|NCT01193452|Antidotes|antidotes|mesh-ancestor
6606489|NCT01193452|Protective Agents|protective agents|mesh-ancestor
6606490|NCT01193452|Vitamin B Complex|vitamin b complex|mesh-ancestor
6606491|NCT01193452|Vitamins|vitamins|mesh-ancestor
6449436|NCT00404456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606492|NCT01193452|Micronutrients|micronutrients|mesh-ancestor
6606493|NCT01193465|Anesthetics|anesthetics|mesh-list
6606494|NCT01193465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6606495|NCT01193465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606496|NCT01193478|Ledipasvir|ledipasvir|mesh-list
6606497|NCT01193478|Antiviral Agents|antiviral agents|mesh-ancestor
6606498|NCT01193478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6606499|NCT01193491|Geldanamycin|geldanamycin|mesh-list
6606500|NCT01193491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6606501|NCT01193491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6606502|NCT01193491|Antiviral Agents|antiviral agents|mesh-ancestor
6606503|NCT01193491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6606504|NCT01193491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6606505|NCT01193491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606506|NCT01193491|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
6606507|NCT01193491|Protease Inhibitors|protease inhibitors|mesh-ancestor
6606508|NCT01193504|Loteprednol Etabonate|loteprednol etabonate|mesh-list
6606509|NCT01193504|Prednisolone acetate|prednisolone acetate|mesh-list
6606510|NCT01193504|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6606511|NCT01193504|Methylprednisolone|methylprednisolone|mesh-list
6606512|NCT01193504|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6606513|NCT01193504|Prednisolone|prednisolone|mesh-list
6606514|NCT01193504|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6606515|NCT01193504|Prednisolone phosphate|prednisolone phosphate|mesh-list
6606516|NCT01193504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6606517|NCT01193504|Antiemetics|antiemetics|mesh-ancestor
6606518|NCT01193504|Autonomic Agents|autonomic agents|mesh-ancestor
6606519|NCT01193504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6606520|NCT01193504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606521|NCT01193504|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6606522|NCT01193504|Glucocorticoids|glucocorticoids|mesh-ancestor
6606523|NCT01193504|Hormones|hormones|mesh-ancestor
6606524|NCT01193504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6606525|NCT01193504|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6606526|NCT01193504|Protective Agents|protective agents|mesh-ancestor
6606527|NCT01193504|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6606528|NCT01193504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6606529|NCT01193504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6606530|NCT01193595|Bevacizumab|bevacizumab|mesh-list
6606531|NCT01193595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6606532|NCT01193595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6606533|NCT01193595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6606534|NCT01193595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6606535|NCT01193595|Growth Substances|growth substances|mesh-ancestor
6606536|NCT01193595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606537|NCT01193595|Growth Inhibitors|growth inhibitors|mesh-ancestor
6606538|NCT01193621|Haloperidol|haloperidol|mesh-list
6606539|NCT01193621|Haloperidol decanoate|haloperidol decanoate|mesh-list
6606540|NCT01193621|Antiemetics|antiemetics|mesh-ancestor
6606541|NCT01193621|Autonomic Agents|autonomic agents|mesh-ancestor
6606542|NCT01193621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6449437|NCT00404456|Protective Agents|protective agents|mesh-ancestor
6449438|NCT00404456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449439|NCT00404456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6449440|NCT00404482|Cyclosporine|cyclosporine|mesh-list
6449441|NCT00404482|Cyclosporins|cyclosporins|mesh-list
6449442|NCT00404482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6449443|NCT00404482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606543|NCT01193621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606544|NCT01193621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6606545|NCT01193621|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6606546|NCT01193621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6606547|NCT01193621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6606548|NCT01193621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6606549|NCT01193621|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6606550|NCT01193621|Dopamine Agents|dopamine agents|mesh-ancestor
6606551|NCT01193621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6606552|NCT01193621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606553|NCT01193621|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6606554|NCT01193816|Loxapine|loxapine|mesh-list
6606555|NCT01193816|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6606556|NCT01193816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6606557|NCT01193816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6606558|NCT01193816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606559|NCT01193816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6606560|NCT01193816|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6606561|NCT01193816|Dopamine Agents|dopamine agents|mesh-ancestor
6606562|NCT01193816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6606563|NCT01193816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606564|NCT01193855|Dutasteride|dutasteride|mesh-list
6606565|NCT01193855|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6606566|NCT01193855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6606567|NCT01193855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6606568|NCT01193855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606569|NCT01193855|Hormone Antagonists|hormone antagonists|mesh-ancestor
6606570|NCT01193855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6606571|NCT01193855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606572|NCT01193881|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6606573|NCT01193881|R04929097|r04929097|mesh-list
6606574|NCT01193881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6606575|NCT01193881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6606576|NCT01193881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6606577|NCT01193881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606578|NCT01194037|Interferons|interferons|mesh-list
6606579|NCT01194037|Interferon-alpha|interferon-alpha|mesh-list
6606580|NCT01194037|Interferon alpha-2|interferon alpha-2|mesh-list
6606581|NCT01194037|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6606582|NCT01194037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6606583|NCT01194037|Antiviral Agents|antiviral agents|mesh-ancestor
6606584|NCT01194037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6606585|NCT01194037|Immunologic Factors|immunologic factors|mesh-ancestor
6606586|NCT01194037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606587|NCT01194115|Metronidazole|metronidazole|mesh-list
6606588|NCT01194115|Cephalexin|cephalexin|mesh-list
6606589|NCT01194115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6606590|NCT01194115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6606591|NCT01194115|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6606592|NCT01194115|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6660584|NCT01494259|Mydriatics|mydriatics|mesh-ancestor
6660585|NCT01494259|Sympathomimetics|sympathomimetics|mesh-ancestor
6660586|NCT01494259|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6660587|NCT01494311|Lidocaine|lidocaine|mesh-list
6660588|NCT01494311|Tetracaine|tetracaine|mesh-list
5501888|NCT04470050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6606593|NCT01194232|Sildenafil Citrate|sildenafil citrate|mesh-list
6606594|NCT01194232|Vasodilator Agents|vasodilator agents|mesh-ancestor
6606595|NCT01194232|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6606596|NCT01194232|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6606597|NCT01194232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6606598|NCT01194232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606599|NCT01194232|Urological Agents|urological agents|mesh-ancestor
6606600|NCT01194284|Mifamurtide|mifamurtide|mesh-list
6606601|NCT01194284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6606602|NCT01194284|Immunologic Factors|immunologic factors|mesh-ancestor
6606603|NCT01194284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606604|NCT01194336|Huperzine A|huperzine a|mesh-list
6606605|NCT01194336|Donepezil|donepezil|mesh-list
6606606|NCT01194336|Galantamine|galantamine|mesh-list
6606607|NCT01194336|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6606608|NCT01194336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6606609|NCT01194336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606610|NCT01194336|Cholinergic Agents|cholinergic agents|mesh-ancestor
6606611|NCT01194336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6606612|NCT01194336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606613|NCT01194336|Nootropic Agents|nootropic agents|mesh-ancestor
6606614|NCT01194336|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6606615|NCT01194336|Autonomic Agents|autonomic agents|mesh-ancestor
6606616|NCT01194336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6606617|NCT01194336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6606618|NCT01194336|Protective Agents|protective agents|mesh-ancestor
6606619|NCT01194700|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6606620|NCT01194700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6606621|NCT01194700|Autonomic Agents|autonomic agents|mesh-ancestor
6606622|NCT01194700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6606623|NCT01194700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606624|NCT01194700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6606625|NCT01194700|Respiratory System Agents|respiratory system agents|mesh-ancestor
6606626|NCT01194700|Glucocorticoids|glucocorticoids|mesh-ancestor
6606627|NCT01194700|Hormones|hormones|mesh-ancestor
6606628|NCT01194700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6606629|NCT01194700|Sympathomimetics|sympathomimetics|mesh-ancestor
6606630|NCT01194778|Vitamins|vitamins|mesh-list
6606631|NCT01194778|Vitamin K|vitamin k|mesh-list
6606632|NCT01194778|Vitamin K 2|vitamin k 2|mesh-list
6606633|NCT01194778|Vitamin K 1|vitamin k 1|mesh-list
6606634|NCT01194778|Micronutrients|micronutrients|mesh-ancestor
6606635|NCT01194778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606636|NCT01194778|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6606637|NCT01194778|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6606638|NCT01194778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606639|NCT01194778|Hemostatics|hemostatics|mesh-ancestor
6606640|NCT01194778|Coagulants|coagulants|mesh-ancestor
6606641|NCT01194791|Dexamethasone|dexamethasone|mesh-list
6606642|NCT01194791|Cyclophosphamide|cyclophosphamide|mesh-list
6606643|NCT01194791|Lenalidomide|lenalidomide|mesh-list
6606644|NCT01194791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6606645|NCT01194791|Immunologic Factors|immunologic factors|mesh-ancestor
6606646|NCT01194791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606647|NCT01194791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6606648|NCT01194791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6606649|NCT01194791|Alkylating Agents|alkylating agents|mesh-ancestor
6606650|NCT01194791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606651|NCT01194791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6606652|NCT01194791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6606653|NCT01194791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6606654|NCT01194791|Antiemetics|antiemetics|mesh-ancestor
6606655|NCT01194791|Autonomic Agents|autonomic agents|mesh-ancestor
6606656|NCT01194791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6606657|NCT01194791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6606658|NCT01194791|Glucocorticoids|glucocorticoids|mesh-ancestor
6606659|NCT01194791|Hormones|hormones|mesh-ancestor
6606660|NCT01194791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6606661|NCT01194791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6606662|NCT01194791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6606663|NCT01194791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6606664|NCT01194791|Growth Substances|growth substances|mesh-ancestor
6606665|NCT01194791|Growth Inhibitors|growth inhibitors|mesh-ancestor
6606666|NCT01194843|Ropivacaine|ropivacaine|mesh-list
6606667|NCT01194843|Anesthetics, Local|anesthetics, local|mesh-ancestor
6606668|NCT01194843|Anesthetics|anesthetics|mesh-ancestor
6606669|NCT01194843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6606670|NCT01194843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606671|NCT01194843|Sensory System Agents|sensory system agents|mesh-ancestor
6606672|NCT01194843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6606673|NCT01194882|Insulin|insulin|mesh-list
6606674|NCT01194882|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6606675|NCT01194882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6606676|NCT01194882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606677|NCT01194934|Lenograstim|lenograstim|mesh-list
6606678|NCT01194934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6606679|NCT01194934|Immunologic Factors|immunologic factors|mesh-ancestor
6606680|NCT01194934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606681|NCT01195181|Ribavirin|ribavirin|mesh-list
6606682|NCT01195181|Antimetabolites|antimetabolites|mesh-ancestor
6606683|NCT01195181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606684|NCT01195181|Antiviral Agents|antiviral agents|mesh-ancestor
6606685|NCT01195181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6606686|NCT01195246|Vaccines|vaccines|mesh-list
6606687|NCT01195246|Immunologic Factors|immunologic factors|mesh-ancestor
6606688|NCT01195246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606689|NCT01195259|Metformin|metformin|mesh-list
6606690|NCT01195259|Rosiglitazone|rosiglitazone|mesh-list
6606691|NCT01195259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6606692|NCT01195259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606693|NCT01195298|Bevacizumab|bevacizumab|mesh-list
6606694|NCT01195298|Capecitabine|capecitabine|mesh-list
6606695|NCT01195298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6606696|NCT01195298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6606697|NCT01195298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6606698|NCT01195298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6606699|NCT01195298|Growth Substances|growth substances|mesh-ancestor
6606700|NCT01195298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606701|NCT01195298|Growth Inhibitors|growth inhibitors|mesh-ancestor
6606702|NCT01195298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6606703|NCT01195298|Antimetabolites|antimetabolites|mesh-ancestor
6606704|NCT01195298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606705|NCT01195324|Canagliflozin|canagliflozin|mesh-list
6606706|NCT01195324|Warfarin|warfarin|mesh-list
6606707|NCT01195324|Anticoagulants|anticoagulants|mesh-ancestor
6606708|NCT01195324|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6606709|NCT01195324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606710|NCT01195324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6606711|NCT01195324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606712|NCT01195376|Dactolisib|dactolisib|mesh-list
6606713|NCT01195376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6606714|NCT01195428|Simvastatin|simvastatin|mesh-list
6606715|NCT01195428|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6606716|NCT01195428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6606717|NCT01195428|Antimetabolites|antimetabolites|mesh-ancestor
6606718|NCT01195428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606719|NCT01195428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6606720|NCT01195428|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6606721|NCT01195428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6606722|NCT01195454|Insulin|insulin|mesh-list
6606723|NCT01195454|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5501889|NCT04470050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5501890|NCT04470050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5501891|NCT04470050|Adrenergic Agents|adrenergic agents|mesh-ancestor
5501892|NCT04470050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5501893|NCT04470050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501894|NCT04470128|Fentanyl|fentanyl|mesh-list
5501895|NCT04470128|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5501896|NCT04470128|Narcotics|narcotics|mesh-ancestor
5501897|NCT04470128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6606724|NCT01195454|Insulin Glargine|insulin glargine|mesh-list
6606725|NCT01195454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6606726|NCT01195454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606727|NCT01195493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6606728|NCT01195571|Vaccines|vaccines|mesh-list
6606729|NCT01195571|Immunologic Factors|immunologic factors|mesh-ancestor
6606730|NCT01195571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606731|NCT01195649|Sorafenib|sorafenib|mesh-list
6606732|NCT01195649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6606733|NCT01195649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6606734|NCT01195649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6606735|NCT01195649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606736|NCT01195714|Ofatumumab|ofatumumab|mesh-list
6606737|NCT01195714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6606738|NCT01195727|Apixaban|apixaban|mesh-list
6606739|NCT01195727|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6606740|NCT01195727|Antithrombins|antithrombins|mesh-ancestor
6606741|NCT01195727|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6606742|NCT01195727|Protease Inhibitors|protease inhibitors|mesh-ancestor
6606743|NCT01195727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6606744|NCT01195727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606745|NCT01195727|Anticoagulants|anticoagulants|mesh-ancestor
6606746|NCT01195766|Ofatumumab|ofatumumab|mesh-list
6606747|NCT01195766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6606748|NCT01195805|Amiloride|amiloride|mesh-list
6606749|NCT01195805|Spironolactone|spironolactone|mesh-list
6606750|NCT01195805|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6606751|NCT01195805|Hormone Antagonists|hormone antagonists|mesh-ancestor
6606752|NCT01195805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6606753|NCT01195805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606754|NCT01195805|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6606755|NCT01195805|Diuretics|diuretics|mesh-ancestor
6606756|NCT01195805|Natriuretic Agents|natriuretic agents|mesh-ancestor
6606757|NCT01195805|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
6606758|NCT01195805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6606759|NCT01195805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6606760|NCT01195805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606761|NCT01195805|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
6606762|NCT01195974|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
6606763|NCT01195974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6606764|NCT01195974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606765|NCT01196013|Clofarabine|clofarabine|mesh-list
6606766|NCT01196013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6606767|NCT01196013|Antimetabolites|antimetabolites|mesh-ancestor
6606768|NCT01196013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606769|NCT01196013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6606770|NCT01196065|Memantine|memantine|mesh-list
6606771|NCT01196065|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6606772|NCT01196065|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6606773|NCT01196065|Dopamine Agents|dopamine agents|mesh-ancestor
6606774|NCT01196065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6606775|NCT01196065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606776|NCT01196065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606777|NCT01196065|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6606778|NCT01196065|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6660589|NCT01494311|Anesthetics, Local|anesthetics, local|mesh-ancestor
6660590|NCT01494311|Anesthetics|anesthetics|mesh-ancestor
6660591|NCT01494311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6660592|NCT01494311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660593|NCT01494311|Sensory System Agents|sensory system agents|mesh-ancestor
6660594|NCT01494311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6660595|NCT01494311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6660596|NCT01494311|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6660597|NCT01494311|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6660598|NCT01494311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6660599|NCT01494311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660600|NCT01494363|Leucovorin|leucovorin|mesh-list
6660601|NCT01494363|Fluorouracil|fluorouracil|mesh-list
6660602|NCT01494363|Oxaliplatin|oxaliplatin|mesh-list
6660603|NCT01494363|Irinotecan|irinotecan|mesh-list
6660604|NCT01494363|Antimetabolites|antimetabolites|mesh-ancestor
6660605|NCT01494363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660606|NCT01494363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6660607|NCT01494363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6660608|NCT01494363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6660609|NCT01494363|Immunologic Factors|immunologic factors|mesh-ancestor
6660610|NCT01494363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660611|NCT01494363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6660612|NCT01494363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6660613|NCT01494363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6660614|NCT01494363|Antidotes|antidotes|mesh-ancestor
6660615|NCT01494363|Protective Agents|protective agents|mesh-ancestor
6660616|NCT01494363|Vitamin B Complex|vitamin b complex|mesh-ancestor
6660617|NCT01494363|Vitamins|vitamins|mesh-ancestor
6660618|NCT01494363|Micronutrients|micronutrients|mesh-ancestor
6660619|NCT01494402|Aspirin|aspirin|mesh-list
6660620|NCT01494402|Esomeprazole|esomeprazole|mesh-list
6660621|NCT01494402|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6660622|NCT01494402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6660623|NCT01494402|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6660624|NCT01494402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6660625|NCT01494402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660626|NCT01494402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6660627|NCT01494402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6660628|NCT01494402|Analgesics|analgesics|mesh-ancestor
6660629|NCT01494402|Sensory System Agents|sensory system agents|mesh-ancestor
6660630|NCT01494402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6660631|NCT01494402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660632|NCT01494402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6660633|NCT01494402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6660634|NCT01494402|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6660635|NCT01494402|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6660636|NCT01494402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6606779|NCT01196169|Vancomycin|vancomycin|mesh-list
6606780|NCT01196169|Daptomycin|daptomycin|mesh-list
6606781|NCT01196169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6606782|NCT01196169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6606783|NCT01196195|Lopinavir|lopinavir|mesh-list
6606784|NCT01196195|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6606785|NCT01196195|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6606786|NCT01196195|Protease Inhibitors|protease inhibitors|mesh-ancestor
6606787|NCT01196195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6606788|NCT01196195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606789|NCT01196195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6606790|NCT01196195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6606791|NCT01196195|Antiviral Agents|antiviral agents|mesh-ancestor
6606792|NCT01196195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6606793|NCT01196195|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6606794|NCT01196195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6606795|NCT01196208|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6606796|NCT01196208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6606797|NCT01196208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6606798|NCT01196234|Paclitaxel|paclitaxel|mesh-list
6606799|NCT01196234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6606800|NCT01196234|Carboplatin|carboplatin|mesh-list
6606801|NCT01196234|Gefitinib|gefitinib|mesh-list
6606802|NCT01196234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6606803|NCT01196234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6606804|NCT01196234|Tubulin Modulators|tubulin modulators|mesh-ancestor
6606805|NCT01196234|Antimitotic Agents|antimitotic agents|mesh-ancestor
6606806|NCT01196234|Mitosis Modulators|mitosis modulators|mesh-ancestor
6606807|NCT01196234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606808|NCT01196234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6606809|NCT01196234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6606810|NCT01196260|Capecitabine|capecitabine|mesh-list
6606811|NCT01196260|Oxaliplatin|oxaliplatin|mesh-list
6606812|NCT01196260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6606813|NCT01196260|Antimetabolites|antimetabolites|mesh-ancestor
6606814|NCT01196260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606815|NCT01196260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6606816|NCT01196455|Capecitabine|capecitabine|mesh-list
6606817|NCT01196455|Mitomycins|mitomycins|mesh-list
6606818|NCT01196455|Mitomycin|mitomycin|mesh-list
6606819|NCT01196455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6606820|NCT01196455|Antimetabolites|antimetabolites|mesh-ancestor
6606821|NCT01196455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606822|NCT01196455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6606823|NCT01196455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6606824|NCT01196455|Alkylating Agents|alkylating agents|mesh-ancestor
6606825|NCT01196455|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6606826|NCT01196455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6606827|NCT01196481|Carvedilol|carvedilol|mesh-list
6606828|NCT01196481|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6606829|NCT01196481|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6606830|NCT01196481|Adrenergic Agents|adrenergic agents|mesh-ancestor
6606831|NCT01196481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6606832|NCT01196481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606833|NCT01196481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606834|NCT01196481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6606835|NCT01196481|Antioxidants|antioxidants|mesh-ancestor
6606836|NCT01196481|Protective Agents|protective agents|mesh-ancestor
6606837|NCT01196481|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6606838|NCT01196481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6606839|NCT01196481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6606840|NCT01196481|Vasodilator Agents|vasodilator agents|mesh-ancestor
6606841|NCT01196481|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6606842|NCT01196481|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6606843|NCT01196507|Carvedilol|carvedilol|mesh-list
6606844|NCT01196507|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6606845|NCT01196507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6606846|NCT01196507|Adrenergic Agents|adrenergic agents|mesh-ancestor
6606847|NCT01196507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6606848|NCT01196507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606849|NCT01196507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606850|NCT01196507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6606851|NCT01196507|Antioxidants|antioxidants|mesh-ancestor
6606852|NCT01196507|Protective Agents|protective agents|mesh-ancestor
6606853|NCT01196507|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6606854|NCT01196507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6606855|NCT01196507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6606856|NCT01196507|Vasodilator Agents|vasodilator agents|mesh-ancestor
6606857|NCT01196507|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6606858|NCT01196507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6606859|NCT01196546|Metformin|metformin|mesh-list
6606860|NCT01196546|Vildagliptin|vildagliptin|mesh-list
6606861|NCT01196546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6606862|NCT01196546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606863|NCT01196546|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6606864|NCT01196546|Protease Inhibitors|protease inhibitors|mesh-ancestor
6606865|NCT01196546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6606866|NCT01196546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606867|NCT01196559|Gemcitabine|gemcitabine|mesh-list
6606868|NCT01196559|Vinorelbine|vinorelbine|mesh-list
6606869|NCT01196559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6606870|NCT01196559|Antimetabolites|antimetabolites|mesh-ancestor
6606871|NCT01196559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606872|NCT01196559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6606873|NCT01196559|Antiviral Agents|antiviral agents|mesh-ancestor
6606874|NCT01196559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6606875|NCT01196559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6606876|NCT01196559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6606877|NCT01196559|Immunologic Factors|immunologic factors|mesh-ancestor
6606878|NCT01196559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606879|NCT01196559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6606880|NCT01196559|Tubulin Modulators|tubulin modulators|mesh-ancestor
6606881|NCT01196559|Antimitotic Agents|antimitotic agents|mesh-ancestor
6606882|NCT01196559|Mitosis Modulators|mitosis modulators|mesh-ancestor
6606883|NCT01196715|Darbepoetin alfa|darbepoetin alfa|mesh-list
6606884|NCT01196715|Hematinics|hematinics|mesh-ancestor
6606885|NCT01196754|Sevoflurane|sevoflurane|mesh-list
6606886|NCT01196754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6606887|NCT01196754|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6606888|NCT01196754|Anesthetics, General|anesthetics, general|mesh-ancestor
6606889|NCT01196754|Anesthetics|anesthetics|mesh-ancestor
6606890|NCT01196754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6606891|NCT01196754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606892|NCT01196767|Ropivacaine|ropivacaine|mesh-list
6606893|NCT01196767|Anesthetics, Local|anesthetics, local|mesh-ancestor
6606894|NCT01196767|Anesthetics|anesthetics|mesh-ancestor
6606895|NCT01196767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6606896|NCT01196767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606897|NCT01196767|Sensory System Agents|sensory system agents|mesh-ancestor
6606898|NCT01196767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6606899|NCT01197001|Losartan|losartan|mesh-list
6606900|NCT01197001|Amlodipine|amlodipine|mesh-list
6606901|NCT01197001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6606902|NCT01197001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6606903|NCT01197001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6606904|NCT01197001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606905|NCT01197001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6606906|NCT01197001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606907|NCT01197001|Vasodilator Agents|vasodilator agents|mesh-ancestor
6606908|NCT01197001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5501898|NCT04470128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606909|NCT01197001|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6606910|NCT01197001|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6606911|NCT01197014|Losartan|losartan|mesh-list
6606912|NCT01197014|Amlodipine|amlodipine|mesh-list
6606913|NCT01197014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6606914|NCT01197014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6606915|NCT01197014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6606916|NCT01197014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606917|NCT01197014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6606918|NCT01197014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606919|NCT01197014|Vasodilator Agents|vasodilator agents|mesh-ancestor
6606920|NCT01197014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6606921|NCT01197014|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6606922|NCT01197014|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6606923|NCT01197040|Mycophenolic Acid|mycophenolic acid|mesh-list
6606924|NCT01197040|Prednisone|prednisone|mesh-list
6606925|NCT01197040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6606926|NCT01197040|Glucocorticoids|glucocorticoids|mesh-ancestor
6606927|NCT01197040|Hormones|hormones|mesh-ancestor
6606928|NCT01197040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6606929|NCT01197040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606930|NCT01197040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6606931|NCT01197040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6606932|NCT01197040|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6606933|NCT01197040|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6606934|NCT01197040|Antitubercular Agents|antitubercular agents|mesh-ancestor
6606935|NCT01197040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6606936|NCT01197040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6606937|NCT01197040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6606938|NCT01197040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606939|NCT01197066|Certolizumab Pegol|certolizumab pegol|mesh-list
6606940|NCT01197066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6606941|NCT01197066|Immunologic Factors|immunologic factors|mesh-ancestor
6606942|NCT01197066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606943|NCT01197066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6606944|NCT01197144|Adalimumab|adalimumab|mesh-list
6606945|NCT01197144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6606946|NCT01197144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6606947|NCT01197157|Nitazoxanide|nitazoxanide|mesh-list
6606948|NCT01197157|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6606949|NCT01197157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6606950|NCT01197170|Bevacizumab|bevacizumab|mesh-list
6606951|NCT01197170|Everolimus|everolimus|mesh-list
6606952|NCT01197170|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6606953|NCT01197170|Sorafenib|sorafenib|mesh-list
6606954|NCT01197170|Anastrozole|anastrozole|mesh-list
6606955|NCT01197170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6606956|NCT01197170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6606957|NCT01197170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6606958|NCT01197170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6606959|NCT01197170|Growth Substances|growth substances|mesh-ancestor
6606960|NCT01197170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606961|NCT01197170|Growth Inhibitors|growth inhibitors|mesh-ancestor
6606962|NCT01197170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6606963|NCT01197170|Immunologic Factors|immunologic factors|mesh-ancestor
6606964|NCT01197170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6606965|NCT01197170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6606966|NCT01197170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606967|NCT01197170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6606968|NCT01197170|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6606969|NCT01197170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6606970|NCT01197170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6606971|NCT01197170|Hormone Antagonists|hormone antagonists|mesh-ancestor
6606972|NCT01197170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6606973|NCT01197235|Darbepoetin alfa|darbepoetin alfa|mesh-list
6606974|NCT01197235|Hematinics|hematinics|mesh-ancestor
6606975|NCT01197261|Oxycodone|oxycodone|mesh-list
6606976|NCT01197261|Naloxone|naloxone|mesh-list
6606977|NCT01197261|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6606978|NCT01197261|Narcotics|narcotics|mesh-ancestor
6606979|NCT01197261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6606980|NCT01197261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6606981|NCT01197261|Analgesics|analgesics|mesh-ancestor
6606982|NCT01197261|Sensory System Agents|sensory system agents|mesh-ancestor
6606983|NCT01197261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6606984|NCT01197261|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6606985|NCT01197469|Tadalafil|tadalafil|mesh-list
6606986|NCT01197469|Vasodilator Agents|vasodilator agents|mesh-ancestor
6606987|NCT01197469|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6606988|NCT01197469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6606989|NCT01197469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6606990|NCT01197469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606991|NCT01197469|Urological Agents|urological agents|mesh-ancestor
6606992|NCT01197664|Fluorouracil|fluorouracil|mesh-list
6606993|NCT01197664|Antimetabolites|antimetabolites|mesh-ancestor
6606994|NCT01197664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6606995|NCT01197664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6606996|NCT01197664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6606997|NCT01197664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6606998|NCT01197664|Immunologic Factors|immunologic factors|mesh-ancestor
6606999|NCT01197664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607000|NCT01197781|Verapamil|verapamil|mesh-list
6607001|NCT01197781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6607002|NCT01197781|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6607003|NCT01197781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6607004|NCT01197781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6607005|NCT01197781|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6607006|NCT01197781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607007|NCT01197781|Vasodilator Agents|vasodilator agents|mesh-ancestor
6607008|NCT01197846|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6607009|NCT01197846|Antidepressive Agents|antidepressive agents|mesh-ancestor
6607010|NCT01197846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6607011|NCT01197846|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6607012|NCT01197846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6607013|NCT01197846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6607014|NCT01197846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607015|NCT01198054|Lenalidomide|lenalidomide|mesh-list
6607016|NCT01198054|Immunologic Factors|immunologic factors|mesh-ancestor
6607017|NCT01198054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607018|NCT01198054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6607019|NCT01198054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6607020|NCT01198054|Growth Substances|growth substances|mesh-ancestor
6607021|NCT01198054|Growth Inhibitors|growth inhibitors|mesh-ancestor
6607022|NCT01198054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6607023|NCT01198067|Pomalidomide|pomalidomide|mesh-list
6607024|NCT01198067|Immunologic Factors|immunologic factors|mesh-ancestor
6607025|NCT01198067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607026|NCT01198067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6607027|NCT01198067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6607028|NCT01198067|Growth Substances|growth substances|mesh-ancestor
6607029|NCT01198067|Growth Inhibitors|growth inhibitors|mesh-ancestor
6607030|NCT01198067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6607031|NCT01198106|Cinnarizine|cinnarizine|mesh-list
6607032|NCT01198106|Scopolamine|scopolamine|mesh-list
6607033|NCT01198106|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
6607034|NCT01198106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6607035|NCT01198106|Antiemetics|antiemetics|mesh-ancestor
6607036|NCT01198106|Autonomic Agents|autonomic agents|mesh-ancestor
6607037|NCT01198106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6607038|NCT01198106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607039|NCT01198106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6607040|NCT01198106|Mydriatics|mydriatics|mesh-ancestor
6607041|NCT01198106|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6607042|NCT01198106|Cholinergic Agents|cholinergic agents|mesh-ancestor
6607043|NCT01198106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6607044|NCT01198106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6607045|NCT01198106|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6607046|NCT01198106|Parasympatholytics|parasympatholytics|mesh-ancestor
6607047|NCT01198106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6607048|NCT01198106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6607049|NCT01198106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6607050|NCT01198106|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6607051|NCT01198106|Histamine Antagonists|histamine antagonists|mesh-ancestor
6607052|NCT01198106|Histamine Agents|histamine agents|mesh-ancestor
6607053|NCT01198184|Sirolimus|sirolimus|mesh-list
6607054|NCT01198184|R04929097|r04929097|mesh-list
6607055|NCT01198184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6607056|NCT01198184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6449444|NCT00404482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6449445|NCT00404482|Immunologic Factors|immunologic factors|mesh-ancestor
6449446|NCT00404482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449447|NCT00404482|Antifungal Agents|antifungal agents|mesh-ancestor
6449448|NCT00404482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6607057|NCT01198184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6449449|NCT00404482|Dermatologic Agents|dermatologic agents|mesh-ancestor
6449450|NCT00404482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6449451|NCT00404482|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6449452|NCT00404508|Hydralazine|hydralazine|mesh-list
6449453|NCT00404508|Valproic Acid|valproic acid|mesh-list
6449454|NCT00404508|Anticonvulsants|anticonvulsants|mesh-ancestor
6449455|NCT00404508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6449456|NCT00404508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6449457|NCT00404508|GABA Agents|gaba agents|mesh-ancestor
6449458|NCT00404508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6607058|NCT01198184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6607059|NCT01198184|Antifungal Agents|antifungal agents|mesh-ancestor
6607060|NCT01198184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6607061|NCT01198184|Immunologic Factors|immunologic factors|mesh-ancestor
6607062|NCT01198184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607063|NCT01198184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6607064|NCT01198184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6607065|NCT01198210|Dexamethasone|dexamethasone|mesh-list
6607066|NCT01198210|Dexamethasone acetate|dexamethasone acetate|mesh-list
6607067|NCT01198210|Ketamine|ketamine|mesh-list
6607068|NCT01198210|BB 1101|bb 1101|mesh-list
6607069|NCT01198210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6607070|NCT01198210|Antiemetics|antiemetics|mesh-ancestor
6607071|NCT01198210|Autonomic Agents|autonomic agents|mesh-ancestor
6607072|NCT01198210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6607073|NCT01198210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607074|NCT01198210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6607075|NCT01198210|Glucocorticoids|glucocorticoids|mesh-ancestor
6607076|NCT01198210|Hormones|hormones|mesh-ancestor
6607077|NCT01198210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6607078|NCT01198210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6607079|NCT01198210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6607080|NCT01198210|Protease Inhibitors|protease inhibitors|mesh-ancestor
6607081|NCT01198210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6607082|NCT01198210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6607083|NCT01198210|Analgesics|analgesics|mesh-ancestor
6607084|NCT01198210|Sensory System Agents|sensory system agents|mesh-ancestor
6607085|NCT01198210|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6607086|NCT01198210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6607087|NCT01198210|Anesthetics, General|anesthetics, general|mesh-ancestor
6449459|NCT00404508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449460|NCT00404508|Antimanic Agents|antimanic agents|mesh-ancestor
6449461|NCT00404508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6449462|NCT00404508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6449463|NCT00404508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6449464|NCT00404508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6449465|NCT00404508|Vasodilator Agents|vasodilator agents|mesh-ancestor
6449466|NCT00404534|Amoxicillin|amoxicillin|mesh-list
6449467|NCT00404534|Clarithromycin|clarithromycin|mesh-list
6449468|NCT00404534|Omeprazole|omeprazole|mesh-list
6449469|NCT00404534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6449470|NCT00404534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6607088|NCT01198210|Anesthetics|anesthetics|mesh-ancestor
6607089|NCT01198210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6607090|NCT01198210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6607091|NCT01198210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6607092|NCT01198210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6607093|NCT01198223|Nystatin|nystatin|mesh-list
6607094|NCT01198223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6607095|NCT01198223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6607096|NCT01198223|Antifungal Agents|antifungal agents|mesh-ancestor
6607097|NCT01198223|Ionophores|ionophores|mesh-ancestor
6607098|NCT01198223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6607099|NCT01198223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6607100|NCT01198236|Itraconazole|itraconazole|mesh-list
6607101|NCT01198236|Antifungal Agents|antifungal agents|mesh-ancestor
6607102|NCT01198236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6607103|NCT01198236|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6607104|NCT01198236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6607105|NCT01198236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6607106|NCT01198236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6607107|NCT01198236|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6607108|NCT01198236|Hormone Antagonists|hormone antagonists|mesh-ancestor
6607109|NCT01198236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6607110|NCT01198236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607111|NCT01198236|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6607112|NCT01198249|Losartan|losartan|mesh-list
6607113|NCT01198249|Amlodipine|amlodipine|mesh-list
6607114|NCT01198249|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6607115|NCT01198249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6607116|NCT01198249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6607117|NCT01198249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6607118|NCT01198249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6607119|NCT01198249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6607120|NCT01198249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607121|NCT01198249|Vasodilator Agents|vasodilator agents|mesh-ancestor
6607122|NCT01198249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6607123|NCT01198249|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6607124|NCT01198249|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6607125|NCT01198249|Diuretics|diuretics|mesh-ancestor
6607126|NCT01198249|Natriuretic Agents|natriuretic agents|mesh-ancestor
6607127|NCT01198249|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6607128|NCT01198314|Immunosuppressive Agents|immunosuppressive agents|mesh-list
6607129|NCT01198314|Immunologic Factors|immunologic factors|mesh-ancestor
6607130|NCT01198314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607131|NCT01198340|Ropivacaine|ropivacaine|mesh-list
6607132|NCT01198340|Anesthetics, Local|anesthetics, local|mesh-list
6607133|NCT01198340|Anesthetics|anesthetics|mesh-list
6607134|NCT01198340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6607135|NCT01198340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607136|NCT01198340|Sensory System Agents|sensory system agents|mesh-ancestor
6607137|NCT01198340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6607138|NCT01198353|Ziprasidone|ziprasidone|mesh-list
6607139|NCT01198353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6607140|NCT01198353|Serotonin Agents|serotonin agents|mesh-ancestor
6607141|NCT01198353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6607142|NCT01198353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6607143|NCT01198353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607144|NCT01198353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6607145|NCT01198353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6607146|NCT01198353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6607147|NCT01198353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6607148|NCT01198353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6607149|NCT01198353|Dopamine Agents|dopamine agents|mesh-ancestor
6607150|NCT01198379|Aspirin|aspirin|mesh-list
6607151|NCT01198379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6607152|NCT01198379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6607153|NCT01198379|Analgesics|analgesics|mesh-ancestor
6607154|NCT01198379|Sensory System Agents|sensory system agents|mesh-ancestor
6607155|NCT01198379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6607156|NCT01198379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607157|NCT01198379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6607158|NCT01198379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6607159|NCT01198379|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6607160|NCT01198379|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6607161|NCT01198379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6607162|NCT01198379|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6607163|NCT01198379|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6607164|NCT01198379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6607165|NCT01198379|Antipyretics|antipyretics|mesh-ancestor
6607166|NCT01198392|Cisplatin|cisplatin|mesh-list
6607167|NCT01198392|Tegafur|tegafur|mesh-list
6607168|NCT01198392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6607169|NCT01198392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6607170|NCT01198392|Antimetabolites|antimetabolites|mesh-ancestor
6607171|NCT01198392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6607172|NCT01198444|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
6607173|NCT01198444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6607174|NCT01198444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607175|NCT01198457|Clodronic Acid|clodronic acid|mesh-list
6607176|NCT01198457|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6607177|NCT01198457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607178|NCT01198496|Losartan|losartan|mesh-list
6607179|NCT01198496|Amlodipine|amlodipine|mesh-list
6607180|NCT01198496|Valsartan|valsartan|mesh-list
6607181|NCT01198496|Telmisartan|telmisartan|mesh-list
6607182|NCT01198496|Candesartan|candesartan|mesh-list
6607183|NCT01198496|Candesartan cilexetil|candesartan cilexetil|mesh-list
6607184|NCT01198496|Olmesartan|olmesartan|mesh-list
6607185|NCT01198496|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6607186|NCT01198496|Spironolactone|spironolactone|mesh-list
6607187|NCT01198496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6607188|NCT01198496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6607189|NCT01198496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6607190|NCT01198496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6607191|NCT01198496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6607192|NCT01198496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607193|NCT01198496|Vasodilator Agents|vasodilator agents|mesh-ancestor
6607194|NCT01198496|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6607195|NCT01198496|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6607196|NCT01198496|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6607197|NCT01198496|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6607198|NCT01198496|Hormone Antagonists|hormone antagonists|mesh-ancestor
6607199|NCT01198496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6607200|NCT01198496|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6607201|NCT01198496|Diuretics|diuretics|mesh-ancestor
6607202|NCT01198496|Natriuretic Agents|natriuretic agents|mesh-ancestor
6607203|NCT01198522|Gemcitabine|gemcitabine|mesh-list
6607204|NCT01198522|Antibodies|antibodies|mesh-list
6607205|NCT01198522|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6607206|NCT01198522|Immunologic Factors|immunologic factors|mesh-ancestor
6607207|NCT01198522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607208|NCT01198522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6607209|NCT01198522|Antimetabolites|antimetabolites|mesh-ancestor
6607210|NCT01198522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6607211|NCT01198522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6607212|NCT01198522|Antiviral Agents|antiviral agents|mesh-ancestor
6607213|NCT01198522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6607214|NCT01198522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6607215|NCT01198522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6607216|NCT01198535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6607217|NCT01198535|Cetuximab|cetuximab|mesh-list
6607218|NCT01198535|Antibodies|antibodies|mesh-list
6607219|NCT01198535|Immunoglobulins|immunoglobulins|mesh-list
6607220|NCT01198535|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6607221|NCT01198535|R04929097|r04929097|mesh-list
6607222|NCT01198535|Immunologic Factors|immunologic factors|mesh-ancestor
6607223|NCT01198535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607224|NCT01198535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6607225|NCT01198535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6607226|NCT01198535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6607227|NCT01198639|Remifentanil|remifentanil|mesh-list
6607228|NCT01198639|Propofol|propofol|mesh-list
6607229|NCT01198639|Anesthetics|anesthetics|mesh-list
6607230|NCT01198639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6607231|NCT01198639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6607232|NCT01198639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607233|NCT01198639|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6607234|NCT01198639|Anesthetics, General|anesthetics, general|mesh-ancestor
6607235|NCT01198639|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6607236|NCT01198639|Narcotics|narcotics|mesh-ancestor
6607237|NCT01198639|Analgesics|analgesics|mesh-ancestor
6607238|NCT01198639|Sensory System Agents|sensory system agents|mesh-ancestor
6607239|NCT01198639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6607240|NCT01198665|Prednisolone|prednisolone|mesh-list
6607241|NCT01198665|Doxorubicin|doxorubicin|mesh-list
6607242|NCT01198665|Vincristine|vincristine|mesh-list
6607243|NCT01198665|Everolimus|everolimus|mesh-list
6607244|NCT01198665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6607245|NCT01198665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6607246|NCT01198665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6607247|NCT01198665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6607248|NCT01198665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6607249|NCT01198665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6607250|NCT01198665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6607251|NCT01198665|Tubulin Modulators|tubulin modulators|mesh-ancestor
6449471|NCT00404534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6449472|NCT00404534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6449473|NCT00404534|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6449474|NCT00404534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6449475|NCT00404534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6607252|NCT01198665|Antimitotic Agents|antimitotic agents|mesh-ancestor
6607253|NCT01198665|Mitosis Modulators|mitosis modulators|mesh-ancestor
6607254|NCT01198665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6607255|NCT01198665|Immunologic Factors|immunologic factors|mesh-ancestor
6607256|NCT01198665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607257|NCT01198665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6607258|NCT01198665|Glucocorticoids|glucocorticoids|mesh-ancestor
6607259|NCT01198665|Hormones|hormones|mesh-ancestor
6607260|NCT01198665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6607261|NCT01198665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6607262|NCT01198782|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6607263|NCT01198782|Lubricant Eye Drops|lubricant eye drops|mesh-list
6607264|NCT01198782|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6607265|NCT01198821|Gemcitabine|gemcitabine|mesh-list
6607266|NCT01198821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6607267|NCT01198821|Antimetabolites|antimetabolites|mesh-ancestor
6607268|NCT01198821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6607269|NCT01198821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6607270|NCT01198821|Antiviral Agents|antiviral agents|mesh-ancestor
6607271|NCT01198821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6607272|NCT01198821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6607273|NCT01198821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6607274|NCT01198821|Immunologic Factors|immunologic factors|mesh-ancestor
6607275|NCT01198821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607276|NCT01198860|Ascorbic Acid|ascorbic acid|mesh-list
6607277|NCT01198860|Tenofovir|tenofovir|mesh-list
6607278|NCT01198860|Antiviral Agents|antiviral agents|mesh-ancestor
6607279|NCT01198860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6607280|NCT01198860|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6607281|NCT01198860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6607282|NCT01198860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6607283|NCT01198860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6449476|NCT00404534|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6449477|NCT00404534|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6449478|NCT00404534|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6449479|NCT00404573|Cariprazine|cariprazine|mesh-list
6607284|NCT01198860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6607285|NCT01198860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6607286|NCT01198860|Antioxidants|antioxidants|mesh-ancestor
6607287|NCT01198860|Protective Agents|protective agents|mesh-ancestor
6607288|NCT01198860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607289|NCT01198860|Vitamins|vitamins|mesh-ancestor
6607290|NCT01198860|Micronutrients|micronutrients|mesh-ancestor
6607291|NCT01198912|Doxycycline|doxycycline|mesh-list
6607292|NCT01198912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6607293|NCT01198912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6607294|NCT01198912|Antimalarials|antimalarials|mesh-ancestor
6607295|NCT01198912|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6607296|NCT01198912|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6607297|NCT01198925|Piperacillin|piperacillin|mesh-list
6607298|NCT01198925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6607299|NCT01198925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6607300|NCT01198938|Melatonin|melatonin|mesh-list
6607301|NCT01198938|Antioxidants|antioxidants|mesh-ancestor
6607302|NCT01198938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6607303|NCT01198938|Protective Agents|protective agents|mesh-ancestor
6607304|NCT01198938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607305|NCT01198938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6607306|NCT01199029|Prednisone|prednisone|mesh-list
6607307|NCT01199029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6607308|NCT01199029|Glucocorticoids|glucocorticoids|mesh-ancestor
6607309|NCT01199029|Hormones|hormones|mesh-ancestor
6607310|NCT01199029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6607311|NCT01199029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607312|NCT01199029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6607313|NCT01199029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6607314|NCT01199081|Dronedarone|dronedarone|mesh-list
6607315|NCT01199081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6607316|NCT01199159|Vitamin B 6|vitamin b 6|mesh-list
6607317|NCT01199159|Pyridoxal|pyridoxal|mesh-list
6607318|NCT01199159|Pyridoxine|pyridoxine|mesh-list
6607319|NCT01199159|Misoprostol|misoprostol|mesh-list
6607320|NCT01199159|Vitamins|vitamins|mesh-ancestor
6607321|NCT01199159|Micronutrients|micronutrients|mesh-ancestor
6607322|NCT01199159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607323|NCT01199159|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6607324|NCT01199159|Abortifacient Agents|abortifacient agents|mesh-ancestor
6607325|NCT01199159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6607326|NCT01199159|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6607327|NCT01199159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6607328|NCT01199159|Oxytocics|oxytocics|mesh-ancestor
6607329|NCT01199159|Vitamin B Complex|vitamin b complex|mesh-ancestor
6607330|NCT01199224|Veliparib|veliparib|mesh-list
6607331|NCT01199224|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6607332|NCT01199224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6607333|NCT01199224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6607334|NCT01199224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6607335|NCT01199276|Sevoflurane|sevoflurane|mesh-list
6607336|NCT01199276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6607337|NCT01199276|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6607338|NCT01199276|Anesthetics, General|anesthetics, general|mesh-ancestor
6607339|NCT01199276|Anesthetics|anesthetics|mesh-ancestor
6607340|NCT01199276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6607341|NCT01199276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607342|NCT01199328|Aspirin|aspirin|mesh-list
6607343|NCT01199328|Esomeprazole|esomeprazole|mesh-list
6607344|NCT01199328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6607345|NCT01199328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6607346|NCT01199328|Analgesics|analgesics|mesh-ancestor
6607347|NCT01199328|Sensory System Agents|sensory system agents|mesh-ancestor
6607348|NCT01199328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6607349|NCT01199328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607350|NCT01199328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5501899|NCT04470128|Analgesics|analgesics|mesh-ancestor
6607351|NCT01199328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6607352|NCT01199328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6607353|NCT01199328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6607354|NCT01199328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6607355|NCT01199328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6607356|NCT01199328|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6607357|NCT01199328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6607358|NCT01199328|Antipyretics|antipyretics|mesh-ancestor
6607359|NCT01199328|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6607360|NCT01199328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6607361|NCT01199328|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6607362|NCT01199341|Warfarin|warfarin|mesh-list
6607363|NCT01199341|Anticoagulants|anticoagulants|mesh-ancestor
6607364|NCT01199367|Letrozole|letrozole|mesh-list
6607365|NCT01199367|Lapatinib|lapatinib|mesh-list
6607366|NCT01199367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6607367|NCT01199367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6607368|NCT01199367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6607369|NCT01199367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6607370|NCT01199367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6607371|NCT01199367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6607372|NCT01199367|Hormone Antagonists|hormone antagonists|mesh-ancestor
6607373|NCT01199367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6607374|NCT01199367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607375|NCT01199367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6607376|NCT01199406|Levobupivacaine|levobupivacaine|mesh-list
6607377|NCT01199406|Anesthetics, Local|anesthetics, local|mesh-ancestor
6607378|NCT01199406|Anesthetics|anesthetics|mesh-ancestor
6607379|NCT01199406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6607380|NCT01199406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607381|NCT01199406|Sensory System Agents|sensory system agents|mesh-ancestor
6607382|NCT01199406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6607383|NCT01199432|Cyclophosphamide|cyclophosphamide|mesh-list
6607384|NCT01199432|Fluorouracil|fluorouracil|mesh-list
6607385|NCT01199432|Epirubicin|epirubicin|mesh-list
6607386|NCT01199432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6607387|NCT01199432|Immunologic Factors|immunologic factors|mesh-ancestor
6607388|NCT01199432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607389|NCT01199432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6607390|NCT01199432|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6607391|NCT01199432|Alkylating Agents|alkylating agents|mesh-ancestor
6607392|NCT01199432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6607393|NCT01199432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6607394|NCT01199432|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6607395|NCT01199432|Antimetabolites|antimetabolites|mesh-ancestor
6449480|NCT00404573|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6449481|NCT00404573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6607396|NCT01199432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6607397|NCT01199432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6607398|NCT01199432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6607399|NCT01199432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6607400|NCT01199432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6607401|NCT01199445|Vitamin A|vitamin a|mesh-list
6607402|NCT01199445|Vitamins|vitamins|mesh-ancestor
6607403|NCT01199445|Micronutrients|micronutrients|mesh-ancestor
6607404|NCT01199445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607405|NCT01199458|Alfentanil|alfentanil|mesh-list
6607406|NCT01199458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6607407|NCT01199458|Narcotics|narcotics|mesh-ancestor
6607408|NCT01199458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6607409|NCT01199458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607410|NCT01199458|Analgesics|analgesics|mesh-ancestor
6607411|NCT01199458|Sensory System Agents|sensory system agents|mesh-ancestor
6607412|NCT01199458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6607413|NCT01199458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6607414|NCT01199458|Anesthetics, General|anesthetics, general|mesh-ancestor
6607415|NCT01199458|Anesthetics|anesthetics|mesh-ancestor
6607416|NCT01199510|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6607417|NCT01199510|Lubricant Eye Drops|lubricant eye drops|mesh-list
6607418|NCT01199510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6607419|NCT01199523|Moxifloxacin|moxifloxacin|mesh-list
6607420|NCT01199523|Mirabegron|mirabegron|mesh-list
6449482|NCT00404573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6449483|NCT00404573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449484|NCT00404573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6449485|NCT00404586|Fluticasone|fluticasone|mesh-list
6607421|NCT01199523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6607422|NCT01199523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6607423|NCT01199523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6607424|NCT01199523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6607425|NCT01199523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6607426|NCT01199523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6607427|NCT01199523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6607428|NCT01199523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607429|NCT01199523|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6607430|NCT01199523|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6607431|NCT01199523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6607432|NCT01199523|Adrenergic Agents|adrenergic agents|mesh-ancestor
6607433|NCT01199523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6607434|NCT01199523|Urological Agents|urological agents|mesh-ancestor
6607435|NCT01199562|Valganciclovir|valganciclovir|mesh-list
6449486|NCT00404586|Xhance|xhance|mesh-list
6449487|NCT00404586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6449488|NCT00404586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6449489|NCT00404586|Autonomic Agents|autonomic agents|mesh-ancestor
6607436|NCT01199562|Ganciclovir|ganciclovir|mesh-list
6607437|NCT01199562|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6607438|NCT01199562|Antiviral Agents|antiviral agents|mesh-list
6607439|NCT01199562|Foscarnet|foscarnet|mesh-list
6607440|NCT01199562|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
6607441|NCT01199562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6607442|NCT01199562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6607443|NCT01199562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6607444|NCT01199562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6607445|NCT01199562|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6607446|NCT01199614|Parathyroid Hormone|parathyroid hormone|mesh-list
6607447|NCT01199614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607448|NCT01199614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6660637|NCT01494402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6660638|NCT01494402|Antipyretics|antipyretics|mesh-ancestor
6660639|NCT01494415|Paclitaxel|paclitaxel|mesh-list
6660640|NCT01494415|Carboplatin|carboplatin|mesh-list
6660641|NCT01494415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6660642|NCT01494415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6660643|NCT01494415|Tubulin Modulators|tubulin modulators|mesh-ancestor
6660644|NCT01494415|Antimitotic Agents|antimitotic agents|mesh-ancestor
6660645|NCT01494415|Mitosis Modulators|mitosis modulators|mesh-ancestor
6660646|NCT01494415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660647|NCT01494441|Calcium, Dietary|calcium, dietary|mesh-list
6660648|NCT01494441|Calcium|calcium|mesh-list
6660649|NCT01494441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6660650|NCT01494441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660651|NCT01494441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6660652|NCT01494597|Cyclosporine|cyclosporine|mesh-list
6660653|NCT01494597|Isavuconazole|isavuconazole|mesh-list
6660654|NCT01494597|Cyclosporins|cyclosporins|mesh-list
6660655|NCT01494597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6660656|NCT01494597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660657|NCT01494597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6660658|NCT01494597|Immunologic Factors|immunologic factors|mesh-ancestor
6660659|NCT01494597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660660|NCT01494597|Antifungal Agents|antifungal agents|mesh-ancestor
6660661|NCT01494597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6660662|NCT01494597|Dermatologic Agents|dermatologic agents|mesh-ancestor
6660663|NCT01494597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6660664|NCT01494597|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6660665|NCT01494636|Lidocaine|lidocaine|mesh-list
6660666|NCT01494636|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6660667|NCT01494636|Anesthetics, Local|anesthetics, local|mesh-ancestor
6660668|NCT01494636|Anesthetics|anesthetics|mesh-ancestor
6660669|NCT01494636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6660670|NCT01494636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660671|NCT01494636|Sensory System Agents|sensory system agents|mesh-ancestor
6660672|NCT01494636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6660673|NCT01494636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6660674|NCT01494636|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6660675|NCT01494636|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6660676|NCT01494636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6660677|NCT01494636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660678|NCT01494688|Paclitaxel|paclitaxel|mesh-list
6660679|NCT01494688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6660680|NCT01494688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6660681|NCT01494688|Tubulin Modulators|tubulin modulators|mesh-ancestor
6660682|NCT01494688|Antimitotic Agents|antimitotic agents|mesh-ancestor
6660683|NCT01494688|Mitosis Modulators|mitosis modulators|mesh-ancestor
6660684|NCT01494688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660685|NCT01494714|Petrolatum|petrolatum|mesh-list
6660686|NCT01494714|Emollients|emollients|mesh-ancestor
6660687|NCT01494714|Dermatologic Agents|dermatologic agents|mesh-ancestor
6660688|NCT01494727|Amlodipine|amlodipine|mesh-list
6660689|NCT01494727|Valsartan|valsartan|mesh-list
6660690|NCT01494727|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
6660691|NCT01494727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6660692|NCT01494727|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6660693|NCT01494727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6660694|NCT01494727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660695|NCT01494727|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6660696|NCT01494727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607449|NCT01199757|Fluticasone|fluticasone|mesh-list
6607450|NCT01199757|Xhance|xhance|mesh-list
6607451|NCT01199757|Mometasone Furoate|mometasone furoate|mesh-list
6607452|NCT01199757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6607453|NCT01199757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6607454|NCT01199757|Autonomic Agents|autonomic agents|mesh-ancestor
6607455|NCT01199757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6607456|NCT01199757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607457|NCT01199757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6607458|NCT01199757|Respiratory System Agents|respiratory system agents|mesh-ancestor
6607459|NCT01199757|Dermatologic Agents|dermatologic agents|mesh-ancestor
6607460|NCT01199757|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6607461|NCT01199783|Vancomycin|vancomycin|mesh-list
6607462|NCT01199783|Daptomycin|daptomycin|mesh-list
6607463|NCT01199783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6607464|NCT01199783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6607465|NCT01199835|Calcium|calcium|mesh-list
6607466|NCT01199835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6607467|NCT01199835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607468|NCT01199900|Prednisone|prednisone|mesh-list
6607469|NCT01199900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6607470|NCT01199900|Glucocorticoids|glucocorticoids|mesh-ancestor
6607471|NCT01199900|Hormones|hormones|mesh-ancestor
6607472|NCT01199900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6607473|NCT01199900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607474|NCT01199900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6607475|NCT01199900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6607476|NCT01200004|Lenalidomide|lenalidomide|mesh-list
6607477|NCT01200004|Azacitidine|azacitidine|mesh-list
6607478|NCT01200004|Immunologic Factors|immunologic factors|mesh-ancestor
6607479|NCT01200004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607480|NCT01200004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6607481|NCT01200004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6607482|NCT01200004|Growth Substances|growth substances|mesh-ancestor
6607483|NCT01200004|Growth Inhibitors|growth inhibitors|mesh-ancestor
6607484|NCT01200004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6607485|NCT01200004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6607486|NCT01200004|Antimetabolites|antimetabolites|mesh-ancestor
6607487|NCT01200004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6607488|NCT01200004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6607489|NCT01200056|Atorvastatin|atorvastatin|mesh-list
6607490|NCT01200056|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6607491|NCT01200056|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6607492|NCT01200056|Antimetabolites|antimetabolites|mesh-ancestor
6607493|NCT01200056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6607494|NCT01200056|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6607495|NCT01200056|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6607496|NCT01200056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6607497|NCT01200108|Budesonide|budesonide|mesh-list
6607498|NCT01200108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6607499|NCT01200108|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6607500|NCT01200108|Autonomic Agents|autonomic agents|mesh-ancestor
6607501|NCT01200108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6607502|NCT01200108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607503|NCT01200108|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6607504|NCT01200108|Respiratory System Agents|respiratory system agents|mesh-ancestor
6607505|NCT01200108|Glucocorticoids|glucocorticoids|mesh-ancestor
6607506|NCT01200108|Hormones|hormones|mesh-ancestor
6607507|NCT01200108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6607508|NCT01200121|Bevacizumab|bevacizumab|mesh-list
6607509|NCT01200121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6607510|NCT01200121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6607511|NCT01200121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6607512|NCT01200121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6607513|NCT01200121|Growth Substances|growth substances|mesh-ancestor
6607514|NCT01200121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607515|NCT01200121|Growth Inhibitors|growth inhibitors|mesh-ancestor
6607516|NCT01200186|Progestins|progestins|mesh-list
6607517|NCT01200186|Hormones|hormones|mesh-ancestor
6607518|NCT01200186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6607519|NCT01200186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607520|NCT01200212|Bevacizumab|bevacizumab|mesh-list
6607521|NCT01200212|Taxane|taxane|mesh-list
6607522|NCT01200212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6607523|NCT01200212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6607524|NCT01200212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6607525|NCT01200212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6607526|NCT01200212|Growth Substances|growth substances|mesh-ancestor
6607527|NCT01200212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607528|NCT01200212|Growth Inhibitors|growth inhibitors|mesh-ancestor
6607529|NCT01200251|Bimatoprost|bimatoprost|mesh-list
6607530|NCT01200251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6607531|NCT01200264|Apremilast|apremilast|mesh-list
6607532|NCT01200264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6607533|NCT01200264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6607534|NCT01200264|Analgesics|analgesics|mesh-ancestor
6607535|NCT01200264|Sensory System Agents|sensory system agents|mesh-ancestor
6607536|NCT01200264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6607537|NCT01200264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607538|NCT01200264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6607539|NCT01200264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6607540|NCT01200264|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6607541|NCT01200264|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6607542|NCT01200264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6607543|NCT01200264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6607544|NCT01200472|Apremilast|apremilast|mesh-list
6607545|NCT01200472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6607546|NCT01200472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6607547|NCT01200472|Analgesics|analgesics|mesh-ancestor
6607548|NCT01200472|Sensory System Agents|sensory system agents|mesh-ancestor
6607549|NCT01200472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6607550|NCT01200472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607551|NCT01200472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6607552|NCT01200472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6607553|NCT01200472|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6607554|NCT01200472|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6607555|NCT01200472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6607556|NCT01200472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6607557|NCT01200537|Norinyl|norinyl|mesh-list
6607558|NCT01200537|Contraceptive Agents|contraceptive agents|mesh-list
6607559|NCT01200537|Contraceptives, Oral|contraceptives, oral|mesh-list
6607560|NCT01200537|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
6607561|NCT01200537|Estradiol|estradiol|mesh-list
6607562|NCT01200537|Estrogens|estrogens|mesh-ancestor
6607563|NCT01200537|Hormones|hormones|mesh-ancestor
6607564|NCT01200537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6607565|NCT01200537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607566|NCT01200537|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6607567|NCT01200537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6607568|NCT01200537|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6607569|NCT01200537|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6607570|NCT01200641|Gabapentin|gabapentin|mesh-list
6607571|NCT01200641|Melatonin|melatonin|mesh-list
6607572|NCT01200641|Analgesics|analgesics|mesh-ancestor
6607573|NCT01200641|Sensory System Agents|sensory system agents|mesh-ancestor
6607574|NCT01200641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6607575|NCT01200641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607576|NCT01200641|Anticonvulsants|anticonvulsants|mesh-ancestor
6607577|NCT01200641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6607578|NCT01200641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6607579|NCT01200641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6607580|NCT01200641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6607581|NCT01200641|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6607582|NCT01200641|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6607583|NCT01200641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6607584|NCT01200641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6607585|NCT01200641|Antimanic Agents|antimanic agents|mesh-ancestor
6607586|NCT01200641|Antioxidants|antioxidants|mesh-ancestor
6607587|NCT01200641|Protective Agents|protective agents|mesh-ancestor
6607588|NCT01200654|Linezolid|linezolid|mesh-list
6607589|NCT01200654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6607590|NCT01200654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6607591|NCT01200654|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6607592|NCT01200654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6607593|NCT01200654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6607594|NCT01200693|Sirolimus|sirolimus|mesh-list
6607595|NCT01200693|Everolimus|everolimus|mesh-list
6607596|NCT01200693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6607597|NCT01200693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6607598|NCT01200693|Immunologic Factors|immunologic factors|mesh-ancestor
6607599|NCT01200693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607600|NCT01200693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6607601|NCT01200693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6607602|NCT01200693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6607603|NCT01200693|Antifungal Agents|antifungal agents|mesh-ancestor
6607604|NCT01200706|Amoxicillin|amoxicillin|mesh-list
6607605|NCT01200706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6607606|NCT01200706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6607607|NCT01200732|Tadalafil|tadalafil|mesh-list
6607608|NCT01200732|Vasodilator Agents|vasodilator agents|mesh-ancestor
6607609|NCT01200732|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6607610|NCT01200732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6607611|NCT01200732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6607612|NCT01200732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6607613|NCT01200732|Urological Agents|urological agents|mesh-ancestor
6607614|NCT01200745|Capsaicin|capsaicin|mesh-list
6607615|NCT01200745|Antipruritics|antipruritics|mesh-ancestor
6607616|NCT01200745|Dermatologic Agents|dermatologic agents|mesh-ancestor
6607617|NCT01200745|Sensory System Agents|sensory system agents|mesh-ancestor
6607618|NCT01200745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6607619|NCT01200745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607620|NCT01200784|Niacinamide|niacinamide|mesh-list
6607621|NCT01200784|Niacin|niacin|mesh-list
6607622|NCT01200784|Nicotinic Acids|nicotinic acids|mesh-list
6607623|NCT01200784|Vitamin B Complex|vitamin b complex|mesh-ancestor
6607624|NCT01200784|Vitamins|vitamins|mesh-ancestor
6607625|NCT01200784|Micronutrients|micronutrients|mesh-ancestor
6607626|NCT01200784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607627|NCT01200784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6607628|NCT01200784|Antimetabolites|antimetabolites|mesh-ancestor
6607629|NCT01200784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6607630|NCT01200784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6607631|NCT01200784|Vasodilator Agents|vasodilator agents|mesh-ancestor
6607632|NCT01200901|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6607633|NCT01200901|Antidepressive Agents|antidepressive agents|mesh-ancestor
6607634|NCT01200901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6607635|NCT01200901|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6607636|NCT01200901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6607637|NCT01200901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6607638|NCT01200901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607639|NCT01200914|Heparin|heparin|mesh-list
6607640|NCT01200914|Anticoagulants|anticoagulants|mesh-ancestor
6607641|NCT01200914|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6607642|NCT01200914|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6607643|NCT01200914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6607644|NCT01201005|Hydroxocobalamin|hydroxocobalamin|mesh-list
6607645|NCT01201005|Vitamin B 12|vitamin b 12|mesh-list
6607646|NCT01201005|Hematinics|hematinics|mesh-ancestor
6607647|NCT01201005|Vitamin B Complex|vitamin b complex|mesh-ancestor
6607648|NCT01201005|Vitamins|vitamins|mesh-ancestor
6607649|NCT01201005|Micronutrients|micronutrients|mesh-ancestor
6607650|NCT01201005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607651|NCT01201044|Gemcitabine|gemcitabine|mesh-list
6607652|NCT01201044|Nedaplatin|nedaplatin|mesh-list
6607653|NCT01201044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6607654|NCT01201044|Antimetabolites|antimetabolites|mesh-ancestor
6607655|NCT01201044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6607656|NCT01201044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6607657|NCT01201044|Antiviral Agents|antiviral agents|mesh-ancestor
6607658|NCT01201044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6607659|NCT01201044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6607660|NCT01201044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6607661|NCT01201044|Immunologic Factors|immunologic factors|mesh-ancestor
6607662|NCT01201044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607663|NCT01201070|Antithrombins|antithrombins|mesh-list
6607664|NCT01201070|Antithrombin III|antithrombin iii|mesh-list
6607665|NCT01201070|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6607666|NCT01201070|Protease Inhibitors|protease inhibitors|mesh-ancestor
6607667|NCT01201070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6607668|NCT01201070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6607669|NCT01201070|Anticoagulants|anticoagulants|mesh-ancestor
6607670|NCT01201122|Mesalamine|mesalamine|mesh-list
6607671|NCT01201122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6607672|NCT01201122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6607673|NCT01201122|Analgesics|analgesics|mesh-ancestor
6607674|NCT01201122|Sensory System Agents|sensory system agents|mesh-ancestor
6607675|NCT01201122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6607676|NCT01201122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607677|NCT01201122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6607678|NCT01201122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6607679|NCT01201161|Ranibizumab|ranibizumab|mesh-list
6607680|NCT01201161|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6607681|NCT01201161|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6607682|NCT01201161|Growth Substances|growth substances|mesh-ancestor
6607683|NCT01201161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607684|NCT01201161|Growth Inhibitors|growth inhibitors|mesh-ancestor
6607685|NCT01201161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6607686|NCT01201213|Anesthetics|anesthetics|mesh-list
6607687|NCT01201213|Anesthetics, Local|anesthetics, local|mesh-list
6607688|NCT01201213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6660697|NCT01494727|Vasodilator Agents|vasodilator agents|mesh-ancestor
6607689|NCT01201213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607690|NCT01201213|Sensory System Agents|sensory system agents|mesh-ancestor
6607691|NCT01201213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6607692|NCT01201239|Raltegravir Potassium|raltegravir potassium|mesh-list
6607693|NCT01201239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6607694|NCT01201239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6607695|NCT01201239|Antiviral Agents|antiviral agents|mesh-ancestor
6607696|NCT01201239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6607697|NCT01201239|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6607698|NCT01201239|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6607699|NCT01201239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6607700|NCT01201239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6607701|NCT01201278|Insulin|insulin|mesh-list
6607702|NCT01201278|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6607703|NCT01201278|Insulin Lispro|insulin lispro|mesh-list
6607704|NCT01201278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6607705|NCT01201278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607706|NCT01201499|Morphine|morphine|mesh-list
6607707|NCT01201499|Remifentanil|remifentanil|mesh-list
6607708|NCT01201499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6607709|NCT01201499|Narcotics|narcotics|mesh-ancestor
6607710|NCT01201499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6607711|NCT01201499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607712|NCT01201499|Analgesics|analgesics|mesh-ancestor
6607713|NCT01201499|Sensory System Agents|sensory system agents|mesh-ancestor
6607714|NCT01201499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6607715|NCT01201551|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6607716|NCT01201551|Latanoprost|latanoprost|mesh-list
6607717|NCT01201551|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6607718|NCT01201551|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6607719|NCT01201551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6607720|NCT01201551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6607721|NCT01201551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6607722|NCT01201551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6607723|NCT01201551|Adrenergic Agents|adrenergic agents|mesh-ancestor
6607724|NCT01201551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6607725|NCT01201551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6607726|NCT01201551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660698|NCT01494727|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6660699|NCT01494727|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6660700|NCT01494740|Vaccines|vaccines|mesh-list
6660701|NCT01494740|Immunologic Factors|immunologic factors|mesh-ancestor
6660702|NCT01494740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660703|NCT01494805|Ranibizumab|ranibizumab|mesh-list
6660704|NCT01494805|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6660705|NCT01494805|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6660706|NCT01494805|Growth Substances|growth substances|mesh-ancestor
6660707|NCT01494805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660708|NCT01494805|Growth Inhibitors|growth inhibitors|mesh-ancestor
6660709|NCT01494805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6660710|NCT01494857|Adalimumab|adalimumab|mesh-list
6660711|NCT01494857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6660712|NCT01494857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6660713|NCT01495026|Tamsulosin|tamsulosin|mesh-list
6660714|NCT01495026|Dutasteride|dutasteride|mesh-list
6660715|NCT01495026|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6660716|NCT01495026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6660717|NCT01495026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6660718|NCT01495026|Adrenergic Agents|adrenergic agents|mesh-ancestor
6660719|NCT01495026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6660720|NCT01495026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6607727|NCT01201577|Azithromycin|azithromycin|mesh-list
6607728|NCT01201577|Sulfalene|sulfalene|mesh-list
6607729|NCT01201577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6607730|NCT01201577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6607731|NCT01201577|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6607732|NCT01201577|Renal Agents|renal agents|mesh-ancestor
6607733|NCT01201577|Antimalarials|antimalarials|mesh-ancestor
6607734|NCT01201577|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6607735|NCT01201577|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6607736|NCT01201642|Prednisolone|prednisolone|mesh-list
6607737|NCT01201642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6607738|NCT01201642|Glucocorticoids|glucocorticoids|mesh-ancestor
6607739|NCT01201642|Hormones|hormones|mesh-ancestor
6607740|NCT01201642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6607741|NCT01201642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607742|NCT01201642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6607743|NCT01201642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6607744|NCT01201694|Curcumin|curcumin|mesh-list
6607745|NCT01201694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6607746|NCT01201694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6607747|NCT01201694|Analgesics|analgesics|mesh-ancestor
6607748|NCT01201694|Sensory System Agents|sensory system agents|mesh-ancestor
6607749|NCT01201694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6020582|NCT00393367|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6020583|NCT00393367|Respiratory System Agents|respiratory system agents|mesh-ancestor
6020584|NCT00393367|Anticonvulsants|anticonvulsants|mesh-ancestor
6020585|NCT00393367|Tocolytic Agents|tocolytic agents|mesh-ancestor
6020586|NCT00393367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6607750|NCT01201694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607751|NCT01201694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6607752|NCT01201694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6607753|NCT01201694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6607754|NCT01201694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6607755|NCT01201694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6607756|NCT01201902|Vaccines|vaccines|mesh-list
6607757|NCT01201902|Immunologic Factors|immunologic factors|mesh-ancestor
6607758|NCT01201902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607759|NCT01201928|Insulin|insulin|mesh-list
6607760|NCT01201928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6607761|NCT01201928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607762|NCT01202032|Bevacizumab|bevacizumab|mesh-list
6607763|NCT01202032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6607764|NCT01202032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6607765|NCT01202032|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6607766|NCT01202032|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6607767|NCT01202032|Growth Substances|growth substances|mesh-ancestor
6607768|NCT01202032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607769|NCT01202032|Growth Inhibitors|growth inhibitors|mesh-ancestor
6607770|NCT01202058|Sirolimus|sirolimus|mesh-list
6607771|NCT01202058|Everolimus|everolimus|mesh-list
6607772|NCT01202058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6607773|NCT01202058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6607774|NCT01202058|Immunologic Factors|immunologic factors|mesh-ancestor
6607775|NCT01202058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607776|NCT01202058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6607777|NCT01202058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6607778|NCT01202058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6607779|NCT01202058|Antifungal Agents|antifungal agents|mesh-ancestor
6607780|NCT01202084|Fluticasone|fluticasone|mesh-list
6607781|NCT01202084|Xhance|xhance|mesh-list
6607782|NCT01202084|Formoterol Fumarate|formoterol fumarate|mesh-list
6607783|NCT01202084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6607784|NCT01202084|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6607785|NCT01202084|Autonomic Agents|autonomic agents|mesh-ancestor
6607786|NCT01202084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6607787|NCT01202084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607788|NCT01202084|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6607789|NCT01202084|Respiratory System Agents|respiratory system agents|mesh-ancestor
6607790|NCT01202084|Dermatologic Agents|dermatologic agents|mesh-ancestor
6607791|NCT01202084|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6607792|NCT01202084|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6607793|NCT01202084|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6607794|NCT01202084|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6607795|NCT01202084|Adrenergic Agents|adrenergic agents|mesh-ancestor
6607796|NCT01202084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6607797|NCT01202084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6449490|NCT00404586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6449491|NCT00404586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449492|NCT00404586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6449493|NCT00404586|Respiratory System Agents|respiratory system agents|mesh-ancestor
6449494|NCT00404586|Dermatologic Agents|dermatologic agents|mesh-ancestor
6449495|NCT00404586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6449496|NCT00404599|Simvastatin|simvastatin|mesh-list
6449497|NCT00404599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6449498|NCT00404599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6449499|NCT00404599|Antimetabolites|antimetabolites|mesh-ancestor
6449500|NCT00404599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6607798|NCT01202097|Fluticasone|fluticasone|mesh-list
6607799|NCT01202097|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6607800|NCT01202097|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6607801|NCT01202097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6607802|NCT01202097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6607803|NCT01202097|Autonomic Agents|autonomic agents|mesh-ancestor
6607804|NCT01202097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6607805|NCT01202097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607806|NCT01202097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6607807|NCT01202097|Respiratory System Agents|respiratory system agents|mesh-ancestor
6607808|NCT01202097|Dermatologic Agents|dermatologic agents|mesh-ancestor
6607809|NCT01202097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6607810|NCT01202097|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6607811|NCT01202097|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6607812|NCT01202097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6607813|NCT01202097|Adrenergic Agents|adrenergic agents|mesh-ancestor
6607814|NCT01202097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6607815|NCT01202097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6607816|NCT01202097|Glucocorticoids|glucocorticoids|mesh-ancestor
6449501|NCT00404599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6449502|NCT00404599|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6449503|NCT00404599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6607817|NCT01202097|Hormones|hormones|mesh-ancestor
6607818|NCT01202097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6607819|NCT01202097|Sympathomimetics|sympathomimetics|mesh-ancestor
6607820|NCT01202149|Pimecrolimus|pimecrolimus|mesh-list
6607821|NCT01202149|Emollients|emollients|mesh-list
6607822|NCT01202149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6607823|NCT01202149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6607824|NCT01202149|Analgesics|analgesics|mesh-ancestor
6607825|NCT01202149|Sensory System Agents|sensory system agents|mesh-ancestor
6607826|NCT01202149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6607827|NCT01202149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607828|NCT01202149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6607829|NCT01202149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6607830|NCT01202149|Dermatologic Agents|dermatologic agents|mesh-ancestor
6607831|NCT01202149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6607832|NCT01202149|Immunologic Factors|immunologic factors|mesh-ancestor
6607833|NCT01202149|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6607834|NCT01202149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6607835|NCT01202149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6449504|NCT00404625|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6607836|NCT01202240|Ketoconazole|ketoconazole|mesh-list
6607837|NCT01202240|Tofacitinib|tofacitinib|mesh-list
6607838|NCT01202240|Antifungal Agents|antifungal agents|mesh-ancestor
6607839|NCT01202240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6607840|NCT01202240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6607841|NCT01202240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6607842|NCT01202240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6607843|NCT01202240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6607844|NCT01202240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6607845|NCT01202240|Hormone Antagonists|hormone antagonists|mesh-ancestor
6607846|NCT01202240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6607847|NCT01202240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607848|NCT01202240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6607849|NCT01202240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6607850|NCT01202331|Azithromycin|azithromycin|mesh-list
6607851|NCT01202331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6449505|NCT00404625|Anti-Infective Agents|anti-infective agents|mesh-list
6449506|NCT00404703|Bevacizumab|bevacizumab|mesh-list
6449507|NCT00404703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6449508|NCT00404703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6449509|NCT00404703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6449510|NCT00404703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6449511|NCT00404703|Growth Substances|growth substances|mesh-ancestor
6449512|NCT00404703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449513|NCT00404703|Growth Inhibitors|growth inhibitors|mesh-ancestor
6449514|NCT00404716|Cilostazol|cilostazol|mesh-list
6449515|NCT00404716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6449516|NCT00404716|Autonomic Agents|autonomic agents|mesh-ancestor
6449517|NCT00404716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6449518|NCT00404716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449519|NCT00404716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6449520|NCT00404716|Respiratory System Agents|respiratory system agents|mesh-ancestor
6607852|NCT01202331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6607853|NCT01202370|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
6607854|NCT01202370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6607855|NCT01202370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6607856|NCT01202422|Pregabalin|pregabalin|mesh-list
6607857|NCT01202422|Analgesics|analgesics|mesh-ancestor
6607858|NCT01202422|Sensory System Agents|sensory system agents|mesh-ancestor
6607859|NCT01202422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6607860|NCT01202422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607861|NCT01202422|Anticonvulsants|anticonvulsants|mesh-ancestor
6607862|NCT01202422|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6607863|NCT01202422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6607864|NCT01202422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6607865|NCT01202422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6607866|NCT01202422|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6607867|NCT01202422|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6607868|NCT01202422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6607869|NCT01202422|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6607870|NCT01202435|Pregabalin|pregabalin|mesh-list
6607871|NCT01202435|Analgesics|analgesics|mesh-ancestor
6607872|NCT01202435|Sensory System Agents|sensory system agents|mesh-ancestor
6607873|NCT01202435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6607874|NCT01202435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607875|NCT01202435|Anticonvulsants|anticonvulsants|mesh-ancestor
6607876|NCT01202435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6607877|NCT01202435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6607878|NCT01202435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6607879|NCT01202435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6607880|NCT01202435|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6607881|NCT01202435|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6607882|NCT01202435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6607883|NCT01202435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6607884|NCT01202474|Insulin|insulin|mesh-list
6607885|NCT01202474|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6607886|NCT01202474|Insulin Glargine|insulin glargine|mesh-list
6607887|NCT01202474|Insulin glulisine|insulin glulisine|mesh-list
6607888|NCT01202474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6607889|NCT01202474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607890|NCT01202487|Lidocaine|lidocaine|mesh-list
6449521|NCT00404716|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6449522|NCT00404716|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6449523|NCT00404716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6449524|NCT00404716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6449525|NCT00404716|Vasodilator Agents|vasodilator agents|mesh-ancestor
6449526|NCT00404716|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6449527|NCT00404716|Protective Agents|protective agents|mesh-ancestor
6449528|NCT00404716|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6607891|NCT01202487|Epinephrine|epinephrine|mesh-list
6607892|NCT01202487|Tetracaine|tetracaine|mesh-list
6607893|NCT01202487|Anesthetics, Local|anesthetics, local|mesh-ancestor
6607894|NCT01202487|Anesthetics|anesthetics|mesh-ancestor
6607895|NCT01202487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6607896|NCT01202487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607897|NCT01202487|Sensory System Agents|sensory system agents|mesh-ancestor
6607898|NCT01202487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6607899|NCT01202487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6607900|NCT01202487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6607901|NCT01202487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6607902|NCT01202487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6607903|NCT01202487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6607904|NCT01202487|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6607905|NCT01202487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6607906|NCT01202487|Adrenergic Agents|adrenergic agents|mesh-ancestor
6607907|NCT01202487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6607908|NCT01202487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6607909|NCT01202487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6607910|NCT01202487|Autonomic Agents|autonomic agents|mesh-ancestor
6607911|NCT01202487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6607912|NCT01202487|Respiratory System Agents|respiratory system agents|mesh-ancestor
6607913|NCT01202487|Mydriatics|mydriatics|mesh-ancestor
6607914|NCT01202487|Sympathomimetics|sympathomimetics|mesh-ancestor
6607915|NCT01202487|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6607916|NCT01202513|Bimatoprost|bimatoprost|mesh-list
6607917|NCT01202513|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6607918|NCT01202513|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6607919|NCT01202513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6607920|NCT01202552|Vaccines|vaccines|mesh-list
6607921|NCT01202552|Immunologic Factors|immunologic factors|mesh-ancestor
6607922|NCT01202552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607923|NCT01202734|Methylphenidate|methylphenidate|mesh-list
6607924|NCT01202734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6607925|NCT01202734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607926|NCT01202734|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6607927|NCT01202734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6607928|NCT01202734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6607929|NCT01202734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6607930|NCT01202734|Dopamine Agents|dopamine agents|mesh-ancestor
6607931|NCT01202734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6607932|NCT01202799|Diclofenac|diclofenac|mesh-list
6020587|NCT00393367|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6607933|NCT01202799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6607934|NCT01202799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6607935|NCT01202799|Analgesics|analgesics|mesh-ancestor
6607936|NCT01202799|Sensory System Agents|sensory system agents|mesh-ancestor
6020588|NCT00393367|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6607937|NCT01202799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6607938|NCT01202799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607939|NCT01202799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6607940|NCT01202799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6607941|NCT01202799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6607942|NCT01202799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6607943|NCT01202799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6607944|NCT01202825|Simeprevir|simeprevir|mesh-list
6607945|NCT01202825|Antiviral Agents|antiviral agents|mesh-ancestor
6607946|NCT01202825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6607947|NCT01202825|Protease Inhibitors|protease inhibitors|mesh-ancestor
6607948|NCT01202825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6607949|NCT01202825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6607950|NCT01202890|Bevacizumab|bevacizumab|mesh-list
6607951|NCT01202890|Lenalidomide|lenalidomide|mesh-list
6607952|NCT01202890|Doxorubicin|doxorubicin|mesh-list
6607953|NCT01202890|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6607954|NCT01202890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6607955|NCT01202890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6607956|NCT01202890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6607957|NCT01202890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6607958|NCT01202890|Growth Substances|growth substances|mesh-ancestor
6607959|NCT01202890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607960|NCT01202890|Growth Inhibitors|growth inhibitors|mesh-ancestor
6607961|NCT01202890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6607962|NCT01202890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6607963|NCT01202890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6607964|NCT01202890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6607965|NCT01202890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6607966|NCT01202890|Immunologic Factors|immunologic factors|mesh-ancestor
6607967|NCT01203020|Vidarabine|vidarabine|mesh-list
6607968|NCT01203020|Fludarabine|fludarabine|mesh-list
6607969|NCT01203020|Fludarabine phosphate|fludarabine phosphate|mesh-list
6607970|NCT01203020|Busulfan|busulfan|mesh-list
6607971|NCT01203020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6607972|NCT01203020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6607973|NCT01203020|Antimetabolites|antimetabolites|mesh-ancestor
6607974|NCT01203020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6607975|NCT01203020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6607976|NCT01203020|Immunologic Factors|immunologic factors|mesh-ancestor
6607977|NCT01203020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607978|NCT01203020|Antiviral Agents|antiviral agents|mesh-ancestor
6607979|NCT01203020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6607980|NCT01203020|Alkylating Agents|alkylating agents|mesh-ancestor
6607981|NCT01203020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6607982|NCT01203020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6607983|NCT01203111|Insulin|insulin|mesh-list
6607984|NCT01203111|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6607985|NCT01203111|Insulin Glargine|insulin glargine|mesh-list
6607986|NCT01203111|Insulin glulisine|insulin glulisine|mesh-list
6607987|NCT01203111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6607988|NCT01203111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6607989|NCT01203202|Clomipramine|clomipramine|mesh-list
6607990|NCT01203202|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6607991|NCT01203202|Antidepressive Agents|antidepressive agents|mesh-ancestor
6607992|NCT01203202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6607993|NCT01203202|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6607994|NCT01203202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6607995|NCT01203202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6607996|NCT01203202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6607997|NCT01203202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6607998|NCT01203202|Serotonin Agents|serotonin agents|mesh-ancestor
6607999|NCT01203202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608000|NCT01203228|Cyclophosphamide|cyclophosphamide|mesh-list
6608001|NCT01203228|Busulfan|busulfan|mesh-list
6608002|NCT01203228|Fludarabine phosphate|fludarabine phosphate|mesh-list
6608003|NCT01203228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6608004|NCT01203228|Immunologic Factors|immunologic factors|mesh-ancestor
6608005|NCT01203228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608006|NCT01203228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6608007|NCT01203228|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6608008|NCT01203228|Alkylating Agents|alkylating agents|mesh-ancestor
6608009|NCT01203228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6608010|NCT01203228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6608011|NCT01203228|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6608012|NCT01203228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6608013|NCT01203228|Antimetabolites|antimetabolites|mesh-ancestor
6608014|NCT01203254|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
6608015|NCT01203254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6608016|NCT01203254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6608017|NCT01203254|Antimetabolites|antimetabolites|mesh-ancestor
6608018|NCT01203254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6608019|NCT01203254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6608020|NCT01203267|Paclitaxel|paclitaxel|mesh-list
6608021|NCT01203267|Carboplatin|carboplatin|mesh-list
6608022|NCT01203267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6608023|NCT01203267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6608024|NCT01203267|Tubulin Modulators|tubulin modulators|mesh-ancestor
6608025|NCT01203267|Antimitotic Agents|antimitotic agents|mesh-ancestor
6608026|NCT01203267|Mitosis Modulators|mitosis modulators|mesh-ancestor
6608027|NCT01203267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6608028|NCT01203306|Bevacizumab|bevacizumab|mesh-list
6608029|NCT01203306|Capecitabine|capecitabine|mesh-list
6608030|NCT01203306|Octreotide|octreotide|mesh-list
6608031|NCT01203306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6608032|NCT01203306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6608033|NCT01203306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6608034|NCT01203306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6608035|NCT01203306|Growth Substances|growth substances|mesh-ancestor
6608036|NCT01203306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608037|NCT01203306|Growth Inhibitors|growth inhibitors|mesh-ancestor
6608038|NCT01203306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6608039|NCT01203306|Antimetabolites|antimetabolites|mesh-ancestor
6608040|NCT01203306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6608041|NCT01203306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6608042|NCT01203306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6608043|NCT01203345|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6608044|NCT01203345|Immunologic Factors|immunologic factors|mesh-ancestor
6608045|NCT01203345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608046|NCT01203358|Beractant|beractant|mesh-list
6608047|NCT01203358|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
6608048|NCT01203358|Respiratory System Agents|respiratory system agents|mesh-ancestor
6660721|NCT01495026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660722|NCT01495026|Urological Agents|urological agents|mesh-ancestor
6660723|NCT01495026|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6660724|NCT01495026|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6660725|NCT01495026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6660726|NCT01495026|Hormone Antagonists|hormone antagonists|mesh-ancestor
6660727|NCT01495026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6660728|NCT01495039|Nystatin|nystatin|mesh-list
6660729|NCT01495039|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6660730|NCT01495039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6660731|NCT01495039|Antifungal Agents|antifungal agents|mesh-ancestor
6660732|NCT01495039|Ionophores|ionophores|mesh-ancestor
6020589|NCT00393367|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6020590|NCT00393367|Adrenergic Agents|adrenergic agents|mesh-ancestor
6020591|NCT00393367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6660733|NCT01495039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6660734|NCT01495039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660735|NCT01495104|Valproic Acid|valproic acid|mesh-list
6660736|NCT01495104|Anticonvulsants|anticonvulsants|mesh-ancestor
6660737|NCT01495104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6660738|NCT01495104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660739|NCT01495104|GABA Agents|gaba agents|mesh-ancestor
6660740|NCT01495104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6660741|NCT01495104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660742|NCT01495104|Antimanic Agents|antimanic agents|mesh-ancestor
6660743|NCT01495104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6660744|NCT01495104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6660745|NCT01495104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6660746|NCT01495117|Iodine|iodine|mesh-list
6660747|NCT01495117|Chlorhexidine|chlorhexidine|mesh-list
6660748|NCT01495117|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6660749|NCT01495117|Povidone-Iodine|povidone-iodine|mesh-list
6660750|NCT01495117|Povidone|povidone|mesh-list
6608049|NCT01203371|Naftopidil|naftopidil|mesh-list
6608050|NCT01203371|Tamsulosin|tamsulosin|mesh-list
6608051|NCT01203371|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6608052|NCT01203371|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6608053|NCT01203371|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6608054|NCT01203371|Adrenergic Agents|adrenergic agents|mesh-ancestor
6608055|NCT01203371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6608056|NCT01203371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6608057|NCT01203371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608058|NCT01203371|Urological Agents|urological agents|mesh-ancestor
6608059|NCT01203371|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6608060|NCT01203371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6608061|NCT01203371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6608062|NCT01203371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6608063|NCT01203371|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6608064|NCT01203384|Flurbiprofen|flurbiprofen|mesh-list
6608065|NCT01203384|Analgesics|analgesics|mesh-ancestor
6608066|NCT01203384|Sensory System Agents|sensory system agents|mesh-ancestor
6608067|NCT01203384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6608068|NCT01203384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608069|NCT01203384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6608070|NCT01203384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6608071|NCT01203384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6608072|NCT01203384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6608073|NCT01203384|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6608074|NCT01203384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6608075|NCT01203384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6608076|NCT01203488|Vitamin A|vitamin a|mesh-list
6608077|NCT01203488|Vitamins|vitamins|mesh-ancestor
6608078|NCT01203488|Micronutrients|micronutrients|mesh-ancestor
6608079|NCT01203488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608080|NCT01203514|Epoetin Alfa|epoetin alfa|mesh-list
6608081|NCT01203514|Hematinics|hematinics|mesh-ancestor
6608082|NCT01203540|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6608083|NCT01203540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6608084|NCT01203592|Albuterol|albuterol|mesh-list
6608085|NCT01203592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6608086|NCT01203592|Autonomic Agents|autonomic agents|mesh-ancestor
6608087|NCT01203592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6608088|NCT01203592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608089|NCT01203592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6608090|NCT01203592|Respiratory System Agents|respiratory system agents|mesh-ancestor
6608091|NCT01203592|Tocolytic Agents|tocolytic agents|mesh-ancestor
6608092|NCT01203592|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6608093|NCT01203592|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6608094|NCT01203592|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6608095|NCT01203592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6608096|NCT01203592|Adrenergic Agents|adrenergic agents|mesh-ancestor
6608097|NCT01203592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6608098|NCT01203592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6608099|NCT01203618|Farletuzumab|farletuzumab|mesh-list
6608100|NCT01203618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6608101|NCT01203696|Amlodipine|amlodipine|mesh-list
6608102|NCT01203696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6608103|NCT01203696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6608104|NCT01203696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6608105|NCT01203696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6608106|NCT01203696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6608107|NCT01203696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608108|NCT01203696|Vasodilator Agents|vasodilator agents|mesh-ancestor
6608109|NCT01203709|Mycophenolic Acid|mycophenolic acid|mesh-list
6608110|NCT01203709|Tacrolimus|tacrolimus|mesh-list
6608111|NCT01203709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6608112|NCT01203709|Immunologic Factors|immunologic factors|mesh-ancestor
6608113|NCT01203709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608114|NCT01203709|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6608115|NCT01203709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6608116|NCT01203709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6608117|NCT01203709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6608118|NCT01203709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6608119|NCT01203709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6608120|NCT01203709|Antitubercular Agents|antitubercular agents|mesh-ancestor
6608121|NCT01203709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6608122|NCT01203709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6608123|NCT01203722|Mycophenolic Acid|mycophenolic acid|mesh-list
6608124|NCT01203722|Sirolimus|sirolimus|mesh-list
6608125|NCT01203722|Fludarabine|fludarabine|mesh-list
6608126|NCT01203722|Cyclophosphamide|cyclophosphamide|mesh-list
6608127|NCT01203722|Tacrolimus|tacrolimus|mesh-list
6608128|NCT01203722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6608129|NCT01203722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6608130|NCT01203722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6608131|NCT01203722|Immunologic Factors|immunologic factors|mesh-ancestor
6608132|NCT01203722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608133|NCT01203722|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6608134|NCT01203722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6608135|NCT01203722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6608136|NCT01203722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6608137|NCT01203722|Alkylating Agents|alkylating agents|mesh-ancestor
6608138|NCT01203722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6608139|NCT01203722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6608140|NCT01203722|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6608141|NCT01203722|Antitubercular Agents|antitubercular agents|mesh-ancestor
6608142|NCT01203722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6608143|NCT01203722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6608144|NCT01203722|Antifungal Agents|antifungal agents|mesh-ancestor
6608145|NCT01203735|Valproic Acid|valproic acid|mesh-list
6608146|NCT01203735|Anticonvulsants|anticonvulsants|mesh-ancestor
6608147|NCT01203735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6608148|NCT01203735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6608149|NCT01203735|GABA Agents|gaba agents|mesh-ancestor
6608150|NCT01203735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6608151|NCT01203735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608152|NCT01203735|Antimanic Agents|antimanic agents|mesh-ancestor
6608153|NCT01203735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6608154|NCT01203735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6608155|NCT01203735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6608156|NCT01203982|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6608157|NCT01203982|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6608158|NCT01203982|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6608159|NCT01203982|Antimetabolites|antimetabolites|mesh-ancestor
6608160|NCT01203982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6608161|NCT01203982|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6608162|NCT01203982|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6608163|NCT01203982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6608164|NCT01204086|Fluoxetine|fluoxetine|mesh-list
6608165|NCT01204086|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6608166|NCT01204086|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6608167|NCT01204086|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6608168|NCT01204086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6608169|NCT01204086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6608170|NCT01204086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6608171|NCT01204086|Serotonin Agents|serotonin agents|mesh-ancestor
6608172|NCT01204086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608173|NCT01204086|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6608174|NCT01204086|Antidepressive Agents|antidepressive agents|mesh-ancestor
6608175|NCT01204086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6020592|NCT00393367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020593|NCT00393367|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6608176|NCT01204086|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6608177|NCT01204086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6608178|NCT01204086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6608179|NCT01204086|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6608180|NCT01204112|Rifampin|rifampin|mesh-list
6608181|NCT01204112|Tofacitinib|tofacitinib|mesh-list
6608182|NCT01204112|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6608183|NCT01204112|Antitubercular Agents|antitubercular agents|mesh-ancestor
6608184|NCT01204112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6608185|NCT01204112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6608186|NCT01204112|Leprostatic Agents|leprostatic agents|mesh-ancestor
6608187|NCT01204112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6608188|NCT01204112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6608189|NCT01204112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6608190|NCT01204112|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6608191|NCT01204112|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6608192|NCT01204112|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6608193|NCT01204112|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6608194|NCT01204112|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6608195|NCT01204112|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6608196|NCT01204112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6608197|NCT01204125|Paclitaxel|paclitaxel|mesh-list
6608198|NCT01204125|Iniparib|iniparib|mesh-list
6608199|NCT01204125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6608200|NCT01204125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6608201|NCT01204125|Tubulin Modulators|tubulin modulators|mesh-ancestor
6608202|NCT01204125|Antimitotic Agents|antimitotic agents|mesh-ancestor
6608203|NCT01204125|Mitosis Modulators|mitosis modulators|mesh-ancestor
6608204|NCT01204125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6608205|NCT01204125|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6608206|NCT01204125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6608207|NCT01204138|Apremilast|apremilast|mesh-list
6608208|NCT01204138|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6608209|NCT01204138|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6608210|NCT01204138|Analgesics|analgesics|mesh-ancestor
6608211|NCT01204138|Sensory System Agents|sensory system agents|mesh-ancestor
6608212|NCT01204138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6608213|NCT01204138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608214|NCT01204138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6608215|NCT01204138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6608216|NCT01204138|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6608217|NCT01204138|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6608218|NCT01204138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6608219|NCT01204138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6608220|NCT01204164|Dexamethasone|dexamethasone|mesh-list
6608221|NCT01204164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6608222|NCT01204164|Antiemetics|antiemetics|mesh-ancestor
6608223|NCT01204164|Autonomic Agents|autonomic agents|mesh-ancestor
6608224|NCT01204164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6608225|NCT01204164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608226|NCT01204164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6608227|NCT01204164|Glucocorticoids|glucocorticoids|mesh-ancestor
6608228|NCT01204164|Hormones|hormones|mesh-ancestor
6608229|NCT01204164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6608230|NCT01204164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6608231|NCT01204164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6608232|NCT01204177|Sorafenib|sorafenib|mesh-list
6608233|NCT01204177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6608234|NCT01204177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6608235|NCT01204177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6608236|NCT01204177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6608237|NCT01204190|Gestodene|gestodene|mesh-list
6608238|NCT01204190|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6608239|NCT01204190|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6608240|NCT01204190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6608241|NCT01204190|Contraceptive Agents|contraceptive agents|mesh-ancestor
6020594|NCT00393367|Cholinergic Agents|cholinergic agents|mesh-ancestor
6608242|NCT01204190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6608243|NCT01204190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608244|NCT01204190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6608245|NCT01204190|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6608246|NCT01204190|Progestins|progestins|mesh-ancestor
6608247|NCT01204190|Hormones|hormones|mesh-ancestor
6020595|NCT00393380|Teriparatide|teriparatide|mesh-list
6020596|NCT00393380|Hormones|hormones|mesh-list
6608248|NCT01204190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6608249|NCT01204216|Biotin|biotin|mesh-list
6608250|NCT01204216|Vitamin B Complex|vitamin b complex|mesh-ancestor
6608251|NCT01204216|Vitamins|vitamins|mesh-ancestor
6608252|NCT01204216|Micronutrients|micronutrients|mesh-ancestor
6608253|NCT01204216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608254|NCT01204242|Lidocaine|lidocaine|mesh-list
6608255|NCT01204242|Anesthetics, Local|anesthetics, local|mesh-ancestor
6608256|NCT01204242|Anesthetics|anesthetics|mesh-ancestor
6608257|NCT01204242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6608258|NCT01204242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608259|NCT01204242|Sensory System Agents|sensory system agents|mesh-ancestor
6608260|NCT01204242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6608261|NCT01204242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6608262|NCT01204242|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6608263|NCT01204242|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6608264|NCT01204242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6608265|NCT01204242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6608266|NCT01204268|Sevoflurane|sevoflurane|mesh-list
6608267|NCT01204268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6608268|NCT01204268|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6608269|NCT01204268|Anesthetics, General|anesthetics, general|mesh-ancestor
6608270|NCT01204268|Anesthetics|anesthetics|mesh-ancestor
6608271|NCT01204268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6608272|NCT01204268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608273|NCT01204307|Cisplatin|cisplatin|mesh-list
6608274|NCT01204307|Docetaxel|docetaxel|mesh-list
6608275|NCT01204307|Pemetrexed|pemetrexed|mesh-list
6608276|NCT01204307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6608277|NCT01204307|Tubulin Modulators|tubulin modulators|mesh-ancestor
6608278|NCT01204307|Antimitotic Agents|antimitotic agents|mesh-ancestor
6608279|NCT01204307|Mitosis Modulators|mitosis modulators|mesh-ancestor
6608280|NCT01204307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6608281|NCT01204307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6608282|NCT01204307|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6608283|NCT01204307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6608284|NCT01204320|Paclitaxel|paclitaxel|mesh-list
6608285|NCT01204320|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6608286|NCT01204320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6020597|NCT00393380|Parathyroid Hormone|parathyroid hormone|mesh-list
6608287|NCT01204320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6608288|NCT01204320|Tubulin Modulators|tubulin modulators|mesh-ancestor
6608289|NCT01204320|Antimitotic Agents|antimitotic agents|mesh-ancestor
6608290|NCT01204320|Mitosis Modulators|mitosis modulators|mesh-ancestor
6608291|NCT01204320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501900|NCT04470128|Sensory System Agents|sensory system agents|mesh-ancestor
5501901|NCT04470128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5501902|NCT04470128|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5501903|NCT04470128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5501904|NCT04470128|Anesthetics, General|anesthetics, general|mesh-ancestor
5501905|NCT04470128|Anesthetics|anesthetics|mesh-ancestor
6020598|NCT00393380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6020599|NCT00393380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020600|NCT00393380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6020601|NCT00393380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6020602|NCT00393458|Formoterol Fumarate|formoterol fumarate|mesh-list
6608292|NCT01204333|Heparin|heparin|mesh-list
6608293|NCT01204333|Anticoagulants|anticoagulants|mesh-ancestor
6608294|NCT01204333|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6608295|NCT01204333|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6608296|NCT01204333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6608297|NCT01204346|Psychotropic Drugs|psychotropic drugs|mesh-list
6608298|NCT01204372|Gemcitabine|gemcitabine|mesh-list
6608299|NCT01204372|Trastuzumab|trastuzumab|mesh-list
6608300|NCT01204372|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6608301|NCT01204372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6020603|NCT00393458|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6020604|NCT00393458|Autonomic Agents|autonomic agents|mesh-ancestor
6020605|NCT00393458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6020606|NCT00393458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020607|NCT00393458|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6020608|NCT00393458|Respiratory System Agents|respiratory system agents|mesh-ancestor
6020609|NCT00393458|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6020610|NCT00393458|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6608302|NCT01204372|Antimetabolites|antimetabolites|mesh-ancestor
6608303|NCT01204372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6608304|NCT01204372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6608305|NCT01204372|Antiviral Agents|antiviral agents|mesh-ancestor
6608306|NCT01204372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6608307|NCT01204372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6608308|NCT01204372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6608309|NCT01204372|Immunologic Factors|immunologic factors|mesh-ancestor
6608310|NCT01204372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608311|NCT01204372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6608312|NCT01204372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6608313|NCT01204411|Artesunate|artesunate|mesh-list
6608314|NCT01204411|Amodiaquine|amodiaquine|mesh-list
6608315|NCT01204411|Antimalarials|antimalarials|mesh-ancestor
6608316|NCT01204411|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6608317|NCT01204411|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6608318|NCT01204411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6608319|NCT01204411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6608320|NCT01204411|Antiviral Agents|antiviral agents|mesh-ancestor
6608321|NCT01204411|Schistosomicides|schistosomicides|mesh-ancestor
6608322|NCT01204411|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6608323|NCT01204411|Anthelmintics|anthelmintics|mesh-ancestor
5501920|NCT04469829|Methotrexate|methotrexate|mesh-list
5724850|NCT03184805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6608324|NCT01204437|Paclitaxel|paclitaxel|mesh-list
6608325|NCT01204437|Cyclophosphamide|cyclophosphamide|mesh-list
6608326|NCT01204437|Capecitabine|capecitabine|mesh-list
6608327|NCT01204437|Methotrexate|methotrexate|mesh-list
6608328|NCT01204437|Epirubicin|epirubicin|mesh-list
6608329|NCT01204437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6608330|NCT01204437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6608331|NCT01204437|Tubulin Modulators|tubulin modulators|mesh-ancestor
6608332|NCT01204437|Antimitotic Agents|antimitotic agents|mesh-ancestor
6608333|NCT01204437|Mitosis Modulators|mitosis modulators|mesh-ancestor
6608334|NCT01204437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6608335|NCT01204437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6608336|NCT01204437|Immunologic Factors|immunologic factors|mesh-ancestor
6608337|NCT01204437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608338|NCT01204437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6608339|NCT01204437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6608340|NCT01204437|Alkylating Agents|alkylating agents|mesh-ancestor
6608341|NCT01204437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6608342|NCT01204437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6608343|NCT01204437|Antimetabolites|antimetabolites|mesh-ancestor
6608344|NCT01204437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6608345|NCT01204437|Abortifacient Agents|abortifacient agents|mesh-ancestor
6608346|NCT01204437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6608347|NCT01204437|Dermatologic Agents|dermatologic agents|mesh-ancestor
6608348|NCT01204437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6608349|NCT01204437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6608350|NCT01204437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6608351|NCT01204437|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6608352|NCT01204437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6608353|NCT01204437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6608354|NCT01204450|Sirolimus|sirolimus|mesh-list
6608355|NCT01204450|Valproic Acid|valproic acid|mesh-list
6608356|NCT01204450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6608357|NCT01204450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6608358|NCT01204450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6608359|NCT01204450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6608360|NCT01204450|Antifungal Agents|antifungal agents|mesh-ancestor
6608361|NCT01204450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6608362|NCT01204450|Immunologic Factors|immunologic factors|mesh-ancestor
6608363|NCT01204450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608364|NCT01204450|Anticonvulsants|anticonvulsants|mesh-ancestor
6608365|NCT01204450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6608366|NCT01204450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6608367|NCT01204450|GABA Agents|gaba agents|mesh-ancestor
6608368|NCT01204450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6608369|NCT01204450|Antimanic Agents|antimanic agents|mesh-ancestor
6608370|NCT01204450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6608371|NCT01204450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6608372|NCT01204450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6608373|NCT01204476|Everolimus|everolimus|mesh-list
6608374|NCT01204476|Octreotide|octreotide|mesh-list
6608375|NCT01204476|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6608376|NCT01204476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6608377|NCT01204476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6608378|NCT01204476|Immunologic Factors|immunologic factors|mesh-ancestor
6608379|NCT01204476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608380|NCT01204476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6608381|NCT01204476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6608382|NCT01204580|Metformin|metformin|mesh-list
6608383|NCT01204580|Glimepiride|glimepiride|mesh-list
6608384|NCT01204580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6608385|NCT01204580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608386|NCT01204580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6608387|NCT01204580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6608388|NCT01204580|Immunologic Factors|immunologic factors|mesh-ancestor
6608389|NCT01204593|Insulin|insulin|mesh-list
6608390|NCT01204593|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6608391|NCT01204593|Insulin Glargine|insulin glargine|mesh-list
6608392|NCT01204593|Insulin glulisine|insulin glulisine|mesh-list
6608393|NCT01204593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6608394|NCT01204593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608395|NCT01204723|Aprepitant|aprepitant|mesh-list
6608396|NCT01204723|Fosaprepitant|fosaprepitant|mesh-list
6608397|NCT01204723|Antiemetics|antiemetics|mesh-ancestor
6608398|NCT01204723|Autonomic Agents|autonomic agents|mesh-ancestor
6608399|NCT01204723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6608400|NCT01204723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608401|NCT01204723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6608402|NCT01204723|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6608403|NCT01204723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6608404|NCT01204723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6608405|NCT01204801|Doxorubicin|doxorubicin|mesh-list
6608406|NCT01204801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6608407|NCT01204801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6608408|NCT01204801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6608409|NCT01204801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6608410|NCT01204801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6608411|NCT01204801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6608412|NCT01204801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6608413|NCT01204840|Hormones|hormones|mesh-list
6608414|NCT01204840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6608415|NCT01204840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608416|NCT01204996|Gemcitabine|gemcitabine|mesh-list
6608417|NCT01204996|Paclitaxel|paclitaxel|mesh-list
6608418|NCT01204996|Docetaxel|docetaxel|mesh-list
6608419|NCT01204996|Carboplatin|carboplatin|mesh-list
6608420|NCT01204996|Doxorubicin|doxorubicin|mesh-list
6608421|NCT01204996|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6608422|NCT01204996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6608423|NCT01204996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6608424|NCT01204996|Tubulin Modulators|tubulin modulators|mesh-ancestor
6608425|NCT01204996|Antimitotic Agents|antimitotic agents|mesh-ancestor
6608426|NCT01204996|Mitosis Modulators|mitosis modulators|mesh-ancestor
6608427|NCT01204996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6608428|NCT01204996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6608429|NCT01204996|Antimetabolites|antimetabolites|mesh-ancestor
6608430|NCT01204996|Antiviral Agents|antiviral agents|mesh-ancestor
6608431|NCT01204996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6608432|NCT01204996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6608433|NCT01204996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6608434|NCT01204996|Immunologic Factors|immunologic factors|mesh-ancestor
6608435|NCT01204996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608436|NCT01204996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6608437|NCT01204996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6608438|NCT01204996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6608439|NCT01205009|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6608440|NCT01205009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5501921|NCT04469829|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6608441|NCT01205009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608442|NCT01205022|Calcium, Dietary|calcium, dietary|mesh-list
6608443|NCT01205022|Leucovorin|leucovorin|mesh-list
6608444|NCT01205022|Bevacizumab|bevacizumab|mesh-list
6608445|NCT01205022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6608446|NCT01205022|Fluorouracil|fluorouracil|mesh-list
6608447|NCT01205022|Irinotecan|irinotecan|mesh-list
6608448|NCT01205022|Camptothecin|camptothecin|mesh-list
6608449|NCT01205022|Antibodies|antibodies|mesh-list
6608450|NCT01205022|Immunoglobulins|immunoglobulins|mesh-list
6608451|NCT01205022|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6608452|NCT01205022|Calcium|calcium|mesh-list
6608453|NCT01205022|Levoleucovorin|levoleucovorin|mesh-list
6608454|NCT01205022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6608455|NCT01205022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6608456|NCT01205022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6608457|NCT01205022|Growth Substances|growth substances|mesh-ancestor
6608458|NCT01205022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608459|NCT01205022|Growth Inhibitors|growth inhibitors|mesh-ancestor
6608460|NCT01205022|Immunologic Factors|immunologic factors|mesh-ancestor
6608461|NCT01205022|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6608462|NCT01205022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6608463|NCT01205022|Antimetabolites|antimetabolites|mesh-ancestor
6608464|NCT01205022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6608465|NCT01205022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6608466|NCT01205022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6608467|NCT01205022|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6608468|NCT01205022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6608469|NCT01205022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6608470|NCT01205022|Antidotes|antidotes|mesh-ancestor
6608471|NCT01205022|Protective Agents|protective agents|mesh-ancestor
6608472|NCT01205022|Vitamin B Complex|vitamin b complex|mesh-ancestor
6608473|NCT01205022|Vitamins|vitamins|mesh-ancestor
6608474|NCT01205022|Micronutrients|micronutrients|mesh-ancestor
6608475|NCT01205022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6608476|NCT01205074|Ethanol|ethanol|mesh-list
6608477|NCT01205074|Propranolol|propranolol|mesh-list
6608478|NCT01205074|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
6608479|NCT01205074|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6608480|NCT01205074|Adrenergic Agents|adrenergic agents|mesh-ancestor
6608481|NCT01205074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6608482|NCT01205074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6608483|NCT01205074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608484|NCT01205074|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6608485|NCT01205074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6608486|NCT01205074|Vasodilator Agents|vasodilator agents|mesh-ancestor
6608487|NCT01205074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6608488|NCT01205074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6608489|NCT01205074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6608490|NCT01205087|Omeprazole|omeprazole|mesh-list
6608491|NCT01205087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6608492|NCT01205087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6608493|NCT01205087|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6608494|NCT01205087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6608495|NCT01205087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660751|NCT01495117|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6660752|NCT01495117|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6660753|NCT01495117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6660754|NCT01495117|Disinfectants|disinfectants|mesh-ancestor
6660755|NCT01495117|Dermatologic Agents|dermatologic agents|mesh-ancestor
6660756|NCT01495117|Trace Elements|trace elements|mesh-ancestor
6660757|NCT01495117|Micronutrients|micronutrients|mesh-ancestor
6660758|NCT01495117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660759|NCT01495117|Plasma Substitutes|plasma substitutes|mesh-ancestor
6660760|NCT01495117|Blood Substitutes|blood substitutes|mesh-ancestor
6664926|NCT01514838|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6664927|NCT01514838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6664928|NCT01514838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6664929|NCT01514838|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6664930|NCT01514838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608496|NCT01205139|Simeprevir|simeprevir|mesh-list
6608497|NCT01205139|Rilpivirine|rilpivirine|mesh-list
6608498|NCT01205139|Antiviral Agents|antiviral agents|mesh-ancestor
6608499|NCT01205139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6608500|NCT01205139|Protease Inhibitors|protease inhibitors|mesh-ancestor
6608501|NCT01205139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6608502|NCT01205139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6608503|NCT01205139|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6608504|NCT01205139|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6608505|NCT01205139|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6608506|NCT01205139|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6449529|NCT00404716|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6608507|NCT01205178|Chloroquine|chloroquine|mesh-list
6608508|NCT01205178|Primaquine|primaquine|mesh-list
6608509|NCT01205178|Tafenoquine|tafenoquine|mesh-list
6608510|NCT01205178|Amebicides|amebicides|mesh-ancestor
6608511|NCT01205178|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6608512|NCT01205178|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6608513|NCT01205178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6608514|NCT01205178|Antimalarials|antimalarials|mesh-ancestor
6608515|NCT01205178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6608516|NCT01205204|Clonidine|clonidine|mesh-list
6608517|NCT01205204|Fentanyl|fentanyl|mesh-list
6608518|NCT01205204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6608519|NCT01205204|Narcotics|narcotics|mesh-ancestor
6608520|NCT01205204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6608521|NCT01205204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608522|NCT01205204|Analgesics|analgesics|mesh-ancestor
6608523|NCT01205204|Sensory System Agents|sensory system agents|mesh-ancestor
6608524|NCT01205204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6608525|NCT01205204|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6608526|NCT01205204|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6608527|NCT01205204|Anesthetics, General|anesthetics, general|mesh-ancestor
6608528|NCT01205204|Anesthetics|anesthetics|mesh-ancestor
6608529|NCT01205204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6608530|NCT01205204|Sympatholytics|sympatholytics|mesh-ancestor
6449530|NCT00404716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6449531|NCT00404729|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
6449532|NCT00404729|Nootropic Agents|nootropic agents|mesh-ancestor
6449533|NCT00404781|Aspirin|aspirin|mesh-list
6449534|NCT00404781|Cilostazol|cilostazol|mesh-list
6449535|NCT00404781|Clopidogrel|clopidogrel|mesh-list
6449536|NCT00404781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6449537|NCT00404781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6449538|NCT00404781|Analgesics|analgesics|mesh-ancestor
6449539|NCT00404781|Sensory System Agents|sensory system agents|mesh-ancestor
6449540|NCT00404781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6449541|NCT00404781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449542|NCT00404781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6449543|NCT00404781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6449544|NCT00404781|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6449545|NCT00404781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6449546|NCT00404781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6449547|NCT00404781|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6449548|NCT00404781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6449549|NCT00404781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6449550|NCT00404781|Antipyretics|antipyretics|mesh-ancestor
6449551|NCT00404781|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6608531|NCT01205204|Autonomic Agents|autonomic agents|mesh-ancestor
6608532|NCT01205204|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6608533|NCT01205204|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6449552|NCT00404781|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6449553|NCT00404781|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6608534|NCT01205204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6608535|NCT01205204|Adrenergic Agents|adrenergic agents|mesh-ancestor
6608536|NCT01205204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6608537|NCT01205204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6608538|NCT01205217|Paclitaxel|paclitaxel|mesh-list
6608539|NCT01205217|Cyclophosphamide|cyclophosphamide|mesh-list
6608540|NCT01205217|Trastuzumab|trastuzumab|mesh-list
6608541|NCT01205217|Epirubicin|epirubicin|mesh-list
6608542|NCT01205217|Lapatinib|lapatinib|mesh-list
6608543|NCT01205217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6608544|NCT01205217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6608545|NCT01205217|Tubulin Modulators|tubulin modulators|mesh-ancestor
6608546|NCT01205217|Antimitotic Agents|antimitotic agents|mesh-ancestor
6608547|NCT01205217|Mitosis Modulators|mitosis modulators|mesh-ancestor
6608548|NCT01205217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6608549|NCT01205217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6608550|NCT01205217|Immunologic Factors|immunologic factors|mesh-ancestor
6608551|NCT01205217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608552|NCT01205217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6608553|NCT01205217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6608554|NCT01205217|Alkylating Agents|alkylating agents|mesh-ancestor
6608555|NCT01205217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6608556|NCT01205217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6608557|NCT01205217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6608558|NCT01205217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6608559|NCT01205217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6608560|NCT01205217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6608561|NCT01205217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6608562|NCT01205243|Abacavir|abacavir|mesh-list
6608563|NCT01205243|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6608564|NCT01205243|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6608565|NCT01205243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6608566|NCT01205243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6608567|NCT01205243|Antiviral Agents|antiviral agents|mesh-ancestor
6608568|NCT01205243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6608569|NCT01205243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6608570|NCT01205243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6608571|NCT01205256|Methadone|methadone|mesh-list
6608572|NCT01205256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6608573|NCT01205256|Narcotics|narcotics|mesh-ancestor
6608574|NCT01205256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6608575|NCT01205256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608576|NCT01205256|Analgesics|analgesics|mesh-ancestor
6608577|NCT01205256|Sensory System Agents|sensory system agents|mesh-ancestor
6608578|NCT01205256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6608579|NCT01205256|Antitussive Agents|antitussive agents|mesh-ancestor
6608580|NCT01205256|Respiratory System Agents|respiratory system agents|mesh-ancestor
6608581|NCT01205282|Pioglitazone|pioglitazone|mesh-list
6449554|NCT00404781|Purinergic Agents|purinergic agents|mesh-ancestor
6449555|NCT00404781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6449556|NCT00404781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6449557|NCT00404781|Autonomic Agents|autonomic agents|mesh-ancestor
6449558|NCT00404781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6449559|NCT00404781|Respiratory System Agents|respiratory system agents|mesh-ancestor
6449560|NCT00404781|Vasodilator Agents|vasodilator agents|mesh-ancestor
6608582|NCT01205282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6608583|NCT01205282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608584|NCT01205321|Gastrin-Releasing Peptide|gastrin-releasing peptide|mesh-list
6608585|NCT01205321|Bombesin|bombesin|mesh-list
6608586|NCT01205321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6608587|NCT01205321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6608588|NCT01205321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608589|NCT01205321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6608590|NCT01205347|Simvastatin|simvastatin|mesh-list
6608591|NCT01205347|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6608592|NCT01205347|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6608593|NCT01205347|Antimetabolites|antimetabolites|mesh-ancestor
6608594|NCT01205347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6608595|NCT01205347|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6660761|NCT01495156|Antipsychotic Agents|antipsychotic agents|mesh-list
6608596|NCT01205347|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6608597|NCT01205347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6608598|NCT01205360|Fentanyl|fentanyl|mesh-list
6608599|NCT01205360|Bupivacaine|bupivacaine|mesh-list
6608600|NCT01205360|Anesthetics, Local|anesthetics, local|mesh-ancestor
6608601|NCT01205360|Anesthetics|anesthetics|mesh-ancestor
6608602|NCT01205360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6608603|NCT01205360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608604|NCT01205360|Sensory System Agents|sensory system agents|mesh-ancestor
6608605|NCT01205360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6608606|NCT01205360|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6608607|NCT01205360|Narcotics|narcotics|mesh-ancestor
6608608|NCT01205360|Analgesics|analgesics|mesh-ancestor
6608609|NCT01205360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6608610|NCT01205360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6608611|NCT01205360|Anesthetics, General|anesthetics, general|mesh-ancestor
6608612|NCT01205464|Doxycycline|doxycycline|mesh-list
6608613|NCT01205464|Tetracycline|tetracycline|mesh-list
6608614|NCT01205464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6608615|NCT01205464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6608616|NCT01205464|Antimalarials|antimalarials|mesh-ancestor
6608617|NCT01205464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6608618|NCT01205464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6608619|NCT01205464|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6608620|NCT01205464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6608621|NCT01205464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6608622|NCT01205477|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6608623|NCT01205477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6608624|NCT01205516|Morphine|morphine|mesh-list
6608625|NCT01205516|Methadone|methadone|mesh-list
6608626|NCT01205516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6608627|NCT01205516|Narcotics|narcotics|mesh-ancestor
6608628|NCT01205516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6608629|NCT01205516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608630|NCT01205516|Analgesics|analgesics|mesh-ancestor
6608631|NCT01205516|Sensory System Agents|sensory system agents|mesh-ancestor
6608632|NCT01205516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6608633|NCT01205516|Antitussive Agents|antitussive agents|mesh-ancestor
6608634|NCT01205516|Respiratory System Agents|respiratory system agents|mesh-ancestor
6608635|NCT01205672|Metformin|metformin|mesh-list
6608636|NCT01205672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6608637|NCT01205672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608638|NCT01205711|Leucovorin|leucovorin|mesh-list
6608639|NCT01205711|Fluorouracil|fluorouracil|mesh-list
6608640|NCT01205711|Irinotecan|irinotecan|mesh-list
6608641|NCT01205711|Calcium|calcium|mesh-list
6608642|NCT01205711|Levoleucovorin|levoleucovorin|mesh-list
6608643|NCT01205711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6608644|NCT01205711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608645|NCT01205711|Antimetabolites|antimetabolites|mesh-ancestor
6608646|NCT01205711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6608647|NCT01205711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6608648|NCT01205711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6608649|NCT01205711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6608650|NCT01205711|Immunologic Factors|immunologic factors|mesh-ancestor
6608651|NCT01205711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6608652|NCT01205711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6608653|NCT01205711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6608654|NCT01205711|Antidotes|antidotes|mesh-ancestor
6608655|NCT01205711|Protective Agents|protective agents|mesh-ancestor
6608656|NCT01205711|Vitamin B Complex|vitamin b complex|mesh-ancestor
6608657|NCT01205711|Vitamins|vitamins|mesh-ancestor
6608658|NCT01205711|Micronutrients|micronutrients|mesh-ancestor
6608659|NCT01205724|Factor VIII|factor viii|mesh-list
6608660|NCT01205724|Coagulants|coagulants|mesh-ancestor
6608661|NCT01205737|Rituximab|rituximab|mesh-list
6608662|NCT01205737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6608663|NCT01205737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6608664|NCT01205737|Immunologic Factors|immunologic factors|mesh-ancestor
6608665|NCT01205737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608666|NCT01205737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6608667|NCT01205750|Insulin|insulin|mesh-list
6608668|NCT01205750|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6608669|NCT01205750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6608670|NCT01205750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608671|NCT01205880|Calcitriol|calcitriol|mesh-list
6608672|NCT01205880|Clobetasol|clobetasol|mesh-list
6608673|NCT01205880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6608674|NCT01205880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608675|NCT01205880|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6608676|NCT01205880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6608677|NCT01205880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6608678|NCT01205880|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6608679|NCT01205880|Vitamins|vitamins|mesh-ancestor
6608680|NCT01205880|Micronutrients|micronutrients|mesh-ancestor
6608681|NCT01205880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6608682|NCT01205880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6608683|NCT01205880|Glucocorticoids|glucocorticoids|mesh-ancestor
6608684|NCT01205880|Hormones|hormones|mesh-ancestor
6608685|NCT01205880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6608686|NCT01205932|Enoxaparin|enoxaparin|mesh-list
6608687|NCT01205932|Rivaroxaban|rivaroxaban|mesh-list
6449561|NCT00404781|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6449562|NCT00404781|Protective Agents|protective agents|mesh-ancestor
6449563|NCT00404781|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6449564|NCT00404781|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6449565|NCT00404794|Mycophenolic Acid|mycophenolic acid|mesh-list
6449566|NCT00404794|Prednisolone|prednisolone|mesh-list
6449567|NCT00404794|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6449568|NCT00404794|Methylprednisolone|methylprednisolone|mesh-list
6449569|NCT00404794|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6608688|NCT01205932|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6608689|NCT01205932|Antithrombins|antithrombins|mesh-ancestor
6608690|NCT01205932|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6608691|NCT01205932|Protease Inhibitors|protease inhibitors|mesh-ancestor
6608692|NCT01205932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6608693|NCT01205932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6608694|NCT01205932|Anticoagulants|anticoagulants|mesh-ancestor
6608695|NCT01205932|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6608696|NCT01205932|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6608697|NCT01205958|Pyranoprofen|pyranoprofen|mesh-list
6608698|NCT01205958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6608699|NCT01205958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6608700|NCT01205958|Analgesics|analgesics|mesh-ancestor
6608701|NCT01205958|Sensory System Agents|sensory system agents|mesh-ancestor
6608702|NCT01205958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6020611|NCT00393458|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6608703|NCT01205958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608704|NCT01205958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6608705|NCT01205958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6608706|NCT01205958|Gout Suppressants|gout suppressants|mesh-ancestor
6608707|NCT01205984|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6608708|NCT01205984|Methylprednisolone|methylprednisolone|mesh-list
6608709|NCT01205984|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6608710|NCT01205984|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6608711|NCT01205984|Prednisolone|prednisolone|mesh-list
6608712|NCT01205984|Prednisolone acetate|prednisolone acetate|mesh-list
6608713|NCT01205984|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6608714|NCT01205984|Prednisolone phosphate|prednisolone phosphate|mesh-list
6608715|NCT01205984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6608716|NCT01205984|Antiemetics|antiemetics|mesh-ancestor
6608717|NCT01205984|Autonomic Agents|autonomic agents|mesh-ancestor
6608718|NCT01205984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6608719|NCT01205984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608720|NCT01205984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6608721|NCT01205984|Glucocorticoids|glucocorticoids|mesh-ancestor
6608722|NCT01205984|Hormones|hormones|mesh-ancestor
6608723|NCT01205984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6608724|NCT01205984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6608725|NCT01205984|Protective Agents|protective agents|mesh-ancestor
6608726|NCT01205984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6608727|NCT01205984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6608728|NCT01205984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6608729|NCT01205984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6608730|NCT01205984|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6608731|NCT01205984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6608732|NCT01205984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6608733|NCT01205997|Magnesium Sulfate|magnesium sulfate|mesh-list
6608734|NCT01205997|Fentanyl|fentanyl|mesh-list
6608735|NCT01205997|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6608736|NCT01205997|Narcotics|narcotics|mesh-ancestor
6608737|NCT01205997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6608738|NCT01205997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608739|NCT01205997|Analgesics|analgesics|mesh-ancestor
6608740|NCT01205997|Sensory System Agents|sensory system agents|mesh-ancestor
6608741|NCT01205997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6608742|NCT01205997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6608743|NCT01205997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6020612|NCT00393458|Adrenergic Agents|adrenergic agents|mesh-ancestor
6020613|NCT00393458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6020614|NCT00393458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020615|NCT00393484|Lamivudine|lamivudine|mesh-list
6020616|NCT00393484|Entecavir|entecavir|mesh-list
6020617|NCT00393484|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6020618|NCT00393484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6020619|NCT00393484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6020620|NCT00393484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020621|NCT00393484|Antiviral Agents|antiviral agents|mesh-ancestor
6020622|NCT00393484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6020623|NCT00393484|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6608744|NCT01205997|Anesthetics, General|anesthetics, general|mesh-ancestor
6608745|NCT01205997|Anesthetics|anesthetics|mesh-ancestor
6608746|NCT01205997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6608747|NCT01205997|Anticonvulsants|anticonvulsants|mesh-ancestor
6608748|NCT01205997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6608749|NCT01205997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6608750|NCT01205997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6608751|NCT01205997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6608752|NCT01205997|Tocolytic Agents|tocolytic agents|mesh-ancestor
6608753|NCT01205997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6608754|NCT01206010|Varenicline|varenicline|mesh-list
6608755|NCT01206010|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6608756|NCT01206010|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6608757|NCT01206010|Cholinergic Agents|cholinergic agents|mesh-ancestor
6608758|NCT01206010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6608759|NCT01206010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6608760|NCT01206010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608761|NCT01206036|Sirolimus|sirolimus|mesh-list
6608762|NCT01206036|Docetaxel|docetaxel|mesh-list
5501922|NCT04469829|Abortifacient Agents|abortifacient agents|mesh-ancestor
6608763|NCT01206036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6608764|NCT01206036|Tubulin Modulators|tubulin modulators|mesh-ancestor
6608765|NCT01206036|Antimitotic Agents|antimitotic agents|mesh-ancestor
6608766|NCT01206036|Mitosis Modulators|mitosis modulators|mesh-ancestor
6608767|NCT01206036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6608768|NCT01206036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6608769|NCT01206036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6608770|NCT01206036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6608771|NCT01206036|Antifungal Agents|antifungal agents|mesh-ancestor
6608772|NCT01206036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6608773|NCT01206036|Immunologic Factors|immunologic factors|mesh-ancestor
6608774|NCT01206036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608775|NCT01206049|Gemcitabine|gemcitabine|mesh-list
6608776|NCT01206049|Bevacizumab|bevacizumab|mesh-list
6608777|NCT01206049|Panitumumab|panitumumab|mesh-list
6608778|NCT01206049|Capecitabine|capecitabine|mesh-list
6608779|NCT01206049|Oxaliplatin|oxaliplatin|mesh-list
6608780|NCT01206049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6608781|NCT01206049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6608782|NCT01206049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6608783|NCT01206049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6608784|NCT01206049|Growth Substances|growth substances|mesh-ancestor
6608785|NCT01206049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608786|NCT01206049|Growth Inhibitors|growth inhibitors|mesh-ancestor
6608787|NCT01206049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6608788|NCT01206049|Antimetabolites|antimetabolites|mesh-ancestor
6608789|NCT01206049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6608790|NCT01206049|Antiviral Agents|antiviral agents|mesh-ancestor
6608791|NCT01206049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6608792|NCT01206049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6608793|NCT01206049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6608794|NCT01206049|Immunologic Factors|immunologic factors|mesh-ancestor
6449570|NCT00404794|Prednisolone acetate|prednisolone acetate|mesh-list
6449571|NCT00404794|Tacrolimus|tacrolimus|mesh-list
6449572|NCT00404794|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6449573|NCT00404794|Prednisolone phosphate|prednisolone phosphate|mesh-list
6449574|NCT00404794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6449575|NCT00404794|Immunologic Factors|immunologic factors|mesh-ancestor
6449576|NCT00404794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449577|NCT00404794|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6449578|NCT00404794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6449579|NCT00404794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6449580|NCT00404794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6449581|NCT00404794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6449582|NCT00404794|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6449583|NCT00404794|Antitubercular Agents|antitubercular agents|mesh-ancestor
6449584|NCT00404794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6449585|NCT00404794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6449586|NCT00404794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6449587|NCT00404794|Glucocorticoids|glucocorticoids|mesh-ancestor
6449588|NCT00404794|Hormones|hormones|mesh-ancestor
6449589|NCT00404794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6449590|NCT00404794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6449591|NCT00404794|Antiemetics|antiemetics|mesh-ancestor
6449592|NCT00404794|Autonomic Agents|autonomic agents|mesh-ancestor
6449593|NCT00404794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6449594|NCT00404794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6449595|NCT00404794|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6608795|NCT01206075|Plerixafor|plerixafor|mesh-list
6608796|NCT01206075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6608797|NCT01206075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6608798|NCT01206075|Antiviral Agents|antiviral agents|mesh-ancestor
6608799|NCT01206075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6608800|NCT01206153|Metformin|metformin|mesh-list
6608801|NCT01206153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6608802|NCT01206153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449596|NCT00404794|Protective Agents|protective agents|mesh-ancestor
6449597|NCT00404833|Mycophenolic Acid|mycophenolic acid|mesh-list
6449598|NCT00404833|Prednisolone|prednisolone|mesh-list
6449599|NCT00404833|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6449600|NCT00404833|Methylprednisolone|methylprednisolone|mesh-list
6449601|NCT00404833|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6449602|NCT00404833|Prednisolone acetate|prednisolone acetate|mesh-list
6449603|NCT00404833|Chlorambucil|chlorambucil|mesh-list
6449604|NCT00404833|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6449605|NCT00404833|Prednisolone phosphate|prednisolone phosphate|mesh-list
6449606|NCT00404833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6449607|NCT00404833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6449608|NCT00404833|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6449609|NCT00404833|Antitubercular Agents|antitubercular agents|mesh-ancestor
6449610|NCT00404833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6449611|NCT00404833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6449612|NCT00404833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6608803|NCT01206205|Lenalidomide|lenalidomide|mesh-list
6608804|NCT01206205|Bortezomib|bortezomib|mesh-list
6608805|NCT01206205|Immunologic Factors|immunologic factors|mesh-ancestor
6608806|NCT01206205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608807|NCT01206205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6608808|NCT01206205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6608809|NCT01206205|Growth Substances|growth substances|mesh-ancestor
6608810|NCT01206205|Growth Inhibitors|growth inhibitors|mesh-ancestor
6608811|NCT01206205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6608812|NCT01206270|Methyltestosterone|methyltestosterone|mesh-list
6608813|NCT01206270|Castor Oil|castor oil|mesh-list
6608814|NCT01206270|Testosterone|testosterone|mesh-list
6608815|NCT01206270|Testosterone undecanoate|testosterone undecanoate|mesh-list
6608816|NCT01206270|Testosterone enanthate|testosterone enanthate|mesh-list
6608817|NCT01206270|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6608818|NCT01206270|Androgens|androgens|mesh-ancestor
6608819|NCT01206270|Hormones|hormones|mesh-ancestor
6608820|NCT01206270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6608821|NCT01206270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608822|NCT01206270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6608823|NCT01206270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6608824|NCT01206270|Anabolic Agents|anabolic agents|mesh-ancestor
6608825|NCT01206270|Cathartics|cathartics|mesh-ancestor
6608826|NCT01206270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6449613|NCT00404833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6608827|NCT01206348|Minocycline|minocycline|mesh-list
6608828|NCT01206348|Clindamycin|clindamycin|mesh-list
6608829|NCT01206348|Clindamycin palmitate|clindamycin palmitate|mesh-list
6608830|NCT01206348|Clindamycin phosphate|clindamycin phosphate|mesh-list
6608831|NCT01206348|Tretinoin|tretinoin|mesh-list
6608832|NCT01206348|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6608833|NCT01206348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6608834|NCT01206348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6608835|NCT01206348|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6608836|NCT01206348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6608837|NCT01206348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6608838|NCT01206348|Dermatologic Agents|dermatologic agents|mesh-ancestor
6608839|NCT01206348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6608840|NCT01206348|Keratolytic Agents|keratolytic agents|mesh-ancestor
6608841|NCT01206530|Leucovorin|leucovorin|mesh-list
6608842|NCT01206530|Hydroxychloroquine|hydroxychloroquine|mesh-list
6608843|NCT01206530|Bevacizumab|bevacizumab|mesh-list
6608844|NCT01206530|Fluorouracil|fluorouracil|mesh-list
6608845|NCT01206530|Oxaliplatin|oxaliplatin|mesh-list
6608846|NCT01206530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6608847|NCT01206530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6608848|NCT01206530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6608849|NCT01206530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6608850|NCT01206530|Growth Substances|growth substances|mesh-ancestor
6608851|NCT01206530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608852|NCT01206530|Growth Inhibitors|growth inhibitors|mesh-ancestor
6608853|NCT01206530|Antimetabolites|antimetabolites|mesh-ancestor
6608854|NCT01206530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6608855|NCT01206530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6608856|NCT01206530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6608857|NCT01206530|Immunologic Factors|immunologic factors|mesh-ancestor
6608858|NCT01206530|Antidotes|antidotes|mesh-ancestor
6608859|NCT01206530|Protective Agents|protective agents|mesh-ancestor
6608860|NCT01206530|Vitamin B Complex|vitamin b complex|mesh-ancestor
6608861|NCT01206530|Vitamins|vitamins|mesh-ancestor
6608862|NCT01206530|Micronutrients|micronutrients|mesh-ancestor
6608863|NCT01206530|Antimalarials|antimalarials|mesh-ancestor
6608864|NCT01206530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6608865|NCT01206530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6608866|NCT01206530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6608867|NCT01206530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6608868|NCT01206530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6608869|NCT01206569|Tacrolimus|tacrolimus|mesh-list
6608870|NCT01206569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6608871|NCT01206569|Immunologic Factors|immunologic factors|mesh-ancestor
6608872|NCT01206569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608873|NCT01206569|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6608874|NCT01206569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6608875|NCT01206569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6608876|NCT01206647|Metformin|metformin|mesh-list
6608877|NCT01206647|Saxagliptin|saxagliptin|mesh-list
6608878|NCT01206647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6608879|NCT01206647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608880|NCT01206647|Incretins|incretins|mesh-ancestor
6608881|NCT01206647|Hormones|hormones|mesh-ancestor
6608882|NCT01206647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6608883|NCT01206647|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6608884|NCT01206647|Protease Inhibitors|protease inhibitors|mesh-ancestor
6608885|NCT01206647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6608886|NCT01206647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6608887|NCT01206803|Ganirelix|ganirelix|mesh-list
6608888|NCT01206803|Hormone Antagonists|hormone antagonists|mesh-ancestor
6608889|NCT01206803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6608890|NCT01206803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608891|NCT01206881|Cyclophosphamide|cyclophosphamide|mesh-list
6608892|NCT01206881|Docetaxel|docetaxel|mesh-list
6608893|NCT01206881|Doxorubicin|doxorubicin|mesh-list
6608894|NCT01206881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6608895|NCT01206881|Trastuzumab|trastuzumab|mesh-list
6608896|NCT01206881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6608897|NCT01206881|Immunologic Factors|immunologic factors|mesh-ancestor
6608898|NCT01206881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608899|NCT01206881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6608900|NCT01206881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6608901|NCT01206881|Alkylating Agents|alkylating agents|mesh-ancestor
6608902|NCT01206881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6608903|NCT01206881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6608904|NCT01206881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6608905|NCT01206881|Tubulin Modulators|tubulin modulators|mesh-ancestor
6608906|NCT01206881|Antimitotic Agents|antimitotic agents|mesh-ancestor
6608907|NCT01206881|Mitosis Modulators|mitosis modulators|mesh-ancestor
6608908|NCT01206881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6608909|NCT01206881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6608910|NCT01206881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6608911|NCT01206881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6608912|NCT01206881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6660762|NCT01495156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6660763|NCT01495156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6660764|NCT01495156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6660765|NCT01495156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660766|NCT01495169|Iloperidone|iloperidone|mesh-list
6660767|NCT01495169|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6660768|NCT01495169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6660769|NCT01495169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6660770|NCT01495169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660771|NCT01495169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6660772|NCT01495195|Selegiline|selegiline|mesh-list
6660773|NCT01495195|Donepezil|donepezil|mesh-list
6660774|NCT01495195|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6660775|NCT01495195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6660776|NCT01495195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660777|NCT01495195|Cholinergic Agents|cholinergic agents|mesh-ancestor
6660778|NCT01495195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6660779|NCT01495195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660780|NCT01495195|Nootropic Agents|nootropic agents|mesh-ancestor
6660781|NCT01495195|Antidepressive Agents|antidepressive agents|mesh-ancestor
6660782|NCT01495195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6660783|NCT01495195|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6660784|NCT01495195|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6660785|NCT01495195|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6660786|NCT01495195|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6660787|NCT01495195|Protective Agents|protective agents|mesh-ancestor
6660788|NCT01495208|Aflibercept|aflibercept|mesh-list
6660789|NCT01495208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6660790|NCT01495208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6660791|NCT01495208|Growth Substances|growth substances|mesh-ancestor
6660792|NCT01495208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660793|NCT01495208|Growth Inhibitors|growth inhibitors|mesh-ancestor
6608913|NCT01206907|Oxymorphone|oxymorphone|mesh-list
6608914|NCT01206907|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6020624|NCT00393484|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6020625|NCT00393705|Insulin|insulin|mesh-list
6020626|NCT00393705|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6020627|NCT00393705|Insulin Lispro|insulin lispro|mesh-list
6020628|NCT00393705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6020629|NCT00393705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020630|NCT00393718|Liraglutide|liraglutide|mesh-list
6608915|NCT01206907|Narcotics|narcotics|mesh-ancestor
6608916|NCT01206907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6608917|NCT01206907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608918|NCT01206907|Analgesics|analgesics|mesh-ancestor
6608919|NCT01206907|Sensory System Agents|sensory system agents|mesh-ancestor
6608920|NCT01206907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6608921|NCT01206907|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6608922|NCT01206946|Betamethasone|betamethasone|mesh-list
6608923|NCT01206946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6020631|NCT00393718|Glyburide|glyburide|mesh-list
6020632|NCT00393718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6608924|NCT01206946|Glucocorticoids|glucocorticoids|mesh-ancestor
6608925|NCT01206946|Hormones|hormones|mesh-ancestor
6608926|NCT01206946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6608927|NCT01206946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608928|NCT01206946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6608929|NCT01206946|Respiratory System Agents|respiratory system agents|mesh-ancestor
6608930|NCT01206972|Enoxaparin|enoxaparin|mesh-list
6608931|NCT01206972|Rivaroxaban|rivaroxaban|mesh-list
6608932|NCT01206972|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6608933|NCT01206972|Antithrombins|antithrombins|mesh-ancestor
6608934|NCT01206972|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6608935|NCT01206972|Protease Inhibitors|protease inhibitors|mesh-ancestor
6608936|NCT01206972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6608937|NCT01206972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6608938|NCT01206972|Anticoagulants|anticoagulants|mesh-ancestor
6608939|NCT01206972|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6608940|NCT01206972|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6608941|NCT01206998|Progesterone|progesterone|mesh-list
6608942|NCT01206998|Progestins|progestins|mesh-ancestor
6608943|NCT01206998|Hormones|hormones|mesh-ancestor
6608944|NCT01206998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6608945|NCT01206998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608946|NCT01207011|Docetaxel|docetaxel|mesh-list
6608947|NCT01207011|Amrubicin|amrubicin|mesh-list
6608948|NCT01207011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6608949|NCT01207011|Tubulin Modulators|tubulin modulators|mesh-ancestor
6608950|NCT01207011|Antimitotic Agents|antimitotic agents|mesh-ancestor
6608951|NCT01207011|Mitosis Modulators|mitosis modulators|mesh-ancestor
6608952|NCT01207011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6608953|NCT01207128|Voriconazole|voriconazole|mesh-list
6608954|NCT01207128|Micafungin|micafungin|mesh-list
6608955|NCT01207128|Antifungal Agents|antifungal agents|mesh-ancestor
6608956|NCT01207128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6608957|NCT01207128|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6608958|NCT01207128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6608959|NCT01207128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6608960|NCT01207128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6608961|NCT01207128|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6608962|NCT01207128|Hormone Antagonists|hormone antagonists|mesh-ancestor
6608963|NCT01207128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6608964|NCT01207128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608965|NCT01207128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6608966|NCT01207206|Ketamine|ketamine|mesh-list
6608967|NCT01207206|Analgesics|analgesics|mesh-ancestor
6608968|NCT01207206|Sensory System Agents|sensory system agents|mesh-ancestor
6608969|NCT01207206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6608970|NCT01207206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608971|NCT01207206|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6608972|NCT01207206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6608973|NCT01207206|Anesthetics, General|anesthetics, general|mesh-ancestor
6608974|NCT01207206|Anesthetics|anesthetics|mesh-ancestor
6608975|NCT01207206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6608976|NCT01207206|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6608977|NCT01207206|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6608978|NCT01207206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6608979|NCT01207206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6608980|NCT01207245|Tobramycin|tobramycin|mesh-list
6608981|NCT01207245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6608982|NCT01207245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6608983|NCT01207297|Cyclophosphamide|cyclophosphamide|mesh-list
6608984|NCT01207297|Tacrolimus|tacrolimus|mesh-list
6608985|NCT01207297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6608986|NCT01207297|Immunologic Factors|immunologic factors|mesh-ancestor
6608987|NCT01207297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6608988|NCT01207297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6608989|NCT01207297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6608990|NCT01207297|Alkylating Agents|alkylating agents|mesh-ancestor
6608991|NCT01207297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6608992|NCT01207297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6608993|NCT01207297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6608994|NCT01207297|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6608995|NCT01207297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6608996|NCT01207310|Nicotine|nicotine|mesh-list
6608997|NCT01207310|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6608998|NCT01207310|Autonomic Agents|autonomic agents|mesh-ancestor
6608999|NCT01207310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6609000|NCT01207310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609001|NCT01207310|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6609002|NCT01207310|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6609003|NCT01207310|Cholinergic Agents|cholinergic agents|mesh-ancestor
6609004|NCT01207310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6609005|NCT01207310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609006|NCT01207622|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6609007|NCT01207622|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6609008|NCT01207622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6609009|NCT01207622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6609010|NCT01207622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609011|NCT01207622|Adrenergic Agents|adrenergic agents|mesh-ancestor
6609012|NCT01207622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6609013|NCT01207622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609014|NCT01207739|Hydroxychloroquine|hydroxychloroquine|mesh-list
6609015|NCT01207739|Doxycycline|doxycycline|mesh-list
6609016|NCT01207739|Clarithromycin|clarithromycin|mesh-list
6609017|NCT01207739|Antimalarials|antimalarials|mesh-ancestor
6609018|NCT01207739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6609019|NCT01207739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6609020|NCT01207739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6609021|NCT01207739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6609022|NCT01207739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609023|NCT01207739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6609024|NCT01207739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6609025|NCT01207739|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6609026|NCT01207739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6609027|NCT01207739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6609028|NCT01207921|Lenalidomide|lenalidomide|mesh-list
6609029|NCT01207921|Immunologic Factors|immunologic factors|mesh-ancestor
6609030|NCT01207921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609031|NCT01207921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6609032|NCT01207921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6609033|NCT01207921|Growth Substances|growth substances|mesh-ancestor
6609034|NCT01207921|Growth Inhibitors|growth inhibitors|mesh-ancestor
6609035|NCT01207921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6609036|NCT01207947|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6609037|NCT01207947|Vasodilator Agents|vasodilator agents|mesh-ancestor
6609038|NCT01207947|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6609039|NCT01207947|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6609040|NCT01207947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6609041|NCT01207947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609042|NCT01207947|Urological Agents|urological agents|mesh-ancestor
6609043|NCT01208012|Liraglutide|liraglutide|mesh-list
6609044|NCT01208012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6609045|NCT01208012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609046|NCT01208012|Incretins|incretins|mesh-ancestor
6609047|NCT01208012|Hormones|hormones|mesh-ancestor
6609048|NCT01208012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6609049|NCT01208090|Ponesimod|ponesimod|mesh-list
6609050|NCT01208090|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6609051|NCT01208090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609052|NCT01208090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6609053|NCT01208090|Immunologic Factors|immunologic factors|mesh-ancestor
6609054|NCT01208090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609055|NCT01208194|Immunologic Factors|immunologic factors|mesh-list
6609056|NCT01208194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609057|NCT01208285|Ivacaftor|ivacaftor|mesh-list
6609058|NCT01208285|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6609059|NCT01208285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6609060|NCT01208285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609061|NCT01208363|Fe(III)-EDTA|fe(iii)-edta|mesh-list
6609062|NCT01208363|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6609063|NCT01208363|Chelating Agents|chelating agents|mesh-ancestor
6609064|NCT01208363|Sequestering Agents|sequestering agents|mesh-ancestor
6609065|NCT01208363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609066|NCT01208441|Letrozole|letrozole|mesh-list
6609067|NCT01208441|R04929097|r04929097|mesh-list
6609068|NCT01208441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6609069|NCT01208441|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6609070|NCT01208441|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6609071|NCT01208441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6609072|NCT01208441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609073|NCT01208441|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6609074|NCT01208441|Hormone Antagonists|hormone antagonists|mesh-ancestor
6609075|NCT01208441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6609076|NCT01208441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609077|NCT01208454|Vitamin A|vitamin a|mesh-list
6609078|NCT01208454|Vorinostat|vorinostat|mesh-list
6609079|NCT01208454|Tretinoin|tretinoin|mesh-list
6609080|NCT01208454|Isotretinoin|isotretinoin|mesh-list
6609081|NCT01208454|Vitamins|vitamins|mesh-ancestor
6609082|NCT01208454|Micronutrients|micronutrients|mesh-ancestor
6609083|NCT01208454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609084|NCT01208454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6609085|NCT01208454|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6609086|NCT01208454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6609087|NCT01208454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609088|NCT01208454|Keratolytic Agents|keratolytic agents|mesh-ancestor
6609089|NCT01208454|Dermatologic Agents|dermatologic agents|mesh-ancestor
6609090|NCT01208480|Carboplatin|carboplatin|mesh-list
6609091|NCT01208480|Docetaxel|docetaxel|mesh-list
6609092|NCT01208480|Bevacizumab|bevacizumab|mesh-list
6609093|NCT01208480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6609094|NCT01208480|Tubulin Modulators|tubulin modulators|mesh-ancestor
6609095|NCT01208480|Antimitotic Agents|antimitotic agents|mesh-ancestor
6609096|NCT01208480|Mitosis Modulators|mitosis modulators|mesh-ancestor
6609097|NCT01208480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609098|NCT01208480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6609099|NCT01208480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6609100|NCT01208480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6609101|NCT01208480|Growth Substances|growth substances|mesh-ancestor
6609102|NCT01208480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609103|NCT01208480|Growth Inhibitors|growth inhibitors|mesh-ancestor
6609104|NCT01208649|Exenatide|exenatide|mesh-list
6609105|NCT01208649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6609106|NCT01208649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609107|NCT01208649|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6609108|NCT01208649|Incretins|incretins|mesh-ancestor
6609109|NCT01208649|Hormones|hormones|mesh-ancestor
6609110|NCT01208649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6609111|NCT01208662|Dexamethasone|dexamethasone|mesh-list
6609112|NCT01208662|Lenalidomide|lenalidomide|mesh-list
6609113|NCT01208662|Bortezomib|bortezomib|mesh-list
6609114|NCT01208662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6609115|NCT01208662|Antiemetics|antiemetics|mesh-ancestor
6609116|NCT01208662|Autonomic Agents|autonomic agents|mesh-ancestor
6609117|NCT01208662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6609118|NCT01208662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609119|NCT01208662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6609120|NCT01208662|Glucocorticoids|glucocorticoids|mesh-ancestor
6609121|NCT01208662|Hormones|hormones|mesh-ancestor
6609122|NCT01208662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6609123|NCT01208662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6609124|NCT01208662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6609125|NCT01208662|Immunologic Factors|immunologic factors|mesh-ancestor
6609126|NCT01208662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6609127|NCT01208662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6609128|NCT01208662|Growth Substances|growth substances|mesh-ancestor
6609129|NCT01208662|Growth Inhibitors|growth inhibitors|mesh-ancestor
6660794|NCT01495208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6660795|NCT01495260|Vitamin E|vitamin e|mesh-list
6660796|NCT01495260|Thioctic Acid|thioctic acid|mesh-list
6660797|NCT01495260|Acetylcysteine|acetylcysteine|mesh-list
6660798|NCT01495260|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6660799|NCT01495260|Vitamins|vitamins|mesh-ancestor
6660800|NCT01495260|Micronutrients|micronutrients|mesh-ancestor
6660801|NCT01495260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660802|NCT01495260|Antiviral Agents|antiviral agents|mesh-ancestor
6660803|NCT01495260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6660804|NCT01495260|Expectorants|expectorants|mesh-ancestor
6660805|NCT01495260|Respiratory System Agents|respiratory system agents|mesh-ancestor
6660806|NCT01495260|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6660807|NCT01495260|Antioxidants|antioxidants|mesh-ancestor
6660808|NCT01495260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660809|NCT01495260|Protective Agents|protective agents|mesh-ancestor
6660810|NCT01495260|Antidotes|antidotes|mesh-ancestor
6660811|NCT01495260|Vitamin B Complex|vitamin b complex|mesh-ancestor
6660812|NCT01495338|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
6660813|NCT01495338|Cetirizine|cetirizine|mesh-list
6660814|NCT01495338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6660815|NCT01495338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6660816|NCT01495338|Analgesics|analgesics|mesh-ancestor
6660817|NCT01495338|Sensory System Agents|sensory system agents|mesh-ancestor
6660818|NCT01495338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6660819|NCT01495338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660820|NCT01495338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6660821|NCT01495338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6660822|NCT01495338|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6660823|NCT01495338|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6660824|NCT01495338|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6660825|NCT01495338|Histamine Antagonists|histamine antagonists|mesh-ancestor
6660826|NCT01495338|Histamine Agents|histamine agents|mesh-ancestor
6660827|NCT01495338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6660828|NCT01495338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660829|NCT01495351|Bortezomib|bortezomib|mesh-list
6660830|NCT01495351|Veliparib|veliparib|mesh-list
6660831|NCT01495351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6660832|NCT01495351|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6660833|NCT01495351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6660834|NCT01495351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660835|NCT01495377|Remifentanil|remifentanil|mesh-list
6660836|NCT01495377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6660837|NCT01495377|Narcotics|narcotics|mesh-ancestor
6660838|NCT01495377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6660839|NCT01495377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660840|NCT01495377|Analgesics|analgesics|mesh-ancestor
6660841|NCT01495377|Sensory System Agents|sensory system agents|mesh-ancestor
6609130|NCT01208701|Atorvastatin|atorvastatin|mesh-list
6609131|NCT01208701|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6609132|NCT01208701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6609133|NCT01208701|Antimetabolites|antimetabolites|mesh-ancestor
6609134|NCT01208701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609135|NCT01208701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6609136|NCT01208701|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6609137|NCT01208701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6609138|NCT01208740|Metformin|metformin|mesh-list
6609139|NCT01208740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6609140|NCT01208740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609141|NCT01208766|Dexamethasone|dexamethasone|mesh-list
6609142|NCT01208766|Prednisone|prednisone|mesh-list
6609143|NCT01208766|Lenalidomide|lenalidomide|mesh-list
6609144|NCT01208766|Bortezomib|bortezomib|mesh-list
6609145|NCT01208766|Melphalan|melphalan|mesh-list
6609146|NCT01208766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6609147|NCT01208766|Antiemetics|antiemetics|mesh-ancestor
6609148|NCT01208766|Autonomic Agents|autonomic agents|mesh-ancestor
6609149|NCT01208766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6609150|NCT01208766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609151|NCT01208766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6609152|NCT01208766|Glucocorticoids|glucocorticoids|mesh-ancestor
6609153|NCT01208766|Hormones|hormones|mesh-ancestor
6609154|NCT01208766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6609155|NCT01208766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6609156|NCT01208766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6609157|NCT01208766|Immunologic Factors|immunologic factors|mesh-ancestor
6609158|NCT01208766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6609159|NCT01208766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6609160|NCT01208766|Growth Substances|growth substances|mesh-ancestor
6609161|NCT01208766|Growth Inhibitors|growth inhibitors|mesh-ancestor
6609162|NCT01208766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6609163|NCT01208766|Alkylating Agents|alkylating agents|mesh-ancestor
6609164|NCT01208766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609165|NCT01208766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6609166|NCT01208766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6609167|NCT01208818|Dexamethasone|dexamethasone|mesh-list
6609168|NCT01208818|Dexamethasone acetate|dexamethasone acetate|mesh-list
6609169|NCT01208818|Cyclophosphamide|cyclophosphamide|mesh-list
6609170|NCT01208818|Bortezomib|bortezomib|mesh-list
6609171|NCT01208818|BB 1101|bb 1101|mesh-list
6609172|NCT01208818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6609173|NCT01208818|Immunologic Factors|immunologic factors|mesh-ancestor
6609174|NCT01208818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609175|NCT01208818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6609176|NCT01208818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6609177|NCT01208818|Alkylating Agents|alkylating agents|mesh-ancestor
6449614|NCT00404833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6449615|NCT00404833|Glucocorticoids|glucocorticoids|mesh-ancestor
6449616|NCT00404833|Hormones|hormones|mesh-ancestor
6449617|NCT00404833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6449618|NCT00404833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449619|NCT00404833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6449620|NCT00404833|Antiemetics|antiemetics|mesh-ancestor
6449621|NCT00404833|Autonomic Agents|autonomic agents|mesh-ancestor
6449622|NCT00404833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6449623|NCT00404833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6449624|NCT00404833|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6449625|NCT00404833|Protective Agents|protective agents|mesh-ancestor
6449626|NCT00404833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6449627|NCT00404833|Alkylating Agents|alkylating agents|mesh-ancestor
6449628|NCT00404937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6449629|NCT00404937|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
6449630|NCT00404937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6449631|NCT00404937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6449632|NCT00404937|Glucocorticoids|glucocorticoids|mesh-ancestor
6449633|NCT00404937|Hormones|hormones|mesh-ancestor
6449634|NCT00404937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6449635|NCT00404937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449636|NCT00404937|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6449637|NCT00404937|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6449638|NCT00405015|Rosiglitazone|rosiglitazone|mesh-list
6449639|NCT00405015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6449640|NCT00405015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449641|NCT00405080|Rifampin|rifampin|mesh-list
6449642|NCT00405080|Casopitant|casopitant|mesh-list
6449643|NCT00405080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6609178|NCT01208818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609179|NCT01208818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6609180|NCT01208818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6609181|NCT01208818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6609182|NCT01208818|Antiemetics|antiemetics|mesh-ancestor
6609183|NCT01208818|Autonomic Agents|autonomic agents|mesh-ancestor
6609184|NCT01208818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6609185|NCT01208818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6609186|NCT01208818|Glucocorticoids|glucocorticoids|mesh-ancestor
6609187|NCT01208818|Hormones|hormones|mesh-ancestor
6609188|NCT01208818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6609189|NCT01208818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6609190|NCT01208818|Protease Inhibitors|protease inhibitors|mesh-ancestor
6609191|NCT01208818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6609192|NCT01208935|Nicotine|nicotine|mesh-list
6609193|NCT01208935|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6609194|NCT01208935|Autonomic Agents|autonomic agents|mesh-ancestor
6609195|NCT01208935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6609196|NCT01208935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609197|NCT01208935|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6609198|NCT01208935|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6609199|NCT01208935|Cholinergic Agents|cholinergic agents|mesh-ancestor
6609200|NCT01208935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6609201|NCT01208935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609202|NCT01209026|Fluticasone|fluticasone|mesh-list
6609203|NCT01209026|Xhance|xhance|mesh-list
6609204|NCT01209026|Moxifloxacin|moxifloxacin|mesh-list
6609205|NCT01209026|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6609206|NCT01209026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6609207|NCT01209026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6609208|NCT01209026|Autonomic Agents|autonomic agents|mesh-ancestor
6609209|NCT01209026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6609210|NCT01209026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609211|NCT01209026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6609212|NCT01209026|Respiratory System Agents|respiratory system agents|mesh-ancestor
6609213|NCT01209026|Dermatologic Agents|dermatologic agents|mesh-ancestor
6609214|NCT01209026|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6609215|NCT01209026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6609216|NCT01209026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6609217|NCT01209026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6609218|NCT01209026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6609219|NCT01209026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6609220|NCT01209026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609221|NCT01209026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6609222|NCT01209026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6609223|NCT01209026|Contraceptive Agents|contraceptive agents|mesh-ancestor
6609224|NCT01209026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6609225|NCT01209026|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6609226|NCT01209026|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6609227|NCT01209026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6609228|NCT01209065|Ritonavir|ritonavir|mesh-list
6609229|NCT01209065|Fosamprenavir|fosamprenavir|mesh-list
6609230|NCT01209065|Dolutegravir|dolutegravir|mesh-list
6609231|NCT01209065|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6609232|NCT01209065|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6609233|NCT01209065|Protease Inhibitors|protease inhibitors|mesh-ancestor
6609234|NCT01209065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6609235|NCT01209065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609236|NCT01209065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6609237|NCT01209065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6609238|NCT01209065|Antiviral Agents|antiviral agents|mesh-ancestor
6609239|NCT01209065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6609240|NCT01209065|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6609241|NCT01209065|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6609242|NCT01209065|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6609243|NCT01209065|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6609244|NCT01209130|Rituximab|rituximab|mesh-list
6020633|NCT00393718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020634|NCT00393718|Incretins|incretins|mesh-ancestor
6020635|NCT00393718|Hormones|hormones|mesh-ancestor
6020636|NCT00393718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6020637|NCT00393796|Sunitinib|sunitinib|mesh-list
6020638|NCT00393796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6020639|NCT00393796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6020640|NCT00393796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6020641|NCT00393796|Growth Substances|growth substances|mesh-ancestor
6449644|NCT00405080|Antitubercular Agents|antitubercular agents|mesh-ancestor
6449645|NCT00405080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6449646|NCT00405080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6449647|NCT00405080|Leprostatic Agents|leprostatic agents|mesh-ancestor
6449648|NCT00405080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6449649|NCT00405080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6449650|NCT00405080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6449651|NCT00405080|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6449652|NCT00405080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6449653|NCT00405080|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6449654|NCT00405080|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6609245|NCT01209130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6609246|NCT01209130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6609247|NCT01209130|Immunologic Factors|immunologic factors|mesh-ancestor
6609248|NCT01209130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609249|NCT01209130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6609250|NCT01209208|Budesonide|budesonide|mesh-list
6609251|NCT01209208|Mesalamine|mesalamine|mesh-list
6609252|NCT01209208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6609253|NCT01209208|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6609254|NCT01209208|Autonomic Agents|autonomic agents|mesh-ancestor
6609255|NCT01209208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6609256|NCT01209208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609257|NCT01209208|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6609258|NCT01209208|Respiratory System Agents|respiratory system agents|mesh-ancestor
6609259|NCT01209208|Glucocorticoids|glucocorticoids|mesh-ancestor
6609260|NCT01209208|Hormones|hormones|mesh-ancestor
6609261|NCT01209208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6609262|NCT01209208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6609263|NCT01209208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6609264|NCT01209208|Analgesics|analgesics|mesh-ancestor
6609265|NCT01209208|Sensory System Agents|sensory system agents|mesh-ancestor
6609266|NCT01209208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6609267|NCT01209351|Teduglutide|teduglutide|mesh-list
6609268|NCT01209351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6609269|NCT01209351|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6609270|NCT01209351|Protective Agents|protective agents|mesh-ancestor
6609271|NCT01209351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609272|NCT01209364|Methylprednisolone|methylprednisolone|mesh-list
6609273|NCT01209364|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6609274|NCT01209364|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6609275|NCT01209364|Prednisolone|prednisolone|mesh-list
6609276|NCT01209364|Prednisolone acetate|prednisolone acetate|mesh-list
6609277|NCT01209364|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6609278|NCT01209364|Prednisolone phosphate|prednisolone phosphate|mesh-list
6609279|NCT01209364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6609280|NCT01209364|Antiemetics|antiemetics|mesh-ancestor
6609281|NCT01209364|Autonomic Agents|autonomic agents|mesh-ancestor
6609282|NCT01209364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6609283|NCT01209364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609284|NCT01209364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6609285|NCT01209364|Glucocorticoids|glucocorticoids|mesh-ancestor
6609286|NCT01209364|Hormones|hormones|mesh-ancestor
6609287|NCT01209364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6609288|NCT01209364|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6609289|NCT01209364|Protective Agents|protective agents|mesh-ancestor
6609290|NCT01209364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6609291|NCT01209364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6609292|NCT01209403|Insulin|insulin|mesh-list
6609293|NCT01209403|Insulin Aspart|insulin aspart|mesh-list
6609294|NCT01209403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6609295|NCT01209403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609296|NCT01209416|Acipimox|acipimox|mesh-list
6609297|NCT01209416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6609298|NCT01209416|Antimetabolites|antimetabolites|mesh-ancestor
6609299|NCT01209416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609300|NCT01209416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6609301|NCT01209429|Hormones|hormones|mesh-list
6609302|NCT01209429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6609303|NCT01209429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609304|NCT01209455|Acetaminophen|acetaminophen|mesh-list
6609305|NCT01209455|Chlorpheniramine|chlorpheniramine|mesh-list
6609306|NCT01209455|Ranitidine|ranitidine|mesh-list
6609307|NCT01209455|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
6609308|NCT01209455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6609309|NCT01209455|Analgesics|analgesics|mesh-ancestor
6609310|NCT01209455|Sensory System Agents|sensory system agents|mesh-ancestor
6609311|NCT01209455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6609312|NCT01209455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609313|NCT01209455|Antipyretics|antipyretics|mesh-ancestor
6609314|NCT01209455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6609315|NCT01209455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6609316|NCT01209455|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6609317|NCT01209455|Histamine Antagonists|histamine antagonists|mesh-ancestor
6609318|NCT01209455|Histamine Agents|histamine agents|mesh-ancestor
6609319|NCT01209455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6609320|NCT01209455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609321|NCT01209455|Antipruritics|antipruritics|mesh-ancestor
6609322|NCT01209455|Dermatologic Agents|dermatologic agents|mesh-ancestor
6609323|NCT01209455|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6609324|NCT01209455|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6609325|NCT01209533|Iloprost|iloprost|mesh-list
6609326|NCT01209533|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6609327|NCT01209533|Vasodilator Agents|vasodilator agents|mesh-ancestor
6609328|NCT01209650|Afatinib|afatinib|mesh-list
6609329|NCT01209650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6609330|NCT01209650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6609331|NCT01209650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6609332|NCT01209650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609333|NCT01209715|Fluticasone|fluticasone|mesh-list
6609334|NCT01209715|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6609335|NCT01209715|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6609336|NCT01209715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6609337|NCT01209715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6609338|NCT01209715|Autonomic Agents|autonomic agents|mesh-ancestor
6609339|NCT01209715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6609340|NCT01209715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449655|NCT00405080|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6449656|NCT00405080|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6449657|NCT00405080|Antiemetics|antiemetics|mesh-ancestor
6449658|NCT00405080|Autonomic Agents|autonomic agents|mesh-ancestor
6609341|NCT01209715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6609342|NCT01209715|Respiratory System Agents|respiratory system agents|mesh-ancestor
6609343|NCT01209715|Dermatologic Agents|dermatologic agents|mesh-ancestor
6609344|NCT01209715|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6609345|NCT01209715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6609346|NCT01209715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6609347|NCT01209715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6609348|NCT01209715|Adrenergic Agents|adrenergic agents|mesh-ancestor
6609349|NCT01209715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6609350|NCT01209715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609351|NCT01209715|Glucocorticoids|glucocorticoids|mesh-ancestor
6609352|NCT01209715|Hormones|hormones|mesh-ancestor
6609353|NCT01209715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6609354|NCT01209715|Sympathomimetics|sympathomimetics|mesh-ancestor
6609355|NCT01209728|Ethanol|ethanol|mesh-list
6609356|NCT01209728|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6609357|NCT01209728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6609358|NCT01209728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6609359|NCT01209728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609360|NCT01209806|Simethicone|simethicone|mesh-list
6609361|NCT01209806|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
6609362|NCT01209806|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6609363|NCT01209806|Magnesium Hydroxide|magnesium hydroxide|mesh-list
6609364|NCT01209806|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
6609365|NCT01209806|TEMPO|tempo|mesh-list
6609366|NCT01209806|Antifoaming Agents|antifoaming agents|mesh-ancestor
6449659|NCT00405080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6449660|NCT00405080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449661|NCT00405080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6449662|NCT00405080|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6449663|NCT00405080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6609367|NCT01209806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609368|NCT01209806|Emollients|emollients|mesh-ancestor
6609369|NCT01209806|Dermatologic Agents|dermatologic agents|mesh-ancestor
6609370|NCT01209806|Antacids|antacids|mesh-ancestor
6609371|NCT01209806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6609372|NCT01209806|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6609373|NCT01209806|Immunologic Factors|immunologic factors|mesh-ancestor
6609374|NCT01209806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609375|NCT01209806|Antioxidants|antioxidants|mesh-ancestor
6609376|NCT01209806|Protective Agents|protective agents|mesh-ancestor
6609377|NCT01209845|Ketamine|ketamine|mesh-list
6609378|NCT01209845|Analgesics|analgesics|mesh-ancestor
6609379|NCT01209845|Sensory System Agents|sensory system agents|mesh-ancestor
6609380|NCT01209845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6609381|NCT01209845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609382|NCT01209845|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6609383|NCT01209845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6609384|NCT01209845|Anesthetics, General|anesthetics, general|mesh-ancestor
6609385|NCT01209845|Anesthetics|anesthetics|mesh-ancestor
6609386|NCT01209845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6609387|NCT01209845|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6609388|NCT01209845|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6609389|NCT01209845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6609390|NCT01209845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609391|NCT01209858|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
6609392|NCT01209858|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
6609393|NCT01209858|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6609394|NCT01209858|Contraceptive Agents|contraceptive agents|mesh-ancestor
6609395|NCT01209858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6609396|NCT01209858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609397|NCT01209858|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6609398|NCT01209858|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6609399|NCT01209858|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6609400|NCT01209858|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6609401|NCT01209858|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6609402|NCT01209858|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
6609403|NCT01209858|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6609404|NCT01209858|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6609405|NCT01209871|Immunoglobulins|immunoglobulins|mesh-list
6609406|NCT01209871|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6609407|NCT01209871|Antibodies|antibodies|mesh-list
6609408|NCT01209871|Immunologic Factors|immunologic factors|mesh-ancestor
6609409|NCT01209871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609410|NCT01209988|Tamsulosin|tamsulosin|mesh-list
6609411|NCT01209988|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6609412|NCT01209988|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6609413|NCT01209988|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6609414|NCT01209988|Adrenergic Agents|adrenergic agents|mesh-ancestor
6609415|NCT01209988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6609416|NCT01209988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609417|NCT01209988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609418|NCT01209988|Urological Agents|urological agents|mesh-ancestor
6609419|NCT01210014|Zinc Sulfate|zinc sulfate|mesh-list
6609420|NCT01210014|Astringents|astringents|mesh-ancestor
6449664|NCT00405119|Esomeprazole|esomeprazole|mesh-list
6449665|NCT00405119|Ranitidine|ranitidine|mesh-list
6449666|NCT00405119|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
6449667|NCT00405119|Loxtidine|loxtidine|mesh-list
6449668|NCT00405119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6449669|NCT00405119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6449670|NCT00405119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6449671|NCT00405119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6449672|NCT00405119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6449673|NCT00405119|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6449674|NCT00405119|Histamine Antagonists|histamine antagonists|mesh-ancestor
6449675|NCT00405119|Histamine Agents|histamine agents|mesh-ancestor
6449676|NCT00405119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6449677|NCT00405119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609421|NCT01210014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609422|NCT01210014|Dermatologic Agents|dermatologic agents|mesh-ancestor
6609423|NCT01210040|Folic Acid|folic acid|mesh-list
6609424|NCT01210040|Vitamin B Complex|vitamin b complex|mesh-list
6609425|NCT01210040|Hematinics|hematinics|mesh-ancestor
6609426|NCT01210040|Vitamins|vitamins|mesh-ancestor
6609427|NCT01210040|Micronutrients|micronutrients|mesh-ancestor
6609428|NCT01210040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609429|NCT01210066|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
6609430|NCT01210066|Fentanyl|fentanyl|mesh-list
6609431|NCT01210066|Analgesics, Opioid|analgesics, opioid|mesh-list
6609432|NCT01210066|Narcotics|narcotics|mesh-ancestor
6609433|NCT01210066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6609434|NCT01210066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609435|NCT01210066|Analgesics|analgesics|mesh-ancestor
6609436|NCT01210066|Sensory System Agents|sensory system agents|mesh-ancestor
6609437|NCT01210066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6609438|NCT01210066|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6609439|NCT01210066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6609440|NCT01210066|Anesthetics, General|anesthetics, general|mesh-ancestor
6609441|NCT01210066|Anesthetics|anesthetics|mesh-ancestor
6609442|NCT01210287|Lamivudine|lamivudine|mesh-list
6609443|NCT01210287|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
6609444|NCT01210287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6609445|NCT01210287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6609446|NCT01210287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609447|NCT01210287|Antiviral Agents|antiviral agents|mesh-ancestor
6609448|NCT01210287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6609449|NCT01210287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6609450|NCT01210287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6609451|NCT01210339|Esomeprazole|esomeprazole|mesh-list
6609452|NCT01210339|Clopidogrel|clopidogrel|mesh-list
6609453|NCT01210339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6609454|NCT01210339|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6609455|NCT01210339|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6609456|NCT01210339|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6609457|NCT01210339|Purinergic Agents|purinergic agents|mesh-ancestor
6609458|NCT01210339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5724851|NCT03184805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609459|NCT01210339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609460|NCT01210339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609461|NCT01210339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6609462|NCT01210339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6609463|NCT01210339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6609464|NCT01210339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6609465|NCT01210378|Nitroglycerin|nitroglycerin|mesh-list
6609466|NCT01210378|Vasodilator Agents|vasodilator agents|mesh-ancestor
6660842|NCT01495377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6660843|NCT01495403|Hydroxychloroquine|hydroxychloroquine|mesh-list
6660844|NCT01495403|Antimalarials|antimalarials|mesh-ancestor
6660845|NCT01495403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6660846|NCT01495403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6660847|NCT01495403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6660848|NCT01495403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6660849|NCT01495403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660850|NCT01495403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6660851|NCT01495468|Hormones|hormones|mesh-list
6660852|NCT01495468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6660853|NCT01495468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660854|NCT01495520|Ranolazine|ranolazine|mesh-list
6660855|NCT01495520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6660856|NCT01495520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6660857|NCT01495520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660858|NCT01495624|Dexamethasone|dexamethasone|mesh-list
6660859|NCT01495624|Dexamethasone acetate|dexamethasone acetate|mesh-list
5724852|NCT03184805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5724853|NCT03184805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5724854|NCT03184805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5724855|NCT03184805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6609467|NCT01210391|Caseins|caseins|mesh-list
6609468|NCT01210391|Chelating Agents|chelating agents|mesh-ancestor
6609469|NCT01210391|Sequestering Agents|sequestering agents|mesh-ancestor
6609470|NCT01210391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609471|NCT01210430|Vitamins|vitamins|mesh-list
6609472|NCT01210430|Ascorbic Acid|ascorbic acid|mesh-list
6609473|NCT01210430|Losartan|losartan|mesh-list
6609474|NCT01210430|Micronutrients|micronutrients|mesh-ancestor
6609475|NCT01210430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609476|NCT01210430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6609477|NCT01210430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6609478|NCT01210430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6609479|NCT01210430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6609480|NCT01210430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609481|NCT01210430|Antioxidants|antioxidants|mesh-ancestor
6609482|NCT01210430|Protective Agents|protective agents|mesh-ancestor
6609483|NCT01210456|Acetylcysteine|acetylcysteine|mesh-list
6609484|NCT01210456|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6609485|NCT01210456|Antiviral Agents|antiviral agents|mesh-ancestor
6609486|NCT01210456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6609487|NCT01210456|Expectorants|expectorants|mesh-ancestor
6609488|NCT01210456|Respiratory System Agents|respiratory system agents|mesh-ancestor
6609489|NCT01210456|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6609490|NCT01210456|Antioxidants|antioxidants|mesh-ancestor
6609491|NCT01210456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609492|NCT01210456|Protective Agents|protective agents|mesh-ancestor
6609493|NCT01210456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609494|NCT01210456|Antidotes|antidotes|mesh-ancestor
6609495|NCT01210482|Sirolimus|sirolimus|mesh-list
6609496|NCT01210482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6609497|NCT01210482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6609498|NCT01210482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6609499|NCT01210482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6609500|NCT01210482|Antifungal Agents|antifungal agents|mesh-ancestor
6609501|NCT01210482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6609502|NCT01210482|Immunologic Factors|immunologic factors|mesh-ancestor
6609503|NCT01210482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609504|NCT01210521|Vitamin D|vitamin d|mesh-list
6609505|NCT01210521|Vitamins|vitamins|mesh-ancestor
6609506|NCT01210521|Micronutrients|micronutrients|mesh-ancestor
6609507|NCT01210521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609508|NCT01210521|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6609509|NCT01210599|Pamidronate|pamidronate|mesh-list
6609510|NCT01210599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6609511|NCT01210599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609512|NCT01210625|Psyllium|psyllium|mesh-list
6609513|NCT01210625|Cathartics|cathartics|mesh-ancestor
6609514|NCT01210625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6609515|NCT01210638|Oxymorphone|oxymorphone|mesh-list
6609516|NCT01210638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6609517|NCT01210638|Narcotics|narcotics|mesh-ancestor
6609518|NCT01210638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6609519|NCT01210638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609520|NCT01210638|Analgesics|analgesics|mesh-ancestor
6609521|NCT01210638|Sensory System Agents|sensory system agents|mesh-ancestor
6609522|NCT01210638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6609523|NCT01210638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6609524|NCT01210677|Prednisone|prednisone|mesh-list
6609525|NCT01210677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6609526|NCT01210677|Glucocorticoids|glucocorticoids|mesh-ancestor
6609527|NCT01210677|Hormones|hormones|mesh-ancestor
6609528|NCT01210677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6609529|NCT01210677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609530|NCT01210677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6609531|NCT01210677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6609532|NCT01210742|Hylan|hylan|mesh-list
6609533|NCT01210742|Viscosupplements|viscosupplements|mesh-ancestor
6609534|NCT01210742|Protective Agents|protective agents|mesh-ancestor
6609535|NCT01210742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609536|NCT01210755|Rivaroxaban|rivaroxaban|mesh-list
6609537|NCT01210755|Dabigatran|dabigatran|mesh-list
6609538|NCT01210755|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6609539|NCT01210755|Antithrombins|antithrombins|mesh-ancestor
6609540|NCT01210755|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6609541|NCT01210755|Protease Inhibitors|protease inhibitors|mesh-ancestor
6609542|NCT01210755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6609543|NCT01210755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6449678|NCT00405158|Acetaminophen|acetaminophen|mesh-list
6609544|NCT01210755|Anticoagulants|anticoagulants|mesh-ancestor
6609545|NCT01210911|Metformin|metformin|mesh-list
6609546|NCT01210911|Gemcitabine|gemcitabine|mesh-list
6609547|NCT01210911|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6609548|NCT01210911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6609549|NCT01210911|Antimetabolites|antimetabolites|mesh-ancestor
6609550|NCT01210911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609551|NCT01210911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6609552|NCT01210911|Antiviral Agents|antiviral agents|mesh-ancestor
6609553|NCT01210911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6609554|NCT01210911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6609555|NCT01210911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6609556|NCT01210911|Immunologic Factors|immunologic factors|mesh-ancestor
6609557|NCT01210911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609558|NCT01210911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6609559|NCT01210911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6609560|NCT01210976|Simendan|simendan|mesh-list
6609561|NCT01210976|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6609562|NCT01210976|Vasodilator Agents|vasodilator agents|mesh-ancestor
6609563|NCT01210976|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6609564|NCT01210976|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6609565|NCT01210976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6609566|NCT01210976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609567|NCT01210976|Protective Agents|protective agents|mesh-ancestor
6609568|NCT01210976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609569|NCT01211002|Endostatins|endostatins|mesh-list
6609570|NCT01211002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6609571|NCT01211002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6609572|NCT01211002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6609573|NCT01211002|Growth Substances|growth substances|mesh-ancestor
6609574|NCT01211002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609575|NCT01211002|Growth Inhibitors|growth inhibitors|mesh-ancestor
6609576|NCT01211080|Propranolol|propranolol|mesh-list
6609577|NCT01211080|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6609578|NCT01211080|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6609579|NCT01211080|Adrenergic Agents|adrenergic agents|mesh-ancestor
6609580|NCT01211080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6609581|NCT01211080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609582|NCT01211080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609583|NCT01211080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6609584|NCT01211080|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6609585|NCT01211080|Vasodilator Agents|vasodilator agents|mesh-ancestor
6609586|NCT01211158|Ketamine|ketamine|mesh-list
6609587|NCT01211158|Propofol|propofol|mesh-list
6609588|NCT01211158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6609589|NCT01211158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6609590|NCT01211158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609591|NCT01211158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6609592|NCT01211158|Anesthetics, General|anesthetics, general|mesh-ancestor
6609593|NCT01211158|Anesthetics|anesthetics|mesh-ancestor
6609594|NCT01211158|Analgesics|analgesics|mesh-ancestor
6609595|NCT01211158|Sensory System Agents|sensory system agents|mesh-ancestor
6609596|NCT01211158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6609597|NCT01211158|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6449679|NCT00405158|Antipyretics|antipyretics|mesh-list
6609598|NCT01211158|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6609599|NCT01211158|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6449680|NCT00405158|Penicillins|penicillins|mesh-list
6449681|NCT00405158|Floxacillin|floxacillin|mesh-list
6449682|NCT00405158|Cefadroxil|cefadroxil|mesh-list
6449683|NCT00405158|Oxytocin|oxytocin|mesh-list
6449684|NCT00405158|Oxytocics|oxytocics|mesh-ancestor
6449685|NCT00405158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6449686|NCT00405158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449687|NCT00405158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6609600|NCT01211158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6609601|NCT01211158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609602|NCT01211171|Telmisartan|telmisartan|mesh-list
6609603|NCT01211171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6609604|NCT01211171|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6020642|NCT00393796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020643|NCT00393796|Growth Inhibitors|growth inhibitors|mesh-ancestor
6020644|NCT00393796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6020645|NCT00393796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6020646|NCT00393796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020647|NCT00393848|Ketoconazole|ketoconazole|mesh-list
6020648|NCT00393848|Antifungal Agents|antifungal agents|mesh-ancestor
6020649|NCT00393848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6020650|NCT00393848|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6020651|NCT00393848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6020652|NCT00393848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6609605|NCT01211171|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6609606|NCT01211171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609607|NCT01211210|Fluorouracil|fluorouracil|mesh-list
6609608|NCT01211210|Oxaliplatin|oxaliplatin|mesh-list
6609609|NCT01211210|Antimetabolites|antimetabolites|mesh-ancestor
6609610|NCT01211210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609611|NCT01211210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6609612|NCT01211210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6609613|NCT01211210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6609614|NCT01211210|Immunologic Factors|immunologic factors|mesh-ancestor
6609615|NCT01211210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609616|NCT01211223|Amoxicillin|amoxicillin|mesh-list
6609617|NCT01211223|Metronidazole|metronidazole|mesh-list
6609618|NCT01211223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6609619|NCT01211223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6609620|NCT01211223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6609621|NCT01211223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6609622|NCT01211275|Cisplatin|cisplatin|mesh-list
6609623|NCT01211275|Pemetrexed|pemetrexed|mesh-list
6609624|NCT01211275|Axitinib|axitinib|mesh-list
6609625|NCT01211275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6609626|NCT01211275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6609627|NCT01211275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609628|NCT01211275|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6609629|NCT01211275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6609630|NCT01211275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6609631|NCT01211314|Enalapril|enalapril|mesh-list
6609632|NCT01211314|Lercanidipine|lercanidipine|mesh-list
6609633|NCT01211314|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6609634|NCT01211314|Protease Inhibitors|protease inhibitors|mesh-ancestor
6609635|NCT01211314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6609636|NCT01211314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609637|NCT01211314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6609638|NCT01211314|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6609639|NCT01211314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6609640|NCT01211314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6609641|NCT01211314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609642|NCT01211327|Cyclosporine|cyclosporine|mesh-list
6609643|NCT01211327|Dexamethasone|dexamethasone|mesh-list
6609644|NCT01211327|Cyclosporins|cyclosporins|mesh-list
6609645|NCT01211327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6609646|NCT01211327|Antiemetics|antiemetics|mesh-ancestor
6609647|NCT01211327|Autonomic Agents|autonomic agents|mesh-ancestor
6609648|NCT01211327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6609649|NCT01211327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609650|NCT01211327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6609651|NCT01211327|Glucocorticoids|glucocorticoids|mesh-ancestor
6609652|NCT01211327|Hormones|hormones|mesh-ancestor
6609653|NCT01211327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6609654|NCT01211327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6609655|NCT01211327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6609656|NCT01211327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6609657|NCT01211327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609658|NCT01211327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6609659|NCT01211327|Immunologic Factors|immunologic factors|mesh-ancestor
6609660|NCT01211327|Antifungal Agents|antifungal agents|mesh-ancestor
6609661|NCT01211327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6609662|NCT01211327|Dermatologic Agents|dermatologic agents|mesh-ancestor
6609663|NCT01211327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6609664|NCT01211327|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6609665|NCT01211457|Decitabine|decitabine|mesh-list
6609666|NCT01211457|Venetoclax|venetoclax|mesh-list
6609667|NCT01211457|Sapacitabine|sapacitabine|mesh-list
6609668|NCT01211457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6609669|NCT01211457|Antimetabolites|antimetabolites|mesh-ancestor
6020653|NCT00393848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020654|NCT00393848|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6020655|NCT00393848|Hormone Antagonists|hormone antagonists|mesh-ancestor
6020656|NCT00393848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6020657|NCT00393848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020658|NCT00393848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6020659|NCT00393861|Bevacizumab|bevacizumab|mesh-list
6020660|NCT00393861|Oxaliplatin|oxaliplatin|mesh-list
6020661|NCT00393861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6020662|NCT00393861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6020663|NCT00393861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6020664|NCT00393861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6449688|NCT00405158|Analgesics|analgesics|mesh-ancestor
6449689|NCT00405158|Sensory System Agents|sensory system agents|mesh-ancestor
6449690|NCT00405158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6449691|NCT00405158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6449692|NCT00405158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6449693|NCT00405171|Nevirapine|nevirapine|mesh-list
6449694|NCT00405171|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6449695|NCT00405171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6449696|NCT00405171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6449697|NCT00405171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6449698|NCT00405171|Antiviral Agents|antiviral agents|mesh-ancestor
6449699|NCT00405171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6449700|NCT00405171|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6449701|NCT00405171|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6449702|NCT00405171|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6449703|NCT00405171|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6449704|NCT00405210|Docetaxel|docetaxel|mesh-list
6449705|NCT00405210|Sorafenib|sorafenib|mesh-list
6449706|NCT00405210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6449707|NCT00405210|Tubulin Modulators|tubulin modulators|mesh-ancestor
6609670|NCT01211457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609671|NCT01211457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6609672|NCT01211457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6609673|NCT01211470|Daptomycin|daptomycin|mesh-list
6609674|NCT01211470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6609675|NCT01211470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6609676|NCT01211496|Methamphetamine|methamphetamine|mesh-list
6609677|NCT01211496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6609678|NCT01211496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609679|NCT01211496|Sympathomimetics|sympathomimetics|mesh-ancestor
6609680|NCT01211496|Autonomic Agents|autonomic agents|mesh-ancestor
6609681|NCT01211496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6609682|NCT01211496|Dopamine Agents|dopamine agents|mesh-ancestor
6609683|NCT01211496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6609684|NCT01211496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609685|NCT01211496|Adrenergic Agents|adrenergic agents|mesh-ancestor
6609686|NCT01211496|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6609687|NCT01211496|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6609688|NCT01211496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6609689|NCT01211496|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6609690|NCT01211509|Montelukast|montelukast|mesh-list
6609691|NCT01211509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6609692|NCT01211509|Respiratory System Agents|respiratory system agents|mesh-ancestor
6609693|NCT01211509|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6609694|NCT01211509|Hormone Antagonists|hormone antagonists|mesh-ancestor
6609695|NCT01211509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6609696|NCT01211509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609697|NCT01211509|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6609698|NCT01211509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6609699|NCT01211509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609700|NCT01211561|Selenium|selenium|mesh-list
6609701|NCT01211561|Antioxidants|antioxidants|mesh-ancestor
6609702|NCT01211561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609703|NCT01211561|Protective Agents|protective agents|mesh-ancestor
6609704|NCT01211561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020665|NCT00393861|Growth Substances|growth substances|mesh-ancestor
6609705|NCT01211561|Trace Elements|trace elements|mesh-ancestor
6609706|NCT01211561|Micronutrients|micronutrients|mesh-ancestor
6609707|NCT01211691|Antibodies|antibodies|mesh-list
6609708|NCT01211691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6609709|NCT01211691|Immunologic Factors|immunologic factors|mesh-ancestor
6609710|NCT01211691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609711|NCT01211704|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6609712|NCT01211704|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6609713|NCT01211704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6609714|NCT01211704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6609715|NCT01211704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609716|NCT01211704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6609717|NCT01211704|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6609718|NCT01211704|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6609719|NCT01211704|Serotonin Agents|serotonin agents|mesh-ancestor
6609720|NCT01211704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6609721|NCT01211704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020666|NCT00393861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020667|NCT00393861|Growth Inhibitors|growth inhibitors|mesh-ancestor
6020668|NCT00393874|Prazosin|prazosin|mesh-list
6609722|NCT01211704|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6609723|NCT01211704|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6609724|NCT01211704|Dopamine Agents|dopamine agents|mesh-ancestor
6609725|NCT01211795|Ketoprofen|ketoprofen|mesh-list
6609726|NCT01211795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6609727|NCT01211795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6609728|NCT01211795|Analgesics|analgesics|mesh-ancestor
6609729|NCT01211795|Sensory System Agents|sensory system agents|mesh-ancestor
6609730|NCT01211795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6609731|NCT01211795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609732|NCT01211795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6609733|NCT01211795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6609734|NCT01211795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6609735|NCT01211795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6609736|NCT01211795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609737|NCT01211808|Diltiazem|diltiazem|mesh-list
6609738|NCT01211808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6609739|NCT01211808|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6609740|NCT01211808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6609741|NCT01211808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609742|NCT01211808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6609743|NCT01211808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609744|NCT01211808|Vasodilator Agents|vasodilator agents|mesh-ancestor
6609745|NCT01211821|Metoprolol|metoprolol|mesh-list
6609746|NCT01211821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6609747|NCT01211821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6609748|NCT01211821|Sympatholytics|sympatholytics|mesh-ancestor
6609749|NCT01211821|Autonomic Agents|autonomic agents|mesh-ancestor
6609750|NCT01211821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6609751|NCT01211821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609752|NCT01211821|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6609753|NCT01211821|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6609754|NCT01211821|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6609755|NCT01211821|Adrenergic Agents|adrenergic agents|mesh-ancestor
6609756|NCT01211821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6609757|NCT01211821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609758|NCT01211834|Antirheumatic Agents|antirheumatic agents|mesh-list
6609759|NCT01211847|Diazoxide|diazoxide|mesh-list
6609760|NCT01211847|Choline|choline|mesh-list
6609761|NCT01211847|Lipotropic Agents|lipotropic agents|mesh-ancestor
6609762|NCT01211847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6609763|NCT01211847|Antimetabolites|antimetabolites|mesh-ancestor
6609764|NCT01211847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609765|NCT01211847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6609766|NCT01211847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6609767|NCT01211847|Nootropic Agents|nootropic agents|mesh-ancestor
6609768|NCT01211847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6609769|NCT01211847|Vasodilator Agents|vasodilator agents|mesh-ancestor
6609770|NCT01211860|Diazoxide|diazoxide|mesh-list
6609771|NCT01211860|Choline|choline|mesh-list
6609772|NCT01211860|Lipotropic Agents|lipotropic agents|mesh-ancestor
6609773|NCT01211860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6609774|NCT01211860|Antimetabolites|antimetabolites|mesh-ancestor
6609775|NCT01211860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609776|NCT01211860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6609777|NCT01211860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6609778|NCT01211860|Nootropic Agents|nootropic agents|mesh-ancestor
6609779|NCT01211860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6609780|NCT01211860|Vasodilator Agents|vasodilator agents|mesh-ancestor
6609781|NCT01211912|Acetaminophen|acetaminophen|mesh-list
6609782|NCT01211912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6609783|NCT01211912|Analgesics|analgesics|mesh-ancestor
6609784|NCT01211912|Sensory System Agents|sensory system agents|mesh-ancestor
6609785|NCT01211912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6609786|NCT01211912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609787|NCT01211912|Antipyretics|antipyretics|mesh-ancestor
6609788|NCT01211925|Aspirin|aspirin|mesh-list
6609789|NCT01211925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6609790|NCT01211925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6609791|NCT01211925|Analgesics|analgesics|mesh-ancestor
6609792|NCT01211925|Sensory System Agents|sensory system agents|mesh-ancestor
6609793|NCT01211925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6609794|NCT01211925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609795|NCT01211925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6609796|NCT01211925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6609797|NCT01211925|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6449708|NCT00405210|Antimitotic Agents|antimitotic agents|mesh-ancestor
6449709|NCT00405210|Mitosis Modulators|mitosis modulators|mesh-ancestor
6449710|NCT00405210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6449711|NCT00405210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6449712|NCT00405210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6449713|NCT00405236|Tiotropium Bromide|tiotropium bromide|mesh-list
6449714|NCT00405236|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6449715|NCT00405236|Autonomic Agents|autonomic agents|mesh-ancestor
6449716|NCT00405236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6449717|NCT00405236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449718|NCT00405236|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6449719|NCT00405236|Respiratory System Agents|respiratory system agents|mesh-ancestor
6449720|NCT00405236|Parasympatholytics|parasympatholytics|mesh-ancestor
6609798|NCT01211925|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6609799|NCT01211925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609800|NCT01211925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6609801|NCT01211925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6609802|NCT01211925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6609803|NCT01211925|Antipyretics|antipyretics|mesh-ancestor
6609804|NCT01211938|Cetuximab|cetuximab|mesh-list
6609805|NCT01211938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6609806|NCT01211938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6660860|NCT01495624|Ropivacaine|ropivacaine|mesh-list
6660861|NCT01495624|Anesthetics|anesthetics|mesh-list
6660862|NCT01495624|BB 1101|bb 1101|mesh-list
6660863|NCT01495624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6660864|NCT01495624|Antiemetics|antiemetics|mesh-ancestor
6660865|NCT01495624|Autonomic Agents|autonomic agents|mesh-ancestor
6660866|NCT01495624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6660867|NCT01495624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660868|NCT01495624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6660869|NCT01495624|Glucocorticoids|glucocorticoids|mesh-ancestor
6660870|NCT01495624|Hormones|hormones|mesh-ancestor
6660871|NCT01495624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6660872|NCT01495624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6660873|NCT01495624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6660874|NCT01495624|Protease Inhibitors|protease inhibitors|mesh-ancestor
6660875|NCT01495624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6660876|NCT01495624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660877|NCT01495624|Anesthetics, Local|anesthetics, local|mesh-ancestor
6660878|NCT01495624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6660879|NCT01495624|Sensory System Agents|sensory system agents|mesh-ancestor
6660880|NCT01495715|Idebenone|idebenone|mesh-list
6660881|NCT01495715|Antioxidants|antioxidants|mesh-ancestor
6660882|NCT01495715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660883|NCT01495715|Protective Agents|protective agents|mesh-ancestor
6660884|NCT01495715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660885|NCT01495806|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
6660886|NCT01495806|Cathartics|cathartics|mesh-ancestor
6660887|NCT01495806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6660888|NCT01495845|Clopidogrel|clopidogrel|mesh-list
6660889|NCT01495845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6660890|NCT01495845|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6660891|NCT01495845|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6660892|NCT01495845|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6660893|NCT01495845|Purinergic Agents|purinergic agents|mesh-ancestor
6660894|NCT01495845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6660895|NCT01495845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660896|NCT01495845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660897|NCT01495884|Lapatinib|lapatinib|mesh-list
6660898|NCT01495884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6660899|NCT01495884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6660900|NCT01495884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6660901|NCT01495884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660902|NCT01495910|Abiraterone Acetate|abiraterone acetate|mesh-list
6660903|NCT01495910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6660904|NCT01495910|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6609807|NCT01212133|Liraglutide|liraglutide|mesh-list
6609808|NCT01212133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6609809|NCT01212133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609810|NCT01212133|Incretins|incretins|mesh-ancestor
6609811|NCT01212133|Hormones|hormones|mesh-ancestor
6609812|NCT01212133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6609813|NCT01212250|Carvedilol|carvedilol|mesh-list
6609814|NCT01212250|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6609815|NCT01212250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6609816|NCT01212250|Adrenergic Agents|adrenergic agents|mesh-ancestor
6609817|NCT01212250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6609818|NCT01212250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609819|NCT01212250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609820|NCT01212250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6609821|NCT01212250|Antioxidants|antioxidants|mesh-ancestor
6609822|NCT01212250|Protective Agents|protective agents|mesh-ancestor
6609823|NCT01212250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6609824|NCT01212250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6609825|NCT01212250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6609826|NCT01212250|Vasodilator Agents|vasodilator agents|mesh-ancestor
6609827|NCT01212250|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6609828|NCT01212250|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6609829|NCT01212315|Triclosan|triclosan|mesh-list
6609830|NCT01212315|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6609831|NCT01212315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6609832|NCT01212315|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6609833|NCT01212315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6609834|NCT01212315|Antimetabolites|antimetabolites|mesh-ancestor
6609835|NCT01212315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609836|NCT01212315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6609837|NCT01212367|Interferons|interferons|mesh-list
6609838|NCT01212367|Interferon-alpha|interferon-alpha|mesh-list
6609839|NCT01212367|Interferon alpha-2|interferon alpha-2|mesh-list
6609840|NCT01212367|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
6609841|NCT01212367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6609842|NCT01212367|Antiviral Agents|antiviral agents|mesh-ancestor
6609843|NCT01212367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6609844|NCT01212367|Immunologic Factors|immunologic factors|mesh-ancestor
6609845|NCT01212367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609846|NCT01212406|Vitamin D|vitamin d|mesh-list
6609847|NCT01212406|Vitamins|vitamins|mesh-ancestor
6609848|NCT01212406|Micronutrients|micronutrients|mesh-ancestor
6609849|NCT01212406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609850|NCT01212406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6609851|NCT01212432|Daptomycin|daptomycin|mesh-list
6609852|NCT01212432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6609853|NCT01212432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6609854|NCT01212523|Propofol|propofol|mesh-list
6609855|NCT01212523|Isoflurane|isoflurane|mesh-list
6609856|NCT01212523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6609857|NCT01212523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6609858|NCT01212523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609859|NCT01212523|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6609860|NCT01212523|Anesthetics, General|anesthetics, general|mesh-ancestor
6609861|NCT01212523|Anesthetics|anesthetics|mesh-ancestor
6609862|NCT01212523|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6609863|NCT01212653|Golimumab|golimumab|mesh-list
6609864|NCT01212653|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6609865|NCT01212653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6609866|NCT01212653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6609867|NCT01212653|Immunologic Factors|immunologic factors|mesh-ancestor
6609868|NCT01212653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609869|NCT01212666|Ropivacaine|ropivacaine|mesh-list
6609870|NCT01212666|Anesthetics, Local|anesthetics, local|mesh-ancestor
6609871|NCT01212666|Anesthetics|anesthetics|mesh-ancestor
6609872|NCT01212666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6609873|NCT01212666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609874|NCT01212666|Sensory System Agents|sensory system agents|mesh-ancestor
6609875|NCT01212666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6609876|NCT01212679|Mitogens|mitogens|mesh-list
6609877|NCT01212679|Mitosis Modulators|mitosis modulators|mesh-ancestor
6609878|NCT01212679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609879|NCT01212809|Hyaluronic Acid|hyaluronic acid|mesh-list
6609880|NCT01212809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6609881|NCT01212809|Immunologic Factors|immunologic factors|mesh-ancestor
6609882|NCT01212809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609883|NCT01212809|Viscosupplements|viscosupplements|mesh-ancestor
6449721|NCT00405236|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6609884|NCT01212809|Protective Agents|protective agents|mesh-ancestor
6609885|NCT01212822|Leucovorin|leucovorin|mesh-list
6609886|NCT01212822|Bevacizumab|bevacizumab|mesh-list
6609887|NCT01212822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6609888|NCT01212822|Fluorouracil|fluorouracil|mesh-list
6609889|NCT01212822|Oxaliplatin|oxaliplatin|mesh-list
6609890|NCT01212822|Antibodies|antibodies|mesh-list
6609891|NCT01212822|Immunoglobulins|immunoglobulins|mesh-list
6609892|NCT01212822|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6609893|NCT01212822|Levoleucovorin|levoleucovorin|mesh-list
6609894|NCT01212822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6609895|NCT01212822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6609896|NCT01212822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6609897|NCT01212822|Growth Substances|growth substances|mesh-ancestor
6609898|NCT01212822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609899|NCT01212822|Growth Inhibitors|growth inhibitors|mesh-ancestor
6609900|NCT01212822|Immunologic Factors|immunologic factors|mesh-ancestor
6609901|NCT01212822|Antimetabolites|antimetabolites|mesh-ancestor
6609902|NCT01212822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609903|NCT01212822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6609904|NCT01212822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6609905|NCT01212822|Antidotes|antidotes|mesh-ancestor
6609906|NCT01212822|Protective Agents|protective agents|mesh-ancestor
6609907|NCT01212822|Vitamin B Complex|vitamin b complex|mesh-ancestor
6609908|NCT01212822|Vitamins|vitamins|mesh-ancestor
6609909|NCT01212822|Micronutrients|micronutrients|mesh-ancestor
6609910|NCT01212887|Aldesleukin|aldesleukin|mesh-list
6609911|NCT01212887|Cyclophosphamide|cyclophosphamide|mesh-list
6609912|NCT01212887|Fludarabine|fludarabine|mesh-list
6609913|NCT01212887|Fludarabine phosphate|fludarabine phosphate|mesh-list
6609914|NCT01212887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6609915|NCT01212887|Immunologic Factors|immunologic factors|mesh-ancestor
6609916|NCT01212887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609917|NCT01212887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6609918|NCT01212887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6609919|NCT01212887|Alkylating Agents|alkylating agents|mesh-ancestor
6609920|NCT01212887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609921|NCT01212887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6609922|NCT01212887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6609923|NCT01212887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6609924|NCT01212887|Antimetabolites|antimetabolites|mesh-ancestor
6609925|NCT01212887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6609926|NCT01212887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6609927|NCT01212887|Antiviral Agents|antiviral agents|mesh-ancestor
6449722|NCT00405236|Cholinergic Agents|cholinergic agents|mesh-ancestor
6449723|NCT00405236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6449724|NCT00405236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6449725|NCT00405249|Dexelvucitabine|dexelvucitabine|mesh-list
6449726|NCT00405249|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6449727|NCT00405249|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6449728|NCT00405249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6449729|NCT00405249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609928|NCT01212887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6609929|NCT01212913|Insulin|insulin|mesh-list
6609930|NCT01212913|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6609931|NCT01212913|Insulin Glargine|insulin glargine|mesh-list
6609932|NCT01212913|Insulin Aspart|insulin aspart|mesh-list
6609933|NCT01212913|Insulin glulisine|insulin glulisine|mesh-list
6609934|NCT01212913|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6609935|NCT01212913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6609936|NCT01212913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609937|NCT01212965|Selenium|selenium|mesh-list
6609938|NCT01212965|Antioxidants|antioxidants|mesh-ancestor
6609939|NCT01212965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609940|NCT01212965|Protective Agents|protective agents|mesh-ancestor
6609941|NCT01212965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609942|NCT01212965|Trace Elements|trace elements|mesh-ancestor
6609943|NCT01212965|Micronutrients|micronutrients|mesh-ancestor
6609944|NCT01213017|Certolizumab Pegol|certolizumab pegol|mesh-list
6609945|NCT01213017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6609946|NCT01213017|Immunologic Factors|immunologic factors|mesh-ancestor
6609947|NCT01213017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609948|NCT01213017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6609949|NCT01213095|Rituximab|rituximab|mesh-list
6609950|NCT01213095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6609951|NCT01213095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6609952|NCT01213095|Immunologic Factors|immunologic factors|mesh-ancestor
6609953|NCT01213095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609954|NCT01213095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6609955|NCT01213121|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6609956|NCT01213121|Antidepressive Agents|antidepressive agents|mesh-ancestor
6609957|NCT01213121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6609958|NCT01213121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6609959|NCT01213121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6609960|NCT01213121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6609961|NCT01213121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609962|NCT01213147|Clomiphene|clomiphene|mesh-list
6609963|NCT01213147|Enclomiphene|enclomiphene|mesh-list
6609964|NCT01213147|Zuclomiphene|zuclomiphene|mesh-list
6609965|NCT01213147|Buserelin|buserelin|mesh-list
6609966|NCT01213147|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6609967|NCT01213147|Hormone Antagonists|hormone antagonists|mesh-ancestor
6609968|NCT01213147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6609969|NCT01213147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609970|NCT01213147|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6609971|NCT01213147|Fertility Agents|fertility agents|mesh-ancestor
6609972|NCT01213147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6609973|NCT01213147|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6609974|NCT01213147|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6609975|NCT01213238|Bevacizumab|bevacizumab|mesh-list
6609976|NCT01213238|Capecitabine|capecitabine|mesh-list
6609977|NCT01213238|Oxaliplatin|oxaliplatin|mesh-list
6609978|NCT01213238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6609979|NCT01213238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6609980|NCT01213238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6609981|NCT01213238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6609982|NCT01213238|Growth Substances|growth substances|mesh-ancestor
6609983|NCT01213238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6609984|NCT01213238|Growth Inhibitors|growth inhibitors|mesh-ancestor
6609985|NCT01213238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6609986|NCT01213238|Antimetabolites|antimetabolites|mesh-ancestor
6660905|NCT01495910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5501923|NCT04469829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5501924|NCT04469829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501925|NCT04469829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5501926|NCT04469829|Antimetabolites|antimetabolites|mesh-ancestor
5501927|NCT04469829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501928|NCT04469829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5501929|NCT04469829|Dermatologic Agents|dermatologic agents|mesh-ancestor
5501930|NCT04469829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5501931|NCT04469829|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5501932|NCT04469829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5501933|NCT04469829|Immunologic Factors|immunologic factors|mesh-ancestor
5501934|NCT04469829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5501935|NCT04469829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5501936|NCT04469842|Mycophenolic Acid|mycophenolic acid|mesh-list
5501937|NCT04469842|Prednisone|prednisone|mesh-list
6609987|NCT01213238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609988|NCT01213355|Scopolamine|scopolamine|mesh-list
6609989|NCT01213355|Donepezil|donepezil|mesh-list
6609990|NCT01213355|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
6609991|NCT01213355|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6609992|NCT01213355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6609993|NCT01213355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6609994|NCT01213355|Cholinergic Agents|cholinergic agents|mesh-ancestor
6609995|NCT01213355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6609996|NCT01213355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501938|NCT04469842|Azathioprine|azathioprine|mesh-list
6609997|NCT01213355|Nootropic Agents|nootropic agents|mesh-ancestor
6609998|NCT01213355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6609999|NCT01213355|Antiemetics|antiemetics|mesh-ancestor
6610000|NCT01213355|Autonomic Agents|autonomic agents|mesh-ancestor
6610001|NCT01213355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6610002|NCT01213355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6610003|NCT01213355|Mydriatics|mydriatics|mesh-ancestor
6610004|NCT01213355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6610005|NCT01213355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6610006|NCT01213355|Parasympatholytics|parasympatholytics|mesh-ancestor
6610007|NCT01213368|Dronedarone|dronedarone|mesh-list
6610008|NCT01213368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6610009|NCT01213381|Gemcitabine|gemcitabine|mesh-list
6610010|NCT01213381|Carboplatin|carboplatin|mesh-list
6610011|NCT01213381|Iniparib|iniparib|mesh-list
6610012|NCT01213381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6610013|NCT01213381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6610014|NCT01213381|Antimetabolites|antimetabolites|mesh-ancestor
6610015|NCT01213381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610016|NCT01213381|Antiviral Agents|antiviral agents|mesh-ancestor
6610017|NCT01213381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6610018|NCT01213381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6610019|NCT01213381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6610020|NCT01213381|Immunologic Factors|immunologic factors|mesh-ancestor
6610021|NCT01213381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610022|NCT01213381|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6610023|NCT01213394|Mycophenolic Acid|mycophenolic acid|mesh-list
6610024|NCT01213394|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6610025|NCT01213394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6610026|NCT01213394|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6610027|NCT01213394|Antitubercular Agents|antitubercular agents|mesh-ancestor
6610028|NCT01213394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6610029|NCT01213394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6610030|NCT01213394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6610031|NCT01213394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610032|NCT01213407|Temozolomide|temozolomide|mesh-list
6610033|NCT01213407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6610034|NCT01213407|Alkylating Agents|alkylating agents|mesh-ancestor
6610035|NCT01213407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610036|NCT01213407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6610037|NCT01213433|Artesunate|artesunate|mesh-list
6610038|NCT01213433|Amodiaquine|amodiaquine|mesh-list
6610039|NCT01213433|Antimalarials|antimalarials|mesh-ancestor
6610040|NCT01213433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6610041|NCT01213433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6610042|NCT01213433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6610043|NCT01213433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6610044|NCT01213433|Antiviral Agents|antiviral agents|mesh-ancestor
6610045|NCT01213433|Schistosomicides|schistosomicides|mesh-ancestor
6610046|NCT01213433|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6610047|NCT01213433|Anthelmintics|anthelmintics|mesh-ancestor
6610048|NCT01213498|Atorvastatin|atorvastatin|mesh-list
6020669|NCT00393874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6020670|NCT00393874|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6020671|NCT00393874|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6610049|NCT01213498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6610050|NCT01213498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6610051|NCT01213498|Antimetabolites|antimetabolites|mesh-ancestor
6610052|NCT01213498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610053|NCT01213498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6610054|NCT01213498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6610055|NCT01213498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6610056|NCT01213550|Chlorhexidine|chlorhexidine|mesh-list
6610057|NCT01213550|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6610058|NCT01213550|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6610059|NCT01213550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6610060|NCT01213550|Disinfectants|disinfectants|mesh-ancestor
6610061|NCT01213550|Dermatologic Agents|dermatologic agents|mesh-ancestor
6610062|NCT01213563|Insulin|insulin|mesh-list
6610063|NCT01213563|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6610064|NCT01213563|Insulin, neutral|insulin, neutral|mesh-list
6610065|NCT01213563|Insulin, Regular, Pork|insulin, regular, pork|mesh-list
6610066|NCT01213563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6610067|NCT01213563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610068|NCT01213667|Ranibizumab|ranibizumab|mesh-list
6610069|NCT01213667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6610070|NCT01213667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6610071|NCT01213667|Growth Substances|growth substances|mesh-ancestor
6610072|NCT01213667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610073|NCT01213667|Growth Inhibitors|growth inhibitors|mesh-ancestor
6610074|NCT01213667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6610075|NCT01213680|Ferric Compounds|ferric compounds|mesh-list
6610076|NCT01213680|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
6610077|NCT01213680|Hematinics|hematinics|mesh-ancestor
6610078|NCT01213693|Fluticasone|fluticasone|mesh-list
6610079|NCT01213693|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6610080|NCT01213693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6610081|NCT01213693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6610082|NCT01213693|Autonomic Agents|autonomic agents|mesh-ancestor
6610083|NCT01213693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6610084|NCT01213693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610085|NCT01213693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6610086|NCT01213693|Respiratory System Agents|respiratory system agents|mesh-ancestor
6610087|NCT01213693|Dermatologic Agents|dermatologic agents|mesh-ancestor
6610088|NCT01213693|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6610089|NCT01213693|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6610090|NCT01213693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6610091|NCT01213693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6610092|NCT01213693|Adrenergic Agents|adrenergic agents|mesh-ancestor
6449730|NCT00405249|Antiviral Agents|antiviral agents|mesh-ancestor
6449731|NCT00405249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6449732|NCT00405249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6449733|NCT00405249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6449734|NCT00405262|Ketorolac|ketorolac|mesh-list
6449735|NCT00405262|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6449736|NCT00405262|Bupivacaine|bupivacaine|mesh-list
6449737|NCT00405262|Anesthetics, Local|anesthetics, local|mesh-ancestor
6449738|NCT00405262|Anesthetics|anesthetics|mesh-ancestor
6449739|NCT00405262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6449740|NCT00405262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449741|NCT00405262|Sensory System Agents|sensory system agents|mesh-ancestor
6449742|NCT00405262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6449743|NCT00405262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6449744|NCT00405262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6449745|NCT00405262|Analgesics|analgesics|mesh-ancestor
6449746|NCT00405262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6449747|NCT00405262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6449748|NCT00405262|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6449749|NCT00405262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6449750|NCT00405262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6449751|NCT00405301|Rifampin|rifampin|mesh-list
6610093|NCT01213693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6610094|NCT01213693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501939|NCT04469842|Tacrolimus|tacrolimus|mesh-list
6449752|NCT00405301|Pyrazinamide|pyrazinamide|mesh-list
6610095|NCT01213719|Betaine|betaine|mesh-list
6610096|NCT01213719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6610097|NCT01213719|Lipotropic Agents|lipotropic agents|mesh-ancestor
6610098|NCT01213719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6610099|NCT01213719|Antimetabolites|antimetabolites|mesh-ancestor
6610100|NCT01213719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610101|NCT01213719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6610102|NCT01213784|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6610103|NCT01213784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660906|NCT01495910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660907|NCT01495910|Hormone Antagonists|hormone antagonists|mesh-ancestor
6660908|NCT01495910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6660909|NCT01495910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660910|NCT01495910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6660911|NCT01495949|Thiopental|thiopental|mesh-list
6660912|NCT01495949|Etomidate|etomidate|mesh-list
6660913|NCT01495949|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6660914|NCT01495949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6660915|NCT01495949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660916|NCT01495949|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6660917|NCT01495949|Anesthetics, General|anesthetics, general|mesh-ancestor
6660918|NCT01495949|Anesthetics|anesthetics|mesh-ancestor
6660919|NCT01495949|Anticonvulsants|anticonvulsants|mesh-ancestor
6660920|NCT01495949|GABA Modulators|gaba modulators|mesh-ancestor
6660921|NCT01495949|GABA Agents|gaba agents|mesh-ancestor
6660922|NCT01495949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6660923|NCT01495949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660924|NCT01495962|Botulinum Toxins|botulinum toxins|mesh-list
6660925|NCT01495962|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6660926|NCT01495962|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6660927|NCT01495962|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6660928|NCT01495962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6660929|NCT01495962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660930|NCT01495962|Cholinergic Agents|cholinergic agents|mesh-ancestor
6660931|NCT01495962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6660932|NCT01495962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660933|NCT01495962|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6660934|NCT01495962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6660935|NCT01496105|Lidocaine|lidocaine|mesh-list
6660936|NCT01496105|Anesthetics, Local|anesthetics, local|mesh-ancestor
6660937|NCT01496105|Anesthetics|anesthetics|mesh-ancestor
6660938|NCT01496105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6610104|NCT01213849|Fluticasone|fluticasone|mesh-list
6610105|NCT01213849|Xhance|xhance|mesh-list
6610106|NCT01213849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6610107|NCT01213849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6610108|NCT01213849|Autonomic Agents|autonomic agents|mesh-ancestor
6610109|NCT01213849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6610110|NCT01213849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610111|NCT01213849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6610112|NCT01213849|Respiratory System Agents|respiratory system agents|mesh-ancestor
6610113|NCT01213849|Dermatologic Agents|dermatologic agents|mesh-ancestor
6610114|NCT01213849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6610115|NCT01213888|Trientine|trientine|mesh-list
6610116|NCT01213888|Chelating Agents|chelating agents|mesh-ancestor
6610117|NCT01213888|Sequestering Agents|sequestering agents|mesh-ancestor
6610118|NCT01213888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610119|NCT01213901|Insulin Lispro|insulin lispro|mesh-list
6610120|NCT01213901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6610121|NCT01213901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610122|NCT01213979|Iron|iron|mesh-list
6610123|NCT01213979|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
6610124|NCT01213979|Ferric Compounds|ferric compounds|mesh-list
6610125|NCT01213979|Trace Elements|trace elements|mesh-ancestor
6610126|NCT01213979|Micronutrients|micronutrients|mesh-ancestor
6610127|NCT01213979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610128|NCT01213979|Hematinics|hematinics|mesh-ancestor
6610129|NCT01213992|Iron|iron|mesh-list
6610130|NCT01213992|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
6610131|NCT01213992|Ferric Compounds|ferric compounds|mesh-list
6610132|NCT01213992|Trace Elements|trace elements|mesh-ancestor
6610133|NCT01213992|Micronutrients|micronutrients|mesh-ancestor
6610134|NCT01213992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610135|NCT01213992|Hematinics|hematinics|mesh-ancestor
6610136|NCT01214122|Warfarin|warfarin|mesh-list
6610137|NCT01214122|Anticoagulants|anticoagulants|mesh-ancestor
6610138|NCT01214226|Pentoxifylline|pentoxifylline|mesh-list
6610139|NCT01214226|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6610140|NCT01214226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6610141|NCT01214226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610142|NCT01214226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6610143|NCT01214226|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6610144|NCT01214226|Protective Agents|protective agents|mesh-ancestor
6610145|NCT01214226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610146|NCT01214226|Vasodilator Agents|vasodilator agents|mesh-ancestor
6610147|NCT01214226|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6610148|NCT01214226|Antioxidants|antioxidants|mesh-ancestor
6020672|NCT00393874|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6020673|NCT00393874|Adrenergic Agents|adrenergic agents|mesh-ancestor
6610149|NCT01214291|Toremifene|toremifene|mesh-list
6610150|NCT01214291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6610151|NCT01214291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6610152|NCT01214291|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6610153|NCT01214291|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6610154|NCT01214291|Hormone Antagonists|hormone antagonists|mesh-ancestor
6610155|NCT01214291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6610156|NCT01214291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610157|NCT01214291|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6610158|NCT01214343|Sorafenib|sorafenib|mesh-list
6610159|NCT01214343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6610160|NCT01214343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6610161|NCT01214343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6610162|NCT01214343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610163|NCT01214382|Sertraline|sertraline|mesh-list
6610164|NCT01214382|Antidepressive Agents|antidepressive agents|mesh-ancestor
6610165|NCT01214382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6610166|NCT01214382|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6610167|NCT01214382|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6610168|NCT01214382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6610169|NCT01214382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610170|NCT01214382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6610171|NCT01214382|Serotonin Agents|serotonin agents|mesh-ancestor
6610172|NCT01214382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610173|NCT01214408|Pantoprazole|pantoprazole|mesh-list
6610174|NCT01214408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6610175|NCT01214408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6610176|NCT01214408|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6610177|NCT01214408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6660939|NCT01496105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610178|NCT01214408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610179|NCT01214486|Raltegravir Potassium|raltegravir potassium|mesh-list
6610180|NCT01214486|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6610181|NCT01214486|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6610182|NCT01214486|Antiviral Agents|antiviral agents|mesh-ancestor
6610183|NCT01214486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6610184|NCT01214486|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6610185|NCT01214486|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6610186|NCT01214486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6610187|NCT01214486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610188|NCT01214746|Atorvastatin|atorvastatin|mesh-list
6610189|NCT01214746|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6610190|NCT01214746|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6610191|NCT01214746|Antimetabolites|antimetabolites|mesh-ancestor
6610192|NCT01214746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610193|NCT01214746|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6610194|NCT01214746|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6610195|NCT01214746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6610196|NCT01214772|Heparin|heparin|mesh-list
6610197|NCT01214772|Anticoagulants|anticoagulants|mesh-ancestor
6610198|NCT01214772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6610199|NCT01214772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6610200|NCT01214772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610201|NCT01214889|Vaccines|vaccines|mesh-list
6610202|NCT01214889|Immunologic Factors|immunologic factors|mesh-ancestor
6610203|NCT01214889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610204|NCT01214928|Vitamin D|vitamin d|mesh-list
6610205|NCT01214928|Cholecalciferol|cholecalciferol|mesh-list
6610206|NCT01214928|Vitamins|vitamins|mesh-ancestor
6610207|NCT01214928|Micronutrients|micronutrients|mesh-ancestor
6610208|NCT01214928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610209|NCT01214928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6610210|NCT01214928|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6610211|NCT01214941|Itraconazole|itraconazole|mesh-list
6610212|NCT01214941|Ticlopidine|ticlopidine|mesh-list
6610213|NCT01214941|Antifungal Agents|antifungal agents|mesh-ancestor
6610214|NCT01214941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6610215|NCT01214941|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6610216|NCT01214941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6610217|NCT01214941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6610218|NCT01214941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610219|NCT01214941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6610220|NCT01214941|Hormone Antagonists|hormone antagonists|mesh-ancestor
6610221|NCT01214941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6610222|NCT01214941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610223|NCT01214941|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6610224|NCT01214941|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6610225|NCT01214941|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6610226|NCT01214941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6610227|NCT01214941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6610228|NCT01214941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6610229|NCT01214941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6610230|NCT01214941|Purinergic Agents|purinergic agents|mesh-ancestor
6610231|NCT01214941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6610232|NCT01214941|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6610233|NCT01214993|Dolutegravir|dolutegravir|mesh-list
6610234|NCT01214993|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6610235|NCT01214993|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6610236|NCT01214993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6610237|NCT01214993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610238|NCT01214993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6610239|NCT01214993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6610240|NCT01214993|Antiviral Agents|antiviral agents|mesh-ancestor
6610241|NCT01214993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6610242|NCT01215019|Mannitol|mannitol|mesh-list
6610243|NCT01215019|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6610244|NCT01215019|Diuretics|diuretics|mesh-ancestor
6610245|NCT01215019|Natriuretic Agents|natriuretic agents|mesh-ancestor
6610246|NCT01215019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610247|NCT01215084|4-Aminopyridine|4-aminopyridine|mesh-list
6610248|NCT01215084|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6610249|NCT01215084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6610250|NCT01215084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610251|NCT01215136|Paclitaxel|paclitaxel|mesh-list
6610252|NCT01215136|Everolimus|everolimus|mesh-list
6610253|NCT01215136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6610254|NCT01215136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6610255|NCT01215136|Tubulin Modulators|tubulin modulators|mesh-ancestor
6610256|NCT01215136|Antimitotic Agents|antimitotic agents|mesh-ancestor
6610257|NCT01215136|Mitosis Modulators|mitosis modulators|mesh-ancestor
6610258|NCT01215136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610259|NCT01215136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6610260|NCT01215136|Immunologic Factors|immunologic factors|mesh-ancestor
6610261|NCT01215136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610262|NCT01215149|Vaccines|vaccines|mesh-list
6610263|NCT01215149|Immunologic Factors|immunologic factors|mesh-ancestor
6610264|NCT01215149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610265|NCT01215214|Midazolam|midazolam|mesh-list
6610266|NCT01215214|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6610267|NCT01215214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6610268|NCT01215214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6610269|NCT01215214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610270|NCT01215214|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6610271|NCT01215214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6610272|NCT01215214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6610273|NCT01215214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6610274|NCT01215214|Anesthetics, General|anesthetics, general|mesh-ancestor
6610275|NCT01215214|Anesthetics|anesthetics|mesh-ancestor
6610276|NCT01215214|GABA Modulators|gaba modulators|mesh-ancestor
6610277|NCT01215214|GABA Agents|gaba agents|mesh-ancestor
6610278|NCT01215214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6610279|NCT01215214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610280|NCT01215266|Sorafenib|sorafenib|mesh-list
6610281|NCT01215266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6610282|NCT01215266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6610283|NCT01215266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6610284|NCT01215266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610285|NCT01215331|Insulin|insulin|mesh-list
6610286|NCT01215331|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6610287|NCT01215331|Metformin|metformin|mesh-list
6610288|NCT01215331|Glyburide|glyburide|mesh-list
6610289|NCT01215331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6610290|NCT01215331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610291|NCT01215409|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6610292|NCT01215409|Vasodilator Agents|vasodilator agents|mesh-ancestor
6610293|NCT01215409|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6610294|NCT01215409|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6610295|NCT01215409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6610296|NCT01215409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610297|NCT01215409|Urological Agents|urological agents|mesh-ancestor
6610298|NCT01215539|Panitumumab|panitumumab|mesh-list
6610299|NCT01215539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6610300|NCT01215539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6610301|NCT01215565|Sunitinib|sunitinib|mesh-list
6610302|NCT01215565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6610303|NCT01215565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6610304|NCT01215565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6610305|NCT01215565|Growth Substances|growth substances|mesh-ancestor
6610306|NCT01215565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610307|NCT01215565|Growth Inhibitors|growth inhibitors|mesh-ancestor
6610308|NCT01215565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6610309|NCT01215565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6610310|NCT01215565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610311|NCT01215578|Sunitinib|sunitinib|mesh-list
6610312|NCT01215578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6610313|NCT01215578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6610314|NCT01215578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6610315|NCT01215578|Growth Substances|growth substances|mesh-ancestor
6610316|NCT01215578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610317|NCT01215578|Growth Inhibitors|growth inhibitors|mesh-ancestor
6610318|NCT01215578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6610319|NCT01215578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6610320|NCT01215578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610321|NCT01215669|Vaccines|vaccines|mesh-list
6610322|NCT01215669|Immunologic Factors|immunologic factors|mesh-ancestor
6610323|NCT01215669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610324|NCT01215682|Vitamin D|vitamin d|mesh-list
6610325|NCT01215682|Vitamins|vitamins|mesh-ancestor
6610326|NCT01215682|Micronutrients|micronutrients|mesh-ancestor
6610327|NCT01215682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610328|NCT01215682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6610329|NCT01215708|Tamsulosin|tamsulosin|mesh-list
6610330|NCT01215708|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6610331|NCT01215708|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6610332|NCT01215708|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6610333|NCT01215708|Adrenergic Agents|adrenergic agents|mesh-ancestor
6610334|NCT01215708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6610335|NCT01215708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610336|NCT01215708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610337|NCT01215708|Urological Agents|urological agents|mesh-ancestor
6610338|NCT01215799|Bafetinib|bafetinib|mesh-list
6610339|NCT01215799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6610340|NCT01215799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6610341|NCT01215799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660940|NCT01496105|Sensory System Agents|sensory system agents|mesh-ancestor
6660941|NCT01496105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6660942|NCT01496105|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6660943|NCT01496105|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6660944|NCT01496105|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6660945|NCT01496105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6660946|NCT01496105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660947|NCT01496196|Tranexamic Acid|tranexamic acid|mesh-list
6660948|NCT01496196|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6660949|NCT01496196|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6660950|NCT01496196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660951|NCT01496196|Hemostatics|hemostatics|mesh-ancestor
6660952|NCT01496196|Coagulants|coagulants|mesh-ancestor
6660953|NCT01496261|Aspirin|aspirin|mesh-list
6660954|NCT01496261|Clopidogrel|clopidogrel|mesh-list
6660955|NCT01496261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6660956|NCT01496261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6660957|NCT01496261|Analgesics|analgesics|mesh-ancestor
6660958|NCT01496261|Sensory System Agents|sensory system agents|mesh-ancestor
6660959|NCT01496261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6660960|NCT01496261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660961|NCT01496261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6660962|NCT01496261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6660963|NCT01496261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6660964|NCT01496261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6660965|NCT01496261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660966|NCT01496261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6660967|NCT01496261|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6660968|NCT01496261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6660969|NCT01496261|Antipyretics|antipyretics|mesh-ancestor
6660970|NCT01496261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6660971|NCT01496261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6660972|NCT01496261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6660973|NCT01496261|Purinergic Agents|purinergic agents|mesh-ancestor
6660974|NCT01496261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6660975|NCT01496326|Ibuprofen|ibuprofen|mesh-list
6660976|NCT01496326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6610342|NCT01215890|Risedronic Acid|risedronic acid|mesh-list
6610343|NCT01215890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6610344|NCT01215890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6610345|NCT01215890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610346|NCT01215890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6610347|NCT01215890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610348|NCT01215890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6610349|NCT01216007|Propofol|propofol|mesh-list
6610350|NCT01216007|Sevoflurane|sevoflurane|mesh-list
6610351|NCT01216007|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6610352|NCT01216007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6610353|NCT01216007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610354|NCT01216007|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6610355|NCT01216007|Anesthetics, General|anesthetics, general|mesh-ancestor
6610356|NCT01216007|Anesthetics|anesthetics|mesh-ancestor
6610357|NCT01216007|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6610358|NCT01216007|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6610359|NCT01216020|Cisplatin|cisplatin|mesh-list
6610360|NCT01216020|Cetuximab|cetuximab|mesh-list
6610361|NCT01216020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6610362|NCT01216020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6610363|NCT01216046|Ivacaftor|ivacaftor|mesh-list
6610364|NCT01216046|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6610365|NCT01216046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6610366|NCT01216046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610367|NCT01216085|Imatinib Mesylate|imatinib mesylate|mesh-list
6610368|NCT01216085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6610369|NCT01216085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6610370|NCT01216085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6610371|NCT01216085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610372|NCT01216111|Paclitaxel|paclitaxel|mesh-list
6610373|NCT01216111|Docetaxel|docetaxel|mesh-list
6610374|NCT01216111|Cyclophosphamide|cyclophosphamide|mesh-list
6610375|NCT01216111|Fluorouracil|fluorouracil|mesh-list
6610376|NCT01216111|Epirubicin|epirubicin|mesh-list
6610377|NCT01216111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6610378|NCT01216111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6610379|NCT01216111|Tubulin Modulators|tubulin modulators|mesh-ancestor
6610380|NCT01216111|Antimitotic Agents|antimitotic agents|mesh-ancestor
6610381|NCT01216111|Mitosis Modulators|mitosis modulators|mesh-ancestor
6610382|NCT01216111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610383|NCT01216111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6610384|NCT01216111|Immunologic Factors|immunologic factors|mesh-ancestor
6610385|NCT01216111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610386|NCT01216111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6610387|NCT01216111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6610388|NCT01216111|Alkylating Agents|alkylating agents|mesh-ancestor
6610389|NCT01216111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6610390|NCT01216111|Antimetabolites|antimetabolites|mesh-ancestor
6610391|NCT01216111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6610392|NCT01216111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6610393|NCT01216111|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6610394|NCT01216111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6610395|NCT01216111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6020674|NCT00393874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6020675|NCT00393874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020676|NCT00393874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020677|NCT00393939|Docetaxel|docetaxel|mesh-list
6020678|NCT00393939|Sunitinib|sunitinib|mesh-list
6020679|NCT00393939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6020680|NCT00393939|Tubulin Modulators|tubulin modulators|mesh-ancestor
6020681|NCT00393939|Antimitotic Agents|antimitotic agents|mesh-ancestor
6020682|NCT00393939|Mitosis Modulators|mitosis modulators|mesh-ancestor
6020683|NCT00393939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020684|NCT00393939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6020685|NCT00393939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6020686|NCT00393939|Growth Substances|growth substances|mesh-ancestor
6020687|NCT00393939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020688|NCT00393939|Growth Inhibitors|growth inhibitors|mesh-ancestor
6020689|NCT00393939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6020690|NCT00393939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6449753|NCT00405301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6449754|NCT00405301|Antitubercular Agents|antitubercular agents|mesh-ancestor
6449755|NCT00405301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6020691|NCT00393978|Topiramate|topiramate|mesh-list
6610396|NCT01216124|Docetaxel|docetaxel|mesh-list
6610397|NCT01216124|Oxaliplatin|oxaliplatin|mesh-list
6610398|NCT01216124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6610399|NCT01216124|Tubulin Modulators|tubulin modulators|mesh-ancestor
6610400|NCT01216124|Antimitotic Agents|antimitotic agents|mesh-ancestor
6610401|NCT01216124|Mitosis Modulators|mitosis modulators|mesh-ancestor
6610402|NCT01216124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610403|NCT01216267|Lansoprazole|lansoprazole|mesh-list
6610404|NCT01216267|Dexlansoprazole|dexlansoprazole|mesh-list
6610405|NCT01216267|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6610406|NCT01216267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6610407|NCT01216267|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6610408|NCT01216267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6610409|NCT01216267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610410|NCT01216293|Esomeprazole|esomeprazole|mesh-list
6610411|NCT01216293|Dexlansoprazole|dexlansoprazole|mesh-list
6610412|NCT01216293|Lansoprazole|lansoprazole|mesh-list
6610413|NCT01216293|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6610414|NCT01216293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6610415|NCT01216293|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6610416|NCT01216293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6610417|NCT01216293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610418|NCT01216345|Gemcitabine|gemcitabine|mesh-list
6610419|NCT01216345|Oxaliplatin|oxaliplatin|mesh-list
6610420|NCT01216345|Cetuximab|cetuximab|mesh-list
6610421|NCT01216345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6610422|NCT01216345|Antimetabolites|antimetabolites|mesh-ancestor
6610423|NCT01216345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610424|NCT01216345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6610425|NCT01216345|Antiviral Agents|antiviral agents|mesh-ancestor
6610426|NCT01216345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6610427|NCT01216345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6610428|NCT01216345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6610429|NCT01216345|Immunologic Factors|immunologic factors|mesh-ancestor
6610430|NCT01216345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610431|NCT01216345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6610432|NCT01216371|Sunitinib|sunitinib|mesh-list
6610433|NCT01216371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6610434|NCT01216371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6610435|NCT01216371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6610436|NCT01216371|Growth Substances|growth substances|mesh-ancestor
6610437|NCT01216371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610438|NCT01216371|Growth Inhibitors|growth inhibitors|mesh-ancestor
6610439|NCT01216371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6610440|NCT01216371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6610441|NCT01216371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610442|NCT01216436|Vaccines|vaccines|mesh-list
6610443|NCT01216436|Immunologic Factors|immunologic factors|mesh-ancestor
6610444|NCT01216436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610445|NCT01216449|Citalopram|citalopram|mesh-list
6610446|NCT01216449|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6610447|NCT01216449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6610448|NCT01216449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6610449|NCT01216449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610450|NCT01216449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6610451|NCT01216449|Serotonin Agents|serotonin agents|mesh-ancestor
6610452|NCT01216449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610453|NCT01216449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6610454|NCT01216449|Antidepressive Agents|antidepressive agents|mesh-ancestor
6610455|NCT01216449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6449756|NCT00405301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6449757|NCT00405301|Leprostatic Agents|leprostatic agents|mesh-ancestor
6610456|NCT01216488|Lidocaine|lidocaine|mesh-list
6449758|NCT00405301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6449759|NCT00405301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6449760|NCT00405301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6449761|NCT00405301|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6449762|NCT00405301|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6449763|NCT00405301|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6610457|NCT01216488|Anesthetics, Local|anesthetics, local|mesh-ancestor
6610458|NCT01216488|Anesthetics|anesthetics|mesh-ancestor
6610459|NCT01216488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6610460|NCT01216488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610461|NCT01216488|Sensory System Agents|sensory system agents|mesh-ancestor
6610462|NCT01216488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6610463|NCT01216488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6610464|NCT01216488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6449764|NCT00405301|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6449765|NCT00405301|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6449766|NCT00405301|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6610465|NCT01216488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6610466|NCT01216488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6610467|NCT01216488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610468|NCT01216579|Mannitol|mannitol|mesh-list
6610469|NCT01216579|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6610470|NCT01216579|Diuretics|diuretics|mesh-ancestor
6610471|NCT01216579|Natriuretic Agents|natriuretic agents|mesh-ancestor
6610472|NCT01216579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610473|NCT01216605|Oxytocin|oxytocin|mesh-list
6610474|NCT01216605|Oxytocics|oxytocics|mesh-ancestor
6610475|NCT01216605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6449767|NCT00405340|Rituximab|rituximab|mesh-list
6449768|NCT00405340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6449769|NCT00405340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6449770|NCT00405340|Immunologic Factors|immunologic factors|mesh-ancestor
6449771|NCT00405340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449772|NCT00405340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6610476|NCT01216605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610477|NCT01216644|Leucovorin|leucovorin|mesh-list
6610478|NCT01216644|Docetaxel|docetaxel|mesh-list
6610479|NCT01216644|Fluorouracil|fluorouracil|mesh-list
6610480|NCT01216644|Oxaliplatin|oxaliplatin|mesh-list
6610481|NCT01216644|Epirubicin|epirubicin|mesh-list
6610482|NCT01216644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6610483|NCT01216644|Tubulin Modulators|tubulin modulators|mesh-ancestor
6610484|NCT01216644|Antimitotic Agents|antimitotic agents|mesh-ancestor
6610485|NCT01216644|Mitosis Modulators|mitosis modulators|mesh-ancestor
6610486|NCT01216644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610487|NCT01216644|Antimetabolites|antimetabolites|mesh-ancestor
6610488|NCT01216644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6610489|NCT01216644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6610490|NCT01216644|Immunologic Factors|immunologic factors|mesh-ancestor
6610491|NCT01216644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610492|NCT01216644|Antidotes|antidotes|mesh-ancestor
6610493|NCT01216644|Protective Agents|protective agents|mesh-ancestor
6610494|NCT01216644|Vitamin B Complex|vitamin b complex|mesh-ancestor
6610495|NCT01216644|Vitamins|vitamins|mesh-ancestor
6610496|NCT01216644|Micronutrients|micronutrients|mesh-ancestor
6610497|NCT01216644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6610498|NCT01216644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6610499|NCT01216644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6610500|NCT01216644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6610501|NCT01216657|Sunitinib|sunitinib|mesh-list
6610502|NCT01216657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6610503|NCT01216657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6610504|NCT01216657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6610505|NCT01216657|Growth Substances|growth substances|mesh-ancestor
6610506|NCT01216657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610507|NCT01216657|Growth Inhibitors|growth inhibitors|mesh-ancestor
6610508|NCT01216657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6610509|NCT01216657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6610510|NCT01216657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610511|NCT01216696|Ipilimumab|ipilimumab|mesh-list
6610512|NCT01216696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6610513|NCT01216696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6610514|NCT01216696|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6610515|NCT01216696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610516|NCT01216709|Iron|iron|mesh-list
6610517|NCT01216709|Trace Elements|trace elements|mesh-ancestor
6610518|NCT01216709|Micronutrients|micronutrients|mesh-ancestor
6610519|NCT01216709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610520|NCT01216787|R04929097|r04929097|mesh-list
6610521|NCT01216787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6610522|NCT01216787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610523|NCT01216826|Everolimus|everolimus|mesh-list
6610524|NCT01216826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6610525|NCT01216826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6610526|NCT01216826|Immunologic Factors|immunologic factors|mesh-ancestor
6610527|NCT01216826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020692|NCT00393978|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6610528|NCT01216839|Everolimus|everolimus|mesh-list
6610529|NCT01216839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6610530|NCT01216839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6610531|NCT01216839|Immunologic Factors|immunologic factors|mesh-ancestor
6610532|NCT01216839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610533|NCT01216852|Losartan|losartan|mesh-list
6610534|NCT01216852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6610535|NCT01216852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6610536|NCT01216852|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6610537|NCT01216852|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6610538|NCT01216852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610539|NCT01216878|Losartan|losartan|mesh-list
6610540|NCT01216878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6610541|NCT01216878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6610542|NCT01216878|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6610543|NCT01216878|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6610544|NCT01216878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610545|NCT01216904|Nicotine|nicotine|mesh-list
6610546|NCT01216904|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6610547|NCT01216904|Autonomic Agents|autonomic agents|mesh-ancestor
6610548|NCT01216904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6610549|NCT01216904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610550|NCT01216904|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6610551|NCT01216904|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6610552|NCT01216904|Cholinergic Agents|cholinergic agents|mesh-ancestor
6610553|NCT01216904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6610554|NCT01216904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610555|NCT01216956|Nicotinic Acids|nicotinic acids|mesh-list
6610556|NCT01216956|Niacin|niacin|mesh-list
6610557|NCT01216956|Niacinamide|niacinamide|mesh-list
6610558|NCT01216956|Vitamin B Complex|vitamin b complex|mesh-ancestor
6610559|NCT01216956|Vitamins|vitamins|mesh-ancestor
6610560|NCT01216956|Micronutrients|micronutrients|mesh-ancestor
6610561|NCT01216956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610562|NCT01216956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6610563|NCT01216956|Antimetabolites|antimetabolites|mesh-ancestor
6610564|NCT01216956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610565|NCT01216956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6610566|NCT01216956|Vasodilator Agents|vasodilator agents|mesh-ancestor
6610567|NCT01217034|Sorafenib|sorafenib|mesh-list
6610568|NCT01217034|Chlorotrianisene|chlorotrianisene|mesh-list
6610569|NCT01217034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6610570|NCT01217034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6610571|NCT01217034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5501940|NCT04469842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6020693|NCT00393978|Antidepressive Agents|antidepressive agents|mesh-ancestor
6020694|NCT00393978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6020695|NCT00393978|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6020696|NCT00393978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6020697|NCT00393978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6020698|NCT00393978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020699|NCT00393978|Anticonvulsants|anticonvulsants|mesh-ancestor
6020700|NCT00393978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6020701|NCT00394082|Paclitaxel|paclitaxel|mesh-list
6610572|NCT01217034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610573|NCT01217034|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6610574|NCT01217034|Estrogens|estrogens|mesh-ancestor
6610575|NCT01217034|Hormones|hormones|mesh-ancestor
6610576|NCT01217034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6610577|NCT01217034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610578|NCT01217034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6610579|NCT01217086|Infliximab|infliximab|mesh-list
6610580|NCT01217086|Dermatologic Agents|dermatologic agents|mesh-ancestor
6610581|NCT01217086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6610582|NCT01217086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6610583|NCT01217099|Azithromycin|azithromycin|mesh-list
6610584|NCT01217099|Methylprednisolone|methylprednisolone|mesh-list
6610585|NCT01217099|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6610586|NCT01217099|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6610587|NCT01217099|Prednisolone|prednisolone|mesh-list
6610588|NCT01217099|Prednisolone acetate|prednisolone acetate|mesh-list
6610589|NCT01217099|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6610590|NCT01217099|Prednisolone phosphate|prednisolone phosphate|mesh-list
6610591|NCT01217099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6610592|NCT01217099|Antiemetics|antiemetics|mesh-ancestor
6610593|NCT01217099|Autonomic Agents|autonomic agents|mesh-ancestor
6610594|NCT01217099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6610595|NCT01217099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610596|NCT01217099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6610597|NCT01217099|Glucocorticoids|glucocorticoids|mesh-ancestor
6610598|NCT01217099|Hormones|hormones|mesh-ancestor
6610599|NCT01217099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6610600|NCT01217099|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6610601|NCT01217099|Protective Agents|protective agents|mesh-ancestor
6610602|NCT01217099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6610603|NCT01217099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6610604|NCT01217099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6610605|NCT01217099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6610606|NCT01217125|Sirolimus|sirolimus|mesh-list
6610607|NCT01217125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6610608|NCT01217125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6610609|NCT01217125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6610610|NCT01217125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6610611|NCT01217125|Antifungal Agents|antifungal agents|mesh-ancestor
6610612|NCT01217125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6610613|NCT01217125|Immunologic Factors|immunologic factors|mesh-ancestor
6610614|NCT01217125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610615|NCT01217138|Epinephrine|epinephrine|mesh-list
6610616|NCT01217138|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6610617|NCT01217138|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6610618|NCT01217138|Adrenergic Agents|adrenergic agents|mesh-ancestor
6610619|NCT01217138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6610620|NCT01217138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610621|NCT01217138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610622|NCT01217138|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6610623|NCT01217138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6610624|NCT01217138|Autonomic Agents|autonomic agents|mesh-ancestor
6610625|NCT01217138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6610626|NCT01217138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6610627|NCT01217138|Respiratory System Agents|respiratory system agents|mesh-ancestor
6610628|NCT01217138|Mydriatics|mydriatics|mesh-ancestor
6610629|NCT01217138|Sympathomimetics|sympathomimetics|mesh-ancestor
6610630|NCT01217138|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6610631|NCT01217177|Everolimus|everolimus|mesh-list
6610632|NCT01217177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6610633|NCT01217177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6610634|NCT01217177|Immunologic Factors|immunologic factors|mesh-ancestor
6610635|NCT01217177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610636|NCT01217203|Lenalidomide|lenalidomide|mesh-list
6610637|NCT01217203|Immunologic Factors|immunologic factors|mesh-ancestor
6020702|NCT00394082|Bevacizumab|bevacizumab|mesh-list
6610638|NCT01217203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610639|NCT01217203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6610640|NCT01217203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6610641|NCT01217203|Growth Substances|growth substances|mesh-ancestor
6610642|NCT01217203|Growth Inhibitors|growth inhibitors|mesh-ancestor
6610643|NCT01217203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6610644|NCT01217294|Morphine|morphine|mesh-list
6610645|NCT01217294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6610646|NCT01217294|Narcotics|narcotics|mesh-ancestor
6610647|NCT01217294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6610648|NCT01217294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610649|NCT01217294|Analgesics|analgesics|mesh-ancestor
6610650|NCT01217294|Sensory System Agents|sensory system agents|mesh-ancestor
6610651|NCT01217294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6610652|NCT01217359|Interferons|interferons|mesh-list
6610653|NCT01217359|Interferon-alpha|interferon-alpha|mesh-list
6610654|NCT01217359|Interferon alpha-2|interferon alpha-2|mesh-list
6610655|NCT01217359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6610656|NCT01217359|Antiviral Agents|antiviral agents|mesh-ancestor
6610657|NCT01217359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6610658|NCT01217359|Immunologic Factors|immunologic factors|mesh-ancestor
6610659|NCT01217359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610660|NCT01217398|Bevacizumab|bevacizumab|mesh-list
6610661|NCT01217398|Temozolomide|temozolomide|mesh-list
6610662|NCT01217398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6610663|NCT01217398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6610664|NCT01217398|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6610665|NCT01217398|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6610666|NCT01217398|Growth Substances|growth substances|mesh-ancestor
6610667|NCT01217398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610668|NCT01217398|Growth Inhibitors|growth inhibitors|mesh-ancestor
6610669|NCT01217398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6610670|NCT01217398|Alkylating Agents|alkylating agents|mesh-ancestor
6610671|NCT01217398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610672|NCT01217450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6610673|NCT01217450|Cetuximab|cetuximab|mesh-list
6610674|NCT01217450|Antibodies|antibodies|mesh-list
6610675|NCT01217450|Immunoglobulins|immunoglobulins|mesh-list
6610676|NCT01217450|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6610677|NCT01217450|Immunologic Factors|immunologic factors|mesh-ancestor
6610678|NCT01217450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610679|NCT01217450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6610680|NCT01217580|Ropivacaine|ropivacaine|mesh-list
6610681|NCT01217580|Anesthetics, Local|anesthetics, local|mesh-ancestor
6610682|NCT01217580|Anesthetics|anesthetics|mesh-ancestor
6610683|NCT01217580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6610684|NCT01217580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610685|NCT01217580|Sensory System Agents|sensory system agents|mesh-ancestor
6610686|NCT01217580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6610687|NCT01217619|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6610688|NCT01217619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6610689|NCT01217619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6610690|NCT01217619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6610691|NCT01217619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610692|NCT01217632|Entecavir|entecavir|mesh-list
6610693|NCT01217632|Antiviral Agents|antiviral agents|mesh-ancestor
6610694|NCT01217632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6660977|NCT01496326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6660978|NCT01496326|Analgesics|analgesics|mesh-ancestor
6660979|NCT01496326|Sensory System Agents|sensory system agents|mesh-ancestor
6660980|NCT01496326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6449773|NCT00405366|Sorafenib|sorafenib|mesh-list
6449774|NCT00405366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6449775|NCT00405366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6449776|NCT00405366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6449777|NCT00405366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6449778|NCT00405405|Bevacizumab|bevacizumab|mesh-list
6449779|NCT00405405|Cisplatin|cisplatin|mesh-list
6449780|NCT00405405|Docetaxel|docetaxel|mesh-list
6660981|NCT01496326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501941|NCT04469842|Glucocorticoids|glucocorticoids|mesh-ancestor
6449781|NCT00405405|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6449782|NCT00405405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6449783|NCT00405405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6660982|NCT01496326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6660983|NCT01496326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6610695|NCT01217671|Protease Inhibitors|protease inhibitors|mesh-list
6610696|NCT01217671|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
6610697|NCT01217671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6610698|NCT01217671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610699|NCT01217671|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6610700|NCT01217671|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6610701|NCT01217697|Prednisone|prednisone|mesh-list
6610702|NCT01217697|Prednisolone|prednisolone|mesh-list
6610703|NCT01217697|Abiraterone Acetate|abiraterone acetate|mesh-list
6610704|NCT01217697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6610705|NCT01217697|Glucocorticoids|glucocorticoids|mesh-ancestor
6610706|NCT01217697|Hormones|hormones|mesh-ancestor
6610707|NCT01217697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6610708|NCT01217697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610709|NCT01217697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6610710|NCT01217697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6610711|NCT01217697|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6610712|NCT01217697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6610713|NCT01217697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610714|NCT01217697|Hormone Antagonists|hormone antagonists|mesh-ancestor
6610715|NCT01217697|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6610716|NCT01217723|Thymoglobulin|thymoglobulin|mesh-list
6610717|NCT01217723|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6610718|NCT01217723|Immunologic Factors|immunologic factors|mesh-ancestor
6610719|NCT01217723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610720|NCT01217723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6610721|NCT01217879|Telmisartan|telmisartan|mesh-list
6610722|NCT01217879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6610723|NCT01217879|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6610724|NCT01217879|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6610725|NCT01217879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610726|NCT01217931|Bevacizumab|bevacizumab|mesh-list
6610727|NCT01217931|Everolimus|everolimus|mesh-list
6610728|NCT01217931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6610729|NCT01217931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6610730|NCT01217931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6610731|NCT01217931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6610732|NCT01217931|Growth Substances|growth substances|mesh-ancestor
6610733|NCT01217931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610734|NCT01217931|Growth Inhibitors|growth inhibitors|mesh-ancestor
6610735|NCT01217931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6610736|NCT01217931|Immunologic Factors|immunologic factors|mesh-ancestor
6610737|NCT01217970|Ibudilast|ibudilast|mesh-list
6610738|NCT01217970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6610739|NCT01217970|Autonomic Agents|autonomic agents|mesh-ancestor
6610740|NCT01217970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6610741|NCT01217970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610742|NCT01217970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6610743|NCT01217970|Respiratory System Agents|respiratory system agents|mesh-ancestor
6610744|NCT01217970|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6610745|NCT01217970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6610746|NCT01217970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610747|NCT01217970|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6610748|NCT01217970|Vasodilator Agents|vasodilator agents|mesh-ancestor
6610749|NCT01218022|Losartan|losartan|mesh-list
6610750|NCT01218022|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6610751|NCT01218022|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6610752|NCT01218022|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6610753|NCT01218022|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6610754|NCT01218022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610755|NCT01218035|Zoledronic Acid|zoledronic acid|mesh-list
6610756|NCT01218035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6610757|NCT01218035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610758|NCT01218217|Rifampin|rifampin|mesh-list
6610759|NCT01218217|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6610760|NCT01218217|Antitubercular Agents|antitubercular agents|mesh-ancestor
6610761|NCT01218217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6610762|NCT01218217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6610763|NCT01218217|Leprostatic Agents|leprostatic agents|mesh-ancestor
6610764|NCT01218217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6610765|NCT01218217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6610766|NCT01218217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610767|NCT01218217|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6610768|NCT01218217|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6610769|NCT01218217|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6610770|NCT01218217|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6610771|NCT01218217|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6610772|NCT01218217|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6610773|NCT01218321|Anticonvulsants|anticonvulsants|mesh-list
6610774|NCT01218347|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6610775|NCT01218347|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6610776|NCT01218347|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6610777|NCT01218347|Antimetabolites|antimetabolites|mesh-ancestor
6610778|NCT01218347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610779|NCT01218347|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6610780|NCT01218347|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6610781|NCT01218347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6610782|NCT01218386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6610783|NCT01218386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6610784|NCT01218386|Estradiol|estradiol|mesh-list
6610785|NCT01218386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6610786|NCT01218386|Estrogens|estrogens|mesh-ancestor
6610787|NCT01218386|Hormones|hormones|mesh-ancestor
6610788|NCT01218386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6610789|NCT01218386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610790|NCT01218386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6610791|NCT01218386|Contraceptive Agents|contraceptive agents|mesh-ancestor
6610792|NCT01218386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6610793|NCT01218386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6610794|NCT01218425|Levodopa|levodopa|mesh-list
6610795|NCT01218425|Carbidopa|carbidopa|mesh-list
6610796|NCT01218425|Domperidone|domperidone|mesh-list
6610797|NCT01218425|Methylphenidate|methylphenidate|mesh-list
6610798|NCT01218425|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6610799|NCT01218425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610800|NCT01218425|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6610801|NCT01218425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6610802|NCT01218425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6610803|NCT01218425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610804|NCT01218425|Dopamine Agents|dopamine agents|mesh-ancestor
6610805|NCT01218425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6610806|NCT01218425|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6610807|NCT01218425|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6610808|NCT01218425|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6610809|NCT01218425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6610810|NCT01218425|Antiemetics|antiemetics|mesh-ancestor
6610811|NCT01218425|Autonomic Agents|autonomic agents|mesh-ancestor
6610812|NCT01218425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6610813|NCT01218425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6610814|NCT01218425|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6610815|NCT01218451|Vaccines|vaccines|mesh-list
6610816|NCT01218451|Immunologic Factors|immunologic factors|mesh-ancestor
6610817|NCT01218451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610818|NCT01218529|Lapatinib|lapatinib|mesh-list
6610819|NCT01218529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6610820|NCT01218529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6610821|NCT01218529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6610822|NCT01218529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610823|NCT01218568|Rifaximin|rifaximin|mesh-list
6610824|NCT01218568|Lactulose|lactulose|mesh-list
6610825|NCT01218568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6610826|NCT01218568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6610827|NCT01218568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6610828|NCT01218581|Letrozole|letrozole|mesh-list
6610829|NCT01218581|Goserelin|goserelin|mesh-list
6610830|NCT01218581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6610831|NCT01218581|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6610832|NCT01218581|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6610833|NCT01218581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6610834|NCT01218581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610835|NCT01218581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6610836|NCT01218581|Hormone Antagonists|hormone antagonists|mesh-ancestor
6610837|NCT01218581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6610838|NCT01218581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610839|NCT01218581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6610840|NCT01218607|Bosentan|bosentan|mesh-list
6610841|NCT01218607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6610842|NCT01218607|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6610843|NCT01218607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610844|NCT01218620|Tolbutamide|tolbutamide|mesh-list
6610845|NCT01218620|Rifampin|rifampin|mesh-list
6610846|NCT01218620|Ketoconazole|ketoconazole|mesh-list
6610847|NCT01218620|Midazolam|midazolam|mesh-list
6610848|NCT01218620|Dextromethorphan|dextromethorphan|mesh-list
5501942|NCT04469842|Hormones|hormones|mesh-ancestor
6610849|NCT01218620|Omeprazole|omeprazole|mesh-list
6610850|NCT01218620|R04929097|r04929097|mesh-list
6610851|NCT01218620|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6610852|NCT01218620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6610853|NCT01218620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6610854|NCT01218620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610855|NCT01218620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6610856|NCT01218620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6610857|NCT01218620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6610858|NCT01218620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6610859|NCT01218620|Anesthetics, General|anesthetics, general|mesh-ancestor
6610860|NCT01218620|Anesthetics|anesthetics|mesh-ancestor
6610861|NCT01218620|GABA Modulators|gaba modulators|mesh-ancestor
6610862|NCT01218620|GABA Agents|gaba agents|mesh-ancestor
6610863|NCT01218620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6610864|NCT01218620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610865|NCT01218620|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6610866|NCT01218620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6610867|NCT01218620|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6610868|NCT01218620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6610869|NCT01218620|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6610870|NCT01218620|Antitubercular Agents|antitubercular agents|mesh-ancestor
6610871|NCT01218620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6610872|NCT01218620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6610873|NCT01218620|Leprostatic Agents|leprostatic agents|mesh-ancestor
6610874|NCT01218620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6610875|NCT01218620|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6610876|NCT01218620|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6610877|NCT01218620|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6020703|NCT00394082|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6020704|NCT00394082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6020705|NCT00394082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6020706|NCT00394082|Tubulin Modulators|tubulin modulators|mesh-ancestor
6020707|NCT00394082|Antimitotic Agents|antimitotic agents|mesh-ancestor
6020708|NCT00394082|Mitosis Modulators|mitosis modulators|mesh-ancestor
6020709|NCT00394082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020710|NCT00394082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6020711|NCT00394082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6449784|NCT00405405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6449785|NCT00405405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6449786|NCT00405405|Growth Substances|growth substances|mesh-ancestor
6449787|NCT00405405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449788|NCT00405405|Growth Inhibitors|growth inhibitors|mesh-ancestor
6449789|NCT00405405|Tubulin Modulators|tubulin modulators|mesh-ancestor
6449790|NCT00405405|Antimitotic Agents|antimitotic agents|mesh-ancestor
6449791|NCT00405405|Mitosis Modulators|mitosis modulators|mesh-ancestor
6449792|NCT00405405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6449793|NCT00405405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6449794|NCT00405405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6449795|NCT00405418|Insulin|insulin|mesh-list
6449796|NCT00405418|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6449797|NCT00405418|Insulin Glargine|insulin glargine|mesh-list
6449798|NCT00405418|Insulin Detemir|insulin detemir|mesh-list
6449799|NCT00405418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6449800|NCT00405418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449801|NCT00405431|Lubricant Eye Drops|lubricant eye drops|mesh-list
6449802|NCT00405431|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6449803|NCT00405431|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6449804|NCT00405444|Fentanyl|fentanyl|mesh-list
6610878|NCT01218620|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6610879|NCT01218620|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6610880|NCT01218620|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6610881|NCT01218620|Antifungal Agents|antifungal agents|mesh-ancestor
6610882|NCT01218620|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6610883|NCT01218620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6610884|NCT01218620|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6610885|NCT01218620|Hormone Antagonists|hormone antagonists|mesh-ancestor
6610886|NCT01218620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6610887|NCT01218620|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6610888|NCT01218620|Antitussive Agents|antitussive agents|mesh-ancestor
6610889|NCT01218620|Respiratory System Agents|respiratory system agents|mesh-ancestor
6610890|NCT01218620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6610891|NCT01218620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6610892|NCT01218620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6610893|NCT01218698|Losartan|losartan|mesh-list
6610894|NCT01218698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6610895|NCT01218698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6610896|NCT01218698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6610897|NCT01218698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6610898|NCT01218698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610899|NCT01218711|Losartan|losartan|mesh-list
6610900|NCT01218711|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6610901|NCT01218711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6610902|NCT01218711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6610903|NCT01218711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6610904|NCT01218711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6610905|NCT01218711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610906|NCT01218711|Diuretics|diuretics|mesh-ancestor
6610907|NCT01218711|Natriuretic Agents|natriuretic agents|mesh-ancestor
6610908|NCT01218711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610909|NCT01218711|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6610910|NCT01218711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6610911|NCT01218724|Losartan|losartan|mesh-list
6610912|NCT01218724|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6610913|NCT01218724|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6610914|NCT01218724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6610915|NCT01218724|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6610916|NCT01218724|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6610917|NCT01218724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610918|NCT01218724|Diuretics|diuretics|mesh-ancestor
6610919|NCT01218724|Natriuretic Agents|natriuretic agents|mesh-ancestor
6610920|NCT01218724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610921|NCT01218724|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6610922|NCT01218724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6610923|NCT01218737|Gatifloxacin|gatifloxacin|mesh-list
6610924|NCT01218737|Prednisolone|prednisolone|mesh-list
6610925|NCT01218737|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6610926|NCT01218737|Methylprednisolone|methylprednisolone|mesh-list
6610927|NCT01218737|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6610928|NCT01218737|Prednisolone acetate|prednisolone acetate|mesh-list
6610929|NCT01218737|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6610930|NCT01218737|Prednisolone phosphate|prednisolone phosphate|mesh-list
6610931|NCT01218737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6610932|NCT01218737|Glucocorticoids|glucocorticoids|mesh-ancestor
6610933|NCT01218737|Hormones|hormones|mesh-ancestor
6610934|NCT01218737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6610935|NCT01218737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610936|NCT01218737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6610937|NCT01218737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6610938|NCT01218737|Antiemetics|antiemetics|mesh-ancestor
6610939|NCT01218737|Autonomic Agents|autonomic agents|mesh-ancestor
6610940|NCT01218737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6610941|NCT01218737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6610942|NCT01218737|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6610943|NCT01218737|Protective Agents|protective agents|mesh-ancestor
6610944|NCT01218737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6610945|NCT01218737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6610946|NCT01218737|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6610947|NCT01218737|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6610948|NCT01218737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6610949|NCT01218737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6610950|NCT01218737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6610951|NCT01218737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610952|NCT01218750|Bevacizumab|bevacizumab|mesh-list
6610953|NCT01218750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6610954|NCT01218750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6610955|NCT01218750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6610956|NCT01218750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6610957|NCT01218750|Growth Substances|growth substances|mesh-ancestor
6610958|NCT01218750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610959|NCT01218750|Growth Inhibitors|growth inhibitors|mesh-ancestor
6610960|NCT01218893|Chloroquine|chloroquine|mesh-list
6610961|NCT01218893|Proguanil|proguanil|mesh-list
6610962|NCT01218893|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
6610963|NCT01218893|Vaccines|vaccines|mesh-list
6610964|NCT01218893|Amebicides|amebicides|mesh-ancestor
6610965|NCT01218893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6610966|NCT01218893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6610967|NCT01218893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6610968|NCT01218893|Antimalarials|antimalarials|mesh-ancestor
6610969|NCT01218893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6610970|NCT01218893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610971|NCT01218893|Immunologic Factors|immunologic factors|mesh-ancestor
6610972|NCT01218893|Antimetabolites|antimetabolites|mesh-ancestor
6610973|NCT01218893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610974|NCT01219010|Siltuximab|siltuximab|mesh-list
6610975|NCT01219010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6610976|NCT01219023|Sildenafil Citrate|sildenafil citrate|mesh-list
6610977|NCT01219023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6610978|NCT01219023|Vasodilator Agents|vasodilator agents|mesh-ancestor
6610979|NCT01219023|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6610980|NCT01219023|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6610981|NCT01219023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6610982|NCT01219023|Urological Agents|urological agents|mesh-ancestor
6610983|NCT01219036|Budesonide|budesonide|mesh-list
6610984|NCT01219036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6610985|NCT01219036|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6610986|NCT01219036|Autonomic Agents|autonomic agents|mesh-ancestor
6610987|NCT01219036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6610988|NCT01219036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6610989|NCT01219036|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6610990|NCT01219036|Respiratory System Agents|respiratory system agents|mesh-ancestor
6610991|NCT01219036|Glucocorticoids|glucocorticoids|mesh-ancestor
6610992|NCT01219036|Hormones|hormones|mesh-ancestor
6610993|NCT01219036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6610994|NCT01219062|Morphine|morphine|mesh-list
6610995|NCT01219062|Bupivacaine|bupivacaine|mesh-list
6610996|NCT01219062|Anesthetics, Local|anesthetics, local|mesh-ancestor
6610997|NCT01219062|Anesthetics|anesthetics|mesh-ancestor
6610998|NCT01219062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6610999|NCT01219062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611000|NCT01219062|Sensory System Agents|sensory system agents|mesh-ancestor
6611001|NCT01219062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6611002|NCT01219062|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6611003|NCT01219062|Narcotics|narcotics|mesh-ancestor
6611004|NCT01219062|Analgesics|analgesics|mesh-ancestor
6611005|NCT01219088|Morphine|morphine|mesh-list
6611006|NCT01219088|Bupivacaine|bupivacaine|mesh-list
6611007|NCT01219088|Anesthetics, Local|anesthetics, local|mesh-ancestor
6611008|NCT01219088|Anesthetics|anesthetics|mesh-ancestor
6611009|NCT01219088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6611010|NCT01219088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611011|NCT01219088|Sensory System Agents|sensory system agents|mesh-ancestor
6611012|NCT01219088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6611013|NCT01219088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6611014|NCT01219088|Narcotics|narcotics|mesh-ancestor
6611015|NCT01219088|Analgesics|analgesics|mesh-ancestor
6611016|NCT01219101|Citric Acid|citric acid|mesh-list
6611017|NCT01219101|Sodium Citrate|sodium citrate|mesh-list
6611018|NCT01219101|Clomiphene|clomiphene|mesh-list
6611019|NCT01219101|Enclomiphene|enclomiphene|mesh-list
6611020|NCT01219101|Zuclomiphene|zuclomiphene|mesh-list
6611021|NCT01219101|Anticoagulants|anticoagulants|mesh-ancestor
6611022|NCT01219101|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5725043|NCT03183310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6611023|NCT01219101|Chelating Agents|chelating agents|mesh-ancestor
6611024|NCT01219101|Sequestering Agents|sequestering agents|mesh-ancestor
6611025|NCT01219101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611026|NCT01219101|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6611027|NCT01219101|Hormone Antagonists|hormone antagonists|mesh-ancestor
6611028|NCT01219101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6611029|NCT01219101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611030|NCT01219101|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6611031|NCT01219101|Fertility Agents|fertility agents|mesh-ancestor
6611032|NCT01219101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6611033|NCT01219101|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6611034|NCT01219101|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6611035|NCT01219153|Letrozole|letrozole|mesh-list
6611036|NCT01219153|LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|lhrh, n-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|mesh-list
6611037|NCT01219153|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
6611038|NCT01219153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6611039|NCT01219153|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6611040|NCT01219153|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6611041|NCT01219153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6611042|NCT01219153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611043|NCT01219153|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6611044|NCT01219153|Hormone Antagonists|hormone antagonists|mesh-ancestor
6611045|NCT01219153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6611046|NCT01219153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611047|NCT01219153|Hormones|hormones|mesh-ancestor
5501943|NCT04469842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5501944|NCT04469842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501945|NCT04469842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5501946|NCT04469842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6611048|NCT01219205|Bevacizumab|bevacizumab|mesh-list
6611049|NCT01219205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6611050|NCT01219205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6611051|NCT01219205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6611052|NCT01219205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5501947|NCT04469842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5501948|NCT04469842|Immunologic Factors|immunologic factors|mesh-ancestor
5501949|NCT04469842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5501950|NCT04469842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6611053|NCT01219205|Growth Substances|growth substances|mesh-ancestor
6611054|NCT01219205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611055|NCT01219205|Growth Inhibitors|growth inhibitors|mesh-ancestor
6611056|NCT01219244|Resveratrol|resveratrol|mesh-list
6611057|NCT01219244|Antioxidants|antioxidants|mesh-ancestor
6611058|NCT01219244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611059|NCT01219244|Protective Agents|protective agents|mesh-ancestor
6611060|NCT01219244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611061|NCT01219244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6611062|NCT01219244|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6611063|NCT01219257|Adalimumab|adalimumab|mesh-list
6611064|NCT01219257|Etanercept|etanercept|mesh-list
6611065|NCT01219257|Golimumab|golimumab|mesh-list
6611066|NCT01219257|Infliximab|infliximab|mesh-list
6611067|NCT01219257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6611068|NCT01219257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6611069|NCT01219257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6611070|NCT01219257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6611071|NCT01219257|Analgesics|analgesics|mesh-ancestor
6611072|NCT01219257|Sensory System Agents|sensory system agents|mesh-ancestor
6611073|NCT01219257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6611074|NCT01219257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611075|NCT01219257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6611076|NCT01219257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6611077|NCT01219257|Immunologic Factors|immunologic factors|mesh-ancestor
6611078|NCT01219257|Dermatologic Agents|dermatologic agents|mesh-ancestor
6611079|NCT01219257|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6611080|NCT01219348|Vaccines|vaccines|mesh-list
6611081|NCT01219348|Immunologic Factors|immunologic factors|mesh-ancestor
6611082|NCT01219348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611083|NCT01219400|Vildagliptin|vildagliptin|mesh-list
6611084|NCT01219400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6449805|NCT00405444|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6449806|NCT00405444|Narcotics|narcotics|mesh-ancestor
6449807|NCT00405444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6449808|NCT00405444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449809|NCT00405444|Analgesics|analgesics|mesh-ancestor
6449810|NCT00405444|Sensory System Agents|sensory system agents|mesh-ancestor
6449811|NCT00405444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6449812|NCT00405444|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5501951|NCT04469842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501952|NCT04469842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5501953|NCT04469842|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5501954|NCT04469842|Antitubercular Agents|antitubercular agents|mesh-ancestor
5501955|NCT04469842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5501956|NCT04469842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5501957|NCT04469842|Antimetabolites|antimetabolites|mesh-ancestor
5501958|NCT04469842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5501959|NCT04469842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5501960|NCT04469777|Epoetin Alfa|epoetin alfa|mesh-list
6449813|NCT00405444|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6449814|NCT00405444|Anesthetics, General|anesthetics, general|mesh-ancestor
6449815|NCT00405444|Anesthetics|anesthetics|mesh-ancestor
6611085|NCT01219400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611086|NCT01219400|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6611087|NCT01219400|Protease Inhibitors|protease inhibitors|mesh-ancestor
6611088|NCT01219400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6611089|NCT01219400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611090|NCT01219413|Perindopril|perindopril|mesh-list
6611091|NCT01219413|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6611092|NCT01219413|Protease Inhibitors|protease inhibitors|mesh-ancestor
6611093|NCT01219413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6611094|NCT01219413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611095|NCT01219413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6660984|NCT01496326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6660985|NCT01496326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6449816|NCT00405457|Cyclosporine|cyclosporine|mesh-list
6449817|NCT00405457|Cyclosporins|cyclosporins|mesh-list
6449818|NCT00405457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6449819|NCT00405457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6449820|NCT00405457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6660986|NCT01496326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660987|NCT01496417|Abatacept|abatacept|mesh-list
6660988|NCT01496417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6660989|NCT01496417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6660990|NCT01496417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6660991|NCT01496417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6660992|NCT01496417|Immunologic Factors|immunologic factors|mesh-ancestor
6660993|NCT01496417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660994|NCT01496417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6660995|NCT01496443|Glimepiride|glimepiride|mesh-list
6660996|NCT01496443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6660997|NCT01496443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6660998|NCT01496443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6660999|NCT01496443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6661000|NCT01496443|Immunologic Factors|immunologic factors|mesh-ancestor
6661001|NCT01496521|Aspirin|aspirin|mesh-list
6661002|NCT01496521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6661003|NCT01496521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6661004|NCT01496521|Analgesics|analgesics|mesh-ancestor
6661005|NCT01496521|Sensory System Agents|sensory system agents|mesh-ancestor
6661006|NCT01496521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6661007|NCT01496521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661008|NCT01496521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6661009|NCT01496521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6661010|NCT01496521|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6661011|NCT01496521|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6661012|NCT01496521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661013|NCT01496521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6661014|NCT01496521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6661015|NCT01496521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6661016|NCT01496521|Antipyretics|antipyretics|mesh-ancestor
6661017|NCT01496534|Carboplatin|carboplatin|mesh-list
6661018|NCT01496534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6661019|NCT01496677|Tedizolid phosphate|tedizolid phosphate|mesh-list
6661020|NCT01496677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6661021|NCT01496677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6661022|NCT01496690|Pregabalin|pregabalin|mesh-list
6661023|NCT01496690|Analgesics|analgesics|mesh-ancestor
6661024|NCT01496690|Sensory System Agents|sensory system agents|mesh-ancestor
6661025|NCT01496690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6661026|NCT01496690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661027|NCT01496690|Anticonvulsants|anticonvulsants|mesh-ancestor
6449821|NCT00405457|Immunologic Factors|immunologic factors|mesh-ancestor
6449822|NCT00405457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449823|NCT00405457|Antifungal Agents|antifungal agents|mesh-ancestor
6449824|NCT00405457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6449825|NCT00405457|Dermatologic Agents|dermatologic agents|mesh-ancestor
6449826|NCT00405457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6449827|NCT00405457|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6449828|NCT00405496|Difluprednate|difluprednate|mesh-list
6611096|NCT01219556|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6611097|NCT01219556|Olmesartan|olmesartan|mesh-list
6611098|NCT01219556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6611099|NCT01219556|Diuretics|diuretics|mesh-ancestor
6611100|NCT01219556|Natriuretic Agents|natriuretic agents|mesh-ancestor
6611101|NCT01219556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611102|NCT01219556|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6611103|NCT01219556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6449829|NCT00405496|Glucocorticoids|glucocorticoids|mesh-ancestor
6449830|NCT00405496|Hormones|hormones|mesh-ancestor
6449831|NCT00405496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6449832|NCT00405496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449833|NCT00405535|Glycine|glycine|mesh-list
6449834|NCT00405535|Glycine Agents|glycine agents|mesh-ancestor
6449835|NCT00405535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6611104|NCT01219556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611105|NCT01219556|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6611106|NCT01219556|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6611107|NCT01219569|Propofol|propofol|mesh-list
6611108|NCT01219569|Sevoflurane|sevoflurane|mesh-list
6611109|NCT01219569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6611110|NCT01219569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6611111|NCT01219569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611112|NCT01219569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6611113|NCT01219569|Anesthetics, General|anesthetics, general|mesh-ancestor
6611114|NCT01219569|Anesthetics|anesthetics|mesh-ancestor
6611115|NCT01219569|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6611116|NCT01219569|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6611117|NCT01219582|Metformin|metformin|mesh-list
6611118|NCT01219582|Acarbose|acarbose|mesh-list
6611119|NCT01219582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6611120|NCT01219582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611121|NCT01219582|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6611122|NCT01219582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6611123|NCT01219582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611124|NCT01219686|Pindolol|pindolol|mesh-list
6611125|NCT01219686|Dexetimide|dexetimide|mesh-list
6611126|NCT01219686|Citalopram|citalopram|mesh-list
6611127|NCT01219686|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6611128|NCT01219686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6611129|NCT01219686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6611130|NCT01219686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611131|NCT01219686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6611132|NCT01219686|Serotonin Agents|serotonin agents|mesh-ancestor
6611133|NCT01219686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611134|NCT01219686|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6611135|NCT01219686|Antidepressive Agents|antidepressive agents|mesh-ancestor
6611136|NCT01219686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6611137|NCT01219686|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6611138|NCT01219686|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6611139|NCT01219686|Parasympatholytics|parasympatholytics|mesh-ancestor
6611140|NCT01219686|Autonomic Agents|autonomic agents|mesh-ancestor
6611141|NCT01219686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6611142|NCT01219686|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6611143|NCT01219686|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6611144|NCT01219686|Cholinergic Agents|cholinergic agents|mesh-ancestor
6611145|NCT01219686|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6611146|NCT01219686|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6611147|NCT01219686|Adrenergic Agents|adrenergic agents|mesh-ancestor
6611148|NCT01219686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6611149|NCT01219686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6611150|NCT01219686|Vasodilator Agents|vasodilator agents|mesh-ancestor
6449836|NCT00405535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6449837|NCT00405535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449838|NCT00405574|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
6449839|NCT00405574|Chelating Agents|chelating agents|mesh-ancestor
6449840|NCT00405574|Sequestering Agents|sequestering agents|mesh-ancestor
6449841|NCT00405574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6449842|NCT00405574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6449843|NCT00405574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6611151|NCT01219699|Fulvestrant|fulvestrant|mesh-list
6449844|NCT00405574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6611152|NCT01219699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6611153|NCT01219699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6611154|NCT01219699|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6611155|NCT01219699|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6611156|NCT01219699|Hormone Antagonists|hormone antagonists|mesh-ancestor
6611157|NCT01219699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6611158|NCT01219699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611159|NCT01219712|Simendan|simendan|mesh-list
6611160|NCT01219712|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6611161|NCT01219712|Vasodilator Agents|vasodilator agents|mesh-ancestor
6611162|NCT01219712|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6611163|NCT01219712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6611164|NCT01219712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6611165|NCT01219712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611166|NCT01219712|Protective Agents|protective agents|mesh-ancestor
6611167|NCT01219712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611168|NCT01219751|Sunitinib|sunitinib|mesh-list
6611169|NCT01219751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6611170|NCT01219751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6611171|NCT01219751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6611172|NCT01219751|Growth Substances|growth substances|mesh-ancestor
6449845|NCT00405574|Growth Substances|growth substances|mesh-ancestor
6449846|NCT00405574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449847|NCT00405574|Growth Inhibitors|growth inhibitors|mesh-ancestor
6449848|NCT00405574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6611173|NCT01219751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611174|NCT01219751|Growth Inhibitors|growth inhibitors|mesh-ancestor
6611175|NCT01219751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6611176|NCT01219751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6611177|NCT01219751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611178|NCT01219764|Amoxicillin|amoxicillin|mesh-list
6611179|NCT01219764|Metronidazole|metronidazole|mesh-list
6611180|NCT01219764|Clarithromycin|clarithromycin|mesh-list
6611181|NCT01219764|Rabeprazole|rabeprazole|mesh-list
6611182|NCT01219764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6611183|NCT01219764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6611184|NCT01219764|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6611185|NCT01219764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6611186|NCT01219764|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6611187|NCT01219764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6611188|NCT01219764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611189|NCT01219764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6611190|NCT01219764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6611191|NCT01219764|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6611192|NCT01219764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6611193|NCT01219764|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6611194|NCT01219816|Epratuzumab|epratuzumab|mesh-list
6611195|NCT01219816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6611196|NCT01219816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6611197|NCT01219907|Cyclophosphamide|cyclophosphamide|mesh-list
6611198|NCT01219907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6611199|NCT01219907|Immunologic Factors|immunologic factors|mesh-ancestor
6611200|NCT01219907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449849|NCT00405613|Aspirin|aspirin|mesh-list
6449850|NCT00405613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6449851|NCT00405613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6449852|NCT00405613|Analgesics|analgesics|mesh-ancestor
6449853|NCT00405613|Sensory System Agents|sensory system agents|mesh-ancestor
6449854|NCT00405613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6611201|NCT01219907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6611202|NCT01219907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6611203|NCT01219907|Alkylating Agents|alkylating agents|mesh-ancestor
6611204|NCT01219907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611205|NCT01219907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6611206|NCT01219907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6611207|NCT01219920|Leucovorin|leucovorin|mesh-list
6611208|NCT01219920|Irinotecan|irinotecan|mesh-list
6611209|NCT01219920|Antidotes|antidotes|mesh-ancestor
6611210|NCT01219920|Protective Agents|protective agents|mesh-ancestor
6611211|NCT01219920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611212|NCT01219920|Vitamin B Complex|vitamin b complex|mesh-ancestor
6611213|NCT01219920|Vitamins|vitamins|mesh-ancestor
6611214|NCT01219920|Micronutrients|micronutrients|mesh-ancestor
6611215|NCT01219920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611216|NCT01219920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6611217|NCT01219920|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6611218|NCT01219920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6611219|NCT01219920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6611220|NCT01220063|Irinotecan|irinotecan|mesh-list
6611221|NCT01220063|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6611222|NCT01220063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6611223|NCT01220063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6611224|NCT01220063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611225|NCT01220063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6611226|NCT01220076|Tamoxifen|tamoxifen|mesh-list
6611227|NCT01220076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6611228|NCT01220076|Hormone Antagonists|hormone antagonists|mesh-ancestor
6611229|NCT01220076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6611230|NCT01220076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611231|NCT01220076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6611232|NCT01220076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6611233|NCT01220076|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6611234|NCT01220076|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6611235|NCT01220076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6611236|NCT01220102|Adapalene|adapalene|mesh-list
6611237|NCT01220102|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6611238|NCT01220102|Dermatologic Agents|dermatologic agents|mesh-ancestor
6611239|NCT01220102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6611240|NCT01220102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6611241|NCT01220102|Analgesics|analgesics|mesh-ancestor
6611242|NCT01220102|Sensory System Agents|sensory system agents|mesh-ancestor
6611243|NCT01220102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6611244|NCT01220102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611245|NCT01220102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6611246|NCT01220102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6611247|NCT01220154|Paclitaxel|paclitaxel|mesh-list
6611248|NCT01220154|Bevacizumab|bevacizumab|mesh-list
6611249|NCT01220154|Carboplatin|carboplatin|mesh-list
6611250|NCT01220154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6611251|NCT01220154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6611252|NCT01220154|Tubulin Modulators|tubulin modulators|mesh-ancestor
6611253|NCT01220154|Antimitotic Agents|antimitotic agents|mesh-ancestor
6611254|NCT01220154|Mitosis Modulators|mitosis modulators|mesh-ancestor
6611255|NCT01220154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611256|NCT01220154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6611257|NCT01220154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6611258|NCT01220154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6611259|NCT01220154|Growth Substances|growth substances|mesh-ancestor
6449855|NCT00405613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449856|NCT00405613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6611260|NCT01220154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611261|NCT01220154|Growth Inhibitors|growth inhibitors|mesh-ancestor
6611262|NCT01220219|Pregabalin|pregabalin|mesh-list
6611263|NCT01220219|Analgesics|analgesics|mesh-ancestor
6611264|NCT01220219|Sensory System Agents|sensory system agents|mesh-ancestor
6611265|NCT01220219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6611266|NCT01220219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611267|NCT01220219|Anticonvulsants|anticonvulsants|mesh-ancestor
6611268|NCT01220219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6611269|NCT01220219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6611270|NCT01220219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611271|NCT01220219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6611272|NCT01220219|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6611273|NCT01220219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6611274|NCT01220219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6611275|NCT01220219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6611276|NCT01220232|Lamivudine|lamivudine|mesh-list
6611277|NCT01220232|Abacavir|abacavir|mesh-list
6611278|NCT01220232|Dideoxynucleosides|dideoxynucleosides|mesh-list
6611279|NCT01220232|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6611280|NCT01220232|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6611281|NCT01220232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6611282|NCT01220232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611283|NCT01220232|Antiviral Agents|antiviral agents|mesh-ancestor
6611284|NCT01220232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6611285|NCT01220232|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6611286|NCT01220232|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6611287|NCT01220232|Antimetabolites|antimetabolites|mesh-ancestor
6611288|NCT01220245|Heparin|heparin|mesh-list
6611289|NCT01220245|Anticoagulants|anticoagulants|mesh-ancestor
6611290|NCT01220245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6611291|NCT01220245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6611292|NCT01220245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611293|NCT01220258|Azithromycin|azithromycin|mesh-list
6611294|NCT01220258|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6611295|NCT01220258|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6611296|NCT01220258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6611297|NCT01220258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6611298|NCT01220284|Vinorelbine|vinorelbine|mesh-list
6449857|NCT00405613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6449858|NCT00405613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6449859|NCT00405613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6449860|NCT00405613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6449861|NCT00405613|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6449862|NCT00405613|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6449863|NCT00405613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6611299|NCT01220284|Satraplatin|satraplatin|mesh-list
6611300|NCT01220284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6611301|NCT01220284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6611302|NCT01220284|Tubulin Modulators|tubulin modulators|mesh-ancestor
6611303|NCT01220284|Antimitotic Agents|antimitotic agents|mesh-ancestor
6611304|NCT01220284|Mitosis Modulators|mitosis modulators|mesh-ancestor
6611305|NCT01220284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611306|NCT01220362|Fentanyl|fentanyl|mesh-list
6611307|NCT01220362|Bupivacaine|bupivacaine|mesh-list
6611308|NCT01220362|Anesthetics, Local|anesthetics, local|mesh-ancestor
6611309|NCT01220362|Anesthetics|anesthetics|mesh-ancestor
6611310|NCT01220362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6611311|NCT01220362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611312|NCT01220362|Sensory System Agents|sensory system agents|mesh-ancestor
6611313|NCT01220362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6611314|NCT01220362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6611315|NCT01220362|Narcotics|narcotics|mesh-ancestor
6611316|NCT01220362|Analgesics|analgesics|mesh-ancestor
6611317|NCT01220362|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6611318|NCT01220362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6611319|NCT01220362|Anesthetics, General|anesthetics, general|mesh-ancestor
6611320|NCT01220375|Plerixafor|plerixafor|mesh-list
6611321|NCT01220375|Vinorelbine|vinorelbine|mesh-list
6611322|NCT01220375|Lenograstim|lenograstim|mesh-list
6611323|NCT01220375|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6611324|NCT01220375|Immunologic Factors|immunologic factors|mesh-ancestor
6611325|NCT01220375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611326|NCT01220375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6611327|NCT01220375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6611328|NCT01220375|Tubulin Modulators|tubulin modulators|mesh-ancestor
6611329|NCT01220375|Antimitotic Agents|antimitotic agents|mesh-ancestor
6611330|NCT01220375|Mitosis Modulators|mitosis modulators|mesh-ancestor
6611331|NCT01220375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611332|NCT01220375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6611333|NCT01220375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6611334|NCT01220375|Antiviral Agents|antiviral agents|mesh-ancestor
6611335|NCT01220375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6611336|NCT01220440|Methylphenidate|methylphenidate|mesh-list
6611337|NCT01220440|Dextroamphetamine|dextroamphetamine|mesh-list
6611338|NCT01220440|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6611339|NCT01220440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611340|NCT01220440|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6611341|NCT01220440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6611342|NCT01220440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6611343|NCT01220440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611344|NCT01220440|Dopamine Agents|dopamine agents|mesh-ancestor
6611345|NCT01220440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6611346|NCT01220518|Infliximab|infliximab|mesh-list
6611347|NCT01220518|Dermatologic Agents|dermatologic agents|mesh-ancestor
6611348|NCT01220518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6611349|NCT01220518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6611350|NCT01220531|Cyclosporine|cyclosporine|mesh-list
6611351|NCT01220531|Mycophenolic Acid|mycophenolic acid|mesh-list
6611352|NCT01220531|Methylprednisolone|methylprednisolone|mesh-list
6611353|NCT01220531|Prednisolone|prednisolone|mesh-list
6611354|NCT01220531|Tacrolimus|tacrolimus|mesh-list
6611355|NCT01220531|Cyclosporins|cyclosporins|mesh-list
6611356|NCT01220531|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6611357|NCT01220531|Thymoglobulin|thymoglobulin|mesh-list
6611358|NCT01220531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6611359|NCT01220531|Immunologic Factors|immunologic factors|mesh-ancestor
6611360|NCT01220531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611361|NCT01220531|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6611362|NCT01220531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6611363|NCT01220531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611364|NCT01220531|Antifungal Agents|antifungal agents|mesh-ancestor
6611365|NCT01220531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6611366|NCT01220531|Dermatologic Agents|dermatologic agents|mesh-ancestor
6611367|NCT01220531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6611368|NCT01220531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6611369|NCT01220531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6611370|NCT01220531|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6611371|NCT01220531|Antitubercular Agents|antitubercular agents|mesh-ancestor
6611372|NCT01220531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6611373|NCT01220531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6611374|NCT01220531|Antiemetics|antiemetics|mesh-ancestor
6611375|NCT01220531|Autonomic Agents|autonomic agents|mesh-ancestor
6611376|NCT01220531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6611377|NCT01220531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6020712|NCT00394082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6611378|NCT01220531|Glucocorticoids|glucocorticoids|mesh-ancestor
6611379|NCT01220531|Hormones|hormones|mesh-ancestor
6611380|NCT01220531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6611381|NCT01220531|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6611382|NCT01220531|Protective Agents|protective agents|mesh-ancestor
6611383|NCT01220531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6611384|NCT01220570|Sirolimus|sirolimus|mesh-list
6611385|NCT01220570|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6611386|NCT01220570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6611387|NCT01220570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6611388|NCT01220570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6611389|NCT01220570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6611390|NCT01220570|Antifungal Agents|antifungal agents|mesh-ancestor
6611391|NCT01220570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6611392|NCT01220570|Immunologic Factors|immunologic factors|mesh-ancestor
6611393|NCT01220570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611394|NCT01220583|Cisplatin|cisplatin|mesh-list
6611395|NCT01220583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6611396|NCT01220596|Interferons|interferons|mesh-list
6611397|NCT01220596|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6611398|NCT01220596|Interferon-alpha|interferon-alpha|mesh-list
6611399|NCT01220596|Entecavir|entecavir|mesh-list
6611400|NCT01220596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6611401|NCT01220596|Antiviral Agents|antiviral agents|mesh-ancestor
6611402|NCT01220596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6611403|NCT01220596|Immunologic Factors|immunologic factors|mesh-ancestor
6611404|NCT01220596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611405|NCT01220622|Nimodipine|nimodipine|mesh-list
6611406|NCT01220622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6611407|NCT01220622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6611408|NCT01220622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6611409|NCT01220622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611410|NCT01220622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6611411|NCT01220622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611412|NCT01220622|Vasodilator Agents|vasodilator agents|mesh-ancestor
6611413|NCT01220648|Interferons|interferons|mesh-list
6611414|NCT01220648|Interferon-alpha|interferon-alpha|mesh-list
6611415|NCT01220648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6611416|NCT01220648|Antiviral Agents|antiviral agents|mesh-ancestor
6611417|NCT01220648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6611418|NCT01220648|Immunologic Factors|immunologic factors|mesh-ancestor
6611419|NCT01220648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611420|NCT01220661|Cefotetan|cefotetan|mesh-list
6611421|NCT01220661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6611422|NCT01220661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6611423|NCT01220791|Progesterone|progesterone|mesh-list
6611424|NCT01220791|Progestins|progestins|mesh-ancestor
6611425|NCT01220791|Hormones|hormones|mesh-ancestor
6611426|NCT01220791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6611427|NCT01220791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611428|NCT01220843|Sevelamer|sevelamer|mesh-list
6611429|NCT01220843|Chelating Agents|chelating agents|mesh-ancestor
6611430|NCT01220843|Sequestering Agents|sequestering agents|mesh-ancestor
6611431|NCT01220843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611432|NCT01221025|Parecoxib|parecoxib|mesh-list
6611433|NCT01221025|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6611434|NCT01221025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6611435|NCT01221025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6611436|NCT01221025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611437|NCT01221025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6611438|NCT01221025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6611439|NCT01221025|Analgesics|analgesics|mesh-ancestor
6611440|NCT01221025|Sensory System Agents|sensory system agents|mesh-ancestor
6611441|NCT01221025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6611442|NCT01221025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611443|NCT01221025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6611444|NCT01221025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6611445|NCT01221103|Dexamethasone|dexamethasone|mesh-list
6611446|NCT01221103|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6611447|NCT01221103|Ofatumumab|ofatumumab|mesh-list
6611448|NCT01221103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6611449|NCT01221103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6611450|NCT01221103|Antiemetics|antiemetics|mesh-ancestor
6611451|NCT01221103|Autonomic Agents|autonomic agents|mesh-ancestor
6611452|NCT01221103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6611453|NCT01221103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611454|NCT01221103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6611455|NCT01221103|Glucocorticoids|glucocorticoids|mesh-ancestor
6611456|NCT01221103|Hormones|hormones|mesh-ancestor
6611457|NCT01221103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6611458|NCT01221103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6611459|NCT01221103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6611460|NCT01221103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6611461|NCT01221103|Alkylating Agents|alkylating agents|mesh-ancestor
6611462|NCT01221103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611463|NCT01221103|Immunologic Factors|immunologic factors|mesh-ancestor
6611464|NCT01221116|Simendan|simendan|mesh-list
6611465|NCT01221116|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6611466|NCT01221116|Vasodilator Agents|vasodilator agents|mesh-ancestor
6611467|NCT01221116|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6611468|NCT01221116|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6611469|NCT01221116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6611470|NCT01221116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611471|NCT01221116|Protective Agents|protective agents|mesh-ancestor
6611472|NCT01221116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661028|NCT01496690|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6661029|NCT01496690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6661030|NCT01496690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661031|NCT01496690|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6661032|NCT01496690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6661033|NCT01496690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6661034|NCT01496690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6661035|NCT01496690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6661036|NCT01496742|Paclitaxel|paclitaxel|mesh-list
6661037|NCT01496742|Bevacizumab|bevacizumab|mesh-list
6661038|NCT01496742|Carboplatin|carboplatin|mesh-list
6661039|NCT01496742|Pemetrexed|pemetrexed|mesh-list
6661040|NCT01496742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6661041|NCT01496742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6661042|NCT01496742|Tubulin Modulators|tubulin modulators|mesh-ancestor
6661043|NCT01496742|Antimitotic Agents|antimitotic agents|mesh-ancestor
6661044|NCT01496742|Mitosis Modulators|mitosis modulators|mesh-ancestor
6661045|NCT01496742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661046|NCT01496742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6661047|NCT01496742|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6611473|NCT01221129|Zinc|zinc|mesh-list
6611474|NCT01221129|Trace Elements|trace elements|mesh-ancestor
6611475|NCT01221129|Micronutrients|micronutrients|mesh-ancestor
6611476|NCT01221129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611477|NCT01221337|Heparin|heparin|mesh-list
6611478|NCT01221337|Anticoagulants|anticoagulants|mesh-ancestor
6611479|NCT01221337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6611480|NCT01221337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6611481|NCT01221337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611482|NCT01221376|Imatinib Mesylate|imatinib mesylate|mesh-list
6611483|NCT01221376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6611484|NCT01221376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6611485|NCT01221376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6611486|NCT01221376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611487|NCT01221402|Niacin|niacin|mesh-list
6611488|NCT01221402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6611489|NCT01221402|Antimetabolites|antimetabolites|mesh-ancestor
6611490|NCT01221402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611491|NCT01221402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6611492|NCT01221402|Vasodilator Agents|vasodilator agents|mesh-ancestor
6611493|NCT01221402|Vitamin B Complex|vitamin b complex|mesh-ancestor
6611494|NCT01221402|Vitamins|vitamins|mesh-ancestor
6611495|NCT01221402|Micronutrients|micronutrients|mesh-ancestor
6611496|NCT01221402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611497|NCT01221558|Lycopene|lycopene|mesh-list
6611498|NCT01221558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6611499|NCT01221558|Antioxidants|antioxidants|mesh-ancestor
6611500|NCT01221558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611501|NCT01221558|Protective Agents|protective agents|mesh-ancestor
6611502|NCT01221558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611503|NCT01221558|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6611504|NCT01221558|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6611505|NCT01221558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6611506|NCT01221636|Abatacept|abatacept|mesh-list
6611507|NCT01221636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6611508|NCT01221636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611509|NCT01221636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6611510|NCT01221636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6611511|NCT01221636|Immunologic Factors|immunologic factors|mesh-ancestor
6611512|NCT01221636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611513|NCT01221636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6611514|NCT01221675|Antibodies|antibodies|mesh-list
6611515|NCT01221675|Immunologic Factors|immunologic factors|mesh-ancestor
6611516|NCT01221675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611517|NCT01221740|Milnacipran|milnacipran|mesh-list
6611518|NCT01221740|Levomilnacipran|levomilnacipran|mesh-list
6611519|NCT01221740|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6611520|NCT01221740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6611521|NCT01221740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6611522|NCT01221740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611523|NCT01221740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6611524|NCT01221740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611525|NCT01221740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6611526|NCT01221740|Analgesics|analgesics|mesh-ancestor
6611527|NCT01221740|Sensory System Agents|sensory system agents|mesh-ancestor
6611528|NCT01221740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6611529|NCT01221740|Antidepressive Agents|antidepressive agents|mesh-ancestor
6611530|NCT01221740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6611531|NCT01221792|Carvedilol|carvedilol|mesh-list
6611532|NCT01221792|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6611533|NCT01221792|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6611534|NCT01221792|Adrenergic Agents|adrenergic agents|mesh-ancestor
6611535|NCT01221792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6611536|NCT01221792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611537|NCT01221792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611538|NCT01221792|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6611539|NCT01221792|Antioxidants|antioxidants|mesh-ancestor
6611540|NCT01221792|Protective Agents|protective agents|mesh-ancestor
6611541|NCT01221792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6611542|NCT01221792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6611543|NCT01221792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6611544|NCT01221792|Vasodilator Agents|vasodilator agents|mesh-ancestor
6611545|NCT01221792|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6611546|NCT01221792|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6611547|NCT01221831|Dienogest|dienogest|mesh-list
6611548|NCT01221831|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6611549|NCT01221831|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6611550|NCT01221831|Estradiol|estradiol|mesh-list
6611551|NCT01221831|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6611552|NCT01221831|Estrogens|estrogens|mesh-ancestor
6611553|NCT01221831|Hormones|hormones|mesh-ancestor
6611554|NCT01221831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6611555|NCT01221831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611556|NCT01221831|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6611557|NCT01221831|Contraceptive Agents|contraceptive agents|mesh-ancestor
6449864|NCT00405613|Antipyretics|antipyretics|mesh-ancestor
6449865|NCT00405717|Atorvastatin|atorvastatin|mesh-list
6449866|NCT00405717|Pravastatin|pravastatin|mesh-list
6449867|NCT00405717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6449868|NCT00405717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6449869|NCT00405717|Antimetabolites|antimetabolites|mesh-ancestor
5724856|NCT03184805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6449870|NCT00405717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611558|NCT01221831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6611559|NCT01221831|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6611560|NCT01221831|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6611561|NCT01221831|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6611562|NCT01221831|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6611563|NCT01221831|Hormone Antagonists|hormone antagonists|mesh-ancestor
5724857|NCT03184805|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5724858|NCT03184805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5724859|NCT03184805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5724860|NCT03184805|Antipyretics|antipyretics|mesh-ancestor
6449871|NCT00405717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6611564|NCT01221831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6611565|NCT01221831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6611566|NCT01221883|Diazepam|diazepam|mesh-list
6611567|NCT01221883|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6611568|NCT01221883|Anticonvulsants|anticonvulsants|mesh-ancestor
6611569|NCT01221883|Antiemetics|antiemetics|mesh-ancestor
6611570|NCT01221883|Autonomic Agents|autonomic agents|mesh-ancestor
6611571|NCT01221883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6611572|NCT01221883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611573|NCT01221883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6611574|NCT01221883|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6611575|NCT01221883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6611576|NCT01221883|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6611577|NCT01221883|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6611578|NCT01221883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6611579|NCT01221883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6611580|NCT01221883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6611581|NCT01221883|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6611582|NCT01221883|Anesthetics, General|anesthetics, general|mesh-ancestor
6611583|NCT01221883|Anesthetics|anesthetics|mesh-ancestor
6611584|NCT01221883|GABA Modulators|gaba modulators|mesh-ancestor
6611585|NCT01221883|GABA Agents|gaba agents|mesh-ancestor
6611586|NCT01221883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6611587|NCT01221883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611588|NCT01221896|Choline|choline|mesh-list
6611589|NCT01221896|Lipotropic Agents|lipotropic agents|mesh-ancestor
6611590|NCT01221896|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6611591|NCT01221896|Antimetabolites|antimetabolites|mesh-ancestor
6611592|NCT01221896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611593|NCT01221896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6611594|NCT01221896|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6611595|NCT01221896|Nootropic Agents|nootropic agents|mesh-ancestor
6611596|NCT01221909|Tranexamic Acid|tranexamic acid|mesh-list
6611597|NCT01221909|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6611598|NCT01221909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6611599|NCT01221909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611600|NCT01221909|Hemostatics|hemostatics|mesh-ancestor
6611601|NCT01221909|Coagulants|coagulants|mesh-ancestor
6611602|NCT01221935|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6611603|NCT01221935|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
6611604|NCT01221935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6611605|NCT01221935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6611606|NCT01221935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611607|NCT01221935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6611608|NCT01221935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611609|NCT01221935|Antidepressive Agents|antidepressive agents|mesh-ancestor
6611610|NCT01221935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6611611|NCT01222013|Imatinib Mesylate|imatinib mesylate|mesh-list
6611612|NCT01222013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6611613|NCT01222013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6611614|NCT01222013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6611615|NCT01222013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611616|NCT01222026|Vitamin D|vitamin d|mesh-list
6611617|NCT01222026|Strontium ranelate|strontium ranelate|mesh-list
6611618|NCT01222026|Vitamins|vitamins|mesh-ancestor
6611619|NCT01222026|Micronutrients|micronutrients|mesh-ancestor
6611620|NCT01222026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611621|NCT01222026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6611622|NCT01222052|Cyclophosphamide|cyclophosphamide|mesh-list
6611623|NCT01222052|Docetaxel|docetaxel|mesh-list
6611624|NCT01222052|Fluorouracil|fluorouracil|mesh-list
6611625|NCT01222052|Epirubicin|epirubicin|mesh-list
6611626|NCT01222052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6611627|NCT01222052|Immunologic Factors|immunologic factors|mesh-ancestor
6611628|NCT01222052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611629|NCT01222052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6611630|NCT01222052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6611631|NCT01222052|Alkylating Agents|alkylating agents|mesh-ancestor
6611632|NCT01222052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611633|NCT01222052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6611634|NCT01222052|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6611635|NCT01222052|Tubulin Modulators|tubulin modulators|mesh-ancestor
6611636|NCT01222052|Antimitotic Agents|antimitotic agents|mesh-ancestor
6611637|NCT01222052|Mitosis Modulators|mitosis modulators|mesh-ancestor
6611638|NCT01222052|Antimetabolites|antimetabolites|mesh-ancestor
6611639|NCT01222052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6611640|NCT01222052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6611641|NCT01222052|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6611642|NCT01222052|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6611643|NCT01222052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6611644|NCT01222169|Propofol|propofol|mesh-list
6611645|NCT01222169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6611646|NCT01222169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6611647|NCT01222169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611648|NCT01222169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6611649|NCT01222169|Anesthetics, General|anesthetics, general|mesh-ancestor
6611650|NCT01222169|Anesthetics|anesthetics|mesh-ancestor
6611651|NCT01222182|Atorvastatin|atorvastatin|mesh-list
6611652|NCT01222182|Simvastatin|simvastatin|mesh-list
5501961|NCT04469777|Hematinics|hematinics|mesh-ancestor
6611653|NCT01222182|Pravastatin|pravastatin|mesh-list
6611654|NCT01222182|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6611655|NCT01222182|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6611656|NCT01222182|Antimetabolites|antimetabolites|mesh-ancestor
6611657|NCT01222182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611658|NCT01222182|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6611659|NCT01222182|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6611660|NCT01222182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6611661|NCT01222221|Temozolomide|temozolomide|mesh-list
6611662|NCT01222221|Sargramostim|sargramostim|mesh-list
6611663|NCT01222221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6611664|NCT01222221|Alkylating Agents|alkylating agents|mesh-ancestor
6611665|NCT01222221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611666|NCT01222221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6611667|NCT01222221|Immunologic Factors|immunologic factors|mesh-ancestor
6611668|NCT01222221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611669|NCT01222312|Docetaxel|docetaxel|mesh-list
6611670|NCT01222312|Oxaliplatin|oxaliplatin|mesh-list
6611671|NCT01222312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6611672|NCT01222312|Tubulin Modulators|tubulin modulators|mesh-ancestor
6611673|NCT01222312|Antimitotic Agents|antimitotic agents|mesh-ancestor
6611674|NCT01222312|Mitosis Modulators|mitosis modulators|mesh-ancestor
6611675|NCT01222312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611676|NCT01222442|Moxifloxacin|moxifloxacin|mesh-list
6611677|NCT01222442|AZD-3199|azd-3199|mesh-list
6611678|NCT01222442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6611679|NCT01222442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6611680|NCT01222442|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6611681|NCT01222442|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6611682|NCT01222442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6611683|NCT01222442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611684|NCT01222442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6611685|NCT01222442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611686|NCT01222442|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6611687|NCT01222442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6611688|NCT01222442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6611689|NCT01222442|Adrenergic Agents|adrenergic agents|mesh-ancestor
6611690|NCT01222442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6611691|NCT01222468|Nabilone|nabilone|mesh-list
6611692|NCT01222468|Antiemetics|antiemetics|mesh-ancestor
6611693|NCT01222468|Autonomic Agents|autonomic agents|mesh-ancestor
6611694|NCT01222468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6611695|NCT01222468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611696|NCT01222468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6611697|NCT01222468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6611698|NCT01222468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6611699|NCT01222468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6611700|NCT01222468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6611701|NCT01222611|Fosamprenavir|fosamprenavir|mesh-list
6611702|NCT01222611|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6611703|NCT01222611|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6611704|NCT01222611|Protease Inhibitors|protease inhibitors|mesh-ancestor
6611705|NCT01222611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6611706|NCT01222611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611707|NCT01222611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6611708|NCT01222611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6611709|NCT01222611|Antiviral Agents|antiviral agents|mesh-ancestor
6611710|NCT01222611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6611711|NCT01222650|Silodosin|silodosin|mesh-list
6611712|NCT01222650|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6611713|NCT01222650|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6611714|NCT01222650|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6611715|NCT01222650|Adrenergic Agents|adrenergic agents|mesh-ancestor
6611716|NCT01222650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6611717|NCT01222650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611718|NCT01222650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611719|NCT01222650|Urological Agents|urological agents|mesh-ancestor
6611720|NCT01222676|Gemcitabine|gemcitabine|mesh-list
6611721|NCT01222676|Sorafenib|sorafenib|mesh-list
6611722|NCT01222676|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6611723|NCT01222676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6611724|NCT01222676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6611725|NCT01222676|Antimetabolites|antimetabolites|mesh-ancestor
5501962|NCT04469686|Hydrocortisone|hydrocortisone|mesh-list
6611726|NCT01222676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611727|NCT01222676|Antiviral Agents|antiviral agents|mesh-ancestor
6611728|NCT01222676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6611729|NCT01222676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6611730|NCT01222676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6611731|NCT01222676|Immunologic Factors|immunologic factors|mesh-ancestor
6611732|NCT01222676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611733|NCT01222676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6611734|NCT01222676|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6611735|NCT01222780|Vincristine|vincristine|mesh-list
6611736|NCT01222780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6611737|NCT01222780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6611738|NCT01222780|Tubulin Modulators|tubulin modulators|mesh-ancestor
6611739|NCT01222780|Antimitotic Agents|antimitotic agents|mesh-ancestor
6611740|NCT01222780|Mitosis Modulators|mitosis modulators|mesh-ancestor
6611741|NCT01222780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611742|NCT01222819|Lenograstim|lenograstim|mesh-list
6611743|NCT01222819|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6611744|NCT01222819|Immunologic Factors|immunologic factors|mesh-ancestor
6611745|NCT01222819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611746|NCT01222897|Valacyclovir|valacyclovir|mesh-list
6611747|NCT01222897|Antiviral Agents|antiviral agents|mesh-ancestor
6611748|NCT01222897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6611749|NCT01222910|Valacyclovir|valacyclovir|mesh-list
6611750|NCT01222910|Antiviral Agents|antiviral agents|mesh-ancestor
6611751|NCT01222910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6611752|NCT01222923|Risperidone|risperidone|mesh-list
6611753|NCT01222923|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6611754|NCT01222923|Serotonin Agents|serotonin agents|mesh-ancestor
6611755|NCT01222923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6611756|NCT01222923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611757|NCT01222923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611758|NCT01222923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6611759|NCT01222923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6611760|NCT01222923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6611761|NCT01222923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6611762|NCT01222923|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6611763|NCT01222923|Dopamine Agents|dopamine agents|mesh-ancestor
6611764|NCT01222936|Panobinostat|panobinostat|mesh-list
6611765|NCT01222936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6611766|NCT01222936|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6611767|NCT01222936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6611768|NCT01222936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611769|NCT01222975|Risperidone|risperidone|mesh-list
6611770|NCT01222975|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6611771|NCT01222975|Serotonin Agents|serotonin agents|mesh-ancestor
6611772|NCT01222975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6611773|NCT01222975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611774|NCT01222975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611775|NCT01222975|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6611776|NCT01222975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6611777|NCT01222975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6611778|NCT01222975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6611779|NCT01222975|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6611780|NCT01222975|Dopamine Agents|dopamine agents|mesh-ancestor
6611781|NCT01223040|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6611782|NCT01223040|Lubricant Eye Drops|lubricant eye drops|mesh-list
6611783|NCT01223040|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6611784|NCT01223053|Ketoprofen|ketoprofen|mesh-list
6611785|NCT01223053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6611786|NCT01223053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6611787|NCT01223053|Analgesics|analgesics|mesh-ancestor
6611788|NCT01223053|Sensory System Agents|sensory system agents|mesh-ancestor
6611789|NCT01223053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6611790|NCT01223053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611791|NCT01223053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6611792|NCT01223053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6611793|NCT01223053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6611794|NCT01223053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6611795|NCT01223053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611796|NCT01223131|Insulin|insulin|mesh-list
6611797|NCT01223131|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6611798|NCT01223131|Insulin Glargine|insulin glargine|mesh-list
6611799|NCT01223131|Insulin, Isophane|insulin, isophane|mesh-list
6611800|NCT01223131|Isophane Insulin, Human|isophane insulin, human|mesh-list
6611801|NCT01223131|Isophane insulin, beef|isophane insulin, beef|mesh-list
6611802|NCT01223131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6611803|NCT01223131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611804|NCT01223326|Acetylcysteine|acetylcysteine|mesh-list
6611805|NCT01223326|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6611806|NCT01223326|Antiviral Agents|antiviral agents|mesh-ancestor
6611807|NCT01223326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6611808|NCT01223326|Expectorants|expectorants|mesh-ancestor
6611809|NCT01223326|Respiratory System Agents|respiratory system agents|mesh-ancestor
6611810|NCT01223326|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6611811|NCT01223326|Antioxidants|antioxidants|mesh-ancestor
6611812|NCT01223326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611813|NCT01223326|Protective Agents|protective agents|mesh-ancestor
6611814|NCT01223326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611815|NCT01223326|Antidotes|antidotes|mesh-ancestor
6611816|NCT01223339|Ertugliflozin|ertugliflozin|mesh-list
6611817|NCT01223339|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6611818|NCT01223339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611819|NCT01223339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6611820|NCT01223339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611821|NCT01223443|Paclitaxel|paclitaxel|mesh-list
6611822|NCT01223443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6611823|NCT01223443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6611824|NCT01223443|Tubulin Modulators|tubulin modulators|mesh-ancestor
6611825|NCT01223443|Antimitotic Agents|antimitotic agents|mesh-ancestor
6611826|NCT01223443|Mitosis Modulators|mitosis modulators|mesh-ancestor
6611827|NCT01223443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611828|NCT01223534|Isoniazid|isoniazid|mesh-list
6611829|NCT01223534|Antitubercular Agents|antitubercular agents|mesh-ancestor
6611830|NCT01223534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6611831|NCT01223534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6611832|NCT01223534|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6611833|NCT01223534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6611834|NCT01223534|Antimetabolites|antimetabolites|mesh-ancestor
6611835|NCT01223534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611836|NCT01223534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6611837|NCT01223560|Insulin Aspart|insulin aspart|mesh-list
6611838|NCT01223560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6611839|NCT01223560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611840|NCT01223612|Ranibizumab|ranibizumab|mesh-list
6611841|NCT01223612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6611842|NCT01223612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6611843|NCT01223612|Growth Substances|growth substances|mesh-ancestor
6611844|NCT01223612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611845|NCT01223612|Growth Inhibitors|growth inhibitors|mesh-ancestor
6611846|NCT01223612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6611847|NCT01223625|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6611848|NCT01223625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6611849|NCT01223625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6611850|NCT01223625|Antimetabolites|antimetabolites|mesh-ancestor
6611851|NCT01223625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611852|NCT01223625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6611853|NCT01223625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6611854|NCT01223625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6611855|NCT01223690|Clarithromycin|clarithromycin|mesh-list
6611856|NCT01223690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6611857|NCT01223690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6611858|NCT01223690|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6611859|NCT01223690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6611860|NCT01223690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611861|NCT01223690|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6611862|NCT01223690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6611863|NCT01223729|Acetylcarnitine|acetylcarnitine|mesh-list
6611864|NCT01223729|Vitamin B Complex|vitamin b complex|mesh-ancestor
6611865|NCT01223729|Vitamins|vitamins|mesh-ancestor
6611866|NCT01223729|Micronutrients|micronutrients|mesh-ancestor
6611867|NCT01223729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611868|NCT01223729|Nootropic Agents|nootropic agents|mesh-ancestor
6611869|NCT01223742|Acetylcarnitine|acetylcarnitine|mesh-list
6611870|NCT01223742|Vitamin B Complex|vitamin b complex|mesh-ancestor
6611871|NCT01223742|Vitamins|vitamins|mesh-ancestor
6611872|NCT01223742|Micronutrients|micronutrients|mesh-ancestor
6611873|NCT01223742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611874|NCT01223742|Nootropic Agents|nootropic agents|mesh-ancestor
6611875|NCT01223755|Sirolimus|sirolimus|mesh-list
6611876|NCT01223755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6611877|NCT01223755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6611878|NCT01223755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6611879|NCT01223755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6611880|NCT01223755|Antifungal Agents|antifungal agents|mesh-ancestor
6611881|NCT01223755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6611882|NCT01223755|Immunologic Factors|immunologic factors|mesh-ancestor
6611883|NCT01223755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611884|NCT01223768|Acetylcarnitine|acetylcarnitine|mesh-list
6611885|NCT01223768|Vitamin B Complex|vitamin b complex|mesh-ancestor
6611886|NCT01223768|Vitamins|vitamins|mesh-ancestor
6611887|NCT01223768|Micronutrients|micronutrients|mesh-ancestor
6611888|NCT01223768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611889|NCT01223768|Nootropic Agents|nootropic agents|mesh-ancestor
6611890|NCT01223820|Capsaicin|capsaicin|mesh-list
6611891|NCT01223820|Antipruritics|antipruritics|mesh-ancestor
6611892|NCT01223820|Dermatologic Agents|dermatologic agents|mesh-ancestor
6611893|NCT01223820|Sensory System Agents|sensory system agents|mesh-ancestor
6611894|NCT01223820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6611895|NCT01223820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611896|NCT01224028|Tacrolimus|tacrolimus|mesh-list
6611897|NCT01224028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6611898|NCT01224028|Immunologic Factors|immunologic factors|mesh-ancestor
6611899|NCT01224028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611900|NCT01224028|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6611901|NCT01224028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6611902|NCT01224028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611903|NCT01224041|Tacrolimus|tacrolimus|mesh-list
6611904|NCT01224041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6611905|NCT01224041|Immunologic Factors|immunologic factors|mesh-ancestor
6611906|NCT01224041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611907|NCT01224041|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6611908|NCT01224041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6611909|NCT01224041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611910|NCT01224067|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6611911|NCT01224067|Antidepressive Agents|antidepressive agents|mesh-ancestor
6611912|NCT01224067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6611913|NCT01224067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6611914|NCT01224067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6611915|NCT01224067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6611916|NCT01224067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611917|NCT01224093|Rituximab|rituximab|mesh-list
6611918|NCT01224093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6611919|NCT01224093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6611920|NCT01224093|Immunologic Factors|immunologic factors|mesh-ancestor
6611921|NCT01224093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611922|NCT01224093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6611923|NCT01224197|Simeprevir|simeprevir|mesh-list
6611924|NCT01224197|Antiviral Agents|antiviral agents|mesh-ancestor
6611925|NCT01224197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6611926|NCT01224197|Protease Inhibitors|protease inhibitors|mesh-ancestor
6611927|NCT01224197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6611928|NCT01224197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611929|NCT01224301|Vaccines|vaccines|mesh-list
6611930|NCT01224301|Immunologic Factors|immunologic factors|mesh-ancestor
6611931|NCT01224301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611932|NCT01224314|Dialysis Solutions|dialysis solutions|mesh-list
6611933|NCT01224314|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6611934|NCT01224353|Thioctic Acid|thioctic acid|mesh-list
6611935|NCT01224353|Antioxidants|antioxidants|mesh-ancestor
6611936|NCT01224353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611937|NCT01224353|Protective Agents|protective agents|mesh-ancestor
6611938|NCT01224353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611939|NCT01224353|Vitamin B Complex|vitamin b complex|mesh-ancestor
6611940|NCT01224353|Vitamins|vitamins|mesh-ancestor
6611941|NCT01224353|Micronutrients|micronutrients|mesh-ancestor
6611942|NCT01224366|Vildagliptin|vildagliptin|mesh-list
6611943|NCT01224366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6611944|NCT01224366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611945|NCT01224366|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6611946|NCT01224366|Protease Inhibitors|protease inhibitors|mesh-ancestor
6611947|NCT01224366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6611948|NCT01224366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611949|NCT01224392|Capecitabine|capecitabine|mesh-list
6611950|NCT01224392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6611951|NCT01224392|Antimetabolites|antimetabolites|mesh-ancestor
6611952|NCT01224392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611953|NCT01224392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6611954|NCT01224405|Docetaxel|docetaxel|mesh-list
6611955|NCT01224405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6611956|NCT01224405|Tubulin Modulators|tubulin modulators|mesh-ancestor
6611957|NCT01224405|Antimitotic Agents|antimitotic agents|mesh-ancestor
6611958|NCT01224405|Mitosis Modulators|mitosis modulators|mesh-ancestor
6611959|NCT01224405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611960|NCT01224418|Tacrolimus|tacrolimus|mesh-list
6611961|NCT01224418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6611962|NCT01224418|Immunologic Factors|immunologic factors|mesh-ancestor
6611963|NCT01224418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611964|NCT01224418|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6611965|NCT01224418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6611966|NCT01224418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611967|NCT01224457|Phenobarbital|phenobarbital|mesh-list
6611968|NCT01224457|Anticonvulsants|anticonvulsants|mesh-ancestor
6611969|NCT01224457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6611970|NCT01224457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6611971|NCT01224457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611972|NCT01224457|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6611973|NCT01224457|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6611974|NCT01224457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6611975|NCT01224457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611976|NCT01224457|GABA Modulators|gaba modulators|mesh-ancestor
6611977|NCT01224457|GABA Agents|gaba agents|mesh-ancestor
6611978|NCT01224457|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6611979|NCT01224457|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6611980|NCT01224457|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6611981|NCT01224470|Dexmedetomidine|dexmedetomidine|mesh-list
6611982|NCT01224470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6611983|NCT01224470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6611984|NCT01224470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6611985|NCT01224470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6611986|NCT01224470|Analgesics|analgesics|mesh-ancestor
6611987|NCT01224470|Sensory System Agents|sensory system agents|mesh-ancestor
6611988|NCT01224470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6611989|NCT01224470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6611990|NCT01224470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6611991|NCT01224470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6611992|NCT01224470|Adrenergic Agents|adrenergic agents|mesh-ancestor
6611993|NCT01224470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6611994|NCT01224470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6611995|NCT01224509|Mifepristone|mifepristone|mesh-list
6611996|NCT01224509|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6611997|NCT01224509|Abortifacient Agents|abortifacient agents|mesh-ancestor
6611998|NCT01224509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6611999|NCT01224509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612000|NCT01224509|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6612001|NCT01224509|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6612002|NCT01224509|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6612003|NCT01224509|Contraceptive Agents|contraceptive agents|mesh-ancestor
6612004|NCT01224509|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6612005|NCT01224509|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6612006|NCT01224509|Hormone Antagonists|hormone antagonists|mesh-ancestor
6612007|NCT01224509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6612008|NCT01224509|Luteolytic Agents|luteolytic agents|mesh-ancestor
6612009|NCT01224509|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6612010|NCT01224509|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6612011|NCT01224535|Micronutrients|micronutrients|mesh-list
6612012|NCT01224535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612013|NCT01224613|Vaccines|vaccines|mesh-list
6612014|NCT01224613|Immunologic Factors|immunologic factors|mesh-ancestor
6612015|NCT01224613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612016|NCT01224652|Paclitaxel|paclitaxel|mesh-list
6612017|NCT01224652|Irinotecan|irinotecan|mesh-list
6612018|NCT01224652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6612019|NCT01224652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6612020|NCT01224652|Tubulin Modulators|tubulin modulators|mesh-ancestor
6612021|NCT01224652|Antimitotic Agents|antimitotic agents|mesh-ancestor
6612022|NCT01224652|Mitosis Modulators|mitosis modulators|mesh-ancestor
6612023|NCT01224652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6612024|NCT01224652|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6612025|NCT01224652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6612026|NCT01224652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6612027|NCT01224717|Teriparatide|teriparatide|mesh-list
6612028|NCT01224717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6612029|NCT01224717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612030|NCT01224717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6612031|NCT01224756|Tinoridine|tinoridine|mesh-list
6612032|NCT01224756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6612033|NCT01224756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6612034|NCT01224756|Analgesics|analgesics|mesh-ancestor
6612035|NCT01224756|Sensory System Agents|sensory system agents|mesh-ancestor
6612036|NCT01224756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6612037|NCT01224756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612038|NCT01224756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6612039|NCT01224756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6612040|NCT01224769|Rituximab|rituximab|mesh-list
6612041|NCT01224769|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6612042|NCT01224769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6612043|NCT01224769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6612044|NCT01224769|Immunologic Factors|immunologic factors|mesh-ancestor
6612045|NCT01224769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612046|NCT01224769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6612047|NCT01224769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6612048|NCT01224769|Alkylating Agents|alkylating agents|mesh-ancestor
6612049|NCT01224769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661048|NCT01496742|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6661049|NCT01496742|Growth Substances|growth substances|mesh-ancestor
6661050|NCT01496742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661051|NCT01496742|Growth Inhibitors|growth inhibitors|mesh-ancestor
6661052|NCT01496742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6661053|NCT01496742|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6661054|NCT01496742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6661055|NCT01496911|Hydroxyzine|hydroxyzine|mesh-list
6661056|NCT01496911|Levocetirizine|levocetirizine|mesh-list
6661057|NCT01496911|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6661058|NCT01496911|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6661059|NCT01496911|Histamine Antagonists|histamine antagonists|mesh-ancestor
6661060|NCT01496911|Histamine Agents|histamine agents|mesh-ancestor
6661061|NCT01496911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6661062|NCT01496911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020713|NCT00394082|Growth Substances|growth substances|mesh-ancestor
6661063|NCT01496911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661064|NCT01496911|Antipruritics|antipruritics|mesh-ancestor
6661065|NCT01496911|Dermatologic Agents|dermatologic agents|mesh-ancestor
6664931|NCT01514838|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6664932|NCT01514851|Calcium Carbonate|calcium carbonate|mesh-list
6664933|NCT01514851|Calcium|calcium|mesh-list
6664934|NCT01514851|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6664935|NCT01514851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664936|NCT01514851|Antacids|antacids|mesh-ancestor
6612050|NCT01224847|Lidocaine|lidocaine|mesh-list
6612051|NCT01224847|Cocaine|cocaine|mesh-list
6612052|NCT01224847|Tetracaine|tetracaine|mesh-list
6612053|NCT01224847|Anesthetics, Local|anesthetics, local|mesh-ancestor
6612054|NCT01224847|Anesthetics|anesthetics|mesh-ancestor
6612055|NCT01224847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6612056|NCT01224847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612057|NCT01224847|Sensory System Agents|sensory system agents|mesh-ancestor
6612058|NCT01224847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6612059|NCT01224847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6612060|NCT01224847|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6612061|NCT01224847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6612062|NCT01224847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6612063|NCT01224847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6612064|NCT01224847|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6612065|NCT01224847|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6612066|NCT01224847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6612067|NCT01224847|Dopamine Agents|dopamine agents|mesh-ancestor
6612068|NCT01224847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6612069|NCT01224860|Losartan|losartan|mesh-list
6612070|NCT01224860|Telmisartan|telmisartan|mesh-list
6612071|NCT01224860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6612072|NCT01224860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6612073|NCT01224860|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6612074|NCT01224860|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6612075|NCT01224860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6612076|NCT01224951|Beclomethasone|beclomethasone|mesh-list
6612077|NCT01224951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6612078|NCT01224951|Glucocorticoids|glucocorticoids|mesh-ancestor
6612079|NCT01224951|Hormones|hormones|mesh-ancestor
6612080|NCT01224951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6612081|NCT01224951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612082|NCT01224951|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6612083|NCT01224951|Respiratory System Agents|respiratory system agents|mesh-ancestor
6612084|NCT01224964|Montelukast|montelukast|mesh-list
6612085|NCT01224964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6612086|NCT01224964|Respiratory System Agents|respiratory system agents|mesh-ancestor
6612087|NCT01224964|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6612088|NCT01224964|Hormone Antagonists|hormone antagonists|mesh-ancestor
6612089|NCT01224964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6612090|NCT01224964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612091|NCT01224964|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6612092|NCT01224964|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6612093|NCT01224964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6612094|NCT01224977|Azithromycin|azithromycin|mesh-list
6612095|NCT01224977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6612096|NCT01224977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6612097|NCT01225081|Pioglitazone|pioglitazone|mesh-list
6612098|NCT01225081|Ipragliflozin|ipragliflozin|mesh-list
6612099|NCT01225081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6612100|NCT01225081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612101|NCT01225081|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6612102|NCT01225081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6612103|NCT01225094|Curcumin|curcumin|mesh-list
6612104|NCT01225094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6612105|NCT01225094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6612106|NCT01225094|Analgesics|analgesics|mesh-ancestor
6612107|NCT01225094|Sensory System Agents|sensory system agents|mesh-ancestor
6612108|NCT01225094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6612109|NCT01225094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612110|NCT01225094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6612111|NCT01225094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6612112|NCT01225094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6449872|NCT00405717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6449873|NCT00405717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6449874|NCT00405730|Ketorolac|ketorolac|mesh-list
6449875|NCT00405730|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6449876|NCT00405730|Nepafenac|nepafenac|mesh-list
6449877|NCT00405730|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6449878|NCT00405730|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6449879|NCT00405730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6612113|NCT01225094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6612114|NCT01225094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6612115|NCT01225198|Vitamins|vitamins|mesh-list
6612116|NCT01225198|Micronutrients|micronutrients|mesh-ancestor
6612117|NCT01225198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612118|NCT01225224|Peficitinib|peficitinib|mesh-list
6612119|NCT01225224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6612120|NCT01225224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6612121|NCT01225224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6612122|NCT01225224|Immunologic Factors|immunologic factors|mesh-ancestor
6612123|NCT01225224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612124|NCT01225237|Ramosetron|ramosetron|mesh-list
6612125|NCT01225237|Antiemetics|antiemetics|mesh-ancestor
6612126|NCT01225237|Autonomic Agents|autonomic agents|mesh-ancestor
6612127|NCT01225237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6612128|NCT01225237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612129|NCT01225237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6612130|NCT01225237|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6612131|NCT01225237|Serotonin Agents|serotonin agents|mesh-ancestor
6612132|NCT01225237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6612133|NCT01225237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6612134|NCT01225302|Paclitaxel|paclitaxel|mesh-list
6612135|NCT01225302|Carboplatin|carboplatin|mesh-list
6612136|NCT01225302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6612137|NCT01225302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6612138|NCT01225302|Tubulin Modulators|tubulin modulators|mesh-ancestor
6612139|NCT01225302|Antimitotic Agents|antimitotic agents|mesh-ancestor
6612140|NCT01225302|Mitosis Modulators|mitosis modulators|mesh-ancestor
6612141|NCT01225302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6612142|NCT01225341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6612143|NCT01225341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6612144|NCT01225341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6612145|NCT01225341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6612146|NCT01225341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612147|NCT01225341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6612148|NCT01225341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6612149|NCT01225341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6612150|NCT01225341|Cholinergic Agents|cholinergic agents|mesh-ancestor
6612151|NCT01225341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6612152|NCT01225406|Tenofovir|tenofovir|mesh-list
6612153|NCT01225406|Antiviral Agents|antiviral agents|mesh-ancestor
6612154|NCT01225406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6612155|NCT01225406|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6612156|NCT01225406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6612157|NCT01225406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6612158|NCT01225406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6612159|NCT01225406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6612160|NCT01225406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6612161|NCT01225419|Plerixafor|plerixafor|mesh-list
6612162|NCT01225419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6612163|NCT01225419|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6612164|NCT01225419|Antiviral Agents|antiviral agents|mesh-ancestor
6612165|NCT01225419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6612166|NCT01225445|Ramipril|ramipril|mesh-list
6612167|NCT01225445|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6612168|NCT01225445|Protease Inhibitors|protease inhibitors|mesh-ancestor
6612169|NCT01225445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6612170|NCT01225445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6612171|NCT01225445|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6612172|NCT01225484|Ropivacaine|ropivacaine|mesh-list
6612173|NCT01225484|Anesthetics, Local|anesthetics, local|mesh-ancestor
6612174|NCT01225484|Anesthetics|anesthetics|mesh-ancestor
6612175|NCT01225484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6612176|NCT01225484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612177|NCT01225484|Sensory System Agents|sensory system agents|mesh-ancestor
6612178|NCT01225484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6612179|NCT01225523|Paclitaxel|paclitaxel|mesh-list
6612180|NCT01225523|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6612181|NCT01225523|Cisplatin|cisplatin|mesh-list
6612182|NCT01225523|Fluorouracil|fluorouracil|mesh-list
6612183|NCT01225523|Capecitabine|capecitabine|mesh-list
6612184|NCT01225523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6612185|NCT01225523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6612186|NCT01225523|Tubulin Modulators|tubulin modulators|mesh-ancestor
6612187|NCT01225523|Antimitotic Agents|antimitotic agents|mesh-ancestor
6612188|NCT01225523|Mitosis Modulators|mitosis modulators|mesh-ancestor
6612189|NCT01225523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6612190|NCT01225523|Antimetabolites|antimetabolites|mesh-ancestor
6612191|NCT01225523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6612192|NCT01225523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6612193|NCT01225523|Immunologic Factors|immunologic factors|mesh-ancestor
6612194|NCT01225523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612195|NCT01225653|Latanoprost|latanoprost|mesh-list
6612196|NCT01225653|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6612197|NCT01225653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6612198|NCT01225705|Ritonavir|ritonavir|mesh-list
6612199|NCT01225705|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6612200|NCT01225705|Raltegravir Potassium|raltegravir potassium|mesh-list
6612201|NCT01225705|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6612202|NCT01225705|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6612203|NCT01225705|Protease Inhibitors|protease inhibitors|mesh-ancestor
6612204|NCT01225705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6612205|NCT01225705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6612206|NCT01225705|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6612207|NCT01225705|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6612208|NCT01225705|Antiviral Agents|antiviral agents|mesh-ancestor
6612209|NCT01225705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6612210|NCT01225705|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6612211|NCT01225705|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6612212|NCT01225705|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6612213|NCT01225705|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6612214|NCT01225744|Oxaliplatin|oxaliplatin|mesh-list
6612215|NCT01225744|Irinotecan|irinotecan|mesh-list
6612216|NCT01225744|Cetuximab|cetuximab|mesh-list
6612217|NCT01225744|Tegafur|tegafur|mesh-list
6612218|NCT01225744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6612219|NCT01225744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6612220|NCT01225744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6612221|NCT01225744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6612222|NCT01225744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6612223|NCT01225744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6612224|NCT01225744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6612225|NCT01225744|Antimetabolites|antimetabolites|mesh-ancestor
6612226|NCT01225874|Cytarabine|cytarabine|mesh-list
6612227|NCT01225874|Dexamethasone|dexamethasone|mesh-list
6612228|NCT01225874|Prednisone|prednisone|mesh-list
6612229|NCT01225874|Methotrexate|methotrexate|mesh-list
6612230|NCT01225874|Vincristine|vincristine|mesh-list
6612231|NCT01225874|Daunorubicin|daunorubicin|mesh-list
6612232|NCT01225874|Asparaginase|asparaginase|mesh-list
6612233|NCT01225874|Pegaspargase|pegaspargase|mesh-list
6612234|NCT01225874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6612235|NCT01225874|Antiemetics|antiemetics|mesh-ancestor
6612236|NCT01225874|Autonomic Agents|autonomic agents|mesh-ancestor
6612237|NCT01225874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6612238|NCT01225874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612239|NCT01225874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6612240|NCT01225874|Glucocorticoids|glucocorticoids|mesh-ancestor
6612241|NCT01225874|Hormones|hormones|mesh-ancestor
6612242|NCT01225874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6612243|NCT01225874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6612244|NCT01225874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6612245|NCT01225874|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6612246|NCT01225874|Abortifacient Agents|abortifacient agents|mesh-ancestor
6612247|NCT01225874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6612248|NCT01225874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6612249|NCT01225874|Antimetabolites|antimetabolites|mesh-ancestor
6612250|NCT01225874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6612251|NCT01225874|Dermatologic Agents|dermatologic agents|mesh-ancestor
6612252|NCT01225874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6612253|NCT01225874|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6612254|NCT01225874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6612255|NCT01225874|Immunologic Factors|immunologic factors|mesh-ancestor
6612256|NCT01225874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6612257|NCT01225874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6612258|NCT01225874|Antiviral Agents|antiviral agents|mesh-ancestor
6612259|NCT01225874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6612260|NCT01225874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6612261|NCT01225874|Tubulin Modulators|tubulin modulators|mesh-ancestor
6612262|NCT01225874|Antimitotic Agents|antimitotic agents|mesh-ancestor
6612263|NCT01225874|Mitosis Modulators|mitosis modulators|mesh-ancestor
6612264|NCT01225874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6612265|NCT01225874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6612266|NCT01225874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6612267|NCT01225913|Fluticasone|fluticasone|mesh-list
6612268|NCT01225913|Xhance|xhance|mesh-list
6612269|NCT01225913|Budesonide|budesonide|mesh-list
6612270|NCT01225913|Formoterol Fumarate|formoterol fumarate|mesh-list
6612271|NCT01225913|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6612272|NCT01225913|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6612273|NCT01225913|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6612274|NCT01225913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6612275|NCT01225913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6612276|NCT01225913|Autonomic Agents|autonomic agents|mesh-ancestor
6612277|NCT01225913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6612278|NCT01225913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612279|NCT01225913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6612280|NCT01225913|Respiratory System Agents|respiratory system agents|mesh-ancestor
6612281|NCT01225913|Dermatologic Agents|dermatologic agents|mesh-ancestor
6612282|NCT01225913|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6612283|NCT01225913|Glucocorticoids|glucocorticoids|mesh-ancestor
6612284|NCT01225913|Hormones|hormones|mesh-ancestor
6612285|NCT01225913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6612286|NCT01225913|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6612287|NCT01225913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6612288|NCT01225913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6612289|NCT01225913|Adrenergic Agents|adrenergic agents|mesh-ancestor
6612290|NCT01225913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6612291|NCT01225913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6612292|NCT01225913|Sympathomimetics|sympathomimetics|mesh-ancestor
6612293|NCT01226017|Oxytocin|oxytocin|mesh-list
6612294|NCT01226017|Oxytocics|oxytocics|mesh-ancestor
6612295|NCT01226017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6612296|NCT01226017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612297|NCT01226056|Everolimus|everolimus|mesh-list
6612298|NCT01226056|Sorafenib|sorafenib|mesh-list
6612299|NCT01226056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6612300|NCT01226056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6612301|NCT01226056|Immunologic Factors|immunologic factors|mesh-ancestor
6612302|NCT01226056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612303|NCT01226056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6612304|NCT01226056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6612305|NCT01226056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6612306|NCT01226069|Magnesium Sulfate|magnesium sulfate|mesh-list
6612307|NCT01226069|Glycerol|glycerol|mesh-list
6612308|NCT01226069|Analgesics|analgesics|mesh-ancestor
6612309|NCT01226069|Sensory System Agents|sensory system agents|mesh-ancestor
6612310|NCT01226069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6612311|NCT01226069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612312|NCT01226069|Anesthetics|anesthetics|mesh-ancestor
6612313|NCT01226069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6612314|NCT01226069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6612315|NCT01226069|Anticonvulsants|anticonvulsants|mesh-ancestor
6612316|NCT01226069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6612317|NCT01226069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6612318|NCT01226069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6612319|NCT01226069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6612320|NCT01226069|Tocolytic Agents|tocolytic agents|mesh-ancestor
6612321|NCT01226069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6612322|NCT01226069|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6612323|NCT01226069|Protective Agents|protective agents|mesh-ancestor
5724861|NCT03184649|Acetaminophen|acetaminophen|mesh-list
6612324|NCT01226186|Morphine|morphine|mesh-list
6612325|NCT01226186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6612326|NCT01226186|Narcotics|narcotics|mesh-ancestor
6612327|NCT01226186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6612328|NCT01226186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612329|NCT01226186|Analgesics|analgesics|mesh-ancestor
6612330|NCT01226186|Sensory System Agents|sensory system agents|mesh-ancestor
6612331|NCT01226186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6612332|NCT01226212|Sulfalene|sulfalene|mesh-list
6612333|NCT01226212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6612334|NCT01226212|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6612335|NCT01226212|Renal Agents|renal agents|mesh-ancestor
6612336|NCT01226212|Antimalarials|antimalarials|mesh-ancestor
6612337|NCT01226212|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6612338|NCT01226212|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6612339|NCT01226303|Tretinoin|tretinoin|mesh-list
6612340|NCT01226303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6612341|NCT01226303|Keratolytic Agents|keratolytic agents|mesh-ancestor
6612342|NCT01226303|Dermatologic Agents|dermatologic agents|mesh-ancestor
6612343|NCT01226355|Sirolimus|sirolimus|mesh-list
6612344|NCT01226355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6612345|NCT01226355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6612346|NCT01226355|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6612347|NCT01226355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6612348|NCT01226355|Antifungal Agents|antifungal agents|mesh-ancestor
6612349|NCT01226355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6612350|NCT01226355|Immunologic Factors|immunologic factors|mesh-ancestor
6612351|NCT01226355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612352|NCT01226446|Vitamin D|vitamin d|mesh-list
6612353|NCT01226446|Vitamins|vitamins|mesh-ancestor
6612354|NCT01226446|Micronutrients|micronutrients|mesh-ancestor
6612355|NCT01226446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612356|NCT01226446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6612357|NCT01226602|Ticagrelor|ticagrelor|mesh-list
6612358|NCT01226602|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6612359|NCT01226602|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6612360|NCT01226602|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6612361|NCT01226602|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6612362|NCT01226602|Purinergic Agents|purinergic agents|mesh-ancestor
6612363|NCT01226602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6612364|NCT01226602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6612365|NCT01226602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612366|NCT01226667|Pregabalin|pregabalin|mesh-list
6612367|NCT01226667|Analgesics|analgesics|mesh-ancestor
6612368|NCT01226667|Sensory System Agents|sensory system agents|mesh-ancestor
6612369|NCT01226667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6612370|NCT01226667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612371|NCT01226667|Anticonvulsants|anticonvulsants|mesh-ancestor
6612372|NCT01226667|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6612373|NCT01226667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6612374|NCT01226667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6612375|NCT01226667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6612376|NCT01226667|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6612377|NCT01226667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6612378|NCT01226667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6612379|NCT01226667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6661066|NCT01496989|Interleukin-12|interleukin-12|mesh-list
6661067|NCT01496989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6661068|NCT01496989|Immunologic Factors|immunologic factors|mesh-ancestor
6661069|NCT01496989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661070|NCT01496989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6661071|NCT01496989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6661072|NCT01496989|Growth Substances|growth substances|mesh-ancestor
6661073|NCT01496989|Growth Inhibitors|growth inhibitors|mesh-ancestor
6661074|NCT01496989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6661075|NCT01497002|Cytarabine|cytarabine|mesh-list
6661076|NCT01497002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6661077|NCT01497002|Antimetabolites|antimetabolites|mesh-ancestor
6661078|NCT01497002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661079|NCT01497002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6661080|NCT01497002|Antiviral Agents|antiviral agents|mesh-ancestor
6661081|NCT01497002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6612380|NCT01226680|Tofacitinib|tofacitinib|mesh-list
6612381|NCT01226680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6612382|NCT01226680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6612383|NCT01226680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6612384|NCT01226771|Ribavirin|ribavirin|mesh-list
6612385|NCT01226771|Antimetabolites|antimetabolites|mesh-ancestor
6449880|NCT00405730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6449881|NCT00405730|Analgesics|analgesics|mesh-ancestor
6449882|NCT00405730|Sensory System Agents|sensory system agents|mesh-ancestor
6449883|NCT00405730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6612386|NCT01226771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6612387|NCT01226771|Antiviral Agents|antiviral agents|mesh-ancestor
6612388|NCT01226771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6612389|NCT01226823|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
6612390|NCT01226823|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6612391|NCT01226823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6449884|NCT00405730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449885|NCT00405730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6449886|NCT00405730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6449887|NCT00405730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6612392|NCT01226849|Rituximab|rituximab|mesh-list
6612393|NCT01226849|Carboplatin|carboplatin|mesh-list
6612394|NCT01226849|Etoposide|etoposide|mesh-list
6612395|NCT01226849|Bortezomib|bortezomib|mesh-list
6612396|NCT01226849|Ifosfamide|ifosfamide|mesh-list
6612397|NCT01226849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6612398|NCT01226849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6612399|NCT01226849|Immunologic Factors|immunologic factors|mesh-ancestor
6612400|NCT01226849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612401|NCT01226849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6612402|NCT01226849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6612403|NCT01226849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6612404|NCT01226849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6612405|NCT01226849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6612406|NCT01226849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6612407|NCT01226849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6612408|NCT01226849|Alkylating Agents|alkylating agents|mesh-ancestor
6612409|NCT01226901|Niraparib|niraparib|mesh-list
6612410|NCT01226901|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6612411|NCT01226901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6612412|NCT01226901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6612413|NCT01226901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6612414|NCT01226966|Liraglutide|liraglutide|mesh-list
6612415|NCT01226966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6612416|NCT01226966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612417|NCT01226966|Incretins|incretins|mesh-ancestor
6612418|NCT01226966|Hormones|hormones|mesh-ancestor
6612419|NCT01226966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6612420|NCT01226992|Vancomycin|vancomycin|mesh-list
6612421|NCT01226992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6612422|NCT01226992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6612423|NCT01227135|Hydroxychloroquine|hydroxychloroquine|mesh-list
6612424|NCT01227135|Imatinib Mesylate|imatinib mesylate|mesh-list
6612425|NCT01227135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6612426|NCT01227135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6612427|NCT01227135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6612428|NCT01227135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6612429|NCT01227135|Antimalarials|antimalarials|mesh-ancestor
6612430|NCT01227135|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6612431|NCT01227135|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6612432|NCT01227135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6612433|NCT01227135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6612434|NCT01227148|Insulin|insulin|mesh-list
6612435|NCT01227148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6612436|NCT01227148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612437|NCT01227174|Propofol|propofol|mesh-list
6612438|NCT01227174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6612439|NCT01227174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6612440|NCT01227174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612441|NCT01227174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6612442|NCT01227174|Anesthetics, General|anesthetics, general|mesh-ancestor
6612443|NCT01227174|Anesthetics|anesthetics|mesh-ancestor
6612444|NCT01227200|Tramadol|tramadol|mesh-list
6612445|NCT01227200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6612446|NCT01227200|Narcotics|narcotics|mesh-ancestor
6612447|NCT01227200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6612448|NCT01227200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612449|NCT01227200|Analgesics|analgesics|mesh-ancestor
6612450|NCT01227200|Sensory System Agents|sensory system agents|mesh-ancestor
6612451|NCT01227200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6612452|NCT01227226|Lubricant Eye Drops|lubricant eye drops|mesh-list
6612453|NCT01227226|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6612454|NCT01227226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6612455|NCT01227239|Oxaliplatin|oxaliplatin|mesh-list
6612456|NCT01227239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6612457|NCT01227356|Interferons|interferons|mesh-list
6612458|NCT01227356|Imatinib Mesylate|imatinib mesylate|mesh-list
6612459|NCT01227356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6612460|NCT01227356|Antiviral Agents|antiviral agents|mesh-ancestor
6612461|NCT01227356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6612462|NCT01227356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6612463|NCT01227356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6612464|NCT01227356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6612465|NCT01227408|Paclitaxel|paclitaxel|mesh-list
6612466|NCT01227408|Cyclophosphamide|cyclophosphamide|mesh-list
6612467|NCT01227408|Doxorubicin|doxorubicin|mesh-list
6612468|NCT01227408|Capecitabine|capecitabine|mesh-list
6612469|NCT01227408|Methotrexate|methotrexate|mesh-list
6612470|NCT01227408|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
6612471|NCT01227408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6612472|NCT01227408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6612473|NCT01227408|Tubulin Modulators|tubulin modulators|mesh-ancestor
6612474|NCT01227408|Antimitotic Agents|antimitotic agents|mesh-ancestor
6612475|NCT01227408|Mitosis Modulators|mitosis modulators|mesh-ancestor
6612476|NCT01227408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6612477|NCT01227408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6612478|NCT01227408|Immunologic Factors|immunologic factors|mesh-ancestor
6612479|NCT01227408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612480|NCT01227408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6612481|NCT01227408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6612482|NCT01227408|Alkylating Agents|alkylating agents|mesh-ancestor
6612483|NCT01227408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6612484|NCT01227408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6612485|NCT01227408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6612486|NCT01227408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6612487|NCT01227408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6612488|NCT01227408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6612489|NCT01227408|Antimetabolites|antimetabolites|mesh-ancestor
6612490|NCT01227408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6612491|NCT01227408|Abortifacient Agents|abortifacient agents|mesh-ancestor
6612492|NCT01227408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6612493|NCT01227408|Dermatologic Agents|dermatologic agents|mesh-ancestor
6612494|NCT01227408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6612495|NCT01227408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6612496|NCT01227460|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6612497|NCT01227460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6612498|NCT01227460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612499|NCT01227460|Incretins|incretins|mesh-ancestor
6612500|NCT01227460|Hormones|hormones|mesh-ancestor
6612501|NCT01227460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6612502|NCT01227460|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6612503|NCT01227460|Protease Inhibitors|protease inhibitors|mesh-ancestor
6612504|NCT01227460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6612505|NCT01227460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6612506|NCT01227590|Ritonavir|ritonavir|mesh-list
6612507|NCT01227590|Lopinavir|lopinavir|mesh-list
6612508|NCT01227590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6612509|NCT01227590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6612510|NCT01227590|Protease Inhibitors|protease inhibitors|mesh-ancestor
6612511|NCT01227590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6612512|NCT01227590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6612513|NCT01227590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6612514|NCT01227590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6612515|NCT01227590|Antiviral Agents|antiviral agents|mesh-ancestor
6612516|NCT01227590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6612517|NCT01227590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6612518|NCT01227590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6612519|NCT01227603|Candesartan|candesartan|mesh-list
6612520|NCT01227603|Candesartan cilexetil|candesartan cilexetil|mesh-list
6612521|NCT01227603|Nifedipine|nifedipine|mesh-list
6612522|NCT01227603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6612523|NCT01227603|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6612524|NCT01227603|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6612525|NCT01227603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6612526|NCT01227603|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6612527|NCT01227603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6612528|NCT01227603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6612529|NCT01227603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612530|NCT01227603|Vasodilator Agents|vasodilator agents|mesh-ancestor
6612531|NCT01227603|Tocolytic Agents|tocolytic agents|mesh-ancestor
6612532|NCT01227603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6612533|NCT01227720|Nicotine|nicotine|mesh-list
6449888|NCT00405730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6449889|NCT00405730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6449890|NCT00405769|Red yeast rice|red yeast rice|mesh-list
6449891|NCT00405769|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6449892|NCT00405769|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6449893|NCT00405769|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6449894|NCT00405769|Antimetabolites|antimetabolites|mesh-ancestor
6449895|NCT00405769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6449896|NCT00405769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6449897|NCT00405769|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6449898|NCT00405808|Rimonabant|rimonabant|mesh-list
6449899|NCT00405808|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6449900|NCT00405808|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
6449901|NCT00405808|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6449902|NCT00405808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6449903|NCT00405808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6449904|NCT00405808|Hormones|hormones|mesh-ancestor
6449905|NCT00405808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6449906|NCT00405808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449907|NCT00405847|Dexmedetomidine|dexmedetomidine|mesh-list
6449908|NCT00405847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6449909|NCT00405847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6449910|NCT00405847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612534|NCT01227720|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6612535|NCT01227720|Autonomic Agents|autonomic agents|mesh-ancestor
6612536|NCT01227720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6612537|NCT01227720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612538|NCT01227720|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6612539|NCT01227720|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5501963|NCT04469686|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
5501964|NCT04469686|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
5501965|NCT04469686|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6449911|NCT00405847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6449912|NCT00405847|Analgesics|analgesics|mesh-ancestor
6449913|NCT00405847|Sensory System Agents|sensory system agents|mesh-ancestor
6449914|NCT00405847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6449915|NCT00405847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6449916|NCT00405847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6449917|NCT00405847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6612540|NCT01227720|Cholinergic Agents|cholinergic agents|mesh-ancestor
6612541|NCT01227720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6612542|NCT01227720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6612543|NCT01227759|Tyrothricin|tyrothricin|mesh-list
6612544|NCT01227759|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6612545|NCT01227759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6612546|NCT01227759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6612547|NCT01227798|Interferons|interferons|mesh-list
6612548|NCT01227798|Interferon alfacon-1|interferon alfacon-1|mesh-list
6612549|NCT01227798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6612550|NCT01227798|Antiviral Agents|antiviral agents|mesh-ancestor
6612551|NCT01227798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6612552|NCT01227811|Darifenacin|darifenacin|mesh-list
6612553|NCT01227811|Muscarinic Antagonists|muscarinic antagonists|mesh-list
6612554|NCT01227811|Cholinergic Agents|cholinergic agents|mesh-list
6612555|NCT01227811|Cholinergic Antagonists|cholinergic antagonists|mesh-list
6612556|NCT01227811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6612557|NCT01227811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6612558|NCT01227811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449918|NCT00405847|Adrenergic Agents|adrenergic agents|mesh-ancestor
6449919|NCT00405847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6612559|NCT01227811|Urological Agents|urological agents|mesh-ancestor
6612560|NCT01227863|Dexamethasone, neomycin, polymyxin B drug combination|dexamethasone, neomycin, polymyxin b drug combination|mesh-list
6612561|NCT01227863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6612562|NCT01227863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6449920|NCT00405847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6612563|NCT01227876|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6612564|NCT01227876|Methylprednisolone|methylprednisolone|mesh-list
6612565|NCT01227876|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6612566|NCT01227876|Prednisolone|prednisolone|mesh-list
6612567|NCT01227876|Prednisolone acetate|prednisolone acetate|mesh-list
6612568|NCT01227876|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6612569|NCT01227876|Prednisolone phosphate|prednisolone phosphate|mesh-list
6449921|NCT00405860|Mycophenolic Acid|mycophenolic acid|mesh-list
6449922|NCT00405860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6449923|NCT00405860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6449924|NCT00405860|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6612570|NCT01227876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6612571|NCT01227876|Antiemetics|antiemetics|mesh-ancestor
6612572|NCT01227876|Autonomic Agents|autonomic agents|mesh-ancestor
6612573|NCT01227876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6612574|NCT01227876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612575|NCT01227876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6612576|NCT01227876|Glucocorticoids|glucocorticoids|mesh-ancestor
6612577|NCT01227876|Hormones|hormones|mesh-ancestor
6612578|NCT01227876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6612579|NCT01227876|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6612580|NCT01227876|Protective Agents|protective agents|mesh-ancestor
6612581|NCT01227876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6612582|NCT01227876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6612583|NCT01227915|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
6612584|NCT01227915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6612585|NCT01227915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6612586|NCT01227915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6612587|NCT01227915|Glucocorticoids|glucocorticoids|mesh-ancestor
6612588|NCT01227915|Hormones|hormones|mesh-ancestor
6612589|NCT01227915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6612590|NCT01227915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612591|NCT01227915|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6612592|NCT01227915|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6612593|NCT01227941|Doxorubicin|doxorubicin|mesh-list
6612594|NCT01227941|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6612595|NCT01227941|Niraparib|niraparib|mesh-list
6612596|NCT01227941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6612597|NCT01227941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6612598|NCT01227941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6612599|NCT01227941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6612600|NCT01227941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6612601|NCT01227941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6612602|NCT01227941|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6612603|NCT01228045|Trastuzumab|trastuzumab|mesh-list
6612604|NCT01228045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6612605|NCT01228045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6612606|NCT01228110|Hydrocortisone|hydrocortisone|mesh-list
6612607|NCT01228110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6612608|NCT01228136|Tranexamic Acid|tranexamic acid|mesh-list
6612609|NCT01228136|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6612610|NCT01228136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6612611|NCT01228136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6612612|NCT01228136|Hemostatics|hemostatics|mesh-ancestor
6612613|NCT01228136|Coagulants|coagulants|mesh-ancestor
6612614|NCT01228214|Aspirin|aspirin|mesh-list
6612615|NCT01228214|Amiloride|amiloride|mesh-list
6612616|NCT01228214|Clopidogrel|clopidogrel|mesh-list
6612617|NCT01228214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6612618|NCT01228214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6612619|NCT01228214|Analgesics|analgesics|mesh-ancestor
6612620|NCT01228214|Sensory System Agents|sensory system agents|mesh-ancestor
6612621|NCT01228214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6612622|NCT01228214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612623|NCT01228214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6612624|NCT01228214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6612625|NCT01228214|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6612626|NCT01228214|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6612627|NCT01228214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6612628|NCT01228214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6612629|NCT01228214|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6612630|NCT01228214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6612631|NCT01228214|Antipyretics|antipyretics|mesh-ancestor
6612632|NCT01228214|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6612633|NCT01228214|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6612634|NCT01228214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6612635|NCT01228214|Purinergic Agents|purinergic agents|mesh-ancestor
6612636|NCT01228214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6612637|NCT01228214|Diuretics|diuretics|mesh-ancestor
6612638|NCT01228214|Natriuretic Agents|natriuretic agents|mesh-ancestor
6612639|NCT01228214|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
6612640|NCT01228214|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6612641|NCT01228214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6612642|NCT01228214|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
6612643|NCT01228214|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6612644|NCT01228227|Atorvastatin|atorvastatin|mesh-list
6612645|NCT01228227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6612646|NCT01228227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6612647|NCT01228227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6612648|NCT01228227|Antimetabolites|antimetabolites|mesh-ancestor
6612649|NCT01228227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6612650|NCT01228227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6612651|NCT01228227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6612652|NCT01228227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6612653|NCT01228240|Metformin|metformin|mesh-list
6612654|NCT01228240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6612655|NCT01228240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612656|NCT01228279|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6612657|NCT01228279|Icodextrin|icodextrin|mesh-list
6612658|NCT01228279|Dialysis Solutions|dialysis solutions|mesh-ancestor
6612659|NCT01228292|Heparin|heparin|mesh-list
6612660|NCT01228292|Calcium heparin|calcium heparin|mesh-list
6612661|NCT01228292|Anticoagulants|anticoagulants|mesh-ancestor
6612662|NCT01228292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6612663|NCT01228292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6612664|NCT01228292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6612665|NCT01228305|Acetaminophen|acetaminophen|mesh-list
6612666|NCT01228305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6612667|NCT01228305|Analgesics|analgesics|mesh-ancestor
6612668|NCT01228305|Sensory System Agents|sensory system agents|mesh-ancestor
6612669|NCT01228305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6612670|NCT01228305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612671|NCT01228305|Antipyretics|antipyretics|mesh-ancestor
6612672|NCT01228331|Cytarabine|cytarabine|mesh-list
6612673|NCT01228331|Dexamethasone|dexamethasone|mesh-list
6612674|NCT01228331|Methylprednisolone|methylprednisolone|mesh-list
6612675|NCT01228331|Cyclophosphamide|cyclophosphamide|mesh-list
6612676|NCT01228331|Doxorubicin|doxorubicin|mesh-list
6612677|NCT01228331|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6612678|NCT01228331|Methotrexate|methotrexate|mesh-list
6612679|NCT01228331|Etoposide|etoposide|mesh-list
6612680|NCT01228331|Vincristine|vincristine|mesh-list
6612681|NCT01228331|Daunorubicin|daunorubicin|mesh-list
6612682|NCT01228331|Mercaptopurine|mercaptopurine|mesh-list
6612683|NCT01228331|Clofarabine|clofarabine|mesh-list
6612684|NCT01228331|Pegaspargase|pegaspargase|mesh-list
6612685|NCT01228331|Thioguanine|thioguanine|mesh-list
6612686|NCT01228331|Etoposide phosphate|etoposide phosphate|mesh-list
6612687|NCT01228331|Amsacrine|amsacrine|mesh-list
6612688|NCT01228331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6612689|NCT01228331|Immunologic Factors|immunologic factors|mesh-ancestor
6612690|NCT01228331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612691|NCT01228331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6612692|NCT01228331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6612693|NCT01228331|Alkylating Agents|alkylating agents|mesh-ancestor
6612694|NCT01228331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724862|NCT03184649|Ibuprofen|ibuprofen|mesh-list
6612695|NCT01228331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6612696|NCT01228331|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6612697|NCT01228331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6612698|NCT01228331|Antiemetics|antiemetics|mesh-ancestor
6612699|NCT01228331|Autonomic Agents|autonomic agents|mesh-ancestor
6612700|NCT01228331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6612701|NCT01228331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6612702|NCT01228331|Glucocorticoids|glucocorticoids|mesh-ancestor
6612703|NCT01228331|Hormones|hormones|mesh-ancestor
6612704|NCT01228331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6612705|NCT01228331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6612706|NCT01228331|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6612707|NCT01228331|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6612708|NCT01228331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6612709|NCT01228331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6612710|NCT01228331|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6612711|NCT01228331|Abortifacient Agents|abortifacient agents|mesh-ancestor
6612712|NCT01228331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6612713|NCT01228331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6612714|NCT01228331|Antimetabolites|antimetabolites|mesh-ancestor
6612715|NCT01228331|Dermatologic Agents|dermatologic agents|mesh-ancestor
6612716|NCT01228331|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6612717|NCT01228331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6612718|NCT01228331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6612719|NCT01228331|Antiviral Agents|antiviral agents|mesh-ancestor
6612720|NCT01228331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6612721|NCT01228331|Tubulin Modulators|tubulin modulators|mesh-ancestor
6612722|NCT01228331|Antimitotic Agents|antimitotic agents|mesh-ancestor
6612723|NCT01228331|Mitosis Modulators|mitosis modulators|mesh-ancestor
6612724|NCT01228331|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6612725|NCT01228331|Protective Agents|protective agents|mesh-ancestor
6612726|NCT01228344|Lumefantrine|lumefantrine|mesh-list
6612727|NCT01228344|Artemether|artemether|mesh-list
6612728|NCT01228344|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6612729|NCT01228344|Antimalarials|antimalarials|mesh-ancestor
6612730|NCT01228344|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6612731|NCT01228344|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6612732|NCT01228344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6612733|NCT01228357|Milnacipran|milnacipran|mesh-list
6612734|NCT01228357|Mirtazapine|mirtazapine|mesh-list
6612735|NCT01228357|Sertraline|sertraline|mesh-list
6612736|NCT01228357|Fluoxetine|fluoxetine|mesh-list
6612737|NCT01228357|Paroxetine|paroxetine|mesh-list
6612738|NCT01228357|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6612739|NCT01228357|Nortriptyline|nortriptyline|mesh-list
6612740|NCT01228357|Antidepressive Agents|antidepressive agents|mesh-ancestor
6612741|NCT01228357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6612742|NCT01228357|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6612743|NCT01228357|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6612744|NCT01228357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6612745|NCT01228357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6612746|NCT01228357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6612747|NCT01228357|Serotonin Agents|serotonin agents|mesh-ancestor
6612748|NCT01228357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612749|NCT01228357|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6612750|NCT01228357|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6612751|NCT01228357|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6612752|NCT01228357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6612753|NCT01228357|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6612754|NCT01228357|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6612755|NCT01228357|Histamine Antagonists|histamine antagonists|mesh-ancestor
6612756|NCT01228357|Histamine Agents|histamine agents|mesh-ancestor
6612757|NCT01228357|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6612758|NCT01228357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6612759|NCT01228357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6612760|NCT01228357|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6612761|NCT01228357|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6612762|NCT01228357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6612763|NCT01228357|Adrenergic Agents|adrenergic agents|mesh-ancestor
6612764|NCT01228357|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6612765|NCT01228357|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6612766|NCT01228357|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6612767|NCT01228357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6612768|NCT01228357|Analgesics|analgesics|mesh-ancestor
6612769|NCT01228357|Sensory System Agents|sensory system agents|mesh-ancestor
6612770|NCT01228357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6612771|NCT01228357|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6612772|NCT01228357|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6612773|NCT01228370|Silodosin|silodosin|mesh-list
6612774|NCT01228370|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6612775|NCT01228370|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6612776|NCT01228370|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6612777|NCT01228370|Adrenergic Agents|adrenergic agents|mesh-ancestor
6612778|NCT01228370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6612779|NCT01228370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6612780|NCT01228370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612781|NCT01228370|Urological Agents|urological agents|mesh-ancestor
6612782|NCT01228409|Acitretin|acitretin|mesh-list
6612783|NCT01228409|Keratolytic Agents|keratolytic agents|mesh-ancestor
6612784|NCT01228409|Dermatologic Agents|dermatologic agents|mesh-ancestor
6612785|NCT01228422|Interferons|interferons|mesh-list
6612786|NCT01228422|Interferon-alpha|interferon-alpha|mesh-list
6612787|NCT01228422|Interferon alpha-2|interferon alpha-2|mesh-list
6612788|NCT01228422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6612789|NCT01228422|Antiviral Agents|antiviral agents|mesh-ancestor
6612790|NCT01228422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6612791|NCT01228422|Immunologic Factors|immunologic factors|mesh-ancestor
6612792|NCT01228422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612793|NCT01228552|Ketoprofen|ketoprofen|mesh-list
6612794|NCT01228552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6612795|NCT01228552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6612796|NCT01228552|Analgesics|analgesics|mesh-ancestor
6612797|NCT01228552|Sensory System Agents|sensory system agents|mesh-ancestor
6612798|NCT01228552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6612799|NCT01228552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612800|NCT01228552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6612801|NCT01228552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6612802|NCT01228552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6612803|NCT01228552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6612804|NCT01228552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6612805|NCT01228565|Cetuximab|cetuximab|mesh-list
6612806|NCT01228565|OTD70DERM|otd70derm|mesh-list
6612807|NCT01228565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6612808|NCT01228565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6612809|NCT01228565|Protective Agents|protective agents|mesh-ancestor
6612810|NCT01228565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661082|NCT01497002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6661083|NCT01497002|Immunologic Factors|immunologic factors|mesh-ancestor
6661084|NCT01497002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661085|NCT01497041|Docetaxel|docetaxel|mesh-list
6661086|NCT01497041|Oxaliplatin|oxaliplatin|mesh-list
6661087|NCT01497041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6661088|NCT01497041|Tubulin Modulators|tubulin modulators|mesh-ancestor
6661089|NCT01497041|Antimitotic Agents|antimitotic agents|mesh-ancestor
6661090|NCT01497041|Mitosis Modulators|mitosis modulators|mesh-ancestor
6661091|NCT01497041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661092|NCT01497093|Thalidomide|thalidomide|mesh-list
6661093|NCT01497093|Dexamethasone|dexamethasone|mesh-list
6661094|NCT01497093|Bortezomib|bortezomib|mesh-list
6661095|NCT01497093|Pomalidomide|pomalidomide|mesh-list
6661096|NCT01497093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6661097|NCT01497093|Antiemetics|antiemetics|mesh-ancestor
6661098|NCT01497093|Autonomic Agents|autonomic agents|mesh-ancestor
6661099|NCT01497093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6661100|NCT01497093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661101|NCT01497093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6661102|NCT01497093|Glucocorticoids|glucocorticoids|mesh-ancestor
6661103|NCT01497093|Hormones|hormones|mesh-ancestor
6661104|NCT01497093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6661105|NCT01497093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6661106|NCT01497093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6661107|NCT01497093|Immunologic Factors|immunologic factors|mesh-ancestor
6661108|NCT01497093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6661109|NCT01497093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6661110|NCT01497093|Growth Substances|growth substances|mesh-ancestor
6661111|NCT01497093|Growth Inhibitors|growth inhibitors|mesh-ancestor
6661112|NCT01497093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6661113|NCT01497093|Leprostatic Agents|leprostatic agents|mesh-ancestor
6661114|NCT01497093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6661115|NCT01497093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6661116|NCT01497132|Vitamin D|vitamin d|mesh-list
6661117|NCT01497132|Cholecalciferol|cholecalciferol|mesh-list
6661118|NCT01497132|Vitamins|vitamins|mesh-ancestor
6661119|NCT01497132|Micronutrients|micronutrients|mesh-ancestor
6661120|NCT01497132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661121|NCT01497132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6661122|NCT01497132|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6661123|NCT01497145|Darbepoetin alfa|darbepoetin alfa|mesh-list
6661124|NCT01497145|Hematinics|hematinics|mesh-ancestor
6661125|NCT01497288|Fentanyl|fentanyl|mesh-list
6661126|NCT01497288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6661127|NCT01497288|Narcotics|narcotics|mesh-ancestor
6661128|NCT01497288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6661129|NCT01497288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661130|NCT01497288|Analgesics|analgesics|mesh-ancestor
6612811|NCT01228604|Methylphenidate|methylphenidate|mesh-list
6612812|NCT01228604|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6612813|NCT01228604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612814|NCT01228604|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6612815|NCT01228604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6612816|NCT01228604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6612817|NCT01228604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6612818|NCT01228604|Dopamine Agents|dopamine agents|mesh-ancestor
6612819|NCT01228604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6612820|NCT01228617|Nicotine|nicotine|mesh-list
6612821|NCT01228617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6612822|NCT01228617|Autonomic Agents|autonomic agents|mesh-ancestor
6612823|NCT01228617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6612824|NCT01228617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612825|NCT01228617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6612826|NCT01228617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6612827|NCT01228617|Cholinergic Agents|cholinergic agents|mesh-ancestor
6612828|NCT01228617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6612829|NCT01228617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6612830|NCT01228630|Loratadine|loratadine|mesh-list
6612831|NCT01228630|Fexofenadine|fexofenadine|mesh-list
6612832|NCT01228630|Pseudoephedrine|pseudoephedrine|mesh-list
6612833|NCT01228630|Ephedrine|ephedrine|mesh-list
6612834|NCT01228630|Antipruritics|antipruritics|mesh-ancestor
6612835|NCT01228630|Dermatologic Agents|dermatologic agents|mesh-ancestor
6612836|NCT01228630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6612837|NCT01228630|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6612838|NCT01228630|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6612839|NCT01228630|Histamine Antagonists|histamine antagonists|mesh-ancestor
6612840|NCT01228630|Histamine Agents|histamine agents|mesh-ancestor
6612841|NCT01228630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6612842|NCT01228630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6612843|NCT01228630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612844|NCT01228630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6612845|NCT01228630|Autonomic Agents|autonomic agents|mesh-ancestor
6612846|NCT01228630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6612847|NCT01228630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6612848|NCT01228630|Respiratory System Agents|respiratory system agents|mesh-ancestor
6612849|NCT01228630|Nasal Decongestants|nasal decongestants|mesh-ancestor
6612850|NCT01228630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6612851|NCT01228630|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6612852|NCT01228630|Sympathomimetics|sympathomimetics|mesh-ancestor
6612853|NCT01228630|Adrenergic Agents|adrenergic agents|mesh-ancestor
6612854|NCT01228656|Mometasone Furoate|mometasone furoate|mesh-list
6612855|NCT01228656|Salicylic Acid|salicylic acid|mesh-list
6612856|NCT01228656|Salicylates|salicylates|mesh-list
6612857|NCT01228656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6612858|NCT01228656|Dermatologic Agents|dermatologic agents|mesh-ancestor
6612859|NCT01228656|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6612860|NCT01228656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6612861|NCT01228656|Antifungal Agents|antifungal agents|mesh-ancestor
6612862|NCT01228656|Keratolytic Agents|keratolytic agents|mesh-ancestor
6612863|NCT01228656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6612864|NCT01228656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6612865|NCT01228656|Analgesics|analgesics|mesh-ancestor
6612866|NCT01228656|Sensory System Agents|sensory system agents|mesh-ancestor
6612867|NCT01228656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6612868|NCT01228656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612869|NCT01228656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6612870|NCT01228656|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6612871|NCT01228656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6612872|NCT01228656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6612873|NCT01228682|Tolvaptan|tolvaptan|mesh-list
6612874|NCT01228682|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6612875|NCT01228682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020714|NCT00394082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612876|NCT01228682|Natriuretic Agents|natriuretic agents|mesh-ancestor
6612877|NCT01228682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612878|NCT01228994|Baclofen|baclofen|mesh-list
6612879|NCT01228994|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6612880|NCT01228994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612881|NCT01228994|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6612882|NCT01228994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6612883|NCT01228994|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6612884|NCT01228994|GABA Agonists|gaba agonists|mesh-ancestor
6612885|NCT01228994|GABA Agents|gaba agents|mesh-ancestor
6612886|NCT01228994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6612887|NCT01228994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6612888|NCT01229046|Clavulanic Acids|clavulanic acids|mesh-list
6612889|NCT01229046|Clavulanic Acid|clavulanic acid|mesh-list
6612890|NCT01229046|Ticarcillin|ticarcillin|mesh-list
6612891|NCT01229046|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
6612892|NCT01229046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6612893|NCT01229046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6612894|NCT01229046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6612895|NCT01229046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6612896|NCT01229046|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6612897|NCT01229072|Heparin|heparin|mesh-list
6612898|NCT01229072|Calcium heparin|calcium heparin|mesh-list
6612899|NCT01229072|Anticoagulants|anticoagulants|mesh-ancestor
6612900|NCT01229072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6612901|NCT01229072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6612902|NCT01229072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6612903|NCT01229085|Salicylic Acid|salicylic acid|mesh-list
6612904|NCT01229085|Salicylates|salicylates|mesh-list
6020715|NCT00394082|Growth Inhibitors|growth inhibitors|mesh-ancestor
6612905|NCT01229085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6612906|NCT01229085|Antifungal Agents|antifungal agents|mesh-ancestor
6612907|NCT01229085|Keratolytic Agents|keratolytic agents|mesh-ancestor
6612908|NCT01229085|Dermatologic Agents|dermatologic agents|mesh-ancestor
6612909|NCT01229085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6612910|NCT01229085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6612911|NCT01229085|Analgesics|analgesics|mesh-ancestor
6612912|NCT01229085|Sensory System Agents|sensory system agents|mesh-ancestor
6612913|NCT01229085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6612914|NCT01229085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612915|NCT01229085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6612916|NCT01229085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6612917|NCT01229085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6612918|NCT01229085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6612919|NCT01229085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6612920|NCT01229189|Vitamin D|vitamin d|mesh-list
6612921|NCT01229189|Vitamins|vitamins|mesh-ancestor
6612922|NCT01229189|Micronutrients|micronutrients|mesh-ancestor
6612923|NCT01229189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612924|NCT01229189|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6612925|NCT01229202|Bevacizumab|bevacizumab|mesh-list
6612926|NCT01229202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6612927|NCT01229202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6612928|NCT01229202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6612929|NCT01229202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6612930|NCT01229202|Growth Substances|growth substances|mesh-ancestor
6612931|NCT01229202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612932|NCT01229202|Growth Inhibitors|growth inhibitors|mesh-ancestor
6612933|NCT01229241|Anesthetics|anesthetics|mesh-list
6612934|NCT01229241|Anesthetics, Local|anesthetics, local|mesh-list
6612935|NCT01229241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6612936|NCT01229241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612937|NCT01229241|Sensory System Agents|sensory system agents|mesh-ancestor
6612938|NCT01229241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6612939|NCT01229280|Darifenacin|darifenacin|mesh-list
6612940|NCT01229280|Muscarinic Antagonists|muscarinic antagonists|mesh-list
6612941|NCT01229280|Cholinergic Agents|cholinergic agents|mesh-list
6612942|NCT01229280|Cholinergic Antagonists|cholinergic antagonists|mesh-list
6612943|NCT01229280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6612944|NCT01229280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6612945|NCT01229280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612946|NCT01229280|Urological Agents|urological agents|mesh-ancestor
6612947|NCT01229319|Imiquimod|imiquimod|mesh-list
6612948|NCT01229319|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6612949|NCT01229319|Immunologic Factors|immunologic factors|mesh-ancestor
6612950|NCT01229319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612951|NCT01229319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6612952|NCT01229319|Interferon Inducers|interferon inducers|mesh-ancestor
6612953|NCT01229332|Carbidopa|carbidopa|mesh-list
6612954|NCT01229332|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6612955|NCT01229332|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6612956|NCT01229332|Dopamine Agents|dopamine agents|mesh-ancestor
6612957|NCT01229332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6612958|NCT01229332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6612959|NCT01229332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612960|NCT01229332|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6612961|NCT01229332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6612962|NCT01229579|Zinc Sulfate|zinc sulfate|mesh-list
6612963|NCT01229579|Astringents|astringents|mesh-ancestor
6612964|NCT01229579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612965|NCT01229579|Dermatologic Agents|dermatologic agents|mesh-ancestor
6612966|NCT01229592|Ethanol|ethanol|mesh-list
6612967|NCT01229592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6612968|NCT01229592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6612969|NCT01229592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6612970|NCT01229592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612971|NCT01229605|Cyclophosphamide|cyclophosphamide|mesh-list
6612972|NCT01229605|Docetaxel|docetaxel|mesh-list
6612973|NCT01229605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6612974|NCT01229605|Immunologic Factors|immunologic factors|mesh-ancestor
6612975|NCT01229605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6612976|NCT01229605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6612977|NCT01229605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6612978|NCT01229605|Alkylating Agents|alkylating agents|mesh-ancestor
6612979|NCT01229605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6612980|NCT01229605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6612981|NCT01229605|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6612982|NCT01229605|Tubulin Modulators|tubulin modulators|mesh-ancestor
6612983|NCT01229605|Antimitotic Agents|antimitotic agents|mesh-ancestor
6612984|NCT01229605|Mitosis Modulators|mitosis modulators|mesh-ancestor
6449925|NCT00405860|Antitubercular Agents|antitubercular agents|mesh-ancestor
6449926|NCT00405860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6449927|NCT00405860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6449928|NCT00405860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6612985|NCT01229761|Trimethoprim|trimethoprim|mesh-list
6612986|NCT01229761|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6612987|NCT01229761|Sulfamethoxazole|sulfamethoxazole|mesh-list
6612988|NCT01229761|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6612989|NCT01229761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6612990|NCT01229761|Renal Agents|renal agents|mesh-ancestor
6612991|NCT01229761|Antimalarials|antimalarials|mesh-ancestor
6612992|NCT01229761|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6612993|NCT01229761|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6612994|NCT01229761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6612995|NCT01229761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6612996|NCT01229761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6612997|NCT01229761|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6612998|NCT01229761|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6612999|NCT01229761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6613000|NCT01229761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6613001|NCT01229774|Diclofenac|diclofenac|mesh-list
6613002|NCT01229774|Etoricoxib|etoricoxib|mesh-list
6613003|NCT01229774|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6613004|NCT01229774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6613005|NCT01229774|Analgesics|analgesics|mesh-ancestor
6613006|NCT01229774|Sensory System Agents|sensory system agents|mesh-ancestor
6613007|NCT01229774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6613008|NCT01229774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613009|NCT01229774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6613010|NCT01229774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6613011|NCT01229774|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6613012|NCT01229774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6613013|NCT01229774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613014|NCT01229774|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6613015|NCT01229813|Bevacizumab|bevacizumab|mesh-list
6613016|NCT01229813|Capecitabine|capecitabine|mesh-list
6613017|NCT01229813|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6613018|NCT01229813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6613019|NCT01229813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6613020|NCT01229813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6613021|NCT01229813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6613022|NCT01229813|Growth Substances|growth substances|mesh-ancestor
6449929|NCT00405860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6449930|NCT00405925|Lamivudine|lamivudine|mesh-list
6449931|NCT00405925|Zidovudine|zidovudine|mesh-list
6613023|NCT01229813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613024|NCT01229813|Growth Inhibitors|growth inhibitors|mesh-ancestor
6613025|NCT01229813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6613026|NCT01229813|Antimetabolites|antimetabolites|mesh-ancestor
6613027|NCT01229813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613028|NCT01229813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6613029|NCT01229813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6613030|NCT01229839|Ethiodized Oil|ethiodized oil|mesh-list
6613031|NCT01229839|Antineoplastic Agents|antineoplastic agents|mesh-list
6613032|NCT01229878|Vitamin D|vitamin d|mesh-list
6613033|NCT01229878|Cholecalciferol|cholecalciferol|mesh-list
6449932|NCT00405925|Abacavir|abacavir|mesh-list
6449933|NCT00405925|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6613034|NCT01229878|Vitamins|vitamins|mesh-ancestor
6613035|NCT01229878|Micronutrients|micronutrients|mesh-ancestor
6613036|NCT01229878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613037|NCT01229878|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6613038|NCT01229878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6613039|NCT01229930|Paclitaxel|paclitaxel|mesh-list
6613040|NCT01229930|Carboplatin|carboplatin|mesh-list
6613041|NCT01229930|Cediranib|cediranib|mesh-list
6613042|NCT01229930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6613043|NCT01229930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6613044|NCT01229930|Tubulin Modulators|tubulin modulators|mesh-ancestor
6613045|NCT01229930|Antimitotic Agents|antimitotic agents|mesh-ancestor
6449934|NCT00405925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6613046|NCT01229930|Mitosis Modulators|mitosis modulators|mesh-ancestor
6613047|NCT01229930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613048|NCT01229930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6613049|NCT01229930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6613050|NCT01230034|Ramipril|ramipril|mesh-list
6613051|NCT01230034|Imidapril|imidapril|mesh-list
6613052|NCT01230034|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6613053|NCT01230034|Protease Inhibitors|protease inhibitors|mesh-ancestor
6613054|NCT01230034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6613055|NCT01230034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613056|NCT01230034|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6661131|NCT01497288|Sensory System Agents|sensory system agents|mesh-ancestor
6661132|NCT01497288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6661133|NCT01497288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6661134|NCT01497288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6449935|NCT00405925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6449936|NCT00405925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6449937|NCT00405925|Antiviral Agents|antiviral agents|mesh-ancestor
6449938|NCT00405925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6449939|NCT00405925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6449940|NCT00405925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6020716|NCT00394095|Topiramate|topiramate|mesh-list
6449941|NCT00405925|Antimetabolites|antimetabolites|mesh-ancestor
6449942|NCT00405977|Magnesium Sulfate|magnesium sulfate|mesh-list
6449943|NCT00405977|Analgesics|analgesics|mesh-ancestor
6449944|NCT00405977|Sensory System Agents|sensory system agents|mesh-ancestor
6449945|NCT00405977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6449946|NCT00405977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6449947|NCT00405977|Anesthetics|anesthetics|mesh-ancestor
6449948|NCT00405977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6449949|NCT00405977|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6449950|NCT00405977|Anticonvulsants|anticonvulsants|mesh-ancestor
6449951|NCT00405977|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6449952|NCT00405977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6449953|NCT00405977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613057|NCT01230359|Pyridoxine|pyridoxine|mesh-list
6449954|NCT00405977|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6449955|NCT00405977|Tocolytic Agents|tocolytic agents|mesh-ancestor
6449956|NCT00405977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6449957|NCT00406003|Paroxetine|paroxetine|mesh-list
6613058|NCT01230359|Vitamin B 6|vitamin b 6|mesh-list
6613059|NCT01230359|Vitamins|vitamins|mesh-ancestor
6613060|NCT01230359|Micronutrients|micronutrients|mesh-ancestor
6613061|NCT01230359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613062|NCT01230359|Vitamin B Complex|vitamin b complex|mesh-ancestor
6613063|NCT01230411|Ibuprofen|ibuprofen|mesh-list
6613064|NCT01230411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6613065|NCT01230411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6613066|NCT01230411|Analgesics|analgesics|mesh-ancestor
6613067|NCT01230411|Sensory System Agents|sensory system agents|mesh-ancestor
6613068|NCT01230411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6613069|NCT01230411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613070|NCT01230411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6613071|NCT01230411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6613072|NCT01230411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6613073|NCT01230411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6613074|NCT01230411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613075|NCT01230463|Ketorolac|ketorolac|mesh-list
6613076|NCT01230463|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6613077|NCT01230463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6613078|NCT01230463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6613079|NCT01230463|Analgesics|analgesics|mesh-ancestor
6613080|NCT01230463|Sensory System Agents|sensory system agents|mesh-ancestor
6613081|NCT01230463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6613082|NCT01230463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613083|NCT01230463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6613084|NCT01230463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6613085|NCT01230463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6613086|NCT01230463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6613087|NCT01230463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613088|NCT01230476|Cetuximab|cetuximab|mesh-list
6613089|NCT01230476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6613090|NCT01230476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6613091|NCT01230541|Udenafil|udenafil|mesh-list
6613092|NCT01230541|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6613093|NCT01230541|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6613094|NCT01230541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6613095|NCT01230541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613096|NCT01230580|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6613097|NCT01230580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
6613098|NCT01230580|Protease Inhibitors|protease inhibitors|mesh-list
6613099|NCT01230580|Antiviral Agents|antiviral agents|mesh-ancestor
6613100|NCT01230580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6613101|NCT01230580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6613102|NCT01230580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613103|NCT01230580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6613104|NCT01230580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6613105|NCT01230697|Sorafenib|sorafenib|mesh-list
6613106|NCT01230697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6613107|NCT01230697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6613108|NCT01230697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6613109|NCT01230697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613110|NCT01230723|Everolimus|everolimus|mesh-list
6613111|NCT01230723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6613112|NCT01230723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6449958|NCT00406003|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6449959|NCT00406003|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6449960|NCT00406003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6449961|NCT00406003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6449962|NCT00406003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6449963|NCT00406003|Serotonin Agents|serotonin agents|mesh-ancestor
6449964|NCT00406003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613113|NCT01230723|Immunologic Factors|immunologic factors|mesh-ancestor
6613114|NCT01230723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613115|NCT01230736|Timolol|timolol|mesh-list
6613116|NCT01230736|Travoprost|travoprost|mesh-list
6613117|NCT01230736|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6613118|NCT01230736|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6613119|NCT01230736|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6613120|NCT01230736|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6613121|NCT01230736|Adrenergic Agents|adrenergic agents|mesh-ancestor
6613122|NCT01230736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6613123|NCT01230736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613124|NCT01230736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613125|NCT01230736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6613126|NCT01230736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6613127|NCT01230775|Anagrelide|anagrelide|mesh-list
6613128|NCT01230775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6613129|NCT01230775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6613130|NCT01230775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613131|NCT01230775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6613132|NCT01230983|Leucovorin|leucovorin|mesh-list
6613133|NCT01230983|Cytarabine|cytarabine|mesh-list
6613134|NCT01230983|Prednisone|prednisone|mesh-list
6613135|NCT01230983|Hydrocortisone|hydrocortisone|mesh-list
6613136|NCT01230983|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6449965|NCT00406003|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6449966|NCT00406003|Antidepressive Agents|antidepressive agents|mesh-ancestor
6449967|NCT00406003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6449968|NCT00406003|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6449969|NCT00406003|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6449970|NCT00406003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6449971|NCT00406042|Prednisolone|prednisolone|mesh-list
6449972|NCT00406042|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6613137|NCT01230983|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6613138|NCT01230983|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6613139|NCT01230983|Doxorubicin|doxorubicin|mesh-list
6613140|NCT01230983|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6613141|NCT01230983|Dexrazoxane|dexrazoxane|mesh-list
6613142|NCT01230983|Methotrexate|methotrexate|mesh-list
6613143|NCT01230983|Vincristine|vincristine|mesh-list
6613144|NCT01230983|Asparaginase|asparaginase|mesh-list
6613145|NCT01230983|Mercaptopurine|mercaptopurine|mesh-list
6613146|NCT01230983|Razoxane|razoxane|mesh-list
6613147|NCT01230983|Levoleucovorin|levoleucovorin|mesh-list
6613148|NCT01230983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6613149|NCT01230983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6613150|NCT01230983|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6613151|NCT01230983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6613152|NCT01230983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6613153|NCT01230983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613154|NCT01230983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613155|NCT01230983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6613156|NCT01230983|Glucocorticoids|glucocorticoids|mesh-ancestor
6613157|NCT01230983|Hormones|hormones|mesh-ancestor
6613158|NCT01230983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6613159|NCT01230983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6613160|NCT01230983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6613161|NCT01230983|Abortifacient Agents|abortifacient agents|mesh-ancestor
6613162|NCT01230983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6613163|NCT01230983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6613164|NCT01230983|Antimetabolites|antimetabolites|mesh-ancestor
6613165|NCT01230983|Dermatologic Agents|dermatologic agents|mesh-ancestor
6613166|NCT01230983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6613167|NCT01230983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6613168|NCT01230983|Immunologic Factors|immunologic factors|mesh-ancestor
6613169|NCT01230983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6613170|NCT01230983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6613171|NCT01230983|Antiviral Agents|antiviral agents|mesh-ancestor
6613172|NCT01230983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6613173|NCT01230983|Antidotes|antidotes|mesh-ancestor
6613174|NCT01230983|Protective Agents|protective agents|mesh-ancestor
6613175|NCT01230983|Vitamin B Complex|vitamin b complex|mesh-ancestor
6613176|NCT01230983|Vitamins|vitamins|mesh-ancestor
6613177|NCT01230983|Micronutrients|micronutrients|mesh-ancestor
6613178|NCT01230983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6613179|NCT01230983|Tubulin Modulators|tubulin modulators|mesh-ancestor
6613180|NCT01230983|Antimitotic Agents|antimitotic agents|mesh-ancestor
6613181|NCT01230983|Mitosis Modulators|mitosis modulators|mesh-ancestor
6613182|NCT01230983|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6613183|NCT01230996|Cisplatin|cisplatin|mesh-list
6613184|NCT01230996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6613185|NCT01231074|Metformin|metformin|mesh-list
6613186|NCT01231074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6613187|NCT01231074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613188|NCT01231113|Artesunate|artesunate|mesh-list
6613189|NCT01231113|Piperaquine|piperaquine|mesh-list
6613190|NCT01231113|Amodiaquine|amodiaquine|mesh-list
6613191|NCT01231113|Artenimol|artenimol|mesh-list
6613192|NCT01231113|Antimalarials|antimalarials|mesh-ancestor
6613193|NCT01231113|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6613194|NCT01231113|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6613195|NCT01231113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6613196|NCT01231113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6613197|NCT01231113|Antiviral Agents|antiviral agents|mesh-ancestor
6613198|NCT01231113|Schistosomicides|schistosomicides|mesh-ancestor
6613199|NCT01231113|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6613200|NCT01231113|Anthelmintics|anthelmintics|mesh-ancestor
6613201|NCT01231126|Misoprostol|misoprostol|mesh-list
6613202|NCT01231126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6613203|NCT01231126|Abortifacient Agents|abortifacient agents|mesh-ancestor
6613204|NCT01231126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6613205|NCT01231126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613206|NCT01231126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6613207|NCT01231126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6613208|NCT01231126|Oxytocics|oxytocics|mesh-ancestor
6613209|NCT01231139|Acetaminophen|acetaminophen|mesh-list
6613210|NCT01231139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6613211|NCT01231139|Analgesics|analgesics|mesh-ancestor
6613212|NCT01231139|Sensory System Agents|sensory system agents|mesh-ancestor
6613213|NCT01231139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6613214|NCT01231139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613215|NCT01231139|Antipyretics|antipyretics|mesh-ancestor
6613216|NCT01231165|Aspirin|aspirin|mesh-list
6613217|NCT01231165|Amiloride|amiloride|mesh-list
6613218|NCT01231165|Clopidogrel|clopidogrel|mesh-list
6613219|NCT01231165|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
6613220|NCT01231165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6613221|NCT01231165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6613222|NCT01231165|Analgesics|analgesics|mesh-ancestor
6613223|NCT01231165|Sensory System Agents|sensory system agents|mesh-ancestor
6613224|NCT01231165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6613225|NCT01231165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613226|NCT01231165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6613227|NCT01231165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6613228|NCT01231165|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6613229|NCT01231165|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6613230|NCT01231165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613231|NCT01231165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6613232|NCT01231165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6613233|NCT01231165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6613234|NCT01231165|Antipyretics|antipyretics|mesh-ancestor
6613235|NCT01231165|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6613236|NCT01231165|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6613237|NCT01231165|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6613238|NCT01231165|Purinergic Agents|purinergic agents|mesh-ancestor
6613239|NCT01231165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6613240|NCT01231165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6613241|NCT01231165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6613242|NCT01231165|Antimetabolites|antimetabolites|mesh-ancestor
6613243|NCT01231165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6613244|NCT01231165|Diuretics|diuretics|mesh-ancestor
6613245|NCT01231165|Natriuretic Agents|natriuretic agents|mesh-ancestor
6613246|NCT01231165|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
6613247|NCT01231165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6613248|NCT01231165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6613249|NCT01231165|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
6613250|NCT01231165|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6613251|NCT01231191|Acetaminophen|acetaminophen|mesh-list
6613252|NCT01231191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6613253|NCT01231191|Analgesics|analgesics|mesh-ancestor
6613254|NCT01231191|Sensory System Agents|sensory system agents|mesh-ancestor
6613255|NCT01231191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6613256|NCT01231191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613257|NCT01231191|Antipyretics|antipyretics|mesh-ancestor
6613258|NCT01231243|Hydrogen Peroxide|hydrogen peroxide|mesh-list
6613259|NCT01231243|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6613260|NCT01231243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6613261|NCT01231438|Alfacalcidol|alfacalcidol|mesh-list
6613262|NCT01231438|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6613263|NCT01231438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613264|NCT01231490|Naproxen|naproxen|mesh-list
6613265|NCT01231490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6613266|NCT01231490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6613267|NCT01231490|Analgesics|analgesics|mesh-ancestor
6613268|NCT01231490|Sensory System Agents|sensory system agents|mesh-ancestor
6613269|NCT01231490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6613270|NCT01231490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613271|NCT01231490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6613272|NCT01231490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6613273|NCT01231490|Gout Suppressants|gout suppressants|mesh-ancestor
6613274|NCT01231490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6613275|NCT01231490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6613276|NCT01231490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613277|NCT01231529|Dolutegravir|dolutegravir|mesh-list
6613278|NCT01231529|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6613279|NCT01231529|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6613280|NCT01231529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6613281|NCT01231529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613282|NCT01231529|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6613283|NCT01231529|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6613284|NCT01231529|Antiviral Agents|antiviral agents|mesh-ancestor
6613285|NCT01231529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6613286|NCT01231542|Rifampin|rifampin|mesh-list
6613287|NCT01231542|Rifabutin|rifabutin|mesh-list
6613288|NCT01231542|Dolutegravir|dolutegravir|mesh-list
6613289|NCT01231542|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6613290|NCT01231542|Antitubercular Agents|antitubercular agents|mesh-ancestor
6613291|NCT01231542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6613292|NCT01231542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6613293|NCT01231542|Leprostatic Agents|leprostatic agents|mesh-ancestor
6613294|NCT01231542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6613295|NCT01231542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6613296|NCT01231542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613297|NCT01231542|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6613298|NCT01231542|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6613299|NCT01231542|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6613300|NCT01231542|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6613301|NCT01231542|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6613302|NCT01231542|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6613303|NCT01231542|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6613304|NCT01231542|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6613305|NCT01231542|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6613306|NCT01231542|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6613307|NCT01231542|Antiviral Agents|antiviral agents|mesh-ancestor
6613308|NCT01231594|Trametinib|trametinib|mesh-list
6613309|NCT01231594|Dabrafenib|dabrafenib|mesh-list
6613310|NCT01231594|Antineoplastic Agents|antineoplastic agents|mesh-list
6613311|NCT01231594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6613312|NCT01231594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6613313|NCT01231594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613314|NCT01231685|Ritonavir|ritonavir|mesh-list
6613315|NCT01231685|Lopinavir|lopinavir|mesh-list
6613316|NCT01231685|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6613317|NCT01231685|Darunavir|darunavir|mesh-list
6613318|NCT01231685|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
6613319|NCT01231685|Raltegravir Potassium|raltegravir potassium|mesh-list
6613320|NCT01231685|Protease Inhibitors|protease inhibitors|mesh-list
6613321|NCT01231685|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6613322|NCT01231685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6613323|NCT01231685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613324|NCT01231685|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6613325|NCT01231685|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6613326|NCT01231685|Antiviral Agents|antiviral agents|mesh-ancestor
6613327|NCT01231685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6613328|NCT01231685|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6613329|NCT01231685|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6613330|NCT01231685|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6613331|NCT01231685|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6613332|NCT01231698|Esmolol|esmolol|mesh-list
6613333|NCT01231698|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6613334|NCT01231698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6613335|NCT01231698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6613336|NCT01231698|Adrenergic Agents|adrenergic agents|mesh-ancestor
6613337|NCT01231698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6613338|NCT01231698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613339|NCT01231698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613340|NCT01231711|Ethanol|ethanol|mesh-list
6613341|NCT01231711|Povidone-Iodine|povidone-iodine|mesh-list
6613342|NCT01231711|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6613343|NCT01231711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6613344|NCT01231711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6613345|NCT01231711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613346|NCT01231737|Prulifloxacin|prulifloxacin|mesh-list
6613347|NCT01231737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6613348|NCT01231737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6613349|NCT01231737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6613350|NCT01231737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6613351|NCT01231737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6613352|NCT01231737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613353|NCT01231737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6613354|NCT01231802|Leucovorin|leucovorin|mesh-list
6613355|NCT01231802|Fluorouracil|fluorouracil|mesh-list
6613356|NCT01231802|Capecitabine|capecitabine|mesh-list
6613357|NCT01231802|Eniluracil|eniluracil|mesh-list
6613358|NCT01231802|Antimetabolites|antimetabolites|mesh-ancestor
6613359|NCT01231802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613360|NCT01231802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6613361|NCT01231802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6613362|NCT01231802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6613363|NCT01231802|Immunologic Factors|immunologic factors|mesh-ancestor
6613364|NCT01231802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613365|NCT01231802|Antidotes|antidotes|mesh-ancestor
6613366|NCT01231802|Protective Agents|protective agents|mesh-ancestor
6613367|NCT01231802|Vitamin B Complex|vitamin b complex|mesh-ancestor
6613368|NCT01231802|Vitamins|vitamins|mesh-ancestor
6613369|NCT01231802|Micronutrients|micronutrients|mesh-ancestor
6613370|NCT01231802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6613371|NCT01231828|Lactulose|lactulose|mesh-list
6613372|NCT01231828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6613373|NCT01231854|Cyclosporine|cyclosporine|mesh-list
6613374|NCT01231854|Alitretinoin|alitretinoin|mesh-list
6613375|NCT01231854|Cyclosporins|cyclosporins|mesh-list
6613376|NCT01231854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6613377|NCT01231854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613378|NCT01231854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6613379|NCT01231854|Immunologic Factors|immunologic factors|mesh-ancestor
6613380|NCT01231854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613381|NCT01231854|Antifungal Agents|antifungal agents|mesh-ancestor
6613382|NCT01231854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6613383|NCT01231854|Dermatologic Agents|dermatologic agents|mesh-ancestor
6613384|NCT01231854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6613385|NCT01231854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6613386|NCT01231854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6613387|NCT01231880|Piperaquine|piperaquine|mesh-list
6613388|NCT01231880|Artenimol|artenimol|mesh-list
6613389|NCT01231880|Antimalarials|antimalarials|mesh-ancestor
6613390|NCT01231880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6613391|NCT01231880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6613392|NCT01231880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6613393|NCT01231997|Udenafil|udenafil|mesh-list
6613394|NCT01231997|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6613395|NCT01231997|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6613396|NCT01231997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6613397|NCT01231997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613398|NCT01232010|Mirodenafil|mirodenafil|mesh-list
6613399|NCT01232010|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6613400|NCT01232010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6613401|NCT01232010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6613402|NCT01232010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613403|NCT01232023|Indobufen|indobufen|mesh-list
6613404|NCT01232023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6613405|NCT01232023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6613406|NCT01232023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6613407|NCT01232023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613408|NCT01232023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6613409|NCT01232023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6613410|NCT01232023|Analgesics|analgesics|mesh-ancestor
6613411|NCT01232023|Sensory System Agents|sensory system agents|mesh-ancestor
6613412|NCT01232023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6613413|NCT01232023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613414|NCT01232023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6613415|NCT01232023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6613416|NCT01232036|Metformin|metformin|mesh-list
6613417|NCT01232036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6613418|NCT01232036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613419|NCT01232075|Letrozole|letrozole|mesh-list
6613420|NCT01232075|Citric Acid|citric acid|mesh-list
6613421|NCT01232075|Sodium Citrate|sodium citrate|mesh-list
6613422|NCT01232075|Clomiphene|clomiphene|mesh-list
6613423|NCT01232075|Enclomiphene|enclomiphene|mesh-list
6613424|NCT01232075|Zuclomiphene|zuclomiphene|mesh-list
6613425|NCT01232075|Anticoagulants|anticoagulants|mesh-ancestor
6613426|NCT01232075|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6613427|NCT01232075|Chelating Agents|chelating agents|mesh-ancestor
6613428|NCT01232075|Sequestering Agents|sequestering agents|mesh-ancestor
6613429|NCT01232075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613430|NCT01232075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6613431|NCT01232075|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6613432|NCT01232075|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6613433|NCT01232075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6613434|NCT01232075|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6613435|NCT01232075|Hormone Antagonists|hormone antagonists|mesh-ancestor
6613436|NCT01232075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6613437|NCT01232075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613438|NCT01232075|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6613439|NCT01232075|Fertility Agents|fertility agents|mesh-ancestor
6613440|NCT01232075|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6613441|NCT01232075|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6613442|NCT01232075|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6613443|NCT01232140|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6613444|NCT01232140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6661135|NCT01497288|Anesthetics, General|anesthetics, general|mesh-ancestor
6661136|NCT01497288|Anesthetics|anesthetics|mesh-ancestor
6661137|NCT01497327|Sofosbuvir|sofosbuvir|mesh-list
6661138|NCT01497327|Antiviral Agents|antiviral agents|mesh-ancestor
6661139|NCT01497327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6661140|NCT01497392|Gemcitabine|gemcitabine|mesh-list
6661141|NCT01497392|Capecitabine|capecitabine|mesh-list
6661142|NCT01497392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6661143|NCT01497392|Antimetabolites|antimetabolites|mesh-ancestor
6661144|NCT01497392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661145|NCT01497392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6661146|NCT01497392|Antiviral Agents|antiviral agents|mesh-ancestor
6661147|NCT01497392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6661148|NCT01497392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6661149|NCT01497392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6661150|NCT01497392|Immunologic Factors|immunologic factors|mesh-ancestor
6661151|NCT01497392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661152|NCT01497431|Selenium|selenium|mesh-list
6661153|NCT01497431|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
6613445|NCT01232244|Glucagon|glucagon|mesh-list
6613446|NCT01232244|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6613447|NCT01232244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6613448|NCT01232244|Hormones|hormones|mesh-ancestor
6613449|NCT01232244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6613450|NCT01232244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613451|NCT01232244|Incretins|incretins|mesh-ancestor
6613452|NCT01232257|Acetylcysteine|acetylcysteine|mesh-list
6613453|NCT01232257|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6613454|NCT01232257|Antiviral Agents|antiviral agents|mesh-ancestor
6613455|NCT01232257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6613456|NCT01232257|Expectorants|expectorants|mesh-ancestor
6613457|NCT01232257|Respiratory System Agents|respiratory system agents|mesh-ancestor
6613458|NCT01232257|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6613459|NCT01232257|Antioxidants|antioxidants|mesh-ancestor
6613460|NCT01232257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613461|NCT01232257|Protective Agents|protective agents|mesh-ancestor
6613462|NCT01232257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613463|NCT01232257|Antidotes|antidotes|mesh-ancestor
6613464|NCT01232270|Propofol|propofol|mesh-list
6613465|NCT01232270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6613466|NCT01232270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6613467|NCT01232270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613468|NCT01232270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6613469|NCT01232270|Anesthetics, General|anesthetics, general|mesh-ancestor
6613470|NCT01232270|Anesthetics|anesthetics|mesh-ancestor
6613471|NCT01232374|Nimotuzumab|nimotuzumab|mesh-list
6613472|NCT01232374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6613473|NCT01232374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6613474|NCT01232400|Esmolol|esmolol|mesh-list
6613475|NCT01232400|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6613476|NCT01232400|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6613477|NCT01232400|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6613478|NCT01232400|Adrenergic Agents|adrenergic agents|mesh-ancestor
6613479|NCT01232400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6613480|NCT01232400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613481|NCT01232400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613482|NCT01232413|Ipragliflozin|ipragliflozin|mesh-list
6613483|NCT01232413|Moxifloxacin|moxifloxacin|mesh-list
6613484|NCT01232413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6613485|NCT01232413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6613486|NCT01232413|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6613487|NCT01232413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6613488|NCT01232413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6613489|NCT01232413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613490|NCT01232413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6613491|NCT01232413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613492|NCT01232413|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6613493|NCT01232413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6613494|NCT01232439|Aticaprant|aticaprant|mesh-list
6613495|NCT01232439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613496|NCT01232439|Sensory System Agents|sensory system agents|mesh-ancestor
6613497|NCT01232439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6613498|NCT01232439|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6613499|NCT01232647|Vitamins|vitamins|mesh-list
6613500|NCT01232647|Vitamin K|vitamin k|mesh-list
6613501|NCT01232647|Vitamin K 2|vitamin k 2|mesh-list
6613502|NCT01232647|Vitamin K 1|vitamin k 1|mesh-list
6613503|NCT01232647|Menatetrenone|menatetrenone|mesh-list
6613504|NCT01232647|Micronutrients|micronutrients|mesh-ancestor
6613505|NCT01232647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613506|NCT01232647|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6613507|NCT01232647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6613508|NCT01232647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613509|NCT01232647|Hemostatics|hemostatics|mesh-ancestor
6613510|NCT01232647|Coagulants|coagulants|mesh-ancestor
6613511|NCT01232660|Hydroxychloroquine|hydroxychloroquine|mesh-list
6613512|NCT01232660|Antimalarials|antimalarials|mesh-ancestor
6613513|NCT01232660|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6613514|NCT01232660|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6613515|NCT01232660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6613516|NCT01232660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6613517|NCT01232660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613518|NCT01232660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6613519|NCT01232777|Bevacizumab|bevacizumab|mesh-list
6613520|NCT01232777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6613521|NCT01232777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6613522|NCT01232777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6613523|NCT01232777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6613524|NCT01232777|Growth Substances|growth substances|mesh-ancestor
6613525|NCT01232777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613526|NCT01232777|Growth Inhibitors|growth inhibitors|mesh-ancestor
6613527|NCT01232803|Tenofovir|tenofovir|mesh-list
6613528|NCT01232803|Antiviral Agents|antiviral agents|mesh-ancestor
6613529|NCT01232803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6613530|NCT01232803|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6613531|NCT01232803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6613532|NCT01232803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6613533|NCT01232803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613534|NCT01232803|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6613535|NCT01232803|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6613536|NCT01233167|Clopidogrel|clopidogrel|mesh-list
6613537|NCT01233167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6613538|NCT01233167|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6449973|NCT00406042|Methylprednisolone|methylprednisolone|mesh-list
6449974|NCT00406042|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6449975|NCT00406042|Prednisolone acetate|prednisolone acetate|mesh-list
6449976|NCT00406042|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6449977|NCT00406042|Prednisolone phosphate|prednisolone phosphate|mesh-list
6449978|NCT00406042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6449979|NCT00406042|Glucocorticoids|glucocorticoids|mesh-ancestor
6449980|NCT00406042|Hormones|hormones|mesh-ancestor
6449981|NCT00406042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6449982|NCT00406042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613539|NCT01233167|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5501966|NCT04469686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6449983|NCT00406042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6613540|NCT01233167|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6613541|NCT01233167|Purinergic Agents|purinergic agents|mesh-ancestor
6613542|NCT01233167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6613543|NCT01233167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613544|NCT01233167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613545|NCT01233206|Metformin|metformin|mesh-list
6613546|NCT01233206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6613547|NCT01233206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613548|NCT01233219|Morphine|morphine|mesh-list
6613549|NCT01233219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6613550|NCT01233219|Narcotics|narcotics|mesh-ancestor
6613551|NCT01233219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6613552|NCT01233219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613553|NCT01233219|Analgesics|analgesics|mesh-ancestor
6613554|NCT01233219|Sensory System Agents|sensory system agents|mesh-ancestor
6613555|NCT01233219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6613556|NCT01233245|Interferons|interferons|mesh-list
6613557|NCT01233245|Interferon-beta|interferon-beta|mesh-list
6613558|NCT01233245|Interferon beta-1b|interferon beta-1b|mesh-list
6613559|NCT01233245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6613560|NCT01233245|Antiviral Agents|antiviral agents|mesh-ancestor
6613561|NCT01233245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6613562|NCT01233245|Immunologic Factors|immunologic factors|mesh-ancestor
6613563|NCT01233245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613564|NCT01233245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6613565|NCT01233297|Azithromycin|azithromycin|mesh-list
6613566|NCT01233297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6613567|NCT01233297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6613568|NCT01233362|Vaccines|vaccines|mesh-list
6613569|NCT01233362|Immunologic Factors|immunologic factors|mesh-ancestor
6613570|NCT01233362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613571|NCT01233453|Umirolimus|umirolimus|mesh-list
6613572|NCT01233453|Everolimus|everolimus|mesh-list
6613573|NCT01233453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6613574|NCT01233453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6613575|NCT01233453|Immunologic Factors|immunologic factors|mesh-ancestor
6613576|NCT01233453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613577|NCT01233453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6613578|NCT01233492|Mannitol|mannitol|mesh-list
6613579|NCT01233492|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6613580|NCT01233492|Diuretics|diuretics|mesh-ancestor
6613581|NCT01233492|Natriuretic Agents|natriuretic agents|mesh-ancestor
6613582|NCT01233492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613583|NCT01233505|Capecitabine|capecitabine|mesh-list
6613584|NCT01233505|Oxaliplatin|oxaliplatin|mesh-list
6613585|NCT01233505|Veliparib|veliparib|mesh-list
6613586|NCT01233505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6613587|NCT01233505|Antimetabolites|antimetabolites|mesh-ancestor
6613588|NCT01233505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613589|NCT01233505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6613590|NCT01233505|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6613591|NCT01233505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6613592|NCT01233570|Tacrolimus|tacrolimus|mesh-list
6613593|NCT01233570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6613594|NCT01233570|Immunologic Factors|immunologic factors|mesh-ancestor
6613595|NCT01233570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613596|NCT01233570|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6613597|NCT01233570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6613598|NCT01233570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613599|NCT01233583|Adalimumab|adalimumab|mesh-list
6613600|NCT01233583|Etanercept|etanercept|mesh-list
6613601|NCT01233583|Infliximab|infliximab|mesh-list
6613602|NCT01233583|Acitretin|acitretin|mesh-list
6613603|NCT01233583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6613604|NCT01233583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6613605|NCT01233583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6613606|NCT01233583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6613607|NCT01233583|Analgesics|analgesics|mesh-ancestor
6613608|NCT01233583|Sensory System Agents|sensory system agents|mesh-ancestor
6020717|NCT00394095|Anticonvulsants|anticonvulsants|mesh-ancestor
6613609|NCT01233583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6613610|NCT01233583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613611|NCT01233583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6613612|NCT01233583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6613613|NCT01233583|Immunologic Factors|immunologic factors|mesh-ancestor
6613614|NCT01233583|Dermatologic Agents|dermatologic agents|mesh-ancestor
6613615|NCT01233583|Keratolytic Agents|keratolytic agents|mesh-ancestor
6613616|NCT01233622|Vildagliptin|vildagliptin|mesh-list
6613617|NCT01233622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6613618|NCT01233622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613619|NCT01233622|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6613620|NCT01233622|Protease Inhibitors|protease inhibitors|mesh-ancestor
6613621|NCT01233622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6613622|NCT01233622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613623|NCT01233635|Losartan|losartan|mesh-list
6613624|NCT01233635|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6613625|NCT01233635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6613626|NCT01233635|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6613627|NCT01233635|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6613628|NCT01233635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613629|NCT01233752|Morphine|morphine|mesh-list
6613630|NCT01233752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6613631|NCT01233752|Narcotics|narcotics|mesh-ancestor
6613632|NCT01233752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6613633|NCT01233752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613634|NCT01233752|Analgesics|analgesics|mesh-ancestor
6613635|NCT01233752|Sensory System Agents|sensory system agents|mesh-ancestor
6613636|NCT01233752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6613637|NCT01233791|Diazepam|diazepam|mesh-list
6613638|NCT01233791|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6613639|NCT01233791|Anticonvulsants|anticonvulsants|mesh-ancestor
6613640|NCT01233791|Antiemetics|antiemetics|mesh-ancestor
6613641|NCT01233791|Autonomic Agents|autonomic agents|mesh-ancestor
6613642|NCT01233791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6613643|NCT01233791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613644|NCT01233791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6613645|NCT01233791|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6613646|NCT01233791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6613647|NCT01233791|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6613648|NCT01233791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6613649|NCT01233791|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6613650|NCT01233791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6613651|NCT01233791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6613652|NCT01233791|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6613653|NCT01233791|Anesthetics, General|anesthetics, general|mesh-ancestor
6613654|NCT01233791|Anesthetics|anesthetics|mesh-ancestor
6613655|NCT01233791|GABA Modulators|gaba modulators|mesh-ancestor
6613656|NCT01233791|GABA Agents|gaba agents|mesh-ancestor
6613657|NCT01233791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6613658|NCT01233791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613659|NCT01233843|Carboplatin|carboplatin|mesh-list
6613660|NCT01233843|Fluorouracil|fluorouracil|mesh-list
6613661|NCT01233843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6613662|NCT01233843|Antimetabolites|antimetabolites|mesh-ancestor
6613663|NCT01233843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613664|NCT01233843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6613665|NCT01233843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6613666|NCT01233843|Immunologic Factors|immunologic factors|mesh-ancestor
6613667|NCT01233843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661154|NCT01497431|Antioxidants|antioxidants|mesh-ancestor
6661155|NCT01497431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661156|NCT01497431|Protective Agents|protective agents|mesh-ancestor
6661157|NCT01497431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661158|NCT01497431|Trace Elements|trace elements|mesh-ancestor
6661159|NCT01497431|Micronutrients|micronutrients|mesh-ancestor
6661160|NCT01497431|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6661161|NCT01497431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6613668|NCT01233895|Bortezomib|bortezomib|mesh-list
6613669|NCT01233895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6613670|NCT01233934|Chlorpheniramine|chlorpheniramine|mesh-list
6613671|NCT01233934|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
6613672|NCT01233934|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6613673|NCT01233934|Histamine Antagonists|histamine antagonists|mesh-ancestor
6613674|NCT01233934|Histamine Agents|histamine agents|mesh-ancestor
6613675|NCT01233934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6613676|NCT01233934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613677|NCT01233934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613678|NCT01233934|Antipruritics|antipruritics|mesh-ancestor
6613679|NCT01233934|Dermatologic Agents|dermatologic agents|mesh-ancestor
6613680|NCT01233934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6613681|NCT01233947|Fulvestrant|fulvestrant|mesh-list
6613682|NCT01233947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6613683|NCT01233947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6613684|NCT01233947|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6613685|NCT01233947|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6020718|NCT00394095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6613686|NCT01233947|Hormone Antagonists|hormone antagonists|mesh-ancestor
6613687|NCT01233947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6613688|NCT01233947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613689|NCT01234051|Docetaxel|docetaxel|mesh-list
6613690|NCT01234051|Oxaliplatin|oxaliplatin|mesh-list
6613691|NCT01234051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6613692|NCT01234051|Tubulin Modulators|tubulin modulators|mesh-ancestor
6613693|NCT01234051|Antimitotic Agents|antimitotic agents|mesh-ancestor
6613694|NCT01234051|Mitosis Modulators|mitosis modulators|mesh-ancestor
6613695|NCT01234051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613696|NCT01234116|Tenofovir|tenofovir|mesh-list
6613697|NCT01234116|Emtricitabine|emtricitabine|mesh-list
6613698|NCT01234116|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6613699|NCT01234116|Antiviral Agents|antiviral agents|mesh-ancestor
6020719|NCT00394095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020720|NCT00394251|Paclitaxel|paclitaxel|mesh-list
6020721|NCT00394251|Cyclophosphamide|cyclophosphamide|mesh-list
6020722|NCT00394251|Bevacizumab|bevacizumab|mesh-list
6020723|NCT00394251|Doxorubicin|doxorubicin|mesh-list
6020724|NCT00394251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6020725|NCT00394251|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6020726|NCT00394251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6020727|NCT00394251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6020728|NCT00394251|Tubulin Modulators|tubulin modulators|mesh-ancestor
6020729|NCT00394251|Antimitotic Agents|antimitotic agents|mesh-ancestor
6020730|NCT00394251|Mitosis Modulators|mitosis modulators|mesh-ancestor
6020731|NCT00394251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020732|NCT00394251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6020733|NCT00394251|Immunologic Factors|immunologic factors|mesh-ancestor
6020734|NCT00394251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613700|NCT01234116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6613701|NCT01234116|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6613702|NCT01234116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6613703|NCT01234116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6613704|NCT01234116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613705|NCT01234116|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6613706|NCT01234116|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6613707|NCT01234129|Zoledronic Acid|zoledronic acid|mesh-list
6613708|NCT01234129|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6449984|NCT00406042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6449985|NCT00406042|Antiemetics|antiemetics|mesh-ancestor
6449986|NCT00406042|Autonomic Agents|autonomic agents|mesh-ancestor
6449987|NCT00406042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6449988|NCT00406042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6613709|NCT01234129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613710|NCT01234142|Varenicline|varenicline|mesh-list
6613711|NCT01234142|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6613712|NCT01234142|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6613713|NCT01234142|Cholinergic Agents|cholinergic agents|mesh-ancestor
6613714|NCT01234142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6613715|NCT01234142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613716|NCT01234142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613717|NCT01234194|Remifentanil|remifentanil|mesh-list
6613718|NCT01234194|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6613719|NCT01234194|Narcotics|narcotics|mesh-ancestor
6449989|NCT00406042|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6449990|NCT00406042|Protective Agents|protective agents|mesh-ancestor
6461843|NCT00456430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6461844|NCT00456430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6613720|NCT01234194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6613721|NCT01234194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613722|NCT01234194|Analgesics|analgesics|mesh-ancestor
6449991|NCT00406094|Montelukast|montelukast|mesh-list
6449992|NCT00406094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6449993|NCT00406094|Respiratory System Agents|respiratory system agents|mesh-ancestor
6449994|NCT00406094|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6449995|NCT00406094|Hormone Antagonists|hormone antagonists|mesh-ancestor
6449996|NCT00406094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6449997|NCT00406094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613723|NCT01234194|Sensory System Agents|sensory system agents|mesh-ancestor
6613724|NCT01234194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6613725|NCT01234272|Morphine|morphine|mesh-list
6613726|NCT01234272|Ropivacaine|ropivacaine|mesh-list
6613727|NCT01234272|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6613728|NCT01234272|Narcotics|narcotics|mesh-ancestor
6613729|NCT01234272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6613730|NCT01234272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613731|NCT01234272|Analgesics|analgesics|mesh-ancestor
6613732|NCT01234272|Sensory System Agents|sensory system agents|mesh-ancestor
6613733|NCT01234272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6613734|NCT01234272|Anesthetics, Local|anesthetics, local|mesh-ancestor
6613735|NCT01234272|Anesthetics|anesthetics|mesh-ancestor
6613736|NCT01234285|Heparin|heparin|mesh-list
6613737|NCT01234285|Calcium heparin|calcium heparin|mesh-list
6613738|NCT01234285|Anticoagulants|anticoagulants|mesh-ancestor
6613739|NCT01234285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6613740|NCT01234285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6613741|NCT01234285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613742|NCT01234298|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6613743|NCT01234298|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6613744|NCT01234298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613745|NCT01234298|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6613746|NCT01234298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6613747|NCT01234298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6613748|NCT01234298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613749|NCT01234298|Dopamine Agents|dopamine agents|mesh-ancestor
6613750|NCT01234298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6613751|NCT01234324|Cisplatin|cisplatin|mesh-list
6613752|NCT01234324|Capecitabine|capecitabine|mesh-list
6613753|NCT01234324|Epirubicin|epirubicin|mesh-list
6613754|NCT01234324|Panitumumab|panitumumab|mesh-list
6613755|NCT01234324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6613756|NCT01234324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6613757|NCT01234324|Antimetabolites|antimetabolites|mesh-ancestor
6613758|NCT01234324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613759|NCT01234324|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6613760|NCT01234324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6613761|NCT01234324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6613762|NCT01234324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6613763|NCT01234324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6613764|NCT01234454|Olanzapine|olanzapine|mesh-list
6613765|NCT01234454|Risperidone|risperidone|mesh-list
6613766|NCT01234454|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6613767|NCT01234454|Serotonin Agents|serotonin agents|mesh-ancestor
6661162|NCT01497444|Sorafenib|sorafenib|mesh-list
6449998|NCT00406094|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6449999|NCT00406094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6613768|NCT01234454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6613769|NCT01234454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613770|NCT01234454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613771|NCT01234454|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6613772|NCT01234454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6613773|NCT01234454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6613774|NCT01234454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6613775|NCT01234454|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6613776|NCT01234454|Dopamine Agents|dopamine agents|mesh-ancestor
6613777|NCT01234454|Antiemetics|antiemetics|mesh-ancestor
6613778|NCT01234454|Autonomic Agents|autonomic agents|mesh-ancestor
6613779|NCT01234454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6613780|NCT01234454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6613781|NCT01234454|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6613782|NCT01234454|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6613783|NCT01234454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6613784|NCT01234506|Vitamin D|vitamin d|mesh-list
6613785|NCT01234506|Secoisolariciresinol|secoisolariciresinol|mesh-list
6450000|NCT00406094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450001|NCT00406146|Artesunate|artesunate|mesh-list
6613786|NCT01234506|Vitamins|vitamins|mesh-ancestor
6613787|NCT01234506|Micronutrients|micronutrients|mesh-ancestor
6613788|NCT01234506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613789|NCT01234506|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6613790|NCT01234506|Phytoestrogens|phytoestrogens|mesh-ancestor
6613791|NCT01234506|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6613792|NCT01234506|Estrogens|estrogens|mesh-ancestor
6613793|NCT01234506|Hormones|hormones|mesh-ancestor
6613794|NCT01234506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6613795|NCT01234532|Anastrozole|anastrozole|mesh-list
6613796|NCT01234532|Entinostat|entinostat|mesh-list
6613797|NCT01234532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6613798|NCT01234532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6450002|NCT00406146|Lumefantrine|lumefantrine|mesh-list
6450003|NCT00406146|Artemether|artemether|mesh-list
6450004|NCT00406146|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6450005|NCT00406146|Amodiaquine|amodiaquine|mesh-list
6450006|NCT00406146|Antimalarials|antimalarials|mesh-ancestor
6450007|NCT00406146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6450008|NCT00406146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6613799|NCT01234532|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6450009|NCT00406146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6450010|NCT00406146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6613800|NCT01234532|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6613801|NCT01234532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6613802|NCT01234532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613803|NCT01234532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6613804|NCT01234532|Hormone Antagonists|hormone antagonists|mesh-ancestor
6613805|NCT01234532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6613806|NCT01234532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613807|NCT01234532|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6613808|NCT01234597|Insulin|insulin|mesh-list
6613809|NCT01234597|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6613810|NCT01234597|Insulin Glargine|insulin glargine|mesh-list
6613811|NCT01234597|Insulin glulisine|insulin glulisine|mesh-list
6613812|NCT01234597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6613813|NCT01234597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613814|NCT01234623|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6613815|NCT01234623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6613816|NCT01234701|Liver Extracts|liver extracts|mesh-list
6613817|NCT01234701|Hematinics|hematinics|mesh-ancestor
6613818|NCT01234740|Bafetinib|bafetinib|mesh-list
6613819|NCT01234740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6613820|NCT01234740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6613821|NCT01234740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613822|NCT01234792|Nicotine|nicotine|mesh-list
6613823|NCT01234792|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6613824|NCT01234792|Autonomic Agents|autonomic agents|mesh-ancestor
6613825|NCT01234792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6450011|NCT00406146|Antiviral Agents|antiviral agents|mesh-ancestor
6450012|NCT00406146|Schistosomicides|schistosomicides|mesh-ancestor
6450013|NCT00406146|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6450014|NCT00406146|Anthelmintics|anthelmintics|mesh-ancestor
6450015|NCT00406172|Bevacizumab|bevacizumab|mesh-list
6450016|NCT00406172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6450017|NCT00406172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6450018|NCT00406172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6450019|NCT00406172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6450020|NCT00406172|Growth Substances|growth substances|mesh-ancestor
6450021|NCT00406172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450022|NCT00406172|Growth Inhibitors|growth inhibitors|mesh-ancestor
6450023|NCT00406237|Tigecycline|tigecycline|mesh-list
6450024|NCT00406237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6613826|NCT01234792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724863|NCT03184649|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6450025|NCT00406237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6613827|NCT01234792|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6613828|NCT01234792|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6613829|NCT01234792|Cholinergic Agents|cholinergic agents|mesh-ancestor
6613830|NCT01234792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6613831|NCT01234792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613832|NCT01234818|Levonorgestrel|levonorgestrel|mesh-list
6613833|NCT01234818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6450026|NCT00406237|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6450027|NCT00406237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6450028|NCT00406237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613834|NCT01234818|Contraceptive Agents|contraceptive agents|mesh-ancestor
6613835|NCT01234818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6613836|NCT01234818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613837|NCT01234818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6613838|NCT01234818|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6613839|NCT01234818|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6613840|NCT01234857|Sirolimus|sirolimus|mesh-list
6613841|NCT01234857|Exemestane|exemestane|mesh-list
6613842|NCT01234857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6613843|NCT01234857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6613844|NCT01234857|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6613845|NCT01234857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6613846|NCT01234857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6613847|NCT01234857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613848|NCT01234857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6450029|NCT00406250|Bevacizumab|bevacizumab|mesh-list
6450030|NCT00406250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6450031|NCT00406250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6450032|NCT00406250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6450033|NCT00406250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6450034|NCT00406250|Growth Substances|growth substances|mesh-ancestor
6450035|NCT00406250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450036|NCT00406250|Growth Inhibitors|growth inhibitors|mesh-ancestor
6613849|NCT01234857|Hormone Antagonists|hormone antagonists|mesh-ancestor
6613850|NCT01234857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6613851|NCT01234857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613852|NCT01234857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6613853|NCT01234857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6613854|NCT01234857|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6613855|NCT01234857|Antifungal Agents|antifungal agents|mesh-ancestor
6613856|NCT01234857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6613857|NCT01234857|Immunologic Factors|immunologic factors|mesh-ancestor
6613858|NCT01234896|Nicotine|nicotine|mesh-list
6613859|NCT01234896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6613860|NCT01234896|Autonomic Agents|autonomic agents|mesh-ancestor
6613861|NCT01234896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6613862|NCT01234896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613863|NCT01234896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6613864|NCT01234896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6613865|NCT01234896|Cholinergic Agents|cholinergic agents|mesh-ancestor
6613866|NCT01234896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6613867|NCT01234896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613868|NCT01234935|Gemcitabine|gemcitabine|mesh-list
6613869|NCT01234935|Dasatinib|dasatinib|mesh-list
6613870|NCT01234935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6613871|NCT01234935|Antimetabolites|antimetabolites|mesh-ancestor
6613872|NCT01234935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613873|NCT01234935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6613874|NCT01234935|Antiviral Agents|antiviral agents|mesh-ancestor
6613875|NCT01234935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6613876|NCT01234935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6613877|NCT01234935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6613878|NCT01234935|Immunologic Factors|immunologic factors|mesh-ancestor
6613879|NCT01234935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613880|NCT01234935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6613881|NCT01234974|Everolimus|everolimus|mesh-list
6613882|NCT01234974|Pasireotide|pasireotide|mesh-list
6613883|NCT01234974|Somatostatin|somatostatin|mesh-list
6613884|NCT01234974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6613885|NCT01234974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6613886|NCT01234974|Immunologic Factors|immunologic factors|mesh-ancestor
6613887|NCT01234974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613888|NCT01234974|Hormones|hormones|mesh-ancestor
6613889|NCT01234974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6613890|NCT01235013|Maraviroc|maraviroc|mesh-list
6613891|NCT01235013|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6613892|NCT01235013|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6613893|NCT01235013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613894|NCT01235013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6613895|NCT01235013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6613896|NCT01235013|Antiviral Agents|antiviral agents|mesh-ancestor
6613897|NCT01235013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6613898|NCT01235013|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6613899|NCT01235117|Azacitidine|azacitidine|mesh-list
6613900|NCT01235117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6613901|NCT01235117|Antimetabolites|antimetabolites|mesh-ancestor
6613902|NCT01235117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613903|NCT01235117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6613904|NCT01235117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6613905|NCT01235143|Sevoflurane|sevoflurane|mesh-list
6613906|NCT01235143|Desflurane|desflurane|mesh-list
6613907|NCT01235143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6613908|NCT01235143|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6613909|NCT01235143|Anesthetics, General|anesthetics, general|mesh-ancestor
6613910|NCT01235143|Anesthetics|anesthetics|mesh-ancestor
6613911|NCT01235143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6613912|NCT01235143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613913|NCT01235221|4-Aminopyridine|4-aminopyridine|mesh-list
6613914|NCT01235221|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6613915|NCT01235221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6613916|NCT01235221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613917|NCT01235260|Becaplermin|becaplermin|mesh-list
6613918|NCT01235260|Anticoagulants|anticoagulants|mesh-ancestor
6613919|NCT01235260|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
6613920|NCT01235260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6613921|NCT01235260|Growth Substances|growth substances|mesh-ancestor
6613922|NCT01235260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613923|NCT01235273|Hormones|hormones|mesh-list
6613924|NCT01235273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6613925|NCT01235273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724864|NCT03184649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6613926|NCT01235325|Vitamin K|vitamin k|mesh-list
6613927|NCT01235325|Vitamin K 1|vitamin k 1|mesh-list
6613928|NCT01235325|Vitamins|vitamins|mesh-ancestor
6613929|NCT01235325|Micronutrients|micronutrients|mesh-ancestor
6613930|NCT01235325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613931|NCT01235325|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6613932|NCT01235325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6613933|NCT01235325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613934|NCT01235325|Hemostatics|hemostatics|mesh-ancestor
6613935|NCT01235325|Coagulants|coagulants|mesh-ancestor
6613936|NCT01235416|Motesanib diphosphate|motesanib diphosphate|mesh-list
6613937|NCT01235416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6613938|NCT01235416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6613939|NCT01235416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613940|NCT01235455|Interferons|interferons|mesh-list
6613941|NCT01235455|Interferon-beta|interferon-beta|mesh-list
6613942|NCT01235455|Interferon beta-1b|interferon beta-1b|mesh-list
6613943|NCT01235455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6613944|NCT01235455|Antiviral Agents|antiviral agents|mesh-ancestor
6613945|NCT01235455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6613946|NCT01235455|Immunologic Factors|immunologic factors|mesh-ancestor
6613947|NCT01235455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613948|NCT01235455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6613949|NCT01235637|Sufentanil|sufentanil|mesh-list
6613950|NCT01235637|Alfentanil|alfentanil|mesh-list
6613951|NCT01235637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6613952|NCT01235637|Narcotics|narcotics|mesh-ancestor
6613953|NCT01235637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6613954|NCT01235637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613955|NCT01235637|Analgesics|analgesics|mesh-ancestor
6613956|NCT01235637|Sensory System Agents|sensory system agents|mesh-ancestor
6613957|NCT01235637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6613958|NCT01235637|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6613959|NCT01235637|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6613960|NCT01235637|Anesthetics, General|anesthetics, general|mesh-ancestor
6613961|NCT01235637|Anesthetics|anesthetics|mesh-ancestor
6661163|NCT01497444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6661164|NCT01497444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6661165|NCT01497444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6661166|NCT01497444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661167|NCT01497470|Paclitaxel|paclitaxel|mesh-list
6661168|NCT01497470|Carboplatin|carboplatin|mesh-list
6661169|NCT01497470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6661170|NCT01497470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6661171|NCT01497470|Tubulin Modulators|tubulin modulators|mesh-ancestor
6661172|NCT01497470|Antimitotic Agents|antimitotic agents|mesh-ancestor
6661173|NCT01497470|Mitosis Modulators|mitosis modulators|mesh-ancestor
6661174|NCT01497470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661175|NCT01497483|Cyclosporine|cyclosporine|mesh-list
6661176|NCT01497483|Pravastatin|pravastatin|mesh-list
6661177|NCT01497483|Cyclosporins|cyclosporins|mesh-list
6661178|NCT01497483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6661179|NCT01497483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661180|NCT01497483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6661181|NCT01497483|Immunologic Factors|immunologic factors|mesh-ancestor
6661182|NCT01497483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661183|NCT01497483|Antifungal Agents|antifungal agents|mesh-ancestor
6661184|NCT01497483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6661185|NCT01497483|Dermatologic Agents|dermatologic agents|mesh-ancestor
6661186|NCT01497483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6661187|NCT01497483|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6661188|NCT01497483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6661189|NCT01497483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6661190|NCT01497483|Antimetabolites|antimetabolites|mesh-ancestor
6661191|NCT01497483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6661192|NCT01497483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6661193|NCT01497509|Epinephrine|epinephrine|mesh-list
6661194|NCT01497509|Racepinephrine|racepinephrine|mesh-list
6661195|NCT01497509|Fentanyl|fentanyl|mesh-list
6661196|NCT01497509|Bupivacaine|bupivacaine|mesh-list
6661197|NCT01497509|Epinephryl borate|epinephryl borate|mesh-list
6661198|NCT01497509|Anesthetics, Local|anesthetics, local|mesh-ancestor
6661199|NCT01497509|Anesthetics|anesthetics|mesh-ancestor
6661200|NCT01497509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6661201|NCT01497509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661202|NCT01497509|Sensory System Agents|sensory system agents|mesh-ancestor
6661203|NCT01497509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6661204|NCT01497509|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6661205|NCT01497509|Narcotics|narcotics|mesh-ancestor
6661206|NCT01497509|Analgesics|analgesics|mesh-ancestor
6661207|NCT01497509|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6661208|NCT01497509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6661209|NCT01497509|Anesthetics, General|anesthetics, general|mesh-ancestor
6661210|NCT01497509|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6661211|NCT01497509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6613962|NCT01235819|Insulin|insulin|mesh-list
6613963|NCT01235819|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6613964|NCT01235819|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6613965|NCT01235819|Exenatide|exenatide|mesh-list
6613966|NCT01235819|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
6613967|NCT01235819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6613968|NCT01235819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613969|NCT01235819|Incretins|incretins|mesh-ancestor
6613970|NCT01235819|Hormones|hormones|mesh-ancestor
6613971|NCT01235819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6613972|NCT01235819|Protease Inhibitors|protease inhibitors|mesh-ancestor
6613973|NCT01235819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6613974|NCT01235819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6613975|NCT01235819|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6613976|NCT01236040|Vaccines|vaccines|mesh-list
6613977|NCT01236040|Immunologic Factors|immunologic factors|mesh-ancestor
6613978|NCT01236040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613979|NCT01236144|Plerixafor|plerixafor|mesh-list
6613980|NCT01236144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6613981|NCT01236144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6613982|NCT01236144|Antiviral Agents|antiviral agents|mesh-ancestor
6613983|NCT01236144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6613984|NCT01236482|Oxytocin|oxytocin|mesh-list
6613985|NCT01236482|Ergonovine|ergonovine|mesh-list
6613986|NCT01236482|Oxytocics|oxytocics|mesh-ancestor
6613987|NCT01236482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6613988|NCT01236482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613989|NCT01236495|Morphine|morphine|mesh-list
6613990|NCT01236495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6613991|NCT01236495|Narcotics|narcotics|mesh-ancestor
6613992|NCT01236495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6613993|NCT01236495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6613994|NCT01236495|Analgesics|analgesics|mesh-ancestor
6613995|NCT01236495|Sensory System Agents|sensory system agents|mesh-ancestor
6613996|NCT01236495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6613997|NCT01236508|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6613998|NCT01236508|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6613999|NCT01236508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614000|NCT01236586|Dexamethasone|dexamethasone|mesh-list
6614001|NCT01236586|R04929097|r04929097|mesh-list
6614002|NCT01236586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6614003|NCT01236586|Antiemetics|antiemetics|mesh-ancestor
6614004|NCT01236586|Autonomic Agents|autonomic agents|mesh-ancestor
6614005|NCT01236586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6614006|NCT01236586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614007|NCT01236586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6614008|NCT01236586|Glucocorticoids|glucocorticoids|mesh-ancestor
6614009|NCT01236586|Hormones|hormones|mesh-ancestor
6614010|NCT01236586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6614011|NCT01236586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6614012|NCT01236586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6614013|NCT01236586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6614014|NCT01236586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614015|NCT01236612|Chloroquine|chloroquine|mesh-list
6614016|NCT01236612|Proguanil|proguanil|mesh-list
6614017|NCT01236612|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
6614018|NCT01236612|Vaccines|vaccines|mesh-list
6614019|NCT01236612|Amebicides|amebicides|mesh-ancestor
6614020|NCT01236612|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6614021|NCT01236612|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6614022|NCT01236612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6614023|NCT01236612|Antimalarials|antimalarials|mesh-ancestor
6614024|NCT01236612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5724865|NCT03184649|Analgesics|analgesics|mesh-ancestor
6614025|NCT01236612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614026|NCT01236612|Immunologic Factors|immunologic factors|mesh-ancestor
6614027|NCT01236612|Antimetabolites|antimetabolites|mesh-ancestor
6614028|NCT01236612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614029|NCT01236651|Drotaverin|drotaverin|mesh-list
6614030|NCT01236651|Meperidine|meperidine|mesh-list
6614031|NCT01236651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6614032|NCT01236651|Narcotics|narcotics|mesh-ancestor
6614033|NCT01236651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6614034|NCT01236651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614035|NCT01236651|Analgesics|analgesics|mesh-ancestor
6614036|NCT01236651|Sensory System Agents|sensory system agents|mesh-ancestor
6614037|NCT01236651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6614038|NCT01236651|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6614039|NCT01236651|Parasympatholytics|parasympatholytics|mesh-ancestor
6614040|NCT01236651|Autonomic Agents|autonomic agents|mesh-ancestor
6614041|NCT01236651|Vasodilator Agents|vasodilator agents|mesh-ancestor
6614042|NCT01236716|Gemcitabine|gemcitabine|mesh-list
6614043|NCT01236716|Paclitaxel|paclitaxel|mesh-list
6614044|NCT01236716|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6614045|NCT01236716|Carboplatin|carboplatin|mesh-list
6614046|NCT01236716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6614047|NCT01236716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6614048|NCT01236716|Tubulin Modulators|tubulin modulators|mesh-ancestor
6614049|NCT01236716|Antimitotic Agents|antimitotic agents|mesh-ancestor
6614050|NCT01236716|Mitosis Modulators|mitosis modulators|mesh-ancestor
6614051|NCT01236716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614052|NCT01236716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6614053|NCT01236716|Antimetabolites|antimetabolites|mesh-ancestor
6614054|NCT01236716|Antiviral Agents|antiviral agents|mesh-ancestor
6614055|NCT01236716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6614056|NCT01236716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6614057|NCT01236716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6614058|NCT01236716|Immunologic Factors|immunologic factors|mesh-ancestor
6614059|NCT01236716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614060|NCT01236859|Gabapentin|gabapentin|mesh-list
6614061|NCT01236859|Analgesics|analgesics|mesh-ancestor
6614062|NCT01236859|Sensory System Agents|sensory system agents|mesh-ancestor
6614063|NCT01236859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6614064|NCT01236859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614065|NCT01236859|Anticonvulsants|anticonvulsants|mesh-ancestor
6614066|NCT01236859|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6614067|NCT01236859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6614068|NCT01236859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6614069|NCT01236859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6614070|NCT01236859|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6614071|NCT01236859|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6614072|NCT01236859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6614073|NCT01236859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614074|NCT01236859|Antimanic Agents|antimanic agents|mesh-ancestor
6614075|NCT01236911|Calcium|calcium|mesh-list
6614076|NCT01236911|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6614077|NCT01236911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614078|NCT01236950|Listerine|listerine|mesh-list
6614079|NCT01236950|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6614080|NCT01236950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6614081|NCT01236963|Listerine|listerine|mesh-list
6614082|NCT01236963|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6614083|NCT01236963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6614084|NCT01236989|Liver Extracts|liver extracts|mesh-list
6614085|NCT01236989|Hematinics|hematinics|mesh-ancestor
6614086|NCT01237028|Calcitriol|calcitriol|mesh-list
6614087|NCT01237028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6614088|NCT01237028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614089|NCT01237028|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6614090|NCT01237028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6614091|NCT01237028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614092|NCT01237028|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6614093|NCT01237028|Vitamins|vitamins|mesh-ancestor
6614094|NCT01237028|Micronutrients|micronutrients|mesh-ancestor
6614095|NCT01237028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6614096|NCT01237067|Carboplatin|carboplatin|mesh-list
6614097|NCT01237067|Olaparib|olaparib|mesh-list
6614098|NCT01237067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6614099|NCT01237067|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6614100|NCT01237067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6614101|NCT01237067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614102|NCT01237119|Liraglutide|liraglutide|mesh-list
6614103|NCT01237119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6614104|NCT01237119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614105|NCT01237119|Incretins|incretins|mesh-ancestor
6614106|NCT01237119|Hormones|hormones|mesh-ancestor
6614107|NCT01237119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6614108|NCT01237249|Dexamethasone|dexamethasone|mesh-list
6614109|NCT01237249|Prednisone|prednisone|mesh-list
6614110|NCT01237249|Melphalan|melphalan|mesh-list
6614111|NCT01237249|Lenalidomide|lenalidomide|mesh-list
6614112|NCT01237249|Bortezomib|bortezomib|mesh-list
6614113|NCT01237249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6614114|NCT01237249|Antiemetics|antiemetics|mesh-ancestor
6614115|NCT01237249|Autonomic Agents|autonomic agents|mesh-ancestor
6614116|NCT01237249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6614117|NCT01237249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614118|NCT01237249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6614119|NCT01237249|Glucocorticoids|glucocorticoids|mesh-ancestor
6614120|NCT01237249|Hormones|hormones|mesh-ancestor
6614121|NCT01237249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6614122|NCT01237249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6614123|NCT01237249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6614124|NCT01237249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6614125|NCT01237249|Alkylating Agents|alkylating agents|mesh-ancestor
6450037|NCT00406289|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6020735|NCT00394251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6020736|NCT00394251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6020737|NCT00394251|Alkylating Agents|alkylating agents|mesh-ancestor
6020738|NCT00394251|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6020739|NCT00394251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6020740|NCT00394251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6020741|NCT00394251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6020742|NCT00394251|Growth Substances|growth substances|mesh-ancestor
6614126|NCT01237249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614127|NCT01237249|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6614128|NCT01237249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6614129|NCT01237249|Immunologic Factors|immunologic factors|mesh-ancestor
6614130|NCT01237249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6614131|NCT01237249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6614132|NCT01237249|Growth Substances|growth substances|mesh-ancestor
6614133|NCT01237249|Growth Inhibitors|growth inhibitors|mesh-ancestor
6614134|NCT01237262|Adalimumab|adalimumab|mesh-list
6614135|NCT01237262|Etanercept|etanercept|mesh-list
6614136|NCT01237262|Infliximab|infliximab|mesh-list
6614137|NCT01237262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6614138|NCT01237262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6614139|NCT01237262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6614140|NCT01237262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6614141|NCT01237262|Analgesics|analgesics|mesh-ancestor
6614142|NCT01237262|Sensory System Agents|sensory system agents|mesh-ancestor
6614143|NCT01237262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6614144|NCT01237262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614145|NCT01237262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6614146|NCT01237262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6614147|NCT01237262|Immunologic Factors|immunologic factors|mesh-ancestor
6614148|NCT01237262|Dermatologic Agents|dermatologic agents|mesh-ancestor
6614149|NCT01237275|Sertraline|sertraline|mesh-list
6614150|NCT01237275|Fluoxetine|fluoxetine|mesh-list
6614151|NCT01237275|Paroxetine|paroxetine|mesh-list
6614152|NCT01237275|Antidepressive Agents|antidepressive agents|mesh-ancestor
6614153|NCT01237275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6614154|NCT01237275|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6614155|NCT01237275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6614156|NCT01237275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6614157|NCT01237275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614158|NCT01237275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6614159|NCT01237275|Serotonin Agents|serotonin agents|mesh-ancestor
6614160|NCT01237275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614161|NCT01237275|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6614162|NCT01237275|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6614163|NCT01237275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6614164|NCT01237275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6614165|NCT01237444|Ritonavir|ritonavir|mesh-list
6450038|NCT00406289|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6450039|NCT00406289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450040|NCT00406302|Docetaxel|docetaxel|mesh-list
6450041|NCT00406302|Oxaliplatin|oxaliplatin|mesh-list
6450042|NCT00406302|Cetuximab|cetuximab|mesh-list
6450043|NCT00406302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6450044|NCT00406302|Tubulin Modulators|tubulin modulators|mesh-ancestor
6450045|NCT00406302|Antimitotic Agents|antimitotic agents|mesh-ancestor
6450046|NCT00406302|Mitosis Modulators|mitosis modulators|mesh-ancestor
6614166|NCT01237444|Lopinavir|lopinavir|mesh-list
6614167|NCT01237444|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6614168|NCT01237444|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6614169|NCT01237444|Protease Inhibitors|protease inhibitors|mesh-ancestor
6614170|NCT01237444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6614171|NCT01237444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614172|NCT01237444|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6614173|NCT01237444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6614174|NCT01237444|Antiviral Agents|antiviral agents|mesh-ancestor
6614175|NCT01237444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6614176|NCT01237444|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6614177|NCT01237444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6614178|NCT01237457|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
6614179|NCT01237457|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6614180|NCT01237457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614181|NCT01237483|Cetuximab|cetuximab|mesh-list
6614182|NCT01237483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6614183|NCT01237483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6614184|NCT01237496|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6614185|NCT01237496|Antiviral Agents|antiviral agents|mesh-ancestor
6614186|NCT01237496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6614187|NCT01237522|Metformin|metformin|mesh-list
6614188|NCT01237522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6614189|NCT01237522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614190|NCT01237535|Progesterone|progesterone|mesh-list
6614191|NCT01237535|Estrogens|estrogens|mesh-list
6614192|NCT01237535|Progestins|progestins|mesh-ancestor
6614193|NCT01237535|Hormones|hormones|mesh-ancestor
6614194|NCT01237535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6614195|NCT01237535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661212|NCT01497509|Adrenergic Agents|adrenergic agents|mesh-ancestor
6661213|NCT01497509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6661214|NCT01497509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661215|NCT01497509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6661216|NCT01497509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6661217|NCT01497509|Autonomic Agents|autonomic agents|mesh-ancestor
6661218|NCT01497509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6661219|NCT01497509|Respiratory System Agents|respiratory system agents|mesh-ancestor
6661220|NCT01497509|Mydriatics|mydriatics|mesh-ancestor
6661221|NCT01497509|Sympathomimetics|sympathomimetics|mesh-ancestor
6661222|NCT01497509|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6661223|NCT01497522|Vildagliptin|vildagliptin|mesh-list
6661224|NCT01497522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6661225|NCT01497522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661226|NCT01497522|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6661227|NCT01497522|Protease Inhibitors|protease inhibitors|mesh-ancestor
6661228|NCT01497522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6661229|NCT01497522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661230|NCT01497535|Insulin|insulin|mesh-list
6661231|NCT01497535|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6661232|NCT01497535|Insulin Glargine|insulin glargine|mesh-list
6661233|NCT01497535|Insulin Detemir|insulin detemir|mesh-list
6661234|NCT01497535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6661235|NCT01497535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661236|NCT01497548|Methylphenidate|methylphenidate|mesh-list
6450047|NCT00406302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450048|NCT00406302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6450049|NCT00406341|Difluprednate|difluprednate|mesh-list
6450050|NCT00406341|Glucocorticoids|glucocorticoids|mesh-ancestor
6450051|NCT00406341|Hormones|hormones|mesh-ancestor
6450052|NCT00406341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6450053|NCT00406341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450054|NCT00406380|Bevacizumab|bevacizumab|mesh-list
6450055|NCT00406380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6450056|NCT00406380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6450057|NCT00406380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6450058|NCT00406380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6450059|NCT00406380|Growth Substances|growth substances|mesh-ancestor
6450060|NCT00406380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450061|NCT00406380|Growth Inhibitors|growth inhibitors|mesh-ancestor
6450062|NCT00406432|Paroxetine|paroxetine|mesh-list
6450063|NCT00406432|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6614196|NCT01237730|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6614197|NCT01237730|Cefuroxime|cefuroxime|mesh-list
6614198|NCT01237730|Cefuroxime axetil|cefuroxime axetil|mesh-list
6614199|NCT01237730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6614200|NCT01237769|Vitamin D|vitamin d|mesh-list
6614201|NCT01237769|Ergocalciferols|ergocalciferols|mesh-list
6614202|NCT01237769|Cholecalciferol|cholecalciferol|mesh-list
6614203|NCT01237769|Vitamins|vitamins|mesh-list
6614204|NCT01237769|Micronutrients|micronutrients|mesh-ancestor
6614205|NCT01237769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614206|NCT01237769|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6614207|NCT01237769|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6614208|NCT01237782|Propolis|propolis|mesh-list
6614209|NCT01237782|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6614210|NCT01237782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6614211|NCT01237808|Cytarabine|cytarabine|mesh-list
6614212|NCT01237808|Etoposide|etoposide|mesh-list
6614213|NCT01237808|Tretinoin|tretinoin|mesh-list
6614214|NCT01237808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6614215|NCT01237808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6614216|NCT01237808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6614217|NCT01237808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6614218|NCT01237808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6614219|NCT01237808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614220|NCT01237808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6614221|NCT01237808|Antimetabolites|antimetabolites|mesh-ancestor
6614222|NCT01237808|Antiviral Agents|antiviral agents|mesh-ancestor
6614223|NCT01237808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6614224|NCT01237808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6614225|NCT01237808|Immunologic Factors|immunologic factors|mesh-ancestor
6614226|NCT01237808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614227|NCT01237808|Keratolytic Agents|keratolytic agents|mesh-ancestor
6614228|NCT01237808|Dermatologic Agents|dermatologic agents|mesh-ancestor
6614229|NCT01237925|Chlorpheniramine|chlorpheniramine|mesh-list
6614230|NCT01237925|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
6614231|NCT01237925|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6614232|NCT01237925|Histamine Antagonists|histamine antagonists|mesh-ancestor
6614233|NCT01237925|Histamine Agents|histamine agents|mesh-ancestor
6614234|NCT01237925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6614235|NCT01237925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614236|NCT01237925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614237|NCT01237925|Antipruritics|antipruritics|mesh-ancestor
6614238|NCT01237925|Dermatologic Agents|dermatologic agents|mesh-ancestor
6614239|NCT01237925|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6614240|NCT01237977|Botulinum Toxins|botulinum toxins|mesh-list
6614241|NCT01237977|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6614242|NCT01237977|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6614243|NCT01237977|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6614244|NCT01237977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6614245|NCT01237977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614246|NCT01237977|Cholinergic Agents|cholinergic agents|mesh-ancestor
6614247|NCT01237977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6614248|NCT01237977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614249|NCT01237977|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6614250|NCT01237977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6614251|NCT01238029|Capecitabine|capecitabine|mesh-list
6614252|NCT01238029|Vinorelbine|vinorelbine|mesh-list
6614253|NCT01238029|Lapatinib|lapatinib|mesh-list
6614254|NCT01238029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6614255|NCT01238029|Antimetabolites|antimetabolites|mesh-ancestor
6614256|NCT01238029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614257|NCT01238029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6614258|NCT01238029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6614259|NCT01238029|Tubulin Modulators|tubulin modulators|mesh-ancestor
6614260|NCT01238029|Antimitotic Agents|antimitotic agents|mesh-ancestor
6614261|NCT01238029|Mitosis Modulators|mitosis modulators|mesh-ancestor
6614262|NCT01238029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6614263|NCT01238029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6614264|NCT01238055|Docetaxel|docetaxel|mesh-list
6614265|NCT01238055|Sunitinib|sunitinib|mesh-list
6614266|NCT01238055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6614267|NCT01238055|Tubulin Modulators|tubulin modulators|mesh-ancestor
6614268|NCT01238055|Antimitotic Agents|antimitotic agents|mesh-ancestor
6614269|NCT01238055|Mitosis Modulators|mitosis modulators|mesh-ancestor
6614270|NCT01238055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614271|NCT01238055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6614272|NCT01238055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6614273|NCT01238055|Growth Substances|growth substances|mesh-ancestor
6614274|NCT01238055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614275|NCT01238055|Growth Inhibitors|growth inhibitors|mesh-ancestor
6614276|NCT01238055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6614277|NCT01238055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6614278|NCT01238094|Simvastatin|simvastatin|mesh-list
6614279|NCT01238094|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6614280|NCT01238094|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6614281|NCT01238094|Antimetabolites|antimetabolites|mesh-ancestor
6614282|NCT01238094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614283|NCT01238094|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6614284|NCT01238094|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6614285|NCT01238094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6614286|NCT01238133|Paclitaxel|paclitaxel|mesh-list
6614287|NCT01238133|Carboplatin|carboplatin|mesh-list
6614288|NCT01238133|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6614289|NCT01238133|R04929097|r04929097|mesh-list
6614290|NCT01238133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6614291|NCT01238133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6614292|NCT01238133|Tubulin Modulators|tubulin modulators|mesh-ancestor
6614293|NCT01238133|Antimitotic Agents|antimitotic agents|mesh-ancestor
6614294|NCT01238133|Mitosis Modulators|mitosis modulators|mesh-ancestor
6614295|NCT01238133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614296|NCT01238133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6614297|NCT01238146|Rituximab|rituximab|mesh-list
6614298|NCT01238146|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6614299|NCT01238146|Obatoclax|obatoclax|mesh-list
6614300|NCT01238146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6614301|NCT01238146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6614302|NCT01238146|Immunologic Factors|immunologic factors|mesh-ancestor
6614303|NCT01238146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614304|NCT01238146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6614305|NCT01238146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6614306|NCT01238146|Alkylating Agents|alkylating agents|mesh-ancestor
6614307|NCT01238146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614308|NCT01238146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6614309|NCT01238185|Aspirin|aspirin|mesh-list
6614310|NCT01238185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6614311|NCT01238185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6614312|NCT01238185|Analgesics|analgesics|mesh-ancestor
6614313|NCT01238185|Sensory System Agents|sensory system agents|mesh-ancestor
6614314|NCT01238185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6614315|NCT01238185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614316|NCT01238185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6614317|NCT01238185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6614318|NCT01238185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6614319|NCT01238185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6614320|NCT01238185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614321|NCT01238185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6614322|NCT01238185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6614323|NCT01238185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6614324|NCT01238185|Antipyretics|antipyretics|mesh-ancestor
6614325|NCT01238224|Tadalafil|tadalafil|mesh-list
6614326|NCT01238224|Vasodilator Agents|vasodilator agents|mesh-ancestor
6614327|NCT01238224|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6614328|NCT01238224|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6614329|NCT01238224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6614330|NCT01238224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614331|NCT01238224|Urological Agents|urological agents|mesh-ancestor
6614332|NCT01238237|Cetuximab|cetuximab|mesh-list
6614333|NCT01238237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6614334|NCT01238237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6614335|NCT01238276|Cefazolin|cefazolin|mesh-list
6614336|NCT01238276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6614337|NCT01238276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6614338|NCT01238328|Thymoglobulin|thymoglobulin|mesh-list
6614339|NCT01238328|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6614340|NCT01238328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6614341|NCT01238328|Immunologic Factors|immunologic factors|mesh-ancestor
6614342|NCT01238328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614343|NCT01238367|Factor VIII|factor viii|mesh-list
6614344|NCT01238367|Coagulants|coagulants|mesh-ancestor
6614345|NCT01238393|Ranibizumab|ranibizumab|mesh-list
6614346|NCT01238393|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6614347|NCT01238393|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6614348|NCT01238393|Growth Substances|growth substances|mesh-ancestor
6614349|NCT01238393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614350|NCT01238393|Growth Inhibitors|growth inhibitors|mesh-ancestor
6614351|NCT01238393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6614352|NCT01238406|Pancrelipase|pancrelipase|mesh-list
6614353|NCT01238406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6614354|NCT01238523|Calpastatin|calpastatin|mesh-list
6614355|NCT01238523|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
6614356|NCT01238523|Protease Inhibitors|protease inhibitors|mesh-ancestor
6614357|NCT01238523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6614358|NCT01238523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614359|NCT01238562|Lenograstim|lenograstim|mesh-list
6614360|NCT01238562|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6614361|NCT01238562|Immunologic Factors|immunologic factors|mesh-ancestor
6614362|NCT01238562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614363|NCT01238627|Nicotine|nicotine|mesh-list
6614364|NCT01238627|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6614365|NCT01238627|Autonomic Agents|autonomic agents|mesh-ancestor
6614366|NCT01238627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6614367|NCT01238627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614368|NCT01238627|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6614369|NCT01238627|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6614370|NCT01238627|Cholinergic Agents|cholinergic agents|mesh-ancestor
6614371|NCT01238627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6614372|NCT01238627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614373|NCT01238692|Rituximab|rituximab|mesh-list
6614374|NCT01238692|Panobinostat|panobinostat|mesh-list
6614375|NCT01238692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6614376|NCT01238692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6614377|NCT01238692|Immunologic Factors|immunologic factors|mesh-ancestor
6614378|NCT01238692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614379|NCT01238692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6614380|NCT01238692|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6614381|NCT01238692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6614382|NCT01238692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614383|NCT01238705|Metoprolol|metoprolol|mesh-list
6614384|NCT01238705|Felodipine|felodipine|mesh-list
6614385|NCT01238705|Irbesartan|irbesartan|mesh-list
6614386|NCT01238705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6614387|NCT01238705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6614388|NCT01238705|Sympatholytics|sympatholytics|mesh-ancestor
6614389|NCT01238705|Autonomic Agents|autonomic agents|mesh-ancestor
6614390|NCT01238705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6614391|NCT01238705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614392|NCT01238705|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6614393|NCT01238705|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6614394|NCT01238705|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6614395|NCT01238705|Adrenergic Agents|adrenergic agents|mesh-ancestor
6614396|NCT01238705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6614397|NCT01238705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614398|NCT01238705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6614399|NCT01238705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6614400|NCT01238705|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6614401|NCT01238705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6614402|NCT01238705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6614403|NCT01238705|Vasodilator Agents|vasodilator agents|mesh-ancestor
6614404|NCT01238718|Lidocaine|lidocaine|mesh-list
6614405|NCT01238718|Anesthetics, Local|anesthetics, local|mesh-ancestor
6614406|NCT01238718|Anesthetics|anesthetics|mesh-ancestor
6614407|NCT01238718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6614408|NCT01238718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614409|NCT01238718|Sensory System Agents|sensory system agents|mesh-ancestor
6614410|NCT01238718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6614411|NCT01238718|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6614412|NCT01238718|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6614413|NCT01238718|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6614414|NCT01238718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6020743|NCT00394251|Growth Inhibitors|growth inhibitors|mesh-ancestor
6020744|NCT00394251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6614415|NCT01238718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614416|NCT01238770|Cyclophosphamide|cyclophosphamide|mesh-list
6614417|NCT01238770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6614418|NCT01238770|Immunologic Factors|immunologic factors|mesh-ancestor
6614419|NCT01238770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614420|NCT01238770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6614421|NCT01238770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6614422|NCT01238770|Alkylating Agents|alkylating agents|mesh-ancestor
6614423|NCT01238770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614424|NCT01238770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6614425|NCT01238770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6614426|NCT01238796|Telavancin|telavancin|mesh-list
6614427|NCT01238796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6614428|NCT01238796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6614429|NCT01238926|Vitamins|vitamins|mesh-list
6614430|NCT01238926|Folic Acid|folic acid|mesh-list
6614431|NCT01238926|Hydroxocobalamin|hydroxocobalamin|mesh-list
6614432|NCT01238926|Vitamin B 12|vitamin b 12|mesh-list
6614433|NCT01238926|Vitamin B 6|vitamin b 6|mesh-list
6614434|NCT01238926|Pyridoxal|pyridoxal|mesh-list
6614435|NCT01238926|Pyridoxine|pyridoxine|mesh-list
6614436|NCT01238926|Vitamin B Complex|vitamin b complex|mesh-list
6614437|NCT01238926|Micronutrients|micronutrients|mesh-ancestor
6614438|NCT01238926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614439|NCT01238926|Hematinics|hematinics|mesh-ancestor
6614440|NCT01238952|Carboplatin|carboplatin|mesh-list
6614441|NCT01238952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6614442|NCT01238965|Calcium, Dietary|calcium, dietary|mesh-list
6614443|NCT01238965|Leucovorin|leucovorin|mesh-list
6614444|NCT01238965|Fluorouracil|fluorouracil|mesh-list
6614445|NCT01238965|Panobinostat|panobinostat|mesh-list
6614446|NCT01238965|Calcium|calcium|mesh-list
6614447|NCT01238965|Levoleucovorin|levoleucovorin|mesh-list
6614448|NCT01238965|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
6614449|NCT01238965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6614450|NCT01238965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614451|NCT01238965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6614452|NCT01238965|Antimetabolites|antimetabolites|mesh-ancestor
6614453|NCT01238965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614454|NCT01238965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6614455|NCT01238965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6614456|NCT01238965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6614457|NCT01238965|Immunologic Factors|immunologic factors|mesh-ancestor
6450064|NCT00406432|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6614458|NCT01238965|Antidotes|antidotes|mesh-ancestor
6614459|NCT01238965|Protective Agents|protective agents|mesh-ancestor
6614460|NCT01238965|Vitamin B Complex|vitamin b complex|mesh-ancestor
6614461|NCT01238965|Vitamins|vitamins|mesh-ancestor
6614462|NCT01238965|Micronutrients|micronutrients|mesh-ancestor
6614463|NCT01238965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6614464|NCT01238978|Vildagliptin|vildagliptin|mesh-list
6614465|NCT01238978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6614466|NCT01238978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614467|NCT01238978|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6614468|NCT01238978|Protease Inhibitors|protease inhibitors|mesh-ancestor
6614469|NCT01238978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6614470|NCT01238978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614471|NCT01239004|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
6450065|NCT00406432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6450066|NCT00406432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450067|NCT00406432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6450068|NCT00406432|Serotonin Agents|serotonin agents|mesh-ancestor
6450069|NCT00406432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450070|NCT00406432|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6450071|NCT00406432|Antidepressive Agents|antidepressive agents|mesh-ancestor
6450072|NCT00406432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6614472|NCT01239004|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6614473|NCT01239004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6614474|NCT01239004|Antimetabolites|antimetabolites|mesh-ancestor
6614475|NCT01239004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614476|NCT01239004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6614477|NCT01239017|Fasinumab|fasinumab|mesh-list
6614478|NCT01239017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6614479|NCT01239017|Analgesics|analgesics|mesh-ancestor
6614480|NCT01239017|Sensory System Agents|sensory system agents|mesh-ancestor
6614481|NCT01239017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6614482|NCT01239017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614483|NCT01239030|Methylphenidate|methylphenidate|mesh-list
6614484|NCT01239030|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6614485|NCT01239030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614486|NCT01239030|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6614487|NCT01239030|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6614488|NCT01239030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6614489|NCT01239030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614490|NCT01239030|Dopamine Agents|dopamine agents|mesh-ancestor
6614491|NCT01239030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6614492|NCT01239173|Propranolol|propranolol|mesh-list
6614493|NCT01239173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6614494|NCT01239173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6614495|NCT01239173|Adrenergic Agents|adrenergic agents|mesh-ancestor
6614496|NCT01239173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6614497|NCT01239173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614498|NCT01239173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614499|NCT01239173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6614500|NCT01239173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6614501|NCT01239173|Vasodilator Agents|vasodilator agents|mesh-ancestor
6661237|NCT01497548|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6661238|NCT01497548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661239|NCT01497548|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6661240|NCT01497548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6661241|NCT01497548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6661242|NCT01497548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661243|NCT01497548|Dopamine Agents|dopamine agents|mesh-ancestor
6661244|NCT01497548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6661245|NCT01497561|Insulin|insulin|mesh-list
6661246|NCT01497561|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6661247|NCT01497561|Insulin Detemir|insulin detemir|mesh-list
6661248|NCT01497561|Isophane Insulin, Human|isophane insulin, human|mesh-list
6661249|NCT01497561|Insulin, Isophane|insulin, isophane|mesh-list
6661250|NCT01497561|Isophane insulin, beef|isophane insulin, beef|mesh-list
6661251|NCT01497561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6661252|NCT01497561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661253|NCT01497574|Insulin|insulin|mesh-list
6661254|NCT01497574|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6661255|NCT01497574|Insulin Glargine|insulin glargine|mesh-list
6661256|NCT01497574|Insulin Detemir|insulin detemir|mesh-list
6661257|NCT01497574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6661258|NCT01497574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661259|NCT01497587|Insulin Detemir|insulin detemir|mesh-list
6661260|NCT01497587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6661261|NCT01497587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661262|NCT01497600|Insulin|insulin|mesh-list
6614502|NCT01239368|Sirolimus|sirolimus|mesh-list
6614503|NCT01239368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6614504|NCT01239368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6614505|NCT01239368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6614506|NCT01239368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6614507|NCT01239368|Antifungal Agents|antifungal agents|mesh-ancestor
6614508|NCT01239368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6614509|NCT01239368|Immunologic Factors|immunologic factors|mesh-ancestor
6614510|NCT01239368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614511|NCT01239459|Teriflunomide|teriflunomide|mesh-list
6614512|NCT01239459|Cholestyramine Resin|cholestyramine resin|mesh-list
6614513|NCT01239459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6614514|NCT01239459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6614515|NCT01239459|Analgesics|analgesics|mesh-ancestor
6614516|NCT01239459|Sensory System Agents|sensory system agents|mesh-ancestor
6614517|NCT01239459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6614518|NCT01239459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614519|NCT01239459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6614520|NCT01239459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6614521|NCT01239459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6614522|NCT01239459|Immunologic Factors|immunologic factors|mesh-ancestor
6614523|NCT01239459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6614524|NCT01239459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6614525|NCT01239459|Antimetabolites|antimetabolites|mesh-ancestor
6614526|NCT01239459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614527|NCT01239459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6614528|NCT01239485|Irinotecan|irinotecan|mesh-list
6614529|NCT01239485|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6614530|NCT01239485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6614531|NCT01239485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6614532|NCT01239485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614533|NCT01239485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6614534|NCT01239498|Lidocaine|lidocaine|mesh-list
6614535|NCT01239498|Epinephrine|epinephrine|mesh-list
6614536|NCT01239498|Racepinephrine|racepinephrine|mesh-list
6614537|NCT01239498|Anesthetics|anesthetics|mesh-list
6614538|NCT01239498|Epinephryl borate|epinephryl borate|mesh-list
6614539|NCT01239498|Anesthetics, Local|anesthetics, local|mesh-ancestor
6614540|NCT01239498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6614541|NCT01239498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614542|NCT01239498|Sensory System Agents|sensory system agents|mesh-ancestor
6614543|NCT01239498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6614544|NCT01239498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6614545|NCT01239498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6614546|NCT01239498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6614547|NCT01239498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6614548|NCT01239498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614549|NCT01239498|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6614550|NCT01239498|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6614551|NCT01239498|Adrenergic Agents|adrenergic agents|mesh-ancestor
6614552|NCT01239498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6614553|NCT01239498|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6614554|NCT01239498|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6614555|NCT01239498|Autonomic Agents|autonomic agents|mesh-ancestor
6614556|NCT01239498|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6614557|NCT01239498|Respiratory System Agents|respiratory system agents|mesh-ancestor
6614558|NCT01239498|Mydriatics|mydriatics|mesh-ancestor
6614559|NCT01239498|Sympathomimetics|sympathomimetics|mesh-ancestor
6614560|NCT01239498|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6614561|NCT01239550|Insulin Detemir|insulin detemir|mesh-list
6614562|NCT01239550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6614563|NCT01239550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614564|NCT01239563|Thymoglobulin|thymoglobulin|mesh-list
6614565|NCT01239563|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6614566|NCT01239563|Basiliximab|basiliximab|mesh-list
6614567|NCT01239563|Immunologic Factors|immunologic factors|mesh-ancestor
6614568|NCT01239563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614569|NCT01239563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6614570|NCT01239719|Clemastine|clemastine|mesh-list
6614571|NCT01239719|Dexamethasone|dexamethasone|mesh-list
6614572|NCT01239719|Dexamethasone acetate|dexamethasone acetate|mesh-list
6614573|NCT01239719|BB 1101|bb 1101|mesh-list
6614574|NCT01239719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6614575|NCT01239719|Antiemetics|antiemetics|mesh-ancestor
6614576|NCT01239719|Autonomic Agents|autonomic agents|mesh-ancestor
6614577|NCT01239719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6614578|NCT01239719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614579|NCT01239719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6614580|NCT01239719|Glucocorticoids|glucocorticoids|mesh-ancestor
6614581|NCT01239719|Hormones|hormones|mesh-ancestor
6614582|NCT01239719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6614583|NCT01239719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6614584|NCT01239719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6614585|NCT01239719|Protease Inhibitors|protease inhibitors|mesh-ancestor
6614586|NCT01239719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6614587|NCT01239719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614588|NCT01239719|Antipruritics|antipruritics|mesh-ancestor
6614589|NCT01239719|Dermatologic Agents|dermatologic agents|mesh-ancestor
6614590|NCT01239719|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6614591|NCT01239719|Histamine Antagonists|histamine antagonists|mesh-ancestor
6614592|NCT01239719|Histamine Agents|histamine agents|mesh-ancestor
6614593|NCT01239719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6614594|NCT01239719|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6614595|NCT01239810|Hyaluronic Acid|hyaluronic acid|mesh-list
6614596|NCT01239810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6614597|NCT01239810|Immunologic Factors|immunologic factors|mesh-ancestor
6614598|NCT01239810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614599|NCT01239810|Viscosupplements|viscosupplements|mesh-ancestor
6614600|NCT01239810|Protective Agents|protective agents|mesh-ancestor
6614601|NCT01239849|Atorvastatin|atorvastatin|mesh-list
6614602|NCT01239849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6614603|NCT01239849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6614604|NCT01239849|Antimetabolites|antimetabolites|mesh-ancestor
6614605|NCT01239849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614606|NCT01239849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6614607|NCT01239849|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6614608|NCT01239849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6614609|NCT01239875|Vaccines|vaccines|mesh-list
6614610|NCT01239875|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6614611|NCT01239875|Immunologic Factors|immunologic factors|mesh-ancestor
6614612|NCT01239875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614613|NCT01239888|Tibolone|tibolone|mesh-list
6614614|NCT01239888|Oxytocin|oxytocin|mesh-list
6614615|NCT01239888|Oxytocics|oxytocics|mesh-ancestor
6614616|NCT01239888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6614617|NCT01239888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614618|NCT01239888|Androgen Antagonists|androgen antagonists|mesh-ancestor
6614619|NCT01239888|Hormone Antagonists|hormone antagonists|mesh-ancestor
6661263|NCT01497600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6614620|NCT01239888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6614621|NCT01239888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6614622|NCT01239888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6614623|NCT01239888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6614624|NCT01239888|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6614625|NCT01239888|Anabolic Agents|anabolic agents|mesh-ancestor
6614626|NCT01239888|Hormones|hormones|mesh-ancestor
6614627|NCT01239940|Paclitaxel|paclitaxel|mesh-list
6614628|NCT01239940|Everolimus|everolimus|mesh-list
6614629|NCT01239940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6614630|NCT01239940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6614631|NCT01239940|Tubulin Modulators|tubulin modulators|mesh-ancestor
6614632|NCT01239940|Antimitotic Agents|antimitotic agents|mesh-ancestor
6614633|NCT01239940|Mitosis Modulators|mitosis modulators|mesh-ancestor
6614634|NCT01239940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614635|NCT01239940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6614636|NCT01239940|Immunologic Factors|immunologic factors|mesh-ancestor
6614637|NCT01239940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614638|NCT01239953|Paclitaxel|paclitaxel|mesh-list
6614639|NCT01239953|Everolimus|everolimus|mesh-list
6614640|NCT01239953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6614641|NCT01239953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6614642|NCT01239953|Tubulin Modulators|tubulin modulators|mesh-ancestor
6614643|NCT01239953|Antimitotic Agents|antimitotic agents|mesh-ancestor
6614644|NCT01239953|Mitosis Modulators|mitosis modulators|mesh-ancestor
6614645|NCT01239953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614646|NCT01239953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6614647|NCT01239953|Immunologic Factors|immunologic factors|mesh-ancestor
6614648|NCT01239953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614649|NCT01240096|Mirtazapine|mirtazapine|mesh-list
6614650|NCT01240096|Antidepressive Agents|antidepressive agents|mesh-ancestor
6614651|NCT01240096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6614652|NCT01240096|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6614653|NCT01240096|Histamine Antagonists|histamine antagonists|mesh-ancestor
6614654|NCT01240096|Histamine Agents|histamine agents|mesh-ancestor
6614655|NCT01240096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6614656|NCT01240096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614657|NCT01240096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614658|NCT01240096|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6614659|NCT01240096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6614660|NCT01240096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6614661|NCT01240096|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6614662|NCT01240096|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6614663|NCT01240096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6614664|NCT01240096|Adrenergic Agents|adrenergic agents|mesh-ancestor
6614665|NCT01240096|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6614666|NCT01240096|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6614667|NCT01240096|Serotonin Agents|serotonin agents|mesh-ancestor
6614668|NCT01240096|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6614669|NCT01240109|Remifentanil|remifentanil|mesh-list
6614670|NCT01240109|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6614671|NCT01240109|Narcotics|narcotics|mesh-ancestor
6614672|NCT01240109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6661264|NCT01497600|Insulin Detemir|insulin detemir|mesh-list
6614673|NCT01240109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614674|NCT01240109|Analgesics|analgesics|mesh-ancestor
6614675|NCT01240109|Sensory System Agents|sensory system agents|mesh-ancestor
6614676|NCT01240109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6614677|NCT01240148|Lidocaine|lidocaine|mesh-list
6614678|NCT01240148|Anesthetics, Local|anesthetics, local|mesh-ancestor
6614679|NCT01240148|Anesthetics|anesthetics|mesh-ancestor
6614680|NCT01240148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6614681|NCT01240148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614682|NCT01240148|Sensory System Agents|sensory system agents|mesh-ancestor
6614683|NCT01240148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6614684|NCT01240148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6614685|NCT01240148|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6614686|NCT01240148|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6614687|NCT01240148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6614688|NCT01240148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614689|NCT01240174|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6614690|NCT01240174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6614691|NCT01240213|Vitamin D|vitamin d|mesh-list
6614692|NCT01240213|Vitamins|vitamins|mesh-ancestor
6614693|NCT01240213|Micronutrients|micronutrients|mesh-ancestor
6614694|NCT01240213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614695|NCT01240213|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6614696|NCT01240226|Ketoconazole|ketoconazole|mesh-list
6614697|NCT01240226|Antifungal Agents|antifungal agents|mesh-ancestor
6614698|NCT01240226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6614699|NCT01240226|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6614700|NCT01240226|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6614701|NCT01240226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6614702|NCT01240226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614703|NCT01240226|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6614704|NCT01240226|Hormone Antagonists|hormone antagonists|mesh-ancestor
6614705|NCT01240226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6614706|NCT01240226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614707|NCT01240226|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6020745|NCT00394251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6020746|NCT00394251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6020747|NCT00394251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6020748|NCT00394277|Ribavirin|ribavirin|mesh-list
6020749|NCT00394277|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6020750|NCT00394277|Interferon-alpha|interferon-alpha|mesh-list
6020751|NCT00394277|Antimetabolites|antimetabolites|mesh-ancestor
6020752|NCT00394277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020753|NCT00394277|Antiviral Agents|antiviral agents|mesh-ancestor
6020754|NCT00394277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6020755|NCT00394277|Immunologic Factors|immunologic factors|mesh-ancestor
6020756|NCT00394277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020757|NCT00394329|Beclomethasone|beclomethasone|mesh-list
6614708|NCT01240252|Insulin|insulin|mesh-list
6614709|NCT01240252|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6614710|NCT01240252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6450073|NCT00406432|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6450074|NCT00406432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6450075|NCT00406432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6450076|NCT00406471|Ranibizumab|ranibizumab|mesh-list
6614711|NCT01240252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614712|NCT01240265|Vitamin D|vitamin d|mesh-list
6614713|NCT01240265|Ergocalciferols|ergocalciferols|mesh-list
6614714|NCT01240265|Cholecalciferol|cholecalciferol|mesh-list
6614715|NCT01240265|Vitamins|vitamins|mesh-list
6614716|NCT01240265|Micronutrients|micronutrients|mesh-ancestor
6614717|NCT01240265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614718|NCT01240265|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6614719|NCT01240265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6614720|NCT01240408|Lenvatinib|lenvatinib|mesh-list
6614721|NCT01240408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6450077|NCT00406471|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6450078|NCT00406471|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6450079|NCT00406471|Growth Substances|growth substances|mesh-ancestor
6450080|NCT00406471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450081|NCT00406471|Growth Inhibitors|growth inhibitors|mesh-ancestor
6450082|NCT00406471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6450083|NCT00406497|Difluprednate|difluprednate|mesh-list
6614722|NCT01240408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6614723|NCT01240408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6614724|NCT01240408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614725|NCT01240538|Cyclophosphamide|cyclophosphamide|mesh-list
6614726|NCT01240538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6614727|NCT01240538|Immunologic Factors|immunologic factors|mesh-ancestor
6614728|NCT01240538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614729|NCT01240538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6614730|NCT01240538|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6614731|NCT01240538|Alkylating Agents|alkylating agents|mesh-ancestor
6614732|NCT01240538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614733|NCT01240538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6614734|NCT01240538|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6614735|NCT01240629|Doxorubicin|doxorubicin|mesh-list
6614736|NCT01240629|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6614737|NCT01240629|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6614738|NCT01240629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6614739|NCT01240629|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6614740|NCT01240629|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6614741|NCT01240629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6020758|NCT00394329|Albuterol|albuterol|mesh-list
6020759|NCT00394329|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6020760|NCT00394329|Autonomic Agents|autonomic agents|mesh-ancestor
6020761|NCT00394329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6020762|NCT00394329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020763|NCT00394329|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6614742|NCT01240629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614743|NCT01240642|Vadimezan|vadimezan|mesh-list
6614744|NCT01240642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6614745|NCT01240655|Paclitaxel|paclitaxel|mesh-list
6614746|NCT01240655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6614747|NCT01240655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6614748|NCT01240655|Tubulin Modulators|tubulin modulators|mesh-ancestor
6614749|NCT01240655|Antimitotic Agents|antimitotic agents|mesh-ancestor
6614750|NCT01240655|Mitosis Modulators|mitosis modulators|mesh-ancestor
6614751|NCT01240655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614752|NCT01240824|Aminophylline|aminophylline|mesh-list
6614753|NCT01240824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6614754|NCT01240824|Autonomic Agents|autonomic agents|mesh-ancestor
6614755|NCT01240824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6614756|NCT01240824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614757|NCT01240824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6614758|NCT01240824|Respiratory System Agents|respiratory system agents|mesh-ancestor
6614759|NCT01240824|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6614760|NCT01240824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6614761|NCT01240824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6614762|NCT01240824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614763|NCT01240824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6614764|NCT01240824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6614765|NCT01240824|Purinergic Agents|purinergic agents|mesh-ancestor
6614766|NCT01240824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6614767|NCT01240824|Protective Agents|protective agents|mesh-ancestor
6614768|NCT01240850|Prednisone|prednisone|mesh-list
6614769|NCT01240850|Methotrexate|methotrexate|mesh-list
6614770|NCT01240850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6614771|NCT01240850|Glucocorticoids|glucocorticoids|mesh-ancestor
6614772|NCT01240850|Hormones|hormones|mesh-ancestor
6614773|NCT01240850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6450084|NCT00406497|Glucocorticoids|glucocorticoids|mesh-ancestor
6450085|NCT00406497|Hormones|hormones|mesh-ancestor
6450086|NCT00406497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6450087|NCT00406497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450088|NCT00406575|Methocarbamol|methocarbamol|mesh-list
6450089|NCT00406575|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6450090|NCT00406575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450091|NCT00406575|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6020764|NCT00394329|Respiratory System Agents|respiratory system agents|mesh-ancestor
6020765|NCT00394329|Tocolytic Agents|tocolytic agents|mesh-ancestor
6020766|NCT00394329|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6020767|NCT00394329|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6020768|NCT00394329|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6020769|NCT00394329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6020770|NCT00394329|Adrenergic Agents|adrenergic agents|mesh-ancestor
6020771|NCT00394329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6020772|NCT00394329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450092|NCT00406575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6450093|NCT00406601|Sorafenib|sorafenib|mesh-list
6450094|NCT00406601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6450095|NCT00406601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6450096|NCT00406601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6614774|NCT01240850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614775|NCT01240850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6614776|NCT01240850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6614777|NCT01240850|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6614778|NCT01240850|Abortifacient Agents|abortifacient agents|mesh-ancestor
6614779|NCT01240850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6614780|NCT01240850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6614781|NCT01240850|Antimetabolites|antimetabolites|mesh-ancestor
6614782|NCT01240850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614783|NCT01240850|Dermatologic Agents|dermatologic agents|mesh-ancestor
6614784|NCT01240850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6614785|NCT01240850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6614786|NCT01240850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6614787|NCT01240850|Immunologic Factors|immunologic factors|mesh-ancestor
6614788|NCT01240850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6614789|NCT01240850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6614790|NCT01240889|Fluticasone|fluticasone|mesh-list
6614791|NCT01240889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6614792|NCT01240889|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6614793|NCT01240889|Autonomic Agents|autonomic agents|mesh-ancestor
6614794|NCT01240889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6614795|NCT01240889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614796|NCT01240889|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6614797|NCT01240889|Respiratory System Agents|respiratory system agents|mesh-ancestor
6614798|NCT01240889|Dermatologic Agents|dermatologic agents|mesh-ancestor
6614799|NCT01240889|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6614800|NCT01240928|Exemestane|exemestane|mesh-list
6614801|NCT01240928|Goserelin|goserelin|mesh-list
6614802|NCT01240928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6614803|NCT01240928|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6614804|NCT01240928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6614805|NCT01240928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6614806|NCT01240928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614807|NCT01240928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6614808|NCT01240928|Hormone Antagonists|hormone antagonists|mesh-ancestor
6614809|NCT01240928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6614810|NCT01240928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614811|NCT01240928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6614812|NCT01240941|Exemestane|exemestane|mesh-list
6614813|NCT01240941|Goserelin|goserelin|mesh-list
6614814|NCT01240941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6614815|NCT01240941|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6614816|NCT01240941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6614817|NCT01240941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6614818|NCT01240941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614819|NCT01240941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6614820|NCT01240941|Hormone Antagonists|hormone antagonists|mesh-ancestor
6614821|NCT01240941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6614822|NCT01240941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614823|NCT01240941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6661265|NCT01497600|Isophane Insulin, Human|isophane insulin, human|mesh-list
6661266|NCT01497600|Insulin, Isophane|insulin, isophane|mesh-list
6661267|NCT01497600|Isophane insulin, beef|isophane insulin, beef|mesh-list
6661268|NCT01497600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6661269|NCT01497600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661270|NCT01497626|Bortezomib|bortezomib|mesh-list
6661271|NCT01497626|Lapatinib|lapatinib|mesh-list
6661272|NCT01497626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6661273|NCT01497626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6661274|NCT01497626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6661275|NCT01497626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661276|NCT01497652|Rasagiline|rasagiline|mesh-list
6661277|NCT01497652|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6661278|NCT01497652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6661279|NCT01497652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661280|NCT01497652|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6661281|NCT01497652|Protective Agents|protective agents|mesh-ancestor
6661282|NCT01497652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661283|NCT01497717|Adalimumab|adalimumab|mesh-list
6661284|NCT01497717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6661285|NCT01497717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6661286|NCT01497873|Topotecan|topotecan|mesh-list
6661287|NCT01497873|Belotecan|belotecan|mesh-list
6661288|NCT01497873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6614824|NCT01241006|Dexamethasone|dexamethasone|mesh-list
6614825|NCT01241006|Prednisone|prednisone|mesh-list
6614826|NCT01241006|Glucocorticoids|glucocorticoids|mesh-list
6614827|NCT01241006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6614828|NCT01241006|Antiemetics|antiemetics|mesh-ancestor
6614829|NCT01241006|Autonomic Agents|autonomic agents|mesh-ancestor
6614830|NCT01241006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6614831|NCT01241006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614832|NCT01241006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6614833|NCT01241006|Hormones|hormones|mesh-ancestor
6614834|NCT01241006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6614835|NCT01241006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6614836|NCT01241006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6614837|NCT01241019|Topiramate|topiramate|mesh-list
6614838|NCT01241019|Anticonvulsants|anticonvulsants|mesh-ancestor
6614839|NCT01241019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6614840|NCT01241019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614841|NCT01241032|Udenafil|udenafil|mesh-list
6614842|NCT01241032|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6614843|NCT01241032|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6614844|NCT01241032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6614845|NCT01241032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614846|NCT01241084|Leukotriene Antagonists|leukotriene antagonists|mesh-list
6614847|NCT01241084|Hormone Antagonists|hormone antagonists|mesh-ancestor
6614848|NCT01241084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6614849|NCT01241084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614850|NCT01241084|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6614851|NCT01241084|Respiratory System Agents|respiratory system agents|mesh-ancestor
6614852|NCT01241097|Simvastatin|simvastatin|mesh-list
6614853|NCT01241097|Ezetimibe|ezetimibe|mesh-list
6614854|NCT01241097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6614855|NCT01241097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6614856|NCT01241097|Antimetabolites|antimetabolites|mesh-ancestor
6614857|NCT01241097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614858|NCT01241097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6614859|NCT01241097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6614860|NCT01241097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6614861|NCT01241110|Ofloxacin|ofloxacin|mesh-list
6614862|NCT01241110|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6614863|NCT01241110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6614864|NCT01241110|Renal Agents|renal agents|mesh-ancestor
6614865|NCT01241110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6614866|NCT01241110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6614867|NCT01241110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6614868|NCT01241110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6614869|NCT01241110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020773|NCT00394329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6020774|NCT00394329|Glucocorticoids|glucocorticoids|mesh-ancestor
6020775|NCT00394329|Hormones|hormones|mesh-ancestor
6020776|NCT00394329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6020777|NCT00394433|Bevacizumab|bevacizumab|mesh-list
6020778|NCT00394433|Cisplatin|cisplatin|mesh-list
6020779|NCT00394433|Docetaxel|docetaxel|mesh-list
6020780|NCT00394433|Irinotecan|irinotecan|mesh-list
6020781|NCT00394433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6020782|NCT00394433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6020783|NCT00394433|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6020784|NCT00394433|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6614870|NCT01241110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6614871|NCT01241110|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6614872|NCT01241110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6614873|NCT01241162|Decitabine|decitabine|mesh-list
6614874|NCT01241162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6614875|NCT01241162|Antimetabolites|antimetabolites|mesh-ancestor
6614876|NCT01241162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614877|NCT01241162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6614878|NCT01241162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6614879|NCT01241175|Magnesium Sulfate|magnesium sulfate|mesh-list
6614880|NCT01241175|Analgesics|analgesics|mesh-ancestor
6614881|NCT01241175|Sensory System Agents|sensory system agents|mesh-ancestor
6614882|NCT01241175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6614883|NCT01241175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614884|NCT01241175|Anesthetics|anesthetics|mesh-ancestor
6614885|NCT01241175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6450097|NCT00406601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450098|NCT00406679|Acetaminophen|acetaminophen|mesh-list
6450099|NCT00406679|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6450100|NCT00406679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6450101|NCT00406679|Analgesics|analgesics|mesh-ancestor
6450102|NCT00406679|Sensory System Agents|sensory system agents|mesh-ancestor
6450103|NCT00406679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6450104|NCT00406679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450105|NCT00406679|Antipyretics|antipyretics|mesh-ancestor
6450106|NCT00406731|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
6450107|NCT00406731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6450108|NCT00406731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450109|NCT00406744|Bevacizumab|bevacizumab|mesh-list
6450110|NCT00406744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6614886|NCT01241175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6614887|NCT01241175|Anticonvulsants|anticonvulsants|mesh-ancestor
6614888|NCT01241175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6614889|NCT01241175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6614890|NCT01241175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614891|NCT01241175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6614892|NCT01241175|Tocolytic Agents|tocolytic agents|mesh-ancestor
6614893|NCT01241175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6614894|NCT01241383|Bosentan|bosentan|mesh-list
6614895|NCT01241383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6614896|NCT01241383|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6614897|NCT01241383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614898|NCT01241409|Rabeprazole|rabeprazole|mesh-list
6614899|NCT01241409|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6614900|NCT01241409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6614901|NCT01241409|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6614902|NCT01241409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6614903|NCT01241409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614904|NCT01241422|Montelukast|montelukast|mesh-list
6614905|NCT01241422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6614906|NCT01241422|Respiratory System Agents|respiratory system agents|mesh-ancestor
6614907|NCT01241422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6614908|NCT01241422|Hormone Antagonists|hormone antagonists|mesh-ancestor
6614909|NCT01241422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6614910|NCT01241422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614911|NCT01241422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6614912|NCT01241422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6661289|NCT01497873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6450111|NCT00406744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6450112|NCT00406744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6614913|NCT01241422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614914|NCT01241487|Amlodipine|amlodipine|mesh-list
6614915|NCT01241487|Valsartan|valsartan|mesh-list
6614916|NCT01241487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6614917|NCT01241487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6614918|NCT01241487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6614919|NCT01241487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614920|NCT01241487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6614921|NCT01241487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614922|NCT01241487|Vasodilator Agents|vasodilator agents|mesh-ancestor
6614923|NCT01241487|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6614924|NCT01241487|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6614925|NCT01241500|ON 01910|on 01910|mesh-list
6614926|NCT01241500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6020785|NCT00394433|Growth Substances|growth substances|mesh-ancestor
6020786|NCT00394433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020787|NCT00394433|Growth Inhibitors|growth inhibitors|mesh-ancestor
6020788|NCT00394433|Tubulin Modulators|tubulin modulators|mesh-ancestor
6020789|NCT00394433|Antimitotic Agents|antimitotic agents|mesh-ancestor
6614927|NCT01241500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6614928|NCT01241500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6661290|NCT01497873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6020790|NCT00394433|Mitosis Modulators|mitosis modulators|mesh-ancestor
6020791|NCT00394433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020792|NCT00394433|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6020793|NCT00394433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6020794|NCT00394433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6020795|NCT00394472|Lesogaberan|lesogaberan|mesh-list
6020796|NCT00394472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5501996|NCT04469556|Leucovorin|leucovorin|mesh-list
5501997|NCT04469556|Gemcitabine|gemcitabine|mesh-list
5501998|NCT04469556|Paclitaxel|paclitaxel|mesh-list
5501999|NCT04469556|Oxaliplatin|oxaliplatin|mesh-list
5502000|NCT04469556|Irinotecan|irinotecan|mesh-list
5502001|NCT04469556|Folfirinox|folfirinox|mesh-list
5502002|NCT04469556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5502003|NCT04469556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5502004|NCT04469556|Tubulin Modulators|tubulin modulators|mesh-ancestor
5502005|NCT04469556|Antimitotic Agents|antimitotic agents|mesh-ancestor
5502006|NCT04469556|Mitosis Modulators|mitosis modulators|mesh-ancestor
5502007|NCT04469556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502008|NCT04469556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5502009|NCT04469556|Antimetabolites|antimetabolites|mesh-ancestor
5502010|NCT04469556|Antiviral Agents|antiviral agents|mesh-ancestor
5502011|NCT04469556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5502012|NCT04469556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5502013|NCT04469556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5502014|NCT04469556|Immunologic Factors|immunologic factors|mesh-ancestor
5502015|NCT04469556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502016|NCT04469556|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5502017|NCT04469556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5502018|NCT04469556|Antidotes|antidotes|mesh-ancestor
5502019|NCT04469556|Protective Agents|protective agents|mesh-ancestor
5502020|NCT04469556|Vitamin B Complex|vitamin b complex|mesh-ancestor
5502021|NCT04469556|Vitamins|vitamins|mesh-ancestor
5502022|NCT04469556|Micronutrients|micronutrients|mesh-ancestor
5502023|NCT04469413|Acetaminophen|acetaminophen|mesh-list
5502024|NCT04469413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5502025|NCT04469413|Analgesics|analgesics|mesh-ancestor
5502026|NCT04469413|Sensory System Agents|sensory system agents|mesh-ancestor
5502027|NCT04469413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5502028|NCT04469413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502029|NCT04469413|Antipyretics|antipyretics|mesh-ancestor
6020797|NCT00394472|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
5502030|NCT04469283|Caffeine|caffeine|mesh-list
5502031|NCT04469283|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6020798|NCT00394472|GABA Agonists|gaba agonists|mesh-ancestor
6614929|NCT01241500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614930|NCT01241682|Cyclophosphamide|cyclophosphamide|mesh-list
6614931|NCT01241682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6614932|NCT01241682|Immunologic Factors|immunologic factors|mesh-ancestor
6614933|NCT01241682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614934|NCT01241682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6614935|NCT01241682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6614936|NCT01241682|Alkylating Agents|alkylating agents|mesh-ancestor
6614937|NCT01241682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614938|NCT01241682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6614939|NCT01241682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6614940|NCT01241708|Bortezomib|bortezomib|mesh-list
6614941|NCT01241708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6614942|NCT01241734|Lenalidomide|lenalidomide|mesh-list
6614943|NCT01241734|Immunologic Factors|immunologic factors|mesh-ancestor
6614944|NCT01241734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614945|NCT01241734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6614946|NCT01241734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6614947|NCT01241734|Growth Substances|growth substances|mesh-ancestor
6614948|NCT01241734|Growth Inhibitors|growth inhibitors|mesh-ancestor
6614949|NCT01241734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6614950|NCT01241773|Efavirenz|efavirenz|mesh-list
6020799|NCT00394472|GABA Agents|gaba agents|mesh-ancestor
6020800|NCT00394472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6020801|NCT00394472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614951|NCT01241773|Raltegravir Potassium|raltegravir potassium|mesh-list
6614952|NCT01241773|Simeprevir|simeprevir|mesh-list
6614953|NCT01241773|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6614954|NCT01241773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6614955|NCT01241773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6614956|NCT01241773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614957|NCT01241773|Antiviral Agents|antiviral agents|mesh-ancestor
6614958|NCT01241773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6614959|NCT01241773|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6614960|NCT01241773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6614961|NCT01241773|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6614962|NCT01241773|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6614963|NCT01241773|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6614964|NCT01241773|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6614965|NCT01241773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6614966|NCT01241773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6614967|NCT01241773|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6614968|NCT01241773|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6614969|NCT01241773|Protease Inhibitors|protease inhibitors|mesh-ancestor
6614970|NCT01241786|Lenalidomide|lenalidomide|mesh-list
6614971|NCT01241786|Azacitidine|azacitidine|mesh-list
6614972|NCT01241786|Immunologic Factors|immunologic factors|mesh-ancestor
6614973|NCT01241786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614974|NCT01241786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6614975|NCT01241786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6614976|NCT01241786|Growth Substances|growth substances|mesh-ancestor
6614977|NCT01241786|Growth Inhibitors|growth inhibitors|mesh-ancestor
6614978|NCT01241786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6614979|NCT01241786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6614980|NCT01241786|Antimetabolites|antimetabolites|mesh-ancestor
6614981|NCT01241786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614982|NCT01241786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6614983|NCT01242046|Caffeine|caffeine|mesh-list
6614984|NCT01242046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6614985|NCT01242046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6614986|NCT01242046|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6614987|NCT01242046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6614988|NCT01242046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614989|NCT01242046|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6614990|NCT01242046|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6614991|NCT01242046|Purinergic Agents|purinergic agents|mesh-ancestor
6614992|NCT01242046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6614993|NCT01242072|Isophosphamide mustard|isophosphamide mustard|mesh-list
6614994|NCT01242072|Ifosfamide|ifosfamide|mesh-list
6614995|NCT01242072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6614996|NCT01242072|Alkylating Agents|alkylating agents|mesh-ancestor
6614997|NCT01242072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6614998|NCT01242072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6614999|NCT01242098|Fluticasone|fluticasone|mesh-list
6615000|NCT01242098|Beclomethasone|beclomethasone|mesh-list
6615001|NCT01242098|Formoterol Fumarate|formoterol fumarate|mesh-list
6615002|NCT01242098|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6615003|NCT01242098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6615004|NCT01242098|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6615005|NCT01242098|Autonomic Agents|autonomic agents|mesh-ancestor
6615006|NCT01242098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6615007|NCT01242098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615008|NCT01242098|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6615009|NCT01242098|Respiratory System Agents|respiratory system agents|mesh-ancestor
6615010|NCT01242098|Dermatologic Agents|dermatologic agents|mesh-ancestor
6615011|NCT01242098|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6615012|NCT01242098|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6615013|NCT01242098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6615014|NCT01242098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6615015|NCT01242098|Adrenergic Agents|adrenergic agents|mesh-ancestor
6615016|NCT01242098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6615017|NCT01242098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615018|NCT01242098|Glucocorticoids|glucocorticoids|mesh-ancestor
6615019|NCT01242098|Hormones|hormones|mesh-ancestor
6615020|NCT01242098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6020802|NCT00394472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020803|NCT00394524|Insulin|insulin|mesh-list
6020804|NCT00394524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6020805|NCT00394524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615021|NCT01242202|Acarbose|acarbose|mesh-list
6615022|NCT01242202|Voglibose|voglibose|mesh-list
6615023|NCT01242202|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
6615024|NCT01242202|Miglitol|miglitol|mesh-list
6615025|NCT01242202|Ipragliflozin|ipragliflozin|mesh-list
6615026|NCT01242202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6615027|NCT01242202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615028|NCT01242202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6615029|NCT01242202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615030|NCT01242202|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6615031|NCT01242215|Glimepiride|glimepiride|mesh-list
6615032|NCT01242215|Gliclazide|gliclazide|mesh-list
6615033|NCT01242215|Glyburide|glyburide|mesh-list
6615034|NCT01242215|Ipragliflozin|ipragliflozin|mesh-list
6615035|NCT01242215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6615036|NCT01242215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6615037|NCT01242215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615038|NCT01242215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6615039|NCT01242215|Immunologic Factors|immunologic factors|mesh-ancestor
6615040|NCT01242215|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6615041|NCT01242215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615042|NCT01242228|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6615043|NCT01242228|Saxagliptin|saxagliptin|mesh-list
6615044|NCT01242228|Vildagliptin|vildagliptin|mesh-list
6615045|NCT01242228|Alogliptin|alogliptin|mesh-list
6615046|NCT01242228|Ipragliflozin|ipragliflozin|mesh-list
6615047|NCT01242228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
6615048|NCT01242228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6615049|NCT01242228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615050|NCT01242228|Incretins|incretins|mesh-ancestor
6615051|NCT01242228|Hormones|hormones|mesh-ancestor
6615052|NCT01242228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6615053|NCT01242228|Protease Inhibitors|protease inhibitors|mesh-ancestor
6615054|NCT01242228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6615055|NCT01242228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615056|NCT01242228|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6615057|NCT01242267|Thalidomide|thalidomide|mesh-list
6615058|NCT01242267|Bortezomib|bortezomib|mesh-list
6615059|NCT01242267|Melphalan|melphalan|mesh-list
6615060|NCT01242267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6615061|NCT01242267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6615062|NCT01242267|Alkylating Agents|alkylating agents|mesh-ancestor
6615063|NCT01242267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615064|NCT01242267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6615065|NCT01242267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6615066|NCT01242267|Immunologic Factors|immunologic factors|mesh-ancestor
6615067|NCT01242267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615068|NCT01242267|Leprostatic Agents|leprostatic agents|mesh-ancestor
6615069|NCT01242267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6615070|NCT01242267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6615071|NCT01242267|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6615072|NCT01242267|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6615073|NCT01242267|Growth Substances|growth substances|mesh-ancestor
6615074|NCT01242267|Growth Inhibitors|growth inhibitors|mesh-ancestor
6615075|NCT01242306|Acetylcholine|acetylcholine|mesh-list
6615076|NCT01242306|Vasodilator Agents|vasodilator agents|mesh-ancestor
6615077|NCT01242306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6615078|NCT01242306|Cholinergic Agents|cholinergic agents|mesh-ancestor
6615079|NCT01242306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6615080|NCT01242306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615081|NCT01242306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615082|NCT01242332|Pregabalin|pregabalin|mesh-list
6615083|NCT01242332|Analgesics|analgesics|mesh-ancestor
6615084|NCT01242332|Sensory System Agents|sensory system agents|mesh-ancestor
6615085|NCT01242332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6615086|NCT01242332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615087|NCT01242332|Anticonvulsants|anticonvulsants|mesh-ancestor
6615088|NCT01242332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6615089|NCT01242332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6615090|NCT01242332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615091|NCT01242332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6615092|NCT01242332|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6615093|NCT01242332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6615094|NCT01242332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6615095|NCT01242332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6615096|NCT01242384|Silicon|silicon|mesh-list
6615097|NCT01242384|Trace Elements|trace elements|mesh-ancestor
6615098|NCT01242384|Micronutrients|micronutrients|mesh-ancestor
6615099|NCT01242384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615100|NCT01242410|Silicon|silicon|mesh-list
6615101|NCT01242410|Trace Elements|trace elements|mesh-ancestor
6615102|NCT01242410|Micronutrients|micronutrients|mesh-ancestor
6615103|NCT01242410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615104|NCT01242449|Trastuzumab|trastuzumab|mesh-list
6615105|NCT01242449|Vinorelbine|vinorelbine|mesh-list
6615106|NCT01242449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6615107|NCT01242449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6615108|NCT01242449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6615109|NCT01242449|Tubulin Modulators|tubulin modulators|mesh-ancestor
6615110|NCT01242449|Antimitotic Agents|antimitotic agents|mesh-ancestor
6615111|NCT01242449|Mitosis Modulators|mitosis modulators|mesh-ancestor
6615112|NCT01242449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615113|NCT01242566|Temozolomide|temozolomide|mesh-list
6615114|NCT01242566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6615115|NCT01242566|Alkylating Agents|alkylating agents|mesh-ancestor
6615116|NCT01242566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615117|NCT01242566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6615118|NCT01242579|Maraviroc|maraviroc|mesh-list
6615119|NCT01242579|Dapivirine|dapivirine|mesh-list
6615120|NCT01242579|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6615121|NCT01242579|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6615122|NCT01242579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615123|NCT01242579|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6615124|NCT01242579|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6615125|NCT01242579|Antiviral Agents|antiviral agents|mesh-ancestor
6615126|NCT01242579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6615127|NCT01242579|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6615128|NCT01242592|Antitubercular Agents|antitubercular agents|mesh-list
6615129|NCT01242592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6615130|NCT01242592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6615131|NCT01242605|Gemcitabine|gemcitabine|mesh-list
6615132|NCT01242605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6020806|NCT00394589|Infliximab|infliximab|mesh-list
6615133|NCT01242605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6615134|NCT01242605|Antimetabolites|antimetabolites|mesh-ancestor
6615135|NCT01242605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615136|NCT01242605|Antiviral Agents|antiviral agents|mesh-ancestor
6615137|NCT01242605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6615138|NCT01242605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6615139|NCT01242605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6615140|NCT01242605|Immunologic Factors|immunologic factors|mesh-ancestor
6615141|NCT01242605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615142|NCT01242631|Everolimus|everolimus|mesh-list
6615143|NCT01242631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6615144|NCT01242631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6615145|NCT01242631|Immunologic Factors|immunologic factors|mesh-ancestor
6615146|NCT01242631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661291|NCT01497873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661292|NCT01497873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6661293|NCT01497912|Atorvastatin|atorvastatin|mesh-list
6661294|NCT01497912|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6661295|NCT01497912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6661296|NCT01497912|Antimetabolites|antimetabolites|mesh-ancestor
6661297|NCT01497912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661298|NCT01497912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6661299|NCT01497912|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6661300|NCT01497912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6661301|NCT01497977|Phytoestrogens|phytoestrogens|mesh-list
6661302|NCT01497977|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6661303|NCT01497977|Estrogens|estrogens|mesh-ancestor
6661304|NCT01497977|Hormones|hormones|mesh-ancestor
6661305|NCT01497977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6661306|NCT01497977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661307|NCT01497990|Ertapenem|ertapenem|mesh-list
6661308|NCT01497990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6661309|NCT01497990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6661310|NCT01498003|Tirofiban|tirofiban|mesh-list
6661311|NCT01498003|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6661312|NCT01498003|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6661313|NCT01498003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661314|NCT01498003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6661315|NCT01498016|Busulfan|busulfan|mesh-list
6661316|NCT01498016|Alkylating Agents|alkylating agents|mesh-ancestor
6661317|NCT01498016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661318|NCT01498016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6661319|NCT01498016|Immunologic Factors|immunologic factors|mesh-ancestor
6661320|NCT01498016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661321|NCT01498016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6661322|NCT01498016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6661323|NCT01498016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6661324|NCT01498081|Tiotropium Bromide|tiotropium bromide|mesh-list
6661325|NCT01498081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6661326|NCT01498081|Autonomic Agents|autonomic agents|mesh-ancestor
6661327|NCT01498081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6661328|NCT01498081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661329|NCT01498081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6661330|NCT01498081|Respiratory System Agents|respiratory system agents|mesh-ancestor
6661331|NCT01498081|Parasympatholytics|parasympatholytics|mesh-ancestor
6661332|NCT01498081|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6661333|NCT01498081|Cholinergic Agents|cholinergic agents|mesh-ancestor
6661334|NCT01498081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6661335|NCT01498081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615147|NCT01242774|Panobinostat|panobinostat|mesh-list
6615148|NCT01242774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6615149|NCT01242774|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6615150|NCT01242774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6615151|NCT01242774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615152|NCT01242787|Entecavir|entecavir|mesh-list
6615153|NCT01242787|Antiviral Agents|antiviral agents|mesh-ancestor
6615154|NCT01242787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6615155|NCT01242826|Insulin Aspart|insulin aspart|mesh-list
6615156|NCT01242826|Biphasic Insulins|biphasic insulins|mesh-list
6615157|NCT01242826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6615158|NCT01242826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615159|NCT01242904|Icodextrin|icodextrin|mesh-list
6615160|NCT01242904|Dialysis Solutions|dialysis solutions|mesh-ancestor
6615161|NCT01242904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6615162|NCT01243060|Zolpidem|zolpidem|mesh-list
6615163|NCT01243060|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6615164|NCT01243060|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6615165|NCT01243060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6615166|NCT01243060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615167|NCT01243060|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6615168|NCT01243060|GABA Agonists|gaba agonists|mesh-ancestor
6615169|NCT01243060|GABA Agents|gaba agents|mesh-ancestor
6615170|NCT01243060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6615171|NCT01243060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615172|NCT01243086|Dexamethasone|dexamethasone|mesh-list
6615173|NCT01243086|Ranibizumab|ranibizumab|mesh-list
6615174|NCT01243086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6615175|NCT01243086|Antiemetics|antiemetics|mesh-ancestor
6615176|NCT01243086|Autonomic Agents|autonomic agents|mesh-ancestor
6615177|NCT01243086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6615178|NCT01243086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615179|NCT01243086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6615180|NCT01243086|Glucocorticoids|glucocorticoids|mesh-ancestor
6615181|NCT01243086|Hormones|hormones|mesh-ancestor
6615182|NCT01243086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6615183|NCT01243086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6615184|NCT01243086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6615185|NCT01243086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6615186|NCT01243086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6615187|NCT01243086|Growth Substances|growth substances|mesh-ancestor
6615188|NCT01243086|Growth Inhibitors|growth inhibitors|mesh-ancestor
6615189|NCT01243203|Varenicline|varenicline|mesh-list
6615190|NCT01243203|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6615191|NCT01243203|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6615192|NCT01243203|Cholinergic Agents|cholinergic agents|mesh-ancestor
6615193|NCT01243203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6615194|NCT01243203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615195|NCT01243203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615196|NCT01243281|Entecavir|entecavir|mesh-list
6615197|NCT01243281|Antiviral Agents|antiviral agents|mesh-ancestor
6615198|NCT01243281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6615199|NCT01243359|Bevacizumab|bevacizumab|mesh-list
6615200|NCT01243359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6615201|NCT01243359|Sunitinib|sunitinib|mesh-list
6615202|NCT01243359|Antibodies|antibodies|mesh-list
6615203|NCT01243359|Immunoglobulins|immunoglobulins|mesh-list
6615204|NCT01243359|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6615205|NCT01243359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6615206|NCT01243359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6615207|NCT01243359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6615208|NCT01243359|Growth Substances|growth substances|mesh-ancestor
6615209|NCT01243359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615210|NCT01243359|Growth Inhibitors|growth inhibitors|mesh-ancestor
6615211|NCT01243359|Immunologic Factors|immunologic factors|mesh-ancestor
6615212|NCT01243359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6615213|NCT01243359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6615214|NCT01243359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615215|NCT01243385|Metformin|metformin|mesh-list
6615216|NCT01243385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6615217|NCT01243385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615218|NCT01243437|Ciprofloxacin|ciprofloxacin|mesh-list
6615219|NCT01243437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6615220|NCT01243437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6615221|NCT01243437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6615222|NCT01243437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6615223|NCT01243437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6615224|NCT01243437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615225|NCT01243437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6615226|NCT01243437|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6615227|NCT01243437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6615228|NCT01243476|Lenalidomide|lenalidomide|mesh-list
6615229|NCT01243476|Immunologic Factors|immunologic factors|mesh-ancestor
6615230|NCT01243476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615231|NCT01243476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6615232|NCT01243476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6615233|NCT01243476|Growth Substances|growth substances|mesh-ancestor
6615234|NCT01243476|Growth Inhibitors|growth inhibitors|mesh-ancestor
6615235|NCT01243476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6615236|NCT01243528|Vitamin D|vitamin d|mesh-list
6615237|NCT01243528|Vitamins|vitamins|mesh-ancestor
6615238|NCT01243528|Micronutrients|micronutrients|mesh-ancestor
6615239|NCT01243528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615240|NCT01243528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6615241|NCT01243632|Gemcitabine|gemcitabine|mesh-list
6615242|NCT01243632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6615243|NCT01243632|Antimetabolites|antimetabolites|mesh-ancestor
6615244|NCT01243632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615245|NCT01243632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6615246|NCT01243632|Antiviral Agents|antiviral agents|mesh-ancestor
6615247|NCT01243632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6615248|NCT01243632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6615249|NCT01243632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6615250|NCT01243632|Immunologic Factors|immunologic factors|mesh-ancestor
6615251|NCT01243632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615252|NCT01243658|Oxytocin|oxytocin|mesh-list
6615253|NCT01243658|Oxytocics|oxytocics|mesh-ancestor
6615254|NCT01243658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6615255|NCT01243658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615256|NCT01243697|Desogestrel|desogestrel|mesh-list
6615257|NCT01243697|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6615258|NCT01243697|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6615259|NCT01243697|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6615260|NCT01243697|Contraceptive Agents|contraceptive agents|mesh-ancestor
6450113|NCT00406744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6615261|NCT01243697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6615262|NCT01243697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615263|NCT01243697|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6615264|NCT01243697|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6615265|NCT01243697|Progestins|progestins|mesh-ancestor
6615266|NCT01243697|Hormones|hormones|mesh-ancestor
6615267|NCT01243697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6615268|NCT01243710|Taurolidine|taurolidine|mesh-list
6615269|NCT01243710|Heparin|heparin|mesh-list
6615270|NCT01243710|Anticoagulants|anticoagulants|mesh-ancestor
6615271|NCT01243710|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6615272|NCT01243710|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6615273|NCT01243710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615274|NCT01243710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6615275|NCT01243710|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6615276|NCT01243710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6615277|NCT01243736|Metoclopramide|metoclopramide|mesh-list
6615278|NCT01243736|Simethicone|simethicone|mesh-list
6615279|NCT01243736|Antiemetics|antiemetics|mesh-ancestor
6615280|NCT01243736|Autonomic Agents|autonomic agents|mesh-ancestor
6615281|NCT01243736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6615282|NCT01243736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615283|NCT01243736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6615284|NCT01243736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6615285|NCT01243736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6615286|NCT01243736|Dopamine Agents|dopamine agents|mesh-ancestor
6615287|NCT01243736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6615288|NCT01243736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615289|NCT01243736|Antifoaming Agents|antifoaming agents|mesh-ancestor
6615290|NCT01243736|Emollients|emollients|mesh-ancestor
6615291|NCT01243736|Dermatologic Agents|dermatologic agents|mesh-ancestor
6615292|NCT01243788|Fluticasone|fluticasone|mesh-list
6615293|NCT01243788|Xhance|xhance|mesh-list
6615294|NCT01243788|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6615295|NCT01243788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6615296|NCT01243788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6615297|NCT01243788|Autonomic Agents|autonomic agents|mesh-ancestor
6615298|NCT01243788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6615299|NCT01243788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615300|NCT01243788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6615301|NCT01243788|Respiratory System Agents|respiratory system agents|mesh-ancestor
6615302|NCT01243788|Dermatologic Agents|dermatologic agents|mesh-ancestor
6615303|NCT01243788|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6615304|NCT01243788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6615305|NCT01243788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6615306|NCT01243788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6615307|NCT01243788|Adrenergic Agents|adrenergic agents|mesh-ancestor
6615308|NCT01243788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6615309|NCT01243788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615310|NCT01243801|Ketamine|ketamine|mesh-list
6450114|NCT00406744|Growth Substances|growth substances|mesh-ancestor
6450115|NCT00406744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450116|NCT00406744|Growth Inhibitors|growth inhibitors|mesh-ancestor
6450117|NCT00406796|Ranibizumab|ranibizumab|mesh-list
6450118|NCT00406796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6450119|NCT00406796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6450120|NCT00406796|Growth Substances|growth substances|mesh-ancestor
6450121|NCT00406796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450122|NCT00406796|Growth Inhibitors|growth inhibitors|mesh-ancestor
6450123|NCT00406796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6450124|NCT00406861|Montelukast|montelukast|mesh-list
6450125|NCT00406861|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6450126|NCT00406861|Respiratory System Agents|respiratory system agents|mesh-ancestor
6450127|NCT00406861|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6615311|NCT01243801|Analgesics|analgesics|mesh-ancestor
6615312|NCT01243801|Sensory System Agents|sensory system agents|mesh-ancestor
6450128|NCT00406861|Hormone Antagonists|hormone antagonists|mesh-ancestor
6450129|NCT00406861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6450130|NCT00406861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450131|NCT00406861|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6450132|NCT00406861|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6450133|NCT00406861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615313|NCT01243801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6615314|NCT01243801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615315|NCT01243801|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6615316|NCT01243801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6615317|NCT01243801|Anesthetics, General|anesthetics, general|mesh-ancestor
6615318|NCT01243801|Anesthetics|anesthetics|mesh-ancestor
6615319|NCT01243801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6615320|NCT01243801|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6615321|NCT01243801|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6615322|NCT01243801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6615323|NCT01243801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615324|NCT01243827|Carvedilol|carvedilol|mesh-list
6615325|NCT01243827|Bisoprolol|bisoprolol|mesh-list
6615326|NCT01243827|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6615327|NCT01243827|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6615328|NCT01243827|Adrenergic Agents|adrenergic agents|mesh-ancestor
6615329|NCT01243827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6615330|NCT01243827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615331|NCT01243827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615332|NCT01243827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6615333|NCT01243827|Antioxidants|antioxidants|mesh-ancestor
6615334|NCT01243827|Protective Agents|protective agents|mesh-ancestor
6615335|NCT01243827|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6615336|NCT01243827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6615337|NCT01243827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6615338|NCT01243827|Vasodilator Agents|vasodilator agents|mesh-ancestor
6615339|NCT01243827|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6615340|NCT01243827|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6615341|NCT01243827|Sympatholytics|sympatholytics|mesh-ancestor
6615342|NCT01243827|Autonomic Agents|autonomic agents|mesh-ancestor
6615343|NCT01243827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6615344|NCT01243827|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6615345|NCT01243970|Phenylephrine|phenylephrine|mesh-list
6615346|NCT01243970|Oxymetazoline|oxymetazoline|mesh-list
6615347|NCT01243970|Ephedrine|ephedrine|mesh-list
6615348|NCT01243970|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6615349|NCT01243970|Mydriatics|mydriatics|mesh-ancestor
6615350|NCT01243970|Autonomic Agents|autonomic agents|mesh-ancestor
6615351|NCT01243970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6615352|NCT01243970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615353|NCT01243970|Sympathomimetics|sympathomimetics|mesh-ancestor
6615354|NCT01243970|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6615355|NCT01243970|Nasal Decongestants|nasal decongestants|mesh-ancestor
6615356|NCT01243970|Respiratory System Agents|respiratory system agents|mesh-ancestor
6615357|NCT01243970|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6615358|NCT01243970|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6615359|NCT01243970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6615360|NCT01243970|Adrenergic Agents|adrenergic agents|mesh-ancestor
6615361|NCT01243970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6615362|NCT01243970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450134|NCT00406874|Folic Acid|folic acid|mesh-list
6450135|NCT00406874|Hematinics|hematinics|mesh-ancestor
6450136|NCT00406874|Vitamin B Complex|vitamin b complex|mesh-ancestor
6450137|NCT00406874|Vitamins|vitamins|mesh-ancestor
6450138|NCT00406874|Micronutrients|micronutrients|mesh-ancestor
6450139|NCT00406874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450140|NCT00406887|Difluprednate|difluprednate|mesh-list
6450141|NCT00406887|Glucocorticoids|glucocorticoids|mesh-ancestor
6450142|NCT00406887|Hormones|hormones|mesh-ancestor
6450143|NCT00406887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6450144|NCT00406887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615363|NCT01243970|Protective Agents|protective agents|mesh-ancestor
6615364|NCT01243970|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6615365|NCT01243996|Ibuprofen|ibuprofen|mesh-list
6615366|NCT01243996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5502032|NCT04469283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502033|NCT04469283|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5502034|NCT04469283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5502035|NCT04469283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502036|NCT04469283|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5502037|NCT04469283|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5502038|NCT04469283|Purinergic Agents|purinergic agents|mesh-ancestor
5502039|NCT04469283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5502040|NCT04469010|Ascorbic Acid|ascorbic acid|mesh-list
5502041|NCT04469010|Iron|iron|mesh-list
5502042|NCT04469010|Chelating Agents|chelating agents|mesh-list
5502043|NCT04469010|Vitamins|vitamins|mesh-ancestor
5502044|NCT04469010|Micronutrients|micronutrients|mesh-ancestor
5502045|NCT04469010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502046|NCT04469010|Trace Elements|trace elements|mesh-ancestor
5502047|NCT04469010|Antioxidants|antioxidants|mesh-ancestor
5502048|NCT04469010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502049|NCT04469010|Protective Agents|protective agents|mesh-ancestor
5502050|NCT04469010|Sequestering Agents|sequestering agents|mesh-ancestor
5502051|NCT04469114|Tofacitinib|tofacitinib|mesh-list
5502052|NCT04469114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5502053|NCT04469114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5502054|NCT04469114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502055|NCT04469062|Mirikizumab|mirikizumab|mesh-list
5502056|NCT04469062|Vedolizumab|vedolizumab|mesh-list
5502057|NCT04469062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5502058|NCT04469062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5502059|NCT04469062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5502060|NCT04469062|Analgesics|analgesics|mesh-ancestor
5502061|NCT04469062|Sensory System Agents|sensory system agents|mesh-ancestor
5502062|NCT04469062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5502063|NCT04469062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502064|NCT04469062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5502065|NCT04469062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5502066|NCT04469062|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5502067|NCT04468815|Esomeprazole|esomeprazole|mesh-list
5502068|NCT04468815|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5502069|NCT04468815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5502070|NCT04468815|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6615367|NCT01243996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6615368|NCT01243996|Analgesics|analgesics|mesh-ancestor
6615369|NCT01243996|Sensory System Agents|sensory system agents|mesh-ancestor
6615370|NCT01243996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6615371|NCT01243996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615372|NCT01243996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6615373|NCT01243996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6615374|NCT01243996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6615375|NCT01243996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6615376|NCT01243996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615377|NCT01244009|Niraparib|niraparib|mesh-list
6615378|NCT01244009|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6615379|NCT01244009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6615380|NCT01244009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615381|NCT01244009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6615382|NCT01244100|Aspirin|aspirin|mesh-list
6615383|NCT01244100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6615384|NCT01244100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6615385|NCT01244100|Analgesics|analgesics|mesh-ancestor
6615386|NCT01244100|Sensory System Agents|sensory system agents|mesh-ancestor
6615387|NCT01244100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5502071|NCT04468815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6450145|NCT00406913|Mupirocin|mupirocin|mesh-list
6615388|NCT01244100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615389|NCT01244100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6615390|NCT01244100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6615391|NCT01244100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6615392|NCT01244100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6615393|NCT01244100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615394|NCT01244100|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6615395|NCT01244100|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6615396|NCT01244100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6615397|NCT01244100|Antipyretics|antipyretics|mesh-ancestor
6615398|NCT01244113|Propofol|propofol|mesh-list
6615399|NCT01244113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6615400|NCT01244113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6615401|NCT01244113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615402|NCT01244113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6615403|NCT01244113|Anesthetics, General|anesthetics, general|mesh-ancestor
6615404|NCT01244113|Anesthetics|anesthetics|mesh-ancestor
6615405|NCT01244178|Insulin|insulin|mesh-list
6615406|NCT01244178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6615407|NCT01244178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6615408|NCT01244178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615409|NCT01244204|Vitamin D|vitamin d|mesh-list
6615410|NCT01244204|Vitamins|vitamins|mesh-ancestor
6615411|NCT01244204|Micronutrients|micronutrients|mesh-ancestor
6615412|NCT01244204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615413|NCT01244204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6615414|NCT01244217|Fexofenadine|fexofenadine|mesh-list
6615415|NCT01244217|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6615416|NCT01244217|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6615417|NCT01244217|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6615418|NCT01244217|Histamine Antagonists|histamine antagonists|mesh-ancestor
6615419|NCT01244217|Histamine Agents|histamine agents|mesh-ancestor
6615420|NCT01244217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6615421|NCT01244217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615422|NCT01244217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615423|NCT01244230|Fexofenadine|fexofenadine|mesh-list
6615424|NCT01244230|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6615425|NCT01244230|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6615426|NCT01244230|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6615427|NCT01244230|Histamine Antagonists|histamine antagonists|mesh-ancestor
6615428|NCT01244230|Histamine Agents|histamine agents|mesh-ancestor
6615429|NCT01244230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6615430|NCT01244230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615431|NCT01244230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615432|NCT01244256|Gentamicins|gentamicins|mesh-list
6615433|NCT01244256|Clotrimazole|clotrimazole|mesh-list
6615434|NCT01244256|Miconazole|miconazole|mesh-list
6615435|NCT01244256|Beclomethasone|beclomethasone|mesh-list
6615436|NCT01244256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6615437|NCT01244256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6615438|NCT01244256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6615439|NCT01244256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6615440|NCT01244256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615441|NCT01244256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6615442|NCT01244256|Glucocorticoids|glucocorticoids|mesh-ancestor
6615443|NCT01244256|Hormones|hormones|mesh-ancestor
6615444|NCT01244256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6615445|NCT01244256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615446|NCT01244256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6615447|NCT01244256|Respiratory System Agents|respiratory system agents|mesh-ancestor
6615448|NCT01244256|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6615449|NCT01244256|Antifungal Agents|antifungal agents|mesh-ancestor
6615450|NCT01244256|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6615451|NCT01244256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6615452|NCT01244256|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6615453|NCT01244256|Hormone Antagonists|hormone antagonists|mesh-ancestor
6615454|NCT01244256|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6615455|NCT01244256|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6615456|NCT01244269|Methylphenidate|methylphenidate|mesh-list
6615457|NCT01244269|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6615458|NCT01244269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615459|NCT01244269|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6615460|NCT01244269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6615461|NCT01244269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6615462|NCT01244269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615463|NCT01244269|Dopamine Agents|dopamine agents|mesh-ancestor
6615464|NCT01244269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6615465|NCT01244334|Prednisolone|prednisolone|mesh-list
6615466|NCT01244334|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6615467|NCT01244334|Methylprednisolone|methylprednisolone|mesh-list
6615468|NCT01244334|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6615469|NCT01244334|Prednisolone acetate|prednisolone acetate|mesh-list
6615470|NCT01244334|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6615471|NCT01244334|Prednisolone phosphate|prednisolone phosphate|mesh-list
6615472|NCT01244334|Difluprednate|difluprednate|mesh-list
6615473|NCT01244334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6615474|NCT01244334|Glucocorticoids|glucocorticoids|mesh-ancestor
6615475|NCT01244334|Hormones|hormones|mesh-ancestor
6615476|NCT01244334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6615477|NCT01244334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615478|NCT01244334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6615479|NCT01244334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6615480|NCT01244334|Antiemetics|antiemetics|mesh-ancestor
6615481|NCT01244334|Autonomic Agents|autonomic agents|mesh-ancestor
6615482|NCT01244334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6615483|NCT01244334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6615484|NCT01244334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6615485|NCT01244334|Protective Agents|protective agents|mesh-ancestor
6615486|NCT01244347|Folic Acid|folic acid|mesh-list
6615487|NCT01244347|Vitamin B Complex|vitamin b complex|mesh-list
6615488|NCT01244347|Hematinics|hematinics|mesh-ancestor
6615489|NCT01244347|Vitamins|vitamins|mesh-ancestor
6615490|NCT01244347|Micronutrients|micronutrients|mesh-ancestor
6615491|NCT01244347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615492|NCT01244360|Resveratrol|resveratrol|mesh-list
6615493|NCT01244360|Antioxidants|antioxidants|mesh-ancestor
6615494|NCT01244360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615495|NCT01244360|Protective Agents|protective agents|mesh-ancestor
6615496|NCT01244360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615497|NCT01244360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6615498|NCT01244360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6615499|NCT01244399|Inositol|inositol|mesh-list
6615500|NCT01244399|Vitamin B Complex|vitamin b complex|mesh-ancestor
6615501|NCT01244399|Vitamins|vitamins|mesh-ancestor
6615502|NCT01244399|Micronutrients|micronutrients|mesh-ancestor
6615503|NCT01244399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661336|NCT01498380|Dexmedetomidine|dexmedetomidine|mesh-list
6661337|NCT01498380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6661338|NCT01498380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6661339|NCT01498380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661340|NCT01498380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6661341|NCT01498380|Analgesics|analgesics|mesh-ancestor
6661342|NCT01498380|Sensory System Agents|sensory system agents|mesh-ancestor
6615504|NCT01244581|Amoxicillin|amoxicillin|mesh-list
6615505|NCT01244581|Clavulanic Acid|clavulanic acid|mesh-list
6615506|NCT01244581|Clavulanic Acids|clavulanic acids|mesh-list
6615507|NCT01244581|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6615508|NCT01244581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6615509|NCT01244581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6615510|NCT01244581|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6615511|NCT01244581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6615512|NCT01244581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615513|NCT01244659|Tacrolimus|tacrolimus|mesh-list
6615514|NCT01244659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6615515|NCT01244659|Immunologic Factors|immunologic factors|mesh-ancestor
6615516|NCT01244659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615517|NCT01244659|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6615518|NCT01244659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6615519|NCT01244659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615520|NCT01244698|Clindamycin|clindamycin|mesh-list
6615521|NCT01244698|Clindamycin palmitate|clindamycin palmitate|mesh-list
6615522|NCT01244698|Clindamycin phosphate|clindamycin phosphate|mesh-list
6615523|NCT01244698|Cefazolin|cefazolin|mesh-list
6615524|NCT01244698|Cefadroxil|cefadroxil|mesh-list
6615525|NCT01244698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6615526|NCT01244698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6615527|NCT01244698|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6615528|NCT01244698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6615529|NCT01244698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615530|NCT01244789|Paclitaxel|paclitaxel|mesh-list
6615531|NCT01244789|Carboplatin|carboplatin|mesh-list
6615532|NCT01244789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6615533|NCT01244789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6615534|NCT01244789|Tubulin Modulators|tubulin modulators|mesh-ancestor
6615535|NCT01244789|Antimitotic Agents|antimitotic agents|mesh-ancestor
6615536|NCT01244789|Mitosis Modulators|mitosis modulators|mesh-ancestor
6615537|NCT01244789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615538|NCT01244880|Ketamine|ketamine|mesh-list
6615539|NCT01244880|Analgesics|analgesics|mesh-ancestor
6615540|NCT01244880|Sensory System Agents|sensory system agents|mesh-ancestor
6615541|NCT01244880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6615542|NCT01244880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615543|NCT01244880|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6450146|NCT00406913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6450147|NCT00406913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6450148|NCT00406913|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6450149|NCT00406913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6450150|NCT00406913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450151|NCT00406952|Sertraline|sertraline|mesh-list
6450152|NCT00406952|Antidepressive Agents|antidepressive agents|mesh-ancestor
6450153|NCT00406952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6450154|NCT00406952|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6450155|NCT00406952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6450156|NCT00406952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6450157|NCT00406952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450158|NCT00406952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6615544|NCT01244880|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6450159|NCT00406952|Serotonin Agents|serotonin agents|mesh-ancestor
6450160|NCT00406952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450161|NCT00406978|Thalidomide|thalidomide|mesh-list
6450162|NCT00406978|Prednisone|prednisone|mesh-list
6450163|NCT00406978|Melphalan|melphalan|mesh-list
6450164|NCT00406978|Defibrotide|defibrotide|mesh-list
6450165|NCT00406978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6450166|NCT00406978|Glucocorticoids|glucocorticoids|mesh-ancestor
6450167|NCT00406978|Hormones|hormones|mesh-ancestor
6450168|NCT00406978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6450169|NCT00406978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450170|NCT00406978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6450171|NCT00406978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6615545|NCT01244880|Anesthetics, General|anesthetics, general|mesh-ancestor
6615546|NCT01244880|Anesthetics|anesthetics|mesh-ancestor
6615547|NCT01244880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6615548|NCT01244880|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6615549|NCT01244880|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6615550|NCT01244880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6661343|NCT01498380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6615551|NCT01244880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615552|NCT01244932|Bupivacaine|bupivacaine|mesh-list
6615553|NCT01244932|Anesthetics, Local|anesthetics, local|mesh-ancestor
6615554|NCT01244932|Anesthetics|anesthetics|mesh-ancestor
6615555|NCT01244932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6615556|NCT01244932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615557|NCT01244932|Sensory System Agents|sensory system agents|mesh-ancestor
6615558|NCT01244932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6615559|NCT01244958|Rituximab|rituximab|mesh-list
6615560|NCT01244958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6615561|NCT01244958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6615562|NCT01244958|Immunologic Factors|immunologic factors|mesh-ancestor
6615563|NCT01244958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615564|NCT01244958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6615565|NCT01244971|Acarbose|acarbose|mesh-list
6615566|NCT01244971|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6615567|NCT01244971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6615568|NCT01244971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615569|NCT01244971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6615570|NCT01244971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615571|NCT01245166|Metformin|metformin|mesh-list
6615572|NCT01245166|Acarbose|acarbose|mesh-list
6615573|NCT01245166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6615574|NCT01245166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615575|NCT01245166|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6615576|NCT01245166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6615577|NCT01245166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615578|NCT01245179|Panobinostat|panobinostat|mesh-list
6615579|NCT01245179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6615580|NCT01245179|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6615581|NCT01245179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6615582|NCT01245179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615583|NCT01245205|Lapatinib|lapatinib|mesh-list
6615584|NCT01245205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6615585|NCT01245205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6615586|NCT01245205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6615587|NCT01245205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615588|NCT01245244|Morphine|morphine|mesh-list
6615589|NCT01245244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6615590|NCT01245244|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6615591|NCT01245244|Narcotics|narcotics|mesh-ancestor
6615592|NCT01245244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6615593|NCT01245244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615594|NCT01245244|Analgesics|analgesics|mesh-ancestor
6615595|NCT01245244|Sensory System Agents|sensory system agents|mesh-ancestor
6615596|NCT01245244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6615597|NCT01245361|Infliximab|infliximab|mesh-list
6615598|NCT01245361|Dermatologic Agents|dermatologic agents|mesh-ancestor
6615599|NCT01245361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6615600|NCT01245361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6615601|NCT01245452|Methotrexate|methotrexate|mesh-list
6615602|NCT01245452|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6615603|NCT01245452|Abortifacient Agents|abortifacient agents|mesh-ancestor
6615604|NCT01245452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6615605|NCT01245452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615606|NCT01245452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6615607|NCT01245452|Antimetabolites|antimetabolites|mesh-ancestor
6615608|NCT01245452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615609|NCT01245452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6615610|NCT01245452|Dermatologic Agents|dermatologic agents|mesh-ancestor
6615611|NCT01245452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6615612|NCT01245452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6615613|NCT01245452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6615614|NCT01245452|Immunologic Factors|immunologic factors|mesh-ancestor
6615615|NCT01245452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6615616|NCT01245452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6615617|NCT01245530|Donepezil|donepezil|mesh-list
6615618|NCT01245530|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6615619|NCT01245530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6615620|NCT01245530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615621|NCT01245530|Cholinergic Agents|cholinergic agents|mesh-ancestor
6615622|NCT01245530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6615623|NCT01245530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615624|NCT01245530|Nootropic Agents|nootropic agents|mesh-ancestor
6615625|NCT01245543|Docetaxel|docetaxel|mesh-list
6615626|NCT01245543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6615627|NCT01245543|Tubulin Modulators|tubulin modulators|mesh-ancestor
6615628|NCT01245543|Antimitotic Agents|antimitotic agents|mesh-ancestor
6615629|NCT01245543|Mitosis Modulators|mitosis modulators|mesh-ancestor
6615630|NCT01245543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615631|NCT01245556|Ipilimumab|ipilimumab|mesh-list
6615632|NCT01245556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6615633|NCT01245556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6615634|NCT01245556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6615635|NCT01245556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615636|NCT01245569|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6615637|NCT01245569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6615638|NCT01245569|Autonomic Agents|autonomic agents|mesh-ancestor
6615639|NCT01245569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6615640|NCT01245569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615641|NCT01245569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6615642|NCT01245569|Respiratory System Agents|respiratory system agents|mesh-ancestor
6615643|NCT01245569|Glucocorticoids|glucocorticoids|mesh-ancestor
6615644|NCT01245569|Hormones|hormones|mesh-ancestor
6615645|NCT01245569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6615646|NCT01245569|Sympathomimetics|sympathomimetics|mesh-ancestor
6615647|NCT01245582|Capecitabine|capecitabine|mesh-list
6615648|NCT01245582|Oxaliplatin|oxaliplatin|mesh-list
6615649|NCT01245582|Sorafenib|sorafenib|mesh-list
6615650|NCT01245582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6615651|NCT01245582|Antimetabolites|antimetabolites|mesh-ancestor
6615652|NCT01245582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615653|NCT01245582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6615654|NCT01245582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6615655|NCT01245582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6615656|NCT01245660|Lapatinib|lapatinib|mesh-list
6615657|NCT01245660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6615658|NCT01245660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6615659|NCT01245660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6615660|NCT01245660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615661|NCT01245725|Tirofiban|tirofiban|mesh-list
6615662|NCT01245725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6615663|NCT01245725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6615664|NCT01245725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615665|NCT01245725|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6615666|NCT01245803|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6615667|NCT01245803|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6615668|NCT01245803|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6615669|NCT01245803|Antimetabolites|antimetabolites|mesh-ancestor
6615670|NCT01245803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615671|NCT01245803|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6615672|NCT01245803|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6615673|NCT01245803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6615674|NCT01245816|Eflornithine|eflornithine|mesh-list
6615675|NCT01245816|Sulindac|sulindac|mesh-list
6615676|NCT01245816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6615677|NCT01245816|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6615678|NCT01245816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6615679|NCT01245816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6615680|NCT01245816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6615681|NCT01245816|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
6615682|NCT01245816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6615683|NCT01245816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615684|NCT01245816|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6615685|NCT01245816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6615686|NCT01245816|Analgesics|analgesics|mesh-ancestor
6615687|NCT01245816|Sensory System Agents|sensory system agents|mesh-ancestor
6615688|NCT01245816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6615689|NCT01245816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615690|NCT01245816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6615691|NCT01245816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6615692|NCT01245816|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6615693|NCT01245855|Alprostadil|alprostadil|mesh-list
6615694|NCT01245855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6615695|NCT01245855|Vasodilator Agents|vasodilator agents|mesh-ancestor
6615696|NCT01245855|Urological Agents|urological agents|mesh-ancestor
6615697|NCT01245868|Lidocaine|lidocaine|mesh-list
6615698|NCT01245868|Bupivacaine|bupivacaine|mesh-list
6615699|NCT01245868|Anesthetics, Local|anesthetics, local|mesh-ancestor
6615700|NCT01245868|Anesthetics|anesthetics|mesh-ancestor
6615701|NCT01245868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6615702|NCT01245868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615703|NCT01245868|Sensory System Agents|sensory system agents|mesh-ancestor
6615704|NCT01245868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6615705|NCT01245868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6615706|NCT01245868|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6615707|NCT01245868|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6615708|NCT01245868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6615709|NCT01245868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615710|NCT01245881|Sunscreening Agents|sunscreening agents|mesh-list
6615711|NCT01245881|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6615712|NCT01245881|Protective Agents|protective agents|mesh-ancestor
6615713|NCT01245881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615714|NCT01245881|Dermatologic Agents|dermatologic agents|mesh-ancestor
6020807|NCT00394589|Dermatologic Agents|dermatologic agents|mesh-ancestor
6020808|NCT00394589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6450172|NCT00406978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6450173|NCT00406978|Alkylating Agents|alkylating agents|mesh-ancestor
6450174|NCT00406978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450175|NCT00406978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6450176|NCT00406978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6450177|NCT00406978|Immunologic Factors|immunologic factors|mesh-ancestor
6450178|NCT00406978|Leprostatic Agents|leprostatic agents|mesh-ancestor
6450179|NCT00406978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6450180|NCT00406978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6450181|NCT00406978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6450182|NCT00406978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6450183|NCT00406978|Growth Substances|growth substances|mesh-ancestor
6450184|NCT00406978|Growth Inhibitors|growth inhibitors|mesh-ancestor
6450185|NCT00406978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6450186|NCT00406978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6450187|NCT00406978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6450188|NCT00406991|Aspirin|aspirin|mesh-list
6450189|NCT00406991|Clopidogrel|clopidogrel|mesh-list
6450190|NCT00406991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6450191|NCT00406991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6450192|NCT00406991|Analgesics|analgesics|mesh-ancestor
6450193|NCT00406991|Sensory System Agents|sensory system agents|mesh-ancestor
6450194|NCT00406991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6450195|NCT00406991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450196|NCT00406991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6450197|NCT00406991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6450198|NCT00406991|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6450199|NCT00406991|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6450200|NCT00406991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450201|NCT00406991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6450202|NCT00406991|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6450203|NCT00406991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6450204|NCT00406991|Antipyretics|antipyretics|mesh-ancestor
6450205|NCT00406991|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6450206|NCT00406991|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6450207|NCT00406991|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6450208|NCT00406991|Purinergic Agents|purinergic agents|mesh-ancestor
6450209|NCT00406991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6450210|NCT00407017|Moxifloxacin|moxifloxacin|mesh-list
6450211|NCT00407017|Gatifloxacin|gatifloxacin|mesh-list
6450212|NCT00407017|Ketorolac|ketorolac|mesh-list
6450213|NCT00407017|Nepafenac|nepafenac|mesh-list
6450214|NCT00407017|Prednisolone acetate|prednisolone acetate|mesh-list
6450215|NCT00407017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6450216|NCT00407017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6450217|NCT00407017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6450218|NCT00407017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6450219|NCT00407017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6450220|NCT00407017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450221|NCT00407017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6450222|NCT00407017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450223|NCT00407017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6450224|NCT00407017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6450225|NCT00407017|Analgesics|analgesics|mesh-ancestor
6450226|NCT00407017|Sensory System Agents|sensory system agents|mesh-ancestor
6450227|NCT00407017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6450228|NCT00407017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6450229|NCT00407017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6020809|NCT00394589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6615715|NCT01245894|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6615716|NCT01245894|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6615717|NCT01245894|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6615718|NCT01245894|Antimetabolites|antimetabolites|mesh-ancestor
6615719|NCT01245894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615720|NCT01245894|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6615721|NCT01245894|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6615722|NCT01245894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6615723|NCT01245946|Doxycycline|doxycycline|mesh-list
6615724|NCT01245946|Adapalene|adapalene|mesh-list
6615725|NCT01245946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6615726|NCT01245946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6615727|NCT01245946|Antimalarials|antimalarials|mesh-ancestor
6615728|NCT01245946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6615729|NCT01245946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6615730|NCT01245946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6615731|NCT01245946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6615732|NCT01245946|Analgesics|analgesics|mesh-ancestor
6615733|NCT01245946|Sensory System Agents|sensory system agents|mesh-ancestor
6615734|NCT01245946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6615735|NCT01245946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615736|NCT01245946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6615737|NCT01245946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6615738|NCT01245946|Dermatologic Agents|dermatologic agents|mesh-ancestor
6615739|NCT01245959|Cisplatin|cisplatin|mesh-list
6615740|NCT01245959|Docetaxel|docetaxel|mesh-list
6615741|NCT01245959|Fluorouracil|fluorouracil|mesh-list
6615742|NCT01245959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6615743|NCT01245959|Tubulin Modulators|tubulin modulators|mesh-ancestor
6615744|NCT01245959|Antimitotic Agents|antimitotic agents|mesh-ancestor
6615745|NCT01245959|Mitosis Modulators|mitosis modulators|mesh-ancestor
6615746|NCT01245959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615747|NCT01245959|Antimetabolites|antimetabolites|mesh-ancestor
6615748|NCT01245959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6615749|NCT01245959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6615750|NCT01245959|Immunologic Factors|immunologic factors|mesh-ancestor
6615751|NCT01245959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615752|NCT01245998|Dalteparin|dalteparin|mesh-list
6615753|NCT01245998|Tinzaparin|tinzaparin|mesh-list
6615754|NCT01245998|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6615755|NCT01245998|Anticoagulants|anticoagulants|mesh-ancestor
6615756|NCT01245998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6615757|NCT01245998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6615758|NCT01245998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615759|NCT01246037|Bisoprolol|bisoprolol|mesh-list
6615760|NCT01246037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6615761|NCT01246037|Sympatholytics|sympatholytics|mesh-ancestor
6615762|NCT01246037|Autonomic Agents|autonomic agents|mesh-ancestor
6615763|NCT01246037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6615764|NCT01246037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615765|NCT01246037|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6615766|NCT01246037|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6615767|NCT01246037|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6615768|NCT01246037|Adrenergic Agents|adrenergic agents|mesh-ancestor
6615769|NCT01246037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6615770|NCT01246037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615771|NCT01246089|Ranibizumab|ranibizumab|mesh-list
6615772|NCT01246089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6615773|NCT01246089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6615774|NCT01246089|Growth Substances|growth substances|mesh-ancestor
6615775|NCT01246089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615776|NCT01246089|Growth Inhibitors|growth inhibitors|mesh-ancestor
6615777|NCT01246089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6615778|NCT01246180|Diclofenac|diclofenac|mesh-list
6615779|NCT01246180|Amiloride|amiloride|mesh-list
6615780|NCT01246180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6615781|NCT01246180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6615782|NCT01246180|Analgesics|analgesics|mesh-ancestor
6615783|NCT01246180|Sensory System Agents|sensory system agents|mesh-ancestor
6615784|NCT01246180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6615785|NCT01246180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615786|NCT01246180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6615787|NCT01246180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6615788|NCT01246180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6615789|NCT01246180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6615790|NCT01246180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615791|NCT01246180|Diuretics|diuretics|mesh-ancestor
6615792|NCT01246180|Natriuretic Agents|natriuretic agents|mesh-ancestor
6615793|NCT01246180|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
6615794|NCT01246180|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6615795|NCT01246180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6615796|NCT01246180|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
6615797|NCT01246180|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6615798|NCT01246232|Amisulpride|amisulpride|mesh-list
6615799|NCT01246232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6615800|NCT01246232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6615801|NCT01246232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6615802|NCT01246232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615803|NCT01246232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6615804|NCT01246232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6615805|NCT01246232|Dopamine Agents|dopamine agents|mesh-ancestor
6615806|NCT01246232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6615807|NCT01246232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615808|NCT01246232|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6615809|NCT01246232|Antidepressive Agents|antidepressive agents|mesh-ancestor
6615810|NCT01246284|Triamcinolone|triamcinolone|mesh-list
6615811|NCT01246284|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6615812|NCT01246284|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6615813|NCT01246284|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6615814|NCT01246284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6615815|NCT01246284|Glucocorticoids|glucocorticoids|mesh-ancestor
6615816|NCT01246284|Hormones|hormones|mesh-ancestor
6615817|NCT01246284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6615818|NCT01246284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615819|NCT01246284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6615820|NCT01246284|Immunologic Factors|immunologic factors|mesh-ancestor
6615821|NCT01246284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6615822|NCT01246284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615823|NCT01246310|Inositol|inositol|mesh-list
6615824|NCT01246310|Vitamin B Complex|vitamin b complex|mesh-ancestor
6615825|NCT01246310|Vitamins|vitamins|mesh-ancestor
6615826|NCT01246310|Micronutrients|micronutrients|mesh-ancestor
6615827|NCT01246310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615828|NCT01246323|Fentanyl|fentanyl|mesh-list
6615829|NCT01246323|Morphine|morphine|mesh-list
6615830|NCT01246323|Anesthetics|anesthetics|mesh-ancestor
6615831|NCT01246323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6615832|NCT01246323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615833|NCT01246323|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6615834|NCT01246323|Narcotics|narcotics|mesh-ancestor
6615835|NCT01246323|Analgesics|analgesics|mesh-ancestor
6615836|NCT01246323|Sensory System Agents|sensory system agents|mesh-ancestor
6615837|NCT01246323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6615838|NCT01246323|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6615839|NCT01246323|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6615840|NCT01246323|Anesthetics, General|anesthetics, general|mesh-ancestor
6615841|NCT01246362|Etoricoxib|etoricoxib|mesh-list
6615842|NCT01246362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6615843|NCT01246362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6615844|NCT01246362|Analgesics|analgesics|mesh-ancestor
6615845|NCT01246362|Sensory System Agents|sensory system agents|mesh-ancestor
6615846|NCT01246362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6615847|NCT01246362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615848|NCT01246362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6615849|NCT01246362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6615850|NCT01246362|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6615851|NCT01246362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6615852|NCT01246362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6615853|NCT01246362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661344|NCT01498380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6661345|NCT01498380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6661346|NCT01498380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6661347|NCT01498380|Adrenergic Agents|adrenergic agents|mesh-ancestor
6661348|NCT01498380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6661349|NCT01498380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661350|NCT01498406|Vitamin D|vitamin d|mesh-list
6661351|NCT01498406|Ergocalciferols|ergocalciferols|mesh-list
6661352|NCT01498406|Vitamins|vitamins|mesh-list
6661353|NCT01498406|Micronutrients|micronutrients|mesh-ancestor
6661354|NCT01498406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661355|NCT01498406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6661356|NCT01498406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6661357|NCT01498523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6661358|NCT01498562|Gefitinib|gefitinib|mesh-list
6661359|NCT01498562|Nimotuzumab|nimotuzumab|mesh-list
6661360|NCT01498562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6661361|NCT01498562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6661362|NCT01498562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6661363|NCT01498562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661364|NCT01498562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6661365|NCT01498718|Vaccines|vaccines|mesh-list
6661366|NCT01498718|Immunologic Factors|immunologic factors|mesh-ancestor
6661367|NCT01498718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664937|NCT01514851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6664938|NCT01514851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6664939|NCT01514903|Sildenafil Citrate|sildenafil citrate|mesh-list
6664940|NCT01514903|Vasodilator Agents|vasodilator agents|mesh-ancestor
6664941|NCT01514903|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6664942|NCT01514903|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6664943|NCT01514903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6664944|NCT01514903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6664945|NCT01514903|Urological Agents|urological agents|mesh-ancestor
6664946|NCT01514929|Moxifloxacin|moxifloxacin|mesh-list
6664947|NCT01514929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6664948|NCT01514929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6664949|NCT01514929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6664950|NCT01514929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6664951|NCT01514929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6664952|NCT01514929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6664953|NCT01514929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6664954|NCT01514942|Folic Acid|folic acid|mesh-list
6664955|NCT01514942|Vitamin B Complex|vitamin b complex|mesh-list
6664956|NCT01514942|Hydroxocobalamin|hydroxocobalamin|mesh-list
6664957|NCT01514942|Vitamin B 12|vitamin b 12|mesh-list
6615854|NCT01246440|Catumaxomab|catumaxomab|mesh-list
6615855|NCT01246440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6615856|NCT01246453|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6615857|NCT01246453|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6615858|NCT01246453|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6615859|NCT01246453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615860|NCT01246557|Dexamethasone|dexamethasone|mesh-list
6615861|NCT01246557|Lenalidomide|lenalidomide|mesh-list
6615862|NCT01246557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6615863|NCT01246557|Antiemetics|antiemetics|mesh-ancestor
6615864|NCT01246557|Autonomic Agents|autonomic agents|mesh-ancestor
6615865|NCT01246557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6615866|NCT01246557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615867|NCT01246557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6615868|NCT01246557|Glucocorticoids|glucocorticoids|mesh-ancestor
6615869|NCT01246557|Hormones|hormones|mesh-ancestor
6615870|NCT01246557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6615871|NCT01246557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6615872|NCT01246557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6615873|NCT01246557|Immunologic Factors|immunologic factors|mesh-ancestor
6615874|NCT01246557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6615875|NCT01246557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6615876|NCT01246557|Growth Substances|growth substances|mesh-ancestor
6615877|NCT01246557|Growth Inhibitors|growth inhibitors|mesh-ancestor
6615878|NCT01246622|Cytarabine|cytarabine|mesh-list
6615879|NCT01246622|Lenalidomide|lenalidomide|mesh-list
6615880|NCT01246622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6615881|NCT01246622|Antimetabolites|antimetabolites|mesh-ancestor
6615882|NCT01246622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615883|NCT01246622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6615884|NCT01246622|Antiviral Agents|antiviral agents|mesh-ancestor
6615885|NCT01246622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6615886|NCT01246622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6615887|NCT01246622|Immunologic Factors|immunologic factors|mesh-ancestor
6615888|NCT01246622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615889|NCT01246622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6615890|NCT01246622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6615891|NCT01246622|Growth Substances|growth substances|mesh-ancestor
6615892|NCT01246622|Growth Inhibitors|growth inhibitors|mesh-ancestor
6615893|NCT01246752|Cytarabine|cytarabine|mesh-list
6615894|NCT01246752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6615895|NCT01246752|Antimetabolites|antimetabolites|mesh-ancestor
6615896|NCT01246752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615897|NCT01246752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6615898|NCT01246752|Antiviral Agents|antiviral agents|mesh-ancestor
6615899|NCT01246752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6615900|NCT01246752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6615901|NCT01246752|Immunologic Factors|immunologic factors|mesh-ancestor
6615902|NCT01246752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615903|NCT01246804|Raltegravir Potassium|raltegravir potassium|mesh-list
6615904|NCT01246804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6615905|NCT01246804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6615906|NCT01246804|Antiviral Agents|antiviral agents|mesh-ancestor
6615907|NCT01246804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6615908|NCT01246804|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6615909|NCT01246804|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6615910|NCT01246804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6615911|NCT01246804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615912|NCT01246817|Sirolimus|sirolimus|mesh-list
6450230|NCT00407017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6450231|NCT00407017|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6450232|NCT00407017|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6450233|NCT00407043|Loteprednol Etabonate|loteprednol etabonate|mesh-list
6450234|NCT00407043|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6450235|NCT00407056|Difluprednate|difluprednate|mesh-list
6450236|NCT00407056|Glucocorticoids|glucocorticoids|mesh-ancestor
6450237|NCT00407056|Hormones|hormones|mesh-ancestor
6450238|NCT00407056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6450239|NCT00407056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615913|NCT01246817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6615914|NCT01246817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6615915|NCT01246817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6615916|NCT01246817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6615917|NCT01246817|Antifungal Agents|antifungal agents|mesh-ancestor
6615918|NCT01246817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6615919|NCT01246817|Immunologic Factors|immunologic factors|mesh-ancestor
6615920|NCT01246817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615921|NCT01246921|Fluticasone|fluticasone|mesh-list
6615922|NCT01246921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6615923|NCT01246921|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6615924|NCT01246921|Autonomic Agents|autonomic agents|mesh-ancestor
6615925|NCT01246921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6615926|NCT01246921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615927|NCT01246921|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6615928|NCT01246921|Respiratory System Agents|respiratory system agents|mesh-ancestor
6615929|NCT01246921|Dermatologic Agents|dermatologic agents|mesh-ancestor
6615930|NCT01246921|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6615931|NCT01247077|Selenium|selenium|mesh-list
6615932|NCT01247077|Antioxidants|antioxidants|mesh-ancestor
6615933|NCT01247077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615934|NCT01247077|Protective Agents|protective agents|mesh-ancestor
6615935|NCT01247077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615936|NCT01247077|Trace Elements|trace elements|mesh-ancestor
6615937|NCT01247077|Micronutrients|micronutrients|mesh-ancestor
6615938|NCT01247311|Vitamin D|vitamin d|mesh-list
6615939|NCT01247311|Ergocalciferols|ergocalciferols|mesh-list
6615940|NCT01247311|Vitamins|vitamins|mesh-list
6615941|NCT01247311|Micronutrients|micronutrients|mesh-ancestor
6615942|NCT01247311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615943|NCT01247311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6615944|NCT01247311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6615945|NCT01247337|Gemcitabine|gemcitabine|mesh-list
6615946|NCT01247337|Capecitabine|capecitabine|mesh-list
6615947|NCT01247337|Oxaliplatin|oxaliplatin|mesh-list
6615948|NCT01247337|Cetuximab|cetuximab|mesh-list
6615949|NCT01247337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6615950|NCT01247337|Antimetabolites|antimetabolites|mesh-ancestor
6615951|NCT01247337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615952|NCT01247337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6450240|NCT00407082|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
6450241|NCT00407082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6450242|NCT00407082|Glucocorticoids|glucocorticoids|mesh-ancestor
6615953|NCT01247337|Antiviral Agents|antiviral agents|mesh-ancestor
6615954|NCT01247337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6615955|NCT01247337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6615956|NCT01247337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6615957|NCT01247337|Immunologic Factors|immunologic factors|mesh-ancestor
6615958|NCT01247337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615959|NCT01247337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6615960|NCT01247493|Cytarabine|cytarabine|mesh-list
6615961|NCT01247493|Fludarabine|fludarabine|mesh-list
6615962|NCT01247493|Idarubicin|idarubicin|mesh-list
6615963|NCT01247493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6615964|NCT01247493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6615965|NCT01247493|Antimetabolites|antimetabolites|mesh-ancestor
6615966|NCT01247493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615967|NCT01247493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6615968|NCT01247493|Immunologic Factors|immunologic factors|mesh-ancestor
6615969|NCT01247493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615970|NCT01247493|Antiviral Agents|antiviral agents|mesh-ancestor
6615971|NCT01247493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6615972|NCT01247493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6615973|NCT01247493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6615974|NCT01247493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6615975|NCT01247493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6615976|NCT01247558|Vitamin B 12|vitamin b 12|mesh-list
6615977|NCT01247558|Vitamin B Complex|vitamin b complex|mesh-ancestor
6615978|NCT01247558|Vitamins|vitamins|mesh-ancestor
6615979|NCT01247558|Micronutrients|micronutrients|mesh-ancestor
6615980|NCT01247558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615981|NCT01247688|Fludarabine|fludarabine|mesh-list
6615982|NCT01247688|Cyclophosphamide|cyclophosphamide|mesh-list
6615983|NCT01247688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6615984|NCT01247688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6615985|NCT01247688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6615986|NCT01247688|Immunologic Factors|immunologic factors|mesh-ancestor
6615987|NCT01247688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450243|NCT00407082|Hormones|hormones|mesh-ancestor
6450244|NCT00407082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6450245|NCT00407082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450246|NCT00407121|Bevacizumab|bevacizumab|mesh-list
6450247|NCT00407121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6615988|NCT01247688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6615989|NCT01247688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6450248|NCT00407121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6450249|NCT00407121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6450250|NCT00407121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6450251|NCT00407121|Growth Substances|growth substances|mesh-ancestor
6615990|NCT01247688|Alkylating Agents|alkylating agents|mesh-ancestor
6615991|NCT01247688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6615992|NCT01247701|Cyclophosphamide|cyclophosphamide|mesh-list
6615993|NCT01247701|Busulfan|busulfan|mesh-list
6615994|NCT01247701|Fludarabine|fludarabine|mesh-list
6615995|NCT01247701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6615996|NCT01247701|Immunologic Factors|immunologic factors|mesh-ancestor
6615997|NCT01247701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6615998|NCT01247701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6615999|NCT01247701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6616000|NCT01247701|Alkylating Agents|alkylating agents|mesh-ancestor
6616001|NCT01247701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616002|NCT01247701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6616003|NCT01247701|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6616004|NCT01247714|Phentermine|phentermine|mesh-list
6616005|NCT01247714|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6616006|NCT01247714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616007|NCT01247714|Appetite Depressants|appetite depressants|mesh-ancestor
6616008|NCT01247714|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6616009|NCT01247714|Sympathomimetics|sympathomimetics|mesh-ancestor
6616010|NCT01247714|Autonomic Agents|autonomic agents|mesh-ancestor
6616011|NCT01247714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6616012|NCT01247714|Adrenergic Agents|adrenergic agents|mesh-ancestor
6616013|NCT01247714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6616014|NCT01247714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616015|NCT01247805|Sildenafil Citrate|sildenafil citrate|mesh-list
6616016|NCT01247805|Citric Acid|citric acid|mesh-list
6616017|NCT01247805|Sodium Citrate|sodium citrate|mesh-list
6616018|NCT01247805|Anticoagulants|anticoagulants|mesh-ancestor
6616019|NCT01247805|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6616020|NCT01247805|Chelating Agents|chelating agents|mesh-ancestor
6616021|NCT01247805|Sequestering Agents|sequestering agents|mesh-ancestor
6616022|NCT01247805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616023|NCT01247805|Vasodilator Agents|vasodilator agents|mesh-ancestor
6616024|NCT01247805|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6616025|NCT01247805|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6616026|NCT01247805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6616027|NCT01247805|Urological Agents|urological agents|mesh-ancestor
6616028|NCT01247857|Ropivacaine|ropivacaine|mesh-list
6616029|NCT01247857|Anesthetics, Local|anesthetics, local|mesh-ancestor
6616030|NCT01247857|Anesthetics|anesthetics|mesh-ancestor
6616031|NCT01247857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6616032|NCT01247857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616033|NCT01247857|Sensory System Agents|sensory system agents|mesh-ancestor
6616034|NCT01247857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6616035|NCT01247870|Metformin|metformin|mesh-list
6616036|NCT01247870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6616037|NCT01247870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616038|NCT01247909|Gentamicins|gentamicins|mesh-list
6616039|NCT01247909|Ceftriaxone|ceftriaxone|mesh-list
6616040|NCT01247909|Penicillins|penicillins|mesh-list
6616041|NCT01247909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6616042|NCT01247909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6616043|NCT01247909|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6616044|NCT01247909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6616045|NCT01247909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616046|NCT01247935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
6616047|NCT01247935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6616048|NCT01247935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616049|NCT01247961|Dexamethasone|dexamethasone|mesh-list
6616050|NCT01247961|Dexamethasone acetate|dexamethasone acetate|mesh-list
6616051|NCT01247961|BB 1101|bb 1101|mesh-list
6616052|NCT01247961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6616053|NCT01247961|Antiemetics|antiemetics|mesh-ancestor
6616054|NCT01247961|Autonomic Agents|autonomic agents|mesh-ancestor
6616055|NCT01247961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6616056|NCT01247961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616057|NCT01247961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6616058|NCT01247961|Glucocorticoids|glucocorticoids|mesh-ancestor
6616059|NCT01247961|Hormones|hormones|mesh-ancestor
6616060|NCT01247961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6616061|NCT01247961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6616062|NCT01247961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6616063|NCT01247961|Protease Inhibitors|protease inhibitors|mesh-ancestor
6616064|NCT01247961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6616065|NCT01247961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616066|NCT01248078|Cephalexin|cephalexin|mesh-list
6616067|NCT01248078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6616068|NCT01248078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6616069|NCT01248091|Nitroprusside|nitroprusside|mesh-list
6616070|NCT01248091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6616071|NCT01248091|Vasodilator Agents|vasodilator agents|mesh-ancestor
6616072|NCT01248091|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6616073|NCT01248091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661368|NCT01498783|Fluorouracil|fluorouracil|mesh-list
6661369|NCT01498783|Antimetabolites|antimetabolites|mesh-ancestor
6661370|NCT01498783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661371|NCT01498783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6661372|NCT01498783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6661373|NCT01498783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6661374|NCT01498783|Immunologic Factors|immunologic factors|mesh-ancestor
6661375|NCT01498783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661376|NCT01498796|Ketorolac|ketorolac|mesh-list
6661377|NCT01498796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6661378|NCT01498796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6661379|NCT01498796|Analgesics|analgesics|mesh-ancestor
6661380|NCT01498796|Sensory System Agents|sensory system agents|mesh-ancestor
6661381|NCT01498796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6661382|NCT01498796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661383|NCT01498796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6661384|NCT01498796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6661385|NCT01498796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6661386|NCT01498796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6661387|NCT01498796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661388|NCT01498809|Midodrine|midodrine|mesh-list
6661389|NCT01498809|Sympathomimetics|sympathomimetics|mesh-ancestor
6661390|NCT01498809|Autonomic Agents|autonomic agents|mesh-ancestor
6661391|NCT01498809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6661392|NCT01498809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661393|NCT01498809|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6661394|NCT01498809|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6661395|NCT01498809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6661396|NCT01498809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6661397|NCT01498809|Adrenergic Agents|adrenergic agents|mesh-ancestor
6661398|NCT01498809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6661399|NCT01498809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661400|NCT01498835|Sunitinib|sunitinib|mesh-list
6661401|NCT01498835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6661402|NCT01498835|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6661403|NCT01498835|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6661404|NCT01498835|Growth Substances|growth substances|mesh-ancestor
6661405|NCT01498835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661406|NCT01498835|Growth Inhibitors|growth inhibitors|mesh-ancestor
6661407|NCT01498835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6661408|NCT01498835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6661409|NCT01498835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661410|NCT01498861|Dolutegravir|dolutegravir|mesh-list
6661411|NCT01498861|Moxifloxacin|moxifloxacin|mesh-list
6661412|NCT01498861|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6661413|NCT01498861|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6661414|NCT01498861|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6661415|NCT01498861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6616074|NCT01248117|Ranibizumab|ranibizumab|mesh-list
6616075|NCT01248117|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6616076|NCT01248117|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6616077|NCT01248117|Growth Substances|growth substances|mesh-ancestor
6616078|NCT01248117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616079|NCT01248117|Growth Inhibitors|growth inhibitors|mesh-ancestor
6616080|NCT01248117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6616081|NCT01248195|Olanzapine|olanzapine|mesh-list
6616082|NCT01248195|Clozapine|clozapine|mesh-list
6616083|NCT01248195|Amisulpride|amisulpride|mesh-list
6616084|NCT01248195|Antiemetics|antiemetics|mesh-ancestor
6616085|NCT01248195|Autonomic Agents|autonomic agents|mesh-ancestor
6616086|NCT01248195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6616087|NCT01248195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616088|NCT01248195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6616089|NCT01248195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6616090|NCT01248195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6616091|NCT01248195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6616092|NCT01248195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6616093|NCT01248195|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6616094|NCT01248195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6616095|NCT01248195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6616096|NCT01248195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616097|NCT01248195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6450252|NCT00407121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450253|NCT00407121|Growth Inhibitors|growth inhibitors|mesh-ancestor
6450254|NCT00407186|Cisplatin|cisplatin|mesh-list
6450255|NCT00407186|Capecitabine|capecitabine|mesh-list
6450256|NCT00407186|Epirubicin|epirubicin|mesh-list
6450257|NCT00407186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6450258|NCT00407186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6450259|NCT00407186|Antimetabolites|antimetabolites|mesh-ancestor
6450260|NCT00407186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450261|NCT00407186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6616098|NCT01248195|Serotonin Agents|serotonin agents|mesh-ancestor
6616099|NCT01248195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6616100|NCT01248195|GABA Antagonists|gaba antagonists|mesh-ancestor
6616101|NCT01248195|GABA Agents|gaba agents|mesh-ancestor
6616102|NCT01248195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6616103|NCT01248195|Dopamine Agents|dopamine agents|mesh-ancestor
6616104|NCT01248195|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6616105|NCT01248195|Antidepressive Agents|antidepressive agents|mesh-ancestor
6616106|NCT01248234|Propofol|propofol|mesh-list
6616107|NCT01248234|Etomidate|etomidate|mesh-list
6616108|NCT01248234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6616109|NCT01248234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6616110|NCT01248234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616111|NCT01248234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6616112|NCT01248234|Anesthetics, General|anesthetics, general|mesh-ancestor
6616113|NCT01248234|Anesthetics|anesthetics|mesh-ancestor
6616114|NCT01248260|Folic Acid|folic acid|mesh-list
6616115|NCT01248260|Hematinics|hematinics|mesh-ancestor
6616116|NCT01248260|Vitamin B Complex|vitamin b complex|mesh-ancestor
6616117|NCT01248260|Vitamins|vitamins|mesh-ancestor
6616118|NCT01248260|Micronutrients|micronutrients|mesh-ancestor
6616119|NCT01248260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616120|NCT01248273|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
6616121|NCT01248273|Immunologic Factors|immunologic factors|mesh-ancestor
6616122|NCT01248273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616123|NCT01248299|Cisplatin|cisplatin|mesh-list
6616124|NCT01248299|Docetaxel|docetaxel|mesh-list
6616125|NCT01248299|Oxaliplatin|oxaliplatin|mesh-list
6616126|NCT01248299|Fluorouracil|fluorouracil|mesh-list
6616127|NCT01248299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6616128|NCT01248299|Tubulin Modulators|tubulin modulators|mesh-ancestor
6616129|NCT01248299|Antimitotic Agents|antimitotic agents|mesh-ancestor
6450262|NCT00407186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6450263|NCT00407186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6616130|NCT01248299|Mitosis Modulators|mitosis modulators|mesh-ancestor
6616131|NCT01248299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616132|NCT01248299|Antimetabolites|antimetabolites|mesh-ancestor
6616133|NCT01248299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6616134|NCT01248299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6450264|NCT00407186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6450265|NCT00407199|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6450266|NCT00407199|Antidepressive Agents|antidepressive agents|mesh-ancestor
5502072|NCT04468815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502073|NCT04468568|Terbutaline|terbutaline|mesh-list
6616135|NCT01248299|Immunologic Factors|immunologic factors|mesh-ancestor
6616136|NCT01248299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616137|NCT01248325|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6616138|NCT01248338|Metoprolol|metoprolol|mesh-list
6616139|NCT01248338|Nebivolol|nebivolol|mesh-list
6616140|NCT01248338|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6616141|NCT01248338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6616142|NCT01248338|Sympatholytics|sympatholytics|mesh-ancestor
6616143|NCT01248338|Autonomic Agents|autonomic agents|mesh-ancestor
6616144|NCT01248338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6616145|NCT01248338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616146|NCT01248338|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5502074|NCT04468568|Atosiban|atosiban|mesh-list
5502075|NCT04468568|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5502076|NCT04468568|Autonomic Agents|autonomic agents|mesh-ancestor
6616147|NCT01248338|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6616148|NCT01248338|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6616149|NCT01248338|Adrenergic Agents|adrenergic agents|mesh-ancestor
6616150|NCT01248338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6616151|NCT01248338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616152|NCT01248338|Vasodilator Agents|vasodilator agents|mesh-ancestor
6616153|NCT01248338|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6616154|NCT01248338|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6616155|NCT01248338|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6616156|NCT01248403|Paclitaxel|paclitaxel|mesh-list
6616157|NCT01248403|Everolimus|everolimus|mesh-list
6616158|NCT01248403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6616159|NCT01248403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6616160|NCT01248403|Tubulin Modulators|tubulin modulators|mesh-ancestor
6616161|NCT01248403|Antimitotic Agents|antimitotic agents|mesh-ancestor
6616162|NCT01248403|Mitosis Modulators|mitosis modulators|mesh-ancestor
6616163|NCT01248403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616164|NCT01248403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6616165|NCT01248403|Immunologic Factors|immunologic factors|mesh-ancestor
6616166|NCT01248403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616167|NCT01248442|Cholecalciferol|cholecalciferol|mesh-list
6616168|NCT01248442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5502077|NCT04468568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6450267|NCT00407199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6450268|NCT00407199|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6450269|NCT00407199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6450270|NCT00407199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6450271|NCT00407199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450272|NCT00407212|Maleic acid|maleic acid|mesh-list
6450273|NCT00407212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6450274|NCT00407212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450275|NCT00407225|Difluprednate|difluprednate|mesh-list
6450276|NCT00407225|Glucocorticoids|glucocorticoids|mesh-ancestor
6450277|NCT00407225|Hormones|hormones|mesh-ancestor
6450278|NCT00407225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6450279|NCT00407225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450280|NCT00407251|Epothilone B|epothilone b|mesh-list
5502078|NCT04468568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616169|NCT01248442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616170|NCT01248442|Vitamins|vitamins|mesh-ancestor
6450281|NCT00407251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6450282|NCT00407251|Tubulin Modulators|tubulin modulators|mesh-ancestor
6450283|NCT00407251|Antimitotic Agents|antimitotic agents|mesh-ancestor
6450284|NCT00407251|Mitosis Modulators|mitosis modulators|mesh-ancestor
6450285|NCT00407251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450286|NCT00407264|Fluticasone|fluticasone|mesh-list
6450287|NCT00407264|Xhance|xhance|mesh-list
6450288|NCT00407264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6450289|NCT00407264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6616171|NCT01248442|Micronutrients|micronutrients|mesh-ancestor
6616172|NCT01248442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6616173|NCT01248481|Acarbose|acarbose|mesh-list
6616174|NCT01248481|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6616175|NCT01248481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6616176|NCT01248481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616177|NCT01248481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6616178|NCT01248481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616179|NCT01248494|Letrozole|letrozole|mesh-list
6616180|NCT01248494|Dactolisib|dactolisib|mesh-list
6616181|NCT01248494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6616182|NCT01248494|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6616183|NCT01248494|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6616184|NCT01248494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6450290|NCT00407264|Autonomic Agents|autonomic agents|mesh-ancestor
6616185|NCT01248494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616186|NCT01248494|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6616187|NCT01248494|Hormone Antagonists|hormone antagonists|mesh-ancestor
6616188|NCT01248494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6616189|NCT01248494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616190|NCT01248611|Fentanyl|fentanyl|mesh-list
6616191|NCT01248611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6616192|NCT01248611|Narcotics|narcotics|mesh-ancestor
6616193|NCT01248611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6616194|NCT01248611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616195|NCT01248611|Analgesics|analgesics|mesh-ancestor
6616196|NCT01248611|Sensory System Agents|sensory system agents|mesh-ancestor
6616197|NCT01248611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6616198|NCT01248611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6616199|NCT01248611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6616200|NCT01248611|Anesthetics, General|anesthetics, general|mesh-ancestor
6450291|NCT00407264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6450292|NCT00407264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450293|NCT00407264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6450294|NCT00407264|Respiratory System Agents|respiratory system agents|mesh-ancestor
6450295|NCT00407264|Dermatologic Agents|dermatologic agents|mesh-ancestor
6450296|NCT00407264|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6450297|NCT00407277|Nicotine|nicotine|mesh-list
6450298|NCT00407277|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6450299|NCT00407277|Autonomic Agents|autonomic agents|mesh-ancestor
6450300|NCT00407277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6450301|NCT00407277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616201|NCT01248611|Anesthetics|anesthetics|mesh-ancestor
6450302|NCT00407277|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6450303|NCT00407277|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6450304|NCT00407277|Cholinergic Agents|cholinergic agents|mesh-ancestor
6450305|NCT00407277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6450306|NCT00407277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450307|NCT00407290|Neostigmine|neostigmine|mesh-list
6616202|NCT01248819|Ropivacaine|ropivacaine|mesh-list
6616203|NCT01248819|Anesthetics, Local|anesthetics, local|mesh-ancestor
6616204|NCT01248819|Anesthetics|anesthetics|mesh-ancestor
6616205|NCT01248819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6616206|NCT01248819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616207|NCT01248819|Sensory System Agents|sensory system agents|mesh-ancestor
6616208|NCT01248819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6616209|NCT01248858|Trametinib|trametinib|mesh-list
6616210|NCT01248858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6616211|NCT01248858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6616212|NCT01248858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6616213|NCT01248858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616214|NCT01248871|Sufentanil|sufentanil|mesh-list
6450308|NCT00407290|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6450309|NCT00407290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6450310|NCT00407290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450311|NCT00407290|Cholinergic Agents|cholinergic agents|mesh-ancestor
6450312|NCT00407290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6450313|NCT00407290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450314|NCT00407290|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6616215|NCT01248871|Remifentanil|remifentanil|mesh-list
6616216|NCT01248871|Dsuvia|dsuvia|mesh-list
6616217|NCT01248871|Propofol|propofol|mesh-list
6616218|NCT01248871|Sevoflurane|sevoflurane|mesh-list
6616219|NCT01248871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6616220|NCT01248871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6616221|NCT01248871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616222|NCT01248871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6616223|NCT01248871|Anesthetics, General|anesthetics, general|mesh-ancestor
6616224|NCT01248871|Anesthetics|anesthetics|mesh-ancestor
6616225|NCT01248871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6616226|NCT01248871|Narcotics|narcotics|mesh-ancestor
6616227|NCT01248871|Analgesics|analgesics|mesh-ancestor
6616228|NCT01248871|Sensory System Agents|sensory system agents|mesh-ancestor
6616229|NCT01248871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6616230|NCT01248871|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6616231|NCT01248871|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6616232|NCT01248871|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6616233|NCT01248923|Dexamethasone|dexamethasone|mesh-list
6616234|NCT01248923|Bortezomib|bortezomib|mesh-list
6616235|NCT01248923|Filanesib|filanesib|mesh-list
6616236|NCT01248923|Lenograstim|lenograstim|mesh-list
6616237|NCT01248923|Sargramostim|sargramostim|mesh-list
6616238|NCT01248923|Proteasome Inhibitors|proteasome inhibitors|mesh-list
6616239|NCT01248923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6616240|NCT01248923|Antiemetics|antiemetics|mesh-ancestor
6616241|NCT01248923|Autonomic Agents|autonomic agents|mesh-ancestor
6616242|NCT01248923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6616243|NCT01248923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616244|NCT01248923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6616245|NCT01248923|Glucocorticoids|glucocorticoids|mesh-ancestor
6616246|NCT01248923|Hormones|hormones|mesh-ancestor
6616247|NCT01248923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6616248|NCT01248923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6616249|NCT01248923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6616250|NCT01248923|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6616251|NCT01248923|Immunologic Factors|immunologic factors|mesh-ancestor
6616252|NCT01248923|Protease Inhibitors|protease inhibitors|mesh-ancestor
6616253|NCT01248923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6616254|NCT01248923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616255|NCT01248923|Antimitotic Agents|antimitotic agents|mesh-ancestor
6616256|NCT01248923|Mitosis Modulators|mitosis modulators|mesh-ancestor
6616257|NCT01249001|Aprepitant|aprepitant|mesh-list
6616258|NCT01249001|Fosaprepitant|fosaprepitant|mesh-list
6616259|NCT01249001|Antiemetics|antiemetics|mesh-ancestor
6616260|NCT01249001|Autonomic Agents|autonomic agents|mesh-ancestor
6616261|NCT01249001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6616262|NCT01249001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616263|NCT01249001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6616264|NCT01249001|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6616265|NCT01249001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6616266|NCT01249001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616267|NCT01249339|Lobeline|lobeline|mesh-list
6616268|NCT01249339|Nicotine|nicotine|mesh-list
6616269|NCT01249339|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6616270|NCT01249339|Autonomic Agents|autonomic agents|mesh-ancestor
6616271|NCT01249339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6616272|NCT01249339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616273|NCT01249339|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6616274|NCT01249339|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6616275|NCT01249339|Cholinergic Agents|cholinergic agents|mesh-ancestor
6616276|NCT01249339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6664958|NCT01514942|Inositol|inositol|mesh-list
6616277|NCT01249339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616278|NCT01249339|Respiratory System Agents|respiratory system agents|mesh-ancestor
6616279|NCT01249352|Fluorouracil|fluorouracil|mesh-list
6616280|NCT01249352|Nimotuzumab|nimotuzumab|mesh-list
6616281|NCT01249352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6616282|NCT01249352|Antimetabolites|antimetabolites|mesh-ancestor
6616283|NCT01249352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616284|NCT01249352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6616285|NCT01249352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6616286|NCT01249352|Immunologic Factors|immunologic factors|mesh-ancestor
6616287|NCT01249352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616288|NCT01249352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6616289|NCT01249430|Cytarabine|cytarabine|mesh-list
6616290|NCT01249430|Etoposide|etoposide|mesh-list
6616291|NCT01249430|Mitoxantrone|mitoxantrone|mesh-list
6616292|NCT01249430|Azacitidine|azacitidine|mesh-list
6616293|NCT01249430|Etoposide phosphate|etoposide phosphate|mesh-list
6616294|NCT01249430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6616295|NCT01249430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6616296|NCT01249430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6616297|NCT01249430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6616298|NCT01249430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6616299|NCT01249430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616300|NCT01249430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6616301|NCT01249430|Antimetabolites|antimetabolites|mesh-ancestor
6616302|NCT01249430|Antiviral Agents|antiviral agents|mesh-ancestor
6616303|NCT01249430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6616304|NCT01249430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6616305|NCT01249430|Immunologic Factors|immunologic factors|mesh-ancestor
6616306|NCT01249430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616307|NCT01249430|Analgesics|analgesics|mesh-ancestor
6616308|NCT01249430|Sensory System Agents|sensory system agents|mesh-ancestor
6616309|NCT01249430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6616310|NCT01249443|Paclitaxel|paclitaxel|mesh-list
6616311|NCT01249443|Carboplatin|carboplatin|mesh-list
6616312|NCT01249443|Vorinostat|vorinostat|mesh-list
6616313|NCT01249443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6616314|NCT01249443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6616315|NCT01249443|Tubulin Modulators|tubulin modulators|mesh-ancestor
6616316|NCT01249443|Antimitotic Agents|antimitotic agents|mesh-ancestor
6616317|NCT01249443|Mitosis Modulators|mitosis modulators|mesh-ancestor
6616318|NCT01249443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616319|NCT01249443|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6616320|NCT01249443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6616321|NCT01249521|Bevacizumab|bevacizumab|mesh-list
6616322|NCT01249521|Trebananib|trebananib|mesh-list
6616323|NCT01249521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6616324|NCT01249521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6616325|NCT01249521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6616326|NCT01249521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6616327|NCT01249521|Growth Substances|growth substances|mesh-ancestor
6616328|NCT01249521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616329|NCT01249521|Growth Inhibitors|growth inhibitors|mesh-ancestor
6616330|NCT01249547|Axitinib|axitinib|mesh-list
6616331|NCT01249547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6616332|NCT01249547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6616333|NCT01249547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6616334|NCT01249547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616335|NCT01249638|Bevacizumab|bevacizumab|mesh-list
6616336|NCT01249638|Capecitabine|capecitabine|mesh-list
6616337|NCT01249638|Irinotecan|irinotecan|mesh-list
6616338|NCT01249638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6616339|NCT01249638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6616340|NCT01249638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6616341|NCT01249638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6616342|NCT01249638|Growth Substances|growth substances|mesh-ancestor
6616343|NCT01249638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616344|NCT01249638|Growth Inhibitors|growth inhibitors|mesh-ancestor
6616345|NCT01249638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6616346|NCT01249638|Antimetabolites|antimetabolites|mesh-ancestor
6616347|NCT01249638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616348|NCT01249638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6616349|NCT01249638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6616350|NCT01249638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6616351|NCT01249677|Insulin Glargine|insulin glargine|mesh-list
6616352|NCT01249677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6616353|NCT01249677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616354|NCT01249690|Thalidomide|thalidomide|mesh-list
6616355|NCT01249690|Dexamethasone|dexamethasone|mesh-list
6616356|NCT01249690|Dexamethasone acetate|dexamethasone acetate|mesh-list
6616357|NCT01249690|Bortezomib|bortezomib|mesh-list
6616358|NCT01249690|Pirarubicin|pirarubicin|mesh-list
6616359|NCT01249690|Doxorubicin|doxorubicin|mesh-list
6616360|NCT01249690|BB 1101|bb 1101|mesh-list
6450315|NCT00407290|Autonomic Agents|autonomic agents|mesh-ancestor
6450316|NCT00407290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6450317|NCT00407342|Alefacept|alefacept|mesh-list
6450318|NCT00407342|Dermatologic Agents|dermatologic agents|mesh-ancestor
6450319|NCT00407342|Immunologic Factors|immunologic factors|mesh-ancestor
6450320|NCT00407342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450321|NCT00407394|Amoxicillin|amoxicillin|mesh-list
6450322|NCT00407394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6450323|NCT00407394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6450324|NCT00407407|Carboplatin|carboplatin|mesh-list
6450325|NCT00407407|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6450326|NCT00407407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6450327|NCT00407433|Gemcitabine|gemcitabine|mesh-list
6450328|NCT00407433|Oxaliplatin|oxaliplatin|mesh-list
6450329|NCT00407433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6450330|NCT00407433|Antimetabolites|antimetabolites|mesh-ancestor
6450331|NCT00407433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616361|NCT01249690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6616362|NCT01249690|Antiemetics|antiemetics|mesh-ancestor
6616363|NCT01249690|Autonomic Agents|autonomic agents|mesh-ancestor
6616364|NCT01249690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6450332|NCT00407433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6450333|NCT00407433|Antiviral Agents|antiviral agents|mesh-ancestor
6450334|NCT00407433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6450335|NCT00407433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6450336|NCT00407433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6450337|NCT00407433|Immunologic Factors|immunologic factors|mesh-ancestor
6616365|NCT01249690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616366|NCT01249690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6616367|NCT01249690|Glucocorticoids|glucocorticoids|mesh-ancestor
6616368|NCT01249690|Hormones|hormones|mesh-ancestor
6616369|NCT01249690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6616370|NCT01249690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6616371|NCT01249690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6616372|NCT01249690|Protease Inhibitors|protease inhibitors|mesh-ancestor
6616373|NCT01249690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6616374|NCT01249690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616375|NCT01249690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6616376|NCT01249690|Immunologic Factors|immunologic factors|mesh-ancestor
6616377|NCT01249690|Leprostatic Agents|leprostatic agents|mesh-ancestor
6616378|NCT01249690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6616379|NCT01249690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6616380|NCT01249690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6616381|NCT01249690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6616382|NCT01249690|Growth Substances|growth substances|mesh-ancestor
6450338|NCT00407433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450339|NCT00407446|Sildenafil Citrate|sildenafil citrate|mesh-list
6450340|NCT00407446|Vasodilator Agents|vasodilator agents|mesh-ancestor
6450341|NCT00407446|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6450342|NCT00407446|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6450343|NCT00407446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6450344|NCT00407446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450345|NCT00407446|Urological Agents|urological agents|mesh-ancestor
6450346|NCT00407459|Bevacizumab|bevacizumab|mesh-list
6616383|NCT01249690|Growth Inhibitors|growth inhibitors|mesh-ancestor
6616384|NCT01249690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6616385|NCT01249690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6616386|NCT01249690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6616387|NCT01249820|Anidulafungin|anidulafungin|mesh-list
6616388|NCT01249820|Antifungal Agents|antifungal agents|mesh-ancestor
6616389|NCT01249820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6661416|NCT01498861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661417|NCT01498861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6661418|NCT01498861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6661419|NCT01498861|Antiviral Agents|antiviral agents|mesh-ancestor
6661420|NCT01498861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6661421|NCT01498861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6661422|NCT01498861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6661423|NCT01498861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6661424|NCT01498861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6661425|NCT01498861|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6661426|NCT01498861|Contraceptive Agents|contraceptive agents|mesh-ancestor
6661427|NCT01498861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6661428|NCT01498861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661429|NCT01498861|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6661430|NCT01498861|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6661431|NCT01498861|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6661432|NCT01498900|Repaglinide|repaglinide|mesh-list
6661433|NCT01498900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6661434|NCT01498900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661435|NCT01498913|Repaglinide|repaglinide|mesh-list
6661436|NCT01498913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6661437|NCT01498913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661438|NCT01498926|Insulin|insulin|mesh-list
6661439|NCT01498926|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6661440|NCT01498926|Insulin Detemir|insulin detemir|mesh-list
6661441|NCT01498926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6661442|NCT01498926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661443|NCT01498939|Insulin Detemir|insulin detemir|mesh-list
6661444|NCT01498939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6661445|NCT01498939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661446|NCT01499004|Tofacitinib|tofacitinib|mesh-list
6616390|NCT01249846|Chlorhexidine|chlorhexidine|mesh-list
6616391|NCT01249846|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6616392|NCT01249846|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6616393|NCT01249846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6616394|NCT01249846|Disinfectants|disinfectants|mesh-ancestor
6616395|NCT01249846|Dermatologic Agents|dermatologic agents|mesh-ancestor
6616396|NCT01249937|Triamcinolone|triamcinolone|mesh-list
6616397|NCT01249937|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6616398|NCT01249937|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6616399|NCT01249937|Ranibizumab|ranibizumab|mesh-list
6616400|NCT01249937|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6616401|NCT01249937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6616402|NCT01249937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6616403|NCT01249937|Growth Substances|growth substances|mesh-ancestor
6616404|NCT01249937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616405|NCT01249937|Growth Inhibitors|growth inhibitors|mesh-ancestor
6616406|NCT01249937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6616407|NCT01249937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6616408|NCT01249937|Glucocorticoids|glucocorticoids|mesh-ancestor
6616409|NCT01249937|Hormones|hormones|mesh-ancestor
6664959|NCT01514942|Manganese|manganese|mesh-list
6616410|NCT01249937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6616411|NCT01249937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6616412|NCT01249937|Immunologic Factors|immunologic factors|mesh-ancestor
6616413|NCT01249937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6616414|NCT01249937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616415|NCT01250236|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6616416|NCT01250236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6616417|NCT01250236|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6450347|NCT00407459|Carboplatin|carboplatin|mesh-list
6450348|NCT00407459|Pemetrexed|pemetrexed|mesh-list
6450349|NCT00407459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6450350|NCT00407459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6450351|NCT00407459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6450352|NCT00407459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6450353|NCT00407459|Growth Substances|growth substances|mesh-ancestor
6450354|NCT00407459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450355|NCT00407459|Growth Inhibitors|growth inhibitors|mesh-ancestor
6450356|NCT00407459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6450357|NCT00407459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450358|NCT00407459|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6450359|NCT00407459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6450360|NCT00407589|Besifloxacin|besifloxacin|mesh-list
6450361|NCT00407589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6616418|NCT01250236|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6616419|NCT01250236|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6616420|NCT01250236|Adrenergic Agents|adrenergic agents|mesh-ancestor
6616421|NCT01250236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6616422|NCT01250236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616423|NCT01250236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450362|NCT00407589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6616424|NCT01250249|Vaccines|vaccines|mesh-list
6616425|NCT01250249|BCG Vaccine|bcg vaccine|mesh-list
6616426|NCT01250249|Immunologic Factors|immunologic factors|mesh-ancestor
6616427|NCT01250249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616428|NCT01250249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6616429|NCT01250340|Aspirin|aspirin|mesh-list
6616430|NCT01250340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6616431|NCT01250340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6450363|NCT00407589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6450364|NCT00407589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6450365|NCT00407589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6450366|NCT00407589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450367|NCT00407589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6450368|NCT00407641|Heparin|heparin|mesh-list
6450369|NCT00407641|Tinzaparin|tinzaparin|mesh-list
6450370|NCT00407641|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6616432|NCT01250340|Analgesics|analgesics|mesh-ancestor
6616433|NCT01250340|Sensory System Agents|sensory system agents|mesh-ancestor
6616434|NCT01250340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6616435|NCT01250340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616436|NCT01250340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6616437|NCT01250340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6616438|NCT01250340|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6616439|NCT01250340|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6616440|NCT01250340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616441|NCT01250340|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6616442|NCT01250340|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6616443|NCT01250340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6616444|NCT01250340|Antipyretics|antipyretics|mesh-ancestor
6616445|NCT01250366|Ribavirin|ribavirin|mesh-list
6616446|NCT01250366|Antimetabolites|antimetabolites|mesh-ancestor
6616447|NCT01250366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616448|NCT01250366|Antiviral Agents|antiviral agents|mesh-ancestor
6616449|NCT01250366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6616450|NCT01250405|Cinacalcet|cinacalcet|mesh-list
6616451|NCT01250405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6616452|NCT01250405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616453|NCT01250405|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6616454|NCT01250405|Hormone Antagonists|hormone antagonists|mesh-ancestor
6616455|NCT01250405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6616456|NCT01250457|Timolol|timolol|mesh-list
6616457|NCT01250457|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6616458|NCT01250457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6616459|NCT01250457|Adrenergic Agents|adrenergic agents|mesh-ancestor
6616460|NCT01250457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6616461|NCT01250457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616462|NCT01250457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616463|NCT01250457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6616464|NCT01250457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6616465|NCT01250470|Sargramostim|sargramostim|mesh-list
6616466|NCT01250470|Immunologic Factors|immunologic factors|mesh-ancestor
6616467|NCT01250470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616468|NCT01250496|Aminophylline|aminophylline|mesh-list
6616469|NCT01250496|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6616470|NCT01250496|Autonomic Agents|autonomic agents|mesh-ancestor
6616471|NCT01250496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6616472|NCT01250496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616473|NCT01250496|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6616474|NCT01250496|Respiratory System Agents|respiratory system agents|mesh-ancestor
6616475|NCT01250496|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6616476|NCT01250496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6616477|NCT01250496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6616478|NCT01250496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616479|NCT01250496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6616480|NCT01250496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6616481|NCT01250496|Purinergic Agents|purinergic agents|mesh-ancestor
6616482|NCT01250496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6616483|NCT01250496|Protective Agents|protective agents|mesh-ancestor
6616484|NCT01250535|Warfarin|warfarin|mesh-list
6616485|NCT01250535|Lovastatin|lovastatin|mesh-list
6616486|NCT01250535|L 647318|l 647318|mesh-list
6616487|NCT01250535|Dihydromevinolin|dihydromevinolin|mesh-list
6616488|NCT01250535|Anticoagulants|anticoagulants|mesh-ancestor
6616489|NCT01250535|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6616490|NCT01250535|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6616491|NCT01250535|Antimetabolites|antimetabolites|mesh-ancestor
6616492|NCT01250535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616493|NCT01250535|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6616494|NCT01250535|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6616495|NCT01250535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6616496|NCT01250548|Apremilast|apremilast|mesh-list
6616497|NCT01250548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6616498|NCT01250548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6616499|NCT01250548|Analgesics|analgesics|mesh-ancestor
6616500|NCT01250548|Sensory System Agents|sensory system agents|mesh-ancestor
6616501|NCT01250548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6616502|NCT01250548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616503|NCT01250548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6616504|NCT01250548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6616505|NCT01250548|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6616506|NCT01250548|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6616507|NCT01250548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6616508|NCT01250548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616509|NCT01250561|Valacyclovir|valacyclovir|mesh-list
6616510|NCT01250561|Gabapentin|gabapentin|mesh-list
6616511|NCT01250561|Analgesics|analgesics|mesh-ancestor
6616512|NCT01250561|Sensory System Agents|sensory system agents|mesh-ancestor
6616513|NCT01250561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6616514|NCT01250561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616515|NCT01250561|Anticonvulsants|anticonvulsants|mesh-ancestor
6616516|NCT01250561|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6616517|NCT01250561|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6616518|NCT01250561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6616519|NCT01250561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6616520|NCT01250561|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6616521|NCT01250561|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6616522|NCT01250561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6616523|NCT01250561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616524|NCT01250561|Antimanic Agents|antimanic agents|mesh-ancestor
6616525|NCT01250561|Antiviral Agents|antiviral agents|mesh-ancestor
6616526|NCT01250561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6616527|NCT01250652|Cetirizine|cetirizine|mesh-list
6616528|NCT01250652|Hydroxyzine|hydroxyzine|mesh-list
6616529|NCT01250652|Levocetirizine|levocetirizine|mesh-list
6616530|NCT01250652|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6616531|NCT01250652|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6616532|NCT01250652|Histamine Antagonists|histamine antagonists|mesh-ancestor
6616533|NCT01250652|Histamine Agents|histamine agents|mesh-ancestor
6616534|NCT01250652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6616535|NCT01250652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616536|NCT01250652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616537|NCT01250652|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6616538|NCT01250652|Antipruritics|antipruritics|mesh-ancestor
6616539|NCT01250652|Dermatologic Agents|dermatologic agents|mesh-ancestor
6616540|NCT01250743|Vitamins|vitamins|mesh-list
6616541|NCT01250743|Ascorbic Acid|ascorbic acid|mesh-list
6616542|NCT01250743|Micronutrients|micronutrients|mesh-ancestor
6616543|NCT01250743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616544|NCT01250743|Antioxidants|antioxidants|mesh-ancestor
6616545|NCT01250743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616546|NCT01250743|Protective Agents|protective agents|mesh-ancestor
6616547|NCT01250808|Dexamethasone|dexamethasone|mesh-list
6616548|NCT01250808|Bortezomib|bortezomib|mesh-list
5502079|NCT04468568|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6616549|NCT01250808|Melphalan|melphalan|mesh-list
6616550|NCT01250808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6616551|NCT01250808|Antiemetics|antiemetics|mesh-ancestor
6616552|NCT01250808|Autonomic Agents|autonomic agents|mesh-ancestor
6616553|NCT01250808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6616554|NCT01250808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616555|NCT01250808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6616556|NCT01250808|Glucocorticoids|glucocorticoids|mesh-ancestor
6616557|NCT01250808|Hormones|hormones|mesh-ancestor
6616558|NCT01250808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6616559|NCT01250808|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6616560|NCT01250808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6616561|NCT01250808|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6616562|NCT01250808|Alkylating Agents|alkylating agents|mesh-ancestor
6616563|NCT01250808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616564|NCT01250808|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6616565|NCT01250808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6616566|NCT01250808|Immunologic Factors|immunologic factors|mesh-ancestor
6616567|NCT01250821|Menotropins|menotropins|mesh-list
6616568|NCT01250821|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6616569|NCT01250821|Fertility Agents|fertility agents|mesh-ancestor
6616570|NCT01250821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6616571|NCT01250821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616572|NCT01250847|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6616573|NCT01250847|Antidepressive Agents|antidepressive agents|mesh-ancestor
6616574|NCT01250847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6616575|NCT01250847|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6616576|NCT01250847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6616577|NCT01250847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6616578|NCT01250847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616579|NCT01250886|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6616580|NCT01250951|Deferasirox|deferasirox|mesh-list
6616581|NCT01250951|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6616582|NCT01250951|Chelating Agents|chelating agents|mesh-ancestor
6616583|NCT01250951|Sequestering Agents|sequestering agents|mesh-ancestor
6616584|NCT01250951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616585|NCT01251029|Acetylcysteine|acetylcysteine|mesh-list
6616586|NCT01251029|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6616587|NCT01251029|Antiviral Agents|antiviral agents|mesh-ancestor
6616588|NCT01251029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6616589|NCT01251029|Expectorants|expectorants|mesh-ancestor
6616590|NCT01251029|Respiratory System Agents|respiratory system agents|mesh-ancestor
6616591|NCT01251029|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6616592|NCT01251029|Antioxidants|antioxidants|mesh-ancestor
6616593|NCT01251029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616594|NCT01251029|Protective Agents|protective agents|mesh-ancestor
6616595|NCT01251029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616596|NCT01251029|Antidotes|antidotes|mesh-ancestor
6616597|NCT01251107|Prednisone|prednisone|mesh-list
6616598|NCT01251107|Cyclophosphamide|cyclophosphamide|mesh-list
6616599|NCT01251107|Dacarbazine|dacarbazine|mesh-list
6616600|NCT01251107|Doxorubicin|doxorubicin|mesh-list
6616601|NCT01251107|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6616602|NCT01251107|Etoposide|etoposide|mesh-list
6616603|NCT01251107|Etoposide phosphate|etoposide phosphate|mesh-list
6616604|NCT01251107|Vincristine|vincristine|mesh-list
6616605|NCT01251107|Bleomycin|bleomycin|mesh-list
6616606|NCT01251107|Vinblastine|vinblastine|mesh-list
6616607|NCT01251107|Procarbazine|procarbazine|mesh-list
6616608|NCT01251107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6616609|NCT01251107|Immunologic Factors|immunologic factors|mesh-ancestor
6616610|NCT01251107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616611|NCT01251107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6616612|NCT01251107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6616613|NCT01251107|Alkylating Agents|alkylating agents|mesh-ancestor
6616614|NCT01251107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616615|NCT01251107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6616616|NCT01251107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6616617|NCT01251107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6616618|NCT01251107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6616619|NCT01251107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6616620|NCT01251107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6616621|NCT01251107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6616622|NCT01251107|Glucocorticoids|glucocorticoids|mesh-ancestor
6616623|NCT01251107|Hormones|hormones|mesh-ancestor
6616624|NCT01251107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6616625|NCT01251107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6616626|NCT01251107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6616627|NCT01251107|Tubulin Modulators|tubulin modulators|mesh-ancestor
6616628|NCT01251107|Antimitotic Agents|antimitotic agents|mesh-ancestor
6616629|NCT01251107|Mitosis Modulators|mitosis modulators|mesh-ancestor
6616630|NCT01251133|Vaccines|vaccines|mesh-list
6616631|NCT01251133|Immunologic Factors|immunologic factors|mesh-ancestor
6616632|NCT01251133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616633|NCT01251172|Melphalan|melphalan|mesh-list
6616634|NCT01251172|Mechlorethamine|mechlorethamine|mesh-list
6616635|NCT01251172|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
6616636|NCT01251172|R04929097|r04929097|mesh-list
6616637|NCT01251172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6616638|NCT01251172|Alkylating Agents|alkylating agents|mesh-ancestor
6616639|NCT01251172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616640|NCT01251172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6616641|NCT01251172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6616642|NCT01251172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6616643|NCT01251172|Immunologic Factors|immunologic factors|mesh-ancestor
6616644|NCT01251172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616645|NCT01251172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6616646|NCT01251211|Botulinum Toxins|botulinum toxins|mesh-list
6616647|NCT01251211|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6616648|NCT01251211|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6616649|NCT01251211|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6616650|NCT01251211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6616651|NCT01251211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616652|NCT01251211|Cholinergic Agents|cholinergic agents|mesh-ancestor
6616653|NCT01251211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6616654|NCT01251211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616655|NCT01251211|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6616656|NCT01251211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6616657|NCT01251263|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6616658|NCT01251263|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6616659|NCT01251263|Estradiol|estradiol|mesh-list
6616660|NCT01251263|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6616661|NCT01251263|Estrogens|estrogens|mesh-ancestor
6616662|NCT01251263|Hormones|hormones|mesh-ancestor
6616663|NCT01251263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6616664|NCT01251263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616665|NCT01251263|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6450371|NCT00407641|Dalteparin|dalteparin|mesh-list
6450372|NCT00407641|Anticoagulants|anticoagulants|mesh-ancestor
6450373|NCT00407641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6450374|NCT00407641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6450375|NCT00407641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450376|NCT00407680|Valsartan|valsartan|mesh-list
6450377|NCT00407680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6450378|NCT00407680|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6450379|NCT00407680|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6450380|NCT00407680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450381|NCT00407719|Bevacizumab|bevacizumab|mesh-list
6616666|NCT01251263|Contraceptive Agents|contraceptive agents|mesh-ancestor
6616667|NCT01251263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6616668|NCT01251263|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6616669|NCT01251328|Anesthetics|anesthetics|mesh-list
6616670|NCT01251328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6616671|NCT01251328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616672|NCT01251458|Sirolimus|sirolimus|mesh-list
6616673|NCT01251458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6616674|NCT01251458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6616675|NCT01251458|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6616676|NCT01251458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6616677|NCT01251458|Antifungal Agents|antifungal agents|mesh-ancestor
6616678|NCT01251458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6616679|NCT01251458|Immunologic Factors|immunologic factors|mesh-ancestor
6616680|NCT01251458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616681|NCT01251471|Citalopram|citalopram|mesh-list
6616682|NCT01251471|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6616683|NCT01251471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6616684|NCT01251471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6616685|NCT01251471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616686|NCT01251471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6616687|NCT01251471|Serotonin Agents|serotonin agents|mesh-ancestor
6616688|NCT01251471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616689|NCT01251471|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6616690|NCT01251471|Antidepressive Agents|antidepressive agents|mesh-ancestor
6616691|NCT01251471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6616692|NCT01251484|Nintedanib|nintedanib|mesh-list
6616693|NCT01251484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6616694|NCT01251484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6616695|NCT01251484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6616696|NCT01251484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661447|NCT01499004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6661448|NCT01499004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6661449|NCT01499004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661450|NCT01499069|Solifenacin Succinate|solifenacin succinate|mesh-list
6661451|NCT01499069|Fesoterodine|fesoterodine|mesh-list
6661452|NCT01499069|Propiverine|propiverine|mesh-list
6661453|NCT01499069|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6661454|NCT01499069|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6661455|NCT01499069|Cholinergic Agents|cholinergic agents|mesh-ancestor
6661456|NCT01499069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6661457|NCT01499069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661458|NCT01499069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661459|NCT01499069|Urological Agents|urological agents|mesh-ancestor
6661460|NCT01499069|Parasympatholytics|parasympatholytics|mesh-ancestor
6661461|NCT01499069|Autonomic Agents|autonomic agents|mesh-ancestor
6661462|NCT01499069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6661463|NCT01499108|Liraglutide|liraglutide|mesh-list
6661464|NCT01499108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6661465|NCT01499108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661466|NCT01499108|Incretins|incretins|mesh-ancestor
6661467|NCT01499108|Hormones|hormones|mesh-ancestor
6661468|NCT01499108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6661469|NCT01499121|Sunitinib|sunitinib|mesh-list
6661470|NCT01499121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6661471|NCT01499121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6661472|NCT01499121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6661473|NCT01499121|Growth Substances|growth substances|mesh-ancestor
6661474|NCT01499121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661475|NCT01499121|Growth Inhibitors|growth inhibitors|mesh-ancestor
6661476|NCT01499121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6661477|NCT01499121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6616697|NCT01251627|Decitabine|decitabine|mesh-list
6616698|NCT01251627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6616699|NCT01251627|Antimetabolites|antimetabolites|mesh-ancestor
6616700|NCT01251627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616701|NCT01251627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6616702|NCT01251627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6616703|NCT01251640|Gemcitabine|gemcitabine|mesh-list
6616704|NCT01251640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6616705|NCT01251640|Antimetabolites|antimetabolites|mesh-ancestor
6616706|NCT01251640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616707|NCT01251640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6616708|NCT01251640|Antiviral Agents|antiviral agents|mesh-ancestor
6616709|NCT01251640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6616710|NCT01251640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6616711|NCT01251640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6616712|NCT01251640|Immunologic Factors|immunologic factors|mesh-ancestor
6616713|NCT01251640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616714|NCT01251718|Donepezil|donepezil|mesh-list
6616715|NCT01251718|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6616716|NCT01251718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6616717|NCT01251718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616718|NCT01251718|Cholinergic Agents|cholinergic agents|mesh-ancestor
6616719|NCT01251718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6616720|NCT01251718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616721|NCT01251718|Nootropic Agents|nootropic agents|mesh-ancestor
6616722|NCT01251796|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6616723|NCT01251796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6616724|NCT01251796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6616725|NCT01251796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6616726|NCT01251796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616727|NCT01251809|Pegaspargase|pegaspargase|mesh-list
6616728|NCT01251809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6616729|NCT01251822|Prucalopride|prucalopride|mesh-list
6616730|NCT01251822|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
6616731|NCT01251822|Laxatives|laxatives|mesh-ancestor
6616732|NCT01251822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6616733|NCT01251822|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
6616734|NCT01251822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6616735|NCT01251822|Serotonin Agents|serotonin agents|mesh-ancestor
6616736|NCT01251822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6616737|NCT01251822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616738|NCT01251822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616739|NCT01251835|Rifampin|rifampin|mesh-list
6616740|NCT01251835|Sitaxsentan|sitaxsentan|mesh-list
6616741|NCT01251835|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6616742|NCT01251835|Antitubercular Agents|antitubercular agents|mesh-ancestor
6616743|NCT01251835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6616744|NCT01251835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6616745|NCT01251835|Leprostatic Agents|leprostatic agents|mesh-ancestor
6616746|NCT01251835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6616747|NCT01251835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6616748|NCT01251835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616749|NCT01251835|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6616750|NCT01251835|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6616751|NCT01251835|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6616752|NCT01251835|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6616753|NCT01251835|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6616754|NCT01251835|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6616755|NCT01251835|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6616756|NCT01251848|Ritonavir|ritonavir|mesh-list
6616757|NCT01251848|Sitaxsentan|sitaxsentan|mesh-list
6616758|NCT01251848|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6616759|NCT01251848|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6616760|NCT01251848|Protease Inhibitors|protease inhibitors|mesh-ancestor
6616761|NCT01251848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6616762|NCT01251848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616763|NCT01251848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6616764|NCT01251848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6616765|NCT01251848|Antiviral Agents|antiviral agents|mesh-ancestor
6616766|NCT01251848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6616767|NCT01251848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6616768|NCT01251848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6616769|NCT01251848|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6616770|NCT01251874|Alovudine|alovudine|mesh-list
6616771|NCT01251874|Carboplatin|carboplatin|mesh-list
6616772|NCT01251874|Veliparib|veliparib|mesh-list
6616773|NCT01251874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6616774|NCT01251874|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6616775|NCT01251874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6616776|NCT01251874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616777|NCT01251874|Antiviral Agents|antiviral agents|mesh-ancestor
6616778|NCT01251874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6616779|NCT01251926|Bevacizumab|bevacizumab|mesh-list
6616780|NCT01251926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6616781|NCT01251926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6616782|NCT01251926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6616783|NCT01251926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6616784|NCT01251926|Growth Substances|growth substances|mesh-ancestor
6616785|NCT01251926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616786|NCT01251926|Growth Inhibitors|growth inhibitors|mesh-ancestor
6616787|NCT01251991|Psyllium|psyllium|mesh-list
6616788|NCT01251991|Calcium polycarbophil|calcium polycarbophil|mesh-list
6616789|NCT01251991|Cathartics|cathartics|mesh-ancestor
6616790|NCT01251991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6616791|NCT01251991|Antidiarrheals|antidiarrheals|mesh-ancestor
6616792|NCT01252056|Cilostazol|cilostazol|mesh-list
6616793|NCT01252056|Probucol|probucol|mesh-list
6616794|NCT01252056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6616795|NCT01252056|Autonomic Agents|autonomic agents|mesh-ancestor
6616796|NCT01252056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6616797|NCT01252056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616798|NCT01252056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6616799|NCT01252056|Respiratory System Agents|respiratory system agents|mesh-ancestor
6616800|NCT01252056|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6616801|NCT01252056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6616802|NCT01252056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616803|NCT01252056|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6616804|NCT01252056|Vasodilator Agents|vasodilator agents|mesh-ancestor
6616805|NCT01252056|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6616806|NCT01252056|Protective Agents|protective agents|mesh-ancestor
6616807|NCT01252056|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6616808|NCT01252056|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6616809|NCT01252056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6616810|NCT01252056|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6616811|NCT01252056|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6616812|NCT01252056|Antimetabolites|antimetabolites|mesh-ancestor
6616813|NCT01252056|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6616814|NCT01252056|Antioxidants|antioxidants|mesh-ancestor
6616815|NCT01252069|Ulipristal acetate|ulipristal acetate|mesh-list
6616816|NCT01252069|Progestins|progestins|mesh-list
6616817|NCT01252069|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6616818|NCT01252069|Contraceptive Agents|contraceptive agents|mesh-ancestor
6616819|NCT01252069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6616820|NCT01252069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616821|NCT01252069|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6616822|NCT01252069|Hormones|hormones|mesh-ancestor
6616823|NCT01252069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6616824|NCT01252121|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6616825|NCT01252121|Lubricant Eye Drops|lubricant eye drops|mesh-list
6616826|NCT01252121|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6616827|NCT01252160|Capsaicin|capsaicin|mesh-list
6616828|NCT01252160|Antipruritics|antipruritics|mesh-ancestor
6616829|NCT01252160|Dermatologic Agents|dermatologic agents|mesh-ancestor
6616830|NCT01252160|Sensory System Agents|sensory system agents|mesh-ancestor
6616831|NCT01252160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6616832|NCT01252160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616833|NCT01252225|Lidocaine|lidocaine|mesh-list
6616834|NCT01252225|Anesthetics, Local|anesthetics, local|mesh-ancestor
6616835|NCT01252225|Anesthetics|anesthetics|mesh-ancestor
6616836|NCT01252225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6616837|NCT01252225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616838|NCT01252225|Sensory System Agents|sensory system agents|mesh-ancestor
6616839|NCT01252225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6616840|NCT01252225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6616841|NCT01252225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6616842|NCT01252225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6616843|NCT01252225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6616844|NCT01252225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616845|NCT01252342|Oxytocin|oxytocin|mesh-list
6616846|NCT01252342|Oxytocics|oxytocics|mesh-ancestor
6616847|NCT01252342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6616848|NCT01252342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616849|NCT01252420|Enoxaparin|enoxaparin|mesh-list
6616850|NCT01252420|Anticoagulants|anticoagulants|mesh-ancestor
6616851|NCT01252420|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6616852|NCT01252420|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6616853|NCT01252420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616854|NCT01252524|Calcium polycarbophil|calcium polycarbophil|mesh-list
6616855|NCT01252524|Psyllium|psyllium|mesh-list
6616856|NCT01252524|Calcium|calcium|mesh-list
6616857|NCT01252524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6616858|NCT01252524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616859|NCT01252524|Antidiarrheals|antidiarrheals|mesh-ancestor
6616860|NCT01252524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6616861|NCT01252524|Cathartics|cathartics|mesh-ancestor
6616862|NCT01252680|Vaccines|vaccines|mesh-list
6616863|NCT01252680|Immunologic Factors|immunologic factors|mesh-ancestor
6616864|NCT01252680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616865|NCT01252719|Vancomycin|vancomycin|mesh-list
6616866|NCT01252719|Oritavancin|oritavancin|mesh-list
6616867|NCT01252719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6616868|NCT01252719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6616869|NCT01252758|Albuterol|albuterol|mesh-list
6616870|NCT01252758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6616871|NCT01252758|Autonomic Agents|autonomic agents|mesh-ancestor
6616872|NCT01252758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6616873|NCT01252758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616874|NCT01252758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6616875|NCT01252758|Respiratory System Agents|respiratory system agents|mesh-ancestor
6616876|NCT01252758|Tocolytic Agents|tocolytic agents|mesh-ancestor
6616877|NCT01252758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6616878|NCT01252758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6616879|NCT01252758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6616880|NCT01252758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6616881|NCT01252758|Adrenergic Agents|adrenergic agents|mesh-ancestor
6616882|NCT01252758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6616883|NCT01252758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616884|NCT01253252|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6616885|NCT01253252|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6616886|NCT01253252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616887|NCT01253382|Ecallantide|ecallantide|mesh-list
6616888|NCT01253382|Analgesics|analgesics|mesh-ancestor
6616889|NCT01253382|Sensory System Agents|sensory system agents|mesh-ancestor
6616890|NCT01253382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6616891|NCT01253382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616892|NCT01253382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6616893|NCT01253382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6616894|NCT01253382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6616895|NCT01253382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6616896|NCT01253473|Budesonide|budesonide|mesh-list
6616897|NCT01253473|Albuterol|albuterol|mesh-list
6616898|NCT01253473|Formoterol Fumarate|formoterol fumarate|mesh-list
6616899|NCT01253473|Ipratropium|ipratropium|mesh-list
6616900|NCT01253473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6616901|NCT01253473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6616902|NCT01253473|Autonomic Agents|autonomic agents|mesh-ancestor
6616903|NCT01253473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6616904|NCT01253473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616905|NCT01253473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6616906|NCT01253473|Respiratory System Agents|respiratory system agents|mesh-ancestor
6616907|NCT01253473|Glucocorticoids|glucocorticoids|mesh-ancestor
6616908|NCT01253473|Hormones|hormones|mesh-ancestor
6616909|NCT01253473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6616910|NCT01253473|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6616911|NCT01253473|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6616912|NCT01253473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6616913|NCT01253473|Adrenergic Agents|adrenergic agents|mesh-ancestor
6616914|NCT01253473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6616915|NCT01253473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616916|NCT01253473|Tocolytic Agents|tocolytic agents|mesh-ancestor
6616917|NCT01253473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6616918|NCT01253473|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6616919|NCT01253473|Cholinergic Agents|cholinergic agents|mesh-ancestor
6661478|NCT01499121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661479|NCT01499225|Doxycycline|doxycycline|mesh-list
6661480|NCT01499225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6661481|NCT01499225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6661482|NCT01499225|Antimalarials|antimalarials|mesh-ancestor
6661483|NCT01499225|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6661484|NCT01499225|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6661485|NCT01499251|Temozolomide|temozolomide|mesh-list
6661486|NCT01499251|Macitentan|macitentan|mesh-list
6661487|NCT01499251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6661488|NCT01499251|Alkylating Agents|alkylating agents|mesh-ancestor
6661489|NCT01499251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661490|NCT01499251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6661491|NCT01499251|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
6661492|NCT01499251|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6661493|NCT01499251|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
6661494|NCT01499407|Abciximab|abciximab|mesh-list
6661495|NCT01499407|Anticoagulants|anticoagulants|mesh-ancestor
6661496|NCT01499407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6661497|NCT01499433|Caspofungin|caspofungin|mesh-list
6661498|NCT01499433|Antifungal Agents|antifungal agents|mesh-ancestor
6661499|NCT01499433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6661500|NCT01499433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6661501|NCT01499433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661502|NCT01499446|Fluticasone|fluticasone|mesh-list
6661503|NCT01499446|Xhance|xhance|mesh-list
6661504|NCT01499446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6661505|NCT01499446|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6661506|NCT01499446|Autonomic Agents|autonomic agents|mesh-ancestor
6661507|NCT01499446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6661508|NCT01499446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661509|NCT01499446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6661510|NCT01499446|Respiratory System Agents|respiratory system agents|mesh-ancestor
6661511|NCT01499446|Dermatologic Agents|dermatologic agents|mesh-ancestor
6661512|NCT01499446|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6661513|NCT01499485|Acetazolamide|acetazolamide|mesh-list
6661514|NCT01499485|Anticonvulsants|anticonvulsants|mesh-ancestor
6661515|NCT01499485|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6661516|NCT01499485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6661517|NCT01499485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661518|NCT01499485|Diuretics|diuretics|mesh-ancestor
6661519|NCT01499485|Natriuretic Agents|natriuretic agents|mesh-ancestor
6616920|NCT01253681|Paclitaxel|paclitaxel|mesh-list
6616921|NCT01253681|Carboplatin|carboplatin|mesh-list
6616922|NCT01253681|Trebananib|trebananib|mesh-list
6616923|NCT01253681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6616924|NCT01253681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6616925|NCT01253681|Tubulin Modulators|tubulin modulators|mesh-ancestor
6616926|NCT01253681|Antimitotic Agents|antimitotic agents|mesh-ancestor
6616927|NCT01253681|Mitosis Modulators|mitosis modulators|mesh-ancestor
6616928|NCT01253681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616929|NCT01253681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6616930|NCT01253681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6616931|NCT01253681|Growth Substances|growth substances|mesh-ancestor
6616932|NCT01253681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616933|NCT01253681|Growth Inhibitors|growth inhibitors|mesh-ancestor
6616934|NCT01253694|Ranibizumab|ranibizumab|mesh-list
6616935|NCT01253694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6616936|NCT01253694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6616937|NCT01253694|Growth Substances|growth substances|mesh-ancestor
6616938|NCT01253694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616939|NCT01253694|Growth Inhibitors|growth inhibitors|mesh-ancestor
6616940|NCT01253694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6616941|NCT01253928|Pioglitazone|pioglitazone|mesh-list
6616942|NCT01253928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6616943|NCT01253928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616944|NCT01254006|Thiamine|thiamine|mesh-list
6616945|NCT01254006|Vitamins|vitamins|mesh-ancestor
6616946|NCT01254006|Micronutrients|micronutrients|mesh-ancestor
6616947|NCT01254006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616948|NCT01254006|Vitamin B Complex|vitamin b complex|mesh-ancestor
6616949|NCT01254071|Tamsulosin|tamsulosin|mesh-list
6616950|NCT01254071|Dutasteride|dutasteride|mesh-list
6616951|NCT01254071|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6616952|NCT01254071|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6616953|NCT01254071|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6616954|NCT01254071|Adrenergic Agents|adrenergic agents|mesh-ancestor
6616955|NCT01254071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6616956|NCT01254071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616957|NCT01254071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616958|NCT01254071|Urological Agents|urological agents|mesh-ancestor
6616959|NCT01254071|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6616960|NCT01254071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6616961|NCT01254071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6616962|NCT01254071|Hormone Antagonists|hormone antagonists|mesh-ancestor
6616963|NCT01254071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6616964|NCT01254123|Exenatide|exenatide|mesh-list
6616965|NCT01254123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6616966|NCT01254123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616967|NCT01254123|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6616968|NCT01254123|Incretins|incretins|mesh-ancestor
6616969|NCT01254123|Hormones|hormones|mesh-ancestor
6616970|NCT01254123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6616971|NCT01254175|Vaccines|vaccines|mesh-list
6616972|NCT01254175|Immunologic Factors|immunologic factors|mesh-ancestor
6616973|NCT01254175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616974|NCT01254383|Sildenafil Citrate|sildenafil citrate|mesh-list
6616975|NCT01254383|Vasodilator Agents|vasodilator agents|mesh-ancestor
6616976|NCT01254383|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6616977|NCT01254383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6616978|NCT01254383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6450382|NCT00407719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6450383|NCT00407719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6450384|NCT00407719|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6616979|NCT01254383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616980|NCT01254383|Urological Agents|urological agents|mesh-ancestor
6616981|NCT01254461|Pravastatin|pravastatin|mesh-list
6616982|NCT01254461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6616983|NCT01254461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6616984|NCT01254461|Antimetabolites|antimetabolites|mesh-ancestor
6616985|NCT01254461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616986|NCT01254461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6616987|NCT01254461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6616988|NCT01254461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6616989|NCT00701207|Nicotine|nicotine|mesh-list
6616990|NCT00701207|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6616991|NCT00701207|Autonomic Agents|autonomic agents|mesh-ancestor
6616992|NCT00701207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6616993|NCT00701207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6616994|NCT00701207|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6616995|NCT00701207|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6616996|NCT00701207|Cholinergic Agents|cholinergic agents|mesh-ancestor
6616997|NCT00701207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6616998|NCT00701207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6616999|NCT01254513|Prednisone|prednisone|mesh-list
6617000|NCT01254513|Docetaxel|docetaxel|mesh-list
6617001|NCT01254513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6617002|NCT01254513|Tubulin Modulators|tubulin modulators|mesh-ancestor
6617003|NCT01254513|Antimitotic Agents|antimitotic agents|mesh-ancestor
6617004|NCT01254513|Mitosis Modulators|mitosis modulators|mesh-ancestor
6617005|NCT01254513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617006|NCT01254513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6617007|NCT01254513|Glucocorticoids|glucocorticoids|mesh-ancestor
6617008|NCT01254513|Hormones|hormones|mesh-ancestor
6617009|NCT01254513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6617010|NCT01254513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617011|NCT01254513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6617012|NCT01254526|Paclitaxel|paclitaxel|mesh-list
6617013|NCT01254526|Bevacizumab|bevacizumab|mesh-list
6617014|NCT01254526|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6617015|NCT01254526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6617016|NCT01254526|Tubulin Modulators|tubulin modulators|mesh-ancestor
6617017|NCT01254526|Antimitotic Agents|antimitotic agents|mesh-ancestor
6617018|NCT01254526|Mitosis Modulators|mitosis modulators|mesh-ancestor
6617019|NCT01254526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617020|NCT01254526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6617021|NCT01254526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6617022|NCT01254526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6617023|NCT01254526|Growth Substances|growth substances|mesh-ancestor
6617024|NCT01254526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617025|NCT01254526|Growth Inhibitors|growth inhibitors|mesh-ancestor
6617026|NCT01254578|Lenalidomide|lenalidomide|mesh-list
6617027|NCT01254578|Immunologic Factors|immunologic factors|mesh-ancestor
6617028|NCT01254578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617029|NCT01254578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6617030|NCT01254578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6617031|NCT01254578|Growth Substances|growth substances|mesh-ancestor
6617032|NCT01254578|Growth Inhibitors|growth inhibitors|mesh-ancestor
6450385|NCT00407719|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6450386|NCT00407719|Growth Substances|growth substances|mesh-ancestor
6450387|NCT00407719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450388|NCT00407719|Growth Inhibitors|growth inhibitors|mesh-ancestor
6450389|NCT00407771|Tirofiban|tirofiban|mesh-list
6450390|NCT00407771|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6450391|NCT00407771|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6450392|NCT00407771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450393|NCT00407771|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6450394|NCT00407784|Eplerenone|eplerenone|mesh-list
6617033|NCT01254578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6617034|NCT01254591|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6617035|NCT01254591|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6617036|NCT01254591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617037|NCT01254617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6617038|NCT01254617|Cetuximab|cetuximab|mesh-list
6617039|NCT01254617|Lenalidomide|lenalidomide|mesh-list
6617040|NCT01254617|Antibodies|antibodies|mesh-list
6617041|NCT01254617|Immunoglobulins|immunoglobulins|mesh-list
6617042|NCT01254617|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6617043|NCT01254617|Immunologic Factors|immunologic factors|mesh-ancestor
6617044|NCT01254617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617045|NCT01254617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6617046|NCT01254617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6617047|NCT01254617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6617048|NCT01254617|Growth Substances|growth substances|mesh-ancestor
6617049|NCT01254617|Growth Inhibitors|growth inhibitors|mesh-ancestor
6617050|NCT00660673|Levodopa|levodopa|mesh-list
6617051|NCT00660673|Carbidopa|carbidopa|mesh-list
6617052|NCT00660673|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
6617053|NCT00660673|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6020810|NCT00394771|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6020811|NCT00394771|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6020812|NCT00394771|Levonorgestrel|levonorgestrel|mesh-list
6020813|NCT00394771|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6020814|NCT00394771|Estradiol|estradiol|mesh-list
6020815|NCT00394771|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6020816|NCT00394771|Estrogens|estrogens|mesh-ancestor
6617054|NCT00660673|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6617055|NCT00660673|Dopamine Agents|dopamine agents|mesh-ancestor
6617056|NCT00660673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6617057|NCT00660673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617058|NCT00660673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617059|NCT00660673|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6617060|NCT00660673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6617061|NCT00660673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6617062|NCT00660673|Immunologic Factors|immunologic factors|mesh-ancestor
6617063|NCT00660673|Dopamine Agonists|dopamine agonists|mesh-ancestor
6617064|NCT01254708|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6617065|NCT01254708|Antifungal Agents|antifungal agents|mesh-ancestor
6617066|NCT01254708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6617067|NCT01254708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6617068|NCT01254708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6617069|NCT01254799|Doxycycline|doxycycline|mesh-list
6617070|NCT01254799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6617071|NCT01254799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6617072|NCT01254799|Antimalarials|antimalarials|mesh-ancestor
6617073|NCT01254799|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6617074|NCT01254799|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6617075|NCT01254825|Ropivacaine|ropivacaine|mesh-list
6617076|NCT01254825|Anesthetics, Local|anesthetics, local|mesh-ancestor
6617077|NCT01254825|Anesthetics|anesthetics|mesh-ancestor
6617078|NCT01254825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6617079|NCT01254825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617080|NCT01254825|Sensory System Agents|sensory system agents|mesh-ancestor
6617081|NCT01254825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6617082|NCT01254864|Prednisone|prednisone|mesh-list
6617083|NCT01254864|Sunitinib|sunitinib|mesh-list
6617084|NCT01254864|Dasatinib|dasatinib|mesh-list
6617085|NCT01254864|Abiraterone Acetate|abiraterone acetate|mesh-list
6617086|NCT01254864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6617087|NCT01254864|Glucocorticoids|glucocorticoids|mesh-ancestor
6617088|NCT01254864|Hormones|hormones|mesh-ancestor
6617089|NCT01254864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6020817|NCT00394771|Hormones|hormones|mesh-ancestor
6617090|NCT01254864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617091|NCT01254864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6617092|NCT01254864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6617093|NCT01254864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6617094|NCT01254864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6617095|NCT01254864|Growth Substances|growth substances|mesh-ancestor
6617096|NCT01254864|Growth Inhibitors|growth inhibitors|mesh-ancestor
6617097|NCT01254864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6617098|NCT01254864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6617099|NCT01254864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617100|NCT01254864|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6617101|NCT01254864|Hormone Antagonists|hormone antagonists|mesh-ancestor
6617102|NCT01254864|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6617103|NCT00660218|Paclitaxel|paclitaxel|mesh-list
6617104|NCT00660218|Cetuximab|cetuximab|mesh-list
6617105|NCT00660218|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
6617106|NCT00660218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6617107|NCT00660218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6617108|NCT00660218|Tubulin Modulators|tubulin modulators|mesh-ancestor
6617109|NCT00660218|Antimitotic Agents|antimitotic agents|mesh-ancestor
6617110|NCT00660218|Mitosis Modulators|mitosis modulators|mesh-ancestor
6617111|NCT00660218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617112|NCT00660218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6617113|NCT01254929|Frovatriptan|frovatriptan|mesh-list
6617114|NCT01254929|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6617115|NCT01254929|Serotonin Agents|serotonin agents|mesh-ancestor
6617116|NCT01254929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6617117|NCT01254929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617118|NCT01254929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617119|NCT01254994|Entecavir|entecavir|mesh-list
6617120|NCT01254994|Antiviral Agents|antiviral agents|mesh-ancestor
6617121|NCT01254994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6617122|NCT01255046|Donepezil|donepezil|mesh-list
6617123|NCT01255046|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6617124|NCT01255046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6617125|NCT01255046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617126|NCT01255046|Cholinergic Agents|cholinergic agents|mesh-ancestor
6617127|NCT01255046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5502080|NCT04468568|Respiratory System Agents|respiratory system agents|mesh-ancestor
5502081|NCT04468568|Sympathomimetics|sympathomimetics|mesh-ancestor
5502082|NCT04468568|Tocolytic Agents|tocolytic agents|mesh-ancestor
5502083|NCT04468568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5502084|NCT04468568|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5502085|NCT04468568|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5502086|NCT04468568|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5502087|NCT04468568|Adrenergic Agents|adrenergic agents|mesh-ancestor
5502088|NCT04468568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5502089|NCT04468568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502090|NCT04468568|Hormone Antagonists|hormone antagonists|mesh-ancestor
5502091|NCT04468568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5502092|NCT04468711|Vitamin D|vitamin d|mesh-list
5502093|NCT04468711|Hydrocortisone|hydrocortisone|mesh-list
5502094|NCT04468711|Vitamins|vitamins|mesh-ancestor
5502095|NCT04468711|Micronutrients|micronutrients|mesh-ancestor
5502096|NCT04468711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502097|NCT04468711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5502098|NCT04468711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6617128|NCT01255046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617129|NCT01255046|Nootropic Agents|nootropic agents|mesh-ancestor
6617130|NCT01255215|Nitric Oxide|nitric oxide|mesh-list
6617131|NCT01255215|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6617132|NCT01255215|Autonomic Agents|autonomic agents|mesh-ancestor
6617133|NCT01255215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6617134|NCT01255215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617135|NCT01255215|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6617136|NCT01255215|Respiratory System Agents|respiratory system agents|mesh-ancestor
6617137|NCT01255215|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6617138|NCT01255215|Antioxidants|antioxidants|mesh-ancestor
6617139|NCT01255215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617140|NCT01255215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6617141|NCT01255215|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6617142|NCT01255215|Vasodilator Agents|vasodilator agents|mesh-ancestor
5502099|NCT04468685|Ondansetron|ondansetron|mesh-list
5502100|NCT04468685|Antiemetics|antiemetics|mesh-ancestor
5502101|NCT04468685|Autonomic Agents|autonomic agents|mesh-ancestor
5502102|NCT04468685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5502103|NCT04468685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502104|NCT04468685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5502105|NCT04468685|Antipruritics|antipruritics|mesh-ancestor
5502106|NCT04468685|Dermatologic Agents|dermatologic agents|mesh-ancestor
5502107|NCT04468685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6617143|NCT01255215|Gasotransmitters|gasotransmitters|mesh-ancestor
6617144|NCT01255215|Protective Agents|protective agents|mesh-ancestor
6661520|NCT01499485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661521|NCT01499589|Anesthetics|anesthetics|mesh-list
6661522|NCT01499589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6661523|NCT01499589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661524|NCT01499602|Norethindrone|norethindrone|mesh-list
6617145|NCT01255358|Dexamethasone|dexamethasone|mesh-list
6617146|NCT01255358|Dexamethasone acetate|dexamethasone acetate|mesh-list
6617147|NCT01255358|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
6617148|NCT01255358|BB 1101|bb 1101|mesh-list
6617149|NCT01255358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6617150|NCT01255358|Antiemetics|antiemetics|mesh-ancestor
6617151|NCT01255358|Autonomic Agents|autonomic agents|mesh-ancestor
6617152|NCT01255358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6617153|NCT01255358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617154|NCT01255358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6617155|NCT01255358|Glucocorticoids|glucocorticoids|mesh-ancestor
6617156|NCT01255358|Hormones|hormones|mesh-ancestor
6617157|NCT01255358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6617158|NCT01255358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6617159|NCT01255358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6617160|NCT01255358|Protease Inhibitors|protease inhibitors|mesh-ancestor
6617161|NCT01255358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6617162|NCT01255358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617163|NCT01255371|Lopinavir|lopinavir|mesh-list
6617164|NCT01255371|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6617165|NCT01255371|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6617166|NCT01255371|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6617167|NCT01255371|Protease Inhibitors|protease inhibitors|mesh-ancestor
6617168|NCT01255371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6617169|NCT01255371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617170|NCT01255371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6617171|NCT01255371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6617172|NCT01255371|Antiviral Agents|antiviral agents|mesh-ancestor
6617173|NCT01255371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6617174|NCT01255371|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6617175|NCT01255371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6617176|NCT01255410|Vaccines|vaccines|mesh-list
6617177|NCT01255410|Immunologic Factors|immunologic factors|mesh-ancestor
6617178|NCT01255410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617179|NCT01255475|Amlodipine|amlodipine|mesh-list
6617180|NCT01255475|Hydralazine|hydralazine|mesh-list
6617181|NCT01255475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6617182|NCT01255475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6617183|NCT01255475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6617184|NCT01255475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617185|NCT01255475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6617186|NCT01255475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617187|NCT01255475|Vasodilator Agents|vasodilator agents|mesh-ancestor
6617188|NCT01255527|Bortezomib|bortezomib|mesh-list
6617189|NCT01255527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6617190|NCT01255579|Fluticasone|fluticasone|mesh-list
6617191|NCT01255579|Beclomethasone|beclomethasone|mesh-list
6617192|NCT01255579|Formoterol Fumarate|formoterol fumarate|mesh-list
6617193|NCT01255579|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6617194|NCT01255579|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6617195|NCT01255579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6617196|NCT01255579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6617197|NCT01255579|Autonomic Agents|autonomic agents|mesh-ancestor
6617198|NCT01255579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6617199|NCT01255579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617200|NCT01255579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6617201|NCT01255579|Respiratory System Agents|respiratory system agents|mesh-ancestor
6617202|NCT01255579|Dermatologic Agents|dermatologic agents|mesh-ancestor
6617203|NCT01255579|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6617204|NCT01255579|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6617205|NCT01255579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6617206|NCT01255579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6617207|NCT01255579|Adrenergic Agents|adrenergic agents|mesh-ancestor
6617208|NCT01255579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6617209|NCT01255579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617210|NCT01255579|Glucocorticoids|glucocorticoids|mesh-ancestor
6617211|NCT01255579|Hormones|hormones|mesh-ancestor
6617212|NCT01255579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6617213|NCT01255579|Sympathomimetics|sympathomimetics|mesh-ancestor
6617214|NCT01255644|Valganciclovir|valganciclovir|mesh-list
6617215|NCT01255644|Antiviral Agents|antiviral agents|mesh-ancestor
6617216|NCT01255644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6617217|NCT01255774|Ranibizumab|ranibizumab|mesh-list
6617218|NCT01255774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6617219|NCT01255774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6617220|NCT01255774|Growth Substances|growth substances|mesh-ancestor
6617221|NCT01255774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617222|NCT01255774|Growth Inhibitors|growth inhibitors|mesh-ancestor
6617223|NCT01255774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6617224|NCT01255800|Cetuximab|cetuximab|mesh-list
6617225|NCT01255800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6617226|NCT01255800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6617227|NCT01255852|Atorvastatin|atorvastatin|mesh-list
6617228|NCT01255852|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6617229|NCT01255852|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6617230|NCT01255852|Antimetabolites|antimetabolites|mesh-ancestor
6617231|NCT01255852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617232|NCT01255852|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6617233|NCT01255852|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6617234|NCT01255852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6617235|NCT01255878|Gabapentin|gabapentin|mesh-list
6617236|NCT01255878|Analgesics|analgesics|mesh-ancestor
6617237|NCT01255878|Sensory System Agents|sensory system agents|mesh-ancestor
6617238|NCT01255878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6617239|NCT01255878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617240|NCT01255878|Anticonvulsants|anticonvulsants|mesh-ancestor
6617241|NCT01255878|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6617242|NCT01255878|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6617243|NCT01255878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6617244|NCT01255878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6617245|NCT01255878|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6617246|NCT01255878|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6617247|NCT01255878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6617248|NCT01255878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617249|NCT01255878|Antimanic Agents|antimanic agents|mesh-ancestor
6617250|NCT01255891|Androgens|androgens|mesh-list
6617251|NCT01255891|Hormones|hormones|mesh-ancestor
6617252|NCT01255891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6617253|NCT01255891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617254|NCT01255956|Sirolimus|sirolimus|mesh-list
6617255|NCT01255956|Paclitaxel|paclitaxel|mesh-list
6617256|NCT01255956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6617257|NCT01255956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6617258|NCT01255956|Tubulin Modulators|tubulin modulators|mesh-ancestor
6617259|NCT01255956|Antimitotic Agents|antimitotic agents|mesh-ancestor
6617260|NCT01255956|Mitosis Modulators|mitosis modulators|mesh-ancestor
6617261|NCT01255956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617262|NCT01255956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6617263|NCT01255956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6617264|NCT01255956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6617265|NCT01255956|Antifungal Agents|antifungal agents|mesh-ancestor
6617266|NCT01255956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6617267|NCT01255956|Immunologic Factors|immunologic factors|mesh-ancestor
6617268|NCT01255956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617269|NCT01256021|Botulinum Toxins|botulinum toxins|mesh-list
6617270|NCT01256021|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6617271|NCT01256021|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6617272|NCT01256021|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6617273|NCT01256021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6617274|NCT01256021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617275|NCT01256021|Cholinergic Agents|cholinergic agents|mesh-ancestor
6617276|NCT01256021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6617277|NCT01256021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617278|NCT01256021|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6617279|NCT01256021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6617280|NCT01256151|Alprazolam|alprazolam|mesh-list
6617281|NCT01256151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6617282|NCT01256151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6617283|NCT01256151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617284|NCT01256151|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6617285|NCT01256151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6617286|NCT01256151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6617287|NCT01256151|GABA Modulators|gaba modulators|mesh-ancestor
6617288|NCT01256151|GABA Agents|gaba agents|mesh-ancestor
6617289|NCT01256151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6617290|NCT01256151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617291|NCT01256268|Paclitaxel|paclitaxel|mesh-list
6617292|NCT01256268|Carboplatin|carboplatin|mesh-list
6617293|NCT01256268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6617294|NCT01256268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6617295|NCT01256268|Tubulin Modulators|tubulin modulators|mesh-ancestor
6617296|NCT01256268|Antimitotic Agents|antimitotic agents|mesh-ancestor
6617297|NCT01256268|Mitosis Modulators|mitosis modulators|mesh-ancestor
6617298|NCT01256268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617299|NCT01256359|Docetaxel|docetaxel|mesh-list
6617300|NCT01256359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6617301|NCT01256359|Tubulin Modulators|tubulin modulators|mesh-ancestor
6617302|NCT01256359|Antimitotic Agents|antimitotic agents|mesh-ancestor
6617303|NCT01256359|Mitosis Modulators|mitosis modulators|mesh-ancestor
6617304|NCT01256359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617305|NCT01256489|Infliximab|infliximab|mesh-list
6617306|NCT01256489|Dermatologic Agents|dermatologic agents|mesh-ancestor
6617307|NCT01256489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6617308|NCT01256489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6617309|NCT01256541|Lactulose|lactulose|mesh-list
6617310|NCT01256541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6617311|NCT01256580|Dexamethasone|dexamethasone|mesh-list
6617312|NCT01256580|Bevacizumab|bevacizumab|mesh-list
6617313|NCT01256580|Verteporfin|verteporfin|mesh-list
6617314|NCT01256580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6617315|NCT01256580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6617316|NCT01256580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6617317|NCT01256580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6617318|NCT01256580|Growth Substances|growth substances|mesh-ancestor
6617319|NCT01256580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617320|NCT01256580|Growth Inhibitors|growth inhibitors|mesh-ancestor
6617321|NCT01256580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6617322|NCT01256580|Antiemetics|antiemetics|mesh-ancestor
6617323|NCT01256580|Autonomic Agents|autonomic agents|mesh-ancestor
6617324|NCT01256580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6617325|NCT01256580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6617326|NCT01256580|Glucocorticoids|glucocorticoids|mesh-ancestor
6617327|NCT01256580|Hormones|hormones|mesh-ancestor
6450395|NCT00407784|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6450396|NCT00407784|Hormone Antagonists|hormone antagonists|mesh-ancestor
6450397|NCT00407784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6450398|NCT00407784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450399|NCT00407784|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6450400|NCT00407784|Diuretics|diuretics|mesh-ancestor
6450401|NCT00407784|Natriuretic Agents|natriuretic agents|mesh-ancestor
6450402|NCT00407784|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6461845|NCT00456430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461846|NCT00456430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6461847|NCT00456430|Serotonin Agents|serotonin agents|mesh-ancestor
6461848|NCT00456430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461849|NCT00456430|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6461850|NCT00456430|Antidepressive Agents|antidepressive agents|mesh-ancestor
6461851|NCT00456430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6461852|NCT00456482|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
6461853|NCT00456482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6461854|NCT00456482|Glucocorticoids|glucocorticoids|mesh-ancestor
6461855|NCT00456482|Hormones|hormones|mesh-ancestor
6461856|NCT00456482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6461857|NCT00456482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617328|NCT01256580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6617329|NCT01256580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6617330|NCT01256580|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6617331|NCT01256580|Dermatologic Agents|dermatologic agents|mesh-ancestor
6617332|NCT01256619|Desogestrel|desogestrel|mesh-list
6617333|NCT01256619|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6617334|NCT01256619|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6617335|NCT01256619|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6617336|NCT01256619|Contraceptive Agents|contraceptive agents|mesh-ancestor
6617337|NCT01256619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6617338|NCT01256619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617339|NCT01256619|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6617340|NCT01256619|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6617341|NCT01256619|Progestins|progestins|mesh-ancestor
6617342|NCT01256619|Hormones|hormones|mesh-ancestor
6617343|NCT01256619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6617344|NCT01256632|Ranibizumab|ranibizumab|mesh-list
6617345|NCT01256632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6617346|NCT01256632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6617347|NCT01256632|Growth Substances|growth substances|mesh-ancestor
6617348|NCT01256632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617349|NCT01256632|Growth Inhibitors|growth inhibitors|mesh-ancestor
6617350|NCT01256632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6617351|NCT01256775|Aspirin|aspirin|mesh-list
6617352|NCT01256775|Nitroaspirin|nitroaspirin|mesh-list
6617353|NCT01256775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6617354|NCT01256775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6617355|NCT01256775|Analgesics|analgesics|mesh-ancestor
6617356|NCT01256775|Sensory System Agents|sensory system agents|mesh-ancestor
6617357|NCT01256775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6617358|NCT01256775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617359|NCT01256775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6617360|NCT01256775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6617361|NCT01256775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6617362|NCT01256775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6617363|NCT01256775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617364|NCT01256775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6617365|NCT01256775|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
6617366|NCT01256775|Protease Inhibitors|protease inhibitors|mesh-ancestor
6617367|NCT01256775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6617368|NCT01256775|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6617369|NCT01256775|Antipyretics|antipyretics|mesh-ancestor
6617370|NCT01256801|Interleukin-2|interleukin-2|mesh-list
6617371|NCT01256801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6617372|NCT01256801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6617373|NCT01256801|Analgesics|analgesics|mesh-ancestor
6617374|NCT01256801|Sensory System Agents|sensory system agents|mesh-ancestor
6661525|NCT01499602|Norethindrone Acetate|norethindrone acetate|mesh-list
6617375|NCT01256801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6617376|NCT01256801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617377|NCT01256866|Midazolam|midazolam|mesh-list
6617378|NCT01256866|Dexmedetomidine|dexmedetomidine|mesh-list
6617379|NCT01256866|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6617380|NCT01256866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6617381|NCT01256866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617382|NCT01256866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6617383|NCT01256866|Analgesics|analgesics|mesh-ancestor
6617384|NCT01256866|Sensory System Agents|sensory system agents|mesh-ancestor
6617385|NCT01256866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6617386|NCT01256866|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6617387|NCT01256866|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6617388|NCT01256866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6617389|NCT01256866|Adrenergic Agents|adrenergic agents|mesh-ancestor
6617390|NCT01256866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6617391|NCT01256866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617392|NCT01256866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6617393|NCT01256866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6617394|NCT01256866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6617395|NCT01256866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6617396|NCT01256866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6617397|NCT01256866|Anesthetics, General|anesthetics, general|mesh-ancestor
6617398|NCT01256866|Anesthetics|anesthetics|mesh-ancestor
6617399|NCT01256866|GABA Modulators|gaba modulators|mesh-ancestor
6617400|NCT01256866|GABA Agents|gaba agents|mesh-ancestor
6617401|NCT01256905|Modafinil|modafinil|mesh-list
6617402|NCT01256905|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6617403|NCT01256905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617404|NCT01256905|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6617405|NCT01256905|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6617406|NCT01256905|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6617407|NCT01256905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617408|NCT01257009|Atorvastatin|atorvastatin|mesh-list
6617409|NCT01257009|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6617410|NCT01257009|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6617411|NCT01257009|Antimetabolites|antimetabolites|mesh-ancestor
6617412|NCT01257009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617413|NCT01257009|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6617414|NCT01257009|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6617415|NCT01257009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6617416|NCT01257035|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
6617417|NCT01257035|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6617418|NCT01257035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617419|NCT01257048|Budesonide|budesonide|mesh-list
6617420|NCT01257048|Formoterol Fumarate|formoterol fumarate|mesh-list
6617421|NCT01257048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6617422|NCT01257048|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6617423|NCT01257048|Autonomic Agents|autonomic agents|mesh-ancestor
6617424|NCT01257048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6617425|NCT01257048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617426|NCT01257048|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6617427|NCT01257048|Respiratory System Agents|respiratory system agents|mesh-ancestor
6617428|NCT01257048|Glucocorticoids|glucocorticoids|mesh-ancestor
6617429|NCT01257048|Hormones|hormones|mesh-ancestor
6617430|NCT01257048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6617431|NCT01257048|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6617432|NCT01257048|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6617433|NCT01257048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6617434|NCT01257048|Adrenergic Agents|adrenergic agents|mesh-ancestor
6617435|NCT01257048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6617436|NCT01257048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617437|NCT01257074|Acyclovir|acyclovir|mesh-list
6617438|NCT01257074|Penciclovir|penciclovir|mesh-list
6617439|NCT01257074|Antiviral Agents|antiviral agents|mesh-ancestor
6617440|NCT01257074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6617441|NCT01257126|Diclofenac|diclofenac|mesh-list
6617442|NCT01257126|Nimesulide|nimesulide|mesh-list
6617443|NCT01257126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6617444|NCT01257126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6617445|NCT01257126|Analgesics|analgesics|mesh-ancestor
6617446|NCT01257126|Sensory System Agents|sensory system agents|mesh-ancestor
6617447|NCT01257126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6617448|NCT01257126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617449|NCT01257126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6617450|NCT01257126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6617451|NCT01257126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6617452|NCT01257126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6617453|NCT01257126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617454|NCT01257139|Docetaxel|docetaxel|mesh-list
6617455|NCT01257139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6617456|NCT01257139|Tubulin Modulators|tubulin modulators|mesh-ancestor
6617457|NCT01257139|Antimitotic Agents|antimitotic agents|mesh-ancestor
6617458|NCT01257139|Mitosis Modulators|mitosis modulators|mesh-ancestor
6617459|NCT01257139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661526|NCT01499602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6661527|NCT01499602|Contraceptive Agents|contraceptive agents|mesh-ancestor
6661528|NCT01499602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6661529|NCT01499602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661530|NCT01499602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6661531|NCT01499602|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6661532|NCT01499602|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6661533|NCT01499602|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6661534|NCT01499641|Methylprednisolone|methylprednisolone|mesh-list
6661535|NCT01499641|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6661536|NCT01499641|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6661537|NCT01499641|Prednisolone|prednisolone|mesh-list
6661538|NCT01499641|Prednisolone acetate|prednisolone acetate|mesh-list
6661539|NCT01499641|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6661540|NCT01499641|Prednisolone phosphate|prednisolone phosphate|mesh-list
6661541|NCT01499641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6661542|NCT01499641|Antiemetics|antiemetics|mesh-ancestor
6661543|NCT01499641|Autonomic Agents|autonomic agents|mesh-ancestor
6661544|NCT01499641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6661545|NCT01499641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661546|NCT01499641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6661547|NCT01499641|Glucocorticoids|glucocorticoids|mesh-ancestor
6661548|NCT01499641|Hormones|hormones|mesh-ancestor
6661549|NCT01499641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6661550|NCT01499641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6661551|NCT01499641|Protective Agents|protective agents|mesh-ancestor
6661552|NCT01499641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6617460|NCT01257165|Ethanol|ethanol|mesh-list
6617461|NCT01257165|Zopiclone|zopiclone|mesh-list
6617462|NCT01257165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6617463|NCT01257165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6617464|NCT01257165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6617465|NCT01257165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617466|NCT01257165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6617467|NCT01257243|Potassium iodate|potassium iodate|mesh-list
6617468|NCT01257243|Phenylpropanolamine|phenylpropanolamine|mesh-list
6617469|NCT01257243|Guaifenesin|guaifenesin|mesh-list
6617470|NCT01257243|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
6617471|NCT01257243|Expectorants|expectorants|mesh-ancestor
6617472|NCT01257243|Respiratory System Agents|respiratory system agents|mesh-ancestor
6617473|NCT01257243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6617474|NCT01257243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6617475|NCT01257243|Adrenergic Agents|adrenergic agents|mesh-ancestor
6617476|NCT01257243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6617477|NCT01257243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617478|NCT01257243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617479|NCT01257243|Appetite Depressants|appetite depressants|mesh-ancestor
6617480|NCT01257243|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6617481|NCT01257243|Sympathomimetics|sympathomimetics|mesh-ancestor
6617482|NCT01257243|Autonomic Agents|autonomic agents|mesh-ancestor
6617483|NCT01257243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6617484|NCT01257243|Nasal Decongestants|nasal decongestants|mesh-ancestor
6617485|NCT01257243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6617486|NCT01257243|Antifungal Agents|antifungal agents|mesh-ancestor
6617487|NCT01257243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6617488|NCT01257334|Empagliflozin|empagliflozin|mesh-list
6617489|NCT01257334|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6617490|NCT01257334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617491|NCT01257334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6617492|NCT01257334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617493|NCT01257360|Panitumumab|panitumumab|mesh-list
6617494|NCT01257360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6617495|NCT01257360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6617496|NCT01257373|Cobalt|cobalt|mesh-list
6617497|NCT01257373|Chromium|chromium|mesh-list
6617498|NCT01257373|Sirolimus|sirolimus|mesh-list
6617499|NCT01257373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6617500|NCT01257373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6617501|NCT01257373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6617502|NCT01257373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6617503|NCT01257373|Antifungal Agents|antifungal agents|mesh-ancestor
6617504|NCT01257373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6617505|NCT01257373|Immunologic Factors|immunologic factors|mesh-ancestor
6617506|NCT01257373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617507|NCT01257373|Trace Elements|trace elements|mesh-ancestor
6617508|NCT01257373|Micronutrients|micronutrients|mesh-ancestor
6617509|NCT01257386|Mesalamine|mesalamine|mesh-list
6617510|NCT01257386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6617511|NCT01257386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6617512|NCT01257386|Analgesics|analgesics|mesh-ancestor
6617513|NCT01257386|Sensory System Agents|sensory system agents|mesh-ancestor
6617514|NCT01257386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6617515|NCT01257386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617516|NCT01257386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6617517|NCT01257386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6617518|NCT01257399|Mesalamine|mesalamine|mesh-list
6617519|NCT01257399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6617520|NCT01257399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6617521|NCT01257399|Analgesics|analgesics|mesh-ancestor
6617522|NCT01257399|Sensory System Agents|sensory system agents|mesh-ancestor
6617523|NCT01257399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6617524|NCT01257399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617525|NCT01257399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6617526|NCT01257399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6617527|NCT01257412|Dapagliflozin|dapagliflozin|mesh-list
6617528|NCT01257412|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6617529|NCT01257412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617530|NCT01257412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6617531|NCT01257412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617532|NCT01257451|Vildagliptin|vildagliptin|mesh-list
6617533|NCT01257451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6617534|NCT01257451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617535|NCT01257451|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6617536|NCT01257451|Protease Inhibitors|protease inhibitors|mesh-ancestor
6617537|NCT01257451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6617538|NCT01257451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617539|NCT01257464|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6617540|NCT01257464|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
6617541|NCT01257464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6617542|NCT01257464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617543|NCT01257464|Incretins|incretins|mesh-ancestor
6617544|NCT01257464|Hormones|hormones|mesh-ancestor
6617545|NCT01257464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6617546|NCT01257464|Protease Inhibitors|protease inhibitors|mesh-ancestor
6617547|NCT01257464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6617548|NCT01257464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617549|NCT01257490|Bupropion|bupropion|mesh-list
6617550|NCT01257490|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6617551|NCT01257490|Antidepressive Agents|antidepressive agents|mesh-ancestor
6617552|NCT01257490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6617553|NCT01257490|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6617554|NCT01257490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6617555|NCT01257490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6617556|NCT01257490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617557|NCT01257490|Dopamine Agents|dopamine agents|mesh-ancestor
6617558|NCT01257490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6617559|NCT01257490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617560|NCT01257490|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6617561|NCT01257490|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6617562|NCT01257490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6617563|NCT01257516|Pregabalin|pregabalin|mesh-list
6617564|NCT01257516|Analgesics|analgesics|mesh-ancestor
6617565|NCT01257516|Sensory System Agents|sensory system agents|mesh-ancestor
6617566|NCT01257516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6617567|NCT01257516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617568|NCT01257516|Anticonvulsants|anticonvulsants|mesh-ancestor
6617569|NCT01257516|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6617570|NCT01257516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6617571|NCT01257516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617572|NCT01257516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6617573|NCT01257516|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6617574|NCT01257516|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6617575|NCT01257516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6617576|NCT01257516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6617577|NCT01257529|Pregabalin|pregabalin|mesh-list
6617578|NCT01257529|Analgesics|analgesics|mesh-ancestor
6617579|NCT01257529|Sensory System Agents|sensory system agents|mesh-ancestor
6617580|NCT01257529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6617581|NCT01257529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617582|NCT01257529|Anticonvulsants|anticonvulsants|mesh-ancestor
6617583|NCT01257529|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6617584|NCT01257529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6617585|NCT01257529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617586|NCT01257529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6617587|NCT01257529|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6617588|NCT01257529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6617589|NCT01257529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6617590|NCT01257529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6617591|NCT01257594|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6617592|NCT01257594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6617593|NCT01257594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6617594|NCT01257594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6617595|NCT01257594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617596|NCT01257672|Ondansetron|ondansetron|mesh-list
6617597|NCT01257672|Domperidone|domperidone|mesh-list
6617598|NCT01257672|Antiemetics|antiemetics|mesh-ancestor
6617599|NCT01257672|Autonomic Agents|autonomic agents|mesh-ancestor
6617600|NCT01257672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6617601|NCT01257672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617602|NCT01257672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6617603|NCT01257672|Antipruritics|antipruritics|mesh-ancestor
6617604|NCT01257672|Dermatologic Agents|dermatologic agents|mesh-ancestor
6617605|NCT01257672|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6617606|NCT01257672|Serotonin Agents|serotonin agents|mesh-ancestor
6617607|NCT01257672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6617608|NCT01257672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617609|NCT01257672|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6617610|NCT01257672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6617611|NCT01257672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6617612|NCT01257672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6617613|NCT01257672|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6617614|NCT01257672|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6617615|NCT01257672|Dopamine Agents|dopamine agents|mesh-ancestor
6617616|NCT00077285|Cyclophosphamide|cyclophosphamide|mesh-list
6617617|NCT00077285|Ifosfamide|ifosfamide|mesh-list
6617618|NCT00077285|Carboplatin|carboplatin|mesh-list
6617619|NCT00077285|Doxorubicin|doxorubicin|mesh-list
6617620|NCT00077285|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6617621|NCT00077285|Irinotecan|irinotecan|mesh-list
6617622|NCT00077285|Etoposide|etoposide|mesh-list
6617623|NCT00077285|Vincristine|vincristine|mesh-list
6617624|NCT00077285|Dexrazoxane|dexrazoxane|mesh-list
6617625|NCT00077285|Razoxane|razoxane|mesh-list
6617626|NCT00077285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6617627|NCT00077285|Immunologic Factors|immunologic factors|mesh-ancestor
6617628|NCT00077285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617629|NCT00077285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6617630|NCT00077285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6617631|NCT00077285|Alkylating Agents|alkylating agents|mesh-ancestor
6617632|NCT00077285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617633|NCT00077285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6617634|NCT00077285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6617635|NCT00077285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6617636|NCT00077285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6617637|NCT00077285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6617638|NCT00077285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6617639|NCT00077285|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6617640|NCT00077285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6617641|NCT00077285|Tubulin Modulators|tubulin modulators|mesh-ancestor
6617642|NCT00077285|Antimitotic Agents|antimitotic agents|mesh-ancestor
6617643|NCT00077285|Mitosis Modulators|mitosis modulators|mesh-ancestor
6617644|NCT00077285|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6617645|NCT00077285|Protective Agents|protective agents|mesh-ancestor
6617646|NCT01257815|Ranibizumab|ranibizumab|mesh-list
6617647|NCT01257815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6617648|NCT01257815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6617649|NCT01257815|Growth Substances|growth substances|mesh-ancestor
6617650|NCT01257815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617651|NCT01257815|Growth Inhibitors|growth inhibitors|mesh-ancestor
6617652|NCT01257815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6617653|NCT01257828|Riluzole|riluzole|mesh-list
6617654|NCT01257828|Anticonvulsants|anticonvulsants|mesh-ancestor
6617655|NCT01257828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6617656|NCT01257828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6617657|NCT01257828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6617658|NCT01257828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617659|NCT01257828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617660|NCT01257828|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6617661|NCT01257828|Protective Agents|protective agents|mesh-ancestor
6617662|NCT01257867|Lithium Carbonate|lithium carbonate|mesh-list
6617663|NCT01257867|Antidepressive Agents|antidepressive agents|mesh-ancestor
6617664|NCT01257867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6617665|NCT01257867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6617666|NCT01257867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617667|NCT01257867|Antimanic Agents|antimanic agents|mesh-ancestor
6617668|NCT01257867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6617669|NCT01257867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6617670|NCT01257867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617671|NCT01257893|Aspirin|aspirin|mesh-list
6617672|NCT01257893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6617673|NCT01257893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6617674|NCT01257893|Analgesics|analgesics|mesh-ancestor
6617675|NCT01257893|Sensory System Agents|sensory system agents|mesh-ancestor
6617676|NCT01257893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6617677|NCT01257893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617678|NCT01257893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6617679|NCT01257893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6617680|NCT01257893|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6617681|NCT01257893|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6617682|NCT01257893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617683|NCT01257893|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6617684|NCT01257893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6617685|NCT01257893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6617686|NCT01257893|Antipyretics|antipyretics|mesh-ancestor
6617687|NCT01257906|Tretinoin|tretinoin|mesh-list
6617688|NCT01257906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6617689|NCT01257906|Keratolytic Agents|keratolytic agents|mesh-ancestor
6617690|NCT01257906|Dermatologic Agents|dermatologic agents|mesh-ancestor
6617691|NCT01257919|Azelaic acid|azelaic acid|mesh-list
6617692|NCT01257919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6617693|NCT01257919|Dermatologic Agents|dermatologic agents|mesh-ancestor
6617694|NCT01257958|Vitamin D|vitamin d|mesh-list
6617695|NCT01257958|Vitamins|vitamins|mesh-ancestor
6617696|NCT01257958|Micronutrients|micronutrients|mesh-ancestor
6617697|NCT01257958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617698|NCT01257958|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6617699|NCT01258010|Tranexamic Acid|tranexamic acid|mesh-list
6617700|NCT01258010|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6617701|NCT01258010|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6617702|NCT01258010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617703|NCT01258010|Hemostatics|hemostatics|mesh-ancestor
6617704|NCT01258010|Coagulants|coagulants|mesh-ancestor
6617705|NCT01258036|Hormones|hormones|mesh-list
6617706|NCT01258036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6617707|NCT01258036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617708|NCT01258192|Paclitaxel|paclitaxel|mesh-list
6617709|NCT01258192|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6617710|NCT01258192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6617711|NCT01258192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6617712|NCT01258192|Tubulin Modulators|tubulin modulators|mesh-ancestor
6617713|NCT01258192|Antimitotic Agents|antimitotic agents|mesh-ancestor
6617714|NCT01258192|Mitosis Modulators|mitosis modulators|mesh-ancestor
6617715|NCT01258192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617716|NCT01258296|Fentanyl|fentanyl|mesh-list
6617717|NCT01258296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6617718|NCT01258296|Narcotics|narcotics|mesh-ancestor
6617719|NCT01258296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6617720|NCT01258296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617721|NCT01258296|Analgesics|analgesics|mesh-ancestor
6617722|NCT01258296|Sensory System Agents|sensory system agents|mesh-ancestor
6617723|NCT01258296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6617724|NCT01258296|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6617725|NCT01258296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6617726|NCT01258296|Anesthetics, General|anesthetics, general|mesh-ancestor
6617727|NCT01258296|Anesthetics|anesthetics|mesh-ancestor
6617728|NCT01258309|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
6617729|NCT01258309|Ketorolac|ketorolac|mesh-list
6617730|NCT01258309|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6617731|NCT01258309|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6617732|NCT01258309|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6617733|NCT01258309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6617734|NCT01258309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6617735|NCT01258309|Analgesics|analgesics|mesh-ancestor
6617736|NCT01258309|Sensory System Agents|sensory system agents|mesh-ancestor
6617737|NCT01258309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6617738|NCT01258309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617739|NCT01258309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6617740|NCT01258309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6617741|NCT01258309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6617742|NCT01258309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6617743|NCT01258309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617744|NCT01258309|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6617745|NCT01258309|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6617746|NCT01258309|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6617747|NCT01258309|Histamine Antagonists|histamine antagonists|mesh-ancestor
6617748|NCT01258309|Histamine Agents|histamine agents|mesh-ancestor
6617749|NCT01258309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6617750|NCT01258322|Pioglitazone|pioglitazone|mesh-list
6617751|NCT01258322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6617752|NCT01258322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617753|NCT01258439|Ritonavir|ritonavir|mesh-list
6617754|NCT01258439|Darunavir|darunavir|mesh-list
6617755|NCT01258439|Tenofovir|tenofovir|mesh-list
6617756|NCT01258439|Emtricitabine|emtricitabine|mesh-list
6617757|NCT01258439|Raltegravir Potassium|raltegravir potassium|mesh-list
6617758|NCT01258439|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6617759|NCT01258439|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6617760|NCT01258439|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6617761|NCT01258439|Protease Inhibitors|protease inhibitors|mesh-ancestor
6617762|NCT01258439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6617763|NCT01258439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617764|NCT01258439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6617765|NCT01258439|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6617766|NCT01258439|Antiviral Agents|antiviral agents|mesh-ancestor
6617767|NCT01258439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6617768|NCT01258439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6617769|NCT01258439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6617770|NCT01258439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6617771|NCT01258439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6617772|NCT01258439|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6617773|NCT01258439|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6617774|NCT01258491|Nicotinic Acids|nicotinic acids|mesh-list
6617775|NCT01258491|Niacin|niacin|mesh-list
6617776|NCT01258491|Niacinamide|niacinamide|mesh-list
6617777|NCT01258491|Vitamin B Complex|vitamin b complex|mesh-ancestor
6617778|NCT01258491|Vitamins|vitamins|mesh-ancestor
6617779|NCT01258491|Micronutrients|micronutrients|mesh-ancestor
6617780|NCT01258491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617781|NCT01258491|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6617782|NCT01258491|Antimetabolites|antimetabolites|mesh-ancestor
6617783|NCT01258491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617784|NCT01258491|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6617785|NCT01258491|Vasodilator Agents|vasodilator agents|mesh-ancestor
6617786|NCT01258530|Oseltamivir|oseltamivir|mesh-list
6617787|NCT01258530|Antiviral Agents|antiviral agents|mesh-ancestor
6617788|NCT01258530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6617789|NCT01258530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6617790|NCT01258530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617791|NCT01258569|Alvimopan|alvimopan|mesh-list
6617792|NCT01258569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6617793|NCT01258634|Leucovorin|leucovorin|mesh-list
6617794|NCT01258634|Doxorubicin|doxorubicin|mesh-list
6617795|NCT01258634|Etoposide|etoposide|mesh-list
6617796|NCT01258634|Ifosfamide|ifosfamide|mesh-list
6617797|NCT01258634|Dexrazoxane|dexrazoxane|mesh-list
6617798|NCT01258634|Razoxane|razoxane|mesh-list
6617799|NCT01258634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6617800|NCT01258634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6617801|NCT01258634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6617802|NCT01258634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6617803|NCT01258634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6617804|NCT01258634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617805|NCT01258634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6617806|NCT01258634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617807|NCT01258634|Antidotes|antidotes|mesh-ancestor
6617808|NCT01258634|Protective Agents|protective agents|mesh-ancestor
6617809|NCT01258634|Vitamin B Complex|vitamin b complex|mesh-ancestor
6617810|NCT01258634|Vitamins|vitamins|mesh-ancestor
6617811|NCT01258634|Micronutrients|micronutrients|mesh-ancestor
6617812|NCT01258634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6617813|NCT01258634|Alkylating Agents|alkylating agents|mesh-ancestor
6617814|NCT01258634|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6617815|NCT01258634|Antimitotic Agents|antimitotic agents|mesh-ancestor
6617816|NCT01258634|Mitosis Modulators|mitosis modulators|mesh-ancestor
6617817|NCT01258686|Silymarin|silymarin|mesh-list
6617818|NCT01258686|Antioxidants|antioxidants|mesh-ancestor
6617819|NCT01258686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617820|NCT01258686|Protective Agents|protective agents|mesh-ancestor
6617821|NCT01258686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617822|NCT01258712|Methotrexate|methotrexate|mesh-list
6617823|NCT01258712|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6617824|NCT01258712|Abortifacient Agents|abortifacient agents|mesh-ancestor
6617825|NCT01258712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6617826|NCT01258712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617827|NCT01258712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6617828|NCT01258712|Antimetabolites|antimetabolites|mesh-ancestor
6617829|NCT01258712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617830|NCT01258712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6617831|NCT01258712|Dermatologic Agents|dermatologic agents|mesh-ancestor
6617832|NCT01258712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6617833|NCT01258712|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6617834|NCT01258712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6617835|NCT01258712|Immunologic Factors|immunologic factors|mesh-ancestor
6617836|NCT01258712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6617837|NCT01258712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6617838|NCT01258764|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6617839|NCT01258764|Lisinopril|lisinopril|mesh-list
6617840|NCT01258764|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6617841|NCT01258764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6617842|NCT01258764|Diuretics|diuretics|mesh-ancestor
6617843|NCT01258764|Natriuretic Agents|natriuretic agents|mesh-ancestor
6617844|NCT01258764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617845|NCT01258764|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6617846|NCT01258764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6617847|NCT01258764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617848|NCT01258764|Protease Inhibitors|protease inhibitors|mesh-ancestor
6617849|NCT01258764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6617850|NCT01258764|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6617851|NCT01258764|Protective Agents|protective agents|mesh-ancestor
6617852|NCT01258777|Golimumab|golimumab|mesh-list
6617853|NCT01258777|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6617854|NCT01258777|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6617855|NCT01258777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6617856|NCT01258777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6617857|NCT01258777|Immunologic Factors|immunologic factors|mesh-ancestor
6617858|NCT01258777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617859|NCT01258868|Celecoxib|celecoxib|mesh-list
6617860|NCT01258868|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6617861|NCT01258868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6617862|NCT01258868|Analgesics|analgesics|mesh-ancestor
6617863|NCT01258868|Sensory System Agents|sensory system agents|mesh-ancestor
6617864|NCT01258868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6617865|NCT01258868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617866|NCT01258868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6617867|NCT01258868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6617868|NCT01258868|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6617869|NCT01258868|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6617870|NCT01258868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6664960|NCT01514942|Hematinics|hematinics|mesh-ancestor
6617871|NCT01258868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661553|NCT01499641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6661554|NCT01499693|Pantoprazole|pantoprazole|mesh-list
6661555|NCT01499693|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6661556|NCT01499693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6661557|NCT01499693|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6661558|NCT01499693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6661559|NCT01499693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661560|NCT01499758|Atorvastatin|atorvastatin|mesh-list
6661561|NCT01499758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6661562|NCT01499758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6661563|NCT01499758|Antimetabolites|antimetabolites|mesh-ancestor
6661564|NCT01499758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661565|NCT01499758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6661566|NCT01499758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6661567|NCT01499758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6661568|NCT01499771|Atorvastatin|atorvastatin|mesh-list
6661569|NCT01499771|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6661570|NCT01499771|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6661571|NCT01499771|Antimetabolites|antimetabolites|mesh-ancestor
6661572|NCT01499771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661573|NCT01499771|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6661574|NCT01499771|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6661575|NCT01499771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6661576|NCT01499875|Penicillin V|penicillin v|mesh-list
6661577|NCT01499875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6020818|NCT00394771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6020819|NCT00394771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020820|NCT00394771|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6661578|NCT01499875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6661579|NCT01499914|Vaccines|vaccines|mesh-list
6661580|NCT01499914|Immunologic Factors|immunologic factors|mesh-ancestor
6661581|NCT01499914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661582|NCT01499953|PENTA|penta|mesh-list
6661583|NCT01499953|Rivaroxaban|rivaroxaban|mesh-list
6661584|NCT01499953|Fondaparinux|fondaparinux|mesh-list
6661585|NCT01499953|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6661586|NCT01499953|Antithrombins|antithrombins|mesh-ancestor
6661587|NCT01499953|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6661588|NCT01499953|Protease Inhibitors|protease inhibitors|mesh-ancestor
6661589|NCT01499953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6661590|NCT01499953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661591|NCT01499953|Anticoagulants|anticoagulants|mesh-ancestor
6020821|NCT00394771|Contraceptive Agents|contraceptive agents|mesh-ancestor
6020822|NCT00394771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6450403|NCT00407836|Vaccines|vaccines|mesh-list
6661592|NCT01499953|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6661593|NCT01499953|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6661594|NCT01500005|Vitamin D|vitamin d|mesh-list
6661595|NCT01500005|Vitamins|vitamins|mesh-ancestor
6661596|NCT01500005|Micronutrients|micronutrients|mesh-ancestor
6450404|NCT00407836|Immunologic Factors|immunologic factors|mesh-ancestor
6450405|NCT00407836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450406|NCT00407849|Triamcinolone|triamcinolone|mesh-list
6450407|NCT00407849|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6450408|NCT00407849|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6450409|NCT00407849|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6450410|NCT00407849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6450411|NCT00407849|Glucocorticoids|glucocorticoids|mesh-ancestor
6450412|NCT00407849|Hormones|hormones|mesh-ancestor
6450413|NCT00407849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6450414|NCT00407849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450415|NCT00407849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6661597|NCT01500005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661598|NCT01500005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6450416|NCT00407849|Immunologic Factors|immunologic factors|mesh-ancestor
6450417|NCT00407849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6450418|NCT00407849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450419|NCT00407862|Losartan|losartan|mesh-list
6450420|NCT00407862|Telmisartan|telmisartan|mesh-list
6450421|NCT00407862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6450422|NCT00407862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6450423|NCT00407862|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6450424|NCT00407862|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6450425|NCT00407862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450426|NCT00407927|Epinastine|epinastine|mesh-list
6450427|NCT00407927|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6450428|NCT00407927|Histamine Antagonists|histamine antagonists|mesh-ancestor
6450429|NCT00407927|Histamine Agents|histamine agents|mesh-ancestor
6617872|NCT01258920|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6617873|NCT01258920|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6617874|NCT01258920|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6617875|NCT01258920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6617876|NCT01258920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617877|NCT01258920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6617878|NCT01258920|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6617879|NCT01258920|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6617880|NCT01258920|Serotonin Agents|serotonin agents|mesh-ancestor
6617881|NCT01258920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6617882|NCT01258920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617883|NCT01258920|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6617884|NCT01258920|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6617885|NCT01258920|Dopamine Agents|dopamine agents|mesh-ancestor
6617886|NCT01258933|Ofatumumab|ofatumumab|mesh-list
6617887|NCT01258933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6617888|NCT01258959|Anesthetics|anesthetics|mesh-list
6617889|NCT01258959|Anesthetics, Local|anesthetics, local|mesh-list
6617890|NCT01258959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6617891|NCT01258959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617892|NCT01258959|Sensory System Agents|sensory system agents|mesh-ancestor
6617893|NCT01258959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6617894|NCT01259050|Copper|copper|mesh-list
6617895|NCT01259050|Trace Elements|trace elements|mesh-ancestor
6617896|NCT01259050|Micronutrients|micronutrients|mesh-ancestor
6617897|NCT01259050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617898|NCT01259141|Azithromycin|azithromycin|mesh-list
6450430|NCT00407927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6450431|NCT00407927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450432|NCT00407927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450433|NCT00408031|Cycloserine|cycloserine|mesh-list
6450434|NCT00408031|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6450435|NCT00408031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6450436|NCT00408031|Renal Agents|renal agents|mesh-ancestor
6450437|NCT00408031|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6617899|NCT01259141|Moxifloxacin|moxifloxacin|mesh-list
6617900|NCT01259141|Cephalosporins|cephalosporins|mesh-list
6617901|NCT01259141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6617902|NCT01259141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6617903|NCT01259141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6617904|NCT01259141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6617905|NCT01259141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6617906|NCT01259141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617907|NCT01259141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6617908|NCT01259193|Zoledronic Acid|zoledronic acid|mesh-list
6617909|NCT01259193|Sorafenib|sorafenib|mesh-list
6617910|NCT01259193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6617911|NCT01259193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6617912|NCT01259193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6617913|NCT01259193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617914|NCT01259193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6617915|NCT01259193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617916|NCT01259219|Rifabutin|rifabutin|mesh-list
6617917|NCT01259219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6450438|NCT00408031|Antitubercular Agents|antitubercular agents|mesh-ancestor
6450439|NCT00408031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6617918|NCT01259219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6617919|NCT01259219|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6617920|NCT01259219|Antitubercular Agents|antitubercular agents|mesh-ancestor
6617921|NCT01259323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6617922|NCT01259323|Immunologic Factors|immunologic factors|mesh-ancestor
6617923|NCT01259323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617924|NCT01259336|Itraconazole|itraconazole|mesh-list
6617925|NCT01259336|Antifungal Agents|antifungal agents|mesh-ancestor
6617926|NCT01259336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6617927|NCT01259336|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6617928|NCT01259336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6617929|NCT01259336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6617930|NCT01259336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617931|NCT01259336|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6617932|NCT01259336|Hormone Antagonists|hormone antagonists|mesh-ancestor
6617933|NCT01259336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6617934|NCT01259336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617935|NCT01259336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6617936|NCT01259362|Cocaine|cocaine|mesh-list
6617937|NCT01259362|Anesthetics, Local|anesthetics, local|mesh-ancestor
6617938|NCT01259362|Anesthetics|anesthetics|mesh-ancestor
6617939|NCT01259362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6617940|NCT01259362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617941|NCT01259362|Sensory System Agents|sensory system agents|mesh-ancestor
6617942|NCT01259362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6617943|NCT01259362|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6617944|NCT01259362|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6617945|NCT01259362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6617946|NCT01259362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6617947|NCT01259362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617948|NCT01259362|Dopamine Agents|dopamine agents|mesh-ancestor
6617949|NCT01259362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6617950|NCT01259414|Ethiodized Oil|ethiodized oil|mesh-list
6617951|NCT01259414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6617952|NCT01259453|Vaccines|vaccines|mesh-list
6617953|NCT01259453|Immunologic Factors|immunologic factors|mesh-ancestor
6617954|NCT01259453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617955|NCT01259479|Satraplatin|satraplatin|mesh-list
6617956|NCT01259479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6617957|NCT01259531|Silodosin|silodosin|mesh-list
6617958|NCT01259531|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6617959|NCT01259531|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6617960|NCT01259531|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6617961|NCT01259531|Adrenergic Agents|adrenergic agents|mesh-ancestor
6617962|NCT01259531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6617963|NCT01259531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6617964|NCT01259531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617965|NCT01259531|Urological Agents|urological agents|mesh-ancestor
6617966|NCT01259557|Botulinum Toxins|botulinum toxins|mesh-list
6617967|NCT01259557|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6617968|NCT01259557|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6450440|NCT00408031|Antimetabolites|antimetabolites|mesh-ancestor
6617969|NCT01259557|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6617970|NCT01259557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6617971|NCT01259557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450441|NCT00408031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450442|NCT00408135|Telithromycin|telithromycin|mesh-list
6450443|NCT00408135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6450444|NCT00408135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6450445|NCT00408148|Rimonabant|rimonabant|mesh-list
6450446|NCT00408148|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6450447|NCT00408148|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
6450448|NCT00408148|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6450449|NCT00408148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6450450|NCT00408148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450451|NCT00408148|Hormones|hormones|mesh-ancestor
6450452|NCT00408148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6020823|NCT00394771|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6617972|NCT01259557|Cholinergic Agents|cholinergic agents|mesh-ancestor
6617973|NCT01259557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6617974|NCT01259557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617975|NCT01259557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6617976|NCT01259557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6617977|NCT01259648|Remifentanil|remifentanil|mesh-list
6617978|NCT01259648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6617979|NCT01259648|Narcotics|narcotics|mesh-ancestor
6617980|NCT01259648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6617981|NCT01259648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617982|NCT01259648|Analgesics|analgesics|mesh-ancestor
6617983|NCT01259648|Sensory System Agents|sensory system agents|mesh-ancestor
6617984|NCT01259648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6617985|NCT01259817|Aspirin|aspirin|mesh-list
6617986|NCT01259817|Interferons|interferons|mesh-list
6617987|NCT01259817|Interferon-alpha|interferon-alpha|mesh-list
6617988|NCT01259817|Interferon alpha-2|interferon alpha-2|mesh-list
6617989|NCT01259817|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6617990|NCT01259817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6617991|NCT01259817|Antiviral Agents|antiviral agents|mesh-ancestor
6617992|NCT01259817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6617993|NCT01259817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6617994|NCT01259817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6617995|NCT01259817|Analgesics|analgesics|mesh-ancestor
6617996|NCT01259817|Sensory System Agents|sensory system agents|mesh-ancestor
6617997|NCT01259817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6617998|NCT01259817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6617999|NCT01259817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6618000|NCT01259817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6618001|NCT01259817|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6618002|NCT01259817|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6618003|NCT01259817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618004|NCT01259817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6618005|NCT01259817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6618006|NCT01259817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6618007|NCT01259817|Antipyretics|antipyretics|mesh-ancestor
6618008|NCT01259817|Immunologic Factors|immunologic factors|mesh-ancestor
6618009|NCT01259830|Etoricoxib|etoricoxib|mesh-list
6618010|NCT01259830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6618011|NCT01259830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6618012|NCT01259830|Analgesics|analgesics|mesh-ancestor
6020824|NCT00394771|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6020825|NCT00394771|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6020826|NCT00394771|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6450453|NCT00408148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450454|NCT00408174|Balsalazide|balsalazide|mesh-list
6450455|NCT00408174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6450456|NCT00408174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6020827|NCT00394836|Ofatumumab|ofatumumab|mesh-list
6020828|NCT00394836|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6020829|NCT00394836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6020830|NCT00394836|Immunologic Factors|immunologic factors|mesh-ancestor
6020831|NCT00394836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020832|NCT00394888|Dermatologic Agents|dermatologic agents|mesh-list
6020833|NCT00394901|Pregabalin|pregabalin|mesh-list
6020834|NCT00394901|Analgesics|analgesics|mesh-ancestor
6020835|NCT00394901|Sensory System Agents|sensory system agents|mesh-ancestor
6020836|NCT00394901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6450457|NCT00408174|Analgesics|analgesics|mesh-ancestor
6450458|NCT00408174|Sensory System Agents|sensory system agents|mesh-ancestor
6450459|NCT00408174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6450460|NCT00408174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450461|NCT00408174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6450462|NCT00408174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6450463|NCT00408174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6450464|NCT00408187|Cyclosporine|cyclosporine|mesh-list
6450465|NCT00408187|Cyclosporins|cyclosporins|mesh-list
6450466|NCT00408187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6461858|NCT00456560|Fluvoxamine|fluvoxamine|mesh-list
6618013|NCT01259830|Sensory System Agents|sensory system agents|mesh-ancestor
6618014|NCT01259830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6618015|NCT01259830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618016|NCT01259830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6618017|NCT01259830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6618018|NCT01259830|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6618019|NCT01259830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6618020|NCT01259830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6618021|NCT01259830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618022|NCT01259934|Interferons|interferons|mesh-list
6618023|NCT01259934|Interferon-alpha|interferon-alpha|mesh-list
6618024|NCT01259934|Interferon alpha-2|interferon alpha-2|mesh-list
6618025|NCT01259934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6618026|NCT01259934|Antiviral Agents|antiviral agents|mesh-ancestor
6618027|NCT01259934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6618028|NCT01259934|Immunologic Factors|immunologic factors|mesh-ancestor
6618029|NCT01259934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618030|NCT01259973|Haloperidol|haloperidol|mesh-list
6618031|NCT01259973|Risperidone|risperidone|mesh-list
6618032|NCT01259973|Haloperidol decanoate|haloperidol decanoate|mesh-list
6618033|NCT01259973|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6618034|NCT01259973|Serotonin Agents|serotonin agents|mesh-ancestor
6618035|NCT01259973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6618036|NCT01259973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618037|NCT01259973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618038|NCT01259973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6618039|NCT01259973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6618040|NCT01259973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6618041|NCT01259973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6618042|NCT01259973|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6618043|NCT01259973|Dopamine Agents|dopamine agents|mesh-ancestor
6618044|NCT01259973|Antiemetics|antiemetics|mesh-ancestor
6618045|NCT01259973|Autonomic Agents|autonomic agents|mesh-ancestor
6618046|NCT01259973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6618047|NCT01259973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6618048|NCT01259973|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6618049|NCT01260012|Praziquantel|praziquantel|mesh-list
6618050|NCT01260012|Antioxidants|antioxidants|mesh-list
6618051|NCT01260012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618052|NCT01260012|Protective Agents|protective agents|mesh-ancestor
6618053|NCT01260012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618054|NCT01260012|Anthelmintics|anthelmintics|mesh-ancestor
6618055|NCT01260012|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6618056|NCT01260012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6618057|NCT01260025|Endostatins|endostatins|mesh-list
6618058|NCT01260025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6618059|NCT01260025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6618060|NCT01260025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6618061|NCT01260025|Growth Substances|growth substances|mesh-ancestor
6618062|NCT01260025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618063|NCT01260025|Growth Inhibitors|growth inhibitors|mesh-ancestor
6618064|NCT01260103|Temozolomide|temozolomide|mesh-list
6618065|NCT01260103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6618066|NCT01260103|Alkylating Agents|alkylating agents|mesh-ancestor
6618067|NCT01260103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618068|NCT01260103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6618069|NCT01260129|Silodosin|silodosin|mesh-list
6618070|NCT01260129|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6618071|NCT01260129|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6618072|NCT01260129|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6618073|NCT01260129|Adrenergic Agents|adrenergic agents|mesh-ancestor
6618074|NCT01260129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6618075|NCT01260129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618076|NCT01260129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618077|NCT01260129|Urological Agents|urological agents|mesh-ancestor
6618078|NCT01260233|Nicotine|nicotine|mesh-list
6618079|NCT01260233|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6618080|NCT01260233|Autonomic Agents|autonomic agents|mesh-ancestor
6618081|NCT01260233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6618082|NCT01260233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618083|NCT01260233|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6618084|NCT01260233|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6618085|NCT01260233|Cholinergic Agents|cholinergic agents|mesh-ancestor
6618086|NCT01260233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6618087|NCT01260233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618088|NCT01260246|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6618089|NCT01260246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6618090|NCT01260246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618091|NCT01260246|Incretins|incretins|mesh-ancestor
6618092|NCT01260246|Hormones|hormones|mesh-ancestor
6618093|NCT01260246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6618094|NCT01260246|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6618095|NCT01260246|Protease Inhibitors|protease inhibitors|mesh-ancestor
6618096|NCT01260246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6618097|NCT01260246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618098|NCT01260285|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6618099|NCT01260285|Vasodilator Agents|vasodilator agents|mesh-ancestor
6618100|NCT01260285|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6618101|NCT01260285|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6618102|NCT01260285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6618103|NCT01260285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618104|NCT01260285|Urological Agents|urological agents|mesh-ancestor
6618105|NCT01260376|Acipimox|acipimox|mesh-list
6618106|NCT01260376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6618107|NCT01260376|Antimetabolites|antimetabolites|mesh-ancestor
6618108|NCT01260376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618109|NCT01260376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6618110|NCT01260415|Oxaliplatin|oxaliplatin|mesh-list
6618111|NCT01260415|Panitumumab|panitumumab|mesh-list
6618112|NCT01260415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6618113|NCT01260415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6618114|NCT01260506|Bevacizumab|bevacizumab|mesh-list
6618115|NCT01260506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6618116|NCT01260506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6618117|NCT01260506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6618118|NCT01260506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6618119|NCT01260506|Growth Substances|growth substances|mesh-ancestor
6618120|NCT01260506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618121|NCT01260506|Growth Inhibitors|growth inhibitors|mesh-ancestor
6618122|NCT01260519|Heparin|heparin|mesh-list
6618123|NCT01260519|Calcium heparin|calcium heparin|mesh-list
6618124|NCT01260519|Anticoagulants|anticoagulants|mesh-ancestor
6618125|NCT01260519|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6618126|NCT01260519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6618127|NCT01260519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618128|NCT01260558|Sirolimus|sirolimus|mesh-list
6618129|NCT01260558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6618130|NCT01260558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6618131|NCT01260558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6618132|NCT01260558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6618133|NCT01260558|Antifungal Agents|antifungal agents|mesh-ancestor
6618134|NCT01260558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6618135|NCT01260558|Immunologic Factors|immunologic factors|mesh-ancestor
6618136|NCT01260558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618137|NCT01260571|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6618138|NCT01260571|Dermatologic Agents|dermatologic agents|mesh-ancestor
6618139|NCT01260610|Tenofovir|tenofovir|mesh-list
6618140|NCT01260610|Telbivudine|telbivudine|mesh-list
6618141|NCT01260610|Antiviral Agents|antiviral agents|mesh-ancestor
6618142|NCT01260610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6618143|NCT01260610|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6618144|NCT01260610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6618145|NCT01260610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6618146|NCT01260610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618147|NCT01260610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6618148|NCT01260610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6618149|NCT01260623|Prednisone|prednisone|mesh-list
6618150|NCT01260623|Prednisolone|prednisolone|mesh-list
6618151|NCT01260623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6618152|NCT01260623|Glucocorticoids|glucocorticoids|mesh-ancestor
6618153|NCT01260623|Hormones|hormones|mesh-ancestor
6618154|NCT01260623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6618155|NCT01260623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618156|NCT01260623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6618157|NCT01260623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6618158|NCT01260675|Buprenorphine|buprenorphine|mesh-list
6618159|NCT01260675|Naloxone|naloxone|mesh-list
6618160|NCT01260675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6618161|NCT01260675|Narcotics|narcotics|mesh-ancestor
6618162|NCT01260675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6618163|NCT01260675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618164|NCT01260675|Analgesics|analgesics|mesh-ancestor
6618165|NCT01260675|Sensory System Agents|sensory system agents|mesh-ancestor
6618166|NCT01260675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6618167|NCT01260675|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6661599|NCT01500018|Phentermine|phentermine|mesh-list
6661600|NCT01500018|Ketamine|ketamine|mesh-list
6618168|NCT01260714|Etoposide|etoposide|mesh-list
6618169|NCT01260714|Podophyllotoxin|podophyllotoxin|mesh-list
6618170|NCT01260714|Mitoxantrone|mitoxantrone|mesh-list
6618171|NCT01260714|Etoposide phosphate|etoposide phosphate|mesh-list
6618172|NCT01260714|Azacitidine|azacitidine|mesh-list
6618173|NCT01260714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6618174|NCT01260714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6618175|NCT01260714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6618176|NCT01260714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6618177|NCT01260714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6618178|NCT01260714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618179|NCT01260714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6618180|NCT01260714|Antimetabolites|antimetabolites|mesh-ancestor
6618181|NCT01260714|Analgesics|analgesics|mesh-ancestor
6618182|NCT01260714|Sensory System Agents|sensory system agents|mesh-ancestor
6618183|NCT01260714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6618184|NCT01260714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618185|NCT01260714|Keratolytic Agents|keratolytic agents|mesh-ancestor
6618186|NCT01260714|Dermatologic Agents|dermatologic agents|mesh-ancestor
6618187|NCT01260714|Tubulin Modulators|tubulin modulators|mesh-ancestor
6618188|NCT01260714|Antimitotic Agents|antimitotic agents|mesh-ancestor
6618189|NCT01260714|Mitosis Modulators|mitosis modulators|mesh-ancestor
6618190|NCT01260727|Vaccines|vaccines|mesh-list
6618191|NCT01260727|Immunologic Factors|immunologic factors|mesh-ancestor
6618192|NCT01260727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618193|NCT01260753|Fluticasone|fluticasone|mesh-list
6618194|NCT01260753|Xhance|xhance|mesh-list
6618195|NCT01260753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6618196|NCT01260753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6618197|NCT01260753|Autonomic Agents|autonomic agents|mesh-ancestor
6618198|NCT01260753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6618199|NCT01260753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618200|NCT01260753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6618201|NCT01260753|Respiratory System Agents|respiratory system agents|mesh-ancestor
6618202|NCT01260753|Dermatologic Agents|dermatologic agents|mesh-ancestor
6618203|NCT01260753|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6618204|NCT01260818|Tranexamic Acid|tranexamic acid|mesh-list
6618205|NCT01260818|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6618206|NCT01260818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6618207|NCT01260818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618208|NCT01260818|Hemostatics|hemostatics|mesh-ancestor
6618209|NCT01260818|Coagulants|coagulants|mesh-ancestor
6618210|NCT01260844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6618211|NCT01260844|Immunologic Factors|immunologic factors|mesh-ancestor
6618212|NCT01260844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618213|NCT01260857|Hydroflumethiazide|hydroflumethiazide|mesh-list
6618214|NCT01260857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6618215|NCT01260857|Diuretics|diuretics|mesh-ancestor
6618216|NCT01260857|Natriuretic Agents|natriuretic agents|mesh-ancestor
6618217|NCT01260857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618218|NCT01260857|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6618219|NCT01260857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6618220|NCT01260857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618221|NCT01260974|Caspofungin|caspofungin|mesh-list
6618222|NCT01260974|Antifungal Agents|antifungal agents|mesh-ancestor
6618223|NCT01260974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6618224|NCT01260974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6618225|NCT01260974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618226|NCT01261065|Carvedilol|carvedilol|mesh-list
6618227|NCT01261065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6618228|NCT01261065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6618229|NCT01261065|Adrenergic Agents|adrenergic agents|mesh-ancestor
6618230|NCT01261065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6618231|NCT01261065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618232|NCT01261065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618233|NCT01261065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6618234|NCT01261065|Antioxidants|antioxidants|mesh-ancestor
6618235|NCT01261065|Protective Agents|protective agents|mesh-ancestor
6618236|NCT01261065|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6618237|NCT01261065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6618238|NCT01261065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6618239|NCT01261065|Vasodilator Agents|vasodilator agents|mesh-ancestor
6618240|NCT01261065|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6618241|NCT01261065|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6618242|NCT01261078|Epinephrine|epinephrine|mesh-list
6618243|NCT01261078|Racepinephrine|racepinephrine|mesh-list
6618244|NCT01261078|Epinephryl borate|epinephryl borate|mesh-list
6618245|NCT01261078|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6618246|NCT01261078|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6618247|NCT01261078|Adrenergic Agents|adrenergic agents|mesh-ancestor
6618248|NCT01261078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6618249|NCT01261078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618250|NCT01261078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618251|NCT01261078|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6618252|NCT01261078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6618253|NCT01261078|Autonomic Agents|autonomic agents|mesh-ancestor
6618254|NCT01261078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6618255|NCT01261078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6618256|NCT01261078|Respiratory System Agents|respiratory system agents|mesh-ancestor
6618257|NCT01261078|Mydriatics|mydriatics|mesh-ancestor
6618258|NCT01261078|Sympathomimetics|sympathomimetics|mesh-ancestor
6618259|NCT01261078|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6618260|NCT01261117|Ibuprofen|ibuprofen|mesh-list
6618261|NCT01261117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6618262|NCT01261117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6618263|NCT01261117|Analgesics|analgesics|mesh-ancestor
6618264|NCT01261117|Sensory System Agents|sensory system agents|mesh-ancestor
6618265|NCT01261117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6618266|NCT01261117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618267|NCT01261117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6618268|NCT01261117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6618269|NCT01261117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6618270|NCT01261117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6618271|NCT01261117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618272|NCT01261130|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6618273|NCT01261130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6618274|NCT01261130|Immunologic Factors|immunologic factors|mesh-ancestor
6618275|NCT01261130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618276|NCT01261130|Antacids|antacids|mesh-ancestor
6618277|NCT01261130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618278|NCT01261130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6618279|NCT01261156|Diltiazem|diltiazem|mesh-list
6618280|NCT01261156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6618281|NCT01261156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6618282|NCT01261156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6618283|NCT01261156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618284|NCT01261156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6618285|NCT01261156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618286|NCT01261156|Vasodilator Agents|vasodilator agents|mesh-ancestor
6618287|NCT01261169|Mycophenolic Acid|mycophenolic acid|mesh-list
6618288|NCT01261169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6618289|NCT01261169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6618290|NCT01261169|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6618291|NCT01261169|Antitubercular Agents|antitubercular agents|mesh-ancestor
6618292|NCT01261169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6618293|NCT01261169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6618294|NCT01261169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6618295|NCT01261169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618296|NCT01261234|Cilostazol|cilostazol|mesh-list
6618297|NCT01261234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6618298|NCT01261234|Autonomic Agents|autonomic agents|mesh-ancestor
6618299|NCT01261234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6618300|NCT01261234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618301|NCT01261234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6618302|NCT01261234|Respiratory System Agents|respiratory system agents|mesh-ancestor
6618303|NCT01261234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6618304|NCT01261234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6618305|NCT01261234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618306|NCT01261234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6618307|NCT01261234|Vasodilator Agents|vasodilator agents|mesh-ancestor
6618308|NCT01261234|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6618309|NCT01261234|Protective Agents|protective agents|mesh-ancestor
6618310|NCT01261234|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6618311|NCT01261234|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6618312|NCT01261234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6618313|NCT01261286|Verapamil|verapamil|mesh-list
6618314|NCT01261286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6618315|NCT01261286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6618316|NCT01261286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6618317|NCT01261286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618318|NCT01261286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5502108|NCT04468685|Serotonin Agents|serotonin agents|mesh-ancestor
6618319|NCT01261286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618320|NCT01261286|Vasodilator Agents|vasodilator agents|mesh-ancestor
6618321|NCT01261299|Carboplatin|carboplatin|mesh-list
6618322|NCT01261299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6618323|NCT01261416|Levetiracetam|levetiracetam|mesh-list
6618324|NCT01261416|Anticonvulsants|anticonvulsants|mesh-ancestor
6618325|NCT01261416|Nootropic Agents|nootropic agents|mesh-ancestor
6618326|NCT01261481|Tolvaptan|tolvaptan|mesh-list
6618327|NCT01261481|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6618328|NCT01261481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618329|NCT01261481|Natriuretic Agents|natriuretic agents|mesh-ancestor
6618330|NCT01261481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618331|NCT01261546|Dexamethasone|dexamethasone|mesh-list
6618332|NCT01261546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6618333|NCT01261546|Antiemetics|antiemetics|mesh-ancestor
6618334|NCT01261546|Autonomic Agents|autonomic agents|mesh-ancestor
6618335|NCT01261546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6618336|NCT01261546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618337|NCT01261546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6618338|NCT01261546|Glucocorticoids|glucocorticoids|mesh-ancestor
6618339|NCT01261546|Hormones|hormones|mesh-ancestor
6618340|NCT01261546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6618341|NCT01261546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6618342|NCT01261546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6618343|NCT01261637|Ropivacaine|ropivacaine|mesh-list
6618344|NCT01261637|Anesthetics, Local|anesthetics, local|mesh-ancestor
6618345|NCT01261637|Anesthetics|anesthetics|mesh-ancestor
6618346|NCT01261637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6618347|NCT01261637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618348|NCT01261637|Sensory System Agents|sensory system agents|mesh-ancestor
6618349|NCT01261637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6618350|NCT01261689|Sufentanil|sufentanil|mesh-list
6618351|NCT01261689|Dsuvia|dsuvia|mesh-list
6618352|NCT01261689|Ropivacaine|ropivacaine|mesh-list
6618353|NCT01261689|Anesthetics, Local|anesthetics, local|mesh-ancestor
6618354|NCT01261689|Anesthetics|anesthetics|mesh-ancestor
6618355|NCT01261689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6618356|NCT01261689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618357|NCT01261689|Sensory System Agents|sensory system agents|mesh-ancestor
6618358|NCT01261689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6618359|NCT01261689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6618360|NCT01261689|Narcotics|narcotics|mesh-ancestor
6618361|NCT01261689|Analgesics|analgesics|mesh-ancestor
6618362|NCT01261689|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6618363|NCT01261689|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6618364|NCT01261689|Anesthetics, General|anesthetics, general|mesh-ancestor
6618365|NCT01261702|Magnesium Sulfate|magnesium sulfate|mesh-list
6618366|NCT01261702|Analgesics|analgesics|mesh-ancestor
6618367|NCT01261702|Sensory System Agents|sensory system agents|mesh-ancestor
6618368|NCT01261702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6618369|NCT01261702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618370|NCT01261702|Anesthetics|anesthetics|mesh-ancestor
6618371|NCT01261702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6618372|NCT01261702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6618373|NCT01261702|Anticonvulsants|anticonvulsants|mesh-ancestor
6618374|NCT01261702|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6618375|NCT01261702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6618376|NCT01261702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618377|NCT01261702|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6618378|NCT01261702|Tocolytic Agents|tocolytic agents|mesh-ancestor
6618379|NCT01261702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6618380|NCT01261741|Memantine|memantine|mesh-list
6618381|NCT01261741|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6618382|NCT01261741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6618383|NCT01261741|Dopamine Agents|dopamine agents|mesh-ancestor
6618384|NCT01261741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6618385|NCT01261741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618386|NCT01261741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618387|NCT01261741|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6618388|NCT01261741|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6618389|NCT01261832|Cilostazol|cilostazol|mesh-list
6618390|NCT01261832|Clopidogrel|clopidogrel|mesh-list
6618391|NCT01261832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6618392|NCT01261832|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6618393|NCT01261832|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6618394|NCT01261832|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6618395|NCT01261832|Purinergic Agents|purinergic agents|mesh-ancestor
6618396|NCT01261832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6618397|NCT01261832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618398|NCT01261832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618399|NCT01261832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6618400|NCT01261832|Autonomic Agents|autonomic agents|mesh-ancestor
6618401|NCT01261832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6618402|NCT01261832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6618403|NCT01261832|Respiratory System Agents|respiratory system agents|mesh-ancestor
6618404|NCT01261832|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6618405|NCT01261832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6618406|NCT01261832|Vasodilator Agents|vasodilator agents|mesh-ancestor
6618407|NCT01261832|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6618408|NCT01261832|Protective Agents|protective agents|mesh-ancestor
6618409|NCT01261832|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6618410|NCT01261832|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6618411|NCT01261832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6618412|NCT01261897|Ropivacaine|ropivacaine|mesh-list
6618413|NCT01261897|Anesthetics, Local|anesthetics, local|mesh-ancestor
6618414|NCT01261897|Anesthetics|anesthetics|mesh-ancestor
6618415|NCT01261897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6618416|NCT01261897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618417|NCT01261897|Sensory System Agents|sensory system agents|mesh-ancestor
6618418|NCT01261897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6618419|NCT01261923|Alitretinoin|alitretinoin|mesh-list
6618420|NCT01261923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6618421|NCT01261923|Dermatologic Agents|dermatologic agents|mesh-ancestor
6450467|NCT00408187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450468|NCT00408187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6450469|NCT00408187|Immunologic Factors|immunologic factors|mesh-ancestor
6450470|NCT00408187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450471|NCT00408187|Antifungal Agents|antifungal agents|mesh-ancestor
6450472|NCT00408187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6450473|NCT00408187|Dermatologic Agents|dermatologic agents|mesh-ancestor
6450474|NCT00408187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6450475|NCT00408187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6450476|NCT00408213|Mycophenolic Acid|mycophenolic acid|mesh-list
6450477|NCT00408213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6450478|NCT00408213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6450479|NCT00408213|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6618422|NCT01262183|Panitumumab|panitumumab|mesh-list
6618423|NCT01262183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6450480|NCT00408213|Antitubercular Agents|antitubercular agents|mesh-ancestor
6450481|NCT00408213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6450482|NCT00408213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6450483|NCT00408213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6450484|NCT00408213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450485|NCT00408226|Pemetrexed|pemetrexed|mesh-list
6450486|NCT00408226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6450487|NCT00408226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6450488|NCT00408226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450489|NCT00408226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6618424|NCT01262183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5502109|NCT04468685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5502110|NCT04468685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502111|NCT04468685|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5502112|NCT04468685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5502113|NCT04468685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5502114|NCT04468685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5502115|NCT04468685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6618425|NCT01262274|Anastrozole|anastrozole|mesh-list
6618426|NCT01262274|Tegafur|tegafur|mesh-list
6618427|NCT01262274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6618428|NCT01262274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6618429|NCT01262274|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6618430|NCT01262274|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6618431|NCT01262274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5502116|NCT04468464|Salicylic Acid|salicylic acid|mesh-list
5502117|NCT04468464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5502118|NCT04468464|Antifungal Agents|antifungal agents|mesh-ancestor
5502119|NCT04468464|Keratolytic Agents|keratolytic agents|mesh-ancestor
5502120|NCT04468464|Dermatologic Agents|dermatologic agents|mesh-ancestor
5502121|NCT04468139|Ascorbic Acid|ascorbic acid|mesh-list
5502122|NCT04468139|Quercetin|quercetin|mesh-list
5502123|NCT04468139|Vitamins|vitamins|mesh-ancestor
5502124|NCT04468139|Micronutrients|micronutrients|mesh-ancestor
5502125|NCT04468139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502126|NCT04468139|Antioxidants|antioxidants|mesh-ancestor
5502127|NCT04468139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502128|NCT04468139|Protective Agents|protective agents|mesh-ancestor
5502129|NCT04468542|Triamcinolone|triamcinolone|mesh-list
5502130|NCT04468542|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5502131|NCT04468542|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5502132|NCT04468542|Bupivacaine|bupivacaine|mesh-list
5502133|NCT04468542|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5502134|NCT04468542|Anesthetics, Local|anesthetics, local|mesh-ancestor
5502135|NCT04468542|Anesthetics|anesthetics|mesh-ancestor
5502136|NCT04468542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5502137|NCT04468542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502138|NCT04468542|Sensory System Agents|sensory system agents|mesh-ancestor
5502139|NCT04468542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5502140|NCT04468542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5502141|NCT04468542|Glucocorticoids|glucocorticoids|mesh-ancestor
5502142|NCT04468542|Hormones|hormones|mesh-ancestor
5502143|NCT04468542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6450490|NCT00408226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6618432|NCT01262274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618433|NCT01262274|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6618434|NCT01262274|Hormone Antagonists|hormone antagonists|mesh-ancestor
6618435|NCT01262274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6618436|NCT01262274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618437|NCT01262274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6618438|NCT01262274|Antimetabolites|antimetabolites|mesh-ancestor
6618439|NCT01262391|Solifenacin Succinate|solifenacin succinate|mesh-list
6618440|NCT01262391|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6618441|NCT01262391|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6618442|NCT01262391|Cholinergic Agents|cholinergic agents|mesh-ancestor
6618443|NCT01262391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6618444|NCT01262391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618445|NCT01262391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618446|NCT01262391|Urological Agents|urological agents|mesh-ancestor
6618447|NCT01262417|Hyaluronic Acid|hyaluronic acid|mesh-list
6618448|NCT01262417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6618449|NCT01262417|Immunologic Factors|immunologic factors|mesh-ancestor
6618450|NCT01262417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618451|NCT01262417|Viscosupplements|viscosupplements|mesh-ancestor
6618452|NCT01262417|Protective Agents|protective agents|mesh-ancestor
6618453|NCT01262469|Capecitabine|capecitabine|mesh-list
6618454|NCT01262469|Lapatinib|lapatinib|mesh-list
6618455|NCT01262469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6618456|NCT01262469|Antimetabolites|antimetabolites|mesh-ancestor
6618457|NCT01262469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618458|NCT01262469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6618459|NCT01262469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6618460|NCT01262469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6661601|NCT01500018|Analgesics|analgesics|mesh-ancestor
6661602|NCT01500018|Sensory System Agents|sensory system agents|mesh-ancestor
6661603|NCT01500018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6661604|NCT01500018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661605|NCT01500018|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6661606|NCT01500018|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6661607|NCT01500018|Anesthetics, General|anesthetics, general|mesh-ancestor
6661608|NCT01500018|Anesthetics|anesthetics|mesh-ancestor
6661609|NCT01500018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6661610|NCT01500018|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6661611|NCT01500018|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6661612|NCT01500018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6661613|NCT01500018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661614|NCT01500018|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6661615|NCT01500018|Appetite Depressants|appetite depressants|mesh-ancestor
6661616|NCT01500018|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6661617|NCT01500018|Sympathomimetics|sympathomimetics|mesh-ancestor
6661618|NCT01500018|Autonomic Agents|autonomic agents|mesh-ancestor
6661619|NCT01500018|Adrenergic Agents|adrenergic agents|mesh-ancestor
6661620|NCT01500070|Everolimus|everolimus|mesh-list
6661621|NCT01500070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6661622|NCT01500070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6661623|NCT01500070|Immunologic Factors|immunologic factors|mesh-ancestor
6661624|NCT01500070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661625|NCT01500161|Cytarabine|cytarabine|mesh-list
6661626|NCT01500161|Fludarabine|fludarabine|mesh-list
6661627|NCT01500161|Etoposide|etoposide|mesh-list
6661628|NCT01500161|Melphalan|melphalan|mesh-list
6661629|NCT01500161|Busulfan|busulfan|mesh-list
6661630|NCT01500161|Carmustine|carmustine|mesh-list
6661631|NCT01500161|Clofarabine|clofarabine|mesh-list
6661632|NCT01500161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6661633|NCT01500161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6661634|NCT01500161|Antimetabolites|antimetabolites|mesh-ancestor
6661635|NCT01500161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661636|NCT01500161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6661637|NCT01500161|Immunologic Factors|immunologic factors|mesh-ancestor
6661638|NCT01500161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661639|NCT01500161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6661640|NCT01500161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6661641|NCT01500161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6661642|NCT01500161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6661643|NCT01500161|Antiviral Agents|antiviral agents|mesh-ancestor
6661644|NCT01500161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6661645|NCT01500161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6661646|NCT01500161|Alkylating Agents|alkylating agents|mesh-ancestor
6661647|NCT01500161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6661648|NCT01500408|Interferons|interferons|mesh-list
6661649|NCT01500408|Interferon-beta|interferon-beta|mesh-list
6661650|NCT01500408|Interferon beta-1a|interferon beta-1a|mesh-list
6618461|NCT01262482|Oxaliplatin|oxaliplatin|mesh-list
6618462|NCT01262482|Sorafenib|sorafenib|mesh-list
6618463|NCT01262482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6618464|NCT01262482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6618465|NCT01262482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6618466|NCT01262482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618467|NCT01262586|Glimepiride|glimepiride|mesh-list
6618468|NCT01262586|Vildagliptin|vildagliptin|mesh-list
6618469|NCT01262586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6618470|NCT01262586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6618471|NCT01262586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618472|NCT01262586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6618473|NCT01262586|Immunologic Factors|immunologic factors|mesh-ancestor
6618474|NCT01262586|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6618475|NCT01262586|Protease Inhibitors|protease inhibitors|mesh-ancestor
6618476|NCT01262586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6618477|NCT01262586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618478|NCT01262612|Cediranib|cediranib|mesh-list
6618479|NCT01262612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6618480|NCT01262612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6618481|NCT01262612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6618482|NCT01262612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618483|NCT01262729|Xenon|xenon|mesh-list
6618484|NCT01262729|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6618485|NCT01262729|Anesthetics, General|anesthetics, general|mesh-ancestor
6618486|NCT01262729|Anesthetics|anesthetics|mesh-ancestor
6618487|NCT01262729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6618488|NCT01262729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618489|NCT01262742|Carbetocin|carbetocin|mesh-list
6618490|NCT01262742|Oxytocin|oxytocin|mesh-list
6618491|NCT01262742|Oxytocics|oxytocics|mesh-ancestor
6618492|NCT01262742|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6618493|NCT01262742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618494|NCT01262859|Bevacizumab|bevacizumab|mesh-list
6618495|NCT01262859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6618496|NCT01262859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6618497|NCT01262859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6618498|NCT01262859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6618499|NCT01262859|Growth Substances|growth substances|mesh-ancestor
6618500|NCT01262859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618501|NCT01262859|Growth Inhibitors|growth inhibitors|mesh-ancestor
6618502|NCT01262924|Vaccines|vaccines|mesh-list
6618503|NCT01262924|Immunologic Factors|immunologic factors|mesh-ancestor
6618504|NCT01262924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618505|NCT01262963|Dabrafenib|dabrafenib|mesh-list
6618506|NCT01262963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6618507|NCT01262963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6618508|NCT01262963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6618509|NCT01262963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618510|NCT01263002|Adefovir|adefovir|mesh-list
6618511|NCT01263002|Clevudine|clevudine|mesh-list
6618512|NCT01263002|Antiviral Agents|antiviral agents|mesh-ancestor
6618513|NCT01263002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6618514|NCT01263002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6618515|NCT01263002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6618516|NCT01263002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6618517|NCT01263002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618518|NCT01263080|Folic Acid|folic acid|mesh-list
6618519|NCT01263080|Vitamin B Complex|vitamin b complex|mesh-list
6618520|NCT01263080|Mirtazapine|mirtazapine|mesh-list
6618521|NCT01263080|Vitamins|vitamins|mesh-ancestor
6618522|NCT01263080|Micronutrients|micronutrients|mesh-ancestor
6618523|NCT01263080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618524|NCT01263080|Hematinics|hematinics|mesh-ancestor
6618525|NCT01263080|Antidepressive Agents|antidepressive agents|mesh-ancestor
6618526|NCT01263080|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6618527|NCT01263080|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6618528|NCT01263080|Histamine Antagonists|histamine antagonists|mesh-ancestor
6618529|NCT01263080|Histamine Agents|histamine agents|mesh-ancestor
6618530|NCT01263080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6618531|NCT01263080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618532|NCT01263080|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6618533|NCT01263080|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6618534|NCT01263080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6618535|NCT01263080|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6618536|NCT01263080|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6618537|NCT01263080|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6618538|NCT01263080|Adrenergic Agents|adrenergic agents|mesh-ancestor
6618539|NCT01263080|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6618540|NCT01263080|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6618541|NCT01263080|Serotonin Agents|serotonin agents|mesh-ancestor
6618542|NCT01263080|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6618543|NCT01263145|Paclitaxel|paclitaxel|mesh-list
6618544|NCT01263145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6618545|NCT01263145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6618546|NCT01263145|Tubulin Modulators|tubulin modulators|mesh-ancestor
6618547|NCT01263145|Antimitotic Agents|antimitotic agents|mesh-ancestor
6618548|NCT01263145|Mitosis Modulators|mitosis modulators|mesh-ancestor
6618549|NCT01263145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618550|NCT01263158|Oxytocin|oxytocin|mesh-list
6618551|NCT01263158|Oxytocics|oxytocics|mesh-ancestor
6618552|NCT01263158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6618553|NCT01263158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618554|NCT01263171|Leucovorin|leucovorin|mesh-list
6618555|NCT01263171|Fluorouracil|fluorouracil|mesh-list
6618556|NCT01263171|Oxaliplatin|oxaliplatin|mesh-list
6618557|NCT01263171|Calcium|calcium|mesh-list
6618558|NCT01263171|Levoleucovorin|levoleucovorin|mesh-list
6618559|NCT01263171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6618560|NCT01263171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618561|NCT01263171|Antimetabolites|antimetabolites|mesh-ancestor
6618562|NCT01263171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618563|NCT01263171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6618564|NCT01263171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6618565|NCT01263171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6618566|NCT01263171|Immunologic Factors|immunologic factors|mesh-ancestor
6618567|NCT01263171|Antidotes|antidotes|mesh-ancestor
6618568|NCT01263171|Protective Agents|protective agents|mesh-ancestor
6450491|NCT00408239|Enoxaparin|enoxaparin|mesh-list
6450492|NCT00408239|Anticoagulants|anticoagulants|mesh-ancestor
6450493|NCT00408239|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6450494|NCT00408239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6450495|NCT00408239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450496|NCT00408252|Sunitinib|sunitinib|mesh-list
6450497|NCT00408252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6450498|NCT00408252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6450499|NCT00408252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6450500|NCT00408252|Growth Substances|growth substances|mesh-ancestor
6450501|NCT00408252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618569|NCT01263171|Vitamin B Complex|vitamin b complex|mesh-ancestor
6618570|NCT01263171|Vitamins|vitamins|mesh-ancestor
6618571|NCT01263171|Micronutrients|micronutrients|mesh-ancestor
6618572|NCT01263210|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6618573|NCT01263210|Immunologic Factors|immunologic factors|mesh-ancestor
6618574|NCT01263210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618575|NCT01263288|Cholecalciferol|cholecalciferol|mesh-list
6618576|NCT01263288|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6618577|NCT01263288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618578|NCT01263288|Vitamins|vitamins|mesh-ancestor
6618579|NCT01263288|Micronutrients|micronutrients|mesh-ancestor
6618580|NCT01263288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6618581|NCT01263353|Everolimus|everolimus|mesh-list
5502144|NCT04468542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5502145|NCT04468542|Immunologic Factors|immunologic factors|mesh-ancestor
5502146|NCT04468542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5502147|NCT04468542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618582|NCT01263353|Pasireotide|pasireotide|mesh-list
6618583|NCT01263353|Somatostatin|somatostatin|mesh-list
6618584|NCT01263353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6618585|NCT01263353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6618586|NCT01263353|Immunologic Factors|immunologic factors|mesh-ancestor
6618587|NCT01263353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618588|NCT01263353|Hormones|hormones|mesh-ancestor
6618589|NCT01263353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6618590|NCT01263366|Norepinephrine|norepinephrine|mesh-list
6618591|NCT01263366|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6618592|NCT01263366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6618593|NCT01263366|Adrenergic Agents|adrenergic agents|mesh-ancestor
6618594|NCT01263366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6618595|NCT01263366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618596|NCT01263366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618597|NCT01263366|Sympathomimetics|sympathomimetics|mesh-ancestor
6618598|NCT01263366|Autonomic Agents|autonomic agents|mesh-ancestor
6618599|NCT01263366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6618600|NCT01263366|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6618601|NCT01263418|Ofatumumab|ofatumumab|mesh-list
6618602|NCT01263418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6618603|NCT01263548|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6618604|NCT01263548|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6618605|NCT01263548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618606|NCT01263548|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5502148|NCT04468165|Dimethyl Fumarate|dimethyl fumarate|mesh-list
6618607|NCT01263548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6618608|NCT01263548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6618609|NCT01263548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618610|NCT01263548|Dopamine Agents|dopamine agents|mesh-ancestor
6618611|NCT01263548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6618612|NCT01263574|Ethanol|ethanol|mesh-list
6020837|NCT00394901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020838|NCT00394901|Anticonvulsants|anticonvulsants|mesh-ancestor
6020839|NCT00394901|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6020840|NCT00394901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6020841|NCT00394901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618613|NCT01263574|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6618614|NCT01263574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6618615|NCT01263574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6618616|NCT01263574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618617|NCT01263652|Dipyrone|dipyrone|mesh-list
6618618|NCT01263652|Diclofenac|diclofenac|mesh-list
6618619|NCT01263652|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
6618620|NCT01263652|Tramadol|tramadol|mesh-list
6618621|NCT01263652|Orphenadrine|orphenadrine|mesh-list
6618622|NCT01263652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6618623|NCT01263652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6618624|NCT01263652|Analgesics|analgesics|mesh-ancestor
6618625|NCT01263652|Sensory System Agents|sensory system agents|mesh-ancestor
6618626|NCT01263652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6618627|NCT01263652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618628|NCT01263652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6618629|NCT01263652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6618630|NCT01263652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6618631|NCT01263652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6618632|NCT01263652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618633|NCT01263652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6618634|NCT01263652|Narcotics|narcotics|mesh-ancestor
6618635|NCT01263652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6618636|NCT01263652|Antipyretics|antipyretics|mesh-ancestor
6618637|NCT01263652|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6618638|NCT01263652|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6618639|NCT01263652|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6618640|NCT01263652|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6618641|NCT01263652|Parasympatholytics|parasympatholytics|mesh-ancestor
6618642|NCT01263652|Autonomic Agents|autonomic agents|mesh-ancestor
6618643|NCT01263652|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6618644|NCT01263652|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6618645|NCT01263652|Cholinergic Agents|cholinergic agents|mesh-ancestor
6618646|NCT01263652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6618647|NCT01263652|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
6618648|NCT01263652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6618649|NCT01263808|Moxifloxacin|moxifloxacin|mesh-list
6618650|NCT01263808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6618651|NCT01263808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6618652|NCT01263808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6618653|NCT01263808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6618654|NCT01263808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6618655|NCT01263808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618656|NCT01263808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6618657|NCT01263834|Bevacizumab|bevacizumab|mesh-list
6618658|NCT01263834|Mitomycins|mitomycins|mesh-list
6618659|NCT01263834|Mitomycin|mitomycin|mesh-list
6618660|NCT01263834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6618661|NCT01263834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6618662|NCT01263834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6618663|NCT01263834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6618664|NCT01263834|Growth Substances|growth substances|mesh-ancestor
6618665|NCT01263834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618666|NCT01263834|Growth Inhibitors|growth inhibitors|mesh-ancestor
6618667|NCT01263834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6618668|NCT01263834|Alkylating Agents|alkylating agents|mesh-ancestor
6618669|NCT01263834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618670|NCT01263834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6618671|NCT01263834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6618672|NCT01263860|Ribavirin|ribavirin|mesh-list
6618673|NCT01263860|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6618674|NCT01263860|Interferon-alpha|interferon-alpha|mesh-list
6618675|NCT01263860|Antimetabolites|antimetabolites|mesh-ancestor
6618676|NCT01263860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618677|NCT01263860|Antiviral Agents|antiviral agents|mesh-ancestor
6618678|NCT01263860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6618679|NCT01263860|Immunologic Factors|immunologic factors|mesh-ancestor
6618680|NCT01263860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618681|NCT01263951|Everolimus|everolimus|mesh-list
6618682|NCT01263951|Sorafenib|sorafenib|mesh-list
6618683|NCT01263951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6618684|NCT01263951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6618685|NCT01263951|Immunologic Factors|immunologic factors|mesh-ancestor
6618686|NCT01263951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618687|NCT01263951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6618688|NCT01263951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6618689|NCT01263951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618690|NCT01264094|Clevudine|clevudine|mesh-list
6618691|NCT01264094|Antiviral Agents|antiviral agents|mesh-ancestor
6618692|NCT01264094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6618693|NCT01264133|Adefovir|adefovir|mesh-list
6618694|NCT01264133|Clevudine|clevudine|mesh-list
6618695|NCT01264133|Antiviral Agents|antiviral agents|mesh-ancestor
6618696|NCT01264133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6618697|NCT01264133|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6618698|NCT01264133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6618699|NCT01264133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6618700|NCT01264133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618701|NCT01264211|Diacetylrhein|diacetylrhein|mesh-list
6618702|NCT01264211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6618703|NCT01264237|Etoricoxib|etoricoxib|mesh-list
6020842|NCT00394901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6020843|NCT00394901|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6020844|NCT00394901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6020845|NCT00394901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6020846|NCT00394901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6020847|NCT00394914|Pleconaril|pleconaril|mesh-list
6020848|NCT00394914|Antiviral Agents|antiviral agents|mesh-ancestor
6020849|NCT00394914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6618704|NCT01264237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6618705|NCT01264237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6618706|NCT01264237|Analgesics|analgesics|mesh-ancestor
6618707|NCT01264237|Sensory System Agents|sensory system agents|mesh-ancestor
6618708|NCT01264237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6618709|NCT01264237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618710|NCT01264237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6618711|NCT01264237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6618712|NCT01264237|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6618713|NCT01264237|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6618714|NCT01264237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6618715|NCT01264237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618716|NCT01264289|Finasteride|finasteride|mesh-list
6618717|NCT01264289|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6618718|NCT01264289|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6618719|NCT01264289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6618720|NCT01264289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618721|NCT01264289|Hormone Antagonists|hormone antagonists|mesh-ancestor
6618722|NCT01264289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6618723|NCT01264289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618724|NCT01264289|Urological Agents|urological agents|mesh-ancestor
6618725|NCT01264302|Finasteride|finasteride|mesh-list
6618726|NCT01264302|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6618727|NCT01264302|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6618728|NCT01264302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6618729|NCT01264302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618730|NCT01264302|Hormone Antagonists|hormone antagonists|mesh-ancestor
6618731|NCT01264302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6618732|NCT01264302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618733|NCT01264302|Urological Agents|urological agents|mesh-ancestor
6618734|NCT01264315|Lenalidomide|lenalidomide|mesh-list
6618735|NCT01264315|Immunologic Factors|immunologic factors|mesh-ancestor
6618736|NCT01264315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618737|NCT01264315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6618738|NCT01264315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6618739|NCT01264315|Growth Substances|growth substances|mesh-ancestor
6618740|NCT01264315|Growth Inhibitors|growth inhibitors|mesh-ancestor
6618741|NCT01264315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6618742|NCT01264328|Paclitaxel|paclitaxel|mesh-list
6618743|NCT01264328|Panitumumab|panitumumab|mesh-list
6618744|NCT01264328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6618745|NCT01264328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6618746|NCT01264328|Tubulin Modulators|tubulin modulators|mesh-ancestor
6618747|NCT01264328|Antimitotic Agents|antimitotic agents|mesh-ancestor
6618748|NCT01264328|Mitosis Modulators|mitosis modulators|mesh-ancestor
6618749|NCT01264328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618750|NCT01264328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6618751|NCT01264341|Sirolimus|sirolimus|mesh-list
6618752|NCT01264341|Bevacizumab|bevacizumab|mesh-list
6618753|NCT01264341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6618754|NCT01264341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6618755|NCT01264341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6618756|NCT01264341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6618757|NCT01264341|Growth Substances|growth substances|mesh-ancestor
6618758|NCT01264341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618759|NCT01264341|Growth Inhibitors|growth inhibitors|mesh-ancestor
6618760|NCT01264341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6618761|NCT01264341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6618762|NCT01264341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6618763|NCT01264341|Antifungal Agents|antifungal agents|mesh-ancestor
6618764|NCT01264341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6618765|NCT01264341|Immunologic Factors|immunologic factors|mesh-ancestor
6618766|NCT01264354|Adefovir|adefovir|mesh-list
6618767|NCT01264354|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6618768|NCT01264354|Clevudine|clevudine|mesh-list
6618769|NCT01264354|Antiviral Agents|antiviral agents|mesh-ancestor
6618770|NCT01264354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6618771|NCT01264354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6618772|NCT01264354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6618773|NCT01264354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6618774|NCT01264354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618775|NCT01264367|Interferons|interferons|mesh-list
6618776|NCT01264367|Clevudine|clevudine|mesh-list
6450502|NCT00408252|Growth Inhibitors|growth inhibitors|mesh-ancestor
6450503|NCT00408252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6450504|NCT00408252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6450505|NCT00408252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450506|NCT00408278|Mitoxantrone|mitoxantrone|mesh-list
6450507|NCT00408278|Analgesics|analgesics|mesh-ancestor
6450508|NCT00408278|Sensory System Agents|sensory system agents|mesh-ancestor
6618777|NCT01264367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6618778|NCT01264367|Antiviral Agents|antiviral agents|mesh-ancestor
6618779|NCT01264367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6661651|NCT01500408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6661652|NCT01500408|Antiviral Agents|antiviral agents|mesh-ancestor
6661653|NCT01500408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6661654|NCT01500408|Immunologic Factors|immunologic factors|mesh-ancestor
6450509|NCT00408278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6661655|NCT01500408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661656|NCT01500408|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6661657|NCT01500473|Desogestrel|desogestrel|mesh-list
6661658|NCT01500473|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6661659|NCT01500473|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6661660|NCT01500473|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6661661|NCT01500473|Contraceptive Agents|contraceptive agents|mesh-ancestor
6661662|NCT01500473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6661663|NCT01500473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661664|NCT01500473|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6661665|NCT01500473|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6661666|NCT01500473|Progestins|progestins|mesh-ancestor
6661667|NCT01500473|Hormones|hormones|mesh-ancestor
5502149|NCT04468165|Dermatologic Agents|dermatologic agents|mesh-ancestor
6450510|NCT00408278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450511|NCT00408278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6450512|NCT00408278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6450513|NCT00408278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6450514|NCT00408278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6618780|NCT01264432|Veliparib|veliparib|mesh-list
6618781|NCT01264432|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6618782|NCT01264432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6618783|NCT01264432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618784|NCT01264432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6618785|NCT01264445|Vaccines|vaccines|mesh-list
6618786|NCT01264445|Immunologic Factors|immunologic factors|mesh-ancestor
6618787|NCT01264445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618788|NCT01264484|Imidacloprid|imidacloprid|mesh-list
6618789|NCT01264484|Cholinergic Agents|cholinergic agents|mesh-ancestor
6618790|NCT01264484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6618791|NCT01264484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618792|NCT01264484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618793|NCT01264497|Tesamorelin|tesamorelin|mesh-list
6618794|NCT01264497|Growth Substances|growth substances|mesh-ancestor
6618795|NCT01264497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618796|NCT01264536|Lactoferrin|lactoferrin|mesh-list
6618797|NCT01264536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6618798|NCT01264575|Epinephrine|epinephrine|mesh-list
6618799|NCT01264575|Racepinephrine|racepinephrine|mesh-list
6618800|NCT01264575|Bupivacaine|bupivacaine|mesh-list
6618801|NCT01264575|Epinephryl borate|epinephryl borate|mesh-list
6618802|NCT01264575|Anesthetics, Local|anesthetics, local|mesh-ancestor
6618803|NCT01264575|Anesthetics|anesthetics|mesh-ancestor
6618804|NCT01264575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6618805|NCT01264575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618806|NCT01264575|Sensory System Agents|sensory system agents|mesh-ancestor
6618807|NCT01264575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6618808|NCT01264575|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6618809|NCT01264575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6618810|NCT01264575|Adrenergic Agents|adrenergic agents|mesh-ancestor
6618811|NCT01264575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6618812|NCT01264575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618813|NCT01264575|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6618814|NCT01264575|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6618815|NCT01264575|Autonomic Agents|autonomic agents|mesh-ancestor
6618816|NCT01264575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6618817|NCT01264575|Respiratory System Agents|respiratory system agents|mesh-ancestor
6618818|NCT01264575|Mydriatics|mydriatics|mesh-ancestor
6618819|NCT01264575|Sympathomimetics|sympathomimetics|mesh-ancestor
6618820|NCT01264575|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6618821|NCT01264588|Calcium|calcium|mesh-list
6618822|NCT01264588|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6618823|NCT01264588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618824|NCT01264640|Aspirin|aspirin|mesh-list
6618825|NCT01264640|Clopidogrel|clopidogrel|mesh-list
6618826|NCT01264640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6618827|NCT01264640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6618828|NCT01264640|Analgesics|analgesics|mesh-ancestor
6618829|NCT01264640|Sensory System Agents|sensory system agents|mesh-ancestor
6618830|NCT01264640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6618831|NCT01264640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618832|NCT01264640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6618833|NCT01264640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6618834|NCT01264640|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6618835|NCT01264640|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6618836|NCT01264640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618837|NCT01264640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6618838|NCT01264640|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6618839|NCT01264640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6618840|NCT01264640|Antipyretics|antipyretics|mesh-ancestor
6664961|NCT01514942|Vitamins|vitamins|mesh-ancestor
6618841|NCT01264640|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6618842|NCT01264640|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6618843|NCT01264640|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6618844|NCT01264640|Purinergic Agents|purinergic agents|mesh-ancestor
6618845|NCT01264640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6618846|NCT01264653|Epinephrine|epinephrine|mesh-list
6618847|NCT01264653|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6618848|NCT01264653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6618849|NCT01264653|Adrenergic Agents|adrenergic agents|mesh-ancestor
6618850|NCT01264653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6618851|NCT01264653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618852|NCT01264653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618853|NCT01264653|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6618854|NCT01264653|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6618855|NCT01264653|Autonomic Agents|autonomic agents|mesh-ancestor
6618856|NCT01264653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6618857|NCT01264653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6618858|NCT01264653|Respiratory System Agents|respiratory system agents|mesh-ancestor
6618859|NCT01264653|Mydriatics|mydriatics|mesh-ancestor
6618860|NCT01264653|Sympathomimetics|sympathomimetics|mesh-ancestor
6618861|NCT01264653|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6618862|NCT01264692|Amlodipine|amlodipine|mesh-list
6618863|NCT01264692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6618864|NCT01264692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6618865|NCT01264692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6618866|NCT01264692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618867|NCT01264692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6618868|NCT01264692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618869|NCT01264692|Vasodilator Agents|vasodilator agents|mesh-ancestor
6618870|NCT01264731|Imiquimod|imiquimod|mesh-list
6618871|NCT01264731|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6618872|NCT01264731|Immunologic Factors|immunologic factors|mesh-ancestor
6618873|NCT01264731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618874|NCT01264731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6618875|NCT01264731|Interferon Inducers|interferon inducers|mesh-ancestor
6618876|NCT01264783|RNS60|rns60|mesh-list
6618877|NCT01264783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6618878|NCT01264783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6618879|NCT01264783|Analgesics|analgesics|mesh-ancestor
6618880|NCT01264783|Sensory System Agents|sensory system agents|mesh-ancestor
6618881|NCT01264783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6618882|NCT01264783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618883|NCT01264783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6618884|NCT01264783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6618885|NCT01264783|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6618886|NCT01264822|Rabeprazole|rabeprazole|mesh-list
6618887|NCT01264822|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6618888|NCT01264822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6618889|NCT01264822|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6618890|NCT01264822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6618891|NCT01264822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618892|NCT01264874|Vitamin D|vitamin d|mesh-list
6618893|NCT01264874|Cholecalciferol|cholecalciferol|mesh-list
6618894|NCT01264874|Vitamins|vitamins|mesh-ancestor
6618895|NCT01264874|Micronutrients|micronutrients|mesh-ancestor
6618896|NCT01264874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618897|NCT01264874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6618898|NCT01264874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6618899|NCT01265004|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6618900|NCT01265004|Hemostatics|hemostatics|mesh-ancestor
6618901|NCT01265004|Coagulants|coagulants|mesh-ancestor
6618902|NCT01265017|Hydrocortisone|hydrocortisone|mesh-list
6618903|NCT01265017|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6618904|NCT01265017|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6618905|NCT01265017|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6618906|NCT01265017|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6618907|NCT01265017|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6618908|NCT01265017|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6618909|NCT01265017|Medroxyprogesterone|medroxyprogesterone|mesh-list
6618910|NCT01265017|Estradiol|estradiol|mesh-list
6618911|NCT01265017|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6618912|NCT01265017|Hormones|hormones|mesh-ancestor
6618913|NCT01265017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6618914|NCT01265017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618915|NCT01265017|Estrogens|estrogens|mesh-ancestor
6618916|NCT01265017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6618917|NCT01265017|Contraceptive Agents|contraceptive agents|mesh-ancestor
6618918|NCT01265017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6618919|NCT01265017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6618920|NCT01265017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6618921|NCT01265017|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6618922|NCT01265017|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6618923|NCT01265017|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6618924|NCT01265017|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6618925|NCT01265017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6618926|NCT01265017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6618927|NCT01265030|Sirolimus|sirolimus|mesh-list
6618928|NCT01265030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6618929|NCT01265030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6618930|NCT01265030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6618931|NCT01265030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6618932|NCT01265030|Antifungal Agents|antifungal agents|mesh-ancestor
6618933|NCT01265030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6618934|NCT01265030|Immunologic Factors|immunologic factors|mesh-ancestor
6618935|NCT01265030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618936|NCT01265108|Iron|iron|mesh-list
6618937|NCT01265108|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6618938|NCT01265108|Trace Elements|trace elements|mesh-ancestor
6618939|NCT01265108|Micronutrients|micronutrients|mesh-ancestor
6618940|NCT01265108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618941|NCT01265108|Hematinics|hematinics|mesh-ancestor
6618942|NCT01265147|Nedaplatin|nedaplatin|mesh-list
6618943|NCT01265147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6618944|NCT01265173|Ciprofloxacin|ciprofloxacin|mesh-list
6618945|NCT01265173|Ceftriaxone|ceftriaxone|mesh-list
6618946|NCT01265173|Cefotaxime|cefotaxime|mesh-list
6618947|NCT01265173|Cefoxitin|cefoxitin|mesh-list
6618948|NCT01265173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6618949|NCT01265173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6618950|NCT01265173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6618951|NCT01265173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6618952|NCT01265173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6618953|NCT01265173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618954|NCT01265173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6618955|NCT01265173|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6618956|NCT01265173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6618957|NCT01265199|Cytarabine|cytarabine|mesh-list
6618958|NCT01265199|Daunorubicin|daunorubicin|mesh-list
6618959|NCT01265199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6618960|NCT01265199|Antimetabolites|antimetabolites|mesh-ancestor
6618961|NCT01265199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618962|NCT01265199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6618963|NCT01265199|Antiviral Agents|antiviral agents|mesh-ancestor
6618964|NCT01265199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6618965|NCT01265199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6618966|NCT01265199|Immunologic Factors|immunologic factors|mesh-ancestor
6618967|NCT01265199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618968|NCT01265199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6618969|NCT01265199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6618970|NCT01265199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6618971|NCT01265199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6618972|NCT01265342|Beclomethasone|beclomethasone|mesh-list
6618973|NCT01265342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6618974|NCT01265342|Glucocorticoids|glucocorticoids|mesh-ancestor
6618975|NCT01265342|Hormones|hormones|mesh-ancestor
6618976|NCT01265342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6618977|NCT01265342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618978|NCT01265342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6618979|NCT01265342|Respiratory System Agents|respiratory system agents|mesh-ancestor
6618980|NCT01265433|Molgramostim|molgramostim|mesh-list
6618981|NCT01265433|Sargramostim|sargramostim|mesh-list
6618982|NCT01265433|Immunologic Factors|immunologic factors|mesh-ancestor
6618983|NCT01265433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618984|NCT01265433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6618985|NCT01265576|Etodolac|etodolac|mesh-list
6618986|NCT01265576|Sorafenib|sorafenib|mesh-list
6618987|NCT01265576|Propranolol|propranolol|mesh-list
6618988|NCT01265576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6618989|NCT01265576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6618990|NCT01265576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6618991|NCT01265576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6618992|NCT01265576|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6618993|NCT01265576|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6618994|NCT01265576|Adrenergic Agents|adrenergic agents|mesh-ancestor
6618995|NCT01265576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6618996|NCT01265576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6618997|NCT01265576|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6618998|NCT01265576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6618999|NCT01265576|Vasodilator Agents|vasodilator agents|mesh-ancestor
6619000|NCT01265576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6619001|NCT01265576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6619002|NCT01265576|Analgesics|analgesics|mesh-ancestor
6619003|NCT01265576|Sensory System Agents|sensory system agents|mesh-ancestor
6619004|NCT01265576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6619005|NCT01265576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6619006|NCT01265576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6619007|NCT01265576|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6619008|NCT01265576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6619009|NCT01265589|Vitamin A|vitamin a|mesh-list
6619010|NCT01265589|Pulmonary Surfactants|pulmonary surfactants|mesh-list
6619011|NCT01265589|Vitamins|vitamins|mesh-ancestor
6619012|NCT01265589|Micronutrients|micronutrients|mesh-ancestor
6619013|NCT01265589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619014|NCT01265589|Respiratory System Agents|respiratory system agents|mesh-ancestor
6619015|NCT01265641|Moxifloxacin|moxifloxacin|mesh-list
6619016|NCT01265641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6619017|NCT01265641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6619018|NCT01265641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6619019|NCT01265641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6619020|NCT01265641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6619021|NCT01265641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619022|NCT01265641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6619023|NCT01265680|Epoetin Alfa|epoetin alfa|mesh-list
6619024|NCT01265680|Hematinics|hematinics|mesh-ancestor
6619025|NCT01265810|Calcium|calcium|mesh-list
6619026|NCT01265810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6619027|NCT01265810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619028|NCT01265849|Indomethacin|indomethacin|mesh-list
6619029|NCT01265849|Cyclophosphamide|cyclophosphamide|mesh-list
6619030|NCT01265849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6619031|NCT01265849|Immunologic Factors|immunologic factors|mesh-ancestor
6619032|NCT01265849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619033|NCT01265849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6619034|NCT01265849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6619035|NCT01265849|Alkylating Agents|alkylating agents|mesh-ancestor
6619036|NCT01265849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619037|NCT01265849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6619038|NCT01265849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6619039|NCT01265849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6619040|NCT01265849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6619041|NCT01265849|Analgesics|analgesics|mesh-ancestor
6619042|NCT01265849|Sensory System Agents|sensory system agents|mesh-ancestor
6619043|NCT01265849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6619044|NCT01265849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6619045|NCT01265849|Gout Suppressants|gout suppressants|mesh-ancestor
6619046|NCT01265849|Tocolytic Agents|tocolytic agents|mesh-ancestor
6619047|NCT01265849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6619048|NCT01265849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6619049|NCT01265849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6619050|NCT01265888|Nitric Oxide|nitric oxide|mesh-list
6619051|NCT01265888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6619052|NCT01265888|Autonomic Agents|autonomic agents|mesh-ancestor
6619053|NCT01265888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6619054|NCT01265888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619055|NCT01265888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6619056|NCT01265888|Respiratory System Agents|respiratory system agents|mesh-ancestor
6619057|NCT01265888|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6619058|NCT01265888|Antioxidants|antioxidants|mesh-ancestor
6619059|NCT01265888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619060|NCT01265888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6619061|NCT01265888|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6619062|NCT01265888|Vasodilator Agents|vasodilator agents|mesh-ancestor
6619063|NCT01265888|Gasotransmitters|gasotransmitters|mesh-ancestor
6619064|NCT01265888|Protective Agents|protective agents|mesh-ancestor
6619065|NCT01265927|Trastuzumab|trastuzumab|mesh-list
6619066|NCT01265927|Imetelstat|imetelstat|mesh-list
6619067|NCT01265927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6619068|NCT01265927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6619069|NCT01265927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6619070|NCT01265927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619071|NCT01265940|Vinblastine|vinblastine|mesh-list
6619072|NCT01265940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6619073|NCT01265940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6619074|NCT01265940|Tubulin Modulators|tubulin modulators|mesh-ancestor
6619075|NCT01265940|Antimitotic Agents|antimitotic agents|mesh-ancestor
6619076|NCT01265940|Mitosis Modulators|mitosis modulators|mesh-ancestor
6619077|NCT01265940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619078|NCT01266005|Entecavir|entecavir|mesh-list
6619079|NCT01266005|Clevudine|clevudine|mesh-list
6619080|NCT01266005|Antiviral Agents|antiviral agents|mesh-ancestor
6619081|NCT01266005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6619082|NCT01266031|Bevacizumab|bevacizumab|mesh-list
6619083|NCT01266031|Vorinostat|vorinostat|mesh-list
6619084|NCT01266031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6619085|NCT01266031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6619086|NCT01266031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6619087|NCT01266031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6619088|NCT01266031|Growth Substances|growth substances|mesh-ancestor
6619089|NCT01266031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619090|NCT01266031|Growth Inhibitors|growth inhibitors|mesh-ancestor
6619091|NCT01266031|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6619092|NCT01266031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6619093|NCT01266031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619094|NCT01266057|Sirolimus|sirolimus|mesh-list
6619095|NCT01266057|Hydroxychloroquine|hydroxychloroquine|mesh-list
6619096|NCT01266057|Vorinostat|vorinostat|mesh-list
6619097|NCT01266057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6619098|NCT01266057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6619099|NCT01266057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6619100|NCT01266057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6619101|NCT01266057|Antifungal Agents|antifungal agents|mesh-ancestor
6619102|NCT01266057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6619103|NCT01266057|Immunologic Factors|immunologic factors|mesh-ancestor
6619104|NCT01266057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619105|NCT01266057|Antimalarials|antimalarials|mesh-ancestor
6619106|NCT01266057|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6619107|NCT01266057|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6619108|NCT01266057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6619109|NCT01266057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619110|NCT01266057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6619111|NCT01266057|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6619112|NCT01266174|Eltoprazine|eltoprazine|mesh-list
6619113|NCT01266174|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6619114|NCT01266174|Serotonin Agents|serotonin agents|mesh-ancestor
6619115|NCT01266174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6619116|NCT01266174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619117|NCT01266174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619118|NCT01266187|Leucovorin|leucovorin|mesh-list
6619119|NCT01266187|Cetuximab|cetuximab|mesh-list
6619120|NCT01266187|Fluorouracil|fluorouracil|mesh-list
6619121|NCT01266187|Oxaliplatin|oxaliplatin|mesh-list
6619122|NCT01266187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6619123|NCT01266187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6619124|NCT01266187|Antimetabolites|antimetabolites|mesh-ancestor
6619125|NCT01266187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619126|NCT01266187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6619127|NCT01266187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6619128|NCT01266187|Immunologic Factors|immunologic factors|mesh-ancestor
6619129|NCT01266187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619130|NCT01266187|Antidotes|antidotes|mesh-ancestor
6619131|NCT01266187|Protective Agents|protective agents|mesh-ancestor
6619132|NCT01266187|Vitamin B Complex|vitamin b complex|mesh-ancestor
6619133|NCT01266187|Vitamins|vitamins|mesh-ancestor
6619134|NCT01266187|Micronutrients|micronutrients|mesh-ancestor
6619135|NCT01266213|Fulvestrant|fulvestrant|mesh-list
6619136|NCT01266213|Anastrozole|anastrozole|mesh-list
6619137|NCT01266213|Goserelin|goserelin|mesh-list
6619138|NCT01266213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6619139|NCT01266213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6619140|NCT01266213|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6619141|NCT01266213|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6619142|NCT01266213|Hormone Antagonists|hormone antagonists|mesh-ancestor
6619143|NCT01266213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6619144|NCT01266213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619145|NCT01266213|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6619146|NCT01266213|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6619147|NCT01266213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6619148|NCT01266213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619149|NCT01266252|Dexmedetomidine|dexmedetomidine|mesh-list
6619150|NCT01266252|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6619151|NCT01266252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6619152|NCT01266252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619153|NCT01266252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6619154|NCT01266252|Analgesics|analgesics|mesh-ancestor
6619155|NCT01266252|Sensory System Agents|sensory system agents|mesh-ancestor
6619156|NCT01266252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6619157|NCT01266252|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6619158|NCT01266252|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6619159|NCT01266252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6619160|NCT01266252|Adrenergic Agents|adrenergic agents|mesh-ancestor
6619161|NCT01266252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6619162|NCT01266252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619163|NCT01266434|Simvastatin|simvastatin|mesh-list
6619164|NCT01266434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6619165|NCT01266434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6619166|NCT01266434|Antimetabolites|antimetabolites|mesh-ancestor
6619167|NCT01266434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619168|NCT01266434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6619169|NCT01266434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6619170|NCT01266434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6619171|NCT01266486|Metformin|metformin|mesh-list
6619172|NCT01266486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6619173|NCT01266486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619174|NCT01266499|Colistin|colistin|mesh-list
6619175|NCT01266499|Polymyxins|polymyxins|mesh-list
6619176|NCT01266499|Gentamicins|gentamicins|mesh-list
6619177|NCT01266499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6619178|NCT01266499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6619179|NCT01266499|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6619180|NCT01266499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6619181|NCT01266499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619182|NCT01266512|Docetaxel|docetaxel|mesh-list
6619183|NCT01266512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6619184|NCT01266512|Tubulin Modulators|tubulin modulators|mesh-ancestor
6619185|NCT01266512|Antimitotic Agents|antimitotic agents|mesh-ancestor
6619186|NCT01266512|Mitosis Modulators|mitosis modulators|mesh-ancestor
6619187|NCT01266512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619188|NCT01266655|Baclofen|baclofen|mesh-list
6619189|NCT01266655|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6619190|NCT01266655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619191|NCT01266655|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6619192|NCT01266655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6619193|NCT01266655|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6619194|NCT01266655|GABA Agonists|gaba agonists|mesh-ancestor
6619195|NCT01266655|GABA Agents|gaba agents|mesh-ancestor
6619196|NCT01266655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6619197|NCT01266655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619198|NCT01266681|Amiodarone|amiodarone|mesh-list
6619199|NCT01266681|Dronedarone|dronedarone|mesh-list
6619200|NCT01266681|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6619201|NCT01266681|Vasodilator Agents|vasodilator agents|mesh-ancestor
6619202|NCT01266681|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6619203|NCT01266681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6619204|NCT01266681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619205|NCT01266681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6619206|NCT01266681|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6619207|NCT01266681|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6619208|NCT01266681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6619209|NCT01266681|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6619210|NCT01266681|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6619211|NCT01266681|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6450515|NCT00408278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450516|NCT00408330|Azelaic acid|azelaic acid|mesh-list
6450517|NCT00408330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6450518|NCT00408330|Dermatologic Agents|dermatologic agents|mesh-ancestor
6450519|NCT00408369|Pafuramidine|pafuramidine|mesh-list
6450520|NCT00408369|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6450521|NCT00408369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6619212|NCT01266694|Colchicine|colchicine|mesh-list
6619213|NCT01266694|Gout Suppressants|gout suppressants|mesh-ancestor
6619214|NCT01266694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6450522|NCT00408369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6450523|NCT00408369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6450524|NCT00408382|Atorvastatin|atorvastatin|mesh-list
6450525|NCT00408382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6450526|NCT00408382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6450527|NCT00408382|Antimetabolites|antimetabolites|mesh-ancestor
6450528|NCT00408382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450529|NCT00408382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6450530|NCT00408382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6619215|NCT01266694|Tubulin Modulators|tubulin modulators|mesh-ancestor
6619216|NCT01266694|Antimitotic Agents|antimitotic agents|mesh-ancestor
6619217|NCT01266694|Mitosis Modulators|mitosis modulators|mesh-ancestor
6619218|NCT01266694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619219|NCT01266694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6619220|NCT01266707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
6619221|NCT01266707|Vaccines|vaccines|mesh-list
6619222|NCT01266707|Immunologic Factors|immunologic factors|mesh-ancestor
6619223|NCT01266707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619224|NCT01266707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6619225|NCT01266707|Growth Substances|growth substances|mesh-ancestor
6619226|NCT01266707|Growth Inhibitors|growth inhibitors|mesh-ancestor
6619227|NCT01266707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6619228|NCT01266720|Gemcitabine|gemcitabine|mesh-list
6619229|NCT01266720|Immunologic Factors|immunologic factors|mesh-ancestor
6619230|NCT01266720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619231|NCT01266720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6619232|NCT01266720|Antimetabolites|antimetabolites|mesh-ancestor
6619233|NCT01266720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619234|NCT01266720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6619235|NCT01266720|Antiviral Agents|antiviral agents|mesh-ancestor
6619236|NCT01266720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6619237|NCT01266720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6619238|NCT01266720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6619239|NCT01266759|NuvaRing|nuvaring|mesh-list
6619240|NCT01266759|Norethindrone|norethindrone|mesh-list
6619241|NCT01266759|Norethindrone Acetate|norethindrone acetate|mesh-list
6619242|NCT01266759|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6619243|NCT01266759|Contraceptive Agents|contraceptive agents|mesh-ancestor
6619244|NCT01266759|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6619245|NCT01266759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619246|NCT01266759|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6619247|NCT01266759|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6619248|NCT01266759|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6619249|NCT01266759|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6619250|NCT01266772|Budesonide|budesonide|mesh-list
6619251|NCT01266772|Montelukast|montelukast|mesh-list
6619252|NCT01266772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6619253|NCT01266772|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6619254|NCT01266772|Autonomic Agents|autonomic agents|mesh-ancestor
6619255|NCT01266772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6619256|NCT01266772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619257|NCT01266772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6020850|NCT00394953|Darbepoetin alfa|darbepoetin alfa|mesh-list
6619258|NCT01266772|Respiratory System Agents|respiratory system agents|mesh-ancestor
6619259|NCT01266772|Glucocorticoids|glucocorticoids|mesh-ancestor
6619260|NCT01266772|Hormones|hormones|mesh-ancestor
6619261|NCT01266772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6619262|NCT01266772|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6619263|NCT01266772|Hormone Antagonists|hormone antagonists|mesh-ancestor
6619264|NCT01266772|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6619265|NCT01266772|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6619266|NCT01266772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619267|NCT01266785|Infliximab|infliximab|mesh-list
6619268|NCT01266785|Dermatologic Agents|dermatologic agents|mesh-ancestor
6619269|NCT01266785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6619270|NCT01266785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6619271|NCT01266811|Dexamethasone|dexamethasone|mesh-list
6619272|NCT01266811|Dexamethasone acetate|dexamethasone acetate|mesh-list
6619273|NCT01266811|Bortezomib|bortezomib|mesh-list
6619274|NCT01266811|Siltuximab|siltuximab|mesh-list
6619275|NCT01266811|BB 1101|bb 1101|mesh-list
6619276|NCT01266811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6619277|NCT01266811|Antiemetics|antiemetics|mesh-ancestor
6619278|NCT01266811|Autonomic Agents|autonomic agents|mesh-ancestor
6619279|NCT01266811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6619280|NCT01266811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619281|NCT01266811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6619282|NCT01266811|Glucocorticoids|glucocorticoids|mesh-ancestor
6619283|NCT01266811|Hormones|hormones|mesh-ancestor
6619284|NCT01266811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6619285|NCT01266811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6619286|NCT01266811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6619287|NCT01266811|Protease Inhibitors|protease inhibitors|mesh-ancestor
6619288|NCT01266811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6619289|NCT01266811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619290|NCT01266837|Everolimus|everolimus|mesh-list
6619291|NCT01266837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6619292|NCT01266837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6619293|NCT01266837|Immunologic Factors|immunologic factors|mesh-ancestor
6619294|NCT01266837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619295|NCT01266928|Ascorbic Acid|ascorbic acid|mesh-list
6619296|NCT01266928|Vitamins|vitamins|mesh-ancestor
6619297|NCT01266928|Micronutrients|micronutrients|mesh-ancestor
6619298|NCT01266928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619299|NCT01266928|Antioxidants|antioxidants|mesh-ancestor
6619300|NCT01266928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619301|NCT01266928|Protective Agents|protective agents|mesh-ancestor
6619302|NCT01267058|Vaccines|vaccines|mesh-list
6619303|NCT01267058|Immunologic Factors|immunologic factors|mesh-ancestor
6020851|NCT00394953|Hematinics|hematinics|mesh-ancestor
6619304|NCT01267058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619305|NCT01267084|Ketoconazole|ketoconazole|mesh-list
6619306|NCT01267084|Dexamethasone|dexamethasone|mesh-list
6619307|NCT01267084|Trabectedin|trabectedin|mesh-list
6619308|NCT01267084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6619309|NCT01267084|Antiemetics|antiemetics|mesh-ancestor
6619310|NCT01267084|Autonomic Agents|autonomic agents|mesh-ancestor
6619311|NCT01267084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6619312|NCT01267084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619313|NCT01267084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6619314|NCT01267084|Glucocorticoids|glucocorticoids|mesh-ancestor
6619315|NCT01267084|Hormones|hormones|mesh-ancestor
6619316|NCT01267084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6619317|NCT01267084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6619318|NCT01267084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6619319|NCT01267084|Antifungal Agents|antifungal agents|mesh-ancestor
6619320|NCT01267084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6619321|NCT01267084|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6619322|NCT01267084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6450531|NCT00408382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6450532|NCT00408447|Fludarabine|fludarabine|mesh-list
6450533|NCT00408447|Busulfan|busulfan|mesh-list
6450534|NCT00408447|Alemtuzumab|alemtuzumab|mesh-list
6450535|NCT00408447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6450536|NCT00408447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450537|NCT00408447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6619323|NCT01267084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6619324|NCT01267084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619325|NCT01267084|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6619326|NCT01267084|Hormone Antagonists|hormone antagonists|mesh-ancestor
6619327|NCT01267084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6619328|NCT01267084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6619329|NCT01267084|Alkylating Agents|alkylating agents|mesh-ancestor
6619330|NCT01267214|Hyaluronic Acid|hyaluronic acid|mesh-list
6619331|NCT01267214|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6619332|NCT01267214|Immunologic Factors|immunologic factors|mesh-ancestor
6619333|NCT01267214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619334|NCT01267214|Viscosupplements|viscosupplements|mesh-ancestor
6619335|NCT01267214|Protective Agents|protective agents|mesh-ancestor
6619336|NCT01267305|Calcium, Dietary|calcium, dietary|mesh-list
6619337|NCT01267305|PENTA|penta|mesh-list
6619338|NCT01267305|Nadroparin|nadroparin|mesh-list
6619339|NCT01267305|Fondaparinux|fondaparinux|mesh-list
6619340|NCT01267305|Calcium|calcium|mesh-list
6619341|NCT01267305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6450538|NCT00408447|Immunologic Factors|immunologic factors|mesh-ancestor
6450539|NCT00408447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450540|NCT00408447|Alkylating Agents|alkylating agents|mesh-ancestor
6619342|NCT01267305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619343|NCT01267305|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6619344|NCT01267305|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6619345|NCT01267305|Antithrombins|antithrombins|mesh-ancestor
6619346|NCT01267305|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6619347|NCT01267305|Protease Inhibitors|protease inhibitors|mesh-ancestor
6619348|NCT01267305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6619349|NCT01267305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619350|NCT01267305|Anticoagulants|anticoagulants|mesh-ancestor
6619351|NCT01267305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6619352|NCT01267305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6619353|NCT01267344|Gemcitabine|gemcitabine|mesh-list
6619354|NCT01267344|Oxaliplatin|oxaliplatin|mesh-list
6619355|NCT01267344|Cetuximab|cetuximab|mesh-list
6619356|NCT01267344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6619357|NCT01267344|Antimetabolites|antimetabolites|mesh-ancestor
6619358|NCT01267344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450541|NCT00408447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6450542|NCT00408447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6461859|NCT00456560|Paroxetine|paroxetine|mesh-list
6619359|NCT01267344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6450543|NCT00408447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6450544|NCT00408525|Donepezil|donepezil|mesh-list
6450545|NCT00408525|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6619360|NCT01267344|Antiviral Agents|antiviral agents|mesh-ancestor
6619361|NCT01267344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6619362|NCT01267344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6450546|NCT00408525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6619363|NCT01267344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6619364|NCT01267344|Immunologic Factors|immunologic factors|mesh-ancestor
6619365|NCT01267344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450547|NCT00408525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450548|NCT00408525|Cholinergic Agents|cholinergic agents|mesh-ancestor
6450549|NCT00408525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6450550|NCT00408525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450551|NCT00408525|Nootropic Agents|nootropic agents|mesh-ancestor
6450552|NCT00408538|UC-781|uc-781|mesh-list
6450553|NCT00408538|Anti-Infective Agents|anti-infective agents|mesh-list
6450554|NCT00408538|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6450555|NCT00408538|Antiviral Agents|antiviral agents|mesh-ancestor
6450556|NCT00408551|Leucovorin|leucovorin|mesh-list
6450557|NCT00408551|Fluorouracil|fluorouracil|mesh-list
6450558|NCT00408551|Floxuridine|floxuridine|mesh-list
6450559|NCT00408551|Oxaliplatin|oxaliplatin|mesh-list
6450560|NCT00408551|Irinotecan|irinotecan|mesh-list
6450561|NCT00408551|Calcium|calcium|mesh-list
6450562|NCT00408551|Levoleucovorin|levoleucovorin|mesh-list
6450563|NCT00408551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6450564|NCT00408551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450565|NCT00408551|Antimetabolites|antimetabolites|mesh-ancestor
6450566|NCT00408551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450567|NCT00408551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6450568|NCT00408551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6450569|NCT00408551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6450570|NCT00408551|Immunologic Factors|immunologic factors|mesh-ancestor
6450571|NCT00408551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6450572|NCT00408551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6450573|NCT00408551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6450574|NCT00408551|Antidotes|antidotes|mesh-ancestor
6450575|NCT00408551|Protective Agents|protective agents|mesh-ancestor
6619366|NCT01267344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6619367|NCT01267383|Sertraline|sertraline|mesh-list
6619368|NCT01267383|Antidepressive Agents|antidepressive agents|mesh-ancestor
6619369|NCT01267383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6619370|NCT01267383|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6619371|NCT01267383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6619372|NCT01267383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6619373|NCT01267383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619374|NCT01267383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6619375|NCT01267383|Serotonin Agents|serotonin agents|mesh-ancestor
6619376|NCT01267383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619377|NCT01267396|Sertraline|sertraline|mesh-list
6619378|NCT01267396|Antidepressive Agents|antidepressive agents|mesh-ancestor
6619379|NCT01267396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6619380|NCT01267396|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6619381|NCT01267396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6619382|NCT01267396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6619383|NCT01267396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619384|NCT01267396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6619385|NCT01267396|Serotonin Agents|serotonin agents|mesh-ancestor
6619386|NCT01267396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619387|NCT01267448|Metformin|metformin|mesh-list
6619388|NCT01267448|Saxagliptin|saxagliptin|mesh-list
6450576|NCT00408551|Vitamin B Complex|vitamin b complex|mesh-ancestor
6450577|NCT00408551|Vitamins|vitamins|mesh-ancestor
6450578|NCT00408551|Micronutrients|micronutrients|mesh-ancestor
6450579|NCT00408655|Sirolimus|sirolimus|mesh-list
6619389|NCT01267448|Glipizide|glipizide|mesh-list
6619390|NCT01267448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6619391|NCT01267448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619392|NCT01267448|Incretins|incretins|mesh-ancestor
6619393|NCT01267448|Hormones|hormones|mesh-ancestor
6619394|NCT01267448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6619395|NCT01267448|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6619396|NCT01267448|Protease Inhibitors|protease inhibitors|mesh-ancestor
6619397|NCT01267448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6450580|NCT00408655|Paclitaxel|paclitaxel|mesh-list
6450581|NCT00408655|Carboplatin|carboplatin|mesh-list
6450582|NCT00408655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6450583|NCT00408655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6450584|NCT00408655|Tubulin Modulators|tubulin modulators|mesh-ancestor
6450585|NCT00408655|Antimitotic Agents|antimitotic agents|mesh-ancestor
6450586|NCT00408655|Mitosis Modulators|mitosis modulators|mesh-ancestor
6450587|NCT00408655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450588|NCT00408655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6450589|NCT00408655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6619398|NCT01267448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619399|NCT01267487|Heparin|heparin|mesh-list
6619400|NCT01267487|Calcium heparin|calcium heparin|mesh-list
6619401|NCT01267487|Protamines|protamines|mesh-list
6619402|NCT01267487|Anticoagulants|anticoagulants|mesh-ancestor
6619403|NCT01267487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6619404|NCT01267487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6619405|NCT01267487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619406|NCT01267487|Heparin Antagonists|heparin antagonists|mesh-ancestor
6619407|NCT01267487|Coagulants|coagulants|mesh-ancestor
6619408|NCT01267578|Vaccines|vaccines|mesh-list
6619409|NCT01267578|Immunologic Factors|immunologic factors|mesh-ancestor
6619410|NCT01267578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619411|NCT01267604|Inositol|inositol|mesh-list
6619412|NCT01267604|Melatonin|melatonin|mesh-list
6619413|NCT01267604|Antioxidants|antioxidants|mesh-ancestor
6619414|NCT01267604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619415|NCT01267604|Protective Agents|protective agents|mesh-ancestor
6619416|NCT01267604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619417|NCT01267604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6619418|NCT01267604|Vitamin B Complex|vitamin b complex|mesh-ancestor
6619419|NCT01267604|Vitamins|vitamins|mesh-ancestor
6619420|NCT01267604|Micronutrients|micronutrients|mesh-ancestor
6619421|NCT01267643|Alefacept|alefacept|mesh-list
6619422|NCT01267643|Dermatologic Agents|dermatologic agents|mesh-ancestor
6619423|NCT01267643|Immunologic Factors|immunologic factors|mesh-ancestor
6619424|NCT01267643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619425|NCT01267669|Somatostatin|somatostatin|mesh-list
6619426|NCT01267669|Hormones|hormones|mesh-ancestor
6619427|NCT01267669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6619428|NCT01267669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619429|NCT01267695|Imatinib Mesylate|imatinib mesylate|mesh-list
6619430|NCT01267695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6619431|NCT01267695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6619432|NCT01267695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6619433|NCT01267695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450590|NCT00408655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6619434|NCT01267734|Everolimus|everolimus|mesh-list
6619435|NCT01267734|Clopidogrel|clopidogrel|mesh-list
6619436|NCT01267734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6619437|NCT01267734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6619438|NCT01267734|Immunologic Factors|immunologic factors|mesh-ancestor
6619439|NCT01267734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619440|NCT01267734|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6619441|NCT01267734|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6619442|NCT01267734|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6619443|NCT01267734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6619444|NCT01267734|Purinergic Agents|purinergic agents|mesh-ancestor
6619445|NCT01267734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6619446|NCT01267734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619447|NCT01267760|Dialysis Solutions|dialysis solutions|mesh-list
6619448|NCT01267760|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6619449|NCT01267903|Vaccines|vaccines|mesh-list
6619450|NCT01267903|Immunologic Factors|immunologic factors|mesh-ancestor
6619451|NCT01267903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619452|NCT01267942|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6619453|NCT01267942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6619454|NCT01267942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6619455|NCT01267942|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6619456|NCT01267942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6619457|NCT01267942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661668|NCT01500473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6661669|NCT01500538|Vorinostat|vorinostat|mesh-list
6661670|NCT01500538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6661671|NCT01500538|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6661672|NCT01500538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6661673|NCT01500538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661674|NCT01500577|Nimesulide|nimesulide|mesh-list
6020852|NCT00395018|Entecavir|entecavir|mesh-list
6020853|NCT00395018|Antiviral Agents|antiviral agents|mesh-ancestor
6020854|NCT00395018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6020855|NCT00395044|Gabapentin|gabapentin|mesh-list
6020856|NCT00395044|Analgesics|analgesics|mesh-ancestor
5502150|NCT04468165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5502151|NCT04468165|Immunologic Factors|immunologic factors|mesh-ancestor
5502152|NCT04468165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502153|NCT04468438|Estrogens|estrogens|mesh-list
5502154|NCT04468438|Hormones|hormones|mesh-ancestor
5502155|NCT04468438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5502156|NCT04468438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502157|NCT04468282|Vigabatrin|vigabatrin|mesh-list
5502158|NCT04468282|Anticonvulsants|anticonvulsants|mesh-ancestor
5502159|NCT04468282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5502160|NCT04468282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502161|NCT04468282|GABA Agents|gaba agents|mesh-ancestor
5502162|NCT04468282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5502163|NCT04468282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502164|NCT04467957|Xenon|xenon|mesh-list
5502165|NCT04467957|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6020857|NCT00395044|Sensory System Agents|sensory system agents|mesh-ancestor
6619458|NCT01268033|Rituximab|rituximab|mesh-list
6619459|NCT01268033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6619460|NCT01268033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6619461|NCT01268033|Immunologic Factors|immunologic factors|mesh-ancestor
6619462|NCT01268033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619463|NCT01268033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6619464|NCT01268163|Docetaxel|docetaxel|mesh-list
6619465|NCT01268163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6619466|NCT01268163|Tubulin Modulators|tubulin modulators|mesh-ancestor
6619467|NCT01268163|Antimitotic Agents|antimitotic agents|mesh-ancestor
6619468|NCT01268163|Mitosis Modulators|mitosis modulators|mesh-ancestor
6619469|NCT01268163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619470|NCT01268176|Vitamin D|vitamin d|mesh-list
6619471|NCT01268176|Cholecalciferol|cholecalciferol|mesh-list
6619472|NCT01268176|Vitamins|vitamins|mesh-ancestor
6619473|NCT01268176|Micronutrients|micronutrients|mesh-ancestor
6619474|NCT01268176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619475|NCT01268176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6619476|NCT01268176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6619477|NCT01268202|Pravastatin|pravastatin|mesh-list
6619478|NCT01268202|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6619479|NCT01268202|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6619480|NCT01268202|Antimetabolites|antimetabolites|mesh-ancestor
6619481|NCT01268202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619482|NCT01268202|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6619483|NCT01268202|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6619484|NCT01268202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6619485|NCT01268215|Budesonide|budesonide|mesh-list
6619486|NCT01268215|Calfactant|calfactant|mesh-list
6619487|NCT01268215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6619488|NCT01268215|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6619489|NCT01268215|Autonomic Agents|autonomic agents|mesh-ancestor
6619490|NCT01268215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6619491|NCT01268215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619492|NCT01268215|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6619493|NCT01268215|Respiratory System Agents|respiratory system agents|mesh-ancestor
6619494|NCT01268215|Glucocorticoids|glucocorticoids|mesh-ancestor
6619495|NCT01268215|Hormones|hormones|mesh-ancestor
6619496|NCT01268215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6619497|NCT01268215|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
6619498|NCT01268371|Everolimus|everolimus|mesh-list
6619499|NCT01268371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6619500|NCT01268371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6619501|NCT01268371|Immunologic Factors|immunologic factors|mesh-ancestor
6619502|NCT01268371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619503|NCT01268384|Gemcitabine|gemcitabine|mesh-list
6619504|NCT01268384|Capecitabine|capecitabine|mesh-list
6619505|NCT01268384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6619506|NCT01268384|Antimetabolites|antimetabolites|mesh-ancestor
6619507|NCT01268384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619508|NCT01268384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6619509|NCT01268384|Antiviral Agents|antiviral agents|mesh-ancestor
6619510|NCT01268384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6619511|NCT01268384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6619512|NCT01268384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6619513|NCT01268384|Immunologic Factors|immunologic factors|mesh-ancestor
6619514|NCT01268384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619515|NCT01268579|Ribavirin|ribavirin|mesh-list
6619516|NCT01268579|Antimetabolites|antimetabolites|mesh-ancestor
6619517|NCT01268579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619518|NCT01268579|Antiviral Agents|antiviral agents|mesh-ancestor
6619519|NCT01268579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6619520|NCT01268631|Pregabalin|pregabalin|mesh-list
6619521|NCT01268631|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6619522|NCT01268631|Analgesics|analgesics|mesh-ancestor
6619523|NCT01268631|Sensory System Agents|sensory system agents|mesh-ancestor
6619524|NCT01268631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6619525|NCT01268631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619526|NCT01268631|Anticonvulsants|anticonvulsants|mesh-ancestor
6619527|NCT01268631|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6619528|NCT01268631|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6619529|NCT01268631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619530|NCT01268631|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6619531|NCT01268631|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6619532|NCT01268631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6619533|NCT01268631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6619534|NCT01268631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6450591|NCT00408655|Antifungal Agents|antifungal agents|mesh-ancestor
6450592|NCT00408655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6619535|NCT01268631|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6619536|NCT01268631|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6619537|NCT01268631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6619538|NCT01268631|Antidepressive Agents|antidepressive agents|mesh-ancestor
6619539|NCT01268631|Dopamine Agents|dopamine agents|mesh-ancestor
6619540|NCT01268670|Ibuprofen|ibuprofen|mesh-list
6619541|NCT01268670|Oxycodone|oxycodone|mesh-list
6619542|NCT01268670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6619543|NCT01268670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6619544|NCT01268670|Analgesics|analgesics|mesh-ancestor
6619545|NCT01268670|Sensory System Agents|sensory system agents|mesh-ancestor
6619546|NCT01268670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6619547|NCT01268670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450593|NCT00408655|Immunologic Factors|immunologic factors|mesh-ancestor
6450594|NCT00408655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450595|NCT00408772|Bevacizumab|bevacizumab|mesh-list
6450596|NCT00408772|Capecitabine|capecitabine|mesh-list
6450597|NCT00408772|Oxaliplatin|oxaliplatin|mesh-list
6450598|NCT00408772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6450599|NCT00408772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6450600|NCT00408772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6619548|NCT01268670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6619549|NCT01268670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6619550|NCT01268670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6619551|NCT01268670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6619552|NCT01268670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619553|NCT01268670|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6619554|NCT01268670|Narcotics|narcotics|mesh-ancestor
6619555|NCT01268670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6619556|NCT01268709|Doxepin|doxepin|mesh-list
6619557|NCT01268709|Nortriptyline|nortriptyline|mesh-list
6619558|NCT01268709|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6619559|NCT01268709|Antidepressive Agents|antidepressive agents|mesh-ancestor
6619560|NCT01268709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6619561|NCT01268709|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6619562|NCT01268709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6619563|NCT01268709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6619564|NCT01268709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619565|NCT01268709|Adrenergic Agents|adrenergic agents|mesh-ancestor
6619566|NCT01268709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6619567|NCT01268709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619568|NCT01268709|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6619569|NCT01268709|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6619570|NCT01268709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6619571|NCT01268709|Histamine Antagonists|histamine antagonists|mesh-ancestor
6619572|NCT01268709|Histamine Agents|histamine agents|mesh-ancestor
6619573|NCT01268735|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6619574|NCT01268735|Lubricant Eye Drops|lubricant eye drops|mesh-list
6619575|NCT01268735|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6619576|NCT01268761|Cetrorelix|cetrorelix|mesh-list
6619577|NCT01268761|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6619578|NCT01268761|Fertility Agents|fertility agents|mesh-ancestor
6619579|NCT01268761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6619580|NCT01268761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619581|NCT01268761|Hormone Antagonists|hormone antagonists|mesh-ancestor
6619582|NCT01268761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6619583|NCT01268839|Efavirenz|efavirenz|mesh-list
6619584|NCT01268839|Rilpivirine|rilpivirine|mesh-list
6619585|NCT01268839|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6619586|NCT01268839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6619587|NCT01268839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6619588|NCT01268839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619589|NCT01268839|Antiviral Agents|antiviral agents|mesh-ancestor
6619590|NCT01268839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6619591|NCT01268839|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6619592|NCT01268839|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6619593|NCT01268839|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6619594|NCT01268839|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6619595|NCT01268839|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6619596|NCT01268839|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6619597|NCT01268839|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6619598|NCT01268839|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6619599|NCT01268904|Valproic Acid|valproic acid|mesh-list
6619600|NCT01268904|Anticonvulsants|anticonvulsants|mesh-ancestor
6619601|NCT01268904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6619602|NCT01268904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619603|NCT01268904|GABA Agents|gaba agents|mesh-ancestor
6619604|NCT01268904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6619605|NCT01268904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619606|NCT01268904|Antimanic Agents|antimanic agents|mesh-ancestor
6619607|NCT01268904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6619608|NCT01268904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6619609|NCT01268904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6619610|NCT01268917|Aspirin|aspirin|mesh-list
6619611|NCT01268917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6619612|NCT01268917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6619613|NCT01268917|Analgesics|analgesics|mesh-ancestor
6619614|NCT01268917|Sensory System Agents|sensory system agents|mesh-ancestor
6619615|NCT01268917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6619616|NCT01268917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619617|NCT01268917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6619618|NCT01268917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6619619|NCT01268917|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6619620|NCT01268917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6619621|NCT01268917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619622|NCT01268917|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6619623|NCT01268917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6619624|NCT01268917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6619625|NCT01268917|Antipyretics|antipyretics|mesh-ancestor
6619626|NCT01268930|Hemostatics|hemostatics|mesh-list
6619627|NCT01268930|Coagulants|coagulants|mesh-ancestor
6619628|NCT01268995|Cyclosporine|cyclosporine|mesh-list
6619629|NCT01268995|Tacrolimus|tacrolimus|mesh-list
6619630|NCT01268995|Cyclosporins|cyclosporins|mesh-list
6619631|NCT01268995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6619632|NCT01268995|Immunologic Factors|immunologic factors|mesh-ancestor
6619633|NCT01268995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619634|NCT01268995|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6619635|NCT01268995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6619636|NCT01268995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619637|NCT01268995|Antifungal Agents|antifungal agents|mesh-ancestor
6619638|NCT01268995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6619639|NCT01268995|Dermatologic Agents|dermatologic agents|mesh-ancestor
6619640|NCT01268995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6619641|NCT01269021|Mycophenolic Acid|mycophenolic acid|mesh-list
6619642|NCT01269021|Prednisone|prednisone|mesh-list
6619643|NCT01269021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6619644|NCT01269021|Glucocorticoids|glucocorticoids|mesh-ancestor
6619645|NCT01269021|Hormones|hormones|mesh-ancestor
6619646|NCT01269021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6619647|NCT01269021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619648|NCT01269021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6619649|NCT01269021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6619650|NCT01269021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6619651|NCT01269021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6619652|NCT01269021|Antitubercular Agents|antitubercular agents|mesh-ancestor
6619653|NCT01269021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6619654|NCT01269021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6619655|NCT01269021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6619656|NCT01269021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619657|NCT01269099|Fentanyl|fentanyl|mesh-list
6619658|NCT01269099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6619659|NCT01269099|Narcotics|narcotics|mesh-ancestor
6619660|NCT01269099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6619661|NCT01269099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619662|NCT01269099|Analgesics|analgesics|mesh-ancestor
6619663|NCT01269099|Sensory System Agents|sensory system agents|mesh-ancestor
6619664|NCT01269099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6450601|NCT00408772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6450602|NCT00408772|Growth Substances|growth substances|mesh-ancestor
6450603|NCT00408772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450604|NCT00408772|Growth Inhibitors|growth inhibitors|mesh-ancestor
6450605|NCT00408772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6450606|NCT00408772|Antimetabolites|antimetabolites|mesh-ancestor
6619665|NCT01269099|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6619666|NCT01269099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6619667|NCT01269099|Anesthetics, General|anesthetics, general|mesh-ancestor
6619668|NCT01269099|Anesthetics|anesthetics|mesh-ancestor
6619669|NCT01269112|Citric Acid|citric acid|mesh-list
6619670|NCT01269112|Sodium Citrate|sodium citrate|mesh-list
6619671|NCT01269112|Anticoagulants|anticoagulants|mesh-ancestor
6619672|NCT01269112|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6619673|NCT01269112|Chelating Agents|chelating agents|mesh-ancestor
6619674|NCT01269112|Sequestering Agents|sequestering agents|mesh-ancestor
6619675|NCT01269112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619676|NCT01269138|Thrombin|thrombin|mesh-list
6619677|NCT01269138|Hemostatics|hemostatics|mesh-ancestor
6619678|NCT01269138|Coagulants|coagulants|mesh-ancestor
6619679|NCT01269151|Ranibizumab|ranibizumab|mesh-list
6619680|NCT01269151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6619681|NCT01269151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6619682|NCT01269151|Growth Substances|growth substances|mesh-ancestor
6619683|NCT01269151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619684|NCT01269151|Growth Inhibitors|growth inhibitors|mesh-ancestor
6619685|NCT01269151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6619686|NCT01269203|Curcumin|curcumin|mesh-list
6619687|NCT01269203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6619688|NCT01269203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6619689|NCT01269203|Analgesics|analgesics|mesh-ancestor
6619690|NCT01269203|Sensory System Agents|sensory system agents|mesh-ancestor
6619691|NCT01269203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6619692|NCT01269203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619693|NCT01269203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6619694|NCT01269203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6619695|NCT01269203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6619696|NCT01269203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6450607|NCT00408772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450608|NCT00408785|Botulinum Toxins|botulinum toxins|mesh-list
6450609|NCT00408785|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6450610|NCT00408785|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6450611|NCT00408785|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6450612|NCT00408785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6450613|NCT00408785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450614|NCT00408785|Cholinergic Agents|cholinergic agents|mesh-ancestor
6450615|NCT00408785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6450616|NCT00408785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450617|NCT00408785|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6450618|NCT00408785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6450619|NCT00408798|Botulinum Toxins|botulinum toxins|mesh-list
6450620|NCT00408798|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6450621|NCT00408798|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6450622|NCT00408798|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6450623|NCT00408798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6450624|NCT00408798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450625|NCT00408798|Cholinergic Agents|cholinergic agents|mesh-ancestor
6450626|NCT00408798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6450627|NCT00408798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450628|NCT00408798|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6450629|NCT00408798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6450630|NCT00408850|Pioglitazone|pioglitazone|mesh-list
6450631|NCT00408850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6619697|NCT01269203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619698|NCT01269216|Leucovorin|leucovorin|mesh-list
6619699|NCT01269216|Irinotecan|irinotecan|mesh-list
6619700|NCT01269216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6619701|NCT01269216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6619702|NCT01269216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6619703|NCT01269216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619704|NCT01269216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6619705|NCT01269216|Antidotes|antidotes|mesh-ancestor
6619706|NCT01269216|Protective Agents|protective agents|mesh-ancestor
6619707|NCT01269216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619708|NCT01269216|Vitamin B Complex|vitamin b complex|mesh-ancestor
6619709|NCT01269216|Vitamins|vitamins|mesh-ancestor
6619710|NCT01269216|Micronutrients|micronutrients|mesh-ancestor
6619711|NCT01269242|Bindarit|bindarit|mesh-list
6619712|NCT01269242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6619713|NCT01269242|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6619714|NCT01269242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6619715|NCT01269242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619716|NCT01269255|Cisplatin|cisplatin|mesh-list
6619717|NCT01269255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6619718|NCT01269281|Sumatriptan|sumatriptan|mesh-list
6619719|NCT01269281|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6619720|NCT01269281|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6619721|NCT01269281|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6619722|NCT01269281|Serotonin Agents|serotonin agents|mesh-ancestor
6619723|NCT01269281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6619724|NCT01269281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619725|NCT01269281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619726|NCT01269294|Moxifloxacin|moxifloxacin|mesh-list
6619727|NCT01269294|Simeprevir|simeprevir|mesh-list
6619728|NCT01269294|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6619729|NCT01269294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6619730|NCT01269294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6619731|NCT01269294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6619732|NCT01269294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6619733|NCT01269294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6619734|NCT01269294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619735|NCT01269294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6619736|NCT01269294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6619737|NCT01269294|Contraceptive Agents|contraceptive agents|mesh-ancestor
6619738|NCT01269294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6619739|NCT01269294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619740|NCT01269294|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6619741|NCT01269294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6619742|NCT01269294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6619743|NCT01269294|Antiviral Agents|antiviral agents|mesh-ancestor
6619744|NCT01269294|Protease Inhibitors|protease inhibitors|mesh-ancestor
6619745|NCT01269307|Ketamine|ketamine|mesh-list
6619746|NCT01269307|Propofol|propofol|mesh-list
6619747|NCT01269307|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6619748|NCT01269307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6619749|NCT01269307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619750|NCT01269307|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6619751|NCT01269307|Anesthetics, General|anesthetics, general|mesh-ancestor
6619752|NCT01269307|Anesthetics|anesthetics|mesh-ancestor
6619753|NCT01269307|Analgesics|analgesics|mesh-ancestor
6619754|NCT01269307|Sensory System Agents|sensory system agents|mesh-ancestor
6619755|NCT01269307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6619756|NCT01269307|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6619757|NCT01269307|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6619758|NCT01269307|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6619759|NCT01269307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6619760|NCT01269307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619761|NCT01269333|Fluvoxamine|fluvoxamine|mesh-list
6619762|NCT01269333|Omeprazole|omeprazole|mesh-list
6619763|NCT01269333|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6619764|NCT01269333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6020858|NCT00395044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6619765|NCT01269333|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6619766|NCT01269333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6619767|NCT01269333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619768|NCT01269333|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6619769|NCT01269333|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6619770|NCT01269333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6619771|NCT01269333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619772|NCT01269333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6619773|NCT01269333|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6619774|NCT01269333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6619775|NCT01269333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6619776|NCT01269333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6619777|NCT01269333|Serotonin Agents|serotonin agents|mesh-ancestor
6619778|NCT01269333|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6619779|NCT01269333|Antidepressive Agents|antidepressive agents|mesh-ancestor
6619780|NCT01269333|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6619781|NCT01269333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6619782|NCT01269333|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6619783|NCT01269411|R04929097|r04929097|mesh-list
6619784|NCT01269411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6619785|NCT01269411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619786|NCT01269437|Budesonide|budesonide|mesh-list
6619787|NCT01269437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6619788|NCT01269437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6619789|NCT01269437|Autonomic Agents|autonomic agents|mesh-ancestor
6619790|NCT01269437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6619791|NCT01269437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619792|NCT01269437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6619793|NCT01269437|Respiratory System Agents|respiratory system agents|mesh-ancestor
5502166|NCT04467957|Anesthetics, General|anesthetics, general|mesh-ancestor
6020859|NCT00395044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619794|NCT01269437|Glucocorticoids|glucocorticoids|mesh-ancestor
6619795|NCT01269437|Hormones|hormones|mesh-ancestor
6619796|NCT01269437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6619797|NCT01269450|Progesterone|progesterone|mesh-list
6619798|NCT01269450|Progestins|progestins|mesh-ancestor
6619799|NCT01269450|Hormones|hormones|mesh-ancestor
6619800|NCT01269450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6619801|NCT01269450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619802|NCT01269463|Methylphenidate|methylphenidate|mesh-list
6619803|NCT01269463|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6619804|NCT01269463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619805|NCT01269463|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6619806|NCT01269463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6619807|NCT01269463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6619808|NCT01269463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619809|NCT01269463|Dopamine Agents|dopamine agents|mesh-ancestor
6619810|NCT01269463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6619811|NCT01269476|Fluorides|fluorides|mesh-list
6619812|NCT01269476|Methanesulfonyl fluoride|methanesulfonyl fluoride|mesh-list
5502167|NCT04467957|Anesthetics|anesthetics|mesh-ancestor
5502168|NCT04467957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5502169|NCT04467957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502170|NCT04467918|Cannabidiol|cannabidiol|mesh-list
5502171|NCT04467918|Anticonvulsants|anticonvulsants|mesh-ancestor
5502172|NCT04467892|Methylprednisolone|methylprednisolone|mesh-list
5502173|NCT04467892|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5502174|NCT04467892|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5502175|NCT04467892|Prednisolone|prednisolone|mesh-list
5502176|NCT04467892|Prednisolone acetate|prednisolone acetate|mesh-list
5502177|NCT04467892|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5502178|NCT04467892|Prednisolone phosphate|prednisolone phosphate|mesh-list
5502179|NCT04467892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5502180|NCT04467892|Antiemetics|antiemetics|mesh-ancestor
5502181|NCT04467892|Autonomic Agents|autonomic agents|mesh-ancestor
5502182|NCT04467892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5502183|NCT04467892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502184|NCT04467892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5502185|NCT04467892|Glucocorticoids|glucocorticoids|mesh-ancestor
5502186|NCT04467892|Hormones|hormones|mesh-ancestor
6619813|NCT01269476|Cariostatic Agents|cariostatic agents|mesh-ancestor
6619814|NCT01269476|Protective Agents|protective agents|mesh-ancestor
6619815|NCT01269476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619816|NCT01269476|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6619817|NCT01269476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6619818|NCT01269476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619819|NCT01269476|Cholinergic Agents|cholinergic agents|mesh-ancestor
6619820|NCT01269476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6619821|NCT01269515|Etoricoxib|etoricoxib|mesh-list
6619822|NCT01269515|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6619823|NCT01269515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6619824|NCT01269515|Analgesics|analgesics|mesh-ancestor
6619825|NCT01269515|Sensory System Agents|sensory system agents|mesh-ancestor
6619826|NCT01269515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6619827|NCT01269515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619828|NCT01269515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6619829|NCT01269515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6619830|NCT01269515|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6619831|NCT01269515|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6619832|NCT01269515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6619833|NCT01269515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619834|NCT01269528|Nitric Oxide|nitric oxide|mesh-list
6619835|NCT01269528|Methacholine Chloride|methacholine chloride|mesh-list
6619836|NCT01269528|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6619837|NCT01269528|Autonomic Agents|autonomic agents|mesh-ancestor
5502187|NCT04467892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5502188|NCT04467892|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5502189|NCT04467892|Protective Agents|protective agents|mesh-ancestor
5502190|NCT04467892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5502191|NCT04467892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5503606|NCT04457180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503607|NCT04457180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5503608|NCT04457180|Antidepressive Agents|antidepressive agents|mesh-ancestor
5503609|NCT04457180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5503610|NCT04457180|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5503611|NCT04457180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5503612|NCT04457180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5503613|NCT04457180|Dopamine Agents|dopamine agents|mesh-ancestor
5503614|NCT04457180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5503615|NCT04457180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503616|NCT04457180|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5503617|NCT04457180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5503618|NCT04457180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5503619|NCT04457232|FAPI-46|fapi-46|mesh-list
5503620|NCT04457232|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5503621|NCT04457232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503682|NCT04456777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619838|NCT01269528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6619839|NCT01269528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619840|NCT01269528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6619841|NCT01269528|Respiratory System Agents|respiratory system agents|mesh-ancestor
6619842|NCT01269528|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6619843|NCT01269528|Antioxidants|antioxidants|mesh-ancestor
6619844|NCT01269528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619845|NCT01269528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6619846|NCT01269528|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6619847|NCT01269528|Vasodilator Agents|vasodilator agents|mesh-ancestor
6619848|NCT01269528|Gasotransmitters|gasotransmitters|mesh-ancestor
6619849|NCT01269528|Protective Agents|protective agents|mesh-ancestor
6619850|NCT01269528|Miotics|miotics|mesh-ancestor
6619851|NCT01269528|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6619852|NCT01269528|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
6619853|NCT01269528|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6619854|NCT01269528|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6619855|NCT01269528|Cholinergic Agents|cholinergic agents|mesh-ancestor
6619856|NCT01269541|Rifampin|rifampin|mesh-list
6619857|NCT01269541|Mupirocin|mupirocin|mesh-list
6619858|NCT01269541|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6619859|NCT01269541|Antitubercular Agents|antitubercular agents|mesh-ancestor
6619860|NCT01269541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6619861|NCT01269541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6619862|NCT01269541|Leprostatic Agents|leprostatic agents|mesh-ancestor
6619863|NCT01269541|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6619864|NCT01269541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6619865|NCT01269541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619866|NCT01269541|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6619867|NCT01269541|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6619868|NCT01269541|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6619869|NCT01269541|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6619870|NCT01269541|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6619871|NCT01269541|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6619872|NCT01269541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6619873|NCT01269606|Insulin|insulin|mesh-list
6619874|NCT01269606|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6619875|NCT01269606|Insulin Aspart|insulin aspart|mesh-list
6619876|NCT01269606|Insulin, Long-Acting|insulin, long-acting|mesh-list
6619877|NCT01269606|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6619878|NCT01269606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6619879|NCT01269606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619880|NCT01269671|Peppermint oil|peppermint oil|mesh-list
6619881|NCT01269671|Melatonin|melatonin|mesh-list
6619882|NCT01269671|Simethicone|simethicone|mesh-list
6619883|NCT01269671|Antioxidants|antioxidants|mesh-ancestor
6619884|NCT01269671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619885|NCT01269671|Protective Agents|protective agents|mesh-ancestor
6619886|NCT01269671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619887|NCT01269671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6619888|NCT01269671|Antifoaming Agents|antifoaming agents|mesh-ancestor
6619889|NCT01269671|Emollients|emollients|mesh-ancestor
6020860|NCT00395044|Anticonvulsants|anticonvulsants|mesh-ancestor
6619890|NCT01269671|Dermatologic Agents|dermatologic agents|mesh-ancestor
6619891|NCT01269671|Antiemetics|antiemetics|mesh-ancestor
6619892|NCT01269671|Autonomic Agents|autonomic agents|mesh-ancestor
6619893|NCT01269671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6619894|NCT01269671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6619895|NCT01269671|Parasympatholytics|parasympatholytics|mesh-ancestor
6619896|NCT01269684|Everolimus|everolimus|mesh-list
6619897|NCT01269684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6619898|NCT01269684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6619899|NCT01269684|Immunologic Factors|immunologic factors|mesh-ancestor
6619900|NCT01269684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661675|NCT01500577|Simvastatin|simvastatin|mesh-list
6661676|NCT01500577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6661677|NCT01500577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6661678|NCT01500577|Antimetabolites|antimetabolites|mesh-ancestor
6661679|NCT01500577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661680|NCT01500577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6661681|NCT01500577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6661682|NCT01500577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6661683|NCT01500577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6661684|NCT01500577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6661685|NCT01500577|Analgesics|analgesics|mesh-ancestor
6661686|NCT01500577|Sensory System Agents|sensory system agents|mesh-ancestor
6661687|NCT01500577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6661688|NCT01500577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661689|NCT01500577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6661690|NCT01500577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6661691|NCT01500577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6661692|NCT01500590|Ramipril|ramipril|mesh-list
6661693|NCT01500590|Irbesartan|irbesartan|mesh-list
6661694|NCT01500590|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6661695|NCT01500590|Protease Inhibitors|protease inhibitors|mesh-ancestor
6661696|NCT01500590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6661697|NCT01500590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661698|NCT01500590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6661699|NCT01500590|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6661700|NCT01500590|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6661701|NCT01500785|Vitamin B 12|vitamin b 12|mesh-list
6661702|NCT01500785|Hydroxocobalamin|hydroxocobalamin|mesh-list
6661703|NCT01500785|Simendan|simendan|mesh-list
6661704|NCT01500785|Vitamins|vitamins|mesh-ancestor
6661705|NCT01500785|Micronutrients|micronutrients|mesh-ancestor
6661706|NCT01500785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661707|NCT01500785|Vitamin B Complex|vitamin b complex|mesh-ancestor
6661708|NCT01500785|Hematinics|hematinics|mesh-ancestor
6661709|NCT01500785|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6661710|NCT01500785|Vasodilator Agents|vasodilator agents|mesh-ancestor
6661711|NCT01500785|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6661712|NCT01500785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6661713|NCT01500785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6661714|NCT01500785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661715|NCT01500785|Protective Agents|protective agents|mesh-ancestor
6664962|NCT01514942|Micronutrients|micronutrients|mesh-ancestor
6664963|NCT01514942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664964|NCT01514942|Trace Elements|trace elements|mesh-ancestor
6664965|NCT01514968|Cyclosporine|cyclosporine|mesh-list
6664966|NCT01514968|Ritonavir|ritonavir|mesh-list
6664967|NCT01514968|Cyclosporins|cyclosporins|mesh-list
6664968|NCT01514968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6664969|NCT01514968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6664970|NCT01514968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6664971|NCT01514968|Immunologic Factors|immunologic factors|mesh-ancestor
6664972|NCT01514968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664973|NCT01514968|Antifungal Agents|antifungal agents|mesh-ancestor
6664974|NCT01514968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6619901|NCT01269788|Fluoxetine|fluoxetine|mesh-list
6619902|NCT01269788|Omeprazole|omeprazole|mesh-list
6619903|NCT01269788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6619904|NCT01269788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6619905|NCT01269788|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6619906|NCT01269788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6619907|NCT01269788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619908|NCT01269788|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6619909|NCT01269788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6619910|NCT01269788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6619911|NCT01269788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6619912|NCT01269788|Serotonin Agents|serotonin agents|mesh-ancestor
6619913|NCT01269788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619914|NCT01269788|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6619915|NCT01269788|Antidepressive Agents|antidepressive agents|mesh-ancestor
6619916|NCT01269788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6619917|NCT01269788|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6619918|NCT01269788|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6619919|NCT01269827|Pentoxifylline|pentoxifylline|mesh-list
6619920|NCT01269827|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6619921|NCT01269827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6619922|NCT01269827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619923|NCT01269827|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6619924|NCT01269827|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6619925|NCT01269827|Protective Agents|protective agents|mesh-ancestor
6619926|NCT01269827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619927|NCT01269827|Vasodilator Agents|vasodilator agents|mesh-ancestor
6619928|NCT01269827|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6619929|NCT01269827|Antioxidants|antioxidants|mesh-ancestor
6619930|NCT01269853|Bevacizumab|bevacizumab|mesh-list
6619931|NCT01269853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6619932|NCT01269853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6619933|NCT01269853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5502192|NCT04467931|Losartan|losartan|mesh-list
6619934|NCT01269853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6619935|NCT01269853|Growth Substances|growth substances|mesh-ancestor
6619936|NCT01269853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619937|NCT01269853|Growth Inhibitors|growth inhibitors|mesh-ancestor
6619938|NCT01269866|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6619939|NCT01269866|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6619940|NCT01269866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6619941|NCT01269866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6619942|NCT01269866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619943|NCT01269866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6619944|NCT01269866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619945|NCT01269866|Analgesics|analgesics|mesh-ancestor
6619946|NCT01269866|Sensory System Agents|sensory system agents|mesh-ancestor
6619947|NCT01269866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6619948|NCT01269866|Antidepressive Agents|antidepressive agents|mesh-ancestor
6619949|NCT01269866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6619950|NCT01269866|Dopamine Agents|dopamine agents|mesh-ancestor
6619951|NCT01269970|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6619952|NCT01269970|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6619953|NCT01269970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619954|NCT01269996|Metformin|metformin|mesh-list
6619955|NCT01269996|Gliclazide|gliclazide|mesh-list
6619956|NCT01269996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6619957|NCT01269996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619958|NCT01270035|Adalimumab|adalimumab|mesh-list
6619959|NCT01270035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6619960|NCT01270035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6619961|NCT01270074|Azithromycin|azithromycin|mesh-list
6619962|NCT01270074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6619963|NCT01270074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6619964|NCT01270087|Adalimumab|adalimumab|mesh-list
6619965|NCT01270087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6619966|NCT01270087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6619967|NCT01270152|Ascorbic Acid|ascorbic acid|mesh-list
6619968|NCT01270152|Antioxidants|antioxidants|mesh-ancestor
6619969|NCT01270152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619970|NCT01270152|Protective Agents|protective agents|mesh-ancestor
6619971|NCT01270152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619972|NCT01270152|Vitamins|vitamins|mesh-ancestor
6619973|NCT01270152|Micronutrients|micronutrients|mesh-ancestor
6619974|NCT01270165|Telbivudine|telbivudine|mesh-list
6619975|NCT01270165|Antiviral Agents|antiviral agents|mesh-ancestor
6619976|NCT01270165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6619977|NCT01270165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6619978|NCT01270165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6619979|NCT01270165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619980|NCT01270178|Entecavir|entecavir|mesh-list
6619981|NCT01270178|Antiviral Agents|antiviral agents|mesh-ancestor
6619982|NCT01270178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6619983|NCT01270191|Exenatide|exenatide|mesh-list
6619984|NCT01270191|Isophane Insulin, Human|isophane insulin, human|mesh-list
6619985|NCT01270191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6619986|NCT01270191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6619987|NCT01270191|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6619988|NCT01270191|Incretins|incretins|mesh-ancestor
6619989|NCT01270191|Hormones|hormones|mesh-ancestor
6619990|NCT01270191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6619991|NCT01270308|Lansoprazole|lansoprazole|mesh-list
6619992|NCT01270308|Dexlansoprazole|dexlansoprazole|mesh-list
6619993|NCT01270308|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6619994|NCT01270308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6619995|NCT01270308|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6619996|NCT01270308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6619997|NCT01270308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6619998|NCT01270373|Docetaxel|docetaxel|mesh-list
6619999|NCT01270373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6620000|NCT01270373|Tubulin Modulators|tubulin modulators|mesh-ancestor
6620001|NCT01270373|Antimitotic Agents|antimitotic agents|mesh-ancestor
6620002|NCT01270373|Mitosis Modulators|mitosis modulators|mesh-ancestor
6620003|NCT01270373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620004|NCT01270386|Apatinib|apatinib|mesh-list
6620005|NCT01270386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6620006|NCT01270386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6620007|NCT01270386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6620008|NCT01270386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620009|NCT01270412|Mitogens|mitogens|mesh-list
6620010|NCT01270412|Hyaluronic Acid|hyaluronic acid|mesh-list
6620011|NCT01270412|Mitosis Modulators|mitosis modulators|mesh-ancestor
6620012|NCT01270412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620013|NCT01270412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6620014|NCT01270412|Immunologic Factors|immunologic factors|mesh-ancestor
6620015|NCT01270412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620016|NCT01270412|Viscosupplements|viscosupplements|mesh-ancestor
6620017|NCT01270412|Protective Agents|protective agents|mesh-ancestor
6620018|NCT01270438|Leucovorin|leucovorin|mesh-list
6620019|NCT01270438|Bevacizumab|bevacizumab|mesh-list
6620020|NCT01270438|Fluorouracil|fluorouracil|mesh-list
6620021|NCT01270438|Oxaliplatin|oxaliplatin|mesh-list
6620022|NCT01270438|Calcium|calcium|mesh-list
6620023|NCT01270438|Levoleucovorin|levoleucovorin|mesh-list
6620024|NCT01270438|R04929097|r04929097|mesh-list
6620025|NCT01270438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6620026|NCT01270438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6620027|NCT01270438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6620028|NCT01270438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6620029|NCT01270438|Growth Substances|growth substances|mesh-ancestor
6620030|NCT01270438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620031|NCT01270438|Growth Inhibitors|growth inhibitors|mesh-ancestor
6620032|NCT01270438|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6620033|NCT01270438|Antimetabolites|antimetabolites|mesh-ancestor
6620034|NCT01270438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620035|NCT01270438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6620036|NCT01270438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6620037|NCT01270438|Immunologic Factors|immunologic factors|mesh-ancestor
6620038|NCT01270438|Antidotes|antidotes|mesh-ancestor
6620039|NCT01270438|Protective Agents|protective agents|mesh-ancestor
6620040|NCT01270438|Vitamin B Complex|vitamin b complex|mesh-ancestor
6620041|NCT01270438|Vitamins|vitamins|mesh-ancestor
6620042|NCT01270438|Micronutrients|micronutrients|mesh-ancestor
6620043|NCT01270438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6620044|NCT01270451|Insulin|insulin|mesh-list
6620045|NCT01270451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6620046|NCT01270451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620047|NCT01270490|Interferons|interferons|mesh-list
6620048|NCT01270490|Interferon-gamma|interferon-gamma|mesh-list
6620049|NCT01270490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6620050|NCT01270490|Antiviral Agents|antiviral agents|mesh-ancestor
6620051|NCT01270490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6620052|NCT01270672|Carvedilol|carvedilol|mesh-list
6620053|NCT01270672|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
6620054|NCT01270672|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6620055|NCT01270672|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6620056|NCT01270672|Adrenergic Agents|adrenergic agents|mesh-ancestor
6620057|NCT01270672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6620058|NCT01270672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620059|NCT01270672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620060|NCT01270672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6620061|NCT01270672|Antioxidants|antioxidants|mesh-ancestor
6620062|NCT01270672|Protective Agents|protective agents|mesh-ancestor
6620063|NCT01270672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6620064|NCT01270672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6620065|NCT01270672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6620066|NCT01270672|Vasodilator Agents|vasodilator agents|mesh-ancestor
6620067|NCT01270672|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6620068|NCT01270672|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6620069|NCT01270672|Hallucinogens|hallucinogens|mesh-ancestor
6620070|NCT01270672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6620071|NCT01270672|Serotonin Agents|serotonin agents|mesh-ancestor
6620072|NCT01270672|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6620073|NCT01270672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6620074|NCT01270724|Gemcitabine|gemcitabine|mesh-list
6620075|NCT01270724|Paclitaxel|paclitaxel|mesh-list
6620076|NCT01270724|Oxaliplatin|oxaliplatin|mesh-list
6620077|NCT01270724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6620078|NCT01270724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6620079|NCT01270724|Tubulin Modulators|tubulin modulators|mesh-ancestor
6620080|NCT01270724|Antimitotic Agents|antimitotic agents|mesh-ancestor
6620081|NCT01270724|Mitosis Modulators|mitosis modulators|mesh-ancestor
6620082|NCT01270724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620083|NCT01270724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6620084|NCT01270724|Antimetabolites|antimetabolites|mesh-ancestor
6620085|NCT01270724|Antiviral Agents|antiviral agents|mesh-ancestor
6620086|NCT01270724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6620087|NCT01270724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6450632|NCT00408850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450633|NCT00408915|Lisuride|lisuride|mesh-list
6450634|NCT00408915|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6450635|NCT00408915|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6450636|NCT00408915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6450637|NCT00408915|Serotonin Agents|serotonin agents|mesh-ancestor
6450638|NCT00408915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6450639|NCT00408915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450640|NCT00408915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450641|NCT00408915|Dopamine Agonists|dopamine agonists|mesh-ancestor
6450642|NCT00408915|Dopamine Agents|dopamine agents|mesh-ancestor
6450643|NCT00408941|Propofol|propofol|mesh-list
6450644|NCT00408941|Prilocaine|prilocaine|mesh-list
6450645|NCT00408941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6450646|NCT00408941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6450647|NCT00408941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620088|NCT01270724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6620089|NCT01270724|Immunologic Factors|immunologic factors|mesh-ancestor
6620090|NCT01270724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620091|NCT01270737|Daidzein|daidzein|mesh-list
6620092|NCT01270737|Phytoestrogens|phytoestrogens|mesh-ancestor
6620093|NCT01270737|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6620094|NCT01270737|Estrogens|estrogens|mesh-ancestor
6620095|NCT01270737|Hormones|hormones|mesh-ancestor
6620096|NCT01270737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6620097|NCT01270737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620098|NCT01270750|Bosentan|bosentan|mesh-list
6620099|NCT01270750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6620100|NCT01270750|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6620101|NCT01270750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620102|NCT01270776|Chlorhexidine|chlorhexidine|mesh-list
6620103|NCT01270776|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6620104|NCT01270776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6620105|NCT01270776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6620106|NCT01270776|Disinfectants|disinfectants|mesh-ancestor
6620107|NCT01270776|Dermatologic Agents|dermatologic agents|mesh-ancestor
6620108|NCT01270789|Liraglutide|liraglutide|mesh-list
6620109|NCT01270789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6620110|NCT01270789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620111|NCT01270789|Incretins|incretins|mesh-ancestor
6620112|NCT01270789|Hormones|hormones|mesh-ancestor
6620113|NCT01270789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6620114|NCT01270815|Pregabalin|pregabalin|mesh-list
6620115|NCT01270815|Analgesics|analgesics|mesh-ancestor
6620116|NCT01270815|Sensory System Agents|sensory system agents|mesh-ancestor
6620117|NCT01270815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6620118|NCT01270815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620119|NCT01270815|Anticonvulsants|anticonvulsants|mesh-ancestor
6620120|NCT01270815|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6620121|NCT01270815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6620122|NCT01270815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620123|NCT01270815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6620124|NCT01270815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6620125|NCT01270815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6620126|NCT01270815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6620127|NCT01270815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6620128|NCT01270854|Plasma-lyte 148|plasma-lyte 148|mesh-list
6620129|NCT01270854|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6620130|NCT01270854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6620131|NCT01270932|Dexamethasone|dexamethasone|mesh-list
6620132|NCT01270932|Dexamethasone acetate|dexamethasone acetate|mesh-list
6620133|NCT01270932|Lenalidomide|lenalidomide|mesh-list
6620134|NCT01270932|BB 1101|bb 1101|mesh-list
6620135|NCT01270932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6620136|NCT01270932|Antiemetics|antiemetics|mesh-ancestor
6620137|NCT01270932|Autonomic Agents|autonomic agents|mesh-ancestor
6620138|NCT01270932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6620139|NCT01270932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620140|NCT01270932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6620141|NCT01270932|Glucocorticoids|glucocorticoids|mesh-ancestor
6620142|NCT01270932|Hormones|hormones|mesh-ancestor
6620143|NCT01270932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6620144|NCT01270932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6620145|NCT01270932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6620146|NCT01270932|Protease Inhibitors|protease inhibitors|mesh-ancestor
6620147|NCT01270932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6620148|NCT01270932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620149|NCT01270932|Immunologic Factors|immunologic factors|mesh-ancestor
6620150|NCT01270932|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6620151|NCT01270932|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6620152|NCT01270932|Growth Substances|growth substances|mesh-ancestor
6620153|NCT01270932|Growth Inhibitors|growth inhibitors|mesh-ancestor
6620154|NCT01270984|Imatinib Mesylate|imatinib mesylate|mesh-list
6620155|NCT01270984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6620156|NCT01270984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6620157|NCT01270984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6620158|NCT01270984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620159|NCT01270997|Etanercept|etanercept|mesh-list
6620160|NCT01270997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6620161|NCT01270997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6620162|NCT01270997|Analgesics|analgesics|mesh-ancestor
6620163|NCT01270997|Sensory System Agents|sensory system agents|mesh-ancestor
6620164|NCT01270997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6620165|NCT01270997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620166|NCT01270997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6620167|NCT01270997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6620168|NCT01270997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6620169|NCT01270997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6620170|NCT01270997|Immunologic Factors|immunologic factors|mesh-ancestor
6620171|NCT01271023|Insulin|insulin|mesh-list
6620172|NCT01271023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6620173|NCT01271023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620174|NCT01271088|Acetylcysteine|acetylcysteine|mesh-list
6620175|NCT01271088|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6620176|NCT01271088|Antiviral Agents|antiviral agents|mesh-ancestor
6620177|NCT01271088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6620178|NCT01271088|Expectorants|expectorants|mesh-ancestor
6620179|NCT01271088|Respiratory System Agents|respiratory system agents|mesh-ancestor
6620180|NCT01271088|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6620181|NCT01271088|Antioxidants|antioxidants|mesh-ancestor
6620182|NCT01271088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620183|NCT01271088|Protective Agents|protective agents|mesh-ancestor
6620184|NCT01271088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620185|NCT01271088|Antidotes|antidotes|mesh-ancestor
6620186|NCT01271114|Terlipressin|terlipressin|mesh-list
6620187|NCT01271114|Norepinephrine|norepinephrine|mesh-list
6620188|NCT01271114|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6620189|NCT01271114|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6620190|NCT01271114|Adrenergic Agents|adrenergic agents|mesh-ancestor
6620191|NCT01271114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6620192|NCT01271114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661716|NCT01500824|Crizotinib|crizotinib|mesh-list
6620193|NCT01271114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620194|NCT01271114|Sympathomimetics|sympathomimetics|mesh-ancestor
6620195|NCT01271114|Autonomic Agents|autonomic agents|mesh-ancestor
6620196|NCT01271114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6620197|NCT01271114|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6620198|NCT01271114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6620199|NCT01271140|Insulin|insulin|mesh-list
6620200|NCT01271140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6620201|NCT01271140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620202|NCT01271153|Dobutamine|dobutamine|mesh-list
6620203|NCT01271153|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6620204|NCT01271153|Sympathomimetics|sympathomimetics|mesh-ancestor
6620205|NCT01271153|Autonomic Agents|autonomic agents|mesh-ancestor
6620206|NCT01271153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6620207|NCT01271153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620208|NCT01271153|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6620209|NCT01271153|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6620210|NCT01271153|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6620211|NCT01271153|Adrenergic Agents|adrenergic agents|mesh-ancestor
6620212|NCT01271153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6620213|NCT01271153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620214|NCT01271153|Protective Agents|protective agents|mesh-ancestor
6620215|NCT01271166|Leucovorin|leucovorin|mesh-list
6620216|NCT01271166|Bevacizumab|bevacizumab|mesh-list
6620217|NCT01271166|Fluorouracil|fluorouracil|mesh-list
6620218|NCT01271166|Oxaliplatin|oxaliplatin|mesh-list
6620219|NCT01271166|Imatinib Mesylate|imatinib mesylate|mesh-list
6620220|NCT01271166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6620221|NCT01271166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6620222|NCT01271166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6620223|NCT01271166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6620224|NCT01271166|Growth Substances|growth substances|mesh-ancestor
6620225|NCT01271166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620226|NCT01271166|Growth Inhibitors|growth inhibitors|mesh-ancestor
6620227|NCT01271166|Antimetabolites|antimetabolites|mesh-ancestor
6620228|NCT01271166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620229|NCT01271166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6620230|NCT01271166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6620231|NCT01271166|Immunologic Factors|immunologic factors|mesh-ancestor
6620232|NCT01271166|Antidotes|antidotes|mesh-ancestor
6620233|NCT01271166|Protective Agents|protective agents|mesh-ancestor
6620234|NCT01271166|Vitamin B Complex|vitamin b complex|mesh-ancestor
6620235|NCT01271166|Vitamins|vitamins|mesh-ancestor
6620236|NCT01271166|Micronutrients|micronutrients|mesh-ancestor
6620237|NCT01271166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6620238|NCT01271166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6620239|NCT01271179|Insulin|insulin|mesh-list
6620240|NCT01271179|Allopurinol|allopurinol|mesh-list
6620241|NCT01271179|Adenosine|adenosine|mesh-list
6620242|NCT01271179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6620243|NCT01271179|Analgesics|analgesics|mesh-ancestor
6620244|NCT01271179|Sensory System Agents|sensory system agents|mesh-ancestor
6620245|NCT01271179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6620246|NCT01271179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620247|NCT01271179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6620248|NCT01271179|Vasodilator Agents|vasodilator agents|mesh-ancestor
6620249|NCT01271179|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6620250|NCT01271179|Purinergic Agonists|purinergic agonists|mesh-ancestor
6620251|NCT01271179|Purinergic Agents|purinergic agents|mesh-ancestor
6620252|NCT01271179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6620253|NCT01271179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620254|NCT01271179|Antimetabolites|antimetabolites|mesh-ancestor
6620255|NCT01271179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6620256|NCT01271179|Gout Suppressants|gout suppressants|mesh-ancestor
6620257|NCT01271179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6620258|NCT01271179|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6620259|NCT01271179|Antioxidants|antioxidants|mesh-ancestor
6620260|NCT01271179|Protective Agents|protective agents|mesh-ancestor
6620261|NCT01271179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6620262|NCT01271231|Azithromycin|azithromycin|mesh-list
6620263|NCT01271231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6620264|NCT01271231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6620265|NCT01271257|Misoprostol|misoprostol|mesh-list
6620266|NCT01271257|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6620267|NCT01271257|Abortifacient Agents|abortifacient agents|mesh-ancestor
6620268|NCT01271257|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6620269|NCT01271257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620270|NCT01271257|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6620271|NCT01271257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6620272|NCT01271257|Oxytocics|oxytocics|mesh-ancestor
6620273|NCT01271283|Lenalidomide|lenalidomide|mesh-list
6620274|NCT01271283|Immunologic Factors|immunologic factors|mesh-ancestor
6620275|NCT01271283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620276|NCT01271283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6620277|NCT01271283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6620278|NCT01271283|Growth Substances|growth substances|mesh-ancestor
6620279|NCT01271283|Growth Inhibitors|growth inhibitors|mesh-ancestor
6620280|NCT01271283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6620281|NCT01271348|Etoricoxib|etoricoxib|mesh-list
6620282|NCT01271348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6620283|NCT01271348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6620284|NCT01271348|Analgesics|analgesics|mesh-ancestor
6620285|NCT01271348|Sensory System Agents|sensory system agents|mesh-ancestor
6620286|NCT01271348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6450648|NCT00408941|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6450649|NCT00408941|Anesthetics, General|anesthetics, general|mesh-ancestor
6450650|NCT00408941|Anesthetics|anesthetics|mesh-ancestor
6450651|NCT00408941|Anesthetics, Local|anesthetics, local|mesh-ancestor
6450652|NCT00408941|Sensory System Agents|sensory system agents|mesh-ancestor
6450653|NCT00408941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6620287|NCT01271348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620288|NCT01271348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6620289|NCT01271348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6620290|NCT01271348|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6620291|NCT01271348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6620292|NCT01271348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6620293|NCT01271348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620294|NCT01271361|Sirolimus|sirolimus|mesh-list
6620295|NCT01271361|Umirolimus|umirolimus|mesh-list
6620296|NCT01271361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6620297|NCT01271361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6620298|NCT01271361|Immunologic Factors|immunologic factors|mesh-ancestor
6620299|NCT01271361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620300|NCT01271361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6620301|NCT01271361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6620302|NCT01271361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6620303|NCT01271361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6620304|NCT01271361|Antifungal Agents|antifungal agents|mesh-ancestor
6620305|NCT01271374|Losartan|losartan|mesh-list
6620306|NCT01271374|Amlodipine|amlodipine|mesh-list
6620307|NCT01271374|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6620308|NCT01271374|Olmesartan|olmesartan|mesh-list
6620309|NCT01271374|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
6620310|NCT01271374|Spironolactone|spironolactone|mesh-list
6664975|NCT01514968|Dermatologic Agents|dermatologic agents|mesh-ancestor
6450654|NCT00409019|Tenofovir|tenofovir|mesh-list
6450655|NCT00409019|Adefovir|adefovir|mesh-list
6450656|NCT00409019|Telbivudine|telbivudine|mesh-list
6450657|NCT00409019|Antiviral Agents|antiviral agents|mesh-ancestor
6450658|NCT00409019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6450659|NCT00409019|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6450660|NCT00409019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6450661|NCT00409019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6450662|NCT00409019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450663|NCT00409019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6620311|NCT01271374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6620312|NCT01271374|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6620313|NCT01271374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6620314|NCT01271374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620315|NCT01271374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6620316|NCT01271374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620317|NCT01271374|Vasodilator Agents|vasodilator agents|mesh-ancestor
6620318|NCT01271374|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6620319|NCT01271374|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6620320|NCT01271374|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6620321|NCT01271374|Diuretics|diuretics|mesh-ancestor
6620322|NCT01271374|Natriuretic Agents|natriuretic agents|mesh-ancestor
6620323|NCT01271374|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6620324|NCT01271374|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6620325|NCT01271374|Hormone Antagonists|hormone antagonists|mesh-ancestor
6620326|NCT01271374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6620327|NCT01271374|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6661717|NCT01500824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6661718|NCT01500824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6661719|NCT01500824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6661720|NCT01500824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661721|NCT01500837|Levofloxacin|levofloxacin|mesh-list
6661722|NCT01500837|Ofloxacin|ofloxacin|mesh-list
6661723|NCT01500837|Rifampin|rifampin|mesh-list
6661724|NCT01500837|Clindamycin|clindamycin|mesh-list
6661725|NCT01500837|Clindamycin palmitate|clindamycin palmitate|mesh-list
6661726|NCT01500837|Clindamycin phosphate|clindamycin phosphate|mesh-list
6661727|NCT01500837|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6661728|NCT01500837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6661729|NCT01500837|Renal Agents|renal agents|mesh-ancestor
6661730|NCT01500837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6661731|NCT01500837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6661732|NCT01500837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6661733|NCT01500837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6661734|NCT01500837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661735|NCT01500837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6661736|NCT01500837|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6661737|NCT01500837|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6661738|NCT01500837|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6661739|NCT01500837|Antitubercular Agents|antitubercular agents|mesh-ancestor
6661740|NCT01500837|Leprostatic Agents|leprostatic agents|mesh-ancestor
6661741|NCT01500837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6661742|NCT01500837|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6661743|NCT01500837|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6661744|NCT01500837|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6661745|NCT01500837|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6661746|NCT01500837|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6661747|NCT01500837|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6620328|NCT01271439|Cetuximab|cetuximab|mesh-list
6620329|NCT01271439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6620330|NCT01271439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6620331|NCT01271478|Telmisartan|telmisartan|mesh-list
6620332|NCT01271478|Captopril|captopril|mesh-list
6620333|NCT01271478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6620334|NCT01271478|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6620335|NCT01271478|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6620336|NCT01271478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620337|NCT01271478|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6620338|NCT01271478|Protease Inhibitors|protease inhibitors|mesh-ancestor
6620339|NCT01271478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6620340|NCT01271517|Insulin, Isophane|insulin, isophane|mesh-list
6620341|NCT01271517|Isophane Insulin, Human|isophane insulin, human|mesh-list
6620342|NCT01271517|Isophane insulin, beef|isophane insulin, beef|mesh-list
6620343|NCT01271517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6620344|NCT01271517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620345|NCT01271556|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6620346|NCT01271556|Bronchodilator Agents|bronchodilator agents|mesh-list
6620347|NCT01271556|Autonomic Agents|autonomic agents|mesh-ancestor
6620348|NCT01271556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6620349|NCT01271556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620350|NCT01271556|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6620351|NCT01271556|Respiratory System Agents|respiratory system agents|mesh-ancestor
6620352|NCT01271556|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6620353|NCT01271556|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6620354|NCT01271556|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6620355|NCT01271556|Adrenergic Agents|adrenergic agents|mesh-ancestor
6620356|NCT01271556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6620357|NCT01271556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620358|NCT01271569|Fospropofol|fospropofol|mesh-list
6620359|NCT01271569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6620360|NCT01271569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6620361|NCT01271569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620362|NCT01271582|Leucovorin|leucovorin|mesh-list
6620363|NCT01271582|Irinotecan|irinotecan|mesh-list
6620364|NCT01271582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6620365|NCT01271582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6620366|NCT01271582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6620367|NCT01271582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620368|NCT01271582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6620369|NCT01271582|Antidotes|antidotes|mesh-ancestor
6620370|NCT01271582|Protective Agents|protective agents|mesh-ancestor
6620371|NCT01271582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620372|NCT01271582|Vitamin B Complex|vitamin b complex|mesh-ancestor
6620373|NCT01271582|Vitamins|vitamins|mesh-ancestor
6620374|NCT01271582|Micronutrients|micronutrients|mesh-ancestor
6620375|NCT01271660|Pregabalin|pregabalin|mesh-list
6620376|NCT01271660|Analgesics|analgesics|mesh-ancestor
6620377|NCT01271660|Sensory System Agents|sensory system agents|mesh-ancestor
6620378|NCT01271660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6620379|NCT01271660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620380|NCT01271660|Anticonvulsants|anticonvulsants|mesh-ancestor
6620381|NCT01271660|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6620382|NCT01271660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6620383|NCT01271660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620384|NCT01271660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6620385|NCT01271660|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6620386|NCT01271660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6620387|NCT01271660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6620388|NCT01271660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6620389|NCT01271881|Heparin|heparin|mesh-list
6620390|NCT01271881|Anticoagulants|anticoagulants|mesh-ancestor
6620391|NCT01271881|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6620392|NCT01271881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6620393|NCT01271881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620394|NCT01271894|Efavirenz|efavirenz|mesh-list
6620395|NCT01271894|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6620396|NCT01271894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6620397|NCT01271894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6620398|NCT01271894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620399|NCT01271894|Antiviral Agents|antiviral agents|mesh-ancestor
6620400|NCT01271894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6620401|NCT01271894|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6620402|NCT01271894|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6620403|NCT01271894|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6620404|NCT01271894|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6620405|NCT01271894|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6620406|NCT01271894|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6620407|NCT01271998|Tedizolid phosphate|tedizolid phosphate|mesh-list
6620408|NCT01271998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6620409|NCT01271998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6620410|NCT01272089|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
6620411|NCT01272089|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6620412|NCT01272089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6620413|NCT01272089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6620414|NCT01272089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6620415|NCT01272089|Analgesics|analgesics|mesh-ancestor
6620416|NCT01272089|Sensory System Agents|sensory system agents|mesh-ancestor
6620417|NCT01272089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6620418|NCT01272089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620419|NCT01272089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6620420|NCT01272089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6620421|NCT01272089|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6620422|NCT01272089|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6620423|NCT01272089|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6620424|NCT01272089|Histamine Antagonists|histamine antagonists|mesh-ancestor
6020861|NCT00395044|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6020862|NCT00395044|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6020863|NCT00395044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6020864|NCT00395044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6620425|NCT01272089|Histamine Agents|histamine agents|mesh-ancestor
6620426|NCT01272089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6620427|NCT01272089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620428|NCT01272128|Interferons|interferons|mesh-list
6620429|NCT01272128|Interferon-beta|interferon-beta|mesh-list
6620430|NCT01272128|Interferon beta-1a|interferon beta-1a|mesh-list
6620431|NCT01272128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6620432|NCT01272128|Antiviral Agents|antiviral agents|mesh-ancestor
6620433|NCT01272128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6620434|NCT01272128|Immunologic Factors|immunologic factors|mesh-ancestor
6620435|NCT01272128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620436|NCT01272128|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6620437|NCT01272258|Leronlimab|leronlimab|mesh-list
6620438|NCT01272258|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6620439|NCT01272258|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6620440|NCT01272258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620441|NCT01272258|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6620442|NCT01272258|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6620443|NCT01272258|Antiviral Agents|antiviral agents|mesh-ancestor
6620444|NCT01272258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6620445|NCT01272310|Interferons|interferons|mesh-list
6620446|NCT01272310|Ribavirin|ribavirin|mesh-list
6620447|NCT01272310|Interferon-alpha|interferon-alpha|mesh-list
6620448|NCT01272310|Interferon alpha-2|interferon alpha-2|mesh-list
6620449|NCT01272310|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6620450|NCT01272310|Hydroxychloroquine|hydroxychloroquine|mesh-list
6620451|NCT01272310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6620452|NCT01272310|Antiviral Agents|antiviral agents|mesh-ancestor
6620453|NCT01272310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6620454|NCT01272310|Antimetabolites|antimetabolites|mesh-ancestor
6620455|NCT01272310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620456|NCT01272310|Immunologic Factors|immunologic factors|mesh-ancestor
6620457|NCT01272310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620458|NCT01272310|Antimalarials|antimalarials|mesh-ancestor
6620459|NCT01272310|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6620460|NCT01272310|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6620461|NCT01272310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6620462|NCT01272310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6620463|NCT01272414|Botulinum Toxins|botulinum toxins|mesh-list
6620464|NCT01272414|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6620465|NCT01272414|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6620466|NCT01272414|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6620467|NCT01272414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6620468|NCT01272414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620469|NCT01272414|Cholinergic Agents|cholinergic agents|mesh-ancestor
6620470|NCT01272414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6620471|NCT01272414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620472|NCT01272414|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6620473|NCT01272414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6620474|NCT01272531|Valproic Acid|valproic acid|mesh-list
6620475|NCT01272531|Lithium Carbonate|lithium carbonate|mesh-list
6620476|NCT01272531|Anticonvulsants|anticonvulsants|mesh-ancestor
6620477|NCT01272531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6620478|NCT01272531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620479|NCT01272531|GABA Agents|gaba agents|mesh-ancestor
6620480|NCT01272531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6620481|NCT01272531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620482|NCT01272531|Antimanic Agents|antimanic agents|mesh-ancestor
6620483|NCT01272531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6620484|NCT01272531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6620485|NCT01272531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6620486|NCT01272531|Antidepressive Agents|antidepressive agents|mesh-ancestor
6620487|NCT01272557|Doxorubicin|doxorubicin|mesh-list
6620488|NCT01272557|Sorafenib|sorafenib|mesh-list
6620489|NCT01272557|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6620490|NCT01272557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6620491|NCT01272557|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6620492|NCT01272557|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6620493|NCT01272557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6620494|NCT01272557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620495|NCT01272557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6620496|NCT01272609|Timolol|timolol|mesh-list
6620497|NCT01272609|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6620498|NCT01272609|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6620499|NCT01272609|Adrenergic Agents|adrenergic agents|mesh-ancestor
6620500|NCT01272609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6620501|NCT01272609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620502|NCT01272609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620503|NCT01272609|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6620504|NCT01272609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6620505|NCT01272778|Lorazepam|lorazepam|mesh-list
6620506|NCT01272778|Anticonvulsants|anticonvulsants|mesh-ancestor
6620507|NCT01272778|Antiemetics|antiemetics|mesh-ancestor
6620508|NCT01272778|Autonomic Agents|autonomic agents|mesh-ancestor
6620509|NCT01272778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6620510|NCT01272778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620511|NCT01272778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6620512|NCT01272778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6620513|NCT01272778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6620514|NCT01272778|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6620515|NCT01272778|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6620516|NCT01272778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6620517|NCT01272778|GABA Modulators|gaba modulators|mesh-ancestor
6620518|NCT01272778|GABA Agents|gaba agents|mesh-ancestor
6620519|NCT01272778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6620520|NCT01272778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620521|NCT01272856|Abatacept|abatacept|mesh-list
6620522|NCT01272856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6620523|NCT01272856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620524|NCT01272856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6620525|NCT01272856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6620526|NCT01272856|Immunologic Factors|immunologic factors|mesh-ancestor
6620527|NCT01272856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620528|NCT01272856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6620529|NCT01272986|Immunoglobulin G|immunoglobulin g|mesh-list
6620530|NCT01272986|Immunologic Factors|immunologic factors|mesh-ancestor
6620531|NCT01272986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620532|NCT01273051|Capecitabine|capecitabine|mesh-list
6020865|NCT00395044|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6620533|NCT01273051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6620534|NCT01273051|Antimetabolites|antimetabolites|mesh-ancestor
6620535|NCT01273051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620536|NCT01273051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6620537|NCT01273090|Imetelstat|imetelstat|mesh-list
6620538|NCT01273090|Motesanib diphosphate|motesanib diphosphate|mesh-list
6620539|NCT01273090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6620540|NCT01273090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620541|NCT01273090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6620542|NCT01273233|Vaccines|vaccines|mesh-list
6620543|NCT01273233|Immunologic Factors|immunologic factors|mesh-ancestor
6620544|NCT01273233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620545|NCT01273246|Vaccines|vaccines|mesh-list
6620546|NCT01273246|Immunologic Factors|immunologic factors|mesh-ancestor
6620547|NCT01273246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620548|NCT01273298|Bisoprolol|bisoprolol|mesh-list
6620549|NCT01273298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6620550|NCT01273298|Sympatholytics|sympatholytics|mesh-ancestor
6620551|NCT01273298|Autonomic Agents|autonomic agents|mesh-ancestor
6620552|NCT01273298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6620553|NCT01273298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620554|NCT01273298|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6620555|NCT01273298|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6620556|NCT01273298|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6620557|NCT01273298|Adrenergic Agents|adrenergic agents|mesh-ancestor
6620558|NCT01273298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6620559|NCT01273298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450664|NCT00409019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6450665|NCT00409071|Sinomenine|sinomenine|mesh-list
6450666|NCT00409071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6450667|NCT00409097|Rosiglitazone|rosiglitazone|mesh-list
6450668|NCT00409097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6450669|NCT00409097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450670|NCT00409201|Reboxetine|reboxetine|mesh-list
6450671|NCT00409201|Antidepressive Agents|antidepressive agents|mesh-ancestor
6450672|NCT00409201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6450673|NCT00409201|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6450674|NCT00409201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6450675|NCT00409201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6450676|NCT00409201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450677|NCT00409201|Adrenergic Agents|adrenergic agents|mesh-ancestor
6450678|NCT00409201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6661748|NCT01500837|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6661749|NCT01500850|Insulin|insulin|mesh-list
6661750|NCT01500850|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5502193|NCT04467931|Timolol|timolol|mesh-list
6661751|NCT01500850|Insulin Glargine|insulin glargine|mesh-list
6620560|NCT01273402|Antibodies|antibodies|mesh-list
6620561|NCT01273402|Immunoglobulins|immunoglobulins|mesh-list
6620562|NCT01273402|Antibodies, Bispecific|antibodies, bispecific|mesh-list
6620563|NCT01273402|Immunologic Factors|immunologic factors|mesh-ancestor
6620564|NCT01273402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620565|NCT01273441|Amoxicillin|amoxicillin|mesh-list
6620566|NCT01273441|Metronidazole|metronidazole|mesh-list
6620567|NCT01273441|Clarithromycin|clarithromycin|mesh-list
6620568|NCT01273441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6620569|NCT01273441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6620570|NCT01273441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6620571|NCT01273441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6620572|NCT01273441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6620573|NCT01273441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6620574|NCT01273441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620575|NCT01273441|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6620576|NCT01273441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6620577|NCT01273454|Hydromorphone|hydromorphone|mesh-list
6620578|NCT01273454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6620579|NCT01273454|Narcotics|narcotics|mesh-ancestor
6620580|NCT01273454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6620581|NCT01273454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620582|NCT01273454|Analgesics|analgesics|mesh-ancestor
6620583|NCT01273454|Sensory System Agents|sensory system agents|mesh-ancestor
6620584|NCT01273454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6620585|NCT01273493|Dexamethasone|dexamethasone|mesh-list
6620586|NCT01273493|Trabectedin|trabectedin|mesh-list
6620587|NCT01273493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6620588|NCT01273493|Antiemetics|antiemetics|mesh-ancestor
6620589|NCT01273493|Autonomic Agents|autonomic agents|mesh-ancestor
6620590|NCT01273493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6620591|NCT01273493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620592|NCT01273493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6620593|NCT01273493|Glucocorticoids|glucocorticoids|mesh-ancestor
6620594|NCT01273493|Hormones|hormones|mesh-ancestor
6620595|NCT01273493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6620596|NCT01273493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6620597|NCT01273493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6620598|NCT01273493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6620599|NCT01273493|Alkylating Agents|alkylating agents|mesh-ancestor
6620600|NCT01273493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620601|NCT01273506|Tapentadol|tapentadol|mesh-list
6620602|NCT01273506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6620603|NCT01273506|Narcotics|narcotics|mesh-ancestor
6620604|NCT01273506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6620605|NCT01273506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620606|NCT01273506|Analgesics|analgesics|mesh-ancestor
6620607|NCT01273506|Sensory System Agents|sensory system agents|mesh-ancestor
6620608|NCT01273506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6620609|NCT01273506|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6620610|NCT01273506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6620611|NCT01273506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6620612|NCT01273506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620613|NCT01273506|Adrenergic Agents|adrenergic agents|mesh-ancestor
6620614|NCT01273506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6620615|NCT01273532|Tapentadol|tapentadol|mesh-list
6620616|NCT01273532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6620617|NCT01273532|Narcotics|narcotics|mesh-ancestor
6620618|NCT01273532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6620619|NCT01273532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620620|NCT01273532|Analgesics|analgesics|mesh-ancestor
6620621|NCT01273532|Sensory System Agents|sensory system agents|mesh-ancestor
6620622|NCT01273532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6450679|NCT00409201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450680|NCT00409214|Talaporfin|talaporfin|mesh-list
6450681|NCT00409214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6450682|NCT00409214|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6450683|NCT00409214|Dermatologic Agents|dermatologic agents|mesh-ancestor
6450684|NCT00409227|Alfuzosin|alfuzosin|mesh-list
6450685|NCT00409227|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
6450686|NCT00409227|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6450687|NCT00409227|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6450688|NCT00409227|Adrenergic Agents|adrenergic agents|mesh-ancestor
6620623|NCT01273532|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6620624|NCT01273532|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6620625|NCT01273532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6620626|NCT01273532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620627|NCT01273532|Adrenergic Agents|adrenergic agents|mesh-ancestor
6620628|NCT01273532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6620629|NCT01273558|Canagliflozin|canagliflozin|mesh-list
6620630|NCT01273558|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6620631|NCT01273558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620632|NCT01273558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6620633|NCT01273558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620634|NCT01273571|Metformin|metformin|mesh-list
6620635|NCT01273571|Canagliflozin|canagliflozin|mesh-list
6620636|NCT01273571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6450689|NCT00409227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6620637|NCT01273571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620638|NCT01273571|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6620639|NCT01273571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620640|NCT01273584|Metformin|metformin|mesh-list
6620641|NCT01273584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6620642|NCT01273584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620643|NCT01273610|Trastuzumab|trastuzumab|mesh-list
6620644|NCT01273610|Lapatinib|lapatinib|mesh-list
6620645|NCT01273610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6620646|NCT01273610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6620647|NCT01273610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6620648|NCT01273610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6620649|NCT01273610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620650|NCT01273662|Axitinib|axitinib|mesh-list
6620651|NCT01273662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6620652|NCT01273662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6620653|NCT01273662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6620654|NCT01273662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620655|NCT01273727|Dexamethasone|dexamethasone|mesh-list
6620656|NCT01273727|Dexamethasone acetate|dexamethasone acetate|mesh-list
6620657|NCT01273727|BB 1101|bb 1101|mesh-list
6620658|NCT01273727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6620659|NCT01273727|Antiemetics|antiemetics|mesh-ancestor
6620660|NCT01273727|Autonomic Agents|autonomic agents|mesh-ancestor
6620661|NCT01273727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6620662|NCT01273727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620663|NCT01273727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6620664|NCT01273727|Glucocorticoids|glucocorticoids|mesh-ancestor
6620665|NCT01273727|Hormones|hormones|mesh-ancestor
6620666|NCT01273727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6620667|NCT01273727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6620668|NCT01273727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6620669|NCT01273727|Protease Inhibitors|protease inhibitors|mesh-ancestor
6620670|NCT01273727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6620671|NCT01273727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620672|NCT01273779|Talactoferrin alfa|talactoferrin alfa|mesh-list
6620673|NCT01273779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6620674|NCT01273831|Cisatracurium|cisatracurium|mesh-list
6620675|NCT01273831|Atracurium|atracurium|mesh-list
6620676|NCT01273831|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6620677|NCT01273831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6620678|NCT01273831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6620679|NCT01273831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620680|NCT01273831|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6620681|NCT01273831|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
6620682|NCT01273831|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6620683|NCT01273831|Cholinergic Agents|cholinergic agents|mesh-ancestor
6620684|NCT01273831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6620685|NCT01273831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620686|NCT01273844|Bortezomib|bortezomib|mesh-list
6450690|NCT00409227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450691|NCT00409227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450692|NCT00409227|Urological Agents|urological agents|mesh-ancestor
6450693|NCT00409253|Nicardipine|nicardipine|mesh-list
6450694|NCT00409253|Urapidil|urapidil|mesh-list
6450695|NCT00409253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6450696|NCT00409253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6450697|NCT00409253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6450698|NCT00409253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620687|NCT01273844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6620688|NCT01273948|Interferons|interferons|mesh-list
6620689|NCT01273948|Bavituximab|bavituximab|mesh-list
6620690|NCT01273948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6620691|NCT01273948|Antiviral Agents|antiviral agents|mesh-ancestor
6620692|NCT01273948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6620693|NCT01273948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6620694|NCT01273974|Vaccines|vaccines|mesh-list
6620695|NCT01273974|Immunologic Factors|immunologic factors|mesh-ancestor
6620696|NCT01273974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620697|NCT01274000|Ramosetron|ramosetron|mesh-list
6620698|NCT01274000|Antiemetics|antiemetics|mesh-ancestor
6620699|NCT01274000|Autonomic Agents|autonomic agents|mesh-ancestor
6620700|NCT01274000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6620701|NCT01274000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620702|NCT01274000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6620703|NCT01274000|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6620704|NCT01274000|Serotonin Agents|serotonin agents|mesh-ancestor
6620705|NCT01274000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6620706|NCT01274000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620707|NCT01274026|Verapamil|verapamil|mesh-list
6620708|NCT01274026|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6620709|NCT01274026|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6620710|NCT01274026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6620711|NCT01274026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620712|NCT01274026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6620713|NCT01274026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620714|NCT01274026|Vasodilator Agents|vasodilator agents|mesh-ancestor
6620715|NCT01274039|Acetazolamide|acetazolamide|mesh-list
6620716|NCT01274039|Anticonvulsants|anticonvulsants|mesh-ancestor
6620717|NCT01274039|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6620718|NCT01274039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6620719|NCT01274039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620720|NCT01274039|Diuretics|diuretics|mesh-ancestor
6620721|NCT01274039|Natriuretic Agents|natriuretic agents|mesh-ancestor
6620722|NCT01274039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620723|NCT01274104|Vitamin D|vitamin d|mesh-list
6620724|NCT01274104|Cholecalciferol|cholecalciferol|mesh-list
6620725|NCT01274104|Vitamins|vitamins|mesh-ancestor
6620726|NCT01274104|Micronutrients|micronutrients|mesh-ancestor
6620727|NCT01274104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620728|NCT01274104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6620729|NCT01274104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6620730|NCT01274130|Metformin|metformin|mesh-list
6620731|NCT01274130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6620732|NCT01274130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620733|NCT01274195|Busulfan|busulfan|mesh-list
6620734|NCT01274195|Alkylating Agents|alkylating agents|mesh-ancestor
6620735|NCT01274195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620736|NCT01274195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6620737|NCT01274195|Immunologic Factors|immunologic factors|mesh-ancestor
6620738|NCT01274195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620739|NCT01274195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6620740|NCT01274195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6620741|NCT01274195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6620742|NCT01274221|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6620743|NCT01274221|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6620744|NCT01274221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620745|NCT01274221|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6620746|NCT01274221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6620747|NCT01274221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6620748|NCT01274221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620749|NCT01274221|Dopamine Agents|dopamine agents|mesh-ancestor
6620750|NCT01274221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6620751|NCT01274247|Benzocaine|benzocaine|mesh-list
6620752|NCT01274247|Anesthetics, Local|anesthetics, local|mesh-ancestor
6620753|NCT01274247|Anesthetics|anesthetics|mesh-ancestor
6620754|NCT01274247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6620755|NCT01274247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620756|NCT01274247|Sensory System Agents|sensory system agents|mesh-ancestor
6620757|NCT01274247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6620758|NCT01274260|Methylprednisolone|methylprednisolone|mesh-list
6620759|NCT01274260|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6620760|NCT01274260|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6620761|NCT01274260|Prednisolone|prednisolone|mesh-list
6620762|NCT01274260|Prednisolone acetate|prednisolone acetate|mesh-list
6620763|NCT01274260|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6620764|NCT01274260|Prednisolone phosphate|prednisolone phosphate|mesh-list
6620765|NCT01274260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6620766|NCT01274260|Antiemetics|antiemetics|mesh-ancestor
6620767|NCT01274260|Autonomic Agents|autonomic agents|mesh-ancestor
6620768|NCT01274260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6620769|NCT01274260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620770|NCT01274260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6620771|NCT01274260|Glucocorticoids|glucocorticoids|mesh-ancestor
6620772|NCT01274260|Hormones|hormones|mesh-ancestor
6620773|NCT01274260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6620774|NCT01274260|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6620775|NCT01274260|Protective Agents|protective agents|mesh-ancestor
6620776|NCT01274260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6620777|NCT01274260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6620778|NCT01274273|Interferons|interferons|mesh-list
6620779|NCT01274273|Interferon-alpha|interferon-alpha|mesh-list
6620780|NCT01274273|Interferon alpha-2|interferon alpha-2|mesh-list
6620781|NCT01274273|Aldesleukin|aldesleukin|mesh-list
6620782|NCT01274273|Bevacizumab|bevacizumab|mesh-list
6620783|NCT01274273|Interleukin-2|interleukin-2|mesh-list
6620784|NCT01274273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6620785|NCT01274273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6620786|NCT01274273|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6620787|NCT01274273|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6620788|NCT01274273|Growth Substances|growth substances|mesh-ancestor
6620789|NCT01274273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620790|NCT01274273|Growth Inhibitors|growth inhibitors|mesh-ancestor
6620791|NCT01274273|Antiviral Agents|antiviral agents|mesh-ancestor
6620792|NCT01274273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6620793|NCT01274273|Immunologic Factors|immunologic factors|mesh-ancestor
6620794|NCT01274273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6620795|NCT01274273|Analgesics|analgesics|mesh-ancestor
6620796|NCT01274273|Sensory System Agents|sensory system agents|mesh-ancestor
6620797|NCT01274273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6620798|NCT01274273|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6620799|NCT01274273|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6620800|NCT01274325|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6620801|NCT01274325|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6620802|NCT01274325|Autonomic Agents|autonomic agents|mesh-ancestor
6620803|NCT01274325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6620804|NCT01274325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620805|NCT01274325|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6620806|NCT01274325|Respiratory System Agents|respiratory system agents|mesh-ancestor
6620807|NCT01274325|Glucocorticoids|glucocorticoids|mesh-ancestor
6620808|NCT01274325|Hormones|hormones|mesh-ancestor
6620809|NCT01274325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6620810|NCT01274325|Sympathomimetics|sympathomimetics|mesh-ancestor
6620811|NCT01274403|Thalidomide|thalidomide|mesh-list
6620812|NCT01274403|Prednisone|prednisone|mesh-list
6620813|NCT01274403|Melphalan|melphalan|mesh-list
6620814|NCT01274403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6620815|NCT01274403|Glucocorticoids|glucocorticoids|mesh-ancestor
6620816|NCT01274403|Hormones|hormones|mesh-ancestor
6620817|NCT01274403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6620818|NCT01274403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620819|NCT01274403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6620820|NCT01274403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6620821|NCT01274403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6620822|NCT01274403|Alkylating Agents|alkylating agents|mesh-ancestor
6620823|NCT01274403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620824|NCT01274403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6620825|NCT01274403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6620826|NCT01274403|Immunologic Factors|immunologic factors|mesh-ancestor
6620827|NCT01274403|Leprostatic Agents|leprostatic agents|mesh-ancestor
6620828|NCT01274403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6620829|NCT01274403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6620830|NCT01274403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6620831|NCT01274403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6620832|NCT01274403|Growth Substances|growth substances|mesh-ancestor
6620833|NCT01274403|Growth Inhibitors|growth inhibitors|mesh-ancestor
6620834|NCT01274481|Iloprost|iloprost|mesh-list
6620835|NCT01274481|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6620836|NCT01274481|Vasodilator Agents|vasodilator agents|mesh-ancestor
6620837|NCT01274624|Leucovorin|leucovorin|mesh-list
6620838|NCT01274624|Bevacizumab|bevacizumab|mesh-list
5502194|NCT04467931|Propranolol|propranolol|mesh-list
6620839|NCT01274624|Fluorouracil|fluorouracil|mesh-list
6620840|NCT01274624|Irinotecan|irinotecan|mesh-list
6620841|NCT01274624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6620842|NCT01274624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6620843|NCT01274624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6661752|NCT01500850|Insulin glulisine|insulin glulisine|mesh-list
6620844|NCT01274624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6620845|NCT01274624|Growth Substances|growth substances|mesh-ancestor
6620846|NCT01274624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620847|NCT01274624|Growth Inhibitors|growth inhibitors|mesh-ancestor
6620848|NCT01274624|Antimetabolites|antimetabolites|mesh-ancestor
6620849|NCT01274624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620850|NCT01274624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6620851|NCT01274624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6620852|NCT01274624|Immunologic Factors|immunologic factors|mesh-ancestor
6620853|NCT01274624|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6620854|NCT01274624|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6620855|NCT01274624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6620856|NCT01274624|Antidotes|antidotes|mesh-ancestor
6620857|NCT01274624|Protective Agents|protective agents|mesh-ancestor
6620858|NCT01274624|Vitamin B Complex|vitamin b complex|mesh-ancestor
6620859|NCT01274624|Vitamins|vitamins|mesh-ancestor
6620860|NCT01274624|Micronutrients|micronutrients|mesh-ancestor
6620861|NCT01274780|Ritonavir|ritonavir|mesh-list
6620862|NCT01274780|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6620863|NCT01274780|Darunavir|darunavir|mesh-list
6620864|NCT01274780|Tenofovir|tenofovir|mesh-list
6620865|NCT01274780|Emtricitabine|emtricitabine|mesh-list
6620866|NCT01274780|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6620867|NCT01274780|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6620868|NCT01274780|Protease Inhibitors|protease inhibitors|mesh-ancestor
6620869|NCT01274780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6620870|NCT01274780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620871|NCT01274780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6620872|NCT01274780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6620873|NCT01274780|Antiviral Agents|antiviral agents|mesh-ancestor
6620874|NCT01274780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6620875|NCT01274780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6620876|NCT01274780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6620877|NCT01274780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6620878|NCT01274780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6620879|NCT01274793|Mosapride|mosapride|mesh-list
6620880|NCT01274793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620881|NCT01274793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6620882|NCT01274793|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6620883|NCT01274793|Serotonin Agents|serotonin agents|mesh-ancestor
6620884|NCT01274793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6620885|NCT01274793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661753|NCT01500850|Insulin, Isophane|insulin, isophane|mesh-list
6661754|NCT01500850|Isophane Insulin, Human|isophane insulin, human|mesh-list
6661755|NCT01500850|Isophane insulin, beef|isophane insulin, beef|mesh-list
6661756|NCT01500850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6661757|NCT01500850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661758|NCT01500863|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6661759|NCT01500863|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6620886|NCT01274988|Methadone|methadone|mesh-list
6620887|NCT01274988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6620888|NCT01274988|Narcotics|narcotics|mesh-ancestor
6620889|NCT01274988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6620890|NCT01274988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620891|NCT01274988|Analgesics|analgesics|mesh-ancestor
6620892|NCT01274988|Sensory System Agents|sensory system agents|mesh-ancestor
6620893|NCT01274988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6620894|NCT01274988|Antitussive Agents|antitussive agents|mesh-ancestor
6620895|NCT01274988|Respiratory System Agents|respiratory system agents|mesh-ancestor
6620896|NCT01275014|Dexamethasone|dexamethasone|mesh-list
6620897|NCT01275014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6620898|NCT01275014|Antiemetics|antiemetics|mesh-ancestor
6620899|NCT01275014|Autonomic Agents|autonomic agents|mesh-ancestor
6620900|NCT01275014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6620901|NCT01275014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620902|NCT01275014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6620903|NCT01275014|Glucocorticoids|glucocorticoids|mesh-ancestor
6620904|NCT01275014|Hormones|hormones|mesh-ancestor
6620905|NCT01275014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6620906|NCT01275014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6620907|NCT01275014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6620908|NCT01275183|Raltegravir Potassium|raltegravir potassium|mesh-list
6620909|NCT01275183|Cisplatin|cisplatin|mesh-list
6620910|NCT01275183|Docetaxel|docetaxel|mesh-list
6620911|NCT01275183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6620912|NCT01275183|Tubulin Modulators|tubulin modulators|mesh-ancestor
6620913|NCT01275183|Antimitotic Agents|antimitotic agents|mesh-ancestor
6620914|NCT01275183|Mitosis Modulators|mitosis modulators|mesh-ancestor
6620915|NCT01275183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620916|NCT01275183|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6620917|NCT01275183|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6620918|NCT01275183|Antiviral Agents|antiviral agents|mesh-ancestor
6620919|NCT01275183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6620920|NCT01275183|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6620921|NCT01275183|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6620922|NCT01275183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6620923|NCT01275248|Ondansetron|ondansetron|mesh-list
6620924|NCT01275248|Antiemetics|antiemetics|mesh-ancestor
6620925|NCT01275248|Autonomic Agents|autonomic agents|mesh-ancestor
6620926|NCT01275248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6620927|NCT01275248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620928|NCT01275248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6620929|NCT01275248|Antipruritics|antipruritics|mesh-ancestor
6620930|NCT01275248|Dermatologic Agents|dermatologic agents|mesh-ancestor
6620931|NCT01275248|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6620932|NCT01275248|Serotonin Agents|serotonin agents|mesh-ancestor
6620933|NCT01275248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6620934|NCT01275248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620935|NCT01275248|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6620936|NCT01275248|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6620937|NCT01275248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6620938|NCT01275248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6620939|NCT01275248|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6620940|NCT01275274|Tretinoin|tretinoin|mesh-list
6620941|NCT01275274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6620942|NCT01275274|Keratolytic Agents|keratolytic agents|mesh-ancestor
6620943|NCT01275274|Dermatologic Agents|dermatologic agents|mesh-ancestor
6620944|NCT01275287|Eculizumab|eculizumab|mesh-list
6620945|NCT01275287|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6620946|NCT01275287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6620947|NCT01275287|Immunologic Factors|immunologic factors|mesh-ancestor
6620948|NCT01275287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620949|NCT01275352|Eplerenone|eplerenone|mesh-list
6620950|NCT01275352|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
6620951|NCT01275352|Hormone Antagonists|hormone antagonists|mesh-ancestor
6620952|NCT01275352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6620953|NCT01275352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620954|NCT01275352|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6620955|NCT01275352|Diuretics|diuretics|mesh-ancestor
6620956|NCT01275352|Natriuretic Agents|natriuretic agents|mesh-ancestor
6620957|NCT01275352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6620958|NCT01275443|Rilpivirine|rilpivirine|mesh-list
6620959|NCT01275443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6620960|NCT01275443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6620961|NCT01275443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6620962|NCT01275443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620963|NCT01275443|Antiviral Agents|antiviral agents|mesh-ancestor
6620964|NCT01275443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6620965|NCT01275443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5502195|NCT04467931|Metoprolol|metoprolol|mesh-list
5502196|NCT04467931|Atenolol|atenolol|mesh-list
5502197|NCT04467931|Verapamil|verapamil|mesh-list
5502198|NCT04467931|Felodipine|felodipine|mesh-list
5502199|NCT04467931|Nadolol|nadolol|mesh-list
5502200|NCT04467931|Acebutolol|acebutolol|mesh-list
5502201|NCT04467931|Amlodipine|amlodipine|mesh-list
5502202|NCT04467931|Valsartan|valsartan|mesh-list
5502203|NCT04467931|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5502204|NCT04467931|Telmisartan|telmisartan|mesh-list
5502205|NCT04467931|Clonidine|clonidine|mesh-list
5502206|NCT04467931|Carvedilol|carvedilol|mesh-list
5502207|NCT04467931|Candesartan|candesartan|mesh-list
5502208|NCT04467931|Candesartan cilexetil|candesartan cilexetil|mesh-list
6620966|NCT01275443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5502209|NCT04467931|Ramipril|ramipril|mesh-list
5502210|NCT04467931|Olmesartan|olmesartan|mesh-list
5502211|NCT04467931|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
5502212|NCT04467931|Enalapril|enalapril|mesh-list
5502213|NCT04467931|Enalaprilat|enalaprilat|mesh-list
6620967|NCT01275508|Adalimumab|adalimumab|mesh-list
6620968|NCT01275508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6620969|NCT01275508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6620970|NCT01275521|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
6620971|NCT01275521|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6620972|NCT01275521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6620973|NCT01275521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620974|NCT01275521|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6620975|NCT01275521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6620976|NCT01275521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620977|NCT01275521|Cholinergic Agents|cholinergic agents|mesh-ancestor
6620978|NCT01275521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6620979|NCT01275547|Midazolam|midazolam|mesh-list
6620980|NCT01275547|Morphine|morphine|mesh-list
6620981|NCT01275547|Ketamine|ketamine|mesh-list
6620982|NCT01275547|Esketamine|esketamine|mesh-list
6620983|NCT01275547|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6620984|NCT01275547|Narcotics|narcotics|mesh-ancestor
6620985|NCT01275547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6620986|NCT01275547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6620987|NCT01275547|Analgesics|analgesics|mesh-ancestor
6620988|NCT01275547|Sensory System Agents|sensory system agents|mesh-ancestor
6620989|NCT01275547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6620990|NCT01275547|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6620991|NCT01275547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6620992|NCT01275547|Anesthetics, General|anesthetics, general|mesh-ancestor
6620993|NCT01275547|Anesthetics|anesthetics|mesh-ancestor
6620994|NCT01275547|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6620995|NCT01275547|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6620996|NCT01275547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6620997|NCT01275547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6620998|NCT01275547|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6620999|NCT01275547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6621000|NCT01275547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6621001|NCT01275547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6621002|NCT01275547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6621003|NCT01275547|GABA Modulators|gaba modulators|mesh-ancestor
6621004|NCT01275547|GABA Agents|gaba agents|mesh-ancestor
6621005|NCT01275547|Antidepressive Agents|antidepressive agents|mesh-ancestor
6621006|NCT01275560|Metronidazole|metronidazole|mesh-list
6621007|NCT01275560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6621008|NCT01275560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6621009|NCT01275560|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6621010|NCT01275560|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6621011|NCT01275599|Buprenorphine|buprenorphine|mesh-list
6621012|NCT01275599|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6621013|NCT01275599|Naloxone|naloxone|mesh-list
6621014|NCT01275599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6621015|NCT01275599|Narcotics|narcotics|mesh-ancestor
6621016|NCT01275599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6621017|NCT01275599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621018|NCT01275599|Analgesics|analgesics|mesh-ancestor
6621019|NCT01275599|Sensory System Agents|sensory system agents|mesh-ancestor
6621020|NCT01275599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6621021|NCT01275599|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6621022|NCT01275638|Prednisolone|prednisolone|mesh-list
6621023|NCT01275638|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6621024|NCT01275638|Methylprednisolone|methylprednisolone|mesh-list
6621025|NCT01275638|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6621026|NCT01275638|Prednisolone acetate|prednisolone acetate|mesh-list
6621027|NCT01275638|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6621028|NCT01275638|Prednisolone phosphate|prednisolone phosphate|mesh-list
6621029|NCT01275638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6621030|NCT01275638|Glucocorticoids|glucocorticoids|mesh-ancestor
6621031|NCT01275638|Hormones|hormones|mesh-ancestor
6621032|NCT01275638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6621033|NCT01275638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621034|NCT01275638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6621035|NCT01275638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5502214|NCT04467931|Lisinopril|lisinopril|mesh-list
6621036|NCT01275638|Antiemetics|antiemetics|mesh-ancestor
6621037|NCT01275638|Autonomic Agents|autonomic agents|mesh-ancestor
5502215|NCT04467931|Irbesartan|irbesartan|mesh-list
6621038|NCT01275638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6621039|NCT01275638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6621040|NCT01275638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6621041|NCT01275638|Protective Agents|protective agents|mesh-ancestor
6621042|NCT01275729|Furosemide|furosemide|mesh-list
6621043|NCT01275729|Diuretics|diuretics|mesh-ancestor
6621044|NCT01275729|Natriuretic Agents|natriuretic agents|mesh-ancestor
6621045|NCT01275729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621046|NCT01275729|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6621047|NCT01275729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6621048|NCT01275729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621049|NCT01275859|Letrozole|letrozole|mesh-list
6621050|NCT01275859|Lapatinib|lapatinib|mesh-list
6621051|NCT01275859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6621052|NCT01275859|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6621053|NCT01275859|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6621054|NCT01275859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6621055|NCT01275859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621056|NCT01275859|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6621057|NCT01275859|Hormone Antagonists|hormone antagonists|mesh-ancestor
6621058|NCT01275859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6621059|NCT01275859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621060|NCT01275859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6621061|NCT01275885|Cholecalciferol|cholecalciferol|mesh-list
6621062|NCT01275885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6621063|NCT01275885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621064|NCT01275885|Vitamins|vitamins|mesh-ancestor
6621065|NCT01275885|Micronutrients|micronutrients|mesh-ancestor
6621066|NCT01275885|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6621067|NCT01275911|Remifentanil|remifentanil|mesh-list
6621068|NCT01275911|Esmolol|esmolol|mesh-list
6621069|NCT01275911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6621070|NCT01275911|Narcotics|narcotics|mesh-ancestor
6621071|NCT01275911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6621072|NCT01275911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621073|NCT01275911|Analgesics|analgesics|mesh-ancestor
6621074|NCT01275911|Sensory System Agents|sensory system agents|mesh-ancestor
6621075|NCT01275911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6621076|NCT01275911|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6621077|NCT01275911|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6621078|NCT01275911|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6621079|NCT01275911|Adrenergic Agents|adrenergic agents|mesh-ancestor
6621080|NCT01275911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6621081|NCT01275911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621082|NCT01275937|Esomeprazole|esomeprazole|mesh-list
6621083|NCT01275937|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6621084|NCT01275937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6621085|NCT01275937|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6621086|NCT01275937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6621087|NCT01275937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621088|NCT01275976|Complement C1s|complement c1s|mesh-list
6621089|NCT01275976|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
6621090|NCT01275976|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
6621091|NCT01275976|Immunologic Factors|immunologic factors|mesh-ancestor
6621092|NCT01275976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621093|NCT01275976|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6621094|NCT01275976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6621095|NCT01276015|Botulinum Toxins|botulinum toxins|mesh-list
6621096|NCT01276015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6621097|NCT01276015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6621098|NCT01276015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6621099|NCT01276015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6621100|NCT01276015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621101|NCT01276015|Cholinergic Agents|cholinergic agents|mesh-ancestor
6621102|NCT01276015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6621103|NCT01276015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621104|NCT01276015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6621105|NCT01276015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6621106|NCT01276067|Donepezil|donepezil|mesh-list
6621107|NCT01276067|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6621108|NCT01276067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6621109|NCT01276067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621110|NCT01276067|Cholinergic Agents|cholinergic agents|mesh-ancestor
6621111|NCT01276067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6621112|NCT01276067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621113|NCT01276067|Nootropic Agents|nootropic agents|mesh-ancestor
6621114|NCT01276080|Donepezil|donepezil|mesh-list
6621115|NCT01276080|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6621116|NCT01276080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6621117|NCT01276080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621118|NCT01276080|Cholinergic Agents|cholinergic agents|mesh-ancestor
6621119|NCT01276080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6621120|NCT01276080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621121|NCT01276080|Nootropic Agents|nootropic agents|mesh-ancestor
6621122|NCT01276093|Amiodarone|amiodarone|mesh-list
6621123|NCT01276093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6621124|NCT01276093|Vasodilator Agents|vasodilator agents|mesh-ancestor
6621125|NCT01276093|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6621126|NCT01276093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6661760|NCT01500863|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6450699|NCT00409253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6450700|NCT00409253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450701|NCT00409253|Vasodilator Agents|vasodilator agents|mesh-ancestor
6450702|NCT00409253|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6450703|NCT00409253|Serotonin Agents|serotonin agents|mesh-ancestor
6450704|NCT00409253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6450705|NCT00409253|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6450706|NCT00409253|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6450707|NCT00409253|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6450708|NCT00409253|Adrenergic Agents|adrenergic agents|mesh-ancestor
6621127|NCT01276093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621128|NCT01276093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6621129|NCT01276093|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6621130|NCT01276093|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6621131|NCT01276093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6621132|NCT01276093|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6621133|NCT01276093|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6621134|NCT01276093|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6621135|NCT01276210|Sorafenib|sorafenib|mesh-list
6621136|NCT01276210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6621137|NCT01276210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6621138|NCT01276210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6621139|NCT01276210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621140|NCT01276262|Contraceptive Agents|contraceptive agents|mesh-list
6621141|NCT01276262|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
6621142|NCT01276262|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
6621143|NCT01276262|Contraceptives, Oral|contraceptives, oral|mesh-list
6621144|NCT01276262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6621145|NCT01276262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621146|NCT01276262|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6621147|NCT01276262|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6621148|NCT01276262|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6621149|NCT01276262|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6621150|NCT01276262|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6621151|NCT01276262|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
6621152|NCT01276262|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6621153|NCT01276262|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6621154|NCT01276431|Buprenorphine|buprenorphine|mesh-list
6621155|NCT01276431|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6621156|NCT01276431|Narcotics|narcotics|mesh-ancestor
6621157|NCT01276431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6621158|NCT01276431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621159|NCT01276431|Analgesics|analgesics|mesh-ancestor
6621160|NCT01276431|Sensory System Agents|sensory system agents|mesh-ancestor
6621161|NCT01276431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6621162|NCT01276431|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6621163|NCT01276496|Paclitaxel|paclitaxel|mesh-list
6621164|NCT01276496|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6621165|NCT01276496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6621166|NCT01276496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6621167|NCT01276496|Tubulin Modulators|tubulin modulators|mesh-ancestor
6621168|NCT01276496|Antimitotic Agents|antimitotic agents|mesh-ancestor
6621169|NCT01276496|Mitosis Modulators|mitosis modulators|mesh-ancestor
6621170|NCT01276496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621171|NCT01276548|Carboplatin|carboplatin|mesh-list
6621172|NCT01276548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6621173|NCT01276600|Tenofovir|tenofovir|mesh-list
6621174|NCT01276600|Emtricitabine|emtricitabine|mesh-list
6621175|NCT01276600|Antiviral Agents|antiviral agents|mesh-ancestor
6621176|NCT01276600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6621177|NCT01276600|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6621178|NCT01276600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6621179|NCT01276600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6621180|NCT01276600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621181|NCT01276600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6621182|NCT01276600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6621183|NCT01276613|Gemcitabine|gemcitabine|mesh-list
6621184|NCT01276613|Losartan|losartan|mesh-list
6621185|NCT01276613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6621186|NCT01276613|Antimetabolites|antimetabolites|mesh-ancestor
6661761|NCT01500863|Estradiol|estradiol|mesh-list
6450709|NCT00409305|Betahistine|betahistine|mesh-list
6621187|NCT01276613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621188|NCT01276613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6621189|NCT01276613|Antiviral Agents|antiviral agents|mesh-ancestor
6621190|NCT01276613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6621191|NCT01276613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6621192|NCT01276613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6621193|NCT01276613|Immunologic Factors|immunologic factors|mesh-ancestor
6621194|NCT01276613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621195|NCT01276613|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6621196|NCT01276613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6621197|NCT01276613|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6621198|NCT01276613|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6621199|NCT01276691|Aspirin|aspirin|mesh-list
6621200|NCT01276691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6621201|NCT01276691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6621202|NCT01276691|Analgesics|analgesics|mesh-ancestor
6621203|NCT01276691|Sensory System Agents|sensory system agents|mesh-ancestor
6621204|NCT01276691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6621205|NCT01276691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621206|NCT01276691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6621207|NCT01276691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6621208|NCT01276691|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6621209|NCT01276691|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6621210|NCT01276691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621211|NCT01276691|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6621212|NCT01276691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6621213|NCT01276691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6621214|NCT01276691|Antipyretics|antipyretics|mesh-ancestor
6621215|NCT01276704|Secoisolariciresinol|secoisolariciresinol|mesh-list
6621216|NCT01276704|Phytoestrogens|phytoestrogens|mesh-ancestor
6621217|NCT01276704|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6621218|NCT01276704|Estrogens|estrogens|mesh-ancestor
6621219|NCT01276704|Hormones|hormones|mesh-ancestor
6621220|NCT01276704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6621221|NCT01276704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621222|NCT01276717|Vorinostat|vorinostat|mesh-list
6621223|NCT01276717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6621224|NCT01276717|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6621225|NCT01276717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6621226|NCT01276717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621227|NCT01276730|Interferons|interferons|mesh-list
6621228|NCT01276730|Tretinoin|tretinoin|mesh-list
6621229|NCT01276730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6621230|NCT01276730|Antiviral Agents|antiviral agents|mesh-ancestor
6621231|NCT01276730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6621232|NCT01276730|Keratolytic Agents|keratolytic agents|mesh-ancestor
6621233|NCT01276730|Dermatologic Agents|dermatologic agents|mesh-ancestor
6621234|NCT01276769|Paclitaxel|paclitaxel|mesh-list
6621235|NCT01276769|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6621236|NCT01276769|Carboplatin|carboplatin|mesh-list
6621237|NCT01276769|Epirubicin|epirubicin|mesh-list
6621238|NCT01276769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6621239|NCT01276769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6621240|NCT01276769|Tubulin Modulators|tubulin modulators|mesh-ancestor
6621241|NCT01276769|Antimitotic Agents|antimitotic agents|mesh-ancestor
6621242|NCT01276769|Mitosis Modulators|mitosis modulators|mesh-ancestor
6621243|NCT01276769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621244|NCT01276769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6621245|NCT01276769|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6621246|NCT01276769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6621247|NCT01276769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6661762|NCT01500863|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6661763|NCT01500863|Progesterone|progesterone|mesh-list
6661764|NCT01500863|Estrogens|estrogens|mesh-ancestor
6661765|NCT01500863|Hormones|hormones|mesh-ancestor
6661766|NCT01500863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6621248|NCT01276834|Everolimus|everolimus|mesh-list
6621249|NCT01276834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6621250|NCT01276834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6621251|NCT01276834|Immunologic Factors|immunologic factors|mesh-ancestor
6621252|NCT01276834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621253|NCT01276886|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6621254|NCT01276886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6621255|NCT01276912|Insulin Glargine|insulin glargine|mesh-list
6621256|NCT01276912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6621257|NCT01276912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621258|NCT01276925|Bupivacaine|bupivacaine|mesh-list
6621259|NCT01276925|Ropivacaine|ropivacaine|mesh-list
6621260|NCT01276925|Anesthetics, Local|anesthetics, local|mesh-ancestor
6621261|NCT01276925|Anesthetics|anesthetics|mesh-ancestor
6621262|NCT01276925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6621263|NCT01276925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621264|NCT01276925|Sensory System Agents|sensory system agents|mesh-ancestor
6621265|NCT01276925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6621266|NCT01276977|Zolmitriptan|zolmitriptan|mesh-list
6621267|NCT01276977|Eletriptan|eletriptan|mesh-list
6621268|NCT01276977|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6621269|NCT01276977|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6621270|NCT01276977|Serotonin Agents|serotonin agents|mesh-ancestor
6621271|NCT01276977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6621272|NCT01276977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621273|NCT01276977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621274|NCT01277016|Melphalan|melphalan|mesh-list
6621275|NCT01277016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6621276|NCT01277016|Alkylating Agents|alkylating agents|mesh-ancestor
6621277|NCT01277016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621278|NCT01277016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6621279|NCT01277016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6621280|NCT01277016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6621281|NCT01277016|Immunologic Factors|immunologic factors|mesh-ancestor
6621282|NCT01277016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621283|NCT01277107|Zaleplon|zaleplon|mesh-list
6621284|NCT01277107|Anticonvulsants|anticonvulsants|mesh-ancestor
6621285|NCT01277107|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6621286|NCT01277107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6621287|NCT01277107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621288|NCT01277107|GABA Modulators|gaba modulators|mesh-ancestor
6621289|NCT01277107|GABA Agents|gaba agents|mesh-ancestor
6621290|NCT01277107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6621291|NCT01277107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621292|NCT01277172|Rituximab|rituximab|mesh-list
6621293|NCT01277172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6621294|NCT01277172|Antibodies|antibodies|mesh-list
6621295|NCT01277172|Immunoglobulins|immunoglobulins|mesh-list
6621296|NCT01277172|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6621297|NCT01277172|Immunologic Factors|immunologic factors|mesh-ancestor
6621298|NCT01277172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621299|NCT01277172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6621300|NCT01277172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6621301|NCT01277185|Calcium, Dietary|calcium, dietary|mesh-list
6621302|NCT01277185|Calcium|calcium|mesh-list
6621303|NCT01277185|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6621304|NCT01277185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621305|NCT01277185|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6621306|NCT01277289|Dexamethasone|dexamethasone|mesh-list
6621307|NCT01277289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6621308|NCT01277289|Antiemetics|antiemetics|mesh-ancestor
6621309|NCT01277289|Autonomic Agents|autonomic agents|mesh-ancestor
6621310|NCT01277289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6621311|NCT01277289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621312|NCT01277289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6621313|NCT01277289|Glucocorticoids|glucocorticoids|mesh-ancestor
6621314|NCT01277289|Hormones|hormones|mesh-ancestor
6621315|NCT01277289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6621316|NCT01277289|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6621317|NCT01277289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6621318|NCT01277315|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6621319|NCT01277315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5502216|NCT04467931|Eplerenone|eplerenone|mesh-list
6621320|NCT01277484|Decitabine|decitabine|mesh-list
6621321|NCT01277484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6621322|NCT01277484|Antimetabolites|antimetabolites|mesh-ancestor
6621323|NCT01277484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621324|NCT01277484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6621325|NCT01277484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6621326|NCT01277497|Calcium|calcium|mesh-list
6621327|NCT01277497|Sevelamer|sevelamer|mesh-list
6621328|NCT01277497|Calcium acetate|calcium acetate|mesh-list
6621329|NCT01277497|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6621330|NCT01277497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621331|NCT01277497|Chelating Agents|chelating agents|mesh-ancestor
6621332|NCT01277497|Sequestering Agents|sequestering agents|mesh-ancestor
6621333|NCT01277497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621334|NCT01277627|Efavirenz|efavirenz|mesh-list
6621335|NCT01277627|Nevirapine|nevirapine|mesh-list
6621336|NCT01277627|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
6621337|NCT01277627|Protease Inhibitors|protease inhibitors|mesh-list
6621338|NCT01277627|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6621339|NCT01277627|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6621340|NCT01277627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6621341|NCT01277627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621342|NCT01277627|Antiviral Agents|antiviral agents|mesh-ancestor
6621343|NCT01277627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6621344|NCT01277627|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6621345|NCT01277627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6621346|NCT01277627|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6621347|NCT01277627|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6621348|NCT01277627|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6621349|NCT01277627|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6621350|NCT01277627|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6621351|NCT01277627|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6621352|NCT01277627|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6621353|NCT01277640|Dapivirine|dapivirine|mesh-list
6621354|NCT01277640|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6621355|NCT01277640|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6621356|NCT01277640|Antiviral Agents|antiviral agents|mesh-ancestor
6621357|NCT01277640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6621358|NCT01277705|Vaccines|vaccines|mesh-list
6621359|NCT01277705|Immunologic Factors|immunologic factors|mesh-ancestor
6621360|NCT01277705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621361|NCT01277731|Methylprednisolone|methylprednisolone|mesh-list
6621362|NCT01277731|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6621363|NCT01277731|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6621364|NCT01277731|Prednisolone|prednisolone|mesh-list
6621365|NCT01277731|Prednisolone acetate|prednisolone acetate|mesh-list
6621366|NCT01277731|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6621367|NCT01277731|Prednisolone phosphate|prednisolone phosphate|mesh-list
6621368|NCT01277731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6621369|NCT01277731|Antiemetics|antiemetics|mesh-ancestor
6621370|NCT01277731|Autonomic Agents|autonomic agents|mesh-ancestor
6621371|NCT01277731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6621372|NCT01277731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621373|NCT01277731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6621374|NCT01277731|Glucocorticoids|glucocorticoids|mesh-ancestor
6621375|NCT01277731|Hormones|hormones|mesh-ancestor
6621376|NCT01277731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6621377|NCT01277731|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6621378|NCT01277731|Protective Agents|protective agents|mesh-ancestor
6621379|NCT01277731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6621380|NCT01277731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6621381|NCT01277770|Thymoglobulin|thymoglobulin|mesh-list
6621382|NCT01277770|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6621383|NCT01277770|Immunologic Factors|immunologic factors|mesh-ancestor
6621384|NCT01277770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621385|NCT01277770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6621386|NCT01277835|Lidocaine|lidocaine|mesh-list
6621387|NCT01277835|Anesthetics, Local|anesthetics, local|mesh-ancestor
6621388|NCT01277835|Anesthetics|anesthetics|mesh-ancestor
6621389|NCT01277835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6621390|NCT01277835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621391|NCT01277835|Sensory System Agents|sensory system agents|mesh-ancestor
6621392|NCT01277835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6621393|NCT01277835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6621394|NCT01277835|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6621395|NCT01277835|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6621396|NCT01277835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6621397|NCT01277835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621398|NCT01277913|Vitamin D|vitamin d|mesh-list
6621399|NCT01277913|Ergocalciferols|ergocalciferols|mesh-list
6621400|NCT01277913|Cholecalciferol|cholecalciferol|mesh-list
6621401|NCT01277913|Vitamins|vitamins|mesh-list
6621402|NCT01277913|Micronutrients|micronutrients|mesh-ancestor
6621403|NCT01277913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621404|NCT01277913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6621405|NCT01277913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6621406|NCT01278004|Ethosuximide|ethosuximide|mesh-list
6621407|NCT01278004|Anticonvulsants|anticonvulsants|mesh-ancestor
6621408|NCT01278017|Ceftriaxone|ceftriaxone|mesh-list
6621409|NCT01278017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6621410|NCT01278017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6621411|NCT01278056|Deferasirox|deferasirox|mesh-list
6621412|NCT01278056|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6621413|NCT01278056|Chelating Agents|chelating agents|mesh-ancestor
6621414|NCT01278056|Sequestering Agents|sequestering agents|mesh-ancestor
6621415|NCT01278056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621416|NCT01278082|Budesonide|budesonide|mesh-list
6621417|NCT01278082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6621418|NCT01278082|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6621419|NCT01278082|Autonomic Agents|autonomic agents|mesh-ancestor
6621420|NCT01278082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6621421|NCT01278082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621422|NCT01278082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6621423|NCT01278082|Respiratory System Agents|respiratory system agents|mesh-ancestor
6621424|NCT01278082|Glucocorticoids|glucocorticoids|mesh-ancestor
6621425|NCT01278082|Hormones|hormones|mesh-ancestor
6621426|NCT01278082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6621427|NCT01278186|Paclitaxel|paclitaxel|mesh-list
6621428|NCT01278186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6621429|NCT01278186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6621430|NCT01278186|Tubulin Modulators|tubulin modulators|mesh-ancestor
6621431|NCT01278186|Antimitotic Agents|antimitotic agents|mesh-ancestor
6621432|NCT01278186|Mitosis Modulators|mitosis modulators|mesh-ancestor
6621433|NCT01278186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621434|NCT01278238|Phenylephrine|phenylephrine|mesh-list
6621435|NCT01278238|Oxymetazoline|oxymetazoline|mesh-list
6621436|NCT01278238|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6621437|NCT01278238|Mydriatics|mydriatics|mesh-ancestor
6621438|NCT01278238|Autonomic Agents|autonomic agents|mesh-ancestor
6621439|NCT01278238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6621440|NCT01278238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621441|NCT01278238|Sympathomimetics|sympathomimetics|mesh-ancestor
6621442|NCT01278238|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6621443|NCT01278238|Nasal Decongestants|nasal decongestants|mesh-ancestor
6621444|NCT01278238|Respiratory System Agents|respiratory system agents|mesh-ancestor
6621445|NCT01278238|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6621446|NCT01278238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6621447|NCT01278238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6621448|NCT01278238|Adrenergic Agents|adrenergic agents|mesh-ancestor
6621449|NCT01278238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6621450|NCT01278238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621451|NCT01278238|Protective Agents|protective agents|mesh-ancestor
6621452|NCT01278264|Ropivacaine|ropivacaine|mesh-list
6621453|NCT01278264|Anesthetics, Local|anesthetics, local|mesh-ancestor
6621454|NCT01278264|Anesthetics|anesthetics|mesh-ancestor
6621455|NCT01278264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6621456|NCT01278264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621457|NCT01278264|Sensory System Agents|sensory system agents|mesh-ancestor
6621458|NCT01278264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6621459|NCT01278290|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6621460|NCT01278290|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
6621461|NCT01278290|Luteolytic Agents|luteolytic agents|mesh-ancestor
6621462|NCT01278290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6621463|NCT01278290|Contraceptive Agents|contraceptive agents|mesh-ancestor
6621464|NCT01278290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6621465|NCT01278290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621466|NCT01278290|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6621467|NCT01278290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6621468|NCT01278290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6621469|NCT01278290|Hormones|hormones|mesh-ancestor
6621470|NCT01278290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6621471|NCT01278446|Caseins|caseins|mesh-list
6621472|NCT01278446|Chelating Agents|chelating agents|mesh-ancestor
6621473|NCT01278446|Sequestering Agents|sequestering agents|mesh-ancestor
6621474|NCT01278446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621475|NCT01278459|Atorvastatin|atorvastatin|mesh-list
6621476|NCT01278459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6621477|NCT01278459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6621478|NCT01278459|Antimetabolites|antimetabolites|mesh-ancestor
6621479|NCT01278459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621480|NCT01278459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6621481|NCT01278459|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6621482|NCT01278459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6621483|NCT01278498|Citalopram|citalopram|mesh-list
6621484|NCT01278498|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6621485|NCT01278498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6621486|NCT01278498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6621487|NCT01278498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621488|NCT01278498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6621489|NCT01278498|Serotonin Agents|serotonin agents|mesh-ancestor
6621490|NCT01278498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621491|NCT01278498|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6621492|NCT01278498|Antidepressive Agents|antidepressive agents|mesh-ancestor
6621493|NCT01278498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6661767|NCT01500863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661768|NCT01500863|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6661769|NCT01500863|Contraceptive Agents|contraceptive agents|mesh-ancestor
6661770|NCT01500863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6661771|NCT01500863|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6661772|NCT01500863|Progestins|progestins|mesh-ancestor
6661773|NCT01500863|Luteolytic Agents|luteolytic agents|mesh-ancestor
6661774|NCT01500863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6661775|NCT01500863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6661776|NCT01500915|Ranibizumab|ranibizumab|mesh-list
6661777|NCT01500915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6661778|NCT01500915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6661779|NCT01500915|Growth Substances|growth substances|mesh-ancestor
6661780|NCT01500915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661781|NCT01500915|Growth Inhibitors|growth inhibitors|mesh-ancestor
6661782|NCT01500915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6661783|NCT01500928|Insulin|insulin|mesh-list
6661784|NCT01500928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6661785|NCT01500928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661786|NCT01500980|Chloroquine|chloroquine|mesh-list
6661787|NCT01500980|Primaquine|primaquine|mesh-list
6661788|NCT01500980|Amebicides|amebicides|mesh-ancestor
6661789|NCT01500980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6661790|NCT01500980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6661791|NCT01500980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6661792|NCT01500980|Antimalarials|antimalarials|mesh-ancestor
6661793|NCT01500980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6661794|NCT01500993|Fluorouracil|fluorouracil|mesh-list
6661795|NCT01500993|Capecitabine|capecitabine|mesh-list
6661796|NCT01500993|Antimetabolites|antimetabolites|mesh-ancestor
6661797|NCT01500993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661798|NCT01500993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6661799|NCT01500993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6661800|NCT01500993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6661801|NCT01500993|Immunologic Factors|immunologic factors|mesh-ancestor
6661802|NCT01500993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661803|NCT01501032|Pancrelipase|pancrelipase|mesh-list
6661804|NCT01501032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6661805|NCT01501084|Exenatide|exenatide|mesh-list
6661806|NCT01501084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6661807|NCT01501084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661808|NCT01501084|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6661809|NCT01501084|Incretins|incretins|mesh-ancestor
6661810|NCT01501084|Hormones|hormones|mesh-ancestor
6661811|NCT01501084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6661812|NCT01501123|Midazolam|midazolam|mesh-list
6661813|NCT01501123|Haloperidol|haloperidol|mesh-list
6661814|NCT01501123|Haloperidol decanoate|haloperidol decanoate|mesh-list
6661815|NCT01501123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6661816|NCT01501123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6661817|NCT01501123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6661818|NCT01501123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661819|NCT01501123|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6661820|NCT01501123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6661821|NCT01501123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6661822|NCT01501123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6661823|NCT01501123|Anesthetics, General|anesthetics, general|mesh-ancestor
6661824|NCT01501123|Anesthetics|anesthetics|mesh-ancestor
6661825|NCT01501123|GABA Modulators|gaba modulators|mesh-ancestor
6661826|NCT01501123|GABA Agents|gaba agents|mesh-ancestor
6661827|NCT01501123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6661828|NCT01501123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661829|NCT01501123|Antiemetics|antiemetics|mesh-ancestor
6621494|NCT01278576|Botulinum Toxins|botulinum toxins|mesh-list
6621495|NCT01278576|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6621496|NCT01278576|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6621497|NCT01278576|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6621498|NCT01278576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6621499|NCT01278576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621500|NCT01278576|Cholinergic Agents|cholinergic agents|mesh-ancestor
6621501|NCT01278576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6621502|NCT01278576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621503|NCT01278576|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6450710|NCT00409305|Vasodilator Agents|vasodilator agents|mesh-ancestor
6450711|NCT00409305|Histamine Agonists|histamine agonists|mesh-ancestor
6450712|NCT00409305|Histamine Agents|histamine agents|mesh-ancestor
6450713|NCT00409305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6450714|NCT00409305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450715|NCT00409305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450716|NCT00409318|Etanercept|etanercept|mesh-list
6621504|NCT01278576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6621505|NCT01278602|Rituximab|rituximab|mesh-list
6621506|NCT01278602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6621507|NCT01278602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6621508|NCT01278602|Immunologic Factors|immunologic factors|mesh-ancestor
6621509|NCT01278602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621510|NCT01278602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6621511|NCT01278758|Vadimezan|vadimezan|mesh-list
6621512|NCT01278758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6621513|NCT01278784|Acetylcysteine|acetylcysteine|mesh-list
6621514|NCT01278784|Chitosan|chitosan|mesh-list
6621515|NCT01278784|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6621516|NCT01278784|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6621517|NCT01278784|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6621518|NCT01278784|Antiviral Agents|antiviral agents|mesh-ancestor
6621519|NCT01278784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6450717|NCT00409318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6450718|NCT00409318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6621520|NCT01278784|Expectorants|expectorants|mesh-ancestor
6621521|NCT01278784|Respiratory System Agents|respiratory system agents|mesh-ancestor
6450719|NCT00409318|Analgesics|analgesics|mesh-ancestor
6621522|NCT01278784|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6621523|NCT01278784|Antioxidants|antioxidants|mesh-ancestor
6621524|NCT01278784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621525|NCT01278784|Protective Agents|protective agents|mesh-ancestor
6621526|NCT01278784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621527|NCT01278784|Antidotes|antidotes|mesh-ancestor
6621528|NCT01278784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6621529|NCT01278784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6621530|NCT01278784|Antimetabolites|antimetabolites|mesh-ancestor
6621531|NCT01278784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6621532|NCT01278784|Chelating Agents|chelating agents|mesh-ancestor
6621533|NCT01278784|Sequestering Agents|sequestering agents|mesh-ancestor
6621534|NCT01278784|Hemostatics|hemostatics|mesh-ancestor
6621535|NCT01278784|Coagulants|coagulants|mesh-ancestor
6621536|NCT01278849|Vadimezan|vadimezan|mesh-list
6621537|NCT01278849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6621538|NCT01279083|Timolol|timolol|mesh-list
6621539|NCT01279083|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6621540|NCT01279083|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6621541|NCT01279083|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6621542|NCT01279083|Adrenergic Agents|adrenergic agents|mesh-ancestor
6621543|NCT01279083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6621544|NCT01279083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621545|NCT01279083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621546|NCT01279083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6621547|NCT01279083|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6621548|NCT01279096|Dexamethasone|dexamethasone|mesh-list
6621549|NCT01279096|Etoposide|etoposide|mesh-list
6621550|NCT01279096|Asparaginase|asparaginase|mesh-list
6621551|NCT01279096|Mitoxantrone|mitoxantrone|mesh-list
6621552|NCT01279096|Clofarabine|clofarabine|mesh-list
6621553|NCT01279096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6621554|NCT01279096|Antiemetics|antiemetics|mesh-ancestor
6621555|NCT01279096|Autonomic Agents|autonomic agents|mesh-ancestor
6621556|NCT01279096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6621557|NCT01279096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621558|NCT01279096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6621559|NCT01279096|Glucocorticoids|glucocorticoids|mesh-ancestor
6621560|NCT01279096|Hormones|hormones|mesh-ancestor
6621561|NCT01279096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6621562|NCT01279096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6621563|NCT01279096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6621564|NCT01279096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6621565|NCT01279096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621566|NCT01279096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6621567|NCT01279096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6621568|NCT01279096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6621569|NCT01279096|Analgesics|analgesics|mesh-ancestor
6621570|NCT01279096|Sensory System Agents|sensory system agents|mesh-ancestor
6621571|NCT01279096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6621572|NCT01279096|Antimetabolites|antimetabolites|mesh-ancestor
6621573|NCT01279213|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6621574|NCT01279213|Clozapine|clozapine|mesh-list
6621575|NCT01279213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6621576|NCT01279213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6621577|NCT01279213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6621578|NCT01279213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621579|NCT01279213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6621580|NCT01279213|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6621581|NCT01279213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6621582|NCT01279213|Serotonin Agents|serotonin agents|mesh-ancestor
6621583|NCT01279213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6621584|NCT01279213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621585|NCT01279213|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6621586|NCT01279213|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6621587|NCT01279213|Dopamine Agents|dopamine agents|mesh-ancestor
6621588|NCT01279213|GABA Antagonists|gaba antagonists|mesh-ancestor
6621589|NCT01279213|GABA Agents|gaba agents|mesh-ancestor
6621590|NCT01279252|Metronidazole|metronidazole|mesh-list
6621591|NCT01279252|Clarithromycin|clarithromycin|mesh-list
6621592|NCT01279252|Ciprofloxacin|ciprofloxacin|mesh-list
6621593|NCT01279252|Lansoprazole|lansoprazole|mesh-list
6621594|NCT01279252|Dexlansoprazole|dexlansoprazole|mesh-list
6621595|NCT01279252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6621596|NCT01279252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6621597|NCT01279252|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6621598|NCT01279252|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6621599|NCT01279252|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6621600|NCT01279252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6621601|NCT01279252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621602|NCT01279252|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6621603|NCT01279252|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6621604|NCT01279252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6621605|NCT01279252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6621606|NCT01279252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6621607|NCT01279252|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6621608|NCT01279252|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6621609|NCT01279252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6621610|NCT01279252|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6621611|NCT01279291|Gemcitabine|gemcitabine|mesh-list
6621612|NCT01279291|Paclitaxel|paclitaxel|mesh-list
6621613|NCT01279291|Carboplatin|carboplatin|mesh-list
6621614|NCT01279291|Doxorubicin|doxorubicin|mesh-list
6621615|NCT01279291|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6621616|NCT01279291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6621617|NCT01279291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6621618|NCT01279291|Tubulin Modulators|tubulin modulators|mesh-ancestor
6621619|NCT01279291|Antimitotic Agents|antimitotic agents|mesh-ancestor
6621620|NCT01279291|Mitosis Modulators|mitosis modulators|mesh-ancestor
6621621|NCT01279291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621622|NCT01279291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6621623|NCT01279291|Antimetabolites|antimetabolites|mesh-ancestor
6621624|NCT01279291|Antiviral Agents|antiviral agents|mesh-ancestor
6621625|NCT01279291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6621626|NCT01279291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6621627|NCT01279291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6621628|NCT01279291|Immunologic Factors|immunologic factors|mesh-ancestor
6621629|NCT01279291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621630|NCT01279291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6621631|NCT01279291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6621632|NCT01279291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6621633|NCT01279434|Vitamins|vitamins|mesh-list
6621634|NCT01279434|Vitamin E|vitamin e|mesh-list
6621635|NCT01279434|Tocopherols|tocopherols|mesh-list
6621636|NCT01279434|Tocotrienols|tocotrienols|mesh-list
6621637|NCT01279434|alpha-Tocopherol|alpha-tocopherol|mesh-list
6621638|NCT01279434|Micronutrients|micronutrients|mesh-ancestor
6621639|NCT01279434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621640|NCT01279434|Antioxidants|antioxidants|mesh-ancestor
6621641|NCT01279434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621642|NCT01279434|Protective Agents|protective agents|mesh-ancestor
6621643|NCT01279499|Remifentanil|remifentanil|mesh-list
6621644|NCT01279499|Propofol|propofol|mesh-list
6621645|NCT01279499|Sevoflurane|sevoflurane|mesh-list
6621646|NCT01279499|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6621647|NCT01279499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6621648|NCT01279499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621649|NCT01279499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6621650|NCT01279499|Anesthetics, General|anesthetics, general|mesh-ancestor
6621651|NCT01279499|Anesthetics|anesthetics|mesh-ancestor
6621652|NCT01279499|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6621653|NCT01279499|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6621654|NCT01279499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6621655|NCT01279499|Narcotics|narcotics|mesh-ancestor
6621656|NCT01279499|Analgesics|analgesics|mesh-ancestor
6621657|NCT01279499|Sensory System Agents|sensory system agents|mesh-ancestor
6621658|NCT01279499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6621659|NCT01279512|Metformin|metformin|mesh-list
6621660|NCT01279512|Acarbose|acarbose|mesh-list
6621661|NCT01279512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6621662|NCT01279512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621663|NCT01279512|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6621664|NCT01279512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6621665|NCT01279512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621666|NCT01279551|Lidocaine|lidocaine|mesh-list
6621667|NCT01279551|Nitroglycerin|nitroglycerin|mesh-list
6621668|NCT01279551|Anesthetics, Local|anesthetics, local|mesh-ancestor
6621669|NCT01279551|Anesthetics|anesthetics|mesh-ancestor
6621670|NCT01279551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6621671|NCT01279551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621672|NCT01279551|Sensory System Agents|sensory system agents|mesh-ancestor
6621673|NCT01279551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6621674|NCT01279551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6621675|NCT01279551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6621676|NCT01279551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6621677|NCT01279551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6621678|NCT01279551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621679|NCT01279551|Vasodilator Agents|vasodilator agents|mesh-ancestor
6621680|NCT01279629|Tazarotene|tazarotene|mesh-list
6621681|NCT01279629|Calcipotriene|calcipotriene|mesh-list
6621682|NCT01279629|Dermatologic Agents|dermatologic agents|mesh-ancestor
6621683|NCT01279629|Keratolytic Agents|keratolytic agents|mesh-ancestor
6621684|NCT01279668|Montelukast|montelukast|mesh-list
6621685|NCT01279668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6621686|NCT01279668|Respiratory System Agents|respiratory system agents|mesh-ancestor
6621687|NCT01279668|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6621688|NCT01279668|Hormone Antagonists|hormone antagonists|mesh-ancestor
6621689|NCT01279668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6621690|NCT01279668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621691|NCT01279668|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6621692|NCT01279668|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6621693|NCT01279668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621694|NCT01279694|Prednisone|prednisone|mesh-list
6621695|NCT01279694|Melphalan|melphalan|mesh-list
6621696|NCT01279694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6621697|NCT01279694|Glucocorticoids|glucocorticoids|mesh-ancestor
6621698|NCT01279694|Hormones|hormones|mesh-ancestor
6621699|NCT01279694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6621700|NCT01279694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621701|NCT01279694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6621702|NCT01279694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6621703|NCT01279694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6621704|NCT01279694|Alkylating Agents|alkylating agents|mesh-ancestor
6621705|NCT01279694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621706|NCT01279694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6621707|NCT01279694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6621708|NCT01279694|Immunologic Factors|immunologic factors|mesh-ancestor
6621709|NCT01279707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6621710|NCT01279707|Epratuzumab|epratuzumab|mesh-list
6621711|NCT01279707|Veltuzumab|veltuzumab|mesh-list
6621712|NCT01279707|Antibodies|antibodies|mesh-list
6621713|NCT01279707|Immunoglobulins|immunoglobulins|mesh-list
6621714|NCT01279707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6621715|NCT01279707|Immunologic Factors|immunologic factors|mesh-ancestor
6621716|NCT01279707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621717|NCT01279707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6621718|NCT01279811|Dopamine|dopamine|mesh-list
6621719|NCT01279811|Norepinephrine|norepinephrine|mesh-list
6621720|NCT01279811|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
6621721|NCT01279811|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6621722|NCT01279811|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6621723|NCT01279811|Adrenergic Agents|adrenergic agents|mesh-ancestor
6621724|NCT01279811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6621725|NCT01279811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621726|NCT01279811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621727|NCT01279811|Sympathomimetics|sympathomimetics|mesh-ancestor
6621728|NCT01279811|Autonomic Agents|autonomic agents|mesh-ancestor
6621729|NCT01279811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6621730|NCT01279811|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6621731|NCT01279811|Dopamine Agents|dopamine agents|mesh-ancestor
6621732|NCT01279811|Protective Agents|protective agents|mesh-ancestor
6621733|NCT01279876|Melatonin|melatonin|mesh-list
6621734|NCT01279876|Antioxidants|antioxidants|mesh-ancestor
6621735|NCT01279876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621736|NCT01279876|Protective Agents|protective agents|mesh-ancestor
6621737|NCT01279876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621738|NCT01279876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6621739|NCT01279902|Rituximab|rituximab|mesh-list
6621740|NCT01279902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6621741|NCT01279902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6621742|NCT01279902|Immunologic Factors|immunologic factors|mesh-ancestor
6621743|NCT01279902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621744|NCT01279902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6621745|NCT01279915|Linaclotide|linaclotide|mesh-list
6621746|NCT01279915|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
6621747|NCT01279915|Enzyme Activators|enzyme activators|mesh-ancestor
6621748|NCT01279915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621749|NCT01279915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6621750|NCT01279980|Anesthetics|anesthetics|mesh-list
6621751|NCT01279980|Anesthetics, Local|anesthetics, local|mesh-list
6621752|NCT01279980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6621753|NCT01279980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621754|NCT01279980|Sensory System Agents|sensory system agents|mesh-ancestor
6621755|NCT01279980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6621756|NCT01280006|Celecoxib|celecoxib|mesh-list
6621757|NCT01280006|Indomethacin|indomethacin|mesh-list
6621758|NCT01280006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6621759|NCT01280006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6621760|NCT01280006|Analgesics|analgesics|mesh-ancestor
6621761|NCT01280006|Sensory System Agents|sensory system agents|mesh-ancestor
6621762|NCT01280006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6621763|NCT01280006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621764|NCT01280006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6621765|NCT01280006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6621766|NCT01280006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6621767|NCT01280006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6621768|NCT01280006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6621769|NCT01280006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621770|NCT01280006|Gout Suppressants|gout suppressants|mesh-ancestor
6621771|NCT01280006|Tocolytic Agents|tocolytic agents|mesh-ancestor
6621772|NCT01280006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6621773|NCT01280071|Aminophylline|aminophylline|mesh-list
6621774|NCT01280071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6621775|NCT01280071|Autonomic Agents|autonomic agents|mesh-ancestor
6621776|NCT01280071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6621777|NCT01280071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621778|NCT01280071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6621779|NCT01280071|Respiratory System Agents|respiratory system agents|mesh-ancestor
6621780|NCT01280071|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6621781|NCT01280071|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6621782|NCT01280071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6621783|NCT01280071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621784|NCT01280071|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6621785|NCT01280071|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6621786|NCT01280071|Purinergic Agents|purinergic agents|mesh-ancestor
6621787|NCT01280071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6621788|NCT01280071|Protective Agents|protective agents|mesh-ancestor
6661830|NCT01501123|Autonomic Agents|autonomic agents|mesh-ancestor
6661831|NCT01501123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6661832|NCT01501123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6661833|NCT01501123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6661834|NCT01501123|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6661835|NCT01501123|Dopamine Agents|dopamine agents|mesh-ancestor
6661836|NCT01501123|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6661837|NCT01501136|Gemcitabine|gemcitabine|mesh-list
6661838|NCT01501136|Dexamethasone|dexamethasone|mesh-list
6661839|NCT01501136|Dexamethasone acetate|dexamethasone acetate|mesh-list
6661840|NCT01501136|Cisplatin|cisplatin|mesh-list
6661841|NCT01501136|Etoposide|etoposide|mesh-list
6661842|NCT01501136|Etoposide phosphate|etoposide phosphate|mesh-list
6661843|NCT01501136|Ifosfamide|ifosfamide|mesh-list
6661844|NCT01501136|Isophosphamide mustard|isophosphamide mustard|mesh-list
6661845|NCT01501136|Pegaspargase|pegaspargase|mesh-list
6661846|NCT01501136|Asparaginase|asparaginase|mesh-list
6661847|NCT01501136|BB 1101|bb 1101|mesh-list
6661848|NCT01501136|Mesna|mesna|mesh-list
6661849|NCT01501136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6661850|NCT01501136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6661851|NCT01501136|Antiemetics|antiemetics|mesh-ancestor
6661852|NCT01501136|Autonomic Agents|autonomic agents|mesh-ancestor
6661853|NCT01501136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6661854|NCT01501136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661855|NCT01501136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6661856|NCT01501136|Glucocorticoids|glucocorticoids|mesh-ancestor
6661857|NCT01501136|Hormones|hormones|mesh-ancestor
6661858|NCT01501136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6661859|NCT01501136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6661860|NCT01501136|Protease Inhibitors|protease inhibitors|mesh-ancestor
6661861|NCT01501136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6661862|NCT01501136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661863|NCT01501136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6661864|NCT01501136|Antimetabolites|antimetabolites|mesh-ancestor
6661865|NCT01501136|Antiviral Agents|antiviral agents|mesh-ancestor
6661866|NCT01501136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6661867|NCT01501136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6661868|NCT01501136|Immunologic Factors|immunologic factors|mesh-ancestor
6664976|NCT01514968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6621789|NCT01280149|Substance P|substance p|mesh-list
6621790|NCT01280149|Neurokinin A|neurokinin a|mesh-list
6621791|NCT01280149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6621792|NCT01280149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621793|NCT01280149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621794|NCT01280162|Piperaquine|piperaquine|mesh-list
6621795|NCT01280162|Artenimol|artenimol|mesh-list
6621796|NCT01280162|Antimalarials|antimalarials|mesh-ancestor
6621797|NCT01280162|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6621798|NCT01280162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6621799|NCT01280162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6621800|NCT01280175|Charcoal|charcoal|mesh-list
6621801|NCT01280175|Antidotes|antidotes|mesh-ancestor
6621802|NCT01280175|Protective Agents|protective agents|mesh-ancestor
6621803|NCT01280175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621804|NCT01280188|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
6621805|NCT01280188|Hemostatics|hemostatics|mesh-ancestor
6621806|NCT01280188|Coagulants|coagulants|mesh-ancestor
6621807|NCT01280188|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6621808|NCT01280188|Natriuretic Agents|natriuretic agents|mesh-ancestor
6621809|NCT01280188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621810|NCT01280214|Triamcinolone|triamcinolone|mesh-list
6621811|NCT01280214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6621812|NCT01280214|Glucocorticoids|glucocorticoids|mesh-ancestor
6621813|NCT01280214|Hormones|hormones|mesh-ancestor
6621814|NCT01280214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6621815|NCT01280214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621816|NCT01280240|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
6621817|NCT01280240|Hematinics|hematinics|mesh-ancestor
6621818|NCT01280305|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
6621819|NCT01280305|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6621820|NCT01280305|Hormone Antagonists|hormone antagonists|mesh-ancestor
6621821|NCT01280305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6621822|NCT01280305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621823|NCT01280305|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6020866|NCT00395044|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6020867|NCT00395044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6020868|NCT00395044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020869|NCT00395044|Antimanic Agents|antimanic agents|mesh-ancestor
6020870|NCT00395057|Ranibizumab|ranibizumab|mesh-list
6020871|NCT00395057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6020872|NCT00395057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6020873|NCT00395057|Growth Substances|growth substances|mesh-ancestor
6621824|NCT01280305|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6621825|NCT01280305|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6621826|NCT01280526|Romidepsin|romidepsin|mesh-list
6621827|NCT01280526|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6621828|NCT01280526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6621829|NCT01280669|Sirolimus|sirolimus|mesh-list
6621830|NCT01280669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6621831|NCT01280669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6621832|NCT01280669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6621833|NCT01280669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6621834|NCT01280669|Antifungal Agents|antifungal agents|mesh-ancestor
6621835|NCT01280669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6621836|NCT01280669|Immunologic Factors|immunologic factors|mesh-ancestor
6020874|NCT00395057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020875|NCT00395057|Growth Inhibitors|growth inhibitors|mesh-ancestor
6621837|NCT01280669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621838|NCT01280682|Rituximab|rituximab|mesh-list
6621839|NCT01280682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6621840|NCT01280682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6621841|NCT01280682|Immunologic Factors|immunologic factors|mesh-ancestor
6621842|NCT01280682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621843|NCT01280682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6621844|NCT01280734|Melatonin|melatonin|mesh-list
6621845|NCT01280734|Antioxidants|antioxidants|mesh-ancestor
6621846|NCT01280734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621847|NCT01280734|Protective Agents|protective agents|mesh-ancestor
6621848|NCT01280734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621849|NCT01280734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6621850|NCT01280929|Ranibizumab|ranibizumab|mesh-list
6621851|NCT01280929|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6621852|NCT01280929|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6621853|NCT01280929|Growth Substances|growth substances|mesh-ancestor
6621854|NCT01280929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621855|NCT01280929|Growth Inhibitors|growth inhibitors|mesh-ancestor
6621856|NCT01280929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6621857|NCT01280994|Xenon|xenon|mesh-list
6621858|NCT01280994|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6621859|NCT01280994|Anesthetics, General|anesthetics, general|mesh-ancestor
6621860|NCT01280994|Anesthetics|anesthetics|mesh-ancestor
6621861|NCT01280994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6621862|NCT01280994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621863|NCT01281111|Aspirin|aspirin|mesh-list
6621864|NCT01281111|Dimethyl Fumarate|dimethyl fumarate|mesh-list
6621865|NCT01281111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6621866|NCT01281111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6621867|NCT01281111|Analgesics|analgesics|mesh-ancestor
6621868|NCT01281111|Sensory System Agents|sensory system agents|mesh-ancestor
6621869|NCT01281111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6621870|NCT01281111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621871|NCT01281111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6621872|NCT01281111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6621873|NCT01281111|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6621874|NCT01281111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6621875|NCT01281111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621876|NCT01281111|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6621877|NCT01281111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6621878|NCT01281111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6621879|NCT01281111|Antipyretics|antipyretics|mesh-ancestor
6621880|NCT01281111|Dermatologic Agents|dermatologic agents|mesh-ancestor
6621881|NCT01281111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6621882|NCT01281111|Immunologic Factors|immunologic factors|mesh-ancestor
6621883|NCT01281150|Paclitaxel|paclitaxel|mesh-list
6621884|NCT01281150|Carboplatin|carboplatin|mesh-list
6621885|NCT01281150|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6621886|NCT01281150|Veliparib|veliparib|mesh-list
6621887|NCT01281150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6621888|NCT01281150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6621889|NCT01281150|Tubulin Modulators|tubulin modulators|mesh-ancestor
6621890|NCT01281150|Antimitotic Agents|antimitotic agents|mesh-ancestor
6621891|NCT01281150|Mitosis Modulators|mitosis modulators|mesh-ancestor
6020876|NCT00395057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6621892|NCT01281150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621893|NCT01281150|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6621894|NCT01281150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6621895|NCT01281163|Lapatinib|lapatinib|mesh-list
6621896|NCT01281163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6621897|NCT01281163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6621898|NCT01281163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6621899|NCT01281163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621900|NCT01281228|Exenatide|exenatide|mesh-list
6621901|NCT01281228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6621902|NCT01281228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621903|NCT01281228|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6621904|NCT01281228|Incretins|incretins|mesh-ancestor
6621905|NCT01281228|Hormones|hormones|mesh-ancestor
6621906|NCT01281228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6621907|NCT01281514|Carboplatin|carboplatin|mesh-list
6621908|NCT01281514|Doxorubicin|doxorubicin|mesh-list
6621909|NCT01281514|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6621910|NCT01281514|Everolimus|everolimus|mesh-list
6621911|NCT01281514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6621912|NCT01281514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6621913|NCT01281514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6621914|NCT01281514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6621915|NCT01281514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6621916|NCT01281514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621917|NCT01281514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6621918|NCT01281514|Immunologic Factors|immunologic factors|mesh-ancestor
6621919|NCT01281514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621920|NCT01281527|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6621921|NCT01281527|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6621922|NCT01281527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6621923|NCT01281527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6621924|NCT01281527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621925|NCT01281527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6621926|NCT01281527|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6621927|NCT01281527|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6621928|NCT01281527|Serotonin Agents|serotonin agents|mesh-ancestor
6621929|NCT01281527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6621930|NCT01281527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621931|NCT01281527|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6621932|NCT01281527|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6621933|NCT01281527|Dopamine Agents|dopamine agents|mesh-ancestor
6621934|NCT01281540|Cisapride|cisapride|mesh-list
6621935|NCT01281540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6621936|NCT01281540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6621937|NCT01281540|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6621938|NCT01281540|Serotonin Agents|serotonin agents|mesh-ancestor
6621939|NCT01281540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6621940|NCT01281540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621941|NCT01281540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621942|NCT01281553|Cisapride|cisapride|mesh-list
6621943|NCT01281553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6621944|NCT01281553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6621945|NCT01281553|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6621946|NCT01281553|Serotonin Agents|serotonin agents|mesh-ancestor
6621947|NCT01281553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6621948|NCT01281553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621949|NCT01281553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621950|NCT01281566|Cisapride|cisapride|mesh-list
6621951|NCT01281566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6621952|NCT01281566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6621953|NCT01281566|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6621954|NCT01281566|Serotonin Agents|serotonin agents|mesh-ancestor
6621955|NCT01281566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6621956|NCT01281566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621957|NCT01281566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621958|NCT01281579|Canagliflozin|canagliflozin|mesh-list
6621959|NCT01281579|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6621960|NCT01281579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621961|NCT01281579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6621962|NCT01281579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621963|NCT01281605|Insulin|insulin|mesh-list
6621964|NCT01281605|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6621965|NCT01281605|Insulin Detemir|insulin detemir|mesh-list
6621966|NCT01281605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6621967|NCT01281605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621968|NCT01281657|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6621969|NCT01281657|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6621970|NCT01281657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621971|NCT01281657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6621972|NCT01281657|Immunologic Factors|immunologic factors|mesh-ancestor
6621973|NCT01281657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621974|NCT01281696|Bevacizumab|bevacizumab|mesh-list
6621975|NCT01281696|Methotrexate|methotrexate|mesh-list
6621976|NCT01281696|Etoposide|etoposide|mesh-list
6621977|NCT01281696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6621978|NCT01281696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6621979|NCT01281696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6621980|NCT01281696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6621981|NCT01281696|Growth Substances|growth substances|mesh-ancestor
6621982|NCT01281696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6621983|NCT01281696|Growth Inhibitors|growth inhibitors|mesh-ancestor
6621984|NCT01281696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6621985|NCT01281696|Abortifacient Agents|abortifacient agents|mesh-ancestor
6621986|NCT01281696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6621987|NCT01281696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6621988|NCT01281696|Antimetabolites|antimetabolites|mesh-ancestor
6621989|NCT01281696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6621990|NCT01281696|Dermatologic Agents|dermatologic agents|mesh-ancestor
6621991|NCT01281696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6621992|NCT01281696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6621993|NCT01281696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6621994|NCT01281696|Immunologic Factors|immunologic factors|mesh-ancestor
6621995|NCT01281696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6621996|NCT01281696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6621997|NCT01281696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6621998|NCT01281696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6621999|NCT01281696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6622000|NCT01281748|Methylprednisolone|methylprednisolone|mesh-list
6622001|NCT01281748|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6622002|NCT01281748|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6622003|NCT01281748|Prednisolone|prednisolone|mesh-list
6622004|NCT01281748|Prednisolone acetate|prednisolone acetate|mesh-list
6622005|NCT01281748|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6622006|NCT01281748|Prednisolone phosphate|prednisolone phosphate|mesh-list
6622007|NCT01281748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6622008|NCT01281748|Antiemetics|antiemetics|mesh-ancestor
6622009|NCT01281748|Autonomic Agents|autonomic agents|mesh-ancestor
6622010|NCT01281748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6622011|NCT01281748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622012|NCT01281748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6622013|NCT01281748|Glucocorticoids|glucocorticoids|mesh-ancestor
6622014|NCT01281748|Hormones|hormones|mesh-ancestor
6622015|NCT01281748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6622016|NCT01281748|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6622017|NCT01281748|Protective Agents|protective agents|mesh-ancestor
6622018|NCT01281748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6622019|NCT01281748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6622020|NCT01281761|Irinotecan|irinotecan|mesh-list
6622021|NCT01281761|Cetuximab|cetuximab|mesh-list
6622022|NCT01281761|Simvastatin|simvastatin|mesh-list
6622023|NCT01281761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6622024|NCT01281761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6622025|NCT01281761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6622026|NCT01281761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622027|NCT01281761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6622028|NCT01281761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6622029|NCT01281761|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6622030|NCT01281761|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6622031|NCT01281761|Antimetabolites|antimetabolites|mesh-ancestor
6622032|NCT01281761|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6661869|NCT01501136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6450720|NCT00409318|Sensory System Agents|sensory system agents|mesh-ancestor
6450721|NCT00409318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6450722|NCT00409318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450723|NCT00409318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6450724|NCT00409318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6450725|NCT00409318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6450726|NCT00409318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6450727|NCT00409318|Immunologic Factors|immunologic factors|mesh-ancestor
6450728|NCT00409357|Alfuzosin|alfuzosin|mesh-list
6450729|NCT00409357|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6450730|NCT00409357|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6450731|NCT00409357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5502217|NCT04467931|Nebivolol|nebivolol|mesh-list
5502218|NCT04467931|Chlorthalidone|chlorthalidone|mesh-list
5502219|NCT04467931|Diltiazem|diltiazem|mesh-list
5502220|NCT04467931|Bisoprolol|bisoprolol|mesh-list
5502221|NCT04467931|Perindopril|perindopril|mesh-list
5502222|NCT04467931|Guanfacine|guanfacine|mesh-list
5502223|NCT04467931|Prazosin|prazosin|mesh-list
6622033|NCT01281761|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6622034|NCT01281787|Losartan|losartan|mesh-list
6622035|NCT01281787|Metoprolol|metoprolol|mesh-list
6622036|NCT01281787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6622037|NCT01281787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6622038|NCT01281787|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6622039|NCT01281787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6622040|NCT01281787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622041|NCT01281787|Sympatholytics|sympatholytics|mesh-ancestor
6622042|NCT01281787|Autonomic Agents|autonomic agents|mesh-ancestor
6622043|NCT01281787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6622044|NCT01281787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622045|NCT01281787|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6622046|NCT01281787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6622047|NCT01281787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6622048|NCT01281787|Adrenergic Agents|adrenergic agents|mesh-ancestor
6622049|NCT01281787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6622050|NCT01281800|Gemcitabine|gemcitabine|mesh-list
6622051|NCT01281800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6622052|NCT01281800|Antimetabolites|antimetabolites|mesh-ancestor
6622053|NCT01281800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622054|NCT01281800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6622055|NCT01281800|Antiviral Agents|antiviral agents|mesh-ancestor
6622056|NCT01281800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6622057|NCT01281800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6622058|NCT01281800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6622059|NCT01281800|Immunologic Factors|immunologic factors|mesh-ancestor
6622060|NCT01281800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622061|NCT01281813|Ritonavir|ritonavir|mesh-list
6622062|NCT01281813|Darunavir|darunavir|mesh-list
6622063|NCT01281813|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6622064|NCT01281813|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6622065|NCT01281813|Protease Inhibitors|protease inhibitors|mesh-ancestor
6622066|NCT01281813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6622067|NCT01281813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622068|NCT01281813|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6622069|NCT01281813|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6622070|NCT01281813|Antiviral Agents|antiviral agents|mesh-ancestor
6622071|NCT01281813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6622072|NCT01281813|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6622073|NCT01281813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6622074|NCT01281852|Paclitaxel|paclitaxel|mesh-list
6622075|NCT01281852|Cisplatin|cisplatin|mesh-list
6622076|NCT01281852|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6622077|NCT01281852|Veliparib|veliparib|mesh-list
6622078|NCT01281852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6622079|NCT01281852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6622080|NCT01281852|Tubulin Modulators|tubulin modulators|mesh-ancestor
6622081|NCT01281852|Antimitotic Agents|antimitotic agents|mesh-ancestor
6622082|NCT01281852|Mitosis Modulators|mitosis modulators|mesh-ancestor
6622083|NCT01281852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622084|NCT01281852|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6622085|NCT01281852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6622086|NCT01281878|Vitamin B 6|vitamin b 6|mesh-list
6622087|NCT01281878|Pyridoxal|pyridoxal|mesh-list
6622088|NCT01281878|Pyridoxine|pyridoxine|mesh-list
6622089|NCT01281878|Vitamins|vitamins|mesh-ancestor
5502224|NCT04467931|Minoxidil|minoxidil|mesh-list
5502225|NCT04467931|Doxazosin|doxazosin|mesh-list
5502226|NCT04467931|Benazepril|benazepril|mesh-list
5502227|NCT04467931|Hydralazine|hydralazine|mesh-list
5502228|NCT04467931|Captopril|captopril|mesh-list
6622090|NCT01281878|Micronutrients|micronutrients|mesh-ancestor
6622091|NCT01281878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622092|NCT01281878|Vitamin B Complex|vitamin b complex|mesh-ancestor
5502229|NCT04467931|Labetalol|labetalol|mesh-list
5502230|NCT04467931|Indapamide|indapamide|mesh-list
5502231|NCT04467931|Nicardipine|nicardipine|mesh-list
5502232|NCT04467931|Quinapril|quinapril|mesh-list
6622093|NCT01281891|Morphine|morphine|mesh-list
6622094|NCT01281891|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6622095|NCT01281891|Narcotics|narcotics|mesh-ancestor
6020877|NCT00395161|Selenium|selenium|mesh-list
6020878|NCT00395161|Metoclopramide|metoclopramide|mesh-list
6020879|NCT00395161|Antioxidants|antioxidants|mesh-ancestor
6622096|NCT01281891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6622097|NCT01281891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622098|NCT01281891|Analgesics|analgesics|mesh-ancestor
6622099|NCT01281891|Sensory System Agents|sensory system agents|mesh-ancestor
6622100|NCT01281891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6622101|NCT01281943|Sirolimus|sirolimus|mesh-list
6622102|NCT01281943|Doxorubicin|doxorubicin|mesh-list
6622103|NCT01281943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6622104|NCT01281943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6622105|NCT01281943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6622106|NCT01281943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6622107|NCT01281943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6622108|NCT01281943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6622109|NCT01281943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622110|NCT01281943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6622111|NCT01281943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6622112|NCT01281943|Antifungal Agents|antifungal agents|mesh-ancestor
6622113|NCT01281943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6622114|NCT01281943|Immunologic Factors|immunologic factors|mesh-ancestor
6622115|NCT01281943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661870|NCT01501136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6661871|NCT01501136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6661872|NCT01501136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6661873|NCT01501136|Alkylating Agents|alkylating agents|mesh-ancestor
6661874|NCT01501136|Protective Agents|protective agents|mesh-ancestor
6661875|NCT01501149|Gemcitabine|gemcitabine|mesh-list
6661876|NCT01501149|Dexamethasone|dexamethasone|mesh-list
6661877|NCT01501149|Etoposide|etoposide|mesh-list
6661878|NCT01501149|Pegaspargase|pegaspargase|mesh-list
6661879|NCT01501149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6661880|NCT01501149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6661881|NCT01501149|Antiemetics|antiemetics|mesh-ancestor
6661882|NCT01501149|Autonomic Agents|autonomic agents|mesh-ancestor
6661883|NCT01501149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6661884|NCT01501149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661885|NCT01501149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6661886|NCT01501149|Glucocorticoids|glucocorticoids|mesh-ancestor
6661887|NCT01501149|Hormones|hormones|mesh-ancestor
6661888|NCT01501149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6661889|NCT01501149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6661890|NCT01501149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6661891|NCT01501149|Antimetabolites|antimetabolites|mesh-ancestor
6661892|NCT01501149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661893|NCT01501149|Antiviral Agents|antiviral agents|mesh-ancestor
6661894|NCT01501149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6661895|NCT01501149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6661896|NCT01501149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6661897|NCT01501149|Immunologic Factors|immunologic factors|mesh-ancestor
6661898|NCT01501149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6661899|NCT01501149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6661900|NCT01501149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6661901|NCT01501214|Atosiban|atosiban|mesh-list
6661902|NCT01501214|Hormone Antagonists|hormone antagonists|mesh-ancestor
6661903|NCT01501214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6661904|NCT01501214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661905|NCT01501214|Tocolytic Agents|tocolytic agents|mesh-ancestor
6661906|NCT01501214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6661907|NCT01501253|Amlodipine|amlodipine|mesh-list
6661908|NCT01501253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6661909|NCT01501253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6661910|NCT01501253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6661911|NCT01501253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020880|NCT00395161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622116|NCT01282047|Lenalidomide|lenalidomide|mesh-list
6622117|NCT01282047|Immunologic Factors|immunologic factors|mesh-ancestor
6622118|NCT01282047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622119|NCT01282047|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6622120|NCT01282047|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6622121|NCT01282047|Growth Substances|growth substances|mesh-ancestor
6622122|NCT01282047|Growth Inhibitors|growth inhibitors|mesh-ancestor
6622123|NCT01282047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6622124|NCT01282073|Cyclosporine|cyclosporine|mesh-list
6622125|NCT01282073|Mycophenolic Acid|mycophenolic acid|mesh-list
6622126|NCT01282073|Cyclosporins|cyclosporins|mesh-list
6622127|NCT01282073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6622128|NCT01282073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622129|NCT01282073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6622130|NCT01282073|Immunologic Factors|immunologic factors|mesh-ancestor
6622131|NCT01282073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622132|NCT01282073|Antifungal Agents|antifungal agents|mesh-ancestor
6622133|NCT01282073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6622134|NCT01282073|Dermatologic Agents|dermatologic agents|mesh-ancestor
6622135|NCT01282073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6622136|NCT01282073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6622137|NCT01282073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6622138|NCT01282073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6622139|NCT01282073|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6622140|NCT01282073|Antitubercular Agents|antitubercular agents|mesh-ancestor
6622141|NCT01282073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6622142|NCT01282151|Cisplatin|cisplatin|mesh-list
6622143|NCT01282151|Pemetrexed|pemetrexed|mesh-list
6622144|NCT01282151|Docetaxel|docetaxel|mesh-list
6622145|NCT01282151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6622146|NCT01282151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6622147|NCT01282151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622148|NCT01282151|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6622149|NCT01282151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6622150|NCT01282151|Tubulin Modulators|tubulin modulators|mesh-ancestor
6622151|NCT01282151|Antimitotic Agents|antimitotic agents|mesh-ancestor
6622152|NCT01282151|Mitosis Modulators|mitosis modulators|mesh-ancestor
6622153|NCT01282333|Gemcitabine|gemcitabine|mesh-list
6622154|NCT01282333|Veliparib|veliparib|mesh-list
6622155|NCT01282333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6622156|NCT01282333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6622157|NCT01282333|Antimetabolites|antimetabolites|mesh-ancestor
6622158|NCT01282333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622159|NCT01282333|Antiviral Agents|antiviral agents|mesh-ancestor
6622160|NCT01282333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6622161|NCT01282333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6622162|NCT01282333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6622163|NCT01282333|Immunologic Factors|immunologic factors|mesh-ancestor
6622164|NCT01282333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622165|NCT01282333|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6622166|NCT01282385|Simvastatin|simvastatin|mesh-list
6622167|NCT01282385|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6622168|NCT01282385|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6622169|NCT01282385|Antimetabolites|antimetabolites|mesh-ancestor
6622170|NCT01282385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622171|NCT01282385|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6622172|NCT01282385|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6622173|NCT01282385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6622174|NCT01282398|Simvastatin|simvastatin|mesh-list
6622175|NCT01282398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6622176|NCT01282398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6622177|NCT01282398|Antimetabolites|antimetabolites|mesh-ancestor
6622178|NCT01282398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622179|NCT01282398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6622180|NCT01282398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6622181|NCT01282398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6622182|NCT01282502|Midostaurin|midostaurin|mesh-list
6622183|NCT01282502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6622184|NCT01282502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6622185|NCT01282502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6622186|NCT01282502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622187|NCT01282515|Clobetasol|clobetasol|mesh-list
6622188|NCT01282515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6622189|NCT01282515|Glucocorticoids|glucocorticoids|mesh-ancestor
6622190|NCT01282515|Hormones|hormones|mesh-ancestor
6622191|NCT01282515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6622192|NCT01282515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622193|NCT01282528|Infliximab|infliximab|mesh-list
6622194|NCT01282528|Dermatologic Agents|dermatologic agents|mesh-ancestor
6622195|NCT01282528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6622196|NCT01282528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6622197|NCT01282541|Botulinum Toxins|botulinum toxins|mesh-list
6622198|NCT01282541|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6622199|NCT01282541|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6622200|NCT01282541|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6622201|NCT01282541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6622202|NCT01282541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622203|NCT01282541|Cholinergic Agents|cholinergic agents|mesh-ancestor
6622204|NCT01282541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6622205|NCT01282541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622206|NCT01282541|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6622207|NCT01282541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6622208|NCT01282619|Huperzine A|huperzine a|mesh-list
6622209|NCT01282619|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6622210|NCT01282619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6622211|NCT01282619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622212|NCT01282619|Cholinergic Agents|cholinergic agents|mesh-ancestor
6622213|NCT01282619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6622214|NCT01282619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622215|NCT01282619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6622216|NCT01282619|Protective Agents|protective agents|mesh-ancestor
6622217|NCT01282632|Olanzapine|olanzapine|mesh-list
6622218|NCT01282632|Risperidone|risperidone|mesh-list
6622219|NCT01282632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6622220|NCT01282632|Serotonin Agents|serotonin agents|mesh-ancestor
6622221|NCT01282632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6622222|NCT01282632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622223|NCT01282632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622224|NCT01282632|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6622225|NCT01282632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6622226|NCT01282632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6622227|NCT01282632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6622228|NCT01282632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6622229|NCT01282632|Dopamine Agents|dopamine agents|mesh-ancestor
5502233|NCT04467931|Trandolapril|trandolapril|mesh-list
6622230|NCT01282632|Antiemetics|antiemetics|mesh-ancestor
6622231|NCT01282632|Autonomic Agents|autonomic agents|mesh-ancestor
6622232|NCT01282632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6622233|NCT01282632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6622234|NCT01282632|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6622235|NCT01282632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6622236|NCT01282632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6622237|NCT01282697|Sirolimus|sirolimus|mesh-list
6622238|NCT01282697|Irinotecan|irinotecan|mesh-list
6622239|NCT01282697|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6622240|NCT01282697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6622241|NCT01282697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6622242|NCT01282697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622243|NCT01282697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6622244|NCT01282697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6622245|NCT01282697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6622246|NCT01282697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6622247|NCT01282697|Antifungal Agents|antifungal agents|mesh-ancestor
6622248|NCT01282697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6622249|NCT01282697|Immunologic Factors|immunologic factors|mesh-ancestor
6622250|NCT01282697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622251|NCT01282762|Vaccines|vaccines|mesh-list
6622252|NCT01282762|Immunologic Factors|immunologic factors|mesh-ancestor
6622253|NCT01282762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622254|NCT01282840|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6622255|NCT01282840|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6622256|NCT01282840|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6622257|NCT01282840|Cholinergic Agents|cholinergic agents|mesh-ancestor
6622258|NCT01282840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6622259|NCT01282840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622260|NCT01282840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622261|NCT01282840|Urological Agents|urological agents|mesh-ancestor
6622262|NCT01282879|Itraconazole|itraconazole|mesh-list
6622263|NCT01282879|Antifungal Agents|antifungal agents|mesh-ancestor
6622264|NCT01282879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6622265|NCT01282879|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6622266|NCT01282879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6622267|NCT01282879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6622268|NCT01282879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622269|NCT01282879|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6622270|NCT01282879|Hormone Antagonists|hormone antagonists|mesh-ancestor
6622271|NCT01282879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6622272|NCT01282879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622273|NCT01282879|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6622274|NCT01283048|Bevacizumab|bevacizumab|mesh-list
6622275|NCT01283048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6622276|NCT01283048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5502234|NCT04467931|Metolazone|metolazone|mesh-list
6622277|NCT01283048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6622278|NCT01283048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6622279|NCT01283048|Growth Substances|growth substances|mesh-ancestor
6622280|NCT01283048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622281|NCT01283048|Growth Inhibitors|growth inhibitors|mesh-ancestor
6622282|NCT01283061|Zafirlukast|zafirlukast|mesh-list
6622283|NCT01283061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6622284|NCT01283061|Respiratory System Agents|respiratory system agents|mesh-ancestor
6622285|NCT01283061|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6622286|NCT01283061|Hormone Antagonists|hormone antagonists|mesh-ancestor
6622287|NCT01283061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6622288|NCT01283061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622289|NCT01283100|Dolutegravir|dolutegravir|mesh-list
6622290|NCT01283100|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6622291|NCT01283100|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6622292|NCT01283100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6622293|NCT01283100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622294|NCT01283100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6622295|NCT01283100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6622296|NCT01283100|Antiviral Agents|antiviral agents|mesh-ancestor
6622297|NCT01283100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6622298|NCT01283126|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6622299|NCT01283126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622300|NCT01283178|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6622301|NCT01283178|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6622302|NCT01283178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622303|NCT01283204|Leucovorin|leucovorin|mesh-list
6622304|NCT01283204|Paclitaxel|paclitaxel|mesh-list
6622305|NCT01283204|Docetaxel|docetaxel|mesh-list
6622306|NCT01283204|Cisplatin|cisplatin|mesh-list
6622307|NCT01283204|Oxaliplatin|oxaliplatin|mesh-list
6622308|NCT01283204|Levoleucovorin|levoleucovorin|mesh-list
6622309|NCT01283204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6622310|NCT01283204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6622311|NCT01283204|Tubulin Modulators|tubulin modulators|mesh-ancestor
6622312|NCT01283204|Antimitotic Agents|antimitotic agents|mesh-ancestor
6622313|NCT01283204|Mitosis Modulators|mitosis modulators|mesh-ancestor
6622314|NCT01283204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622315|NCT01283204|Antidotes|antidotes|mesh-ancestor
6622316|NCT01283204|Protective Agents|protective agents|mesh-ancestor
6622317|NCT01283204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622318|NCT01283204|Vitamin B Complex|vitamin b complex|mesh-ancestor
6622319|NCT01283204|Vitamins|vitamins|mesh-ancestor
6622320|NCT01283204|Micronutrients|micronutrients|mesh-ancestor
6622321|NCT01283217|Cisplatin|cisplatin|mesh-list
6622322|NCT01283217|Docetaxel|docetaxel|mesh-list
6622323|NCT01283217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6622324|NCT01283217|Tubulin Modulators|tubulin modulators|mesh-ancestor
6622325|NCT01283217|Antimitotic Agents|antimitotic agents|mesh-ancestor
6622326|NCT01283217|Mitosis Modulators|mitosis modulators|mesh-ancestor
6622327|NCT01283217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622328|NCT01283256|Zonisamide|zonisamide|mesh-list
6622329|NCT01283256|Anticonvulsants|anticonvulsants|mesh-ancestor
6622330|NCT01283256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6622331|NCT01283256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6622332|NCT01283256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622333|NCT01283256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6622334|NCT01283256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622335|NCT01283360|Tenofovir|tenofovir|mesh-list
6622336|NCT01283360|Antiviral Agents|antiviral agents|mesh-ancestor
6622337|NCT01283360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6622338|NCT01283360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6622339|NCT01283360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6622340|NCT01283360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6622341|NCT01283360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622342|NCT01283360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6622343|NCT01283360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6622344|NCT01283412|Dexmedetomidine|dexmedetomidine|mesh-list
6622345|NCT01283412|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6622346|NCT01283412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6622347|NCT01283412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622348|NCT01283412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6622349|NCT01283412|Analgesics|analgesics|mesh-ancestor
6622350|NCT01283412|Sensory System Agents|sensory system agents|mesh-ancestor
6622351|NCT01283412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6622352|NCT01283412|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6622353|NCT01283412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6622354|NCT01283412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6622355|NCT01283412|Adrenergic Agents|adrenergic agents|mesh-ancestor
6622356|NCT01283412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6622357|NCT01283412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622358|NCT01283646|Vitamins|vitamins|mesh-list
6622359|NCT01283646|Ascorbic Acid|ascorbic acid|mesh-list
6622360|NCT01283646|Folic Acid|folic acid|mesh-list
6622361|NCT01283646|Vitamin B Complex|vitamin b complex|mesh-list
6622362|NCT01283646|Micronutrients|micronutrients|mesh-ancestor
6622363|NCT01283646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622364|NCT01283646|Antioxidants|antioxidants|mesh-ancestor
6622365|NCT01283646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622366|NCT01283646|Protective Agents|protective agents|mesh-ancestor
6622367|NCT01283646|Hematinics|hematinics|mesh-ancestor
6622368|NCT01283724|Dienogest|dienogest|mesh-list
6622369|NCT01283724|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6622370|NCT01283724|Contraceptive Agents|contraceptive agents|mesh-ancestor
6622371|NCT01283724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6622372|NCT01283724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622373|NCT01283724|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6622374|NCT01283724|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6622375|NCT01283724|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6622376|NCT01283724|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6622377|NCT01283724|Hormone Antagonists|hormone antagonists|mesh-ancestor
6622378|NCT01283724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6622379|NCT01283724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6622380|NCT01283724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6622381|NCT01283763|Imiquimod|imiquimod|mesh-list
6622382|NCT01283763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6622383|NCT01283763|Immunologic Factors|immunologic factors|mesh-ancestor
6622384|NCT01283763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622385|NCT01283763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6622386|NCT01283763|Interferon Inducers|interferon inducers|mesh-ancestor
6622387|NCT01283776|Cyclophosphamide|cyclophosphamide|mesh-list
6622388|NCT01283776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6622389|NCT01283776|Immunologic Factors|immunologic factors|mesh-ancestor
6622390|NCT01283776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622391|NCT01283776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6622392|NCT01283776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6622393|NCT01283776|Alkylating Agents|alkylating agents|mesh-ancestor
6622394|NCT01283776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622395|NCT01283776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6622396|NCT01283776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6661912|NCT01501253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6661913|NCT01501253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661914|NCT01501253|Vasodilator Agents|vasodilator agents|mesh-ancestor
6661915|NCT01501344|Calcium|calcium|mesh-list
6661916|NCT01501344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6661917|NCT01501344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661918|NCT01501370|Dexamethasone|dexamethasone|mesh-list
6661919|NCT01501370|Dexamethasone acetate|dexamethasone acetate|mesh-list
6661920|NCT01501370|Lenalidomide|lenalidomide|mesh-list
6661921|NCT01501370|Vorinostat|vorinostat|mesh-list
6661922|NCT01501370|BB 1101|bb 1101|mesh-list
6661923|NCT01501370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6661924|NCT01501370|Antiemetics|antiemetics|mesh-ancestor
6661925|NCT01501370|Autonomic Agents|autonomic agents|mesh-ancestor
6661926|NCT01501370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6661927|NCT01501370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661928|NCT01501370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6661929|NCT01501370|Glucocorticoids|glucocorticoids|mesh-ancestor
6661930|NCT01501370|Hormones|hormones|mesh-ancestor
6661931|NCT01501370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6661932|NCT01501370|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6661933|NCT01501370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6661934|NCT01501370|Protease Inhibitors|protease inhibitors|mesh-ancestor
6661935|NCT01501370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6661936|NCT01501370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661937|NCT01501370|Immunologic Factors|immunologic factors|mesh-ancestor
5502235|NCT04467931|Torsemide|torsemide|mesh-list
6622397|NCT01283789|Everolimus|everolimus|mesh-list
6622398|NCT01283789|Lapatinib|lapatinib|mesh-list
6622399|NCT01283789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6622400|NCT01283789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6622401|NCT01283789|Immunologic Factors|immunologic factors|mesh-ancestor
6622402|NCT01283789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622403|NCT01283789|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6622404|NCT01283789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6622405|NCT01283789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622406|NCT01283841|Mycophenolic Acid|mycophenolic acid|mesh-list
6622407|NCT01283841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6622408|NCT01283841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6622409|NCT01283841|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6622410|NCT01283841|Antitubercular Agents|antitubercular agents|mesh-ancestor
6622411|NCT01283841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6622412|NCT01283841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6622413|NCT01283841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6622414|NCT01283841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622415|NCT01283867|Mycophenolic Acid|mycophenolic acid|mesh-list
6622416|NCT01283867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6622417|NCT01283867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6622418|NCT01283867|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6622419|NCT01283867|Antitubercular Agents|antitubercular agents|mesh-ancestor
6622420|NCT01283867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6622421|NCT01283867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6622422|NCT01283867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6622423|NCT01283867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622424|NCT01283919|Pantoprazole|pantoprazole|mesh-list
6622425|NCT01283919|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6622426|NCT01283919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6622427|NCT01283919|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6622428|NCT01283919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6622429|NCT01283919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622430|NCT01283932|Pantoprazole|pantoprazole|mesh-list
6622431|NCT01283932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6622432|NCT01283932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6622433|NCT01283932|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6622434|NCT01283932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6622435|NCT01283932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622436|NCT01283997|Minocycline|minocycline|mesh-list
6622437|NCT01283997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6622438|NCT01283997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6622439|NCT01284049|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6622440|NCT01284049|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6622441|NCT01284049|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6622442|NCT01284049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6622443|NCT01284166|Timolol|timolol|mesh-list
6622444|NCT01284166|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6622445|NCT01284166|Dorzolamide|dorzolamide|mesh-list
6622446|NCT01284166|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6622447|NCT01284166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6622448|NCT01284166|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6622449|NCT01284166|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6622450|NCT01284166|Adrenergic Agents|adrenergic agents|mesh-ancestor
6622451|NCT01284166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6622452|NCT01284166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622453|NCT01284166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622454|NCT01284166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6622455|NCT01284166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6622456|NCT01284166|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6622457|NCT01284166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6622458|NCT01284166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6622459|NCT01284166|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6622460|NCT01284166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6622461|NCT01284205|BCG Vaccine|bcg vaccine|mesh-list
6622462|NCT01284205|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6622463|NCT01284205|Immunologic Factors|immunologic factors|mesh-ancestor
6622464|NCT01284205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622465|NCT01284309|Mirabegron|mirabegron|mesh-list
6622466|NCT01284309|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6622467|NCT01284309|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6622468|NCT01284309|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6622469|NCT01284309|Adrenergic Agents|adrenergic agents|mesh-ancestor
6622470|NCT01284309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6622471|NCT01284309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622472|NCT01284309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622473|NCT01284309|Urological Agents|urological agents|mesh-ancestor
6622474|NCT01284413|Gemcitabine|gemcitabine|mesh-list
6622475|NCT01284413|Cisplatin|cisplatin|mesh-list
6622476|NCT01284413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6622477|NCT01284413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6622478|NCT01284413|Antimetabolites|antimetabolites|mesh-ancestor
6622479|NCT01284413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622480|NCT01284413|Antiviral Agents|antiviral agents|mesh-ancestor
6622481|NCT01284413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6622482|NCT01284413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6622483|NCT01284413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6622484|NCT01284413|Immunologic Factors|immunologic factors|mesh-ancestor
6622485|NCT01284413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622486|NCT01284439|Hyaluronic Acid|hyaluronic acid|mesh-list
6622487|NCT01284439|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6622488|NCT01284439|Immunologic Factors|immunologic factors|mesh-ancestor
6622489|NCT01284439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622490|NCT01284439|Viscosupplements|viscosupplements|mesh-ancestor
6622491|NCT01284439|Protective Agents|protective agents|mesh-ancestor
6622492|NCT01284452|Hydrocortisone|hydrocortisone|mesh-list
6622493|NCT01284452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6622494|NCT01284478|Dexamethasone|dexamethasone|mesh-list
6622495|NCT01284478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6622496|NCT01284478|Antiemetics|antiemetics|mesh-ancestor
6622497|NCT01284478|Autonomic Agents|autonomic agents|mesh-ancestor
6622498|NCT01284478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6622499|NCT01284478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622500|NCT01284478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6622501|NCT01284478|Glucocorticoids|glucocorticoids|mesh-ancestor
6622502|NCT01284478|Hormones|hormones|mesh-ancestor
6622503|NCT01284478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6622504|NCT01284478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6622505|NCT01284478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6622506|NCT01284556|Phenobarbital|phenobarbital|mesh-list
6622507|NCT01284556|Anticonvulsants|anticonvulsants|mesh-ancestor
6622508|NCT01284556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6622509|NCT01284556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6622510|NCT01284556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622511|NCT01284556|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6622512|NCT01284556|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6622513|NCT01284556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6622514|NCT01284556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622515|NCT01284556|GABA Modulators|gaba modulators|mesh-ancestor
6622516|NCT01284556|GABA Agents|gaba agents|mesh-ancestor
6622517|NCT01284556|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6622518|NCT01284556|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6622519|NCT01284556|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6622520|NCT01284647|Geranylgeranylacetone|geranylgeranylacetone|mesh-list
6622521|NCT01284647|Sucralfate|sucralfate|mesh-list
6622522|NCT01284647|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6622523|NCT01284647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6622524|NCT01284647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6622525|NCT01284725|Mycophenolic Acid|mycophenolic acid|mesh-list
6622526|NCT01284725|Azathioprine|azathioprine|mesh-list
6622527|NCT01284725|Immunosuppressive Agents|immunosuppressive agents|mesh-list
6622528|NCT01284725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6622529|NCT01284725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6622530|NCT01284725|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6622531|NCT01284725|Antitubercular Agents|antitubercular agents|mesh-ancestor
6622532|NCT01284725|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6622533|NCT01284725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6622534|NCT01284725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6622535|NCT01284725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622536|NCT01284725|Antimetabolites|antimetabolites|mesh-ancestor
6622537|NCT01284725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6622538|NCT01284725|Immunologic Factors|immunologic factors|mesh-ancestor
6622539|NCT01284725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622540|NCT01284725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6622541|NCT01284764|Mosapride|mosapride|mesh-list
6622542|NCT01284764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6622543|NCT01284764|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6622544|NCT01284764|Serotonin Agents|serotonin agents|mesh-ancestor
6622545|NCT01284764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6622546|NCT01284764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622547|NCT01284764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622548|NCT01284855|Antivenins|antivenins|mesh-list
6622549|NCT01284855|Immunologic Factors|immunologic factors|mesh-ancestor
6622550|NCT01284855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622551|NCT01284868|Propranolol|propranolol|mesh-list
6622552|NCT01284868|Bisoprolol|bisoprolol|mesh-list
6622553|NCT01284868|Mirabegron|mirabegron|mesh-list
6622554|NCT01284868|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6622555|NCT01284868|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6622556|NCT01284868|Adrenergic Agents|adrenergic agents|mesh-ancestor
6622557|NCT01284868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6622558|NCT01284868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622559|NCT01284868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622560|NCT01284868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6622561|NCT01284868|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6622562|NCT01284868|Vasodilator Agents|vasodilator agents|mesh-ancestor
6622563|NCT01284868|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6622564|NCT01284868|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6622565|NCT01284868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6622566|NCT01284868|Urological Agents|urological agents|mesh-ancestor
6622567|NCT01284868|Sympatholytics|sympatholytics|mesh-ancestor
6622568|NCT01284868|Autonomic Agents|autonomic agents|mesh-ancestor
6622569|NCT01284868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6622570|NCT01284868|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6622571|NCT01284907|Vitamin D|vitamin d|mesh-list
6622572|NCT01284907|Cholecalciferol|cholecalciferol|mesh-list
6622573|NCT01284907|Vitamins|vitamins|mesh-ancestor
6622574|NCT01284907|Micronutrients|micronutrients|mesh-ancestor
6622575|NCT01284907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622576|NCT01284907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6622577|NCT01284907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6622578|NCT01284946|Deferasirox|deferasirox|mesh-list
6622579|NCT01284946|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6622580|NCT01284946|Chelating Agents|chelating agents|mesh-ancestor
6622581|NCT01284946|Sequestering Agents|sequestering agents|mesh-ancestor
6622582|NCT01284946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502236|NCT04467931|Methyldopa|methyldopa|mesh-list
5502237|NCT04467931|Fosinopril|fosinopril|mesh-list
5502238|NCT04467931|Isradipine|isradipine|mesh-list
5502239|NCT04467931|Eprosartan|eprosartan|mesh-list
6622583|NCT01285037|Gemcitabine|gemcitabine|mesh-list
6622584|NCT01285037|Cetuximab|cetuximab|mesh-list
6622585|NCT01285037|Ramucirumab|ramucirumab|mesh-list
6622586|NCT01285037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6622587|NCT01285037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6622588|NCT01285037|Antimetabolites|antimetabolites|mesh-ancestor
6622589|NCT01285037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622590|NCT01285037|Antiviral Agents|antiviral agents|mesh-ancestor
6622591|NCT01285037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6622592|NCT01285037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6622593|NCT01285037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6622594|NCT01285037|Immunologic Factors|immunologic factors|mesh-ancestor
5502240|NCT04467931|Pindolol|pindolol|mesh-list
5502241|NCT04467931|Moexipril|moexipril|mesh-list
5502242|NCT04467931|Betaxolol|betaxolol|mesh-list
5502243|NCT04467931|Reserpine|reserpine|mesh-list
5502244|NCT04467931|Bendroflumethiazide|bendroflumethiazide|mesh-list
5502245|NCT04467931|Chlorothiazide|chlorothiazide|mesh-list
5502246|NCT04467931|Guanabenz|guanabenz|mesh-list
5502247|NCT04467931|Nisoldipine|nisoldipine|mesh-list
5502248|NCT04467931|Penbutolol|penbutolol|mesh-list
6622595|NCT01285037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622596|NCT01285037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6622597|NCT01285141|polysaccharide-K|polysaccharide-k|mesh-list
6622598|NCT01285141|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6622599|NCT01285141|Immunologic Factors|immunologic factors|mesh-ancestor
6622600|NCT01285141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622601|NCT01285141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6622602|NCT01285141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6622603|NCT01285141|Antiviral Agents|antiviral agents|mesh-ancestor
6622604|NCT01285141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6622605|NCT01285141|Interferon Inducers|interferon inducers|mesh-ancestor
6622606|NCT01285141|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6622607|NCT01285141|Protective Agents|protective agents|mesh-ancestor
6622608|NCT01285219|Lenograstim|lenograstim|mesh-list
6622609|NCT01285219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6622610|NCT01285219|Immunologic Factors|immunologic factors|mesh-ancestor
6622611|NCT01285219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622612|NCT01285232|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5502249|NCT04467931|Nifedipine|nifedipine|mesh-list
5502250|NCT04467931|Amiloride|amiloride|mesh-list
5502251|NCT04467931|Triamterene|triamterene|mesh-list
5502252|NCT04467931|Furosemide|furosemide|mesh-list
5502253|NCT04467931|Spironolactone|spironolactone|mesh-list
5502254|NCT04467931|Bumetanide|bumetanide|mesh-list
5502255|NCT04467931|Ethacrynic Acid|ethacrynic acid|mesh-list
6622613|NCT01285232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6622614|NCT01285245|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6622615|NCT01285245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6622616|NCT01285271|Sevoflurane|sevoflurane|mesh-list
6622617|NCT01285271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6622618|NCT01285271|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6622619|NCT01285271|Anesthetics, General|anesthetics, general|mesh-ancestor
6622620|NCT01285271|Anesthetics|anesthetics|mesh-ancestor
6622621|NCT01285271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6622622|NCT01285271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622623|NCT01285375|Curcumin|curcumin|mesh-list
6622624|NCT01285375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6622625|NCT01285375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5502256|NCT04467931|Terazosin|terazosin|mesh-list
5502257|NCT04467931|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
5502258|NCT04467931|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
5502259|NCT04467931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5502260|NCT04467931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6622626|NCT01285375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6622627|NCT01285375|Analgesics|analgesics|mesh-ancestor
6622628|NCT01285375|Sensory System Agents|sensory system agents|mesh-ancestor
6622629|NCT01285375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6622630|NCT01285375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622631|NCT01285375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6622632|NCT01285375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6622633|NCT01285375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6622634|NCT01285375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6622635|NCT01285375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622636|NCT01285388|Beta-lapachone|beta-lapachone|mesh-list
6622637|NCT01285388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6622638|NCT01285388|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6622639|NCT01285388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6622640|NCT01285388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6622641|NCT01285388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622642|NCT01285388|Antiviral Agents|antiviral agents|mesh-ancestor
6622643|NCT01285414|Temozolomide|temozolomide|mesh-list
6622644|NCT01285414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6622645|NCT01285414|Alkylating Agents|alkylating agents|mesh-ancestor
6622646|NCT01285414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622647|NCT01285414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6622648|NCT01285453|Vadimezan|vadimezan|mesh-list
6622649|NCT01285453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6661938|NCT01501370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6661939|NCT01501370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6661940|NCT01501370|Growth Substances|growth substances|mesh-ancestor
6661941|NCT01501370|Growth Inhibitors|growth inhibitors|mesh-ancestor
6661942|NCT01501370|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6661943|NCT01501396|Megestrol|megestrol|mesh-list
6661944|NCT01501396|Megestrol Acetate|megestrol acetate|mesh-list
6661945|NCT01501396|Mirtazapine|mirtazapine|mesh-list
6661946|NCT01501396|Antidepressive Agents|antidepressive agents|mesh-ancestor
6661947|NCT01501396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6661948|NCT01501396|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6661949|NCT01501396|Histamine Antagonists|histamine antagonists|mesh-ancestor
6661950|NCT01501396|Histamine Agents|histamine agents|mesh-ancestor
6661951|NCT01501396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6661952|NCT01501396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661953|NCT01501396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661954|NCT01501396|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6661955|NCT01501396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6661956|NCT01501396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6661957|NCT01501396|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6661958|NCT01501396|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6661959|NCT01501396|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6661960|NCT01501396|Adrenergic Agents|adrenergic agents|mesh-ancestor
6661961|NCT01501396|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6661962|NCT01501396|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6661963|NCT01501396|Serotonin Agents|serotonin agents|mesh-ancestor
6661964|NCT01501396|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6661965|NCT01501396|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6661966|NCT01501396|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6661967|NCT01501396|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6661968|NCT01501396|Contraceptive Agents|contraceptive agents|mesh-ancestor
6661969|NCT01501396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6661970|NCT01501396|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6661971|NCT01501396|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6661972|NCT01501396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6661973|NCT01501396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6661974|NCT01501396|Appetite Stimulants|appetite stimulants|mesh-ancestor
6661975|NCT01501396|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6450732|NCT00409357|Adrenergic Agents|adrenergic agents|mesh-ancestor
6450733|NCT00409357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6450734|NCT00409357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450735|NCT00409357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450736|NCT00409357|Urological Agents|urological agents|mesh-ancestor
6450737|NCT00409383|Paclitaxel|paclitaxel|mesh-list
6450738|NCT00409383|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6450739|NCT00409383|Temozolomide|temozolomide|mesh-list
6450740|NCT00409383|Oblimersen|oblimersen|mesh-list
6450741|NCT00409383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6450742|NCT00409383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6450743|NCT00409383|Tubulin Modulators|tubulin modulators|mesh-ancestor
6450744|NCT00409383|Antimitotic Agents|antimitotic agents|mesh-ancestor
6622650|NCT01285466|Paclitaxel|paclitaxel|mesh-list
6622651|NCT01285466|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6622652|NCT01285466|Trastuzumab|trastuzumab|mesh-list
6450745|NCT00409383|Mitosis Modulators|mitosis modulators|mesh-ancestor
6450746|NCT00409383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450747|NCT00409383|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6450748|NCT00409383|Alkylating Agents|alkylating agents|mesh-ancestor
6450749|NCT00409435|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
6450750|NCT00409435|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6450751|NCT00409435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6450752|NCT00409435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450753|NCT00409435|Cholinergic Agents|cholinergic agents|mesh-ancestor
6622653|NCT01285466|Dactolisib|dactolisib|mesh-list
6622654|NCT01285466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6622655|NCT01285466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6622656|NCT01285466|Tubulin Modulators|tubulin modulators|mesh-ancestor
6622657|NCT01285466|Antimitotic Agents|antimitotic agents|mesh-ancestor
6622658|NCT01285466|Mitosis Modulators|mitosis modulators|mesh-ancestor
6622659|NCT01285466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622660|NCT01285466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6622661|NCT01285479|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6622662|NCT01285479|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6622663|NCT01285479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622664|NCT01285479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6622665|NCT01285479|Immunologic Factors|immunologic factors|mesh-ancestor
6622666|NCT01285479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622667|NCT01285505|Alprazolam|alprazolam|mesh-list
6622668|NCT01285505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6622669|NCT01285505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6622670|NCT01285505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622671|NCT01285505|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6622672|NCT01285505|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6622673|NCT01285505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6622674|NCT01285505|GABA Modulators|gaba modulators|mesh-ancestor
6622675|NCT01285505|GABA Agents|gaba agents|mesh-ancestor
6622676|NCT01285505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6622677|NCT01285505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622678|NCT01285544|Atorvastatin|atorvastatin|mesh-list
6622679|NCT01285544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6622680|NCT01285544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6622681|NCT01285544|Antimetabolites|antimetabolites|mesh-ancestor
6622682|NCT01285544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622683|NCT01285544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6622684|NCT01285544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6622685|NCT01285544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6622686|NCT01285557|Cisplatin|cisplatin|mesh-list
6622687|NCT01285557|Fluorouracil|fluorouracil|mesh-list
6622688|NCT01285557|Tegafur|tegafur|mesh-list
6622689|NCT01285557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6622690|NCT01285557|Antimetabolites|antimetabolites|mesh-ancestor
6622691|NCT01285557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622692|NCT01285557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6622693|NCT01285557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6622694|NCT01285557|Immunologic Factors|immunologic factors|mesh-ancestor
6622695|NCT01285557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622696|NCT01285596|Mirabegron|mirabegron|mesh-list
6622697|NCT01285596|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6622698|NCT01285596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6622699|NCT01285596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6622700|NCT01285596|Adrenergic Agents|adrenergic agents|mesh-ancestor
6622701|NCT01285596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6622702|NCT01285596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622703|NCT01285596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622704|NCT01285596|Urological Agents|urological agents|mesh-ancestor
6622705|NCT01285661|Vitamin K|vitamin k|mesh-list
6622706|NCT01285661|Warfarin|warfarin|mesh-list
6622707|NCT01285661|Anticoagulants|anticoagulants|mesh-list
6622708|NCT01285661|Vitamins|vitamins|mesh-ancestor
6622709|NCT01285661|Micronutrients|micronutrients|mesh-ancestor
6622710|NCT01285661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622711|NCT01285661|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6622712|NCT01285661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6622713|NCT01285661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622714|NCT01285661|Hemostatics|hemostatics|mesh-ancestor
6622715|NCT01285661|Coagulants|coagulants|mesh-ancestor
6622716|NCT01285674|Cisplatin|cisplatin|mesh-list
6622717|NCT01285674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6622718|NCT01285765|Rituximab|rituximab|mesh-list
6622719|NCT01285765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6622720|NCT01285765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6622721|NCT01285765|Immunologic Factors|immunologic factors|mesh-ancestor
6622722|NCT01285765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622723|NCT01285765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6622724|NCT01285778|Panitumumab|panitumumab|mesh-list
6622725|NCT01285778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6622726|NCT01285778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6622727|NCT01285817|Celecoxib|celecoxib|mesh-list
6622728|NCT01285817|Cyclophosphamide|cyclophosphamide|mesh-list
6622729|NCT01285817|Methotrexate|methotrexate|mesh-list
6622730|NCT01285817|Vinblastine|vinblastine|mesh-list
6622731|NCT01285817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6622732|NCT01285817|Immunologic Factors|immunologic factors|mesh-ancestor
6622733|NCT01285817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622734|NCT01285817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6622735|NCT01285817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6622736|NCT01285817|Alkylating Agents|alkylating agents|mesh-ancestor
6622737|NCT01285817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622738|NCT01285817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6622739|NCT01285817|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6622740|NCT01285817|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6622741|NCT01285817|Abortifacient Agents|abortifacient agents|mesh-ancestor
6622742|NCT01285817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6622743|NCT01285817|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6622744|NCT01285817|Antimetabolites|antimetabolites|mesh-ancestor
6622745|NCT01285817|Dermatologic Agents|dermatologic agents|mesh-ancestor
6622746|NCT01285817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6622747|NCT01285817|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6622748|NCT01285817|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6622749|NCT01285817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5478857|NCT04571645|Heparin|heparin|mesh-list
5478858|NCT04571645|Anticoagulants|anticoagulants|mesh-ancestor
5478859|NCT04571645|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5478860|NCT04571645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5478861|NCT04571645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5478862|NCT04570839|Nivolumab|nivolumab|mesh-list
5478863|NCT04570839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5478864|NCT04570839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5478865|NCT04570839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5478866|NCT04570839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5478867|NCT04564547|Islatravir|islatravir|mesh-list
5478868|NCT04564547|Antiviral Agents|antiviral agents|mesh-ancestor
5478869|NCT04564547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5478870|NCT04564547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5478871|NCT04564547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5478872|NCT04564547|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5478873|NCT04564547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5478874|NCT04564547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5478875|NCT04561180|Dexamethasone|dexamethasone|mesh-list
5478876|NCT04561180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5478877|NCT04561180|Antiemetics|antiemetics|mesh-ancestor
5478878|NCT04561180|Autonomic Agents|autonomic agents|mesh-ancestor
5478879|NCT04561180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5478880|NCT04561180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5478881|NCT04561180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5478882|NCT04561180|Glucocorticoids|glucocorticoids|mesh-ancestor
5478883|NCT04561180|Hormones|hormones|mesh-ancestor
5478884|NCT04561180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6450754|NCT00409435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6450755|NCT00409435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450756|NCT00409461|Sirolimus|sirolimus|mesh-list
6450757|NCT00409461|Tacrolimus|tacrolimus|mesh-list
6450758|NCT00409461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6450759|NCT00409461|Immunologic Factors|immunologic factors|mesh-ancestor
6450760|NCT00409461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450761|NCT00409461|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6450762|NCT00409461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6450763|NCT00409461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450764|NCT00409461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6450765|NCT00409461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6450766|NCT00409461|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6450767|NCT00409461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6450768|NCT00409461|Antifungal Agents|antifungal agents|mesh-ancestor
6450769|NCT00409526|Iloprost|iloprost|mesh-list
6450770|NCT00409526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6450771|NCT00409526|Vasodilator Agents|vasodilator agents|mesh-ancestor
6450772|NCT00409591|Ritonavir|ritonavir|mesh-list
6450773|NCT00409591|Lopinavir|lopinavir|mesh-list
6450774|NCT00409591|Zidovudine|zidovudine|mesh-list
6450775|NCT00409591|Nevirapine|nevirapine|mesh-list
6622750|NCT01285817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6622751|NCT01285817|Analgesics|analgesics|mesh-ancestor
6622752|NCT01285817|Sensory System Agents|sensory system agents|mesh-ancestor
6622753|NCT01285817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6622754|NCT01285817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6622755|NCT01285817|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6622756|NCT01285817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6622757|NCT01285817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6622758|NCT01285817|Tubulin Modulators|tubulin modulators|mesh-ancestor
6622759|NCT01285817|Antimitotic Agents|antimitotic agents|mesh-ancestor
6622760|NCT01285817|Mitosis Modulators|mitosis modulators|mesh-ancestor
6622761|NCT01285934|Insulin|insulin|mesh-list
6622762|NCT01285934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6622763|NCT01285934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622764|NCT01286051|Ganirelix|ganirelix|mesh-list
6622765|NCT01286051|Hormone Antagonists|hormone antagonists|mesh-ancestor
6622766|NCT01286051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6622767|NCT01286051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450776|NCT00409591|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6450777|NCT00409591|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6450778|NCT00409591|Protease Inhibitors|protease inhibitors|mesh-ancestor
6450779|NCT00409591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6450780|NCT00409591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450781|NCT00409591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6450782|NCT00409591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6450783|NCT00409591|Antiviral Agents|antiviral agents|mesh-ancestor
6450784|NCT00409591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6450785|NCT00409591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6450786|NCT00409591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6450787|NCT00409591|Antimetabolites|antimetabolites|mesh-ancestor
6450788|NCT00409591|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6450789|NCT00409591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6450790|NCT00409591|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6450791|NCT00409591|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6450792|NCT00409630|Fluticasone|fluticasone|mesh-list
6450793|NCT00409630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6450794|NCT00409630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6450795|NCT00409630|Autonomic Agents|autonomic agents|mesh-ancestor
6450796|NCT00409630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6622768|NCT01286090|Cisapride|cisapride|mesh-list
6622769|NCT01286090|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6622770|NCT01286090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6622771|NCT01286090|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6622772|NCT01286090|Serotonin Agents|serotonin agents|mesh-ancestor
6622773|NCT01286090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6622774|NCT01286090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5478885|NCT04561180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5478886|NCT04561180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5478887|NCT04527003|Cannabidiol|cannabidiol|mesh-list
5478888|NCT04527003|Norethindrone|norethindrone|mesh-list
5478889|NCT04527003|Norethindrone Acetate|norethindrone acetate|mesh-list
5478890|NCT04527003|Anticonvulsants|anticonvulsants|mesh-ancestor
5478891|NCT04527003|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5478892|NCT04527003|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5478893|NCT04527003|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5478894|NCT04527003|Contraceptive Agents|contraceptive agents|mesh-ancestor
5478895|NCT04527003|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5478896|NCT04527003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5478897|NCT04527003|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5478898|NCT04527003|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5478899|NCT04486833|Osimertinib|osimertinib|mesh-list
5478900|NCT04486833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5478901|NCT04486833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5478902|NCT04486833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5478903|NCT04486833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5478904|NCT04457323|Metoprolol|metoprolol|mesh-list
5478905|NCT04457323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5478906|NCT04457323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5478907|NCT04457323|Sympatholytics|sympatholytics|mesh-ancestor
5478908|NCT04457323|Autonomic Agents|autonomic agents|mesh-ancestor
5478909|NCT04457323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5478910|NCT04457323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503622|NCT04457245|Fluorides|fluorides|mesh-list
6661976|NCT01501422|Estrogens|estrogens|mesh-list
6622775|NCT01286090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622776|NCT01286103|Canagliflozin|canagliflozin|mesh-list
6622777|NCT01286103|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6622778|NCT01286103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5478911|NCT04457323|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5478912|NCT04457323|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5478913|NCT04457323|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5478914|NCT04457323|Adrenergic Agents|adrenergic agents|mesh-ancestor
5478915|NCT04457323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5478916|NCT04457323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5478917|NCT04448431|Vortioxetine|vortioxetine|mesh-list
5478918|NCT04448431|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
5478919|NCT04448431|Antidepressive Agents|antidepressive agents|mesh-ancestor
5478920|NCT04448431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5478921|NCT04448431|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5478922|NCT04448431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5478923|NCT04448431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6622779|NCT01286103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6622780|NCT01286103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622781|NCT01286194|Rabeprazole|rabeprazole|mesh-list
6622782|NCT01286194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6622783|NCT01286194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6622784|NCT01286194|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6622785|NCT01286194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6622786|NCT01286194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622787|NCT01286233|Metformin|metformin|mesh-list
6622788|NCT01286233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6622789|NCT01286233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622790|NCT01286246|Progesterone|progesterone|mesh-list
6622791|NCT01286246|Progestins|progestins|mesh-ancestor
6622792|NCT01286246|Hormones|hormones|mesh-ancestor
6622793|NCT01286246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6622794|NCT01286246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622795|NCT01286584|Varenicline|varenicline|mesh-list
6622796|NCT01286584|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6622797|NCT01286584|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6622798|NCT01286584|Cholinergic Agents|cholinergic agents|mesh-ancestor
6622799|NCT01286584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6622800|NCT01286584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622801|NCT01286584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622802|NCT01286688|Terbinafine|terbinafine|mesh-list
6622803|NCT01286688|Antifungal Agents|antifungal agents|mesh-ancestor
6622804|NCT01286688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6622805|NCT01286688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6622806|NCT01286688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622807|NCT01286701|Terbinafine|terbinafine|mesh-list
6622808|NCT01286701|Antifungal Agents|antifungal agents|mesh-ancestor
6622809|NCT01286701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6622810|NCT01286701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6622811|NCT01286701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622812|NCT01286766|Cisplatin|cisplatin|mesh-list
6622813|NCT01286766|Docetaxel|docetaxel|mesh-list
6622814|NCT01286766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6622815|NCT01286766|Tubulin Modulators|tubulin modulators|mesh-ancestor
6622816|NCT01286766|Antimitotic Agents|antimitotic agents|mesh-ancestor
6622817|NCT01286766|Mitosis Modulators|mitosis modulators|mesh-ancestor
6622818|NCT01286766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622819|NCT01286857|Silicon|silicon|mesh-list
6622820|NCT01286857|Trace Elements|trace elements|mesh-ancestor
6622821|NCT01286857|Micronutrients|micronutrients|mesh-ancestor
6622822|NCT01286857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622823|NCT01286896|Sunitinib|sunitinib|mesh-list
6622824|NCT01286896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6622825|NCT01286896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6622826|NCT01286896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6622827|NCT01286896|Growth Substances|growth substances|mesh-ancestor
6622828|NCT01286896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622829|NCT01286896|Growth Inhibitors|growth inhibitors|mesh-ancestor
6622830|NCT01286896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6622831|NCT01286896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6622832|NCT01286896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622833|NCT01286909|Lycopene|lycopene|mesh-list
6622834|NCT01286909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6622835|NCT01286909|Antioxidants|antioxidants|mesh-ancestor
6661977|NCT01501422|Hormones|hormones|mesh-ancestor
5478924|NCT04448431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5478925|NCT04448431|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5478926|NCT04448431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5478927|NCT04448431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5478928|NCT04448431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5478929|NCT04448431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5478930|NCT04448431|Serotonin Agents|serotonin agents|mesh-ancestor
5478931|NCT04448431|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5478932|NCT04448431|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5503623|NCT04457245|Cariostatic Agents|cariostatic agents|mesh-ancestor
6450797|NCT00409630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450798|NCT00409630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6622836|NCT01286909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622837|NCT01286909|Protective Agents|protective agents|mesh-ancestor
6622838|NCT01286909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622839|NCT01286909|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6622840|NCT01286909|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6622841|NCT01286909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6622842|NCT01286948|Levonorgestrel|levonorgestrel|mesh-list
6622843|NCT01286948|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6622844|NCT01286948|Contraceptive Agents|contraceptive agents|mesh-ancestor
6622845|NCT01286948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6622846|NCT01286948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622847|NCT01286948|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6622848|NCT01286948|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6622849|NCT01286948|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6622850|NCT01287052|Nitrous Oxide|nitrous oxide|mesh-list
6622851|NCT01287052|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6622852|NCT01287052|Anesthetics, General|anesthetics, general|mesh-ancestor
6622853|NCT01287052|Anesthetics|anesthetics|mesh-ancestor
6622854|NCT01287052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6622855|NCT01287052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622856|NCT01287052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6622857|NCT01287052|Analgesics|analgesics|mesh-ancestor
6622858|NCT01287052|Sensory System Agents|sensory system agents|mesh-ancestor
6622859|NCT01287052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6622860|NCT01287091|Rabeprazole|rabeprazole|mesh-list
6622861|NCT01287091|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6622862|NCT01287091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6622863|NCT01287091|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6622864|NCT01287091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6622865|NCT01287091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622866|NCT01287130|Cetuximab|cetuximab|mesh-list
6622867|NCT01287130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6622868|NCT01287130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6622869|NCT01287247|Botulinum Toxins|botulinum toxins|mesh-list
6622870|NCT01287247|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
6622871|NCT01287247|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6622872|NCT01287247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6622873|NCT01287247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622874|NCT01287247|Cholinergic Agents|cholinergic agents|mesh-ancestor
6622875|NCT01287247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6622876|NCT01287247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622877|NCT01287247|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6622878|NCT01287247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6622879|NCT01287260|Nifedipine|nifedipine|mesh-list
6622880|NCT01287260|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6622881|NCT01287260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6622882|NCT01287260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622883|NCT01287260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6450799|NCT00409630|Respiratory System Agents|respiratory system agents|mesh-ancestor
6450800|NCT00409630|Dermatologic Agents|dermatologic agents|mesh-ancestor
6450801|NCT00409630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6450802|NCT00409643|Amlodipine|amlodipine|mesh-list
6450803|NCT00409643|Valsartan|valsartan|mesh-list
6450804|NCT00409643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6450805|NCT00409643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6450806|NCT00409643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6450807|NCT00409643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450808|NCT00409643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6450809|NCT00409643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622884|NCT01287260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622885|NCT01287260|Vasodilator Agents|vasodilator agents|mesh-ancestor
6622886|NCT01287260|Tocolytic Agents|tocolytic agents|mesh-ancestor
6622887|NCT01287260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6661978|NCT01501422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6661979|NCT01501422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661980|NCT01501435|Fenofibric acid|fenofibric acid|mesh-list
6661981|NCT01501435|Fenofibrate|fenofibrate|mesh-list
6661982|NCT01501435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6661983|NCT01501435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6661984|NCT01501435|Antimetabolites|antimetabolites|mesh-ancestor
6661985|NCT01501435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6661986|NCT01501435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6661987|NCT01501448|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6661988|NCT01501448|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6661989|NCT01501448|Levonorgestrel|levonorgestrel|mesh-list
6661990|NCT01501448|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6661991|NCT01501448|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
6661992|NCT01501448|Estradiol|estradiol|mesh-list
6661993|NCT01501448|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6661994|NCT01501448|Estrogens|estrogens|mesh-ancestor
6661995|NCT01501448|Hormones|hormones|mesh-ancestor
6661996|NCT01501448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6661997|NCT01501448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6661998|NCT01501448|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6661999|NCT01501448|Contraceptive Agents|contraceptive agents|mesh-ancestor
6662000|NCT01501448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6662001|NCT01501448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6662002|NCT01501448|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6662003|NCT01501448|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6662004|NCT01501448|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6662005|NCT01501448|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6662006|NCT01501487|Paclitaxel|paclitaxel|mesh-list
6662007|NCT01501487|Docetaxel|docetaxel|mesh-list
6662008|NCT01501487|Trastuzumab|trastuzumab|mesh-list
6662009|NCT01501487|Pertuzumab|pertuzumab|mesh-list
6662010|NCT01501487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6662011|NCT01501487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6662012|NCT01501487|Tubulin Modulators|tubulin modulators|mesh-ancestor
6662013|NCT01501487|Antimitotic Agents|antimitotic agents|mesh-ancestor
6662014|NCT01501487|Mitosis Modulators|mitosis modulators|mesh-ancestor
6662015|NCT01501487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662016|NCT01501487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6662017|NCT01501500|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6662018|NCT01501500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6662019|NCT01501500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6662020|NCT01501500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662021|NCT01501500|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6662022|NCT01501500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6662023|NCT01501500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662024|NCT01501500|Cholinergic Agents|cholinergic agents|mesh-ancestor
6662025|NCT01501500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6662026|NCT01501591|Hydroxyzine|hydroxyzine|mesh-list
6662027|NCT01501591|Antipruritics|antipruritics|mesh-ancestor
6662028|NCT01501591|Dermatologic Agents|dermatologic agents|mesh-ancestor
6662029|NCT01501591|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6662030|NCT01501591|Histamine Antagonists|histamine antagonists|mesh-ancestor
6662031|NCT01501591|Histamine Agents|histamine agents|mesh-ancestor
6662032|NCT01501591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6662033|NCT01501591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662034|NCT01501591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662035|NCT01501669|Capecitabine|capecitabine|mesh-list
6662036|NCT01501669|Irinotecan|irinotecan|mesh-list
6662037|NCT01501669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6662038|NCT01501669|Antimetabolites|antimetabolites|mesh-ancestor
6662039|NCT01501669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662040|NCT01501669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6662041|NCT01501669|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6662042|NCT01501669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6662043|NCT01501669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5478933|NCT04448431|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5478934|NCT04448431|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6662044|NCT01501695|Tiapride Hydrochloride|tiapride hydrochloride|mesh-list
6622888|NCT01287338|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
6622889|NCT01287338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6622890|NCT01287338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6622891|NCT01287338|Analgesics|analgesics|mesh-ancestor
6622892|NCT01287338|Sensory System Agents|sensory system agents|mesh-ancestor
6622893|NCT01287338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6622894|NCT01287338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622895|NCT01287338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6622896|NCT01287338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6622897|NCT01287338|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6622898|NCT01287338|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6622899|NCT01287338|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6622900|NCT01287338|Histamine Antagonists|histamine antagonists|mesh-ancestor
6622901|NCT01287338|Histamine Agents|histamine agents|mesh-ancestor
6622902|NCT01287338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6622903|NCT01287338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622904|NCT01287351|Fluticasone|fluticasone|mesh-list
5478935|NCT04448431|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5478936|NCT04372017|Vitamin D|vitamin d|mesh-list
5478937|NCT04372017|Hydroxychloroquine|hydroxychloroquine|mesh-list
5478938|NCT04372017|Vitamins|vitamins|mesh-ancestor
5478939|NCT04372017|Micronutrients|micronutrients|mesh-ancestor
5478940|NCT04372017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5478941|NCT04372017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5478942|NCT04372017|Antimalarials|antimalarials|mesh-ancestor
5478943|NCT04372017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5478944|NCT04372017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5478945|NCT04372017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5478946|NCT04372017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5478947|NCT04372017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5478948|NCT04372017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5478949|NCT04339049|Lidocaine|lidocaine|mesh-list
5478950|NCT04339049|Misoprostol|misoprostol|mesh-list
5478951|NCT04339049|Anesthetics, Local|anesthetics, local|mesh-ancestor
5478952|NCT04339049|Anesthetics|anesthetics|mesh-ancestor
5478953|NCT04339049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5478954|NCT04339049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5478955|NCT04339049|Sensory System Agents|sensory system agents|mesh-ancestor
6622905|NCT01287351|Xhance|xhance|mesh-list
6622906|NCT01287351|Beclomethasone|beclomethasone|mesh-list
6622907|NCT01287351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6622908|NCT01287351|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6622909|NCT01287351|Autonomic Agents|autonomic agents|mesh-ancestor
6622910|NCT01287351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6622911|NCT01287351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622912|NCT01287351|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6622913|NCT01287351|Respiratory System Agents|respiratory system agents|mesh-ancestor
6622914|NCT01287351|Dermatologic Agents|dermatologic agents|mesh-ancestor
6622915|NCT01287351|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6622916|NCT01287351|Glucocorticoids|glucocorticoids|mesh-ancestor
6622917|NCT01287351|Hormones|hormones|mesh-ancestor
6622918|NCT01287351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6622919|NCT01287455|Vitamin D|vitamin d|mesh-list
6622920|NCT01287455|Cholecalciferol|cholecalciferol|mesh-list
6622921|NCT01287455|Vitamins|vitamins|mesh-ancestor
6622922|NCT01287455|Micronutrients|micronutrients|mesh-ancestor
6622923|NCT01287455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622924|NCT01287455|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6622925|NCT01287455|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6622926|NCT01287494|Sertraline|sertraline|mesh-list
6622927|NCT01287494|Antidepressive Agents|antidepressive agents|mesh-ancestor
6622928|NCT01287494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6622929|NCT01287494|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6622930|NCT01287494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6622931|NCT01287494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6622932|NCT01287494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622933|NCT01287494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6622934|NCT01287494|Serotonin Agents|serotonin agents|mesh-ancestor
6622935|NCT01287494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622936|NCT01287507|Lactoferrin|lactoferrin|mesh-list
6622937|NCT01287507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6622938|NCT01287533|Ibandronic Acid|ibandronic acid|mesh-list
6622939|NCT01287533|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5724866|NCT03184649|Sensory System Agents|sensory system agents|mesh-ancestor
6622940|NCT01287533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622941|NCT01287546|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6622942|NCT01287546|Trametinib|trametinib|mesh-list
6622943|NCT01287546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6622944|NCT01287546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6450810|NCT00409643|Vasodilator Agents|vasodilator agents|mesh-ancestor
6450811|NCT00409643|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6450812|NCT00409643|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6450813|NCT00409656|Basiliximab|basiliximab|mesh-list
6622945|NCT01287546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6622946|NCT01287546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622947|NCT01287598|Rosiglitazone|rosiglitazone|mesh-list
6622948|NCT01287598|Midazolam|midazolam|mesh-list
6622949|NCT01287598|Omeprazole|omeprazole|mesh-list
6622950|NCT01287598|Warfarin|warfarin|mesh-list
6622951|NCT01287598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6622952|NCT01287598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6622953|NCT01287598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6622954|NCT01287598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622955|NCT01287598|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6622956|NCT01287598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6622957|NCT01287598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6622958|NCT01287598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6622959|NCT01287598|Anesthetics, General|anesthetics, general|mesh-ancestor
6622960|NCT01287598|Anesthetics|anesthetics|mesh-ancestor
6622961|NCT01287598|GABA Modulators|gaba modulators|mesh-ancestor
6622962|NCT01287598|GABA Agents|gaba agents|mesh-ancestor
6622963|NCT01287598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6622964|NCT01287598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622965|NCT01287598|Anticoagulants|anticoagulants|mesh-ancestor
6622966|NCT01287598|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6622967|NCT01287598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6622968|NCT01287598|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6622969|NCT01287598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6622970|NCT01287598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6622971|NCT01287624|Gemcitabine|gemcitabine|mesh-list
6622972|NCT01287624|Paclitaxel|paclitaxel|mesh-list
6622973|NCT01287624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6622974|NCT01287624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6622975|NCT01287624|Tubulin Modulators|tubulin modulators|mesh-ancestor
6622976|NCT01287624|Antimitotic Agents|antimitotic agents|mesh-ancestor
6622977|NCT01287624|Mitosis Modulators|mitosis modulators|mesh-ancestor
6622978|NCT01287624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622979|NCT01287624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6622980|NCT01287624|Antimetabolites|antimetabolites|mesh-ancestor
6622981|NCT01287624|Antiviral Agents|antiviral agents|mesh-ancestor
6622982|NCT01287624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6622983|NCT01287624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6622984|NCT01287624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6622985|NCT01287624|Immunologic Factors|immunologic factors|mesh-ancestor
6622986|NCT01287624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622987|NCT01287663|Permethrin|permethrin|mesh-list
6622988|NCT01287663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6622989|NCT01287663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6622990|NCT01287689|Immunoglobulins|immunoglobulins|mesh-list
6622991|NCT01287689|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6622992|NCT01287689|Antibodies|antibodies|mesh-list
6622993|NCT01287689|Immunoglobulin G|immunoglobulin g|mesh-list
6622994|NCT01287689|Immunologic Factors|immunologic factors|mesh-ancestor
6622995|NCT01287689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6622996|NCT01287715|Etanercept|etanercept|mesh-list
6622997|NCT01287715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6622998|NCT01287715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6622999|NCT01287715|Analgesics|analgesics|mesh-ancestor
6623000|NCT01287715|Sensory System Agents|sensory system agents|mesh-ancestor
6623001|NCT01287715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6623002|NCT01287715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623003|NCT01287715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6623004|NCT01287715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6623005|NCT01287715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6623006|NCT01287715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6450814|NCT00409656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6450815|NCT00409656|Immunologic Factors|immunologic factors|mesh-ancestor
6450816|NCT00409656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450817|NCT00409695|Thymoglobulin|thymoglobulin|mesh-list
6450818|NCT00409695|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6623007|NCT01287715|Immunologic Factors|immunologic factors|mesh-ancestor
6623008|NCT01287741|Prednisone|prednisone|mesh-list
6623009|NCT01287741|Cyclophosphamide|cyclophosphamide|mesh-list
6623010|NCT01287741|Rituximab|rituximab|mesh-list
6623011|NCT01287741|Doxorubicin|doxorubicin|mesh-list
6623012|NCT01287741|Vincristine|vincristine|mesh-list
6623013|NCT01287741|Obinutuzumab|obinutuzumab|mesh-list
6623014|NCT01287741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6623015|NCT01287741|Immunologic Factors|immunologic factors|mesh-ancestor
6623016|NCT01287741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623017|NCT01287741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6623018|NCT01287741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6623019|NCT01287741|Alkylating Agents|alkylating agents|mesh-ancestor
6623020|NCT01287741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623021|NCT01287741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6623022|NCT01287741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6623023|NCT01287741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6623024|NCT01287741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6623025|NCT01287741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6623026|NCT01287741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6623027|NCT01287741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6623028|NCT01287741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6623029|NCT01287741|Glucocorticoids|glucocorticoids|mesh-ancestor
6623030|NCT01287741|Hormones|hormones|mesh-ancestor
6623031|NCT01287741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6623032|NCT01287741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6623033|NCT01287741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6623034|NCT01287741|Tubulin Modulators|tubulin modulators|mesh-ancestor
6623035|NCT01287741|Antimitotic Agents|antimitotic agents|mesh-ancestor
6623036|NCT01287741|Mitosis Modulators|mitosis modulators|mesh-ancestor
6623037|NCT01287780|Gentamicins|gentamicins|mesh-list
6623038|NCT01287780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5478956|NCT04339049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5478957|NCT04339049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6623039|NCT01287780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6623040|NCT01287780|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6623041|NCT01287780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6623042|NCT01287780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623043|NCT01287793|Moxifloxacin|moxifloxacin|mesh-list
6623044|NCT01287793|Tigecycline|tigecycline|mesh-list
6623045|NCT01287793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6623046|NCT01287793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6623047|NCT01287793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6623048|NCT01287793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6623049|NCT01287793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6623050|NCT01287793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623051|NCT01287793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6623052|NCT01287793|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6623053|NCT01287806|Urinastatin|urinastatin|mesh-list
6623054|NCT01287806|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6623055|NCT01287806|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6623056|NCT01287806|Protease Inhibitors|protease inhibitors|mesh-ancestor
6623057|NCT01287806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6623058|NCT01287806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623059|NCT01287949|Vaccines|vaccines|mesh-list
6623060|NCT01287949|Immunologic Factors|immunologic factors|mesh-ancestor
6623061|NCT01287949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623062|NCT01287962|Apatinib|apatinib|mesh-list
6623063|NCT01287962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6623064|NCT01287962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6623065|NCT01287962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6623066|NCT01287962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623067|NCT01288092|Dactolisib|dactolisib|mesh-list
6623068|NCT01288092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6623069|NCT01288131|Cyclosporine|cyclosporine|mesh-list
6623070|NCT01288131|Mycophenolic Acid|mycophenolic acid|mesh-list
6623071|NCT01288131|Cyclophosphamide|cyclophosphamide|mesh-list
6623072|NCT01288131|Cyclosporins|cyclosporins|mesh-list
6623073|NCT01288131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6623074|NCT01288131|Immunologic Factors|immunologic factors|mesh-ancestor
6623075|NCT01288131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623076|NCT01288131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6623077|NCT01288131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6623078|NCT01288131|Alkylating Agents|alkylating agents|mesh-ancestor
6623079|NCT01288131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623080|NCT01288131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6623081|NCT01288131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6623082|NCT01288131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6623083|NCT01288131|Antifungal Agents|antifungal agents|mesh-ancestor
6623084|NCT01288131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6623085|NCT01288131|Dermatologic Agents|dermatologic agents|mesh-ancestor
6623086|NCT01288131|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6623087|NCT01288131|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6623088|NCT01288131|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6623089|NCT01288131|Antitubercular Agents|antitubercular agents|mesh-ancestor
6623090|NCT01288131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6623091|NCT01288157|Golimumab|golimumab|mesh-list
6623092|NCT01288157|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5478958|NCT04339049|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5478959|NCT04339049|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5478960|NCT04339049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5478961|NCT04339049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5478962|NCT04339049|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5478963|NCT04339049|Abortifacient Agents|abortifacient agents|mesh-ancestor
5478964|NCT04339049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5478965|NCT04339049|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5478966|NCT04339049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5478967|NCT04339049|Oxytocics|oxytocics|mesh-ancestor
5478968|NCT04312971|Norepinephrine|norepinephrine|mesh-list
5478969|NCT04312971|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5478970|NCT04312971|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5478971|NCT04312971|Adrenergic Agents|adrenergic agents|mesh-ancestor
5478972|NCT04312971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5478973|NCT04312971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5478974|NCT04312971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623093|NCT01288157|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6623094|NCT01288157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6623095|NCT01288157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6623096|NCT01288157|Immunologic Factors|immunologic factors|mesh-ancestor
6623097|NCT01288157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623098|NCT01288170|Tobramycin|tobramycin|mesh-list
6623099|NCT01288170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6623100|NCT01288170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6623101|NCT01288261|Paclitaxel|paclitaxel|mesh-list
6623102|NCT01288261|Bavituximab|bavituximab|mesh-list
6623103|NCT01288261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6623104|NCT01288261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6623105|NCT01288261|Tubulin Modulators|tubulin modulators|mesh-ancestor
6623106|NCT01288261|Antimitotic Agents|antimitotic agents|mesh-ancestor
6623107|NCT01288261|Mitosis Modulators|mitosis modulators|mesh-ancestor
6623108|NCT01288261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623109|NCT01288261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6623110|NCT01288326|Liraglutide|liraglutide|mesh-list
6623111|NCT01288326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6623112|NCT01288326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623113|NCT01288326|Incretins|incretins|mesh-ancestor
6623114|NCT01288326|Hormones|hormones|mesh-ancestor
6623115|NCT01288326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6623116|NCT01288339|Leucovorin|leucovorin|mesh-list
6623117|NCT01288339|Fluorouracil|fluorouracil|mesh-list
6623118|NCT01288339|Oxaliplatin|oxaliplatin|mesh-list
6623119|NCT01288339|Panitumumab|panitumumab|mesh-list
6623120|NCT01288339|Antimetabolites|antimetabolites|mesh-ancestor
6623121|NCT01288339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623122|NCT01288339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6623123|NCT01288339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6623124|NCT01288339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6623125|NCT01288339|Immunologic Factors|immunologic factors|mesh-ancestor
6623126|NCT01288339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623127|NCT01288339|Antidotes|antidotes|mesh-ancestor
6623128|NCT01288339|Protective Agents|protective agents|mesh-ancestor
6623129|NCT01288339|Vitamin B Complex|vitamin b complex|mesh-ancestor
6623130|NCT01288339|Vitamins|vitamins|mesh-ancestor
6623131|NCT01288339|Micronutrients|micronutrients|mesh-ancestor
6623132|NCT01288339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6623133|NCT01288378|Caspofungin|caspofungin|mesh-list
6623134|NCT01288378|Antifungal Agents|antifungal agents|mesh-ancestor
6623135|NCT01288378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6623136|NCT01288378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6623137|NCT01288378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623138|NCT01288404|Fluorometholone|fluorometholone|mesh-list
6623139|NCT01288404|Bevacizumab|bevacizumab|mesh-list
6623140|NCT01288404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6450819|NCT00409695|Immunologic Factors|immunologic factors|mesh-ancestor
6450820|NCT00409695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450821|NCT00409695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6450822|NCT00409721|Memantine|memantine|mesh-list
6450823|NCT00409721|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6450824|NCT00409721|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6623141|NCT01288404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6623142|NCT01288404|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6623143|NCT01288404|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6623144|NCT01288404|Growth Substances|growth substances|mesh-ancestor
6623145|NCT01288404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623146|NCT01288404|Growth Inhibitors|growth inhibitors|mesh-ancestor
6623147|NCT01288404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6623148|NCT01288404|Glucocorticoids|glucocorticoids|mesh-ancestor
5478975|NCT04312971|Sympathomimetics|sympathomimetics|mesh-ancestor
5478976|NCT04312971|Autonomic Agents|autonomic agents|mesh-ancestor
5478977|NCT04312971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5478978|NCT04312971|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6623149|NCT01288404|Hormones|hormones|mesh-ancestor
6623150|NCT01288404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6623151|NCT01288404|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6623152|NCT01288417|Raltegravir Potassium|raltegravir potassium|mesh-list
6623153|NCT01288417|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6623154|NCT01288417|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6623155|NCT01288417|Antiviral Agents|antiviral agents|mesh-ancestor
6623156|NCT01288417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6623157|NCT01288417|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6623158|NCT01288417|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6623159|NCT01288417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6623160|NCT01288417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623161|NCT01288495|Psyllium|psyllium|mesh-list
6623162|NCT01288495|Cathartics|cathartics|mesh-ancestor
6623163|NCT01288495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6623164|NCT01288508|Psyllium|psyllium|mesh-list
6623165|NCT01288508|Cathartics|cathartics|mesh-ancestor
6623166|NCT01288508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6623167|NCT01288547|Theobromine|theobromine|mesh-list
6623168|NCT01288547|Caffeine|caffeine|mesh-list
6623169|NCT01288547|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6623170|NCT01288547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623171|NCT01288547|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6623172|NCT01288547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6623173|NCT01288547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623174|NCT01288547|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6623175|NCT01288547|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6623176|NCT01288547|Purinergic Agents|purinergic agents|mesh-ancestor
6623177|NCT01288547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6623178|NCT01288547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6623179|NCT01288547|Autonomic Agents|autonomic agents|mesh-ancestor
6623180|NCT01288547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6623181|NCT01288547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6623182|NCT01288547|Respiratory System Agents|respiratory system agents|mesh-ancestor
6623183|NCT01288547|Vasodilator Agents|vasodilator agents|mesh-ancestor
6623184|NCT01288573|Plerixafor|plerixafor|mesh-list
6623185|NCT01288573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6623186|NCT01288573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6623187|NCT01288573|Antiviral Agents|antiviral agents|mesh-ancestor
6623188|NCT01288573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6623189|NCT01288664|Tacrolimus|tacrolimus|mesh-list
6623190|NCT01288664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6623191|NCT01288664|Immunologic Factors|immunologic factors|mesh-ancestor
5478979|NCT04282278|Apatinib|apatinib|mesh-list
5478980|NCT04282278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5478981|NCT04282278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5478982|NCT04282278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5478983|NCT04282278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502261|NCT04467931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5502262|NCT04467931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503624|NCT04457245|Protective Agents|protective agents|mesh-ancestor
6450825|NCT00409721|Dopamine Agents|dopamine agents|mesh-ancestor
6450826|NCT00409721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6450827|NCT00409721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450828|NCT00409721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450829|NCT00409721|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6623192|NCT01288664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623193|NCT01288664|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6623194|NCT01288664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6623195|NCT01288664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623196|NCT01288716|Baclofen|baclofen|mesh-list
6623197|NCT01288716|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6623198|NCT01288716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623199|NCT01288716|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6623200|NCT01288716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6623201|NCT01288716|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6623202|NCT01288716|GABA Agonists|gaba agonists|mesh-ancestor
5478984|NCT04243629|Pramlintide|pramlintide|mesh-list
5478985|NCT04243629|Insulin, Short-Acting|insulin, short-acting|mesh-list
5478986|NCT04243629|Pancrelipase|pancrelipase|mesh-list
5478987|NCT04243629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5478988|NCT04243629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5478989|NCT04243629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5478990|NCT04194528|Acetaminophen|acetaminophen|mesh-list
5478991|NCT04194528|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
5478992|NCT04194528|Oxycodone|oxycodone|mesh-list
5478993|NCT04194528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5478994|NCT04194528|Analgesics|analgesics|mesh-ancestor
5478995|NCT04194528|Sensory System Agents|sensory system agents|mesh-ancestor
5478996|NCT04194528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5478997|NCT04194528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5478998|NCT04194528|Antipyretics|antipyretics|mesh-ancestor
6623203|NCT01288716|GABA Agents|gaba agents|mesh-ancestor
6623204|NCT01288716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6623205|NCT01288716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623206|NCT01288742|Simeprevir|simeprevir|mesh-list
6623207|NCT01288742|Digoxin|digoxin|mesh-list
6623208|NCT01288742|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6623209|NCT01288742|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6623210|NCT01288742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5478999|NCT04194528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5479000|NCT04194528|Narcotics|narcotics|mesh-ancestor
5479001|NCT04194528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5479002|NCT04194528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5479003|NCT04194528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5479004|NCT04194528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6623211|NCT01288742|Antimetabolites|antimetabolites|mesh-ancestor
6623212|NCT01288742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623213|NCT01288742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6623214|NCT01288742|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6623215|NCT01288742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6623216|NCT01288742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6623217|NCT01288742|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6623218|NCT01288742|Protective Agents|protective agents|mesh-ancestor
6623219|NCT01288742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623220|NCT01288742|Antiviral Agents|antiviral agents|mesh-ancestor
6623221|NCT01288742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6623222|NCT01288742|Protease Inhibitors|protease inhibitors|mesh-ancestor
6623223|NCT01288755|Raltegravir Potassium|raltegravir potassium|mesh-list
6623224|NCT01288755|Rilpivirine|rilpivirine|mesh-list
6623225|NCT01288755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6623226|NCT01288755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6623227|NCT01288755|Antiviral Agents|antiviral agents|mesh-ancestor
6623228|NCT01288755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6623229|NCT01288755|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6623230|NCT01288755|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6623231|NCT01288755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6623232|NCT01288755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479005|NCT04179162|Gemcitabine|gemcitabine|mesh-list
5479006|NCT04179162|BCG Vaccine|bcg vaccine|mesh-list
5479007|NCT04179162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5479008|NCT04179162|Antimetabolites|antimetabolites|mesh-ancestor
6662045|NCT01501695|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5503625|NCT04457245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623233|NCT01288755|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6623234|NCT01288755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6623235|NCT01288794|Furosemide|furosemide|mesh-list
6623236|NCT01288794|Diuretics|diuretics|mesh-list
6623237|NCT01288794|Natriuretic Agents|natriuretic agents|mesh-ancestor
6623238|NCT01288794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623239|NCT01288794|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6623240|NCT01288794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6623241|NCT01288794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623242|NCT01288820|Artesunate|artesunate|mesh-list
6623243|NCT01288820|Piperaquine|piperaquine|mesh-list
6623244|NCT01288820|Primaquine|primaquine|mesh-list
6623245|NCT01288820|Amodiaquine|amodiaquine|mesh-list
6623246|NCT01288820|Artenimol|artenimol|mesh-list
6623247|NCT01288820|Antimalarials|antimalarials|mesh-ancestor
6623248|NCT01288820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6623249|NCT01288820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6623250|NCT01288820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6623251|NCT01288820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6623252|NCT01288820|Antiviral Agents|antiviral agents|mesh-ancestor
6623253|NCT01288820|Schistosomicides|schistosomicides|mesh-ancestor
6623254|NCT01288820|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5479009|NCT04179162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623255|NCT01288820|Anthelmintics|anthelmintics|mesh-ancestor
6623256|NCT01288872|Praziquantel|praziquantel|mesh-list
6623257|NCT01288872|Anthelmintics|anthelmintics|mesh-ancestor
6623258|NCT01288872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6623259|NCT01288872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6623260|NCT01288885|Ipragliflozin|ipragliflozin|mesh-list
6623261|NCT01288885|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6623262|NCT01288885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623263|NCT01288885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6623264|NCT01288885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623265|NCT01288898|Ipragliflozin|ipragliflozin|mesh-list
6623266|NCT01288898|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6623267|NCT01288898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623268|NCT01288898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6623269|NCT01288898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623270|NCT01288924|Parecoxib|parecoxib|mesh-list
6623271|NCT01288924|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6623272|NCT01288924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6623273|NCT01288924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6623274|NCT01288924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623275|NCT01288924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6623276|NCT01288924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6623277|NCT01288924|Analgesics|analgesics|mesh-ancestor
6623278|NCT01288924|Sensory System Agents|sensory system agents|mesh-ancestor
6623279|NCT01288924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6623280|NCT01288924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623281|NCT01288924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6623282|NCT01288924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6623283|NCT01288950|Vitamin D|vitamin d|mesh-list
6623284|NCT01288950|Ergocalciferols|ergocalciferols|mesh-list
6623285|NCT01288950|Cholecalciferol|cholecalciferol|mesh-list
6623286|NCT01288950|Vitamins|vitamins|mesh-list
6623287|NCT01288950|Micronutrients|micronutrients|mesh-ancestor
6623288|NCT01288950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623289|NCT01288950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6623290|NCT01288950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6623291|NCT01288963|Aldesleukin|aldesleukin|mesh-list
6623292|NCT01288963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6623293|NCT01288963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6623294|NCT01288963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6623295|NCT01288963|Antiviral Agents|antiviral agents|mesh-ancestor
6623296|NCT01288963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5479010|NCT04179162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5479011|NCT04179162|Antiviral Agents|antiviral agents|mesh-ancestor
5479012|NCT04179162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5479013|NCT04179162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6623297|NCT01289054|Imatinib Mesylate|imatinib mesylate|mesh-list
6623298|NCT01289054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6623299|NCT01289054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6623300|NCT01289054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6623301|NCT01289054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623302|NCT01289132|Candesartan|candesartan|mesh-list
6623303|NCT01289132|Candesartan cilexetil|candesartan cilexetil|mesh-list
6623304|NCT01289132|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
6623305|NCT01289132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6623306|NCT01289132|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6623307|NCT01289132|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6623308|NCT01289132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662046|NCT01501695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6662047|NCT01501695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6662048|NCT01501695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662049|NCT01501695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6662050|NCT01501695|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6662051|NCT01501695|Dopamine Agents|dopamine agents|mesh-ancestor
6662052|NCT01501695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6662053|NCT01501695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479014|NCT04179162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5479015|NCT04179162|Immunologic Factors|immunologic factors|mesh-ancestor
5479016|NCT04179162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479017|NCT04179162|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5479018|NCT04176172|Nicotine|nicotine|mesh-list
5479019|NCT04176172|Varenicline|varenicline|mesh-list
6662054|NCT01501708|Voriconazole|voriconazole|mesh-list
6662055|NCT01501708|Amphotericin B|amphotericin b|mesh-list
6662056|NCT01501708|Caspofungin|caspofungin|mesh-list
6662057|NCT01501708|Antifungal Agents|antifungal agents|mesh-ancestor
6662058|NCT01501708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6662059|NCT01501708|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6662060|NCT01501708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6662061|NCT01501708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6662062|NCT01501708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662063|NCT01501708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6662064|NCT01501708|Hormone Antagonists|hormone antagonists|mesh-ancestor
6662065|NCT01501708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6662066|NCT01501708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662067|NCT01501708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5479020|NCT04176172|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5479021|NCT04176172|Autonomic Agents|autonomic agents|mesh-ancestor
5479022|NCT04176172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5479023|NCT04176172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479024|NCT04176172|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5479025|NCT04176172|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5479026|NCT04176172|Cholinergic Agents|cholinergic agents|mesh-ancestor
5479027|NCT04176172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5479028|NCT04176172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479029|NCT04170998|Metformin|metformin|mesh-list
5479030|NCT04170998|Dapagliflozin|dapagliflozin|mesh-list
5479031|NCT04170998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5479032|NCT04170998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479033|NCT04170998|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5479034|NCT04170998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479035|NCT04147650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5479036|NCT04147650|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5479037|NCT04082442|Evolocumab|evolocumab|mesh-list
6623309|NCT01289171|Glycolic acid|glycolic acid|mesh-list
6623310|NCT01289171|Keratolytic Agents|keratolytic agents|mesh-ancestor
6623311|NCT01289171|Dermatologic Agents|dermatologic agents|mesh-ancestor
6623312|NCT01289223|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6623313|NCT01289223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6623314|NCT01289223|Alkylating Agents|alkylating agents|mesh-ancestor
6623315|NCT01289223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623316|NCT01289223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6623317|NCT01289236|Milnacipran|milnacipran|mesh-list
6623318|NCT01289236|Levomilnacipran|levomilnacipran|mesh-list
6623319|NCT01289236|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6623320|NCT01289236|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6623321|NCT01289236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6623322|NCT01289236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623323|NCT01289236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6623324|NCT01289236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623325|NCT01289236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6623326|NCT01289236|Analgesics|analgesics|mesh-ancestor
6623327|NCT01289236|Sensory System Agents|sensory system agents|mesh-ancestor
6623328|NCT01289236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6623329|NCT01289236|Antidepressive Agents|antidepressive agents|mesh-ancestor
6623330|NCT01289236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6623331|NCT01289301|Cyclosporine|cyclosporine|mesh-list
6623332|NCT01289301|Sirolimus|sirolimus|mesh-list
6623333|NCT01289301|Everolimus|everolimus|mesh-list
6623334|NCT01289301|Tacrolimus|tacrolimus|mesh-list
6623335|NCT01289301|Cyclosporins|cyclosporins|mesh-list
6623336|NCT01289301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
5479038|NCT04082442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5479039|NCT04082442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5479040|NCT04082442|Antimetabolites|antimetabolites|mesh-ancestor
5479041|NCT04082442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479042|NCT04082442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5479043|NCT04070573|Aspirin|aspirin|mesh-list
5479044|NCT04070573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5479045|NCT04070573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5479046|NCT04070573|Analgesics|analgesics|mesh-ancestor
5479047|NCT04070573|Sensory System Agents|sensory system agents|mesh-ancestor
5479048|NCT04070573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6450830|NCT00409721|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6461860|NCT00456560|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6461861|NCT00456560|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6623337|NCT01289301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6623338|NCT01289301|Immunologic Factors|immunologic factors|mesh-ancestor
6623339|NCT01289301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623340|NCT01289301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6623341|NCT01289301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623342|NCT01289301|Antifungal Agents|antifungal agents|mesh-ancestor
6623343|NCT01289301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6623344|NCT01289301|Dermatologic Agents|dermatologic agents|mesh-ancestor
6623345|NCT01289301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6623346|NCT01289301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6623347|NCT01289301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6623348|NCT01289301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6623349|NCT01289327|Midazolam|midazolam|mesh-list
6623350|NCT01289327|Alfentanil|alfentanil|mesh-list
6623351|NCT01289327|Propofol|propofol|mesh-list
6623352|NCT01289327|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6623353|NCT01289327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6461862|NCT00456560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6461863|NCT00456560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461864|NCT00456560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6461865|NCT00456560|Serotonin Agents|serotonin agents|mesh-ancestor
6461866|NCT00456560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461867|NCT00456560|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6461868|NCT00456560|Antidepressive Agents|antidepressive agents|mesh-ancestor
6461869|NCT00456560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6461870|NCT00456560|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6461871|NCT00456560|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6461872|NCT00456560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6623354|NCT01289327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623355|NCT01289327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6623356|NCT01289327|Anesthetics, General|anesthetics, general|mesh-ancestor
6623357|NCT01289327|Anesthetics|anesthetics|mesh-ancestor
6623358|NCT01289327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6623359|NCT01289327|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6623360|NCT01289327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6623361|NCT01289327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6623362|NCT01289327|GABA Modulators|gaba modulators|mesh-ancestor
6623363|NCT01289327|GABA Agents|gaba agents|mesh-ancestor
6623364|NCT01289327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6623365|NCT01289327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623366|NCT01289327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6623367|NCT01289327|Narcotics|narcotics|mesh-ancestor
6623368|NCT01289327|Analgesics|analgesics|mesh-ancestor
6623369|NCT01289327|Sensory System Agents|sensory system agents|mesh-ancestor
6623370|NCT01289327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6623371|NCT01289483|Fospropofol|fospropofol|mesh-list
6623372|NCT01289483|Propofol|propofol|mesh-list
6623373|NCT01289483|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6623374|NCT01289483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6623375|NCT01289483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623376|NCT01289483|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6623377|NCT01289483|Anesthetics, General|anesthetics, general|mesh-ancestor
6623378|NCT01289483|Anesthetics|anesthetics|mesh-ancestor
6623379|NCT01289496|Interferons|interferons|mesh-list
6623380|NCT01289496|Ribavirin|ribavirin|mesh-list
5479049|NCT04070573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479050|NCT04070573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5479051|NCT04070573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5479052|NCT04070573|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5479053|NCT04070573|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5479054|NCT04070573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479055|NCT04070573|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5479056|NCT04070573|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5479057|NCT04070573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5479058|NCT04070573|Antipyretics|antipyretics|mesh-ancestor
5479059|NCT04070443|Imatinib Mesylate|imatinib mesylate|mesh-list
5479060|NCT04070443|Ponatinib|ponatinib|mesh-list
5479061|NCT04070443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5479062|NCT04070443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5479063|NCT04070443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5479064|NCT04070443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479065|NCT03990077|Docetaxel|docetaxel|mesh-list
5479066|NCT03990077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5479067|NCT03990077|Tubulin Modulators|tubulin modulators|mesh-ancestor
5479068|NCT03990077|Antimitotic Agents|antimitotic agents|mesh-ancestor
5479069|NCT03990077|Mitosis Modulators|mitosis modulators|mesh-ancestor
5479070|NCT03990077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479071|NCT03972280|Antibodies|antibodies|mesh-list
5479072|NCT03972280|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5479073|NCT03972280|Sargramostim|sargramostim|mesh-list
5479074|NCT03972280|Lenograstim|lenograstim|mesh-list
5479075|NCT03972280|Immunologic Factors|immunologic factors|mesh-ancestor
5479076|NCT03972280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479077|NCT03972280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5479078|NCT03954613|Memantine|memantine|mesh-list
5479079|NCT03954613|Donepezil|donepezil|mesh-list
5479080|NCT03954613|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5479081|NCT03954613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5479082|NCT03954613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479083|NCT03954613|Cholinergic Agents|cholinergic agents|mesh-ancestor
5479084|NCT03954613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5479085|NCT03954613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479086|NCT03954613|Nootropic Agents|nootropic agents|mesh-ancestor
5479087|NCT03954613|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5479088|NCT03954613|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6623381|NCT01289496|Interferon-alpha|interferon-alpha|mesh-list
6623382|NCT01289496|Interferon alpha-2|interferon alpha-2|mesh-list
6623383|NCT01289496|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6623384|NCT01289496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6623385|NCT01289496|Antiviral Agents|antiviral agents|mesh-ancestor
6623386|NCT01289496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6623387|NCT01289496|Antimetabolites|antimetabolites|mesh-ancestor
6623388|NCT01289496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623389|NCT01289496|Immunologic Factors|immunologic factors|mesh-ancestor
6623390|NCT01289496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623391|NCT01289561|Ethanol|ethanol|mesh-list
6623392|NCT01289561|Quinine|quinine|mesh-list
6623393|NCT01289561|Caffeine|caffeine|mesh-list
6623394|NCT01289561|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6623395|NCT01289561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6623396|NCT01289561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6623397|NCT01289561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623398|NCT01289561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6623399|NCT01289561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6623400|NCT01289561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6623401|NCT01289561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623402|NCT01289561|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6623403|NCT01289561|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6623404|NCT01289561|Purinergic Agents|purinergic agents|mesh-ancestor
6623405|NCT01289561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6623406|NCT01289561|Antimalarials|antimalarials|mesh-ancestor
6623407|NCT01289561|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6623408|NCT01289561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6623409|NCT01289561|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6623410|NCT01289561|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6623411|NCT01289561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6623412|NCT01289561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6623413|NCT01289561|Analgesics|analgesics|mesh-ancestor
6623414|NCT01289561|Sensory System Agents|sensory system agents|mesh-ancestor
6623415|NCT01289730|Etanercept|etanercept|mesh-list
6623416|NCT01289730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6623417|NCT01289730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6623418|NCT01289730|Analgesics|analgesics|mesh-ancestor
6623419|NCT01289730|Sensory System Agents|sensory system agents|mesh-ancestor
6623420|NCT01289730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6623421|NCT01289730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623422|NCT01289730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6623423|NCT01289730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6623424|NCT01289730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6623425|NCT01289730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6623426|NCT01289730|Immunologic Factors|immunologic factors|mesh-ancestor
6623427|NCT01289743|Etanercept|etanercept|mesh-list
6623428|NCT01289743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6623429|NCT01289743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6623430|NCT01289743|Analgesics|analgesics|mesh-ancestor
6623431|NCT01289743|Sensory System Agents|sensory system agents|mesh-ancestor
6623432|NCT01289743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6623433|NCT01289743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623434|NCT01289743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6623435|NCT01289743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6623436|NCT01289743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6623437|NCT01289743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6623438|NCT01289743|Immunologic Factors|immunologic factors|mesh-ancestor
6623439|NCT01289756|Clarithromycin|clarithromycin|mesh-list
6623440|NCT01289756|Paroxetine|paroxetine|mesh-list
6623441|NCT01289756|Clomiphene|clomiphene|mesh-list
6623442|NCT01289756|Enclomiphene|enclomiphene|mesh-list
6623443|NCT01289756|Zuclomiphene|zuclomiphene|mesh-list
6623444|NCT01289756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6623445|NCT01289756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6623446|NCT01289756|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6623447|NCT01289756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6623448|NCT01289756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623449|NCT01289756|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6623450|NCT01289756|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6623451|NCT01289756|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6623452|NCT01289756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6623453|NCT01289756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6623454|NCT01289756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6623455|NCT01289756|Serotonin Agents|serotonin agents|mesh-ancestor
6623456|NCT01289756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623457|NCT01289756|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6623458|NCT01289756|Antidepressive Agents|antidepressive agents|mesh-ancestor
6623459|NCT01289756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6623460|NCT01289756|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6623461|NCT01289756|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6623462|NCT01289756|Hormone Antagonists|hormone antagonists|mesh-ancestor
6623463|NCT01289756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6623464|NCT01289756|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6623465|NCT01289756|Fertility Agents|fertility agents|mesh-ancestor
6450831|NCT00409760|Amlodipine|amlodipine|mesh-list
6450832|NCT00409760|Valsartan|valsartan|mesh-list
6450833|NCT00409760|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6450834|NCT00409760|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6450835|NCT00409760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6623466|NCT01289756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6623467|NCT01289756|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6623468|NCT01289756|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6623469|NCT01289769|Dexmedetomidine|dexmedetomidine|mesh-list
6623470|NCT01289769|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6623471|NCT01289769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6623472|NCT01289769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623473|NCT01289769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5479089|NCT03954613|Dopamine Agents|dopamine agents|mesh-ancestor
5479090|NCT03954613|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5479091|NCT03954613|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5479092|NCT03842696|Cyclosporine|cyclosporine|mesh-list
5479093|NCT03842696|Mycophenolic Acid|mycophenolic acid|mesh-list
5479094|NCT03842696|Cyclophosphamide|cyclophosphamide|mesh-list
5479095|NCT03842696|Methotrexate|methotrexate|mesh-list
5479096|NCT03842696|Vorinostat|vorinostat|mesh-list
5479097|NCT03842696|Tacrolimus|tacrolimus|mesh-list
5479098|NCT03842696|Cyclosporins|cyclosporins|mesh-list
5479099|NCT03842696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5479100|NCT03842696|Immunologic Factors|immunologic factors|mesh-ancestor
5479101|NCT03842696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479102|NCT03842696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5479103|NCT03842696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5479104|NCT03842696|Alkylating Agents|alkylating agents|mesh-ancestor
5479105|NCT03842696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479106|NCT03842696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5479107|NCT03842696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5479108|NCT03842696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5479109|NCT03842696|Abortifacient Agents|abortifacient agents|mesh-ancestor
5479110|NCT03842696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5479111|NCT03842696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5479112|NCT03842696|Antimetabolites|antimetabolites|mesh-ancestor
5479113|NCT03842696|Dermatologic Agents|dermatologic agents|mesh-ancestor
5479114|NCT03842696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5479115|NCT03842696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5479116|NCT03842696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5479117|NCT03842696|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5479118|NCT03842696|Antifungal Agents|antifungal agents|mesh-ancestor
5479119|NCT03842696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5479120|NCT03842696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6450836|NCT00409760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450837|NCT00409760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6450838|NCT00409760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623474|NCT01289769|Analgesics|analgesics|mesh-ancestor
6623475|NCT01289769|Sensory System Agents|sensory system agents|mesh-ancestor
6623476|NCT01289769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6623477|NCT01289769|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6623478|NCT01289769|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6623479|NCT01289769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5479121|NCT03842696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5479122|NCT03842696|Antitubercular Agents|antitubercular agents|mesh-ancestor
6450839|NCT00409760|Vasodilator Agents|vasodilator agents|mesh-ancestor
5479123|NCT03842696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6623480|NCT01289769|Adrenergic Agents|adrenergic agents|mesh-ancestor
6623481|NCT01289769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6623482|NCT01289769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623483|NCT01289925|Selenium|selenium|mesh-list
6623484|NCT01289925|Antioxidants|antioxidants|mesh-ancestor
6623485|NCT01289925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623486|NCT01289925|Protective Agents|protective agents|mesh-ancestor
6623487|NCT01289925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623488|NCT01289925|Trace Elements|trace elements|mesh-ancestor
6623489|NCT01289925|Micronutrients|micronutrients|mesh-ancestor
6623490|NCT01289938|Diphenhydramine|diphenhydramine|mesh-list
6623491|NCT01289938|Promethazine|promethazine|mesh-list
6623492|NCT01289938|Metoclopramide|metoclopramide|mesh-list
6623493|NCT01289938|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6623494|NCT01289938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6623495|NCT01289938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6623496|NCT01289938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623497|NCT01289938|Anesthetics, Local|anesthetics, local|mesh-ancestor
6623498|NCT01289938|Anesthetics|anesthetics|mesh-ancestor
6623499|NCT01289938|Sensory System Agents|sensory system agents|mesh-ancestor
6623500|NCT01289938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6623501|NCT01289938|Antiemetics|antiemetics|mesh-ancestor
6623502|NCT01289938|Autonomic Agents|autonomic agents|mesh-ancestor
6623503|NCT01289938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6623504|NCT01289938|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6623505|NCT01289938|Histamine Antagonists|histamine antagonists|mesh-ancestor
6623506|NCT01289938|Histamine Agents|histamine agents|mesh-ancestor
6623507|NCT01289938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5479124|NCT03842696|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5479125|NCT03792841|Etanercept|etanercept|mesh-list
5479126|NCT03792841|Pembrolizumab|pembrolizumab|mesh-list
5479127|NCT03792841|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5479128|NCT03792841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5479129|NCT03792841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5479130|NCT03792841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5479131|NCT03792841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5479132|NCT03792841|Analgesics|analgesics|mesh-ancestor
5479133|NCT03792841|Sensory System Agents|sensory system agents|mesh-ancestor
5479134|NCT03792841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5479135|NCT03792841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479136|NCT03792841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5479137|NCT03792841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5479138|NCT03792841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5479139|NCT03792841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5479140|NCT03792841|Immunologic Factors|immunologic factors|mesh-ancestor
5479141|NCT03792841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479142|NCT03761277|Morphine|morphine|mesh-list
5479143|NCT03761277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5479144|NCT03761277|Narcotics|narcotics|mesh-ancestor
5479145|NCT03761277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5479146|NCT03761277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479147|NCT03761277|Analgesics|analgesics|mesh-ancestor
6623508|NCT01289938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623509|NCT01289938|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6623510|NCT01289938|Antipruritics|antipruritics|mesh-ancestor
6623511|NCT01289938|Dermatologic Agents|dermatologic agents|mesh-ancestor
6623512|NCT01289938|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6623513|NCT01289938|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6623514|NCT01289938|Dopamine Agents|dopamine agents|mesh-ancestor
6623515|NCT01289951|Raltegravir Potassium|raltegravir potassium|mesh-list
6623516|NCT01289951|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6623517|NCT01289951|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6623518|NCT01289951|Antiviral Agents|antiviral agents|mesh-ancestor
6623519|NCT01289951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6623520|NCT01289951|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6623521|NCT01289951|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6623522|NCT01289951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6623523|NCT01289951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623524|NCT01290003|Tazobactam|tazobactam|mesh-list
6623525|NCT01290003|Piperacillin|piperacillin|mesh-list
6623526|NCT01290003|Amikacin|amikacin|mesh-list
6623527|NCT01290003|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
6623528|NCT01290003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6623529|NCT01290003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5479148|NCT03761277|Sensory System Agents|sensory system agents|mesh-ancestor
6623530|NCT01290003|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6623531|NCT01290003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6623532|NCT01290003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479149|NCT03761277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5479150|NCT03729258|Amantadine|amantadine|mesh-list
5479151|NCT03729258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5479152|NCT03729258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5479153|NCT03729258|Antiviral Agents|antiviral agents|mesh-ancestor
5479154|NCT03729258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5479155|NCT03729258|Dopamine Agents|dopamine agents|mesh-ancestor
5479156|NCT03729258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5479157|NCT03729258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479158|NCT03729258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479159|NCT03729258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5479160|NCT03729258|Analgesics|analgesics|mesh-ancestor
5479161|NCT03729258|Sensory System Agents|sensory system agents|mesh-ancestor
5479162|NCT03729258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5479163|NCT03716349|Anesthetics|anesthetics|mesh-list
5479164|NCT03716349|Anesthetics, Local|anesthetics, local|mesh-list
5479165|NCT03716349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5479166|NCT03716349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479167|NCT03716349|Sensory System Agents|sensory system agents|mesh-ancestor
5479168|NCT03716349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5479169|NCT03634488|Hydroxyurea|hydroxyurea|mesh-list
5479170|NCT03634488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5479171|NCT03634488|Antisickling Agents|antisickling agents|mesh-ancestor
5479172|NCT03634488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5479173|NCT03634488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479174|NCT03634488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5479175|NCT03573960|Lenvatinib|lenvatinib|mesh-list
6623533|NCT01290042|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6623534|NCT01290042|Immunologic Factors|immunologic factors|mesh-ancestor
6623535|NCT01290042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623536|NCT01290120|Rituximab|rituximab|mesh-list
6623537|NCT01290120|Doxorubicin|doxorubicin|mesh-list
6623538|NCT01290120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6623539|NCT01290120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6623540|NCT01290120|Immunologic Factors|immunologic factors|mesh-ancestor
6623541|NCT01290120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623542|NCT01290120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6623543|NCT01290120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6623544|NCT01290120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6623545|NCT01290120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6623546|NCT01290120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6623547|NCT01290120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623548|NCT01290133|Vestipitant|vestipitant|mesh-list
6623549|NCT01290133|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6623550|NCT01290133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6623551|NCT01290133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623552|NCT01290133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623553|NCT01290146|Simendan|simendan|mesh-list
6623554|NCT01290146|Diuretics|diuretics|mesh-list
6623555|NCT01290146|Natriuretic Agents|natriuretic agents|mesh-ancestor
6623556|NCT01290146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623557|NCT01290146|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6623558|NCT01290146|Vasodilator Agents|vasodilator agents|mesh-ancestor
6623559|NCT01290146|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6623560|NCT01290146|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5479176|NCT03573960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5479177|NCT03573960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5479178|NCT03573960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5479179|NCT03573960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479180|NCT03527238|Tacrolimus|tacrolimus|mesh-list
5479181|NCT03527238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5479182|NCT03527238|Immunologic Factors|immunologic factors|mesh-ancestor
5479183|NCT03527238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623561|NCT01290146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6623562|NCT01290146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623563|NCT01290146|Protective Agents|protective agents|mesh-ancestor
6623564|NCT01290172|Somatostatin|somatostatin|mesh-list
6623565|NCT01290172|Hormones|hormones|mesh-ancestor
6623566|NCT01290172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5479184|NCT03527238|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5479185|NCT03527238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6623567|NCT01290172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479186|NCT03527238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479187|NCT03514368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5479188|NCT03514368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020881|NCT00395161|Protective Agents|protective agents|mesh-ancestor
6450840|NCT00409760|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6450841|NCT00409760|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6623568|NCT01290198|Fluconazole|fluconazole|mesh-list
6623569|NCT01290198|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
6623570|NCT01290198|Antifungal Agents|antifungal agents|mesh-ancestor
6623571|NCT01290198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6450842|NCT00409851|Amlodipine|amlodipine|mesh-list
6450843|NCT00409851|Valsartan|valsartan|mesh-list
6450844|NCT00409851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6623572|NCT01290198|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6623573|NCT01290198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6623574|NCT01290198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6623575|NCT01290198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623576|NCT01290198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6623577|NCT01290198|Hormone Antagonists|hormone antagonists|mesh-ancestor
6623578|NCT01290198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6623579|NCT01290198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623580|NCT01290198|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6623581|NCT01290198|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6623582|NCT01290211|Ritonavir|ritonavir|mesh-list
6623583|NCT01290211|Fosamprenavir|fosamprenavir|mesh-list
6623584|NCT01290211|Maraviroc|maraviroc|mesh-list
6623585|NCT01290211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6623586|NCT01290211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6623587|NCT01290211|Protease Inhibitors|protease inhibitors|mesh-ancestor
6623588|NCT01290211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6623589|NCT01290211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623590|NCT01290211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6623591|NCT01290211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6623592|NCT01290211|Antiviral Agents|antiviral agents|mesh-ancestor
6623593|NCT01290211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6623594|NCT01290211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6623595|NCT01290211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6623596|NCT01290211|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6623597|NCT01290211|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6623598|NCT01290211|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6623599|NCT01290276|Ondansetron|ondansetron|mesh-list
6623600|NCT01290276|Methylphenidate|methylphenidate|mesh-list
6623601|NCT01290276|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6623602|NCT01290276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623603|NCT01290276|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6623604|NCT01290276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6623605|NCT01290276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6623606|NCT01290276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623607|NCT01290276|Dopamine Agents|dopamine agents|mesh-ancestor
6623608|NCT01290276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6623609|NCT01290276|Antiemetics|antiemetics|mesh-ancestor
6623610|NCT01290276|Autonomic Agents|autonomic agents|mesh-ancestor
6623611|NCT01290276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6623612|NCT01290276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6623613|NCT01290276|Antipruritics|antipruritics|mesh-ancestor
6623614|NCT01290276|Dermatologic Agents|dermatologic agents|mesh-ancestor
6623615|NCT01290276|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6623616|NCT01290276|Serotonin Agents|serotonin agents|mesh-ancestor
6623617|NCT01290276|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6623618|NCT01290276|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6623619|NCT01290276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6623620|NCT01290276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6623621|NCT01290276|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6623622|NCT01290302|Azacitidine|azacitidine|mesh-list
6623623|NCT01290302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6623624|NCT01290302|Antimetabolites|antimetabolites|mesh-ancestor
6623625|NCT01290302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450845|NCT00409851|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6450846|NCT00409851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6450847|NCT00409851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450848|NCT00409851|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6623626|NCT01290302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6623627|NCT01290302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6623628|NCT01290328|Epoetin Alfa|epoetin alfa|mesh-list
6623629|NCT01290328|Hematinics|hematinics|mesh-ancestor
6623630|NCT01290354|Lapatinib|lapatinib|mesh-list
6623631|NCT01290354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6623632|NCT01290354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6623633|NCT01290354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6623634|NCT01290354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623635|NCT01290367|Hyaluronic Acid|hyaluronic acid|mesh-list
6623636|NCT01290367|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6623637|NCT01290367|Immunologic Factors|immunologic factors|mesh-ancestor
6623638|NCT01290367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623639|NCT01290367|Viscosupplements|viscosupplements|mesh-ancestor
6623640|NCT01290367|Protective Agents|protective agents|mesh-ancestor
6623641|NCT01290380|Vadimezan|vadimezan|mesh-list
6623642|NCT01290380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6623643|NCT01290406|Dactolisib|dactolisib|mesh-list
6623644|NCT01290406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6623645|NCT01290419|Vaccines|vaccines|mesh-list
6623646|NCT01290419|Immunologic Factors|immunologic factors|mesh-ancestor
6623647|NCT01290419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623648|NCT01290432|Folic Acid|folic acid|mesh-list
6623649|NCT01290432|Melatonin|melatonin|mesh-list
6623650|NCT01290432|Antioxidants|antioxidants|mesh-ancestor
5479189|NCT03514368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5479190|NCT03490864|Melatonin|melatonin|mesh-list
5479191|NCT03490864|Antioxidants|antioxidants|mesh-ancestor
5479192|NCT03490864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479193|NCT03490864|Protective Agents|protective agents|mesh-ancestor
5479194|NCT03490864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479195|NCT03490864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5479196|NCT03455764|Trametinib|trametinib|mesh-list
5479197|NCT03455764|Dabrafenib|dabrafenib|mesh-list
5479198|NCT03455764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5479199|NCT03455764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5479200|NCT03455764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5479201|NCT03455764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502263|NCT04467931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6623651|NCT01290432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623652|NCT01290432|Protective Agents|protective agents|mesh-ancestor
6623653|NCT01290432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623654|NCT01290432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6623655|NCT01290432|Hematinics|hematinics|mesh-ancestor
6623656|NCT01290432|Vitamin B Complex|vitamin b complex|mesh-ancestor
6623657|NCT01290432|Vitamins|vitamins|mesh-ancestor
6623658|NCT01290432|Micronutrients|micronutrients|mesh-ancestor
6623659|NCT01290458|Vitamins|vitamins|mesh-list
6623660|NCT01290458|Ascorbic Acid|ascorbic acid|mesh-list
6623661|NCT01290458|Vitamin E|vitamin e|mesh-list
6623662|NCT01290458|Tocopherols|tocopherols|mesh-list
6623663|NCT01290458|alpha-Tocopherol|alpha-tocopherol|mesh-list
6623664|NCT01290458|Antioxidants|antioxidants|mesh-list
6623665|NCT01290458|Micronutrients|micronutrients|mesh-ancestor
6623666|NCT01290458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623667|NCT01290458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623668|NCT01290458|Protective Agents|protective agents|mesh-ancestor
6623669|NCT01290471|U3-1565|u3-1565|mesh-list
6623670|NCT01290471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6623671|NCT01290471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6623672|NCT01290497|Hyaluronic Acid|hyaluronic acid|mesh-list
6623673|NCT01290497|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6623674|NCT01290497|Immunologic Factors|immunologic factors|mesh-ancestor
6623675|NCT01290497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623676|NCT01290497|Viscosupplements|viscosupplements|mesh-ancestor
6623677|NCT01290497|Protective Agents|protective agents|mesh-ancestor
6623678|NCT01290510|Hyaluronic Acid|hyaluronic acid|mesh-list
6450849|NCT00409851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450850|NCT00409851|Vasodilator Agents|vasodilator agents|mesh-ancestor
6450851|NCT00409851|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6450852|NCT00409851|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6450853|NCT00409890|Scopolamine|scopolamine|mesh-list
6450854|NCT00409890|Bromides|bromides|mesh-list
6450855|NCT00409890|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
6450856|NCT00409890|Anticonvulsants|anticonvulsants|mesh-ancestor
6450857|NCT00409890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6450858|NCT00409890|Antiemetics|antiemetics|mesh-ancestor
5479202|NCT03380507|Thiamine|thiamine|mesh-list
5479203|NCT03380507|Hydrocortisone|hydrocortisone|mesh-list
5479204|NCT03380507|Vitamins|vitamins|mesh-ancestor
5479205|NCT03380507|Micronutrients|micronutrients|mesh-ancestor
5479206|NCT03380507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450859|NCT00409890|Autonomic Agents|autonomic agents|mesh-ancestor
6450860|NCT00409890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6450861|NCT00409890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623679|NCT01290510|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6623680|NCT01290510|Immunologic Factors|immunologic factors|mesh-ancestor
6623681|NCT01290510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623682|NCT01290510|Viscosupplements|viscosupplements|mesh-ancestor
6623683|NCT01290510|Protective Agents|protective agents|mesh-ancestor
6623684|NCT01290549|Rituximab|rituximab|mesh-list
6623685|NCT01290549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6623686|NCT01290549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6623687|NCT01290549|Immunologic Factors|immunologic factors|mesh-ancestor
6623688|NCT01290549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623689|NCT01290549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6623690|NCT01290692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
6623691|NCT01290692|Immunologic Factors|immunologic factors|mesh-ancestor
6623692|NCT01290692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623693|NCT01290744|Clofazimine|clofazimine|mesh-list
6623694|NCT01290744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6623695|NCT01290744|Leprostatic Agents|leprostatic agents|mesh-ancestor
6623696|NCT01290744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6623697|NCT01290744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6623698|NCT01290783|Irinotecan|irinotecan|mesh-list
6623699|NCT01290783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6623700|NCT01290783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6623701|NCT01290783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6623702|NCT01290783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623703|NCT01290783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6623704|NCT01290900|Moxifloxacin|moxifloxacin|mesh-list
6623705|NCT01290900|Ceftazidime|ceftazidime|mesh-list
5479207|NCT03380507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6623706|NCT01290900|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
6623707|NCT01290900|Avibactam|avibactam|mesh-list
6623708|NCT01290900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6623709|NCT01290900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6623710|NCT01290900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6623711|NCT01290900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6623712|NCT01290900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6623713|NCT01290900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623714|NCT01290900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6623715|NCT01290900|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6450862|NCT00409890|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6623716|NCT01290926|Sorafenib|sorafenib|mesh-list
6623717|NCT01290926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6623718|NCT01290926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6623719|NCT01290926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6623720|NCT01290926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623721|NCT01290939|Bevacizumab|bevacizumab|mesh-list
6623722|NCT01290939|Lomustine|lomustine|mesh-list
6623723|NCT01290939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6623724|NCT01290939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6623725|NCT01290939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6623726|NCT01290939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6623727|NCT01290939|Growth Substances|growth substances|mesh-ancestor
5479208|NCT03380507|Vitamin B Complex|vitamin b complex|mesh-ancestor
5479209|NCT03376659|Bevacizumab|bevacizumab|mesh-list
5479210|NCT03376659|Durvalumab|durvalumab|mesh-list
6623728|NCT01290939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623729|NCT01290939|Growth Inhibitors|growth inhibitors|mesh-ancestor
6623730|NCT01290939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6623731|NCT01290939|Alkylating Agents|alkylating agents|mesh-ancestor
6623732|NCT01290939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623733|NCT01291069|Tadalafil|tadalafil|mesh-list
6623734|NCT01291069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623735|NCT01291069|Vasodilator Agents|vasodilator agents|mesh-ancestor
6623736|NCT01291069|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6623737|NCT01291069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6623738|NCT01291069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6623739|NCT01291069|Urological Agents|urological agents|mesh-ancestor
6662068|NCT01501708|Amebicides|amebicides|mesh-ancestor
6662069|NCT01501708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6662070|NCT01501708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6662071|NCT01501708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6662072|NCT01501747|Acetaminophen|acetaminophen|mesh-list
6662073|NCT01501747|Cephalexin|cephalexin|mesh-list
6662074|NCT01501747|Ibuprofen|ibuprofen|mesh-list
6662075|NCT01501747|Caffeine|caffeine|mesh-list
6662076|NCT01501747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6662077|NCT01501747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6662078|NCT01501747|Analgesics|analgesics|mesh-ancestor
6662079|NCT01501747|Sensory System Agents|sensory system agents|mesh-ancestor
6662080|NCT01501747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6662081|NCT01501747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662082|NCT01501747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6662083|NCT01501747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6662084|NCT01501747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6662085|NCT01501747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6662086|NCT01501747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662087|NCT01501747|Antipyretics|antipyretics|mesh-ancestor
6662088|NCT01501747|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6662089|NCT01501747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6662090|NCT01501747|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6662091|NCT01501747|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6662092|NCT01501747|Purinergic Agents|purinergic agents|mesh-ancestor
6662093|NCT01501747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6662094|NCT01501747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6662095|NCT01501747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6662096|NCT01501760|Bevacizumab|bevacizumab|mesh-list
6662097|NCT01501760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6662098|NCT01501760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6662099|NCT01501760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6662100|NCT01501760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6662101|NCT01501760|Growth Substances|growth substances|mesh-ancestor
6662102|NCT01501760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662103|NCT01501760|Growth Inhibitors|growth inhibitors|mesh-ancestor
6662104|NCT01501786|Ketamine|ketamine|mesh-list
6662105|NCT01501786|Propofol|propofol|mesh-list
6662106|NCT01501786|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6662107|NCT01501786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6662108|NCT01501786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662109|NCT01501786|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6662110|NCT01501786|Anesthetics, General|anesthetics, general|mesh-ancestor
6662111|NCT01501786|Anesthetics|anesthetics|mesh-ancestor
6662112|NCT01501786|Analgesics|analgesics|mesh-ancestor
6662113|NCT01501786|Sensory System Agents|sensory system agents|mesh-ancestor
6662114|NCT01501786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5479211|NCT03376659|Capecitabine|capecitabine|mesh-list
6662115|NCT01501786|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6662116|NCT01501786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6450863|NCT00409890|Mydriatics|mydriatics|mesh-ancestor
6623740|NCT01291095|Cisplatin|cisplatin|mesh-list
6623741|NCT01291095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6623742|NCT01291121|Ranibizumab|ranibizumab|mesh-list
6623743|NCT01291121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6623744|NCT01291121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6623745|NCT01291121|Growth Substances|growth substances|mesh-ancestor
6623746|NCT01291121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623747|NCT01291121|Growth Inhibitors|growth inhibitors|mesh-ancestor
6623748|NCT01291121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6623749|NCT01291186|Epinephrine|epinephrine|mesh-list
5479212|NCT03376659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5479213|NCT03376659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5479214|NCT03376659|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5479215|NCT03376659|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5479216|NCT03376659|Growth Substances|growth substances|mesh-ancestor
5479217|NCT03376659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479218|NCT03376659|Growth Inhibitors|growth inhibitors|mesh-ancestor
5479219|NCT03376659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5479220|NCT03376659|Antimetabolites|antimetabolites|mesh-ancestor
5479221|NCT03376659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479222|NCT03363503|Fluticasone|fluticasone|mesh-list
6450864|NCT00409890|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5479223|NCT03363503|Xhance|xhance|mesh-list
5479224|NCT03363503|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5479225|NCT03363503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5479226|NCT03363503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5479227|NCT03363503|Autonomic Agents|autonomic agents|mesh-ancestor
5479228|NCT03363503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5479229|NCT03363503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479230|NCT03363503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5479231|NCT03363503|Respiratory System Agents|respiratory system agents|mesh-ancestor
5479232|NCT03363503|Dermatologic Agents|dermatologic agents|mesh-ancestor
5479233|NCT03363503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5479234|NCT03363503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5479235|NCT03363503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5479236|NCT03363503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5479237|NCT03363503|Adrenergic Agents|adrenergic agents|mesh-ancestor
5479238|NCT03363503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5479239|NCT03363503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479240|NCT03321630|Pembrolizumab|pembrolizumab|mesh-list
5479241|NCT03321630|Lenvatinib|lenvatinib|mesh-list
5479242|NCT03321630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5479243|NCT03321630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5479244|NCT03321630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5479245|NCT03321630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5479246|NCT03321630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479247|NCT03246230|BCG Vaccine|bcg vaccine|mesh-list
5479248|NCT03246230|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5479249|NCT03246230|Immunologic Factors|immunologic factors|mesh-ancestor
5479250|NCT03246230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479251|NCT03235739|Naloxegol|naloxegol|mesh-list
5479252|NCT03235739|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5479253|NCT03235739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479254|NCT03235739|Sensory System Agents|sensory system agents|mesh-ancestor
6450865|NCT00409890|Cholinergic Agents|cholinergic agents|mesh-ancestor
6450866|NCT00409890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6450867|NCT00409890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450868|NCT00409890|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6450869|NCT00409890|Parasympatholytics|parasympatholytics|mesh-ancestor
6450870|NCT00409903|Eprosartan|eprosartan|mesh-list
6450871|NCT00409903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6450872|NCT00409903|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
6450873|NCT00409903|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6450874|NCT00409903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450875|NCT00409942|Torsemide|torsemide|mesh-list
6623750|NCT01291186|Racepinephrine|racepinephrine|mesh-list
5479255|NCT03235739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5479256|NCT03194165|Ritonavir|ritonavir|mesh-list
6623751|NCT01291186|Bupivacaine|bupivacaine|mesh-list
6623752|NCT01291186|Epinephryl borate|epinephryl borate|mesh-list
6623753|NCT01291186|Anesthetics, Local|anesthetics, local|mesh-ancestor
6623754|NCT01291186|Anesthetics|anesthetics|mesh-ancestor
6623755|NCT01291186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6623756|NCT01291186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479257|NCT03194165|Atazanavir Sulfate|atazanavir sulfate|mesh-list
5479258|NCT03194165|Darunavir|darunavir|mesh-list
5479259|NCT03194165|Raltegravir Potassium|raltegravir potassium|mesh-list
6623757|NCT01291186|Sensory System Agents|sensory system agents|mesh-ancestor
6623758|NCT01291186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6623759|NCT01291186|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6623760|NCT01291186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6623761|NCT01291186|Adrenergic Agents|adrenergic agents|mesh-ancestor
6623762|NCT01291186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6623763|NCT01291186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623764|NCT01291186|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6623765|NCT01291186|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6623766|NCT01291186|Autonomic Agents|autonomic agents|mesh-ancestor
6623767|NCT01291186|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6623768|NCT01291186|Respiratory System Agents|respiratory system agents|mesh-ancestor
6623769|NCT01291186|Mydriatics|mydriatics|mesh-ancestor
6623770|NCT01291186|Sympathomimetics|sympathomimetics|mesh-ancestor
6623771|NCT01291186|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6623772|NCT01291199|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6623773|NCT01291199|Vasodilator Agents|vasodilator agents|mesh-ancestor
6623774|NCT01291199|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6623775|NCT01291199|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6623776|NCT01291199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6623777|NCT01291199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479260|NCT03194165|Nevirapine|nevirapine|mesh-list
5479261|NCT03194165|Dolutegravir|dolutegravir|mesh-list
5479262|NCT03194165|Rilpivirine|rilpivirine|mesh-list
5479263|NCT03194165|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6623778|NCT01291199|Urological Agents|urological agents|mesh-ancestor
6623779|NCT01291212|Methyltestosterone|methyltestosterone|mesh-list
6623780|NCT01291212|Testosterone|testosterone|mesh-list
6623781|NCT01291212|Testosterone undecanoate|testosterone undecanoate|mesh-list
6623782|NCT01291212|Testosterone enanthate|testosterone enanthate|mesh-list
6623783|NCT01291212|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6623784|NCT01291212|Androgens|androgens|mesh-ancestor
6623785|NCT01291212|Hormones|hormones|mesh-ancestor
6623786|NCT01291212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6623787|NCT01291212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623788|NCT01291212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6623789|NCT01291212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6623790|NCT01291212|Anabolic Agents|anabolic agents|mesh-ancestor
6623791|NCT01291316|Clonazepam|clonazepam|mesh-list
5479264|NCT03194165|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5479265|NCT03194165|Protease Inhibitors|protease inhibitors|mesh-ancestor
5479266|NCT03194165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5479267|NCT03194165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479268|NCT03194165|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6450876|NCT00409942|Furosemide|furosemide|mesh-list
6450877|NCT00409942|Diuretics|diuretics|mesh-ancestor
6623792|NCT01291316|Clobazam|clobazam|mesh-list
6623793|NCT01291316|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6623794|NCT01291316|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6623795|NCT01291316|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6623796|NCT01291316|Cholinergic Agents|cholinergic agents|mesh-ancestor
6623797|NCT01291316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6623798|NCT01291316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623799|NCT01291316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623800|NCT01291316|Urological Agents|urological agents|mesh-ancestor
6623801|NCT01291316|Anticonvulsants|anticonvulsants|mesh-ancestor
6623802|NCT01291316|GABA Modulators|gaba modulators|mesh-ancestor
6623803|NCT01291316|GABA Agents|gaba agents|mesh-ancestor
6623804|NCT01291316|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6623805|NCT01291316|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6623806|NCT01291316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6450878|NCT00409942|Natriuretic Agents|natriuretic agents|mesh-ancestor
6450879|NCT00409942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450880|NCT00409942|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6450881|NCT00409942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6450882|NCT00409942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450883|NCT00409942|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6450884|NCT00409981|Paclitaxel|paclitaxel|mesh-list
6450885|NCT00409981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6450886|NCT00409981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6450887|NCT00409981|Tubulin Modulators|tubulin modulators|mesh-ancestor
6623807|NCT01291316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6623808|NCT01291316|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6623809|NCT01291316|GABA Agonists|gaba agonists|mesh-ancestor
6623810|NCT01291420|Vaccines|vaccines|mesh-list
6623811|NCT01291420|Immunologic Factors|immunologic factors|mesh-ancestor
6623812|NCT01291420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623813|NCT01291433|Clodronic Acid|clodronic acid|mesh-list
6623814|NCT01291433|Tocopherols|tocopherols|mesh-list
6623815|NCT01291433|Vitamin E|vitamin e|mesh-list
6623816|NCT01291433|Tocotrienols|tocotrienols|mesh-list
6623817|NCT01291433|alpha-Tocopherol|alpha-tocopherol|mesh-list
6623818|NCT01291433|Pentoxifylline|pentoxifylline|mesh-list
6623819|NCT01291433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6623820|NCT01291433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6623821|NCT01291433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623822|NCT01291433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6623823|NCT01291433|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6623824|NCT01291433|Protective Agents|protective agents|mesh-ancestor
6623825|NCT01291433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623826|NCT01291433|Vasodilator Agents|vasodilator agents|mesh-ancestor
6623827|NCT01291433|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6623828|NCT01291433|Antioxidants|antioxidants|mesh-ancestor
6623829|NCT01291433|Vitamins|vitamins|mesh-ancestor
6623830|NCT01291433|Micronutrients|micronutrients|mesh-ancestor
6623831|NCT01291433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6623832|NCT01291459|Tenofovir|tenofovir|mesh-list
6623833|NCT01291459|Emtricitabine|emtricitabine|mesh-list
6623834|NCT01291459|Raltegravir Potassium|raltegravir potassium|mesh-list
6623835|NCT01291459|Maraviroc|maraviroc|mesh-list
6623836|NCT01291459|Antiviral Agents|antiviral agents|mesh-ancestor
6623837|NCT01291459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6623838|NCT01291459|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6623839|NCT01291459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6623840|NCT01291459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6623841|NCT01291459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623842|NCT01291459|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6623843|NCT01291459|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6623844|NCT01291459|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6623845|NCT01291459|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6623846|NCT01291459|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6623847|NCT01291459|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6623848|NCT01291459|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6623849|NCT01291472|Ketorolac|ketorolac|mesh-list
6623850|NCT01291472|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6623851|NCT01291472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6623852|NCT01291472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6623853|NCT01291472|Analgesics|analgesics|mesh-ancestor
6623854|NCT01291472|Sensory System Agents|sensory system agents|mesh-ancestor
6623855|NCT01291472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6623856|NCT01291472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623857|NCT01291472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6623858|NCT01291472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6623859|NCT01291472|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6623860|NCT01291472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6623861|NCT01291472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623862|NCT01291511|Iloperidone|iloperidone|mesh-list
6623863|NCT01291511|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6623864|NCT01291511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6623865|NCT01291511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5479269|NCT03194165|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5479270|NCT03194165|Antiviral Agents|antiviral agents|mesh-ancestor
5479271|NCT03194165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5479272|NCT03194165|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5479273|NCT03194165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5479274|NCT03194165|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5479275|NCT03194165|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5479276|NCT03194165|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5479277|NCT03194165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5479278|NCT03194165|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5479279|NCT03194165|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5479280|NCT03179475|Oxycodone|oxycodone|mesh-list
5479281|NCT03179475|Naloxone|naloxone|mesh-list
5479282|NCT03179475|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5479283|NCT03179475|Narcotics|narcotics|mesh-ancestor
5479284|NCT03179475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5479285|NCT03179475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479286|NCT03179475|Analgesics|analgesics|mesh-ancestor
5479287|NCT03179475|Sensory System Agents|sensory system agents|mesh-ancestor
5479288|NCT03179475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5479289|NCT03179475|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5479290|NCT03177746|Tadalafil|tadalafil|mesh-list
5479291|NCT03177746|Vasodilator Agents|vasodilator agents|mesh-ancestor
5479292|NCT03177746|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5479293|NCT03177746|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6623866|NCT01291511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623867|NCT01291511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6623868|NCT01291524|Pregabalin|pregabalin|mesh-list
6623869|NCT01291524|Analgesics|analgesics|mesh-ancestor
6623870|NCT01291524|Sensory System Agents|sensory system agents|mesh-ancestor
6623871|NCT01291524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6623872|NCT01291524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623873|NCT01291524|Anticonvulsants|anticonvulsants|mesh-ancestor
6623874|NCT01291524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6623875|NCT01291524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6623876|NCT01291524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623877|NCT01291524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6623878|NCT01291524|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6623879|NCT01291524|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6623880|NCT01291524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6623881|NCT01291524|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6623882|NCT01291537|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
6623883|NCT01291537|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6623884|NCT01291537|Immunologic Factors|immunologic factors|mesh-ancestor
5479294|NCT03177746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6623885|NCT01291537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623886|NCT01291537|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6623887|NCT01291537|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6623888|NCT01291537|Dopamine Agonists|dopamine agonists|mesh-ancestor
6623889|NCT01291537|Dopamine Agents|dopamine agents|mesh-ancestor
6623890|NCT01291537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6623891|NCT01291537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623892|NCT01291563|Moxifloxacin|moxifloxacin|mesh-list
6623893|NCT01291563|Bedaquiline|bedaquiline|mesh-list
6623894|NCT01291563|Diarylquinolines|diarylquinolines|mesh-list
6623895|NCT01291563|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6623896|NCT01291563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6623897|NCT01291563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6623898|NCT01291563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6623899|NCT01291563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6623900|NCT01291563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6623901|NCT01291563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623902|NCT01291563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6623903|NCT01291563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6623904|NCT01291563|Contraceptive Agents|contraceptive agents|mesh-ancestor
6623905|NCT01291563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6623906|NCT01291563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623907|NCT01291563|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6623908|NCT01291563|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6623909|NCT01291563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6623910|NCT01291563|Antitubercular Agents|antitubercular agents|mesh-ancestor
6623911|NCT01291602|Avibactam|avibactam|mesh-list
6623912|NCT01291602|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6623913|NCT01291602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6623914|NCT01291602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623915|NCT01291602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6623916|NCT01291602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6623917|NCT01291615|Gemcitabine|gemcitabine|mesh-list
6623918|NCT01291615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6623919|NCT01291615|Antimetabolites|antimetabolites|mesh-ancestor
6623920|NCT01291615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623921|NCT01291615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6623922|NCT01291615|Antiviral Agents|antiviral agents|mesh-ancestor
6623923|NCT01291615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6623924|NCT01291615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6623925|NCT01291615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6623926|NCT01291615|Immunologic Factors|immunologic factors|mesh-ancestor
6623927|NCT01291615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623928|NCT01291628|Copper|copper|mesh-list
6623929|NCT01291628|Trace Elements|trace elements|mesh-ancestor
6623930|NCT01291628|Micronutrients|micronutrients|mesh-ancestor
6623931|NCT01291628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623932|NCT01291641|Cilostazol|cilostazol|mesh-list
6623933|NCT01291641|Probucol|probucol|mesh-list
6623934|NCT01291641|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
6623935|NCT01291641|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6623936|NCT01291641|Autonomic Agents|autonomic agents|mesh-ancestor
6623937|NCT01291641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6623938|NCT01291641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623939|NCT01291641|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6623940|NCT01291641|Respiratory System Agents|respiratory system agents|mesh-ancestor
6623941|NCT01291641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6623942|NCT01291641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6623943|NCT01291641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623944|NCT01291641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5479295|NCT03177746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479296|NCT03177746|Urological Agents|urological agents|mesh-ancestor
5479297|NCT03136497|Rituximab|rituximab|mesh-list
5479298|NCT03136497|Venetoclax|venetoclax|mesh-list
5479299|NCT03136497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5479300|NCT03136497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6623945|NCT01291641|Vasodilator Agents|vasodilator agents|mesh-ancestor
6623946|NCT01291641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6623947|NCT01291641|Protective Agents|protective agents|mesh-ancestor
6623948|NCT01291641|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6623949|NCT01291641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6623950|NCT01291641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5479301|NCT03136497|Immunologic Factors|immunologic factors|mesh-ancestor
6623951|NCT01291641|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6623952|NCT01291641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6623953|NCT01291641|Antimetabolites|antimetabolites|mesh-ancestor
6623954|NCT01291641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6623955|NCT01291641|Antioxidants|antioxidants|mesh-ancestor
6623956|NCT01291654|Acetaminophen|acetaminophen|mesh-list
6623957|NCT01291654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6623958|NCT01291654|Analgesics|analgesics|mesh-ancestor
6623959|NCT01291654|Sensory System Agents|sensory system agents|mesh-ancestor
6623960|NCT01291654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6623961|NCT01291654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623962|NCT01291654|Antipyretics|antipyretics|mesh-ancestor
6623963|NCT01291719|Insulin|insulin|mesh-list
6623964|NCT01291719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6623965|NCT01291719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623966|NCT01291823|Gefitinib|gefitinib|mesh-list
6623967|NCT01291823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6623968|NCT01291823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6623969|NCT01291823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5479302|NCT03136497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479303|NCT03136497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5479304|NCT03132129|Manganese|manganese|mesh-list
5479305|NCT03132129|Calcium|calcium|mesh-list
5479306|NCT03132129|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5479307|NCT03132129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479308|NCT03132129|Trace Elements|trace elements|mesh-ancestor
5479309|NCT03132129|Micronutrients|micronutrients|mesh-ancestor
5479310|NCT03022097|Bromides|bromides|mesh-list
5479311|NCT03022097|Formoterol Fumarate|formoterol fumarate|mesh-list
5479312|NCT03022097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5479313|NCT03022097|Autonomic Agents|autonomic agents|mesh-ancestor
5479314|NCT03022097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5479315|NCT03022097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479316|NCT03022097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5479317|NCT03022097|Respiratory System Agents|respiratory system agents|mesh-ancestor
5479318|NCT03022097|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5479319|NCT03022097|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5479320|NCT03022097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5479321|NCT03022097|Adrenergic Agents|adrenergic agents|mesh-ancestor
5479322|NCT03022097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5479323|NCT03022097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479324|NCT03022097|Anticonvulsants|anticonvulsants|mesh-ancestor
5479325|NCT02910700|Nivolumab|nivolumab|mesh-list
5479326|NCT02910700|Trametinib|trametinib|mesh-list
5479327|NCT02910700|Dabrafenib|dabrafenib|mesh-list
5479328|NCT02910700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5479329|NCT02910700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5479330|NCT02910700|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6450888|NCT00409981|Antimitotic Agents|antimitotic agents|mesh-ancestor
6450889|NCT00409981|Mitosis Modulators|mitosis modulators|mesh-ancestor
6450890|NCT00409981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450891|NCT00409994|Sirolimus|sirolimus|mesh-list
6450892|NCT00409994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6623970|NCT01291823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623971|NCT01291927|Pancrelipase|pancrelipase|mesh-list
6623972|NCT01291927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6623973|NCT01291940|Petrolatum|petrolatum|mesh-list
6623974|NCT01291940|Emollients|emollients|mesh-ancestor
6623975|NCT01291940|Dermatologic Agents|dermatologic agents|mesh-ancestor
6623976|NCT01291979|Lidocaine|lidocaine|mesh-list
6020882|NCT00395161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020883|NCT00395161|Trace Elements|trace elements|mesh-ancestor
6020884|NCT00395161|Micronutrients|micronutrients|mesh-ancestor
6020885|NCT00395161|Antiemetics|antiemetics|mesh-ancestor
6020886|NCT00395161|Autonomic Agents|autonomic agents|mesh-ancestor
6020887|NCT00395161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6020888|NCT00395161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6020889|NCT00395161|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6020890|NCT00395161|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6020891|NCT00395161|Dopamine Agents|dopamine agents|mesh-ancestor
6020892|NCT00395161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6450893|NCT00409994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6450894|NCT00409994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6450895|NCT00409994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5479331|NCT02910700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623977|NCT01291979|Anesthetics, Local|anesthetics, local|mesh-ancestor
6623978|NCT01291979|Anesthetics|anesthetics|mesh-ancestor
6623979|NCT01291979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6623980|NCT01291979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020893|NCT00395226|Zinc Sulfate|zinc sulfate|mesh-list
6020894|NCT00395226|Astringents|astringents|mesh-ancestor
6020895|NCT00395226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6623981|NCT01291979|Sensory System Agents|sensory system agents|mesh-ancestor
6623982|NCT01291979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6623983|NCT01291979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6623984|NCT01291979|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6623985|NCT01291979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6623986|NCT01291979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6623987|NCT01291979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623988|NCT01292031|Meropenem|meropenem|mesh-list
6623989|NCT01292031|Colistin|colistin|mesh-list
6623990|NCT01292031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6623991|NCT01292031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6623992|NCT01292083|Azacitidine|azacitidine|mesh-list
6623993|NCT01292083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6623994|NCT01292083|Antimetabolites|antimetabolites|mesh-ancestor
6623995|NCT01292083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6623996|NCT01292083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6623997|NCT01292083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6623998|NCT01292109|Picosulfate sodium|picosulfate sodium|mesh-list
6623999|NCT01292109|Cathartics|cathartics|mesh-ancestor
6624000|NCT01292109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6624001|NCT01292161|Silymarin|silymarin|mesh-list
6624002|NCT01292161|Antioxidants|antioxidants|mesh-ancestor
6624003|NCT01292161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624004|NCT01292161|Protective Agents|protective agents|mesh-ancestor
6624005|NCT01292161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624006|NCT01292174|Ibalizumab|ibalizumab|mesh-list
6624007|NCT01292174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6624008|NCT01292174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6624009|NCT01292174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6624010|NCT01292174|Antiviral Agents|antiviral agents|mesh-ancestor
6624011|NCT01292174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6624012|NCT01292174|Immunologic Factors|immunologic factors|mesh-ancestor
6624013|NCT01292174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624014|NCT01292343|Listerine|listerine|mesh-list
6624015|NCT01292343|Triclosan|triclosan|mesh-list
6624016|NCT01292343|Fluorides|fluorides|mesh-list
6624017|NCT01292343|Sodium Fluoride|sodium fluoride|mesh-list
6624018|NCT01292343|Cariostatic Agents|cariostatic agents|mesh-ancestor
6624019|NCT01292343|Protective Agents|protective agents|mesh-ancestor
6624020|NCT01292343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624021|NCT01292343|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6624022|NCT01292343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6624023|NCT01292343|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6624024|NCT01292343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6624025|NCT01292343|Antimetabolites|antimetabolites|mesh-ancestor
6624026|NCT01292343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624027|NCT01292343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6624028|NCT01292356|Cetuximab|cetuximab|mesh-list
6624029|NCT01292356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6624030|NCT01292356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6624031|NCT01292408|Hydroxychloroquine|hydroxychloroquine|mesh-list
6624032|NCT01292408|Antimalarials|antimalarials|mesh-ancestor
6624033|NCT01292408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6624034|NCT01292408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6624035|NCT01292408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6624036|NCT01292408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6624037|NCT01292408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624038|NCT01292408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6624039|NCT01292460|Timolol|timolol|mesh-list
6624040|NCT01292460|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6624041|NCT01292460|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6624042|NCT01292460|Adrenergic Agents|adrenergic agents|mesh-ancestor
6624043|NCT01292460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6624044|NCT01292460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624045|NCT01292460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624046|NCT01292460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6624047|NCT01292460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6624048|NCT01292525|Tacrolimus|tacrolimus|mesh-list
6624049|NCT01292525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6624050|NCT01292525|Immunologic Factors|immunologic factors|mesh-ancestor
6624051|NCT01292525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624052|NCT01292525|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6624053|NCT01292525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6624054|NCT01292525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624055|NCT01292551|Bosentan|bosentan|mesh-list
6624056|NCT01292551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5479332|NCT02910700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5479333|NCT02910700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5479334|NCT02898207|Olaparib|olaparib|mesh-list
5479335|NCT02898207|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
5479336|NCT02898207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6450896|NCT00409994|Antifungal Agents|antifungal agents|mesh-ancestor
6450897|NCT00409994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6450898|NCT00409994|Immunologic Factors|immunologic factors|mesh-ancestor
6450899|NCT00409994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450900|NCT00410033|Insulin|insulin|mesh-list
6450901|NCT00410033|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6450902|NCT00410033|Insulin Aspart|insulin aspart|mesh-list
6450903|NCT00410033|Isophane Insulin, Human|isophane insulin, human|mesh-list
6450904|NCT00410033|Insulin, Isophane|insulin, isophane|mesh-list
6450905|NCT00410033|Isophane insulin, beef|isophane insulin, beef|mesh-list
6450906|NCT00410033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6450907|NCT00410033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450908|NCT00410215|Bisacodyl|bisacodyl|mesh-list
6450909|NCT00410215|Cathartics|cathartics|mesh-ancestor
6450910|NCT00410215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6450911|NCT00410215|Laxatives|laxatives|mesh-ancestor
6450912|NCT00410254|Midazolam|midazolam|mesh-list
6450913|NCT00410254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6450914|NCT00410254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6450915|NCT00410254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6450916|NCT00410254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450917|NCT00410254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6450918|NCT00410254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6450919|NCT00410254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6450920|NCT00410254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6450921|NCT00410254|Anesthetics, General|anesthetics, general|mesh-ancestor
6450922|NCT00410254|Anesthetics|anesthetics|mesh-ancestor
6450923|NCT00410254|GABA Modulators|gaba modulators|mesh-ancestor
6450924|NCT00410254|GABA Agents|gaba agents|mesh-ancestor
6450925|NCT00410254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6450926|NCT00410254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450927|NCT00410306|Methyltestosterone|methyltestosterone|mesh-list
6450928|NCT00410306|Testosterone|testosterone|mesh-list
6450929|NCT00410306|Testosterone undecanoate|testosterone undecanoate|mesh-list
6450930|NCT00410306|Testosterone enanthate|testosterone enanthate|mesh-list
6450931|NCT00410306|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6450932|NCT00410306|Androgens|androgens|mesh-ancestor
6450933|NCT00410306|Hormones|hormones|mesh-ancestor
6450934|NCT00410306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6450935|NCT00410306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450936|NCT00410306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6450937|NCT00410306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6450938|NCT00410306|Anabolic Agents|anabolic agents|mesh-ancestor
6450939|NCT00410345|Mifepristone|mifepristone|mesh-list
6450940|NCT00410345|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6450941|NCT00410345|Abortifacient Agents|abortifacient agents|mesh-ancestor
6450942|NCT00410345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6450943|NCT00410345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450944|NCT00410345|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6450945|NCT00410345|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6450946|NCT00410345|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5479337|NCT02898207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624057|NCT01292551|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6624058|NCT01292551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624059|NCT01292616|Antirheumatic Agents|antirheumatic agents|mesh-list
6624060|NCT01292668|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6624061|NCT01292668|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
6624062|NCT01292668|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6624063|NCT01292668|Dermatologic Agents|dermatologic agents|mesh-ancestor
6624064|NCT01292694|Losartan|losartan|mesh-list
6624065|NCT01292694|Captopril|captopril|mesh-list
6624066|NCT01292694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6624067|NCT01292694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6624068|NCT01292694|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6450947|NCT00410345|Contraceptive Agents|contraceptive agents|mesh-ancestor
6450948|NCT00410345|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6450949|NCT00410345|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6624069|NCT01292694|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6624070|NCT01292694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624071|NCT01292694|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6624072|NCT01292694|Protease Inhibitors|protease inhibitors|mesh-ancestor
6624073|NCT01292694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6624074|NCT01292720|Vitamin D|vitamin d|mesh-list
6624075|NCT01292720|Cholecalciferol|cholecalciferol|mesh-list
6624076|NCT01292720|Vitamins|vitamins|mesh-ancestor
5479338|NCT02898207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5479339|NCT02777372|Sertraline|sertraline|mesh-list
5479340|NCT02777372|Antidepressive Agents|antidepressive agents|mesh-ancestor
6624077|NCT01292720|Micronutrients|micronutrients|mesh-ancestor
6624078|NCT01292720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624079|NCT01292720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6624080|NCT01292720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6662117|NCT01501786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6662118|NCT01501786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6662119|NCT01501786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662120|NCT01501799|Adapalene|adapalene|mesh-list
6662121|NCT01501799|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6662122|NCT01501799|Dermatologic Agents|dermatologic agents|mesh-ancestor
6662123|NCT01501799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6662124|NCT01501799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6662125|NCT01501799|Analgesics|analgesics|mesh-ancestor
6662126|NCT01501799|Sensory System Agents|sensory system agents|mesh-ancestor
6662127|NCT01501799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6662128|NCT01501799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662129|NCT01501799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6662130|NCT01501799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6662131|NCT01501890|Algestone|algestone|mesh-list
6450950|NCT00410345|Hormone Antagonists|hormone antagonists|mesh-ancestor
6450951|NCT00410345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6450952|NCT00410345|Luteolytic Agents|luteolytic agents|mesh-ancestor
6450953|NCT00410345|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6450954|NCT00410345|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6450955|NCT00410371|Lamotrigine|lamotrigine|mesh-list
6450956|NCT00410371|Anticonvulsants|anticonvulsants|mesh-ancestor
6450957|NCT00410371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6450958|NCT00410371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6450959|NCT00410371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662132|NCT01501890|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
6624081|NCT01292785|Hormones|hormones|mesh-list
6624082|NCT01292785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6624083|NCT01292785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624084|NCT01292863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6624085|NCT01292863|Dialysis Solutions|dialysis solutions|mesh-list
6624086|NCT01292993|Metformin|metformin|mesh-list
5479341|NCT02777372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5479342|NCT02777372|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5479343|NCT02777372|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5479344|NCT02777372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5479345|NCT02777372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479346|NCT02777372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5479347|NCT02777372|Serotonin Agents|serotonin agents|mesh-ancestor
5479348|NCT02777372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479349|NCT02744092|Enoxaparin|enoxaparin|mesh-list
5479350|NCT02744092|Dalteparin|dalteparin|mesh-list
6624087|NCT01292993|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
6624088|NCT01292993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6624089|NCT01292993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624090|NCT01292993|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6624091|NCT01292993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624092|NCT01293058|Naloxone|naloxone|mesh-list
5479351|NCT02744092|PENTA|penta|mesh-list
5479352|NCT02744092|Warfarin|warfarin|mesh-list
5479353|NCT02744092|Rivaroxaban|rivaroxaban|mesh-list
5479354|NCT02744092|Dabigatran|dabigatran|mesh-list
5479355|NCT02744092|Apixaban|apixaban|mesh-list
5479356|NCT02744092|Edoxaban|edoxaban|mesh-list
5479357|NCT02744092|Fondaparinux|fondaparinux|mesh-list
5479358|NCT02744092|Anticoagulants|anticoagulants|mesh-ancestor
5479359|NCT02744092|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5479360|NCT02744092|Antithrombins|antithrombins|mesh-ancestor
5479361|NCT02744092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5479362|NCT02744092|Protease Inhibitors|protease inhibitors|mesh-ancestor
5479363|NCT02744092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5479364|NCT02744092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479365|NCT02744092|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5479366|NCT02744092|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6624093|NCT01293058|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6624094|NCT01293058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624095|NCT01293058|Sensory System Agents|sensory system agents|mesh-ancestor
6624096|NCT01293058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6624097|NCT01293071|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6624098|NCT01293071|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6624099|NCT01293071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6624100|NCT01293071|Antitubercular Agents|antitubercular agents|mesh-ancestor
6624101|NCT01293097|Atorvastatin|atorvastatin|mesh-list
6624102|NCT01293097|Pravastatin|pravastatin|mesh-list
6624103|NCT01293097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6624104|NCT01293097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6624105|NCT01293097|Antimetabolites|antimetabolites|mesh-ancestor
6624106|NCT01293097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624107|NCT01293097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6624108|NCT01293097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6624109|NCT01293097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6624110|NCT01293136|Analgesics, Opioid|analgesics, opioid|mesh-list
6624111|NCT01293136|Narcotics|narcotics|mesh-ancestor
6624112|NCT01293136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6624113|NCT01293136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624114|NCT01293136|Analgesics|analgesics|mesh-ancestor
6624115|NCT01293136|Sensory System Agents|sensory system agents|mesh-ancestor
6624116|NCT01293136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5479367|NCT02682901|Bromocriptine|bromocriptine|mesh-list
5479368|NCT02682901|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5479369|NCT02682901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6624117|NCT01293149|Clonidine|clonidine|mesh-list
6624118|NCT01293149|Ropivacaine|ropivacaine|mesh-list
6624119|NCT01293149|Anesthetics, Local|anesthetics, local|mesh-ancestor
6624120|NCT01293149|Anesthetics|anesthetics|mesh-ancestor
6624121|NCT01293149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6624122|NCT01293149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624123|NCT01293149|Sensory System Agents|sensory system agents|mesh-ancestor
6624124|NCT01293149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6624125|NCT01293149|Analgesics|analgesics|mesh-ancestor
6624126|NCT01293149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6624127|NCT01293149|Sympatholytics|sympatholytics|mesh-ancestor
5479370|NCT02682901|Hormone Antagonists|hormone antagonists|mesh-ancestor
5479371|NCT02682901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5479372|NCT02682901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479373|NCT02682901|Dopamine Agonists|dopamine agonists|mesh-ancestor
5479374|NCT02682901|Dopamine Agents|dopamine agents|mesh-ancestor
5479375|NCT02682901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5479376|NCT02682901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479377|NCT02567825|Amoxicillin|amoxicillin|mesh-list
5479378|NCT02567825|Ceftriaxone|ceftriaxone|mesh-list
5479379|NCT02567825|Clavulanic Acid|clavulanic acid|mesh-list
5479380|NCT02567825|Clavulanic Acids|clavulanic acids|mesh-list
5479381|NCT02567825|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5479382|NCT02567825|Ofloxacin|ofloxacin|mesh-list
5479383|NCT02567825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5479384|NCT02567825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5479385|NCT02567825|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5479386|NCT02567825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5479387|NCT02567825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479388|NCT02567825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5479389|NCT02567825|Renal Agents|renal agents|mesh-ancestor
5479390|NCT02567825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5479391|NCT02567825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5479392|NCT02567825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5479393|NCT02567825|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6450960|NCT00410371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6450961|NCT00410371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450962|NCT00410371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6450963|NCT00410371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6450964|NCT00410371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6450965|NCT00410371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6624128|NCT01293149|Autonomic Agents|autonomic agents|mesh-ancestor
6624129|NCT01293149|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6624130|NCT01293149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5479394|NCT02567825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6450966|NCT00410371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6450967|NCT00410449|Tocopherols|tocopherols|mesh-list
6624131|NCT01293149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6624132|NCT01293149|Adrenergic Agents|adrenergic agents|mesh-ancestor
6624133|NCT01293149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6624134|NCT01293149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624135|NCT01293162|Folic Acid|folic acid|mesh-list
6624136|NCT01293162|Policosanol|policosanol|mesh-list
6624137|NCT01293162|Hematinics|hematinics|mesh-ancestor
6624138|NCT01293162|Vitamin B Complex|vitamin b complex|mesh-ancestor
6624139|NCT01293162|Vitamins|vitamins|mesh-ancestor
6624140|NCT01293162|Micronutrients|micronutrients|mesh-ancestor
6624141|NCT01293162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624142|NCT01293162|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6624143|NCT01293162|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6624144|NCT01293162|Antimetabolites|antimetabolites|mesh-ancestor
6624145|NCT01293162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624146|NCT01293162|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6624147|NCT01293162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6624148|NCT01293266|Propofol|propofol|mesh-list
6624149|NCT01293266|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6624150|NCT01293266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6624151|NCT01293266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624152|NCT01293266|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6624153|NCT01293266|Anesthetics, General|anesthetics, general|mesh-ancestor
6624154|NCT01293266|Anesthetics|anesthetics|mesh-ancestor
5479395|NCT02555657|Gemcitabine|gemcitabine|mesh-list
6450968|NCT00410449|Vitamin E|vitamin e|mesh-list
6624155|NCT01293292|Teriparatide|teriparatide|mesh-list
6624156|NCT01293292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6624157|NCT01293292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624158|NCT01293292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6624159|NCT01293422|Rifampin|rifampin|mesh-list
6624160|NCT01293422|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6624161|NCT01293422|Antitubercular Agents|antitubercular agents|mesh-ancestor
6624162|NCT01293422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6624163|NCT01293422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6624164|NCT01293422|Leprostatic Agents|leprostatic agents|mesh-ancestor
6624165|NCT01293422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6624166|NCT01293422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6624167|NCT01293422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624168|NCT01293422|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6624169|NCT01293422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6624170|NCT01293422|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6624171|NCT01293422|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6624172|NCT01293422|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6624173|NCT01293422|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6624174|NCT01293630|Paclitaxel|paclitaxel|mesh-list
6624175|NCT01293630|Carboplatin|carboplatin|mesh-list
6624176|NCT01293630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6624177|NCT01293630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6624178|NCT01293630|Tubulin Modulators|tubulin modulators|mesh-ancestor
6624179|NCT01293630|Antimitotic Agents|antimitotic agents|mesh-ancestor
6624180|NCT01293630|Mitosis Modulators|mitosis modulators|mesh-ancestor
6624181|NCT01293630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624182|NCT01293643|Clindamycin|clindamycin|mesh-list
6624183|NCT01293643|Clindamycin palmitate|clindamycin palmitate|mesh-list
6624184|NCT01293643|Clindamycin phosphate|clindamycin phosphate|mesh-list
6624185|NCT01293643|Amphotericin B|amphotericin b|mesh-list
6624186|NCT01293643|Tetracycline|tetracycline|mesh-list
6624187|NCT01293643|Ketoconazole|ketoconazole|mesh-list
6624188|NCT01293643|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6624189|NCT01293643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6624190|NCT01293643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6624191|NCT01293643|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6624192|NCT01293643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6624193|NCT01293643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624194|NCT01293643|Antifungal Agents|antifungal agents|mesh-ancestor
6624195|NCT01293643|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6624196|NCT01293643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6624197|NCT01293643|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6624198|NCT01293643|Hormone Antagonists|hormone antagonists|mesh-ancestor
6624199|NCT01293643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6624200|NCT01293643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624201|NCT01293643|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6624202|NCT01293643|Amebicides|amebicides|mesh-ancestor
6624203|NCT01293643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6624204|NCT01293643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6624205|NCT01293734|Budesonide|budesonide|mesh-list
6624206|NCT01293734|Theophylline|theophylline|mesh-list
6624207|NCT01293734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6624208|NCT01293734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6624209|NCT01293734|Autonomic Agents|autonomic agents|mesh-ancestor
6624210|NCT01293734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6624211|NCT01293734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624212|NCT01293734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6624213|NCT01293734|Respiratory System Agents|respiratory system agents|mesh-ancestor
6624214|NCT01293734|Glucocorticoids|glucocorticoids|mesh-ancestor
6624215|NCT01293734|Hormones|hormones|mesh-ancestor
6624216|NCT01293734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6624217|NCT01293734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6624218|NCT01293734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6624219|NCT01293734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624220|NCT01293734|Vasodilator Agents|vasodilator agents|mesh-ancestor
6624221|NCT01293734|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6624222|NCT01293734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6624223|NCT01293734|Purinergic Agents|purinergic agents|mesh-ancestor
6624224|NCT01293734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6624225|NCT01293747|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6624226|NCT01293747|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6624227|NCT01293747|Estradiol|estradiol|mesh-list
6624228|NCT01293747|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6624229|NCT01293747|Progesterone|progesterone|mesh-list
6624230|NCT01293747|Estrogens|estrogens|mesh-ancestor
6624231|NCT01293747|Hormones|hormones|mesh-ancestor
6624232|NCT01293747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5479396|NCT02555657|Capecitabine|capecitabine|mesh-list
5479397|NCT02555657|Pembrolizumab|pembrolizumab|mesh-list
5479398|NCT02555657|Vinorelbine|vinorelbine|mesh-list
5479399|NCT02555657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5479400|NCT02555657|Antimetabolites|antimetabolites|mesh-ancestor
5479401|NCT02555657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479402|NCT02555657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5479403|NCT02555657|Antiviral Agents|antiviral agents|mesh-ancestor
6624233|NCT01293747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624234|NCT01293747|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6624235|NCT01293747|Contraceptive Agents|contraceptive agents|mesh-ancestor
6624236|NCT01293747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6624237|NCT01293747|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6624238|NCT01293747|Progestins|progestins|mesh-ancestor
6624239|NCT01293838|Citalopram|citalopram|mesh-list
6624240|NCT01293838|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6624241|NCT01293838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6624242|NCT01293838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6624243|NCT01293838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624244|NCT01293838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6624245|NCT01293838|Serotonin Agents|serotonin agents|mesh-ancestor
6624246|NCT01293838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624247|NCT01293838|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6624248|NCT01293838|Antidepressive Agents|antidepressive agents|mesh-ancestor
6624249|NCT01293838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6624250|NCT01293942|Bevacizumab|bevacizumab|mesh-list
6624251|NCT01293942|Capecitabine|capecitabine|mesh-list
6624252|NCT01293942|Oxaliplatin|oxaliplatin|mesh-list
6624253|NCT01293942|Irinotecan|irinotecan|mesh-list
6624254|NCT01293942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6624255|NCT01293942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6624256|NCT01293942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6624257|NCT01293942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6624258|NCT01293942|Growth Substances|growth substances|mesh-ancestor
6624259|NCT01293942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624260|NCT01293942|Growth Inhibitors|growth inhibitors|mesh-ancestor
6624261|NCT01293942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6624262|NCT01293942|Antimetabolites|antimetabolites|mesh-ancestor
6624263|NCT01293942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624264|NCT01293942|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5479404|NCT02555657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5479405|NCT02555657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5479406|NCT02555657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5479407|NCT02555657|Immunologic Factors|immunologic factors|mesh-ancestor
5479408|NCT02555657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479409|NCT02555657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5479410|NCT02555657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5479411|NCT02555657|Tubulin Modulators|tubulin modulators|mesh-ancestor
6624265|NCT01293942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6624266|NCT01293942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6624267|NCT01294059|Milnacipran|milnacipran|mesh-list
6624268|NCT01294059|Levomilnacipran|levomilnacipran|mesh-list
6624269|NCT01294059|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6624270|NCT01294059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6624271|NCT01294059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6624272|NCT01294059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624273|NCT01294059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6624274|NCT01294059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624275|NCT01294059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6624276|NCT01294059|Analgesics|analgesics|mesh-ancestor
6624277|NCT01294059|Sensory System Agents|sensory system agents|mesh-ancestor
6624278|NCT01294059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6624279|NCT01294059|Antidepressive Agents|antidepressive agents|mesh-ancestor
6624280|NCT01294059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6624281|NCT01294072|Curcumin|curcumin|mesh-list
6624282|NCT01294072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6624283|NCT01294072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6624284|NCT01294072|Analgesics|analgesics|mesh-ancestor
6624285|NCT01294072|Sensory System Agents|sensory system agents|mesh-ancestor
5479412|NCT02555657|Antimitotic Agents|antimitotic agents|mesh-ancestor
5479413|NCT02555657|Mitosis Modulators|mitosis modulators|mesh-ancestor
6624286|NCT01294072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6624287|NCT01294072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624288|NCT01294072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6624289|NCT01294072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6624290|NCT01294072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6624291|NCT01294072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6624292|NCT01294072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624293|NCT01294176|Thioctic Acid|thioctic acid|mesh-list
6624294|NCT01294176|Antioxidants|antioxidants|mesh-ancestor
6624295|NCT01294176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624296|NCT01294176|Protective Agents|protective agents|mesh-ancestor
6624297|NCT01294176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624298|NCT01294176|Vitamin B Complex|vitamin b complex|mesh-ancestor
6624299|NCT01294176|Vitamins|vitamins|mesh-ancestor
6624300|NCT01294176|Micronutrients|micronutrients|mesh-ancestor
6624301|NCT01294215|Nifedipine|nifedipine|mesh-list
6624302|NCT01294215|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6624303|NCT01294215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6624304|NCT01294215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624305|NCT01294215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6624306|NCT01294215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624307|NCT01294215|Vasodilator Agents|vasodilator agents|mesh-ancestor
6624308|NCT01294215|Tocolytic Agents|tocolytic agents|mesh-ancestor
6624309|NCT01294215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6624310|NCT01294293|Paclitaxel|paclitaxel|mesh-list
6624311|NCT01294293|Doxorubicin|doxorubicin|mesh-list
5479414|NCT02457156|Octreotide|octreotide|mesh-list
5479415|NCT02457156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5479416|NCT02457156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5479417|NCT02457156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5479418|NCT02402439|Pancrelipase|pancrelipase|mesh-list
5479419|NCT02402439|Pancreatin|pancreatin|mesh-list
5479420|NCT02402439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5479421|NCT02328014|Acalabrutinib|acalabrutinib|mesh-list
5479422|NCT02328014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5479423|NCT02272348|Insulin|insulin|mesh-list
5479424|NCT02272348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5479425|NCT02272348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479426|NCT02190721|Lenograstim|lenograstim|mesh-list
6624312|NCT01294293|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6624313|NCT01294293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6624314|NCT01294293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6624315|NCT01294293|Tubulin Modulators|tubulin modulators|mesh-ancestor
6624316|NCT01294293|Antimitotic Agents|antimitotic agents|mesh-ancestor
6624317|NCT01294293|Mitosis Modulators|mitosis modulators|mesh-ancestor
6624318|NCT01294293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624319|NCT01294293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6624320|NCT01294293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6624321|NCT01294293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6624322|NCT01294293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6624323|NCT01294410|Antibodies|antibodies|mesh-list
6624324|NCT01294410|Immunoglobulins|immunoglobulins|mesh-list
6624325|NCT01294410|Immunologic Factors|immunologic factors|mesh-ancestor
6624326|NCT01294410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624327|NCT01294605|Edetic Acid|edetic acid|mesh-list
6624328|NCT01294605|Pentetic Acid|pentetic acid|mesh-list
6624329|NCT01294605|Antidotes|antidotes|mesh-ancestor
6624330|NCT01294605|Protective Agents|protective agents|mesh-ancestor
6624331|NCT01294605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624332|NCT01294605|Chelating Agents|chelating agents|mesh-ancestor
6624333|NCT01294605|Sequestering Agents|sequestering agents|mesh-ancestor
6624334|NCT01294605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624335|NCT01294605|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6624336|NCT01294605|Anticoagulants|anticoagulants|mesh-ancestor
6624337|NCT01294605|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6662133|NCT01501890|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
6662134|NCT01501890|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6662135|NCT01501890|Hormone Antagonists|hormone antagonists|mesh-ancestor
6662136|NCT01501890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6662137|NCT01501890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662138|NCT01501890|Progestins|progestins|mesh-ancestor
6662139|NCT01501890|Hormones|hormones|mesh-ancestor
6662140|NCT01501890|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6662141|NCT01501890|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6662142|NCT01501890|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5479427|NCT02190721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5479428|NCT02190721|Immunologic Factors|immunologic factors|mesh-ancestor
6624338|NCT01294618|Interferons|interferons|mesh-list
6624339|NCT01294618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6624340|NCT01294618|Antiviral Agents|antiviral agents|mesh-ancestor
6624341|NCT01294618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6624342|NCT01294631|Canagliflozin|canagliflozin|mesh-list
6624343|NCT01294631|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6624344|NCT01294631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624345|NCT01294631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6624346|NCT01294631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624347|NCT01294735|Temozolomide|temozolomide|mesh-list
6624348|NCT01294735|Niraparib|niraparib|mesh-list
6624349|NCT01294735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5479429|NCT02190721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479430|NCT02109744|Decitabine|decitabine|mesh-list
5479431|NCT02109744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5479432|NCT02109744|Antimetabolites|antimetabolites|mesh-ancestor
5479433|NCT02109744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624350|NCT01294735|Alkylating Agents|alkylating agents|mesh-ancestor
6624351|NCT01294735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624352|NCT01294735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6624353|NCT01294735|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6624354|NCT01294735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6624355|NCT01294761|Raltegravir Potassium|raltegravir potassium|mesh-list
6624356|NCT01294761|Darunavir|darunavir|mesh-list
6624357|NCT01294761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6624358|NCT01294761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6624359|NCT01294761|Antiviral Agents|antiviral agents|mesh-ancestor
6624360|NCT01294761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6624361|NCT01294761|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6624362|NCT01294761|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6624363|NCT01294761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6624364|NCT01294761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624365|NCT01294761|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6624366|NCT01294761|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6624367|NCT01294761|Protease Inhibitors|protease inhibitors|mesh-ancestor
6624368|NCT01294826|Cetuximab|cetuximab|mesh-list
6624369|NCT01294826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6624370|NCT01294826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6624371|NCT01294852|Pulmonary Surfactants|pulmonary surfactants|mesh-list
6624372|NCT01294852|Respiratory System Agents|respiratory system agents|mesh-ancestor
6624373|NCT01294878|Omalizumab|omalizumab|mesh-list
6624374|NCT01294878|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6624375|NCT01294878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6624376|NCT01294878|Respiratory System Agents|respiratory system agents|mesh-ancestor
6624377|NCT01294956|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6624378|NCT01294956|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6624379|NCT01294956|Lubricant Eye Drops|lubricant eye drops|mesh-list
6624380|NCT01294956|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6624381|NCT01294956|Laxatives|laxatives|mesh-ancestor
6624382|NCT01294956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6624383|NCT01294969|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
6624384|NCT01294969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6624385|NCT01294969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6624386|NCT01294969|Analgesics|analgesics|mesh-ancestor
6624387|NCT01294969|Sensory System Agents|sensory system agents|mesh-ancestor
6624388|NCT01294969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6624389|NCT01294969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479434|NCT02109744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5479435|NCT02109744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5479436|NCT01740557|Aldesleukin|aldesleukin|mesh-list
5479437|NCT01740557|Cyclophosphamide|cyclophosphamide|mesh-list
5479438|NCT01740557|Fludarabine|fludarabine|mesh-list
5479439|NCT01740557|Fludarabine phosphate|fludarabine phosphate|mesh-list
5479440|NCT01740557|Interleukin-2|interleukin-2|mesh-list
5479441|NCT01740557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5479442|NCT01740557|Immunologic Factors|immunologic factors|mesh-ancestor
6624390|NCT01294969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6624391|NCT01294969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6624392|NCT01294969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6624393|NCT01294969|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6624394|NCT01294969|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6624395|NCT01294969|Histamine Antagonists|histamine antagonists|mesh-ancestor
6624396|NCT01294969|Histamine Agents|histamine agents|mesh-ancestor
6624397|NCT01294969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6624398|NCT01294969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624399|NCT01295047|Atenolol|atenolol|mesh-list
6624400|NCT01295047|Verapamil|verapamil|mesh-list
6624401|NCT01295047|Perindopril|perindopril|mesh-list
6624402|NCT01295047|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6624403|NCT01295047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6624404|NCT01295047|Sympatholytics|sympatholytics|mesh-ancestor
6624405|NCT01295047|Autonomic Agents|autonomic agents|mesh-ancestor
6624406|NCT01295047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6624407|NCT01295047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624408|NCT01295047|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6624409|NCT01295047|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6624410|NCT01295047|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6624411|NCT01295047|Adrenergic Agents|adrenergic agents|mesh-ancestor
6624412|NCT01295047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6624413|NCT01295047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479443|NCT01740557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479444|NCT01740557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5479445|NCT01740557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5479446|NCT01740557|Alkylating Agents|alkylating agents|mesh-ancestor
5503626|NCT04457219|Hemostatics|hemostatics|mesh-list
6624414|NCT01295047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6624415|NCT01295047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6624416|NCT01295047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6624417|NCT01295047|Vasodilator Agents|vasodilator agents|mesh-ancestor
6624418|NCT01295047|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6624419|NCT01295047|Protease Inhibitors|protease inhibitors|mesh-ancestor
6624420|NCT01295047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6624421|NCT01295073|Trientine|trientine|mesh-list
6624422|NCT01295073|Chelating Agents|chelating agents|mesh-ancestor
6624423|NCT01295073|Sequestering Agents|sequestering agents|mesh-ancestor
6624424|NCT01295073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624425|NCT01295086|Docetaxel|docetaxel|mesh-list
6624426|NCT01295086|Capecitabine|capecitabine|mesh-list
6624427|NCT01295086|Oxaliplatin|oxaliplatin|mesh-list
6624428|NCT01295086|Trastuzumab|trastuzumab|mesh-list
6624429|NCT01295086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6624430|NCT01295086|Tubulin Modulators|tubulin modulators|mesh-ancestor
6624431|NCT01295086|Antimitotic Agents|antimitotic agents|mesh-ancestor
6624432|NCT01295086|Mitosis Modulators|mitosis modulators|mesh-ancestor
6624433|NCT01295086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624434|NCT01295086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6624435|NCT01295086|Antimetabolites|antimetabolites|mesh-ancestor
6624436|NCT01295086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6624437|NCT01295099|Triamcinolone|triamcinolone|mesh-list
6624438|NCT01295099|Fluorouracil|fluorouracil|mesh-list
6624439|NCT01295099|Antimetabolites|antimetabolites|mesh-ancestor
6624440|NCT01295099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624441|NCT01295099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6624442|NCT01295099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6624443|NCT01295099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6624444|NCT01295099|Immunologic Factors|immunologic factors|mesh-ancestor
6624445|NCT01295099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624446|NCT01295099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6624447|NCT01295099|Glucocorticoids|glucocorticoids|mesh-ancestor
6624448|NCT01295099|Hormones|hormones|mesh-ancestor
6624449|NCT01295099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6624450|NCT01295138|Lactulose|lactulose|mesh-list
6624451|NCT01295138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6624452|NCT01295151|Adalimumab|adalimumab|mesh-list
6624453|NCT01295151|Etanercept|etanercept|mesh-list
6624454|NCT01295151|Golimumab|golimumab|mesh-list
6624455|NCT01295151|Rituximab|rituximab|mesh-list
6624456|NCT01295151|Abatacept|abatacept|mesh-list
6624457|NCT01295151|Infliximab|infliximab|mesh-list
6624458|NCT01295151|Certolizumab Pegol|certolizumab pegol|mesh-list
6624459|NCT01295151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6624460|NCT01295151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6624461|NCT01295151|Immunologic Factors|immunologic factors|mesh-ancestor
6624462|NCT01295151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624463|NCT01295151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6624464|NCT01295151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6624465|NCT01295151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6624466|NCT01295151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6624467|NCT01295151|Analgesics|analgesics|mesh-ancestor
6624468|NCT01295151|Sensory System Agents|sensory system agents|mesh-ancestor
6624469|NCT01295151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6624470|NCT01295151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6624471|NCT01295151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6624472|NCT01295151|Dermatologic Agents|dermatologic agents|mesh-ancestor
6624473|NCT01295151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6624474|NCT01295151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624475|NCT01295151|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6624476|NCT01295177|Insulin|insulin|mesh-list
6624477|NCT01295177|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6624478|NCT01295177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6624479|NCT01295177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624480|NCT01295268|Emu Oil|emu oil|mesh-list
6624481|NCT01295268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6624482|NCT01295268|Dermatologic Agents|dermatologic agents|mesh-ancestor
6624483|NCT01295294|Mefenamic Acid|mefenamic acid|mesh-list
6624484|NCT01295294|Tranexamic Acid|tranexamic acid|mesh-list
6624485|NCT01295294|Levonorgestrel|levonorgestrel|mesh-list
6624486|NCT01295294|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6624487|NCT01295294|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6624488|NCT01295294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624489|NCT01295294|Hemostatics|hemostatics|mesh-ancestor
6624490|NCT01295294|Coagulants|coagulants|mesh-ancestor
6624491|NCT01295294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6624492|NCT01295294|Contraceptive Agents|contraceptive agents|mesh-ancestor
6624493|NCT01295294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6624494|NCT01295294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624495|NCT01295294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6624496|NCT01295294|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6624497|NCT01295294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6624498|NCT01295294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6624499|NCT01295294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6624500|NCT01295294|Analgesics|analgesics|mesh-ancestor
6624501|NCT01295294|Sensory System Agents|sensory system agents|mesh-ancestor
6624502|NCT01295294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6624503|NCT01295294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6624504|NCT01295294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6624505|NCT01295294|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6624506|NCT01295294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6624507|NCT01295307|Clofarabine|clofarabine|mesh-list
6624508|NCT01295307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6624509|NCT01295307|Antimetabolites|antimetabolites|mesh-ancestor
6624510|NCT01295307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624511|NCT01295307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6624512|NCT01295372|Risperidone|risperidone|mesh-list
6624513|NCT01295372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6624514|NCT01295372|Serotonin Agents|serotonin agents|mesh-ancestor
6624515|NCT01295372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6624516|NCT01295372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624517|NCT01295372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624518|NCT01295372|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6624519|NCT01295372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6624520|NCT01295372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6624521|NCT01295372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6624522|NCT01295372|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6624523|NCT01295372|Dopamine Agents|dopamine agents|mesh-ancestor
6450969|NCT00410449|Tocotrienols|tocotrienols|mesh-list
6450970|NCT00410449|alpha-Tocopherol|alpha-tocopherol|mesh-list
6450971|NCT00410449|Antioxidants|antioxidants|mesh-ancestor
6450972|NCT00410449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450973|NCT00410449|Protective Agents|protective agents|mesh-ancestor
6450974|NCT00410449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450975|NCT00410449|Vitamins|vitamins|mesh-ancestor
6450976|NCT00410449|Micronutrients|micronutrients|mesh-ancestor
6450977|NCT00410462|Doxorubicin|doxorubicin|mesh-list
6450978|NCT00410462|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6450979|NCT00410462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6450980|NCT00410462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6461873|NCT00456560|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6624524|NCT01295450|Vitamins|vitamins|mesh-list
6624525|NCT01295450|Micronutrients|micronutrients|mesh-ancestor
6624526|NCT01295450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624527|NCT01295502|Paclitaxel|paclitaxel|mesh-list
6624528|NCT01295502|Cisplatin|cisplatin|mesh-list
6624529|NCT01295502|Carboplatin|carboplatin|mesh-list
6624530|NCT01295502|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6624531|NCT01295502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6624532|NCT01295502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6624533|NCT01295502|Tubulin Modulators|tubulin modulators|mesh-ancestor
6624534|NCT01295502|Antimitotic Agents|antimitotic agents|mesh-ancestor
6624535|NCT01295502|Mitosis Modulators|mitosis modulators|mesh-ancestor
6624536|NCT01295502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624537|NCT01295567|Dipyridamole|dipyridamole|mesh-list
6624538|NCT01295567|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6624539|NCT01295567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6624540|NCT01295567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624541|NCT01295567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6624542|NCT01295567|Vasodilator Agents|vasodilator agents|mesh-ancestor
6624543|NCT01295593|Cladribine|cladribine|mesh-list
6624544|NCT01295593|Valproic Acid|valproic acid|mesh-list
6624545|NCT01295593|Anticonvulsants|anticonvulsants|mesh-ancestor
6624546|NCT01295593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6624547|NCT01295593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624548|NCT01295593|GABA Agents|gaba agents|mesh-ancestor
6624549|NCT01295593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6624550|NCT01295593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624551|NCT01295593|Antimanic Agents|antimanic agents|mesh-ancestor
6624552|NCT01295593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6624553|NCT01295593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6624554|NCT01295593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6624555|NCT01295593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6624556|NCT01295593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6624557|NCT01295593|Immunologic Factors|immunologic factors|mesh-ancestor
6624558|NCT01295606|Cefazolin|cefazolin|mesh-list
6624559|NCT01295606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6624560|NCT01295606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6624561|NCT01295645|Cidofovir|cidofovir|mesh-list
6624562|NCT01295645|Antiviral Agents|antiviral agents|mesh-ancestor
6624563|NCT01295645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6624564|NCT01295645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6624565|NCT01295645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624566|NCT01295736|Sildenafil Citrate|sildenafil citrate|mesh-list
6624567|NCT01295736|Vasodilator Agents|vasodilator agents|mesh-ancestor
6624568|NCT01295736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5479447|NCT01740557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479448|NCT01740557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5479449|NCT01740557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5479450|NCT01740557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5479451|NCT01740557|Antimetabolites|antimetabolites|mesh-ancestor
6450981|NCT00410462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6624569|NCT01295736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6624570|NCT01295736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6624571|NCT01295736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624572|NCT01295736|Urological Agents|urological agents|mesh-ancestor
6624573|NCT01295775|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
6624574|NCT01295775|Anticoagulants|anticoagulants|mesh-ancestor
6624575|NCT01295775|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6624576|NCT01295775|Antimetabolites|antimetabolites|mesh-ancestor
6624577|NCT01295775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624578|NCT01295775|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6624579|NCT01295775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6624580|NCT01295775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6624581|NCT01295775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6662143|NCT01501890|Contraceptive Agents|contraceptive agents|mesh-ancestor
6450982|NCT00410462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6450983|NCT00410462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6450984|NCT00410462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6450985|NCT00410527|Meropenem|meropenem|mesh-list
6450986|NCT00410527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6450987|NCT00410527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6450988|NCT00410540|Morphine|morphine|mesh-list
6450989|NCT00410540|Hydromorphone|hydromorphone|mesh-list
6450990|NCT00410540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6450991|NCT00410540|Narcotics|narcotics|mesh-ancestor
6450992|NCT00410540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6624582|NCT01295775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624583|NCT01295866|Nitric Oxide|nitric oxide|mesh-list
6624584|NCT01295866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6624585|NCT01295866|Autonomic Agents|autonomic agents|mesh-ancestor
6624586|NCT01295866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6624587|NCT01295866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624588|NCT01295866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6624589|NCT01295866|Respiratory System Agents|respiratory system agents|mesh-ancestor
6624590|NCT01295866|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6624591|NCT01295866|Antioxidants|antioxidants|mesh-ancestor
6624592|NCT01295866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624593|NCT01295866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6624594|NCT01295866|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6624595|NCT01295866|Vasodilator Agents|vasodilator agents|mesh-ancestor
6624596|NCT01295866|Gasotransmitters|gasotransmitters|mesh-ancestor
6624597|NCT01295866|Protective Agents|protective agents|mesh-ancestor
6624598|NCT01295892|Estrogens|estrogens|mesh-list
6624599|NCT01295892|Hormones|hormones|mesh-ancestor
6624600|NCT01295892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6624601|NCT01295892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624602|NCT01295918|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6624603|NCT01295918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6624604|NCT01296074|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6624605|NCT01296074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6624606|NCT01296074|Glucocorticoids|glucocorticoids|mesh-ancestor
5479452|NCT01740557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6624607|NCT01296074|Hormones|hormones|mesh-ancestor
6624608|NCT01296074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6624609|NCT01296074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624610|NCT01296074|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6624611|NCT01296074|Protective Agents|protective agents|mesh-ancestor
6624612|NCT01296074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6624613|NCT01296074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6624614|NCT01296139|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
6624615|NCT01296139|Hematinics|hematinics|mesh-ancestor
6624616|NCT01296139|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6624617|NCT01296139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6624618|NCT01296178|Idarubicin|idarubicin|mesh-list
6624619|NCT01296178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6624620|NCT01296178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6624621|NCT01296178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6624622|NCT01296178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6624623|NCT01296178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6624624|NCT01296178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624625|NCT01296204|Antibodies|antibodies|mesh-list
6624626|NCT01296204|Immunologic Factors|immunologic factors|mesh-ancestor
6624627|NCT01296204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624628|NCT01296230|Hormones|hormones|mesh-list
6624629|NCT01296230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6624630|NCT01296230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624631|NCT01296256|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6624632|NCT01296256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6624633|NCT01296256|Alkylating Agents|alkylating agents|mesh-ancestor
6624634|NCT01296256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624635|NCT01296256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6624636|NCT01296269|Vasopressins|vasopressins|mesh-list
6624637|NCT01296269|Arginine Vasopressin|arginine vasopressin|mesh-list
6624638|NCT01296269|Oxytocin|oxytocin|mesh-list
6624639|NCT01296269|Oxytocics|oxytocics|mesh-ancestor
5479453|NCT01740557|Analgesics|analgesics|mesh-ancestor
5479454|NCT01740557|Sensory System Agents|sensory system agents|mesh-ancestor
5479455|NCT01740557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5479456|NCT01740557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6624640|NCT01296269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6624641|NCT01296269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624642|NCT01296269|Hemostatics|hemostatics|mesh-ancestor
6624643|NCT01296269|Coagulants|coagulants|mesh-ancestor
6624644|NCT01296269|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6624645|NCT01296269|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6624646|NCT01296269|Natriuretic Agents|natriuretic agents|mesh-ancestor
6662144|NCT01501890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6662145|NCT01501890|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6662146|NCT01501890|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6662147|NCT01501916|Vitamin D|vitamin d|mesh-list
6662148|NCT01501916|Cholecalciferol|cholecalciferol|mesh-list
6662149|NCT01501916|Vitamins|vitamins|mesh-ancestor
6662150|NCT01501916|Micronutrients|micronutrients|mesh-ancestor
6662151|NCT01501916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662152|NCT01501916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6662153|NCT01501916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6662154|NCT01501942|Glycine|glycine|mesh-list
6662155|NCT01501942|Glycine Agents|glycine agents|mesh-ancestor
6662156|NCT01501942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6662157|NCT01501942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662158|NCT01501942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662159|NCT01501968|Ascorbic Acid|ascorbic acid|mesh-list
6662160|NCT01501968|Colistin|colistin|mesh-list
6662161|NCT01501968|Vitamins|vitamins|mesh-ancestor
6662162|NCT01501968|Micronutrients|micronutrients|mesh-ancestor
6662163|NCT01501968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662164|NCT01501968|Antioxidants|antioxidants|mesh-ancestor
6662165|NCT01501968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662166|NCT01501968|Protective Agents|protective agents|mesh-ancestor
6662167|NCT01501968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6662168|NCT01501968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6662169|NCT01502020|Imiquimod|imiquimod|mesh-list
6662170|NCT01502020|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6662171|NCT01502020|Immunologic Factors|immunologic factors|mesh-ancestor
6662172|NCT01502020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662173|NCT01502020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6662174|NCT01502020|Interferon Inducers|interferon inducers|mesh-ancestor
6662175|NCT01502046|Dronabinol|dronabinol|mesh-list
6662176|NCT01502046|Cannabidiol|cannabidiol|mesh-list
6662177|NCT01502046|Anticonvulsants|anticonvulsants|mesh-ancestor
6662178|NCT01502046|Hallucinogens|hallucinogens|mesh-ancestor
6662179|NCT01502046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662180|NCT01502046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6662181|NCT01502046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6662182|NCT01502046|Analgesics|analgesics|mesh-ancestor
6662183|NCT01502046|Sensory System Agents|sensory system agents|mesh-ancestor
6662184|NCT01502046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6662185|NCT01502046|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6662186|NCT01502046|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6662187|NCT01502046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6662188|NCT01502046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479457|NCT01740557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5479458|NCT01740557|Antiviral Agents|antiviral agents|mesh-ancestor
5479459|NCT01740557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5479460|NCT01625611|Naltrexone|naltrexone|mesh-list
5479461|NCT01625611|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5479462|NCT01625611|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5479463|NCT01625611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479464|NCT01625611|Sensory System Agents|sensory system agents|mesh-ancestor
6662189|NCT01502046|Hormones|hormones|mesh-ancestor
6662190|NCT01502046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6662191|NCT01502202|Pemetrexed|pemetrexed|mesh-list
6662192|NCT01502202|Gefitinib|gefitinib|mesh-list
6662193|NCT01502202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6662194|NCT01502202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6662195|NCT01502202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624647|NCT01296334|Morphine|morphine|mesh-list
6624648|NCT01296334|Buprenorphine|buprenorphine|mesh-list
6624649|NCT01296334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6624650|NCT01296334|Narcotics|narcotics|mesh-ancestor
6624651|NCT01296334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6624652|NCT01296334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624653|NCT01296334|Analgesics|analgesics|mesh-ancestor
6624654|NCT01296334|Sensory System Agents|sensory system agents|mesh-ancestor
6624655|NCT01296334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6624656|NCT01296334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6624657|NCT01296438|Insulin|insulin|mesh-list
6624658|NCT01296438|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6624659|NCT01296438|Insulin Aspart|insulin aspart|mesh-list
6624660|NCT01296438|Insulin, Long-Acting|insulin, long-acting|mesh-list
6624661|NCT01296438|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6624662|NCT01296438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6624663|NCT01296438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624664|NCT01296464|Carbidopa|carbidopa|mesh-list
6624665|NCT01296464|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6624666|NCT01296464|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6624667|NCT01296464|Dopamine Agents|dopamine agents|mesh-ancestor
6624668|NCT01296464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6624669|NCT01296464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624670|NCT01296464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624671|NCT01296464|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6624672|NCT01296464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6624673|NCT01296503|Thalidomide|thalidomide|mesh-list
6624674|NCT01296503|Dexamethasone|dexamethasone|mesh-list
6624675|NCT01296503|Dexamethasone acetate|dexamethasone acetate|mesh-list
6624676|NCT01296503|BB 1101|bb 1101|mesh-list
6624677|NCT01296503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6624678|NCT01296503|Antiemetics|antiemetics|mesh-ancestor
6624679|NCT01296503|Autonomic Agents|autonomic agents|mesh-ancestor
6624680|NCT01296503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5479465|NCT01625611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6020896|NCT00395226|Dermatologic Agents|dermatologic agents|mesh-ancestor
6020897|NCT00395304|Fluticasone|fluticasone|mesh-list
6020898|NCT00395304|Xhance|xhance|mesh-list
5479469|NCT00715611|Carboplatin|carboplatin|mesh-list
5479470|NCT00715611|Pemetrexed|pemetrexed|mesh-list
5479471|NCT00715611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5479472|NCT00715611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5479473|NCT00715611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479474|NCT00715611|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5479475|NCT00715611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5502264|NCT04467931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502265|NCT04467931|Vasodilator Agents|vasodilator agents|mesh-ancestor
5502266|NCT04467931|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5502267|NCT04467931|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5502268|NCT04467931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5502269|NCT04467931|Diuretics|diuretics|mesh-ancestor
5502270|NCT04467931|Natriuretic Agents|natriuretic agents|mesh-ancestor
5502271|NCT04467931|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6624681|NCT01296503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624682|NCT01296503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6624683|NCT01296503|Glucocorticoids|glucocorticoids|mesh-ancestor
6624684|NCT01296503|Hormones|hormones|mesh-ancestor
6624685|NCT01296503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6624686|NCT01296503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6624687|NCT01296503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6624688|NCT01296503|Protease Inhibitors|protease inhibitors|mesh-ancestor
6624689|NCT01296503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5502272|NCT04467931|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6020899|NCT00395304|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6624690|NCT01296503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624691|NCT01296503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6624692|NCT01296503|Immunologic Factors|immunologic factors|mesh-ancestor
6624693|NCT01296503|Leprostatic Agents|leprostatic agents|mesh-ancestor
6624694|NCT01296503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6624695|NCT01296503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6624696|NCT01296503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6624697|NCT01296503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6624698|NCT01296503|Growth Substances|growth substances|mesh-ancestor
6624699|NCT01296503|Growth Inhibitors|growth inhibitors|mesh-ancestor
6624700|NCT01296555|Letrozole|letrozole|mesh-list
6624701|NCT01296555|Fulvestrant|fulvestrant|mesh-list
6624702|NCT01296555|Midazolam|midazolam|mesh-list
6624703|NCT01296555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6624704|NCT01296555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6624705|NCT01296555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6624706|NCT01296555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624707|NCT01296555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6624708|NCT01296555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6624709|NCT01296555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6624710|NCT01296555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6624711|NCT01296555|Anesthetics, General|anesthetics, general|mesh-ancestor
6624712|NCT01296555|Anesthetics|anesthetics|mesh-ancestor
6624713|NCT01296555|GABA Modulators|gaba modulators|mesh-ancestor
6624714|NCT01296555|GABA Agents|gaba agents|mesh-ancestor
5479476|NCT00308516|Leucovorin|leucovorin|mesh-list
5479477|NCT00308516|Bevacizumab|bevacizumab|mesh-list
5479478|NCT00308516|Fluorouracil|fluorouracil|mesh-list
5479479|NCT00308516|Oxaliplatin|oxaliplatin|mesh-list
5479480|NCT00308516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5479481|NCT00308516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5479482|NCT00308516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6450993|NCT00410540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6450994|NCT00410540|Analgesics|analgesics|mesh-ancestor
6450995|NCT00410540|Sensory System Agents|sensory system agents|mesh-ancestor
6450996|NCT00410540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6450997|NCT00410553|Gemcitabine|gemcitabine|mesh-list
6450998|NCT00410553|Halichondrin B|halichondrin b|mesh-list
6450999|NCT00410553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6624715|NCT01296555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6624716|NCT01296555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624717|NCT01296555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6624718|NCT01296555|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6624719|NCT01296555|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6624720|NCT01296555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6624721|NCT01296555|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6624722|NCT01296555|Hormone Antagonists|hormone antagonists|mesh-ancestor
6624723|NCT01296555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6624724|NCT01296555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6624725|NCT01296555|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6624726|NCT01296802|Fenfluramine|fenfluramine|mesh-list
6624727|NCT01296802|Dexfenfluramine|dexfenfluramine|mesh-list
6624728|NCT01296802|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6624729|NCT01296802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6624730|NCT01296802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6624731|NCT01296802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624732|NCT01296802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6624733|NCT01296802|Serotonin Agents|serotonin agents|mesh-ancestor
6624734|NCT01296802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624735|NCT01296802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6624736|NCT01296958|Niclosamide|niclosamide|mesh-list
6624737|NCT01296958|Anticestodal Agents|anticestodal agents|mesh-ancestor
6624738|NCT01296958|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6624739|NCT01296958|Anthelmintics|anthelmintics|mesh-ancestor
6624740|NCT01296958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6624741|NCT01296958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5479483|NCT00308516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6451000|NCT00410553|Antimetabolites|antimetabolites|mesh-ancestor
6451001|NCT00410553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451002|NCT00410553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6451003|NCT00410553|Antiviral Agents|antiviral agents|mesh-ancestor
6451004|NCT00410553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6451005|NCT00410553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6451006|NCT00410553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6624742|NCT01296958|Antinematodal Agents|antinematodal agents|mesh-ancestor
6624743|NCT01296971|Ribavirin|ribavirin|mesh-list
6624744|NCT01296971|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6624745|NCT01296971|Antimetabolites|antimetabolites|mesh-ancestor
6624746|NCT01296971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624747|NCT01296971|Antiviral Agents|antiviral agents|mesh-ancestor
6624748|NCT01296971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6624749|NCT01296997|Calcium|calcium|mesh-list
6624750|NCT01296997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6624751|NCT01296997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624752|NCT01297010|Dexamethasone|dexamethasone|mesh-list
6624753|NCT01297010|Dexamethasone acetate|dexamethasone acetate|mesh-list
5479484|NCT00308516|Growth Substances|growth substances|mesh-ancestor
5479485|NCT00308516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479486|NCT00308516|Growth Inhibitors|growth inhibitors|mesh-ancestor
5479487|NCT00308516|Antimetabolites|antimetabolites|mesh-ancestor
5479488|NCT00308516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479489|NCT00308516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5479490|NCT00308516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5479491|NCT00308516|Immunologic Factors|immunologic factors|mesh-ancestor
5479492|NCT00308516|Antidotes|antidotes|mesh-ancestor
5479493|NCT00308516|Protective Agents|protective agents|mesh-ancestor
5479494|NCT00308516|Vitamin B Complex|vitamin b complex|mesh-ancestor
6624754|NCT01297010|BB 1101|bb 1101|mesh-list
6624755|NCT01297010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6624756|NCT01297010|Antiemetics|antiemetics|mesh-ancestor
6624757|NCT01297010|Autonomic Agents|autonomic agents|mesh-ancestor
6624758|NCT01297010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6624759|NCT01297010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624760|NCT01297010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6624761|NCT01297010|Glucocorticoids|glucocorticoids|mesh-ancestor
6624762|NCT01297010|Hormones|hormones|mesh-ancestor
6624763|NCT01297010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6624764|NCT01297010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6624765|NCT01297010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6624766|NCT01297010|Protease Inhibitors|protease inhibitors|mesh-ancestor
6624767|NCT01297010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6624768|NCT01297010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624769|NCT01297023|Calcium, Dietary|calcium, dietary|mesh-list
6624770|NCT01297023|Vitamin D|vitamin d|mesh-list
6624771|NCT01297023|Ergocalciferols|ergocalciferols|mesh-list
6624772|NCT01297023|Vitamins|vitamins|mesh-list
6624773|NCT01297023|Calcium|calcium|mesh-list
6624774|NCT01297023|Micronutrients|micronutrients|mesh-ancestor
6624775|NCT01297023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624776|NCT01297023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6624777|NCT01297023|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6624778|NCT01297036|Donepezil|donepezil|mesh-list
6624779|NCT01297036|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6624780|NCT01297036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6624781|NCT01297036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624782|NCT01297036|Cholinergic Agents|cholinergic agents|mesh-ancestor
6624783|NCT01297036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6624784|NCT01297036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624785|NCT01297036|Nootropic Agents|nootropic agents|mesh-ancestor
6624786|NCT01297101|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6624787|NCT01297101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5479495|NCT00308516|Vitamins|vitamins|mesh-ancestor
5479496|NCT00308516|Micronutrients|micronutrients|mesh-ancestor
5479497|NCT00005780|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
5479498|NCT00005780|Immunologic Factors|immunologic factors|mesh-ancestor
5479499|NCT00005780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479500|NCT02325960|Insulin Glargine|insulin glargine|mesh-list
5479501|NCT02325960|Exenatide|exenatide|mesh-list
5479502|NCT02325960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5479503|NCT02325960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479504|NCT02325960|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5479505|NCT02325960|Incretins|incretins|mesh-ancestor
6624788|NCT01297101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6624789|NCT01297101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6624790|NCT01297101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624791|NCT01297166|Calcitriol|calcitriol|mesh-list
6624792|NCT01297166|Calcipotriene|calcipotriene|mesh-list
5479506|NCT02325960|Hormones|hormones|mesh-ancestor
5479507|NCT02325960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6624793|NCT01297166|Dermatologic Agents|dermatologic agents|mesh-ancestor
6624794|NCT01297166|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6624795|NCT01297166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624796|NCT01297166|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6624797|NCT01297166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6624798|NCT01297166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624799|NCT01297166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6624800|NCT01297166|Vitamins|vitamins|mesh-ancestor
6624801|NCT01297166|Micronutrients|micronutrients|mesh-ancestor
6624802|NCT01297166|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6624803|NCT01297179|Levonorgestrel|levonorgestrel|mesh-list
6624804|NCT01297179|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6624805|NCT01297179|Mirabegron|mirabegron|mesh-list
6624806|NCT01297179|Estradiol|estradiol|mesh-list
6624807|NCT01297179|Estrogens|estrogens|mesh-ancestor
6624808|NCT01297179|Hormones|hormones|mesh-ancestor
6624809|NCT01297179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6624810|NCT01297179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624811|NCT01297179|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6624812|NCT01297179|Contraceptive Agents|contraceptive agents|mesh-ancestor
6624813|NCT01297179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6624814|NCT01297179|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6624815|NCT01297179|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6451007|NCT00410553|Immunologic Factors|immunologic factors|mesh-ancestor
6451008|NCT00410553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451009|NCT00410553|Tubulin Modulators|tubulin modulators|mesh-ancestor
6451010|NCT00410553|Antimitotic Agents|antimitotic agents|mesh-ancestor
6451011|NCT00410553|Mitosis Modulators|mitosis modulators|mesh-ancestor
6451012|NCT00410592|Esomeprazole|esomeprazole|mesh-list
6451013|NCT00410592|Pantoprazole|pantoprazole|mesh-list
6624816|NCT01297179|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6624817|NCT01297179|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6624818|NCT01297179|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6624819|NCT01297179|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6624820|NCT01297179|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6624821|NCT01297179|Adrenergic Agents|adrenergic agents|mesh-ancestor
6624822|NCT01297179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6624823|NCT01297179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624824|NCT01297179|Urological Agents|urological agents|mesh-ancestor
6624825|NCT01297192|Solifenacin Succinate|solifenacin succinate|mesh-list
6624826|NCT01297192|Mirabegron|mirabegron|mesh-list
5479508|NCT05155592|Adalimumab|adalimumab|mesh-list
5479509|NCT05155592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5479510|NCT05155592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5479511|NCT05155579|Vaccines|vaccines|mesh-list
5479512|NCT05155579|Immunologic Factors|immunologic factors|mesh-ancestor
5479513|NCT05155579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479514|NCT05155527|Ivermectin|ivermectin|mesh-list
5479515|NCT05155527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5479516|NCT05155527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5479517|NCT05155215|Cyclophosphamide|cyclophosphamide|mesh-list
5479518|NCT05155215|Fludarabine|fludarabine|mesh-list
5479519|NCT05155215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5479520|NCT05155215|Immunologic Factors|immunologic factors|mesh-ancestor
5479521|NCT05155215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479522|NCT05155215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5479523|NCT05155215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5479524|NCT05155215|Alkylating Agents|alkylating agents|mesh-ancestor
5479525|NCT05155215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479526|NCT05155215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5479527|NCT05155215|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5479528|NCT05155202|Antihypertensive Agents|antihypertensive agents|mesh-list
5479529|NCT05155124|Cetuximab|cetuximab|mesh-list
5479530|NCT05155124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5479531|NCT05155124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5479532|NCT05154955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5479533|NCT05154747|Rilpivirine|rilpivirine|mesh-list
5479534|NCT05154747|Cabotegravir|cabotegravir|mesh-list
5479535|NCT05154747|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5479536|NCT05154747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5479537|NCT05154747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6624827|NCT01297192|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6624828|NCT01297192|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6624829|NCT01297192|Cholinergic Agents|cholinergic agents|mesh-ancestor
6624830|NCT01297192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6624831|NCT01297192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624832|NCT01297192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451014|NCT00410592|Lansoprazole|lansoprazole|mesh-list
6451015|NCT00410592|Dexlansoprazole|dexlansoprazole|mesh-list
6624833|NCT01297192|Urological Agents|urological agents|mesh-ancestor
5479538|NCT05154747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479539|NCT05154747|Antiviral Agents|antiviral agents|mesh-ancestor
5479540|NCT05154747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5479541|NCT05154747|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5479542|NCT05154747|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5479543|NCT05154747|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5479544|NCT05154747|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6624834|NCT01297192|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6624835|NCT01297192|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6624836|NCT01297192|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6624837|NCT01297192|Adrenergic Agents|adrenergic agents|mesh-ancestor
6624838|NCT01297452|Paclitaxel|paclitaxel|mesh-list
6624839|NCT01297452|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6624840|NCT01297452|Carboplatin|carboplatin|mesh-list
6624841|NCT01297452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6624842|NCT01297452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6624843|NCT01297452|Tubulin Modulators|tubulin modulators|mesh-ancestor
6624844|NCT01297452|Antimitotic Agents|antimitotic agents|mesh-ancestor
6624845|NCT01297452|Mitosis Modulators|mitosis modulators|mesh-ancestor
6624846|NCT01297452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624847|NCT01297569|Ranibizumab|ranibizumab|mesh-list
6624848|NCT01297569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6624849|NCT01297569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6624850|NCT01297569|Growth Substances|growth substances|mesh-ancestor
6624851|NCT01297569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624852|NCT01297569|Growth Inhibitors|growth inhibitors|mesh-ancestor
6624853|NCT01297569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6624854|NCT01297634|Botulinum Toxins|botulinum toxins|mesh-list
6624855|NCT01297634|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6624856|NCT01297634|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6624857|NCT01297634|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6624858|NCT01297634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6624859|NCT01297634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624860|NCT01297634|Cholinergic Agents|cholinergic agents|mesh-ancestor
6624861|NCT01297634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6624862|NCT01297634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624863|NCT01297634|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6624864|NCT01297634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6624865|NCT01297686|Dexamethasone|dexamethasone|mesh-list
6624866|NCT01297686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6624867|NCT01297686|Antiemetics|antiemetics|mesh-ancestor
6624868|NCT01297686|Autonomic Agents|autonomic agents|mesh-ancestor
6624869|NCT01297686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6624870|NCT01297686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624871|NCT01297686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6624872|NCT01297686|Glucocorticoids|glucocorticoids|mesh-ancestor
6624873|NCT01297686|Hormones|hormones|mesh-ancestor
6624874|NCT01297686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6624875|NCT01297686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6624876|NCT01297686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6624877|NCT01297764|Dexamethasone|dexamethasone|mesh-list
6624878|NCT01297764|Dexamethasone acetate|dexamethasone acetate|mesh-list
6624879|NCT01297764|Lenalidomide|lenalidomide|mesh-list
6624880|NCT01297764|Vorinostat|vorinostat|mesh-list
6624881|NCT01297764|BB 1101|bb 1101|mesh-list
6624882|NCT01297764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6624883|NCT01297764|Antiemetics|antiemetics|mesh-ancestor
6624884|NCT01297764|Autonomic Agents|autonomic agents|mesh-ancestor
6624885|NCT01297764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6624886|NCT01297764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624887|NCT01297764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6624888|NCT01297764|Glucocorticoids|glucocorticoids|mesh-ancestor
6624889|NCT01297764|Hormones|hormones|mesh-ancestor
6624890|NCT01297764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6624891|NCT01297764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6624892|NCT01297764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6624893|NCT01297764|Protease Inhibitors|protease inhibitors|mesh-ancestor
6624894|NCT01297764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6624895|NCT01297764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624896|NCT01297764|Immunologic Factors|immunologic factors|mesh-ancestor
6624897|NCT01297764|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6624898|NCT01297764|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6624899|NCT01297764|Growth Substances|growth substances|mesh-ancestor
5479545|NCT05154682|Acetaminophen|acetaminophen|mesh-list
6624900|NCT01297764|Growth Inhibitors|growth inhibitors|mesh-ancestor
6624901|NCT01297764|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6624902|NCT01297777|Imatinib Mesylate|imatinib mesylate|mesh-list
6624903|NCT01297777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6624904|NCT01297777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6624905|NCT01297777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6624906|NCT01297777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624907|NCT01297803|Mitomycins|mitomycins|mesh-list
6624908|NCT01297803|Mitomycin|mitomycin|mesh-list
6624909|NCT01297803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6624910|NCT01297803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6624911|NCT01297803|Alkylating Agents|alkylating agents|mesh-ancestor
6624912|NCT01297803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624913|NCT01297803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6624914|NCT01297803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6624915|NCT01297816|Minocycline|minocycline|mesh-list
6624916|NCT01297816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6624917|NCT01297816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6624918|NCT01297829|Ibuprofen|ibuprofen|mesh-list
6624919|NCT01297829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6624920|NCT01297829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6624921|NCT01297829|Analgesics|analgesics|mesh-ancestor
6624922|NCT01297829|Sensory System Agents|sensory system agents|mesh-ancestor
6624923|NCT01297829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6624924|NCT01297829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624925|NCT01297829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6624926|NCT01297829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6624927|NCT01297829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6624928|NCT01297829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6624929|NCT01297829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624930|NCT01297842|Meropenem|meropenem|mesh-list
6624931|NCT01297842|Imipenem|imipenem|mesh-list
6624932|NCT01297842|Ertapenem|ertapenem|mesh-list
6624933|NCT01297842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6624934|NCT01297842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6624935|NCT01297855|Rifampin|rifampin|mesh-list
6624936|NCT01297855|Colistin|colistin|mesh-list
6624937|NCT01297855|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6624938|NCT01297855|Antitubercular Agents|antitubercular agents|mesh-ancestor
6624939|NCT01297855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6624940|NCT01297855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6624941|NCT01297855|Leprostatic Agents|leprostatic agents|mesh-ancestor
6624942|NCT01297855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6624943|NCT01297855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6624944|NCT01297855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624945|NCT01297855|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6624946|NCT01297855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6624947|NCT01297855|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6624948|NCT01297855|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6624949|NCT01297855|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6624950|NCT01297855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6624951|NCT01297894|Colistin|colistin|mesh-list
6624952|NCT01297894|Fosfomycin|fosfomycin|mesh-list
6624953|NCT01297894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6624954|NCT01297894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6624955|NCT01297907|Methacholine Chloride|methacholine chloride|mesh-list
6624956|NCT01297907|Miotics|miotics|mesh-ancestor
6624957|NCT01297907|Autonomic Agents|autonomic agents|mesh-ancestor
6624958|NCT01297907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6624959|NCT01297907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624960|NCT01297907|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6624961|NCT01297907|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
6624962|NCT01297907|Respiratory System Agents|respiratory system agents|mesh-ancestor
6624963|NCT01297907|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6624964|NCT01297907|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6624965|NCT01297907|Cholinergic Agents|cholinergic agents|mesh-ancestor
6624966|NCT01297907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6624967|NCT01297907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624968|NCT01297946|Hormones|hormones|mesh-list
6624969|NCT01297946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624970|NCT01297946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6624971|NCT01297998|Gemcitabine|gemcitabine|mesh-list
6624972|NCT01297998|Cisplatin|cisplatin|mesh-list
6624973|NCT01297998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6624974|NCT01297998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6624975|NCT01297998|Antimetabolites|antimetabolites|mesh-ancestor
6624976|NCT01297998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624977|NCT01297998|Antiviral Agents|antiviral agents|mesh-ancestor
6624978|NCT01297998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6624979|NCT01297998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6624980|NCT01297998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6624981|NCT01297998|Immunologic Factors|immunologic factors|mesh-ancestor
6624982|NCT01297998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6624983|NCT01298011|Gemcitabine|gemcitabine|mesh-list
6624984|NCT01298011|Paclitaxel|paclitaxel|mesh-list
6624985|NCT01298011|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6624986|NCT01298011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6624987|NCT01298011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6624988|NCT01298011|Tubulin Modulators|tubulin modulators|mesh-ancestor
6624989|NCT01298011|Antimitotic Agents|antimitotic agents|mesh-ancestor
6624990|NCT01298011|Mitosis Modulators|mitosis modulators|mesh-ancestor
6624991|NCT01298011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6624992|NCT01298011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6624993|NCT01298011|Antimetabolites|antimetabolites|mesh-ancestor
6624994|NCT01298011|Antiviral Agents|antiviral agents|mesh-ancestor
6624995|NCT01298011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6624996|NCT01298011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6624997|NCT01298011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6624998|NCT01298011|Immunologic Factors|immunologic factors|mesh-ancestor
6624999|NCT01298011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662196|NCT01502202|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6662197|NCT01502202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6662198|NCT01502202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6664977|NCT01514968|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6664978|NCT01514968|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6664979|NCT01514968|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6664980|NCT01514968|Protease Inhibitors|protease inhibitors|mesh-ancestor
6664981|NCT01514968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6664982|NCT01514968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6664983|NCT01514968|Antiviral Agents|antiviral agents|mesh-ancestor
6664984|NCT01514968|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6664985|NCT01514968|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6664986|NCT01514981|Mogamulizumab|mogamulizumab|mesh-list
6664987|NCT01514981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6664988|NCT01515020|Vancomycin|vancomycin|mesh-list
6664989|NCT01515020|Daptomycin|daptomycin|mesh-list
6664990|NCT01515020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6664991|NCT01515020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6664992|NCT01515137|Sulindac|sulindac|mesh-list
6664993|NCT01515137|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6664994|NCT01515137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6664995|NCT01515137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5479546|NCT05154682|Naproxen|naproxen|mesh-list
5479547|NCT05154682|Oxycodone|oxycodone|mesh-list
5479548|NCT05154682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5479549|NCT05154682|Analgesics|analgesics|mesh-ancestor
5479550|NCT05154682|Sensory System Agents|sensory system agents|mesh-ancestor
5479551|NCT05154682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5479552|NCT05154682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451016|NCT00410592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6451017|NCT00410592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6451018|NCT00410592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6451019|NCT00410592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6451020|NCT00410592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054332|NCT00602459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6664996|NCT01515137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6664997|NCT01515137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6664998|NCT01515137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6664999|NCT01515137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6665000|NCT01515137|Analgesics|analgesics|mesh-ancestor
6665001|NCT01515137|Sensory System Agents|sensory system agents|mesh-ancestor
6665002|NCT01515137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6665003|NCT01515137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665004|NCT01515137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6665005|NCT01515137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6451021|NCT00410631|Cyclophosphamide|cyclophosphamide|mesh-list
6451022|NCT00410631|Melphalan|melphalan|mesh-list
6451023|NCT00410631|Ifosfamide|ifosfamide|mesh-list
6665006|NCT01515137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6665007|NCT01515228|Paclitaxel|paclitaxel|mesh-list
5479553|NCT05154682|Antipyretics|antipyretics|mesh-ancestor
6451024|NCT00410631|Dacarbazine|dacarbazine|mesh-list
6665008|NCT01515228|Everolimus|everolimus|mesh-list
6625000|NCT01298076|Dexamethasone|dexamethasone|mesh-list
6625001|NCT01298076|Bevacizumab|bevacizumab|mesh-list
6625002|NCT01298076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6625003|NCT01298076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6625004|NCT01298076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6625005|NCT01298076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6625006|NCT01298076|Growth Substances|growth substances|mesh-ancestor
6625007|NCT01298076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625008|NCT01298076|Growth Inhibitors|growth inhibitors|mesh-ancestor
6625009|NCT01298076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6625010|NCT01298076|Antiemetics|antiemetics|mesh-ancestor
6625011|NCT01298076|Autonomic Agents|autonomic agents|mesh-ancestor
6625012|NCT01298076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6625013|NCT01298076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6625014|NCT01298076|Glucocorticoids|glucocorticoids|mesh-ancestor
6625015|NCT01298076|Hormones|hormones|mesh-ancestor
6625016|NCT01298076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6625017|NCT01298076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6625018|NCT01298180|Hormones|hormones|mesh-list
6625019|NCT01298180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6625020|NCT01298180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625021|NCT01298271|Propranolol|propranolol|mesh-list
6625022|NCT01298271|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6625023|NCT01298271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6625024|NCT01298271|Adrenergic Agents|adrenergic agents|mesh-ancestor
6625025|NCT01298271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6625026|NCT01298271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625027|NCT01298271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625028|NCT01298271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6625029|NCT01298271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6625030|NCT01298271|Vasodilator Agents|vasodilator agents|mesh-ancestor
6625031|NCT01298284|Propranolol|propranolol|mesh-list
6625032|NCT01298284|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6625033|NCT01298284|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6625034|NCT01298284|Adrenergic Agents|adrenergic agents|mesh-ancestor
6625035|NCT01298284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6625036|NCT01298284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625037|NCT01298284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625038|NCT01298284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6625039|NCT01298284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6625040|NCT01298284|Vasodilator Agents|vasodilator agents|mesh-ancestor
6625041|NCT01298297|Morphine|morphine|mesh-list
6625042|NCT01298297|Buprenorphine|buprenorphine|mesh-list
6625043|NCT01298297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6625044|NCT01298297|Narcotics|narcotics|mesh-ancestor
6625045|NCT01298297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6625046|NCT01298297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625047|NCT01298297|Analgesics|analgesics|mesh-ancestor
6625048|NCT01298297|Sensory System Agents|sensory system agents|mesh-ancestor
6625049|NCT01298297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6625050|NCT01298297|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6625051|NCT01298310|Lidocaine|lidocaine|mesh-list
6625052|NCT01298310|Anesthetics, Local|anesthetics, local|mesh-ancestor
6625053|NCT01298310|Anesthetics|anesthetics|mesh-ancestor
6625054|NCT01298310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6625055|NCT01298310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625056|NCT01298310|Sensory System Agents|sensory system agents|mesh-ancestor
6625057|NCT01298310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6625058|NCT01298310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6625059|NCT01298310|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6625060|NCT01298310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6625061|NCT01298310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6662199|NCT01502241|Temozolomide|temozolomide|mesh-list
5479554|NCT05154682|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5479555|NCT05154682|Narcotics|narcotics|mesh-ancestor
5479556|NCT05154682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5479557|NCT05154682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5479558|NCT05154682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5479559|NCT05154682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5479560|NCT05154682|Gout Suppressants|gout suppressants|mesh-ancestor
5479561|NCT05154682|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5479562|NCT05154682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5479563|NCT05154682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479564|NCT05154487|Fulvestrant|fulvestrant|mesh-list
5479565|NCT05154487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5479566|NCT05154487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5479567|NCT05154487|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5479568|NCT05154487|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5479569|NCT05154487|Hormone Antagonists|hormone antagonists|mesh-ancestor
5479570|NCT05154487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5479571|NCT05154487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479572|NCT05154396|Loperamide|loperamide|mesh-list
5479573|NCT05154396|Antidiarrheals|antidiarrheals|mesh-ancestor
5479574|NCT05154396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5479575|NCT05154383|Vaccines|vaccines|mesh-list
5479576|NCT05154383|Immunologic Factors|immunologic factors|mesh-ancestor
5479577|NCT05154383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479578|NCT05154370|Immunoglobulins|immunoglobulins|mesh-list
5479579|NCT05154370|Immunologic Factors|immunologic factors|mesh-ancestor
5479580|NCT05154370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479581|NCT05136443|Loteprednol Etabonate|loteprednol etabonate|mesh-list
5479582|NCT05136443|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5479583|NCT05134584|Lactulose|lactulose|mesh-list
5479584|NCT05134584|Linaclotide|linaclotide|mesh-list
5479585|NCT05134584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5479586|NCT05134584|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
5479587|NCT05134584|Enzyme Activators|enzyme activators|mesh-ancestor
5479588|NCT05134584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479589|NCT05134415|Menthol|menthol|mesh-list
5479590|NCT05134415|Antipruritics|antipruritics|mesh-ancestor
5479591|NCT05134415|Dermatologic Agents|dermatologic agents|mesh-ancestor
5479592|NCT05115838|Islatravir|islatravir|mesh-list
5479593|NCT05115838|Antiviral Agents|antiviral agents|mesh-ancestor
5479594|NCT05115838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5479595|NCT05115838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5479596|NCT05115838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625062|NCT01298310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625063|NCT01298336|Moxifloxacin|moxifloxacin|mesh-list
6625064|NCT01298336|Clarithromycin|clarithromycin|mesh-list
6625065|NCT01298336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6625066|NCT01298336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6625067|NCT01298336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6625068|NCT01298336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6625069|NCT01298336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6625070|NCT01298336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625071|NCT01298336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6625072|NCT01298336|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6625073|NCT01298336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6625074|NCT01298336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6625075|NCT01298401|Gemcitabine|gemcitabine|mesh-list
6625076|NCT01298401|Capecitabine|capecitabine|mesh-list
6625077|NCT01298401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6625078|NCT01298401|Antimetabolites|antimetabolites|mesh-ancestor
6665009|NCT01515228|Cilostazol|cilostazol|mesh-list
6625079|NCT01298401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625080|NCT01298401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6625081|NCT01298401|Antiviral Agents|antiviral agents|mesh-ancestor
6625082|NCT01298401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6625083|NCT01298401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6625084|NCT01298401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6625085|NCT01298401|Immunologic Factors|immunologic factors|mesh-ancestor
6625086|NCT01298401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625087|NCT01298466|Pregabalin|pregabalin|mesh-list
6625088|NCT01298466|Analgesics|analgesics|mesh-ancestor
6625089|NCT01298466|Sensory System Agents|sensory system agents|mesh-ancestor
6625090|NCT01298466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6625091|NCT01298466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625092|NCT01298466|Anticonvulsants|anticonvulsants|mesh-ancestor
6625093|NCT01298466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6451025|NCT00410631|Carboplatin|carboplatin|mesh-list
6451026|NCT00410631|Doxorubicin|doxorubicin|mesh-list
6451027|NCT00410631|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6451028|NCT00410631|Etoposide|etoposide|mesh-list
6451029|NCT00410631|Vincristine|vincristine|mesh-list
6451030|NCT00410631|Topotecan|topotecan|mesh-list
5479597|NCT05115838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5479598|NCT05115838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5479599|NCT05115838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5479600|NCT05109234|Brivaracetam|brivaracetam|mesh-list
5479601|NCT05109234|Anticonvulsants|anticonvulsants|mesh-ancestor
6625094|NCT01298466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6625095|NCT01298466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625096|NCT01298466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6625097|NCT01298466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6625098|NCT01298466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6625099|NCT01298466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6625100|NCT01298466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6451031|NCT00410631|Etoposide phosphate|etoposide phosphate|mesh-list
6451032|NCT00410631|Vindesine|vindesine|mesh-list
6451033|NCT00410631|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
6451034|NCT00410631|Isotretinoin|isotretinoin|mesh-list
6451035|NCT00410631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6451036|NCT00410631|Immunologic Factors|immunologic factors|mesh-ancestor
6451037|NCT00410631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451038|NCT00410631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6451039|NCT00410631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6451040|NCT00410631|Alkylating Agents|alkylating agents|mesh-ancestor
6451041|NCT00410631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625101|NCT01298505|Fexofenadine|fexofenadine|mesh-list
6625102|NCT01298505|Terfenadine|terfenadine|mesh-list
6625103|NCT01298505|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6625104|NCT01298505|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6625105|NCT01298505|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6625106|NCT01298505|Histamine Antagonists|histamine antagonists|mesh-ancestor
6625107|NCT01298505|Histamine Agents|histamine agents|mesh-ancestor
6625108|NCT01298505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6625109|NCT01298505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625110|NCT01298505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625111|NCT01298713|Tamoxifen|tamoxifen|mesh-list
6625112|NCT01298713|Everolimus|everolimus|mesh-list
6625113|NCT01298713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6625114|NCT01298713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6625115|NCT01298713|Immunologic Factors|immunologic factors|mesh-ancestor
6625116|NCT01298713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625117|NCT01298713|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6625118|NCT01298713|Hormone Antagonists|hormone antagonists|mesh-ancestor
6625119|NCT01298713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6625120|NCT01298713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6625121|NCT01298713|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6625122|NCT01298713|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6625123|NCT01298713|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6625124|NCT01298843|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
6625125|NCT01298843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6625126|NCT01298843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6625127|NCT01298882|Diacetylrhein|diacetylrhein|mesh-list
6625128|NCT01298882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6625129|NCT01298934|Panobinostat|panobinostat|mesh-list
5502273|NCT04467931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6451042|NCT00410631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6625130|NCT01298934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6625131|NCT01298934|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6625132|NCT01298934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6625133|NCT01298934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625134|NCT01299012|Liraglutide|liraglutide|mesh-list
6625135|NCT01299012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6625136|NCT01299012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625137|NCT01299012|Incretins|incretins|mesh-ancestor
6625138|NCT01299012|Hormones|hormones|mesh-ancestor
6625139|NCT01299012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6625140|NCT01299181|Atorvastatin|atorvastatin|mesh-list
6625141|NCT01299181|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6625142|NCT01299181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6625143|NCT01299181|Antimetabolites|antimetabolites|mesh-ancestor
6625144|NCT01299181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625145|NCT01299181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6625146|NCT01299181|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6625147|NCT01299181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6625148|NCT01299194|Atorvastatin|atorvastatin|mesh-list
6625149|NCT01299194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6625150|NCT01299194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6625151|NCT01299194|Antimetabolites|antimetabolites|mesh-ancestor
6625152|NCT01299194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625153|NCT01299194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6625154|NCT01299194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6625155|NCT01299194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6625156|NCT01299220|Acitretin|acitretin|mesh-list
6625157|NCT01299220|Keratolytic Agents|keratolytic agents|mesh-ancestor
6625158|NCT01299220|Dermatologic Agents|dermatologic agents|mesh-ancestor
6625159|NCT01299298|Mipomersen|mipomersen|mesh-list
6625160|NCT01299298|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6625161|NCT01299298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6625162|NCT01299298|Antimetabolites|antimetabolites|mesh-ancestor
6625163|NCT01299298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625164|NCT01299298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6625165|NCT01299415|Vadimezan|vadimezan|mesh-list
6625166|NCT01299415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6625167|NCT01299558|Fluticasone|fluticasone|mesh-list
6625168|NCT01299558|Xhance|xhance|mesh-list
6625169|NCT01299558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6625170|NCT01299558|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6625171|NCT01299558|Autonomic Agents|autonomic agents|mesh-ancestor
6625172|NCT01299558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6625173|NCT01299558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479602|NCT05058092|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5479603|NCT05052710|Midazolam|midazolam|mesh-list
5479604|NCT05052710|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5479605|NCT05052710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6625174|NCT01299558|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6625175|NCT01299558|Respiratory System Agents|respiratory system agents|mesh-ancestor
6625176|NCT01299558|Dermatologic Agents|dermatologic agents|mesh-ancestor
6625177|NCT01299558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6625178|NCT01299597|Atorvastatin|atorvastatin|mesh-list
6625179|NCT01299597|Simvastatin|simvastatin|mesh-list
6625180|NCT01299597|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6625181|NCT01299597|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6625182|NCT01299597|Antimetabolites|antimetabolites|mesh-ancestor
6625183|NCT01299597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625184|NCT01299597|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6625185|NCT01299597|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6625186|NCT01299597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6625187|NCT01299662|Poly ICLC|poly iclc|mesh-list
6625188|NCT01299662|Interferon Inducers|interferon inducers|mesh-ancestor
6625189|NCT01299662|Immunologic Factors|immunologic factors|mesh-ancestor
6625190|NCT01299662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625191|NCT01299701|Vadimezan|vadimezan|mesh-list
6625192|NCT01299701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6625193|NCT01299753|Propranolol|propranolol|mesh-list
5479606|NCT05052710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5479607|NCT05052710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479608|NCT05052710|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5479609|NCT05052710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5479610|NCT05052710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6625194|NCT01299753|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5479611|NCT05052710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6625195|NCT01299753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6625196|NCT01299753|Adrenergic Agents|adrenergic agents|mesh-ancestor
6625197|NCT01299753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6625198|NCT01299753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625199|NCT01299753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625200|NCT01299753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6625201|NCT01299753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6625202|NCT01299753|Vasodilator Agents|vasodilator agents|mesh-ancestor
6625203|NCT01299779|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
6625204|NCT01299779|Laxatives|laxatives|mesh-ancestor
6625205|NCT01299779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6625206|NCT01299831|Hormones|hormones|mesh-list
6625207|NCT01299831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6625208|NCT01299831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625209|NCT01299857|Rituximab|rituximab|mesh-list
6625210|NCT01299857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6625211|NCT01299857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6625212|NCT01299857|Immunologic Factors|immunologic factors|mesh-ancestor
6625213|NCT01299857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625214|NCT01299857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6625215|NCT01299922|Cyclosporine|cyclosporine|mesh-list
6625216|NCT01299922|Mycophenolic Acid|mycophenolic acid|mesh-list
6625217|NCT01299922|Cyclosporins|cyclosporins|mesh-list
6625218|NCT01299922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6625219|NCT01299922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625220|NCT01299922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6625221|NCT01299922|Immunologic Factors|immunologic factors|mesh-ancestor
6625222|NCT01299922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625223|NCT01299922|Antifungal Agents|antifungal agents|mesh-ancestor
6625224|NCT01299922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5479612|NCT05052710|Anesthetics, General|anesthetics, general|mesh-ancestor
5479613|NCT05052710|Anesthetics|anesthetics|mesh-ancestor
5479614|NCT05052710|GABA Modulators|gaba modulators|mesh-ancestor
5479615|NCT05052710|GABA Agents|gaba agents|mesh-ancestor
5479616|NCT05052710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5479617|NCT05052710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479618|NCT05051293|Testosterone|testosterone|mesh-list
5479619|NCT05051293|Estrogens|estrogens|mesh-list
5479620|NCT05051293|Androgens|androgens|mesh-ancestor
5479621|NCT05051293|Hormones|hormones|mesh-ancestor
5479622|NCT05051293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5479623|NCT05051293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479624|NCT05047770|Vaccines|vaccines|mesh-list
5479625|NCT05047770|Immunologic Factors|immunologic factors|mesh-ancestor
5479626|NCT05047770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479627|NCT05017584|Bupivacaine|bupivacaine|mesh-list
5479628|NCT05017584|Anesthetics, Local|anesthetics, local|mesh-ancestor
5479629|NCT05017584|Anesthetics|anesthetics|mesh-ancestor
5479630|NCT05017584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5479631|NCT05017584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479632|NCT05017584|Sensory System Agents|sensory system agents|mesh-ancestor
5479633|NCT05017584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5479634|NCT05015439|Cannabidiol|cannabidiol|mesh-list
5479635|NCT05015439|Anticonvulsants|anticonvulsants|mesh-ancestor
5479636|NCT05005897|Vitamin B 12|vitamin b 12|mesh-list
5479637|NCT05005897|Hydroxocobalamin|hydroxocobalamin|mesh-list
5479638|NCT05005897|Vitamins|vitamins|mesh-ancestor
5479639|NCT05005897|Micronutrients|micronutrients|mesh-ancestor
6625225|NCT01299922|Dermatologic Agents|dermatologic agents|mesh-ancestor
6625226|NCT01299922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6625227|NCT01299922|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6625228|NCT01299922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6625229|NCT01299922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5479640|NCT05005897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479641|NCT05005897|Vitamin B Complex|vitamin b complex|mesh-ancestor
5479642|NCT05005897|Hematinics|hematinics|mesh-ancestor
5479643|NCT04976634|Pembrolizumab|pembrolizumab|mesh-list
5479644|NCT04976634|Lenvatinib|lenvatinib|mesh-list
5479645|NCT04976634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5479646|NCT04976634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5479647|NCT04976634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5479648|NCT04976634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5479649|NCT04976634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479650|NCT04960215|Ubiquinone|ubiquinone|mesh-list
5479651|NCT04960215|Coenzyme Q10|coenzyme q10|mesh-list
5479652|NCT04960215|Micronutrients|micronutrients|mesh-ancestor
5479653|NCT04960215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479654|NCT04960215|Vitamins|vitamins|mesh-ancestor
5479655|NCT04881032|Temozolomide|temozolomide|mesh-list
5479656|NCT04881032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6625230|NCT01299922|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6625231|NCT01299922|Antitubercular Agents|antitubercular agents|mesh-ancestor
6625232|NCT01299922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6662200|NCT01502241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6662201|NCT01502241|Alkylating Agents|alkylating agents|mesh-ancestor
6662202|NCT01502241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662203|NCT01502241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6662204|NCT01502267|Rituximab|rituximab|mesh-list
6662205|NCT01502267|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6662206|NCT01502267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6662207|NCT01502267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6662208|NCT01502267|Immunologic Factors|immunologic factors|mesh-ancestor
6662209|NCT01502267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662210|NCT01502267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6662211|NCT01502280|Ascorbic Acid|ascorbic acid|mesh-list
6662212|NCT01502280|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6662213|NCT01502280|Antioxidants|antioxidants|mesh-ancestor
6662214|NCT01502280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662215|NCT01502280|Protective Agents|protective agents|mesh-ancestor
6662216|NCT01502280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662217|NCT01502280|Vitamins|vitamins|mesh-ancestor
6662218|NCT01502280|Micronutrients|micronutrients|mesh-ancestor
6662219|NCT01502280|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6662220|NCT01502280|Dermatologic Agents|dermatologic agents|mesh-ancestor
6662221|NCT01502358|Vaccines|vaccines|mesh-list
6662222|NCT01502358|Immunologic Factors|immunologic factors|mesh-ancestor
6662223|NCT01502358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662224|NCT01502592|Ipilimumab|ipilimumab|mesh-list
6662225|NCT01502592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6662226|NCT01502592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6662227|NCT01502592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6662228|NCT01502592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662229|NCT01502605|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6662230|NCT01502605|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6662231|NCT01502605|Dermatologic Agents|dermatologic agents|mesh-ancestor
6662232|NCT01502696|Interferon alpha-2|interferon alpha-2|mesh-list
6662233|NCT01502696|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6662234|NCT01502696|Antiviral Agents|antiviral agents|mesh-ancestor
6662235|NCT01502696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6662236|NCT01502696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6662237|NCT01502774|Cyclosporine|cyclosporine|mesh-list
6662238|NCT01502774|Cyclosporins|cyclosporins|mesh-list
6662239|NCT01502774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6662240|NCT01502774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662241|NCT01502774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6662242|NCT01502774|Immunologic Factors|immunologic factors|mesh-ancestor
6662243|NCT01502774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662244|NCT01502774|Antifungal Agents|antifungal agents|mesh-ancestor
6662245|NCT01502774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6662246|NCT01502774|Dermatologic Agents|dermatologic agents|mesh-ancestor
6662247|NCT01502774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6662248|NCT01502774|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6662249|NCT01502800|Beta-lapachone|beta-lapachone|mesh-list
6662250|NCT01502800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6662251|NCT01502800|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6662252|NCT01502800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6662253|NCT01502800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6662254|NCT01502800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662255|NCT01502800|Antiviral Agents|antiviral agents|mesh-ancestor
6662256|NCT01502878|Cefpodoxime|cefpodoxime|mesh-list
6662257|NCT01502878|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
6662258|NCT01502878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6662259|NCT01502878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6662260|NCT01502904|Sirolimus|sirolimus|mesh-list
5479657|NCT04881032|Alkylating Agents|alkylating agents|mesh-ancestor
6625233|NCT01299948|Prednisolone|prednisolone|mesh-list
6625234|NCT01299948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6625235|NCT01299948|Glucocorticoids|glucocorticoids|mesh-ancestor
6625236|NCT01299948|Hormones|hormones|mesh-ancestor
6625237|NCT01299948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6625238|NCT01299948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625239|NCT01299948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6625240|NCT01299948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6625241|NCT01300026|N-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine|n-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9h-purin-6-amine|mesh-list
6625242|NCT01300026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6625243|NCT01300026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479658|NCT04881032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479659|NCT04881032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5479660|NCT04849650|Amisulpride|amisulpride|mesh-list
5479661|NCT04849650|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5479662|NCT04849650|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5479663|NCT04849650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5479664|NCT04849650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479665|NCT04849650|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5479666|NCT04849650|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5479667|NCT04849650|Dopamine Agents|dopamine agents|mesh-ancestor
5479668|NCT04849650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5479669|NCT04849650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479670|NCT04849650|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5479671|NCT04849650|Antidepressive Agents|antidepressive agents|mesh-ancestor
5479672|NCT04783376|Insulin|insulin|mesh-list
5479673|NCT04783376|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5479674|NCT04783376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6625244|NCT01300156|Oxaliplatin|oxaliplatin|mesh-list
6625245|NCT01300156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6625246|NCT01300312|Diclofenac|diclofenac|mesh-list
6625247|NCT01300312|Eperisone|eperisone|mesh-list
6625248|NCT01300312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6625249|NCT01300312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6625250|NCT01300312|Analgesics|analgesics|mesh-ancestor
6625251|NCT01300312|Sensory System Agents|sensory system agents|mesh-ancestor
6625252|NCT01300312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5479675|NCT04783376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479676|NCT04775953|Vancomycin|vancomycin|mesh-list
5479677|NCT04775953|Cefazolin|cefazolin|mesh-list
5479678|NCT04775953|Daptomycin|daptomycin|mesh-list
5479679|NCT04775953|Dalbavancin|dalbavancin|mesh-list
5479680|NCT04775953|Oxacillin|oxacillin|mesh-list
5479681|NCT04775953|Nafcillin|nafcillin|mesh-list
5479682|NCT04775953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5479683|NCT04775953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5479684|NCT04765137|Atorvastatin|atorvastatin|mesh-list
5479685|NCT04765137|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5479686|NCT04765137|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5479687|NCT04765137|Antimetabolites|antimetabolites|mesh-ancestor
5479688|NCT04765137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625253|NCT01300312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625254|NCT01300312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6625255|NCT01300312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6625256|NCT01300312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6625257|NCT01300312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6625258|NCT01300312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625259|NCT01300312|Anticonvulsants|anticonvulsants|mesh-ancestor
6625260|NCT01300312|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6625261|NCT01300312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6625262|NCT01300312|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6625263|NCT01300312|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6625264|NCT01300312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6625265|NCT01300312|Parasympatholytics|parasympatholytics|mesh-ancestor
6625266|NCT01300312|Autonomic Agents|autonomic agents|mesh-ancestor
6625267|NCT01300312|Vasodilator Agents|vasodilator agents|mesh-ancestor
6625268|NCT01300364|Citalopram|citalopram|mesh-list
6625269|NCT01300364|Reboxetine|reboxetine|mesh-list
6625270|NCT01300364|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6625271|NCT01300364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6625272|NCT01300364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6625273|NCT01300364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625274|NCT01300364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5479689|NCT04765137|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6625275|NCT01300364|Serotonin Agents|serotonin agents|mesh-ancestor
6625276|NCT01300364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625277|NCT01300364|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6625278|NCT01300364|Antidepressive Agents|antidepressive agents|mesh-ancestor
6625279|NCT01300364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6625280|NCT01300364|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6625281|NCT01300364|Adrenergic Agents|adrenergic agents|mesh-ancestor
6625282|NCT01300377|Lidocaine|lidocaine|mesh-list
6625283|NCT01300377|Bupivacaine|bupivacaine|mesh-list
6625284|NCT01300377|Anesthetics, Local|anesthetics, local|mesh-ancestor
6625285|NCT01300377|Anesthetics|anesthetics|mesh-ancestor
6625286|NCT01300377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6625287|NCT01300377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625288|NCT01300377|Sensory System Agents|sensory system agents|mesh-ancestor
6625289|NCT01300377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6625290|NCT01300377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6625291|NCT01300377|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6625292|NCT01300377|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5479690|NCT04765137|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5479691|NCT04765137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5479692|NCT04721821|Tofacitinib|tofacitinib|mesh-list
6625293|NCT01300377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5479693|NCT04721821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5479694|NCT04721821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5479695|NCT04721821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479696|NCT04721457|Povidone-Iodine|povidone-iodine|mesh-list
5479697|NCT04721457|Listerine|listerine|mesh-list
5479698|NCT04721457|Hydrogen Peroxide|hydrogen peroxide|mesh-list
5479699|NCT04721457|Cetylpyridinium|cetylpyridinium|mesh-list
5479700|NCT04721457|Sodium Hypochlorite|sodium hypochlorite|mesh-list
5479701|NCT04721457|Eusol|eusol|mesh-list
5479702|NCT04721457|Povidone|povidone|mesh-list
5479703|NCT04721457|Sodium Fluoride|sodium fluoride|mesh-list
5479704|NCT04721457|Plasma Substitutes|plasma substitutes|mesh-ancestor
5479705|NCT04721457|Blood Substitutes|blood substitutes|mesh-ancestor
5479706|NCT04721457|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5479707|NCT04721457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5479708|NCT04721457|Cariostatic Agents|cariostatic agents|mesh-ancestor
5479709|NCT04721457|Protective Agents|protective agents|mesh-ancestor
5479710|NCT04721457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479711|NCT04721457|Disinfectants|disinfectants|mesh-ancestor
5479712|NCT04704505|Androgens|androgens|mesh-list
5479713|NCT04704505|Hormones|hormones|mesh-ancestor
5479714|NCT04704505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5502274|NCT04467931|Adrenergic Agents|adrenergic agents|mesh-ancestor
6625294|NCT01300377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625295|NCT01300611|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
6625296|NCT01300611|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6625297|NCT01300611|Vasodilator Agents|vasodilator agents|mesh-ancestor
6625298|NCT01300637|Metformin|metformin|mesh-list
6625299|NCT01300637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6625300|NCT01300637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625301|NCT01300676|Estradiol|estradiol|mesh-list
6625302|NCT01300676|Dydrogesterone|dydrogesterone|mesh-list
6625303|NCT01300676|Estrogens|estrogens|mesh-ancestor
6625304|NCT01300676|Hormones|hormones|mesh-ancestor
6625305|NCT01300676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6625306|NCT01300676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625307|NCT01300676|Progestins|progestins|mesh-ancestor
6625308|NCT01300754|Lidocaine|lidocaine|mesh-list
6625309|NCT01300754|Anesthetics, Local|anesthetics, local|mesh-ancestor
6625310|NCT01300754|Anesthetics|anesthetics|mesh-ancestor
6625311|NCT01300754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6625312|NCT01300754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625313|NCT01300754|Sensory System Agents|sensory system agents|mesh-ancestor
6625314|NCT01300754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6625315|NCT01300754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6625316|NCT01300754|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6625317|NCT01300754|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6625318|NCT01300754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5479715|NCT04704505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479716|NCT04627922|Acetylcysteine|acetylcysteine|mesh-list
5479717|NCT04627922|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5479718|NCT04627922|Antiviral Agents|antiviral agents|mesh-ancestor
5479719|NCT04627922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5479720|NCT04627922|Expectorants|expectorants|mesh-ancestor
5479721|NCT04627922|Respiratory System Agents|respiratory system agents|mesh-ancestor
5479722|NCT04627922|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5479723|NCT04627922|Antioxidants|antioxidants|mesh-ancestor
5479724|NCT04627922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479725|NCT04627922|Protective Agents|protective agents|mesh-ancestor
5479726|NCT04627922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479727|NCT04627922|Antidotes|antidotes|mesh-ancestor
5479728|NCT04601857|Pembrolizumab|pembrolizumab|mesh-list
5479729|NCT04601857|Futibatinib|futibatinib|mesh-list
5479730|NCT04601857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5479731|NCT04601857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5479732|NCT04586920|Itraconazole|itraconazole|mesh-list
5479733|NCT04586920|Midazolam|midazolam|mesh-list
5479734|NCT04586920|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5479735|NCT04586920|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6625319|NCT01300754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625320|NCT01300780|Etoricoxib|etoricoxib|mesh-list
6625321|NCT01300780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6625322|NCT01300780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6625323|NCT01300780|Analgesics|analgesics|mesh-ancestor
6625324|NCT01300780|Sensory System Agents|sensory system agents|mesh-ancestor
6625325|NCT01300780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6625326|NCT01300780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625327|NCT01300780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6625328|NCT01300780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6625329|NCT01300780|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6625330|NCT01300780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6625331|NCT01300780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6625332|NCT01300780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625333|NCT01300793|Rituximab|rituximab|mesh-list
6625334|NCT01300793|Carboplatin|carboplatin|mesh-list
6625335|NCT01300793|Etoposide|etoposide|mesh-list
6625336|NCT01300793|Bortezomib|bortezomib|mesh-list
6625337|NCT01300793|Ifosfamide|ifosfamide|mesh-list
6625338|NCT01300793|Isophosphamide mustard|isophosphamide mustard|mesh-list
6625339|NCT01300793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6625340|NCT01300793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6625341|NCT01300793|Immunologic Factors|immunologic factors|mesh-ancestor
6625342|NCT01300793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625343|NCT01300793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6625344|NCT01300793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6625345|NCT01300793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6625346|NCT01300793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6625347|NCT01300793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6625348|NCT01300793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625349|NCT01300793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6625350|NCT01300793|Alkylating Agents|alkylating agents|mesh-ancestor
5479736|NCT04586920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5479737|NCT04586920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479738|NCT04586920|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5479739|NCT04586920|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5479740|NCT04586920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5479741|NCT04586920|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5479742|NCT04586920|Anesthetics, General|anesthetics, general|mesh-ancestor
6625351|NCT01300962|Capecitabine|capecitabine|mesh-list
6625352|NCT01300962|Trastuzumab|trastuzumab|mesh-list
6625353|NCT01300962|Lapatinib|lapatinib|mesh-list
6625354|NCT01300962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6625355|NCT01300962|Antimetabolites|antimetabolites|mesh-ancestor
6625356|NCT01300962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625357|NCT01300962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6625358|NCT01300962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6625359|NCT01300962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6625360|NCT01300962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6625361|NCT01300988|Aprepitant|aprepitant|mesh-list
6625362|NCT01300988|Fosaprepitant|fosaprepitant|mesh-list
6625363|NCT01300988|Antiemetics|antiemetics|mesh-ancestor
6625364|NCT01300988|Autonomic Agents|autonomic agents|mesh-ancestor
6625365|NCT01300988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6625366|NCT01300988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625367|NCT01300988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6625368|NCT01300988|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6625369|NCT01300988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6625370|NCT01300988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625371|NCT01301040|Cyclophosphamide|cyclophosphamide|mesh-list
6625372|NCT01301040|Docetaxel|docetaxel|mesh-list
6625373|NCT01301040|Epirubicin|epirubicin|mesh-list
6625374|NCT01301040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6625375|NCT01301040|Immunologic Factors|immunologic factors|mesh-ancestor
6625376|NCT01301040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625377|NCT01301040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6625378|NCT01301040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6625379|NCT01301040|Alkylating Agents|alkylating agents|mesh-ancestor
6625380|NCT01301040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625381|NCT01301040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6625382|NCT01301040|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6625383|NCT01301040|Tubulin Modulators|tubulin modulators|mesh-ancestor
6625384|NCT01301040|Antimitotic Agents|antimitotic agents|mesh-ancestor
6625385|NCT01301040|Mitosis Modulators|mitosis modulators|mesh-ancestor
6625386|NCT01301040|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6625387|NCT01301040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6625388|NCT01301040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6625389|NCT01301040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6625390|NCT01301053|Insulin|insulin|mesh-list
6625391|NCT01301053|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6625392|NCT01301053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6625393|NCT01301053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625394|NCT01301222|Octreotide|octreotide|mesh-list
6625395|NCT01301222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6625396|NCT01301222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6625397|NCT01301222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6625398|NCT01301248|Cisplatin|cisplatin|mesh-list
6625399|NCT01301248|Cetuximab|cetuximab|mesh-list
6625400|NCT01301248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5479743|NCT04586920|Anesthetics|anesthetics|mesh-ancestor
5479744|NCT04586920|GABA Modulators|gaba modulators|mesh-ancestor
5479745|NCT04586920|GABA Agents|gaba agents|mesh-ancestor
5479746|NCT04586920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5479747|NCT04586920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479748|NCT04586920|Antifungal Agents|antifungal agents|mesh-ancestor
5479749|NCT04586920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5479750|NCT04586920|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6662261|NCT01502904|Pravastatin|pravastatin|mesh-list
6625401|NCT01301248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6451043|NCT00410631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6451044|NCT00410631|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6020900|NCT00395304|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6020901|NCT00395304|Montelukast|montelukast|mesh-list
6020902|NCT00395304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6625402|NCT01301313|Simendan|simendan|mesh-list
6625403|NCT01301313|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6625404|NCT01301313|Vasodilator Agents|vasodilator agents|mesh-ancestor
6625405|NCT01301313|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6625406|NCT01301313|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6625407|NCT01301313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6625408|NCT01301313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625409|NCT01301313|Protective Agents|protective agents|mesh-ancestor
6625410|NCT01301313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625411|NCT01301469|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6625412|NCT01301586|Doxycycline|doxycycline|mesh-list
6625413|NCT01301586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6625414|NCT01301586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6625415|NCT01301586|Antimalarials|antimalarials|mesh-ancestor
6625416|NCT01301586|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6625417|NCT01301586|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6625418|NCT01301599|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
6625419|NCT01301599|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
6625420|NCT01301599|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6625421|NCT01301599|Adrenergic Agents|adrenergic agents|mesh-ancestor
6625422|NCT01301599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6625423|NCT01301599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625424|NCT01301599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625425|NCT01301599|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6625426|NCT01301599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6625427|NCT01301599|Hormone Antagonists|hormone antagonists|mesh-ancestor
6625428|NCT01301599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6625429|NCT01301612|Cisplatin|cisplatin|mesh-list
5479751|NCT04586920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5479752|NCT04586920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5479753|NCT04586920|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5479754|NCT04586920|Hormone Antagonists|hormone antagonists|mesh-ancestor
5479755|NCT04586920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5479756|NCT04586920|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5479757|NCT04508621|Cyclobenzaprine|cyclobenzaprine|mesh-list
5479758|NCT04508621|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5479759|NCT04508621|Antidepressive Agents|antidepressive agents|mesh-ancestor
5479760|NCT04508621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5479761|NCT04508621|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5479762|NCT04508621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479763|NCT04508621|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5479764|NCT04508621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5479765|NCT04508621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5479766|NCT04508621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5479767|NCT04454905|Apatinib|apatinib|mesh-list
5479768|NCT04454905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6625430|NCT01301612|Nimotuzumab|nimotuzumab|mesh-list
6625431|NCT01301612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6625432|NCT01301612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6625433|NCT01301677|Hydrocortisone|hydrocortisone|mesh-list
6625434|NCT01301677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6625435|NCT01301716|Paclitaxel|paclitaxel|mesh-list
6625436|NCT01301716|Bevacizumab|bevacizumab|mesh-list
5479769|NCT04454905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5479770|NCT04454905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6054333|NCT00602459|Immunologic Factors|immunologic factors|mesh-ancestor
6451045|NCT00410631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6451046|NCT00410631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6451047|NCT00410631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6451048|NCT00410631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6451049|NCT00410631|Tubulin Modulators|tubulin modulators|mesh-ancestor
6451050|NCT00410631|Antimitotic Agents|antimitotic agents|mesh-ancestor
6451051|NCT00410631|Mitosis Modulators|mitosis modulators|mesh-ancestor
6451052|NCT00410631|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6451053|NCT00410631|Dermatologic Agents|dermatologic agents|mesh-ancestor
6451054|NCT00410631|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6625437|NCT01301716|Carboplatin|carboplatin|mesh-list
5503627|NCT04457219|Coagulants|coagulants|mesh-ancestor
6625438|NCT01301716|Pemetrexed|pemetrexed|mesh-list
6625439|NCT01301716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6625440|NCT01301716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6625441|NCT01301716|Tubulin Modulators|tubulin modulators|mesh-ancestor
6625442|NCT01301716|Antimitotic Agents|antimitotic agents|mesh-ancestor
6625443|NCT01301716|Mitosis Modulators|mitosis modulators|mesh-ancestor
6625444|NCT01301716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625445|NCT01301716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6625446|NCT01301716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6625447|NCT01301716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6625448|NCT01301716|Growth Substances|growth substances|mesh-ancestor
6625449|NCT01301716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625450|NCT01301716|Growth Inhibitors|growth inhibitors|mesh-ancestor
6625451|NCT01301716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6625452|NCT01301716|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6625453|NCT01301716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6662262|NCT01502904|Pitavastatin|pitavastatin|mesh-list
6662263|NCT01502904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6662264|NCT01502904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6662265|NCT01502904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6662266|NCT01502904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6662267|NCT01502904|Antifungal Agents|antifungal agents|mesh-ancestor
6662268|NCT01502904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6662269|NCT01502904|Immunologic Factors|immunologic factors|mesh-ancestor
6662270|NCT01502904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662271|NCT01502904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6662272|NCT01502904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6662273|NCT01502904|Antimetabolites|antimetabolites|mesh-ancestor
6662274|NCT01502904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662275|NCT01502904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6662276|NCT01502904|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6662277|NCT01502904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6662278|NCT01502943|Aspirin|aspirin|mesh-list
6662279|NCT01502943|Atorvastatin|atorvastatin|mesh-list
6662280|NCT01502943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662281|NCT01502943|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6662282|NCT01502943|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6662283|NCT01502943|Analgesics|analgesics|mesh-ancestor
6662284|NCT01502943|Sensory System Agents|sensory system agents|mesh-ancestor
6662285|NCT01502943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6662286|NCT01502943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6662287|NCT01502943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6662288|NCT01502943|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6662289|NCT01502943|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6662290|NCT01502943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662291|NCT01502943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6662292|NCT01502943|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6662293|NCT01502943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6662294|NCT01502943|Antipyretics|antipyretics|mesh-ancestor
6662295|NCT01502943|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6662296|NCT01502943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6662297|NCT01502943|Antimetabolites|antimetabolites|mesh-ancestor
6662298|NCT01502943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6662299|NCT01502943|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6662300|NCT01503008|Metformin|metformin|mesh-list
6662301|NCT01503008|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
6662302|NCT01503008|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6662303|NCT01503008|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
6662304|NCT01503008|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
6662305|NCT01503008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662306|NCT01503008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6662307|NCT01503008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662308|NCT01503008|Protease Inhibitors|protease inhibitors|mesh-ancestor
6662309|NCT01503060|Lidocaine|lidocaine|mesh-list
6662310|NCT01503060|Anesthetics, Local|anesthetics, local|mesh-ancestor
6662311|NCT01503060|Anesthetics|anesthetics|mesh-ancestor
6662312|NCT01503060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6662313|NCT01503060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662314|NCT01503060|Sensory System Agents|sensory system agents|mesh-ancestor
6662315|NCT01503060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6662316|NCT01503060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6662317|NCT01503060|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6020903|NCT00395304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6625454|NCT01301807|Panobinostat|panobinostat|mesh-list
6625455|NCT01301807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6625456|NCT01301807|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6625457|NCT01301807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6625458|NCT01301807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625459|NCT01301820|Lenalidomide|lenalidomide|mesh-list
6625460|NCT01301820|Azacitidine|azacitidine|mesh-list
6625461|NCT01301820|Immunologic Factors|immunologic factors|mesh-ancestor
6625462|NCT01301820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625463|NCT01301820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6625464|NCT01301820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6625465|NCT01301820|Growth Substances|growth substances|mesh-ancestor
6625466|NCT01301820|Growth Inhibitors|growth inhibitors|mesh-ancestor
6625467|NCT01301820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6625468|NCT01301820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6625469|NCT01301820|Antimetabolites|antimetabolites|mesh-ancestor
6625470|NCT01301820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625471|NCT01301820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6625472|NCT01301924|Meglumine Antimoniate|meglumine antimoniate|mesh-list
6625473|NCT01301924|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6625474|NCT01301924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6625475|NCT01301924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6625476|NCT01301937|Meglumine Antimoniate|meglumine antimoniate|mesh-list
6625477|NCT01301937|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6625478|NCT01301937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6625479|NCT01301937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6625480|NCT01302002|Metformin|metformin|mesh-list
6625481|NCT01302002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6020904|NCT00395304|Autonomic Agents|autonomic agents|mesh-ancestor
6020905|NCT00395304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6020906|NCT00395304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451055|NCT00410644|Hydromorphone|hydromorphone|mesh-list
6451056|NCT00410644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6451057|NCT00410644|Narcotics|narcotics|mesh-ancestor
6451058|NCT00410644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6451059|NCT00410644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451060|NCT00410644|Analgesics|analgesics|mesh-ancestor
6451061|NCT00410644|Sensory System Agents|sensory system agents|mesh-ancestor
6451062|NCT00410644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6451063|NCT00410657|Prednisone|prednisone|mesh-list
6451064|NCT00410657|Methylprednisolone|methylprednisolone|mesh-list
6451065|NCT00410657|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6451066|NCT00410657|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6451067|NCT00410657|Prednisolone|prednisolone|mesh-list
6451068|NCT00410657|Prednisolone acetate|prednisolone acetate|mesh-list
6451069|NCT00410657|Alemtuzumab|alemtuzumab|mesh-list
6451070|NCT00410657|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6451071|NCT00410657|Prednisolone phosphate|prednisolone phosphate|mesh-list
6451072|NCT00410657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6451073|NCT00410657|Glucocorticoids|glucocorticoids|mesh-ancestor
6451074|NCT00410657|Hormones|hormones|mesh-ancestor
6451075|NCT00410657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6451076|NCT00410657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451077|NCT00410657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6451078|NCT00410657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6451079|NCT00410657|Antiemetics|antiemetics|mesh-ancestor
6451080|NCT00410657|Autonomic Agents|autonomic agents|mesh-ancestor
6451081|NCT00410657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6451082|NCT00410657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6451083|NCT00410657|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6625482|NCT01302002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625483|NCT01302028|Ipragliflozin|ipragliflozin|mesh-list
6625484|NCT01302028|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6625485|NCT01302028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625486|NCT01302028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6625487|NCT01302028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625488|NCT01302093|Racecadotril|racecadotril|mesh-list
6625489|NCT01302093|Thiorphan|thiorphan|mesh-list
6625490|NCT01302093|Antidiarrheals|antidiarrheals|mesh-ancestor
6625491|NCT01302093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6625492|NCT01302093|Protease Inhibitors|protease inhibitors|mesh-ancestor
6625493|NCT01302093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6625494|NCT01302093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625495|NCT01302106|Clofarabine|clofarabine|mesh-list
6625496|NCT01302106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6625497|NCT01302106|Antimetabolites|antimetabolites|mesh-ancestor
6625498|NCT01302106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625499|NCT01302106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6625500|NCT01302132|Ipragliflozin|ipragliflozin|mesh-list
6625501|NCT01302132|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6625502|NCT01302132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625503|NCT01302132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6625504|NCT01302132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625505|NCT01302145|Metformin|metformin|mesh-list
6625506|NCT01302145|Ipragliflozin|ipragliflozin|mesh-list
6625507|NCT01302145|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6625508|NCT01302145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625509|NCT01302145|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6625510|NCT01302145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625511|NCT01302158|Glimepiride|glimepiride|mesh-list
6625512|NCT01302158|Ipragliflozin|ipragliflozin|mesh-list
6625513|NCT01302158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6625514|NCT01302158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6625515|NCT01302158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625516|NCT01302158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6625517|NCT01302158|Immunologic Factors|immunologic factors|mesh-ancestor
6625518|NCT01302158|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6625519|NCT01302158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625520|NCT01302171|Sargramostim|sargramostim|mesh-list
6625521|NCT01302171|Lenograstim|lenograstim|mesh-list
6625522|NCT01302171|Immunologic Factors|immunologic factors|mesh-ancestor
6625523|NCT01302171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625524|NCT01302171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6625525|NCT01302210|Mupirocin|mupirocin|mesh-list
6625526|NCT01302210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6625527|NCT01302210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6625528|NCT01302210|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6625529|NCT01302210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6625530|NCT01302210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625531|NCT01302236|Eplerenone|eplerenone|mesh-list
6625532|NCT01302236|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6625533|NCT01302236|Hormone Antagonists|hormone antagonists|mesh-ancestor
6625534|NCT01302236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6625535|NCT01302236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625536|NCT01302236|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6625537|NCT01302236|Diuretics|diuretics|mesh-ancestor
6625538|NCT01302236|Natriuretic Agents|natriuretic agents|mesh-ancestor
6625539|NCT01302236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6625540|NCT01302275|Oxcarbazepine|oxcarbazepine|mesh-list
6625541|NCT01302275|Anticonvulsants|anticonvulsants|mesh-ancestor
6625542|NCT01302275|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6625543|NCT01302275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6625544|NCT01302275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5479771|NCT04454905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479772|NCT04418167|Dabrafenib|dabrafenib|mesh-list
5479773|NCT04418167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5479774|NCT04418167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5479775|NCT04418167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5479776|NCT04418167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502275|NCT04467931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5502276|NCT04467931|Sympatholytics|sympatholytics|mesh-ancestor
5502277|NCT04467931|Autonomic Agents|autonomic agents|mesh-ancestor
5502278|NCT04467931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5502279|NCT04467931|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5502280|NCT04467931|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5502281|NCT04467931|Analgesics|analgesics|mesh-ancestor
5502282|NCT04467931|Sensory System Agents|sensory system agents|mesh-ancestor
5502283|NCT04467931|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5502284|NCT04467931|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5502285|NCT04467931|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5502286|NCT04467931|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5502287|NCT04467931|Hormone Antagonists|hormone antagonists|mesh-ancestor
5502288|NCT04467931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5502289|NCT04467931|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5502290|NCT04467931|Antioxidants|antioxidants|mesh-ancestor
5502291|NCT04467931|Protective Agents|protective agents|mesh-ancestor
5502292|NCT04467931|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5502293|NCT04467931|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5502294|NCT04467931|Protease Inhibitors|protease inhibitors|mesh-ancestor
5502295|NCT04467931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5502296|NCT04467931|Tocolytic Agents|tocolytic agents|mesh-ancestor
5502297|NCT04467931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5502298|NCT04467931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5502299|NCT04467931|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5502300|NCT04467931|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5502301|NCT04467931|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
5502302|NCT04467931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5502303|NCT04467931|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
6625545|NCT01302275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625546|NCT01302275|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6625547|NCT01302275|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6625548|NCT01302327|Exenatide|exenatide|mesh-list
6625549|NCT01302327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6625550|NCT01302327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625551|NCT01302327|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6625552|NCT01302327|Incretins|incretins|mesh-ancestor
6625553|NCT01302327|Hormones|hormones|mesh-ancestor
6625554|NCT01302327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6625555|NCT01302340|Dronabinol|dronabinol|mesh-list
6625556|NCT01302340|Hallucinogens|hallucinogens|mesh-ancestor
6625557|NCT01302340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625558|NCT01302340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6625559|NCT01302340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6625560|NCT01302340|Analgesics|analgesics|mesh-ancestor
6625561|NCT01302340|Sensory System Agents|sensory system agents|mesh-ancestor
6625562|NCT01302340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6625563|NCT01302340|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6625564|NCT01302340|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6625565|NCT01302340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6625566|NCT01302340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625567|NCT01302340|Hormones|hormones|mesh-ancestor
6662318|NCT01503060|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6625568|NCT01302340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6625569|NCT01302353|Isoflurane|isoflurane|mesh-list
6625570|NCT01302353|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6625571|NCT01302353|Anesthetics, General|anesthetics, general|mesh-ancestor
6625572|NCT01302353|Anesthetics|anesthetics|mesh-ancestor
6625573|NCT01302353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6625574|NCT01302353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625575|NCT01302496|Ipilimumab|ipilimumab|mesh-list
6625576|NCT01302496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6625577|NCT01302496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6625578|NCT01302496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6625579|NCT01302496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625580|NCT01302587|Albuterol|albuterol|mesh-list
6625581|NCT01302587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6625582|NCT01302587|Autonomic Agents|autonomic agents|mesh-ancestor
6625583|NCT01302587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6625584|NCT01302587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625585|NCT01302587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6625586|NCT01302587|Respiratory System Agents|respiratory system agents|mesh-ancestor
6625587|NCT01302587|Tocolytic Agents|tocolytic agents|mesh-ancestor
6625588|NCT01302587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6625589|NCT01302587|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6625590|NCT01302587|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6625591|NCT01302587|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6625592|NCT01302587|Adrenergic Agents|adrenergic agents|mesh-ancestor
6625593|NCT01302587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6625594|NCT01302587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625595|NCT01302613|Leucovorin|leucovorin|mesh-list
6625596|NCT01302613|Capecitabine|capecitabine|mesh-list
6625597|NCT01302613|Oxaliplatin|oxaliplatin|mesh-list
6625598|NCT01302613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6625599|NCT01302613|Antimetabolites|antimetabolites|mesh-ancestor
6625600|NCT01302613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625601|NCT01302613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6625602|NCT01302613|Antidotes|antidotes|mesh-ancestor
6625603|NCT01302613|Protective Agents|protective agents|mesh-ancestor
6625604|NCT01302613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625605|NCT01302613|Vitamin B Complex|vitamin b complex|mesh-ancestor
6625606|NCT01302613|Vitamins|vitamins|mesh-ancestor
6625607|NCT01302613|Micronutrients|micronutrients|mesh-ancestor
6625608|NCT01302756|Folic Acid|folic acid|mesh-list
6625609|NCT01302756|Hematinics|hematinics|mesh-ancestor
6451084|NCT00410657|Protective Agents|protective agents|mesh-ancestor
6451085|NCT00410657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6451086|NCT00410696|Lenograstim|lenograstim|mesh-list
6451087|NCT00410696|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6451088|NCT00410696|Immunologic Factors|immunologic factors|mesh-ancestor
6451089|NCT00410696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451090|NCT00410735|Pranlukast|pranlukast|mesh-list
6451091|NCT00410735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6451092|NCT00410735|Respiratory System Agents|respiratory system agents|mesh-ancestor
6451093|NCT00410735|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6451094|NCT00410735|Hormone Antagonists|hormone antagonists|mesh-ancestor
5479777|NCT04331717|Leuprolide|leuprolide|mesh-list
5479778|NCT04331717|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5479779|NCT04331717|Fertility Agents|fertility agents|mesh-ancestor
5479780|NCT04331717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5479781|NCT04331717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461874|NCT00456560|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6625610|NCT01302756|Vitamin B Complex|vitamin b complex|mesh-ancestor
6625611|NCT01302756|Vitamins|vitamins|mesh-ancestor
6625612|NCT01302756|Micronutrients|micronutrients|mesh-ancestor
6625613|NCT01302756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625614|NCT01302821|Tryptophan|tryptophan|mesh-list
6625615|NCT01302821|Vaccines|vaccines|mesh-list
6451095|NCT00410735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6451096|NCT00410735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625616|NCT01302821|Immunologic Factors|immunologic factors|mesh-ancestor
6625617|NCT01302821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625618|NCT01302821|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6625619|NCT01302821|Antidepressive Agents|antidepressive agents|mesh-ancestor
6625620|NCT01302821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6625621|NCT01302847|Dolutegravir|dolutegravir|mesh-list
6625622|NCT01302847|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6625623|NCT01302847|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6625624|NCT01302847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6625625|NCT01302847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451097|NCT00410748|Hydromorphone|hydromorphone|mesh-list
6451098|NCT00410748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6451099|NCT00410748|Narcotics|narcotics|mesh-ancestor
6451100|NCT00410748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6451101|NCT00410748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451102|NCT00410748|Analgesics|analgesics|mesh-ancestor
6451103|NCT00410748|Sensory System Agents|sensory system agents|mesh-ancestor
6451104|NCT00410748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6451105|NCT00410774|Gemcitabine|gemcitabine|mesh-list
6451106|NCT00410774|Bevacizumab|bevacizumab|mesh-list
6625626|NCT01302847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6625627|NCT01302847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6625628|NCT01302847|Antiviral Agents|antiviral agents|mesh-ancestor
6625629|NCT01302847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6625630|NCT01302951|Moxifloxacin|moxifloxacin|mesh-list
6625631|NCT01302951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6625632|NCT01302951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6625633|NCT01302951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6625634|NCT01302951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6625635|NCT01302951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5479782|NCT04331717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5479783|NCT04331717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5479784|NCT04309409|Nivolumab|nivolumab|mesh-list
5479785|NCT04309409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5479786|NCT04309409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5479787|NCT04309409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6625636|NCT01302951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625637|NCT01302951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6625638|NCT01303029|Gemcitabine|gemcitabine|mesh-list
6625639|NCT01303029|Capecitabine|capecitabine|mesh-list
6625640|NCT01303029|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6625641|NCT01303029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6625642|NCT01303029|Antimetabolites|antimetabolites|mesh-ancestor
6625643|NCT01303029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625644|NCT01303029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6625645|NCT01303029|Antiviral Agents|antiviral agents|mesh-ancestor
6625646|NCT01303029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6625647|NCT01303029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6625648|NCT01303029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5479788|NCT04309409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479789|NCT04285684|Ketamine|ketamine|mesh-list
5479790|NCT04285684|Analgesics|analgesics|mesh-ancestor
5479791|NCT04285684|Sensory System Agents|sensory system agents|mesh-ancestor
5479792|NCT04285684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5479793|NCT04285684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479794|NCT04285684|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5479795|NCT04285684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5479796|NCT04285684|Anesthetics, General|anesthetics, general|mesh-ancestor
5479797|NCT04285684|Anesthetics|anesthetics|mesh-ancestor
6625649|NCT01303029|Immunologic Factors|immunologic factors|mesh-ancestor
6625650|NCT01303029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625651|NCT01303029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6625652|NCT01303042|Insulin Lispro|insulin lispro|mesh-list
6625653|NCT01303042|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
5479798|NCT04285684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5479799|NCT04285684|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5479800|NCT04285684|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5479801|NCT04285684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5479802|NCT04285684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479803|NCT04144023|Molgramostim|molgramostim|mesh-list
5479804|NCT04144023|Vaccines|vaccines|mesh-list
6451107|NCT00410774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6625654|NCT01303042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6625655|NCT01303042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625656|NCT01303055|Metformin|metformin|mesh-list
6625657|NCT01303055|Alogliptin|alogliptin|mesh-list
6625658|NCT01303055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6625659|NCT01303055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625660|NCT01303055|Incretins|incretins|mesh-ancestor
6625661|NCT01303055|Hormones|hormones|mesh-ancestor
6625662|NCT01303055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6625663|NCT01303055|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6625664|NCT01303055|Protease Inhibitors|protease inhibitors|mesh-ancestor
6625665|NCT01303055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6625666|NCT01303055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625667|NCT01303094|Trabectedin|trabectedin|mesh-list
6625668|NCT01303094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6625669|NCT01303094|Alkylating Agents|alkylating agents|mesh-ancestor
6625670|NCT01303094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625671|NCT01303094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6625672|NCT01303107|Bupivacaine|bupivacaine|mesh-list
5479805|NCT04144023|Sargramostim|sargramostim|mesh-list
5479806|NCT04144023|Immunologic Factors|immunologic factors|mesh-ancestor
5479807|NCT04144023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479808|NCT04144023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5479809|NCT04079218|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5479810|NCT04079218|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5479811|NCT04079218|Estradiol|estradiol|mesh-list
5479812|NCT04079218|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5479813|NCT04079218|Estrogens|estrogens|mesh-ancestor
5479814|NCT04079218|Hormones|hormones|mesh-ancestor
6625673|NCT01303107|Anesthetics, Local|anesthetics, local|mesh-ancestor
6625674|NCT01303107|Anesthetics|anesthetics|mesh-ancestor
6625675|NCT01303107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6625676|NCT01303107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625677|NCT01303107|Sensory System Agents|sensory system agents|mesh-ancestor
6625678|NCT01303107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6625679|NCT01303237|Cetuximab|cetuximab|mesh-list
6625680|NCT01303237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6625681|NCT01303237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6625682|NCT01303250|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
6625683|NCT01303250|Plasma Substitutes|plasma substitutes|mesh-ancestor
6625684|NCT01303250|Blood Substitutes|blood substitutes|mesh-ancestor
6625685|NCT01303471|Remifentanil|remifentanil|mesh-list
6625686|NCT01303471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6625687|NCT01303471|Narcotics|narcotics|mesh-ancestor
6625688|NCT01303471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6625689|NCT01303471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625690|NCT01303471|Analgesics|analgesics|mesh-ancestor
5479815|NCT04079218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5479816|NCT04079218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479817|NCT04079218|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6625691|NCT01303471|Sensory System Agents|sensory system agents|mesh-ancestor
6625692|NCT01303471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6625693|NCT01303497|Paclitaxel|paclitaxel|mesh-list
6625694|NCT01303497|Bevacizumab|bevacizumab|mesh-list
6625695|NCT01303497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6625696|NCT01303497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6625697|NCT01303497|Tubulin Modulators|tubulin modulators|mesh-ancestor
6625698|NCT01303497|Antimitotic Agents|antimitotic agents|mesh-ancestor
6625699|NCT01303497|Mitosis Modulators|mitosis modulators|mesh-ancestor
6625700|NCT01303497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625701|NCT01303497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6625702|NCT01303497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6625703|NCT01303497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6625704|NCT01303497|Growth Substances|growth substances|mesh-ancestor
6625705|NCT01303497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625706|NCT01303497|Growth Inhibitors|growth inhibitors|mesh-ancestor
6625707|NCT01303536|Ondansetron|ondansetron|mesh-list
6625708|NCT01303536|Antiemetics|antiemetics|mesh-ancestor
6625709|NCT01303536|Autonomic Agents|autonomic agents|mesh-ancestor
6625710|NCT01303536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6625711|NCT01303536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625712|NCT01303536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6625713|NCT01303536|Antipruritics|antipruritics|mesh-ancestor
6625714|NCT01303536|Dermatologic Agents|dermatologic agents|mesh-ancestor
6625715|NCT01303536|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6625716|NCT01303536|Serotonin Agents|serotonin agents|mesh-ancestor
6625717|NCT01303536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6625718|NCT01303536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625719|NCT01303536|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6625720|NCT01303536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6625721|NCT01303536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6625722|NCT01303536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6625723|NCT01303536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6625724|NCT01303549|Amphotericin B|amphotericin b|mesh-list
6625725|NCT01303549|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
5479818|NCT04079218|Contraceptive Agents|contraceptive agents|mesh-ancestor
5479819|NCT04079218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5479820|NCT04079218|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5479821|NCT04078152|Durvalumab|durvalumab|mesh-list
5479822|NCT04078152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5479823|NCT04078152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5479824|NCT04026009|Vaccines|vaccines|mesh-list
5479825|NCT04026009|Immunologic Factors|immunologic factors|mesh-ancestor
5479826|NCT04026009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479827|NCT04013555|Acetylcysteine|acetylcysteine|mesh-list
5479828|NCT04013555|Tryptophan|tryptophan|mesh-list
5479829|NCT04013555|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5479830|NCT04013555|Antiviral Agents|antiviral agents|mesh-ancestor
5479831|NCT04013555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5479832|NCT04013555|Expectorants|expectorants|mesh-ancestor
5479833|NCT04013555|Respiratory System Agents|respiratory system agents|mesh-ancestor
5479834|NCT04013555|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5479835|NCT04013555|Antioxidants|antioxidants|mesh-ancestor
5479836|NCT04013555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479837|NCT04013555|Protective Agents|protective agents|mesh-ancestor
5479838|NCT04013555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625726|NCT01303549|Anidulafungin|anidulafungin|mesh-list
6625727|NCT01303549|Amebicides|amebicides|mesh-ancestor
6625728|NCT01303549|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6625729|NCT01303549|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6625730|NCT01303549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6625731|NCT01303549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6625732|NCT01303549|Antifungal Agents|antifungal agents|mesh-ancestor
6662319|NCT01503060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6662320|NCT01503060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662321|NCT01503216|Vitamin D|vitamin d|mesh-list
6662322|NCT01503216|Cholecalciferol|cholecalciferol|mesh-list
6662323|NCT01503216|Ergocalciferols|ergocalciferols|mesh-list
6662324|NCT01503216|Vitamins|vitamins|mesh-ancestor
6662325|NCT01503216|Micronutrients|micronutrients|mesh-ancestor
6662326|NCT01503216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662327|NCT01503216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6662328|NCT01503216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6662329|NCT01503242|Cyclosporine|cyclosporine|mesh-list
6662330|NCT01503242|Mycophenolic Acid|mycophenolic acid|mesh-list
6662331|NCT01503242|Fludarabine|fludarabine|mesh-list
5479839|NCT04013555|Antidotes|antidotes|mesh-ancestor
6662332|NCT01503242|Fludarabine phosphate|fludarabine phosphate|mesh-list
6625733|NCT01303601|Olanzapine|olanzapine|mesh-list
6625734|NCT01303601|Antiemetics|antiemetics|mesh-ancestor
6625735|NCT01303601|Autonomic Agents|autonomic agents|mesh-ancestor
6625736|NCT01303601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6625737|NCT01303601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625738|NCT01303601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6625739|NCT01303601|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6625740|NCT01303601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6625741|NCT01303601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6625742|NCT01303601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6625743|NCT01303601|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6625744|NCT01303601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6625745|NCT01303601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6625746|NCT01303601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479840|NCT04013555|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5479841|NCT04013555|Antidepressive Agents|antidepressive agents|mesh-ancestor
5479842|NCT04013555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5479843|NCT03994172|Calcium, Dietary|calcium, dietary|mesh-list
5479844|NCT03994172|Vitamin D|vitamin d|mesh-list
5479845|NCT03994172|Cholecalciferol|cholecalciferol|mesh-list
5479846|NCT03994172|Teriparatide|teriparatide|mesh-list
5479847|NCT03994172|Citric Acid|citric acid|mesh-list
5479848|NCT03994172|Sodium Citrate|sodium citrate|mesh-list
6625747|NCT01303601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6625748|NCT01303601|Serotonin Agents|serotonin agents|mesh-ancestor
6625749|NCT01303614|Lidocaine|lidocaine|mesh-list
5479849|NCT03994172|Calcium|calcium|mesh-list
5479850|NCT03994172|Parathyroid Hormone|parathyroid hormone|mesh-list
5479851|NCT03994172|Cinacalcet|cinacalcet|mesh-list
5479852|NCT03994172|Hormones|hormones|mesh-list
5479853|NCT03994172|Vitamins|vitamins|mesh-ancestor
5479854|NCT03994172|Micronutrients|micronutrients|mesh-ancestor
5479855|NCT03994172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479856|NCT03994172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5479857|NCT03994172|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5479858|NCT03994172|Anticoagulants|anticoagulants|mesh-ancestor
5479859|NCT03994172|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5479860|NCT03994172|Chelating Agents|chelating agents|mesh-ancestor
6625750|NCT01303614|Prilocaine|prilocaine|mesh-list
6625751|NCT01303614|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
6625752|NCT01303614|Anesthetics, Local|anesthetics, local|mesh-ancestor
6625753|NCT01303614|Anesthetics|anesthetics|mesh-ancestor
6625754|NCT01303614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6625755|NCT01303614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625756|NCT01303614|Sensory System Agents|sensory system agents|mesh-ancestor
6625757|NCT01303614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6625758|NCT01303614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6625759|NCT01303614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6625760|NCT01303614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6625761|NCT01303614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6625762|NCT01303614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625763|NCT01303614|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
6625764|NCT01303640|Everolimus|everolimus|mesh-list
6625765|NCT01303640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6625766|NCT01303640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6625767|NCT01303640|Immunologic Factors|immunologic factors|mesh-ancestor
6625768|NCT01303640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625769|NCT01303679|Paclitaxel|paclitaxel|mesh-list
6625770|NCT01303679|Bevacizumab|bevacizumab|mesh-list
6625771|NCT01303679|Exemestane|exemestane|mesh-list
6625772|NCT01303679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6625773|NCT01303679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6625774|NCT01303679|Tubulin Modulators|tubulin modulators|mesh-ancestor
6625775|NCT01303679|Antimitotic Agents|antimitotic agents|mesh-ancestor
6625776|NCT01303679|Mitosis Modulators|mitosis modulators|mesh-ancestor
6625777|NCT01303679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625778|NCT01303679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6625779|NCT01303679|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6625780|NCT01303679|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6625781|NCT01303679|Growth Substances|growth substances|mesh-ancestor
6625782|NCT01303679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625783|NCT01303679|Growth Inhibitors|growth inhibitors|mesh-ancestor
5479861|NCT03994172|Sequestering Agents|sequestering agents|mesh-ancestor
5479862|NCT03994172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479863|NCT03994172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6625784|NCT01303679|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6625785|NCT01303679|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6625786|NCT01303679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6625787|NCT01303679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6625788|NCT01303679|Hormone Antagonists|hormone antagonists|mesh-ancestor
6625789|NCT01303679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6625790|NCT01303705|Cyclophosphamide|cyclophosphamide|mesh-list
6625791|NCT01303705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6625792|NCT01303705|Immunologic Factors|immunologic factors|mesh-ancestor
6625793|NCT01303705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625794|NCT01303705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6625795|NCT01303705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6625796|NCT01303705|Alkylating Agents|alkylating agents|mesh-ancestor
6625797|NCT01303705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625798|NCT01303705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6625799|NCT01303705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6625800|NCT01303731|Fentanyl|fentanyl|mesh-list
6625801|NCT01303731|Bupivacaine|bupivacaine|mesh-list
6625802|NCT01303731|Anesthetics, Local|anesthetics, local|mesh-ancestor
6625803|NCT01303731|Anesthetics|anesthetics|mesh-ancestor
6625804|NCT01303731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6625805|NCT01303731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625806|NCT01303731|Sensory System Agents|sensory system agents|mesh-ancestor
6625807|NCT01303731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6625808|NCT01303731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5479864|NCT03994172|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
5479865|NCT03994172|Hormone Antagonists|hormone antagonists|mesh-ancestor
5479866|NCT03924947|Pancrelipase|pancrelipase|mesh-list
5479867|NCT03924947|Pancreatin|pancreatin|mesh-list
5479868|NCT03924947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5479869|NCT03919435|Trimethoprim|trimethoprim|mesh-list
5479870|NCT03919435|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
5479871|NCT03919435|Sulfamethoxazole|sulfamethoxazole|mesh-list
5479872|NCT03919435|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5479873|NCT03919435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5479874|NCT03919435|Renal Agents|renal agents|mesh-ancestor
5479875|NCT03919435|Antimalarials|antimalarials|mesh-ancestor
5479876|NCT03919435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5479877|NCT03919435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5479878|NCT03919435|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5479879|NCT03919435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6625809|NCT01303731|Narcotics|narcotics|mesh-ancestor
6625810|NCT01303731|Analgesics|analgesics|mesh-ancestor
6625811|NCT01303731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6625812|NCT01303731|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6625813|NCT01303731|Anesthetics, General|anesthetics, general|mesh-ancestor
6625814|NCT01303796|Decitabine|decitabine|mesh-list
6625815|NCT01303796|Sapacitabine|sapacitabine|mesh-list
6625816|NCT01303796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5479880|NCT03919435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625817|NCT01303796|Antimetabolites|antimetabolites|mesh-ancestor
6625818|NCT01303796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625819|NCT01303796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6625820|NCT01303796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6625821|NCT01303874|Etanercept|etanercept|mesh-list
6625822|NCT01303874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6625823|NCT01303874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6625824|NCT01303874|Analgesics|analgesics|mesh-ancestor
6625825|NCT01303874|Sensory System Agents|sensory system agents|mesh-ancestor
6625826|NCT01303874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6625827|NCT01303874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479881|NCT03919435|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5479882|NCT03919435|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
5479883|NCT03919435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5479884|NCT03919435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5479885|NCT03887936|Testosterone|testosterone|mesh-list
5479886|NCT03887936|Androgens|androgens|mesh-ancestor
5479887|NCT03887936|Hormones|hormones|mesh-ancestor
5479888|NCT03887936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5479889|NCT03887936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479890|NCT03884439|Infliximab|infliximab|mesh-list
5479891|NCT03884439|Dermatologic Agents|dermatologic agents|mesh-ancestor
5479892|NCT03884439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6625828|NCT01303874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6625829|NCT01303874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5479893|NCT03884439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5479894|NCT03831711|Gastrin-Releasing Peptide|gastrin-releasing peptide|mesh-list
5479895|NCT03831711|Bombesin|bombesin|mesh-list
5479896|NCT03831711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479897|NCT03831711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5479898|NCT03831711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479899|NCT03831711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5479900|NCT03829462|Irinotecan|irinotecan|mesh-list
5479901|NCT03829462|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5479902|NCT03829462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5479903|NCT03829462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6020907|NCT00395304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6020908|NCT00395304|Respiratory System Agents|respiratory system agents|mesh-ancestor
6451108|NCT00410774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6451109|NCT00410774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6451110|NCT00410774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6451111|NCT00410774|Growth Substances|growth substances|mesh-ancestor
6451112|NCT00410774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451113|NCT00410774|Growth Inhibitors|growth inhibitors|mesh-ancestor
6451114|NCT00410774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6451115|NCT00410774|Antimetabolites|antimetabolites|mesh-ancestor
6451116|NCT00410774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451117|NCT00410774|Antiviral Agents|antiviral agents|mesh-ancestor
6451118|NCT00410774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6451119|NCT00410774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6451120|NCT00410774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6451121|NCT00410774|Immunologic Factors|immunologic factors|mesh-ancestor
6451122|NCT00410787|Hydromorphone|hydromorphone|mesh-list
5502304|NCT04467931|Sympathomimetics|sympathomimetics|mesh-ancestor
6625830|NCT01303874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6625831|NCT01303874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6625832|NCT01303874|Immunologic Factors|immunologic factors|mesh-ancestor
6625833|NCT01303887|Prednisolone|prednisolone|mesh-list
6625834|NCT01303887|Cyclophosphamide|cyclophosphamide|mesh-list
6625835|NCT01303887|Rituximab|rituximab|mesh-list
6625836|NCT01303887|Fludarabine|fludarabine|mesh-list
6625837|NCT01303887|Vincristine|vincristine|mesh-list
6625838|NCT01303887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6625839|NCT01303887|Immunologic Factors|immunologic factors|mesh-ancestor
6625840|NCT01303887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625841|NCT01303887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6625842|NCT01303887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6625843|NCT01303887|Alkylating Agents|alkylating agents|mesh-ancestor
6625844|NCT01303887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625845|NCT01303887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6625846|NCT01303887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6625847|NCT01303887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6625848|NCT01303887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6625849|NCT01303887|Tubulin Modulators|tubulin modulators|mesh-ancestor
6625850|NCT01303887|Antimitotic Agents|antimitotic agents|mesh-ancestor
6625851|NCT01303887|Mitosis Modulators|mitosis modulators|mesh-ancestor
6625852|NCT01303887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6625853|NCT01303887|Glucocorticoids|glucocorticoids|mesh-ancestor
6625854|NCT01303887|Hormones|hormones|mesh-ancestor
6625855|NCT01303887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6625856|NCT01303887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6625857|NCT01303926|Paclitaxel|paclitaxel|mesh-list
6625858|NCT01303926|Bevacizumab|bevacizumab|mesh-list
6625859|NCT01303926|Carboplatin|carboplatin|mesh-list
6625860|NCT01303926|Pemetrexed|pemetrexed|mesh-list
6625861|NCT01303926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6625862|NCT01303926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6625863|NCT01303926|Tubulin Modulators|tubulin modulators|mesh-ancestor
6625864|NCT01303926|Antimitotic Agents|antimitotic agents|mesh-ancestor
6625865|NCT01303926|Mitosis Modulators|mitosis modulators|mesh-ancestor
6625866|NCT01303926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625867|NCT01303926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5479904|NCT03829462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479905|NCT03829462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5479906|NCT03801278|Bemarituzumab|bemarituzumab|mesh-list
5479907|NCT03801278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5479908|NCT03801278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5479909|NCT03774641|Lamotrigine|lamotrigine|mesh-list
5479910|NCT03774641|Anticonvulsants|anticonvulsants|mesh-ancestor
5479911|NCT03774641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6625868|NCT01303926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6625869|NCT01303926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6625870|NCT01303926|Growth Substances|growth substances|mesh-ancestor
6625871|NCT01303926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625872|NCT01303926|Growth Inhibitors|growth inhibitors|mesh-ancestor
6625873|NCT01303926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6625874|NCT01303926|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6625875|NCT01303926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6625876|NCT01303952|Eculizumab|eculizumab|mesh-list
6625877|NCT01303952|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6625878|NCT01303952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6625879|NCT01303952|Immunologic Factors|immunologic factors|mesh-ancestor
6625880|NCT01303952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625881|NCT01304069|Etoricoxib|etoricoxib|mesh-list
6625882|NCT01304069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6625883|NCT01304069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6625884|NCT01304069|Analgesics|analgesics|mesh-ancestor
6625885|NCT01304069|Sensory System Agents|sensory system agents|mesh-ancestor
6625886|NCT01304069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6625887|NCT01304069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625888|NCT01304069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6625889|NCT01304069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6625890|NCT01304069|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6625891|NCT01304069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6625892|NCT01304069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6625893|NCT01304069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625894|NCT01304095|Ranolazine|ranolazine|mesh-list
6625895|NCT01304095|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6625896|NCT01304095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6625897|NCT01304095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625898|NCT01304134|Morphine|morphine|mesh-list
6625899|NCT01304134|Oxycodone|oxycodone|mesh-list
6625900|NCT01304134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6625901|NCT01304134|Narcotics|narcotics|mesh-ancestor
6625902|NCT01304134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6625903|NCT01304134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625904|NCT01304134|Analgesics|analgesics|mesh-ancestor
6625905|NCT01304134|Sensory System Agents|sensory system agents|mesh-ancestor
6625906|NCT01304134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6625907|NCT01304212|Ketorolac|ketorolac|mesh-list
6625908|NCT01304212|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6625909|NCT01304212|Epinephrine|epinephrine|mesh-list
6625910|NCT01304212|Racepinephrine|racepinephrine|mesh-list
6625911|NCT01304212|Morphine|morphine|mesh-list
6625912|NCT01304212|Ropivacaine|ropivacaine|mesh-list
6625913|NCT01304212|Epinephryl borate|epinephryl borate|mesh-list
6625914|NCT01304212|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6625915|NCT01304212|Narcotics|narcotics|mesh-ancestor
6625916|NCT01304212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6625917|NCT01304212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625918|NCT01304212|Analgesics|analgesics|mesh-ancestor
6625919|NCT01304212|Sensory System Agents|sensory system agents|mesh-ancestor
6625920|NCT01304212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6625921|NCT01304212|Anesthetics, Local|anesthetics, local|mesh-ancestor
6625922|NCT01304212|Anesthetics|anesthetics|mesh-ancestor
6625923|NCT01304212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6625924|NCT01304212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6625925|NCT01304212|Adrenergic Agents|adrenergic agents|mesh-ancestor
6625926|NCT01304212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6625927|NCT01304212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625928|NCT01304212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6625929|NCT01304212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6625930|NCT01304212|Autonomic Agents|autonomic agents|mesh-ancestor
6625931|NCT01304212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6625932|NCT01304212|Respiratory System Agents|respiratory system agents|mesh-ancestor
6625933|NCT01304212|Mydriatics|mydriatics|mesh-ancestor
6625934|NCT01304212|Sympathomimetics|sympathomimetics|mesh-ancestor
6625935|NCT01304212|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5479912|NCT03774641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5479913|NCT03774641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479914|NCT03774641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5479915|NCT03774641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479916|NCT03774641|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5479917|NCT03774641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5479918|NCT03774641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5479919|NCT03774641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5479920|NCT03774641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5479921|NCT03695380|Atezolizumab|atezolizumab|mesh-list
5479922|NCT03695380|Niraparib|niraparib|mesh-list
5479923|NCT03695380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5479924|NCT03695380|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5479925|NCT03695380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5479926|NCT03695380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451123|NCT00410787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6451124|NCT00410787|Narcotics|narcotics|mesh-ancestor
6451125|NCT00410787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6451126|NCT00410787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451127|NCT00410787|Analgesics|analgesics|mesh-ancestor
6451128|NCT00410787|Sensory System Agents|sensory system agents|mesh-ancestor
6451129|NCT00410787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6451130|NCT00410852|Insulin|insulin|mesh-list
6451131|NCT00410852|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6451132|NCT00410852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5479927|NCT03669718|Cemiplimab|cemiplimab|mesh-list
6451133|NCT00410852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625936|NCT01304212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6625937|NCT01304212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6625938|NCT01304212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6625939|NCT01304212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6625940|NCT01304212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6625941|NCT01304212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6625942|NCT01304264|Maleic acid|maleic acid|mesh-list
6625943|NCT01304264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6625944|NCT01304264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625945|NCT01304316|Phenylephrine|phenylephrine|mesh-list
6625946|NCT01304316|Oxymetazoline|oxymetazoline|mesh-list
6625947|NCT01304316|Tetracaine|tetracaine|mesh-list
6625948|NCT01304316|Anesthetics, Local|anesthetics, local|mesh-ancestor
6625949|NCT01304316|Anesthetics|anesthetics|mesh-ancestor
6625950|NCT01304316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6625951|NCT01304316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625952|NCT01304316|Sensory System Agents|sensory system agents|mesh-ancestor
6625953|NCT01304316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6625954|NCT01304316|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6625955|NCT01304316|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6625956|NCT01304316|Adrenergic Agents|adrenergic agents|mesh-ancestor
6625957|NCT01304316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6625958|NCT01304316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625959|NCT01304316|Sympathomimetics|sympathomimetics|mesh-ancestor
6625960|NCT01304316|Autonomic Agents|autonomic agents|mesh-ancestor
6625961|NCT01304316|Nasal Decongestants|nasal decongestants|mesh-ancestor
6625962|NCT01304316|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6625963|NCT01304316|Respiratory System Agents|respiratory system agents|mesh-ancestor
6625964|NCT01304316|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6625965|NCT01304316|Mydriatics|mydriatics|mesh-ancestor
6625966|NCT01304316|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5479928|NCT03669718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5479929|NCT03669718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5479930|NCT03643965|Budesonide|budesonide|mesh-list
5479931|NCT03643965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5479932|NCT03643965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5479933|NCT03643965|Autonomic Agents|autonomic agents|mesh-ancestor
5479934|NCT03643965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6625967|NCT01304316|Protective Agents|protective agents|mesh-ancestor
6625968|NCT01304342|Fentanyl|fentanyl|mesh-list
6625969|NCT01304342|Remifentanil|remifentanil|mesh-list
6625970|NCT01304342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6625971|NCT01304342|Narcotics|narcotics|mesh-ancestor
6625972|NCT01304342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6625973|NCT01304342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625974|NCT01304342|Analgesics|analgesics|mesh-ancestor
6625975|NCT01304342|Sensory System Agents|sensory system agents|mesh-ancestor
6625976|NCT01304342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6625977|NCT01304342|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6625978|NCT01304342|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6625979|NCT01304342|Anesthetics, General|anesthetics, general|mesh-ancestor
6625980|NCT01304342|Anesthetics|anesthetics|mesh-ancestor
6625981|NCT01304472|Clopidogrel|clopidogrel|mesh-list
6625982|NCT01304472|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6625983|NCT01304472|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6625984|NCT01304472|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6625985|NCT01304472|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5479935|NCT03643965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625986|NCT01304472|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6625987|NCT01304472|Purinergic Agents|purinergic agents|mesh-ancestor
6625988|NCT01304472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6625989|NCT01304472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625990|NCT01304472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6625991|NCT01304537|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
6625992|NCT01304537|Protein C Inhibitor|protein c inhibitor|mesh-list
6625993|NCT01304537|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6625994|NCT01304537|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6625995|NCT01304537|Protease Inhibitors|protease inhibitors|mesh-ancestor
6625996|NCT01304537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6625997|NCT01304537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6625998|NCT01304563|Vaccines|vaccines|mesh-list
6625999|NCT01304563|Immunologic Factors|immunologic factors|mesh-ancestor
6626000|NCT01304563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626001|NCT01304602|Irinotecan|irinotecan|mesh-list
6626002|NCT01304602|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6626003|NCT01304602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6626004|NCT01304602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6626005|NCT01304602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6626006|NCT01304602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6626007|NCT01304784|Paclitaxel|paclitaxel|mesh-list
6626008|NCT01304784|Docetaxel|docetaxel|mesh-list
6626009|NCT01304784|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6626010|NCT01304784|Capecitabine|capecitabine|mesh-list
6626011|NCT01304784|Trastuzumab|trastuzumab|mesh-list
6626012|NCT01304784|Lapatinib|lapatinib|mesh-list
6626013|NCT01304784|Antibodies, Bispecific|antibodies, bispecific|mesh-list
6626014|NCT01304784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6626015|NCT01304784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6626016|NCT01304784|Tubulin Modulators|tubulin modulators|mesh-ancestor
6626017|NCT01304784|Antimitotic Agents|antimitotic agents|mesh-ancestor
6626018|NCT01304784|Mitosis Modulators|mitosis modulators|mesh-ancestor
6626019|NCT01304784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6626020|NCT01304784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6626021|NCT01304784|Antimetabolites|antimetabolites|mesh-ancestor
6626022|NCT01304784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6626023|NCT01304784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6626024|NCT01304784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6626025|NCT01304784|Immunologic Factors|immunologic factors|mesh-ancestor
6626026|NCT01304784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626027|NCT01304797|Cyclophosphamide|cyclophosphamide|mesh-list
6626028|NCT01304797|Trastuzumab|trastuzumab|mesh-list
6626029|NCT01304797|Doxorubicin|doxorubicin|mesh-list
6626030|NCT01304797|Immunoconjugates|immunoconjugates|mesh-list
6626031|NCT01304797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6626032|NCT01304797|Immunologic Factors|immunologic factors|mesh-ancestor
6626033|NCT01304797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626034|NCT01304797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6626035|NCT01304797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6626036|NCT01304797|Alkylating Agents|alkylating agents|mesh-ancestor
6626037|NCT01304797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6626038|NCT01304797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6626039|NCT01304797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6626040|NCT01304797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6626041|NCT01304797|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6626042|NCT01304797|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6626043|NCT01304797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6626044|NCT01304797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6626045|NCT01304836|Mycophenolic Acid|mycophenolic acid|mesh-list
6626046|NCT01304836|Methylprednisolone|methylprednisolone|mesh-list
6626047|NCT01304836|Prednisolone|prednisolone|mesh-list
6451134|NCT00410878|Hydromorphone|hydromorphone|mesh-list
6451135|NCT00410878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6451136|NCT00410878|Narcotics|narcotics|mesh-ancestor
6451137|NCT00410878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6451138|NCT00410878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451139|NCT00410878|Analgesics|analgesics|mesh-ancestor
6451140|NCT00410878|Sensory System Agents|sensory system agents|mesh-ancestor
6451141|NCT00410878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6451142|NCT00410943|Hydromorphone|hydromorphone|mesh-list
6451143|NCT00410943|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6451144|NCT00410943|Narcotics|narcotics|mesh-ancestor
6626048|NCT01304836|Tacrolimus|tacrolimus|mesh-list
6626049|NCT01304836|Basiliximab|basiliximab|mesh-list
6626050|NCT01304836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6626051|NCT01304836|Immunologic Factors|immunologic factors|mesh-ancestor
6626052|NCT01304836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626053|NCT01304836|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6626054|NCT01304836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6626055|NCT01304836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6626056|NCT01304836|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6626057|NCT01304836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6626058|NCT01304836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6626059|NCT01304836|Antitubercular Agents|antitubercular agents|mesh-ancestor
6626060|NCT01304836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6626061|NCT01304836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6626062|NCT01304836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5479936|NCT03643965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5479937|NCT03643965|Respiratory System Agents|respiratory system agents|mesh-ancestor
5479938|NCT03643965|Glucocorticoids|glucocorticoids|mesh-ancestor
5479939|NCT03643965|Hormones|hormones|mesh-ancestor
5479940|NCT03643965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5479941|NCT03621670|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5479942|NCT03621670|Immunologic Factors|immunologic factors|mesh-ancestor
5479943|NCT03621670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479944|NCT03616574|Trifluridine|trifluridine|mesh-list
5479945|NCT03616574|Antimetabolites|antimetabolites|mesh-ancestor
5479946|NCT03616574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479947|NCT03616574|Antiviral Agents|antiviral agents|mesh-ancestor
5479948|NCT03616574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5479949|NCT03595566|Vancomycin|vancomycin|mesh-list
5479950|NCT03595566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5479951|NCT03595566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5479952|NCT03595553|Vancomycin|vancomycin|mesh-list
5479953|NCT03595553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5479954|NCT03595553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5479955|NCT03584334|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5479956|NCT03584334|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5479957|NCT03584334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479958|NCT03530397|Carboplatin|carboplatin|mesh-list
5479959|NCT03530397|Pembrolizumab|pembrolizumab|mesh-list
5479960|NCT03530397|Pemetrexed|pemetrexed|mesh-list
5479961|NCT03530397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5479962|NCT03530397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5479963|NCT03530397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6626063|NCT01304836|Antiemetics|antiemetics|mesh-ancestor
6626064|NCT01304836|Autonomic Agents|autonomic agents|mesh-ancestor
6626065|NCT01304836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6626066|NCT01304836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6626067|NCT01304836|Glucocorticoids|glucocorticoids|mesh-ancestor
6626068|NCT01304836|Hormones|hormones|mesh-ancestor
6626069|NCT01304836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6626070|NCT01304836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6626071|NCT01304836|Protective Agents|protective agents|mesh-ancestor
6626072|NCT01304836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6626073|NCT01304901|Montelukast|montelukast|mesh-list
6626074|NCT01304901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6626075|NCT01304901|Respiratory System Agents|respiratory system agents|mesh-ancestor
6626076|NCT01304901|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6626077|NCT01304901|Hormone Antagonists|hormone antagonists|mesh-ancestor
6626078|NCT01304901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5479964|NCT03530397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479965|NCT03530397|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5479966|NCT03530397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5479967|NCT03516292|Mitogens|mitogens|mesh-list
5479968|NCT03516292|Mitosis Modulators|mitosis modulators|mesh-ancestor
5479969|NCT03516292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479970|NCT03401918|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5479971|NCT03401918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5479972|NCT03336541|Ketamine|ketamine|mesh-list
5479973|NCT03336541|Analgesics|analgesics|mesh-ancestor
6626079|NCT01304901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626080|NCT01304901|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6626081|NCT01304901|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6626082|NCT01304901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6626083|NCT01304927|Vitamin D|vitamin d|mesh-list
6626084|NCT01304927|Cholecalciferol|cholecalciferol|mesh-list
6626085|NCT01304927|Calcium|calcium|mesh-list
5479974|NCT03336541|Sensory System Agents|sensory system agents|mesh-ancestor
5479975|NCT03336541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5479976|NCT03336541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479977|NCT03336541|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5479978|NCT03336541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5479979|NCT03336541|Anesthetics, General|anesthetics, general|mesh-ancestor
5479980|NCT03336541|Anesthetics|anesthetics|mesh-ancestor
5479981|NCT03336541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5479982|NCT03336541|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5479983|NCT03336541|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5479984|NCT03336541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5479985|NCT03336541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479986|NCT03241732|Acetylcysteine|acetylcysteine|mesh-list
5479987|NCT03241732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
5479988|NCT03241732|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5479989|NCT03241732|Antiviral Agents|antiviral agents|mesh-ancestor
5479990|NCT03241732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5479991|NCT03241732|Expectorants|expectorants|mesh-ancestor
5479992|NCT03241732|Respiratory System Agents|respiratory system agents|mesh-ancestor
5479993|NCT03241732|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5479994|NCT03241732|Antioxidants|antioxidants|mesh-ancestor
5479995|NCT03241732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5479996|NCT03241732|Protective Agents|protective agents|mesh-ancestor
5479997|NCT03241732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5479998|NCT03241732|Antidotes|antidotes|mesh-ancestor
5502305|NCT04467931|Urological Agents|urological agents|mesh-ancestor
5502306|NCT04467931|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
6626086|NCT01304927|Vitamins|vitamins|mesh-ancestor
6626087|NCT01304927|Micronutrients|micronutrients|mesh-ancestor
6626088|NCT01304927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626089|NCT01304927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6626090|NCT01304927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6626091|NCT01305057|Pyridoxine|pyridoxine|mesh-list
6626092|NCT01305057|Vitamin B Complex|vitamin b complex|mesh-ancestor
6626093|NCT01305057|Vitamins|vitamins|mesh-ancestor
6626094|NCT01305057|Micronutrients|micronutrients|mesh-ancestor
6626095|NCT01305057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626096|NCT01305083|Udenafil|udenafil|mesh-list
6626097|NCT01305083|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6626098|NCT01305083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6626099|NCT01305083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6626100|NCT01305083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6626101|NCT01305135|Azacitidine|azacitidine|mesh-list
6626102|NCT01305135|Idarubicin|idarubicin|mesh-list
6626103|NCT01305135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6626104|NCT01305135|Antimetabolites|antimetabolites|mesh-ancestor
6626105|NCT01305135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6626106|NCT01305135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6626107|NCT01305135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6626108|NCT01305135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6626109|NCT01305135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6626110|NCT01305135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6626111|NCT01305148|Warfarin|warfarin|mesh-list
5502307|NCT04467931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5502308|NCT04467931|Serotonin Agents|serotonin agents|mesh-ancestor
5502309|NCT04467931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5502310|NCT04467931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5502311|NCT04467931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5502312|NCT04467931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5502313|NCT04467931|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5502314|NCT04467931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6451145|NCT00410943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6451146|NCT00410943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451147|NCT00410943|Analgesics|analgesics|mesh-ancestor
6451148|NCT00410943|Sensory System Agents|sensory system agents|mesh-ancestor
6451149|NCT00410943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6451150|NCT00410956|Dexamethasone|dexamethasone|mesh-list
6451151|NCT00410956|Bevacizumab|bevacizumab|mesh-list
6451152|NCT00410956|Floxuridine|floxuridine|mesh-list
6451153|NCT00410956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6451154|NCT00410956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6451155|NCT00410956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6451156|NCT00410956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6451157|NCT00410956|Growth Substances|growth substances|mesh-ancestor
6451158|NCT00410956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626112|NCT01305148|Anticoagulants|anticoagulants|mesh-ancestor
5502315|NCT04467983|Denosumab|denosumab|mesh-list
6626113|NCT01305187|Hyaluronic Acid|hyaluronic acid|mesh-list
6626114|NCT01305187|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6626115|NCT01305187|Immunologic Factors|immunologic factors|mesh-ancestor
6626116|NCT01305187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626117|NCT01305187|Viscosupplements|viscosupplements|mesh-ancestor
6626118|NCT01305187|Protective Agents|protective agents|mesh-ancestor
6626119|NCT01305226|Streptokinase|streptokinase|mesh-list
6626120|NCT01305226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6626121|NCT01305226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6626122|NCT01305226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6626123|NCT01305317|Atorvastatin|atorvastatin|mesh-list
6626124|NCT01305317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6626125|NCT01305317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6626126|NCT01305317|Antimetabolites|antimetabolites|mesh-ancestor
6626127|NCT01305317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6626128|NCT01305317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6626129|NCT01305317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6626130|NCT01305317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6626131|NCT01305369|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6626132|NCT01305369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6626133|NCT01305395|Sirolimus|sirolimus|mesh-list
6626134|NCT01305395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6626135|NCT01305395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6626136|NCT01305395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6626137|NCT01305395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6626138|NCT01305395|Antifungal Agents|antifungal agents|mesh-ancestor
6626139|NCT01305395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6626140|NCT01305395|Immunologic Factors|immunologic factors|mesh-ancestor
6626141|NCT01305395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626142|NCT01305551|Metformin|metformin|mesh-list
6626143|NCT01305551|Saxagliptin|saxagliptin|mesh-list
6626144|NCT01305551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6626145|NCT01305551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626146|NCT01305551|Incretins|incretins|mesh-ancestor
6626147|NCT01305551|Hormones|hormones|mesh-ancestor
6626148|NCT01305551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6626149|NCT01305551|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6626150|NCT01305551|Protease Inhibitors|protease inhibitors|mesh-ancestor
6626151|NCT01305551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6626152|NCT01305551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6626153|NCT01305603|Bupivacaine|bupivacaine|mesh-list
6626154|NCT01305603|Anesthetics, Local|anesthetics, local|mesh-list
6626155|NCT01305603|Anesthetics|anesthetics|mesh-list
6626156|NCT01305603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6626157|NCT01305603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626158|NCT01305603|Sensory System Agents|sensory system agents|mesh-ancestor
6626159|NCT01305603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6626160|NCT01305707|Diazepam|diazepam|mesh-list
6626161|NCT01305707|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6626162|NCT01305707|Lorazepam|lorazepam|mesh-list
6626163|NCT01305707|Clorazepate Dipotassium|clorazepate dipotassium|mesh-list
6626164|NCT01305707|Dexetimide|dexetimide|mesh-list
6626165|NCT01305707|Olanzapine|olanzapine|mesh-list
5479999|NCT03230916|Relebactam|relebactam|mesh-list
5480000|NCT03230916|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5480001|NCT03230916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5480002|NCT03230916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480003|NCT03230916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5480004|NCT03230916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5480005|NCT03202667|Empagliflozin|empagliflozin|mesh-list
5480006|NCT03202667|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5480007|NCT03202667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480008|NCT03202667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5480009|NCT03202667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480010|NCT03169972|Factor VIII|factor viii|mesh-list
5480011|NCT03169972|BAX 855|bax 855|mesh-list
5480012|NCT03169972|Coagulants|coagulants|mesh-ancestor
5480013|NCT03021993|Nivolumab|nivolumab|mesh-list
5480014|NCT03021993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5480015|NCT03021993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5480016|NCT03021993|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5724867|NCT03184649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6626166|NCT01305707|Risperidone|risperidone|mesh-list
6626167|NCT01305707|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6626168|NCT01305707|Aripiprazole|aripiprazole|mesh-list
6626169|NCT01305707|Antipsychotic Agents|antipsychotic agents|mesh-list
6626170|NCT01305707|Lithium Carbonate|lithium carbonate|mesh-list
6626171|NCT01305707|Mirtazapine|mirtazapine|mesh-list
6626172|NCT01305707|Citalopram|citalopram|mesh-list
6626173|NCT01305707|Sertraline|sertraline|mesh-list
6626174|NCT01305707|Fluoxetine|fluoxetine|mesh-list
6626175|NCT01305707|Paroxetine|paroxetine|mesh-list
6626176|NCT01305707|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6626177|NCT01305707|Nortriptyline|nortriptyline|mesh-list
6626178|NCT01305707|Imipramine|imipramine|mesh-list
6626179|NCT01305707|Clomipramine|clomipramine|mesh-list
6626180|NCT01305707|Mianserin|mianserin|mesh-list
6626181|NCT01305707|Antidepressive Agents|antidepressive agents|mesh-list
6626182|NCT01305707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6626183|NCT01305707|Serotonin Agents|serotonin agents|mesh-ancestor
6626184|NCT01305707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6626185|NCT01305707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6626186|NCT01305707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626187|NCT01305707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6626188|NCT01305707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6626189|NCT01305707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6626190|NCT01305707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6626191|NCT01305707|Dopamine Agents|dopamine agents|mesh-ancestor
6626192|NCT01305707|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6626193|NCT01305707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6626194|NCT01305707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6626195|NCT01305707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6626196|NCT01305707|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6626197|NCT01305707|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6626198|NCT01305707|Parasympatholytics|parasympatholytics|mesh-ancestor
6626199|NCT01305707|Autonomic Agents|autonomic agents|mesh-ancestor
6626200|NCT01305707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6626201|NCT01305707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6626202|NCT01305707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6626203|NCT01305707|Cholinergic Agents|cholinergic agents|mesh-ancestor
6626204|NCT01305707|Antiemetics|antiemetics|mesh-ancestor
6626205|NCT01305707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6626206|NCT01305707|Dopamine Agonists|dopamine agonists|mesh-ancestor
6626207|NCT01305707|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6626208|NCT01305707|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6626209|NCT01305707|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6626210|NCT01305707|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6626211|NCT01305707|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6626212|NCT01305707|Analgesics|analgesics|mesh-ancestor
6626213|NCT01305707|Sensory System Agents|sensory system agents|mesh-ancestor
6626214|NCT01305707|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6626215|NCT01305707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6626216|NCT01305707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6626217|NCT01305707|Antimanic Agents|antimanic agents|mesh-ancestor
6626218|NCT01305707|Anticonvulsants|anticonvulsants|mesh-ancestor
6626219|NCT01305707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5480017|NCT03021993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480018|NCT02954081|Apremilast|apremilast|mesh-list
5480019|NCT02954081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5480020|NCT02954081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5480021|NCT02954081|Analgesics|analgesics|mesh-ancestor
6626220|NCT01305707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6626221|NCT01305707|GABA Modulators|gaba modulators|mesh-ancestor
6626222|NCT01305707|GABA Agents|gaba agents|mesh-ancestor
6626223|NCT01305707|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6626224|NCT01305707|Histamine Antagonists|histamine antagonists|mesh-ancestor
6626225|NCT01305707|Histamine Agents|histamine agents|mesh-ancestor
6626226|NCT01305707|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6626227|NCT01305707|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6626228|NCT01305707|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6626229|NCT01305707|Adrenergic Agents|adrenergic agents|mesh-ancestor
6626230|NCT01305707|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6626231|NCT01305707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6626232|NCT01305707|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6626233|NCT01305707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6626234|NCT01305707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6626235|NCT01305707|Anesthetics, General|anesthetics, general|mesh-ancestor
6626236|NCT01305707|Anesthetics|anesthetics|mesh-ancestor
6626237|NCT01305707|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6626238|NCT01305707|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6626239|NCT01305733|Ketorolac|ketorolac|mesh-list
6626240|NCT01305733|Epinephrine|epinephrine|mesh-list
6626241|NCT01305733|Racepinephrine|racepinephrine|mesh-list
6626242|NCT01305733|Levobupivacaine|levobupivacaine|mesh-list
6626243|NCT01305733|Epinephryl borate|epinephryl borate|mesh-list
6626244|NCT01305733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6626245|NCT01305733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6626246|NCT01305733|Analgesics|analgesics|mesh-ancestor
6626247|NCT01305733|Sensory System Agents|sensory system agents|mesh-ancestor
6626248|NCT01305733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6626249|NCT01305733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626250|NCT01305733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6626251|NCT01305733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6626252|NCT01305733|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6626253|NCT01305733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6626254|NCT01305733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6626255|NCT01305733|Anesthetics, Local|anesthetics, local|mesh-ancestor
6626256|NCT01305733|Anesthetics|anesthetics|mesh-ancestor
6626257|NCT01305733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6626258|NCT01305733|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5480022|NCT02954081|Sensory System Agents|sensory system agents|mesh-ancestor
5480023|NCT02954081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5480024|NCT02954081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480025|NCT02954081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5480026|NCT02954081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5480027|NCT02954081|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5480028|NCT02954081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5480029|NCT02954081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6626259|NCT01305733|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6626260|NCT01305733|Adrenergic Agents|adrenergic agents|mesh-ancestor
6626261|NCT01305733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6626262|NCT01305733|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6626263|NCT01305733|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6626264|NCT01305733|Autonomic Agents|autonomic agents|mesh-ancestor
6626265|NCT01305733|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6626266|NCT01305733|Respiratory System Agents|respiratory system agents|mesh-ancestor
6626267|NCT01305733|Mydriatics|mydriatics|mesh-ancestor
6626268|NCT01305733|Sympathomimetics|sympathomimetics|mesh-ancestor
6626269|NCT01305733|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5480030|NCT02954081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480031|NCT02782702|Botulinum Toxins|botulinum toxins|mesh-list
5480032|NCT02782702|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5480033|NCT02782702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5480034|NCT02782702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480035|NCT02782702|Cholinergic Agents|cholinergic agents|mesh-ancestor
5480036|NCT02782702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5480037|NCT02782702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480038|NCT02763319|Rituximab|rituximab|mesh-list
5480039|NCT02763319|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5480040|NCT02763319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5480041|NCT02763319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6626270|NCT01305837|Methylprednisolone|methylprednisolone|mesh-list
6626271|NCT01305837|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6626272|NCT01305837|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5480042|NCT02763319|Immunologic Factors|immunologic factors|mesh-ancestor
5480043|NCT02763319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480044|NCT02763319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5480045|NCT02763319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5480046|NCT02763319|Alkylating Agents|alkylating agents|mesh-ancestor
5480047|NCT02763319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480053|NCT02673567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5480054|NCT02673567|Antibodies|antibodies|mesh-list
5480055|NCT02673567|Immunoglobulins|immunoglobulins|mesh-list
5480056|NCT02673567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5480057|NCT02673567|Immunologic Factors|immunologic factors|mesh-ancestor
5480058|NCT02673567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626273|NCT01305837|Prednisolone|prednisolone|mesh-list
6626274|NCT01305837|Prednisolone acetate|prednisolone acetate|mesh-list
6626275|NCT01305837|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6626276|NCT01305837|Prednisolone phosphate|prednisolone phosphate|mesh-list
6626277|NCT01305837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6626278|NCT01305837|Antiemetics|antiemetics|mesh-ancestor
6626279|NCT01305837|Autonomic Agents|autonomic agents|mesh-ancestor
6626280|NCT01305837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6626281|NCT01305837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626282|NCT01305837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6626283|NCT01305837|Glucocorticoids|glucocorticoids|mesh-ancestor
6626284|NCT01305837|Hormones|hormones|mesh-ancestor
6626285|NCT01305837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6626286|NCT01305837|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6626287|NCT01305837|Protective Agents|protective agents|mesh-ancestor
6626288|NCT01305837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6626289|NCT01305837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6626290|NCT01305850|Losartan|losartan|mesh-list
6626291|NCT01305850|Enalapril|enalapril|mesh-list
6626292|NCT01305850|Enalaprilat|enalaprilat|mesh-list
6626293|NCT01305850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6626294|NCT01305850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6626295|NCT01305850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6626296|NCT01305850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6626297|NCT01305850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6626298|NCT01305850|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6626299|NCT01305850|Protease Inhibitors|protease inhibitors|mesh-ancestor
6626300|NCT01305850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6626301|NCT01305889|Sertraline|sertraline|mesh-list
6626302|NCT01305889|Antidepressive Agents|antidepressive agents|mesh-ancestor
6451159|NCT00410956|Growth Inhibitors|growth inhibitors|mesh-ancestor
6451160|NCT00410956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6451161|NCT00410956|Antiemetics|antiemetics|mesh-ancestor
6451162|NCT00410956|Autonomic Agents|autonomic agents|mesh-ancestor
6451163|NCT00410956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6451164|NCT00410956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6020909|NCT00395304|Dermatologic Agents|dermatologic agents|mesh-ancestor
6020910|NCT00395304|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6451165|NCT00410956|Glucocorticoids|glucocorticoids|mesh-ancestor
6451166|NCT00410956|Hormones|hormones|mesh-ancestor
6451167|NCT00410956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6451168|NCT00410956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6451169|NCT00410956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6451170|NCT00410956|Antimetabolites|antimetabolites|mesh-ancestor
6451171|NCT00410956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451172|NCT00410982|Gemcitabine|gemcitabine|mesh-list
6451173|NCT00410982|Rituximab|rituximab|mesh-list
6451174|NCT00410982|Melphalan|melphalan|mesh-list
6451175|NCT00410982|Busulfan|busulfan|mesh-list
6451176|NCT00410982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6451177|NCT00410982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6451178|NCT00410982|Immunologic Factors|immunologic factors|mesh-ancestor
6626303|NCT01305889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6626304|NCT01305889|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6626305|NCT01305889|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6626306|NCT01305889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6626307|NCT01305889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6626308|NCT01305889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6626309|NCT01305889|Serotonin Agents|serotonin agents|mesh-ancestor
6626310|NCT01305889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626311|NCT01306006|Vaccines|vaccines|mesh-list
6626312|NCT01306006|Immunologic Factors|immunologic factors|mesh-ancestor
6626313|NCT01306006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626314|NCT01306097|Zinc|zinc|mesh-list
6626315|NCT01306097|Zinc Sulfate|zinc sulfate|mesh-list
6626316|NCT01306097|Trace Elements|trace elements|mesh-ancestor
6626317|NCT01306097|Micronutrients|micronutrients|mesh-ancestor
6626318|NCT01306097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626319|NCT01306097|Astringents|astringents|mesh-ancestor
6626320|NCT01306097|Dermatologic Agents|dermatologic agents|mesh-ancestor
6626321|NCT01306123|Vitamin B 12|vitamin b 12|mesh-list
6626322|NCT01306123|Hydroxocobalamin|hydroxocobalamin|mesh-list
6626323|NCT01306123|Vitamins|vitamins|mesh-ancestor
6626324|NCT01306123|Micronutrients|micronutrients|mesh-ancestor
6626325|NCT01306123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626326|NCT01306123|Vitamin B Complex|vitamin b complex|mesh-ancestor
6626327|NCT01306123|Hematinics|hematinics|mesh-ancestor
6626328|NCT01306240|Pulmonary Surfactants|pulmonary surfactants|mesh-list
6626329|NCT01306240|Respiratory System Agents|respiratory system agents|mesh-ancestor
6626330|NCT01306266|Rizatriptan|rizatriptan|mesh-list
6626331|NCT01306266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6626332|NCT01306266|Serotonin Agents|serotonin agents|mesh-ancestor
6626333|NCT01306266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6626334|NCT01306266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6626335|NCT01306266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626336|NCT01306318|Diclofenac|diclofenac|mesh-list
6626337|NCT01306318|Eperisone|eperisone|mesh-list
6626338|NCT01306318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6626339|NCT01306318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6626340|NCT01306318|Analgesics|analgesics|mesh-ancestor
6626341|NCT01306318|Sensory System Agents|sensory system agents|mesh-ancestor
6626342|NCT01306318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6626343|NCT01306318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626344|NCT01306318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6626345|NCT01306318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6626346|NCT01306318|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6626347|NCT01306318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6626348|NCT01306318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6626349|NCT01306318|Anticonvulsants|anticonvulsants|mesh-ancestor
6626350|NCT01306318|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6626351|NCT01306318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6626352|NCT01306318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6626353|NCT01306318|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6626354|NCT01306318|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6626355|NCT01306318|Parasympatholytics|parasympatholytics|mesh-ancestor
6626356|NCT01306318|Autonomic Agents|autonomic agents|mesh-ancestor
6626357|NCT01306318|Vasodilator Agents|vasodilator agents|mesh-ancestor
6626358|NCT01306357|Hormones|hormones|mesh-list
6626359|NCT01306357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6626360|NCT01306357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626361|NCT01306370|Tranexamic Acid|tranexamic acid|mesh-list
6626362|NCT01306370|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6626363|NCT01306370|Hemostatics|hemostatics|mesh-list
6626364|NCT01306370|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6626365|NCT01306370|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6626366|NCT01306370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6626367|NCT01306370|Coagulants|coagulants|mesh-ancestor
6626368|NCT01306409|Darbepoetin alfa|darbepoetin alfa|mesh-list
6626369|NCT01306409|Hematinics|hematinics|mesh-ancestor
6626370|NCT01306461|Timolol|timolol|mesh-list
6626371|NCT01306461|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6626372|NCT01306461|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6626373|NCT01306461|Adrenergic Agents|adrenergic agents|mesh-ancestor
6626374|NCT01306461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6626375|NCT01306461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6626376|NCT01306461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626377|NCT01306461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6626378|NCT01306461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6626379|NCT01306565|Atorvastatin|atorvastatin|mesh-list
6626380|NCT01306565|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6626381|NCT01306565|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6626382|NCT01306565|Antimetabolites|antimetabolites|mesh-ancestor
6626383|NCT01306565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6626384|NCT01306565|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6626385|NCT01306565|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6626386|NCT01306565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6626387|NCT01306591|Bevacizumab|bevacizumab|mesh-list
6626388|NCT01306591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6626389|NCT01306591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6626390|NCT01306591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6626391|NCT01306591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6626392|NCT01306591|Growth Substances|growth substances|mesh-ancestor
6626393|NCT01306591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626394|NCT01306591|Growth Inhibitors|growth inhibitors|mesh-ancestor
6626395|NCT01306630|Capecitabine|capecitabine|mesh-list
6626396|NCT01306630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6626397|NCT01306630|Antimetabolites|antimetabolites|mesh-ancestor
6626398|NCT01306630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6626399|NCT01306630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6626400|NCT01306708|Amitriptyline|amitriptyline|mesh-list
6626401|NCT01306708|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6626402|NCT01306708|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6626403|NCT01306708|Antidepressive Agents|antidepressive agents|mesh-ancestor
6626404|NCT01306708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5480059|NCT02673567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5480060|NCT02628626|Clonidine|clonidine|mesh-list
5480061|NCT02628626|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
5480062|NCT02628626|Analgesics|analgesics|mesh-ancestor
5480063|NCT02628626|Sensory System Agents|sensory system agents|mesh-ancestor
6451179|NCT00410982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451180|NCT00410982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6451181|NCT00410982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6451182|NCT00410982|Antimetabolites|antimetabolites|mesh-ancestor
6451183|NCT00410982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451184|NCT00410982|Antiviral Agents|antiviral agents|mesh-ancestor
6451185|NCT00410982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6451186|NCT00410982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6451187|NCT00410982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6451188|NCT00410982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5502316|NCT04467983|Abaloparatide|abaloparatide|mesh-list
6626405|NCT01306708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6626406|NCT01306708|Analgesics|analgesics|mesh-ancestor
6626407|NCT01306708|Sensory System Agents|sensory system agents|mesh-ancestor
6626408|NCT01306708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6626409|NCT01306708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626410|NCT01306708|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6626411|NCT01306708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6626412|NCT01306708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6626413|NCT01306708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6626414|NCT01306708|Adrenergic Agents|adrenergic agents|mesh-ancestor
6626415|NCT01306708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6626416|NCT01306708|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6626417|NCT01306708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6626418|NCT01306708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6626419|NCT01306721|Fexofenadine|fexofenadine|mesh-list
6626420|NCT01306721|Pseudoephedrine|pseudoephedrine|mesh-list
6626421|NCT01306721|Ephedrine|ephedrine|mesh-list
6626422|NCT01306721|Terfenadine|terfenadine|mesh-list
6626423|NCT01306721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6626424|NCT01306721|Autonomic Agents|autonomic agents|mesh-ancestor
6626425|NCT01306721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6626426|NCT01306721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626427|NCT01306721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6626428|NCT01306721|Respiratory System Agents|respiratory system agents|mesh-ancestor
6626429|NCT01306721|Nasal Decongestants|nasal decongestants|mesh-ancestor
6626430|NCT01306721|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6626431|NCT01306721|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6626432|NCT01306721|Sympathomimetics|sympathomimetics|mesh-ancestor
6626433|NCT01306721|Adrenergic Agents|adrenergic agents|mesh-ancestor
6626434|NCT01306721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6626435|NCT01306721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6626436|NCT01306721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6626437|NCT01306721|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6626438|NCT01306721|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6626439|NCT01306721|Histamine Antagonists|histamine antagonists|mesh-ancestor
6626440|NCT01306721|Histamine Agents|histamine agents|mesh-ancestor
6626441|NCT01306760|Ketamine|ketamine|mesh-list
6626442|NCT01306760|Propofol|propofol|mesh-list
6626443|NCT01306760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6626444|NCT01306760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6626445|NCT01306760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626446|NCT01306760|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6626447|NCT01306760|Anesthetics, General|anesthetics, general|mesh-ancestor
6626448|NCT01306760|Anesthetics|anesthetics|mesh-ancestor
6626449|NCT01306760|Analgesics|analgesics|mesh-ancestor
6626450|NCT01306760|Sensory System Agents|sensory system agents|mesh-ancestor
6626451|NCT01306760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6626452|NCT01306760|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6626453|NCT01306760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6626454|NCT01306760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6626455|NCT01306760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6626456|NCT01306760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6626457|NCT01306773|Oseltamivir|oseltamivir|mesh-list
6626458|NCT01306773|Antiviral Agents|antiviral agents|mesh-ancestor
6626459|NCT01306773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6626460|NCT01306773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6626461|NCT01306773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6626462|NCT01306851|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6626463|NCT01306851|Hemostatics|hemostatics|mesh-ancestor
6626464|NCT01306851|Coagulants|coagulants|mesh-ancestor
6626465|NCT01306864|Hemostatics|hemostatics|mesh-list
6626466|NCT01306864|Coagulants|coagulants|mesh-ancestor
5480064|NCT02628626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5480065|NCT02628626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480066|NCT02628626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5480067|NCT02628626|Sympatholytics|sympatholytics|mesh-ancestor
5480068|NCT02628626|Autonomic Agents|autonomic agents|mesh-ancestor
5480069|NCT02628626|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5480070|NCT02628626|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5480071|NCT02628626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5480072|NCT02628626|Adrenergic Agents|adrenergic agents|mesh-ancestor
5480073|NCT02628626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5480074|NCT02628626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480075|NCT02628626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5480076|NCT02628626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5480077|NCT02628626|Antimetabolites|antimetabolites|mesh-ancestor
5480078|NCT02628626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5480079|NCT02553460|Leucovorin|leucovorin|mesh-list
5480080|NCT02553460|Cytarabine|cytarabine|mesh-list
5480081|NCT02553460|Dexamethasone|dexamethasone|mesh-list
5480082|NCT02553460|Hydrocortisone|hydrocortisone|mesh-list
6626467|NCT01306981|Ranibizumab|ranibizumab|mesh-list
6626468|NCT01306981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6626469|NCT01306981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6626470|NCT01306981|Growth Substances|growth substances|mesh-ancestor
6626471|NCT01306981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626472|NCT01306981|Growth Inhibitors|growth inhibitors|mesh-ancestor
6626473|NCT01306981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6626474|NCT01306994|Adenosine|adenosine|mesh-list
6626475|NCT01306994|Analgesics|analgesics|mesh-ancestor
6626476|NCT01306994|Sensory System Agents|sensory system agents|mesh-ancestor
6626477|NCT01306994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6626478|NCT01306994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480083|NCT02553460|Cyclophosphamide|cyclophosphamide|mesh-list
5480084|NCT02553460|Methotrexate|methotrexate|mesh-list
5480085|NCT02553460|Etoposide|etoposide|mesh-list
6451189|NCT00410982|Alkylating Agents|alkylating agents|mesh-ancestor
6451190|NCT00410982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6451191|NCT00410995|Naproxen|naproxen|mesh-list
6451192|NCT00410995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6451193|NCT00410995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6451194|NCT00410995|Analgesics|analgesics|mesh-ancestor
6451195|NCT00410995|Sensory System Agents|sensory system agents|mesh-ancestor
5480086|NCT02553460|Vincristine|vincristine|mesh-list
5480087|NCT02553460|Bortezomib|bortezomib|mesh-list
5480088|NCT02553460|Asparaginase|asparaginase|mesh-list
6451196|NCT00410995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6626479|NCT01306994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6626480|NCT01306994|Vasodilator Agents|vasodilator agents|mesh-ancestor
6626481|NCT01306994|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6626482|NCT01306994|Purinergic Agonists|purinergic agonists|mesh-ancestor
6626483|NCT01306994|Purinergic Agents|purinergic agents|mesh-ancestor
6626484|NCT01306994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6626485|NCT01306994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662333|NCT01503242|Antibodies|antibodies|mesh-list
6662334|NCT01503242|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6662335|NCT01503242|Cyclosporins|cyclosporins|mesh-list
6662336|NCT01503242|Immunologic Factors|immunologic factors|mesh-ancestor
6662337|NCT01503242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662338|NCT01503242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6662339|NCT01503242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6662340|NCT01503242|Antimetabolites|antimetabolites|mesh-ancestor
6662341|NCT01503242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662342|NCT01503242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6662343|NCT01503242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6662344|NCT01503242|Antifungal Agents|antifungal agents|mesh-ancestor
6662345|NCT01503242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6662346|NCT01503242|Dermatologic Agents|dermatologic agents|mesh-ancestor
6662347|NCT01503242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6662348|NCT01503242|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6662349|NCT01503242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6662350|NCT01503242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6662351|NCT01503242|Antitubercular Agents|antitubercular agents|mesh-ancestor
6662352|NCT01503242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6020911|NCT00395304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6020912|NCT00395304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6020913|NCT00395304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6020914|NCT00395304|Adrenergic Agents|adrenergic agents|mesh-ancestor
6451197|NCT00410995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020915|NCT00395304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6020916|NCT00395304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020917|NCT00395304|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6020918|NCT00395304|Hormone Antagonists|hormone antagonists|mesh-ancestor
6451198|NCT00410995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6451199|NCT00410995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6451200|NCT00410995|Gout Suppressants|gout suppressants|mesh-ancestor
6451201|NCT00410995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6451202|NCT00410995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6451203|NCT00410995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662353|NCT01503359|Glycine|glycine|mesh-list
6662354|NCT01503359|Glycine Agents|glycine agents|mesh-ancestor
6662355|NCT01503359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6662356|NCT01503359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662357|NCT01503359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662358|NCT01503372|Leucovorin|leucovorin|mesh-list
6662359|NCT01503372|Oxaliplatin|oxaliplatin|mesh-list
6662360|NCT01503372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6662361|NCT01503372|Antidotes|antidotes|mesh-ancestor
6662362|NCT01503372|Protective Agents|protective agents|mesh-ancestor
6662363|NCT01503372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662364|NCT01503372|Vitamin B Complex|vitamin b complex|mesh-ancestor
6662365|NCT01503372|Vitamins|vitamins|mesh-ancestor
6662366|NCT01503372|Micronutrients|micronutrients|mesh-ancestor
6662367|NCT01503385|Celecoxib|celecoxib|mesh-list
6662368|NCT01503385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6662369|NCT01503385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6662370|NCT01503385|Analgesics|analgesics|mesh-ancestor
6662371|NCT01503385|Sensory System Agents|sensory system agents|mesh-ancestor
6662372|NCT01503385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6662373|NCT01503385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662374|NCT01503385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6662375|NCT01503385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6662376|NCT01503385|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6451204|NCT00411034|Hydromorphone|hydromorphone|mesh-list
6451205|NCT00411034|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6626486|NCT01307124|Lopinavir|lopinavir|mesh-list
6626487|NCT01307124|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6626488|NCT01307124|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6626489|NCT01307124|Protease Inhibitors|protease inhibitors|mesh-ancestor
6626490|NCT01307124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6626491|NCT01307124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6626492|NCT01307124|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6626493|NCT01307124|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6626494|NCT01307124|Antiviral Agents|antiviral agents|mesh-ancestor
6626495|NCT01307124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6626496|NCT01307124|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6626497|NCT01307124|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6626498|NCT01307189|Tiotropium Bromide|tiotropium bromide|mesh-list
6626499|NCT01307189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6626500|NCT01307189|Autonomic Agents|autonomic agents|mesh-ancestor
6626501|NCT01307189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6626502|NCT01307189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626503|NCT01307189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6626504|NCT01307189|Respiratory System Agents|respiratory system agents|mesh-ancestor
6626505|NCT01307189|Parasympatholytics|parasympatholytics|mesh-ancestor
6626506|NCT01307189|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6626507|NCT01307189|Cholinergic Agents|cholinergic agents|mesh-ancestor
6626508|NCT01307189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6626509|NCT01307189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6626510|NCT01307202|Gabapentin|gabapentin|mesh-list
6626511|NCT01307202|Analgesics|analgesics|mesh-ancestor
6626512|NCT01307202|Sensory System Agents|sensory system agents|mesh-ancestor
6626513|NCT01307202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6626514|NCT01307202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626515|NCT01307202|Anticonvulsants|anticonvulsants|mesh-ancestor
6626516|NCT01307202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6626517|NCT01307202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6626518|NCT01307202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6626519|NCT01307202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6451206|NCT00411034|Narcotics|narcotics|mesh-ancestor
6451207|NCT00411034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6451208|NCT00411034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451209|NCT00411034|Analgesics|analgesics|mesh-ancestor
6451210|NCT00411034|Sensory System Agents|sensory system agents|mesh-ancestor
6451211|NCT00411034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6451212|NCT00411047|Gefitinib|gefitinib|mesh-list
6451213|NCT00411047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6451214|NCT00411047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6451215|NCT00411047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6451216|NCT00411047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451217|NCT00411073|Darapladib|darapladib|mesh-list
6451218|NCT00411073|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
6451219|NCT00411073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6451220|NCT00411073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451221|NCT00411125|Calcitonin|calcitonin|mesh-list
6451222|NCT00411125|Salmon calcitonin|salmon calcitonin|mesh-list
6451223|NCT00411125|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
6451224|NCT00411125|Katacalcin|katacalcin|mesh-list
6451225|NCT00411125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6451226|NCT00411125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451227|NCT00411125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5480089|NCT02553460|Mercaptopurine|mercaptopurine|mesh-list
5480090|NCT02553460|Mitoxantrone|mitoxantrone|mesh-list
5480091|NCT02553460|Vorinostat|vorinostat|mesh-list
5480092|NCT02553460|Pegaspargase|pegaspargase|mesh-list
5480093|NCT02553460|Levoleucovorin|levoleucovorin|mesh-list
6626520|NCT01307202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6626521|NCT01307202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6626522|NCT01307202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6626523|NCT01307202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6626524|NCT01307202|Antimanic Agents|antimanic agents|mesh-ancestor
6626525|NCT01307215|Ropivacaine|ropivacaine|mesh-list
6626526|NCT01307215|Anesthetics, Local|anesthetics, local|mesh-ancestor
6626527|NCT01307215|Anesthetics|anesthetics|mesh-ancestor
6626528|NCT01307215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6626529|NCT01307215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626530|NCT01307215|Sensory System Agents|sensory system agents|mesh-ancestor
6626531|NCT01307215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6626532|NCT01307306|Metformin|metformin|mesh-list
6626533|NCT01307306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6626534|NCT01307306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626535|NCT01307332|Alemtuzumab|alemtuzumab|mesh-list
6626536|NCT01307332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6626537|NCT01307332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6626538|NCT01307475|Adenosine|adenosine|mesh-list
6626539|NCT01307475|Analgesics|analgesics|mesh-ancestor
6626540|NCT01307475|Sensory System Agents|sensory system agents|mesh-ancestor
6626541|NCT01307475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6626542|NCT01307475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626543|NCT01307475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6626544|NCT01307475|Vasodilator Agents|vasodilator agents|mesh-ancestor
6626545|NCT01307475|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6626546|NCT01307475|Purinergic Agonists|purinergic agonists|mesh-ancestor
6626547|NCT01307475|Purinergic Agents|purinergic agents|mesh-ancestor
6626548|NCT01307475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6626549|NCT01307475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6626550|NCT01307488|Ritonavir|ritonavir|mesh-list
6626551|NCT01307488|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6626552|NCT01307488|Lamivudine|lamivudine|mesh-list
6626553|NCT01307488|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6626554|NCT01307488|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6626555|NCT01307488|Protease Inhibitors|protease inhibitors|mesh-ancestor
5480094|NCT02553460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5480095|NCT02553460|Immunologic Factors|immunologic factors|mesh-ancestor
5480096|NCT02553460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480097|NCT02553460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5480098|NCT02553460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5480099|NCT02553460|Alkylating Agents|alkylating agents|mesh-ancestor
5480100|NCT02553460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480101|NCT02553460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5480102|NCT02553460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6626556|NCT01307488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6626557|NCT01307488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6626558|NCT01307488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6626559|NCT01307488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6626560|NCT01307488|Antiviral Agents|antiviral agents|mesh-ancestor
6626561|NCT01307488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6626562|NCT01307488|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6626563|NCT01307488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6626564|NCT01307488|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6626565|NCT01307488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6626566|NCT01307527|Riboflavin|riboflavin|mesh-list
6626567|NCT01307527|Vitamin B Complex|vitamin b complex|mesh-ancestor
6626568|NCT01307527|Vitamins|vitamins|mesh-ancestor
5480103|NCT02553460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5480104|NCT02553460|Antiemetics|antiemetics|mesh-ancestor
5480105|NCT02553460|Autonomic Agents|autonomic agents|mesh-ancestor
5480106|NCT02553460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5480107|NCT02553460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5480108|NCT02553460|Glucocorticoids|glucocorticoids|mesh-ancestor
5480109|NCT02553460|Hormones|hormones|mesh-ancestor
6626569|NCT01307527|Micronutrients|micronutrients|mesh-ancestor
6626570|NCT01307527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626571|NCT01307527|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6626572|NCT01307527|Dermatologic Agents|dermatologic agents|mesh-ancestor
6626573|NCT01307592|Gemcitabine|gemcitabine|mesh-list
6626574|NCT01307592|Rituximab|rituximab|mesh-list
6626575|NCT01307592|Oxaliplatin|oxaliplatin|mesh-list
6626576|NCT01307592|Lenalidomide|lenalidomide|mesh-list
6626577|NCT01307592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6626578|NCT01307592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6626579|NCT01307592|Immunologic Factors|immunologic factors|mesh-ancestor
6626580|NCT01307592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626581|NCT01307592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6626582|NCT01307592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6626583|NCT01307592|Antimetabolites|antimetabolites|mesh-ancestor
6626584|NCT01307592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6626585|NCT01307592|Antiviral Agents|antiviral agents|mesh-ancestor
6626586|NCT01307592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6626587|NCT01307592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6626588|NCT01307592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6626589|NCT01307592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6626590|NCT01307592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6626591|NCT01307592|Growth Substances|growth substances|mesh-ancestor
6626592|NCT01307592|Growth Inhibitors|growth inhibitors|mesh-ancestor
6626593|NCT01307605|Rituximab|rituximab|mesh-list
6626594|NCT01307605|Lenalidomide|lenalidomide|mesh-list
6626595|NCT01307605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6626596|NCT01307605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6626597|NCT01307605|Immunologic Factors|immunologic factors|mesh-ancestor
5480110|NCT02553460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5480111|NCT02553460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5480112|NCT02553460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5480113|NCT02553460|Abortifacient Agents|abortifacient agents|mesh-ancestor
5480114|NCT02553460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5480115|NCT02553460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5480116|NCT02553460|Antimetabolites|antimetabolites|mesh-ancestor
5480117|NCT02553460|Dermatologic Agents|dermatologic agents|mesh-ancestor
5480118|NCT02553460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5480119|NCT02553460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5480120|NCT02553460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6626598|NCT01307605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626599|NCT01307605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6626600|NCT01307605|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6626601|NCT01307605|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6626602|NCT01307605|Growth Substances|growth substances|mesh-ancestor
6626603|NCT01307605|Growth Inhibitors|growth inhibitors|mesh-ancestor
6626604|NCT01307839|Lidocaine|lidocaine|mesh-list
6626605|NCT01307839|Anesthetics, Local|anesthetics, local|mesh-ancestor
5503628|NCT04456959|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
6626606|NCT01307839|Anesthetics|anesthetics|mesh-ancestor
6626607|NCT01307839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6626608|NCT01307839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626609|NCT01307839|Sensory System Agents|sensory system agents|mesh-ancestor
6626610|NCT01307839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6626611|NCT01307839|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6626612|NCT01307839|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6626613|NCT01307839|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6626614|NCT01307839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6626615|NCT01307839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6626616|NCT01307865|Mannitol|mannitol|mesh-list
6626617|NCT01307865|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6626618|NCT01307865|Diuretics|diuretics|mesh-ancestor
6626619|NCT01307865|Natriuretic Agents|natriuretic agents|mesh-ancestor
6626620|NCT01307865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626621|NCT01307969|Lidocaine|lidocaine|mesh-list
6626622|NCT01307969|Epinephrine|epinephrine|mesh-list
6626623|NCT01307969|Racepinephrine|racepinephrine|mesh-list
6626624|NCT01307969|Ropivacaine|ropivacaine|mesh-list
6626625|NCT01307969|Epinephryl borate|epinephryl borate|mesh-list
6626626|NCT01307969|Anesthetics, Local|anesthetics, local|mesh-ancestor
6626627|NCT01307969|Anesthetics|anesthetics|mesh-ancestor
6626628|NCT01307969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6626629|NCT01307969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626630|NCT01307969|Sensory System Agents|sensory system agents|mesh-ancestor
6626631|NCT01307969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6626632|NCT01307969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6626633|NCT01307969|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6626634|NCT01307969|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6626635|NCT01307969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6626636|NCT01307969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6626637|NCT01307969|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6626638|NCT01307969|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6626639|NCT01307969|Adrenergic Agents|adrenergic agents|mesh-ancestor
6626640|NCT01307969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6626641|NCT01307969|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6626642|NCT01307969|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6626643|NCT01307969|Autonomic Agents|autonomic agents|mesh-ancestor
6626644|NCT01307969|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6626645|NCT01307969|Respiratory System Agents|respiratory system agents|mesh-ancestor
6626646|NCT01307969|Mydriatics|mydriatics|mesh-ancestor
6626647|NCT01307969|Sympathomimetics|sympathomimetics|mesh-ancestor
6626648|NCT01307969|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6626649|NCT01308047|Bupivacaine|bupivacaine|mesh-list
6626650|NCT01308047|Anesthetics, Local|anesthetics, local|mesh-ancestor
5480121|NCT02553460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5480122|NCT02553460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5480123|NCT02553460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5480124|NCT02553460|Antiviral Agents|antiviral agents|mesh-ancestor
5480125|NCT02553460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5480126|NCT02553460|Antidotes|antidotes|mesh-ancestor
5480127|NCT02553460|Protective Agents|protective agents|mesh-ancestor
5480128|NCT02553460|Vitamin B Complex|vitamin b complex|mesh-ancestor
5480129|NCT02553460|Vitamins|vitamins|mesh-ancestor
5480130|NCT02553460|Micronutrients|micronutrients|mesh-ancestor
5480131|NCT02553460|Tubulin Modulators|tubulin modulators|mesh-ancestor
5480132|NCT02553460|Antimitotic Agents|antimitotic agents|mesh-ancestor
5480133|NCT02553460|Mitosis Modulators|mitosis modulators|mesh-ancestor
5480134|NCT02553460|Analgesics|analgesics|mesh-ancestor
5480135|NCT02553460|Sensory System Agents|sensory system agents|mesh-ancestor
5480136|NCT02553460|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5480137|NCT02536183|Doxorubicin|doxorubicin|mesh-list
5480138|NCT02536183|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5480139|NCT02536183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5480140|NCT02536183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5480141|NCT02536183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5480142|NCT02536183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5480143|NCT02536183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5480144|NCT02536183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480145|NCT02523313|Nivolumab|nivolumab|mesh-list
5480146|NCT02523313|Ipilimumab|ipilimumab|mesh-list
5480147|NCT02523313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5480148|NCT02523313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6626651|NCT01308047|Anesthetics|anesthetics|mesh-ancestor
6626652|NCT01308047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6626653|NCT01308047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626654|NCT01308047|Sensory System Agents|sensory system agents|mesh-ancestor
6626655|NCT01308047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6626656|NCT01308086|Leucovorin|leucovorin|mesh-list
6626657|NCT01308086|Fluorouracil|fluorouracil|mesh-list
5480149|NCT02523313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5480150|NCT02523313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480151|NCT02445651|Acetylcysteine|acetylcysteine|mesh-list
5480152|NCT02445651|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5480153|NCT02445651|Antiviral Agents|antiviral agents|mesh-ancestor
5480154|NCT02445651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5480155|NCT02445651|Expectorants|expectorants|mesh-ancestor
5480156|NCT02445651|Respiratory System Agents|respiratory system agents|mesh-ancestor
5480157|NCT02445651|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5480158|NCT02445651|Antioxidants|antioxidants|mesh-ancestor
6451228|NCT00411125|Vasodilator Agents|vasodilator agents|mesh-ancestor
6451229|NCT00411138|Paclitaxel|paclitaxel|mesh-list
6451230|NCT00411138|Carboplatin|carboplatin|mesh-list
6451231|NCT00411138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6451232|NCT00411138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6451233|NCT00411138|Tubulin Modulators|tubulin modulators|mesh-ancestor
6451234|NCT00411138|Antimitotic Agents|antimitotic agents|mesh-ancestor
6451235|NCT00411138|Mitosis Modulators|mitosis modulators|mesh-ancestor
6451236|NCT00411138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451237|NCT00411164|Hydromorphone|hydromorphone|mesh-list
6451238|NCT00411164|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6451239|NCT00411164|Narcotics|narcotics|mesh-ancestor
5480159|NCT02445651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480160|NCT02445651|Protective Agents|protective agents|mesh-ancestor
5480161|NCT02445651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480162|NCT02445651|Antidotes|antidotes|mesh-ancestor
5480163|NCT02318329|Bemarituzumab|bemarituzumab|mesh-list
5480164|NCT02318329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6626658|NCT01308086|Capecitabine|capecitabine|mesh-list
6626659|NCT01308086|Oxaliplatin|oxaliplatin|mesh-list
6626660|NCT01308086|Levoleucovorin|levoleucovorin|mesh-list
6626661|NCT01308086|Antimetabolites|antimetabolites|mesh-ancestor
6626662|NCT01308086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6626663|NCT01308086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6626664|NCT01308086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6626665|NCT01308086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6626666|NCT01308086|Immunologic Factors|immunologic factors|mesh-ancestor
5480165|NCT02318329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5480166|NCT02088632|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
6626667|NCT01308086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626668|NCT01308086|Antidotes|antidotes|mesh-ancestor
6626669|NCT01308086|Protective Agents|protective agents|mesh-ancestor
6626670|NCT01308086|Vitamin B Complex|vitamin b complex|mesh-ancestor
6626671|NCT01308086|Vitamins|vitamins|mesh-ancestor
5480167|NCT02088632|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5480168|NCT02088632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5480169|NCT02088632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480170|NCT02088632|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5480171|NCT02088632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5480172|NCT02088632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480173|NCT02088632|Cholinergic Agents|cholinergic agents|mesh-ancestor
5480174|NCT02088632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5480175|NCT01861106|Mycophenolic Acid|mycophenolic acid|mesh-list
6626672|NCT01308086|Micronutrients|micronutrients|mesh-ancestor
6626673|NCT01308177|Ecabet|ecabet|mesh-list
6626674|NCT01308177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6626675|NCT01308177|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6626676|NCT01308177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6626677|NCT01308177|Protease Inhibitors|protease inhibitors|mesh-ancestor
6626678|NCT01308177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6626679|NCT01308177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6626680|NCT01308177|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6626681|NCT01308177|Protective Agents|protective agents|mesh-ancestor
6020919|NCT00395304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6020920|NCT00395304|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6020921|NCT00395304|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6451240|NCT00411164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5480176|NCT01861106|Cyclophosphamide|cyclophosphamide|mesh-list
5480177|NCT01861106|Busulfan|busulfan|mesh-list
5480178|NCT01861106|Fludarabine|fludarabine|mesh-list
5480179|NCT01861106|Fludarabine phosphate|fludarabine phosphate|mesh-list
5480180|NCT01861106|Tacrolimus|tacrolimus|mesh-list
5480181|NCT01861106|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5480182|NCT01861106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5480183|NCT01861106|Immunologic Factors|immunologic factors|mesh-ancestor
5480184|NCT01861106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480185|NCT01861106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5480186|NCT01861106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5480187|NCT01861106|Alkylating Agents|alkylating agents|mesh-ancestor
5480188|NCT01861106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480189|NCT01861106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5480190|NCT01861106|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5480191|NCT01861106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5480192|NCT01861106|Antimetabolites|antimetabolites|mesh-ancestor
6451241|NCT00411164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451242|NCT00411164|Analgesics|analgesics|mesh-ancestor
6451243|NCT00411164|Sensory System Agents|sensory system agents|mesh-ancestor
6451244|NCT00411164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6451245|NCT00411190|Acetaminophen|acetaminophen|mesh-list
6451246|NCT00411190|Ibuprofen|ibuprofen|mesh-list
6451247|NCT00411190|Atorvastatin|atorvastatin|mesh-list
6626682|NCT01308177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626683|NCT01308177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6626684|NCT01308203|Niacin|niacin|mesh-list
6626685|NCT01308203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6626686|NCT01308203|Antimetabolites|antimetabolites|mesh-ancestor
6626687|NCT01308203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6626688|NCT01308203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6626689|NCT01308203|Vasodilator Agents|vasodilator agents|mesh-ancestor
6626690|NCT01308203|Vitamin B Complex|vitamin b complex|mesh-ancestor
6626691|NCT01308203|Vitamins|vitamins|mesh-ancestor
6626692|NCT01308203|Micronutrients|micronutrients|mesh-ancestor
6626693|NCT01308203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626694|NCT01308229|Paclitaxel|paclitaxel|mesh-list
6626695|NCT01308229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6626696|NCT01308229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6626697|NCT01308229|Tubulin Modulators|tubulin modulators|mesh-ancestor
6626698|NCT01308229|Antimitotic Agents|antimitotic agents|mesh-ancestor
6626699|NCT01308229|Mitosis Modulators|mitosis modulators|mesh-ancestor
6626700|NCT01308229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6626701|NCT01308242|Sevelamer|sevelamer|mesh-list
6626702|NCT01308242|Chelating Agents|chelating agents|mesh-ancestor
6626703|NCT01308242|Sequestering Agents|sequestering agents|mesh-ancestor
6626704|NCT01308242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6626705|NCT01308255|Vitamins|vitamins|mesh-list
6626706|NCT01308255|Folic Acid|folic acid|mesh-list
6626707|NCT01308255|Methylprednisolone|methylprednisolone|mesh-list
6626708|NCT01308255|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6626709|NCT01308255|Methotrexate|methotrexate|mesh-list
6626710|NCT01308255|Infliximab|infliximab|mesh-list
6626711|NCT01308255|Micronutrients|micronutrients|mesh-ancestor
6626712|NCT01308255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626713|NCT01308255|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6626714|NCT01308255|Abortifacient Agents|abortifacient agents|mesh-ancestor
6626715|NCT01308255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6626716|NCT01308255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6626717|NCT01308255|Antimetabolites|antimetabolites|mesh-ancestor
6626718|NCT01308255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6626719|NCT01308255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6626720|NCT01308255|Dermatologic Agents|dermatologic agents|mesh-ancestor
6626721|NCT01308255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6626722|NCT01308255|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6626723|NCT01308255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6626724|NCT01308255|Immunologic Factors|immunologic factors|mesh-ancestor
6626725|NCT01308255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6626726|NCT01308255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6626727|NCT01308255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6626728|NCT01308255|Antiemetics|antiemetics|mesh-ancestor
6626729|NCT01308255|Autonomic Agents|autonomic agents|mesh-ancestor
6626730|NCT01308255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6626731|NCT01308255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6626732|NCT01308255|Glucocorticoids|glucocorticoids|mesh-ancestor
6626733|NCT01308255|Hormones|hormones|mesh-ancestor
6626734|NCT01308255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6626735|NCT01308255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6626736|NCT01308255|Protective Agents|protective agents|mesh-ancestor
6626737|NCT01308255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6626738|NCT01308255|Hematinics|hematinics|mesh-ancestor
6626739|NCT01308255|Vitamin B Complex|vitamin b complex|mesh-ancestor
6626740|NCT01308268|Ivermectin|ivermectin|mesh-list
6626741|NCT01308268|Albendazole|albendazole|mesh-list
6626742|NCT01308268|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6626743|NCT01308268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6626744|NCT01308268|Anthelmintics|anthelmintics|mesh-ancestor
6626745|NCT01308268|Anticestodal Agents|anticestodal agents|mesh-ancestor
6626746|NCT01308268|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6626747|NCT01308268|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6626748|NCT01308268|Tubulin Modulators|tubulin modulators|mesh-ancestor
6626749|NCT01308268|Antimitotic Agents|antimitotic agents|mesh-ancestor
6626750|NCT01308268|Mitosis Modulators|mitosis modulators|mesh-ancestor
6626751|NCT01308268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6626752|NCT01308268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6626753|NCT01308320|Fentanyl|fentanyl|mesh-list
6626754|NCT01308320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6626755|NCT01308320|Narcotics|narcotics|mesh-ancestor
6626756|NCT01308320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6626757|NCT01308320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480193|NCT01861106|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5480194|NCT01861106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6626758|NCT01308320|Analgesics|analgesics|mesh-ancestor
6626759|NCT01308320|Sensory System Agents|sensory system agents|mesh-ancestor
6626760|NCT01308320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6626761|NCT01308320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6626762|NCT01308320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6626763|NCT01308320|Anesthetics, General|anesthetics, general|mesh-ancestor
6626764|NCT01308320|Anesthetics|anesthetics|mesh-ancestor
6626765|NCT01308346|Everolimus|everolimus|mesh-list
5480195|NCT01861106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5480196|NCT01861106|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5480197|NCT01861106|Antitubercular Agents|antitubercular agents|mesh-ancestor
5480198|NCT01861106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5480199|NCT01861106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5480200|NCT01602666|Carboplatin|carboplatin|mesh-list
5480201|NCT01602666|Etoposide|etoposide|mesh-list
5480202|NCT01602666|Etoposide phosphate|etoposide phosphate|mesh-list
5480203|NCT01602666|Ifosfamide|ifosfamide|mesh-list
6626766|NCT01308346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6626767|NCT01308346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6626768|NCT01308346|Immunologic Factors|immunologic factors|mesh-ancestor
6626769|NCT01308346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626770|NCT01308437|Insulin|insulin|mesh-list
6626771|NCT01308437|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6626772|NCT01308437|Isophane Insulin, Human|isophane insulin, human|mesh-list
6626773|NCT01308437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6626774|NCT01308437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626775|NCT01308528|Enoxaparin|enoxaparin|mesh-list
6626776|NCT01308528|Enoxaparin sodium|enoxaparin sodium|mesh-list
6626777|NCT01308528|Anticoagulants|anticoagulants|mesh-ancestor
6626778|NCT01308528|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6626779|NCT01308528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6626780|NCT01308528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6626781|NCT01308541|Propofol|propofol|mesh-list
6626782|NCT01308541|Fospropofol|fospropofol|mesh-list
6626783|NCT01308541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6626784|NCT01308541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6626785|NCT01308541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626786|NCT01308541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6626787|NCT01308541|Anesthetics, General|anesthetics, general|mesh-ancestor
6626788|NCT01308541|Anesthetics|anesthetics|mesh-ancestor
6626789|NCT01308554|Bupivacaine|bupivacaine|mesh-list
6626790|NCT01308554|Anesthetics, Local|anesthetics, local|mesh-ancestor
6626791|NCT01308554|Anesthetics|anesthetics|mesh-ancestor
6626792|NCT01308554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6626793|NCT01308554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626794|NCT01308554|Sensory System Agents|sensory system agents|mesh-ancestor
6626795|NCT01308554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6626796|NCT01308606|Simeprevir|simeprevir|mesh-list
6626797|NCT01308606|Antiviral Agents|antiviral agents|mesh-ancestor
6626798|NCT01308606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6626799|NCT01308606|Protease Inhibitors|protease inhibitors|mesh-ancestor
6626800|NCT01308606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6626801|NCT01308606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6626802|NCT01308632|Irinotecan|irinotecan|mesh-list
6626803|NCT01308632|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6626804|NCT01308632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5480204|NCT01602666|Isophosphamide mustard|isophosphamide mustard|mesh-list
5480205|NCT01602666|Podophyllotoxin|podophyllotoxin|mesh-list
5480206|NCT01602666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6020922|NCT00395304|Glucocorticoids|glucocorticoids|mesh-ancestor
6626805|NCT01308632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6626806|NCT01308632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480207|NCT01602666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5480208|NCT01602666|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5480209|NCT01602666|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5480210|NCT01602666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5480211|NCT01602666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480212|NCT01602666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5480213|NCT01602666|Alkylating Agents|alkylating agents|mesh-ancestor
5480214|NCT01602666|Keratolytic Agents|keratolytic agents|mesh-ancestor
5480215|NCT01602666|Dermatologic Agents|dermatologic agents|mesh-ancestor
6626807|NCT01308632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6626808|NCT01308658|Ritonavir|ritonavir|mesh-list
6626809|NCT01308658|Darunavir|darunavir|mesh-list
6626810|NCT01308658|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6626811|NCT01308658|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6626812|NCT01308658|Protease Inhibitors|protease inhibitors|mesh-ancestor
6626813|NCT01308658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6626814|NCT01308658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6626815|NCT01308658|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6626816|NCT01308658|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6626817|NCT01308658|Antiviral Agents|antiviral agents|mesh-ancestor
6626818|NCT01308658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6626819|NCT01308658|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6626820|NCT01308658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6626821|NCT01308671|Varenicline|varenicline|mesh-list
6626822|NCT01308671|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6626823|NCT01308671|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6626824|NCT01308671|Cholinergic Agents|cholinergic agents|mesh-ancestor
6626825|NCT01308671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6626826|NCT01308671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6626827|NCT01308671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626828|NCT01308684|Bevacizumab|bevacizumab|mesh-list
6626829|NCT01308684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6626830|NCT01308684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6626831|NCT01308684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6626832|NCT01308684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6626833|NCT01308684|Growth Substances|growth substances|mesh-ancestor
6626834|NCT01308684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480216|NCT01602666|Tubulin Modulators|tubulin modulators|mesh-ancestor
5480217|NCT01602666|Antimitotic Agents|antimitotic agents|mesh-ancestor
5480218|NCT01602666|Mitosis Modulators|mitosis modulators|mesh-ancestor
6626835|NCT01308684|Growth Inhibitors|growth inhibitors|mesh-ancestor
6626836|NCT01308723|Sorafenib|sorafenib|mesh-list
6626837|NCT01308723|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6626838|NCT01308723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6626839|NCT01308723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6626840|NCT01308723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6626841|NCT01308723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6626842|NCT01308723|Immunologic Factors|immunologic factors|mesh-ancestor
6626843|NCT01308723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662377|NCT01503385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6662378|NCT01503385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6662379|NCT01503385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662380|NCT01503398|Olanzapine|olanzapine|mesh-list
6662381|NCT01503398|Antiemetics|antiemetics|mesh-ancestor
6662382|NCT01503398|Autonomic Agents|autonomic agents|mesh-ancestor
6662383|NCT01503398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6662384|NCT01503398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662385|NCT01503398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6662386|NCT01503398|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6662387|NCT01503398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6662388|NCT01503398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6662389|NCT01503398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6662390|NCT01503398|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6662391|NCT01503398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6662392|NCT01503398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6662393|NCT01503398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6626844|NCT01308944|Propranolol|propranolol|mesh-list
6626845|NCT01308944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6626846|NCT01308944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6626847|NCT01308944|Adrenergic Agents|adrenergic agents|mesh-ancestor
6626848|NCT01308944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6626849|NCT01308944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6626850|NCT01308944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626851|NCT01308944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6626852|NCT01308944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6626853|NCT01308944|Vasodilator Agents|vasodilator agents|mesh-ancestor
6626854|NCT01308983|Amiloride|amiloride|mesh-list
6626855|NCT01308983|Diuretics|diuretics|mesh-ancestor
6626856|NCT01308983|Natriuretic Agents|natriuretic agents|mesh-ancestor
6626857|NCT01308983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626858|NCT01308983|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
6626859|NCT01308983|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6626860|NCT01308983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6626861|NCT01308983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6626862|NCT01308983|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
6626863|NCT01308983|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6626864|NCT01309009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6626865|NCT01309009|MEN 11420|men 11420|mesh-list
6626866|NCT01309009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6626867|NCT01309009|Autonomic Agents|autonomic agents|mesh-ancestor
6626868|NCT01309009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6626869|NCT01309009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626870|NCT01309009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6626871|NCT01309009|Respiratory System Agents|respiratory system agents|mesh-ancestor
6451248|NCT00411190|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6451249|NCT00411190|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6451250|NCT00411190|Antimetabolites|antimetabolites|mesh-ancestor
6451251|NCT00411190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451252|NCT00411190|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6451253|NCT00411190|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6451254|NCT00411190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6451255|NCT00411190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6451256|NCT00411190|Analgesics|analgesics|mesh-ancestor
6451257|NCT00411190|Sensory System Agents|sensory system agents|mesh-ancestor
5480219|NCT01489813|Genistein|genistein|mesh-list
6451258|NCT00411190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6451259|NCT00411190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451260|NCT00411190|Antipyretics|antipyretics|mesh-ancestor
6451261|NCT00411190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6451262|NCT00411190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6451263|NCT00411190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6451264|NCT00411190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6451265|NCT00411203|Tamoxifen|tamoxifen|mesh-list
6451266|NCT00411203|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6451267|NCT00411203|Hormone Antagonists|hormone antagonists|mesh-ancestor
6451268|NCT00411203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6451269|NCT00411203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626872|NCT01309022|Mycophenolic Acid|mycophenolic acid|mesh-list
6626873|NCT01309022|Sirolimus|sirolimus|mesh-list
6626874|NCT01309022|Tacrolimus|tacrolimus|mesh-list
6626875|NCT01309022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6626876|NCT01309022|Immunologic Factors|immunologic factors|mesh-ancestor
6626877|NCT01309022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626878|NCT01309022|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6626879|NCT01309022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6626880|NCT01309022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6626881|NCT01309022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6451270|NCT00411203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6451271|NCT00411203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6451272|NCT00411203|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6451273|NCT00411203|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6451274|NCT00411203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6451275|NCT00411229|Capecitabine|capecitabine|mesh-list
6451276|NCT00411229|Oxaliplatin|oxaliplatin|mesh-list
6451277|NCT00411229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6451278|NCT00411229|Antimetabolites|antimetabolites|mesh-ancestor
6451279|NCT00411229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451280|NCT00411229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6451281|NCT00411268|Hydromorphone|hydromorphone|mesh-list
6451282|NCT00411268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6626882|NCT01309022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6626883|NCT01309022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6626884|NCT01309022|Antitubercular Agents|antitubercular agents|mesh-ancestor
6626885|NCT01309022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6626886|NCT01309022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6626887|NCT01309022|Antifungal Agents|antifungal agents|mesh-ancestor
6626888|NCT01309074|Pregabalin|pregabalin|mesh-list
6451283|NCT00411268|Narcotics|narcotics|mesh-ancestor
6451284|NCT00411268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6451285|NCT00411268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451286|NCT00411268|Analgesics|analgesics|mesh-ancestor
6451287|NCT00411268|Sensory System Agents|sensory system agents|mesh-ancestor
6451288|NCT00411268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6451289|NCT00411281|Cytarabine|cytarabine|mesh-list
6451290|NCT00411281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6451291|NCT00411281|Antimetabolites|antimetabolites|mesh-ancestor
6451292|NCT00411281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451293|NCT00411281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6451294|NCT00411281|Antiviral Agents|antiviral agents|mesh-ancestor
6451295|NCT00411281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6451296|NCT00411281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6451297|NCT00411281|Immunologic Factors|immunologic factors|mesh-ancestor
6451298|NCT00411281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451299|NCT00411307|Hydromorphone|hydromorphone|mesh-list
6451300|NCT00411307|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6451301|NCT00411307|Narcotics|narcotics|mesh-ancestor
6451302|NCT00411307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6451303|NCT00411307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451304|NCT00411307|Analgesics|analgesics|mesh-ancestor
6451305|NCT00411307|Sensory System Agents|sensory system agents|mesh-ancestor
6451306|NCT00411307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6451307|NCT00411320|Dexamethasone|dexamethasone|mesh-list
6451308|NCT00411320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6451309|NCT00411320|Antiemetics|antiemetics|mesh-ancestor
6451310|NCT00411320|Autonomic Agents|autonomic agents|mesh-ancestor
6626889|NCT01309074|Sertraline|sertraline|mesh-list
5480220|NCT01489813|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5480221|NCT01489813|Protective Agents|protective agents|mesh-ancestor
5480222|NCT01489813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480223|NCT01489813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6451311|NCT00411320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6451312|NCT00411320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480224|NCT01489813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5480225|NCT01489813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6626890|NCT01309074|Analgesics|analgesics|mesh-ancestor
6626891|NCT01309074|Sensory System Agents|sensory system agents|mesh-ancestor
6626892|NCT01309074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6626893|NCT01309074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626894|NCT01309074|Anticonvulsants|anticonvulsants|mesh-ancestor
6626895|NCT01309074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6626896|NCT01309074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6626897|NCT01309074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6626898|NCT01309074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6626899|NCT01309074|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6626900|NCT01309074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6626901|NCT01309074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6626902|NCT01309074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6626903|NCT01309074|Antidepressive Agents|antidepressive agents|mesh-ancestor
6626904|NCT01309074|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6626905|NCT01309074|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6626906|NCT01309074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6626907|NCT01309074|Serotonin Agents|serotonin agents|mesh-ancestor
6626908|NCT01309126|Cetuximab|cetuximab|mesh-list
6626909|NCT01309126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6626910|NCT01309126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5480226|NCT01489813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480227|NCT01489813|Phytoestrogens|phytoestrogens|mesh-ancestor
5480228|NCT01489813|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
5480229|NCT01489813|Estrogens|estrogens|mesh-ancestor
5480230|NCT01489813|Hormones|hormones|mesh-ancestor
5480231|NCT01489813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5480232|NCT01375959|Resveratrol|resveratrol|mesh-list
5480233|NCT01375959|Antioxidants|antioxidants|mesh-ancestor
5480234|NCT01375959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480235|NCT01375959|Protective Agents|protective agents|mesh-ancestor
5480236|NCT01375959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480237|NCT01375959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5480238|NCT01375959|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5480239|NCT00567567|Vitamin A|vitamin a|mesh-list
5480240|NCT00567567|Cyclophosphamide|cyclophosphamide|mesh-list
5480241|NCT00567567|Melphalan|melphalan|mesh-list
5480242|NCT00567567|Mechlorethamine|mechlorethamine|mesh-list
5480243|NCT00567567|Thiotepa|thiotepa|mesh-list
5480244|NCT00567567|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
5480245|NCT00567567|Cisplatin|cisplatin|mesh-list
5480246|NCT00567567|Carboplatin|carboplatin|mesh-list
6626911|NCT01309139|Tiotropium Bromide|tiotropium bromide|mesh-list
6626912|NCT01309139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6626913|NCT01309139|Autonomic Agents|autonomic agents|mesh-ancestor
6626914|NCT01309139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6626915|NCT01309139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626916|NCT01309139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6626917|NCT01309139|Respiratory System Agents|respiratory system agents|mesh-ancestor
6626918|NCT01309139|Parasympatholytics|parasympatholytics|mesh-ancestor
6626919|NCT01309139|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6626920|NCT01309139|Cholinergic Agents|cholinergic agents|mesh-ancestor
6626921|NCT01309139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6626922|NCT01309139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480247|NCT00567567|Doxorubicin|doxorubicin|mesh-list
5480248|NCT00567567|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5480249|NCT00567567|Etoposide|etoposide|mesh-list
5480250|NCT00567567|Vincristine|vincristine|mesh-list
5480251|NCT00567567|Etoposide phosphate|etoposide phosphate|mesh-list
5480252|NCT00567567|Topotecan|topotecan|mesh-list
5480253|NCT00567567|Tretinoin|tretinoin|mesh-list
5480254|NCT00567567|Podophyllotoxin|podophyllotoxin|mesh-list
5480255|NCT00567567|Isotretinoin|isotretinoin|mesh-list
5480256|NCT00567567|Lenograstim|lenograstim|mesh-list
6626923|NCT01309178|Mannitol|mannitol|mesh-list
6626924|NCT01309178|Amitriptyline|amitriptyline|mesh-list
6626925|NCT01309178|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6626926|NCT01309178|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6626927|NCT01309178|Antidepressive Agents|antidepressive agents|mesh-ancestor
6626928|NCT01309178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6626929|NCT01309178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6626930|NCT01309178|Analgesics|analgesics|mesh-ancestor
6626931|NCT01309178|Sensory System Agents|sensory system agents|mesh-ancestor
6626932|NCT01309178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6626933|NCT01309178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626934|NCT01309178|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6626935|NCT01309178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5480257|NCT00567567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5480258|NCT00567567|Immunologic Factors|immunologic factors|mesh-ancestor
5480259|NCT00567567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480260|NCT00567567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5480261|NCT00567567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5480262|NCT00567567|Alkylating Agents|alkylating agents|mesh-ancestor
5480263|NCT00567567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480264|NCT00567567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6626936|NCT01309178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6626937|NCT01309178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6626938|NCT01309178|Adrenergic Agents|adrenergic agents|mesh-ancestor
6626939|NCT01309178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6626940|NCT01309178|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6626941|NCT01309178|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6626942|NCT01309178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6626943|NCT01309178|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6626944|NCT01309178|Diuretics|diuretics|mesh-ancestor
6626945|NCT01309178|Natriuretic Agents|natriuretic agents|mesh-ancestor
6626946|NCT01309191|Minoxidil|minoxidil|mesh-list
6626947|NCT01309191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6626948|NCT01309191|Vasodilator Agents|vasodilator agents|mesh-ancestor
6626949|NCT01309399|Teriparatide|teriparatide|mesh-list
6626950|NCT01309399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6626951|NCT01309399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626952|NCT01309399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6626953|NCT01309412|Siltuximab|siltuximab|mesh-list
6626954|NCT01309412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6626955|NCT01309425|Tapentadol|tapentadol|mesh-list
6626956|NCT01309425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6626957|NCT01309425|Narcotics|narcotics|mesh-ancestor
6626958|NCT01309425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6626959|NCT01309425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626960|NCT01309425|Analgesics|analgesics|mesh-ancestor
6626961|NCT01309425|Sensory System Agents|sensory system agents|mesh-ancestor
6626962|NCT01309425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6626963|NCT01309425|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6626964|NCT01309425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6626965|NCT01309425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6626966|NCT01309425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6626967|NCT01309425|Adrenergic Agents|adrenergic agents|mesh-ancestor
6626968|NCT01309425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6626969|NCT01309438|Erythromycin|erythromycin|mesh-list
6626970|NCT01309438|Erythromycin Estolate|erythromycin estolate|mesh-list
6626971|NCT01309438|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
6626972|NCT01309438|Erythromycin stearate|erythromycin stearate|mesh-list
6626973|NCT01309438|Rivaroxaban|rivaroxaban|mesh-list
6626974|NCT01309438|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6626975|NCT01309438|Antithrombins|antithrombins|mesh-ancestor
6626976|NCT01309438|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6626977|NCT01309438|Protease Inhibitors|protease inhibitors|mesh-ancestor
6626978|NCT01309438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6626979|NCT01309438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6626980|NCT01309438|Anticoagulants|anticoagulants|mesh-ancestor
6626981|NCT01309438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6626982|NCT01309438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6626983|NCT01309438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6626984|NCT01309438|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6626985|NCT01309477|Tacrolimus|tacrolimus|mesh-list
6626986|NCT01309477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6626987|NCT01309477|Immunologic Factors|immunologic factors|mesh-ancestor
6626988|NCT01309477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6626989|NCT01309477|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6626990|NCT01309477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6626991|NCT01309477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6626992|NCT01309490|Ribavirin|ribavirin|mesh-list
6626993|NCT01309490|Antimetabolites|antimetabolites|mesh-ancestor
6626994|NCT01309490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6626995|NCT01309490|Antiviral Agents|antiviral agents|mesh-ancestor
6626996|NCT01309490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6626997|NCT01309542|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6626998|NCT01309542|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5480265|NCT00567567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5480266|NCT00567567|Vitamins|vitamins|mesh-ancestor
5480267|NCT00567567|Micronutrients|micronutrients|mesh-ancestor
5480268|NCT00567567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5480269|NCT00567567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5480270|NCT00567567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6626999|NCT01309542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6627000|NCT01309542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5480271|NCT00567567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5480272|NCT00567567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5480273|NCT00567567|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5480274|NCT00567567|Tubulin Modulators|tubulin modulators|mesh-ancestor
5480275|NCT00567567|Antimitotic Agents|antimitotic agents|mesh-ancestor
5480276|NCT00567567|Mitosis Modulators|mitosis modulators|mesh-ancestor
5480277|NCT00567567|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6627001|NCT01309542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627002|NCT01309542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6627003|NCT01309542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627004|NCT01309542|Antidepressive Agents|antidepressive agents|mesh-ancestor
6627005|NCT01309542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6627006|NCT01309607|Paclitaxel|paclitaxel|mesh-list
6627007|NCT01309607|Carboplatin|carboplatin|mesh-list
6627008|NCT01309607|Lapatinib|lapatinib|mesh-list
6627009|NCT01309607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6627010|NCT01309607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6627011|NCT01309607|Tubulin Modulators|tubulin modulators|mesh-ancestor
6627012|NCT01309607|Antimitotic Agents|antimitotic agents|mesh-ancestor
6627013|NCT01309607|Mitosis Modulators|mitosis modulators|mesh-ancestor
6627014|NCT01309607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627015|NCT01309607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6627016|NCT01309607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6627017|NCT01309620|Zinc|zinc|mesh-list
6627018|NCT01309620|Trace Elements|trace elements|mesh-ancestor
6627019|NCT01309620|Micronutrients|micronutrients|mesh-ancestor
6627020|NCT01309620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627021|NCT01309633|Gemcitabine|gemcitabine|mesh-list
6627022|NCT01309633|Bevacizumab|bevacizumab|mesh-list
6627023|NCT01309633|Sunitinib|sunitinib|mesh-list
6627024|NCT01309633|Cisplatin|cisplatin|mesh-list
6627025|NCT01309633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6627026|NCT01309633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6627027|NCT01309633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6627028|NCT01309633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6627029|NCT01309633|Growth Substances|growth substances|mesh-ancestor
6627030|NCT01309633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480278|NCT00567567|Keratolytic Agents|keratolytic agents|mesh-ancestor
5480279|NCT00567567|Dermatologic Agents|dermatologic agents|mesh-ancestor
5480280|NCT00380653|Sapacitabine|sapacitabine|mesh-list
5480281|NCT00380653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6627031|NCT01309633|Growth Inhibitors|growth inhibitors|mesh-ancestor
6627032|NCT01309633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6627033|NCT01309633|Antimetabolites|antimetabolites|mesh-ancestor
6627034|NCT01309633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627035|NCT01309633|Antiviral Agents|antiviral agents|mesh-ancestor
6627036|NCT01309633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6627037|NCT01309633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6627038|NCT01309633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6627039|NCT01309633|Immunologic Factors|immunologic factors|mesh-ancestor
6627040|NCT01309633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6627041|NCT01309685|Varenicline|varenicline|mesh-list
6627042|NCT01309685|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6627043|NCT01309685|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5480282|NCT00354835|Dactinomycin|dactinomycin|mesh-list
5480283|NCT00354835|Cyclophosphamide|cyclophosphamide|mesh-list
5480284|NCT00354835|Irinotecan|irinotecan|mesh-list
5480285|NCT00354835|Vincristine|vincristine|mesh-list
5480286|NCT00354835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5480287|NCT00354835|Immunologic Factors|immunologic factors|mesh-ancestor
5480288|NCT00354835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480289|NCT00354835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5480290|NCT00354835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5480291|NCT00354835|Alkylating Agents|alkylating agents|mesh-ancestor
5480292|NCT00354835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480293|NCT00354835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6627044|NCT01309685|Cholinergic Agents|cholinergic agents|mesh-ancestor
6627045|NCT01309685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6627046|NCT01309685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627047|NCT01309685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627048|NCT01309698|Inositol|inositol|mesh-list
6627049|NCT01309698|Vildagliptin|vildagliptin|mesh-list
6627050|NCT01309698|Voglibose|voglibose|mesh-list
5480294|NCT00354835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5480295|NCT00354835|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6627051|NCT01309698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6627052|NCT01309698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627053|NCT01309698|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6627054|NCT01309698|Protease Inhibitors|protease inhibitors|mesh-ancestor
6627055|NCT01309698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6627056|NCT01309698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627057|NCT01309698|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6627058|NCT01309698|Vitamin B Complex|vitamin b complex|mesh-ancestor
6627059|NCT01309698|Vitamins|vitamins|mesh-ancestor
6627060|NCT01309698|Micronutrients|micronutrients|mesh-ancestor
6627061|NCT01309776|Citalopram|citalopram|mesh-list
6627062|NCT01309776|Tianeptine|tianeptine|mesh-list
6627063|NCT01309776|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6627064|NCT01309776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6627065|NCT01309776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6627066|NCT01309776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627067|NCT01309776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6627068|NCT01309776|Serotonin Agents|serotonin agents|mesh-ancestor
6627069|NCT01309776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627070|NCT01309776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6627071|NCT01309776|Antidepressive Agents|antidepressive agents|mesh-ancestor
6627072|NCT01309776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6627073|NCT01309776|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6627074|NCT01309789|Prednisone|prednisone|mesh-list
6627075|NCT01309789|Cyclophosphamide|cyclophosphamide|mesh-list
6627076|NCT01309789|Doxorubicin|doxorubicin|mesh-list
5480296|NCT00354835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5480297|NCT00354835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5480298|NCT00354835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5480299|NCT00354835|Tubulin Modulators|tubulin modulators|mesh-ancestor
5480300|NCT00354835|Antimitotic Agents|antimitotic agents|mesh-ancestor
5480301|NCT00354835|Mitosis Modulators|mitosis modulators|mesh-ancestor
5480302|NCT00354835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5480303|NCT00354835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6627077|NCT01309789|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6627078|NCT01309789|Vincristine|vincristine|mesh-list
6627079|NCT01309789|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6627080|NCT01309789|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6627081|NCT01309789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6627082|NCT01309789|Immunologic Factors|immunologic factors|mesh-ancestor
6627083|NCT01309789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627084|NCT01309789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6627085|NCT01309789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6627086|NCT01309789|Alkylating Agents|alkylating agents|mesh-ancestor
6627087|NCT01309789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627088|NCT01309789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5480304|NCT00354835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5480305|NCT00354835|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5480306|NCT00354835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5480307|NCT05157269|Nitazoxanide|nitazoxanide|mesh-list
5480308|NCT05157269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5480309|NCT05157269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5480310|NCT05157243|Nitazoxanide|nitazoxanide|mesh-list
5480311|NCT05157243|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5480312|NCT05157243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5480313|NCT05156970|Carboplatin|carboplatin|mesh-list
5480314|NCT05156970|Docetaxel|docetaxel|mesh-list
6451313|NCT00411320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6451314|NCT00411320|Glucocorticoids|glucocorticoids|mesh-ancestor
6451315|NCT00411320|Hormones|hormones|mesh-ancestor
6451316|NCT00411320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6451317|NCT00411320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6451318|NCT00411320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6451319|NCT00411333|Triamcinolone|triamcinolone|mesh-list
6451320|NCT00411333|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6451321|NCT00411333|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6451322|NCT00411333|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6451323|NCT00411333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6627089|NCT01309789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5480315|NCT05156970|Apatinib|apatinib|mesh-list
5480316|NCT05156970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5480317|NCT05156970|Tubulin Modulators|tubulin modulators|mesh-ancestor
5480318|NCT05156970|Antimitotic Agents|antimitotic agents|mesh-ancestor
6627090|NCT01309789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6627091|NCT01309789|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6627092|NCT01309789|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6627093|NCT01309789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6627094|NCT01309789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6627095|NCT01309789|Glucocorticoids|glucocorticoids|mesh-ancestor
6627096|NCT01309789|Hormones|hormones|mesh-ancestor
6627097|NCT01309789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6627098|NCT01309789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6627099|NCT01309789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6627100|NCT01309789|Tubulin Modulators|tubulin modulators|mesh-ancestor
6627101|NCT01309789|Antimitotic Agents|antimitotic agents|mesh-ancestor
6627102|NCT01309789|Mitosis Modulators|mitosis modulators|mesh-ancestor
6627103|NCT01309789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6627104|NCT01309854|Pioglitazone|pioglitazone|mesh-list
6627105|NCT01309854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6627106|NCT01309854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627107|NCT01309984|Propofol|propofol|mesh-list
6627108|NCT01309984|Fospropofol|fospropofol|mesh-list
6627109|NCT01309984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6627110|NCT01309984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6451324|NCT00411333|Glucocorticoids|glucocorticoids|mesh-ancestor
6451325|NCT00411333|Hormones|hormones|mesh-ancestor
6451326|NCT00411333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6627111|NCT01309984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627112|NCT01309984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6627113|NCT01309984|Anesthetics, General|anesthetics, general|mesh-ancestor
6627114|NCT01309984|Anesthetics|anesthetics|mesh-ancestor
6627115|NCT01310010|Dasatinib|dasatinib|mesh-list
6627116|NCT01310010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6627117|NCT01310010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6627118|NCT01310010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6627119|NCT01310010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627120|NCT01310101|Dexamethasone|dexamethasone|mesh-list
6627121|NCT01310101|Ofatumumab|ofatumumab|mesh-list
6627122|NCT01310101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6627123|NCT01310101|Antiemetics|antiemetics|mesh-ancestor
6627124|NCT01310101|Autonomic Agents|autonomic agents|mesh-ancestor
6627125|NCT01310101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6627126|NCT01310101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627127|NCT01310101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6627128|NCT01310101|Glucocorticoids|glucocorticoids|mesh-ancestor
6627129|NCT01310101|Hormones|hormones|mesh-ancestor
6627130|NCT01310101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6627131|NCT01310101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6627132|NCT01310101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6627133|NCT01310166|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6627134|NCT01310166|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6627135|NCT01310166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627136|NCT01310166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6627137|NCT01310166|Immunologic Factors|immunologic factors|mesh-ancestor
6627138|NCT01310166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627139|NCT01310192|Choline|choline|mesh-list
6627140|NCT01310192|Lipotropic Agents|lipotropic agents|mesh-ancestor
6627141|NCT01310192|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6627142|NCT01310192|Antimetabolites|antimetabolites|mesh-ancestor
6627143|NCT01310192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627144|NCT01310192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6627145|NCT01310192|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6627146|NCT01310192|Nootropic Agents|nootropic agents|mesh-ancestor
6627147|NCT01310244|Paclitaxel|paclitaxel|mesh-list
6627148|NCT01310244|Carboplatin|carboplatin|mesh-list
6451327|NCT00411333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451328|NCT00411333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6451329|NCT00411333|Immunologic Factors|immunologic factors|mesh-ancestor
6451330|NCT00411333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6451331|NCT00411333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451332|NCT00411372|Fluticasone|fluticasone|mesh-list
6451333|NCT00411372|Xhance|xhance|mesh-list
5480319|NCT05156970|Mitosis Modulators|mitosis modulators|mesh-ancestor
6020923|NCT00395304|Hormones|hormones|mesh-ancestor
6451334|NCT00411372|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6627149|NCT01310244|Belinostat|belinostat|mesh-list
6627150|NCT01310244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6627151|NCT01310244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6627152|NCT01310244|Tubulin Modulators|tubulin modulators|mesh-ancestor
6627153|NCT01310244|Antimitotic Agents|antimitotic agents|mesh-ancestor
6627154|NCT01310244|Mitosis Modulators|mitosis modulators|mesh-ancestor
6627155|NCT01310244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627156|NCT01310244|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6627157|NCT01310244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6627158|NCT01310283|Fluorides|fluorides|mesh-list
6627159|NCT01310283|Fluorides, Topical|fluorides, topical|mesh-list
6627160|NCT01310283|Cariostatic Agents|cariostatic agents|mesh-ancestor
6627161|NCT01310283|Protective Agents|protective agents|mesh-ancestor
6627162|NCT01310283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627163|NCT01310296|Lofexidine|lofexidine|mesh-list
6627164|NCT01310296|Clonidine|clonidine|mesh-list
6627165|NCT01310296|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6627166|NCT01310296|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6627167|NCT01310296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627168|NCT01310296|Sensory System Agents|sensory system agents|mesh-ancestor
6627169|NCT01310296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6627170|NCT01310296|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6627171|NCT01310296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6627172|NCT01310296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6627173|NCT01310296|Adrenergic Agents|adrenergic agents|mesh-ancestor
6627174|NCT01310296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6627175|NCT01310296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627176|NCT01310296|Analgesics|analgesics|mesh-ancestor
6627177|NCT01310296|Sympatholytics|sympatholytics|mesh-ancestor
6627178|NCT01310296|Autonomic Agents|autonomic agents|mesh-ancestor
6627179|NCT01310361|Amoxicillin|amoxicillin|mesh-list
6627180|NCT01310361|Penicillins|penicillins|mesh-list
6627181|NCT01310361|Penicillin G|penicillin g|mesh-list
6627182|NCT01310361|Penicillin G Benzathine|penicillin g benzathine|mesh-list
6627183|NCT01310361|Penicillin G Procaine|penicillin g procaine|mesh-list
6627184|NCT01310361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6627185|NCT01310361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6627186|NCT01310452|Insulin|insulin|mesh-list
6627187|NCT01310452|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6627188|NCT01310452|Insulin Detemir|insulin detemir|mesh-list
6627189|NCT01310452|Protamines|protamines|mesh-list
6627190|NCT01310452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6627191|NCT01310452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627192|NCT01310452|Heparin Antagonists|heparin antagonists|mesh-ancestor
5480320|NCT05156970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480321|NCT05156970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5480322|NCT05156970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5480323|NCT05156892|Tamoxifen|tamoxifen|mesh-list
5480324|NCT05156892|Itraconazole|itraconazole|mesh-list
5480325|NCT05156892|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5480326|NCT05156892|Hormone Antagonists|hormone antagonists|mesh-ancestor
6020924|NCT00395304|Sympathomimetics|sympathomimetics|mesh-ancestor
6627193|NCT01310452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627194|NCT01310452|Coagulants|coagulants|mesh-ancestor
6627195|NCT01310465|Zoledronic Acid|zoledronic acid|mesh-list
6627196|NCT01310465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6627197|NCT01310465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627198|NCT01310478|Endostatins|endostatins|mesh-list
6627199|NCT01310478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6627200|NCT01310478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6627201|NCT01310478|Growth Substances|growth substances|mesh-ancestor
6627202|NCT01310478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627203|NCT01310478|Growth Inhibitors|growth inhibitors|mesh-ancestor
6627204|NCT01310478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6627205|NCT01310621|Pulmonary Surfactants|pulmonary surfactants|mesh-list
6627206|NCT01310621|Respiratory System Agents|respiratory system agents|mesh-ancestor
6627207|NCT01310647|Estradiol|estradiol|mesh-list
6627208|NCT01310647|Testosterone|testosterone|mesh-list
6627209|NCT01310647|Estrogens|estrogens|mesh-ancestor
6627210|NCT01310647|Hormones|hormones|mesh-ancestor
6627211|NCT01310647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6627212|NCT01310647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627213|NCT01310647|Androgens|androgens|mesh-ancestor
6662394|NCT01503398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6662395|NCT01503398|Serotonin Agents|serotonin agents|mesh-ancestor
6662396|NCT01503424|Olanzapine|olanzapine|mesh-list
6662397|NCT01503424|Antiemetics|antiemetics|mesh-ancestor
6662398|NCT01503424|Autonomic Agents|autonomic agents|mesh-ancestor
6627214|NCT01310673|Allopurinol|allopurinol|mesh-list
6627215|NCT01310673|Antimetabolites|antimetabolites|mesh-ancestor
6627216|NCT01310673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627217|NCT01310673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6627218|NCT01310673|Gout Suppressants|gout suppressants|mesh-ancestor
6627219|NCT01310673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6627220|NCT01310673|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6627221|NCT01310673|Antioxidants|antioxidants|mesh-ancestor
6627222|NCT01310673|Protective Agents|protective agents|mesh-ancestor
6627223|NCT01310673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627224|NCT01310712|Oxybutynin|oxybutynin|mesh-list
6627225|NCT01310712|Parasympatholytics|parasympatholytics|mesh-ancestor
6627226|NCT01310712|Autonomic Agents|autonomic agents|mesh-ancestor
6627227|NCT01310712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5480327|NCT05156892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5480328|NCT05156892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480329|NCT05156892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5480330|NCT05156892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5480331|NCT05156892|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5480332|NCT05156892|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5480333|NCT05156892|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5480334|NCT05156892|Antifungal Agents|antifungal agents|mesh-ancestor
5480335|NCT05156892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5480336|NCT05156892|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5480337|NCT05156892|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5480338|NCT05156892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5480339|NCT05156892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480340|NCT05156892|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5480341|NCT05156892|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5480342|NCT05156788|Lenvatinib|lenvatinib|mesh-list
5480343|NCT05156788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5480344|NCT05156788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5480345|NCT05156788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5480346|NCT05156788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480347|NCT05156749|Calpastatin|calpastatin|mesh-list
5480348|NCT05156749|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
5480349|NCT05156749|Protease Inhibitors|protease inhibitors|mesh-ancestor
5480350|NCT05156749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5480351|NCT05156749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480352|NCT05156658|Etonogestrel|etonogestrel|mesh-list
5480353|NCT05156658|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5480354|NCT05156658|Contraceptive Agents|contraceptive agents|mesh-ancestor
6627228|NCT01310712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627229|NCT01310712|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6627230|NCT01310712|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6627231|NCT01310712|Cholinergic Agents|cholinergic agents|mesh-ancestor
6627232|NCT01310712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6627233|NCT01310712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627234|NCT01310712|Urological Agents|urological agents|mesh-ancestor
6627235|NCT01310738|Amphotericin B|amphotericin b|mesh-list
6627236|NCT01310738|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6627237|NCT01310738|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
6627238|NCT01310738|Meglumine Antimoniate|meglumine antimoniate|mesh-list
6627239|NCT01310738|Deoxycholic Acid|deoxycholic acid|mesh-list
6627240|NCT01310738|Amebicides|amebicides|mesh-ancestor
6627241|NCT01310738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6627242|NCT01310738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6627243|NCT01310738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6627244|NCT01310738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6627245|NCT01310738|Antifungal Agents|antifungal agents|mesh-ancestor
6627246|NCT01310738|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6627247|NCT01310738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6627248|NCT01310751|Iloprost|iloprost|mesh-list
6627249|NCT01310751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6627250|NCT01310751|Vasodilator Agents|vasodilator agents|mesh-ancestor
6627251|NCT01310842|Nicotine|nicotine|mesh-list
6627252|NCT01310842|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6627253|NCT01310842|Autonomic Agents|autonomic agents|mesh-ancestor
6627254|NCT01310842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6627255|NCT01310842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627256|NCT01310842|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6627257|NCT01310842|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6627258|NCT01310842|Cholinergic Agents|cholinergic agents|mesh-ancestor
6627259|NCT01310842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6627260|NCT01310842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627261|NCT01310985|Capecitabine|capecitabine|mesh-list
6627262|NCT01310985|Cetuximab|cetuximab|mesh-list
6627263|NCT01310985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6627264|NCT01310985|Antimetabolites|antimetabolites|mesh-ancestor
6627265|NCT01310985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627266|NCT01310985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6627267|NCT01310985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6627268|NCT01311037|Aromatase Inhibitors|aromatase inhibitors|mesh-list
6627269|NCT01311037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6627270|NCT01311037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6627271|NCT01311037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627272|NCT01311037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6627273|NCT01311037|Hormone Antagonists|hormone antagonists|mesh-ancestor
6627274|NCT01311037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6627275|NCT01311037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627276|NCT01311050|Bevacizumab|bevacizumab|mesh-list
6627277|NCT01311050|Capecitabine|capecitabine|mesh-list
6627278|NCT01311050|Oxaliplatin|oxaliplatin|mesh-list
6627279|NCT01311050|Irinotecan|irinotecan|mesh-list
6627280|NCT01311050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6627281|NCT01311050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6627282|NCT01311050|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6627283|NCT01311050|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6627284|NCT01311050|Growth Substances|growth substances|mesh-ancestor
6627285|NCT01311050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480355|NCT05156658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5480356|NCT05156658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480357|NCT05156658|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5480358|NCT05156632|Aluminum Hydroxide|aluminum hydroxide|mesh-list
5480359|NCT05156632|Vaccines|vaccines|mesh-list
5480360|NCT05156632|Immunologic Factors|immunologic factors|mesh-ancestor
5480361|NCT05156632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627286|NCT01311050|Growth Inhibitors|growth inhibitors|mesh-ancestor
6627287|NCT01311050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6627288|NCT01311050|Antimetabolites|antimetabolites|mesh-ancestor
6627289|NCT01311050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627290|NCT01311050|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6627291|NCT01311050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5480362|NCT05156632|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5480363|NCT05156632|Antacids|antacids|mesh-ancestor
5480364|NCT05156632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480365|NCT05156632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5480366|NCT05156606|Testosterone|testosterone|mesh-list
5480367|NCT05156606|Androgens|androgens|mesh-ancestor
5480368|NCT05156606|Hormones|hormones|mesh-ancestor
5480369|NCT05156606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5480370|NCT05156606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480371|NCT05156541|Interferons|interferons|mesh-list
5480372|NCT05156541|Interferon-gamma|interferon-gamma|mesh-list
5480373|NCT05156541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5480374|NCT05156541|Antiviral Agents|antiviral agents|mesh-ancestor
5480375|NCT05156541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5724868|NCT03184649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480376|NCT05156450|Prednisone|prednisone|mesh-list
5480377|NCT05156450|Abiraterone Acetate|abiraterone acetate|mesh-list
5480378|NCT05156450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5480379|NCT05156450|Glucocorticoids|glucocorticoids|mesh-ancestor
5480380|NCT05156450|Hormones|hormones|mesh-ancestor
5480381|NCT05156450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5480382|NCT05156450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480383|NCT05156450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5480384|NCT05156450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5480385|NCT05156450|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5480386|NCT05156450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5480387|NCT05156450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480388|NCT05156450|Hormone Antagonists|hormone antagonists|mesh-ancestor
5480389|NCT05156450|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6627292|NCT01311050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6627293|NCT01311076|Insulin|insulin|mesh-list
6627294|NCT01311076|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6627295|NCT01311076|Insulin Lispro|insulin lispro|mesh-list
6627296|NCT01311076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6627297|NCT01311076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627298|NCT01311141|Doripenem|doripenem|mesh-list
6627299|NCT01311141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6627300|NCT01311141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6627301|NCT01311167|Dexamethasone|dexamethasone|mesh-list
5502317|NCT04467983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5502318|NCT04467983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502319|NCT04467463|Levobupivacaine|levobupivacaine|mesh-list
5502320|NCT04467463|Anesthetics, Local|anesthetics, local|mesh-ancestor
5502321|NCT04467463|Anesthetics|anesthetics|mesh-ancestor
5502322|NCT04467463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5502323|NCT04467463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502324|NCT04467463|Sensory System Agents|sensory system agents|mesh-ancestor
5502325|NCT04467463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5502326|NCT04467450|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5502327|NCT04467450|Botulinum Toxins|botulinum toxins|mesh-list
5502328|NCT04467450|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5502329|NCT04467450|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5502330|NCT04467450|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5502331|NCT04467450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5503629|NCT04456959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6627302|NCT01311167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6627303|NCT01311167|Antiemetics|antiemetics|mesh-ancestor
6627304|NCT01311167|Autonomic Agents|autonomic agents|mesh-ancestor
6627305|NCT01311167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6627306|NCT01311167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627307|NCT01311167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6627308|NCT01311167|Glucocorticoids|glucocorticoids|mesh-ancestor
6627309|NCT01311167|Hormones|hormones|mesh-ancestor
6627310|NCT01311167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6627311|NCT01311167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6627312|NCT01311167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6627313|NCT01311336|Loratadine|loratadine|mesh-list
6627314|NCT01311336|Antipruritics|antipruritics|mesh-ancestor
6627315|NCT01311336|Dermatologic Agents|dermatologic agents|mesh-ancestor
6627316|NCT01311336|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6627317|NCT01311336|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6627318|NCT01311336|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6627319|NCT01311336|Histamine Antagonists|histamine antagonists|mesh-ancestor
6627320|NCT01311336|Histamine Agents|histamine agents|mesh-ancestor
6627321|NCT01311336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6627322|NCT01311336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627323|NCT01311336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627324|NCT01311414|Urapidil|urapidil|mesh-list
6627325|NCT01311414|Theodrenaline|theodrenaline|mesh-list
6627326|NCT01311414|Cafedrine|cafedrine|mesh-list
6627327|NCT01311414|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6627328|NCT01311414|Vasodilator Agents|vasodilator agents|mesh-ancestor
6627329|NCT01311414|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6627330|NCT01311414|Serotonin Agents|serotonin agents|mesh-ancestor
6627331|NCT01311414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6627332|NCT01311414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627333|NCT01311414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627334|NCT01311414|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6020925|NCT00395343|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6627335|NCT01311414|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5480390|NCT05156385|Antihypertensive Agents|antihypertensive agents|mesh-list
5480391|NCT05156021|Bevacizumab|bevacizumab|mesh-list
5480392|NCT05156021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5480393|NCT05156021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6627336|NCT01311414|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6627337|NCT01311414|Adrenergic Agents|adrenergic agents|mesh-ancestor
6627338|NCT01311570|Buprenorphine|buprenorphine|mesh-list
6627339|NCT01311570|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6627340|NCT01311570|Narcotics|narcotics|mesh-ancestor
6627341|NCT01311570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6627342|NCT01311570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627343|NCT01311570|Analgesics|analgesics|mesh-ancestor
6627344|NCT01311570|Sensory System Agents|sensory system agents|mesh-ancestor
6627345|NCT01311570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6627346|NCT01311570|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6627347|NCT01311622|Warfarin|warfarin|mesh-list
6627348|NCT01311622|Anticoagulants|anticoagulants|mesh-ancestor
6627349|NCT01311700|Metoprolol|metoprolol|mesh-list
6627350|NCT01311700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6627351|NCT01311700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6627352|NCT01311700|Sympatholytics|sympatholytics|mesh-ancestor
6627353|NCT01311700|Autonomic Agents|autonomic agents|mesh-ancestor
6627354|NCT01311700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6627355|NCT01311700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627356|NCT01311700|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6627357|NCT01311700|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6627358|NCT01311700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6627359|NCT01311700|Adrenergic Agents|adrenergic agents|mesh-ancestor
6627360|NCT01311700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6627361|NCT01311700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627362|NCT01311739|Vitamin B 12|vitamin b 12|mesh-list
6451335|NCT00411372|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6451336|NCT00411372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6451337|NCT00411372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6451338|NCT00411372|Autonomic Agents|autonomic agents|mesh-ancestor
6451339|NCT00411372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6451340|NCT00411372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451341|NCT00411372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6451342|NCT00411372|Respiratory System Agents|respiratory system agents|mesh-ancestor
6451343|NCT00411372|Dermatologic Agents|dermatologic agents|mesh-ancestor
6451344|NCT00411372|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6451345|NCT00411372|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6451346|NCT00411372|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6020926|NCT00395343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6020927|NCT00395343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627363|NCT01311739|Hydroxocobalamin|hydroxocobalamin|mesh-list
6627364|NCT01311739|Vitamin B Complex|vitamin b complex|mesh-ancestor
6627365|NCT01311739|Vitamins|vitamins|mesh-ancestor
6627366|NCT01311739|Micronutrients|micronutrients|mesh-ancestor
6627367|NCT01311739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627368|NCT01311739|Hematinics|hematinics|mesh-ancestor
6627369|NCT01311765|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6627370|NCT01311765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6627371|NCT01311778|Fentanyl|fentanyl|mesh-list
6627372|NCT01311778|Cannabidiol|cannabidiol|mesh-list
6627373|NCT01311778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6627374|NCT01311778|Narcotics|narcotics|mesh-ancestor
6627375|NCT01311778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6627376|NCT01311778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627377|NCT01311778|Analgesics|analgesics|mesh-ancestor
6627378|NCT01311778|Sensory System Agents|sensory system agents|mesh-ancestor
6627379|NCT01311778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6627380|NCT01311778|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6627381|NCT01311778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6627382|NCT01311778|Anesthetics, General|anesthetics, general|mesh-ancestor
6627383|NCT01311778|Anesthetics|anesthetics|mesh-ancestor
6627384|NCT01311778|Anticonvulsants|anticonvulsants|mesh-ancestor
6627385|NCT01311804|Parecoxib|parecoxib|mesh-list
6627386|NCT01311804|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6627387|NCT01311804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6627388|NCT01311804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6627389|NCT01311804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627390|NCT01311804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5480394|NCT05156021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6627391|NCT01311804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6627392|NCT01311804|Analgesics|analgesics|mesh-ancestor
6627393|NCT01311804|Sensory System Agents|sensory system agents|mesh-ancestor
6627394|NCT01311804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6627395|NCT01311804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627396|NCT01311804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6627397|NCT01311804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6627398|NCT01311882|Zopiclone|zopiclone|mesh-list
6627399|NCT01311882|Suvorexant|suvorexant|mesh-list
6627400|NCT01311882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6627401|NCT01311882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6627402|NCT01311882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627403|NCT01311882|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6627404|NCT01311882|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
6627405|NCT01311882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6627406|NCT01311882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627407|NCT01311947|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6627408|NCT01311947|Antiviral Agents|antiviral agents|mesh-ancestor
6627409|NCT01311947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6627410|NCT01311960|Bevacizumab|bevacizumab|mesh-list
6627411|NCT01311960|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6627412|NCT01311960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6627413|NCT01311960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6627414|NCT01311960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6627415|NCT01311960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6627416|NCT01311960|Growth Substances|growth substances|mesh-ancestor
6627417|NCT01311960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480395|NCT05156021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5480396|NCT05156021|Growth Substances|growth substances|mesh-ancestor
5480397|NCT05156021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480398|NCT05156021|Growth Inhibitors|growth inhibitors|mesh-ancestor
5480399|NCT05155969|Ketamine|ketamine|mesh-list
5480400|NCT05155969|Esketamine|esketamine|mesh-list
5480401|NCT05155969|Analgesics|analgesics|mesh-ancestor
5480402|NCT05155969|Sensory System Agents|sensory system agents|mesh-ancestor
5480403|NCT05155969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5480404|NCT05155969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480405|NCT05155969|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5480406|NCT05155969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5480407|NCT05155969|Anesthetics, General|anesthetics, general|mesh-ancestor
5480408|NCT05155969|Anesthetics|anesthetics|mesh-ancestor
5480409|NCT05155969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5480410|NCT05155969|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6627418|NCT01311960|Growth Inhibitors|growth inhibitors|mesh-ancestor
6627419|NCT01311960|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6627420|NCT01312012|Antiviral Agents|antiviral agents|mesh-list
6627421|NCT01312012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6627422|NCT01312064|Rituximab|rituximab|mesh-list
6627423|NCT01312064|Everolimus|everolimus|mesh-list
6627424|NCT01312064|Tacrolimus|tacrolimus|mesh-list
6627425|NCT01312064|Thymoglobulin|thymoglobulin|mesh-list
6627426|NCT01312064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6627427|NCT01312064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6627428|NCT01312064|Immunologic Factors|immunologic factors|mesh-ancestor
6627429|NCT01312064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627430|NCT01312064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6627431|NCT01312064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6627432|NCT01312064|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6627433|NCT01312064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6627434|NCT01312064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627435|NCT01312077|Morphine|morphine|mesh-list
6627436|NCT01312077|Levobupivacaine|levobupivacaine|mesh-list
6627437|NCT01312077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6627438|NCT01312077|Narcotics|narcotics|mesh-ancestor
6627439|NCT01312077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6627440|NCT01312077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627441|NCT01312077|Analgesics|analgesics|mesh-ancestor
6627442|NCT01312077|Sensory System Agents|sensory system agents|mesh-ancestor
6627443|NCT01312077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6627444|NCT01312077|Anesthetics, Local|anesthetics, local|mesh-ancestor
6627445|NCT01312077|Anesthetics|anesthetics|mesh-ancestor
6662399|NCT01503424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6662400|NCT01503424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662401|NCT01503424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6662402|NCT01503424|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6662403|NCT01503424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6662404|NCT01503424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6662405|NCT01503424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6662406|NCT01503424|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6662407|NCT01503424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6662408|NCT01503424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6662409|NCT01503424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662410|NCT01503424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6662411|NCT01503424|Serotonin Agents|serotonin agents|mesh-ancestor
6662412|NCT01503437|Olanzapine|olanzapine|mesh-list
6662413|NCT01503437|Antiemetics|antiemetics|mesh-ancestor
6662414|NCT01503437|Autonomic Agents|autonomic agents|mesh-ancestor
6662415|NCT01503437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6662416|NCT01503437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662417|NCT01503437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6662418|NCT01503437|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6662419|NCT01503437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6662420|NCT01503437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6662421|NCT01503437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6662422|NCT01503437|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6662423|NCT01503437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6662424|NCT01503437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6662425|NCT01503437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662426|NCT01503437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6662427|NCT01503437|Serotonin Agents|serotonin agents|mesh-ancestor
6662428|NCT01503450|Olanzapine|olanzapine|mesh-list
6662429|NCT01503450|Antiemetics|antiemetics|mesh-ancestor
6662430|NCT01503450|Autonomic Agents|autonomic agents|mesh-ancestor
6662431|NCT01503450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6662432|NCT01503450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662433|NCT01503450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6662434|NCT01503450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6662435|NCT01503450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6662436|NCT01503450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6662437|NCT01503450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6662438|NCT01503450|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6662439|NCT01503450|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6662440|NCT01503450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6662441|NCT01503450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662442|NCT01503450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6662443|NCT01503450|Serotonin Agents|serotonin agents|mesh-ancestor
6662444|NCT01503502|Imatinib Mesylate|imatinib mesylate|mesh-list
6662445|NCT01503502|HH-GV-678|hh-gv-678|mesh-list
6662446|NCT01503502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6662447|NCT01503502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6662448|NCT01503502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6665010|NCT01515228|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6451347|NCT00411372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6451348|NCT00411372|Adrenergic Agents|adrenergic agents|mesh-ancestor
6451349|NCT00411372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6451350|NCT00411372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451351|NCT00411372|Glucocorticoids|glucocorticoids|mesh-ancestor
6451352|NCT00411372|Hormones|hormones|mesh-ancestor
6451353|NCT00411372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6451354|NCT00411372|Sympathomimetics|sympathomimetics|mesh-ancestor
6451355|NCT00411437|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6451356|NCT00411437|Oxybutynin|oxybutynin|mesh-list
6451357|NCT00411437|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6451358|NCT00411437|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6451359|NCT00411437|Cholinergic Agents|cholinergic agents|mesh-ancestor
6451360|NCT00411437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6451361|NCT00411437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451362|NCT00411437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451363|NCT00411437|Urological Agents|urological agents|mesh-ancestor
6451364|NCT00411437|Parasympatholytics|parasympatholytics|mesh-ancestor
6627446|NCT01312298|Bupivacaine|bupivacaine|mesh-list
6627447|NCT01312298|Anesthetics|anesthetics|mesh-list
6627448|NCT01312298|Propofol|propofol|mesh-list
6627449|NCT01312298|Succinylcholine|succinylcholine|mesh-list
6627450|NCT01312298|Anesthetics, Local|anesthetics, local|mesh-ancestor
6627451|NCT01312298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6627452|NCT01312298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627453|NCT01312298|Sensory System Agents|sensory system agents|mesh-ancestor
6627454|NCT01312298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6627455|NCT01312298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6627456|NCT01312298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6627457|NCT01312298|Anesthetics, General|anesthetics, general|mesh-ancestor
6627458|NCT01312298|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
6627459|NCT01312298|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6627460|NCT01312298|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6627461|NCT01312311|Docetaxel|docetaxel|mesh-list
6627462|NCT01312311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6627463|NCT01312311|Tubulin Modulators|tubulin modulators|mesh-ancestor
6627464|NCT01312311|Antimitotic Agents|antimitotic agents|mesh-ancestor
6627465|NCT01312311|Mitosis Modulators|mitosis modulators|mesh-ancestor
6627466|NCT01312311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627467|NCT01312324|Docetaxel|docetaxel|mesh-list
6627468|NCT01312324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6627469|NCT01312324|Tubulin Modulators|tubulin modulators|mesh-ancestor
6627470|NCT01312324|Antimitotic Agents|antimitotic agents|mesh-ancestor
6627471|NCT01312324|Mitosis Modulators|mitosis modulators|mesh-ancestor
6627472|NCT01312324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627473|NCT01312337|Gefitinib|gefitinib|mesh-list
6627474|NCT01312337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6627475|NCT01312337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6627476|NCT01312337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6627477|NCT01312337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627478|NCT01312350|Docetaxel|docetaxel|mesh-list
6627479|NCT01312350|Fluorouracil|fluorouracil|mesh-list
5480411|NCT05155969|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5480412|NCT05155969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5480413|NCT05155969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480414|NCT05155969|Antidepressive Agents|antidepressive agents|mesh-ancestor
5480415|NCT05155969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5480416|NCT05155917|Insulin Glargine|insulin glargine|mesh-list
5480417|NCT05155917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5480418|NCT05155917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480419|NCT05150496|Vaccines|vaccines|mesh-list
5480420|NCT05150496|Immunologic Factors|immunologic factors|mesh-ancestor
5480421|NCT05150496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480422|NCT05117034|Morphine|morphine|mesh-list
5480423|NCT05117034|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5480424|NCT05117034|Narcotics|narcotics|mesh-ancestor
5480425|NCT05117034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5480426|NCT05117034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627480|NCT01312350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6627481|NCT01312350|Tubulin Modulators|tubulin modulators|mesh-ancestor
6627482|NCT01312350|Antimitotic Agents|antimitotic agents|mesh-ancestor
6627483|NCT01312350|Mitosis Modulators|mitosis modulators|mesh-ancestor
6627484|NCT01312350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627485|NCT01312350|Antimetabolites|antimetabolites|mesh-ancestor
6627486|NCT01312350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6627487|NCT01312350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6627488|NCT01312350|Immunologic Factors|immunologic factors|mesh-ancestor
6627489|NCT01312350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627490|NCT01312363|Rivastigmine|rivastigmine|mesh-list
6627491|NCT01312363|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6627492|NCT01312363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6627493|NCT01312363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627494|NCT01312363|Cholinergic Agents|cholinergic agents|mesh-ancestor
6627495|NCT01312363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6627496|NCT01312363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627497|NCT01312363|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6627498|NCT01312363|Protective Agents|protective agents|mesh-ancestor
6627499|NCT01312376|Cyclophosphamide|cyclophosphamide|mesh-list
6627500|NCT01312376|Bevacizumab|bevacizumab|mesh-list
6627501|NCT01312376|Fludarabine|fludarabine|mesh-list
6627502|NCT01312376|Vaccines|vaccines|mesh-list
5480427|NCT05117034|Analgesics|analgesics|mesh-ancestor
6627503|NCT01312376|Immunologic Factors|immunologic factors|mesh-ancestor
6627504|NCT01312376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627505|NCT01312376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6627506|NCT01312376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6627507|NCT01312376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6627508|NCT01312376|Alkylating Agents|alkylating agents|mesh-ancestor
6627509|NCT01312376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627510|NCT01312376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6627511|NCT01312376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6627512|NCT01312376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6627513|NCT01312376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6627514|NCT01312376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6627515|NCT01312376|Growth Substances|growth substances|mesh-ancestor
6627516|NCT01312376|Growth Inhibitors|growth inhibitors|mesh-ancestor
6627517|NCT01312402|Brinzolamide|brinzolamide|mesh-list
6627518|NCT01312402|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5480428|NCT05117034|Sensory System Agents|sensory system agents|mesh-ancestor
5480429|NCT05117034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5480430|NCT05112913|Vaccines|vaccines|mesh-list
5480431|NCT05112913|Immunologic Factors|immunologic factors|mesh-ancestor
5480432|NCT05112913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480433|NCT05112549|Nivolumab|nivolumab|mesh-list
6627519|NCT01312402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6627520|NCT01312402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627521|NCT01312415|Morphine|morphine|mesh-list
6627522|NCT01312415|Levobupivacaine|levobupivacaine|mesh-list
6627523|NCT01312415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6627524|NCT01312415|Narcotics|narcotics|mesh-ancestor
6627525|NCT01312415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6627526|NCT01312415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627527|NCT01312415|Analgesics|analgesics|mesh-ancestor
6627528|NCT01312415|Sensory System Agents|sensory system agents|mesh-ancestor
6627529|NCT01312415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6627530|NCT01312415|Anesthetics, Local|anesthetics, local|mesh-ancestor
6627531|NCT01312415|Anesthetics|anesthetics|mesh-ancestor
6627532|NCT01312441|Ergocalciferols|ergocalciferols|mesh-list
6627533|NCT01312441|Vitamin D|vitamin d|mesh-list
6627534|NCT01312441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6627535|NCT01312441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627536|NCT01312441|Vitamins|vitamins|mesh-ancestor
6627537|NCT01312441|Micronutrients|micronutrients|mesh-ancestor
6627538|NCT01312441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6627539|NCT01312493|Panitumumab|panitumumab|mesh-list
6627540|NCT01312493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6627541|NCT01312493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6627542|NCT01312714|Vitamin D|vitamin d|mesh-list
6627543|NCT01312714|Cholecalciferol|cholecalciferol|mesh-list
6627544|NCT01312714|Vitamins|vitamins|mesh-ancestor
6627545|NCT01312714|Micronutrients|micronutrients|mesh-ancestor
5480434|NCT05112549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5480435|NCT05112549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6627546|NCT01312714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627547|NCT01312714|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6627548|NCT01312714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6627549|NCT01312792|Ampicillin|ampicillin|mesh-list
6627550|NCT01312792|Cephradine|cephradine|mesh-list
6627551|NCT01312792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6627552|NCT01312792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6627553|NCT01312831|Vitamin B 12|vitamin b 12|mesh-list
6627554|NCT01312831|Hydroxocobalamin|hydroxocobalamin|mesh-list
6627555|NCT01312831|Vitamins|vitamins|mesh-ancestor
6627556|NCT01312831|Micronutrients|micronutrients|mesh-ancestor
6627557|NCT01312831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627558|NCT01312831|Vitamin B Complex|vitamin b complex|mesh-ancestor
6627559|NCT01312831|Hematinics|hematinics|mesh-ancestor
6627560|NCT01312857|Panitumumab|panitumumab|mesh-list
6627561|NCT01312857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6627562|NCT01312857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6627563|NCT01312922|Dexetimide|dexetimide|mesh-list
6627564|NCT01312922|Pipamperone|pipamperone|mesh-list
6627565|NCT01312922|Citalopram|citalopram|mesh-list
6627566|NCT01312922|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6627567|NCT01312922|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6627568|NCT01312922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6627569|NCT01312922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627570|NCT01312922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6627571|NCT01312922|Serotonin Agents|serotonin agents|mesh-ancestor
6627572|NCT01312922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627573|NCT01312922|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6627574|NCT01312922|Antidepressive Agents|antidepressive agents|mesh-ancestor
6627575|NCT01312922|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6627576|NCT01312922|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6627577|NCT01312922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6627578|NCT01312922|Parasympatholytics|parasympatholytics|mesh-ancestor
6627579|NCT01312922|Autonomic Agents|autonomic agents|mesh-ancestor
6627580|NCT01312922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6627581|NCT01312922|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6627582|NCT01312922|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6627583|NCT01312922|Cholinergic Agents|cholinergic agents|mesh-ancestor
6627584|NCT01312922|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6627585|NCT01312922|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6627586|NCT01312922|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6627587|NCT01312922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6627588|NCT01313143|Esmolol|esmolol|mesh-list
6627589|NCT01313143|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6627590|NCT01313143|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6627591|NCT01313143|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6627592|NCT01313143|Adrenergic Agents|adrenergic agents|mesh-ancestor
6627593|NCT01313143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6627594|NCT01313143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627595|NCT01313143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627596|NCT01313247|Acetaminophen|acetaminophen|mesh-list
6627597|NCT01313247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6627598|NCT01313247|Analgesics|analgesics|mesh-ancestor
6627599|NCT01313247|Sensory System Agents|sensory system agents|mesh-ancestor
6627600|NCT01313247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6627601|NCT01313247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627602|NCT01313247|Antipyretics|antipyretics|mesh-ancestor
6627603|NCT01313377|Gemcitabine|gemcitabine|mesh-list
6627604|NCT01313377|Oxaliplatin|oxaliplatin|mesh-list
6627605|NCT01313377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6627606|NCT01313377|Antimetabolites|antimetabolites|mesh-ancestor
6627607|NCT01313377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627608|NCT01313377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6627609|NCT01313377|Antiviral Agents|antiviral agents|mesh-ancestor
6627610|NCT01313377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6627611|NCT01313377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5480436|NCT05112549|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5480437|NCT05112549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480438|NCT05057689|Fentanyl|fentanyl|mesh-list
5480439|NCT05057689|Midazolam|midazolam|mesh-list
5480440|NCT05057689|Dexmedetomidine|dexmedetomidine|mesh-list
6627612|NCT01313377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6627613|NCT01313377|Immunologic Factors|immunologic factors|mesh-ancestor
6627614|NCT01313377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627615|NCT01313390|Docetaxel|docetaxel|mesh-list
6627616|NCT01313390|Everolimus|everolimus|mesh-list
6627617|NCT01313390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6627618|NCT01313390|Tubulin Modulators|tubulin modulators|mesh-ancestor
6627619|NCT01313390|Antimitotic Agents|antimitotic agents|mesh-ancestor
6627620|NCT01313390|Mitosis Modulators|mitosis modulators|mesh-ancestor
6627621|NCT01313390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627622|NCT01313390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6627623|NCT01313390|Immunologic Factors|immunologic factors|mesh-ancestor
6627624|NCT01313390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627625|NCT01313403|Antidepressive Agents|antidepressive agents|mesh-list
6627626|NCT01313403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6627627|NCT01313429|Celecoxib|celecoxib|mesh-list
6627628|NCT01313429|Cyclophosphamide|cyclophosphamide|mesh-list
6627629|NCT01313429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6627630|NCT01313429|Immunologic Factors|immunologic factors|mesh-ancestor
6627631|NCT01313429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627632|NCT01313429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6627633|NCT01313429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5480441|NCT05057689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5480442|NCT05057689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5480443|NCT05057689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480444|NCT05057689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5480445|NCT05057689|Analgesics|analgesics|mesh-ancestor
5480446|NCT05057689|Sensory System Agents|sensory system agents|mesh-ancestor
5480447|NCT05057689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5480448|NCT05057689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5480449|NCT05057689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5480450|NCT05057689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5480451|NCT05057689|Adrenergic Agents|adrenergic agents|mesh-ancestor
5480452|NCT05057689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5480453|NCT05057689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480454|NCT05057689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5480455|NCT05057689|Narcotics|narcotics|mesh-ancestor
6627634|NCT01313429|Alkylating Agents|alkylating agents|mesh-ancestor
6627635|NCT01313429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627636|NCT01313429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6627637|NCT01313429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6627638|NCT01313429|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6627639|NCT01313429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6627640|NCT01313429|Analgesics|analgesics|mesh-ancestor
6627641|NCT01313429|Sensory System Agents|sensory system agents|mesh-ancestor
6627642|NCT01313429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6627643|NCT01313429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6627644|NCT01313429|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6627645|NCT01313429|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6627646|NCT01313429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6627647|NCT01313585|Beclomethasone|beclomethasone|mesh-list
6627648|NCT01313585|Albuterol|albuterol|mesh-list
6627649|NCT01313585|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6627650|NCT01313585|Autonomic Agents|autonomic agents|mesh-ancestor
6627651|NCT01313585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6627652|NCT01313585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627653|NCT01313585|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6627654|NCT01313585|Respiratory System Agents|respiratory system agents|mesh-ancestor
6627655|NCT01313585|Tocolytic Agents|tocolytic agents|mesh-ancestor
6627656|NCT01313585|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6627657|NCT01313585|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6627658|NCT01313585|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6627659|NCT01313585|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6627660|NCT01313585|Adrenergic Agents|adrenergic agents|mesh-ancestor
6627661|NCT01313585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5480456|NCT05057689|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5480457|NCT05057689|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5480458|NCT05057689|Anesthetics, General|anesthetics, general|mesh-ancestor
5480459|NCT05057689|Anesthetics|anesthetics|mesh-ancestor
5480460|NCT05057689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5480461|NCT05057689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5480462|NCT05057689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5480463|NCT05057689|GABA Modulators|gaba modulators|mesh-ancestor
5480464|NCT05057689|GABA Agents|gaba agents|mesh-ancestor
5480465|NCT04996719|Sirolimus|sirolimus|mesh-list
5480466|NCT04996719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6627662|NCT01313585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480467|NCT04996719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5480468|NCT04996719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5480469|NCT04996719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5480470|NCT04996719|Antifungal Agents|antifungal agents|mesh-ancestor
5480471|NCT04996719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5480472|NCT04996719|Immunologic Factors|immunologic factors|mesh-ancestor
5480473|NCT04996719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480474|NCT04969887|Nivolumab|nivolumab|mesh-list
5480475|NCT04969887|Ipilimumab|ipilimumab|mesh-list
5480476|NCT04969887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5480477|NCT04969887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5480478|NCT04969887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5480479|NCT04969887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480480|NCT04952324|Folic Acid|folic acid|mesh-list
5480481|NCT04952324|Vitamin B 12|vitamin b 12|mesh-list
5480482|NCT04952324|Hydroxocobalamin|hydroxocobalamin|mesh-list
5480483|NCT04952324|Vitamins|vitamins|mesh-ancestor
5480484|NCT04952324|Micronutrients|micronutrients|mesh-ancestor
5480485|NCT04952324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480486|NCT04952324|Hematinics|hematinics|mesh-ancestor
5480487|NCT04952324|Vitamin B Complex|vitamin b complex|mesh-ancestor
5480488|NCT04934020|Metronidazole|metronidazole|mesh-list
6627663|NCT01313585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6627664|NCT01313585|Glucocorticoids|glucocorticoids|mesh-ancestor
6627665|NCT01313585|Hormones|hormones|mesh-ancestor
6627666|NCT01313585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6627667|NCT01313611|Rituximab|rituximab|mesh-list
6627668|NCT01313611|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6627669|NCT01313611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6627670|NCT01313611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6627671|NCT01313611|Immunologic Factors|immunologic factors|mesh-ancestor
6627672|NCT01313611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627673|NCT01313611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6627674|NCT01313611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6627675|NCT01313611|Alkylating Agents|alkylating agents|mesh-ancestor
6627676|NCT01313611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627677|NCT01313689|Ofatumumab|ofatumumab|mesh-list
6627678|NCT01313689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6627679|NCT01313702|Atenolol|atenolol|mesh-list
6627680|NCT01313702|Lisinopril|lisinopril|mesh-list
5480489|NCT04934020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5480490|NCT04934020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5480491|NCT04934020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5480492|NCT04934020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5480493|NCT04931017|Metformin|metformin|mesh-list
5480494|NCT04931017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5480495|NCT04931017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480496|NCT04915950|APD791|apd791|mesh-list
5480497|NCT04915950|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5480498|NCT04915950|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5480499|NCT04915950|Serotonin Agents|serotonin agents|mesh-ancestor
6451365|NCT00411437|Autonomic Agents|autonomic agents|mesh-ancestor
6451366|NCT00411437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6451367|NCT00411515|Mycophenolic Acid|mycophenolic acid|mesh-list
6451368|NCT00411515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6451369|NCT00411515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6451370|NCT00411515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6451371|NCT00411515|Antitubercular Agents|antitubercular agents|mesh-ancestor
6451372|NCT00411515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6451373|NCT00411515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6451374|NCT00411515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6451375|NCT00411515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451376|NCT00411541|Dexamethasone|dexamethasone|mesh-list
6451377|NCT00411541|Vincristine|vincristine|mesh-list
6451378|NCT00411541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6451379|NCT00411541|Antiemetics|antiemetics|mesh-ancestor
6451380|NCT00411541|Autonomic Agents|autonomic agents|mesh-ancestor
6451381|NCT00411541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6451382|NCT00411541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451383|NCT00411541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6451384|NCT00411541|Glucocorticoids|glucocorticoids|mesh-ancestor
6451385|NCT00411541|Hormones|hormones|mesh-ancestor
6451386|NCT00411541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6627681|NCT01313702|Simvastatin|simvastatin|mesh-list
5480500|NCT04915950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5480501|NCT04915950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480502|NCT04915950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480503|NCT04914741|Prednisolone|prednisolone|mesh-list
6627682|NCT01313702|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6627683|NCT01313702|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6627684|NCT01313702|Antimetabolites|antimetabolites|mesh-ancestor
6627685|NCT01313702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627686|NCT01313702|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6627687|NCT01313702|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6627688|NCT01313702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6627689|NCT01313702|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6627690|NCT01313702|Protease Inhibitors|protease inhibitors|mesh-ancestor
6627691|NCT01313702|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6627692|NCT01313702|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6627693|NCT01313702|Protective Agents|protective agents|mesh-ancestor
6627694|NCT01313702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627695|NCT01313702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6627696|NCT01313702|Sympatholytics|sympatholytics|mesh-ancestor
6627697|NCT01313702|Autonomic Agents|autonomic agents|mesh-ancestor
6627698|NCT01313702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6627699|NCT01313702|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6627700|NCT01313702|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6627701|NCT01313702|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6627702|NCT01313702|Adrenergic Agents|adrenergic agents|mesh-ancestor
6627703|NCT01313702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6627704|NCT01313819|Amantadine|amantadine|mesh-list
6627705|NCT01313819|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6627706|NCT01313819|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6627707|NCT01313819|Antiviral Agents|antiviral agents|mesh-ancestor
6627708|NCT01313819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6627709|NCT01313819|Dopamine Agents|dopamine agents|mesh-ancestor
6627710|NCT01313819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6627711|NCT01313819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627712|NCT01313819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627713|NCT01313819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6627714|NCT01313819|Analgesics|analgesics|mesh-ancestor
6627715|NCT01313819|Sensory System Agents|sensory system agents|mesh-ancestor
6627716|NCT01313819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6627717|NCT01313845|Amantadine|amantadine|mesh-list
6627718|NCT01313845|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6627719|NCT01313845|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6627720|NCT01313845|Antiviral Agents|antiviral agents|mesh-ancestor
6627721|NCT01313845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6627722|NCT01313845|Dopamine Agents|dopamine agents|mesh-ancestor
6627723|NCT01313845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6627724|NCT01313845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627725|NCT01313845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627726|NCT01313845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6627727|NCT01313845|Analgesics|analgesics|mesh-ancestor
6627728|NCT01313845|Sensory System Agents|sensory system agents|mesh-ancestor
6627729|NCT01313845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6627730|NCT01314027|Gemcitabine|gemcitabine|mesh-list
6627731|NCT01314027|Oxaliplatin|oxaliplatin|mesh-list
6627732|NCT01314027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6627733|NCT01314027|Antimetabolites|antimetabolites|mesh-ancestor
6627734|NCT01314027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627735|NCT01314027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6627736|NCT01314027|Antiviral Agents|antiviral agents|mesh-ancestor
6627737|NCT01314027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6627738|NCT01314027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6627739|NCT01314027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6627740|NCT01314027|Immunologic Factors|immunologic factors|mesh-ancestor
6627741|NCT01314027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627742|NCT01314066|Bevacizumab|bevacizumab|mesh-list
6627743|NCT01314066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5480504|NCT04914741|Cyclophosphamide|cyclophosphamide|mesh-list
5480505|NCT04914741|Rituximab|rituximab|mesh-list
6627744|NCT01314066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6627745|NCT01314066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6627746|NCT01314066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6627747|NCT01314066|Growth Substances|growth substances|mesh-ancestor
6627748|NCT01314066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627749|NCT01314066|Growth Inhibitors|growth inhibitors|mesh-ancestor
6627750|NCT01314144|Bupivacaine|bupivacaine|mesh-list
6627751|NCT01314144|Anesthetics, Local|anesthetics, local|mesh-ancestor
6627752|NCT01314144|Anesthetics|anesthetics|mesh-ancestor
6627753|NCT01314144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6627754|NCT01314144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627755|NCT01314144|Sensory System Agents|sensory system agents|mesh-ancestor
6627756|NCT01314144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6627757|NCT01314209|Dexmedetomidine|dexmedetomidine|mesh-list
5480506|NCT04914741|Doxorubicin|doxorubicin|mesh-list
5480507|NCT04914741|Vincristine|vincristine|mesh-list
5480508|NCT04914741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5480509|NCT04914741|Immunologic Factors|immunologic factors|mesh-ancestor
5480510|NCT04914741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480511|NCT04914741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6627758|NCT01314209|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6627759|NCT01314209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5480512|NCT04914741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5480513|NCT04914741|Alkylating Agents|alkylating agents|mesh-ancestor
5480514|NCT04914741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480515|NCT04914741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5480516|NCT04914741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5480517|NCT04914741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5480518|NCT04914741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5480519|NCT04914741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6627760|NCT01314209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627761|NCT01314209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6627762|NCT01314209|Analgesics|analgesics|mesh-ancestor
6627763|NCT01314209|Sensory System Agents|sensory system agents|mesh-ancestor
6627764|NCT01314209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6627765|NCT01314209|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6627766|NCT01314209|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6627767|NCT01314209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6627768|NCT01314209|Adrenergic Agents|adrenergic agents|mesh-ancestor
6627769|NCT01314209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6627770|NCT01314209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627771|NCT01314274|Bevacizumab|bevacizumab|mesh-list
6627772|NCT01314274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5480520|NCT04914741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5480521|NCT04914741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5480522|NCT04914741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5480523|NCT04914741|Tubulin Modulators|tubulin modulators|mesh-ancestor
5480524|NCT04914741|Antimitotic Agents|antimitotic agents|mesh-ancestor
5480525|NCT04914741|Mitosis Modulators|mitosis modulators|mesh-ancestor
5480526|NCT04914741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5480527|NCT04914741|Glucocorticoids|glucocorticoids|mesh-ancestor
5480528|NCT04914741|Hormones|hormones|mesh-ancestor
5480529|NCT04914741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6451387|NCT00411541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6451388|NCT00411541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6451389|NCT00411541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6451390|NCT00411541|Tubulin Modulators|tubulin modulators|mesh-ancestor
6451391|NCT00411541|Antimitotic Agents|antimitotic agents|mesh-ancestor
6451392|NCT00411541|Mitosis Modulators|mitosis modulators|mesh-ancestor
6451393|NCT00411541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480530|NCT04914741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5480531|NCT04910061|Niacinamide|niacinamide|mesh-list
5480532|NCT04910061|Niacin|niacin|mesh-list
5480533|NCT04910061|Nicotinic Acids|nicotinic acids|mesh-list
5480534|NCT04910061|Vitamin B Complex|vitamin b complex|mesh-ancestor
5480535|NCT04910061|Vitamins|vitamins|mesh-ancestor
5480536|NCT04910061|Micronutrients|micronutrients|mesh-ancestor
5480537|NCT04910061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480538|NCT04910061|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5480539|NCT04910061|Antimetabolites|antimetabolites|mesh-ancestor
5480540|NCT04910061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451394|NCT00411593|Bevacizumab|bevacizumab|mesh-list
6451395|NCT00411593|Bortezomib|bortezomib|mesh-list
6627773|NCT01314274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6627774|NCT01314274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6627775|NCT01314274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6627776|NCT01314274|Growth Substances|growth substances|mesh-ancestor
6627777|NCT01314274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627778|NCT01314274|Growth Inhibitors|growth inhibitors|mesh-ancestor
6662449|NCT01503502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662450|NCT01503580|Solifenacin Succinate|solifenacin succinate|mesh-list
6662451|NCT01503580|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6662452|NCT01503580|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6662453|NCT01503580|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6662454|NCT01503580|Cholinergic Agents|cholinergic agents|mesh-ancestor
6662455|NCT01503580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6662456|NCT01503580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662457|NCT01503580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480541|NCT04910061|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5480542|NCT04910061|Vasodilator Agents|vasodilator agents|mesh-ancestor
5480543|NCT04903353|Risperidone|risperidone|mesh-list
5480544|NCT04903353|Aripiprazole|aripiprazole|mesh-list
5480545|NCT04903353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6662458|NCT01503580|Urological Agents|urological agents|mesh-ancestor
6662459|NCT01503593|Calcium|calcium|mesh-list
6662460|NCT01503593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6662461|NCT01503593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662462|NCT01503606|Clarithromycin|clarithromycin|mesh-list
6662463|NCT01503606|Cefazolin|cefazolin|mesh-list
6662464|NCT01503606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6662465|NCT01503606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6662466|NCT01503606|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6662467|NCT01503606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6662468|NCT01503606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662469|NCT01503606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6662470|NCT01503606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6662471|NCT01503658|Aspirin|aspirin|mesh-list
6662472|NCT01503658|Clopidogrel|clopidogrel|mesh-list
6662473|NCT01503658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6662474|NCT01503658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5480546|NCT04903353|Serotonin Agents|serotonin agents|mesh-ancestor
5480547|NCT04903353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5480548|NCT04903353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480549|NCT04903353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480550|NCT04903353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6662475|NCT01503658|Analgesics|analgesics|mesh-ancestor
6662476|NCT01503658|Sensory System Agents|sensory system agents|mesh-ancestor
6662477|NCT01503658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6662478|NCT01503658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662479|NCT01503658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6662480|NCT01503658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5480551|NCT04903353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5480552|NCT04903353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5480553|NCT04903353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5480554|NCT04903353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5480555|NCT04903353|Dopamine Agents|dopamine agents|mesh-ancestor
5480556|NCT04903353|Antidepressive Agents|antidepressive agents|mesh-ancestor
5480557|NCT04903353|Dopamine Agonists|dopamine agonists|mesh-ancestor
5480558|NCT04903353|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5480559|NCT04903353|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5480560|NCT04903353|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5480561|NCT04903353|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5480562|NCT04902443|Nivolumab|nivolumab|mesh-list
5480563|NCT04902443|Pomalidomide|pomalidomide|mesh-list
5480564|NCT04902443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5480565|NCT04902443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6662481|NCT01503658|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6662482|NCT01503658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6662483|NCT01503658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662484|NCT01503658|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6662485|NCT01503658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6662486|NCT01503658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6662487|NCT01503658|Antipyretics|antipyretics|mesh-ancestor
6662488|NCT01503658|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5480566|NCT04902443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6020928|NCT00395343|Incretins|incretins|mesh-ancestor
6627779|NCT01314300|Lidocaine|lidocaine|mesh-list
6627780|NCT01314300|Anesthetics, Local|anesthetics, local|mesh-ancestor
6627781|NCT01314300|Anesthetics|anesthetics|mesh-ancestor
6627782|NCT01314300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6627783|NCT01314300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627784|NCT01314300|Sensory System Agents|sensory system agents|mesh-ancestor
6627785|NCT01314300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6627786|NCT01314300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6627787|NCT01314300|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6627788|NCT01314300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6627789|NCT01314300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6627790|NCT01314300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627791|NCT01314339|Desloratadine|desloratadine|mesh-list
6627792|NCT01314339|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6627793|NCT01314339|Cholinergic Agents|cholinergic agents|mesh-ancestor
6627794|NCT01314339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6627795|NCT01314339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627796|NCT01314339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627797|NCT01314339|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6627798|NCT01314339|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6627799|NCT01314339|Histamine Antagonists|histamine antagonists|mesh-ancestor
6627800|NCT01314339|Histamine Agents|histamine agents|mesh-ancestor
6627801|NCT01314352|Desloratadine|desloratadine|mesh-list
6627802|NCT01314352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6627803|NCT01314352|Cholinergic Agents|cholinergic agents|mesh-ancestor
6627804|NCT01314352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6627805|NCT01314352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627806|NCT01314352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627807|NCT01314352|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6627808|NCT01314352|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6627809|NCT01314352|Histamine Antagonists|histamine antagonists|mesh-ancestor
5480567|NCT04902443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480568|NCT04902443|Immunologic Factors|immunologic factors|mesh-ancestor
5480569|NCT04902443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451396|NCT00411593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6451397|NCT00411593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6451398|NCT00411593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6451399|NCT00411593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6451400|NCT00411593|Growth Substances|growth substances|mesh-ancestor
6451401|NCT00411593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480570|NCT04902443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6627810|NCT01314352|Histamine Agents|histamine agents|mesh-ancestor
6627811|NCT01314482|Minocycline|minocycline|mesh-list
6627812|NCT01314482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6627813|NCT01314482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6627814|NCT01314495|Abatacept|abatacept|mesh-list
6627815|NCT01314495|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6627816|NCT01314495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627817|NCT01314495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5480571|NCT04902443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5480572|NCT04902443|Growth Substances|growth substances|mesh-ancestor
5480573|NCT04902443|Growth Inhibitors|growth inhibitors|mesh-ancestor
6451402|NCT00411593|Growth Inhibitors|growth inhibitors|mesh-ancestor
6461875|NCT00456560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6461876|NCT00456560|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6627818|NCT01314495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6627819|NCT01314495|Immunologic Factors|immunologic factors|mesh-ancestor
6627820|NCT01314495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627821|NCT01314495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6461877|NCT00456560|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6461878|NCT00456586|Istradefylline|istradefylline|mesh-list
6461879|NCT00456586|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
6461880|NCT00456586|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6627822|NCT01314508|Mecasermin|mecasermin|mesh-list
6627823|NCT01314508|Growth Substances|growth substances|mesh-ancestor
6627824|NCT01314508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627825|NCT01314586|Secoisolariciresinol|secoisolariciresinol|mesh-list
6627826|NCT01314586|Phytoestrogens|phytoestrogens|mesh-ancestor
6627827|NCT01314586|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6627828|NCT01314586|Estrogens|estrogens|mesh-ancestor
6627829|NCT01314586|Hormones|hormones|mesh-ancestor
6627830|NCT01314586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6627831|NCT01314586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627832|NCT01314599|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6627833|NCT01314677|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6627834|NCT01314677|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6627835|NCT01314677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627836|NCT01314781|Solifenacin Succinate|solifenacin succinate|mesh-list
6627837|NCT01314781|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6627838|NCT01314781|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6627839|NCT01314781|Cholinergic Agents|cholinergic agents|mesh-ancestor
6627840|NCT01314781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6627841|NCT01314781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627842|NCT01314781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627843|NCT01314781|Urological Agents|urological agents|mesh-ancestor
6627844|NCT01314833|Paclitaxel|paclitaxel|mesh-list
6627845|NCT01314833|Docetaxel|docetaxel|mesh-list
6627846|NCT01314833|Cyclophosphamide|cyclophosphamide|mesh-list
6627847|NCT01314833|Fluorouracil|fluorouracil|mesh-list
6627848|NCT01314833|Epirubicin|epirubicin|mesh-list
6627849|NCT01314833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6627850|NCT01314833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6627851|NCT01314833|Tubulin Modulators|tubulin modulators|mesh-ancestor
6627852|NCT01314833|Antimitotic Agents|antimitotic agents|mesh-ancestor
6627853|NCT01314833|Mitosis Modulators|mitosis modulators|mesh-ancestor
6627854|NCT01314833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627855|NCT01314833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6627856|NCT01314833|Immunologic Factors|immunologic factors|mesh-ancestor
6627857|NCT01314833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627858|NCT01314833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6627859|NCT01314833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6627860|NCT01314833|Alkylating Agents|alkylating agents|mesh-ancestor
6627861|NCT01314833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6627862|NCT01314833|Antimetabolites|antimetabolites|mesh-ancestor
6627863|NCT01314833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6627864|NCT01314833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6627865|NCT01314833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6627866|NCT01314833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6020929|NCT00395343|Hormones|hormones|mesh-ancestor
6020930|NCT00395343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6020931|NCT00395343|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6451403|NCT00411736|Azithromycin|azithromycin|mesh-list
6451404|NCT00411736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6451405|NCT00411736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6451406|NCT00411866|Ketoconazole|ketoconazole|mesh-list
6451407|NCT00411866|Antifungal Agents|antifungal agents|mesh-ancestor
6451408|NCT00411866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6451409|NCT00411866|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6451410|NCT00411866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6451411|NCT00411866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6451412|NCT00411866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451413|NCT00411866|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6451414|NCT00411866|Hormone Antagonists|hormone antagonists|mesh-ancestor
6451415|NCT00411866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6451416|NCT00411866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451417|NCT00411866|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6451418|NCT00411879|Vasopressins|vasopressins|mesh-list
6451419|NCT00411879|Arginine Vasopressin|arginine vasopressin|mesh-list
6451420|NCT00411879|Epinephrine|epinephrine|mesh-list
6451421|NCT00411879|Racepinephrine|racepinephrine|mesh-list
6451422|NCT00411879|Epinephryl borate|epinephryl borate|mesh-list
6451423|NCT00411879|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6451424|NCT00411879|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6451425|NCT00411879|Adrenergic Agents|adrenergic agents|mesh-ancestor
6451426|NCT00411879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6451427|NCT00411879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451428|NCT00411879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451429|NCT00411879|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6451430|NCT00411879|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6627867|NCT01314833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6627868|NCT01314859|Nifedipine|nifedipine|mesh-list
6627869|NCT01314859|Atosiban|atosiban|mesh-list
6627870|NCT01314859|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6627871|NCT01314859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6627872|NCT01314859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627873|NCT01314859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6627874|NCT01314859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627875|NCT01314859|Vasodilator Agents|vasodilator agents|mesh-ancestor
6627876|NCT01314859|Tocolytic Agents|tocolytic agents|mesh-ancestor
6627877|NCT01314859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6627878|NCT01314859|Hormone Antagonists|hormone antagonists|mesh-ancestor
6627879|NCT01314859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6627880|NCT01314898|Spironolactone|spironolactone|mesh-list
6627881|NCT01314898|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6627882|NCT01314898|Hormone Antagonists|hormone antagonists|mesh-ancestor
6627883|NCT01314898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6627884|NCT01314898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627885|NCT01314898|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6627886|NCT01314898|Diuretics|diuretics|mesh-ancestor
6627887|NCT01314898|Natriuretic Agents|natriuretic agents|mesh-ancestor
6627888|NCT01314937|Mebendazole|mebendazole|mesh-list
6627889|NCT01314937|Piperazine|piperazine|mesh-list
6627890|NCT01314937|Piperazine citrate|piperazine citrate|mesh-list
6627891|NCT01314937|DMP 777|dmp 777|mesh-list
6627892|NCT01314937|Antinematodal Agents|antinematodal agents|mesh-ancestor
6627893|NCT01314937|Anthelmintics|anthelmintics|mesh-ancestor
6627894|NCT01314937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6627895|NCT01314937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6627896|NCT01314937|Tubulin Modulators|tubulin modulators|mesh-ancestor
6627897|NCT01314937|Antimitotic Agents|antimitotic agents|mesh-ancestor
6627898|NCT01314937|Mitosis Modulators|mitosis modulators|mesh-ancestor
6627899|NCT01314937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627900|NCT01314937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6627901|NCT01314937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6627902|NCT01314976|Metronidazole|metronidazole|mesh-list
6627903|NCT01314976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6627904|NCT01314976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6627905|NCT01314976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6627906|NCT01314976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6627907|NCT01314989|Cyproheptadine|cyproheptadine|mesh-list
6627908|NCT01314989|Antipruritics|antipruritics|mesh-ancestor
6627909|NCT01314989|Dermatologic Agents|dermatologic agents|mesh-ancestor
6627910|NCT01314989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6627911|NCT01314989|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6627912|NCT01314989|Histamine Antagonists|histamine antagonists|mesh-ancestor
6627913|NCT01314989|Histamine Agents|histamine agents|mesh-ancestor
6627914|NCT01314989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6627915|NCT01314989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627916|NCT01314989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627917|NCT01314989|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6627918|NCT01314989|Serotonin Agents|serotonin agents|mesh-ancestor
6627919|NCT01314989|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6627920|NCT01315093|Heparin|heparin|mesh-list
6627921|NCT01315093|Calcium heparin|calcium heparin|mesh-list
6627922|NCT01315093|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6627923|NCT01315093|Tinzaparin|tinzaparin|mesh-list
6627924|NCT01315093|Dalteparin|dalteparin|mesh-list
6451431|NCT00411879|Autonomic Agents|autonomic agents|mesh-ancestor
6451432|NCT00411879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6451433|NCT00411879|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6451434|NCT00411879|Respiratory System Agents|respiratory system agents|mesh-ancestor
6451435|NCT00411879|Mydriatics|mydriatics|mesh-ancestor
6451436|NCT00411879|Sympathomimetics|sympathomimetics|mesh-ancestor
6451437|NCT00411879|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6451438|NCT00411879|Hemostatics|hemostatics|mesh-ancestor
6451439|NCT00411879|Coagulants|coagulants|mesh-ancestor
6451440|NCT00411879|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6451441|NCT00411879|Natriuretic Agents|natriuretic agents|mesh-ancestor
6451442|NCT00411905|Bortezomib|bortezomib|mesh-list
6451443|NCT00411905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6451444|NCT00411957|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6627925|NCT01315093|Anticoagulants|anticoagulants|mesh-ancestor
6627926|NCT01315093|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6627927|NCT01315093|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6627928|NCT01315093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627929|NCT01315262|Sildenafil Citrate|sildenafil citrate|mesh-list
6627930|NCT01315262|Vasodilator Agents|vasodilator agents|mesh-ancestor
6627931|NCT01315262|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6627932|NCT01315262|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6627933|NCT01315262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6627934|NCT01315262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627935|NCT01315262|Urological Agents|urological agents|mesh-ancestor
6627936|NCT01315275|Ranibizumab|ranibizumab|mesh-list
6627937|NCT01315275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6627938|NCT01315275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6627939|NCT01315275|Growth Substances|growth substances|mesh-ancestor
6627940|NCT01315275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627941|NCT01315275|Growth Inhibitors|growth inhibitors|mesh-ancestor
5480574|NCT04901702|Irinotecan|irinotecan|mesh-list
5480575|NCT04901702|Temozolomide|temozolomide|mesh-list
5480576|NCT04901702|Talazoparib|talazoparib|mesh-list
5480577|NCT04901702|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5480578|NCT04901702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5480579|NCT04901702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5480580|NCT04901702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480581|NCT04901702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5480582|NCT04901702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5480583|NCT04901702|Alkylating Agents|alkylating agents|mesh-ancestor
5480584|NCT04901702|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5502332|NCT04467450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502333|NCT04467450|Cholinergic Agents|cholinergic agents|mesh-ancestor
5502334|NCT04467450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5502335|NCT04467450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502336|NCT04467450|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5502337|NCT04467450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5502338|NCT04467450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6627942|NCT01315275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6627943|NCT01315431|Capecitabine|capecitabine|mesh-list
6627944|NCT01315431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6627945|NCT01315431|Antimetabolites|antimetabolites|mesh-ancestor
6627946|NCT01315431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020932|NCT00395343|Protease Inhibitors|protease inhibitors|mesh-ancestor
6451445|NCT00411957|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5502339|NCT04467281|Daratumumab|daratumumab|mesh-list
5502340|NCT04467281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5502341|NCT04467346|Temozolomide|temozolomide|mesh-list
6020933|NCT00395343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6451446|NCT00411957|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6451447|NCT00411957|Protease Inhibitors|protease inhibitors|mesh-ancestor
6451448|NCT00411957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6451449|NCT00411957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451450|NCT00411957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6451451|NCT00411957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6451452|NCT00411957|Antiviral Agents|antiviral agents|mesh-ancestor
6451453|NCT00411957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6451454|NCT00411996|Ritonavir|ritonavir|mesh-list
6451455|NCT00411996|Indinavir|indinavir|mesh-list
6451456|NCT00411996|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6451457|NCT00411996|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6451458|NCT00411996|Protease Inhibitors|protease inhibitors|mesh-ancestor
6451459|NCT00411996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6451460|NCT00411996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451461|NCT00411996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5480585|NCT04883749|Acalabrutinib|acalabrutinib|mesh-list
5480586|NCT04883749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5480587|NCT04862338|Niacinamide|niacinamide|mesh-list
5480588|NCT04862338|Niacin|niacin|mesh-list
5480589|NCT04862338|Nicotinic Acids|nicotinic acids|mesh-list
5480590|NCT04862338|Vitamin B Complex|vitamin b complex|mesh-ancestor
6627947|NCT01315431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6627948|NCT01315470|Lenograstim|lenograstim|mesh-list
6627949|NCT01315470|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6627950|NCT01315470|Immunologic Factors|immunologic factors|mesh-ancestor
6627951|NCT01315470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627952|NCT01315496|Immunoglobulins|immunoglobulins|mesh-list
6627953|NCT01315496|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6627954|NCT01315496|Antibodies|antibodies|mesh-list
6627955|NCT01315496|Immunoglobulin G|immunoglobulin g|mesh-list
6627956|NCT01315496|Immunologic Factors|immunologic factors|mesh-ancestor
6627957|NCT01315496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627958|NCT01315691|Amikacin|amikacin|mesh-list
6627959|NCT01315691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6627960|NCT01315691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6627961|NCT01315704|Vitamin D|vitamin d|mesh-list
6627962|NCT01315704|Vitamins|vitamins|mesh-ancestor
6627963|NCT01315704|Micronutrients|micronutrients|mesh-ancestor
6627964|NCT01315704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627965|NCT01315704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6627966|NCT01315795|Lanreotide|lanreotide|mesh-list
6627967|NCT01315795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6627968|NCT01315886|Fentanyl|fentanyl|mesh-list
6627969|NCT01315886|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6627970|NCT01315886|Narcotics|narcotics|mesh-ancestor
6627971|NCT01315886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6627972|NCT01315886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627973|NCT01315886|Analgesics|analgesics|mesh-ancestor
6627974|NCT01315886|Sensory System Agents|sensory system agents|mesh-ancestor
6627975|NCT01315886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6627976|NCT01315886|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6627977|NCT01315886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6627978|NCT01315886|Anesthetics, General|anesthetics, general|mesh-ancestor
6627979|NCT01315886|Anesthetics|anesthetics|mesh-ancestor
6627980|NCT01315912|Letrozole|letrozole|mesh-list
6627981|NCT01315912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6627982|NCT01315912|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6627983|NCT01315912|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6627984|NCT01315912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6627985|NCT01315912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627986|NCT01315912|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6627987|NCT01315912|Hormone Antagonists|hormone antagonists|mesh-ancestor
6627988|NCT01315912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6627989|NCT01315912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662489|NCT01503658|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6662490|NCT01503658|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6662491|NCT01503658|Purinergic Agents|purinergic agents|mesh-ancestor
6662492|NCT01503658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6662493|NCT01503671|Atorvastatin|atorvastatin|mesh-list
6662494|NCT01503671|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6662495|NCT01503671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6662496|NCT01503671|Antimetabolites|antimetabolites|mesh-ancestor
6662497|NCT01503671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480591|NCT04862338|Vitamins|vitamins|mesh-ancestor
5480592|NCT04862338|Micronutrients|micronutrients|mesh-ancestor
5480593|NCT04862338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480594|NCT04862338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5480595|NCT04862338|Antimetabolites|antimetabolites|mesh-ancestor
5480596|NCT04862338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480597|NCT04862338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5480598|NCT04862338|Vasodilator Agents|vasodilator agents|mesh-ancestor
5480599|NCT04843423|Cariprazine|cariprazine|mesh-list
5480600|NCT04843423|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5480601|NCT04843423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5480602|NCT04843423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5480603|NCT04843423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480604|NCT04843423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6662498|NCT01503671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6662499|NCT01503671|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6662500|NCT01503671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6662501|NCT01503736|Citric Acid|citric acid|mesh-list
5480605|NCT04798469|Methyltestosterone|methyltestosterone|mesh-list
5480606|NCT04798469|Testosterone|testosterone|mesh-list
6627990|NCT01315938|Abatacept|abatacept|mesh-list
6627991|NCT01315938|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6627992|NCT01315938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6627993|NCT01315938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6627994|NCT01315938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6627995|NCT01315938|Immunologic Factors|immunologic factors|mesh-ancestor
6627996|NCT01315938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6627997|NCT01315938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6627998|NCT01315951|Petrolatum|petrolatum|mesh-list
6627999|NCT01315951|Emollients|emollients|mesh-ancestor
6628000|NCT01315951|Dermatologic Agents|dermatologic agents|mesh-ancestor
6628001|NCT01315990|Cetuximab|cetuximab|mesh-list
6628002|NCT01315990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6628003|NCT01315990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6628004|NCT01316068|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
5480607|NCT04798469|Testosterone undecanoate|testosterone undecanoate|mesh-list
5480608|NCT04798469|Testosterone enanthate|testosterone enanthate|mesh-list
5480609|NCT04798469|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5480610|NCT04798469|Androgens|androgens|mesh-ancestor
5480611|NCT04798469|Hormones|hormones|mesh-ancestor
5480612|NCT04798469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5480613|NCT04798469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628005|NCT01316068|Anticoagulants|anticoagulants|mesh-ancestor
6628006|NCT01316068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6628007|NCT01316068|Antimetabolites|antimetabolites|mesh-ancestor
6628008|NCT01316068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628009|NCT01316068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6628010|NCT01316068|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6628011|NCT01316068|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6628012|NCT01316068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6628013|NCT01316068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628014|NCT01316081|Vitamins|vitamins|mesh-list
6628015|NCT01316081|Ascorbic Acid|ascorbic acid|mesh-list
6628016|NCT01316081|Vitamin E|vitamin e|mesh-list
6628017|NCT01316081|Tocopherols|tocopherols|mesh-list
6628018|NCT01316081|Tocotrienols|tocotrienols|mesh-list
6628019|NCT01316081|alpha-Tocopherol|alpha-tocopherol|mesh-list
6628020|NCT01316081|Micronutrients|micronutrients|mesh-ancestor
6628021|NCT01316081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628022|NCT01316081|Antioxidants|antioxidants|mesh-ancestor
6628023|NCT01316081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480614|NCT04798469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5480615|NCT04798469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5480616|NCT04798469|Anabolic Agents|anabolic agents|mesh-ancestor
5480617|NCT04778618|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5480618|NCT04778618|Immunologic Factors|immunologic factors|mesh-ancestor
6628024|NCT01316081|Protective Agents|protective agents|mesh-ancestor
6628025|NCT01316094|Ipragliflozin|ipragliflozin|mesh-list
6628026|NCT01316094|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6628027|NCT01316094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628028|NCT01316094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6628029|NCT01316094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628030|NCT01316107|Ipragliflozin|ipragliflozin|mesh-list
6628031|NCT01316107|Nateglinide|nateglinide|mesh-list
6628032|NCT01316107|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6628033|NCT01316107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628034|NCT01316107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6628035|NCT01316107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628036|NCT01316133|Tacrolimus|tacrolimus|mesh-list
6628037|NCT01316133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6628038|NCT01316133|Immunologic Factors|immunologic factors|mesh-ancestor
6628039|NCT01316133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628040|NCT01316133|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6628041|NCT01316133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6628042|NCT01316133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628043|NCT01316445|Midazolam|midazolam|mesh-list
6628044|NCT01316445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6628045|NCT01316445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6628046|NCT01316445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6628047|NCT01316445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628048|NCT01316445|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6628049|NCT01316445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6628050|NCT01316445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6628051|NCT01316445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6628052|NCT01316445|Anesthetics, General|anesthetics, general|mesh-ancestor
6628053|NCT01316445|Anesthetics|anesthetics|mesh-ancestor
6628054|NCT01316445|GABA Modulators|gaba modulators|mesh-ancestor
6628055|NCT01316445|GABA Agents|gaba agents|mesh-ancestor
6628056|NCT01316445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6628057|NCT01316445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628058|NCT01316458|Imatinib Mesylate|imatinib mesylate|mesh-list
6628059|NCT01316458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6628060|NCT01316458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6628061|NCT01316458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6628062|NCT01316458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628063|NCT01316549|Fludarabine|fludarabine|mesh-list
6628064|NCT01316549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6628065|NCT01316718|Mesalamine|mesalamine|mesh-list
6628066|NCT01316718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6628067|NCT01316718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6628068|NCT01316718|Analgesics|analgesics|mesh-ancestor
6628069|NCT01316718|Sensory System Agents|sensory system agents|mesh-ancestor
6628070|NCT01316718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6628071|NCT01316718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628072|NCT01316718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6628073|NCT01316718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5480619|NCT04778618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480620|NCT04778618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5480621|NCT04774250|Zonisamide|zonisamide|mesh-list
5480622|NCT04774250|Anticonvulsants|anticonvulsants|mesh-ancestor
5480623|NCT04774250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5480624|NCT04774250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5480625|NCT04774250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480626|NCT04774250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6628074|NCT01316744|Ketamine|ketamine|mesh-list
6628075|NCT01316744|Analgesics|analgesics|mesh-ancestor
6628076|NCT01316744|Sensory System Agents|sensory system agents|mesh-ancestor
6628077|NCT01316744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6628078|NCT01316744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628079|NCT01316744|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6628080|NCT01316744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6628081|NCT01316744|Anesthetics, General|anesthetics, general|mesh-ancestor
6628082|NCT01316744|Anesthetics|anesthetics|mesh-ancestor
6628083|NCT01316744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6628084|NCT01316744|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6628085|NCT01316744|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6628086|NCT01316744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6628087|NCT01316744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628088|NCT01316757|Paclitaxel|paclitaxel|mesh-list
6628089|NCT01316757|Carboplatin|carboplatin|mesh-list
6628090|NCT01316757|Cetuximab|cetuximab|mesh-list
6628091|NCT01316757|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6628092|NCT01316757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6628093|NCT01316757|Antibodies|antibodies|mesh-list
6628094|NCT01316757|Immunoglobulins|immunoglobulins|mesh-list
6628095|NCT01316757|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6628096|NCT01316757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6628097|NCT01316757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6628098|NCT01316757|Tubulin Modulators|tubulin modulators|mesh-ancestor
6628099|NCT01316757|Antimitotic Agents|antimitotic agents|mesh-ancestor
6628100|NCT01316757|Mitosis Modulators|mitosis modulators|mesh-ancestor
6628101|NCT01316757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628102|NCT01316757|Immunologic Factors|immunologic factors|mesh-ancestor
6628103|NCT01316757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480627|NCT04774250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480628|NCT04768569|Zonisamide|zonisamide|mesh-list
6451462|NCT00411996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6451463|NCT00411996|Antiviral Agents|antiviral agents|mesh-ancestor
6451464|NCT00411996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6451465|NCT00411996|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6451466|NCT00411996|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6451467|NCT00412022|Tamoxifen|tamoxifen|mesh-list
6451468|NCT00412022|Zoledronic Acid|zoledronic acid|mesh-list
6451469|NCT00412022|Letrozole|letrozole|mesh-list
6451470|NCT00412022|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6451471|NCT00412022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6451472|NCT00412022|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6451473|NCT00412022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5480629|NCT04768569|Anticonvulsants|anticonvulsants|mesh-ancestor
6628104|NCT01316757|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6628105|NCT01316757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6628106|NCT01316861|Acarbose|acarbose|mesh-list
5480630|NCT04768569|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5480631|NCT04768569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5480632|NCT04768569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480633|NCT04768569|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5480634|NCT04768569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480635|NCT04750070|Dopamine|dopamine|mesh-list
5480636|NCT04750070|Epinephrine|epinephrine|mesh-list
5480637|NCT04750070|Racepinephrine|racepinephrine|mesh-list
5480638|NCT04750070|Epinephryl borate|epinephryl borate|mesh-list
5480639|NCT04750070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5480640|NCT04750070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5480641|NCT04750070|Adrenergic Agents|adrenergic agents|mesh-ancestor
5480642|NCT04750070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5480643|NCT04750070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480644|NCT04750070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480645|NCT04750070|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6451474|NCT00412022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6451475|NCT00412022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451476|NCT00412022|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6451477|NCT00412022|Hormone Antagonists|hormone antagonists|mesh-ancestor
5480646|NCT04750070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5480647|NCT04750070|Autonomic Agents|autonomic agents|mesh-ancestor
5480648|NCT04750070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5480649|NCT04750070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5480650|NCT04750070|Respiratory System Agents|respiratory system agents|mesh-ancestor
5480651|NCT04750070|Mydriatics|mydriatics|mesh-ancestor
5480652|NCT04750070|Sympathomimetics|sympathomimetics|mesh-ancestor
5480653|NCT04750070|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5480654|NCT04750070|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5480655|NCT04750070|Dopamine Agents|dopamine agents|mesh-ancestor
5480656|NCT04750070|Protective Agents|protective agents|mesh-ancestor
5480657|NCT04645602|Pembrolizumab|pembrolizumab|mesh-list
5480658|NCT04645602|Lenvatinib|lenvatinib|mesh-list
6628107|NCT01316861|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6628108|NCT01316861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6628109|NCT01316861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628110|NCT01316861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6628111|NCT01316861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628112|NCT01316874|Valrubicin|valrubicin|mesh-list
6628113|NCT01316874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6628114|NCT01316874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6628115|NCT01316874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6628116|NCT01316874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6628117|NCT01316874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628118|NCT01316952|Carvedilol|carvedilol|mesh-list
6628119|NCT01316952|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
6628120|NCT01316952|Adrenergic Agents|adrenergic agents|mesh-list
5480659|NCT04645602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5480660|NCT04645602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5480661|NCT04645602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5480662|NCT04645602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5480663|NCT04645602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480664|NCT04560725|Choline|choline|mesh-list
5480665|NCT04560725|Lipotropic Agents|lipotropic agents|mesh-ancestor
5480666|NCT04560725|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5480667|NCT04560725|Antimetabolites|antimetabolites|mesh-ancestor
5480668|NCT04560725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480669|NCT04560725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6628121|NCT01316952|Adrenergic Antagonists|adrenergic antagonists|mesh-list
6628122|NCT01316952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6628123|NCT01316952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628124|NCT01316952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480670|NCT04560725|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5480671|NCT04560725|Nootropic Agents|nootropic agents|mesh-ancestor
6451478|NCT00412022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6451479|NCT00412022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451480|NCT00412022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6451481|NCT00412022|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6451482|NCT00412022|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6451483|NCT00412022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6451484|NCT00412022|Luteolytic Agents|luteolytic agents|mesh-ancestor
6451485|NCT00412022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6628125|NCT01316952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6628126|NCT01316952|Antioxidants|antioxidants|mesh-ancestor
6628127|NCT01316952|Protective Agents|protective agents|mesh-ancestor
6628128|NCT01316952|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6628129|NCT01316952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6628130|NCT01316952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6628131|NCT01316952|Vasodilator Agents|vasodilator agents|mesh-ancestor
6628132|NCT01316952|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6628133|NCT01316952|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6628134|NCT01316978|Ibuprofen|ibuprofen|mesh-list
6628135|NCT01316978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6628136|NCT01316978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6628137|NCT01316978|Analgesics|analgesics|mesh-ancestor
6628138|NCT01316978|Sensory System Agents|sensory system agents|mesh-ancestor
6628139|NCT01316978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6628140|NCT01316978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628141|NCT01316978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6628142|NCT01316978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6628143|NCT01316978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6628144|NCT01316978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6628145|NCT01316978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628146|NCT01317017|Interferon-gamma|interferon-gamma|mesh-list
6628147|NCT01317017|Antiviral Agents|antiviral agents|mesh-ancestor
6628148|NCT01317017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6628149|NCT01317069|Fluorouracil|fluorouracil|mesh-list
6628150|NCT01317069|Antimetabolites|antimetabolites|mesh-ancestor
6628151|NCT01317069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628152|NCT01317069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6628153|NCT01317069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6628154|NCT01317069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6628155|NCT01317069|Immunologic Factors|immunologic factors|mesh-ancestor
6628156|NCT01317069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480672|NCT04553692|Leucovorin|leucovorin|mesh-list
5480673|NCT04553692|Bevacizumab|bevacizumab|mesh-list
5480674|NCT04553692|Fluorouracil|fluorouracil|mesh-list
5480675|NCT04553692|Irinotecan|irinotecan|mesh-list
5480676|NCT04553692|Venetoclax|venetoclax|mesh-list
5480677|NCT04553692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5480678|NCT04553692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5480679|NCT04553692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6628157|NCT01317212|Carboplatin|carboplatin|mesh-list
6628158|NCT01317212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6628159|NCT01317225|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
6628160|NCT01317225|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
6628161|NCT01317225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6628162|NCT01317225|Hormone Antagonists|hormone antagonists|mesh-ancestor
6628163|NCT01317225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6628164|NCT01317225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480680|NCT04553692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5480681|NCT04553692|Growth Substances|growth substances|mesh-ancestor
5480682|NCT04553692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480683|NCT04553692|Growth Inhibitors|growth inhibitors|mesh-ancestor
5480684|NCT04553692|Antimetabolites|antimetabolites|mesh-ancestor
5480685|NCT04553692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480686|NCT04553692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5480687|NCT04553692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5480688|NCT04553692|Immunologic Factors|immunologic factors|mesh-ancestor
5480689|NCT04553692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5480690|NCT04553692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5480691|NCT04553692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6628165|NCT01317225|Progestins|progestins|mesh-ancestor
6628166|NCT01317225|Hormones|hormones|mesh-ancestor
6628167|NCT01317368|Ropivacaine|ropivacaine|mesh-list
6628168|NCT01317368|Anesthetics, Local|anesthetics, local|mesh-ancestor
6628169|NCT01317368|Anesthetics|anesthetics|mesh-ancestor
5480692|NCT04553692|Antidotes|antidotes|mesh-ancestor
5480693|NCT04553692|Protective Agents|protective agents|mesh-ancestor
6628170|NCT01317368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6628171|NCT01317368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628172|NCT01317368|Sensory System Agents|sensory system agents|mesh-ancestor
6628173|NCT01317368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6628174|NCT01317433|Doxycycline|doxycycline|mesh-list
6628175|NCT01317433|Cetuximab|cetuximab|mesh-list
6628176|NCT01317433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6628177|NCT01317433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6628178|NCT01317433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6628179|NCT01317433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6628180|NCT01317433|Antimalarials|antimalarials|mesh-ancestor
6628181|NCT01317433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5480694|NCT04553692|Vitamin B Complex|vitamin b complex|mesh-ancestor
5480695|NCT04553692|Vitamins|vitamins|mesh-ancestor
5480696|NCT04553692|Micronutrients|micronutrients|mesh-ancestor
5480697|NCT04552288|Benralizumab|benralizumab|mesh-list
5480698|NCT04552288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5480699|NCT04552288|Respiratory System Agents|respiratory system agents|mesh-ancestor
5480700|NCT04549051|Anesthetics|anesthetics|mesh-list
5480701|NCT04549051|Anesthetics, Local|anesthetics, local|mesh-list
5480702|NCT04549051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6628182|NCT01317433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6628183|NCT01317446|Fluorides|fluorides|mesh-list
6628184|NCT01317446|Tin Fluorides|tin fluorides|mesh-list
6628185|NCT01317446|Cariostatic Agents|cariostatic agents|mesh-ancestor
6628186|NCT01317446|Protective Agents|protective agents|mesh-ancestor
6628187|NCT01317446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628188|NCT01317511|Caseins|caseins|mesh-list
6628189|NCT01317511|Chelating Agents|chelating agents|mesh-ancestor
6628190|NCT01317511|Sequestering Agents|sequestering agents|mesh-ancestor
6628191|NCT01317511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628192|NCT01317563|Vitamin A|vitamin a|mesh-list
6628193|NCT01317563|Selenium|selenium|mesh-list
6628194|NCT01317563|Vitamins|vitamins|mesh-ancestor
5480703|NCT04549051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480704|NCT04549051|Sensory System Agents|sensory system agents|mesh-ancestor
5480705|NCT04549051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5480706|NCT04530539|Ascorbic Acid|ascorbic acid|mesh-list
5480707|NCT04530539|Melatonin|melatonin|mesh-list
5480708|NCT04530539|Vitamins|vitamins|mesh-ancestor
5480709|NCT04530539|Micronutrients|micronutrients|mesh-ancestor
5480710|NCT04530539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480711|NCT04530539|Antioxidants|antioxidants|mesh-ancestor
5480712|NCT04530539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480713|NCT04530539|Protective Agents|protective agents|mesh-ancestor
5480714|NCT04530539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5480715|NCT04518306|Amlodipine|amlodipine|mesh-list
5480716|NCT04518306|Telmisartan|telmisartan|mesh-list
5480717|NCT04518306|Indapamide|indapamide|mesh-list
5480718|NCT04518306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5480719|NCT04518306|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5480720|NCT04518306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5480721|NCT04518306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480722|NCT04518306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5480723|NCT04518306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451486|NCT00412022|Contraceptive Agents|contraceptive agents|mesh-ancestor
6451487|NCT00412022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6451488|NCT00412022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6451489|NCT00412035|Botulinum Toxins|botulinum toxins|mesh-list
6451490|NCT00412035|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6451491|NCT00412035|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6451492|NCT00412035|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6451493|NCT00412035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6451494|NCT00412035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451495|NCT00412035|Cholinergic Agents|cholinergic agents|mesh-ancestor
6451496|NCT00412035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6451497|NCT00412035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628195|NCT01317563|Micronutrients|micronutrients|mesh-ancestor
6628196|NCT01317563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628197|NCT01317563|Antioxidants|antioxidants|mesh-ancestor
6628198|NCT01317563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628199|NCT01317563|Protective Agents|protective agents|mesh-ancestor
6628200|NCT01317563|Trace Elements|trace elements|mesh-ancestor
6628201|NCT01317589|Fentanyl|fentanyl|mesh-list
6628202|NCT01317589|Methadone|methadone|mesh-list
6628203|NCT01317589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6628204|NCT01317589|Narcotics|narcotics|mesh-ancestor
6662502|NCT01503736|Sodium Citrate|sodium citrate|mesh-list
6628205|NCT01317589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6628206|NCT01317589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628207|NCT01317589|Analgesics|analgesics|mesh-ancestor
6628208|NCT01317589|Sensory System Agents|sensory system agents|mesh-ancestor
6628209|NCT01317589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6628210|NCT01317589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6628211|NCT01317589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6628212|NCT01317589|Anesthetics, General|anesthetics, general|mesh-ancestor
6628213|NCT01317589|Anesthetics|anesthetics|mesh-ancestor
6628214|NCT01317589|Antitussive Agents|antitussive agents|mesh-ancestor
6628215|NCT01317589|Respiratory System Agents|respiratory system agents|mesh-ancestor
6662503|NCT01503736|Ferric Compounds|ferric compounds|mesh-list
6662504|NCT01503736|Anticoagulants|anticoagulants|mesh-ancestor
6662505|NCT01503736|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6662506|NCT01503736|Chelating Agents|chelating agents|mesh-ancestor
6662507|NCT01503736|Sequestering Agents|sequestering agents|mesh-ancestor
6662508|NCT01503736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662509|NCT01503736|Hematinics|hematinics|mesh-ancestor
6662510|NCT01503788|Midazolam|midazolam|mesh-list
6662511|NCT01503788|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6662512|NCT01503788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6662513|NCT01503788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6662514|NCT01503788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662515|NCT01503788|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6662516|NCT01503788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6662517|NCT01503788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6662518|NCT01503788|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6662519|NCT01503788|Anesthetics, General|anesthetics, general|mesh-ancestor
6662520|NCT01503788|Anesthetics|anesthetics|mesh-ancestor
6662521|NCT01503788|GABA Modulators|gaba modulators|mesh-ancestor
6662522|NCT01503788|GABA Agents|gaba agents|mesh-ancestor
6662523|NCT01503788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6662524|NCT01503788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662525|NCT01503801|Nitric Oxide|nitric oxide|mesh-list
6662526|NCT01503801|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-list
6662527|NCT01503801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6662528|NCT01503801|Autonomic Agents|autonomic agents|mesh-ancestor
6662529|NCT01503801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6662530|NCT01503801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662531|NCT01503801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6662532|NCT01503801|Respiratory System Agents|respiratory system agents|mesh-ancestor
6662533|NCT01503801|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6662534|NCT01503801|Antioxidants|antioxidants|mesh-ancestor
6662535|NCT01503801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662536|NCT01503801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6662537|NCT01503801|Vasodilator Agents|vasodilator agents|mesh-ancestor
6662538|NCT01503801|Gasotransmitters|gasotransmitters|mesh-ancestor
6662539|NCT01503801|Protective Agents|protective agents|mesh-ancestor
6665011|NCT01515228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6665012|NCT01515228|Tubulin Modulators|tubulin modulators|mesh-ancestor
6665013|NCT01515228|Antimitotic Agents|antimitotic agents|mesh-ancestor
6665014|NCT01515228|Mitosis Modulators|mitosis modulators|mesh-ancestor
6665015|NCT01515228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665016|NCT01515228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6665017|NCT01515228|Immunologic Factors|immunologic factors|mesh-ancestor
6665018|NCT01515228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665019|NCT01515228|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6665020|NCT01515228|Autonomic Agents|autonomic agents|mesh-ancestor
6665021|NCT01515228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6451498|NCT00412035|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6451499|NCT00412035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6628216|NCT01317784|Antibodies|antibodies|mesh-list
6628217|NCT01317784|Immunoglobulins|immunoglobulins|mesh-list
6628218|NCT01317784|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
6628219|NCT01317784|Immunologic Factors|immunologic factors|mesh-ancestor
6628220|NCT01317784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628221|NCT01317849|Vitamins|vitamins|mesh-list
6628222|NCT01317849|Folic Acid|folic acid|mesh-list
6628223|NCT01317849|Vitamin B 12|vitamin b 12|mesh-list
6628224|NCT01317849|Hydroxocobalamin|hydroxocobalamin|mesh-list
6628225|NCT01317849|Pyridoxine|pyridoxine|mesh-list
6628226|NCT01317849|Pyridoxal|pyridoxal|mesh-list
6628227|NCT01317849|Vitamin B 6|vitamin b 6|mesh-list
6628228|NCT01317849|Vitamin B Complex|vitamin b complex|mesh-list
6628229|NCT01317849|Micronutrients|micronutrients|mesh-ancestor
6628230|NCT01317849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628231|NCT01317849|Hematinics|hematinics|mesh-ancestor
6628232|NCT01317927|Belinostat|belinostat|mesh-list
6628233|NCT01317927|Warfarin|warfarin|mesh-list
6628234|NCT01317927|Anticoagulants|anticoagulants|mesh-ancestor
6628235|NCT01317927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6628236|NCT01317927|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6628237|NCT01317927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6628238|NCT01317927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628239|NCT01317953|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
6628240|NCT01317953|Antioxidants|antioxidants|mesh-ancestor
6628241|NCT01317953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628242|NCT01317953|Protective Agents|protective agents|mesh-ancestor
5480724|NCT04518306|Vasodilator Agents|vasodilator agents|mesh-ancestor
5480725|NCT04518306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5480726|NCT04518306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5480727|NCT04518306|Diuretics|diuretics|mesh-ancestor
5480728|NCT04518306|Natriuretic Agents|natriuretic agents|mesh-ancestor
5480729|NCT04518306|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5480730|NCT04518293|Amlodipine|amlodipine|mesh-list
5480731|NCT04518293|Telmisartan|telmisartan|mesh-list
5480732|NCT04518293|Indapamide|indapamide|mesh-list
5480733|NCT04518293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6451500|NCT00412100|Oxycodone|oxycodone|mesh-list
6451501|NCT00412100|Naloxone|naloxone|mesh-list
6451502|NCT00412100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6451503|NCT00412100|Narcotics|narcotics|mesh-ancestor
6451504|NCT00412100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6451505|NCT00412100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451506|NCT00412100|Analgesics|analgesics|mesh-ancestor
6451507|NCT00412100|Sensory System Agents|sensory system agents|mesh-ancestor
6451508|NCT00412100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6451509|NCT00412100|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6451510|NCT00412126|Insulin|insulin|mesh-list
6451511|NCT00412126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6451512|NCT00412126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451513|NCT00412152|Oxycodone|oxycodone|mesh-list
6451514|NCT00412152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6451515|NCT00412152|Narcotics|narcotics|mesh-ancestor
6451516|NCT00412152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6451517|NCT00412152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451518|NCT00412152|Analgesics|analgesics|mesh-ancestor
6451519|NCT00412152|Sensory System Agents|sensory system agents|mesh-ancestor
6451520|NCT00412152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6451521|NCT00412191|Lamotrigine|lamotrigine|mesh-list
6451522|NCT00412191|Anticonvulsants|anticonvulsants|mesh-ancestor
6628243|NCT01317953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628244|NCT01317953|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
6628245|NCT01317953|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5480734|NCT04518293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5480735|NCT04518293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6628246|NCT01317953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6628247|NCT01317953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6628248|NCT01317966|Rituximab|rituximab|mesh-list
6628249|NCT01317966|Oprelvekin|oprelvekin|mesh-list
6628250|NCT01317966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6628251|NCT01317966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6628252|NCT01317966|Immunologic Factors|immunologic factors|mesh-ancestor
6628253|NCT01317966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628254|NCT01317966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6628255|NCT01317992|Ibudilast|ibudilast|mesh-list
6628256|NCT01317992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6628257|NCT01317992|Autonomic Agents|autonomic agents|mesh-ancestor
6628258|NCT01317992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6628259|NCT01317992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628260|NCT01317992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6628261|NCT01317992|Respiratory System Agents|respiratory system agents|mesh-ancestor
6628262|NCT01317992|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6628263|NCT01317992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6628264|NCT01317992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628265|NCT01317992|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6628266|NCT01317992|Vasodilator Agents|vasodilator agents|mesh-ancestor
6628267|NCT01318005|Contraceptive Agents|contraceptive agents|mesh-list
6628268|NCT01318005|Norinyl|norinyl|mesh-list
6628269|NCT01318005|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
6628270|NCT01318005|Contraceptives, Oral|contraceptives, oral|mesh-list
6628271|NCT01318005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5480736|NCT04518293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480737|NCT04518293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5480738|NCT04518293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480739|NCT04518293|Vasodilator Agents|vasodilator agents|mesh-ancestor
5480740|NCT04518293|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5480741|NCT04518293|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5480742|NCT04518293|Diuretics|diuretics|mesh-ancestor
5480743|NCT04518293|Natriuretic Agents|natriuretic agents|mesh-ancestor
5480744|NCT04518293|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5480745|NCT04506138|Paclitaxel|paclitaxel|mesh-list
5480746|NCT04506138|Carboplatin|carboplatin|mesh-list
5480747|NCT04506138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5480748|NCT04506138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5480749|NCT04506138|Tubulin Modulators|tubulin modulators|mesh-ancestor
5480750|NCT04506138|Antimitotic Agents|antimitotic agents|mesh-ancestor
5480751|NCT04506138|Mitosis Modulators|mitosis modulators|mesh-ancestor
6628272|NCT01318005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628273|NCT01318005|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6628274|NCT01318005|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6628275|NCT01318005|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6628276|NCT01318005|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6628277|NCT01318005|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
5480752|NCT04506138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480753|NCT04503707|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5480754|NCT04503707|Hormones|hormones|mesh-ancestor
5480755|NCT04503707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5480756|NCT04503707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480757|NCT04479241|Pembrolizumab|pembrolizumab|mesh-list
5480758|NCT04479241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5480759|NCT04479241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5480760|NCT04462952|Adavosertib|adavosertib|mesh-list
5480761|NCT04462952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5480762|NCT04462952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628278|NCT01318005|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6628279|NCT01318044|Thiopental|thiopental|mesh-list
6628280|NCT01318044|Propofol|propofol|mesh-list
6628281|NCT01318044|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6628282|NCT01318044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6628283|NCT01318044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628284|NCT01318044|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6628285|NCT01318044|Anesthetics, General|anesthetics, general|mesh-ancestor
6628286|NCT01318044|Anesthetics|anesthetics|mesh-ancestor
6628287|NCT01318044|Anticonvulsants|anticonvulsants|mesh-ancestor
6628288|NCT01318044|GABA Modulators|gaba modulators|mesh-ancestor
5480763|NCT04456153|Atovaquone|atovaquone|mesh-list
5480764|NCT04456153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5480765|NCT04456153|Antimalarials|antimalarials|mesh-ancestor
5480766|NCT04456153|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5480767|NCT04456153|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5480768|NCT04456153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5480769|NCT04456153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480770|NCT04455464|Midodrine|midodrine|mesh-list
5480771|NCT04455464|Sympathomimetics|sympathomimetics|mesh-ancestor
5480772|NCT04455464|Autonomic Agents|autonomic agents|mesh-ancestor
5480773|NCT04455464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5480774|NCT04455464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480775|NCT04455464|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5480776|NCT04455464|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5480777|NCT04455464|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5480778|NCT04455464|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5480779|NCT04455464|Adrenergic Agents|adrenergic agents|mesh-ancestor
5480780|NCT04455464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5480781|NCT04455464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480782|NCT04447027|Dexamethasone|dexamethasone|mesh-list
5480783|NCT04447027|Lenalidomide|lenalidomide|mesh-list
6628289|NCT01318044|GABA Agents|gaba agents|mesh-ancestor
6628290|NCT01318044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6628291|NCT01318044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628292|NCT01318096|Tenofovir|tenofovir|mesh-list
6628293|NCT01318096|Lamivudine|lamivudine|mesh-list
6628294|NCT01318096|Efavirenz|efavirenz|mesh-list
6628295|NCT01318096|Raltegravir Potassium|raltegravir potassium|mesh-list
6628296|NCT01318096|Antiviral Agents|antiviral agents|mesh-ancestor
6628297|NCT01318096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6628298|NCT01318096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6628299|NCT01318096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6628300|NCT01318096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6628301|NCT01318096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628302|NCT01318096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6628303|NCT01318096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6628304|NCT01318096|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6628305|NCT01318096|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6628306|NCT01318096|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6628307|NCT01318096|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6628308|NCT01318096|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6628309|NCT01318096|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6628310|NCT01318096|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6628311|NCT01318096|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6628312|NCT01318148|Caspofungin|caspofungin|mesh-list
6628313|NCT01318148|Antifungal Agents|antifungal agents|mesh-ancestor
6628314|NCT01318148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6628315|NCT01318148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5480784|NCT04447027|Azacitidine|azacitidine|mesh-list
5480785|NCT04447027|Romidepsin|romidepsin|mesh-list
5480786|NCT04447027|Cc-486|cc-486|mesh-list
5480787|NCT04447027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5480788|NCT04447027|Antiemetics|antiemetics|mesh-ancestor
5480789|NCT04447027|Autonomic Agents|autonomic agents|mesh-ancestor
5480790|NCT04447027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5480791|NCT04447027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480792|NCT04447027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5480793|NCT04447027|Glucocorticoids|glucocorticoids|mesh-ancestor
5480794|NCT04447027|Hormones|hormones|mesh-ancestor
6628316|NCT01318148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628317|NCT01318161|Morphine|morphine|mesh-list
6628318|NCT01318161|Ropivacaine|ropivacaine|mesh-list
6628319|NCT01318161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5480795|NCT04447027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5480796|NCT04447027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5480797|NCT04447027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5480798|NCT04447027|Immunologic Factors|immunologic factors|mesh-ancestor
5480799|NCT04447027|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6628320|NCT01318161|Narcotics|narcotics|mesh-ancestor
6628321|NCT01318161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6628322|NCT01318161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628323|NCT01318161|Analgesics|analgesics|mesh-ancestor
6628324|NCT01318161|Sensory System Agents|sensory system agents|mesh-ancestor
6628325|NCT01318161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6628326|NCT01318161|Anesthetics, Local|anesthetics, local|mesh-ancestor
6628327|NCT01318161|Anesthetics|anesthetics|mesh-ancestor
6628328|NCT01318187|Acetaminophen|acetaminophen|mesh-list
6628329|NCT01318187|Morphine|morphine|mesh-list
6628330|NCT01318187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6628331|NCT01318187|Narcotics|narcotics|mesh-ancestor
6628332|NCT01318187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6628333|NCT01318187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628334|NCT01318187|Analgesics|analgesics|mesh-ancestor
6628335|NCT01318187|Sensory System Agents|sensory system agents|mesh-ancestor
6628336|NCT01318187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6628337|NCT01318187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5480800|NCT04447027|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5480801|NCT04447027|Growth Substances|growth substances|mesh-ancestor
5480802|NCT04447027|Growth Inhibitors|growth inhibitors|mesh-ancestor
5480803|NCT04447027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5480804|NCT04447027|Antimetabolites|antimetabolites|mesh-ancestor
5480805|NCT04447027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480806|NCT04447027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5480807|NCT04447027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5480808|NCT04430517|Niacinamide|niacinamide|mesh-list
5480809|NCT04430517|Niacin|niacin|mesh-list
5480810|NCT04430517|Nicotinic Acids|nicotinic acids|mesh-list
5480811|NCT04430517|Vitamin B Complex|vitamin b complex|mesh-ancestor
5480812|NCT04430517|Vitamins|vitamins|mesh-ancestor
5480813|NCT04430517|Micronutrients|micronutrients|mesh-ancestor
5480814|NCT04430517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480815|NCT04430517|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5480816|NCT04430517|Antimetabolites|antimetabolites|mesh-ancestor
5480817|NCT04430517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480818|NCT04430517|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5480819|NCT04430517|Vasodilator Agents|vasodilator agents|mesh-ancestor
6628338|NCT01318187|Antipyretics|antipyretics|mesh-ancestor
6628339|NCT01318265|Ketoconazole|ketoconazole|mesh-list
6628340|NCT01318265|Antifungal Agents|antifungal agents|mesh-ancestor
6628341|NCT01318265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6628342|NCT01318265|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6628343|NCT01318265|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6628344|NCT01318265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6628345|NCT01318265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628346|NCT01318265|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6628347|NCT01318265|Hormone Antagonists|hormone antagonists|mesh-ancestor
6628348|NCT01318265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6628349|NCT01318265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628350|NCT01318265|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6628351|NCT01318369|Diazepam|diazepam|mesh-list
6628352|NCT01318369|Dronabinol|dronabinol|mesh-list
6628353|NCT01318369|Hallucinogens|hallucinogens|mesh-ancestor
6628354|NCT01318369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628355|NCT01318369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6628356|NCT01318369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6628357|NCT01318369|Analgesics|analgesics|mesh-ancestor
6628358|NCT01318369|Sensory System Agents|sensory system agents|mesh-ancestor
6628359|NCT01318369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6628360|NCT01318369|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6628361|NCT01318369|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6628362|NCT01318369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6628363|NCT01318369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628364|NCT01318369|Hormones|hormones|mesh-ancestor
6628365|NCT01318369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6628366|NCT01318369|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6628367|NCT01318369|Anticonvulsants|anticonvulsants|mesh-ancestor
6628368|NCT01318369|Antiemetics|antiemetics|mesh-ancestor
6628369|NCT01318369|Autonomic Agents|autonomic agents|mesh-ancestor
6628370|NCT01318369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6628371|NCT01318369|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6628372|NCT01318369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5480820|NCT04403971|Chlorhexidine|chlorhexidine|mesh-list
6628373|NCT01318369|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6628374|NCT01318369|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6628375|NCT01318369|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6628376|NCT01318369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6628377|NCT01318369|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5480821|NCT04403971|Listerine|listerine|mesh-list
5480822|NCT04403971|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5480823|NCT04403971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5480824|NCT04403971|Disinfectants|disinfectants|mesh-ancestor
5480825|NCT04379518|Interferons|interferons|mesh-list
5480826|NCT04379518|Interferon-alpha|interferon-alpha|mesh-list
5480827|NCT04379518|Interferon alpha-2|interferon alpha-2|mesh-list
5480828|NCT04379518|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
5480829|NCT04379518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5480830|NCT04379518|Antiviral Agents|antiviral agents|mesh-ancestor
5480831|NCT04379518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5480832|NCT04379518|Immunologic Factors|immunologic factors|mesh-ancestor
5480833|NCT04379518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480834|NCT04351243|Gimsilumab|gimsilumab|mesh-list
6628378|NCT01318369|Anesthetics, General|anesthetics, general|mesh-ancestor
6628379|NCT01318369|Anesthetics|anesthetics|mesh-ancestor
6628380|NCT01318369|GABA Modulators|gaba modulators|mesh-ancestor
6628381|NCT01318369|GABA Agents|gaba agents|mesh-ancestor
6628382|NCT01318460|Simendan|simendan|mesh-list
6628383|NCT01318460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6628384|NCT01318460|Vasodilator Agents|vasodilator agents|mesh-ancestor
6628385|NCT01318460|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6628386|NCT01318460|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6628387|NCT01318460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6628388|NCT01318460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628389|NCT01318460|Protective Agents|protective agents|mesh-ancestor
6628390|NCT01318460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628391|NCT01318564|Metformin|metformin|mesh-list
6628392|NCT01318564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6628393|NCT01318564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628394|NCT01318590|Triamcinolone|triamcinolone|mesh-list
6628395|NCT01318590|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6628396|NCT01318590|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6628397|NCT01318590|Bupivacaine|bupivacaine|mesh-list
6628398|NCT01318590|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6628399|NCT01318590|Anesthetics, Local|anesthetics, local|mesh-ancestor
6628400|NCT01318590|Anesthetics|anesthetics|mesh-ancestor
6628401|NCT01318590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6628402|NCT01318590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628403|NCT01318590|Sensory System Agents|sensory system agents|mesh-ancestor
6628404|NCT01318590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6628405|NCT01318590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6628406|NCT01318590|Glucocorticoids|glucocorticoids|mesh-ancestor
6628407|NCT01318590|Hormones|hormones|mesh-ancestor
6628408|NCT01318590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6628409|NCT01318590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6628410|NCT01318590|Immunologic Factors|immunologic factors|mesh-ancestor
6628411|NCT01318590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6628412|NCT01318590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628413|NCT01318655|Naloxegol|naloxegol|mesh-list
6628414|NCT01318655|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6628415|NCT01318655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628416|NCT01318655|Sensory System Agents|sensory system agents|mesh-ancestor
6628417|NCT01318655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6628418|NCT01318668|Vaccines|vaccines|mesh-list
6628419|NCT01318668|Immunologic Factors|immunologic factors|mesh-ancestor
6628420|NCT01318668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628421|NCT01318681|Fluticasone|fluticasone|mesh-list
6628422|NCT01318681|Xhance|xhance|mesh-list
6628423|NCT01318681|Cetirizine|cetirizine|mesh-list
6628424|NCT01318681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6628425|NCT01318681|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6628426|NCT01318681|Autonomic Agents|autonomic agents|mesh-ancestor
6628427|NCT01318681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6628428|NCT01318681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628429|NCT01318681|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5480835|NCT04351243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5480836|NCT04351243|Antiviral Agents|antiviral agents|mesh-ancestor
5480837|NCT04351243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5480838|NCT04351061|Acetazolamide|acetazolamide|mesh-list
5480839|NCT04351061|Anticonvulsants|anticonvulsants|mesh-ancestor
6628430|NCT01318681|Respiratory System Agents|respiratory system agents|mesh-ancestor
6628431|NCT01318681|Dermatologic Agents|dermatologic agents|mesh-ancestor
6628432|NCT01318681|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6628433|NCT01318681|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6628434|NCT01318681|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6628435|NCT01318681|Histamine Antagonists|histamine antagonists|mesh-ancestor
6628436|NCT01318681|Histamine Agents|histamine agents|mesh-ancestor
6628437|NCT01318681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6628438|NCT01318681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628439|NCT01318837|Solifenacin Succinate|solifenacin succinate|mesh-list
6628440|NCT01318837|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6628441|NCT01318837|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6628442|NCT01318837|Cholinergic Agents|cholinergic agents|mesh-ancestor
6628443|NCT01318837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6628444|NCT01318837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628445|NCT01318837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628446|NCT01318837|Urological Agents|urological agents|mesh-ancestor
6628447|NCT01318928|Metronidazole|metronidazole|mesh-list
6628448|NCT01318928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6628449|NCT01318928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5480840|NCT04351061|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5480841|NCT04351061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5480842|NCT04351061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480843|NCT04351061|Diuretics|diuretics|mesh-ancestor
5480844|NCT04351061|Natriuretic Agents|natriuretic agents|mesh-ancestor
5480845|NCT04351061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502342|NCT04467346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5502343|NCT04467346|Alkylating Agents|alkylating agents|mesh-ancestor
5502344|NCT04467346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502345|NCT04467346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5502346|NCT04467125|Lidocaine|lidocaine|mesh-list
6628450|NCT01318928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6628451|NCT01318928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6628452|NCT01318941|Ranibizumab|ranibizumab|mesh-list
6628453|NCT01318941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6628454|NCT01318941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6628455|NCT01318941|Growth Substances|growth substances|mesh-ancestor
6628456|NCT01318941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502347|NCT04467125|Prilocaine|prilocaine|mesh-list
5502348|NCT04467125|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
5502349|NCT04467125|Anesthetics, Local|anesthetics, local|mesh-ancestor
5502350|NCT04467125|Anesthetics|anesthetics|mesh-ancestor
5502351|NCT04467125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5502352|NCT04467125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502353|NCT04467125|Sensory System Agents|sensory system agents|mesh-ancestor
5502354|NCT04467125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5502355|NCT04467125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5502356|NCT04467125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5502357|NCT04467125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6628457|NCT01318941|Growth Inhibitors|growth inhibitors|mesh-ancestor
6628458|NCT01318941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6628459|NCT01319006|Glycine|glycine|mesh-list
6628460|NCT01319006|Glycine Agents|glycine agents|mesh-ancestor
6628461|NCT01319006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6628462|NCT01319006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628463|NCT01319006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628464|NCT01319019|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6628465|NCT01319019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6628466|NCT01319019|Autonomic Agents|autonomic agents|mesh-ancestor
6628467|NCT01319019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6628468|NCT01319019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628469|NCT01319019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6628470|NCT01319019|Respiratory System Agents|respiratory system agents|mesh-ancestor
6628471|NCT01319019|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6628472|NCT01319019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6628473|NCT01319019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6628474|NCT01319019|Adrenergic Agents|adrenergic agents|mesh-ancestor
6628475|NCT01319019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5502358|NCT04467125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5502359|NCT04467125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628476|NCT01319019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628477|NCT01319188|Ranibizumab|ranibizumab|mesh-list
6628478|NCT01319188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6628479|NCT01319188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6628480|NCT01319188|Growth Substances|growth substances|mesh-ancestor
6628481|NCT01319188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628482|NCT01319188|Growth Inhibitors|growth inhibitors|mesh-ancestor
5480846|NCT04338204|Tofacitinib|tofacitinib|mesh-list
5480847|NCT04338204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5480848|NCT04338204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5480849|NCT04338204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480850|NCT04334174|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5480851|NCT04334174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5480852|NCT04334174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5480853|NCT04325659|Lofexidine|lofexidine|mesh-list
5480854|NCT04325659|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5480855|NCT04325659|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5480856|NCT04325659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480857|NCT04325659|Sensory System Agents|sensory system agents|mesh-ancestor
5480858|NCT04325659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5480859|NCT04325659|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5480860|NCT04325659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6628483|NCT01319188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6628484|NCT01319214|Propranolol|propranolol|mesh-list
6628485|NCT01319214|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6628486|NCT01319214|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6628487|NCT01319214|Adrenergic Agents|adrenergic agents|mesh-ancestor
6628488|NCT01319214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6628489|NCT01319214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628490|NCT01319214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628491|NCT01319214|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6628492|NCT01319214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5480861|NCT04325659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5480862|NCT04325659|Adrenergic Agents|adrenergic agents|mesh-ancestor
5480863|NCT04325659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5480864|NCT04325659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480865|NCT04321174|Ritonavir|ritonavir|mesh-list
5480866|NCT04321174|Lopinavir|lopinavir|mesh-list
5480867|NCT04321174|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5480868|NCT04321174|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5480869|NCT04321174|Protease Inhibitors|protease inhibitors|mesh-ancestor
5480870|NCT04321174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5480871|NCT04321174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480872|NCT04321174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5480873|NCT04321174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5480874|NCT04321174|Antiviral Agents|antiviral agents|mesh-ancestor
5480875|NCT04321174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5480876|NCT04321174|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5480877|NCT04321174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6628493|NCT01319214|Vasodilator Agents|vasodilator agents|mesh-ancestor
6628494|NCT01319240|Insulin|insulin|mesh-list
6628495|NCT01319240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6628496|NCT01319240|Liraglutide|liraglutide|mesh-list
6628497|NCT01319240|Insulin, Long-Acting|insulin, long-acting|mesh-list
6628498|NCT01319240|Xultophy|xultophy|mesh-list
6628499|NCT01319240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6628500|NCT01319240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628501|NCT01319240|Incretins|incretins|mesh-ancestor
6628502|NCT01319240|Hormones|hormones|mesh-ancestor
6628503|NCT01319240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6628504|NCT01319266|Hydrocodone|hydrocodone|mesh-list
6628505|NCT01319266|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6628506|NCT01319266|Narcotics|narcotics|mesh-ancestor
6628507|NCT01319266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5480878|NCT04318145|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5480879|NCT04278781|Ivosidenib|ivosidenib|mesh-list
5480880|NCT04278781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5480881|NCT04278781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5480882|NCT04278781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480883|NCT04216329|Temozolomide|temozolomide|mesh-list
5480884|NCT04216329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5480885|NCT04216329|Alkylating Agents|alkylating agents|mesh-ancestor
5480886|NCT04216329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480887|NCT04216329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5480888|NCT04206761|Mometasone Furoate|mometasone furoate|mesh-list
5480889|NCT04206761|Glycopyrrolate|glycopyrrolate|mesh-list
5480890|NCT04206761|Bromides|bromides|mesh-list
5480891|NCT04206761|Anticonvulsants|anticonvulsants|mesh-ancestor
6628508|NCT01319266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628509|NCT01319266|Analgesics|analgesics|mesh-ancestor
6628510|NCT01319266|Sensory System Agents|sensory system agents|mesh-ancestor
6628511|NCT01319266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6628512|NCT01319266|Antitussive Agents|antitussive agents|mesh-ancestor
5480892|NCT04206761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5480893|NCT04206761|Dermatologic Agents|dermatologic agents|mesh-ancestor
5480894|NCT04206761|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5480895|NCT04206761|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5480896|NCT04206761|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5480897|NCT04206761|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5480898|NCT04206761|Cholinergic Agents|cholinergic agents|mesh-ancestor
5480899|NCT04206761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5480900|NCT04206761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480901|NCT04206761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480902|NCT04194814|Betamethasone|betamethasone|mesh-list
5480903|NCT04194814|Betamethasone Valerate|betamethasone valerate|mesh-list
5480904|NCT04194814|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5480905|NCT04194814|Betamethasone benzoate|betamethasone benzoate|mesh-list
5480906|NCT04194814|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
5480907|NCT04194814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5480908|NCT04194814|Glucocorticoids|glucocorticoids|mesh-ancestor
5480909|NCT04194814|Hormones|hormones|mesh-ancestor
5480910|NCT04194814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5480911|NCT04194814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480912|NCT04194814|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5480913|NCT04194814|Respiratory System Agents|respiratory system agents|mesh-ancestor
5480914|NCT04185220|Mogamulizumab|mogamulizumab|mesh-list
5480915|NCT04185220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5480916|NCT04143204|Insulin|insulin|mesh-list
5480917|NCT04143204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5480918|NCT04143204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480919|NCT04129931|Imatinib Mesylate|imatinib mesylate|mesh-list
5480920|NCT04129931|Broncho-Vaxom|broncho-vaxom|mesh-list
5480921|NCT04129931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5480922|NCT04129931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5480923|NCT04129931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5480924|NCT04129931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480925|NCT04129931|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5480926|NCT04129931|Immunologic Factors|immunologic factors|mesh-ancestor
5480927|NCT04129931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480928|NCT04118036|Pembrolizumab|pembrolizumab|mesh-list
6451523|NCT00412191|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6451524|NCT00412191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6628513|NCT01319266|Respiratory System Agents|respiratory system agents|mesh-ancestor
6628514|NCT01319279|Hydrocodone|hydrocodone|mesh-list
6451525|NCT00412191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451526|NCT00412191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6451527|NCT00412191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628515|NCT01319279|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6628516|NCT01319279|Narcotics|narcotics|mesh-ancestor
6628517|NCT01319279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6628518|NCT01319279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628519|NCT01319279|Analgesics|analgesics|mesh-ancestor
6628520|NCT01319279|Sensory System Agents|sensory system agents|mesh-ancestor
6628521|NCT01319279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6628522|NCT01319279|Antitussive Agents|antitussive agents|mesh-ancestor
6451528|NCT00412191|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6451529|NCT00412191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6451530|NCT00412191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6628523|NCT01319279|Respiratory System Agents|respiratory system agents|mesh-ancestor
6628524|NCT01319331|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
6628525|NCT01319331|Protein C Inhibitor|protein c inhibitor|mesh-list
6628526|NCT01319331|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6628527|NCT01319331|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6628528|NCT01319331|Protease Inhibitors|protease inhibitors|mesh-ancestor
6628529|NCT01319331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6628530|NCT01319331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628531|NCT01319344|Eplerenone|eplerenone|mesh-list
6628532|NCT01319344|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6628533|NCT01319344|Hormone Antagonists|hormone antagonists|mesh-ancestor
6628534|NCT01319344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6628535|NCT01319344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628536|NCT01319344|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6628537|NCT01319344|Diuretics|diuretics|mesh-ancestor
6628538|NCT01319344|Natriuretic Agents|natriuretic agents|mesh-ancestor
6628539|NCT01319344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6628540|NCT01319357|Saxagliptin|saxagliptin|mesh-list
6628541|NCT01319357|Incretins|incretins|mesh-ancestor
6628542|NCT01319357|Hormones|hormones|mesh-ancestor
6628543|NCT01319357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6628544|NCT01319357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628545|NCT01319357|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6628546|NCT01319357|Protease Inhibitors|protease inhibitors|mesh-ancestor
6628547|NCT01319357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6628548|NCT01319357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628549|NCT01319357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6628550|NCT01319370|Minoxidil|minoxidil|mesh-list
6628551|NCT01319370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6628552|NCT01319370|Vasodilator Agents|vasodilator agents|mesh-ancestor
6628553|NCT01319448|Artesunate|artesunate|mesh-list
6628554|NCT01319448|Pyrimethamine|pyrimethamine|mesh-list
6628555|NCT01319448|Sulfadoxine|sulfadoxine|mesh-list
6628556|NCT01319448|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6628557|NCT01319448|Amodiaquine|amodiaquine|mesh-list
6628558|NCT01319448|Mefloquine|mefloquine|mesh-list
6628559|NCT01319448|Proguanil|proguanil|mesh-list
6628560|NCT01319448|Antimalarials|antimalarials|mesh-ancestor
6628561|NCT01319448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6628562|NCT01319448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6628563|NCT01319448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6628564|NCT01319448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6628565|NCT01319448|Antiviral Agents|antiviral agents|mesh-ancestor
6628566|NCT01319448|Schistosomicides|schistosomicides|mesh-ancestor
6628567|NCT01319448|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6628568|NCT01319448|Anthelmintics|anthelmintics|mesh-ancestor
6628569|NCT01319448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6628570|NCT01319448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6628571|NCT01319448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628572|NCT01319448|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6628573|NCT01319448|Renal Agents|renal agents|mesh-ancestor
6628574|NCT01319448|Antimetabolites|antimetabolites|mesh-ancestor
6628575|NCT01319461|Hyaluronic Acid|hyaluronic acid|mesh-list
6628576|NCT01319461|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6628577|NCT01319461|Immunologic Factors|immunologic factors|mesh-ancestor
6628578|NCT01319461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628579|NCT01319461|Viscosupplements|viscosupplements|mesh-ancestor
6628580|NCT01319461|Protective Agents|protective agents|mesh-ancestor
6628581|NCT01319487|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6628582|NCT01319487|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6662540|NCT01503905|Tamoxifen|tamoxifen|mesh-list
6662541|NCT01503905|Cyclophosphamide|cyclophosphamide|mesh-list
6662542|NCT01503905|Docetaxel|docetaxel|mesh-list
6662543|NCT01503905|Trastuzumab|trastuzumab|mesh-list
6662544|NCT01503905|Epirubicin|epirubicin|mesh-list
6662545|NCT01503905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6662546|NCT01503905|Immunologic Factors|immunologic factors|mesh-ancestor
6662547|NCT01503905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662548|NCT01503905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6662549|NCT01503905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6662550|NCT01503905|Alkylating Agents|alkylating agents|mesh-ancestor
6628583|NCT01319682|Lidocaine|lidocaine|mesh-list
6628584|NCT01319682|Anesthetics, Local|anesthetics, local|mesh-ancestor
6628585|NCT01319682|Anesthetics|anesthetics|mesh-ancestor
6628586|NCT01319682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6628587|NCT01319682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628588|NCT01319682|Sensory System Agents|sensory system agents|mesh-ancestor
6628589|NCT01319682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6628590|NCT01319682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6628591|NCT01319682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6628592|NCT01319682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6628593|NCT01319682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6628594|NCT01319682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628595|NCT01319695|Hormones|hormones|mesh-list
6628596|NCT01319695|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6628597|NCT01319695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6628598|NCT01319695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628599|NCT01319734|Ascorbic Acid|ascorbic acid|mesh-list
6628600|NCT01319734|Glyburide|glyburide|mesh-list
6628601|NCT01319734|Vitamins|vitamins|mesh-ancestor
6628602|NCT01319734|Micronutrients|micronutrients|mesh-ancestor
6628603|NCT01319734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628604|NCT01319734|Antioxidants|antioxidants|mesh-ancestor
6628605|NCT01319734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628606|NCT01319734|Protective Agents|protective agents|mesh-ancestor
6628607|NCT01319734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6628608|NCT01319825|Milnacipran|milnacipran|mesh-list
6628609|NCT01319825|Levomilnacipran|levomilnacipran|mesh-list
6628610|NCT01319825|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6628611|NCT01319825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6628612|NCT01319825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6628613|NCT01319825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628614|NCT01319825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6628615|NCT01319825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628616|NCT01319825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6628617|NCT01319825|Analgesics|analgesics|mesh-ancestor
6628618|NCT01319825|Sensory System Agents|sensory system agents|mesh-ancestor
6628619|NCT01319825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6628620|NCT01319825|Antidepressive Agents|antidepressive agents|mesh-ancestor
6628621|NCT01319825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6628622|NCT01319838|Isotretinoin|isotretinoin|mesh-list
6628623|NCT01319838|Dermatologic Agents|dermatologic agents|mesh-ancestor
6628624|NCT01319864|Plerixafor|plerixafor|mesh-list
6628625|NCT01319864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6628626|NCT01319864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6628627|NCT01319864|Antiviral Agents|antiviral agents|mesh-ancestor
6628628|NCT01319864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6628629|NCT01319903|Antibodies|antibodies|mesh-list
6628630|NCT01319903|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6628631|NCT01319903|Immunologic Factors|immunologic factors|mesh-ancestor
6628632|NCT01319903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628633|NCT01319942|Sorafenib|sorafenib|mesh-list
6628634|NCT01319942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6628635|NCT01319942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6628636|NCT01319942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6628637|NCT01319942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628638|NCT01319981|Cytarabine|cytarabine|mesh-list
6628639|NCT01319981|Dexamethasone|dexamethasone|mesh-list
6628640|NCT01319981|Methylprednisolone|methylprednisolone|mesh-list
6628641|NCT01319981|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6628642|NCT01319981|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6628643|NCT01319981|Prednisolone|prednisolone|mesh-list
6628644|NCT01319981|Prednisolone acetate|prednisolone acetate|mesh-list
6628645|NCT01319981|Cyclophosphamide|cyclophosphamide|mesh-list
6628646|NCT01319981|Rituximab|rituximab|mesh-list
6628647|NCT01319981|Doxorubicin|doxorubicin|mesh-list
6628648|NCT01319981|Methotrexate|methotrexate|mesh-list
6628649|NCT01319981|Vincristine|vincristine|mesh-list
6628650|NCT01319981|Imatinib Mesylate|imatinib mesylate|mesh-list
6628651|NCT01319981|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6628652|NCT01319981|Prednisolone phosphate|prednisolone phosphate|mesh-list
6628653|NCT01319981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6628654|NCT01319981|Immunologic Factors|immunologic factors|mesh-ancestor
6628655|NCT01319981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628656|NCT01319981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6628657|NCT01319981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6628658|NCT01319981|Alkylating Agents|alkylating agents|mesh-ancestor
6628659|NCT01319981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628660|NCT01319981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6628661|NCT01319981|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6628662|NCT01319981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6628663|NCT01319981|Antiemetics|antiemetics|mesh-ancestor
6628664|NCT01319981|Autonomic Agents|autonomic agents|mesh-ancestor
6628665|NCT01319981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6628666|NCT01319981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6628667|NCT01319981|Glucocorticoids|glucocorticoids|mesh-ancestor
6628668|NCT01319981|Hormones|hormones|mesh-ancestor
6628669|NCT01319981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6628670|NCT01319981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6628671|NCT01319981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6628672|NCT01319981|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6628673|NCT01319981|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6628674|NCT01319981|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6628675|NCT01319981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6628676|NCT01319981|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6628677|NCT01319981|Abortifacient Agents|abortifacient agents|mesh-ancestor
6628678|NCT01319981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6628679|NCT01319981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6628680|NCT01319981|Antimetabolites|antimetabolites|mesh-ancestor
6628681|NCT01319981|Dermatologic Agents|dermatologic agents|mesh-ancestor
6628682|NCT01319981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6628683|NCT01319981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6628684|NCT01319981|Antiviral Agents|antiviral agents|mesh-ancestor
6628685|NCT01319981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6628686|NCT01319981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6628687|NCT01319981|Tubulin Modulators|tubulin modulators|mesh-ancestor
6628688|NCT01319981|Antimitotic Agents|antimitotic agents|mesh-ancestor
6628689|NCT01319981|Mitosis Modulators|mitosis modulators|mesh-ancestor
6628690|NCT01319981|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6628691|NCT01319981|Protective Agents|protective agents|mesh-ancestor
6628692|NCT01319981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6628693|NCT01320007|Furosemide|furosemide|mesh-list
5480929|NCT04118036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5480930|NCT04118036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5480931|NCT04099251|Nivolumab|nivolumab|mesh-list
5480932|NCT04099251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5480933|NCT04099251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5480934|NCT04099251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5480935|NCT04099251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628694|NCT01320007|Diuretics|diuretics|mesh-ancestor
6628695|NCT01320007|Natriuretic Agents|natriuretic agents|mesh-ancestor
6628696|NCT01320007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628697|NCT01320007|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6628698|NCT01320007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6628699|NCT01320007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628700|NCT01320020|Catumaxomab|catumaxomab|mesh-list
6628701|NCT01320020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6628702|NCT01320111|Paclitaxel|paclitaxel|mesh-list
6628703|NCT01320111|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6628704|NCT01320111|Sorafenib|sorafenib|mesh-list
6628705|NCT01320111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6628706|NCT01320111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6628707|NCT01320111|Tubulin Modulators|tubulin modulators|mesh-ancestor
6628708|NCT01320111|Antimitotic Agents|antimitotic agents|mesh-ancestor
6628709|NCT01320111|Mitosis Modulators|mitosis modulators|mesh-ancestor
6628710|NCT01320111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628711|NCT01320111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6628712|NCT01320111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6628713|NCT01320176|Vaccines|vaccines|mesh-list
6628714|NCT01320176|Immunologic Factors|immunologic factors|mesh-ancestor
6628715|NCT01320176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628716|NCT01320254|Gemcitabine|gemcitabine|mesh-list
6628717|NCT01320254|Cisplatin|cisplatin|mesh-list
6628718|NCT01320254|Panitumumab|panitumumab|mesh-list
6628719|NCT01320254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6628720|NCT01320254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6628721|NCT01320254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6628722|NCT01320254|Antimetabolites|antimetabolites|mesh-ancestor
6628723|NCT01320254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628724|NCT01320254|Antiviral Agents|antiviral agents|mesh-ancestor
6628725|NCT01320254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6628726|NCT01320254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6628727|NCT01320254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6628728|NCT01320254|Immunologic Factors|immunologic factors|mesh-ancestor
6628729|NCT01320254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628730|NCT01320254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6628731|NCT01320280|Afatinib|afatinib|mesh-list
6628732|NCT01320280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6628733|NCT01320280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6628734|NCT01320280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6628735|NCT01320280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628736|NCT01320345|Fenofibrate|fenofibrate|mesh-list
6628737|NCT01320345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6628738|NCT01320345|Antimetabolites|antimetabolites|mesh-ancestor
5480936|NCT04093752|Insulin Glargine|insulin glargine|mesh-list
5480937|NCT04093752|Tirzepatide|tirzepatide|mesh-list
5480938|NCT04093752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5480939|NCT04093752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480940|NCT04093752|Incretins|incretins|mesh-ancestor
5480941|NCT04093752|Hormones|hormones|mesh-ancestor
5480942|NCT04093752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6628739|NCT01320345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628740|NCT01320345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6628741|NCT01320397|Losartan|losartan|mesh-list
6628742|NCT01320397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6628743|NCT01320397|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6628744|NCT01320397|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6628745|NCT01320397|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6628746|NCT01320397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628747|NCT01320436|Aminosalicylic Acid|aminosalicylic acid|mesh-list
6628748|NCT01320436|Curcumin|curcumin|mesh-list
5480943|NCT04055428|Valsartan|valsartan|mesh-list
5480944|NCT04055428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5480945|NCT04055428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5480946|NCT04055428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6628749|NCT01320436|Mesalamine|mesalamine|mesh-list
6628750|NCT01320436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6628751|NCT01320436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6628752|NCT01320436|Analgesics|analgesics|mesh-ancestor
6628753|NCT01320436|Sensory System Agents|sensory system agents|mesh-ancestor
6628754|NCT01320436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6628755|NCT01320436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628756|NCT01320436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6628757|NCT01320436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6628758|NCT01320436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6628759|NCT01320436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6628760|NCT01320436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628761|NCT01320436|Antitubercular Agents|antitubercular agents|mesh-ancestor
6628762|NCT01320436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6628763|NCT01320436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6628764|NCT01320449|Epoetin Alfa|epoetin alfa|mesh-list
6628765|NCT01320449|Hematinics|hematinics|mesh-ancestor
6628766|NCT01320475|Sufentanil|sufentanil|mesh-list
6628767|NCT01320475|Ketamine|ketamine|mesh-list
5480947|NCT04055428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480948|NCT03998293|Somatostatin|somatostatin|mesh-list
5480949|NCT03998293|Hormones|hormones|mesh-ancestor
5480950|NCT03998293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5480951|NCT03998293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480952|NCT03962998|Lactulose|lactulose|mesh-list
5480953|NCT03962998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5480954|NCT03947255|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5480955|NCT03947255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6628768|NCT01320475|Analgesics|analgesics|mesh-ancestor
6628769|NCT01320475|Sensory System Agents|sensory system agents|mesh-ancestor
6628770|NCT01320475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6628771|NCT01320475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628772|NCT01320475|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6628773|NCT01320475|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6628774|NCT01320475|Anesthetics, General|anesthetics, general|mesh-ancestor
6628775|NCT01320475|Anesthetics|anesthetics|mesh-ancestor
6628776|NCT01320475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6628777|NCT01320475|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6628778|NCT01320475|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6628779|NCT01320475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6628780|NCT01320475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628781|NCT01320475|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6628782|NCT01320475|Narcotics|narcotics|mesh-ancestor
6628783|NCT01320475|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6628784|NCT01320501|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6628785|NCT01320501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6628786|NCT01320501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6628787|NCT01320501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6628788|NCT01320501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628789|NCT01320514|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6628790|NCT01320514|Hemostatics|hemostatics|mesh-ancestor
6628791|NCT01320514|Coagulants|coagulants|mesh-ancestor
6628792|NCT01320579|Tacrolimus|tacrolimus|mesh-list
6628793|NCT01320579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6451531|NCT00412191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6451532|NCT00412191|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6451533|NCT00412204|Bromides|bromides|mesh-list
6451534|NCT00412204|Tiotropium Bromide|tiotropium bromide|mesh-list
6628794|NCT01320579|Immunologic Factors|immunologic factors|mesh-ancestor
6628795|NCT01320579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628796|NCT01320579|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6628797|NCT01320579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6628798|NCT01320579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628799|NCT01320592|Paclitaxel|paclitaxel|mesh-list
6628800|NCT01320592|Palbociclib|palbociclib|mesh-list
6628801|NCT01320592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6628802|NCT01320592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6628803|NCT01320592|Tubulin Modulators|tubulin modulators|mesh-ancestor
5480956|NCT03947255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5480957|NCT03925246|Nivolumab|nivolumab|mesh-list
5480958|NCT03925246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5480959|NCT03925246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5480960|NCT03925246|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5480961|NCT03925246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5480962|NCT03836261|Venetoclax|venetoclax|mesh-list
5480963|NCT03836261|Obinutuzumab|obinutuzumab|mesh-list
5480964|NCT03836261|Acalabrutinib|acalabrutinib|mesh-list
5480965|NCT03836261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5480966|NCT03836261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5480967|NCT03815175|Aspirin|aspirin|mesh-list
5480968|NCT03815175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5480969|NCT03815175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5480970|NCT03815175|Analgesics|analgesics|mesh-ancestor
5480971|NCT03815175|Sensory System Agents|sensory system agents|mesh-ancestor
5480972|NCT03815175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5480973|NCT03815175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480974|NCT03815175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5480975|NCT03815175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5480976|NCT03815175|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5480977|NCT03815175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5480978|NCT03815175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451535|NCT00412204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6451536|NCT00412204|Autonomic Agents|autonomic agents|mesh-ancestor
6451537|NCT00412204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6451538|NCT00412204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451539|NCT00412204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6451540|NCT00412204|Respiratory System Agents|respiratory system agents|mesh-ancestor
6628804|NCT01320592|Antimitotic Agents|antimitotic agents|mesh-ancestor
6628805|NCT01320592|Mitosis Modulators|mitosis modulators|mesh-ancestor
6628806|NCT01320592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628807|NCT01320592|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6628808|NCT01320592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6628809|NCT01320709|Piroxicam|piroxicam|mesh-list
6628810|NCT01320709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6628811|NCT01320709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6628812|NCT01320709|Analgesics|analgesics|mesh-ancestor
6628813|NCT01320709|Sensory System Agents|sensory system agents|mesh-ancestor
6628814|NCT01320709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6628815|NCT01320709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628816|NCT01320709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6628817|NCT01320709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6628818|NCT01320709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6628819|NCT01320709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6628820|NCT01320709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628821|NCT01320878|Iloprost|iloprost|mesh-list
6628822|NCT01320878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6628823|NCT01320878|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6628824|NCT01320878|Vasodilator Agents|vasodilator agents|mesh-ancestor
6628825|NCT01320917|Levonorgestrel|levonorgestrel|mesh-list
6628826|NCT01320917|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6628827|NCT01320917|Contraceptive Agents|contraceptive agents|mesh-ancestor
6628828|NCT01320917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6628829|NCT01320917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628830|NCT01320917|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6628831|NCT01320917|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6628832|NCT01320917|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6628833|NCT01320982|Aspirin|aspirin|mesh-list
6628834|NCT01320982|Minocycline|minocycline|mesh-list
6628835|NCT01320982|Pramipexole|pramipexole|mesh-list
6628836|NCT01320982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6628837|NCT01320982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6628838|NCT01320982|Analgesics|analgesics|mesh-ancestor
6628839|NCT01320982|Sensory System Agents|sensory system agents|mesh-ancestor
6628840|NCT01320982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6628841|NCT01320982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628842|NCT01320982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6628843|NCT01320982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6628844|NCT01320982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6628845|NCT01320982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6628846|NCT01320982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628847|NCT01320982|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6628848|NCT01320982|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6628849|NCT01320982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6628850|NCT01320982|Antipyretics|antipyretics|mesh-ancestor
6628851|NCT01320982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6628852|NCT01320982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6628853|NCT01320982|Antioxidants|antioxidants|mesh-ancestor
6628854|NCT01320982|Protective Agents|protective agents|mesh-ancestor
6628855|NCT01320982|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6628856|NCT01320982|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6628857|NCT01320982|Dopamine Agonists|dopamine agonists|mesh-ancestor
6628858|NCT01320982|Dopamine Agents|dopamine agents|mesh-ancestor
6628859|NCT01320982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6628860|NCT01321021|Diphenhydramine|diphenhydramine|mesh-list
6628861|NCT01321021|Promethazine|promethazine|mesh-list
6628862|NCT01321021|Losartan|losartan|mesh-list
6628863|NCT01321021|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6628864|NCT01321021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6628865|NCT01321021|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6451541|NCT00412204|Parasympatholytics|parasympatholytics|mesh-ancestor
6451542|NCT00412204|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6451543|NCT00412204|Cholinergic Agents|cholinergic agents|mesh-ancestor
6451544|NCT00412204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6451545|NCT00412204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451546|NCT00412204|Anticonvulsants|anticonvulsants|mesh-ancestor
6451547|NCT00412321|Siltuximab|siltuximab|mesh-list
6451548|NCT00412321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6451549|NCT00412334|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6451550|NCT00412334|Interferon-alpha|interferon-alpha|mesh-list
6451551|NCT00412334|Ribavirin|ribavirin|mesh-list
6451552|NCT00412334|Antiviral Agents|antiviral agents|mesh-ancestor
6628866|NCT01321021|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6628867|NCT01321021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628868|NCT01321021|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6628869|NCT01321021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6628870|NCT01321021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6628871|NCT01321021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628872|NCT01321021|Anesthetics, Local|anesthetics, local|mesh-ancestor
6628873|NCT01321021|Anesthetics|anesthetics|mesh-ancestor
6628874|NCT01321021|Sensory System Agents|sensory system agents|mesh-ancestor
6628875|NCT01321021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6628876|NCT01321021|Antiemetics|antiemetics|mesh-ancestor
6628877|NCT01321021|Autonomic Agents|autonomic agents|mesh-ancestor
6628878|NCT01321021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6628879|NCT01321021|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6628880|NCT01321021|Histamine Antagonists|histamine antagonists|mesh-ancestor
6628881|NCT01321021|Histamine Agents|histamine agents|mesh-ancestor
6628882|NCT01321021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6628883|NCT01321021|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6628884|NCT01321021|Antipruritics|antipruritics|mesh-ancestor
6628885|NCT01321021|Dermatologic Agents|dermatologic agents|mesh-ancestor
6628886|NCT01321034|Niacin|niacin|mesh-list
5480979|NCT03815175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5480980|NCT03815175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5480981|NCT03815175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5480982|NCT03815175|Antipyretics|antipyretics|mesh-ancestor
6628887|NCT01321034|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6628888|NCT01321034|Antimetabolites|antimetabolites|mesh-ancestor
6628889|NCT01321034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628890|NCT01321034|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6628891|NCT01321034|Vasodilator Agents|vasodilator agents|mesh-ancestor
6628892|NCT01321034|Vitamin B Complex|vitamin b complex|mesh-ancestor
6628893|NCT01321034|Vitamins|vitamins|mesh-ancestor
6628894|NCT01321034|Micronutrients|micronutrients|mesh-ancestor
6628895|NCT01321034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628896|NCT01321047|Propofol|propofol|mesh-list
6628897|NCT01321047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6628898|NCT01321047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6628899|NCT01321047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628900|NCT01321047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6628901|NCT01321047|Anesthetics, General|anesthetics, general|mesh-ancestor
6628902|NCT01321047|Anesthetics|anesthetics|mesh-ancestor
6628903|NCT01321099|Ascorbic Acid|ascorbic acid|mesh-list
6628904|NCT01321099|Fe(III)-EDTA|fe(iii)-edta|mesh-list
6628905|NCT01321099|Vitamins|vitamins|mesh-ancestor
6628906|NCT01321099|Micronutrients|micronutrients|mesh-ancestor
6628907|NCT01321099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628908|NCT01321099|Antioxidants|antioxidants|mesh-ancestor
6628909|NCT01321099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628910|NCT01321099|Protective Agents|protective agents|mesh-ancestor
6628911|NCT01321099|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6628912|NCT01321099|Chelating Agents|chelating agents|mesh-ancestor
6628913|NCT01321099|Sequestering Agents|sequestering agents|mesh-ancestor
6628914|NCT01321125|Chlorhexidine|chlorhexidine|mesh-list
6628915|NCT01321125|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6628916|NCT01321125|Povidone-Iodine|povidone-iodine|mesh-list
6628917|NCT01321125|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
6628918|NCT01321125|Povidone|povidone|mesh-list
6628919|NCT01321125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6628920|NCT01321125|Disinfectants|disinfectants|mesh-ancestor
6628921|NCT01321125|Dermatologic Agents|dermatologic agents|mesh-ancestor
6628922|NCT01321125|Plasma Substitutes|plasma substitutes|mesh-ancestor
6628923|NCT01321125|Blood Substitutes|blood substitutes|mesh-ancestor
6628924|NCT01321138|Morphine|morphine|mesh-list
6628925|NCT01321138|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6628926|NCT01321138|Narcotics|narcotics|mesh-ancestor
6628927|NCT01321138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6628928|NCT01321138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628929|NCT01321138|Analgesics|analgesics|mesh-ancestor
6628930|NCT01321138|Sensory System Agents|sensory system agents|mesh-ancestor
6628931|NCT01321138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6662551|NCT01503905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662552|NCT01503905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6662553|NCT01503905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6662554|NCT01503905|Tubulin Modulators|tubulin modulators|mesh-ancestor
6662555|NCT01503905|Antimitotic Agents|antimitotic agents|mesh-ancestor
6662556|NCT01503905|Mitosis Modulators|mitosis modulators|mesh-ancestor
6662557|NCT01503905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6662558|NCT01503905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6662559|NCT01503905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5480983|NCT03777215|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
5480984|NCT03777215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5480985|NCT03777215|Vasodilator Agents|vasodilator agents|mesh-ancestor
5480986|NCT03743402|Analgesics, Opioid|analgesics, opioid|mesh-list
5480987|NCT03743402|Narcotics|narcotics|mesh-ancestor
5480988|NCT03743402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5480989|NCT03743402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5480990|NCT03743402|Analgesics|analgesics|mesh-ancestor
5480991|NCT03743402|Sensory System Agents|sensory system agents|mesh-ancestor
5480992|NCT03743402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5480993|NCT03742505|Cholecalciferol|cholecalciferol|mesh-list
6628932|NCT01321255|Aspirin|aspirin|mesh-list
6628933|NCT01321255|Ramipril|ramipril|mesh-list
6628934|NCT01321255|Simvastatin|simvastatin|mesh-list
6628935|NCT01321255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6628936|NCT01321255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6628937|NCT01321255|Analgesics|analgesics|mesh-ancestor
6628938|NCT01321255|Sensory System Agents|sensory system agents|mesh-ancestor
6628939|NCT01321255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6628940|NCT01321255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628941|NCT01321255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6628942|NCT01321255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6628943|NCT01321255|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6628944|NCT01321255|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6628945|NCT01321255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628946|NCT01321255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6628947|NCT01321255|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6628948|NCT01321255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6628949|NCT01321255|Antipyretics|antipyretics|mesh-ancestor
6628950|NCT01321255|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6628951|NCT01321255|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6628952|NCT01321255|Antimetabolites|antimetabolites|mesh-ancestor
6628953|NCT01321255|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6628954|NCT01321255|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6628955|NCT01321255|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6628956|NCT01321255|Protease Inhibitors|protease inhibitors|mesh-ancestor
6628957|NCT01321255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6628958|NCT01321268|Beta Carotene|beta carotene|mesh-list
6628959|NCT01321268|Lycopene|lycopene|mesh-list
6628960|NCT01321268|Resveratrol|resveratrol|mesh-list
6628961|NCT01321268|Carotenoids|carotenoids|mesh-list
6628962|NCT01321268|Antioxidants|antioxidants|mesh-ancestor
6628963|NCT01321268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628964|NCT01321268|Protective Agents|protective agents|mesh-ancestor
6628965|NCT01321268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628966|NCT01321268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6628967|NCT01321268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6628968|NCT01321268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6628969|NCT01321268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6628970|NCT01321268|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6628971|NCT01321268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6628972|NCT01321268|Provitamins|provitamins|mesh-ancestor
6628973|NCT01321268|Vitamins|vitamins|mesh-ancestor
6628974|NCT01321268|Micronutrients|micronutrients|mesh-ancestor
6628975|NCT01321346|Cytarabine|cytarabine|mesh-list
6628976|NCT01321346|Panobinostat|panobinostat|mesh-list
6628977|NCT01321346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6628978|NCT01321346|Antimetabolites|antimetabolites|mesh-ancestor
6628979|NCT01321346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628980|NCT01321346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6628981|NCT01321346|Antiviral Agents|antiviral agents|mesh-ancestor
6628982|NCT01321346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6628983|NCT01321346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6628984|NCT01321346|Immunologic Factors|immunologic factors|mesh-ancestor
6628985|NCT01321346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628986|NCT01321346|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6628987|NCT01321346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6628988|NCT01321489|Sildenafil Citrate|sildenafil citrate|mesh-list
6628989|NCT01321489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6628990|NCT01321489|Vasodilator Agents|vasodilator agents|mesh-ancestor
6628991|NCT01321489|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6628992|NCT01321489|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6628993|NCT01321489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6628994|NCT01321489|Urological Agents|urological agents|mesh-ancestor
6628995|NCT01321502|Famciclovir|famciclovir|mesh-list
6628996|NCT01321502|Antiviral Agents|antiviral agents|mesh-ancestor
6628997|NCT01321502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5480994|NCT03742505|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5480995|NCT03742505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6628998|NCT01321502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6628999|NCT01321502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6629000|NCT01321502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629001|NCT01321515|Famciclovir|famciclovir|mesh-list
5480996|NCT03742505|Vitamins|vitamins|mesh-ancestor
5480997|NCT03742505|Micronutrients|micronutrients|mesh-ancestor
5480998|NCT03742505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6629002|NCT01321515|Antiviral Agents|antiviral agents|mesh-ancestor
6629003|NCT01321515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6629004|NCT01321515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6629005|NCT01321515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6629006|NCT01321515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629007|NCT01321567|Rabeprazole|rabeprazole|mesh-list
6629008|NCT01321567|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6629009|NCT01321567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6629010|NCT01321567|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6451553|NCT00412334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6451554|NCT00412334|Immunologic Factors|immunologic factors|mesh-ancestor
6451555|NCT00412334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451556|NCT00412334|Antimetabolites|antimetabolites|mesh-ancestor
6451557|NCT00412334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451558|NCT00412347|Insulin|insulin|mesh-list
6451559|NCT00412347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6629011|NCT01321567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6629012|NCT01321567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629013|NCT01321671|Pregabalin|pregabalin|mesh-list
6629014|NCT01321671|Analgesics|analgesics|mesh-ancestor
6629015|NCT01321671|Sensory System Agents|sensory system agents|mesh-ancestor
6629016|NCT01321671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6629017|NCT01321671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629018|NCT01321671|Anticonvulsants|anticonvulsants|mesh-ancestor
6629019|NCT01321671|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6629020|NCT01321671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6629021|NCT01321671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629022|NCT01321671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6629023|NCT01321671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6629024|NCT01321671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6629025|NCT01321671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6629026|NCT01321671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6629027|NCT01321775|Paclitaxel|paclitaxel|mesh-list
5480999|NCT03668639|Dexamethasone|dexamethasone|mesh-list
5481000|NCT03668639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6451560|NCT00412347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451561|NCT00412412|Trastuzumab|trastuzumab|mesh-list
6451562|NCT00412412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6629028|NCT01321775|Cyclophosphamide|cyclophosphamide|mesh-list
6629029|NCT01321775|Bevacizumab|bevacizumab|mesh-list
6629030|NCT01321775|Trastuzumab|trastuzumab|mesh-list
6629031|NCT01321775|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6629032|NCT01321775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6629033|NCT01321775|Tubulin Modulators|tubulin modulators|mesh-ancestor
6629034|NCT01321775|Antimitotic Agents|antimitotic agents|mesh-ancestor
6629035|NCT01321775|Mitosis Modulators|mitosis modulators|mesh-ancestor
6629036|NCT01321775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629037|NCT01321775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6629038|NCT01321775|Immunologic Factors|immunologic factors|mesh-ancestor
6629039|NCT01321775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629040|NCT01321775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6629041|NCT01321775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6629042|NCT01321775|Alkylating Agents|alkylating agents|mesh-ancestor
6629043|NCT01321775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6629044|NCT01321775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5481001|NCT03668639|Antiemetics|antiemetics|mesh-ancestor
6629045|NCT01321775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6629046|NCT01321775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6629047|NCT01321775|Growth Substances|growth substances|mesh-ancestor
6629048|NCT01321775|Growth Inhibitors|growth inhibitors|mesh-ancestor
6629049|NCT01321788|Tinzaparin|tinzaparin|mesh-list
6629050|NCT01321788|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6629051|NCT01321788|Dalteparin|dalteparin|mesh-list
6629052|NCT01321788|Anticoagulants|anticoagulants|mesh-ancestor
6629053|NCT01321788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6629054|NCT01321788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6629055|NCT01321788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629056|NCT01321801|Pregabalin|pregabalin|mesh-list
6629057|NCT01321801|Analgesics|analgesics|mesh-ancestor
6629058|NCT01321801|Sensory System Agents|sensory system agents|mesh-ancestor
6629059|NCT01321801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6629060|NCT01321801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629061|NCT01321801|Anticonvulsants|anticonvulsants|mesh-ancestor
6629062|NCT01321801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6629063|NCT01321801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6629064|NCT01321801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629065|NCT01321801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6629066|NCT01321801|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6629067|NCT01321801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6629068|NCT01321801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6629069|NCT01321801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6629070|NCT01321827|Itraconazole|itraconazole|mesh-list
6629071|NCT01321827|Prednisolone|prednisolone|mesh-list
6629072|NCT01321827|Glucocorticoids|glucocorticoids|mesh-list
6629073|NCT01321827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6629074|NCT01321827|Hormones|hormones|mesh-ancestor
6629075|NCT01321827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6629076|NCT01321827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629077|NCT01321827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6629078|NCT01321827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6629079|NCT01321827|Antifungal Agents|antifungal agents|mesh-ancestor
6629080|NCT01321827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6629081|NCT01321827|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6629082|NCT01321827|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6629083|NCT01321827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6629084|NCT01321827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629085|NCT01321827|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6629086|NCT01321827|Hormone Antagonists|hormone antagonists|mesh-ancestor
6629087|NCT01321827|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6629088|NCT01321905|Vitamin D|vitamin d|mesh-list
6629089|NCT01321905|Ergocalciferols|ergocalciferols|mesh-list
6629090|NCT01321905|Vitamins|vitamins|mesh-ancestor
6629091|NCT01321905|Micronutrients|micronutrients|mesh-ancestor
6629092|NCT01321905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629093|NCT01321905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6629094|NCT01321905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6629095|NCT01321931|Nicotine|nicotine|mesh-list
5481002|NCT03668639|Autonomic Agents|autonomic agents|mesh-ancestor
5481003|NCT03668639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5481004|NCT03668639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481005|NCT03668639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5481006|NCT03668639|Glucocorticoids|glucocorticoids|mesh-ancestor
5481007|NCT03668639|Hormones|hormones|mesh-ancestor
5481008|NCT03668639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5481009|NCT03668639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5481010|NCT03668639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5481011|NCT03638128|Denosumab|denosumab|mesh-list
5481012|NCT03638128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5481013|NCT03638128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502360|NCT04467125|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
5502361|NCT04467086|Propranolol|propranolol|mesh-list
5502362|NCT04467086|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5502363|NCT04467086|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5502364|NCT04467086|Adrenergic Agents|adrenergic agents|mesh-ancestor
5502365|NCT04467086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6629096|NCT01321931|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6629097|NCT01321931|Autonomic Agents|autonomic agents|mesh-ancestor
6629098|NCT01321931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6629099|NCT01321931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629100|NCT01321931|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6629101|NCT01321931|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6629102|NCT01321931|Cholinergic Agents|cholinergic agents|mesh-ancestor
6629103|NCT01321931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6629104|NCT01321931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629105|NCT01321944|Nicotine|nicotine|mesh-list
6629106|NCT01321944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6629107|NCT01321944|Autonomic Agents|autonomic agents|mesh-ancestor
6629108|NCT01321944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6629109|NCT01321944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629110|NCT01321944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6629111|NCT01321944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6629112|NCT01321944|Cholinergic Agents|cholinergic agents|mesh-ancestor
6629113|NCT01321944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6629114|NCT01321944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451563|NCT00412412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6451564|NCT00412503|Temozolomide|temozolomide|mesh-list
6451565|NCT00412503|Topotecan|topotecan|mesh-list
6451566|NCT00412503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6451567|NCT00412503|Alkylating Agents|alkylating agents|mesh-ancestor
6451568|NCT00412503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451569|NCT00412503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6451570|NCT00412503|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6451571|NCT00412503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6451572|NCT00412503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6451573|NCT00412555|Oseltamivir|oseltamivir|mesh-list
6629115|NCT01321957|Bevacizumab|bevacizumab|mesh-list
6629116|NCT01321957|Oxaliplatin|oxaliplatin|mesh-list
6629117|NCT01321957|Irinotecan|irinotecan|mesh-list
6629118|NCT01321957|Fluorouracil|fluorouracil|mesh-list
6629119|NCT01321957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6629120|NCT01321957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6629121|NCT01321957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5481014|NCT03618693|Anesthetics|anesthetics|mesh-list
6629122|NCT01321957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6629123|NCT01321957|Growth Substances|growth substances|mesh-ancestor
6629124|NCT01321957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629125|NCT01321957|Growth Inhibitors|growth inhibitors|mesh-ancestor
6629126|NCT01321957|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6629127|NCT01321957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6629128|NCT01321957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6629129|NCT01321957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629130|NCT01321957|Antimetabolites|antimetabolites|mesh-ancestor
6629131|NCT01321957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6629132|NCT01321957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6629133|NCT01321957|Immunologic Factors|immunologic factors|mesh-ancestor
6629134|NCT01322061|Ascorbic Acid|ascorbic acid|mesh-list
6629135|NCT01322061|Vitamins|vitamins|mesh-ancestor
6629136|NCT01322061|Micronutrients|micronutrients|mesh-ancestor
6629137|NCT01322061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629138|NCT01322061|Antioxidants|antioxidants|mesh-ancestor
6629139|NCT01322061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629140|NCT01322061|Protective Agents|protective agents|mesh-ancestor
6629141|NCT01322100|Bleomycin|bleomycin|mesh-list
6629142|NCT01322100|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6629143|NCT01322100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6629144|NCT01322139|Moxifloxacin|moxifloxacin|mesh-list
6629145|NCT01322139|Nabiximols|nabiximols|mesh-list
6629146|NCT01322139|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6629147|NCT01322139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6629148|NCT01322139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6629149|NCT01322139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6629150|NCT01322139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6629151|NCT01322139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6629152|NCT01322139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629153|NCT01322139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6629154|NCT01322139|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6629155|NCT01322139|Contraceptive Agents|contraceptive agents|mesh-ancestor
6629156|NCT01322139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6629157|NCT01322139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629158|NCT01322139|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6629159|NCT01322139|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6629160|NCT01322139|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6629161|NCT01322139|Analgesics|analgesics|mesh-ancestor
6629162|NCT01322139|Sensory System Agents|sensory system agents|mesh-ancestor
6629163|NCT01322139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6629164|NCT01322152|Capecitabine|capecitabine|mesh-list
6629165|NCT01322152|Irinotecan|irinotecan|mesh-list
6629166|NCT01322152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6629167|NCT01322152|Antimetabolites|antimetabolites|mesh-ancestor
6629168|NCT01322152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629169|NCT01322152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6629170|NCT01322152|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6629171|NCT01322152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6629172|NCT01322152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6629173|NCT01322178|Cetuximab|cetuximab|mesh-list
6629174|NCT01322178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6629175|NCT01322178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5481015|NCT03618693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5481016|NCT03618693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481017|NCT03612713|Oxycodone|oxycodone|mesh-list
5481018|NCT03612713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5481019|NCT03612713|Narcotics|narcotics|mesh-ancestor
6629176|NCT01322191|Morphine|morphine|mesh-list
6629177|NCT01322191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6629178|NCT01322191|Narcotics|narcotics|mesh-ancestor
6629179|NCT01322191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6629180|NCT01322191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629181|NCT01322191|Analgesics|analgesics|mesh-ancestor
6629182|NCT01322191|Sensory System Agents|sensory system agents|mesh-ancestor
6629183|NCT01322191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6629184|NCT01322204|Codeine|codeine|mesh-list
5481020|NCT03612713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5481021|NCT03612713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481022|NCT03612713|Analgesics|analgesics|mesh-ancestor
5481023|NCT03612713|Sensory System Agents|sensory system agents|mesh-ancestor
5481024|NCT03612713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5481025|NCT03604289|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
5481026|NCT03604289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5481027|NCT03604289|Vasodilator Agents|vasodilator agents|mesh-ancestor
5481028|NCT03600714|Interferons|interferons|mesh-list
5481029|NCT03600714|Ritonavir|ritonavir|mesh-list
5481030|NCT03600714|Lonafarnib|lonafarnib|mesh-list
5481031|NCT03600714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5481032|NCT03600714|Antiviral Agents|antiviral agents|mesh-ancestor
5481033|NCT03600714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6629185|NCT01322204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6629186|NCT01322204|Narcotics|narcotics|mesh-ancestor
6629187|NCT01322204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6629188|NCT01322204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629189|NCT01322204|Analgesics|analgesics|mesh-ancestor
5481034|NCT03600714|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5481035|NCT03600714|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6451574|NCT00412555|Antiviral Agents|antiviral agents|mesh-ancestor
6451575|NCT00412555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6629190|NCT01322204|Sensory System Agents|sensory system agents|mesh-ancestor
6629191|NCT01322204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6629192|NCT01322204|Antitussive Agents|antitussive agents|mesh-ancestor
6451576|NCT00412555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6451577|NCT00412555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451578|NCT00412581|Lenalidomide|lenalidomide|mesh-list
6451579|NCT00412581|Dacarbazine|dacarbazine|mesh-list
6451580|NCT00412581|Immunologic Factors|immunologic factors|mesh-ancestor
6451581|NCT00412581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451582|NCT00412581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6451583|NCT00412581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6451584|NCT00412581|Growth Substances|growth substances|mesh-ancestor
6451585|NCT00412581|Growth Inhibitors|growth inhibitors|mesh-ancestor
6451586|NCT00412581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6629193|NCT01322204|Respiratory System Agents|respiratory system agents|mesh-ancestor
6629194|NCT01322282|Cetirizine|cetirizine|mesh-list
6629195|NCT01322282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5481036|NCT03600714|Protease Inhibitors|protease inhibitors|mesh-ancestor
5481037|NCT03600714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6629196|NCT01322282|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6629197|NCT01322282|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6629198|NCT01322282|Histamine Antagonists|histamine antagonists|mesh-ancestor
6629199|NCT01322282|Histamine Agents|histamine agents|mesh-ancestor
6629200|NCT01322282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6629201|NCT01322282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629202|NCT01322282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629203|NCT01322308|Pioglitazone|pioglitazone|mesh-list
6629204|NCT01322308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5481038|NCT03600714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481039|NCT03600714|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5481040|NCT03600714|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5481041|NCT03600714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5481042|NCT03600714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5481043|NCT03530124|Vaccines|vaccines|mesh-list
5481044|NCT03530124|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5481045|NCT03530124|Immunologic Factors|immunologic factors|mesh-ancestor
5481046|NCT03530124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481047|NCT03518203|Eculizumab|eculizumab|mesh-list
5481048|NCT03518203|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5481049|NCT03518203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5481050|NCT03518203|Immunologic Factors|immunologic factors|mesh-ancestor
5481051|NCT03518203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481052|NCT03479307|Ketotifen|ketotifen|mesh-list
5481053|NCT03479307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5481054|NCT03479307|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5481055|NCT03479307|Antipruritics|antipruritics|mesh-ancestor
5481056|NCT03479307|Dermatologic Agents|dermatologic agents|mesh-ancestor
5481057|NCT03479307|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5481058|NCT03479307|Histamine Antagonists|histamine antagonists|mesh-ancestor
5481059|NCT03479307|Histamine Agents|histamine agents|mesh-ancestor
5481060|NCT03479307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5481061|NCT03479307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481062|NCT03479307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481063|NCT03479307|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5481064|NCT03474640|Antibodies|antibodies|mesh-list
5481065|NCT03474640|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5481066|NCT03474640|Immunologic Factors|immunologic factors|mesh-ancestor
5481067|NCT03474640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481068|NCT03448939|Benzoyl Peroxide|benzoyl peroxide|mesh-list
5481069|NCT03448939|Dermatologic Agents|dermatologic agents|mesh-ancestor
5481070|NCT03393741|Paclitaxel|paclitaxel|mesh-list
6629205|NCT01322308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629206|NCT01322438|Rifampin|rifampin|mesh-list
6629207|NCT01322438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6629208|NCT01322438|Antitubercular Agents|antitubercular agents|mesh-ancestor
6629209|NCT01322438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6629210|NCT01322438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6629211|NCT01322438|Leprostatic Agents|leprostatic agents|mesh-ancestor
6629212|NCT01322438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6451587|NCT00412581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6629213|NCT01322438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6629214|NCT01322438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629215|NCT01322438|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6629216|NCT01322438|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6451588|NCT00412581|Alkylating Agents|alkylating agents|mesh-ancestor
6451589|NCT00412581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451590|NCT00412594|Rituximab|rituximab|mesh-list
6451591|NCT00412594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6451592|NCT00412594|Cladribine|cladribine|mesh-list
6451593|NCT00412594|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
6451594|NCT00412594|Antibodies|antibodies|mesh-list
6451595|NCT00412594|Immunoglobulins|immunoglobulins|mesh-list
6451596|NCT00412594|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6451597|NCT00412594|Immunologic Factors|immunologic factors|mesh-ancestor
6629217|NCT01322438|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6629218|NCT01322438|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6629219|NCT01322438|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6629220|NCT01322438|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6629221|NCT01322464|Nabiximols|nabiximols|mesh-list
6629222|NCT01322464|Analgesics|analgesics|mesh-ancestor
6629223|NCT01322464|Sensory System Agents|sensory system agents|mesh-ancestor
6629224|NCT01322464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6629225|NCT01322464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629226|NCT01322477|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6629227|NCT01322477|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6629228|NCT01322477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481071|NCT03393741|Vinorelbine|vinorelbine|mesh-list
5481072|NCT03393741|Docetaxel|docetaxel|mesh-list
5481073|NCT03393741|Epothilones|epothilones|mesh-list
5481074|NCT03393741|Vinca Alkaloids|vinca alkaloids|mesh-list
5481075|NCT03393741|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5481076|NCT03393741|Taxane|taxane|mesh-list
5481077|NCT03393741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5481078|NCT03393741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5481079|NCT03393741|Tubulin Modulators|tubulin modulators|mesh-ancestor
5481080|NCT03393741|Antimitotic Agents|antimitotic agents|mesh-ancestor
5481081|NCT03393741|Mitosis Modulators|mitosis modulators|mesh-ancestor
5481082|NCT03393741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481083|NCT03379389|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5481084|NCT03379389|Methenamine hippurate|methenamine hippurate|mesh-list
5481085|NCT03379389|Methenamine mandelate|methenamine mandelate|mesh-list
5481086|NCT03379389|Methenamine|methenamine|mesh-list
5481087|NCT03379389|Acriflavine|acriflavine|mesh-list
5481088|NCT03379389|Methylene Blue|methylene blue|mesh-list
5481089|NCT03379389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6629229|NCT01322711|Atorvastatin|atorvastatin|mesh-list
6629230|NCT01322711|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6629231|NCT01322711|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6629232|NCT01322711|Antimetabolites|antimetabolites|mesh-ancestor
6629233|NCT01322711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629234|NCT01322711|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6629235|NCT01322711|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6629236|NCT01322711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6629237|NCT01322776|Cyclophosphamide|cyclophosphamide|mesh-list
6629238|NCT01322776|Fludarabine|fludarabine|mesh-list
6629239|NCT01322776|Bortezomib|bortezomib|mesh-list
6629240|NCT01322776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6629241|NCT01322776|Immunologic Factors|immunologic factors|mesh-ancestor
6629242|NCT01322776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629243|NCT01322776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6629244|NCT01322776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6629245|NCT01322776|Alkylating Agents|alkylating agents|mesh-ancestor
6629246|NCT01322776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629247|NCT01322776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6629248|NCT01322776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6662560|NCT01503905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6662561|NCT01503905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6662562|NCT01503905|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6662563|NCT01503905|Hormone Antagonists|hormone antagonists|mesh-ancestor
6662564|NCT01503905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6662565|NCT01503905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6662566|NCT01503905|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6662567|NCT01503905|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6662568|NCT01503905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6662569|NCT01503918|Valacyclovir|valacyclovir|mesh-list
6662570|NCT01503918|Valganciclovir|valganciclovir|mesh-list
6662571|NCT01503918|Acyclovir|acyclovir|mesh-list
6662572|NCT01503918|Ganciclovir|ganciclovir|mesh-list
6662573|NCT01503918|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6662574|NCT01503918|Antiviral Agents|antiviral agents|mesh-ancestor
6662575|NCT01503918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6662576|NCT01503918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6662577|NCT01503918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6662578|NCT01503918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662579|NCT01503983|Capecitabine|capecitabine|mesh-list
6662580|NCT01503983|Oxaliplatin|oxaliplatin|mesh-list
6662581|NCT01503983|Trastuzumab|trastuzumab|mesh-list
6662582|NCT01503983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5481090|NCT03379389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5503630|NCT04456959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6629249|NCT01322867|Alprazolam|alprazolam|mesh-list
5481091|NCT03379389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481092|NCT03379389|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5481093|NCT03379389|Renal Agents|renal agents|mesh-ancestor
5481094|NCT03379389|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5481095|NCT03377803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5481096|NCT03377803|Cantharidin|cantharidin|mesh-list
5481097|NCT03377803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5481098|NCT03377803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481099|NCT03301896|Spartalizumab|spartalizumab|mesh-list
5481100|NCT03301896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5481101|NCT03301896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481102|NCT03301896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5481103|NCT03283371|Natalizumab|natalizumab|mesh-list
5481104|NCT03283371|Immunologic Factors|immunologic factors|mesh-ancestor
6629250|NCT01322867|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6629251|NCT01322867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6629252|NCT01322867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629253|NCT01322867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6629254|NCT01322867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6629255|NCT01322867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6629256|NCT01322867|GABA Modulators|gaba modulators|mesh-ancestor
6629257|NCT01322867|GABA Agents|gaba agents|mesh-ancestor
6629258|NCT01322867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6629259|NCT01322867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629260|NCT01323062|Bavituximab|bavituximab|mesh-list
6629261|NCT01323062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5481105|NCT03283371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481106|NCT03269994|Tazobactam|tazobactam|mesh-list
5481107|NCT03269994|Piperacillin|piperacillin|mesh-list
5481108|NCT03269994|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
5481109|NCT03269994|Cefoxitin|cefoxitin|mesh-list
5481110|NCT03269994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5481111|NCT03269994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6629262|NCT01323062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6629263|NCT01323101|Doxycycline|doxycycline|mesh-list
6629264|NCT01323101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6629265|NCT01323101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6629266|NCT01323101|Antimalarials|antimalarials|mesh-ancestor
5481112|NCT03269994|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5481113|NCT03269994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6629267|NCT01323101|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6629268|NCT01323101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6629269|NCT01323218|Vitamin D|vitamin d|mesh-list
6629270|NCT01323218|Vitamins|vitamins|mesh-ancestor
6629271|NCT01323218|Micronutrients|micronutrients|mesh-ancestor
6629272|NCT01323218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629273|NCT01323218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6629274|NCT01323244|Simeprevir|simeprevir|mesh-list
6629275|NCT01323244|Antiviral Agents|antiviral agents|mesh-ancestor
6629276|NCT01323244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6629277|NCT01323244|Protease Inhibitors|protease inhibitors|mesh-ancestor
6629278|NCT01323244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6629279|NCT01323244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629280|NCT01323257|Ritonavir|ritonavir|mesh-list
6629281|NCT01323257|Darunavir|darunavir|mesh-list
6629282|NCT01323257|Erythromycin|erythromycin|mesh-list
5481114|NCT03269994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481115|NCT03257254|Polidocanol|polidocanol|mesh-list
5481116|NCT03257254|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
6629283|NCT01323257|Erythromycin Estolate|erythromycin estolate|mesh-list
6629284|NCT01323257|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
6629285|NCT01323257|Erythromycin stearate|erythromycin stearate|mesh-list
6629286|NCT01323257|Simeprevir|simeprevir|mesh-list
6629287|NCT01323257|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6629288|NCT01323257|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6629289|NCT01323257|Protease Inhibitors|protease inhibitors|mesh-ancestor
6629290|NCT01323257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6629291|NCT01323257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629292|NCT01323257|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6629293|NCT01323257|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6629294|NCT01323257|Antiviral Agents|antiviral agents|mesh-ancestor
6629295|NCT01323257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6629296|NCT01323257|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6629297|NCT01323257|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6629298|NCT01323257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6629299|NCT01323257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5481117|NCT03257254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5481118|NCT03240068|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
5481119|NCT03240068|Angiotensin II|angiotensin ii|mesh-list
5481120|NCT03240068|Angiotensinogen|angiotensinogen|mesh-list
5481121|NCT03240068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5481122|NCT03240068|Vasodilator Agents|vasodilator agents|mesh-ancestor
5481123|NCT03240068|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6629300|NCT01323257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6629301|NCT01323296|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
6629302|NCT01323296|Hematinics|hematinics|mesh-ancestor
6629303|NCT01323296|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5481124|NCT03240068|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5481125|NCT03240068|Protease Inhibitors|protease inhibitors|mesh-ancestor
5481126|NCT03240068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5481127|NCT03240068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481128|NCT03153319|Adalimumab|adalimumab|mesh-list
5481129|NCT03153319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5481130|NCT03153319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5481131|NCT03089203|Cyclophosphamide|cyclophosphamide|mesh-list
5481132|NCT03089203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5481133|NCT03089203|Immunologic Factors|immunologic factors|mesh-ancestor
5481134|NCT03089203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481135|NCT03089203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6629304|NCT01323296|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6629305|NCT01323335|Rasburicase|rasburicase|mesh-list
6629306|NCT01323335|Uric Acid|uric acid|mesh-list
6629307|NCT01323335|Gout Suppressants|gout suppressants|mesh-ancestor
6629308|NCT01323335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6629309|NCT01323335|Antioxidants|antioxidants|mesh-ancestor
6629310|NCT01323335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629311|NCT01323335|Protective Agents|protective agents|mesh-ancestor
6629312|NCT01323335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629313|NCT01323374|Carbidopa|carbidopa|mesh-list
6629314|NCT01323374|Droxidopa|droxidopa|mesh-list
6629315|NCT01323374|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6629316|NCT01323374|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6629317|NCT01323374|Dopamine Agents|dopamine agents|mesh-ancestor
6629318|NCT01323374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6629319|NCT01323374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629320|NCT01323374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629321|NCT01323374|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6629322|NCT01323374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6629323|NCT01323452|Entecavir|entecavir|mesh-list
6629324|NCT01323452|Antiviral Agents|antiviral agents|mesh-ancestor
6629325|NCT01323452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6629326|NCT01323465|Ketoconazole|ketoconazole|mesh-list
6629327|NCT01323465|Rifampin|rifampin|mesh-list
6629328|NCT01323465|Nabiximols|nabiximols|mesh-list
6629329|NCT01323465|Omeprazole|omeprazole|mesh-list
6629330|NCT01323465|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6629331|NCT01323465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6629332|NCT01323465|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6629333|NCT01323465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6629334|NCT01323465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629335|NCT01323465|Antifungal Agents|antifungal agents|mesh-ancestor
6629336|NCT01323465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6629337|NCT01323465|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6629338|NCT01323465|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6629339|NCT01323465|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6629340|NCT01323465|Hormone Antagonists|hormone antagonists|mesh-ancestor
6629341|NCT01323465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6629342|NCT01323465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629343|NCT01323465|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6629344|NCT01323465|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6629345|NCT01323465|Antitubercular Agents|antitubercular agents|mesh-ancestor
6629346|NCT01323465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6629347|NCT01323465|Leprostatic Agents|leprostatic agents|mesh-ancestor
6629348|NCT01323465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6629349|NCT01323465|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6629350|NCT01323465|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5481136|NCT03089203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5481137|NCT03089203|Alkylating Agents|alkylating agents|mesh-ancestor
6629351|NCT01323465|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6629352|NCT01323465|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6629353|NCT01323465|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6629354|NCT01323465|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6629355|NCT01323465|Analgesics|analgesics|mesh-ancestor
6629356|NCT01323465|Sensory System Agents|sensory system agents|mesh-ancestor
6629357|NCT01323465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6629358|NCT01323491|Nicotine|nicotine|mesh-list
6629359|NCT01323491|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6629360|NCT01323491|Autonomic Agents|autonomic agents|mesh-ancestor
6629361|NCT01323491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6629362|NCT01323491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629363|NCT01323491|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6629364|NCT01323491|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6629365|NCT01323491|Cholinergic Agents|cholinergic agents|mesh-ancestor
6629366|NCT01323491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6629367|NCT01323491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481138|NCT03089203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481139|NCT03089203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5481140|NCT03089203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5481141|NCT03084718|Beclomethasone|beclomethasone|mesh-list
6629368|NCT01323569|Nabiximols|nabiximols|mesh-list
6629369|NCT01323569|Dronabinol|dronabinol|mesh-list
6629370|NCT01323569|Analgesics|analgesics|mesh-ancestor
6629371|NCT01323569|Sensory System Agents|sensory system agents|mesh-ancestor
6629372|NCT01323569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6629373|NCT01323569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629374|NCT01323569|Hallucinogens|hallucinogens|mesh-ancestor
6629375|NCT01323569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6629376|NCT01323569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6629377|NCT01323569|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6629378|NCT01323569|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6629379|NCT01323569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6629380|NCT01323569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629381|NCT01323569|Hormones|hormones|mesh-ancestor
6629382|NCT01323569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6629383|NCT01323608|Vitamin D|vitamin d|mesh-list
6629384|NCT01323608|Cholecalciferol|cholecalciferol|mesh-list
5481142|NCT03084718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5481143|NCT03084718|Glucocorticoids|glucocorticoids|mesh-ancestor
5481144|NCT03084718|Hormones|hormones|mesh-ancestor
5481145|NCT03084718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5481146|NCT03084718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481147|NCT03084718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5481148|NCT03084718|Respiratory System Agents|respiratory system agents|mesh-ancestor
5481149|NCT03059511|Nalbuphine|nalbuphine|mesh-list
5481150|NCT03059511|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5481151|NCT03059511|Narcotics|narcotics|mesh-ancestor
5481152|NCT03059511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5481153|NCT03059511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020934|NCT00395343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629385|NCT01323608|Vitamins|vitamins|mesh-ancestor
6629386|NCT01323608|Micronutrients|micronutrients|mesh-ancestor
6629387|NCT01323608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629388|NCT01323608|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6629389|NCT01323608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6629390|NCT01323712|Vitamin D|vitamin d|mesh-list
6629391|NCT01323712|Cholecalciferol|cholecalciferol|mesh-list
6629392|NCT01323712|Vitamins|vitamins|mesh-ancestor
6451598|NCT00412594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020935|NCT00395486|Atorvastatin|atorvastatin|mesh-list
6020936|NCT00395486|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6020937|NCT00395486|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6020938|NCT00395486|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6020939|NCT00395486|Antimetabolites|antimetabolites|mesh-ancestor
6020940|NCT00395486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020941|NCT00395486|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6451599|NCT00412594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6451600|NCT00412594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6629393|NCT01323712|Micronutrients|micronutrients|mesh-ancestor
6629394|NCT01323712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451601|NCT00412594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6451602|NCT00412594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6451603|NCT00412594|Antimetabolites|antimetabolites|mesh-ancestor
6451604|NCT00412594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451605|NCT00412633|Sulfamethazine|sulfamethazine|mesh-list
6451606|NCT00412633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6451607|NCT00412646|Etravirine|etravirine|mesh-list
6629395|NCT01323712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6629396|NCT01323712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6629397|NCT01323751|Ricolinostat|ricolinostat|mesh-list
6629398|NCT01323751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6629399|NCT01323751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6629400|NCT01323751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6629401|NCT01323751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629402|NCT01324063|Cytarabine|cytarabine|mesh-list
6629403|NCT01324063|Daunorubicin|daunorubicin|mesh-list
6629404|NCT01324063|Amsacrine|amsacrine|mesh-list
6629405|NCT01324063|Sargramostim|sargramostim|mesh-list
6629406|NCT01324063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6629407|NCT01324063|Antimetabolites|antimetabolites|mesh-ancestor
6629408|NCT01324063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629409|NCT01324063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6629410|NCT01324063|Antiviral Agents|antiviral agents|mesh-ancestor
6629411|NCT01324063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6629412|NCT01324063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6629413|NCT01324063|Immunologic Factors|immunologic factors|mesh-ancestor
6629414|NCT01324063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629415|NCT01324063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6629416|NCT01324063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6629417|NCT01324063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6629418|NCT01324063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6629419|NCT01324076|Doxorubicin|doxorubicin|mesh-list
6629420|NCT01324076|Sorafenib|sorafenib|mesh-list
6629421|NCT01324076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6629422|NCT01324076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6629423|NCT01324076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6629424|NCT01324076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6629425|NCT01324076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6629426|NCT01324076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629427|NCT01324076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6629428|NCT01324089|Resveratrol|resveratrol|mesh-list
6629429|NCT01324089|Piperine|piperine|mesh-list
6629430|NCT01324089|Antioxidants|antioxidants|mesh-ancestor
6629431|NCT01324089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629432|NCT01324089|Protective Agents|protective agents|mesh-ancestor
6629433|NCT01324089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629434|NCT01324089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6629435|NCT01324089|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5481154|NCT03059511|Analgesics|analgesics|mesh-ancestor
5481155|NCT03059511|Sensory System Agents|sensory system agents|mesh-ancestor
5481156|NCT03059511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5481157|NCT03033303|Isotretinoin|isotretinoin|mesh-list
5481158|NCT03033303|Dermatologic Agents|dermatologic agents|mesh-ancestor
6020942|NCT00395486|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6020943|NCT00395486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6020944|NCT00395512|Pioglitazone|pioglitazone|mesh-list
6020945|NCT00395512|Alogliptin|alogliptin|mesh-list
6020946|NCT00395512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6020947|NCT00395512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020948|NCT00395512|Incretins|incretins|mesh-ancestor
6020949|NCT00395512|Hormones|hormones|mesh-ancestor
6020950|NCT00395512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6020951|NCT00395512|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6020952|NCT00395512|Protease Inhibitors|protease inhibitors|mesh-ancestor
6020953|NCT00395512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5481171|NCT02972840|Rituximab|rituximab|mesh-list
5481172|NCT02972840|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5481173|NCT02972840|Acalabrutinib|acalabrutinib|mesh-list
5481174|NCT02972840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5481175|NCT02972840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5481176|NCT02972840|Immunologic Factors|immunologic factors|mesh-ancestor
5481177|NCT02972840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629436|NCT01324089|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6629437|NCT01324115|Nitroarginine|nitroarginine|mesh-list
6629438|NCT01324115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6629439|NCT01324115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629440|NCT01324180|Metformin|metformin|mesh-list
6629441|NCT01324180|Dexamethasone|dexamethasone|mesh-list
6629442|NCT01324180|Doxorubicin|doxorubicin|mesh-list
6629443|NCT01324180|Vincristine|vincristine|mesh-list
6629444|NCT01324180|Asparaginase|asparaginase|mesh-list
6629445|NCT01324180|Pegaspargase|pegaspargase|mesh-list
6629446|NCT01324180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5481178|NCT02972840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5481179|NCT02972840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5481180|NCT02972840|Alkylating Agents|alkylating agents|mesh-ancestor
5481181|NCT02972840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481182|NCT02944578|Curcumin|curcumin|mesh-list
5481183|NCT02944578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5481184|NCT02944578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5481185|NCT02944578|Analgesics|analgesics|mesh-ancestor
5481186|NCT02944578|Sensory System Agents|sensory system agents|mesh-ancestor
5481187|NCT02944578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5481188|NCT02944578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481189|NCT02944578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5481190|NCT02944578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5481191|NCT02944578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5481192|NCT02944578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5481193|NCT02944578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481194|NCT02938624|Pembrolizumab|pembrolizumab|mesh-list
6629447|NCT01324180|Antiemetics|antiemetics|mesh-ancestor
6629448|NCT01324180|Autonomic Agents|autonomic agents|mesh-ancestor
6629449|NCT01324180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5481195|NCT02938624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5481196|NCT02938624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5481197|NCT02866838|Tranexamic Acid|tranexamic acid|mesh-list
6629450|NCT01324180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629451|NCT01324180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6629452|NCT01324180|Glucocorticoids|glucocorticoids|mesh-ancestor
6629453|NCT01324180|Hormones|hormones|mesh-ancestor
6629454|NCT01324180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6629455|NCT01324180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6629456|NCT01324180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6629457|NCT01324180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6629458|NCT01324180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6629459|NCT01324180|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6629460|NCT01324180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6629461|NCT01324180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5481198|NCT02866838|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5481199|NCT02866838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5481200|NCT02866838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481201|NCT02866838|Hemostatics|hemostatics|mesh-ancestor
5481202|NCT02866838|Coagulants|coagulants|mesh-ancestor
5481203|NCT02824679|Scopolamine|scopolamine|mesh-list
5481204|NCT02824679|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
5481205|NCT02824679|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5481206|NCT02824679|Antiemetics|antiemetics|mesh-ancestor
5481207|NCT02824679|Autonomic Agents|autonomic agents|mesh-ancestor
5481208|NCT02824679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6629462|NCT01324180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629463|NCT01324180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6629464|NCT01324180|Tubulin Modulators|tubulin modulators|mesh-ancestor
6629465|NCT01324180|Antimitotic Agents|antimitotic agents|mesh-ancestor
6629466|NCT01324180|Mitosis Modulators|mitosis modulators|mesh-ancestor
6629467|NCT01324245|Fenoldopam|fenoldopam|mesh-list
6629468|NCT01324245|Enalaprilat|enalaprilat|mesh-list
6629469|NCT01324245|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6629470|NCT01324245|Vasodilator Agents|vasodilator agents|mesh-ancestor
6629471|NCT01324245|Dopamine Agonists|dopamine agonists|mesh-ancestor
6629472|NCT01324245|Dopamine Agents|dopamine agents|mesh-ancestor
6629473|NCT01324245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6629474|NCT01324245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629475|NCT01324245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629476|NCT01324245|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6629477|NCT01324245|Protease Inhibitors|protease inhibitors|mesh-ancestor
6629478|NCT01324245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6629479|NCT01324258|Gemcitabine|gemcitabine|mesh-list
6629480|NCT01324258|Trametinib|trametinib|mesh-list
5481209|NCT02824679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481210|NCT02824679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5481211|NCT02824679|Mydriatics|mydriatics|mesh-ancestor
5481212|NCT02824679|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6629481|NCT01324258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6629482|NCT01324258|Antimetabolites|antimetabolites|mesh-ancestor
6629483|NCT01324258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629484|NCT01324258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6629485|NCT01324258|Antiviral Agents|antiviral agents|mesh-ancestor
5481213|NCT02824679|Cholinergic Agents|cholinergic agents|mesh-ancestor
6629486|NCT01324258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5481214|NCT02824679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5481215|NCT02824679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481216|NCT02824679|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5481217|NCT02824679|Parasympatholytics|parasympatholytics|mesh-ancestor
5481218|NCT02754141|Nivolumab|nivolumab|mesh-list
5481219|NCT02754141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5481220|NCT02754141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5481221|NCT02754141|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5481222|NCT02754141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481223|NCT02684461|Paclitaxel|paclitaxel|mesh-list
5481224|NCT02684461|Pembrolizumab|pembrolizumab|mesh-list
5481225|NCT02684461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5481226|NCT02684461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5481227|NCT02684461|Tubulin Modulators|tubulin modulators|mesh-ancestor
5481228|NCT02684461|Antimitotic Agents|antimitotic agents|mesh-ancestor
6629487|NCT01324258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6629488|NCT01324258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6629489|NCT01324258|Immunologic Factors|immunologic factors|mesh-ancestor
6629490|NCT01324258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629491|NCT01324258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6629492|NCT01324284|Lubiprostone|lubiprostone|mesh-list
6629493|NCT01324284|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6629494|NCT01324284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6629495|NCT01324284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629496|NCT01324336|Mercaptopurine|mercaptopurine|mesh-list
6629497|NCT01324336|Antimetabolites|antimetabolites|mesh-ancestor
6629498|NCT01324336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629499|NCT01324336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6629500|NCT01324336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6629501|NCT01324336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6629502|NCT01324336|Immunologic Factors|immunologic factors|mesh-ancestor
5481229|NCT02684461|Mitosis Modulators|mitosis modulators|mesh-ancestor
5481230|NCT02684461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481231|NCT02684461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5481232|NCT02632344|Pembrolizumab|pembrolizumab|mesh-list
5481233|NCT02632344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5481234|NCT02632344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5481235|NCT02445131|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5481236|NCT02445131|Obinutuzumab|obinutuzumab|mesh-list
6629503|NCT01324336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629504|NCT01324336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6629505|NCT01324336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6451608|NCT00412646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6451609|NCT00412646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6451610|NCT00412646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6451611|NCT00412646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451612|NCT00412646|Antiviral Agents|antiviral agents|mesh-ancestor
6629506|NCT01324492|Everolimus|everolimus|mesh-list
6629507|NCT01324492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6629508|NCT01324492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5481237|NCT02445131|Idelalisib|idelalisib|mesh-list
6451613|NCT00412646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6451614|NCT00412698|Rimonabant|rimonabant|mesh-list
6451615|NCT00412698|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6629509|NCT01324492|Immunologic Factors|immunologic factors|mesh-ancestor
6629510|NCT01324492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629511|NCT01324544|Buprenorphine|buprenorphine|mesh-list
6629512|NCT01324544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6629513|NCT01324544|Narcotics|narcotics|mesh-ancestor
6629514|NCT01324544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6629515|NCT01324544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629516|NCT01324544|Analgesics|analgesics|mesh-ancestor
6629517|NCT01324544|Sensory System Agents|sensory system agents|mesh-ancestor
6629518|NCT01324544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6629519|NCT01324544|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6629520|NCT01324583|Prednisolone|prednisolone|mesh-list
6629521|NCT01324583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6629522|NCT01324583|Glucocorticoids|glucocorticoids|mesh-ancestor
6629523|NCT01324583|Hormones|hormones|mesh-ancestor
6629524|NCT01324583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6629525|NCT01324583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629526|NCT01324583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6629527|NCT01324583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6629528|NCT01324596|Prednisolone|prednisolone|mesh-list
6629529|NCT01324596|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6629530|NCT01324596|Methylprednisolone|methylprednisolone|mesh-list
6629531|NCT01324596|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6629532|NCT01324596|Prednisolone acetate|prednisolone acetate|mesh-list
6629533|NCT01324596|Cyclophosphamide|cyclophosphamide|mesh-list
6629534|NCT01324596|Rituximab|rituximab|mesh-list
6629535|NCT01324596|Doxorubicin|doxorubicin|mesh-list
6629536|NCT01324596|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6629537|NCT01324596|Vincristine|vincristine|mesh-list
6629538|NCT01324596|Bortezomib|bortezomib|mesh-list
6629539|NCT01324596|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6629540|NCT01324596|Prednisolone phosphate|prednisolone phosphate|mesh-list
6629541|NCT01324596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6629542|NCT01324596|Immunologic Factors|immunologic factors|mesh-ancestor
6629543|NCT01324596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629544|NCT01324596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5481238|NCT02445131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5481239|NCT02445131|Alkylating Agents|alkylating agents|mesh-ancestor
5481240|NCT02445131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481241|NCT02445131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6629545|NCT01324596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6629546|NCT01324596|Alkylating Agents|alkylating agents|mesh-ancestor
6629547|NCT01324596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629548|NCT01324596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6629549|NCT01324596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6629550|NCT01324596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6629551|NCT01324596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6629552|NCT01324596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6629553|NCT01324596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6629554|NCT01324596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6629555|NCT01324596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6629556|NCT01324596|Tubulin Modulators|tubulin modulators|mesh-ancestor
6629557|NCT01324596|Antimitotic Agents|antimitotic agents|mesh-ancestor
6629558|NCT01324596|Mitosis Modulators|mitosis modulators|mesh-ancestor
6629559|NCT01324596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6629560|NCT01324596|Glucocorticoids|glucocorticoids|mesh-ancestor
6629561|NCT01324596|Hormones|hormones|mesh-ancestor
6629562|NCT01324596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6629563|NCT01324596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6629564|NCT01324596|Antiemetics|antiemetics|mesh-ancestor
6629565|NCT01324596|Autonomic Agents|autonomic agents|mesh-ancestor
6629566|NCT01324596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6629567|NCT01324596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6629568|NCT01324596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6629569|NCT01324596|Protective Agents|protective agents|mesh-ancestor
6629570|NCT01324635|Panobinostat|panobinostat|mesh-list
6629571|NCT01324635|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
6629572|NCT01324635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6629573|NCT01324635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6629574|NCT01324635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629575|NCT01324739|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6629576|NCT01324739|Natriuretic Agents|natriuretic agents|mesh-ancestor
6629577|NCT01324739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629578|NCT01324752|Losartan|losartan|mesh-list
6629579|NCT01324752|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6629580|NCT01324752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6629581|NCT01324752|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6629582|NCT01324752|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6629583|NCT01324752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662583|NCT01503983|Antimetabolites|antimetabolites|mesh-ancestor
6662584|NCT01503983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662585|NCT01503983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6662586|NCT01503983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6662587|NCT01504074|Triamcinolone|triamcinolone|mesh-list
6662588|NCT01504074|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6662589|NCT01504074|Levobunolol|levobunolol|mesh-list
6662590|NCT01504074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6662591|NCT01504074|Glucocorticoids|glucocorticoids|mesh-ancestor
6662592|NCT01504074|Hormones|hormones|mesh-ancestor
6662593|NCT01504074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6662594|NCT01504074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662595|NCT01504074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662596|NCT01504074|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6662597|NCT01504074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5481242|NCT02445131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5481243|NCT02445131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5481244|NCT02437318|Fulvestrant|fulvestrant|mesh-list
5481245|NCT02437318|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5481246|NCT02437318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5481247|NCT02437318|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5481248|NCT02437318|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5481249|NCT02437318|Hormone Antagonists|hormone antagonists|mesh-ancestor
5481250|NCT02437318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5481251|NCT02437318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481252|NCT02422615|Fulvestrant|fulvestrant|mesh-list
5481253|NCT02422615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5481254|NCT02422615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5481255|NCT02422615|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5481256|NCT02422615|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5481257|NCT02422615|Hormone Antagonists|hormone antagonists|mesh-ancestor
5481258|NCT02422615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5481259|NCT02422615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502366|NCT04467086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502367|NCT04467086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502368|NCT04467086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5502369|NCT04467086|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5502370|NCT04467086|Vasodilator Agents|vasodilator agents|mesh-ancestor
5502371|NCT04466904|Dulaglutide|dulaglutide|mesh-list
5502372|NCT04466904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6662598|NCT01504074|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6662599|NCT01504074|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6662600|NCT01504074|Adrenergic Agents|adrenergic agents|mesh-ancestor
6662601|NCT01504074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6662602|NCT01504074|Sympatholytics|sympatholytics|mesh-ancestor
6662603|NCT01504074|Autonomic Agents|autonomic agents|mesh-ancestor
6662604|NCT01504126|Propranolol|propranolol|mesh-list
6662605|NCT01504126|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6662606|NCT01504126|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6662607|NCT01504126|Adrenergic Agents|adrenergic agents|mesh-ancestor
6662608|NCT01504126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6662609|NCT01504126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662610|NCT01504126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662611|NCT01504126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6662612|NCT01504126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5481260|NCT02296918|Rituximab|rituximab|mesh-list
5481261|NCT02296918|Obinutuzumab|obinutuzumab|mesh-list
5481262|NCT02296918|Venetoclax|venetoclax|mesh-list
5481263|NCT02296918|Acalabrutinib|acalabrutinib|mesh-list
5481264|NCT02296918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5481265|NCT02296918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5481266|NCT02296918|Immunologic Factors|immunologic factors|mesh-ancestor
5481267|NCT02296918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481268|NCT02296918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5481269|NCT02259517|Guanfacine|guanfacine|mesh-list
5481270|NCT02259517|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
5481271|NCT02259517|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5481272|NCT02259517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481273|NCT02259517|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5481274|NCT02259517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5481275|NCT02259517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5481276|NCT02259517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481277|NCT02259517|Dopamine Agents|dopamine agents|mesh-ancestor
5481278|NCT02259517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5481279|NCT02259517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6629584|NCT01324843|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
6629585|NCT01324843|Anesthetics, Local|anesthetics, local|mesh-ancestor
6629586|NCT01324843|Anesthetics|anesthetics|mesh-ancestor
6629587|NCT01324843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6629588|NCT01324843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629589|NCT01324843|Sensory System Agents|sensory system agents|mesh-ancestor
6629590|NCT01324843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6629591|NCT01324843|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
6629592|NCT01324960|Aldesleukin|aldesleukin|mesh-list
6629593|NCT01324960|Azacitidine|azacitidine|mesh-list
6629594|NCT01324960|Histamine|histamine|mesh-list
6629595|NCT01324960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6629596|NCT01324960|Antimetabolites|antimetabolites|mesh-ancestor
6629597|NCT01324960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629598|NCT01324960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6629599|NCT01324960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5481280|NCT02259517|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5481281|NCT02259517|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5481282|NCT02259517|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5481283|NCT02259517|Adrenergic Agents|adrenergic agents|mesh-ancestor
5481284|NCT02209545|Pyridoxine|pyridoxine|mesh-list
5481285|NCT02209545|Vitamin B 6|vitamin b 6|mesh-list
5481286|NCT02209545|Misoprostol|misoprostol|mesh-list
5481287|NCT02209545|Vitamins|vitamins|mesh-ancestor
6629600|NCT01324960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629601|NCT01324960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6629602|NCT01324960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6629603|NCT01324960|Antiviral Agents|antiviral agents|mesh-ancestor
6629604|NCT01324960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6629605|NCT01324960|Histamine Agonists|histamine agonists|mesh-ancestor
6629606|NCT01324960|Histamine Agents|histamine agents|mesh-ancestor
6629607|NCT01324960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6629608|NCT01325051|Raltegravir Potassium|raltegravir potassium|mesh-list
6629609|NCT01325051|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6629610|NCT01325051|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6629611|NCT01325051|Antiviral Agents|antiviral agents|mesh-ancestor
6629612|NCT01325051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5481288|NCT02209545|Micronutrients|micronutrients|mesh-ancestor
5481289|NCT02209545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481290|NCT02209545|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5481291|NCT02209545|Abortifacient Agents|abortifacient agents|mesh-ancestor
6629613|NCT01325051|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5481292|NCT02209545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5481293|NCT02209545|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5481294|NCT02209545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6451616|NCT00412698|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
6451617|NCT00412698|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6451618|NCT00412698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6451619|NCT00412698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451620|NCT00412698|Hormones|hormones|mesh-ancestor
6451621|NCT00412698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6451622|NCT00412698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629614|NCT01325051|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6629615|NCT01325051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5481295|NCT02209545|Oxytocics|oxytocics|mesh-ancestor
6629616|NCT01325051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629617|NCT01325168|Oxytocin|oxytocin|mesh-list
6629618|NCT01325168|Oxytocics|oxytocics|mesh-ancestor
6629619|NCT01325168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6629620|NCT01325168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629621|NCT01325194|Cytarabine|cytarabine|mesh-list
6629622|NCT01325194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6629623|NCT01325194|Antimetabolites|antimetabolites|mesh-ancestor
6629624|NCT01325194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629625|NCT01325194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6629626|NCT01325194|Antiviral Agents|antiviral agents|mesh-ancestor
6629627|NCT01325194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6629628|NCT01325194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6629629|NCT01325194|Immunologic Factors|immunologic factors|mesh-ancestor
6629630|NCT01325194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629631|NCT01325220|Baclofen|baclofen|mesh-list
6629632|NCT01325220|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6629633|NCT01325220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629634|NCT01325220|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5481296|NCT02209545|Vitamin B Complex|vitamin b complex|mesh-ancestor
5481297|NCT01969643|Trastuzumab|trastuzumab|mesh-list
5481298|NCT01969643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5481299|NCT01969643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5481300|NCT01796197|Paclitaxel|paclitaxel|mesh-list
5481301|NCT01796197|Cyclophosphamide|cyclophosphamide|mesh-list
5481302|NCT01796197|Doxorubicin|doxorubicin|mesh-list
5481303|NCT01796197|Trastuzumab|trastuzumab|mesh-list
5481304|NCT01796197|Pertuzumab|pertuzumab|mesh-list
5481305|NCT01796197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5481306|NCT01796197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5481307|NCT01796197|Tubulin Modulators|tubulin modulators|mesh-ancestor
5481308|NCT01796197|Antimitotic Agents|antimitotic agents|mesh-ancestor
5481309|NCT01796197|Mitosis Modulators|mitosis modulators|mesh-ancestor
6629635|NCT01325220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6629636|NCT01325220|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6629637|NCT01325220|GABA Agonists|gaba agonists|mesh-ancestor
6629638|NCT01325220|GABA Agents|gaba agents|mesh-ancestor
6629639|NCT01325220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6629640|NCT01325220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629641|NCT01325259|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5481310|NCT01796197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481311|NCT01796197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5481312|NCT01796197|Immunologic Factors|immunologic factors|mesh-ancestor
5481313|NCT01796197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481314|NCT01796197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5481315|NCT01796197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5481316|NCT01796197|Alkylating Agents|alkylating agents|mesh-ancestor
5481317|NCT01796197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5481318|NCT01796197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5481319|NCT01796197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5481320|NCT01796197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5481321|NCT01796197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5481322|NCT01796197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6629642|NCT01325259|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6629643|NCT01325259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629644|NCT01325298|Riboflavin|riboflavin|mesh-list
6629645|NCT01325298|Vitamin B Complex|vitamin b complex|mesh-ancestor
6629646|NCT01325298|Vitamins|vitamins|mesh-ancestor
6629647|NCT01325298|Micronutrients|micronutrients|mesh-ancestor
6629648|NCT01325298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629649|NCT01325298|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6629650|NCT01325298|Dermatologic Agents|dermatologic agents|mesh-ancestor
6629651|NCT01325415|Moxifloxacin|moxifloxacin|mesh-list
6629652|NCT01325415|Naloxegol|naloxegol|mesh-list
5481323|NCT01585805|Gemcitabine|gemcitabine|mesh-list
5481324|NCT01585805|Cisplatin|cisplatin|mesh-list
5481325|NCT01585805|Veliparib|veliparib|mesh-list
5481326|NCT01585805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6629653|NCT01325415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6629654|NCT01325415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6629655|NCT01325415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6629656|NCT01325415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6629657|NCT01325415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5481327|NCT01585805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5481328|NCT01585805|Antimetabolites|antimetabolites|mesh-ancestor
5481329|NCT01585805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662613|NCT01504126|Vasodilator Agents|vasodilator agents|mesh-ancestor
5481330|NCT01585805|Antiviral Agents|antiviral agents|mesh-ancestor
5481331|NCT01585805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5481332|NCT01585805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6629658|NCT01325415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629659|NCT01325415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6629660|NCT01325415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629661|NCT01325415|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6629662|NCT01325415|Sensory System Agents|sensory system agents|mesh-ancestor
6629663|NCT01325415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6629664|NCT01325441|Paclitaxel|paclitaxel|mesh-list
6629665|NCT01325441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6629666|NCT01325441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6629667|NCT01325441|Tubulin Modulators|tubulin modulators|mesh-ancestor
6629668|NCT01325441|Antimitotic Agents|antimitotic agents|mesh-ancestor
6629669|NCT01325441|Mitosis Modulators|mitosis modulators|mesh-ancestor
6629670|NCT01325441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629671|NCT01325558|Gemcitabine|gemcitabine|mesh-list
6629672|NCT01325558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6629673|NCT01325558|Antimetabolites|antimetabolites|mesh-ancestor
6629674|NCT01325558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629675|NCT01325558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6629676|NCT01325558|Antiviral Agents|antiviral agents|mesh-ancestor
6629677|NCT01325558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6629678|NCT01325558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6629679|NCT01325558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6629680|NCT01325558|Immunologic Factors|immunologic factors|mesh-ancestor
6629681|NCT01325558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629682|NCT01325571|Tacrolimus|tacrolimus|mesh-list
5481333|NCT01585805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5481334|NCT01585805|Immunologic Factors|immunologic factors|mesh-ancestor
5481335|NCT01585805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481336|NCT01585805|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5481337|NCT01147822|Sunitinib|sunitinib|mesh-list
5481338|NCT01147822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5481339|NCT01147822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5481340|NCT01147822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5481341|NCT01147822|Growth Substances|growth substances|mesh-ancestor
5481342|NCT01147822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481343|NCT01147822|Growth Inhibitors|growth inhibitors|mesh-ancestor
5481344|NCT01147822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5481345|NCT01147822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5481346|NCT01147822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481347|NCT01090154|Certolizumab Pegol|certolizumab pegol|mesh-list
5481348|NCT01090154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5481349|NCT01090154|Immunologic Factors|immunologic factors|mesh-ancestor
5481350|NCT01090154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481351|NCT01090154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5481352|NCT00695279|Vaccines|vaccines|mesh-list
5481353|NCT00695279|Immunologic Factors|immunologic factors|mesh-ancestor
6629683|NCT01325571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6629684|NCT01325571|Immunologic Factors|immunologic factors|mesh-ancestor
6629685|NCT01325571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629686|NCT01325571|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6629687|NCT01325571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6629688|NCT01325571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629689|NCT01325610|Cholecalciferol|cholecalciferol|mesh-list
6629690|NCT01325610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6629691|NCT01325610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629692|NCT01325610|Vitamins|vitamins|mesh-ancestor
6629693|NCT01325610|Micronutrients|micronutrients|mesh-ancestor
6629694|NCT01325610|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6629695|NCT01325779|Heparin|heparin|mesh-list
6629696|NCT01325779|Enoxaparin|enoxaparin|mesh-list
6629697|NCT01325779|Anticoagulants|anticoagulants|mesh-ancestor
6629698|NCT01325779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6629699|NCT01325779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6629700|NCT01325779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629701|NCT01325818|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6629702|NCT01325818|Pravastatin|pravastatin|mesh-list
6629703|NCT01325818|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5481354|NCT00695279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629704|NCT01325818|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6629705|NCT01325818|Antimetabolites|antimetabolites|mesh-ancestor
6629706|NCT01325818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629707|NCT01325818|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6629708|NCT01325818|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6629709|NCT01325818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6629710|NCT01325844|Anesthetics|anesthetics|mesh-list
6629711|NCT01325844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6629712|NCT01325844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629713|NCT01325896|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6629714|NCT01325896|Antiviral Agents|antiviral agents|mesh-ancestor
6629715|NCT01325896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5481355|NCT00521846|Cimetidine|cimetidine|mesh-list
5481356|NCT00521846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5481357|NCT00521846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5481358|NCT00521846|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5481359|NCT00521846|Histamine Antagonists|histamine antagonists|mesh-ancestor
5481360|NCT00521846|Histamine Agents|histamine agents|mesh-ancestor
5481361|NCT00521846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5481362|NCT00521846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481363|NCT00521846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481364|NCT00521846|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5481365|NCT00521846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5481366|NCT00521846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5481367|NCT00328653|Cyclosporine|cyclosporine|mesh-list
5481368|NCT00328653|Cyclosporins|cyclosporins|mesh-list
5481369|NCT00328653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5481370|NCT00328653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481371|NCT00328653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5481372|NCT00328653|Immunologic Factors|immunologic factors|mesh-ancestor
5481373|NCT00328653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629716|NCT01325935|Clopidogrel|clopidogrel|mesh-list
6629717|NCT01325935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6629718|NCT01325935|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6629719|NCT01325935|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6629720|NCT01325935|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6629721|NCT01325935|Purinergic Agents|purinergic agents|mesh-ancestor
6629722|NCT01325935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6629723|NCT01325935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629724|NCT01325935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629725|NCT01325987|Vitamin D|vitamin d|mesh-list
6629726|NCT01325987|Ergocalciferols|ergocalciferols|mesh-list
6629727|NCT01325987|Vitamins|vitamins|mesh-list
6629728|NCT01325987|Micronutrients|micronutrients|mesh-ancestor
6629729|NCT01325987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629730|NCT01325987|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6629731|NCT01325987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6629732|NCT01326000|Cetuximab|cetuximab|mesh-list
6629733|NCT01326000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6629734|NCT01326000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6629735|NCT01326039|Bupivacaine|bupivacaine|mesh-list
6629736|NCT01326039|Anesthetics, Local|anesthetics, local|mesh-ancestor
6629737|NCT01326039|Anesthetics|anesthetics|mesh-ancestor
6629738|NCT01326039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6629739|NCT01326039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629740|NCT01326039|Sensory System Agents|sensory system agents|mesh-ancestor
6662614|NCT01504139|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5481374|NCT00328653|Antifungal Agents|antifungal agents|mesh-ancestor
5481375|NCT00328653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5481376|NCT00328653|Dermatologic Agents|dermatologic agents|mesh-ancestor
5481377|NCT00328653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5481378|NCT00328653|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5481379|NCT05159050|Paclitaxel|paclitaxel|mesh-list
5481380|NCT05159050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5481381|NCT05159050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6629741|NCT01326039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6629742|NCT01326078|Propofol|propofol|mesh-list
6629743|NCT01326078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6629744|NCT01326078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6629745|NCT01326078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629746|NCT01326078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6629747|NCT01326078|Anesthetics, General|anesthetics, general|mesh-ancestor
6629748|NCT01326078|Anesthetics|anesthetics|mesh-ancestor
6629749|NCT01326117|Tadalafil|tadalafil|mesh-list
6629750|NCT01326117|Vasodilator Agents|vasodilator agents|mesh-ancestor
6629751|NCT01326117|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6629752|NCT01326117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6629753|NCT01326117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6629754|NCT01326117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629755|NCT01326117|Urological Agents|urological agents|mesh-ancestor
6629756|NCT01326221|Tenofovir|tenofovir|mesh-list
6629757|NCT01326221|Emtricitabine|emtricitabine|mesh-list
6629758|NCT01326221|Antiviral Agents|antiviral agents|mesh-ancestor
6629759|NCT01326221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6629760|NCT01326221|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6629761|NCT01326221|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6629762|NCT01326221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6629763|NCT01326221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629764|NCT01326221|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6629765|NCT01326221|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6629766|NCT01326312|Leuprolide|leuprolide|mesh-list
6629767|NCT01326312|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6629768|NCT01326312|Fertility Agents|fertility agents|mesh-ancestor
6629769|NCT01326312|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6629770|NCT01326312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629771|NCT01326312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6629772|NCT01326312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6629773|NCT01326325|Ketamine|ketamine|mesh-list
6629774|NCT01326325|Analgesics|analgesics|mesh-ancestor
6629775|NCT01326325|Sensory System Agents|sensory system agents|mesh-ancestor
6629776|NCT01326325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6629777|NCT01326325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629778|NCT01326325|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6629779|NCT01326325|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6629780|NCT01326325|Anesthetics, General|anesthetics, general|mesh-ancestor
5481382|NCT05159050|Tubulin Modulators|tubulin modulators|mesh-ancestor
5481383|NCT05159050|Antimitotic Agents|antimitotic agents|mesh-ancestor
5481384|NCT05159050|Mitosis Modulators|mitosis modulators|mesh-ancestor
5481385|NCT05159050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481386|NCT05158777|Vaccines|vaccines|mesh-list
5481387|NCT05158777|Immunologic Factors|immunologic factors|mesh-ancestor
5481388|NCT05158777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481389|NCT05158699|Dexamethasone|dexamethasone|mesh-list
5481390|NCT05158699|Dexamethasone acetate|dexamethasone acetate|mesh-list
5481391|NCT05158699|Triamcinolone|triamcinolone|mesh-list
5481392|NCT05158699|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6629781|NCT01326325|Anesthetics|anesthetics|mesh-ancestor
6629782|NCT01326325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6629783|NCT01326325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6629784|NCT01326325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6629785|NCT01326325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6629786|NCT01326325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629787|NCT01326338|Nitazoxanide|nitazoxanide|mesh-list
6629788|NCT01326338|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6629789|NCT01326338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6662615|NCT01504139|Estradiol|estradiol|mesh-list
6662616|NCT01504139|Progesterone|progesterone|mesh-list
6662617|NCT01504139|Estrogens|estrogens|mesh-ancestor
5481393|NCT05158699|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6662618|NCT01504139|Hormones|hormones|mesh-ancestor
6662619|NCT01504139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6629790|NCT01326403|Tranexamic Acid|tranexamic acid|mesh-list
6629791|NCT01326403|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6629792|NCT01326403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6629793|NCT01326403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629794|NCT01326403|Hemostatics|hemostatics|mesh-ancestor
6629795|NCT01326403|Coagulants|coagulants|mesh-ancestor
6629796|NCT01326442|Vitamin D|vitamin d|mesh-list
6629797|NCT01326442|Vitamins|vitamins|mesh-ancestor
6629798|NCT01326442|Micronutrients|micronutrients|mesh-ancestor
6629799|NCT01326442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629800|NCT01326442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6629801|NCT01326468|Sirolimus|sirolimus|mesh-list
6629802|NCT01326468|Cisplatin|cisplatin|mesh-list
6629803|NCT01326468|Cetuximab|cetuximab|mesh-list
6629804|NCT01326468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6629805|NCT01326468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6629806|NCT01326468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6629807|NCT01326468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6629808|NCT01326468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6629809|NCT01326468|Antifungal Agents|antifungal agents|mesh-ancestor
6629810|NCT01326468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6629811|NCT01326468|Immunologic Factors|immunologic factors|mesh-ancestor
6629812|NCT01326468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629813|NCT01326494|Prednisone|prednisone|mesh-list
6629814|NCT01326494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6629815|NCT01326494|Glucocorticoids|glucocorticoids|mesh-ancestor
6629816|NCT01326494|Hormones|hormones|mesh-ancestor
6629817|NCT01326494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6629818|NCT01326494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629819|NCT01326494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6629820|NCT01326494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6629821|NCT01326559|Docetaxel|docetaxel|mesh-list
6629822|NCT01326559|Cetuximab|cetuximab|mesh-list
5481394|NCT05158699|Ketorolac|ketorolac|mesh-list
5481395|NCT05158699|Bromfenac|bromfenac|mesh-list
6629823|NCT01326559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6629824|NCT01326559|Tubulin Modulators|tubulin modulators|mesh-ancestor
6629825|NCT01326559|Antimitotic Agents|antimitotic agents|mesh-ancestor
6629826|NCT01326559|Mitosis Modulators|mitosis modulators|mesh-ancestor
6629827|NCT01326559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629828|NCT01326559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6629829|NCT01326585|Dexamethasone|dexamethasone|mesh-list
6629830|NCT01326585|Dexamethasone acetate|dexamethasone acetate|mesh-list
6629831|NCT01326585|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
6629832|NCT01326585|BB 1101|bb 1101|mesh-list
6629833|NCT01326585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6629834|NCT01326585|Antiemetics|antiemetics|mesh-ancestor
6629835|NCT01326585|Autonomic Agents|autonomic agents|mesh-ancestor
6629836|NCT01326585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6629837|NCT01326585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629838|NCT01326585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6629839|NCT01326585|Glucocorticoids|glucocorticoids|mesh-ancestor
6629840|NCT01326585|Hormones|hormones|mesh-ancestor
6629841|NCT01326585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6629842|NCT01326585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6629843|NCT01326585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6629844|NCT01326585|Protease Inhibitors|protease inhibitors|mesh-ancestor
6629845|NCT01326585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6629846|NCT01326585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629847|NCT01326611|Clarithromycin|clarithromycin|mesh-list
6629848|NCT01326611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6629849|NCT01326611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5481396|NCT05158699|Phenylephrine|phenylephrine|mesh-list
5481397|NCT05158699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6629850|NCT01326611|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6629851|NCT01326611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6629852|NCT01326611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629853|NCT01326611|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6629854|NCT01326611|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6629855|NCT01326650|Vitamin D|vitamin d|mesh-list
6629856|NCT01326650|Ergocalciferols|ergocalciferols|mesh-list
6629857|NCT01326650|Vitamins|vitamins|mesh-list
6629858|NCT01326650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6629859|NCT01326650|Micronutrients|micronutrients|mesh-ancestor
6629860|NCT01326650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629861|NCT01326650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6629862|NCT01326650|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6629863|NCT01326754|Artesunate|artesunate|mesh-list
6629864|NCT01326754|Lumefantrine|lumefantrine|mesh-list
6629865|NCT01326754|Artemether|artemether|mesh-list
6629866|NCT01326754|Piperaquine|piperaquine|mesh-list
6629867|NCT01326754|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6629868|NCT01326754|Amodiaquine|amodiaquine|mesh-list
6629869|NCT01326754|Artenimol|artenimol|mesh-list
6629870|NCT01326754|Amodiaquine, artesunate drug combination|amodiaquine, artesunate drug combination|mesh-list
6629871|NCT01326754|Antimalarials|antimalarials|mesh-ancestor
6629872|NCT01326754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6629873|NCT01326754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6629874|NCT01326754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6629875|NCT01326754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6629876|NCT01326754|Antiviral Agents|antiviral agents|mesh-ancestor
6629877|NCT01326754|Schistosomicides|schistosomicides|mesh-ancestor
6629878|NCT01326754|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6629879|NCT01326754|Anthelmintics|anthelmintics|mesh-ancestor
6629880|NCT01326767|Paclitaxel|paclitaxel|mesh-list
6629881|NCT01326767|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6629882|NCT01326767|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6629883|NCT01326767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6629884|NCT01326767|Tubulin Modulators|tubulin modulators|mesh-ancestor
6629885|NCT01326767|Antimitotic Agents|antimitotic agents|mesh-ancestor
6629886|NCT01326767|Mitosis Modulators|mitosis modulators|mesh-ancestor
6629887|NCT01326767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629888|NCT01326858|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
6629889|NCT01326858|Ketotifen|ketotifen|mesh-list
6629890|NCT01326858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6629891|NCT01326858|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6629892|NCT01326858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6629893|NCT01326858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6629894|NCT01326858|Analgesics|analgesics|mesh-ancestor
6629895|NCT01326858|Sensory System Agents|sensory system agents|mesh-ancestor
6629896|NCT01326858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6629897|NCT01326858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481398|NCT05158699|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5481399|NCT05158699|BB 1101|bb 1101|mesh-list
5481400|NCT05158699|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5481401|NCT05158699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5481402|NCT05158699|Antiemetics|antiemetics|mesh-ancestor
5481403|NCT05158699|Autonomic Agents|autonomic agents|mesh-ancestor
5481404|NCT05158699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6629898|NCT01326858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6629899|NCT01326858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5481405|NCT05158699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451623|NCT00412763|Silymarin|silymarin|mesh-list
6451624|NCT00412763|Antioxidants|antioxidants|mesh-ancestor
6451625|NCT00412763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451626|NCT00412763|Protective Agents|protective agents|mesh-ancestor
6451627|NCT00412763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451628|NCT00412789|Epothilone B|epothilone b|mesh-list
6451629|NCT00412789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6451630|NCT00412789|Tubulin Modulators|tubulin modulators|mesh-ancestor
6451631|NCT00412789|Antimitotic Agents|antimitotic agents|mesh-ancestor
5481406|NCT05158699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5481407|NCT05158699|Glucocorticoids|glucocorticoids|mesh-ancestor
6629900|NCT01326858|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6629901|NCT01326858|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6629902|NCT01326858|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6629903|NCT01326858|Histamine Antagonists|histamine antagonists|mesh-ancestor
6629904|NCT01326858|Histamine Agents|histamine agents|mesh-ancestor
6629905|NCT01326858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6629906|NCT01326858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629907|NCT01326858|Antipruritics|antipruritics|mesh-ancestor
6629908|NCT01326858|Dermatologic Agents|dermatologic agents|mesh-ancestor
6629909|NCT01326871|Gemcitabine|gemcitabine|mesh-list
6629910|NCT01326871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6629911|NCT01326871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6629912|NCT01326871|Antimetabolites|antimetabolites|mesh-ancestor
6629913|NCT01326871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629914|NCT01326871|Antiviral Agents|antiviral agents|mesh-ancestor
6629915|NCT01326871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6629916|NCT01326871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6629917|NCT01326871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6629918|NCT01326871|Immunologic Factors|immunologic factors|mesh-ancestor
6629919|NCT01326871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629920|NCT01326988|Anesthetics|anesthetics|mesh-list
6629921|NCT01326988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6629922|NCT01326988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629923|NCT01327027|Vasopressins|vasopressins|mesh-list
6629924|NCT01327027|Arginine Vasopressin|arginine vasopressin|mesh-list
6629925|NCT01327027|Hemostatics|hemostatics|mesh-ancestor
6629926|NCT01327027|Coagulants|coagulants|mesh-ancestor
6629927|NCT01327027|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6629928|NCT01327027|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6629929|NCT01327027|Natriuretic Agents|natriuretic agents|mesh-ancestor
6629930|NCT01327027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629931|NCT01327066|Moxifloxacin|moxifloxacin|mesh-list
6629932|NCT01327066|Droxidopa|droxidopa|mesh-list
6629933|NCT01327066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6629934|NCT01327066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6629935|NCT01327066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6629936|NCT01327066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6629937|NCT01327066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6629938|NCT01327066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629939|NCT01327066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6629940|NCT01327066|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6629941|NCT01327066|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6629942|NCT01327079|Methadone|methadone|mesh-list
6629943|NCT01327079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6629944|NCT01327079|Narcotics|narcotics|mesh-ancestor
6629945|NCT01327079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6629946|NCT01327079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629947|NCT01327079|Analgesics|analgesics|mesh-ancestor
6629948|NCT01327079|Sensory System Agents|sensory system agents|mesh-ancestor
6629949|NCT01327079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6629950|NCT01327079|Antitussive Agents|antitussive agents|mesh-ancestor
6629951|NCT01327079|Respiratory System Agents|respiratory system agents|mesh-ancestor
5481408|NCT05158699|Hormones|hormones|mesh-ancestor
5481409|NCT05158699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5481410|NCT05158699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5481411|NCT05158699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5481412|NCT05158699|Protease Inhibitors|protease inhibitors|mesh-ancestor
5481413|NCT05158699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5481414|NCT05158699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481415|NCT05158699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5481416|NCT05158699|Immunologic Factors|immunologic factors|mesh-ancestor
5481417|NCT05158699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5481418|NCT05158699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5481419|NCT05158699|Analgesics|analgesics|mesh-ancestor
5481420|NCT05158699|Sensory System Agents|sensory system agents|mesh-ancestor
5481421|NCT05158699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5481422|NCT05158699|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5481423|NCT05158699|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6629952|NCT01327118|Dinoprost|dinoprost|mesh-list
6629953|NCT01327118|Dinoprost tromethamine|dinoprost tromethamine|mesh-list
6629954|NCT01327118|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6629955|NCT01327118|Abortifacient Agents|abortifacient agents|mesh-ancestor
6629956|NCT01327118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6629957|NCT01327118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629958|NCT01327118|Oxytocics|oxytocics|mesh-ancestor
6629959|NCT01327144|Acyclovir|acyclovir|mesh-list
6629960|NCT01327144|Famciclovir|famciclovir|mesh-list
6629961|NCT01327144|Antiviral Agents|antiviral agents|mesh-ancestor
6629962|NCT01327144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6629963|NCT01327144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6629964|NCT01327144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6629965|NCT01327144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629966|NCT01327222|Bevacizumab|bevacizumab|mesh-list
6629967|NCT01327222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6629968|NCT01327222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6629969|NCT01327222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6629970|NCT01327222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6629971|NCT01327222|Growth Substances|growth substances|mesh-ancestor
6629972|NCT01327222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629973|NCT01327222|Growth Inhibitors|growth inhibitors|mesh-ancestor
6629974|NCT01327235|Cisplatin|cisplatin|mesh-list
6629975|NCT01327235|Endostar protein|endostar protein|mesh-list
6629976|NCT01327235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6629977|NCT01327235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6629978|NCT01327235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6629979|NCT01327235|Growth Substances|growth substances|mesh-ancestor
6629980|NCT01327235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629981|NCT01327235|Growth Inhibitors|growth inhibitors|mesh-ancestor
6629982|NCT01327261|Levodopa|levodopa|mesh-list
6629983|NCT01327261|Benserazide|benserazide|mesh-list
6629984|NCT01327261|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6629985|NCT01327261|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6629986|NCT01327261|Dopamine Agents|dopamine agents|mesh-ancestor
6629987|NCT01327261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6629988|NCT01327261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6629989|NCT01327261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629990|NCT01327261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6629991|NCT01327326|Naltrexone|naltrexone|mesh-list
6629992|NCT01327326|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6629993|NCT01327326|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6629994|NCT01327326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6629995|NCT01327326|Sensory System Agents|sensory system agents|mesh-ancestor
6629996|NCT01327326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6629997|NCT01327469|Albendazole|albendazole|mesh-list
6629998|NCT01327469|Mebendazole|mebendazole|mesh-list
6629999|NCT01327469|Piperazine|piperazine|mesh-list
6630000|NCT01327469|Piperazine citrate|piperazine citrate|mesh-list
6630001|NCT01327469|Pyrantel|pyrantel|mesh-list
6630002|NCT01327469|Oxantel|oxantel|mesh-list
6630003|NCT01327469|DMP 777|dmp 777|mesh-list
5481424|NCT05158699|Mydriatics|mydriatics|mesh-ancestor
6630004|NCT01327469|Anthelmintics|anthelmintics|mesh-ancestor
6630005|NCT01327469|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6630006|NCT01327469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6630007|NCT01327469|Anticestodal Agents|anticestodal agents|mesh-ancestor
5481425|NCT05158699|Sympathomimetics|sympathomimetics|mesh-ancestor
5481426|NCT05158699|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5481427|NCT05158699|Nasal Decongestants|nasal decongestants|mesh-ancestor
5481428|NCT05158699|Respiratory System Agents|respiratory system agents|mesh-ancestor
5481429|NCT05158699|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5481430|NCT05158699|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5481431|NCT05158699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5481432|NCT05158699|Adrenergic Agents|adrenergic agents|mesh-ancestor
6630008|NCT01327469|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6630009|NCT01327469|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6630010|NCT01327469|Tubulin Modulators|tubulin modulators|mesh-ancestor
6630011|NCT01327469|Antimitotic Agents|antimitotic agents|mesh-ancestor
6630012|NCT01327469|Mitosis Modulators|mitosis modulators|mesh-ancestor
6630013|NCT01327469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481433|NCT05158699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5481434|NCT05158699|Protective Agents|protective agents|mesh-ancestor
5481435|NCT05158686|Paclitaxel|paclitaxel|mesh-list
5481436|NCT05158686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5481437|NCT05158686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5481438|NCT05158686|Tubulin Modulators|tubulin modulators|mesh-ancestor
5481439|NCT05158686|Antimitotic Agents|antimitotic agents|mesh-ancestor
5481440|NCT05158686|Mitosis Modulators|mitosis modulators|mesh-ancestor
5481441|NCT05158686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481442|NCT05158647|Magnesium Sulfate|magnesium sulfate|mesh-list
5481443|NCT05158647|Analgesics|analgesics|mesh-ancestor
5481444|NCT05158647|Sensory System Agents|sensory system agents|mesh-ancestor
5481445|NCT05158647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5481446|NCT05158647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481447|NCT05158647|Anesthetics|anesthetics|mesh-ancestor
5481448|NCT05158647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5481449|NCT05158647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5481450|NCT05158647|Anticonvulsants|anticonvulsants|mesh-ancestor
5481451|NCT05158647|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5481452|NCT05158647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5481453|NCT05158647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481454|NCT05158647|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5481455|NCT05158647|Tocolytic Agents|tocolytic agents|mesh-ancestor
5481456|NCT05158647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5481457|NCT05158517|Vedolizumab|vedolizumab|mesh-list
5481458|NCT05158517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5481459|NCT05158426|Propofol|propofol|mesh-list
5481460|NCT05158426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5481461|NCT05158426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6630014|NCT01327469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6630015|NCT01327469|Antinematodal Agents|antinematodal agents|mesh-ancestor
5481462|NCT05158426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630016|NCT01327469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6630017|NCT01327469|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
6630018|NCT01327469|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6630019|NCT01327469|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6630020|NCT01327469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6630021|NCT01327469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630022|NCT01327521|Gemcitabine|gemcitabine|mesh-list
6630023|NCT01327521|Cisplatin|cisplatin|mesh-list
6630024|NCT01327521|Doxorubicin|doxorubicin|mesh-list
6630025|NCT01327521|Fluorouracil|fluorouracil|mesh-list
6630026|NCT01327521|Epirubicin|epirubicin|mesh-list
6630027|NCT01327521|Mitomycins|mitomycins|mesh-list
6630028|NCT01327521|Mitomycin|mitomycin|mesh-list
6630029|NCT01327521|Maleic acid|maleic acid|mesh-list
6630030|NCT01327521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6451632|NCT00412789|Mitosis Modulators|mitosis modulators|mesh-ancestor
6451633|NCT00412789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451634|NCT00412802|Enoxaparin|enoxaparin|mesh-list
6451635|NCT00412802|Enoxaparin sodium|enoxaparin sodium|mesh-list
6451636|NCT00412802|Anticoagulants|anticoagulants|mesh-ancestor
6630031|NCT01327521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6630032|NCT01327521|Antimetabolites|antimetabolites|mesh-ancestor
6630033|NCT01327521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630034|NCT01327521|Antiviral Agents|antiviral agents|mesh-ancestor
6630035|NCT01327521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6630036|NCT01327521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6630037|NCT01327521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6630038|NCT01327521|Immunologic Factors|immunologic factors|mesh-ancestor
6630039|NCT01327521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630040|NCT01327521|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6630041|NCT01327521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6630042|NCT01327521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6630043|NCT01327521|Alkylating Agents|alkylating agents|mesh-ancestor
6630044|NCT01327521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6630045|NCT01327534|Clopidogrel|clopidogrel|mesh-list
6630046|NCT01327534|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6630047|NCT01327534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6630048|NCT01327534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6630049|NCT01327534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6630050|NCT01327534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6630051|NCT01327534|Purinergic Agents|purinergic agents|mesh-ancestor
6630052|NCT01327534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6630053|NCT01327534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630054|NCT01327534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630055|NCT01327625|Azithromycin|azithromycin|mesh-list
6630056|NCT01327625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6630057|NCT01327625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6630058|NCT01327729|Interferons|interferons|mesh-list
6630059|NCT01327729|Interferon-alpha|interferon-alpha|mesh-list
6630060|NCT01327729|Interferon alpha-2|interferon alpha-2|mesh-list
6630061|NCT01327729|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6630062|NCT01327729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5481463|NCT05158426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5481464|NCT05158426|Anesthetics, General|anesthetics, general|mesh-ancestor
5481465|NCT05158426|Anesthetics|anesthetics|mesh-ancestor
5481466|NCT05158348|Lidocaine|lidocaine|mesh-list
5481467|NCT05158348|Dexmedetomidine|dexmedetomidine|mesh-list
5481468|NCT05158348|Anesthetics, Local|anesthetics, local|mesh-ancestor
6451637|NCT00412802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6451638|NCT00412802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6451639|NCT00412802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451640|NCT00412919|Azacitidine|azacitidine|mesh-list
6451641|NCT00412919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6451642|NCT00412919|Antimetabolites|antimetabolites|mesh-ancestor
6451643|NCT00412919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451644|NCT00412919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6451645|NCT00412919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6451646|NCT00412997|Panobinostat|panobinostat|mesh-list
6451647|NCT00412997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6451648|NCT00412997|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6451649|NCT00412997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6451650|NCT00412997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451651|NCT00413023|Casopitant|casopitant|mesh-list
6451652|NCT00413023|Antiemetics|antiemetics|mesh-ancestor
6451653|NCT00413023|Autonomic Agents|autonomic agents|mesh-ancestor
6630063|NCT01327729|Antiviral Agents|antiviral agents|mesh-ancestor
6630064|NCT01327729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6630065|NCT01327729|Immunologic Factors|immunologic factors|mesh-ancestor
6630066|NCT01327729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630067|NCT01327755|Selenium|selenium|mesh-list
6630068|NCT01327755|Antioxidants|antioxidants|mesh-ancestor
6630069|NCT01327755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630070|NCT01327755|Protective Agents|protective agents|mesh-ancestor
6630071|NCT01327755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630072|NCT01327755|Trace Elements|trace elements|mesh-ancestor
6630073|NCT01327755|Micronutrients|micronutrients|mesh-ancestor
5481469|NCT05158348|Anesthetics|anesthetics|mesh-ancestor
6630074|NCT01327859|Donepezil|donepezil|mesh-list
6630075|NCT01327859|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5481470|NCT05158348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5481471|NCT05158348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481472|NCT05158348|Sensory System Agents|sensory system agents|mesh-ancestor
5481473|NCT05158348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5481474|NCT05158348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6451654|NCT00413023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6451655|NCT00413023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451656|NCT00413023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6451657|NCT00413023|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6451658|NCT00413023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6451659|NCT00413023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451660|NCT00413075|Belinostat|belinostat|mesh-list
6451661|NCT00413075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6451662|NCT00413075|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6451663|NCT00413075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6451664|NCT00413075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451665|NCT00413088|Bemiparin|bemiparin|mesh-list
6451666|NCT00413088|Anticoagulants|anticoagulants|mesh-ancestor
6451667|NCT00413101|Epoetin Alfa|epoetin alfa|mesh-list
6451668|NCT00413101|Hematinics|hematinics|mesh-ancestor
6451669|NCT00413127|Lidocaine|lidocaine|mesh-list
6451670|NCT00413127|Anesthetics, Local|anesthetics, local|mesh-ancestor
6451671|NCT00413127|Anesthetics|anesthetics|mesh-ancestor
6451672|NCT00413127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6451673|NCT00413127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451674|NCT00413127|Sensory System Agents|sensory system agents|mesh-ancestor
6451675|NCT00413127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6451676|NCT00413127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6451677|NCT00413127|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6451678|NCT00413127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6451679|NCT00413127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6451680|NCT00413127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451681|NCT00413179|Metformin|metformin|mesh-list
6451682|NCT00413179|Clomiphene|clomiphene|mesh-list
6451683|NCT00413179|Enclomiphene|enclomiphene|mesh-list
6451684|NCT00413179|Zuclomiphene|zuclomiphene|mesh-list
6451685|NCT00413179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6451686|NCT00413179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451687|NCT00413179|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6451688|NCT00413179|Hormone Antagonists|hormone antagonists|mesh-ancestor
6451689|NCT00413179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6451690|NCT00413179|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6451691|NCT00413179|Fertility Agents|fertility agents|mesh-ancestor
6630076|NCT01327859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6630077|NCT01327859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630078|NCT01327859|Cholinergic Agents|cholinergic agents|mesh-ancestor
6630079|NCT01327859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6630080|NCT01327859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630081|NCT01327859|Nootropic Agents|nootropic agents|mesh-ancestor
6630082|NCT01328015|Oxybutynin|oxybutynin|mesh-list
6630083|NCT01328015|Cholinergic Antagonists|cholinergic antagonists|mesh-list
6630084|NCT01328015|Parasympatholytics|parasympatholytics|mesh-ancestor
6630085|NCT01328015|Autonomic Agents|autonomic agents|mesh-ancestor
6630086|NCT01328015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6630087|NCT01328015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630088|NCT01328015|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6630089|NCT01328015|Cholinergic Agents|cholinergic agents|mesh-ancestor
6630090|NCT01328015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6630091|NCT01328015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630092|NCT01328015|Urological Agents|urological agents|mesh-ancestor
6630093|NCT01328106|Trametinib|trametinib|mesh-list
6630094|NCT01328106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6630095|NCT01328106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6630096|NCT01328106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6630097|NCT01328106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630098|NCT01328145|Aspirin|aspirin|mesh-list
6630099|NCT01328145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6630100|NCT01328145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6630101|NCT01328145|Analgesics|analgesics|mesh-ancestor
6630102|NCT01328145|Sensory System Agents|sensory system agents|mesh-ancestor
6630103|NCT01328145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6630104|NCT01328145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481475|NCT05158348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5481476|NCT05158348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5481477|NCT05158348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5481478|NCT05158348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481479|NCT05158348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5481480|NCT05158348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5481481|NCT05158348|Analgesics|analgesics|mesh-ancestor
5481482|NCT05158348|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5481483|NCT05158348|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5481484|NCT05158348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6630105|NCT01328145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6630106|NCT01328145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6630107|NCT01328145|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6630108|NCT01328145|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6630109|NCT01328145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630110|NCT01328145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6630111|NCT01328145|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6630112|NCT01328145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6630113|NCT01328145|Antipyretics|antipyretics|mesh-ancestor
6630114|NCT01328171|Folic Acid|folic acid|mesh-list
6630115|NCT01328171|Vitamin B Complex|vitamin b complex|mesh-list
6630116|NCT01328171|Oxaliplatin|oxaliplatin|mesh-list
6630117|NCT01328171|Irinotecan|irinotecan|mesh-list
6630118|NCT01328171|Panitumumab|panitumumab|mesh-list
6630119|NCT01328171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6630120|NCT01328171|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6630121|NCT01328171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6630122|NCT01328171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6630123|NCT01328171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630124|NCT01328171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630125|NCT01328171|Hematinics|hematinics|mesh-ancestor
6630126|NCT01328171|Vitamins|vitamins|mesh-ancestor
6630127|NCT01328171|Micronutrients|micronutrients|mesh-ancestor
6630128|NCT01328171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6630129|NCT01328223|Sorafenib|sorafenib|mesh-list
6630130|NCT01328223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6630131|NCT01328223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6630132|NCT01328223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6630133|NCT01328223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630134|NCT01328236|Dexamethasone|dexamethasone|mesh-list
6630135|NCT01328236|Doxorubicin|doxorubicin|mesh-list
6630136|NCT01328236|Bortezomib|bortezomib|mesh-list
6630137|NCT01328236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6630138|NCT01328236|Antiemetics|antiemetics|mesh-ancestor
6630139|NCT01328236|Autonomic Agents|autonomic agents|mesh-ancestor
6630140|NCT01328236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5481485|NCT05158348|Adrenergic Agents|adrenergic agents|mesh-ancestor
5481486|NCT05158348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5481487|NCT05158309|Capsaicin|capsaicin|mesh-list
5481488|NCT05158309|Antipruritics|antipruritics|mesh-ancestor
6451692|NCT00413179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6451693|NCT00413179|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6451694|NCT00413179|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6451695|NCT00413257|Nefopam|nefopam|mesh-list
6451696|NCT00413257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6451697|NCT00413257|Analgesics|analgesics|mesh-ancestor
6451698|NCT00413257|Sensory System Agents|sensory system agents|mesh-ancestor
6451699|NCT00413257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6451700|NCT00413257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451701|NCT00413296|Levetiracetam|levetiracetam|mesh-list
6451702|NCT00413296|Anticonvulsants|anticonvulsants|mesh-ancestor
6451703|NCT00413296|Nootropic Agents|nootropic agents|mesh-ancestor
6451704|NCT00413322|Fluorouracil|fluorouracil|mesh-list
6451705|NCT00413322|Belinostat|belinostat|mesh-list
6451706|NCT00413322|Antimetabolites|antimetabolites|mesh-ancestor
6451707|NCT00413322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451708|NCT00413322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6451709|NCT00413322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6451710|NCT00413322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6451711|NCT00413322|Immunologic Factors|immunologic factors|mesh-ancestor
6630141|NCT01328236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630142|NCT01328236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6630143|NCT01328236|Glucocorticoids|glucocorticoids|mesh-ancestor
6630144|NCT01328236|Hormones|hormones|mesh-ancestor
6630145|NCT01328236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6630146|NCT01328236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6630147|NCT01328236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6630148|NCT01328236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6630149|NCT01328236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6630150|NCT01328236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6630151|NCT01328236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6630152|NCT01328236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662620|NCT01504139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662621|NCT01504139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6662622|NCT01504139|Progestins|progestins|mesh-ancestor
6662623|NCT01504178|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6662624|NCT01504178|Levodopa|levodopa|mesh-list
6662625|NCT01504178|Apomorphine|apomorphine|mesh-list
6662626|NCT01504178|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
6662627|NCT01504178|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6662628|NCT01504178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6662629|NCT01504178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6662630|NCT01504178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662631|NCT01504178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6662632|NCT01504178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662633|NCT01504178|Analgesics|analgesics|mesh-ancestor
6662634|NCT01504178|Sensory System Agents|sensory system agents|mesh-ancestor
5481489|NCT05158309|Dermatologic Agents|dermatologic agents|mesh-ancestor
5481490|NCT05158309|Sensory System Agents|sensory system agents|mesh-ancestor
5481491|NCT05158309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5481492|NCT05158309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481493|NCT05158166|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5481494|NCT05158166|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5481495|NCT05158166|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5481496|NCT05158166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5481497|NCT05158166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481498|NCT05158166|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5481499|NCT05158166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5481500|NCT05158166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630153|NCT01328301|Methamphetamine|methamphetamine|mesh-list
6630154|NCT01328301|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6630155|NCT01328301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630156|NCT01328301|Sympathomimetics|sympathomimetics|mesh-ancestor
6630157|NCT01328301|Autonomic Agents|autonomic agents|mesh-ancestor
6630158|NCT01328301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6630159|NCT01328301|Dopamine Agents|dopamine agents|mesh-ancestor
6630160|NCT01328301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6630161|NCT01328301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630162|NCT01328301|Adrenergic Agents|adrenergic agents|mesh-ancestor
6630163|NCT01328301|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6630164|NCT01328301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6630165|NCT01328301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6630166|NCT01328301|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6630167|NCT01328340|Methamphetamine|methamphetamine|mesh-list
6630168|NCT01328340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6630169|NCT01328340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630170|NCT01328340|Sympathomimetics|sympathomimetics|mesh-ancestor
6630171|NCT01328340|Autonomic Agents|autonomic agents|mesh-ancestor
6630172|NCT01328340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6630173|NCT01328340|Dopamine Agents|dopamine agents|mesh-ancestor
6630174|NCT01328340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6630175|NCT01328340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630176|NCT01328340|Adrenergic Agents|adrenergic agents|mesh-ancestor
6630177|NCT01328340|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6630178|NCT01328340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6630179|NCT01328340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6630180|NCT01328340|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6630181|NCT01328392|Dexlansoprazole|dexlansoprazole|mesh-list
6630182|NCT01328392|Lansoprazole|lansoprazole|mesh-list
6630183|NCT01328392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6630184|NCT01328392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6630185|NCT01328392|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6630186|NCT01328392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6630187|NCT01328392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630188|NCT01328457|Paromomycin|paromomycin|mesh-list
6630189|NCT01328457|Neomycin|neomycin|mesh-list
6630190|NCT01328457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6630191|NCT01328457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6630192|NCT01328457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6630193|NCT01328457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6630194|NCT01328457|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6630195|NCT01328457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6630196|NCT01328457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630197|NCT01328470|Cilostazol|cilostazol|mesh-list
6630198|NCT01328470|Clopidogrel|clopidogrel|mesh-list
6630199|NCT01328470|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6630200|NCT01328470|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6630201|NCT01328470|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6630202|NCT01328470|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6630203|NCT01328470|Purinergic Agents|purinergic agents|mesh-ancestor
6630204|NCT01328470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6630205|NCT01328470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630206|NCT01328470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630207|NCT01328470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6630208|NCT01328470|Autonomic Agents|autonomic agents|mesh-ancestor
6630209|NCT01328470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6630210|NCT01328470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6630211|NCT01328470|Respiratory System Agents|respiratory system agents|mesh-ancestor
6630212|NCT01328470|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6630213|NCT01328470|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5481501|NCT05158166|Cholinergic Agents|cholinergic agents|mesh-ancestor
5481502|NCT05158166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5481503|NCT05158153|Furosemide|furosemide|mesh-list
5481504|NCT05158153|Diuretics|diuretics|mesh-ancestor
5481505|NCT05158153|Natriuretic Agents|natriuretic agents|mesh-ancestor
5481506|NCT05158153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481507|NCT05158153|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5481508|NCT05158153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5481509|NCT05158153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481510|NCT05158062|Paclitaxel|paclitaxel|mesh-list
5481511|NCT05158062|Docetaxel|docetaxel|mesh-list
5481512|NCT05158062|Bevacizumab|bevacizumab|mesh-list
5481513|NCT05158062|Carboplatin|carboplatin|mesh-list
5481514|NCT05158062|Pembrolizumab|pembrolizumab|mesh-list
6630214|NCT01328470|Vasodilator Agents|vasodilator agents|mesh-ancestor
6630215|NCT01328470|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6630216|NCT01328470|Protective Agents|protective agents|mesh-ancestor
6630217|NCT01328470|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6630218|NCT01328470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6630219|NCT01328470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6630220|NCT01328652|Dexlansoprazole|dexlansoprazole|mesh-list
6630221|NCT01328652|Lansoprazole|lansoprazole|mesh-list
6630222|NCT01328652|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
6630223|NCT01328652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6630224|NCT01328652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630225|NCT01328652|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6630226|NCT01328652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6630227|NCT01328821|Pentoxifylline|pentoxifylline|mesh-list
6630228|NCT01328821|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6630229|NCT01328821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6630230|NCT01328821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630231|NCT01328821|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6630232|NCT01328821|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6630233|NCT01328821|Protective Agents|protective agents|mesh-ancestor
5481515|NCT05158062|Olaparib|olaparib|mesh-list
6630234|NCT01328821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630235|NCT01328821|Vasodilator Agents|vasodilator agents|mesh-ancestor
6630236|NCT01328821|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6630237|NCT01328821|Antioxidants|antioxidants|mesh-ancestor
6630238|NCT01328834|Tacrolimus|tacrolimus|mesh-list
6630239|NCT01328834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6630240|NCT01328834|Immunologic Factors|immunologic factors|mesh-ancestor
6630241|NCT01328834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630242|NCT01328834|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6630243|NCT01328834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6630244|NCT01328834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630245|NCT01328886|Omalizumab|omalizumab|mesh-list
6630246|NCT01328886|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6630247|NCT01328886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6630248|NCT01328886|Respiratory System Agents|respiratory system agents|mesh-ancestor
6630249|NCT01328925|Nitazoxanide|nitazoxanide|mesh-list
6630250|NCT01328925|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6630251|NCT01328925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6630252|NCT01328990|Pyrimethamine|pyrimethamine|mesh-list
6630253|NCT01328990|Sulfadoxine|sulfadoxine|mesh-list
6630254|NCT01328990|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6630255|NCT01328990|Amodiaquine|amodiaquine|mesh-list
6630256|NCT01328990|Antimalarials|antimalarials|mesh-ancestor
6630257|NCT01328990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6630258|NCT01328990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6630259|NCT01328990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6630260|NCT01328990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6630261|NCT01328990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6630262|NCT01328990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630263|NCT01328990|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5481516|NCT05158062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5481517|NCT05158062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5481518|NCT05158062|Tubulin Modulators|tubulin modulators|mesh-ancestor
5481519|NCT05158062|Antimitotic Agents|antimitotic agents|mesh-ancestor
5481520|NCT05158062|Mitosis Modulators|mitosis modulators|mesh-ancestor
5481521|NCT05158062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481522|NCT05158062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5481523|NCT05158062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5481524|NCT05158062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5481525|NCT05158062|Growth Substances|growth substances|mesh-ancestor
5481526|NCT05158062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481527|NCT05158062|Growth Inhibitors|growth inhibitors|mesh-ancestor
5481528|NCT05158062|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5481529|NCT05158062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5481530|NCT05157997|Antibodies|antibodies|mesh-list
5481531|NCT05157997|Immunologic Factors|immunologic factors|mesh-ancestor
5481532|NCT05157997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481533|NCT05157893|Analgesics|analgesics|mesh-list
5481534|NCT05157893|Sensory System Agents|sensory system agents|mesh-ancestor
5481535|NCT05157893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5481536|NCT05157893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481537|NCT05157867|Trypsin Inhibitors|trypsin inhibitors|mesh-list
5481538|NCT05157867|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5481539|NCT05157867|Protease Inhibitors|protease inhibitors|mesh-ancestor
5481540|NCT05157867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5481541|NCT05157867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481542|NCT05157841|Bupivacaine|bupivacaine|mesh-list
5481543|NCT05157841|Anesthetics, Local|anesthetics, local|mesh-ancestor
5481544|NCT05157841|Anesthetics|anesthetics|mesh-ancestor
5481545|NCT05157841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6451712|NCT00413322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451713|NCT00413322|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6451714|NCT00413322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6451715|NCT00413361|Hydroxychloroquine|hydroxychloroquine|mesh-list
6451716|NCT00413361|Antimalarials|antimalarials|mesh-ancestor
6451717|NCT00413361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6451718|NCT00413361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6451719|NCT00413361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6451720|NCT00413361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6451721|NCT00413361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451722|NCT00413361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6451723|NCT00413387|Budesonide|budesonide|mesh-list
6451724|NCT00413387|Beclomethasone|beclomethasone|mesh-list
6451725|NCT00413387|Formoterol Fumarate|formoterol fumarate|mesh-list
6630264|NCT01328990|Renal Agents|renal agents|mesh-ancestor
6630265|NCT01329016|Metformin|metformin|mesh-list
6630266|NCT01329016|Glyburide|glyburide|mesh-list
6630267|NCT01329016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6630268|NCT01329016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630269|NCT01329042|Citric Acid|citric acid|mesh-list
6630270|NCT01329042|Sodium Citrate|sodium citrate|mesh-list
6630271|NCT01329042|Anticoagulants|anticoagulants|mesh-ancestor
6630272|NCT01329042|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6630273|NCT01329042|Chelating Agents|chelating agents|mesh-ancestor
6630274|NCT01329042|Sequestering Agents|sequestering agents|mesh-ancestor
6630275|NCT01329042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630276|NCT01329250|Moxifloxacin|moxifloxacin|mesh-list
6630277|NCT01329250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6630278|NCT01329250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6630279|NCT01329250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5481546|NCT05157841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481547|NCT05157841|Sensory System Agents|sensory system agents|mesh-ancestor
5481548|NCT05157841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5481549|NCT05157711|Bismuth subgallate|bismuth subgallate|mesh-list
5481550|NCT05157711|Phenylephrine|phenylephrine|mesh-list
5481551|NCT05157711|Oxymetazoline|oxymetazoline|mesh-list
5481552|NCT05157711|Zinc Oxide|zinc oxide|mesh-list
5481553|NCT05157711|Bismuth|bismuth|mesh-list
5481554|NCT05157711|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5481555|NCT05157711|Mydriatics|mydriatics|mesh-ancestor
6630280|NCT01329250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6630281|NCT01329250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6630282|NCT01329250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630283|NCT01329250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6630284|NCT01329276|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6630285|NCT01329276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6630286|NCT01329276|Respiratory System Agents|respiratory system agents|mesh-ancestor
6630287|NCT01329289|Dexamethasone|dexamethasone|mesh-list
6630288|NCT01329289|Dexamethasone acetate|dexamethasone acetate|mesh-list
6630289|NCT01329289|Bortezomib|bortezomib|mesh-list
6630290|NCT01329289|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
6630291|NCT01329289|Pasireotide|pasireotide|mesh-list
6630292|NCT01329289|BB 1101|bb 1101|mesh-list
6630293|NCT01329289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6630294|NCT01329289|Antiemetics|antiemetics|mesh-ancestor
6630295|NCT01329289|Autonomic Agents|autonomic agents|mesh-ancestor
5481556|NCT05157711|Autonomic Agents|autonomic agents|mesh-ancestor
5481557|NCT05157711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5481558|NCT05157711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481559|NCT05157711|Sympathomimetics|sympathomimetics|mesh-ancestor
5481560|NCT05157711|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5481561|NCT05157711|Nasal Decongestants|nasal decongestants|mesh-ancestor
5481562|NCT05157711|Respiratory System Agents|respiratory system agents|mesh-ancestor
5481563|NCT05157711|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5481564|NCT05157711|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5481565|NCT05157711|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5481566|NCT05157711|Adrenergic Agents|adrenergic agents|mesh-ancestor
5481567|NCT05157711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6630296|NCT01329289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6630297|NCT01329289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630298|NCT01329289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6630299|NCT01329289|Glucocorticoids|glucocorticoids|mesh-ancestor
6630300|NCT01329289|Hormones|hormones|mesh-ancestor
6630301|NCT01329289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6630302|NCT01329289|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6630303|NCT01329289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6630304|NCT01329289|Protease Inhibitors|protease inhibitors|mesh-ancestor
6630305|NCT01329289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6630306|NCT01329289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630307|NCT01329367|Antioxidants|antioxidants|mesh-list
6630308|NCT01329367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630309|NCT01329367|Protective Agents|protective agents|mesh-ancestor
6630310|NCT01329367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630311|NCT01329406|Milnacipran|milnacipran|mesh-list
5481568|NCT05157711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481569|NCT05157711|Protective Agents|protective agents|mesh-ancestor
5481570|NCT05157711|Antacids|antacids|mesh-ancestor
5481571|NCT05157711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5481572|NCT05157711|Dermatologic Agents|dermatologic agents|mesh-ancestor
5481573|NCT05157711|Sunscreening Agents|sunscreening agents|mesh-ancestor
6630312|NCT01329406|Levomilnacipran|levomilnacipran|mesh-list
5481574|NCT05157711|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6630313|NCT01329406|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6630314|NCT01329406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6630315|NCT01329406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6630316|NCT01329406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630317|NCT01329406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6630318|NCT01329406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630319|NCT01329406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6630320|NCT01329406|Analgesics|analgesics|mesh-ancestor
6630321|NCT01329406|Sensory System Agents|sensory system agents|mesh-ancestor
6630322|NCT01329406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6630323|NCT01329406|Antidepressive Agents|antidepressive agents|mesh-ancestor
6630324|NCT01329406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6630325|NCT01329588|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6630326|NCT01329588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6630327|NCT01329614|Nicotine|nicotine|mesh-list
6630328|NCT01329614|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6630329|NCT01329614|Autonomic Agents|autonomic agents|mesh-ancestor
6630330|NCT01329614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6630331|NCT01329614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630332|NCT01329614|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6630333|NCT01329614|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6630334|NCT01329614|Cholinergic Agents|cholinergic agents|mesh-ancestor
6630335|NCT01329614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6630336|NCT01329614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630337|NCT01329627|Paclitaxel|paclitaxel|mesh-list
6630338|NCT01329627|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6630339|NCT01329627|Cyclophosphamide|cyclophosphamide|mesh-list
6630340|NCT01329627|Doxorubicin|doxorubicin|mesh-list
6630341|NCT01329627|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6630342|NCT01329627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6630343|NCT01329627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6630344|NCT01329627|Tubulin Modulators|tubulin modulators|mesh-ancestor
6630345|NCT01329627|Antimitotic Agents|antimitotic agents|mesh-ancestor
6630346|NCT01329627|Mitosis Modulators|mitosis modulators|mesh-ancestor
6630347|NCT01329627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630348|NCT01329627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6630349|NCT01329627|Immunologic Factors|immunologic factors|mesh-ancestor
6630350|NCT01329627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630351|NCT01329627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6630352|NCT01329627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6630353|NCT01329627|Alkylating Agents|alkylating agents|mesh-ancestor
6630354|NCT01329627|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6630355|NCT01329627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6630356|NCT01329627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6630357|NCT01329627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6630358|NCT01329627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6630359|NCT01329640|Paclitaxel|paclitaxel|mesh-list
6630360|NCT01329640|Cyclophosphamide|cyclophosphamide|mesh-list
6630361|NCT01329640|Trastuzumab|trastuzumab|mesh-list
6630362|NCT01329640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6630363|NCT01329640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6630364|NCT01329640|Tubulin Modulators|tubulin modulators|mesh-ancestor
5481575|NCT05157711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5481576|NCT05157711|Hemostatics|hemostatics|mesh-ancestor
5481577|NCT05157711|Coagulants|coagulants|mesh-ancestor
5502373|NCT04466904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502374|NCT04466917|Paclitaxel|paclitaxel|mesh-list
5502375|NCT04466917|Bevacizumab|bevacizumab|mesh-list
6630365|NCT01329640|Antimitotic Agents|antimitotic agents|mesh-ancestor
6630366|NCT01329640|Mitosis Modulators|mitosis modulators|mesh-ancestor
6630367|NCT01329640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502376|NCT04466917|Carboplatin|carboplatin|mesh-list
5502377|NCT04466917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5502378|NCT04466917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5502379|NCT04466917|Tubulin Modulators|tubulin modulators|mesh-ancestor
5502380|NCT04466917|Antimitotic Agents|antimitotic agents|mesh-ancestor
5502381|NCT04466917|Mitosis Modulators|mitosis modulators|mesh-ancestor
5503631|NCT04456959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6630368|NCT01329640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6630369|NCT01329640|Immunologic Factors|immunologic factors|mesh-ancestor
6630370|NCT01329640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630371|NCT01329640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6630372|NCT01329640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6630373|NCT01329640|Alkylating Agents|alkylating agents|mesh-ancestor
6630374|NCT01329640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6630375|NCT01329640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6630376|NCT01329666|Vitamin D|vitamin d|mesh-list
6630377|NCT01329666|Cholecalciferol|cholecalciferol|mesh-list
6630378|NCT01329666|Vitamins|vitamins|mesh-ancestor
6630379|NCT01329666|Micronutrients|micronutrients|mesh-ancestor
5481578|NCT05157672|Letrozole|letrozole|mesh-list
5481579|NCT05157672|Nicotine|nicotine|mesh-list
5481580|NCT05157672|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5481581|NCT05157672|Autonomic Agents|autonomic agents|mesh-ancestor
5481582|NCT05157672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5481583|NCT05157672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481584|NCT05157672|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5481585|NCT05157672|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5481586|NCT05157672|Cholinergic Agents|cholinergic agents|mesh-ancestor
5481587|NCT05157672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5481588|NCT05157672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481589|NCT05157672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5481590|NCT05157672|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5481591|NCT05157672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5481592|NCT05157672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5481593|NCT05157672|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5481594|NCT05157672|Hormone Antagonists|hormone antagonists|mesh-ancestor
5481595|NCT05157672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5481596|NCT05157581|Methoxsalen|methoxsalen|mesh-list
5481597|NCT05157581|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5481598|NCT05157581|Dermatologic Agents|dermatologic agents|mesh-ancestor
5481599|NCT05157542|Paclitaxel|paclitaxel|mesh-list
5481600|NCT05157542|Durvalumab|durvalumab|mesh-list
5481601|NCT05157542|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5481602|NCT05157542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5481603|NCT05157542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5481604|NCT05157542|Tubulin Modulators|tubulin modulators|mesh-ancestor
5481605|NCT05157542|Antimitotic Agents|antimitotic agents|mesh-ancestor
5481606|NCT05157542|Mitosis Modulators|mitosis modulators|mesh-ancestor
5481607|NCT05157542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481608|NCT05157542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5481609|NCT05157360|Vitamins|vitamins|mesh-list
5481610|NCT05157360|Hydrocortisone|hydrocortisone|mesh-list
5481611|NCT05157360|Micronutrients|micronutrients|mesh-ancestor
5481612|NCT05157360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481613|NCT05157360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5481614|NCT05157295|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5481615|NCT05157295|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5481616|NCT05157295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5481617|NCT05157295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6630380|NCT01329666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630381|NCT01329666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6630382|NCT01329666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5481618|NCT05157295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481619|NCT05157295|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5481620|NCT05157295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5481621|NCT05157295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481622|NCT05157295|Cholinergic Agents|cholinergic agents|mesh-ancestor
5481623|NCT05157295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5481624|NCT05080946|Aspirin|aspirin|mesh-list
5481625|NCT05080946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5481626|NCT05080946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5481627|NCT05080946|Analgesics|analgesics|mesh-ancestor
5481628|NCT05080946|Sensory System Agents|sensory system agents|mesh-ancestor
5481629|NCT05080946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5481630|NCT05080946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481631|NCT05080946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5481632|NCT05080946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5481633|NCT05080946|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5481634|NCT05080946|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5481635|NCT05080946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630383|NCT01329731|Olaflur|olaflur|mesh-list
5481636|NCT05080946|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5481637|NCT05080946|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5481638|NCT05080946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5481639|NCT05080946|Antipyretics|antipyretics|mesh-ancestor
5481640|NCT05079126|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
5481641|NCT05079126|Antioxidants|antioxidants|mesh-ancestor
5481642|NCT05079126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481643|NCT05079126|Protective Agents|protective agents|mesh-ancestor
6630384|NCT01329731|Cariostatic Agents|cariostatic agents|mesh-ancestor
6630385|NCT01329731|Protective Agents|protective agents|mesh-ancestor
6630386|NCT01329731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630387|NCT01329744|Mecasermin|mecasermin|mesh-list
6630388|NCT01329744|Growth Substances|growth substances|mesh-ancestor
6630389|NCT01329744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630390|NCT01329770|Vitamins|vitamins|mesh-list
6630391|NCT01329770|Ascorbic Acid|ascorbic acid|mesh-list
6630392|NCT01329770|Vitamin E|vitamin e|mesh-list
6630393|NCT01329770|Tocopherols|tocopherols|mesh-list
6630394|NCT01329770|alpha-Tocopherol|alpha-tocopherol|mesh-list
6630395|NCT01329770|Micronutrients|micronutrients|mesh-ancestor
6630396|NCT01329770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630397|NCT01329770|Antioxidants|antioxidants|mesh-ancestor
6630398|NCT01329770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630399|NCT01329770|Protective Agents|protective agents|mesh-ancestor
6630400|NCT01329783|Maraviroc|maraviroc|mesh-list
6630401|NCT01329783|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6630402|NCT01329783|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6630403|NCT01329783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630404|NCT01329783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6630405|NCT01329783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6630406|NCT01329783|Antiviral Agents|antiviral agents|mesh-ancestor
6630407|NCT01329783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6630408|NCT01329783|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6630409|NCT01329796|Lidocaine|lidocaine|mesh-list
6630410|NCT01329796|Anesthetics, Local|anesthetics, local|mesh-ancestor
6630411|NCT01329796|Anesthetics|anesthetics|mesh-ancestor
6630412|NCT01329796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6630413|NCT01329796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630414|NCT01329796|Sensory System Agents|sensory system agents|mesh-ancestor
6630415|NCT01329796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5481644|NCT05079126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481645|NCT05079126|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5481646|NCT05079126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5481647|NCT05076253|Ivermectin|ivermectin|mesh-list
6630416|NCT01329796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6630417|NCT01329796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6630418|NCT01329796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6630419|NCT01329796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6630420|NCT01329796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630421|NCT01329809|Molgramostim|molgramostim|mesh-list
6630422|NCT01329809|Sargramostim|sargramostim|mesh-list
6630423|NCT01329809|Immunologic Factors|immunologic factors|mesh-ancestor
6630424|NCT01329809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630425|NCT01329809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6630426|NCT01329887|Ketanserin|ketanserin|mesh-list
6630427|NCT01329887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6630428|NCT01329887|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6630429|NCT01329887|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6630430|NCT01329887|Serotonin Agents|serotonin agents|mesh-ancestor
6630431|NCT01329887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6630432|NCT01329887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630433|NCT01329887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630434|NCT01330082|Photosensitizing Agents|photosensitizing agents|mesh-list
6630435|NCT01330082|Dermatologic Agents|dermatologic agents|mesh-ancestor
6662635|NCT01504178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6662636|NCT01504178|Antidepressive Agents|antidepressive agents|mesh-ancestor
6662637|NCT01504178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6662638|NCT01504178|Dopamine Agents|dopamine agents|mesh-ancestor
6662639|NCT01504178|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6662640|NCT01504178|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6662641|NCT01504178|Emetics|emetics|mesh-ancestor
6662642|NCT01504178|Autonomic Agents|autonomic agents|mesh-ancestor
5481648|NCT05076253|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5481649|NCT05076253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5481650|NCT05071183|Trametinib|trametinib|mesh-list
5481651|NCT05071183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5481652|NCT05071183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5481653|NCT05071183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6451726|NCT00413387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6451727|NCT00413387|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6451728|NCT00413387|Autonomic Agents|autonomic agents|mesh-ancestor
6451729|NCT00413387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5481654|NCT05071183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481655|NCT05039073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5481656|NCT05039073|Nivolumab|nivolumab|mesh-list
5481657|NCT05039073|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5481658|NCT05039073|Antibodies|antibodies|mesh-list
5481659|NCT05039073|Immunoglobulins|immunoglobulins|mesh-list
5481660|NCT05039073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5481661|NCT05039073|Immunoconjugates|immunoconjugates|mesh-list
5481662|NCT05039073|Immunologic Factors|immunologic factors|mesh-ancestor
5481663|NCT05039073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481664|NCT05039073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5481665|NCT05039073|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5481666|NCT05039073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481667|NCT05022563|Warfarin|warfarin|mesh-list
5481668|NCT05022563|Rivaroxaban|rivaroxaban|mesh-list
5481669|NCT05022563|Dabigatran|dabigatran|mesh-list
6630436|NCT01330238|Zoledronic Acid|zoledronic acid|mesh-list
6630437|NCT01330238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6630438|NCT01330238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630439|NCT01330446|Modafinil|modafinil|mesh-list
6630440|NCT01330446|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6630441|NCT01330446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630442|NCT01330446|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6630443|NCT01330446|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6630444|NCT01330446|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6630445|NCT01330446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630446|NCT01330472|Alprazolam|alprazolam|mesh-list
6630447|NCT01330472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6630448|NCT01330472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6630449|NCT01330472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630450|NCT01330472|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6630451|NCT01330472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6630452|NCT01330472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6630453|NCT01330472|GABA Modulators|gaba modulators|mesh-ancestor
6630454|NCT01330472|GABA Agents|gaba agents|mesh-ancestor
6630455|NCT01330472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5481670|NCT05022563|Apixaban|apixaban|mesh-list
5481671|NCT05022563|Edoxaban|edoxaban|mesh-list
5481672|NCT05022563|Anticoagulants|anticoagulants|mesh-list
5481673|NCT05022563|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5481674|NCT05022563|Antithrombins|antithrombins|mesh-ancestor
5481675|NCT05022563|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5481676|NCT05022563|Protease Inhibitors|protease inhibitors|mesh-ancestor
5481677|NCT05022563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5481678|NCT05022563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481679|NCT05020327|Amoxicillin|amoxicillin|mesh-list
5481680|NCT05020327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5481681|NCT05020327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5481682|NCT04983888|Obinutuzumab|obinutuzumab|mesh-list
6451730|NCT00413387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451731|NCT00413387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6451732|NCT00413387|Respiratory System Agents|respiratory system agents|mesh-ancestor
6451733|NCT00413387|Glucocorticoids|glucocorticoids|mesh-ancestor
6451734|NCT00413387|Hormones|hormones|mesh-ancestor
6451735|NCT00413387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6451736|NCT00413387|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6451737|NCT00413387|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6451738|NCT00413387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6451739|NCT00413387|Adrenergic Agents|adrenergic agents|mesh-ancestor
6451740|NCT00413387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6451741|NCT00413387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451742|NCT00413426|Darifenacin|darifenacin|mesh-list
6451743|NCT00413426|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6451744|NCT00413426|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6451745|NCT00413426|Cholinergic Agents|cholinergic agents|mesh-ancestor
6451746|NCT00413426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6451747|NCT00413426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451748|NCT00413426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451749|NCT00413426|Urological Agents|urological agents|mesh-ancestor
5481683|NCT04983888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6630456|NCT01330472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630457|NCT01330524|Triamcinolone|triamcinolone|mesh-list
6630458|NCT01330524|Bevacizumab|bevacizumab|mesh-list
6630459|NCT01330524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6630460|NCT01330524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6630461|NCT01330524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6630462|NCT01330524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6630463|NCT01330524|Growth Substances|growth substances|mesh-ancestor
6630464|NCT01330524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630465|NCT01330524|Growth Inhibitors|growth inhibitors|mesh-ancestor
6630466|NCT01330524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6630467|NCT01330524|Glucocorticoids|glucocorticoids|mesh-ancestor
6630468|NCT01330524|Hormones|hormones|mesh-ancestor
6630469|NCT01330524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6630470|NCT01330563|Ketoconazole|ketoconazole|mesh-list
6630471|NCT01330563|Antifungal Agents|antifungal agents|mesh-ancestor
6630472|NCT01330563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6630473|NCT01330563|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6630474|NCT01330563|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6630475|NCT01330563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6630476|NCT01330563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630477|NCT01330563|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6630478|NCT01330563|Hormone Antagonists|hormone antagonists|mesh-ancestor
6630479|NCT01330563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6630480|NCT01330563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630481|NCT01330563|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6630482|NCT01330615|Lidocaine|lidocaine|mesh-list
6630483|NCT01330615|Prilocaine|prilocaine|mesh-list
6630484|NCT01330615|Anesthetics, Local|anesthetics, local|mesh-ancestor
6630485|NCT01330615|Anesthetics|anesthetics|mesh-ancestor
6630486|NCT01330615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6630487|NCT01330615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630488|NCT01330615|Sensory System Agents|sensory system agents|mesh-ancestor
6630489|NCT01330615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6630490|NCT01330615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6630491|NCT01330615|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6630492|NCT01330615|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6630493|NCT01330615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6630494|NCT01330615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630495|NCT01330654|Metoprolol|metoprolol|mesh-list
6630496|NCT01330654|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6630497|NCT01330654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6630498|NCT01330654|Sympatholytics|sympatholytics|mesh-ancestor
6630499|NCT01330654|Autonomic Agents|autonomic agents|mesh-ancestor
6630500|NCT01330654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6630501|NCT01330654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630502|NCT01330654|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6630503|NCT01330654|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6630504|NCT01330654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6630505|NCT01330654|Adrenergic Agents|adrenergic agents|mesh-ancestor
5481684|NCT04983888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5481685|NCT04983498|Ondansetron|ondansetron|mesh-list
5481686|NCT04983498|Antiemetics|antiemetics|mesh-ancestor
5481687|NCT04983498|Autonomic Agents|autonomic agents|mesh-ancestor
5481688|NCT04983498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5481689|NCT04983498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481690|NCT04983498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6630506|NCT01330654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6630507|NCT01330654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630508|NCT01330693|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6630509|NCT01330693|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6630510|NCT01330693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6630511|NCT01330693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5481691|NCT04983498|Antipruritics|antipruritics|mesh-ancestor
5481692|NCT04983498|Dermatologic Agents|dermatologic agents|mesh-ancestor
5481693|NCT04983498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5481694|NCT04983498|Serotonin Agents|serotonin agents|mesh-ancestor
5481695|NCT04983498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5481696|NCT04983498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481697|NCT04983498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5481698|NCT04983498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6630512|NCT01330693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451750|NCT00413439|Isavuconazole|isavuconazole|mesh-list
6451751|NCT00413439|Antifungal Agents|antifungal agents|mesh-ancestor
6451752|NCT00413439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6451753|NCT00413452|Etanercept|etanercept|mesh-list
6451754|NCT00413452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6451755|NCT00413452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6451756|NCT00413452|Analgesics|analgesics|mesh-ancestor
6630513|NCT01330693|Adrenergic Agents|adrenergic agents|mesh-ancestor
6630514|NCT01330693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6630515|NCT01330693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451757|NCT00413452|Sensory System Agents|sensory system agents|mesh-ancestor
6451758|NCT00413452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6630516|NCT01330706|Polihexanide|polihexanide|mesh-list
6630517|NCT01330706|Disinfectants|disinfectants|mesh-ancestor
6630518|NCT01330706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6630519|NCT01330810|Curcumin|curcumin|mesh-list
6630520|NCT01330810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6630521|NCT01330810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6630522|NCT01330810|Analgesics|analgesics|mesh-ancestor
6630523|NCT01330810|Sensory System Agents|sensory system agents|mesh-ancestor
6630524|NCT01330810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6630525|NCT01330810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630526|NCT01330810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6630527|NCT01330810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6630528|NCT01330810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6630529|NCT01330810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6630530|NCT01330810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630531|NCT01330901|Ustekinumab|ustekinumab|mesh-list
6630532|NCT01330901|Dermatologic Agents|dermatologic agents|mesh-ancestor
6630533|NCT01331122|Droxidopa|droxidopa|mesh-list
6630534|NCT01331122|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6630535|NCT01331122|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6630536|NCT01331135|Sirolimus|sirolimus|mesh-list
6630537|NCT01331135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6630538|NCT01331135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6630539|NCT01331135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6630540|NCT01331135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6630541|NCT01331135|Antifungal Agents|antifungal agents|mesh-ancestor
6630542|NCT01331135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6630543|NCT01331135|Immunologic Factors|immunologic factors|mesh-ancestor
6630544|NCT01331135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630545|NCT01331148|Vitamin D|vitamin d|mesh-list
6630546|NCT01331148|Cholecalciferol|cholecalciferol|mesh-list
6630547|NCT01331148|Vitamins|vitamins|mesh-ancestor
6630548|NCT01331148|Micronutrients|micronutrients|mesh-ancestor
6630549|NCT01331148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630550|NCT01331148|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6630551|NCT01331148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6630552|NCT01331382|Resveratrol|resveratrol|mesh-list
6630553|NCT01331382|Antioxidants|antioxidants|mesh-ancestor
6630554|NCT01331382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630555|NCT01331382|Protective Agents|protective agents|mesh-ancestor
6630556|NCT01331382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630557|NCT01331382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6630558|NCT01331382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6630559|NCT01331421|Exemestane|exemestane|mesh-list
6630560|NCT01331421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6630561|NCT01331421|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6630562|NCT01331421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6630563|NCT01331421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6630564|NCT01331421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630565|NCT01331421|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6630566|NCT01331421|Hormone Antagonists|hormone antagonists|mesh-ancestor
6630567|NCT01331421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6630568|NCT01331421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630569|NCT01331434|Exemestane|exemestane|mesh-list
6630570|NCT01331434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6630571|NCT01331434|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6630572|NCT01331434|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6630573|NCT01331434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6630574|NCT01331434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630575|NCT01331434|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6630576|NCT01331434|Hormone Antagonists|hormone antagonists|mesh-ancestor
6630577|NCT01331434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6630578|NCT01331434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630579|NCT01331447|Exemestane|exemestane|mesh-list
6630580|NCT01331447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6630581|NCT01331447|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6630582|NCT01331447|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6630583|NCT01331447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6630584|NCT01331447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630585|NCT01331447|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6630586|NCT01331447|Hormone Antagonists|hormone antagonists|mesh-ancestor
6630587|NCT01331447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5481699|NCT04983498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5481700|NCT04983498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5481701|NCT04983498|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5481702|NCT04963439|Macitentan|macitentan|mesh-list
5481703|NCT04963439|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
5481704|NCT04963439|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5481705|NCT04963439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630588|NCT01331447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630589|NCT01331525|Ipilimumab|ipilimumab|mesh-list
6630590|NCT01331525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6630591|NCT01331525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6630592|NCT01331525|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6630593|NCT01331525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630594|NCT01331590|Dexamethasone|dexamethasone|mesh-list
6630595|NCT01331590|Etoposide|etoposide|mesh-list
6630596|NCT01331590|Ifosfamide|ifosfamide|mesh-list
6630597|NCT01331590|Lenograstim|lenograstim|mesh-list
6630598|NCT01331590|Sargramostim|sargramostim|mesh-list
6630599|NCT01331590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6630600|NCT01331590|Antiemetics|antiemetics|mesh-ancestor
6630601|NCT01331590|Autonomic Agents|autonomic agents|mesh-ancestor
6630602|NCT01331590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6630603|NCT01331590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630604|NCT01331590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6630605|NCT01331590|Glucocorticoids|glucocorticoids|mesh-ancestor
6630606|NCT01331590|Hormones|hormones|mesh-ancestor
6630607|NCT01331590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6630608|NCT01331590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6630609|NCT01331590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6630610|NCT01331590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6630611|NCT01331590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6630612|NCT01331590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6630613|NCT01331590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6630614|NCT01331590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630615|NCT01331590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6630616|NCT01331590|Immunologic Factors|immunologic factors|mesh-ancestor
5481706|NCT04963439|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
5481707|NCT04949828|Pancrelipase|pancrelipase|mesh-list
5481708|NCT04949828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5481709|NCT04947592|Fluconazole|fluconazole|mesh-list
5481710|NCT04947592|Antifungal Agents|antifungal agents|mesh-ancestor
5481711|NCT04947592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5481712|NCT04947592|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5481713|NCT04947592|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5481714|NCT04947592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5481715|NCT04947592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481716|NCT04947592|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5481717|NCT04947592|Hormone Antagonists|hormone antagonists|mesh-ancestor
5481718|NCT04947592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5481719|NCT04947592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481720|NCT04947592|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5481721|NCT04947592|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5481722|NCT04865939|Gemcitabine|gemcitabine|mesh-list
5481723|NCT04865939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5481724|NCT04865939|Antimetabolites|antimetabolites|mesh-ancestor
5481725|NCT04865939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481726|NCT04865939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6630617|NCT01331590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6630618|NCT01331590|Alkylating Agents|alkylating agents|mesh-ancestor
6630619|NCT01331655|Tetrahydrofolates|tetrahydrofolates|mesh-list
6630620|NCT01331655|Drospirenone|drospirenone|mesh-list
6630621|NCT01331655|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6630622|NCT01331655|Hormone Antagonists|hormone antagonists|mesh-ancestor
6630623|NCT01331655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6630624|NCT01331655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630625|NCT01331655|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6630626|NCT01331655|Diuretics|diuretics|mesh-ancestor
6630627|NCT01331655|Natriuretic Agents|natriuretic agents|mesh-ancestor
6630628|NCT01331655|Vitamin B Complex|vitamin b complex|mesh-ancestor
6630629|NCT01331655|Vitamins|vitamins|mesh-ancestor
6630630|NCT01331655|Micronutrients|micronutrients|mesh-ancestor
6630631|NCT01331707|Everolimus|everolimus|mesh-list
6630632|NCT01331707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6630633|NCT01331707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6630634|NCT01331707|Immunologic Factors|immunologic factors|mesh-ancestor
6630635|NCT01331707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630636|NCT01331785|Midodrine|midodrine|mesh-list
6630637|NCT01331785|Sympathomimetics|sympathomimetics|mesh-ancestor
6630638|NCT01331785|Autonomic Agents|autonomic agents|mesh-ancestor
6630639|NCT01331785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6630640|NCT01331785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630641|NCT01331785|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6630642|NCT01331785|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6630643|NCT01331785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6630644|NCT01331785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6630645|NCT01331785|Adrenergic Agents|adrenergic agents|mesh-ancestor
6630646|NCT01331785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6630647|NCT01331785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630648|NCT01331902|Nicorandil|nicorandil|mesh-list
6630649|NCT01331902|Adenosine|adenosine|mesh-list
6630650|NCT01331902|Analgesics|analgesics|mesh-ancestor
6630651|NCT01331902|Sensory System Agents|sensory system agents|mesh-ancestor
6630652|NCT01331902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6630653|NCT01331902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630654|NCT01331902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6630655|NCT01331902|Vasodilator Agents|vasodilator agents|mesh-ancestor
6630656|NCT01331902|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6630657|NCT01331902|Purinergic Agonists|purinergic agonists|mesh-ancestor
6630658|NCT01331902|Purinergic Agents|purinergic agents|mesh-ancestor
6630659|NCT01331902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6630660|NCT01331902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630661|NCT01331902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6630662|NCT01331902|Vitamin B Complex|vitamin b complex|mesh-ancestor
6630663|NCT01331902|Vitamins|vitamins|mesh-ancestor
6630664|NCT01331902|Micronutrients|micronutrients|mesh-ancestor
6662643|NCT01504178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6662644|NCT01504178|Dopamine Agonists|dopamine agonists|mesh-ancestor
6662645|NCT01504256|Leucovorin|leucovorin|mesh-list
6662646|NCT01504256|Docetaxel|docetaxel|mesh-list
6662647|NCT01504256|Fluorouracil|fluorouracil|mesh-list
6662648|NCT01504256|Oxaliplatin|oxaliplatin|mesh-list
6662649|NCT01504256|Catumaxomab|catumaxomab|mesh-list
6662650|NCT01504256|Antibodies, Bispecific|antibodies, bispecific|mesh-list
6662651|NCT01504256|Levoleucovorin|levoleucovorin|mesh-list
6662652|NCT01504256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6662653|NCT01504256|Tubulin Modulators|tubulin modulators|mesh-ancestor
6662654|NCT01504256|Antimitotic Agents|antimitotic agents|mesh-ancestor
6662655|NCT01504256|Mitosis Modulators|mitosis modulators|mesh-ancestor
6662656|NCT01504256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662657|NCT01504256|Antimetabolites|antimetabolites|mesh-ancestor
6662658|NCT01504256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6662659|NCT01504256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6662660|NCT01504256|Immunologic Factors|immunologic factors|mesh-ancestor
6662661|NCT01504256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662662|NCT01504256|Antidotes|antidotes|mesh-ancestor
6662663|NCT01504256|Protective Agents|protective agents|mesh-ancestor
6662664|NCT01504256|Vitamin B Complex|vitamin b complex|mesh-ancestor
6662665|NCT01504256|Vitamins|vitamins|mesh-ancestor
6662666|NCT01504256|Micronutrients|micronutrients|mesh-ancestor
6662667|NCT01504256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6662668|NCT01504282|Mitomycins|mitomycins|mesh-list
6662669|NCT01504282|Mitomycin|mitomycin|mesh-list
6662670|NCT01504282|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6662671|NCT01504282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6662672|NCT01504282|Alkylating Agents|alkylating agents|mesh-ancestor
6630665|NCT01331928|Docetaxel|docetaxel|mesh-list
6630666|NCT01331928|Capecitabine|capecitabine|mesh-list
6630667|NCT01331928|Oxaliplatin|oxaliplatin|mesh-list
6630668|NCT01331928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6630669|NCT01331928|Tubulin Modulators|tubulin modulators|mesh-ancestor
6630670|NCT01331928|Antimitotic Agents|antimitotic agents|mesh-ancestor
6630671|NCT01331928|Mitosis Modulators|mitosis modulators|mesh-ancestor
6630672|NCT01331928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630673|NCT01331928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6630674|NCT01331928|Antimetabolites|antimetabolites|mesh-ancestor
6630675|NCT01331941|Paclitaxel|paclitaxel|mesh-list
6630676|NCT01331941|Trebananib|trebananib|mesh-list
6630677|NCT01331941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6630678|NCT01331941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6630679|NCT01331941|Tubulin Modulators|tubulin modulators|mesh-ancestor
6630680|NCT01331941|Antimitotic Agents|antimitotic agents|mesh-ancestor
6630681|NCT01331941|Mitosis Modulators|mitosis modulators|mesh-ancestor
6630682|NCT01331941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630683|NCT01331941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6630684|NCT01331941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6630685|NCT01331941|Growth Substances|growth substances|mesh-ancestor
6630686|NCT01331941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481727|NCT04865939|Antiviral Agents|antiviral agents|mesh-ancestor
5481728|NCT04865939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5481729|NCT04865939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5481730|NCT04865939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5481731|NCT04865939|Immunologic Factors|immunologic factors|mesh-ancestor
5481732|NCT04865939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481733|NCT04831892|Isosorbide|isosorbide|mesh-list
5481734|NCT04831892|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
5481735|NCT04831892|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
5481736|NCT04831892|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6020954|NCT00395512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020955|NCT00395629|Deferasirox|deferasirox|mesh-list
6020956|NCT00395629|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6020957|NCT00395629|Chelating Agents|chelating agents|mesh-ancestor
6020958|NCT00395629|Sequestering Agents|sequestering agents|mesh-ancestor
6020959|NCT00395629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020960|NCT00395694|Lamotrigine|lamotrigine|mesh-list
6020961|NCT00395694|Anticonvulsants|anticonvulsants|mesh-ancestor
6020962|NCT00395694|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6020963|NCT00395694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6020964|NCT00395694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020965|NCT00395694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6020966|NCT00395694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020967|NCT00395694|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6020968|NCT00395694|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6020969|NCT00395694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6020970|NCT00395694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6020971|NCT00395694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6020972|NCT00395746|Liraglutide|liraglutide|mesh-list
6020973|NCT00395746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6020974|NCT00395746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6020975|NCT00395746|Incretins|incretins|mesh-ancestor
6020976|NCT00395746|Hormones|hormones|mesh-ancestor
6451759|NCT00413452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451760|NCT00413452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6451761|NCT00413452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6451762|NCT00413452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6451763|NCT00413452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6451764|NCT00413452|Immunologic Factors|immunologic factors|mesh-ancestor
6451765|NCT00413504|PENTA|penta|mesh-list
6451766|NCT00413504|Fondaparinux|fondaparinux|mesh-list
6451767|NCT00413504|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6451768|NCT00413504|Antithrombins|antithrombins|mesh-ancestor
6451769|NCT00413504|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6451770|NCT00413504|Protease Inhibitors|protease inhibitors|mesh-ancestor
6451771|NCT00413504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6451772|NCT00413504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451773|NCT00413504|Anticoagulants|anticoagulants|mesh-ancestor
6451774|NCT00413504|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6451775|NCT00413504|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6630687|NCT01331941|Growth Inhibitors|growth inhibitors|mesh-ancestor
6630688|NCT01331967|Pioglitazone|pioglitazone|mesh-list
5481737|NCT04831892|Diuretics|diuretics|mesh-ancestor
6451776|NCT00413608|Clopidogrel|clopidogrel|mesh-list
6451777|NCT00413608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5481738|NCT04831892|Natriuretic Agents|natriuretic agents|mesh-ancestor
6630689|NCT01331967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6630690|NCT01331967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630691|NCT01331993|Naproxen|naproxen|mesh-list
6630692|NCT01331993|Esomeprazole|esomeprazole|mesh-list
6630693|NCT01331993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6630694|NCT01331993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6630695|NCT01331993|Analgesics|analgesics|mesh-ancestor
6630696|NCT01331993|Sensory System Agents|sensory system agents|mesh-ancestor
6630697|NCT01331993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6630698|NCT01331993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630699|NCT01331993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6630700|NCT01331993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6630701|NCT01331993|Gout Suppressants|gout suppressants|mesh-ancestor
6630702|NCT01331993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6630703|NCT01331993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6630704|NCT01331993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630705|NCT01331993|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6630706|NCT01331993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6630707|NCT01331993|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6630708|NCT01332097|Prednisone|prednisone|mesh-list
6451778|NCT00413608|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6451779|NCT00413608|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6451780|NCT00413608|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6451781|NCT00413608|Purinergic Agents|purinergic agents|mesh-ancestor
6451782|NCT00413608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6451783|NCT00413608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451784|NCT00413608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451785|NCT00413686|Gemcitabine|gemcitabine|mesh-list
6451786|NCT00413686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6451787|NCT00413686|Antimetabolites|antimetabolites|mesh-ancestor
6630709|NCT01332097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6630710|NCT01332097|Glucocorticoids|glucocorticoids|mesh-ancestor
6630711|NCT01332097|Hormones|hormones|mesh-ancestor
6630712|NCT01332097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6630713|NCT01332097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630714|NCT01332097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6630715|NCT01332097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6630716|NCT01332201|Tacrolimus|tacrolimus|mesh-list
6630717|NCT01332201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6630718|NCT01332201|Immunologic Factors|immunologic factors|mesh-ancestor
6630719|NCT01332201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630720|NCT01332201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6630721|NCT01332201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6630722|NCT01332201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630723|NCT01332279|Everolimus|everolimus|mesh-list
6630724|NCT01332279|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6630725|NCT01332279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6630726|NCT01332279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6630727|NCT01332279|Immunologic Factors|immunologic factors|mesh-ancestor
6630728|NCT01332279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630729|NCT01332279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5481739|NCT04831892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481740|NCT04831892|Vasodilator Agents|vasodilator agents|mesh-ancestor
5481741|NCT04831892|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5481742|NCT04831892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502382|NCT04466917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502383|NCT04466917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5502384|NCT04466917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5502385|NCT04466917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6451788|NCT00413686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630730|NCT01332279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6630731|NCT01332279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630732|NCT01332344|Fluticasone|fluticasone|mesh-list
6020977|NCT00395746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6020978|NCT00395850|Disulfiram|disulfiram|mesh-list
6020979|NCT00395850|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6020980|NCT00395850|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
6020981|NCT00395850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6020982|NCT00395850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6020983|NCT00395876|Tenecteplase|tenecteplase|mesh-list
6020984|NCT00395876|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6020985|NCT00395876|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6020986|NCT00395876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630733|NCT01332344|Xhance|xhance|mesh-list
6630734|NCT01332344|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6630735|NCT01332344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6630736|NCT01332344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6630737|NCT01332344|Autonomic Agents|autonomic agents|mesh-ancestor
5481743|NCT04761627|Ustekinumab|ustekinumab|mesh-list
5481744|NCT04761627|Dermatologic Agents|dermatologic agents|mesh-ancestor
5481745|NCT04761614|Calcium, Dietary|calcium, dietary|mesh-list
6630738|NCT01332344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6630739|NCT01332344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630740|NCT01332344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6630741|NCT01332344|Respiratory System Agents|respiratory system agents|mesh-ancestor
6630742|NCT01332344|Dermatologic Agents|dermatologic agents|mesh-ancestor
6630743|NCT01332344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6630744|NCT01332344|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6630745|NCT01332344|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6630746|NCT01332344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6630747|NCT01332344|Adrenergic Agents|adrenergic agents|mesh-ancestor
6630748|NCT01332344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6630749|NCT01332344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630750|NCT01332370|Metformin|metformin|mesh-list
6630751|NCT01332370|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6630752|NCT01332370|Rosiglitazone|rosiglitazone|mesh-list
6630753|NCT01332370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5481746|NCT04761614|Leucovorin|leucovorin|mesh-list
5481747|NCT04761614|Folic Acid|folic acid|mesh-list
5481748|NCT04761614|Bevacizumab|bevacizumab|mesh-list
5481749|NCT04761614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5481750|NCT04761614|Fluorouracil|fluorouracil|mesh-list
5481751|NCT04761614|Oxaliplatin|oxaliplatin|mesh-list
5481752|NCT04761614|Riluzole|riluzole|mesh-list
5481753|NCT04761614|Endothelial Growth Factors|endothelial growth factors|mesh-list
5481754|NCT04761614|Antibodies|antibodies|mesh-list
5481755|NCT04761614|Immunoglobulins|immunoglobulins|mesh-list
5481756|NCT04761614|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5481757|NCT04761614|Immunoglobulin G|immunoglobulin g|mesh-list
5481758|NCT04761614|Calcium|calcium|mesh-list
5481759|NCT04761614|Levoleucovorin|levoleucovorin|mesh-list
5481760|NCT04761614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5481761|NCT04761614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5481762|NCT04761614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5481763|NCT04761614|Growth Substances|growth substances|mesh-ancestor
5481764|NCT04761614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481765|NCT04761614|Growth Inhibitors|growth inhibitors|mesh-ancestor
5481766|NCT04761614|Immunologic Factors|immunologic factors|mesh-ancestor
5481767|NCT04761614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5481768|NCT04761614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5481769|NCT04761614|Antimetabolites|antimetabolites|mesh-ancestor
6630754|NCT01332370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630755|NCT01332370|Incretins|incretins|mesh-ancestor
6630756|NCT01332370|Hormones|hormones|mesh-ancestor
6630757|NCT01332370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6630758|NCT01332370|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5481770|NCT04761614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481771|NCT04761614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5481772|NCT04761614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6630759|NCT01332370|Protease Inhibitors|protease inhibitors|mesh-ancestor
6630760|NCT01332370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6630761|NCT01332370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630762|NCT01332383|Naratriptan|naratriptan|mesh-list
6630763|NCT01332383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6630764|NCT01332383|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6630765|NCT01332383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6630766|NCT01332383|Serotonin Agents|serotonin agents|mesh-ancestor
6630767|NCT01332383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6630768|NCT01332383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630769|NCT01332383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630770|NCT01332396|Lapatinib|lapatinib|mesh-list
6630771|NCT01332396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6630772|NCT01332396|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6630773|NCT01332396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6630774|NCT01332396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630775|NCT01332409|Fluticasone|fluticasone|mesh-list
6630776|NCT01332409|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6630777|NCT01332409|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6630778|NCT01332409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6630779|NCT01332409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6630780|NCT01332409|Autonomic Agents|autonomic agents|mesh-ancestor
6630781|NCT01332409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6630782|NCT01332409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630783|NCT01332409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6630784|NCT01332409|Respiratory System Agents|respiratory system agents|mesh-ancestor
6630785|NCT01332409|Dermatologic Agents|dermatologic agents|mesh-ancestor
6630786|NCT01332409|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6630787|NCT01332409|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6630788|NCT01332409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6630789|NCT01332409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6630790|NCT01332409|Adrenergic Agents|adrenergic agents|mesh-ancestor
6630791|NCT01332409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6630792|NCT01332409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630793|NCT01332409|Glucocorticoids|glucocorticoids|mesh-ancestor
6630794|NCT01332409|Hormones|hormones|mesh-ancestor
6630795|NCT01332409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6630796|NCT01332409|Sympathomimetics|sympathomimetics|mesh-ancestor
6630797|NCT01332422|Fluticasone|fluticasone|mesh-list
6630798|NCT01332422|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6630799|NCT01332422|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6630800|NCT01332422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6630801|NCT01332422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6630802|NCT01332422|Autonomic Agents|autonomic agents|mesh-ancestor
6630803|NCT01332422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6630804|NCT01332422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630805|NCT01332422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6630806|NCT01332422|Respiratory System Agents|respiratory system agents|mesh-ancestor
6630807|NCT01332422|Dermatologic Agents|dermatologic agents|mesh-ancestor
6630808|NCT01332422|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6630809|NCT01332422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6630810|NCT01332422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6630811|NCT01332422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6630812|NCT01332422|Adrenergic Agents|adrenergic agents|mesh-ancestor
6630813|NCT01332422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6630814|NCT01332422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630815|NCT01332422|Glucocorticoids|glucocorticoids|mesh-ancestor
6630816|NCT01332422|Hormones|hormones|mesh-ancestor
6630817|NCT01332422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6630818|NCT01332422|Sympathomimetics|sympathomimetics|mesh-ancestor
6630819|NCT01332448|Orlistat|orlistat|mesh-list
6630820|NCT01332448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6630821|NCT01332448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630822|NCT01332448|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6630823|NCT01332448|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6630824|NCT01332552|Ritonavir|ritonavir|mesh-list
6630825|NCT01332552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6630826|NCT01332552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6630827|NCT01332552|Protease Inhibitors|protease inhibitors|mesh-ancestor
6630828|NCT01332552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6630829|NCT01332552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630830|NCT01332552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6630831|NCT01332552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6630832|NCT01332552|Antiviral Agents|antiviral agents|mesh-ancestor
6630833|NCT01332552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6630834|NCT01332552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6630835|NCT01332552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6630836|NCT01332565|Dolutegravir|dolutegravir|mesh-list
6630837|NCT01332565|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6630838|NCT01332565|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6630839|NCT01332565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6630840|NCT01332565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630841|NCT01332565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6630842|NCT01332565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6630843|NCT01332565|Antiviral Agents|antiviral agents|mesh-ancestor
6630844|NCT01332565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6630845|NCT01332604|Bevacizumab|bevacizumab|mesh-list
6630846|NCT01332604|Capecitabine|capecitabine|mesh-list
6630847|NCT01332604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6630848|NCT01332604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6630849|NCT01332604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6630850|NCT01332604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6630851|NCT01332604|Growth Substances|growth substances|mesh-ancestor
6630852|NCT01332604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630853|NCT01332604|Growth Inhibitors|growth inhibitors|mesh-ancestor
6630854|NCT01332604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6630855|NCT01332604|Antimetabolites|antimetabolites|mesh-ancestor
6630856|NCT01332604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481773|NCT04761614|Antidotes|antidotes|mesh-ancestor
5481774|NCT04761614|Protective Agents|protective agents|mesh-ancestor
5481775|NCT04761614|Vitamin B Complex|vitamin b complex|mesh-ancestor
5481776|NCT04761614|Vitamins|vitamins|mesh-ancestor
5481777|NCT04761614|Micronutrients|micronutrients|mesh-ancestor
5481778|NCT04761614|Hematinics|hematinics|mesh-ancestor
5481779|NCT04761614|Anticonvulsants|anticonvulsants|mesh-ancestor
5481780|NCT04761614|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5481781|NCT04761614|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5481782|NCT04761614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5481783|NCT04761614|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5481784|NCT04713592|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5481785|NCT04713592|Immunologic Factors|immunologic factors|mesh-ancestor
5481786|NCT04713592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481787|NCT04694248|Aspirin|aspirin|mesh-list
5481788|NCT04694248|Rivaroxaban|rivaroxaban|mesh-list
5481789|NCT04694248|Anticoagulants|anticoagulants|mesh-list
5481790|NCT04694248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5481791|NCT04694248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5481792|NCT04694248|Analgesics|analgesics|mesh-ancestor
5481793|NCT04694248|Sensory System Agents|sensory system agents|mesh-ancestor
5481794|NCT04694248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5481795|NCT04694248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481796|NCT04694248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5481797|NCT04694248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5481798|NCT04694248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5481799|NCT04694248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5481800|NCT04694248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481801|NCT04694248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5481802|NCT04694248|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5481803|NCT04694248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5481804|NCT04694248|Antipyretics|antipyretics|mesh-ancestor
5481805|NCT04694248|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5481806|NCT04694248|Antithrombins|antithrombins|mesh-ancestor
5481807|NCT04694248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5481808|NCT04694248|Protease Inhibitors|protease inhibitors|mesh-ancestor
6630857|NCT01332617|Zoledronic Acid|zoledronic acid|mesh-list
6630858|NCT01332617|Methylprednisolone|methylprednisolone|mesh-list
6630859|NCT01332617|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5481809|NCT04684238|Midazolam|midazolam|mesh-list
5481810|NCT04684238|Isoflurane|isoflurane|mesh-list
5481811|NCT04684238|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5481812|NCT04684238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5481813|NCT04684238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5481814|NCT04684238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630860|NCT01332617|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6630861|NCT01332617|Prednisolone|prednisolone|mesh-list
6451789|NCT00413686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6451790|NCT00413686|Antiviral Agents|antiviral agents|mesh-ancestor
6451791|NCT00413686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6451792|NCT00413686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6451793|NCT00413686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6451794|NCT00413686|Immunologic Factors|immunologic factors|mesh-ancestor
6451795|NCT00413686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451796|NCT00413699|Tofacitinib|tofacitinib|mesh-list
6451797|NCT00413699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6451798|NCT00413699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6451799|NCT00413699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451800|NCT00413712|Adenosine|adenosine|mesh-list
6451801|NCT00413712|Calcium Channel Blockers|calcium channel blockers|mesh-list
6451802|NCT00413712|Calcium|calcium|mesh-list
6451803|NCT00413712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6451804|NCT00413712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451805|NCT00413712|Analgesics|analgesics|mesh-ancestor
6451806|NCT00413712|Sensory System Agents|sensory system agents|mesh-ancestor
6451807|NCT00413712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6451808|NCT00413712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6451809|NCT00413712|Vasodilator Agents|vasodilator agents|mesh-ancestor
6451810|NCT00413712|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6630862|NCT01332617|Prednisolone acetate|prednisolone acetate|mesh-list
6630863|NCT01332617|Diclofenac|diclofenac|mesh-list
6630864|NCT01332617|Bortezomib|bortezomib|mesh-list
6630865|NCT01332617|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6630866|NCT01332617|Simvastatin|simvastatin|mesh-list
6630867|NCT01332617|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6630868|NCT01332617|Prednisolone phosphate|prednisolone phosphate|mesh-list
6630869|NCT01332617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6630870|NCT01332617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6630871|NCT01332617|Antiemetics|antiemetics|mesh-ancestor
6630872|NCT01332617|Autonomic Agents|autonomic agents|mesh-ancestor
6630873|NCT01332617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6630874|NCT01332617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630875|NCT01332617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6630876|NCT01332617|Glucocorticoids|glucocorticoids|mesh-ancestor
6630877|NCT01332617|Hormones|hormones|mesh-ancestor
6630878|NCT01332617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6630879|NCT01332617|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6630880|NCT01332617|Protective Agents|protective agents|mesh-ancestor
6630881|NCT01332617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6630882|NCT01332617|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6630883|NCT01332617|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6630884|NCT01332617|Antimetabolites|antimetabolites|mesh-ancestor
6630885|NCT01332617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630886|NCT01332617|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5481815|NCT04684238|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5481816|NCT04684238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5481817|NCT04684238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5481818|NCT04684238|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5481819|NCT04684238|Anesthetics, General|anesthetics, general|mesh-ancestor
5481820|NCT04684238|Anesthetics|anesthetics|mesh-ancestor
6630887|NCT01332617|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6630888|NCT01332617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6630889|NCT01332617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6630890|NCT01332617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6020987|NCT00395967|Plerixafor|plerixafor|mesh-list
6020988|NCT00395967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6020989|NCT00395967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6020990|NCT00395967|Antiviral Agents|antiviral agents|mesh-ancestor
6020991|NCT00395967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6020992|NCT00396006|Protease Inhibitors|protease inhibitors|mesh-list
6020993|NCT00396006|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
6020994|NCT00396006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6020995|NCT00396006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630891|NCT01332617|Analgesics|analgesics|mesh-ancestor
6630892|NCT01332617|Sensory System Agents|sensory system agents|mesh-ancestor
6630893|NCT01332617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6630894|NCT01332617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6630895|NCT01332617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6630896|NCT01332617|Alkylating Agents|alkylating agents|mesh-ancestor
6630897|NCT01332617|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6630898|NCT01332734|Magnesium Sulfate|magnesium sulfate|mesh-list
5481821|NCT04684238|GABA Modulators|gaba modulators|mesh-ancestor
6020996|NCT00396006|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6630899|NCT01332734|Analgesics|analgesics|mesh-ancestor
6630900|NCT01332734|Sensory System Agents|sensory system agents|mesh-ancestor
6630901|NCT01332734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6630902|NCT01332734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630903|NCT01332734|Anesthetics|anesthetics|mesh-ancestor
6630904|NCT01332734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6630905|NCT01332734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6630906|NCT01332734|Anticonvulsants|anticonvulsants|mesh-ancestor
6630907|NCT01332734|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6630908|NCT01332734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6630909|NCT01332734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630910|NCT01332734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6630911|NCT01332734|Tocolytic Agents|tocolytic agents|mesh-ancestor
6630912|NCT01332734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6630913|NCT01332747|Atorvastatin|atorvastatin|mesh-list
6630914|NCT01332747|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6630915|NCT01332747|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6630916|NCT01332747|Antimetabolites|antimetabolites|mesh-ancestor
6630917|NCT01332747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630918|NCT01332747|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6630919|NCT01332747|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6630920|NCT01332747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6630921|NCT01332786|Tigecycline|tigecycline|mesh-list
6630922|NCT01332786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6630923|NCT01332786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6630924|NCT01332786|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6630925|NCT01332786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6630926|NCT01332786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630927|NCT01332929|Bevacizumab|bevacizumab|mesh-list
6630928|NCT01332929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6630929|NCT01332929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6630930|NCT01332929|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6630931|NCT01332929|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6630932|NCT01332929|Growth Substances|growth substances|mesh-ancestor
6630933|NCT01332929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630934|NCT01332929|Growth Inhibitors|growth inhibitors|mesh-ancestor
6630935|NCT01332955|Ribavirin|ribavirin|mesh-list
6630936|NCT01332955|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6630937|NCT01332955|Antimetabolites|antimetabolites|mesh-ancestor
6630938|NCT01332955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630939|NCT01332955|Antiviral Agents|antiviral agents|mesh-ancestor
6630940|NCT01332955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6630941|NCT01333085|Paclitaxel|paclitaxel|mesh-list
6630942|NCT01333085|Carboplatin|carboplatin|mesh-list
6630943|NCT01333085|Everolimus|everolimus|mesh-list
6630944|NCT01333085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6630945|NCT01333085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6630946|NCT01333085|Tubulin Modulators|tubulin modulators|mesh-ancestor
6630947|NCT01333085|Antimitotic Agents|antimitotic agents|mesh-ancestor
6630948|NCT01333085|Mitosis Modulators|mitosis modulators|mesh-ancestor
6630949|NCT01333085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630950|NCT01333085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6630951|NCT01333085|Immunologic Factors|immunologic factors|mesh-ancestor
6630952|NCT01333085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630953|NCT01333124|Gemcitabine|gemcitabine|mesh-list
6630954|NCT01333124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6630955|NCT01333124|Antimetabolites|antimetabolites|mesh-ancestor
6630956|NCT01333124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630957|NCT01333124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6630958|NCT01333124|Antiviral Agents|antiviral agents|mesh-ancestor
6630959|NCT01333124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6630960|NCT01333124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6630961|NCT01333124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6630962|NCT01333124|Immunologic Factors|immunologic factors|mesh-ancestor
6630963|NCT01333124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630964|NCT01333137|Gemcitabine|gemcitabine|mesh-list
6630965|NCT01333137|Carboplatin|carboplatin|mesh-list
6630966|NCT01333137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6630967|NCT01333137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6630968|NCT01333137|Antimetabolites|antimetabolites|mesh-ancestor
6630969|NCT01333137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630970|NCT01333137|Antiviral Agents|antiviral agents|mesh-ancestor
6630971|NCT01333137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5481822|NCT04684238|GABA Agents|gaba agents|mesh-ancestor
5481823|NCT04684238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5481824|NCT04684238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481825|NCT04684238|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5481826|NCT04650152|Fenofibrate|fenofibrate|mesh-list
5481827|NCT04650152|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5481828|NCT04650152|Antimetabolites|antimetabolites|mesh-ancestor
5481829|NCT04650152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481830|NCT04650152|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5481831|NCT04631601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5481832|NCT04631601|Androgens|androgens|mesh-list
5481833|NCT04631601|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
5481834|NCT04631601|Hormones|hormones|mesh-ancestor
5481835|NCT04631601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5481836|NCT04631601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481837|NCT04631601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481838|NCT04631601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5481839|NCT04631601|Androgen Antagonists|androgen antagonists|mesh-ancestor
5481840|NCT04631601|Hormone Antagonists|hormone antagonists|mesh-ancestor
5481841|NCT04623216|Azacitidine|azacitidine|mesh-list
5481842|NCT04623216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6630972|NCT01333137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6630973|NCT01333137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6630974|NCT01333137|Immunologic Factors|immunologic factors|mesh-ancestor
6630975|NCT01333137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630976|NCT01333150|Propranolol|propranolol|mesh-list
6630977|NCT01333150|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6630978|NCT01333150|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6630979|NCT01333150|Adrenergic Agents|adrenergic agents|mesh-ancestor
6630980|NCT01333150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6630981|NCT01333150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630982|NCT01333150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630983|NCT01333150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6630984|NCT01333150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6630985|NCT01333150|Vasodilator Agents|vasodilator agents|mesh-ancestor
6630986|NCT01333267|Hormones|hormones|mesh-list
6630987|NCT01333267|Testosterone Congeners|testosterone congeners|mesh-list
6630988|NCT01333267|Parathyroid Hormone|parathyroid hormone|mesh-list
6630989|NCT01333267|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
6630990|NCT01333267|Anabolic Agents|anabolic agents|mesh-list
6630991|NCT01333267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6630992|NCT01333267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6630993|NCT01333267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6630994|NCT01333332|Capecitabine|capecitabine|mesh-list
6630995|NCT01333332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6630996|NCT01333332|Antimetabolites|antimetabolites|mesh-ancestor
6630997|NCT01333332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6630998|NCT01333332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6630999|NCT01333358|Alemtuzumab|alemtuzumab|mesh-list
6631000|NCT01333358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6631001|NCT01333358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6631002|NCT01333410|Mometasone Furoate|mometasone furoate|mesh-list
6631003|NCT01333410|Tacrolimus|tacrolimus|mesh-list
6631004|NCT01333410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6631005|NCT01333410|Immunologic Factors|immunologic factors|mesh-ancestor
6631006|NCT01333410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631007|NCT01333410|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6631008|NCT01333410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6631009|NCT01333410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631010|NCT01333410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6631011|NCT01333410|Dermatologic Agents|dermatologic agents|mesh-ancestor
6631012|NCT01333410|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6631013|NCT01333423|Roscovitine|roscovitine|mesh-list
6631014|NCT01333423|Doxorubicin|doxorubicin|mesh-list
6631015|NCT01333423|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6631016|NCT01333423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6631017|NCT01333423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6631018|NCT01333423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6631019|NCT01333423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6631020|NCT01333423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6631021|NCT01333423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631022|NCT01333423|Antiviral Agents|antiviral agents|mesh-ancestor
6631023|NCT01333423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6631024|NCT01333423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6631025|NCT01333449|Decitabine|decitabine|mesh-list
6631026|NCT01333449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6631027|NCT01333449|Antimetabolites|antimetabolites|mesh-ancestor
6631028|NCT01333449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631029|NCT01333449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6631030|NCT01333449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6631031|NCT01333514|Insulin Aspart|insulin aspart|mesh-list
6631032|NCT01333514|Insulin, Long-Acting|insulin, long-acting|mesh-list
6631033|NCT01333514|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6631034|NCT01333514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6631035|NCT01333514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631036|NCT01333631|Valproic Acid|valproic acid|mesh-list
6631037|NCT01333631|Anticonvulsants|anticonvulsants|mesh-ancestor
6631038|NCT01333631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6631039|NCT01333631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631040|NCT01333631|GABA Agents|gaba agents|mesh-ancestor
6631041|NCT01333631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6631042|NCT01333631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631043|NCT01333631|Antimanic Agents|antimanic agents|mesh-ancestor
6631044|NCT01333631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6631045|NCT01333631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6631046|NCT01333631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6631047|NCT01333670|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6631048|NCT01333696|Pemetrexed|pemetrexed|mesh-list
6631049|NCT01333696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6631050|NCT01333696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6631051|NCT01333696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631052|NCT01333696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6631053|NCT01333696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6631054|NCT01333709|Folfirinox|folfirinox|mesh-list
6631055|NCT01333709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6631056|NCT01333774|Acarbose|acarbose|mesh-list
6631057|NCT01333774|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6631058|NCT01333774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6631059|NCT01333774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631060|NCT01333774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6631061|NCT01333774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662673|NCT01504282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662674|NCT01504282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6662675|NCT01504282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6662676|NCT01504295|Metadoxine|metadoxine|mesh-list
6662677|NCT01504295|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6662678|NCT01504321|Moxonidine|moxonidine|mesh-list
6662679|NCT01504321|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6662680|NCT01504334|Pirfenidone|pirfenidone|mesh-list
6662681|NCT01504334|Analgesics|analgesics|mesh-ancestor
6662682|NCT01504334|Sensory System Agents|sensory system agents|mesh-ancestor
6662683|NCT01504334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6662684|NCT01504334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662685|NCT01504334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6662686|NCT01504334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6662687|NCT01504334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6451811|NCT00413712|Purinergic Agonists|purinergic agonists|mesh-ancestor
6451812|NCT00413712|Purinergic Agents|purinergic agents|mesh-ancestor
6451813|NCT00413712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6451814|NCT00413712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451815|NCT00413712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6662688|NCT01504334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6662689|NCT01504334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5481843|NCT04623216|Antimetabolites|antimetabolites|mesh-ancestor
5481844|NCT04623216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451816|NCT00413738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
6451817|NCT00413738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6451818|NCT00413751|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6451819|NCT00413751|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6451820|NCT00413751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6451821|NCT00413751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6451822|NCT00413751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6451823|NCT00413751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6631062|NCT01333800|Ciclesonide|ciclesonide|mesh-list
6631063|NCT01333800|Beclomethasone|beclomethasone|mesh-list
6631064|NCT01333800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6631065|NCT01333800|Glucocorticoids|glucocorticoids|mesh-ancestor
6631066|NCT01333800|Hormones|hormones|mesh-ancestor
6631067|NCT01333800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6631068|NCT01333800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631069|NCT01333800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6631070|NCT01333800|Respiratory System Agents|respiratory system agents|mesh-ancestor
6631071|NCT01333800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6631072|NCT01333852|Metformin|metformin|mesh-list
6631073|NCT01333852|Paclitaxel|paclitaxel|mesh-list
6631074|NCT01333852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6631075|NCT01333852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6631076|NCT01333852|Tubulin Modulators|tubulin modulators|mesh-ancestor
6631077|NCT01333852|Antimitotic Agents|antimitotic agents|mesh-ancestor
6631078|NCT01333852|Mitosis Modulators|mitosis modulators|mesh-ancestor
6631079|NCT01333852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631080|NCT01333852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5481845|NCT04623216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5481846|NCT04623216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5481847|NCT04615624|Furosemide|furosemide|mesh-list
6631081|NCT01333852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631082|NCT01333878|Abatacept|abatacept|mesh-list
6631083|NCT01333878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6631084|NCT01333878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631085|NCT01333878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6631086|NCT01333878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6631087|NCT01333878|Immunologic Factors|immunologic factors|mesh-ancestor
6631088|NCT01333878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631089|NCT01333878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6631090|NCT01333891|Nitroprusside|nitroprusside|mesh-list
6631091|NCT01333891|Phenylephrine|phenylephrine|mesh-list
6631092|NCT01333891|Oxymetazoline|oxymetazoline|mesh-list
5481848|NCT04615624|Diuretics|diuretics|mesh-ancestor
5481849|NCT04615624|Natriuretic Agents|natriuretic agents|mesh-ancestor
5481850|NCT04615624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481851|NCT04615624|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5481852|NCT04615624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5481853|NCT04615624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481854|NCT04608955|Bedaquiline|bedaquiline|mesh-list
5481855|NCT04608955|Antitubercular Agents|antitubercular agents|mesh-ancestor
5481856|NCT04608955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6631093|NCT01333891|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6631094|NCT01333891|Mydriatics|mydriatics|mesh-ancestor
6631095|NCT01333891|Autonomic Agents|autonomic agents|mesh-ancestor
6631096|NCT01333891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6631097|NCT01333891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481857|NCT04608955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5481858|NCT04579783|Triamcinolone|triamcinolone|mesh-list
5481859|NCT04579783|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5481860|NCT04579783|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5481861|NCT04579783|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5481862|NCT04579783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5481863|NCT04579783|Glucocorticoids|glucocorticoids|mesh-ancestor
5481864|NCT04579783|Hormones|hormones|mesh-ancestor
5481865|NCT04579783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5481866|NCT04579783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481867|NCT04579783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5481868|NCT04579783|Immunologic Factors|immunologic factors|mesh-ancestor
5481869|NCT04579783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6631098|NCT01333891|Sympathomimetics|sympathomimetics|mesh-ancestor
6631099|NCT01333891|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6631100|NCT01333891|Nasal Decongestants|nasal decongestants|mesh-ancestor
6631101|NCT01333891|Respiratory System Agents|respiratory system agents|mesh-ancestor
6631102|NCT01333891|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6631103|NCT01333891|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6631104|NCT01333891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6631105|NCT01333891|Adrenergic Agents|adrenergic agents|mesh-ancestor
6631106|NCT01333891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6631107|NCT01333891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631108|NCT01333891|Protective Agents|protective agents|mesh-ancestor
6631109|NCT01333891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6631110|NCT01333891|Vasodilator Agents|vasodilator agents|mesh-ancestor
5481870|NCT04579783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481871|NCT04559347|Bupivacaine|bupivacaine|mesh-list
5481872|NCT04559347|Ropivacaine|ropivacaine|mesh-list
5481873|NCT04559347|Anesthetics, Local|anesthetics, local|mesh-ancestor
5481874|NCT04559347|Anesthetics|anesthetics|mesh-ancestor
5481875|NCT04559347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5481876|NCT04559347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481877|NCT04559347|Sensory System Agents|sensory system agents|mesh-ancestor
5481878|NCT04559347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5481879|NCT04558918|Eculizumab|eculizumab|mesh-list
5481880|NCT04558918|Ravulizumab|ravulizumab|mesh-list
5481881|NCT04558918|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5481882|NCT04558918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5481883|NCT04558918|Immunologic Factors|immunologic factors|mesh-ancestor
5481884|NCT04558918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481885|NCT04557956|Trametinib|trametinib|mesh-list
5481886|NCT04557956|Dabrafenib|dabrafenib|mesh-list
5481887|NCT04557956|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
6631111|NCT01333891|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6631112|NCT01333917|Curcumin|curcumin|mesh-list
6631113|NCT01333917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6631114|NCT01333917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6631115|NCT01333917|Analgesics|analgesics|mesh-ancestor
6631116|NCT01333917|Sensory System Agents|sensory system agents|mesh-ancestor
6631117|NCT01333917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6631118|NCT01333917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631119|NCT01333917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6631120|NCT01333917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6631121|NCT01333917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6631122|NCT01333917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6631123|NCT01333917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631124|NCT01333982|Amoxicillin|amoxicillin|mesh-list
6631125|NCT01333982|Gentamicins|gentamicins|mesh-list
6631126|NCT01333982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6631127|NCT01333982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6631128|NCT01333982|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6631129|NCT01333982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6631130|NCT01333982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631131|NCT01334034|Insulin Glargine|insulin glargine|mesh-list
5481888|NCT04557956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5481889|NCT04557956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5481890|NCT04557956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5481891|NCT04557956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481892|NCT04557956|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
5481893|NCT04557956|Protective Agents|protective agents|mesh-ancestor
5481894|NCT04557956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481895|NCT04557956|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5481896|NCT04557956|Antioxidants|antioxidants|mesh-ancestor
5481897|NCT04533737|Brodalumab|brodalumab|mesh-list
5481898|NCT04533737|Dermatologic Agents|dermatologic agents|mesh-ancestor
5481899|NCT04523857|Hydroxychloroquine|hydroxychloroquine|mesh-list
5481900|NCT04523857|Antimalarials|antimalarials|mesh-ancestor
5481901|NCT04523857|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5481902|NCT04523857|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5481903|NCT04523857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6631132|NCT01334034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6631133|NCT01334034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631134|NCT01334047|Vaccines|vaccines|mesh-list
6631135|NCT01334047|Immunologic Factors|immunologic factors|mesh-ancestor
6631136|NCT01334047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631137|NCT01334060|Vaccines|vaccines|mesh-list
6631138|NCT01334060|Immunologic Factors|immunologic factors|mesh-ancestor
6631139|NCT01334060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631140|NCT01334073|Everolimus|everolimus|mesh-list
6631141|NCT01334073|Axitinib|axitinib|mesh-list
6631142|NCT01334073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6631143|NCT01334073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6631144|NCT01334073|Immunologic Factors|immunologic factors|mesh-ancestor
6631145|NCT01334073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631146|NCT01334073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6631147|NCT01334073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6631148|NCT01334073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631149|NCT01334099|Tremelimumab|tremelimumab|mesh-list
6631150|NCT01334099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5481904|NCT04523857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5481905|NCT04523857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481906|NCT04523857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5481907|NCT04455750|Leuprolide|leuprolide|mesh-list
5481908|NCT04455750|Goserelin|goserelin|mesh-list
6631151|NCT01334112|Axitinib|axitinib|mesh-list
6631152|NCT01334112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6631153|NCT01334112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6631154|NCT01334112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6631155|NCT01334112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631156|NCT01334151|Insulin|insulin|mesh-list
6631157|NCT01334151|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6631158|NCT01334151|Insulin Lispro|insulin lispro|mesh-list
6631159|NCT01334151|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6631160|NCT01334151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631161|NCT01334177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6631162|NCT01334177|Cetuximab|cetuximab|mesh-list
6631163|NCT01334177|Antibodies|antibodies|mesh-list
6631164|NCT01334177|Immunoglobulins|immunoglobulins|mesh-list
6631165|NCT01334177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6631166|NCT01334177|Immunologic Factors|immunologic factors|mesh-ancestor
6631167|NCT01334177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631168|NCT01334177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6631169|NCT01334203|Ranolazine|ranolazine|mesh-list
6631170|NCT01334203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6631171|NCT01334203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6631172|NCT01334203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631173|NCT01334268|Paclitaxel|paclitaxel|mesh-list
6631174|NCT01334268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6631175|NCT01334268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6631176|NCT01334268|Tubulin Modulators|tubulin modulators|mesh-ancestor
6631177|NCT01334268|Antimitotic Agents|antimitotic agents|mesh-ancestor
6631178|NCT01334268|Mitosis Modulators|mitosis modulators|mesh-ancestor
6631179|NCT01334268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631180|NCT01334333|Tacrolimus|tacrolimus|mesh-list
6631181|NCT01334333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6631182|NCT01334333|Immunologic Factors|immunologic factors|mesh-ancestor
6631183|NCT01334333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631184|NCT01334333|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5481909|NCT04455750|Rucaparib|rucaparib|mesh-list
5481910|NCT04455750|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5481911|NCT04455750|Fertility Agents|fertility agents|mesh-ancestor
5481912|NCT04455750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5481913|NCT04455750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481914|NCT04455750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6631185|NCT01334333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6631186|NCT01334333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631187|NCT01334424|Propofol|propofol|mesh-list
6631188|NCT01334424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6631189|NCT01334424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6631190|NCT01334424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631191|NCT01334424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6631192|NCT01334424|Anesthetics, General|anesthetics, general|mesh-ancestor
6631193|NCT01334424|Anesthetics|anesthetics|mesh-ancestor
6631194|NCT01334502|Prednisone|prednisone|mesh-list
6631195|NCT01334502|Cyclophosphamide|cyclophosphamide|mesh-list
6631196|NCT01334502|Rituximab|rituximab|mesh-list
6631197|NCT01334502|Doxorubicin|doxorubicin|mesh-list
6631198|NCT01334502|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6631199|NCT01334502|Vincristine|vincristine|mesh-list
6631200|NCT01334502|Everolimus|everolimus|mesh-list
6631201|NCT01334502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6631202|NCT01334502|Immunologic Factors|immunologic factors|mesh-ancestor
6631203|NCT01334502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631204|NCT01334502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6631205|NCT01334502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6631206|NCT01334502|Alkylating Agents|alkylating agents|mesh-ancestor
6631207|NCT01334502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631208|NCT01334502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6631209|NCT01334502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6631210|NCT01334502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6631211|NCT01334502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6631212|NCT01334502|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6631213|NCT01334502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6631214|NCT01334502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6631215|NCT01334502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6631216|NCT01334502|Glucocorticoids|glucocorticoids|mesh-ancestor
6631217|NCT01334502|Hormones|hormones|mesh-ancestor
6631218|NCT01334502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6631219|NCT01334502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6631220|NCT01334502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6631221|NCT01334502|Tubulin Modulators|tubulin modulators|mesh-ancestor
6631222|NCT01334502|Antimitotic Agents|antimitotic agents|mesh-ancestor
6631223|NCT01334502|Mitosis Modulators|mitosis modulators|mesh-ancestor
6631224|NCT01334567|Tenofovir|tenofovir|mesh-list
6631225|NCT01334567|Antiviral Agents|antiviral agents|mesh-ancestor
6631226|NCT01334567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6631227|NCT01334567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6631228|NCT01334567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6631229|NCT01334567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6631230|NCT01334567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631231|NCT01334567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6631232|NCT01334567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6631233|NCT01334580|Methadone|methadone|mesh-list
6631234|NCT01334580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6631235|NCT01334580|Narcotics|narcotics|mesh-ancestor
6631236|NCT01334580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6631237|NCT01334580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631238|NCT01334580|Analgesics|analgesics|mesh-ancestor
6631239|NCT01334580|Sensory System Agents|sensory system agents|mesh-ancestor
6631240|NCT01334580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6631241|NCT01334580|Antitussive Agents|antitussive agents|mesh-ancestor
6631242|NCT01334580|Respiratory System Agents|respiratory system agents|mesh-ancestor
6631243|NCT01334619|Ropivacaine|ropivacaine|mesh-list
6631244|NCT01334619|Anesthetics, Local|anesthetics, local|mesh-ancestor
6631245|NCT01334619|Anesthetics|anesthetics|mesh-ancestor
6631246|NCT01334619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6631247|NCT01334619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631248|NCT01334619|Sensory System Agents|sensory system agents|mesh-ancestor
6631249|NCT01334619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6631250|NCT01334632|Morphine|morphine|mesh-list
6631251|NCT01334632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6631252|NCT01334632|Narcotics|narcotics|mesh-ancestor
6631253|NCT01334632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6631254|NCT01334632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631255|NCT01334632|Analgesics|analgesics|mesh-ancestor
6631256|NCT01334632|Sensory System Agents|sensory system agents|mesh-ancestor
6631257|NCT01334632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6631258|NCT01334645|Arginine Vasopressin|arginine vasopressin|mesh-list
6631259|NCT01334645|Hemostatics|hemostatics|mesh-ancestor
6631260|NCT01334645|Coagulants|coagulants|mesh-ancestor
6631261|NCT01334645|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6631262|NCT01334645|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6631263|NCT01334645|Natriuretic Agents|natriuretic agents|mesh-ancestor
6631264|NCT01334645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631265|NCT01334671|Atorvastatin|atorvastatin|mesh-list
6631266|NCT01334671|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6631267|NCT01334671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6631268|NCT01334671|Antimetabolites|antimetabolites|mesh-ancestor
6631269|NCT01334671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631270|NCT01334671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6631271|NCT01334671|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6631272|NCT01334671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6631273|NCT01334684|Metformin|metformin|mesh-list
6631274|NCT01334684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6631275|NCT01334684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631276|NCT01334762|Letrozole|letrozole|mesh-list
6631277|NCT01334762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6631278|NCT01334762|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6631279|NCT01334762|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6631280|NCT01334762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6631281|NCT01334762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631282|NCT01334762|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6631283|NCT01334762|Hormone Antagonists|hormone antagonists|mesh-ancestor
6631284|NCT01334762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6631285|NCT01334762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631286|NCT01334879|Ranibizumab|ranibizumab|mesh-list
6631287|NCT01334879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6631288|NCT01334879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6631289|NCT01334879|Growth Substances|growth substances|mesh-ancestor
6631290|NCT01334879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631291|NCT01334879|Growth Inhibitors|growth inhibitors|mesh-ancestor
6631292|NCT01334879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6631293|NCT01334892|Cyclosporine|cyclosporine|mesh-list
6631294|NCT01334892|Cyclosporins|cyclosporins|mesh-list
6631295|NCT01334892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6631296|NCT01334892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631297|NCT01334892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6631298|NCT01334892|Immunologic Factors|immunologic factors|mesh-ancestor
6631299|NCT01334892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631300|NCT01334892|Antifungal Agents|antifungal agents|mesh-ancestor
6631301|NCT01334892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6631302|NCT01334892|Dermatologic Agents|dermatologic agents|mesh-ancestor
6631303|NCT01334892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6631304|NCT01334892|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6631305|NCT01334905|Mirabegron|mirabegron|mesh-list
6631306|NCT01334905|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6631307|NCT01334905|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6631308|NCT01334905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6631309|NCT01334905|Adrenergic Agents|adrenergic agents|mesh-ancestor
6631310|NCT01334905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6631311|NCT01334905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631312|NCT01334905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631313|NCT01334905|Urological Agents|urological agents|mesh-ancestor
6631314|NCT01335035|Deferasirox|deferasirox|mesh-list
6631315|NCT01335035|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6631316|NCT01335035|Chelating Agents|chelating agents|mesh-ancestor
6631317|NCT01335035|Sequestering Agents|sequestering agents|mesh-ancestor
6631318|NCT01335035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631319|NCT01335048|Clopidogrel|clopidogrel|mesh-list
6631320|NCT01335048|Atorvastatin|atorvastatin|mesh-list
6631321|NCT01335048|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6631322|NCT01335048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6631323|NCT01335048|Antimetabolites|antimetabolites|mesh-ancestor
6631324|NCT01335048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631325|NCT01335048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6631326|NCT01335048|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6631327|NCT01335048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6631328|NCT01335048|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6631329|NCT01335048|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6631330|NCT01335048|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6631331|NCT01335048|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6631332|NCT01335048|Purinergic Agents|purinergic agents|mesh-ancestor
6631333|NCT01335048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6631334|NCT01335048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631335|NCT01335074|Sirolimus|sirolimus|mesh-list
6631336|NCT01335074|Sorafenib|sorafenib|mesh-list
6631337|NCT01335074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6631338|NCT01335074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6631339|NCT01335074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5481915|NCT04455750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5481916|NCT04455750|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5481917|NCT04455750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5481918|NCT04455750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481919|NCT04376268|Chlorhexidine|chlorhexidine|mesh-list
5481920|NCT04376268|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5481921|NCT04376268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5481922|NCT04376268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5481923|NCT04376268|Disinfectants|disinfectants|mesh-ancestor
5481924|NCT04376268|Dermatologic Agents|dermatologic agents|mesh-ancestor
5481925|NCT04375631|Cytarabine|cytarabine|mesh-list
5481926|NCT04375631|Cyclosporine|cyclosporine|mesh-list
5481927|NCT04375631|Mycophenolic Acid|mycophenolic acid|mesh-list
5481928|NCT04375631|Cyclophosphamide|cyclophosphamide|mesh-list
5481929|NCT04375631|Mitoxantrone|mitoxantrone|mesh-list
6451824|NCT00413751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6451825|NCT00413751|Adrenergic Agents|adrenergic agents|mesh-ancestor
6451826|NCT00413751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6451827|NCT00413751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451828|NCT00413751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461881|NCT00456586|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6461882|NCT00456586|Purinergic Agents|purinergic agents|mesh-ancestor
6461883|NCT00456586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6461884|NCT00456586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461885|NCT00456586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461886|NCT00456677|Minocycline|minocycline|mesh-list
6461887|NCT00456677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6461888|NCT00456677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6461889|NCT00456716|Sorafenib|sorafenib|mesh-list
6461890|NCT00456716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6461891|NCT00456716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6631340|NCT01335074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631341|NCT01335074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6631342|NCT01335074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6631343|NCT01335074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6631344|NCT01335074|Antifungal Agents|antifungal agents|mesh-ancestor
6631345|NCT01335074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6631346|NCT01335074|Immunologic Factors|immunologic factors|mesh-ancestor
5481930|NCT04375631|Cladribine|cladribine|mesh-list
5481931|NCT04375631|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
5481932|NCT04375631|Cyclosporins|cyclosporins|mesh-list
5481933|NCT04375631|Lenograstim|lenograstim|mesh-list
5481934|NCT04375631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5481935|NCT04375631|Immunologic Factors|immunologic factors|mesh-ancestor
5481936|NCT04375631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5481937|NCT04375631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5481938|NCT04375631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5481939|NCT04375631|Alkylating Agents|alkylating agents|mesh-ancestor
5481940|NCT04375631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481941|NCT04375631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5481942|NCT04375631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5481943|NCT04375631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5481944|NCT04375631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5481945|NCT04375631|Antimetabolites|antimetabolites|mesh-ancestor
5481946|NCT04375631|Antiviral Agents|antiviral agents|mesh-ancestor
5481947|NCT04375631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6451829|NCT00413790|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6451830|NCT00413790|Darifenacin|darifenacin|mesh-list
6451831|NCT00413790|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6451832|NCT00413790|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6451833|NCT00413790|Cholinergic Agents|cholinergic agents|mesh-ancestor
6631347|NCT01335074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631348|NCT01335126|Lubricant Eye Drops|lubricant eye drops|mesh-list
6631349|NCT01335126|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6631350|NCT01335126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6631351|NCT01335139|Immunologic Factors|immunologic factors|mesh-list
6631352|NCT01335139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631353|NCT01335321|Triamcinolone|triamcinolone|mesh-list
6631354|NCT01335321|Hyaluronic Acid|hyaluronic acid|mesh-list
6631355|NCT01335321|Hylan|hylan|mesh-list
6631356|NCT01335321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6631357|NCT01335321|Glucocorticoids|glucocorticoids|mesh-ancestor
6631358|NCT01335321|Hormones|hormones|mesh-ancestor
6631359|NCT01335321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6631360|NCT01335321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631361|NCT01335321|Immunologic Factors|immunologic factors|mesh-ancestor
6631362|NCT01335321|Viscosupplements|viscosupplements|mesh-ancestor
6631363|NCT01335321|Protective Agents|protective agents|mesh-ancestor
6631364|NCT01335321|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6631365|NCT01335334|Metronidazole|metronidazole|mesh-list
6631366|NCT01335334|Tetracycline|tetracycline|mesh-list
6631367|NCT01335334|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
6631368|NCT01335334|Omeprazole|omeprazole|mesh-list
6631369|NCT01335334|Bismuth|bismuth|mesh-list
6631370|NCT01335334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6631371|NCT01335334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6631372|NCT01335334|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6631373|NCT01335334|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6631374|NCT01335334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6631375|NCT01335334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6631376|NCT01335334|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6631377|NCT01335334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6631378|NCT01335334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631379|NCT01335334|Antacids|antacids|mesh-ancestor
6631380|NCT01335334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6631381|NCT01335360|Nevirapine|nevirapine|mesh-list
6631382|NCT01335360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6631383|NCT01335360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5481948|NCT04375631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6451834|NCT00413790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6451835|NCT00413790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451836|NCT00413790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451837|NCT00413790|Urological Agents|urological agents|mesh-ancestor
6451838|NCT00413829|Ranibizumab|ranibizumab|mesh-list
6451839|NCT00413829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6631384|NCT01335360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6631385|NCT01335360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631386|NCT01335360|Antiviral Agents|antiviral agents|mesh-ancestor
6631387|NCT01335360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6631388|NCT01335360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6631389|NCT01335360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6631390|NCT01335360|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6631391|NCT01335360|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6631392|NCT01335373|Metronidazole|metronidazole|mesh-list
6631393|NCT01335373|Miconazole|miconazole|mesh-list
6631394|NCT01335373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6631395|NCT01335373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6631396|NCT01335373|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6631397|NCT01335373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6631398|NCT01335373|Antifungal Agents|antifungal agents|mesh-ancestor
6631399|NCT01335373|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6631400|NCT01335373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6631401|NCT01335373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6631402|NCT01335373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631403|NCT01335373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6631404|NCT01335373|Hormone Antagonists|hormone antagonists|mesh-ancestor
6631405|NCT01335373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6631406|NCT01335373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631407|NCT01335373|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6631408|NCT01335373|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6631409|NCT01335386|Glycerol|glycerol|mesh-list
6631410|NCT01335386|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6631411|NCT01335386|Protective Agents|protective agents|mesh-ancestor
6631412|NCT01335386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662690|NCT01504347|Vaccines|vaccines|mesh-list
6662691|NCT01504347|Immunologic Factors|immunologic factors|mesh-ancestor
6662692|NCT01504347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451840|NCT00413829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5481949|NCT04375631|Antifungal Agents|antifungal agents|mesh-ancestor
5481950|NCT04375631|Dermatologic Agents|dermatologic agents|mesh-ancestor
5481951|NCT04375631|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5481952|NCT04375631|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5481953|NCT04375631|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5481954|NCT04375631|Antitubercular Agents|antitubercular agents|mesh-ancestor
5481955|NCT04375631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5481956|NCT04375631|Analgesics|analgesics|mesh-ancestor
6662693|NCT01504386|Ropivacaine|ropivacaine|mesh-list
6662694|NCT01504386|Anesthetics, Local|anesthetics, local|mesh-ancestor
6662695|NCT01504386|Anesthetics|anesthetics|mesh-ancestor
6662696|NCT01504386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6662697|NCT01504386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662698|NCT01504386|Sensory System Agents|sensory system agents|mesh-ancestor
6662699|NCT01504386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6662700|NCT01504490|Bexarotene|bexarotene|mesh-list
6662701|NCT01504490|Efatutazone|efatutazone|mesh-list
6662702|NCT01504490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6662703|NCT01504503|Donepezil|donepezil|mesh-list
6662704|NCT01504503|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6662705|NCT01504503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6662706|NCT01504503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662707|NCT01504503|Cholinergic Agents|cholinergic agents|mesh-ancestor
6662708|NCT01504503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6662709|NCT01504503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662710|NCT01504503|Nootropic Agents|nootropic agents|mesh-ancestor
6662711|NCT01504516|Donepezil|donepezil|mesh-list
6662712|NCT01504516|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5481957|NCT04375631|Sensory System Agents|sensory system agents|mesh-ancestor
5481958|NCT04375631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5481959|NCT04375631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6451841|NCT00413829|Growth Substances|growth substances|mesh-ancestor
6451842|NCT00413829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451843|NCT00413829|Growth Inhibitors|growth inhibitors|mesh-ancestor
6451844|NCT00413829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6451845|NCT00413946|Epoetin Alfa|epoetin alfa|mesh-list
6451846|NCT00413946|Hematinics|hematinics|mesh-ancestor
6451847|NCT00414024|Tegaserod|tegaserod|mesh-list
6451848|NCT00414024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6451849|NCT00414024|Serotonin Agents|serotonin agents|mesh-ancestor
6451850|NCT00414024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6451851|NCT00414024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461892|NCT00456716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6662713|NCT01504516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6631413|NCT01335516|Terlipressin|terlipressin|mesh-list
6631414|NCT01335516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6631415|NCT01335516|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6631416|NCT01335529|Interferons|interferons|mesh-list
6631417|NCT01335529|Ribavirin|ribavirin|mesh-list
6631418|NCT01335529|Interferon-alpha|interferon-alpha|mesh-list
6631419|NCT01335529|Interferon alpha-2|interferon alpha-2|mesh-list
6631420|NCT01335529|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6631421|NCT01335529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6631422|NCT01335529|Antiviral Agents|antiviral agents|mesh-ancestor
6631423|NCT01335529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6631424|NCT01335529|Antimetabolites|antimetabolites|mesh-ancestor
6631425|NCT01335529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631426|NCT01335529|Immunologic Factors|immunologic factors|mesh-ancestor
6631427|NCT01335529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631428|NCT01335646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
6631429|NCT01335646|Analgesics|analgesics|mesh-list
6631430|NCT01335646|Sensory System Agents|sensory system agents|mesh-ancestor
6631431|NCT01335646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6631432|NCT01335646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631433|NCT01335685|Prednisone|prednisone|mesh-list
6631434|NCT01335685|Melphalan|melphalan|mesh-list
6631435|NCT01335685|Ixazomib|ixazomib|mesh-list
6631436|NCT01335685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6631437|NCT01335685|Glucocorticoids|glucocorticoids|mesh-ancestor
6631438|NCT01335685|Hormones|hormones|mesh-ancestor
6631439|NCT01335685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6631440|NCT01335685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631441|NCT01335685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6631442|NCT01335685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6631443|NCT01335685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6631444|NCT01335685|Alkylating Agents|alkylating agents|mesh-ancestor
6631445|NCT01335685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631446|NCT01335685|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6631447|NCT01335685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6631448|NCT01335685|Immunologic Factors|immunologic factors|mesh-ancestor
6631449|NCT01335685|Protease Inhibitors|protease inhibitors|mesh-ancestor
6631450|NCT01335685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6631451|NCT01335763|Insulin Glargine|insulin glargine|mesh-list
6631452|NCT01335763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6631453|NCT01335763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631454|NCT01336010|Ribavirin|ribavirin|mesh-list
6631455|NCT01336010|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6631456|NCT01336010|Antimetabolites|antimetabolites|mesh-ancestor
6631457|NCT01336010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631458|NCT01336010|Antiviral Agents|antiviral agents|mesh-ancestor
6631459|NCT01336010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6631460|NCT01336049|Nimotuzumab|nimotuzumab|mesh-list
6631461|NCT01336049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6631462|NCT01336049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6631463|NCT01336062|Paclitaxel|paclitaxel|mesh-list
6631464|NCT01336062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6631465|NCT01336062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6631466|NCT01336062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6631467|NCT01336062|Tubulin Modulators|tubulin modulators|mesh-ancestor
6631468|NCT01336062|Antimitotic Agents|antimitotic agents|mesh-ancestor
6631469|NCT01336062|Mitosis Modulators|mitosis modulators|mesh-ancestor
6631470|NCT01336062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631471|NCT01336166|Vaccines|vaccines|mesh-list
6631472|NCT01336166|Immunologic Factors|immunologic factors|mesh-ancestor
6631473|NCT01336166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631474|NCT01336192|Gemcitabine|gemcitabine|mesh-list
6631475|NCT01336192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6631476|NCT01336192|Antimetabolites|antimetabolites|mesh-ancestor
6631477|NCT01336192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631478|NCT01336192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6631479|NCT01336192|Antiviral Agents|antiviral agents|mesh-ancestor
6631480|NCT01336192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6631481|NCT01336192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6631482|NCT01336192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6631483|NCT01336192|Immunologic Factors|immunologic factors|mesh-ancestor
6631484|NCT01336192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631485|NCT01336218|Rifampin|rifampin|mesh-list
6631486|NCT01336218|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6631487|NCT01336218|Antitubercular Agents|antitubercular agents|mesh-ancestor
6631488|NCT01336218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6631489|NCT01336218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5481960|NCT04375631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5481961|NCT04345861|Azithromycin|azithromycin|mesh-list
5481962|NCT04345861|Hydroxychloroquine|hydroxychloroquine|mesh-list
5481963|NCT04345861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5481964|NCT04345861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5481965|NCT04345861|Antimalarials|antimalarials|mesh-ancestor
5481966|NCT04345861|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5481967|NCT04345861|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5481968|NCT04345861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5481969|NCT04345861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5481970|NCT04345861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5481971|NCT04278404|Metformin|metformin|mesh-list
5481972|NCT04278404|Interferons|interferons|mesh-list
5481973|NCT04278404|Ritonavir|ritonavir|mesh-list
5481974|NCT04278404|Ribavirin|ribavirin|mesh-list
5481975|NCT04278404|Lopinavir|lopinavir|mesh-list
5481976|NCT04278404|Oseltamivir|oseltamivir|mesh-list
5481977|NCT04278404|Remdesivir|remdesivir|mesh-list
5481978|NCT04278404|Azithromycin|azithromycin|mesh-list
5481979|NCT04278404|Clindamycin|clindamycin|mesh-list
5481980|NCT04278404|Meropenem|meropenem|mesh-list
6631490|NCT01336218|Leprostatic Agents|leprostatic agents|mesh-ancestor
6631491|NCT01336218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6631492|NCT01336218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6631493|NCT01336218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631494|NCT01336218|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6631495|NCT01336218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6631496|NCT01336218|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6631497|NCT01336218|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6631498|NCT01336218|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6631499|NCT01336218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6631500|NCT01336322|Metformin|metformin|mesh-list
6631501|NCT01336322|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6631502|NCT01336322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6631503|NCT01336322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631504|NCT01336322|Incretins|incretins|mesh-ancestor
6631505|NCT01336322|Hormones|hormones|mesh-ancestor
6631506|NCT01336322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6631507|NCT01336322|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6631508|NCT01336322|Protease Inhibitors|protease inhibitors|mesh-ancestor
5481981|NCT04278404|Voriconazole|voriconazole|mesh-list
5481982|NCT04278404|Ceftazidime|ceftazidime|mesh-list
5481983|NCT04278404|Cefepime|cefepime|mesh-list
5481984|NCT04278404|Fosfomycin|fosfomycin|mesh-list
5481985|NCT04278404|Cefdinir|cefdinir|mesh-list
5481986|NCT04278404|Dexamethasone|dexamethasone|mesh-list
5481987|NCT04278404|Budesonide|budesonide|mesh-list
5481988|NCT04278404|Hydrocortisone|hydrocortisone|mesh-list
5481989|NCT04278404|Colchicine|colchicine|mesh-list
6631509|NCT01336322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6631510|NCT01336322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631511|NCT01336348|Tirofiban|tirofiban|mesh-list
6631512|NCT01336348|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6631513|NCT01336348|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6631514|NCT01336348|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5481990|NCT04278404|Amiodarone|amiodarone|mesh-list
5481991|NCT04278404|Bosentan|bosentan|mesh-list
5481992|NCT04278404|Guanfacine|guanfacine|mesh-list
5481993|NCT04278404|Labetalol|labetalol|mesh-list
5481994|NCT04278404|Nicardipine|nicardipine|mesh-list
5481995|NCT04278404|Nifedipine|nifedipine|mesh-list
5481996|NCT04278404|Milrinone|milrinone|mesh-list
6631515|NCT01336348|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6631516|NCT01336348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631517|NCT01336439|Botulinum Toxins|botulinum toxins|mesh-list
6631518|NCT01336439|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6631519|NCT01336439|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6631520|NCT01336439|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6631521|NCT01336439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6631522|NCT01336439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631523|NCT01336439|Cholinergic Agents|cholinergic agents|mesh-ancestor
5481997|NCT04278404|Furosemide|furosemide|mesh-list
5481998|NCT04278404|Spironolactone|spironolactone|mesh-list
5481999|NCT04278404|Dexmedetomidine|dexmedetomidine|mesh-list
5482000|NCT04278404|Oxycodone|oxycodone|mesh-list
5482001|NCT04278404|Gabapentin|gabapentin|mesh-list
5482002|NCT04278404|Nalbuphine|nalbuphine|mesh-list
5482003|NCT04278404|Clobazam|clobazam|mesh-list
5482004|NCT04278404|Zolpidem|zolpidem|mesh-list
5482005|NCT04278404|Risperidone|risperidone|mesh-list
5482006|NCT04278404|Amphetamine|amphetamine|mesh-list
5482007|NCT04278404|Dextroamphetamine|dextroamphetamine|mesh-list
5482008|NCT04278404|Sertraline|sertraline|mesh-list
6631524|NCT01336439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6631525|NCT01336439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631526|NCT01336439|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6631527|NCT01336439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6631528|NCT01336543|Gemcitabine|gemcitabine|mesh-list
6631529|NCT01336543|Cisplatin|cisplatin|mesh-list
6631530|NCT01336543|Etoposide|etoposide|mesh-list
6631531|NCT01336543|Pemetrexed|pemetrexed|mesh-list
6631532|NCT01336543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6631533|NCT01336543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6631534|NCT01336543|Antimetabolites|antimetabolites|mesh-ancestor
6631535|NCT01336543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631536|NCT01336543|Antiviral Agents|antiviral agents|mesh-ancestor
6631537|NCT01336543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6631538|NCT01336543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6631539|NCT01336543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6631540|NCT01336543|Immunologic Factors|immunologic factors|mesh-ancestor
6631541|NCT01336543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631542|NCT01336543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6631543|NCT01336543|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6631544|NCT01336543|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6631545|NCT01336543|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6631546|NCT01336543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6631547|NCT01336582|Docetaxel|docetaxel|mesh-list
6631548|NCT01336582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6631549|NCT01336582|Tubulin Modulators|tubulin modulators|mesh-ancestor
6631550|NCT01336582|Antimitotic Agents|antimitotic agents|mesh-ancestor
6631551|NCT01336582|Mitosis Modulators|mitosis modulators|mesh-ancestor
6631552|NCT01336582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631553|NCT01336595|Cobalt|cobalt|mesh-list
6631554|NCT01336595|Triamcinolone|triamcinolone|mesh-list
6631555|NCT01336595|Trace Elements|trace elements|mesh-ancestor
6631556|NCT01336595|Micronutrients|micronutrients|mesh-ancestor
6631557|NCT01336595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631558|NCT01336595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6631559|NCT01336595|Glucocorticoids|glucocorticoids|mesh-ancestor
6631560|NCT01336595|Hormones|hormones|mesh-ancestor
6631561|NCT01336595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6631562|NCT01336621|Ezogabine|ezogabine|mesh-list
6631563|NCT01336621|Anticonvulsants|anticonvulsants|mesh-ancestor
6631564|NCT01336621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6631565|NCT01336621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631566|NCT01336660|Antivenins|antivenins|mesh-list
6631567|NCT01336660|Immunologic Factors|immunologic factors|mesh-ancestor
6631568|NCT01336660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631569|NCT01336751|Insulin|insulin|mesh-list
6631570|NCT01336751|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6631571|NCT01336751|Insulin Glargine|insulin glargine|mesh-list
6631572|NCT01336751|Insulin Lispro|insulin lispro|mesh-list
6631573|NCT01336751|Protamines|protamines|mesh-list
6631574|NCT01336751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6631575|NCT01336751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631576|NCT01336751|Heparin Antagonists|heparin antagonists|mesh-ancestor
6631577|NCT01336751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631578|NCT01336751|Coagulants|coagulants|mesh-ancestor
6631579|NCT01336829|Rilpivirine|rilpivirine|mesh-list
6631580|NCT01336829|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6631581|NCT01336829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6631582|NCT01336829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6631583|NCT01336829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631584|NCT01336829|Antiviral Agents|antiviral agents|mesh-ancestor
6631585|NCT01336829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6631586|NCT01336829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6631587|NCT01336829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6631588|NCT01336842|Pemetrexed|pemetrexed|mesh-list
6631589|NCT01336842|Panobinostat|panobinostat|mesh-list
6631590|NCT01336842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6631591|NCT01336842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6631592|NCT01336842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631593|NCT01336842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6631594|NCT01336842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6631595|NCT01336842|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6631596|NCT01336985|Irinotecan|irinotecan|mesh-list
6631597|NCT01336985|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6631598|NCT01336985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6631599|NCT01336985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6631600|NCT01336985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631601|NCT01336985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6631602|NCT01337219|Tobramycin|tobramycin|mesh-list
6631603|NCT01337219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6631604|NCT01337219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6631605|NCT01337258|Dutasteride|dutasteride|mesh-list
6631606|NCT01337258|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
5482009|NCT04278404|Tranexamic Acid|tranexamic acid|mesh-list
5482010|NCT04278404|Aminocaproic Acid|aminocaproic acid|mesh-list
5482011|NCT04278404|Terbutaline|terbutaline|mesh-list
5482012|NCT04278404|Sevelamer|sevelamer|mesh-list
5482013|NCT04278404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5482014|NCT04278404|Antiemetics|antiemetics|mesh-ancestor
5482015|NCT04278404|Autonomic Agents|autonomic agents|mesh-ancestor
5482016|NCT04278404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5482017|NCT04278404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5482018|NCT04278404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5482019|NCT04278404|Glucocorticoids|glucocorticoids|mesh-ancestor
5482020|NCT04278404|Hormones|hormones|mesh-ancestor
5482021|NCT04278404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5482022|NCT04278404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5482023|NCT04278404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5482024|NCT04278404|Protease Inhibitors|protease inhibitors|mesh-ancestor
5482025|NCT04278404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5482026|NCT04278404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5482027|NCT04278404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5482028|NCT04278404|Antiviral Agents|antiviral agents|mesh-ancestor
5482029|NCT04278404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5482030|NCT04278404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5482031|NCT04278404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5482032|NCT04278404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5482033|NCT04278404|Analgesics|analgesics|mesh-ancestor
5482034|NCT04278404|Sensory System Agents|sensory system agents|mesh-ancestor
5482035|NCT04278404|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5482036|NCT04278404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5482037|NCT04278404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5482038|NCT04278404|Adrenergic Agents|adrenergic agents|mesh-ancestor
5482039|NCT04278404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5482040|NCT04278404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5482041|NCT04278404|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5482042|NCT04278404|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6631607|NCT01337258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6631608|NCT01337258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6631609|NCT01337258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631610|NCT01337258|Hormone Antagonists|hormone antagonists|mesh-ancestor
6631611|NCT01337258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6631612|NCT01337258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662714|NCT01504516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662715|NCT01504516|Cholinergic Agents|cholinergic agents|mesh-ancestor
6662716|NCT01504516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6662717|NCT01504516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662718|NCT01504516|Nootropic Agents|nootropic agents|mesh-ancestor
6662719|NCT01504542|Vaccines|vaccines|mesh-list
6662720|NCT01504542|Immunologic Factors|immunologic factors|mesh-ancestor
6662721|NCT01504542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662722|NCT01504581|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6662723|NCT01504581|Antiviral Agents|antiviral agents|mesh-ancestor
6662724|NCT01504581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6662725|NCT01504620|Insulin|insulin|mesh-list
6662726|NCT01504620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6662727|NCT01504620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662728|NCT01504646|Lyprinol|lyprinol|mesh-list
6662729|NCT01504646|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6662730|NCT01504646|Hormone Antagonists|hormone antagonists|mesh-ancestor
6662731|NCT01504646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6662732|NCT01504646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662733|NCT01504659|Ketamine|ketamine|mesh-list
6662734|NCT01504659|Analgesics|analgesics|mesh-ancestor
6662735|NCT01504659|Sensory System Agents|sensory system agents|mesh-ancestor
6662736|NCT01504659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6662737|NCT01504659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662738|NCT01504659|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6662739|NCT01504659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6662740|NCT01504659|Anesthetics, General|anesthetics, general|mesh-ancestor
6662741|NCT01504659|Anesthetics|anesthetics|mesh-ancestor
6631613|NCT01337323|Fluticasone|fluticasone|mesh-list
6631614|NCT01337323|Xhance|xhance|mesh-list
6631615|NCT01337323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6631616|NCT01337323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6631617|NCT01337323|Autonomic Agents|autonomic agents|mesh-ancestor
6631618|NCT01337323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6631619|NCT01337323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631620|NCT01337323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6631621|NCT01337323|Respiratory System Agents|respiratory system agents|mesh-ancestor
6631622|NCT01337323|Dermatologic Agents|dermatologic agents|mesh-ancestor
6631623|NCT01337323|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6631624|NCT01337349|Pentoxifylline|pentoxifylline|mesh-list
6631625|NCT01337349|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6631626|NCT01337349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6631627|NCT01337349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631628|NCT01337349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6631629|NCT01337349|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6631630|NCT01337349|Protective Agents|protective agents|mesh-ancestor
6631631|NCT01337349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631632|NCT01337349|Vasodilator Agents|vasodilator agents|mesh-ancestor
6631633|NCT01337349|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6631634|NCT01337349|Antioxidants|antioxidants|mesh-ancestor
5482043|NCT04278404|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5482044|NCT04278404|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5482045|NCT04278404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6631635|NCT01337362|Insulin|insulin|mesh-list
6631636|NCT01337362|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6631637|NCT01337362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6631638|NCT01337362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5482046|NCT04278404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5482047|NCT04278404|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5482048|NCT04278404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5482049|NCT04278404|Antimetabolites|antimetabolites|mesh-ancestor
5482050|NCT04278404|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5482051|NCT04278404|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6631639|NCT01337375|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6631640|NCT01337375|Interferon-alpha|interferon-alpha|mesh-list
6631641|NCT01337375|Antiviral Agents|antiviral agents|mesh-ancestor
6631642|NCT01337375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6631643|NCT01337375|Immunologic Factors|immunologic factors|mesh-ancestor
6631644|NCT01337375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631645|NCT01337401|Cediranib|cediranib|mesh-list
6631646|NCT01337401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6631647|NCT01337401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6631648|NCT01337401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6631649|NCT01337401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631650|NCT01337427|Interferons|interferons|mesh-list
5482052|NCT04278404|Respiratory System Agents|respiratory system agents|mesh-ancestor
5482053|NCT04278404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5482054|NCT04278404|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5482055|NCT04278404|Hemostatics|hemostatics|mesh-ancestor
5482056|NCT04278404|Coagulants|coagulants|mesh-ancestor
6631651|NCT01337427|Interferon-beta|interferon-beta|mesh-list
6631652|NCT01337427|Interferon beta-1a|interferon beta-1a|mesh-list
6631653|NCT01337427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6631654|NCT01337427|Antiviral Agents|antiviral agents|mesh-ancestor
6631655|NCT01337427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6631656|NCT01337427|Immunologic Factors|immunologic factors|mesh-ancestor
6631657|NCT01337427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631658|NCT01337427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6631659|NCT01337440|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6631660|NCT01337440|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
6631661|NCT01337440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6631662|NCT01337440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631663|NCT01337440|Incretins|incretins|mesh-ancestor
6631664|NCT01337440|Hormones|hormones|mesh-ancestor
6631665|NCT01337440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6631666|NCT01337440|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6631667|NCT01337440|Protease Inhibitors|protease inhibitors|mesh-ancestor
6631668|NCT01337440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6631669|NCT01337440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631670|NCT01337440|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6631671|NCT01337440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6631672|NCT01337466|Fialuridine|fialuridine|mesh-list
6631673|NCT01337466|Antiviral Agents|antiviral agents|mesh-ancestor
6631674|NCT01337466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6631675|NCT01337466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6631676|NCT01337466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6631677|NCT01337466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631678|NCT01337492|Sorafenib|sorafenib|mesh-list
6631679|NCT01337492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6631680|NCT01337492|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6631681|NCT01337492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6631682|NCT01337492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631683|NCT01337518|Androgens|androgens|mesh-list
6631684|NCT01337518|Hormones|hormones|mesh-ancestor
6631685|NCT01337518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6631686|NCT01337518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631687|NCT01337557|Bepotastine besilate|bepotastine besilate|mesh-list
6631688|NCT01337557|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6631689|NCT01337570|Dapivirine|dapivirine|mesh-list
6631690|NCT01337570|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6631691|NCT01337570|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6631692|NCT01337570|Antiviral Agents|antiviral agents|mesh-ancestor
6631693|NCT01337570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6631694|NCT01337583|Dapivirine|dapivirine|mesh-list
6631695|NCT01337583|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6631696|NCT01337583|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6631697|NCT01337583|Antiviral Agents|antiviral agents|mesh-ancestor
6631698|NCT01337583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6631699|NCT01337765|Dactolisib|dactolisib|mesh-list
6631700|NCT01337765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6631701|NCT01337791|Telbivudine|telbivudine|mesh-list
6631702|NCT01337791|Antiviral Agents|antiviral agents|mesh-ancestor
6631703|NCT01337791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6631704|NCT01337791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6631705|NCT01337791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6631706|NCT01337791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631707|NCT01337804|Omeprazole|omeprazole|mesh-list
6631708|NCT01337804|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6631709|NCT01337804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6631710|NCT01337804|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6631711|NCT01337804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6631712|NCT01337804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631713|NCT01338077|Omeprazole|omeprazole|mesh-list
6631714|NCT01338077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6631715|NCT01338077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6631716|NCT01338077|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6631717|NCT01338077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6631718|NCT01338077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631719|NCT01338090|Bevacizumab|bevacizumab|mesh-list
6631720|NCT01338090|Everolimus|everolimus|mesh-list
6631721|NCT01338090|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
6631722|NCT01338090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6631723|NCT01338090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6631724|NCT01338090|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6631725|NCT01338090|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6631726|NCT01338090|Growth Substances|growth substances|mesh-ancestor
6631727|NCT01338090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631728|NCT01338090|Growth Inhibitors|growth inhibitors|mesh-ancestor
6631729|NCT01338090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6631730|NCT01338090|Immunologic Factors|immunologic factors|mesh-ancestor
6631731|NCT01338090|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6631732|NCT01338090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631733|NCT01338103|Rituximab|rituximab|mesh-list
6631734|NCT01338103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6631735|NCT01338103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6631736|NCT01338103|Immunologic Factors|immunologic factors|mesh-ancestor
6631737|NCT01338103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631738|NCT01338103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6631739|NCT01338116|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6631740|NCT01338116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6631741|NCT01338129|Ascorbic Acid|ascorbic acid|mesh-list
6631742|NCT01338129|Vitamins|vitamins|mesh-ancestor
6631743|NCT01338129|Micronutrients|micronutrients|mesh-ancestor
6631744|NCT01338129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631745|NCT01338129|Antioxidants|antioxidants|mesh-ancestor
6631746|NCT01338129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631747|NCT01338129|Protective Agents|protective agents|mesh-ancestor
6631748|NCT01338311|Albuterol|albuterol|mesh-list
6631749|NCT01338311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6631750|NCT01338311|Autonomic Agents|autonomic agents|mesh-ancestor
6631751|NCT01338311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6631752|NCT01338311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631753|NCT01338311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6631754|NCT01338311|Respiratory System Agents|respiratory system agents|mesh-ancestor
6631755|NCT01338311|Tocolytic Agents|tocolytic agents|mesh-ancestor
6631756|NCT01338311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6631757|NCT01338311|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6631758|NCT01338311|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6631759|NCT01338311|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6631760|NCT01338311|Adrenergic Agents|adrenergic agents|mesh-ancestor
6631761|NCT01338311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6631762|NCT01338311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631763|NCT01338324|Simvastatin|simvastatin|mesh-list
6631764|NCT01338324|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6631765|NCT01338324|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6631766|NCT01338324|Antimetabolites|antimetabolites|mesh-ancestor
6631767|NCT01338324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631768|NCT01338324|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6631769|NCT01338324|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6631770|NCT01338324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6631771|NCT01338337|Azacitidine|azacitidine|mesh-list
6631772|NCT01338337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6631773|NCT01338337|Antimetabolites|antimetabolites|mesh-ancestor
6631774|NCT01338337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5482057|NCT04278404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5482058|NCT04278404|Narcotics|narcotics|mesh-ancestor
5482059|NCT04278404|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5482060|NCT04278404|Serotonin Agents|serotonin agents|mesh-ancestor
5482061|NCT04278404|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5482062|NCT04278404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5482063|NCT04278404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5482064|NCT04278404|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5482065|NCT04278404|Dopamine Agents|dopamine agents|mesh-ancestor
5482066|NCT04278404|Anticonvulsants|anticonvulsants|mesh-ancestor
5482067|NCT04278404|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5482068|NCT04278404|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5482069|NCT04278404|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5482070|NCT04278404|Antimanic Agents|antimanic agents|mesh-ancestor
5482071|NCT04278404|Antidepressive Agents|antidepressive agents|mesh-ancestor
5482072|NCT04278404|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5482073|NCT04278404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5482074|NCT04278404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5482075|NCT04278404|Diuretics|diuretics|mesh-ancestor
5482076|NCT04278404|Natriuretic Agents|natriuretic agents|mesh-ancestor
5482077|NCT04278404|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5482078|NCT04278404|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5482079|NCT04278404|Hormone Antagonists|hormone antagonists|mesh-ancestor
5482080|NCT04278404|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5482081|NCT04278404|Gout Suppressants|gout suppressants|mesh-ancestor
5482082|NCT04278404|Tubulin Modulators|tubulin modulators|mesh-ancestor
5482083|NCT04278404|Antimitotic Agents|antimitotic agents|mesh-ancestor
5482084|NCT04278404|Mitosis Modulators|mitosis modulators|mesh-ancestor
5482085|NCT04278404|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5482086|NCT04278404|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5482087|NCT04278404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5482088|NCT04278404|Vasodilator Agents|vasodilator agents|mesh-ancestor
5482089|NCT04278404|Tocolytic Agents|tocolytic agents|mesh-ancestor
5482090|NCT04278404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5482091|NCT04278404|Antifungal Agents|antifungal agents|mesh-ancestor
5482092|NCT04278404|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6631775|NCT01338337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6631776|NCT01338337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6631777|NCT01338389|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
6631778|NCT01338389|Nootropic Agents|nootropic agents|mesh-ancestor
6631779|NCT01338441|Erythromycin|erythromycin|mesh-list
6631780|NCT01338441|Erythromycin Estolate|erythromycin estolate|mesh-list
5482093|NCT04278404|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5482094|NCT04278404|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5482095|NCT04278404|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6631781|NCT01338441|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
6631782|NCT01338441|Erythromycin stearate|erythromycin stearate|mesh-list
6631783|NCT01338441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6631784|NCT01338441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6631785|NCT01338441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6631786|NCT01338441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6631787|NCT01338441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6631788|NCT01338441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631789|NCT01338454|Tranexamic Acid|tranexamic acid|mesh-list
6631790|NCT01338454|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6631791|NCT01338454|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6631792|NCT01338454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631793|NCT01338454|Hemostatics|hemostatics|mesh-ancestor
6631794|NCT01338454|Coagulants|coagulants|mesh-ancestor
6631795|NCT01338558|Bevacizumab|bevacizumab|mesh-list
5482096|NCT04278404|GABA Agonists|gaba agonists|mesh-ancestor
5482097|NCT04278404|GABA Agents|gaba agents|mesh-ancestor
5482098|NCT04278404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5482099|NCT04278404|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5482100|NCT04278404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5482101|NCT04278404|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5482102|NCT04278404|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5482103|NCT04278404|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5482104|NCT04278404|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5482105|NCT04278404|Sympathomimetics|sympathomimetics|mesh-ancestor
5482106|NCT04278404|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5482107|NCT04278404|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5482108|NCT04278404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5482109|NCT04278404|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5482110|NCT04278404|Chelating Agents|chelating agents|mesh-ancestor
5482111|NCT04278404|Sequestering Agents|sequestering agents|mesh-ancestor
5482112|NCT04278404|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5482113|NCT04278404|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5482114|NCT04278404|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6451852|NCT00414024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451853|NCT00414037|Eszopiclone|eszopiclone|mesh-list
6631796|NCT01338558|Cetuximab|cetuximab|mesh-list
6631797|NCT01338558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6631798|NCT01338558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6631799|NCT01338558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6631800|NCT01338558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6631801|NCT01338558|Growth Substances|growth substances|mesh-ancestor
6631802|NCT01338558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631803|NCT01338558|Growth Inhibitors|growth inhibitors|mesh-ancestor
6631804|NCT01338675|Busulfan|busulfan|mesh-list
6631805|NCT01338675|Alkylating Agents|alkylating agents|mesh-ancestor
6631806|NCT01338675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631807|NCT01338675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6631808|NCT01338675|Immunologic Factors|immunologic factors|mesh-ancestor
6631809|NCT01338675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631810|NCT01338675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6631811|NCT01338675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6631812|NCT01338675|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6631813|NCT01338740|Adalimumab|adalimumab|mesh-list
6631814|NCT01338740|Infliximab|infliximab|mesh-list
6451854|NCT00414037|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6451855|NCT00414037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6451856|NCT00414037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451857|NCT00414089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6451858|NCT00414089|Immunologic Factors|immunologic factors|mesh-ancestor
6451859|NCT00414089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451860|NCT00414128|Mycophenolic Acid|mycophenolic acid|mesh-list
6451861|NCT00414128|Cyclophosphamide|cyclophosphamide|mesh-list
6451862|NCT00414128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6451863|NCT00414128|Immunologic Factors|immunologic factors|mesh-ancestor
6451864|NCT00414128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451865|NCT00414128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6451866|NCT00414128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6451867|NCT00414128|Alkylating Agents|alkylating agents|mesh-ancestor
6451868|NCT00414128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451869|NCT00414128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6451870|NCT00414128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6451871|NCT00414128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5482115|NCT04278404|Protective Agents|protective agents|mesh-ancestor
5482116|NCT04278404|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5482117|NCT04278404|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5482118|NCT04278404|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6631815|NCT01338740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6631816|NCT01338740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6631817|NCT01338740|Dermatologic Agents|dermatologic agents|mesh-ancestor
6631818|NCT01338740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6631819|NCT01338753|Bevacizumab|bevacizumab|mesh-list
6631820|NCT01338753|Docetaxel|docetaxel|mesh-list
6631821|NCT01338753|Doxorubicin|doxorubicin|mesh-list
6631822|NCT01338753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6631823|NCT01338753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6631824|NCT01338753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6631825|NCT01338753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6631826|NCT01338753|Growth Substances|growth substances|mesh-ancestor
6631827|NCT01338753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631828|NCT01338753|Growth Inhibitors|growth inhibitors|mesh-ancestor
6631829|NCT01338753|Tubulin Modulators|tubulin modulators|mesh-ancestor
6631830|NCT01338753|Antimitotic Agents|antimitotic agents|mesh-ancestor
6631831|NCT01338753|Mitosis Modulators|mitosis modulators|mesh-ancestor
6631832|NCT01338753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631833|NCT01338753|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6631834|NCT01338753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6631835|NCT01338753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6631836|NCT01338753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6631837|NCT01338844|Inositol|inositol|mesh-list
6631838|NCT01338844|Vitamin B Complex|vitamin b complex|mesh-ancestor
6631839|NCT01338844|Vitamins|vitamins|mesh-ancestor
6631840|NCT01338844|Micronutrients|micronutrients|mesh-ancestor
6631841|NCT01338844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631842|NCT01338896|Rotigotine|rotigotine|mesh-list
6631843|NCT01338896|Dopamine Agonists|dopamine agonists|mesh-ancestor
6631844|NCT01338896|Dopamine Agents|dopamine agents|mesh-ancestor
6631845|NCT01338896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6631846|NCT01338896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631847|NCT01338896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631848|NCT01338909|Clopidogrel|clopidogrel|mesh-list
6631849|NCT01338909|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6631850|NCT01338909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6631851|NCT01338909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6631852|NCT01338909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6631853|NCT01338909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6631854|NCT01338909|Purinergic Agents|purinergic agents|mesh-ancestor
6631855|NCT01338909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6631856|NCT01338909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631857|NCT01338909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631858|NCT01338922|Insulin|insulin|mesh-list
6631859|NCT01338922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6631860|NCT01338922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631861|NCT01339026|Clopidogrel|clopidogrel|mesh-list
6631862|NCT01339026|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6631863|NCT01339026|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6631864|NCT01339026|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6631865|NCT01339026|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6631866|NCT01339026|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6631867|NCT01339026|Purinergic Agents|purinergic agents|mesh-ancestor
6631868|NCT01339026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6631869|NCT01339026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631870|NCT01339026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631871|NCT01339039|Plerixafor|plerixafor|mesh-list
6631872|NCT01339039|Bevacizumab|bevacizumab|mesh-list
6631873|NCT01339039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6631874|NCT01339039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5482119|NCT04278404|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5482120|NCT04278404|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5482121|NCT04278404|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5482122|NCT04266379|Insulin|insulin|mesh-list
5482123|NCT04266379|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5482124|NCT04266379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5482125|NCT04266379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5482126|NCT04240093|Analgesics, Opioid|analgesics, opioid|mesh-list
5724869|NCT03184649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6631875|NCT01339039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5482127|NCT04240093|Narcotics|narcotics|mesh-ancestor
5482128|NCT04240093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5482129|NCT04240093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5482130|NCT04240093|Analgesics|analgesics|mesh-ancestor
5482131|NCT04240093|Sensory System Agents|sensory system agents|mesh-ancestor
6631876|NCT01339039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6631877|NCT01339039|Growth Substances|growth substances|mesh-ancestor
6631878|NCT01339039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631879|NCT01339039|Growth Inhibitors|growth inhibitors|mesh-ancestor
6631880|NCT01339039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6631881|NCT01339039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6631882|NCT01339039|Antiviral Agents|antiviral agents|mesh-ancestor
5482132|NCT04240093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6020997|NCT00396006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6053231|NCT00593827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053232|NCT00593827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6053233|NCT00593866|Gemcitabine|gemcitabine|mesh-list
6053234|NCT00593866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6053235|NCT00593866|Antimetabolites|antimetabolites|mesh-ancestor
6053236|NCT00593866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053237|NCT00593866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6053238|NCT00593866|Antiviral Agents|antiviral agents|mesh-ancestor
6053239|NCT00593866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6053240|NCT00593866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6053241|NCT00593866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6053242|NCT00593866|Immunologic Factors|immunologic factors|mesh-ancestor
6053243|NCT00593866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631883|NCT01339039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6631884|NCT01339065|Ketamine|ketamine|mesh-list
6631885|NCT01339065|Analgesics|analgesics|mesh-ancestor
6631886|NCT01339065|Sensory System Agents|sensory system agents|mesh-ancestor
6631887|NCT01339065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6631888|NCT01339065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631889|NCT01339065|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6631890|NCT01339065|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6631891|NCT01339065|Anesthetics, General|anesthetics, general|mesh-ancestor
6631892|NCT01339065|Anesthetics|anesthetics|mesh-ancestor
6631893|NCT01339065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6631894|NCT01339065|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6631895|NCT01339065|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6631896|NCT01339065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6631897|NCT01339065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631898|NCT01339143|Pioglitazone|pioglitazone|mesh-list
6631899|NCT01339143|Vildagliptin|vildagliptin|mesh-list
6631900|NCT01339143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6631901|NCT01339143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631902|NCT01339143|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6631903|NCT01339143|Protease Inhibitors|protease inhibitors|mesh-ancestor
6631904|NCT01339143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6054263|NCT00601965|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6054264|NCT00601965|Antidepressive Agents|antidepressive agents|mesh-ancestor
6054265|NCT00601965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6631905|NCT01339143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662742|NCT01504659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6662743|NCT01504659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6662744|NCT01504659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6662745|NCT01504659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6662746|NCT01504659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662747|NCT01504724|Bevacizumab|bevacizumab|mesh-list
6662748|NCT01504724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6662749|NCT01504724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6662750|NCT01504724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6662751|NCT01504724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6662752|NCT01504724|Growth Substances|growth substances|mesh-ancestor
6662753|NCT01504724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662754|NCT01504724|Growth Inhibitors|growth inhibitors|mesh-ancestor
6662755|NCT01504776|Bortezomib|bortezomib|mesh-list
6662756|NCT01504776|Panobinostat|panobinostat|mesh-list
6662757|NCT01504776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6662758|NCT01504776|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6662759|NCT01504776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6662760|NCT01504776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662761|NCT01504815|Cisplatin|cisplatin|mesh-list
5482151|NCT04234477|Metoprolol|metoprolol|mesh-list
5482152|NCT04234477|Verapamil|verapamil|mesh-list
6631906|NCT01339286|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6631907|NCT01339286|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6631908|NCT01339286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6631909|NCT01339286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6631910|NCT01339286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631911|NCT01339286|Adrenergic Agents|adrenergic agents|mesh-ancestor
6631912|NCT01339286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6631913|NCT01339286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631914|NCT01339312|Vaccines|vaccines|mesh-list
6631915|NCT01339312|Immunologic Factors|immunologic factors|mesh-ancestor
6631916|NCT01339312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631917|NCT01339442|Fulvestrant|fulvestrant|mesh-list
6631918|NCT01339442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6631919|NCT01339442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6631920|NCT01339442|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6631921|NCT01339442|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6631922|NCT01339442|Hormone Antagonists|hormone antagonists|mesh-ancestor
6631923|NCT01339442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6631924|NCT01339442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631925|NCT01339468|Tacrolimus|tacrolimus|mesh-list
6631926|NCT01339468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6631927|NCT01339468|Immunologic Factors|immunologic factors|mesh-ancestor
6631928|NCT01339468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631929|NCT01339468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6631930|NCT01339468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6631931|NCT01339468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631932|NCT01339481|Abatacept|abatacept|mesh-list
6631933|NCT01339481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6631934|NCT01339481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631935|NCT01339481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6631936|NCT01339481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6631937|NCT01339481|Immunologic Factors|immunologic factors|mesh-ancestor
6631938|NCT01339481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631939|NCT01339481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6631940|NCT01339572|Plerixafor|plerixafor|mesh-list
6631941|NCT01339572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6631942|NCT01339572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6631943|NCT01339572|Antiviral Agents|antiviral agents|mesh-ancestor
6631944|NCT01339572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6631945|NCT01339624|Ketorolac|ketorolac|mesh-list
6631946|NCT01339624|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6631947|NCT01339624|Fentanyl|fentanyl|mesh-list
6631948|NCT01339624|Morphine|morphine|mesh-list
6631949|NCT01339624|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6631950|NCT01339624|Narcotics|narcotics|mesh-ancestor
6631951|NCT01339624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6631952|NCT01339624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631953|NCT01339624|Analgesics|analgesics|mesh-ancestor
6631954|NCT01339624|Sensory System Agents|sensory system agents|mesh-ancestor
6631955|NCT01339624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6631956|NCT01339624|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6631957|NCT01339624|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6631958|NCT01339624|Anesthetics, General|anesthetics, general|mesh-ancestor
6631959|NCT01339624|Anesthetics|anesthetics|mesh-ancestor
6631960|NCT01339624|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6631961|NCT01339624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6631962|NCT01339624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6631963|NCT01339624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6631964|NCT01339624|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6631965|NCT01339624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6631966|NCT01339624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631967|NCT01339663|Aldesleukin|aldesleukin|mesh-list
6631968|NCT01339663|Cyclophosphamide|cyclophosphamide|mesh-list
5482153|NCT04234477|Diltiazem|diltiazem|mesh-list
5482154|NCT04234477|Calcium Channel Blockers|calcium channel blockers|mesh-list
5482155|NCT04234477|Calcium|calcium|mesh-list
5482156|NCT04234477|Esmolol|esmolol|mesh-list
5482157|NCT04234477|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
5482158|NCT04234477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5482159|NCT04234477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5482160|NCT04234477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5482161|NCT04234477|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5482162|NCT04234477|Sympatholytics|sympatholytics|mesh-ancestor
5482163|NCT04234477|Autonomic Agents|autonomic agents|mesh-ancestor
6631969|NCT01339663|Interleukin-2|interleukin-2|mesh-list
6631970|NCT01339663|Vaccines|vaccines|mesh-list
6631971|NCT01339663|Immunologic Factors|immunologic factors|mesh-ancestor
6631972|NCT01339663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631973|NCT01339663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6631974|NCT01339663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6631975|NCT01339663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6631976|NCT01339663|Alkylating Agents|alkylating agents|mesh-ancestor
6631977|NCT01339663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6631978|NCT01339663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6631979|NCT01339663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6631980|NCT01339663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6631981|NCT01339663|Analgesics|analgesics|mesh-ancestor
6631982|NCT01339663|Sensory System Agents|sensory system agents|mesh-ancestor
6631983|NCT01339663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6631984|NCT01339663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6631985|NCT01339663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6631986|NCT01339663|Antiviral Agents|antiviral agents|mesh-ancestor
6631987|NCT01339663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6631988|NCT01339676|Vitamin D|vitamin d|mesh-list
6631989|NCT01339676|Cholecalciferol|cholecalciferol|mesh-list
6631990|NCT01339676|Vitamins|vitamins|mesh-ancestor
6631991|NCT01339676|Micronutrients|micronutrients|mesh-ancestor
6631992|NCT01339676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6631993|NCT01339676|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6631994|NCT01339676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6631995|NCT01339741|Vitamin D|vitamin d|mesh-list
6631996|NCT01339741|Cholecalciferol|cholecalciferol|mesh-list
6631997|NCT01339741|Vitamins|vitamins|mesh-ancestor
6631998|NCT01339741|Micronutrients|micronutrients|mesh-ancestor
6631999|NCT01339741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632000|NCT01339741|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6632001|NCT01339741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6632002|NCT01339754|Trabectedin|trabectedin|mesh-list
6632003|NCT01339754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6632004|NCT01339754|Alkylating Agents|alkylating agents|mesh-ancestor
6632005|NCT01339754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632006|NCT01339754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6632007|NCT01339819|Dabigatran|dabigatran|mesh-list
6632008|NCT01339819|Phenprocoumon|phenprocoumon|mesh-list
6632009|NCT01339819|Antithrombins|antithrombins|mesh-ancestor
6632010|NCT01339819|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6632011|NCT01339819|Protease Inhibitors|protease inhibitors|mesh-ancestor
6632012|NCT01339819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6632013|NCT01339819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632014|NCT01339819|Anticoagulants|anticoagulants|mesh-ancestor
6632015|NCT01339871|Vorinostat|vorinostat|mesh-list
6632016|NCT01339871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6632017|NCT01339871|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6632018|NCT01339871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6632019|NCT01339871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632020|NCT01339884|Resveratrol|resveratrol|mesh-list
6632021|NCT01339884|Antioxidants|antioxidants|mesh-ancestor
6632022|NCT01339884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632023|NCT01339884|Protective Agents|protective agents|mesh-ancestor
6632024|NCT01339884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632025|NCT01339884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6632026|NCT01339884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6632027|NCT01339988|Cyclophosphamide|cyclophosphamide|mesh-list
6632028|NCT01339988|Busulfan|busulfan|mesh-list
6632029|NCT01339988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6632030|NCT01339988|Immunologic Factors|immunologic factors|mesh-ancestor
6632031|NCT01339988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632032|NCT01339988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6632033|NCT01339988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6632034|NCT01339988|Alkylating Agents|alkylating agents|mesh-ancestor
6632035|NCT01339988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632036|NCT01339988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6632037|NCT01339988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6632038|NCT01340118|Budesonide|budesonide|mesh-list
6632039|NCT01340118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6632040|NCT01340118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6632041|NCT01340118|Autonomic Agents|autonomic agents|mesh-ancestor
5502386|NCT04466917|Growth Substances|growth substances|mesh-ancestor
6632042|NCT01340118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6632043|NCT01340118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451872|NCT00414128|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6451873|NCT00414128|Antitubercular Agents|antitubercular agents|mesh-ancestor
6451874|NCT00414128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6451875|NCT00414128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6451876|NCT00414128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6451877|NCT00414180|Bupropion|bupropion|mesh-list
6451878|NCT00414180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6451879|NCT00414180|Antidepressive Agents|antidepressive agents|mesh-ancestor
6451880|NCT00414180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6451881|NCT00414180|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6451882|NCT00414180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6632044|NCT01340118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6632045|NCT01340118|Respiratory System Agents|respiratory system agents|mesh-ancestor
6632046|NCT01340118|Glucocorticoids|glucocorticoids|mesh-ancestor
6632047|NCT01340118|Hormones|hormones|mesh-ancestor
6632048|NCT01340118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6632049|NCT01340235|Erythromycin|erythromycin|mesh-list
6632050|NCT01340235|Erythromycin Estolate|erythromycin estolate|mesh-list
6632051|NCT01340235|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
6632052|NCT01340235|Erythromycin stearate|erythromycin stearate|mesh-list
6632053|NCT01340235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6632054|NCT01340235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6632055|NCT01340235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6632056|NCT01340235|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6632057|NCT01340235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6632058|NCT01340235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632059|NCT01340248|Carvedilol|carvedilol|mesh-list
6632060|NCT01340248|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6632061|NCT01340248|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6632062|NCT01340248|Adrenergic Agents|adrenergic agents|mesh-ancestor
5482164|NCT04234477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5482165|NCT04234477|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5482166|NCT04234477|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5482167|NCT04234477|Adrenergic Agents|adrenergic agents|mesh-ancestor
5482168|NCT04234477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5482169|NCT04234477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5482170|NCT04234477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5482171|NCT04234477|Vasodilator Agents|vasodilator agents|mesh-ancestor
6451883|NCT00414180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6632063|NCT01340248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6632064|NCT01340248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632065|NCT01340248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632066|NCT01340248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6632067|NCT01340248|Antioxidants|antioxidants|mesh-ancestor
6632068|NCT01340248|Protective Agents|protective agents|mesh-ancestor
6632069|NCT01340248|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6632070|NCT01340248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6632071|NCT01340248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6632072|NCT01340248|Vasodilator Agents|vasodilator agents|mesh-ancestor
6632073|NCT01340248|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6632074|NCT01340248|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6632075|NCT01340326|Valsartan|valsartan|mesh-list
6632076|NCT01340326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6632077|NCT01340326|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6632078|NCT01340326|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6632079|NCT01340326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632080|NCT01340417|Melatonin|melatonin|mesh-list
6632081|NCT01340417|Antioxidants|antioxidants|mesh-ancestor
6632082|NCT01340417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632083|NCT01340417|Protective Agents|protective agents|mesh-ancestor
6632084|NCT01340417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632085|NCT01340417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6632086|NCT01340430|Trastuzumab|trastuzumab|mesh-list
6632087|NCT01340430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6632088|NCT01340430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6632089|NCT01340456|Rifampin|rifampin|mesh-list
6632090|NCT01340456|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6632091|NCT01340456|Antitubercular Agents|antitubercular agents|mesh-ancestor
6632092|NCT01340456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6632093|NCT01340456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6632094|NCT01340456|Leprostatic Agents|leprostatic agents|mesh-ancestor
6632095|NCT01340456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6632096|NCT01340456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6632097|NCT01340456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632098|NCT01340456|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6632099|NCT01340456|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6632100|NCT01340456|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6020998|NCT00396019|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6020999|NCT00396019|Antiviral Agents|antiviral agents|mesh-ancestor
6021000|NCT00396019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5482175|NCT04217967|Lenalidomide|lenalidomide|mesh-list
5482176|NCT04217967|Ixazomib|ixazomib|mesh-list
5482177|NCT04217967|Immunologic Factors|immunologic factors|mesh-ancestor
5482178|NCT04217967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632101|NCT01340456|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6632102|NCT01340456|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6632103|NCT01340456|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6632104|NCT01340521|Clomiphene|clomiphene|mesh-list
6632105|NCT01340521|Enclomiphene|enclomiphene|mesh-list
6632106|NCT01340521|Zuclomiphene|zuclomiphene|mesh-list
6632107|NCT01340521|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6632108|NCT01340521|Hormone Antagonists|hormone antagonists|mesh-ancestor
5482179|NCT04217967|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5482180|NCT04217967|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5482181|NCT04217967|Growth Substances|growth substances|mesh-ancestor
5482182|NCT04217967|Growth Inhibitors|growth inhibitors|mesh-ancestor
5482183|NCT04217967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5482184|NCT04217967|Protease Inhibitors|protease inhibitors|mesh-ancestor
5482185|NCT04217967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6632109|NCT01340521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6632110|NCT01340521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632111|NCT01340521|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6632112|NCT01340521|Fertility Agents|fertility agents|mesh-ancestor
6632113|NCT01340521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6632114|NCT01340521|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6632115|NCT01340521|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6632116|NCT01340547|Isophosphamide mustard|isophosphamide mustard|mesh-list
6632117|NCT01340547|Ifosfamide|ifosfamide|mesh-list
6632118|NCT01340547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6632119|NCT01340547|Alkylating Agents|alkylating agents|mesh-ancestor
6632120|NCT01340547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632121|NCT01340547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6632122|NCT01340599|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
6632123|NCT01340599|Antioxidants|antioxidants|mesh-ancestor
6632124|NCT01340599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632125|NCT01340599|Protective Agents|protective agents|mesh-ancestor
5482186|NCT04217967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502387|NCT04466917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502388|NCT04466917|Growth Inhibitors|growth inhibitors|mesh-ancestor
5502389|NCT04466943|Rocuronium|rocuronium|mesh-list
5502390|NCT04466943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502391|NCT04466943|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5502392|NCT04466943|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5502393|NCT04466943|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5502394|NCT04466943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5502395|NCT04466670|Aspirin|aspirin|mesh-list
5502396|NCT04466670|Heparin|heparin|mesh-list
5502397|NCT04466670|Calcium heparin|calcium heparin|mesh-list
5502398|NCT04466670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5502399|NCT04466670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5502400|NCT04466670|Analgesics|analgesics|mesh-ancestor
6632126|NCT01340599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632127|NCT01340599|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
6632128|NCT01340599|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6632129|NCT01340599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6632130|NCT01340599|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6632131|NCT01340677|Canagliflozin|canagliflozin|mesh-list
6632132|NCT01340677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6632133|NCT01340677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632134|NCT01340677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6632135|NCT01340677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632136|NCT01340820|BCG Vaccine|bcg vaccine|mesh-list
5502401|NCT04466670|Sensory System Agents|sensory system agents|mesh-ancestor
5502402|NCT04466670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5502403|NCT04466670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632137|NCT01340820|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6632138|NCT01340820|Immunologic Factors|immunologic factors|mesh-ancestor
6632139|NCT01340820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632140|NCT01340833|Dabrafenib|dabrafenib|mesh-list
6632141|NCT01340833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6632142|NCT01340833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6632143|NCT01340833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6632144|NCT01340833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632145|NCT01340846|Ketoconazole|ketoconazole|mesh-list
6632146|NCT01340846|Dabrafenib|dabrafenib|mesh-list
6632147|NCT01340846|Warfarin|warfarin|mesh-list
6632148|NCT01340846|Gemfibrozil|gemfibrozil|mesh-list
6632149|NCT01340846|Anticoagulants|anticoagulants|mesh-ancestor
6632150|NCT01340846|Antifungal Agents|antifungal agents|mesh-ancestor
6632151|NCT01340846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6632152|NCT01340846|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6632153|NCT01340846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6632154|NCT01340846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6632155|NCT01340846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632156|NCT01340846|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6632157|NCT01340846|Hormone Antagonists|hormone antagonists|mesh-ancestor
6632158|NCT01340846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6632159|NCT01340846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632160|NCT01340846|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6632161|NCT01340846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6632162|NCT01340846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6632163|NCT01340846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6632164|NCT01340846|Antimetabolites|antimetabolites|mesh-ancestor
6632165|NCT01340846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6632166|NCT01340846|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6662762|NCT01504815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6662763|NCT01504828|Ramipril|ramipril|mesh-list
6662764|NCT01504828|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6662765|NCT01504828|Protease Inhibitors|protease inhibitors|mesh-ancestor
6662766|NCT01504828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6662767|NCT01504828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662768|NCT01504828|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6662769|NCT01504906|Cyclosporine|cyclosporine|mesh-list
6662770|NCT01504906|Ticagrelor|ticagrelor|mesh-list
6662771|NCT01504906|Cyclosporins|cyclosporins|mesh-list
6662772|NCT01504906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6662773|NCT01504906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662774|NCT01504906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6662775|NCT01504906|Immunologic Factors|immunologic factors|mesh-ancestor
6662776|NCT01504906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662777|NCT01504906|Antifungal Agents|antifungal agents|mesh-ancestor
6662778|NCT01504906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6662779|NCT01504906|Dermatologic Agents|dermatologic agents|mesh-ancestor
6662780|NCT01504906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6662781|NCT01504906|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6662782|NCT01504906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6662783|NCT01504906|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6662784|NCT01504906|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6662785|NCT01504906|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6662786|NCT01504906|Purinergic Agents|purinergic agents|mesh-ancestor
6662787|NCT01504906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6662788|NCT01504919|Nicotine|nicotine|mesh-list
6662789|NCT01504919|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6662790|NCT01504919|Autonomic Agents|autonomic agents|mesh-ancestor
6662791|NCT01504919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6662792|NCT01504919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662793|NCT01504919|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6662794|NCT01504919|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6662795|NCT01504919|Cholinergic Agents|cholinergic agents|mesh-ancestor
6662796|NCT01504919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6662797|NCT01504919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662798|NCT01504984|Imatinib Mesylate|imatinib mesylate|mesh-list
6662799|NCT01504984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6662800|NCT01504984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6662801|NCT01504984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6662802|NCT01504984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662803|NCT01505049|Vaccines|vaccines|mesh-list
6662804|NCT01505049|Immunologic Factors|immunologic factors|mesh-ancestor
6662805|NCT01505049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632167|NCT01340950|Tenofovir|tenofovir|mesh-list
6632168|NCT01340950|Lamivudine|lamivudine|mesh-list
6632169|NCT01340950|Zidovudine|zidovudine|mesh-list
6632170|NCT01340950|Efavirenz|efavirenz|mesh-list
6632171|NCT01340950|Nevirapine|nevirapine|mesh-list
5482187|NCT04156698|Docetaxel|docetaxel|mesh-list
5482188|NCT04156698|Capecitabine|capecitabine|mesh-list
5482189|NCT04156698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5482190|NCT04156698|Tubulin Modulators|tubulin modulators|mesh-ancestor
5482191|NCT04156698|Antimitotic Agents|antimitotic agents|mesh-ancestor
5482192|NCT04156698|Mitosis Modulators|mitosis modulators|mesh-ancestor
5482193|NCT04156698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5482194|NCT04156698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5482195|NCT04156698|Antimetabolites|antimetabolites|mesh-ancestor
5482196|NCT04046614|Nivolumab|nivolumab|mesh-list
5482197|NCT04046614|Nintedanib|nintedanib|mesh-list
5482198|NCT04046614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5482199|NCT04046614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5482200|NCT04046614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5482201|NCT04046614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5482202|NCT04046614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5482203|NCT04046614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5482204|NCT04001881|Anesthetics|anesthetics|mesh-list
5482205|NCT04001881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5482206|NCT04001881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5482207|NCT03940196|Paclitaxel|paclitaxel|mesh-list
5482208|NCT03940196|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5482209|NCT03940196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5482210|NCT03940196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5482211|NCT03940196|Tubulin Modulators|tubulin modulators|mesh-ancestor
5482212|NCT03940196|Antimitotic Agents|antimitotic agents|mesh-ancestor
5482213|NCT03940196|Mitosis Modulators|mitosis modulators|mesh-ancestor
5482214|NCT03940196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5482215|NCT03916185|Vaccines|vaccines|mesh-list
5482216|NCT03916185|Immunologic Factors|immunologic factors|mesh-ancestor
5482217|NCT03916185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5482218|NCT03915860|Trifarotene|trifarotene|mesh-list
5482219|NCT03915860|Dermatologic Agents|dermatologic agents|mesh-ancestor
5482220|NCT03852901|Empagliflozin|empagliflozin|mesh-list
5482221|NCT03852901|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5482222|NCT03852901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5482223|NCT03852901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6451884|NCT00414180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451885|NCT00414180|Dopamine Agents|dopamine agents|mesh-ancestor
6451886|NCT00414180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6451887|NCT00414180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451888|NCT00414180|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6632172|NCT01340950|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6632173|NCT01340950|Antiviral Agents|antiviral agents|mesh-ancestor
6632174|NCT01340950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6632175|NCT01340950|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6632176|NCT01340950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6632177|NCT01340950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6632178|NCT01340950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632179|NCT01340950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6632180|NCT01340950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6632181|NCT01340950|Antimetabolites|antimetabolites|mesh-ancestor
6632182|NCT01340950|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6632183|NCT01340950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6632184|NCT01340950|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6632185|NCT01340950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6632186|NCT01340950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5482224|NCT03852901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5482225|NCT03795233|Vancomycin|vancomycin|mesh-list
5482226|NCT03795233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5482227|NCT03795233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6451889|NCT00414180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6451890|NCT00414180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6451891|NCT00414245|Metformin|metformin|mesh-list
6632187|NCT01340950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6632188|NCT01341041|Chlorine dioxide|chlorine dioxide|mesh-list
6451892|NCT00414245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6451893|NCT00414245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632189|NCT01341041|Dental Disinfectants|dental disinfectants|mesh-ancestor
5482228|NCT03783091|Hydroxocobalamin|hydroxocobalamin|mesh-list
6632190|NCT01341041|Disinfectants|disinfectants|mesh-ancestor
6632191|NCT01341041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6632192|NCT01341080|Varenicline|varenicline|mesh-list
6632193|NCT01341080|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6632194|NCT01341080|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6632195|NCT01341080|Cholinergic Agents|cholinergic agents|mesh-ancestor
6632196|NCT01341080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6632197|NCT01341080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632198|NCT01341080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632199|NCT01341106|Entecavir|entecavir|mesh-list
6632200|NCT01341106|Antiviral Agents|antiviral agents|mesh-ancestor
6632201|NCT01341106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6632202|NCT01341158|Interferons|interferons|mesh-list
6632203|NCT01341158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6632204|NCT01341158|Antiviral Agents|antiviral agents|mesh-ancestor
6632205|NCT01341158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6632206|NCT01341184|Rifampin|rifampin|mesh-list
6632207|NCT01341184|Rifabutin|rifabutin|mesh-list
6632208|NCT01341184|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6632209|NCT01341184|Antitubercular Agents|antitubercular agents|mesh-ancestor
6632210|NCT01341184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6632211|NCT01341184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6632212|NCT01341184|Leprostatic Agents|leprostatic agents|mesh-ancestor
6632213|NCT01341184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6632214|NCT01341184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6632215|NCT01341184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632216|NCT01341184|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6632217|NCT01341184|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6632218|NCT01341184|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6632219|NCT01341184|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6632220|NCT01341184|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6632221|NCT01341184|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6632222|NCT01341262|Zoledronic Acid|zoledronic acid|mesh-list
6632223|NCT01341262|Thalidomide|thalidomide|mesh-list
6632224|NCT01341262|Dexamethasone|dexamethasone|mesh-list
6632225|NCT01341262|Cyclophosphamide|cyclophosphamide|mesh-list
6632226|NCT01341262|Melphalan|melphalan|mesh-list
6632227|NCT01341262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6632228|NCT01341262|Immunologic Factors|immunologic factors|mesh-ancestor
6632229|NCT01341262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632230|NCT01341262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6632231|NCT01341262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6632232|NCT01341262|Alkylating Agents|alkylating agents|mesh-ancestor
6632233|NCT01341262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632234|NCT01341262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6632235|NCT01341262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6632236|NCT01341262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6632237|NCT01341262|Antiemetics|antiemetics|mesh-ancestor
6632238|NCT01341262|Autonomic Agents|autonomic agents|mesh-ancestor
6632239|NCT01341262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6632240|NCT01341262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6632241|NCT01341262|Glucocorticoids|glucocorticoids|mesh-ancestor
6632242|NCT01341262|Hormones|hormones|mesh-ancestor
6632243|NCT01341262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6632244|NCT01341262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6632245|NCT01341262|Leprostatic Agents|leprostatic agents|mesh-ancestor
6632246|NCT01341262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6632247|NCT01341262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6632248|NCT01341262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6632249|NCT01341262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6632250|NCT01341262|Growth Substances|growth substances|mesh-ancestor
6632251|NCT01341262|Growth Inhibitors|growth inhibitors|mesh-ancestor
6632252|NCT01341262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6632253|NCT01341275|Vaccines|vaccines|mesh-list
6632254|NCT01341275|Immunologic Factors|immunologic factors|mesh-ancestor
6632255|NCT01341275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632256|NCT01341340|Everolimus|everolimus|mesh-list
6632257|NCT01341340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6632258|NCT01341340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6632259|NCT01341340|Immunologic Factors|immunologic factors|mesh-ancestor
6632260|NCT01341340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632261|NCT01341353|Amiodarone|amiodarone|mesh-list
6632262|NCT01341353|Calcium Channel Blockers|calcium channel blockers|mesh-list
6632263|NCT01341353|Calcium|calcium|mesh-list
6632264|NCT01341353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6632265|NCT01341353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632266|NCT01341353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6632267|NCT01341353|Vasodilator Agents|vasodilator agents|mesh-ancestor
6632268|NCT01341353|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6632269|NCT01341353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5482229|NCT03783091|Vitamin B 12|vitamin b 12|mesh-list
5482230|NCT03783091|Hematinics|hematinics|mesh-ancestor
6632270|NCT01341353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632271|NCT01341353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6632272|NCT01341353|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6632273|NCT01341353|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6632274|NCT01341353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6632275|NCT01341353|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6632276|NCT01341353|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6632277|NCT01341353|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6632278|NCT01341392|Amlodipine|amlodipine|mesh-list
6632279|NCT01341392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6632280|NCT01341392|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6632281|NCT01341392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5482231|NCT03783091|Vitamin B Complex|vitamin b complex|mesh-ancestor
5482232|NCT03783091|Vitamins|vitamins|mesh-ancestor
5482233|NCT03783091|Micronutrients|micronutrients|mesh-ancestor
5482234|NCT03783091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5482235|NCT03770286|Fluorides|fluorides|mesh-list
5482236|NCT03770286|Fluorides, Topical|fluorides, topical|mesh-list
5482237|NCT03770286|Cariostatic Agents|cariostatic agents|mesh-ancestor
5482238|NCT03770286|Protective Agents|protective agents|mesh-ancestor
5482239|NCT03770286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5482240|NCT03769376|Salvin|salvin|mesh-list
5482241|NCT03769376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5482242|NCT03769376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5482243|NCT03769376|Antioxidants|antioxidants|mesh-ancestor
6632282|NCT01341392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632283|NCT01341392|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6632284|NCT01341392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632285|NCT01341392|Vasodilator Agents|vasodilator agents|mesh-ancestor
5482244|NCT03769376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5482245|NCT03769376|Protective Agents|protective agents|mesh-ancestor
6632286|NCT01341405|Celecoxib|celecoxib|mesh-list
6632287|NCT01341405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6632288|NCT01341405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6632289|NCT01341405|Analgesics|analgesics|mesh-ancestor
6632290|NCT01341405|Sensory System Agents|sensory system agents|mesh-ancestor
6632291|NCT01341405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6632292|NCT01341405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632293|NCT01341405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6632294|NCT01341405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6632295|NCT01341405|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6632296|NCT01341405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6632297|NCT01341405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6632298|NCT01341405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632299|NCT01341496|Celecoxib|celecoxib|mesh-list
6632300|NCT01341496|Cyclophosphamide|cyclophosphamide|mesh-list
6632301|NCT01341496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6632302|NCT01341496|Immunologic Factors|immunologic factors|mesh-ancestor
6632303|NCT01341496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632304|NCT01341496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6632305|NCT01341496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6632306|NCT01341496|Alkylating Agents|alkylating agents|mesh-ancestor
6632307|NCT01341496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632308|NCT01341496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6632309|NCT01341496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6632310|NCT01341496|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6632311|NCT01341496|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6632312|NCT01341496|Analgesics|analgesics|mesh-ancestor
6632313|NCT01341496|Sensory System Agents|sensory system agents|mesh-ancestor
6632314|NCT01341496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6632315|NCT01341496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6632316|NCT01341496|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6632317|NCT01341496|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6632318|NCT01341496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6632319|NCT01341717|Metformin|metformin|mesh-list
6632320|NCT01341717|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5482246|NCT03769376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5482247|NCT03683251|Ranibizumab|ranibizumab|mesh-list
6632321|NCT01341717|Glimepiride|glimepiride|mesh-list
6632322|NCT01341717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6632323|NCT01341717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632324|NCT01341717|Incretins|incretins|mesh-ancestor
6632325|NCT01341717|Hormones|hormones|mesh-ancestor
6632326|NCT01341717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6632327|NCT01341717|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6632328|NCT01341717|Protease Inhibitors|protease inhibitors|mesh-ancestor
6632329|NCT01341717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6632330|NCT01341717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632331|NCT01341717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6632332|NCT01341717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6632333|NCT01341717|Immunologic Factors|immunologic factors|mesh-ancestor
6632334|NCT01341743|Entecavir|entecavir|mesh-list
6632335|NCT01341743|Adefovir|adefovir|mesh-list
6632336|NCT01341743|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6632337|NCT01341743|Antiviral Agents|antiviral agents|mesh-ancestor
6632338|NCT01341743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6632339|NCT01341743|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6632340|NCT01341743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6632341|NCT01341743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6632342|NCT01341743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632343|NCT01341834|Everolimus|everolimus|mesh-list
6632344|NCT01341834|Panobinostat|panobinostat|mesh-list
6632345|NCT01341834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6632346|NCT01341834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6632347|NCT01341834|Immunologic Factors|immunologic factors|mesh-ancestor
6632348|NCT01341834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632349|NCT01341834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6632350|NCT01341834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5482248|NCT03683251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5482249|NCT03683251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5482250|NCT03683251|Growth Substances|growth substances|mesh-ancestor
5482251|NCT03683251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5482252|NCT03683251|Growth Inhibitors|growth inhibitors|mesh-ancestor
5482253|NCT03683251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5482254|NCT03645863|Iron|iron|mesh-list
5482255|NCT03645863|Trace Elements|trace elements|mesh-ancestor
5482256|NCT03645863|Micronutrients|micronutrients|mesh-ancestor
6632351|NCT01341834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632352|NCT01341886|Metformin|metformin|mesh-list
6632353|NCT01341886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6632354|NCT01341886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632355|NCT01341938|Nicotine|nicotine|mesh-list
6632356|NCT01341938|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6632357|NCT01341938|Autonomic Agents|autonomic agents|mesh-ancestor
6632358|NCT01341938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6632359|NCT01341938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632360|NCT01341938|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6632361|NCT01341938|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6632362|NCT01341938|Cholinergic Agents|cholinergic agents|mesh-ancestor
6632363|NCT01341938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6632364|NCT01341938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632365|NCT01341951|Sargramostim|sargramostim|mesh-list
6632366|NCT01341951|Lenograstim|lenograstim|mesh-list
6632367|NCT01341951|Immunologic Factors|immunologic factors|mesh-ancestor
6632368|NCT01341951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632369|NCT01341951|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6632370|NCT01341964|Aspirin|aspirin|mesh-list
6632371|NCT01341964|Clopidogrel|clopidogrel|mesh-list
6632372|NCT01341964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6632373|NCT01341964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6632374|NCT01341964|Analgesics|analgesics|mesh-ancestor
6632375|NCT01341964|Sensory System Agents|sensory system agents|mesh-ancestor
6632376|NCT01341964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6632377|NCT01341964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632378|NCT01341964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6632379|NCT01341964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6632380|NCT01341964|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6632381|NCT01341964|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6632382|NCT01341964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632383|NCT01341964|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5482257|NCT03645863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632384|NCT01341964|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6632385|NCT01341964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5482258|NCT03565991|Avelumab|avelumab|mesh-list
6632386|NCT01341964|Antipyretics|antipyretics|mesh-ancestor
6632387|NCT01341964|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6632388|NCT01341964|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6632389|NCT01341964|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6632390|NCT01341964|Purinergic Agents|purinergic agents|mesh-ancestor
6632391|NCT01341964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6632392|NCT01342016|Prednisone|prednisone|mesh-list
6632393|NCT01342016|Tacrolimus|tacrolimus|mesh-list
6632394|NCT01342016|Leflunomide|leflunomide|mesh-list
6632395|NCT01342016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6632396|NCT01342016|Glucocorticoids|glucocorticoids|mesh-ancestor
6632397|NCT01342016|Hormones|hormones|mesh-ancestor
6632398|NCT01342016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6632399|NCT01342016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5482259|NCT03565991|Talazoparib|talazoparib|mesh-list
5482260|NCT03565991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5482261|NCT03565991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5482262|NCT03565991|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5482263|NCT03565991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5482264|NCT03565991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5482265|NCT03564145|Benzoyl Peroxide|benzoyl peroxide|mesh-list
5482266|NCT03564145|Dermatologic Agents|dermatologic agents|mesh-ancestor
5482267|NCT03564119|Benzoyl Peroxide|benzoyl peroxide|mesh-list
5482268|NCT03564119|Dermatologic Agents|dermatologic agents|mesh-ancestor
5482269|NCT03476369|Fentanyl|fentanyl|mesh-list
5482270|NCT03476369|Ticagrelor|ticagrelor|mesh-list
5482271|NCT03476369|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5482272|NCT03476369|Narcotics|narcotics|mesh-ancestor
5482273|NCT03476369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5482274|NCT03476369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5482275|NCT03476369|Analgesics|analgesics|mesh-ancestor
6632400|NCT01342016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6632401|NCT01342016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6632402|NCT01342016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6632403|NCT01342016|Immunologic Factors|immunologic factors|mesh-ancestor
6632404|NCT01342016|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6632405|NCT01342016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6632406|NCT01342016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5482276|NCT03476369|Sensory System Agents|sensory system agents|mesh-ancestor
5482277|NCT03476369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6632407|NCT01342146|Hormones|hormones|mesh-list
6632408|NCT01342146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6632409|NCT01342146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632410|NCT01342185|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
6632411|NCT01342185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6632412|NCT01342198|Erythromycin|erythromycin|mesh-list
6632413|NCT01342198|Erythromycin Estolate|erythromycin estolate|mesh-list
6632414|NCT01342198|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
6632415|NCT01342198|Erythromycin stearate|erythromycin stearate|mesh-list
6632416|NCT01342198|Pregabalin|pregabalin|mesh-list
6632417|NCT01342198|Analgesics|analgesics|mesh-ancestor
6632418|NCT01342198|Sensory System Agents|sensory system agents|mesh-ancestor
6632419|NCT01342198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6632420|NCT01342198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632421|NCT01342198|Anticonvulsants|anticonvulsants|mesh-ancestor
6632422|NCT01342198|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6632423|NCT01342198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6632424|NCT01342198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632425|NCT01342198|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6632426|NCT01342198|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6632427|NCT01342198|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6632428|NCT01342198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6632429|NCT01342198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6632430|NCT01342198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6632431|NCT01342198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6632432|NCT01342198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6632433|NCT01342198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6632434|NCT01342198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6632435|NCT01342224|Gemcitabine|gemcitabine|mesh-list
6632436|NCT01342224|Tadalafil|tadalafil|mesh-list
6632437|NCT01342224|Sargramostim|sargramostim|mesh-list
6632438|NCT01342224|Immunologic Factors|immunologic factors|mesh-ancestor
6632439|NCT01342224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632440|NCT01342224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5482278|NCT03476369|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6632441|NCT01342224|Antimetabolites|antimetabolites|mesh-ancestor
6632442|NCT01342224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632443|NCT01342224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6632444|NCT01342224|Antiviral Agents|antiviral agents|mesh-ancestor
6451894|NCT00414284|Lopinavir|lopinavir|mesh-list
6451895|NCT00414284|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6451896|NCT00414284|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6451897|NCT00414284|Protease Inhibitors|protease inhibitors|mesh-ancestor
6451898|NCT00414284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6451899|NCT00414284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451900|NCT00414284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6451901|NCT00414284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6451902|NCT00414284|Antiviral Agents|antiviral agents|mesh-ancestor
6451903|NCT00414284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6451904|NCT00414284|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6451905|NCT00414284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6451906|NCT00414323|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6451907|NCT00414323|Citalopram|citalopram|mesh-list
6451908|NCT00414323|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6451909|NCT00414323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6451910|NCT00414323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6451911|NCT00414323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451912|NCT00414323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6451913|NCT00414323|Serotonin Agents|serotonin agents|mesh-ancestor
6632445|NCT01342224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6632446|NCT01342224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6632447|NCT01342224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6632448|NCT01342224|Vasodilator Agents|vasodilator agents|mesh-ancestor
6632449|NCT01342224|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6632450|NCT01342224|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6632451|NCT01342224|Urological Agents|urological agents|mesh-ancestor
6632452|NCT01342237|Carboplatin|carboplatin|mesh-list
6632453|NCT01342237|Etoposide|etoposide|mesh-list
6632454|NCT01342237|Melphalan|melphalan|mesh-list
6632455|NCT01342237|Topotecan|topotecan|mesh-list
6632456|NCT01342237|Thiotepa|thiotepa|mesh-list
6632457|NCT01342237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6632458|NCT01342237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6632459|NCT01342237|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6632460|NCT01342237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6632461|NCT01342237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6632462|NCT01342237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632463|NCT01342237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6632464|NCT01342237|Alkylating Agents|alkylating agents|mesh-ancestor
6632465|NCT01342237|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6632466|NCT01342237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6632467|NCT01342237|Immunologic Factors|immunologic factors|mesh-ancestor
6632468|NCT01342237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632469|NCT01342237|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6632470|NCT01342289|Mycophenolic Acid|mycophenolic acid|mesh-list
6632471|NCT01342289|Cyclophosphamide|cyclophosphamide|mesh-list
6632472|NCT01342289|Fludarabine|fludarabine|mesh-list
6632473|NCT01342289|Tacrolimus|tacrolimus|mesh-list
6632474|NCT01342289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6632475|NCT01342289|Immunologic Factors|immunologic factors|mesh-ancestor
6632476|NCT01342289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632477|NCT01342289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6632478|NCT01342289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6632479|NCT01342289|Alkylating Agents|alkylating agents|mesh-ancestor
6632480|NCT01342289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632481|NCT01342289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6632482|NCT01342289|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6632483|NCT01342289|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6632484|NCT01342289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6632485|NCT01342289|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6632486|NCT01342289|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6632487|NCT01342289|Antitubercular Agents|antitubercular agents|mesh-ancestor
6632488|NCT01342289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6632489|NCT01342289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6632490|NCT01342328|Dexmedetomidine|dexmedetomidine|mesh-list
6632491|NCT01342328|Propofol|propofol|mesh-list
6632492|NCT01342328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6632493|NCT01342328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6632494|NCT01342328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632495|NCT01342328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6632496|NCT01342328|Anesthetics, General|anesthetics, general|mesh-ancestor
6632497|NCT01342328|Anesthetics|anesthetics|mesh-ancestor
6632498|NCT01342328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6632499|NCT01342328|Analgesics|analgesics|mesh-ancestor
6632500|NCT01342328|Sensory System Agents|sensory system agents|mesh-ancestor
6632501|NCT01342328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6632502|NCT01342328|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6632503|NCT01342328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6632504|NCT01342328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6632505|NCT01342328|Adrenergic Agents|adrenergic agents|mesh-ancestor
6632506|NCT01342328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6632507|NCT01342328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632508|NCT01342562|Anesthetics|anesthetics|mesh-list
6632509|NCT01342562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6632510|NCT01342562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632511|NCT01342601|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6632512|NCT01342601|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6632513|NCT01342614|Metformin|metformin|mesh-list
6632514|NCT01342614|Fosinopril|fosinopril|mesh-list
6632515|NCT01342614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6632516|NCT01342614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632517|NCT01342614|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6632518|NCT01342614|Protease Inhibitors|protease inhibitors|mesh-ancestor
6632519|NCT01342614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6632520|NCT01342614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632521|NCT01342614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6632522|NCT01342627|Sorafenib|sorafenib|mesh-list
6632523|NCT01342627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6632524|NCT01342627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6632525|NCT01342627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6632526|NCT01342627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632527|NCT01342679|Dasatinib|dasatinib|mesh-list
6632528|NCT01342679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6632529|NCT01342679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6632530|NCT01342679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6632531|NCT01342679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662806|NCT01505088|Benzalkonium Compounds|benzalkonium compounds|mesh-list
6662807|NCT01505088|Dexamethasone|dexamethasone|mesh-list
6662808|NCT01505088|Prednisolone|prednisolone|mesh-list
6662809|NCT01505088|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6662810|NCT01505088|Methylprednisolone|methylprednisolone|mesh-list
6662811|NCT01505088|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6662812|NCT01505088|Prednisolone acetate|prednisolone acetate|mesh-list
6662813|NCT01505088|Citric Acid|citric acid|mesh-list
6662814|NCT01505088|Sodium Citrate|sodium citrate|mesh-list
6662815|NCT01505088|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6662816|NCT01505088|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6662817|NCT01505088|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6662818|NCT01505088|Prednisolone phosphate|prednisolone phosphate|mesh-list
6662819|NCT01505088|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
6662820|NCT01505088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6662821|NCT01505088|Antiemetics|antiemetics|mesh-ancestor
6662822|NCT01505088|Autonomic Agents|autonomic agents|mesh-ancestor
6662823|NCT01505088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6662824|NCT01505088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662825|NCT01505088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5482279|NCT03476369|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5482280|NCT03476369|Anesthetics, General|anesthetics, general|mesh-ancestor
5482281|NCT03476369|Anesthetics|anesthetics|mesh-ancestor
6662826|NCT01505088|Glucocorticoids|glucocorticoids|mesh-ancestor
6662827|NCT01505088|Hormones|hormones|mesh-ancestor
6662828|NCT01505088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6662829|NCT01505088|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6662830|NCT01505088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6662831|NCT01505088|Anticoagulants|anticoagulants|mesh-ancestor
6662832|NCT01505088|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6662833|NCT01505088|Chelating Agents|chelating agents|mesh-ancestor
6662834|NCT01505088|Sequestering Agents|sequestering agents|mesh-ancestor
6662835|NCT01505088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662836|NCT01505088|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6662837|NCT01505088|Protective Agents|protective agents|mesh-ancestor
6662838|NCT01505088|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5482282|NCT03476369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5482283|NCT03476369|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5482284|NCT03476369|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6662839|NCT01505088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5482285|NCT03476369|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5482286|NCT03476369|Purinergic Agents|purinergic agents|mesh-ancestor
5482287|NCT03476369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5482288|NCT03476369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632532|NCT01342692|Lenalidomide|lenalidomide|mesh-list
6632533|NCT01342692|Azacitidine|azacitidine|mesh-list
6632534|NCT01342692|Idarubicin|idarubicin|mesh-list
6632535|NCT01342692|Valproic Acid|valproic acid|mesh-list
6632536|NCT01342692|Immunologic Factors|immunologic factors|mesh-ancestor
5482289|NCT03423355|Dapagliflozin|dapagliflozin|mesh-list
5482290|NCT03423355|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5482291|NCT03423355|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5482292|NCT03423355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5482293|NCT03423355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5482294|NCT03423355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5482295|NCT03423355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5482296|NCT03423355|Diuretics|diuretics|mesh-ancestor
5482297|NCT03423355|Natriuretic Agents|natriuretic agents|mesh-ancestor
5482298|NCT03423355|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5482299|NCT03423355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5482300|NCT03417544|Trastuzumab|trastuzumab|mesh-list
5482301|NCT03417544|Pertuzumab|pertuzumab|mesh-list
5482302|NCT03417544|Atezolizumab|atezolizumab|mesh-list
5482303|NCT03417544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5482304|NCT03417544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5482305|NCT03365635|Ribavirin|ribavirin|mesh-list
5482306|NCT03365635|Grazoprevir|grazoprevir|mesh-list
5482307|NCT03365635|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
5482308|NCT03365635|Antimetabolites|antimetabolites|mesh-ancestor
5482309|NCT03365635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5482310|NCT03365635|Antiviral Agents|antiviral agents|mesh-ancestor
5482311|NCT03365635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5482312|NCT03338959|Pembrolizumab|pembrolizumab|mesh-list
5482313|NCT03338959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5482314|NCT03338959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5482315|NCT03330405|Avelumab|avelumab|mesh-list
5482316|NCT03330405|Talazoparib|talazoparib|mesh-list
5482317|NCT03330405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5482318|NCT03330405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5482319|NCT03330405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5482320|NCT03330405|Immunologic Factors|immunologic factors|mesh-ancestor
5482321|NCT03330405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5482322|NCT03330405|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5482323|NCT03330405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5482324|NCT03330405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5482325|NCT03324373|Everolimus|everolimus|mesh-list
5482326|NCT03324373|Lenvatinib|lenvatinib|mesh-list
5482327|NCT03324373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5482328|NCT03324373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5482329|NCT03324373|Immunologic Factors|immunologic factors|mesh-ancestor
5482330|NCT03324373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5482331|NCT03324373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5482332|NCT03324373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5482333|NCT03324373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5482334|NCT03287050|Pembrolizumab|pembrolizumab|mesh-list
5482335|NCT03287050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5482336|NCT03287050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5482337|NCT03254667|Brodalumab|brodalumab|mesh-list
5482338|NCT03254667|Dermatologic Agents|dermatologic agents|mesh-ancestor
5482339|NCT03238534|Omeprazole|omeprazole|mesh-list
5482340|NCT03238534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5482341|NCT03238534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5482342|NCT03238534|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5482343|NCT03238534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5482344|NCT03238534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502404|NCT04466670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5502405|NCT04466670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5502406|NCT04466670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5502407|NCT04466670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5502408|NCT04466670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502409|NCT04466670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5502410|NCT04466670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5502411|NCT04466670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5502412|NCT04466670|Antipyretics|antipyretics|mesh-ancestor
6632537|NCT01342692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632538|NCT01342692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6632539|NCT01342692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6632540|NCT01342692|Growth Substances|growth substances|mesh-ancestor
6632541|NCT01342692|Growth Inhibitors|growth inhibitors|mesh-ancestor
6632542|NCT01342692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6632543|NCT01342692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6632544|NCT01342692|Antimetabolites|antimetabolites|mesh-ancestor
6632545|NCT01342692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632546|NCT01342692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6632547|NCT01342692|Anticonvulsants|anticonvulsants|mesh-ancestor
6632548|NCT01342692|GABA Agents|gaba agents|mesh-ancestor
6632549|NCT01342692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5482345|NCT03223350|Capsaicin|capsaicin|mesh-list
5482346|NCT03223350|Antipruritics|antipruritics|mesh-ancestor
5482347|NCT03223350|Dermatologic Agents|dermatologic agents|mesh-ancestor
5482348|NCT03223350|Sensory System Agents|sensory system agents|mesh-ancestor
5482349|NCT03223350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5482350|NCT03223350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5482351|NCT03197467|Pembrolizumab|pembrolizumab|mesh-list
5482352|NCT03197467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5482353|NCT03197467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5482354|NCT03193931|Pembrolizumab|pembrolizumab|mesh-list
5482355|NCT03193931|Methotrexate|methotrexate|mesh-list
5482356|NCT03193931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5482357|NCT03193931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5482358|NCT03193931|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5482359|NCT03193931|Abortifacient Agents|abortifacient agents|mesh-ancestor
5482360|NCT03193931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5482361|NCT03193931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5482362|NCT03193931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5482363|NCT03193931|Antimetabolites|antimetabolites|mesh-ancestor
5482364|NCT03193931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5482365|NCT03193931|Dermatologic Agents|dermatologic agents|mesh-ancestor
5482366|NCT03193931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5482367|NCT03193931|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5482368|NCT03193931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5482369|NCT03193931|Immunologic Factors|immunologic factors|mesh-ancestor
5482370|NCT03193931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5482371|NCT03193931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5482372|NCT03181828|Acetohydroxamic acid|acetohydroxamic acid|mesh-list
5482373|NCT03181828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5482374|NCT03181828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632550|NCT01342692|Antimanic Agents|antimanic agents|mesh-ancestor
6632551|NCT01342692|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6632552|NCT01342692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6632553|NCT01342692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6632554|NCT01342692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6632555|NCT01342692|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6632556|NCT01342692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6632557|NCT01342731|Tigecycline|tigecycline|mesh-list
6632558|NCT01342731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5482375|NCT03181529|Psilocybin|psilocybin|mesh-list
5482376|NCT03181529|Hallucinogens|hallucinogens|mesh-ancestor
5482377|NCT03181529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5482378|NCT03181529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5482379|NCT03164928|Denosumab|denosumab|mesh-list
5482380|NCT03164928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5482381|NCT03164928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5482382|NCT03106987|Olaparib|olaparib|mesh-list
5482383|NCT03106987|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5482384|NCT03106987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6632559|NCT01342731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6632560|NCT01342731|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6632561|NCT01342731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6632562|NCT01342731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632563|NCT01342744|Metformin|metformin|mesh-list
6632564|NCT01342744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6632565|NCT01342744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632566|NCT01342835|Propofol|propofol|mesh-list
6632567|NCT01342835|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6632568|NCT01342835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6632569|NCT01342835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632570|NCT01342835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6632571|NCT01342835|Anesthetics, General|anesthetics, general|mesh-ancestor
6632572|NCT01342835|Anesthetics|anesthetics|mesh-ancestor
6632573|NCT01342874|Inositol|inositol|mesh-list
6632574|NCT01342874|Vitamin B Complex|vitamin b complex|mesh-ancestor
6632575|NCT01342874|Vitamins|vitamins|mesh-ancestor
6632576|NCT01342874|Micronutrients|micronutrients|mesh-ancestor
6632577|NCT01342874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451914|NCT00414323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451915|NCT00414323|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6451916|NCT00414323|Antidepressive Agents|antidepressive agents|mesh-ancestor
6451917|NCT00414323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6451918|NCT00414323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6451919|NCT00414323|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6451920|NCT00414323|Analgesics|analgesics|mesh-ancestor
6632578|NCT01342939|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6632579|NCT01342939|Incretins|incretins|mesh-list
6632580|NCT01342939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6632581|NCT01342939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632582|NCT01342939|Hormones|hormones|mesh-ancestor
6632583|NCT01342939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5482385|NCT03106987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5482386|NCT03106987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5482387|NCT03056001|Doxorubicin|doxorubicin|mesh-list
5482388|NCT03056001|Pembrolizumab|pembrolizumab|mesh-list
5482389|NCT03056001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6632584|NCT01342939|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6632585|NCT01342939|Protease Inhibitors|protease inhibitors|mesh-ancestor
6632586|NCT01342939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6632587|NCT01342939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632588|NCT05251584|Gentamicins|gentamicins|mesh-list
6632589|NCT05251584|Mupirocin|mupirocin|mesh-list
6632590|NCT05251584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6632591|NCT05251584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6632592|NCT05251584|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6632593|NCT05251584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6632594|NCT05251584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632595|NCT05251493|Iron|iron|mesh-list
6632596|NCT05251493|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6632597|NCT05251493|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
6632598|NCT05251493|Trace Elements|trace elements|mesh-ancestor
6632599|NCT05251493|Micronutrients|micronutrients|mesh-ancestor
6632600|NCT05251493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632601|NCT05251493|Hematinics|hematinics|mesh-ancestor
6632602|NCT05251376|Morphine|morphine|mesh-list
6632603|NCT05251376|Methadone|methadone|mesh-list
6632604|NCT05251376|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6632605|NCT05251376|Narcotics|narcotics|mesh-ancestor
6632606|NCT05251376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6632607|NCT05251376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632608|NCT05251376|Analgesics|analgesics|mesh-ancestor
6632609|NCT05251376|Sensory System Agents|sensory system agents|mesh-ancestor
6632610|NCT05251376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6632611|NCT05251376|Antitussive Agents|antitussive agents|mesh-ancestor
6632612|NCT05251376|Respiratory System Agents|respiratory system agents|mesh-ancestor
6632613|NCT05251259|Montelukast|montelukast|mesh-list
6632614|NCT05251259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6632615|NCT05251259|Respiratory System Agents|respiratory system agents|mesh-ancestor
6632616|NCT05251259|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6632617|NCT05251259|Hormone Antagonists|hormone antagonists|mesh-ancestor
6632618|NCT05251259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6632619|NCT05251259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632620|NCT05251259|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6632621|NCT05251259|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6451921|NCT00414323|Sensory System Agents|sensory system agents|mesh-ancestor
6451922|NCT00414323|Dopamine Agents|dopamine agents|mesh-ancestor
6451923|NCT00414336|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6451924|NCT00414336|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6662840|NCT01505127|Amoxicillin|amoxicillin|mesh-list
6632622|NCT05251259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632623|NCT05251233|Pantoprazole|pantoprazole|mesh-list
6632624|NCT05251233|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6632625|NCT05251233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6632626|NCT05251233|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6632627|NCT05251233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6632628|NCT05251233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632629|NCT05251129|Atorvastatin|atorvastatin|mesh-list
6632630|NCT05251129|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6632631|NCT05251129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6632632|NCT05251129|Antimetabolites|antimetabolites|mesh-ancestor
6632633|NCT05251129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632634|NCT05251129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6632635|NCT05251129|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6632636|NCT05251129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6632637|NCT05251038|Leucovorin|leucovorin|mesh-list
6632638|NCT05251038|Gemcitabine|gemcitabine|mesh-list
6632639|NCT05251038|Paclitaxel|paclitaxel|mesh-list
6632640|NCT05251038|Fluorouracil|fluorouracil|mesh-list
6632641|NCT05251038|Irinotecan|irinotecan|mesh-list
5482390|NCT03056001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5482391|NCT03056001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5482392|NCT03056001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5482393|NCT03056001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5482394|NCT03056001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5482395|NCT03056001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5482396|NCT03049189|Everolimus|everolimus|mesh-list
5482397|NCT03049189|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5482398|NCT03049189|Edotreotide|edotreotide|mesh-list
5482399|NCT03049189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5482400|NCT03049189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5482401|NCT03049189|Immunologic Factors|immunologic factors|mesh-ancestor
5482402|NCT03049189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5482403|NCT03049189|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5482404|NCT03049189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5482405|NCT03043729|Leucovorin|leucovorin|mesh-list
5482406|NCT03043729|Oxaliplatin|oxaliplatin|mesh-list
5482407|NCT03043729|Aflibercept|aflibercept|mesh-list
5482408|NCT03043729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5482409|NCT03043729|Antidotes|antidotes|mesh-ancestor
5482410|NCT03043729|Protective Agents|protective agents|mesh-ancestor
6632642|NCT05251038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6632643|NCT05251038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6632644|NCT05251038|Tubulin Modulators|tubulin modulators|mesh-ancestor
6632645|NCT05251038|Antimitotic Agents|antimitotic agents|mesh-ancestor
6632646|NCT05251038|Mitosis Modulators|mitosis modulators|mesh-ancestor
6632647|NCT05251038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632648|NCT05251038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6632649|NCT05251038|Antimetabolites|antimetabolites|mesh-ancestor
6632650|NCT05251038|Antiviral Agents|antiviral agents|mesh-ancestor
6632651|NCT05251038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6632652|NCT05251038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6632653|NCT05251038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6632654|NCT05251038|Immunologic Factors|immunologic factors|mesh-ancestor
6632655|NCT05251038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632656|NCT05251038|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6632657|NCT05251038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6632658|NCT05251038|Antidotes|antidotes|mesh-ancestor
6632659|NCT05251038|Protective Agents|protective agents|mesh-ancestor
6632660|NCT05251038|Vitamin B Complex|vitamin b complex|mesh-ancestor
6632661|NCT05251038|Vitamins|vitamins|mesh-ancestor
6632662|NCT05251038|Micronutrients|micronutrients|mesh-ancestor
6632663|NCT05250895|Misonidazole|misonidazole|mesh-list
6632664|NCT05250895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6632665|NCT05250895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6632666|NCT05250895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6632667|NCT05250895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6632668|NCT05250843|Lenvatinib|lenvatinib|mesh-list
6632669|NCT05250843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6632670|NCT05250843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6632671|NCT05250843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6632672|NCT05250843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632673|NCT05250791|Lidocaine|lidocaine|mesh-list
6632674|NCT05250791|Anesthetics, Local|anesthetics, local|mesh-ancestor
6632675|NCT05250791|Anesthetics|anesthetics|mesh-ancestor
6632676|NCT05250791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6632677|NCT05250791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632678|NCT05250791|Sensory System Agents|sensory system agents|mesh-ancestor
6632679|NCT05250791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6632680|NCT05250791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6632681|NCT05250791|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6632682|NCT05250791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6632683|NCT05250791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6632684|NCT05250791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632685|NCT05250752|Dapagliflozin|dapagliflozin|mesh-list
6632686|NCT05250752|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6632687|NCT05250752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632688|NCT05250752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6632689|NCT05250752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632690|NCT05250661|Propolis|propolis|mesh-list
6632691|NCT05250661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6632692|NCT05250596|Colchicine|colchicine|mesh-list
6632693|NCT05250596|Atorvastatin|atorvastatin|mesh-list
6632694|NCT05250596|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6632695|NCT05250596|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6632696|NCT05250596|Antimetabolites|antimetabolites|mesh-ancestor
6632697|NCT05250596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632698|NCT05250596|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6632699|NCT05250596|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6632700|NCT05250596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6632701|NCT05250596|Gout Suppressants|gout suppressants|mesh-ancestor
6632702|NCT05250596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6632703|NCT05250596|Tubulin Modulators|tubulin modulators|mesh-ancestor
6632704|NCT05250596|Antimitotic Agents|antimitotic agents|mesh-ancestor
6632705|NCT05250596|Mitosis Modulators|mitosis modulators|mesh-ancestor
6632706|NCT05250596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6662841|NCT01505127|Clarithromycin|clarithromycin|mesh-list
6662842|NCT01505127|Lansoprazole|lansoprazole|mesh-list
6662843|NCT01505127|Dexlansoprazole|dexlansoprazole|mesh-list
6662844|NCT01505127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6662845|NCT01505127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6662846|NCT01505127|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6662847|NCT01505127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6662848|NCT01505127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662849|NCT01505127|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6662850|NCT01505127|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6662851|NCT01505127|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6662852|NCT01505127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6662853|NCT01505127|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6662854|NCT01505218|Propofol|propofol|mesh-list
6662855|NCT01505218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6632707|NCT05250245|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6632708|NCT05250245|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6632709|NCT05250245|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6632710|NCT05250245|Cholinergic Agents|cholinergic agents|mesh-ancestor
6632711|NCT05250245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6632712|NCT05250245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632713|NCT05250245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632714|NCT05250245|Urological Agents|urological agents|mesh-ancestor
6632725|NCT05250050|Amoxicillin|amoxicillin|mesh-list
6632726|NCT05250050|Metronidazole|metronidazole|mesh-list
6632727|NCT05250050|Clarithromycin|clarithromycin|mesh-list
6632728|NCT05250050|Levofloxacin|levofloxacin|mesh-list
6632729|NCT05250050|Tetracycline|tetracycline|mesh-list
6632730|NCT05250050|Potassium Citrate|potassium citrate|mesh-list
6632731|NCT05250050|Esomeprazole|esomeprazole|mesh-list
6632732|NCT05250050|Bismuth|bismuth|mesh-list
6632733|NCT05250050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632734|NCT05250050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6632735|NCT05250050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6632736|NCT05250050|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6632737|NCT05250050|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6632738|NCT05250050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6632739|NCT05250050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6632740|NCT05250050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6632741|NCT05250050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6632742|NCT05250050|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6632743|NCT05250050|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6632744|NCT05250050|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6632745|NCT05250050|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6632746|NCT05250050|Renal Agents|renal agents|mesh-ancestor
6632747|NCT05250050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6632748|NCT05250050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6632749|NCT05250050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6632750|NCT05250050|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6632751|NCT05250050|Antacids|antacids|mesh-ancestor
6632752|NCT05250050|Diuretics|diuretics|mesh-ancestor
6632753|NCT05250050|Natriuretic Agents|natriuretic agents|mesh-ancestor
6632754|NCT05250050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632755|NCT05250050|Expectorants|expectorants|mesh-ancestor
6632756|NCT05250050|Respiratory System Agents|respiratory system agents|mesh-ancestor
6632757|NCT05250011|Dapagliflozin|dapagliflozin|mesh-list
6632758|NCT05250011|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6632759|NCT05250011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632760|NCT05250011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6632761|NCT05250011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632762|NCT05249972|Calcitriol|calcitriol|mesh-list
6632763|NCT05249972|Betamethasone|betamethasone|mesh-list
6632764|NCT05249972|Betamethasone Valerate|betamethasone valerate|mesh-list
6632765|NCT05249972|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
6632766|NCT05249972|Betamethasone benzoate|betamethasone benzoate|mesh-list
6632767|NCT05249972|Calcipotriene|calcipotriene|mesh-list
6632768|NCT05249972|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
6632769|NCT05249972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6632770|NCT05249972|Glucocorticoids|glucocorticoids|mesh-ancestor
6632771|NCT05249972|Hormones|hormones|mesh-ancestor
6632772|NCT05249972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6632773|NCT05249972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632774|NCT05249972|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5482411|NCT03043729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5482412|NCT03043729|Vitamin B Complex|vitamin b complex|mesh-ancestor
5482413|NCT03043729|Vitamins|vitamins|mesh-ancestor
5482414|NCT03043729|Micronutrients|micronutrients|mesh-ancestor
6632775|NCT05249972|Respiratory System Agents|respiratory system agents|mesh-ancestor
6632776|NCT05249972|Dermatologic Agents|dermatologic agents|mesh-ancestor
6632777|NCT05249972|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6632778|NCT05249972|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6632779|NCT05249972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6632780|NCT05249972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632781|NCT05249972|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6632782|NCT05249972|Vitamins|vitamins|mesh-ancestor
6632783|NCT05249972|Micronutrients|micronutrients|mesh-ancestor
6632784|NCT05249972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6632785|NCT05249959|Rituximab|rituximab|mesh-list
6632786|NCT05249959|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
6632787|NCT05249959|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6632788|NCT05249959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6632789|NCT05249959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6632790|NCT05249959|Immunologic Factors|immunologic factors|mesh-ancestor
6632791|NCT05249959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632792|NCT05249959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6632793|NCT05249959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6632794|NCT05249959|Alkylating Agents|alkylating agents|mesh-ancestor
6632795|NCT05249959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632796|NCT05249933|Benzocaine|benzocaine|mesh-list
6632797|NCT05249933|Anesthetics, Local|anesthetics, local|mesh-ancestor
6632798|NCT05249933|Anesthetics|anesthetics|mesh-ancestor
5482415|NCT03043729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5482416|NCT03043729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5482417|NCT03043729|Growth Substances|growth substances|mesh-ancestor
5482418|NCT03043729|Growth Inhibitors|growth inhibitors|mesh-ancestor
5482419|NCT03018080|Paclitaxel|paclitaxel|mesh-list
5482420|NCT03018080|Pembrolizumab|pembrolizumab|mesh-list
5482421|NCT03018080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5482422|NCT03018080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5482423|NCT03018080|Tubulin Modulators|tubulin modulators|mesh-ancestor
5482424|NCT03018080|Antimitotic Agents|antimitotic agents|mesh-ancestor
5482425|NCT03018080|Mitosis Modulators|mitosis modulators|mesh-ancestor
5482426|NCT03018080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5482427|NCT03018080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5482428|NCT02973789|Docetaxel|docetaxel|mesh-list
5482429|NCT02973789|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5482430|NCT02973789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5482431|NCT02973789|Tubulin Modulators|tubulin modulators|mesh-ancestor
5482432|NCT02973789|Antimitotic Agents|antimitotic agents|mesh-ancestor
6632799|NCT05249933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6632800|NCT05249933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632801|NCT05249933|Sensory System Agents|sensory system agents|mesh-ancestor
6632802|NCT05249933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6632803|NCT05249920|Edaravone|edaravone|mesh-list
6632804|NCT05249920|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6632805|NCT05249920|Antioxidants|antioxidants|mesh-ancestor
6451925|NCT00414336|Immunologic Factors|immunologic factors|mesh-ancestor
6451926|NCT00414336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451927|NCT00414336|Antacids|antacids|mesh-ancestor
6451928|NCT00414336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451929|NCT00414336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6451930|NCT00414349|Analgesics|analgesics|mesh-list
6451931|NCT00414349|Sensory System Agents|sensory system agents|mesh-ancestor
6451932|NCT00414349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6451933|NCT00414349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451934|NCT00414414|Prednisone|prednisone|mesh-list
6451935|NCT00414414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6451936|NCT00414414|Glucocorticoids|glucocorticoids|mesh-ancestor
6451937|NCT00414414|Hormones|hormones|mesh-ancestor
6451938|NCT00414414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6451939|NCT00414414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451940|NCT00414414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5482433|NCT02973789|Mitosis Modulators|mitosis modulators|mesh-ancestor
5482434|NCT02973789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5482435|NCT02932475|Metformin|metformin|mesh-list
5482436|NCT02932475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5482437|NCT02932475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632806|NCT05249920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632807|NCT05249920|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6632808|NCT05249920|Protective Agents|protective agents|mesh-ancestor
6632809|NCT05249920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632810|NCT05249751|Arginine Vasopressin|arginine vasopressin|mesh-list
6632811|NCT05249751|Hemostatics|hemostatics|mesh-ancestor
5482438|NCT02914938|Rituximab|rituximab|mesh-list
5482439|NCT02914938|Zanubrutinib|zanubrutinib|mesh-list
5482440|NCT02914938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6632812|NCT05249751|Coagulants|coagulants|mesh-ancestor
6632813|NCT05249751|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5482441|NCT02914938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5482442|NCT02914938|Immunologic Factors|immunologic factors|mesh-ancestor
5482443|NCT02914938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5482444|NCT02914938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5482445|NCT02914938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5482446|NCT02914938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5482447|NCT02914938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5482448|NCT02899052|Dexamethasone|dexamethasone|mesh-list
5482449|NCT02899052|Venetoclax|venetoclax|mesh-list
5482450|NCT02899052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5482451|NCT02899052|Antiemetics|antiemetics|mesh-ancestor
5482452|NCT02899052|Autonomic Agents|autonomic agents|mesh-ancestor
5482453|NCT02899052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5482454|NCT02899052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5482455|NCT02899052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5482456|NCT02899052|Glucocorticoids|glucocorticoids|mesh-ancestor
5482457|NCT02899052|Hormones|hormones|mesh-ancestor
5482458|NCT02899052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6632814|NCT05249751|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6632815|NCT05249751|Natriuretic Agents|natriuretic agents|mesh-ancestor
6632816|NCT05249751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632817|NCT05249725|Irsogladine|irsogladine|mesh-list
6632818|NCT05249725|Hydrotalcite|hydrotalcite|mesh-list
6632819|NCT05249725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5482459|NCT02899052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5482460|NCT02899052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5482461|NCT02891538|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
5482462|NCT02891538|Antioxidants|antioxidants|mesh-ancestor
5482463|NCT02891538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5482464|NCT02891538|Protective Agents|protective agents|mesh-ancestor
6632820|NCT05249725|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6632821|NCT05249725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6632822|NCT05249725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6632823|NCT05249725|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6632824|NCT05249725|Protective Agents|protective agents|mesh-ancestor
6632825|NCT05249725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632826|NCT05249725|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6632827|NCT05249725|Antacids|antacids|mesh-ancestor
6632828|NCT05249712|Androgens|androgens|mesh-list
6632829|NCT05249712|Hormones|hormones|mesh-ancestor
6632830|NCT05249712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6632831|NCT05249712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632832|NCT05249699|Isoniazid|isoniazid|mesh-list
6632833|NCT05249699|Antitubercular Agents|antitubercular agents|mesh-list
6632834|NCT05249699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6632835|NCT05249699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6632836|NCT05249699|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6632837|NCT05249699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6632838|NCT05249699|Antimetabolites|antimetabolites|mesh-ancestor
6632839|NCT05249699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632840|NCT05249699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6632841|NCT05246046|Bromides|bromides|mesh-list
6632842|NCT05246046|Tiotropium Bromide|tiotropium bromide|mesh-list
6632843|NCT05246046|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6632844|NCT05246046|Autonomic Agents|autonomic agents|mesh-ancestor
6632845|NCT05246046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6632846|NCT05246046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632847|NCT05246046|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6632848|NCT05246046|Respiratory System Agents|respiratory system agents|mesh-ancestor
6632849|NCT05246046|Parasympatholytics|parasympatholytics|mesh-ancestor
6632850|NCT05246046|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6632851|NCT05246046|Cholinergic Agents|cholinergic agents|mesh-ancestor
6632852|NCT05246046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5502413|NCT04466670|Anticoagulants|anticoagulants|mesh-ancestor
6632853|NCT05246046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632854|NCT05246046|Anticonvulsants|anticonvulsants|mesh-ancestor
6632855|NCT05244538|Remifentanil|remifentanil|mesh-list
6632856|NCT05244538|Propofol|propofol|mesh-list
6632857|NCT05244538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6632858|NCT05244538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6632859|NCT05244538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632860|NCT05244538|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6632861|NCT05244538|Anesthetics, General|anesthetics, general|mesh-ancestor
6632862|NCT05244538|Anesthetics|anesthetics|mesh-ancestor
6632863|NCT05244538|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6632864|NCT05244538|Narcotics|narcotics|mesh-ancestor
6632865|NCT05244538|Analgesics|analgesics|mesh-ancestor
6632866|NCT05244538|Sensory System Agents|sensory system agents|mesh-ancestor
6632867|NCT05244538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6632868|NCT05239468|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
6632869|NCT05239468|Bezafibrate|bezafibrate|mesh-list
6632870|NCT05239468|Cathartics|cathartics|mesh-ancestor
6632871|NCT05239468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6632872|NCT05239468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6632873|NCT05239468|Antimetabolites|antimetabolites|mesh-ancestor
6632874|NCT05239468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632875|NCT05239468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6632876|NCT05227833|Pantoprazole|pantoprazole|mesh-list
6632877|NCT05227833|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6632878|NCT05227833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6632879|NCT05227833|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6632880|NCT05227833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6632881|NCT05227833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632882|NCT05227612|Psilocybin|psilocybin|mesh-list
6632883|NCT05227612|Hallucinogens|hallucinogens|mesh-ancestor
6632884|NCT05227612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632885|NCT05227612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6632886|NCT05227456|Etonogestrel|etonogestrel|mesh-list
6632887|NCT05227456|Desogestrel|desogestrel|mesh-list
6632888|NCT05227456|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6632889|NCT05227456|Contraceptive Agents|contraceptive agents|mesh-ancestor
6632890|NCT05227456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6632891|NCT05227456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632892|NCT05227456|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6632893|NCT05227456|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6632894|NCT05227456|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6632895|NCT05227456|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6632896|NCT05227456|Progestins|progestins|mesh-ancestor
6632897|NCT05227456|Hormones|hormones|mesh-ancestor
6632898|NCT05227456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6632899|NCT05226442|Heparin|heparin|mesh-list
6632900|NCT05226442|Calcium heparin|calcium heparin|mesh-list
5482465|NCT02891538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5482466|NCT02891538|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
5482467|NCT02891538|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5482468|NCT02891538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5482469|NCT02891538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5482470|NCT02884206|Valsartan|valsartan|mesh-list
5482471|NCT02884206|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5482472|NCT02884206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5482473|NCT02884206|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5502414|NCT04466540|Hydroxychloroquine|hydroxychloroquine|mesh-list
6451941|NCT00414414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6451942|NCT00414531|Atorvastatin|atorvastatin|mesh-list
6451943|NCT00414531|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6451944|NCT00414531|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6451945|NCT00414531|Antimetabolites|antimetabolites|mesh-ancestor
6451946|NCT00414531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451947|NCT00414531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6451948|NCT00414531|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6451949|NCT00414531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6451950|NCT00414648|Sirolimus|sirolimus|mesh-list
6451951|NCT00414648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6451952|NCT00414648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6451953|NCT00414648|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6451954|NCT00414648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6451955|NCT00414648|Antifungal Agents|antifungal agents|mesh-ancestor
6632901|NCT05226442|Argatroban|argatroban|mesh-list
6632902|NCT05226442|Anticoagulants|anticoagulants|mesh-ancestor
6632903|NCT05226442|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6632904|NCT05226442|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6632905|NCT05226442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632906|NCT05226442|Antithrombins|antithrombins|mesh-ancestor
6632907|NCT05226442|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6632908|NCT05226442|Protease Inhibitors|protease inhibitors|mesh-ancestor
6632909|NCT05226442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6632910|NCT05226442|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6632911|NCT05220319|Methylprednisolone|methylprednisolone|mesh-list
6632912|NCT05220319|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6632913|NCT05220319|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6632914|NCT05220319|Prednisolone|prednisolone|mesh-list
6632915|NCT05220319|Prednisolone acetate|prednisolone acetate|mesh-list
6632916|NCT05220319|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6632917|NCT05220319|Prednisolone phosphate|prednisolone phosphate|mesh-list
6632918|NCT05220319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6632919|NCT05220319|Antiemetics|antiemetics|mesh-ancestor
6632920|NCT05220319|Autonomic Agents|autonomic agents|mesh-ancestor
6632921|NCT05220319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6632922|NCT05220319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632923|NCT05220319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6632924|NCT05220319|Glucocorticoids|glucocorticoids|mesh-ancestor
6632925|NCT05220319|Hormones|hormones|mesh-ancestor
6632926|NCT05220319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6632927|NCT05220319|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6632928|NCT05220319|Protective Agents|protective agents|mesh-ancestor
6632929|NCT05220319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6632930|NCT05220319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6632931|NCT05214066|Thymoglobulin|thymoglobulin|mesh-list
6632932|NCT05214066|Immunologic Factors|immunologic factors|mesh-ancestor
6632933|NCT05214066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632934|NCT05214066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6662856|NCT01505218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6662857|NCT01505218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662858|NCT01505218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6662859|NCT01505218|Anesthetics, General|anesthetics, general|mesh-ancestor
6662860|NCT01505218|Anesthetics|anesthetics|mesh-ancestor
6662861|NCT01505231|Vasopressins|vasopressins|mesh-list
6662862|NCT01505231|Arginine Vasopressin|arginine vasopressin|mesh-list
6662863|NCT01505231|Norepinephrine|norepinephrine|mesh-list
6662864|NCT01505231|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6662865|NCT01505231|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6662866|NCT01505231|Adrenergic Agents|adrenergic agents|mesh-ancestor
6662867|NCT01505231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6662868|NCT01505231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662869|NCT01505231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662870|NCT01505231|Sympathomimetics|sympathomimetics|mesh-ancestor
6662871|NCT01505231|Autonomic Agents|autonomic agents|mesh-ancestor
6662872|NCT01505231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6662873|NCT01505231|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6662874|NCT01505231|Hemostatics|hemostatics|mesh-ancestor
5482474|NCT02884206|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5482475|NCT02884206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5482476|NCT02840136|Meropenem|meropenem|mesh-list
5482477|NCT02840136|Tazobactam|tazobactam|mesh-list
5482478|NCT02840136|Piperacillin|piperacillin|mesh-list
5482479|NCT02840136|Ceftazidime|ceftazidime|mesh-list
5482480|NCT02840136|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
5482481|NCT02840136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5482482|NCT02840136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5482483|NCT02840136|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5482484|NCT02840136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6451956|NCT00414648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6451957|NCT00414648|Immunologic Factors|immunologic factors|mesh-ancestor
6451958|NCT00414648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451959|NCT00414687|Iloprost|iloprost|mesh-list
6451960|NCT00414687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6451961|NCT00414687|Vasodilator Agents|vasodilator agents|mesh-ancestor
6451962|NCT00414739|Benzalkonium Compounds|benzalkonium compounds|mesh-list
6451963|NCT00414739|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6451964|NCT00414739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6451965|NCT00414921|Clonidine|clonidine|mesh-list
6451966|NCT00414921|Methylphenidate|methylphenidate|mesh-list
6451967|NCT00414921|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6662875|NCT01505231|Coagulants|coagulants|mesh-ancestor
6662876|NCT01505231|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6662877|NCT01505231|Natriuretic Agents|natriuretic agents|mesh-ancestor
6632935|NCT05211024|Penicillins|penicillins|mesh-list
6632936|NCT05211024|Penicillin G|penicillin g|mesh-list
6632937|NCT05211024|Penicillin G Benzathine|penicillin g benzathine|mesh-list
6632938|NCT05211024|Penicillin G Procaine|penicillin g procaine|mesh-list
6632939|NCT05211024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6632940|NCT05211024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6632941|NCT05206266|Turmeric extract|turmeric extract|mesh-list
6632942|NCT05206266|Antioxidants|antioxidants|mesh-ancestor
6632943|NCT05206266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632944|NCT05206266|Protective Agents|protective agents|mesh-ancestor
6632945|NCT05206266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632946|NCT05204290|Pembrolizumab|pembrolizumab|mesh-list
6632947|NCT05204290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6632948|NCT05204290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6632949|NCT05202353|Liraglutide|liraglutide|mesh-list
6632950|NCT05202353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6632951|NCT05202353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632952|NCT05202353|Incretins|incretins|mesh-ancestor
6632953|NCT05202353|Hormones|hormones|mesh-ancestor
6632954|NCT05202353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6632955|NCT05198128|Calcium|calcium|mesh-list
6632956|NCT05198128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6632957|NCT05198128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632958|NCT05193396|Hydrocortisone|hydrocortisone|mesh-list
6632959|NCT05193396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6632960|NCT05182840|Empagliflozin|empagliflozin|mesh-list
6632961|NCT05182840|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6632962|NCT05182840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632963|NCT05182840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6632964|NCT05182840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632968|NCT05178888|Palbociclib|palbociclib|mesh-list
6632969|NCT05178888|Adagrasib|adagrasib|mesh-list
6632970|NCT05178888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6632971|NCT05178888|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6632972|NCT05178888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6632973|NCT05178888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5482485|NCT02840136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5482486|NCT02820961|Exemestane|exemestane|mesh-list
5482487|NCT02820961|Entinostat|entinostat|mesh-list
5482488|NCT02820961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5482489|NCT02820961|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5502415|NCT04466540|Antimalarials|antimalarials|mesh-ancestor
6632974|NCT05170334|Belinostat|belinostat|mesh-list
6632975|NCT05170334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6632976|NCT05170334|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6632977|NCT05170334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6632978|NCT05170334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632979|NCT05164549|Buprenorphine|buprenorphine|mesh-list
6632980|NCT05164549|Methadone|methadone|mesh-list
6632981|NCT05164549|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6632982|NCT05164549|Narcotics|narcotics|mesh-ancestor
6632983|NCT05164549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6632984|NCT05164549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6632985|NCT05164549|Analgesics|analgesics|mesh-ancestor
6632986|NCT05164549|Sensory System Agents|sensory system agents|mesh-ancestor
6632987|NCT05164549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6632988|NCT05164549|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6632989|NCT05164549|Antitussive Agents|antitussive agents|mesh-ancestor
6632990|NCT05164549|Respiratory System Agents|respiratory system agents|mesh-ancestor
6632991|NCT05162274|Lazertinib|lazertinib|mesh-list
6451968|NCT00414921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451969|NCT00414921|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6632992|NCT05162274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6632993|NCT05162274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6632994|NCT05162274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6632995|NCT05157698|Naltrexone|naltrexone|mesh-list
6632996|NCT05157698|Bupropion|bupropion|mesh-list
6632997|NCT05157698|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6632998|NCT05157698|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6632999|NCT05157698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633000|NCT05157698|Sensory System Agents|sensory system agents|mesh-ancestor
6633001|NCT05157698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6633002|NCT05157698|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6633003|NCT05157698|Antidepressive Agents|antidepressive agents|mesh-ancestor
6633004|NCT05157698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6633005|NCT05157698|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6633006|NCT05157698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6633007|NCT05157698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6633008|NCT05157698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633009|NCT05157698|Dopamine Agents|dopamine agents|mesh-ancestor
6633010|NCT05157698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6633011|NCT05157698|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6633012|NCT05157698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6633013|NCT05157698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6633014|NCT05156281|Teriflunomide|teriflunomide|mesh-list
6633015|NCT05156281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6633016|NCT05156281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6633017|NCT05156281|Analgesics|analgesics|mesh-ancestor
6633018|NCT05156281|Sensory System Agents|sensory system agents|mesh-ancestor
6633019|NCT05156281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6633020|NCT05156281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633021|NCT05156281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6633022|NCT05156281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6633023|NCT05156281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6633024|NCT05156281|Immunologic Factors|immunologic factors|mesh-ancestor
6633025|NCT05154279|Terlipressin|terlipressin|mesh-list
6633026|NCT05154279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6633027|NCT05154279|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6633028|NCT05148312|Budesonide|budesonide|mesh-list
6633029|NCT05148312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6633030|NCT05148312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6633031|NCT05148312|Autonomic Agents|autonomic agents|mesh-ancestor
6633032|NCT05148312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5482490|NCT02820961|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5482491|NCT02820961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5482492|NCT02820961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5482493|NCT02820961|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5482494|NCT02820961|Hormone Antagonists|hormone antagonists|mesh-ancestor
5482495|NCT02820961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5482496|NCT02820961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5482497|NCT02820961|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6451970|NCT00414921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6451971|NCT00414921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6451972|NCT00414921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451973|NCT00414921|Dopamine Agents|dopamine agents|mesh-ancestor
6451974|NCT00414921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5482498|NCT02804932|Methamphetamine|methamphetamine|mesh-list
5482499|NCT02804932|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5482500|NCT02804932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5482501|NCT02804932|Sympathomimetics|sympathomimetics|mesh-ancestor
5482502|NCT02804932|Autonomic Agents|autonomic agents|mesh-ancestor
5482503|NCT02804932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5482504|NCT02804932|Dopamine Agents|dopamine agents|mesh-ancestor
5482505|NCT02804932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5482506|NCT02804932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724870|NCT03184649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6451975|NCT00414921|Analgesics|analgesics|mesh-ancestor
6451976|NCT00414921|Sensory System Agents|sensory system agents|mesh-ancestor
6451977|NCT00414921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6451978|NCT00414921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6451979|NCT00414921|Sympatholytics|sympatholytics|mesh-ancestor
6451980|NCT00414921|Autonomic Agents|autonomic agents|mesh-ancestor
6633033|NCT05148312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633034|NCT05148312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6633035|NCT05148312|Respiratory System Agents|respiratory system agents|mesh-ancestor
6633036|NCT05148312|Glucocorticoids|glucocorticoids|mesh-ancestor
6633037|NCT05148312|Hormones|hormones|mesh-ancestor
6633038|NCT05148312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6633039|NCT05147376|Curcumin|curcumin|mesh-list
6633040|NCT05147376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6633041|NCT05147376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6633042|NCT05147376|Analgesics|analgesics|mesh-ancestor
6633043|NCT05147376|Sensory System Agents|sensory system agents|mesh-ancestor
6633044|NCT05147376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6633045|NCT05147376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633046|NCT05147376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6633047|NCT05147376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6633048|NCT05147376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6633049|NCT05147376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6633050|NCT05147376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633051|NCT05137262|Cisplatin|cisplatin|mesh-list
6633052|NCT05137262|Doxorubicin|doxorubicin|mesh-list
6633053|NCT05137262|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6633054|NCT05137262|Methotrexate|methotrexate|mesh-list
6633055|NCT05137262|Durvalumab|durvalumab|mesh-list
6633056|NCT05137262|Abiraterone Acetate|abiraterone acetate|mesh-list
6633057|NCT05137262|Vinblastine|vinblastine|mesh-list
6633058|NCT05137262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6633059|NCT05137262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6633060|NCT05137262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6633061|NCT05137262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5482507|NCT02804932|Adrenergic Agents|adrenergic agents|mesh-ancestor
5482508|NCT02804932|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5482509|NCT02804932|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5482510|NCT02804932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5482511|NCT02804932|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5482512|NCT02722941|Panobinostat|panobinostat|mesh-list
5482513|NCT02722941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5482514|NCT02722941|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5482515|NCT02722941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5482516|NCT02722941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5482517|NCT02704390|Methylphenidate|methylphenidate|mesh-list
5482518|NCT02704390|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5482519|NCT02704390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5482520|NCT02704390|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5482521|NCT02704390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5482522|NCT02704390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5482523|NCT02704390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5482524|NCT02704390|Dopamine Agents|dopamine agents|mesh-ancestor
5482525|NCT02704390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5482526|NCT02659930|Doxorubicin|doxorubicin|mesh-list
5482527|NCT02659930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5482528|NCT02659930|Pomalidomide|pomalidomide|mesh-list
5482529|NCT02659930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5482530|NCT02659930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5482531|NCT02659930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5482532|NCT02659930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5482533|NCT02659930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6633062|NCT05137262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6633063|NCT05137262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633064|NCT05137262|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6633065|NCT05137262|Abortifacient Agents|abortifacient agents|mesh-ancestor
6633066|NCT05137262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6633067|NCT05137262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633068|NCT05137262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6633069|NCT05137262|Antimetabolites|antimetabolites|mesh-ancestor
6633070|NCT05137262|Dermatologic Agents|dermatologic agents|mesh-ancestor
6633071|NCT05137262|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6633072|NCT05137262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6633073|NCT05137262|Immunologic Factors|immunologic factors|mesh-ancestor
6633074|NCT05137262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6633075|NCT05137262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6633076|NCT05137262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5502416|NCT04466540|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6633077|NCT05137262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5482534|NCT02659930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5482535|NCT02659930|Immunologic Factors|immunologic factors|mesh-ancestor
5482536|NCT02659930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5482537|NCT02659930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5482538|NCT02659930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5482539|NCT02659930|Growth Substances|growth substances|mesh-ancestor
5482540|NCT02659930|Growth Inhibitors|growth inhibitors|mesh-ancestor
6633078|NCT05137262|Hormone Antagonists|hormone antagonists|mesh-ancestor
6633079|NCT05137262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6633080|NCT05137262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6633081|NCT05137262|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6633082|NCT05137262|Tubulin Modulators|tubulin modulators|mesh-ancestor
6633083|NCT05137262|Antimitotic Agents|antimitotic agents|mesh-ancestor
6633084|NCT05137262|Mitosis Modulators|mitosis modulators|mesh-ancestor
6633085|NCT05130463|Empagliflozin|empagliflozin|mesh-list
6633086|NCT05130463|Linagliptin|linagliptin|mesh-list
6633087|NCT05130463|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6633088|NCT05130463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633089|NCT05130463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6633090|NCT05130463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633091|NCT05130463|Incretins|incretins|mesh-ancestor
6633092|NCT05130463|Hormones|hormones|mesh-ancestor
6633093|NCT05130463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6633094|NCT05130463|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6633095|NCT05130463|Protease Inhibitors|protease inhibitors|mesh-ancestor
6633096|NCT05130463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6633097|NCT05128773|Tamoxifen|tamoxifen|mesh-list
6633098|NCT05128773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6633099|NCT05128773|Hormone Antagonists|hormone antagonists|mesh-ancestor
6633100|NCT05128773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6633101|NCT05128773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633102|NCT05128773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6633103|NCT05128773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6633104|NCT05128773|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6662878|NCT01505283|Lidocaine|lidocaine|mesh-list
5482541|NCT02643381|Ketamine|ketamine|mesh-list
5482542|NCT02643381|Etomidate|etomidate|mesh-list
5482543|NCT02643381|Analgesics|analgesics|mesh-ancestor
5482544|NCT02643381|Sensory System Agents|sensory system agents|mesh-ancestor
5482545|NCT02643381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5482546|NCT02643381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5482547|NCT02643381|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5482548|NCT02643381|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5482549|NCT02643381|Anesthetics, General|anesthetics, general|mesh-ancestor
5482550|NCT02643381|Anesthetics|anesthetics|mesh-ancestor
5482551|NCT02643381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5482552|NCT02643381|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5482553|NCT02643381|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5482554|NCT02643381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5482555|NCT02643381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5482556|NCT02643381|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5482557|NCT02611960|Gemcitabine|gemcitabine|mesh-list
5482558|NCT02611960|Capecitabine|capecitabine|mesh-list
5482559|NCT02611960|Docetaxel|docetaxel|mesh-list
6451981|NCT00414921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6451982|NCT00414921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6451983|NCT00414921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6451984|NCT00414921|Adrenergic Agents|adrenergic agents|mesh-ancestor
6451985|NCT00414947|Vildagliptin|vildagliptin|mesh-list
6451986|NCT00414947|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6451987|NCT00414947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451988|NCT00414947|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6451989|NCT00414947|Protease Inhibitors|protease inhibitors|mesh-ancestor
6451990|NCT00414947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6451991|NCT00414947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6451992|NCT00415064|Dexamethasone|dexamethasone|mesh-list
6451993|NCT00415064|Lenalidomide|lenalidomide|mesh-list
6451994|NCT00415064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6451995|NCT00415064|Antiemetics|antiemetics|mesh-ancestor
6451996|NCT00415064|Autonomic Agents|autonomic agents|mesh-ancestor
6451997|NCT00415064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6451998|NCT00415064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6451999|NCT00415064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6633105|NCT05128773|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6633106|NCT05128773|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5482560|NCT02611960|Pembrolizumab|pembrolizumab|mesh-list
5482561|NCT02611960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5482562|NCT02611960|Antimetabolites|antimetabolites|mesh-ancestor
5482563|NCT02611960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5482564|NCT02611960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5482565|NCT02611960|Antiviral Agents|antiviral agents|mesh-ancestor
5482566|NCT02611960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5482567|NCT02611960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5482568|NCT02611960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5482569|NCT02611960|Immunologic Factors|immunologic factors|mesh-ancestor
6633107|NCT05124691|Ivermectin|ivermectin|mesh-list
6633108|NCT05124691|Albendazole|albendazole|mesh-list
6633109|NCT05124691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6633110|NCT05124691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6633111|NCT05124691|Anthelmintics|anthelmintics|mesh-ancestor
6633112|NCT05124691|Anticestodal Agents|anticestodal agents|mesh-ancestor
6633113|NCT05124691|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6633114|NCT05124691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5482570|NCT02611960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5482571|NCT02611960|Tubulin Modulators|tubulin modulators|mesh-ancestor
5482572|NCT02611960|Antimitotic Agents|antimitotic agents|mesh-ancestor
5482573|NCT02611960|Mitosis Modulators|mitosis modulators|mesh-ancestor
5482574|NCT02611960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5482575|NCT02603900|Bupivacaine|bupivacaine|mesh-list
5482576|NCT02603900|Ropivacaine|ropivacaine|mesh-list
5482577|NCT02603900|Anesthetics, Local|anesthetics, local|mesh-ancestor
5482578|NCT02603900|Anesthetics|anesthetics|mesh-ancestor
5482579|NCT02603900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5482580|NCT02603900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5482581|NCT02603900|Sensory System Agents|sensory system agents|mesh-ancestor
5482582|NCT02603900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5482583|NCT02595372|Omeprazole|omeprazole|mesh-list
5482584|NCT02595372|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5482585|NCT02595372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5482586|NCT02595372|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5482587|NCT02595372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5482588|NCT02595372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5482589|NCT02521844|Pembrolizumab|pembrolizumab|mesh-list
5482590|NCT02521844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5482591|NCT02521844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5482592|NCT02434354|Pembrolizumab|pembrolizumab|mesh-list
6633115|NCT05124691|Tubulin Modulators|tubulin modulators|mesh-ancestor
6633116|NCT05124691|Antimitotic Agents|antimitotic agents|mesh-ancestor
6633117|NCT05124691|Mitosis Modulators|mitosis modulators|mesh-ancestor
6633118|NCT05124691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633119|NCT05124691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6633120|NCT05119101|Magnesium Sulfate|magnesium sulfate|mesh-list
6633121|NCT05119101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6633122|NCT05119101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633123|NCT05119101|Analgesics|analgesics|mesh-ancestor
6633124|NCT05119101|Sensory System Agents|sensory system agents|mesh-ancestor
6633125|NCT05119101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6633126|NCT05119101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633127|NCT05119101|Anesthetics|anesthetics|mesh-ancestor
6633128|NCT05119101|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6633129|NCT05119101|Anticonvulsants|anticonvulsants|mesh-ancestor
6633130|NCT05119101|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6633131|NCT05119101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6633132|NCT05119101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6633133|NCT05119101|Tocolytic Agents|tocolytic agents|mesh-ancestor
6633134|NCT05119101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6633135|NCT05118477|Caffeine|caffeine|mesh-list
6633136|NCT05118477|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6633137|NCT05118477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633138|NCT05118477|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6633139|NCT05118477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6633140|NCT05118477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633141|NCT05118477|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6633142|NCT05118477|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5482593|NCT02434354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5482594|NCT02434354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5482595|NCT02334722|Levetiracetam|levetiracetam|mesh-list
5482596|NCT02334722|Anticonvulsants|anticonvulsants|mesh-ancestor
6633143|NCT05118477|Purinergic Agents|purinergic agents|mesh-ancestor
6633144|NCT05118477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6633145|NCT05109455|Proanthocyanidin|proanthocyanidin|mesh-list
6633146|NCT05109455|Procyanidin|procyanidin|mesh-list
6633147|NCT05109455|Antioxidants|antioxidants|mesh-ancestor
6633148|NCT05109455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633149|NCT05109455|Protective Agents|protective agents|mesh-ancestor
6633150|NCT05109455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633151|NCT05109455|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6633152|NCT05109455|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6633153|NCT05109455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6633154|NCT05105841|Venetoclax|venetoclax|mesh-list
6633155|NCT05105841|Obinutuzumab|obinutuzumab|mesh-list
6633156|NCT05105841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6633157|NCT05105841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6633158|NCT05090657|Chlorhexidine|chlorhexidine|mesh-list
6633159|NCT05090657|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6633160|NCT05090657|Methylene Blue|methylene blue|mesh-list
6633161|NCT05090657|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6633162|NCT05090657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6633163|NCT05090657|Disinfectants|disinfectants|mesh-ancestor
6633164|NCT05090657|Dermatologic Agents|dermatologic agents|mesh-ancestor
6633165|NCT05090657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6633166|NCT05090657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633167|NCT05075980|Cisplatin|cisplatin|mesh-list
6633168|NCT05075980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6633169|NCT05073250|Rituximab|rituximab|mesh-list
6633170|NCT05073250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6633171|NCT05073250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6633172|NCT05073250|Immunologic Factors|immunologic factors|mesh-ancestor
6633173|NCT05073250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633174|NCT05073250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6633175|NCT05070403|Afatinib|afatinib|mesh-list
6633176|NCT05070403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6633177|NCT05070403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6633178|NCT05070403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6633179|NCT05070403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633180|NCT05065190|Nintedanib|nintedanib|mesh-list
6633181|NCT05065190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6633182|NCT05065190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6633183|NCT05065190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6633184|NCT05065190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633185|NCT05063565|Durvalumab|durvalumab|mesh-list
6633186|NCT05063565|Tremelimumab|tremelimumab|mesh-list
6633187|NCT05063565|Immunologic Factors|immunologic factors|mesh-list
5482597|NCT02334722|Nootropic Agents|nootropic agents|mesh-ancestor
6633188|NCT05063565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6633189|NCT05063565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6633190|NCT05063565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633191|NCT05063149|Broncho-Vaxom|broncho-vaxom|mesh-list
6633192|NCT05063149|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6633193|NCT05063149|Immunologic Factors|immunologic factors|mesh-ancestor
6633194|NCT05063149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633195|NCT05059522|Pemetrexed|pemetrexed|mesh-list
6633196|NCT05059522|Avelumab|avelumab|mesh-list
6633197|NCT05059522|Axitinib|axitinib|mesh-list
6633198|NCT05059522|Talazoparib|talazoparib|mesh-list
6633199|NCT05059522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6633200|NCT05059522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6633201|NCT05059522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633202|NCT05059522|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6633203|NCT05059522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6633204|NCT05059522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6633205|NCT05059522|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6633206|NCT05059522|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6633207|NCT05037500|Decitabine|decitabine|mesh-list
6633208|NCT05037500|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6633209|NCT05037500|Antimetabolites|antimetabolites|mesh-ancestor
5482598|NCT02251821|Mycophenolic Acid|mycophenolic acid|mesh-list
5482599|NCT02251821|Cyclophosphamide|cyclophosphamide|mesh-list
6633210|NCT05037500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633211|NCT05037500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6633212|NCT05037500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6633213|NCT05034562|Edetic Acid|edetic acid|mesh-list
6633214|NCT05034562|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
6633215|NCT05034562|Chelating Agents|chelating agents|mesh-ancestor
6633216|NCT05034562|Sequestering Agents|sequestering agents|mesh-ancestor
6633217|NCT05034562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633218|NCT05034562|Anticoagulants|anticoagulants|mesh-ancestor
6633219|NCT05034562|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6633220|NCT05034562|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6633221|NCT05031026|Dexmedetomidine|dexmedetomidine|mesh-list
6633222|NCT05031026|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6633223|NCT05031026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6633224|NCT05031026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633225|NCT05031026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6633226|NCT05031026|Analgesics|analgesics|mesh-ancestor
6633227|NCT05031026|Sensory System Agents|sensory system agents|mesh-ancestor
6633228|NCT05031026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6633229|NCT05031026|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6633230|NCT05031026|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6633231|NCT05031026|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6633232|NCT05031026|Adrenergic Agents|adrenergic agents|mesh-ancestor
6633233|NCT05031026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6633234|NCT05031026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633235|NCT05027919|Lofexidine|lofexidine|mesh-list
6633236|NCT05027919|Clonidine|clonidine|mesh-list
6633237|NCT05027919|Morphine|morphine|mesh-list
6633238|NCT05027919|Naloxone|naloxone|mesh-list
6633239|NCT05027919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6633240|NCT05027919|Narcotics|narcotics|mesh-ancestor
6633241|NCT05027919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6633242|NCT05027919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633243|NCT05027919|Analgesics|analgesics|mesh-ancestor
6633244|NCT05027919|Sensory System Agents|sensory system agents|mesh-ancestor
6633245|NCT05027919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6633246|NCT05027919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6633247|NCT05027919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6633248|NCT05027919|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6633249|NCT05027919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6633250|NCT05027919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6633251|NCT05027919|Adrenergic Agents|adrenergic agents|mesh-ancestor
6633252|NCT05027919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6633253|NCT05027919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633254|NCT05027919|Sympatholytics|sympatholytics|mesh-ancestor
6633255|NCT05027919|Autonomic Agents|autonomic agents|mesh-ancestor
6633256|NCT05027048|Calcium|calcium|mesh-list
6633257|NCT05027048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6633258|NCT05027048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633259|NCT05024032|Tirzepatide|tirzepatide|mesh-list
6633260|NCT05024032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6633261|NCT05024032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633262|NCT05024032|Incretins|incretins|mesh-ancestor
6633263|NCT05024032|Hormones|hormones|mesh-ancestor
6633264|NCT05024032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6662879|NCT01505283|Sufentanil|sufentanil|mesh-list
6662880|NCT01505283|Anesthetics, Local|anesthetics, local|mesh-ancestor
6662881|NCT01505283|Anesthetics|anesthetics|mesh-ancestor
6662882|NCT01505283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6662883|NCT01505283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662884|NCT01505283|Sensory System Agents|sensory system agents|mesh-ancestor
6662885|NCT01505283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6662886|NCT01505283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6662887|NCT01505283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6662888|NCT01505283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6662889|NCT01505283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6662890|NCT01505283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662891|NCT01505283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6662892|NCT01505283|Narcotics|narcotics|mesh-ancestor
6662893|NCT01505283|Analgesics|analgesics|mesh-ancestor
6662894|NCT01505283|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6662895|NCT01505283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6662896|NCT01505283|Anesthetics, General|anesthetics, general|mesh-ancestor
6662897|NCT01505296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
6665022|NCT01515228|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6665023|NCT01515228|Respiratory System Agents|respiratory system agents|mesh-ancestor
6665024|NCT01515228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6665025|NCT01515228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6665026|NCT01515228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6665027|NCT01515228|Vasodilator Agents|vasodilator agents|mesh-ancestor
5482600|NCT02251821|Melphalan|melphalan|mesh-list
5482601|NCT02251821|Busulfan|busulfan|mesh-list
5482602|NCT02251821|Mechlorethamine|mechlorethamine|mesh-list
5482603|NCT02251821|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
5482604|NCT02251821|Methotrexate|methotrexate|mesh-list
5482605|NCT02251821|Fludarabine|fludarabine|mesh-list
5482606|NCT02251821|Fludarabine phosphate|fludarabine phosphate|mesh-list
5482607|NCT02251821|Tacrolimus|tacrolimus|mesh-list
5482608|NCT02251821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5482609|NCT02251821|Immunologic Factors|immunologic factors|mesh-ancestor
5482610|NCT02251821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5482611|NCT02251821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5482612|NCT02251821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5482613|NCT02251821|Alkylating Agents|alkylating agents|mesh-ancestor
5482614|NCT02251821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5482615|NCT02251821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5482616|NCT02251821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5482617|NCT02251821|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5482618|NCT02251821|Abortifacient Agents|abortifacient agents|mesh-ancestor
5482619|NCT02251821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5482620|NCT02251821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6665028|NCT01515228|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6665029|NCT01515228|Protective Agents|protective agents|mesh-ancestor
6665030|NCT01515228|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6665031|NCT01515228|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6665032|NCT01515228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6665033|NCT01515371|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
6665034|NCT01515371|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6665035|NCT01515371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6665036|NCT01515371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665037|NCT01515371|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6665038|NCT01515371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6665039|NCT01515371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665040|NCT01515371|Cholinergic Agents|cholinergic agents|mesh-ancestor
6665041|NCT01515371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5482621|NCT02251821|Antimetabolites|antimetabolites|mesh-ancestor
5482622|NCT02251821|Dermatologic Agents|dermatologic agents|mesh-ancestor
6665042|NCT01515397|Polygeline|polygeline|mesh-list
5482623|NCT02251821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5482624|NCT02251821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6633265|NCT05003895|Cyclophosphamide|cyclophosphamide|mesh-list
6633266|NCT05003895|Fludarabine|fludarabine|mesh-list
6633267|NCT05003895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6633268|NCT05003895|Immunologic Factors|immunologic factors|mesh-ancestor
6633269|NCT05003895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633270|NCT05003895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6633271|NCT05003895|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6633272|NCT05003895|Alkylating Agents|alkylating agents|mesh-ancestor
6633273|NCT05003895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633274|NCT05003895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6633275|NCT05003895|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6633276|NCT04999241|Mesalamine|mesalamine|mesh-list
6633277|NCT04999241|Infliximab|infliximab|mesh-list
6633278|NCT04999241|Dermatologic Agents|dermatologic agents|mesh-ancestor
6633279|NCT04999241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6633280|NCT04999241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6633281|NCT04999241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6633282|NCT04999241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6633283|NCT04999241|Analgesics|analgesics|mesh-ancestor
6633284|NCT04999241|Sensory System Agents|sensory system agents|mesh-ancestor
6633285|NCT04999241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6633286|NCT04999241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633287|NCT04999241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6633288|NCT04999228|Mesalamine|mesalamine|mesh-list
6633289|NCT04999228|Infliximab|infliximab|mesh-list
6633290|NCT04999228|Dermatologic Agents|dermatologic agents|mesh-ancestor
6633291|NCT04999228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6633292|NCT04999228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6633293|NCT04999228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6633294|NCT04999228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6633295|NCT04999228|Analgesics|analgesics|mesh-ancestor
6633296|NCT04999228|Sensory System Agents|sensory system agents|mesh-ancestor
6633297|NCT04999228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6633298|NCT04999228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633299|NCT04999228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6633300|NCT04983407|Gemcitabine|gemcitabine|mesh-list
6633301|NCT04983407|Paclitaxel|paclitaxel|mesh-list
6633302|NCT04983407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6633303|NCT04983407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6633304|NCT04983407|Tubulin Modulators|tubulin modulators|mesh-ancestor
6633305|NCT04983407|Antimitotic Agents|antimitotic agents|mesh-ancestor
6633306|NCT04983407|Mitosis Modulators|mitosis modulators|mesh-ancestor
6633307|NCT04983407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633308|NCT04983407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6633309|NCT04983407|Antimetabolites|antimetabolites|mesh-ancestor
6633310|NCT04983407|Antiviral Agents|antiviral agents|mesh-ancestor
6633311|NCT04983407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6633312|NCT04983407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6633313|NCT04983407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6633314|NCT04983407|Immunologic Factors|immunologic factors|mesh-ancestor
6633315|NCT04983407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633316|NCT04971226|Imatinib Mesylate|imatinib mesylate|mesh-list
5482625|NCT02251821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5482626|NCT02251821|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5482627|NCT02251821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5482628|NCT02251821|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5482629|NCT02251821|Antitubercular Agents|antitubercular agents|mesh-ancestor
5482630|NCT02251821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5482631|NCT02251821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5482632|NCT01966731|Hydroxyurea|hydroxyurea|mesh-list
5482633|NCT01966731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5482634|NCT01966731|Antisickling Agents|antisickling agents|mesh-ancestor
5482635|NCT01966731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5482636|NCT01966731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633317|NCT04971226|Dasatinib|dasatinib|mesh-list
6633318|NCT04971226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6633319|NCT04971226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6633320|NCT04971226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6633321|NCT04971226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633322|NCT04955743|Pembrolizumab|pembrolizumab|mesh-list
6633323|NCT04955743|Lenvatinib|lenvatinib|mesh-list
6633324|NCT04955743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6633325|NCT04955743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6633326|NCT04955743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6633327|NCT04955743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6633328|NCT04955743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633329|NCT04947007|Bupivacaine|bupivacaine|mesh-list
6633330|NCT04947007|Anesthetics, Local|anesthetics, local|mesh-ancestor
6633331|NCT04947007|Anesthetics|anesthetics|mesh-ancestor
6633332|NCT04947007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6633333|NCT04947007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633334|NCT04947007|Sensory System Agents|sensory system agents|mesh-ancestor
6633335|NCT04947007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6633336|NCT04944134|Vaccines|vaccines|mesh-list
6633337|NCT04944134|Immunologic Factors|immunologic factors|mesh-ancestor
6633338|NCT04944134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633339|NCT04936542|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6633340|NCT04936542|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6633341|NCT04936542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6633342|NCT04936542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633343|NCT04936542|Cholinergic Agents|cholinergic agents|mesh-ancestor
6633344|NCT04936542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6633345|NCT04936542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633346|NCT04927975|Upadacitinib|upadacitinib|mesh-list
6633347|NCT04927975|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
6633348|NCT04927975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6633349|NCT04927975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6633350|NCT04927975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633351|NCT04927975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6633352|NCT04920331|Erenumab|erenumab|mesh-list
6633353|NCT04920331|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
6633354|NCT04920331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633355|NCT04920331|Analgesics|analgesics|mesh-ancestor
6633356|NCT04920331|Sensory System Agents|sensory system agents|mesh-ancestor
6633357|NCT04920331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6633358|NCT04920331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633359|NCT04916197|Dexmedetomidine|dexmedetomidine|mesh-list
5482637|NCT01966731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5482638|NCT01952288|Simvastatin|simvastatin|mesh-list
5482639|NCT01952288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5482640|NCT01952288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5482641|NCT01952288|Antimetabolites|antimetabolites|mesh-ancestor
5482642|NCT01952288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5482643|NCT01952288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6633360|NCT04916197|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6633361|NCT04916197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6633362|NCT04916197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633363|NCT04916197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6633364|NCT04916197|Analgesics|analgesics|mesh-ancestor
6633365|NCT04916197|Sensory System Agents|sensory system agents|mesh-ancestor
6633366|NCT04916197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6633367|NCT04916197|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6633368|NCT04916197|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6633369|NCT04916197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5482644|NCT01952288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5482645|NCT01952288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5482646|NCT01858740|Methotrexate|methotrexate|mesh-list
6633370|NCT04916197|Adrenergic Agents|adrenergic agents|mesh-ancestor
6633371|NCT04916197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6633372|NCT04916197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633373|NCT04895748|Everolimus|everolimus|mesh-list
6633374|NCT04895748|Spartalizumab|spartalizumab|mesh-list
6633375|NCT04895748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6633376|NCT04895748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6633377|NCT04895748|Immunologic Factors|immunologic factors|mesh-ancestor
6633378|NCT04895748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633379|NCT04895748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6633380|NCT04895748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633381|NCT04895410|Dexamethasone|dexamethasone|mesh-list
6633382|NCT04895410|Daratumumab|daratumumab|mesh-list
6633383|NCT04895410|Pomalidomide|pomalidomide|mesh-list
6633384|NCT04895410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6633385|NCT04895410|Antiemetics|antiemetics|mesh-ancestor
6633386|NCT04895410|Autonomic Agents|autonomic agents|mesh-ancestor
6633387|NCT04895410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6633388|NCT04895410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633389|NCT04895410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6633390|NCT04895410|Glucocorticoids|glucocorticoids|mesh-ancestor
6633391|NCT04895410|Hormones|hormones|mesh-ancestor
6633392|NCT04895410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6633393|NCT04895410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6633394|NCT04895410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5482647|NCT01858740|Fludarabine phosphate|fludarabine phosphate|mesh-list
5482648|NCT01858740|Fludarabine|fludarabine|mesh-list
5482649|NCT01858740|Thiotepa|thiotepa|mesh-list
5482650|NCT01858740|Tacrolimus|tacrolimus|mesh-list
5482651|NCT01858740|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5482652|NCT01858740|Abortifacient Agents|abortifacient agents|mesh-ancestor
6633395|NCT04895410|Immunologic Factors|immunologic factors|mesh-ancestor
6633396|NCT04895410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6633397|NCT04895410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6633398|NCT04895410|Growth Substances|growth substances|mesh-ancestor
6633399|NCT04895410|Growth Inhibitors|growth inhibitors|mesh-ancestor
6633400|NCT04863885|Nivolumab|nivolumab|mesh-list
6633401|NCT04863885|Ipilimumab|ipilimumab|mesh-list
6633402|NCT04863885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6633403|NCT04863885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6633404|NCT04863885|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6633405|NCT04863885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633406|NCT04861987|Capecitabine|capecitabine|mesh-list
6633407|NCT04861987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6633408|NCT04861987|Antimetabolites|antimetabolites|mesh-ancestor
6633409|NCT04861987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633410|NCT04861987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6633411|NCT04832438|Carboplatin|carboplatin|mesh-list
6633412|NCT04832438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6633413|NCT04832087|Teduglutide|teduglutide|mesh-list
6633414|NCT04832087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6633415|NCT04832087|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6633416|NCT04832087|Protective Agents|protective agents|mesh-ancestor
6633417|NCT04832087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633418|NCT04831398|Melatonin|melatonin|mesh-list
6633419|NCT04831398|Antioxidants|antioxidants|mesh-ancestor
6633420|NCT04831398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633421|NCT04831398|Protective Agents|protective agents|mesh-ancestor
6633422|NCT04831398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633423|NCT04831398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6633424|NCT04809766|Cyclophosphamide|cyclophosphamide|mesh-list
6633425|NCT04809766|Fludarabine|fludarabine|mesh-list
6633426|NCT04809766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6633427|NCT04809766|Immunologic Factors|immunologic factors|mesh-ancestor
5482653|NCT01858740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5482654|NCT01858740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633428|NCT04809766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633429|NCT04809766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5482655|NCT01858740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5482656|NCT01858740|Antimetabolites|antimetabolites|mesh-ancestor
5482657|NCT01858740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5482658|NCT01858740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5482659|NCT01858740|Dermatologic Agents|dermatologic agents|mesh-ancestor
6633430|NCT04809766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6633431|NCT04809766|Alkylating Agents|alkylating agents|mesh-ancestor
6633432|NCT04809766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633433|NCT04809766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6633434|NCT04809766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6633435|NCT04793958|Cetuximab|cetuximab|mesh-list
6633436|NCT04793958|Adagrasib|adagrasib|mesh-list
6633437|NCT04793958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6633438|NCT04793958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6633439|NCT04763343|Ketamine|ketamine|mesh-list
6633440|NCT04763343|Analgesics|analgesics|mesh-ancestor
6633441|NCT04763343|Sensory System Agents|sensory system agents|mesh-ancestor
6633442|NCT04763343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5482660|NCT01858740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5482661|NCT01858740|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5482662|NCT01858740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5482663|NCT01858740|Immunologic Factors|immunologic factors|mesh-ancestor
5482664|NCT01858740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5482665|NCT01858740|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6633443|NCT04763343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633444|NCT04763343|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6633445|NCT04763343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6633446|NCT04763343|Anesthetics, General|anesthetics, general|mesh-ancestor
6633447|NCT04763343|Anesthetics|anesthetics|mesh-ancestor
6633448|NCT04763343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6633449|NCT04763343|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6633450|NCT04763343|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6633451|NCT04763343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6633452|NCT04763343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633453|NCT04761848|Cilostazol|cilostazol|mesh-list
6633454|NCT04761848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6633455|NCT04761848|Autonomic Agents|autonomic agents|mesh-ancestor
6633456|NCT04761848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6633457|NCT04761848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633458|NCT04761848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6633459|NCT04761848|Respiratory System Agents|respiratory system agents|mesh-ancestor
6633460|NCT04761848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6633461|NCT04761848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6633462|NCT04761848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633463|NCT04761848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6633464|NCT04761848|Vasodilator Agents|vasodilator agents|mesh-ancestor
6633465|NCT04761848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6633466|NCT04761848|Protective Agents|protective agents|mesh-ancestor
6633467|NCT04761848|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5482666|NCT01858740|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5482667|NCT01858740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5482668|NCT01858740|Alkylating Agents|alkylating agents|mesh-ancestor
5482669|NCT01858740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5482670|NCT01846663|Rifaximin|rifaximin|mesh-list
6452000|NCT00415064|Glucocorticoids|glucocorticoids|mesh-ancestor
6452001|NCT00415064|Hormones|hormones|mesh-ancestor
6452002|NCT00415064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6452003|NCT00415064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6452004|NCT00415064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6452005|NCT00415064|Immunologic Factors|immunologic factors|mesh-ancestor
6452006|NCT00415064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6452007|NCT00415064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6452008|NCT00415064|Growth Substances|growth substances|mesh-ancestor
6452009|NCT00415064|Growth Inhibitors|growth inhibitors|mesh-ancestor
6452010|NCT00415090|Nevirapine|nevirapine|mesh-list
6452011|NCT00415090|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6633468|NCT04761848|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6633469|NCT04761848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6633470|NCT04757571|Paroxetine|paroxetine|mesh-list
6633471|NCT04757571|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6633472|NCT04757571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6633473|NCT04757571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6633474|NCT04757571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633475|NCT04757571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6633476|NCT04757571|Serotonin Agents|serotonin agents|mesh-ancestor
6633477|NCT04757571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633478|NCT04757571|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6633479|NCT04757571|Antidepressive Agents|antidepressive agents|mesh-ancestor
6633480|NCT04757571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6633481|NCT04757571|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6633482|NCT04757571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6633483|NCT04757571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6633484|NCT04753957|Progesterone|progesterone|mesh-list
6633485|NCT04753957|Progestins|progestins|mesh-ancestor
6633486|NCT04753957|Hormones|hormones|mesh-ancestor
6633487|NCT04753957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6633488|NCT04753957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633489|NCT04736394|Epirubicin|epirubicin|mesh-list
6633490|NCT04736394|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6633491|NCT04736394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5482671|NCT01846663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5482672|NCT01846663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5482673|NCT01846663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5482674|NCT01844518|Abatacept|abatacept|mesh-list
5482675|NCT01844518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5482676|NCT01844518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5482677|NCT01844518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5482678|NCT01844518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5482679|NCT01844518|Immunologic Factors|immunologic factors|mesh-ancestor
6633492|NCT04736394|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6633493|NCT04736394|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6633494|NCT04736394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6633495|NCT04736394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633496|NCT04736199|Androgens|androgens|mesh-list
6633497|NCT04736199|Hormones|hormones|mesh-ancestor
6633498|NCT04736199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6633499|NCT04736199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633500|NCT04721132|Bevacizumab|bevacizumab|mesh-list
6633501|NCT04721132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6633502|NCT04721132|Atezolizumab|atezolizumab|mesh-list
6633503|NCT04721132|Endothelial Growth Factors|endothelial growth factors|mesh-list
6633504|NCT04721132|Antibodies|antibodies|mesh-list
6633505|NCT04721132|Immunoglobulins|immunoglobulins|mesh-list
6633506|NCT04721132|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6633507|NCT04721132|Immunoglobulin G|immunoglobulin g|mesh-list
6633508|NCT04721132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6633509|NCT04721132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6633510|NCT04721132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6633511|NCT04721132|Growth Substances|growth substances|mesh-ancestor
6633512|NCT04721132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633513|NCT04721132|Growth Inhibitors|growth inhibitors|mesh-ancestor
6633514|NCT04721132|Immunologic Factors|immunologic factors|mesh-ancestor
6633515|NCT04720157|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
6633516|NCT04720157|177Lu-PSMA-617|177lu-psma-617|mesh-list
6633517|NCT04720157|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6633518|NCT04720157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633519|NCT04718155|Atorvastatin|atorvastatin|mesh-list
6633520|NCT04718155|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6633521|NCT04718155|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6633522|NCT04718155|Antimetabolites|antimetabolites|mesh-ancestor
6633523|NCT04718155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633524|NCT04718155|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6633525|NCT04718155|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6633526|NCT04718155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6662898|NCT01505413|Gemcitabine|gemcitabine|mesh-list
6662899|NCT01505413|Oxaliplatin|oxaliplatin|mesh-list
6662900|NCT01505413|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6662901|NCT01505413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6662902|NCT01505413|Antimetabolites|antimetabolites|mesh-ancestor
6662903|NCT01505413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633527|NCT04705883|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
6633528|NCT04705883|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6633529|NCT04705883|Immunologic Factors|immunologic factors|mesh-ancestor
6633530|NCT04705883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633531|NCT04693689|Vaccines|vaccines|mesh-list
6633532|NCT04693689|Immunologic Factors|immunologic factors|mesh-ancestor
6633533|NCT04693689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633534|NCT04661514|Psilocybin|psilocybin|mesh-list
6633535|NCT04661514|Hallucinogens|hallucinogens|mesh-ancestor
6633536|NCT04661514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633537|NCT04661514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6633538|NCT04657003|Tirzepatide|tirzepatide|mesh-list
6633539|NCT04657003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6633540|NCT04657003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633541|NCT04657003|Incretins|incretins|mesh-ancestor
6633542|NCT04657003|Hormones|hormones|mesh-ancestor
6633543|NCT04657003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6633544|NCT04640194|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6633545|NCT04640194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6633546|NCT04640194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6633547|NCT04640194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633548|NCT04624230|Tofacitinib|tofacitinib|mesh-list
6633549|NCT04624230|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6452012|NCT00415090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6452013|NCT00415090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6452014|NCT00415090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6452015|NCT00415090|Antiviral Agents|antiviral agents|mesh-ancestor
6452016|NCT00415090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6452017|NCT00415090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6452018|NCT00415090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6452019|NCT00415090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6452020|NCT00415090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6633550|NCT04624230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6633551|NCT04624230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633552|NCT04606771|Osimertinib|osimertinib|mesh-list
6633553|NCT04606771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5482680|NCT01844518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5482681|NCT01844518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5482682|NCT01795586|Carboplatin|carboplatin|mesh-list
5482683|NCT01795586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5482684|NCT01717586|Pravastatin|pravastatin|mesh-list
5482685|NCT01717586|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5482686|NCT01717586|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5482687|NCT01717586|Antimetabolites|antimetabolites|mesh-ancestor
5482688|NCT01717586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5482689|NCT01717586|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5482690|NCT01717586|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5482691|NCT01717586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5482692|NCT01398839|Riboflavin|riboflavin|mesh-list
5482693|NCT01398839|Vitamin B Complex|vitamin b complex|mesh-ancestor
5482694|NCT01398839|Vitamins|vitamins|mesh-ancestor
5482695|NCT01398839|Micronutrients|micronutrients|mesh-ancestor
5482696|NCT01398839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5482697|NCT01398839|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5482698|NCT01398839|Dermatologic Agents|dermatologic agents|mesh-ancestor
5482699|NCT01349959|Azacitidine|azacitidine|mesh-list
5482700|NCT01349959|Entinostat|entinostat|mesh-list
5482701|NCT01349959|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
5482702|NCT01349959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5482703|NCT01349959|Antimetabolites|antimetabolites|mesh-ancestor
5482704|NCT01349959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5482705|NCT01349959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5482706|NCT01349959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5482707|NCT01331018|Plerixafor|plerixafor|mesh-list
5482708|NCT01331018|Prednisone|prednisone|mesh-list
5482709|NCT01331018|Methylprednisolone|methylprednisolone|mesh-list
5482710|NCT01331018|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5482711|NCT01331018|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5482712|NCT01331018|Prednisolone|prednisolone|mesh-list
5482713|NCT01331018|Prednisolone acetate|prednisolone acetate|mesh-list
6452021|NCT00415103|Aprepitant|aprepitant|mesh-list
6633554|NCT04606771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6633555|NCT04606771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6633556|NCT04606771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5482714|NCT01331018|Cortisone|cortisone|mesh-list
6633557|NCT04588545|Trastuzumab|trastuzumab|mesh-list
6633558|NCT04588545|Pertuzumab|pertuzumab|mesh-list
5482715|NCT01331018|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5482716|NCT01331018|Prednisolone phosphate|prednisolone phosphate|mesh-list
5482717|NCT01331018|Lenograstim|lenograstim|mesh-list
6633559|NCT04588545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6633560|NCT04588545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5482718|NCT01331018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5482719|NCT01331018|Glucocorticoids|glucocorticoids|mesh-ancestor
5482720|NCT01331018|Hormones|hormones|mesh-ancestor
5482721|NCT01331018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5482722|NCT01331018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5482723|NCT01331018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5482724|NCT01331018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5482725|NCT01331018|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5482726|NCT01331018|Immunologic Factors|immunologic factors|mesh-ancestor
5482727|NCT01331018|Antiemetics|antiemetics|mesh-ancestor
6633580|NCT04577755|Pomalidomide|pomalidomide|mesh-list
6633581|NCT04577755|Immunologic Factors|immunologic factors|mesh-ancestor
6633582|NCT04577755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633583|NCT04577755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6633584|NCT04577755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6633585|NCT04577755|Growth Substances|growth substances|mesh-ancestor
6633586|NCT04577755|Growth Inhibitors|growth inhibitors|mesh-ancestor
6633587|NCT04577755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6633588|NCT04563273|Vaccines|vaccines|mesh-list
6633589|NCT04563273|BCG Vaccine|bcg vaccine|mesh-list
6633590|NCT04563273|Immunologic Factors|immunologic factors|mesh-ancestor
6633591|NCT04563273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633592|NCT04563273|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6633593|NCT04543409|Benralizumab|benralizumab|mesh-list
6633594|NCT04543409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6633595|NCT04543409|Respiratory System Agents|respiratory system agents|mesh-ancestor
6633596|NCT04541108|Paclitaxel|paclitaxel|mesh-list
6633597|NCT04541108|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6633598|NCT04541108|Carboplatin|carboplatin|mesh-list
6633599|NCT04541108|Pembrolizumab|pembrolizumab|mesh-list
6633600|NCT04541108|Fluorouracil|fluorouracil|mesh-list
6633601|NCT04541108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6633602|NCT04541108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6633603|NCT04541108|Tubulin Modulators|tubulin modulators|mesh-ancestor
6633604|NCT04541108|Antimitotic Agents|antimitotic agents|mesh-ancestor
6633605|NCT04541108|Mitosis Modulators|mitosis modulators|mesh-ancestor
6633606|NCT04541108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633607|NCT04541108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6633608|NCT04541108|Antimetabolites|antimetabolites|mesh-ancestor
6633609|NCT04541108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6633610|NCT04541108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6633611|NCT04541108|Immunologic Factors|immunologic factors|mesh-ancestor
6633612|NCT04541108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633613|NCT04535544|Tenofovir|tenofovir|mesh-list
6633614|NCT04535544|Entecavir|entecavir|mesh-list
6633615|NCT04535544|Antiviral Agents|antiviral agents|mesh-ancestor
6633616|NCT04535544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6633617|NCT04535544|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6633618|NCT04535544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6633619|NCT04535544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6633620|NCT04535544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633621|NCT04535544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6633622|NCT04535544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6633623|NCT04534270|Dapagliflozin|dapagliflozin|mesh-list
6633624|NCT04534270|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6633625|NCT04534270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633626|NCT04534270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6633627|NCT04534270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633628|NCT04521478|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6633629|NCT04521478|Antidepressive Agents|antidepressive agents|mesh-ancestor
6633630|NCT04521478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6633631|NCT04521478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6633632|NCT04521478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6633633|NCT04521478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6633634|NCT04521478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633641|NCT04490993|Epirubicin|epirubicin|mesh-list
6633642|NCT04490993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6633643|NCT04490993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6633644|NCT04490993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6633645|NCT04490993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6633646|NCT04490993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6633647|NCT04490993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633648|NCT04449861|Durvalumab|durvalumab|mesh-list
6633649|NCT04449861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6633650|NCT04449861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6633651|NCT04420624|Colchicine|colchicine|mesh-list
6633652|NCT04420624|Gout Suppressants|gout suppressants|mesh-ancestor
6633653|NCT04420624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6633654|NCT04420624|Tubulin Modulators|tubulin modulators|mesh-ancestor
6633655|NCT04420624|Antimitotic Agents|antimitotic agents|mesh-ancestor
6633656|NCT04420624|Mitosis Modulators|mitosis modulators|mesh-ancestor
6633657|NCT04420624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633658|NCT04420624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6633659|NCT04417621|Trametinib|trametinib|mesh-list
6633660|NCT04417621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6633661|NCT04417621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6633662|NCT04417621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6633663|NCT04417621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633664|NCT04409964|Lidocaine|lidocaine|mesh-list
6633665|NCT04409964|Dexmedetomidine|dexmedetomidine|mesh-list
6633666|NCT04409964|Remifentanil|remifentanil|mesh-list
6633667|NCT04409964|Anesthetics, Local|anesthetics, local|mesh-ancestor
6633668|NCT04409964|Anesthetics|anesthetics|mesh-ancestor
6633669|NCT04409964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6633670|NCT04409964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633671|NCT04409964|Sensory System Agents|sensory system agents|mesh-ancestor
6633672|NCT04409964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6633673|NCT04409964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6633674|NCT04409964|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6633675|NCT04409964|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6633676|NCT04409964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6633677|NCT04409964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633678|NCT04409964|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6633679|NCT04409964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6633680|NCT04409964|Analgesics|analgesics|mesh-ancestor
6633681|NCT04409964|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6633682|NCT04409964|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6633683|NCT04409964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6633684|NCT04409964|Adrenergic Agents|adrenergic agents|mesh-ancestor
6633685|NCT04409964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6633686|NCT04409964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6633687|NCT04409964|Narcotics|narcotics|mesh-ancestor
6633688|NCT04401059|Gefitinib|gefitinib|mesh-list
6633689|NCT04401059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6633690|NCT04401059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6633691|NCT04401059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6633692|NCT04401059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633693|NCT04394546|Anticoagulants|anticoagulants|mesh-list
6633694|NCT04390763|Gemcitabine|gemcitabine|mesh-list
6633695|NCT04390763|Paclitaxel|paclitaxel|mesh-list
6633696|NCT04390763|Spartalizumab|spartalizumab|mesh-list
6633697|NCT04390763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6633698|NCT04390763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6633699|NCT04390763|Tubulin Modulators|tubulin modulators|mesh-ancestor
6633700|NCT04390763|Antimitotic Agents|antimitotic agents|mesh-ancestor
6633701|NCT04390763|Mitosis Modulators|mitosis modulators|mesh-ancestor
6633702|NCT04390763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633703|NCT04390763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6633704|NCT04390763|Antimetabolites|antimetabolites|mesh-ancestor
6633705|NCT04390763|Antiviral Agents|antiviral agents|mesh-ancestor
6633706|NCT04390763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6633707|NCT04390763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6633708|NCT04390763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6633709|NCT04390763|Immunologic Factors|immunologic factors|mesh-ancestor
6633710|NCT04390763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633711|NCT04390763|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5482728|NCT01331018|Autonomic Agents|autonomic agents|mesh-ancestor
5482729|NCT01331018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5482730|NCT01331018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5482731|NCT01331018|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5482732|NCT01331018|Protective Agents|protective agents|mesh-ancestor
5482733|NCT01331018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5482734|NCT01331018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5482735|NCT01331018|Antiviral Agents|antiviral agents|mesh-ancestor
5482736|NCT01331018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5482737|NCT01327781|Tamoxifen|tamoxifen|mesh-list
6633712|NCT04377997|Heparin|heparin|mesh-list
6633713|NCT04377997|Calcium heparin|calcium heparin|mesh-list
6633714|NCT04377997|Enoxaparin|enoxaparin|mesh-list
6633715|NCT04377997|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6633716|NCT04377997|Tinzaparin|tinzaparin|mesh-list
6633717|NCT04377997|Dalteparin|dalteparin|mesh-list
6633718|NCT04377997|Anticoagulants|anticoagulants|mesh-ancestor
6633719|NCT04377997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6633720|NCT04377997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6633721|NCT04377997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633722|NCT04356989|Rivaroxaban|rivaroxaban|mesh-list
6633723|NCT04356989|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6633724|NCT04356989|Antithrombins|antithrombins|mesh-ancestor
6633725|NCT04356989|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6633726|NCT04356989|Protease Inhibitors|protease inhibitors|mesh-ancestor
6633727|NCT04356989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6633728|NCT04356989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633729|NCT04356989|Anticoagulants|anticoagulants|mesh-ancestor
5482738|NCT01327781|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5482739|NCT01327781|Hormone Antagonists|hormone antagonists|mesh-ancestor
5482740|NCT01327781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5482741|NCT01327781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452022|NCT00415103|Palonosetron|palonosetron|mesh-list
6633730|NCT04346394|Yohimbine|yohimbine|mesh-list
6633731|NCT04346394|Mydriatics|mydriatics|mesh-ancestor
6633732|NCT04346394|Autonomic Agents|autonomic agents|mesh-ancestor
6633733|NCT04346394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6633734|NCT04346394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633735|NCT04346394|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5482742|NCT01327781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6452023|NCT00415103|Granisetron|granisetron|mesh-list
6452024|NCT00415103|Antiemetics|antiemetics|mesh-ancestor
6452025|NCT00415103|Autonomic Agents|autonomic agents|mesh-ancestor
6452026|NCT00415103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6452027|NCT00415103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452028|NCT00415103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6452029|NCT00415103|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6452030|NCT00415103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6452031|NCT00415103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6452032|NCT00415103|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6452033|NCT00415103|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6452034|NCT00415103|Serotonin Agents|serotonin agents|mesh-ancestor
6452035|NCT00415116|Carboplatin|carboplatin|mesh-list
6452036|NCT00415116|Docetaxel|docetaxel|mesh-list
6452037|NCT00415116|Lenalidomide|lenalidomide|mesh-list
6452038|NCT00415116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6452039|NCT00415116|Tubulin Modulators|tubulin modulators|mesh-ancestor
6452040|NCT00415116|Antimitotic Agents|antimitotic agents|mesh-ancestor
6452041|NCT00415116|Mitosis Modulators|mitosis modulators|mesh-ancestor
6452042|NCT00415116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6452043|NCT00415116|Immunologic Factors|immunologic factors|mesh-ancestor
6633736|NCT04346394|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6633737|NCT04346394|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6633738|NCT04346394|Adrenergic Agents|adrenergic agents|mesh-ancestor
6633739|NCT04346394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6633740|NCT04346394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633741|NCT04346394|Urological Agents|urological agents|mesh-ancestor
6633742|NCT04326933|Imatinib Mesylate|imatinib mesylate|mesh-list
5482743|NCT01327781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5482744|NCT01327781|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5482745|NCT01327781|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5482746|NCT01327781|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5482747|NCT01281176|Paclitaxel|paclitaxel|mesh-list
5482748|NCT01281176|Carboplatin|carboplatin|mesh-list
5482749|NCT01281176|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5482750|NCT01281176|Vorinostat|vorinostat|mesh-list
5482751|NCT01281176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6633743|NCT04326933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6633744|NCT04326933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6633745|NCT04326933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6633746|NCT04326933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633747|NCT04311502|Pyridoxine|pyridoxine|mesh-list
6633748|NCT04311502|Pyridoxal|pyridoxal|mesh-list
6633749|NCT04311502|Vitamin B 6|vitamin b 6|mesh-list
6633750|NCT04311502|Rifampin|rifampin|mesh-list
6633751|NCT04311502|Rifapentine|rifapentine|mesh-list
6633752|NCT04311502|Clofazimine|clofazimine|mesh-list
6633753|NCT04311502|Isoniazid|isoniazid|mesh-list
6633754|NCT04311502|Pyrazinamide|pyrazinamide|mesh-list
6633755|NCT04311502|Ethambutol|ethambutol|mesh-list
6633756|NCT04311502|Vitamins|vitamins|mesh-ancestor
6633757|NCT04311502|Micronutrients|micronutrients|mesh-ancestor
6633758|NCT04311502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633759|NCT04311502|Vitamin B Complex|vitamin b complex|mesh-ancestor
6633760|NCT04311502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6633761|NCT04311502|Antitubercular Agents|antitubercular agents|mesh-ancestor
5482752|NCT01281176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6021001|NCT00396032|Tenecteplase|tenecteplase|mesh-list
6633762|NCT04311502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6633763|NCT04311502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6633764|NCT04311502|Leprostatic Agents|leprostatic agents|mesh-ancestor
6633765|NCT04311502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6633766|NCT04311502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6633767|NCT04311502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633768|NCT04311502|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6633769|NCT04311502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6633770|NCT04311502|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6633771|NCT04311502|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6633772|NCT04311502|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6633773|NCT04311502|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6633774|NCT04311502|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6633775|NCT04311502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6633776|NCT04311502|Antimetabolites|antimetabolites|mesh-ancestor
6633777|NCT04311502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6633778|NCT04311502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5482753|NCT01281176|Tubulin Modulators|tubulin modulators|mesh-ancestor
6633804|NCT04301011|Pembrolizumab|pembrolizumab|mesh-list
6633805|NCT04301011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6633806|NCT04301011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6633807|NCT04300140|Nivolumab|nivolumab|mesh-list
6633808|NCT04300140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6633809|NCT04300140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6633810|NCT04300140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6633811|NCT04300140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662904|NCT01505413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6662905|NCT01505413|Antiviral Agents|antiviral agents|mesh-ancestor
6662906|NCT01505413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6662907|NCT01505413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6662908|NCT01505413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6662909|NCT01505413|Immunologic Factors|immunologic factors|mesh-ancestor
6662910|NCT01505413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662911|NCT01505413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6662912|NCT01505426|Metformin|metformin|mesh-list
6662913|NCT01505426|Ipragliflozin|ipragliflozin|mesh-list
6662914|NCT01505426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6662915|NCT01505426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662916|NCT01505426|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6662917|NCT01505426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662918|NCT01505439|Solifenacin Succinate|solifenacin succinate|mesh-list
6662919|NCT01505439|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6662920|NCT01505439|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6662921|NCT01505439|Cholinergic Agents|cholinergic agents|mesh-ancestor
6662922|NCT01505439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6662923|NCT01505439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662924|NCT01505439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662925|NCT01505439|Urological Agents|urological agents|mesh-ancestor
6662926|NCT01505504|Mirtazapine|mirtazapine|mesh-list
6662927|NCT01505504|Antidepressive Agents|antidepressive agents|mesh-ancestor
6662928|NCT01505504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6662929|NCT01505504|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6662930|NCT01505504|Histamine Antagonists|histamine antagonists|mesh-ancestor
6662931|NCT01505504|Histamine Agents|histamine agents|mesh-ancestor
6662932|NCT01505504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6662933|NCT01505504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662934|NCT01505504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662935|NCT01505504|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6662936|NCT01505504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6662937|NCT01505504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6662938|NCT01505504|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6662939|NCT01505504|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6662940|NCT01505504|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6662941|NCT01505504|Adrenergic Agents|adrenergic agents|mesh-ancestor
6662942|NCT01505504|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6662943|NCT01505504|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6662944|NCT01505504|Serotonin Agents|serotonin agents|mesh-ancestor
6662945|NCT01505504|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6662946|NCT01505569|Etoposide|etoposide|mesh-list
6662947|NCT01505569|Carboplatin|carboplatin|mesh-list
6662948|NCT01505569|Melphalan|melphalan|mesh-list
6662949|NCT01505569|Busulfan|busulfan|mesh-list
6662950|NCT01505569|Ifosfamide|ifosfamide|mesh-list
6662951|NCT01505569|Thiotepa|thiotepa|mesh-list
6662952|NCT01505569|Lenograstim|lenograstim|mesh-list
6662953|NCT01505569|Mesna|mesna|mesh-list
6662954|NCT01505569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6662955|NCT01505569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6662956|NCT01505569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662957|NCT01505569|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6662958|NCT01505569|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6662959|NCT01505569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6662960|NCT01505569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6662961|NCT01505569|Alkylating Agents|alkylating agents|mesh-ancestor
6662962|NCT01505569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6662963|NCT01505569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6662964|NCT01505569|Immunologic Factors|immunologic factors|mesh-ancestor
6662965|NCT01505569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662966|NCT01505569|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6662967|NCT01505569|Protective Agents|protective agents|mesh-ancestor
6662968|NCT01505777|Mosapride|mosapride|mesh-list
6662969|NCT01505777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6633812|NCT04258488|Vitamin K|vitamin k|mesh-list
6633813|NCT04258488|Warfarin|warfarin|mesh-list
6633814|NCT04258488|Rivaroxaban|rivaroxaban|mesh-list
6633815|NCT04258488|Vitamins|vitamins|mesh-ancestor
6633816|NCT04258488|Micronutrients|micronutrients|mesh-ancestor
6633817|NCT04258488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633818|NCT04258488|Anticoagulants|anticoagulants|mesh-ancestor
6633819|NCT04258488|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6633820|NCT04258488|Antithrombins|antithrombins|mesh-ancestor
6633821|NCT04258488|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6633822|NCT04258488|Protease Inhibitors|protease inhibitors|mesh-ancestor
6633823|NCT04258488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6633824|NCT04258488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633825|NCT04258488|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6633826|NCT04258488|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6633827|NCT04258488|Hemostatics|hemostatics|mesh-ancestor
6633828|NCT04258488|Coagulants|coagulants|mesh-ancestor
6633829|NCT04239313|Vaccines|vaccines|mesh-list
6633830|NCT04239313|Immunologic Factors|immunologic factors|mesh-ancestor
6633831|NCT04239313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633832|NCT04216134|Edetic Acid|edetic acid|mesh-list
6633833|NCT04216134|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
6633834|NCT04216134|Chelating Agents|chelating agents|mesh-ancestor
6633835|NCT04216134|Sequestering Agents|sequestering agents|mesh-ancestor
6633836|NCT04216134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633837|NCT04216134|Anticoagulants|anticoagulants|mesh-ancestor
6633838|NCT04216134|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6633839|NCT04216134|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6633840|NCT04213677|Dapagliflozin|dapagliflozin|mesh-list
6633841|NCT04213677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6633842|NCT04213677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633843|NCT04213677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6633844|NCT04213677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5482754|NCT01281176|Antimitotic Agents|antimitotic agents|mesh-ancestor
5482755|NCT01281176|Mitosis Modulators|mitosis modulators|mesh-ancestor
5482756|NCT01281176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5482757|NCT01281176|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6633845|NCT04188548|Trastuzumab|trastuzumab|mesh-list
6633846|NCT04188548|Pertuzumab|pertuzumab|mesh-list
6633847|NCT04188548|Everolimus|everolimus|mesh-list
6633848|NCT04188548|Aromatase Inhibitors|aromatase inhibitors|mesh-list
6633849|NCT04188548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6633850|NCT04188548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6633851|NCT04188548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6633852|NCT04188548|Immunologic Factors|immunologic factors|mesh-ancestor
6633853|NCT04188548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633854|NCT04188548|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6633855|NCT04188548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6633856|NCT04188548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633857|NCT04188548|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6633858|NCT04188548|Hormone Antagonists|hormone antagonists|mesh-ancestor
6633859|NCT04188548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6633860|NCT04179110|Pembrolizumab|pembrolizumab|mesh-list
6633861|NCT04179110|Ramucirumab|ramucirumab|mesh-list
6633862|NCT04179110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6633863|NCT04179110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6633864|NCT04174859|Rivaroxaban|rivaroxaban|mesh-list
6633865|NCT04174859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6633866|NCT04174859|Antithrombins|antithrombins|mesh-ancestor
6633867|NCT04174859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6633868|NCT04174859|Protease Inhibitors|protease inhibitors|mesh-ancestor
6633869|NCT04174859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6633870|NCT04174859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633871|NCT04174859|Anticoagulants|anticoagulants|mesh-ancestor
5482758|NCT01281176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5482759|NCT01193842|Prednisone|prednisone|mesh-list
5482760|NCT01193842|Cortisone|cortisone|mesh-list
5482761|NCT01193842|Cyclophosphamide|cyclophosphamide|mesh-list
5482762|NCT01193842|Rituximab|rituximab|mesh-list
5482763|NCT01193842|Doxorubicin|doxorubicin|mesh-list
5724871|NCT03184649|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6633881|NCT04137224|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6633882|NCT04137224|Immunologic Factors|immunologic factors|mesh-ancestor
6021002|NCT00396032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6633883|NCT04137224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633884|NCT04105335|Pembrolizumab|pembrolizumab|mesh-list
6633885|NCT04105335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6633886|NCT04105335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6633887|NCT04101461|Iron|iron|mesh-list
6633888|NCT04101461|Hepcidins|hepcidins|mesh-list
6633889|NCT04101461|Trace Elements|trace elements|mesh-ancestor
6633890|NCT04101461|Micronutrients|micronutrients|mesh-ancestor
6633891|NCT04101461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633892|NCT04101461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6633893|NCT04091022|Eflornithine|eflornithine|mesh-list
6633894|NCT04091022|Diclofenac|diclofenac|mesh-list
6633895|NCT04091022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6633896|NCT04091022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6633897|NCT04091022|Analgesics|analgesics|mesh-ancestor
6633898|NCT04091022|Sensory System Agents|sensory system agents|mesh-ancestor
6633899|NCT04091022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6633900|NCT04091022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633901|NCT04091022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6633902|NCT04091022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6633903|NCT04091022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6633904|NCT04091022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6633905|NCT04091022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633906|NCT04091022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6633907|NCT04091022|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6633908|NCT04091022|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6633909|NCT04091022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6633910|NCT04091022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6633911|NCT04091022|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
6633912|NCT04090775|Cyclophosphamide|cyclophosphamide|mesh-list
6633913|NCT04090775|Nivolumab|nivolumab|mesh-list
6633914|NCT04090775|Ipilimumab|ipilimumab|mesh-list
6633915|NCT04090775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6633916|NCT04090775|Immunologic Factors|immunologic factors|mesh-ancestor
6633917|NCT04090775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633918|NCT04090775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6633919|NCT04090775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6633920|NCT04090775|Alkylating Agents|alkylating agents|mesh-ancestor
6633921|NCT04090775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633922|NCT04090775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6633923|NCT04090775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6633924|NCT04090775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6633925|NCT04090775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6633926|NCT04077723|Obinutuzumab|obinutuzumab|mesh-list
6633927|NCT04077723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6633928|NCT04077723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6633929|NCT04068753|Niraparib|niraparib|mesh-list
6633930|NCT04068753|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6633931|NCT04068753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6633932|NCT04068753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633933|NCT04068753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6633934|NCT04052334|Cyclophosphamide|cyclophosphamide|mesh-list
6633935|NCT04052334|Fludarabine|fludarabine|mesh-list
6633936|NCT04052334|Interleukin-2|interleukin-2|mesh-list
6633937|NCT04052334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6633938|NCT04052334|Immunologic Factors|immunologic factors|mesh-ancestor
6633939|NCT04052334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633940|NCT04052334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6665043|NCT01515397|Plasma Substitutes|plasma substitutes|mesh-ancestor
6633941|NCT04052334|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6633942|NCT04052334|Alkylating Agents|alkylating agents|mesh-ancestor
6633943|NCT04052334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633944|NCT04052334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6633945|NCT04052334|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6633946|NCT04052334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6633947|NCT04052334|Analgesics|analgesics|mesh-ancestor
6633948|NCT04052334|Sensory System Agents|sensory system agents|mesh-ancestor
6633949|NCT04052334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6633950|NCT03981614|Trifluridine|trifluridine|mesh-list
6633951|NCT03981614|Palbociclib|palbociclib|mesh-list
6633952|NCT03981614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6633953|NCT03981614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6633954|NCT03981614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6633955|NCT03981614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633956|NCT03981614|Antimetabolites|antimetabolites|mesh-ancestor
6633957|NCT03981614|Antiviral Agents|antiviral agents|mesh-ancestor
6633958|NCT03981614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6633959|NCT03952637|Sirolimus|sirolimus|mesh-list
6633960|NCT03952637|Prednisone|prednisone|mesh-list
6633961|NCT03952637|Methylprednisolone|methylprednisolone|mesh-list
6633962|NCT03952637|Rituximab|rituximab|mesh-list
6633963|NCT03952637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6633964|NCT03952637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6633965|NCT03952637|Immunologic Factors|immunologic factors|mesh-ancestor
6633966|NCT03952637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633967|NCT03952637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6633968|NCT03952637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6633969|NCT03952637|Glucocorticoids|glucocorticoids|mesh-ancestor
6633970|NCT03952637|Hormones|hormones|mesh-ancestor
6633971|NCT03952637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6633972|NCT03952637|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6633973|NCT03952637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6633974|NCT03952637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6633975|NCT03952637|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6633976|NCT03952637|Antifungal Agents|antifungal agents|mesh-ancestor
6633977|NCT03952637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6633978|NCT03952637|Antiemetics|antiemetics|mesh-ancestor
6633979|NCT03952637|Autonomic Agents|autonomic agents|mesh-ancestor
6633980|NCT03952637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6633981|NCT03952637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6633982|NCT03952637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6633983|NCT03952637|Protective Agents|protective agents|mesh-ancestor
6633984|NCT03951649|Acetaminophen|acetaminophen|mesh-list
6633985|NCT03951649|Caffeine|caffeine|mesh-list
6633986|NCT03951649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6633987|NCT03951649|Analgesics|analgesics|mesh-ancestor
6633988|NCT03951649|Sensory System Agents|sensory system agents|mesh-ancestor
6633989|NCT03951649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6633990|NCT03951649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6633991|NCT03951649|Antipyretics|antipyretics|mesh-ancestor
5482764|NCT01193842|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5482765|NCT01193842|Etoposide|etoposide|mesh-list
5482766|NCT01193842|Vincristine|vincristine|mesh-list
5482767|NCT01193842|Etoposide phosphate|etoposide phosphate|mesh-list
5482768|NCT01193842|Vorinostat|vorinostat|mesh-list
5482769|NCT01193842|Podophyllotoxin|podophyllotoxin|mesh-list
5482770|NCT01193842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6633992|NCT03951649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6633993|NCT03951649|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6633994|NCT03951649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6633995|NCT03951649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6633996|NCT03951649|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6633997|NCT03951649|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6633998|NCT03951649|Purinergic Agents|purinergic agents|mesh-ancestor
6633999|NCT03951649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6634000|NCT03907046|Aspirin|aspirin|mesh-list
6634001|NCT03907046|Apixaban|apixaban|mesh-list
6634002|NCT03907046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5482771|NCT01193842|Antibodies|antibodies|mesh-list
5482772|NCT01193842|Immunoglobulins|immunoglobulins|mesh-list
5482773|NCT01193842|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5482774|NCT01193842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5482775|NCT01193842|Immunologic Factors|immunologic factors|mesh-ancestor
6634003|NCT03907046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5482776|NCT01193842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5482777|NCT01193842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6634004|NCT03907046|Analgesics|analgesics|mesh-ancestor
6634005|NCT03907046|Sensory System Agents|sensory system agents|mesh-ancestor
6634006|NCT03907046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6634007|NCT03907046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6634008|NCT03907046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6634009|NCT03907046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6634010|NCT03907046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6634011|NCT03907046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6634012|NCT03907046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634013|NCT03907046|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6634014|NCT03907046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6634015|NCT03907046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6634016|NCT03907046|Antipyretics|antipyretics|mesh-ancestor
6634017|NCT03907046|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6634018|NCT03907046|Antithrombins|antithrombins|mesh-ancestor
6634019|NCT03907046|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6634020|NCT03907046|Protease Inhibitors|protease inhibitors|mesh-ancestor
6634021|NCT03907046|Anticoagulants|anticoagulants|mesh-ancestor
6634022|NCT03887780|Rivaroxaban|rivaroxaban|mesh-list
6634023|NCT03887780|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6634024|NCT03887780|Antithrombins|antithrombins|mesh-ancestor
6634025|NCT03887780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6634026|NCT03887780|Protease Inhibitors|protease inhibitors|mesh-ancestor
6634027|NCT03887780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6634028|NCT03887780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634029|NCT03887780|Anticoagulants|anticoagulants|mesh-ancestor
6634030|NCT03875690|Methylprednisolone|methylprednisolone|mesh-list
6634031|NCT03875690|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6634032|NCT03875690|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6634033|NCT03875690|Prednisolone|prednisolone|mesh-list
6634034|NCT03875690|Prednisolone acetate|prednisolone acetate|mesh-list
6634035|NCT03875690|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6634036|NCT03875690|Prednisolone phosphate|prednisolone phosphate|mesh-list
6634037|NCT03875690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6634038|NCT03875690|Antiemetics|antiemetics|mesh-ancestor
6634039|NCT03875690|Autonomic Agents|autonomic agents|mesh-ancestor
6634040|NCT03875690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6634041|NCT03875690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6634042|NCT03875690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6634043|NCT03875690|Glucocorticoids|glucocorticoids|mesh-ancestor
6634044|NCT03875690|Hormones|hormones|mesh-ancestor
6634045|NCT03875690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6634046|NCT03875690|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6634047|NCT03875690|Protective Agents|protective agents|mesh-ancestor
6634048|NCT03875690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6634049|NCT03875690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6634058|NCT03860038|Dexamethasone|dexamethasone|mesh-list
6634059|NCT03860038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6634060|NCT03860038|Antiemetics|antiemetics|mesh-ancestor
6634061|NCT03860038|Autonomic Agents|autonomic agents|mesh-ancestor
6634062|NCT03860038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6634063|NCT03860038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6634064|NCT03860038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6634065|NCT03860038|Glucocorticoids|glucocorticoids|mesh-ancestor
6634066|NCT03860038|Hormones|hormones|mesh-ancestor
6634067|NCT03860038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6634068|NCT03860038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6634069|NCT03860038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6634070|NCT03859973|BI 425809|bi 425809|mesh-list
6634071|NCT03859973|Nootropic Agents|nootropic agents|mesh-ancestor
6634072|NCT03845296|Rucaparib|rucaparib|mesh-list
6634073|NCT03845296|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6634074|NCT03845296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6634075|NCT03845296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634076|NCT03845296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6634077|NCT03809013|Trastuzumab|trastuzumab|mesh-list
6634078|NCT03809013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6634079|NCT03809013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5482778|NCT01193842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5482779|NCT01193842|Alkylating Agents|alkylating agents|mesh-ancestor
5482780|NCT01193842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5482781|NCT01193842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5482782|NCT01193842|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5482783|NCT01193842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5482784|NCT01193842|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5482785|NCT01193842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5482786|NCT01193842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5482787|NCT01193842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6634080|NCT03807765|Nivolumab|nivolumab|mesh-list
6634081|NCT03807765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6634082|NCT03807765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6634083|NCT03807765|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6634084|NCT03807765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634085|NCT03795428|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
6634086|NCT03795428|Vasodilator Agents|vasodilator agents|mesh-ancestor
6634087|NCT03785249|Pembrolizumab|pembrolizumab|mesh-list
6634088|NCT03785249|Cetuximab|cetuximab|mesh-list
6634089|NCT03785249|Afatinib|afatinib|mesh-list
6634090|NCT03785249|Adagrasib|adagrasib|mesh-list
6634091|NCT03785249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6634092|NCT03785249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6634093|NCT03785249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6634094|NCT03785249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6634095|NCT03785249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634096|NCT03772717|Immunoglobulins|immunoglobulins|mesh-list
6634097|NCT03772717|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6634098|NCT03772717|gamma-Globulins|gamma-globulins|mesh-list
6634099|NCT03772717|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6634100|NCT03772717|Immunologic Factors|immunologic factors|mesh-ancestor
6634101|NCT03772717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6634102|NCT03749057|Rivaroxaban|rivaroxaban|mesh-list
6634103|NCT03749057|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6634104|NCT03749057|Antithrombins|antithrombins|mesh-ancestor
6634105|NCT03749057|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6634106|NCT03749057|Protease Inhibitors|protease inhibitors|mesh-ancestor
6634107|NCT03749057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6634108|NCT03749057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634109|NCT03749057|Anticoagulants|anticoagulants|mesh-ancestor
6634110|NCT03740958|Argatroban|argatroban|mesh-list
6634111|NCT03740958|Antithrombins|antithrombins|mesh-ancestor
6634112|NCT03740958|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6634113|NCT03740958|Protease Inhibitors|protease inhibitors|mesh-ancestor
6634114|NCT03740958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6634115|NCT03740958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634116|NCT03740958|Anticoagulants|anticoagulants|mesh-ancestor
6634117|NCT03740958|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6634118|NCT03711318|Buprenorphine|buprenorphine|mesh-list
6634119|NCT03711318|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6634120|NCT03711318|Naloxone|naloxone|mesh-list
6634121|NCT03711318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6634122|NCT03711318|Narcotics|narcotics|mesh-ancestor
6634123|NCT03711318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6634124|NCT03711318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6634125|NCT03711318|Analgesics|analgesics|mesh-ancestor
6634126|NCT03711318|Sensory System Agents|sensory system agents|mesh-ancestor
6634127|NCT03711318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6634128|NCT03711318|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6634129|NCT03686488|Ramucirumab|ramucirumab|mesh-list
6634130|NCT03686488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5482788|NCT01193842|Glucocorticoids|glucocorticoids|mesh-ancestor
5482789|NCT01193842|Hormones|hormones|mesh-ancestor
5482790|NCT01193842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5482791|NCT01193842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5482792|NCT01193842|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5482793|NCT01193842|Tubulin Modulators|tubulin modulators|mesh-ancestor
5482794|NCT01193842|Antimitotic Agents|antimitotic agents|mesh-ancestor
6634131|NCT03685188|Sufentanil|sufentanil|mesh-list
6634132|NCT03685188|Oxycodone|oxycodone|mesh-list
6634133|NCT03685188|Dsuvia|dsuvia|mesh-list
6634134|NCT03685188|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6634135|NCT03685188|Narcotics|narcotics|mesh-ancestor
6634136|NCT03685188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6634137|NCT03685188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6634138|NCT03685188|Analgesics|analgesics|mesh-ancestor
6634139|NCT03685188|Sensory System Agents|sensory system agents|mesh-ancestor
6634140|NCT03685188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6634141|NCT03685188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6634142|NCT03685188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6634143|NCT03685188|Anesthetics, General|anesthetics, general|mesh-ancestor
6634144|NCT03685188|Anesthetics|anesthetics|mesh-ancestor
6662970|NCT01505777|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6662971|NCT01505777|Serotonin Agents|serotonin agents|mesh-ancestor
6662972|NCT01505777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6662973|NCT01505777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662974|NCT01505777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662975|NCT01505790|Clopidogrel|clopidogrel|mesh-list
6662976|NCT01505790|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6662977|NCT01505790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6662978|NCT01505790|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6662979|NCT01505790|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6662980|NCT01505790|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6662981|NCT01505790|Purinergic Agents|purinergic agents|mesh-ancestor
6662982|NCT01505790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6662983|NCT01505790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662984|NCT01505790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662985|NCT01505855|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6662986|NCT01505855|Immunologic Factors|immunologic factors|mesh-ancestor
6662987|NCT01505855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662988|NCT01505894|BI 409306|bi 409306|mesh-list
6662989|NCT01505894|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6662990|NCT01505894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6662991|NCT01505894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6662992|NCT01505920|Lidocaine|lidocaine|mesh-list
6662993|NCT01505920|Anesthetics, Local|anesthetics, local|mesh-ancestor
6662994|NCT01505920|Anesthetics|anesthetics|mesh-ancestor
6662995|NCT01505920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6662996|NCT01505920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6662997|NCT01505920|Sensory System Agents|sensory system agents|mesh-ancestor
6662998|NCT01505920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6662999|NCT01505920|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6663000|NCT01505920|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6663001|NCT01505920|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6663002|NCT01505920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6663003|NCT01505920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663004|NCT01505946|Thrombin|thrombin|mesh-list
6663005|NCT01505946|Hemostatics|hemostatics|mesh-ancestor
6663006|NCT01505946|Coagulants|coagulants|mesh-ancestor
6663007|NCT01505998|Amlodipine|amlodipine|mesh-list
6663008|NCT01505998|Benazepril|benazepril|mesh-list
5482795|NCT01193842|Mitosis Modulators|mitosis modulators|mesh-ancestor
5482796|NCT01193842|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5482797|NCT01193842|Keratolytic Agents|keratolytic agents|mesh-ancestor
5482798|NCT01193842|Dermatologic Agents|dermatologic agents|mesh-ancestor
5482799|NCT01168219|Methotrexate|methotrexate|mesh-list
5482800|NCT01168219|Fludarabine phosphate|fludarabine phosphate|mesh-list
5482801|NCT01168219|Azacitidine|azacitidine|mesh-list
5482802|NCT01168219|Fludarabine|fludarabine|mesh-list
5482803|NCT01168219|Busulfan|busulfan|mesh-list
5482804|NCT01168219|Tacrolimus|tacrolimus|mesh-list
5482805|NCT01168219|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5482806|NCT01168219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5482807|NCT01168219|Abortifacient Agents|abortifacient agents|mesh-ancestor
5482808|NCT01168219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5482809|NCT01168219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5482810|NCT01168219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5482811|NCT01168219|Antimetabolites|antimetabolites|mesh-ancestor
5482812|NCT01168219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5482813|NCT01168219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5482814|NCT01168219|Dermatologic Agents|dermatologic agents|mesh-ancestor
5482815|NCT01168219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5482816|NCT01168219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5482817|NCT01168219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5482818|NCT01168219|Immunologic Factors|immunologic factors|mesh-ancestor
5482819|NCT01168219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5482820|NCT01168219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5482821|NCT01168219|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5482822|NCT01168219|Alkylating Agents|alkylating agents|mesh-ancestor
5482823|NCT01168219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6634145|NCT03649880|Misonidazole|misonidazole|mesh-list
6634146|NCT03649880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6634147|NCT03649880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6634148|NCT03649880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6634149|NCT03649880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6634150|NCT03635749|Aspirin|aspirin|mesh-list
6634151|NCT03635749|Atorvastatin|atorvastatin|mesh-list
6634152|NCT03635749|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
6634153|NCT03635749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6634154|NCT03635749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6634155|NCT03635749|Analgesics|analgesics|mesh-ancestor
6634156|NCT03635749|Sensory System Agents|sensory system agents|mesh-ancestor
6634157|NCT03635749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6634158|NCT03635749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6634159|NCT03635749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6634160|NCT03635749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6634161|NCT03635749|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6634162|NCT03635749|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6634163|NCT03635749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634164|NCT03635749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6634165|NCT03635749|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6634166|NCT03635749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6634167|NCT03635749|Antipyretics|antipyretics|mesh-ancestor
6634168|NCT03635749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6634169|NCT03635749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6634170|NCT03635749|Antimetabolites|antimetabolites|mesh-ancestor
6634171|NCT03635749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6634172|NCT03630159|Pembrolizumab|pembrolizumab|mesh-list
6634173|NCT03630159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6634174|NCT03630159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6634175|NCT03616587|Everolimus|everolimus|mesh-list
6634176|NCT03616587|Palbociclib|palbociclib|mesh-list
6634177|NCT03616587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6634178|NCT03616587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6634179|NCT03616587|Immunologic Factors|immunologic factors|mesh-ancestor
6634180|NCT03616587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6634181|NCT03616587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6634182|NCT03616587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6634183|NCT03616587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634184|NCT03599791|Fluticasone|fluticasone|mesh-list
6634185|NCT03599791|Xhance|xhance|mesh-list
6634186|NCT03599791|Azelastine|azelastine|mesh-list
6634187|NCT03599791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6634188|NCT03599791|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5482824|NCT01168219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5502417|NCT04466540|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6634189|NCT03599791|Autonomic Agents|autonomic agents|mesh-ancestor
6634190|NCT03599791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6634191|NCT03599791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6634192|NCT03599791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6634193|NCT03599791|Respiratory System Agents|respiratory system agents|mesh-ancestor
6634194|NCT03599791|Dermatologic Agents|dermatologic agents|mesh-ancestor
6634195|NCT03599791|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6634196|NCT03599791|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6634197|NCT03599791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6634198|NCT03599791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634199|NCT03599791|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6634200|NCT03599791|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6634201|NCT03599791|Histamine Antagonists|histamine antagonists|mesh-ancestor
6634202|NCT03599791|Histamine Agents|histamine agents|mesh-ancestor
6634203|NCT03599791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6634204|NCT03591510|Cytarabine|cytarabine|mesh-list
6634205|NCT03591510|Fludarabine|fludarabine|mesh-list
6634206|NCT03591510|Etoposide|etoposide|mesh-list
6634207|NCT03591510|Daunorubicin|daunorubicin|mesh-list
6634208|NCT03591510|Mitoxantrone|mitoxantrone|mesh-list
6634209|NCT03591510|Idarubicin|idarubicin|mesh-list
6634210|NCT03591510|Midostaurin|midostaurin|mesh-list
6634211|NCT03591510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6634212|NCT03591510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6634213|NCT03591510|Antimetabolites|antimetabolites|mesh-ancestor
6634214|NCT03591510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634215|NCT03591510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6634216|NCT03591510|Immunologic Factors|immunologic factors|mesh-ancestor
6634217|NCT03591510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6634218|NCT03591510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6634219|NCT03591510|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6634220|NCT03591510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6634221|NCT03591510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6634222|NCT03591510|Antiviral Agents|antiviral agents|mesh-ancestor
6634223|NCT03591510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6634224|NCT03591510|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6634225|NCT03591510|Analgesics|analgesics|mesh-ancestor
6634226|NCT03591510|Sensory System Agents|sensory system agents|mesh-ancestor
5482825|NCT01081262|Paclitaxel|paclitaxel|mesh-list
5482826|NCT01081262|Bevacizumab|bevacizumab|mesh-list
5482827|NCT01081262|Carboplatin|carboplatin|mesh-list
5482828|NCT01081262|Capecitabine|capecitabine|mesh-list
5482829|NCT01081262|Oxaliplatin|oxaliplatin|mesh-list
5482830|NCT01081262|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5482831|NCT01081262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5482832|NCT01081262|Endothelial Growth Factors|endothelial growth factors|mesh-list
5482833|NCT01081262|Antibodies|antibodies|mesh-list
5482834|NCT01081262|Immunoglobulins|immunoglobulins|mesh-list
5482835|NCT01081262|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5482836|NCT01081262|Immunoglobulin G|immunoglobulin g|mesh-list
5482837|NCT01081262|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5482838|NCT01081262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5482839|NCT01081262|Tubulin Modulators|tubulin modulators|mesh-ancestor
5482840|NCT01081262|Antimitotic Agents|antimitotic agents|mesh-ancestor
5482841|NCT01081262|Mitosis Modulators|mitosis modulators|mesh-ancestor
5482842|NCT01081262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5482843|NCT01081262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5482844|NCT01081262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5482845|NCT01081262|Growth Substances|growth substances|mesh-ancestor
5482846|NCT01081262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5482847|NCT01081262|Growth Inhibitors|growth inhibitors|mesh-ancestor
5482848|NCT01081262|Immunologic Factors|immunologic factors|mesh-ancestor
5482849|NCT01081262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5482850|NCT01081262|Antimetabolites|antimetabolites|mesh-ancestor
5482851|NCT01062425|Temozolomide|temozolomide|mesh-list
5482852|NCT01062425|Cediranib|cediranib|mesh-list
6634227|NCT03591510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6634228|NCT03591510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6634229|NCT03587142|Buspirone|buspirone|mesh-list
6634230|NCT03587142|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6634231|NCT03587142|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6634232|NCT03587142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6634233|NCT03587142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6634234|NCT03587142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6634235|NCT03587142|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6634236|NCT03587142|Serotonin Agents|serotonin agents|mesh-ancestor
6634237|NCT03587142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6634238|NCT03587142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634239|NCT03556020|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
6634240|NCT03556020|Vasodilator Agents|vasodilator agents|mesh-ancestor
6634241|NCT03526432|Bevacizumab|bevacizumab|mesh-list
6634242|NCT03526432|Atezolizumab|atezolizumab|mesh-list
6634243|NCT03526432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6634244|NCT03526432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6634245|NCT03526432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6634246|NCT03526432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6634247|NCT03526432|Growth Substances|growth substances|mesh-ancestor
6634248|NCT03526432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6634249|NCT03526432|Growth Inhibitors|growth inhibitors|mesh-ancestor
6634250|NCT03513952|Atezolizumab|atezolizumab|mesh-list
6634251|NCT03513952|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6634252|NCT03513952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6634253|NCT03513952|Immunologic Factors|immunologic factors|mesh-ancestor
6634254|NCT03513952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6634255|NCT03510468|Pyridoxine|pyridoxine|mesh-list
6634256|NCT03510468|Isoniazid|isoniazid|mesh-list
6634257|NCT03510468|Rifapentine|rifapentine|mesh-list
6634258|NCT03510468|Antitubercular Agents|antitubercular agents|mesh-ancestor
6634259|NCT03510468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6634260|NCT03510468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6634261|NCT03510468|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6634262|NCT03510468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6634263|NCT03510468|Antimetabolites|antimetabolites|mesh-ancestor
6634264|NCT03510468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634265|NCT03510468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6634266|NCT03510468|Vitamin B Complex|vitamin b complex|mesh-ancestor
5482853|NCT01062425|Maleic acid|maleic acid|mesh-list
5482854|NCT01062425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5482855|NCT01062425|Alkylating Agents|alkylating agents|mesh-ancestor
6634267|NCT03510468|Vitamins|vitamins|mesh-ancestor
6634268|NCT03510468|Micronutrients|micronutrients|mesh-ancestor
6634269|NCT03510468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6634270|NCT03510468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6634271|NCT03510468|Leprostatic Agents|leprostatic agents|mesh-ancestor
6634272|NCT03502330|Nivolumab|nivolumab|mesh-list
6634273|NCT03502330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6634274|NCT03502330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6634275|NCT03502330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6634276|NCT03502330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634277|NCT03429543|Empagliflozin|empagliflozin|mesh-list
6634278|NCT03429543|Linagliptin|linagliptin|mesh-list
6634279|NCT03429543|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6634280|NCT03429543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634281|NCT03429543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6634282|NCT03429543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6634283|NCT03429543|Incretins|incretins|mesh-ancestor
6634284|NCT03429543|Hormones|hormones|mesh-ancestor
6634285|NCT03429543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6634286|NCT03429543|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6634287|NCT03429543|Protease Inhibitors|protease inhibitors|mesh-ancestor
6634288|NCT03429543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6634289|NCT03429140|Hyaluronic Acid|hyaluronic acid|mesh-list
6634290|NCT03429140|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6634291|NCT03429140|Immunologic Factors|immunologic factors|mesh-ancestor
6634292|NCT03429140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6634293|NCT03429140|Viscosupplements|viscosupplements|mesh-ancestor
6634294|NCT03429140|Protective Agents|protective agents|mesh-ancestor
6634295|NCT03363035|Enoxaparin|enoxaparin|mesh-list
6634296|NCT03363035|Rivaroxaban|rivaroxaban|mesh-list
6634297|NCT03363035|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6634298|NCT03363035|Antithrombins|antithrombins|mesh-ancestor
6634299|NCT03363035|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6634300|NCT03363035|Protease Inhibitors|protease inhibitors|mesh-ancestor
6634301|NCT03363035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6634302|NCT03363035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634303|NCT03363035|Anticoagulants|anticoagulants|mesh-ancestor
6634304|NCT03363035|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6634305|NCT03363035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6634306|NCT03337087|Calcium, Dietary|calcium, dietary|mesh-list
6634307|NCT03337087|Leucovorin|leucovorin|mesh-list
6634308|NCT03337087|Folic Acid|folic acid|mesh-list
6634309|NCT03337087|Fluorouracil|fluorouracil|mesh-list
6634310|NCT03337087|Irinotecan|irinotecan|mesh-list
6634311|NCT03337087|Rucaparib|rucaparib|mesh-list
6634312|NCT03337087|Calcium|calcium|mesh-list
6634313|NCT03337087|Levoleucovorin|levoleucovorin|mesh-list
5482856|NCT01062425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5482857|NCT01062425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5482858|NCT01062425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5482859|NCT01062425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5482860|NCT01023737|Hydroxychloroquine|hydroxychloroquine|mesh-list
5482861|NCT01023737|Vorinostat|vorinostat|mesh-list
5482862|NCT01023737|Antimalarials|antimalarials|mesh-ancestor
5482863|NCT01023737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5482864|NCT01023737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5482865|NCT01023737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5482866|NCT01023737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6452044|NCT00415116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452045|NCT00415116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6452046|NCT00415116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6452047|NCT00415116|Growth Substances|growth substances|mesh-ancestor
6452048|NCT00415116|Growth Inhibitors|growth inhibitors|mesh-ancestor
6452049|NCT00415233|Hormones|hormones|mesh-list
6452050|NCT00415233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6452051|NCT00415233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452052|NCT00415246|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6452053|NCT00415246|Luteolytic Agents|luteolytic agents|mesh-ancestor
6452054|NCT00415246|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6452055|NCT00415246|Contraceptive Agents|contraceptive agents|mesh-ancestor
6452056|NCT00415246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6452057|NCT00415246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6634314|NCT03337087|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6634315|NCT03337087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6634316|NCT03337087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6634317|NCT03337087|Antimetabolites|antimetabolites|mesh-ancestor
5503632|NCT04457089|Simvastatin|simvastatin|mesh-list
5482867|NCT01023737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5482868|NCT01023737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6634318|NCT03337087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634319|NCT03337087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6634320|NCT03337087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6634321|NCT03337087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6634322|NCT03337087|Immunologic Factors|immunologic factors|mesh-ancestor
6634323|NCT03337087|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6634324|NCT03337087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6634325|NCT03337087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6634326|NCT03337087|Antidotes|antidotes|mesh-ancestor
6634327|NCT03337087|Protective Agents|protective agents|mesh-ancestor
6634328|NCT03337087|Vitamin B Complex|vitamin b complex|mesh-ancestor
6634329|NCT03337087|Vitamins|vitamins|mesh-ancestor
6634330|NCT03337087|Micronutrients|micronutrients|mesh-ancestor
6634331|NCT03337087|Hematinics|hematinics|mesh-ancestor
6634332|NCT03337087|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6634333|NCT03327805|Choline|choline|mesh-list
6634334|NCT03327805|Lipotropic Agents|lipotropic agents|mesh-ancestor
6634335|NCT03327805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6634336|NCT03327805|Antimetabolites|antimetabolites|mesh-ancestor
6634337|NCT03327805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634338|NCT03327805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6634339|NCT03327805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6634340|NCT03327805|Nootropic Agents|nootropic agents|mesh-ancestor
6634341|NCT03313180|Nintedanib|nintedanib|mesh-list
6634342|NCT03313180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6634343|NCT03313180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6634344|NCT03313180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6634345|NCT03313180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634346|NCT03270176|Avelumab|avelumab|mesh-list
6634347|NCT03270176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6634348|NCT03270176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6634349|NCT03246958|Nivolumab|nivolumab|mesh-list
6634350|NCT03246958|Ipilimumab|ipilimumab|mesh-list
6634351|NCT03246958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6634352|NCT03246958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6634353|NCT03246958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6634354|NCT03246958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634355|NCT03207867|Spartalizumab|spartalizumab|mesh-list
6634356|NCT03207867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6634357|NCT03207867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634358|NCT03207867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6634359|NCT03192345|Cemiplimab|cemiplimab|mesh-list
6634360|NCT03192345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6634361|NCT03192345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6634362|NCT03160521|Risperidone|risperidone|mesh-list
6634363|NCT03160521|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6634364|NCT03160521|Serotonin Agents|serotonin agents|mesh-ancestor
6634365|NCT03160521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6634366|NCT03160521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634367|NCT03160521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6634368|NCT03160521|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6634369|NCT03160521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6634370|NCT03160521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6634371|NCT03160521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6634372|NCT03160521|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6634373|NCT03160521|Dopamine Agents|dopamine agents|mesh-ancestor
6634374|NCT03150329|Pembrolizumab|pembrolizumab|mesh-list
6634375|NCT03150329|Vorinostat|vorinostat|mesh-list
6634376|NCT03150329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6634377|NCT03150329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6634378|NCT03150329|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6634379|NCT03150329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6634380|NCT03150329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634381|NCT03143816|Insulin|insulin|mesh-list
6634382|NCT03143816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6634383|NCT03143816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6634384|NCT03133988|Margetuximab|margetuximab|mesh-list
6634385|NCT03133988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6634386|NCT03122847|Methylprednisolone|methylprednisolone|mesh-list
6634387|NCT03122847|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6634388|NCT03122847|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6634389|NCT03122847|Prednisolone|prednisolone|mesh-list
6634390|NCT03122847|Prednisolone acetate|prednisolone acetate|mesh-list
6634391|NCT03122847|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6634392|NCT03122847|Prednisolone phosphate|prednisolone phosphate|mesh-list
6634393|NCT03122847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6634394|NCT03122847|Antiemetics|antiemetics|mesh-ancestor
6634395|NCT03122847|Autonomic Agents|autonomic agents|mesh-ancestor
6634396|NCT03122847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6634397|NCT03122847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6634398|NCT03122847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6634399|NCT03122847|Glucocorticoids|glucocorticoids|mesh-ancestor
6634400|NCT03122847|Hormones|hormones|mesh-ancestor
6634401|NCT03122847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6634402|NCT03122847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6634403|NCT03122847|Protective Agents|protective agents|mesh-ancestor
6634404|NCT03122847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6634405|NCT03122847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6634406|NCT03088813|Irinotecan|irinotecan|mesh-list
6634407|NCT03088813|Topotecan|topotecan|mesh-list
6634408|NCT03088813|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6634409|NCT03088813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6634410|NCT03088813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6634411|NCT03088813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634412|NCT03088813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6634413|NCT03078192|Xenon|xenon|mesh-list
6634414|NCT03078192|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6634415|NCT03078192|Anesthetics, General|anesthetics, general|mesh-ancestor
6634416|NCT03078192|Anesthetics|anesthetics|mesh-ancestor
5482869|NCT01023737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5482870|NCT01023737|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5482871|NCT00741988|Bevacizumab|bevacizumab|mesh-list
5482872|NCT00741988|Carboplatin|carboplatin|mesh-list
5482873|NCT00741988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5482874|NCT00741988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5482875|NCT00741988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5482876|NCT00741988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5482877|NCT00741988|Growth Substances|growth substances|mesh-ancestor
5482878|NCT00741988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5482879|NCT00741988|Growth Inhibitors|growth inhibitors|mesh-ancestor
5482880|NCT00568997|Pimecrolimus|pimecrolimus|mesh-list
5482881|NCT00568997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5482882|NCT00568997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5482883|NCT00568997|Analgesics|analgesics|mesh-ancestor
5482884|NCT00568997|Sensory System Agents|sensory system agents|mesh-ancestor
5482885|NCT00568997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5482886|NCT00568997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5482887|NCT00568997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5482888|NCT00568997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5482889|NCT00568997|Dermatologic Agents|dermatologic agents|mesh-ancestor
5482890|NCT00568997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5482891|NCT00568997|Immunologic Factors|immunologic factors|mesh-ancestor
5482892|NCT00568997|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5482893|NCT00568997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5482894|NCT00568997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5482895|NCT00563576|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
5482896|NCT00563576|Medroxyprogesterone|medroxyprogesterone|mesh-list
5482897|NCT00563576|Estradiol|estradiol|mesh-list
5482898|NCT00563576|Estrogens|estrogens|mesh-ancestor
5482899|NCT00563576|Hormones|hormones|mesh-ancestor
6634417|NCT03078192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6634418|NCT03078192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6634419|NCT03057795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6634420|NCT03057795|Nivolumab|nivolumab|mesh-list
5482900|NCT00563576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5724872|NCT03184649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6634421|NCT03057795|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6634422|NCT03057795|Antibodies|antibodies|mesh-list
6634423|NCT03057795|Immunoglobulins|immunoglobulins|mesh-list
6634424|NCT03057795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6634425|NCT03057795|Immunoconjugates|immunoconjugates|mesh-list
6634426|NCT03057795|Immunologic Factors|immunologic factors|mesh-ancestor
6634427|NCT03057795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6634428|NCT03057795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6634429|NCT03057795|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6634430|NCT03057795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634431|NCT03004131|Fluticasone|fluticasone|mesh-list
6634432|NCT03004131|Xhance|xhance|mesh-list
6634433|NCT03004131|Loratadine|loratadine|mesh-list
6634434|NCT03004131|Azelastine|azelastine|mesh-list
6634435|NCT03004131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6634436|NCT03004131|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6634437|NCT03004131|Autonomic Agents|autonomic agents|mesh-ancestor
6634438|NCT03004131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6634439|NCT03004131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6634440|NCT03004131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6634441|NCT03004131|Respiratory System Agents|respiratory system agents|mesh-ancestor
6634442|NCT03004131|Dermatologic Agents|dermatologic agents|mesh-ancestor
6634443|NCT03004131|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6634444|NCT03004131|Antipruritics|antipruritics|mesh-ancestor
6634445|NCT03004131|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6634446|NCT03004131|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6634447|NCT03004131|Histamine Antagonists|histamine antagonists|mesh-ancestor
6634448|NCT03004131|Histamine Agents|histamine agents|mesh-ancestor
6634449|NCT03004131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6634450|NCT03004131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634451|NCT03004131|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6634452|NCT03004131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6634453|NCT02959944|Prednisone|prednisone|mesh-list
6634454|NCT02959944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6634455|NCT02959944|Glucocorticoids|glucocorticoids|mesh-ancestor
6634456|NCT02959944|Hormones|hormones|mesh-ancestor
6634457|NCT02959944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6634458|NCT02959944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6634459|NCT02959944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6634460|NCT02959944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6634461|NCT02959463|Pembrolizumab|pembrolizumab|mesh-list
6634462|NCT02959463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6634463|NCT02959463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6634473|NCT02903823|Baclofen|baclofen|mesh-list
6634474|NCT02903823|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6634475|NCT02903823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6634476|NCT02903823|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6634477|NCT02903823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6634478|NCT02903823|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6634479|NCT02903823|GABA Agonists|gaba agonists|mesh-ancestor
6634480|NCT02903823|GABA Agents|gaba agents|mesh-ancestor
6634481|NCT02903823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6634482|NCT02903823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634483|NCT02876302|Paclitaxel|paclitaxel|mesh-list
6634484|NCT02876302|Cyclophosphamide|cyclophosphamide|mesh-list
6634485|NCT02876302|Doxorubicin|doxorubicin|mesh-list
6634486|NCT02876302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6634487|NCT02876302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6634488|NCT02876302|Tubulin Modulators|tubulin modulators|mesh-ancestor
6634489|NCT02876302|Antimitotic Agents|antimitotic agents|mesh-ancestor
6634490|NCT02876302|Mitosis Modulators|mitosis modulators|mesh-ancestor
6634491|NCT02876302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634492|NCT02876302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6634493|NCT02876302|Immunologic Factors|immunologic factors|mesh-ancestor
6634494|NCT02876302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6634495|NCT02876302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6634496|NCT02876302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5482901|NCT00563576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5482902|NCT00563576|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5482903|NCT00563576|Contraceptive Agents|contraceptive agents|mesh-ancestor
5482904|NCT00563576|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5482905|NCT00563576|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5482906|NCT00563576|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5482907|NCT00563576|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5482908|NCT00563576|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5482909|NCT00563576|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5482910|NCT00563576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5482911|NCT00563576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5482912|NCT00455403|Chloroquine|chloroquine|mesh-list
5482913|NCT00455403|Amebicides|amebicides|mesh-ancestor
5482914|NCT00455403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5482915|NCT00455403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5482916|NCT00455403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6634497|NCT02876302|Alkylating Agents|alkylating agents|mesh-ancestor
6634498|NCT02876302|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6634499|NCT02876302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6634500|NCT02876302|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6634501|NCT02876302|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6634502|NCT02876302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6634503|NCT02869009|Aspirin|aspirin|mesh-list
6634504|NCT02869009|Clopidogrel|clopidogrel|mesh-list
6634505|NCT02869009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6634506|NCT02869009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6634507|NCT02869009|Analgesics|analgesics|mesh-ancestor
6634508|NCT02869009|Sensory System Agents|sensory system agents|mesh-ancestor
6634509|NCT02869009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6634510|NCT02869009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6634511|NCT02869009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6634512|NCT02869009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6634513|NCT02869009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6634514|NCT02869009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6634515|NCT02869009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634516|NCT02869009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6634517|NCT02869009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6634518|NCT02869009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6634519|NCT02869009|Antipyretics|antipyretics|mesh-ancestor
6634520|NCT02869009|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6634521|NCT02869009|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6634522|NCT02869009|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6634523|NCT02869009|Purinergic Agents|purinergic agents|mesh-ancestor
6634524|NCT02869009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6634525|NCT02855697|Olaparib|olaparib|mesh-list
6634526|NCT02855697|Cediranib|cediranib|mesh-list
5482917|NCT00455403|Antimalarials|antimalarials|mesh-ancestor
5482918|NCT00455403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5482919|NCT00238420|Paclitaxel|paclitaxel|mesh-list
5482920|NCT00238420|Trastuzumab|trastuzumab|mesh-list
5482921|NCT00238420|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5482922|NCT00238420|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
5482923|NCT00238420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6634527|NCT02855697|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6634528|NCT02855697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6634529|NCT02855697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634530|NCT02855697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6634531|NCT02855697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6634532|NCT02835222|Cytarabine|cytarabine|mesh-list
6634533|NCT02835222|Daunorubicin|daunorubicin|mesh-list
6634534|NCT02835222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6634535|NCT02835222|Antimetabolites|antimetabolites|mesh-ancestor
6634536|NCT02835222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634537|NCT02835222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6634538|NCT02835222|Antiviral Agents|antiviral agents|mesh-ancestor
6634539|NCT02835222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6634540|NCT02835222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6634541|NCT02835222|Immunologic Factors|immunologic factors|mesh-ancestor
6634542|NCT02835222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6634543|NCT02835222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6634544|NCT02835222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6634545|NCT02835222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5482924|NCT00238420|Antibodies|antibodies|mesh-list
6634546|NCT02835222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6634547|NCT02710097|Ethanol|ethanol|mesh-list
6634548|NCT02710097|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6634549|NCT02710097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6634550|NCT02710097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6634551|NCT02710097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6634552|NCT02709954|Ethanol|ethanol|mesh-list
6634553|NCT02709954|Dronabinol|dronabinol|mesh-list
6634554|NCT02709954|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6634555|NCT02709954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6634556|NCT02709954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5482925|NCT00238420|Immunoglobulins|immunoglobulins|mesh-list
5482926|NCT00238420|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5482927|NCT00238420|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5482928|NCT00238420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5482929|NCT00238420|Tubulin Modulators|tubulin modulators|mesh-ancestor
5482930|NCT00238420|Antimitotic Agents|antimitotic agents|mesh-ancestor
6634557|NCT02709954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6634558|NCT02709954|Hallucinogens|hallucinogens|mesh-ancestor
6634559|NCT02709954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6634560|NCT02709954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6634561|NCT02709954|Analgesics|analgesics|mesh-ancestor
6634562|NCT02709954|Sensory System Agents|sensory system agents|mesh-ancestor
6634563|NCT02709954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6634564|NCT02709954|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6634565|NCT02709954|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6634566|NCT02709954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6634567|NCT02709954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634568|NCT02709954|Hormones|hormones|mesh-ancestor
6634569|NCT02709954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6634570|NCT02681549|Bevacizumab|bevacizumab|mesh-list
6634571|NCT02681549|Pembrolizumab|pembrolizumab|mesh-list
5482931|NCT00238420|Mitosis Modulators|mitosis modulators|mesh-ancestor
5482932|NCT00238420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5482933|NCT00238420|Immunologic Factors|immunologic factors|mesh-ancestor
5482934|NCT00238420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5482935|NCT05160805|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5482936|NCT05160805|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5482937|NCT05160623|Povidone-Iodine|povidone-iodine|mesh-list
5482938|NCT05160623|Povidone|povidone|mesh-list
6634572|NCT02681549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5482939|NCT05160623|Plasma Substitutes|plasma substitutes|mesh-ancestor
5482940|NCT05160623|Blood Substitutes|blood substitutes|mesh-ancestor
5482941|NCT05160623|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5482942|NCT05160623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5482943|NCT05160506|Hydrocortisone|hydrocortisone|mesh-list
5482944|NCT05160506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5482945|NCT05160493|Pregabalin|pregabalin|mesh-list
5482946|NCT05160493|Ketamine|ketamine|mesh-list
5482947|NCT05160493|Esketamine|esketamine|mesh-list
5482948|NCT05160493|Analgesics|analgesics|mesh-ancestor
5482949|NCT05160493|Sensory System Agents|sensory system agents|mesh-ancestor
5482950|NCT05160493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5482951|NCT05160493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5482952|NCT05160493|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5482953|NCT05160493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6452058|NCT00415246|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6452059|NCT00415246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6452060|NCT00415246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6452061|NCT00415285|Docetaxel|docetaxel|mesh-list
6452062|NCT00415285|Capecitabine|capecitabine|mesh-list
6452063|NCT00415285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6452064|NCT00415285|Tubulin Modulators|tubulin modulators|mesh-ancestor
6452065|NCT00415285|Antimitotic Agents|antimitotic agents|mesh-ancestor
5482954|NCT05160493|Anesthetics, General|anesthetics, general|mesh-ancestor
5482955|NCT05160493|Anesthetics|anesthetics|mesh-ancestor
6634573|NCT02681549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6634574|NCT02681549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6634575|NCT02681549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6634576|NCT02681549|Growth Substances|growth substances|mesh-ancestor
6634577|NCT02681549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6634578|NCT02681549|Growth Inhibitors|growth inhibitors|mesh-ancestor
6634579|NCT02616302|Dexlansoprazole|dexlansoprazole|mesh-list
6634580|NCT02616302|Lansoprazole|lansoprazole|mesh-list
5482956|NCT05160493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5482957|NCT05160493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5482958|NCT05160493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5482959|NCT05160493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5482960|NCT05160493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5482961|NCT05160493|Anticonvulsants|anticonvulsants|mesh-ancestor
5482962|NCT05160493|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6634581|NCT02616302|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6634582|NCT02616302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6634583|NCT02616302|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6634584|NCT02616302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6634585|NCT02616302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634586|NCT02615184|Dexlansoprazole|dexlansoprazole|mesh-list
6634587|NCT02615184|Lansoprazole|lansoprazole|mesh-list
6634588|NCT02615184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6634589|NCT02615184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6634590|NCT02615184|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6634591|NCT02615184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6634592|NCT02615184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634593|NCT02608268|Decitabine|decitabine|mesh-list
6634594|NCT02608268|Spartalizumab|spartalizumab|mesh-list
6634595|NCT02608268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6634596|NCT02608268|Antimetabolites|antimetabolites|mesh-ancestor
6634597|NCT02608268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634598|NCT02608268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6634599|NCT02608268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6634600|NCT02608268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6634601|NCT02607319|Bemiparin|bemiparin|mesh-list
6634602|NCT02607319|Anticoagulants|anticoagulants|mesh-ancestor
6634603|NCT02576574|Gemcitabine|gemcitabine|mesh-list
6634604|NCT02576574|Paclitaxel|paclitaxel|mesh-list
6634605|NCT02576574|Carboplatin|carboplatin|mesh-list
6634606|NCT02576574|Pemetrexed|pemetrexed|mesh-list
6634607|NCT02576574|Avelumab|avelumab|mesh-list
6634608|NCT02576574|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6634609|NCT02576574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6634610|NCT02576574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5482963|NCT05160493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5482964|NCT05160493|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5482965|NCT05160493|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5482966|NCT05160493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5482967|NCT05160493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5482968|NCT05160493|Antidepressive Agents|antidepressive agents|mesh-ancestor
6634611|NCT02576574|Tubulin Modulators|tubulin modulators|mesh-ancestor
6634612|NCT02576574|Antimitotic Agents|antimitotic agents|mesh-ancestor
6634613|NCT02576574|Mitosis Modulators|mitosis modulators|mesh-ancestor
6634614|NCT02576574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634615|NCT02576574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6634616|NCT02576574|Antimetabolites|antimetabolites|mesh-ancestor
6634617|NCT02576574|Antiviral Agents|antiviral agents|mesh-ancestor
6634618|NCT02576574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6634619|NCT02576574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6634620|NCT02576574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6634621|NCT02576574|Immunologic Factors|immunologic factors|mesh-ancestor
6634622|NCT02576574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6634623|NCT02576574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6634624|NCT02576574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6634625|NCT02576574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6663009|NCT01505998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6663010|NCT01505998|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6663011|NCT01505998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6663012|NCT01505998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663013|NCT01505998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6663014|NCT01505998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663015|NCT01505998|Vasodilator Agents|vasodilator agents|mesh-ancestor
6663016|NCT01505998|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5482969|NCT05160363|Piperaquine|piperaquine|mesh-list
5482970|NCT05160363|Pyronaridine|pyronaridine|mesh-list
5482971|NCT05160363|Antimalarials|antimalarials|mesh-ancestor
5482972|NCT05160363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6452066|NCT00415285|Mitosis Modulators|mitosis modulators|mesh-ancestor
6452067|NCT00415285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6452068|NCT00415285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6452069|NCT00415285|Antimetabolites|antimetabolites|mesh-ancestor
6452070|NCT00415298|Oxaliplatin|oxaliplatin|mesh-list
6452071|NCT00415298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6452072|NCT00415311|Lectins|lectins|mesh-list
6452073|NCT00415311|Agglutinins|agglutinins|mesh-ancestor
5482973|NCT05160363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5482974|NCT05160363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6452074|NCT00415311|Immunologic Factors|immunologic factors|mesh-ancestor
5482975|NCT05160298|Ropivacaine|ropivacaine|mesh-list
5482976|NCT05160298|Anesthetics, Local|anesthetics, local|mesh-ancestor
5482977|NCT05160298|Anesthetics|anesthetics|mesh-ancestor
5482978|NCT05160298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5482979|NCT05160298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5482980|NCT05160298|Sensory System Agents|sensory system agents|mesh-ancestor
5482981|NCT05160298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5482982|NCT05160285|Nivolumab|nivolumab|mesh-list
5482983|NCT05160285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5482984|NCT05160285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5482985|NCT05160285|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5482986|NCT05160285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5482987|NCT05160220|Psilocybin|psilocybin|mesh-list
5482988|NCT05160220|Hallucinogens|hallucinogens|mesh-ancestor
5482989|NCT05160220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5482990|NCT05160220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5482991|NCT05160090|Bupropion|bupropion|mesh-list
5482992|NCT05160090|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5482993|NCT05160090|Antidepressive Agents|antidepressive agents|mesh-ancestor
5482994|NCT05160090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6634626|NCT02562599|Raltitrexed|raltitrexed|mesh-list
6634627|NCT02562599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6634628|NCT02562599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6634629|NCT02562599|Antimetabolites|antimetabolites|mesh-ancestor
6634630|NCT02562599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634631|NCT02562599|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6634632|NCT02562599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6634633|NCT02489448|Durvalumab|durvalumab|mesh-list
6634634|NCT02489448|Tremelimumab|tremelimumab|mesh-list
6634635|NCT02489448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6634636|NCT02489448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6634637|NCT02467582|Aspirin|aspirin|mesh-list
6634638|NCT02467582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5482995|NCT05160090|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5482996|NCT05160090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5482997|NCT05160090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5482998|NCT05160090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5482999|NCT05160090|Dopamine Agents|dopamine agents|mesh-ancestor
6634639|NCT02467582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6634640|NCT02467582|Analgesics|analgesics|mesh-ancestor
6634641|NCT02467582|Sensory System Agents|sensory system agents|mesh-ancestor
6634642|NCT02467582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6634643|NCT02467582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483000|NCT05160090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5483001|NCT05160090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483002|NCT05160090|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5483003|NCT05160090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5483004|NCT05160090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5483005|NCT05160051|FAPI-46|fapi-46|mesh-list
5483006|NCT05160051|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5483007|NCT05160051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483008|NCT05159882|Dapagliflozin|dapagliflozin|mesh-list
5483009|NCT05159882|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5483010|NCT05159882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483011|NCT05159882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5483012|NCT05159882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6634644|NCT02467582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6634645|NCT02467582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6634646|NCT02467582|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6634647|NCT02467582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6634648|NCT02467582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634649|NCT02467582|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6634650|NCT02467582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5483013|NCT05159830|Cannabidiol|cannabidiol|mesh-list
5483014|NCT05159830|Anticonvulsants|anticonvulsants|mesh-ancestor
6634651|NCT02467582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6634652|NCT02467582|Antipyretics|antipyretics|mesh-ancestor
6634653|NCT02456012|Esomeprazole|esomeprazole|mesh-list
6634654|NCT02456012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6634655|NCT02456012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6634656|NCT02456012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6634657|NCT02456012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6634658|NCT02456012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634659|NCT02398773|Estradiol|estradiol|mesh-list
6634660|NCT02398773|Estrogens|estrogens|mesh-ancestor
6634661|NCT02398773|Hormones|hormones|mesh-ancestor
6634662|NCT02398773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6634663|NCT02398773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6634664|NCT02250157|Irinotecan|irinotecan|mesh-list
6634665|NCT02250157|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6634666|NCT02250157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6634667|NCT02250157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6634668|NCT02250157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634669|NCT02250157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6634670|NCT02225405|Cisplatin|cisplatin|mesh-list
6634671|NCT02225405|Docetaxel|docetaxel|mesh-list
6634672|NCT02225405|Nintedanib|nintedanib|mesh-list
6634673|NCT02225405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6634674|NCT02225405|Tubulin Modulators|tubulin modulators|mesh-ancestor
6634675|NCT02225405|Antimitotic Agents|antimitotic agents|mesh-ancestor
6634676|NCT02225405|Mitosis Modulators|mitosis modulators|mesh-ancestor
6634677|NCT02225405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634678|NCT02225405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6634679|NCT02225405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6634680|NCT02141438|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
6634681|NCT02141438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6634682|NCT02087865|Donepezil|donepezil|mesh-list
5483015|NCT05159687|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
5483016|NCT05159687|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5483017|NCT05159687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5483018|NCT05159687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5483019|NCT05159687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483020|NCT05159687|Adrenergic Agents|adrenergic agents|mesh-ancestor
5483021|NCT05159687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5483022|NCT05159687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483023|NCT05159674|Dexmedetomidine|dexmedetomidine|mesh-list
5483024|NCT05159674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5483025|NCT05159674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483026|NCT05159674|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5483027|NCT05159674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5483028|NCT05159674|Analgesics|analgesics|mesh-ancestor
6452075|NCT00415311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452076|NCT00415311|Coagulants|coagulants|mesh-ancestor
6452077|NCT00415324|Cisplatin|cisplatin|mesh-list
6452078|NCT00415324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6452079|NCT00415350|Azithromycin|azithromycin|mesh-list
6452080|NCT00415350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6452081|NCT00415350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6452082|NCT00415376|Levetiracetam|levetiracetam|mesh-list
6452083|NCT00415376|Anticonvulsants|anticonvulsants|mesh-ancestor
6452084|NCT00415376|Nootropic Agents|nootropic agents|mesh-ancestor
6452085|NCT00415402|Vitamin D|vitamin d|mesh-list
6452086|NCT00415402|Cholecalciferol|cholecalciferol|mesh-list
6452087|NCT00415402|Vitamins|vitamins|mesh-ancestor
6452088|NCT00415402|Micronutrients|micronutrients|mesh-ancestor
6452089|NCT00415402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452090|NCT00415402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6452091|NCT00415402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6452092|NCT00415584|Cinacalcet|cinacalcet|mesh-list
6452093|NCT00415584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6634683|NCT02087865|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6634684|NCT02087865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6634685|NCT02087865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634686|NCT02087865|Cholinergic Agents|cholinergic agents|mesh-ancestor
6634687|NCT02087865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6634688|NCT02087865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6634689|NCT02087865|Nootropic Agents|nootropic agents|mesh-ancestor
6634690|NCT02047097|Dimethyl Fumarate|dimethyl fumarate|mesh-list
6634691|NCT02047097|Dermatologic Agents|dermatologic agents|mesh-ancestor
6634692|NCT02047097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6634693|NCT02047097|Immunologic Factors|immunologic factors|mesh-ancestor
6634694|NCT02047097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6634695|NCT02022098|Cisplatin|cisplatin|mesh-list
5483029|NCT05159674|Sensory System Agents|sensory system agents|mesh-ancestor
5483030|NCT05159674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5483031|NCT05159674|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5483032|NCT05159674|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5483033|NCT05159674|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5483034|NCT05159674|Adrenergic Agents|adrenergic agents|mesh-ancestor
5483035|NCT05159674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5483036|NCT05159674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483037|NCT05159531|Tenofovir|tenofovir|mesh-list
5483038|NCT05159531|Emtricitabine|emtricitabine|mesh-list
5483039|NCT05159531|Antiviral Agents|antiviral agents|mesh-ancestor
5483040|NCT05159531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5483041|NCT05159531|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5483042|NCT05159531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5483043|NCT05159531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5483044|NCT05159531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634696|NCT02022098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6634697|NCT01989585|Trametinib|trametinib|mesh-list
6634698|NCT01989585|Dabrafenib|dabrafenib|mesh-list
6634699|NCT01989585|Navitoclax|navitoclax|mesh-list
6634700|NCT01989585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6634701|NCT01989585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6634702|NCT01989585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6634703|NCT01989585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634704|NCT01921140|Olaparib|olaparib|mesh-list
6634705|NCT01921140|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6634706|NCT01921140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6634707|NCT01921140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634708|NCT01921140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6634709|NCT01912625|Paclitaxel|paclitaxel|mesh-list
6634710|NCT01912625|Carboplatin|carboplatin|mesh-list
6634711|NCT01912625|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6634712|NCT01912625|Trametinib|trametinib|mesh-list
6634713|NCT01912625|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6634714|NCT01912625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6634715|NCT01912625|Tubulin Modulators|tubulin modulators|mesh-ancestor
6634716|NCT01912625|Antimitotic Agents|antimitotic agents|mesh-ancestor
6634717|NCT01912625|Mitosis Modulators|mitosis modulators|mesh-ancestor
6634718|NCT01912625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634719|NCT01912625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6634720|NCT01912625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6634721|NCT01909934|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6634722|NCT01909934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6634723|NCT01909934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6634724|NCT01547117|Carbon Monoxide|carbon monoxide|mesh-list
6634725|NCT01547117|Antimetabolites|antimetabolites|mesh-ancestor
6634726|NCT01547117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634727|NCT01547117|Gasotransmitters|gasotransmitters|mesh-ancestor
6634728|NCT01547117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6634729|NCT01547117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6634730|NCT01431508|Losartan|losartan|mesh-list
6634731|NCT01431508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6634732|NCT01431508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6634733|NCT01431508|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6634734|NCT01431508|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6634735|NCT01431508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634736|NCT01174121|Aldesleukin|aldesleukin|mesh-list
6634737|NCT01174121|Cyclophosphamide|cyclophosphamide|mesh-list
6634738|NCT01174121|Pembrolizumab|pembrolizumab|mesh-list
6634739|NCT01174121|Fludarabine|fludarabine|mesh-list
6634740|NCT01174121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5483045|NCT05159531|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5483046|NCT05159531|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6634741|NCT01174121|Immunologic Factors|immunologic factors|mesh-ancestor
6634742|NCT01174121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6634743|NCT01174121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6634744|NCT01174121|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6634745|NCT01174121|Alkylating Agents|alkylating agents|mesh-ancestor
6634746|NCT01174121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634747|NCT01174121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6634748|NCT01174121|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6634749|NCT01174121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6634750|NCT01174121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6634751|NCT01174121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6634752|NCT01174121|Antiviral Agents|antiviral agents|mesh-ancestor
6634753|NCT01174121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6634754|NCT00871351|Atorvastatin|atorvastatin|mesh-list
6634755|NCT00871351|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6634756|NCT00871351|Ezetimibe|ezetimibe|mesh-list
6634757|NCT00871351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6634758|NCT00871351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6634759|NCT00871351|Antimetabolites|antimetabolites|mesh-ancestor
6634760|NCT00871351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634761|NCT00871351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6634762|NCT00871351|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6634763|NCT00871351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6634764|NCT00832455|Montelukast|montelukast|mesh-list
6634765|NCT00832455|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6634766|NCT00832455|Respiratory System Agents|respiratory system agents|mesh-ancestor
6634767|NCT00832455|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5483047|NCT05159284|Hydrocortisone|hydrocortisone|mesh-list
5483048|NCT05159284|Lubricant Eye Drops|lubricant eye drops|mesh-list
5483049|NCT05159284|Hyaluronic Acid|hyaluronic acid|mesh-list
6634768|NCT00832455|Hormone Antagonists|hormone antagonists|mesh-ancestor
6634769|NCT00832455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6634770|NCT00832455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6634771|NCT00832455|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6634772|NCT00832455|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6634773|NCT00832455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634774|NCT00812006|Rizatriptan|rizatriptan|mesh-list
6634775|NCT00812006|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6634776|NCT00812006|Serotonin Agents|serotonin agents|mesh-ancestor
6634777|NCT00812006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6634778|NCT00812006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634779|NCT00812006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6634780|NCT00777582|Olaparib|olaparib|mesh-list
6634781|NCT00777582|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5483050|NCT05159284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5483051|NCT05159284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5483052|NCT05159284|Immunologic Factors|immunologic factors|mesh-ancestor
5483053|NCT05159284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483054|NCT05159284|Viscosupplements|viscosupplements|mesh-ancestor
6634782|NCT00777582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6634783|NCT00777582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634784|NCT00777582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6634785|NCT00739050|Simvastatin|simvastatin|mesh-list
6634786|NCT00739050|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6634787|NCT00739050|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6634788|NCT00739050|Antimetabolites|antimetabolites|mesh-ancestor
6634789|NCT00739050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634790|NCT00739050|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6634791|NCT00739050|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6634792|NCT00739050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6634793|NCT00687531|Mometasone Furoate|mometasone furoate|mesh-list
6634794|NCT00687531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6634795|NCT00687531|Dermatologic Agents|dermatologic agents|mesh-ancestor
6634796|NCT00687531|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6634797|NCT00654628|Simvastatin|simvastatin|mesh-list
6634798|NCT00654628|Ezetimibe|ezetimibe|mesh-list
6634799|NCT00654628|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6634800|NCT00654628|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6634801|NCT00654628|Antimetabolites|antimetabolites|mesh-ancestor
6634802|NCT00654628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634803|NCT00654628|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6634804|NCT00654628|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5483055|NCT05159284|Protective Agents|protective agents|mesh-ancestor
6634805|NCT00654628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6634806|NCT00604812|Rizatriptan|rizatriptan|mesh-list
6634807|NCT00604812|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6634808|NCT00604812|Serotonin Agents|serotonin agents|mesh-ancestor
6634809|NCT00604812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6634810|NCT00604812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634811|NCT00604812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6634812|NCT00536380|Loratadine|loratadine|mesh-list
6634813|NCT00536380|Desloratadine|desloratadine|mesh-list
6634814|NCT00536380|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6634815|NCT00536380|Cholinergic Agents|cholinergic agents|mesh-ancestor
6634816|NCT00536380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6634817|NCT00536380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634818|NCT00536380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6634819|NCT00536380|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6634820|NCT00536380|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6634821|NCT00536380|Histamine Antagonists|histamine antagonists|mesh-ancestor
6634822|NCT00536380|Histamine Agents|histamine agents|mesh-ancestor
6634823|NCT00536380|Antipruritics|antipruritics|mesh-ancestor
6634824|NCT00536380|Dermatologic Agents|dermatologic agents|mesh-ancestor
6634825|NCT00536380|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6634826|NCT00521599|Mometasone Furoate|mometasone furoate|mesh-list
6634827|NCT00521599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6634828|NCT00521599|Dermatologic Agents|dermatologic agents|mesh-ancestor
6634829|NCT00521599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6634830|NCT00516724|Paclitaxel|paclitaxel|mesh-list
6634831|NCT00516724|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6634832|NCT00516724|Carboplatin|carboplatin|mesh-list
6634833|NCT00516724|Olaparib|olaparib|mesh-list
6634834|NCT00516724|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
6634835|NCT00516724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6634836|NCT00516724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6634837|NCT00516724|Tubulin Modulators|tubulin modulators|mesh-ancestor
6634838|NCT00516724|Antimitotic Agents|antimitotic agents|mesh-ancestor
6634839|NCT00516724|Mitosis Modulators|mitosis modulators|mesh-ancestor
6634840|NCT00516724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634841|NCT00516724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6634842|NCT00496834|Losartan|losartan|mesh-list
6634843|NCT00496834|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6634844|NCT00496834|Carvedilol|carvedilol|mesh-list
6634845|NCT00496834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6634846|NCT00496834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6634847|NCT00496834|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6634848|NCT00496834|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6634849|NCT00496834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634850|NCT00496834|Diuretics|diuretics|mesh-ancestor
6634851|NCT00496834|Natriuretic Agents|natriuretic agents|mesh-ancestor
6634852|NCT00496834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6634853|NCT00496834|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6634854|NCT00496834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6634855|NCT00496834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6634856|NCT00496834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6634857|NCT00496834|Adrenergic Agents|adrenergic agents|mesh-ancestor
6634858|NCT00496834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6634859|NCT00496834|Antioxidants|antioxidants|mesh-ancestor
6634860|NCT00496834|Protective Agents|protective agents|mesh-ancestor
6634861|NCT00496834|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6634862|NCT00496834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5483056|NCT05159284|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5483057|NCT05159284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5483058|NCT05159219|Colchicine|colchicine|mesh-list
5483059|NCT05159219|Gout Suppressants|gout suppressants|mesh-ancestor
5483060|NCT05159219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6634863|NCT00496834|Vasodilator Agents|vasodilator agents|mesh-ancestor
6634864|NCT00496834|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6634865|NCT00496834|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6634866|NCT00442897|Atorvastatin|atorvastatin|mesh-list
6634867|NCT00442897|Simvastatin|simvastatin|mesh-list
6634868|NCT00442897|Ezetimibe|ezetimibe|mesh-list
6634869|NCT00442897|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6634870|NCT00442897|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6634871|NCT00442897|Antimetabolites|antimetabolites|mesh-ancestor
6634872|NCT00442897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483061|NCT05159219|Tubulin Modulators|tubulin modulators|mesh-ancestor
6634873|NCT00442897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6663017|NCT01505998|Protease Inhibitors|protease inhibitors|mesh-ancestor
5483062|NCT05159219|Antimitotic Agents|antimitotic agents|mesh-ancestor
6634874|NCT00442897|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6634875|NCT00442897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6634876|NCT00423579|Simvastatin|simvastatin|mesh-list
6634877|NCT00423579|Ezetimibe|ezetimibe|mesh-list
6634878|NCT00423579|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
6634879|NCT00423579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6634880|NCT00423579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6634881|NCT00423579|Antimetabolites|antimetabolites|mesh-ancestor
6634882|NCT00423579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634883|NCT00423579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6634884|NCT00423579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6634885|NCT00423579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6634886|NCT00394355|Fluticasone|fluticasone|mesh-list
6634887|NCT00394355|Xhance|xhance|mesh-list
6634888|NCT00394355|Mometasone Furoate|mometasone furoate|mesh-list
6634889|NCT00394355|Montelukast|montelukast|mesh-list
6634890|NCT00394355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6634891|NCT00394355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6634892|NCT00394355|Autonomic Agents|autonomic agents|mesh-ancestor
6634893|NCT00394355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6634894|NCT00394355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6634895|NCT00394355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6634896|NCT00394355|Respiratory System Agents|respiratory system agents|mesh-ancestor
6634897|NCT00394355|Dermatologic Agents|dermatologic agents|mesh-ancestor
6634898|NCT00394355|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6634899|NCT00394355|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6634900|NCT00394355|Hormone Antagonists|hormone antagonists|mesh-ancestor
5483063|NCT05159219|Mitosis Modulators|mitosis modulators|mesh-ancestor
5483064|NCT05159219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483065|NCT05159219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5483066|NCT05157087|Omalizumab|omalizumab|mesh-list
5483067|NCT05157087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5483068|NCT05157087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5483069|NCT05157087|Respiratory System Agents|respiratory system agents|mesh-ancestor
5483070|NCT05150431|Parecoxib|parecoxib|mesh-list
5483071|NCT05150431|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5483072|NCT05150431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5483073|NCT05150431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5483074|NCT05150431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483075|NCT05150431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5483076|NCT05150431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5483077|NCT05150431|Analgesics|analgesics|mesh-ancestor
5483078|NCT05150431|Sensory System Agents|sensory system agents|mesh-ancestor
5483079|NCT05150431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5483080|NCT05150431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483081|NCT05150431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5483082|NCT05150431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5483083|NCT05146687|Bevacizumab|bevacizumab|mesh-list
5483084|NCT05146687|Ranibizumab|ranibizumab|mesh-list
5483085|NCT05146687|Aflibercept|aflibercept|mesh-list
5483086|NCT05146687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6634901|NCT00394355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6634902|NCT00394355|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6634903|NCT00394355|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6634904|NCT00394355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634905|NCT00359216|Mometasone Furoate|mometasone furoate|mesh-list
6634906|NCT00359216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6634907|NCT00359216|Dermatologic Agents|dermatologic agents|mesh-ancestor
6634908|NCT00359216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6634909|NCT00189280|Imiquimod|imiquimod|mesh-list
6634910|NCT00189280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6634911|NCT00189280|Immunologic Factors|immunologic factors|mesh-ancestor
6634912|NCT00189280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6634913|NCT00189280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6634914|NCT00189280|Interferon Inducers|interferon inducers|mesh-ancestor
6634915|NCT00166504|Atorvastatin|atorvastatin|mesh-list
6634916|NCT00166504|Simvastatin|simvastatin|mesh-list
6634917|NCT00166504|Ezetimibe|ezetimibe|mesh-list
6634918|NCT00166504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6634919|NCT00166504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6634920|NCT00166504|Antimetabolites|antimetabolites|mesh-ancestor
6634921|NCT00166504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634922|NCT00166504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6634923|NCT00166504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5483087|NCT05146687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6634924|NCT00166504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6634925|NCT00101972|Antibodies|antibodies|mesh-list
6634926|NCT00101972|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6634927|NCT00101972|Immunologic Factors|immunologic factors|mesh-ancestor
6634928|NCT00101972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6634929|NCT01343173|Imatinib Mesylate|imatinib mesylate|mesh-list
6634930|NCT01343173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6634931|NCT01343173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6634932|NCT01343173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6634933|NCT01343173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634934|NCT01343186|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6634935|NCT01343186|Interferon-alpha|interferon-alpha|mesh-list
6634936|NCT01343186|Antiviral Agents|antiviral agents|mesh-ancestor
6634937|NCT01343186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6634938|NCT01343186|Immunologic Factors|immunologic factors|mesh-ancestor
6634939|NCT01343186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6634940|NCT01343225|Ritonavir|ritonavir|mesh-list
5483088|NCT05146687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5483089|NCT05146687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5483090|NCT05146687|Growth Substances|growth substances|mesh-ancestor
6634941|NCT01343225|Darunavir|darunavir|mesh-list
6634942|NCT01343225|Raltegravir Potassium|raltegravir potassium|mesh-list
6634943|NCT01343225|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6634944|NCT01343225|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6634945|NCT01343225|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6634946|NCT01343225|Protease Inhibitors|protease inhibitors|mesh-ancestor
6634947|NCT01343225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6634948|NCT01343225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634949|NCT01343225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6634950|NCT01343225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6634951|NCT01343225|Antiviral Agents|antiviral agents|mesh-ancestor
6634952|NCT01343225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6634953|NCT01343225|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6634954|NCT01343225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6634955|NCT01343225|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6634956|NCT01343225|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6634957|NCT01343225|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6634958|NCT01343225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6634959|NCT01343290|Canagliflozin|canagliflozin|mesh-list
6634960|NCT01343290|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6634961|NCT01343290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634962|NCT01343290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6634963|NCT01343290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6634964|NCT01343303|Naproxen|naproxen|mesh-list
6634965|NCT01343303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6634966|NCT01343303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6634967|NCT01343303|Analgesics|analgesics|mesh-ancestor
6634968|NCT01343303|Sensory System Agents|sensory system agents|mesh-ancestor
6634969|NCT01343303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6634970|NCT01343303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6634971|NCT01343303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6634972|NCT01343303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6634973|NCT01343303|Gout Suppressants|gout suppressants|mesh-ancestor
6634974|NCT01343303|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6634975|NCT01343303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6634976|NCT01343303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634977|NCT01343329|Propranolol|propranolol|mesh-list
6634978|NCT01343329|Esmolol|esmolol|mesh-list
6634979|NCT01343329|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6634980|NCT01343329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6634981|NCT01343329|Adrenergic Agents|adrenergic agents|mesh-ancestor
6634982|NCT01343329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6634983|NCT01343329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634984|NCT01343329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6634985|NCT01343329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6634986|NCT01343329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6634987|NCT01343329|Vasodilator Agents|vasodilator agents|mesh-ancestor
6634988|NCT01343329|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6634989|NCT01343381|Heparin|heparin|mesh-list
6634990|NCT01343381|Calcium heparin|calcium heparin|mesh-list
6634991|NCT01343381|Anticoagulants|anticoagulants|mesh-ancestor
6634992|NCT01343381|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6634993|NCT01343381|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6634994|NCT01343381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6634995|NCT01343498|Dactolisib|dactolisib|mesh-list
6634996|NCT01343498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6634997|NCT01343628|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6634998|NCT01343628|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6634999|NCT01343628|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6635000|NCT01343628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6635001|NCT01343628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635002|NCT01343628|Adrenergic Agents|adrenergic agents|mesh-ancestor
6635003|NCT01343628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6635004|NCT01343628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635005|NCT01343680|Heparin|heparin|mesh-list
6635006|NCT01343680|Anticoagulants|anticoagulants|mesh-ancestor
6635007|NCT01343680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6635008|NCT01343680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6635009|NCT01343680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483091|NCT05146687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483092|NCT05146687|Growth Inhibitors|growth inhibitors|mesh-ancestor
5483093|NCT05142098|Dexamethasone|dexamethasone|mesh-list
5483094|NCT05142098|Etoricoxib|etoricoxib|mesh-list
5483095|NCT05142098|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
6635010|NCT01343706|BI 409306|bi 409306|mesh-list
6635011|NCT01343706|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6635012|NCT01343706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6635013|NCT01343706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635014|NCT01343745|Formoterol Fumarate|formoterol fumarate|mesh-list
6635015|NCT01343745|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6635016|NCT01343745|Autonomic Agents|autonomic agents|mesh-ancestor
6635017|NCT01343745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6635018|NCT01343745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635019|NCT01343745|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6635020|NCT01343745|Respiratory System Agents|respiratory system agents|mesh-ancestor
6635021|NCT01343745|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6635022|NCT01343745|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5483096|NCT05142098|Glucocorticoids|glucocorticoids|mesh-list
5483097|NCT05142098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5483098|NCT05142098|Antiemetics|antiemetics|mesh-ancestor
5483099|NCT05142098|Autonomic Agents|autonomic agents|mesh-ancestor
5483100|NCT05142098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5483101|NCT05142098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483102|NCT05142098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5483103|NCT05142098|Hormones|hormones|mesh-ancestor
5483104|NCT05142098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5483105|NCT05142098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5483106|NCT05142098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5483107|NCT05142098|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5483108|NCT05142098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5483109|NCT05142098|Analgesics|analgesics|mesh-ancestor
5483110|NCT05142098|Sensory System Agents|sensory system agents|mesh-ancestor
5483111|NCT05142098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6635023|NCT01343745|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6635024|NCT01343745|Adrenergic Agents|adrenergic agents|mesh-ancestor
6635025|NCT01343745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6635026|NCT01343745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663018|NCT01505998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5483112|NCT05142098|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6663019|NCT01506011|Amlodipine|amlodipine|mesh-list
6663020|NCT01506011|Benazepril|benazepril|mesh-list
6635027|NCT01343862|Cycloserine|cycloserine|mesh-list
6635028|NCT01343862|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6635029|NCT01343862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6635030|NCT01343862|Renal Agents|renal agents|mesh-ancestor
6635031|NCT01343862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6635032|NCT01343862|Antitubercular Agents|antitubercular agents|mesh-ancestor
6635033|NCT01343862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6635034|NCT01343862|Antimetabolites|antimetabolites|mesh-ancestor
6635035|NCT01343862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635036|NCT01344031|Fulvestrant|fulvestrant|mesh-list
6635037|NCT01344031|Anastrozole|anastrozole|mesh-list
6635038|NCT01344031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6635039|NCT01344031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6635040|NCT01344031|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5483113|NCT05142098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5483114|NCT05142098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483115|NCT05141669|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
5483116|NCT05141669|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5483117|NCT05141669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483118|NCT05141669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5483119|NCT05141669|Immunologic Factors|immunologic factors|mesh-ancestor
5483120|NCT05141669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483121|NCT05141240|Palbociclib|palbociclib|mesh-list
5483122|NCT05141240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5483123|NCT05141240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5483124|NCT05141240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5483125|NCT05141240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635041|NCT01344031|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6635042|NCT01344031|Hormone Antagonists|hormone antagonists|mesh-ancestor
6635043|NCT01344031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6635044|NCT01344031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635045|NCT01344031|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6635046|NCT01344031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6635047|NCT01344031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6635048|NCT01344031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635049|NCT01344083|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
6635050|NCT01344083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6635051|NCT01344083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6635052|NCT01344083|Analgesics|analgesics|mesh-ancestor
6635053|NCT01344083|Sensory System Agents|sensory system agents|mesh-ancestor
6635054|NCT01344083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6635055|NCT01344083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635056|NCT01344083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6635057|NCT01344083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6635058|NCT01344083|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6635059|NCT01344083|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6635060|NCT01344083|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6635061|NCT01344083|Histamine Antagonists|histamine antagonists|mesh-ancestor
6635062|NCT01344083|Histamine Agents|histamine agents|mesh-ancestor
6635063|NCT01344083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6635064|NCT01344083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635065|NCT01344174|Lamivudine|lamivudine|mesh-list
6635066|NCT01344174|Dexamethasone|dexamethasone|mesh-list
6635067|NCT01344174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6635068|NCT01344174|Antiemetics|antiemetics|mesh-ancestor
6635069|NCT01344174|Autonomic Agents|autonomic agents|mesh-ancestor
6635070|NCT01344174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6635071|NCT01344174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635072|NCT01344174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6635073|NCT01344174|Glucocorticoids|glucocorticoids|mesh-ancestor
6635074|NCT01344174|Hormones|hormones|mesh-ancestor
6635075|NCT01344174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6635076|NCT01344174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6635077|NCT01344174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6635078|NCT01344174|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6635079|NCT01344174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6635080|NCT01344174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6635081|NCT01344174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635082|NCT01344174|Antiviral Agents|antiviral agents|mesh-ancestor
6635083|NCT01344174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6635084|NCT01344174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6635085|NCT01344174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6635086|NCT01344200|Celecoxib|celecoxib|mesh-list
6635087|NCT01344200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6635088|NCT01344200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6635089|NCT01344200|Analgesics|analgesics|mesh-ancestor
6635090|NCT01344200|Sensory System Agents|sensory system agents|mesh-ancestor
6635091|NCT01344200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6635092|NCT01344200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635093|NCT01344200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6635094|NCT01344200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6635095|NCT01344200|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6635096|NCT01344200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6635097|NCT01344200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6635098|NCT01344200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635099|NCT01344213|Celecoxib|celecoxib|mesh-list
6635100|NCT01344213|Pregabalin|pregabalin|mesh-list
6635101|NCT01344213|Analgesics|analgesics|mesh-ancestor
6635102|NCT01344213|Sensory System Agents|sensory system agents|mesh-ancestor
6635103|NCT01344213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6635104|NCT01344213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021003|NCT00396032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6452094|NCT00415584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452095|NCT00415584|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6452096|NCT00415584|Hormone Antagonists|hormone antagonists|mesh-ancestor
6452097|NCT00415584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6021004|NCT00396032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021005|NCT00396084|Moxifloxacin|moxifloxacin|mesh-list
6635105|NCT01344213|Anticonvulsants|anticonvulsants|mesh-ancestor
6635106|NCT01344213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6635107|NCT01344213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6635108|NCT01344213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635109|NCT01344213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6635110|NCT01344213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6635111|NCT01344213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6635112|NCT01344213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6635113|NCT01344213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6635114|NCT01344213|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6635115|NCT01344213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6635116|NCT01344213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6635117|NCT01344213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6635118|NCT01344213|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6635119|NCT01344213|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6635120|NCT01344213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6635121|NCT01344252|Lidocaine|lidocaine|mesh-list
6635122|NCT01344252|Anesthetics, Local|anesthetics, local|mesh-ancestor
6635123|NCT01344252|Anesthetics|anesthetics|mesh-ancestor
6635124|NCT01344252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6635125|NCT01344252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635126|NCT01344252|Sensory System Agents|sensory system agents|mesh-ancestor
6635127|NCT01344252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6635128|NCT01344252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6635129|NCT01344252|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6635130|NCT01344252|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6635131|NCT01344252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6635132|NCT01344252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635133|NCT01344291|Curcumin|curcumin|mesh-list
6635134|NCT01344291|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6635135|NCT01344291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6635136|NCT01344291|Analgesics|analgesics|mesh-ancestor
6635137|NCT01344291|Sensory System Agents|sensory system agents|mesh-ancestor
6635138|NCT01344291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6635139|NCT01344291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635140|NCT01344291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6635141|NCT01344291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6635142|NCT01344291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6635143|NCT01344291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6635144|NCT01344291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021006|NCT00396084|Levofloxacin|levofloxacin|mesh-list
6461893|NCT00456716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461894|NCT00456729|Metronidazole|metronidazole|mesh-list
6461895|NCT00456729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6461896|NCT00456729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6461897|NCT00456729|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6635145|NCT01344304|Aprepitant|aprepitant|mesh-list
5483126|NCT05137080|Dexamethasone|dexamethasone|mesh-list
5483127|NCT05137080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5483128|NCT05137080|Antiemetics|antiemetics|mesh-ancestor
5483129|NCT05137080|Autonomic Agents|autonomic agents|mesh-ancestor
5483130|NCT05137080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5483131|NCT05137080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483132|NCT05137080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5483133|NCT05137080|Glucocorticoids|glucocorticoids|mesh-ancestor
5483134|NCT05137080|Hormones|hormones|mesh-ancestor
5483135|NCT05137080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5483136|NCT05137080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5483137|NCT05137080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5483138|NCT05132660|Levodopa|levodopa|mesh-list
6635146|NCT01344304|Fosaprepitant|fosaprepitant|mesh-list
6635147|NCT01344304|Antiemetics|antiemetics|mesh-ancestor
6635148|NCT01344304|Autonomic Agents|autonomic agents|mesh-ancestor
6635149|NCT01344304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6635150|NCT01344304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635151|NCT01344304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6635152|NCT01344304|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6635153|NCT01344304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6635154|NCT01344304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635155|NCT01344395|Ketorolac|ketorolac|mesh-list
6635156|NCT01344395|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6635157|NCT01344395|Ropivacaine|ropivacaine|mesh-list
6635158|NCT01344395|Anesthetics, Local|anesthetics, local|mesh-ancestor
6635159|NCT01344395|Anesthetics|anesthetics|mesh-ancestor
6635160|NCT01344395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6635161|NCT01344395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635162|NCT01344395|Sensory System Agents|sensory system agents|mesh-ancestor
6635163|NCT01344395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6635164|NCT01344395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6635165|NCT01344395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6635166|NCT01344395|Analgesics|analgesics|mesh-ancestor
6635167|NCT01344395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6635168|NCT01344395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6635169|NCT01344395|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6635170|NCT01344395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6635171|NCT01344395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635172|NCT01344473|Caseins|caseins|mesh-list
6635173|NCT01344473|Chelating Agents|chelating agents|mesh-ancestor
6635174|NCT01344473|Sequestering Agents|sequestering agents|mesh-ancestor
6635175|NCT01344473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635176|NCT01344512|Ciprofloxacin|ciprofloxacin|mesh-list
6635177|NCT01344512|Ceftazidime|ceftazidime|mesh-list
6635178|NCT01344512|Voriconazole|voriconazole|mesh-list
6635179|NCT01344512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6635180|NCT01344512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6635181|NCT01344512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6635182|NCT01344512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6635183|NCT01344512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6635184|NCT01344512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635185|NCT01344512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6635186|NCT01344512|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6635187|NCT01344512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6635188|NCT01344512|Antifungal Agents|antifungal agents|mesh-ancestor
6635189|NCT01344512|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6635190|NCT01344512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6635191|NCT01344512|Hormone Antagonists|hormone antagonists|mesh-ancestor
6635192|NCT01344512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6635193|NCT01344512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635194|NCT01344512|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6635195|NCT01344564|Leuprolide|leuprolide|mesh-list
6635196|NCT01344564|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6635197|NCT01344564|Fertility Agents|fertility agents|mesh-ancestor
6635198|NCT01344564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6635199|NCT01344564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635200|NCT01344564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6635201|NCT01344564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6635202|NCT01344590|Ethanol|ethanol|mesh-list
5483139|NCT05132660|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
5483140|NCT05132660|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5483141|NCT05132660|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6635203|NCT01344590|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6635204|NCT01344590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6635205|NCT01344590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6635206|NCT01344590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635207|NCT01344655|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6635208|NCT01344655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6635209|NCT01344655|Autonomic Agents|autonomic agents|mesh-ancestor
6635210|NCT01344655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6635211|NCT01344655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635212|NCT01344655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6635213|NCT01344655|Respiratory System Agents|respiratory system agents|mesh-ancestor
6635214|NCT01344655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6635215|NCT01344655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6635216|NCT01344655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6635217|NCT01344655|Adrenergic Agents|adrenergic agents|mesh-ancestor
6635218|NCT01344655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6635219|NCT01344655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635220|NCT01344681|Itraconazole|itraconazole|mesh-list
6635221|NCT01344681|Micafungin|micafungin|mesh-list
6635222|NCT01344681|Antifungal Agents|antifungal agents|mesh-ancestor
6635223|NCT01344681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6635224|NCT01344681|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6635225|NCT01344681|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6635226|NCT01344681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6635227|NCT01344681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635228|NCT01344681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6635229|NCT01344681|Hormone Antagonists|hormone antagonists|mesh-ancestor
6635230|NCT01344681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6635231|NCT01344681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635232|NCT01344681|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6635233|NCT01344720|Etoricoxib|etoricoxib|mesh-list
6635234|NCT01344720|Oxycodone|oxycodone|mesh-list
6635235|NCT01344720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6635236|NCT01344720|Narcotics|narcotics|mesh-ancestor
6635237|NCT01344720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6635238|NCT01344720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635239|NCT01344720|Analgesics|analgesics|mesh-ancestor
6635240|NCT01344720|Sensory System Agents|sensory system agents|mesh-ancestor
6635241|NCT01344720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6635242|NCT01344720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6635243|NCT01344720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6635244|NCT01344720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6635245|NCT01344720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6635246|NCT01344720|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6635247|NCT01344720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6635248|NCT01344720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5483142|NCT05132660|Dopamine Agents|dopamine agents|mesh-ancestor
5483143|NCT05132660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5483144|NCT05132660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483145|NCT05132660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483146|NCT05132660|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6635249|NCT01344720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635250|NCT01344863|Trastuzumab|trastuzumab|mesh-list
6635251|NCT01344863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6635252|NCT01344863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6635253|NCT01344954|Rivaroxaban|rivaroxaban|mesh-list
6635254|NCT01344954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6635255|NCT01344954|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6635256|NCT01344954|Antithrombins|antithrombins|mesh-ancestor
6635257|NCT01344954|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6635258|NCT01344954|Protease Inhibitors|protease inhibitors|mesh-ancestor
6635259|NCT01344954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6635260|NCT01344954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635261|NCT01344954|Anticoagulants|anticoagulants|mesh-ancestor
6635262|NCT01344954|Immunologic Factors|immunologic factors|mesh-ancestor
5483147|NCT05132660|Immunologic Factors|immunologic factors|mesh-ancestor
5483148|NCT05132660|Dopamine Agonists|dopamine agonists|mesh-ancestor
5483149|NCT05124340|Vaccines|vaccines|mesh-list
5483150|NCT05124340|Immunologic Factors|immunologic factors|mesh-ancestor
5483151|NCT05124340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483152|NCT05117450|Heparin|heparin|mesh-list
6665044|NCT01515397|Blood Substitutes|blood substitutes|mesh-ancestor
5483153|NCT05117450|Anticoagulants|anticoagulants|mesh-ancestor
5483154|NCT05117450|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6635263|NCT01344954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635264|NCT01344967|Zoledronic Acid|zoledronic acid|mesh-list
6635265|NCT01344967|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6635266|NCT01344967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635267|NCT01345084|Nimotuzumab|nimotuzumab|mesh-list
6635268|NCT01345084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6635269|NCT01345084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6635270|NCT01345136|Everolimus|everolimus|mesh-list
6635271|NCT01345136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6635272|NCT01345136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6635273|NCT01345136|Immunologic Factors|immunologic factors|mesh-ancestor
6635274|NCT01345136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635275|NCT01345175|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6635276|NCT01345175|Metronidazole|metronidazole|mesh-list
6635277|NCT01345175|Rifaximin|rifaximin|mesh-list
6635278|NCT01345175|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6635279|NCT01345175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6635280|NCT01345175|Antitubercular Agents|antitubercular agents|mesh-ancestor
6635281|NCT01345175|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6635282|NCT01345175|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6635283|NCT01345175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6635284|NCT01345240|Vaccines|vaccines|mesh-list
6635285|NCT01345240|Immunologic Factors|immunologic factors|mesh-ancestor
6635286|NCT01345240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635287|NCT01345279|Paclitaxel|paclitaxel|mesh-list
5483155|NCT05117450|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5483156|NCT05117450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483157|NCT05116930|Atropine|atropine|mesh-list
5483158|NCT05116930|Neostigmine|neostigmine|mesh-list
6635288|NCT01345279|Topotecan|topotecan|mesh-list
6635289|NCT01345279|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6635290|NCT01345279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6635291|NCT01345279|Tubulin Modulators|tubulin modulators|mesh-ancestor
6635292|NCT01345279|Antimitotic Agents|antimitotic agents|mesh-ancestor
6635293|NCT01345279|Mitosis Modulators|mitosis modulators|mesh-ancestor
6635294|NCT01345279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635295|NCT01345279|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6635296|NCT01345279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6635297|NCT01345279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6635298|NCT01345357|Gemcitabine|gemcitabine|mesh-list
6635299|NCT01345357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6635300|NCT01345357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6635301|NCT01345357|Antimetabolites|antimetabolites|mesh-ancestor
6635302|NCT01345357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635303|NCT01345357|Antiviral Agents|antiviral agents|mesh-ancestor
6635304|NCT01345357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6635305|NCT01345357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6635306|NCT01345357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6635307|NCT01345357|Immunologic Factors|immunologic factors|mesh-ancestor
6635308|NCT01345357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635309|NCT01345370|Temozolomide|temozolomide|mesh-list
6635310|NCT01345370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6635311|NCT01345370|Alkylating Agents|alkylating agents|mesh-ancestor
6635312|NCT01345370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635313|NCT01345370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6635314|NCT01345448|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6635315|NCT01345448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6635316|NCT01345448|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6635317|NCT01345448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6635318|NCT01345448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6635319|NCT01345448|Adrenergic Agents|adrenergic agents|mesh-ancestor
6635320|NCT01345448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6635321|NCT01345448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635322|NCT01345448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635323|NCT01345604|Ropivacaine|ropivacaine|mesh-list
6635324|NCT01345604|Anesthetics, Local|anesthetics, local|mesh-ancestor
6635325|NCT01345604|Anesthetics|anesthetics|mesh-ancestor
6635326|NCT01345604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6635327|NCT01345604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483159|NCT05116930|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5483160|NCT05116930|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5483161|NCT05116930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6635328|NCT01345604|Sensory System Agents|sensory system agents|mesh-ancestor
6635329|NCT01345604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6635330|NCT01345708|Prednisone|prednisone|mesh-list
6635331|NCT01345708|Rituximab|rituximab|mesh-list
6635332|NCT01345708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6635333|NCT01345708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6635334|NCT01345708|Immunologic Factors|immunologic factors|mesh-ancestor
6635335|NCT01345708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635336|NCT01345708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6635337|NCT01345708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6635338|NCT01345708|Glucocorticoids|glucocorticoids|mesh-ancestor
6635339|NCT01345708|Hormones|hormones|mesh-ancestor
6635340|NCT01345708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6635341|NCT01345708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6635342|NCT01345734|Liraglutide|liraglutide|mesh-list
6635343|NCT01345734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6635344|NCT01345734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635345|NCT01345734|Incretins|incretins|mesh-ancestor
6635346|NCT01345734|Hormones|hormones|mesh-ancestor
6635347|NCT01345734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6635348|NCT01345851|Paclitaxel|paclitaxel|mesh-list
6635349|NCT01345851|Carboplatin|carboplatin|mesh-list
6635350|NCT01345851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6635351|NCT01345851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6635352|NCT01345851|Tubulin Modulators|tubulin modulators|mesh-ancestor
6635353|NCT01345851|Antimitotic Agents|antimitotic agents|mesh-ancestor
6635354|NCT01345851|Mitosis Modulators|mitosis modulators|mesh-ancestor
6635355|NCT01345851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635356|NCT01345864|Scopolamine|scopolamine|mesh-list
6635357|NCT01345864|Donepezil|donepezil|mesh-list
6635358|NCT01345864|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
6635359|NCT01345864|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6635360|NCT01345864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6635361|NCT01345864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635362|NCT01345864|Cholinergic Agents|cholinergic agents|mesh-ancestor
6635363|NCT01345864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6635364|NCT01345864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635365|NCT01345864|Nootropic Agents|nootropic agents|mesh-ancestor
6635366|NCT01345864|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6635367|NCT01345864|Antiemetics|antiemetics|mesh-ancestor
6635368|NCT01345864|Autonomic Agents|autonomic agents|mesh-ancestor
6635369|NCT01345864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6635370|NCT01345864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5483162|NCT05116930|Autonomic Agents|autonomic agents|mesh-ancestor
5483163|NCT05116930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5483164|NCT05116930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483165|NCT05116930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5483166|NCT05116930|Respiratory System Agents|respiratory system agents|mesh-ancestor
5483167|NCT05116930|Mydriatics|mydriatics|mesh-ancestor
5483168|NCT05116930|Parasympatholytics|parasympatholytics|mesh-ancestor
5483169|NCT05116930|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5483170|NCT05116930|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5483171|NCT05116930|Cholinergic Agents|cholinergic agents|mesh-ancestor
5483172|NCT05116930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5483173|NCT05116930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483174|NCT05116930|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5483175|NCT05116930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5483176|NCT05116930|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5483177|NCT05111431|Dexmedetomidine|dexmedetomidine|mesh-list
5483178|NCT05111431|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5483179|NCT05111431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5483180|NCT05111431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483181|NCT05111431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5483182|NCT05111431|Analgesics|analgesics|mesh-ancestor
5483183|NCT05111431|Sensory System Agents|sensory system agents|mesh-ancestor
6021007|NCT00396084|Ofloxacin|ofloxacin|mesh-list
6635371|NCT01345864|Mydriatics|mydriatics|mesh-ancestor
6635372|NCT01345864|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6635373|NCT01345864|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6635374|NCT01345864|Parasympatholytics|parasympatholytics|mesh-ancestor
6452098|NCT00415701|Hydrocortisone|hydrocortisone|mesh-list
6452099|NCT00415701|Propofol|propofol|mesh-list
6452100|NCT00415701|Etomidate|etomidate|mesh-list
6452101|NCT00415701|Cosyntropin|cosyntropin|mesh-list
6452102|NCT00415701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6452103|NCT00415701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6452104|NCT00415701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452105|NCT00415701|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6452106|NCT00415701|Anesthetics, General|anesthetics, general|mesh-ancestor
6452107|NCT00415701|Anesthetics|anesthetics|mesh-ancestor
6452108|NCT00415701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6452109|NCT00415701|Hormones|hormones|mesh-ancestor
6452110|NCT00415701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6452111|NCT00415740|Levodopa|levodopa|mesh-list
6452112|NCT00415740|Carbidopa|carbidopa|mesh-list
6452113|NCT00415740|Entacapone|entacapone|mesh-list
6452114|NCT00415740|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
6452115|NCT00415740|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6452116|NCT00415740|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6452117|NCT00415740|Dopamine Agents|dopamine agents|mesh-ancestor
6021008|NCT00396084|Isoniazid|isoniazid|mesh-list
6021009|NCT00396084|Linezolid|linezolid|mesh-list
6635375|NCT01345981|Lidocaine|lidocaine|mesh-list
6635376|NCT01345981|Anesthetics, Local|anesthetics, local|mesh-ancestor
5483184|NCT05111431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5483185|NCT05111431|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6635377|NCT01345981|Anesthetics|anesthetics|mesh-ancestor
6635378|NCT01345981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6635379|NCT01345981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635380|NCT01345981|Sensory System Agents|sensory system agents|mesh-ancestor
6635381|NCT01345981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6635382|NCT01345981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6635383|NCT01345981|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6635384|NCT01345981|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6635385|NCT01345981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6635386|NCT01345981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635387|NCT01346007|Vaccines|vaccines|mesh-list
6635388|NCT01346007|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6635389|NCT01346007|Immunologic Factors|immunologic factors|mesh-ancestor
6635390|NCT01346007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635391|NCT01346137|Meloxicam|meloxicam|mesh-list
6635392|NCT01346137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6635393|NCT01346137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6635394|NCT01346137|Analgesics|analgesics|mesh-ancestor
6635395|NCT01346137|Sensory System Agents|sensory system agents|mesh-ancestor
6635396|NCT01346137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6635397|NCT01346137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635398|NCT01346137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6635399|NCT01346137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6635400|NCT01346137|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6635401|NCT01346137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6635402|NCT01346137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6635403|NCT01346137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635404|NCT01346215|Heparin|heparin|mesh-list
6635405|NCT01346215|Calcium heparin|calcium heparin|mesh-list
6635406|NCT01346215|Anticoagulants|anticoagulants|mesh-ancestor
6635407|NCT01346215|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6635408|NCT01346215|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6635409|NCT01346215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635410|NCT01346254|Pioglitazone|pioglitazone|mesh-list
6635411|NCT01346254|Vildagliptin|vildagliptin|mesh-list
6635412|NCT01346254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6635413|NCT01346254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483186|NCT05111431|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5483187|NCT05111431|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5483188|NCT05111431|Adrenergic Agents|adrenergic agents|mesh-ancestor
5483189|NCT05111431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5483190|NCT05111431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483191|NCT05110300|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5483192|NCT05110300|Luteolytic Agents|luteolytic agents|mesh-ancestor
5483193|NCT05110300|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6021010|NCT00396084|Gatifloxacin|gatifloxacin|mesh-list
6452118|NCT00415740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6452119|NCT00415740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635414|NCT01346254|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6635415|NCT01346254|Protease Inhibitors|protease inhibitors|mesh-ancestor
6635416|NCT01346254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6635417|NCT01346254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635418|NCT01346670|Lovastatin|lovastatin|mesh-list
6635419|NCT01346670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6635420|NCT01346670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6635421|NCT01346670|Antimetabolites|antimetabolites|mesh-ancestor
6635422|NCT01346670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635423|NCT01346670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6635424|NCT01346670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6635425|NCT01346670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6635426|NCT01346787|Dexamethasone|dexamethasone|mesh-list
6635427|NCT01346787|Cyclophosphamide|cyclophosphamide|mesh-list
6635428|NCT01346787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6635429|NCT01346787|Immunologic Factors|immunologic factors|mesh-ancestor
6635430|NCT01346787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635431|NCT01346787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6635432|NCT01346787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6635433|NCT01346787|Alkylating Agents|alkylating agents|mesh-ancestor
6635434|NCT01346787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635435|NCT01346787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6635436|NCT01346787|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6635437|NCT01346787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6635438|NCT01346787|Antiemetics|antiemetics|mesh-ancestor
6635439|NCT01346787|Autonomic Agents|autonomic agents|mesh-ancestor
6635440|NCT01346787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6635441|NCT01346787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6635442|NCT01346787|Glucocorticoids|glucocorticoids|mesh-ancestor
6635443|NCT01346787|Hormones|hormones|mesh-ancestor
6635444|NCT01346787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6635445|NCT01346787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6635446|NCT01346800|Ritonavir|ritonavir|mesh-list
6635447|NCT01346800|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6635448|NCT01346800|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6635449|NCT01346800|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6635450|NCT01346800|Protease Inhibitors|protease inhibitors|mesh-ancestor
6635451|NCT01346800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6635452|NCT01346800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635453|NCT01346800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6635454|NCT01346800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6635455|NCT01346800|Antiviral Agents|antiviral agents|mesh-ancestor
6635456|NCT01346800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6635457|NCT01346800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6635458|NCT01346800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6635459|NCT01346800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6635460|NCT01346826|Infliximab|infliximab|mesh-list
6635461|NCT01346826|Dermatologic Agents|dermatologic agents|mesh-ancestor
6635462|NCT01346826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6635463|NCT01346826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6635464|NCT01346865|Cilostazol|cilostazol|mesh-list
6635465|NCT01346865|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6635466|NCT01346865|Autonomic Agents|autonomic agents|mesh-ancestor
6635467|NCT01346865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6635468|NCT01346865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635469|NCT01346865|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6635470|NCT01346865|Respiratory System Agents|respiratory system agents|mesh-ancestor
6635471|NCT01346865|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6635472|NCT01346865|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6635473|NCT01346865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635474|NCT01346865|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6635475|NCT01346865|Vasodilator Agents|vasodilator agents|mesh-ancestor
6635476|NCT01346865|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6635477|NCT01346865|Protective Agents|protective agents|mesh-ancestor
6635478|NCT01346865|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6635479|NCT01346865|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6635480|NCT01346865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6635481|NCT01346917|Lidocaine|lidocaine|mesh-list
6635482|NCT01346917|Anesthetics, Local|anesthetics, local|mesh-ancestor
6635483|NCT01346917|Anesthetics|anesthetics|mesh-ancestor
6635484|NCT01346917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6635485|NCT01346917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635486|NCT01346917|Sensory System Agents|sensory system agents|mesh-ancestor
6635487|NCT01346917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6635488|NCT01346917|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6635489|NCT01346917|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6635490|NCT01346917|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6635491|NCT01346917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6635492|NCT01346917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635493|NCT01346930|Macitentan|macitentan|mesh-list
6635494|NCT01346930|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
6635495|NCT01346930|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6635496|NCT01346930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635497|NCT01346930|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
6635498|NCT01347268|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
6635499|NCT01347268|Hormones|hormones|mesh-ancestor
6635500|NCT01347268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6635501|NCT01347268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635502|NCT01347294|Bleomycin|bleomycin|mesh-list
6635503|NCT01347294|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6635504|NCT01347294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6663021|NCT01506011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6663022|NCT01506011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6663023|NCT01506011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6663024|NCT01506011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663025|NCT01506011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6663026|NCT01506011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663027|NCT01506011|Vasodilator Agents|vasodilator agents|mesh-ancestor
6663028|NCT01506011|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6663029|NCT01506011|Protease Inhibitors|protease inhibitors|mesh-ancestor
6663030|NCT01506011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6663031|NCT01506024|Tacrine|tacrine|mesh-list
6663032|NCT01506024|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6663033|NCT01506024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6663034|NCT01506024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663035|NCT01506024|Cholinergic Agents|cholinergic agents|mesh-ancestor
6663036|NCT01506024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6663037|NCT01506024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663038|NCT01506024|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6663039|NCT01506024|Autonomic Agents|autonomic agents|mesh-ancestor
6663040|NCT01506024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6663041|NCT01506024|Nootropic Agents|nootropic agents|mesh-ancestor
6663042|NCT01506037|Desloratadine|desloratadine|mesh-list
6663043|NCT01506037|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6663044|NCT01506037|Cholinergic Agents|cholinergic agents|mesh-ancestor
6663045|NCT01506037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6663046|NCT01506037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663047|NCT01506037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663048|NCT01506037|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6663049|NCT01506037|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6663050|NCT01506037|Histamine Antagonists|histamine antagonists|mesh-ancestor
6663051|NCT01506037|Histamine Agents|histamine agents|mesh-ancestor
6663052|NCT01506050|Desloratadine|desloratadine|mesh-list
6663053|NCT01506050|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6663054|NCT01506050|Cholinergic Agents|cholinergic agents|mesh-ancestor
6663055|NCT01506050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6663056|NCT01506050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663057|NCT01506050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663058|NCT01506050|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6663059|NCT01506050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6663060|NCT01506050|Histamine Antagonists|histamine antagonists|mesh-ancestor
6663061|NCT01506050|Histamine Agents|histamine agents|mesh-ancestor
6663062|NCT01506063|Levocetirizine|levocetirizine|mesh-list
6663063|NCT01506063|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6663064|NCT01506063|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6663065|NCT01506063|Histamine Antagonists|histamine antagonists|mesh-ancestor
6663066|NCT01506063|Histamine Agents|histamine agents|mesh-ancestor
6663067|NCT01506063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6663068|NCT01506063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663069|NCT01506063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663070|NCT01506076|Levocetirizine|levocetirizine|mesh-list
5483194|NCT05110300|Contraceptive Agents|contraceptive agents|mesh-ancestor
6053244|NCT00593957|Dextromethorphan|dextromethorphan|mesh-list
6663071|NCT01506076|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6665045|NCT01515553|Liraglutide|liraglutide|mesh-list
6635505|NCT01347424|Paclitaxel|paclitaxel|mesh-list
6635506|NCT01347424|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6635507|NCT01347424|Carboplatin|carboplatin|mesh-list
6635508|NCT01347424|Endostatins|endostatins|mesh-list
6635509|NCT01347424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6635510|NCT01347424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6635511|NCT01347424|Tubulin Modulators|tubulin modulators|mesh-ancestor
6635512|NCT01347424|Antimitotic Agents|antimitotic agents|mesh-ancestor
6635513|NCT01347424|Mitosis Modulators|mitosis modulators|mesh-ancestor
6635514|NCT01347424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635515|NCT01347424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6635516|NCT01347424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6635517|NCT01347424|Growth Substances|growth substances|mesh-ancestor
6635518|NCT01347424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635519|NCT01347424|Growth Inhibitors|growth inhibitors|mesh-ancestor
6635520|NCT01347593|Ceftizoxime|ceftizoxime|mesh-list
6635521|NCT01347593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6635522|NCT01347593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6635523|NCT01347684|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
6635524|NCT01347684|Antidepressive Agents|antidepressive agents|mesh-ancestor
5483195|NCT05110300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6452120|NCT00415740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452121|NCT00415740|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6452122|NCT00415740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6452123|NCT00415740|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6452124|NCT00415740|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6452125|NCT00415740|Immunologic Factors|immunologic factors|mesh-ancestor
6452126|NCT00415740|Dopamine Agonists|dopamine agonists|mesh-ancestor
6452127|NCT00415753|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6452128|NCT00415753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6635525|NCT01347684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6635526|NCT01347814|Domperidone|domperidone|mesh-list
6635527|NCT01347814|Antiemetics|antiemetics|mesh-ancestor
6635528|NCT01347814|Autonomic Agents|autonomic agents|mesh-ancestor
6635529|NCT01347814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6635530|NCT01347814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635531|NCT01347814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6452129|NCT00415766|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5483196|NCT05110300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483197|NCT05110300|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5483198|NCT05110300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5483199|NCT05110300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6635532|NCT01347814|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6635533|NCT01347814|Dopamine Agents|dopamine agents|mesh-ancestor
6635534|NCT01347814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6635535|NCT01347814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635536|NCT01347853|Ketorolac|ketorolac|mesh-list
6635537|NCT01347853|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6635538|NCT01347853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6635539|NCT01347853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6635540|NCT01347853|Analgesics|analgesics|mesh-ancestor
6635541|NCT01347853|Sensory System Agents|sensory system agents|mesh-ancestor
6635542|NCT01347853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6635543|NCT01347853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635544|NCT01347853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6635545|NCT01347853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6635546|NCT01347853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6635547|NCT01347853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6635548|NCT01347853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635549|NCT01347944|Lenalidomide|lenalidomide|mesh-list
6635550|NCT01347944|Immunologic Factors|immunologic factors|mesh-ancestor
6635551|NCT01347944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635552|NCT01347944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6635553|NCT01347944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6635554|NCT01347944|Growth Substances|growth substances|mesh-ancestor
5483200|NCT05110001|Chlorhexidine|chlorhexidine|mesh-list
6635555|NCT01347944|Growth Inhibitors|growth inhibitors|mesh-ancestor
6635556|NCT01347944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6635557|NCT01347957|Nitric Oxide|nitric oxide|mesh-list
6635558|NCT01347957|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6635559|NCT01347957|Autonomic Agents|autonomic agents|mesh-ancestor
6635560|NCT01347957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6635561|NCT01347957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635562|NCT01347957|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6635563|NCT01347957|Respiratory System Agents|respiratory system agents|mesh-ancestor
6635564|NCT01347957|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6635565|NCT01347957|Antioxidants|antioxidants|mesh-ancestor
6635566|NCT01347957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635567|NCT01347957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6635568|NCT01347957|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6635569|NCT01347957|Vasodilator Agents|vasodilator agents|mesh-ancestor
6635570|NCT01347957|Gasotransmitters|gasotransmitters|mesh-ancestor
6635571|NCT01347957|Protective Agents|protective agents|mesh-ancestor
6635572|NCT01347970|Carvedilol|carvedilol|mesh-list
6635573|NCT01347970|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6635574|NCT01347970|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6635575|NCT01347970|Adrenergic Agents|adrenergic agents|mesh-ancestor
6635576|NCT01347970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6635577|NCT01347970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635578|NCT01347970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635579|NCT01347970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6635580|NCT01347970|Antioxidants|antioxidants|mesh-ancestor
6635581|NCT01347970|Protective Agents|protective agents|mesh-ancestor
6635582|NCT01347970|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6635583|NCT01347970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6635584|NCT01347970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6635585|NCT01347970|Vasodilator Agents|vasodilator agents|mesh-ancestor
6635586|NCT01347970|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6635587|NCT01347970|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6635588|NCT01347983|Methotrexate|methotrexate|mesh-list
6635589|NCT01347983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6635590|NCT01347983|Abortifacient Agents|abortifacient agents|mesh-ancestor
6635591|NCT01347983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6635592|NCT01347983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635593|NCT01347983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6635594|NCT01347983|Antimetabolites|antimetabolites|mesh-ancestor
6635595|NCT01347983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635596|NCT01347983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6635597|NCT01347983|Dermatologic Agents|dermatologic agents|mesh-ancestor
6635598|NCT01347983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6635599|NCT01347983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6635600|NCT01347983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6635601|NCT01347983|Immunologic Factors|immunologic factors|mesh-ancestor
6635602|NCT01347983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6635603|NCT01347983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6635604|NCT01347996|Interleukin-2|interleukin-2|mesh-list
6635605|NCT01347996|Histamine|histamine|mesh-list
6635606|NCT01347996|Histamine phosphate|histamine phosphate|mesh-list
6635607|NCT01347996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6635608|NCT01347996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6635609|NCT01347996|Analgesics|analgesics|mesh-ancestor
6635610|NCT01347996|Sensory System Agents|sensory system agents|mesh-ancestor
6635611|NCT01347996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6635612|NCT01347996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483201|NCT05110001|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5483202|NCT05110001|Natamycin|natamycin|mesh-list
5483203|NCT05110001|Moxifloxacin|moxifloxacin|mesh-list
5483204|NCT05110001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5483205|NCT05110001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5483206|NCT05110001|Disinfectants|disinfectants|mesh-ancestor
5483207|NCT05110001|Dermatologic Agents|dermatologic agents|mesh-ancestor
5483208|NCT05110001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5483209|NCT05110001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5483210|NCT05110001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5483211|NCT05110001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5483212|NCT05110001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483213|NCT05110001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6635613|NCT01347996|Histamine Agonists|histamine agonists|mesh-ancestor
6635614|NCT01347996|Histamine Agents|histamine agents|mesh-ancestor
6635615|NCT01347996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6665046|NCT01515553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6635616|NCT01347996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635617|NCT01348009|Cisplatin|cisplatin|mesh-list
6635618|NCT01348009|Capecitabine|capecitabine|mesh-list
6635619|NCT01348009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6635620|NCT01348009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6635621|NCT01348009|Antimetabolites|antimetabolites|mesh-ancestor
6635622|NCT01348009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635623|NCT01348126|Docetaxel|docetaxel|mesh-list
6635624|NCT01348126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6635625|NCT01348126|Tubulin Modulators|tubulin modulators|mesh-ancestor
6635626|NCT01348126|Antimitotic Agents|antimitotic agents|mesh-ancestor
6635627|NCT01348126|Mitosis Modulators|mitosis modulators|mesh-ancestor
6635628|NCT01348126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635629|NCT01348204|Quercetin|quercetin|mesh-list
6635630|NCT01348204|Antioxidants|antioxidants|mesh-ancestor
6635631|NCT01348204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483214|NCT05110001|Antifungal Agents|antifungal agents|mesh-ancestor
5483215|NCT05096039|Valsartan|valsartan|mesh-list
5483216|NCT05096039|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5483217|NCT05096039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5483218|NCT05096039|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5483219|NCT05096039|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6635632|NCT01348204|Protective Agents|protective agents|mesh-ancestor
6635633|NCT01348204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635634|NCT01348243|Clodronic Acid|clodronic acid|mesh-list
6635635|NCT01348243|Lidocaine|lidocaine|mesh-list
6635636|NCT01348243|Anesthetics, Local|anesthetics, local|mesh-ancestor
6635637|NCT01348243|Anesthetics|anesthetics|mesh-ancestor
6635638|NCT01348243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6635639|NCT01348243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635640|NCT01348243|Sensory System Agents|sensory system agents|mesh-ancestor
6635641|NCT01348243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6635642|NCT01348243|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6635643|NCT01348243|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6635644|NCT01348243|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6635645|NCT01348243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6635646|NCT01348243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635647|NCT01348243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6635648|NCT01348269|Zoledronic Acid|zoledronic acid|mesh-list
6635649|NCT01348269|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6635650|NCT01348269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635651|NCT01348282|Rivastigmine|rivastigmine|mesh-list
6635652|NCT01348282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6635653|NCT01348282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483220|NCT05096039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483221|NCT05084651|Itraconazole|itraconazole|mesh-list
5483222|NCT05084651|Lumefantrine|lumefantrine|mesh-list
5483223|NCT05084651|Antifungal Agents|antifungal agents|mesh-ancestor
5483224|NCT05084651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5483225|NCT05084651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5483226|NCT05084651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5483227|NCT05084651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5483228|NCT05084651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483229|NCT05084651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5483230|NCT05084651|Hormone Antagonists|hormone antagonists|mesh-ancestor
5483231|NCT05084651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5483232|NCT05084651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483233|NCT05084651|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6635654|NCT01348282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635655|NCT01348282|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6635656|NCT01348282|Cholinergic Agents|cholinergic agents|mesh-ancestor
6635657|NCT01348282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6635658|NCT01348282|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6635659|NCT01348282|Protective Agents|protective agents|mesh-ancestor
6635660|NCT01348308|Maraviroc|maraviroc|mesh-list
6635661|NCT01348308|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6635662|NCT01348308|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6635663|NCT01348308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635664|NCT01348308|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6635665|NCT01348308|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6635666|NCT01348308|Antiviral Agents|antiviral agents|mesh-ancestor
6635667|NCT01348308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6635668|NCT01348308|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6635669|NCT01348321|Levamisole|levamisole|mesh-list
6635670|NCT01348321|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6635671|NCT01348321|Immunologic Factors|immunologic factors|mesh-ancestor
6021011|NCT00396084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6021012|NCT00396084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6021013|NCT00396084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6021014|NCT00396084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6635672|NCT01348321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635673|NCT01348321|Antinematodal Agents|antinematodal agents|mesh-ancestor
6635674|NCT01348321|Anthelmintics|anthelmintics|mesh-ancestor
6635675|NCT01348321|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6635676|NCT01348321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6635677|NCT01348321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6635678|NCT01348412|Oxaliplatin|oxaliplatin|mesh-list
6635679|NCT01348412|Raltitrexed|raltitrexed|mesh-list
6635680|NCT01348412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6635681|NCT01348412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6635682|NCT01348412|Antimetabolites|antimetabolites|mesh-ancestor
6635683|NCT01348412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635684|NCT01348412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6635685|NCT01348412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6635686|NCT01348503|Lenalidomide|lenalidomide|mesh-list
6635687|NCT01348503|Sorafenib|sorafenib|mesh-list
6635688|NCT01348503|Immunologic Factors|immunologic factors|mesh-ancestor
6635689|NCT01348503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635690|NCT01348503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6635691|NCT01348503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6635692|NCT01348503|Growth Substances|growth substances|mesh-ancestor
6635693|NCT01348503|Growth Inhibitors|growth inhibitors|mesh-ancestor
6635694|NCT01348503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6635695|NCT01348503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6635696|NCT01348503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6635697|NCT01348503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635698|NCT01348724|Naloxegol|naloxegol|mesh-list
6635699|NCT01348724|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6635700|NCT01348724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635701|NCT01348724|Sensory System Agents|sensory system agents|mesh-ancestor
6635702|NCT01348724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6635703|NCT01348880|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6635704|NCT01348880|Vasodilator Agents|vasodilator agents|mesh-ancestor
6635705|NCT01348880|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6635706|NCT01348880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6635707|NCT01348880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6635708|NCT01348880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635709|NCT01348880|Urological Agents|urological agents|mesh-ancestor
6635710|NCT01348984|Fentanyl|fentanyl|mesh-list
6635711|NCT01348984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6635712|NCT01348984|Narcotics|narcotics|mesh-ancestor
6635713|NCT01348984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6635714|NCT01348984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635715|NCT01348984|Analgesics|analgesics|mesh-ancestor
6635716|NCT01348984|Sensory System Agents|sensory system agents|mesh-ancestor
6635717|NCT01348984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6635718|NCT01348984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6635719|NCT01348984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6635720|NCT01348984|Anesthetics, General|anesthetics, general|mesh-ancestor
6635721|NCT01348984|Anesthetics|anesthetics|mesh-ancestor
6663072|NCT01506076|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6663073|NCT01506076|Histamine Antagonists|histamine antagonists|mesh-ancestor
6663074|NCT01506076|Histamine Agents|histamine agents|mesh-ancestor
6663075|NCT01506076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6663076|NCT01506076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663077|NCT01506076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663078|NCT01506115|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
6663079|NCT01506115|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
6663080|NCT01506115|Trioxsalen|trioxsalen|mesh-list
6663081|NCT01506115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6663082|NCT01506115|Dermatologic Agents|dermatologic agents|mesh-ancestor
6663083|NCT01506115|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6663084|NCT01506167|Leucovorin|leucovorin|mesh-list
6663085|NCT01506167|Folic Acid|folic acid|mesh-list
5483234|NCT05084651|Antimalarials|antimalarials|mesh-ancestor
5483235|NCT05084651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5483236|NCT05084651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5483237|NCT05070650|Acetaminophen|acetaminophen|mesh-list
5483238|NCT05070650|Acetylcysteine|acetylcysteine|mesh-list
5483239|NCT05070650|Phenylephrine|phenylephrine|mesh-list
5483240|NCT05070650|Oxymetazoline|oxymetazoline|mesh-list
5483241|NCT05070650|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6452130|NCT00415766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6452131|NCT00415766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452132|NCT00415779|Zoledronic Acid|zoledronic acid|mesh-list
6452133|NCT00415779|Docetaxel|docetaxel|mesh-list
6452134|NCT00415779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6452135|NCT00415779|Tubulin Modulators|tubulin modulators|mesh-ancestor
6452136|NCT00415779|Antimitotic Agents|antimitotic agents|mesh-ancestor
6452137|NCT00415779|Mitosis Modulators|mitosis modulators|mesh-ancestor
6452138|NCT00415779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6452139|NCT00415779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5483242|NCT05070650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5483243|NCT05070650|Analgesics|analgesics|mesh-ancestor
5483244|NCT05070650|Sensory System Agents|sensory system agents|mesh-ancestor
5483245|NCT05070650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5483246|NCT05070650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483247|NCT05070650|Antipyretics|antipyretics|mesh-ancestor
5483248|NCT05070650|Antiviral Agents|antiviral agents|mesh-ancestor
5483249|NCT05070650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5483250|NCT05070650|Expectorants|expectorants|mesh-ancestor
6635722|NCT01349010|Probucol|probucol|mesh-list
6635723|NCT01349010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6635724|NCT01349010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6635725|NCT01349010|Antimetabolites|antimetabolites|mesh-ancestor
6635726|NCT01349010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635727|NCT01349010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6635728|NCT01349010|Antioxidants|antioxidants|mesh-ancestor
6635729|NCT01349010|Protective Agents|protective agents|mesh-ancestor
6635730|NCT01349010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635731|NCT01349088|Niacinamide|niacinamide|mesh-list
6635732|NCT01349088|Capecitabine|capecitabine|mesh-list
6635733|NCT01349088|Motesanib diphosphate|motesanib diphosphate|mesh-list
6635734|NCT01349088|Imetelstat|imetelstat|mesh-list
6635735|NCT01349088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6635736|NCT01349088|Antimetabolites|antimetabolites|mesh-ancestor
6635737|NCT01349088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635738|NCT01349088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6635739|NCT01349088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6635740|NCT01349088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6635741|NCT01349088|Vitamin B Complex|vitamin b complex|mesh-ancestor
6635742|NCT01349088|Vitamins|vitamins|mesh-ancestor
6635743|NCT01349088|Micronutrients|micronutrients|mesh-ancestor
6635744|NCT01349088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635745|NCT01349127|Calcium, Dietary|calcium, dietary|mesh-list
6635746|NCT01349127|Vitamin D|vitamin d|mesh-list
6635747|NCT01349127|Ergocalciferols|ergocalciferols|mesh-list
6635748|NCT01349127|Cholecalciferol|cholecalciferol|mesh-list
6635749|NCT01349127|Vitamins|vitamins|mesh-list
6635750|NCT01349127|Calcium|calcium|mesh-list
6635751|NCT01349127|Micronutrients|micronutrients|mesh-ancestor
6635752|NCT01349127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635753|NCT01349127|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6635754|NCT01349127|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6635755|NCT01349205|Sodium Benzoate|sodium benzoate|mesh-list
6635756|NCT01349205|Caffeine, sodium benzoate drug combination|caffeine, sodium benzoate drug combination|mesh-list
6635757|NCT01349205|Caffeine|caffeine|mesh-list
6635758|NCT01349205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6635759|NCT01349205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635760|NCT01349205|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6635761|NCT01349205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6635762|NCT01349205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635763|NCT01349205|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6635764|NCT01349205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6635765|NCT01349205|Purinergic Agents|purinergic agents|mesh-ancestor
6635766|NCT01349205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5483251|NCT05070650|Respiratory System Agents|respiratory system agents|mesh-ancestor
6452140|NCT00415779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483252|NCT05070650|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5483253|NCT05070650|Antioxidants|antioxidants|mesh-ancestor
6452141|NCT00415792|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6635767|NCT01349205|Antifungal Agents|antifungal agents|mesh-ancestor
6635768|NCT01349205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6635769|NCT01349205|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
6635770|NCT01349205|Protective Agents|protective agents|mesh-ancestor
6635771|NCT01349205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6635772|NCT01349205|Analgesics|analgesics|mesh-ancestor
6635773|NCT01349205|Sensory System Agents|sensory system agents|mesh-ancestor
6635774|NCT01349205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6635775|NCT01349257|Formoterol Fumarate|formoterol fumarate|mesh-list
6635776|NCT01349257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6635777|NCT01349257|Autonomic Agents|autonomic agents|mesh-ancestor
6635778|NCT01349257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6635779|NCT01349257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635780|NCT01349257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6635781|NCT01349257|Respiratory System Agents|respiratory system agents|mesh-ancestor
6635782|NCT01349257|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6635783|NCT01349257|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6635784|NCT01349257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6635785|NCT01349257|Adrenergic Agents|adrenergic agents|mesh-ancestor
6635786|NCT01349257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6635787|NCT01349257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635788|NCT01349270|Prednisone|prednisone|mesh-list
6635789|NCT01349270|Immunoglobulins|immunoglobulins|mesh-list
6635790|NCT01349270|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6635791|NCT01349270|Antibodies|antibodies|mesh-list
6635792|NCT01349270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6635793|NCT01349270|Glucocorticoids|glucocorticoids|mesh-ancestor
6635794|NCT01349270|Hormones|hormones|mesh-ancestor
6635795|NCT01349270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6635796|NCT01349270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635797|NCT01349270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6635798|NCT01349270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6635799|NCT01349270|Immunologic Factors|immunologic factors|mesh-ancestor
6635800|NCT01349296|Everolimus|everolimus|mesh-list
6635801|NCT01349296|Nintedanib|nintedanib|mesh-list
6635802|NCT01349296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6635803|NCT01349296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6635804|NCT01349296|Immunologic Factors|immunologic factors|mesh-ancestor
6635805|NCT01349296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635806|NCT01349296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5483254|NCT05070650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483255|NCT05070650|Protective Agents|protective agents|mesh-ancestor
5483256|NCT05070650|Antidotes|antidotes|mesh-ancestor
5483257|NCT05070650|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5483258|NCT05070650|Mydriatics|mydriatics|mesh-ancestor
5483259|NCT05070650|Autonomic Agents|autonomic agents|mesh-ancestor
5483260|NCT05070650|Sympathomimetics|sympathomimetics|mesh-ancestor
5483261|NCT05070650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5483262|NCT05070650|Nasal Decongestants|nasal decongestants|mesh-ancestor
5483263|NCT05070650|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5483264|NCT05070650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5483265|NCT05070650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5483266|NCT05070650|Adrenergic Agents|adrenergic agents|mesh-ancestor
5483267|NCT05070650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5483268|NCT05061563|Esomeprazole|esomeprazole|mesh-list
5483269|NCT05061563|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5483270|NCT05061563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5483271|NCT05061563|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5483272|NCT05061563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5483273|NCT05061563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483274|NCT05025293|Zoledronic Acid|zoledronic acid|mesh-list
6635807|NCT01349296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6635808|NCT01349296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635809|NCT01349335|Tolvaptan|tolvaptan|mesh-list
6635810|NCT01349335|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6635811|NCT01349335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635812|NCT01349335|Natriuretic Agents|natriuretic agents|mesh-ancestor
6635813|NCT01349335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635814|NCT01349348|Tolvaptan|tolvaptan|mesh-list
6635815|NCT01349348|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6635816|NCT01349348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635817|NCT01349348|Natriuretic Agents|natriuretic agents|mesh-ancestor
6635818|NCT01349348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635819|NCT01349387|Metformin|metformin|mesh-list
6635820|NCT01349387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6663086|NCT01506167|Bevacizumab|bevacizumab|mesh-list
6452142|NCT00415792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6452143|NCT00415792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483275|NCT05025293|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5483276|NCT05025293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483277|NCT05022472|Vaccines|vaccines|mesh-list
5483278|NCT05022472|Immunologic Factors|immunologic factors|mesh-ancestor
5483279|NCT05022472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483280|NCT05020912|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5483281|NCT05020912|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5483282|NCT05020912|Dermatologic Agents|dermatologic agents|mesh-ancestor
6635821|NCT01349387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635822|NCT01349413|Esomeprazole|esomeprazole|mesh-list
6635823|NCT01349413|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6635824|NCT01349413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6635825|NCT01349413|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6635826|NCT01349413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6635827|NCT01349413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635828|NCT01349439|Propranolol|propranolol|mesh-list
6635829|NCT01349439|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6635830|NCT01349439|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6635831|NCT01349439|Adrenergic Agents|adrenergic agents|mesh-ancestor
6635832|NCT01349439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6635833|NCT01349439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635834|NCT01349439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635835|NCT01349439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6635836|NCT01349439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6635837|NCT01349439|Vasodilator Agents|vasodilator agents|mesh-ancestor
6635838|NCT01349452|Ganciclovir|ganciclovir|mesh-list
6635839|NCT01349452|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6635840|NCT01349452|Lubricant Eye Drops|lubricant eye drops|mesh-list
6635841|NCT01349452|Antiviral Agents|antiviral agents|mesh-ancestor
6635842|NCT01349452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6635843|NCT01349452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6635844|NCT01349452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6635845|NCT01349452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635846|NCT01349452|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6635847|NCT01349452|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6635848|NCT01349556|Tretinoin|tretinoin|mesh-list
6635849|NCT01349556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6635850|NCT01349556|Keratolytic Agents|keratolytic agents|mesh-ancestor
5483283|NCT05013632|Remdesivir|remdesivir|mesh-list
5483284|NCT05013632|Antibodies|antibodies|mesh-list
5483285|NCT05013632|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5483286|NCT05013632|Immunologic Factors|immunologic factors|mesh-ancestor
5483287|NCT05013632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483288|NCT05013632|Antimetabolites|antimetabolites|mesh-ancestor
5483289|NCT05013632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021015|NCT00396084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6021016|NCT00396084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021017|NCT00396084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6021018|NCT00396084|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6021019|NCT00396084|Renal Agents|renal agents|mesh-ancestor
6021020|NCT00396084|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6021021|NCT00396084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6021022|NCT00396084|Antitubercular Agents|antitubercular agents|mesh-ancestor
6021023|NCT00396084|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6021024|NCT00396084|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6021025|NCT00396084|Antimetabolites|antimetabolites|mesh-ancestor
6021026|NCT00396084|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6452144|NCT00415831|Levodopa|levodopa|mesh-list
6452145|NCT00415831|Carbidopa|carbidopa|mesh-list
6452146|NCT00415831|Entacapone|entacapone|mesh-list
6452147|NCT00415831|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
6452148|NCT00415831|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6452149|NCT00415831|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6452150|NCT00415831|Dopamine Agents|dopamine agents|mesh-ancestor
6635851|NCT01349556|Dermatologic Agents|dermatologic agents|mesh-ancestor
6635852|NCT01349647|Vaccines|vaccines|mesh-list
6635853|NCT01349647|Immunologic Factors|immunologic factors|mesh-ancestor
6635854|NCT01349647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635855|NCT01349699|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6635856|NCT01349699|Deferasirox|deferasirox|mesh-list
6635857|NCT01349699|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6635858|NCT01349699|Chelating Agents|chelating agents|mesh-ancestor
6635859|NCT01349699|Sequestering Agents|sequestering agents|mesh-ancestor
6635860|NCT01349699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635861|NCT01349699|Hematinics|hematinics|mesh-ancestor
6635862|NCT01349738|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6635863|NCT01349738|Ciprofloxacin|ciprofloxacin|mesh-list
6635864|NCT01349738|Levofloxacin|levofloxacin|mesh-list
6635865|NCT01349738|Ofloxacin|ofloxacin|mesh-list
6635866|NCT01349738|Gentamicins|gentamicins|mesh-list
6635867|NCT01349738|Cefazolin|cefazolin|mesh-list
6635868|NCT01349738|Tobramycin|tobramycin|mesh-list
6635869|NCT01349738|Ampicillin|ampicillin|mesh-list
6635870|NCT01349738|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6635871|NCT01349738|Nitrofurantoin|nitrofurantoin|mesh-list
6635872|NCT01349738|Sulbactam|sulbactam|mesh-list
6635873|NCT01349738|Trimethoprim|trimethoprim|mesh-list
6635874|NCT01349738|Sulfamethoxazole|sulfamethoxazole|mesh-list
6635875|NCT01349738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6635876|NCT01349738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6635877|NCT01349738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6635878|NCT01349738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6635879|NCT01349738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635880|NCT01349738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6635881|NCT01349738|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6635882|NCT01349738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6635883|NCT01349738|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6635884|NCT01349738|Renal Agents|renal agents|mesh-ancestor
6635885|NCT01349738|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6635886|NCT01349738|Antimalarials|antimalarials|mesh-ancestor
6635887|NCT01349738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6635888|NCT01349738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6635889|NCT01349738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6635890|NCT01349738|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6635891|NCT01349738|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6635892|NCT01349738|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6635893|NCT01349751|Levobupivacaine|levobupivacaine|mesh-list
6635894|NCT01349751|Anesthetics, Local|anesthetics, local|mesh-ancestor
6635895|NCT01349751|Anesthetics|anesthetics|mesh-ancestor
6635896|NCT01349751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6635897|NCT01349751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635898|NCT01349751|Sensory System Agents|sensory system agents|mesh-ancestor
6635899|NCT01349751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6635900|NCT01349764|Vitamin D|vitamin d|mesh-list
6635901|NCT01349764|Cholecalciferol|cholecalciferol|mesh-list
6635902|NCT01349764|Vitamins|vitamins|mesh-ancestor
6635903|NCT01349764|Micronutrients|micronutrients|mesh-ancestor
6635904|NCT01349764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635905|NCT01349764|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6635906|NCT01349764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6635907|NCT01349777|Clopidogrel|clopidogrel|mesh-list
6635908|NCT01349777|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6635909|NCT01349777|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6635910|NCT01349777|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6635911|NCT01349777|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6635912|NCT01349777|Purinergic Agents|purinergic agents|mesh-ancestor
6635913|NCT01349777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6635914|NCT01349777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635915|NCT01349777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635916|NCT01349855|Insulin Glargine|insulin glargine|mesh-list
6635917|NCT01349855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6635918|NCT01349855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635919|NCT01350024|Lidocaine|lidocaine|mesh-list
6635920|NCT01350024|Epinephrine|epinephrine|mesh-list
6635921|NCT01350024|Racepinephrine|racepinephrine|mesh-list
6635922|NCT01350024|Epinephryl borate|epinephryl borate|mesh-list
6635923|NCT01350024|Anesthetics, Local|anesthetics, local|mesh-ancestor
6635924|NCT01350024|Anesthetics|anesthetics|mesh-ancestor
6635925|NCT01350024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6635926|NCT01350024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635927|NCT01350024|Sensory System Agents|sensory system agents|mesh-ancestor
6635928|NCT01350024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6635929|NCT01350024|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6635930|NCT01350024|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6635931|NCT01350024|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6635932|NCT01350024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6635933|NCT01350024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483290|NCT05013632|Antiviral Agents|antiviral agents|mesh-ancestor
5483291|NCT05013632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5483292|NCT05003453|Palmidrol|palmidrol|mesh-list
5483293|NCT05003453|Analgesics|analgesics|mesh-ancestor
5483294|NCT05003453|Sensory System Agents|sensory system agents|mesh-ancestor
5483295|NCT05003453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5483296|NCT05003453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483297|NCT05003453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5483298|NCT05003453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5483299|NCT05003453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5483300|NCT05003453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5483301|NCT05003453|Antiviral Agents|antiviral agents|mesh-ancestor
6635934|NCT01350024|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6635935|NCT01350024|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6635936|NCT01350024|Adrenergic Agents|adrenergic agents|mesh-ancestor
6635937|NCT01350024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6635938|NCT01350024|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6635939|NCT01350024|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6635940|NCT01350024|Autonomic Agents|autonomic agents|mesh-ancestor
6635941|NCT01350024|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6635942|NCT01350024|Respiratory System Agents|respiratory system agents|mesh-ancestor
6635943|NCT01350024|Mydriatics|mydriatics|mesh-ancestor
6635944|NCT01350024|Sympathomimetics|sympathomimetics|mesh-ancestor
6635945|NCT01350024|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6635946|NCT01350037|Remifentanil|remifentanil|mesh-list
6635947|NCT01350037|Alfentanil|alfentanil|mesh-list
6635948|NCT01350037|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6635949|NCT01350037|Narcotics|narcotics|mesh-ancestor
6635950|NCT01350037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6635951|NCT01350037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635952|NCT01350037|Analgesics|analgesics|mesh-ancestor
6635953|NCT01350037|Sensory System Agents|sensory system agents|mesh-ancestor
6635954|NCT01350037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6635955|NCT01350037|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6635956|NCT01350037|Anesthetics, General|anesthetics, general|mesh-ancestor
6635957|NCT01350037|Anesthetics|anesthetics|mesh-ancestor
6635958|NCT01350050|Carticaine|carticaine|mesh-list
6635959|NCT01350050|Anesthetics, Local|anesthetics, local|mesh-ancestor
6635960|NCT01350050|Anesthetics|anesthetics|mesh-ancestor
6635961|NCT01350050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6635962|NCT01350050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635963|NCT01350050|Sensory System Agents|sensory system agents|mesh-ancestor
6635964|NCT01350050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6635965|NCT01350063|Troclosene|troclosene|mesh-list
6635966|NCT01350063|Antifungal Agents|antifungal agents|mesh-ancestor
6635967|NCT01350063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6635968|NCT01350063|Antiviral Agents|antiviral agents|mesh-ancestor
6635969|NCT01350063|Disinfectants|disinfectants|mesh-ancestor
6635970|NCT01350089|Ethanol|ethanol|mesh-list
6635971|NCT01350089|Caffeine|caffeine|mesh-list
6635972|NCT01350089|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6635973|NCT01350089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6635974|NCT01350089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5483302|NCT05003453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5483303|NCT05003453|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5483304|NCT05003453|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5483305|NCT05003453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6635975|NCT01350089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635976|NCT01350089|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6635977|NCT01350089|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6635978|NCT01350089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6635979|NCT01350089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635980|NCT01350089|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6635981|NCT01350089|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6635982|NCT01350089|Purinergic Agents|purinergic agents|mesh-ancestor
6635983|NCT01350089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6635984|NCT01350154|Sildenafil Citrate|sildenafil citrate|mesh-list
6635985|NCT01350154|Vasodilator Agents|vasodilator agents|mesh-ancestor
6635986|NCT01350154|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6635987|NCT01350154|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6635988|NCT01350154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6635989|NCT01350154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6635990|NCT01350154|Urological Agents|urological agents|mesh-ancestor
6635991|NCT01350323|Bevacizumab|bevacizumab|mesh-list
6635992|NCT01350323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6635993|NCT01350323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6635994|NCT01350323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6635995|NCT01350323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6635996|NCT01350323|Growth Substances|growth substances|mesh-ancestor
6635997|NCT01350323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6635998|NCT01350323|Growth Inhibitors|growth inhibitors|mesh-ancestor
6635999|NCT01350570|Loperamide|loperamide|mesh-list
6636000|NCT01350570|Antidiarrheals|antidiarrheals|mesh-list
6636001|NCT01350570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6636002|NCT01350596|Ibuprofen|ibuprofen|mesh-list
6636003|NCT01350596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6636004|NCT01350596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6636005|NCT01350596|Analgesics|analgesics|mesh-ancestor
6636006|NCT01350596|Sensory System Agents|sensory system agents|mesh-ancestor
6636007|NCT01350596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6636008|NCT01350596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636009|NCT01350596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6636010|NCT01350596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5483306|NCT05003453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483307|NCT05003453|Hormones|hormones|mesh-ancestor
5483308|NCT05003453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5483309|NCT05000216|Mycophenolic Acid|mycophenolic acid|mesh-list
5483310|NCT05000216|Methotrexate|methotrexate|mesh-list
5483311|NCT05000216|Vaccines|vaccines|mesh-list
5483312|NCT05000216|Immunologic Factors|immunologic factors|mesh-ancestor
6636011|NCT01350596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6636012|NCT01350596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6636013|NCT01350596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636014|NCT01350609|Candesartan|candesartan|mesh-list
6636015|NCT01350609|Candesartan cilexetil|candesartan cilexetil|mesh-list
6636016|NCT01350609|Nifedipine|nifedipine|mesh-list
6636017|NCT01350609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6636018|NCT01350609|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6636019|NCT01350609|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6636020|NCT01350609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636021|NCT01350609|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6636022|NCT01350609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6636023|NCT01350609|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6636024|NCT01350609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636025|NCT01350609|Vasodilator Agents|vasodilator agents|mesh-ancestor
6636026|NCT01350609|Tocolytic Agents|tocolytic agents|mesh-ancestor
6636027|NCT01350609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6636028|NCT01350622|Diclofenac|diclofenac|mesh-list
6636029|NCT01350622|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
6636030|NCT01350622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6636031|NCT01350622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6636032|NCT01350622|Analgesics|analgesics|mesh-ancestor
6636033|NCT01350622|Sensory System Agents|sensory system agents|mesh-ancestor
6636034|NCT01350622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6636035|NCT01350622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636036|NCT01350622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6636037|NCT01350622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6636038|NCT01350622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6636039|NCT01350622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6636040|NCT01350622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636041|NCT01350713|Povidone-Iodine|povidone-iodine|mesh-list
6636042|NCT01350713|Povidone|povidone|mesh-list
6636043|NCT01350713|Plasma Substitutes|plasma substitutes|mesh-ancestor
5483313|NCT05000216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636044|NCT01350713|Blood Substitutes|blood substitutes|mesh-ancestor
6636045|NCT01350713|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6636046|NCT01350713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6636047|NCT01350817|Docetaxel|docetaxel|mesh-list
6636048|NCT01350817|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6636049|NCT01350817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6636050|NCT01350817|Tubulin Modulators|tubulin modulators|mesh-ancestor
6636051|NCT01350817|Antimitotic Agents|antimitotic agents|mesh-ancestor
6636052|NCT01350817|Mitosis Modulators|mitosis modulators|mesh-ancestor
6636053|NCT01350817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636054|NCT01350817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6636055|NCT01350817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6636056|NCT01350856|Artesunate|artesunate|mesh-list
6636057|NCT01350856|Antimalarials|antimalarials|mesh-ancestor
6636058|NCT01350856|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6636059|NCT01350856|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6636060|NCT01350856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6636061|NCT01350856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6636062|NCT01350856|Antiviral Agents|antiviral agents|mesh-ancestor
6636063|NCT01350856|Schistosomicides|schistosomicides|mesh-ancestor
6636064|NCT01350856|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6636065|NCT01350856|Anthelmintics|anthelmintics|mesh-ancestor
6636066|NCT01350882|Rituximab|rituximab|mesh-list
6636067|NCT01350882|Citric Acid|citric acid|mesh-list
6636068|NCT01350882|Sodium Citrate|sodium citrate|mesh-list
6636069|NCT01350882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6636070|NCT01350882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6636071|NCT01350882|Immunologic Factors|immunologic factors|mesh-ancestor
6636072|NCT01350882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636073|NCT01350882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6636074|NCT01350882|Anticoagulants|anticoagulants|mesh-ancestor
6636075|NCT01350882|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6636076|NCT01350882|Chelating Agents|chelating agents|mesh-ancestor
6636077|NCT01350882|Sequestering Agents|sequestering agents|mesh-ancestor
6636078|NCT01350882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663087|NCT01506167|Fluorouracil|fluorouracil|mesh-list
6663088|NCT01506167|Capecitabine|capecitabine|mesh-list
6663089|NCT01506167|Oxaliplatin|oxaliplatin|mesh-list
6663090|NCT01506167|Irinotecan|irinotecan|mesh-list
6663091|NCT01506167|Levoleucovorin|levoleucovorin|mesh-list
6663092|NCT01506167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6663093|NCT01506167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6663094|NCT01506167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6663095|NCT01506167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6663096|NCT01506167|Growth Substances|growth substances|mesh-ancestor
6663097|NCT01506167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663098|NCT01506167|Growth Inhibitors|growth inhibitors|mesh-ancestor
6663099|NCT01506167|Antimetabolites|antimetabolites|mesh-ancestor
6663100|NCT01506167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663101|NCT01506167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6663102|NCT01506167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6663103|NCT01506167|Immunologic Factors|immunologic factors|mesh-ancestor
6663104|NCT01506167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6663105|NCT01506167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6663106|NCT01506167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6663107|NCT01506167|Antidotes|antidotes|mesh-ancestor
6663108|NCT01506167|Protective Agents|protective agents|mesh-ancestor
6663109|NCT01506167|Vitamin B Complex|vitamin b complex|mesh-ancestor
6663110|NCT01506167|Vitamins|vitamins|mesh-ancestor
6663111|NCT01506167|Micronutrients|micronutrients|mesh-ancestor
6663112|NCT01506167|Hematinics|hematinics|mesh-ancestor
6663113|NCT01506336|Sunitinib|sunitinib|mesh-list
6663114|NCT01506336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6663115|NCT01506336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6663116|NCT01506336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6663117|NCT01506336|Growth Substances|growth substances|mesh-ancestor
6663118|NCT01506336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663119|NCT01506336|Growth Inhibitors|growth inhibitors|mesh-ancestor
6663120|NCT01506336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6663121|NCT01506336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6663122|NCT01506336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663123|NCT01506388|Misoprostol|misoprostol|mesh-list
6663124|NCT01506388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6663125|NCT01506388|Abortifacient Agents|abortifacient agents|mesh-ancestor
6663126|NCT01506388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6663127|NCT01506388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663128|NCT01506388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6663129|NCT01506388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5483314|NCT05000216|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5483315|NCT05000216|Abortifacient Agents|abortifacient agents|mesh-ancestor
5483316|NCT05000216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5483317|NCT05000216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5483318|NCT05000216|Antimetabolites|antimetabolites|mesh-ancestor
5483319|NCT05000216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483320|NCT05000216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5483321|NCT05000216|Dermatologic Agents|dermatologic agents|mesh-ancestor
5483322|NCT05000216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5483323|NCT05000216|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5483324|NCT05000216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5483325|NCT05000216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5483326|NCT05000216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5483327|NCT05000216|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5483328|NCT05000216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5483329|NCT05000216|Antitubercular Agents|antitubercular agents|mesh-ancestor
5483330|NCT05000216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5483331|NCT05000216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6636079|NCT01350921|Ticagrelor|ticagrelor|mesh-list
6636080|NCT01350921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6636081|NCT01350921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6636082|NCT01350921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6636083|NCT01350921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6636084|NCT01350921|Purinergic Agents|purinergic agents|mesh-ancestor
6636085|NCT01350921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6636086|NCT01350921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483332|NCT04979052|Interferons|interferons|mesh-list
5483333|NCT04979052|Interferon-gamma|interferon-gamma|mesh-list
5483334|NCT04979052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5483335|NCT04979052|Antiviral Agents|antiviral agents|mesh-ancestor
5483336|NCT04979052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5483337|NCT04946526|Mechlorethamine|mechlorethamine|mesh-list
5483338|NCT04946526|Alkylating Agents|alkylating agents|mesh-ancestor
5483339|NCT04946526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483340|NCT04946526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5483341|NCT04946526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6021027|NCT00396084|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6636087|NCT01350921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483344|NCT04893096|Felzartamab|felzartamab|mesh-list
5483345|NCT04893096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5483346|NCT04893096|Immunologic Factors|immunologic factors|mesh-ancestor
5483347|NCT04893096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483348|NCT04888377|Aspirin|aspirin|mesh-list
5483349|NCT04888377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6636088|NCT01351038|Capecitabine|capecitabine|mesh-list
6636089|NCT01351038|Oxaliplatin|oxaliplatin|mesh-list
6636090|NCT01351038|Panitumumab|panitumumab|mesh-list
6636091|NCT01351038|Epirubicin|epirubicin|mesh-list
6636092|NCT01351038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6636093|NCT01351038|Antimetabolites|antimetabolites|mesh-ancestor
6636094|NCT01351038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636095|NCT01351038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6636096|NCT01351038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6636097|NCT01351038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6636098|NCT01351038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6636099|NCT01351038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6636100|NCT01351038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6636101|NCT01351168|Levodopa|levodopa|mesh-list
6636102|NCT01351168|Zolpidem|zolpidem|mesh-list
6636103|NCT01351168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6636104|NCT01351168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6636105|NCT01351168|Dopamine Agents|dopamine agents|mesh-ancestor
6636106|NCT01351168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6636107|NCT01351168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636108|NCT01351168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636109|NCT01351168|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6636110|NCT01351168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6636111|NCT01351168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6636112|NCT01351168|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6636113|NCT01351168|GABA Agonists|gaba agonists|mesh-ancestor
6636114|NCT01351168|GABA Agents|gaba agents|mesh-ancestor
6636115|NCT01351272|Methylphenidate|methylphenidate|mesh-list
6636116|NCT01351272|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6636117|NCT01351272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636118|NCT01351272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6636119|NCT01351272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5483350|NCT04888377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5483351|NCT04888377|Analgesics|analgesics|mesh-ancestor
5483352|NCT04888377|Sensory System Agents|sensory system agents|mesh-ancestor
5483353|NCT04888377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5483354|NCT04888377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483355|NCT04888377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6636120|NCT01351272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6636121|NCT01351272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636122|NCT01351272|Dopamine Agents|dopamine agents|mesh-ancestor
5483356|NCT04888377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5483357|NCT04888377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5483358|NCT04888377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5483359|NCT04888377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483360|NCT04888377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6636123|NCT01351272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6636124|NCT01351285|Remifentanil|remifentanil|mesh-list
6636125|NCT01351285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6636126|NCT01351285|Narcotics|narcotics|mesh-ancestor
6636127|NCT01351285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6636128|NCT01351285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636129|NCT01351285|Analgesics|analgesics|mesh-ancestor
6636130|NCT01351285|Sensory System Agents|sensory system agents|mesh-ancestor
6636131|NCT01351285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6636132|NCT01351298|Lidocaine|lidocaine|mesh-list
6636133|NCT01351298|Xylometazoline|xylometazoline|mesh-list
6636134|NCT01351298|Anesthetics, Local|anesthetics, local|mesh-ancestor
6636135|NCT01351298|Anesthetics|anesthetics|mesh-ancestor
6636136|NCT01351298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6636137|NCT01351298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636138|NCT01351298|Sensory System Agents|sensory system agents|mesh-ancestor
6636139|NCT01351298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6636140|NCT01351298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6636141|NCT01351298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6636142|NCT01351298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6636143|NCT01351298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6636144|NCT01351298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636145|NCT01351298|Nasal Decongestants|nasal decongestants|mesh-ancestor
6636146|NCT01351298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6636147|NCT01351298|Respiratory System Agents|respiratory system agents|mesh-ancestor
6636148|NCT01351428|Nifedipine|nifedipine|mesh-list
6636149|NCT01351428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6636150|NCT01351428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6636151|NCT01351428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636152|NCT01351428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6636153|NCT01351428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636154|NCT01351428|Vasodilator Agents|vasodilator agents|mesh-ancestor
6636155|NCT01351428|Tocolytic Agents|tocolytic agents|mesh-ancestor
6636156|NCT01351428|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6636157|NCT01351493|Nitric Oxide|nitric oxide|mesh-list
6636158|NCT01351493|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6636159|NCT01351493|Autonomic Agents|autonomic agents|mesh-ancestor
6636160|NCT01351493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6636161|NCT01351493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636162|NCT01351493|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6636163|NCT01351493|Respiratory System Agents|respiratory system agents|mesh-ancestor
6636164|NCT01351493|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6636165|NCT01351493|Antioxidants|antioxidants|mesh-ancestor
6636166|NCT01351493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636167|NCT01351493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6636168|NCT01351493|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6636169|NCT01351493|Vasodilator Agents|vasodilator agents|mesh-ancestor
6636170|NCT01351493|Gasotransmitters|gasotransmitters|mesh-ancestor
6636171|NCT01351493|Protective Agents|protective agents|mesh-ancestor
6636172|NCT01351519|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6636173|NCT01351519|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6636174|NCT01351519|Dermatologic Agents|dermatologic agents|mesh-ancestor
6636175|NCT01351597|Docetaxel|docetaxel|mesh-list
6636176|NCT01351597|Oxaliplatin|oxaliplatin|mesh-list
6636177|NCT01351597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6636178|NCT01351597|Tubulin Modulators|tubulin modulators|mesh-ancestor
6636179|NCT01351597|Antimitotic Agents|antimitotic agents|mesh-ancestor
6636180|NCT01351597|Mitosis Modulators|mitosis modulators|mesh-ancestor
6636181|NCT01351597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636182|NCT01351636|Arotinolol|arotinolol|mesh-list
6636183|NCT01351636|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6636184|NCT01351636|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6636185|NCT01351636|Adrenergic Agents|adrenergic agents|mesh-ancestor
6636186|NCT01351636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6636187|NCT01351636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636188|NCT01351636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636189|NCT01351636|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6636190|NCT01351792|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6636191|NCT01351792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6636192|NCT01351792|Respiratory System Agents|respiratory system agents|mesh-ancestor
6636193|NCT01351818|Hormones|hormones|mesh-list
6636194|NCT01351818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6636195|NCT01351818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636196|NCT01351948|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6636197|NCT01351948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6636198|NCT01351948|Immunologic Factors|immunologic factors|mesh-ancestor
6636199|NCT01351948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483361|NCT04888377|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5483362|NCT04888377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5483363|NCT04888377|Antipyretics|antipyretics|mesh-ancestor
5502418|NCT04466540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5502419|NCT04466540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5502420|NCT04466540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502421|NCT04466540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5502422|NCT04466618|Heparin|heparin|mesh-list
5502423|NCT04466618|Calcium heparin|calcium heparin|mesh-list
5502424|NCT04466618|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
5502425|NCT04466618|Anticoagulants|anticoagulants|mesh-ancestor
5502426|NCT04466618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5502427|NCT04466618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5502428|NCT04466618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502429|NCT04466618|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
5502430|NCT04466618|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5502431|NCT04466618|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5502432|NCT04466436|Tryptophan|tryptophan|mesh-list
5502433|NCT04466436|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5502434|NCT04466436|Antidepressive Agents|antidepressive agents|mesh-ancestor
5502435|NCT04466436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5502436|NCT04466423|Sulfamethazine|sulfamethazine|mesh-list
5502437|NCT04466423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5502438|NCT04466046|Midazolam|midazolam|mesh-list
5502439|NCT04466046|Palonosetron|palonosetron|mesh-list
5502440|NCT04466046|Ramosetron|ramosetron|mesh-list
5502441|NCT04466046|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5502442|NCT04466046|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6636200|NCT01351948|Antacids|antacids|mesh-ancestor
6636201|NCT01351948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636202|NCT01351948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6636203|NCT01352026|Metformin|metformin|mesh-list
6636204|NCT01352026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6636205|NCT01352026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636206|NCT01352039|Heparin|heparin|mesh-list
6636207|NCT01352039|Calcium heparin|calcium heparin|mesh-list
6636208|NCT01352039|Anticoagulants|anticoagulants|mesh-ancestor
6636209|NCT01352039|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6636210|NCT01352039|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6636211|NCT01352039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636212|NCT01352065|Bosentan|bosentan|mesh-list
6636213|NCT01352065|Ambrisentan|ambrisentan|mesh-list
6636214|NCT01352065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5502443|NCT04466046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6636215|NCT01352065|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6636216|NCT01352065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636217|NCT01352091|Goserelin|goserelin|mesh-list
6636218|NCT01352091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6636219|NCT01352091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6636220|NCT01352130|Ondansetron|ondansetron|mesh-list
6636221|NCT01352130|Granisetron|granisetron|mesh-list
6636222|NCT01352130|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
6636223|NCT01352130|Antiemetics|antiemetics|mesh-ancestor
6636224|NCT01352130|Autonomic Agents|autonomic agents|mesh-ancestor
6636225|NCT01352130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6636226|NCT01352130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636227|NCT01352130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6636228|NCT01352130|Antipruritics|antipruritics|mesh-ancestor
6636229|NCT01352130|Dermatologic Agents|dermatologic agents|mesh-ancestor
6636230|NCT01352130|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6636231|NCT01352130|Serotonin Agents|serotonin agents|mesh-ancestor
6636232|NCT01352130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6636233|NCT01352130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636234|NCT01352130|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6636235|NCT01352130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6636236|NCT01352130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5483364|NCT04859582|Fluorouracil|fluorouracil|mesh-list
5483365|NCT04859582|Pembrolizumab|pembrolizumab|mesh-list
5483366|NCT04859582|Capecitabine|capecitabine|mesh-list
5483367|NCT04859582|Oxaliplatin|oxaliplatin|mesh-list
5483368|NCT04859582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5483369|NCT04859582|Antimetabolites|antimetabolites|mesh-ancestor
5483370|NCT04859582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483371|NCT04859582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6636237|NCT01352130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6636238|NCT01352130|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6636239|NCT01352143|Thrombin|thrombin|mesh-list
6636240|NCT01352143|Hemostatics|hemostatics|mesh-ancestor
6636241|NCT01352143|Coagulants|coagulants|mesh-ancestor
6636242|NCT01352234|Aspirin|aspirin|mesh-list
6636243|NCT01352234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6636244|NCT01352234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6636245|NCT01352234|Analgesics|analgesics|mesh-ancestor
6636246|NCT01352234|Sensory System Agents|sensory system agents|mesh-ancestor
6636247|NCT01352234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6636248|NCT01352234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636249|NCT01352234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6636250|NCT01352234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6636251|NCT01352234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6636252|NCT01352234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6636253|NCT01352234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636254|NCT01352234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6021028|NCT00396084|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6021029|NCT00396084|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6021030|NCT00396201|Plerixafor|plerixafor|mesh-list
6021031|NCT00396201|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6021032|NCT00396201|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6452151|NCT00415831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6452152|NCT00415831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6452153|NCT00415831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452154|NCT00415831|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6452155|NCT00415831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6452156|NCT00415831|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6452157|NCT00415831|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5483372|NCT04859582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6021033|NCT00396201|Antiviral Agents|antiviral agents|mesh-ancestor
6452158|NCT00415831|Immunologic Factors|immunologic factors|mesh-ancestor
6452159|NCT00415831|Dopamine Agonists|dopamine agonists|mesh-ancestor
6452160|NCT00415844|Levodopa|levodopa|mesh-list
6452161|NCT00415844|Carbidopa|carbidopa|mesh-list
6452162|NCT00415844|Entacapone|entacapone|mesh-list
6452163|NCT00415844|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
6452164|NCT00415844|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6452165|NCT00415844|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6452166|NCT00415844|Dopamine Agents|dopamine agents|mesh-ancestor
6452167|NCT00415844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6452168|NCT00415844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6452169|NCT00415844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452170|NCT00415844|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6636255|NCT01352234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6636256|NCT01352234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6636257|NCT01352234|Antipyretics|antipyretics|mesh-ancestor
6636258|NCT01352299|Pyrithione zinc|pyrithione zinc|mesh-list
6636259|NCT01352299|Keratolytic Agents|keratolytic agents|mesh-ancestor
6636260|NCT01352299|Dermatologic Agents|dermatologic agents|mesh-ancestor
6636261|NCT01352312|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6636262|NCT01352312|Ofatumumab|ofatumumab|mesh-list
6636263|NCT01352312|Pentostatin|pentostatin|mesh-list
6636264|NCT01352312|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6636265|NCT01352312|Alkylating Agents|alkylating agents|mesh-ancestor
6636266|NCT01352312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636267|NCT01352312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6636268|NCT01352312|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
6636269|NCT01352312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6636270|NCT01352338|Prednisone|prednisone|mesh-list
6636271|NCT01352338|Cyclophosphamide|cyclophosphamide|mesh-list
6636272|NCT01352338|Lenalidomide|lenalidomide|mesh-list
5483373|NCT04859582|Immunologic Factors|immunologic factors|mesh-ancestor
5483374|NCT04859582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483375|NCT04859582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5483376|NCT04856215|Antibodies|antibodies|mesh-list
5483377|NCT04856215|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6636273|NCT01352338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6636274|NCT01352338|Immunologic Factors|immunologic factors|mesh-ancestor
6636275|NCT01352338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636276|NCT01352338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6636277|NCT01352338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6636278|NCT01352338|Alkylating Agents|alkylating agents|mesh-ancestor
6636279|NCT01352338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636280|NCT01352338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6636281|NCT01352338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6636282|NCT01352338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6636283|NCT01352338|Glucocorticoids|glucocorticoids|mesh-ancestor
6636284|NCT01352338|Hormones|hormones|mesh-ancestor
6636285|NCT01352338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6636286|NCT01352338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6636287|NCT01352338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6636288|NCT01352338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6636289|NCT01352338|Growth Substances|growth substances|mesh-ancestor
6636290|NCT01352338|Growth Inhibitors|growth inhibitors|mesh-ancestor
6636291|NCT01352494|Gemcitabine|gemcitabine|mesh-list
6636292|NCT01352494|Docetaxel|docetaxel|mesh-list
6636293|NCT01352494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6636294|NCT01352494|Antimetabolites|antimetabolites|mesh-ancestor
6636295|NCT01352494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636296|NCT01352494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6636297|NCT01352494|Antiviral Agents|antiviral agents|mesh-ancestor
6636298|NCT01352494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6636299|NCT01352494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6636300|NCT01352494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6636301|NCT01352494|Immunologic Factors|immunologic factors|mesh-ancestor
6636302|NCT01352494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636303|NCT01352494|Tubulin Modulators|tubulin modulators|mesh-ancestor
6636304|NCT01352494|Antimitotic Agents|antimitotic agents|mesh-ancestor
6636305|NCT01352494|Mitosis Modulators|mitosis modulators|mesh-ancestor
6636306|NCT01352559|Milnacipran|milnacipran|mesh-list
6636307|NCT01352559|Mirtazapine|mirtazapine|mesh-list
6636308|NCT01352559|Sertraline|sertraline|mesh-list
6636309|NCT01352559|Fluoxetine|fluoxetine|mesh-list
6636310|NCT01352559|Paroxetine|paroxetine|mesh-list
6636311|NCT01352559|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6636312|NCT01352559|Nortriptyline|nortriptyline|mesh-list
6636313|NCT01352559|Antidepressive Agents|antidepressive agents|mesh-ancestor
6636314|NCT01352559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6636315|NCT01352559|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6636316|NCT01352559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6636317|NCT01352559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6636318|NCT01352559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636319|NCT01352559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6636320|NCT01352559|Serotonin Agents|serotonin agents|mesh-ancestor
6636321|NCT01352559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636322|NCT01352559|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6636323|NCT01352559|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6636324|NCT01352559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6636325|NCT01352559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6636326|NCT01352559|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6636327|NCT01352559|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6636328|NCT01352559|Histamine Antagonists|histamine antagonists|mesh-ancestor
6636329|NCT01352559|Histamine Agents|histamine agents|mesh-ancestor
6636330|NCT01352559|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6636331|NCT01352559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6636332|NCT01352559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6636333|NCT01352559|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6636334|NCT01352559|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6636335|NCT01352559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6636336|NCT01352559|Adrenergic Agents|adrenergic agents|mesh-ancestor
6636337|NCT01352559|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6636338|NCT01352559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6636339|NCT01352559|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6636340|NCT01352559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6636341|NCT01352559|Analgesics|analgesics|mesh-ancestor
6636342|NCT01352559|Sensory System Agents|sensory system agents|mesh-ancestor
6636343|NCT01352559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6636344|NCT01352559|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6636345|NCT01352559|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6636346|NCT01352572|Milnacipran|milnacipran|mesh-list
6636347|NCT01352572|Mirtazapine|mirtazapine|mesh-list
6636348|NCT01352572|Sertraline|sertraline|mesh-list
6636349|NCT01352572|Fluoxetine|fluoxetine|mesh-list
6636350|NCT01352572|Paroxetine|paroxetine|mesh-list
6636351|NCT01352572|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6636352|NCT01352572|Antidepressive Agents|antidepressive agents|mesh-list
6636353|NCT01352572|Levomilnacipran|levomilnacipran|mesh-list
6636354|NCT01352572|Nortriptyline|nortriptyline|mesh-list
6636355|NCT01352572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6636356|NCT01352572|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6636357|NCT01352572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6636358|NCT01352572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6636359|NCT01352572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636360|NCT01352572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6636361|NCT01352572|Serotonin Agents|serotonin agents|mesh-ancestor
6636362|NCT01352572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636363|NCT01352572|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6636364|NCT01352572|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6636365|NCT01352572|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6636366|NCT01352572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6636367|NCT01352572|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6636368|NCT01352572|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6636369|NCT01352572|Histamine Antagonists|histamine antagonists|mesh-ancestor
6636370|NCT01352572|Histamine Agents|histamine agents|mesh-ancestor
6636371|NCT01352572|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6636372|NCT01352572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6636373|NCT01352572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6636374|NCT01352572|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6636375|NCT01352572|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6636376|NCT01352572|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6636377|NCT01352572|Adrenergic Agents|adrenergic agents|mesh-ancestor
6636378|NCT01352572|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6636379|NCT01352572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6636380|NCT01352572|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6636381|NCT01352572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6636382|NCT01352572|Analgesics|analgesics|mesh-ancestor
6636383|NCT01352572|Sensory System Agents|sensory system agents|mesh-ancestor
6636384|NCT01352572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6636385|NCT01352572|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6636386|NCT01352572|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6636387|NCT01352611|Baclofen|baclofen|mesh-list
6636388|NCT01352611|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6636389|NCT01352611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636390|NCT01352611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6636391|NCT01352611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6636392|NCT01352611|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6636393|NCT01352611|GABA Agonists|gaba agonists|mesh-ancestor
6636394|NCT01352611|GABA Agents|gaba agents|mesh-ancestor
6636395|NCT01352611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6636396|NCT01352611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636397|NCT01352650|Plerixafor|plerixafor|mesh-list
6636398|NCT01352650|Decitabine|decitabine|mesh-list
6636399|NCT01352650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5483378|NCT04856215|Immunologic Factors|immunologic factors|mesh-ancestor
5483379|NCT04856215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483380|NCT04756726|Dexamethasone|dexamethasone|mesh-list
5483381|NCT04756726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5483382|NCT04756726|Antiemetics|antiemetics|mesh-ancestor
5483383|NCT04756726|Autonomic Agents|autonomic agents|mesh-ancestor
5483384|NCT04756726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5483385|NCT04756726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483386|NCT04756726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5483387|NCT04756726|Glucocorticoids|glucocorticoids|mesh-ancestor
6636400|NCT01352650|Antimetabolites|antimetabolites|mesh-ancestor
6636401|NCT01352650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636402|NCT01352650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5483388|NCT04756726|Hormones|hormones|mesh-ancestor
5483389|NCT04756726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5483390|NCT04756726|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5483391|NCT04756726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5483392|NCT04755283|Rivaroxaban|rivaroxaban|mesh-list
5483393|NCT04755283|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5483394|NCT04755283|Antithrombins|antithrombins|mesh-ancestor
5483395|NCT04755283|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5483396|NCT04755283|Protease Inhibitors|protease inhibitors|mesh-ancestor
5483397|NCT04755283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5483398|NCT04755283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636403|NCT01352650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6636404|NCT01352650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6636405|NCT01352650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6636406|NCT01352650|Antiviral Agents|antiviral agents|mesh-ancestor
6636407|NCT01352650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6636408|NCT01352663|Insulin|insulin|mesh-list
6636409|NCT01352663|Insulin Glargine|insulin glargine|mesh-list
6636410|NCT01352663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6452171|NCT00415844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6452172|NCT00415844|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6452173|NCT00415844|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6452174|NCT00415844|Immunologic Factors|immunologic factors|mesh-ancestor
6452175|NCT00415844|Dopamine Agonists|dopamine agonists|mesh-ancestor
6636411|NCT01352663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636412|NCT01352702|Dabigatran|dabigatran|mesh-list
6636413|NCT01352702|Phenprocoumon|phenprocoumon|mesh-list
6636414|NCT01352702|Antithrombins|antithrombins|mesh-ancestor
6636415|NCT01352702|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6636416|NCT01352702|Protease Inhibitors|protease inhibitors|mesh-ancestor
6636417|NCT01352702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6636418|NCT01352702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636419|NCT01352702|Anticoagulants|anticoagulants|mesh-ancestor
6636420|NCT01352728|Axitinib|axitinib|mesh-list
6636421|NCT01352728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6636422|NCT01352728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6636423|NCT01352728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6636424|NCT01352728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663130|NCT01506388|Oxytocics|oxytocics|mesh-ancestor
6663131|NCT01506414|Rituximab|rituximab|mesh-list
6663132|NCT01506414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6663133|NCT01506414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6663134|NCT01506414|Immunologic Factors|immunologic factors|mesh-ancestor
6663135|NCT01506414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663136|NCT01506414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6663137|NCT01506505|Aspirin|aspirin|mesh-list
6663138|NCT01506505|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6663139|NCT01506505|Lisinopril|lisinopril|mesh-list
6663140|NCT01506505|Simvastatin|simvastatin|mesh-list
6663141|NCT01506505|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6663142|NCT01506505|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6663143|NCT01506505|Antimetabolites|antimetabolites|mesh-ancestor
6663144|NCT01506505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663145|NCT01506505|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6663146|NCT01506505|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5483399|NCT04755283|Anticoagulants|anticoagulants|mesh-ancestor
6452176|NCT00415883|Valsartan|valsartan|mesh-list
6452177|NCT00415883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6452178|NCT00415883|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5483400|NCT04713137|Erythritol|erythritol|mesh-list
5483401|NCT04713137|Vasodilator Agents|vasodilator agents|mesh-ancestor
6452179|NCT00415883|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6636425|NCT01352988|Dimethyl Fumarate|dimethyl fumarate|mesh-list
6636426|NCT01352988|Dermatologic Agents|dermatologic agents|mesh-ancestor
6636427|NCT01352988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6636428|NCT01352988|Immunologic Factors|immunologic factors|mesh-ancestor
6636429|NCT01352988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636430|NCT01353170|Dialysis Solutions|dialysis solutions|mesh-list
6636431|NCT01353170|Calcium|calcium|mesh-list
6636432|NCT01353170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6636433|NCT01353170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636434|NCT01353170|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6636435|NCT01353209|Letrozole|letrozole|mesh-list
6636436|NCT01353209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6636437|NCT01353209|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6636438|NCT01353209|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6636439|NCT01353209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6636440|NCT01353209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636441|NCT01353209|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6636442|NCT01353209|Hormone Antagonists|hormone antagonists|mesh-ancestor
6636443|NCT01353209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6636444|NCT01353209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636445|NCT01353235|Prednisolone|prednisolone|mesh-list
6636446|NCT01353235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6636447|NCT01353235|Glucocorticoids|glucocorticoids|mesh-ancestor
6636448|NCT01353235|Hormones|hormones|mesh-ancestor
6636449|NCT01353235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6636450|NCT01353235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636451|NCT01353235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6636452|NCT01353235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6636453|NCT01353339|Levofloxacin|levofloxacin|mesh-list
6636454|NCT01353339|Ofloxacin|ofloxacin|mesh-list
6636455|NCT01353339|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6636456|NCT01353339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6636457|NCT01353339|Renal Agents|renal agents|mesh-ancestor
6636458|NCT01353339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6636459|NCT01353339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6636460|NCT01353339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6636461|NCT01353339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6636462|NCT01353339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636463|NCT01353339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6636464|NCT01353339|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6636465|NCT01353339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6636466|NCT01353378|Dexmedetomidine|dexmedetomidine|mesh-list
6636467|NCT01353378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6636468|NCT01353378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6636469|NCT01353378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636470|NCT01353378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5483402|NCT04682847|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
5483403|NCT04682847|Hematinics|hematinics|mesh-ancestor
5483404|NCT04682847|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5483405|NCT04682847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5483406|NCT04622553|Mexiletine|mexiletine|mesh-list
6636471|NCT01353378|Analgesics|analgesics|mesh-ancestor
6636472|NCT01353378|Sensory System Agents|sensory system agents|mesh-ancestor
6636473|NCT01353378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6636474|NCT01353378|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6636475|NCT01353378|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6636476|NCT01353378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6636477|NCT01353378|Adrenergic Agents|adrenergic agents|mesh-ancestor
6636478|NCT01353378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6636479|NCT01353378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636480|NCT01353391|Metformin|metformin|mesh-list
6636481|NCT01353391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6636482|NCT01353391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636483|NCT01353456|Dexmedetomidine|dexmedetomidine|mesh-list
6636484|NCT01353456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6636485|NCT01353456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6636486|NCT01353456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636487|NCT01353456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6636488|NCT01353456|Analgesics|analgesics|mesh-ancestor
6636489|NCT01353456|Sensory System Agents|sensory system agents|mesh-ancestor
6636490|NCT01353456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6636491|NCT01353456|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5483407|NCT04622553|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6663147|NCT01506505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6636492|NCT01353456|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6636493|NCT01353456|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6636494|NCT01353456|Adrenergic Agents|adrenergic agents|mesh-ancestor
6636495|NCT01353456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6636496|NCT01353456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636497|NCT01353469|Insulin|insulin|mesh-list
6636498|NCT01353469|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6636499|NCT01353469|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6636500|NCT01353469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636501|NCT01353482|Pemetrexed|pemetrexed|mesh-list
6636502|NCT01353482|Vorinostat|vorinostat|mesh-list
6636503|NCT01353482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6636504|NCT01353482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6636505|NCT01353482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636506|NCT01353482|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6636507|NCT01353482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6636508|NCT01353482|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6636509|NCT01353599|Mometasone Furoate|mometasone furoate|mesh-list
6636510|NCT01353599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6636511|NCT01353599|Dermatologic Agents|dermatologic agents|mesh-ancestor
6636512|NCT01353599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6636513|NCT01353716|Dolutegravir|dolutegravir|mesh-list
6636514|NCT01353716|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6636515|NCT01353716|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6636516|NCT01353716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6636517|NCT01353716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636518|NCT01353716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6636519|NCT01353716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6636520|NCT01353716|Antiviral Agents|antiviral agents|mesh-ancestor
6636521|NCT01353716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6636522|NCT01353729|Moxifloxacin|moxifloxacin|mesh-list
6636523|NCT01353729|Zanamivir|zanamivir|mesh-list
6636524|NCT01353729|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6636525|NCT01353729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6636526|NCT01353729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6636527|NCT01353729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6636528|NCT01353729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6636529|NCT01353729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6636530|NCT01353729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636531|NCT01353729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6636532|NCT01353729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6636533|NCT01353729|Contraceptive Agents|contraceptive agents|mesh-ancestor
6636534|NCT01353729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6636535|NCT01353729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636536|NCT01353729|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6636537|NCT01353729|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6636538|NCT01353729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6636539|NCT01353729|Antiviral Agents|antiviral agents|mesh-ancestor
6636540|NCT01353742|Lamivudine|lamivudine|mesh-list
6636541|NCT01353742|Adefovir|adefovir|mesh-list
6636542|NCT01353742|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6636543|NCT01353742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6636544|NCT01353742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6636545|NCT01353742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6663148|NCT01506505|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6636546|NCT01353742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636547|NCT01353742|Antiviral Agents|antiviral agents|mesh-ancestor
6636548|NCT01353742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6636549|NCT01353742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5483408|NCT04622553|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5483409|NCT04622553|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5483410|NCT04622553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5483411|NCT04622553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483412|NCT04564443|Calcium|calcium|mesh-list
5483413|NCT04564443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5483414|NCT04564443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483415|NCT04564339|Ravulizumab|ravulizumab|mesh-list
5483416|NCT04564339|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5483417|NCT04564339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5483418|NCT04564339|Immunologic Factors|immunologic factors|mesh-ancestor
5483419|NCT04564339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483420|NCT04557085|Cenobamate|cenobamate|mesh-list
5483421|NCT04557085|Anticonvulsants|anticonvulsants|mesh-ancestor
5483422|NCT04532346|Hydroxychloroquine|hydroxychloroquine|mesh-list
5483423|NCT04532346|Antimalarials|antimalarials|mesh-ancestor
5483424|NCT04532346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5483425|NCT04532346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5483426|NCT04532346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6636550|NCT01353742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6636551|NCT01353794|Sorafenib|sorafenib|mesh-list
6636552|NCT01353794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6636553|NCT01353794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6636554|NCT01353794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6636555|NCT01353794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636556|NCT01353833|Aldesleukin|aldesleukin|mesh-list
6636557|NCT01353833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6636558|NCT01353833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6636559|NCT01353833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6636560|NCT01353833|Antiviral Agents|antiviral agents|mesh-ancestor
6636561|NCT01353833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6636562|NCT01353846|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6636563|NCT01353846|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6636564|NCT01353846|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6636565|NCT01353846|Estradiol|estradiol|mesh-list
6636566|NCT01353846|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6636567|NCT01353846|Progesterone|progesterone|mesh-list
6636568|NCT01353846|Estrogens|estrogens|mesh-ancestor
6636569|NCT01353846|Hormones|hormones|mesh-ancestor
6636570|NCT01353846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6636571|NCT01353846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636572|NCT01353846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6636573|NCT01353846|Contraceptive Agents|contraceptive agents|mesh-ancestor
6636574|NCT01353846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6636575|NCT01353846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6636576|NCT01353846|Progestins|progestins|mesh-ancestor
6636577|NCT01353846|Luteolytic Agents|luteolytic agents|mesh-ancestor
6636578|NCT01353846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6636579|NCT01353846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6636580|NCT01353924|Aluminum sulfate|aluminum sulfate|mesh-list
6636581|NCT01353924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6636582|NCT01353924|Immunologic Factors|immunologic factors|mesh-ancestor
6636583|NCT01353924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636584|NCT01353937|Plerixafor|plerixafor|mesh-list
6636585|NCT01353937|Becaplermin|becaplermin|mesh-list
6636586|NCT01353937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6636587|NCT01353937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6636588|NCT01353937|Antiviral Agents|antiviral agents|mesh-ancestor
6636589|NCT01353937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6636590|NCT01353937|Anticoagulants|anticoagulants|mesh-ancestor
6636591|NCT01353937|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
6636592|NCT01353937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6636593|NCT01353937|Growth Substances|growth substances|mesh-ancestor
6636594|NCT01353937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636595|NCT01354158|Droxidopa|droxidopa|mesh-list
6636596|NCT01354158|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6636597|NCT01354158|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6636598|NCT01354262|Vitamin D|vitamin d|mesh-list
6636599|NCT01354262|Ergocalciferols|ergocalciferols|mesh-list
6636600|NCT01354262|Vitamins|vitamins|mesh-list
6636601|NCT01354262|Micronutrients|micronutrients|mesh-ancestor
6636602|NCT01354262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636603|NCT01354262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5483427|NCT04532346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6636604|NCT01354262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6636605|NCT01354275|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
6636606|NCT01354275|Hormones|hormones|mesh-ancestor
6636607|NCT01354275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6636608|NCT01354275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636609|NCT01354301|Mycophenolic Acid|mycophenolic acid|mesh-list
6636610|NCT01354301|Everolimus|everolimus|mesh-list
6636611|NCT01354301|Tacrolimus|tacrolimus|mesh-list
6636612|NCT01354301|Thymoglobulin|thymoglobulin|mesh-list
6636613|NCT01354301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6636614|NCT01354301|Immunologic Factors|immunologic factors|mesh-ancestor
6636615|NCT01354301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636616|NCT01354301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6636617|NCT01354301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6636618|NCT01354301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636619|NCT01354301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6636620|NCT01354301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6636621|NCT01354301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6636622|NCT01354301|Antitubercular Agents|antitubercular agents|mesh-ancestor
6636623|NCT01354301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6636624|NCT01354301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6636625|NCT01354405|Lanreotide|lanreotide|mesh-list
6636626|NCT01354405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6636627|NCT01354418|Phenylephrine|phenylephrine|mesh-list
6636628|NCT01354418|Oxymetazoline|oxymetazoline|mesh-list
6636629|NCT01354418|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6636630|NCT01354418|Mydriatics|mydriatics|mesh-ancestor
6636631|NCT01354418|Autonomic Agents|autonomic agents|mesh-ancestor
6636632|NCT01354418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6636633|NCT01354418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636634|NCT01354418|Sympathomimetics|sympathomimetics|mesh-ancestor
6636635|NCT01354418|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6636636|NCT01354418|Nasal Decongestants|nasal decongestants|mesh-ancestor
6636637|NCT01354418|Respiratory System Agents|respiratory system agents|mesh-ancestor
6636638|NCT01354418|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6636639|NCT01354418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6636640|NCT01354418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6636641|NCT01354418|Adrenergic Agents|adrenergic agents|mesh-ancestor
6636642|NCT01354418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6636643|NCT01354418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636644|NCT01354418|Protective Agents|protective agents|mesh-ancestor
6636645|NCT01354457|Epratuzumab|epratuzumab|mesh-list
6636646|NCT01354457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6636647|NCT01354457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6636648|NCT01354470|Modafinil|modafinil|mesh-list
6636649|NCT01354470|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6636650|NCT01354470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636651|NCT01354470|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6636652|NCT01354470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6636653|NCT01354470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6636654|NCT01354470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636655|NCT01354483|Methylprednisolone|methylprednisolone|mesh-list
6636656|NCT01354483|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6636657|NCT01354483|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6636658|NCT01354483|Prednisolone|prednisolone|mesh-list
6636659|NCT01354483|Prednisolone acetate|prednisolone acetate|mesh-list
6636660|NCT01354483|Lithium Carbonate|lithium carbonate|mesh-list
6636661|NCT01354483|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6636662|NCT01354483|Prednisolone phosphate|prednisolone phosphate|mesh-list
6636663|NCT01354483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6636664|NCT01354483|Antiemetics|antiemetics|mesh-ancestor
6636665|NCT01354483|Autonomic Agents|autonomic agents|mesh-ancestor
6636666|NCT01354483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6636667|NCT01354483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636668|NCT01354483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6636669|NCT01354483|Glucocorticoids|glucocorticoids|mesh-ancestor
6636670|NCT01354483|Hormones|hormones|mesh-ancestor
6636671|NCT01354483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6636672|NCT01354483|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6636673|NCT01354483|Protective Agents|protective agents|mesh-ancestor
6636674|NCT01354483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6636675|NCT01354483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6636676|NCT01354483|Antidepressive Agents|antidepressive agents|mesh-ancestor
6636677|NCT01354483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5483428|NCT04532346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483429|NCT04532346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5483430|NCT04524351|Phenserine|phenserine|mesh-list
5483431|NCT04524351|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5483432|NCT04524351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5483433|NCT04524351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483434|NCT04524351|Cholinergic Agents|cholinergic agents|mesh-ancestor
5483435|NCT04524351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6636678|NCT01354483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6636679|NCT01354483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636680|NCT01354483|Antimanic Agents|antimanic agents|mesh-ancestor
6636681|NCT01354483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6636682|NCT01354483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6636683|NCT01354522|Cyclophosphamide|cyclophosphamide|mesh-list
6636684|NCT01354522|Docetaxel|docetaxel|mesh-list
6636685|NCT01354522|Doxorubicin|doxorubicin|mesh-list
6636686|NCT01354522|Capecitabine|capecitabine|mesh-list
6636687|NCT01354522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6636688|NCT01354522|Immunologic Factors|immunologic factors|mesh-ancestor
6636689|NCT01354522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636690|NCT01354522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6636691|NCT01354522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6636692|NCT01354522|Alkylating Agents|alkylating agents|mesh-ancestor
6636693|NCT01354522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636694|NCT01354522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6636695|NCT01354522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6636696|NCT01354522|Tubulin Modulators|tubulin modulators|mesh-ancestor
6636697|NCT01354522|Antimitotic Agents|antimitotic agents|mesh-ancestor
6636698|NCT01354522|Mitosis Modulators|mitosis modulators|mesh-ancestor
6636699|NCT01354522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6636700|NCT01354522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6636701|NCT01354522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6636702|NCT01354522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6636703|NCT01354522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6636704|NCT01354522|Antimetabolites|antimetabolites|mesh-ancestor
6663149|NCT01506505|Diuretics|diuretics|mesh-ancestor
6663150|NCT01506505|Natriuretic Agents|natriuretic agents|mesh-ancestor
6663151|NCT01506505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663152|NCT01506505|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6663153|NCT01506505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6663154|NCT01506505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6663155|NCT01506505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6663156|NCT01506505|Analgesics|analgesics|mesh-ancestor
6663157|NCT01506505|Sensory System Agents|sensory system agents|mesh-ancestor
6663158|NCT01506505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5483436|NCT04524351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483437|NCT04499677|Ritonavir|ritonavir|mesh-list
5483438|NCT04499677|Lopinavir|lopinavir|mesh-list
5483439|NCT04499677|Favipiravir|favipiravir|mesh-list
5483440|NCT04499677|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5483441|NCT04499677|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5483442|NCT04499677|Protease Inhibitors|protease inhibitors|mesh-ancestor
5483443|NCT04499677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5483444|NCT04499677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483445|NCT04499677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5483446|NCT04499677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5483447|NCT04499677|Antiviral Agents|antiviral agents|mesh-ancestor
5483448|NCT04499677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5483449|NCT04499677|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5483450|NCT04499677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5483451|NCT04492956|Ecopipam|ecopipam|mesh-list
5483452|NCT04492956|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5483453|NCT04492956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5483454|NCT04492956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5483455|NCT04492956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483456|NCT04492956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5483457|NCT04492956|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5483458|NCT04492956|Dopamine Agents|dopamine agents|mesh-ancestor
6663159|NCT01506505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6663160|NCT01506505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6663161|NCT01506505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6663162|NCT01506505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6663163|NCT01506505|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5483459|NCT04492956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5502444|NCT04466046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483460|NCT04492956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483461|NCT04491526|Tamsulosin|tamsulosin|mesh-list
5483462|NCT04491526|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5483463|NCT04491526|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5483464|NCT04491526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5483465|NCT04491526|Adrenergic Agents|adrenergic agents|mesh-ancestor
5483466|NCT04491526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5483467|NCT04491526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483468|NCT04491526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483469|NCT04491526|Urological Agents|urological agents|mesh-ancestor
5483470|NCT04489719|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
5483471|NCT04489719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5483472|NCT04481113|Niraparib|niraparib|mesh-list
5483473|NCT04481113|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6636705|NCT01354613|Amlodipine|amlodipine|mesh-list
6636706|NCT01354613|Dobutamine|dobutamine|mesh-list
6636707|NCT01354613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6636708|NCT01354613|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6636709|NCT01354613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6636710|NCT01354613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636711|NCT01354613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6636712|NCT01354613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636713|NCT01354613|Vasodilator Agents|vasodilator agents|mesh-ancestor
6636714|NCT01354613|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6636715|NCT01354613|Sympathomimetics|sympathomimetics|mesh-ancestor
6636716|NCT01354613|Autonomic Agents|autonomic agents|mesh-ancestor
6636717|NCT01354613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6636718|NCT01354613|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6636719|NCT01354613|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6636720|NCT01354613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6636721|NCT01354613|Adrenergic Agents|adrenergic agents|mesh-ancestor
6636722|NCT01354613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6636723|NCT01354613|Protective Agents|protective agents|mesh-ancestor
6636724|NCT01354665|Interferons|interferons|mesh-list
6636725|NCT01354665|Interferon-beta|interferon-beta|mesh-list
6636726|NCT01354665|Interferon beta-1b|interferon beta-1b|mesh-list
6636727|NCT01354665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6636728|NCT01354665|Antiviral Agents|antiviral agents|mesh-ancestor
6636729|NCT01354665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6636730|NCT01354665|Immunologic Factors|immunologic factors|mesh-ancestor
6636731|NCT01354665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636732|NCT01354665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6636733|NCT01354704|Enoxaparin|enoxaparin|mesh-list
6636734|NCT01354704|Anticoagulants|anticoagulants|mesh-ancestor
6636735|NCT01354704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5483474|NCT04481113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5483475|NCT04481113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483476|NCT04481113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5483477|NCT04478266|Letrozole|letrozole|mesh-list
5483478|NCT04478266|Palbociclib|palbociclib|mesh-list
5483479|NCT04478266|Goserelin|goserelin|mesh-list
5502445|NCT04466046|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6452180|NCT00415883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6452181|NCT00415922|Levodopa|levodopa|mesh-list
6452182|NCT00415922|Carbidopa|carbidopa|mesh-list
6452183|NCT00415922|Entacapone|entacapone|mesh-list
6452184|NCT00415922|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
6452185|NCT00415922|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6452186|NCT00415922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6452187|NCT00415922|Dopamine Agents|dopamine agents|mesh-ancestor
6452188|NCT00415922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6452189|NCT00415922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6452190|NCT00415922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452191|NCT00415922|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6452192|NCT00415922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6452193|NCT00415922|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6452194|NCT00415922|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6452195|NCT00415922|Immunologic Factors|immunologic factors|mesh-ancestor
6452196|NCT00415922|Dopamine Agonists|dopamine agonists|mesh-ancestor
6452197|NCT00415935|Methotrexate|methotrexate|mesh-list
6452198|NCT00415935|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6452199|NCT00415935|Abortifacient Agents|abortifacient agents|mesh-ancestor
6452200|NCT00415935|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6636736|NCT01354704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6636737|NCT01354704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636738|NCT01354743|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6636739|NCT01354743|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6636740|NCT01354743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6636741|NCT01354743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636742|NCT01354743|Cholinergic Agents|cholinergic agents|mesh-ancestor
6636743|NCT01354743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6021034|NCT00396201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6021035|NCT00396253|Tenecteplase|tenecteplase|mesh-list
6021036|NCT00396253|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6021037|NCT00396253|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6021038|NCT00396253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021039|NCT00396266|Plerixafor|plerixafor|mesh-list
6021040|NCT00396266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6021041|NCT00396266|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6636744|NCT01354743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636745|NCT01354860|Lobeline|lobeline|mesh-list
6636746|NCT01354860|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6636747|NCT01354860|Autonomic Agents|autonomic agents|mesh-ancestor
6636748|NCT01354860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6636749|NCT01354860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636750|NCT01354860|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6636751|NCT01354860|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6636752|NCT01354860|Cholinergic Agents|cholinergic agents|mesh-ancestor
6636753|NCT01354860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6636754|NCT01354860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636755|NCT01354860|Respiratory System Agents|respiratory system agents|mesh-ancestor
6636756|NCT01354886|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6636757|NCT01354886|Hormones|hormones|mesh-ancestor
6636758|NCT01354886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6636759|NCT01354886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636760|NCT01354925|Insulin|insulin|mesh-list
6636761|NCT01354925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6636762|NCT01354925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636763|NCT01354977|Resveratrol|resveratrol|mesh-list
6636764|NCT01354977|Antioxidants|antioxidants|mesh-ancestor
6636765|NCT01354977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636766|NCT01354977|Protective Agents|protective agents|mesh-ancestor
6636767|NCT01354977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636768|NCT01354977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6636769|NCT01354977|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6636770|NCT01355120|Ipilimumab|ipilimumab|mesh-list
6636771|NCT01355120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6636772|NCT01355120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6636773|NCT01355120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6636774|NCT01355120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636775|NCT01355198|Acetylcysteine|acetylcysteine|mesh-list
6636776|NCT01355198|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6636777|NCT01355198|Glycine|glycine|mesh-list
5483480|NCT04478266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5483481|NCT04478266|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5483482|NCT04478266|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5483483|NCT04478266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5483484|NCT04478266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483485|NCT04478266|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6021042|NCT00396266|Antiviral Agents|antiviral agents|mesh-ancestor
6021043|NCT00396266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6021044|NCT00396279|Vitamin D|vitamin d|mesh-list
6021045|NCT00396279|Denosumab|denosumab|mesh-list
6021046|NCT00396279|Calcium|calcium|mesh-list
6021047|NCT00396279|Vitamins|vitamins|mesh-ancestor
6021048|NCT00396279|Micronutrients|micronutrients|mesh-ancestor
6021049|NCT00396279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021050|NCT00396279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6452201|NCT00415935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021051|NCT00396279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6452202|NCT00415935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6452203|NCT00415935|Antimetabolites|antimetabolites|mesh-ancestor
6452204|NCT00415935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6452205|NCT00415935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6452206|NCT00415935|Dermatologic Agents|dermatologic agents|mesh-ancestor
6452207|NCT00415935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6452208|NCT00415935|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6452209|NCT00415935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6636778|NCT01355198|Antiviral Agents|antiviral agents|mesh-ancestor
6636779|NCT01355198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6636780|NCT01355198|Expectorants|expectorants|mesh-ancestor
6636781|NCT01355198|Respiratory System Agents|respiratory system agents|mesh-ancestor
6636782|NCT01355198|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6636783|NCT01355198|Antioxidants|antioxidants|mesh-ancestor
6636784|NCT01355198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636785|NCT01355198|Protective Agents|protective agents|mesh-ancestor
6636786|NCT01355198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636787|NCT01355198|Antidotes|antidotes|mesh-ancestor
5483486|NCT04478266|Hormone Antagonists|hormone antagonists|mesh-ancestor
5483487|NCT04478266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5483488|NCT04478266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636788|NCT01355198|Glycine Agents|glycine agents|mesh-ancestor
6636789|NCT01355198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6636790|NCT01355263|Vitamin A|vitamin a|mesh-list
6636791|NCT01355263|Vitamins|vitamins|mesh-ancestor
6636792|NCT01355263|Micronutrients|micronutrients|mesh-ancestor
6636793|NCT01355263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636794|NCT01355276|Domperidone|domperidone|mesh-list
6636795|NCT01355276|Cinitapride|cinitapride|mesh-list
6636796|NCT01355276|Antiemetics|antiemetics|mesh-ancestor
6636797|NCT01355276|Autonomic Agents|autonomic agents|mesh-ancestor
6636798|NCT01355276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6636799|NCT01355276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636800|NCT01355276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6636801|NCT01355276|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6636802|NCT01355276|Dopamine Agents|dopamine agents|mesh-ancestor
6636803|NCT01355276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6636804|NCT01355276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483489|NCT04478266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5483490|NCT04478266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5483491|NCT04477343|Nivolumab|nivolumab|mesh-list
5483492|NCT04477343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5483493|NCT04477343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5483494|NCT04477343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5483495|NCT04477343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483496|NCT04452877|Trametinib|trametinib|mesh-list
5483497|NCT04452877|Dabrafenib|dabrafenib|mesh-list
6452210|NCT00415935|Immunologic Factors|immunologic factors|mesh-ancestor
6636805|NCT01355276|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6636806|NCT01355354|Digoxin|digoxin|mesh-list
6636807|NCT01355354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6636808|NCT01355354|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6636809|NCT01355354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6636810|NCT01355354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636811|NCT01355354|Protective Agents|protective agents|mesh-ancestor
6636812|NCT01355354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636813|NCT01355367|Nifedipine|nifedipine|mesh-list
6636814|NCT01355367|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6452211|NCT00415935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6452212|NCT00415935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6452213|NCT00415961|Paclitaxel|paclitaxel|mesh-list
6452214|NCT00415961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6452215|NCT00415961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6452216|NCT00415961|Tubulin Modulators|tubulin modulators|mesh-ancestor
6452217|NCT00415961|Antimitotic Agents|antimitotic agents|mesh-ancestor
6452218|NCT00415961|Mitosis Modulators|mitosis modulators|mesh-ancestor
6452219|NCT00415961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6452220|NCT00416039|Midazolam|midazolam|mesh-list
6452221|NCT00416039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6452222|NCT00416039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6452223|NCT00416039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6452224|NCT00416039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452225|NCT00416039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6452226|NCT00416039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6636815|NCT01355367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6636816|NCT01355367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636817|NCT01355367|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6636818|NCT01355367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636819|NCT01355367|Vasodilator Agents|vasodilator agents|mesh-ancestor
6636820|NCT01355367|Tocolytic Agents|tocolytic agents|mesh-ancestor
6636821|NCT01355367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6636822|NCT01355380|Iloprost|iloprost|mesh-list
6452227|NCT00416039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6636823|NCT01355380|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6636824|NCT01355380|Vasodilator Agents|vasodilator agents|mesh-ancestor
6636825|NCT01355445|Irinotecan|irinotecan|mesh-list
6636826|NCT01355445|Vincristine|vincristine|mesh-list
6636827|NCT01355445|Temozolomide|temozolomide|mesh-list
6636828|NCT01355445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6636829|NCT01355445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6636830|NCT01355445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6636831|NCT01355445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636832|NCT01355445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6636833|NCT01355445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6636834|NCT01355445|Tubulin Modulators|tubulin modulators|mesh-ancestor
6636835|NCT01355445|Antimitotic Agents|antimitotic agents|mesh-ancestor
6636836|NCT01355445|Mitosis Modulators|mitosis modulators|mesh-ancestor
6636837|NCT01355445|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6636838|NCT01355445|Alkylating Agents|alkylating agents|mesh-ancestor
6636839|NCT01355562|Interleukin-2|interleukin-2|mesh-list
6636840|NCT01355562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6636841|NCT01355562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6636842|NCT01355562|Analgesics|analgesics|mesh-ancestor
6636843|NCT01355562|Sensory System Agents|sensory system agents|mesh-ancestor
6636844|NCT01355562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6636845|NCT01355562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636846|NCT01355614|Infliximab|infliximab|mesh-list
6636847|NCT01355614|Dermatologic Agents|dermatologic agents|mesh-ancestor
6636848|NCT01355614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6636849|NCT01355614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6636850|NCT01355718|Repaglinide|repaglinide|mesh-list
6636851|NCT01355718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6636852|NCT01355718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636853|NCT01355757|Anesthetics|anesthetics|mesh-list
6636854|NCT01355757|Anesthetics, Local|anesthetics, local|mesh-list
6636855|NCT01355757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6636856|NCT01355757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636857|NCT01355757|Sensory System Agents|sensory system agents|mesh-ancestor
6636858|NCT01355757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6636859|NCT01355939|Zinc Oxide|zinc oxide|mesh-list
6636860|NCT01355939|Dermatologic Agents|dermatologic agents|mesh-ancestor
6636861|NCT01355939|Sunscreening Agents|sunscreening agents|mesh-ancestor
6636862|NCT01355939|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6636863|NCT01355939|Protective Agents|protective agents|mesh-ancestor
6636864|NCT01355939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636865|NCT01355952|Thioctic Acid|thioctic acid|mesh-list
6636866|NCT01355952|Antioxidants|antioxidants|mesh-ancestor
6636867|NCT01355952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636868|NCT01355952|Protective Agents|protective agents|mesh-ancestor
6636869|NCT01355952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636870|NCT01355952|Vitamin B Complex|vitamin b complex|mesh-ancestor
6636871|NCT01355952|Vitamins|vitamins|mesh-ancestor
5483498|NCT04452877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5483499|NCT04452877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5483500|NCT04452877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5483501|NCT04452877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483502|NCT04419519|Venetoclax|venetoclax|mesh-list
5483503|NCT04419519|Antibodies|antibodies|mesh-list
5483504|NCT04419519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5483505|NCT04419519|Immunologic Factors|immunologic factors|mesh-ancestor
5483506|NCT04419519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483507|NCT04419519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5483508|NCT04384692|Mycophenolic Acid|mycophenolic acid|mesh-list
6452228|NCT00416039|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6452229|NCT00416039|Anesthetics, General|anesthetics, general|mesh-ancestor
6452230|NCT00416039|Anesthetics|anesthetics|mesh-ancestor
6452231|NCT00416039|GABA Modulators|gaba modulators|mesh-ancestor
6452232|NCT00416039|GABA Agents|gaba agents|mesh-ancestor
6452233|NCT00416039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6452234|NCT00416039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6452235|NCT00416130|Vorinostat|vorinostat|mesh-list
6452236|NCT00416130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6452237|NCT00416130|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6636872|NCT01355952|Micronutrients|micronutrients|mesh-ancestor
6636873|NCT01355991|Tiotropium Bromide|tiotropium bromide|mesh-list
6452238|NCT00416130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6461898|NCT00456729|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6636874|NCT01355991|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6636875|NCT01355991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6636876|NCT01355991|Autonomic Agents|autonomic agents|mesh-ancestor
6636877|NCT01355991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6636878|NCT01355991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636879|NCT01355991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6636880|NCT01355991|Respiratory System Agents|respiratory system agents|mesh-ancestor
6636881|NCT01355991|Parasympatholytics|parasympatholytics|mesh-ancestor
6636882|NCT01355991|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6636883|NCT01355991|Cholinergic Agents|cholinergic agents|mesh-ancestor
6636884|NCT01355991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6636885|NCT01355991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636886|NCT01355991|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6636887|NCT01355991|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6636888|NCT01355991|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5483509|NCT04384692|Cyclophosphamide|cyclophosphamide|mesh-list
5483510|NCT04384692|Melphalan|melphalan|mesh-list
5483511|NCT04384692|Busulfan|busulfan|mesh-list
5483512|NCT04384692|Mechlorethamine|mechlorethamine|mesh-list
5483513|NCT04384692|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
5483514|NCT04384692|Methotrexate|methotrexate|mesh-list
5483515|NCT04384692|Fludarabine|fludarabine|mesh-list
5483516|NCT04384692|Tacrolimus|tacrolimus|mesh-list
5483517|NCT04384692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5483518|NCT04384692|Immunologic Factors|immunologic factors|mesh-ancestor
5483519|NCT04384692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483520|NCT04384692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6636889|NCT01355991|Adrenergic Agents|adrenergic agents|mesh-ancestor
6636890|NCT01356017|Amlodipine|amlodipine|mesh-list
6636891|NCT01356017|Telmisartan|telmisartan|mesh-list
6636892|NCT01356017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6636893|NCT01356017|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6636894|NCT01356017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6636895|NCT01356017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636896|NCT01356017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6636897|NCT01356017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636898|NCT01356017|Vasodilator Agents|vasodilator agents|mesh-ancestor
6636899|NCT01356017|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6636900|NCT01356017|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6636901|NCT01356043|Niacin|niacin|mesh-list
6636902|NCT01356043|Amlodipine|amlodipine|mesh-list
6636903|NCT01356043|Telmisartan|telmisartan|mesh-list
6636904|NCT01356043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6636905|NCT01356043|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6636906|NCT01356043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6636907|NCT01356043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636908|NCT01356043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6636909|NCT01356043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636910|NCT01356043|Vasodilator Agents|vasodilator agents|mesh-ancestor
6636911|NCT01356043|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6636912|NCT01356043|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6636913|NCT01356043|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6636914|NCT01356043|Antimetabolites|antimetabolites|mesh-ancestor
6636915|NCT01356043|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6636916|NCT01356043|Vitamin B Complex|vitamin b complex|mesh-ancestor
6636917|NCT01356043|Vitamins|vitamins|mesh-ancestor
6636918|NCT01356043|Micronutrients|micronutrients|mesh-ancestor
6636919|NCT01356121|Midazolam|midazolam|mesh-list
6636920|NCT01356121|Propofol|propofol|mesh-list
5483521|NCT04384692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5483522|NCT04384692|Alkylating Agents|alkylating agents|mesh-ancestor
5483523|NCT04384692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483524|NCT04384692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5483525|NCT04384692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6636921|NCT01356121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6636922|NCT01356121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6636923|NCT01356121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636924|NCT01356121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6636925|NCT01356121|Anesthetics, General|anesthetics, general|mesh-ancestor
6636926|NCT01356121|Anesthetics|anesthetics|mesh-ancestor
5483526|NCT04384692|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6636927|NCT01356121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6636928|NCT01356121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6636929|NCT01356121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6636930|NCT01356121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6636931|NCT01356121|GABA Modulators|gaba modulators|mesh-ancestor
6636932|NCT01356121|GABA Agents|gaba agents|mesh-ancestor
6636933|NCT01356121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5483527|NCT04384692|Abortifacient Agents|abortifacient agents|mesh-ancestor
5483528|NCT04384692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5483529|NCT04384692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5483530|NCT04384692|Antimetabolites|antimetabolites|mesh-ancestor
5483531|NCT04384692|Dermatologic Agents|dermatologic agents|mesh-ancestor
5483532|NCT04384692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5483533|NCT04384692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5483534|NCT04384692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5483535|NCT04384692|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5483536|NCT04384692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5483537|NCT04384692|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6636934|NCT01356121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636935|NCT01356212|Ketorolac|ketorolac|mesh-list
6636936|NCT01356212|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6636937|NCT01356212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6636938|NCT01356212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6636939|NCT01356212|Analgesics|analgesics|mesh-ancestor
6636940|NCT01356212|Sensory System Agents|sensory system agents|mesh-ancestor
6636941|NCT01356212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6636942|NCT01356212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636943|NCT01356212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6636944|NCT01356212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6636945|NCT01356212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6636946|NCT01356212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6636947|NCT01356212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636948|NCT01356225|Ketorolac|ketorolac|mesh-list
6636949|NCT01356225|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6636950|NCT01356225|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6636951|NCT01356225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6636952|NCT01356225|Analgesics|analgesics|mesh-ancestor
6636953|NCT01356225|Sensory System Agents|sensory system agents|mesh-ancestor
6636954|NCT01356225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6636955|NCT01356225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636956|NCT01356225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6636957|NCT01356225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6636958|NCT01356225|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6636959|NCT01356225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6636960|NCT01356225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636961|NCT01356290|Cytarabine|cytarabine|mesh-list
6636962|NCT01356290|Thalidomide|thalidomide|mesh-list
6636963|NCT01356290|Celecoxib|celecoxib|mesh-list
6636964|NCT01356290|Cyclophosphamide|cyclophosphamide|mesh-list
6636965|NCT01356290|Bevacizumab|bevacizumab|mesh-list
6636966|NCT01356290|Etoposide|etoposide|mesh-list
6636967|NCT01356290|Etoposide phosphate|etoposide phosphate|mesh-list
6636968|NCT01356290|Fenofibric acid|fenofibric acid|mesh-list
6636969|NCT01356290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6636970|NCT01356290|Immunologic Factors|immunologic factors|mesh-ancestor
6636971|NCT01356290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636972|NCT01356290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6636973|NCT01356290|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6636974|NCT01356290|Alkylating Agents|alkylating agents|mesh-ancestor
6636975|NCT01356290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6636976|NCT01356290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6636977|NCT01356290|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6636978|NCT01356290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6636979|NCT01356290|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6636980|NCT01356290|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6636981|NCT01356290|Growth Substances|growth substances|mesh-ancestor
6636982|NCT01356290|Growth Inhibitors|growth inhibitors|mesh-ancestor
6636983|NCT01356290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6636984|NCT01356290|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6636985|NCT01356290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6636986|NCT01356290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6636987|NCT01356290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6636988|NCT01356290|Antimetabolites|antimetabolites|mesh-ancestor
6636989|NCT01356290|Antiviral Agents|antiviral agents|mesh-ancestor
6636990|NCT01356290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6636991|NCT01356290|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6636992|NCT01356290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6636993|NCT01356290|Analgesics|analgesics|mesh-ancestor
6636994|NCT01356290|Sensory System Agents|sensory system agents|mesh-ancestor
6636995|NCT01356290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5483538|NCT04384692|Antitubercular Agents|antitubercular agents|mesh-ancestor
5483539|NCT04384692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5483540|NCT04384692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5502446|NCT04466046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5502447|NCT04466046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5502448|NCT04466046|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5502449|NCT04466046|Anesthetics, General|anesthetics, general|mesh-ancestor
5502450|NCT04466046|Anesthetics|anesthetics|mesh-ancestor
5502451|NCT04466046|GABA Modulators|gaba modulators|mesh-ancestor
5502452|NCT04466046|GABA Agents|gaba agents|mesh-ancestor
5502453|NCT04466046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5502454|NCT04466046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502455|NCT04466046|Antiemetics|antiemetics|mesh-ancestor
5502456|NCT04466046|Autonomic Agents|autonomic agents|mesh-ancestor
5502457|NCT04466046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5502458|NCT04466046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5502459|NCT04466046|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5502460|NCT04466046|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5502461|NCT04466046|Serotonin Agents|serotonin agents|mesh-ancestor
5502462|NCT04466150|Ocrelizumab|ocrelizumab|mesh-list
5502463|NCT04466150|Immunologic Factors|immunologic factors|mesh-ancestor
5502464|NCT04466150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6636996|NCT01356290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6636997|NCT01356290|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6636998|NCT01356290|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6636999|NCT01356290|Leprostatic Agents|leprostatic agents|mesh-ancestor
6637000|NCT01356290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6637001|NCT01356290|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6637002|NCT01356290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6637003|NCT01356290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6637004|NCT01356303|Docetaxel|docetaxel|mesh-list
6637005|NCT01356303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6637006|NCT01356303|Tubulin Modulators|tubulin modulators|mesh-ancestor
6637007|NCT01356303|Antimitotic Agents|antimitotic agents|mesh-ancestor
6637008|NCT01356303|Mitosis Modulators|mitosis modulators|mesh-ancestor
6637009|NCT01356303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663164|NCT01506505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6663165|NCT01506505|Antipyretics|antipyretics|mesh-ancestor
6663166|NCT01506505|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6663167|NCT01506505|Protease Inhibitors|protease inhibitors|mesh-ancestor
6663168|NCT01506505|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6663169|NCT01506505|Protective Agents|protective agents|mesh-ancestor
6663170|NCT01506544|Hydroxyurea|hydroxyurea|mesh-list
6663171|NCT01506544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6663172|NCT01506544|Antisickling Agents|antisickling agents|mesh-ancestor
6663173|NCT01506544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6663174|NCT01506544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663175|NCT01506544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6663176|NCT01506557|Cholecalciferol|cholecalciferol|mesh-list
6663177|NCT01506557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6663178|NCT01506557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663179|NCT01506557|Vitamins|vitamins|mesh-ancestor
6663180|NCT01506557|Micronutrients|micronutrients|mesh-ancestor
6663181|NCT01506557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6663182|NCT01506570|Vaccines|vaccines|mesh-list
6663183|NCT01506570|Immunologic Factors|immunologic factors|mesh-ancestor
6663184|NCT01506570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663185|NCT01506622|Fentanyl|fentanyl|mesh-list
5502465|NCT04466280|Hydroxychloroquine|hydroxychloroquine|mesh-list
6663186|NCT01506622|Propofol|propofol|mesh-list
6637010|NCT01356329|Heparin|heparin|mesh-list
6637011|NCT01356329|Enoxaparin|enoxaparin|mesh-list
6637012|NCT01356329|Anticoagulants|anticoagulants|mesh-ancestor
6637013|NCT01356329|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6637014|NCT01356329|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6637015|NCT01356329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637016|NCT01356355|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6637017|NCT01356355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6637018|NCT01356355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6637019|NCT01356355|Cholinergic Agents|cholinergic agents|mesh-ancestor
6637020|NCT01356355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6637021|NCT01356355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637022|NCT01356355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637023|NCT01356355|Urological Agents|urological agents|mesh-ancestor
6637024|NCT01356368|Docetaxel|docetaxel|mesh-list
6637025|NCT01356368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6637026|NCT01356368|Tubulin Modulators|tubulin modulators|mesh-ancestor
6637027|NCT01356368|Antimitotic Agents|antimitotic agents|mesh-ancestor
6637028|NCT01356368|Mitosis Modulators|mitosis modulators|mesh-ancestor
6637029|NCT01356368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637030|NCT01356381|Vildagliptin|vildagliptin|mesh-list
6637031|NCT01356381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6637032|NCT01356381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637033|NCT01356381|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6637034|NCT01356381|Protease Inhibitors|protease inhibitors|mesh-ancestor
6637035|NCT01356381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6637036|NCT01356381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637037|NCT01356433|Vitamins|vitamins|mesh-list
6637038|NCT01356433|Ascorbic Acid|ascorbic acid|mesh-list
6637039|NCT01356433|Micronutrients|micronutrients|mesh-ancestor
6637040|NCT01356433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637041|NCT01356433|Antioxidants|antioxidants|mesh-ancestor
6637042|NCT01356433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637043|NCT01356433|Protective Agents|protective agents|mesh-ancestor
6637044|NCT01356472|Imipenem|imipenem|mesh-list
6637045|NCT01356472|Cilastatin|cilastatin|mesh-list
6637046|NCT01356472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6637047|NCT01356472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6637048|NCT01356472|Protease Inhibitors|protease inhibitors|mesh-ancestor
6637049|NCT01356472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6637050|NCT01356472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637051|NCT01356485|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6637052|NCT01356511|Dexamethasone|dexamethasone|mesh-list
5483541|NCT04328961|Ascorbic Acid|ascorbic acid|mesh-list
5483542|NCT04328961|Hydroxychloroquine|hydroxychloroquine|mesh-list
5483543|NCT04328961|Antimalarials|antimalarials|mesh-ancestor
5483544|NCT04328961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5483545|NCT04328961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5483546|NCT04328961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5483547|NCT04328961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5483548|NCT04328961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483549|NCT04328961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5483550|NCT04328961|Antioxidants|antioxidants|mesh-ancestor
5483551|NCT04328961|Protective Agents|protective agents|mesh-ancestor
5483552|NCT04328961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637053|NCT01356511|Prednisone|prednisone|mesh-list
6637054|NCT01356511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6637055|NCT01356511|Antiemetics|antiemetics|mesh-ancestor
6637056|NCT01356511|Autonomic Agents|autonomic agents|mesh-ancestor
6637057|NCT01356511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6637058|NCT01356511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637059|NCT01356511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6637060|NCT01356511|Glucocorticoids|glucocorticoids|mesh-ancestor
6637061|NCT01356511|Hormones|hormones|mesh-ancestor
6637062|NCT01356511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6637063|NCT01356511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6637064|NCT01356511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6637065|NCT01356524|Progesterone|progesterone|mesh-list
6637066|NCT01356524|Progestins|progestins|mesh-ancestor
6637067|NCT01356524|Hormones|hormones|mesh-ancestor
6637068|NCT01356524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6637069|NCT01356524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637070|NCT01356615|Heparin|heparin|mesh-list
6637071|NCT01356615|Calcium heparin|calcium heparin|mesh-list
6637072|NCT01356615|Enoxaparin|enoxaparin|mesh-list
6637073|NCT01356615|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6637074|NCT01356615|Tinzaparin|tinzaparin|mesh-list
6637075|NCT01356615|Dalteparin|dalteparin|mesh-list
6637076|NCT01356615|Enoxaparin sodium|enoxaparin sodium|mesh-list
6637077|NCT01356615|Anticoagulants|anticoagulants|mesh-ancestor
6637078|NCT01356615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6637079|NCT01356615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6637080|NCT01356615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637081|NCT01356641|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6637082|NCT01356641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6637083|NCT01356680|Prednisone|prednisone|mesh-list
6637084|NCT01356680|Cyclophosphamide|cyclophosphamide|mesh-list
6637085|NCT01356680|Dacarbazine|dacarbazine|mesh-list
6637086|NCT01356680|Etoposide|etoposide|mesh-list
6637087|NCT01356680|Vincristine|vincristine|mesh-list
6637088|NCT01356680|Doxorubicin|doxorubicin|mesh-list
6637089|NCT01356680|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6637090|NCT01356680|Bleomycin|bleomycin|mesh-list
6637091|NCT01356680|Vinblastine|vinblastine|mesh-list
6637092|NCT01356680|Procarbazine|procarbazine|mesh-list
6637093|NCT01356680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6637094|NCT01356680|Immunologic Factors|immunologic factors|mesh-ancestor
6637095|NCT01356680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637096|NCT01356680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6637097|NCT01356680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6637098|NCT01356680|Alkylating Agents|alkylating agents|mesh-ancestor
6637099|NCT01356680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637100|NCT01356680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6637101|NCT01356680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6637102|NCT01356680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6637103|NCT01356680|Glucocorticoids|glucocorticoids|mesh-ancestor
6637104|NCT01356680|Hormones|hormones|mesh-ancestor
6637105|NCT01356680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6637106|NCT01356680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6637107|NCT01356680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6637108|NCT01356680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6637109|NCT01356680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6637110|NCT01356680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6637111|NCT01356680|Tubulin Modulators|tubulin modulators|mesh-ancestor
6637112|NCT01356680|Antimitotic Agents|antimitotic agents|mesh-ancestor
6637113|NCT01356680|Mitosis Modulators|mitosis modulators|mesh-ancestor
6637114|NCT01356680|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6637115|NCT01356732|Sufentanil|sufentanil|mesh-list
6637116|NCT01356732|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6637117|NCT01356732|Narcotics|narcotics|mesh-ancestor
6637118|NCT01356732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6637119|NCT01356732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637120|NCT01356732|Analgesics|analgesics|mesh-ancestor
6637121|NCT01356732|Sensory System Agents|sensory system agents|mesh-ancestor
6637122|NCT01356732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6637123|NCT01356732|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6637124|NCT01356732|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6637125|NCT01356732|Anesthetics, General|anesthetics, general|mesh-ancestor
6637126|NCT01356732|Anesthetics|anesthetics|mesh-ancestor
6637127|NCT01356745|Nitrous Oxide|nitrous oxide|mesh-list
6637128|NCT01356745|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6637129|NCT01356745|Anesthetics, General|anesthetics, general|mesh-ancestor
6637130|NCT01356745|Anesthetics|anesthetics|mesh-ancestor
6637131|NCT01356745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6637132|NCT01356745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637133|NCT01356745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6637134|NCT01356745|Analgesics|analgesics|mesh-ancestor
6637135|NCT01356745|Sensory System Agents|sensory system agents|mesh-ancestor
6637136|NCT01356745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6637137|NCT01356758|Adalimumab|adalimumab|mesh-list
6637138|NCT01356758|Etanercept|etanercept|mesh-list
6637139|NCT01356758|Infliximab|infliximab|mesh-list
6637140|NCT01356758|Ustekinumab|ustekinumab|mesh-list
6637141|NCT01356758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6637142|NCT01356758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6637143|NCT01356758|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6637144|NCT01356758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6637145|NCT01356758|Analgesics|analgesics|mesh-ancestor
6637146|NCT01356758|Sensory System Agents|sensory system agents|mesh-ancestor
6637147|NCT01356758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6637148|NCT01356758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637149|NCT01356758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6637150|NCT01356758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6637151|NCT01356758|Immunologic Factors|immunologic factors|mesh-ancestor
6637152|NCT01356758|Dermatologic Agents|dermatologic agents|mesh-ancestor
6637153|NCT01356797|Fentanyl|fentanyl|mesh-list
6637154|NCT01356797|Bupivacaine|bupivacaine|mesh-list
6637155|NCT01356797|Levobupivacaine|levobupivacaine|mesh-list
6637156|NCT01356797|Anesthetics, Local|anesthetics, local|mesh-ancestor
6637157|NCT01356797|Anesthetics|anesthetics|mesh-ancestor
6637158|NCT01356797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6637159|NCT01356797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637160|NCT01356797|Sensory System Agents|sensory system agents|mesh-ancestor
6637161|NCT01356797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5483553|NCT04328961|Vitamins|vitamins|mesh-ancestor
5483554|NCT04328961|Micronutrients|micronutrients|mesh-ancestor
5483555|NCT04274361|Ketamine|ketamine|mesh-list
5483556|NCT04274361|Analgesics|analgesics|mesh-ancestor
5483557|NCT04274361|Sensory System Agents|sensory system agents|mesh-ancestor
5483558|NCT04274361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5483559|NCT04274361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483560|NCT04274361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5483561|NCT04274361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5483562|NCT04274361|Anesthetics, General|anesthetics, general|mesh-ancestor
5483563|NCT04274361|Anesthetics|anesthetics|mesh-ancestor
5483564|NCT04274361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5483565|NCT04274361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5483566|NCT04274361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5483567|NCT04274361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5483568|NCT04274361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483569|NCT04263792|Trimethoprim|trimethoprim|mesh-list
5483570|NCT04263792|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6637162|NCT01356797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6637163|NCT01356797|Narcotics|narcotics|mesh-ancestor
6637164|NCT01356797|Analgesics|analgesics|mesh-ancestor
6637165|NCT01356797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6637166|NCT01356797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6637167|NCT01356797|Anesthetics, General|anesthetics, general|mesh-ancestor
6637168|NCT01356862|Pasireotide|pasireotide|mesh-list
6637169|NCT01356862|Hormones|hormones|mesh-ancestor
6637170|NCT01356862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6637171|NCT01356862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637172|NCT01356927|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6637173|NCT01356927|Etonogestrel|etonogestrel|mesh-list
6637174|NCT01356927|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6637175|NCT01356927|Contraceptive Agents|contraceptive agents|mesh-ancestor
6637176|NCT01356927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6637177|NCT01356927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637178|NCT01356927|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6637179|NCT01356927|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6637180|NCT01356927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6637181|NCT01356927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6637182|NCT01356992|Enoxaparin|enoxaparin|mesh-list
6637183|NCT01356992|Anticoagulants|anticoagulants|mesh-ancestor
6637184|NCT01356992|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6637185|NCT01356992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6637186|NCT01356992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637187|NCT01357031|Amitriptyline|amitriptyline|mesh-list
6637188|NCT01357031|Melatonin|melatonin|mesh-list
6637189|NCT01357031|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6637190|NCT01357031|Antioxidants|antioxidants|mesh-ancestor
6637191|NCT01357031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637192|NCT01357031|Protective Agents|protective agents|mesh-ancestor
6637193|NCT01357031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637194|NCT01357031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6637195|NCT01357031|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6637196|NCT01357031|Antidepressive Agents|antidepressive agents|mesh-ancestor
6637197|NCT01357031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6637198|NCT01357031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6637199|NCT01357031|Analgesics|analgesics|mesh-ancestor
6637200|NCT01357031|Sensory System Agents|sensory system agents|mesh-ancestor
6637201|NCT01357031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6637202|NCT01357031|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6637203|NCT01357031|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6637204|NCT01357031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6637205|NCT01357031|Adrenergic Agents|adrenergic agents|mesh-ancestor
6637206|NCT01357031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6637207|NCT01357031|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6637208|NCT01357031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6637209|NCT01357109|Bosentan|bosentan|mesh-list
6637210|NCT01357109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6637211|NCT01357109|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6637212|NCT01357109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637213|NCT01357252|Vildagliptin|vildagliptin|mesh-list
6637214|NCT01357252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6637215|NCT01357252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637216|NCT01357252|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6637217|NCT01357252|Protease Inhibitors|protease inhibitors|mesh-ancestor
6637218|NCT01357252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6637219|NCT01357252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637220|NCT01357317|Calcium, Dietary|calcium, dietary|mesh-list
6637221|NCT01357317|Calcium|calcium|mesh-list
6637222|NCT01357317|Calcium acetate|calcium acetate|mesh-list
6637223|NCT01357317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6637224|NCT01357317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637225|NCT01357317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6637226|NCT01357317|Chelating Agents|chelating agents|mesh-ancestor
6637227|NCT01357317|Sequestering Agents|sequestering agents|mesh-ancestor
6637228|NCT01357317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637229|NCT01357486|Sorafenib|sorafenib|mesh-list
6637230|NCT01357486|Pravastatin|pravastatin|mesh-list
6637231|NCT01357486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6637232|NCT01357486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6637233|NCT01357486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6637234|NCT01357486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637235|NCT01357486|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6637236|NCT01357486|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6637237|NCT01357486|Antimetabolites|antimetabolites|mesh-ancestor
6637238|NCT01357486|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6637239|NCT01357486|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6637240|NCT01357603|Insulin Glargine|insulin glargine|mesh-list
6637241|NCT01357603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6637242|NCT01357603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637243|NCT01357681|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
6637244|NCT01357681|Antioxidants|antioxidants|mesh-ancestor
6637245|NCT01357681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637246|NCT01357681|Protective Agents|protective agents|mesh-ancestor
6637247|NCT01357681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637248|NCT01357681|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
6637249|NCT01357681|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6637250|NCT01357681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6637251|NCT01357681|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6637252|NCT01357694|Psychotropic Drugs|psychotropic drugs|mesh-list
6637253|NCT01357772|Tamoxifen|tamoxifen|mesh-list
6637254|NCT01357772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6637255|NCT01357772|Hormone Antagonists|hormone antagonists|mesh-ancestor
6637256|NCT01357772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6637257|NCT01357772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637258|NCT01357772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6637259|NCT01357772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6637260|NCT01357772|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6637261|NCT01357772|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5483571|NCT04263792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5483572|NCT04263792|Renal Agents|renal agents|mesh-ancestor
5483573|NCT04263792|Antimalarials|antimalarials|mesh-ancestor
6637262|NCT01357772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6637263|NCT01357798|Botulinum Toxins|botulinum toxins|mesh-list
6637264|NCT01357798|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6637265|NCT01357798|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6637266|NCT01357798|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6637267|NCT01357798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6637268|NCT01357798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637269|NCT01357798|Cholinergic Agents|cholinergic agents|mesh-ancestor
6637270|NCT01357798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6637271|NCT01357798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637272|NCT01357798|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6637273|NCT01357798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6637274|NCT01357811|Digoxin|digoxin|mesh-list
6637275|NCT01357811|Eliglustat|eliglustat|mesh-list
6637276|NCT01357811|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6637277|NCT01357811|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6637278|NCT01357811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6637279|NCT01357811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637280|NCT01357811|Protective Agents|protective agents|mesh-ancestor
6637281|NCT01357811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637282|NCT01357876|Metformin|metformin|mesh-list
6637283|NCT01357876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6637284|NCT01357876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637285|NCT01357902|Lamotrigine|lamotrigine|mesh-list
6637286|NCT01357902|Anticonvulsants|anticonvulsants|mesh-ancestor
6637287|NCT01357902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5483574|NCT04263792|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5483575|NCT04263792|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5483576|NCT04263792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5483577|NCT04263792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5483578|NCT04263792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483579|NCT04263792|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5483580|NCT04263792|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
5483581|NCT04263792|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5483582|NCT04259996|Estradiol|estradiol|mesh-list
5483583|NCT04259996|Progesterone|progesterone|mesh-list
5483584|NCT04259996|Estrogens|estrogens|mesh-ancestor
5483585|NCT04259996|Hormones|hormones|mesh-ancestor
5483586|NCT04259996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5483587|NCT04259996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483588|NCT04259996|Progestins|progestins|mesh-ancestor
5483589|NCT04253626|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
5483590|NCT04253626|Hematinics|hematinics|mesh-ancestor
5483591|NCT04253626|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5483592|NCT04253626|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5483593|NCT04210349|Vaccines|vaccines|mesh-list
5483594|NCT04210349|Immunologic Factors|immunologic factors|mesh-ancestor
6637288|NCT01357902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6637289|NCT01357902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637290|NCT01357902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6637291|NCT01357902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637292|NCT01357902|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6637293|NCT01357902|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6637294|NCT01357902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6637295|NCT01357902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6637296|NCT01357902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6637297|NCT01357967|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6637298|NCT01357967|Antidepressive Agents|antidepressive agents|mesh-ancestor
6637299|NCT01357967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6637300|NCT01357967|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6637301|NCT01357967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6637302|NCT01357967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6637303|NCT01357967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663187|NCT01506622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6663188|NCT01506622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6663189|NCT01506622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663190|NCT01506622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6663191|NCT01506622|Anesthetics, General|anesthetics, general|mesh-ancestor
6663192|NCT01506622|Anesthetics|anesthetics|mesh-ancestor
6663193|NCT01506622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6663194|NCT01506622|Narcotics|narcotics|mesh-ancestor
6663195|NCT01506622|Analgesics|analgesics|mesh-ancestor
6663196|NCT01506622|Sensory System Agents|sensory system agents|mesh-ancestor
6663197|NCT01506622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6663198|NCT01506622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6663199|NCT01506635|Timolol|timolol|mesh-list
6663200|NCT01506635|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6663201|NCT01506635|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6663202|NCT01506635|Adrenergic Agents|adrenergic agents|mesh-ancestor
6663203|NCT01506635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6663204|NCT01506635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663205|NCT01506635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663206|NCT01506635|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6663207|NCT01506635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6663208|NCT01506713|Clopidogrel|clopidogrel|mesh-list
6663209|NCT01506713|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6663210|NCT01506713|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6663211|NCT01506713|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6663212|NCT01506713|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6663213|NCT01506713|Purinergic Agents|purinergic agents|mesh-ancestor
6663214|NCT01506713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5483595|NCT04210349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483596|NCT04192136|Niacinamide|niacinamide|mesh-list
6665047|NCT01515553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483597|NCT04192136|Niacin|niacin|mesh-list
6637304|NCT01358045|Calcitriol|calcitriol|mesh-list
6637305|NCT01358045|Diclofenac|diclofenac|mesh-list
6637306|NCT01358045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6637307|NCT01358045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6637308|NCT01358045|Analgesics|analgesics|mesh-ancestor
5483598|NCT04192136|Nicotinic Acids|nicotinic acids|mesh-list
5483599|NCT04192136|Vitamin B Complex|vitamin b complex|mesh-ancestor
6637309|NCT01358045|Sensory System Agents|sensory system agents|mesh-ancestor
6637310|NCT01358045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6637311|NCT01358045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637312|NCT01358045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6637313|NCT01358045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6637314|NCT01358045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6637315|NCT01358045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6637316|NCT01358045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637317|NCT01358045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6637318|NCT01358045|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6637319|NCT01358045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6637320|NCT01358045|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6637321|NCT01358045|Vitamins|vitamins|mesh-ancestor
6637322|NCT01358045|Micronutrients|micronutrients|mesh-ancestor
6637323|NCT01358045|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6637324|NCT01358071|Doxorubicin|doxorubicin|mesh-list
6637325|NCT01358071|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6637326|NCT01358071|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6637327|NCT01358071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6637328|NCT01358071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6637329|NCT01358071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6637330|NCT01358071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6637331|NCT01358071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637332|NCT01358240|Econazole|econazole|mesh-list
6637333|NCT01358240|Antifungal Agents|antifungal agents|mesh-ancestor
6637334|NCT01358240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6637335|NCT01358240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6637336|NCT01358240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6637337|NCT01358240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6637338|NCT01358240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637339|NCT01358240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6637340|NCT01358240|Hormone Antagonists|hormone antagonists|mesh-ancestor
6637341|NCT01358240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6637342|NCT01358240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637343|NCT01358253|Cytarabine|cytarabine|mesh-list
6637344|NCT01358253|Dexamethasone|dexamethasone|mesh-list
6637345|NCT01358253|Prednisone|prednisone|mesh-list
6637346|NCT01358253|Cyclophosphamide|cyclophosphamide|mesh-list
6637347|NCT01358253|Rituximab|rituximab|mesh-list
6637348|NCT01358253|Doxorubicin|doxorubicin|mesh-list
6637349|NCT01358253|Methotrexate|methotrexate|mesh-list
6637350|NCT01358253|Vincristine|vincristine|mesh-list
6637351|NCT01358253|Asparaginase|asparaginase|mesh-list
6637352|NCT01358253|Mercaptopurine|mercaptopurine|mesh-list
6637353|NCT01358253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6637354|NCT01358253|Immunologic Factors|immunologic factors|mesh-ancestor
6637355|NCT01358253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637356|NCT01358253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6637357|NCT01358253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6637358|NCT01358253|Alkylating Agents|alkylating agents|mesh-ancestor
6665048|NCT01515553|Incretins|incretins|mesh-ancestor
6637359|NCT01358253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637360|NCT01358253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6637361|NCT01358253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6637362|NCT01358253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6637363|NCT01358253|Antiemetics|antiemetics|mesh-ancestor
6637364|NCT01358253|Autonomic Agents|autonomic agents|mesh-ancestor
6637365|NCT01358253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6637366|NCT01358253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6637367|NCT01358253|Glucocorticoids|glucocorticoids|mesh-ancestor
6637368|NCT01358253|Hormones|hormones|mesh-ancestor
6637369|NCT01358253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6637370|NCT01358253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6637371|NCT01358253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6637372|NCT01358253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6637373|NCT01358253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6637374|NCT01358253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6637375|NCT01358253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6637376|NCT01358253|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6637377|NCT01358253|Abortifacient Agents|abortifacient agents|mesh-ancestor
6637378|NCT01358253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6637379|NCT01358253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6637380|NCT01358253|Antimetabolites|antimetabolites|mesh-ancestor
6637381|NCT01358253|Dermatologic Agents|dermatologic agents|mesh-ancestor
6637382|NCT01358253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6637383|NCT01358253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6637384|NCT01358253|Antiviral Agents|antiviral agents|mesh-ancestor
6637385|NCT01358253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6637386|NCT01358253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6637387|NCT01358253|Tubulin Modulators|tubulin modulators|mesh-ancestor
6637388|NCT01358253|Antimitotic Agents|antimitotic agents|mesh-ancestor
6637389|NCT01358253|Mitosis Modulators|mitosis modulators|mesh-ancestor
6637390|NCT01358344|Pantoprazole|pantoprazole|mesh-list
5483600|NCT04192136|Vitamins|vitamins|mesh-ancestor
5483601|NCT04192136|Micronutrients|micronutrients|mesh-ancestor
5483602|NCT04192136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483603|NCT04192136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5483604|NCT04192136|Antimetabolites|antimetabolites|mesh-ancestor
5483605|NCT04192136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637391|NCT01358344|Vorapaxar|vorapaxar|mesh-list
6637392|NCT01358344|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6637393|NCT01358344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6637394|NCT01358344|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6637395|NCT01358344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6637396|NCT01358344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637397|NCT01358344|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6637398|NCT01358383|Naproxen|naproxen|mesh-list
6637399|NCT01358383|Esomeprazole|esomeprazole|mesh-list
6637400|NCT01358383|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6637401|NCT01358383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6637402|NCT01358383|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6637403|NCT01358383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6637404|NCT01358383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637405|NCT01358383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6637406|NCT01358383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6637407|NCT01358383|Analgesics|analgesics|mesh-ancestor
6637408|NCT01358383|Sensory System Agents|sensory system agents|mesh-ancestor
6637409|NCT01358383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6637410|NCT01358383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637411|NCT01358383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6637412|NCT01358383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6637413|NCT01358383|Gout Suppressants|gout suppressants|mesh-ancestor
6637414|NCT01358383|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6637415|NCT01358409|Nebivolol|nebivolol|mesh-list
6637416|NCT01358409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6637417|NCT01358409|Vasodilator Agents|vasodilator agents|mesh-ancestor
6637418|NCT01358409|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5483606|NCT04192136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5483607|NCT04192136|Vasodilator Agents|vasodilator agents|mesh-ancestor
5483608|NCT04142983|Vaccines|vaccines|mesh-list
6637419|NCT01358409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6637420|NCT01358409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6637421|NCT01358409|Adrenergic Agents|adrenergic agents|mesh-ancestor
6637422|NCT01358409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6637423|NCT01358409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637424|NCT01358409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637425|NCT01358435|Insulin|insulin|mesh-list
6637426|NCT01358435|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6637427|NCT01358435|Insulin, Isophane|insulin, isophane|mesh-list
6637428|NCT01358435|Isophane Insulin, Human|isophane insulin, human|mesh-list
6637429|NCT01358435|Isophane insulin, beef|isophane insulin, beef|mesh-list
6637430|NCT01358435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6637431|NCT01358435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637432|NCT01358500|Fentanyl|fentanyl|mesh-list
6637433|NCT01358500|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6637434|NCT01358500|Narcotics|narcotics|mesh-ancestor
6637435|NCT01358500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6637436|NCT01358500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637437|NCT01358500|Analgesics|analgesics|mesh-ancestor
6637438|NCT01358500|Sensory System Agents|sensory system agents|mesh-ancestor
6637439|NCT01358500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6637440|NCT01358500|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6637441|NCT01358500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6637442|NCT01358500|Anesthetics, General|anesthetics, general|mesh-ancestor
6637443|NCT01358500|Anesthetics|anesthetics|mesh-ancestor
6637444|NCT01358591|Calcium Carbonate|calcium carbonate|mesh-list
6637445|NCT01358591|Calcium|calcium|mesh-list
6637446|NCT01358591|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6637447|NCT01358591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637448|NCT01358591|Antacids|antacids|mesh-ancestor
6637449|NCT01358591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637450|NCT01358591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6637451|NCT01358812|Panitumumab|panitumumab|mesh-list
6637452|NCT01358812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6637453|NCT01358812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6637454|NCT01358916|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6637455|NCT01358916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6637456|NCT01359020|Acetaminophen|acetaminophen|mesh-list
6637457|NCT01359020|Dipyrone|dipyrone|mesh-list
6637458|NCT01359020|Ibuprofen|ibuprofen|mesh-list
6637459|NCT01359020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6637460|NCT01359020|Analgesics|analgesics|mesh-ancestor
6637461|NCT01359020|Sensory System Agents|sensory system agents|mesh-ancestor
6637462|NCT01359020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6637463|NCT01359020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637464|NCT01359020|Antipyretics|antipyretics|mesh-ancestor
6637465|NCT01359020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6637466|NCT01359020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6637467|NCT01359020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6637468|NCT01359020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6637469|NCT01359020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6637470|NCT01359020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637471|NCT01359059|Pregabalin|pregabalin|mesh-list
6637472|NCT01359059|Analgesics|analgesics|mesh-ancestor
6637473|NCT01359059|Sensory System Agents|sensory system agents|mesh-ancestor
6637474|NCT01359059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6637475|NCT01359059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637476|NCT01359059|Anticonvulsants|anticonvulsants|mesh-ancestor
6637477|NCT01359059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6637478|NCT01359059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6637479|NCT01359059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637480|NCT01359059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6637481|NCT01359059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6637482|NCT01359059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6637483|NCT01359059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6637484|NCT01359059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6637485|NCT01359085|Pregabalin|pregabalin|mesh-list
6637486|NCT01359085|Analgesics|analgesics|mesh-ancestor
6637487|NCT01359085|Sensory System Agents|sensory system agents|mesh-ancestor
6637488|NCT01359085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6637489|NCT01359085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637490|NCT01359085|Anticonvulsants|anticonvulsants|mesh-ancestor
6637491|NCT01359085|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6637492|NCT01359085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6637493|NCT01359085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637494|NCT01359085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6637495|NCT01359085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6637496|NCT01359085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6637497|NCT01359085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6637498|NCT01359085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5483609|NCT04142983|Immunologic Factors|immunologic factors|mesh-ancestor
5483610|NCT04142983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483611|NCT04076579|Olaparib|olaparib|mesh-list
5483612|NCT04076579|Trabectedin|trabectedin|mesh-list
5483613|NCT04076579|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5483614|NCT04076579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5483615|NCT04076579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483616|NCT04076579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5483617|NCT04076579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5483618|NCT04076579|Alkylating Agents|alkylating agents|mesh-ancestor
6637499|NCT01359098|Ciprofloxacin|ciprofloxacin|mesh-list
6637500|NCT01359098|Dexamethasone|dexamethasone|mesh-list
6637501|NCT01359098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6637502|NCT01359098|Antiemetics|antiemetics|mesh-ancestor
6637503|NCT01359098|Autonomic Agents|autonomic agents|mesh-ancestor
6637504|NCT01359098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5483619|NCT04047472|Aflibercept|aflibercept|mesh-list
5483620|NCT04047472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5483621|NCT04047472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5483622|NCT04047472|Growth Substances|growth substances|mesh-ancestor
5483623|NCT04047472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483624|NCT04047472|Growth Inhibitors|growth inhibitors|mesh-ancestor
5483625|NCT04047472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5483626|NCT04031846|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5483627|NCT04031846|Immunologic Factors|immunologic factors|mesh-ancestor
5483628|NCT04031846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483629|NCT04028362|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
5483630|NCT04028362|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5483631|NCT04028362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5483632|NCT04028362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483633|NCT03971071|Erenumab|erenumab|mesh-list
6637505|NCT01359098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637506|NCT01359098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6637507|NCT01359098|Glucocorticoids|glucocorticoids|mesh-ancestor
6637508|NCT01359098|Hormones|hormones|mesh-ancestor
6637509|NCT01359098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6637510|NCT01359098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6637511|NCT01359098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6637512|NCT01359098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6637513|NCT01359098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637514|NCT01359098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6637515|NCT01359098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6637516|NCT01359098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6637517|NCT01359098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6637518|NCT01359098|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6637519|NCT01359098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6637520|NCT01359163|Ethynodiol Diacetate|ethynodiol diacetate|mesh-list
6637521|NCT01359163|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6637522|NCT01359163|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6637523|NCT01359163|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6637524|NCT01359163|Contraceptive Agents|contraceptive agents|mesh-ancestor
6637525|NCT01359163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6637526|NCT01359163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637527|NCT01359163|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6637528|NCT01359163|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6637529|NCT01359202|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6637530|NCT01359228|Rifaximin|rifaximin|mesh-list
5483634|NCT03971071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5483635|NCT03971071|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
5483636|NCT03971071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483637|NCT03971071|Analgesics|analgesics|mesh-ancestor
5483638|NCT03971071|Sensory System Agents|sensory system agents|mesh-ancestor
5483639|NCT03971071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5483640|NCT03971071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483641|NCT03971071|Immunologic Factors|immunologic factors|mesh-ancestor
5483642|NCT03945448|Fluconazole|fluconazole|mesh-list
5483643|NCT03945448|Amphotericin B|amphotericin b|mesh-list
5483644|NCT03945448|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
5483645|NCT03945448|Antifungal Agents|antifungal agents|mesh-ancestor
5483646|NCT03945448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5502466|NCT04466280|Antimalarials|antimalarials|mesh-ancestor
6637531|NCT01359228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6637532|NCT01359228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6637533|NCT01359228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6637534|NCT01359241|Insulin|insulin|mesh-list
6637535|NCT01359241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6637536|NCT01359241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637537|NCT01359397|Bevacizumab|bevacizumab|mesh-list
6637538|NCT01359397|Trastuzumab|trastuzumab|mesh-list
6637539|NCT01359397|Docetaxel|docetaxel|mesh-list
6637540|NCT01359397|Oxaliplatin|oxaliplatin|mesh-list
6637541|NCT01359397|Capecitabine|capecitabine|mesh-list
6637542|NCT01359397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6637543|NCT01359397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6637544|NCT01359397|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6637545|NCT01359397|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6637546|NCT01359397|Growth Substances|growth substances|mesh-ancestor
6637547|NCT01359397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637548|NCT01359397|Growth Inhibitors|growth inhibitors|mesh-ancestor
6637549|NCT01359397|Tubulin Modulators|tubulin modulators|mesh-ancestor
6637550|NCT01359397|Antimitotic Agents|antimitotic agents|mesh-ancestor
6637551|NCT01359397|Mitosis Modulators|mitosis modulators|mesh-ancestor
6637552|NCT01359397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6452239|NCT00416130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6452240|NCT00416143|Prednisone|prednisone|mesh-list
6452241|NCT00416143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5483647|NCT03945448|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5483648|NCT03945448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5483649|NCT03945448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6452242|NCT00416143|Glucocorticoids|glucocorticoids|mesh-ancestor
6452243|NCT00416143|Hormones|hormones|mesh-ancestor
6452244|NCT00416143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6637553|NCT01359397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6637554|NCT01359397|Antimetabolites|antimetabolites|mesh-ancestor
6637555|NCT01359423|Cilostazol|cilostazol|mesh-list
6637556|NCT01359423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6637557|NCT01359423|Autonomic Agents|autonomic agents|mesh-ancestor
6637558|NCT01359423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6637559|NCT01359423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637560|NCT01359423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6637561|NCT01359423|Respiratory System Agents|respiratory system agents|mesh-ancestor
6637562|NCT01359423|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6637563|NCT01359423|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6637564|NCT01359423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637565|NCT01359423|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6637566|NCT01359423|Vasodilator Agents|vasodilator agents|mesh-ancestor
6637567|NCT01359423|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6637568|NCT01359423|Protective Agents|protective agents|mesh-ancestor
6637569|NCT01359423|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6637570|NCT01359423|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6637571|NCT01359423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6637572|NCT01359436|Antibodies|antibodies|mesh-list
6637573|NCT01359436|Immunologic Factors|immunologic factors|mesh-ancestor
6637574|NCT01359436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637575|NCT01359462|Tolvaptan|tolvaptan|mesh-list
6637576|NCT01359462|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6637577|NCT01359462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637578|NCT01359462|Natriuretic Agents|natriuretic agents|mesh-ancestor
6637579|NCT01359462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452245|NCT00416143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452246|NCT00416143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6452247|NCT00416143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6452248|NCT00416169|Galantamine|galantamine|mesh-list
6452249|NCT00416169|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6452250|NCT00416169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6452251|NCT00416169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6452252|NCT00416169|Cholinergic Agents|cholinergic agents|mesh-ancestor
6452253|NCT00416169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6452254|NCT00416169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452255|NCT00416169|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6452256|NCT00416169|Autonomic Agents|autonomic agents|mesh-ancestor
6452257|NCT00416169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6452258|NCT00416169|Nootropic Agents|nootropic agents|mesh-ancestor
6452259|NCT00416208|Bortezomib|bortezomib|mesh-list
6452260|NCT00416208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6452261|NCT00416221|Citalopram|citalopram|mesh-list
6452262|NCT00416221|Antidepressive Agents|antidepressive agents|mesh-list
5483650|NCT03945448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637580|NCT01359488|Hormones|hormones|mesh-list
6637581|NCT01359488|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
6637582|NCT01359488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6637583|NCT01359488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637584|NCT01359514|Pregabalin|pregabalin|mesh-list
6637585|NCT01359514|Calcium Channel Blockers|calcium channel blockers|mesh-list
6637586|NCT01359514|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6637587|NCT01359514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6637588|NCT01359514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637589|NCT01359514|Analgesics|analgesics|mesh-ancestor
6637590|NCT01359514|Sensory System Agents|sensory system agents|mesh-ancestor
6637591|NCT01359514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6637592|NCT01359514|Anticonvulsants|anticonvulsants|mesh-ancestor
6637593|NCT01359514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6637594|NCT01359514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637595|NCT01359514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6637596|NCT01359514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5483651|NCT03945448|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5483652|NCT03945448|Hormone Antagonists|hormone antagonists|mesh-ancestor
6637597|NCT01359514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6637598|NCT01359514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6637599|NCT01359514|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6637600|NCT01359514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6637601|NCT01359514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6637602|NCT01359514|Antidepressive Agents|antidepressive agents|mesh-ancestor
6637603|NCT01359514|Dopamine Agents|dopamine agents|mesh-ancestor
6637604|NCT01359579|Varespladib methyl|varespladib methyl|mesh-list
6637605|NCT01359579|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
6637606|NCT01359579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6637607|NCT01359579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637608|NCT01359605|Varespladib methyl|varespladib methyl|mesh-list
6637609|NCT01359605|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
6637610|NCT01359605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6637611|NCT01359605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637612|NCT01359618|Moxifloxacin|moxifloxacin|mesh-list
6637613|NCT01359618|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6637614|NCT01359618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6637615|NCT01359618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6637616|NCT01359618|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6637617|NCT01359618|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6637618|NCT01359618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6637619|NCT01359618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483653|NCT03945448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5483654|NCT03945448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483655|NCT03945448|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5483656|NCT03945448|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5483657|NCT03945448|Amebicides|amebicides|mesh-ancestor
6637620|NCT01359618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6637621|NCT01359618|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6637622|NCT01359618|Contraceptive Agents|contraceptive agents|mesh-ancestor
5483658|NCT03945448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5483659|NCT03945448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5483660|NCT03945448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5483661|NCT03909334|Osimertinib|osimertinib|mesh-list
5483662|NCT03909334|Ramucirumab|ramucirumab|mesh-list
5483663|NCT03909334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5483664|NCT03909334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5483665|NCT03909334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5483666|NCT03909334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483667|NCT03829722|Paclitaxel|paclitaxel|mesh-list
5483668|NCT03829722|Carboplatin|carboplatin|mesh-list
5483669|NCT03829722|Nivolumab|nivolumab|mesh-list
5483670|NCT03829722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5483671|NCT03829722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5483672|NCT03829722|Tubulin Modulators|tubulin modulators|mesh-ancestor
5483673|NCT03829722|Antimitotic Agents|antimitotic agents|mesh-ancestor
5483674|NCT03829722|Mitosis Modulators|mitosis modulators|mesh-ancestor
5483675|NCT03829722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483676|NCT03829722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5483677|NCT03829722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6637623|NCT01359618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6637624|NCT01359618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637625|NCT01359618|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6637626|NCT01359618|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6637627|NCT01359618|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6637628|NCT01359657|Dexamethasone|dexamethasone|mesh-list
6637629|NCT01359657|Dexamethasone acetate|dexamethasone acetate|mesh-list
6637630|NCT01359657|Lenalidomide|lenalidomide|mesh-list
6637631|NCT01359657|Bortezomib|bortezomib|mesh-list
6637632|NCT01359657|BB 1101|bb 1101|mesh-list
6637633|NCT01359657|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6637634|NCT01359657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6637635|NCT01359657|Antiemetics|antiemetics|mesh-ancestor
6637636|NCT01359657|Autonomic Agents|autonomic agents|mesh-ancestor
6637637|NCT01359657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6637638|NCT01359657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637639|NCT01359657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6637640|NCT01359657|Glucocorticoids|glucocorticoids|mesh-ancestor
6637641|NCT01359657|Hormones|hormones|mesh-ancestor
6637642|NCT01359657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6637643|NCT01359657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6637644|NCT01359657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6637645|NCT01359657|Protease Inhibitors|protease inhibitors|mesh-ancestor
6637646|NCT01359657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6637647|NCT01359657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637648|NCT01359657|Immunologic Factors|immunologic factors|mesh-ancestor
6637649|NCT01359657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6637650|NCT01359657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6637651|NCT01359657|Growth Substances|growth substances|mesh-ancestor
6637652|NCT01359657|Growth Inhibitors|growth inhibitors|mesh-ancestor
6637653|NCT01359670|Sildenafil Citrate|sildenafil citrate|mesh-list
6637654|NCT01359670|Tadalafil|tadalafil|mesh-list
6637655|NCT01359670|Vasodilator Agents|vasodilator agents|mesh-ancestor
6637656|NCT01359670|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6637657|NCT01359670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6637658|NCT01359670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6637659|NCT01359670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637660|NCT01359670|Urological Agents|urological agents|mesh-ancestor
6663215|NCT01506713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663216|NCT01506713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663217|NCT01506739|Donepezil|donepezil|mesh-list
6663218|NCT01506739|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6663219|NCT01506739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6663220|NCT01506739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663221|NCT01506739|Cholinergic Agents|cholinergic agents|mesh-ancestor
6663222|NCT01506739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6663223|NCT01506739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663224|NCT01506739|Nootropic Agents|nootropic agents|mesh-ancestor
6663225|NCT01506752|Donepezil|donepezil|mesh-list
6663226|NCT01506752|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6663227|NCT01506752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6663228|NCT01506752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663229|NCT01506752|Cholinergic Agents|cholinergic agents|mesh-ancestor
6663230|NCT01506752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6663231|NCT01506752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663232|NCT01506752|Nootropic Agents|nootropic agents|mesh-ancestor
6663233|NCT01506765|Acetylcysteine|acetylcysteine|mesh-list
6663234|NCT01506765|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6663235|NCT01506765|Antiviral Agents|antiviral agents|mesh-ancestor
6663236|NCT01506765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6663237|NCT01506765|Expectorants|expectorants|mesh-ancestor
6663238|NCT01506765|Respiratory System Agents|respiratory system agents|mesh-ancestor
6663239|NCT01506765|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6663240|NCT01506765|Antioxidants|antioxidants|mesh-ancestor
6663241|NCT01506765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663242|NCT01506765|Protective Agents|protective agents|mesh-ancestor
6663243|NCT01506765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663244|NCT01506765|Antidotes|antidotes|mesh-ancestor
6663245|NCT01506791|Pseudoephedrine|pseudoephedrine|mesh-list
6663246|NCT01506791|Ephedrine|ephedrine|mesh-list
6663247|NCT01506791|Desloratadine|desloratadine|mesh-list
6663248|NCT01506791|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6663249|NCT01506791|Cholinergic Agents|cholinergic agents|mesh-ancestor
6663250|NCT01506791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6663251|NCT01506791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665049|NCT01515553|Hormones|hormones|mesh-ancestor
5483678|NCT03818399|Buprenorphine|buprenorphine|mesh-list
5483679|NCT03818399|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5483680|NCT03818399|Narcotics|narcotics|mesh-ancestor
5483681|NCT03818399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5483682|NCT03818399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637661|NCT01359696|Gemcitabine|gemcitabine|mesh-list
6637662|NCT01359696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6637663|NCT01359696|Antimetabolites|antimetabolites|mesh-ancestor
6637664|NCT01359696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637665|NCT01359696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6637666|NCT01359696|Antiviral Agents|antiviral agents|mesh-ancestor
6637667|NCT01359696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6637668|NCT01359696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6637669|NCT01359696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5483683|NCT03818399|Analgesics|analgesics|mesh-ancestor
5483684|NCT03818399|Sensory System Agents|sensory system agents|mesh-ancestor
5483685|NCT03818399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5483686|NCT03818399|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5483687|NCT03782636|Aldesleukin|aldesleukin|mesh-list
5483688|NCT03782636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6637670|NCT01359696|Immunologic Factors|immunologic factors|mesh-ancestor
6637671|NCT01359696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637672|NCT01359709|Nicotine|nicotine|mesh-list
6637673|NCT01359709|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5483689|NCT03782636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5483690|NCT03782636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5483691|NCT03782636|Antiviral Agents|antiviral agents|mesh-ancestor
5483692|NCT03782636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5483693|NCT03761810|Tretinoin|tretinoin|mesh-list
5483694|NCT03761810|Benzoyl Peroxide|benzoyl peroxide|mesh-list
5483695|NCT03761810|Dermatologic Agents|dermatologic agents|mesh-ancestor
5483696|NCT03761810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5483697|NCT03761810|Keratolytic Agents|keratolytic agents|mesh-ancestor
5483698|NCT03761784|Tretinoin|tretinoin|mesh-list
5483699|NCT03761784|Benzoyl Peroxide|benzoyl peroxide|mesh-list
5483700|NCT03761784|Dermatologic Agents|dermatologic agents|mesh-ancestor
5483701|NCT03761784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5483702|NCT03761784|Keratolytic Agents|keratolytic agents|mesh-ancestor
5483703|NCT03739099|Pancrelipase|pancrelipase|mesh-list
5483704|NCT03739099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5483705|NCT03703778|Ascorbic Acid|ascorbic acid|mesh-list
5483706|NCT03703778|Methyltestosterone|methyltestosterone|mesh-list
5483707|NCT03703778|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
5483708|NCT03703778|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
5483709|NCT03703778|Androgens|androgens|mesh-list
6637674|NCT01359709|Autonomic Agents|autonomic agents|mesh-ancestor
6637675|NCT01359709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6637676|NCT01359709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637677|NCT01359709|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6637678|NCT01359709|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6637679|NCT01359709|Cholinergic Agents|cholinergic agents|mesh-ancestor
6637680|NCT01359709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6637681|NCT01359709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637682|NCT01359722|Acetylcysteine|acetylcysteine|mesh-list
6637683|NCT01359722|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6637684|NCT01359722|Antiviral Agents|antiviral agents|mesh-ancestor
6637685|NCT01359722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6637686|NCT01359722|Expectorants|expectorants|mesh-ancestor
6637687|NCT01359722|Respiratory System Agents|respiratory system agents|mesh-ancestor
6637688|NCT01359722|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6637689|NCT01359722|Antioxidants|antioxidants|mesh-ancestor
6637690|NCT01359722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637691|NCT01359722|Protective Agents|protective agents|mesh-ancestor
5483710|NCT03703778|Hormones|hormones|mesh-ancestor
5483711|NCT03703778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6637692|NCT01359722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483712|NCT03703778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483713|NCT03703778|Antioxidants|antioxidants|mesh-ancestor
6637693|NCT01359722|Antidotes|antidotes|mesh-ancestor
6637694|NCT01359826|Milnacipran|milnacipran|mesh-list
6637695|NCT01359826|Levomilnacipran|levomilnacipran|mesh-list
6637696|NCT01359826|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5483714|NCT03703778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483715|NCT03703778|Protective Agents|protective agents|mesh-ancestor
5483716|NCT03703778|Vitamins|vitamins|mesh-ancestor
5483717|NCT03703778|Micronutrients|micronutrients|mesh-ancestor
5483718|NCT03703778|Estrogens|estrogens|mesh-ancestor
5483719|NCT03703778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5483720|NCT03703778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5483721|NCT03703778|Anabolic Agents|anabolic agents|mesh-ancestor
5483722|NCT03702283|Penicillins|penicillins|mesh-list
5483723|NCT03702283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5483724|NCT03702283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5483725|NCT03684785|Pembrolizumab|pembrolizumab|mesh-list
5483726|NCT03684785|Cemiplimab|cemiplimab|mesh-list
5483727|NCT03684785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5483728|NCT03684785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6452263|NCT00416221|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6637697|NCT01359826|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6637698|NCT01359826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6637699|NCT01359826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637700|NCT01359826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6637701|NCT01359826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021052|NCT00396318|Tenecteplase|tenecteplase|mesh-list
6021053|NCT00396318|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6021054|NCT00396318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6021055|NCT00396318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021056|NCT00396331|Plerixafor|plerixafor|mesh-list
6021057|NCT00396331|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6021058|NCT00396331|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6021059|NCT00396331|Antiviral Agents|antiviral agents|mesh-ancestor
6021060|NCT00396331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6021061|NCT00396383|Plerixafor|plerixafor|mesh-list
6021062|NCT00396383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6021063|NCT00396383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6021064|NCT00396383|Antiviral Agents|antiviral agents|mesh-ancestor
6021065|NCT00396383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6021066|NCT00396409|Omalizumab|omalizumab|mesh-list
6021067|NCT00396409|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6021068|NCT00396409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6452264|NCT00416221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6452265|NCT00416221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6452266|NCT00416221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6452267|NCT00416221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6452268|NCT00416221|Serotonin Agents|serotonin agents|mesh-ancestor
6452269|NCT00416221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452270|NCT00416221|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6452271|NCT00416221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6452272|NCT00416273|Bortezomib|bortezomib|mesh-list
6452273|NCT00416273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6452274|NCT00416325|Lycopene|lycopene|mesh-list
6452275|NCT00416325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6452276|NCT00416325|Antioxidants|antioxidants|mesh-ancestor
6452277|NCT00416325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6452278|NCT00416325|Protective Agents|protective agents|mesh-ancestor
6452279|NCT00416325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452280|NCT00416325|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6452281|NCT00416325|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6021069|NCT00396409|Respiratory System Agents|respiratory system agents|mesh-ancestor
6021070|NCT00396565|Olanzapine|olanzapine|mesh-list
6021071|NCT00396565|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6021072|NCT00396565|Antiemetics|antiemetics|mesh-ancestor
6021073|NCT00396565|Autonomic Agents|autonomic agents|mesh-ancestor
6637702|NCT01359826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6637703|NCT01359826|Analgesics|analgesics|mesh-ancestor
6637704|NCT01359826|Sensory System Agents|sensory system agents|mesh-ancestor
6637705|NCT01359826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6637706|NCT01359826|Antidepressive Agents|antidepressive agents|mesh-ancestor
6637707|NCT01359826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6637708|NCT01359930|Naltrexone|naltrexone|mesh-list
6637709|NCT01359930|Bupropion|bupropion|mesh-list
6637710|NCT01359930|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6637711|NCT01359930|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6637712|NCT01359930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637713|NCT01359930|Sensory System Agents|sensory system agents|mesh-ancestor
6637714|NCT01359930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6637715|NCT01359930|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6637716|NCT01359930|Antidepressive Agents|antidepressive agents|mesh-ancestor
6637717|NCT01359930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6637718|NCT01359930|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6637719|NCT01359930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6637720|NCT01359930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6637721|NCT01359930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637722|NCT01359930|Dopamine Agents|dopamine agents|mesh-ancestor
6637723|NCT01359930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6637724|NCT01359930|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6637725|NCT01359930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6637726|NCT01359930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6637727|NCT01360034|Indomethacin|indomethacin|mesh-list
6637728|NCT01360034|Nifedipine|nifedipine|mesh-list
6637729|NCT01360034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6637730|NCT01360034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6637731|NCT01360034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637732|NCT01360034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6637733|NCT01360034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637734|NCT01360034|Vasodilator Agents|vasodilator agents|mesh-ancestor
6637735|NCT01360034|Tocolytic Agents|tocolytic agents|mesh-ancestor
6637736|NCT01360034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6637737|NCT01360034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6637738|NCT01360034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6637739|NCT01360034|Analgesics|analgesics|mesh-ancestor
6637740|NCT01360034|Sensory System Agents|sensory system agents|mesh-ancestor
6637741|NCT01360034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6637742|NCT01360034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6637743|NCT01360034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6637744|NCT01360034|Gout Suppressants|gout suppressants|mesh-ancestor
6637745|NCT01360034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6637746|NCT01360034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6637747|NCT01360060|Magnesium Sulfate|magnesium sulfate|mesh-list
6637748|NCT01360060|Analgesics|analgesics|mesh-ancestor
6637749|NCT01360060|Sensory System Agents|sensory system agents|mesh-ancestor
6021074|NCT00396565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6021075|NCT00396565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021076|NCT00396565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6021077|NCT00396565|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6021078|NCT00396565|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6021079|NCT00396565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6021080|NCT00396565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6452282|NCT00416325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6452283|NCT00416351|Clofarabine|clofarabine|mesh-list
6452284|NCT00416351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6452285|NCT00416351|Antimetabolites|antimetabolites|mesh-ancestor
6452286|NCT00416351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6452287|NCT00416351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6452288|NCT00416377|Prednisolone|prednisolone|mesh-list
6452289|NCT00416377|Doxorubicin|doxorubicin|mesh-list
6452290|NCT00416377|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6452291|NCT00416377|Bleomycin|bleomycin|mesh-list
6452292|NCT00416377|Vincristine|vincristine|mesh-list
6452293|NCT00416377|Dacarbazine|dacarbazine|mesh-list
6452294|NCT00416377|Vinblastine|vinblastine|mesh-list
6452295|NCT00416377|Procarbazine|procarbazine|mesh-list
6452296|NCT00416377|Chlorambucil|chlorambucil|mesh-list
6452297|NCT00416377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6452298|NCT00416377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6637750|NCT01360060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6637751|NCT01360060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637752|NCT01360060|Anesthetics|anesthetics|mesh-ancestor
6637753|NCT01360060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6637754|NCT01360060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6637755|NCT01360060|Anticonvulsants|anticonvulsants|mesh-ancestor
6637756|NCT01360060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6637757|NCT01360060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6637758|NCT01360060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637759|NCT01360060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6637760|NCT01360060|Tocolytic Agents|tocolytic agents|mesh-ancestor
6637761|NCT01360060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6637762|NCT01360086|Leucovorin|leucovorin|mesh-list
5483729|NCT03675737|Fluorouracil|fluorouracil|mesh-list
5483730|NCT03675737|Pembrolizumab|pembrolizumab|mesh-list
6637763|NCT01360086|Fluorouracil|fluorouracil|mesh-list
6637764|NCT01360086|Cetuximab|cetuximab|mesh-list
6637765|NCT01360086|Calcium|calcium|mesh-list
6637766|NCT01360086|Levoleucovorin|levoleucovorin|mesh-list
6637767|NCT01360086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6637768|NCT01360086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6637769|NCT01360086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637770|NCT01360086|Antimetabolites|antimetabolites|mesh-ancestor
6637771|NCT01360086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637772|NCT01360086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6637773|NCT01360086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6637774|NCT01360086|Immunologic Factors|immunologic factors|mesh-ancestor
6637775|NCT01360086|Antidotes|antidotes|mesh-ancestor
6637776|NCT01360086|Protective Agents|protective agents|mesh-ancestor
6637777|NCT01360086|Vitamin B Complex|vitamin b complex|mesh-ancestor
6637778|NCT01360086|Vitamins|vitamins|mesh-ancestor
6637779|NCT01360086|Micronutrients|micronutrients|mesh-ancestor
6637780|NCT01360086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6637781|NCT01360151|Ranibizumab|ranibizumab|mesh-list
6637782|NCT01360151|Verteporfin|verteporfin|mesh-list
6637783|NCT01360151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6637784|NCT01360151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6637785|NCT01360151|Growth Substances|growth substances|mesh-ancestor
5483731|NCT03675737|Capecitabine|capecitabine|mesh-list
5483732|NCT03675737|Oxaliplatin|oxaliplatin|mesh-list
5483733|NCT03675737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5483734|NCT03675737|Antimetabolites|antimetabolites|mesh-ancestor
5483735|NCT03675737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483736|NCT03675737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5483737|NCT03675737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5483738|NCT03675737|Immunologic Factors|immunologic factors|mesh-ancestor
5483739|NCT03675737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637786|NCT01360151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637787|NCT01360151|Growth Inhibitors|growth inhibitors|mesh-ancestor
6637788|NCT01360151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6637789|NCT01360151|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6637790|NCT01360151|Dermatologic Agents|dermatologic agents|mesh-ancestor
6637791|NCT01360190|Fluoxetine|fluoxetine|mesh-list
6637792|NCT01360190|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5483740|NCT03675737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5483741|NCT03625141|Atezolizumab|atezolizumab|mesh-list
5483742|NCT03625141|Vemurafenib|vemurafenib|mesh-list
6637793|NCT01360190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6021081|NCT00396565|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6021082|NCT00396565|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5483743|NCT03625141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5483744|NCT03625141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5483745|NCT03625141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5483746|NCT03625141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483747|NCT03576261|Polygeline|polygeline|mesh-list
5483748|NCT03576261|Plasma Substitutes|plasma substitutes|mesh-ancestor
5483749|NCT03576261|Blood Substitutes|blood substitutes|mesh-ancestor
5502467|NCT04466280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5502468|NCT04466280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5502469|NCT04466280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5502470|NCT04466280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5502471|NCT04466280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502472|NCT04466280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5502473|NCT04466254|Cetuximab|cetuximab|mesh-list
5502474|NCT04466254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5502475|NCT04466254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5502476|NCT04466176|Fluticasone|fluticasone|mesh-list
5502477|NCT04466176|Xhance|xhance|mesh-list
5502478|NCT04466176|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6021083|NCT00396565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6637794|NCT01360190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6637795|NCT01360190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637796|NCT01360190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6637797|NCT01360190|Serotonin Agents|serotonin agents|mesh-ancestor
6637798|NCT01360190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637799|NCT01360190|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6637800|NCT01360190|Antidepressive Agents|antidepressive agents|mesh-ancestor
6637801|NCT01360190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6637802|NCT01360190|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6637803|NCT01360190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6021084|NCT00396565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021085|NCT00396565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6021086|NCT00396565|Serotonin Agents|serotonin agents|mesh-ancestor
6021087|NCT00396565|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6021088|NCT00396565|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6021089|NCT00396565|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6452299|NCT00416377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6452300|NCT00416377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6637804|NCT01360190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6637805|NCT01360372|Methylnaltrexone|methylnaltrexone|mesh-list
5502479|NCT04466176|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
5502480|NCT04466176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5502481|NCT04466176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6452301|NCT00416377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6452302|NCT00416377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6452303|NCT00416377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6452304|NCT00416377|Tubulin Modulators|tubulin modulators|mesh-ancestor
5502482|NCT04466176|Autonomic Agents|autonomic agents|mesh-ancestor
5502483|NCT04466176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5502484|NCT04466176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502485|NCT04466176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5502486|NCT04466176|Respiratory System Agents|respiratory system agents|mesh-ancestor
5502487|NCT04466176|Dermatologic Agents|dermatologic agents|mesh-ancestor
5502488|NCT04466176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6452305|NCT00416377|Antimitotic Agents|antimitotic agents|mesh-ancestor
6637806|NCT01360372|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6637807|NCT01360372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637808|NCT01360372|Sensory System Agents|sensory system agents|mesh-ancestor
6452306|NCT00416377|Mitosis Modulators|mitosis modulators|mesh-ancestor
6452307|NCT00416377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5502489|NCT04466176|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5502490|NCT04466176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6637809|NCT01360372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6637810|NCT01360424|Teriparatide|teriparatide|mesh-list
6637811|NCT01360424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6021090|NCT00396565|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6021091|NCT00396565|Dopamine Agents|dopamine agents|mesh-ancestor
6021092|NCT00396591|Aflibercept|aflibercept|mesh-list
6021093|NCT00396591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5483750|NCT03527186|Risperidone|risperidone|mesh-list
5483751|NCT03527186|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5483752|NCT03527186|Serotonin Agents|serotonin agents|mesh-ancestor
5483753|NCT03527186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5483754|NCT03527186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483755|NCT03527186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483756|NCT03527186|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6021094|NCT00396591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6021095|NCT00396591|Growth Substances|growth substances|mesh-ancestor
6637812|NCT01360424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637813|NCT01360424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6637814|NCT01360437|Ticagrelor|ticagrelor|mesh-list
6637815|NCT01360437|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6637816|NCT01360437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6637817|NCT01360437|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6637818|NCT01360437|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6637819|NCT01360437|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6637820|NCT01360437|Purinergic Agents|purinergic agents|mesh-ancestor
6637821|NCT01360437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6637822|NCT01360437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637823|NCT01360437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637824|NCT01360463|Methadone|methadone|mesh-list
6637825|NCT01360463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6637826|NCT01360463|Narcotics|narcotics|mesh-ancestor
6637827|NCT01360463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6637828|NCT01360463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637829|NCT01360463|Analgesics|analgesics|mesh-ancestor
6637830|NCT01360463|Sensory System Agents|sensory system agents|mesh-ancestor
6637831|NCT01360463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6637832|NCT01360463|Antitussive Agents|antitussive agents|mesh-ancestor
6637833|NCT01360463|Respiratory System Agents|respiratory system agents|mesh-ancestor
6637834|NCT01360476|Vitamin D|vitamin d|mesh-list
6637835|NCT01360476|Cholecalciferol|cholecalciferol|mesh-list
6637836|NCT01360476|Vitamins|vitamins|mesh-ancestor
6637837|NCT01360476|Micronutrients|micronutrients|mesh-ancestor
6637838|NCT01360476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637839|NCT01360476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6637840|NCT01360476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6637841|NCT01360593|Gemcitabine|gemcitabine|mesh-list
6637842|NCT01360593|Capecitabine|capecitabine|mesh-list
6637843|NCT01360593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6637844|NCT01360593|Antimetabolites|antimetabolites|mesh-ancestor
5483757|NCT03527186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5483758|NCT03527186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5483759|NCT03527186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5483760|NCT03527186|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5483761|NCT03527186|Dopamine Agents|dopamine agents|mesh-ancestor
5483762|NCT03369223|Nivolumab|nivolumab|mesh-list
5483763|NCT03369223|Ipilimumab|ipilimumab|mesh-list
5483764|NCT03369223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5483765|NCT03369223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6637845|NCT01360593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637846|NCT01360593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6637847|NCT01360593|Antiviral Agents|antiviral agents|mesh-ancestor
6637848|NCT01360593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6637849|NCT01360593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6637850|NCT01360593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6637851|NCT01360593|Immunologic Factors|immunologic factors|mesh-ancestor
6637852|NCT01360593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637853|NCT01360658|Immunoglobulins|immunoglobulins|mesh-list
6637854|NCT01360658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6637855|NCT01360658|Antibodies|antibodies|mesh-list
6637856|NCT01360658|gamma-Globulins|gamma-globulins|mesh-list
6637857|NCT01360658|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6637858|NCT01360658|Immunologic Factors|immunologic factors|mesh-ancestor
6637859|NCT01360658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637860|NCT01360671|Sildenafil Citrate|sildenafil citrate|mesh-list
6637861|NCT01360671|Vasodilator Agents|vasodilator agents|mesh-ancestor
6637862|NCT01360671|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6637863|NCT01360671|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6637864|NCT01360671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6637865|NCT01360671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637866|NCT01360671|Urological Agents|urological agents|mesh-ancestor
6637867|NCT01360710|Irbesartan|irbesartan|mesh-list
6637868|NCT01360710|Moxonidine|moxonidine|mesh-list
6637869|NCT01360710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6637870|NCT01360710|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6637871|NCT01360710|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6637872|NCT01360710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021096|NCT00396591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021097|NCT00396591|Growth Inhibitors|growth inhibitors|mesh-ancestor
6021098|NCT00396591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6021099|NCT00396656|Atenolol|atenolol|mesh-list
5483766|NCT03369223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5483767|NCT03369223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483768|NCT03361865|Pembrolizumab|pembrolizumab|mesh-list
5483769|NCT03361865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5483770|NCT03361865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5483771|NCT03320070|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
5483772|NCT03320070|Hormones|hormones|mesh-ancestor
5483773|NCT03320070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5483774|NCT03320070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637873|NCT01360749|Lidocaine|lidocaine|mesh-list
6637874|NCT01360749|Anesthetics, Local|anesthetics, local|mesh-ancestor
6637875|NCT01360749|Anesthetics|anesthetics|mesh-ancestor
6637876|NCT01360749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6637877|NCT01360749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483775|NCT03294304|Gemcitabine|gemcitabine|mesh-list
5483776|NCT03294304|Nivolumab|nivolumab|mesh-list
5483777|NCT03294304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5483778|NCT03294304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5483779|NCT03294304|Antimetabolites|antimetabolites|mesh-ancestor
6021100|NCT00396656|Valsartan|valsartan|mesh-list
6637878|NCT01360749|Sensory System Agents|sensory system agents|mesh-ancestor
6637879|NCT01360749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6637880|NCT01360749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6637881|NCT01360749|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6637882|NCT01360749|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6637883|NCT01360749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6637884|NCT01360749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637885|NCT01360788|Albuterol|albuterol|mesh-list
6637886|NCT01360788|Ipratropium|ipratropium|mesh-list
6637887|NCT01360788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6637888|NCT01360788|Autonomic Agents|autonomic agents|mesh-ancestor
6637889|NCT01360788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6637890|NCT01360788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637891|NCT01360788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6637892|NCT01360788|Respiratory System Agents|respiratory system agents|mesh-ancestor
6637893|NCT01360788|Tocolytic Agents|tocolytic agents|mesh-ancestor
6637894|NCT01360788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6637895|NCT01360788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6637896|NCT01360788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6637897|NCT01360788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6637898|NCT01360788|Adrenergic Agents|adrenergic agents|mesh-ancestor
6637899|NCT01360788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6637900|NCT01360788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637901|NCT01360788|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6637902|NCT01360788|Cholinergic Agents|cholinergic agents|mesh-ancestor
6637903|NCT01360827|Cisplatin|cisplatin|mesh-list
6637904|NCT01360827|Fluorouracil|fluorouracil|mesh-list
6637905|NCT01360827|Cetuximab|cetuximab|mesh-list
6637906|NCT01360827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6637907|NCT01360827|Antimetabolites|antimetabolites|mesh-ancestor
6637908|NCT01360827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637909|NCT01360827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6637910|NCT01360827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6637911|NCT01360827|Immunologic Factors|immunologic factors|mesh-ancestor
6637912|NCT01360827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637913|NCT01360827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6637914|NCT01361022|Brotizolam|brotizolam|mesh-list
6637915|NCT01361022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6637916|NCT01361022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6637917|NCT01361022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637918|NCT01361269|Clindamycin|clindamycin|mesh-list
6637919|NCT01361269|Clindamycin palmitate|clindamycin palmitate|mesh-list
6637920|NCT01361269|Clindamycin phosphate|clindamycin phosphate|mesh-list
6637921|NCT01361269|Fosmidomycin|fosmidomycin|mesh-list
6637922|NCT01361269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6637923|NCT01361269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6637924|NCT01361269|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6637925|NCT01361269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6637926|NCT01361269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663252|NCT01506791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663253|NCT01506791|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6663254|NCT01506791|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6663255|NCT01506791|Histamine Antagonists|histamine antagonists|mesh-ancestor
6663256|NCT01506791|Histamine Agents|histamine agents|mesh-ancestor
6663257|NCT01506791|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6663258|NCT01506791|Autonomic Agents|autonomic agents|mesh-ancestor
6663259|NCT01506791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6663260|NCT01506791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6663261|NCT01506791|Respiratory System Agents|respiratory system agents|mesh-ancestor
6663262|NCT01506791|Nasal Decongestants|nasal decongestants|mesh-ancestor
6663263|NCT01506791|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6663264|NCT01506791|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6663265|NCT01506791|Sympathomimetics|sympathomimetics|mesh-ancestor
6663266|NCT01506791|Adrenergic Agents|adrenergic agents|mesh-ancestor
6663267|NCT01506804|Methylprednisolone|methylprednisolone|mesh-list
6663268|NCT01506804|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6663269|NCT01506804|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6663270|NCT01506804|Prednisolone|prednisolone|mesh-list
6663271|NCT01506804|Prednisolone acetate|prednisolone acetate|mesh-list
6021101|NCT00396656|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6021102|NCT00396656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6021103|NCT00396656|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6021104|NCT00396656|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5483780|NCT03294304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663272|NCT01506804|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6663273|NCT01506804|Prednisolone phosphate|prednisolone phosphate|mesh-list
6663274|NCT01506804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6663275|NCT01506804|Antiemetics|antiemetics|mesh-ancestor
6663276|NCT01506804|Autonomic Agents|autonomic agents|mesh-ancestor
6663277|NCT01506804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6663278|NCT01506804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663279|NCT01506804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6663280|NCT01506804|Glucocorticoids|glucocorticoids|mesh-ancestor
6663281|NCT01506804|Hormones|hormones|mesh-ancestor
6663282|NCT01506804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6663283|NCT01506804|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6663284|NCT01506804|Protective Agents|protective agents|mesh-ancestor
6663285|NCT01506804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6663286|NCT01506804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6663287|NCT01506856|Paclitaxel|paclitaxel|mesh-list
6663288|NCT01506856|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6663289|NCT01506856|Carboplatin|carboplatin|mesh-list
6663290|NCT01506856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6663291|NCT01506856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6663292|NCT01506856|Tubulin Modulators|tubulin modulators|mesh-ancestor
6663293|NCT01506856|Antimitotic Agents|antimitotic agents|mesh-ancestor
6663294|NCT01506856|Mitosis Modulators|mitosis modulators|mesh-ancestor
6663295|NCT01506856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663296|NCT01506895|Darapladib|darapladib|mesh-list
6663297|NCT01506895|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
6637927|NCT01361373|Levodopa|levodopa|mesh-list
6637928|NCT01361373|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6637929|NCT01361373|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6637930|NCT01361373|Dopamine Agents|dopamine agents|mesh-ancestor
6637931|NCT01361373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6637932|NCT01361373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637933|NCT01361373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637934|NCT01361399|Aspirin|aspirin|mesh-list
6637935|NCT01361399|Lidocaine|lidocaine|mesh-list
6637936|NCT01361399|Anesthetics, Local|anesthetics, local|mesh-ancestor
6021105|NCT00396656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021106|NCT00396656|Diuretics|diuretics|mesh-ancestor
6021107|NCT00396656|Natriuretic Agents|natriuretic agents|mesh-ancestor
6021108|NCT00396656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021109|NCT00396656|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6021110|NCT00396656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6021111|NCT00396656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6021112|NCT00396656|Sympatholytics|sympatholytics|mesh-ancestor
6021113|NCT00396656|Autonomic Agents|autonomic agents|mesh-ancestor
6021114|NCT00396656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6021115|NCT00396656|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6021116|NCT00396656|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6021117|NCT00396656|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6021118|NCT00396656|Adrenergic Agents|adrenergic agents|mesh-ancestor
6021119|NCT00396656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6021120|NCT00396812|Rituximab|rituximab|mesh-list
6637937|NCT01361399|Anesthetics|anesthetics|mesh-ancestor
6637938|NCT01361399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6637939|NCT01361399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637940|NCT01361399|Sensory System Agents|sensory system agents|mesh-ancestor
6637941|NCT01361399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6637942|NCT01361399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6637943|NCT01361399|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6637944|NCT01361399|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6637945|NCT01361399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6637946|NCT01361399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637947|NCT01361399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5483781|NCT03294304|Antiviral Agents|antiviral agents|mesh-ancestor
5483782|NCT03294304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5483783|NCT03294304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5483784|NCT03294304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5483785|NCT03294304|Immunologic Factors|immunologic factors|mesh-ancestor
5483786|NCT03294304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483787|NCT03294304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5483788|NCT03294304|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5483789|NCT03252756|Cannabidiol|cannabidiol|mesh-list
5483790|NCT03252756|Anticonvulsants|anticonvulsants|mesh-ancestor
5483791|NCT03240016|Pembrolizumab|pembrolizumab|mesh-list
5483792|NCT03240016|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5483793|NCT03240016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5483794|NCT03240016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6637948|NCT01361399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6637949|NCT01361399|Analgesics|analgesics|mesh-ancestor
6637950|NCT01361399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6637951|NCT01361399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6637952|NCT01361399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6637953|NCT01361399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6637954|NCT01361399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6637955|NCT01361399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6637956|NCT01361399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6637957|NCT01361399|Antipyretics|antipyretics|mesh-ancestor
6637958|NCT01361425|Methyldopa|methyldopa|mesh-list
6637959|NCT01361425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6637960|NCT01361425|Sympatholytics|sympatholytics|mesh-ancestor
6637961|NCT01361425|Autonomic Agents|autonomic agents|mesh-ancestor
6637962|NCT01361425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6021121|NCT00396812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6021122|NCT00396812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6021123|NCT00396812|Immunologic Factors|immunologic factors|mesh-ancestor
6021124|NCT00396812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021125|NCT00396812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6021126|NCT00396877|Clopidogrel|clopidogrel|mesh-list
6021127|NCT00396877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5483795|NCT03188796|Vitamin D|vitamin d|mesh-list
5483796|NCT03188796|Cholecalciferol|cholecalciferol|mesh-list
6021128|NCT00396877|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6021129|NCT00396877|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6021130|NCT00396877|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6637963|NCT01361425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637964|NCT01361425|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6637965|NCT01361425|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5483797|NCT03188796|Vitamins|vitamins|mesh-ancestor
5483798|NCT03188796|Micronutrients|micronutrients|mesh-ancestor
5483799|NCT03188796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483800|NCT03188796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5483801|NCT03188796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5483802|NCT03188354|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5483803|NCT03188354|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5483804|NCT03188354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483805|NCT03122431|Hydroxychloroquine|hydroxychloroquine|mesh-list
5483806|NCT03122431|Thalidomide|thalidomide|mesh-list
5483807|NCT03122431|Antimalarials|antimalarials|mesh-ancestor
5483808|NCT03122431|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5483809|NCT03122431|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5483810|NCT03122431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6637966|NCT01361425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6021131|NCT00396877|Purinergic Agents|purinergic agents|mesh-ancestor
6021132|NCT00396877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6021133|NCT00396877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021134|NCT00396877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021135|NCT00397020|Valproic Acid|valproic acid|mesh-list
6021136|NCT00397020|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6021137|NCT00397020|Antidepressive Agents|antidepressive agents|mesh-ancestor
5483811|NCT03122431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5483812|NCT03122431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483813|NCT03122431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6021138|NCT00397020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6021139|NCT00397020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6021140|NCT00397020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6021141|NCT00397020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6021142|NCT00397020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021143|NCT00397020|Anticonvulsants|anticonvulsants|mesh-ancestor
6021144|NCT00397020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6021145|NCT00397020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021146|NCT00397020|GABA Agents|gaba agents|mesh-ancestor
6021147|NCT00397020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6021148|NCT00397020|Antimanic Agents|antimanic agents|mesh-ancestor
6021149|NCT00397033|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6021150|NCT00397033|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6021151|NCT00397033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6637967|NCT01361425|Adrenergic Agents|adrenergic agents|mesh-ancestor
6637968|NCT01361425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6637969|NCT01361425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637970|NCT01361516|Anesthetics|anesthetics|mesh-list
6637971|NCT01361516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6637972|NCT01361516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637973|NCT01361542|Etanercept|etanercept|mesh-list
6452308|NCT00416377|Glucocorticoids|glucocorticoids|mesh-ancestor
6452309|NCT00416377|Hormones|hormones|mesh-ancestor
6452310|NCT00416377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6637974|NCT01361542|Infliximab|infliximab|mesh-list
6637975|NCT01361542|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6637976|NCT01361542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6637977|NCT01361542|Analgesics|analgesics|mesh-ancestor
6637978|NCT01361542|Sensory System Agents|sensory system agents|mesh-ancestor
6637979|NCT01361542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6637980|NCT01361542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637981|NCT01361542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6021152|NCT00397033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6021153|NCT00397033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452311|NCT00416377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6637982|NCT01361542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6452312|NCT00416377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6452313|NCT00416377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6452314|NCT00416377|Alkylating Agents|alkylating agents|mesh-ancestor
6452315|NCT00416390|Lycopene|lycopene|mesh-list
6452316|NCT00416390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6452317|NCT00416390|Antioxidants|antioxidants|mesh-ancestor
6637983|NCT01361542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6637984|NCT01361542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6637985|NCT01361542|Immunologic Factors|immunologic factors|mesh-ancestor
6637986|NCT01361542|Dermatologic Agents|dermatologic agents|mesh-ancestor
6637987|NCT01361763|Dabigatran|dabigatran|mesh-list
6637988|NCT01361763|Antithrombins|antithrombins|mesh-ancestor
6637989|NCT01361763|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6637990|NCT01361763|Protease Inhibitors|protease inhibitors|mesh-ancestor
6637991|NCT01361763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6637992|NCT01361763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6637993|NCT01361763|Anticoagulants|anticoagulants|mesh-ancestor
6637994|NCT01361789|Dexamethasone|dexamethasone|mesh-list
6637995|NCT01361789|Dexamethasone acetate|dexamethasone acetate|mesh-list
6637996|NCT01361789|Etoricoxib|etoricoxib|mesh-list
6637997|NCT01361789|Parecoxib|parecoxib|mesh-list
6637998|NCT01361789|Valdecoxib|valdecoxib|mesh-list
6637999|NCT01361789|BB 1101|bb 1101|mesh-list
6638000|NCT01361789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6638001|NCT01361789|Antiemetics|antiemetics|mesh-ancestor
6021154|NCT00397033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6021155|NCT00397033|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6021156|NCT00397033|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6021157|NCT00397033|Serotonin Agents|serotonin agents|mesh-ancestor
6021158|NCT00397033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6021159|NCT00397033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021160|NCT00397033|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6021161|NCT00397033|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6021162|NCT00397033|Dopamine Agents|dopamine agents|mesh-ancestor
6021163|NCT00397189|Melatonin|melatonin|mesh-list
6638002|NCT01361789|Autonomic Agents|autonomic agents|mesh-ancestor
6638003|NCT01361789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6638004|NCT01361789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483814|NCT03122431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5483815|NCT03122431|Immunologic Factors|immunologic factors|mesh-ancestor
5483816|NCT03122431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638005|NCT01361789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6638006|NCT01361789|Glucocorticoids|glucocorticoids|mesh-ancestor
6638007|NCT01361789|Hormones|hormones|mesh-ancestor
6638008|NCT01361789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5483817|NCT03122431|Leprostatic Agents|leprostatic agents|mesh-ancestor
5483818|NCT03122431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6021164|NCT00397189|Antioxidants|antioxidants|mesh-ancestor
6021165|NCT00397189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021166|NCT00397189|Protective Agents|protective agents|mesh-ancestor
6021167|NCT00397189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021168|NCT00397189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6021169|NCT00397488|Sunitinib|sunitinib|mesh-list
5483819|NCT03122431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5483820|NCT03122431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5483821|NCT03122431|Growth Substances|growth substances|mesh-ancestor
5483822|NCT03122431|Growth Inhibitors|growth inhibitors|mesh-ancestor
5483823|NCT03122431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5483824|NCT03119363|Methamphetamine|methamphetamine|mesh-list
5483825|NCT03119363|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5483826|NCT03119363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483827|NCT03119363|Sympathomimetics|sympathomimetics|mesh-ancestor
5483828|NCT03119363|Autonomic Agents|autonomic agents|mesh-ancestor
6452318|NCT00416390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6452319|NCT00416390|Protective Agents|protective agents|mesh-ancestor
6452320|NCT00416390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452321|NCT00416390|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6452322|NCT00416390|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6452323|NCT00416390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6452324|NCT00416429|Interferons|interferons|mesh-list
6452325|NCT00416429|Interferon-alpha|interferon-alpha|mesh-list
6452326|NCT00416429|Interferon alpha-2|interferon alpha-2|mesh-list
6452327|NCT00416429|Aldesleukin|aldesleukin|mesh-list
6452328|NCT00416429|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6452329|NCT00416429|Medroxyprogesterone|medroxyprogesterone|mesh-list
6452330|NCT00416429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6452331|NCT00416429|Antiviral Agents|antiviral agents|mesh-ancestor
6452332|NCT00416429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6452333|NCT00416429|Immunologic Factors|immunologic factors|mesh-ancestor
6452334|NCT00416429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452335|NCT00416429|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6638009|NCT01361789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5483829|NCT03119363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5483830|NCT03119363|Dopamine Agents|dopamine agents|mesh-ancestor
5483831|NCT03119363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5483832|NCT03119363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638010|NCT01361789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6638011|NCT01361789|Protease Inhibitors|protease inhibitors|mesh-ancestor
6638012|NCT01361789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5483833|NCT03119363|Adrenergic Agents|adrenergic agents|mesh-ancestor
6452336|NCT00416429|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6452337|NCT00416429|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6452338|NCT00416429|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6452339|NCT00416429|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6452340|NCT00416429|Contraceptive Agents|contraceptive agents|mesh-ancestor
5483834|NCT03119363|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5483835|NCT03119363|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5483836|NCT03119363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5483837|NCT03119363|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5483838|NCT03099356|Sirolimus|sirolimus|mesh-list
5483839|NCT03099356|Cyclophosphamide|cyclophosphamide|mesh-list
5483840|NCT03099356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5483841|NCT03099356|Immunologic Factors|immunologic factors|mesh-ancestor
5483842|NCT03099356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483843|NCT03099356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5483844|NCT03099356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5483845|NCT03099356|Alkylating Agents|alkylating agents|mesh-ancestor
5483846|NCT03099356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483847|NCT03099356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5483848|NCT03099356|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5483849|NCT03099356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5483850|NCT03099356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5483851|NCT03099356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5483852|NCT03099356|Antifungal Agents|antifungal agents|mesh-ancestor
5483853|NCT03084939|Capecitabine|capecitabine|mesh-list
5483854|NCT03084939|Trastuzumab|trastuzumab|mesh-list
5483855|NCT03084939|Lapatinib|lapatinib|mesh-list
5483856|NCT03084939|Maytansine|maytansine|mesh-list
5483857|NCT03084939|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
5483858|NCT03084939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5483859|NCT03084939|Antimetabolites|antimetabolites|mesh-ancestor
6452341|NCT00416429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6452342|NCT00416429|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6452343|NCT00416429|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6452344|NCT00416429|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6452345|NCT00416429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6452346|NCT00416468|Valsartan|valsartan|mesh-list
6452347|NCT00416468|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5483860|NCT03084939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483861|NCT03084939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5483862|NCT03084939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5483863|NCT03084939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5483864|NCT03084939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6638013|NCT01361789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638014|NCT01361789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6638015|NCT01361789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6638016|NCT01361789|Analgesics|analgesics|mesh-ancestor
6638017|NCT01361789|Sensory System Agents|sensory system agents|mesh-ancestor
6638018|NCT01361789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6638019|NCT01361789|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6638020|NCT01361789|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6638021|NCT01361841|Bimatoprost|bimatoprost|mesh-list
6638022|NCT01361841|Travoprost|travoprost|mesh-list
6638023|NCT01361841|Latanoprost|latanoprost|mesh-list
6452348|NCT00416468|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6452349|NCT00416468|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6452350|NCT00416468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638024|NCT01361841|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6638025|NCT01361841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6638026|NCT01361841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6638027|NCT01361984|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6638028|NCT01361984|Formoterol Fumarate|formoterol fumarate|mesh-list
6638029|NCT01361984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6638030|NCT01361984|Autonomic Agents|autonomic agents|mesh-ancestor
6638031|NCT01361984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6638032|NCT01361984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638033|NCT01361984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6638034|NCT01361984|Respiratory System Agents|respiratory system agents|mesh-ancestor
6638035|NCT01361984|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6638036|NCT01361984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6638037|NCT01361984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6638038|NCT01361984|Adrenergic Agents|adrenergic agents|mesh-ancestor
6638039|NCT01361984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6638040|NCT01361984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638041|NCT01361997|Ethanol|ethanol|mesh-list
6638042|NCT01361997|Chlorhexidine|chlorhexidine|mesh-list
6638043|NCT01361997|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5483865|NCT03084939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5483866|NCT03084939|Tubulin Modulators|tubulin modulators|mesh-ancestor
5483867|NCT03084939|Antimitotic Agents|antimitotic agents|mesh-ancestor
5483868|NCT03084939|Mitosis Modulators|mitosis modulators|mesh-ancestor
5483869|NCT03009201|Doxorubicin|doxorubicin|mesh-list
5483870|NCT03009201|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5483871|NCT03009201|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5483872|NCT03009201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6452351|NCT00416507|Gemcitabine|gemcitabine|mesh-list
6452352|NCT00416507|Fluorouracil|fluorouracil|mesh-list
6452353|NCT00416507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6452354|NCT00416507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6452355|NCT00416507|Antimetabolites|antimetabolites|mesh-ancestor
6452356|NCT00416507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6452357|NCT00416507|Antiviral Agents|antiviral agents|mesh-ancestor
6452358|NCT00416507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6452359|NCT00416507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6452360|NCT00416507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6452361|NCT00416507|Immunologic Factors|immunologic factors|mesh-ancestor
6452362|NCT00416507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452363|NCT00416533|Prednisone|prednisone|mesh-list
6452364|NCT00416533|Docetaxel|docetaxel|mesh-list
6452365|NCT00416533|Doxorubicin|doxorubicin|mesh-list
6452366|NCT00416533|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6452367|NCT00416533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5483873|NCT03009201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5483874|NCT03009201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5483875|NCT03009201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5483876|NCT03009201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483877|NCT02982083|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
5483878|NCT02982083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5483879|NCT02982083|Hormone Antagonists|hormone antagonists|mesh-ancestor
5483880|NCT02982083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6638044|NCT01361997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6638045|NCT01361997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6638046|NCT01361997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638047|NCT01361997|Disinfectants|disinfectants|mesh-ancestor
6638048|NCT01362010|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6638049|NCT01362010|Minocycline|minocycline|mesh-list
6638050|NCT01362010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6638051|NCT01362036|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
6638052|NCT01362036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6638053|NCT01362036|Vasodilator Agents|vasodilator agents|mesh-ancestor
6638054|NCT01362153|Golimumab|golimumab|mesh-list
6638055|NCT01362153|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6638056|NCT01362153|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
5483881|NCT02982083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483882|NCT02982083|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5483883|NCT02982083|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5483884|NCT02982083|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5483885|NCT02956382|Venetoclax|venetoclax|mesh-list
5483886|NCT02956382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6638057|NCT01362153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6638058|NCT01362153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6452368|NCT00416533|Tubulin Modulators|tubulin modulators|mesh-ancestor
6638059|NCT01362153|Immunologic Factors|immunologic factors|mesh-ancestor
6638060|NCT01362153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638061|NCT01362218|Aspirin|aspirin|mesh-list
6638062|NCT01362218|Ramipril|ramipril|mesh-list
6638063|NCT01362218|Simvastatin|simvastatin|mesh-list
6638064|NCT01362218|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6638065|NCT01362218|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6638066|NCT01362218|Antimetabolites|antimetabolites|mesh-ancestor
6638067|NCT01362218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638068|NCT01362218|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6638069|NCT01362218|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6638070|NCT01362218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6638071|NCT01362218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6638072|NCT01362218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6638073|NCT01362218|Analgesics|analgesics|mesh-ancestor
6638074|NCT01362218|Sensory System Agents|sensory system agents|mesh-ancestor
6638075|NCT01362218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6638076|NCT01362218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638077|NCT01362218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6638078|NCT01362218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6021170|NCT00397488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6021171|NCT00397488|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6021172|NCT00397488|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6021173|NCT00397488|Growth Substances|growth substances|mesh-ancestor
6021174|NCT00397488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021175|NCT00397488|Growth Inhibitors|growth inhibitors|mesh-ancestor
6021176|NCT00397488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6021177|NCT00397488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6021178|NCT00397488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483887|NCT02936843|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
6021179|NCT00397631|Pioglitazone|pioglitazone|mesh-list
6021180|NCT00397631|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6021181|NCT00397631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6021182|NCT00397631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021183|NCT00397631|Incretins|incretins|mesh-ancestor
6021184|NCT00397631|Hormones|hormones|mesh-ancestor
6021185|NCT00397631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5483888|NCT02936843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5483889|NCT02936843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5483890|NCT02936843|Analgesics|analgesics|mesh-ancestor
5483891|NCT02936843|Sensory System Agents|sensory system agents|mesh-ancestor
5483892|NCT02936843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5483893|NCT02936843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483894|NCT02936843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5483895|NCT02936843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5483896|NCT02896855|Docetaxel|docetaxel|mesh-list
5483897|NCT02896855|Trastuzumab|trastuzumab|mesh-list
5483898|NCT02896855|Pertuzumab|pertuzumab|mesh-list
5483899|NCT02896855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5483900|NCT02896855|Tubulin Modulators|tubulin modulators|mesh-ancestor
6021186|NCT00397631|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6021187|NCT00397631|Protease Inhibitors|protease inhibitors|mesh-ancestor
6021188|NCT00397631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6021189|NCT00397631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638079|NCT01362218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5483901|NCT02896855|Antimitotic Agents|antimitotic agents|mesh-ancestor
6021190|NCT00397813|Cyclosporine|cyclosporine|mesh-list
6021191|NCT00397813|Mycophenolic Acid|mycophenolic acid|mesh-list
6021192|NCT00397813|Fludarabine|fludarabine|mesh-list
6021193|NCT00397813|Fludarabine phosphate|fludarabine phosphate|mesh-list
6021194|NCT00397813|Cyclosporins|cyclosporins|mesh-list
6021195|NCT00397813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6021196|NCT00397813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6021197|NCT00397813|Antimetabolites|antimetabolites|mesh-ancestor
6021198|NCT00397813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021199|NCT00397813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6021200|NCT00397813|Immunologic Factors|immunologic factors|mesh-ancestor
6021201|NCT00397813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021202|NCT00397813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6021203|NCT00397813|Antifungal Agents|antifungal agents|mesh-ancestor
6021204|NCT00397813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6021205|NCT00397813|Dermatologic Agents|dermatologic agents|mesh-ancestor
6021206|NCT00397813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6021207|NCT00397813|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6021208|NCT00397813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6021209|NCT00397813|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6021210|NCT00397813|Antitubercular Agents|antitubercular agents|mesh-ancestor
6638080|NCT01362218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6638081|NCT01362218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6638082|NCT01362218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6638083|NCT01362218|Antipyretics|antipyretics|mesh-ancestor
6638084|NCT01362218|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6638085|NCT01362218|Protease Inhibitors|protease inhibitors|mesh-ancestor
6638086|NCT01362218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6638087|NCT01362309|Cycloserine|cycloserine|mesh-list
6638088|NCT01362309|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6638089|NCT01362309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6638090|NCT01362309|Renal Agents|renal agents|mesh-ancestor
6638091|NCT01362309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6638092|NCT01362309|Antitubercular Agents|antitubercular agents|mesh-ancestor
6638093|NCT01362309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6638094|NCT01362309|Antimetabolites|antimetabolites|mesh-ancestor
6638095|NCT01362309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638096|NCT01362361|Nintedanib|nintedanib|mesh-list
6638097|NCT01362361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6638098|NCT01362361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6638099|NCT01362361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6638100|NCT01362361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021211|NCT00397813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6638101|NCT01362400|Docetaxel|docetaxel|mesh-list
6638102|NCT01362400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6021212|NCT00397839|Ibandronic Acid|ibandronic acid|mesh-list
6021213|NCT00397839|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6021214|NCT00397839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021215|NCT00397878|Saracatinib|saracatinib|mesh-list
6021216|NCT00397878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6021217|NCT00397878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6021218|NCT00397878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021219|NCT00397904|Irinotecan|irinotecan|mesh-list
6638103|NCT01362400|Tubulin Modulators|tubulin modulators|mesh-ancestor
6638104|NCT01362400|Antimitotic Agents|antimitotic agents|mesh-ancestor
6638105|NCT01362400|Mitosis Modulators|mitosis modulators|mesh-ancestor
6638106|NCT01362400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638107|NCT01362426|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6638108|NCT01362426|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6638109|NCT01362426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6638110|NCT01362426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6638111|NCT01362426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638112|NCT01362426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6638113|NCT01362426|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5483902|NCT02896855|Mitosis Modulators|mitosis modulators|mesh-ancestor
5483903|NCT02896855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483904|NCT02896855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5483905|NCT02871778|Ivacaftor|ivacaftor|mesh-list
5483906|NCT02871778|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
5483907|NCT02871778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5483908|NCT02871778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483909|NCT02756208|Vaccines|vaccines|mesh-list
5483910|NCT02756208|Immunologic Factors|immunologic factors|mesh-ancestor
5483911|NCT02756208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483912|NCT02714218|Nivolumab|nivolumab|mesh-list
5483913|NCT02714218|Ipilimumab|ipilimumab|mesh-list
6021220|NCT00397904|Cetuximab|cetuximab|mesh-list
6021221|NCT00397904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6021222|NCT00397904|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6021223|NCT00397904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6021224|NCT00397904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6021225|NCT00397904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021226|NCT00397904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6638114|NCT01362426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6638115|NCT01362426|Serotonin Agents|serotonin agents|mesh-ancestor
6638116|NCT01362426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6638117|NCT01362426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638118|NCT01362426|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6638119|NCT01362426|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6638120|NCT01362426|Dopamine Agents|dopamine agents|mesh-ancestor
6638121|NCT01362764|Abiraterone Acetate|abiraterone acetate|mesh-list
6638122|NCT01362764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6638123|NCT01362764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6638124|NCT01362764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6638125|NCT01362764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638126|NCT01362764|Hormone Antagonists|hormone antagonists|mesh-ancestor
6638127|NCT01362764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6638128|NCT01362764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638129|NCT01362764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6638130|NCT01362998|Fentanyl|fentanyl|mesh-list
6638131|NCT01362998|Morphine|morphine|mesh-list
6638132|NCT01362998|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6638133|NCT01362998|Narcotics|narcotics|mesh-ancestor
6638134|NCT01362998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6638135|NCT01362998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638136|NCT01362998|Analgesics|analgesics|mesh-ancestor
6638137|NCT01362998|Sensory System Agents|sensory system agents|mesh-ancestor
5483914|NCT02714218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5483915|NCT02714218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5483916|NCT02714218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5483917|NCT02714218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483918|NCT02621151|Gemcitabine|gemcitabine|mesh-list
5483919|NCT02621151|Pembrolizumab|pembrolizumab|mesh-list
5483920|NCT02621151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5483921|NCT02621151|Antimetabolites|antimetabolites|mesh-ancestor
5483922|NCT02621151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483923|NCT02621151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5483924|NCT02621151|Antiviral Agents|antiviral agents|mesh-ancestor
5483925|NCT02621151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5483926|NCT02621151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5483927|NCT02621151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5483928|NCT02621151|Immunologic Factors|immunologic factors|mesh-ancestor
5483929|NCT02621151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483930|NCT02621151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5483931|NCT02564263|Paclitaxel|paclitaxel|mesh-list
5483932|NCT02564263|Docetaxel|docetaxel|mesh-list
5483933|NCT02564263|Pembrolizumab|pembrolizumab|mesh-list
5483934|NCT02564263|Irinotecan|irinotecan|mesh-list
5483935|NCT02564263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5483936|NCT02564263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5483937|NCT02564263|Tubulin Modulators|tubulin modulators|mesh-ancestor
5483938|NCT02564263|Antimitotic Agents|antimitotic agents|mesh-ancestor
5483939|NCT02564263|Mitosis Modulators|mitosis modulators|mesh-ancestor
5483940|NCT02564263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483941|NCT02564263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5483942|NCT02564263|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5483943|NCT02564263|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5483944|NCT02564263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5502491|NCT04466176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5502492|NCT04466176|Adrenergic Agents|adrenergic agents|mesh-ancestor
5502493|NCT04466176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5502494|NCT04466176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502495|NCT04466176|Glucocorticoids|glucocorticoids|mesh-ancestor
5502496|NCT04466176|Hormones|hormones|mesh-ancestor
5502497|NCT04466176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5502498|NCT04466176|Sympathomimetics|sympathomimetics|mesh-ancestor
5502499|NCT04466241|Ritonavir|ritonavir|mesh-list
5502500|NCT04466241|Lopinavir|lopinavir|mesh-list
5502501|NCT04466241|Telmisartan|telmisartan|mesh-list
6021227|NCT00397943|Vaccines|vaccines|mesh-list
6021228|NCT00397943|Immunologic Factors|immunologic factors|mesh-ancestor
6638138|NCT01362998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6638139|NCT01362998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6638140|NCT01362998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6638141|NCT01362998|Anesthetics, General|anesthetics, general|mesh-ancestor
6638142|NCT01362998|Anesthetics|anesthetics|mesh-ancestor
6638143|NCT01363037|Maraviroc|maraviroc|mesh-list
6638144|NCT01363037|Dapivirine|dapivirine|mesh-list
6638145|NCT01363037|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6638146|NCT01363037|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6638147|NCT01363037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638148|NCT01363037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6638149|NCT01363037|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6638150|NCT01363037|Antiviral Agents|antiviral agents|mesh-ancestor
6638151|NCT01363037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6638152|NCT01363037|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6638153|NCT01363063|Ketorolac|ketorolac|mesh-list
6638154|NCT01363063|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6638155|NCT01363063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5502502|NCT04466241|Atorvastatin|atorvastatin|mesh-list
6021229|NCT00397943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021230|NCT00397982|Sirolimus|sirolimus|mesh-list
6021231|NCT00397982|Bevacizumab|bevacizumab|mesh-list
6021232|NCT00397982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6021233|NCT00397982|Endothelial Growth Factors|endothelial growth factors|mesh-list
6021234|NCT00397982|Antibodies|antibodies|mesh-list
6021235|NCT00397982|Immunoglobulins|immunoglobulins|mesh-list
6021236|NCT00397982|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5502503|NCT04466241|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6021237|NCT00397982|Immunoglobulin G|immunoglobulin g|mesh-list
6021238|NCT00397982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6638156|NCT01363063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6638157|NCT01363063|Analgesics|analgesics|mesh-ancestor
6638158|NCT01363063|Sensory System Agents|sensory system agents|mesh-ancestor
6638159|NCT01363063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6638160|NCT01363063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638161|NCT01363063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6638162|NCT01363063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6638163|NCT01363063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6638164|NCT01363063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6638165|NCT01363063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638166|NCT01363089|Ketorolac|ketorolac|mesh-list
6638167|NCT01363089|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6638168|NCT01363089|Phenylephrine|phenylephrine|mesh-list
6638169|NCT01363089|Oxymetazoline|oxymetazoline|mesh-list
6638170|NCT01363089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6638171|NCT01363089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6638172|NCT01363089|Analgesics|analgesics|mesh-ancestor
6638173|NCT01363089|Sensory System Agents|sensory system agents|mesh-ancestor
6638174|NCT01363089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6638175|NCT01363089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638176|NCT01363089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6638177|NCT01363089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6638178|NCT01363089|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6638179|NCT01363089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6638180|NCT01363089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638181|NCT01363089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6638182|NCT01363089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6638183|NCT01363089|Adrenergic Agents|adrenergic agents|mesh-ancestor
6638184|NCT01363089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6638185|NCT01363089|Sympathomimetics|sympathomimetics|mesh-ancestor
6638186|NCT01363089|Autonomic Agents|autonomic agents|mesh-ancestor
6638187|NCT01363089|Nasal Decongestants|nasal decongestants|mesh-ancestor
6638188|NCT01363089|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6638189|NCT01363089|Respiratory System Agents|respiratory system agents|mesh-ancestor
6638190|NCT01363089|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6638191|NCT01363089|Mydriatics|mydriatics|mesh-ancestor
6638192|NCT01363089|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6638193|NCT01363089|Protective Agents|protective agents|mesh-ancestor
6638194|NCT01363115|Vitamin D|vitamin d|mesh-list
6638195|NCT01363115|Calcium|calcium|mesh-list
6638196|NCT01363115|Vitamins|vitamins|mesh-ancestor
6638197|NCT01363115|Micronutrients|micronutrients|mesh-ancestor
6638198|NCT01363115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638199|NCT01363115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6638200|NCT01363115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6663298|NCT01506895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6663299|NCT01506895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663300|NCT01506921|Ketamine|ketamine|mesh-list
6663301|NCT01506921|Esketamine|esketamine|mesh-list
6663302|NCT01506921|Analgesics|analgesics|mesh-ancestor
6663303|NCT01506921|Sensory System Agents|sensory system agents|mesh-ancestor
6663304|NCT01506921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6663305|NCT01506921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663306|NCT01506921|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6663307|NCT01506921|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6663308|NCT01506921|Anesthetics, General|anesthetics, general|mesh-ancestor
6663309|NCT01506921|Anesthetics|anesthetics|mesh-ancestor
6663310|NCT01506921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6663311|NCT01506921|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6663312|NCT01506921|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6663313|NCT01506921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6663314|NCT01506921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663315|NCT01506921|Antidepressive Agents|antidepressive agents|mesh-ancestor
6663316|NCT01506921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6663317|NCT01506973|Gemcitabine|gemcitabine|mesh-list
6663318|NCT01506973|Hydroxychloroquine|hydroxychloroquine|mesh-list
6663319|NCT01506973|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6663320|NCT01506973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6663321|NCT01506973|Antimetabolites|antimetabolites|mesh-ancestor
6663322|NCT01506973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663323|NCT01506973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6663324|NCT01506973|Antiviral Agents|antiviral agents|mesh-ancestor
6663325|NCT01506973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6663326|NCT01506973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6663327|NCT01506973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6663328|NCT01506973|Immunologic Factors|immunologic factors|mesh-ancestor
6663329|NCT01506973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638201|NCT01363167|Vitamin D|vitamin d|mesh-list
6638202|NCT01363167|Cholecalciferol|cholecalciferol|mesh-list
6638203|NCT01363167|Vitamins|vitamins|mesh-ancestor
6638204|NCT01363167|Micronutrients|micronutrients|mesh-ancestor
6638205|NCT01363167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638206|NCT01363167|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6638207|NCT01363167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6638208|NCT01363193|Heparin|heparin|mesh-list
6638209|NCT01363193|Calcium heparin|calcium heparin|mesh-list
6638210|NCT01363193|Anticoagulants|anticoagulants|mesh-ancestor
5483945|NCT02450331|Atezolizumab|atezolizumab|mesh-list
5483946|NCT02450331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5483947|NCT02421341|Fentanyl|fentanyl|mesh-list
6638211|NCT01363193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6638212|NCT01363193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6638213|NCT01363193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638214|NCT01363206|Ipilimumab|ipilimumab|mesh-list
6638215|NCT01363206|Molgramostim|molgramostim|mesh-list
6638216|NCT01363206|Sargramostim|sargramostim|mesh-list
6638217|NCT01363206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6638218|NCT01363206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6638219|NCT01363206|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6638220|NCT01363206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638221|NCT01363206|Immunologic Factors|immunologic factors|mesh-ancestor
6638222|NCT01363206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638223|NCT01363271|Vancomycin|vancomycin|mesh-list
6638224|NCT01363271|Linezolid|linezolid|mesh-list
6638225|NCT01363271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6638226|NCT01363271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6638227|NCT01363271|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6638228|NCT01363271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6638229|NCT01363271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638230|NCT01363284|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6638231|NCT01363284|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6638232|NCT01363284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6638233|NCT01363284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6638234|NCT01363284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638235|NCT01363284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5483948|NCT02421341|Analgesics, Opioid|analgesics, opioid|mesh-list
5483949|NCT02421341|Analgesics|analgesics|mesh-list
5483950|NCT02421341|Narcotics|narcotics|mesh-ancestor
6638236|NCT01363284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638237|NCT01363284|Analgesics|analgesics|mesh-ancestor
6638238|NCT01363284|Sensory System Agents|sensory system agents|mesh-ancestor
6638239|NCT01363284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6638240|NCT01363284|Antidepressive Agents|antidepressive agents|mesh-ancestor
5483951|NCT02421341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5483952|NCT02421341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483953|NCT02421341|Sensory System Agents|sensory system agents|mesh-ancestor
5483954|NCT02421341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5483955|NCT02421341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5483956|NCT02421341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5483957|NCT02421341|Anesthetics, General|anesthetics, general|mesh-ancestor
5483958|NCT02421341|Anesthetics|anesthetics|mesh-ancestor
5483959|NCT02149121|Rituximab|rituximab|mesh-list
5483960|NCT02149121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5483961|NCT02149121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5483962|NCT02149121|Immunologic Factors|immunologic factors|mesh-ancestor
5483963|NCT02149121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483964|NCT02149121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5483965|NCT02066181|Sorafenib|sorafenib|mesh-list
5483966|NCT02066181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5483967|NCT02066181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5483968|NCT02066181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5502504|NCT04466241|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6452369|NCT00416533|Antimitotic Agents|antimitotic agents|mesh-ancestor
6452370|NCT00416533|Mitosis Modulators|mitosis modulators|mesh-ancestor
6452371|NCT00416533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6452372|NCT00416533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6452373|NCT00416533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6452374|NCT00416533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6452375|NCT00416533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6452376|NCT00416533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6452377|NCT00416533|Glucocorticoids|glucocorticoids|mesh-ancestor
6452378|NCT00416533|Hormones|hormones|mesh-ancestor
6638241|NCT01363284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6638242|NCT01363284|Dopamine Agents|dopamine agents|mesh-ancestor
6638243|NCT01363310|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6638244|NCT01363310|Citalopram|citalopram|mesh-list
6638245|NCT01363310|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6638246|NCT01363310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6638247|NCT01363310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6638248|NCT01363310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638249|NCT01363310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6638250|NCT01363310|Serotonin Agents|serotonin agents|mesh-ancestor
6638251|NCT01363310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483969|NCT02066181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483970|NCT01935921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5483971|NCT01935921|Cetuximab|cetuximab|mesh-list
5483972|NCT01935921|Ipilimumab|ipilimumab|mesh-list
5483973|NCT01935921|Antibodies|antibodies|mesh-list
6638252|NCT01363310|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6638253|NCT01363310|Antidepressive Agents|antidepressive agents|mesh-ancestor
6638254|NCT01363310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6638255|NCT01363310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6638256|NCT01363310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6638257|NCT01363310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6638258|NCT01363323|Moxifloxacin|moxifloxacin|mesh-list
6638259|NCT01363323|Naltrexone|naltrexone|mesh-list
6638260|NCT01363323|Methylnaltrexone|methylnaltrexone|mesh-list
6638261|NCT01363323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6638262|NCT01363323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6638263|NCT01363323|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6638264|NCT01363323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6638265|NCT01363323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6638266|NCT01363323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638267|NCT01363323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6638268|NCT01363323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638269|NCT01363323|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6638270|NCT01363323|Sensory System Agents|sensory system agents|mesh-ancestor
6638271|NCT01363323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6638272|NCT01363323|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6638273|NCT01363336|Nifedipine|nifedipine|mesh-list
6638274|NCT01363336|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6638275|NCT01363336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6638276|NCT01363336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638277|NCT01363336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6638278|NCT01363336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638279|NCT01363336|Vasodilator Agents|vasodilator agents|mesh-ancestor
6638280|NCT01363336|Tocolytic Agents|tocolytic agents|mesh-ancestor
6638281|NCT01363336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6638282|NCT01363375|Carbon Fiber|carbon fiber|mesh-list
6638283|NCT01363375|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6638284|NCT01363375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6638285|NCT01363414|Hyaluronic Acid|hyaluronic acid|mesh-list
6638286|NCT01363414|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5483974|NCT01935921|Immunoglobulins|immunoglobulins|mesh-list
5483975|NCT01935921|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5483976|NCT01935921|Immunologic Factors|immunologic factors|mesh-ancestor
5483977|NCT01935921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483978|NCT01935921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5483979|NCT01935921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5483980|NCT01935921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483981|NCT01933932|Docetaxel|docetaxel|mesh-list
5483982|NCT01933932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6638287|NCT01363414|Immunologic Factors|immunologic factors|mesh-ancestor
6638288|NCT01363414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638289|NCT01363414|Viscosupplements|viscosupplements|mesh-ancestor
6638290|NCT01363414|Protective Agents|protective agents|mesh-ancestor
6638291|NCT01363531|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6638292|NCT01363531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6638293|NCT01363544|Methylphenidate|methylphenidate|mesh-list
6638294|NCT01363544|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6638295|NCT01363544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638296|NCT01363544|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6638297|NCT01363544|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6638298|NCT01363544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6638299|NCT01363544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638300|NCT01363544|Dopamine Agents|dopamine agents|mesh-ancestor
6638301|NCT01363544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6638302|NCT01363557|Gefitinib|gefitinib|mesh-list
6638303|NCT01363557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6638304|NCT01363557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6638305|NCT01363557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6638306|NCT01363557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638307|NCT01363570|Ranibizumab|ranibizumab|mesh-list
6638308|NCT01363570|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6638309|NCT01363570|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6638310|NCT01363570|Growth Substances|growth substances|mesh-ancestor
6638311|NCT01363570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638312|NCT01363570|Growth Inhibitors|growth inhibitors|mesh-ancestor
6638313|NCT01363570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6638314|NCT01363583|Epoprostenol|epoprostenol|mesh-list
6638315|NCT01363583|Tezosentan|tezosentan|mesh-list
6638316|NCT01363583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6638317|NCT01363583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6638318|NCT01363583|Vasodilator Agents|vasodilator agents|mesh-ancestor
6638319|NCT01363609|Insulin Glargine|insulin glargine|mesh-list
6638320|NCT01363609|Liraglutide|liraglutide|mesh-list
6638321|NCT01363609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6638322|NCT01363609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638323|NCT01363609|Incretins|incretins|mesh-ancestor
6638324|NCT01363609|Hormones|hormones|mesh-ancestor
6638325|NCT01363609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6638326|NCT01363648|Choline|choline|mesh-list
6638327|NCT01363648|Lipotropic Agents|lipotropic agents|mesh-ancestor
6638328|NCT01363648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6638329|NCT01363648|Antimetabolites|antimetabolites|mesh-ancestor
6638330|NCT01363648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638331|NCT01363648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6638332|NCT01363648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6638333|NCT01363648|Nootropic Agents|nootropic agents|mesh-ancestor
6638334|NCT01363752|Mycophenolic Acid|mycophenolic acid|mesh-list
6638335|NCT01363752|Sirolimus|sirolimus|mesh-list
6638336|NCT01363752|Tacrolimus|tacrolimus|mesh-list
6638337|NCT01363752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6638338|NCT01363752|Immunologic Factors|immunologic factors|mesh-ancestor
6638339|NCT01363752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638340|NCT01363752|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6638341|NCT01363752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6638342|NCT01363752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638343|NCT01363752|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6638344|NCT01363752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6638345|NCT01363752|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6638346|NCT01363752|Antitubercular Agents|antitubercular agents|mesh-ancestor
6638347|NCT01363752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6638348|NCT01363752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6638349|NCT01363752|Antifungal Agents|antifungal agents|mesh-ancestor
6638350|NCT01363817|Dexamethasone|dexamethasone|mesh-list
6638351|NCT01363817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6638352|NCT01363817|Antiemetics|antiemetics|mesh-ancestor
6638353|NCT01363817|Autonomic Agents|autonomic agents|mesh-ancestor
6638354|NCT01363817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6638355|NCT01363817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638356|NCT01363817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6638357|NCT01363817|Glucocorticoids|glucocorticoids|mesh-ancestor
6638358|NCT01363817|Hormones|hormones|mesh-ancestor
6638359|NCT01363817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6638360|NCT01363817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6638361|NCT01363817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6638362|NCT01363934|Darbepoetin alfa|darbepoetin alfa|mesh-list
6638363|NCT01363934|Hematinics|hematinics|mesh-ancestor
6638364|NCT01364012|Paclitaxel|paclitaxel|mesh-list
6638365|NCT01364012|Bevacizumab|bevacizumab|mesh-list
6638366|NCT01364012|Carboplatin|carboplatin|mesh-list
6638367|NCT01364012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6021239|NCT00397982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6021240|NCT00397982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6021241|NCT00397982|Growth Substances|growth substances|mesh-ancestor
6021242|NCT00397982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021243|NCT00397982|Growth Inhibitors|growth inhibitors|mesh-ancestor
6638368|NCT01364012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6638369|NCT01364012|Tubulin Modulators|tubulin modulators|mesh-ancestor
6638370|NCT01364012|Antimitotic Agents|antimitotic agents|mesh-ancestor
6638371|NCT01364012|Mitosis Modulators|mitosis modulators|mesh-ancestor
6638372|NCT01364012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638373|NCT01364012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6638374|NCT01364012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6638375|NCT01364012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6638376|NCT01364012|Growth Substances|growth substances|mesh-ancestor
6638377|NCT01364012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638378|NCT01364012|Growth Inhibitors|growth inhibitors|mesh-ancestor
6638379|NCT01364051|Cediranib|cediranib|mesh-list
6638380|NCT01364051|Maleic acid|maleic acid|mesh-list
6638381|NCT01364051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6638382|NCT01364051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638383|NCT01364051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6638384|NCT01364051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6638385|NCT01364181|Udenafil|udenafil|mesh-list
6638386|NCT01364181|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6638387|NCT01364181|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6638388|NCT01364181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6638389|NCT01364181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638390|NCT01364194|Bupivacaine|bupivacaine|mesh-list
6638391|NCT01364194|Anesthetics, Local|anesthetics, local|mesh-ancestor
6638392|NCT01364194|Anesthetics|anesthetics|mesh-ancestor
6638393|NCT01364194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6638394|NCT01364194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638395|NCT01364194|Sensory System Agents|sensory system agents|mesh-ancestor
6638396|NCT01364194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6638397|NCT01364220|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6638398|NCT01364220|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6638399|NCT01364220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6638400|NCT01364220|Antimetabolites|antimetabolites|mesh-ancestor
6638401|NCT01364220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638402|NCT01364220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6638403|NCT01364220|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6638404|NCT01364220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6638405|NCT01364324|Antitubercular Agents|antitubercular agents|mesh-list
6638406|NCT01364324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6638407|NCT01364324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6638408|NCT01364376|Leucovorin|leucovorin|mesh-list
6638409|NCT01364376|Oxaliplatin|oxaliplatin|mesh-list
6638410|NCT01364376|Calcium|calcium|mesh-list
6638411|NCT01364376|Levoleucovorin|levoleucovorin|mesh-list
6638412|NCT01364376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6638413|NCT01364376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638414|NCT01364376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6638415|NCT01364376|Antidotes|antidotes|mesh-ancestor
6638416|NCT01364376|Protective Agents|protective agents|mesh-ancestor
6638417|NCT01364376|Vitamin B Complex|vitamin b complex|mesh-ancestor
6638418|NCT01364376|Vitamins|vitamins|mesh-ancestor
6638419|NCT01364376|Micronutrients|micronutrients|mesh-ancestor
6638420|NCT01364402|Epoetin Alfa|epoetin alfa|mesh-list
6638421|NCT01364402|Hematinics|hematinics|mesh-ancestor
6638422|NCT01364415|Pasireotide|pasireotide|mesh-list
6638423|NCT01364415|Hormones|hormones|mesh-ancestor
6638424|NCT01364415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6638425|NCT01364415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5483983|NCT01933932|Tubulin Modulators|tubulin modulators|mesh-ancestor
5483984|NCT01933932|Antimitotic Agents|antimitotic agents|mesh-ancestor
5483985|NCT01933932|Mitosis Modulators|mitosis modulators|mesh-ancestor
5483986|NCT01933932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483987|NCT01927419|Nivolumab|nivolumab|mesh-list
5483988|NCT01927419|Ipilimumab|ipilimumab|mesh-list
5483989|NCT01927419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5483990|NCT01927419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5483991|NCT01927419|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5483992|NCT01927419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5483993|NCT01889186|Venetoclax|venetoclax|mesh-list
5483994|NCT01889186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5483995|NCT01861314|Bortezomib|bortezomib|mesh-list
5483996|NCT01861314|Sorafenib|sorafenib|mesh-list
5483997|NCT01861314|Decitabine|decitabine|mesh-list
5483998|NCT01861314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5483999|NCT01861314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5484000|NCT01861314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5484001|NCT01861314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484002|NCT01861314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5484003|NCT01861314|Antimetabolites|antimetabolites|mesh-ancestor
6638426|NCT01364493|Capecitabine|capecitabine|mesh-list
6638427|NCT01364493|Oxaliplatin|oxaliplatin|mesh-list
6638428|NCT01364493|Trastuzumab|trastuzumab|mesh-list
6638429|NCT01364493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6638430|NCT01364493|Antimetabolites|antimetabolites|mesh-ancestor
6638431|NCT01364493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638432|NCT01364493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6638433|NCT01364493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6638434|NCT01364519|Fluticasone|fluticasone|mesh-list
6638435|NCT01364519|Xhance|xhance|mesh-list
6021244|NCT00397982|Immunologic Factors|immunologic factors|mesh-ancestor
6021245|NCT00397982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6021246|NCT00397982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6021247|NCT00397982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6021248|NCT00397982|Antifungal Agents|antifungal agents|mesh-ancestor
6021249|NCT00397982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6021250|NCT00398047|Mitogens|mitogens|mesh-list
6021251|NCT00398047|Mitosis Modulators|mitosis modulators|mesh-ancestor
6021252|NCT00398047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021253|NCT00398086|Gemcitabine|gemcitabine|mesh-list
6021254|NCT00398086|Paclitaxel|paclitaxel|mesh-list
5484004|NCT01850004|Dasatinib|dasatinib|mesh-list
5484005|NCT01850004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5484006|NCT01850004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5484007|NCT01850004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5484008|NCT01850004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484009|NCT01844505|Nivolumab|nivolumab|mesh-list
5484010|NCT01844505|Ipilimumab|ipilimumab|mesh-list
5484011|NCT01844505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5484012|NCT01844505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5484013|NCT01844505|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5484014|NCT01844505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484015|NCT01757535|Azacitidine|azacitidine|mesh-list
5484016|NCT01757535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5484017|NCT01757535|Antimetabolites|antimetabolites|mesh-ancestor
5484018|NCT01757535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484019|NCT01757535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5484020|NCT01757535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5484021|NCT01750281|Docetaxel|docetaxel|mesh-list
6638436|NCT01364519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6638437|NCT01364519|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6638438|NCT01364519|Autonomic Agents|autonomic agents|mesh-ancestor
6638439|NCT01364519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6638440|NCT01364519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638441|NCT01364519|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6638442|NCT01364519|Respiratory System Agents|respiratory system agents|mesh-ancestor
6638443|NCT01364519|Dermatologic Agents|dermatologic agents|mesh-ancestor
6638444|NCT01364519|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6638445|NCT01364571|Vaccines|vaccines|mesh-list
6638446|NCT01364571|Immunologic Factors|immunologic factors|mesh-ancestor
6638447|NCT01364571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638448|NCT01364675|Metformin|metformin|mesh-list
6638449|NCT01364675|Enalapril|enalapril|mesh-list
5484022|NCT01750281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5484023|NCT01750281|Tubulin Modulators|tubulin modulators|mesh-ancestor
5484024|NCT01750281|Antimitotic Agents|antimitotic agents|mesh-ancestor
6638450|NCT01364675|Simvastatin|simvastatin|mesh-list
6638451|NCT01364675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6638452|NCT01364675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638453|NCT01364675|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6638454|NCT01364675|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6638455|NCT01364675|Antimetabolites|antimetabolites|mesh-ancestor
6638456|NCT01364675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638457|NCT01364675|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6638458|NCT01364675|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5484025|NCT01750281|Mitosis Modulators|mitosis modulators|mesh-ancestor
5484026|NCT01750281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484027|NCT01660971|Gemcitabine|gemcitabine|mesh-list
6638459|NCT01364675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6638460|NCT01364675|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5484028|NCT01660971|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5484029|NCT01660971|Dasatinib|dasatinib|mesh-list
5484030|NCT01660971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5484031|NCT01660971|Antimetabolites|antimetabolites|mesh-ancestor
6638461|NCT01364675|Protease Inhibitors|protease inhibitors|mesh-ancestor
6638462|NCT01364675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6638463|NCT01364688|Alfacalcidol|alfacalcidol|mesh-list
6638464|NCT01364688|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
6638465|NCT01364688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6638466|NCT01364688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638467|NCT01364688|Vitamins|vitamins|mesh-ancestor
6638468|NCT01364688|Micronutrients|micronutrients|mesh-ancestor
6021255|NCT00398086|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5484032|NCT01660971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484033|NCT01660971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5484034|NCT01660971|Antiviral Agents|antiviral agents|mesh-ancestor
5484035|NCT01660971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6452379|NCT00416533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6452380|NCT00416533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452381|NCT00416533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6452382|NCT00416585|Isotretinoin|isotretinoin|mesh-list
6021256|NCT00398086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6021257|NCT00398086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6021258|NCT00398086|Tubulin Modulators|tubulin modulators|mesh-ancestor
6021259|NCT00398086|Antimitotic Agents|antimitotic agents|mesh-ancestor
6021260|NCT00398086|Mitosis Modulators|mitosis modulators|mesh-ancestor
6021261|NCT00398086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021262|NCT00398086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6021263|NCT00398086|Antimetabolites|antimetabolites|mesh-ancestor
6021264|NCT00398086|Antiviral Agents|antiviral agents|mesh-ancestor
6021265|NCT00398086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6021266|NCT00398086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6021267|NCT00398086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6021268|NCT00398086|Immunologic Factors|immunologic factors|mesh-ancestor
6021269|NCT00398086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021270|NCT00398112|Sunitinib|sunitinib|mesh-list
6021271|NCT00398112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6021272|NCT00398112|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6021273|NCT00398112|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6021274|NCT00398112|Growth Substances|growth substances|mesh-ancestor
6021275|NCT00398112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021276|NCT00398112|Growth Inhibitors|growth inhibitors|mesh-ancestor
6021277|NCT00398112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6021278|NCT00398112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6021279|NCT00398112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021280|NCT00398138|Sargramostim|sargramostim|mesh-list
6021281|NCT00398138|Freund's Adjuvant|freund's adjuvant|mesh-list
6021282|NCT00398138|Immunologic Factors|immunologic factors|mesh-ancestor
6021283|NCT00398138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021284|NCT00398138|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6021285|NCT00398216|Edoxaban|edoxaban|mesh-list
6021286|NCT00398216|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
6021287|NCT00398216|Antithrombins|antithrombins|mesh-ancestor
6021288|NCT00398216|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6021289|NCT00398216|Protease Inhibitors|protease inhibitors|mesh-ancestor
6021290|NCT00398216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6021291|NCT00398216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021292|NCT00398216|Anticoagulants|anticoagulants|mesh-ancestor
6021293|NCT00398320|Bevacizumab|bevacizumab|mesh-list
6021294|NCT00398320|Capecitabine|capecitabine|mesh-list
6021295|NCT00398320|Oxaliplatin|oxaliplatin|mesh-list
6021296|NCT00398320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6021297|NCT00398320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6021298|NCT00398320|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6452383|NCT00416585|Dermatologic Agents|dermatologic agents|mesh-ancestor
6452384|NCT00416637|Bevacizumab|bevacizumab|mesh-list
6452385|NCT00416637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6452386|NCT00416637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6452387|NCT00416637|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6452388|NCT00416637|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6638469|NCT01364701|Sildenafil Citrate|sildenafil citrate|mesh-list
6638470|NCT01364701|Tadalafil|tadalafil|mesh-list
6021299|NCT00398320|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6021300|NCT00398320|Growth Substances|growth substances|mesh-ancestor
6021301|NCT00398320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021302|NCT00398320|Growth Inhibitors|growth inhibitors|mesh-ancestor
6021303|NCT00398320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6021304|NCT00398320|Antimetabolites|antimetabolites|mesh-ancestor
6452389|NCT00416637|Growth Substances|growth substances|mesh-ancestor
6452390|NCT00416637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452391|NCT00416637|Growth Inhibitors|growth inhibitors|mesh-ancestor
6452392|NCT00416650|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6638471|NCT01364701|Vasodilator Agents|vasodilator agents|mesh-ancestor
6638472|NCT01364701|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6638473|NCT01364701|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6638474|NCT01364701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6638475|NCT01364701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638476|NCT01364701|Urological Agents|urological agents|mesh-ancestor
6638477|NCT01364792|Valacyclovir|valacyclovir|mesh-list
6638478|NCT01364792|Antiviral Agents|antiviral agents|mesh-ancestor
6638479|NCT01364792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6638480|NCT01364805|Ascorbic Acid|ascorbic acid|mesh-list
6638481|NCT01364805|Gemcitabine|gemcitabine|mesh-list
6638482|NCT01364805|Vitamins|vitamins|mesh-ancestor
6638483|NCT01364805|Micronutrients|micronutrients|mesh-ancestor
6638484|NCT01364805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452393|NCT00416650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6452394|NCT00416650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6452395|NCT00416650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6452396|NCT00416650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484036|NCT01660971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5484037|NCT01660971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5484038|NCT01660971|Immunologic Factors|immunologic factors|mesh-ancestor
5484039|NCT01660971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638485|NCT01364805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6638486|NCT01364805|Antimetabolites|antimetabolites|mesh-ancestor
6638487|NCT01364805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638488|NCT01364805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6638489|NCT01364805|Antiviral Agents|antiviral agents|mesh-ancestor
6638490|NCT01364805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6638491|NCT01364805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6638492|NCT01364805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6638493|NCT01364805|Immunologic Factors|immunologic factors|mesh-ancestor
6638494|NCT01364805|Antioxidants|antioxidants|mesh-ancestor
6638495|NCT01364805|Protective Agents|protective agents|mesh-ancestor
6638496|NCT01364857|GTPase-Activating Proteins|gtpase-activating proteins|mesh-list
6638497|NCT01364857|GTP Phosphohydrolase Activators|gtp phosphohydrolase activators|mesh-ancestor
6638498|NCT01364857|Enzyme Activators|enzyme activators|mesh-ancestor
6638499|NCT01364857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484040|NCT01660971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5484041|NCT01523977|Prednisone|prednisone|mesh-list
5484042|NCT01523977|Doxorubicin|doxorubicin|mesh-list
6452397|NCT00416676|Cyclophosphamide|cyclophosphamide|mesh-list
6452398|NCT00416676|Carboplatin|carboplatin|mesh-list
6452399|NCT00416676|Etoposide|etoposide|mesh-list
6452400|NCT00416676|Vincristine|vincristine|mesh-list
6452401|NCT00416676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6452402|NCT00416676|Immunologic Factors|immunologic factors|mesh-ancestor
6452403|NCT00416676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452404|NCT00416676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6452405|NCT00416676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6452406|NCT00416676|Alkylating Agents|alkylating agents|mesh-ancestor
6452407|NCT00416676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6452408|NCT00416676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6452409|NCT00416676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6452410|NCT00416676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6452411|NCT00416676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6452412|NCT00416676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6638500|NCT01364883|Vaccines|vaccines|mesh-list
6638501|NCT01364883|Immunologic Factors|immunologic factors|mesh-ancestor
5484043|NCT01523977|Dexrazoxane|dexrazoxane|mesh-list
5484044|NCT01523977|Vincristine|vincristine|mesh-list
5484045|NCT01523977|Everolimus|everolimus|mesh-list
6638502|NCT01364883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663330|NCT01506973|Antimalarials|antimalarials|mesh-ancestor
6663331|NCT01506973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6663332|NCT01506973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6663333|NCT01506973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6663334|NCT01506986|Metronidazole|metronidazole|mesh-list
6021305|NCT00398320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021306|NCT00398398|Capecitabine|capecitabine|mesh-list
6021307|NCT00398398|Oxaliplatin|oxaliplatin|mesh-list
6021308|NCT00398398|Cetuximab|cetuximab|mesh-list
6021309|NCT00398398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6452413|NCT00416676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6452414|NCT00416676|Tubulin Modulators|tubulin modulators|mesh-ancestor
6452415|NCT00416676|Antimitotic Agents|antimitotic agents|mesh-ancestor
6452416|NCT00416676|Mitosis Modulators|mitosis modulators|mesh-ancestor
6452417|NCT00416728|Valsartan|valsartan|mesh-list
6452418|NCT00416728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6452419|NCT00416728|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6452420|NCT00416728|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6452421|NCT00416728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6452422|NCT00416767|Leucovorin|leucovorin|mesh-list
6452423|NCT00416767|Fluorouracil|fluorouracil|mesh-list
6452424|NCT00416767|Irinotecan|irinotecan|mesh-list
6452425|NCT00416767|Calcium|calcium|mesh-list
6452426|NCT00416767|Levoleucovorin|levoleucovorin|mesh-list
6452427|NCT00416767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6452428|NCT00416767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452429|NCT00416767|Antimetabolites|antimetabolites|mesh-ancestor
6452430|NCT00416767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6452431|NCT00416767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6663335|NCT01506986|Clarithromycin|clarithromycin|mesh-list
6663336|NCT01506986|Lansoprazole|lansoprazole|mesh-list
6663337|NCT01506986|Dexlansoprazole|dexlansoprazole|mesh-list
6021310|NCT00398398|Antimetabolites|antimetabolites|mesh-ancestor
6452432|NCT00416767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6663338|NCT01506986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6663339|NCT01506986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6663340|NCT01506986|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6663341|NCT01506986|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6663342|NCT01506986|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6663343|NCT01506986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6663344|NCT01506986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6452433|NCT00416767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6452434|NCT00416767|Immunologic Factors|immunologic factors|mesh-ancestor
6452435|NCT00416767|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6452436|NCT00416767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6452437|NCT00416767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6452438|NCT00416767|Antidotes|antidotes|mesh-ancestor
6452439|NCT00416767|Protective Agents|protective agents|mesh-ancestor
6452440|NCT00416767|Vitamin B Complex|vitamin b complex|mesh-ancestor
6452441|NCT00416767|Vitamins|vitamins|mesh-ancestor
6452442|NCT00416767|Micronutrients|micronutrients|mesh-ancestor
6452443|NCT00416819|Leucovorin|leucovorin|mesh-list
6452444|NCT00416819|Cytarabine|cytarabine|mesh-list
6452445|NCT00416819|Rituximab|rituximab|mesh-list
6452446|NCT00416819|Methotrexate|methotrexate|mesh-list
6452447|NCT00416819|Etoposide|etoposide|mesh-list
6663345|NCT01506986|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6663346|NCT01506986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5484046|NCT01523977|Asparaginase|asparaginase|mesh-list
5484047|NCT01523977|Pegaspargase|pegaspargase|mesh-list
5484048|NCT01523977|Razoxane|razoxane|mesh-list
5484049|NCT01523977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5484050|NCT01523977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5484051|NCT01523977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5484052|NCT01523977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5484053|NCT01523977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5484054|NCT01523977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484055|NCT01523977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5484056|NCT01523977|Glucocorticoids|glucocorticoids|mesh-ancestor
5484057|NCT01523977|Hormones|hormones|mesh-ancestor
5484058|NCT01523977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5484059|NCT01523977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484060|NCT01523977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5484061|NCT01523977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5484062|NCT01523977|Tubulin Modulators|tubulin modulators|mesh-ancestor
5484063|NCT01523977|Antimitotic Agents|antimitotic agents|mesh-ancestor
5484064|NCT01523977|Mitosis Modulators|mitosis modulators|mesh-ancestor
6638503|NCT01364961|Resveratrol|resveratrol|mesh-list
6638504|NCT01364961|Antioxidants|antioxidants|mesh-ancestor
6638505|NCT01364961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638506|NCT01364961|Protective Agents|protective agents|mesh-ancestor
6638507|NCT01364961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638508|NCT01364961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6638509|NCT01364961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6638510|NCT01364974|Peficitinib|peficitinib|mesh-list
6638511|NCT01364974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6638512|NCT01364974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638513|NCT01364974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6638514|NCT01364974|Immunologic Factors|immunologic factors|mesh-ancestor
6638515|NCT01364974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638516|NCT01364987|Mycophenolic Acid|mycophenolic acid|mesh-list
6021311|NCT00398398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021312|NCT00398398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6021313|NCT00398398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6021314|NCT00398411|Moxifloxacin|moxifloxacin|mesh-list
6021315|NCT00398411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6021316|NCT00398411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6021317|NCT00398411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6021318|NCT00398411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6021319|NCT00398411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6053245|NCT00593957|Antitussive Agents|antitussive agents|mesh-ancestor
6638517|NCT01364987|Peficitinib|peficitinib|mesh-list
6638518|NCT01364987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6638519|NCT01364987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6638520|NCT01364987|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6638521|NCT01364987|Antitubercular Agents|antitubercular agents|mesh-ancestor
6638522|NCT01364987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5484065|NCT01523977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6638523|NCT01364987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6638524|NCT01364987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6638525|NCT01364987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638526|NCT01364987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6638527|NCT01364987|Immunologic Factors|immunologic factors|mesh-ancestor
6638528|NCT01364987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638529|NCT01365000|Naloxegol|naloxegol|mesh-list
6638530|NCT01365000|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6638531|NCT01365000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638532|NCT01365000|Sensory System Agents|sensory system agents|mesh-ancestor
6638533|NCT01365000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6452448|NCT00416819|Temozolomide|temozolomide|mesh-list
6452449|NCT00416819|Etoposide phosphate|etoposide phosphate|mesh-list
6452450|NCT00416819|Levoleucovorin|levoleucovorin|mesh-list
6638534|NCT01365065|Vorinostat|vorinostat|mesh-list
6638535|NCT01365065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6638536|NCT01365065|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5484066|NCT01523977|Immunologic Factors|immunologic factors|mesh-ancestor
5484067|NCT01523977|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5484068|NCT01523977|Protective Agents|protective agents|mesh-ancestor
5484069|NCT01510184|Rituximab|rituximab|mesh-list
5484070|NCT01510184|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5484071|NCT01510184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5484072|NCT01510184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5484073|NCT01510184|Immunologic Factors|immunologic factors|mesh-ancestor
5484074|NCT01510184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484075|NCT01510184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5484076|NCT01471444|Vidarabine|vidarabine|mesh-list
5484077|NCT01471444|Methotrexate|methotrexate|mesh-list
5484078|NCT01471444|Fludarabine phosphate|fludarabine phosphate|mesh-list
5484079|NCT01471444|Clofarabine|clofarabine|mesh-list
5484080|NCT01471444|Fludarabine|fludarabine|mesh-list
5484081|NCT01471444|Busulfan|busulfan|mesh-list
5484082|NCT01471444|Tacrolimus|tacrolimus|mesh-list
5484083|NCT01471444|Thymoglobulin|thymoglobulin|mesh-list
6638537|NCT01365065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6638538|NCT01365065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638539|NCT01365104|Deferoxamine|deferoxamine|mesh-list
6638540|NCT01365104|Siderophores|siderophores|mesh-ancestor
6638541|NCT01365104|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6638542|NCT01365104|Chelating Agents|chelating agents|mesh-ancestor
6638543|NCT01365104|Sequestering Agents|sequestering agents|mesh-ancestor
6638544|NCT01365104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638545|NCT01365117|Insulin|insulin|mesh-list
6638546|NCT01365117|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6638547|NCT01365117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6638548|NCT01365117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638549|NCT01365221|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6638550|NCT01365221|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6638551|NCT01365260|Hyaluronic Acid|hyaluronic acid|mesh-list
6638552|NCT01365260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6638553|NCT01365260|Immunologic Factors|immunologic factors|mesh-ancestor
6638554|NCT01365260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638555|NCT01365260|Viscosupplements|viscosupplements|mesh-ancestor
6638556|NCT01365260|Protective Agents|protective agents|mesh-ancestor
6638557|NCT01365312|Ethanol|ethanol|mesh-list
6638558|NCT01365312|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6638559|NCT01365312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6638560|NCT01365312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6638561|NCT01365312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638562|NCT01365351|Hormones|hormones|mesh-list
6638563|NCT01365351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6638564|NCT01365351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638565|NCT01365403|Carbamazepine|carbamazepine|mesh-list
5484084|NCT01471444|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5484085|NCT01471444|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5484086|NCT01471444|Abortifacient Agents|abortifacient agents|mesh-ancestor
5502505|NCT04466241|Antimetabolites|antimetabolites|mesh-ancestor
6452451|NCT00416819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6452452|NCT00416819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6452453|NCT00416819|Immunologic Factors|immunologic factors|mesh-ancestor
6452454|NCT00416819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452455|NCT00416819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6452456|NCT00416819|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6638566|NCT01365403|Anticonvulsants|anticonvulsants|mesh-ancestor
6638567|NCT01365403|Antimanic Agents|antimanic agents|mesh-ancestor
6638568|NCT01365403|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6638569|NCT01365403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6638570|NCT01365403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638571|NCT01365403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6638572|NCT01365403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6638573|NCT01365403|Analgesics|analgesics|mesh-ancestor
5484087|NCT01471444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5484088|NCT01471444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484089|NCT01471444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5484090|NCT01471444|Antimetabolites|antimetabolites|mesh-ancestor
5484091|NCT01471444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484092|NCT01471444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5484093|NCT01471444|Dermatologic Agents|dermatologic agents|mesh-ancestor
5484094|NCT01471444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5484095|NCT01471444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5484096|NCT01471444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5484097|NCT01471444|Immunologic Factors|immunologic factors|mesh-ancestor
5484098|NCT01471444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5484099|NCT01471444|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5484100|NCT01471444|Antiviral Agents|antiviral agents|mesh-ancestor
5484101|NCT01471444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5484102|NCT01471444|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5484103|NCT01471444|Alkylating Agents|alkylating agents|mesh-ancestor
5484104|NCT01471444|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5484105|NCT01471444|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5484106|NCT01238211|Cytarabine|cytarabine|mesh-list
5484107|NCT01238211|Daunorubicin|daunorubicin|mesh-list
5484108|NCT01238211|Dasatinib|dasatinib|mesh-list
5484109|NCT01238211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5484110|NCT01238211|Antimetabolites|antimetabolites|mesh-ancestor
5484111|NCT01238211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484112|NCT01238211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5484113|NCT01238211|Antiviral Agents|antiviral agents|mesh-ancestor
5484114|NCT01238211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5484115|NCT01238211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5484116|NCT01238211|Immunologic Factors|immunologic factors|mesh-ancestor
5484117|NCT01238211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484118|NCT01238211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5484119|NCT01238211|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5484120|NCT01238211|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5484121|NCT01238211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6638574|NCT01365403|Sensory System Agents|sensory system agents|mesh-ancestor
6638575|NCT01365403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6638576|NCT01365403|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6638577|NCT01365403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6638578|NCT01365403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638579|NCT01365403|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6638580|NCT01365403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6638581|NCT01365598|Primaquine|primaquine|mesh-list
6638582|NCT01365598|Antimalarials|antimalarials|mesh-ancestor
6638583|NCT01365598|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6638584|NCT01365598|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6638585|NCT01365598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6638586|NCT01365741|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6638587|NCT01365741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6638588|NCT01365871|Anesthetics|anesthetics|mesh-list
6638589|NCT01365871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6638590|NCT01365871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638591|NCT01365897|Modafinil|modafinil|mesh-list
6638592|NCT01365897|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6638593|NCT01365897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638594|NCT01365897|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6638595|NCT01365897|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6638596|NCT01365897|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6638597|NCT01365897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638598|NCT01365923|Dexmedetomidine|dexmedetomidine|mesh-list
6638599|NCT01365923|Remifentanil|remifentanil|mesh-list
6638600|NCT01365923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6638601|NCT01365923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6638602|NCT01365923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638603|NCT01365923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6638604|NCT01365923|Analgesics|analgesics|mesh-ancestor
6638605|NCT01365923|Sensory System Agents|sensory system agents|mesh-ancestor
6638606|NCT01365923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5484122|NCT01238211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5484123|NCT05162872|Niraparib|niraparib|mesh-list
5484124|NCT05162872|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5484125|NCT05162872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6638607|NCT01365923|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6638608|NCT01365923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6638609|NCT01365923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6638610|NCT01365923|Adrenergic Agents|adrenergic agents|mesh-ancestor
6638611|NCT01365923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6638612|NCT01365923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638613|NCT01365923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6638614|NCT01365923|Narcotics|narcotics|mesh-ancestor
6638615|NCT01365936|Menotropins|menotropins|mesh-list
6638616|NCT01365936|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6638617|NCT01365936|Fertility Agents|fertility agents|mesh-ancestor
6638618|NCT01365936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6638619|NCT01365936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638620|NCT01366001|Buprenorphine|buprenorphine|mesh-list
6638621|NCT01366001|ALKS-33|alks-33|mesh-list
6638622|NCT01366001|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6452457|NCT00416819|Abortifacient Agents|abortifacient agents|mesh-ancestor
6452458|NCT00416819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5484126|NCT05162872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484127|NCT05162872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5484128|NCT05162742|Colchicine|colchicine|mesh-list
5484129|NCT05162742|Gout Suppressants|gout suppressants|mesh-ancestor
5484130|NCT05162742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5484131|NCT05162742|Tubulin Modulators|tubulin modulators|mesh-ancestor
5484132|NCT05162742|Antimitotic Agents|antimitotic agents|mesh-ancestor
5484133|NCT05162742|Mitosis Modulators|mitosis modulators|mesh-ancestor
5484134|NCT05162742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484135|NCT05162742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5484136|NCT05162690|Dapagliflozin|dapagliflozin|mesh-list
5484137|NCT05162690|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5484138|NCT05162690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484139|NCT05162690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5484140|NCT05162690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484141|NCT05162625|Moxifloxacin|moxifloxacin|mesh-list
5484142|NCT05162625|Ciprofloxacin|ciprofloxacin|mesh-list
6452459|NCT00416819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6452460|NCT00416819|Antimetabolites|antimetabolites|mesh-ancestor
6452461|NCT00416819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484143|NCT05162625|Cefazolin|cefazolin|mesh-list
5484144|NCT05162625|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5484145|NCT05162625|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5484146|NCT05162625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5484147|NCT05162625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5484148|NCT05162625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5484149|NCT05162625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5484150|NCT05162625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5484151|NCT05162625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484152|NCT05162625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5484153|NCT05162625|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5484154|NCT05162625|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5484155|NCT05162456|Antibodies|antibodies|mesh-list
5484156|NCT05162456|Immunoglobulins|immunoglobulins|mesh-list
5484157|NCT05162456|Immunoglobulin G|immunoglobulin g|mesh-list
5484158|NCT05162456|Immunologic Factors|immunologic factors|mesh-ancestor
6452462|NCT00416819|Dermatologic Agents|dermatologic agents|mesh-ancestor
6452463|NCT00416819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6452464|NCT00416819|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6452465|NCT00416819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6452466|NCT00416819|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6452467|NCT00416819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6452468|NCT00416819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6452469|NCT00416819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6452470|NCT00416819|Antiviral Agents|antiviral agents|mesh-ancestor
6452471|NCT00416819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6452472|NCT00416819|Antidotes|antidotes|mesh-ancestor
6452473|NCT00416819|Protective Agents|protective agents|mesh-ancestor
6452474|NCT00416819|Vitamin B Complex|vitamin b complex|mesh-ancestor
6452475|NCT00416819|Vitamins|vitamins|mesh-ancestor
6452476|NCT00416819|Micronutrients|micronutrients|mesh-ancestor
6452477|NCT00416819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6638623|NCT01366001|Narcotics|narcotics|mesh-ancestor
6638624|NCT01366001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6638625|NCT01366001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638626|NCT01366001|Analgesics|analgesics|mesh-ancestor
6638627|NCT01366001|Sensory System Agents|sensory system agents|mesh-ancestor
6638628|NCT01366001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6638629|NCT01366001|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6638630|NCT01366118|Oxaliplatin|oxaliplatin|mesh-list
5484159|NCT05162456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484160|NCT05162430|Propofol|propofol|mesh-list
5484161|NCT05162430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5484162|NCT05162430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5484163|NCT05162430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484164|NCT05162430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5484165|NCT05162430|Anesthetics, General|anesthetics, general|mesh-ancestor
5484166|NCT05162430|Anesthetics|anesthetics|mesh-ancestor
6638631|NCT01366118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6638632|NCT01366183|Paclitaxel|paclitaxel|mesh-list
6638633|NCT01366183|Carboplatin|carboplatin|mesh-list
6638634|NCT01366183|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6638635|NCT01366183|Lenograstim|lenograstim|mesh-list
6638636|NCT01366183|Sargramostim|sargramostim|mesh-list
6638637|NCT01366183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6638638|NCT01366183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6638639|NCT01366183|Tubulin Modulators|tubulin modulators|mesh-ancestor
6638640|NCT01366183|Antimitotic Agents|antimitotic agents|mesh-ancestor
6638641|NCT01366183|Mitosis Modulators|mitosis modulators|mesh-ancestor
6638642|NCT01366183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638643|NCT01366183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6638644|NCT01366183|Immunologic Factors|immunologic factors|mesh-ancestor
6638645|NCT01366183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638646|NCT01366235|Chloroquine|chloroquine|mesh-list
6638647|NCT01366235|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
6638648|NCT01366235|Amebicides|amebicides|mesh-ancestor
6638649|NCT01366235|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6638650|NCT01366235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6638651|NCT01366235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6638652|NCT01366235|Antimalarials|antimalarials|mesh-ancestor
6638653|NCT01366235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6638654|NCT01366235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6638655|NCT01366235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6638656|NCT01366235|Analgesics|analgesics|mesh-ancestor
6638657|NCT01366235|Sensory System Agents|sensory system agents|mesh-ancestor
6638658|NCT01366235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6638659|NCT01366235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638660|NCT01366235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6638661|NCT01366235|Filaricides|filaricides|mesh-ancestor
6638662|NCT01366235|Antinematodal Agents|antinematodal agents|mesh-ancestor
6638663|NCT01366235|Anthelmintics|anthelmintics|mesh-ancestor
6638664|NCT01366300|Lidocaine|lidocaine|mesh-list
6638665|NCT01366300|Propofol|propofol|mesh-list
6638666|NCT01366300|Anesthetics, Local|anesthetics, local|mesh-ancestor
5484167|NCT05162417|Tolonium Chloride|tolonium chloride|mesh-list
6452478|NCT00416819|Alkylating Agents|alkylating agents|mesh-ancestor
6452479|NCT00416832|Prednisone|prednisone|mesh-list
6452480|NCT00416832|Cyclophosphamide|cyclophosphamide|mesh-list
6452481|NCT00416832|Dacarbazine|dacarbazine|mesh-list
6452482|NCT00416832|Doxorubicin|doxorubicin|mesh-list
6452483|NCT00416832|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6452484|NCT00416832|Etoposide|etoposide|mesh-list
6452485|NCT00416832|Vincristine|vincristine|mesh-list
6452486|NCT00416832|Procarbazine|procarbazine|mesh-list
6452487|NCT00416832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6452488|NCT00416832|Immunologic Factors|immunologic factors|mesh-ancestor
6452489|NCT00416832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452490|NCT00416832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6452491|NCT00416832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6452492|NCT00416832|Alkylating Agents|alkylating agents|mesh-ancestor
6452493|NCT00416832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6452494|NCT00416832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6452495|NCT00416832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6452496|NCT00416832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6452497|NCT00416832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6452498|NCT00416832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6638667|NCT01366300|Anesthetics|anesthetics|mesh-ancestor
6638668|NCT01366300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6638669|NCT01366300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638670|NCT01366300|Sensory System Agents|sensory system agents|mesh-ancestor
6638671|NCT01366300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6638672|NCT01366300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5484168|NCT05162417|Methylene Blue|methylene blue|mesh-list
5484169|NCT05162417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5484170|NCT05162417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484171|NCT05162417|Hemostatics|hemostatics|mesh-ancestor
5484172|NCT05162417|Coagulants|coagulants|mesh-ancestor
5484173|NCT05162417|Heparin Antagonists|heparin antagonists|mesh-ancestor
5484174|NCT05162300|Botulinum Toxins|botulinum toxins|mesh-list
5484175|NCT05162300|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5484176|NCT05162300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5484177|NCT05162300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484178|NCT05162300|Cholinergic Agents|cholinergic agents|mesh-ancestor
5484179|NCT05162300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6638673|NCT01366300|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6638674|NCT01366300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6638675|NCT01366300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6638676|NCT01366300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638677|NCT01366300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6638678|NCT01366300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6638679|NCT01366300|Anesthetics, General|anesthetics, general|mesh-ancestor
6638680|NCT01366313|Acetaminophen|acetaminophen|mesh-list
6638681|NCT01366313|Morphine|morphine|mesh-list
6638682|NCT01366313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6638683|NCT01366313|Narcotics|narcotics|mesh-ancestor
6638684|NCT01366313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6638685|NCT01366313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638686|NCT01366313|Analgesics|analgesics|mesh-ancestor
6638687|NCT01366313|Sensory System Agents|sensory system agents|mesh-ancestor
6638688|NCT01366313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6638689|NCT01366313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5484180|NCT05162300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484181|NCT05162196|Niraparib|niraparib|mesh-list
6638690|NCT01366313|Antipyretics|antipyretics|mesh-ancestor
6638691|NCT01366326|Bromides|bromides|mesh-list
6638692|NCT01366326|Methylnaltrexone|methylnaltrexone|mesh-list
6638693|NCT01366326|Anticonvulsants|anticonvulsants|mesh-ancestor
6638694|NCT01366326|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6638695|NCT01366326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638696|NCT01366326|Sensory System Agents|sensory system agents|mesh-ancestor
6638697|NCT01366326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6638698|NCT01366339|Methylnaltrexone|methylnaltrexone|mesh-list
6638699|NCT01366339|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6638700|NCT01366339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638701|NCT01366339|Sensory System Agents|sensory system agents|mesh-ancestor
6638702|NCT01366339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6638703|NCT01366352|Methylnaltrexone|methylnaltrexone|mesh-list
6638704|NCT01366352|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6638705|NCT01366352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638706|NCT01366352|Sensory System Agents|sensory system agents|mesh-ancestor
6638707|NCT01366352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6638708|NCT01366365|Methylnaltrexone|methylnaltrexone|mesh-list
6638709|NCT01366365|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6638710|NCT01366365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638711|NCT01366365|Sensory System Agents|sensory system agents|mesh-ancestor
6638712|NCT01366365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6638713|NCT01366378|Methylnaltrexone|methylnaltrexone|mesh-list
6638714|NCT01366378|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6638715|NCT01366378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638716|NCT01366378|Sensory System Agents|sensory system agents|mesh-ancestor
6638717|NCT01366378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6638718|NCT01366391|Metformin|metformin|mesh-list
6638719|NCT01366391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6638720|NCT01366391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638721|NCT01366547|Lamivudine|lamivudine|mesh-list
6638722|NCT01366547|Abacavir|abacavir|mesh-list
6638723|NCT01366547|Dideoxynucleosides|dideoxynucleosides|mesh-list
6638724|NCT01366547|Dolutegravir|dolutegravir|mesh-list
6638725|NCT01366547|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6638726|NCT01366547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6638727|NCT01366547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5484182|NCT05162196|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6021320|NCT00398411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021321|NCT00398411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6021322|NCT00398476|Fluticasone|fluticasone|mesh-list
6638728|NCT01366547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638729|NCT01366547|Antiviral Agents|antiviral agents|mesh-ancestor
5484183|NCT05162196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5484184|NCT05162196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484185|NCT05162196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5484186|NCT05162183|Liraglutide|liraglutide|mesh-list
5484187|NCT05162183|Glimepiride|glimepiride|mesh-list
5484188|NCT05162183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5484189|NCT05162183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484190|NCT05162183|Incretins|incretins|mesh-ancestor
5484191|NCT05162183|Hormones|hormones|mesh-ancestor
5484192|NCT05162183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6021323|NCT00398476|Xhance|xhance|mesh-list
6021324|NCT00398476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6021325|NCT00398476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6021326|NCT00398476|Autonomic Agents|autonomic agents|mesh-ancestor
6021327|NCT00398476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6021328|NCT00398476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021329|NCT00398476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6021330|NCT00398476|Respiratory System Agents|respiratory system agents|mesh-ancestor
6021331|NCT00398476|Dermatologic Agents|dermatologic agents|mesh-ancestor
6021332|NCT00398476|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6021333|NCT00398567|Trastuzumab|trastuzumab|mesh-list
6021334|NCT00398567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6021335|NCT00398567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6021336|NCT00398632|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6021337|NCT00398632|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6021338|NCT00398632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6638730|NCT01366547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6638731|NCT01366547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6638732|NCT01366547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6638733|NCT01366547|Antimetabolites|antimetabolites|mesh-ancestor
6638734|NCT01366547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6638735|NCT01366547|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6638752|NCT01366651|Doripenem|doripenem|mesh-list
6638753|NCT01366651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6638754|NCT01366651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6663347|NCT01506986|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6663348|NCT01506986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6663349|NCT01506986|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6665050|NCT01515553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6665051|NCT01515579|Liraglutide|liraglutide|mesh-list
6665052|NCT01515579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6665053|NCT01515579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665054|NCT01515579|Incretins|incretins|mesh-ancestor
6665055|NCT01515579|Hormones|hormones|mesh-ancestor
6665119|NCT01515826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6638755|NCT01367028|Bevacizumab|bevacizumab|mesh-list
6638756|NCT01367028|Trastuzumab|trastuzumab|mesh-list
6638757|NCT01367028|Docetaxel|docetaxel|mesh-list
6638758|NCT01367028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6638759|NCT01367028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6638760|NCT01367028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6638761|NCT01367028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6452499|NCT00416832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6452500|NCT00416832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6452501|NCT00416832|Glucocorticoids|glucocorticoids|mesh-ancestor
6452502|NCT00416832|Hormones|hormones|mesh-ancestor
6452503|NCT00416832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6452504|NCT00416832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6452505|NCT00416832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6452506|NCT00416832|Tubulin Modulators|tubulin modulators|mesh-ancestor
6452507|NCT00416832|Antimitotic Agents|antimitotic agents|mesh-ancestor
6452508|NCT00416832|Mitosis Modulators|mitosis modulators|mesh-ancestor
6452509|NCT00416845|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6452510|NCT00416845|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6452511|NCT00416845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6452512|NCT00416845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6452513|NCT00416845|Immunologic Factors|immunologic factors|mesh-ancestor
6452514|NCT00416845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452515|NCT00416858|Fluorouracil|fluorouracil|mesh-list
6452516|NCT00416858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6452517|NCT00416858|Antimetabolites|antimetabolites|mesh-ancestor
6452518|NCT00416858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6452519|NCT00416858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6452520|NCT00416858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6452521|NCT00416858|Immunologic Factors|immunologic factors|mesh-ancestor
6452522|NCT00416858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452523|NCT00416871|Interferons|interferons|mesh-list
6452524|NCT00416871|Interferon-alpha|interferon-alpha|mesh-list
6452525|NCT00416871|Aldesleukin|aldesleukin|mesh-list
6452526|NCT00416871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6452527|NCT00416871|Antiviral Agents|antiviral agents|mesh-ancestor
6452528|NCT00416871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6452529|NCT00416871|Immunologic Factors|immunologic factors|mesh-ancestor
6452530|NCT00416871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452531|NCT00416871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6452532|NCT00416871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6452533|NCT00416897|Dexamethasone|dexamethasone|mesh-list
6452534|NCT00416897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6452535|NCT00416897|Antiemetics|antiemetics|mesh-ancestor
6452536|NCT00416897|Autonomic Agents|autonomic agents|mesh-ancestor
6452537|NCT00416897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6452538|NCT00416897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452539|NCT00416897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6452540|NCT00416897|Glucocorticoids|glucocorticoids|mesh-ancestor
6452541|NCT00416897|Hormones|hormones|mesh-ancestor
6452542|NCT00416897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6452543|NCT00416897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6452544|NCT00416897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6452545|NCT00416910|Cyclophosphamide|cyclophosphamide|mesh-list
6452546|NCT00416910|Fludarabine|fludarabine|mesh-list
6452547|NCT00416910|Mitoxantrone|mitoxantrone|mesh-list
6452548|NCT00416910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6452549|NCT00416910|Immunologic Factors|immunologic factors|mesh-ancestor
6452550|NCT00416910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452551|NCT00416910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6452552|NCT00416910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6452553|NCT00416910|Alkylating Agents|alkylating agents|mesh-ancestor
6452554|NCT00416910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6452555|NCT00416910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6452556|NCT00416910|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6452557|NCT00416910|Analgesics|analgesics|mesh-ancestor
6452558|NCT00416910|Sensory System Agents|sensory system agents|mesh-ancestor
6452559|NCT00416910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6452560|NCT00416910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6452561|NCT00416910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6452562|NCT00416910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6638762|NCT01367028|Growth Substances|growth substances|mesh-ancestor
6638763|NCT01367028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638764|NCT01367028|Growth Inhibitors|growth inhibitors|mesh-ancestor
6638765|NCT01367028|Tubulin Modulators|tubulin modulators|mesh-ancestor
5484193|NCT05162183|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5484194|NCT05162183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5484195|NCT05162183|Immunologic Factors|immunologic factors|mesh-ancestor
5484196|NCT05162053|Clopidogrel|clopidogrel|mesh-list
5484197|NCT05162053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5484198|NCT05162053|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5484199|NCT05162053|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5484200|NCT05162053|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5484201|NCT05162053|Purinergic Agents|purinergic agents|mesh-ancestor
5484202|NCT05162053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5484203|NCT05162053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484204|NCT05162053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484205|NCT05162027|Erenumab|erenumab|mesh-list
5484206|NCT05162027|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
5484207|NCT05162027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484208|NCT05162027|Analgesics|analgesics|mesh-ancestor
5484209|NCT05162027|Sensory System Agents|sensory system agents|mesh-ancestor
5484210|NCT05162027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5484211|NCT05162027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638766|NCT01367028|Antimitotic Agents|antimitotic agents|mesh-ancestor
6638767|NCT01367028|Mitosis Modulators|mitosis modulators|mesh-ancestor
6638768|NCT01367028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638769|NCT01367054|Metformin|metformin|mesh-list
6638770|NCT01367054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6638771|NCT01367054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638772|NCT01367210|Maraviroc|maraviroc|mesh-list
6638773|NCT01367210|Darunavir|darunavir|mesh-list
6638774|NCT01367210|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6638775|NCT01367210|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6638776|NCT01367210|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6638777|NCT01367210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638778|NCT01367210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6638779|NCT01367210|Antiviral Agents|antiviral agents|mesh-ancestor
6638780|NCT01367210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6638781|NCT01367210|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6638782|NCT01367210|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6638783|NCT01367210|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6638784|NCT01367210|Protease Inhibitors|protease inhibitors|mesh-ancestor
6638785|NCT01367210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6638786|NCT01367223|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
6638787|NCT01367223|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6638788|NCT01367223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6638789|NCT01367288|Zoledronic Acid|zoledronic acid|mesh-list
6638790|NCT01367288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6638791|NCT01367288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638792|NCT01367301|Paclitaxel|paclitaxel|mesh-list
6638793|NCT01367301|Carboplatin|carboplatin|mesh-list
6638794|NCT01367301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6638795|NCT01367301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6638796|NCT01367301|Tubulin Modulators|tubulin modulators|mesh-ancestor
6638797|NCT01367301|Antimitotic Agents|antimitotic agents|mesh-ancestor
6638798|NCT01367301|Mitosis Modulators|mitosis modulators|mesh-ancestor
6638799|NCT01367301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638800|NCT01367418|Sufentanil|sufentanil|mesh-list
5484212|NCT05162001|Disulfiram|disulfiram|mesh-list
5484213|NCT05162001|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5484214|NCT05162001|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
5484215|NCT05162001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5484216|NCT05162001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638801|NCT01367418|Morphine|morphine|mesh-list
6638802|NCT01367418|Bupivacaine|bupivacaine|mesh-list
6638803|NCT01367418|Ropivacaine|ropivacaine|mesh-list
6638804|NCT01367418|Anesthetics, Local|anesthetics, local|mesh-ancestor
6638805|NCT01367418|Anesthetics|anesthetics|mesh-ancestor
6638806|NCT01367418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5484217|NCT05161975|Vitamin K|vitamin k|mesh-list
5484218|NCT05161975|Vitamin K 2|vitamin k 2|mesh-list
5484219|NCT05161975|Vitamins|vitamins|mesh-ancestor
5484220|NCT05161975|Micronutrients|micronutrients|mesh-ancestor
5484221|NCT05161975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484222|NCT05161975|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5484223|NCT05161975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5484224|NCT05161975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484225|NCT05161975|Hemostatics|hemostatics|mesh-ancestor
5484226|NCT05161975|Coagulants|coagulants|mesh-ancestor
5502506|NCT04466241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502507|NCT04466241|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5502508|NCT04466241|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5502509|NCT04466241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5502510|NCT04466241|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5502511|NCT04466241|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5502512|NCT04466241|Protease Inhibitors|protease inhibitors|mesh-ancestor
5502513|NCT04466241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5502514|NCT04466241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6638807|NCT01367418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638808|NCT01367418|Sensory System Agents|sensory system agents|mesh-ancestor
6638809|NCT01367418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6638810|NCT01367418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6638811|NCT01367418|Narcotics|narcotics|mesh-ancestor
6638812|NCT01367418|Analgesics|analgesics|mesh-ancestor
6638813|NCT01367418|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6638814|NCT01367418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6638815|NCT01367418|Anesthetics, General|anesthetics, general|mesh-ancestor
6638816|NCT01367431|Xanthohumol|xanthohumol|mesh-list
6638817|NCT01367431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6638818|NCT01367431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6638819|NCT01367431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6638820|NCT01367431|Growth Substances|growth substances|mesh-ancestor
6638821|NCT01367431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638822|NCT01367431|Growth Inhibitors|growth inhibitors|mesh-ancestor
6638823|NCT01367483|Methylnaltrexone|methylnaltrexone|mesh-list
6638824|NCT01367483|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6638825|NCT01367483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638826|NCT01367483|Sensory System Agents|sensory system agents|mesh-ancestor
6638827|NCT01367483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6638828|NCT01367496|Naltrexone|naltrexone|mesh-list
6638829|NCT01367496|Methylnaltrexone|methylnaltrexone|mesh-list
6638830|NCT01367496|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6638831|NCT01367496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638832|NCT01367496|Sensory System Agents|sensory system agents|mesh-ancestor
6638833|NCT01367496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6638834|NCT01367496|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6638835|NCT01367509|Methylnaltrexone|methylnaltrexone|mesh-list
6638836|NCT01367509|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6638837|NCT01367509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638838|NCT01367509|Sensory System Agents|sensory system agents|mesh-ancestor
6638839|NCT01367509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6638840|NCT01367522|Methylnaltrexone|methylnaltrexone|mesh-list
6638841|NCT01367522|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6638842|NCT01367522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638843|NCT01367522|Sensory System Agents|sensory system agents|mesh-ancestor
6638844|NCT01367522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6638845|NCT01367535|Naltrexone|naltrexone|mesh-list
6638846|NCT01367535|Methylnaltrexone|methylnaltrexone|mesh-list
6638847|NCT01367535|Paroxetine|paroxetine|mesh-list
6638848|NCT01367535|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6638849|NCT01367535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6638850|NCT01367535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6638851|NCT01367535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638852|NCT01367535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6638853|NCT01367535|Serotonin Agents|serotonin agents|mesh-ancestor
6638854|NCT01367535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638855|NCT01367535|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6638856|NCT01367535|Antidepressive Agents|antidepressive agents|mesh-ancestor
6638857|NCT01367535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6638858|NCT01367535|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6638859|NCT01367535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6638860|NCT01367535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6638861|NCT01367535|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5484227|NCT05161572|Oxaliplatin|oxaliplatin|mesh-list
5484228|NCT05161572|Tegafur|tegafur|mesh-list
6638862|NCT01367535|Sensory System Agents|sensory system agents|mesh-ancestor
6638863|NCT01367535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6638864|NCT01367535|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6638865|NCT01367548|Methylnaltrexone|methylnaltrexone|mesh-list
6638866|NCT01367548|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6638867|NCT01367548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638868|NCT01367548|Sensory System Agents|sensory system agents|mesh-ancestor
6638869|NCT01367548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5484229|NCT05161572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5484230|NCT05161572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5484231|NCT05161572|Antimetabolites|antimetabolites|mesh-ancestor
5484232|NCT05161572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484233|NCT05161533|Cisplatin|cisplatin|mesh-list
6452563|NCT00416923|Rituximab|rituximab|mesh-list
6638870|NCT01367561|Naloxone|naloxone|mesh-list
6638871|NCT01367561|Methylnaltrexone|methylnaltrexone|mesh-list
6638872|NCT01367561|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6638873|NCT01367561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638874|NCT01367561|Sensory System Agents|sensory system agents|mesh-ancestor
6638875|NCT01367561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6638876|NCT01367574|Methylnaltrexone|methylnaltrexone|mesh-list
6638877|NCT01367574|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6638878|NCT01367574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638879|NCT01367574|Sensory System Agents|sensory system agents|mesh-ancestor
6638880|NCT01367574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6638881|NCT01367587|Methylnaltrexone|methylnaltrexone|mesh-list
6638882|NCT01367587|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6638883|NCT01367587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638884|NCT01367587|Sensory System Agents|sensory system agents|mesh-ancestor
6638885|NCT01367587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6638886|NCT01367600|Methylnaltrexone|methylnaltrexone|mesh-list
6638887|NCT01367600|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6638888|NCT01367600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484234|NCT05161533|Carboplatin|carboplatin|mesh-list
5484235|NCT05161533|Etoposide|etoposide|mesh-list
6452564|NCT00416923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6452565|NCT00416923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6452566|NCT00416923|Immunologic Factors|immunologic factors|mesh-ancestor
6452567|NCT00416923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452568|NCT00416923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6452569|NCT00416962|Oseltamivir|oseltamivir|mesh-list
6452570|NCT00416962|Amantadine|amantadine|mesh-list
6452571|NCT00416962|Antiviral Agents|antiviral agents|mesh-ancestor
6452572|NCT00416962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6452573|NCT00416962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6452574|NCT00416962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6452575|NCT00416962|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6452576|NCT00416962|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6452577|NCT00416962|Dopamine Agents|dopamine agents|mesh-ancestor
6452578|NCT00416962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6452579|NCT00416962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452580|NCT00416962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6638889|NCT01367600|Sensory System Agents|sensory system agents|mesh-ancestor
6638890|NCT01367600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6638891|NCT01367613|Methylnaltrexone|methylnaltrexone|mesh-list
6638892|NCT01367613|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6638893|NCT01367613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638894|NCT01367613|Sensory System Agents|sensory system agents|mesh-ancestor
6638895|NCT01367613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6638896|NCT01367626|Letrozole|letrozole|mesh-list
6638897|NCT01367626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6638898|NCT01367626|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6638899|NCT01367626|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6638900|NCT01367626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6638901|NCT01367626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638902|NCT01367626|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6638903|NCT01367626|Hormone Antagonists|hormone antagonists|mesh-ancestor
6638904|NCT01367626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6638905|NCT01367626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638906|NCT01367652|Letrozole|letrozole|mesh-list
6638907|NCT01367652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6638908|NCT01367652|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6638909|NCT01367652|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6638910|NCT01367652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6638911|NCT01367652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638912|NCT01367652|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6638913|NCT01367652|Hormone Antagonists|hormone antagonists|mesh-ancestor
6638914|NCT01367652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6638915|NCT01367652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638916|NCT01367678|Chlorhexidine|chlorhexidine|mesh-list
6638917|NCT01367678|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6638918|NCT01367678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6638919|NCT01367678|Disinfectants|disinfectants|mesh-ancestor
6638920|NCT01367743|Epinephrine|epinephrine|mesh-list
6638921|NCT01367743|Norepinephrine|norepinephrine|mesh-list
6638922|NCT01367743|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
6638923|NCT01367743|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6638924|NCT01367743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6638925|NCT01367743|Adrenergic Agents|adrenergic agents|mesh-ancestor
6638926|NCT01367743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6638927|NCT01367743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638928|NCT01367743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638929|NCT01367743|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6638930|NCT01367743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6638931|NCT01367743|Autonomic Agents|autonomic agents|mesh-ancestor
6638932|NCT01367743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6638933|NCT01367743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6638934|NCT01367743|Respiratory System Agents|respiratory system agents|mesh-ancestor
6638935|NCT01367743|Mydriatics|mydriatics|mesh-ancestor
6638936|NCT01367743|Sympathomimetics|sympathomimetics|mesh-ancestor
6638937|NCT01367756|Citalopram|citalopram|mesh-list
6638938|NCT01367756|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6638939|NCT01367756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6638940|NCT01367756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6638941|NCT01367756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638942|NCT01367756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6638943|NCT01367756|Serotonin Agents|serotonin agents|mesh-ancestor
6638944|NCT01367756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638945|NCT01367756|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6638946|NCT01367756|Antidepressive Agents|antidepressive agents|mesh-ancestor
6638947|NCT01367756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6638948|NCT01367912|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6638949|NCT01367912|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6638950|NCT01367912|Estradiol|estradiol|mesh-list
6638951|NCT01367912|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6638952|NCT01367912|Estrogens|estrogens|mesh-ancestor
6638953|NCT01367912|Hormones|hormones|mesh-ancestor
6638954|NCT01367912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6638955|NCT01367912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638956|NCT01367912|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6638957|NCT01367912|Contraceptive Agents|contraceptive agents|mesh-ancestor
6638958|NCT01367912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6663350|NCT01507064|Sorafenib|sorafenib|mesh-list
6021339|NCT00398632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6021340|NCT00398632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021341|NCT00398632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6021342|NCT00398632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021343|NCT00398632|Analgesics|analgesics|mesh-ancestor
6021344|NCT00398632|Sensory System Agents|sensory system agents|mesh-ancestor
6021345|NCT00398632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6021346|NCT00398632|Antidepressive Agents|antidepressive agents|mesh-ancestor
6021347|NCT00398632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6021348|NCT00398632|Dopamine Agents|dopamine agents|mesh-ancestor
6021349|NCT00398866|Triamcinolone|triamcinolone|mesh-list
6021350|NCT00398866|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6021351|NCT00398866|Bupivacaine|bupivacaine|mesh-list
6021352|NCT00398866|Hyaluronic Acid|hyaluronic acid|mesh-list
6021353|NCT00398866|Hylan|hylan|mesh-list
6021354|NCT00398866|Anesthetics, Local|anesthetics, local|mesh-ancestor
6021355|NCT00398866|Anesthetics|anesthetics|mesh-ancestor
6021356|NCT00398866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6638959|NCT01367912|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6638960|NCT01367964|Hormones|hormones|mesh-list
6638961|NCT01367964|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6638962|NCT01367964|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
6638963|NCT01367964|beta-Endorphin|beta-endorphin|mesh-list
6638964|NCT01367964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6638965|NCT01367964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638966|NCT01367964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6638967|NCT01367964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638968|NCT01367990|Norepinephrine|norepinephrine|mesh-list
6638969|NCT01367990|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6638970|NCT01367990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6638971|NCT01367990|Adrenergic Agents|adrenergic agents|mesh-ancestor
6638972|NCT01367990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6638973|NCT01367990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638974|NCT01367990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638975|NCT01367990|Sympathomimetics|sympathomimetics|mesh-ancestor
6638976|NCT01367990|Autonomic Agents|autonomic agents|mesh-ancestor
6638977|NCT01367990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6021357|NCT00398866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021358|NCT00398866|Sensory System Agents|sensory system agents|mesh-ancestor
6021359|NCT00398866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6021360|NCT00398866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6021361|NCT00398866|Glucocorticoids|glucocorticoids|mesh-ancestor
6021362|NCT00398866|Hormones|hormones|mesh-ancestor
6021363|NCT00398866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6021364|NCT00398866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6021365|NCT00398866|Immunologic Factors|immunologic factors|mesh-ancestor
6452581|NCT00416962|Analgesics|analgesics|mesh-ancestor
6452582|NCT00416962|Sensory System Agents|sensory system agents|mesh-ancestor
6452583|NCT00416962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6452584|NCT00417014|Prednisolone|prednisolone|mesh-list
6452585|NCT00417014|Vinblastine|vinblastine|mesh-list
6452586|NCT00417014|Procarbazine|procarbazine|mesh-list
6452587|NCT00417014|Chlorambucil|chlorambucil|mesh-list
6452588|NCT00417014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6452589|NCT00417014|Glucocorticoids|glucocorticoids|mesh-ancestor
6452590|NCT00417014|Hormones|hormones|mesh-ancestor
6452591|NCT00417014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6452592|NCT00417014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452593|NCT00417014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6452594|NCT00417014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6452595|NCT00417014|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6638978|NCT01367990|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6638979|NCT01368003|Dutasteride|dutasteride|mesh-list
6638980|NCT01368003|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6452596|NCT00417014|Tubulin Modulators|tubulin modulators|mesh-ancestor
6452597|NCT00417014|Antimitotic Agents|antimitotic agents|mesh-ancestor
6452598|NCT00417014|Mitosis Modulators|mitosis modulators|mesh-ancestor
6461899|NCT00456794|Istradefylline|istradefylline|mesh-list
6638981|NCT01368003|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6638982|NCT01368003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6638983|NCT01368003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638984|NCT01368003|Hormone Antagonists|hormone antagonists|mesh-ancestor
6663351|NCT01507064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6638985|NCT01368003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6638986|NCT01368003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638987|NCT01368016|Nicotine|nicotine|mesh-list
6638988|NCT01368016|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6638989|NCT01368016|Autonomic Agents|autonomic agents|mesh-ancestor
6638990|NCT01368016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6638991|NCT01368016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6638992|NCT01368016|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6638993|NCT01368016|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6638994|NCT01368016|Cholinergic Agents|cholinergic agents|mesh-ancestor
6638995|NCT01368016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6638996|NCT01368016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6638997|NCT01368068|Tibolone|tibolone|mesh-list
6638998|NCT01368068|Citalopram|citalopram|mesh-list
6638999|NCT01368068|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6639000|NCT01368068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6639001|NCT01368068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6639002|NCT01368068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639003|NCT01368068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6639004|NCT01368068|Serotonin Agents|serotonin agents|mesh-ancestor
6639005|NCT01368068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639006|NCT01368068|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6639007|NCT01368068|Antidepressive Agents|antidepressive agents|mesh-ancestor
6639008|NCT01368068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6639009|NCT01368068|Androgen Antagonists|androgen antagonists|mesh-ancestor
6639010|NCT01368068|Hormone Antagonists|hormone antagonists|mesh-ancestor
6639011|NCT01368068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6639012|NCT01368068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6639013|NCT01368068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6639014|NCT01368068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6639015|NCT01368068|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6639016|NCT01368068|Anabolic Agents|anabolic agents|mesh-ancestor
6639017|NCT01368068|Hormones|hormones|mesh-ancestor
6639018|NCT01368198|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6639019|NCT01368198|Lubricant Eye Drops|lubricant eye drops|mesh-list
6639020|NCT01368198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6639021|NCT01368328|Chromium|chromium|mesh-list
6639022|NCT01368328|Niacin|niacin|mesh-list
6639023|NCT01368328|Trace Elements|trace elements|mesh-ancestor
6021366|NCT00398866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6021367|NCT00398866|Viscosupplements|viscosupplements|mesh-ancestor
6021368|NCT00398866|Protective Agents|protective agents|mesh-ancestor
6021369|NCT00398918|Zonisamide|zonisamide|mesh-list
6021370|NCT00398918|Anticonvulsants|anticonvulsants|mesh-ancestor
6639024|NCT01368328|Micronutrients|micronutrients|mesh-ancestor
6639025|NCT01368328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639026|NCT01368328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6639027|NCT01368328|Antimetabolites|antimetabolites|mesh-ancestor
6639028|NCT01368328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639029|NCT01368328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6639030|NCT01368328|Vasodilator Agents|vasodilator agents|mesh-ancestor
6639031|NCT01368328|Vitamin B Complex|vitamin b complex|mesh-ancestor
6639032|NCT01368328|Vitamins|vitamins|mesh-ancestor
6639033|NCT01368341|Amoxicillin|amoxicillin|mesh-list
6639034|NCT01368341|Doxycycline|doxycycline|mesh-list
6639035|NCT01368341|Penicillin V|penicillin v|mesh-list
6639036|NCT01368341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6639037|NCT01368341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6639038|NCT01368341|Antimalarials|antimalarials|mesh-ancestor
6639039|NCT01368341|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6639040|NCT01368341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6663352|NCT01507064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6021371|NCT00398918|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6021372|NCT00398918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5484236|NCT05161533|Etoposide phosphate|etoposide phosphate|mesh-list
5484237|NCT05161533|Durvalumab|durvalumab|mesh-list
5484238|NCT05161533|Podophyllotoxin|podophyllotoxin|mesh-list
5484239|NCT05161533|Immunoglobulins|immunoglobulins|mesh-list
5484240|NCT05161533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5484241|NCT05161533|Immunoglobulin G|immunoglobulin g|mesh-list
5484242|NCT05161533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5484243|NCT05161533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5484244|NCT05161533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6021373|NCT00398918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054266|NCT00602043|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5484245|NCT05161533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6639041|NCT01368419|Endostar protein|endostar protein|mesh-list
6639042|NCT01368419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6639043|NCT01368419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6639044|NCT01368419|Growth Substances|growth substances|mesh-ancestor
6639045|NCT01368419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639046|NCT01368419|Growth Inhibitors|growth inhibitors|mesh-ancestor
6639047|NCT01368419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6639048|NCT01368445|Azelastine|azelastine|mesh-list
5484246|NCT05161533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5484247|NCT05161533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484248|NCT05161533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5484249|NCT05161533|Immunologic Factors|immunologic factors|mesh-ancestor
5484250|NCT05161533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484251|NCT05161533|Keratolytic Agents|keratolytic agents|mesh-ancestor
5484252|NCT05161533|Dermatologic Agents|dermatologic agents|mesh-ancestor
5484253|NCT05161533|Tubulin Modulators|tubulin modulators|mesh-ancestor
5484254|NCT05161533|Antimitotic Agents|antimitotic agents|mesh-ancestor
5484255|NCT05161533|Mitosis Modulators|mitosis modulators|mesh-ancestor
6639049|NCT01368445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6639050|NCT01368445|Autonomic Agents|autonomic agents|mesh-ancestor
6639051|NCT01368445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6639052|NCT01368445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639053|NCT01368445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6639054|NCT01368445|Respiratory System Agents|respiratory system agents|mesh-ancestor
6639055|NCT01368445|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6639056|NCT01368445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6639057|NCT01368445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639058|NCT01368445|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6639059|NCT01368445|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6639060|NCT01368445|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6639061|NCT01368445|Histamine Antagonists|histamine antagonists|mesh-ancestor
6639062|NCT01368445|Histamine Agents|histamine agents|mesh-ancestor
6639063|NCT01368445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6639064|NCT01368458|Antipsychotic Agents|antipsychotic agents|mesh-list
6639065|NCT01368458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6639066|NCT01368458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6639067|NCT01368458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639068|NCT01368458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6639069|NCT01368627|Sirolimus|sirolimus|mesh-list
6639070|NCT01368627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6639071|NCT01368627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6639072|NCT01368627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6639073|NCT01368627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5484256|NCT05161403|Hyaluronic Acid|hyaluronic acid|mesh-list
5484257|NCT05161403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5484258|NCT05161403|Immunologic Factors|immunologic factors|mesh-ancestor
5484259|NCT05161403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639074|NCT01368627|Antifungal Agents|antifungal agents|mesh-ancestor
6639075|NCT01368627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6639076|NCT01368627|Immunologic Factors|immunologic factors|mesh-ancestor
6639077|NCT01368627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639078|NCT01368757|Lenalidomide|lenalidomide|mesh-list
6639079|NCT01368757|Immunologic Factors|immunologic factors|mesh-ancestor
6639080|NCT01368757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639081|NCT01368757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6639082|NCT01368757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6639083|NCT01368757|Growth Substances|growth substances|mesh-ancestor
6639084|NCT01368757|Growth Inhibitors|growth inhibitors|mesh-ancestor
6639085|NCT01368757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6639086|NCT01368783|Ritonavir|ritonavir|mesh-list
6639087|NCT01368783|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6639088|NCT01368783|Tenofovir|tenofovir|mesh-list
6639089|NCT01368783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6639090|NCT01368783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6639091|NCT01368783|Protease Inhibitors|protease inhibitors|mesh-ancestor
5484260|NCT05161403|Viscosupplements|viscosupplements|mesh-ancestor
5484261|NCT05161403|Protective Agents|protective agents|mesh-ancestor
5484262|NCT05161351|Vitamin D|vitamin d|mesh-list
5484263|NCT05161351|Cholecalciferol|cholecalciferol|mesh-list
5484264|NCT05161351|Baclofen|baclofen|mesh-list
5484265|NCT05161351|Vitamins|vitamins|mesh-ancestor
5484266|NCT05161351|Micronutrients|micronutrients|mesh-ancestor
5484267|NCT05161351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484268|NCT05161351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5484269|NCT05161351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6639092|NCT01368783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6452599|NCT00417014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6452600|NCT00417014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6452601|NCT00417014|Alkylating Agents|alkylating agents|mesh-ancestor
6452602|NCT00417053|Cyclophosphamide|cyclophosphamide|mesh-list
6452603|NCT00417053|Melphalan|melphalan|mesh-list
6452604|NCT00417053|Busulfan|busulfan|mesh-list
6452605|NCT00417053|Carboplatin|carboplatin|mesh-list
6452606|NCT00417053|Doxorubicin|doxorubicin|mesh-list
6452607|NCT00417053|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6452608|NCT00417053|Etoposide|etoposide|mesh-list
6639093|NCT01368783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639094|NCT01368783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6639095|NCT01368783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6639096|NCT01368783|Antiviral Agents|antiviral agents|mesh-ancestor
6639097|NCT01368783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5484270|NCT05161351|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5484271|NCT05161351|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5484272|NCT05161351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5484273|NCT05161351|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
5484274|NCT05161351|GABA Agonists|gaba agonists|mesh-ancestor
5484275|NCT05161351|GABA Agents|gaba agents|mesh-ancestor
5484276|NCT05161351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5484277|NCT05161351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484278|NCT05161338|Estradiol|estradiol|mesh-list
5484279|NCT05161338|Progesterone|progesterone|mesh-list
5484280|NCT05161338|Estrogens|estrogens|mesh-ancestor
5484281|NCT05161338|Hormones|hormones|mesh-ancestor
5484282|NCT05161338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5484283|NCT05161338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484284|NCT05161338|Progestins|progestins|mesh-ancestor
5484285|NCT05161221|Acetaminophen|acetaminophen|mesh-list
5484286|NCT05161221|Naproxen|naproxen|mesh-list
5484287|NCT05161221|Oxycodone|oxycodone|mesh-list
5484288|NCT05161221|Bupivacaine|bupivacaine|mesh-list
5484289|NCT05161221|Anesthetics, Local|anesthetics, local|mesh-ancestor
5484290|NCT05161221|Anesthetics|anesthetics|mesh-ancestor
5484291|NCT05161221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5484292|NCT05161221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484293|NCT05161221|Sensory System Agents|sensory system agents|mesh-ancestor
5484294|NCT05161221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5484295|NCT05161221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5484296|NCT05161221|Narcotics|narcotics|mesh-ancestor
5484297|NCT05161221|Analgesics|analgesics|mesh-ancestor
5484298|NCT05161221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5484299|NCT05161221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5484300|NCT05161221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5484301|NCT05161221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5484302|NCT05161221|Gout Suppressants|gout suppressants|mesh-ancestor
5484303|NCT05161221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6639098|NCT01368783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6639099|NCT01368783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6639100|NCT01368783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6639101|NCT01368783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6639102|NCT01368848|Bevacizumab|bevacizumab|mesh-list
6639103|NCT01368848|Docetaxel|docetaxel|mesh-list
6639104|NCT01368848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6639105|NCT01368848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6639106|NCT01368848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6639107|NCT01368848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6639108|NCT01368848|Growth Substances|growth substances|mesh-ancestor
6639109|NCT01368848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639110|NCT01368848|Growth Inhibitors|growth inhibitors|mesh-ancestor
5484304|NCT05161221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6452609|NCT00417053|Vincristine|vincristine|mesh-list
6639111|NCT01368848|Tubulin Modulators|tubulin modulators|mesh-ancestor
6639112|NCT01368848|Antimitotic Agents|antimitotic agents|mesh-ancestor
6639113|NCT01368848|Mitosis Modulators|mitosis modulators|mesh-ancestor
6639114|NCT01368848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639115|NCT01368887|Niacinamide|niacinamide|mesh-list
6639116|NCT01368887|Niacin|niacin|mesh-list
6639117|NCT01368887|Nicotinic Acids|nicotinic acids|mesh-list
5484305|NCT05161221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484306|NCT05161221|Antipyretics|antipyretics|mesh-ancestor
5484307|NCT05161208|Varenicline|varenicline|mesh-list
5484308|NCT05161208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5484309|NCT05161208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6639118|NCT01368887|Calcipotriene|calcipotriene|mesh-list
6639119|NCT01368887|Vitamin B Complex|vitamin b complex|mesh-ancestor
6639120|NCT01368887|Vitamins|vitamins|mesh-ancestor
6639121|NCT01368887|Micronutrients|micronutrients|mesh-ancestor
6639122|NCT01368887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639123|NCT01368887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6639124|NCT01368887|Antimetabolites|antimetabolites|mesh-ancestor
6639125|NCT01368887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639126|NCT01368887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5484310|NCT05161208|Cholinergic Agents|cholinergic agents|mesh-ancestor
5484311|NCT05161208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5484312|NCT05161208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484313|NCT05161208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484314|NCT05161195|Tamoxifen|tamoxifen|mesh-list
5484315|NCT05161195|Letrozole|letrozole|mesh-list
5484316|NCT05161195|Fulvestrant|fulvestrant|mesh-list
5484317|NCT05161195|Anastrozole|anastrozole|mesh-list
6639127|NCT01368887|Vasodilator Agents|vasodilator agents|mesh-ancestor
6639128|NCT01368887|Dermatologic Agents|dermatologic agents|mesh-ancestor
6639129|NCT01369017|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6639130|NCT01369017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6639131|NCT01369043|Vitamins|vitamins|mesh-list
6639132|NCT01369043|Ascorbic Acid|ascorbic acid|mesh-list
6639133|NCT01369043|Vitamin E|vitamin e|mesh-list
6639134|NCT01369043|Micronutrients|micronutrients|mesh-ancestor
6639135|NCT01369043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639136|NCT01369043|Antioxidants|antioxidants|mesh-ancestor
6639137|NCT01369043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639138|NCT01369043|Protective Agents|protective agents|mesh-ancestor
6639139|NCT01369082|Cyclosporine|cyclosporine|mesh-list
6639140|NCT01369082|Sirolimus|sirolimus|mesh-list
6639141|NCT01369082|Mycophenolic Acid|mycophenolic acid|mesh-list
6639142|NCT01369082|Tacrolimus|tacrolimus|mesh-list
6639143|NCT01369082|Cyclosporins|cyclosporins|mesh-list
6639144|NCT01369082|Immunosuppressive Agents|immunosuppressive agents|mesh-list
6639145|NCT01369082|Immunologic Factors|immunologic factors|mesh-ancestor
6639146|NCT01369082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639147|NCT01369082|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6639148|NCT01369082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6639149|NCT01369082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639150|NCT01369082|Antifungal Agents|antifungal agents|mesh-ancestor
6639151|NCT01369082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6639152|NCT01369082|Dermatologic Agents|dermatologic agents|mesh-ancestor
6639153|NCT01369082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6639154|NCT01369082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6639155|NCT01369082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6639156|NCT01369082|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6639157|NCT01369082|Antitubercular Agents|antitubercular agents|mesh-ancestor
6639158|NCT01369082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6639159|NCT01369121|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
6639160|NCT01369121|Hormones|hormones|mesh-ancestor
6639161|NCT01369121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6639162|NCT01369121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639163|NCT01369186|Morphine|morphine|mesh-list
6639164|NCT01369186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6639165|NCT01369186|Narcotics|narcotics|mesh-ancestor
6639166|NCT01369186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6639167|NCT01369186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639168|NCT01369186|Analgesics|analgesics|mesh-ancestor
6639169|NCT01369186|Sensory System Agents|sensory system agents|mesh-ancestor
6639170|NCT01369186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5484318|NCT05161195|Goserelin|goserelin|mesh-list
6639171|NCT01369212|Tenofovir|tenofovir|mesh-list
6639172|NCT01369212|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6639173|NCT01369212|Antiviral Agents|antiviral agents|mesh-ancestor
6639174|NCT01369212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6663353|NCT01507064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6639175|NCT01369212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6452610|NCT00417053|Etoposide phosphate|etoposide phosphate|mesh-list
6452611|NCT00417053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6452612|NCT00417053|Immunologic Factors|immunologic factors|mesh-ancestor
6452613|NCT00417053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452614|NCT00417053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6452615|NCT00417053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6452616|NCT00417053|Alkylating Agents|alkylating agents|mesh-ancestor
6452617|NCT00417053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6452618|NCT00417053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6452619|NCT00417053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6452620|NCT00417053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6639176|NCT01369212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6639177|NCT01369212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6639178|NCT01369212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021374|NCT00398918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6021375|NCT00398918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021376|NCT00398983|Decitabine|decitabine|mesh-list
6452621|NCT00417053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6452622|NCT00417053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6452623|NCT00417053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6452624|NCT00417053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6452625|NCT00417053|Tubulin Modulators|tubulin modulators|mesh-ancestor
6452626|NCT00417053|Antimitotic Agents|antimitotic agents|mesh-ancestor
6452627|NCT00417053|Mitosis Modulators|mitosis modulators|mesh-ancestor
6452628|NCT00417066|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6452629|NCT00417066|Ganirelix|ganirelix|mesh-list
6452630|NCT00417066|Luteolytic Agents|luteolytic agents|mesh-ancestor
6639179|NCT01369212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6639180|NCT01369212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6452631|NCT00417066|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6452632|NCT00417066|Contraceptive Agents|contraceptive agents|mesh-ancestor
6452633|NCT00417066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6639181|NCT01369238|Pyranoprofen|pyranoprofen|mesh-list
6639182|NCT01369238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6639183|NCT01369238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6639184|NCT01369238|Analgesics|analgesics|mesh-ancestor
6639185|NCT01369238|Sensory System Agents|sensory system agents|mesh-ancestor
6639186|NCT01369238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6639187|NCT01369238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639188|NCT01369238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6639189|NCT01369238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6639190|NCT01369238|Gout Suppressants|gout suppressants|mesh-ancestor
6639191|NCT01369277|Nicotinic Acids|nicotinic acids|mesh-list
6639192|NCT01369277|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
6639193|NCT01369277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6639194|NCT01369277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639195|NCT01369277|Vitamin B Complex|vitamin b complex|mesh-ancestor
6639196|NCT01369277|Vitamins|vitamins|mesh-ancestor
6639197|NCT01369277|Micronutrients|micronutrients|mesh-ancestor
6639198|NCT01369277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639199|NCT01369290|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6639200|NCT01369290|Citalopram|citalopram|mesh-list
6639201|NCT01369290|Bupropion|bupropion|mesh-list
6639202|NCT01369290|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6639203|NCT01369290|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6639204|NCT01369290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6639205|NCT01369290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6665120|NCT01515826|Protease Inhibitors|protease inhibitors|mesh-ancestor
6021377|NCT00398983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6021378|NCT00398983|Antimetabolites|antimetabolites|mesh-ancestor
6021379|NCT00398983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021380|NCT00398983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6021381|NCT00398983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6021382|NCT00399035|Leucovorin|leucovorin|mesh-list
6021383|NCT00399035|Fluorouracil|fluorouracil|mesh-list
6021384|NCT00399035|Capecitabine|capecitabine|mesh-list
6021385|NCT00399035|Oxaliplatin|oxaliplatin|mesh-list
6021386|NCT00399035|Cediranib|cediranib|mesh-list
6021387|NCT00399035|Levoleucovorin|levoleucovorin|mesh-list
6021388|NCT00399035|Antimetabolites|antimetabolites|mesh-ancestor
6021389|NCT00399035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021390|NCT00399035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6021391|NCT00399035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6021392|NCT00399035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6021393|NCT00399035|Immunologic Factors|immunologic factors|mesh-ancestor
6021394|NCT00399035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021395|NCT00399035|Antidotes|antidotes|mesh-ancestor
6021396|NCT00399035|Protective Agents|protective agents|mesh-ancestor
6021397|NCT00399035|Vitamin B Complex|vitamin b complex|mesh-ancestor
6021398|NCT00399035|Vitamins|vitamins|mesh-ancestor
6021399|NCT00399035|Micronutrients|micronutrients|mesh-ancestor
6021400|NCT00399035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6639206|NCT01369290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639207|NCT01369290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6639208|NCT01369290|Serotonin Agents|serotonin agents|mesh-ancestor
6639209|NCT01369290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639210|NCT01369290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6639211|NCT01369290|Antidepressive Agents|antidepressive agents|mesh-ancestor
6639212|NCT01369290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6639213|NCT01369290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6639214|NCT01369290|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6639215|NCT01369290|Dopamine Agents|dopamine agents|mesh-ancestor
6639216|NCT01369290|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6639217|NCT01369290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6639218|NCT01369290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6639219|NCT01369290|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6639220|NCT01369290|Analgesics|analgesics|mesh-ancestor
6639221|NCT01369290|Sensory System Agents|sensory system agents|mesh-ancestor
6639222|NCT01369303|Tenofovir|tenofovir|mesh-list
6639223|NCT01369303|Antiviral Agents|antiviral agents|mesh-ancestor
6639224|NCT01369303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6639225|NCT01369303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6639226|NCT01369303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6639227|NCT01369303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6639228|NCT01369303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639229|NCT01369303|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6639230|NCT01369303|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6639231|NCT01369368|Azacitidine|azacitidine|mesh-list
6639232|NCT01369368|Valproic Acid|valproic acid|mesh-list
6639233|NCT01369368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6639234|NCT01369368|Antimetabolites|antimetabolites|mesh-ancestor
5484319|NCT05161195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5484320|NCT05161195|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6639235|NCT01369368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639236|NCT01369368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6639237|NCT01369368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6639238|NCT01369368|Anticonvulsants|anticonvulsants|mesh-ancestor
6639239|NCT01369368|GABA Agents|gaba agents|mesh-ancestor
6639240|NCT01369368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6639241|NCT01369368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639242|NCT01369368|Antimanic Agents|antimanic agents|mesh-ancestor
6639243|NCT01369368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6639244|NCT01369368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6021401|NCT00399035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6639245|NCT01369368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6639246|NCT01369472|Carvedilol|carvedilol|mesh-list
5484321|NCT05161195|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5484322|NCT05161195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5484323|NCT05161195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484324|NCT05161195|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5484325|NCT05161195|Hormone Antagonists|hormone antagonists|mesh-ancestor
5484326|NCT05161195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5484327|NCT05161195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484328|NCT05161195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5484329|NCT05161195|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5484330|NCT05161195|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5484331|NCT05161195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5484332|NCT05161195|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5484333|NCT05161156|Bromides|bromides|mesh-list
5484334|NCT05161156|Tiotropium Bromide|tiotropium bromide|mesh-list
5484335|NCT05161156|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5484336|NCT05161156|Autonomic Agents|autonomic agents|mesh-ancestor
5484337|NCT05161156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5484338|NCT05161156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484339|NCT05161156|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5484340|NCT05161156|Respiratory System Agents|respiratory system agents|mesh-ancestor
5484341|NCT05161156|Parasympatholytics|parasympatholytics|mesh-ancestor
5484342|NCT05161156|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5484343|NCT05161156|Cholinergic Agents|cholinergic agents|mesh-ancestor
5484344|NCT05161156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5484345|NCT05161156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484346|NCT05161156|Anticonvulsants|anticonvulsants|mesh-ancestor
5484347|NCT05144542|Nicotine|nicotine|mesh-list
5484348|NCT05144542|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5484349|NCT05144542|Autonomic Agents|autonomic agents|mesh-ancestor
5502515|NCT04466241|Antiviral Agents|antiviral agents|mesh-ancestor
6639247|NCT01369472|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6639248|NCT01369472|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6021402|NCT00399360|Metformin|metformin|mesh-list
6021403|NCT00399360|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6021404|NCT00399360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021405|NCT00399490|Tanezumab|tanezumab|mesh-list
6021406|NCT00399490|Analgesics|analgesics|mesh-ancestor
6021407|NCT00399490|Sensory System Agents|sensory system agents|mesh-ancestor
6639249|NCT01369472|Adrenergic Agents|adrenergic agents|mesh-ancestor
6639250|NCT01369472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6639251|NCT01369472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639252|NCT01369472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639253|NCT01369472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6639254|NCT01369472|Antioxidants|antioxidants|mesh-ancestor
6639255|NCT01369472|Protective Agents|protective agents|mesh-ancestor
6639256|NCT01369472|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6639257|NCT01369472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6639258|NCT01369472|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6639259|NCT01369472|Vasodilator Agents|vasodilator agents|mesh-ancestor
6639260|NCT01369472|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6639261|NCT01369472|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6639262|NCT01369576|Zopiclone|zopiclone|mesh-list
6639263|NCT01369576|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6639264|NCT01369576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6639265|NCT01369576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639266|NCT01369602|Nicotinic Acids|nicotinic acids|mesh-list
6639267|NCT01369602|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
6639268|NCT01369602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6639269|NCT01369602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639270|NCT01369602|Vitamin B Complex|vitamin b complex|mesh-ancestor
6639271|NCT01369602|Vitamins|vitamins|mesh-ancestor
6639272|NCT01369602|Micronutrients|micronutrients|mesh-ancestor
6054267|NCT00602043|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6452634|NCT00417066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452635|NCT00417066|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6452636|NCT00417066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6452637|NCT00417066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6452638|NCT00417066|Hormone Antagonists|hormone antagonists|mesh-ancestor
6452639|NCT00417066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6452640|NCT00417144|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6452641|NCT00417144|Ganirelix|ganirelix|mesh-list
6452642|NCT00417144|Luteolytic Agents|luteolytic agents|mesh-ancestor
6452643|NCT00417144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6452644|NCT00417144|Contraceptive Agents|contraceptive agents|mesh-ancestor
6452645|NCT00417144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6452646|NCT00417144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452647|NCT00417144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6452648|NCT00417144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6639273|NCT01369602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639274|NCT01369667|Vitamin D|vitamin d|mesh-list
5484350|NCT05144542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5484351|NCT05144542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484352|NCT05144542|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6639275|NCT01369667|Cholecalciferol|cholecalciferol|mesh-list
6639276|NCT01369667|Vitamins|vitamins|mesh-ancestor
6639277|NCT01369667|Micronutrients|micronutrients|mesh-ancestor
6639278|NCT01369667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639279|NCT01369667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6639280|NCT01369667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6639281|NCT01369693|Lobeline|lobeline|mesh-list
6639282|NCT01369693|Nicotine|nicotine|mesh-list
6639283|NCT01369693|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6639284|NCT01369693|Autonomic Agents|autonomic agents|mesh-ancestor
6639285|NCT01369693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6639286|NCT01369693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639287|NCT01369693|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6639288|NCT01369693|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6639289|NCT01369693|Cholinergic Agents|cholinergic agents|mesh-ancestor
6639290|NCT01369693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6639291|NCT01369693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639292|NCT01369693|Respiratory System Agents|respiratory system agents|mesh-ancestor
6639293|NCT01369719|Deferasirox|deferasirox|mesh-list
6639294|NCT01369719|Deferoxamine|deferoxamine|mesh-list
6639295|NCT01369719|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6639296|NCT01369719|Chelating Agents|chelating agents|mesh-ancestor
6639297|NCT01369719|Sequestering Agents|sequestering agents|mesh-ancestor
6639298|NCT01369719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639299|NCT01369719|Siderophores|siderophores|mesh-ancestor
6639300|NCT01369979|Imidacloprid|imidacloprid|mesh-list
6452649|NCT00417144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6452650|NCT00417144|Hormone Antagonists|hormone antagonists|mesh-ancestor
6452651|NCT00417144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6452652|NCT00417157|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6452653|NCT00417157|Ganirelix|ganirelix|mesh-list
6452654|NCT00417157|Hormone Antagonists|hormone antagonists|mesh-ancestor
6639301|NCT01369979|Cholinergic Agents|cholinergic agents|mesh-ancestor
5484353|NCT05144542|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5484354|NCT05144542|Cholinergic Agents|cholinergic agents|mesh-ancestor
5484355|NCT05144542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5484356|NCT05144542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484357|NCT05141903|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5484358|NCT05141903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5484359|NCT05141838|Vitamin D|vitamin d|mesh-list
6639302|NCT01369979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6639303|NCT01369979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639304|NCT01369979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484360|NCT05141838|Vitamins|vitamins|mesh-ancestor
5484361|NCT05141838|Micronutrients|micronutrients|mesh-ancestor
5484362|NCT05141838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484363|NCT05141838|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5484364|NCT05141149|Gemcitabine|gemcitabine|mesh-list
5484365|NCT05141149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5484366|NCT05141149|Antimetabolites|antimetabolites|mesh-ancestor
5484367|NCT05141149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461900|NCT00456794|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
6639305|NCT01370031|Charcoal|charcoal|mesh-list
6639306|NCT01370031|Antidotes|antidotes|mesh-ancestor
6639307|NCT01370031|Protective Agents|protective agents|mesh-ancestor
6639308|NCT01370031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639309|NCT01370096|Epoprostenol|epoprostenol|mesh-list
6639310|NCT01370096|Vasopressins|vasopressins|mesh-list
6639311|NCT01370096|Arginine Vasopressin|arginine vasopressin|mesh-list
6639312|NCT01370096|Tezosentan|tezosentan|mesh-list
6639313|NCT01370096|Hemostatics|hemostatics|mesh-ancestor
6639314|NCT01370096|Coagulants|coagulants|mesh-ancestor
5484368|NCT05141149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5484369|NCT05141149|Antiviral Agents|antiviral agents|mesh-ancestor
5484370|NCT05141149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5484371|NCT05141149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5484372|NCT05141149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5484373|NCT05141149|Immunologic Factors|immunologic factors|mesh-ancestor
5484374|NCT05141149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484375|NCT05137886|Decitabine|decitabine|mesh-list
5484376|NCT05137886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5484377|NCT05137886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5484378|NCT05137886|Antimetabolites|antimetabolites|mesh-ancestor
5484379|NCT05137886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484380|NCT05137886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5484381|NCT05137886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5484382|NCT05132231|Brodalumab|brodalumab|mesh-list
5484383|NCT05132231|Dermatologic Agents|dermatologic agents|mesh-ancestor
5484384|NCT05109702|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5484385|NCT05109702|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5484386|NCT05104099|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
5484387|NCT05104099|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5484388|NCT05104099|Dermatologic Agents|dermatologic agents|mesh-ancestor
5484389|NCT05096728|Nifedipine|nifedipine|mesh-list
5484390|NCT05096728|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5484391|NCT05096728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5484392|NCT05096728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484393|NCT05096728|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5484394|NCT05096728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484395|NCT05096728|Vasodilator Agents|vasodilator agents|mesh-ancestor
5484396|NCT05096728|Tocolytic Agents|tocolytic agents|mesh-ancestor
6639315|NCT01370096|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6639316|NCT01370096|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6639317|NCT01370096|Natriuretic Agents|natriuretic agents|mesh-ancestor
6639318|NCT01370096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639319|NCT01370096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6639320|NCT01370096|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6639321|NCT01370096|Vasodilator Agents|vasodilator agents|mesh-ancestor
6639322|NCT01370135|Ranibizumab|ranibizumab|mesh-list
6639323|NCT01370135|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6639324|NCT01370135|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6639325|NCT01370135|Growth Substances|growth substances|mesh-ancestor
6639326|NCT01370135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639327|NCT01370135|Growth Inhibitors|growth inhibitors|mesh-ancestor
6639328|NCT01370135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6639329|NCT01370148|Conivaptan|conivaptan|mesh-list
5484397|NCT05096728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5484398|NCT05079698|177Lu-PSMA-617|177lu-psma-617|mesh-list
6452655|NCT00417157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6452656|NCT00417157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452657|NCT00417157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5484399|NCT05079698|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5484400|NCT05079698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484401|NCT05074056|Ketorolac|ketorolac|mesh-list
5484402|NCT05074056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5484403|NCT05074056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5484404|NCT05074056|Analgesics|analgesics|mesh-ancestor
5484405|NCT05074056|Sensory System Agents|sensory system agents|mesh-ancestor
5484406|NCT05074056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5484407|NCT05074056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452658|NCT00417183|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6452659|NCT00417183|Ganirelix|ganirelix|mesh-list
6452660|NCT00417183|Luteolytic Agents|luteolytic agents|mesh-ancestor
6452661|NCT00417183|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6452662|NCT00417183|Contraceptive Agents|contraceptive agents|mesh-ancestor
6452663|NCT00417183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6639330|NCT01370148|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6639331|NCT01370148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639332|NCT01370148|Natriuretic Agents|natriuretic agents|mesh-ancestor
6639333|NCT01370148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452664|NCT00417183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452665|NCT00417183|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6452666|NCT00417183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6452667|NCT00417183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6639334|NCT01370161|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
6639335|NCT01370161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6639336|NCT01370161|Adrenergic Agents|adrenergic agents|mesh-ancestor
6639337|NCT01370161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6639338|NCT01370161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639339|NCT01370161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639340|NCT01370187|Montelukast|montelukast|mesh-list
6639341|NCT01370187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6639342|NCT01370187|Respiratory System Agents|respiratory system agents|mesh-ancestor
6452668|NCT00417183|Hormone Antagonists|hormone antagonists|mesh-ancestor
6452669|NCT00417183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6452670|NCT00417222|Olmesartan|olmesartan|mesh-list
6452671|NCT00417222|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6452672|NCT00417222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6452673|NCT00417222|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6452674|NCT00417222|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6452675|NCT00417222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6452676|NCT00417235|Chlorhexidine|chlorhexidine|mesh-list
6452677|NCT00417235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6452678|NCT00417235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6452679|NCT00417235|Disinfectants|disinfectants|mesh-ancestor
6452680|NCT00417326|Sivelestat|sivelestat|mesh-list
6452681|NCT00417326|Glycine|glycine|mesh-list
6452682|NCT00417326|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6452683|NCT00417326|Protease Inhibitors|protease inhibitors|mesh-ancestor
6452684|NCT00417326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6452685|NCT00417326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6452686|NCT00417326|Glycine Agents|glycine agents|mesh-ancestor
6452687|NCT00417326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6452688|NCT00417326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461901|NCT00456794|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6639343|NCT01370187|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6639344|NCT01370187|Hormone Antagonists|hormone antagonists|mesh-ancestor
6639345|NCT01370187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6639346|NCT01370187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639347|NCT01370187|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6639348|NCT01370187|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6639349|NCT01370187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665121|NCT01515826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6021408|NCT00399490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6021409|NCT00399490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021410|NCT00399529|Cyclophosphamide|cyclophosphamide|mesh-list
6021411|NCT00399529|Trastuzumab|trastuzumab|mesh-list
6021412|NCT00399529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6021413|NCT00399529|Immunologic Factors|immunologic factors|mesh-ancestor
6021414|NCT00399529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021415|NCT00399529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6021416|NCT00399529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6021417|NCT00399529|Alkylating Agents|alkylating agents|mesh-ancestor
6021418|NCT00399529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021419|NCT00399529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6021420|NCT00399529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6021421|NCT00399529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6639350|NCT01370291|Risperidone|risperidone|mesh-list
6639351|NCT01370291|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6639352|NCT01370291|Serotonin Agents|serotonin agents|mesh-ancestor
6639353|NCT01370291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6639354|NCT01370291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639355|NCT01370291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639356|NCT01370291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5484408|NCT05074056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5484409|NCT05074056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5484410|NCT05074056|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5484411|NCT05074056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5484412|NCT05074056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639357|NCT01370291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6639358|NCT01370291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6639359|NCT01370291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6021422|NCT00399542|Lubiprostone|lubiprostone|mesh-list
6021423|NCT00399542|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6021424|NCT00399542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6021425|NCT00399542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021426|NCT00399568|Acetaminophen|acetaminophen|mesh-list
6021427|NCT00399568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6021428|NCT00399568|Analgesics|analgesics|mesh-ancestor
6021429|NCT00399568|Sensory System Agents|sensory system agents|mesh-ancestor
6639360|NCT01370291|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6639361|NCT01370291|Dopamine Agents|dopamine agents|mesh-ancestor
6639362|NCT01370304|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6639363|NCT01370304|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6639364|NCT01370304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6639365|NCT01370304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6639366|NCT01370304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484413|NCT05067933|Vaccines|vaccines|mesh-list
5484414|NCT05067933|Immunologic Factors|immunologic factors|mesh-ancestor
5484415|NCT05067933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484416|NCT05067270|Insulin Lispro|insulin lispro|mesh-list
5484417|NCT05067270|Treprostinil|treprostinil|mesh-list
5484418|NCT05067270|Citric Acid|citric acid|mesh-list
5484419|NCT05067270|Sodium Citrate|sodium citrate|mesh-list
6639367|NCT01370304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6639368|NCT01370304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639369|NCT01370304|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6639370|NCT01370304|Antidepressive Agents|antidepressive agents|mesh-ancestor
6639371|NCT01370304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6639372|NCT01370330|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
6639373|NCT01370330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6639374|NCT01370330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6639375|NCT01370330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639376|NCT01370330|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6639377|NCT01370343|Nicotinic Acids|nicotinic acids|mesh-list
6639378|NCT01370343|Cyclosporine|cyclosporine|mesh-list
6639379|NCT01370343|Cyclosporins|cyclosporins|mesh-list
6639380|NCT01370343|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
6639381|NCT01370343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6639382|NCT01370343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639383|NCT01370343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6639384|NCT01370343|Immunologic Factors|immunologic factors|mesh-ancestor
6639385|NCT01370343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639386|NCT01370343|Antifungal Agents|antifungal agents|mesh-ancestor
6639387|NCT01370343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6639388|NCT01370343|Dermatologic Agents|dermatologic agents|mesh-ancestor
6639389|NCT01370343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6639390|NCT01370343|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6639391|NCT01370343|Vitamin B Complex|vitamin b complex|mesh-ancestor
6639392|NCT01370343|Vitamins|vitamins|mesh-ancestor
6639393|NCT01370343|Micronutrients|micronutrients|mesh-ancestor
5484420|NCT05067270|Anticoagulants|anticoagulants|mesh-ancestor
5484421|NCT05067270|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5484422|NCT05067270|Chelating Agents|chelating agents|mesh-ancestor
5484423|NCT05067270|Sequestering Agents|sequestering agents|mesh-ancestor
5484424|NCT05067270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484425|NCT05067270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5484426|NCT05067270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484427|NCT05067270|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5484428|NCT05063851|Memantine|memantine|mesh-list
5484429|NCT05063851|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5484430|NCT05063851|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5484431|NCT05063851|Dopamine Agents|dopamine agents|mesh-ancestor
5484432|NCT05063851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5484433|NCT05063851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484434|NCT05063851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484435|NCT05063851|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6021430|NCT00399568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6021431|NCT00399568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639394|NCT01370434|Dexamethasone|dexamethasone|mesh-list
6639395|NCT01370434|Doxorubicin|doxorubicin|mesh-list
6639396|NCT01370434|Vincristine|vincristine|mesh-list
6639397|NCT01370434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6639398|NCT01370434|Antiemetics|antiemetics|mesh-ancestor
6639399|NCT01370434|Autonomic Agents|autonomic agents|mesh-ancestor
6639400|NCT01370434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6639401|NCT01370434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639402|NCT01370434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6639403|NCT01370434|Glucocorticoids|glucocorticoids|mesh-ancestor
6639404|NCT01370434|Hormones|hormones|mesh-ancestor
6639405|NCT01370434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6639406|NCT01370434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6639407|NCT01370434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6639408|NCT01370434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6639409|NCT01370434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639410|NCT01370434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6639411|NCT01370434|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6639412|NCT01370434|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6639413|NCT01370434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6639414|NCT01370434|Tubulin Modulators|tubulin modulators|mesh-ancestor
6639415|NCT01370434|Antimitotic Agents|antimitotic agents|mesh-ancestor
6639416|NCT01370434|Mitosis Modulators|mitosis modulators|mesh-ancestor
6639417|NCT01370486|Melatonin|melatonin|mesh-list
6639418|NCT01370486|Antioxidants|antioxidants|mesh-ancestor
5484436|NCT05063851|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5484437|NCT05060237|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5484438|NCT05060237|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5484439|NCT05060237|Dermatologic Agents|dermatologic agents|mesh-ancestor
5484440|NCT05046522|Palmidrol|palmidrol|mesh-list
6639419|NCT01370486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639420|NCT01370486|Protective Agents|protective agents|mesh-ancestor
6639421|NCT01370486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639422|NCT01370486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6639423|NCT01370707|Metformin|metformin|mesh-list
6639424|NCT01370707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6639425|NCT01370707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639426|NCT01370772|Cyclophosphamide|cyclophosphamide|mesh-list
6639427|NCT01370772|Rituximab|rituximab|mesh-list
6639428|NCT01370772|Fludarabine|fludarabine|mesh-list
6639429|NCT01370772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6639430|NCT01370772|Immunologic Factors|immunologic factors|mesh-ancestor
6639431|NCT01370772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639432|NCT01370772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6639433|NCT01370772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5484441|NCT05046522|Analgesics|analgesics|mesh-ancestor
5484442|NCT05046522|Sensory System Agents|sensory system agents|mesh-ancestor
5484443|NCT05046522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5484444|NCT05046522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484445|NCT05046522|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5484446|NCT05046522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5484447|NCT05046522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5484448|NCT05046522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6639434|NCT01370772|Alkylating Agents|alkylating agents|mesh-ancestor
6639435|NCT01370772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639436|NCT01370772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6639437|NCT01370772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6639438|NCT01370772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6639439|NCT01370811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6639440|NCT01370876|Oxaliplatin|oxaliplatin|mesh-list
6639441|NCT01370876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6639442|NCT01370889|Resveratrol|resveratrol|mesh-list
6639443|NCT01370889|Antioxidants|antioxidants|mesh-ancestor
6639444|NCT01370889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639445|NCT01370889|Protective Agents|protective agents|mesh-ancestor
6639446|NCT01370889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639447|NCT01370889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6639448|NCT01370889|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6639449|NCT01370915|Vitamins|vitamins|mesh-list
6639450|NCT01370915|Pregabalin|pregabalin|mesh-list
6639451|NCT01370915|Micronutrients|micronutrients|mesh-ancestor
6639452|NCT01370915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639453|NCT01370915|Analgesics|analgesics|mesh-ancestor
6639454|NCT01370915|Sensory System Agents|sensory system agents|mesh-ancestor
6639455|NCT01370915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6639456|NCT01370915|Anticonvulsants|anticonvulsants|mesh-ancestor
6639457|NCT01370915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6639458|NCT01370915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5484449|NCT05046522|Antiviral Agents|antiviral agents|mesh-ancestor
5484450|NCT05046522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5484451|NCT05046522|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5484452|NCT05046522|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5484453|NCT05046522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5484454|NCT05046522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484455|NCT05046522|Hormones|hormones|mesh-ancestor
5484456|NCT05046522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5484457|NCT05041946|Methylphenidate|methylphenidate|mesh-list
5484458|NCT05041946|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5484459|NCT05041946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484460|NCT05041946|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5484461|NCT05041946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5484462|NCT05041946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5484463|NCT05041946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484464|NCT05041946|Dopamine Agents|dopamine agents|mesh-ancestor
5484465|NCT05041946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6021432|NCT00399568|Antipyretics|antipyretics|mesh-ancestor
6639459|NCT01370915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639460|NCT01370915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6639461|NCT01370915|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6639462|NCT01370915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6639463|NCT01370915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6639464|NCT01370915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6639465|NCT01371058|Clopidogrel|clopidogrel|mesh-list
6639466|NCT01371058|Policosanol|policosanol|mesh-list
6639467|NCT01371058|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6639468|NCT01371058|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6639469|NCT01371058|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6639470|NCT01371058|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6639471|NCT01371058|Purinergic Agents|purinergic agents|mesh-ancestor
6639472|NCT01371058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6639473|NCT01371058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639474|NCT01371058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639475|NCT01371058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6639476|NCT01371058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6639477|NCT01371058|Antimetabolites|antimetabolites|mesh-ancestor
6639478|NCT01371058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6639479|NCT01371201|Sunitinib|sunitinib|mesh-list
5484466|NCT05034952|Acetaminophen|acetaminophen|mesh-list
5484467|NCT05034952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5484468|NCT05034952|Analgesics|analgesics|mesh-ancestor
5484469|NCT05034952|Sensory System Agents|sensory system agents|mesh-ancestor
5484470|NCT05034952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5484471|NCT05034952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484472|NCT05034952|Antipyretics|antipyretics|mesh-ancestor
5484473|NCT04998786|Dexamethasone|dexamethasone|mesh-list
6639480|NCT01371201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6639481|NCT01371201|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6639482|NCT01371201|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6639483|NCT01371201|Growth Substances|growth substances|mesh-ancestor
6639484|NCT01371201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639485|NCT01371201|Growth Inhibitors|growth inhibitors|mesh-ancestor
6452689|NCT00417404|Vitamins|vitamins|mesh-list
6452690|NCT00417404|Vitamin A|vitamin a|mesh-list
6452691|NCT00417404|Retinol palmitate|retinol palmitate|mesh-list
6639486|NCT01371201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6639487|NCT01371201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6639488|NCT01371201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639489|NCT01371240|Secretin|secretin|mesh-list
6639490|NCT01371240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6639491|NCT01371240|Hormones|hormones|mesh-ancestor
6639492|NCT01371240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6639493|NCT01371240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639494|NCT01371331|Tacrolimus|tacrolimus|mesh-list
6639495|NCT01371331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6639496|NCT01371331|Immunologic Factors|immunologic factors|mesh-ancestor
6639497|NCT01371331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452692|NCT00417404|Micronutrients|micronutrients|mesh-ancestor
6452693|NCT00417404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452694|NCT00417404|Antioxidants|antioxidants|mesh-ancestor
6452695|NCT00417404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6452696|NCT00417404|Protective Agents|protective agents|mesh-ancestor
6452697|NCT00417404|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6452698|NCT00417404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6452699|NCT00417430|Fulvestrant|fulvestrant|mesh-list
6452700|NCT00417430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6452701|NCT00417430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6452702|NCT00417430|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6452703|NCT00417430|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6452704|NCT00417430|Hormone Antagonists|hormone antagonists|mesh-ancestor
6452705|NCT00417430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6452706|NCT00417430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452707|NCT00417443|Clonidine|clonidine|mesh-list
6452708|NCT00417443|Analgesics|analgesics|mesh-ancestor
6639498|NCT01371331|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6639499|NCT01371331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6639500|NCT01371331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639501|NCT01371344|Tacrolimus|tacrolimus|mesh-list
6639502|NCT01371344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6639503|NCT01371344|Immunologic Factors|immunologic factors|mesh-ancestor
6639504|NCT01371344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639505|NCT01371344|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6639506|NCT01371344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6639507|NCT01371344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639508|NCT01371435|Paroxetine|paroxetine|mesh-list
6639509|NCT01371435|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6639510|NCT01371435|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6639511|NCT01371435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6639512|NCT01371435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639513|NCT01371435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6639514|NCT01371435|Serotonin Agents|serotonin agents|mesh-ancestor
6639515|NCT01371435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639516|NCT01371435|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6639517|NCT01371435|Antidepressive Agents|antidepressive agents|mesh-ancestor
6639518|NCT01371435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6639519|NCT01371435|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6639520|NCT01371435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6639521|NCT01371435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6639522|NCT01371448|Paroxetine|paroxetine|mesh-list
5484474|NCT04998786|Ixazomib|ixazomib|mesh-list
5484475|NCT04998786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5484476|NCT04998786|Antiemetics|antiemetics|mesh-ancestor
6452709|NCT00417443|Sensory System Agents|sensory system agents|mesh-ancestor
5484477|NCT04998786|Autonomic Agents|autonomic agents|mesh-ancestor
5484478|NCT04998786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5484479|NCT04998786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484480|NCT04998786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5484481|NCT04998786|Glucocorticoids|glucocorticoids|mesh-ancestor
5484482|NCT04998786|Hormones|hormones|mesh-ancestor
5484483|NCT04998786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5484484|NCT04998786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5484485|NCT04998786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5484486|NCT04998786|Protease Inhibitors|protease inhibitors|mesh-ancestor
5484487|NCT04998786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5484488|NCT04998786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484489|NCT04991974|Buprenorphine|buprenorphine|mesh-list
5484490|NCT04991974|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6639523|NCT01371448|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6639524|NCT01371448|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6639525|NCT01371448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6639526|NCT01371448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639527|NCT01371448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6639528|NCT01371448|Serotonin Agents|serotonin agents|mesh-ancestor
6639529|NCT01371448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639530|NCT01371448|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6639531|NCT01371448|Antidepressive Agents|antidepressive agents|mesh-ancestor
6639532|NCT01371448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6639533|NCT01371448|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6639534|NCT01371448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6639535|NCT01371448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6639536|NCT01371461|Paroxetine|paroxetine|mesh-list
6639537|NCT01371461|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6639538|NCT01371461|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6639539|NCT01371461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6639540|NCT01371461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639541|NCT01371461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6639542|NCT01371461|Serotonin Agents|serotonin agents|mesh-ancestor
6639543|NCT01371461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639544|NCT01371461|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6639545|NCT01371461|Antidepressive Agents|antidepressive agents|mesh-ancestor
6639546|NCT01371461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6639547|NCT01371461|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6639548|NCT01371461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6639549|NCT01371461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6639550|NCT01371474|Paroxetine|paroxetine|mesh-list
6639551|NCT01371474|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6639552|NCT01371474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6639553|NCT01371474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6639554|NCT01371474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639555|NCT01371474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6639556|NCT01371474|Serotonin Agents|serotonin agents|mesh-ancestor
6639557|NCT01371474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665146|NCT01515839|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6639558|NCT01371474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6639559|NCT01371474|Antidepressive Agents|antidepressive agents|mesh-ancestor
6639560|NCT01371474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6639561|NCT01371474|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6639562|NCT01371474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6639563|NCT01371474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6639564|NCT01371487|Trametinib|trametinib|mesh-list
6639565|NCT01371487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6639566|NCT01371487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6639567|NCT01371487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6639568|NCT01371487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639569|NCT01371526|Cosyntropin|cosyntropin|mesh-list
6639570|NCT01371526|Hormones|hormones|mesh-ancestor
6639571|NCT01371526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6639572|NCT01371526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639573|NCT01371604|Ribavirin|ribavirin|mesh-list
6639574|NCT01371604|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6639575|NCT01371604|Antimetabolites|antimetabolites|mesh-ancestor
5484491|NCT04991974|Naloxone|naloxone|mesh-list
5484492|NCT04991974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5484493|NCT04991974|Narcotics|narcotics|mesh-ancestor
5484494|NCT04991974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5484495|NCT04991974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484496|NCT04991974|Analgesics|analgesics|mesh-ancestor
6639576|NCT01371604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639577|NCT01371604|Antiviral Agents|antiviral agents|mesh-ancestor
6639578|NCT01371604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6639579|NCT01371682|Ropinirole|ropinirole|mesh-list
6021433|NCT00399763|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6021434|NCT00399763|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6021435|NCT00399763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6021436|NCT00399763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6021437|NCT00399763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021438|NCT00399763|Adrenergic Agents|adrenergic agents|mesh-ancestor
6021439|NCT00399763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6021440|NCT00399763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021441|NCT00399893|Octreotide|octreotide|mesh-list
6021442|NCT00399893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6021443|NCT00399893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6021444|NCT00399893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6021445|NCT00400153|Ipratropium|ipratropium|mesh-list
6021446|NCT00400153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6021447|NCT00400153|Autonomic Agents|autonomic agents|mesh-ancestor
6021448|NCT00400153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6021449|NCT00400153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021450|NCT00400153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6021451|NCT00400153|Respiratory System Agents|respiratory system agents|mesh-ancestor
6021452|NCT00400153|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6021453|NCT00400153|Cholinergic Agents|cholinergic agents|mesh-ancestor
6021454|NCT00400153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5484497|NCT04991974|Sensory System Agents|sensory system agents|mesh-ancestor
5484498|NCT04991974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5484499|NCT04991974|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5484500|NCT04976257|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5484501|NCT04976257|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6021455|NCT00400153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021456|NCT00400179|Cisplatin|cisplatin|mesh-list
6021457|NCT00400179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6021458|NCT00400205|Docetaxel|docetaxel|mesh-list
6021459|NCT00400205|Fluorouracil|fluorouracil|mesh-list
6021460|NCT00400205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6021461|NCT00400205|Tubulin Modulators|tubulin modulators|mesh-ancestor
6021462|NCT00400205|Antimitotic Agents|antimitotic agents|mesh-ancestor
6021463|NCT00400205|Mitosis Modulators|mitosis modulators|mesh-ancestor
6053246|NCT00593957|Respiratory System Agents|respiratory system agents|mesh-ancestor
5484502|NCT04976257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021464|NCT00400205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021465|NCT00400205|Antimetabolites|antimetabolites|mesh-ancestor
6639580|NCT01371682|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6639581|NCT01371682|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6639582|NCT01371682|Dopamine Agonists|dopamine agonists|mesh-ancestor
6639583|NCT01371682|Dopamine Agents|dopamine agents|mesh-ancestor
6639584|NCT01371682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6639585|NCT01371682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639586|NCT01371682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639587|NCT01371968|Alfentanil|alfentanil|mesh-list
6639588|NCT01371968|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6639589|NCT01371968|Narcotics|narcotics|mesh-ancestor
6639590|NCT01371968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6639591|NCT01371968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639592|NCT01371968|Analgesics|analgesics|mesh-ancestor
6639593|NCT01371968|Sensory System Agents|sensory system agents|mesh-ancestor
6639594|NCT01371968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6639595|NCT01371968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6639596|NCT01371968|Anesthetics, General|anesthetics, general|mesh-ancestor
6639597|NCT01371968|Anesthetics|anesthetics|mesh-ancestor
6639598|NCT01372007|Lanreotide|lanreotide|mesh-list
6639599|NCT01372007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6639600|NCT01372111|Cisplatin|cisplatin|mesh-list
6639601|NCT01372111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6663354|NCT01507064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663355|NCT01507077|CKD732|ckd732|mesh-list
6663356|NCT01507077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6663357|NCT01507077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6663358|NCT01507077|Growth Substances|growth substances|mesh-ancestor
6663359|NCT01507077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663360|NCT01507077|Growth Inhibitors|growth inhibitors|mesh-ancestor
6663361|NCT01507077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6663362|NCT01507194|Ondansetron|ondansetron|mesh-list
6663363|NCT01507194|Vestipitant|vestipitant|mesh-list
6663364|NCT01507194|Antiemetics|antiemetics|mesh-ancestor
6663365|NCT01507194|Autonomic Agents|autonomic agents|mesh-ancestor
6663366|NCT01507194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6663367|NCT01507194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663368|NCT01507194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6663369|NCT01507194|Antipruritics|antipruritics|mesh-ancestor
6663370|NCT01507194|Dermatologic Agents|dermatologic agents|mesh-ancestor
6663371|NCT01507194|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6663372|NCT01507194|Serotonin Agents|serotonin agents|mesh-ancestor
6663373|NCT01507194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6663374|NCT01507194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663375|NCT01507194|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6663376|NCT01507194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6663377|NCT01507194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6663378|NCT01507194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6663379|NCT01507194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6663380|NCT01507194|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6663381|NCT01507272|Liraglutide|liraglutide|mesh-list
6663382|NCT01507272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6663383|NCT01507272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663384|NCT01507272|Incretins|incretins|mesh-ancestor
6663385|NCT01507272|Hormones|hormones|mesh-ancestor
6663386|NCT01507272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6663387|NCT01507285|Liraglutide|liraglutide|mesh-list
6639602|NCT01372280|Galantamine|galantamine|mesh-list
6639603|NCT01372280|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6639604|NCT01372280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6639605|NCT01372280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6452710|NCT00417443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6452711|NCT00417443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452712|NCT00417443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6452713|NCT00417443|Sympatholytics|sympatholytics|mesh-ancestor
6452714|NCT00417443|Autonomic Agents|autonomic agents|mesh-ancestor
6452715|NCT00417443|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6452716|NCT00417443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6452717|NCT00417443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6452718|NCT00417443|Adrenergic Agents|adrenergic agents|mesh-ancestor
6452719|NCT00417443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6452720|NCT00417443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6452721|NCT00417573|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6452722|NCT00417573|Immunologic Factors|immunologic factors|mesh-ancestor
6452723|NCT00417573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452724|NCT00417664|Midazolam|midazolam|mesh-list
6452725|NCT00417664|Dexmedetomidine|dexmedetomidine|mesh-list
6639606|NCT01372280|Cholinergic Agents|cholinergic agents|mesh-ancestor
6639607|NCT01372280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6639608|NCT01372280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639609|NCT01372280|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6639610|NCT01372280|Autonomic Agents|autonomic agents|mesh-ancestor
6639611|NCT01372280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6639612|NCT01372280|Nootropic Agents|nootropic agents|mesh-ancestor
6639613|NCT01372293|Contraceptive Agents|contraceptive agents|mesh-list
6639614|NCT01372293|Contraceptives, Oral|contraceptives, oral|mesh-list
6639615|NCT01372293|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
6452726|NCT00417664|Propofol|propofol|mesh-list
6452727|NCT00417664|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6452728|NCT00417664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6452729|NCT00417664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452730|NCT00417664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6639616|NCT01372293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6639617|NCT01372293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639618|NCT01372293|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6639619|NCT01372306|Galantamine|galantamine|mesh-list
6639620|NCT01372306|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6639621|NCT01372306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6639622|NCT01372306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639623|NCT01372306|Cholinergic Agents|cholinergic agents|mesh-ancestor
6639624|NCT01372306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6639625|NCT01372306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639626|NCT01372306|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6639627|NCT01372306|Autonomic Agents|autonomic agents|mesh-ancestor
6639628|NCT01372306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6639629|NCT01372306|Nootropic Agents|nootropic agents|mesh-ancestor
6639630|NCT01372371|Vancomycin|vancomycin|mesh-list
6639631|NCT01372371|Gentamicins|gentamicins|mesh-list
6639632|NCT01372371|Cefuroxime|cefuroxime|mesh-list
6639633|NCT01372371|Cefuroxime axetil|cefuroxime axetil|mesh-list
6452731|NCT00417664|Anesthetics, General|anesthetics, general|mesh-ancestor
6452732|NCT00417664|Anesthetics|anesthetics|mesh-ancestor
6452733|NCT00417664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6452734|NCT00417664|Analgesics|analgesics|mesh-ancestor
6452735|NCT00417664|Sensory System Agents|sensory system agents|mesh-ancestor
6452736|NCT00417664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6452737|NCT00417664|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6452738|NCT00417664|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6452739|NCT00417664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6452740|NCT00417664|Adrenergic Agents|adrenergic agents|mesh-ancestor
6452741|NCT00417664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6452742|NCT00417664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6452743|NCT00417664|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6452744|NCT00417664|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6452745|NCT00417664|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6452746|NCT00417664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6452747|NCT00417664|GABA Modulators|gaba modulators|mesh-ancestor
6452748|NCT00417664|GABA Agents|gaba agents|mesh-ancestor
6452749|NCT00417677|Sirolimus|sirolimus|mesh-list
6452750|NCT00417677|Sunitinib|sunitinib|mesh-list
6452751|NCT00417677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6452752|NCT00417677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5484503|NCT04976192|Omalizumab|omalizumab|mesh-list
5484504|NCT04976192|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5484505|NCT04976192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6452753|NCT00417677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6452754|NCT00417677|Growth Substances|growth substances|mesh-ancestor
6452755|NCT00417677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452756|NCT00417677|Growth Inhibitors|growth inhibitors|mesh-ancestor
6452757|NCT00417677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6452758|NCT00417677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6452759|NCT00417677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6452760|NCT00417677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6452761|NCT00417677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5484506|NCT04976192|Respiratory System Agents|respiratory system agents|mesh-ancestor
5484507|NCT04961619|Trametinib|trametinib|mesh-list
5484508|NCT04961619|Dabrafenib|dabrafenib|mesh-list
5484509|NCT04961619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5484510|NCT04961619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5484511|NCT04961619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5484512|NCT04961619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6452762|NCT00417677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6452763|NCT00417677|Antifungal Agents|antifungal agents|mesh-ancestor
6452764|NCT00417677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6452765|NCT00417677|Immunologic Factors|immunologic factors|mesh-ancestor
6639634|NCT01372371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6639635|NCT01372371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6639636|NCT01372371|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6639637|NCT01372371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6639638|NCT01372371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639639|NCT01372423|Lubiprostone|lubiprostone|mesh-list
6639640|NCT01372423|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6639641|NCT01372423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6639642|NCT01372423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639643|NCT01372449|Memantine|memantine|mesh-list
6639644|NCT01372449|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6639645|NCT01372449|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6639646|NCT01372449|Dopamine Agents|dopamine agents|mesh-ancestor
6639647|NCT01372449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6639648|NCT01372449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639649|NCT01372449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639650|NCT01372449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6639651|NCT01372449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6639652|NCT01372540|Filanesib|filanesib|mesh-list
6639653|NCT01372540|Antimitotic Agents|antimitotic agents|mesh-ancestor
6639654|NCT01372540|Mitosis Modulators|mitosis modulators|mesh-ancestor
6639655|NCT01372540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639656|NCT01372540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6639657|NCT01372579|Carboplatin|carboplatin|mesh-list
6639658|NCT01372579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6639659|NCT01372644|Pasireotide|pasireotide|mesh-list
6639660|NCT01372644|Hormones|hormones|mesh-ancestor
6663388|NCT01507285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5484513|NCT04886284|Ertapenem|ertapenem|mesh-list
5484514|NCT04886284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5484515|NCT04886284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5484516|NCT04869488|Prednisone|prednisone|mesh-list
5484517|NCT04869488|Apatinib|apatinib|mesh-list
5484518|NCT04869488|Abiraterone Acetate|abiraterone acetate|mesh-list
5484519|NCT04869488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5484520|NCT04869488|Glucocorticoids|glucocorticoids|mesh-ancestor
6639661|NCT01372644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6639662|NCT01372644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639663|NCT01372670|Hydroxyzine|hydroxyzine|mesh-list
6021466|NCT00400205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6021467|NCT00400205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6021468|NCT00400205|Immunologic Factors|immunologic factors|mesh-ancestor
6021469|NCT00400205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021470|NCT00400400|Mycophenolic Acid|mycophenolic acid|mesh-list
6021471|NCT00400400|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6021472|NCT00400400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6021473|NCT00400400|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6021474|NCT00400400|Antitubercular Agents|antitubercular agents|mesh-ancestor
6021475|NCT00400400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6021476|NCT00400400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6021477|NCT00400400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6021478|NCT00400400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021479|NCT00400439|Dalcetrapib|dalcetrapib|mesh-list
6021480|NCT00400439|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6021481|NCT00400439|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6021482|NCT00400439|Antimetabolites|antimetabolites|mesh-ancestor
6021483|NCT00400439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021484|NCT00400439|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6021485|NCT00400517|Thalidomide|thalidomide|mesh-list
6452766|NCT00417690|Aminosalicylic Acid|aminosalicylic acid|mesh-list
6639664|NCT01372670|Antipruritics|antipruritics|mesh-ancestor
6639665|NCT01372670|Dermatologic Agents|dermatologic agents|mesh-ancestor
6639666|NCT01372670|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6639667|NCT01372670|Histamine Antagonists|histamine antagonists|mesh-ancestor
6639668|NCT01372670|Histamine Agents|histamine agents|mesh-ancestor
6639669|NCT01372670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6639670|NCT01372670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639671|NCT01372670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639672|NCT01372761|CKD732|ckd732|mesh-list
6639673|NCT01372761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6639674|NCT01372761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6639675|NCT01372761|Growth Substances|growth substances|mesh-ancestor
6639676|NCT01372761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639677|NCT01372761|Growth Inhibitors|growth inhibitors|mesh-ancestor
6639678|NCT01372761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6639679|NCT01372826|Naloxegol|naloxegol|mesh-list
6639680|NCT01372826|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6639681|NCT01372826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639682|NCT01372826|Sensory System Agents|sensory system agents|mesh-ancestor
6639683|NCT01372826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6639684|NCT01372839|Atorvastatin|atorvastatin|mesh-list
6639685|NCT01372839|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6639686|NCT01372839|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6639687|NCT01372839|Antimetabolites|antimetabolites|mesh-ancestor
6639688|NCT01372839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639689|NCT01372839|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6639690|NCT01372839|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6639691|NCT01372839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6452767|NCT00417690|Antitubercular Agents|antitubercular agents|mesh-ancestor
6452768|NCT00417690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6452769|NCT00417690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6452770|NCT00417716|Bevacizumab|bevacizumab|mesh-list
6452771|NCT00417716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6452772|NCT00417716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6452773|NCT00417716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6452774|NCT00417716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6452775|NCT00417716|Growth Substances|growth substances|mesh-ancestor
6452776|NCT00417716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452777|NCT00417716|Growth Inhibitors|growth inhibitors|mesh-ancestor
6452778|NCT00417729|Acarbose|acarbose|mesh-list
6452779|NCT00417729|Glyburide|glyburide|mesh-list
6452780|NCT00417729|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6452781|NCT00417729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6639692|NCT01372865|Mometasone Furoate|mometasone furoate|mesh-list
5484521|NCT04869488|Hormones|hormones|mesh-ancestor
6639693|NCT01372865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6639694|NCT01372865|Dermatologic Agents|dermatologic agents|mesh-ancestor
6639695|NCT01372865|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6639696|NCT01372904|Dexamethasone|dexamethasone|mesh-list
6639697|NCT01372904|Dexamethasone acetate|dexamethasone acetate|mesh-list
6639698|NCT01372904|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
6639699|NCT01372904|BB 1101|bb 1101|mesh-list
6639700|NCT01372904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6639701|NCT01372904|Antiemetics|antiemetics|mesh-ancestor
6639702|NCT01372904|Autonomic Agents|autonomic agents|mesh-ancestor
6639703|NCT01372904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6639704|NCT01372904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639705|NCT01372904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5484522|NCT04869488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5484523|NCT04869488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484524|NCT04869488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5484525|NCT04869488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5484526|NCT04869488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5484527|NCT04869488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6639706|NCT01372904|Glucocorticoids|glucocorticoids|mesh-ancestor
6639707|NCT01372904|Hormones|hormones|mesh-ancestor
6639708|NCT01372904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6639709|NCT01372904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6639710|NCT01372904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6639711|NCT01372904|Protease Inhibitors|protease inhibitors|mesh-ancestor
6639712|NCT01372904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6639713|NCT01372904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639714|NCT01372930|Etanercept|etanercept|mesh-list
6639715|NCT01372930|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6639716|NCT01372930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6639717|NCT01372930|Analgesics|analgesics|mesh-ancestor
6639718|NCT01372930|Sensory System Agents|sensory system agents|mesh-ancestor
6639719|NCT01372930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6639720|NCT01372930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639721|NCT01372930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6639722|NCT01372930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6639723|NCT01372930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6639724|NCT01372930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6639725|NCT01372930|Immunologic Factors|immunologic factors|mesh-ancestor
6639726|NCT01372982|Letrozole|letrozole|mesh-list
6639727|NCT01372982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6639728|NCT01372982|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6639729|NCT01372982|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6639730|NCT01372982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6639731|NCT01372982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639732|NCT01372982|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6639733|NCT01372982|Hormone Antagonists|hormone antagonists|mesh-ancestor
6639734|NCT01372982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6639735|NCT01372982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639736|NCT01373008|Beclomethasone|beclomethasone|mesh-list
6639737|NCT01373008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6639738|NCT01373008|Glucocorticoids|glucocorticoids|mesh-ancestor
6639739|NCT01373008|Hormones|hormones|mesh-ancestor
6639740|NCT01373008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6639741|NCT01373008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639742|NCT01373008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6639743|NCT01373008|Respiratory System Agents|respiratory system agents|mesh-ancestor
6639744|NCT01373021|Fentanyl|fentanyl|mesh-list
6639745|NCT01373021|Dexmedetomidine|dexmedetomidine|mesh-list
6639746|NCT01373021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6639747|NCT01373021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6639748|NCT01373021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639749|NCT01373021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6639750|NCT01373021|Analgesics|analgesics|mesh-ancestor
6639751|NCT01373021|Sensory System Agents|sensory system agents|mesh-ancestor
6639752|NCT01373021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6639753|NCT01373021|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6639754|NCT01373021|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6639755|NCT01373021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6639756|NCT01373021|Adrenergic Agents|adrenergic agents|mesh-ancestor
6639757|NCT01373021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6639758|NCT01373021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639759|NCT01373021|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6639760|NCT01373021|Narcotics|narcotics|mesh-ancestor
6639761|NCT01373021|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6639762|NCT01373021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6639763|NCT01373021|Anesthetics, General|anesthetics, general|mesh-ancestor
6639764|NCT01373021|Anesthetics|anesthetics|mesh-ancestor
6639765|NCT01373060|Ipragliflozin|ipragliflozin|mesh-list
6639766|NCT01373060|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6639767|NCT01373060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639768|NCT01373060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6639769|NCT01373060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452782|NCT00417729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6452783|NCT00417729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6452784|NCT00417729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452785|NCT00417768|Plasminogen|plasminogen|mesh-list
6639770|NCT01373138|Pseudoephedrine|pseudoephedrine|mesh-list
6639771|NCT01373138|Ephedrine|ephedrine|mesh-list
6639772|NCT01373138|Desloratadine|desloratadine|mesh-list
6639773|NCT01373138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6639774|NCT01373138|Cholinergic Agents|cholinergic agents|mesh-ancestor
6639775|NCT01373138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6639776|NCT01373138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639777|NCT01373138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639778|NCT01373138|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6639779|NCT01373138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6639780|NCT01373138|Histamine Antagonists|histamine antagonists|mesh-ancestor
6639781|NCT01373138|Histamine Agents|histamine agents|mesh-ancestor
6639782|NCT01373138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6639783|NCT01373138|Autonomic Agents|autonomic agents|mesh-ancestor
6639784|NCT01373138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6639785|NCT01373138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6639786|NCT01373138|Respiratory System Agents|respiratory system agents|mesh-ancestor
6639787|NCT01373138|Nasal Decongestants|nasal decongestants|mesh-ancestor
6639788|NCT01373138|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6639789|NCT01373138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6639790|NCT01373138|Sympathomimetics|sympathomimetics|mesh-ancestor
6639791|NCT01373138|Adrenergic Agents|adrenergic agents|mesh-ancestor
6639792|NCT01373216|Exenatide|exenatide|mesh-list
5484528|NCT04869488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484529|NCT04869488|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5484530|NCT04869488|Hormone Antagonists|hormone antagonists|mesh-ancestor
5484531|NCT04869488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5484532|NCT04867798|Tenofovir|tenofovir|mesh-list
5484533|NCT04867798|Lamivudine|lamivudine|mesh-list
5484534|NCT04867798|Antiviral Agents|antiviral agents|mesh-ancestor
5484535|NCT04867798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5484536|NCT04867798|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5484537|NCT04867798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5484538|NCT04867798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5484539|NCT04867798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484540|NCT04867798|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6021486|NCT00400517|Sargramostim|sargramostim|mesh-list
6021487|NCT00400517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6021488|NCT00400517|Immunologic Factors|immunologic factors|mesh-ancestor
6021489|NCT00400517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452786|NCT00417768|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6452787|NCT00417768|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6452788|NCT00417768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6452789|NCT00417768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6452790|NCT00417794|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6452791|NCT00417794|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6452792|NCT00417794|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6452793|NCT00417794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6452794|NCT00417794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6452795|NCT00417794|Adrenergic Agents|adrenergic agents|mesh-ancestor
6639793|NCT01373216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6639794|NCT01373216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639795|NCT01373216|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6639796|NCT01373216|Incretins|incretins|mesh-ancestor
6639797|NCT01373216|Hormones|hormones|mesh-ancestor
6639798|NCT01373216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6639799|NCT01373333|Amifampridine|amifampridine|mesh-list
6639800|NCT01373333|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6639801|NCT01373333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6639802|NCT01373333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639803|NCT01373333|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6639804|NCT01373333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6639805|NCT01373333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639806|NCT01373359|Misoprostol|misoprostol|mesh-list
6639807|NCT01373359|Oxytocin|oxytocin|mesh-list
6639808|NCT01373359|Oxytocics|oxytocics|mesh-ancestor
6639809|NCT01373359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6639810|NCT01373359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639811|NCT01373359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6639812|NCT01373359|Abortifacient Agents|abortifacient agents|mesh-ancestor
6639813|NCT01373359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6639814|NCT01373359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6639815|NCT01373372|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
6639816|NCT01373372|Hormones|hormones|mesh-ancestor
6639817|NCT01373372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6639818|NCT01373372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639819|NCT01373398|Apaziquone|apaziquone|mesh-list
6639820|NCT01373398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6639821|NCT01373411|Ticagrelor|ticagrelor|mesh-list
6639822|NCT01373411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5484541|NCT04867798|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5484542|NCT04858009|Cisplatin|cisplatin|mesh-list
5484543|NCT04858009|Mitomycins|mitomycins|mesh-list
5484544|NCT04858009|Mitomycin|mitomycin|mesh-list
5484545|NCT04858009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6639823|NCT01373411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6639824|NCT01373411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5484546|NCT04858009|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6021490|NCT00400517|Leprostatic Agents|leprostatic agents|mesh-ancestor
6021491|NCT00400517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6021492|NCT00400517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6021493|NCT00400517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6021494|NCT00400517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6021495|NCT00400517|Growth Substances|growth substances|mesh-ancestor
5484547|NCT04858009|Alkylating Agents|alkylating agents|mesh-ancestor
5484548|NCT04858009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484549|NCT04858009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5484550|NCT04858009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6021496|NCT00400517|Growth Inhibitors|growth inhibitors|mesh-ancestor
6021497|NCT00400517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6021498|NCT00400569|Sunitinib|sunitinib|mesh-list
6021499|NCT00400569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6021500|NCT00400569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6021501|NCT00400569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6021502|NCT00400569|Growth Substances|growth substances|mesh-ancestor
6021503|NCT00400569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021504|NCT00400569|Growth Inhibitors|growth inhibitors|mesh-ancestor
6021505|NCT00400569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6021506|NCT00400569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6021507|NCT00400569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021508|NCT00400686|Epoetin Alfa|epoetin alfa|mesh-list
6021509|NCT00400686|Hematinics|hematinics|mesh-ancestor
6021510|NCT00400764|Rituximab|rituximab|mesh-list
6021511|NCT00400764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6021512|NCT00400764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6021513|NCT00400764|Immunologic Factors|immunologic factors|mesh-ancestor
6021514|NCT00400764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021515|NCT00400764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6021516|NCT00400803|Gemcitabine|gemcitabine|mesh-list
5484570|NCT04840888|Itraconazole|itraconazole|mesh-list
5484571|NCT04840888|Carbamazepine|carbamazepine|mesh-list
5484572|NCT04840888|Omeprazole|omeprazole|mesh-list
5484573|NCT04840888|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5484574|NCT04840888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6021517|NCT00400803|Bevacizumab|bevacizumab|mesh-list
5484575|NCT04840888|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6021518|NCT00400803|Carboplatin|carboplatin|mesh-list
6021519|NCT00400803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6021520|NCT00400803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6021521|NCT00400803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6021522|NCT00400803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6639825|NCT01373411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6639826|NCT01373411|Purinergic Agents|purinergic agents|mesh-ancestor
6639827|NCT01373411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6639828|NCT01373411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639829|NCT01373411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639830|NCT01373463|Carboplatin|carboplatin|mesh-list
6639831|NCT01373463|Pemetrexed|pemetrexed|mesh-list
6639832|NCT01373463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6639833|NCT01373463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6639834|NCT01373463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639835|NCT01373463|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6639836|NCT01373463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6639837|NCT01373528|Budesonide|budesonide|mesh-list
6639838|NCT01373528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6639839|NCT01373528|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6639840|NCT01373528|Autonomic Agents|autonomic agents|mesh-ancestor
6639841|NCT01373528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6639842|NCT01373528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639843|NCT01373528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6639844|NCT01373528|Respiratory System Agents|respiratory system agents|mesh-ancestor
6639845|NCT01373528|Glucocorticoids|glucocorticoids|mesh-ancestor
6639846|NCT01373528|Hormones|hormones|mesh-ancestor
6639847|NCT01373528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6639848|NCT01373541|Palmitic Acid|palmitic acid|mesh-list
6639849|NCT01373541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6639850|NCT01373541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639851|NCT01373554|Oltipraz|oltipraz|mesh-list
6639852|NCT01373554|Antiviral Agents|antiviral agents|mesh-ancestor
6639853|NCT01373554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6639854|NCT01373554|Schistosomicides|schistosomicides|mesh-ancestor
6639855|NCT01373554|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6639856|NCT01373554|Anthelmintics|anthelmintics|mesh-ancestor
6639857|NCT01373554|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6639858|NCT01373554|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6639859|NCT01373554|Protective Agents|protective agents|mesh-ancestor
5484576|NCT04840888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5484577|NCT04840888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484578|NCT04840888|Antifungal Agents|antifungal agents|mesh-ancestor
5484579|NCT04840888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5484580|NCT04840888|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5484581|NCT04840888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5484582|NCT04840888|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5484583|NCT04840888|Hormone Antagonists|hormone antagonists|mesh-ancestor
5484584|NCT04840888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5484585|NCT04840888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484586|NCT04840888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5484587|NCT04840888|Anticonvulsants|anticonvulsants|mesh-ancestor
5484588|NCT04840888|Antimanic Agents|antimanic agents|mesh-ancestor
5484589|NCT04840888|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5484590|NCT04840888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5484591|NCT04840888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6639860|NCT01373554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639861|NCT01373554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6639862|NCT01373554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6665147|NCT01515839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5484592|NCT04840888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5484593|NCT04840888|Analgesics|analgesics|mesh-ancestor
5484594|NCT04840888|Sensory System Agents|sensory system agents|mesh-ancestor
5484595|NCT04840888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5484596|NCT04840888|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5484597|NCT04840888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5484598|NCT04840888|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5484599|NCT04840888|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5484600|NCT04836832|Acalabrutinib|acalabrutinib|mesh-list
5484601|NCT04836832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5484602|NCT04821869|Albuterol|albuterol|mesh-list
5484603|NCT04821869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5484604|NCT04821869|Autonomic Agents|autonomic agents|mesh-ancestor
5484605|NCT04821869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6639863|NCT01373554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6639864|NCT01373554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6639865|NCT01373554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639866|NCT01373593|Lidocaine|lidocaine|mesh-list
6639867|NCT01373593|Anesthetics, Local|anesthetics, local|mesh-ancestor
6639868|NCT01373593|Anesthetics|anesthetics|mesh-ancestor
6639869|NCT01373593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6639870|NCT01373593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639871|NCT01373593|Sensory System Agents|sensory system agents|mesh-ancestor
6639872|NCT01373593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6639873|NCT01373593|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6639874|NCT01373593|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6639875|NCT01373593|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6639876|NCT01373593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6639877|NCT01373593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639878|NCT01373606|Terlipressin|terlipressin|mesh-list
6639879|NCT01373606|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6639880|NCT01373606|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5484606|NCT04821869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484607|NCT04821869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5484608|NCT04821869|Respiratory System Agents|respiratory system agents|mesh-ancestor
5484609|NCT04821869|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5484610|NCT04821869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5484611|NCT04821869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5484612|NCT04821869|Adrenergic Agents|adrenergic agents|mesh-ancestor
5484613|NCT04821869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5484614|NCT04821869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484615|NCT04821869|Tocolytic Agents|tocolytic agents|mesh-ancestor
5484616|NCT04821869|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5484617|NCT04821284|Leucovorin|leucovorin|mesh-list
5484618|NCT04821284|Gemcitabine|gemcitabine|mesh-list
5484619|NCT04821284|Paclitaxel|paclitaxel|mesh-list
5484620|NCT04821284|Fluorouracil|fluorouracil|mesh-list
6639881|NCT01373632|Sirolimus|sirolimus|mesh-list
6639882|NCT01373632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6639883|NCT01373632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6639884|NCT01373632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6639885|NCT01373632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6639886|NCT01373632|Antifungal Agents|antifungal agents|mesh-ancestor
6639887|NCT01373632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6639888|NCT01373632|Immunologic Factors|immunologic factors|mesh-ancestor
6639889|NCT01373632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639890|NCT01373684|Tenofovir|tenofovir|mesh-list
6639891|NCT01373684|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6639892|NCT01373684|Entecavir|entecavir|mesh-list
6639893|NCT01373684|Adefovir|adefovir|mesh-list
6639894|NCT01373684|Antiviral Agents|antiviral agents|mesh-ancestor
6639895|NCT01373684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6639896|NCT01373684|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6639897|NCT01373684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6639898|NCT01373684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6639899|NCT01373684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639900|NCT01373684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6639901|NCT01373684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6639902|NCT01373697|Ibuprofen|ibuprofen|mesh-list
6639903|NCT01373697|Ketoprofen|ketoprofen|mesh-list
6639904|NCT01373697|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6639905|NCT01373697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5484621|NCT04821284|Oxaliplatin|oxaliplatin|mesh-list
5484622|NCT04821284|Irinotecan|irinotecan|mesh-list
6639906|NCT01373697|Analgesics|analgesics|mesh-ancestor
6639907|NCT01373697|Sensory System Agents|sensory system agents|mesh-ancestor
6639908|NCT01373697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6639909|NCT01373697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639910|NCT01373697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6639911|NCT01373697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6639912|NCT01373697|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6639913|NCT01373697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6639914|NCT01373697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639915|NCT01373710|Trastuzumab|trastuzumab|mesh-list
6639916|NCT01373710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6639917|NCT01373710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6639918|NCT01373736|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
6639919|NCT01373736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6639920|NCT01373736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6639921|NCT01373736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639922|NCT01373736|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6639923|NCT01373749|Sildenafil Citrate|sildenafil citrate|mesh-list
6639924|NCT01373749|Vasodilator Agents|vasodilator agents|mesh-ancestor
6639925|NCT01373749|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6639926|NCT01373749|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6639927|NCT01373749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6639928|NCT01373749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639929|NCT01373749|Urological Agents|urological agents|mesh-ancestor
6663389|NCT01507285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663390|NCT01507285|Incretins|incretins|mesh-ancestor
6663391|NCT01507285|Hormones|hormones|mesh-ancestor
6663392|NCT01507285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6663393|NCT01507311|Liraglutide|liraglutide|mesh-list
6663394|NCT01507311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6663395|NCT01507311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663396|NCT01507311|Incretins|incretins|mesh-ancestor
6663397|NCT01507311|Hormones|hormones|mesh-ancestor
6663398|NCT01507311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6663399|NCT01507337|Liraglutide|liraglutide|mesh-list
6663400|NCT01507337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6663401|NCT01507337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663402|NCT01507337|Incretins|incretins|mesh-ancestor
6663403|NCT01507337|Hormones|hormones|mesh-ancestor
6663404|NCT01507337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6663405|NCT01507363|Gabapentin|gabapentin|mesh-list
6663406|NCT01507363|Analgesics|analgesics|mesh-ancestor
6663407|NCT01507363|Sensory System Agents|sensory system agents|mesh-ancestor
6663408|NCT01507363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5484623|NCT04821284|Calcium|calcium|mesh-list
5484624|NCT04821284|Levoleucovorin|levoleucovorin|mesh-list
5484625|NCT04821284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5484626|NCT04821284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6663409|NCT01507363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663410|NCT01507363|Anticonvulsants|anticonvulsants|mesh-ancestor
6663411|NCT01507363|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6663412|NCT01507363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6663413|NCT01507363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6663414|NCT01507363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6663415|NCT01507363|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6663416|NCT01507363|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6663417|NCT01507363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6663418|NCT01507363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663419|NCT01507363|Antimanic Agents|antimanic agents|mesh-ancestor
6663420|NCT01507376|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5484627|NCT04821284|Tubulin Modulators|tubulin modulators|mesh-ancestor
5484628|NCT04821284|Antimitotic Agents|antimitotic agents|mesh-ancestor
5484629|NCT04821284|Mitosis Modulators|mitosis modulators|mesh-ancestor
6021523|NCT00400803|Growth Substances|growth substances|mesh-ancestor
6639930|NCT01373970|Pantoprazole|pantoprazole|mesh-list
6639931|NCT01373970|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6639932|NCT01373970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6639933|NCT01373970|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6639934|NCT01373970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6639935|NCT01373970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639936|NCT01373983|Ziconotide|ziconotide|mesh-list
6639937|NCT01373983|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6639938|NCT01373983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6639939|NCT01373983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021524|NCT00400803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021525|NCT00400803|Growth Inhibitors|growth inhibitors|mesh-ancestor
6021526|NCT00400803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6021527|NCT00400803|Antimetabolites|antimetabolites|mesh-ancestor
6021528|NCT00400803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021529|NCT00400803|Antiviral Agents|antiviral agents|mesh-ancestor
6021530|NCT00400803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6021531|NCT00400803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6021532|NCT00400803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6021533|NCT00400803|Immunologic Factors|immunologic factors|mesh-ancestor
5484630|NCT04821284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484631|NCT04821284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5484632|NCT04821284|Antimetabolites|antimetabolites|mesh-ancestor
5484633|NCT04821284|Antiviral Agents|antiviral agents|mesh-ancestor
5484634|NCT04821284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5484635|NCT04821284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5484636|NCT04821284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5484637|NCT04821284|Immunologic Factors|immunologic factors|mesh-ancestor
5484638|NCT04821284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484639|NCT04821284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5484640|NCT04821284|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5484641|NCT04821284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5484642|NCT04821284|Antidotes|antidotes|mesh-ancestor
5484643|NCT04821284|Protective Agents|protective agents|mesh-ancestor
5484644|NCT04821284|Vitamin B Complex|vitamin b complex|mesh-ancestor
5484645|NCT04821284|Vitamins|vitamins|mesh-ancestor
5484646|NCT04821284|Micronutrients|micronutrients|mesh-ancestor
5484647|NCT04738123|Xanomeline|xanomeline|mesh-list
5484648|NCT04738123|Trospium chloride|trospium chloride|mesh-list
5484649|NCT04738123|Parasympatholytics|parasympatholytics|mesh-ancestor
5484650|NCT04738123|Autonomic Agents|autonomic agents|mesh-ancestor
5484651|NCT04738123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6021534|NCT00400946|Leucovorin|leucovorin|mesh-list
6021535|NCT00400946|Cytarabine|cytarabine|mesh-list
6021536|NCT00400946|Dexamethasone|dexamethasone|mesh-list
6021537|NCT00400946|Methylprednisolone|methylprednisolone|mesh-list
6021538|NCT00400946|Prednisolone|prednisolone|mesh-list
6021539|NCT00400946|Hydrocortisone|hydrocortisone|mesh-list
6021540|NCT00400946|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6021541|NCT00400946|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6021542|NCT00400946|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6021543|NCT00400946|Cyclophosphamide|cyclophosphamide|mesh-list
6021544|NCT00400946|Doxorubicin|doxorubicin|mesh-list
6021545|NCT00400946|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6021546|NCT00400946|Methotrexate|methotrexate|mesh-list
6021547|NCT00400946|Etoposide|etoposide|mesh-list
6021548|NCT00400946|Vincristine|vincristine|mesh-list
6021549|NCT00400946|Asparaginase|asparaginase|mesh-list
6021550|NCT00400946|Mercaptopurine|mercaptopurine|mesh-list
6021551|NCT00400946|Pegaspargase|pegaspargase|mesh-list
6639940|NCT01373983|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6639941|NCT01373983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639942|NCT01373983|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6639943|NCT01373983|Protective Agents|protective agents|mesh-ancestor
6639944|NCT01373983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6021552|NCT00400946|Dexrazoxane|dexrazoxane|mesh-list
6021553|NCT00400946|Razoxane|razoxane|mesh-list
6021554|NCT00400946|Levoleucovorin|levoleucovorin|mesh-list
6021555|NCT00400946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6021556|NCT00400946|Immunologic Factors|immunologic factors|mesh-ancestor
6021557|NCT00400946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021558|NCT00400946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6021559|NCT00400946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6021560|NCT00400946|Alkylating Agents|alkylating agents|mesh-ancestor
6639945|NCT01373983|Analgesics|analgesics|mesh-ancestor
5484652|NCT04738123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021561|NCT00400946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021562|NCT00400946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6021563|NCT00400946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6021564|NCT00400946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6021565|NCT00400946|Antiemetics|antiemetics|mesh-ancestor
6021566|NCT00400946|Autonomic Agents|autonomic agents|mesh-ancestor
6021567|NCT00400946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6021568|NCT00400946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6639946|NCT01373983|Sensory System Agents|sensory system agents|mesh-ancestor
6639947|NCT01373983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6639948|NCT01374126|Azithromycin|azithromycin|mesh-list
6639949|NCT01374126|Artesunate|artesunate|mesh-list
6639950|NCT01374126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6639951|NCT01374126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6639952|NCT01374126|Antimalarials|antimalarials|mesh-ancestor
6639953|NCT01374126|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6639954|NCT01374126|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6639955|NCT01374126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6639956|NCT01374126|Antiviral Agents|antiviral agents|mesh-ancestor
6639957|NCT01374126|Schistosomicides|schistosomicides|mesh-ancestor
6639958|NCT01374126|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6639959|NCT01374126|Anthelmintics|anthelmintics|mesh-ancestor
6639960|NCT01374191|Botulinum Toxins|botulinum toxins|mesh-list
6639961|NCT01374191|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6639962|NCT01374191|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6639963|NCT01374191|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6639964|NCT01374191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6639965|NCT01374191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639966|NCT01374191|Cholinergic Agents|cholinergic agents|mesh-ancestor
6639967|NCT01374191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6639968|NCT01374191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639969|NCT01374191|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6639970|NCT01374191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6639971|NCT01374282|Penicillamine|penicillamine|mesh-list
6639972|NCT01374282|Antidotes|antidotes|mesh-ancestor
6639973|NCT01374282|Protective Agents|protective agents|mesh-ancestor
6639974|NCT01374282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639975|NCT01374282|Chelating Agents|chelating agents|mesh-ancestor
6639976|NCT01374282|Sequestering Agents|sequestering agents|mesh-ancestor
6639977|NCT01374282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6639978|NCT01374282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6639979|NCT01374308|Interferons|interferons|mesh-list
6639980|NCT01374308|Interferon-alpha|interferon-alpha|mesh-list
6639981|NCT01374308|Interferon alpha-2|interferon alpha-2|mesh-list
6639982|NCT01374308|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6639983|NCT01374308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6639984|NCT01374308|Antiviral Agents|antiviral agents|mesh-ancestor
6452796|NCT00417794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6452797|NCT00417794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452798|NCT00417807|Imatinib Mesylate|imatinib mesylate|mesh-list
6452799|NCT00417807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6452800|NCT00417807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6452801|NCT00417807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6452802|NCT00417807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6452803|NCT00417833|Bevacizumab|bevacizumab|mesh-list
6639985|NCT01374308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5484653|NCT04738123|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5484654|NCT04738123|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5484655|NCT04738123|Cholinergic Agents|cholinergic agents|mesh-ancestor
5484656|NCT04738123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5484657|NCT04738123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484658|NCT04738123|Urological Agents|urological agents|mesh-ancestor
5484659|NCT04738123|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5484660|NCT04738123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5484661|NCT04738123|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
5484662|NCT04738123|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6639986|NCT01374308|Immunologic Factors|immunologic factors|mesh-ancestor
6639987|NCT01374308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639988|NCT01374373|Epoetin Alfa|epoetin alfa|mesh-list
6639989|NCT01374373|Hematinics|hematinics|mesh-ancestor
6639990|NCT01374464|Levobupivacaine|levobupivacaine|mesh-list
6639991|NCT01374464|Anesthetics, Local|anesthetics, local|mesh-ancestor
6639992|NCT01374464|Anesthetics|anesthetics|mesh-ancestor
6639993|NCT01374464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6639994|NCT01374464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639995|NCT01374464|Sensory System Agents|sensory system agents|mesh-ancestor
6639996|NCT01374464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6639997|NCT01374581|Artesunate|artesunate|mesh-list
6021569|NCT00400946|Glucocorticoids|glucocorticoids|mesh-ancestor
5484663|NCT04729621|Denosumab|denosumab|mesh-list
5484664|NCT04729621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5484665|NCT04729621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6639998|NCT01374581|Lumefantrine|lumefantrine|mesh-list
6639999|NCT01374581|Artemether|artemether|mesh-list
6640000|NCT01374581|Amodiaquine|amodiaquine|mesh-list
6640001|NCT01374581|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6640002|NCT01374581|Quinine|quinine|mesh-list
6640003|NCT01374581|Clindamycin|clindamycin|mesh-list
6640004|NCT01374581|Clindamycin palmitate|clindamycin palmitate|mesh-list
6640005|NCT01374581|Clindamycin phosphate|clindamycin phosphate|mesh-list
6640006|NCT01374581|Antimalarials|antimalarials|mesh-ancestor
6640007|NCT01374581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6640008|NCT01374581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6640009|NCT01374581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6640010|NCT01374581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6640011|NCT01374581|Antiviral Agents|antiviral agents|mesh-ancestor
6640012|NCT01374581|Schistosomicides|schistosomicides|mesh-ancestor
6640013|NCT01374581|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6640014|NCT01374581|Anthelmintics|anthelmintics|mesh-ancestor
6640015|NCT01374581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6640016|NCT01374581|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6640017|NCT01374581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6640018|NCT01374581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484666|NCT04712903|Carboplatin|carboplatin|mesh-list
5484667|NCT04712903|Etoposide|etoposide|mesh-list
5484668|NCT04712903|Durvalumab|durvalumab|mesh-list
5484669|NCT04712903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5484670|NCT04712903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5484671|NCT04712903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6640019|NCT01374581|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6640020|NCT01374581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640021|NCT01374581|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6640022|NCT01374581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6640023|NCT01374581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6640024|NCT01374581|Analgesics|analgesics|mesh-ancestor
6640025|NCT01374581|Sensory System Agents|sensory system agents|mesh-ancestor
6640026|NCT01374620|Paclitaxel|paclitaxel|mesh-list
5484672|NCT04712903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5484673|NCT04712903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5484674|NCT04712903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484675|NCT04712903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5484676|NCT04648826|Azacitidine|azacitidine|mesh-list
5484677|NCT04648826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5484678|NCT04648826|Antimetabolites|antimetabolites|mesh-ancestor
6640027|NCT01374620|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6640028|NCT01374620|Cyclophosphamide|cyclophosphamide|mesh-list
6640029|NCT01374620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6640030|NCT01374620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6640031|NCT01374620|Tubulin Modulators|tubulin modulators|mesh-ancestor
6640032|NCT01374620|Antimitotic Agents|antimitotic agents|mesh-ancestor
6640033|NCT01374620|Mitosis Modulators|mitosis modulators|mesh-ancestor
6640034|NCT01374620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640035|NCT01374620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6640036|NCT01374620|Immunologic Factors|immunologic factors|mesh-ancestor
6640037|NCT01374620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640038|NCT01374620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6640039|NCT01374620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6640040|NCT01374620|Alkylating Agents|alkylating agents|mesh-ancestor
5502516|NCT04466241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6640041|NCT01374620|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6640042|NCT01374633|Sevoflurane|sevoflurane|mesh-list
6640043|NCT01374633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6640044|NCT01374633|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6640045|NCT01374633|Anesthetics, General|anesthetics, general|mesh-ancestor
6640046|NCT01374633|Anesthetics|anesthetics|mesh-ancestor
6640047|NCT01374633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6640048|NCT01374633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640049|NCT01374698|Aspirin|aspirin|mesh-list
6640050|NCT01374698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6640051|NCT01374698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6640052|NCT01374698|Analgesics|analgesics|mesh-ancestor
6640053|NCT01374698|Sensory System Agents|sensory system agents|mesh-ancestor
6640054|NCT01374698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6640055|NCT01374698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640056|NCT01374698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6640057|NCT01374698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6640058|NCT01374698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6640059|NCT01374698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6640060|NCT01374698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640061|NCT01374698|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6640062|NCT01374698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6640063|NCT01374698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6640064|NCT01374698|Antipyretics|antipyretics|mesh-ancestor
6640065|NCT01374737|Dexmedetomidine|dexmedetomidine|mesh-list
6640066|NCT01374737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6640067|NCT01374737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6640068|NCT01374737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640069|NCT01374737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6640070|NCT01374737|Analgesics|analgesics|mesh-ancestor
6640071|NCT01374737|Sensory System Agents|sensory system agents|mesh-ancestor
6640072|NCT01374737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6640073|NCT01374737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6640074|NCT01374737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6640075|NCT01374737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6640076|NCT01374737|Adrenergic Agents|adrenergic agents|mesh-ancestor
6640077|NCT01374737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6640078|NCT01374737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640079|NCT01374750|Cyclosporine|cyclosporine|mesh-list
6640080|NCT01374750|Sirolimus|sirolimus|mesh-list
6640081|NCT01374750|Tacrolimus|tacrolimus|mesh-list
6640082|NCT01374750|Cyclosporins|cyclosporins|mesh-list
6640083|NCT01374750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6640084|NCT01374750|Immunologic Factors|immunologic factors|mesh-ancestor
6640085|NCT01374750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640086|NCT01374750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6640087|NCT01374750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6640088|NCT01374750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640089|NCT01374750|Antifungal Agents|antifungal agents|mesh-ancestor
6640090|NCT01374750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6640091|NCT01374750|Dermatologic Agents|dermatologic agents|mesh-ancestor
6640092|NCT01374750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6640093|NCT01374750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6640094|NCT01374750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6640095|NCT01374750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6021570|NCT00400946|Hormones|hormones|mesh-ancestor
6021571|NCT00400946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6021572|NCT00400946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6021573|NCT00400946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6021574|NCT00400946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6021575|NCT00400946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6021576|NCT00400946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6021577|NCT00400946|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6021578|NCT00400946|Abortifacient Agents|abortifacient agents|mesh-ancestor
6021579|NCT00400946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6021580|NCT00400946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6021581|NCT00400946|Antimetabolites|antimetabolites|mesh-ancestor
6021582|NCT00400946|Dermatologic Agents|dermatologic agents|mesh-ancestor
6021583|NCT00400946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6021584|NCT00400946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6021585|NCT00400946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6021586|NCT00400946|Antiviral Agents|antiviral agents|mesh-ancestor
6640096|NCT01374763|Oxycodone|oxycodone|mesh-list
6640097|NCT01374763|Naloxone|naloxone|mesh-list
6640098|NCT01374763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6640099|NCT01374763|Narcotics|narcotics|mesh-ancestor
6665148|NCT01515839|Cholinergic Agents|cholinergic agents|mesh-ancestor
6640100|NCT01374763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6640101|NCT01374763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640102|NCT01374763|Analgesics|analgesics|mesh-ancestor
6640103|NCT01374763|Sensory System Agents|sensory system agents|mesh-ancestor
6640104|NCT01374763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6640105|NCT01374763|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5484679|NCT04648826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484680|NCT04648826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5484681|NCT04648826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5484682|NCT04606394|Albuterol|albuterol|mesh-list
5484683|NCT04606394|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5484684|NCT04606394|Autonomic Agents|autonomic agents|mesh-ancestor
5484685|NCT04606394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5484686|NCT04606394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484687|NCT04606394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5484688|NCT04606394|Respiratory System Agents|respiratory system agents|mesh-ancestor
5484689|NCT04606394|Tocolytic Agents|tocolytic agents|mesh-ancestor
5484690|NCT04606394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5484691|NCT04606394|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5484692|NCT04606394|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5484693|NCT04606394|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5484694|NCT04606394|Adrenergic Agents|adrenergic agents|mesh-ancestor
5484695|NCT04606394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5484696|NCT04606394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021587|NCT00400946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6021588|NCT00400946|Antidotes|antidotes|mesh-ancestor
6640106|NCT01374789|Panitumumab|panitumumab|mesh-list
6640107|NCT01374789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6640108|NCT01374789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6640109|NCT01374828|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6640110|NCT01374828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6640111|NCT01374828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6640112|NCT01374828|Analgesics|analgesics|mesh-ancestor
6640113|NCT01374828|Sensory System Agents|sensory system agents|mesh-ancestor
6640114|NCT01374828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6640115|NCT01374828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640116|NCT01374828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6640117|NCT01374828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6640118|NCT01374828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6640119|NCT01374828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6640120|NCT01374828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640121|NCT01374841|Cyclophosphamide|cyclophosphamide|mesh-list
6640122|NCT01374841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6640123|NCT01374841|Immunologic Factors|immunologic factors|mesh-ancestor
6640124|NCT01374841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640125|NCT01374841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6452804|NCT00417833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6452805|NCT00417833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6452806|NCT00417833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6452807|NCT00417833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6452808|NCT00417833|Growth Substances|growth substances|mesh-ancestor
6452809|NCT00417833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452810|NCT00417833|Growth Inhibitors|growth inhibitors|mesh-ancestor
6452811|NCT00417872|Metronidazole|metronidazole|mesh-list
6452812|NCT00417872|Nitazoxanide|nitazoxanide|mesh-list
6452813|NCT00417872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6452814|NCT00417872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6452815|NCT00417872|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6452816|NCT00417872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6452817|NCT00417898|Aspirin|aspirin|mesh-list
6452818|NCT00417898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6452819|NCT00417898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6452820|NCT00417898|Analgesics|analgesics|mesh-ancestor
6452821|NCT00417898|Sensory System Agents|sensory system agents|mesh-ancestor
6452822|NCT00417898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6452823|NCT00417898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021589|NCT00400946|Protective Agents|protective agents|mesh-ancestor
5484700|NCT04586985|Midazolam|midazolam|mesh-list
5484701|NCT04586985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5484702|NCT04586985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5484703|NCT04586985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6452824|NCT00417898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6640126|NCT01374841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6640127|NCT01374841|Alkylating Agents|alkylating agents|mesh-ancestor
6640128|NCT01374841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640129|NCT01374841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6640130|NCT01374841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6640131|NCT01374984|Immunoglobulins|immunoglobulins|mesh-list
6640132|NCT01374984|gamma-Globulins|gamma-globulins|mesh-list
6640133|NCT01374984|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6640134|NCT01374984|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6640135|NCT01374984|Immunologic Factors|immunologic factors|mesh-ancestor
6640136|NCT01374984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640137|NCT01375023|Thymoglobulin|thymoglobulin|mesh-list
6640138|NCT01375023|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6640139|NCT01375023|Immunologic Factors|immunologic factors|mesh-ancestor
6640140|NCT01375023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640141|NCT01375023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6640142|NCT01375088|Propolis|propolis|mesh-list
6640143|NCT01375088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6640144|NCT01375101|Quercetin|quercetin|mesh-list
6640145|NCT01375101|Antioxidants|antioxidants|mesh-ancestor
6640146|NCT01375101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640147|NCT01375101|Protective Agents|protective agents|mesh-ancestor
6640148|NCT01375101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640149|NCT01375244|Lisinopril|lisinopril|mesh-list
6640150|NCT01375244|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6640151|NCT01375244|Protease Inhibitors|protease inhibitors|mesh-ancestor
6640152|NCT01375244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6640153|NCT01375244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640154|NCT01375244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6640155|NCT01375244|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6640156|NCT01375244|Protective Agents|protective agents|mesh-ancestor
6640157|NCT01375244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452825|NCT00417898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6452826|NCT00417898|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6452827|NCT00417898|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6452828|NCT00417898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6452829|NCT00417898|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6452830|NCT00417898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5484704|NCT04586985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484705|NCT04586985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5484706|NCT04586985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5484707|NCT04586985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5484708|NCT04586985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5484709|NCT04586985|Anesthetics, General|anesthetics, general|mesh-ancestor
5484710|NCT04586985|Anesthetics|anesthetics|mesh-ancestor
5484711|NCT04586985|GABA Modulators|gaba modulators|mesh-ancestor
5484712|NCT04586985|GABA Agents|gaba agents|mesh-ancestor
5484713|NCT04586985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5484714|NCT04586985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502517|NCT04466241|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5502518|NCT04466241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5502519|NCT04466241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5502520|NCT04466241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5502521|NCT04466241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5502522|NCT04465968|Durvalumab|durvalumab|mesh-list
5502523|NCT04465968|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5502524|NCT04465968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5502525|NCT04465968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5502526|NCT04465968|Immunologic Factors|immunologic factors|mesh-ancestor
5502527|NCT04465968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502528|NCT04466085|Vaccines|vaccines|mesh-list
5502529|NCT04466085|Immunologic Factors|immunologic factors|mesh-ancestor
5502530|NCT04466085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503633|NCT04457089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5503634|NCT04457089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5503635|NCT04457089|Antimetabolites|antimetabolites|mesh-ancestor
6452831|NCT00417898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6640158|NCT01375257|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6452832|NCT00417898|Antipyretics|antipyretics|mesh-ancestor
6452833|NCT00417911|Bortezomib|bortezomib|mesh-list
6452834|NCT00417911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6452835|NCT00417937|Azelaic acid|azelaic acid|mesh-list
6452836|NCT00417937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6452837|NCT00417937|Dermatologic Agents|dermatologic agents|mesh-ancestor
6452838|NCT00417950|Acarbose|acarbose|mesh-list
6452839|NCT00417950|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6452840|NCT00417950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6640159|NCT01375257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6640160|NCT01375257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6640161|NCT01375257|Antitubercular Agents|antitubercular agents|mesh-ancestor
6640162|NCT01375322|Amlodipine|amlodipine|mesh-list
6640163|NCT01375322|Valsartan|valsartan|mesh-list
6640164|NCT01375322|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6640165|NCT01375322|Benazepril|benazepril|mesh-list
6640166|NCT01375322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6640167|NCT01375322|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6640168|NCT01375322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6640169|NCT01375322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640170|NCT01375322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6640171|NCT01375322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640172|NCT01375322|Vasodilator Agents|vasodilator agents|mesh-ancestor
6640173|NCT01375322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6640174|NCT01375322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6640175|NCT01375322|Diuretics|diuretics|mesh-ancestor
6640176|NCT01375322|Natriuretic Agents|natriuretic agents|mesh-ancestor
6640177|NCT01375322|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6640178|NCT01375322|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5484715|NCT04577690|Epinephrine|epinephrine|mesh-list
5484716|NCT04577690|Racepinephrine|racepinephrine|mesh-list
5484717|NCT04577690|Bupivacaine|bupivacaine|mesh-list
5484718|NCT04577690|Epinephryl borate|epinephryl borate|mesh-list
5484719|NCT04577690|Anesthetics, Local|anesthetics, local|mesh-ancestor
5484720|NCT04577690|Anesthetics|anesthetics|mesh-ancestor
5484721|NCT04577690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5484722|NCT04577690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640179|NCT01375322|Protease Inhibitors|protease inhibitors|mesh-ancestor
6640180|NCT01375322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6640181|NCT01375335|Dobutamine|dobutamine|mesh-list
6640182|NCT01375335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6640183|NCT01375335|Sympathomimetics|sympathomimetics|mesh-ancestor
6640184|NCT01375335|Autonomic Agents|autonomic agents|mesh-ancestor
6640185|NCT01375335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6640186|NCT01375335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640187|NCT01375335|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6640188|NCT01375335|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6640189|NCT01375335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6640190|NCT01375335|Adrenergic Agents|adrenergic agents|mesh-ancestor
6640191|NCT01375335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6640192|NCT01375335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640193|NCT01375335|Protective Agents|protective agents|mesh-ancestor
6640194|NCT01375348|Remifentanil|remifentanil|mesh-list
6640195|NCT01375348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6640196|NCT01375348|Narcotics|narcotics|mesh-ancestor
6640197|NCT01375348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6640198|NCT01375348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640199|NCT01375348|Analgesics|analgesics|mesh-ancestor
6640200|NCT01375348|Sensory System Agents|sensory system agents|mesh-ancestor
6640201|NCT01375348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6640202|NCT01375361|Albuterol|albuterol|mesh-list
6640203|NCT01375361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6640204|NCT01375361|Autonomic Agents|autonomic agents|mesh-ancestor
6640205|NCT01375361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6640206|NCT01375361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640207|NCT01375361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6640208|NCT01375361|Respiratory System Agents|respiratory system agents|mesh-ancestor
6640209|NCT01375361|Tocolytic Agents|tocolytic agents|mesh-ancestor
6640210|NCT01375361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6640211|NCT01375361|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6640212|NCT01375361|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6640213|NCT01375361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6640214|NCT01375361|Adrenergic Agents|adrenergic agents|mesh-ancestor
6640215|NCT01375361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6640216|NCT01375361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640217|NCT01375387|Lacosamide|lacosamide|mesh-list
6640218|NCT01375387|Anticonvulsants|anticonvulsants|mesh-ancestor
6640219|NCT01375387|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5484723|NCT04577690|Sensory System Agents|sensory system agents|mesh-ancestor
5484724|NCT04577690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5484725|NCT04577690|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5484726|NCT04577690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5484727|NCT04577690|Adrenergic Agents|adrenergic agents|mesh-ancestor
6640220|NCT01375387|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6640221|NCT01375387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6640222|NCT01375387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484728|NCT04577690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5484729|NCT04577690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484730|NCT04577690|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5484731|NCT04577690|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5484732|NCT04577690|Autonomic Agents|autonomic agents|mesh-ancestor
5484733|NCT04577690|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5484734|NCT04577690|Respiratory System Agents|respiratory system agents|mesh-ancestor
5484735|NCT04577690|Mydriatics|mydriatics|mesh-ancestor
5484736|NCT04577690|Sympathomimetics|sympathomimetics|mesh-ancestor
5484737|NCT04577690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5484738|NCT04574856|Temozolomide|temozolomide|mesh-list
5484739|NCT04574856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5484740|NCT04574856|Alkylating Agents|alkylating agents|mesh-ancestor
5484741|NCT04574856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484742|NCT04574856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5484743|NCT04570501|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
5484744|NCT04570501|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5484745|NCT04570501|Vasodilator Agents|vasodilator agents|mesh-ancestor
5484746|NCT04551482|Oxytocin|oxytocin|mesh-list
5484747|NCT04551482|Oxytocics|oxytocics|mesh-ancestor
5484748|NCT04551482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6640223|NCT01375400|Aspirin|aspirin|mesh-list
6640224|NCT01375400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6640225|NCT01375400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6640226|NCT01375400|Analgesics|analgesics|mesh-ancestor
6640227|NCT01375400|Sensory System Agents|sensory system agents|mesh-ancestor
6452841|NCT00417950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6452842|NCT00417950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6452843|NCT00417950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452844|NCT00418054|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6452845|NCT00418054|Interferon-alpha|interferon-alpha|mesh-list
6452846|NCT00418054|Nitazoxanide|nitazoxanide|mesh-list
6452847|NCT00418054|Antiviral Agents|antiviral agents|mesh-ancestor
6640228|NCT01375400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6640229|NCT01375400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640230|NCT01375400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6640231|NCT01375400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6640232|NCT01375400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6640233|NCT01375400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6640234|NCT01375400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640235|NCT01375400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6640236|NCT01375400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6640237|NCT01375400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6640238|NCT01375400|Antipyretics|antipyretics|mesh-ancestor
6640239|NCT01375426|Amoxicillin|amoxicillin|mesh-list
6640240|NCT01375426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6640241|NCT01375426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6640242|NCT01375452|Letrozole|letrozole|mesh-list
6640243|NCT01375452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6640244|NCT01375452|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6640245|NCT01375452|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6640246|NCT01375452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6640247|NCT01375452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640248|NCT01375452|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6640249|NCT01375452|Hormone Antagonists|hormone antagonists|mesh-ancestor
6640250|NCT01375452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6640251|NCT01375452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663421|NCT01507376|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6663422|NCT01507376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663423|NCT01507389|Liraglutide|liraglutide|mesh-list
6663424|NCT01507389|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6663425|NCT01507389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663426|NCT01507389|Incretins|incretins|mesh-ancestor
6663427|NCT01507389|Hormones|hormones|mesh-ancestor
6663428|NCT01507389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6663429|NCT01507428|Deoxyglucose|deoxyglucose|mesh-list
6663430|NCT01507428|Misonidazole|misonidazole|mesh-list
6663431|NCT01507428|Paclitaxel|paclitaxel|mesh-list
6663432|NCT01507428|Carboplatin|carboplatin|mesh-list
6663433|NCT01507428|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5484749|NCT04551482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452848|NCT00418054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6452849|NCT00418054|Immunologic Factors|immunologic factors|mesh-ancestor
6640252|NCT01375556|Ethanol|ethanol|mesh-list
6640253|NCT01375556|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6640254|NCT01375556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6640255|NCT01375556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6640256|NCT01375556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484750|NCT04539964|Antirheumatic Agents|antirheumatic agents|mesh-list
5484751|NCT04523922|Oxytocin|oxytocin|mesh-list
5484752|NCT04523922|Oxytocics|oxytocics|mesh-ancestor
5484753|NCT04523922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5484754|NCT04523922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484755|NCT04510311|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
6640257|NCT01375582|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6640258|NCT01375582|Lubricant Eye Drops|lubricant eye drops|mesh-list
5484756|NCT04510311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5484757|NCT04510311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5484758|NCT04510311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484759|NCT04510311|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6640259|NCT01375582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6640260|NCT01375634|Midazolam|midazolam|mesh-list
6640261|NCT01375634|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6640262|NCT01375634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6640263|NCT01375634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6640264|NCT01375634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640265|NCT01375634|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6640266|NCT01375634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6640267|NCT01375634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6640268|NCT01375634|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6640269|NCT01375634|Anesthetics, General|anesthetics, general|mesh-ancestor
6640270|NCT01375634|Anesthetics|anesthetics|mesh-ancestor
6640271|NCT01375634|GABA Modulators|gaba modulators|mesh-ancestor
6640272|NCT01375634|GABA Agents|gaba agents|mesh-ancestor
6640273|NCT01375634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6640274|NCT01375634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640275|NCT01375699|Doxorubicin|doxorubicin|mesh-list
6640276|NCT01375699|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6640277|NCT01375699|Sildenafil Citrate|sildenafil citrate|mesh-list
6640278|NCT01375699|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6640279|NCT01375699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6640280|NCT01375699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6640281|NCT01375699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6640282|NCT01375699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5484760|NCT04496596|Suramin|suramin|mesh-list
5484761|NCT04496596|Antinematodal Agents|antinematodal agents|mesh-ancestor
5484762|NCT04496596|Anthelmintics|anthelmintics|mesh-ancestor
5484763|NCT04496596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5484764|NCT04496596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5484765|NCT04496596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5484766|NCT04496596|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5484767|NCT04496596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5484768|NCT04487067|Bevacizumab|bevacizumab|mesh-list
5484769|NCT04487067|Atezolizumab|atezolizumab|mesh-list
5484770|NCT04487067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5484771|NCT04487067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6640283|NCT01375699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640284|NCT01375699|Vasodilator Agents|vasodilator agents|mesh-ancestor
6640285|NCT01375699|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6640286|NCT01375699|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6640287|NCT01375699|Urological Agents|urological agents|mesh-ancestor
6640288|NCT01375816|Leucovorin|leucovorin|mesh-list
6640289|NCT01375816|Bevacizumab|bevacizumab|mesh-list
6640290|NCT01375816|Fluorouracil|fluorouracil|mesh-list
6640291|NCT01375816|Irinotecan|irinotecan|mesh-list
6640292|NCT01375816|Calcium|calcium|mesh-list
6640293|NCT01375816|Levoleucovorin|levoleucovorin|mesh-list
6640294|NCT01375816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6640295|NCT01375816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6640296|NCT01375816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6640297|NCT01375816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6640298|NCT01375816|Growth Substances|growth substances|mesh-ancestor
6640299|NCT01375816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640300|NCT01375816|Growth Inhibitors|growth inhibitors|mesh-ancestor
6640301|NCT01375816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6640302|NCT01375816|Antimetabolites|antimetabolites|mesh-ancestor
6640303|NCT01375816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484772|NCT04487067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6640304|NCT01375816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6640305|NCT01375816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6640306|NCT01375816|Immunologic Factors|immunologic factors|mesh-ancestor
6640307|NCT01375816|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6640308|NCT01375816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6640309|NCT01375816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6640310|NCT01375816|Antidotes|antidotes|mesh-ancestor
6640311|NCT01375816|Protective Agents|protective agents|mesh-ancestor
6640312|NCT01375816|Vitamin B Complex|vitamin b complex|mesh-ancestor
6640313|NCT01375816|Vitamins|vitamins|mesh-ancestor
6640314|NCT01375816|Micronutrients|micronutrients|mesh-ancestor
6640315|NCT01375829|Sirolimus|sirolimus|mesh-list
6640316|NCT01375829|Epothilone B|epothilone b|mesh-list
6640317|NCT01375829|Epothilones|epothilones|mesh-list
6640318|NCT01375829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6640319|NCT01375829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6640320|NCT01375829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6640321|NCT01375829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6640322|NCT01375829|Antifungal Agents|antifungal agents|mesh-ancestor
6640323|NCT01375829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5484773|NCT04487067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5484774|NCT04487067|Growth Substances|growth substances|mesh-ancestor
5484775|NCT04487067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484776|NCT04487067|Growth Inhibitors|growth inhibitors|mesh-ancestor
5484777|NCT04447053|Belimumab|belimumab|mesh-list
5484778|NCT04447053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5484779|NCT04447053|Immunologic Factors|immunologic factors|mesh-ancestor
5484780|NCT04447053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484781|NCT04410042|Tranexamic Acid|tranexamic acid|mesh-list
5484782|NCT04410042|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5484783|NCT04410042|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5484784|NCT04410042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484785|NCT04410042|Hemostatics|hemostatics|mesh-ancestor
5484786|NCT04410042|Coagulants|coagulants|mesh-ancestor
5484787|NCT04393311|Urinastatin|urinastatin|mesh-list
5484788|NCT04393311|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5484789|NCT04393311|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5484790|NCT04393311|Protease Inhibitors|protease inhibitors|mesh-ancestor
5484791|NCT04393311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5484792|NCT04393311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484793|NCT04393298|Leucovorin|leucovorin|mesh-list
6640324|NCT01375829|Immunologic Factors|immunologic factors|mesh-ancestor
6640325|NCT01375829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640326|NCT01375829|Tubulin Modulators|tubulin modulators|mesh-ancestor
6640327|NCT01375829|Antimitotic Agents|antimitotic agents|mesh-ancestor
6640328|NCT01375829|Mitosis Modulators|mitosis modulators|mesh-ancestor
6640329|NCT01375829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640330|NCT01375842|Atezolizumab|atezolizumab|mesh-list
6640331|NCT01375842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6640332|NCT01375881|Ritonavir|ritonavir|mesh-list
6640333|NCT01375881|Darunavir|darunavir|mesh-list
6640334|NCT01375881|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6640335|NCT01375881|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6640336|NCT01375881|Protease Inhibitors|protease inhibitors|mesh-ancestor
6640337|NCT01375881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6640338|NCT01375881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640339|NCT01375881|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6640340|NCT01375881|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6640341|NCT01375881|Antiviral Agents|antiviral agents|mesh-ancestor
6640342|NCT01375881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6640343|NCT01375881|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6640344|NCT01375881|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6640345|NCT01375920|Metyrapone|metyrapone|mesh-list
5484794|NCT04393298|Trifluridine|trifluridine|mesh-list
5484795|NCT04393298|Fluorouracil|fluorouracil|mesh-list
5484796|NCT04393298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640346|NCT01375920|Antimetabolites|antimetabolites|mesh-ancestor
6640347|NCT01375920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640348|NCT01375920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6640349|NCT01375972|Gemcitabine|gemcitabine|mesh-list
6640350|NCT01375972|Cisplatin|cisplatin|mesh-list
6640351|NCT01375972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6640352|NCT01375972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6640353|NCT01375972|Antimetabolites|antimetabolites|mesh-ancestor
6640354|NCT01375972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640355|NCT01375972|Antiviral Agents|antiviral agents|mesh-ancestor
6640356|NCT01375972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6640357|NCT01375972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6640358|NCT01375972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6640359|NCT01375972|Immunologic Factors|immunologic factors|mesh-ancestor
6640360|NCT01375972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640361|NCT01375985|Radavirsen|radavirsen|mesh-list
6640362|NCT01375985|Antiviral Agents|antiviral agents|mesh-ancestor
6640363|NCT01375985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6640364|NCT01376011|Quercetin|quercetin|mesh-list
6640365|NCT01376011|Antioxidants|antioxidants|mesh-ancestor
6640366|NCT01376011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640367|NCT01376011|Protective Agents|protective agents|mesh-ancestor
6640368|NCT01376011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640369|NCT01376076|Moxifloxacin|moxifloxacin|mesh-list
6640370|NCT01376076|Risperidone|risperidone|mesh-list
6640371|NCT01376076|Cariprazine|cariprazine|mesh-list
6640372|NCT01376076|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6640373|NCT01376076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6640374|NCT01376076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6640375|NCT01376076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6640376|NCT01376076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6640377|NCT01376076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6640378|NCT01376076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640379|NCT01376076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6640380|NCT01376076|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6640381|NCT01376076|Contraceptive Agents|contraceptive agents|mesh-ancestor
6640382|NCT01376076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6640383|NCT01376076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640384|NCT01376076|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6640385|NCT01376076|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6640386|NCT01376076|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6640387|NCT01376076|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6640388|NCT01376076|Serotonin Agents|serotonin agents|mesh-ancestor
6452850|NCT00418054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452851|NCT00418054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6452852|NCT00418067|Sirolimus|sirolimus|mesh-list
6452853|NCT00418067|Paclitaxel|paclitaxel|mesh-list
6452854|NCT00418067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6452855|NCT00418067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6452856|NCT00418067|Tubulin Modulators|tubulin modulators|mesh-ancestor
6452857|NCT00418067|Antimitotic Agents|antimitotic agents|mesh-ancestor
6452858|NCT00418067|Mitosis Modulators|mitosis modulators|mesh-ancestor
6452859|NCT00418067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6452860|NCT00418067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6452861|NCT00418067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6452862|NCT00418067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6452863|NCT00418067|Antifungal Agents|antifungal agents|mesh-ancestor
6452864|NCT00418067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6452865|NCT00418067|Immunologic Factors|immunologic factors|mesh-ancestor
6640389|NCT01376076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6640390|NCT01376076|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6640391|NCT01376076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6640392|NCT01376076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6640393|NCT01376076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6640394|NCT01376076|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6640395|NCT01376076|Dopamine Agents|dopamine agents|mesh-ancestor
6640396|NCT01376102|Ibandronic Acid|ibandronic acid|mesh-list
6640397|NCT01376102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6640398|NCT01376102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484797|NCT04393298|Antimetabolites|antimetabolites|mesh-ancestor
5484798|NCT04393298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484799|NCT04393298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5484800|NCT04393298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5484801|NCT04393298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5484802|NCT04393298|Immunologic Factors|immunologic factors|mesh-ancestor
6640399|NCT01376128|Paroxetine|paroxetine|mesh-list
6452866|NCT00418067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640400|NCT01376128|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6640401|NCT01376128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6640402|NCT01376128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6640403|NCT01376128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640404|NCT01376128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6640405|NCT01376128|Serotonin Agents|serotonin agents|mesh-ancestor
6640406|NCT01376128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640407|NCT01376128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6640408|NCT01376128|Antidepressive Agents|antidepressive agents|mesh-ancestor
6640409|NCT01376128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6640410|NCT01376128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6640411|NCT01376128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6640412|NCT01376128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6640413|NCT01376141|Sumatriptan|sumatriptan|mesh-list
6640414|NCT01376141|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6640415|NCT01376141|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6640416|NCT01376141|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6640417|NCT01376141|Serotonin Agents|serotonin agents|mesh-ancestor
6640418|NCT01376141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6640419|NCT01376141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640420|NCT01376141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640421|NCT01376154|Lamivudine|lamivudine|mesh-list
6640422|NCT01376154|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6640423|NCT01376154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6640424|NCT01376154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6640425|NCT01376154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640426|NCT01376154|Antiviral Agents|antiviral agents|mesh-ancestor
6640427|NCT01376154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6640428|NCT01376154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6640429|NCT01376154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6640430|NCT01376180|Lamotrigine|lamotrigine|mesh-list
6640431|NCT01376180|Anticonvulsants|anticonvulsants|mesh-ancestor
6640432|NCT01376180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6640433|NCT01376180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6640434|NCT01376180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640435|NCT01376180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6640436|NCT01376180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640437|NCT01376180|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6640438|NCT01376180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6640439|NCT01376180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6640440|NCT01376180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6640441|NCT01376180|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6640442|NCT01376193|Naratriptan|naratriptan|mesh-list
6640443|NCT01376193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6640444|NCT01376193|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6640445|NCT01376193|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6640446|NCT01376193|Serotonin Agents|serotonin agents|mesh-ancestor
6640447|NCT01376193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6640448|NCT01376193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640449|NCT01376193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640450|NCT01376206|Fluticasone|fluticasone|mesh-list
6640451|NCT01376206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6640452|NCT01376206|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6640453|NCT01376206|Autonomic Agents|autonomic agents|mesh-ancestor
6640454|NCT01376206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6640455|NCT01376206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640456|NCT01376206|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6640457|NCT01376206|Respiratory System Agents|respiratory system agents|mesh-ancestor
6640458|NCT01376206|Dermatologic Agents|dermatologic agents|mesh-ancestor
6640459|NCT01376206|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6452867|NCT00418080|Bicalutamide|bicalutamide|mesh-list
6452868|NCT00418080|Androgen Antagonists|androgen antagonists|mesh-ancestor
6452869|NCT00418080|Hormone Antagonists|hormone antagonists|mesh-ancestor
6452870|NCT00418080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6452871|NCT00418080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452872|NCT00418080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6452873|NCT00418119|Epoetin Alfa|epoetin alfa|mesh-list
6452874|NCT00418119|Hematinics|hematinics|mesh-ancestor
6452875|NCT00418132|Thalidomide|thalidomide|mesh-list
6452876|NCT00418132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6452877|NCT00418132|Immunologic Factors|immunologic factors|mesh-ancestor
6452878|NCT00418132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640460|NCT01376232|Gemfibrozil|gemfibrozil|mesh-list
6640461|NCT01376232|Glycine|glycine|mesh-list
6640462|NCT01376232|Glycine Agents|glycine agents|mesh-ancestor
6640463|NCT01376232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6640464|NCT01376232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640465|NCT01376232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640466|NCT01376232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6640467|NCT01376232|Antimetabolites|antimetabolites|mesh-ancestor
6640468|NCT01376232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6640469|NCT01376232|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6640470|NCT01376232|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6640471|NCT01376232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6640472|NCT01376258|Finasteride|finasteride|mesh-list
6640473|NCT01376258|Dutasteride|dutasteride|mesh-list
6640474|NCT01376258|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6640475|NCT01376258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6640476|NCT01376258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6640477|NCT01376258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640478|NCT01376258|Hormone Antagonists|hormone antagonists|mesh-ancestor
6640479|NCT01376258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6640480|NCT01376258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640481|NCT01376258|Urological Agents|urological agents|mesh-ancestor
6640482|NCT01376271|Paroxetine|paroxetine|mesh-list
6640483|NCT01376271|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6640484|NCT01376271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6640485|NCT01376271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6640486|NCT01376271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640487|NCT01376271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6640488|NCT01376271|Serotonin Agents|serotonin agents|mesh-ancestor
6640489|NCT01376271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640490|NCT01376271|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6640491|NCT01376271|Antidepressive Agents|antidepressive agents|mesh-ancestor
6640492|NCT01376271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6640493|NCT01376271|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6640494|NCT01376271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6640495|NCT01376271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5484803|NCT04393298|Antiviral Agents|antiviral agents|mesh-ancestor
5484804|NCT04393298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5484805|NCT04393298|Antidotes|antidotes|mesh-ancestor
6640496|NCT01376284|Dutasteride|dutasteride|mesh-list
6640497|NCT01376284|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6640498|NCT01376284|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6640499|NCT01376284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6640500|NCT01376284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640501|NCT01376284|Hormone Antagonists|hormone antagonists|mesh-ancestor
6640502|NCT01376284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6640503|NCT01376284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640504|NCT01376323|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6640505|NCT01376323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6640506|NCT01376323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640507|NCT01376323|Incretins|incretins|mesh-ancestor
6640508|NCT01376323|Hormones|hormones|mesh-ancestor
6640509|NCT01376323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6640510|NCT01376323|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6640511|NCT01376323|Protease Inhibitors|protease inhibitors|mesh-ancestor
5484806|NCT04393298|Protective Agents|protective agents|mesh-ancestor
5484807|NCT04393298|Vitamin B Complex|vitamin b complex|mesh-ancestor
6640512|NCT01376323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6640513|NCT01376323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640514|NCT01376401|Prednisone|prednisone|mesh-list
6640515|NCT01376401|Bortezomib|bortezomib|mesh-list
6640516|NCT01376401|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6640517|NCT01376401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6640518|NCT01376401|Glucocorticoids|glucocorticoids|mesh-ancestor
6640519|NCT01376401|Hormones|hormones|mesh-ancestor
6640520|NCT01376401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6640521|NCT01376401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640522|NCT01376401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6640523|NCT01376401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6640524|NCT01376401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5484808|NCT04393298|Vitamins|vitamins|mesh-ancestor
5484809|NCT04393298|Micronutrients|micronutrients|mesh-ancestor
5484810|NCT04361799|Insulin|insulin|mesh-list
5484811|NCT04361799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5484812|NCT04361799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021590|NCT00400946|Vitamin B Complex|vitamin b complex|mesh-ancestor
6021591|NCT00400946|Vitamins|vitamins|mesh-ancestor
6640525|NCT01376401|Alkylating Agents|alkylating agents|mesh-ancestor
6640526|NCT01376401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640527|NCT01376440|Sodium Hypochlorite|sodium hypochlorite|mesh-list
6640528|NCT01376440|Eusol|eusol|mesh-list
6640529|NCT01376440|Disinfectants|disinfectants|mesh-ancestor
6640530|NCT01376440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6640531|NCT01376453|Fluorouracil|fluorouracil|mesh-list
6640532|NCT01376453|Sorafenib|sorafenib|mesh-list
6640533|NCT01376453|Antimetabolites|antimetabolites|mesh-ancestor
6640534|NCT01376453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640535|NCT01376453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6640536|NCT01376453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6640537|NCT01376453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6640538|NCT01376453|Immunologic Factors|immunologic factors|mesh-ancestor
6640539|NCT01376453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640540|NCT01376453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6640541|NCT01376453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6640542|NCT01376505|Vaccines|vaccines|mesh-list
6640543|NCT01376505|Immunologic Factors|immunologic factors|mesh-ancestor
6640544|NCT01376505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640545|NCT01376713|Dacarbazine|dacarbazine|mesh-list
6640546|NCT01376713|Ofatumumab|ofatumumab|mesh-list
6640547|NCT01376713|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6640548|NCT01376713|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6640549|NCT01376713|Alkylating Agents|alkylating agents|mesh-ancestor
6640550|NCT01376713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640551|NCT01376713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6640552|NCT01376713|Immunologic Factors|immunologic factors|mesh-ancestor
6640553|NCT01376713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640554|NCT01376765|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6640555|NCT01376765|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6640556|NCT01376765|Immunologic Factors|immunologic factors|mesh-ancestor
6640557|NCT01376765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640558|NCT01376765|Antacids|antacids|mesh-ancestor
6640559|NCT01376765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640560|NCT01376765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6640561|NCT01376817|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6640562|NCT01376817|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6640563|NCT01376817|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6640564|NCT01376817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6640565|NCT01376882|Caffeine|caffeine|mesh-list
6640566|NCT01376882|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6640567|NCT01376882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640568|NCT01376882|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6640569|NCT01376882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6640570|NCT01376882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640571|NCT01376882|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6640572|NCT01376882|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6021592|NCT00400946|Micronutrients|micronutrients|mesh-ancestor
6021593|NCT00400946|Tubulin Modulators|tubulin modulators|mesh-ancestor
6021594|NCT00400946|Antimitotic Agents|antimitotic agents|mesh-ancestor
6021595|NCT00400946|Mitosis Modulators|mitosis modulators|mesh-ancestor
5484819|NCT04306510|Antibodies|antibodies|mesh-list
5484820|NCT04306510|Immunoglobulins|immunoglobulins|mesh-list
5484821|NCT04306510|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5484822|NCT04306510|Immunologic Factors|immunologic factors|mesh-ancestor
5484823|NCT04306510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484824|NCT04277637|Zanubrutinib|zanubrutinib|mesh-list
5484825|NCT04277637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5484826|NCT04277637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5484827|NCT04277637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5484828|NCT04277637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021596|NCT00400946|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6021597|NCT00400946|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6021598|NCT00401193|Tranexamic Acid|tranexamic acid|mesh-list
6021599|NCT00401193|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6021600|NCT00401193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6021601|NCT00401193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021602|NCT00401193|Hemostatics|hemostatics|mesh-ancestor
6640573|NCT01376882|Purinergic Agents|purinergic agents|mesh-ancestor
6640574|NCT01376882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6640575|NCT01376999|Hormones|hormones|mesh-list
6640576|NCT01376999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6640577|NCT01376999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640578|NCT01377025|Sorafenib|sorafenib|mesh-list
6640579|NCT01377025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6640580|NCT01377025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6640581|NCT01377025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6640582|NCT01377025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640583|NCT01377051|Maleic acid|maleic acid|mesh-list
6640584|NCT01377051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6640585|NCT01377051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640586|NCT01377103|Testosterone|testosterone|mesh-list
6640587|NCT01377103|Androgens|androgens|mesh-ancestor
6640588|NCT01377103|Hormones|hormones|mesh-ancestor
6640589|NCT01377103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6640590|NCT01377103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663434|NCT01507428|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6663435|NCT01507428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6663436|NCT01507428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6663437|NCT01507428|Tubulin Modulators|tubulin modulators|mesh-ancestor
6663438|NCT01507428|Antimitotic Agents|antimitotic agents|mesh-ancestor
6663439|NCT01507428|Mitosis Modulators|mitosis modulators|mesh-ancestor
6663440|NCT01507428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663441|NCT01507428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6021603|NCT00401193|Coagulants|coagulants|mesh-ancestor
6663442|NCT01507428|Antimetabolites|antimetabolites|mesh-ancestor
6663443|NCT01507428|Antiviral Agents|antiviral agents|mesh-ancestor
6663444|NCT01507428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6663445|NCT01507428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6663446|NCT01507428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6663447|NCT01507454|Estradiol|estradiol|mesh-list
6663448|NCT01507454|Estrogens|estrogens|mesh-ancestor
6663449|NCT01507454|Hormones|hormones|mesh-ancestor
6663450|NCT01507454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6663451|NCT01507454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663452|NCT01507467|Nimorazole|nimorazole|mesh-list
6663453|NCT01507467|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
6663454|NCT01507467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6021604|NCT00401245|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6021605|NCT00401245|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6021606|NCT00401245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5484841|NCT04146935|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5484842|NCT04146935|Immunologic Factors|immunologic factors|mesh-ancestor
5484843|NCT04146935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484844|NCT04132817|Paclitaxel|paclitaxel|mesh-list
6663455|NCT01507467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6663456|NCT01507467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6663457|NCT01507480|Bevacizumab|bevacizumab|mesh-list
6663458|NCT01507480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6663459|NCT01507480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6663460|NCT01507480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6663461|NCT01507480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6663462|NCT01507480|Growth Substances|growth substances|mesh-ancestor
6663463|NCT01507480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663464|NCT01507480|Growth Inhibitors|growth inhibitors|mesh-ancestor
6663465|NCT01507519|Sirolimus|sirolimus|mesh-list
6663466|NCT01507519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5484845|NCT04132817|Nivolumab|nivolumab|mesh-list
6640591|NCT01377155|Insulin Detemir|insulin detemir|mesh-list
6640592|NCT01377155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6640593|NCT01377155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640594|NCT01377168|Naltrexone|naltrexone|mesh-list
6640595|NCT01377168|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6640596|NCT01377168|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6640597|NCT01377168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640598|NCT01377168|Sensory System Agents|sensory system agents|mesh-ancestor
6640599|NCT01377168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6640600|NCT01377220|Choline|choline|mesh-list
6640601|NCT01377220|Lipotropic Agents|lipotropic agents|mesh-ancestor
6640602|NCT01377220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6640603|NCT01377220|Antimetabolites|antimetabolites|mesh-ancestor
6640604|NCT01377220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484846|NCT04132817|Ipilimumab|ipilimumab|mesh-list
5484847|NCT04132817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5484848|NCT04132817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5484849|NCT04132817|Tubulin Modulators|tubulin modulators|mesh-ancestor
5484850|NCT04132817|Antimitotic Agents|antimitotic agents|mesh-ancestor
5484851|NCT04132817|Mitosis Modulators|mitosis modulators|mesh-ancestor
5484852|NCT04132817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484853|NCT04132817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5484854|NCT04132817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5484855|NCT04101890|Allantoin|allantoin|mesh-list
5484856|NCT04101890|Zinc Oxide|zinc oxide|mesh-list
5484857|NCT04101890|Dermatologic Agents|dermatologic agents|mesh-ancestor
5484858|NCT04101890|Sunscreening Agents|sunscreening agents|mesh-ancestor
5484859|NCT04101890|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5484860|NCT04101890|Protective Agents|protective agents|mesh-ancestor
5484861|NCT04101890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484862|NCT04069156|Aspirin|aspirin|mesh-list
5484863|NCT04069156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5484864|NCT04069156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6452879|NCT00418132|Leprostatic Agents|leprostatic agents|mesh-ancestor
6640605|NCT01377220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6640606|NCT01377220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6640607|NCT01377220|Nootropic Agents|nootropic agents|mesh-ancestor
6640608|NCT01377246|Octreotide|octreotide|mesh-list
6640609|NCT01377246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6640610|NCT01377246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6640611|NCT01377246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6640612|NCT01377259|Anesthetics|anesthetics|mesh-list
6640613|NCT01377259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6640614|NCT01377259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640615|NCT01377285|Pentoxifylline|pentoxifylline|mesh-list
6640616|NCT01377285|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
6640617|NCT01377285|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6640618|NCT01377285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6640619|NCT01377285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640620|NCT01377285|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6640621|NCT01377285|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6640622|NCT01377285|Protective Agents|protective agents|mesh-ancestor
6640623|NCT01377285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640624|NCT01377285|Vasodilator Agents|vasodilator agents|mesh-ancestor
6640625|NCT01377285|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6640626|NCT01377285|Antioxidants|antioxidants|mesh-ancestor
6640627|NCT01377324|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6640628|NCT01377324|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6640629|NCT01377324|Estradiol|estradiol|mesh-list
6452880|NCT00418132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6452881|NCT00418132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6452882|NCT00418132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6452883|NCT00418132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6452884|NCT00418132|Growth Substances|growth substances|mesh-ancestor
6452885|NCT00418132|Growth Inhibitors|growth inhibitors|mesh-ancestor
6452886|NCT00418132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6452887|NCT00418171|Olanzapine|olanzapine|mesh-list
6452888|NCT00418171|Ziprasidone|ziprasidone|mesh-list
6452889|NCT00418171|Antiemetics|antiemetics|mesh-ancestor
6452890|NCT00418171|Autonomic Agents|autonomic agents|mesh-ancestor
6452891|NCT00418171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6452892|NCT00418171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452893|NCT00418171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6452894|NCT00418171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5484865|NCT04069156|Analgesics|analgesics|mesh-ancestor
6452895|NCT00418171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6640630|NCT01377324|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6640631|NCT01377324|Estrogens|estrogens|mesh-ancestor
6640632|NCT01377324|Hormones|hormones|mesh-ancestor
6640633|NCT01377324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5484866|NCT04069156|Sensory System Agents|sensory system agents|mesh-ancestor
5484867|NCT04069156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5484868|NCT04069156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484869|NCT04069156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5484870|NCT04069156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5484871|NCT04069156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5484872|NCT04069156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5484873|NCT04069156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484874|NCT04069156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5484875|NCT04069156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5484876|NCT04069156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5484877|NCT04069156|Antipyretics|antipyretics|mesh-ancestor
5484878|NCT04028050|Carboplatin|carboplatin|mesh-list
5484879|NCT04028050|Etoposide|etoposide|mesh-list
5484880|NCT04028050|Atezolizumab|atezolizumab|mesh-list
5484881|NCT04028050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5484882|NCT04028050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5484883|NCT04028050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6452896|NCT00418171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6452897|NCT00418171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6452898|NCT00418171|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6452899|NCT00418171|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6452900|NCT00418171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6452901|NCT00418171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6452902|NCT00418171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6452903|NCT00418171|Serotonin Agents|serotonin agents|mesh-ancestor
6452904|NCT00418171|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6452905|NCT00418171|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6452906|NCT00418171|Dopamine Agents|dopamine agents|mesh-ancestor
6452907|NCT00418249|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
6640634|NCT01377324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640635|NCT01377324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6640636|NCT01377324|Contraceptive Agents|contraceptive agents|mesh-ancestor
6640637|NCT01377324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6640638|NCT01377324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6640639|NCT01377376|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6452908|NCT00418249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6452909|NCT00418249|Immunologic Factors|immunologic factors|mesh-ancestor
6452910|NCT00418249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452911|NCT00418249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6452912|NCT00418249|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6452913|NCT00418249|Protective Agents|protective agents|mesh-ancestor
6452914|NCT00418249|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6452915|NCT00418249|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6452916|NCT00418249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6452917|NCT00418249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6452918|NCT00418249|Antiviral Agents|antiviral agents|mesh-ancestor
6452919|NCT00418249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6452920|NCT00418275|Plasminogen|plasminogen|mesh-list
6452921|NCT00418275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6452922|NCT00418275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6452923|NCT00418275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6452924|NCT00418288|Glucagon|glucagon|mesh-list
6452925|NCT00418288|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6640640|NCT01377376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5484884|NCT04028050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5484885|NCT04028050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5484886|NCT04028050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484887|NCT04017442|Morphine|morphine|mesh-list
5484888|NCT04017442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5484889|NCT04017442|Narcotics|narcotics|mesh-ancestor
5484890|NCT04017442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5484891|NCT04017442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484892|NCT04017442|Analgesics|analgesics|mesh-ancestor
5484893|NCT04017442|Sensory System Agents|sensory system agents|mesh-ancestor
5484894|NCT04017442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5484895|NCT03993314|Bupivacaine|bupivacaine|mesh-list
5484896|NCT03993314|Chloroprocaine|chloroprocaine|mesh-list
5484897|NCT03993314|Anesthetics, Local|anesthetics, local|mesh-ancestor
5484898|NCT03993314|Anesthetics|anesthetics|mesh-ancestor
6640641|NCT01377376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6640642|NCT01377376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6640643|NCT01377376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640644|NCT01377415|Bupivacaine|bupivacaine|mesh-list
6640645|NCT01377415|Anesthetics, Local|anesthetics, local|mesh-ancestor
6640646|NCT01377415|Anesthetics|anesthetics|mesh-ancestor
6640647|NCT01377415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6640648|NCT01377415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640649|NCT01377415|Sensory System Agents|sensory system agents|mesh-ancestor
6640650|NCT01377415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6640651|NCT01377428|Formoterol Fumarate|formoterol fumarate|mesh-list
6452926|NCT00418288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6452927|NCT00418288|Hormones|hormones|mesh-ancestor
6452928|NCT00418288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6452929|NCT00418288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452930|NCT00418288|Incretins|incretins|mesh-ancestor
6452931|NCT00418327|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6452932|NCT00418327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6452933|NCT00418327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6452934|NCT00418327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6452935|NCT00418327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6452936|NCT00418353|Dexamethasone|dexamethasone|mesh-list
6452937|NCT00418353|Betamethasone|betamethasone|mesh-list
6452938|NCT00418353|Betamethasone Valerate|betamethasone valerate|mesh-list
6640652|NCT01377428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6640653|NCT01377428|Autonomic Agents|autonomic agents|mesh-ancestor
6640654|NCT01377428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6640655|NCT01377428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640656|NCT01377428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6640657|NCT01377428|Respiratory System Agents|respiratory system agents|mesh-ancestor
6640658|NCT01377428|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6640659|NCT01377428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6640660|NCT01377428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6640661|NCT01377428|Adrenergic Agents|adrenergic agents|mesh-ancestor
6640662|NCT01377428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5484899|NCT03993314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5484900|NCT03993314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484901|NCT03993314|Sensory System Agents|sensory system agents|mesh-ancestor
5484902|NCT03993314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5502531|NCT04465916|Tenofovir|tenofovir|mesh-list
5502532|NCT04465916|Entecavir|entecavir|mesh-list
5502533|NCT04465916|Antiviral Agents|antiviral agents|mesh-ancestor
5502534|NCT04465916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5502535|NCT04465916|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5502536|NCT04465916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5502537|NCT04465916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6452939|NCT00418353|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
6452940|NCT00418353|Betamethasone benzoate|betamethasone benzoate|mesh-list
6452941|NCT00418353|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
6452942|NCT00418353|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
6452943|NCT00418353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6452944|NCT00418353|Antiemetics|antiemetics|mesh-ancestor
6452945|NCT00418353|Autonomic Agents|autonomic agents|mesh-ancestor
6452946|NCT00418353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6452947|NCT00418353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452948|NCT00418353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6452949|NCT00418353|Glucocorticoids|glucocorticoids|mesh-ancestor
5502538|NCT04465916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502539|NCT04465916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5502540|NCT04465916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5502541|NCT04465942|Paclitaxel|paclitaxel|mesh-list
5502542|NCT04465942|Pembrolizumab|pembrolizumab|mesh-list
5502543|NCT04465942|Nivolumab|nivolumab|mesh-list
5502544|NCT04465942|Pemetrexed|pemetrexed|mesh-list
5502545|NCT04465942|Atezolizumab|atezolizumab|mesh-list
5502546|NCT04465942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5502547|NCT04465942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5502548|NCT04465942|Tubulin Modulators|tubulin modulators|mesh-ancestor
5502549|NCT04465942|Antimitotic Agents|antimitotic agents|mesh-ancestor
5502550|NCT04465942|Mitosis Modulators|mitosis modulators|mesh-ancestor
5502551|NCT04465942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502552|NCT04465942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5502553|NCT04465942|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5502554|NCT04465942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5484903|NCT03969953|Rivaroxaban|rivaroxaban|mesh-list
5484904|NCT03969953|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5484905|NCT03969953|Antithrombins|antithrombins|mesh-ancestor
5484906|NCT03969953|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6640663|NCT01377428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640664|NCT01377532|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
6640665|NCT01377532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6640666|NCT01377532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6640667|NCT01377532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640668|NCT01377532|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6640669|NCT01377545|Anesthetics|anesthetics|mesh-list
6640670|NCT01377545|Anesthetics, Local|anesthetics, local|mesh-list
6640671|NCT01377545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6640672|NCT01377545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640673|NCT01377545|Sensory System Agents|sensory system agents|mesh-ancestor
5484907|NCT03969953|Protease Inhibitors|protease inhibitors|mesh-ancestor
5484908|NCT03969953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5484909|NCT03969953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484910|NCT03969953|Anticoagulants|anticoagulants|mesh-ancestor
6021607|NCT00401245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6021608|NCT00401245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021609|NCT00401245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6021610|NCT00401245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021611|NCT00401245|Antidepressive Agents|antidepressive agents|mesh-ancestor
5484916|NCT03949894|Tolvaptan|tolvaptan|mesh-list
5484917|NCT03949894|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
5484918|NCT03949894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484919|NCT03949894|Natriuretic Agents|natriuretic agents|mesh-ancestor
5484920|NCT03949894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484921|NCT03942224|Dexamethasone|dexamethasone|mesh-list
5484922|NCT03942224|Bortezomib|bortezomib|mesh-list
5484923|NCT03942224|Daratumumab|daratumumab|mesh-list
6640674|NCT01377545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6640675|NCT01377597|Ranibizumab|ranibizumab|mesh-list
6640676|NCT01377597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6640677|NCT01377597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6640678|NCT01377597|Growth Substances|growth substances|mesh-ancestor
6640679|NCT01377597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640680|NCT01377597|Growth Inhibitors|growth inhibitors|mesh-ancestor
6640681|NCT01377597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6640682|NCT01377610|Naltrexone|naltrexone|mesh-list
6640683|NCT01377610|Buprenorphine|buprenorphine|mesh-list
6640684|NCT01377610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6640685|NCT01377610|Narcotics|narcotics|mesh-ancestor
6640686|NCT01377610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6640687|NCT01377610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640688|NCT01377610|Analgesics|analgesics|mesh-ancestor
6640689|NCT01377610|Sensory System Agents|sensory system agents|mesh-ancestor
5484924|NCT03942224|Ixazomib|ixazomib|mesh-list
5484925|NCT03942224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5484926|NCT03942224|Antiemetics|antiemetics|mesh-ancestor
5484927|NCT03942224|Autonomic Agents|autonomic agents|mesh-ancestor
5484928|NCT03942224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5484929|NCT03942224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484930|NCT03942224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5484931|NCT03942224|Glucocorticoids|glucocorticoids|mesh-ancestor
6640690|NCT01377610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6640691|NCT01377610|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6640692|NCT01377610|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6640693|NCT01377961|Lycopene|lycopene|mesh-list
6640694|NCT01377961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6640695|NCT01377961|Antioxidants|antioxidants|mesh-ancestor
6640696|NCT01377961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640697|NCT01377961|Protective Agents|protective agents|mesh-ancestor
6640698|NCT01377961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640699|NCT01377961|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6640700|NCT01377961|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6640701|NCT01377961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6640702|NCT01377974|Miltefosine|miltefosine|mesh-list
6640703|NCT01377974|Meglumine Antimoniate|meglumine antimoniate|mesh-list
6640704|NCT01377974|Antifungal Agents|antifungal agents|mesh-ancestor
6640705|NCT01377974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6640706|NCT01377974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5484932|NCT03942224|Hormones|hormones|mesh-ancestor
5484933|NCT03942224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6640707|NCT01377974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6640708|NCT01377974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6640709|NCT01378039|Budesonide|budesonide|mesh-list
6640710|NCT01378039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6640711|NCT01378039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6640712|NCT01378039|Autonomic Agents|autonomic agents|mesh-ancestor
6640713|NCT01378039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6640714|NCT01378039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640715|NCT01378039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6640716|NCT01378039|Respiratory System Agents|respiratory system agents|mesh-ancestor
6640717|NCT01378039|Glucocorticoids|glucocorticoids|mesh-ancestor
6640718|NCT01378039|Hormones|hormones|mesh-ancestor
6640719|NCT01378039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6640720|NCT01378091|Prednisone|prednisone|mesh-list
5484934|NCT03942224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5484935|NCT03942224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5484936|NCT03942224|Protease Inhibitors|protease inhibitors|mesh-ancestor
5484937|NCT03942224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5484938|NCT03942224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484939|NCT03928847|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
5484940|NCT03928847|Antioxidants|antioxidants|mesh-ancestor
5484941|NCT03928847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484942|NCT03928847|Protective Agents|protective agents|mesh-ancestor
5484943|NCT03928847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484944|NCT03928847|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
5484945|NCT03928847|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5484946|NCT03928847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6640721|NCT01378091|Docetaxel|docetaxel|mesh-list
6640722|NCT01378091|Lenalidomide|lenalidomide|mesh-list
6640723|NCT01378091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6640724|NCT01378091|Tubulin Modulators|tubulin modulators|mesh-ancestor
6640725|NCT01378091|Antimitotic Agents|antimitotic agents|mesh-ancestor
6640726|NCT01378091|Mitosis Modulators|mitosis modulators|mesh-ancestor
6640727|NCT01378091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640728|NCT01378091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6640729|NCT01378091|Glucocorticoids|glucocorticoids|mesh-ancestor
6640730|NCT01378091|Hormones|hormones|mesh-ancestor
6640731|NCT01378091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6640732|NCT01378091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640733|NCT01378091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6640734|NCT01378091|Immunologic Factors|immunologic factors|mesh-ancestor
6640735|NCT01378091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6640736|NCT01378091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6640737|NCT01378091|Growth Substances|growth substances|mesh-ancestor
6640738|NCT01378091|Growth Inhibitors|growth inhibitors|mesh-ancestor
6640739|NCT01378143|Pentamidine|pentamidine|mesh-list
6640740|NCT01378143|Antifungal Agents|antifungal agents|mesh-ancestor
6640741|NCT01378143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6640742|NCT01378143|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6640743|NCT01378143|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6640744|NCT01378143|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6640745|NCT01378156|Vaccines|vaccines|mesh-list
6640746|NCT01378156|Immunologic Factors|immunologic factors|mesh-ancestor
6640747|NCT01378156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640748|NCT01378286|Artesunate|artesunate|mesh-list
5484947|NCT03928847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5484948|NCT03924414|Zoledronic Acid|zoledronic acid|mesh-list
5484949|NCT03924414|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5484950|NCT03924414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484951|NCT03922997|Atezolizumab|atezolizumab|mesh-list
5484952|NCT03922997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5484953|NCT03879109|Folfirinox|folfirinox|mesh-list
5484954|NCT03879109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5484955|NCT03856359|Rifaximin|rifaximin|mesh-list
5484956|NCT03856359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5484957|NCT03856359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5484958|NCT03856359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5484959|NCT03846505|Oxytocin|oxytocin|mesh-list
5484960|NCT03846505|Oxytocics|oxytocics|mesh-ancestor
5484961|NCT03846505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5484962|NCT03846505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484963|NCT03837015|Estradiol|estradiol|mesh-list
5484964|NCT03837015|Estrogens|estrogens|mesh-ancestor
5484965|NCT03837015|Hormones|hormones|mesh-ancestor
6021612|NCT00401245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6640749|NCT01378286|Chloroquine|chloroquine|mesh-list
6640750|NCT01378286|Amodiaquine|amodiaquine|mesh-list
6640751|NCT01378286|Antimalarials|antimalarials|mesh-ancestor
6640752|NCT01378286|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6640753|NCT01378286|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6640754|NCT01378286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6640755|NCT01378286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6640756|NCT01378286|Antiviral Agents|antiviral agents|mesh-ancestor
6640757|NCT01378286|Schistosomicides|schistosomicides|mesh-ancestor
6640758|NCT01378286|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6640759|NCT01378286|Anthelmintics|anthelmintics|mesh-ancestor
6640760|NCT01378286|Amebicides|amebicides|mesh-ancestor
6640761|NCT01378286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6640762|NCT01378481|Vorinostat|vorinostat|mesh-list
6640763|NCT01378481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6640764|NCT01378481|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6640765|NCT01378481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6640766|NCT01378481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640767|NCT01378533|Paclitaxel|paclitaxel|mesh-list
6640768|NCT01378533|Cyclophosphamide|cyclophosphamide|mesh-list
6640769|NCT01378533|Carboplatin|carboplatin|mesh-list
6640770|NCT01378533|Epirubicin|epirubicin|mesh-list
6640771|NCT01378533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6640772|NCT01378533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6640773|NCT01378533|Tubulin Modulators|tubulin modulators|mesh-ancestor
6640774|NCT01378533|Antimitotic Agents|antimitotic agents|mesh-ancestor
6640775|NCT01378533|Mitosis Modulators|mitosis modulators|mesh-ancestor
6640776|NCT01378533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640777|NCT01378533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6640778|NCT01378533|Immunologic Factors|immunologic factors|mesh-ancestor
6640779|NCT01378533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640780|NCT01378533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6640781|NCT01378533|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6640782|NCT01378533|Alkylating Agents|alkylating agents|mesh-ancestor
6640783|NCT01378533|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6640784|NCT01378533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6640785|NCT01378533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6640786|NCT01378533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6640787|NCT01378533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6640788|NCT01378546|Amifampridine|amifampridine|mesh-list
6640789|NCT01378546|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6640790|NCT01378546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6640791|NCT01378546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640792|NCT01378546|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6640793|NCT01378546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6640794|NCT01378546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640795|NCT01378650|Cilostazol|cilostazol|mesh-list
6640796|NCT01378650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6640797|NCT01378650|Autonomic Agents|autonomic agents|mesh-ancestor
6640798|NCT01378650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6640799|NCT01378650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640800|NCT01378650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6640801|NCT01378650|Respiratory System Agents|respiratory system agents|mesh-ancestor
6640802|NCT01378650|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6452950|NCT00418353|Hormones|hormones|mesh-ancestor
6452951|NCT00418353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6452952|NCT00418353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6452953|NCT00418353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6452954|NCT00418353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6452955|NCT00418353|Respiratory System Agents|respiratory system agents|mesh-ancestor
6452956|NCT00418353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6452957|NCT00418366|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6452958|NCT00418366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6452959|NCT00418366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452960|NCT00418366|Incretins|incretins|mesh-ancestor
6452961|NCT00418366|Hormones|hormones|mesh-ancestor
6452962|NCT00418366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6452963|NCT00418366|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6452964|NCT00418366|Protease Inhibitors|protease inhibitors|mesh-ancestor
6640803|NCT01378650|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6640804|NCT01378650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640805|NCT01378650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6640806|NCT01378650|Vasodilator Agents|vasodilator agents|mesh-ancestor
6640807|NCT01378650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6640808|NCT01378650|Protective Agents|protective agents|mesh-ancestor
6640809|NCT01378650|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6640810|NCT01378650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6640811|NCT01378650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6640812|NCT01378715|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6640813|NCT01378715|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6640814|NCT01378715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6640815|NCT01378715|Antimetabolites|antimetabolites|mesh-ancestor
6640816|NCT01378715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484966|NCT03837015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5484967|NCT03837015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021613|NCT00401258|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6021614|NCT00401258|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6021615|NCT00401258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6021616|NCT00401258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6021617|NCT00401258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021618|NCT00401258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6640817|NCT01378715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5484975|NCT03690011|Cyclophosphamide|cyclophosphamide|mesh-list
5484976|NCT03690011|Fludarabine|fludarabine|mesh-list
5484977|NCT03690011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5484978|NCT03690011|Immunologic Factors|immunologic factors|mesh-ancestor
5484979|NCT03690011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484980|NCT03690011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5484981|NCT03690011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5484982|NCT03690011|Alkylating Agents|alkylating agents|mesh-ancestor
5484983|NCT03690011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484984|NCT03690011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5484985|NCT03690011|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5484986|NCT03674827|Vaccines|vaccines|mesh-list
5484987|NCT03674827|Immunologic Factors|immunologic factors|mesh-list
5484988|NCT03674827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484989|NCT03654729|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
5484990|NCT03654729|Edetic Acid|edetic acid|mesh-list
5484991|NCT03654729|Anticoagulants|anticoagulants|mesh-ancestor
5484992|NCT03654729|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5484993|NCT03654729|Chelating Agents|chelating agents|mesh-ancestor
6640818|NCT01378715|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6640819|NCT01378715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6640820|NCT01378741|Dexmedetomidine|dexmedetomidine|mesh-list
6640821|NCT01378741|Propofol|propofol|mesh-list
6640822|NCT01378741|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6640823|NCT01378741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6640824|NCT01378741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640825|NCT01378741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6640826|NCT01378741|Anesthetics, General|anesthetics, general|mesh-ancestor
6640827|NCT01378741|Anesthetics|anesthetics|mesh-ancestor
6640828|NCT01378741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6640829|NCT01378741|Analgesics|analgesics|mesh-ancestor
6640830|NCT01378741|Sensory System Agents|sensory system agents|mesh-ancestor
6640831|NCT01378741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6640832|NCT01378741|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6640833|NCT01378741|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6640834|NCT01378741|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6640835|NCT01378741|Adrenergic Agents|adrenergic agents|mesh-ancestor
6640836|NCT01378741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6640837|NCT01378741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640838|NCT01378754|Fospropofol|fospropofol|mesh-list
6640839|NCT01378754|Propofol|propofol|mesh-list
6640840|NCT01378754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6640841|NCT01378754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6640842|NCT01378754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640843|NCT01378754|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6640844|NCT01378754|Anesthetics, General|anesthetics, general|mesh-ancestor
5484994|NCT03654729|Sequestering Agents|sequestering agents|mesh-ancestor
5484995|NCT03654729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5484996|NCT03654729|Vitamin B Complex|vitamin b complex|mesh-ancestor
5484997|NCT03654729|Vitamins|vitamins|mesh-ancestor
5484998|NCT03654729|Micronutrients|micronutrients|mesh-ancestor
6640845|NCT01378754|Anesthetics|anesthetics|mesh-ancestor
6640846|NCT01378832|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6640847|NCT01378832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6663467|NCT01507519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6663468|NCT01507519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6663469|NCT01507519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6663470|NCT01507519|Antifungal Agents|antifungal agents|mesh-ancestor
6663471|NCT01507519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6663472|NCT01507519|Immunologic Factors|immunologic factors|mesh-ancestor
6663473|NCT01507519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5484999|NCT03654729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485000|NCT03582176|Ketotifen|ketotifen|mesh-list
5485001|NCT03582176|Antipruritics|antipruritics|mesh-ancestor
5485002|NCT03582176|Dermatologic Agents|dermatologic agents|mesh-ancestor
5485003|NCT03582176|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6663474|NCT01507558|Dexamethasone|dexamethasone|mesh-list
6663475|NCT01507558|Dexamethasone acetate|dexamethasone acetate|mesh-list
6663476|NCT01507558|BB 1101|bb 1101|mesh-list
6663477|NCT01507558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6663478|NCT01507558|Antiemetics|antiemetics|mesh-ancestor
6663479|NCT01507558|Autonomic Agents|autonomic agents|mesh-ancestor
6663480|NCT01507558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6663481|NCT01507558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663482|NCT01507558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6663483|NCT01507558|Glucocorticoids|glucocorticoids|mesh-ancestor
6452965|NCT00418366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6452966|NCT00418366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6452967|NCT00418392|Minocycline|minocycline|mesh-list
6452968|NCT00418392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6452969|NCT00418392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6452970|NCT00418431|Bevacizumab|bevacizumab|mesh-list
6452971|NCT00418431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6452972|NCT00418431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6452973|NCT00418431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6452974|NCT00418431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6452975|NCT00418431|Growth Substances|growth substances|mesh-ancestor
6452976|NCT00418431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6452977|NCT00418431|Growth Inhibitors|growth inhibitors|mesh-ancestor
6452978|NCT00418470|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6452979|NCT00418470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6452980|NCT00418470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6452981|NCT00418470|Antitubercular Agents|antitubercular agents|mesh-ancestor
5485004|NCT03582176|Histamine Antagonists|histamine antagonists|mesh-ancestor
5485005|NCT03582176|Histamine Agents|histamine agents|mesh-ancestor
6452982|NCT00418483|Fibrinolysin|fibrinolysin|mesh-list
6663484|NCT01507558|Hormones|hormones|mesh-ancestor
6640848|NCT01378845|Bosentan|bosentan|mesh-list
6640849|NCT01378845|Alprostadil|alprostadil|mesh-list
6640850|NCT01378845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6640851|NCT01378845|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6640852|NCT01378845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640853|NCT01378845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6640854|NCT01378845|Vasodilator Agents|vasodilator agents|mesh-ancestor
6640855|NCT01378845|Urological Agents|urological agents|mesh-ancestor
6640856|NCT01378884|Domperidone|domperidone|mesh-list
6640857|NCT01378884|Antiemetics|antiemetics|mesh-ancestor
6640858|NCT01378884|Autonomic Agents|autonomic agents|mesh-ancestor
6640859|NCT01378884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6640860|NCT01378884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640861|NCT01378884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6640862|NCT01378884|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6640863|NCT01378884|Dopamine Agents|dopamine agents|mesh-ancestor
6640864|NCT01378884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6640865|NCT01378884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640866|NCT01378949|Morphine|morphine|mesh-list
6640867|NCT01378949|Bupivacaine|bupivacaine|mesh-list
6640868|NCT01378949|Anesthetics, Local|anesthetics, local|mesh-ancestor
6640869|NCT01378949|Anesthetics|anesthetics|mesh-ancestor
6640870|NCT01378949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6640871|NCT01378949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640872|NCT01378949|Sensory System Agents|sensory system agents|mesh-ancestor
5485006|NCT03582176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5502555|NCT04465942|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6640873|NCT01378949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6640874|NCT01378949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6640875|NCT01378949|Narcotics|narcotics|mesh-ancestor
6640876|NCT01378949|Analgesics|analgesics|mesh-ancestor
6640877|NCT01379001|Scopolamine|scopolamine|mesh-list
6640878|NCT01379001|Donepezil|donepezil|mesh-list
6640879|NCT01379001|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
6640880|NCT01379001|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6640881|NCT01379001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6640882|NCT01379001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640883|NCT01379001|Cholinergic Agents|cholinergic agents|mesh-ancestor
6640884|NCT01379001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6640885|NCT01379001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640886|NCT01379001|Nootropic Agents|nootropic agents|mesh-ancestor
6640887|NCT01379001|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6640888|NCT01379001|Antiemetics|antiemetics|mesh-ancestor
6640889|NCT01379001|Autonomic Agents|autonomic agents|mesh-ancestor
6640890|NCT01379001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6640891|NCT01379001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6640892|NCT01379001|Mydriatics|mydriatics|mesh-ancestor
6640893|NCT01379001|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6640894|NCT01379001|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6640895|NCT01379001|Parasympatholytics|parasympatholytics|mesh-ancestor
6640896|NCT01379079|Aspirin|aspirin|mesh-list
6640897|NCT01379079|Calcium, Dietary|calcium, dietary|mesh-list
6640898|NCT01379079|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
6640899|NCT01379079|Carbaspirin calcium|carbaspirin calcium|mesh-list
6640900|NCT01379079|Calcium|calcium|mesh-list
6640901|NCT01379079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6640902|NCT01379079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640903|NCT01379079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6640904|NCT01379079|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6640905|NCT01379079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6640906|NCT01379079|Analgesics|analgesics|mesh-ancestor
6640907|NCT01379079|Sensory System Agents|sensory system agents|mesh-ancestor
6640908|NCT01379079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6640909|NCT01379079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6640910|NCT01379079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6640911|NCT01379079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6640912|NCT01379079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6640913|NCT01379079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640914|NCT01379079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6640915|NCT01379079|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6640916|NCT01379079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6640917|NCT01379079|Antipyretics|antipyretics|mesh-ancestor
6640918|NCT01379144|Latanoprost|latanoprost|mesh-list
6640919|NCT01379144|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6640920|NCT01379144|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6640921|NCT01379157|Imipenem|imipenem|mesh-list
6640922|NCT01379157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6640923|NCT01379157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6640924|NCT01379196|Azithromycin|azithromycin|mesh-list
6640925|NCT01379196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6640926|NCT01379196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6640927|NCT01379300|Rivaroxaban|rivaroxaban|mesh-list
6640928|NCT01379300|Dabigatran|dabigatran|mesh-list
6640929|NCT01379300|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6640930|NCT01379300|Antithrombins|antithrombins|mesh-ancestor
6640931|NCT01379300|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6640932|NCT01379300|Protease Inhibitors|protease inhibitors|mesh-ancestor
6640933|NCT01379300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6640934|NCT01379300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640935|NCT01379300|Anticoagulants|anticoagulants|mesh-ancestor
6640936|NCT01379326|Mebendazole|mebendazole|mesh-list
6640937|NCT01379326|Piperazine|piperazine|mesh-list
6640938|NCT01379326|Piperazine citrate|piperazine citrate|mesh-list
6640939|NCT01379326|DMP 777|dmp 777|mesh-list
5485007|NCT03582176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485008|NCT03582176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485009|NCT03582176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6640940|NCT01379326|Antinematodal Agents|antinematodal agents|mesh-ancestor
6640941|NCT01379326|Anthelmintics|anthelmintics|mesh-ancestor
6640942|NCT01379326|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6640943|NCT01379326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6640944|NCT01379326|Tubulin Modulators|tubulin modulators|mesh-ancestor
6640945|NCT01379326|Antimitotic Agents|antimitotic agents|mesh-ancestor
5485019|NCT03547973|Pembrolizumab|pembrolizumab|mesh-list
5485020|NCT03547973|Avelumab|avelumab|mesh-list
5485021|NCT03547973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5485022|NCT03547973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5485023|NCT03486197|Pembrolizumab|pembrolizumab|mesh-list
5485024|NCT03486197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5485025|NCT03486197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5485026|NCT03484923|Spartalizumab|spartalizumab|mesh-list
5485027|NCT03484923|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5485028|NCT03484923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485029|NCT03484923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5485030|NCT03462290|Botulinum Toxins|botulinum toxins|mesh-list
5485031|NCT03462290|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5485032|NCT03462290|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5485033|NCT03462290|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6452983|NCT00418483|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6452984|NCT00418483|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6452985|NCT00418483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6452986|NCT00418496|Aldesleukin|aldesleukin|mesh-list
6452987|NCT00418496|Sorafenib|sorafenib|mesh-list
6452988|NCT00418496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6452989|NCT00418496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6452990|NCT00418496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5485034|NCT03462290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5485035|NCT03462290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485036|NCT03462290|Cholinergic Agents|cholinergic agents|mesh-ancestor
5485037|NCT03462290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5485038|NCT03462290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485039|NCT03462290|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5485040|NCT03462290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5485041|NCT03406286|Tolvaptan|tolvaptan|mesh-list
5485042|NCT03406286|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
5485043|NCT03406286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485044|NCT03406286|Natriuretic Agents|natriuretic agents|mesh-ancestor
5485045|NCT03406286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485046|NCT03393845|Pembrolizumab|pembrolizumab|mesh-list
5485047|NCT03393845|Fulvestrant|fulvestrant|mesh-list
5485048|NCT03393845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5485049|NCT03393845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5485050|NCT03393845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5485051|NCT03393845|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5485052|NCT03393845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5485053|NCT03393845|Hormone Antagonists|hormone antagonists|mesh-ancestor
5485054|NCT03393845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5485055|NCT03393845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485056|NCT03376763|Aripiprazole|aripiprazole|mesh-list
5485057|NCT03376763|Antidepressive Agents|antidepressive agents|mesh-ancestor
5485058|NCT03376763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5485059|NCT03376763|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5485060|NCT03376763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5485061|NCT03376763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5485062|NCT03376763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485063|NCT03376763|Dopamine Agonists|dopamine agonists|mesh-ancestor
5485064|NCT03376763|Dopamine Agents|dopamine agents|mesh-ancestor
5485065|NCT03376763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5485066|NCT03376763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485067|NCT03376763|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5485068|NCT03376763|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5485069|NCT03376763|Serotonin Agents|serotonin agents|mesh-ancestor
5485070|NCT03376763|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5485071|NCT03376763|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5485072|NCT03376763|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5485073|NCT03376763|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5485074|NCT03336203|Allopurinol|allopurinol|mesh-list
5485075|NCT03336203|Febuxostat|febuxostat|mesh-list
5485076|NCT03336203|Antimetabolites|antimetabolites|mesh-ancestor
5485077|NCT03336203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485078|NCT03336203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6452991|NCT00418496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6452992|NCT00418496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6452993|NCT00418496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6452994|NCT00418496|Antiviral Agents|antiviral agents|mesh-ancestor
6452995|NCT00418496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6452996|NCT00418509|Mometasone Furoate|mometasone furoate|mesh-list
6452997|NCT00418509|Formoterol Fumarate|formoterol fumarate|mesh-list
6452998|NCT00418509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6452999|NCT00418509|Autonomic Agents|autonomic agents|mesh-ancestor
6453000|NCT00418509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6453001|NCT00418509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453002|NCT00418509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6453003|NCT00418509|Respiratory System Agents|respiratory system agents|mesh-ancestor
5485079|NCT03336203|Gout Suppressants|gout suppressants|mesh-ancestor
5485080|NCT03336203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5485081|NCT03336203|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5485082|NCT03336203|Antioxidants|antioxidants|mesh-ancestor
5485083|NCT03336203|Protective Agents|protective agents|mesh-ancestor
5485084|NCT03336203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485085|NCT03296033|Enoxaparin|enoxaparin|mesh-list
5485086|NCT03296033|Enoxaparin sodium|enoxaparin sodium|mesh-list
6453004|NCT00418509|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6453005|NCT00418509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6453006|NCT00418509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6453007|NCT00418509|Adrenergic Agents|adrenergic agents|mesh-ancestor
6453008|NCT00418509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6453009|NCT00418509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453010|NCT00418509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6453011|NCT00418509|Dermatologic Agents|dermatologic agents|mesh-ancestor
6453012|NCT00418509|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6453013|NCT00418535|Cisplatin|cisplatin|mesh-list
6453014|NCT00418535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6453015|NCT00418548|Etanercept|etanercept|mesh-list
6453016|NCT00418548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6453017|NCT00418548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6453018|NCT00418548|Analgesics|analgesics|mesh-ancestor
6453019|NCT00418548|Sensory System Agents|sensory system agents|mesh-ancestor
6453020|NCT00418548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6453021|NCT00418548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640946|NCT01379326|Mitosis Modulators|mitosis modulators|mesh-ancestor
6640947|NCT01379326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640948|NCT01379326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6640949|NCT01379326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6640950|NCT01379482|Paclitaxel|paclitaxel|mesh-list
6640951|NCT01379482|Docetaxel|docetaxel|mesh-list
6640952|NCT01379482|Cisplatin|cisplatin|mesh-list
6640953|NCT01379482|Doxorubicin|doxorubicin|mesh-list
6640954|NCT01379482|Oxaliplatin|oxaliplatin|mesh-list
6640955|NCT01379482|Irinotecan|irinotecan|mesh-list
6640956|NCT01379482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6640957|NCT01379482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6640958|NCT01379482|Tubulin Modulators|tubulin modulators|mesh-ancestor
6640959|NCT01379482|Antimitotic Agents|antimitotic agents|mesh-ancestor
6640960|NCT01379482|Mitosis Modulators|mitosis modulators|mesh-ancestor
6640961|NCT01379482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640962|NCT01379482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6640963|NCT01379482|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6640964|NCT01379482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6640965|NCT01379482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6640966|NCT01379482|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6640967|NCT01379547|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6640968|NCT01379547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6640969|NCT01379560|Isopropyl unoprostone|isopropyl unoprostone|mesh-list
6640970|NCT01379560|Dinoprost|dinoprost|mesh-list
6640971|NCT01379560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6640972|NCT01379560|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6640973|NCT01379560|Abortifacient Agents|abortifacient agents|mesh-ancestor
6640974|NCT01379560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6640975|NCT01379560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640976|NCT01379560|Oxytocics|oxytocics|mesh-ancestor
6640977|NCT01379677|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
6640978|NCT01379677|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6640979|NCT01379677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640980|NCT01379807|Docetaxel|docetaxel|mesh-list
6640981|NCT01379807|Panitumumab|panitumumab|mesh-list
6640982|NCT01379807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6640983|NCT01379807|Tubulin Modulators|tubulin modulators|mesh-ancestor
6640984|NCT01379807|Antimitotic Agents|antimitotic agents|mesh-ancestor
6640985|NCT01379807|Mitosis Modulators|mitosis modulators|mesh-ancestor
6640986|NCT01379807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6640987|NCT01379807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6640988|NCT01379846|Vaccines|vaccines|mesh-list
6640989|NCT01379846|Immunologic Factors|immunologic factors|mesh-ancestor
6640990|NCT01379846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6640991|NCT01379898|Doxazosin|doxazosin|mesh-list
6640992|NCT01379898|Phenoxybenzamine|phenoxybenzamine|mesh-list
5485087|NCT03296033|Anticoagulants|anticoagulants|mesh-ancestor
6453022|NCT00418548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6640993|NCT01379898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6640994|NCT01379898|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5485088|NCT03296033|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5485089|NCT03296033|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5485090|NCT03296033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485091|NCT03237286|Ketamine|ketamine|mesh-list
5485092|NCT03237286|Analgesics|analgesics|mesh-ancestor
5485093|NCT03237286|Sensory System Agents|sensory system agents|mesh-ancestor
5485094|NCT03237286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5485095|NCT03237286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485096|NCT03237286|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5485097|NCT03237286|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5485098|NCT03237286|Anesthetics, General|anesthetics, general|mesh-ancestor
5485099|NCT03237286|Anesthetics|anesthetics|mesh-ancestor
5485100|NCT03237286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5485101|NCT03237286|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5485102|NCT03237286|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5485103|NCT03237286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5485104|NCT03237286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502556|NCT04465942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5502557|NCT04465864|Dexamethasone|dexamethasone|mesh-list
5502558|NCT04465864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5502559|NCT04465864|Antiemetics|antiemetics|mesh-ancestor
5502560|NCT04465864|Autonomic Agents|autonomic agents|mesh-ancestor
5502561|NCT04465864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5502562|NCT04465864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502563|NCT04465864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5502564|NCT04465864|Glucocorticoids|glucocorticoids|mesh-ancestor
6640995|NCT01379898|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6640996|NCT01379898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6640997|NCT01379898|Adrenergic Agents|adrenergic agents|mesh-ancestor
6640998|NCT01379898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6640999|NCT01379898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641000|NCT01379898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641001|NCT01379898|Vasodilator Agents|vasodilator agents|mesh-ancestor
6641002|NCT01379976|Acetylcarnitine|acetylcarnitine|mesh-list
6641003|NCT01379976|Vitamin B Complex|vitamin b complex|mesh-ancestor
6641004|NCT01379976|Vitamins|vitamins|mesh-ancestor
6641005|NCT01379976|Micronutrients|micronutrients|mesh-ancestor
6641006|NCT01379976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641007|NCT01379976|Nootropic Agents|nootropic agents|mesh-ancestor
6641008|NCT01380015|Rosmarinic acid|rosmarinic acid|mesh-list
6641009|NCT01380015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6641010|NCT01380015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5502565|NCT04465864|Hormones|hormones|mesh-ancestor
5502566|NCT04465864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5502567|NCT04465864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5502568|NCT04465864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5502569|NCT04465734|Sorafenib|sorafenib|mesh-list
5502570|NCT04465734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5502571|NCT04465734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5502572|NCT04465734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5502573|NCT04465734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502574|NCT04465760|Antibodies|antibodies|mesh-list
5502575|NCT04465760|Immunoglobulins|immunoglobulins|mesh-list
5502576|NCT04465760|Immunologic Factors|immunologic factors|mesh-ancestor
5502577|NCT04465760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502578|NCT04465773|Remifentanil|remifentanil|mesh-list
5502579|NCT04465773|Propofol|propofol|mesh-list
5502580|NCT04465773|Anesthetics|anesthetics|mesh-ancestor
5502581|NCT04465773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5502582|NCT04465773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502583|NCT04465773|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5502584|NCT04465773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5502585|NCT04465773|Anesthetics, General|anesthetics, general|mesh-ancestor
5502586|NCT04465773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5502587|NCT04465773|Narcotics|narcotics|mesh-ancestor
5502588|NCT04465773|Analgesics|analgesics|mesh-ancestor
5502589|NCT04465773|Sensory System Agents|sensory system agents|mesh-ancestor
5502590|NCT04465773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5502591|NCT04465643|Nivolumab|nivolumab|mesh-list
6641011|NCT01380015|Analgesics|analgesics|mesh-ancestor
6641012|NCT01380015|Sensory System Agents|sensory system agents|mesh-ancestor
6641013|NCT01380015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6641014|NCT01380015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641015|NCT01380015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6641016|NCT01380015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6641017|NCT01380015|Antioxidants|antioxidants|mesh-ancestor
6641018|NCT01380015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641019|NCT01380015|Protective Agents|protective agents|mesh-ancestor
6641020|NCT01380015|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6641021|NCT01380015|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6641022|NCT01380015|Protease Inhibitors|protease inhibitors|mesh-ancestor
6641023|NCT01380015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6641024|NCT01380249|Bromides|bromides|mesh-list
6641025|NCT01380249|Anticonvulsants|anticonvulsants|mesh-ancestor
6641026|NCT01380275|Docetaxel|docetaxel|mesh-list
6641027|NCT01380275|Irinotecan|irinotecan|mesh-list
6641028|NCT01380275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6641029|NCT01380275|Tubulin Modulators|tubulin modulators|mesh-ancestor
6641030|NCT01380275|Antimitotic Agents|antimitotic agents|mesh-ancestor
6641031|NCT01380275|Mitosis Modulators|mitosis modulators|mesh-ancestor
6641032|NCT01380275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641033|NCT01380275|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6641034|NCT01380275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6641035|NCT01380275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6641036|NCT01380288|Rivastigmine|rivastigmine|mesh-list
6641037|NCT01380288|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6641038|NCT01380288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6641039|NCT01380288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641040|NCT01380288|Cholinergic Agents|cholinergic agents|mesh-ancestor
6641041|NCT01380288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6641042|NCT01380288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641043|NCT01380288|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6641044|NCT01380288|Protective Agents|protective agents|mesh-ancestor
6641045|NCT01380301|Miltefosine|miltefosine|mesh-list
6641046|NCT01380301|Antifungal Agents|antifungal agents|mesh-ancestor
6641047|NCT01380301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5485105|NCT03171025|Nivolumab|nivolumab|mesh-list
5485106|NCT03171025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5485107|NCT03171025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5485108|NCT03171025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5485109|NCT03171025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485110|NCT03158857|Sofosbuvir|sofosbuvir|mesh-list
5485111|NCT03158857|Antiviral Agents|antiviral agents|mesh-ancestor
5485112|NCT03158857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5485113|NCT03155061|Nivolumab|nivolumab|mesh-list
5485114|NCT03155061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5485115|NCT03155061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5485116|NCT03155061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5485117|NCT03155061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485118|NCT03141424|Fluticasone|fluticasone|mesh-list
5485119|NCT03141424|Mometasone Furoate|mometasone furoate|mesh-list
5485120|NCT03141424|Ciclesonide|ciclesonide|mesh-list
5485121|NCT03141424|Budesonide|budesonide|mesh-list
5485122|NCT03141424|Beclomethasone|beclomethasone|mesh-list
5485123|NCT03141424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5485124|NCT03141424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5485125|NCT03141424|Autonomic Agents|autonomic agents|mesh-ancestor
5485126|NCT03141424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5485127|NCT03141424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485128|NCT03141424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5485129|NCT03141424|Respiratory System Agents|respiratory system agents|mesh-ancestor
5485130|NCT03141424|Dermatologic Agents|dermatologic agents|mesh-ancestor
5485131|NCT03141424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5485132|NCT03141424|Glucocorticoids|glucocorticoids|mesh-ancestor
6641048|NCT01380301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6641049|NCT01380301|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6641050|NCT01380301|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6641051|NCT01380314|Miltefosine|miltefosine|mesh-list
6641052|NCT01380314|Imiquimod|imiquimod|mesh-list
6641053|NCT01380314|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6641054|NCT01380314|Immunologic Factors|immunologic factors|mesh-ancestor
6641055|NCT01380314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641056|NCT01380314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6641057|NCT01380314|Interferon Inducers|interferon inducers|mesh-ancestor
6641058|NCT01380314|Antifungal Agents|antifungal agents|mesh-ancestor
6641059|NCT01380314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6641060|NCT01380314|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6641061|NCT01380314|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6641062|NCT01380353|Diclofenac|diclofenac|mesh-list
6641063|NCT01380353|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
6641064|NCT01380353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5485133|NCT03141424|Hormones|hormones|mesh-ancestor
5485134|NCT03141424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6641065|NCT01380353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6641066|NCT01380353|Analgesics|analgesics|mesh-ancestor
6641067|NCT01380353|Sensory System Agents|sensory system agents|mesh-ancestor
6641068|NCT01380353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6641069|NCT01380353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641070|NCT01380353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6641071|NCT01380353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6641072|NCT01380353|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6641073|NCT01380353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6641074|NCT01380353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641075|NCT01380431|Lisinopril|lisinopril|mesh-list
6641076|NCT01380431|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6641077|NCT01380431|Protease Inhibitors|protease inhibitors|mesh-ancestor
6641078|NCT01380431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6641079|NCT01380431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641080|NCT01380431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6641081|NCT01380431|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6641082|NCT01380431|Protective Agents|protective agents|mesh-ancestor
6641083|NCT01380431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641084|NCT01380457|Dronabinol|dronabinol|mesh-list
6641085|NCT01380457|Hallucinogens|hallucinogens|mesh-ancestor
5485135|NCT03106688|Carfentanil|carfentanil|mesh-list
5485136|NCT03106688|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5485137|NCT03106688|Narcotics|narcotics|mesh-ancestor
5485138|NCT03106688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5485139|NCT03106688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485140|NCT03106688|Analgesics|analgesics|mesh-ancestor
5485141|NCT03106688|Sensory System Agents|sensory system agents|mesh-ancestor
6641086|NCT01380457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641087|NCT01380457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6641088|NCT01380457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6641089|NCT01380457|Analgesics|analgesics|mesh-ancestor
6641090|NCT01380457|Sensory System Agents|sensory system agents|mesh-ancestor
6641091|NCT01380457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6641092|NCT01380457|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6641093|NCT01380457|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6641094|NCT01380457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6641095|NCT01380457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641096|NCT01380457|Hormones|hormones|mesh-ancestor
6641097|NCT01380457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6641098|NCT01380483|Doxycycline|doxycycline|mesh-list
6641099|NCT01380483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6641100|NCT01380483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6641101|NCT01380483|Antimalarials|antimalarials|mesh-ancestor
6641102|NCT01380483|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6641103|NCT01380483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6641104|NCT01380496|Doxycycline|doxycycline|mesh-list
6641105|NCT01380496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6641106|NCT01380496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6641107|NCT01380496|Antimalarials|antimalarials|mesh-ancestor
6641108|NCT01380496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6641109|NCT01380496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6641110|NCT01380509|Metronidazole|metronidazole|mesh-list
6641111|NCT01380509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6641112|NCT01380509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6641113|NCT01380509|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6641114|NCT01380509|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6641115|NCT01380522|Metronidazole|metronidazole|mesh-list
6641116|NCT01380522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6641117|NCT01380522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6641118|NCT01380522|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6641119|NCT01380522|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6641120|NCT01380548|Iron|iron|mesh-list
6641121|NCT01380548|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6641122|NCT01380548|Trace Elements|trace elements|mesh-ancestor
6641123|NCT01380548|Micronutrients|micronutrients|mesh-ancestor
6641124|NCT01380548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641125|NCT01380548|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6641126|NCT01380548|Dermatologic Agents|dermatologic agents|mesh-ancestor
6663485|NCT01507558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6663486|NCT01507558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6663487|NCT01507558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6663488|NCT01507558|Protease Inhibitors|protease inhibitors|mesh-ancestor
6663489|NCT01507558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6663490|NCT01507558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663491|NCT01507571|Psychotropic Drugs|psychotropic drugs|mesh-list
5485142|NCT03106688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5485143|NCT03080259|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
5485144|NCT03080259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485145|NCT03069378|Pembrolizumab|pembrolizumab|mesh-list
5485146|NCT03069378|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
5485147|NCT03069378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5485148|NCT03069378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5485149|NCT03032601|Acetylcysteine|acetylcysteine|mesh-list
5485150|NCT03032601|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5485151|NCT03032601|Antiviral Agents|antiviral agents|mesh-ancestor
6641127|NCT01380600|Molgramostim|molgramostim|mesh-list
6641128|NCT01380600|Sargramostim|sargramostim|mesh-list
6641129|NCT01380600|Immunologic Factors|immunologic factors|mesh-ancestor
6641130|NCT01380600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641131|NCT01380600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6641132|NCT01380678|Bevacizumab|bevacizumab|mesh-list
6641133|NCT01380678|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
6641134|NCT01380678|Histamine Antagonists|histamine antagonists|mesh-list
6641135|NCT01380678|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
6641136|NCT01380678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6641137|NCT01380678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6641138|NCT01380678|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6641139|NCT01380678|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6641140|NCT01380678|Growth Substances|growth substances|mesh-ancestor
6641141|NCT01380678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641142|NCT01380678|Growth Inhibitors|growth inhibitors|mesh-ancestor
6641143|NCT01380678|Histamine Agents|histamine agents|mesh-ancestor
6641144|NCT01380678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6641145|NCT01380678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641146|NCT01380717|Calcium Channel Blockers|calcium channel blockers|mesh-list
6641147|NCT01380717|Calcium|calcium|mesh-list
6641148|NCT01380717|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
6641149|NCT01380717|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6641150|NCT01380717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6641151|NCT01380717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641152|NCT01380717|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6641153|NCT01380717|Adrenergic Agents|adrenergic agents|mesh-ancestor
6641154|NCT01380717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6641155|NCT01380717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641156|NCT01380717|Protease Inhibitors|protease inhibitors|mesh-ancestor
6641157|NCT01380717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6641158|NCT01380717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6641159|NCT01380808|Capecitabine|capecitabine|mesh-list
6641160|NCT01380808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6641161|NCT01380808|Antimetabolites|antimetabolites|mesh-ancestor
6641162|NCT01380808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641163|NCT01380808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6641164|NCT01380912|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6641165|NCT01380912|Methylprednisolone|methylprednisolone|mesh-list
6641166|NCT01380912|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6641167|NCT01380912|Prednisolone|prednisolone|mesh-list
6641168|NCT01380912|Prednisolone acetate|prednisolone acetate|mesh-list
6641169|NCT01380912|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6641170|NCT01380912|Prednisolone phosphate|prednisolone phosphate|mesh-list
6641171|NCT01380912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6641172|NCT01380912|Antiemetics|antiemetics|mesh-ancestor
6641173|NCT01380912|Autonomic Agents|autonomic agents|mesh-ancestor
6641174|NCT01380912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6641175|NCT01380912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641176|NCT01380912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6641177|NCT01380912|Glucocorticoids|glucocorticoids|mesh-ancestor
6641178|NCT01380912|Hormones|hormones|mesh-ancestor
6641179|NCT01380912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6641180|NCT01380912|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5485152|NCT03032601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5485153|NCT03032601|Expectorants|expectorants|mesh-ancestor
5485154|NCT03032601|Respiratory System Agents|respiratory system agents|mesh-ancestor
5485155|NCT03032601|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5485156|NCT03032601|Antioxidants|antioxidants|mesh-ancestor
5485157|NCT03032601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485158|NCT03032601|Protective Agents|protective agents|mesh-ancestor
5485159|NCT03032601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485160|NCT03032601|Antidotes|antidotes|mesh-ancestor
5485161|NCT03032328|Vitamin D|vitamin d|mesh-list
5485162|NCT03032328|Vitamins|vitamins|mesh-ancestor
6641181|NCT01380912|Protective Agents|protective agents|mesh-ancestor
6641182|NCT01380912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6641183|NCT01380912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6641184|NCT01380938|Ribavirin|ribavirin|mesh-list
6641185|NCT01380938|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6641186|NCT01380938|Interferon-alpha|interferon-alpha|mesh-list
6641187|NCT01380938|Antimetabolites|antimetabolites|mesh-ancestor
6641188|NCT01380938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641189|NCT01380938|Antiviral Agents|antiviral agents|mesh-ancestor
6641190|NCT01380938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6641191|NCT01380938|Immunologic Factors|immunologic factors|mesh-ancestor
6641192|NCT01380938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641193|NCT01380951|Telbivudine|telbivudine|mesh-list
6641194|NCT01380951|Antiviral Agents|antiviral agents|mesh-ancestor
6641195|NCT01380951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6641196|NCT01380951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6641197|NCT01380951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6641198|NCT01380951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641199|NCT01381055|Pentoxifylline|pentoxifylline|mesh-list
6641200|NCT01381055|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6641201|NCT01381055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6641202|NCT01381055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641203|NCT01381055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6641204|NCT01381055|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6641205|NCT01381055|Protective Agents|protective agents|mesh-ancestor
6641206|NCT01381055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641207|NCT01381055|Vasodilator Agents|vasodilator agents|mesh-ancestor
6641208|NCT01381055|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6641209|NCT01381055|Antioxidants|antioxidants|mesh-ancestor
6641210|NCT01381185|Aspirin|aspirin|mesh-list
6641211|NCT01381185|Clopidogrel|clopidogrel|mesh-list
6641212|NCT01381185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6641213|NCT01381185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6641214|NCT01381185|Analgesics|analgesics|mesh-ancestor
6641215|NCT01381185|Sensory System Agents|sensory system agents|mesh-ancestor
6641216|NCT01381185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6641217|NCT01381185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641218|NCT01381185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6641219|NCT01381185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6641220|NCT01381185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5485163|NCT03032328|Micronutrients|micronutrients|mesh-ancestor
5485164|NCT03032328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485165|NCT03032328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5485166|NCT02966873|Acetylcysteine|acetylcysteine|mesh-list
6641221|NCT01381185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6641222|NCT01381185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641223|NCT01381185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6641224|NCT01381185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6641225|NCT01381185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6641226|NCT01381185|Antipyretics|antipyretics|mesh-ancestor
5485167|NCT02966873|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5485168|NCT02966873|Antiviral Agents|antiviral agents|mesh-ancestor
5485169|NCT02966873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5485170|NCT02966873|Expectorants|expectorants|mesh-ancestor
5485171|NCT02966873|Respiratory System Agents|respiratory system agents|mesh-ancestor
5485172|NCT02966873|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5485173|NCT02966873|Antioxidants|antioxidants|mesh-ancestor
5485174|NCT02966873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485175|NCT02966873|Protective Agents|protective agents|mesh-ancestor
5485176|NCT02966873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485177|NCT02966873|Antidotes|antidotes|mesh-ancestor
5485178|NCT02951767|Atezolizumab|atezolizumab|mesh-list
5485179|NCT02951767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5485180|NCT02685735|Gabapentin|gabapentin|mesh-list
5485181|NCT02685735|Analgesics|analgesics|mesh-ancestor
5485182|NCT02685735|Sensory System Agents|sensory system agents|mesh-ancestor
5485183|NCT02685735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5485184|NCT02685735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485185|NCT02685735|Anticonvulsants|anticonvulsants|mesh-ancestor
5485186|NCT02685735|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5485187|NCT02685735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5485188|NCT02685735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5485189|NCT02685735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5485190|NCT02685735|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6641227|NCT01381185|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5485191|NCT02685735|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5485192|NCT02685735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5485193|NCT02685735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485194|NCT02685735|Antimanic Agents|antimanic agents|mesh-ancestor
6021619|NCT00401258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021620|NCT00401258|Analgesics|analgesics|mesh-ancestor
6021621|NCT00401258|Sensory System Agents|sensory system agents|mesh-ancestor
6021622|NCT00401258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6641228|NCT01381185|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6641229|NCT01381185|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6641230|NCT01381185|Purinergic Agents|purinergic agents|mesh-ancestor
6641231|NCT01381185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6641232|NCT01381276|Beta Carotene|beta carotene|mesh-list
6641233|NCT01381276|Vitamin A|vitamin a|mesh-list
6641234|NCT01381276|Retinol palmitate|retinol palmitate|mesh-list
6641235|NCT01381276|Carotenoids|carotenoids|mesh-list
6641236|NCT01381276|Antioxidants|antioxidants|mesh-ancestor
6641237|NCT01381276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641238|NCT01381276|Protective Agents|protective agents|mesh-ancestor
6641239|NCT01381276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641240|NCT01381276|Provitamins|provitamins|mesh-ancestor
6641241|NCT01381276|Vitamins|vitamins|mesh-ancestor
6021623|NCT00401258|Antidepressive Agents|antidepressive agents|mesh-ancestor
6021624|NCT00401258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6021625|NCT00401258|Dopamine Agents|dopamine agents|mesh-ancestor
6021626|NCT00401375|Methylnaltrexone|methylnaltrexone|mesh-list
5485203|NCT02631070|Luspatercept|luspatercept|mesh-list
6453023|NCT00418548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6453024|NCT00418548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6453025|NCT00418548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6453026|NCT00418548|Immunologic Factors|immunologic factors|mesh-ancestor
6453027|NCT00418587|Vitamin D|vitamin d|mesh-list
5485204|NCT02631070|Hematinics|hematinics|mesh-ancestor
5485205|NCT02630641|Hormones|hormones|mesh-list
5485206|NCT02630641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5485207|NCT02630641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485208|NCT02616185|Tremelimumab|tremelimumab|mesh-list
5485209|NCT02616185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5485210|NCT02513667|Ceritinib|ceritinib|mesh-list
5485211|NCT02513667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5485212|NCT02513667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5485213|NCT02513667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6641242|NCT01381276|Micronutrients|micronutrients|mesh-ancestor
6641243|NCT01381276|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6641244|NCT01381276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6641245|NCT01381289|Ivacaftor|ivacaftor|mesh-list
6641246|NCT01381289|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6641247|NCT01381289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6641248|NCT01381289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641249|NCT01381354|Riboflavin|riboflavin|mesh-list
5485214|NCT02513667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485215|NCT02513329|Bupivacaine|bupivacaine|mesh-list
5485216|NCT02513329|Anesthetics, Local|anesthetics, local|mesh-ancestor
5485217|NCT02513329|Anesthetics|anesthetics|mesh-ancestor
5485218|NCT02513329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5485219|NCT02513329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485220|NCT02513329|Sensory System Agents|sensory system agents|mesh-ancestor
5485221|NCT02513329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5485222|NCT02297139|Dasatinib|dasatinib|mesh-list
5485223|NCT02297139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5485224|NCT02297139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6021627|NCT00401375|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6453028|NCT00418587|Ergocalciferols|ergocalciferols|mesh-list
6641250|NCT01381354|Thioctic Acid|thioctic acid|mesh-list
6641251|NCT01381354|Thiamine|thiamine|mesh-list
6453029|NCT00418587|Cholecalciferol|cholecalciferol|mesh-list
6453030|NCT00418587|Vitamins|vitamins|mesh-list
6453031|NCT00418587|Micronutrients|micronutrients|mesh-ancestor
6453032|NCT00418587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453033|NCT00418587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6453034|NCT00418587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6453035|NCT00418600|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
6453036|NCT00418600|Ergocalciferols|ergocalciferols|mesh-list
6453037|NCT00418600|Vitamins|vitamins|mesh-ancestor
6641252|NCT01381354|Niacinamide|niacinamide|mesh-list
6641253|NCT01381354|Niacin|niacin|mesh-list
6453038|NCT00418600|Micronutrients|micronutrients|mesh-ancestor
6641254|NCT01381354|Nicotinic Acids|nicotinic acids|mesh-list
6641255|NCT01381354|Acetylcarnitine|acetylcarnitine|mesh-list
5485225|NCT02297139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5485226|NCT02297139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485227|NCT02281955|Cisplatin|cisplatin|mesh-list
5485228|NCT02281955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5485229|NCT02108652|Atezolizumab|atezolizumab|mesh-list
5485230|NCT02108652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5485231|NCT02097134|Melphalan|melphalan|mesh-list
5485232|NCT02097134|Mechlorethamine|mechlorethamine|mesh-list
5485233|NCT02097134|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
6641256|NCT01381354|Ubiquinone|ubiquinone|mesh-list
6641257|NCT01381354|Acetylcysteine|acetylcysteine|mesh-list
6641258|NCT01381354|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
6641259|NCT01381354|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6641260|NCT01381354|Vitamins|vitamins|mesh-ancestor
6641261|NCT01381354|Micronutrients|micronutrients|mesh-ancestor
6641262|NCT01381354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641263|NCT01381354|Antiviral Agents|antiviral agents|mesh-ancestor
6641264|NCT01381354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6641265|NCT01381354|Expectorants|expectorants|mesh-ancestor
6641266|NCT01381354|Respiratory System Agents|respiratory system agents|mesh-ancestor
6641267|NCT01381354|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6641268|NCT01381354|Antioxidants|antioxidants|mesh-ancestor
6641269|NCT01381354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641270|NCT01381354|Protective Agents|protective agents|mesh-ancestor
6641271|NCT01381354|Antidotes|antidotes|mesh-ancestor
6641272|NCT01381354|Vitamin B Complex|vitamin b complex|mesh-ancestor
6641273|NCT01381354|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6641274|NCT01381354|Dermatologic Agents|dermatologic agents|mesh-ancestor
6641275|NCT01381354|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6641276|NCT01381354|Antimetabolites|antimetabolites|mesh-ancestor
6641277|NCT01381354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6641278|NCT01381354|Vasodilator Agents|vasodilator agents|mesh-ancestor
6641279|NCT01381354|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6641280|NCT01381354|Nootropic Agents|nootropic agents|mesh-ancestor
6641281|NCT01381367|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6641282|NCT01381367|Immunologic Factors|immunologic factors|mesh-ancestor
6641283|NCT01381367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641284|NCT01381393|Ibandronic Acid|ibandronic acid|mesh-list
6641285|NCT01381393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6641286|NCT01381393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641287|NCT01381432|Azathioprine|azathioprine|mesh-list
6641288|NCT01381432|Antimetabolites|antimetabolites|mesh-ancestor
6641289|NCT01381432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641290|NCT01381432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6641291|NCT01381432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6641292|NCT01381432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6641293|NCT01381432|Immunologic Factors|immunologic factors|mesh-ancestor
6641294|NCT01381432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641295|NCT01381432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6641296|NCT01381445|Clobetasol|clobetasol|mesh-list
6641297|NCT01381445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6641298|NCT01381445|Glucocorticoids|glucocorticoids|mesh-ancestor
6641299|NCT01381445|Hormones|hormones|mesh-ancestor
6641300|NCT01381445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6641301|NCT01381445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641302|NCT01381497|Naproxen|naproxen|mesh-list
6641303|NCT01381497|Sumatriptan|sumatriptan|mesh-list
6641304|NCT01381497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6641305|NCT01381497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6641306|NCT01381497|Analgesics|analgesics|mesh-ancestor
6641307|NCT01381497|Sensory System Agents|sensory system agents|mesh-ancestor
6641308|NCT01381497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6641309|NCT01381497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641310|NCT01381497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6641311|NCT01381497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6641312|NCT01381497|Gout Suppressants|gout suppressants|mesh-ancestor
6641313|NCT01381497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5502592|NCT04465643|Ipilimumab|ipilimumab|mesh-list
5485234|NCT02097134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5485235|NCT02097134|Alkylating Agents|alkylating agents|mesh-ancestor
5485236|NCT02097134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485237|NCT02097134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5485238|NCT02097134|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5485239|NCT02097134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5485240|NCT02097134|Immunologic Factors|immunologic factors|mesh-ancestor
5485241|NCT02097134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485242|NCT01588431|Bevacizumab|bevacizumab|mesh-list
5485243|NCT01588431|Cetuximab|cetuximab|mesh-list
5485244|NCT01588431|Cisplatin|cisplatin|mesh-list
5485245|NCT01588431|Docetaxel|docetaxel|mesh-list
5485246|NCT01588431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5485247|NCT01588431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5485248|NCT01588431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5485249|NCT01588431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5485250|NCT01588431|Growth Substances|growth substances|mesh-ancestor
5485251|NCT01588431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485252|NCT01588431|Growth Inhibitors|growth inhibitors|mesh-ancestor
5485253|NCT01588431|Tubulin Modulators|tubulin modulators|mesh-ancestor
5485254|NCT01588431|Antimitotic Agents|antimitotic agents|mesh-ancestor
5485255|NCT01588431|Mitosis Modulators|mitosis modulators|mesh-ancestor
5485256|NCT01588431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485257|NCT01564537|Dexamethasone|dexamethasone|mesh-list
5485258|NCT01564537|Lenalidomide|lenalidomide|mesh-list
5485259|NCT01564537|Ixazomib|ixazomib|mesh-list
5485260|NCT01564537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5485261|NCT01564537|Antiemetics|antiemetics|mesh-ancestor
5485262|NCT01564537|Autonomic Agents|autonomic agents|mesh-ancestor
5485263|NCT01564537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5485264|NCT01564537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485265|NCT01564537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5485266|NCT01564537|Glucocorticoids|glucocorticoids|mesh-ancestor
5485267|NCT01564537|Hormones|hormones|mesh-ancestor
5485268|NCT01564537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5485269|NCT01564537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5485270|NCT01564537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6641314|NCT01381497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6641315|NCT01381497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641316|NCT01381497|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6641317|NCT01381497|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6641318|NCT01381497|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6641319|NCT01381497|Serotonin Agents|serotonin agents|mesh-ancestor
6641320|NCT01381497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6641321|NCT01381510|Finasteride|finasteride|mesh-list
6641322|NCT01381510|Dutasteride|dutasteride|mesh-list
6641323|NCT01381510|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
6641324|NCT01381510|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6641325|NCT01381510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6641326|NCT01381510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641327|NCT01381510|Hormone Antagonists|hormone antagonists|mesh-ancestor
6641328|NCT01381510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6641329|NCT01381510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641330|NCT01381510|Urological Agents|urological agents|mesh-ancestor
6641331|NCT01381523|Naproxen|naproxen|mesh-list
6641332|NCT01381523|Sumatriptan|sumatriptan|mesh-list
6641333|NCT01381523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6641334|NCT01381523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6641335|NCT01381523|Analgesics|analgesics|mesh-ancestor
6641336|NCT01381523|Sensory System Agents|sensory system agents|mesh-ancestor
6641337|NCT01381523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6641338|NCT01381523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641339|NCT01381523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5485271|NCT01564537|Immunologic Factors|immunologic factors|mesh-ancestor
6641340|NCT01381523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6641341|NCT01381523|Gout Suppressants|gout suppressants|mesh-ancestor
6641342|NCT01381523|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6641343|NCT01381523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6641344|NCT01381523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641345|NCT01381523|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6641346|NCT01381523|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6641347|NCT01381523|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6641348|NCT01381523|Serotonin Agents|serotonin agents|mesh-ancestor
6641349|NCT01381523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6641350|NCT01381536|Belimumab|belimumab|mesh-list
6641351|NCT01381536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6641352|NCT01381536|Immunologic Factors|immunologic factors|mesh-ancestor
6641353|NCT01381536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641354|NCT01381601|Bevacizumab|bevacizumab|mesh-list
6641355|NCT01381601|Sunitinib|sunitinib|mesh-list
6641356|NCT01381601|Sorafenib|sorafenib|mesh-list
5485272|NCT01564537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5485273|NCT01564537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5485274|NCT01564537|Growth Substances|growth substances|mesh-ancestor
5485275|NCT01564537|Growth Inhibitors|growth inhibitors|mesh-ancestor
5485276|NCT01564537|Protease Inhibitors|protease inhibitors|mesh-ancestor
5485277|NCT01564537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5485278|NCT01564537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485279|NCT01230242|Levonorgestrel|levonorgestrel|mesh-list
5485280|NCT01230242|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5485281|NCT01230242|Contraceptive Agents|contraceptive agents|mesh-ancestor
5485282|NCT01230242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5485283|NCT01230242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485284|NCT01230242|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5485285|NCT01230242|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5485286|NCT01230242|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5485287|NCT00983437|Modafinil|modafinil|mesh-list
5485288|NCT00983437|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5485289|NCT00983437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485290|NCT00983437|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
5485291|NCT00983437|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5485292|NCT00983437|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5485293|NCT00983437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485294|NCT00893789|Modafinil|modafinil|mesh-list
5485295|NCT00893789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5485296|NCT00893789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485297|NCT00893789|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
5485298|NCT00893789|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5485299|NCT00893789|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5485300|NCT00893789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485301|NCT00805129|Everolimus|everolimus|mesh-list
5485302|NCT00805129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5485303|NCT00805129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5485304|NCT00805129|Immunologic Factors|immunologic factors|mesh-ancestor
5485305|NCT00805129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485306|NCT00708448|Bevacizumab|bevacizumab|mesh-list
6641357|NCT01381601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6641358|NCT01381601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6641359|NCT01381601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6641360|NCT01381601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6641361|NCT01381601|Growth Substances|growth substances|mesh-ancestor
6641362|NCT01381601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641363|NCT01381601|Growth Inhibitors|growth inhibitors|mesh-ancestor
6641364|NCT01381601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6641365|NCT01381601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6641366|NCT01381601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641367|NCT01381614|Bevacizumab|bevacizumab|mesh-list
6641368|NCT01381614|Sunitinib|sunitinib|mesh-list
6641369|NCT01381614|Sorafenib|sorafenib|mesh-list
6641370|NCT01381614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6641371|NCT01381614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6641372|NCT01381614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6641373|NCT01381614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6641374|NCT01381614|Growth Substances|growth substances|mesh-ancestor
6641375|NCT01381614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641376|NCT01381614|Growth Inhibitors|growth inhibitors|mesh-ancestor
6641377|NCT01381614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5485307|NCT00708448|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6641378|NCT01381614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6641379|NCT01381614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641380|NCT01381627|Dexmedetomidine|dexmedetomidine|mesh-list
6641381|NCT01381627|Remifentanil|remifentanil|mesh-list
6641382|NCT01381627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6641383|NCT01381627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6641384|NCT01381627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641385|NCT01381627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5485308|NCT00708448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5485309|NCT00708448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5485310|NCT00708448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5485311|NCT00708448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5485312|NCT00708448|Growth Substances|growth substances|mesh-ancestor
5485313|NCT00708448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485314|NCT00708448|Growth Inhibitors|growth inhibitors|mesh-ancestor
6641386|NCT01381627|Analgesics|analgesics|mesh-ancestor
6641387|NCT01381627|Sensory System Agents|sensory system agents|mesh-ancestor
5485315|NCT00708448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6641388|NCT01381627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6641389|NCT01381627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6641390|NCT01381627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6641391|NCT01381627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6641392|NCT01381627|Adrenergic Agents|adrenergic agents|mesh-ancestor
6641393|NCT01381627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6641394|NCT01381627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641395|NCT01381627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6641396|NCT01381627|Narcotics|narcotics|mesh-ancestor
6641397|NCT01381640|Acetaminophen|acetaminophen|mesh-list
6641398|NCT01381640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6641399|NCT01381640|Analgesics|analgesics|mesh-ancestor
6641400|NCT01381640|Sensory System Agents|sensory system agents|mesh-ancestor
6641401|NCT01381640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6641402|NCT01381640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641403|NCT01381640|Antipyretics|antipyretics|mesh-ancestor
6641404|NCT01381705|Rituximab|rituximab|mesh-list
6641405|NCT01381705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6641406|NCT01381705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5485316|NCT00708448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5485317|NCT00708448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485318|NCT05164614|Teriparatide|teriparatide|mesh-list
5485319|NCT05164614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6641407|NCT01381705|Immunologic Factors|immunologic factors|mesh-ancestor
6641408|NCT01381705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641409|NCT01381705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6641410|NCT01381796|Sumatriptan|sumatriptan|mesh-list
6641411|NCT01381796|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6641412|NCT01381796|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6641413|NCT01381796|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6641414|NCT01381796|Serotonin Agents|serotonin agents|mesh-ancestor
6641415|NCT01381796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6641416|NCT01381796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663492|NCT01507597|Glucagon|glucagon|mesh-list
5485320|NCT05164614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641417|NCT01381796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485321|NCT05164614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5485322|NCT05164367|Atropine|atropine|mesh-list
5485323|NCT05164367|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5485324|NCT05164367|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5485325|NCT05164367|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5485326|NCT05164367|Autonomic Agents|autonomic agents|mesh-ancestor
5485327|NCT05164367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5485328|NCT05164367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485329|NCT05164367|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5485330|NCT05164367|Respiratory System Agents|respiratory system agents|mesh-ancestor
5485331|NCT05164367|Mydriatics|mydriatics|mesh-ancestor
6641418|NCT01381809|Epoetin Alfa|epoetin alfa|mesh-list
6641419|NCT01381809|Hematinics|hematinics|mesh-ancestor
6641420|NCT01381835|Simeprevir|simeprevir|mesh-list
6641421|NCT01381835|Antiviral Agents|antiviral agents|mesh-ancestor
6641422|NCT01381835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6641423|NCT01381835|Protease Inhibitors|protease inhibitors|mesh-ancestor
6641424|NCT01381835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6641425|NCT01381835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641426|NCT01381848|Doripenem|doripenem|mesh-list
5485332|NCT05164367|Parasympatholytics|parasympatholytics|mesh-ancestor
5485333|NCT05164367|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5485334|NCT05164367|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5485335|NCT05164367|Cholinergic Agents|cholinergic agents|mesh-ancestor
5485336|NCT05164367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5485337|NCT05164367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502593|NCT04465643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5502594|NCT04465643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5502595|NCT04465643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5502596|NCT04465643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502597|NCT04465500|Androgens|androgens|mesh-list
5502598|NCT04465500|Hormones|hormones|mesh-ancestor
5502599|NCT04465500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5502600|NCT04465500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502601|NCT04465695|Interferons|interferons|mesh-list
5502602|NCT04465695|Interferon-beta|interferon-beta|mesh-list
5502603|NCT04465695|Clofazimine|clofazimine|mesh-list
5502604|NCT04465695|Interferon beta-1b|interferon beta-1b|mesh-list
5502605|NCT04465695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5502606|NCT04465695|Antiviral Agents|antiviral agents|mesh-ancestor
5502607|NCT04465695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5502608|NCT04465695|Immunologic Factors|immunologic factors|mesh-ancestor
5502609|NCT04465695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502610|NCT04465695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5502611|NCT04465695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5502612|NCT04465695|Leprostatic Agents|leprostatic agents|mesh-ancestor
5502613|NCT04465695|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5502614|NCT04465851|Curcumin|curcumin|mesh-list
6641427|NCT01381848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6641428|NCT01381848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6641429|NCT01381887|Canagliflozin|canagliflozin|mesh-list
6641430|NCT01381887|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6641431|NCT01381887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641432|NCT01381887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6641433|NCT01381887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641434|NCT01382004|Azithromycin|azithromycin|mesh-list
6641435|NCT01382004|Penicillins|penicillins|mesh-list
6641436|NCT01382004|Penicillin G|penicillin g|mesh-list
6641437|NCT01382004|Penicillin G Benzathine|penicillin g benzathine|mesh-list
6641438|NCT01382004|Penicillin G Procaine|penicillin g procaine|mesh-list
6641439|NCT01382004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6641440|NCT01382004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6641441|NCT01382017|Lacosamide|lacosamide|mesh-list
6641442|NCT01382017|Carbamazepine|carbamazepine|mesh-list
6641443|NCT01382017|Anticonvulsants|anticonvulsants|mesh-ancestor
6641444|NCT01382017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6641445|NCT01382017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6641446|NCT01382017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6641447|NCT01382017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641448|NCT01382017|Antimanic Agents|antimanic agents|mesh-ancestor
6641449|NCT01382017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6641450|NCT01382017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5502615|NCT04465851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6641451|NCT01382017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641452|NCT01382017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5485338|NCT05164198|Adalimumab|adalimumab|mesh-list
5485339|NCT05164198|Etanercept|etanercept|mesh-list
5485340|NCT05164198|Golimumab|golimumab|mesh-list
5485341|NCT05164198|Infliximab|infliximab|mesh-list
5485342|NCT05164198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6641453|NCT01382017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6641454|NCT01382017|Analgesics|analgesics|mesh-ancestor
6641455|NCT01382017|Sensory System Agents|sensory system agents|mesh-ancestor
6641456|NCT01382017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6641457|NCT01382017|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6641458|NCT01382017|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6641459|NCT01382134|Aspirin|aspirin|mesh-list
6641460|NCT01382134|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
6641461|NCT01382134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6641462|NCT01382134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6641463|NCT01382134|Analgesics|analgesics|mesh-ancestor
6641464|NCT01382134|Sensory System Agents|sensory system agents|mesh-ancestor
6641465|NCT01382134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6641466|NCT01382134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641467|NCT01382134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6641468|NCT01382134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6641469|NCT01382134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6641470|NCT01382134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6641471|NCT01382134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641472|NCT01382134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6641473|NCT01382134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6641474|NCT01382134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6641475|NCT01382134|Antipyretics|antipyretics|mesh-ancestor
6641476|NCT01382134|Hemostatics|hemostatics|mesh-ancestor
6641477|NCT01382134|Coagulants|coagulants|mesh-ancestor
6641478|NCT01382134|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6641479|NCT01382134|Natriuretic Agents|natriuretic agents|mesh-ancestor
6641480|NCT01382147|Daunorubicin|daunorubicin|mesh-list
6641481|NCT01382147|Mitoxantrone|mitoxantrone|mesh-list
6641482|NCT01382147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6641483|NCT01382147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6641484|NCT01382147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6641485|NCT01382147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6641486|NCT01382147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6641487|NCT01382147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641488|NCT01382147|Analgesics|analgesics|mesh-ancestor
6641489|NCT01382147|Sensory System Agents|sensory system agents|mesh-ancestor
6641490|NCT01382147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6641491|NCT01382147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641492|NCT01382160|Adalimumab|adalimumab|mesh-list
6641493|NCT01382160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6641494|NCT01382160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6641495|NCT01382199|Lactoferrin|lactoferrin|mesh-list
6641496|NCT01382199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6641497|NCT01382238|Dolutegravir|dolutegravir|mesh-list
6641498|NCT01382238|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6641499|NCT01382238|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6641500|NCT01382238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6641501|NCT01382238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641502|NCT01382238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6641503|NCT01382238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6641504|NCT01382238|Antiviral Agents|antiviral agents|mesh-ancestor
6641505|NCT01382238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6641506|NCT01382277|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6641507|NCT01382277|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6641508|NCT01382277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6641509|NCT01382277|Antimetabolites|antimetabolites|mesh-ancestor
6641510|NCT01382277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641511|NCT01382277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6641512|NCT01382277|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6641513|NCT01382277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6641514|NCT01382342|Rasagiline|rasagiline|mesh-list
6641515|NCT01382342|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6641516|NCT01382342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6641517|NCT01382342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641518|NCT01382342|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6641519|NCT01382342|Protective Agents|protective agents|mesh-ancestor
6641520|NCT01382342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663493|NCT01507597|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6663494|NCT01507597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6663495|NCT01507597|Hormones|hormones|mesh-ancestor
5485343|NCT05164198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5485344|NCT05164198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5485345|NCT05164198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5485346|NCT05164198|Analgesics|analgesics|mesh-ancestor
5485347|NCT05164198|Sensory System Agents|sensory system agents|mesh-ancestor
5485348|NCT05164198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5485349|NCT05164198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485350|NCT05164198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5485351|NCT05164198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5485352|NCT05164198|Immunologic Factors|immunologic factors|mesh-ancestor
5485353|NCT05164198|Dermatologic Agents|dermatologic agents|mesh-ancestor
5485354|NCT05164198|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
5485355|NCT05164159|Propofol|propofol|mesh-list
5485356|NCT05164159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5485357|NCT05164159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6641521|NCT01382368|Sildenafil Citrate|sildenafil citrate|mesh-list
6641522|NCT01382368|Vasodilator Agents|vasodilator agents|mesh-ancestor
6641523|NCT01382368|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6641524|NCT01382368|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6641525|NCT01382368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6641526|NCT01382368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641527|NCT01382368|Urological Agents|urological agents|mesh-ancestor
6641528|NCT01382407|Cetuximab|cetuximab|mesh-list
6641529|NCT01382407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6641530|NCT01382407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5485358|NCT05164159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485359|NCT05164159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6641531|NCT01382472|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6641532|NCT01382472|Simvastatin|simvastatin|mesh-list
6641533|NCT01382472|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6641534|NCT01382472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6641535|NCT01382472|Antimetabolites|antimetabolites|mesh-ancestor
6641536|NCT01382472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641537|NCT01382472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6641538|NCT01382472|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6641539|NCT01382472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6641540|NCT01382498|Calcium Dobesilate|calcium dobesilate|mesh-list
6641541|NCT01382498|Calcium|calcium|mesh-list
6641542|NCT01382498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6641543|NCT01382498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641544|NCT01382498|Hemostatics|hemostatics|mesh-ancestor
6641545|NCT01382498|Coagulants|coagulants|mesh-ancestor
6641546|NCT01382511|Simvastatin|simvastatin|mesh-list
6641547|NCT01382511|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6641548|NCT01382511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6641549|NCT01382511|Antimetabolites|antimetabolites|mesh-ancestor
6641550|NCT01382511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641551|NCT01382511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6641552|NCT01382511|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6641553|NCT01382511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6641554|NCT01382589|Afamelanotide|afamelanotide|mesh-list
6641555|NCT01382589|Dermatologic Agents|dermatologic agents|mesh-ancestor
6641556|NCT01382706|Docetaxel|docetaxel|mesh-list
6641557|NCT01382706|Lapatinib|lapatinib|mesh-list
6641558|NCT01382706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6641559|NCT01382706|Tubulin Modulators|tubulin modulators|mesh-ancestor
6641560|NCT01382706|Antimitotic Agents|antimitotic agents|mesh-ancestor
6641561|NCT01382706|Mitosis Modulators|mitosis modulators|mesh-ancestor
6641562|NCT01382706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641563|NCT01382706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6641564|NCT01382706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6641565|NCT01382732|Oxytocin|oxytocin|mesh-list
6641566|NCT01382732|Carbetocin|carbetocin|mesh-list
6641567|NCT01382732|Oxytocics|oxytocics|mesh-ancestor
6641568|NCT01382732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6641569|NCT01382732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641570|NCT01382745|Nimotuzumab|nimotuzumab|mesh-list
6641571|NCT01382745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6641572|NCT01382745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6641573|NCT01382888|Heparin|heparin|mesh-list
6641574|NCT01382888|Anticoagulants|anticoagulants|mesh-ancestor
6641575|NCT01382888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6641576|NCT01382888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6641577|NCT01382888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641578|NCT01382914|Chlorhexidine|chlorhexidine|mesh-list
6641579|NCT01382914|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6641580|NCT01382914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6641581|NCT01382914|Disinfectants|disinfectants|mesh-ancestor
6641582|NCT01383044|Carvedilol|carvedilol|mesh-list
6641583|NCT01383044|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6641584|NCT01383044|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6641585|NCT01383044|Adrenergic Agents|adrenergic agents|mesh-ancestor
6641586|NCT01383044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6641587|NCT01383044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641588|NCT01383044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641589|NCT01383044|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5485360|NCT05164159|Anesthetics, General|anesthetics, general|mesh-ancestor
5485361|NCT05164159|Anesthetics|anesthetics|mesh-ancestor
5485362|NCT05164146|Propofol|propofol|mesh-list
5485363|NCT05164146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5485364|NCT05164146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5485365|NCT05164146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485366|NCT05164146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5485367|NCT05164146|Anesthetics, General|anesthetics, general|mesh-ancestor
5485368|NCT05164146|Anesthetics|anesthetics|mesh-ancestor
5485369|NCT05164081|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5485370|NCT05164081|Clindamycin|clindamycin|mesh-list
5485371|NCT05164081|Clindamycin palmitate|clindamycin palmitate|mesh-list
5485372|NCT05164081|Clindamycin phosphate|clindamycin phosphate|mesh-list
5485373|NCT05164081|Gentamicins|gentamicins|mesh-list
5485374|NCT05164081|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5485375|NCT05164081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5485376|NCT05164081|Antitubercular Agents|antitubercular agents|mesh-ancestor
5485377|NCT05164081|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5485378|NCT05164081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5485379|NCT05164081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485380|NCT05163834|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5485381|NCT05163834|Immunologic Factors|immunologic factors|mesh-ancestor
5485382|NCT05163834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641590|NCT01383044|Antioxidants|antioxidants|mesh-ancestor
6641591|NCT01383044|Protective Agents|protective agents|mesh-ancestor
6641592|NCT01383044|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6641593|NCT01383044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6641594|NCT01383044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6641595|NCT01383044|Vasodilator Agents|vasodilator agents|mesh-ancestor
6641596|NCT01383044|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6641597|NCT01383044|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6641598|NCT01383148|Gemcitabine|gemcitabine|mesh-list
6641599|NCT01383148|Paclitaxel|paclitaxel|mesh-list
6641600|NCT01383148|Cisplatin|cisplatin|mesh-list
6641601|NCT01383148|Carboplatin|carboplatin|mesh-list
6641602|NCT01383148|Pemetrexed|pemetrexed|mesh-list
6641603|NCT01383148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6641604|NCT01383148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6641605|NCT01383148|Tubulin Modulators|tubulin modulators|mesh-ancestor
6641606|NCT01383148|Antimitotic Agents|antimitotic agents|mesh-ancestor
5485383|NCT05163704|Dexmedetomidine|dexmedetomidine|mesh-list
5485384|NCT05163704|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6641607|NCT01383148|Mitosis Modulators|mitosis modulators|mesh-ancestor
6641608|NCT01383148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641609|NCT01383148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641610|NCT01383148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6641611|NCT01383148|Antimetabolites|antimetabolites|mesh-ancestor
6641612|NCT01383148|Antiviral Agents|antiviral agents|mesh-ancestor
6641613|NCT01383148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6641614|NCT01383148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6641615|NCT01383148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5485385|NCT05163704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6641616|NCT01383148|Immunologic Factors|immunologic factors|mesh-ancestor
6641617|NCT01383148|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6641618|NCT01383148|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6641619|NCT01383330|Megestrol Acetate|megestrol acetate|mesh-list
6641620|NCT01383330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6641621|NCT01383330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6641622|NCT01383330|Appetite Stimulants|appetite stimulants|mesh-ancestor
6641623|NCT01383330|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6641624|NCT01383330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641625|NCT01383343|Calcium, Dietary|calcium, dietary|mesh-list
6641626|NCT01383343|Leucovorin|leucovorin|mesh-list
6641627|NCT01383343|Folic Acid|folic acid|mesh-list
6641628|NCT01383343|Bevacizumab|bevacizumab|mesh-list
6641629|NCT01383343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6641630|NCT01383343|Fluorouracil|fluorouracil|mesh-list
6641631|NCT01383343|Irinotecan|irinotecan|mesh-list
6641632|NCT01383343|Sorafenib|sorafenib|mesh-list
6641633|NCT01383343|Camptothecin|camptothecin|mesh-list
6641634|NCT01383343|Endothelial Growth Factors|endothelial growth factors|mesh-list
6641635|NCT01383343|Antibodies|antibodies|mesh-list
6641636|NCT01383343|Immunoglobulins|immunoglobulins|mesh-list
6641637|NCT01383343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6641638|NCT01383343|Immunoglobulin G|immunoglobulin g|mesh-list
6641639|NCT01383343|Calcium|calcium|mesh-list
6641640|NCT01383343|Levoleucovorin|levoleucovorin|mesh-list
6641641|NCT01383343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6641642|NCT01383343|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6641643|NCT01383343|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5485386|NCT05163704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485387|NCT05163704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5485388|NCT05163704|Analgesics|analgesics|mesh-ancestor
6453039|NCT00418600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453040|NCT00418600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6453041|NCT00418600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6453042|NCT00418639|Nitazoxanide|nitazoxanide|mesh-list
6453043|NCT00418639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6453044|NCT00418639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6453045|NCT00418678|Nabilone|nabilone|mesh-list
6453046|NCT00418678|Antiemetics|antiemetics|mesh-ancestor
6641644|NCT01383343|Growth Substances|growth substances|mesh-ancestor
6641645|NCT01383343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641646|NCT01383343|Growth Inhibitors|growth inhibitors|mesh-ancestor
6641647|NCT01383343|Immunologic Factors|immunologic factors|mesh-ancestor
6641648|NCT01383343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6641649|NCT01383343|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6641650|NCT01383343|Antimetabolites|antimetabolites|mesh-ancestor
6641651|NCT01383343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485389|NCT05163704|Sensory System Agents|sensory system agents|mesh-ancestor
5485390|NCT05163704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5485391|NCT05163704|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5485392|NCT05163704|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5485393|NCT05163704|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5485394|NCT05163704|Adrenergic Agents|adrenergic agents|mesh-ancestor
5485395|NCT05163704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5485396|NCT05163704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485397|NCT05163691|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
5485398|NCT05163691|Hallucinogens|hallucinogens|mesh-ancestor
5485399|NCT05163691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485400|NCT05163691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5485401|NCT05163691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5485402|NCT05163691|Serotonin Agents|serotonin agents|mesh-ancestor
5485403|NCT05163691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5485404|NCT05163691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485405|NCT05163691|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5485406|NCT05163483|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
6641652|NCT01383343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5485407|NCT05163483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485408|NCT05163483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5485409|NCT05163405|Bortezomib|bortezomib|mesh-list
5485410|NCT05163405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5485411|NCT05163366|Morphine|morphine|mesh-list
6453047|NCT00418678|Autonomic Agents|autonomic agents|mesh-ancestor
6641653|NCT01383343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6641654|NCT01383343|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6641655|NCT01383343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6641656|NCT01383343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6641657|NCT01383343|Antidotes|antidotes|mesh-ancestor
6641658|NCT01383343|Protective Agents|protective agents|mesh-ancestor
6641659|NCT01383343|Vitamin B Complex|vitamin b complex|mesh-ancestor
6641660|NCT01383343|Vitamins|vitamins|mesh-ancestor
6641661|NCT01383343|Micronutrients|micronutrients|mesh-ancestor
6641662|NCT01383343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6641663|NCT01383343|Hematinics|hematinics|mesh-ancestor
6641664|NCT01383343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6641665|NCT01383395|Cilostazol|cilostazol|mesh-list
6641666|NCT01383395|Simvastatin|simvastatin|mesh-list
6641667|NCT01383395|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6641668|NCT01383395|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6641669|NCT01383395|Antimetabolites|antimetabolites|mesh-ancestor
6641670|NCT01383395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641671|NCT01383395|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6641672|NCT01383395|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6641673|NCT01383395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6641674|NCT01383395|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6641675|NCT01383395|Autonomic Agents|autonomic agents|mesh-ancestor
6641676|NCT01383395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6641677|NCT01383395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641678|NCT01383395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6641679|NCT01383395|Respiratory System Agents|respiratory system agents|mesh-ancestor
6641680|NCT01383395|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6641681|NCT01383395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6641682|NCT01383395|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6641683|NCT01383395|Vasodilator Agents|vasodilator agents|mesh-ancestor
6641684|NCT01383395|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6641685|NCT01383395|Protective Agents|protective agents|mesh-ancestor
6641686|NCT01383395|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6641687|NCT01383395|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6641688|NCT01383460|Epoetin Alfa|epoetin alfa|mesh-list
6641689|NCT01383460|Sargramostim|sargramostim|mesh-list
6641690|NCT01383460|Lenograstim|lenograstim|mesh-list
6641691|NCT01383460|Immunologic Factors|immunologic factors|mesh-ancestor
6641692|NCT01383460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641693|NCT01383460|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6641694|NCT01383460|Hematinics|hematinics|mesh-ancestor
6641695|NCT01383538|Leucovorin|leucovorin|mesh-list
6641696|NCT01383538|Oxaliplatin|oxaliplatin|mesh-list
6641697|NCT01383538|Irinotecan|irinotecan|mesh-list
6641698|NCT01383538|Folfirinox|folfirinox|mesh-list
6641699|NCT01383538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6641700|NCT01383538|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6641701|NCT01383538|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6641702|NCT01383538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6641703|NCT01383538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641704|NCT01383538|Antidotes|antidotes|mesh-ancestor
6641705|NCT01383538|Protective Agents|protective agents|mesh-ancestor
6641706|NCT01383538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641707|NCT01383538|Vitamin B Complex|vitamin b complex|mesh-ancestor
6641708|NCT01383538|Vitamins|vitamins|mesh-ancestor
6641709|NCT01383538|Micronutrients|micronutrients|mesh-ancestor
6641710|NCT01383655|Magnesium Sulfate|magnesium sulfate|mesh-list
6641711|NCT01383655|Analgesics|analgesics|mesh-ancestor
6641712|NCT01383655|Sensory System Agents|sensory system agents|mesh-ancestor
6641713|NCT01383655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6641714|NCT01383655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641715|NCT01383655|Anesthetics|anesthetics|mesh-ancestor
6641716|NCT01383655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6641717|NCT01383655|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6641718|NCT01383655|Anticonvulsants|anticonvulsants|mesh-ancestor
5485412|NCT05163366|Ketamine|ketamine|mesh-list
5485413|NCT05163366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5485414|NCT05163366|Narcotics|narcotics|mesh-ancestor
5724873|NCT03184649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641719|NCT01383655|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6641720|NCT01383655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6641721|NCT01383655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641722|NCT01383655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6641723|NCT01383655|Tocolytic Agents|tocolytic agents|mesh-ancestor
6641724|NCT01383655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6641725|NCT01383668|Sirolimus|sirolimus|mesh-list
6641726|NCT01383668|Gold Sodium Thiomalate|gold sodium thiomalate|mesh-list
6641727|NCT01383668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6641728|NCT01383668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6641729|NCT01383668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6641730|NCT01383668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6641731|NCT01383668|Antifungal Agents|antifungal agents|mesh-ancestor
6641732|NCT01383668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6641733|NCT01383668|Immunologic Factors|immunologic factors|mesh-ancestor
6641734|NCT01383668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641735|NCT01383668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6641736|NCT01383694|Piperine|piperine|mesh-list
6641737|NCT01383694|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6641738|NCT01383694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6641739|NCT01383694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641740|NCT01383785|Abciximab|abciximab|mesh-list
6641741|NCT01383785|Anticoagulants|anticoagulants|mesh-ancestor
6641742|NCT01383785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6663496|NCT01507597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6663497|NCT01507597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663498|NCT01507597|Incretins|incretins|mesh-ancestor
6663499|NCT01507610|Sumatriptan|sumatriptan|mesh-list
6663500|NCT01507610|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6663501|NCT01507610|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6663502|NCT01507610|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6663503|NCT01507610|Serotonin Agents|serotonin agents|mesh-ancestor
6663504|NCT01507610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6663505|NCT01507610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663506|NCT01507610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663507|NCT01507701|Clonidine|clonidine|mesh-list
6663508|NCT01507701|Analgesics|analgesics|mesh-ancestor
6663509|NCT01507701|Sensory System Agents|sensory system agents|mesh-ancestor
6663510|NCT01507701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6663511|NCT01507701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663512|NCT01507701|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6663513|NCT01507701|Sympatholytics|sympatholytics|mesh-ancestor
6663514|NCT01507701|Autonomic Agents|autonomic agents|mesh-ancestor
6663515|NCT01507701|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6663516|NCT01507701|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6663517|NCT01507701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6663518|NCT01507701|Adrenergic Agents|adrenergic agents|mesh-ancestor
6663519|NCT01507701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6663520|NCT01507701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663521|NCT01507727|Tolvaptan|tolvaptan|mesh-list
6663522|NCT01507727|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6663523|NCT01507727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663524|NCT01507727|Natriuretic Agents|natriuretic agents|mesh-ancestor
6663525|NCT01507727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663526|NCT01507740|Bevacizumab|bevacizumab|mesh-list
6663527|NCT01507740|Sorafenib|sorafenib|mesh-list
6663528|NCT01507740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6663529|NCT01507740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6663530|NCT01507740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5485415|NCT05163366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5485416|NCT05163366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485417|NCT05163366|Analgesics|analgesics|mesh-ancestor
5485418|NCT05163366|Sensory System Agents|sensory system agents|mesh-ancestor
5485419|NCT05163366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5485420|NCT05163366|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5485421|NCT05163366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5485422|NCT05163366|Anesthetics, General|anesthetics, general|mesh-ancestor
5485423|NCT05163366|Anesthetics|anesthetics|mesh-ancestor
5485424|NCT05163366|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5485425|NCT05163366|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5485426|NCT05163366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5485427|NCT05163366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485428|NCT05163249|Osimertinib|osimertinib|mesh-list
5485429|NCT05163249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5485430|NCT05163249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5485431|NCT05163249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5485432|NCT05163249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485433|NCT05163223|Pembrolizumab|pembrolizumab|mesh-list
5485434|NCT05163223|Capecitabine|capecitabine|mesh-list
5485435|NCT05163223|Sargramostim|sargramostim|mesh-list
5485436|NCT05163223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5485437|NCT05163223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5485438|NCT05163223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6663531|NCT01507740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6641743|NCT01384058|Simvastatin|simvastatin|mesh-list
6641744|NCT01384058|Ezetimibe|ezetimibe|mesh-list
6641745|NCT01384058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6641746|NCT01384058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6641747|NCT01384058|Antimetabolites|antimetabolites|mesh-ancestor
6641748|NCT01384058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641749|NCT01384058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6641750|NCT01384058|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6641751|NCT01384058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6641752|NCT01384214|Botulinum Toxins|botulinum toxins|mesh-list
6641753|NCT01384214|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6641754|NCT01384214|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6641755|NCT01384214|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6641756|NCT01384214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6641757|NCT01384214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641758|NCT01384214|Cholinergic Agents|cholinergic agents|mesh-ancestor
6641759|NCT01384214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6641760|NCT01384214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641761|NCT01384214|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6641762|NCT01384214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5485439|NCT05163223|Antimetabolites|antimetabolites|mesh-ancestor
5485440|NCT05163223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641763|NCT01384227|Proflavine|proflavine|mesh-list
6641764|NCT01384227|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6641765|NCT01384227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6641766|NCT01384240|Proflavine|proflavine|mesh-list
6641767|NCT01384240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6641768|NCT01384240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6641769|NCT01384253|Trastuzumab|trastuzumab|mesh-list
6641770|NCT01384253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6641771|NCT01384253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6641772|NCT01384279|Metformin|metformin|mesh-list
6641773|NCT01384279|Topiramate|topiramate|mesh-list
6641774|NCT01384279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6641775|NCT01384279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641776|NCT01384279|Anticonvulsants|anticonvulsants|mesh-ancestor
6641777|NCT01384331|NuvaRing|nuvaring|mesh-list
6641778|NCT01384331|Desogestrel|desogestrel|mesh-list
6641779|NCT01384331|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6641780|NCT01384331|Contraceptive Agents|contraceptive agents|mesh-ancestor
6641781|NCT01384331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6641782|NCT01384331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641783|NCT01384331|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6641784|NCT01384331|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6641785|NCT01384331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6641786|NCT01384331|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6641787|NCT01384331|Progestins|progestins|mesh-ancestor
6641788|NCT01384331|Hormones|hormones|mesh-ancestor
6641789|NCT01384331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6641790|NCT01384448|Dobutamine|dobutamine|mesh-list
5485441|NCT05163223|Immunologic Factors|immunologic factors|mesh-ancestor
5485442|NCT05163223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021628|NCT00401375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021629|NCT00401375|Sensory System Agents|sensory system agents|mesh-ancestor
6641791|NCT01384448|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6641792|NCT01384448|Sympathomimetics|sympathomimetics|mesh-ancestor
6641793|NCT01384448|Autonomic Agents|autonomic agents|mesh-ancestor
6641794|NCT01384448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6641795|NCT01384448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641796|NCT01384448|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6641797|NCT01384448|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6641798|NCT01384448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6641799|NCT01384448|Adrenergic Agents|adrenergic agents|mesh-ancestor
6641800|NCT01384448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6641801|NCT01384448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641802|NCT01384448|Protective Agents|protective agents|mesh-ancestor
6641803|NCT01384513|Vidarabine|vidarabine|mesh-list
6641804|NCT01384513|Mycophenolic Acid|mycophenolic acid|mesh-list
6641805|NCT01384513|Cyclophosphamide|cyclophosphamide|mesh-list
6641806|NCT01384513|Busulfan|busulfan|mesh-list
6641807|NCT01384513|Fludarabine|fludarabine|mesh-list
6641808|NCT01384513|Fludarabine phosphate|fludarabine phosphate|mesh-list
6641809|NCT01384513|Tacrolimus|tacrolimus|mesh-list
6641810|NCT01384513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6641811|NCT01384513|Immunologic Factors|immunologic factors|mesh-ancestor
6641812|NCT01384513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641813|NCT01384513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6641814|NCT01384513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6641815|NCT01384513|Alkylating Agents|alkylating agents|mesh-ancestor
6641816|NCT01384513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641817|NCT01384513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6641818|NCT01384513|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6641819|NCT01384513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6641820|NCT01384513|Antimetabolites|antimetabolites|mesh-ancestor
6641821|NCT01384513|Antiviral Agents|antiviral agents|mesh-ancestor
6641822|NCT01384513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6641823|NCT01384513|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6641824|NCT01384513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6641825|NCT01384513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6641826|NCT01384513|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6641827|NCT01384513|Antitubercular Agents|antitubercular agents|mesh-ancestor
6641828|NCT01384513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6641829|NCT01384578|Vitamins|vitamins|mesh-list
6641830|NCT01384578|Vitamin E|vitamin e|mesh-list
6641831|NCT01384578|Tocopherols|tocopherols|mesh-list
6641832|NCT01384578|Tocotrienols|tocotrienols|mesh-list
6641833|NCT01384578|alpha-Tocopherol|alpha-tocopherol|mesh-list
6641834|NCT01384578|Pentoxifylline|pentoxifylline|mesh-list
6641835|NCT01384578|Micronutrients|micronutrients|mesh-ancestor
6641836|NCT01384578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641837|NCT01384578|Antioxidants|antioxidants|mesh-ancestor
6641838|NCT01384578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641839|NCT01384578|Protective Agents|protective agents|mesh-ancestor
6641840|NCT01384578|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6641841|NCT01384578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6641842|NCT01384578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6641843|NCT01384578|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6641844|NCT01384578|Vasodilator Agents|vasodilator agents|mesh-ancestor
6641845|NCT01384578|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6641846|NCT01384643|Propofol|propofol|mesh-list
6641847|NCT01384643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6641848|NCT01384643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6641849|NCT01384643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641850|NCT01384643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6641851|NCT01384643|Anesthetics, General|anesthetics, general|mesh-ancestor
6641852|NCT01384643|Anesthetics|anesthetics|mesh-ancestor
6641853|NCT01384656|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6641854|NCT01384682|Maraviroc|maraviroc|mesh-list
6641855|NCT01384682|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6641856|NCT01384682|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6641857|NCT01384682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641858|NCT01384682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6641859|NCT01384682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6641860|NCT01384682|Antiviral Agents|antiviral agents|mesh-ancestor
6641861|NCT01384682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6641862|NCT01384682|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6641863|NCT01384695|Proflavine|proflavine|mesh-list
6641864|NCT01384695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6641865|NCT01384695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6641866|NCT01384708|Proflavine|proflavine|mesh-list
6641867|NCT01384708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6641868|NCT01384708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6641869|NCT01384773|Riboflavin|riboflavin|mesh-list
6641870|NCT01384773|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6641871|NCT01384773|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6641872|NCT01384773|Vitamin B Complex|vitamin b complex|mesh-ancestor
6641873|NCT01384773|Vitamins|vitamins|mesh-ancestor
6641874|NCT01384773|Micronutrients|micronutrients|mesh-ancestor
6641875|NCT01384773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641876|NCT01384773|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6641877|NCT01384773|Dermatologic Agents|dermatologic agents|mesh-ancestor
6641878|NCT01384799|Cisplatin|cisplatin|mesh-list
6641879|NCT01384799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6641880|NCT01384812|Dinoprostone|dinoprostone|mesh-list
6021630|NCT00401375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6021631|NCT00401401|Zalutumumab|zalutumumab|mesh-list
6021632|NCT00401401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6021633|NCT00401401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6021634|NCT00401414|Warfarin|warfarin|mesh-list
6021635|NCT00401414|Anticoagulants|anticoagulants|mesh-ancestor
6641881|NCT01384812|Oxytocics|oxytocics|mesh-ancestor
6641882|NCT01384812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6641883|NCT01384812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641884|NCT01384864|Proflavine|proflavine|mesh-list
6453048|NCT00418678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6453049|NCT00418678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453050|NCT00418678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6453051|NCT00418678|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6641885|NCT01384864|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6641886|NCT01384864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6641887|NCT01384903|Antithrombins|antithrombins|mesh-list
6641888|NCT01384903|Antithrombin III|antithrombin iii|mesh-list
6641889|NCT01384903|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6641890|NCT01384903|Protease Inhibitors|protease inhibitors|mesh-ancestor
6641891|NCT01384903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6641892|NCT01384903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641893|NCT01384903|Anticoagulants|anticoagulants|mesh-ancestor
6641894|NCT01384994|Folic Acid|folic acid|mesh-list
6641895|NCT01384994|Vitamin B Complex|vitamin b complex|mesh-list
6641896|NCT01384994|Oxaliplatin|oxaliplatin|mesh-list
6641897|NCT01384994|Fluorouracil|fluorouracil|mesh-list
6641898|NCT01384994|Panitumumab|panitumumab|mesh-list
6641899|NCT01384994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6641900|NCT01384994|Antimetabolites|antimetabolites|mesh-ancestor
6641901|NCT01384994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641902|NCT01384994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6641903|NCT01384994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6641904|NCT01384994|Immunologic Factors|immunologic factors|mesh-ancestor
6641905|NCT01384994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641906|NCT01384994|Hematinics|hematinics|mesh-ancestor
6641907|NCT01384994|Vitamins|vitamins|mesh-ancestor
6641908|NCT01384994|Micronutrients|micronutrients|mesh-ancestor
6021636|NCT00401531|Vaccines|vaccines|mesh-list
6021637|NCT00401531|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6021638|NCT00401531|Immunologic Factors|immunologic factors|mesh-ancestor
5485455|NCT05162976|Nivolumab|nivolumab|mesh-list
5485456|NCT05162976|Azacitidine|azacitidine|mesh-list
5485457|NCT05162976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5485458|NCT05162976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5485459|NCT05162976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5485460|NCT05162976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485461|NCT05162976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5485462|NCT05162976|Antimetabolites|antimetabolites|mesh-ancestor
5485463|NCT05162976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5485464|NCT05162937|Antibodies|antibodies|mesh-list
5485465|NCT05162937|Immunologic Factors|immunologic factors|mesh-ancestor
5485466|NCT05162937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485467|NCT05161611|Zinc Sulfate|zinc sulfate|mesh-list
5485468|NCT05161611|Astringents|astringents|mesh-ancestor
5485469|NCT05161611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485470|NCT05161611|Dermatologic Agents|dermatologic agents|mesh-ancestor
5485471|NCT05160727|Irinotecan|irinotecan|mesh-list
5485472|NCT05160727|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5485473|NCT05160727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5485474|NCT05160727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6453052|NCT00418678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6453053|NCT00418678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6453054|NCT00418678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6453055|NCT00418704|Docetaxel|docetaxel|mesh-list
6453056|NCT00418704|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6453057|NCT00418704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6453058|NCT00418704|Tubulin Modulators|tubulin modulators|mesh-ancestor
6453059|NCT00418704|Antimitotic Agents|antimitotic agents|mesh-ancestor
6453060|NCT00418704|Mitosis Modulators|mitosis modulators|mesh-ancestor
6453061|NCT00418704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453062|NCT00418704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6453063|NCT00418704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6453064|NCT00418730|Proteasome Inhibitors|proteasome inhibitors|mesh-list
6453065|NCT00418730|Protease Inhibitors|protease inhibitors|mesh-ancestor
6453066|NCT00418730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6453067|NCT00418730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453068|NCT00418782|Naproxen|naproxen|mesh-list
6453069|NCT00418782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6453070|NCT00418782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6453071|NCT00418782|Analgesics|analgesics|mesh-ancestor
6453072|NCT00418782|Sensory System Agents|sensory system agents|mesh-ancestor
6453073|NCT00418782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6641909|NCT01384994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6641910|NCT01385020|Gemfibrozil|gemfibrozil|mesh-list
6021639|NCT00401531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641911|NCT01385020|Red yeast rice|red yeast rice|mesh-list
6641912|NCT01385020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6641913|NCT01385020|Antimetabolites|antimetabolites|mesh-ancestor
6641914|NCT01385020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641915|NCT01385020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6641916|NCT01385020|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6641917|NCT01385020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6641918|NCT01385020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6641919|NCT01385020|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6641920|NCT01385020|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6641921|NCT01385059|Axitinib|axitinib|mesh-list
6641922|NCT01385059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6641923|NCT01385059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6641924|NCT01385059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6641925|NCT01385059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641926|NCT01385124|Cannabidiol|cannabidiol|mesh-list
6641927|NCT01385124|Anticonvulsants|anticonvulsants|mesh-ancestor
6641928|NCT01385228|Prednisone|prednisone|mesh-list
6641929|NCT01385228|Docetaxel|docetaxel|mesh-list
6641930|NCT01385228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6641931|NCT01385228|Tubulin Modulators|tubulin modulators|mesh-ancestor
6641932|NCT01385228|Antimitotic Agents|antimitotic agents|mesh-ancestor
6641933|NCT01385228|Mitosis Modulators|mitosis modulators|mesh-ancestor
6641934|NCT01385228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641935|NCT01385228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6641936|NCT01385228|Glucocorticoids|glucocorticoids|mesh-ancestor
6641937|NCT01385228|Hormones|hormones|mesh-ancestor
6641938|NCT01385228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6641939|NCT01385228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641940|NCT01385228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6641941|NCT01385345|Vitamin D|vitamin d|mesh-list
6641942|NCT01385345|Cholecalciferol|cholecalciferol|mesh-list
6641943|NCT01385345|Vitamins|vitamins|mesh-ancestor
6641944|NCT01385345|Micronutrients|micronutrients|mesh-ancestor
6641945|NCT01385345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641946|NCT01385345|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6641947|NCT01385345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6641948|NCT01385527|Triamcinolone|triamcinolone|mesh-list
6641949|NCT01385527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6641950|NCT01385527|Glucocorticoids|glucocorticoids|mesh-ancestor
6641951|NCT01385527|Hormones|hormones|mesh-ancestor
6641952|NCT01385527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6641953|NCT01385527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641954|NCT01385631|Ezetimibe|ezetimibe|mesh-list
6641955|NCT01385631|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6641956|NCT01385631|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6641957|NCT01385631|Antimetabolites|antimetabolites|mesh-ancestor
6641958|NCT01385631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641959|NCT01385631|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5485475|NCT05160727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485476|NCT05160727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5485477|NCT05145101|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5485478|NCT05145101|Immunologic Factors|immunologic factors|mesh-ancestor
5485479|NCT05145101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485480|NCT05141422|Efavirenz|efavirenz|mesh-list
5485481|NCT05141422|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5485482|NCT05141422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5485483|NCT05141422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5485484|NCT05141422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485485|NCT05141422|Antiviral Agents|antiviral agents|mesh-ancestor
6663532|NCT01507740|Growth Substances|growth substances|mesh-ancestor
6663533|NCT01507740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663534|NCT01507740|Growth Inhibitors|growth inhibitors|mesh-ancestor
6663535|NCT01507740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6663536|NCT01507740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6663537|NCT01507740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663538|NCT01507792|Loratadine|loratadine|mesh-list
6663539|NCT01507792|Omeprazole|omeprazole|mesh-list
6663540|NCT01507792|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
6663541|NCT01507792|Histamine|histamine|mesh-list
6663542|NCT01507792|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6663543|NCT01507792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6663544|NCT01507792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6663545|NCT01507792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485486|NCT05141422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5485487|NCT05141422|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5485488|NCT05141422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5485489|NCT05141422|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5485490|NCT05141422|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5485491|NCT05141422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5485492|NCT05141422|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5485493|NCT05140148|Amantadine|amantadine|mesh-list
5485494|NCT05140148|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5485495|NCT05140148|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5485496|NCT05140148|Antiviral Agents|antiviral agents|mesh-ancestor
5485497|NCT05140148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5485498|NCT05140148|Dopamine Agents|dopamine agents|mesh-ancestor
5485499|NCT05140148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5485500|NCT05140148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485501|NCT05140148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485502|NCT05140148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5485503|NCT05140148|Analgesics|analgesics|mesh-ancestor
5485504|NCT05140148|Sensory System Agents|sensory system agents|mesh-ancestor
5485505|NCT05140148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5485506|NCT05137678|Glyburide|glyburide|mesh-list
5485507|NCT05137678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6641960|NCT01385683|Clarithromycin|clarithromycin|mesh-list
6641961|NCT01385683|Dabigatran|dabigatran|mesh-list
6641962|NCT01385683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5485508|NCT05137678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485509|NCT05101018|Denosumab|denosumab|mesh-list
5485510|NCT05101018|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5485511|NCT05101018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485512|NCT05097651|Cannabidiol|cannabidiol|mesh-list
5485513|NCT05097651|Anticonvulsants|anticonvulsants|mesh-ancestor
5485514|NCT05091346|Pembrolizumab|pembrolizumab|mesh-list
5485515|NCT05091346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5485516|NCT05091346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5485517|NCT05088980|Lidocaine|lidocaine|mesh-list
5485518|NCT05088980|Anesthetics, Local|anesthetics, local|mesh-ancestor
5485519|NCT05088980|Anesthetics|anesthetics|mesh-ancestor
6641963|NCT01385683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6641964|NCT01385683|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6641965|NCT01385683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6641966|NCT01385683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641967|NCT01385683|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6641968|NCT01385683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6641969|NCT01385683|Antithrombins|antithrombins|mesh-ancestor
6641970|NCT01385683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6641971|NCT01385683|Protease Inhibitors|protease inhibitors|mesh-ancestor
6641972|NCT01385683|Anticoagulants|anticoagulants|mesh-ancestor
6641973|NCT01385735|Rasagiline|rasagiline|mesh-list
6641974|NCT01385735|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6641975|NCT01385735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6641976|NCT01385735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641977|NCT01385735|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6641978|NCT01385735|Protective Agents|protective agents|mesh-ancestor
6641979|NCT01385735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641980|NCT01385826|Antibodies|antibodies|mesh-list
6641981|NCT01385826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6641982|NCT01385826|Immunologic Factors|immunologic factors|mesh-ancestor
6641983|NCT01385826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6641984|NCT01385891|Etoposide|etoposide|mesh-list
6641985|NCT01385891|Clofarabine|clofarabine|mesh-list
6641986|NCT01385891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6641987|NCT01385891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6641988|NCT01385891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6641989|NCT01385891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6641990|NCT01385891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6641991|NCT01385891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641992|NCT01385891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6641993|NCT01385891|Antimetabolites|antimetabolites|mesh-ancestor
6641994|NCT01385956|Gemcitabine|gemcitabine|mesh-list
6641995|NCT01385956|Pasireotide|pasireotide|mesh-list
6641996|NCT01385956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6021640|NCT00401544|Dextrans|dextrans|mesh-list
6021641|NCT00401544|Darbepoetin alfa|darbepoetin alfa|mesh-list
6641997|NCT01385956|Antimetabolites|antimetabolites|mesh-ancestor
6641998|NCT01385956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6641999|NCT01385956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6642000|NCT01385956|Antiviral Agents|antiviral agents|mesh-ancestor
6642001|NCT01385956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6642002|NCT01385956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6642003|NCT01385956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6642004|NCT01385956|Immunologic Factors|immunologic factors|mesh-ancestor
6642005|NCT01385956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642006|NCT01385956|Hormones|hormones|mesh-ancestor
6642007|NCT01385956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6642008|NCT01386086|Aripiprazole|aripiprazole|mesh-list
6642009|NCT01386086|Antidepressive Agents|antidepressive agents|mesh-ancestor
6642010|NCT01386086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6642011|NCT01386086|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6642012|NCT01386086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6642013|NCT01386086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6642014|NCT01386086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642015|NCT01386086|Dopamine Agonists|dopamine agonists|mesh-ancestor
6642016|NCT01386086|Dopamine Agents|dopamine agents|mesh-ancestor
6642017|NCT01386086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6642018|NCT01386086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642019|NCT01386086|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5485520|NCT05088980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5485521|NCT05088980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485522|NCT05088980|Sensory System Agents|sensory system agents|mesh-ancestor
5485523|NCT05088980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5485524|NCT05088980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5485525|NCT05088980|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5485526|NCT05088980|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5485527|NCT05088980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5485528|NCT05088980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502616|NCT04465851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5502617|NCT04465851|Analgesics|analgesics|mesh-ancestor
6642020|NCT01386086|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6642021|NCT01386086|Serotonin Agents|serotonin agents|mesh-ancestor
6642022|NCT01386086|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6642023|NCT01386086|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6642024|NCT01386086|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6642025|NCT01386086|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6642026|NCT01386151|Mitogens|mitogens|mesh-list
6642027|NCT01386151|Mitosis Modulators|mitosis modulators|mesh-ancestor
6642028|NCT01386151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642029|NCT01386164|Vaccines|vaccines|mesh-list
6642030|NCT01386164|Immunologic Factors|immunologic factors|mesh-ancestor
6642031|NCT01386164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642032|NCT01386177|Doxazosin|doxazosin|mesh-list
6642033|NCT01386177|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
6642034|NCT01386177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6642035|NCT01386177|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6642036|NCT01386177|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5502618|NCT04465851|Sensory System Agents|sensory system agents|mesh-ancestor
5502619|NCT04465851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5502620|NCT04465851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502621|NCT04465851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5502622|NCT04465851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5502623|NCT04465851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6453074|NCT00418782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453075|NCT00418782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6453076|NCT00418782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6453077|NCT00418782|Gout Suppressants|gout suppressants|mesh-ancestor
6453078|NCT00418782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6453079|NCT00418782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6453080|NCT00418782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453081|NCT00418847|Miglustat|miglustat|mesh-list
6642037|NCT01386177|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6642038|NCT01386177|Adrenergic Agents|adrenergic agents|mesh-ancestor
6642039|NCT01386177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6642040|NCT01386177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642041|NCT01386177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642042|NCT01386177|Hallucinogens|hallucinogens|mesh-ancestor
6642043|NCT01386177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6642044|NCT01386177|Serotonin Agents|serotonin agents|mesh-ancestor
6642045|NCT01386177|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6642046|NCT01386177|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6642047|NCT01386177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6642048|NCT01386229|Ketamine|ketamine|mesh-list
6642049|NCT01386229|Etomidate|etomidate|mesh-list
6642050|NCT01386229|Analgesics|analgesics|mesh-ancestor
6642051|NCT01386229|Sensory System Agents|sensory system agents|mesh-ancestor
6642052|NCT01386229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6642053|NCT01386229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642054|NCT01386229|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6642055|NCT01386229|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6642056|NCT01386229|Anesthetics, General|anesthetics, general|mesh-ancestor
6642057|NCT01386229|Anesthetics|anesthetics|mesh-ancestor
6642058|NCT01386229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6642059|NCT01386229|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6642060|NCT01386229|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6642061|NCT01386229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6642062|NCT01386229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642063|NCT01386229|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6642064|NCT01386242|Interferons|interferons|mesh-list
6642065|NCT01386242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6642066|NCT01386242|Antiviral Agents|antiviral agents|mesh-ancestor
6642067|NCT01386242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6642068|NCT01386255|Baclofen|baclofen|mesh-list
6642069|NCT01386255|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6642070|NCT01386255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642071|NCT01386255|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6642072|NCT01386255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5485529|NCT05080764|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5485530|NCT05080764|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6642073|NCT01386255|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6642074|NCT01386255|GABA Agonists|gaba agonists|mesh-ancestor
6642075|NCT01386255|GABA Agents|gaba agents|mesh-ancestor
6642076|NCT01386255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6642077|NCT01386255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642078|NCT01386268|Factor VIII|factor viii|mesh-list
6642079|NCT01386268|Coagulants|coagulants|mesh-ancestor
6642080|NCT01386294|Tenofovir|tenofovir|mesh-list
6642081|NCT01386294|Antiviral Agents|antiviral agents|mesh-ancestor
6642082|NCT01386294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6642083|NCT01386294|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6642084|NCT01386294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5485531|NCT05080764|Dermatologic Agents|dermatologic agents|mesh-ancestor
5485532|NCT05045378|Midazolam|midazolam|mesh-list
5485533|NCT05045378|Ketamine|ketamine|mesh-list
5485534|NCT05045378|Analgesics|analgesics|mesh-ancestor
5485535|NCT05045378|Sensory System Agents|sensory system agents|mesh-ancestor
5485536|NCT05045378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5502624|NCT04465851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6642085|NCT01386294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6642086|NCT01386294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642087|NCT01386294|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6642088|NCT01386294|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6642089|NCT01386333|Oxytocin|oxytocin|mesh-list
6642090|NCT01386333|Oxytocics|oxytocics|mesh-ancestor
6642091|NCT01386333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6642092|NCT01386333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642093|NCT01386346|Capecitabine|capecitabine|mesh-list
6642094|NCT01386346|Azacitidine|azacitidine|mesh-list
6642095|NCT01386346|Oxaliplatin|oxaliplatin|mesh-list
6642096|NCT01386346|Epirubicin|epirubicin|mesh-list
6642097|NCT01386346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6642098|NCT01386346|Antimetabolites|antimetabolites|mesh-ancestor
6642099|NCT01386346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642100|NCT01386346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6642101|NCT01386346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6642102|NCT01386346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6642103|NCT01386346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6642104|NCT01386346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6642105|NCT01386372|Tolvaptan|tolvaptan|mesh-list
6642106|NCT01386372|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6642107|NCT01386372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642108|NCT01386372|Natriuretic Agents|natriuretic agents|mesh-ancestor
6642109|NCT01386372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642110|NCT01386398|Bortezomib|bortezomib|mesh-list
6642111|NCT01386398|Vorinostat|vorinostat|mesh-list
6642112|NCT01386398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6642113|NCT01386398|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6642114|NCT01386398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6642115|NCT01386398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642116|NCT01386502|Pidilizumab|pidilizumab|mesh-list
6642117|NCT01386502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6642118|NCT01386502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6642119|NCT01386567|Methyltestosterone|methyltestosterone|mesh-list
5485537|NCT05045378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485538|NCT05045378|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5485539|NCT05045378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5485540|NCT05045378|Anesthetics, General|anesthetics, general|mesh-ancestor
5485541|NCT05045378|Anesthetics|anesthetics|mesh-ancestor
5485542|NCT05045378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5485543|NCT05045378|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5485544|NCT05045378|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5485545|NCT05045378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5485546|NCT05045378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485547|NCT05045378|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5485548|NCT05045378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5485549|NCT05045378|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5485550|NCT05045378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6642120|NCT01386567|Citric Acid|citric acid|mesh-list
6642121|NCT01386567|Sodium Citrate|sodium citrate|mesh-list
6642122|NCT01386567|Enclomiphene|enclomiphene|mesh-list
6642123|NCT01386567|Clomiphene|clomiphene|mesh-list
6642124|NCT01386567|Zuclomiphene|zuclomiphene|mesh-list
6642125|NCT01386567|Testosterone|testosterone|mesh-list
6642126|NCT01386567|Testosterone undecanoate|testosterone undecanoate|mesh-list
6642127|NCT01386567|Testosterone enanthate|testosterone enanthate|mesh-list
6642128|NCT01386567|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6642129|NCT01386567|Anticoagulants|anticoagulants|mesh-ancestor
6642130|NCT01386567|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6642131|NCT01386567|Chelating Agents|chelating agents|mesh-ancestor
6642132|NCT01386567|Sequestering Agents|sequestering agents|mesh-ancestor
6642133|NCT01386567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642134|NCT01386567|Androgens|androgens|mesh-ancestor
6642135|NCT01386567|Hormones|hormones|mesh-ancestor
6642136|NCT01386567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6642137|NCT01386567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642138|NCT01386567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6642139|NCT01386567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6642140|NCT01386567|Anabolic Agents|anabolic agents|mesh-ancestor
6642141|NCT01386567|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6642142|NCT01386567|Hormone Antagonists|hormone antagonists|mesh-ancestor
6642143|NCT01386567|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6642144|NCT01386567|Fertility Agents|fertility agents|mesh-ancestor
6642145|NCT01386567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6642146|NCT01386567|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6642147|NCT01386567|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6642148|NCT01386580|Doxorubicin|doxorubicin|mesh-list
6642149|NCT01386580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6642150|NCT01386580|Trastuzumab|trastuzumab|mesh-list
6642151|NCT01386580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6642152|NCT01386580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6642153|NCT01386580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6642154|NCT01386580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6642155|NCT01386580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6642156|NCT01386580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642157|NCT01386580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6642158|NCT01386593|Ciprofloxacin|ciprofloxacin|mesh-list
6642159|NCT01386593|Rifampin|rifampin|mesh-list
6642160|NCT01386593|Fluconazole|fluconazole|mesh-list
6642161|NCT01386593|Paroxetine|paroxetine|mesh-list
6642162|NCT01386593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6642163|NCT01386593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6642164|NCT01386593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6642165|NCT01386593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6642166|NCT01386593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6642167|NCT01386593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642168|NCT01386593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6642169|NCT01386593|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6642170|NCT01386593|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6642171|NCT01386593|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6642172|NCT01386593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6642173|NCT01386593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6642174|NCT01386593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6642175|NCT01386593|Serotonin Agents|serotonin agents|mesh-ancestor
6642176|NCT01386593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642177|NCT01386593|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6642178|NCT01386593|Antidepressive Agents|antidepressive agents|mesh-ancestor
6642179|NCT01386593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6642180|NCT01386593|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6642181|NCT01386593|Antifungal Agents|antifungal agents|mesh-ancestor
6642182|NCT01386593|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6642183|NCT01386593|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6642184|NCT01386593|Hormone Antagonists|hormone antagonists|mesh-ancestor
6642185|NCT01386593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6642186|NCT01386593|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6642187|NCT01386593|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6642188|NCT01386593|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6642189|NCT01386593|Antitubercular Agents|antitubercular agents|mesh-ancestor
6642190|NCT01386593|Leprostatic Agents|leprostatic agents|mesh-ancestor
6642191|NCT01386593|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6642192|NCT01386593|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6642193|NCT01386593|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6642194|NCT01386593|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6642195|NCT01386593|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6642196|NCT01386593|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6642197|NCT01386593|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6642198|NCT01386658|Icatibant|icatibant|mesh-list
6642199|NCT01386658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6642200|NCT01386658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6642201|NCT01386658|Analgesics|analgesics|mesh-ancestor
6642202|NCT01386658|Sensory System Agents|sensory system agents|mesh-ancestor
6642203|NCT01386658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6642204|NCT01386658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642205|NCT01386658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6642206|NCT01386658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6642207|NCT01386658|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
6642208|NCT01386658|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
6642209|NCT01386658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642210|NCT01386658|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6642211|NCT01386658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5485551|NCT05045378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6642212|NCT01386658|Immunologic Factors|immunologic factors|mesh-ancestor
6642213|NCT01386671|Metformin|metformin|mesh-list
6642214|NCT01386671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6642215|NCT01386671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642216|NCT01386710|Bevacizumab|bevacizumab|mesh-list
6642217|NCT01386710|Carboplatin|carboplatin|mesh-list
6642218|NCT01386710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6642219|NCT01386710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6642220|NCT01386710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6642221|NCT01386710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6642222|NCT01386710|Growth Substances|growth substances|mesh-ancestor
5485552|NCT05045378|GABA Modulators|gaba modulators|mesh-ancestor
5485553|NCT05045378|GABA Agents|gaba agents|mesh-ancestor
5485554|NCT05040360|Capecitabine|capecitabine|mesh-list
5485555|NCT05040360|Temozolomide|temozolomide|mesh-list
5485556|NCT05040360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5485557|NCT05040360|Antimetabolites|antimetabolites|mesh-ancestor
5485558|NCT05040360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485559|NCT05040360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5485560|NCT05040360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5485561|NCT05040360|Alkylating Agents|alkylating agents|mesh-ancestor
5485562|NCT04965064|Capecitabine|capecitabine|mesh-list
5485563|NCT04965064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5485564|NCT04965064|Antimetabolites|antimetabolites|mesh-ancestor
6642223|NCT01386710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642224|NCT01386710|Growth Inhibitors|growth inhibitors|mesh-ancestor
6642225|NCT01386736|Vitamin D|vitamin d|mesh-list
6642226|NCT01386736|Vitamins|vitamins|mesh-ancestor
6642227|NCT01386736|Micronutrients|micronutrients|mesh-ancestor
6642228|NCT01386736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642229|NCT01386736|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6642230|NCT01386827|Vaccines|vaccines|mesh-list
6642231|NCT01386827|Immunologic Factors|immunologic factors|mesh-ancestor
6642232|NCT01386827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642233|NCT01386853|Atorvastatin|atorvastatin|mesh-list
6642234|NCT01386853|Pitavastatin|pitavastatin|mesh-list
6642235|NCT01386853|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6642236|NCT01386853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6642237|NCT01386853|Antimetabolites|antimetabolites|mesh-ancestor
6642238|NCT01386853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642239|NCT01386853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5485565|NCT04965064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485566|NCT04965064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5485567|NCT04959760|Antibodies|antibodies|mesh-list
6642240|NCT01386853|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6642241|NCT01386853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6642242|NCT01386866|Motesanib diphosphate|motesanib diphosphate|mesh-list
6642243|NCT01386866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6642244|NCT01386866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6642245|NCT01386866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642246|NCT01386879|Methylene Blue|methylene blue|mesh-list
6642247|NCT01386879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6642248|NCT01386879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642249|NCT01386996|Budesonide|budesonide|mesh-list
6642250|NCT01386996|Formoterol Fumarate|formoterol fumarate|mesh-list
6642251|NCT01386996|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6642252|NCT01386996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6642253|NCT01386996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6642254|NCT01386996|Autonomic Agents|autonomic agents|mesh-ancestor
6642255|NCT01386996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6642256|NCT01386996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642257|NCT01386996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6642258|NCT01386996|Respiratory System Agents|respiratory system agents|mesh-ancestor
6642259|NCT01386996|Glucocorticoids|glucocorticoids|mesh-ancestor
6642260|NCT01386996|Hormones|hormones|mesh-ancestor
6663546|NCT01507792|Antipruritics|antipruritics|mesh-ancestor
6642261|NCT01386996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6642262|NCT01386996|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6642263|NCT01386996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6642264|NCT01386996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6642265|NCT01386996|Adrenergic Agents|adrenergic agents|mesh-ancestor
6642266|NCT01386996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5485568|NCT04959760|Immunoglobulins|immunoglobulins|mesh-list
5485569|NCT04959760|Immunoglobulin G|immunoglobulin g|mesh-list
5485570|NCT04959760|Immunologic Factors|immunologic factors|mesh-ancestor
5485571|NCT04959760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485572|NCT04956575|Vaccines|vaccines|mesh-list
6453082|NCT00418847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6453083|NCT00418847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642267|NCT01386996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642268|NCT01387048|Adapalene|adapalene|mesh-list
6642269|NCT01387048|Azelaic acid|azelaic acid|mesh-list
6642270|NCT01387048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6642271|NCT01387048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6642272|NCT01387048|Analgesics|analgesics|mesh-ancestor
6642273|NCT01387048|Sensory System Agents|sensory system agents|mesh-ancestor
6642274|NCT01387048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6642275|NCT01387048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642276|NCT01387048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6642277|NCT01387048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6642278|NCT01387048|Dermatologic Agents|dermatologic agents|mesh-ancestor
6642279|NCT01387048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6642280|NCT01387087|Peficitinib|peficitinib|mesh-list
6642281|NCT01387087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6642282|NCT01387087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642283|NCT01387087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6642284|NCT01387087|Immunologic Factors|immunologic factors|mesh-ancestor
6642285|NCT01387087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642286|NCT01387191|Epoprostenol|epoprostenol|mesh-list
6642287|NCT01387191|Tezosentan|tezosentan|mesh-list
6642288|NCT01387191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6642289|NCT01387191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6642290|NCT01387191|Vasodilator Agents|vasodilator agents|mesh-ancestor
6642291|NCT01387204|Trametinib|trametinib|mesh-list
6642292|NCT01387204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6642293|NCT01387204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6642294|NCT01387204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6642295|NCT01387204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642296|NCT01387243|Orlistat|orlistat|mesh-list
6642297|NCT01387243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6642298|NCT01387243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642299|NCT01387243|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6642300|NCT01387243|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6663547|NCT01507792|Dermatologic Agents|dermatologic agents|mesh-ancestor
6663548|NCT01507792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6663549|NCT01507792|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6663550|NCT01507792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6663551|NCT01507792|Histamine Antagonists|histamine antagonists|mesh-ancestor
6663552|NCT01507792|Histamine Agents|histamine agents|mesh-ancestor
6663553|NCT01507792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6663554|NCT01507792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663555|NCT01507792|Histamine Agonists|histamine agonists|mesh-ancestor
6663556|NCT01507857|Vaccines|vaccines|mesh-list
6663557|NCT01507857|Immunologic Factors|immunologic factors|mesh-ancestor
5485573|NCT04956575|Immunologic Factors|immunologic factors|mesh-ancestor
6453084|NCT00418847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6453085|NCT00418847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6453086|NCT00418847|Antiviral Agents|antiviral agents|mesh-ancestor
6453087|NCT00418847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6453088|NCT00418847|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6453089|NCT00418847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6453090|NCT00418847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453091|NCT00418860|Aspirin|aspirin|mesh-list
6453092|NCT00418860|Clopidogrel|clopidogrel|mesh-list
6453093|NCT00418860|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6453094|NCT00418860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6453095|NCT00418860|Analgesics|analgesics|mesh-ancestor
6453096|NCT00418860|Sensory System Agents|sensory system agents|mesh-ancestor
6453097|NCT00418860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5485574|NCT04956575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485575|NCT04939597|Memantine|memantine|mesh-list
5485576|NCT04939597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5485577|NCT04939597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5485578|NCT04939597|Dopamine Agents|dopamine agents|mesh-ancestor
6642301|NCT01387295|Capecitabine|capecitabine|mesh-list
6642302|NCT01387295|Oxaliplatin|oxaliplatin|mesh-list
6642303|NCT01387295|Trastuzumab|trastuzumab|mesh-list
6642304|NCT01387295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6642305|NCT01387295|Antimetabolites|antimetabolites|mesh-ancestor
6642306|NCT01387295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642307|NCT01387295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6642308|NCT01387295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6642309|NCT01387373|Capecitabine|capecitabine|mesh-list
6642310|NCT01387373|Oxaliplatin|oxaliplatin|mesh-list
6642311|NCT01387373|Trastuzumab|trastuzumab|mesh-list
6642312|NCT01387373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6642313|NCT01387373|Antimetabolites|antimetabolites|mesh-ancestor
6642314|NCT01387373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642315|NCT01387373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6642316|NCT01387373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6642317|NCT01387399|Cisplatin|cisplatin|mesh-list
6642318|NCT01387399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6642319|NCT01387425|Varenicline|varenicline|mesh-list
6642320|NCT01387425|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6642321|NCT01387425|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6642322|NCT01387425|Cholinergic Agents|cholinergic agents|mesh-ancestor
6642323|NCT01387425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6642324|NCT01387425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642325|NCT01387425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642326|NCT01387568|Lidocaine|lidocaine|mesh-list
6642327|NCT01387568|Anesthetics, Local|anesthetics, local|mesh-ancestor
5485579|NCT04939597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5485580|NCT04939597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485581|NCT04939597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485582|NCT04939597|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5485583|NCT04939597|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5485584|NCT04820179|Atezolizumab|atezolizumab|mesh-list
5485585|NCT04820179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5485586|NCT04809051|Metronidazole|metronidazole|mesh-list
5485587|NCT04809051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5485588|NCT04809051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5485589|NCT04809051|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5485590|NCT04809051|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5485591|NCT04760730|Vaccines|vaccines|mesh-list
5485592|NCT04760730|Immunologic Factors|immunologic factors|mesh-ancestor
5485593|NCT04760730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485594|NCT04750954|Peposertib|peposertib|mesh-list
5485595|NCT04750954|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
5485596|NCT04750954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485597|NCT04750954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5485598|NCT04750954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6642328|NCT01387568|Anesthetics|anesthetics|mesh-ancestor
6642329|NCT01387568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6642330|NCT01387568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642331|NCT01387568|Sensory System Agents|sensory system agents|mesh-ancestor
6642332|NCT01387568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6642333|NCT01387568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6642334|NCT01387568|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6642335|NCT01387568|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6642336|NCT01387568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6642337|NCT01387568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642338|NCT01387620|Hyaluronic Acid|hyaluronic acid|mesh-list
6642339|NCT01387620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6642340|NCT01387620|Immunologic Factors|immunologic factors|mesh-ancestor
6642341|NCT01387620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724874|NCT03184649|Antipyretics|antipyretics|mesh-ancestor
6642342|NCT01387620|Viscosupplements|viscosupplements|mesh-ancestor
6642343|NCT01387620|Protective Agents|protective agents|mesh-ancestor
6642344|NCT01387763|Interferons|interferons|mesh-list
6642345|NCT01387763|Interferon-alpha|interferon-alpha|mesh-list
6642346|NCT01387763|Interferon alpha-2|interferon alpha-2|mesh-list
6642347|NCT01387763|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6642348|NCT01387763|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6642349|NCT01387763|Hydroxyurea|hydroxyurea|mesh-list
5485599|NCT04750954|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5485600|NCT04735367|Letrozole|letrozole|mesh-list
5485601|NCT04735367|Palbociclib|palbociclib|mesh-list
6642350|NCT01387763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6642351|NCT01387763|Antiviral Agents|antiviral agents|mesh-ancestor
6642352|NCT01387763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6642353|NCT01387763|Immunologic Factors|immunologic factors|mesh-ancestor
6642354|NCT01387763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642355|NCT01387763|Antisickling Agents|antisickling agents|mesh-ancestor
6642356|NCT01387763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6642357|NCT01387763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642358|NCT01387763|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6642359|NCT01387880|Everolimus|everolimus|mesh-list
6642360|NCT01387880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6642361|NCT01387880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6642362|NCT01387880|Immunologic Factors|immunologic factors|mesh-ancestor
6642363|NCT01387880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642364|NCT01387906|Bimatoprost|bimatoprost|mesh-list
6642365|NCT01387906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6642366|NCT01387997|Antibodies|antibodies|mesh-list
6642367|NCT01387997|Immunologic Factors|immunologic factors|mesh-ancestor
6642368|NCT01387997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642369|NCT01388023|Chlorhexidine|chlorhexidine|mesh-list
6642370|NCT01388023|Listerine|listerine|mesh-list
6642371|NCT01388023|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6642372|NCT01388023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6642373|NCT01388023|Disinfectants|disinfectants|mesh-ancestor
6642374|NCT01388036|Esmolol|esmolol|mesh-list
6642375|NCT01388036|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6642376|NCT01388036|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6642377|NCT01388036|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6642378|NCT01388036|Adrenergic Agents|adrenergic agents|mesh-ancestor
6642379|NCT01388036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6642380|NCT01388036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642381|NCT01388036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642382|NCT01388049|Antibodies|antibodies|mesh-list
6642383|NCT01388049|Immunologic Factors|immunologic factors|mesh-ancestor
6642384|NCT01388049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642385|NCT01388062|Antibodies|antibodies|mesh-list
6642386|NCT01388062|Immunologic Factors|immunologic factors|mesh-ancestor
6642387|NCT01388062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642388|NCT01388075|Rifampin|rifampin|mesh-list
6642389|NCT01388075|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6642390|NCT01388075|Antitubercular Agents|antitubercular agents|mesh-ancestor
6642391|NCT01388075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6642392|NCT01388075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6642393|NCT01388075|Leprostatic Agents|leprostatic agents|mesh-ancestor
6642394|NCT01388075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6642395|NCT01388075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6642396|NCT01388075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642397|NCT01388075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6642398|NCT01388075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6642399|NCT01388075|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6642400|NCT01388075|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6642401|NCT01388075|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6642402|NCT01388075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6642403|NCT01388088|Amiloride|amiloride|mesh-list
6642404|NCT01388088|Spironolactone|spironolactone|mesh-list
6642405|NCT01388088|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6642406|NCT01388088|Hormone Antagonists|hormone antagonists|mesh-ancestor
6642407|NCT01388088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6642408|NCT01388088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642409|NCT01388088|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6642410|NCT01388088|Diuretics|diuretics|mesh-ancestor
6642411|NCT01388088|Natriuretic Agents|natriuretic agents|mesh-ancestor
6642412|NCT01388088|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
6642413|NCT01388088|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6642414|NCT01388088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6642415|NCT01388088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642416|NCT01388088|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
6642417|NCT01388101|Antibodies|antibodies|mesh-list
6642418|NCT01388101|Immunologic Factors|immunologic factors|mesh-ancestor
6642419|NCT01388101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642420|NCT01388114|Antibodies|antibodies|mesh-list
6642421|NCT01388114|Immunologic Factors|immunologic factors|mesh-ancestor
6642422|NCT01388114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642423|NCT01388153|Acarbose|acarbose|mesh-list
5485602|NCT04735367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5485603|NCT04735367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5485604|NCT04735367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5485605|NCT04735367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5485606|NCT04735367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485607|NCT04735367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6642424|NCT01388153|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6642425|NCT01388153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6642426|NCT01388153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642427|NCT01388153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6642428|NCT01388153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642429|NCT01388270|Heparin|heparin|mesh-list
6642430|NCT01388270|Calcium heparin|calcium heparin|mesh-list
6642431|NCT01388270|Anticoagulants|anticoagulants|mesh-ancestor
6642432|NCT01388270|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6642433|NCT01388270|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6642434|NCT01388270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642435|NCT01388322|Enoxaparin|enoxaparin|mesh-list
6642436|NCT01388322|Anticoagulants|anticoagulants|mesh-ancestor
6642437|NCT01388322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6642438|NCT01388322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6642439|NCT01388322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642440|NCT01388387|Tacrolimus|tacrolimus|mesh-list
6642441|NCT01388387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6642442|NCT01388387|Immunologic Factors|immunologic factors|mesh-ancestor
6642443|NCT01388387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642444|NCT01388387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6642445|NCT01388387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6642446|NCT01388387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642447|NCT01388413|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6642448|NCT01388413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6642449|NCT01388439|Oseltamivir|oseltamivir|mesh-list
6642450|NCT01388439|Antiviral Agents|antiviral agents|mesh-ancestor
6642451|NCT01388439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6642452|NCT01388439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6642453|NCT01388439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642454|NCT01388517|Vitamin D|vitamin d|mesh-list
6642455|NCT01388517|Calcitriol|calcitriol|mesh-list
6642456|NCT01388517|Petrolatum|petrolatum|mesh-list
6642457|NCT01388517|Tacrolimus|tacrolimus|mesh-list
6642458|NCT01388517|Vitamins|vitamins|mesh-ancestor
6642459|NCT01388517|Micronutrients|micronutrients|mesh-ancestor
6642460|NCT01388517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642461|NCT01388517|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6642462|NCT01388517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6642463|NCT01388517|Immunologic Factors|immunologic factors|mesh-ancestor
6642464|NCT01388517|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6642465|NCT01388517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6642466|NCT01388517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642467|NCT01388517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5485608|NCT04735367|Hormone Antagonists|hormone antagonists|mesh-ancestor
5485609|NCT04735367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5485610|NCT04735367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485611|NCT04735367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5485612|NCT04698603|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
5485613|NCT04698603|Hallucinogens|hallucinogens|mesh-ancestor
5485614|NCT04698603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485615|NCT04698603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5485616|NCT04698603|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5485617|NCT04698603|Serotonin Agents|serotonin agents|mesh-ancestor
5485618|NCT04698603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5485619|NCT04698603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485620|NCT04698603|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5485621|NCT04662086|Camostat|camostat|mesh-list
5485622|NCT04662086|Protease Inhibitors|protease inhibitors|mesh-ancestor
5485623|NCT04662086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5485624|NCT04662086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485625|NCT04662086|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5485626|NCT04662086|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5485627|NCT04662073|Camostat|camostat|mesh-list
5485628|NCT04662073|Protease Inhibitors|protease inhibitors|mesh-ancestor
5485629|NCT04662073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5485630|NCT04662073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642468|NCT01388517|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
5485631|NCT04662073|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5485632|NCT04662073|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5485633|NCT04658173|Alfentanil|alfentanil|mesh-list
6642469|NCT01388517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6642470|NCT01388517|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6642471|NCT01388517|Emollients|emollients|mesh-ancestor
6642472|NCT01388517|Dermatologic Agents|dermatologic agents|mesh-ancestor
6642473|NCT01388582|Copper|copper|mesh-list
6642474|NCT01388582|Contraceptive Agents|contraceptive agents|mesh-list
6642475|NCT01388582|Levonorgestrel|levonorgestrel|mesh-list
6642476|NCT01388582|Etonogestrel|etonogestrel|mesh-list
6642477|NCT01388582|Desogestrel|desogestrel|mesh-list
6642478|NCT01388582|Contraceptives, Oral|contraceptives, oral|mesh-list
6642479|NCT01388582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6642480|NCT01388582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642481|NCT01388582|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6642482|NCT01388582|Trace Elements|trace elements|mesh-ancestor
6642483|NCT01388582|Micronutrients|micronutrients|mesh-ancestor
6642484|NCT01388582|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6642485|NCT01388582|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6642486|NCT01388582|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6642487|NCT01388582|Progestins|progestins|mesh-ancestor
6642488|NCT01388582|Hormones|hormones|mesh-ancestor
6642489|NCT01388582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6642490|NCT01388595|Fluticasone|fluticasone|mesh-list
6642491|NCT01388595|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6642492|NCT01388595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6642493|NCT01388595|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6642494|NCT01388595|Autonomic Agents|autonomic agents|mesh-ancestor
6642495|NCT01388595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6642496|NCT01388595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642497|NCT01388595|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6642498|NCT01388595|Respiratory System Agents|respiratory system agents|mesh-ancestor
6642499|NCT01388595|Dermatologic Agents|dermatologic agents|mesh-ancestor
6642500|NCT01388595|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6642501|NCT01388595|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6642502|NCT01388595|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6642503|NCT01388595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6642504|NCT01388595|Adrenergic Agents|adrenergic agents|mesh-ancestor
6642505|NCT01388595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6642506|NCT01388595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642507|NCT01388621|Gemcitabine|gemcitabine|mesh-list
6642508|NCT01388621|Carboplatin|carboplatin|mesh-list
6642509|NCT01388621|Doxorubicin|doxorubicin|mesh-list
6642510|NCT01388621|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6642511|NCT01388621|Panitumumab|panitumumab|mesh-list
5485634|NCT04658173|Propofol|propofol|mesh-list
5485635|NCT04658173|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5485636|NCT04658173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5485637|NCT04658173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485638|NCT04658173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5485639|NCT04658173|Anesthetics, General|anesthetics, general|mesh-ancestor
5485640|NCT04658173|Anesthetics|anesthetics|mesh-ancestor
5485641|NCT04658173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5485642|NCT04658173|Narcotics|narcotics|mesh-ancestor
5485643|NCT04658173|Analgesics|analgesics|mesh-ancestor
5485644|NCT04658173|Sensory System Agents|sensory system agents|mesh-ancestor
5485645|NCT04658173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5485646|NCT04627285|Lacosamide|lacosamide|mesh-list
5485647|NCT04627285|Anticonvulsants|anticonvulsants|mesh-ancestor
5485648|NCT04627285|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6642512|NCT01388621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6642513|NCT01388621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6642514|NCT01388621|Antimetabolites|antimetabolites|mesh-ancestor
6642515|NCT01388621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642516|NCT01388621|Antiviral Agents|antiviral agents|mesh-ancestor
6642517|NCT01388621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6642518|NCT01388621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5485649|NCT04627285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6642519|NCT01388621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6642520|NCT01388621|Immunologic Factors|immunologic factors|mesh-ancestor
6642521|NCT01388621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642522|NCT01388621|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6642523|NCT01388621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6642524|NCT01388621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6642525|NCT01388621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6642526|NCT01388660|Clopidogrel|clopidogrel|mesh-list
6642527|NCT01388660|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6642528|NCT01388660|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6642529|NCT01388660|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6642530|NCT01388660|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6642531|NCT01388660|Purinergic Agents|purinergic agents|mesh-ancestor
6642532|NCT01388660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6642533|NCT01388660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642534|NCT01388660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642535|NCT01388738|Cerebrolysin|cerebrolysin|mesh-list
6642536|NCT01388738|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
6642537|NCT01388738|Nootropic Agents|nootropic agents|mesh-ancestor
6642538|NCT01388738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6642539|NCT01388738|Protective Agents|protective agents|mesh-ancestor
6642540|NCT01388738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642541|NCT01388842|Nitric Oxide|nitric oxide|mesh-list
6642542|NCT01388842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6642543|NCT01388842|Autonomic Agents|autonomic agents|mesh-ancestor
6642544|NCT01388842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6642545|NCT01388842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642546|NCT01388842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6642547|NCT01388842|Respiratory System Agents|respiratory system agents|mesh-ancestor
6642548|NCT01388842|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6642549|NCT01388842|Antioxidants|antioxidants|mesh-ancestor
6642550|NCT01388842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642551|NCT01388842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6642552|NCT01388842|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6642553|NCT01388842|Vasodilator Agents|vasodilator agents|mesh-ancestor
6642554|NCT01388842|Gasotransmitters|gasotransmitters|mesh-ancestor
6642555|NCT01388842|Protective Agents|protective agents|mesh-ancestor
6642556|NCT01388855|Vitamin D|vitamin d|mesh-list
6642557|NCT01388855|Cholecalciferol|cholecalciferol|mesh-list
6642558|NCT01388855|Vitamins|vitamins|mesh-ancestor
5485650|NCT04627285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5485651|NCT04627285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485652|NCT04612751|Carboplatin|carboplatin|mesh-list
5485653|NCT04612751|Durvalumab|durvalumab|mesh-list
5485654|NCT04612751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5485655|NCT04612751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5485656|NCT04598009|Imatinib Mesylate|imatinib mesylate|mesh-list
5485657|NCT04598009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5485658|NCT04598009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5485659|NCT04598009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5485660|NCT04598009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485661|NCT04587687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5485662|NCT04587687|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5485663|NCT04587687|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5485664|NCT04587687|Antibodies|antibodies|mesh-list
5485665|NCT04587687|Immunoglobulins|immunoglobulins|mesh-list
5485666|NCT04587687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5485667|NCT04587687|Immunoconjugates|immunoconjugates|mesh-list
6642559|NCT01388855|Micronutrients|micronutrients|mesh-ancestor
6642560|NCT01388855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642561|NCT01388855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6642562|NCT01388855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6663558|NCT01507857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663559|NCT01507922|Fenoverine|fenoverine|mesh-list
6663560|NCT01507922|Parasympatholytics|parasympatholytics|mesh-ancestor
6663561|NCT01507922|Autonomic Agents|autonomic agents|mesh-ancestor
6663562|NCT01507922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6663563|NCT01507922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663564|NCT01507974|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6663565|NCT01507974|Amoxicillin|amoxicillin|mesh-list
6663566|NCT01507974|Clavulanic Acid|clavulanic acid|mesh-list
6663567|NCT01507974|Cephalexin|cephalexin|mesh-list
6663568|NCT01507974|Cefuroxime|cefuroxime|mesh-list
6663569|NCT01507974|Nitrofurantoin|nitrofurantoin|mesh-list
6663570|NCT01507974|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
5485668|NCT04587687|Immunologic Factors|immunologic factors|mesh-ancestor
5485669|NCT04587687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485670|NCT04587687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5485671|NCT04587687|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5485672|NCT04587687|Alkylating Agents|alkylating agents|mesh-ancestor
5485673|NCT04587687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485674|NCT04578600|Lenalidomide|lenalidomide|mesh-list
5485675|NCT04578600|Azacitidine|azacitidine|mesh-list
5485676|NCT04578600|Obinutuzumab|obinutuzumab|mesh-list
5485677|NCT04578600|Immunologic Factors|immunologic factors|mesh-ancestor
5485678|NCT04578600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485679|NCT04578600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6642563|NCT01388959|Rituximab|rituximab|mesh-list
6642564|NCT01388959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6642565|NCT01388959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6642566|NCT01388959|Immunologic Factors|immunologic factors|mesh-ancestor
6642567|NCT01388959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642568|NCT01388959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6642569|NCT01389024|Hydroxyurea|hydroxyurea|mesh-list
6642570|NCT01389024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6642571|NCT01389024|Antisickling Agents|antisickling agents|mesh-ancestor
6642572|NCT01389024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6642573|NCT01389024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642574|NCT01389024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6642575|NCT01389063|Maraviroc|maraviroc|mesh-list
6642576|NCT01389063|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6642577|NCT01389063|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6642578|NCT01389063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642579|NCT01389063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6642580|NCT01389063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6642581|NCT01389063|Antiviral Agents|antiviral agents|mesh-ancestor
6642582|NCT01389063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6642583|NCT01389063|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6642584|NCT01389167|Naltrexone|naltrexone|mesh-list
6642585|NCT01389167|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6642586|NCT01389167|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6642587|NCT01389167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642588|NCT01389167|Sensory System Agents|sensory system agents|mesh-ancestor
6642589|NCT01389167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6642590|NCT01389193|Ibudilast|ibudilast|mesh-list
6642591|NCT01389193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6642592|NCT01389193|Autonomic Agents|autonomic agents|mesh-ancestor
6642593|NCT01389193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6642594|NCT01389193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642595|NCT01389193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6642596|NCT01389193|Respiratory System Agents|respiratory system agents|mesh-ancestor
6642597|NCT01389193|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6642598|NCT01389193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6642599|NCT01389193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642600|NCT01389193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6642601|NCT01389193|Vasodilator Agents|vasodilator agents|mesh-ancestor
6642602|NCT01389206|Bosentan|bosentan|mesh-list
6642603|NCT01389206|Selexipag|selexipag|mesh-list
6642604|NCT01389206|Iloprost|iloprost|mesh-list
6642605|NCT01389206|Macitentan|macitentan|mesh-list
6642606|NCT01389206|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6642607|NCT01389206|Vasodilator Agents|vasodilator agents|mesh-ancestor
6642608|NCT01389206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6642609|NCT01389206|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6642610|NCT01389206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642611|NCT01389206|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
6642612|NCT01389206|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
6642613|NCT01389271|Iloprost|iloprost|mesh-list
6642614|NCT01389271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6642615|NCT01389271|Vasodilator Agents|vasodilator agents|mesh-ancestor
6642616|NCT01389388|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6642617|NCT01389388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6642618|NCT01389388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6642619|NCT01389388|Antimetabolites|antimetabolites|mesh-ancestor
6642620|NCT01389388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642621|NCT01389388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6642622|NCT01389388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5485680|NCT04578600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5485681|NCT04578600|Growth Substances|growth substances|mesh-ancestor
6642623|NCT01389388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6642624|NCT01389401|Omeprazole|omeprazole|mesh-list
6642625|NCT01389401|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6642626|NCT01389401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6642627|NCT01389401|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6642628|NCT01389401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6642629|NCT01389401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642630|NCT01389414|Gemcitabine|gemcitabine|mesh-list
6642631|NCT01389414|Oxaliplatin|oxaliplatin|mesh-list
5485682|NCT04578600|Growth Inhibitors|growth inhibitors|mesh-ancestor
5485683|NCT04578600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5485684|NCT04578600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5485685|NCT04578600|Antimetabolites|antimetabolites|mesh-ancestor
5485686|NCT04578600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642632|NCT01389414|Panitumumab|panitumumab|mesh-list
6642633|NCT01389414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6642634|NCT01389414|Antimetabolites|antimetabolites|mesh-ancestor
6642635|NCT01389414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642636|NCT01389414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6642637|NCT01389414|Antiviral Agents|antiviral agents|mesh-ancestor
6642638|NCT01389414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6642639|NCT01389414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6642640|NCT01389414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6642641|NCT01389414|Immunologic Factors|immunologic factors|mesh-ancestor
6642642|NCT01389414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642643|NCT01389414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6642644|NCT01389427|Sirolimus|sirolimus|mesh-list
6642645|NCT01389427|Prednisone|prednisone|mesh-list
6642646|NCT01389427|Doxorubicin|doxorubicin|mesh-list
6642647|NCT01389427|Cyclophosphamide|cyclophosphamide|mesh-list
6642648|NCT01389427|Vincristine|vincristine|mesh-list
6642649|NCT01389427|Rituximab|rituximab|mesh-list
6642650|NCT01389427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6642651|NCT01389427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6642652|NCT01389427|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6642653|NCT01389427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6642654|NCT01389427|Antifungal Agents|antifungal agents|mesh-ancestor
6642655|NCT01389427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6642656|NCT01389427|Immunologic Factors|immunologic factors|mesh-ancestor
6642657|NCT01389427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642658|NCT01389427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6642659|NCT01389427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6642660|NCT01389427|Alkylating Agents|alkylating agents|mesh-ancestor
6642661|NCT01389427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642662|NCT01389427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6642663|NCT01389427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6642664|NCT01389427|Glucocorticoids|glucocorticoids|mesh-ancestor
6642665|NCT01389427|Hormones|hormones|mesh-ancestor
6642666|NCT01389427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6642667|NCT01389427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6642668|NCT01389427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6642669|NCT01389427|Tubulin Modulators|tubulin modulators|mesh-ancestor
6642670|NCT01389427|Antimitotic Agents|antimitotic agents|mesh-ancestor
6642671|NCT01389427|Mitosis Modulators|mitosis modulators|mesh-ancestor
6642672|NCT01389427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6642673|NCT01389427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6642674|NCT01389427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6642675|NCT01389427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6642676|NCT01389440|Gemcitabine|gemcitabine|mesh-list
6642677|NCT01389440|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6642678|NCT01389440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6642679|NCT01389440|Antimetabolites|antimetabolites|mesh-ancestor
6642680|NCT01389440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642681|NCT01389440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6642682|NCT01389440|Antiviral Agents|antiviral agents|mesh-ancestor
6642683|NCT01389440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6642684|NCT01389440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6642685|NCT01389440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6642686|NCT01389440|Immunologic Factors|immunologic factors|mesh-ancestor
6642687|NCT01389440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642688|NCT01389440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6642689|NCT01389505|Bevacizumab|bevacizumab|mesh-list
6642690|NCT01389505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6642691|NCT01389505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6642692|NCT01389505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6642693|NCT01389505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6642694|NCT01389505|Growth Substances|growth substances|mesh-ancestor
6642695|NCT01389505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642696|NCT01389505|Growth Inhibitors|growth inhibitors|mesh-ancestor
6642697|NCT01389544|Ritonavir|ritonavir|mesh-list
6642698|NCT01389544|Methadone|methadone|mesh-list
6642699|NCT01389544|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6642700|NCT01389544|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6642701|NCT01389544|Protease Inhibitors|protease inhibitors|mesh-ancestor
6642702|NCT01389544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6642703|NCT01389544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642704|NCT01389544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6642705|NCT01389544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6642706|NCT01389544|Antiviral Agents|antiviral agents|mesh-ancestor
6642707|NCT01389544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6642708|NCT01389544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6642709|NCT01389544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6642710|NCT01389544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6642711|NCT01389544|Narcotics|narcotics|mesh-ancestor
6642712|NCT01389544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6642713|NCT01389544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642714|NCT01389544|Analgesics|analgesics|mesh-ancestor
6642715|NCT01389544|Sensory System Agents|sensory system agents|mesh-ancestor
6642716|NCT01389544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6642717|NCT01389544|Antitussive Agents|antitussive agents|mesh-ancestor
6642718|NCT01389544|Respiratory System Agents|respiratory system agents|mesh-ancestor
6642719|NCT01389557|Piperaquine|piperaquine|mesh-list
6642720|NCT01389557|Primaquine|primaquine|mesh-list
6642721|NCT01389557|Artenimol|artenimol|mesh-list
6642722|NCT01389557|Antimalarials|antimalarials|mesh-ancestor
6642723|NCT01389557|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6642724|NCT01389557|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6642725|NCT01389557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6642726|NCT01389609|Doxazosin|doxazosin|mesh-list
6642727|NCT01389609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6642728|NCT01389609|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6642729|NCT01389609|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6642730|NCT01389609|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6642731|NCT01389609|Adrenergic Agents|adrenergic agents|mesh-ancestor
6642732|NCT01389609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6642733|NCT01389609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642734|NCT01389609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642735|NCT01389713|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6642736|NCT01389713|Clomiphene|clomiphene|mesh-list
6642737|NCT01389713|Enclomiphene|enclomiphene|mesh-list
6642738|NCT01389713|Zuclomiphene|zuclomiphene|mesh-list
6642739|NCT01389713|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6642740|NCT01389713|Hormone Antagonists|hormone antagonists|mesh-ancestor
6642741|NCT01389713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6642742|NCT01389713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642743|NCT01389713|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5485687|NCT04578600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5485688|NCT04578600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5485689|NCT04565392|Famotidine|famotidine|mesh-list
5485690|NCT04565392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5485691|NCT04565392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5485692|NCT04565392|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5485693|NCT04565392|Histamine Antagonists|histamine antagonists|mesh-ancestor
5485694|NCT04565392|Histamine Agents|histamine agents|mesh-ancestor
5485695|NCT04565392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5485696|NCT04565392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485697|NCT04565392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485698|NCT04560179|Tobramycin|tobramycin|mesh-list
5485699|NCT04560179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5485700|NCT04560179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6021642|NCT00401544|Iron-Dextran Complex|iron-dextran complex|mesh-list
6021643|NCT00401544|Hematinics|hematinics|mesh-ancestor
6021644|NCT00401544|Anticoagulants|anticoagulants|mesh-ancestor
5485704|NCT04478942|Misoprostol|misoprostol|mesh-list
5485705|NCT04478942|Oxytocin|oxytocin|mesh-list
5485706|NCT04478942|Oxytocics|oxytocics|mesh-ancestor
6642744|NCT01389713|Fertility Agents|fertility agents|mesh-ancestor
6642745|NCT01389713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6642746|NCT01389713|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6642747|NCT01389713|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6642748|NCT01389713|Luteolytic Agents|luteolytic agents|mesh-ancestor
6642749|NCT01389713|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6642750|NCT01389713|Contraceptive Agents|contraceptive agents|mesh-ancestor
5485707|NCT04478942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5485708|NCT04478942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485709|NCT04478942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5485710|NCT04478942|Abortifacient Agents|abortifacient agents|mesh-ancestor
5485711|NCT04478942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5485712|NCT04478942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5485713|NCT04467593|Gemcitabine|gemcitabine|mesh-list
5485714|NCT04467593|Paclitaxel|paclitaxel|mesh-list
5485715|NCT04467593|Folfirinox|folfirinox|mesh-list
5485716|NCT04467593|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5485717|NCT04467593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5485718|NCT04467593|Tubulin Modulators|tubulin modulators|mesh-ancestor
5485719|NCT04467593|Antimitotic Agents|antimitotic agents|mesh-ancestor
5485720|NCT04467593|Mitosis Modulators|mitosis modulators|mesh-ancestor
5485721|NCT04467593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485722|NCT04467593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5485723|NCT04467593|Antimetabolites|antimetabolites|mesh-ancestor
5485724|NCT04467593|Antiviral Agents|antiviral agents|mesh-ancestor
5485725|NCT04467593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5485726|NCT04467593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5485727|NCT04467593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5485728|NCT04467593|Immunologic Factors|immunologic factors|mesh-ancestor
5485729|NCT04467593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485730|NCT04463693|Etonogestrel|etonogestrel|mesh-list
5485731|NCT04463693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5485732|NCT04463693|Contraceptive Agents|contraceptive agents|mesh-ancestor
6642751|NCT01389713|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6642752|NCT01389713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6642753|NCT01389713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6642754|NCT01389778|Metformin|metformin|mesh-list
6642755|NCT01389778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6642756|NCT01389778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642757|NCT01389791|Magnesium Sulfate|magnesium sulfate|mesh-list
6642758|NCT01389791|Rocuronium|rocuronium|mesh-list
6642759|NCT01389791|Analgesics|analgesics|mesh-ancestor
6642760|NCT01389791|Sensory System Agents|sensory system agents|mesh-ancestor
6642761|NCT01389791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6642762|NCT01389791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642763|NCT01389791|Anesthetics|anesthetics|mesh-ancestor
6642764|NCT01389791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6642765|NCT01389791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6642766|NCT01389791|Anticonvulsants|anticonvulsants|mesh-ancestor
6642767|NCT01389791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6642768|NCT01389791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6642769|NCT01389791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485733|NCT04463693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5485734|NCT04463693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485735|NCT04463693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5485736|NCT04463680|Rifampin|rifampin|mesh-list
5485737|NCT04463680|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5485738|NCT04463680|Antitubercular Agents|antitubercular agents|mesh-ancestor
5485739|NCT04463680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5485740|NCT04463680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5485741|NCT04463680|Leprostatic Agents|leprostatic agents|mesh-ancestor
5485742|NCT04463680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5485743|NCT04463680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5485744|NCT04463680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485745|NCT04463680|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5485746|NCT04463680|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5485747|NCT04463680|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5485748|NCT04463680|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5485749|NCT04463680|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5485750|NCT04463680|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5485751|NCT04463498|Methamphetamine|methamphetamine|mesh-list
5485752|NCT04463498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5485753|NCT04463498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485754|NCT04463498|Sympathomimetics|sympathomimetics|mesh-ancestor
5485755|NCT04463498|Autonomic Agents|autonomic agents|mesh-ancestor
5485756|NCT04463498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5485757|NCT04463498|Dopamine Agents|dopamine agents|mesh-ancestor
5485758|NCT04463498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5485759|NCT04463498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642770|NCT01389791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6642771|NCT01389791|Tocolytic Agents|tocolytic agents|mesh-ancestor
6642772|NCT01389791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6642773|NCT01389791|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6642774|NCT01389791|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6642775|NCT01389791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6642776|NCT01389908|Olanzapine|olanzapine|mesh-list
6642777|NCT01389908|Antiemetics|antiemetics|mesh-ancestor
6642778|NCT01389908|Autonomic Agents|autonomic agents|mesh-ancestor
6642779|NCT01389908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6642780|NCT01389908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642781|NCT01389908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6642782|NCT01389908|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6642783|NCT01389908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6642784|NCT01389908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6642785|NCT01389908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6642786|NCT01389908|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6642787|NCT01389908|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6642788|NCT01389908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6642789|NCT01389908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642790|NCT01389908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6642791|NCT01389908|Serotonin Agents|serotonin agents|mesh-ancestor
6642792|NCT01390012|Dexamethasone|dexamethasone|mesh-list
6642793|NCT01390012|Dexamethasone acetate|dexamethasone acetate|mesh-list
6642794|NCT01390012|BB 1101|bb 1101|mesh-list
6642795|NCT01390012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6642796|NCT01390012|Antiemetics|antiemetics|mesh-ancestor
6642797|NCT01390012|Autonomic Agents|autonomic agents|mesh-ancestor
6642798|NCT01390012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6642799|NCT01390012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642800|NCT01390012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6642801|NCT01390012|Glucocorticoids|glucocorticoids|mesh-ancestor
6642802|NCT01390012|Hormones|hormones|mesh-ancestor
6642803|NCT01390012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5485760|NCT04463498|Adrenergic Agents|adrenergic agents|mesh-ancestor
5485761|NCT04463498|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5485762|NCT04463498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5485763|NCT04463498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5485764|NCT04463498|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5485765|NCT04453137|Adalimumab|adalimumab|mesh-list
5485766|NCT04453137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5485767|NCT04453137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5485768|NCT04375956|Pembrolizumab|pembrolizumab|mesh-list
5485769|NCT04375956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5485770|NCT04375956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5485771|NCT04373707|Enoxaparin|enoxaparin|mesh-list
5485772|NCT04373707|Dalteparin|dalteparin|mesh-list
5485773|NCT04373707|Tinzaparin|tinzaparin|mesh-list
5485774|NCT04373707|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5485775|NCT04373707|Nadroparin|nadroparin|mesh-list
5485776|NCT04373707|Enoxaparin sodium|enoxaparin sodium|mesh-list
6642804|NCT01390012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6642805|NCT01390012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6642806|NCT01390012|Protease Inhibitors|protease inhibitors|mesh-ancestor
6642807|NCT01390012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6642808|NCT01390012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642809|NCT01390051|Tinzaparin|tinzaparin|mesh-list
6642810|NCT01390051|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6642811|NCT01390051|Dalteparin|dalteparin|mesh-list
6642812|NCT01390051|Anticoagulants|anticoagulants|mesh-ancestor
6642813|NCT01390051|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6642814|NCT01390051|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6642815|NCT01390051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642816|NCT01390311|Azacitidine|azacitidine|mesh-list
6642817|NCT01390311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6642818|NCT01390311|Antimetabolites|antimetabolites|mesh-ancestor
6642819|NCT01390311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642820|NCT01390311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6642821|NCT01390311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6642822|NCT01390324|Naproxen|naproxen|mesh-list
6642823|NCT01390324|Naratriptan|naratriptan|mesh-list
6642824|NCT01390324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6642825|NCT01390324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6642826|NCT01390324|Analgesics|analgesics|mesh-ancestor
6642827|NCT01390324|Sensory System Agents|sensory system agents|mesh-ancestor
6642828|NCT01390324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6642829|NCT01390324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642830|NCT01390324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6642831|NCT01390324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6642832|NCT01390324|Gout Suppressants|gout suppressants|mesh-ancestor
6642833|NCT01390324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6642834|NCT01390324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6642835|NCT01390324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642836|NCT01390324|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6642837|NCT01390324|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6642838|NCT01390324|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6642839|NCT01390324|Serotonin Agents|serotonin agents|mesh-ancestor
6642840|NCT01390324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6642841|NCT01390337|Cytarabine|cytarabine|mesh-list
6642842|NCT01390337|Daunorubicin|daunorubicin|mesh-list
6642843|NCT01390337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6642844|NCT01390337|Antimetabolites|antimetabolites|mesh-ancestor
6642845|NCT01390337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642846|NCT01390337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6642847|NCT01390337|Antiviral Agents|antiviral agents|mesh-ancestor
6642848|NCT01390337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6642849|NCT01390337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6642850|NCT01390337|Immunologic Factors|immunologic factors|mesh-ancestor
6642851|NCT01390337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642852|NCT01390337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6642853|NCT01390337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6642854|NCT01390337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6642855|NCT01390337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6642856|NCT01390480|Cholecalciferol|cholecalciferol|mesh-list
6642857|NCT01390480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6642858|NCT01390480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642859|NCT01390480|Vitamins|vitamins|mesh-ancestor
6642860|NCT01390480|Micronutrients|micronutrients|mesh-ancestor
6642861|NCT01390480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6642862|NCT01390506|Selenious Acid|selenious acid|mesh-list
6642863|NCT01390506|Sodium Selenite|sodium selenite|mesh-list
6642864|NCT01390506|Trace Elements|trace elements|mesh-ancestor
6642865|NCT01390506|Micronutrients|micronutrients|mesh-ancestor
6642866|NCT01390506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642867|NCT01390519|Everolimus|everolimus|mesh-list
6642868|NCT01390519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6642869|NCT01390519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6642870|NCT01390519|Immunologic Factors|immunologic factors|mesh-ancestor
6642871|NCT01390519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642872|NCT01390571|Temozolomide|temozolomide|mesh-list
6642873|NCT01390571|Olaparib|olaparib|mesh-list
6642874|NCT01390571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6642875|NCT01390571|Alkylating Agents|alkylating agents|mesh-ancestor
6642876|NCT01390571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642877|NCT01390571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6642878|NCT01390571|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6642879|NCT01390571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6642880|NCT01390623|Ceftriaxone|ceftriaxone|mesh-list
6642881|NCT01390623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6642882|NCT01390623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6642883|NCT01390662|Vitamin D|vitamin d|mesh-list
6642884|NCT01390662|Cholecalciferol|cholecalciferol|mesh-list
6642885|NCT01390662|Vitamins|vitamins|mesh-ancestor
6642886|NCT01390662|Micronutrients|micronutrients|mesh-ancestor
6642887|NCT01390662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642888|NCT01390662|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6642889|NCT01390662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6663571|NCT01507974|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6663572|NCT01507974|Trimethoprim|trimethoprim|mesh-list
6663573|NCT01507974|Sulfamethoxazole|sulfamethoxazole|mesh-list
5485777|NCT04373707|Anticoagulants|anticoagulants|mesh-ancestor
5485778|NCT04373707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5485779|NCT04373707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5485780|NCT04373707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663574|NCT01507974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6663575|NCT01507974|Antitubercular Agents|antitubercular agents|mesh-ancestor
6663576|NCT01507974|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6663577|NCT01507974|Renal Agents|renal agents|mesh-ancestor
6663578|NCT01507974|Antimalarials|antimalarials|mesh-ancestor
6663579|NCT01507974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6663580|NCT01507974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6663581|NCT01507974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6663582|NCT01507974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6663583|NCT01507974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663584|NCT01507974|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6663585|NCT01507974|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6663586|NCT01507974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6663587|NCT01507974|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6663588|NCT01508000|Bevacizumab|bevacizumab|mesh-list
6663589|NCT01508000|Panitumumab|panitumumab|mesh-list
6663590|NCT01508000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6663591|NCT01508000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6663592|NCT01508000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6663593|NCT01508000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6663594|NCT01508000|Growth Substances|growth substances|mesh-ancestor
6663595|NCT01508000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663596|NCT01508000|Growth Inhibitors|growth inhibitors|mesh-ancestor
6663597|NCT01508104|Everolimus|everolimus|mesh-list
6663598|NCT01508104|Dactolisib|dactolisib|mesh-list
6663599|NCT01508104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6663600|NCT01508104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6663601|NCT01508104|Immunologic Factors|immunologic factors|mesh-ancestor
6663602|NCT01508104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663603|NCT01508143|Misoprostol|misoprostol|mesh-list
6663604|NCT01508143|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6663605|NCT01508143|Abortifacient Agents|abortifacient agents|mesh-ancestor
6663606|NCT01508143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6663607|NCT01508143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663608|NCT01508143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6663609|NCT01508143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6663610|NCT01508143|Oxytocics|oxytocics|mesh-ancestor
6663611|NCT01508182|Metformin|metformin|mesh-list
6663612|NCT01508182|Canagliflozin|canagliflozin|mesh-list
6663613|NCT01508182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6663614|NCT01508182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663615|NCT01508182|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6453098|NCT00418860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453099|NCT00418860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6453100|NCT00418860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6453101|NCT00418860|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6453102|NCT00418860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6663616|NCT01508182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663617|NCT01508195|Metformin|metformin|mesh-list
6663618|NCT01508195|Canagliflozin|canagliflozin|mesh-list
6663619|NCT01508195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6021645|NCT00401544|Plasma Substitutes|plasma substitutes|mesh-ancestor
6453103|NCT00418860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453104|NCT00418860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6663620|NCT01508195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663621|NCT01508195|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6663622|NCT01508195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021646|NCT00401544|Blood Substitutes|blood substitutes|mesh-ancestor
6021647|NCT00401726|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6021648|NCT00401726|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6021649|NCT00401726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6021650|NCT00401726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6021651|NCT00401726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021652|NCT00401726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6642890|NCT01390766|Azathioprine|azathioprine|mesh-list
6642891|NCT01390766|Antimetabolites|antimetabolites|mesh-ancestor
6642892|NCT01390766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642893|NCT01390766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6642894|NCT01390766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6642895|NCT01390766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6642896|NCT01390766|Immunologic Factors|immunologic factors|mesh-ancestor
6021653|NCT00401726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021654|NCT00401726|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6021655|NCT00401726|Antidepressive Agents|antidepressive agents|mesh-ancestor
6453105|NCT00418860|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5502625|NCT04465851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502626|NCT04465539|Hydrocortisone|hydrocortisone|mesh-list
6453106|NCT00418860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6453107|NCT00418860|Antipyretics|antipyretics|mesh-ancestor
6642897|NCT01390766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642898|NCT01390766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6642899|NCT01390792|Zanamivir|zanamivir|mesh-list
6642900|NCT01390792|Antiviral Agents|antiviral agents|mesh-ancestor
6642901|NCT01390792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6642902|NCT01390792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6642903|NCT01390792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642904|NCT01390805|Valacyclovir|valacyclovir|mesh-list
6642905|NCT01390805|Antiviral Agents|antiviral agents|mesh-ancestor
6642906|NCT01390805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6642907|NCT01390883|PENTA|penta|mesh-list
6642908|NCT01390883|Fondaparinux|fondaparinux|mesh-list
6642909|NCT01390883|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6642910|NCT01390883|Antithrombins|antithrombins|mesh-ancestor
6642911|NCT01390883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6642912|NCT01390883|Protease Inhibitors|protease inhibitors|mesh-ancestor
6642913|NCT01390883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6642914|NCT01390883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642915|NCT01390883|Anticoagulants|anticoagulants|mesh-ancestor
6642916|NCT01390883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6642917|NCT01390883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6642918|NCT01390896|PENTA|penta|mesh-list
6642919|NCT01390896|Fondaparinux|fondaparinux|mesh-list
6642920|NCT01390896|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6642921|NCT01390896|Antithrombins|antithrombins|mesh-ancestor
6642922|NCT01390896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6642923|NCT01390896|Protease Inhibitors|protease inhibitors|mesh-ancestor
6642924|NCT01390896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6642925|NCT01390896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642926|NCT01390896|Anticoagulants|anticoagulants|mesh-ancestor
6642927|NCT01390896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6642928|NCT01390896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6642929|NCT01390922|Botulinum Toxins|botulinum toxins|mesh-list
6453108|NCT00418860|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6453109|NCT00418860|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6453110|NCT00418860|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6453111|NCT00418860|Purinergic Agents|purinergic agents|mesh-ancestor
6453112|NCT00418860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6453113|NCT00418873|Risperidone|risperidone|mesh-list
6453114|NCT00418873|Zotepine|zotepine|mesh-list
6453115|NCT00418873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6453116|NCT00418873|Serotonin Agents|serotonin agents|mesh-ancestor
6453117|NCT00418873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6453118|NCT00418873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453119|NCT00418873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453120|NCT00418873|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6453121|NCT00418873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6453122|NCT00418873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6453123|NCT00418873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6642930|NCT01390922|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6642931|NCT01390922|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6642932|NCT01390922|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5485794|NCT04363697|Dapagliflozin|dapagliflozin|mesh-list
5485795|NCT04363697|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5485796|NCT04363697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642933|NCT01390922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6642934|NCT01390922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642935|NCT01390922|Cholinergic Agents|cholinergic agents|mesh-ancestor
6642936|NCT01390922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6642937|NCT01390922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642938|NCT01390922|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6642939|NCT01390922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6642940|NCT01390935|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
6642941|NCT01390935|Hormone Antagonists|hormone antagonists|mesh-ancestor
6642942|NCT01390935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6642943|NCT01390935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642944|NCT01390935|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6642945|NCT01390935|Diuretics|diuretics|mesh-ancestor
6642946|NCT01390935|Natriuretic Agents|natriuretic agents|mesh-ancestor
6642947|NCT01390961|Pheniramine|pheniramine|mesh-list
6642948|NCT01390961|Naphazoline|naphazoline|mesh-list
6642949|NCT01390961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642950|NCT01390961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6642951|NCT01390961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6642952|NCT01390961|Adrenergic Agents|adrenergic agents|mesh-ancestor
6642953|NCT01390961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6642954|NCT01390961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642955|NCT01390961|Nasal Decongestants|nasal decongestants|mesh-ancestor
6642956|NCT01390961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6642957|NCT01390961|Respiratory System Agents|respiratory system agents|mesh-ancestor
6642958|NCT01390961|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6642959|NCT01390961|Histamine Antagonists|histamine antagonists|mesh-ancestor
6642960|NCT01390961|Histamine Agents|histamine agents|mesh-ancestor
6642961|NCT01390961|Antipruritics|antipruritics|mesh-ancestor
6642962|NCT01390961|Dermatologic Agents|dermatologic agents|mesh-ancestor
6642963|NCT01390961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5485797|NCT04363697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5485798|NCT04363697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485799|NCT04317066|Pembrolizumab|pembrolizumab|mesh-list
5485800|NCT04317066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5485801|NCT04317066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5485802|NCT04287816|Antithrombin III|antithrombin iii|mesh-list
5485803|NCT04287816|Antithrombins|antithrombins|mesh-list
5485804|NCT04287816|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5485805|NCT04287816|Protease Inhibitors|protease inhibitors|mesh-ancestor
5485806|NCT04287816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5485807|NCT04287816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485808|NCT04287816|Anticoagulants|anticoagulants|mesh-ancestor
5485809|NCT04220489|Ketamine|ketamine|mesh-list
5485810|NCT04220489|Analgesics|analgesics|mesh-ancestor
5485811|NCT04220489|Sensory System Agents|sensory system agents|mesh-ancestor
5485812|NCT04220489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5485813|NCT04220489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485814|NCT04220489|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5485815|NCT04220489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5485816|NCT04220489|Anesthetics, General|anesthetics, general|mesh-ancestor
5485817|NCT04220489|Anesthetics|anesthetics|mesh-ancestor
5485818|NCT04220489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5485819|NCT04220489|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5485820|NCT04220489|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5485821|NCT04220489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5485822|NCT04220489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485823|NCT04218786|Colchicine|colchicine|mesh-list
5485824|NCT04218786|Gout Suppressants|gout suppressants|mesh-ancestor
6453124|NCT00418873|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6453125|NCT00418873|Dopamine Agents|dopamine agents|mesh-ancestor
6453126|NCT00418925|Dronabinol|dronabinol|mesh-list
6453127|NCT00418925|Hallucinogens|hallucinogens|mesh-ancestor
6453128|NCT00418925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453129|NCT00418925|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6453130|NCT00418925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6453131|NCT00418925|Analgesics|analgesics|mesh-ancestor
6453132|NCT00418925|Sensory System Agents|sensory system agents|mesh-ancestor
6453133|NCT00418925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6453134|NCT00418925|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6642964|NCT01391052|Norethindrone|norethindrone|mesh-list
6642965|NCT01391052|Norethindrone Acetate|norethindrone acetate|mesh-list
6642966|NCT01391052|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6642967|NCT01391052|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6642968|NCT01391052|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6642969|NCT01391052|Contraceptive Agents|contraceptive agents|mesh-ancestor
6642970|NCT01391052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6642971|NCT01391052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642972|NCT01391052|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6642973|NCT01391052|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6642974|NCT01391104|Sildenafil Citrate|sildenafil citrate|mesh-list
6642975|NCT01391104|Vasodilator Agents|vasodilator agents|mesh-ancestor
6642976|NCT01391104|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6642977|NCT01391104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6642978|NCT01391104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6642979|NCT01391104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642980|NCT01391104|Urological Agents|urological agents|mesh-ancestor
6642981|NCT01391156|Minoxidil|minoxidil|mesh-list
6642982|NCT01391156|Finasteride|finasteride|mesh-list
6642983|NCT01391156|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6642984|NCT01391156|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6642985|NCT01391156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6642986|NCT01391156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642987|NCT01391156|Hormone Antagonists|hormone antagonists|mesh-ancestor
6642988|NCT01391156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6642989|NCT01391156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6642990|NCT01391156|Urological Agents|urological agents|mesh-ancestor
6642991|NCT01391156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6642992|NCT01391156|Vasodilator Agents|vasodilator agents|mesh-ancestor
6642993|NCT01391221|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6642994|NCT01391221|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6642995|NCT01391221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6642996|NCT01391221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5485825|NCT04218786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5485826|NCT04218786|Tubulin Modulators|tubulin modulators|mesh-ancestor
5485827|NCT04218786|Antimitotic Agents|antimitotic agents|mesh-ancestor
5485828|NCT04218786|Mitosis Modulators|mitosis modulators|mesh-ancestor
5485829|NCT04218786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485830|NCT04218786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5485831|NCT04206813|Vaccines|vaccines|mesh-list
5485832|NCT04206813|Immunologic Factors|immunologic factors|mesh-ancestor
5485833|NCT04206813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485834|NCT04133376|Nicotine|nicotine|mesh-list
6453135|NCT00418925|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6453136|NCT00418925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6453137|NCT00418925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453138|NCT00418925|Hormones|hormones|mesh-ancestor
6453139|NCT00418925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6642997|NCT01391221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6642998|NCT01391221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6642999|NCT01391221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643000|NCT01391221|Analgesics|analgesics|mesh-ancestor
6643001|NCT01391221|Sensory System Agents|sensory system agents|mesh-ancestor
6643002|NCT01391221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6643003|NCT01391221|Antidepressive Agents|antidepressive agents|mesh-ancestor
6643004|NCT01391221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6643005|NCT01391221|Dopamine Agents|dopamine agents|mesh-ancestor
6643006|NCT01391260|Gefitinib|gefitinib|mesh-list
6643007|NCT01391260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6643008|NCT01391260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6643009|NCT01391260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6643010|NCT01391260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643011|NCT01391377|Niacin|niacin|mesh-list
6643012|NCT01391377|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6453140|NCT00419042|Gemcitabine|gemcitabine|mesh-list
6453141|NCT00419042|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6453142|NCT00419042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6453143|NCT00419042|Antimetabolites|antimetabolites|mesh-ancestor
6453144|NCT00419042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453145|NCT00419042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6453146|NCT00419042|Antiviral Agents|antiviral agents|mesh-ancestor
6453147|NCT00419042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6453148|NCT00419042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6643013|NCT01391377|Antimetabolites|antimetabolites|mesh-ancestor
6643014|NCT01391377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643015|NCT01391377|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6643016|NCT01391377|Vasodilator Agents|vasodilator agents|mesh-ancestor
6643017|NCT01391377|Vitamin B Complex|vitamin b complex|mesh-ancestor
6643018|NCT01391377|Vitamins|vitamins|mesh-ancestor
6643019|NCT01391377|Micronutrients|micronutrients|mesh-ancestor
6643020|NCT01391377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643021|NCT01391390|Melatonin|melatonin|mesh-list
6643022|NCT01391390|Antioxidants|antioxidants|mesh-ancestor
6643023|NCT01391390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643024|NCT01391390|Protective Agents|protective agents|mesh-ancestor
6643025|NCT01391390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643026|NCT01391390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6643027|NCT01391403|Artemisinins|artemisinins|mesh-list
6643028|NCT01391403|Artemisinin|artemisinin|mesh-list
6643029|NCT01391403|Antimalarials|antimalarials|mesh-ancestor
6643030|NCT01391403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6643031|NCT01391403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6643032|NCT01391403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6643033|NCT01391520|Deferiprone|deferiprone|mesh-list
6643034|NCT01391520|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6643035|NCT01391520|Chelating Agents|chelating agents|mesh-ancestor
6643036|NCT01391520|Sequestering Agents|sequestering agents|mesh-ancestor
6643037|NCT01391520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643038|NCT01391572|Fluorouracil|fluorouracil|mesh-list
6643039|NCT01391572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6643040|NCT01391572|Antimetabolites|antimetabolites|mesh-ancestor
6643041|NCT01391572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643042|NCT01391572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6643043|NCT01391572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6643044|NCT01391572|Immunologic Factors|immunologic factors|mesh-ancestor
6643045|NCT01391572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643046|NCT01391598|Lidocaine|lidocaine|mesh-list
6643047|NCT01391598|Anesthetics, Local|anesthetics, local|mesh-ancestor
6643048|NCT01391598|Anesthetics|anesthetics|mesh-ancestor
6643049|NCT01391598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6643050|NCT01391598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643051|NCT01391598|Sensory System Agents|sensory system agents|mesh-ancestor
6643052|NCT01391598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6643053|NCT01391598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6643054|NCT01391598|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6643055|NCT01391598|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6643056|NCT01391598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6643057|NCT01391598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643058|NCT01391624|Mineral Oil|mineral oil|mesh-list
6643059|NCT01391624|Emollients|emollients|mesh-ancestor
6643060|NCT01391624|Dermatologic Agents|dermatologic agents|mesh-ancestor
6643061|NCT01391689|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
6643062|NCT01391689|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6643063|NCT01391689|Protective Agents|protective agents|mesh-ancestor
6643064|NCT01391689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643065|NCT01391689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6643066|NCT01391715|Rabeprazole|rabeprazole|mesh-list
6643067|NCT01391715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6643068|NCT01391715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6643069|NCT01391715|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6643070|NCT01391715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6643071|NCT01391715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643072|NCT01391845|Ulipristal acetate|ulipristal acetate|mesh-list
6643073|NCT01391845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6643074|NCT01391845|Contraceptive Agents|contraceptive agents|mesh-ancestor
6643075|NCT01391845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6643076|NCT01391845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643077|NCT01391845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6643078|NCT01392014|Piperaquine|piperaquine|mesh-list
6643079|NCT01392014|Primaquine|primaquine|mesh-list
6643080|NCT01392014|Artenimol|artenimol|mesh-list
6643081|NCT01392014|Artemisinins|artemisinins|mesh-list
6643082|NCT01392014|Antimalarials|antimalarials|mesh-ancestor
6643083|NCT01392014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6643084|NCT01392014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6643085|NCT01392014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6643086|NCT01392079|Alemtuzumab|alemtuzumab|mesh-list
6643087|NCT01392079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6643088|NCT01392079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6643089|NCT01392144|Nitric Oxide|nitric oxide|mesh-list
6643090|NCT01392144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6643091|NCT01392144|Autonomic Agents|autonomic agents|mesh-ancestor
6643092|NCT01392144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6643093|NCT01392144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643094|NCT01392144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6643095|NCT01392144|Respiratory System Agents|respiratory system agents|mesh-ancestor
6643096|NCT01392144|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6643097|NCT01392144|Antioxidants|antioxidants|mesh-ancestor
6643098|NCT01392144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643099|NCT01392144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6643100|NCT01392144|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6643101|NCT01392144|Vasodilator Agents|vasodilator agents|mesh-ancestor
6643102|NCT01392144|Gasotransmitters|gasotransmitters|mesh-ancestor
6643103|NCT01392144|Protective Agents|protective agents|mesh-ancestor
6643104|NCT01392157|Copper|copper|mesh-list
6643105|NCT01392157|Levonorgestrel|levonorgestrel|mesh-list
6643106|NCT01392157|Trace Elements|trace elements|mesh-ancestor
6643107|NCT01392157|Micronutrients|micronutrients|mesh-ancestor
6643108|NCT01392157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643109|NCT01392157|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6643110|NCT01392157|Contraceptive Agents|contraceptive agents|mesh-ancestor
6643111|NCT01392157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6643112|NCT01392157|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6643113|NCT01392157|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6643114|NCT01392157|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6643115|NCT01392209|Bevacizumab|bevacizumab|mesh-list
6643116|NCT01392209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6643117|NCT01392209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6643118|NCT01392209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6643119|NCT01392209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6643120|NCT01392209|Growth Substances|growth substances|mesh-ancestor
6643121|NCT01392209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643122|NCT01392209|Growth Inhibitors|growth inhibitors|mesh-ancestor
6643123|NCT01392287|Memantine|memantine|mesh-list
6643124|NCT01392287|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6643125|NCT01392287|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6643126|NCT01392287|Dopamine Agents|dopamine agents|mesh-ancestor
6643127|NCT01392287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6643128|NCT01392287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643129|NCT01392287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643130|NCT01392287|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6643131|NCT01392287|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6643132|NCT01392430|Azithromycin|azithromycin|mesh-list
6643133|NCT01392430|Dapsone|dapsone|mesh-list
6643134|NCT01392430|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6643135|NCT01392430|Itraconazole|itraconazole|mesh-list
6643136|NCT01392430|Fluconazole|fluconazole|mesh-list
6643137|NCT01392430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6643138|NCT01392430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6643139|NCT01392430|Antifungal Agents|antifungal agents|mesh-ancestor
6643140|NCT01392430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5485835|NCT04133376|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5485836|NCT04133376|Autonomic Agents|autonomic agents|mesh-ancestor
5485837|NCT04133376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5485838|NCT04133376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485839|NCT04133376|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5485840|NCT04133376|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5485841|NCT04133376|Cholinergic Agents|cholinergic agents|mesh-ancestor
5485842|NCT04133376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5485843|NCT04133376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643141|NCT01392430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6643142|NCT01392430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6643143|NCT01392430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643144|NCT01392430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6643145|NCT01392430|Hormone Antagonists|hormone antagonists|mesh-ancestor
6643146|NCT01392430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6643147|NCT01392430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643148|NCT01392430|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6643149|NCT01392430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6643150|NCT01392430|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6643151|NCT01392430|Antimalarials|antimalarials|mesh-ancestor
6643152|NCT01392430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6643153|NCT01392430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6643154|NCT01392430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6643155|NCT01392430|Leprostatic Agents|leprostatic agents|mesh-ancestor
6643156|NCT01392430|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6643157|NCT01392430|Renal Agents|renal agents|mesh-ancestor
6663623|NCT01508221|Vitamin E|vitamin e|mesh-list
6663624|NCT01508221|Pentoxifylline|pentoxifylline|mesh-list
6663625|NCT01508221|Vitamins|vitamins|mesh-ancestor
6663626|NCT01508221|Micronutrients|micronutrients|mesh-ancestor
6663627|NCT01508221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663628|NCT01508221|Antioxidants|antioxidants|mesh-ancestor
6663629|NCT01508221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663630|NCT01508221|Protective Agents|protective agents|mesh-ancestor
6663631|NCT01508221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6663632|NCT01508221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6663633|NCT01508221|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6663634|NCT01508221|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6663635|NCT01508221|Vasodilator Agents|vasodilator agents|mesh-ancestor
6663636|NCT01508221|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6663637|NCT01508260|Furosemide|furosemide|mesh-list
6663638|NCT01508260|Diuretics|diuretics|mesh-ancestor
6663639|NCT01508260|Natriuretic Agents|natriuretic agents|mesh-ancestor
6663640|NCT01508260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663641|NCT01508260|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6663642|NCT01508260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6663643|NCT01508260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663644|NCT01508286|Ribavirin|ribavirin|mesh-list
6663645|NCT01508286|Antimetabolites|antimetabolites|mesh-ancestor
6663646|NCT01508286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663647|NCT01508286|Antiviral Agents|antiviral agents|mesh-ancestor
6663648|NCT01508286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6663649|NCT01508312|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6663650|NCT01508312|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6663651|NCT01508312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6663652|NCT01508312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6663653|NCT01508312|Immunologic Factors|immunologic factors|mesh-ancestor
6663654|NCT01508312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663655|NCT01508364|Sorafenib|sorafenib|mesh-list
6663656|NCT01508364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6663657|NCT01508364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6663658|NCT01508364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6663659|NCT01508364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663660|NCT01508429|Misoprostol|misoprostol|mesh-list
6663661|NCT01508429|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6663662|NCT01508429|Abortifacient Agents|abortifacient agents|mesh-ancestor
6663663|NCT01508429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6663664|NCT01508429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663665|NCT01508429|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6663666|NCT01508429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6663667|NCT01508429|Oxytocics|oxytocics|mesh-ancestor
6663668|NCT01508468|Rituximab|rituximab|mesh-list
6663669|NCT01508468|Angiotensin II|angiotensin ii|mesh-list
6663670|NCT01508468|Giapreza|giapreza|mesh-list
6663671|NCT01508468|Calcium|calcium|mesh-list
6663672|NCT01508468|Diuretics|diuretics|mesh-list
5485844|NCT04050085|Nivolumab|nivolumab|mesh-list
5485845|NCT04050085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5485846|NCT04050085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5485847|NCT04050085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5485848|NCT04050085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485849|NCT04002362|Triamcinolone|triamcinolone|mesh-list
5485850|NCT04002362|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5485851|NCT04002362|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5485852|NCT04002362|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5485853|NCT04002362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5485854|NCT04002362|Glucocorticoids|glucocorticoids|mesh-ancestor
5485855|NCT04002362|Hormones|hormones|mesh-ancestor
5485856|NCT04002362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5485857|NCT04002362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485858|NCT04002362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5485859|NCT04002362|Immunologic Factors|immunologic factors|mesh-ancestor
5485860|NCT04002362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5724875|NCT03184480|Fluticasone|fluticasone|mesh-list
6663673|NCT01508468|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
6663674|NCT01508468|Enzyme Inhibitors|enzyme inhibitors|mesh-list
6663675|NCT01508468|Angiotensinogen|angiotensinogen|mesh-list
5724876|NCT03184480|Xhance|xhance|mesh-list
6643158|NCT01392534|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6643159|NCT01392534|Telmisartan|telmisartan|mesh-list
6643160|NCT01392534|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
6643161|NCT01392534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6643162|NCT01392534|Diuretics|diuretics|mesh-ancestor
6643163|NCT01392534|Natriuretic Agents|natriuretic agents|mesh-ancestor
6643164|NCT01392534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643165|NCT01392534|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6643166|NCT01392534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6643167|NCT01392534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643168|NCT01392534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6643169|NCT01392534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6643170|NCT01392612|Epoetin Alfa|epoetin alfa|mesh-list
6643171|NCT01392612|Hematinics|hematinics|mesh-ancestor
6643172|NCT01392638|Sildenafil Citrate|sildenafil citrate|mesh-list
6643173|NCT01392638|Vasodilator Agents|vasodilator agents|mesh-ancestor
6643174|NCT01392638|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6643175|NCT01392638|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6643176|NCT01392638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6021656|NCT00401726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6643177|NCT01392638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643178|NCT01392638|Urological Agents|urological agents|mesh-ancestor
6643179|NCT01392716|Rituximab|rituximab|mesh-list
6643180|NCT01392716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6643181|NCT01392716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6643182|NCT01392716|Immunologic Factors|immunologic factors|mesh-ancestor
6643183|NCT01392716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643184|NCT01392716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6643185|NCT01392755|Ritonavir|ritonavir|mesh-list
6643186|NCT01392755|Omeprazole|omeprazole|mesh-list
6643187|NCT01392755|Ranitidine|ranitidine|mesh-list
6643188|NCT01392755|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
6643189|NCT01392755|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6643190|NCT01392755|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6643191|NCT01392755|Protease Inhibitors|protease inhibitors|mesh-ancestor
6643192|NCT01392755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6643193|NCT01392755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643194|NCT01392755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6643195|NCT01392755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6643196|NCT01392755|Antiviral Agents|antiviral agents|mesh-ancestor
6643197|NCT01392755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6643198|NCT01392755|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6643199|NCT01392755|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6643200|NCT01392755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6643201|NCT01392755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6643202|NCT01392755|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6643203|NCT01392755|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6643204|NCT01392755|Histamine Antagonists|histamine antagonists|mesh-ancestor
6643205|NCT01392755|Histamine Agents|histamine agents|mesh-ancestor
6643206|NCT01392755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6643207|NCT01392755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643208|NCT01392768|Levetiracetam|levetiracetam|mesh-list
6643209|NCT01392768|Anticonvulsants|anticonvulsants|mesh-ancestor
6643210|NCT01392768|Nootropic Agents|nootropic agents|mesh-ancestor
6643211|NCT01392794|Ramosetron|ramosetron|mesh-list
6643212|NCT01392794|Antiemetics|antiemetics|mesh-ancestor
6643213|NCT01392794|Autonomic Agents|autonomic agents|mesh-ancestor
6643214|NCT01392794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6643215|NCT01392794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643216|NCT01392794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6643217|NCT01392794|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6643218|NCT01392794|Serotonin Agents|serotonin agents|mesh-ancestor
6643219|NCT01392794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6643220|NCT01392794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643221|NCT01392807|Naloxegol|naloxegol|mesh-list
6643222|NCT01392807|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6643223|NCT01392807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643224|NCT01392807|Sensory System Agents|sensory system agents|mesh-ancestor
6643225|NCT01392807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6643226|NCT01392833|Prednisone|prednisone|mesh-list
6643227|NCT01392833|Methylprednisolone|methylprednisolone|mesh-list
6643228|NCT01392833|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6643229|NCT01392833|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6643230|NCT01392833|Prednisolone|prednisolone|mesh-list
6643231|NCT01392833|Prednisolone acetate|prednisolone acetate|mesh-list
6643232|NCT01392833|Azathioprine|azathioprine|mesh-list
6643233|NCT01392833|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6643234|NCT01392833|Prednisolone phosphate|prednisolone phosphate|mesh-list
6643235|NCT01392833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6643236|NCT01392833|Glucocorticoids|glucocorticoids|mesh-ancestor
6643237|NCT01392833|Hormones|hormones|mesh-ancestor
6643238|NCT01392833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6643239|NCT01392833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643240|NCT01392833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6643241|NCT01392833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6643242|NCT01392833|Antiemetics|antiemetics|mesh-ancestor
6643243|NCT01392833|Autonomic Agents|autonomic agents|mesh-ancestor
6643244|NCT01392833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6643245|NCT01392833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6643246|NCT01392833|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6643247|NCT01392833|Protective Agents|protective agents|mesh-ancestor
6643248|NCT01392833|Antimetabolites|antimetabolites|mesh-ancestor
6643249|NCT01392833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643250|NCT01392833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6643251|NCT01392833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6643252|NCT01392833|Immunologic Factors|immunologic factors|mesh-ancestor
6643253|NCT01392833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6643254|NCT01392898|Liraglutide|liraglutide|mesh-list
6643255|NCT01392898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6643256|NCT01392898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643257|NCT01392898|Incretins|incretins|mesh-ancestor
6643258|NCT01392898|Hormones|hormones|mesh-ancestor
6643259|NCT01392898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6643260|NCT01392911|Rifampin|rifampin|mesh-list
6643261|NCT01392911|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6643262|NCT01392911|Antitubercular Agents|antitubercular agents|mesh-ancestor
6643263|NCT01392911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6643264|NCT01392911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6643265|NCT01392911|Leprostatic Agents|leprostatic agents|mesh-ancestor
6643266|NCT01392911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6643267|NCT01392911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6643268|NCT01392911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643269|NCT01392911|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6643270|NCT01392911|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6643271|NCT01392911|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6643272|NCT01392911|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6643273|NCT01392911|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6643274|NCT01392911|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6643275|NCT01393080|Nimotuzumab|nimotuzumab|mesh-list
6643276|NCT01393080|Cisplatin|cisplatin|mesh-list
6643277|NCT01393080|Paclitaxel|paclitaxel|mesh-list
6643278|NCT01393080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6643279|NCT01393080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6643280|NCT01393080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6643281|NCT01393080|Tubulin Modulators|tubulin modulators|mesh-ancestor
6643282|NCT01393080|Antimitotic Agents|antimitotic agents|mesh-ancestor
6643283|NCT01393080|Mitosis Modulators|mitosis modulators|mesh-ancestor
6643284|NCT01393080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643285|NCT01393145|Fluticasone|fluticasone|mesh-list
6643286|NCT01393145|Xhance|xhance|mesh-list
6643287|NCT01393145|Formoterol Fumarate|formoterol fumarate|mesh-list
6643288|NCT01393145|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6643289|NCT01393145|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6643290|NCT01393145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6643291|NCT01393145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6643292|NCT01393145|Autonomic Agents|autonomic agents|mesh-ancestor
6643293|NCT01393145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6643294|NCT01393145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643295|NCT01393145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6643296|NCT01393145|Respiratory System Agents|respiratory system agents|mesh-ancestor
6643297|NCT01393145|Dermatologic Agents|dermatologic agents|mesh-ancestor
6643298|NCT01393145|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6643299|NCT01393145|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6643300|NCT01393145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6643301|NCT01393145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6643302|NCT01393145|Adrenergic Agents|adrenergic agents|mesh-ancestor
6643303|NCT01393145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6643304|NCT01393145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643305|NCT01393145|Glucocorticoids|glucocorticoids|mesh-ancestor
6643306|NCT01393145|Hormones|hormones|mesh-ancestor
6643307|NCT01393145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6643308|NCT01393145|Sympathomimetics|sympathomimetics|mesh-ancestor
6643309|NCT01393184|Nimotuzumab|nimotuzumab|mesh-list
6643310|NCT01393184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6643311|NCT01393184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6643312|NCT01393288|Lorazepam|lorazepam|mesh-list
6643313|NCT01393288|Ondansetron|ondansetron|mesh-list
6643314|NCT01393288|Aprepitant|aprepitant|mesh-list
6643315|NCT01393288|Antiemetics|antiemetics|mesh-ancestor
6643316|NCT01393288|Autonomic Agents|autonomic agents|mesh-ancestor
6643317|NCT01393288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6643318|NCT01393288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643319|NCT01393288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6643320|NCT01393288|Antipruritics|antipruritics|mesh-ancestor
6643321|NCT01393288|Dermatologic Agents|dermatologic agents|mesh-ancestor
6643322|NCT01393288|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6643323|NCT01393288|Serotonin Agents|serotonin agents|mesh-ancestor
6643324|NCT01393288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6643325|NCT01393288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643326|NCT01393288|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6643327|NCT01393288|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6643328|NCT01393288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6643329|NCT01393288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6643330|NCT01393288|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6643331|NCT01393288|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6643332|NCT01393288|Anticonvulsants|anticonvulsants|mesh-ancestor
6643333|NCT01393288|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6643334|NCT01393288|GABA Modulators|gaba modulators|mesh-ancestor
6643335|NCT01393288|GABA Agents|gaba agents|mesh-ancestor
6643336|NCT01393340|Omalizumab|omalizumab|mesh-list
6643337|NCT01393340|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6643338|NCT01393340|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6643339|NCT01393340|Respiratory System Agents|respiratory system agents|mesh-ancestor
6643340|NCT01393509|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
6643341|NCT01393509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6643342|NCT01393522|Milnacipran|milnacipran|mesh-list
6643343|NCT01393522|Levomilnacipran|levomilnacipran|mesh-list
6643344|NCT01393522|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6643345|NCT01393522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6643346|NCT01393522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6643347|NCT01393522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643348|NCT01393522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6643349|NCT01393522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643350|NCT01393522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6643351|NCT01393522|Analgesics|analgesics|mesh-ancestor
6643352|NCT01393522|Sensory System Agents|sensory system agents|mesh-ancestor
6643353|NCT01393522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6643354|NCT01393522|Antidepressive Agents|antidepressive agents|mesh-ancestor
6643355|NCT01393522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6643356|NCT01393548|Brompheniramine|brompheniramine|mesh-list
6643357|NCT01393548|Phenylephrine|phenylephrine|mesh-list
6643358|NCT01393548|Oxymetazoline|oxymetazoline|mesh-list
6643359|NCT01393548|Pseudoephedrine|pseudoephedrine|mesh-list
6643360|NCT01393548|Ephedrine|ephedrine|mesh-list
6643361|NCT01393548|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6643362|NCT01393548|Mydriatics|mydriatics|mesh-ancestor
6643363|NCT01393548|Autonomic Agents|autonomic agents|mesh-ancestor
6643364|NCT01393548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6643365|NCT01393548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643366|NCT01393548|Sympathomimetics|sympathomimetics|mesh-ancestor
6643367|NCT01393548|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6643368|NCT01393548|Nasal Decongestants|nasal decongestants|mesh-ancestor
6643369|NCT01393548|Respiratory System Agents|respiratory system agents|mesh-ancestor
6643370|NCT01393548|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6643371|NCT01393548|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6643372|NCT01393548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6643373|NCT01393548|Adrenergic Agents|adrenergic agents|mesh-ancestor
6643374|NCT01393548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6643375|NCT01393548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643376|NCT01393548|Protective Agents|protective agents|mesh-ancestor
6643377|NCT01393548|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6643378|NCT01393548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6643379|NCT01393548|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6643380|NCT01393548|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6643381|NCT01393548|Histamine Antagonists|histamine antagonists|mesh-ancestor
6021657|NCT00401752|Esomeprazole|esomeprazole|mesh-list
6643382|NCT01393548|Histamine Agents|histamine agents|mesh-ancestor
6643383|NCT01393548|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6643384|NCT01393574|Melatonin|melatonin|mesh-list
6643385|NCT01393574|Methylphenidate|methylphenidate|mesh-list
6643386|NCT01393574|Antioxidants|antioxidants|mesh-ancestor
6643387|NCT01393574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643388|NCT01393574|Protective Agents|protective agents|mesh-ancestor
6643389|NCT01393574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643390|NCT01393574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6643391|NCT01393574|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6643392|NCT01393574|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6643393|NCT01393574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6643394|NCT01393574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6643395|NCT01393574|Dopamine Agents|dopamine agents|mesh-ancestor
6643396|NCT01393574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6643397|NCT01393756|Lenalidomide|lenalidomide|mesh-list
6643398|NCT01393756|Immunologic Factors|immunologic factors|mesh-ancestor
6643399|NCT01393756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643400|NCT01393756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6643401|NCT01393756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6643402|NCT01393756|Growth Substances|growth substances|mesh-ancestor
6643403|NCT01393756|Growth Inhibitors|growth inhibitors|mesh-ancestor
6643404|NCT01393756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6643405|NCT01393769|Melphalan|melphalan|mesh-list
6643406|NCT01393769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6643407|NCT01393769|Alkylating Agents|alkylating agents|mesh-ancestor
6643408|NCT01393769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643409|NCT01393769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6643410|NCT01393769|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6643411|NCT01393769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6643412|NCT01393769|Immunologic Factors|immunologic factors|mesh-ancestor
6453149|NCT00419042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6453150|NCT00419042|Immunologic Factors|immunologic factors|mesh-ancestor
6453151|NCT00419042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453152|NCT00419042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6453153|NCT00419068|Cholecalciferol|cholecalciferol|mesh-list
6453154|NCT00419068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6453155|NCT00419068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453156|NCT00419068|Vitamins|vitamins|mesh-ancestor
6453157|NCT00419068|Micronutrients|micronutrients|mesh-ancestor
6453158|NCT00419068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6643413|NCT01393769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643414|NCT01393782|Angiotensin II|angiotensin ii|mesh-list
6643415|NCT01393782|Giapreza|giapreza|mesh-list
6643416|NCT01393782|Angiotensinogen|angiotensinogen|mesh-list
6643417|NCT01393782|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6643418|NCT01393782|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6643419|NCT01393782|Protease Inhibitors|protease inhibitors|mesh-ancestor
6643420|NCT01393782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6643421|NCT01393782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461902|NCT00456794|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6643422|NCT01393795|Capsaicin|capsaicin|mesh-list
6643423|NCT01393795|Antipruritics|antipruritics|mesh-ancestor
6643424|NCT01393795|Dermatologic Agents|dermatologic agents|mesh-ancestor
6643425|NCT01393795|Sensory System Agents|sensory system agents|mesh-ancestor
6643426|NCT01393795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6643427|NCT01393795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643428|NCT01393912|Crenolanib|crenolanib|mesh-list
6643429|NCT01393912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6643430|NCT01393925|Parecoxib|parecoxib|mesh-list
6643431|NCT01393925|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6643432|NCT01393925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6643433|NCT01393925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6643434|NCT01393925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643435|NCT01393925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6643436|NCT01393925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6643437|NCT01393925|Analgesics|analgesics|mesh-ancestor
6643438|NCT01393925|Sensory System Agents|sensory system agents|mesh-ancestor
6643439|NCT01393925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5485861|NCT04002362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485862|NCT03963518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5485863|NCT03963518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485864|NCT03963518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6643440|NCT01393925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643441|NCT01393925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6643442|NCT01393925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6643443|NCT01394016|Fulvestrant|fulvestrant|mesh-list
6643444|NCT01394016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6643445|NCT01394016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6643446|NCT01394016|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6643447|NCT01394016|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6643448|NCT01394016|Hormone Antagonists|hormone antagonists|mesh-ancestor
6643449|NCT01394016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5485865|NCT03940690|Bevacizumab|bevacizumab|mesh-list
5485866|NCT03940690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5485867|NCT03940690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5485868|NCT03940690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5485869|NCT03940690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6453159|NCT00419146|Vitamins|vitamins|mesh-list
6453160|NCT00419146|Vitamin E|vitamin e|mesh-list
6453161|NCT00419146|Tocopherols|tocopherols|mesh-list
6453162|NCT00419146|Tocotrienols|tocotrienols|mesh-list
6453163|NCT00419146|alpha-Tocopherol|alpha-tocopherol|mesh-list
6453164|NCT00419146|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
6453165|NCT00419146|Micronutrients|micronutrients|mesh-ancestor
6453166|NCT00419146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453167|NCT00419146|Antioxidants|antioxidants|mesh-ancestor
6453168|NCT00419146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453169|NCT00419146|Protective Agents|protective agents|mesh-ancestor
5485870|NCT03940690|Growth Substances|growth substances|mesh-ancestor
5485871|NCT03940690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485872|NCT03940690|Growth Inhibitors|growth inhibitors|mesh-ancestor
5485873|NCT03933449|Paclitaxel|paclitaxel|mesh-list
5485874|NCT03933449|Docetaxel|docetaxel|mesh-list
5485875|NCT03933449|Pembrolizumab|pembrolizumab|mesh-list
5485876|NCT03933449|Irinotecan|irinotecan|mesh-list
5485877|NCT03933449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5485878|NCT03933449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5485879|NCT03933449|Tubulin Modulators|tubulin modulators|mesh-ancestor
5485880|NCT03933449|Antimitotic Agents|antimitotic agents|mesh-ancestor
5485881|NCT03933449|Mitosis Modulators|mitosis modulators|mesh-ancestor
5485882|NCT03933449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485883|NCT03933449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5485884|NCT03933449|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6643450|NCT01394016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643451|NCT01394029|Deferasirox|deferasirox|mesh-list
6643452|NCT01394029|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6643453|NCT01394029|Chelating Agents|chelating agents|mesh-ancestor
6643454|NCT01394029|Sequestering Agents|sequestering agents|mesh-ancestor
6643455|NCT01394029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643456|NCT01394094|Calcium|calcium|mesh-list
6643457|NCT01394094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6643458|NCT01394094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643459|NCT01394133|Ritonavir|ritonavir|mesh-list
6643460|NCT01394133|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6643461|NCT01394133|Tenofovir|tenofovir|mesh-list
6643462|NCT01394133|Emtricitabine|emtricitabine|mesh-list
6643463|NCT01394133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6643464|NCT01394133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6643465|NCT01394133|Protease Inhibitors|protease inhibitors|mesh-ancestor
6643466|NCT01394133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6643467|NCT01394133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643468|NCT01394133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6643469|NCT01394133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6643470|NCT01394133|Antiviral Agents|antiviral agents|mesh-ancestor
6643471|NCT01394133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6643472|NCT01394133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6643473|NCT01394133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6643474|NCT01394133|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6643475|NCT01394133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6643476|NCT01394224|Levetiracetam|levetiracetam|mesh-list
6643477|NCT01394224|Anticonvulsants|anticonvulsants|mesh-ancestor
6643478|NCT01394224|Nootropic Agents|nootropic agents|mesh-ancestor
6643479|NCT01394263|Goserelin|goserelin|mesh-list
6643480|NCT01394263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6643481|NCT01394263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6663676|NCT01508468|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
6663677|NCT01508468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6663678|NCT01508468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6663679|NCT01508468|Immunologic Factors|immunologic factors|mesh-ancestor
6663680|NCT01508468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663681|NCT01508468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6663682|NCT01508468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6663683|NCT01508468|Natriuretic Agents|natriuretic agents|mesh-ancestor
6663684|NCT01508468|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6663685|NCT01508468|Adrenergic Agents|adrenergic agents|mesh-ancestor
6663686|NCT01508468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6663687|NCT01508468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663688|NCT01508468|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6663689|NCT01508468|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5485885|NCT03933449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5485886|NCT03933449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5485887|NCT03901144|Glycerol|glycerol|mesh-list
5485888|NCT03901144|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
5485889|NCT03901144|Protective Agents|protective agents|mesh-ancestor
6663690|NCT01508468|Protease Inhibitors|protease inhibitors|mesh-ancestor
6663691|NCT01508468|Hormone Antagonists|hormone antagonists|mesh-ancestor
6663692|NCT01508468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6663693|NCT01508468|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6663694|NCT01508494|Galantamine|galantamine|mesh-list
6663695|NCT01508494|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6663696|NCT01508494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6663697|NCT01508494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663698|NCT01508494|Cholinergic Agents|cholinergic agents|mesh-ancestor
6663699|NCT01508494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6663700|NCT01508494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663701|NCT01508494|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6663702|NCT01508494|Autonomic Agents|autonomic agents|mesh-ancestor
6663703|NCT01508494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6663704|NCT01508494|Nootropic Agents|nootropic agents|mesh-ancestor
6663705|NCT01508572|Bevacizumab|bevacizumab|mesh-list
6663706|NCT01508572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6663707|NCT01508572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6663708|NCT01508572|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6663709|NCT01508572|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6663710|NCT01508572|Growth Substances|growth substances|mesh-ancestor
6663711|NCT01508572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663712|NCT01508572|Growth Inhibitors|growth inhibitors|mesh-ancestor
6663713|NCT01508611|Fluorides|fluorides|mesh-list
6663714|NCT01508611|Cariostatic Agents|cariostatic agents|mesh-ancestor
6663715|NCT01508611|Protective Agents|protective agents|mesh-ancestor
6663716|NCT01508611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663717|NCT01508637|Terazosin|terazosin|mesh-list
6663718|NCT01508637|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6663719|NCT01508637|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6663720|NCT01508637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6663721|NCT01508637|Adrenergic Agents|adrenergic agents|mesh-ancestor
6663722|NCT01508637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6663723|NCT01508637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663724|NCT01508637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663725|NCT01508637|Urological Agents|urological agents|mesh-ancestor
5485890|NCT03901144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485891|NCT03891355|Dexamethasone|dexamethasone|mesh-list
5485892|NCT03891355|Lenalidomide|lenalidomide|mesh-list
6643482|NCT01394341|Liraglutide|liraglutide|mesh-list
6643483|NCT01394341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6643484|NCT01394341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643485|NCT01394341|Incretins|incretins|mesh-ancestor
6643486|NCT01394341|Hormones|hormones|mesh-ancestor
6643487|NCT01394341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6643488|NCT01394354|Dexamethasone|dexamethasone|mesh-list
6643489|NCT01394354|Dexamethasone acetate|dexamethasone acetate|mesh-list
6643490|NCT01394354|Doxorubicin|doxorubicin|mesh-list
6643491|NCT01394354|Bortezomib|bortezomib|mesh-list
6643492|NCT01394354|Vorinostat|vorinostat|mesh-list
6643493|NCT01394354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6643494|NCT01394354|Antiemetics|antiemetics|mesh-ancestor
6643495|NCT01394354|Autonomic Agents|autonomic agents|mesh-ancestor
6643496|NCT01394354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6643497|NCT01394354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643498|NCT01394354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6643499|NCT01394354|Glucocorticoids|glucocorticoids|mesh-ancestor
6643500|NCT01394354|Hormones|hormones|mesh-ancestor
6643501|NCT01394354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6643502|NCT01394354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6643503|NCT01394354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6643504|NCT01394354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6643505|NCT01394354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6643506|NCT01394354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6643507|NCT01394354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6643508|NCT01394354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643509|NCT01394354|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6643510|NCT01394406|Ketamine|ketamine|mesh-list
6643511|NCT01394406|Analgesics|analgesics|mesh-ancestor
6643512|NCT01394406|Sensory System Agents|sensory system agents|mesh-ancestor
6643513|NCT01394406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6643514|NCT01394406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643515|NCT01394406|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6643516|NCT01394406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6643517|NCT01394406|Anesthetics, General|anesthetics, general|mesh-ancestor
6643518|NCT01394406|Anesthetics|anesthetics|mesh-ancestor
6643519|NCT01394406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6643520|NCT01394406|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6643521|NCT01394406|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6643522|NCT01394406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6643523|NCT01394406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643524|NCT01394419|Acetylcysteine|acetylcysteine|mesh-list
6643525|NCT01394419|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6643526|NCT01394419|Antiviral Agents|antiviral agents|mesh-ancestor
6643527|NCT01394419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6643528|NCT01394419|Expectorants|expectorants|mesh-ancestor
6643529|NCT01394419|Respiratory System Agents|respiratory system agents|mesh-ancestor
6643530|NCT01394419|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6643531|NCT01394419|Antioxidants|antioxidants|mesh-ancestor
6643532|NCT01394419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643533|NCT01394419|Protective Agents|protective agents|mesh-ancestor
6643534|NCT01394419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643535|NCT01394419|Antidotes|antidotes|mesh-ancestor
6643536|NCT01394445|Physostigmine|physostigmine|mesh-list
6643537|NCT01394445|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6643538|NCT01394445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6643539|NCT01394445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643540|NCT01394445|Cholinergic Agents|cholinergic agents|mesh-ancestor
6643541|NCT01394445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6643542|NCT01394445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643543|NCT01394445|Miotics|miotics|mesh-ancestor
6643544|NCT01394445|Autonomic Agents|autonomic agents|mesh-ancestor
6643545|NCT01394445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6643546|NCT01394458|Ethanol|ethanol|mesh-list
6643547|NCT01394458|Heparin|heparin|mesh-list
6643548|NCT01394458|Citric Acid|citric acid|mesh-list
6643549|NCT01394458|Sodium Citrate|sodium citrate|mesh-list
6643550|NCT01394458|Anticoagulants|anticoagulants|mesh-ancestor
5485893|NCT03891355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5485894|NCT03891355|Antiemetics|antiemetics|mesh-ancestor
5485895|NCT03891355|Autonomic Agents|autonomic agents|mesh-ancestor
5485896|NCT03891355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5485897|NCT03891355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485898|NCT03891355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5485899|NCT03891355|Glucocorticoids|glucocorticoids|mesh-ancestor
5485900|NCT03891355|Hormones|hormones|mesh-ancestor
6453170|NCT00419146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6453171|NCT00419146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6453172|NCT00419172|Rifampin|rifampin|mesh-list
6453173|NCT00419172|Deferasirox|deferasirox|mesh-list
6453174|NCT00419172|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6453175|NCT00419172|Antitubercular Agents|antitubercular agents|mesh-ancestor
6453176|NCT00419172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6453177|NCT00419172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6453178|NCT00419172|Leprostatic Agents|leprostatic agents|mesh-ancestor
6453179|NCT00419172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6453180|NCT00419172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6453181|NCT00419172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453182|NCT00419172|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6453183|NCT00419172|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6453184|NCT00419172|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6453185|NCT00419172|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6453186|NCT00419172|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6453187|NCT00419172|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6453188|NCT00419172|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6453189|NCT00419172|Chelating Agents|chelating agents|mesh-ancestor
6453190|NCT00419172|Sequestering Agents|sequestering agents|mesh-ancestor
6643551|NCT01394458|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6643552|NCT01394458|Chelating Agents|chelating agents|mesh-ancestor
6643553|NCT01394458|Sequestering Agents|sequestering agents|mesh-ancestor
6643554|NCT01394458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643555|NCT01394458|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6643556|NCT01394458|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6643557|NCT01394458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6643558|NCT01394458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6643559|NCT01394458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6643560|NCT01394458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643561|NCT01394471|Oxytocin|oxytocin|mesh-list
6643562|NCT01394471|Oxytocics|oxytocics|mesh-ancestor
6643563|NCT01394471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6643564|NCT01394471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643565|NCT01394497|Acetylcysteine|acetylcysteine|mesh-list
6643566|NCT01394497|Antiviral Agents|antiviral agents|mesh-ancestor
6643567|NCT01394497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6643568|NCT01394497|Expectorants|expectorants|mesh-ancestor
6643569|NCT01394497|Respiratory System Agents|respiratory system agents|mesh-ancestor
6643570|NCT01394497|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6643571|NCT01394497|Antioxidants|antioxidants|mesh-ancestor
6643572|NCT01394497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643573|NCT01394497|Protective Agents|protective agents|mesh-ancestor
6643574|NCT01394497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643575|NCT01394640|Vaccines|vaccines|mesh-list
6643576|NCT01394640|Immunologic Factors|immunologic factors|mesh-ancestor
6663726|NCT01508663|Everolimus|everolimus|mesh-list
6643577|NCT01394640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643578|NCT01394653|Ramosetron|ramosetron|mesh-list
6643579|NCT01394653|Antiemetics|antiemetics|mesh-ancestor
6643580|NCT01394653|Autonomic Agents|autonomic agents|mesh-ancestor
6643581|NCT01394653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6643582|NCT01394653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643583|NCT01394653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6643584|NCT01394653|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6643585|NCT01394653|Serotonin Agents|serotonin agents|mesh-ancestor
6643586|NCT01394653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6643587|NCT01394653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643588|NCT01394679|Deoxyglucose|deoxyglucose|mesh-list
6643589|NCT01394679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643590|NCT01394679|Antimetabolites|antimetabolites|mesh-ancestor
6643591|NCT01394679|Antiviral Agents|antiviral agents|mesh-ancestor
6643592|NCT01394679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6643593|NCT01394731|Acetaminophen|acetaminophen|mesh-list
6643594|NCT01394731|Meperidine|meperidine|mesh-list
6643595|NCT01394731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6643596|NCT01394731|Analgesics|analgesics|mesh-ancestor
6643597|NCT01394731|Sensory System Agents|sensory system agents|mesh-ancestor
6643598|NCT01394731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6643599|NCT01394731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643600|NCT01394731|Antipyretics|antipyretics|mesh-ancestor
6643601|NCT01394731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6643602|NCT01394731|Narcotics|narcotics|mesh-ancestor
6643603|NCT01394731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6643604|NCT01394731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6643605|NCT01394757|Ketamine|ketamine|mesh-list
6643606|NCT01394757|Esketamine|esketamine|mesh-list
6643607|NCT01394757|Analgesics|analgesics|mesh-ancestor
6643608|NCT01394757|Sensory System Agents|sensory system agents|mesh-ancestor
6643609|NCT01394757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6643610|NCT01394757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643611|NCT01394757|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6643612|NCT01394757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6643613|NCT01394757|Anesthetics, General|anesthetics, general|mesh-ancestor
6643614|NCT01394757|Anesthetics|anesthetics|mesh-ancestor
6643615|NCT01394757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6643616|NCT01394757|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6643617|NCT01394757|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6643618|NCT01394757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6643619|NCT01394757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643620|NCT01394757|Antidepressive Agents|antidepressive agents|mesh-ancestor
6643621|NCT01394757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6643622|NCT01394770|Amlodipine|amlodipine|mesh-list
6643623|NCT01394770|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6643624|NCT01394770|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6643625|NCT01394770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6643626|NCT01394770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643627|NCT01394770|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6643628|NCT01394770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643629|NCT01394770|Vasodilator Agents|vasodilator agents|mesh-ancestor
6643630|NCT01394796|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
6643631|NCT01394796|Antioxidants|antioxidants|mesh-ancestor
6643632|NCT01394796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643633|NCT01394796|Protective Agents|protective agents|mesh-ancestor
6643634|NCT01394796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643635|NCT01394796|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
6643636|NCT01394796|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6643637|NCT01394796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6643638|NCT01394796|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6643639|NCT01394835|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
6643640|NCT01394835|Protein C Inhibitor|protein c inhibitor|mesh-list
6643641|NCT01394835|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6643642|NCT01394835|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6643643|NCT01394835|Protease Inhibitors|protease inhibitors|mesh-ancestor
6643644|NCT01394835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6643645|NCT01394835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643646|NCT01394848|Everolimus|everolimus|mesh-list
6643647|NCT01394848|Clopidogrel|clopidogrel|mesh-list
6643648|NCT01394848|Atorvastatin|atorvastatin|mesh-list
6643649|NCT01394848|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6643650|NCT01394848|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6643651|NCT01394848|Antimetabolites|antimetabolites|mesh-ancestor
6643652|NCT01394848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643653|NCT01394848|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6643654|NCT01394848|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6643655|NCT01394848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6643656|NCT01394848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6643657|NCT01394848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6643658|NCT01394848|Immunologic Factors|immunologic factors|mesh-ancestor
6643659|NCT01394848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643660|NCT01394848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6643661|NCT01394848|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6643662|NCT01394848|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6643663|NCT01394848|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6643664|NCT01394848|Purinergic Agents|purinergic agents|mesh-ancestor
6643665|NCT01394848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6643666|NCT01394887|Metformin|metformin|mesh-list
5485901|NCT03891355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5485902|NCT03891355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5485903|NCT03891355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5485904|NCT03891355|Immunologic Factors|immunologic factors|mesh-ancestor
5485905|NCT03891355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5485906|NCT03891355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5485907|NCT03891355|Growth Substances|growth substances|mesh-ancestor
5485908|NCT03891355|Growth Inhibitors|growth inhibitors|mesh-ancestor
5485909|NCT03765632|Busulfan|busulfan|mesh-list
5485910|NCT03765632|Alkylating Agents|alkylating agents|mesh-ancestor
5485911|NCT03765632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643667|NCT01394887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6643668|NCT01394887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643669|NCT01394913|Etanercept|etanercept|mesh-list
6643670|NCT01394913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6643671|NCT01394913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6643672|NCT01394913|Analgesics|analgesics|mesh-ancestor
6643673|NCT01394913|Sensory System Agents|sensory system agents|mesh-ancestor
6643674|NCT01394913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6643675|NCT01394913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643676|NCT01394913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6643677|NCT01394913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6643678|NCT01394913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6643679|NCT01394913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6643680|NCT01394913|Immunologic Factors|immunologic factors|mesh-ancestor
6643681|NCT01395069|Ketorolac|ketorolac|mesh-list
6643682|NCT01395069|Nepafenac|nepafenac|mesh-list
6643683|NCT01395069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6643684|NCT01395069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6643685|NCT01395069|Analgesics|analgesics|mesh-ancestor
6643686|NCT01395069|Sensory System Agents|sensory system agents|mesh-ancestor
6643687|NCT01395069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6643688|NCT01395069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643689|NCT01395069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6643690|NCT01395069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6643691|NCT01395069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6643692|NCT01395069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6643693|NCT01395069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643694|NCT01395147|Vortioxetine|vortioxetine|mesh-list
6643695|NCT01395147|Antidepressive Agents|antidepressive agents|mesh-ancestor
6643696|NCT01395147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6643697|NCT01395147|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6643698|NCT01395147|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6643699|NCT01395147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6643700|NCT01395147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643701|NCT01395147|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6643702|NCT01395147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6643703|NCT01395147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6643704|NCT01395147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643705|NCT01395147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5485912|NCT03765632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5485913|NCT03765632|Immunologic Factors|immunologic factors|mesh-ancestor
5485914|NCT03765632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485915|NCT03765632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5485916|NCT03765632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5485917|NCT03765632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6021658|NCT00401752|Ranitidine|ranitidine|mesh-list
6643706|NCT01395147|Serotonin Agents|serotonin agents|mesh-ancestor
6643707|NCT01395147|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6643708|NCT01395147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6643709|NCT01395147|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6643710|NCT01395147|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6643711|NCT01395199|Amlodipine|amlodipine|mesh-list
6643712|NCT01395199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6643713|NCT01395199|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6643714|NCT01395199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6643715|NCT01395199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643716|NCT01395199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6643717|NCT01395199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643718|NCT01395199|Vasodilator Agents|vasodilator agents|mesh-ancestor
6643719|NCT01395251|Prednisolone|prednisolone|mesh-list
6643720|NCT01395251|Glucocorticoids|glucocorticoids|mesh-list
6643721|NCT01395251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6643722|NCT01395251|Hormones|hormones|mesh-ancestor
6643723|NCT01395251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6643724|NCT01395251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643725|NCT01395251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6643726|NCT01395251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6643727|NCT01395290|Cholecalciferol|cholecalciferol|mesh-list
6643728|NCT01395290|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5485918|NCT03761173|Anticoagulants|anticoagulants|mesh-list
5485919|NCT03703297|Durvalumab|durvalumab|mesh-list
5485920|NCT03703297|Tremelimumab|tremelimumab|mesh-list
5485921|NCT03703297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5485922|NCT03703297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5485923|NCT03695250|Nivolumab|nivolumab|mesh-list
5485924|NCT03695250|Linrodostat|linrodostat|mesh-list
5485925|NCT03695250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6643729|NCT01395290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643730|NCT01395290|Vitamins|vitamins|mesh-ancestor
6643731|NCT01395290|Micronutrients|micronutrients|mesh-ancestor
6643732|NCT01395290|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6643733|NCT01395381|Albendazole|albendazole|mesh-list
6643734|NCT01395381|Anthelmintics|anthelmintics|mesh-ancestor
6643735|NCT01395381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6643736|NCT01395381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6643737|NCT01395381|Anticestodal Agents|anticestodal agents|mesh-ancestor
5485926|NCT03695250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5485927|NCT03695250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5485928|NCT03695250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485929|NCT03695250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5485930|NCT03645928|Pembrolizumab|pembrolizumab|mesh-list
5485931|NCT03645928|Nivolumab|nivolumab|mesh-list
5485932|NCT03645928|Ipilimumab|ipilimumab|mesh-list
5485933|NCT03645928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5485934|NCT03645928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5485935|NCT03645928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5485936|NCT03645928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485937|NCT03632941|Pembrolizumab|pembrolizumab|mesh-list
5485938|NCT03632941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5485939|NCT03632941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5485940|NCT03603912|Metformin|metformin|mesh-list
5485941|NCT03603912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5485942|NCT03603912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485943|NCT03558152|Vedolizumab|vedolizumab|mesh-list
5485944|NCT03558152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5485945|NCT03549000|Spartalizumab|spartalizumab|mesh-list
6643738|NCT01395381|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6643739|NCT01395381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6643740|NCT01395381|Tubulin Modulators|tubulin modulators|mesh-ancestor
5485946|NCT03549000|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5485947|NCT03549000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485948|NCT03549000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5485949|NCT03548246|Hydrocortisone|hydrocortisone|mesh-list
5485950|NCT03548246|Fludrocortisone|fludrocortisone|mesh-list
5485951|NCT03548246|Abiraterone Acetate|abiraterone acetate|mesh-list
5485952|NCT03548246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5485953|NCT03548246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6643741|NCT01395381|Antimitotic Agents|antimitotic agents|mesh-ancestor
6643742|NCT01395381|Mitosis Modulators|mitosis modulators|mesh-ancestor
5485954|NCT03548246|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5485955|NCT03548246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6643743|NCT01395381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643744|NCT01395381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6643745|NCT01395420|Ceftazidime|ceftazidime|mesh-list
6643746|NCT01395420|Avibactam|avibactam|mesh-list
6643747|NCT01395420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6643748|NCT01395420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6643749|NCT01395420|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6643750|NCT01395420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6643751|NCT01395420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643752|NCT01395433|Dexetimide|dexetimide|mesh-list
6643753|NCT01395433|Citalopram|citalopram|mesh-list
6643754|NCT01395433|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6643755|NCT01395433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6643756|NCT01395433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6643757|NCT01395433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643758|NCT01395433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6643759|NCT01395433|Serotonin Agents|serotonin agents|mesh-ancestor
6643760|NCT01395433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643761|NCT01395433|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6643762|NCT01395433|Antidepressive Agents|antidepressive agents|mesh-ancestor
6643763|NCT01395433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6643764|NCT01395433|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6643765|NCT01395433|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6643766|NCT01395433|Parasympatholytics|parasympatholytics|mesh-ancestor
6643767|NCT01395433|Autonomic Agents|autonomic agents|mesh-ancestor
6643768|NCT01395433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6643769|NCT01395433|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6643770|NCT01395433|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6643771|NCT01395433|Cholinergic Agents|cholinergic agents|mesh-ancestor
6643772|NCT01395485|Brodalumab|brodalumab|mesh-list
6643773|NCT01395485|Dermatologic Agents|dermatologic agents|mesh-ancestor
6643774|NCT01395589|Vitamin D|vitamin d|mesh-list
6643775|NCT01395589|Vitamins|vitamins|mesh-ancestor
6643776|NCT01395589|Micronutrients|micronutrients|mesh-ancestor
6643777|NCT01395589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643778|NCT01395589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6643779|NCT01395602|Cabergoline|cabergoline|mesh-list
6643780|NCT01395602|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6643781|NCT01395602|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6643782|NCT01395602|Dopamine Agonists|dopamine agonists|mesh-ancestor
6643783|NCT01395602|Dopamine Agents|dopamine agents|mesh-ancestor
6643784|NCT01395602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6643785|NCT01395602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643786|NCT01395602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643787|NCT01395654|Rifampin|rifampin|mesh-list
6643788|NCT01395654|Isoniazid|isoniazid|mesh-list
6643789|NCT01395654|Pyrazinamide|pyrazinamide|mesh-list
6643790|NCT01395654|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6643791|NCT01395654|Antitubercular Agents|antitubercular agents|mesh-ancestor
6643792|NCT01395654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6643793|NCT01395654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6643794|NCT01395654|Leprostatic Agents|leprostatic agents|mesh-ancestor
6643795|NCT01395654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6643796|NCT01395654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6643797|NCT01395654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643798|NCT01395654|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6643799|NCT01395654|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6643800|NCT01395654|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6643801|NCT01395654|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6643802|NCT01395654|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6643803|NCT01395654|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6643804|NCT01395654|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6643805|NCT01395654|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6643806|NCT01395654|Antimetabolites|antimetabolites|mesh-ancestor
6643807|NCT01395654|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6643808|NCT01395667|Leucovorin|leucovorin|mesh-list
6643809|NCT01395667|Fluorouracil|fluorouracil|mesh-list
6643810|NCT01395667|Oxaliplatin|oxaliplatin|mesh-list
6643811|NCT01395667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6643812|NCT01395667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643813|NCT01395667|Antimetabolites|antimetabolites|mesh-ancestor
6643814|NCT01395667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643815|NCT01395667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6643816|NCT01395667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6643817|NCT01395667|Immunologic Factors|immunologic factors|mesh-ancestor
5485956|NCT03548246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485957|NCT03548246|Hormone Antagonists|hormone antagonists|mesh-ancestor
5485958|NCT03548246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5485959|NCT03548246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643818|NCT01395667|Antidotes|antidotes|mesh-ancestor
6643819|NCT01395667|Protective Agents|protective agents|mesh-ancestor
6643820|NCT01395667|Vitamin B Complex|vitamin b complex|mesh-ancestor
6643821|NCT01395667|Vitamins|vitamins|mesh-ancestor
6643822|NCT01395667|Micronutrients|micronutrients|mesh-ancestor
6643823|NCT01395732|Bosentan|bosentan|mesh-list
6643824|NCT01395732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6643825|NCT01395732|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5485960|NCT03548246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5502627|NCT04465539|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
5502628|NCT04465539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6643826|NCT01395732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643827|NCT01395849|Fluticasone|fluticasone|mesh-list
6643828|NCT01395849|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6643829|NCT01395849|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6643830|NCT01395849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6643831|NCT01395849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6643832|NCT01395849|Autonomic Agents|autonomic agents|mesh-ancestor
6643833|NCT01395849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6643834|NCT01395849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643835|NCT01395849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6643836|NCT01395849|Respiratory System Agents|respiratory system agents|mesh-ancestor
6643837|NCT01395849|Dermatologic Agents|dermatologic agents|mesh-ancestor
6643838|NCT01395849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6643839|NCT01395849|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6643840|NCT01395849|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6643841|NCT01395849|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6643842|NCT01395849|Adrenergic Agents|adrenergic agents|mesh-ancestor
6643843|NCT01395849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6643844|NCT01395849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643845|NCT01395849|Glucocorticoids|glucocorticoids|mesh-ancestor
6643846|NCT01395849|Hormones|hormones|mesh-ancestor
6643847|NCT01395849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6643848|NCT01395849|Sympathomimetics|sympathomimetics|mesh-ancestor
6643849|NCT01395862|Fluticasone|fluticasone|mesh-list
6643850|NCT01395862|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6643851|NCT01395862|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6643852|NCT01395862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6643853|NCT01395862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6643854|NCT01395862|Autonomic Agents|autonomic agents|mesh-ancestor
6643855|NCT01395862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6643856|NCT01395862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643857|NCT01395862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6643858|NCT01395862|Respiratory System Agents|respiratory system agents|mesh-ancestor
6643859|NCT01395862|Dermatologic Agents|dermatologic agents|mesh-ancestor
6643860|NCT01395862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6643861|NCT01395862|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6643862|NCT01395862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6643863|NCT01395862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6643864|NCT01395862|Adrenergic Agents|adrenergic agents|mesh-ancestor
6643865|NCT01395862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6643866|NCT01395862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643867|NCT01395862|Glucocorticoids|glucocorticoids|mesh-ancestor
6643868|NCT01395862|Hormones|hormones|mesh-ancestor
6643869|NCT01395862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6643870|NCT01395862|Sympathomimetics|sympathomimetics|mesh-ancestor
6643871|NCT01395875|Fluticasone|fluticasone|mesh-list
6643872|NCT01395875|Xhance|xhance|mesh-list
6643873|NCT01395875|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6643874|NCT01395875|Cholinergic Antagonists|cholinergic antagonists|mesh-list
6643875|NCT01395875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6643876|NCT01395875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6643877|NCT01395875|Autonomic Agents|autonomic agents|mesh-ancestor
6643878|NCT01395875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6643879|NCT01395875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643880|NCT01395875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6643881|NCT01395875|Respiratory System Agents|respiratory system agents|mesh-ancestor
6643882|NCT01395875|Dermatologic Agents|dermatologic agents|mesh-ancestor
6643883|NCT01395875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6643884|NCT01395875|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6643885|NCT01395875|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6643886|NCT01395875|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6643887|NCT01395875|Adrenergic Agents|adrenergic agents|mesh-ancestor
6643888|NCT01395875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6643889|NCT01395875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643890|NCT01395875|Cholinergic Agents|cholinergic agents|mesh-ancestor
6643891|NCT01395927|Canagliflozin|canagliflozin|mesh-list
6643892|NCT01395927|Rifampin|rifampin|mesh-list
6643893|NCT01395927|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6643894|NCT01395927|Antitubercular Agents|antitubercular agents|mesh-ancestor
6643895|NCT01395927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6643896|NCT01395927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6643897|NCT01395927|Leprostatic Agents|leprostatic agents|mesh-ancestor
6643898|NCT01395927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6643899|NCT01395927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6643900|NCT01395927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643901|NCT01395927|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6643902|NCT01395927|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5485961|NCT03519295|Atezolizumab|atezolizumab|mesh-list
5485962|NCT03519295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5485963|NCT03462459|Vancomycin|vancomycin|mesh-list
5485964|NCT03462459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5485965|NCT03462459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5485966|NCT03457948|Pembrolizumab|pembrolizumab|mesh-list
5485967|NCT03457948|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
5485968|NCT03457948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5485969|NCT03457948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5485970|NCT03457948|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5485971|NCT03457948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485972|NCT03396445|Paclitaxel|paclitaxel|mesh-list
5485973|NCT03396445|Carboplatin|carboplatin|mesh-list
5485974|NCT03396445|Pembrolizumab|pembrolizumab|mesh-list
5485975|NCT03396445|Pemetrexed|pemetrexed|mesh-list
5485976|NCT03396445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5485977|NCT03396445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5485978|NCT03396445|Tubulin Modulators|tubulin modulators|mesh-ancestor
5485979|NCT03396445|Antimitotic Agents|antimitotic agents|mesh-ancestor
5485980|NCT03396445|Mitosis Modulators|mitosis modulators|mesh-ancestor
5485981|NCT03396445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485982|NCT03396445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5485983|NCT03396445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5485984|NCT03396445|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5485985|NCT03396445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5485986|NCT03328273|Acalabrutinib|acalabrutinib|mesh-list
5485987|NCT03328273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5485988|NCT03323398|Durvalumab|durvalumab|mesh-list
5485989|NCT03323398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5485990|NCT03323398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5485991|NCT03282123|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
5485992|NCT03282123|Hallucinogens|hallucinogens|mesh-ancestor
5485993|NCT03282123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5485994|NCT03282123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5485995|NCT03282123|Serotonin Agents|serotonin agents|mesh-ancestor
5485996|NCT03282123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5485997|NCT03282123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5485998|NCT03282123|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5485999|NCT03282123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5486000|NCT03282123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5486001|NCT03282123|Adrenergic Agents|adrenergic agents|mesh-ancestor
5486002|NCT03205553|Dialysis Solutions|dialysis solutions|mesh-list
5486003|NCT03205553|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5486004|NCT03166085|Paclitaxel|paclitaxel|mesh-list
6643903|NCT01395927|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6643904|NCT01395927|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6643905|NCT01395927|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6643906|NCT01395927|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6643907|NCT01395927|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6643908|NCT01395927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6643909|NCT01395927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643910|NCT01395953|Buspirone|buspirone|mesh-list
6643911|NCT01395953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6643912|NCT01395953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6643913|NCT01395953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5486005|NCT03166085|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
5486006|NCT03166085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5486007|NCT03166085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5486008|NCT03166085|Tubulin Modulators|tubulin modulators|mesh-ancestor
5486009|NCT03166085|Antimitotic Agents|antimitotic agents|mesh-ancestor
5486010|NCT03166085|Mitosis Modulators|mitosis modulators|mesh-ancestor
5486011|NCT03166085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643914|NCT01395953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643915|NCT01395953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6643916|NCT01395953|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6643917|NCT01395953|Serotonin Agents|serotonin agents|mesh-ancestor
6643918|NCT01395953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6643919|NCT01395953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486012|NCT03161054|Prednisone|prednisone|mesh-list
5486013|NCT03161054|Cyclophosphamide|cyclophosphamide|mesh-list
5486014|NCT03161054|Rituximab|rituximab|mesh-list
6453191|NCT00419250|Lenalidomide|lenalidomide|mesh-list
6453192|NCT00419250|Immunologic Factors|immunologic factors|mesh-ancestor
6453193|NCT00419250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643920|NCT01395992|Asenapine|asenapine|mesh-list
6643921|NCT01395992|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6643922|NCT01395992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6643923|NCT01395992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6643924|NCT01395992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643925|NCT01395992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6663727|NCT01508663|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6663728|NCT01508663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6663729|NCT01508663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6663730|NCT01508663|Immunologic Factors|immunologic factors|mesh-ancestor
6663731|NCT01508663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663732|NCT01508663|Protease Inhibitors|protease inhibitors|mesh-ancestor
6663733|NCT01508663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6663734|NCT01508663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663735|NCT01508741|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6663736|NCT01508741|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6663737|NCT01508741|Dermatologic Agents|dermatologic agents|mesh-ancestor
6665056|NCT01515579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6665057|NCT01515592|Liraglutide|liraglutide|mesh-list
6665058|NCT01515592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6665059|NCT01515592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665060|NCT01515592|Incretins|incretins|mesh-ancestor
6665061|NCT01515592|Hormones|hormones|mesh-ancestor
6665062|NCT01515592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6665063|NCT01515683|Anesthetics|anesthetics|mesh-list
6665064|NCT01515683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6665065|NCT01515683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665122|NCT01515826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665123|NCT01515826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6665124|NCT01515826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6665125|NCT01515826|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6665126|NCT01515826|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6665127|NCT01515826|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6665128|NCT01515826|Contraceptive Agents|contraceptive agents|mesh-ancestor
6665129|NCT01515826|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6665130|NCT01515826|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6665131|NCT01515826|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6665132|NCT01515826|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6665133|NCT01515839|Thioctic Acid|thioctic acid|mesh-list
6665134|NCT01515839|Acetylcarnitine|acetylcarnitine|mesh-list
6665135|NCT01515839|Acetylcysteine|acetylcysteine|mesh-list
6665136|NCT01515839|Vinpocetine|vinpocetine|mesh-list
6665137|NCT01515839|Huperzine A|huperzine a|mesh-list
6665138|NCT01515839|Antioxidants|antioxidants|mesh-ancestor
6665139|NCT01515839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665140|NCT01515839|Protective Agents|protective agents|mesh-ancestor
6665141|NCT01515839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665142|NCT01515839|Vitamin B Complex|vitamin b complex|mesh-ancestor
5486015|NCT03161054|Etoposide|etoposide|mesh-list
6453194|NCT00419250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6453195|NCT00419250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6453196|NCT00419250|Growth Substances|growth substances|mesh-ancestor
6453197|NCT00419250|Growth Inhibitors|growth inhibitors|mesh-ancestor
6453198|NCT00419250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6643926|NCT01396200|Hydroxychloroquine|hydroxychloroquine|mesh-list
6643927|NCT01396200|Sirolimus|sirolimus|mesh-list
6643928|NCT01396200|Antimalarials|antimalarials|mesh-ancestor
6643929|NCT01396200|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6643930|NCT01396200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6643931|NCT01396200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6643932|NCT01396200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6643933|NCT01396200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643934|NCT01396200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6643935|NCT01396200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6643936|NCT01396200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6643937|NCT01396200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6643938|NCT01396200|Antifungal Agents|antifungal agents|mesh-ancestor
6643939|NCT01396200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6643940|NCT01396200|Immunologic Factors|immunologic factors|mesh-ancestor
6643941|NCT01396200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643942|NCT01396291|Asenapine|asenapine|mesh-list
6643943|NCT01396291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6643944|NCT01396291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6643945|NCT01396291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6643946|NCT01396291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643947|NCT01396291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6643948|NCT01396304|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6643949|NCT01396304|Calcium|calcium|mesh-list
6643950|NCT01396304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6643951|NCT01396304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643952|NCT01396304|Laxatives|laxatives|mesh-ancestor
6643953|NCT01396304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6643954|NCT01396408|Sirolimus|sirolimus|mesh-list
6643955|NCT01396408|Sunitinib|sunitinib|mesh-list
6643956|NCT01396408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6643957|NCT01396408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6643958|NCT01396408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6643959|NCT01396408|Growth Substances|growth substances|mesh-ancestor
6643960|NCT01396408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6643961|NCT01396408|Growth Inhibitors|growth inhibitors|mesh-ancestor
6643962|NCT01396408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6643963|NCT01396408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6643964|NCT01396408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643965|NCT01396408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6643966|NCT01396408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6643967|NCT01396408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6643968|NCT01396408|Antifungal Agents|antifungal agents|mesh-ancestor
6643969|NCT01396408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6643970|NCT01396408|Immunologic Factors|immunologic factors|mesh-ancestor
6643971|NCT01396564|Metformin|metformin|mesh-list
6643972|NCT01396564|Pioglitazone|pioglitazone|mesh-list
6643973|NCT01396564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6643974|NCT01396564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486016|NCT03161054|Vinorelbine|vinorelbine|mesh-list
5486017|NCT03161054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5486018|NCT03161054|Immunologic Factors|immunologic factors|mesh-ancestor
5486019|NCT03161054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486020|NCT03161054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5486021|NCT03161054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6643975|NCT01396642|Emollients|emollients|mesh-list
6643976|NCT01396642|Dermatologic Agents|dermatologic agents|mesh-ancestor
6643977|NCT01396655|Docetaxel|docetaxel|mesh-list
6643978|NCT01396655|Doxorubicin|doxorubicin|mesh-list
6643979|NCT01396655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6643980|NCT01396655|Tubulin Modulators|tubulin modulators|mesh-ancestor
6643981|NCT01396655|Antimitotic Agents|antimitotic agents|mesh-ancestor
5486022|NCT03161054|Alkylating Agents|alkylating agents|mesh-ancestor
6643982|NCT01396655|Mitosis Modulators|mitosis modulators|mesh-ancestor
6643983|NCT01396655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643984|NCT01396655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6643985|NCT01396655|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6643986|NCT01396655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6643987|NCT01396655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6643988|NCT01396668|Gemcitabine|gemcitabine|mesh-list
6643989|NCT01396668|Capecitabine|capecitabine|mesh-list
6643990|NCT01396668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6643991|NCT01396668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6643992|NCT01396668|Antimetabolites|antimetabolites|mesh-ancestor
6643993|NCT01396668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6643994|NCT01396668|Antiviral Agents|antiviral agents|mesh-ancestor
6643995|NCT01396668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6643996|NCT01396668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6643997|NCT01396668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6643998|NCT01396668|Immunologic Factors|immunologic factors|mesh-ancestor
6643999|NCT01396668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644000|NCT01396681|Gemcitabine|gemcitabine|mesh-list
6644001|NCT01396681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6644002|NCT01396681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6644003|NCT01396681|Antimetabolites|antimetabolites|mesh-ancestor
6644004|NCT01396681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644005|NCT01396681|Antiviral Agents|antiviral agents|mesh-ancestor
6644006|NCT01396681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6644007|NCT01396681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6644008|NCT01396681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6644009|NCT01396681|Immunologic Factors|immunologic factors|mesh-ancestor
6644010|NCT01396681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644011|NCT01396707|Capecitabine|capecitabine|mesh-list
6644012|NCT01396707|Oxaliplatin|oxaliplatin|mesh-list
6644013|NCT01396707|Trastuzumab|trastuzumab|mesh-list
6644014|NCT01396707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6644015|NCT01396707|Antimetabolites|antimetabolites|mesh-ancestor
6644016|NCT01396707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644017|NCT01396707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6644018|NCT01396707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6644019|NCT01396720|Fluvoxamine|fluvoxamine|mesh-list
6644020|NCT01396720|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6644021|NCT01396720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6644022|NCT01396720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6644023|NCT01396720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486023|NCT03161054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486024|NCT03161054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5486025|NCT03161054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5486026|NCT03161054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5486027|NCT03161054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5486028|NCT03161054|Glucocorticoids|glucocorticoids|mesh-ancestor
5486029|NCT03161054|Hormones|hormones|mesh-ancestor
5486030|NCT03161054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5486031|NCT03161054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5486032|NCT03161054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5486033|NCT03161054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5486034|NCT03161054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5486035|NCT03161054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5486036|NCT03161054|Tubulin Modulators|tubulin modulators|mesh-ancestor
5486037|NCT03161054|Antimitotic Agents|antimitotic agents|mesh-ancestor
6644024|NCT01396720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6644025|NCT01396720|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6644026|NCT01396720|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6644027|NCT01396720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6644028|NCT01396720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644029|NCT01396720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6644030|NCT01396720|Serotonin Agents|serotonin agents|mesh-ancestor
6644031|NCT01396720|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6644032|NCT01396720|Antidepressive Agents|antidepressive agents|mesh-ancestor
6644033|NCT01396720|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6644034|NCT01396720|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6644035|NCT01396720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6644036|NCT01396720|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6644037|NCT01396733|Thioctic Acid|thioctic acid|mesh-list
6644038|NCT01396733|Antioxidants|antioxidants|mesh-ancestor
6644039|NCT01396733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644040|NCT01396733|Protective Agents|protective agents|mesh-ancestor
6644041|NCT01396733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644042|NCT01396733|Vitamin B Complex|vitamin b complex|mesh-ancestor
6644043|NCT01396733|Vitamins|vitamins|mesh-ancestor
6644044|NCT01396733|Micronutrients|micronutrients|mesh-ancestor
6644045|NCT01397006|Pregabalin|pregabalin|mesh-list
6644046|NCT01397006|Analgesics|analgesics|mesh-ancestor
6644047|NCT01397006|Sensory System Agents|sensory system agents|mesh-ancestor
6644048|NCT01397006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6644049|NCT01397006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644050|NCT01397006|Anticonvulsants|anticonvulsants|mesh-ancestor
6644051|NCT01397006|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6644052|NCT01397006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6644053|NCT01397006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644054|NCT01397006|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6644055|NCT01397006|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6644056|NCT01397006|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6644057|NCT01397006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6644058|NCT01397006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6644059|NCT01397019|Leucovorin|leucovorin|mesh-list
6644060|NCT01397019|Oxaliplatin|oxaliplatin|mesh-list
6644061|NCT01397019|Irinotecan|irinotecan|mesh-list
6644062|NCT01397019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6644063|NCT01397019|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6644064|NCT01397019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6644065|NCT01397019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6644066|NCT01397019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644067|NCT01397019|Antidotes|antidotes|mesh-ancestor
6644068|NCT01397019|Protective Agents|protective agents|mesh-ancestor
6644069|NCT01397019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644070|NCT01397019|Vitamin B Complex|vitamin b complex|mesh-ancestor
6644071|NCT01397019|Vitamins|vitamins|mesh-ancestor
6644072|NCT01397019|Micronutrients|micronutrients|mesh-ancestor
6644073|NCT01397097|Etonogestrel|etonogestrel|mesh-list
6644074|NCT01397097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5486038|NCT03161054|Mitosis Modulators|mitosis modulators|mesh-ancestor
5486039|NCT03050814|Leucovorin|leucovorin|mesh-list
5486040|NCT03050814|Bevacizumab|bevacizumab|mesh-list
5486041|NCT03050814|Avelumab|avelumab|mesh-list
5486042|NCT03050814|Fluorouracil|fluorouracil|mesh-list
5486043|NCT03050814|Capecitabine|capecitabine|mesh-list
5486044|NCT03050814|Oxaliplatin|oxaliplatin|mesh-list
6644075|NCT01397097|Contraceptive Agents|contraceptive agents|mesh-ancestor
6644076|NCT01397097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6644077|NCT01397097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644078|NCT01397097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6644079|NCT01397175|Everolimus|everolimus|mesh-list
6644080|NCT01397175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6644081|NCT01397175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5486045|NCT03050814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5486046|NCT03050814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5486047|NCT03050814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5486048|NCT03050814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5486049|NCT03050814|Growth Substances|growth substances|mesh-ancestor
5486050|NCT03050814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644082|NCT01397175|Immunologic Factors|immunologic factors|mesh-ancestor
6644083|NCT01397175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644084|NCT01397214|Megestrol Acetate|megestrol acetate|mesh-list
6644085|NCT01397214|Megestrol|megestrol|mesh-list
6644086|NCT01397214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5486051|NCT03050814|Growth Inhibitors|growth inhibitors|mesh-ancestor
5486052|NCT03050814|Antimetabolites|antimetabolites|mesh-ancestor
5502629|NCT04465539|Plasma Substitutes|plasma substitutes|mesh-ancestor
6644087|NCT01397214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6644088|NCT01397214|Appetite Stimulants|appetite stimulants|mesh-ancestor
6644089|NCT01397214|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6644090|NCT01397214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644091|NCT01397214|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6644092|NCT01397214|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6644093|NCT01397214|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6644094|NCT01397214|Contraceptive Agents|contraceptive agents|mesh-ancestor
6644095|NCT01397214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6644096|NCT01397214|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6644097|NCT01397214|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6644098|NCT01397305|Pemetrexed|pemetrexed|mesh-list
6644099|NCT01397305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6644100|NCT01397305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6644101|NCT01397305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644102|NCT01397305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6644103|NCT01397305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6644104|NCT01397331|Propofol|propofol|mesh-list
6644105|NCT01397331|Isoflurane|isoflurane|mesh-list
6644106|NCT01397331|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6644107|NCT01397331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6644108|NCT01397331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644109|NCT01397331|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6644110|NCT01397331|Anesthetics, General|anesthetics, general|mesh-ancestor
6644111|NCT01397331|Anesthetics|anesthetics|mesh-ancestor
6644112|NCT01397331|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6644113|NCT01397500|Testosterone|testosterone|mesh-list
6644114|NCT01397500|Androgens|androgens|mesh-ancestor
6644115|NCT01397500|Hormones|hormones|mesh-ancestor
6644116|NCT01397500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5486053|NCT03050814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486054|NCT03050814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5486055|NCT03050814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5486056|NCT03050814|Immunologic Factors|immunologic factors|mesh-ancestor
6644117|NCT01397500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644118|NCT01397513|Aspirin|aspirin|mesh-list
6644119|NCT01397513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6644120|NCT01397513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6644121|NCT01397513|Analgesics|analgesics|mesh-ancestor
6644122|NCT01397513|Sensory System Agents|sensory system agents|mesh-ancestor
6644123|NCT01397513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6644124|NCT01397513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486057|NCT03050814|Antidotes|antidotes|mesh-ancestor
5486058|NCT03050814|Protective Agents|protective agents|mesh-ancestor
5486059|NCT03050814|Vitamin B Complex|vitamin b complex|mesh-ancestor
5486060|NCT03050814|Vitamins|vitamins|mesh-ancestor
5486061|NCT03050814|Micronutrients|micronutrients|mesh-ancestor
5486062|NCT02916316|Doxorubicin|doxorubicin|mesh-list
5486063|NCT02916316|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5486064|NCT02916316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6644125|NCT01397513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6644126|NCT01397513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6644127|NCT01397513|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6644128|NCT01397513|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6644129|NCT01397513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644130|NCT01397513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5486065|NCT02916316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5486066|NCT02916316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5486067|NCT02916316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5486068|NCT02916316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5486069|NCT02916316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486070|NCT02827838|Durvalumab|durvalumab|mesh-list
5486071|NCT02827838|Immunoglobulins|immunoglobulins|mesh-list
5486072|NCT02827838|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5486073|NCT02827838|Immunoglobulin G|immunoglobulin g|mesh-list
6644131|NCT01397513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6644132|NCT01397513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6644133|NCT01397513|Antipyretics|antipyretics|mesh-ancestor
6644134|NCT01397630|Oxytocin|oxytocin|mesh-list
6644135|NCT01397630|Oxytocics|oxytocics|mesh-ancestor
6644136|NCT01397630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6644137|NCT01397630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644138|NCT01397734|Arsenic Trioxide|arsenic trioxide|mesh-list
6644139|NCT01397734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6644140|NCT01397799|Tirbanibulin|tirbanibulin|mesh-list
6644141|NCT01397799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6644142|NCT01397799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663738|NCT01508806|Liraglutide|liraglutide|mesh-list
6663739|NCT01508806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6663740|NCT01508806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663741|NCT01508806|Incretins|incretins|mesh-ancestor
6663742|NCT01508806|Hormones|hormones|mesh-ancestor
6663743|NCT01508806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6663744|NCT01508845|Vitamin D|vitamin d|mesh-list
6663745|NCT01508845|Ergocalciferols|ergocalciferols|mesh-list
6663746|NCT01508845|Cholecalciferol|cholecalciferol|mesh-list
6663747|NCT01508845|Vitamins|vitamins|mesh-list
6663748|NCT01508845|Micronutrients|micronutrients|mesh-ancestor
6663749|NCT01508845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663750|NCT01508845|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6663751|NCT01508845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6663752|NCT01508858|Liraglutide|liraglutide|mesh-list
6663753|NCT01508858|Levonorgestrel|levonorgestrel|mesh-list
6663754|NCT01508858|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6663755|NCT01508858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6663756|NCT01508858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663757|NCT01508858|Incretins|incretins|mesh-ancestor
6663758|NCT01508858|Hormones|hormones|mesh-ancestor
6663759|NCT01508858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6663760|NCT01508858|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6663761|NCT01508858|Contraceptive Agents|contraceptive agents|mesh-ancestor
6663762|NCT01508858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6663763|NCT01508858|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6663764|NCT01508858|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6663765|NCT01508858|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6663766|NCT01508858|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6663767|NCT01508858|Estrogens|estrogens|mesh-ancestor
6663768|NCT01508884|Imiquimod|imiquimod|mesh-list
5486074|NCT02827838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5486075|NCT02827838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5486076|NCT02827838|Immunologic Factors|immunologic factors|mesh-ancestor
5486077|NCT02827838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486078|NCT02803203|Bevacizumab|bevacizumab|mesh-list
5486079|NCT02803203|Osimertinib|osimertinib|mesh-list
5486080|NCT02803203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5486081|NCT02803203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5486082|NCT02803203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5486083|NCT02803203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5486084|NCT02803203|Growth Substances|growth substances|mesh-ancestor
5486085|NCT02803203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486086|NCT02803203|Growth Inhibitors|growth inhibitors|mesh-ancestor
6663769|NCT01508884|Vaccines|vaccines|mesh-list
6663770|NCT01508884|Immunologic Factors|immunologic factors|mesh-ancestor
6663771|NCT01508884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663772|NCT01508884|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6663773|NCT01508884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6663774|NCT01508884|Interferon Inducers|interferon inducers|mesh-ancestor
6663775|NCT01508897|Liraglutide|liraglutide|mesh-list
6663776|NCT01508897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6663777|NCT01508897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663778|NCT01508897|Incretins|incretins|mesh-ancestor
6663779|NCT01508897|Hormones|hormones|mesh-ancestor
6663780|NCT01508897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6663781|NCT01508923|Liraglutide|liraglutide|mesh-list
6663782|NCT01508923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6663783|NCT01508923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663784|NCT01508923|Incretins|incretins|mesh-ancestor
6663785|NCT01508923|Hormones|hormones|mesh-ancestor
6663786|NCT01508923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6663787|NCT01508949|Liraglutide|liraglutide|mesh-list
6663788|NCT01508949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6663789|NCT01508949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644143|NCT01397994|Nicorandil|nicorandil|mesh-list
6644144|NCT01397994|Atenolol|atenolol|mesh-list
6644145|NCT01397994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6644146|NCT01397994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6644147|NCT01397994|Sympatholytics|sympatholytics|mesh-ancestor
6644148|NCT01397994|Autonomic Agents|autonomic agents|mesh-ancestor
6644149|NCT01397994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6644150|NCT01397994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644151|NCT01397994|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6644152|NCT01397994|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6644153|NCT01397994|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6644154|NCT01397994|Adrenergic Agents|adrenergic agents|mesh-ancestor
6644155|NCT01397994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6644156|NCT01397994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644157|NCT01397994|Vasodilator Agents|vasodilator agents|mesh-ancestor
6644158|NCT01397994|Vitamin B Complex|vitamin b complex|mesh-ancestor
6644159|NCT01397994|Vitamins|vitamins|mesh-ancestor
6644160|NCT01397994|Micronutrients|micronutrients|mesh-ancestor
6644161|NCT01398033|Paclitaxel|paclitaxel|mesh-list
6644162|NCT01398033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6644163|NCT01398033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6644164|NCT01398033|Tubulin Modulators|tubulin modulators|mesh-ancestor
6644165|NCT01398033|Antimitotic Agents|antimitotic agents|mesh-ancestor
6644166|NCT01398033|Mitosis Modulators|mitosis modulators|mesh-ancestor
6644167|NCT01398033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644168|NCT01398046|Dasatinib|dasatinib|mesh-list
6644169|NCT01398046|Rabeprazole|rabeprazole|mesh-list
6644170|NCT01398046|Betaine|betaine|mesh-list
6644171|NCT01398046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6644172|NCT01398046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6644173|NCT01398046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6644174|NCT01398046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644175|NCT01398046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6644176|NCT01398046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6644177|NCT01398046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6644178|NCT01398046|Lipotropic Agents|lipotropic agents|mesh-ancestor
6644179|NCT01398046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6644180|NCT01398046|Antimetabolites|antimetabolites|mesh-ancestor
6644181|NCT01398046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6644182|NCT01398072|Azithromycin|azithromycin|mesh-list
6644183|NCT01398072|Moxifloxacin|moxifloxacin|mesh-list
6644184|NCT01398072|Doxycycline|doxycycline|mesh-list
6644185|NCT01398072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6644186|NCT01398072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6644187|NCT01398072|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6644188|NCT01398072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6644189|NCT01398072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6644190|NCT01398072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644191|NCT01398072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6644192|NCT01398072|Antimalarials|antimalarials|mesh-ancestor
6644193|NCT01398072|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6644194|NCT01398072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6644195|NCT01398111|Glycopyrrolate|glycopyrrolate|mesh-list
6644196|NCT01398111|Formoterol Fumarate|formoterol fumarate|mesh-list
5486087|NCT02803203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5486088|NCT02803203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5486089|NCT02803203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486090|NCT02791568|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
5486091|NCT02791568|Hematinics|hematinics|mesh-ancestor
5486092|NCT02791568|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5486093|NCT02791568|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5486094|NCT02724241|Nicotine|nicotine|mesh-list
5486095|NCT02724241|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5486096|NCT02724241|Autonomic Agents|autonomic agents|mesh-ancestor
5486097|NCT02724241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5486098|NCT02724241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486099|NCT02724241|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5486100|NCT02724241|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5486101|NCT02724241|Cholinergic Agents|cholinergic agents|mesh-ancestor
5486102|NCT02724241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6644197|NCT01398111|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6644198|NCT01398111|Autonomic Agents|autonomic agents|mesh-ancestor
6644199|NCT01398111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6644200|NCT01398111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644201|NCT01398111|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6644202|NCT01398111|Respiratory System Agents|respiratory system agents|mesh-ancestor
6644203|NCT01398111|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5486103|NCT02724241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486104|NCT02639910|Venetoclax|venetoclax|mesh-list
5486105|NCT02639910|Idelalisib|idelalisib|mesh-list
5486106|NCT02639910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5486107|NCT02639910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5486108|NCT02639910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486109|NCT02618980|Hemostatics|hemostatics|mesh-list
5486110|NCT02618980|Coagulants|coagulants|mesh-ancestor
5486111|NCT02613598|Bortezomib|bortezomib|mesh-list
5486112|NCT02613598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5486113|NCT02595320|Capecitabine|capecitabine|mesh-list
5486114|NCT02595320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5486115|NCT02595320|Antimetabolites|antimetabolites|mesh-ancestor
6644204|NCT01398111|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6644205|NCT01398111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6644206|NCT01398111|Adrenergic Agents|adrenergic agents|mesh-ancestor
6644207|NCT01398111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6644208|NCT01398111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644209|NCT01398111|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6644210|NCT01398111|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6644211|NCT01398111|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6644212|NCT01398111|Cholinergic Agents|cholinergic agents|mesh-ancestor
6644213|NCT01398189|Clozapine|clozapine|mesh-list
6644214|NCT01398189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6644215|NCT01398189|Serotonin Agents|serotonin agents|mesh-ancestor
6644216|NCT01398189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6644217|NCT01398189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644218|NCT01398189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644219|NCT01398189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6644220|NCT01398189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6644221|NCT01398189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6644222|NCT01398189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6644223|NCT01398189|GABA Antagonists|gaba antagonists|mesh-ancestor
6644224|NCT01398189|GABA Agents|gaba agents|mesh-ancestor
6644225|NCT01398202|Vitamin D|vitamin d|mesh-list
6644226|NCT01398202|Cholecalciferol|cholecalciferol|mesh-list
6644227|NCT01398202|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
6644228|NCT01398202|Calcifediol|calcifediol|mesh-list
6644229|NCT01398202|Vitamins|vitamins|mesh-ancestor
6644230|NCT01398202|Micronutrients|micronutrients|mesh-ancestor
5486116|NCT02595320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486117|NCT02595320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5486118|NCT02594384|Rituximab|rituximab|mesh-list
5486119|NCT02594384|Atezolizumab|atezolizumab|mesh-list
5486120|NCT02594384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5486121|NCT02594384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5486122|NCT02594384|Immunologic Factors|immunologic factors|mesh-ancestor
5486123|NCT02594384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486124|NCT02594384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5486125|NCT02586623|Droxidopa|droxidopa|mesh-list
5486126|NCT02586623|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5486127|NCT02586623|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5486128|NCT02497131|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5486129|NCT02497131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6644231|NCT01398202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644232|NCT01398202|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6644233|NCT01398202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6644234|NCT01398267|Lisinopril|lisinopril|mesh-list
6644235|NCT01398267|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6644236|NCT01398267|Protease Inhibitors|protease inhibitors|mesh-ancestor
6644237|NCT01398267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6644238|NCT01398267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644239|NCT01398267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6644240|NCT01398267|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6644241|NCT01398267|Protective Agents|protective agents|mesh-ancestor
5486130|NCT02497131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5486131|NCT02492867|Paclitaxel|paclitaxel|mesh-list
6453199|NCT00419302|Insulin|insulin|mesh-list
6453200|NCT00419302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6453201|NCT00419302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453202|NCT00419367|Vorinostat|vorinostat|mesh-list
6453203|NCT00419367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6453204|NCT00419367|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6453205|NCT00419367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6453206|NCT00419367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453207|NCT00419419|Nitroglycerin|nitroglycerin|mesh-list
6644242|NCT01398267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486132|NCT02492867|Carboplatin|carboplatin|mesh-list
5486133|NCT02492867|Durvalumab|durvalumab|mesh-list
5486134|NCT02492867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5486135|NCT02492867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5486136|NCT02492867|Tubulin Modulators|tubulin modulators|mesh-ancestor
5486137|NCT02492867|Antimitotic Agents|antimitotic agents|mesh-ancestor
5486138|NCT02492867|Mitosis Modulators|mitosis modulators|mesh-ancestor
5486139|NCT02492867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486140|NCT02492867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5486141|NCT02458313|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
5486142|NCT02458313|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5486143|NCT02458313|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5486144|NCT02458313|Cholinergic Agents|cholinergic agents|mesh-ancestor
6644243|NCT01398293|Ritonavir|ritonavir|mesh-list
6644244|NCT01398293|Moxifloxacin|moxifloxacin|mesh-list
6644245|NCT01398293|Lactams|lactams|mesh-list
6644246|NCT01398293|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6644247|NCT01398293|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6644248|NCT01398293|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6644249|NCT01398293|Protease Inhibitors|protease inhibitors|mesh-ancestor
6644250|NCT01398293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6644251|NCT01398293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644252|NCT01398293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6644253|NCT01398293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6644254|NCT01398293|Antiviral Agents|antiviral agents|mesh-ancestor
6644255|NCT01398293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6644256|NCT01398293|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6644257|NCT01398293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6644258|NCT01398293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6644259|NCT01398293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6644260|NCT01398293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6644261|NCT01398293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6644262|NCT01398293|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6644263|NCT01398293|Contraceptive Agents|contraceptive agents|mesh-ancestor
6644264|NCT01398293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6644265|NCT01398293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644266|NCT01398293|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6644267|NCT01398293|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6644268|NCT01398293|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6644269|NCT01398371|Digoxin|digoxin|mesh-list
6644270|NCT01398371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6644271|NCT01398371|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6644272|NCT01398371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6644273|NCT01398371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644274|NCT01398371|Protective Agents|protective agents|mesh-ancestor
6644275|NCT01398371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644276|NCT01398384|Nitric Oxide|nitric oxide|mesh-list
6644277|NCT01398384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6644278|NCT01398384|Autonomic Agents|autonomic agents|mesh-ancestor
5486145|NCT02458313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5486146|NCT02458313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486147|NCT02458313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486148|NCT02426892|Nivolumab|nivolumab|mesh-list
5486149|NCT02426892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5486150|NCT02426892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5486151|NCT02426892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5486152|NCT02426892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644279|NCT01398384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6644280|NCT01398384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644281|NCT01398384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6644282|NCT01398384|Respiratory System Agents|respiratory system agents|mesh-ancestor
5486153|NCT02409368|Nivolumab|nivolumab|mesh-list
5486154|NCT02409368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5486155|NCT02409368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5486156|NCT02409368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5486157|NCT02409368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486158|NCT02375555|Dexamethasone|dexamethasone|mesh-list
5486159|NCT02375555|Lenalidomide|lenalidomide|mesh-list
5486160|NCT02375555|Bortezomib|bortezomib|mesh-list
5486161|NCT02375555|Elotuzumab|elotuzumab|mesh-list
5486162|NCT02375555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6644283|NCT01398384|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5486163|NCT02375555|Antiemetics|antiemetics|mesh-ancestor
6644284|NCT01398384|Antioxidants|antioxidants|mesh-ancestor
6644285|NCT01398384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644286|NCT01398384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6644287|NCT01398384|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6644288|NCT01398384|Vasodilator Agents|vasodilator agents|mesh-ancestor
6644289|NCT01398384|Gasotransmitters|gasotransmitters|mesh-ancestor
6644290|NCT01398384|Protective Agents|protective agents|mesh-ancestor
6644291|NCT01398501|Sorafenib|sorafenib|mesh-list
6644292|NCT01398501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6644293|NCT01398501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6644294|NCT01398501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6644295|NCT01398501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644296|NCT01398592|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6644297|NCT01398592|Vildagliptin|vildagliptin|mesh-list
6644298|NCT01398592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6644299|NCT01398592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644300|NCT01398592|Incretins|incretins|mesh-ancestor
6644301|NCT01398592|Hormones|hormones|mesh-ancestor
6644302|NCT01398592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6644303|NCT01398592|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6644304|NCT01398592|Protease Inhibitors|protease inhibitors|mesh-ancestor
6644305|NCT01398592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6644306|NCT01398592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644307|NCT01398618|Rifampin|rifampin|mesh-list
6644308|NCT01398618|Isoniazid|isoniazid|mesh-list
6644309|NCT01398618|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6644310|NCT01398618|Antitubercular Agents|antitubercular agents|mesh-ancestor
6644311|NCT01398618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6644312|NCT01398618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6644313|NCT01398618|Leprostatic Agents|leprostatic agents|mesh-ancestor
6644314|NCT01398618|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6644315|NCT01398618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6644316|NCT01398618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644317|NCT01398618|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6644318|NCT01398618|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6644319|NCT01398618|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6644320|NCT01398618|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6644321|NCT01398618|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6644322|NCT01398618|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6644323|NCT01398618|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6644324|NCT01398618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5486164|NCT02375555|Autonomic Agents|autonomic agents|mesh-ancestor
5486165|NCT02375555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6644325|NCT01398618|Antimetabolites|antimetabolites|mesh-ancestor
6644326|NCT01398618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6644327|NCT01398657|Androgens|androgens|mesh-list
6644328|NCT01398657|Hormones|hormones|mesh-ancestor
6644329|NCT01398657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6644330|NCT01398657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644331|NCT01398670|Insulin|insulin|mesh-list
6644332|NCT01398670|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6644333|NCT01398670|Insulin Lispro|insulin lispro|mesh-list
6644334|NCT01398670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5486166|NCT02375555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486167|NCT02375555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5486168|NCT02375555|Glucocorticoids|glucocorticoids|mesh-ancestor
5486169|NCT02375555|Hormones|hormones|mesh-ancestor
5486170|NCT02375555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5486171|NCT02375555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6663790|NCT01508949|Incretins|incretins|mesh-ancestor
5486172|NCT02375555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5486173|NCT02375555|Immunologic Factors|immunologic factors|mesh-ancestor
5486174|NCT02375555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5486175|NCT02375555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5486176|NCT02375555|Growth Substances|growth substances|mesh-ancestor
5486177|NCT02375555|Growth Inhibitors|growth inhibitors|mesh-ancestor
5486178|NCT02322593|Oxaliplatin|oxaliplatin|mesh-list
5486179|NCT02322593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5486180|NCT02220894|Paclitaxel|paclitaxel|mesh-list
5486181|NCT02220894|Carboplatin|carboplatin|mesh-list
5486182|NCT02220894|Pembrolizumab|pembrolizumab|mesh-list
5486183|NCT02220894|Pemetrexed|pemetrexed|mesh-list
5486184|NCT02220894|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5486185|NCT02220894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5486186|NCT02220894|Tubulin Modulators|tubulin modulators|mesh-ancestor
5486187|NCT02220894|Antimitotic Agents|antimitotic agents|mesh-ancestor
5486188|NCT02220894|Mitosis Modulators|mitosis modulators|mesh-ancestor
5486189|NCT02220894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486190|NCT02220894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5486191|NCT02220894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5486192|NCT02220894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5486193|NCT02220894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5486194|NCT02124824|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
5486195|NCT02124824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5486196|NCT02124824|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5486197|NCT02124824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486198|NCT01936831|Vitamin B 6|vitamin b 6|mesh-list
5486199|NCT01936831|Pyridoxal|pyridoxal|mesh-list
5486200|NCT01936831|Pyridoxine|pyridoxine|mesh-list
5486201|NCT01936831|Isoniazid|isoniazid|mesh-list
5486202|NCT01936831|Vitamins|vitamins|mesh-ancestor
5486203|NCT01936831|Micronutrients|micronutrients|mesh-ancestor
5486204|NCT01936831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486205|NCT01936831|Vitamin B Complex|vitamin b complex|mesh-ancestor
5486206|NCT01936831|Antitubercular Agents|antitubercular agents|mesh-ancestor
5486207|NCT01936831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6644335|NCT01398670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644336|NCT01398722|Insulin|insulin|mesh-list
6644337|NCT01398722|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6644338|NCT01398722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6644339|NCT01398722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644340|NCT01398995|Insulin|insulin|mesh-list
6644341|NCT01398995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6644342|NCT01398995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644343|NCT01399086|Fulvestrant|fulvestrant|mesh-list
6644344|NCT01399086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6644345|NCT01399086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6644346|NCT01399086|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6453208|NCT00419419|Vasodilator Agents|vasodilator agents|mesh-ancestor
6453209|NCT00419471|Citalopram|citalopram|mesh-list
6644347|NCT01399086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6644348|NCT01399086|Hormone Antagonists|hormone antagonists|mesh-ancestor
6644349|NCT01399086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6644350|NCT01399086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644351|NCT01399151|Vitamin D|vitamin d|mesh-list
6644352|NCT01399151|Ergocalciferols|ergocalciferols|mesh-list
6644353|NCT01399151|Vitamins|vitamins|mesh-list
6644354|NCT01399151|Micronutrients|micronutrients|mesh-ancestor
6644355|NCT01399151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644356|NCT01399151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6644357|NCT01399151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6644358|NCT01399216|Fucoidan|fucoidan|mesh-list
6644359|NCT01399216|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5486208|NCT01936831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5486209|NCT01936831|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6453210|NCT00419471|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6453211|NCT00419471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6453212|NCT00419471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6453213|NCT00419471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453214|NCT00419471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6453215|NCT00419471|Serotonin Agents|serotonin agents|mesh-ancestor
6453216|NCT00419471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453217|NCT00419471|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6461903|NCT00456794|Purinergic Agents|purinergic agents|mesh-ancestor
5486210|NCT01936831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6644360|NCT01399216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5486211|NCT01936831|Antimetabolites|antimetabolites|mesh-ancestor
5486212|NCT01936831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486213|NCT01936831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5486214|NCT01772004|Avelumab|avelumab|mesh-list
5486215|NCT01772004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5486216|NCT01772004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5486217|NCT01750567|Metformin|metformin|mesh-list
5486218|NCT01750567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5486219|NCT01750567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021659|NCT00401752|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
6021660|NCT00401752|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6021661|NCT00401752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6021662|NCT00401752|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6021663|NCT00401752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5486225|NCT01721759|Nivolumab|nivolumab|mesh-list
5486226|NCT01721759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5486227|NCT01721759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5486228|NCT01721759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6644361|NCT01399216|Anticoagulants|anticoagulants|mesh-ancestor
6644362|NCT01399216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6644363|NCT01399242|Everolimus|everolimus|mesh-list
6644364|NCT01399242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6644365|NCT01399242|Immunologic Factors|immunologic factors|mesh-ancestor
6644366|NCT01399242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644367|NCT01399242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6644368|NCT01399255|Insulin Lispro|insulin lispro|mesh-list
6644369|NCT01399255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6644370|NCT01399255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644371|NCT01399346|Insulin|insulin|mesh-list
6644372|NCT01399346|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6644373|NCT01399346|Insulin Aspart|insulin aspart|mesh-list
6644374|NCT01399346|Insulin, Long-Acting|insulin, long-acting|mesh-list
6644375|NCT01399346|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6644376|NCT01399346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6644377|NCT01399346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644378|NCT01399450|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6644379|NCT01399450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6644380|NCT01399450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6644381|NCT01399450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6644382|NCT01399450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644383|NCT01399450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6644384|NCT01399450|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6644385|NCT01399450|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5486229|NCT01721759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486230|NCT01633541|Carboplatin|carboplatin|mesh-list
6644386|NCT01399450|Serotonin Agents|serotonin agents|mesh-ancestor
6644387|NCT01399450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5486231|NCT01633541|Docetaxel|docetaxel|mesh-list
6644388|NCT01399450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644389|NCT01399450|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6644390|NCT01399450|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6644391|NCT01399450|Dopamine Agents|dopamine agents|mesh-ancestor
6644392|NCT01399463|Paclitaxel|paclitaxel|mesh-list
6644393|NCT01399463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6644394|NCT01399463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6644395|NCT01399463|Tubulin Modulators|tubulin modulators|mesh-ancestor
6644396|NCT01399463|Antimitotic Agents|antimitotic agents|mesh-ancestor
6644397|NCT01399463|Mitosis Modulators|mitosis modulators|mesh-ancestor
6644398|NCT01399463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644399|NCT01399515|Valproic Acid|valproic acid|mesh-list
6644400|NCT01399515|Anticonvulsants|anticonvulsants|mesh-ancestor
6644401|NCT01399515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6644402|NCT01399515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644403|NCT01399515|GABA Agents|gaba agents|mesh-ancestor
6644404|NCT01399515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6644405|NCT01399515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644406|NCT01399515|Antimanic Agents|antimanic agents|mesh-ancestor
6644407|NCT01399515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6644408|NCT01399515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6644409|NCT01399515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6663791|NCT01508949|Hormones|hormones|mesh-ancestor
6663792|NCT01508949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6663793|NCT01509001|Metformin|metformin|mesh-list
6663794|NCT01509001|Glimepiride|glimepiride|mesh-list
6663795|NCT01509001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6663796|NCT01509001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663797|NCT01509001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6663798|NCT01509001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6663799|NCT01509001|Immunologic Factors|immunologic factors|mesh-ancestor
6663800|NCT01509131|Bisacodyl|bisacodyl|mesh-list
6663801|NCT01509131|Cathartics|cathartics|mesh-ancestor
6663802|NCT01509131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6663803|NCT01509131|Laxatives|laxatives|mesh-ancestor
6663804|NCT01509144|Vaccines|vaccines|mesh-list
6663805|NCT01509144|Immunologic Factors|immunologic factors|mesh-ancestor
6663806|NCT01509144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663807|NCT01509209|Pseudoephedrine|pseudoephedrine|mesh-list
6663808|NCT01509209|Ephedrine|ephedrine|mesh-list
6663809|NCT01509209|Levocetirizine|levocetirizine|mesh-list
6663810|NCT01509209|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6663811|NCT01509209|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6663812|NCT01509209|Histamine Antagonists|histamine antagonists|mesh-ancestor
6663813|NCT01509209|Histamine Agents|histamine agents|mesh-ancestor
6663814|NCT01509209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6663815|NCT01509209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453218|NCT00419471|Antidepressive Agents|antidepressive agents|mesh-ancestor
6453219|NCT00419471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6453220|NCT00419484|Pioglitazone|pioglitazone|mesh-list
5486232|NCT01633541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5486233|NCT01633541|Tubulin Modulators|tubulin modulators|mesh-ancestor
5486234|NCT01633541|Antimitotic Agents|antimitotic agents|mesh-ancestor
5486235|NCT01633541|Mitosis Modulators|mitosis modulators|mesh-ancestor
5486236|NCT01633541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486237|NCT01539447|Naproxen|naproxen|mesh-list
5486238|NCT01539447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5486239|NCT01539447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5486240|NCT01539447|Analgesics|analgesics|mesh-ancestor
5486241|NCT01539447|Sensory System Agents|sensory system agents|mesh-ancestor
5486242|NCT01539447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5486243|NCT01539447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486244|NCT01539447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6453221|NCT00419484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6453222|NCT00419484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453223|NCT00419536|Panobinostat|panobinostat|mesh-list
6453224|NCT00419536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6453225|NCT00419536|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6453226|NCT00419536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6453227|NCT00419536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453228|NCT00419549|Valdecoxib|valdecoxib|mesh-list
6453229|NCT00419549|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6453230|NCT00419549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6453231|NCT00419549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6461904|NCT00456794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6663816|NCT01509209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663817|NCT01509209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6644410|NCT01399645|Insulin|insulin|mesh-list
6644411|NCT01399645|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6644412|NCT01399645|Metformin|metformin|mesh-list
6644413|NCT01399645|Insulin Glargine|insulin glargine|mesh-list
6644414|NCT01399645|Liraglutide|liraglutide|mesh-list
6644415|NCT01399645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6644416|NCT01399645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644417|NCT01399645|Incretins|incretins|mesh-ancestor
6644418|NCT01399645|Hormones|hormones|mesh-ancestor
6644419|NCT01399645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6644420|NCT01399840|Talazoparib|talazoparib|mesh-list
6644421|NCT01399840|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6644422|NCT01399840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6644423|NCT01399840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644424|NCT01399840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6644425|NCT01399853|Vaccines|vaccines|mesh-list
6644426|NCT01399853|Immunologic Factors|immunologic factors|mesh-ancestor
6644427|NCT01399853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644428|NCT01400009|Vitamin D|vitamin d|mesh-list
6644429|NCT01400009|Cholecalciferol|cholecalciferol|mesh-list
6644430|NCT01400009|Vitamins|vitamins|mesh-ancestor
6644431|NCT01400009|Micronutrients|micronutrients|mesh-ancestor
6644432|NCT01400009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644433|NCT01400009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6644434|NCT01400009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6644435|NCT01400022|Cortisone|cortisone|mesh-list
6644436|NCT01400022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6644437|NCT01400074|Imatinib Mesylate|imatinib mesylate|mesh-list
6644438|NCT01400074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6644439|NCT01400074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6644440|NCT01400074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6644441|NCT01400074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644442|NCT01400100|Octreotide|octreotide|mesh-list
6644443|NCT01400100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6644444|NCT01400100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6644445|NCT01400100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6644446|NCT01400100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6644447|NCT01400165|Pindolol|pindolol|mesh-list
6644448|NCT01400165|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6644449|NCT01400165|Trazodone|trazodone|mesh-list
6644450|NCT01400165|Antidepressive Agents|antidepressive agents|mesh-ancestor
6644451|NCT01400165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6644452|NCT01400165|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6644453|NCT01400165|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6644454|NCT01400165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6644455|NCT01400165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644456|NCT01400165|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6644457|NCT01400165|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6644458|NCT01400165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6644459|NCT01400165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6644460|NCT01400165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486245|NCT01539447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5486246|NCT01539447|Gout Suppressants|gout suppressants|mesh-ancestor
5486247|NCT01539447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5486248|NCT01539447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5486249|NCT01539447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486250|NCT01322971|Metronidazole|metronidazole|mesh-list
5486251|NCT01322971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5486252|NCT01322971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5486253|NCT01322971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5486254|NCT01322971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5486255|NCT01285102|Irinotecan|irinotecan|mesh-list
5486256|NCT01285102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5486257|NCT01285102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5486258|NCT01285102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5486259|NCT01285102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486260|NCT01285102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5486261|NCT01026220|Prednisone|prednisone|mesh-list
5486262|NCT01026220|Cyclophosphamide|cyclophosphamide|mesh-list
5486263|NCT01026220|Ifosfamide|ifosfamide|mesh-list
5486264|NCT01026220|Doxorubicin|doxorubicin|mesh-list
5486265|NCT01026220|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5486266|NCT01026220|Etoposide|etoposide|mesh-list
5486267|NCT01026220|Vincristine|vincristine|mesh-list
5486268|NCT01026220|Vinorelbine|vinorelbine|mesh-list
5486269|NCT01026220|Bleomycin|bleomycin|mesh-list
6644461|NCT01400165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6644462|NCT01400165|Serotonin Agents|serotonin agents|mesh-ancestor
6644463|NCT01400165|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6644464|NCT01400165|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6644465|NCT01400165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6644466|NCT01400165|Adrenergic Agents|adrenergic agents|mesh-ancestor
6644467|NCT01400165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6644468|NCT01400165|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6644469|NCT01400165|Vasodilator Agents|vasodilator agents|mesh-ancestor
6644470|NCT01400191|Metformin|metformin|mesh-list
6644471|NCT01400191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6644472|NCT01400191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644473|NCT01400217|Beclomethasone|beclomethasone|mesh-list
6644474|NCT01400217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6644475|NCT01400217|Glucocorticoids|glucocorticoids|mesh-ancestor
6644476|NCT01400217|Hormones|hormones|mesh-ancestor
6644477|NCT01400217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6644478|NCT01400217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644479|NCT01400217|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6644480|NCT01400217|Respiratory System Agents|respiratory system agents|mesh-ancestor
6644481|NCT01400256|Valsartan|valsartan|mesh-list
6644482|NCT01400256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6644483|NCT01400256|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6644484|NCT01400256|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6644485|NCT01400256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644486|NCT01400308|Mupirocin|mupirocin|mesh-list
6644487|NCT01400308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6644488|NCT01400308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6644489|NCT01400308|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6644490|NCT01400308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6644491|NCT01400308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486270|NCT01026220|Etoposide phosphate|etoposide phosphate|mesh-list
5486271|NCT01026220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5486272|NCT01026220|Immunologic Factors|immunologic factors|mesh-ancestor
5486273|NCT01026220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486274|NCT01026220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5486275|NCT01026220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5486276|NCT01026220|Alkylating Agents|alkylating agents|mesh-ancestor
5486277|NCT01026220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486278|NCT01026220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5486279|NCT01026220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5486280|NCT01026220|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5486281|NCT01026220|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5486282|NCT01026220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6644492|NCT01400360|Vasodilator Agents|vasodilator agents|mesh-list
6644493|NCT01400464|Prednisone|prednisone|mesh-list
6644494|NCT01400464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6644495|NCT01400464|Glucocorticoids|glucocorticoids|mesh-ancestor
6644496|NCT01400464|Hormones|hormones|mesh-ancestor
6644497|NCT01400464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6644498|NCT01400464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644499|NCT01400464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6644500|NCT01400464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6644501|NCT01400568|Fluticasone|fluticasone|mesh-list
6644502|NCT01400568|Xhance|xhance|mesh-list
6644503|NCT01400568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6644504|NCT01400568|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6644505|NCT01400568|Autonomic Agents|autonomic agents|mesh-ancestor
6644506|NCT01400568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6644507|NCT01400568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644508|NCT01400568|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5486283|NCT01026220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5486284|NCT01026220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6644509|NCT01400568|Respiratory System Agents|respiratory system agents|mesh-ancestor
6644510|NCT01400568|Dermatologic Agents|dermatologic agents|mesh-ancestor
6644511|NCT01400568|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6644512|NCT01400633|Decitabine|decitabine|mesh-list
6644513|NCT01400633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5486285|NCT01026220|Glucocorticoids|glucocorticoids|mesh-ancestor
5486286|NCT01026220|Hormones|hormones|mesh-ancestor
5486287|NCT01026220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5486288|NCT01026220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5486289|NCT01026220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5486290|NCT01026220|Tubulin Modulators|tubulin modulators|mesh-ancestor
5486291|NCT01026220|Antimitotic Agents|antimitotic agents|mesh-ancestor
5486292|NCT01026220|Mitosis Modulators|mitosis modulators|mesh-ancestor
6644514|NCT01400633|Antimetabolites|antimetabolites|mesh-ancestor
6644515|NCT01400633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644516|NCT01400633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6644517|NCT01400633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6644518|NCT01400646|Vitamins|vitamins|mesh-list
6644519|NCT01400646|Vitamin K|vitamin k|mesh-list
6644520|NCT01400646|Warfarin|warfarin|mesh-list
6644521|NCT01400646|Rivaroxaban|rivaroxaban|mesh-list
6644522|NCT01400646|Micronutrients|micronutrients|mesh-ancestor
6644523|NCT01400646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453232|NCT00419549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453233|NCT00419549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6453234|NCT00419549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6453235|NCT00419549|Analgesics|analgesics|mesh-ancestor
6453236|NCT00419549|Sensory System Agents|sensory system agents|mesh-ancestor
6453237|NCT00419549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6453238|NCT00419549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453239|NCT00419549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6453240|NCT00419549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6453241|NCT00419601|Fentanyl|fentanyl|mesh-list
6453242|NCT00419601|Remifentanil|remifentanil|mesh-list
6453243|NCT00419601|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6453244|NCT00419601|Narcotics|narcotics|mesh-ancestor
6453245|NCT00419601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6453246|NCT00419601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453247|NCT00419601|Analgesics|analgesics|mesh-ancestor
6453248|NCT00419601|Sensory System Agents|sensory system agents|mesh-ancestor
6453249|NCT00419601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6453250|NCT00419601|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6453251|NCT00419601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6644524|NCT01400646|Anticoagulants|anticoagulants|mesh-ancestor
6644525|NCT01400646|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6644526|NCT01400646|Antithrombins|antithrombins|mesh-ancestor
6644527|NCT01400646|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6644528|NCT01400646|Protease Inhibitors|protease inhibitors|mesh-ancestor
6644529|NCT01400646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6644530|NCT01400646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644531|NCT01400646|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6644532|NCT01400646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6644533|NCT01400646|Hemostatics|hemostatics|mesh-ancestor
6644534|NCT01400646|Coagulants|coagulants|mesh-ancestor
6644535|NCT01400672|Imiquimod|imiquimod|mesh-list
6644536|NCT01400672|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6644537|NCT01400672|Immunologic Factors|immunologic factors|mesh-ancestor
6644538|NCT01400672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644539|NCT01400672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6644540|NCT01400672|Interferon Inducers|interferon inducers|mesh-ancestor
6644541|NCT01400685|Rituximab|rituximab|mesh-list
6644542|NCT01400685|Lenalidomide|lenalidomide|mesh-list
6644543|NCT01400685|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6644544|NCT01400685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6644545|NCT01400685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6644546|NCT01400685|Immunologic Factors|immunologic factors|mesh-ancestor
6644547|NCT01400685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644548|NCT01400685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6644549|NCT01400685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6644550|NCT01400685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6644551|NCT01400685|Growth Substances|growth substances|mesh-ancestor
6644552|NCT01400685|Growth Inhibitors|growth inhibitors|mesh-ancestor
6644553|NCT01400685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6644554|NCT01400685|Alkylating Agents|alkylating agents|mesh-ancestor
6644555|NCT01400685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644556|NCT01400737|Ibuprofen|ibuprofen|mesh-list
6644557|NCT01400737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6644558|NCT01400737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6644559|NCT01400737|Analgesics|analgesics|mesh-ancestor
6644560|NCT01400737|Sensory System Agents|sensory system agents|mesh-ancestor
6644561|NCT01400737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6644562|NCT01400737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644563|NCT01400737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6644564|NCT01400737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6644565|NCT01400737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6644566|NCT01400737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6644567|NCT01400737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644568|NCT01400750|Ciprofloxacin|ciprofloxacin|mesh-list
6644569|NCT01400750|Tobramycin|tobramycin|mesh-list
6644570|NCT01400750|Colistin|colistin|mesh-list
6644571|NCT01400750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6644572|NCT01400750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6644573|NCT01400750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6644574|NCT01400750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6644575|NCT01400750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6644576|NCT01400750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644577|NCT01400750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6644578|NCT01400750|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6644579|NCT01400750|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6644580|NCT01400789|Insulin Lispro|insulin lispro|mesh-list
6644581|NCT01400789|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
6644582|NCT01400789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6644583|NCT01400789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644584|NCT01400802|Insulin Lispro|insulin lispro|mesh-list
6644585|NCT01400802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6644586|NCT01400802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644587|NCT01400828|Desloratadine|desloratadine|mesh-list
6644588|NCT01400828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6644589|NCT01400828|Cholinergic Agents|cholinergic agents|mesh-ancestor
5486293|NCT00952692|Lapatinib|lapatinib|mesh-list
5486294|NCT00952692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5486295|NCT00952692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5486296|NCT00952692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5486297|NCT00952692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486298|NCT00424099|Methylphenidate|methylphenidate|mesh-list
5486299|NCT00424099|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5486300|NCT00424099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486301|NCT00424099|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5486302|NCT00424099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5486303|NCT00424099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5486304|NCT00424099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486305|NCT00424099|Dopamine Agents|dopamine agents|mesh-ancestor
5486306|NCT00424099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5486307|NCT00001521|Hydrocortisone|hydrocortisone|mesh-list
5486308|NCT00001521|Fludrocortisone|fludrocortisone|mesh-list
5486309|NCT00001521|Letrozole|letrozole|mesh-list
5486310|NCT00001521|Flutamide|flutamide|mesh-list
6644590|NCT01400828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6644591|NCT01400828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644592|NCT01400828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486311|NCT00001521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5486312|NCT00001521|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5486313|NCT00001521|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5486314|NCT00001521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6644593|NCT01400828|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6644594|NCT01400828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6644595|NCT01400828|Histamine Antagonists|histamine antagonists|mesh-ancestor
6644596|NCT01400828|Histamine Agents|histamine agents|mesh-ancestor
6644597|NCT01400867|Vancomycin|vancomycin|mesh-list
6644598|NCT01400867|Clindamycin|clindamycin|mesh-list
6644599|NCT01400867|Clindamycin palmitate|clindamycin palmitate|mesh-list
6644600|NCT01400867|Clindamycin phosphate|clindamycin phosphate|mesh-list
6644601|NCT01400867|Cefazolin|cefazolin|mesh-list
6644602|NCT01400867|Linezolid|linezolid|mesh-list
6644603|NCT01400867|Cephalexin|cephalexin|mesh-list
6644604|NCT01400867|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
6644605|NCT01400867|Aztreonam|aztreonam|mesh-list
6644606|NCT01400867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6644607|NCT01400867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6644608|NCT01400867|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6644609|NCT01400867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6644610|NCT01400867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644611|NCT01400945|Pantoprazole|pantoprazole|mesh-list
6644612|NCT01400945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6644613|NCT01400945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6644614|NCT01400945|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6644615|NCT01400945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6644616|NCT01400945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644617|NCT01401036|Umirolimus|umirolimus|mesh-list
6644618|NCT01401036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6644619|NCT01401036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6644620|NCT01401036|Immunologic Factors|immunologic factors|mesh-ancestor
6644621|NCT01401036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644622|NCT01401075|Viscum album peptide|viscum album peptide|mesh-list
6644623|NCT01401075|Doxifluridine|doxifluridine|mesh-list
6644624|NCT01401075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6644625|NCT01401075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6644626|NCT01401075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6644627|NCT01401075|Antiviral Agents|antiviral agents|mesh-ancestor
6644628|NCT01401075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6644629|NCT01401075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6644630|NCT01401075|Antimetabolites|antimetabolites|mesh-ancestor
6644631|NCT01401075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644632|NCT01401075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6644633|NCT01401075|Immunologic Factors|immunologic factors|mesh-ancestor
6644634|NCT01401075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644635|NCT01401075|Appetite Stimulants|appetite stimulants|mesh-ancestor
6644636|NCT01401075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6644637|NCT01401179|Clarithromycin|clarithromycin|mesh-list
6644638|NCT01401179|Cefazolin|cefazolin|mesh-list
6644639|NCT01401179|Erythromycin|erythromycin|mesh-list
6644640|NCT01401179|Erythromycin Estolate|erythromycin estolate|mesh-list
6644641|NCT01401179|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
6644642|NCT01401179|Erythromycin stearate|erythromycin stearate|mesh-list
6644643|NCT01401179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6644644|NCT01401179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6644645|NCT01401179|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6644646|NCT01401179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6644647|NCT01401179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644648|NCT01401179|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6644649|NCT01401179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6644650|NCT01401179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6644651|NCT01401192|Gemcitabine|gemcitabine|mesh-list
6644652|NCT01401192|Cisplatin|cisplatin|mesh-list
5486315|NCT00001521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486316|NCT00001521|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5486317|NCT00001521|Hormone Antagonists|hormone antagonists|mesh-ancestor
5486318|NCT00001521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5486319|NCT00001521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486320|NCT00001521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6644653|NCT01401192|Pemetrexed|pemetrexed|mesh-list
6644654|NCT01401192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6644655|NCT01401192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6644656|NCT01401192|Antimetabolites|antimetabolites|mesh-ancestor
6644657|NCT01401192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644658|NCT01401192|Antiviral Agents|antiviral agents|mesh-ancestor
6644659|NCT01401192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6644660|NCT01401192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6644661|NCT01401192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6644662|NCT01401192|Immunologic Factors|immunologic factors|mesh-ancestor
6644663|NCT01401192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644664|NCT01401192|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6644665|NCT01401192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6644666|NCT01401387|Pancreatin|pancreatin|mesh-list
6644667|NCT01401387|Pancrelipase|pancrelipase|mesh-list
6644668|NCT01401387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6644669|NCT01401491|Clozapine|clozapine|mesh-list
6644670|NCT01401491|Fluvoxamine|fluvoxamine|mesh-list
6644671|NCT01401491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6644672|NCT01401491|Serotonin Agents|serotonin agents|mesh-ancestor
6644673|NCT01401491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6644674|NCT01401491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644675|NCT01401491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644676|NCT01401491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6644677|NCT01401491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6644678|NCT01401491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6644679|NCT01401491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6644680|NCT01401491|GABA Antagonists|gaba antagonists|mesh-ancestor
6644681|NCT01401491|GABA Agents|gaba agents|mesh-ancestor
6644682|NCT01401491|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6644683|NCT01401491|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6644684|NCT01401491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6644685|NCT01401491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6644686|NCT01401491|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6644687|NCT01401491|Antidepressive Agents|antidepressive agents|mesh-ancestor
6644688|NCT01401491|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6644689|NCT01401491|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6644690|NCT01401491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6644691|NCT01401491|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6644692|NCT01401803|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6644693|NCT01401803|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6644694|NCT01401803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6644695|NCT01401803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644696|NCT01401803|Cholinergic Agents|cholinergic agents|mesh-ancestor
6644697|NCT01401803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6644698|NCT01401803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644699|NCT01401933|Rifampin|rifampin|mesh-list
6644700|NCT01401933|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6644701|NCT01401933|Antitubercular Agents|antitubercular agents|mesh-ancestor
6644702|NCT01401933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6644703|NCT01401933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6644704|NCT01401933|Leprostatic Agents|leprostatic agents|mesh-ancestor
6644705|NCT01401933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6644706|NCT01401933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6644707|NCT01401933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644708|NCT01401933|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6644709|NCT01401933|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6644710|NCT01401933|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6644711|NCT01401933|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6644712|NCT01401933|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6644713|NCT01401933|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6644714|NCT01402024|Aprepitant|aprepitant|mesh-list
6644715|NCT01402024|Antiemetics|antiemetics|mesh-ancestor
6644716|NCT01402024|Autonomic Agents|autonomic agents|mesh-ancestor
6644717|NCT01402024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6644718|NCT01402024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644719|NCT01402024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6644720|NCT01402024|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6644721|NCT01402024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5486321|NCT00001521|Androgen Antagonists|androgen antagonists|mesh-ancestor
5486322|NCT00001521|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5486323|NCT05166343|Epinephrine|epinephrine|mesh-list
5486324|NCT05166343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5486325|NCT05166343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5486326|NCT05166343|Adrenergic Agents|adrenergic agents|mesh-ancestor
5486327|NCT05166343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5502630|NCT04465539|Blood Substitutes|blood substitutes|mesh-ancestor
6644722|NCT01402024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644723|NCT01402076|Rosiglitazone|rosiglitazone|mesh-list
6644724|NCT01402076|Midazolam|midazolam|mesh-list
6644725|NCT01402076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6644726|NCT01402076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6644727|NCT01402076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6644728|NCT01402076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644729|NCT01402076|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6644730|NCT01402076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6644731|NCT01402076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6644732|NCT01402076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6644733|NCT01402076|Anesthetics, General|anesthetics, general|mesh-ancestor
6644734|NCT01402076|Anesthetics|anesthetics|mesh-ancestor
6644735|NCT01402076|GABA Modulators|gaba modulators|mesh-ancestor
6644736|NCT01402076|GABA Agents|gaba agents|mesh-ancestor
6644737|NCT01402076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6644738|NCT01402076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644739|NCT01402076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6644740|NCT01402089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6644741|NCT01402089|Sunitinib|sunitinib|mesh-list
6644742|NCT01402089|Midazolam|midazolam|mesh-list
6644743|NCT01402089|Caffeine|caffeine|mesh-list
6644744|NCT01402089|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6644745|NCT01402089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6644746|NCT01402089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6644747|NCT01402089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644748|NCT01402089|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6644749|NCT01402089|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6644750|NCT01402089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6644751|NCT01402089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6644752|NCT01402089|Anesthetics, General|anesthetics, general|mesh-ancestor
6644753|NCT01402089|Anesthetics|anesthetics|mesh-ancestor
6644754|NCT01402089|GABA Modulators|gaba modulators|mesh-ancestor
6644755|NCT01402089|GABA Agents|gaba agents|mesh-ancestor
6644756|NCT01402089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6644757|NCT01402089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644758|NCT01402089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6644759|NCT01402089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6644760|NCT01402089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6644761|NCT01402089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6644762|NCT01402089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6644763|NCT01402089|Growth Substances|growth substances|mesh-ancestor
6644764|NCT01402089|Growth Inhibitors|growth inhibitors|mesh-ancestor
6644765|NCT01402089|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6644766|NCT01402089|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6644767|NCT01402089|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6644768|NCT01402089|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6644769|NCT01402089|Purinergic Agents|purinergic agents|mesh-ancestor
6644770|NCT01402180|Nimotuzumab|nimotuzumab|mesh-list
6644771|NCT01402180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6644772|NCT01402180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6644773|NCT01402193|Anastrozole|anastrozole|mesh-list
6644774|NCT01402193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6644775|NCT01402193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6644776|NCT01402193|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6644777|NCT01402193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6644778|NCT01402193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6644779|NCT01402193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644780|NCT01402193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6644781|NCT01402193|Hormone Antagonists|hormone antagonists|mesh-ancestor
6644782|NCT01402193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6644783|NCT01402193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644784|NCT01402245|Vaccines|vaccines|mesh-list
6644785|NCT01402245|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6644786|NCT01402245|Immunologic Factors|immunologic factors|mesh-ancestor
6644787|NCT01402245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644788|NCT01402271|Paclitaxel|paclitaxel|mesh-list
6644789|NCT01402271|Carboplatin|carboplatin|mesh-list
6644790|NCT01402271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6644791|NCT01402271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6644792|NCT01402271|Tubulin Modulators|tubulin modulators|mesh-ancestor
6644793|NCT01402271|Antimitotic Agents|antimitotic agents|mesh-ancestor
6644794|NCT01402271|Mitosis Modulators|mitosis modulators|mesh-ancestor
6644795|NCT01402271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644796|NCT01402297|Acetovanillone|acetovanillone|mesh-list
6644797|NCT01402297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6644798|NCT01402297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6644799|NCT01402297|Analgesics|analgesics|mesh-ancestor
6644800|NCT01402297|Sensory System Agents|sensory system agents|mesh-ancestor
6644801|NCT01402297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6644802|NCT01402297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644803|NCT01402297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6644804|NCT01402297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6644805|NCT01402297|Antioxidants|antioxidants|mesh-ancestor
6644806|NCT01402297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644807|NCT01402297|Protective Agents|protective agents|mesh-ancestor
6644808|NCT01402297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6644809|NCT01402336|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6644810|NCT01402336|Cetrorelix|cetrorelix|mesh-list
6644811|NCT01402336|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
6644812|NCT01402336|Hormones|hormones|mesh-ancestor
6644813|NCT01402336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6644814|NCT01402336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644815|NCT01402336|Luteolytic Agents|luteolytic agents|mesh-ancestor
6644816|NCT01402336|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6644817|NCT01402336|Contraceptive Agents|contraceptive agents|mesh-ancestor
6644818|NCT01402336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6644819|NCT01402336|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6644820|NCT01402336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6644821|NCT01402336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6644822|NCT01402336|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6644823|NCT01402336|Fertility Agents|fertility agents|mesh-ancestor
6644824|NCT01402336|Hormone Antagonists|hormone antagonists|mesh-ancestor
6644825|NCT01402479|Ramipril|ramipril|mesh-list
6644826|NCT01402479|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6644827|NCT01402479|Protease Inhibitors|protease inhibitors|mesh-ancestor
6644828|NCT01402479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6663818|NCT01509209|Autonomic Agents|autonomic agents|mesh-ancestor
6644829|NCT01402479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644830|NCT01402479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6644831|NCT01402583|Ribavirin|ribavirin|mesh-list
6644832|NCT01402583|Antimetabolites|antimetabolites|mesh-ancestor
6644833|NCT01402583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644834|NCT01402583|Antiviral Agents|antiviral agents|mesh-ancestor
6644835|NCT01402583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6644836|NCT01402596|Midazolam|midazolam|mesh-list
6644837|NCT01402596|Chloral Hydrate|chloral hydrate|mesh-list
6644838|NCT01402596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6644839|NCT01402596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6644840|NCT01402596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6644841|NCT01402596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644842|NCT01402596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6644843|NCT01402596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6644844|NCT01402596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6644845|NCT01402596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6644846|NCT01402596|Anesthetics, General|anesthetics, general|mesh-ancestor
6644847|NCT01402596|Anesthetics|anesthetics|mesh-ancestor
6644848|NCT01402596|GABA Modulators|gaba modulators|mesh-ancestor
6644849|NCT01402596|GABA Agents|gaba agents|mesh-ancestor
6644850|NCT01402596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6644851|NCT01402596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644852|NCT01402622|Propofol|propofol|mesh-list
6644853|NCT01402622|Anesthetics|anesthetics|mesh-ancestor
6644854|NCT01402622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6644855|NCT01402622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644856|NCT01402622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6644857|NCT01402622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6644858|NCT01402622|Anesthetics, General|anesthetics, general|mesh-ancestor
6644859|NCT01402674|Phentermine|phentermine|mesh-list
6644860|NCT01402674|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6644861|NCT01402674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644862|NCT01402674|Appetite Depressants|appetite depressants|mesh-ancestor
6644863|NCT01402674|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6644864|NCT01402674|Sympathomimetics|sympathomimetics|mesh-ancestor
6644865|NCT01402674|Autonomic Agents|autonomic agents|mesh-ancestor
6644866|NCT01402674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6644867|NCT01402674|Adrenergic Agents|adrenergic agents|mesh-ancestor
6644868|NCT01402674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6644869|NCT01402674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644870|NCT01402843|Valsartan|valsartan|mesh-list
6644871|NCT01402843|Pitavastatin|pitavastatin|mesh-list
6644872|NCT01402843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6644873|NCT01402843|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6644874|NCT01402843|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6644875|NCT01402843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644876|NCT01402843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6644877|NCT01402843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6644878|NCT01402843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6644879|NCT01402843|Antimetabolites|antimetabolites|mesh-ancestor
6644880|NCT01402843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6644881|NCT01402843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5486328|NCT05166343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486329|NCT05166343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486330|NCT05166343|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5486331|NCT05166343|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5486332|NCT05166343|Autonomic Agents|autonomic agents|mesh-ancestor
5486333|NCT05166343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5486334|NCT05166343|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6644882|NCT01402882|Tranexamic Acid|tranexamic acid|mesh-list
6644883|NCT01402882|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6644884|NCT01402882|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6644885|NCT01402882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644886|NCT01402882|Hemostatics|hemostatics|mesh-ancestor
6644887|NCT01402882|Coagulants|coagulants|mesh-ancestor
6644888|NCT01403025|Liraglutide|liraglutide|mesh-list
6644889|NCT01403025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6644890|NCT01403025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644891|NCT01403025|Incretins|incretins|mesh-ancestor
6644892|NCT01403025|Hormones|hormones|mesh-ancestor
6644893|NCT01403025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5486335|NCT05166343|Respiratory System Agents|respiratory system agents|mesh-ancestor
5486336|NCT05166343|Mydriatics|mydriatics|mesh-ancestor
5486337|NCT05166343|Sympathomimetics|sympathomimetics|mesh-ancestor
5486338|NCT05166343|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6021664|NCT00401752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021665|NCT00401752|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6021666|NCT00401752|Histamine Antagonists|histamine antagonists|mesh-ancestor
6021667|NCT00401752|Histamine Agents|histamine agents|mesh-ancestor
6021668|NCT00401752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6021669|NCT00401752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021670|NCT00401778|Everolimus|everolimus|mesh-list
6021671|NCT00401778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5502631|NCT04465123|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5502632|NCT04465123|Spironolactone|spironolactone|mesh-list
5502633|NCT04465123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5502634|NCT04465123|Diuretics|diuretics|mesh-ancestor
5502635|NCT04465123|Natriuretic Agents|natriuretic agents|mesh-ancestor
5502636|NCT04465123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502637|NCT04465123|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5502638|NCT04465123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5502639|NCT04465123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502640|NCT04465123|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6644894|NCT01403103|Vitamin D|vitamin d|mesh-list
6644895|NCT01403103|Cholecalciferol|cholecalciferol|mesh-list
6644896|NCT01403103|Vitamins|vitamins|mesh-ancestor
6644897|NCT01403103|Micronutrients|micronutrients|mesh-ancestor
6644898|NCT01403103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644899|NCT01403103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6644900|NCT01403103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6644901|NCT01403168|Analgesics|analgesics|mesh-list
6644902|NCT01403168|Sensory System Agents|sensory system agents|mesh-ancestor
6644903|NCT01403168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6644904|NCT01403168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644905|NCT01403181|Ribavirin|ribavirin|mesh-list
6644906|NCT01403181|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6644907|NCT01403181|Antimetabolites|antimetabolites|mesh-ancestor
6644908|NCT01403181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644909|NCT01403181|Antiviral Agents|antiviral agents|mesh-ancestor
6644910|NCT01403181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6644911|NCT01403259|Oxaliplatin|oxaliplatin|mesh-list
6644912|NCT01403259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6644913|NCT01403285|Cyclophosphamide|cyclophosphamide|mesh-list
6644914|NCT01403285|Molgramostim|molgramostim|mesh-list
6644915|NCT01403285|Imiquimod|imiquimod|mesh-list
6644916|NCT01403285|Sargramostim|sargramostim|mesh-list
6644917|NCT01403285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6644918|NCT01403285|Immunologic Factors|immunologic factors|mesh-ancestor
6644919|NCT01403285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644920|NCT01403285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6644921|NCT01403285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6644922|NCT01403285|Alkylating Agents|alkylating agents|mesh-ancestor
6644923|NCT01403285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644924|NCT01403285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6665066|NCT01515774|Pramipexole|pramipexole|mesh-list
6644925|NCT01403285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6644926|NCT01403285|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6644927|NCT01403285|Interferon Inducers|interferon inducers|mesh-ancestor
6663819|NCT01509209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6663820|NCT01509209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6663821|NCT01509209|Respiratory System Agents|respiratory system agents|mesh-ancestor
6663822|NCT01509209|Nasal Decongestants|nasal decongestants|mesh-ancestor
6663823|NCT01509209|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5486347|NCT05166096|Aspirin|aspirin|mesh-list
5486348|NCT05166096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5486349|NCT05166096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5486350|NCT05166096|Analgesics|analgesics|mesh-ancestor
5486351|NCT05166096|Sensory System Agents|sensory system agents|mesh-ancestor
6663824|NCT01509209|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6663825|NCT01509209|Sympathomimetics|sympathomimetics|mesh-ancestor
6663826|NCT01509209|Adrenergic Agents|adrenergic agents|mesh-ancestor
6663827|NCT01509261|Lansoprazole|lansoprazole|mesh-list
6663828|NCT01509261|Dexlansoprazole|dexlansoprazole|mesh-list
6663829|NCT01509261|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6453252|NCT00419601|Anesthetics, General|anesthetics, general|mesh-ancestor
6453253|NCT00419601|Anesthetics|anesthetics|mesh-ancestor
6453254|NCT00419653|Haloperidol|haloperidol|mesh-list
6453255|NCT00419653|Olanzapine|olanzapine|mesh-list
6453256|NCT00419653|Haloperidol decanoate|haloperidol decanoate|mesh-list
6453257|NCT00419653|Amisulpride|amisulpride|mesh-list
6453258|NCT00419653|Antiemetics|antiemetics|mesh-ancestor
6453259|NCT00419653|Autonomic Agents|autonomic agents|mesh-ancestor
6453260|NCT00419653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6453261|NCT00419653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663830|NCT01509261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6663831|NCT01509261|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6663832|NCT01509261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6663833|NCT01509261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663834|NCT01509300|Mycophenolic Acid|mycophenolic acid|mesh-list
5486352|NCT05166096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5486353|NCT05166096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486354|NCT05166096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5486355|NCT05166096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5486356|NCT05166096|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5486357|NCT05166096|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5486358|NCT05166096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486359|NCT05166096|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5486360|NCT05166096|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5486361|NCT05166096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5486362|NCT05166096|Antipyretics|antipyretics|mesh-ancestor
5486363|NCT05166083|Testosterone|testosterone|mesh-list
5486364|NCT05166083|Androgens|androgens|mesh-ancestor
5486365|NCT05166083|Hormones|hormones|mesh-ancestor
6663835|NCT01509300|Cyclophosphamide|cyclophosphamide|mesh-list
6663836|NCT01509300|Rituximab|rituximab|mesh-list
6663837|NCT01509300|Fludarabine|fludarabine|mesh-list
6663838|NCT01509300|Tacrolimus|tacrolimus|mesh-list
5486366|NCT05166083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5486367|NCT05166083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486368|NCT05166005|Vitamin D|vitamin d|mesh-list
5486369|NCT05166005|Vitamins|vitamins|mesh-ancestor
5486370|NCT05166005|Micronutrients|micronutrients|mesh-ancestor
5486371|NCT05166005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486372|NCT05166005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6663839|NCT01509300|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6663840|NCT01509300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6663841|NCT01509300|Immunologic Factors|immunologic factors|mesh-ancestor
6663842|NCT01509300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663843|NCT01509300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6663844|NCT01509300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6663845|NCT01509300|Alkylating Agents|alkylating agents|mesh-ancestor
6663846|NCT01509300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663847|NCT01509300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6663848|NCT01509300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6663849|NCT01509300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6663850|NCT01509300|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6663851|NCT01509300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6663852|NCT01509300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5486373|NCT05165966|Vaccines|vaccines|mesh-list
6453262|NCT00419653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6663853|NCT01509300|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6453263|NCT00419653|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6644928|NCT01403363|Fentanyl|fentanyl|mesh-list
6644929|NCT01403363|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6644930|NCT01403363|Narcotics|narcotics|mesh-ancestor
5486374|NCT05165966|Immunologic Factors|immunologic factors|mesh-ancestor
5486375|NCT05165966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486376|NCT05165914|Midazolam|midazolam|mesh-list
5486377|NCT05165914|Anesthetics|anesthetics|mesh-list
5486378|NCT05165914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5486379|NCT05165914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486380|NCT05165914|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5486381|NCT05165914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5486382|NCT05165914|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5486383|NCT05165914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5486384|NCT05165914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5486385|NCT05165914|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5486386|NCT05165914|Anesthetics, General|anesthetics, general|mesh-ancestor
5486387|NCT05165914|GABA Modulators|gaba modulators|mesh-ancestor
5486388|NCT05165914|GABA Agents|gaba agents|mesh-ancestor
6644931|NCT01403363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6644932|NCT01403363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644933|NCT01403363|Analgesics|analgesics|mesh-ancestor
6644934|NCT01403363|Sensory System Agents|sensory system agents|mesh-ancestor
6644935|NCT01403363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6644936|NCT01403363|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6644937|NCT01403363|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6644938|NCT01403363|Anesthetics, General|anesthetics, general|mesh-ancestor
6644939|NCT01403363|Anesthetics|anesthetics|mesh-ancestor
6644940|NCT01403389|Eculizumab|eculizumab|mesh-list
6644941|NCT01403389|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6644942|NCT01403389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6644943|NCT01403389|Immunologic Factors|immunologic factors|mesh-ancestor
6644944|NCT01403389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644945|NCT01403415|Sirolimus|sirolimus|mesh-list
6644946|NCT01403415|Dexamethasone|dexamethasone|mesh-list
6644947|NCT01403415|Dexamethasone acetate|dexamethasone acetate|mesh-list
6644948|NCT01403415|Methotrexate|methotrexate|mesh-list
6644949|NCT01403415|Vincristine|vincristine|mesh-list
6644950|NCT01403415|Asparaginase|asparaginase|mesh-list
6644951|NCT01403415|Mitoxantrone|mitoxantrone|mesh-list
6644952|NCT01403415|Pegaspargase|pegaspargase|mesh-list
6644953|NCT01403415|BB 1101|bb 1101|mesh-list
6644954|NCT01403415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6644955|NCT01403415|Antiemetics|antiemetics|mesh-ancestor
6644956|NCT01403415|Autonomic Agents|autonomic agents|mesh-ancestor
6644957|NCT01403415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6644958|NCT01403415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6644959|NCT01403415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6644960|NCT01403415|Glucocorticoids|glucocorticoids|mesh-ancestor
6644961|NCT01403415|Hormones|hormones|mesh-ancestor
6644962|NCT01403415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6644963|NCT01403415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6644964|NCT01403415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6644965|NCT01403415|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6644966|NCT01403415|Abortifacient Agents|abortifacient agents|mesh-ancestor
6644967|NCT01403415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6644968|NCT01403415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6644969|NCT01403415|Antimetabolites|antimetabolites|mesh-ancestor
6644970|NCT01403415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6644971|NCT01403415|Dermatologic Agents|dermatologic agents|mesh-ancestor
6644972|NCT01403415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6644973|NCT01403415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6644974|NCT01403415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6644975|NCT01403415|Immunologic Factors|immunologic factors|mesh-ancestor
6644976|NCT01403415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6644977|NCT01403415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6644978|NCT01403415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6644979|NCT01403415|Tubulin Modulators|tubulin modulators|mesh-ancestor
6644980|NCT01403415|Antimitotic Agents|antimitotic agents|mesh-ancestor
5502641|NCT04465123|Hormone Antagonists|hormone antagonists|mesh-ancestor
6644981|NCT01403415|Mitosis Modulators|mitosis modulators|mesh-ancestor
6644982|NCT01403415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6644983|NCT01403415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6644984|NCT01403415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6644985|NCT01403415|Antifungal Agents|antifungal agents|mesh-ancestor
6644986|NCT01403415|Protease Inhibitors|protease inhibitors|mesh-ancestor
6644987|NCT01403415|Analgesics|analgesics|mesh-ancestor
6644988|NCT01403415|Sensory System Agents|sensory system agents|mesh-ancestor
5486389|NCT05165914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5486390|NCT05165914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486391|NCT05165771|Tofacitinib|tofacitinib|mesh-list
5486392|NCT05165771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5486393|NCT05165771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5486394|NCT05165771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486395|NCT05165732|Vaccines|vaccines|mesh-list
5486396|NCT05165732|Immunologic Factors|immunologic factors|mesh-ancestor
5486397|NCT05165732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486398|NCT05165641|Anesthetics|anesthetics|mesh-list
5486399|NCT05165641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5486400|NCT05165641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486401|NCT05165615|Insulin|insulin|mesh-list
5486402|NCT05165615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5486403|NCT05165615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486404|NCT05165433|Pembrolizumab|pembrolizumab|mesh-list
6644989|NCT01403415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6644990|NCT01403415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6644991|NCT01403506|Acetylcysteine|acetylcysteine|mesh-list
6644992|NCT01403506|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6644993|NCT01403506|Antiviral Agents|antiviral agents|mesh-ancestor
6644994|NCT01403506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6644995|NCT01403506|Expectorants|expectorants|mesh-ancestor
6644996|NCT01403506|Respiratory System Agents|respiratory system agents|mesh-ancestor
6644997|NCT01403506|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6644998|NCT01403506|Antioxidants|antioxidants|mesh-ancestor
6644999|NCT01403506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645000|NCT01403506|Protective Agents|protective agents|mesh-ancestor
6645001|NCT01403506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645002|NCT01403506|Antidotes|antidotes|mesh-ancestor
5486405|NCT05165433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5486406|NCT05165433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5486407|NCT05165303|Lidocaine|lidocaine|mesh-list
5486408|NCT05165303|Propofol|propofol|mesh-list
5486409|NCT05165303|Anesthetics, Local|anesthetics, local|mesh-ancestor
5486410|NCT05165303|Anesthetics|anesthetics|mesh-ancestor
5486411|NCT05165303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5486412|NCT05165303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486413|NCT05165303|Sensory System Agents|sensory system agents|mesh-ancestor
5486414|NCT05165303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5486415|NCT05165303|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5486416|NCT05165303|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5486417|NCT05165303|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5486418|NCT05165303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5486419|NCT05165303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486420|NCT05165303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5486421|NCT05165303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5486422|NCT05165303|Anesthetics, General|anesthetics, general|mesh-ancestor
5486423|NCT05165290|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5486424|NCT05165290|Latanoprost|latanoprost|mesh-list
5486425|NCT05165290|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5486426|NCT05165277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5486427|NCT05165212|Amoxicillin|amoxicillin|mesh-list
5486428|NCT05165212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5486429|NCT05165212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5486430|NCT05165082|Timolol|timolol|mesh-list
5486431|NCT05165082|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5486432|NCT05165082|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5486433|NCT05165082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5486434|NCT05165082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5486435|NCT05165082|Adrenergic Agents|adrenergic agents|mesh-ancestor
5486436|NCT05165082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5486437|NCT05165082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486438|NCT05165082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645003|NCT01403545|Curcumin|curcumin|mesh-list
6645004|NCT01403545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6645005|NCT01403545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6645006|NCT01403545|Analgesics|analgesics|mesh-ancestor
6645007|NCT01403545|Sensory System Agents|sensory system agents|mesh-ancestor
6645008|NCT01403545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6645009|NCT01403545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645010|NCT01403545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6645011|NCT01403545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6645012|NCT01403545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6645013|NCT01403545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6645014|NCT01403545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645015|NCT01403649|Vaccines|vaccines|mesh-list
6645016|NCT01403649|Immunologic Factors|immunologic factors|mesh-ancestor
6645017|NCT01403649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645018|NCT01403662|Minocycline|minocycline|mesh-list
6645019|NCT01403662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6645020|NCT01403662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6645021|NCT01403740|Cyclosporine|cyclosporine|mesh-list
6645022|NCT01403740|Rituximab|rituximab|mesh-list
6645023|NCT01403740|Azathioprine|azathioprine|mesh-list
6645024|NCT01403740|Cyclosporins|cyclosporins|mesh-list
6645025|NCT01403740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6645026|NCT01403740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6645027|NCT01403740|Immunologic Factors|immunologic factors|mesh-ancestor
6645028|NCT01403740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645029|NCT01403740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6645030|NCT01403740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6645031|NCT01403740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645032|NCT01403740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6645033|NCT01403740|Antifungal Agents|antifungal agents|mesh-ancestor
6645034|NCT01403740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6645035|NCT01403740|Dermatologic Agents|dermatologic agents|mesh-ancestor
6645036|NCT01403740|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6645037|NCT01403740|Antimetabolites|antimetabolites|mesh-ancestor
6645038|NCT01403740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6645039|NCT01403818|Ipragliflozin|ipragliflozin|mesh-list
6645040|NCT01403818|Mitiglinide|mitiglinide|mesh-list
6645041|NCT01403818|Calcium|calcium|mesh-list
6645042|NCT01403818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6645043|NCT01403818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645044|NCT01403818|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6645045|NCT01403818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453264|NCT00419653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6453265|NCT00419653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6453266|NCT00419653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6453267|NCT00419653|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6453268|NCT00419653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6453269|NCT00419653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6453270|NCT00419653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645046|NCT01403818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6645047|NCT01403844|Carotenoids|carotenoids|mesh-list
6645048|NCT01403844|Antioxidants|antioxidants|mesh-ancestor
6645049|NCT01403844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645050|NCT01403844|Protective Agents|protective agents|mesh-ancestor
6645051|NCT01403844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645052|NCT01403896|Plerixafor|plerixafor|mesh-list
6645053|NCT01403896|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6645054|NCT01403896|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6645055|NCT01403896|Antiviral Agents|antiviral agents|mesh-ancestor
6645056|NCT01403896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6645057|NCT01403948|BI 836826|bi 836826|mesh-list
6645058|NCT01403948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6645059|NCT01403948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6645060|NCT01404000|Charcoal|charcoal|mesh-list
6645061|NCT01404000|Antidotes|antidotes|mesh-ancestor
6645062|NCT01404000|Protective Agents|protective agents|mesh-ancestor
6645063|NCT01404000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021672|NCT00401778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6021673|NCT00401778|Immunologic Factors|immunologic factors|mesh-ancestor
6021674|NCT00401778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021675|NCT00401817|Bevacizumab|bevacizumab|mesh-list
6453271|NCT00419653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6453272|NCT00419653|Serotonin Agents|serotonin agents|mesh-ancestor
6453273|NCT00419653|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6453274|NCT00419653|Dopamine Agents|dopamine agents|mesh-ancestor
6453275|NCT00419653|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6645064|NCT01404013|Montelukast|montelukast|mesh-list
6645065|NCT01404013|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
5486439|NCT05165082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5486440|NCT05165082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5486441|NCT05164978|Antibodies|antibodies|mesh-list
5486442|NCT05164978|Immunologic Factors|immunologic factors|mesh-ancestor
5486443|NCT05164978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486444|NCT05164952|Zoledronic Acid|zoledronic acid|mesh-list
6453276|NCT00419653|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6645066|NCT01404013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6645067|NCT01404013|Respiratory System Agents|respiratory system agents|mesh-ancestor
6645068|NCT01404013|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6645069|NCT01404013|Hormone Antagonists|hormone antagonists|mesh-ancestor
6645070|NCT01404013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6645071|NCT01404013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645072|NCT01404013|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6645073|NCT01404013|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6645074|NCT01404013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645075|NCT01404104|Sirolimus|sirolimus|mesh-list
6645076|NCT01404104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6645077|NCT01404104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6645078|NCT01404104|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6645079|NCT01404104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6645080|NCT01404104|Antifungal Agents|antifungal agents|mesh-ancestor
6645081|NCT01404104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6645082|NCT01404104|Immunologic Factors|immunologic factors|mesh-ancestor
6645083|NCT01404104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645084|NCT01404117|Interferons|interferons|mesh-list
6645085|NCT01404117|Interferon-beta|interferon-beta|mesh-list
6645086|NCT01404117|Glatiramer Acetate|glatiramer acetate|mesh-list
6645087|NCT01404117|(T,G)-A-L|(t,g)-a-l|mesh-list
6645088|NCT01404117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6645089|NCT01404117|Antiviral Agents|antiviral agents|mesh-ancestor
6645090|NCT01404117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6645091|NCT01404117|Immunologic Factors|immunologic factors|mesh-ancestor
6645092|NCT01404117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645093|NCT01404117|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6645094|NCT01404117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6645095|NCT01404117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6645096|NCT01404130|Isotretinoin|isotretinoin|mesh-list
6645097|NCT01404130|Dermatologic Agents|dermatologic agents|mesh-ancestor
6645098|NCT01404156|Leucovorin|leucovorin|mesh-list
6645099|NCT01404156|Paclitaxel|paclitaxel|mesh-list
6645100|NCT01404156|Docetaxel|docetaxel|mesh-list
6645101|NCT01404156|Carboplatin|carboplatin|mesh-list
6645102|NCT01404156|Fluorouracil|fluorouracil|mesh-list
6645103|NCT01404156|Oxaliplatin|oxaliplatin|mesh-list
6645104|NCT01404156|Epirubicin|epirubicin|mesh-list
6645105|NCT01404156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6645106|NCT01404156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6645107|NCT01404156|Tubulin Modulators|tubulin modulators|mesh-ancestor
6645108|NCT01404156|Antimitotic Agents|antimitotic agents|mesh-ancestor
6645109|NCT01404156|Mitosis Modulators|mitosis modulators|mesh-ancestor
6645110|NCT01404156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645111|NCT01404156|Antimetabolites|antimetabolites|mesh-ancestor
6645112|NCT01404156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6453277|NCT00419653|Antidepressive Agents|antidepressive agents|mesh-ancestor
6453278|NCT00419692|Ropinirole|ropinirole|mesh-list
6453279|NCT00419692|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6453280|NCT00419692|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6453281|NCT00419692|Dopamine Agonists|dopamine agonists|mesh-ancestor
6453282|NCT00419692|Dopamine Agents|dopamine agents|mesh-ancestor
6453283|NCT00419692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6453284|NCT00419692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453285|NCT00419692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453286|NCT00419718|Insulin|insulin|mesh-list
6453287|NCT00419718|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6453288|NCT00419718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6453289|NCT00419718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453290|NCT00419731|Naltrexone|naltrexone|mesh-list
6453291|NCT00419731|Bupropion|bupropion|mesh-list
6453292|NCT00419731|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6453293|NCT00419731|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6453294|NCT00419731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453295|NCT00419731|Sensory System Agents|sensory system agents|mesh-ancestor
6645113|NCT01404156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6645114|NCT01404156|Immunologic Factors|immunologic factors|mesh-ancestor
5486445|NCT05164952|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6453296|NCT00419731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5486446|NCT05164952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486447|NCT05164848|Afatinib|afatinib|mesh-list
5486448|NCT05164848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5486449|NCT05164848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5486450|NCT05164848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5486451|NCT05164848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486452|NCT05164770|Prednisone|prednisone|mesh-list
5486453|NCT05164770|Cyclophosphamide|cyclophosphamide|mesh-list
5486454|NCT05164770|Vincristine|vincristine|mesh-list
5486455|NCT05164770|Rituximab|rituximab|mesh-list
5486456|NCT05164770|Doxorubicin|doxorubicin|mesh-list
5486457|NCT05164770|Zanubrutinib|zanubrutinib|mesh-list
5486458|NCT05164770|Etoposide|etoposide|mesh-list
6645115|NCT01404156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645116|NCT01404156|Antidotes|antidotes|mesh-ancestor
6645117|NCT01404156|Protective Agents|protective agents|mesh-ancestor
6645118|NCT01404156|Vitamin B Complex|vitamin b complex|mesh-ancestor
6645119|NCT01404156|Vitamins|vitamins|mesh-ancestor
6645120|NCT01404156|Micronutrients|micronutrients|mesh-ancestor
5486459|NCT05164770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5486460|NCT05164770|Immunologic Factors|immunologic factors|mesh-ancestor
5486461|NCT05164770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486462|NCT05164770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5486463|NCT05164770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5486464|NCT05164770|Alkylating Agents|alkylating agents|mesh-ancestor
5486465|NCT05164770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486466|NCT05164770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6645121|NCT01404156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6645122|NCT01404156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6645123|NCT01404156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6645124|NCT01404156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6645125|NCT01404169|Donepezil|donepezil|mesh-list
6645126|NCT01404169|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6645127|NCT01404169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6645128|NCT01404169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645129|NCT01404169|Cholinergic Agents|cholinergic agents|mesh-ancestor
6645130|NCT01404169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6645131|NCT01404169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645132|NCT01404169|Nootropic Agents|nootropic agents|mesh-ancestor
6645133|NCT01404182|Vaccines|vaccines|mesh-list
6645134|NCT01404182|Immunologic Factors|immunologic factors|mesh-ancestor
6645135|NCT01404182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645136|NCT01404312|Pyridoxine|pyridoxine|mesh-list
6645137|NCT01404312|Pyridoxal|pyridoxal|mesh-list
6645138|NCT01404312|Vitamin B 6|vitamin b 6|mesh-list
6645139|NCT01404312|Isoniazid|isoniazid|mesh-list
6645140|NCT01404312|Rifapentine|rifapentine|mesh-list
6645141|NCT01404312|Vitamins|vitamins|mesh-ancestor
6645142|NCT01404312|Micronutrients|micronutrients|mesh-ancestor
6645143|NCT01404312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645144|NCT01404312|Vitamin B Complex|vitamin b complex|mesh-ancestor
6645145|NCT01404312|Antitubercular Agents|antitubercular agents|mesh-ancestor
6645146|NCT01404312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6645147|NCT01404312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6645148|NCT01404312|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6645149|NCT01404312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6645150|NCT01404312|Antimetabolites|antimetabolites|mesh-ancestor
6645151|NCT01404312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645152|NCT01404312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6645153|NCT01404312|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6645154|NCT01404312|Leprostatic Agents|leprostatic agents|mesh-ancestor
6645155|NCT01404338|Halobetasol|halobetasol|mesh-list
6645156|NCT01404338|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6645157|NCT01404364|Triamcinolone|triamcinolone|mesh-list
6645158|NCT01404364|Chlorpromazine|chlorpromazine|mesh-list
6645159|NCT01404364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6645160|NCT01404364|Glucocorticoids|glucocorticoids|mesh-ancestor
5486467|NCT05164770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5486468|NCT05164770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5486469|NCT05164770|Glucocorticoids|glucocorticoids|mesh-ancestor
5486470|NCT05164770|Hormones|hormones|mesh-ancestor
5486471|NCT05164770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5486472|NCT05164770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6645161|NCT01404364|Hormones|hormones|mesh-ancestor
6645162|NCT01404364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5486473|NCT05164770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6645163|NCT01404364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663854|NCT01509300|Antitubercular Agents|antitubercular agents|mesh-ancestor
6645164|NCT01404364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645165|NCT01404364|Antiemetics|antiemetics|mesh-ancestor
6645166|NCT01404364|Autonomic Agents|autonomic agents|mesh-ancestor
6645167|NCT01404364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6645168|NCT01404364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6645169|NCT01404364|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6645170|NCT01404364|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6645171|NCT01404364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6645172|NCT01404364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6645173|NCT01404364|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6645174|NCT01404364|Dopamine Agents|dopamine agents|mesh-ancestor
6645175|NCT01404364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6645176|NCT01404377|Ropivacaine|ropivacaine|mesh-list
6645177|NCT01404377|Anesthetics, Local|anesthetics, local|mesh-ancestor
6645178|NCT01404377|Anesthetics|anesthetics|mesh-ancestor
6645179|NCT01404377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6645180|NCT01404377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645181|NCT01404377|Sensory System Agents|sensory system agents|mesh-ancestor
6645182|NCT01404377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6645183|NCT01404442|Midazolam|midazolam|mesh-list
6645184|NCT01404442|Ketamine|ketamine|mesh-list
6645185|NCT01404442|Analgesics|analgesics|mesh-ancestor
6645186|NCT01404442|Sensory System Agents|sensory system agents|mesh-ancestor
6645187|NCT01404442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6645188|NCT01404442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645189|NCT01404442|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6645190|NCT01404442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6645191|NCT01404442|Anesthetics, General|anesthetics, general|mesh-ancestor
6645192|NCT01404442|Anesthetics|anesthetics|mesh-ancestor
6645193|NCT01404442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6645194|NCT01404442|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6645195|NCT01404442|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6645196|NCT01404442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5486474|NCT05164770|Tubulin Modulators|tubulin modulators|mesh-ancestor
5486475|NCT05164770|Antimitotic Agents|antimitotic agents|mesh-ancestor
5486476|NCT05164770|Mitosis Modulators|mitosis modulators|mesh-ancestor
5486477|NCT05164770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6645197|NCT01404442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645198|NCT01404442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6645199|NCT01404442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6645200|NCT01404442|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6645201|NCT01404442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6645202|NCT01404442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6645203|NCT01404442|GABA Modulators|gaba modulators|mesh-ancestor
6645204|NCT01404442|GABA Agents|gaba agents|mesh-ancestor
6645205|NCT01404468|Lidocaine|lidocaine|mesh-list
6645206|NCT01404468|Anesthetics, Local|anesthetics, local|mesh-ancestor
6645207|NCT01404468|Anesthetics|anesthetics|mesh-ancestor
6645208|NCT01404468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6645209|NCT01404468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645210|NCT01404468|Sensory System Agents|sensory system agents|mesh-ancestor
6645211|NCT01404468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6645212|NCT01404468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6645213|NCT01404468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6645214|NCT01404468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6645215|NCT01404468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6645216|NCT01404468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645217|NCT01404507|Abciximab|abciximab|mesh-list
6645218|NCT01404507|Anticoagulants|anticoagulants|mesh-ancestor
6645219|NCT01404507|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6645220|NCT01404598|Naproxen|naproxen|mesh-list
6645221|NCT01404598|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
6645222|NCT01404598|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6645223|NCT01404598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6645224|NCT01404598|Analgesics|analgesics|mesh-ancestor
6645225|NCT01404598|Sensory System Agents|sensory system agents|mesh-ancestor
6645226|NCT01404598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6645227|NCT01404598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645228|NCT01404598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6645229|NCT01404598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6645230|NCT01404598|Gout Suppressants|gout suppressants|mesh-ancestor
6645231|NCT01404598|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6645232|NCT01404598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6663855|NCT01509300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5486478|NCT05164770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6645233|NCT01404598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645234|NCT01404598|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6645235|NCT01404637|Tamsulosin|tamsulosin|mesh-list
6645236|NCT01404637|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6645237|NCT01404637|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6645238|NCT01404637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6645239|NCT01404637|Adrenergic Agents|adrenergic agents|mesh-ancestor
6645240|NCT01404637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6645241|NCT01404637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645242|NCT01404637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645243|NCT01404637|Urological Agents|urological agents|mesh-ancestor
6645244|NCT01404676|Glimepiride|glimepiride|mesh-list
6645245|NCT01404676|Vildagliptin|vildagliptin|mesh-list
6645246|NCT01404676|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6645247|NCT01404676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6645248|NCT01404676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645249|NCT01404676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6645250|NCT01404676|Immunologic Factors|immunologic factors|mesh-ancestor
6645251|NCT01404676|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6645252|NCT01404676|Protease Inhibitors|protease inhibitors|mesh-ancestor
6645253|NCT01404676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6645254|NCT01404676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645255|NCT01404689|Dexmedetomidine|dexmedetomidine|mesh-list
5486479|NCT05164770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5486480|NCT05164770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5486481|NCT05164770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5486482|NCT05164770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6645256|NCT01404689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6645257|NCT01404689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6645258|NCT01404689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645259|NCT01404689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5486483|NCT05164627|Magnesium Sulfate|magnesium sulfate|mesh-list
5486484|NCT05164627|Dexmedetomidine|dexmedetomidine|mesh-list
5486485|NCT05164627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5486486|NCT05164627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5486487|NCT05164627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645260|NCT01404689|Analgesics|analgesics|mesh-ancestor
6645261|NCT01404689|Sensory System Agents|sensory system agents|mesh-ancestor
6645262|NCT01404689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6645263|NCT01404689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5486488|NCT05164627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5486489|NCT05164627|Analgesics|analgesics|mesh-ancestor
5486490|NCT05164627|Sensory System Agents|sensory system agents|mesh-ancestor
5486491|NCT05164627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5486492|NCT05164627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5486493|NCT05164627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5486494|NCT05164627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5486495|NCT05164627|Adrenergic Agents|adrenergic agents|mesh-ancestor
5486496|NCT05164627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5486497|NCT05164627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486498|NCT05164627|Anesthetics|anesthetics|mesh-ancestor
5486499|NCT05164627|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5486500|NCT05164627|Anticonvulsants|anticonvulsants|mesh-ancestor
5486501|NCT05164627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5486502|NCT05164627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5486503|NCT05164627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5486504|NCT05164627|Tocolytic Agents|tocolytic agents|mesh-ancestor
5486505|NCT05164627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5486506|NCT05164263|Empagliflozin|empagliflozin|mesh-list
6645264|NCT01404689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6645265|NCT01404689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6645266|NCT01404689|Adrenergic Agents|adrenergic agents|mesh-ancestor
6645267|NCT01404689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6645268|NCT01404689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645269|NCT01404702|Zoledronic Acid|zoledronic acid|mesh-list
6645270|NCT01404702|Aldesleukin|aldesleukin|mesh-list
6645271|NCT01404702|Interleukin-2|interleukin-2|mesh-list
6645272|NCT01404702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6645273|NCT01404702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6645274|NCT01404702|Analgesics|analgesics|mesh-ancestor
6645275|NCT01404702|Sensory System Agents|sensory system agents|mesh-ancestor
6645276|NCT01404702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6645277|NCT01404702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645278|NCT01404702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6645279|NCT01404702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6645280|NCT01404702|Antiviral Agents|antiviral agents|mesh-ancestor
6645281|NCT01404702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6645282|NCT01404702|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6645283|NCT01404715|Metformin|metformin|mesh-list
6645284|NCT01404715|Imatinib Mesylate|imatinib mesylate|mesh-list
6645285|NCT01404715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6645286|NCT01404715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645287|NCT01404715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6645288|NCT01404715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6645289|NCT01404715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6645290|NCT01404715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645291|NCT01404741|Azacitidine|azacitidine|mesh-list
6645292|NCT01404741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6645293|NCT01404741|Antimetabolites|antimetabolites|mesh-ancestor
6645294|NCT01404741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645295|NCT01404741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6645296|NCT01404741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6645297|NCT01404767|Metoprolol|metoprolol|mesh-list
6645298|NCT01404767|Esmolol|esmolol|mesh-list
6645299|NCT01404767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6645300|NCT01404767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6645301|NCT01404767|Sympatholytics|sympatholytics|mesh-ancestor
6645302|NCT01404767|Autonomic Agents|autonomic agents|mesh-ancestor
6645303|NCT01404767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6645304|NCT01404767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645305|NCT01404767|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6645306|NCT01404767|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5486507|NCT05164263|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5486508|NCT05164263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486509|NCT05164263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5486510|NCT05164263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486511|NCT05161741|Insulin|insulin|mesh-list
5486512|NCT05161741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5486513|NCT05161741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486514|NCT05153590|Liraglutide|liraglutide|mesh-list
6645307|NCT01404767|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6645308|NCT01404767|Adrenergic Agents|adrenergic agents|mesh-ancestor
6645309|NCT01404767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6645310|NCT01404767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645311|NCT01404793|Rocuronium|rocuronium|mesh-list
6645312|NCT01404793|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6645313|NCT01404793|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6645314|NCT01404793|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6645315|NCT01404793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6645316|NCT01404793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645317|NCT01404806|Dolutegravir|dolutegravir|mesh-list
6645318|NCT01404806|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6645319|NCT01404806|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6645320|NCT01404806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6645321|NCT01404806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645322|NCT01404806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6645323|NCT01404806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6645324|NCT01404806|Antiviral Agents|antiviral agents|mesh-ancestor
6645325|NCT01404806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6645326|NCT01404819|Anesthetics|anesthetics|mesh-list
6645327|NCT01404819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6645328|NCT01404819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645329|NCT01404871|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6645330|NCT01404871|Citalopram|citalopram|mesh-list
6645331|NCT01404871|Clomipramine|clomipramine|mesh-list
6645332|NCT01404871|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6645333|NCT01404871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6645334|NCT01404871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6645335|NCT01404871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645336|NCT01404871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6645337|NCT01404871|Serotonin Agents|serotonin agents|mesh-ancestor
6645338|NCT01404871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645339|NCT01404871|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6645340|NCT01404871|Antidepressive Agents|antidepressive agents|mesh-ancestor
5486515|NCT05153590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5486516|NCT05153590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486517|NCT05153590|Incretins|incretins|mesh-ancestor
5486518|NCT05153590|Hormones|hormones|mesh-ancestor
6645341|NCT01404871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6645342|NCT01404871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6645343|NCT01404871|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6645344|NCT01404871|Analgesics|analgesics|mesh-ancestor
6645345|NCT01404871|Sensory System Agents|sensory system agents|mesh-ancestor
6645346|NCT01404871|Dopamine Agents|dopamine agents|mesh-ancestor
6645347|NCT01404871|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6663856|NCT01509300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6663857|NCT01509365|Clopidogrel|clopidogrel|mesh-list
6663858|NCT01509365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6453297|NCT00419731|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6453298|NCT00419731|Antidepressive Agents|antidepressive agents|mesh-ancestor
6453299|NCT00419731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6453300|NCT00419731|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6453301|NCT00419731|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6453302|NCT00419731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6453303|NCT00419731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453304|NCT00419731|Dopamine Agents|dopamine agents|mesh-ancestor
6453305|NCT00419731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6453306|NCT00419731|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6453307|NCT00419731|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6453308|NCT00419731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6453309|NCT00419783|Moxifloxacin|moxifloxacin|mesh-list
6453310|NCT00419783|Ketoconazole|ketoconazole|mesh-list
6453311|NCT00419783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6453312|NCT00419783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6453313|NCT00419783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6663859|NCT01509365|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6663860|NCT01509365|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6663861|NCT01509365|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6663862|NCT01509365|Purinergic Agents|purinergic agents|mesh-ancestor
6663863|NCT01509365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6663864|NCT01509365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663865|NCT01509365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663866|NCT01509391|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
6663867|NCT01509391|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6663868|NCT01509391|Immunologic Factors|immunologic factors|mesh-ancestor
5486519|NCT05153590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5486520|NCT05153135|Palbociclib|palbociclib|mesh-list
5486521|NCT05153135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5486522|NCT05153135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5486523|NCT05153135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5486524|NCT05153135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486525|NCT05150704|Methylprednisolone|methylprednisolone|mesh-list
6663869|NCT01509391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663870|NCT01509469|Caseins|caseins|mesh-list
6663871|NCT01509469|Chelating Agents|chelating agents|mesh-ancestor
6663872|NCT01509469|Sequestering Agents|sequestering agents|mesh-ancestor
6663873|NCT01509469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645348|NCT01405079|Vinorelbine|vinorelbine|mesh-list
6645349|NCT01405079|Gefitinib|gefitinib|mesh-list
6645350|NCT01405079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6645351|NCT01405079|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6645352|NCT01405079|Tubulin Modulators|tubulin modulators|mesh-ancestor
6645353|NCT01405079|Antimitotic Agents|antimitotic agents|mesh-ancestor
6645354|NCT01405079|Mitosis Modulators|mitosis modulators|mesh-ancestor
6645355|NCT01405079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645356|NCT01405079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6645357|NCT01405079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6645358|NCT01405118|Metformin|metformin|mesh-list
6645359|NCT01405118|Tofacitinib|tofacitinib|mesh-list
6645360|NCT01405118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6645361|NCT01405118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645362|NCT01405118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6645363|NCT01405118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6645364|NCT01405118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645365|NCT01405131|Methylprednisolone|methylprednisolone|mesh-list
6645366|NCT01405131|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6645367|NCT01405131|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6645368|NCT01405131|Prednisolone|prednisolone|mesh-list
6645369|NCT01405131|Prednisolone acetate|prednisolone acetate|mesh-list
6645370|NCT01405131|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6645371|NCT01405131|Prednisolone phosphate|prednisolone phosphate|mesh-list
6645372|NCT01405131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6645373|NCT01405131|Antiemetics|antiemetics|mesh-ancestor
6645374|NCT01405131|Autonomic Agents|autonomic agents|mesh-ancestor
6645375|NCT01405131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6645376|NCT01405131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645377|NCT01405131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6645378|NCT01405131|Glucocorticoids|glucocorticoids|mesh-ancestor
5486526|NCT05150704|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5486527|NCT05150704|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5486528|NCT05150704|Prednisolone|prednisolone|mesh-list
5486529|NCT05150704|Prednisolone acetate|prednisolone acetate|mesh-list
5486530|NCT05150704|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5486531|NCT05150704|Prednisolone phosphate|prednisolone phosphate|mesh-list
5486532|NCT05150704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5486533|NCT05150704|Antiemetics|antiemetics|mesh-ancestor
5486534|NCT05150704|Autonomic Agents|autonomic agents|mesh-ancestor
6645379|NCT01405131|Hormones|hormones|mesh-ancestor
6645380|NCT01405131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6645381|NCT01405131|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6645382|NCT01405131|Protective Agents|protective agents|mesh-ancestor
6645383|NCT01405131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6645384|NCT01405131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6645385|NCT01405144|Fluorouracil|fluorouracil|mesh-list
6645386|NCT01405144|Antimetabolites|antimetabolites|mesh-ancestor
6645387|NCT01405144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645388|NCT01405144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6645389|NCT01405144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6645390|NCT01405144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6645391|NCT01405144|Immunologic Factors|immunologic factors|mesh-ancestor
6645392|NCT01405144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645393|NCT01405157|Methylprednisolone|methylprednisolone|mesh-list
6645394|NCT01405157|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6645395|NCT01405157|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6645396|NCT01405157|Prednisolone|prednisolone|mesh-list
6645397|NCT01405157|Prednisolone acetate|prednisolone acetate|mesh-list
6645398|NCT01405157|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6645399|NCT01405157|Prednisolone phosphate|prednisolone phosphate|mesh-list
6645400|NCT01405157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6645401|NCT01405157|Antiemetics|antiemetics|mesh-ancestor
6645402|NCT01405157|Autonomic Agents|autonomic agents|mesh-ancestor
6645403|NCT01405157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6645404|NCT01405157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645405|NCT01405157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6645406|NCT01405157|Glucocorticoids|glucocorticoids|mesh-ancestor
5486535|NCT05150704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5486536|NCT05150704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486537|NCT05150704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5486538|NCT05150704|Glucocorticoids|glucocorticoids|mesh-ancestor
5486539|NCT05150704|Hormones|hormones|mesh-ancestor
5486540|NCT05150704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5486541|NCT05150704|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6645407|NCT01405157|Hormones|hormones|mesh-ancestor
6645408|NCT01405157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6645409|NCT01405157|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6645410|NCT01405157|Protective Agents|protective agents|mesh-ancestor
6645411|NCT01405157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6645412|NCT01405157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6645413|NCT01405170|Methylprednisolone|methylprednisolone|mesh-list
6645414|NCT01405170|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6645415|NCT01405170|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6645416|NCT01405170|Prednisolone|prednisolone|mesh-list
6645417|NCT01405170|Prednisolone acetate|prednisolone acetate|mesh-list
6645418|NCT01405170|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6645419|NCT01405170|Prednisolone phosphate|prednisolone phosphate|mesh-list
6645420|NCT01405170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6645421|NCT01405170|Antiemetics|antiemetics|mesh-ancestor
6645422|NCT01405170|Autonomic Agents|autonomic agents|mesh-ancestor
5486542|NCT05150704|Protective Agents|protective agents|mesh-ancestor
5486543|NCT05150704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5486544|NCT05150704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5486545|NCT05146479|Fluorides|fluorides|mesh-list
5486546|NCT05146479|Fluorides, Topical|fluorides, topical|mesh-list
6645423|NCT01405170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6645424|NCT01405170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645425|NCT01405170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6645426|NCT01405170|Glucocorticoids|glucocorticoids|mesh-ancestor
6645427|NCT01405170|Hormones|hormones|mesh-ancestor
6645428|NCT01405170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6645429|NCT01405170|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6645430|NCT01405170|Protective Agents|protective agents|mesh-ancestor
6645431|NCT01405170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6645432|NCT01405170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6645433|NCT01405235|Paclitaxel|paclitaxel|mesh-list
6645434|NCT01405235|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6645435|NCT01405235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6645436|NCT01405235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6645437|NCT01405235|Tubulin Modulators|tubulin modulators|mesh-ancestor
6645438|NCT01405235|Antimitotic Agents|antimitotic agents|mesh-ancestor
6645439|NCT01405235|Mitosis Modulators|mitosis modulators|mesh-ancestor
6645440|NCT01405235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645441|NCT01405248|3-n-butylphthalide|3-n-butylphthalide|mesh-list
6645442|NCT01405248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6645443|NCT01405248|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6645444|NCT01405248|Protective Agents|protective agents|mesh-ancestor
6645445|NCT01405248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645446|NCT01405326|Adalimumab|adalimumab|mesh-list
6645447|NCT01405326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6645448|NCT01405326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6645449|NCT01405339|Budesonide|budesonide|mesh-list
6645450|NCT01405339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6645451|NCT01405339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6645452|NCT01405339|Autonomic Agents|autonomic agents|mesh-ancestor
6645453|NCT01405339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6645454|NCT01405339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645455|NCT01405339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6645456|NCT01405339|Respiratory System Agents|respiratory system agents|mesh-ancestor
6645457|NCT01405339|Glucocorticoids|glucocorticoids|mesh-ancestor
6645458|NCT01405339|Hormones|hormones|mesh-ancestor
5486547|NCT05146479|Cariostatic Agents|cariostatic agents|mesh-ancestor
5486548|NCT05146479|Protective Agents|protective agents|mesh-ancestor
5486549|NCT05146479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486550|NCT05145621|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
5486551|NCT05145621|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5486552|NCT05145621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486553|NCT05145621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5486554|NCT05145621|Immunologic Factors|immunologic factors|mesh-ancestor
5486555|NCT05145621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502642|NCT04465123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5502643|NCT04465123|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5502644|NCT04465357|Erenumab|erenumab|mesh-list
5502645|NCT04465357|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
5502646|NCT04465357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502647|NCT04465357|Analgesics|analgesics|mesh-ancestor
5502648|NCT04465357|Sensory System Agents|sensory system agents|mesh-ancestor
5502649|NCT04465357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6645459|NCT01405339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6645460|NCT01405352|Vitamin A|vitamin a|mesh-list
6645461|NCT01405352|Vitamins|vitamins|mesh-ancestor
6645462|NCT01405352|Micronutrients|micronutrients|mesh-ancestor
5502650|NCT04465357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502651|NCT04465318|Nicotine|nicotine|mesh-list
5502652|NCT04465318|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5502653|NCT04465318|Autonomic Agents|autonomic agents|mesh-ancestor
5502654|NCT04465318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5502655|NCT04465318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502656|NCT04465318|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5502657|NCT04465318|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5502658|NCT04465318|Cholinergic Agents|cholinergic agents|mesh-ancestor
5502659|NCT04465318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5502660|NCT04465318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502661|NCT04465175|Magnesium Sulfate|magnesium sulfate|mesh-list
5502662|NCT04465175|Analgesics|analgesics|mesh-ancestor
5502663|NCT04465175|Sensory System Agents|sensory system agents|mesh-ancestor
5502664|NCT04465175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5502665|NCT04465175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645463|NCT01405352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645464|NCT01405365|Metronidazole|metronidazole|mesh-list
6645465|NCT01405365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6645466|NCT01405365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6645467|NCT01405365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5502666|NCT04465175|Anesthetics|anesthetics|mesh-ancestor
5502667|NCT04465175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5502668|NCT04465175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5502669|NCT04465175|Anticonvulsants|anticonvulsants|mesh-ancestor
5502670|NCT04465175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5502671|NCT04465175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5503683|NCT04456777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5486556|NCT05110209|Bevacizumab|bevacizumab|mesh-list
6645468|NCT01405365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6645469|NCT01405430|Bevacizumab|bevacizumab|mesh-list
6645470|NCT01405430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5486557|NCT05110209|Ranibizumab|ranibizumab|mesh-list
5486558|NCT05110209|Aflibercept|aflibercept|mesh-list
5486559|NCT05110209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5486560|NCT05110209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5486561|NCT05110209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5486562|NCT05110209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5486563|NCT05110209|Growth Substances|growth substances|mesh-ancestor
5486564|NCT05110209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486565|NCT05110209|Growth Inhibitors|growth inhibitors|mesh-ancestor
6645471|NCT01405430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6645472|NCT01405430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6645473|NCT01405430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6645474|NCT01405430|Growth Substances|growth substances|mesh-ancestor
6645475|NCT01405430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645476|NCT01405430|Growth Inhibitors|growth inhibitors|mesh-ancestor
6645477|NCT01405482|Botulinum Toxins|botulinum toxins|mesh-list
6645478|NCT01405482|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6645479|NCT01405482|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6645480|NCT01405482|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6645481|NCT01405482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6645482|NCT01405482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645483|NCT01405482|Cholinergic Agents|cholinergic agents|mesh-ancestor
6645484|NCT01405482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6645485|NCT01405482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645486|NCT01405482|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6645487|NCT01405482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6645488|NCT01405521|Vaccines|vaccines|mesh-list
6645489|NCT01405521|Immunologic Factors|immunologic factors|mesh-ancestor
6645490|NCT01405521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645491|NCT01405573|Sorafenib|sorafenib|mesh-list
6645492|NCT01405573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6645493|NCT01405573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6645494|NCT01405573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6645495|NCT01405573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645496|NCT01405586|Gemcitabine|gemcitabine|mesh-list
6645497|NCT01405586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6645498|NCT01405586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6645499|NCT01405586|Antimetabolites|antimetabolites|mesh-ancestor
6645500|NCT01405586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645501|NCT01405586|Antiviral Agents|antiviral agents|mesh-ancestor
6645502|NCT01405586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6645503|NCT01405586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6645504|NCT01405586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6645505|NCT01405586|Immunologic Factors|immunologic factors|mesh-ancestor
6645506|NCT01405586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645507|NCT01405612|Midazolam|midazolam|mesh-list
6645508|NCT01405612|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6645509|NCT01405612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6645510|NCT01405612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6645511|NCT01405612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645512|NCT01405612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6645513|NCT01405612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6645514|NCT01405612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6645515|NCT01405612|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5486566|NCT05096143|Valsartan|valsartan|mesh-list
5486567|NCT05096143|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5486568|NCT05096143|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5486569|NCT05096143|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5486570|NCT05096143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645516|NCT01405612|Anesthetics, General|anesthetics, general|mesh-ancestor
6645517|NCT01405612|Anesthetics|anesthetics|mesh-ancestor
6645518|NCT01405612|GABA Modulators|gaba modulators|mesh-ancestor
6645519|NCT01405612|GABA Agents|gaba agents|mesh-ancestor
6645520|NCT01405612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6645521|NCT01405612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486571|NCT05056974|UB-421|ub-421|mesh-list
5486572|NCT05056974|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5486573|NCT05056974|Antiviral Agents|antiviral agents|mesh-ancestor
5486574|NCT05056974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5486575|NCT05053659|Venetoclax|venetoclax|mesh-list
5486576|NCT05053659|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
5486577|NCT05053659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5486578|NCT05053659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5486579|NCT05051566|Esomeprazole|esomeprazole|mesh-list
5486580|NCT05051566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5486581|NCT05051566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5486582|NCT05051566|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5486583|NCT05051566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5486584|NCT05051566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486585|NCT05042648|Buprenorphine|buprenorphine|mesh-list
5486586|NCT05042648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5486587|NCT05042648|Narcotics|narcotics|mesh-ancestor
5486588|NCT05042648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5486589|NCT05042648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486590|NCT05042648|Analgesics|analgesics|mesh-ancestor
5486591|NCT05042648|Sensory System Agents|sensory system agents|mesh-ancestor
5486592|NCT05042648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6645522|NCT01405807|Alemtuzumab|alemtuzumab|mesh-list
6645523|NCT01405807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6645524|NCT01405807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6645525|NCT01405846|Gefitinib|gefitinib|mesh-list
6645526|NCT01405846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6645527|NCT01405846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6645528|NCT01405846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6645529|NCT01405846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645530|NCT01405872|Interferon beta-1a|interferon beta-1a|mesh-list
6645531|NCT01405872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6645532|NCT01405872|Immunologic Factors|immunologic factors|mesh-ancestor
6645533|NCT01405872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645534|NCT01405872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6645535|NCT01405872|Antiviral Agents|antiviral agents|mesh-ancestor
6645536|NCT01405872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6645537|NCT01405989|Ketoconazole|ketoconazole|mesh-list
6645538|NCT01405989|Darexaban|darexaban|mesh-list
6645539|NCT01405989|Antifungal Agents|antifungal agents|mesh-ancestor
6645540|NCT01405989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6645541|NCT01405989|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6645542|NCT01405989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6645543|NCT01405989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6645544|NCT01405989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645545|NCT01405989|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6645546|NCT01405989|Hormone Antagonists|hormone antagonists|mesh-ancestor
6645547|NCT01405989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6645548|NCT01405989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645549|NCT01405989|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6645550|NCT01405989|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6645551|NCT01405989|Antithrombins|antithrombins|mesh-ancestor
6645552|NCT01405989|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6645553|NCT01405989|Protease Inhibitors|protease inhibitors|mesh-ancestor
6645554|NCT01405989|Anticoagulants|anticoagulants|mesh-ancestor
6645555|NCT01406002|Rifampin|rifampin|mesh-list
6645556|NCT01406002|Darexaban|darexaban|mesh-list
6645557|NCT01406002|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6645558|NCT01406002|Antitubercular Agents|antitubercular agents|mesh-ancestor
6645559|NCT01406002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6645560|NCT01406002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6645561|NCT01406002|Leprostatic Agents|leprostatic agents|mesh-ancestor
6645562|NCT01406002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6645563|NCT01406002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6645564|NCT01406002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645565|NCT01406002|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6645566|NCT01406002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6645567|NCT01406002|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5486593|NCT05042648|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6645568|NCT01406002|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6645569|NCT01406002|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6645570|NCT01406002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6645571|NCT01406002|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6645572|NCT01406002|Antithrombins|antithrombins|mesh-ancestor
6645573|NCT01406002|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6645574|NCT01406002|Protease Inhibitors|protease inhibitors|mesh-ancestor
6645575|NCT01406002|Anticoagulants|anticoagulants|mesh-ancestor
6645576|NCT01406080|Adapalene|adapalene|mesh-list
6645577|NCT01406080|Tretinoin|tretinoin|mesh-list
6645578|NCT01406080|Emollients|emollients|mesh-list
6645579|NCT01406080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6645580|NCT01406080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6645581|NCT01406080|Analgesics|analgesics|mesh-ancestor
6645582|NCT01406080|Sensory System Agents|sensory system agents|mesh-ancestor
6645583|NCT01406080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6645584|NCT01406080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645585|NCT01406080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6645586|NCT01406080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6645587|NCT01406080|Dermatologic Agents|dermatologic agents|mesh-ancestor
6645588|NCT01406080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6645589|NCT01406080|Keratolytic Agents|keratolytic agents|mesh-ancestor
6645590|NCT01406132|Peficitinib|peficitinib|mesh-list
6645591|NCT01406132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6645592|NCT01406132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645593|NCT01406132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6645594|NCT01406132|Immunologic Factors|immunologic factors|mesh-ancestor
6645595|NCT01406132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645596|NCT01406158|Solifenacin Succinate|solifenacin succinate|mesh-list
6645597|NCT01406158|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6645598|NCT01406158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6645599|NCT01406158|Cholinergic Agents|cholinergic agents|mesh-ancestor
6645600|NCT01406158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6645601|NCT01406158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645602|NCT01406158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645603|NCT01406158|Urological Agents|urological agents|mesh-ancestor
6645604|NCT01406171|Isavuconazole|isavuconazole|mesh-list
6645605|NCT01406171|Midazolam|midazolam|mesh-list
6645606|NCT01406171|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6645607|NCT01406171|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6645608|NCT01406171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6645609|NCT01406171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645610|NCT01406171|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6645611|NCT01406171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6645612|NCT01406171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6645613|NCT01406171|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6645614|NCT01406171|Anesthetics, General|anesthetics, general|mesh-ancestor
6645615|NCT01406171|Anesthetics|anesthetics|mesh-ancestor
6645616|NCT01406171|GABA Modulators|gaba modulators|mesh-ancestor
6645617|NCT01406171|GABA Agents|gaba agents|mesh-ancestor
6645618|NCT01406171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6645619|NCT01406171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645620|NCT01406171|Antifungal Agents|antifungal agents|mesh-ancestor
6645621|NCT01406171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6645622|NCT01406197|Progesterone|progesterone|mesh-list
6645623|NCT01406197|Progestins|progestins|mesh-ancestor
6645624|NCT01406197|Hormones|hormones|mesh-ancestor
6645625|NCT01406197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6645626|NCT01406197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645627|NCT01406262|Moxifloxacin|moxifloxacin|mesh-list
6645628|NCT01406262|rGLP-1 protein|rglp-1 protein|mesh-list
6645629|NCT01406262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6645630|NCT01406262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6645631|NCT01406262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6645632|NCT01406262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6645633|NCT01406262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6645634|NCT01406262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645635|NCT01406262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6645636|NCT01406262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645637|NCT01406262|Incretins|incretins|mesh-ancestor
6645638|NCT01406262|Hormones|hormones|mesh-ancestor
6645639|NCT01406262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6645640|NCT01406275|Amoxicillin|amoxicillin|mesh-list
6645641|NCT01406275|Clavulanic Acid|clavulanic acid|mesh-list
6645642|NCT01406275|Clavulanic Acids|clavulanic acids|mesh-list
6645643|NCT01406275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5486594|NCT05039944|Irinotecan|irinotecan|mesh-list
5486595|NCT05039944|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6645644|NCT01406275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6645645|NCT01406275|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6645646|NCT01406275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6645647|NCT01406275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645648|NCT01406301|PENTA|penta|mesh-list
6645649|NCT01406301|Fondaparinux|fondaparinux|mesh-list
6645650|NCT01406301|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6645651|NCT01406301|Antithrombins|antithrombins|mesh-ancestor
5486596|NCT05039944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5486597|NCT05039944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5486598|NCT05039944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486599|NCT05039944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5486600|NCT05023343|Ropivacaine|ropivacaine|mesh-list
5486601|NCT05023343|Anesthetics, Local|anesthetics, local|mesh-ancestor
5486602|NCT05023343|Anesthetics|anesthetics|mesh-ancestor
5486603|NCT05023343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5486604|NCT05023343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486605|NCT05023343|Sensory System Agents|sensory system agents|mesh-ancestor
5486606|NCT05023343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5486607|NCT05022654|Irinotecan|irinotecan|mesh-list
5486608|NCT05022654|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5486609|NCT05022654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5486610|NCT05022654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5486611|NCT05022654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486612|NCT05022654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5486613|NCT05020769|Osimertinib|osimertinib|mesh-list
5486614|NCT05020769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5486615|NCT05020769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5486616|NCT05020769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5486617|NCT05020769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486618|NCT05020457|Paclitaxel|paclitaxel|mesh-list
5486619|NCT05020457|Docetaxel|docetaxel|mesh-list
5486620|NCT05020457|Cisplatin|cisplatin|mesh-list
5486621|NCT05020457|Pemetrexed|pemetrexed|mesh-list
5486622|NCT05020457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6645652|NCT01406301|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6645653|NCT01406301|Protease Inhibitors|protease inhibitors|mesh-ancestor
6645654|NCT01406301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6645655|NCT01406301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645656|NCT01406301|Anticoagulants|anticoagulants|mesh-ancestor
6645657|NCT01406301|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6645658|NCT01406301|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6645659|NCT01406327|Ambrisentan|ambrisentan|mesh-list
6645660|NCT01406327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6645661|NCT01406392|Misoprostol|misoprostol|mesh-list
6645662|NCT01406392|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6645663|NCT01406392|Abortifacient Agents|abortifacient agents|mesh-ancestor
6645664|NCT01406392|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6645665|NCT01406392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645666|NCT01406392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6645667|NCT01406392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6645668|NCT01406392|Oxytocics|oxytocics|mesh-ancestor
6645669|NCT01406431|Valsartan|valsartan|mesh-list
6645670|NCT01406431|Pitavastatin|pitavastatin|mesh-list
6645671|NCT01406431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6645672|NCT01406431|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6645673|NCT01406431|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6645674|NCT01406431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645675|NCT01406431|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6645676|NCT01406431|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6645677|NCT01406431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6645678|NCT01406431|Antimetabolites|antimetabolites|mesh-ancestor
6645679|NCT01406431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6645680|NCT01406431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6645681|NCT01406470|Immunoglobulins|immunoglobulins|mesh-list
5486623|NCT05020457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5486624|NCT05020457|Tubulin Modulators|tubulin modulators|mesh-ancestor
5486625|NCT05020457|Antimitotic Agents|antimitotic agents|mesh-ancestor
5486626|NCT05020457|Mitosis Modulators|mitosis modulators|mesh-ancestor
5486627|NCT05020457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645682|NCT01406470|Antibodies|antibodies|mesh-list
6645683|NCT01406470|gamma-Globulins|gamma-globulins|mesh-list
6645684|NCT01406470|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6645685|NCT01406470|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6645686|NCT01406470|Immunoglobulin G|immunoglobulin g|mesh-list
6645687|NCT01406470|Immunologic Factors|immunologic factors|mesh-ancestor
6645688|NCT01406470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645689|NCT01406496|Insulin|insulin|mesh-list
6645690|NCT01406496|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6645691|NCT01406496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6645692|NCT01406496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645693|NCT01406522|Tacrine|tacrine|mesh-list
5486628|NCT05020457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5486629|NCT05020457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5486630|NCT05020457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5486631|NCT05007145|Paclitaxel|paclitaxel|mesh-list
5486632|NCT05007145|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5486633|NCT05007145|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5486634|NCT05007145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5486635|NCT05007145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5486636|NCT05007145|Tubulin Modulators|tubulin modulators|mesh-ancestor
5486637|NCT05007145|Antimitotic Agents|antimitotic agents|mesh-ancestor
5486638|NCT05007145|Mitosis Modulators|mitosis modulators|mesh-ancestor
6645694|NCT01406522|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6645695|NCT01406522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6645696|NCT01406522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645697|NCT01406522|Cholinergic Agents|cholinergic agents|mesh-ancestor
6645698|NCT01406522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6645699|NCT01406522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645700|NCT01406522|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6645701|NCT01406522|Autonomic Agents|autonomic agents|mesh-ancestor
6645702|NCT01406522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6645703|NCT01406522|Nootropic Agents|nootropic agents|mesh-ancestor
6663874|NCT01509521|Phenylephrine|phenylephrine|mesh-list
6663875|NCT01509521|Oxymetazoline|oxymetazoline|mesh-list
6663876|NCT01509521|Ephedrine|ephedrine|mesh-list
6663877|NCT01509521|Pseudoephedrine|pseudoephedrine|mesh-list
6663878|NCT01509521|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6663879|NCT01509521|Mydriatics|mydriatics|mesh-ancestor
6663880|NCT01509521|Autonomic Agents|autonomic agents|mesh-ancestor
6663881|NCT01509521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6663882|NCT01509521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663883|NCT01509521|Sympathomimetics|sympathomimetics|mesh-ancestor
6663884|NCT01509521|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6663885|NCT01509521|Nasal Decongestants|nasal decongestants|mesh-ancestor
6663886|NCT01509521|Respiratory System Agents|respiratory system agents|mesh-ancestor
6663887|NCT01509521|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6663888|NCT01509521|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6663889|NCT01509521|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6663890|NCT01509521|Adrenergic Agents|adrenergic agents|mesh-ancestor
6663891|NCT01509521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6663892|NCT01509521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663893|NCT01509521|Protective Agents|protective agents|mesh-ancestor
6663894|NCT01509521|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6663895|NCT01509521|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6663896|NCT01509521|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6663897|NCT01509560|Everolimus|everolimus|mesh-list
6663898|NCT01509560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6663899|NCT01509560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6663900|NCT01509560|Immunologic Factors|immunologic factors|mesh-ancestor
6663901|NCT01509560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663902|NCT01509599|Methyl salicylate|methyl salicylate|mesh-list
6663903|NCT01509599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6663904|NCT01509742|Liraglutide|liraglutide|mesh-list
6663905|NCT01509742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6663906|NCT01509742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663907|NCT01509742|Incretins|incretins|mesh-ancestor
6663908|NCT01509742|Hormones|hormones|mesh-ancestor
5503684|NCT04456777|Serotonin Agents|serotonin agents|mesh-ancestor
6663909|NCT01509742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6663910|NCT01509755|Liraglutide|liraglutide|mesh-list
6663911|NCT01509755|Glimepiride|glimepiride|mesh-list
6645704|NCT01406535|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6645705|NCT01406535|Vasodilator Agents|vasodilator agents|mesh-ancestor
6645706|NCT01406535|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6645707|NCT01406535|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6645708|NCT01406535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6645709|NCT01406535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645710|NCT01406535|Urological Agents|urological agents|mesh-ancestor
6645711|NCT01406548|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6645712|NCT01406548|Immunologic Factors|immunologic factors|mesh-ancestor
6645713|NCT01406548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645714|NCT01406600|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6645715|NCT01406600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6645716|NCT01406600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486639|NCT05007145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486640|NCT04968951|Metronidazole|metronidazole|mesh-list
5486641|NCT04968951|Vancomycin|vancomycin|mesh-list
5486642|NCT04968951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5486643|NCT04968951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5486644|NCT04968951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5486645|NCT04968951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5486646|NCT04952857|Vitamin D|vitamin d|mesh-list
5486647|NCT04952857|Cholecalciferol|cholecalciferol|mesh-list
5486648|NCT04952857|Vitamins|vitamins|mesh-ancestor
5486649|NCT04952857|Micronutrients|micronutrients|mesh-ancestor
5486650|NCT04952857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486651|NCT04952857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5486652|NCT04952857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5486653|NCT04943445|Paclitaxel|paclitaxel|mesh-list
5486654|NCT04943445|Carboplatin|carboplatin|mesh-list
5486655|NCT04943445|Pembrolizumab|pembrolizumab|mesh-list
5486656|NCT04943445|Immunologic Factors|immunologic factors|mesh-list
5486657|NCT04943445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5486658|NCT04943445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6645717|NCT01406639|Ranibizumab|ranibizumab|mesh-list
6645718|NCT01406639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6645719|NCT01406639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6645720|NCT01406639|Growth Substances|growth substances|mesh-ancestor
6645721|NCT01406639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645722|NCT01406639|Growth Inhibitors|growth inhibitors|mesh-ancestor
6645723|NCT01406639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6645724|NCT01406678|Sufentanil|sufentanil|mesh-list
6645725|NCT01406678|Dsuvia|dsuvia|mesh-list
6645726|NCT01406678|Isoflurane|isoflurane|mesh-list
6645727|NCT01406678|Anesthetics|anesthetics|mesh-ancestor
6645728|NCT01406678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6645729|NCT01406678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645730|NCT01406678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6645731|NCT01406678|Narcotics|narcotics|mesh-ancestor
6645732|NCT01406678|Analgesics|analgesics|mesh-ancestor
6645733|NCT01406678|Sensory System Agents|sensory system agents|mesh-ancestor
6645734|NCT01406678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6645735|NCT01406678|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5486659|NCT04943445|Tubulin Modulators|tubulin modulators|mesh-ancestor
5486660|NCT04943445|Antimitotic Agents|antimitotic agents|mesh-ancestor
5486661|NCT04943445|Mitosis Modulators|mitosis modulators|mesh-ancestor
5486662|NCT04943445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486663|NCT04943445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6645736|NCT01406678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6645737|NCT01406678|Anesthetics, General|anesthetics, general|mesh-ancestor
6645738|NCT01406678|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6645739|NCT01406704|Thioctic Acid|thioctic acid|mesh-list
6645740|NCT01406704|Rosiglitazone|rosiglitazone|mesh-list
6645741|NCT01406704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6645742|NCT01406704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645743|NCT01406704|Antioxidants|antioxidants|mesh-ancestor
6645744|NCT01406704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645745|NCT01406704|Protective Agents|protective agents|mesh-ancestor
6645746|NCT01406704|Vitamin B Complex|vitamin b complex|mesh-ancestor
6645747|NCT01406704|Vitamins|vitamins|mesh-ancestor
6645748|NCT01406704|Micronutrients|micronutrients|mesh-ancestor
6645749|NCT01406782|Rituximab|rituximab|mesh-list
6645750|NCT01406782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6645751|NCT01406782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6645752|NCT01406782|Immunologic Factors|immunologic factors|mesh-ancestor
6645753|NCT01406782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486664|NCT04943445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645754|NCT01406782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5486665|NCT04928261|Trastuzumab|trastuzumab|mesh-list
5486666|NCT04928261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5486667|NCT04928261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6645755|NCT01407016|Metronidazole|metronidazole|mesh-list
6645756|NCT01407016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6645757|NCT01407016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6645758|NCT01407016|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6645759|NCT01407016|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6645760|NCT01407211|Vitamin A|vitamin a|mesh-list
6645761|NCT01407211|Vitamins|vitamins|mesh-ancestor
6645762|NCT01407211|Micronutrients|micronutrients|mesh-ancestor
6645763|NCT01407211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645764|NCT01407237|Angiotensin II|angiotensin ii|mesh-list
6645765|NCT01407237|Giapreza|giapreza|mesh-list
6645766|NCT01407237|Angiotensinogen|angiotensinogen|mesh-list
6645767|NCT01407237|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6645768|NCT01407237|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6645769|NCT01407237|Protease Inhibitors|protease inhibitors|mesh-ancestor
6645770|NCT01407237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6645771|NCT01407237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645772|NCT01407263|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6645773|NCT01407263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6645774|NCT01407289|Insulin|insulin|mesh-list
6645775|NCT01407289|Insulin Glargine|insulin glargine|mesh-list
6645776|NCT01407289|Insulin Aspart|insulin aspart|mesh-list
6645777|NCT01407289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6645778|NCT01407289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645779|NCT01407432|Folic Acid|folic acid|mesh-list
6645780|NCT01407432|Vitamin B Complex|vitamin b complex|mesh-list
6645781|NCT01407432|Hematinics|hematinics|mesh-ancestor
6645782|NCT01407432|Vitamins|vitamins|mesh-ancestor
6645783|NCT01407432|Micronutrients|micronutrients|mesh-ancestor
6645784|NCT01407432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645785|NCT01407471|Clobetasol|clobetasol|mesh-list
6645786|NCT01407471|Spironolactone|spironolactone|mesh-list
6645787|NCT01407471|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6645788|NCT01407471|Hormone Antagonists|hormone antagonists|mesh-ancestor
6645789|NCT01407471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6645790|NCT01407471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645791|NCT01407471|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6645792|NCT01407471|Diuretics|diuretics|mesh-ancestor
6645793|NCT01407471|Natriuretic Agents|natriuretic agents|mesh-ancestor
6645794|NCT01407471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6645795|NCT01407471|Glucocorticoids|glucocorticoids|mesh-ancestor
6645796|NCT01407471|Hormones|hormones|mesh-ancestor
6645797|NCT01407484|Prednisone|prednisone|mesh-list
6645798|NCT01407484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6645799|NCT01407484|Glucocorticoids|glucocorticoids|mesh-ancestor
6645800|NCT01407484|Hormones|hormones|mesh-ancestor
6645801|NCT01407484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6645802|NCT01407484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645803|NCT01407484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6645804|NCT01407484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6645805|NCT01407497|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6645806|NCT01407562|Paclitaxel|paclitaxel|mesh-list
6645807|NCT01407562|Carboplatin|carboplatin|mesh-list
6645808|NCT01407562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6645809|NCT01407562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6645810|NCT01407562|Tubulin Modulators|tubulin modulators|mesh-ancestor
6645811|NCT01407562|Antimitotic Agents|antimitotic agents|mesh-ancestor
6645812|NCT01407562|Mitosis Modulators|mitosis modulators|mesh-ancestor
6645813|NCT01407562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645814|NCT01407666|Anesthetics|anesthetics|mesh-list
5486668|NCT04923295|Dapagliflozin|dapagliflozin|mesh-list
6645815|NCT01407666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6645816|NCT01407666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645817|NCT01407679|Alitretinoin|alitretinoin|mesh-list
6645818|NCT01407679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6645819|NCT01407679|Dermatologic Agents|dermatologic agents|mesh-ancestor
6645820|NCT01407822|Gemcitabine|gemcitabine|mesh-list
6645821|NCT01407822|Cisplatin|cisplatin|mesh-list
6645822|NCT01407822|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5486669|NCT04923295|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5486670|NCT04923295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486671|NCT04923295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5486672|NCT04923295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486673|NCT04899232|Antithrombins|antithrombins|mesh-list
5486674|NCT04899232|Antithrombin III|antithrombin iii|mesh-list
5486675|NCT04899232|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5486676|NCT04899232|Protease Inhibitors|protease inhibitors|mesh-ancestor
5486677|NCT04899232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5486678|NCT04899232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645823|NCT01407822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6645824|NCT01407822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6645825|NCT01407822|Antimetabolites|antimetabolites|mesh-ancestor
5486679|NCT04899232|Anticoagulants|anticoagulants|mesh-ancestor
5486680|NCT04825262|Tacrolimus|tacrolimus|mesh-list
5486681|NCT04825262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5486682|NCT04825262|Immunologic Factors|immunologic factors|mesh-ancestor
5486683|NCT04825262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486684|NCT04825262|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5486685|NCT04825262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5486686|NCT04825262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486687|NCT04821830|Levodopa|levodopa|mesh-list
5486688|NCT04821830|Carbidopa|carbidopa|mesh-list
6645826|NCT01407822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645827|NCT01407822|Antiviral Agents|antiviral agents|mesh-ancestor
6645828|NCT01407822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6645829|NCT01407822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6645830|NCT01407822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6645831|NCT01407822|Immunologic Factors|immunologic factors|mesh-ancestor
6645832|NCT01407822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645833|NCT01407822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6645834|NCT01407848|Furosemide|furosemide|mesh-list
6645835|NCT01407848|Diuretics|diuretics|mesh-ancestor
6645836|NCT01407848|Natriuretic Agents|natriuretic agents|mesh-ancestor
6645837|NCT01407848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645838|NCT01407848|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6645839|NCT01407848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6645840|NCT01407848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645841|NCT01407887|Artesunate|artesunate|mesh-list
6645842|NCT01407887|Amodiaquine|amodiaquine|mesh-list
6645843|NCT01407887|Methylene Blue|methylene blue|mesh-list
6645844|NCT01407887|Antimalarials|antimalarials|mesh-ancestor
6645845|NCT01407887|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6645846|NCT01407887|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6645847|NCT01407887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6645848|NCT01407887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6645849|NCT01407887|Antiviral Agents|antiviral agents|mesh-ancestor
6645850|NCT01407887|Schistosomicides|schistosomicides|mesh-ancestor
6645851|NCT01407887|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6645852|NCT01407887|Anthelmintics|anthelmintics|mesh-ancestor
6645853|NCT01407887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6645854|NCT01407887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645855|NCT01407978|Vaccines|vaccines|mesh-list
6645856|NCT01407978|Immunologic Factors|immunologic factors|mesh-ancestor
6645857|NCT01407978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645858|NCT01408004|Everolimus|everolimus|mesh-list
6645859|NCT01408004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6645860|NCT01408004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6645861|NCT01408004|Immunologic Factors|immunologic factors|mesh-ancestor
6645862|NCT01408004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645863|NCT01408056|Mupirocin|mupirocin|mesh-list
6645864|NCT01408056|Timolol|timolol|mesh-list
6645865|NCT01408056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6645866|NCT01408056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6645867|NCT01408056|Adrenergic Agents|adrenergic agents|mesh-ancestor
6645868|NCT01408056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6645869|NCT01408056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645870|NCT01408056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021676|NCT00401817|Rituximab|rituximab|mesh-list
6645871|NCT01408056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6645872|NCT01408056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6645873|NCT01408056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6645874|NCT01408056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6645875|NCT01408056|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6645876|NCT01408056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6645877|NCT01408095|Glimepiride|glimepiride|mesh-list
6645878|NCT01408095|Globalagliatin|globalagliatin|mesh-list
6645879|NCT01408095|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6645880|NCT01408095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6645881|NCT01408095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645882|NCT01408095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6645883|NCT01408095|Immunologic Factors|immunologic factors|mesh-ancestor
6645884|NCT01408095|Enzyme Activators|enzyme activators|mesh-ancestor
6645885|NCT01408095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645886|NCT01408160|Cytarabine|cytarabine|mesh-list
6645887|NCT01408160|Immunotoxins|immunotoxins|mesh-list
6645888|NCT01408160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6645889|NCT01408160|Antimetabolites|antimetabolites|mesh-ancestor
6645890|NCT01408160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645891|NCT01408160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6645892|NCT01408160|Antiviral Agents|antiviral agents|mesh-ancestor
6645893|NCT01408160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6645894|NCT01408160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6645895|NCT01408160|Immunologic Factors|immunologic factors|mesh-ancestor
6645896|NCT01408160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663912|NCT01509755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6663913|NCT01509755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663914|NCT01509755|Incretins|incretins|mesh-ancestor
6663915|NCT01509755|Hormones|hormones|mesh-ancestor
6663916|NCT01509755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6663917|NCT01509755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6663918|NCT01509755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6663919|NCT01509755|Immunologic Factors|immunologic factors|mesh-ancestor
6663920|NCT01509911|Gemcitabine|gemcitabine|mesh-list
6663921|NCT01509911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6663922|NCT01509911|Antimetabolites|antimetabolites|mesh-ancestor
6663923|NCT01509911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663924|NCT01509911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6663925|NCT01509911|Antiviral Agents|antiviral agents|mesh-ancestor
6663926|NCT01509911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6663927|NCT01509911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6663928|NCT01509911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6663929|NCT01509911|Immunologic Factors|immunologic factors|mesh-ancestor
6663930|NCT01509911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663931|NCT01509976|Triclosan|triclosan|mesh-list
6663932|NCT01509976|Triclocarban|triclocarban|mesh-list
6663933|NCT01509976|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6663934|NCT01509976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6663935|NCT01509976|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6663936|NCT01509976|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6663937|NCT01509976|Antimetabolites|antimetabolites|mesh-ancestor
6663938|NCT01509976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663939|NCT01509976|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5486689|NCT04821830|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
5486690|NCT04821830|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5486691|NCT04821830|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5486692|NCT04821830|Dopamine Agents|dopamine agents|mesh-ancestor
5486693|NCT04821830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5486694|NCT04821830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486695|NCT04821830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486696|NCT04821830|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5486697|NCT04821830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5486698|NCT04821830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5486699|NCT04821830|Immunologic Factors|immunologic factors|mesh-ancestor
5486700|NCT04821830|Dopamine Agonists|dopamine agonists|mesh-ancestor
5486701|NCT04803994|Bevacizumab|bevacizumab|mesh-list
5486702|NCT04803994|Atezolizumab|atezolizumab|mesh-list
5486703|NCT04803994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6663940|NCT01510015|Risperidone|risperidone|mesh-list
6663941|NCT01510015|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6663942|NCT01510015|Serotonin Agents|serotonin agents|mesh-ancestor
6663943|NCT01510015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6663944|NCT01510015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663945|NCT01510015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486704|NCT04803994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6663946|NCT01510015|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5486705|NCT04803994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5486706|NCT04803994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5486707|NCT04803994|Growth Substances|growth substances|mesh-ancestor
5486708|NCT04803994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486709|NCT04803994|Growth Inhibitors|growth inhibitors|mesh-ancestor
5486710|NCT04708782|Treprostinil|treprostinil|mesh-list
5486711|NCT04708782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5486712|NCT04693507|Antarelix|antarelix|mesh-list
5486713|NCT04693507|Hormone Antagonists|hormone antagonists|mesh-ancestor
5486714|NCT04693507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5486715|NCT04693507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486716|NCT04692467|Amlodipine|amlodipine|mesh-list
5486717|NCT04692467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6645897|NCT01408173|Caffeine|caffeine|mesh-list
6645898|NCT01408173|Caffeine citrate|caffeine citrate|mesh-list
6645899|NCT01408173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645900|NCT01408173|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6645901|NCT01408173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645902|NCT01408173|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6645903|NCT01408173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6645904|NCT01408173|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6645905|NCT01408173|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6645906|NCT01408173|Purinergic Agents|purinergic agents|mesh-ancestor
6645907|NCT01408173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6645908|NCT01408186|Rabeprazole|rabeprazole|mesh-list
6645909|NCT01408186|Famotidine|famotidine|mesh-list
6645910|NCT01408186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6645911|NCT01408186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6645912|NCT01408186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6645913|NCT01408186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6645914|NCT01408186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645915|NCT01408186|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6645916|NCT01408186|Histamine Antagonists|histamine antagonists|mesh-ancestor
6645917|NCT01408186|Histamine Agents|histamine agents|mesh-ancestor
6645918|NCT01408186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6645919|NCT01408186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645920|NCT01408199|Lenalidomide|lenalidomide|mesh-list
6645921|NCT01408199|Immunologic Factors|immunologic factors|mesh-ancestor
6645922|NCT01408199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486718|NCT04692467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5486719|NCT04692467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5486720|NCT04692467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453314|NCT00419783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6453315|NCT00419783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6453316|NCT00419783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486721|NCT04692467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5486722|NCT04692467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486723|NCT04692467|Vasodilator Agents|vasodilator agents|mesh-ancestor
5502672|NCT04465175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502673|NCT04465175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5502674|NCT04465175|Tocolytic Agents|tocolytic agents|mesh-ancestor
5502675|NCT04465175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5502676|NCT04465396|Teduglutide|teduglutide|mesh-list
5502677|NCT04465396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5502678|NCT04465396|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5502679|NCT04465396|Protective Agents|protective agents|mesh-ancestor
5502680|NCT04465396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502681|NCT04465383|Propofol|propofol|mesh-list
5502682|NCT04465383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6453317|NCT00419783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6453318|NCT00419783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453319|NCT00419783|Antifungal Agents|antifungal agents|mesh-ancestor
6453320|NCT00419783|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6453321|NCT00419783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6453322|NCT00419783|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6453323|NCT00419783|Hormone Antagonists|hormone antagonists|mesh-ancestor
6453324|NCT00419783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6453325|NCT00419783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6453326|NCT00419796|Lumiracoxib|lumiracoxib|mesh-list
6453327|NCT00419796|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6453328|NCT00419796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6645923|NCT01408199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6645924|NCT01408199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6645925|NCT01408199|Growth Substances|growth substances|mesh-ancestor
6645926|NCT01408199|Growth Inhibitors|growth inhibitors|mesh-ancestor
6645927|NCT01408199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6645928|NCT01408290|Vaccines|vaccines|mesh-list
6645929|NCT01408290|Immunologic Factors|immunologic factors|mesh-ancestor
6645930|NCT01408290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645931|NCT01408342|Rituximab|rituximab|mesh-list
6645932|NCT01408342|Alemtuzumab|alemtuzumab|mesh-list
6645933|NCT01408342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6645934|NCT01408342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5486724|NCT04618016|Vitamins|vitamins|mesh-list
5486725|NCT04618016|Vitamin E|vitamin e|mesh-list
5486726|NCT04618016|Tocopherols|tocopherols|mesh-list
5486727|NCT04618016|Tocotrienols|tocotrienols|mesh-list
5486728|NCT04618016|alpha-Tocopherol|alpha-tocopherol|mesh-list
5486729|NCT04618016|Micronutrients|micronutrients|mesh-ancestor
5486730|NCT04618016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645935|NCT01408342|Immunologic Factors|immunologic factors|mesh-ancestor
6645936|NCT01408342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645937|NCT01408342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6645938|NCT01408394|Ecopipam|ecopipam|mesh-list
6645939|NCT01408394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6645940|NCT01408394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6645941|NCT01408394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6645942|NCT01408394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486731|NCT04618016|Antioxidants|antioxidants|mesh-ancestor
5486732|NCT04618016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486733|NCT04618016|Protective Agents|protective agents|mesh-ancestor
5486734|NCT04615286|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5486735|NCT04615286|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5486736|NCT04615286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5486737|NCT04615286|Antitubercular Agents|antitubercular agents|mesh-ancestor
5486738|NCT04571944|Suvorexant|suvorexant|mesh-list
5486739|NCT04571944|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5486740|NCT04571944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5486741|NCT04571944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5486742|NCT04571944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486743|NCT04571944|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
5486744|NCT04571944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5486745|NCT04571944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486746|NCT04527289|Amantadine|amantadine|mesh-list
5486747|NCT04527289|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5486748|NCT04527289|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5486749|NCT04527289|Antiviral Agents|antiviral agents|mesh-ancestor
5486750|NCT04527289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5486751|NCT04527289|Dopamine Agents|dopamine agents|mesh-ancestor
5486752|NCT04527289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5486753|NCT04527289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486754|NCT04527289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486755|NCT04527289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5486756|NCT04527289|Analgesics|analgesics|mesh-ancestor
5486757|NCT04527289|Sensory System Agents|sensory system agents|mesh-ancestor
5486758|NCT04527289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5486759|NCT04525898|Methadone|methadone|mesh-list
6645943|NCT01408394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6645944|NCT01408394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6645945|NCT01408394|Dopamine Agents|dopamine agents|mesh-ancestor
6645946|NCT01408394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6645947|NCT01408394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645948|NCT01408446|Menthol|menthol|mesh-list
6645949|NCT01408446|Antipruritics|antipruritics|mesh-ancestor
6645950|NCT01408446|Dermatologic Agents|dermatologic agents|mesh-ancestor
6645951|NCT01408498|Testosterone|testosterone|mesh-list
5486760|NCT04525898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5486761|NCT04525898|Narcotics|narcotics|mesh-ancestor
6645952|NCT01408498|Androgens|androgens|mesh-ancestor
6645953|NCT01408498|Hormones|hormones|mesh-ancestor
6645954|NCT01408498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6645955|NCT01408498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645956|NCT01408524|Diltiazem|diltiazem|mesh-list
6645957|NCT01408524|Labetalol|labetalol|mesh-list
6645958|NCT01408524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5486762|NCT04525898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5486763|NCT04525898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645959|NCT01408524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6645960|NCT01408524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6645961|NCT01408524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645962|NCT01408524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6645963|NCT01408524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645964|NCT01408524|Vasodilator Agents|vasodilator agents|mesh-ancestor
6645965|NCT01408524|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5486764|NCT04525898|Analgesics|analgesics|mesh-ancestor
5486765|NCT04525898|Sensory System Agents|sensory system agents|mesh-ancestor
5486766|NCT04525898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5486767|NCT04525898|Antitussive Agents|antitussive agents|mesh-ancestor
5486768|NCT04525898|Respiratory System Agents|respiratory system agents|mesh-ancestor
5486769|NCT04518124|Propranolol|propranolol|mesh-list
5486770|NCT04518124|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5486771|NCT04518124|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5486772|NCT04518124|Adrenergic Agents|adrenergic agents|mesh-ancestor
5486773|NCT04518124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5486774|NCT04518124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486775|NCT04518124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486776|NCT04518124|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5486777|NCT04518124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5486778|NCT04518124|Vasodilator Agents|vasodilator agents|mesh-ancestor
5486779|NCT04511052|Carotenoids|carotenoids|mesh-list
5486780|NCT04511052|Antioxidants|antioxidants|mesh-ancestor
5486781|NCT04511052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486782|NCT04511052|Protective Agents|protective agents|mesh-ancestor
5486783|NCT04511052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486784|NCT04460326|Insulin|insulin|mesh-list
5486785|NCT04460326|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5486786|NCT04460326|Insulin Glargine|insulin glargine|mesh-list
5486787|NCT04460326|Insulin Aspart|insulin aspart|mesh-list
5486788|NCT04460326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5486789|NCT04460326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486790|NCT04451772|Upadacitinib|upadacitinib|mesh-list
5486791|NCT04451772|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
5486792|NCT04451772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6645966|NCT01408524|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6645967|NCT01408524|Adrenergic Agents|adrenergic agents|mesh-ancestor
6645968|NCT01408524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6645969|NCT01408524|Sympathomimetics|sympathomimetics|mesh-ancestor
6645970|NCT01408524|Autonomic Agents|autonomic agents|mesh-ancestor
6645971|NCT01408524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6645972|NCT01408524|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6645973|NCT01408524|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6645974|NCT01408589|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6645975|NCT01408589|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6645976|NCT01408589|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6645977|NCT01408589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6663947|NCT01510015|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5486793|NCT04451772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5486794|NCT04451772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486795|NCT04451772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5486796|NCT04433858|Psilocybin|psilocybin|mesh-list
5486797|NCT04433858|Hallucinogens|hallucinogens|mesh-ancestor
5486798|NCT04433858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645978|NCT01408589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6645979|NCT01408589|Adrenergic Agents|adrenergic agents|mesh-ancestor
6645980|NCT01408589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6645981|NCT01408589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645982|NCT01408680|Ubiquinone|ubiquinone|mesh-list
6645983|NCT01408680|Coenzyme Q10|coenzyme q10|mesh-list
6645984|NCT01408680|Micronutrients|micronutrients|mesh-ancestor
6645985|NCT01408680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645986|NCT01408680|Vitamins|vitamins|mesh-ancestor
6645987|NCT01408797|Bortezomib|bortezomib|mesh-list
6645988|NCT01408797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6645989|NCT01408810|Infliximab|infliximab|mesh-list
5486799|NCT04433858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5486800|NCT04339270|Azithromycin|azithromycin|mesh-list
5486801|NCT04339270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5486802|NCT04339270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5486803|NCT04282070|Gemcitabine|gemcitabine|mesh-list
5486804|NCT04282070|Paclitaxel|paclitaxel|mesh-list
5486805|NCT04282070|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5486806|NCT04282070|Cisplatin|cisplatin|mesh-list
5486807|NCT04282070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5486808|NCT04282070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5486809|NCT04282070|Tubulin Modulators|tubulin modulators|mesh-ancestor
5486810|NCT04282070|Antimitotic Agents|antimitotic agents|mesh-ancestor
5486811|NCT04282070|Mitosis Modulators|mitosis modulators|mesh-ancestor
5486812|NCT04282070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486813|NCT04282070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5486814|NCT04282070|Antimetabolites|antimetabolites|mesh-ancestor
5486815|NCT04282070|Antiviral Agents|antiviral agents|mesh-ancestor
5486816|NCT04282070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5486817|NCT04282070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5486818|NCT04282070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5486819|NCT04282070|Immunologic Factors|immunologic factors|mesh-ancestor
5486820|NCT04282070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6645990|NCT01408810|Dermatologic Agents|dermatologic agents|mesh-ancestor
6645991|NCT01408810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6645992|NCT01408810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6645993|NCT01408836|Prednisolone|prednisolone|mesh-list
6645994|NCT01408836|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6645995|NCT01408836|Methylprednisolone|methylprednisolone|mesh-list
6645996|NCT01408836|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6645997|NCT01408836|Prednisolone acetate|prednisolone acetate|mesh-list
6645998|NCT01408836|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6645999|NCT01408836|Prednisolone phosphate|prednisolone phosphate|mesh-list
6646000|NCT01408836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6646001|NCT01408836|Glucocorticoids|glucocorticoids|mesh-ancestor
6646002|NCT01408836|Hormones|hormones|mesh-ancestor
6646003|NCT01408836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6646004|NCT01408836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646005|NCT01408836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6646006|NCT01408836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6646007|NCT01408836|Antiemetics|antiemetics|mesh-ancestor
6646008|NCT01408836|Autonomic Agents|autonomic agents|mesh-ancestor
6646009|NCT01408836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6646010|NCT01408836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6646011|NCT01408836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6646012|NCT01408836|Protective Agents|protective agents|mesh-ancestor
6646013|NCT01408849|Omeprazole|omeprazole|mesh-list
6646014|NCT01408849|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6646015|NCT01408849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6646016|NCT01408849|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6646017|NCT01408849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6646018|NCT01408849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646019|NCT01408927|Aspirin|aspirin|mesh-list
6646020|NCT01408927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6646021|NCT01408927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6646022|NCT01408927|Analgesics|analgesics|mesh-ancestor
6646023|NCT01408927|Sensory System Agents|sensory system agents|mesh-ancestor
6646024|NCT01408927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6646025|NCT01408927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646026|NCT01408927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6646027|NCT01408927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6646028|NCT01408927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6646029|NCT01408927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5486821|NCT04260126|Pembrolizumab|pembrolizumab|mesh-list
6646030|NCT01408927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486822|NCT04260126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5486823|NCT04260126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5486824|NCT04259255|Edaravone|edaravone|mesh-list
5486825|NCT04259255|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5486826|NCT04259255|Antioxidants|antioxidants|mesh-ancestor
5486827|NCT04259255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486828|NCT04259255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5486829|NCT04259255|Protective Agents|protective agents|mesh-ancestor
5486830|NCT04259255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486831|NCT04246554|Acetaminophen|acetaminophen|mesh-list
5486832|NCT04246554|Ketorolac|ketorolac|mesh-list
5486833|NCT04246554|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
5486834|NCT04246554|Oxycodone|oxycodone|mesh-list
5486835|NCT04246554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5486836|NCT04246554|Analgesics|analgesics|mesh-ancestor
5486837|NCT04246554|Sensory System Agents|sensory system agents|mesh-ancestor
5486838|NCT04246554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5486839|NCT04246554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486840|NCT04246554|Antipyretics|antipyretics|mesh-ancestor
5486841|NCT04246554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5486842|NCT04246554|Narcotics|narcotics|mesh-ancestor
5486843|NCT04246554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6646031|NCT01408927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6646032|NCT01408927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6646033|NCT01408927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6646034|NCT01408927|Antipyretics|antipyretics|mesh-ancestor
6646035|NCT01408953|Bevacizumab|bevacizumab|mesh-list
6646036|NCT01408953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6646037|NCT01408953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6646038|NCT01408953|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6646039|NCT01408953|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6646040|NCT01408953|Growth Substances|growth substances|mesh-ancestor
6646041|NCT01408953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646042|NCT01408953|Growth Inhibitors|growth inhibitors|mesh-ancestor
6646043|NCT01408979|Magnesium Sulfate|magnesium sulfate|mesh-list
6646044|NCT01408979|Analgesics|analgesics|mesh-ancestor
6646045|NCT01408979|Sensory System Agents|sensory system agents|mesh-ancestor
6646046|NCT01408979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6646047|NCT01408979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646048|NCT01408979|Anesthetics|anesthetics|mesh-ancestor
6646049|NCT01408979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6646050|NCT01408979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6646051|NCT01408979|Anticonvulsants|anticonvulsants|mesh-ancestor
5486844|NCT04246554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5486845|NCT04246554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5486846|NCT04246554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5486847|NCT04246554|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5486848|NCT04246554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5486849|NCT04246554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646052|NCT01408979|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6646053|NCT01408979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6646054|NCT01408979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646055|NCT01408979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6646056|NCT01408979|Tocolytic Agents|tocolytic agents|mesh-ancestor
6646057|NCT01408979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6646058|NCT01409005|Gemcitabine|gemcitabine|mesh-list
5486850|NCT04101721|Aflibercept|aflibercept|mesh-list
6453329|NCT00419796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6453330|NCT00419796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453331|NCT00419796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6453332|NCT00419796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6453333|NCT00419796|Analgesics|analgesics|mesh-ancestor
6453334|NCT00419796|Sensory System Agents|sensory system agents|mesh-ancestor
6453335|NCT00419796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6453336|NCT00419796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453337|NCT00419796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6646059|NCT01409005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5486851|NCT04101721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5486852|NCT04101721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5486853|NCT04101721|Growth Substances|growth substances|mesh-ancestor
5486854|NCT04101721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486855|NCT04101721|Growth Inhibitors|growth inhibitors|mesh-ancestor
5486856|NCT04101721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5486857|NCT04093570|Decitabine|decitabine|mesh-list
5486858|NCT04093570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5486859|NCT04093570|Antimetabolites|antimetabolites|mesh-ancestor
5486860|NCT04093570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486861|NCT04093570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5486862|NCT04093570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5486863|NCT04083495|Cyclophosphamide|cyclophosphamide|mesh-list
5486864|NCT04083495|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5486865|NCT04083495|Fludarabine|fludarabine|mesh-list
5486866|NCT04083495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5486867|NCT04083495|Immunologic Factors|immunologic factors|mesh-ancestor
5486868|NCT04083495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486869|NCT04083495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5486870|NCT04083495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5486871|NCT04083495|Alkylating Agents|alkylating agents|mesh-ancestor
5486872|NCT04083495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646060|NCT01409005|Antimetabolites|antimetabolites|mesh-ancestor
6646061|NCT01409005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646062|NCT01409005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5486873|NCT04083495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5486874|NCT04083495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5486875|NCT04078906|SMOFlipid|smoflipid|mesh-list
5486876|NCT04078906|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
5486877|NCT04078906|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5486878|NCT04078906|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6021677|NCT00401817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6021678|NCT00401817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6021679|NCT00401817|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6021680|NCT00401817|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6021681|NCT00401817|Growth Substances|growth substances|mesh-ancestor
6021682|NCT00401817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021683|NCT00401817|Growth Inhibitors|growth inhibitors|mesh-ancestor
6021684|NCT00401817|Immunologic Factors|immunologic factors|mesh-ancestor
6021685|NCT00401817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6646063|NCT01409005|Antiviral Agents|antiviral agents|mesh-ancestor
6646064|NCT01409005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6646065|NCT01409005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6646066|NCT01409005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6646067|NCT01409005|Immunologic Factors|immunologic factors|mesh-ancestor
6646068|NCT01409005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646069|NCT01409018|Itraconazole|itraconazole|mesh-list
6646070|NCT01409018|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
6646071|NCT01409018|Antifungal Agents|antifungal agents|mesh-ancestor
6646072|NCT01409018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6646073|NCT01409018|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6646074|NCT01409018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6646075|NCT01409018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6646076|NCT01409018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646077|NCT01409018|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6646078|NCT01409018|Hormone Antagonists|hormone antagonists|mesh-ancestor
6646079|NCT01409018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6646080|NCT01409018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646081|NCT01409018|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6646082|NCT01409122|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6646083|NCT01409148|Antibodies|antibodies|mesh-list
6646084|NCT01409148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6646085|NCT01409148|Immunologic Factors|immunologic factors|mesh-ancestor
6646086|NCT01409148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646087|NCT01409161|Vitamins|vitamins|mesh-list
6646088|NCT01409161|Vitamin A|vitamin a|mesh-list
6646089|NCT01409161|Retinol palmitate|retinol palmitate|mesh-list
6646090|NCT01409161|Tretinoin|tretinoin|mesh-list
6646091|NCT01409161|Arsenic Trioxide|arsenic trioxide|mesh-list
6646092|NCT01409161|Gemtuzumab|gemtuzumab|mesh-list
6646093|NCT01409161|Calicheamicins|calicheamicins|mesh-list
6646094|NCT01409161|Micronutrients|micronutrients|mesh-ancestor
6646095|NCT01409161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646096|NCT01409161|Antioxidants|antioxidants|mesh-ancestor
6646097|NCT01409161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646098|NCT01409161|Protective Agents|protective agents|mesh-ancestor
6646099|NCT01409161|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6646100|NCT01409161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6646101|NCT01409161|Keratolytic Agents|keratolytic agents|mesh-ancestor
6646102|NCT01409161|Dermatologic Agents|dermatologic agents|mesh-ancestor
6646103|NCT01409161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6646104|NCT01409161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6646105|NCT01409174|Interferons|interferons|mesh-list
6646106|NCT01409174|Interferon-alpha|interferon-alpha|mesh-list
6646107|NCT01409174|Interferon alpha-2|interferon alpha-2|mesh-list
6646108|NCT01409174|Aldesleukin|aldesleukin|mesh-list
6646109|NCT01409174|Cisplatin|cisplatin|mesh-list
6646110|NCT01409174|Temozolomide|temozolomide|mesh-list
6646111|NCT01409174|Ipilimumab|ipilimumab|mesh-list
6646112|NCT01409174|Interleukin-2|interleukin-2|mesh-list
6646113|NCT01409174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6646114|NCT01409174|Antiviral Agents|antiviral agents|mesh-ancestor
6021686|NCT00401830|Lacosamide|lacosamide|mesh-list
6021687|NCT00401830|Anticonvulsants|anticonvulsants|mesh-ancestor
5486891|NCT04035486|Carboplatin|carboplatin|mesh-list
5486892|NCT04035486|Pemetrexed|pemetrexed|mesh-list
5486893|NCT04035486|Osimertinib|osimertinib|mesh-list
5486894|NCT04035486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5486895|NCT04035486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5486896|NCT04035486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486897|NCT04035486|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5486898|NCT04035486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5486899|NCT04035486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5486900|NCT04030962|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5486901|NCT04030962|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5486902|NCT04024462|Cyclophosphamide|cyclophosphamide|mesh-list
6646115|NCT01409174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6646116|NCT01409174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6646117|NCT01409174|Alkylating Agents|alkylating agents|mesh-ancestor
6646118|NCT01409174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646119|NCT01409174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6646120|NCT01409174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6646121|NCT01409174|Immunologic Factors|immunologic factors|mesh-ancestor
6646122|NCT01409174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646123|NCT01409174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6646124|NCT01409174|Analgesics|analgesics|mesh-ancestor
6646125|NCT01409174|Sensory System Agents|sensory system agents|mesh-ancestor
6646126|NCT01409174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6646127|NCT01409174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6646128|NCT01409174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6646129|NCT01409187|Interferons|interferons|mesh-list
6646130|NCT01409187|Interferon-alpha|interferon-alpha|mesh-list
6646131|NCT01409187|Interferon alpha-2|interferon alpha-2|mesh-list
6646132|NCT01409187|Aldesleukin|aldesleukin|mesh-list
6646133|NCT01409187|Ipilimumab|ipilimumab|mesh-list
6646134|NCT01409187|Interleukin-2|interleukin-2|mesh-list
5486903|NCT04024462|Docetaxel|docetaxel|mesh-list
5486904|NCT04024462|Doxorubicin|doxorubicin|mesh-list
6453338|NCT00419796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6453339|NCT00419835|Losartan|losartan|mesh-list
6453340|NCT00419835|Enalapril|enalapril|mesh-list
6453341|NCT00419835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6453342|NCT00419835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6453343|NCT00419835|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6453344|NCT00419835|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6453345|NCT00419835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453346|NCT00419835|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6453347|NCT00419835|Protease Inhibitors|protease inhibitors|mesh-ancestor
6453348|NCT00419835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6453349|NCT00419848|Azithromycin|azithromycin|mesh-list
6453350|NCT00419848|Doxycycline|doxycycline|mesh-list
6453351|NCT00419848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6453352|NCT00419848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6646135|NCT01409187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6646136|NCT01409187|Antiviral Agents|antiviral agents|mesh-ancestor
6646137|NCT01409187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6646138|NCT01409187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6646139|NCT01409187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6646140|NCT01409187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646141|NCT01409187|Immunologic Factors|immunologic factors|mesh-ancestor
6646142|NCT01409187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646143|NCT01409187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6646144|NCT01409187|Analgesics|analgesics|mesh-ancestor
6646145|NCT01409187|Sensory System Agents|sensory system agents|mesh-ancestor
6646146|NCT01409187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6646147|NCT01409187|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6646148|NCT01409187|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6646149|NCT01409200|Ascorbic Acid|ascorbic acid|mesh-list
6646150|NCT01409200|Axitinib|axitinib|mesh-list
6646151|NCT01409200|Methyltestosterone|methyltestosterone|mesh-list
6646152|NCT01409200|Hormones|hormones|mesh-list
6646153|NCT01409200|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6646154|NCT01409200|Androgens|androgens|mesh-list
6646155|NCT01409200|Androgen Antagonists|androgen antagonists|mesh-list
6646156|NCT01409200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6646157|NCT01409200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646158|NCT01409200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6646159|NCT01409200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6646160|NCT01409200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6646161|NCT01409200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646162|NCT01409200|Antioxidants|antioxidants|mesh-ancestor
6646163|NCT01409200|Protective Agents|protective agents|mesh-ancestor
6646164|NCT01409200|Vitamins|vitamins|mesh-ancestor
6646165|NCT01409200|Micronutrients|micronutrients|mesh-ancestor
6646166|NCT01409200|Estrogens|estrogens|mesh-ancestor
6646167|NCT01409200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6646168|NCT01409200|Anabolic Agents|anabolic agents|mesh-ancestor
6646169|NCT01409200|Hormone Antagonists|hormone antagonists|mesh-ancestor
6646170|NCT01409278|Ropivacaine|ropivacaine|mesh-list
6646171|NCT01409278|Anesthetics, Local|anesthetics, local|mesh-ancestor
6646172|NCT01409278|Anesthetics|anesthetics|mesh-ancestor
6646173|NCT01409278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6646174|NCT01409278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646175|NCT01409278|Sensory System Agents|sensory system agents|mesh-ancestor
6646176|NCT01409278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6646177|NCT01409369|Charcoal|charcoal|mesh-list
6646178|NCT01409369|Antidotes|antidotes|mesh-ancestor
6646179|NCT01409369|Protective Agents|protective agents|mesh-ancestor
6646180|NCT01409369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646181|NCT01409395|Metformin|metformin|mesh-list
6646182|NCT01409395|Nizatidine|nizatidine|mesh-list
6646183|NCT01409395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5486905|NCT04024462|Trastuzumab|trastuzumab|mesh-list
5486906|NCT04024462|Pertuzumab|pertuzumab|mesh-list
5486907|NCT04024462|Hormones|hormones|mesh-list
5486908|NCT04024462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5486909|NCT04024462|Immunologic Factors|immunologic factors|mesh-ancestor
5486910|NCT04024462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486911|NCT04024462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5486912|NCT04024462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5486913|NCT04024462|Alkylating Agents|alkylating agents|mesh-ancestor
5486914|NCT04024462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486915|NCT04024462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5486916|NCT04024462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6646184|NCT01409395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646185|NCT01409395|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6646186|NCT01409395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6646187|NCT01409395|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6646188|NCT01409395|Histamine Antagonists|histamine antagonists|mesh-ancestor
6646189|NCT01409395|Histamine Agents|histamine agents|mesh-ancestor
6646190|NCT01409395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6646191|NCT01409395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646192|NCT01409408|Amlodipine|amlodipine|mesh-list
6453353|NCT00419848|Antimalarials|antimalarials|mesh-ancestor
6453354|NCT00419848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6453355|NCT00419848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6453356|NCT00419887|Vildagliptin|vildagliptin|mesh-list
6453357|NCT00419887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6453358|NCT00419887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646193|NCT01409408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6646194|NCT01409408|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6646195|NCT01409408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6646196|NCT01409408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646197|NCT01409408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6646198|NCT01409408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646199|NCT01409408|Vasodilator Agents|vasodilator agents|mesh-ancestor
6646200|NCT01409421|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6646201|NCT01409421|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6646202|NCT01409499|Sorafenib|sorafenib|mesh-list
6646203|NCT01409499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6646204|NCT01409499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6646205|NCT01409499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6646206|NCT01409499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646207|NCT01409603|Naproxen|naproxen|mesh-list
6646208|NCT01409603|Darexaban|darexaban|mesh-list
6646209|NCT01409603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6646210|NCT01409603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6646211|NCT01409603|Analgesics|analgesics|mesh-ancestor
6646212|NCT01409603|Sensory System Agents|sensory system agents|mesh-ancestor
6646213|NCT01409603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6646214|NCT01409603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646215|NCT01409603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6646216|NCT01409603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6646217|NCT01409603|Gout Suppressants|gout suppressants|mesh-ancestor
6646218|NCT01409603|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6646219|NCT01409603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6646220|NCT01409603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646221|NCT01409603|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6646222|NCT01409603|Antithrombins|antithrombins|mesh-ancestor
6646223|NCT01409603|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6646224|NCT01409603|Protease Inhibitors|protease inhibitors|mesh-ancestor
6453359|NCT00419887|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6453360|NCT00419887|Protease Inhibitors|protease inhibitors|mesh-ancestor
6453361|NCT00419887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6646225|NCT01409603|Anticoagulants|anticoagulants|mesh-ancestor
6646226|NCT01409616|Aspirin|aspirin|mesh-list
6646227|NCT01409616|Salicylic Acid|salicylic acid|mesh-list
6646228|NCT01409616|Salicylates|salicylates|mesh-list
6646229|NCT01409616|Darexaban|darexaban|mesh-list
6646230|NCT01409616|Clopidogrel|clopidogrel|mesh-list
6646231|NCT01409616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6646232|NCT01409616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6646233|NCT01409616|Analgesics|analgesics|mesh-ancestor
6646234|NCT01409616|Sensory System Agents|sensory system agents|mesh-ancestor
6646235|NCT01409616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6646236|NCT01409616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646237|NCT01409616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6646238|NCT01409616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6646239|NCT01409616|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6646240|NCT01409616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6646241|NCT01409616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646242|NCT01409616|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6646243|NCT01409616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6646244|NCT01409616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6646245|NCT01409616|Antipyretics|antipyretics|mesh-ancestor
6646246|NCT01409616|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5486917|NCT04024462|Tubulin Modulators|tubulin modulators|mesh-ancestor
5486918|NCT04024462|Antimitotic Agents|antimitotic agents|mesh-ancestor
6453362|NCT00419887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453363|NCT00419913|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
6453364|NCT00419913|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6453365|NCT00419913|Immunologic Factors|immunologic factors|mesh-ancestor
6646247|NCT01409616|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6646248|NCT01409616|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6453366|NCT00419913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646249|NCT01409616|Purinergic Agents|purinergic agents|mesh-ancestor
6646250|NCT01409616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6646251|NCT01409616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6646252|NCT01409616|Antifungal Agents|antifungal agents|mesh-ancestor
6646253|NCT01409616|Keratolytic Agents|keratolytic agents|mesh-ancestor
6646254|NCT01409616|Dermatologic Agents|dermatologic agents|mesh-ancestor
6646255|NCT01409616|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6646256|NCT01409616|Antithrombins|antithrombins|mesh-ancestor
6453367|NCT00419991|Tigecycline|tigecycline|mesh-list
6453368|NCT00419991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6453369|NCT00419991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6453370|NCT00419991|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6453371|NCT00419991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6453372|NCT00419991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453373|NCT00420030|Abciximab|abciximab|mesh-list
6453374|NCT00420030|Anticoagulants|anticoagulants|mesh-ancestor
6453375|NCT00420030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6453376|NCT00420043|Imatinib Mesylate|imatinib mesylate|mesh-list
6453377|NCT00420043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6453378|NCT00420043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6453379|NCT00420043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6453380|NCT00420043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453381|NCT00420082|Cetirizine|cetirizine|mesh-list
6453382|NCT00420082|Fexofenadine|fexofenadine|mesh-list
6453383|NCT00420082|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6453384|NCT00420082|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6453385|NCT00420082|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6453386|NCT00420082|Histamine Antagonists|histamine antagonists|mesh-ancestor
6453387|NCT00420082|Histamine Agents|histamine agents|mesh-ancestor
6453388|NCT00420082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6453389|NCT00420082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453390|NCT00420082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453391|NCT00420277|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
6453392|NCT00420277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6646257|NCT01409616|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6646258|NCT01409616|Protease Inhibitors|protease inhibitors|mesh-ancestor
6646259|NCT01409616|Anticoagulants|anticoagulants|mesh-ancestor
6646260|NCT01409694|Vitamin D|vitamin d|mesh-list
6646261|NCT01409694|Ergocalciferols|ergocalciferols|mesh-list
6646262|NCT01409694|Vitamins|vitamins|mesh-list
6646263|NCT01409694|Memantine|memantine|mesh-list
6646264|NCT01409694|Micronutrients|micronutrients|mesh-ancestor
6646265|NCT01409694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646266|NCT01409694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6646267|NCT01409694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6646268|NCT01409694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6646269|NCT01409694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6646270|NCT01409694|Dopamine Agents|dopamine agents|mesh-ancestor
6646271|NCT01409694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6646272|NCT01409694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646273|NCT01409694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6646274|NCT01409694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6646275|NCT01409733|Doxorubicin|doxorubicin|mesh-list
6646276|NCT01409733|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6646277|NCT01409733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6646278|NCT01409733|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6646279|NCT01409733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6646280|NCT01409733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6646281|NCT01409733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646282|NCT01409772|Ethanol|ethanol|mesh-list
6646283|NCT01409772|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6646284|NCT01409772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6646285|NCT01409772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6646286|NCT01409772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663948|NCT01510015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6663949|NCT01510015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6663950|NCT01510015|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6663951|NCT01510015|Dopamine Agents|dopamine agents|mesh-ancestor
6663952|NCT01510093|Insulin Aspart|insulin aspart|mesh-list
6663953|NCT01510093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6663954|NCT01510093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663955|NCT01510132|Timolol|timolol|mesh-list
6663956|NCT01510132|Travoprost|travoprost|mesh-list
6663957|NCT01510132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6663958|NCT01510132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6663959|NCT01510132|Adrenergic Agents|adrenergic agents|mesh-ancestor
6663960|NCT01510132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6663961|NCT01510132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663962|NCT01510132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663963|NCT01510132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6663964|NCT01510132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6663965|NCT01510171|Ticagrelor|ticagrelor|mesh-list
6663966|NCT01510171|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6663967|NCT01510171|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6663968|NCT01510171|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6663969|NCT01510171|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6663970|NCT01510171|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6663971|NCT01510171|Purinergic Agents|purinergic agents|mesh-ancestor
6663972|NCT01510171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6663973|NCT01510171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663974|NCT01510171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663975|NCT01510288|Ipilimumab|ipilimumab|mesh-list
6663976|NCT01510288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6663977|NCT01510288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6663978|NCT01510288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6663979|NCT01510288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6663980|NCT01510366|Vaccines|vaccines|mesh-list
6663981|NCT01510366|Immunologic Factors|immunologic factors|mesh-ancestor
6663982|NCT01510366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663983|NCT01510431|Remestemcel-l|remestemcel-l|mesh-list
6663984|NCT01510431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6663985|NCT01510431|Antiviral Agents|antiviral agents|mesh-ancestor
6663986|NCT01510431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6665067|NCT01515774|Antioxidants|antioxidants|mesh-ancestor
6665068|NCT01515774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665069|NCT01515774|Protective Agents|protective agents|mesh-ancestor
6665070|NCT01515774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665071|NCT01515774|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6665072|NCT01515774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6665073|NCT01515774|Dopamine Agonists|dopamine agonists|mesh-ancestor
6665074|NCT01515774|Dopamine Agents|dopamine agents|mesh-ancestor
6665075|NCT01515774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6665076|NCT01515813|Tenofovir|tenofovir|mesh-list
6665077|NCT01515813|Emtricitabine|emtricitabine|mesh-list
6665078|NCT01515813|Efavirenz|efavirenz|mesh-list
6665079|NCT01515813|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6665080|NCT01515813|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6665081|NCT01515813|Pravastatin|pravastatin|mesh-list
6665082|NCT01515813|Antiviral Agents|antiviral agents|mesh-ancestor
6665083|NCT01515813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6665084|NCT01515813|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6665085|NCT01515813|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6665086|NCT01515813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6665087|NCT01515813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665088|NCT01515813|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6665089|NCT01515813|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6665090|NCT01515813|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6665091|NCT01515813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6665092|NCT01515813|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6665143|NCT01515839|Vitamins|vitamins|mesh-ancestor
6646287|NCT01410162|Tacrolimus|tacrolimus|mesh-list
6646288|NCT01410162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6646289|NCT01410162|Immunologic Factors|immunologic factors|mesh-ancestor
6646290|NCT01410162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646291|NCT01410162|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5486919|NCT04024462|Mitosis Modulators|mitosis modulators|mesh-ancestor
5486920|NCT04024462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5486921|NCT04024462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5486922|NCT04024462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5486923|NCT04024462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5486924|NCT04024462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5486925|NCT04024462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6646292|NCT01410162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6646293|NCT01410162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646294|NCT01410201|Dexamethasone|dexamethasone|mesh-list
6646295|NCT01410201|Dexamethasone acetate|dexamethasone acetate|mesh-list
6646296|NCT01410201|BB 1101|bb 1101|mesh-list
6646297|NCT01410201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6646298|NCT01410201|Antiemetics|antiemetics|mesh-ancestor
6646299|NCT01410201|Autonomic Agents|autonomic agents|mesh-ancestor
6646300|NCT01410201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6646301|NCT01410201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646302|NCT01410201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6646303|NCT01410201|Glucocorticoids|glucocorticoids|mesh-ancestor
6646304|NCT01410201|Hormones|hormones|mesh-ancestor
6646305|NCT01410201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6646306|NCT01410201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6646307|NCT01410201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6646308|NCT01410201|Protease Inhibitors|protease inhibitors|mesh-ancestor
6646309|NCT01410201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6646310|NCT01410201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646311|NCT01410214|Cisplatin|cisplatin|mesh-list
6646312|NCT01410214|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6646313|NCT01410214|Vinorelbine|vinorelbine|mesh-list
6646314|NCT01410214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6646315|NCT01410214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6646316|NCT01410214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6646317|NCT01410214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646318|NCT01410214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6646319|NCT01410214|Tubulin Modulators|tubulin modulators|mesh-ancestor
6646320|NCT01410214|Antimitotic Agents|antimitotic agents|mesh-ancestor
6646321|NCT01410214|Mitosis Modulators|mitosis modulators|mesh-ancestor
6646322|NCT01410370|Endostar protein|endostar protein|mesh-list
6646323|NCT01410370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6646324|NCT01410370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6646325|NCT01410370|Growth Substances|growth substances|mesh-ancestor
6646326|NCT01410370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646327|NCT01410370|Growth Inhibitors|growth inhibitors|mesh-ancestor
6646328|NCT01410370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6646329|NCT01410630|Telbivudine|telbivudine|mesh-list
6646330|NCT01410630|Antiviral Agents|antiviral agents|mesh-ancestor
6646331|NCT01410630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6646332|NCT01410630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6646333|NCT01410630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6646334|NCT01410630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646335|NCT01410682|Chlorhexidine|chlorhexidine|mesh-list
6646336|NCT01410682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6646337|NCT01410682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5486926|NCT04008355|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5486927|NCT03978624|Pembrolizumab|pembrolizumab|mesh-list
5486928|NCT03978624|Entinostat|entinostat|mesh-list
5486929|NCT03978624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6453393|NCT00420277|Plasma Substitutes|plasma substitutes|mesh-ancestor
6453394|NCT00420277|Blood Substitutes|blood substitutes|mesh-ancestor
6453395|NCT00420355|Ritonavir|ritonavir|mesh-list
6453396|NCT00420355|Lopinavir|lopinavir|mesh-list
6453397|NCT00420355|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6453398|NCT00420355|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6453399|NCT00420355|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6453400|NCT00420355|Protease Inhibitors|protease inhibitors|mesh-ancestor
6453401|NCT00420355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6453402|NCT00420355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453403|NCT00420355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6453404|NCT00420355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6453405|NCT00420355|Antiviral Agents|antiviral agents|mesh-ancestor
5486930|NCT03978624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5486931|NCT03978624|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5486932|NCT03978624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5486933|NCT03978624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486934|NCT03976310|Benralizumab|benralizumab|mesh-list
5486935|NCT03976310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5486936|NCT03976310|Respiratory System Agents|respiratory system agents|mesh-ancestor
5486937|NCT03941132|Ustekinumab|ustekinumab|mesh-list
5486938|NCT03941132|Dermatologic Agents|dermatologic agents|mesh-ancestor
5486939|NCT03934671|Antioxidants|antioxidants|mesh-list
5486940|NCT03934671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486941|NCT03934671|Protective Agents|protective agents|mesh-ancestor
6646338|NCT01410682|Disinfectants|disinfectants|mesh-ancestor
6646339|NCT01410708|Dasatinib|dasatinib|mesh-list
6646340|NCT01410708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6646341|NCT01410708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6646342|NCT01410708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6646343|NCT01410708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646344|NCT01410747|Tacrolimus|tacrolimus|mesh-list
6646345|NCT01410747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6646346|NCT01410747|Immunologic Factors|immunologic factors|mesh-ancestor
6646347|NCT01410747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646348|NCT01410747|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6646349|NCT01410747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6646350|NCT01410747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646351|NCT01410916|Eculizumab|eculizumab|mesh-list
6646352|NCT01410916|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6646353|NCT01410916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6646354|NCT01410916|Immunologic Factors|immunologic factors|mesh-ancestor
6646355|NCT01410916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646356|NCT01410942|Methylphenidate|methylphenidate|mesh-list
6646357|NCT01410942|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6646358|NCT01410942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646359|NCT01410942|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6646360|NCT01410942|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6646361|NCT01410942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6646362|NCT01410942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646363|NCT01410942|Dopamine Agents|dopamine agents|mesh-ancestor
6646364|NCT01410942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6646365|NCT01410968|Poly ICLC|poly iclc|mesh-list
5486942|NCT03934671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502683|NCT04465383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5502684|NCT04465383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502685|NCT04465383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5502686|NCT04465383|Anesthetics, General|anesthetics, general|mesh-ancestor
5502687|NCT04465383|Anesthetics|anesthetics|mesh-ancestor
5502688|NCT04465071|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5502689|NCT04465071|Lubricant Eye Drops|lubricant eye drops|mesh-list
5502690|NCT04465071|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5502691|NCT04464967|Trastuzumab|trastuzumab|mesh-list
5502692|NCT04464967|Cetuximab|cetuximab|mesh-list
5502693|NCT04464967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5502694|NCT04464967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5502695|NCT04464759|Hydroxychloroquine|hydroxychloroquine|mesh-list
5502696|NCT04464759|Nivolumab|nivolumab|mesh-list
5502697|NCT04464759|Ipilimumab|ipilimumab|mesh-list
5502698|NCT04464759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5502699|NCT04464759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5502700|NCT04464759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5502701|NCT04464759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502702|NCT04464759|Antimalarials|antimalarials|mesh-ancestor
5502703|NCT04464759|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5502704|NCT04464759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5502705|NCT04464759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5502706|NCT04464759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5502707|NCT04464759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5502708|NCT04464694|Ranibizumab|ranibizumab|mesh-list
5502709|NCT04464694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5502710|NCT04464694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5502711|NCT04464694|Growth Substances|growth substances|mesh-ancestor
5502712|NCT04464694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502713|NCT04464694|Growth Inhibitors|growth inhibitors|mesh-ancestor
5502714|NCT04464694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5502715|NCT04464811|Furosemide|furosemide|mesh-list
5502716|NCT04464811|Diuretics|diuretics|mesh-ancestor
6646366|NCT01410968|Interferon Inducers|interferon inducers|mesh-ancestor
6646367|NCT01410968|Immunologic Factors|immunologic factors|mesh-ancestor
6646368|NCT01410968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646369|NCT01411072|Gemcitabine|gemcitabine|mesh-list
6646370|NCT01411072|Fluorouracil|fluorouracil|mesh-list
6646371|NCT01411072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6646372|NCT01411072|Antimetabolites|antimetabolites|mesh-ancestor
6646373|NCT01411072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646374|NCT01411072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6646375|NCT01411072|Antiviral Agents|antiviral agents|mesh-ancestor
6646376|NCT01411072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6646377|NCT01411072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6646378|NCT01411072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6646379|NCT01411072|Immunologic Factors|immunologic factors|mesh-ancestor
6646380|NCT01411072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646381|NCT01411098|Etoposide|etoposide|mesh-list
6646382|NCT01411098|Etoposide phosphate|etoposide phosphate|mesh-list
6646383|NCT01411098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6646384|NCT01411098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6646385|NCT01411098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6646386|NCT01411098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6646387|NCT01411098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6646388|NCT01411098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646389|NCT01411111|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6646390|NCT01411111|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6646391|NCT01411111|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6646392|NCT01411111|Antimetabolites|antimetabolites|mesh-ancestor
6646393|NCT01411111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646394|NCT01411111|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6646395|NCT01411111|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6646396|NCT01411111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6646397|NCT01411124|Diphenhydramine|diphenhydramine|mesh-list
6646398|NCT01411124|Promethazine|promethazine|mesh-list
5486943|NCT03897881|Pembrolizumab|pembrolizumab|mesh-list
5486944|NCT03897881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5486945|NCT03897881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6646399|NCT01411124|Gabapentin|gabapentin|mesh-list
6646400|NCT01411124|Analgesics|analgesics|mesh-ancestor
6646401|NCT01411124|Sensory System Agents|sensory system agents|mesh-ancestor
6646402|NCT01411124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6646403|NCT01411124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646404|NCT01411124|Anticonvulsants|anticonvulsants|mesh-ancestor
6646405|NCT01411124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6646406|NCT01411124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6646407|NCT01411124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6646408|NCT01411124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6646409|NCT01411124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6646410|NCT01411124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6646411|NCT01411124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6646412|NCT01411124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646413|NCT01411124|Antimanic Agents|antimanic agents|mesh-ancestor
6646414|NCT01411124|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6646415|NCT01411124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6646416|NCT01411124|Anesthetics, Local|anesthetics, local|mesh-ancestor
6646417|NCT01411124|Anesthetics|anesthetics|mesh-ancestor
6646418|NCT01411124|Antiemetics|antiemetics|mesh-ancestor
6646419|NCT01411124|Autonomic Agents|autonomic agents|mesh-ancestor
6646420|NCT01411124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6646421|NCT01411124|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6646422|NCT01411124|Histamine Antagonists|histamine antagonists|mesh-ancestor
5486946|NCT03875079|Pembrolizumab|pembrolizumab|mesh-list
6646423|NCT01411124|Histamine Agents|histamine agents|mesh-ancestor
6646424|NCT01411124|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6646425|NCT01411124|Antipruritics|antipruritics|mesh-ancestor
6646426|NCT01411124|Dermatologic Agents|dermatologic agents|mesh-ancestor
6646427|NCT01411176|Menthol|menthol|mesh-list
6646428|NCT01411176|Antipruritics|antipruritics|mesh-ancestor
6646429|NCT01411176|Dermatologic Agents|dermatologic agents|mesh-ancestor
6646430|NCT01411189|Menthol|menthol|mesh-list
6646431|NCT01411189|Antipruritics|antipruritics|mesh-ancestor
6646432|NCT01411189|Dermatologic Agents|dermatologic agents|mesh-ancestor
6646433|NCT01411202|Doxycycline|doxycycline|mesh-list
6646434|NCT01411202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6646435|NCT01411202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6646436|NCT01411202|Antimalarials|antimalarials|mesh-ancestor
6646437|NCT01411202|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6646438|NCT01411202|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6646439|NCT01411254|Betamethasone|betamethasone|mesh-list
6646440|NCT01411254|Betamethasone Valerate|betamethasone valerate|mesh-list
6646441|NCT01411254|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
6646442|NCT01411254|Betamethasone benzoate|betamethasone benzoate|mesh-list
6646443|NCT01411254|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
6646444|NCT01411254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6646445|NCT01411254|Glucocorticoids|glucocorticoids|mesh-ancestor
6646446|NCT01411254|Hormones|hormones|mesh-ancestor
6646447|NCT01411254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6646448|NCT01411254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646449|NCT01411254|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6646450|NCT01411254|Respiratory System Agents|respiratory system agents|mesh-ancestor
6646451|NCT01411280|Methylphenidate|methylphenidate|mesh-list
6646452|NCT01411280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6646453|NCT01411280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646454|NCT01411280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6646455|NCT01411280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6646456|NCT01411280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6646457|NCT01411280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646458|NCT01411280|Dopamine Agents|dopamine agents|mesh-ancestor
6646459|NCT01411280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6646460|NCT01411410|Paclitaxel|paclitaxel|mesh-list
6646461|NCT01411410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6646462|NCT01411410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6646463|NCT01411410|Tubulin Modulators|tubulin modulators|mesh-ancestor
6646464|NCT01411410|Antimitotic Agents|antimitotic agents|mesh-ancestor
6646465|NCT01411410|Mitosis Modulators|mitosis modulators|mesh-ancestor
6646466|NCT01411410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646467|NCT01411423|Sorafenib|sorafenib|mesh-list
6646468|NCT01411423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6646469|NCT01411423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6646470|NCT01411423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6646471|NCT01411423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646472|NCT01411436|Sorafenib|sorafenib|mesh-list
6646473|NCT01411436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6646474|NCT01411436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6646475|NCT01411436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6646476|NCT01411436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646477|NCT01411514|Prednisone|prednisone|mesh-list
6646478|NCT01411514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6646479|NCT01411514|Glucocorticoids|glucocorticoids|mesh-ancestor
6646480|NCT01411514|Hormones|hormones|mesh-ancestor
6646481|NCT01411514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6646482|NCT01411514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646483|NCT01411514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6646484|NCT01411514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6646485|NCT01411670|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
6646486|NCT01411670|Protein C|protein c|mesh-list
6646487|NCT01411670|Anticoagulants|anticoagulants|mesh-ancestor
6646488|NCT01411670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6646489|NCT01411670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5486947|NCT03875079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5486948|NCT03875079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5486949|NCT03827798|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5486950|NCT03827798|Immunologic Factors|immunologic factors|mesh-ancestor
5486951|NCT03827798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486952|NCT03739931|Durvalumab|durvalumab|mesh-list
5486953|NCT03739931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5486954|NCT03739931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6646490|NCT01411670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486955|NCT03737461|Lidocaine|lidocaine|mesh-list
6646491|NCT01411670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6646492|NCT01411735|Enalapril|enalapril|mesh-list
6646493|NCT01411735|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6646494|NCT01411735|Protease Inhibitors|protease inhibitors|mesh-ancestor
6646495|NCT01411735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6646496|NCT01411735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646497|NCT01411735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6646498|NCT01411930|Olanzapine|olanzapine|mesh-list
6646499|NCT01411930|Aripiprazole|aripiprazole|mesh-list
6646500|NCT01411930|Antiemetics|antiemetics|mesh-ancestor
6646501|NCT01411930|Autonomic Agents|autonomic agents|mesh-ancestor
6646502|NCT01411930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6646503|NCT01411930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646504|NCT01411930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6646505|NCT01411930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6646506|NCT01411930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6646507|NCT01411930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6646508|NCT01411930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6646509|NCT01411930|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6646510|NCT01411930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6646511|NCT01411930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6646512|NCT01411930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646513|NCT01411930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6646514|NCT01411930|Serotonin Agents|serotonin agents|mesh-ancestor
6646515|NCT01411930|Antidepressive Agents|antidepressive agents|mesh-ancestor
6646516|NCT01411930|Dopamine Agonists|dopamine agonists|mesh-ancestor
6646517|NCT01411930|Dopamine Agents|dopamine agents|mesh-ancestor
6646518|NCT01411930|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6646519|NCT01411930|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6646520|NCT01411930|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6646521|NCT01411930|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6646522|NCT01411930|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6646523|NCT01411930|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6646524|NCT01411969|Phenylephrine|phenylephrine|mesh-list
6646525|NCT01411969|Oxymetazoline|oxymetazoline|mesh-list
6646526|NCT01411969|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6646527|NCT01411969|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6646528|NCT01411969|Adrenergic Agents|adrenergic agents|mesh-ancestor
6646529|NCT01411969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6646530|NCT01411969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646531|NCT01411969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646532|NCT01411969|Sympathomimetics|sympathomimetics|mesh-ancestor
6646533|NCT01411969|Autonomic Agents|autonomic agents|mesh-ancestor
6646534|NCT01411969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6646535|NCT01411969|Nasal Decongestants|nasal decongestants|mesh-ancestor
6646536|NCT01411969|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6646537|NCT01411969|Respiratory System Agents|respiratory system agents|mesh-ancestor
6646538|NCT01411969|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6646539|NCT01411969|Mydriatics|mydriatics|mesh-ancestor
6646540|NCT01411969|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6646541|NCT01411969|Protective Agents|protective agents|mesh-ancestor
6646542|NCT01412008|Botulinum Toxins|botulinum toxins|mesh-list
6646543|NCT01412008|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6646544|NCT01412008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6646545|NCT01412008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646546|NCT01412008|Cholinergic Agents|cholinergic agents|mesh-ancestor
6646547|NCT01412008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6646548|NCT01412008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646549|NCT01412073|Misoprostol|misoprostol|mesh-list
6646550|NCT01412073|Oxytocin|oxytocin|mesh-list
6646551|NCT01412073|Oxytocics|oxytocics|mesh-ancestor
6646552|NCT01412073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6646553|NCT01412073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646554|NCT01412073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6646555|NCT01412073|Abortifacient Agents|abortifacient agents|mesh-ancestor
6646556|NCT01412073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6646557|NCT01412073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6646558|NCT01412190|Hyaluronic Acid|hyaluronic acid|mesh-list
5486956|NCT03737461|Anesthetics, Local|anesthetics, local|mesh-ancestor
5486957|NCT03737461|Anesthetics|anesthetics|mesh-ancestor
5486958|NCT03737461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5486959|NCT03737461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486960|NCT03737461|Sensory System Agents|sensory system agents|mesh-ancestor
5486961|NCT03737461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6646559|NCT01412190|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5486962|NCT03737461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5486963|NCT03737461|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5486964|NCT03737461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5486965|NCT03737461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5486966|NCT03737461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486967|NCT03712098|Liraglutide|liraglutide|mesh-list
6646560|NCT01412190|Immunologic Factors|immunologic factors|mesh-ancestor
6646561|NCT01412190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646562|NCT01412190|Viscosupplements|viscosupplements|mesh-ancestor
6646563|NCT01412190|Protective Agents|protective agents|mesh-ancestor
6646564|NCT01412294|Capecitabine|capecitabine|mesh-list
6646565|NCT01412294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6646566|NCT01412294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6646567|NCT01412294|Antimetabolites|antimetabolites|mesh-ancestor
6646568|NCT01412294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646569|NCT01412307|Lenalidomide|lenalidomide|mesh-list
6646570|NCT01412307|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6646571|NCT01412307|Immunologic Factors|immunologic factors|mesh-ancestor
6646572|NCT01412307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646573|NCT01412307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6646574|NCT01412307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6646575|NCT01412307|Growth Substances|growth substances|mesh-ancestor
6646576|NCT01412307|Growth Inhibitors|growth inhibitors|mesh-ancestor
6646577|NCT01412307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6646578|NCT01412307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6646579|NCT01412307|Alkylating Agents|alkylating agents|mesh-ancestor
6646580|NCT01412307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646581|NCT01412385|Immunoglobulins|immunoglobulins|mesh-list
6646582|NCT01412385|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6646583|NCT01412385|Antibodies|antibodies|mesh-list
6646584|NCT01412385|gamma-Globulins|gamma-globulins|mesh-list
6646585|NCT01412385|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6646586|NCT01412385|Immunoglobulin G|immunoglobulin g|mesh-list
6646587|NCT01412385|Immunologic Factors|immunologic factors|mesh-ancestor
6646588|NCT01412385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646589|NCT01412411|Micronutrients|micronutrients|mesh-list
6646590|NCT01412411|Trace Elements|trace elements|mesh-list
6646591|NCT01412411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646592|NCT01412437|Verapamil|verapamil|mesh-list
6646593|NCT01412437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6646594|NCT01412437|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6646595|NCT01412437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6646596|NCT01412437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646597|NCT01412437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6646598|NCT01412437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646599|NCT01412437|Vasodilator Agents|vasodilator agents|mesh-ancestor
6646600|NCT01412515|Everolimus|everolimus|mesh-list
6646601|NCT01412515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6646602|NCT01412515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6646603|NCT01412515|Immunologic Factors|immunologic factors|mesh-ancestor
6646604|NCT01412515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646605|NCT01412567|Vaccines|vaccines|mesh-list
6646606|NCT01412567|Immunologic Factors|immunologic factors|mesh-ancestor
6646607|NCT01412567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646608|NCT01412632|Remifentanil|remifentanil|mesh-list
6646609|NCT01412632|Propofol|propofol|mesh-list
6646610|NCT01412632|Prilocaine|prilocaine|mesh-list
6646611|NCT01412632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6646612|NCT01412632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6646613|NCT01412632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646614|NCT01412632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6646615|NCT01412632|Anesthetics, General|anesthetics, general|mesh-ancestor
6646616|NCT01412632|Anesthetics|anesthetics|mesh-ancestor
6646617|NCT01412632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6646618|NCT01412632|Narcotics|narcotics|mesh-ancestor
6646619|NCT01412632|Analgesics|analgesics|mesh-ancestor
6646620|NCT01412632|Sensory System Agents|sensory system agents|mesh-ancestor
6646621|NCT01412632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6646622|NCT01412632|Anesthetics, Local|anesthetics, local|mesh-ancestor
6646623|NCT01412645|Resveratrol|resveratrol|mesh-list
5486968|NCT03712098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6646624|NCT01412645|Antioxidants|antioxidants|mesh-ancestor
6646625|NCT01412645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646626|NCT01412645|Protective Agents|protective agents|mesh-ancestor
6646627|NCT01412645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646628|NCT01412645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6646629|NCT01412645|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6646630|NCT01412658|Caseins|caseins|mesh-list
6646631|NCT01412658|Glycerol|glycerol|mesh-list
6646632|NCT01412658|Chelating Agents|chelating agents|mesh-ancestor
6646633|NCT01412658|Sequestering Agents|sequestering agents|mesh-ancestor
6646634|NCT01412658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646635|NCT01412658|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6646636|NCT01412658|Protective Agents|protective agents|mesh-ancestor
6646637|NCT01412658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646638|NCT01412671|Sorafenib|sorafenib|mesh-list
6646639|NCT01412671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6646640|NCT01412671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6646641|NCT01412671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6646642|NCT01412671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646643|NCT01412840|Diclofenac|diclofenac|mesh-list
6646644|NCT01412840|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6646645|NCT01412840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6646646|NCT01412840|Analgesics|analgesics|mesh-ancestor
6646647|NCT01412840|Sensory System Agents|sensory system agents|mesh-ancestor
6646648|NCT01412840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6646649|NCT01412840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646650|NCT01412840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6646651|NCT01412840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6646652|NCT01412840|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6646653|NCT01412840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6646654|NCT01412840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646655|NCT01412892|Everolimus|everolimus|mesh-list
6646656|NCT01412892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6646657|NCT01412892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6646658|NCT01412892|Immunologic Factors|immunologic factors|mesh-ancestor
6646659|NCT01412892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646660|NCT01413022|Leucovorin|leucovorin|mesh-list
6646661|NCT01413022|Fluorouracil|fluorouracil|mesh-list
6646662|NCT01413022|Oxaliplatin|oxaliplatin|mesh-list
6646663|NCT01413022|Irinotecan|irinotecan|mesh-list
6646664|NCT01413022|Antimetabolites|antimetabolites|mesh-ancestor
6646665|NCT01413022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646666|NCT01413022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6646667|NCT01413022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6646668|NCT01413022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6646669|NCT01413022|Immunologic Factors|immunologic factors|mesh-ancestor
6646670|NCT01413022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646671|NCT01413022|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6646672|NCT01413022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6646673|NCT01413022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6646674|NCT01413022|Antidotes|antidotes|mesh-ancestor
6646675|NCT01413022|Protective Agents|protective agents|mesh-ancestor
6646676|NCT01413022|Vitamin B Complex|vitamin b complex|mesh-ancestor
6646677|NCT01413022|Vitamins|vitamins|mesh-ancestor
6646678|NCT01413022|Micronutrients|micronutrients|mesh-ancestor
6646679|NCT01413048|Carvedilol|carvedilol|mesh-list
6646680|NCT01413048|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6646681|NCT01413048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6646682|NCT01413048|Adrenergic Agents|adrenergic agents|mesh-ancestor
5486969|NCT03712098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486970|NCT03712098|Incretins|incretins|mesh-ancestor
5486971|NCT03712098|Hormones|hormones|mesh-ancestor
5486972|NCT03712098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5486973|NCT03694834|Pembrolizumab|pembrolizumab|mesh-list
5486974|NCT03694834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5486975|NCT03694834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5486976|NCT03679091|Clopidogrel|clopidogrel|mesh-list
5486977|NCT03679091|Ticagrelor|ticagrelor|mesh-list
5486978|NCT03679091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6646683|NCT01413048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6646684|NCT01413048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646685|NCT01413048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646686|NCT01413048|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6646687|NCT01413048|Antioxidants|antioxidants|mesh-ancestor
6646688|NCT01413048|Protective Agents|protective agents|mesh-ancestor
6646689|NCT01413048|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6646690|NCT01413048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6646691|NCT01413048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6646692|NCT01413048|Vasodilator Agents|vasodilator agents|mesh-ancestor
6646693|NCT01413048|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6646694|NCT01413048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6646695|NCT01413230|Cholecalciferol|cholecalciferol|mesh-list
6646696|NCT01413230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6646697|NCT01413230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646698|NCT01413230|Vitamins|vitamins|mesh-ancestor
6646699|NCT01413230|Micronutrients|micronutrients|mesh-ancestor
6646700|NCT01413230|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5486979|NCT03679091|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5486980|NCT03679091|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5486981|NCT03679091|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5486982|NCT03679091|Purinergic Agents|purinergic agents|mesh-ancestor
5486983|NCT03679091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5486984|NCT03679091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486985|NCT03679091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486986|NCT03677141|Prednisone|prednisone|mesh-list
5486987|NCT03677141|Cyclophosphamide|cyclophosphamide|mesh-list
5486988|NCT03677141|Doxorubicin|doxorubicin|mesh-list
5486989|NCT03677141|Vincristine|vincristine|mesh-list
5486990|NCT03677141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5486991|NCT03677141|Immunologic Factors|immunologic factors|mesh-ancestor
5502717|NCT04464811|Natriuretic Agents|natriuretic agents|mesh-ancestor
6663987|NCT01510509|Everolimus|everolimus|mesh-list
6663988|NCT01510509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6663989|NCT01510509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6663990|NCT01510509|Immunologic Factors|immunologic factors|mesh-ancestor
6663991|NCT01510509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663992|NCT01510522|Metformin|metformin|mesh-list
6663993|NCT01510522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6663994|NCT01510522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6663995|NCT01510548|Adalimumab|adalimumab|mesh-list
6663996|NCT01510548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6663997|NCT01510548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6663998|NCT01510561|Gemcitabine|gemcitabine|mesh-list
6663999|NCT01510561|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6664000|NCT01510561|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
6664001|NCT01510561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6664002|NCT01510561|Antimetabolites|antimetabolites|mesh-ancestor
6664003|NCT01510561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6664004|NCT01510561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6664005|NCT01510561|Antiviral Agents|antiviral agents|mesh-ancestor
6664006|NCT01510561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6664007|NCT01510561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6664008|NCT01510561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6664009|NCT01510561|Immunologic Factors|immunologic factors|mesh-ancestor
6664010|NCT01510561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664011|NCT01510561|Chelating Agents|chelating agents|mesh-ancestor
6664012|NCT01510561|Sequestering Agents|sequestering agents|mesh-ancestor
6664013|NCT01510574|Misoprostol|misoprostol|mesh-list
6664014|NCT01510574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6664015|NCT01510574|Abortifacient Agents|abortifacient agents|mesh-ancestor
6664016|NCT01510574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6664017|NCT01510574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664018|NCT01510574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6664019|NCT01510574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6664020|NCT01510574|Oxytocics|oxytocics|mesh-ancestor
6664021|NCT01510613|Dexamethasone|dexamethasone|mesh-list
6664022|NCT01510613|Pomalidomide|pomalidomide|mesh-list
6664023|NCT01510613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6664024|NCT01510613|Antiemetics|antiemetics|mesh-ancestor
6664025|NCT01510613|Autonomic Agents|autonomic agents|mesh-ancestor
6664026|NCT01510613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6664027|NCT01510613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664028|NCT01510613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6664029|NCT01510613|Glucocorticoids|glucocorticoids|mesh-ancestor
6664030|NCT01510613|Hormones|hormones|mesh-ancestor
6664031|NCT01510613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6664032|NCT01510613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6664033|NCT01510613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6664034|NCT01510613|Immunologic Factors|immunologic factors|mesh-ancestor
6664035|NCT01510613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6664036|NCT01510613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6664037|NCT01510613|Growth Substances|growth substances|mesh-ancestor
6664038|NCT01510613|Growth Inhibitors|growth inhibitors|mesh-ancestor
6664039|NCT01510626|Omalizumab|omalizumab|mesh-list
6664040|NCT01510626|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6664041|NCT01510626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6664042|NCT01510626|Respiratory System Agents|respiratory system agents|mesh-ancestor
6646701|NCT01413477|Calcitriol|calcitriol|mesh-list
6646702|NCT01413477|Betamethasone|betamethasone|mesh-list
6646703|NCT01413477|Betamethasone Valerate|betamethasone valerate|mesh-list
6646704|NCT01413477|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
6646705|NCT01413477|Betamethasone benzoate|betamethasone benzoate|mesh-list
6646706|NCT01413477|Calcipotriene|calcipotriene|mesh-list
6646707|NCT01413477|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
6646708|NCT01413477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6646709|NCT01413477|Glucocorticoids|glucocorticoids|mesh-ancestor
6646710|NCT01413477|Hormones|hormones|mesh-ancestor
6646711|NCT01413477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6646712|NCT01413477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646713|NCT01413477|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6646714|NCT01413477|Respiratory System Agents|respiratory system agents|mesh-ancestor
6646715|NCT01413477|Dermatologic Agents|dermatologic agents|mesh-ancestor
6646716|NCT01413477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6646717|NCT01413477|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6646718|NCT01413477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6646719|NCT01413477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646720|NCT01413477|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6646721|NCT01413477|Vitamins|vitamins|mesh-ancestor
6646722|NCT01413477|Micronutrients|micronutrients|mesh-ancestor
6646723|NCT01413477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6646724|NCT01413490|Rimantadine|rimantadine|mesh-list
6646725|NCT01413490|Antiviral Agents|antiviral agents|mesh-ancestor
6646726|NCT01413490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6646727|NCT01413490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6646728|NCT01413490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6646729|NCT01413490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646730|NCT01413581|Bile Acids and Salts|bile acids and salts|mesh-list
6646731|NCT01413581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6646732|NCT01413620|Vitamins|vitamins|mesh-list
6646733|NCT01413620|Vitamin E|vitamin e|mesh-list
6646734|NCT01413620|Tocopherols|tocopherols|mesh-list
6646735|NCT01413620|Tocotrienols|tocotrienols|mesh-list
6646736|NCT01413620|alpha-Tocopherol|alpha-tocopherol|mesh-list
6646737|NCT01413620|Micronutrients|micronutrients|mesh-ancestor
6646738|NCT01413620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646739|NCT01413620|Antioxidants|antioxidants|mesh-ancestor
6646740|NCT01413620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646741|NCT01413620|Protective Agents|protective agents|mesh-ancestor
6646742|NCT01413711|Vigabatrin|vigabatrin|mesh-list
6646743|NCT01413711|Anticonvulsants|anticonvulsants|mesh-ancestor
6646744|NCT01413711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6646745|NCT01413711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646746|NCT01413711|GABA Agents|gaba agents|mesh-ancestor
6646747|NCT01413711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6646748|NCT01413711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646749|NCT01413763|Imiquimod|imiquimod|mesh-list
6646750|NCT01413763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6646751|NCT01413763|Immunologic Factors|immunologic factors|mesh-ancestor
6646752|NCT01413763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646753|NCT01413763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6646754|NCT01413763|Interferon Inducers|interferon inducers|mesh-ancestor
6646755|NCT01413854|Diclofenac|diclofenac|mesh-list
6646756|NCT01413854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6646757|NCT01413854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6646758|NCT01413854|Analgesics|analgesics|mesh-ancestor
6646759|NCT01413854|Sensory System Agents|sensory system agents|mesh-ancestor
6646760|NCT01413854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6646761|NCT01413854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486992|NCT03677141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5486993|NCT03677141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5486994|NCT03677141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5486995|NCT03677141|Alkylating Agents|alkylating agents|mesh-ancestor
5486996|NCT03677141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5486997|NCT03677141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5486998|NCT03677141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5486999|NCT03677141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5487000|NCT03677141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5487001|NCT03677141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5487002|NCT03677141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5487003|NCT03677141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6646762|NCT01413854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6646763|NCT01413854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5487004|NCT03677141|Glucocorticoids|glucocorticoids|mesh-ancestor
6646764|NCT01413854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6646765|NCT01413854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6646766|NCT01413854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646767|NCT01414140|Levonorgestrel|levonorgestrel|mesh-list
6646768|NCT01414140|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6646769|NCT01414140|Contraceptive Agents|contraceptive agents|mesh-ancestor
6646770|NCT01414140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6646771|NCT01414140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5487005|NCT03677141|Hormones|hormones|mesh-ancestor
5487006|NCT03677141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5487007|NCT03677141|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5487008|NCT03677141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5487009|NCT03677141|Tubulin Modulators|tubulin modulators|mesh-ancestor
5487010|NCT03677141|Antimitotic Agents|antimitotic agents|mesh-ancestor
5487011|NCT03677141|Mitosis Modulators|mitosis modulators|mesh-ancestor
5487012|NCT03651518|Rituximab|rituximab|mesh-list
5487013|NCT03651518|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5487014|NCT03651518|Ustekinumab|ustekinumab|mesh-list
5487015|NCT03651518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5487016|NCT03651518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5487017|NCT03651518|Immunologic Factors|immunologic factors|mesh-ancestor
5487018|NCT03651518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5487019|NCT03651518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5487020|NCT03651518|Dermatologic Agents|dermatologic agents|mesh-ancestor
5487021|NCT03624517|Octreotide|octreotide|mesh-list
5487022|NCT03624517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5487023|NCT03624517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5487024|NCT03624517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5487025|NCT03594474|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
5487026|NCT03594474|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
5487027|NCT03594474|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5487028|NCT03594474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5487029|NCT03592212|Albuterol|albuterol|mesh-list
5487030|NCT03592212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5487031|NCT03592212|Autonomic Agents|autonomic agents|mesh-ancestor
5487032|NCT03592212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5487033|NCT03592212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5487034|NCT03592212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5487035|NCT03592212|Respiratory System Agents|respiratory system agents|mesh-ancestor
5487036|NCT03592212|Tocolytic Agents|tocolytic agents|mesh-ancestor
5487037|NCT03592212|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5487038|NCT03592212|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5487039|NCT03592212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5487040|NCT03592212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6646772|NCT01414140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6646773|NCT01414140|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6646774|NCT01414140|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6646775|NCT01414231|Cytarabine|cytarabine|mesh-list
6646776|NCT01414231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6646777|NCT01414231|Antimetabolites|antimetabolites|mesh-ancestor
6646778|NCT01414231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646779|NCT01414231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6646780|NCT01414231|Antiviral Agents|antiviral agents|mesh-ancestor
6646781|NCT01414231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6646782|NCT01414231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6646783|NCT01414231|Immunologic Factors|immunologic factors|mesh-ancestor
6646784|NCT01414231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646785|NCT01414465|Orlistat|orlistat|mesh-list
6646786|NCT01414465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6646787|NCT01414465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646788|NCT01414465|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6646789|NCT01414465|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6646790|NCT01414504|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6646791|NCT01414504|Immunologic Factors|immunologic factors|mesh-ancestor
6646792|NCT01414504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646793|NCT01414530|Contraceptive Agents|contraceptive agents|mesh-list
6646794|NCT01414530|Contraceptives, Oral|contraceptives, oral|mesh-list
6646795|NCT01414530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5487041|NCT03592212|Adrenergic Agents|adrenergic agents|mesh-ancestor
5487042|NCT03592212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5487043|NCT03592212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487044|NCT03475381|Ivacaftor|ivacaftor|mesh-list
5487045|NCT03475381|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6646796|NCT01414530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646797|NCT01414530|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6646798|NCT01414556|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
6646799|NCT01414556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6646800|NCT01414556|Incretins|incretins|mesh-ancestor
6646801|NCT01414556|Hormones|hormones|mesh-ancestor
6646802|NCT01414556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6646803|NCT01414556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646804|NCT01414569|Dexamethasone|dexamethasone|mesh-list
6646805|NCT01414569|Dexamethasone acetate|dexamethasone acetate|mesh-list
6646806|NCT01414569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6646807|NCT01414569|Antiemetics|antiemetics|mesh-ancestor
6646808|NCT01414569|Autonomic Agents|autonomic agents|mesh-ancestor
6646809|NCT01414569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6646810|NCT01414569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646811|NCT01414569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6646812|NCT01414569|Glucocorticoids|glucocorticoids|mesh-ancestor
6646813|NCT01414569|Hormones|hormones|mesh-ancestor
6646814|NCT01414569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6646815|NCT01414569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6646816|NCT01414569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6646817|NCT01414608|Paclitaxel|paclitaxel|mesh-list
6646818|NCT01414608|Cisplatin|cisplatin|mesh-list
6646819|NCT01414608|Carboplatin|carboplatin|mesh-list
6646820|NCT01414608|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6646821|NCT01414608|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6646822|NCT01414608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6646823|NCT01414608|Tubulin Modulators|tubulin modulators|mesh-ancestor
6646824|NCT01414608|Antimitotic Agents|antimitotic agents|mesh-ancestor
6646825|NCT01414608|Mitosis Modulators|mitosis modulators|mesh-ancestor
6646826|NCT01414608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646827|NCT01414777|Ondansetron|ondansetron|mesh-list
6646828|NCT01414777|Antiemetics|antiemetics|mesh-ancestor
6646829|NCT01414777|Autonomic Agents|autonomic agents|mesh-ancestor
6646830|NCT01414777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6646831|NCT01414777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646832|NCT01414777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6646833|NCT01414777|Antipruritics|antipruritics|mesh-ancestor
6646834|NCT01414777|Dermatologic Agents|dermatologic agents|mesh-ancestor
6646835|NCT01414777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6646836|NCT01414777|Serotonin Agents|serotonin agents|mesh-ancestor
6646837|NCT01414777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6646838|NCT01414777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646839|NCT01414777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6646840|NCT01414777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6646841|NCT01414777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5487046|NCT03475381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5487047|NCT03475381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487048|NCT03465540|Dexamethasone|dexamethasone|mesh-list
5487049|NCT03465540|Azacitidine|azacitidine|mesh-list
5487050|NCT03465540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5487051|NCT03465540|Antiemetics|antiemetics|mesh-ancestor
5487052|NCT03465540|Autonomic Agents|autonomic agents|mesh-ancestor
5487053|NCT03465540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6646842|NCT01414777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6646843|NCT01414777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6646844|NCT01414816|Interferons|interferons|mesh-list
6646845|NCT01414816|Interferon-beta|interferon-beta|mesh-list
6646846|NCT01414816|Interferon beta-1b|interferon beta-1b|mesh-list
6646847|NCT01414816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6646848|NCT01414816|Antiviral Agents|antiviral agents|mesh-ancestor
6646849|NCT01414816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6646850|NCT01414816|Immunologic Factors|immunologic factors|mesh-ancestor
6646851|NCT01414816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646852|NCT01414816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6646853|NCT01414842|Dialysis Solutions|dialysis solutions|mesh-list
6646854|NCT01414842|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6646855|NCT01414868|Montelukast|montelukast|mesh-list
6646856|NCT01414868|Leukotriene Antagonists|leukotriene antagonists|mesh-list
6646857|NCT01414868|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6646858|NCT01414868|Respiratory System Agents|respiratory system agents|mesh-ancestor
6646859|NCT01414868|Hormone Antagonists|hormone antagonists|mesh-ancestor
6646860|NCT01414868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6646861|NCT01414868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646862|NCT01414868|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6646863|NCT01414868|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6646864|NCT01414868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646865|NCT01414881|Mipomersen|mipomersen|mesh-list
6646866|NCT01414881|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6646867|NCT01414881|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6646868|NCT01414881|Antimetabolites|antimetabolites|mesh-ancestor
6646869|NCT01414881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646870|NCT01414881|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5487054|NCT03465540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5487055|NCT03465540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5487056|NCT03465540|Glucocorticoids|glucocorticoids|mesh-ancestor
5487057|NCT03465540|Hormones|hormones|mesh-ancestor
5487058|NCT03465540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5487059|NCT03465540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5487060|NCT03465540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5487061|NCT03465540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5487062|NCT03465540|Antimetabolites|antimetabolites|mesh-ancestor
5487063|NCT03465540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487064|NCT03465540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5487065|NCT03436199|Amantadine|amantadine|mesh-list
5487066|NCT03436199|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5487067|NCT03436199|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5487068|NCT03436199|Antiviral Agents|antiviral agents|mesh-ancestor
5487069|NCT03436199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5487070|NCT03436199|Dopamine Agents|dopamine agents|mesh-ancestor
5487071|NCT03436199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5487072|NCT03436199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487073|NCT03436199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5487074|NCT03436199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5487075|NCT03436199|Analgesics|analgesics|mesh-ancestor
5487076|NCT03436199|Sensory System Agents|sensory system agents|mesh-ancestor
6646871|NCT01414972|Vitamin A|vitamin a|mesh-list
6646872|NCT01414972|Vitamins|vitamins|mesh-ancestor
6646873|NCT01414972|Micronutrients|micronutrients|mesh-ancestor
6646874|NCT01414972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646875|NCT01414998|Nicotine|nicotine|mesh-list
6646876|NCT01414998|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6646877|NCT01414998|Autonomic Agents|autonomic agents|mesh-ancestor
6646878|NCT01414998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6646879|NCT01414998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646880|NCT01414998|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6646881|NCT01414998|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5487077|NCT03436199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5487078|NCT03353233|Ropivacaine|ropivacaine|mesh-list
5487079|NCT03353233|Anesthetics, Local|anesthetics, local|mesh-ancestor
5487080|NCT03353233|Anesthetics|anesthetics|mesh-ancestor
5487081|NCT03353233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5487082|NCT03353233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5487083|NCT03353233|Sensory System Agents|sensory system agents|mesh-ancestor
6646882|NCT01414998|Cholinergic Agents|cholinergic agents|mesh-ancestor
6646883|NCT01414998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6646884|NCT01414998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646885|NCT01415011|Afatinib|afatinib|mesh-list
6646886|NCT01415011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6646887|NCT01415011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6646888|NCT01415011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6646889|NCT01415011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6664043|NCT01510665|Magnesium citrate|magnesium citrate|mesh-list
6664044|NCT01510665|Cathartics|cathartics|mesh-ancestor
6664045|NCT01510665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6664046|NCT01510795|Spironolactone|spironolactone|mesh-list
6664047|NCT01510795|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6664048|NCT01510795|Hormone Antagonists|hormone antagonists|mesh-ancestor
6664049|NCT01510795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6664050|NCT01510795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664051|NCT01510795|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6664052|NCT01510795|Diuretics|diuretics|mesh-ancestor
6664053|NCT01510795|Natriuretic Agents|natriuretic agents|mesh-ancestor
6664054|NCT01510847|Testosterone undecanoate|testosterone undecanoate|mesh-list
6664055|NCT01510847|Androgens|androgens|mesh-ancestor
6664056|NCT01510847|Hormones|hormones|mesh-ancestor
6664057|NCT01510847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6664058|NCT01510847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664059|NCT01510860|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
6664060|NCT01510860|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5487084|NCT03353233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5487085|NCT03313778|Pembrolizumab|pembrolizumab|mesh-list
5487086|NCT03313778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5487087|NCT03313778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5487088|NCT03273322|Rivaroxaban|rivaroxaban|mesh-list
5487089|NCT03273322|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5487090|NCT03273322|Antithrombins|antithrombins|mesh-ancestor
5487091|NCT03273322|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5487092|NCT03273322|Protease Inhibitors|protease inhibitors|mesh-ancestor
5487093|NCT03273322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5487094|NCT03273322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487095|NCT03273322|Anticoagulants|anticoagulants|mesh-ancestor
5487096|NCT03255252|Cisplatin|cisplatin|mesh-list
5487097|NCT03255252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5487098|NCT03250273|Nivolumab|nivolumab|mesh-list
5487099|NCT03250273|Entinostat|entinostat|mesh-list
5487100|NCT03250273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5487101|NCT03250273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5487102|NCT03250273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5487103|NCT03250273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487104|NCT03250273|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5487105|NCT03250273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5487106|NCT03217136|Metronidazole|metronidazole|mesh-list
5487107|NCT03217136|Meropenem|meropenem|mesh-list
5487108|NCT03217136|Tazobactam|tazobactam|mesh-list
6664061|NCT01510860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6664062|NCT01510977|Bisacodyl|bisacodyl|mesh-list
6664063|NCT01510977|Cathartics|cathartics|mesh-ancestor
6664064|NCT01510977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6664065|NCT01510977|Laxatives|laxatives|mesh-ancestor
6664066|NCT01510990|Gefitinib|gefitinib|mesh-list
6664067|NCT01510990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6664068|NCT01510990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6664069|NCT01510990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6664070|NCT01510990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6664071|NCT01511003|Tacrolimus|tacrolimus|mesh-list
6664072|NCT01511003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6664073|NCT01511003|Immunologic Factors|immunologic factors|mesh-ancestor
6664074|NCT01511003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5487109|NCT03217136|Ceftolozane|ceftolozane|mesh-list
6664075|NCT01511003|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6664076|NCT01511003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5487110|NCT03217136|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
5487111|NCT03217136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5487112|NCT03217136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6646890|NCT01415128|Rosiglitazone|rosiglitazone|mesh-list
6646891|NCT01415128|Desipramine|desipramine|mesh-list
6646892|NCT01415128|Omeprazole|omeprazole|mesh-list
6646893|NCT01415128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6646894|NCT01415128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6646895|NCT01415128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6646896|NCT01415128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6646897|NCT01415128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646898|NCT01415128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6646899|NCT01415128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646900|NCT01415128|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6646901|NCT01415128|Antidepressive Agents|antidepressive agents|mesh-ancestor
6646902|NCT01415128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6646903|NCT01415128|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6646904|NCT01415128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6646905|NCT01415128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5487113|NCT03217136|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5487114|NCT03217136|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6646906|NCT01415128|Adrenergic Agents|adrenergic agents|mesh-ancestor
6646907|NCT01415128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6646908|NCT01415141|Ribavirin|ribavirin|mesh-list
6646909|NCT01415141|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6646910|NCT01415141|Antimetabolites|antimetabolites|mesh-ancestor
6646911|NCT01415141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646912|NCT01415141|Antiviral Agents|antiviral agents|mesh-ancestor
6646913|NCT01415141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6646914|NCT01415284|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
6646915|NCT01415284|Plasma Substitutes|plasma substitutes|mesh-ancestor
6646916|NCT01415284|Blood Substitutes|blood substitutes|mesh-ancestor
6646917|NCT01415336|Cyclophosphamide|cyclophosphamide|mesh-list
5487115|NCT03217136|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5487116|NCT03217136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5487117|NCT03217136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487118|NCT03217136|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5487119|NCT03217136|Renal Agents|renal agents|mesh-ancestor
5487120|NCT03051659|Pembrolizumab|pembrolizumab|mesh-list
5487121|NCT03051659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5487122|NCT03051659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5487123|NCT02985957|Prednisone|prednisone|mesh-list
5487124|NCT02985957|Nivolumab|nivolumab|mesh-list
5487125|NCT02985957|Ipilimumab|ipilimumab|mesh-list
5487126|NCT02985957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5487127|NCT02985957|Glucocorticoids|glucocorticoids|mesh-ancestor
6646918|NCT01415336|Doxorubicin|doxorubicin|mesh-list
6646919|NCT01415336|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6646920|NCT01415336|Capecitabine|capecitabine|mesh-list
6646921|NCT01415336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6646922|NCT01415336|Immunologic Factors|immunologic factors|mesh-ancestor
6646923|NCT01415336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646924|NCT01415336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6646925|NCT01415336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6646926|NCT01415336|Alkylating Agents|alkylating agents|mesh-ancestor
6646927|NCT01415336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646928|NCT01415336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6646929|NCT01415336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6646930|NCT01415336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6646931|NCT01415336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6646932|NCT01415336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6646933|NCT01415336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6646934|NCT01415336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6646935|NCT01415336|Antimetabolites|antimetabolites|mesh-ancestor
6646936|NCT01415466|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6646937|NCT01415466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6646938|NCT01415466|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6646939|NCT01415466|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6646940|NCT01415466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646941|NCT01415505|Valsartan|valsartan|mesh-list
6646942|NCT01415505|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6646943|NCT01415505|Nebivolol|nebivolol|mesh-list
6646944|NCT01415505|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6646945|NCT01415505|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6646946|NCT01415505|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5487128|NCT02985957|Hormones|hormones|mesh-ancestor
6665093|NCT01515813|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6646947|NCT01415505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646948|NCT01415505|Diuretics|diuretics|mesh-ancestor
6646949|NCT01415505|Natriuretic Agents|natriuretic agents|mesh-ancestor
6646950|NCT01415505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646951|NCT01415505|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6646952|NCT01415505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6646953|NCT01415505|Vasodilator Agents|vasodilator agents|mesh-ancestor
6646954|NCT01415505|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6646955|NCT01415505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6646956|NCT01415505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6646957|NCT01415505|Adrenergic Agents|adrenergic agents|mesh-ancestor
6646958|NCT01415505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6453406|NCT00420355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6453407|NCT00420355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6453408|NCT00420355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6453409|NCT00420472|Mycophenolic Acid|mycophenolic acid|mesh-list
6453410|NCT00420472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6453411|NCT00420472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6453412|NCT00420472|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6453413|NCT00420472|Antitubercular Agents|antitubercular agents|mesh-ancestor
6453414|NCT00420472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6453415|NCT00420472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6453416|NCT00420472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6453417|NCT00420472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453418|NCT00420498|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6646959|NCT01415557|Micronutrients|micronutrients|mesh-list
6646960|NCT01415557|Trace Elements|trace elements|mesh-list
6646961|NCT01415557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6646962|NCT01415596|Albuterol|albuterol|mesh-list
6646963|NCT01415596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6646964|NCT01415596|Autonomic Agents|autonomic agents|mesh-ancestor
6646965|NCT01415596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6646966|NCT01415596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5487129|NCT02985957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5487130|NCT02985957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5487131|NCT02985957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5487132|NCT02985957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5487133|NCT02985957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6646967|NCT01415596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6646968|NCT01415596|Respiratory System Agents|respiratory system agents|mesh-ancestor
6646969|NCT01415596|Tocolytic Agents|tocolytic agents|mesh-ancestor
6646970|NCT01415596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6646971|NCT01415596|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6646972|NCT01415596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6646973|NCT01415596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6646974|NCT01415596|Adrenergic Agents|adrenergic agents|mesh-ancestor
6646975|NCT01415596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6646976|NCT01415596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646977|NCT01415687|Bisacodyl|bisacodyl|mesh-list
6646978|NCT01415687|Magnesium citrate|magnesium citrate|mesh-list
6646979|NCT01415687|Citric Acid|citric acid|mesh-list
6646980|NCT01415687|Sodium Citrate|sodium citrate|mesh-list
6646981|NCT01415687|Anticoagulants|anticoagulants|mesh-ancestor
6646982|NCT01415687|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6646983|NCT01415687|Chelating Agents|chelating agents|mesh-ancestor
6646984|NCT01415687|Sequestering Agents|sequestering agents|mesh-ancestor
6646985|NCT01415687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646986|NCT01415687|Cathartics|cathartics|mesh-ancestor
6646987|NCT01415687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6646988|NCT01415687|Laxatives|laxatives|mesh-ancestor
6646989|NCT01415713|Leucovorin|leucovorin|mesh-list
6646990|NCT01415713|Gemcitabine|gemcitabine|mesh-list
6646991|NCT01415713|Oxaliplatin|oxaliplatin|mesh-list
6646992|NCT01415713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6646993|NCT01415713|Antimetabolites|antimetabolites|mesh-ancestor
6646994|NCT01415713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6646995|NCT01415713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6646996|NCT01415713|Antiviral Agents|antiviral agents|mesh-ancestor
6646997|NCT01415713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6646998|NCT01415713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6646999|NCT01415713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6647000|NCT01415713|Immunologic Factors|immunologic factors|mesh-ancestor
6647001|NCT01415713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647002|NCT01415713|Antidotes|antidotes|mesh-ancestor
6647003|NCT01415713|Protective Agents|protective agents|mesh-ancestor
6647004|NCT01415713|Vitamin B Complex|vitamin b complex|mesh-ancestor
6647005|NCT01415713|Vitamins|vitamins|mesh-ancestor
6647006|NCT01415713|Micronutrients|micronutrients|mesh-ancestor
6647007|NCT01415765|Prednisone|prednisone|mesh-list
6647008|NCT01415765|Cyclophosphamide|cyclophosphamide|mesh-list
6647009|NCT01415765|Rituximab|rituximab|mesh-list
6647010|NCT01415765|Doxorubicin|doxorubicin|mesh-list
6647011|NCT01415765|Etoposide|etoposide|mesh-list
6647012|NCT01415765|Vincristine|vincristine|mesh-list
6647013|NCT01415765|Pevonedistat|pevonedistat|mesh-list
6647014|NCT01415765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6647015|NCT01415765|Immunologic Factors|immunologic factors|mesh-ancestor
6647016|NCT01415765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647017|NCT01415765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6647018|NCT01415765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6647019|NCT01415765|Alkylating Agents|alkylating agents|mesh-ancestor
6647020|NCT01415765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6647021|NCT01415765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6647022|NCT01415765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6647023|NCT01415765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6647024|NCT01415765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6647025|NCT01415765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6647026|NCT01415765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6647027|NCT01415765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6647028|NCT01415765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6647029|NCT01415765|Glucocorticoids|glucocorticoids|mesh-ancestor
6647030|NCT01415765|Hormones|hormones|mesh-ancestor
6647031|NCT01415765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6647032|NCT01415765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6647033|NCT01415765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6647034|NCT01415765|Tubulin Modulators|tubulin modulators|mesh-ancestor
6647035|NCT01415765|Antimitotic Agents|antimitotic agents|mesh-ancestor
6647036|NCT01415765|Mitosis Modulators|mitosis modulators|mesh-ancestor
6647037|NCT01415778|Bicalutamide|bicalutamide|mesh-list
6647038|NCT01415778|Androgen Antagonists|androgen antagonists|mesh-ancestor
6647039|NCT01415778|Hormone Antagonists|hormone antagonists|mesh-ancestor
6647040|NCT01415778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6647041|NCT01415778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647042|NCT01415778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6647043|NCT01415791|Bicalutamide|bicalutamide|mesh-list
6647044|NCT01415791|Androgen Antagonists|androgen antagonists|mesh-ancestor
6647045|NCT01415791|Hormone Antagonists|hormone antagonists|mesh-ancestor
6647046|NCT01415791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6647047|NCT01415791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647048|NCT01415791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6647049|NCT01415895|Clonidine|clonidine|mesh-list
6647050|NCT01415895|Naltrexone|naltrexone|mesh-list
6647051|NCT01415895|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6647052|NCT01415895|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6647053|NCT01415895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647054|NCT01415895|Sensory System Agents|sensory system agents|mesh-ancestor
6647055|NCT01415895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6647056|NCT01415895|Analgesics|analgesics|mesh-ancestor
5487134|NCT02985957|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5487135|NCT02985957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487136|NCT02983617|Obinutuzumab|obinutuzumab|mesh-list
5487137|NCT02983617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5487138|NCT02983617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6647057|NCT01415895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6647058|NCT01415895|Sympatholytics|sympatholytics|mesh-ancestor
6647059|NCT01415895|Autonomic Agents|autonomic agents|mesh-ancestor
6647060|NCT01415895|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6647061|NCT01415895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6647062|NCT01415895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6647063|NCT01415895|Adrenergic Agents|adrenergic agents|mesh-ancestor
6647064|NCT01415895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6647065|NCT01415895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6647066|NCT01416038|Cyclophosphamide|cyclophosphamide|mesh-list
6647067|NCT01416038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6647068|NCT01416038|Immunologic Factors|immunologic factors|mesh-ancestor
6647069|NCT01416038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647070|NCT01416038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6647071|NCT01416038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5487139|NCT02979977|Cetuximab|cetuximab|mesh-list
6647072|NCT01416038|Alkylating Agents|alkylating agents|mesh-ancestor
6647073|NCT01416038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6647074|NCT01416038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6647075|NCT01416038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6647076|NCT01416116|Lidocaine|lidocaine|mesh-list
6647077|NCT01416116|Tramadol|tramadol|mesh-list
6647078|NCT01416116|Capsaicin|capsaicin|mesh-list
6647079|NCT01416116|Anesthetics, Local|anesthetics, local|mesh-ancestor
6647080|NCT01416116|Anesthetics|anesthetics|mesh-ancestor
6647081|NCT01416116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6647082|NCT01416116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647083|NCT01416116|Sensory System Agents|sensory system agents|mesh-ancestor
6647084|NCT01416116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6647085|NCT01416116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6647086|NCT01416116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6647087|NCT01416116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6647088|NCT01416116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6647089|NCT01416116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6647090|NCT01416116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6647091|NCT01416116|Narcotics|narcotics|mesh-ancestor
6647092|NCT01416116|Analgesics|analgesics|mesh-ancestor
6647093|NCT01416116|Antipruritics|antipruritics|mesh-ancestor
6647094|NCT01416116|Dermatologic Agents|dermatologic agents|mesh-ancestor
6647095|NCT01416207|Interferons|interferons|mesh-list
6647096|NCT01416207|Interferon beta-1a|interferon beta-1a|mesh-list
6647097|NCT01416207|Interferon-beta|interferon-beta|mesh-list
6647098|NCT01416207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6647099|NCT01416207|Antiviral Agents|antiviral agents|mesh-ancestor
6647100|NCT01416207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6647101|NCT01416207|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6647102|NCT01416207|Immunologic Factors|immunologic factors|mesh-ancestor
6647103|NCT01416207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647104|NCT01416220|Lithium Carbonate|lithium carbonate|mesh-list
6647105|NCT01416220|Paroxetine|paroxetine|mesh-list
6647106|NCT01416220|Antidepressive Agents|antidepressive agents|mesh-ancestor
6647107|NCT01416220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6647108|NCT01416220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6647109|NCT01416220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6647110|NCT01416220|Antimanic Agents|antimanic agents|mesh-ancestor
6647111|NCT01416220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6647112|NCT01416220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6647113|NCT01416220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647114|NCT01416220|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6647115|NCT01416220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6647116|NCT01416220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6647117|NCT01416220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6647118|NCT01416220|Serotonin Agents|serotonin agents|mesh-ancestor
6647119|NCT01416220|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6647120|NCT01416220|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6647121|NCT01416220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6647122|NCT01416246|Anti-Infective Agents|anti-infective agents|mesh-list
6647123|NCT01416246|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6647124|NCT01416337|Trametinib|trametinib|mesh-list
6647125|NCT01416337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6647126|NCT01416337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6647127|NCT01416337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6647128|NCT01416337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6647129|NCT01416350|Azithromycin|azithromycin|mesh-list
6647130|NCT01416350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6647131|NCT01416350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6647132|NCT01416415|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6647133|NCT01416415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6647134|NCT01416480|Theobromine|theobromine|mesh-list
6647135|NCT01416480|Dipropizine|dipropizine|mesh-list
6647136|NCT01416480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6647137|NCT01416480|Autonomic Agents|autonomic agents|mesh-ancestor
6647138|NCT01416480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6647139|NCT01416480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647140|NCT01416480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6647141|NCT01416480|Respiratory System Agents|respiratory system agents|mesh-ancestor
6647142|NCT01416480|Vasodilator Agents|vasodilator agents|mesh-ancestor
6647143|NCT01416480|Antitussive Agents|antitussive agents|mesh-ancestor
6647144|NCT01416558|Paclitaxel|paclitaxel|mesh-list
6647145|NCT01416558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6647146|NCT01416558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6647147|NCT01416558|Tubulin Modulators|tubulin modulators|mesh-ancestor
6647148|NCT01416558|Antimitotic Agents|antimitotic agents|mesh-ancestor
6647149|NCT01416558|Mitosis Modulators|mitosis modulators|mesh-ancestor
6647150|NCT01416558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6647151|NCT01416649|Exenatide|exenatide|mesh-list
6647152|NCT01416649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6647153|NCT01416649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647154|NCT01416649|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6647155|NCT01416649|Incretins|incretins|mesh-ancestor
6647156|NCT01416649|Hormones|hormones|mesh-ancestor
6647157|NCT01416649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6647158|NCT01416662|Gemcitabine|gemcitabine|mesh-list
6647159|NCT01416662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6647160|NCT01416662|Antimetabolites|antimetabolites|mesh-ancestor
6647161|NCT01416662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6647162|NCT01416662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6647163|NCT01416662|Antiviral Agents|antiviral agents|mesh-ancestor
6647164|NCT01416662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6647165|NCT01416662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6647166|NCT01416662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6647167|NCT01416662|Immunologic Factors|immunologic factors|mesh-ancestor
6647168|NCT01416662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647169|NCT01416701|Vitamin D|vitamin d|mesh-list
6647170|NCT01416701|Cholecalciferol|cholecalciferol|mesh-list
6647171|NCT01416701|Vitamins|vitamins|mesh-list
6647172|NCT01416701|Micronutrients|micronutrients|mesh-ancestor
6647173|NCT01416701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647174|NCT01416701|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6647175|NCT01416701|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6647176|NCT01416831|Interleukin-2|interleukin-2|mesh-list
6647177|NCT01416831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6647178|NCT01416831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6647179|NCT01416831|Analgesics|analgesics|mesh-ancestor
6647180|NCT01416831|Sensory System Agents|sensory system agents|mesh-ancestor
6647181|NCT01416831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6647182|NCT01416831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647183|NCT01416870|Bicalutamide|bicalutamide|mesh-list
6647184|NCT01416870|Androgen Antagonists|androgen antagonists|mesh-ancestor
6647185|NCT01416870|Hormone Antagonists|hormone antagonists|mesh-ancestor
6647186|NCT01416870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6647187|NCT01416870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647188|NCT01416870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6664077|NCT01511003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6664078|NCT01511029|Moxifloxacin|moxifloxacin|mesh-list
6664079|NCT01511029|Pramipexole|pramipexole|mesh-list
6664080|NCT01511029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6664081|NCT01511029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6664082|NCT01511029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6664083|NCT01511029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6664084|NCT01511029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6664085|NCT01511029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6664086|NCT01511029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6664087|NCT01511029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664088|NCT01511029|Antioxidants|antioxidants|mesh-ancestor
6664089|NCT01511029|Protective Agents|protective agents|mesh-ancestor
6664090|NCT01511029|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5487140|NCT02979977|Afatinib|afatinib|mesh-list
5487141|NCT02979977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5487142|NCT02979977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6664091|NCT01511029|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6664092|NCT01511029|Dopamine Agonists|dopamine agonists|mesh-ancestor
6664093|NCT01511029|Dopamine Agents|dopamine agents|mesh-ancestor
6664094|NCT01511029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6664095|NCT01511042|Norepinephrine|norepinephrine|mesh-list
6664096|NCT01511042|Angiotensin II|angiotensin ii|mesh-list
6664097|NCT01511042|Giapreza|giapreza|mesh-list
6664098|NCT01511042|Angiotensinogen|angiotensinogen|mesh-list
6664099|NCT01511042|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6664100|NCT01511042|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6664101|NCT01511042|Adrenergic Agents|adrenergic agents|mesh-ancestor
6664102|NCT01511042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6664103|NCT01511042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6664104|NCT01511042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664105|NCT01511042|Sympathomimetics|sympathomimetics|mesh-ancestor
6664106|NCT01511042|Autonomic Agents|autonomic agents|mesh-ancestor
6664107|NCT01511042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6664108|NCT01511042|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6665144|NCT01515839|Micronutrients|micronutrients|mesh-ancestor
5487143|NCT02979977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5487144|NCT02979977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5487145|NCT02979977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487146|NCT02975492|Vitamin D|vitamin d|mesh-list
5487147|NCT02975492|Ergocalciferols|ergocalciferols|mesh-list
5487148|NCT02975492|Cholecalciferol|cholecalciferol|mesh-list
5487149|NCT02975492|Vitamins|vitamins|mesh-list
5487150|NCT02975492|Micronutrients|micronutrients|mesh-ancestor
5487151|NCT02975492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647189|NCT01416883|Bicalutamide|bicalutamide|mesh-list
6647190|NCT01416883|Androgen Antagonists|androgen antagonists|mesh-ancestor
6647191|NCT01416883|Hormone Antagonists|hormone antagonists|mesh-ancestor
6647192|NCT01416883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6647193|NCT01416883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647194|NCT01416883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6647195|NCT01416909|Laxatives|laxatives|mesh-list
6647196|NCT01416909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6647197|NCT01416948|Methylphenidate|methylphenidate|mesh-list
6647198|NCT01416948|Galantamine|galantamine|mesh-list
6647199|NCT01416948|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6647200|NCT01416948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647201|NCT01416948|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6647202|NCT01416948|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6647203|NCT01416948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6647204|NCT01416948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6647205|NCT01416948|Dopamine Agents|dopamine agents|mesh-ancestor
6647206|NCT01416948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6647207|NCT01416948|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6647208|NCT01416948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6647209|NCT01416948|Cholinergic Agents|cholinergic agents|mesh-ancestor
6647210|NCT01416948|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6647211|NCT01416948|Autonomic Agents|autonomic agents|mesh-ancestor
6647212|NCT01416948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6647213|NCT01416948|Nootropic Agents|nootropic agents|mesh-ancestor
6647214|NCT01416961|Etoposide|etoposide|mesh-list
6647215|NCT01416961|Etoposide phosphate|etoposide phosphate|mesh-list
6647216|NCT01416961|Cisplatin|cisplatin|mesh-list
6647217|NCT01416961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6647218|NCT01416961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6647219|NCT01416961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6647220|NCT01416961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6647221|NCT01416961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6647222|NCT01416961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6647223|NCT01416974|Cyclophosphamide|cyclophosphamide|mesh-list
6647224|NCT01416974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6647225|NCT01416974|Immunologic Factors|immunologic factors|mesh-ancestor
6647226|NCT01416974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647227|NCT01416974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6647228|NCT01416974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6647229|NCT01416974|Alkylating Agents|alkylating agents|mesh-ancestor
6647230|NCT01416974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6647231|NCT01416974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6647232|NCT01416974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6647233|NCT01417013|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6647234|NCT01417013|Lubricant Eye Drops|lubricant eye drops|mesh-list
6647235|NCT01417013|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6647236|NCT01417065|Sirolimus|sirolimus|mesh-list
6647237|NCT01417065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6647238|NCT01417065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6647239|NCT01417065|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6647240|NCT01417065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6647241|NCT01417065|Antifungal Agents|antifungal agents|mesh-ancestor
6647242|NCT01417065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6647243|NCT01417065|Immunologic Factors|immunologic factors|mesh-ancestor
6647244|NCT01417065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647245|NCT01417169|Micafungin|micafungin|mesh-list
6647246|NCT01417169|Antifungal Agents|antifungal agents|mesh-ancestor
6647247|NCT01417169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6647248|NCT01417273|Vitamin A|vitamin a|mesh-list
6647249|NCT01417273|Vitamins|vitamins|mesh-ancestor
6647250|NCT01417273|Micronutrients|micronutrients|mesh-ancestor
6647251|NCT01417273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647252|NCT01417351|Vitamin D|vitamin d|mesh-list
5487152|NCT02975492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6647253|NCT01417351|Ergocalciferols|ergocalciferols|mesh-list
6647254|NCT01417351|Cholecalciferol|cholecalciferol|mesh-list
6647255|NCT01417351|Vitamins|vitamins|mesh-list
6647256|NCT01417351|Micronutrients|micronutrients|mesh-ancestor
6647257|NCT01417351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647258|NCT01417351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6647259|NCT01417351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6647260|NCT01417364|Methyltestosterone|methyltestosterone|mesh-list
6647261|NCT01417364|Testosterone|testosterone|mesh-list
6647262|NCT01417364|Testosterone undecanoate|testosterone undecanoate|mesh-list
6647263|NCT01417364|Testosterone enanthate|testosterone enanthate|mesh-list
6647264|NCT01417364|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5487153|NCT02975492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5487154|NCT02866682|Tacrolimus|tacrolimus|mesh-list
5487155|NCT02866682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5487156|NCT02866682|Immunologic Factors|immunologic factors|mesh-ancestor
5487157|NCT02866682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5487158|NCT02866682|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6647265|NCT01417364|Androgens|androgens|mesh-ancestor
6647266|NCT01417364|Hormones|hormones|mesh-ancestor
6647267|NCT01417364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6647268|NCT01417364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5487159|NCT02866682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5487160|NCT02866682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487161|NCT02864251|Carboplatin|carboplatin|mesh-list
6647269|NCT01417364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6647270|NCT01417364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6647271|NCT01417364|Anabolic Agents|anabolic agents|mesh-ancestor
6647272|NCT01417390|Gemcitabine|gemcitabine|mesh-list
6647273|NCT01417390|Cisplatin|cisplatin|mesh-list
6647274|NCT01417390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6647275|NCT01417390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6647276|NCT01417390|Antimetabolites|antimetabolites|mesh-ancestor
6647277|NCT01417390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6647278|NCT01417390|Antiviral Agents|antiviral agents|mesh-ancestor
6647279|NCT01417390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6647280|NCT01417390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6647281|NCT01417390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6647282|NCT01417390|Immunologic Factors|immunologic factors|mesh-ancestor
6647283|NCT01417390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647284|NCT01417403|Hydroxychloroquine|hydroxychloroquine|mesh-list
6647285|NCT01417403|Antimalarials|antimalarials|mesh-ancestor
6647286|NCT01417403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6647287|NCT01417403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6647288|NCT01417403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5487162|NCT02864251|Nivolumab|nivolumab|mesh-list
5487163|NCT02864251|Pemetrexed|pemetrexed|mesh-list
5487164|NCT02864251|Ipilimumab|ipilimumab|mesh-list
5487165|NCT02864251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5487166|NCT02864251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5487167|NCT02864251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5487168|NCT02864251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487169|NCT02864251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5487170|NCT02864251|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5487171|NCT02864251|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5487172|NCT02855229|Methylphenidate|methylphenidate|mesh-list
5487173|NCT02855229|Modafinil|modafinil|mesh-list
5487174|NCT02855229|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5487175|NCT02855229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5487176|NCT02855229|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5487177|NCT02855229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5487178|NCT02855229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5487179|NCT02855229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487180|NCT02855229|Dopamine Agents|dopamine agents|mesh-ancestor
5487181|NCT02855229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5487182|NCT02855229|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
5487183|NCT02855229|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5487184|NCT02855229|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5502718|NCT04464811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502719|NCT04464811|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5502720|NCT04464811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6647289|NCT01417403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6647290|NCT01417403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6647291|NCT01417403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6647292|NCT01417429|Galantamine|galantamine|mesh-list
6647293|NCT01417429|Nicotine|nicotine|mesh-list
6647294|NCT01417429|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6647295|NCT01417429|Autonomic Agents|autonomic agents|mesh-ancestor
6647296|NCT01417429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6647297|NCT01417429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647298|NCT01417429|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6647299|NCT01417429|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6647300|NCT01417429|Cholinergic Agents|cholinergic agents|mesh-ancestor
6647301|NCT01417429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6647302|NCT01417429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6647303|NCT01417429|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6647304|NCT01417429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6647305|NCT01417429|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6647306|NCT01417429|Nootropic Agents|nootropic agents|mesh-ancestor
6647307|NCT01417494|Leucovorin|leucovorin|mesh-list
5487185|NCT02835157|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5487186|NCT02827526|Ketamine|ketamine|mesh-list
5487187|NCT02827526|Analgesics|analgesics|mesh-ancestor
5487188|NCT02827526|Sensory System Agents|sensory system agents|mesh-ancestor
5487189|NCT02827526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5487190|NCT02827526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5487191|NCT02827526|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5487192|NCT02827526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5487193|NCT02827526|Anesthetics, General|anesthetics, general|mesh-ancestor
5487194|NCT02827526|Anesthetics|anesthetics|mesh-ancestor
5487195|NCT02827526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5487196|NCT02827526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5487197|NCT02827526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5487198|NCT02827526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5487199|NCT02827526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487200|NCT02757872|Vitamin D|vitamin d|mesh-list
5487201|NCT02757872|Ergocalciferols|ergocalciferols|mesh-list
5487202|NCT02757872|Cholecalciferol|cholecalciferol|mesh-list
5487203|NCT02757872|Vitamins|vitamins|mesh-list
5487204|NCT02757872|Micronutrients|micronutrients|mesh-ancestor
5487205|NCT02757872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5487206|NCT02757872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5487207|NCT02757872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6647308|NCT01417494|Bevacizumab|bevacizumab|mesh-list
6647309|NCT01417494|Fluorouracil|fluorouracil|mesh-list
6647310|NCT01417494|Oxaliplatin|oxaliplatin|mesh-list
6647311|NCT01417494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6647312|NCT01417494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6647313|NCT01417494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6647314|NCT01417494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6647315|NCT01417494|Growth Substances|growth substances|mesh-ancestor
6647316|NCT01417494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647317|NCT01417494|Growth Inhibitors|growth inhibitors|mesh-ancestor
6647318|NCT01417494|Antimetabolites|antimetabolites|mesh-ancestor
6647319|NCT01417494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6647320|NCT01417494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6647321|NCT01417494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6647322|NCT01417494|Immunologic Factors|immunologic factors|mesh-ancestor
6647323|NCT01417494|Antidotes|antidotes|mesh-ancestor
6647324|NCT01417494|Protective Agents|protective agents|mesh-ancestor
6647325|NCT01417494|Vitamin B Complex|vitamin b complex|mesh-ancestor
6647326|NCT01417494|Vitamins|vitamins|mesh-ancestor
6647327|NCT01417494|Micronutrients|micronutrients|mesh-ancestor
6647328|NCT01417572|Lidocaine|lidocaine|mesh-list
6647329|NCT01417572|Anesthetics, Local|anesthetics, local|mesh-ancestor
6647330|NCT01417572|Anesthetics|anesthetics|mesh-ancestor
6647331|NCT01417572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6647332|NCT01417572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647333|NCT01417572|Sensory System Agents|sensory system agents|mesh-ancestor
6647334|NCT01417572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6647335|NCT01417572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6647336|NCT01417572|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6647337|NCT01417572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6647338|NCT01417572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6647339|NCT01417572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6647340|NCT01417689|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6647341|NCT01417689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6647342|NCT01417754|Toremifene|toremifene|mesh-list
6647343|NCT01417754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6647344|NCT01417754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6647345|NCT01417754|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5487208|NCT02753998|Paclitaxel|paclitaxel|mesh-list
6647346|NCT01417754|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6647347|NCT01417754|Hormone Antagonists|hormone antagonists|mesh-ancestor
6647348|NCT01417754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6647349|NCT01417754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647350|NCT01417754|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6647351|NCT01417767|Decitabine|decitabine|mesh-list
6647352|NCT01417767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6647353|NCT01417767|Antimetabolites|antimetabolites|mesh-ancestor
6647354|NCT01417767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6647355|NCT01417767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6647356|NCT01417767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6647357|NCT01417806|Topotecan|topotecan|mesh-list
6647358|NCT01417806|Pasireotide|pasireotide|mesh-list
6647359|NCT01417806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6647360|NCT01417806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6647361|NCT01417806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6647362|NCT01417806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6647363|NCT01417806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6647364|NCT01417806|Hormones|hormones|mesh-ancestor
6647365|NCT01417806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6647366|NCT01417806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647367|NCT01417858|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6647368|NCT01417858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6647369|NCT01417858|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6647370|NCT01417858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6647371|NCT01417858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6647372|NCT01417858|Adrenergic Agents|adrenergic agents|mesh-ancestor
6647373|NCT01417858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6647374|NCT01417858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6647375|NCT01417858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647376|NCT01417897|Insulin|insulin|mesh-list
6647377|NCT01417897|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6647378|NCT01417897|Insulin Aspart|insulin aspart|mesh-list
6647379|NCT01417897|Insulin glulisine|insulin glulisine|mesh-list
6647380|NCT01417897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6647381|NCT01417897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647382|NCT01417923|Vitamin D|vitamin d|mesh-list
6647383|NCT01417923|Vitamins|vitamins|mesh-ancestor
6647384|NCT01417923|Micronutrients|micronutrients|mesh-ancestor
6647385|NCT01417923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647386|NCT01417923|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6647387|NCT01417949|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
5487209|NCT02753998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5487210|NCT02753998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5487211|NCT02753998|Tubulin Modulators|tubulin modulators|mesh-ancestor
5487212|NCT02753998|Antimitotic Agents|antimitotic agents|mesh-ancestor
5487213|NCT02753998|Mitosis Modulators|mitosis modulators|mesh-ancestor
5487214|NCT02753998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487215|NCT02743923|Paclitaxel|paclitaxel|mesh-list
5487216|NCT02743923|Bevacizumab|bevacizumab|mesh-list
5487217|NCT02743923|Carboplatin|carboplatin|mesh-list
5487218|NCT02743923|Pemetrexed|pemetrexed|mesh-list
5487219|NCT02743923|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5487220|NCT02743923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5487221|NCT02743923|Tubulin Modulators|tubulin modulators|mesh-ancestor
5487222|NCT02743923|Antimitotic Agents|antimitotic agents|mesh-ancestor
5487223|NCT02743923|Mitosis Modulators|mitosis modulators|mesh-ancestor
5487224|NCT02743923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487225|NCT02743923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5487226|NCT02743923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5487227|NCT02743923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5487228|NCT02743923|Growth Substances|growth substances|mesh-ancestor
5487229|NCT02743923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5487230|NCT02743923|Growth Inhibitors|growth inhibitors|mesh-ancestor
5487231|NCT02743923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5487232|NCT02743923|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5487233|NCT02743923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6647388|NCT01417949|Antiviral Agents|antiviral agents|mesh-ancestor
6647389|NCT01417949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6647390|NCT01418118|Dobutamine|dobutamine|mesh-list
6647391|NCT01418118|Epinephrine|epinephrine|mesh-list
6647392|NCT01418118|Norepinephrine|norepinephrine|mesh-list
6647393|NCT01418118|Dopexamine|dopexamine|mesh-list
5487234|NCT02735707|Aspirin|aspirin|mesh-list
6647394|NCT01418118|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5487235|NCT02735707|Vitamins|vitamins|mesh-list
6647395|NCT01418118|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6647396|NCT01418118|Adrenergic Agents|adrenergic agents|mesh-ancestor
6647397|NCT01418118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6021688|NCT00401830|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6021689|NCT00401830|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6021690|NCT00401830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6021691|NCT00401830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021692|NCT00401843|Dexamethasone|dexamethasone|mesh-list
6021693|NCT00401843|Bortezomib|bortezomib|mesh-list
6021694|NCT00401843|Siltuximab|siltuximab|mesh-list
6021695|NCT00401843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6021696|NCT00401843|Antiemetics|antiemetics|mesh-ancestor
6021697|NCT00401843|Autonomic Agents|autonomic agents|mesh-ancestor
6021698|NCT00401843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6021699|NCT00401843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021700|NCT00401843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6021701|NCT00401843|Glucocorticoids|glucocorticoids|mesh-ancestor
6021702|NCT00401843|Hormones|hormones|mesh-ancestor
6021703|NCT00401843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6021704|NCT00401843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6021705|NCT00401843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6021706|NCT00401882|Metoprolol|metoprolol|mesh-list
6647398|NCT01418118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487236|NCT02735707|Ascorbic Acid|ascorbic acid|mesh-list
5487237|NCT02735707|Interferons|interferons|mesh-list
5487238|NCT02735707|Ritonavir|ritonavir|mesh-list
5487239|NCT02735707|Lopinavir|lopinavir|mesh-list
5487240|NCT02735707|Interferon-beta|interferon-beta|mesh-list
5487241|NCT02735707|Oseltamivir|oseltamivir|mesh-list
5487242|NCT02735707|Interferon beta-1a|interferon beta-1a|mesh-list
5487243|NCT02735707|Antiviral Agents|antiviral agents|mesh-list
5487244|NCT02735707|Amoxicillin|amoxicillin|mesh-list
5487245|NCT02735707|Moxifloxacin|moxifloxacin|mesh-list
5487246|NCT02735707|Hydroxychloroquine|hydroxychloroquine|mesh-list
5487247|NCT02735707|Levofloxacin|levofloxacin|mesh-list
5487248|NCT02735707|Ivermectin|ivermectin|mesh-list
5487249|NCT02735707|Tazobactam|tazobactam|mesh-list
5487250|NCT02735707|Ceftriaxone|ceftriaxone|mesh-list
5487251|NCT02735707|Piperacillin|piperacillin|mesh-list
5487252|NCT02735707|Clavulanic Acid|clavulanic acid|mesh-list
5487253|NCT02735707|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
5487254|NCT02735707|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
6647399|NCT01418118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647400|NCT01418118|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6647401|NCT01418118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6647402|NCT01418118|Autonomic Agents|autonomic agents|mesh-ancestor
6647403|NCT01418118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6647404|NCT01418118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6647405|NCT01418118|Respiratory System Agents|respiratory system agents|mesh-ancestor
6647406|NCT01418118|Mydriatics|mydriatics|mesh-ancestor
6647407|NCT01418118|Sympathomimetics|sympathomimetics|mesh-ancestor
6647408|NCT01418118|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6647409|NCT01418118|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6647410|NCT01418118|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6647411|NCT01418118|Protective Agents|protective agents|mesh-ancestor
6647412|NCT01418118|Vasodilator Agents|vasodilator agents|mesh-ancestor
6647413|NCT01418118|Dopamine Agonists|dopamine agonists|mesh-ancestor
6647414|NCT01418118|Dopamine Agents|dopamine agents|mesh-ancestor
6647415|NCT01418131|Tacrolimus|tacrolimus|mesh-list
6647416|NCT01418131|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
6647417|NCT01418131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6647418|NCT01418131|Immunologic Factors|immunologic factors|mesh-ancestor
6647419|NCT01418131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647420|NCT01418131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6647421|NCT01418131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6647422|NCT01418144|Ropivacaine|ropivacaine|mesh-list
6647423|NCT01418144|Anesthetics, Local|anesthetics, local|mesh-ancestor
6647424|NCT01418144|Anesthetics|anesthetics|mesh-ancestor
6647425|NCT01418144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6647426|NCT01418144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647427|NCT01418144|Sensory System Agents|sensory system agents|mesh-ancestor
6647428|NCT01418144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6647429|NCT01418157|Acetazolamide|acetazolamide|mesh-list
6647430|NCT01418157|Anticonvulsants|anticonvulsants|mesh-ancestor
5487255|NCT02735707|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5487256|NCT02735707|Apremilast|apremilast|mesh-list
5487257|NCT02735707|Hydrocortisone|hydrocortisone|mesh-list
5487258|NCT02735707|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6021707|NCT00401882|Epinephrine|epinephrine|mesh-list
5487259|NCT02735707|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
5487260|NCT02735707|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
5487261|NCT02735707|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5487262|NCT02735707|Losartan|losartan|mesh-list
5487263|NCT02735707|Valsartan|valsartan|mesh-list
5487264|NCT02735707|Telmisartan|telmisartan|mesh-list
5487265|NCT02735707|Candesartan|candesartan|mesh-list
5487266|NCT02735707|Ramipril|ramipril|mesh-list
5487267|NCT02735707|Olmesartan|olmesartan|mesh-list
5487268|NCT02735707|Enalapril|enalapril|mesh-list
5487269|NCT02735707|Lisinopril|lisinopril|mesh-list
6647431|NCT01418157|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6647432|NCT01418157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6647433|NCT01418157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6647434|NCT01418157|Diuretics|diuretics|mesh-ancestor
6647435|NCT01418157|Natriuretic Agents|natriuretic agents|mesh-ancestor
6647436|NCT01418157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647437|NCT01418183|Levobupivacaine|levobupivacaine|mesh-list
6647438|NCT01418183|Anesthetics, Local|anesthetics, local|mesh-ancestor
6647439|NCT01418183|Anesthetics|anesthetics|mesh-ancestor
6647440|NCT01418183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6647441|NCT01418183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647442|NCT01418183|Sensory System Agents|sensory system agents|mesh-ancestor
6647443|NCT01418183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6647444|NCT01418235|MF59 oil emulsion|mf59 oil emulsion|mesh-list
6647445|NCT01418235|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6647446|NCT01418235|Immunologic Factors|immunologic factors|mesh-ancestor
6647447|NCT01418235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647448|NCT01418274|Ritonavir|ritonavir|mesh-list
6647449|NCT01418274|Citalopram|citalopram|mesh-list
6647450|NCT01418274|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6647451|NCT01418274|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6647452|NCT01418274|Protease Inhibitors|protease inhibitors|mesh-ancestor
6647453|NCT01418274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6647454|NCT01418274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6647455|NCT01418274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6647456|NCT01418274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6647457|NCT01418274|Antiviral Agents|antiviral agents|mesh-ancestor
6647458|NCT01418274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6647459|NCT01418274|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6647460|NCT01418274|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6647461|NCT01418274|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6647462|NCT01418274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6647463|NCT01418274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6647464|NCT01418274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6647465|NCT01418274|Serotonin Agents|serotonin agents|mesh-ancestor
6647466|NCT01418274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647467|NCT01418274|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6647468|NCT01418274|Antidepressive Agents|antidepressive agents|mesh-ancestor
6647469|NCT01418274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6647470|NCT01418417|Pantoprazole|pantoprazole|mesh-list
6647471|NCT01418417|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6647472|NCT01418417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6647473|NCT01418417|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6647474|NCT01418417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6647475|NCT01418417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487270|NCT02735707|Irbesartan|irbesartan|mesh-list
5487271|NCT02735707|Perindopril|perindopril|mesh-list
5487272|NCT02735707|Captopril|captopril|mesh-list
5487273|NCT02735707|Trandolapril|trandolapril|mesh-list
5487274|NCT02735707|Clopidogrel|clopidogrel|mesh-list
5487275|NCT02735707|Ticagrelor|ticagrelor|mesh-list
5487276|NCT02735707|Simvastatin|simvastatin|mesh-list
5487277|NCT02735707|Enzyme Inhibitors|enzyme inhibitors|mesh-list
5487278|NCT02735707|Immunoglobulins|immunoglobulins|mesh-list
5487279|NCT02735707|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5487280|NCT02735707|Antibodies|antibodies|mesh-list
5487281|NCT02735707|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
5487282|NCT02735707|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
5487283|NCT02735707|Cysteamine|cysteamine|mesh-list
5487284|NCT02735707|Micronutrients|micronutrients|mesh-ancestor
5487285|NCT02735707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647476|NCT01418430|Daclizumab|daclizumab|mesh-list
5487286|NCT02735707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5487287|NCT02735707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5487288|NCT02735707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5487289|NCT02735707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5487290|NCT02735707|Analgesics|analgesics|mesh-ancestor
5487291|NCT02735707|Sensory System Agents|sensory system agents|mesh-ancestor
5487292|NCT02735707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5487293|NCT02735707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5487294|NCT02735707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5487295|NCT02735707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5487296|NCT02735707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5487297|NCT02735707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487298|NCT02735707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5487299|NCT02735707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5487300|NCT02735707|Antipyretics|antipyretics|mesh-ancestor
5487301|NCT02735707|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5487302|NCT02735707|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5487303|NCT02735707|Protease Inhibitors|protease inhibitors|mesh-ancestor
5487304|NCT02735707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5487305|NCT02735707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5487306|NCT02735707|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5487307|NCT02735707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5487308|NCT02735707|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6021708|NCT00401882|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6021709|NCT00401882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6647477|NCT01418430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6647478|NCT01418430|Immunologic Factors|immunologic factors|mesh-ancestor
6647479|NCT01418430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647480|NCT01418443|Pantoprazole|pantoprazole|mesh-list
6647481|NCT01418443|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6647482|NCT01418443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6647483|NCT01418443|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6647484|NCT01418443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6647485|NCT01418443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6647486|NCT01418456|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6647487|NCT01418456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6647488|NCT01418521|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6647489|NCT01418534|Isosorbide|isosorbide|mesh-list
6647490|NCT01418534|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
6647491|NCT01418534|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
6647492|NCT01418534|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6647493|NCT01418534|Diuretics|diuretics|mesh-ancestor
6647494|NCT01418534|Natriuretic Agents|natriuretic agents|mesh-ancestor
6647495|NCT01418534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647496|NCT01418534|Vasodilator Agents|vasodilator agents|mesh-ancestor
6647497|NCT01418534|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6647498|NCT01418534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6647499|NCT01418547|Isosorbide|isosorbide|mesh-list
6647500|NCT01418547|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
6647501|NCT01418547|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
6647502|NCT01418547|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6647503|NCT01418547|Diuretics|diuretics|mesh-ancestor
6647504|NCT01418547|Natriuretic Agents|natriuretic agents|mesh-ancestor
6647505|NCT01418547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647506|NCT01418547|Vasodilator Agents|vasodilator agents|mesh-ancestor
6647507|NCT01418547|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6647508|NCT01418547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6664109|NCT01511042|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6664110|NCT01511042|Protease Inhibitors|protease inhibitors|mesh-ancestor
6664111|NCT01511042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6664112|NCT01511146|Gemcitabine|gemcitabine|mesh-list
6664113|NCT01511146|Oxaliplatin|oxaliplatin|mesh-list
6664114|NCT01511146|Mitomycins|mitomycins|mesh-list
6664115|NCT01511146|Mitomycin|mitomycin|mesh-list
6664116|NCT01511146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6664117|NCT01511146|Antimetabolites|antimetabolites|mesh-ancestor
6664118|NCT01511146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6664119|NCT01511146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6664120|NCT01511146|Antiviral Agents|antiviral agents|mesh-ancestor
6664121|NCT01511146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6664122|NCT01511146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6664123|NCT01511146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6664124|NCT01511146|Immunologic Factors|immunologic factors|mesh-ancestor
6664125|NCT01511146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664126|NCT01511146|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6664127|NCT01511146|Alkylating Agents|alkylating agents|mesh-ancestor
6664128|NCT01511146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6664129|NCT01511159|Insulin|insulin|mesh-list
6664130|NCT01511159|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6664131|NCT01511159|Liraglutide|liraglutide|mesh-list
6664132|NCT01511159|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5487309|NCT02735707|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6021710|NCT00401882|Adrenergic Agents|adrenergic agents|mesh-ancestor
6021711|NCT00401882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6021712|NCT00401882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021713|NCT00401882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021714|NCT00401882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6021715|NCT00401882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6021716|NCT00401882|Autonomic Agents|autonomic agents|mesh-ancestor
6021717|NCT00401882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6021718|NCT00401882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6021719|NCT00401882|Respiratory System Agents|respiratory system agents|mesh-ancestor
6647509|NCT01418586|Alfuzosin|alfuzosin|mesh-list
6647510|NCT01418586|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6647511|NCT01418586|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6647512|NCT01418586|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6647513|NCT01418586|Adrenergic Agents|adrenergic agents|mesh-ancestor
6647514|NCT01418586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6647515|NCT01418586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6647516|NCT01418586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5487310|NCT02735707|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5487311|NCT02735707|Purinergic Agents|purinergic agents|mesh-ancestor
5487312|NCT02735707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6647517|NCT01418586|Urological Agents|urological agents|mesh-ancestor
6647518|NCT01418599|Alfuzosin|alfuzosin|mesh-list
6647519|NCT01418599|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6647520|NCT01418599|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6647521|NCT01418599|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6647522|NCT01418599|Adrenergic Agents|adrenergic agents|mesh-ancestor
6647523|NCT01418599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6647524|NCT01418599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6647525|NCT01418599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647526|NCT01418599|Urological Agents|urological agents|mesh-ancestor
6647527|NCT01418612|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6647528|NCT01418612|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6647529|NCT01418612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6647530|NCT01418612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6647531|NCT01418612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6647532|NCT01418612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6647533|NCT01418612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647534|NCT01418612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6647535|NCT01418612|Antidepressive Agents|antidepressive agents|mesh-ancestor
6647536|NCT01418612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6647537|NCT01418625|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6647538|NCT01418625|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6647539|NCT01418625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6647540|NCT01418625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6647541|NCT01418625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6647542|NCT01418625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6647543|NCT01418625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647544|NCT01418625|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6647545|NCT01418625|Antidepressive Agents|antidepressive agents|mesh-ancestor
6647546|NCT01418625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6647547|NCT01418651|Milnacipran|milnacipran|mesh-list
6647548|NCT01418651|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6647549|NCT01418651|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6647550|NCT01418651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6647551|NCT01418651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6647552|NCT01418651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6647553|NCT01418651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647554|NCT01418651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6647555|NCT01418651|Analgesics|analgesics|mesh-ancestor
6647556|NCT01418651|Sensory System Agents|sensory system agents|mesh-ancestor
6647557|NCT01418651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6647558|NCT01418729|Pravastatin|pravastatin|mesh-list
6647559|NCT01418729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6647560|NCT01418729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6647561|NCT01418729|Antimetabolites|antimetabolites|mesh-ancestor
6665145|NCT01515839|Nootropic Agents|nootropic agents|mesh-ancestor
5487313|NCT02735707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6647562|NCT01418729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6647563|NCT01418729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6647564|NCT01418729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6647565|NCT01418729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6647566|NCT01418742|Doxycycline|doxycycline|mesh-list
6647567|NCT01418742|Panitumumab|panitumumab|mesh-list
6647568|NCT01418742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6647569|NCT01418742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6647570|NCT01418742|Antimalarials|antimalarials|mesh-ancestor
6647571|NCT01418742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6647572|NCT01418742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6647573|NCT01418742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6647574|NCT01418742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6647575|NCT01418794|Sirolimus|sirolimus|mesh-list
6647576|NCT01418794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6647577|NCT01418794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6647578|NCT01418794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6647579|NCT01418794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6647580|NCT01418794|Antifungal Agents|antifungal agents|mesh-ancestor
6647581|NCT01418794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6647582|NCT01418794|Immunologic Factors|immunologic factors|mesh-ancestor
6647583|NCT01418794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647584|NCT01419041|Crizotinib|crizotinib|mesh-list
6647585|NCT01419041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6647586|NCT01419041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6647587|NCT01419041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6647588|NCT01419041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6647589|NCT01419119|Cholecalciferol|cholecalciferol|mesh-list
6647590|NCT01419119|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6647591|NCT01419119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6647592|NCT01419119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647593|NCT01419119|Vitamins|vitamins|mesh-ancestor
6647594|NCT01419119|Micronutrients|micronutrients|mesh-ancestor
6647595|NCT01419119|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6647596|NCT01419132|Furosemide|furosemide|mesh-list
6647597|NCT01419132|Diuretics|diuretics|mesh-list
6647598|NCT01419132|Natriuretic Agents|natriuretic agents|mesh-ancestor
6647599|NCT01419132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647600|NCT01419132|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6647601|NCT01419132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6647602|NCT01419132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6647603|NCT01419262|Vitamin D|vitamin d|mesh-list
6647604|NCT01419262|Ergocalciferols|ergocalciferols|mesh-list
6647605|NCT01419262|Cholecalciferol|cholecalciferol|mesh-list
6647606|NCT01419262|Vitamins|vitamins|mesh-list
6647607|NCT01419262|Micronutrients|micronutrients|mesh-ancestor
6647608|NCT01419262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647609|NCT01419262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6647610|NCT01419262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6647611|NCT01419340|Donepezil|donepezil|mesh-list
6647612|NCT01419340|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6647613|NCT01419340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6647614|NCT01419340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6647615|NCT01419340|Cholinergic Agents|cholinergic agents|mesh-ancestor
6647616|NCT01419340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6647617|NCT01419340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647618|NCT01419340|Nootropic Agents|nootropic agents|mesh-ancestor
6647619|NCT01419353|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6647620|NCT01419353|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6647621|NCT01419353|Estradiol|estradiol|mesh-list
6647622|NCT01419353|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6647623|NCT01419353|Estrogens|estrogens|mesh-ancestor
6647624|NCT01419353|Hormones|hormones|mesh-ancestor
6647625|NCT01419353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6647626|NCT01419353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647627|NCT01419353|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6647628|NCT01419353|Contraceptive Agents|contraceptive agents|mesh-ancestor
6647629|NCT01419353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6647630|NCT01419353|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6647631|NCT01419366|Donepezil|donepezil|mesh-list
6647632|NCT01419366|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6647633|NCT01419366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6647634|NCT01419366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6647635|NCT01419366|Cholinergic Agents|cholinergic agents|mesh-ancestor
5487314|NCT02735707|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5487315|NCT02735707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5487316|NCT02735707|Antimetabolites|antimetabolites|mesh-ancestor
5487317|NCT02735707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5487318|NCT02735707|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5487319|NCT02735707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5487320|NCT02735707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5487321|NCT02735707|Immunologic Factors|immunologic factors|mesh-ancestor
5487322|NCT02735707|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5487323|NCT02735707|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5487324|NCT02735707|Antimalarials|antimalarials|mesh-ancestor
5487325|NCT02735707|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6021720|NCT00401882|Mydriatics|mydriatics|mesh-ancestor
6021721|NCT00401882|Sympathomimetics|sympathomimetics|mesh-ancestor
6021722|NCT00401882|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6021723|NCT00401882|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6647636|NCT01419366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6647637|NCT01419366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647638|NCT01419366|Nootropic Agents|nootropic agents|mesh-ancestor
6647639|NCT01419392|Sildenafil Citrate|sildenafil citrate|mesh-list
6647640|NCT01419392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6647641|NCT01419392|Vasodilator Agents|vasodilator agents|mesh-ancestor
6647642|NCT01419392|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6647643|NCT01419392|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6647644|NCT01419392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6647645|NCT01419392|Urological Agents|urological agents|mesh-ancestor
6647646|NCT01419405|Pregabalin|pregabalin|mesh-list
6647647|NCT01419405|Remifentanil|remifentanil|mesh-list
6647648|NCT01419405|Analgesics|analgesics|mesh-ancestor
6647649|NCT01419405|Sensory System Agents|sensory system agents|mesh-ancestor
6647650|NCT01419405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6647651|NCT01419405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647652|NCT01419405|Anticonvulsants|anticonvulsants|mesh-ancestor
6647653|NCT01419405|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6647654|NCT01419405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6647655|NCT01419405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6647656|NCT01419405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6647657|NCT01419405|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6647658|NCT01419405|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6647659|NCT01419405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6647660|NCT01419405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6647661|NCT01419405|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6647662|NCT01419405|Narcotics|narcotics|mesh-ancestor
6647663|NCT01419457|Favipiravir|favipiravir|mesh-list
6647664|NCT01419457|Antiviral Agents|antiviral agents|mesh-ancestor
6647665|NCT01419457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6647666|NCT01419548|Paclitaxel|paclitaxel|mesh-list
6647667|NCT01419548|Carboplatin|carboplatin|mesh-list
6647668|NCT01419548|Veliparib|veliparib|mesh-list
6647669|NCT01419548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6647670|NCT01419548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6647671|NCT01419548|Tubulin Modulators|tubulin modulators|mesh-ancestor
6647672|NCT01419548|Antimitotic Agents|antimitotic agents|mesh-ancestor
6647673|NCT01419548|Mitosis Modulators|mitosis modulators|mesh-ancestor
6647674|NCT01419548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6647675|NCT01419548|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6647676|NCT01419548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6647677|NCT01419652|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6647678|NCT01419652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647679|NCT01419691|Auranofin|auranofin|mesh-list
6647680|NCT01419691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6647681|NCT01419730|Vitamin D|vitamin d|mesh-list
6647682|NCT01419730|Cholecalciferol|cholecalciferol|mesh-list
6647683|NCT01419730|Vitamins|vitamins|mesh-ancestor
6647684|NCT01419730|Micronutrients|micronutrients|mesh-ancestor
6647685|NCT01419730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647686|NCT01419730|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6647687|NCT01419730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6647688|NCT01419821|Vitamin D|vitamin d|mesh-list
6647689|NCT01419821|Ergocalciferols|ergocalciferols|mesh-list
6647690|NCT01419821|Vitamins|vitamins|mesh-list
6647691|NCT01419821|Micronutrients|micronutrients|mesh-ancestor
6647692|NCT01419821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021724|NCT00401882|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6647693|NCT01419821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6647694|NCT01419821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6647695|NCT01419834|Antibodies|antibodies|mesh-list
6647696|NCT01419834|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6647697|NCT01419834|Immunologic Factors|immunologic factors|mesh-ancestor
6647698|NCT01419834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647699|NCT01419847|Ciclopirox|ciclopirox|mesh-list
6647700|NCT01419847|Antifungal Agents|antifungal agents|mesh-ancestor
6647701|NCT01419847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6647702|NCT01419873|Insulin|insulin|mesh-list
6647703|NCT01419873|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6647704|NCT01419873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6647705|NCT01419873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647706|NCT01420055|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6647707|NCT01420055|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6647708|NCT01420055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6647709|NCT01420055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6647710|NCT01420055|Immunologic Factors|immunologic factors|mesh-ancestor
6647711|NCT01420055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647712|NCT01420094|Aspirin|aspirin|mesh-list
6647713|NCT01420094|Acetaminophen|acetaminophen|mesh-list
6647714|NCT01420094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6647715|NCT01420094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6647716|NCT01420094|Analgesics|analgesics|mesh-ancestor
6647717|NCT01420094|Sensory System Agents|sensory system agents|mesh-ancestor
6647718|NCT01420094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6647719|NCT01420094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647720|NCT01420094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6647721|NCT01420094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6647722|NCT01420094|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6647723|NCT01420094|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6647724|NCT01420094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6647725|NCT01420094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6647726|NCT01420094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6647727|NCT01420094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6647728|NCT01420094|Antipyretics|antipyretics|mesh-ancestor
6647729|NCT01420159|Methoxyflurane|methoxyflurane|mesh-list
6647730|NCT01420159|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6647731|NCT01420159|Anesthetics, General|anesthetics, general|mesh-ancestor
6647732|NCT01420159|Anesthetics|anesthetics|mesh-ancestor
6647733|NCT01420159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6647734|NCT01420159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664133|NCT01511159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664134|NCT01511159|Incretins|incretins|mesh-ancestor
6664135|NCT01511159|Hormones|hormones|mesh-ancestor
6664136|NCT01511159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6664137|NCT01511172|Metformin|metformin|mesh-list
6664138|NCT01511172|Liraglutide|liraglutide|mesh-list
5487326|NCT02735707|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5487327|NCT02735707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5487328|NCT02735707|Antioxidants|antioxidants|mesh-ancestor
5487329|NCT02735707|Protective Agents|protective agents|mesh-ancestor
5487330|NCT02735707|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5487331|NCT02735707|Renal Agents|renal agents|mesh-ancestor
5487332|NCT02735707|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5487333|NCT02735707|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5487334|NCT02735707|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5487335|NCT02735707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5487336|NCT02735707|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5487337|NCT02735707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5487338|NCT02735707|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
5487339|NCT02714205|Nitroglycerin|nitroglycerin|mesh-list
5487340|NCT02714205|Vasodilator Agents|vasodilator agents|mesh-ancestor
5487341|NCT02431247|Tenofovir|tenofovir|mesh-list
5487342|NCT02431247|Emtricitabine|emtricitabine|mesh-list
5487343|NCT02431247|Darunavir|darunavir|mesh-list
5487344|NCT02431247|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5487345|NCT02431247|Cobicistat|cobicistat|mesh-list
5487346|NCT02431247|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
5487347|NCT02431247|Antiviral Agents|antiviral agents|mesh-ancestor
5487348|NCT02431247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5487349|NCT02431247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5487350|NCT02431247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5487351|NCT02431247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5487352|NCT02431247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487353|NCT02431247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5724877|NCT03184480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6664139|NCT01511172|Glimepiride|glimepiride|mesh-list
6664140|NCT01511172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6647735|NCT01420250|Bicalutamide|bicalutamide|mesh-list
6647736|NCT01420250|Hormones|hormones|mesh-list
6647737|NCT01420250|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
6647738|NCT01420250|Androgen Antagonists|androgen antagonists|mesh-list
6647739|NCT01420250|Androgens|androgens|mesh-list
6647740|NCT01420250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6647741|NCT01420250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647742|NCT01420250|Hormone Antagonists|hormone antagonists|mesh-ancestor
6647743|NCT01420250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6647744|NCT01420302|Insulin|insulin|mesh-list
6647745|NCT01420302|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6647746|NCT01420302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6647747|NCT01420302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647748|NCT01420328|Simvastatin|simvastatin|mesh-list
6647749|NCT01420328|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
6647750|NCT01420328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6647751|NCT01420328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6647752|NCT01420328|Antimetabolites|antimetabolites|mesh-ancestor
6647753|NCT01420328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6647754|NCT01420328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6647755|NCT01420328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6647756|NCT01420328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6647757|NCT01420341|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6647758|NCT01420341|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6647759|NCT01420341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6647760|NCT01420341|Renal Agents|renal agents|mesh-ancestor
6647761|NCT01420341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6647762|NCT01420341|Antimalarials|antimalarials|mesh-ancestor
6647763|NCT01420341|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6647764|NCT01420341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6647765|NCT01420367|Metronidazole|metronidazole|mesh-list
6647766|NCT01420367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6647767|NCT01420367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6647768|NCT01420367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6647769|NCT01420367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6647770|NCT01420406|Vitamin A|vitamin a|mesh-list
5487354|NCT02431247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5487355|NCT02431247|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5487356|NCT02431247|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5487357|NCT02431247|Protease Inhibitors|protease inhibitors|mesh-ancestor
5487358|NCT02431247|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5487359|NCT02431247|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5487360|NCT02397226|Anesthetics|anesthetics|mesh-list
5487361|NCT02397226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5487362|NCT02397226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5487363|NCT02395666|Eflornithine|eflornithine|mesh-list
5487364|NCT02395666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5487365|NCT02395666|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5487366|NCT02395666|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5487367|NCT02395666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5487368|NCT02395666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5487369|NCT02395666|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
5487370|NCT02395666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6647771|NCT01420406|Vitamins|vitamins|mesh-ancestor
6647772|NCT01420406|Micronutrients|micronutrients|mesh-ancestor
6647773|NCT01420406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647774|NCT01420471|Triamcinolone|triamcinolone|mesh-list
6647775|NCT01420471|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6647776|NCT01420471|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6647777|NCT01420471|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6647778|NCT01420471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5487371|NCT02395666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487372|NCT02345850|Cyclophosphamide|cyclophosphamide|mesh-list
5487373|NCT02345850|Methotrexate|methotrexate|mesh-list
5487374|NCT02345850|Tacrolimus|tacrolimus|mesh-list
5487375|NCT02345850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5487376|NCT02345850|Immunologic Factors|immunologic factors|mesh-ancestor
5487377|NCT02345850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5487378|NCT02345850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5487379|NCT02345850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5487380|NCT02345850|Alkylating Agents|alkylating agents|mesh-ancestor
5487381|NCT02345850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487382|NCT02345850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5487383|NCT02345850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6647779|NCT01420471|Glucocorticoids|glucocorticoids|mesh-ancestor
6647780|NCT01420471|Hormones|hormones|mesh-ancestor
6647781|NCT01420471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6647782|NCT01420471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647783|NCT01420471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6647784|NCT01420471|Immunologic Factors|immunologic factors|mesh-ancestor
6647785|NCT01420471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6647786|NCT01420471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6647787|NCT01420523|Raltegravir Potassium|raltegravir potassium|mesh-list
6647788|NCT01420523|Maraviroc|maraviroc|mesh-list
6647789|NCT01420523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6647790|NCT01420523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6647791|NCT01420523|Antiviral Agents|antiviral agents|mesh-ancestor
6647792|NCT01420523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6647793|NCT01420523|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6647794|NCT01420523|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6647795|NCT01420523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6647796|NCT01420523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6647797|NCT01420523|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6647798|NCT01420523|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6647799|NCT01420523|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6647800|NCT01420575|Olanzapine|olanzapine|mesh-list
6647801|NCT01420575|Antiemetics|antiemetics|mesh-ancestor
6647802|NCT01420575|Autonomic Agents|autonomic agents|mesh-ancestor
6647803|NCT01420575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6647804|NCT01420575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5487384|NCT02345850|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5487385|NCT02345850|Abortifacient Agents|abortifacient agents|mesh-ancestor
5487386|NCT02345850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5487387|NCT02345850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5487388|NCT02345850|Antimetabolites|antimetabolites|mesh-ancestor
5487389|NCT02345850|Dermatologic Agents|dermatologic agents|mesh-ancestor
6453419|NCT00420498|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6453420|NCT00420498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6453421|NCT00420498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6453422|NCT00420498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453423|NCT00420498|Adrenergic Agents|adrenergic agents|mesh-ancestor
6453424|NCT00420498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6453425|NCT00420498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453426|NCT00420524|Epothilone B|epothilone b|mesh-list
6453427|NCT00420524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6453428|NCT00420524|Tubulin Modulators|tubulin modulators|mesh-ancestor
5487390|NCT02345850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5487391|NCT02345850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5487392|NCT02345850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5487393|NCT02345850|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5487394|NCT02332928|Melatonin|melatonin|mesh-list
5487395|NCT02332928|Antioxidants|antioxidants|mesh-ancestor
5487396|NCT02332928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487397|NCT02332928|Protective Agents|protective agents|mesh-ancestor
5487398|NCT02332928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5487399|NCT02332928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5487400|NCT02281084|Azacitidine|azacitidine|mesh-list
5487401|NCT02281084|Durvalumab|durvalumab|mesh-list
5487402|NCT02281084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5487403|NCT02281084|Antimetabolites|antimetabolites|mesh-ancestor
5487404|NCT02281084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487405|NCT02281084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5487406|NCT02281084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5487407|NCT02281084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5487408|NCT02220985|Mycophenolic Acid|mycophenolic acid|mesh-list
6647805|NCT01420575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6647806|NCT01420575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6647807|NCT01420575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6647808|NCT01420575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6647809|NCT01420575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6647810|NCT01420575|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6647811|NCT01420575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6647812|NCT01420575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6647813|NCT01420575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6647814|NCT01420575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6647815|NCT01420575|Serotonin Agents|serotonin agents|mesh-ancestor
6647816|NCT01420666|Acetaminophen|acetaminophen|mesh-list
6647817|NCT01420666|Ibuprofen|ibuprofen|mesh-list
5487409|NCT02220985|Cyclophosphamide|cyclophosphamide|mesh-list
6647818|NCT01420666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6647819|NCT01420666|Analgesics|analgesics|mesh-ancestor
6647820|NCT01420666|Sensory System Agents|sensory system agents|mesh-ancestor
6647821|NCT01420666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6647822|NCT01420666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647823|NCT01420666|Antipyretics|antipyretics|mesh-ancestor
6647824|NCT01420666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6647825|NCT01420666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6647826|NCT01420666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6647827|NCT01420666|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6647828|NCT01420666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6647829|NCT01420666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6647830|NCT01420692|Insulin Detemir|insulin detemir|mesh-list
6647831|NCT01420692|Gliclazide|gliclazide|mesh-list
6647832|NCT01420692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6647833|NCT01420692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647834|NCT01420822|Fluticasone|fluticasone|mesh-list
6647835|NCT01420822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6647836|NCT01420822|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6647837|NCT01420822|Autonomic Agents|autonomic agents|mesh-ancestor
6647838|NCT01420822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6647839|NCT01420822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647840|NCT01420822|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6647841|NCT01420822|Respiratory System Agents|respiratory system agents|mesh-ancestor
6647842|NCT01420822|Dermatologic Agents|dermatologic agents|mesh-ancestor
6647843|NCT01420822|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6647844|NCT01420874|Leucovorin|leucovorin|mesh-list
6647845|NCT01420874|Fluorouracil|fluorouracil|mesh-list
6647846|NCT01420874|Oxaliplatin|oxaliplatin|mesh-list
6647847|NCT01420874|Antimetabolites|antimetabolites|mesh-ancestor
6647848|NCT01420874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6647849|NCT01420874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6647850|NCT01420874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5487410|NCT02220985|Thiotepa|thiotepa|mesh-list
5487411|NCT02220985|Methotrexate|methotrexate|mesh-list
6647851|NCT01420874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6647852|NCT01420874|Immunologic Factors|immunologic factors|mesh-ancestor
6647853|NCT01420874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647854|NCT01420874|Antidotes|antidotes|mesh-ancestor
6647855|NCT01420874|Protective Agents|protective agents|mesh-ancestor
6647856|NCT01420874|Vitamin B Complex|vitamin b complex|mesh-ancestor
6647857|NCT01420874|Vitamins|vitamins|mesh-ancestor
6647858|NCT01420874|Micronutrients|micronutrients|mesh-ancestor
6647859|NCT01420900|Tacrine|tacrine|mesh-list
6647860|NCT01420900|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6647861|NCT01420900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6647862|NCT01420900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6647863|NCT01420900|Cholinergic Agents|cholinergic agents|mesh-ancestor
6647864|NCT01420900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6647865|NCT01420900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647866|NCT01420900|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6647867|NCT01420900|Autonomic Agents|autonomic agents|mesh-ancestor
6647868|NCT01420900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6647869|NCT01420900|Nootropic Agents|nootropic agents|mesh-ancestor
6647870|NCT01420913|Pregabalin|pregabalin|mesh-list
6647871|NCT01420913|Analgesics|analgesics|mesh-ancestor
6647872|NCT01420913|Sensory System Agents|sensory system agents|mesh-ancestor
6647873|NCT01420913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6647874|NCT01420913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647875|NCT01420913|Anticonvulsants|anticonvulsants|mesh-ancestor
6647876|NCT01420913|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6647877|NCT01420913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6647878|NCT01420913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6647879|NCT01420913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6647880|NCT01420913|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6647881|NCT01420913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6647882|NCT01420913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6647883|NCT01420913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6647884|NCT01421043|Triazolam|triazolam|mesh-list
6647885|NCT01421043|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6647886|NCT01421043|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6647887|NCT01421043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6647888|NCT01421043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6647889|NCT01421043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5487412|NCT02220985|Fludarabine|fludarabine|mesh-list
6647890|NCT01421043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6647891|NCT01421043|GABA Modulators|gaba modulators|mesh-ancestor
5487413|NCT02220985|Fludarabine phosphate|fludarabine phosphate|mesh-list
5487414|NCT02220985|Tacrolimus|tacrolimus|mesh-list
5487415|NCT02220985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5487416|NCT02220985|Immunologic Factors|immunologic factors|mesh-ancestor
5487417|NCT02220985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647892|NCT01421043|GABA Agents|gaba agents|mesh-ancestor
6647893|NCT01421043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6647894|NCT01421043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6647895|NCT01421069|Etanercept|etanercept|mesh-list
6647896|NCT01421069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6647897|NCT01421069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6647898|NCT01421069|Analgesics|analgesics|mesh-ancestor
6647899|NCT01421069|Sensory System Agents|sensory system agents|mesh-ancestor
6647900|NCT01421069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6647901|NCT01421069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647902|NCT01421069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6647903|NCT01421069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6647904|NCT01421069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6647905|NCT01421069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6647906|NCT01421069|Immunologic Factors|immunologic factors|mesh-ancestor
6647907|NCT01421121|Vaccines|vaccines|mesh-list
6647908|NCT01421121|Immunologic Factors|immunologic factors|mesh-ancestor
6647909|NCT01421121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647910|NCT01421160|Citric Acid|citric acid|mesh-list
6647911|NCT01421160|Sodium Citrate|sodium citrate|mesh-list
6647912|NCT01421160|Anticoagulants|anticoagulants|mesh-ancestor
6647913|NCT01421160|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6647914|NCT01421160|Chelating Agents|chelating agents|mesh-ancestor
6647915|NCT01421160|Sequestering Agents|sequestering agents|mesh-ancestor
6647916|NCT01421160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6647917|NCT01421173|Gemcitabine|gemcitabine|mesh-list
6647918|NCT01421173|Dexamethasone|dexamethasone|mesh-list
6647919|NCT01421173|Dexamethasone acetate|dexamethasone acetate|mesh-list
6647920|NCT01421173|Rituximab|rituximab|mesh-list
6647921|NCT01421173|Melphalan|melphalan|mesh-list
6647922|NCT01421173|Busulfan|busulfan|mesh-list
6647923|NCT01421173|Vorinostat|vorinostat|mesh-list
6647924|NCT01421173|BB 1101|bb 1101|mesh-list
6647925|NCT01421173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6647926|NCT01421173|Antiemetics|antiemetics|mesh-ancestor
6647927|NCT01421173|Autonomic Agents|autonomic agents|mesh-ancestor
6647928|NCT01421173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6647929|NCT01421173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647930|NCT01421173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6647931|NCT01421173|Glucocorticoids|glucocorticoids|mesh-ancestor
6647932|NCT01421173|Hormones|hormones|mesh-ancestor
6647933|NCT01421173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6647934|NCT01421173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6647935|NCT01421173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6647936|NCT01421173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6647937|NCT01421173|Immunologic Factors|immunologic factors|mesh-ancestor
6647938|NCT01421173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6647939|NCT01421173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6647940|NCT01421173|Antimetabolites|antimetabolites|mesh-ancestor
6647941|NCT01421173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6647942|NCT01421173|Antiviral Agents|antiviral agents|mesh-ancestor
6647943|NCT01421173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6647944|NCT01421173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6647945|NCT01421173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6647946|NCT01421173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6647947|NCT01421173|Alkylating Agents|alkylating agents|mesh-ancestor
6647948|NCT01421173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6647949|NCT01421173|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6647950|NCT01421173|Protease Inhibitors|protease inhibitors|mesh-ancestor
6647951|NCT01421212|Immunoglobulins|immunoglobulins|mesh-list
5487418|NCT02220985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5487419|NCT02220985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5487420|NCT02220985|Alkylating Agents|alkylating agents|mesh-ancestor
5487421|NCT02220985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487422|NCT02220985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5487423|NCT02220985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5487424|NCT02220985|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5487425|NCT02220985|Abortifacient Agents|abortifacient agents|mesh-ancestor
6647952|NCT01421212|Antibodies|antibodies|mesh-list
6647953|NCT01421212|gamma-Globulins|gamma-globulins|mesh-list
6647954|NCT01421212|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6647955|NCT01421212|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6647956|NCT01421212|Immunoglobulin G|immunoglobulin g|mesh-list
6647957|NCT01421212|Immunologic Factors|immunologic factors|mesh-ancestor
6647958|NCT01421212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647959|NCT01421264|Gabapentin|gabapentin|mesh-list
6647960|NCT01421264|Analgesics|analgesics|mesh-ancestor
6647961|NCT01421264|Sensory System Agents|sensory system agents|mesh-ancestor
6647962|NCT01421264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6647963|NCT01421264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647964|NCT01421264|Anticonvulsants|anticonvulsants|mesh-ancestor
6647965|NCT01421264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6647966|NCT01421264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6647967|NCT01421264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6647968|NCT01421264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6647969|NCT01421264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6647970|NCT01421264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6647971|NCT01421264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6647972|NCT01421264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6647973|NCT01421264|Antimanic Agents|antimanic agents|mesh-ancestor
6647974|NCT01421368|Tenofovir|tenofovir|mesh-list
5487426|NCT02220985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5487427|NCT02220985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5487428|NCT02220985|Antimetabolites|antimetabolites|mesh-ancestor
5487429|NCT02220985|Dermatologic Agents|dermatologic agents|mesh-ancestor
5487430|NCT02220985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5487431|NCT02220985|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5487432|NCT02220985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5487433|NCT02220985|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5487434|NCT02220985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5487435|NCT02220985|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5487436|NCT02220985|Antitubercular Agents|antitubercular agents|mesh-ancestor
5487437|NCT02220985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5487438|NCT02220985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5487439|NCT02109081|Dexamethasone|dexamethasone|mesh-list
5487440|NCT02109081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5487441|NCT02109081|Antiemetics|antiemetics|mesh-ancestor
5487442|NCT02109081|Autonomic Agents|autonomic agents|mesh-ancestor
5487443|NCT02109081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5487444|NCT02109081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5487445|NCT02109081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5487446|NCT02109081|Glucocorticoids|glucocorticoids|mesh-ancestor
5487447|NCT02109081|Hormones|hormones|mesh-ancestor
5487448|NCT02109081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5487449|NCT02109081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5487450|NCT02109081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5487451|NCT01962792|Dexamethasone|dexamethasone|mesh-list
5487452|NCT01962792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5487453|NCT01962792|Antiemetics|antiemetics|mesh-ancestor
5487454|NCT01962792|Autonomic Agents|autonomic agents|mesh-ancestor
5487455|NCT01962792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5487456|NCT01962792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5487457|NCT01962792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5487458|NCT01962792|Glucocorticoids|glucocorticoids|mesh-ancestor
5487459|NCT01962792|Hormones|hormones|mesh-ancestor
5487460|NCT01962792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5487461|NCT01962792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5487462|NCT01962792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5487463|NCT01850108|Mycophenolic Acid|mycophenolic acid|mesh-list
6647975|NCT01421368|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6647976|NCT01421368|Contraceptive Agents|contraceptive agents|mesh-list
6647977|NCT01421368|Medroxyprogesterone|medroxyprogesterone|mesh-list
6647978|NCT01421368|Contraceptives, Oral|contraceptives, oral|mesh-list
6647979|NCT01421368|Antiviral Agents|antiviral agents|mesh-ancestor
6647980|NCT01421368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6647981|NCT01421368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6647982|NCT01421368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6647983|NCT01421368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6647984|NCT01421368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487464|NCT01850108|Sirolimus|sirolimus|mesh-list
5487465|NCT01850108|Cyclophosphamide|cyclophosphamide|mesh-list
5487466|NCT01850108|Fludarabine|fludarabine|mesh-list
5487467|NCT01850108|Thymoglobulin|thymoglobulin|mesh-list
5487468|NCT01850108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5487469|NCT01850108|Immunologic Factors|immunologic factors|mesh-ancestor
5487470|NCT01850108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647985|NCT01421368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6647986|NCT01421368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6647987|NCT01421368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6647988|NCT01421368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6647989|NCT01421368|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6647990|NCT01421368|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6647991|NCT01421368|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6647992|NCT01421368|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6647993|NCT01421368|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6647994|NCT01421368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6647995|NCT01421368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6647996|NCT01421693|Ceftriaxone|ceftriaxone|mesh-list
6647997|NCT01421693|Gatifloxacin|gatifloxacin|mesh-list
6647998|NCT01421693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6647999|NCT01421693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6648000|NCT01421693|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6648001|NCT01421693|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6648002|NCT01421693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6648003|NCT01421693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6648004|NCT01421693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6648005|NCT01421693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6648006|NCT01421693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6648007|NCT01421706|Clarithromycin|clarithromycin|mesh-list
6648008|NCT01421706|Sibutramine|sibutramine|mesh-list
6648009|NCT01421706|Clopidogrel|clopidogrel|mesh-list
6648010|NCT01421706|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6648011|NCT01421706|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6648012|NCT01421706|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6648013|NCT01421706|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6648014|NCT01421706|Purinergic Agents|purinergic agents|mesh-ancestor
6648015|NCT01421706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6648016|NCT01421706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487471|NCT01850108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5487472|NCT01850108|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5487473|NCT01850108|Alkylating Agents|alkylating agents|mesh-ancestor
5487474|NCT01850108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487475|NCT01850108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5487476|NCT01850108|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5487477|NCT01850108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5487478|NCT01850108|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5487479|NCT01850108|Antitubercular Agents|antitubercular agents|mesh-ancestor
5487480|NCT01850108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5487481|NCT01850108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5487482|NCT01850108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5487483|NCT01850108|Antifungal Agents|antifungal agents|mesh-ancestor
5487484|NCT01546948|Methadone|methadone|mesh-list
6648017|NCT01421706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648018|NCT01421706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6648019|NCT01421706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6648020|NCT01421706|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6648021|NCT01421706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6648022|NCT01421706|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6648023|NCT01421706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6648024|NCT01421706|Antidepressive Agents|antidepressive agents|mesh-ancestor
6648025|NCT01421706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6648026|NCT01421706|Appetite Depressants|appetite depressants|mesh-ancestor
6648027|NCT01421706|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6648028|NCT01421771|Antihypertensive Agents|antihypertensive agents|mesh-list
6648029|NCT01421797|Dexamethasone|dexamethasone|mesh-list
6648030|NCT01421797|Cosyntropin|cosyntropin|mesh-list
6648031|NCT01421797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6648032|NCT01421797|Antiemetics|antiemetics|mesh-ancestor
6648033|NCT01421797|Autonomic Agents|autonomic agents|mesh-ancestor
6648034|NCT01421797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6648035|NCT01421797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648036|NCT01421797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6648037|NCT01421797|Glucocorticoids|glucocorticoids|mesh-ancestor
6648038|NCT01421797|Hormones|hormones|mesh-ancestor
6648039|NCT01421797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6648040|NCT01421797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6648041|NCT01421797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6648042|NCT01421810|Dexamethasone|dexamethasone|mesh-list
6648043|NCT01421810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6648044|NCT01421810|Antiemetics|antiemetics|mesh-ancestor
6648045|NCT01421810|Autonomic Agents|autonomic agents|mesh-ancestor
6648046|NCT01421810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6648047|NCT01421810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453429|NCT00420524|Antimitotic Agents|antimitotic agents|mesh-ancestor
6453430|NCT00420524|Mitosis Modulators|mitosis modulators|mesh-ancestor
6648048|NCT01421810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6648049|NCT01421810|Glucocorticoids|glucocorticoids|mesh-ancestor
6648050|NCT01421810|Hormones|hormones|mesh-ancestor
6648051|NCT01421810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6021725|NCT00401882|Sympatholytics|sympatholytics|mesh-ancestor
6021726|NCT00401882|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6021727|NCT00401882|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6648052|NCT01421810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6648053|NCT01421810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6648054|NCT01421901|Ertapenem|ertapenem|mesh-list
6648055|NCT01421901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6648056|NCT01421901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6648057|NCT01421914|Bupivacaine|bupivacaine|mesh-list
6648058|NCT01421914|Anesthetics, Local|anesthetics, local|mesh-ancestor
6648059|NCT01421914|Anesthetics|anesthetics|mesh-ancestor
6648060|NCT01421914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6648061|NCT01421914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648062|NCT01421914|Sensory System Agents|sensory system agents|mesh-ancestor
6648063|NCT01421914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6648064|NCT01421927|Lenalidomide|lenalidomide|mesh-list
5487485|NCT01546948|Hydromorphone|hydromorphone|mesh-list
5487486|NCT01546948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5487487|NCT01546948|Narcotics|narcotics|mesh-ancestor
5487488|NCT01546948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5487489|NCT01546948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5487490|NCT01546948|Analgesics|analgesics|mesh-ancestor
5487491|NCT01546948|Sensory System Agents|sensory system agents|mesh-ancestor
5487492|NCT01546948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5487493|NCT01546948|Antitussive Agents|antitussive agents|mesh-ancestor
5487494|NCT01546948|Respiratory System Agents|respiratory system agents|mesh-ancestor
5487495|NCT01495676|Gemcitabine|gemcitabine|mesh-list
5487496|NCT01495676|Cisplatin|cisplatin|mesh-list
5487497|NCT01495676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5487498|NCT01495676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5487499|NCT01495676|Antimetabolites|antimetabolites|mesh-ancestor
5487500|NCT01495676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487501|NCT01495676|Antiviral Agents|antiviral agents|mesh-ancestor
5487502|NCT01495676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5487503|NCT01495676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5487504|NCT01495676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5487505|NCT01495676|Immunologic Factors|immunologic factors|mesh-ancestor
5487506|NCT01495676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5487507|NCT01464164|Prednisone|prednisone|mesh-list
5487508|NCT01464164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5487509|NCT01464164|Glucocorticoids|glucocorticoids|mesh-ancestor
5487510|NCT01464164|Hormones|hormones|mesh-ancestor
5487511|NCT01464164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5487512|NCT01464164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5487513|NCT01464164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5487514|NCT01464164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5487515|NCT01318317|Plerixafor|plerixafor|mesh-list
5487516|NCT01318317|Rituximab|rituximab|mesh-list
5487517|NCT01318317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5487518|NCT01318317|Antibodies|antibodies|mesh-list
5487519|NCT01318317|Immunoglobulins|immunoglobulins|mesh-list
5487520|NCT01318317|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5487521|NCT01318317|Lenograstim|lenograstim|mesh-list
6453431|NCT00420524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453432|NCT00420537|Cyclosporine|cyclosporine|mesh-list
6453433|NCT00420537|Mycophenolic Acid|mycophenolic acid|mesh-list
6648065|NCT01421927|Immunologic Factors|immunologic factors|mesh-ancestor
5487522|NCT01318317|Sargramostim|sargramostim|mesh-list
5487523|NCT01318317|Immunologic Factors|immunologic factors|mesh-ancestor
6453434|NCT00420537|Everolimus|everolimus|mesh-list
6453435|NCT00420537|Cyclosporins|cyclosporins|mesh-list
6453436|NCT00420537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6453437|NCT00420537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453438|NCT00420537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6453439|NCT00420537|Immunologic Factors|immunologic factors|mesh-ancestor
6453440|NCT00420537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453441|NCT00420537|Antifungal Agents|antifungal agents|mesh-ancestor
6453442|NCT00420537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6453443|NCT00420537|Dermatologic Agents|dermatologic agents|mesh-ancestor
5487524|NCT01318317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5487525|NCT01318317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5487526|NCT01318317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6648066|NCT01421927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648067|NCT01421927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6648068|NCT01421927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6648069|NCT01421927|Growth Substances|growth substances|mesh-ancestor
6648070|NCT01421927|Growth Inhibitors|growth inhibitors|mesh-ancestor
6648071|NCT01421927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6664141|NCT01511172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664142|NCT01511172|Incretins|incretins|mesh-ancestor
5487527|NCT01318317|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5487528|NCT01318317|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5487529|NCT01318317|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5487530|NCT01318317|Antiviral Agents|antiviral agents|mesh-ancestor
5487531|NCT01318317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5487532|NCT01111565|Aripiprazole|aripiprazole|mesh-list
5487533|NCT01111565|Citalopram|citalopram|mesh-list
6664143|NCT01511172|Hormones|hormones|mesh-ancestor
6664144|NCT01511172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6664145|NCT01511172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6664146|NCT01511172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6664147|NCT01511172|Immunologic Factors|immunologic factors|mesh-ancestor
6664148|NCT01511185|Liraglutide|liraglutide|mesh-list
6664149|NCT01511185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6664150|NCT01511185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664151|NCT01511185|Incretins|incretins|mesh-ancestor
6664152|NCT01511185|Hormones|hormones|mesh-ancestor
6664153|NCT01511185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6664154|NCT01511198|Metformin|metformin|mesh-list
6664155|NCT01511198|Liraglutide|liraglutide|mesh-list
6664156|NCT01511198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5487534|NCT01111565|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5487535|NCT01111565|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5487536|NCT01111565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5487537|NCT01111565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487538|NCT01111565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5487539|NCT01111565|Serotonin Agents|serotonin agents|mesh-ancestor
5487540|NCT01111565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5487541|NCT01111565|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5487542|NCT01111565|Antidepressive Agents|antidepressive agents|mesh-ancestor
5487543|NCT01111565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5487544|NCT01111565|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5487545|NCT01111565|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5487546|NCT01111565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5487547|NCT01111565|Dopamine Agonists|dopamine agonists|mesh-ancestor
5487548|NCT01111565|Dopamine Agents|dopamine agents|mesh-ancestor
5487549|NCT01111565|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5487550|NCT01111565|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5487551|NCT01111565|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5487552|NCT01111565|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5487553|NCT01111565|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5487554|NCT01111565|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5487555|NCT00950989|Folic Acid|folic acid|mesh-list
5487556|NCT00950989|Methotrexate|methotrexate|mesh-list
5487557|NCT00950989|Brodalumab|brodalumab|mesh-list
5487558|NCT00950989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6664157|NCT01511198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664158|NCT01511198|Incretins|incretins|mesh-ancestor
6664159|NCT01511198|Hormones|hormones|mesh-ancestor
6664160|NCT01511198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6664161|NCT01511211|Dexamethasone|dexamethasone|mesh-list
6664162|NCT01511211|Ropivacaine|ropivacaine|mesh-list
6648072|NCT01421940|Udenafil|udenafil|mesh-list
6648073|NCT01421940|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6648074|NCT01421940|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6648075|NCT01421940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6648076|NCT01421940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6648077|NCT01421979|Caffeine|caffeine|mesh-list
6648078|NCT01421979|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6648079|NCT01421979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648080|NCT01421979|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6648081|NCT01421979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6648082|NCT01421979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6648083|NCT01421979|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6648084|NCT01421979|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6648085|NCT01421979|Purinergic Agents|purinergic agents|mesh-ancestor
6648086|NCT01421979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6648087|NCT01421992|Methylphenidate|methylphenidate|mesh-list
6648088|NCT01421992|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6648089|NCT01421992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648090|NCT01421992|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6648091|NCT01421992|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6648092|NCT01421992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6648093|NCT01421992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6648094|NCT01421992|Dopamine Agents|dopamine agents|mesh-ancestor
6648095|NCT01421992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6648096|NCT01422018|Bevacizumab|bevacizumab|mesh-list
6648097|NCT01422018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6648098|NCT01422018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6648099|NCT01422018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6648100|NCT01422018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6648101|NCT01422018|Growth Substances|growth substances|mesh-ancestor
6648102|NCT01422018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648103|NCT01422018|Growth Inhibitors|growth inhibitors|mesh-ancestor
6648104|NCT01422096|Leuprolide|leuprolide|mesh-list
6648105|NCT01422096|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6648106|NCT01422096|Fertility Agents|fertility agents|mesh-ancestor
6648107|NCT01422096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6648108|NCT01422096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5487559|NCT00950989|Abortifacient Agents|abortifacient agents|mesh-ancestor
5487560|NCT00950989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5487561|NCT00950989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5487562|NCT00950989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5487563|NCT00950989|Antimetabolites|antimetabolites|mesh-ancestor
5487564|NCT00950989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487565|NCT00950989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5487566|NCT00950989|Dermatologic Agents|dermatologic agents|mesh-ancestor
5487567|NCT00950989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5487568|NCT00950989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5487569|NCT00950989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5487570|NCT00950989|Immunologic Factors|immunologic factors|mesh-ancestor
5487571|NCT00950989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5487572|NCT00950989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5487573|NCT00950989|Hematinics|hematinics|mesh-ancestor
5487574|NCT00950989|Vitamin B Complex|vitamin b complex|mesh-ancestor
5487575|NCT00950989|Vitamins|vitamins|mesh-ancestor
5487576|NCT00950989|Micronutrients|micronutrients|mesh-ancestor
5487577|NCT00904046|Pioglitazone|pioglitazone|mesh-list
5487578|NCT00904046|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
5487579|NCT00904046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6453444|NCT00420537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6453445|NCT00420537|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6453446|NCT00420537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6453447|NCT00420537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6453448|NCT00420537|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6453449|NCT00420537|Antitubercular Agents|antitubercular agents|mesh-ancestor
6453450|NCT00420537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6453451|NCT00420563|Cyclophosphamide|cyclophosphamide|mesh-list
6453452|NCT00420563|Megestrol|megestrol|mesh-list
6453453|NCT00420563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6453454|NCT00420563|Immunologic Factors|immunologic factors|mesh-ancestor
6453455|NCT00420563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453456|NCT00420563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6453457|NCT00420563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6453458|NCT00420563|Alkylating Agents|alkylating agents|mesh-ancestor
6648109|NCT01422096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6648110|NCT01422096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6648111|NCT01422109|Aspirin|aspirin|mesh-list
6648112|NCT01422109|Clopidogrel|clopidogrel|mesh-list
6648113|NCT01422109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5487580|NCT00904046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5487581|NCT00601900|Tamoxifen|tamoxifen|mesh-list
5487582|NCT00601900|Bevacizumab|bevacizumab|mesh-list
5487583|NCT00601900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5487584|NCT00601900|Letrozole|letrozole|mesh-list
5487585|NCT00601900|Endothelial Growth Factors|endothelial growth factors|mesh-list
5487586|NCT00601900|Antibodies|antibodies|mesh-list
5487587|NCT00601900|Immunoglobulins|immunoglobulins|mesh-list
5487588|NCT00601900|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5487589|NCT00601900|Immunoglobulin G|immunoglobulin g|mesh-list
5487590|NCT00601900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5487591|NCT00601900|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5487592|NCT00601900|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5487593|NCT00601900|Growth Substances|growth substances|mesh-ancestor
6648114|NCT01422109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6648115|NCT01422109|Analgesics|analgesics|mesh-ancestor
6648116|NCT01422109|Sensory System Agents|sensory system agents|mesh-ancestor
6648117|NCT01422109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6648118|NCT01422109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5487594|NCT00601900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5487595|NCT00601900|Growth Inhibitors|growth inhibitors|mesh-ancestor
5487596|NCT00601900|Immunologic Factors|immunologic factors|mesh-ancestor
6648119|NCT01422109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6648120|NCT01422109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6648121|NCT01422109|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6648122|NCT01422109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6648123|NCT01422109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6648124|NCT01422109|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6648125|NCT01422109|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6648126|NCT01422109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6648127|NCT01422109|Antipyretics|antipyretics|mesh-ancestor
6648128|NCT01422109|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6648129|NCT01422109|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6648130|NCT01422109|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6453459|NCT00420563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453460|NCT00420563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6453461|NCT00420563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6453462|NCT00420563|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6453463|NCT00420563|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6453464|NCT00420563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6453465|NCT00420563|Contraceptive Agents|contraceptive agents|mesh-ancestor
6453466|NCT00420563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6453467|NCT00420563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6648131|NCT01422109|Purinergic Agents|purinergic agents|mesh-ancestor
6648132|NCT01422109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6648133|NCT01422122|Vitamin D|vitamin d|mesh-list
6648134|NCT01422122|Ergocalciferols|ergocalciferols|mesh-list
6648135|NCT01422122|Cholecalciferol|cholecalciferol|mesh-list
6648136|NCT01422122|Vitamins|vitamins|mesh-list
6648137|NCT01422122|Micronutrients|micronutrients|mesh-ancestor
6648138|NCT01422122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648139|NCT01422122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6648140|NCT01422122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6648141|NCT01422148|Minocycline|minocycline|mesh-list
6648142|NCT01422148|Amiodarone|amiodarone|mesh-list
6648143|NCT01422148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6648144|NCT01422148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6648145|NCT01422148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6648146|NCT01422148|Vasodilator Agents|vasodilator agents|mesh-ancestor
6648147|NCT01422148|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5487597|NCT00601900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487598|NCT00601900|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5487599|NCT00601900|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5487600|NCT00601900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5487601|NCT00601900|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5487602|NCT00601900|Hormone Antagonists|hormone antagonists|mesh-ancestor
6453468|NCT00420563|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6648148|NCT01422148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6648149|NCT01422148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6648150|NCT01422148|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5487603|NCT00601900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5487604|NCT00601900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5487605|NCT00601900|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6648151|NCT01422148|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6648152|NCT01422148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6648153|NCT01422148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6648154|NCT01422148|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6648155|NCT01422148|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6648156|NCT01422148|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6648157|NCT01422291|Acetaminophen|acetaminophen|mesh-list
6648158|NCT01422291|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
6648159|NCT01422291|Morphine|morphine|mesh-list
6648160|NCT01422291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6648161|NCT01422291|Narcotics|narcotics|mesh-ancestor
6648162|NCT01422291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6648163|NCT01422291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648164|NCT01422291|Analgesics|analgesics|mesh-ancestor
6648165|NCT01422291|Sensory System Agents|sensory system agents|mesh-ancestor
6648166|NCT01422291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6648167|NCT01422291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6648168|NCT01422291|Antipyretics|antipyretics|mesh-ancestor
6648169|NCT01422291|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6648170|NCT01422291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6648171|NCT01422291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6648172|NCT01422317|Tocopherols|tocopherols|mesh-list
6648173|NCT01422317|Vitamin E|vitamin e|mesh-list
6648174|NCT01422317|Tocotrienols|tocotrienols|mesh-list
6648175|NCT01422317|alpha-Tocopherol|alpha-tocopherol|mesh-list
6648176|NCT01422317|Antioxidants|antioxidants|mesh-ancestor
6648177|NCT01422317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6648178|NCT01422317|Protective Agents|protective agents|mesh-ancestor
5487606|NCT00601900|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5487607|NCT00601900|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5487608|NCT00489307|Dexamethasone|dexamethasone|mesh-list
5487609|NCT00489307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5487610|NCT00489307|Antiemetics|antiemetics|mesh-ancestor
5487611|NCT00489307|Autonomic Agents|autonomic agents|mesh-ancestor
5487612|NCT00489307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5487613|NCT00489307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5487614|NCT00489307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5487615|NCT00489307|Glucocorticoids|glucocorticoids|mesh-ancestor
5487616|NCT00489307|Hormones|hormones|mesh-ancestor
5487617|NCT00489307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5487618|NCT00489307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5487619|NCT00489307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5487620|NCT00072410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5487621|NCT00072410|Antibodies|antibodies|mesh-list
5487622|NCT00072410|Immunoglobulins|immunoglobulins|mesh-list
5487623|NCT00072410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5487624|NCT00072410|Immunologic Factors|immunologic factors|mesh-ancestor
5487625|NCT00072410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5487626|NCT00072410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5487627|NCT05171400|Insulin|insulin|mesh-list
5487628|NCT05171400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5487629|NCT05171400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5487630|NCT05171374|Trametinib|trametinib|mesh-list
5487631|NCT05171374|Dabrafenib|dabrafenib|mesh-list
5487632|NCT05171374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5487633|NCT05171374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5487634|NCT05171374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5487635|NCT05171374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487636|NCT05171335|Lenvatinib|lenvatinib|mesh-list
5487637|NCT05171335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5487638|NCT05171335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5487639|NCT05171335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6648179|NCT01422317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648180|NCT01422317|Vitamins|vitamins|mesh-ancestor
6648181|NCT01422317|Micronutrients|micronutrients|mesh-ancestor
6648182|NCT01422330|Etravirine|etravirine|mesh-list
6648183|NCT01422330|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6648184|NCT01422330|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6648185|NCT01422330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6648186|NCT01422330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6648187|NCT01422330|Antiviral Agents|antiviral agents|mesh-ancestor
6648188|NCT01422330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6648189|NCT01422460|Mitogens|mitogens|mesh-list
6648190|NCT01422460|Mitosis Modulators|mitosis modulators|mesh-ancestor
6648191|NCT01422460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6648192|NCT01422499|Vorinostat|vorinostat|mesh-list
6648193|NCT01422499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6648194|NCT01422499|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6648195|NCT01422499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6648196|NCT01422499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6648197|NCT01422590|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6648198|NCT01422590|Mitiglinide|mitiglinide|mesh-list
6648199|NCT01422590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6648200|NCT01422590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648201|NCT01422590|Incretins|incretins|mesh-ancestor
6648202|NCT01422590|Hormones|hormones|mesh-ancestor
6648203|NCT01422590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5487640|NCT05171335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487641|NCT05171309|Apatinib|apatinib|mesh-list
5487642|NCT05171309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5487643|NCT05171309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5487644|NCT05171309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5487645|NCT05171309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487646|NCT05171257|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5487647|NCT05171257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5487648|NCT05171257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5487649|NCT05171257|Antitubercular Agents|antitubercular agents|mesh-ancestor
5487650|NCT05171231|Hemostatics|hemostatics|mesh-list
5487651|NCT05171231|Coagulants|coagulants|mesh-ancestor
5487652|NCT05171179|Lidocaine|lidocaine|mesh-list
5487653|NCT05171179|Bupivacaine|bupivacaine|mesh-list
5487654|NCT05171179|Anesthetics, Local|anesthetics, local|mesh-ancestor
5487655|NCT05171179|Anesthetics|anesthetics|mesh-ancestor
5487656|NCT05171179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5487657|NCT05171179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5487658|NCT05171179|Sensory System Agents|sensory system agents|mesh-ancestor
5487659|NCT05171179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5487660|NCT05171179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6648204|NCT01422590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6648205|NCT01422590|Protease Inhibitors|protease inhibitors|mesh-ancestor
6648206|NCT01422590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6648207|NCT01422590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487661|NCT05171179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5487662|NCT05171179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5487663|NCT05171179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5487664|NCT05171179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487665|NCT05171075|Dalteparin|dalteparin|mesh-list
5487666|NCT05171075|Tinzaparin|tinzaparin|mesh-list
5487667|NCT05171075|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5487668|NCT05171075|Anticoagulants|anticoagulants|mesh-ancestor
5487669|NCT05171075|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5487670|NCT05171075|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5487671|NCT05171075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487672|NCT05171049|Apixaban|apixaban|mesh-list
5487673|NCT05171049|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5487674|NCT05171049|Antithrombins|antithrombins|mesh-ancestor
5487675|NCT05171049|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5487676|NCT05171049|Protease Inhibitors|protease inhibitors|mesh-ancestor
5487677|NCT05171049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6648208|NCT01422603|Clofarabine|clofarabine|mesh-list
6648209|NCT01422603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6648210|NCT01422603|Antimetabolites|antimetabolites|mesh-ancestor
6648211|NCT01422603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6648212|NCT01422603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6648213|NCT01422616|Metoprolol|metoprolol|mesh-list
5487678|NCT05171049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487679|NCT05171049|Anticoagulants|anticoagulants|mesh-ancestor
5487680|NCT05170828|Mycophenolic Acid|mycophenolic acid|mesh-list
5487681|NCT05170828|Sirolimus|sirolimus|mesh-list
5487682|NCT05170828|Cyclophosphamide|cyclophosphamide|mesh-list
5487683|NCT05170828|Busulfan|busulfan|mesh-list
5487684|NCT05170828|Fludarabine|fludarabine|mesh-list
5487685|NCT05170828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5487686|NCT05170828|Immunologic Factors|immunologic factors|mesh-ancestor
5487687|NCT05170828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648214|NCT01422616|Clonidine|clonidine|mesh-list
6648215|NCT01422616|Hydralazine|hydralazine|mesh-list
6648216|NCT01422616|Labetalol|labetalol|mesh-list
6648217|NCT01422616|Nicardipine|nicardipine|mesh-list
6648218|NCT01422616|Phentolamine|phentolamine|mesh-list
6648219|NCT01422616|Urapidil|urapidil|mesh-list
6648220|NCT01422616|Enalaprilat|enalaprilat|mesh-list
6648221|NCT01422616|Enalapril|enalapril|mesh-list
6648222|NCT01422616|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6453469|NCT00420563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6453470|NCT00420589|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
6453471|NCT00420589|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6453472|NCT00420589|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6453473|NCT00420589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6453474|NCT00420589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453475|NCT00420589|Hormones|hormones|mesh-ancestor
6648223|NCT01422616|Nitroglycerin|nitroglycerin|mesh-list
6648224|NCT01422616|Esmolol|esmolol|mesh-list
6648225|NCT01422616|Glycerol|glycerol|mesh-list
6648226|NCT01422616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6648227|NCT01422616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6648228|NCT01422616|Sympatholytics|sympatholytics|mesh-ancestor
6648229|NCT01422616|Autonomic Agents|autonomic agents|mesh-ancestor
6648230|NCT01422616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6648231|NCT01422616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648232|NCT01422616|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6648233|NCT01422616|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6648234|NCT01422616|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6648235|NCT01422616|Adrenergic Agents|adrenergic agents|mesh-ancestor
6648236|NCT01422616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6648237|NCT01422616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6648238|NCT01422616|Analgesics|analgesics|mesh-ancestor
6648239|NCT01422616|Sensory System Agents|sensory system agents|mesh-ancestor
6648240|NCT01422616|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6648241|NCT01422616|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6648242|NCT01422616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6648243|NCT01422616|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6648244|NCT01422616|Protective Agents|protective agents|mesh-ancestor
6648245|NCT01422616|Vasodilator Agents|vasodilator agents|mesh-ancestor
6648246|NCT01422616|Sympathomimetics|sympathomimetics|mesh-ancestor
6648247|NCT01422616|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6648248|NCT01422616|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6648249|NCT01422616|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6648250|NCT01422616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6648251|NCT01422616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6648252|NCT01422616|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6648253|NCT01422616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6648254|NCT01422616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6648255|NCT01422616|Serotonin Agents|serotonin agents|mesh-ancestor
6648256|NCT01422616|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5487688|NCT05170828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5487689|NCT05170828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5487690|NCT05170828|Alkylating Agents|alkylating agents|mesh-ancestor
5487691|NCT05170828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487692|NCT05170828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5487693|NCT05170828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5487694|NCT05170828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5487695|NCT05170828|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5487696|NCT05170828|Antitubercular Agents|antitubercular agents|mesh-ancestor
5487697|NCT05170828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5487698|NCT05170828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6648257|NCT01422616|Protease Inhibitors|protease inhibitors|mesh-ancestor
6648258|NCT01422616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6648259|NCT01422707|Hydrocortisone|hydrocortisone|mesh-list
6648260|NCT01422707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6648261|NCT01422733|Dexamethasone|dexamethasone|mesh-list
6648262|NCT01422733|Hydrocortisone|hydrocortisone|mesh-list
6648263|NCT01422733|Cosyntropin|cosyntropin|mesh-list
6648264|NCT01422733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6648265|NCT01422733|Antiemetics|antiemetics|mesh-ancestor
6648266|NCT01422733|Autonomic Agents|autonomic agents|mesh-ancestor
6648267|NCT01422733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5487699|NCT05170828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5487700|NCT05170828|Antifungal Agents|antifungal agents|mesh-ancestor
5487701|NCT05170789|Dexamethasone|dexamethasone|mesh-list
5487702|NCT05170789|Elotuzumab|elotuzumab|mesh-list
5487703|NCT05170789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5487704|NCT05170789|Antiemetics|antiemetics|mesh-ancestor
6648268|NCT01422733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648269|NCT01422733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6648270|NCT01422733|Glucocorticoids|glucocorticoids|mesh-ancestor
6648271|NCT01422733|Hormones|hormones|mesh-ancestor
6648272|NCT01422733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6648273|NCT01422733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6648274|NCT01422733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6648275|NCT01422746|Metformin|metformin|mesh-list
6648276|NCT01422746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6648277|NCT01422746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648278|NCT01422759|Spironolactone|spironolactone|mesh-list
5487705|NCT05170789|Autonomic Agents|autonomic agents|mesh-ancestor
5487706|NCT05170789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5487707|NCT05170789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5487708|NCT05170789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5487709|NCT05170789|Glucocorticoids|glucocorticoids|mesh-ancestor
5487710|NCT05170789|Hormones|hormones|mesh-ancestor
5487711|NCT05170789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6648279|NCT01422759|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6648280|NCT01422759|Hormone Antagonists|hormone antagonists|mesh-ancestor
6648281|NCT01422759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6648282|NCT01422759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648283|NCT01422759|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6648284|NCT01422759|Diuretics|diuretics|mesh-ancestor
6648285|NCT01422759|Natriuretic Agents|natriuretic agents|mesh-ancestor
6648286|NCT01422785|Clindamycin|clindamycin|mesh-list
6648287|NCT01422785|Clindamycin palmitate|clindamycin palmitate|mesh-list
6648288|NCT01422785|Clindamycin phosphate|clindamycin phosphate|mesh-list
6648289|NCT01422785|Tretinoin|tretinoin|mesh-list
6648290|NCT01422785|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6648291|NCT01422785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6648292|NCT01422785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6648293|NCT01422785|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6648294|NCT01422785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6648295|NCT01422785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6648296|NCT01422785|Dermatologic Agents|dermatologic agents|mesh-ancestor
6648297|NCT01422785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6648298|NCT01422785|Keratolytic Agents|keratolytic agents|mesh-ancestor
6648299|NCT01422954|Chloroquine|chloroquine|mesh-list
6648300|NCT01422954|Mefloquine|mefloquine|mesh-list
6648301|NCT01422954|Proguanil|proguanil|mesh-list
6648302|NCT01422954|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
6648303|NCT01422954|Vaccines|vaccines|mesh-list
6648304|NCT01422954|Amebicides|amebicides|mesh-ancestor
6648305|NCT01422954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6648306|NCT01422954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6648307|NCT01422954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6648308|NCT01422954|Antimalarials|antimalarials|mesh-ancestor
6648309|NCT01422954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6648310|NCT01422954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648311|NCT01422954|Immunologic Factors|immunologic factors|mesh-ancestor
6648312|NCT01422954|Antimetabolites|antimetabolites|mesh-ancestor
6648313|NCT01422954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6648314|NCT01423019|Synephrine|synephrine|mesh-list
6648315|NCT01423019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6648316|NCT01423019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6648317|NCT01423019|Adrenergic Agents|adrenergic agents|mesh-ancestor
6648318|NCT01423019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6648319|NCT01423019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487712|NCT05170789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5487713|NCT05170789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5502721|NCT04464811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502722|NCT04465097|Exemestane|exemestane|mesh-list
5502723|NCT04465097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5502724|NCT04465097|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5502725|NCT04465097|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5502726|NCT04465097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5502727|NCT04465097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502728|NCT04465097|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5502729|NCT04465097|Hormone Antagonists|hormone antagonists|mesh-ancestor
6648320|NCT01423019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648321|NCT01423019|Sympathomimetics|sympathomimetics|mesh-ancestor
6648322|NCT01423019|Autonomic Agents|autonomic agents|mesh-ancestor
6648323|NCT01423019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6648324|NCT01423019|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5487714|NCT05170672|Abatacept|abatacept|mesh-list
5487715|NCT05170672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5487716|NCT05170672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487717|NCT05170672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5487718|NCT05170672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5487719|NCT05170672|Immunologic Factors|immunologic factors|mesh-ancestor
5487720|NCT05170672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5487721|NCT05170672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5487722|NCT05170607|Antibodies|antibodies|mesh-list
5487723|NCT05170607|Immunologic Factors|immunologic factors|mesh-ancestor
5487724|NCT05170607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5487725|NCT05170594|Bevacizumab|bevacizumab|mesh-list
5487726|NCT05170594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
5487727|NCT05170594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5487728|NCT05170594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5487729|NCT05170594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5487730|NCT05170594|Growth Substances|growth substances|mesh-ancestor
5487731|NCT05170594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5487732|NCT05170594|Growth Inhibitors|growth inhibitors|mesh-ancestor
5487733|NCT05170581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5487734|NCT05170581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487735|NCT05170581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5487736|NCT05170555|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
6648325|NCT01423019|Nasal Decongestants|nasal decongestants|mesh-ancestor
6648326|NCT01423019|Respiratory System Agents|respiratory system agents|mesh-ancestor
6648327|NCT01423032|Fludarabine|fludarabine|mesh-list
6648328|NCT01423032|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6648329|NCT01423032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6648330|NCT01423032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6648331|NCT01423032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6648332|NCT01423032|Alkylating Agents|alkylating agents|mesh-ancestor
6648333|NCT01423123|Paclitaxel|paclitaxel|mesh-list
6648334|NCT01423123|Trastuzumab|trastuzumab|mesh-list
6648335|NCT01423123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6648336|NCT01423123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6648337|NCT01423123|Tubulin Modulators|tubulin modulators|mesh-ancestor
6648338|NCT01423123|Antimitotic Agents|antimitotic agents|mesh-ancestor
6648339|NCT01423123|Mitosis Modulators|mitosis modulators|mesh-ancestor
6648340|NCT01423123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6648341|NCT01423123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6648342|NCT01423175|Clofarabine|clofarabine|mesh-list
6648343|NCT01423175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6648344|NCT01423175|Antimetabolites|antimetabolites|mesh-ancestor
6648345|NCT01423175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6648346|NCT01423175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6648347|NCT01423240|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
6648348|NCT01423240|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6648349|NCT01423240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6648350|NCT01423240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6648351|NCT01423240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648352|NCT01423240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6648353|NCT01423240|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6648354|NCT01423240|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6648355|NCT01423240|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6648356|NCT01423240|Adrenergic Agents|adrenergic agents|mesh-ancestor
6648357|NCT01423240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6648358|NCT01423240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6648359|NCT01423240|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6648360|NCT01423240|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6648361|NCT01423240|Serotonin Agents|serotonin agents|mesh-ancestor
6648362|NCT01423240|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6648363|NCT01423240|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6648364|NCT01423240|Dopamine Agents|dopamine agents|mesh-ancestor
6648365|NCT01423292|Bupivacaine|bupivacaine|mesh-list
5487737|NCT05170555|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
5487738|NCT05170555|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5487739|NCT05170555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487740|NCT05170256|Trastuzumab|trastuzumab|mesh-list
5487741|NCT05170256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5487742|NCT05170256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5487743|NCT05170230|Terlipressin|terlipressin|mesh-list
5487744|NCT05170230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5487745|NCT05170230|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5487746|NCT05170217|Cannabidiol|cannabidiol|mesh-list
5487747|NCT05170217|Anticonvulsants|anticonvulsants|mesh-ancestor
5487748|NCT05170113|Caffeine|caffeine|mesh-list
5487749|NCT05170113|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5487750|NCT05170113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5487751|NCT05170113|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5487752|NCT05170113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5487753|NCT05170113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6648366|NCT01423292|Anesthetics, Local|anesthetics, local|mesh-ancestor
6648367|NCT01423292|Anesthetics|anesthetics|mesh-ancestor
6648368|NCT01423292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6648369|NCT01423292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648370|NCT01423292|Sensory System Agents|sensory system agents|mesh-ancestor
6648371|NCT01423292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6648372|NCT01423305|Budesonide|budesonide|mesh-list
6648373|NCT01423305|Formoterol Fumarate|formoterol fumarate|mesh-list
6648374|NCT01423305|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6648375|NCT01423305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6648376|NCT01423305|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6648377|NCT01423305|Autonomic Agents|autonomic agents|mesh-ancestor
6648378|NCT01423305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6648379|NCT01423305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648380|NCT01423305|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6648381|NCT01423305|Respiratory System Agents|respiratory system agents|mesh-ancestor
6648382|NCT01423305|Glucocorticoids|glucocorticoids|mesh-ancestor
6648383|NCT01423305|Hormones|hormones|mesh-ancestor
6648384|NCT01423305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6648385|NCT01423305|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6648386|NCT01423305|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6648387|NCT01423305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6648388|NCT01423305|Adrenergic Agents|adrenergic agents|mesh-ancestor
6648389|NCT01423305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6648390|NCT01423305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6648391|NCT01423370|Tadalafil|tadalafil|mesh-list
6648392|NCT01423370|Vasodilator Agents|vasodilator agents|mesh-ancestor
6648393|NCT01423370|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6648394|NCT01423370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6648395|NCT01423370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6648396|NCT01423370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6648397|NCT01423370|Urological Agents|urological agents|mesh-ancestor
6648398|NCT01423435|Beraprost|beraprost|mesh-list
6648399|NCT01423435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6648400|NCT01423435|Vasodilator Agents|vasodilator agents|mesh-ancestor
6648401|NCT01423487|Metformin|metformin|mesh-list
6648402|NCT01423487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6648403|NCT01423487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648404|NCT01423500|Fludarabine|fludarabine|mesh-list
6648405|NCT01423500|Etoposide|etoposide|mesh-list
6648406|NCT01423500|Etoposide phosphate|etoposide phosphate|mesh-list
6648407|NCT01423500|Thiotepa|thiotepa|mesh-list
5487754|NCT05170113|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5487755|NCT05170113|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5487756|NCT05170113|Purinergic Agents|purinergic agents|mesh-ancestor
5487757|NCT05170113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5487758|NCT05170061|Valsartan|valsartan|mesh-list
5487759|NCT05170061|Nebivolol|nebivolol|mesh-list
5487760|NCT05170061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5487761|NCT05170061|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5487762|NCT05170061|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5487763|NCT05170061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487764|NCT05170061|Vasodilator Agents|vasodilator agents|mesh-ancestor
5487765|NCT05170061|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5487766|NCT05170061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5487767|NCT05170061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6648408|NCT01423500|Treosulfan|treosulfan|mesh-list
6648409|NCT01423500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6648410|NCT01423500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6648411|NCT01423500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6648412|NCT01423500|Immunologic Factors|immunologic factors|mesh-ancestor
6648413|NCT01423500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648414|NCT01423500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6648415|NCT01423500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6648416|NCT01423500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6648417|NCT01423500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6648418|NCT01423500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6648419|NCT01423500|Alkylating Agents|alkylating agents|mesh-ancestor
6648420|NCT01423500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6648421|NCT01423539|Rituximab|rituximab|mesh-list
6648422|NCT01423539|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6648423|NCT01423539|Navitoclax|navitoclax|mesh-list
6648424|NCT01423539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6648425|NCT01423539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6648426|NCT01423539|Immunologic Factors|immunologic factors|mesh-ancestor
6648427|NCT01423539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648428|NCT01423539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6648429|NCT01423539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6648430|NCT01423539|Alkylating Agents|alkylating agents|mesh-ancestor
6648431|NCT01423539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6648432|NCT01423591|Infliximab|infliximab|mesh-list
5487768|NCT05170061|Adrenergic Agents|adrenergic agents|mesh-ancestor
5487769|NCT05170061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5487770|NCT05170061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5487771|NCT05170009|Oseltamivir|oseltamivir|mesh-list
5487772|NCT05170009|Baloxavir|baloxavir|mesh-list
5487773|NCT05170009|Antiviral Agents|antiviral agents|mesh-ancestor
5487774|NCT05170009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5487775|NCT05170009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5487776|NCT05170009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487777|NCT05169957|Nivolumab|nivolumab|mesh-list
5487778|NCT05169957|Ipilimumab|ipilimumab|mesh-list
5487779|NCT05169957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5487780|NCT05169957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5487781|NCT05169957|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5487782|NCT05169957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6648433|NCT01423591|Dermatologic Agents|dermatologic agents|mesh-ancestor
6648434|NCT01423591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6648435|NCT01423591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6664163|NCT01511211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6664164|NCT01511211|Antiemetics|antiemetics|mesh-ancestor
6664165|NCT01511211|Autonomic Agents|autonomic agents|mesh-ancestor
6664166|NCT01511211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6664167|NCT01511211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664168|NCT01511211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6664169|NCT01511211|Glucocorticoids|glucocorticoids|mesh-ancestor
6664170|NCT01511211|Hormones|hormones|mesh-ancestor
6664171|NCT01511211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6664172|NCT01511211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6664173|NCT01511211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6664174|NCT01511211|Anesthetics, Local|anesthetics, local|mesh-ancestor
6664175|NCT01511211|Anesthetics|anesthetics|mesh-ancestor
6664176|NCT01511211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6664177|NCT01511211|Sensory System Agents|sensory system agents|mesh-ancestor
6664178|NCT01511237|Lamivudine|lamivudine|mesh-list
6664179|NCT01511237|Zidovudine|zidovudine|mesh-list
6664180|NCT01511237|Nevirapine|nevirapine|mesh-list
6664181|NCT01511237|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6664182|NCT01511237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6664183|NCT01511237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6664184|NCT01511237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6664185|NCT01511237|Antiviral Agents|antiviral agents|mesh-ancestor
6664186|NCT01511237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6664187|NCT01511237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6664188|NCT01511237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6664189|NCT01511237|Antimetabolites|antimetabolites|mesh-ancestor
5487783|NCT05169944|Magrolimab|magrolimab|mesh-list
5487784|NCT05169944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5487785|NCT05169944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5487786|NCT05169801|Paclitaxel|paclitaxel|mesh-list
5487787|NCT05169801|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5487788|NCT05169801|Carboplatin|carboplatin|mesh-list
5487789|NCT05169801|Bevacizumab|bevacizumab|mesh-list
5487790|NCT05169801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6664190|NCT01511237|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6664191|NCT01511237|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6664192|NCT01511263|Amiodarone|amiodarone|mesh-list
6664193|NCT01511263|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
6664194|NCT01511263|Diuretics|diuretics|mesh-list
6664195|NCT01511263|Natriuretic Agents|natriuretic agents|mesh-ancestor
6664196|NCT01511263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5487791|NCT05169801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5487792|NCT05169801|Tubulin Modulators|tubulin modulators|mesh-ancestor
6648436|NCT01423695|Paclitaxel|paclitaxel|mesh-list
6648437|NCT01423695|Trastuzumab|trastuzumab|mesh-list
6648438|NCT01423695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6648439|NCT01423695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6648440|NCT01423695|Tubulin Modulators|tubulin modulators|mesh-ancestor
6648441|NCT01423695|Antimitotic Agents|antimitotic agents|mesh-ancestor
6648442|NCT01423695|Mitosis Modulators|mitosis modulators|mesh-ancestor
6648443|NCT01423695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6648444|NCT01423695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6648445|NCT01423708|Everolimus|everolimus|mesh-list
6648446|NCT01423708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6648447|NCT01423708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6648448|NCT01423708|Immunologic Factors|immunologic factors|mesh-ancestor
6648449|NCT01423708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648450|NCT01423747|Fludarabine|fludarabine|mesh-list
6648451|NCT01423747|Etoposide|etoposide|mesh-list
6648452|NCT01423747|Etoposide phosphate|etoposide phosphate|mesh-list
6648453|NCT01423747|Thiotepa|thiotepa|mesh-list
6648454|NCT01423747|Treosulfan|treosulfan|mesh-list
6648455|NCT01423747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6648456|NCT01423747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6648457|NCT01423747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5487793|NCT05169801|Antimitotic Agents|antimitotic agents|mesh-ancestor
5487794|NCT05169801|Mitosis Modulators|mitosis modulators|mesh-ancestor
5487795|NCT05169801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487796|NCT05169801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5487797|NCT05169801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5487798|NCT05169801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5487799|NCT05169801|Growth Substances|growth substances|mesh-ancestor
6648458|NCT01423747|Immunologic Factors|immunologic factors|mesh-ancestor
6648459|NCT01423747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648460|NCT01423747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6648461|NCT01423747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6648462|NCT01423747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6648463|NCT01423747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6648464|NCT01423747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6648465|NCT01423747|Alkylating Agents|alkylating agents|mesh-ancestor
6648466|NCT01423747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6648467|NCT01423838|Solifenacin Succinate|solifenacin succinate|mesh-list
6648468|NCT01423838|Oxybutynin|oxybutynin|mesh-list
6648469|NCT01423838|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6648470|NCT01423838|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6648471|NCT01423838|Cholinergic Agents|cholinergic agents|mesh-ancestor
6648472|NCT01423838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6648473|NCT01423838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6648474|NCT01423838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648475|NCT01423838|Urological Agents|urological agents|mesh-ancestor
6648476|NCT01423838|Parasympatholytics|parasympatholytics|mesh-ancestor
6648477|NCT01423838|Autonomic Agents|autonomic agents|mesh-ancestor
6648478|NCT01423838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6648479|NCT01423864|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6648480|NCT01423864|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6648481|NCT01423864|Methylprednisolone|methylprednisolone|mesh-list
6648482|NCT01423864|Prednisolone|prednisolone|mesh-list
6648483|NCT01423864|Prednisolone acetate|prednisolone acetate|mesh-list
6453476|NCT00420589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6453477|NCT00420589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453478|NCT00420615|Epothilone B|epothilone b|mesh-list
6453479|NCT00420615|Epothilones|epothilones|mesh-list
6453480|NCT00420615|Omeprazole|omeprazole|mesh-list
6453481|NCT00420615|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6648484|NCT01423864|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6648485|NCT01423864|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6648486|NCT01423864|Prednisolone phosphate|prednisolone phosphate|mesh-list
6648487|NCT01423864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6648488|NCT01423864|Glucocorticoids|glucocorticoids|mesh-ancestor
6648489|NCT01423864|Hormones|hormones|mesh-ancestor
6648490|NCT01423864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6648491|NCT01423864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648492|NCT01423864|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6648493|NCT01423864|Protective Agents|protective agents|mesh-ancestor
6648494|NCT01423864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6648495|NCT01423864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6648496|NCT01423864|Antiemetics|antiemetics|mesh-ancestor
6648497|NCT01423864|Autonomic Agents|autonomic agents|mesh-ancestor
6648498|NCT01423864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6648499|NCT01423864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6648500|NCT01423955|Epoetin Alfa|epoetin alfa|mesh-list
6648501|NCT01423955|Hematinics|hematinics|mesh-ancestor
6648502|NCT01424046|Insulin Glargine|insulin glargine|mesh-list
6648503|NCT01424046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5487800|NCT05169801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5487801|NCT05169801|Growth Inhibitors|growth inhibitors|mesh-ancestor
6648504|NCT01424046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648505|NCT01424111|Citalopram|citalopram|mesh-list
6648506|NCT01424111|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6648507|NCT01424111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6648508|NCT01424111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6648509|NCT01424111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6648510|NCT01424111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6648511|NCT01424111|Serotonin Agents|serotonin agents|mesh-ancestor
6648512|NCT01424111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724878|NCT03184480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5724879|NCT03184480|Autonomic Agents|autonomic agents|mesh-ancestor
5724880|NCT03184480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5724881|NCT03184480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453482|NCT00420615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6453483|NCT00420615|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6453484|NCT00420615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6453485|NCT00420615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453486|NCT00420615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6453487|NCT00420615|Tubulin Modulators|tubulin modulators|mesh-ancestor
6453488|NCT00420615|Antimitotic Agents|antimitotic agents|mesh-ancestor
6453489|NCT00420615|Mitosis Modulators|mitosis modulators|mesh-ancestor
6453490|NCT00420654|Hormones|hormones|mesh-list
6453491|NCT00420654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6453492|NCT00420654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453493|NCT00420667|Enoxaparin|enoxaparin|mesh-list
6453494|NCT00420667|Anticoagulants|anticoagulants|mesh-ancestor
6453495|NCT00420667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6453496|NCT00420667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6462220|NCT00458185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6648513|NCT01424111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6648514|NCT01424111|Antidepressive Agents|antidepressive agents|mesh-ancestor
6648515|NCT01424111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6648516|NCT01424124|Montelukast|montelukast|mesh-list
6648517|NCT01424124|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6648518|NCT01424124|Respiratory System Agents|respiratory system agents|mesh-ancestor
6648519|NCT01424124|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6648520|NCT01424124|Hormone Antagonists|hormone antagonists|mesh-ancestor
5487821|NCT05169593|Adalimumab|adalimumab|mesh-list
5487822|NCT05169593|Infliximab|infliximab|mesh-list
5487823|NCT05169593|Ustekinumab|ustekinumab|mesh-list
5487824|NCT05169593|Vedolizumab|vedolizumab|mesh-list
5487825|NCT05169593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5487826|NCT05169593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5487827|NCT05169593|Dermatologic Agents|dermatologic agents|mesh-ancestor
5487828|NCT05169593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5487829|NCT05169554|Amoxicillin|amoxicillin|mesh-list
5487830|NCT05169554|Clarithromycin|clarithromycin|mesh-list
6648521|NCT01424124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6648522|NCT01424124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648523|NCT01424124|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6648524|NCT01424124|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6648525|NCT01424124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6648526|NCT01424137|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6648527|NCT01424137|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6648528|NCT01424137|Autonomic Agents|autonomic agents|mesh-ancestor
6648529|NCT01424137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6648530|NCT01424137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648531|NCT01424137|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6648532|NCT01424137|Respiratory System Agents|respiratory system agents|mesh-ancestor
6648533|NCT01424137|Glucocorticoids|glucocorticoids|mesh-ancestor
6648534|NCT01424137|Hormones|hormones|mesh-ancestor
6648535|NCT01424137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6648536|NCT01424137|Sympathomimetics|sympathomimetics|mesh-ancestor
6648537|NCT01424176|Pramipexole|pramipexole|mesh-list
5487831|NCT05169554|Rifampin|rifampin|mesh-list
5487832|NCT05169554|Clavulanic Acid|clavulanic acid|mesh-list
5487833|NCT05169554|Clavulanic Acids|clavulanic acids|mesh-list
5487834|NCT05169554|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5487835|NCT05169554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5487836|NCT05169554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5487837|NCT05169554|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5487838|NCT05169554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6648538|NCT01424176|Antioxidants|antioxidants|mesh-ancestor
6648539|NCT01424176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6648540|NCT01424176|Protective Agents|protective agents|mesh-ancestor
6648541|NCT01424176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648542|NCT01424176|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6648543|NCT01424176|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6648544|NCT01424176|Dopamine Agonists|dopamine agonists|mesh-ancestor
6648545|NCT01424176|Dopamine Agents|dopamine agents|mesh-ancestor
6648546|NCT01424176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6648547|NCT01424241|Octreotide|octreotide|mesh-list
6648548|NCT01424241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6648549|NCT01424241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6648550|NCT01424241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5487839|NCT05169554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487840|NCT05169554|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5487841|NCT05169554|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5487842|NCT05169554|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6648551|NCT01424319|Atrasentan|atrasentan|mesh-list
6648552|NCT01424319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6648553|NCT01424319|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
6648554|NCT01424319|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6648555|NCT01424319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6648556|NCT01424332|Aspirin|aspirin|mesh-list
6648557|NCT01424332|Salicylic Acid|salicylic acid|mesh-list
6648558|NCT01424332|Salicylates|salicylates|mesh-list
6648559|NCT01424332|Darexaban|darexaban|mesh-list
6648560|NCT01424332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6648561|NCT01424332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6648562|NCT01424332|Analgesics|analgesics|mesh-ancestor
5487843|NCT05169554|Antitubercular Agents|antitubercular agents|mesh-ancestor
5487844|NCT05169554|Leprostatic Agents|leprostatic agents|mesh-ancestor
5487845|NCT05169554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5487846|NCT05169554|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5487847|NCT05169554|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5487848|NCT05169554|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5487849|NCT05169554|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5487850|NCT05169554|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5487851|NCT05169554|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5487852|NCT05169554|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5487853|NCT05169268|Aripiprazole|aripiprazole|mesh-list
5487854|NCT05169268|Brexpiprazole|brexpiprazole|mesh-list
5487855|NCT05169268|Antidepressive Agents|antidepressive agents|mesh-ancestor
5487856|NCT05169268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5487857|NCT05169268|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5487858|NCT05169268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5487859|NCT05169268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5487860|NCT05169268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648563|NCT01424332|Sensory System Agents|sensory system agents|mesh-ancestor
6648564|NCT01424332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6648565|NCT01424332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648566|NCT01424332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6648567|NCT01424332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6648568|NCT01424332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6648569|NCT01424332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6648570|NCT01424332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487861|NCT05169268|Dopamine Agonists|dopamine agonists|mesh-ancestor
5487862|NCT05169268|Dopamine Agents|dopamine agents|mesh-ancestor
5487863|NCT05169268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5487864|NCT05169268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487865|NCT05169268|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5487866|NCT05169268|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5487867|NCT05169268|Serotonin Agents|serotonin agents|mesh-ancestor
5487868|NCT05169268|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5487869|NCT05169268|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5487870|NCT05169268|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5487871|NCT05169268|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5487872|NCT05169255|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5487873|NCT05169255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5487874|NCT05169229|Vancomycin|vancomycin|mesh-list
5487875|NCT05169229|Tobramycin|tobramycin|mesh-list
5487876|NCT05169229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5487877|NCT05169229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5487878|NCT05169125|Dialysis Solutions|dialysis solutions|mesh-list
5487879|NCT05169125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5487880|NCT05169112|Leuprolide|leuprolide|mesh-list
5487881|NCT05169112|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5487882|NCT05169112|Fertility Agents|fertility agents|mesh-ancestor
5487883|NCT05169112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5487884|NCT05169112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5487885|NCT05169112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5487886|NCT05169112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5487887|NCT05169060|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
5487888|NCT05169060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5487889|NCT05169060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5487890|NCT05169060|Analgesics|analgesics|mesh-ancestor
5487891|NCT05169060|Sensory System Agents|sensory system agents|mesh-ancestor
5487892|NCT05169060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6648571|NCT01424332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6648572|NCT01424332|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6648573|NCT01424332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6648574|NCT01424332|Antipyretics|antipyretics|mesh-ancestor
6648575|NCT01424332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6648576|NCT01424332|Antifungal Agents|antifungal agents|mesh-ancestor
6648577|NCT01424332|Keratolytic Agents|keratolytic agents|mesh-ancestor
6648578|NCT01424332|Dermatologic Agents|dermatologic agents|mesh-ancestor
6648579|NCT01424332|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6648580|NCT01424332|Antithrombins|antithrombins|mesh-ancestor
6648581|NCT01424332|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6648582|NCT01424332|Protease Inhibitors|protease inhibitors|mesh-ancestor
6648583|NCT01424332|Anticoagulants|anticoagulants|mesh-ancestor
6648584|NCT01424345|Immunosuppressive Agents|immunosuppressive agents|mesh-list
6648585|NCT01424345|Immunologic Factors|immunologic factors|mesh-ancestor
6648586|NCT01424345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648587|NCT01424384|Citalopram|citalopram|mesh-list
6648588|NCT01424384|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6648589|NCT01424384|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6648590|NCT01424384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6648591|NCT01424384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6648592|NCT01424384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6648593|NCT01424384|Serotonin Agents|serotonin agents|mesh-ancestor
6648594|NCT01424384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648595|NCT01424384|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6648596|NCT01424384|Antidepressive Agents|antidepressive agents|mesh-ancestor
6648597|NCT01424384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6648598|NCT01424449|Aripiprazole|aripiprazole|mesh-list
6648599|NCT01424449|Antidepressive Agents|antidepressive agents|mesh-ancestor
6648600|NCT01424449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6648601|NCT01424449|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5487893|NCT05169060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5487894|NCT05169060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5487895|NCT05169060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5487896|NCT05169021|Folic Acid|folic acid|mesh-list
5487897|NCT05169021|Vitamin B Complex|vitamin b complex|mesh-list
5487898|NCT05169021|Amlodipine|amlodipine|mesh-list
5487899|NCT05169021|Antihypertensive Agents|antihypertensive agents|mesh-list
5487900|NCT05169021|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5487901|NCT05169021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6648602|NCT01424449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6648603|NCT01424449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6648604|NCT01424449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648605|NCT01424449|Dopamine Agonists|dopamine agonists|mesh-ancestor
6648606|NCT01424449|Dopamine Agents|dopamine agents|mesh-ancestor
6648607|NCT01424449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6648608|NCT01424449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6648609|NCT01424449|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6648610|NCT01424449|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6648611|NCT01424449|Serotonin Agents|serotonin agents|mesh-ancestor
6648612|NCT01424449|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6648613|NCT01424449|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6648614|NCT01424449|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6648615|NCT01424449|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6648616|NCT01424618|Leuprolide|leuprolide|mesh-list
6648617|NCT01424618|Ganirelix|ganirelix|mesh-list
6648618|NCT01424618|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6648619|NCT01424618|Fertility Agents|fertility agents|mesh-ancestor
6648620|NCT01424618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6648621|NCT01424618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648622|NCT01424618|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6648623|NCT01424618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6648624|NCT01424618|Hormone Antagonists|hormone antagonists|mesh-ancestor
6648625|NCT01424618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6648626|NCT01424709|Gemcitabine|gemcitabine|mesh-list
6648627|NCT01424709|Cisplatin|cisplatin|mesh-list
6648628|NCT01424709|Docetaxel|docetaxel|mesh-list
6648629|NCT01424709|Irinotecan|irinotecan|mesh-list
6648630|NCT01424709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6648631|NCT01424709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6648632|NCT01424709|Antimetabolites|antimetabolites|mesh-ancestor
5487902|NCT05169021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487903|NCT05169021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5487904|NCT05169021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5487905|NCT05169021|Vasodilator Agents|vasodilator agents|mesh-ancestor
5487906|NCT05169021|Hematinics|hematinics|mesh-ancestor
5487907|NCT05169021|Vitamins|vitamins|mesh-ancestor
5487908|NCT05169021|Micronutrients|micronutrients|mesh-ancestor
5487909|NCT05168930|Venetoclax|venetoclax|mesh-list
5487910|NCT05168930|Zanubrutinib|zanubrutinib|mesh-list
5487911|NCT05168930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5487912|NCT05168930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5487913|NCT05168930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5487914|NCT05168930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487915|NCT05168787|Valsartan|valsartan|mesh-list
5487916|NCT05168787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5487917|NCT05168787|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5487918|NCT05168787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5487919|NCT05168787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487920|NCT05168735|Ketamine|ketamine|mesh-list
6664197|NCT01511263|Vasodilator Agents|vasodilator agents|mesh-ancestor
5487921|NCT05168735|Analgesics|analgesics|mesh-ancestor
5487922|NCT05168735|Sensory System Agents|sensory system agents|mesh-ancestor
5487923|NCT05168735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5487924|NCT05168735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5487925|NCT05168735|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5487926|NCT05168735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5487927|NCT05168735|Anesthetics, General|anesthetics, general|mesh-ancestor
5487928|NCT05168735|Anesthetics|anesthetics|mesh-ancestor
5487929|NCT05168735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5487930|NCT05168735|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5487931|NCT05168735|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5487932|NCT05168735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5487933|NCT05168735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502730|NCT04465097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5502731|NCT04465097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502732|NCT04465110|Grape Seed Extract|grape seed extract|mesh-list
5502733|NCT04465110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5502734|NCT04465110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5502735|NCT04465110|Antioxidants|antioxidants|mesh-ancestor
5502736|NCT04465110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502737|NCT04465110|Protective Agents|protective agents|mesh-ancestor
5502738|NCT04465110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502739|NCT04464850|Iron|iron|mesh-list
5502740|NCT04464850|Ferrous fumarate|ferrous fumarate|mesh-list
5502741|NCT04464850|Folic Acid|folic acid|mesh-list
5502742|NCT04464850|Trace Elements|trace elements|mesh-ancestor
5502743|NCT04464850|Micronutrients|micronutrients|mesh-ancestor
5502744|NCT04464850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502745|NCT04464850|Hematinics|hematinics|mesh-ancestor
6648633|NCT01424709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6648634|NCT01424709|Antiviral Agents|antiviral agents|mesh-ancestor
6648635|NCT01424709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6648636|NCT01424709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6648637|NCT01424709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6648638|NCT01424709|Immunologic Factors|immunologic factors|mesh-ancestor
6648639|NCT01424709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648640|NCT01424709|Tubulin Modulators|tubulin modulators|mesh-ancestor
6648641|NCT01424709|Antimitotic Agents|antimitotic agents|mesh-ancestor
6648642|NCT01424709|Mitosis Modulators|mitosis modulators|mesh-ancestor
6648643|NCT01424709|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6648644|NCT01424709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6648645|NCT01424761|Ubiquinone|ubiquinone|mesh-list
6648646|NCT01424761|Coenzyme Q10|coenzyme q10|mesh-list
6648647|NCT01424761|Micronutrients|micronutrients|mesh-ancestor
6648648|NCT01424761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648649|NCT01424761|Vitamins|vitamins|mesh-ancestor
6648650|NCT01424826|Raltegravir Potassium|raltegravir potassium|mesh-list
6648651|NCT01424826|Rifampin|rifampin|mesh-list
6648652|NCT01424826|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6648653|NCT01424826|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6648654|NCT01424826|Antiviral Agents|antiviral agents|mesh-ancestor
6648655|NCT01424826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6648656|NCT01424826|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6648657|NCT01424826|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6648658|NCT01424826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6648659|NCT01424826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6648660|NCT01424826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6648661|NCT01424826|Antitubercular Agents|antitubercular agents|mesh-ancestor
6648662|NCT01424826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6648663|NCT01424826|Leprostatic Agents|leprostatic agents|mesh-ancestor
6648664|NCT01424826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6648665|NCT01424826|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6648666|NCT01424826|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6648667|NCT01424826|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6648668|NCT01424826|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6648669|NCT01424826|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6648670|NCT01424826|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6648671|NCT01424839|Cisplatin|cisplatin|mesh-list
6648672|NCT01424839|Carboplatin|carboplatin|mesh-list
6648673|NCT01424839|Etoposide|etoposide|mesh-list
6648674|NCT01424839|Etoposide phosphate|etoposide phosphate|mesh-list
6648675|NCT01424839|Ifosfamide|ifosfamide|mesh-list
6648676|NCT01424839|Isophosphamide mustard|isophosphamide mustard|mesh-list
6648677|NCT01424839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6648678|NCT01424839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6648679|NCT01424839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6648680|NCT01424839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6648681|NCT01424839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6648682|NCT01424839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6648683|NCT01424839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6648684|NCT01424839|Alkylating Agents|alkylating agents|mesh-ancestor
6648685|NCT01424891|Simvastatin|simvastatin|mesh-list
6648686|NCT01424891|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6648687|NCT01424891|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6648688|NCT01424891|Antimetabolites|antimetabolites|mesh-ancestor
6648689|NCT01424891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6648690|NCT01424891|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6648691|NCT01424891|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6648692|NCT01424891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6648693|NCT01425060|Contraceptive Agents|contraceptive agents|mesh-list
6648694|NCT01425060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6648695|NCT01425060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648696|NCT01425073|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6648697|NCT01425073|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6648698|NCT01425073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6648699|NCT01425073|Renal Agents|renal agents|mesh-ancestor
6648700|NCT01425073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6648701|NCT01425073|Antimalarials|antimalarials|mesh-ancestor
6648702|NCT01425073|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6648703|NCT01425073|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6648704|NCT01425099|Dolutegravir|dolutegravir|mesh-list
6648705|NCT01425099|Prednisone|prednisone|mesh-list
6648706|NCT01425099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6648707|NCT01425099|Glucocorticoids|glucocorticoids|mesh-ancestor
6648708|NCT01425099|Hormones|hormones|mesh-ancestor
6648709|NCT01425099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6648710|NCT01425099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648711|NCT01425099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6648712|NCT01425099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6648713|NCT01425099|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6648714|NCT01425099|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6648715|NCT01425099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6648716|NCT01425099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6648717|NCT01425099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6648718|NCT01425099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6648719|NCT01425099|Antiviral Agents|antiviral agents|mesh-ancestor
6648720|NCT01425099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6648721|NCT01425125|Tolvaptan|tolvaptan|mesh-list
6648722|NCT01425125|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6648723|NCT01425125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6648724|NCT01425125|Natriuretic Agents|natriuretic agents|mesh-ancestor
6648725|NCT01425125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021728|NCT00401882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6021729|NCT00401960|Daptomycin|daptomycin|mesh-list
6021730|NCT00401960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5487937|NCT05168566|Maleic acid|maleic acid|mesh-list
5487938|NCT05168566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6648726|NCT01425164|Carvedilol|carvedilol|mesh-list
6648727|NCT01425164|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6648728|NCT01425164|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6648729|NCT01425164|Adrenergic Agents|adrenergic agents|mesh-ancestor
6648730|NCT01425164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6648731|NCT01425164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487939|NCT05168566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487940|NCT05168475|Rituximab|rituximab|mesh-list
5487941|NCT05168475|Infliximab|infliximab|mesh-list
5487942|NCT05168475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5487943|NCT05168475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5487944|NCT05168475|Immunologic Factors|immunologic factors|mesh-ancestor
5487945|NCT05168475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5487946|NCT05168475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5487947|NCT05168475|Dermatologic Agents|dermatologic agents|mesh-ancestor
5487948|NCT05168475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5487949|NCT05168280|Dexmedetomidine|dexmedetomidine|mesh-list
5487950|NCT05168280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5487951|NCT05168280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5487952|NCT05168280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5487953|NCT05168280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5487954|NCT05168280|Analgesics|analgesics|mesh-ancestor
5487955|NCT05168280|Sensory System Agents|sensory system agents|mesh-ancestor
5487956|NCT05168280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5487957|NCT05168280|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5487958|NCT05168280|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5487959|NCT05168280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5487960|NCT05168280|Adrenergic Agents|adrenergic agents|mesh-ancestor
5487961|NCT05168280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5487962|NCT05168280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021731|NCT00401960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6021732|NCT00401973|Metformin|metformin|mesh-list
6021733|NCT00401973|Amantadine|amantadine|mesh-list
6021734|NCT00401973|Zonisamide|zonisamide|mesh-list
6021735|NCT00401973|Olanzapine|olanzapine|mesh-list
6021736|NCT00401973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5487969|NCT05168176|Dolutegravir|dolutegravir|mesh-list
5487970|NCT05168176|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5487971|NCT05168176|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5487972|NCT05168176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5487973|NCT05168176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487974|NCT05168176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5487975|NCT05168176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5487976|NCT05168176|Antiviral Agents|antiviral agents|mesh-ancestor
5487977|NCT05168176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5487978|NCT05168137|Colchicine|colchicine|mesh-list
5487979|NCT05168137|Gout Suppressants|gout suppressants|mesh-ancestor
5487980|NCT05168137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6648732|NCT01425164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648733|NCT01425164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6648734|NCT01425164|Antioxidants|antioxidants|mesh-ancestor
6648735|NCT01425164|Protective Agents|protective agents|mesh-ancestor
6648736|NCT01425164|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6648737|NCT01425164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6648738|NCT01425164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5487981|NCT05168137|Tubulin Modulators|tubulin modulators|mesh-ancestor
5487982|NCT05168137|Antimitotic Agents|antimitotic agents|mesh-ancestor
5487983|NCT05168137|Mitosis Modulators|mitosis modulators|mesh-ancestor
5487984|NCT05168137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5487985|NCT05168137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5487986|NCT05168059|Clevidipine|clevidipine|mesh-list
5487987|NCT05168059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5487988|NCT05168059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5487989|NCT05168059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021737|NCT00401973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648739|NCT01425164|Vasodilator Agents|vasodilator agents|mesh-ancestor
6021738|NCT00401973|Antiemetics|antiemetics|mesh-ancestor
6648740|NCT01425164|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6648741|NCT01425164|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6648742|NCT01425216|Sorafenib|sorafenib|mesh-list
6648743|NCT01425216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6648744|NCT01425216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6648745|NCT01425216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6648746|NCT01425216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6648747|NCT01425242|Amlodipine|amlodipine|mesh-list
6648748|NCT01425242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6648749|NCT01425242|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6648750|NCT01425242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6648751|NCT01425242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6648752|NCT01425242|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6648753|NCT01425242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648754|NCT01425242|Vasodilator Agents|vasodilator agents|mesh-ancestor
6648755|NCT01425320|Dapsone|dapsone|mesh-list
6648756|NCT01425320|Adapalene|adapalene|mesh-list
6648757|NCT01425320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5487990|NCT05168059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5487991|NCT05168059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5487992|NCT05168007|Cariprazine|cariprazine|mesh-list
5487993|NCT05168007|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5487994|NCT05168007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5487995|NCT05168007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5487996|NCT05168007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5487997|NCT05168007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5487998|NCT05167851|Lazertinib|lazertinib|mesh-list
6648758|NCT01425320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6648759|NCT01425320|Analgesics|analgesics|mesh-ancestor
6648760|NCT01425320|Sensory System Agents|sensory system agents|mesh-ancestor
6648761|NCT01425320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6648762|NCT01425320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648763|NCT01425320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6648764|NCT01425320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6648765|NCT01425320|Dermatologic Agents|dermatologic agents|mesh-ancestor
6648766|NCT01425320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6648767|NCT01425320|Antimalarials|antimalarials|mesh-ancestor
6648768|NCT01425320|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6648769|NCT01425320|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6648770|NCT01425320|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6648771|NCT01425320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6648772|NCT01425320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6648773|NCT01425320|Leprostatic Agents|leprostatic agents|mesh-ancestor
6648774|NCT01425320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6664198|NCT01511263|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6664199|NCT01511263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6664200|NCT01511263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6664201|NCT01511263|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6664202|NCT01511263|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6664203|NCT01511263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6664204|NCT01511263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6664205|NCT01511263|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6664206|NCT01511263|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6664207|NCT01511263|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6664208|NCT01511289|Imatinib Mesylate|imatinib mesylate|mesh-list
6664209|NCT01511289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6664210|NCT01511289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6664211|NCT01511289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6664212|NCT01511289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6664213|NCT01511302|Budesonide|budesonide|mesh-list
6664214|NCT01511302|RNS60|rns60|mesh-list
6648775|NCT01425398|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6648776|NCT01425398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6648777|NCT01425398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6648778|NCT01425398|Antimetabolites|antimetabolites|mesh-ancestor
6648779|NCT01425398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6648780|NCT01425398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6648781|NCT01425398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6648782|NCT01425398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6648783|NCT01425411|Valsartan|valsartan|mesh-list
6648784|NCT01425411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6648785|NCT01425411|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6648786|NCT01425411|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6648787|NCT01425411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6648788|NCT01425424|Vitamin D|vitamin d|mesh-list
6648789|NCT01425424|Ergocalciferols|ergocalciferols|mesh-list
6648790|NCT01425424|Vitamins|vitamins|mesh-list
6648791|NCT01425424|Micronutrients|micronutrients|mesh-ancestor
5487999|NCT05167851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5488000|NCT05167851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5488001|NCT05167851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488002|NCT05167760|Apraclonidine|apraclonidine|mesh-list
6648792|NCT01425424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648793|NCT01425424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6648794|NCT01425424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6648795|NCT01425476|Vitamin D|vitamin d|mesh-list
6648796|NCT01425476|Cholecalciferol|cholecalciferol|mesh-list
6648797|NCT01425476|Celecoxib|celecoxib|mesh-list
6648798|NCT01425476|Vitamins|vitamins|mesh-ancestor
6648799|NCT01425476|Micronutrients|micronutrients|mesh-ancestor
6648800|NCT01425476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648801|NCT01425476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6648802|NCT01425476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6648803|NCT01425476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6648804|NCT01425476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6648805|NCT01425476|Analgesics|analgesics|mesh-ancestor
6648806|NCT01425476|Sensory System Agents|sensory system agents|mesh-ancestor
6648807|NCT01425476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6648808|NCT01425476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6648809|NCT01425476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6648810|NCT01425476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6648811|NCT01425476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6648812|NCT01425476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6648813|NCT01425476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6648814|NCT01425541|Progesterone|progesterone|mesh-list
6648815|NCT01425541|Estradiol|estradiol|mesh-list
6648816|NCT01425541|Estrogens|estrogens|mesh-list
6648817|NCT01425541|Progestins|progestins|mesh-ancestor
6648818|NCT01425541|Hormones|hormones|mesh-ancestor
6648819|NCT01425541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6648820|NCT01425541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648821|NCT01425567|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
6648822|NCT01425567|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6648823|NCT01425567|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6648824|NCT01425580|Metformin|metformin|mesh-list
6648825|NCT01425580|Liraglutide|liraglutide|mesh-list
6648826|NCT01425580|Glimepiride|glimepiride|mesh-list
6648827|NCT01425580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6648828|NCT01425580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648829|NCT01425580|Incretins|incretins|mesh-ancestor
6648830|NCT01425580|Hormones|hormones|mesh-ancestor
6648831|NCT01425580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6648832|NCT01425580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6648833|NCT01425580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6648834|NCT01425580|Immunologic Factors|immunologic factors|mesh-ancestor
6648835|NCT01425619|Lidocaine|lidocaine|mesh-list
6648836|NCT01425619|Prilocaine|prilocaine|mesh-list
6648837|NCT01425619|Anesthetics, Local|anesthetics, local|mesh-ancestor
6648838|NCT01425619|Anesthetics|anesthetics|mesh-ancestor
6648839|NCT01425619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6648840|NCT01425619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648841|NCT01425619|Sensory System Agents|sensory system agents|mesh-ancestor
5502746|NCT04464850|Vitamin B Complex|vitamin b complex|mesh-ancestor
6648842|NCT01425619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6648843|NCT01425619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6648844|NCT01425619|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5488003|NCT05167760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5488004|NCT05167760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6648845|NCT01425619|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6648846|NCT01425619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6648847|NCT01425619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488005|NCT05167760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5488006|NCT05167760|Adrenergic Agents|adrenergic agents|mesh-ancestor
5488007|NCT05167760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5488008|NCT05167760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488009|NCT05167760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488010|NCT05167734|Dextrans|dextrans|mesh-list
5488011|NCT05167734|Epoetin Alfa|epoetin alfa|mesh-list
6648848|NCT01425658|Clonidine|clonidine|mesh-list
6648849|NCT01425658|Fentanyl|fentanyl|mesh-list
6648850|NCT01425658|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6648851|NCT01425658|Narcotics|narcotics|mesh-ancestor
6648852|NCT01425658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6648853|NCT01425658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648854|NCT01425658|Analgesics|analgesics|mesh-ancestor
6648855|NCT01425658|Sensory System Agents|sensory system agents|mesh-ancestor
6648856|NCT01425658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6648857|NCT01425658|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6648858|NCT01425658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6648859|NCT01425658|Anesthetics, General|anesthetics, general|mesh-ancestor
6648860|NCT01425658|Anesthetics|anesthetics|mesh-ancestor
6648861|NCT01425658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6648862|NCT01425658|Sympatholytics|sympatholytics|mesh-ancestor
6648863|NCT01425658|Autonomic Agents|autonomic agents|mesh-ancestor
6648864|NCT01425658|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6648865|NCT01425658|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6648866|NCT01425658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6648867|NCT01425658|Adrenergic Agents|adrenergic agents|mesh-ancestor
6648868|NCT01425658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5488012|NCT05167734|Iron-Dextran Complex|iron-dextran complex|mesh-list
6648869|NCT01425658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6648870|NCT01425697|Chlorhexidine|chlorhexidine|mesh-list
6648871|NCT01425697|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6648872|NCT01425697|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6648873|NCT01425697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6648874|NCT01425697|Disinfectants|disinfectants|mesh-ancestor
6648875|NCT01425697|Dermatologic Agents|dermatologic agents|mesh-ancestor
6648876|NCT01425736|Cisplatin|cisplatin|mesh-list
6648877|NCT01425736|Docetaxel|docetaxel|mesh-list
6648878|NCT01425736|Fluorouracil|fluorouracil|mesh-list
6648879|NCT01425736|Nimotuzumab|nimotuzumab|mesh-list
6648880|NCT01425736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6648881|NCT01425736|Tubulin Modulators|tubulin modulators|mesh-ancestor
6648882|NCT01425736|Antimitotic Agents|antimitotic agents|mesh-ancestor
6648883|NCT01425736|Mitosis Modulators|mitosis modulators|mesh-ancestor
6648884|NCT01425736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488013|NCT05167734|Hematinics|hematinics|mesh-ancestor
5488014|NCT05167734|Anticoagulants|anticoagulants|mesh-ancestor
5488015|NCT05167734|Plasma Substitutes|plasma substitutes|mesh-ancestor
6648885|NCT01425736|Antimetabolites|antimetabolites|mesh-ancestor
6648886|NCT01425736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6648887|NCT01425736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6648888|NCT01425736|Immunologic Factors|immunologic factors|mesh-ancestor
6648889|NCT01425736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648890|NCT01425736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6648891|NCT01425775|Vitamin D|vitamin d|mesh-list
6648892|NCT01425775|Vitamins|vitamins|mesh-ancestor
6648893|NCT01425775|Micronutrients|micronutrients|mesh-ancestor
6648894|NCT01425775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648895|NCT01425775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6648896|NCT01425827|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6648897|NCT01425827|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6648898|NCT01425827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6648899|NCT01425827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6648900|NCT01425827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6648901|NCT01425827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6648902|NCT01425827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648903|NCT01425827|Analgesics|analgesics|mesh-ancestor
6648904|NCT01425827|Sensory System Agents|sensory system agents|mesh-ancestor
6648905|NCT01425827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6648906|NCT01425827|Antidepressive Agents|antidepressive agents|mesh-ancestor
6648907|NCT01425827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6648908|NCT01425827|Dopamine Agents|dopamine agents|mesh-ancestor
6648909|NCT01425840|Lidocaine|lidocaine|mesh-list
6648910|NCT01425840|Anesthetics, Local|anesthetics, local|mesh-ancestor
6648911|NCT01425840|Anesthetics|anesthetics|mesh-ancestor
6648912|NCT01425840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6648913|NCT01425840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648914|NCT01425840|Sensory System Agents|sensory system agents|mesh-ancestor
6648915|NCT01425840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6648916|NCT01425840|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6648917|NCT01425840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6648918|NCT01425840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6648919|NCT01425840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6648920|NCT01425840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6648921|NCT01425996|Camptothecin|camptothecin|mesh-list
6648922|NCT01425996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6648923|NCT01425996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6648924|NCT01425996|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6648925|NCT01425996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6648926|NCT01425996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6648927|NCT01425996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6648928|NCT01426022|Ethanol|ethanol|mesh-list
6648929|NCT01426022|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6648930|NCT01426022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6648931|NCT01426022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6648932|NCT01426022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648933|NCT01426074|Bevacizumab|bevacizumab|mesh-list
6648934|NCT01426074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6648935|NCT01426074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6648936|NCT01426074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6648937|NCT01426074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6648938|NCT01426074|Growth Substances|growth substances|mesh-ancestor
6648939|NCT01426074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488016|NCT05167734|Blood Substitutes|blood substitutes|mesh-ancestor
5488017|NCT05167643|Anastrozole|anastrozole|mesh-list
5488018|NCT05167643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6648940|NCT01426074|Growth Inhibitors|growth inhibitors|mesh-ancestor
5488019|NCT05167643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5488020|NCT05167643|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5488021|NCT05167643|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5488022|NCT05167643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5488023|NCT05167643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6648941|NCT01426087|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6648942|NCT01426087|Somatostatin|somatostatin|mesh-list
6648943|NCT01426087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6648944|NCT01426087|Hormones|hormones|mesh-ancestor
6648945|NCT01426087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6648946|NCT01426087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648947|NCT01426100|Telmisartan|telmisartan|mesh-list
6648948|NCT01426100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6648949|NCT01426100|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6648950|NCT01426100|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6648951|NCT01426100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6648952|NCT01426165|Magnesium Sulfate|magnesium sulfate|mesh-list
6648953|NCT01426165|Analgesics|analgesics|mesh-ancestor
6648954|NCT01426165|Sensory System Agents|sensory system agents|mesh-ancestor
6648955|NCT01426165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6648956|NCT01426165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648957|NCT01426165|Anesthetics|anesthetics|mesh-ancestor
6648958|NCT01426165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6648959|NCT01426165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6648960|NCT01426165|Anticonvulsants|anticonvulsants|mesh-ancestor
6648961|NCT01426165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6648962|NCT01426165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6648963|NCT01426165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6648964|NCT01426165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6648965|NCT01426165|Tocolytic Agents|tocolytic agents|mesh-ancestor
6648966|NCT01426165|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5488024|NCT05167643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5488025|NCT05167643|Hormone Antagonists|hormone antagonists|mesh-ancestor
5488026|NCT05167643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5488027|NCT05167643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488028|NCT05167513|Metformin|metformin|mesh-list
5488029|NCT05167513|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5488030|NCT05167513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5488031|NCT05167513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488032|NCT05167513|Incretins|incretins|mesh-ancestor
5488033|NCT05167513|Hormones|hormones|mesh-ancestor
5488034|NCT05167513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5488035|NCT05167513|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5488036|NCT05167513|Protease Inhibitors|protease inhibitors|mesh-ancestor
5488037|NCT05167513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5488038|NCT05167513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488039|NCT05167175|Prednisone|prednisone|mesh-list
5488040|NCT05167175|Olaparib|olaparib|mesh-list
5488041|NCT05167175|Abiraterone Acetate|abiraterone acetate|mesh-list
5488042|NCT05167175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5488043|NCT05167175|Glucocorticoids|glucocorticoids|mesh-ancestor
6648967|NCT01426243|Vaccines|vaccines|mesh-list
6648968|NCT01426243|Immunologic Factors|immunologic factors|mesh-ancestor
6648969|NCT01426243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648970|NCT01426256|Vitamin D|vitamin d|mesh-list
6648971|NCT01426256|Cholecalciferol|cholecalciferol|mesh-list
6648972|NCT01426256|Vitamins|vitamins|mesh-ancestor
6648973|NCT01426256|Micronutrients|micronutrients|mesh-ancestor
6648974|NCT01426256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648975|NCT01426256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6648976|NCT01426256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6648977|NCT01426334|Cyclosporine|cyclosporine|mesh-list
6648978|NCT01426334|Dasatinib|dasatinib|mesh-list
6648979|NCT01426334|Cyclosporins|cyclosporins|mesh-list
6648980|NCT01426334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6648981|NCT01426334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6648982|NCT01426334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6648983|NCT01426334|Immunologic Factors|immunologic factors|mesh-ancestor
6648984|NCT01426334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648985|NCT01426334|Antifungal Agents|antifungal agents|mesh-ancestor
6648986|NCT01426334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6648987|NCT01426334|Dermatologic Agents|dermatologic agents|mesh-ancestor
6648988|NCT01426334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6648989|NCT01426334|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6648990|NCT01426334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5488044|NCT05167175|Hormones|hormones|mesh-ancestor
5488045|NCT05167175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5488046|NCT05167175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488047|NCT05167175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5488048|NCT05167175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5488049|NCT05167175|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6453497|NCT00420667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453498|NCT00420693|Sevoflurane|sevoflurane|mesh-list
6453499|NCT00420693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6453500|NCT00420693|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6453501|NCT00420693|Anesthetics, General|anesthetics, general|mesh-ancestor
6453502|NCT00420693|Anesthetics|anesthetics|mesh-ancestor
6453503|NCT00420693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6453504|NCT00420693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453505|NCT00420797|Phenylephrine|phenylephrine|mesh-list
6648991|NCT01426334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6648992|NCT01426399|Metformin|metformin|mesh-list
6648993|NCT01426399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6648994|NCT01426399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6648995|NCT01426464|Latanoprost|latanoprost|mesh-list
6648996|NCT01426464|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6648997|NCT01426464|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6648998|NCT01426490|Vitamins|vitamins|mesh-list
6648999|NCT01426490|Ascorbic Acid|ascorbic acid|mesh-list
6649000|NCT01426490|Folic Acid|folic acid|mesh-list
6649001|NCT01426490|Pyridoxine|pyridoxine|mesh-list
6649002|NCT01426490|Pyridoxal|pyridoxal|mesh-list
6649003|NCT01426490|Vitamin B 6|vitamin b 6|mesh-list
6649004|NCT01426490|Vitamin B Complex|vitamin b complex|mesh-list
6649005|NCT01426490|Micronutrients|micronutrients|mesh-ancestor
6649006|NCT01426490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649007|NCT01426490|Antioxidants|antioxidants|mesh-ancestor
6649008|NCT01426490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649009|NCT01426490|Protective Agents|protective agents|mesh-ancestor
6649010|NCT01426490|Hematinics|hematinics|mesh-ancestor
6649011|NCT01426529|Norepinephrine|norepinephrine|mesh-list
6649012|NCT01426529|Angiotensin II|angiotensin ii|mesh-list
6649013|NCT01426529|Giapreza|giapreza|mesh-list
6453506|NCT00420797|Oxymetazoline|oxymetazoline|mesh-list
6453507|NCT00420797|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6453508|NCT00420797|Mydriatics|mydriatics|mesh-ancestor
6453509|NCT00420797|Autonomic Agents|autonomic agents|mesh-ancestor
6453510|NCT00420797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6453511|NCT00420797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649014|NCT01426529|Angiotensinogen|angiotensinogen|mesh-list
6649015|NCT01426529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6649016|NCT01426529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6649017|NCT01426529|Adrenergic Agents|adrenergic agents|mesh-ancestor
6649018|NCT01426529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6649019|NCT01426529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649020|NCT01426529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649021|NCT01426529|Sympathomimetics|sympathomimetics|mesh-ancestor
6649022|NCT01426529|Autonomic Agents|autonomic agents|mesh-ancestor
6453512|NCT00420797|Sympathomimetics|sympathomimetics|mesh-ancestor
6453513|NCT00420797|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6453514|NCT00420797|Nasal Decongestants|nasal decongestants|mesh-ancestor
6453515|NCT00420797|Respiratory System Agents|respiratory system agents|mesh-ancestor
6453516|NCT00420797|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6453517|NCT00420797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6453518|NCT00420797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6453519|NCT00420797|Adrenergic Agents|adrenergic agents|mesh-ancestor
6453520|NCT00420797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6453521|NCT00420797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453522|NCT00420797|Protective Agents|protective agents|mesh-ancestor
6453523|NCT00420836|Tobramycin|tobramycin|mesh-list
6453524|NCT00420836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6649023|NCT01426529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6649024|NCT01426529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6649025|NCT01426529|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6649026|NCT01426529|Protease Inhibitors|protease inhibitors|mesh-ancestor
6649027|NCT01426529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6649028|NCT01426542|Topiramate|topiramate|mesh-list
6649029|NCT01426542|Anticonvulsants|anticonvulsants|mesh-ancestor
6649030|NCT01426542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6649031|NCT01426542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649032|NCT01426633|Gemcitabine|gemcitabine|mesh-list
6649033|NCT01426633|Trabectedin|trabectedin|mesh-list
6649034|NCT01426633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6649035|NCT01426633|Antimetabolites|antimetabolites|mesh-ancestor
6649036|NCT01426633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649037|NCT01426633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6649038|NCT01426633|Antiviral Agents|antiviral agents|mesh-ancestor
6649039|NCT01426633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6649040|NCT01426633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6649041|NCT01426633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6649042|NCT01426633|Immunologic Factors|immunologic factors|mesh-ancestor
6649043|NCT01426633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649044|NCT01426633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6649045|NCT01426633|Alkylating Agents|alkylating agents|mesh-ancestor
6649046|NCT01426646|Cisplatin|cisplatin|mesh-list
6649047|NCT01426646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6649048|NCT01426737|Vildagliptin|vildagliptin|mesh-list
6649049|NCT01426737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6649050|NCT01426737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649051|NCT01426737|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6649052|NCT01426737|Protease Inhibitors|protease inhibitors|mesh-ancestor
6649053|NCT01426737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6649054|NCT01426737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649055|NCT01426802|Vildagliptin|vildagliptin|mesh-list
6649056|NCT01426802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6649057|NCT01426802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649058|NCT01426802|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6649059|NCT01426802|Protease Inhibitors|protease inhibitors|mesh-ancestor
6649060|NCT01426802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6649061|NCT01426802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649062|NCT01426815|Golimumab|golimumab|mesh-list
6649063|NCT01426815|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6649064|NCT01426815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6649065|NCT01426815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6649066|NCT01426815|Immunologic Factors|immunologic factors|mesh-ancestor
6649067|NCT01426815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649068|NCT01426880|Paclitaxel|paclitaxel|mesh-list
6649069|NCT01426880|Carboplatin|carboplatin|mesh-list
6649070|NCT01426880|Lapatinib|lapatinib|mesh-list
6649071|NCT01426880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6649072|NCT01426880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6649073|NCT01426880|Tubulin Modulators|tubulin modulators|mesh-ancestor
5488050|NCT05167175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5488051|NCT05167175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488052|NCT05167175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5488053|NCT05167175|Hormone Antagonists|hormone antagonists|mesh-ancestor
5488054|NCT05167175|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5488055|NCT05167123|Calcium|calcium|mesh-list
5488056|NCT05167123|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5488057|NCT05167123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488058|NCT05166746|Clindamycin|clindamycin|mesh-list
5488059|NCT05166746|Clindamycin palmitate|clindamycin palmitate|mesh-list
5488060|NCT05166746|Clindamycin phosphate|clindamycin phosphate|mesh-list
6453525|NCT00420836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6453526|NCT00420901|Sildenafil Citrate|sildenafil citrate|mesh-list
6453527|NCT00420901|Vasodilator Agents|vasodilator agents|mesh-ancestor
6453528|NCT00420901|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6453529|NCT00420901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6453530|NCT00420901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6453531|NCT00420901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453532|NCT00420901|Urological Agents|urological agents|mesh-ancestor
6453533|NCT00420953|Amiodarone|amiodarone|mesh-list
6453534|NCT00420953|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6453535|NCT00420953|Vasodilator Agents|vasodilator agents|mesh-ancestor
6453536|NCT00420953|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6453537|NCT00420953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6649074|NCT01426880|Antimitotic Agents|antimitotic agents|mesh-ancestor
6649075|NCT01426880|Mitosis Modulators|mitosis modulators|mesh-ancestor
6649076|NCT01426880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649077|NCT01426880|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6649078|NCT01426880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6649079|NCT01426906|Ketoconazole|ketoconazole|mesh-list
6649080|NCT01426906|Rifampin|rifampin|mesh-list
6649081|NCT01426906|Antifungal Agents|antifungal agents|mesh-ancestor
6649082|NCT01426906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6649083|NCT01426906|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6649084|NCT01426906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6649085|NCT01426906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6649086|NCT01426906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649087|NCT01426906|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6649088|NCT01426906|Hormone Antagonists|hormone antagonists|mesh-ancestor
6649089|NCT01426906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6649090|NCT01426906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649091|NCT01426906|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6649092|NCT01426906|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6649093|NCT01426906|Antitubercular Agents|antitubercular agents|mesh-ancestor
6649094|NCT01426906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6649095|NCT01426906|Leprostatic Agents|leprostatic agents|mesh-ancestor
6649096|NCT01426906|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6649097|NCT01426906|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6649098|NCT01426906|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6649099|NCT01426906|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6649100|NCT01426906|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6649101|NCT01426906|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6649102|NCT01426906|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6649103|NCT01426971|Ibuprofen|ibuprofen|mesh-list
6649104|NCT01426971|Caffeine|caffeine|mesh-list
6649105|NCT01426971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6649106|NCT01426971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6649107|NCT01426971|Analgesics|analgesics|mesh-ancestor
6649108|NCT01426971|Sensory System Agents|sensory system agents|mesh-ancestor
6649109|NCT01426971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6649110|NCT01426971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649111|NCT01426971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6649112|NCT01426971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6649113|NCT01426971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6649114|NCT01426971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6649115|NCT01426971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649116|NCT01426971|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6649117|NCT01426971|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6649118|NCT01426971|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6649119|NCT01426971|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6649120|NCT01426971|Purinergic Agents|purinergic agents|mesh-ancestor
6649121|NCT01426971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6649122|NCT01426984|Methylphenidate|methylphenidate|mesh-list
5488061|NCT05166746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5488062|NCT05166746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5488063|NCT05166746|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5488064|NCT05166746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6649123|NCT01426984|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6649124|NCT01426984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649125|NCT01426984|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6649126|NCT01426984|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6649127|NCT01426984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6649128|NCT01426984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649129|NCT01426984|Dopamine Agents|dopamine agents|mesh-ancestor
6649130|NCT01426984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6664215|NCT01511302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6664216|NCT01511302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6664217|NCT01511302|Autonomic Agents|autonomic agents|mesh-ancestor
6664218|NCT01511302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6664219|NCT01511302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664220|NCT01511302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6664221|NCT01511302|Respiratory System Agents|respiratory system agents|mesh-ancestor
6664222|NCT01511302|Glucocorticoids|glucocorticoids|mesh-ancestor
6664223|NCT01511302|Hormones|hormones|mesh-ancestor
6664224|NCT01511302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5502747|NCT04464850|Vitamins|vitamins|mesh-ancestor
5488065|NCT05166746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488066|NCT05166668|Letrozole|letrozole|mesh-list
5488067|NCT05166668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5488068|NCT05166668|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5488069|NCT05166668|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5488070|NCT05166668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5488071|NCT05166668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488072|NCT05166668|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5488073|NCT05166668|Hormone Antagonists|hormone antagonists|mesh-ancestor
5488074|NCT05166668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5488075|NCT05166668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502748|NCT04464863|Metronidazole|metronidazole|mesh-list
5502749|NCT04464863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5502750|NCT04464863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5502751|NCT04464863|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5502752|NCT04464863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5502753|NCT04464629|Prednisolone|prednisolone|mesh-list
5502754|NCT04464629|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5502755|NCT04464629|Methylprednisolone|methylprednisolone|mesh-list
5502756|NCT04464629|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5502757|NCT04464629|Prednisolone acetate|prednisolone acetate|mesh-list
5502758|NCT04464629|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5502759|NCT04464629|Prednisolone phosphate|prednisolone phosphate|mesh-list
5502760|NCT04464629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5502761|NCT04464629|Glucocorticoids|glucocorticoids|mesh-ancestor
5502762|NCT04464629|Hormones|hormones|mesh-ancestor
5502763|NCT04464629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5502764|NCT04464629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502765|NCT04464629|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6649131|NCT01427114|Prednisolone|prednisolone|mesh-list
6649132|NCT01427114|Cyclophosphamide|cyclophosphamide|mesh-list
6649133|NCT01427114|Rituximab|rituximab|mesh-list
6649134|NCT01427114|Vincristine|vincristine|mesh-list
6649135|NCT01427114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6649136|NCT01427114|Immunologic Factors|immunologic factors|mesh-ancestor
6649137|NCT01427114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649138|NCT01427114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6649139|NCT01427114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6649140|NCT01427114|Alkylating Agents|alkylating agents|mesh-ancestor
6649141|NCT01427114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649142|NCT01427114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6649143|NCT01427114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6649144|NCT01427114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6649145|NCT01427114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6649146|NCT01427114|Tubulin Modulators|tubulin modulators|mesh-ancestor
6649147|NCT01427114|Antimitotic Agents|antimitotic agents|mesh-ancestor
6649148|NCT01427114|Mitosis Modulators|mitosis modulators|mesh-ancestor
6649149|NCT01427114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6649150|NCT01427114|Glucocorticoids|glucocorticoids|mesh-ancestor
6649151|NCT01427114|Hormones|hormones|mesh-ancestor
6649152|NCT01427114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6649153|NCT01427114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6649154|NCT01427127|Ramosetron|ramosetron|mesh-list
5502766|NCT04464629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5502767|NCT04464629|Antiemetics|antiemetics|mesh-ancestor
5502768|NCT04464629|Autonomic Agents|autonomic agents|mesh-ancestor
5502769|NCT04464629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5502770|NCT04464629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5502771|NCT04464629|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5502772|NCT04464629|Protective Agents|protective agents|mesh-ancestor
5502773|NCT04464577|Itraconazole|itraconazole|mesh-list
5502774|NCT04464577|Fluconazole|fluconazole|mesh-list
5502775|NCT04464577|Bupropion|bupropion|mesh-list
5502776|NCT04464577|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6453538|NCT00420953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453539|NCT00420953|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6453540|NCT00420953|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6453541|NCT00420953|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6453542|NCT00420953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6453543|NCT00420953|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6453544|NCT00420953|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6453545|NCT00420953|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6649155|NCT01427127|Antiemetics|antiemetics|mesh-ancestor
6649156|NCT01427127|Autonomic Agents|autonomic agents|mesh-ancestor
6649157|NCT01427127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6649158|NCT01427127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649159|NCT01427127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5488076|NCT05166577|Valganciclovir|valganciclovir|mesh-list
5488077|NCT05166577|Pembrolizumab|pembrolizumab|mesh-list
5488078|NCT05166577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5488079|NCT05166577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5488080|NCT05166577|Antiviral Agents|antiviral agents|mesh-ancestor
5488081|NCT05166577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5488082|NCT05166538|Clopidogrel|clopidogrel|mesh-list
5488083|NCT05166538|Ticagrelor|ticagrelor|mesh-list
6649160|NCT01427127|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6649161|NCT01427127|Serotonin Agents|serotonin agents|mesh-ancestor
6649162|NCT01427127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6649163|NCT01427127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649164|NCT01427192|Acetazolamide|acetazolamide|mesh-list
6649165|NCT01427192|Anticonvulsants|anticonvulsants|mesh-ancestor
6649166|NCT01427192|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6649167|NCT01427192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6649168|NCT01427192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649169|NCT01427192|Diuretics|diuretics|mesh-ancestor
6649170|NCT01427192|Natriuretic Agents|natriuretic agents|mesh-ancestor
6649171|NCT01427192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649172|NCT01427205|Cetuximab|cetuximab|mesh-list
6649173|NCT01427205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6649174|NCT01427205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6649175|NCT01427244|Trastuzumab|trastuzumab|mesh-list
6649176|NCT01427244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5488084|NCT05166538|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5488085|NCT05166538|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5488086|NCT05166538|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5488087|NCT05166538|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5488088|NCT05166538|Purinergic Agents|purinergic agents|mesh-ancestor
5488089|NCT05166538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6649177|NCT01427244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6649178|NCT01427270|Oxycodone|oxycodone|mesh-list
6649179|NCT01427270|Naloxone|naloxone|mesh-list
6649180|NCT01427270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6649181|NCT01427270|Narcotics|narcotics|mesh-ancestor
6649182|NCT01427270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6649183|NCT01427270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649184|NCT01427270|Analgesics|analgesics|mesh-ancestor
6649185|NCT01427270|Sensory System Agents|sensory system agents|mesh-ancestor
6649186|NCT01427270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6649187|NCT01427270|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6649188|NCT01427283|Oxycodone|oxycodone|mesh-list
6649189|NCT01427283|Naloxone|naloxone|mesh-list
6649190|NCT01427283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6649191|NCT01427283|Narcotics|narcotics|mesh-ancestor
6649192|NCT01427283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6649193|NCT01427283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649194|NCT01427283|Analgesics|analgesics|mesh-ancestor
6649195|NCT01427283|Sensory System Agents|sensory system agents|mesh-ancestor
6649196|NCT01427283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6649197|NCT01427283|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6649198|NCT01427322|Lapatinib|lapatinib|mesh-list
6649199|NCT01427322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6649200|NCT01427322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6649201|NCT01427322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6649202|NCT01427322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649203|NCT01427335|Calcium, Dietary|calcium, dietary|mesh-list
6649204|NCT01427335|Calcium|calcium|mesh-list
6649205|NCT01427335|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6649206|NCT01427335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649207|NCT01427335|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6649208|NCT01427387|Linaclotide|linaclotide|mesh-list
6649209|NCT01427387|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
6649210|NCT01427387|Enzyme Activators|enzyme activators|mesh-ancestor
6649211|NCT01427387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649212|NCT01427387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6649213|NCT01427400|Botulinum Toxins|botulinum toxins|mesh-list
6649214|NCT01427400|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6649215|NCT01427400|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5488090|NCT05166538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488091|NCT05166538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649216|NCT01427400|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6649217|NCT01427400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6649218|NCT01427400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649219|NCT01427400|Cholinergic Agents|cholinergic agents|mesh-ancestor
6649220|NCT01427400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6649221|NCT01427400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649222|NCT01427400|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6649223|NCT01427400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6649224|NCT01427478|Afatinib|afatinib|mesh-list
6649225|NCT01427478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6649226|NCT01427478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6649227|NCT01427478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6649228|NCT01427478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649229|NCT01427491|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6649230|NCT01427491|Laxatives|laxatives|mesh-ancestor
6649231|NCT01427491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6649232|NCT01427582|Trabectedin|trabectedin|mesh-list
6649233|NCT01427582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6649234|NCT01427582|Alkylating Agents|alkylating agents|mesh-ancestor
6649235|NCT01427582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649236|NCT01427582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6649237|NCT01427686|Dobutamine|dobutamine|mesh-list
6649238|NCT01427686|Dopamine|dopamine|mesh-list
6649239|NCT01427686|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6649240|NCT01427686|Sympathomimetics|sympathomimetics|mesh-ancestor
6649241|NCT01427686|Autonomic Agents|autonomic agents|mesh-ancestor
6649242|NCT01427686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6649243|NCT01427686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649244|NCT01427686|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6649245|NCT01427686|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6649246|NCT01427686|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6649247|NCT01427686|Adrenergic Agents|adrenergic agents|mesh-ancestor
6649248|NCT01427686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5488092|NCT05161429|Insulin|insulin|mesh-list
5488093|NCT05161429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5488094|NCT05161429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488095|NCT05159453|Insulin|insulin|mesh-list
5488096|NCT05159453|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5488097|NCT05159453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5488098|NCT05159453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488099|NCT05148949|Vaccines|vaccines|mesh-list
5488100|NCT05148949|Immunologic Factors|immunologic factors|mesh-ancestor
5488101|NCT05148949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488102|NCT05148377|Heparin|heparin|mesh-list
5488103|NCT05148377|Anticoagulants|anticoagulants|mesh-ancestor
5488104|NCT05148377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5488105|NCT05148377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5488106|NCT05148377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488107|NCT05144698|Sirolimus|sirolimus|mesh-list
5488108|NCT05144698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5488109|NCT05144698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6649249|NCT01427686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649250|NCT01427686|Protective Agents|protective agents|mesh-ancestor
6649251|NCT01427686|Dopamine Agents|dopamine agents|mesh-ancestor
6649252|NCT01427699|Antibodies|antibodies|mesh-list
6649253|NCT01427699|Immunologic Factors|immunologic factors|mesh-ancestor
6649254|NCT01427699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649255|NCT01427842|Vancomycin|vancomycin|mesh-list
6649256|NCT01427842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6649257|NCT01427842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6649258|NCT01427868|Maleic acid|maleic acid|mesh-list
6649259|NCT01427868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6649260|NCT01427868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649261|NCT01427946|Everolimus|everolimus|mesh-list
6649262|NCT01427946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6649263|NCT01427946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6649264|NCT01427946|Immunologic Factors|immunologic factors|mesh-ancestor
6649265|NCT01427946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649266|NCT01427985|Atropine|atropine|mesh-list
6649267|NCT01427985|Fentanyl|fentanyl|mesh-list
6649268|NCT01427985|Mivacurium|mivacurium|mesh-list
6649269|NCT01427985|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6649270|NCT01427985|Narcotics|narcotics|mesh-ancestor
5488110|NCT05144698|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6649271|NCT01427985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5488111|NCT05144698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6649272|NCT01427985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453546|NCT00421018|Montelukast|montelukast|mesh-list
6453547|NCT00421018|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6453548|NCT00421018|Respiratory System Agents|respiratory system agents|mesh-ancestor
6453549|NCT00421018|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6453550|NCT00421018|Hormone Antagonists|hormone antagonists|mesh-ancestor
6453551|NCT00421018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6453552|NCT00421018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453553|NCT00421018|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6649273|NCT01427985|Analgesics|analgesics|mesh-ancestor
6649274|NCT01427985|Sensory System Agents|sensory system agents|mesh-ancestor
6649275|NCT01427985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6649276|NCT01427985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6649277|NCT01427985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6649278|NCT01427985|Anesthetics, General|anesthetics, general|mesh-ancestor
6649279|NCT01427985|Anesthetics|anesthetics|mesh-ancestor
6649280|NCT01427985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6649281|NCT01427985|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6649282|NCT01427985|Autonomic Agents|autonomic agents|mesh-ancestor
6649283|NCT01427985|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6649284|NCT01427985|Respiratory System Agents|respiratory system agents|mesh-ancestor
6649285|NCT01427985|Mydriatics|mydriatics|mesh-ancestor
6649286|NCT01427985|Parasympatholytics|parasympatholytics|mesh-ancestor
6649287|NCT01427985|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6649288|NCT01427985|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6649289|NCT01427985|Cholinergic Agents|cholinergic agents|mesh-ancestor
6649290|NCT01427985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6649291|NCT01427985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649292|NCT01427985|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6649293|NCT01427985|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6649294|NCT01427985|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6649295|NCT01428037|Misoprostol|misoprostol|mesh-list
6649296|NCT01428037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6649297|NCT01428037|Abortifacient Agents|abortifacient agents|mesh-ancestor
6649298|NCT01428037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6649299|NCT01428037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649300|NCT01428037|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6649301|NCT01428037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6649302|NCT01428037|Oxytocics|oxytocics|mesh-ancestor
6649303|NCT01428050|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6649304|NCT01428089|Progesterone|progesterone|mesh-list
6649305|NCT01428089|Progestins|progestins|mesh-ancestor
6649306|NCT01428089|Hormones|hormones|mesh-ancestor
6649307|NCT01428089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6649308|NCT01428089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649309|NCT01428154|Darbepoetin alfa|darbepoetin alfa|mesh-list
6649310|NCT01428154|Hematinics|hematinics|mesh-ancestor
6649311|NCT01428180|Ibuprofen|ibuprofen|mesh-list
6649312|NCT01428180|Indomethacin|indomethacin|mesh-list
6649313|NCT01428180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6649314|NCT01428180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6649315|NCT01428180|Analgesics|analgesics|mesh-ancestor
6649316|NCT01428180|Sensory System Agents|sensory system agents|mesh-ancestor
6649317|NCT01428180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6649318|NCT01428180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649319|NCT01428180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6649320|NCT01428180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6649321|NCT01428180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6649322|NCT01428180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6649323|NCT01428180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649324|NCT01428180|Gout Suppressants|gout suppressants|mesh-ancestor
6649325|NCT01428180|Tocolytic Agents|tocolytic agents|mesh-ancestor
6649326|NCT01428180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6649327|NCT01428284|Canagliflozin|canagliflozin|mesh-list
6649328|NCT01428284|Probenecid|probenecid|mesh-list
6649329|NCT01428284|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6649330|NCT01428284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649331|NCT01428284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6649332|NCT01428284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649333|NCT01428284|Uricosuric Agents|uricosuric agents|mesh-ancestor
6649334|NCT01428284|Gout Suppressants|gout suppressants|mesh-ancestor
6649335|NCT01428284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6649336|NCT01428284|Renal Agents|renal agents|mesh-ancestor
6649337|NCT01428375|Acetaminophen|acetaminophen|mesh-list
6649338|NCT01428375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6649339|NCT01428375|Analgesics|analgesics|mesh-ancestor
6649340|NCT01428375|Sensory System Agents|sensory system agents|mesh-ancestor
6649341|NCT01428375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6649342|NCT01428375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649343|NCT01428375|Antipyretics|antipyretics|mesh-ancestor
6649344|NCT01428388|Bevacizumab|bevacizumab|mesh-list
6649345|NCT01428388|Ranibizumab|ranibizumab|mesh-list
6649346|NCT01428388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6649347|NCT01428388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6649348|NCT01428388|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6649349|NCT01428388|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6649350|NCT01428388|Growth Substances|growth substances|mesh-ancestor
6649351|NCT01428388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649352|NCT01428388|Growth Inhibitors|growth inhibitors|mesh-ancestor
6649353|NCT01428414|Paclitaxel|paclitaxel|mesh-list
6649354|NCT01428414|Carboplatin|carboplatin|mesh-list
6649355|NCT01428414|Trastuzumab|trastuzumab|mesh-list
6649356|NCT01428414|Epirubicin|epirubicin|mesh-list
6649357|NCT01428414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6649358|NCT01428414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6649359|NCT01428414|Tubulin Modulators|tubulin modulators|mesh-ancestor
6649360|NCT01428414|Antimitotic Agents|antimitotic agents|mesh-ancestor
6649361|NCT01428414|Mitosis Modulators|mitosis modulators|mesh-ancestor
6649362|NCT01428414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649363|NCT01428414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6649364|NCT01428414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6649365|NCT01428414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6649366|NCT01428414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6649367|NCT01428414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6649368|NCT01428427|Gemcitabine|gemcitabine|mesh-list
6649369|NCT01428427|Trametinib|trametinib|mesh-list
6649370|NCT01428427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6649371|NCT01428427|Antimetabolites|antimetabolites|mesh-ancestor
6649372|NCT01428427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649373|NCT01428427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6649374|NCT01428427|Antiviral Agents|antiviral agents|mesh-ancestor
6649375|NCT01428427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6649376|NCT01428427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6649377|NCT01428427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6649378|NCT01428427|Immunologic Factors|immunologic factors|mesh-ancestor
6649379|NCT01428427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649380|NCT01428427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6649381|NCT01428466|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6649382|NCT01428466|Dermatologic Agents|dermatologic agents|mesh-ancestor
5488112|NCT05144698|Antifungal Agents|antifungal agents|mesh-ancestor
5488113|NCT05144698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5488114|NCT05144698|Immunologic Factors|immunologic factors|mesh-ancestor
5488115|NCT05144698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488116|NCT05141721|Bevacizumab|bevacizumab|mesh-list
5488117|NCT05141721|Ipilimumab|ipilimumab|mesh-list
5488118|NCT05141721|Oxaliplatin|oxaliplatin|mesh-list
5488119|NCT05141721|Atezolizumab|atezolizumab|mesh-list
5488120|NCT05141721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5488121|NCT05141721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5488122|NCT05141721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5488123|NCT05141721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6649383|NCT01428492|Dexamethasone|dexamethasone|mesh-list
6649384|NCT01428492|Bortezomib|bortezomib|mesh-list
6649385|NCT01428492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6649386|NCT01428492|Antiemetics|antiemetics|mesh-ancestor
6649387|NCT01428492|Autonomic Agents|autonomic agents|mesh-ancestor
6649388|NCT01428492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6649389|NCT01428492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649390|NCT01428492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6649391|NCT01428492|Glucocorticoids|glucocorticoids|mesh-ancestor
5488124|NCT05141721|Growth Substances|growth substances|mesh-ancestor
5488125|NCT05141721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488126|NCT05141721|Growth Inhibitors|growth inhibitors|mesh-ancestor
5488127|NCT05141721|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5488128|NCT05141721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488129|NCT05139121|Contraceptive Agents|contraceptive agents|mesh-list
5488130|NCT05139121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5488131|NCT05139121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488132|NCT05134441|Calcium, Dietary|calcium, dietary|mesh-list
5488133|NCT05134441|Calcium|calcium|mesh-list
6021739|NCT00401973|Autonomic Agents|autonomic agents|mesh-ancestor
6649392|NCT01428492|Hormones|hormones|mesh-ancestor
6649393|NCT01428492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6649394|NCT01428492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6649395|NCT01428492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5488134|NCT05134441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5488135|NCT05134441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649396|NCT01428518|Lamotrigine|lamotrigine|mesh-list
6649397|NCT01428518|Anticonvulsants|anticonvulsants|mesh-ancestor
6649398|NCT01428518|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6649399|NCT01428518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6649400|NCT01428518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649401|NCT01428518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6649402|NCT01428518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649403|NCT01428518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6649404|NCT01428518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6649405|NCT01428518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6649406|NCT01428518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6649407|NCT01428518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6649408|NCT01428531|PENTA|penta|mesh-list
6649409|NCT01428531|Fondaparinux|fondaparinux|mesh-list
6649410|NCT01428531|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6649411|NCT01428531|Antithrombins|antithrombins|mesh-ancestor
6649412|NCT01428531|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6649413|NCT01428531|Protease Inhibitors|protease inhibitors|mesh-ancestor
5488136|NCT05134441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5488137|NCT05133531|Ravulizumab|ravulizumab|mesh-list
5488138|NCT05133531|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6649414|NCT01428531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6649415|NCT01428531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649416|NCT01428531|Anticoagulants|anticoagulants|mesh-ancestor
6649417|NCT01428531|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6649418|NCT01428531|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6649419|NCT01428544|PENTA|penta|mesh-list
6649420|NCT01428544|Fondaparinux|fondaparinux|mesh-list
6649421|NCT01428544|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6649422|NCT01428544|Antithrombins|antithrombins|mesh-ancestor
6649423|NCT01428544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6649424|NCT01428544|Protease Inhibitors|protease inhibitors|mesh-ancestor
6649425|NCT01428544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6649426|NCT01428544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649427|NCT01428544|Anticoagulants|anticoagulants|mesh-ancestor
6649428|NCT01428544|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6649429|NCT01428544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6649430|NCT01428622|Olodaterol|olodaterol|mesh-list
6649431|NCT01428622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6649432|NCT01428622|Autonomic Agents|autonomic agents|mesh-ancestor
6649433|NCT01428622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6649434|NCT01428622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649435|NCT01428622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6649436|NCT01428622|Respiratory System Agents|respiratory system agents|mesh-ancestor
6649437|NCT01428817|Carbetocin|carbetocin|mesh-list
6649438|NCT01428817|Oxytocin|oxytocin|mesh-list
6649439|NCT01428817|Oxytocics|oxytocics|mesh-ancestor
6649440|NCT01428817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6649441|NCT01428817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488139|NCT05133531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5488140|NCT05133531|Immunologic Factors|immunologic factors|mesh-ancestor
5488141|NCT05133531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488142|NCT05132920|Dexamethasone|dexamethasone|mesh-list
5488143|NCT05132920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5488144|NCT05132920|Antiemetics|antiemetics|mesh-ancestor
5488145|NCT05132920|Autonomic Agents|autonomic agents|mesh-ancestor
5488146|NCT05132920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5488147|NCT05132920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488148|NCT05132920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5488149|NCT05132920|Glucocorticoids|glucocorticoids|mesh-ancestor
5488150|NCT05132920|Hormones|hormones|mesh-ancestor
6664225|NCT01511302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6664226|NCT01511302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6664227|NCT01511302|Analgesics|analgesics|mesh-ancestor
5488151|NCT05132920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5488152|NCT05132920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5488153|NCT05132920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5488154|NCT05119894|Brexpiprazole|brexpiprazole|mesh-list
5488155|NCT05119894|Serotonin Agents|serotonin agents|mesh-ancestor
5488156|NCT05119894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5488157|NCT05119894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488158|NCT05119894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488159|NCT05119894|Dopamine Agonists|dopamine agonists|mesh-ancestor
5488160|NCT05119894|Dopamine Agents|dopamine agents|mesh-ancestor
5488161|NCT05116059|Amphotericin B|amphotericin b|mesh-list
5488162|NCT05116059|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
5488163|NCT05116059|Amebicides|amebicides|mesh-ancestor
5488164|NCT05116059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5488165|NCT05116059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6649442|NCT01428908|Vaccines|vaccines|mesh-list
6649443|NCT01428908|Immunologic Factors|immunologic factors|mesh-ancestor
6649444|NCT01428908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649445|NCT01428973|Mycophenolic Acid|mycophenolic acid|mesh-list
6649446|NCT01428973|Sirolimus|sirolimus|mesh-list
6649447|NCT01428973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6649448|NCT01428973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6649449|NCT01428973|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6649450|NCT01428973|Antitubercular Agents|antitubercular agents|mesh-ancestor
6649451|NCT01428973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6649452|NCT01428973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6649453|NCT01428973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6649454|NCT01428973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649455|NCT01428973|Antifungal Agents|antifungal agents|mesh-ancestor
6649456|NCT01428973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6649457|NCT01428973|Immunologic Factors|immunologic factors|mesh-ancestor
6649458|NCT01428973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649459|NCT01428986|Maraviroc|maraviroc|mesh-list
6649460|NCT01428986|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6649461|NCT01428986|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6649462|NCT01428986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488166|NCT05116059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5488167|NCT05116059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5488168|NCT05116059|Antifungal Agents|antifungal agents|mesh-ancestor
5488169|NCT05111912|Liraglutide|liraglutide|mesh-list
5488170|NCT05111912|Glucagon|glucagon|mesh-list
5488171|NCT05111912|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5488172|NCT05111912|Incretins|incretins|mesh-ancestor
5488173|NCT05111912|Hormones|hormones|mesh-ancestor
5488174|NCT05111912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5488175|NCT05111912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488176|NCT05111912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5488177|NCT05111912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5488178|NCT05107050|Anti-Infective Agents|anti-infective agents|mesh-list
5488179|NCT05107050|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5488180|NCT05105672|Cisplatin|cisplatin|mesh-list
5488181|NCT05105672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5488182|NCT05100654|Doxycycline|doxycycline|mesh-list
5488183|NCT05100654|Ciprofloxacin|ciprofloxacin|mesh-list
5488184|NCT05100654|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6649463|NCT01428986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6649464|NCT01428986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6649465|NCT01428986|Antiviral Agents|antiviral agents|mesh-ancestor
6649466|NCT01428986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6649467|NCT01428986|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6649468|NCT01429025|Rituximab|rituximab|mesh-list
6649469|NCT01429025|Lenalidomide|lenalidomide|mesh-list
6649470|NCT01429025|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6649471|NCT01429025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6649472|NCT01429025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6649473|NCT01429025|Immunologic Factors|immunologic factors|mesh-ancestor
6649474|NCT01429025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649475|NCT01429025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6649476|NCT01429025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6649477|NCT01429025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6649478|NCT01429025|Growth Substances|growth substances|mesh-ancestor
6649479|NCT01429025|Growth Inhibitors|growth inhibitors|mesh-ancestor
6649480|NCT01429025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6649481|NCT01429025|Alkylating Agents|alkylating agents|mesh-ancestor
6649482|NCT01429025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649483|NCT01429090|Methantheline|methantheline|mesh-list
6649484|NCT01429090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6649485|NCT01429090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5488185|NCT05100654|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
5488186|NCT05100654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5488187|NCT05100654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6649486|NCT01429090|Cholinergic Agents|cholinergic agents|mesh-ancestor
6649487|NCT01429090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6649488|NCT01429090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649489|NCT01429090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649490|NCT01429129|Nicotine|nicotine|mesh-list
6649491|NCT01429129|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6649492|NCT01429129|Autonomic Agents|autonomic agents|mesh-ancestor
6649493|NCT01429129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6649494|NCT01429129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649495|NCT01429129|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6649496|NCT01429129|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6649497|NCT01429129|Cholinergic Agents|cholinergic agents|mesh-ancestor
6649498|NCT01429129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6649499|NCT01429129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649500|NCT01429181|Methadone|methadone|mesh-list
6649501|NCT01429181|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6649502|NCT01429181|Narcotics|narcotics|mesh-ancestor
6649503|NCT01429181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6649504|NCT01429181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649505|NCT01429181|Analgesics|analgesics|mesh-ancestor
6649506|NCT01429181|Sensory System Agents|sensory system agents|mesh-ancestor
6649507|NCT01429181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6649508|NCT01429181|Antitussive Agents|antitussive agents|mesh-ancestor
6649509|NCT01429181|Respiratory System Agents|respiratory system agents|mesh-ancestor
6649510|NCT01429337|Midostaurin|midostaurin|mesh-list
6649511|NCT01429337|Staurosporine|staurosporine|mesh-list
6649512|NCT01429337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6649513|NCT01429337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6649514|NCT01429337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6649515|NCT01429337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649516|NCT01429402|Botulinum Toxins|botulinum toxins|mesh-list
6649517|NCT01429402|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6649518|NCT01429402|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6649519|NCT01429402|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6649520|NCT01429402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6649521|NCT01429402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649522|NCT01429402|Cholinergic Agents|cholinergic agents|mesh-ancestor
5488188|NCT05100654|Antimalarials|antimalarials|mesh-ancestor
5488189|NCT05100654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5488190|NCT05100654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5488191|NCT05100654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6453554|NCT00421018|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6453555|NCT00421018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453556|NCT00421044|Epothilone B|epothilone b|mesh-list
6453557|NCT00421044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6453558|NCT00421044|Tubulin Modulators|tubulin modulators|mesh-ancestor
6453559|NCT00421044|Antimitotic Agents|antimitotic agents|mesh-ancestor
6453560|NCT00421044|Mitosis Modulators|mitosis modulators|mesh-ancestor
6453561|NCT00421044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453562|NCT00421083|Tadalafil|tadalafil|mesh-list
6453563|NCT00421083|Vasodilator Agents|vasodilator agents|mesh-ancestor
6453564|NCT00421083|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6453565|NCT00421083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6453566|NCT00421083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6453567|NCT00421083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649523|NCT01429402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6649524|NCT01429402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649525|NCT01429402|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6649526|NCT01429402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6649527|NCT01429415|Magnesium Sulfate|magnesium sulfate|mesh-list
6649528|NCT01429415|Analgesics|analgesics|mesh-ancestor
6649529|NCT01429415|Sensory System Agents|sensory system agents|mesh-ancestor
6649530|NCT01429415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6649531|NCT01429415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649532|NCT01429415|Anesthetics|anesthetics|mesh-ancestor
6649533|NCT01429415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6649534|NCT01429415|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6649535|NCT01429415|Anticonvulsants|anticonvulsants|mesh-ancestor
5488192|NCT05100654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5488193|NCT05100654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6649536|NCT01429415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6649537|NCT01429415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6649538|NCT01429415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649539|NCT01429415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6649540|NCT01429415|Tocolytic Agents|tocolytic agents|mesh-ancestor
6649541|NCT01429415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6649542|NCT01429545|Nifedipine|nifedipine|mesh-list
6649543|NCT01429545|Vasotocin|vasotocin|mesh-list
6649544|NCT01429545|Atosiban|atosiban|mesh-list
6649545|NCT01429545|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5488194|NCT05100654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488195|NCT05100654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5488196|NCT05100654|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5488197|NCT05100654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5488198|NCT05100654|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5488199|NCT05100654|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5488200|NCT05100654|Renal Agents|renal agents|mesh-ancestor
5502777|NCT04464577|Antidepressive Agents|antidepressive agents|mesh-ancestor
5502778|NCT04464577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5502779|NCT04464577|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5502780|NCT04464577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5502781|NCT04464577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5502782|NCT04464577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502783|NCT04464577|Dopamine Agents|dopamine agents|mesh-ancestor
5502784|NCT04464577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5502785|NCT04464577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502786|NCT04464577|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5502787|NCT04464577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5502788|NCT04464577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5502789|NCT04464577|Antifungal Agents|antifungal agents|mesh-ancestor
5502790|NCT04464577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5502791|NCT04464577|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5502792|NCT04464577|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6649546|NCT01429545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6649547|NCT01429545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649548|NCT01429545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6649549|NCT01429545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649550|NCT01429545|Vasodilator Agents|vasodilator agents|mesh-ancestor
6649551|NCT01429545|Tocolytic Agents|tocolytic agents|mesh-ancestor
6649552|NCT01429545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6453568|NCT00421083|Urological Agents|urological agents|mesh-ancestor
6453569|NCT00421096|Gemcitabine|gemcitabine|mesh-list
6453570|NCT00421096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6453571|NCT00421096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6453572|NCT00421096|Antimetabolites|antimetabolites|mesh-ancestor
6453573|NCT00421096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453574|NCT00421096|Antiviral Agents|antiviral agents|mesh-ancestor
6453575|NCT00421096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6649553|NCT01429545|Hormone Antagonists|hormone antagonists|mesh-ancestor
6649554|NCT01429545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6649555|NCT01429545|Oxytocics|oxytocics|mesh-ancestor
6649556|NCT01429545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6649557|NCT01429571|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6649558|NCT01429571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6649559|NCT01429610|Cytarabine|cytarabine|mesh-list
6649560|NCT01429610|Rituximab|rituximab|mesh-list
6649561|NCT01429610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6649562|NCT01429610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6649563|NCT01429610|Immunologic Factors|immunologic factors|mesh-ancestor
6649564|NCT01429610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649565|NCT01429610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6649566|NCT01429610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5502793|NCT04464577|Hormone Antagonists|hormone antagonists|mesh-ancestor
5502794|NCT04464577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5502795|NCT04464577|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5502796|NCT04464577|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5502797|NCT04464577|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5502798|NCT04464512|Sufentanil|sufentanil|mesh-list
6649567|NCT01429610|Antimetabolites|antimetabolites|mesh-ancestor
6649568|NCT01429610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649569|NCT01429610|Antiviral Agents|antiviral agents|mesh-ancestor
6649570|NCT01429610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6649571|NCT01429610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6649572|NCT01429675|Ibandronic Acid|ibandronic acid|mesh-list
6649573|NCT01429675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6649574|NCT01429675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649575|NCT01429701|Gentamicins|gentamicins|mesh-list
6649576|NCT01429701|Polymyxins|polymyxins|mesh-list
6649577|NCT01429701|Polymyxin B|polymyxin b|mesh-list
6649578|NCT01429701|Prednisolone|prednisolone|mesh-list
6649579|NCT01429701|Betamethasone|betamethasone|mesh-list
6649580|NCT01429701|Benzocaine|benzocaine|mesh-list
6649581|NCT01429701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6649582|NCT01429701|Glucocorticoids|glucocorticoids|mesh-ancestor
6649583|NCT01429701|Hormones|hormones|mesh-ancestor
6649584|NCT01429701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6649585|NCT01429701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649586|NCT01429701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6649587|NCT01429701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6649588|NCT01429701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6649589|NCT01429701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6649590|NCT01429701|Respiratory System Agents|respiratory system agents|mesh-ancestor
6649591|NCT01429701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6649592|NCT01429701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6649593|NCT01429701|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6649594|NCT01429701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6649595|NCT01429701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649596|NCT01429701|Anesthetics, Local|anesthetics, local|mesh-ancestor
6649597|NCT01429701|Anesthetics|anesthetics|mesh-ancestor
6649598|NCT01429701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6649599|NCT01429701|Sensory System Agents|sensory system agents|mesh-ancestor
6649600|NCT01429714|Oxymetazoline|oxymetazoline|mesh-list
6649601|NCT01429714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6649602|NCT01429714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6649603|NCT01429714|Adrenergic Agents|adrenergic agents|mesh-ancestor
6649604|NCT01429714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6649605|NCT01429714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649606|NCT01429714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488201|NCT05093517|Volagidemab|volagidemab|mesh-list
5488202|NCT05093517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5488203|NCT05093517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488204|NCT05075161|Pirfenidone|pirfenidone|mesh-list
5488205|NCT05075161|Analgesics|analgesics|mesh-ancestor
5488206|NCT05075161|Sensory System Agents|sensory system agents|mesh-ancestor
5488207|NCT05075161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5488208|NCT05075161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488209|NCT05075161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5488210|NCT05075161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5488211|NCT05075161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5488212|NCT05075161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5488213|NCT05075161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5488214|NCT05071313|Vaccines|vaccines|mesh-list
5488215|NCT05071313|Immunologic Factors|immunologic factors|mesh-ancestor
5488216|NCT05071313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488217|NCT05070156|Vaccines|vaccines|mesh-list
5488218|NCT05070156|Immunologic Factors|immunologic factors|mesh-ancestor
5488219|NCT05070156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488220|NCT05067920|Antibodies|antibodies|mesh-list
5488221|NCT05067920|Immunologic Factors|immunologic factors|mesh-ancestor
5488222|NCT05067920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488223|NCT05067894|Vaccines|vaccines|mesh-list
6453576|NCT00421096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6453577|NCT00421096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6453578|NCT00421096|Immunologic Factors|immunologic factors|mesh-ancestor
6453579|NCT00421096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453580|NCT00421109|Levocetirizine|levocetirizine|mesh-list
6453581|NCT00421109|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6453582|NCT00421109|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6453583|NCT00421109|Histamine Antagonists|histamine antagonists|mesh-ancestor
6453584|NCT00421109|Histamine Agents|histamine agents|mesh-ancestor
6453585|NCT00421109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6453586|NCT00421109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453587|NCT00421109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453588|NCT00421122|Budesonide|budesonide|mesh-list
5488224|NCT05067894|Immunologic Factors|immunologic factors|mesh-ancestor
5488225|NCT05067894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488226|NCT05061550|Durvalumab|durvalumab|mesh-list
5488227|NCT05061550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5488228|NCT05061550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5488229|NCT05053971|Entinostat|entinostat|mesh-list
5488230|NCT05053971|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
5488231|NCT05053971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5488232|NCT05053971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5488233|NCT05053971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488234|NCT05053828|Clopidogrel|clopidogrel|mesh-list
5488235|NCT05053828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
5488236|NCT05053828|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6649607|NCT01429714|Sympathomimetics|sympathomimetics|mesh-ancestor
6649608|NCT01429714|Autonomic Agents|autonomic agents|mesh-ancestor
6649609|NCT01429714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6649610|NCT01429714|Nasal Decongestants|nasal decongestants|mesh-ancestor
6649611|NCT01429714|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6649612|NCT01429714|Respiratory System Agents|respiratory system agents|mesh-ancestor
6649613|NCT01429818|Metformin|metformin|mesh-list
6649614|NCT01429818|Glimepiride|glimepiride|mesh-list
5488237|NCT05053828|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5488238|NCT05053828|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5488239|NCT05053828|Purinergic Agents|purinergic agents|mesh-ancestor
5488240|NCT05053828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5488241|NCT05053828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488242|NCT05053828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488243|NCT05053087|Ropivacaine|ropivacaine|mesh-list
5488244|NCT05053087|Anesthetics, Local|anesthetics, local|mesh-ancestor
6453589|NCT00421122|Terbutaline|terbutaline|mesh-list
6453590|NCT00421122|Formoterol Fumarate|formoterol fumarate|mesh-list
6453591|NCT00421122|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6649615|NCT01429818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6649616|NCT01429818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649617|NCT01429818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6649618|NCT01429818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6649619|NCT01429818|Immunologic Factors|immunologic factors|mesh-ancestor
6649620|NCT01429831|Aripiprazole|aripiprazole|mesh-list
6649621|NCT01429831|Antidepressive Agents|antidepressive agents|mesh-ancestor
6649622|NCT01429831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6649623|NCT01429831|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6649624|NCT01429831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6649625|NCT01429831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6649626|NCT01429831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649627|NCT01429831|Dopamine Agonists|dopamine agonists|mesh-ancestor
5488245|NCT05053087|Anesthetics|anesthetics|mesh-ancestor
5488246|NCT05053087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5488247|NCT05053087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488248|NCT05053087|Sensory System Agents|sensory system agents|mesh-ancestor
5488249|NCT05053087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5488250|NCT05051189|Fentanyl|fentanyl|mesh-list
5488251|NCT05051189|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5488252|NCT05051189|Narcotics|narcotics|mesh-ancestor
5488253|NCT05051189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5488254|NCT05051189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488255|NCT05051189|Analgesics|analgesics|mesh-ancestor
5488256|NCT05051189|Sensory System Agents|sensory system agents|mesh-ancestor
5488257|NCT05051189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5488258|NCT05051189|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5488259|NCT05051189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5488260|NCT05051189|Anesthetics, General|anesthetics, general|mesh-ancestor
5488261|NCT05051189|Anesthetics|anesthetics|mesh-ancestor
5488262|NCT05045144|Vaccines|vaccines|mesh-list
5488263|NCT05045144|Immunologic Factors|immunologic factors|mesh-ancestor
5488264|NCT05045144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488265|NCT05031078|Lidocaine|lidocaine|mesh-list
5488266|NCT05031078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453592|NCT00421122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6453593|NCT00421122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6453594|NCT00421122|Autonomic Agents|autonomic agents|mesh-ancestor
6453595|NCT00421122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6453596|NCT00421122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453597|NCT00421122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6649628|NCT01429831|Dopamine Agents|dopamine agents|mesh-ancestor
6649629|NCT01429831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6649630|NCT01429831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649631|NCT01429831|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6649632|NCT01429831|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6649633|NCT01429831|Serotonin Agents|serotonin agents|mesh-ancestor
6649634|NCT01429831|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6649635|NCT01429831|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6649636|NCT01429831|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6649637|NCT01429831|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6649638|NCT01429844|Cyclosporine|cyclosporine|mesh-list
6649639|NCT01429844|Tacrolimus|tacrolimus|mesh-list
6649640|NCT01429844|Cyclosporins|cyclosporins|mesh-list
6649641|NCT01429844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6649642|NCT01429844|Immunologic Factors|immunologic factors|mesh-ancestor
6649643|NCT01429844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649644|NCT01429844|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6649645|NCT01429844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6649646|NCT01429844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649647|NCT01429844|Antifungal Agents|antifungal agents|mesh-ancestor
6649648|NCT01429844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6649649|NCT01429844|Dermatologic Agents|dermatologic agents|mesh-ancestor
6649650|NCT01429844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6649651|NCT01429870|Triamcinolone|triamcinolone|mesh-list
6649652|NCT01429870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6649653|NCT01429870|Glucocorticoids|glucocorticoids|mesh-ancestor
6649654|NCT01429870|Hormones|hormones|mesh-ancestor
6649655|NCT01429870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6649656|NCT01429870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649657|NCT01429935|Ibuprofen|ibuprofen|mesh-list
6649658|NCT01429935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6649659|NCT01429935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6649660|NCT01429935|Analgesics|analgesics|mesh-ancestor
6649661|NCT01429935|Sensory System Agents|sensory system agents|mesh-ancestor
6649662|NCT01429935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6649663|NCT01429935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649664|NCT01429935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6649665|NCT01429935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6649666|NCT01429935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6649667|NCT01429935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6649668|NCT01429935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649669|NCT01430013|Endostar protein|endostar protein|mesh-list
6649670|NCT01430013|Endostatins|endostatins|mesh-list
6649671|NCT01430013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6649672|NCT01430013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6649673|NCT01430013|Growth Substances|growth substances|mesh-ancestor
5488267|NCT05031078|Anesthetics, Local|anesthetics, local|mesh-ancestor
5488268|NCT05031078|Anesthetics|anesthetics|mesh-ancestor
5488269|NCT05031078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5488270|NCT05031078|Sensory System Agents|sensory system agents|mesh-ancestor
5488271|NCT05031078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5488272|NCT05031078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5488273|NCT05031078|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6649674|NCT01430013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649675|NCT01430013|Growth Inhibitors|growth inhibitors|mesh-ancestor
6649676|NCT01430013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6649677|NCT01430052|Gemcitabine|gemcitabine|mesh-list
6649678|NCT01430052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6649679|NCT01430052|Antimetabolites|antimetabolites|mesh-ancestor
6649680|NCT01430052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649681|NCT01430052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5488274|NCT05031078|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5502799|NCT04464512|Buprenorphine|buprenorphine|mesh-list
6649682|NCT01430052|Antiviral Agents|antiviral agents|mesh-ancestor
6649683|NCT01430052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6649684|NCT01430052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6649685|NCT01430052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6649686|NCT01430052|Immunologic Factors|immunologic factors|mesh-ancestor
6649687|NCT01430052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649688|NCT01430065|Tacrolimus|tacrolimus|mesh-list
6649689|NCT01430065|Peficitinib|peficitinib|mesh-list
6649690|NCT01430065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6649691|NCT01430065|Immunologic Factors|immunologic factors|mesh-ancestor
6649692|NCT01430065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649693|NCT01430065|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6649694|NCT01430065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6664228|NCT01511302|Sensory System Agents|sensory system agents|mesh-ancestor
6649695|NCT01430065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649696|NCT01430078|Niacinamide|niacinamide|mesh-list
6649697|NCT01430078|Peficitinib|peficitinib|mesh-list
6649698|NCT01430078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6649699|NCT01430078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649700|NCT01430078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6649701|NCT01430078|Immunologic Factors|immunologic factors|mesh-ancestor
6649702|NCT01430078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649703|NCT01430078|Vitamin B Complex|vitamin b complex|mesh-ancestor
6649704|NCT01430078|Vitamins|vitamins|mesh-ancestor
6649705|NCT01430078|Micronutrients|micronutrients|mesh-ancestor
5488275|NCT05031078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5488276|NCT05031078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488277|NCT05026905|Leucovorin|leucovorin|mesh-list
5488278|NCT05026905|Gemcitabine|gemcitabine|mesh-list
6649706|NCT01430195|Afamelanotide|afamelanotide|mesh-list
6649707|NCT01430195|Dermatologic Agents|dermatologic agents|mesh-ancestor
6649708|NCT01430234|Pancreatin|pancreatin|mesh-list
6649709|NCT01430234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6649710|NCT01430260|Ciclesonide|ciclesonide|mesh-list
6649711|NCT01430260|Cetirizine|cetirizine|mesh-list
6649712|NCT01430260|Levocetirizine|levocetirizine|mesh-list
6649713|NCT01430260|Glucocorticoids|glucocorticoids|mesh-ancestor
6649714|NCT01430260|Hormones|hormones|mesh-ancestor
6649715|NCT01430260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5488279|NCT05026905|Paclitaxel|paclitaxel|mesh-list
5488280|NCT05026905|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5488281|NCT05026905|Oxaliplatin|oxaliplatin|mesh-list
5488282|NCT05026905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5488283|NCT05026905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5488284|NCT05026905|Tubulin Modulators|tubulin modulators|mesh-ancestor
5488285|NCT05026905|Antimitotic Agents|antimitotic agents|mesh-ancestor
6649716|NCT01430260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649717|NCT01430260|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6649718|NCT01430260|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6649719|NCT01430260|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6649720|NCT01430260|Histamine Antagonists|histamine antagonists|mesh-ancestor
6649721|NCT01430260|Histamine Agents|histamine agents|mesh-ancestor
6649722|NCT01430260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6649723|NCT01430260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649724|NCT01430312|Azelaic acid|azelaic acid|mesh-list
6649725|NCT01430312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6649726|NCT01430312|Dermatologic Agents|dermatologic agents|mesh-ancestor
6649727|NCT01430351|Metformin|metformin|mesh-list
6649728|NCT01430351|Mefloquine|mefloquine|mesh-list
6649729|NCT01430351|Temozolomide|temozolomide|mesh-list
6649730|NCT01430351|Memantine|memantine|mesh-list
6649731|NCT01430351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6649732|NCT01430351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649733|NCT01430351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6649734|NCT01430351|Alkylating Agents|alkylating agents|mesh-ancestor
6649735|NCT01430351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649736|NCT01430351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6649737|NCT01430351|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6649738|NCT01430351|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6649739|NCT01430351|Dopamine Agents|dopamine agents|mesh-ancestor
6649740|NCT01430351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6649741|NCT01430351|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6649742|NCT01430351|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6649743|NCT01430351|Antimalarials|antimalarials|mesh-ancestor
6649744|NCT01430351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6649745|NCT01430351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6649746|NCT01430351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6649747|NCT01430390|Cyclophosphamide|cyclophosphamide|mesh-list
6649748|NCT01430390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6649749|NCT01430390|Immunologic Factors|immunologic factors|mesh-ancestor
6649750|NCT01430390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649751|NCT01430390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6649752|NCT01430390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6649753|NCT01430390|Alkylating Agents|alkylating agents|mesh-ancestor
6649754|NCT01430390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649755|NCT01430390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6649756|NCT01430390|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5488286|NCT05026905|Mitosis Modulators|mitosis modulators|mesh-ancestor
6649757|NCT01430520|Citalopram|citalopram|mesh-list
6649758|NCT01430520|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6649759|NCT01430520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6649760|NCT01430520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6649761|NCT01430520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649762|NCT01430520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6649763|NCT01430520|Serotonin Agents|serotonin agents|mesh-ancestor
6649764|NCT01430520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649765|NCT01430520|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6649766|NCT01430520|Antidepressive Agents|antidepressive agents|mesh-ancestor
6649767|NCT01430520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6649768|NCT01430533|Azelaic acid|azelaic acid|mesh-list
6649769|NCT01430533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6649770|NCT01430533|Dermatologic Agents|dermatologic agents|mesh-ancestor
6664229|NCT01511302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6664230|NCT01511302|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6664231|NCT01511367|Fluticasone|fluticasone|mesh-list
6664232|NCT01511367|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6664233|NCT01511367|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6664234|NCT01511367|Autonomic Agents|autonomic agents|mesh-ancestor
6664235|NCT01511367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6664236|NCT01511367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664237|NCT01511367|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6664238|NCT01511367|Respiratory System Agents|respiratory system agents|mesh-ancestor
6664239|NCT01511367|Glucocorticoids|glucocorticoids|mesh-ancestor
6664240|NCT01511367|Hormones|hormones|mesh-ancestor
6664241|NCT01511367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6664242|NCT01511367|Sympathomimetics|sympathomimetics|mesh-ancestor
6664243|NCT01511367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6664244|NCT01511367|Dermatologic Agents|dermatologic agents|mesh-ancestor
6664245|NCT01511367|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6664246|NCT01511471|Ticagrelor|ticagrelor|mesh-list
6664247|NCT01511471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6664248|NCT01511471|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6664249|NCT01511471|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6664250|NCT01511471|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6664251|NCT01511471|Purinergic Agents|purinergic agents|mesh-ancestor
5488287|NCT05026905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488288|NCT05026905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6664252|NCT01511471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6664253|NCT01511471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6664254|NCT01511471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664255|NCT01511562|Cytarabine|cytarabine|mesh-list
6664256|NCT01511562|Etoposide|etoposide|mesh-list
6664257|NCT01511562|Thiotepa|thiotepa|mesh-list
6664258|NCT01511562|Carmustine|carmustine|mesh-list
6664259|NCT01511562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6664260|NCT01511562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6664261|NCT01511562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6664262|NCT01511562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6664263|NCT01511562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6664264|NCT01511562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6664265|NCT01511562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6664266|NCT01511562|Antimetabolites|antimetabolites|mesh-ancestor
6664267|NCT01511562|Antiviral Agents|antiviral agents|mesh-ancestor
6664268|NCT01511562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5488289|NCT05026905|Antimetabolites|antimetabolites|mesh-ancestor
5488290|NCT05026905|Antiviral Agents|antiviral agents|mesh-ancestor
5488291|NCT05026905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5488292|NCT05026905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5488293|NCT05026905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5488294|NCT05026905|Immunologic Factors|immunologic factors|mesh-ancestor
5488295|NCT05026905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488296|NCT05026905|Antidotes|antidotes|mesh-ancestor
6649771|NCT01430572|Everolimus|everolimus|mesh-list
6649772|NCT01430572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6649773|NCT01430572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6649774|NCT01430572|Immunologic Factors|immunologic factors|mesh-ancestor
6649775|NCT01430572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649776|NCT01430650|Saw palmetto extract|saw palmetto extract|mesh-list
6649777|NCT01430650|Urological Agents|urological agents|mesh-ancestor
6649778|NCT01430689|Vaccines|vaccines|mesh-list
6649779|NCT01430689|Immunologic Factors|immunologic factors|mesh-ancestor
6649780|NCT01430689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488297|NCT05026905|Protective Agents|protective agents|mesh-ancestor
5488298|NCT05026905|Vitamin B Complex|vitamin b complex|mesh-ancestor
5488299|NCT05026905|Vitamins|vitamins|mesh-ancestor
5488300|NCT05026905|Micronutrients|micronutrients|mesh-ancestor
5488301|NCT05024188|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5488302|NCT05024188|Metronidazole|metronidazole|mesh-list
5488303|NCT05024188|Ciprofloxacin|ciprofloxacin|mesh-list
6453598|NCT00421122|Respiratory System Agents|respiratory system agents|mesh-ancestor
6453599|NCT00421122|Glucocorticoids|glucocorticoids|mesh-ancestor
6453600|NCT00421122|Hormones|hormones|mesh-ancestor
6453601|NCT00421122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6453602|NCT00421122|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6453603|NCT00421122|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6453604|NCT00421122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6453605|NCT00421122|Adrenergic Agents|adrenergic agents|mesh-ancestor
6453606|NCT00421122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6453607|NCT00421122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453608|NCT00421122|Sympathomimetics|sympathomimetics|mesh-ancestor
6453609|NCT00421122|Tocolytic Agents|tocolytic agents|mesh-ancestor
6453610|NCT00421122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6649781|NCT01430793|Vitamin D|vitamin d|mesh-list
6649782|NCT01430793|Ergocalciferols|ergocalciferols|mesh-list
6649783|NCT01430793|Cholecalciferol|cholecalciferol|mesh-list
6649784|NCT01430793|Vitamins|vitamins|mesh-list
6649785|NCT01430793|Micronutrients|micronutrients|mesh-ancestor
6649786|NCT01430793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649787|NCT01430793|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6649788|NCT01430793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6649789|NCT01430806|Dronedarone|dronedarone|mesh-list
6649790|NCT01430806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6649791|NCT01430910|Ceftazidime|ceftazidime|mesh-list
6649792|NCT01430910|Avibactam|avibactam|mesh-list
6649793|NCT01430910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6649794|NCT01430910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6649795|NCT01430910|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6649796|NCT01430910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6649797|NCT01430910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649798|NCT01430923|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6649799|NCT01430923|Latanoprost|latanoprost|mesh-list
6649800|NCT01430923|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6649801|NCT01431053|Aspirin|aspirin|mesh-list
6649802|NCT01431053|Exemestane|exemestane|mesh-list
6649803|NCT01431053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6649804|NCT01431053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6649805|NCT01431053|Analgesics|analgesics|mesh-ancestor
6649806|NCT01431053|Sensory System Agents|sensory system agents|mesh-ancestor
6649807|NCT01431053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6649808|NCT01431053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649809|NCT01431053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6649810|NCT01431053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6649811|NCT01431053|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6649812|NCT01431053|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6649813|NCT01431053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649814|NCT01431053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6649815|NCT01431053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6649816|NCT01431053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6649817|NCT01431053|Antipyretics|antipyretics|mesh-ancestor
6649818|NCT01431053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6649819|NCT01431053|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6649820|NCT01431053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6649821|NCT01431053|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6649822|NCT01431053|Hormone Antagonists|hormone antagonists|mesh-ancestor
5488304|NCT05024188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5488305|NCT05024188|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6649823|NCT01431053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6649824|NCT01431092|Melatonin|melatonin|mesh-list
6649825|NCT01431092|Antioxidants|antioxidants|mesh-ancestor
6649826|NCT01431092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649827|NCT01431092|Protective Agents|protective agents|mesh-ancestor
6649828|NCT01431092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649829|NCT01431092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6649830|NCT01431118|Camphor|camphor|mesh-list
6649831|NCT01431118|Salicylates|salicylates|mesh-list
6649832|NCT01431118|Methyl salicylate|methyl salicylate|mesh-list
5488306|NCT05024188|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5488307|NCT05024188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5488308|NCT05024188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5488309|NCT05024188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5488310|NCT05024188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649833|NCT01431118|Menthol|menthol|mesh-list
6649834|NCT01431118|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6649835|NCT01431118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6649836|NCT01431118|Antipruritics|antipruritics|mesh-ancestor
6649837|NCT01431118|Dermatologic Agents|dermatologic agents|mesh-ancestor
6649838|NCT01431118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6649839|NCT01431118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6649840|NCT01431118|Analgesics|analgesics|mesh-ancestor
6649841|NCT01431118|Sensory System Agents|sensory system agents|mesh-ancestor
6649842|NCT01431118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6649843|NCT01431118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649844|NCT01431118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6649845|NCT01431118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6649846|NCT01431118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6649847|NCT01431118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6649848|NCT01431118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649849|NCT01431183|Vaccines|vaccines|mesh-list
6649850|NCT01431183|Immunologic Factors|immunologic factors|mesh-ancestor
6649851|NCT01431183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649852|NCT01431196|Vaccines|vaccines|mesh-list
6649853|NCT01431196|Immunologic Factors|immunologic factors|mesh-ancestor
6649854|NCT01431196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649855|NCT01431326|Vancomycin|vancomycin|mesh-list
6649856|NCT01431326|Ciprofloxacin|ciprofloxacin|mesh-list
6649857|NCT01431326|Tazobactam|tazobactam|mesh-list
6649858|NCT01431326|Piperacillin|piperacillin|mesh-list
6649859|NCT01431326|Tobramycin|tobramycin|mesh-list
6649860|NCT01431326|Amikacin|amikacin|mesh-list
6649861|NCT01431326|Cefepime|cefepime|mesh-list
6649862|NCT01431326|Fosfomycin|fosfomycin|mesh-list
6649863|NCT01431326|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
6649864|NCT01431326|Nafcillin|nafcillin|mesh-list
6649865|NCT01431326|Cidofovir|cidofovir|mesh-list
6649866|NCT01431326|Methylprednisolone|methylprednisolone|mesh-list
6649867|NCT01431326|Bosentan|bosentan|mesh-list
6649868|NCT01431326|Labetalol|labetalol|mesh-list
6649869|NCT01431326|Nifedipine|nifedipine|mesh-list
6649870|NCT01431326|Spironolactone|spironolactone|mesh-list
6649871|NCT01431326|Pentobarbital|pentobarbital|mesh-list
6649872|NCT01431326|Oxycodone|oxycodone|mesh-list
6649873|NCT01431326|Alfentanil|alfentanil|mesh-list
6649874|NCT01431326|Haloperidol|haloperidol|mesh-list
6649875|NCT01431326|Zolpidem|zolpidem|mesh-list
6649876|NCT01431326|Ziprasidone|ziprasidone|mesh-list
6649877|NCT01431326|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
6649878|NCT01431326|Clozapine|clozapine|mesh-list
6649879|NCT01431326|Molindone|molindone|mesh-list
6649880|NCT01431326|Warfarin|warfarin|mesh-list
6649881|NCT01431326|Tranexamic Acid|tranexamic acid|mesh-list
6649882|NCT01431326|Aminocaproic Acid|aminocaproic acid|mesh-list
6649883|NCT01431326|Rocuronium|rocuronium|mesh-list
6649884|NCT01431326|Sevelamer|sevelamer|mesh-list
6649885|NCT01431326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6649886|NCT01431326|Antiemetics|antiemetics|mesh-ancestor
6649887|NCT01431326|Autonomic Agents|autonomic agents|mesh-ancestor
6649888|NCT01431326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6649889|NCT01431326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649890|NCT01431326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6649891|NCT01431326|Glucocorticoids|glucocorticoids|mesh-ancestor
6649892|NCT01431326|Hormones|hormones|mesh-ancestor
6649893|NCT01431326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6649894|NCT01431326|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6649895|NCT01431326|Protective Agents|protective agents|mesh-ancestor
6649896|NCT01431326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6649897|NCT01431326|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6649898|NCT01431326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6649899|NCT01431326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649900|NCT01431326|Hemostatics|hemostatics|mesh-ancestor
6649901|NCT01431326|Coagulants|coagulants|mesh-ancestor
6649902|NCT01431326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6649903|NCT01431326|Narcotics|narcotics|mesh-ancestor
6649904|NCT01431326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6649905|NCT01431326|Analgesics|analgesics|mesh-ancestor
6649906|NCT01431326|Sensory System Agents|sensory system agents|mesh-ancestor
6649907|NCT01431326|Anticoagulants|anticoagulants|mesh-ancestor
5488311|NCT05024188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5488312|NCT05024188|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5488313|NCT05024188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5488314|NCT05006079|Morphine|morphine|mesh-list
5488315|NCT05006079|Alprazolam|alprazolam|mesh-list
5488316|NCT05006079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5488317|NCT05006079|Narcotics|narcotics|mesh-ancestor
5488318|NCT05006079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6453611|NCT00421187|Amphotericin B|amphotericin b|mesh-list
6453612|NCT00421187|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6453613|NCT00421187|Amebicides|amebicides|mesh-ancestor
6453614|NCT00421187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6453615|NCT00421187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6453616|NCT00421187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6453617|NCT00421187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6453618|NCT00421187|Antifungal Agents|antifungal agents|mesh-ancestor
6453619|NCT00421200|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
6453620|NCT00421200|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6453621|NCT00421200|Plasma Substitutes|plasma substitutes|mesh-ancestor
6453622|NCT00421200|Blood Substitutes|blood substitutes|mesh-ancestor
6453623|NCT00421252|Clopidogrel|clopidogrel|mesh-list
6453624|NCT00421252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6453625|NCT00421252|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6453626|NCT00421252|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6453627|NCT00421252|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6453628|NCT00421252|Purinergic Agents|purinergic agents|mesh-ancestor
6453629|NCT00421252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6453630|NCT00421252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453631|NCT00421252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453632|NCT00421317|Imatinib Mesylate|imatinib mesylate|mesh-list
6453633|NCT00421317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6453634|NCT00421317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6453635|NCT00421317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6453636|NCT00421317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453637|NCT00421369|Sertraline|sertraline|mesh-list
6453638|NCT00421369|Reboxetine|reboxetine|mesh-list
6453639|NCT00421369|Antidepressive Agents|antidepressive agents|mesh-ancestor
6453640|NCT00421369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6453641|NCT00421369|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6453642|NCT00421369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6453643|NCT00421369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6453644|NCT00421369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453645|NCT00421369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6453646|NCT00421369|Serotonin Agents|serotonin agents|mesh-ancestor
6453647|NCT00421369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453648|NCT00421369|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6453649|NCT00421369|Adrenergic Agents|adrenergic agents|mesh-ancestor
6453650|NCT00421395|Epratuzumab|epratuzumab|mesh-list
6453651|NCT00421395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6453652|NCT00421395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6453653|NCT00421421|Dutasteride|dutasteride|mesh-list
6453654|NCT00421421|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6453655|NCT00421421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6453656|NCT00421421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6453657|NCT00421421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488319|NCT05006079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649908|NCT01431326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6649909|NCT01431326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6649910|NCT01431326|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6649911|NCT01431326|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6649912|NCT01431326|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6649913|NCT01431326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6649914|NCT01431326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6649915|NCT01431326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6649916|NCT01431326|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6649917|NCT01431326|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6649918|NCT01431326|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6649919|NCT01431326|Hormone Antagonists|hormone antagonists|mesh-ancestor
6649920|NCT01431326|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5488320|NCT05006079|Analgesics|analgesics|mesh-ancestor
5488321|NCT05006079|Sensory System Agents|sensory system agents|mesh-ancestor
5488322|NCT05006079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5488323|NCT05006079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5488324|NCT05006079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5488325|NCT05006079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5488326|NCT05006079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5488327|NCT05006079|GABA Modulators|gaba modulators|mesh-ancestor
5488328|NCT05006079|GABA Agents|gaba agents|mesh-ancestor
5488329|NCT05006079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5488330|NCT05006079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488331|NCT05002244|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5488332|NCT05002244|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
5488333|NCT05002244|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5488334|NCT05002244|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5488335|NCT05002244|Antimetabolites|antimetabolites|mesh-ancestor
5488336|NCT05002244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488337|NCT05002244|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5488338|NCT05002244|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5488339|NCT05002244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5488340|NCT05002244|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5488341|NCT05002244|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5488342|NCT04995536|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
5488343|NCT04995536|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5488344|NCT04995536|Immunologic Factors|immunologic factors|mesh-ancestor
5488345|NCT04995536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488346|NCT04982367|Sirolimus|sirolimus|mesh-list
5488347|NCT04982367|Paclitaxel|paclitaxel|mesh-list
5488348|NCT04982367|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5488349|NCT04982367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5488350|NCT04982367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5488351|NCT04982367|Tubulin Modulators|tubulin modulators|mesh-ancestor
5488352|NCT04982367|Antimitotic Agents|antimitotic agents|mesh-ancestor
5488353|NCT04982367|Mitosis Modulators|mitosis modulators|mesh-ancestor
5488354|NCT04982367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488355|NCT04982367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5488356|NCT04982367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5488357|NCT04982367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5488358|NCT04982367|Antifungal Agents|antifungal agents|mesh-ancestor
6453658|NCT00421421|Hormone Antagonists|hormone antagonists|mesh-ancestor
6453659|NCT00421421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6649921|NCT01431326|Diuretics|diuretics|mesh-ancestor
6649922|NCT01431326|Natriuretic Agents|natriuretic agents|mesh-ancestor
6649923|NCT01431326|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6649924|NCT01431326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6649925|NCT01431326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6649926|NCT01431326|Vasodilator Agents|vasodilator agents|mesh-ancestor
6649927|NCT01431326|Tocolytic Agents|tocolytic agents|mesh-ancestor
6649928|NCT01431326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6649929|NCT01431326|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6649930|NCT01431326|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6649931|NCT01431326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6649932|NCT01431326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6649933|NCT01431326|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6649934|NCT01431326|Dopamine Agents|dopamine agents|mesh-ancestor
6453660|NCT00421421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453661|NCT00421434|Ribavirin|ribavirin|mesh-list
6453662|NCT00421434|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6453663|NCT00421434|Interferon-alpha|interferon-alpha|mesh-list
6453664|NCT00421434|Nitazoxanide|nitazoxanide|mesh-list
6453665|NCT00421434|Antimetabolites|antimetabolites|mesh-ancestor
5488359|NCT04982367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5488360|NCT04982367|Immunologic Factors|immunologic factors|mesh-ancestor
5488361|NCT04982367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488362|NCT04975152|Cemiplimab|cemiplimab|mesh-list
5488363|NCT04975152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5488364|NCT04975152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5488365|NCT04965506|Dulaglutide|dulaglutide|mesh-list
5488366|NCT04965506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5488367|NCT04965506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488368|NCT04962724|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5488369|NCT04960930|Minocycline|minocycline|mesh-list
5488370|NCT04960930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5488371|NCT04960930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5488372|NCT04957368|Midazolam|midazolam|mesh-list
5488373|NCT04957368|Nitrous Oxide|nitrous oxide|mesh-list
5488374|NCT04957368|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6649935|NCT01431326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6649936|NCT01431326|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6649937|NCT01431326|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6649938|NCT01431326|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6649939|NCT01431326|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6649940|NCT01431326|GABA Agonists|gaba agonists|mesh-ancestor
6649941|NCT01431326|GABA Agents|gaba agents|mesh-ancestor
6649942|NCT01431326|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6649943|NCT01431326|Serotonin Agents|serotonin agents|mesh-ancestor
6649944|NCT01431326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6649945|NCT01431326|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6649946|NCT01431326|Chelating Agents|chelating agents|mesh-ancestor
6649947|NCT01431326|Sequestering Agents|sequestering agents|mesh-ancestor
6649948|NCT01431326|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6649949|NCT01431326|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5488375|NCT04957368|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5488376|NCT04957368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5488377|NCT04957368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488378|NCT04957368|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5488379|NCT04957368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6649950|NCT01431326|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6649951|NCT01431326|Adrenergic Agents|adrenergic agents|mesh-ancestor
6649952|NCT01431326|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6649953|NCT01431326|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6649954|NCT01431326|GABA Antagonists|gaba antagonists|mesh-ancestor
6649955|NCT01431326|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6649956|NCT01431326|Sympathomimetics|sympathomimetics|mesh-ancestor
5488380|NCT04957368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5488381|NCT04957368|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5488382|NCT04957368|Anesthetics, General|anesthetics, general|mesh-ancestor
6649957|NCT01431326|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6649958|NCT01431326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6649959|NCT01431326|Anesthetics, General|anesthetics, general|mesh-ancestor
6649960|NCT01431326|Anesthetics|anesthetics|mesh-ancestor
6649961|NCT01431326|Antiviral Agents|antiviral agents|mesh-ancestor
6649962|NCT01431326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6649963|NCT01431326|GABA Modulators|gaba modulators|mesh-ancestor
6649964|NCT01431352|Letrozole|letrozole|mesh-list
6649965|NCT01431352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6649966|NCT01431352|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6649967|NCT01431352|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6649968|NCT01431352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6649969|NCT01431352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6649970|NCT01431352|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6649971|NCT01431352|Hormone Antagonists|hormone antagonists|mesh-ancestor
6649972|NCT01431352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6649973|NCT01431352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649974|NCT01431404|Etanercept|etanercept|mesh-list
6649975|NCT01431404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6649976|NCT01431404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6649977|NCT01431404|Analgesics|analgesics|mesh-ancestor
6649978|NCT01431404|Sensory System Agents|sensory system agents|mesh-ancestor
5488383|NCT04957368|Anesthetics|anesthetics|mesh-ancestor
5488384|NCT04957368|GABA Modulators|gaba modulators|mesh-ancestor
6649979|NCT01431404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5488385|NCT04957368|GABA Agents|gaba agents|mesh-ancestor
5488386|NCT04957368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6649980|NCT01431404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649981|NCT01431404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6649982|NCT01431404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6649983|NCT01431404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6649984|NCT01431404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6649985|NCT01431404|Immunologic Factors|immunologic factors|mesh-ancestor
6649986|NCT01431430|Cholecalciferol|cholecalciferol|mesh-list
6649987|NCT01431430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6649988|NCT01431430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6649989|NCT01431430|Vitamins|vitamins|mesh-ancestor
6649990|NCT01431430|Micronutrients|micronutrients|mesh-ancestor
6649991|NCT01431430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6649992|NCT01431443|Theobromine|theobromine|mesh-list
6649993|NCT01431443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6649994|NCT01431443|Autonomic Agents|autonomic agents|mesh-ancestor
6649995|NCT01431443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6649996|NCT01431443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488387|NCT04957368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488388|NCT04957368|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5488389|NCT04957368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5488390|NCT04957368|Analgesics|analgesics|mesh-ancestor
5488391|NCT04957368|Sensory System Agents|sensory system agents|mesh-ancestor
5488392|NCT04957368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5488393|NCT04950608|Psilocybin|psilocybin|mesh-list
5488394|NCT04950608|Hallucinogens|hallucinogens|mesh-ancestor
5488395|NCT04950608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488396|NCT04950608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5502800|NCT04464512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5502801|NCT04464512|Narcotics|narcotics|mesh-ancestor
5502802|NCT04464512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5502803|NCT04464512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502804|NCT04464512|Analgesics|analgesics|mesh-ancestor
5502805|NCT04464512|Sensory System Agents|sensory system agents|mesh-ancestor
6649997|NCT01431443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6649998|NCT01431443|Respiratory System Agents|respiratory system agents|mesh-ancestor
6649999|NCT01431443|Vasodilator Agents|vasodilator agents|mesh-ancestor
6650000|NCT01431456|Nadroparin|nadroparin|mesh-list
6650001|NCT01431456|Rivaroxaban|rivaroxaban|mesh-list
6650002|NCT01431456|Dabigatran|dabigatran|mesh-list
6650003|NCT01431456|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6650004|NCT01431456|Antithrombins|antithrombins|mesh-ancestor
6650005|NCT01431456|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6650006|NCT01431456|Protease Inhibitors|protease inhibitors|mesh-ancestor
6650007|NCT01431456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6650008|NCT01431456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650009|NCT01431456|Anticoagulants|anticoagulants|mesh-ancestor
6650010|NCT01431456|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6650011|NCT01431456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6650012|NCT01431495|Clopidogrel|clopidogrel|mesh-list
6650013|NCT01431495|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6650014|NCT01431495|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6650015|NCT01431495|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6650016|NCT01431495|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6650017|NCT01431495|Purinergic Agents|purinergic agents|mesh-ancestor
6650018|NCT01431495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6650019|NCT01431495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650020|NCT01431495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650021|NCT01431547|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6650022|NCT01431547|Immunologic Factors|immunologic factors|mesh-ancestor
6650023|NCT01431547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650024|NCT01431612|Phenylephrine|phenylephrine|mesh-list
6650025|NCT01431612|Oxymetazoline|oxymetazoline|mesh-list
6650026|NCT01431612|Esmolol|esmolol|mesh-list
6650027|NCT01431612|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6650028|NCT01431612|Mydriatics|mydriatics|mesh-ancestor
6650029|NCT01431612|Autonomic Agents|autonomic agents|mesh-ancestor
6650030|NCT01431612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6650031|NCT01431612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650032|NCT01431612|Sympathomimetics|sympathomimetics|mesh-ancestor
6650033|NCT01431612|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6650034|NCT01431612|Nasal Decongestants|nasal decongestants|mesh-ancestor
6650035|NCT01431612|Respiratory System Agents|respiratory system agents|mesh-ancestor
6650036|NCT01431612|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6650037|NCT01431612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6650038|NCT01431612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6650039|NCT01431612|Adrenergic Agents|adrenergic agents|mesh-ancestor
6650040|NCT01431612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6650041|NCT01431612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650042|NCT01431612|Protective Agents|protective agents|mesh-ancestor
5488397|NCT04939792|Vitamin D|vitamin d|mesh-list
5488398|NCT04939792|Ergocalciferols|ergocalciferols|mesh-list
5488399|NCT04939792|Vitamins|vitamins|mesh-list
5488400|NCT04939792|Micronutrients|micronutrients|mesh-ancestor
5488401|NCT04939792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488402|NCT04939792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5488403|NCT04939792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6021740|NCT00401973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6021741|NCT00401973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6021742|NCT00401973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6021743|NCT00401973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6021744|NCT00401973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6021745|NCT00401973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6021746|NCT00401973|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6021747|NCT00401973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6021748|NCT00401973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6650043|NCT01431612|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5488414|NCT04933682|Rifampin|rifampin|mesh-list
5488415|NCT04933682|Fluconazole|fluconazole|mesh-list
5488416|NCT04933682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5488417|NCT04933682|Antitubercular Agents|antitubercular agents|mesh-ancestor
5488418|NCT04933682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5488419|NCT04933682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5488420|NCT04933682|Leprostatic Agents|leprostatic agents|mesh-ancestor
5488421|NCT04933682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5488422|NCT04933682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5488423|NCT04933682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488424|NCT04933682|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5488425|NCT04933682|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5488426|NCT04933682|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5488427|NCT04933682|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5488428|NCT04933682|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5488429|NCT04933682|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5488430|NCT04933682|Antifungal Agents|antifungal agents|mesh-ancestor
5488431|NCT04933682|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5488432|NCT04933682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5488433|NCT04933682|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5488434|NCT04933682|Hormone Antagonists|hormone antagonists|mesh-ancestor
5488435|NCT04933682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5488436|NCT04933682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488437|NCT04933682|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5488438|NCT04933682|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5488439|NCT04929600|Amlodipine|amlodipine|mesh-list
5488440|NCT04929600|Valsartan|valsartan|mesh-list
5488441|NCT04929600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5488442|NCT04929600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5488443|NCT04929600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5488444|NCT04929600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650044|NCT01431612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6650045|NCT01431612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6650046|NCT01431690|Warfarin|warfarin|mesh-list
6650047|NCT01431690|Anticoagulants|anticoagulants|mesh-list
6650048|NCT01431729|Propolis|propolis|mesh-list
6650049|NCT01431729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6650050|NCT01431742|Buprenorphine|buprenorphine|mesh-list
6650051|NCT01431742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6650052|NCT01431742|Narcotics|narcotics|mesh-ancestor
6650053|NCT01431742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6650054|NCT01431742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650055|NCT01431742|Analgesics|analgesics|mesh-ancestor
6650056|NCT01431742|Sensory System Agents|sensory system agents|mesh-ancestor
6650057|NCT01431742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6650058|NCT01431742|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6650059|NCT01431781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
6650060|NCT01431781|Somatostatin|somatostatin|mesh-list
6650061|NCT01431781|Hormones|hormones|mesh-ancestor
6650062|NCT01431781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6650063|NCT01431781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650064|NCT01431833|Tedizolid phosphate|tedizolid phosphate|mesh-list
6650065|NCT01431833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6650066|NCT01431833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6650067|NCT01431924|Fluticasone|fluticasone|mesh-list
6650068|NCT01431924|Xhance|xhance|mesh-list
5488445|NCT04929600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5488446|NCT04929600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488447|NCT04929600|Vasodilator Agents|vasodilator agents|mesh-ancestor
5488448|NCT04929600|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6650069|NCT01431924|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6650070|NCT01431924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6650071|NCT01431924|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6650072|NCT01431924|Autonomic Agents|autonomic agents|mesh-ancestor
6650073|NCT01431924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6650074|NCT01431924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650075|NCT01431924|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6650076|NCT01431924|Respiratory System Agents|respiratory system agents|mesh-ancestor
6650077|NCT01431924|Dermatologic Agents|dermatologic agents|mesh-ancestor
6650078|NCT01431924|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6650079|NCT01431924|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6650080|NCT01431924|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6650081|NCT01431924|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6650082|NCT01431924|Adrenergic Agents|adrenergic agents|mesh-ancestor
6650083|NCT01431924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6650084|NCT01431924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650085|NCT01432028|Drospirenone|drospirenone|mesh-list
6650086|NCT01432028|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6650087|NCT01432028|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6650088|NCT01432028|Estradiol|estradiol|mesh-list
6650089|NCT01432028|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6650090|NCT01432028|Progesterone|progesterone|mesh-list
6650091|NCT01432028|Estrogens|estrogens|mesh-ancestor
6650092|NCT01432028|Hormones|hormones|mesh-ancestor
6650093|NCT01432028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6650094|NCT01432028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650095|NCT01432028|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6650096|NCT01432028|Contraceptive Agents|contraceptive agents|mesh-ancestor
6650097|NCT01432028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6650098|NCT01432028|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5488449|NCT04929600|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5488450|NCT04928521|Bupivacaine|bupivacaine|mesh-list
5488451|NCT04928521|Anesthetics, Local|anesthetics, local|mesh-ancestor
5488452|NCT04928521|Anesthetics|anesthetics|mesh-ancestor
5488453|NCT04928521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5488454|NCT04928521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488455|NCT04928521|Sensory System Agents|sensory system agents|mesh-ancestor
5488456|NCT04928521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5488457|NCT04923542|Hormones|hormones|mesh-list
5488458|NCT04923542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5488459|NCT04923542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488460|NCT04914676|Cytarabine|cytarabine|mesh-list
5488461|NCT04914676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5488462|NCT04914676|Antimetabolites|antimetabolites|mesh-ancestor
5488463|NCT04914676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650099|NCT01432028|Progestins|progestins|mesh-ancestor
6650100|NCT01432028|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6650101|NCT01432028|Hormone Antagonists|hormone antagonists|mesh-ancestor
6650102|NCT01432028|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6650103|NCT01432028|Diuretics|diuretics|mesh-ancestor
6650104|NCT01432028|Natriuretic Agents|natriuretic agents|mesh-ancestor
6650105|NCT01432080|Azithromycin|azithromycin|mesh-list
6650106|NCT01432080|Prednisone|prednisone|mesh-list
6650107|NCT01432080|Budesonide|budesonide|mesh-list
5488464|NCT04914676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5488465|NCT04914676|Antiviral Agents|antiviral agents|mesh-ancestor
5488466|NCT04914676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5488467|NCT04914676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5488468|NCT04914676|Immunologic Factors|immunologic factors|mesh-ancestor
5488469|NCT04914676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488470|NCT04907539|Denosumab|denosumab|mesh-list
5488471|NCT04907539|Nivolumab|nivolumab|mesh-list
5488472|NCT04907539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5488473|NCT04907539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5488474|NCT04907539|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5488475|NCT04907539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488476|NCT04907539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5488477|NCT04907539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488478|NCT04889118|Pembrolizumab|pembrolizumab|mesh-list
5488479|NCT04889118|Lenvatinib|lenvatinib|mesh-list
5488480|NCT04889118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5488481|NCT04889118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5488482|NCT04889118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5488483|NCT04889118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5488484|NCT04889118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488485|NCT04885530|Fluticasone|fluticasone|mesh-list
5488486|NCT04885530|Xhance|xhance|mesh-list
5488487|NCT04885530|Ivermectin|ivermectin|mesh-list
5488488|NCT04885530|Fluvoxamine|fluvoxamine|mesh-list
5488489|NCT04885530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5488490|NCT04885530|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5488491|NCT04885530|Autonomic Agents|autonomic agents|mesh-ancestor
5488492|NCT04885530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5488493|NCT04885530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488494|NCT04885530|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5488495|NCT04885530|Respiratory System Agents|respiratory system agents|mesh-ancestor
5488496|NCT04885530|Dermatologic Agents|dermatologic agents|mesh-ancestor
5488497|NCT04885530|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5488498|NCT04885530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5488499|NCT04885530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488500|NCT04885530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5488501|NCT04885530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5488502|NCT04885530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5488503|NCT04885530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5488504|NCT04885530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5488505|NCT04885530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5488506|NCT04885530|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5488507|NCT04885530|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5488508|NCT04885530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5488509|NCT04885530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5488510|NCT04885530|Serotonin Agents|serotonin agents|mesh-ancestor
5488511|NCT04885530|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5488512|NCT04885530|Antidepressive Agents|antidepressive agents|mesh-ancestor
5488513|NCT04885530|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6650108|NCT01432080|Formoterol Fumarate|formoterol fumarate|mesh-list
6650109|NCT01432080|Montelukast|montelukast|mesh-list
6650110|NCT01432080|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6650111|NCT01432080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6650112|NCT01432080|Glucocorticoids|glucocorticoids|mesh-ancestor
6650113|NCT01432080|Hormones|hormones|mesh-ancestor
6650114|NCT01432080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6650115|NCT01432080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650116|NCT01432080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6650117|NCT01432080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6650118|NCT01432080|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6650119|NCT01432080|Autonomic Agents|autonomic agents|mesh-ancestor
6650120|NCT01432080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6650121|NCT01432080|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6650122|NCT01432080|Respiratory System Agents|respiratory system agents|mesh-ancestor
6650123|NCT01432080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6650124|NCT01432080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6650125|NCT01432080|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6650126|NCT01432080|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5488514|NCT04885530|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5488515|NCT04885530|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5488516|NCT04863950|Lomustine|lomustine|mesh-list
5488517|NCT04863950|Imipramine|imipramine|mesh-list
6650127|NCT01432080|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6650128|NCT01432080|Adrenergic Agents|adrenergic agents|mesh-ancestor
6650129|NCT01432080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6650130|NCT01432080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650131|NCT01432080|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6650132|NCT01432080|Hormone Antagonists|hormone antagonists|mesh-ancestor
6650133|NCT01432080|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6650134|NCT01432080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6650135|NCT01432106|Valsartan|valsartan|mesh-list
6650136|NCT01432106|Ramipril|ramipril|mesh-list
6650137|NCT01432106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6650138|NCT01432106|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6650139|NCT01432106|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6650140|NCT01432106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650141|NCT01432106|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6650142|NCT01432106|Protease Inhibitors|protease inhibitors|mesh-ancestor
6650143|NCT01432106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6650144|NCT01432119|Cetuximab|cetuximab|mesh-list
6650145|NCT01432119|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6650146|NCT01432119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6650147|NCT01432119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6650148|NCT01432119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6650149|NCT01432119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6650150|NCT01432119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650151|NCT01432158|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6650152|NCT01432158|Immunologic Factors|immunologic factors|mesh-ancestor
6650153|NCT01432158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650154|NCT01432223|Paclitaxel|paclitaxel|mesh-list
6650155|NCT01432223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6650156|NCT01432223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6650157|NCT01432223|Tubulin Modulators|tubulin modulators|mesh-ancestor
6650158|NCT01432223|Antimitotic Agents|antimitotic agents|mesh-ancestor
6650159|NCT01432223|Mitosis Modulators|mitosis modulators|mesh-ancestor
6650160|NCT01432223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650161|NCT01432249|Etanercept|etanercept|mesh-list
6650162|NCT01432249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6650163|NCT01432249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6650164|NCT01432249|Analgesics|analgesics|mesh-ancestor
6650165|NCT01432249|Sensory System Agents|sensory system agents|mesh-ancestor
6650166|NCT01432249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6650167|NCT01432249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650168|NCT01432249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6650169|NCT01432249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6650170|NCT01432249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6650171|NCT01432249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6650172|NCT01432249|Immunologic Factors|immunologic factors|mesh-ancestor
6664269|NCT01511562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6664270|NCT01511562|Immunologic Factors|immunologic factors|mesh-ancestor
6664271|NCT01511562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664272|NCT01511562|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6664273|NCT01511562|Alkylating Agents|alkylating agents|mesh-ancestor
6664274|NCT01511562|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6664275|NCT01511627|Anesthetics|anesthetics|mesh-list
6664276|NCT01511627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6664277|NCT01511627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664278|NCT01511692|Liraglutide|liraglutide|mesh-list
6664279|NCT01511692|Glimepiride|glimepiride|mesh-list
6664280|NCT01511692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6664281|NCT01511692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664282|NCT01511692|Incretins|incretins|mesh-ancestor
6664283|NCT01511692|Hormones|hormones|mesh-ancestor
6664284|NCT01511692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6664285|NCT01511692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6664286|NCT01511692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6664287|NCT01511692|Immunologic Factors|immunologic factors|mesh-ancestor
6664288|NCT01511705|Ondansetron|ondansetron|mesh-list
6664289|NCT01511705|Antiemetics|antiemetics|mesh-ancestor
6650173|NCT01432470|Oxytocin|oxytocin|mesh-list
6650174|NCT01432470|Oxytocics|oxytocics|mesh-ancestor
6650175|NCT01432470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6650176|NCT01432470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650177|NCT01432483|Denileukin diftitox|denileukin diftitox|mesh-list
6650178|NCT01432483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6650179|NCT01432496|Ropivacaine|ropivacaine|mesh-list
6650180|NCT01432496|Anesthetics, Local|anesthetics, local|mesh-ancestor
6650181|NCT01432496|Anesthetics|anesthetics|mesh-ancestor
6650182|NCT01432496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6650183|NCT01432496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650184|NCT01432496|Sensory System Agents|sensory system agents|mesh-ancestor
6650185|NCT01432496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6650186|NCT01432522|Epinephrine|epinephrine|mesh-list
6650187|NCT01432522|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6650188|NCT01432522|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6650189|NCT01432522|Adrenergic Agents|adrenergic agents|mesh-ancestor
6650190|NCT01432522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6650191|NCT01432522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650192|NCT01432522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650193|NCT01432522|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6650194|NCT01432522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6650195|NCT01432522|Autonomic Agents|autonomic agents|mesh-ancestor
6650196|NCT01432522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6650197|NCT01432522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6650198|NCT01432522|Respiratory System Agents|respiratory system agents|mesh-ancestor
6650199|NCT01432522|Mydriatics|mydriatics|mesh-ancestor
6650200|NCT01432522|Sympathomimetics|sympathomimetics|mesh-ancestor
6650201|NCT01432522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6650202|NCT01432587|Diflunisal|diflunisal|mesh-list
6650203|NCT01432587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6650204|NCT01432587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6650205|NCT01432587|Analgesics|analgesics|mesh-ancestor
6650206|NCT01432587|Sensory System Agents|sensory system agents|mesh-ancestor
6650207|NCT01432587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6650208|NCT01432587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650209|NCT01432587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6650210|NCT01432587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6650211|NCT01432587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6650212|NCT01432587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6650213|NCT01432587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650214|NCT01432665|Sildenafil Citrate|sildenafil citrate|mesh-list
6650215|NCT01432665|Testosterone|testosterone|mesh-list
6650216|NCT01432665|Androgens|androgens|mesh-ancestor
6650217|NCT01432665|Hormones|hormones|mesh-ancestor
6650218|NCT01432665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6650219|NCT01432665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650220|NCT01432665|Vasodilator Agents|vasodilator agents|mesh-ancestor
6650221|NCT01432665|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6650222|NCT01432665|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6650223|NCT01432665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6650224|NCT01432665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650225|NCT01432665|Urological Agents|urological agents|mesh-ancestor
6650226|NCT01432704|Cholecalciferol|cholecalciferol|mesh-list
6650227|NCT01432704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6650228|NCT01432704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650229|NCT01432704|Vitamins|vitamins|mesh-ancestor
6650230|NCT01432704|Micronutrients|micronutrients|mesh-ancestor
6650231|NCT01432704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6650232|NCT01432717|Luspatercept|luspatercept|mesh-list
6650233|NCT01432717|Hematinics|hematinics|mesh-ancestor
6650234|NCT01432782|Botulinum Toxins|botulinum toxins|mesh-list
6650235|NCT01432782|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6650236|NCT01432782|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6650237|NCT01432782|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6650238|NCT01432782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6650239|NCT01432782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650240|NCT01432782|Cholinergic Agents|cholinergic agents|mesh-ancestor
6650241|NCT01432782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6664290|NCT01511705|Autonomic Agents|autonomic agents|mesh-ancestor
5488518|NCT04863950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5488519|NCT04863950|Alkylating Agents|alkylating agents|mesh-ancestor
5488520|NCT04863950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488521|NCT04863950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5488522|NCT04863950|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5488523|NCT04863950|Antidepressive Agents|antidepressive agents|mesh-ancestor
5488524|NCT04863950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6650242|NCT01432782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650243|NCT01432782|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6650244|NCT01432782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6650245|NCT01432821|Apomorphine|apomorphine|mesh-list
6650246|NCT01432821|Emetics|emetics|mesh-ancestor
6650247|NCT01432821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650248|NCT01432821|Autonomic Agents|autonomic agents|mesh-ancestor
6650249|NCT01432821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6650250|NCT01432821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6650251|NCT01432821|Dopamine Agonists|dopamine agonists|mesh-ancestor
6650252|NCT01432821|Dopamine Agents|dopamine agents|mesh-ancestor
6650253|NCT01432821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6650254|NCT01432821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650255|NCT01432873|Selenium|selenium|mesh-list
6650256|NCT01432873|Antioxidants|antioxidants|mesh-ancestor
6650257|NCT01432873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650258|NCT01432873|Protective Agents|protective agents|mesh-ancestor
6650259|NCT01432873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650260|NCT01432873|Trace Elements|trace elements|mesh-ancestor
6650261|NCT01432873|Micronutrients|micronutrients|mesh-ancestor
6650262|NCT01432977|Acetaminophen|acetaminophen|mesh-list
6650263|NCT01432977|Droperidol|droperidol|mesh-list
6650264|NCT01432977|Ondansetron|ondansetron|mesh-list
6650265|NCT01432977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6650266|NCT01432977|Analgesics|analgesics|mesh-ancestor
6650267|NCT01432977|Sensory System Agents|sensory system agents|mesh-ancestor
6650268|NCT01432977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6650269|NCT01432977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650270|NCT01432977|Antipyretics|antipyretics|mesh-ancestor
6650271|NCT01432977|Antiemetics|antiemetics|mesh-ancestor
6650272|NCT01432977|Autonomic Agents|autonomic agents|mesh-ancestor
5488525|NCT04863950|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5488526|NCT04863950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5488527|NCT04863950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5488528|NCT04863950|Adrenergic Agents|adrenergic agents|mesh-ancestor
5488529|NCT04863950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5488530|NCT04863950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488531|NCT04851964|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5488532|NCT04851964|Immunologic Factors|immunologic factors|mesh-ancestor
6650273|NCT01432977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6650274|NCT01432977|Antipruritics|antipruritics|mesh-ancestor
6650275|NCT01432977|Dermatologic Agents|dermatologic agents|mesh-ancestor
6650276|NCT01432977|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6650277|NCT01432977|Serotonin Agents|serotonin agents|mesh-ancestor
6650278|NCT01432977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6453666|NCT00421434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453667|NCT00421434|Antiviral Agents|antiviral agents|mesh-ancestor
6453668|NCT00421434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6453669|NCT00421434|Immunologic Factors|immunologic factors|mesh-ancestor
6453670|NCT00421434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453671|NCT00421434|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6453672|NCT00421447|Anastrozole|anastrozole|mesh-list
6453673|NCT00421447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6650279|NCT01432977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650280|NCT01432977|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6650281|NCT01432977|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6650282|NCT01432977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5488533|NCT04851964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488534|NCT04850599|Pomalidomide|pomalidomide|mesh-list
5488535|NCT04850599|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5488536|NCT04850599|Immunologic Factors|immunologic factors|mesh-ancestor
5488537|NCT04850599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488538|NCT04850599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5488539|NCT04850599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5488540|NCT04850599|Growth Substances|growth substances|mesh-ancestor
5488541|NCT04850599|Growth Inhibitors|growth inhibitors|mesh-ancestor
5488542|NCT04850599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5488543|NCT04847206|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
5488544|NCT04847206|3,4-Methylenedioxyamphetamine|3,4-methylenedioxyamphetamine|mesh-list
5488545|NCT04847206|Hallucinogens|hallucinogens|mesh-ancestor
5488546|NCT04847206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488547|NCT04847206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5488548|NCT04847206|Serotonin Agents|serotonin agents|mesh-ancestor
5488549|NCT04847206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5488550|NCT04847206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488551|NCT04847206|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5488552|NCT04847206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5488553|NCT04847206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5488554|NCT04847206|Adrenergic Agents|adrenergic agents|mesh-ancestor
5488555|NCT04840615|Ipilimumab|ipilimumab|mesh-list
5488556|NCT04840615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5488557|NCT04840615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5488558|NCT04840615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5488559|NCT04840615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488560|NCT04826588|Methylprednisolone|methylprednisolone|mesh-list
5488561|NCT04826588|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5488562|NCT04826588|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5488563|NCT04826588|Prednisolone|prednisolone|mesh-list
5488564|NCT04826588|Prednisolone acetate|prednisolone acetate|mesh-list
5488565|NCT04826588|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5488566|NCT04826588|Prednisolone phosphate|prednisolone phosphate|mesh-list
6650283|NCT01432977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6650284|NCT01432977|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6650285|NCT01432977|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6650286|NCT01432977|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6650287|NCT01432977|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6650288|NCT01432977|Dopamine Agents|dopamine agents|mesh-ancestor
6650289|NCT01433289|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
6650290|NCT01433289|Antioxidants|antioxidants|mesh-ancestor
6650291|NCT01433289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650292|NCT01433289|Protective Agents|protective agents|mesh-ancestor
6650293|NCT01433289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650294|NCT01433289|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
6650295|NCT01433289|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6650296|NCT01433289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6650297|NCT01433289|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6650298|NCT01433328|Lidocaine|lidocaine|mesh-list
6650299|NCT01433328|Anesthetics, Local|anesthetics, local|mesh-ancestor
6650300|NCT01433328|Anesthetics|anesthetics|mesh-ancestor
6650301|NCT01433328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6650302|NCT01433328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650303|NCT01433328|Sensory System Agents|sensory system agents|mesh-ancestor
6650304|NCT01433328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6650305|NCT01433328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6650306|NCT01433328|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6650307|NCT01433328|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6650308|NCT01433328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6650309|NCT01433328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650310|NCT01433445|Panobinostat|panobinostat|mesh-list
6650311|NCT01433445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6650312|NCT01433445|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6650313|NCT01433445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6650314|NCT01433445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650315|NCT01433614|Paclitaxel|paclitaxel|mesh-list
6650316|NCT01433614|Capecitabine|capecitabine|mesh-list
6650317|NCT01433614|Epirubicin|epirubicin|mesh-list
6650318|NCT01433614|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6650319|NCT01433614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6650320|NCT01433614|Tubulin Modulators|tubulin modulators|mesh-ancestor
6650321|NCT01433614|Antimitotic Agents|antimitotic agents|mesh-ancestor
6650322|NCT01433614|Mitosis Modulators|mitosis modulators|mesh-ancestor
6650323|NCT01433614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650324|NCT01433614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6650325|NCT01433614|Antimetabolites|antimetabolites|mesh-ancestor
6650326|NCT01433614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6650327|NCT01433614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6650328|NCT01433614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6650329|NCT01433614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6650330|NCT01433627|Hirudins|hirudins|mesh-list
6650331|NCT01433627|Bivalirudin|bivalirudin|mesh-list
6650332|NCT01433627|Antithrombins|antithrombins|mesh-ancestor
6650333|NCT01433627|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6650334|NCT01433627|Protease Inhibitors|protease inhibitors|mesh-ancestor
6650335|NCT01433627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6650336|NCT01433627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650337|NCT01433627|Anticoagulants|anticoagulants|mesh-ancestor
6650338|NCT01433627|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6650339|NCT01433627|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6650340|NCT01433666|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-list
6650341|NCT01433666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6650342|NCT01433666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6650343|NCT01433666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650344|NCT01433705|Regadenoson|regadenoson|mesh-list
6650345|NCT01433705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650346|NCT01433705|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
6650347|NCT01433705|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6650348|NCT01433705|Purinergic Agonists|purinergic agonists|mesh-ancestor
6650349|NCT01433705|Purinergic Agents|purinergic agents|mesh-ancestor
6650350|NCT01433705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6650351|NCT01433705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650352|NCT01433757|Ampicillin|ampicillin|mesh-list
6650353|NCT01433757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6650354|NCT01433757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6650355|NCT01433770|Alefacept|alefacept|mesh-list
6650356|NCT01433770|Dermatologic Agents|dermatologic agents|mesh-ancestor
6650357|NCT01433770|Immunologic Factors|immunologic factors|mesh-ancestor
6650358|NCT01433770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650359|NCT01433887|Ribavirin|ribavirin|mesh-list
6650360|NCT01433887|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6650361|NCT01433887|Antimetabolites|antimetabolites|mesh-ancestor
6650362|NCT01433887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650363|NCT01433887|Antiviral Agents|antiviral agents|mesh-ancestor
6650364|NCT01433887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6650365|NCT01433900|Latanoprost|latanoprost|mesh-list
6650366|NCT01433900|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6650367|NCT01433900|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6650368|NCT01433952|Thiamine|thiamine|mesh-list
6650369|NCT01433952|Vitamin B Complex|vitamin b complex|mesh-ancestor
6650370|NCT01433952|Vitamins|vitamins|mesh-ancestor
6650371|NCT01433952|Micronutrients|micronutrients|mesh-ancestor
6650372|NCT01433952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650373|NCT01433965|Lenalidomide|lenalidomide|mesh-list
6650374|NCT01433965|Immunologic Factors|immunologic factors|mesh-ancestor
6650375|NCT01433965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650376|NCT01433965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6650377|NCT01433965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6650378|NCT01433965|Growth Substances|growth substances|mesh-ancestor
6650379|NCT01433965|Growth Inhibitors|growth inhibitors|mesh-ancestor
6650380|NCT01433965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6650381|NCT01434017|Dexamethasone|dexamethasone|mesh-list
6650382|NCT01434017|Dexamethasone acetate|dexamethasone acetate|mesh-list
6650383|NCT01434017|Droperidol|droperidol|mesh-list
6650384|NCT01434017|Ondansetron|ondansetron|mesh-list
6650385|NCT01434017|BB 1101|bb 1101|mesh-list
6650386|NCT01434017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6650387|NCT01434017|Antiemetics|antiemetics|mesh-ancestor
6650388|NCT01434017|Autonomic Agents|autonomic agents|mesh-ancestor
6650389|NCT01434017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6650390|NCT01434017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650391|NCT01434017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6650392|NCT01434017|Glucocorticoids|glucocorticoids|mesh-ancestor
6650393|NCT01434017|Hormones|hormones|mesh-ancestor
6650394|NCT01434017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6650395|NCT01434017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6650396|NCT01434017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6650397|NCT01434017|Protease Inhibitors|protease inhibitors|mesh-ancestor
6650398|NCT01434017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6650399|NCT01434017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650400|NCT01434017|Antipruritics|antipruritics|mesh-ancestor
6650401|NCT01434017|Dermatologic Agents|dermatologic agents|mesh-ancestor
6650402|NCT01434017|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6650403|NCT01434017|Serotonin Agents|serotonin agents|mesh-ancestor
6650404|NCT01434017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6650405|NCT01434017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6650406|NCT01434017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6650407|NCT01434017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6650408|NCT01434017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6650409|NCT01434017|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6650410|NCT01434017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6650411|NCT01434017|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6650412|NCT01434017|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6650413|NCT01434017|Dopamine Agents|dopamine agents|mesh-ancestor
6650414|NCT01434069|Leucovorin|leucovorin|mesh-list
6650415|NCT01434069|Fluorouracil|fluorouracil|mesh-list
6650416|NCT01434069|Pasireotide|pasireotide|mesh-list
6650417|NCT01434069|Antimetabolites|antimetabolites|mesh-ancestor
6650418|NCT01434069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650419|NCT01434069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6650420|NCT01434069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6650421|NCT01434069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6650422|NCT01434069|Immunologic Factors|immunologic factors|mesh-ancestor
6650423|NCT01434069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650424|NCT01434069|Antidotes|antidotes|mesh-ancestor
6650425|NCT01434069|Protective Agents|protective agents|mesh-ancestor
6650426|NCT01434069|Vitamin B Complex|vitamin b complex|mesh-ancestor
6650427|NCT01434069|Vitamins|vitamins|mesh-ancestor
6650428|NCT01434069|Micronutrients|micronutrients|mesh-ancestor
6650429|NCT01434069|Hormones|hormones|mesh-ancestor
6650430|NCT01434069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6650431|NCT01434108|Phenylacetic acid|phenylacetic acid|mesh-list
6650432|NCT01434108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6650433|NCT01434108|Antimetabolites|antimetabolites|mesh-ancestor
5488567|NCT04826588|Immunoglobulins|immunoglobulins|mesh-list
5488568|NCT04826588|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5488569|NCT04826588|Antibodies|antibodies|mesh-list
5488570|NCT04826588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5488571|NCT04826588|Antiemetics|antiemetics|mesh-ancestor
5488572|NCT04826588|Autonomic Agents|autonomic agents|mesh-ancestor
6453674|NCT00421447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6650434|NCT01434108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650435|NCT01434108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6650436|NCT01434134|Metoprolol|metoprolol|mesh-list
6650437|NCT01434134|Candesartan|candesartan|mesh-list
6650438|NCT01434134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6650439|NCT01434134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6650440|NCT01434134|Sympatholytics|sympatholytics|mesh-ancestor
6650441|NCT01434134|Autonomic Agents|autonomic agents|mesh-ancestor
6650442|NCT01434134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6650443|NCT01434134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488573|NCT04826588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6453675|NCT00421447|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6453676|NCT00421447|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6453677|NCT00421447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6453678|NCT00421447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453679|NCT00421447|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6453680|NCT00421447|Hormone Antagonists|hormone antagonists|mesh-ancestor
6453681|NCT00421447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6453682|NCT00421447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453683|NCT00421460|Methyltestosterone|methyltestosterone|mesh-list
6453684|NCT00421460|Testosterone|testosterone|mesh-list
6453685|NCT00421460|Testosterone undecanoate|testosterone undecanoate|mesh-list
6453686|NCT00421460|Testosterone enanthate|testosterone enanthate|mesh-list
6650444|NCT01434134|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5488574|NCT04826588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488575|NCT04826588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5488576|NCT04826588|Glucocorticoids|glucocorticoids|mesh-ancestor
5488577|NCT04826588|Hormones|hormones|mesh-ancestor
5488578|NCT04826588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5488579|NCT04826588|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5488580|NCT04826588|Protective Agents|protective agents|mesh-ancestor
5488581|NCT04826588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5488582|NCT04826588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5488583|NCT04826588|Immunologic Factors|immunologic factors|mesh-ancestor
5488584|NCT04817241|Cytarabine|cytarabine|mesh-list
5488585|NCT04817241|Decitabine|decitabine|mesh-list
5488586|NCT04817241|Daunorubicin|daunorubicin|mesh-list
5488587|NCT04817241|Venetoclax|venetoclax|mesh-list
6650445|NCT01434134|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5488588|NCT04817241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5488589|NCT04817241|Antimetabolites|antimetabolites|mesh-ancestor
5488590|NCT04817241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488591|NCT04817241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5488592|NCT04817241|Antiviral Agents|antiviral agents|mesh-ancestor
5488593|NCT04817241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5488594|NCT04817241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5488595|NCT04817241|Immunologic Factors|immunologic factors|mesh-ancestor
5488596|NCT04817241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488597|NCT04817241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5488598|NCT04817241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5488599|NCT04817241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5488600|NCT04817241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5488601|NCT04812002|Bevacizumab|bevacizumab|mesh-list
5488602|NCT04812002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5488603|NCT04812002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5488604|NCT04812002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5488605|NCT04812002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5488606|NCT04812002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5488607|NCT04812002|Growth Substances|growth substances|mesh-ancestor
5488608|NCT04812002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488609|NCT04812002|Growth Inhibitors|growth inhibitors|mesh-ancestor
5488610|NCT04812002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488611|NCT04809311|Insulin|insulin|mesh-list
5488612|NCT04809311|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5488613|NCT04809311|Glucagon|glucagon|mesh-list
5488614|NCT04809311|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5488615|NCT04809311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5488616|NCT04809311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488617|NCT04809311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5488618|NCT04809311|Hormones|hormones|mesh-ancestor
5488619|NCT04809311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5488620|NCT04809311|Incretins|incretins|mesh-ancestor
5488621|NCT04804722|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5488622|NCT04804722|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5488623|NCT04804722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488624|NCT04796363|Anesthetics|anesthetics|mesh-list
5488625|NCT04796363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5488626|NCT04796363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488627|NCT04795557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5488628|NCT04790188|Nootropic Agents|nootropic agents|mesh-list
5488629|NCT04784208|Hormones|hormones|mesh-list
5488630|NCT04784208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5488631|NCT04784208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488632|NCT04780321|Antibodies|antibodies|mesh-list
5488633|NCT04780321|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5488634|NCT04780321|Immunologic Factors|immunologic factors|mesh-ancestor
6453687|NCT00421460|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6453688|NCT00421460|Androgens|androgens|mesh-ancestor
6453689|NCT00421460|Hormones|hormones|mesh-ancestor
6453690|NCT00421460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6453691|NCT00421460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453692|NCT00421460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6453693|NCT00421460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6453694|NCT00421460|Anabolic Agents|anabolic agents|mesh-ancestor
6453695|NCT00421473|Atovaquone|atovaquone|mesh-list
6453696|NCT00421473|Proguanil|proguanil|mesh-list
6453697|NCT00421473|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
6453698|NCT00421473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6453699|NCT00421473|Antimalarials|antimalarials|mesh-ancestor
6650446|NCT01434134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6650447|NCT01434134|Adrenergic Agents|adrenergic agents|mesh-ancestor
6650448|NCT01434134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6650449|NCT01434134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650450|NCT01434134|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6650451|NCT01434134|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6650452|NCT01434147|Bevacizumab|bevacizumab|mesh-list
6650453|NCT01434147|Capecitabine|capecitabine|mesh-list
6650454|NCT01434147|Oxaliplatin|oxaliplatin|mesh-list
6650455|NCT01434147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6650456|NCT01434147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6650457|NCT01434147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6650458|NCT01434147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6650459|NCT01434147|Growth Substances|growth substances|mesh-ancestor
6650460|NCT01434147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650461|NCT01434147|Growth Inhibitors|growth inhibitors|mesh-ancestor
6650462|NCT01434147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6650463|NCT01434147|Antimetabolites|antimetabolites|mesh-ancestor
6650464|NCT01434147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650465|NCT01434160|Levonorgestrel|levonorgestrel|mesh-list
6650466|NCT01434160|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6650467|NCT01434160|Contraceptive Agents|contraceptive agents|mesh-ancestor
6650468|NCT01434160|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6650469|NCT01434160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650470|NCT01434160|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6650471|NCT01434160|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6650472|NCT01434160|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6650473|NCT01434173|Amoxicillin|amoxicillin|mesh-list
6650474|NCT01434173|Moxifloxacin|moxifloxacin|mesh-list
6650475|NCT01434173|Clarithromycin|clarithromycin|mesh-list
6650476|NCT01434173|Doxycycline|doxycycline|mesh-list
6650477|NCT01434173|Levofloxacin|levofloxacin|mesh-list
6650478|NCT01434173|Clavulanic Acids|clavulanic acids|mesh-list
6650479|NCT01434173|Clavulanic Acid|clavulanic acid|mesh-list
6650480|NCT01434173|Cefuroxime|cefuroxime|mesh-list
6650481|NCT01434173|Telithromycin|telithromycin|mesh-list
6650482|NCT01434173|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6650483|NCT01434173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6650484|NCT01434173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6650485|NCT01434173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5488635|NCT04780321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488636|NCT04780204|Tenofovir|tenofovir|mesh-list
5488637|NCT04780204|Antiviral Agents|antiviral agents|mesh-ancestor
5488638|NCT04780204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5488639|NCT04780204|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5488640|NCT04780204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5488641|NCT04780204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5488642|NCT04780204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488643|NCT04780204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5488644|NCT04780204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5488645|NCT04773353|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5488646|NCT04773353|Hormones|hormones|mesh-ancestor
5488647|NCT04773353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5488648|NCT04773353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488649|NCT04772547|Vigabatrin|vigabatrin|mesh-list
6650486|NCT01434173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6650487|NCT01434173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6650488|NCT01434173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650489|NCT01434173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6650490|NCT01434173|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6650491|NCT01434173|Contraceptive Agents|contraceptive agents|mesh-ancestor
6650492|NCT01434173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6650493|NCT01434173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488650|NCT04772547|Anticonvulsants|anticonvulsants|mesh-ancestor
5488651|NCT04772547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5488652|NCT04772547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488653|NCT04772547|GABA Agents|gaba agents|mesh-ancestor
6650494|NCT01434173|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6650495|NCT01434173|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6650496|NCT01434173|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6650497|NCT01434173|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6650498|NCT01434173|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6650499|NCT01434173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6650500|NCT01434173|Antimalarials|antimalarials|mesh-ancestor
6650501|NCT01434173|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6650502|NCT01434173|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6650503|NCT01434173|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6650504|NCT01434173|Renal Agents|renal agents|mesh-ancestor
6650505|NCT01434173|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6650506|NCT01434173|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6664291|NCT01511705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6664292|NCT01511705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664293|NCT01511705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6664294|NCT01511705|Antipruritics|antipruritics|mesh-ancestor
6664295|NCT01511705|Dermatologic Agents|dermatologic agents|mesh-ancestor
6664296|NCT01511705|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6664297|NCT01511705|Serotonin Agents|serotonin agents|mesh-ancestor
6664298|NCT01511705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6664299|NCT01511705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6664300|NCT01511705|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6664301|NCT01511705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6664302|NCT01511705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6664303|NCT01511705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6664304|NCT01511705|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5488654|NCT04772547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5488655|NCT04772547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488656|NCT04769206|Galantamine|galantamine|mesh-list
5488657|NCT04769206|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5488658|NCT04769206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5488659|NCT04769206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488660|NCT04769206|Cholinergic Agents|cholinergic agents|mesh-ancestor
5488661|NCT04769206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5488662|NCT04769206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488663|NCT04769206|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5488664|NCT04769206|Autonomic Agents|autonomic agents|mesh-ancestor
5488665|NCT04769206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5488666|NCT04769206|Nootropic Agents|nootropic agents|mesh-ancestor
5488667|NCT04764721|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5488668|NCT04764721|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5488669|NCT04764721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502806|NCT04464512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5502807|NCT04464512|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5502808|NCT04464512|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5502809|NCT04464512|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5502810|NCT04464512|Anesthetics, General|anesthetics, general|mesh-ancestor
5502811|NCT04464512|Anesthetics|anesthetics|mesh-ancestor
5502812|NCT04464642|Methotrexate|methotrexate|mesh-list
5502813|NCT04464642|Tofacitinib|tofacitinib|mesh-list
5502814|NCT04464642|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5502815|NCT04464642|Abortifacient Agents|abortifacient agents|mesh-ancestor
5502816|NCT04464642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5502817|NCT04464642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502818|NCT04464642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5502819|NCT04464642|Antimetabolites|antimetabolites|mesh-ancestor
5502820|NCT04464642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502821|NCT04464642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5502822|NCT04464642|Dermatologic Agents|dermatologic agents|mesh-ancestor
6664305|NCT01511718|Ondansetron|ondansetron|mesh-list
6664306|NCT01511718|Antiemetics|antiemetics|mesh-ancestor
5502823|NCT04464642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5502824|NCT04464642|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5502825|NCT04464642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5502826|NCT04464642|Immunologic Factors|immunologic factors|mesh-ancestor
5502827|NCT04464642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6664307|NCT01511718|Autonomic Agents|autonomic agents|mesh-ancestor
6664308|NCT01511718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6664309|NCT01511718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664310|NCT01511718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6650507|NCT01434212|Interferons|interferons|mesh-list
6650508|NCT01434212|Ribavirin|ribavirin|mesh-list
6650509|NCT01434212|Interferon-alpha|interferon-alpha|mesh-list
6650510|NCT01434212|Interferon alpha-2|interferon alpha-2|mesh-list
6650511|NCT01434212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6650512|NCT01434212|Antiviral Agents|antiviral agents|mesh-ancestor
6650513|NCT01434212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6650514|NCT01434212|Antimetabolites|antimetabolites|mesh-ancestor
6650515|NCT01434212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650516|NCT01434212|Immunologic Factors|immunologic factors|mesh-ancestor
6650517|NCT01434212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650518|NCT01434225|Bumetanide|bumetanide|mesh-list
6650519|NCT01434225|Diuretics|diuretics|mesh-ancestor
6650520|NCT01434225|Natriuretic Agents|natriuretic agents|mesh-ancestor
6650521|NCT01434225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650522|NCT01434225|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6650523|NCT01434225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6650524|NCT01434225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650525|NCT01434251|Antihypertensive Agents|antihypertensive agents|mesh-list
6650526|NCT01434277|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6650527|NCT01434277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6650528|NCT01434303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6650529|NCT01434303|Trastuzumab|trastuzumab|mesh-list
6650530|NCT01434303|Lapatinib|lapatinib|mesh-list
6650531|NCT01434303|Entinostat|entinostat|mesh-list
6650532|NCT01434303|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
6650533|NCT01434303|Antibodies|antibodies|mesh-list
6650534|NCT01434303|Immunoglobulins|immunoglobulins|mesh-list
6650535|NCT01434303|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6650536|NCT01434303|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
6650537|NCT01434303|Immunologic Factors|immunologic factors|mesh-ancestor
6650538|NCT01434303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650539|NCT01434303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6650540|NCT01434303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6650541|NCT01434303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6650542|NCT01434303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650543|NCT01434381|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6650544|NCT01434381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6650545|NCT01434381|Immunologic Factors|immunologic factors|mesh-ancestor
6650546|NCT01434381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650547|NCT01434381|Antacids|antacids|mesh-ancestor
6650548|NCT01434381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650549|NCT01434381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5488670|NCT04762160|Rituximab|rituximab|mesh-list
5488671|NCT04762160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5488672|NCT04762160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5488673|NCT04762160|Immunologic Factors|immunologic factors|mesh-ancestor
5488674|NCT04762160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453700|NCT00421473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6453701|NCT00421473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6453702|NCT00421473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6453703|NCT00421473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488675|NCT04762160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5488676|NCT04757090|Trastuzumab|trastuzumab|mesh-list
5488677|NCT04757090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5488678|NCT04757090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5488679|NCT04745975|Gemcitabine|gemcitabine|mesh-list
5488680|NCT04745975|Paclitaxel|paclitaxel|mesh-list
5488681|NCT04745975|Vinorelbine|vinorelbine|mesh-list
5488682|NCT04745975|Capecitabine|capecitabine|mesh-list
6650550|NCT01434394|Cetuximab|cetuximab|mesh-list
6650551|NCT01434394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6650552|NCT01434394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6650553|NCT01434459|Gemcitabine|gemcitabine|mesh-list
6650554|NCT01434459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6650555|NCT01434459|Antimetabolites|antimetabolites|mesh-ancestor
6650556|NCT01434459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650557|NCT01434459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6650558|NCT01434459|Antiviral Agents|antiviral agents|mesh-ancestor
6650559|NCT01434459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5488683|NCT04745975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6453704|NCT00421473|Antimetabolites|antimetabolites|mesh-ancestor
6453705|NCT00421512|Bevacizumab|bevacizumab|mesh-list
6453706|NCT00421512|Sunitinib|sunitinib|mesh-list
6453707|NCT00421512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6453708|NCT00421512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6650560|NCT01434459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5488684|NCT04745975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5488685|NCT04745975|Tubulin Modulators|tubulin modulators|mesh-ancestor
5488686|NCT04745975|Antimitotic Agents|antimitotic agents|mesh-ancestor
5488687|NCT04745975|Mitosis Modulators|mitosis modulators|mesh-ancestor
5488688|NCT04745975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650561|NCT01434459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6650562|NCT01434459|Immunologic Factors|immunologic factors|mesh-ancestor
6650563|NCT01434459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650564|NCT01434849|Timolol|timolol|mesh-list
6650565|NCT01434849|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6650566|NCT01434849|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6650567|NCT01434849|Adrenergic Agents|adrenergic agents|mesh-ancestor
6650568|NCT01434849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6650569|NCT01434849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650570|NCT01434849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650571|NCT01434849|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6650572|NCT01434849|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6650573|NCT01434862|Pramlintide|pramlintide|mesh-list
6650574|NCT01434862|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
6650575|NCT01434862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6650576|NCT01434862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650577|NCT01434862|Appetite Depressants|appetite depressants|mesh-ancestor
6650578|NCT01434862|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6650579|NCT01434862|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
6650580|NCT01434862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650581|NCT01434888|Timolol|timolol|mesh-list
5488689|NCT04745975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5488690|NCT04745975|Antimetabolites|antimetabolites|mesh-ancestor
5488691|NCT04745975|Antiviral Agents|antiviral agents|mesh-ancestor
5488692|NCT04745975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5488693|NCT04745975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5488694|NCT04745975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5488695|NCT04745975|Immunologic Factors|immunologic factors|mesh-ancestor
5488696|NCT04745975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488697|NCT04727307|Bevacizumab|bevacizumab|mesh-list
5488698|NCT04727307|Atezolizumab|atezolizumab|mesh-list
5488699|NCT04727307|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5488700|NCT04727307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5488701|NCT04727307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5488702|NCT04727307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5488703|NCT04727307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5488704|NCT04727307|Growth Substances|growth substances|mesh-ancestor
5488705|NCT04727307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488706|NCT04727307|Growth Inhibitors|growth inhibitors|mesh-ancestor
5488707|NCT04727307|Immunologic Factors|immunologic factors|mesh-ancestor
5488708|NCT04726969|Ivermectin|ivermectin|mesh-list
5488709|NCT04726969|Albendazole|albendazole|mesh-list
6650582|NCT01434888|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6650583|NCT01434888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6650584|NCT01434888|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6650585|NCT01434888|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6650586|NCT01434888|Adrenergic Agents|adrenergic agents|mesh-ancestor
6650587|NCT01434888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6650588|NCT01434888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650589|NCT01434888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650590|NCT01434888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6650591|NCT01434888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6650592|NCT01434901|Bethanechol|bethanechol|mesh-list
6650593|NCT01434901|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6650594|NCT01434901|Autonomic Agents|autonomic agents|mesh-ancestor
6650595|NCT01434901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6650596|NCT01434901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650597|NCT01434901|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6650598|NCT01434901|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6650599|NCT01434901|Cholinergic Agents|cholinergic agents|mesh-ancestor
6650600|NCT01434901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6650601|NCT01434901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650602|NCT01434914|Octenidine|octenidine|mesh-list
6650603|NCT01434914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6650604|NCT01434914|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6650605|NCT01435083|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
6650606|NCT01435083|Hemostatics|hemostatics|mesh-ancestor
6650607|NCT01435083|Coagulants|coagulants|mesh-ancestor
6650608|NCT01435083|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5488710|NCT04726969|Moxidectin|moxidectin|mesh-list
5488711|NCT04726969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6650609|NCT01435083|Natriuretic Agents|natriuretic agents|mesh-ancestor
5488712|NCT04726969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5488713|NCT04726969|Anthelmintics|anthelmintics|mesh-ancestor
5488714|NCT04726969|Anticestodal Agents|anticestodal agents|mesh-ancestor
5488715|NCT04726969|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5488716|NCT04726969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5488717|NCT04726969|Tubulin Modulators|tubulin modulators|mesh-ancestor
5488718|NCT04726969|Antimitotic Agents|antimitotic agents|mesh-ancestor
5488719|NCT04726969|Mitosis Modulators|mitosis modulators|mesh-ancestor
5488720|NCT04726969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488721|NCT04726969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5488722|NCT04726969|Antinematodal Agents|antinematodal agents|mesh-ancestor
5488723|NCT04704531|Hyaluronic Acid|hyaluronic acid|mesh-list
5488724|NCT04704531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5488725|NCT04704531|Immunologic Factors|immunologic factors|mesh-ancestor
5488726|NCT04704531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488727|NCT04704531|Viscosupplements|viscosupplements|mesh-ancestor
5488728|NCT04704531|Protective Agents|protective agents|mesh-ancestor
5488729|NCT04704518|Hyaluronic Acid|hyaluronic acid|mesh-list
5488730|NCT04704518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5488731|NCT04704518|Immunologic Factors|immunologic factors|mesh-ancestor
5488732|NCT04704518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488733|NCT04704518|Viscosupplements|viscosupplements|mesh-ancestor
5488734|NCT04704518|Protective Agents|protective agents|mesh-ancestor
6650610|NCT01435083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650611|NCT01435161|Telmisartan|telmisartan|mesh-list
6650612|NCT01435161|Antihypertensive Agents|antihypertensive agents|mesh-list
6650613|NCT01435161|Nifedipine|nifedipine|mesh-list
6650614|NCT01435161|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6650615|NCT01435161|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6650616|NCT01435161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650617|NCT01435161|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6650618|NCT01435161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6650619|NCT01435161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6650620|NCT01435161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488735|NCT04691960|Metformin|metformin|mesh-list
5488736|NCT04691960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5488737|NCT04691960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488738|NCT04679012|Prednisone|prednisone|mesh-list
5488739|NCT04679012|Cyclophosphamide|cyclophosphamide|mesh-list
5488740|NCT04679012|Rituximab|rituximab|mesh-list
5488741|NCT04679012|Doxorubicin|doxorubicin|mesh-list
5488742|NCT04679012|Etoposide|etoposide|mesh-list
5488743|NCT04679012|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5488744|NCT04679012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5488745|NCT04679012|Immunologic Factors|immunologic factors|mesh-ancestor
5488746|NCT04679012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488747|NCT04679012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5488748|NCT04679012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5488749|NCT04679012|Alkylating Agents|alkylating agents|mesh-ancestor
5502828|NCT04464642|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6650621|NCT01435161|Vasodilator Agents|vasodilator agents|mesh-ancestor
6650622|NCT01435161|Tocolytic Agents|tocolytic agents|mesh-ancestor
6650623|NCT01435161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6650624|NCT01435200|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6650625|NCT01435200|Hematinics|hematinics|mesh-ancestor
6650626|NCT01435213|Insulin|insulin|mesh-list
6650627|NCT01435213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6650628|NCT01435213|Ketamine|ketamine|mesh-list
6650629|NCT01435213|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6650630|NCT01435213|Atipamezole|atipamezole|mesh-list
6650631|NCT01435213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6650632|NCT01435213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650633|NCT01435213|Analgesics|analgesics|mesh-ancestor
6650634|NCT01435213|Sensory System Agents|sensory system agents|mesh-ancestor
6650635|NCT01435213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6650636|NCT01435213|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6650637|NCT01435213|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6650638|NCT01435213|Anesthetics, General|anesthetics, general|mesh-ancestor
6650639|NCT01435213|Anesthetics|anesthetics|mesh-ancestor
6650640|NCT01435213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6650641|NCT01435213|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6650642|NCT01435213|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6650643|NCT01435213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6650644|NCT01435213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650645|NCT01435213|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6650646|NCT01435213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6650647|NCT01435213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6650648|NCT01435213|Adrenergic Agents|adrenergic agents|mesh-ancestor
6650649|NCT01435213|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6650650|NCT01435213|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6650651|NCT01435213|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6650652|NCT01435252|Cetuximab|cetuximab|mesh-list
6650653|NCT01435252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6650654|NCT01435252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6650655|NCT01435291|Tacrolimus|tacrolimus|mesh-list
6650656|NCT01435291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6650657|NCT01435291|Immunologic Factors|immunologic factors|mesh-ancestor
6650658|NCT01435291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650659|NCT01435291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6650660|NCT01435291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6650661|NCT01435291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650662|NCT01435343|Cytarabine|cytarabine|mesh-list
6650663|NCT01435343|Plerixafor|plerixafor|mesh-list
6650664|NCT01435343|Fludarabine|fludarabine|mesh-list
6650665|NCT01435343|Idarubicin|idarubicin|mesh-list
6650666|NCT01435343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6650667|NCT01435343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6650668|NCT01435343|Antimetabolites|antimetabolites|mesh-ancestor
6650669|NCT01435343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650670|NCT01435343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6650671|NCT01435343|Immunologic Factors|immunologic factors|mesh-ancestor
6650672|NCT01435343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650673|NCT01435343|Antiviral Agents|antiviral agents|mesh-ancestor
6650674|NCT01435343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6650675|NCT01435343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6650676|NCT01435343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6650677|NCT01435343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6650678|NCT01435343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6650679|NCT01435343|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6650680|NCT01435343|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6650681|NCT01435395|Bevacizumab|bevacizumab|mesh-list
6650682|NCT01435395|Bortezomib|bortezomib|mesh-list
6650683|NCT01435395|Temozolomide|temozolomide|mesh-list
6650684|NCT01435395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5488750|NCT04679012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488751|NCT04679012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5488752|NCT04679012|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5488753|NCT04679012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5488754|NCT04679012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5488755|NCT04679012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5488756|NCT04679012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5488757|NCT04679012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5488758|NCT04679012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5488759|NCT04679012|Glucocorticoids|glucocorticoids|mesh-ancestor
6650685|NCT01435395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6650686|NCT01435395|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6650687|NCT01435395|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6650688|NCT01435395|Growth Substances|growth substances|mesh-ancestor
6650689|NCT01435395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650690|NCT01435395|Growth Inhibitors|growth inhibitors|mesh-ancestor
6650691|NCT01435395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6650692|NCT01435395|Alkylating Agents|alkylating agents|mesh-ancestor
6650693|NCT01435395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650694|NCT01435486|Caffeine|caffeine|mesh-list
6650695|NCT01435486|Caffeine citrate|caffeine citrate|mesh-list
6650696|NCT01435486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650697|NCT01435486|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6650698|NCT01435486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650699|NCT01435486|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5488760|NCT04679012|Hormones|hormones|mesh-ancestor
5488761|NCT04679012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5488762|NCT04679012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5488763|NCT04679012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5488764|NCT04677959|Fluticasone|fluticasone|mesh-list
5488765|NCT04677959|Xhance|xhance|mesh-list
5488766|NCT04677959|Albuterol|albuterol|mesh-list
5488767|NCT04677959|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5488768|NCT04677959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5488769|NCT04677959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5488770|NCT04677959|Autonomic Agents|autonomic agents|mesh-ancestor
5488771|NCT04677959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5488772|NCT04677959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650700|NCT01435486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6650701|NCT01435486|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6650702|NCT01435486|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6650703|NCT01435486|Purinergic Agents|purinergic agents|mesh-ancestor
5488773|NCT04677959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5488774|NCT04677959|Respiratory System Agents|respiratory system agents|mesh-ancestor
5488775|NCT04677959|Dermatologic Agents|dermatologic agents|mesh-ancestor
5488776|NCT04677959|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5488777|NCT04677959|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5488778|NCT04677959|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5488779|NCT04677959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5488780|NCT04677959|Adrenergic Agents|adrenergic agents|mesh-ancestor
5488781|NCT04677959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5488782|NCT04677959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488783|NCT04677959|Tocolytic Agents|tocolytic agents|mesh-ancestor
5488784|NCT04677959|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5488785|NCT04673617|Cyclophosphamide|cyclophosphamide|mesh-list
5488786|NCT04673617|Rituximab|rituximab|mesh-list
6650704|NCT01435486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6650705|NCT01435499|Cyclophosphamide|cyclophosphamide|mesh-list
6650706|NCT01435499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6650707|NCT01435499|Immunologic Factors|immunologic factors|mesh-ancestor
6650708|NCT01435499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650709|NCT01435499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6650710|NCT01435499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6650711|NCT01435499|Alkylating Agents|alkylating agents|mesh-ancestor
6650712|NCT01435499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650713|NCT01435499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5488787|NCT04673617|Fludarabine|fludarabine|mesh-list
5488788|NCT04673617|Interleukin-2|interleukin-2|mesh-list
5488789|NCT04673617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5488790|NCT04673617|Immunologic Factors|immunologic factors|mesh-ancestor
5488791|NCT04673617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488792|NCT04673617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6021749|NCT00401973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021750|NCT00401973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6021751|NCT00401973|Serotonin Agents|serotonin agents|mesh-ancestor
6021752|NCT00401973|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6021753|NCT00401973|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6021754|NCT00401973|Antiviral Agents|antiviral agents|mesh-ancestor
6021755|NCT00401973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6021756|NCT00401973|Dopamine Agents|dopamine agents|mesh-ancestor
6021757|NCT00401973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6021758|NCT00401973|Analgesics|analgesics|mesh-ancestor
6021759|NCT00401973|Sensory System Agents|sensory system agents|mesh-ancestor
6021760|NCT00401973|Anticonvulsants|anticonvulsants|mesh-ancestor
6650714|NCT01435499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6650715|NCT01435707|Triamcinolone|triamcinolone|mesh-list
6650716|NCT01435707|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6650717|NCT01435707|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6650718|NCT01435707|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6650719|NCT01435707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6650720|NCT01435707|Glucocorticoids|glucocorticoids|mesh-ancestor
6650721|NCT01435707|Hormones|hormones|mesh-ancestor
6650722|NCT01435707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6650723|NCT01435707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650724|NCT01435707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5488793|NCT04673617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5488794|NCT04673617|Alkylating Agents|alkylating agents|mesh-ancestor
5488795|NCT04673617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488796|NCT04673617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5488797|NCT04673617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6650725|NCT01435707|Immunologic Factors|immunologic factors|mesh-ancestor
5488798|NCT04673617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5488799|NCT04673617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5488800|NCT04673617|Analgesics|analgesics|mesh-ancestor
5488801|NCT04673617|Sensory System Agents|sensory system agents|mesh-ancestor
6650726|NCT01435707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6650727|NCT01435707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650728|NCT01435837|Caffeine|caffeine|mesh-list
6650729|NCT01435837|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6650730|NCT01435837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650731|NCT01435837|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6650732|NCT01435837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6650733|NCT01435837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650734|NCT01435837|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6650735|NCT01435837|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6650736|NCT01435837|Purinergic Agents|purinergic agents|mesh-ancestor
6650737|NCT01435837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6650738|NCT01435902|Fluticasone|fluticasone|mesh-list
6650739|NCT01435902|Xhance|xhance|mesh-list
6650740|NCT01435902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6650741|NCT01435902|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6650742|NCT01435902|Autonomic Agents|autonomic agents|mesh-ancestor
6650743|NCT01435902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6650744|NCT01435902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650745|NCT01435902|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6650746|NCT01435902|Respiratory System Agents|respiratory system agents|mesh-ancestor
6650747|NCT01435902|Dermatologic Agents|dermatologic agents|mesh-ancestor
6650748|NCT01435902|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6650749|NCT01435915|Ropinirole|ropinirole|mesh-list
6650750|NCT01435915|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6650751|NCT01435915|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6650752|NCT01435915|Dopamine Agonists|dopamine agonists|mesh-ancestor
6650753|NCT01435915|Dopamine Agents|dopamine agents|mesh-ancestor
6650754|NCT01435915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6650755|NCT01435915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650756|NCT01435915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650757|NCT01435941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
6650758|NCT01435941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
6650759|NCT01435941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6650760|NCT01435941|Analgesics|analgesics|mesh-ancestor
6650761|NCT01435941|Sensory System Agents|sensory system agents|mesh-ancestor
6650762|NCT01435941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6650763|NCT01435941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650764|NCT01435941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6650765|NCT01435954|Doxazosin|doxazosin|mesh-list
6650766|NCT01435954|Tamsulosin|tamsulosin|mesh-list
6650767|NCT01435954|Finasteride|finasteride|mesh-list
6650768|NCT01435954|Silodosin|silodosin|mesh-list
6650769|NCT01435954|Terazosin|terazosin|mesh-list
6650770|NCT01435954|Alfuzosin|alfuzosin|mesh-list
6650771|NCT01435954|Dutasteride|dutasteride|mesh-list
6650772|NCT01435954|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6650773|NCT01435954|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6650774|NCT01435954|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6650775|NCT01435954|Adrenergic Agents|adrenergic agents|mesh-ancestor
6650776|NCT01435954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6650777|NCT01435954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488802|NCT04673617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6453709|NCT00421512|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6453710|NCT00421512|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6453711|NCT00421512|Growth Substances|growth substances|mesh-ancestor
6453712|NCT00421512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453713|NCT00421512|Growth Inhibitors|growth inhibitors|mesh-ancestor
6453714|NCT00421512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6453715|NCT00421512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6453716|NCT00421512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453717|NCT00421538|Nadroparin|nadroparin|mesh-list
6453718|NCT00421538|Calcium|calcium|mesh-list
6453719|NCT00421538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6453720|NCT00421538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453721|NCT00421538|Anticoagulants|anticoagulants|mesh-ancestor
6453722|NCT00421538|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6453723|NCT00421538|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6650778|NCT01435954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650779|NCT01435954|Urological Agents|urological agents|mesh-ancestor
5488803|NCT04673383|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
5488804|NCT04673383|Hallucinogens|hallucinogens|mesh-ancestor
5488805|NCT04673383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488806|NCT04673383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5488807|NCT04673383|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5488808|NCT04673383|Serotonin Agents|serotonin agents|mesh-ancestor
5488809|NCT04673383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5488810|NCT04673383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488811|NCT04673383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6021761|NCT00401973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6021762|NCT00401973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6021763|NCT00402025|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
6021764|NCT00402025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6021765|NCT00402025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6021766|NCT00402051|Carboplatin|carboplatin|mesh-list
6021767|NCT00402051|Pemetrexed|pemetrexed|mesh-list
6021768|NCT00402051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6021769|NCT00402051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5488821|NCT04662944|Ranibizumab|ranibizumab|mesh-list
5488822|NCT04662944|Aflibercept|aflibercept|mesh-list
5488823|NCT04662944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6650780|NCT01435954|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6650781|NCT01435954|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6650782|NCT01435954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6650783|NCT01435954|Hormone Antagonists|hormone antagonists|mesh-ancestor
6650784|NCT01435954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6650785|NCT01435954|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6650786|NCT01435980|Exenatide|exenatide|mesh-list
6650787|NCT01435980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6650788|NCT01435980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650789|NCT01435980|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6650790|NCT01435980|Incretins|incretins|mesh-ancestor
6650791|NCT01435980|Hormones|hormones|mesh-ancestor
6650792|NCT01435980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6664311|NCT01511718|Antipruritics|antipruritics|mesh-ancestor
6664312|NCT01511718|Dermatologic Agents|dermatologic agents|mesh-ancestor
6664313|NCT01511718|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6664314|NCT01511718|Serotonin Agents|serotonin agents|mesh-ancestor
6664315|NCT01511718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6664316|NCT01511718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6664317|NCT01511718|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6664318|NCT01511718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6664319|NCT01511718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6664320|NCT01511718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6664321|NCT01511718|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6664322|NCT01511731|Famotidine|famotidine|mesh-list
6664323|NCT01511731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6664324|NCT01511731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6664325|NCT01511731|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6664326|NCT01511731|Histamine Antagonists|histamine antagonists|mesh-ancestor
6664327|NCT01511731|Histamine Agents|histamine agents|mesh-ancestor
6664328|NCT01511731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6664329|NCT01511731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6664330|NCT01511731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664331|NCT01511757|Fluconazole|fluconazole|mesh-list
6664332|NCT01511757|Antifungal Agents|antifungal agents|mesh-ancestor
5488824|NCT04662944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5488825|NCT04662944|Growth Substances|growth substances|mesh-ancestor
5488826|NCT04662944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664333|NCT01511757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6664334|NCT01511757|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6664335|NCT01511757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6664336|NCT01511757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6664337|NCT01511757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6664338|NCT01511757|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6664339|NCT01511757|Hormone Antagonists|hormone antagonists|mesh-ancestor
6664340|NCT01511757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6664341|NCT01511757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664342|NCT01511757|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6664343|NCT01511757|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6664344|NCT01511770|Fluconazole|fluconazole|mesh-list
6664345|NCT01511770|Antifungal Agents|antifungal agents|mesh-ancestor
6053247|NCT00593957|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6650793|NCT01436123|Everolimus|everolimus|mesh-list
5488827|NCT04662944|Growth Inhibitors|growth inhibitors|mesh-ancestor
6453724|NCT00421538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453725|NCT00421551|Ritonavir|ritonavir|mesh-list
6453726|NCT00421551|Darunavir|darunavir|mesh-list
6453727|NCT00421551|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6453728|NCT00421551|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6453729|NCT00421551|Protease Inhibitors|protease inhibitors|mesh-ancestor
6453730|NCT00421551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6453731|NCT00421551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453732|NCT00421551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6650794|NCT01436123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6650795|NCT01436123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6650796|NCT01436123|Immunologic Factors|immunologic factors|mesh-ancestor
6650797|NCT01436123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650798|NCT01436188|Ibuprofen|ibuprofen|mesh-list
6650799|NCT01436188|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6650800|NCT01436188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6650801|NCT01436188|Analgesics|analgesics|mesh-ancestor
6650802|NCT01436188|Sensory System Agents|sensory system agents|mesh-ancestor
6650803|NCT01436188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6650804|NCT01436188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650805|NCT01436188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6650806|NCT01436188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6650807|NCT01436188|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6650808|NCT01436188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6650809|NCT01436188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650810|NCT01436422|Vaccines|vaccines|mesh-list
6650811|NCT01436422|Immunologic Factors|immunologic factors|mesh-ancestor
6650812|NCT01436422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650813|NCT01436474|Varenicline|varenicline|mesh-list
6650814|NCT01436474|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6650815|NCT01436474|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6650816|NCT01436474|Cholinergic Agents|cholinergic agents|mesh-ancestor
6650817|NCT01436474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6650818|NCT01436474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650819|NCT01436474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650820|NCT01436513|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6650821|NCT01436513|Estrogens|estrogens|mesh-ancestor
6650822|NCT01436513|Hormones|hormones|mesh-ancestor
6650823|NCT01436513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6650824|NCT01436513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650825|NCT01436539|Adefovir|adefovir|mesh-list
6650826|NCT01436539|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6650827|NCT01436539|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
6650828|NCT01436539|Antiviral Agents|antiviral agents|mesh-ancestor
6650829|NCT01436539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6650830|NCT01436539|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6650831|NCT01436539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6650832|NCT01436539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6650833|NCT01436539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650834|NCT01436539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6650835|NCT01436539|Antimetabolites|antimetabolites|mesh-ancestor
6650836|NCT01436539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6650837|NCT01436578|Posaconazole|posaconazole|mesh-list
6650838|NCT01436578|Antifungal Agents|antifungal agents|mesh-ancestor
6650839|NCT01436578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6650840|NCT01436578|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6650841|NCT01436578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6650842|NCT01436578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6650843|NCT01436578|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6650844|NCT01436578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6021770|NCT00402051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021771|NCT00402051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6021772|NCT00402051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6021773|NCT00402103|Amlodipine|amlodipine|mesh-list
6021774|NCT00402103|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6021775|NCT00402103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6650845|NCT01436578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6650846|NCT01436578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650847|NCT01436578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6650848|NCT01436578|Hormone Antagonists|hormone antagonists|mesh-ancestor
6650849|NCT01436578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6650850|NCT01436578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650851|NCT01436825|Factor VIII|factor viii|mesh-list
6650852|NCT01436825|Coagulants|coagulants|mesh-ancestor
6650853|NCT01436838|Interferons|interferons|mesh-list
6650854|NCT01436838|Interferon-beta|interferon-beta|mesh-list
6650855|NCT01436838|Interferon beta-1b|interferon beta-1b|mesh-list
6650856|NCT01436838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6650857|NCT01436838|Antiviral Agents|antiviral agents|mesh-ancestor
6650858|NCT01436838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6650859|NCT01436838|Immunologic Factors|immunologic factors|mesh-ancestor
6650860|NCT01436838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650861|NCT01436838|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6650862|NCT01436916|Cholecalciferol|cholecalciferol|mesh-list
6650863|NCT01436916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6650864|NCT01436916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650865|NCT01436916|Vitamins|vitamins|mesh-ancestor
6650866|NCT01436916|Micronutrients|micronutrients|mesh-ancestor
6650867|NCT01436916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6650868|NCT01436929|Silymarin|silymarin|mesh-list
6650869|NCT01436929|Antioxidants|antioxidants|mesh-ancestor
6650870|NCT01436929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650871|NCT01436929|Protective Agents|protective agents|mesh-ancestor
6650872|NCT01436929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650873|NCT01436968|Valacyclovir|valacyclovir|mesh-list
6650874|NCT01436968|Antiviral Agents|antiviral agents|mesh-ancestor
6650875|NCT01436968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6650876|NCT01436994|Propylthiouracil|propylthiouracil|mesh-list
6650877|NCT01436994|Carbimazole|carbimazole|mesh-list
6650878|NCT01436994|Antimetabolites|antimetabolites|mesh-ancestor
6021776|NCT00402103|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5488828|NCT04662944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5488829|NCT04653207|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5488830|NCT04652700|Tenofovir|tenofovir|mesh-list
5488831|NCT04652700|Emtricitabine|emtricitabine|mesh-list
5488832|NCT04652700|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5488833|NCT04652700|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
5488834|NCT04652700|Antiviral Agents|antiviral agents|mesh-ancestor
5488835|NCT04652700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5488836|NCT04652700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5488837|NCT04652700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5488838|NCT04652700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5488839|NCT04652700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488840|NCT04652700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5488841|NCT04652700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6650879|NCT01436994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650880|NCT01436994|Antithyroid Agents|antithyroid agents|mesh-ancestor
6650881|NCT01436994|Hormone Antagonists|hormone antagonists|mesh-ancestor
6650882|NCT01436994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6650883|NCT01436994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650884|NCT01437020|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6650885|NCT01437020|Antifungal Agents|antifungal agents|mesh-ancestor
6650886|NCT01437020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6650887|NCT01437020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6650888|NCT01437020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6650889|NCT01437046|Doxazosin|doxazosin|mesh-list
6650890|NCT01437046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6650891|NCT01437046|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6650892|NCT01437046|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6650893|NCT01437046|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6650894|NCT01437046|Adrenergic Agents|adrenergic agents|mesh-ancestor
6650895|NCT01437046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6650896|NCT01437046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488842|NCT04648930|Omalizumab|omalizumab|mesh-list
6650897|NCT01437046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650898|NCT01437189|Sertraline|sertraline|mesh-list
6650899|NCT01437189|Antidepressive Agents|antidepressive agents|mesh-ancestor
5488843|NCT04648930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5488844|NCT04648930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5488845|NCT04648930|Respiratory System Agents|respiratory system agents|mesh-ancestor
5488846|NCT04648033|Atovaquone|atovaquone|mesh-list
5488847|NCT04648033|Cisplatin|cisplatin|mesh-list
5488848|NCT04648033|Vinorelbine|vinorelbine|mesh-list
5488849|NCT04648033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5488850|NCT04648033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5488851|NCT04648033|Tubulin Modulators|tubulin modulators|mesh-ancestor
5488852|NCT04648033|Antimitotic Agents|antimitotic agents|mesh-ancestor
5488853|NCT04648033|Mitosis Modulators|mitosis modulators|mesh-ancestor
5488854|NCT04648033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488855|NCT04648033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5488856|NCT04648033|Antimalarials|antimalarials|mesh-ancestor
6650900|NCT01437189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6650901|NCT01437189|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6650902|NCT01437189|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5488857|NCT04648033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5488858|NCT04648033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5488859|NCT04648033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5488860|NCT04645212|Aflibercept|aflibercept|mesh-list
5488861|NCT04645212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6650903|NCT01437189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6650904|NCT01437189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650905|NCT01437189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6650906|NCT01437189|Serotonin Agents|serotonin agents|mesh-ancestor
6453733|NCT00421551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6453734|NCT00421551|Antiviral Agents|antiviral agents|mesh-ancestor
6453735|NCT00421551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6453736|NCT00421551|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6453737|NCT00421551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6453738|NCT00421642|Adalimumab|adalimumab|mesh-list
6453739|NCT00421642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6453740|NCT00421642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6453741|NCT00421694|Bicalutamide|bicalutamide|mesh-list
6453742|NCT00421694|Androgen Antagonists|androgen antagonists|mesh-ancestor
6453743|NCT00421694|Hormone Antagonists|hormone antagonists|mesh-ancestor
6453744|NCT00421694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6453745|NCT00421694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453746|NCT00421694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6453747|NCT00421720|Sufentanil|sufentanil|mesh-list
6453748|NCT00421720|Remifentanil|remifentanil|mesh-list
6650907|NCT01437189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488862|NCT04645212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5488863|NCT04645212|Growth Substances|growth substances|mesh-ancestor
5488864|NCT04645212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021777|NCT00402103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6650908|NCT01437228|Povidone-Iodine|povidone-iodine|mesh-list
6650909|NCT01437228|Povidone|povidone|mesh-list
6650910|NCT01437228|Plasma Substitutes|plasma substitutes|mesh-ancestor
6650911|NCT01437228|Blood Substitutes|blood substitutes|mesh-ancestor
6650912|NCT01437228|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6650913|NCT01437228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6650914|NCT01437293|Carbidopa|carbidopa|mesh-list
6650915|NCT01437293|Entacapone|entacapone|mesh-list
6650916|NCT01437293|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6650917|NCT01437293|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6650918|NCT01437293|Dopamine Agents|dopamine agents|mesh-ancestor
6650919|NCT01437293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6650920|NCT01437293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650921|NCT01437293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650922|NCT01437293|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6650923|NCT01437293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6650924|NCT01437293|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6650925|NCT01437306|Lofexidine|lofexidine|mesh-list
6650926|NCT01437306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6650927|NCT01437306|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6650928|NCT01437306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650929|NCT01437306|Sensory System Agents|sensory system agents|mesh-ancestor
6650930|NCT01437306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5488865|NCT04645212|Growth Inhibitors|growth inhibitors|mesh-ancestor
5488866|NCT04645212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5488867|NCT04645121|Carbon Monoxide|carbon monoxide|mesh-list
5488868|NCT04645121|Antimetabolites|antimetabolites|mesh-ancestor
6650931|NCT01437306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6650932|NCT01437306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6650933|NCT01437306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6650934|NCT01437306|Adrenergic Agents|adrenergic agents|mesh-ancestor
6650935|NCT01437306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6650936|NCT01437306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650937|NCT01437371|Ramipril|ramipril|mesh-list
6650938|NCT01437371|Enalapril|enalapril|mesh-list
6650939|NCT01437371|Lisinopril|lisinopril|mesh-list
6650940|NCT01437371|Captopril|captopril|mesh-list
6650941|NCT01437371|Trandolapril|trandolapril|mesh-list
6650942|NCT01437371|Enzyme Inhibitors|enzyme inhibitors|mesh-list
6650943|NCT01437371|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5488869|NCT04645121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488870|NCT04645121|Gasotransmitters|gasotransmitters|mesh-ancestor
5488871|NCT04645121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5488872|NCT04645121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488873|NCT04644029|Tenofovir|tenofovir|mesh-list
6650944|NCT01437371|Protease Inhibitors|protease inhibitors|mesh-ancestor
6650945|NCT01437371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650946|NCT01437371|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6650947|NCT01437371|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6650948|NCT01437371|Protective Agents|protective agents|mesh-ancestor
6650949|NCT01437371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650950|NCT01437462|Propofol|propofol|mesh-list
6650951|NCT01437462|Sevoflurane|sevoflurane|mesh-list
6650952|NCT01437462|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6650953|NCT01437462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6650954|NCT01437462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650955|NCT01437462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6650956|NCT01437462|Anesthetics, General|anesthetics, general|mesh-ancestor
6650957|NCT01437462|Anesthetics|anesthetics|mesh-ancestor
6650958|NCT01437462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6650959|NCT01437462|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5488874|NCT04644029|Emtricitabine|emtricitabine|mesh-list
5488875|NCT04644029|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5488876|NCT04644029|Islatravir|islatravir|mesh-list
5488877|NCT04644029|Antiviral Agents|antiviral agents|mesh-ancestor
5488878|NCT04644029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5488879|NCT04644029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5488880|NCT04644029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5488881|NCT04644029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6650960|NCT01437566|Fulvestrant|fulvestrant|mesh-list
6650961|NCT01437566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6650962|NCT01437566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6650963|NCT01437566|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5488882|NCT04644029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488883|NCT04644029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5488884|NCT04644029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5488885|NCT04632706|Ivermectin|ivermectin|mesh-list
5488886|NCT04632706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5488887|NCT04632706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5488888|NCT04629781|Docetaxel|docetaxel|mesh-list
5488889|NCT04629781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5488890|NCT04629781|Tubulin Modulators|tubulin modulators|mesh-ancestor
5488891|NCT04629781|Antimitotic Agents|antimitotic agents|mesh-ancestor
5488892|NCT04629781|Mitosis Modulators|mitosis modulators|mesh-ancestor
6650964|NCT01437566|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6650965|NCT01437566|Hormone Antagonists|hormone antagonists|mesh-ancestor
6650966|NCT01437566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6650967|NCT01437566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650968|NCT01437579|Botulinum Toxins|botulinum toxins|mesh-list
6650969|NCT01437579|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6650970|NCT01437579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6650971|NCT01437579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650972|NCT01437579|Cholinergic Agents|cholinergic agents|mesh-ancestor
6650973|NCT01437579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6650974|NCT01437579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650975|NCT01437592|Insulin|insulin|mesh-list
6650976|NCT01437592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6650977|NCT01437592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650978|NCT01437618|Bevacizumab|bevacizumab|mesh-list
6650979|NCT01437618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6650980|NCT01437618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6650981|NCT01437618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6650982|NCT01437618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6650983|NCT01437618|Growth Substances|growth substances|mesh-ancestor
6650984|NCT01437618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650985|NCT01437618|Growth Inhibitors|growth inhibitors|mesh-ancestor
6650986|NCT01437644|Botulinum Toxins|botulinum toxins|mesh-list
6650987|NCT01437644|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6650988|NCT01437644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6650989|NCT01437644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650990|NCT01437644|Cholinergic Agents|cholinergic agents|mesh-ancestor
6650991|NCT01437644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6650992|NCT01437644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6650993|NCT01437670|Solifenacin Succinate|solifenacin succinate|mesh-list
6650994|NCT01437670|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6650995|NCT01437670|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6650996|NCT01437670|Cholinergic Agents|cholinergic agents|mesh-ancestor
6650997|NCT01437670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6650998|NCT01437670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6650999|NCT01437670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651000|NCT01437670|Urological Agents|urological agents|mesh-ancestor
6651001|NCT01437696|Vitamin D|vitamin d|mesh-list
6651002|NCT01437696|Ergocalciferols|ergocalciferols|mesh-list
6651003|NCT01437696|Vitamins|vitamins|mesh-list
6651004|NCT01437696|Micronutrients|micronutrients|mesh-ancestor
6651005|NCT01437696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651006|NCT01437696|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6651007|NCT01437696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6651008|NCT01437709|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6651009|NCT01437709|Ofatumumab|ofatumumab|mesh-list
6651010|NCT01437709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6651011|NCT01437709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6651012|NCT01437709|Alkylating Agents|alkylating agents|mesh-ancestor
6651013|NCT01437709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651014|NCT01437709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6651015|NCT01437709|Immunologic Factors|immunologic factors|mesh-ancestor
6651016|NCT01437709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651017|NCT01437748|Bromides|bromides|mesh-list
6651018|NCT01437748|Tiotropium Bromide|tiotropium bromide|mesh-list
6651019|NCT01437748|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6651020|NCT01437748|Autonomic Agents|autonomic agents|mesh-ancestor
5488893|NCT04629781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488894|NCT04626635|Cemiplimab|cemiplimab|mesh-list
5488895|NCT04626635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5488896|NCT04626635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5488897|NCT04620187|Cisplatin|cisplatin|mesh-list
5488898|NCT04620187|Carboplatin|carboplatin|mesh-list
6651021|NCT01437748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5488899|NCT04620187|Trastuzumab|trastuzumab|mesh-list
6651022|NCT01437748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651023|NCT01437748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6651024|NCT01437748|Respiratory System Agents|respiratory system agents|mesh-ancestor
6651025|NCT01437748|Parasympatholytics|parasympatholytics|mesh-ancestor
6651026|NCT01437748|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6651027|NCT01437748|Cholinergic Agents|cholinergic agents|mesh-ancestor
6651028|NCT01437748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6651029|NCT01437748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651030|NCT01437748|Anticonvulsants|anticonvulsants|mesh-ancestor
6651031|NCT01437800|Metformin|metformin|mesh-list
6651032|NCT01437800|Glimepiride|glimepiride|mesh-list
6651033|NCT01437800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5488900|NCT04620187|Maytansine|maytansine|mesh-list
5488901|NCT04620187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5488902|NCT04620187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5488903|NCT04620187|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5488904|NCT04620187|Tubulin Modulators|tubulin modulators|mesh-ancestor
5488905|NCT04620187|Antimitotic Agents|antimitotic agents|mesh-ancestor
5488906|NCT04620187|Mitosis Modulators|mitosis modulators|mesh-ancestor
5488907|NCT04620187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488908|NCT04608019|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5488909|NCT04608019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6021778|NCT00402103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021779|NCT00402103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6651034|NCT01437800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651035|NCT01437800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6651036|NCT01437800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6651037|NCT01437800|Immunologic Factors|immunologic factors|mesh-ancestor
6651038|NCT01437813|Metformin|metformin|mesh-list
6651039|NCT01437813|Glimepiride|glimepiride|mesh-list
6651040|NCT01437813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6651041|NCT01437813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651042|NCT01437813|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6651043|NCT01437813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6651044|NCT01437813|Immunologic Factors|immunologic factors|mesh-ancestor
6651045|NCT01437826|Selenium|selenium|mesh-list
6651046|NCT01437826|Antioxidants|antioxidants|mesh-list
6651047|NCT01437826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651048|NCT01437826|Protective Agents|protective agents|mesh-ancestor
6651049|NCT01437826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651050|NCT01437826|Trace Elements|trace elements|mesh-ancestor
6651051|NCT01437826|Micronutrients|micronutrients|mesh-ancestor
6664346|NCT01511770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6664347|NCT01511770|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6664348|NCT01511770|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6664349|NCT01511770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6021780|NCT00402103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021781|NCT00402103|Vasodilator Agents|vasodilator agents|mesh-ancestor
6664350|NCT01511770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488915|NCT04595370|Dapagliflozin|dapagliflozin|mesh-list
5488916|NCT04595370|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5488917|NCT04595370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488918|NCT04595370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5488919|NCT04595370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488920|NCT04588818|Adalimumab|adalimumab|mesh-list
5488921|NCT04588818|Methotrexate|methotrexate|mesh-list
5488922|NCT04588818|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5488923|NCT04588818|Abortifacient Agents|abortifacient agents|mesh-ancestor
6453749|NCT00421720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6453750|NCT00421720|Narcotics|narcotics|mesh-ancestor
6453751|NCT00421720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6453752|NCT00421720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651052|NCT01437839|Apixaban|apixaban|mesh-list
6651053|NCT01437839|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6651054|NCT01437839|Antithrombins|antithrombins|mesh-ancestor
6651055|NCT01437839|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6651056|NCT01437839|Protease Inhibitors|protease inhibitors|mesh-ancestor
6651057|NCT01437839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6651058|NCT01437839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651059|NCT01437839|Anticoagulants|anticoagulants|mesh-ancestor
6651060|NCT01437982|Loteprednol Etabonate|loteprednol etabonate|mesh-list
6651061|NCT01437982|Prednisolone|prednisolone|mesh-list
6651062|NCT01437982|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6651063|NCT01437982|Methylprednisolone|methylprednisolone|mesh-list
5488924|NCT04588818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5488925|NCT04588818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488926|NCT04588818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5488927|NCT04588818|Antimetabolites|antimetabolites|mesh-ancestor
5488928|NCT04588818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488929|NCT04588818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5488930|NCT04588818|Dermatologic Agents|dermatologic agents|mesh-ancestor
5488931|NCT04588818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5488932|NCT04588818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5488933|NCT04588818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5488934|NCT04588818|Immunologic Factors|immunologic factors|mesh-ancestor
5488935|NCT04588818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5488936|NCT04588818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5488937|NCT04588818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5488938|NCT04579510|Vaccines|vaccines|mesh-list
5488939|NCT04579510|Immunologic Factors|immunologic factors|mesh-ancestor
5488940|NCT04579510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488941|NCT04576091|Pembrolizumab|pembrolizumab|mesh-list
6651064|NCT01437982|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6651065|NCT01437982|Prednisolone acetate|prednisolone acetate|mesh-list
6651066|NCT01437982|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6651067|NCT01437982|Prednisolone phosphate|prednisolone phosphate|mesh-list
6651068|NCT01437982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6651069|NCT01437982|Glucocorticoids|glucocorticoids|mesh-ancestor
6651070|NCT01437982|Hormones|hormones|mesh-ancestor
6651071|NCT01437982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6651072|NCT01437982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651073|NCT01437982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6651074|NCT01437982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5488942|NCT04576091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5488943|NCT04576091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5502829|NCT04464642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5502830|NCT04464616|Anesthetics|anesthetics|mesh-list
5502831|NCT04464616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5502832|NCT04464616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502833|NCT04464265|Propofol|propofol|mesh-list
5502834|NCT04464265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5502835|NCT04464265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5502836|NCT04464265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502837|NCT04464265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5502838|NCT04464265|Anesthetics, General|anesthetics, general|mesh-ancestor
5502839|NCT04464265|Anesthetics|anesthetics|mesh-ancestor
5502840|NCT04464135|Acetic Acid|acetic acid|mesh-list
5502841|NCT04464135|Retinol acetate|retinol acetate|mesh-list
5502842|NCT04464135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5502843|NCT04464135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5502844|NCT04464135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6453753|NCT00421720|Analgesics|analgesics|mesh-ancestor
6453754|NCT00421720|Sensory System Agents|sensory system agents|mesh-ancestor
6453755|NCT00421720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6651075|NCT01437982|Antiemetics|antiemetics|mesh-ancestor
6651076|NCT01437982|Autonomic Agents|autonomic agents|mesh-ancestor
6651077|NCT01437982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6651078|NCT01437982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5502845|NCT04464135|Immunologic Factors|immunologic factors|mesh-ancestor
5502846|NCT04464135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502847|NCT04464135|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6453756|NCT00421720|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6453757|NCT00421720|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5488944|NCT04575948|Chlorhexidine|chlorhexidine|mesh-list
5488945|NCT04575948|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5488946|NCT04575948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5488947|NCT04575948|Disinfectants|disinfectants|mesh-ancestor
5488948|NCT04553666|Vitamins|vitamins|mesh-list
5488949|NCT04553666|Ascorbic Acid|ascorbic acid|mesh-list
5488950|NCT04553666|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
5488951|NCT04553666|Micronutrients|micronutrients|mesh-ancestor
6651079|NCT01437982|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6651080|NCT01437982|Protective Agents|protective agents|mesh-ancestor
6651081|NCT01437982|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6651082|NCT01438021|Methotrexate|methotrexate|mesh-list
6651083|NCT01438021|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6651084|NCT01438021|Abortifacient Agents|abortifacient agents|mesh-ancestor
6651085|NCT01438021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6651086|NCT01438021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651087|NCT01438021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6651088|NCT01438021|Antimetabolites|antimetabolites|mesh-ancestor
6651089|NCT01438021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651090|NCT01438021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6651091|NCT01438021|Dermatologic Agents|dermatologic agents|mesh-ancestor
5488952|NCT04553666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488953|NCT04553666|Antioxidants|antioxidants|mesh-ancestor
6651092|NCT01438021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6651093|NCT01438021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6651094|NCT01438021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6651095|NCT01438021|Immunologic Factors|immunologic factors|mesh-ancestor
6651096|NCT01438021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6651097|NCT01438021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6651098|NCT01438073|Hormones|hormones|mesh-list
6651099|NCT01438073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6651100|NCT01438073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651101|NCT01438086|Mecasermin|mecasermin|mesh-list
5488954|NCT04553666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488955|NCT04553666|Protective Agents|protective agents|mesh-ancestor
5488956|NCT04553666|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
5488957|NCT04553666|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5488958|NCT04553666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5488959|NCT04553666|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5488960|NCT04540835|Calcium|calcium|mesh-list
5488961|NCT04540835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5488962|NCT04540835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488963|NCT04539730|Bupivacaine|bupivacaine|mesh-list
6651102|NCT01438086|Growth Substances|growth substances|mesh-ancestor
6651103|NCT01438086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651104|NCT01438112|Gemcitabine|gemcitabine|mesh-list
6651105|NCT01438112|Interferons|interferons|mesh-list
6651106|NCT01438112|Mitomycins|mitomycins|mesh-list
6651107|NCT01438112|Mitomycin|mitomycin|mesh-list
6651108|NCT01438112|Valrubicin|valrubicin|mesh-list
6651109|NCT01438112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6651110|NCT01438112|Antimetabolites|antimetabolites|mesh-ancestor
6651111|NCT01438112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488964|NCT04539730|Ropivacaine|ropivacaine|mesh-list
5488965|NCT04539730|Anesthetics, Local|anesthetics, local|mesh-ancestor
5488966|NCT04539730|Anesthetics|anesthetics|mesh-ancestor
6651112|NCT01438112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6021782|NCT00402103|Diuretics|diuretics|mesh-ancestor
6453758|NCT00421720|Anesthetics, General|anesthetics, general|mesh-ancestor
6651113|NCT01438112|Antiviral Agents|antiviral agents|mesh-ancestor
6651114|NCT01438112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6651115|NCT01438112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6651116|NCT01438112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6651117|NCT01438112|Immunologic Factors|immunologic factors|mesh-ancestor
6651118|NCT01438112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651119|NCT01438112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6651120|NCT01438112|Alkylating Agents|alkylating agents|mesh-ancestor
6651121|NCT01438112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6651122|NCT01438112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6651123|NCT01438112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6651124|NCT01438190|Metformin|metformin|mesh-list
6651125|NCT01438190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6651126|NCT01438190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651127|NCT01438320|Quercetin|quercetin|mesh-list
6651128|NCT01438320|Antioxidants|antioxidants|mesh-ancestor
6651129|NCT01438320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651130|NCT01438320|Protective Agents|protective agents|mesh-ancestor
6651131|NCT01438320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651132|NCT01438359|Furosemide|furosemide|mesh-list
6651133|NCT01438359|Diuretics|diuretics|mesh-ancestor
6651134|NCT01438359|Natriuretic Agents|natriuretic agents|mesh-ancestor
6651135|NCT01438359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651136|NCT01438359|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6651137|NCT01438359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6651138|NCT01438359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651139|NCT01438372|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6651140|NCT01438372|Hematinics|hematinics|mesh-ancestor
6651141|NCT01438515|Chlorhexidine|chlorhexidine|mesh-list
6651142|NCT01438515|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6651143|NCT01438515|Doxycycline|doxycycline|mesh-list
6651144|NCT01438515|Rifampin|rifampin|mesh-list
6651145|NCT01438515|Mupirocin|mupirocin|mesh-list
6651146|NCT01438515|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6651147|NCT01438515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6651148|NCT01438515|Disinfectants|disinfectants|mesh-ancestor
6651149|NCT01438515|Dermatologic Agents|dermatologic agents|mesh-ancestor
6651150|NCT01438515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6651151|NCT01438515|Antimalarials|antimalarials|mesh-ancestor
6651152|NCT01438515|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6651153|NCT01438515|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6651154|NCT01438515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6651155|NCT01438515|Antitubercular Agents|antitubercular agents|mesh-ancestor
6651156|NCT01438515|Leprostatic Agents|leprostatic agents|mesh-ancestor
6651157|NCT01438515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6651158|NCT01438515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6651159|NCT01438515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651160|NCT01438515|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6651161|NCT01438515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6651162|NCT01438515|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6651163|NCT01438515|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6651164|NCT01438515|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6651165|NCT01438515|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6651166|NCT01438515|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6651167|NCT01438554|Trametinib|trametinib|mesh-list
6453759|NCT00421720|Anesthetics|anesthetics|mesh-ancestor
6453760|NCT00421785|Acetylcysteine|acetylcysteine|mesh-list
6453761|NCT00421785|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6453762|NCT00421785|Antiviral Agents|antiviral agents|mesh-ancestor
6453763|NCT00421785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6453764|NCT00421785|Expectorants|expectorants|mesh-ancestor
6453765|NCT00421785|Respiratory System Agents|respiratory system agents|mesh-ancestor
6453766|NCT00421785|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6453767|NCT00421785|Antioxidants|antioxidants|mesh-ancestor
6453768|NCT00421785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453769|NCT00421785|Protective Agents|protective agents|mesh-ancestor
6453770|NCT00421785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453771|NCT00421785|Antidotes|antidotes|mesh-ancestor
6453772|NCT00421811|Melphalan|melphalan|mesh-list
6453773|NCT00421811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6453774|NCT00421811|Alkylating Agents|alkylating agents|mesh-ancestor
6453775|NCT00421811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453776|NCT00421811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6651168|NCT01438554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6651169|NCT01438554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6651170|NCT01438554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6651171|NCT01438554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651172|NCT01438567|Oxycodone|oxycodone|mesh-list
6651173|NCT01438567|Naloxone|naloxone|mesh-list
6651174|NCT01438567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6651175|NCT01438567|Narcotics|narcotics|mesh-ancestor
6651176|NCT01438567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6651177|NCT01438567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651178|NCT01438567|Analgesics|analgesics|mesh-ancestor
6651179|NCT01438567|Sensory System Agents|sensory system agents|mesh-ancestor
6651180|NCT01438567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6651181|NCT01438567|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6651182|NCT01438580|Aspirin|aspirin|mesh-list
6651183|NCT01438580|Warfarin|warfarin|mesh-list
6651184|NCT01438580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6651185|NCT01438580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6651186|NCT01438580|Analgesics|analgesics|mesh-ancestor
6651187|NCT01438580|Sensory System Agents|sensory system agents|mesh-ancestor
6651188|NCT01438580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6651189|NCT01438580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651190|NCT01438580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6651191|NCT01438580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6651192|NCT01438580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6651193|NCT01438580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6651194|NCT01438580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651195|NCT01438580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6651196|NCT01438580|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6651197|NCT01438580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6651198|NCT01438580|Antipyretics|antipyretics|mesh-ancestor
6651199|NCT01438580|Anticoagulants|anticoagulants|mesh-ancestor
6651200|NCT01438632|Insulin|insulin|mesh-list
6651201|NCT01438632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6651202|NCT01438632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651203|NCT01438723|Metformin|metformin|mesh-list
6651204|NCT01438723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6651205|NCT01438723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651206|NCT01438736|Etonogestrel|etonogestrel|mesh-list
6651207|NCT01438736|Desogestrel|desogestrel|mesh-list
6651208|NCT01438736|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6651209|NCT01438736|Contraceptive Agents|contraceptive agents|mesh-ancestor
6651210|NCT01438736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6651211|NCT01438736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651212|NCT01438736|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6651213|NCT01438736|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6651214|NCT01438736|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6651215|NCT01438736|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6651216|NCT01438736|Progestins|progestins|mesh-ancestor
6651217|NCT01438736|Hormones|hormones|mesh-ancestor
6651218|NCT01438736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6651219|NCT01438749|Diazepam|diazepam|mesh-list
6651220|NCT01438749|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6651221|NCT01438749|Anticonvulsants|anticonvulsants|mesh-ancestor
6651222|NCT01438749|Antiemetics|antiemetics|mesh-ancestor
6651223|NCT01438749|Autonomic Agents|autonomic agents|mesh-ancestor
6651224|NCT01438749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5488967|NCT04539730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5488968|NCT04539730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488969|NCT04539730|Sensory System Agents|sensory system agents|mesh-ancestor
5488970|NCT04539730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5488971|NCT04537208|Vaccines|vaccines|mesh-list
6651225|NCT01438749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651226|NCT01438749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6651227|NCT01438749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6651228|NCT01438749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6651229|NCT01438749|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6651230|NCT01438749|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6651231|NCT01438749|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6651232|NCT01438749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6651233|NCT01438749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6651234|NCT01438749|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6651235|NCT01438749|Anesthetics, General|anesthetics, general|mesh-ancestor
6651236|NCT01438749|Anesthetics|anesthetics|mesh-ancestor
6651237|NCT01438749|GABA Modulators|gaba modulators|mesh-ancestor
6651238|NCT01438749|GABA Agents|gaba agents|mesh-ancestor
6651239|NCT01438749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6651240|NCT01438749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651241|NCT01438866|Fluorides|fluorides|mesh-list
6651242|NCT01438866|Sodium Fluoride|sodium fluoride|mesh-list
6651243|NCT01438866|Fluorides, Topical|fluorides, topical|mesh-list
6651244|NCT01438866|Cariostatic Agents|cariostatic agents|mesh-ancestor
6651245|NCT01438866|Protective Agents|protective agents|mesh-ancestor
6651246|NCT01438866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651247|NCT01438944|Nicotine|nicotine|mesh-list
6651248|NCT01438944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6651249|NCT01438944|Autonomic Agents|autonomic agents|mesh-ancestor
6651250|NCT01438944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6651251|NCT01438944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651252|NCT01438944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6651253|NCT01438944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5488972|NCT04537208|Immunologic Factors|immunologic factors|mesh-ancestor
5488973|NCT04537208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488974|NCT04535791|Vitamin D|vitamin d|mesh-list
5488975|NCT04535791|Cholecalciferol|cholecalciferol|mesh-list
5488976|NCT04535791|Vitamins|vitamins|mesh-ancestor
5488977|NCT04535791|Micronutrients|micronutrients|mesh-ancestor
6651254|NCT01438944|Cholinergic Agents|cholinergic agents|mesh-ancestor
6651255|NCT01438944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6651256|NCT01438944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651257|NCT01439100|Oxycodone|oxycodone|mesh-list
5488978|NCT04535791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488979|NCT04535791|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5488980|NCT04535791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5488981|NCT04523246|Vaccines|vaccines|mesh-list
5488982|NCT04523246|Immunologic Factors|immunologic factors|mesh-ancestor
6453777|NCT00421811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6453778|NCT00421811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6453779|NCT00421811|Immunologic Factors|immunologic factors|mesh-ancestor
6453780|NCT00421811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453781|NCT00421824|Capecitabine|capecitabine|mesh-list
6453782|NCT00421824|Oxaliplatin|oxaliplatin|mesh-list
6453783|NCT00421824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6453784|NCT00421824|Antimetabolites|antimetabolites|mesh-ancestor
6453785|NCT00421824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651258|NCT01439100|Naloxone|naloxone|mesh-list
6651259|NCT01439100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6651260|NCT01439100|Narcotics|narcotics|mesh-ancestor
6651261|NCT01439100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6651262|NCT01439100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651263|NCT01439100|Analgesics|analgesics|mesh-ancestor
6651264|NCT01439100|Sensory System Agents|sensory system agents|mesh-ancestor
6651265|NCT01439100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5502848|NCT04464135|Protective Agents|protective agents|mesh-ancestor
6453786|NCT00421824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6453787|NCT00421863|Amlodipine|amlodipine|mesh-list
6453788|NCT00421863|Telmisartan|telmisartan|mesh-list
6453789|NCT00421863|Clonidine|clonidine|mesh-list
6453790|NCT00421863|Ramipril|ramipril|mesh-list
6453791|NCT00421863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6453792|NCT00421863|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6453793|NCT00421863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6453794|NCT00421863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651266|NCT01439100|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6651267|NCT01439152|Maytansine|maytansine|mesh-list
6651268|NCT01439152|Immunoconjugates|immunoconjugates|mesh-list
6651269|NCT01439152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6651270|NCT01439152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6651271|NCT01439152|Tubulin Modulators|tubulin modulators|mesh-ancestor
6651272|NCT01439152|Antimitotic Agents|antimitotic agents|mesh-ancestor
6651273|NCT01439152|Mitosis Modulators|mitosis modulators|mesh-ancestor
6651274|NCT01439152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651275|NCT01439152|Immunologic Factors|immunologic factors|mesh-ancestor
6651276|NCT01439152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651277|NCT01439178|Bevacizumab|bevacizumab|mesh-list
6651278|NCT01439178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6651279|NCT01439178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6651280|NCT01439178|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6651281|NCT01439178|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6651282|NCT01439178|Growth Substances|growth substances|mesh-ancestor
5488983|NCT04523246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5488984|NCT04517058|Antidepressive Agents|antidepressive agents|mesh-list
5488985|NCT04517058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5488986|NCT04500847|Emtricitabine|emtricitabine|mesh-list
5488987|NCT04500847|Antiviral Agents|antiviral agents|mesh-ancestor
5488988|NCT04500847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5488989|NCT04500847|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5488990|NCT04500847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5488991|NCT04500847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5502849|NCT04464135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6651283|NCT01439178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651284|NCT01439178|Growth Inhibitors|growth inhibitors|mesh-ancestor
6651285|NCT01439191|Vinorelbine|vinorelbine|mesh-list
6651286|NCT01439191|Antibodies|antibodies|mesh-list
6651287|NCT01439191|Immunologic Factors|immunologic factors|mesh-ancestor
6651288|NCT01439191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651289|NCT01439191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6651290|NCT01439191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6651291|NCT01439191|Tubulin Modulators|tubulin modulators|mesh-ancestor
6651292|NCT01439191|Antimitotic Agents|antimitotic agents|mesh-ancestor
6651293|NCT01439191|Mitosis Modulators|mitosis modulators|mesh-ancestor
6651294|NCT01439191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651295|NCT01439230|Donepezil|donepezil|mesh-list
6651296|NCT01439230|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6651297|NCT01439230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6651298|NCT01439230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651299|NCT01439230|Cholinergic Agents|cholinergic agents|mesh-ancestor
6651300|NCT01439230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6651301|NCT01439230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651302|NCT01439230|Nootropic Agents|nootropic agents|mesh-ancestor
6651303|NCT01439243|Donepezil|donepezil|mesh-list
6651304|NCT01439243|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6651305|NCT01439243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6651306|NCT01439243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651307|NCT01439243|Cholinergic Agents|cholinergic agents|mesh-ancestor
6651308|NCT01439243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6651309|NCT01439243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651310|NCT01439243|Nootropic Agents|nootropic agents|mesh-ancestor
6651311|NCT01439399|Lidocaine|lidocaine|mesh-list
6651312|NCT01439399|Ketamine|ketamine|mesh-list
6651313|NCT01439399|Anesthetics, Local|anesthetics, local|mesh-ancestor
6651314|NCT01439399|Anesthetics|anesthetics|mesh-ancestor
6651315|NCT01439399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6651316|NCT01439399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651317|NCT01439399|Sensory System Agents|sensory system agents|mesh-ancestor
6651318|NCT01439399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6651319|NCT01439399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6651320|NCT01439399|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6651321|NCT01439399|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6651322|NCT01439399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6651323|NCT01439399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651324|NCT01439399|Analgesics|analgesics|mesh-ancestor
6651325|NCT01439399|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6651326|NCT01439399|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6651327|NCT01439399|Anesthetics, General|anesthetics, general|mesh-ancestor
6651328|NCT01439399|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6651329|NCT01439399|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6651330|NCT01439399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6651331|NCT01439438|Topiramate|topiramate|mesh-list
6651332|NCT01439438|Anticonvulsants|anticonvulsants|mesh-ancestor
6651333|NCT01439438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6651334|NCT01439438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651335|NCT01439542|Hormones|hormones|mesh-list
6651336|NCT01439542|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
6651337|NCT01439542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6651338|NCT01439542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664351|NCT01511770|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6664352|NCT01511770|Hormone Antagonists|hormone antagonists|mesh-ancestor
6664353|NCT01511770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6664354|NCT01511770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664355|NCT01511770|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6664356|NCT01511770|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6664357|NCT01511822|Inositol|inositol|mesh-list
6664358|NCT01511822|Drospirenone|drospirenone|mesh-list
6664359|NCT01511822|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6664360|NCT01511822|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6664361|NCT01511822|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6664362|NCT01511822|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
6664363|NCT01511822|Estradiol|estradiol|mesh-list
6664364|NCT01511822|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6664365|NCT01511822|Estrogens|estrogens|mesh-ancestor
6664366|NCT01511822|Hormones|hormones|mesh-ancestor
6664367|NCT01511822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6664368|NCT01511822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664369|NCT01511822|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6664370|NCT01511822|Contraceptive Agents|contraceptive agents|mesh-ancestor
6664371|NCT01511822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6664372|NCT01511822|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5488992|NCT04500847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5488993|NCT04500847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5488994|NCT04500847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5488995|NCT04493216|Dolutegravir|dolutegravir|mesh-list
5488996|NCT04493216|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5488997|NCT04493216|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5488998|NCT04493216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5488999|NCT04493216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489000|NCT04493216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5489001|NCT04493216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6664373|NCT01511822|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6664374|NCT01511822|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6664375|NCT01511822|Vitamin B Complex|vitamin b complex|mesh-ancestor
5489002|NCT04493216|Antiviral Agents|antiviral agents|mesh-ancestor
5489003|NCT04493216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5489004|NCT04484675|Milrinone|milrinone|mesh-list
5489005|NCT04484675|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5502850|NCT04464005|Magnesium Sulfate|magnesium sulfate|mesh-list
6664376|NCT01511822|Vitamins|vitamins|mesh-ancestor
6664377|NCT01511822|Micronutrients|micronutrients|mesh-ancestor
6651339|NCT01439750|Rituximab|rituximab|mesh-list
6651340|NCT01439750|Bortezomib|bortezomib|mesh-list
6651341|NCT01439750|Cladribine|cladribine|mesh-list
6651342|NCT01439750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6651343|NCT01439750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6651344|NCT01439750|Immunologic Factors|immunologic factors|mesh-ancestor
6651345|NCT01439750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651346|NCT01439750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6651347|NCT01439750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6651348|NCT01439802|Copper|copper|mesh-list
6651349|NCT01439802|Trace Elements|trace elements|mesh-ancestor
6651350|NCT01439802|Micronutrients|micronutrients|mesh-ancestor
6651351|NCT01439802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651352|NCT01439984|Clomipramine|clomipramine|mesh-list
6651353|NCT01439984|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6651354|NCT01439984|Antidepressive Agents|antidepressive agents|mesh-ancestor
6651355|NCT01439984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6651356|NCT01439984|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6651357|NCT01439984|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6651358|NCT01439984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6651359|NCT01439984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651360|NCT01439984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6651361|NCT01439984|Serotonin Agents|serotonin agents|mesh-ancestor
6651362|NCT01439984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651363|NCT01439997|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
6651364|NCT01439997|Hemostatics|hemostatics|mesh-ancestor
6651365|NCT01439997|Coagulants|coagulants|mesh-ancestor
5489006|NCT04484675|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5489007|NCT04484675|Vasodilator Agents|vasodilator agents|mesh-ancestor
5489008|NCT04484675|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5489009|NCT04484675|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5489010|NCT04484675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6651366|NCT01439997|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6651367|NCT01439997|Natriuretic Agents|natriuretic agents|mesh-ancestor
6651368|NCT01439997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651369|NCT01440062|Vitamin D|vitamin d|mesh-list
6651370|NCT01440062|Ergocalciferols|ergocalciferols|mesh-list
6651371|NCT01440062|Vitamins|vitamins|mesh-list
6651372|NCT01440062|Micronutrients|micronutrients|mesh-ancestor
6651373|NCT01440062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651374|NCT01440062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6651375|NCT01440062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6651376|NCT01440088|Doxorubicin|doxorubicin|mesh-list
6651377|NCT01440088|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6651378|NCT01440088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6651379|NCT01440088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6651380|NCT01440088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6651381|NCT01440088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6651382|NCT01440088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6651383|NCT01440088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651384|NCT01440114|Fentanyl|fentanyl|mesh-list
6651385|NCT01440114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6651386|NCT01440114|Narcotics|narcotics|mesh-ancestor
6651387|NCT01440114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6651388|NCT01440114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651389|NCT01440114|Analgesics|analgesics|mesh-ancestor
6651390|NCT01440114|Sensory System Agents|sensory system agents|mesh-ancestor
6651391|NCT01440114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6651392|NCT01440114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6651393|NCT01440114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6651394|NCT01440114|Anesthetics, General|anesthetics, general|mesh-ancestor
6651395|NCT01440114|Anesthetics|anesthetics|mesh-ancestor
6651396|NCT01440127|Metformin|metformin|mesh-list
6651397|NCT01440127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6651398|NCT01440127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651399|NCT01440140|Insulin|insulin|mesh-list
6651400|NCT01440140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6651401|NCT01440140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651402|NCT01440270|Cetuximab|cetuximab|mesh-list
6651403|NCT01440270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6651404|NCT01440270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6651405|NCT01440309|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
6651406|NCT01440309|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6651407|NCT01440309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6651408|NCT01440335|Fenoterol|fenoterol|mesh-list
6651409|NCT01440335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6651410|NCT01440335|Autonomic Agents|autonomic agents|mesh-ancestor
6651411|NCT01440335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6651412|NCT01440335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651413|NCT01440335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6651414|NCT01440335|Respiratory System Agents|respiratory system agents|mesh-ancestor
6651415|NCT01440335|Sympathomimetics|sympathomimetics|mesh-ancestor
6651416|NCT01440335|Tocolytic Agents|tocolytic agents|mesh-ancestor
6651417|NCT01440335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6651418|NCT01440335|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6651419|NCT01440335|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6651420|NCT01440335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6651421|NCT01440335|Adrenergic Agents|adrenergic agents|mesh-ancestor
6651422|NCT01440335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6651423|NCT01440335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651424|NCT01440361|Belimumab|belimumab|mesh-list
6651425|NCT01440361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6651426|NCT01440361|Immunologic Factors|immunologic factors|mesh-ancestor
6651427|NCT01440361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651428|NCT01440400|Anesthetics|anesthetics|mesh-list
6651429|NCT01440400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6651430|NCT01440400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651431|NCT01440439|Insulin|insulin|mesh-list
6651432|NCT01440439|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6651433|NCT01440439|Insulin Glargine|insulin glargine|mesh-list
6651434|NCT01440439|Insulin Detemir|insulin detemir|mesh-list
6651435|NCT01440439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6651436|NCT01440439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651437|NCT01440582|Dexamethasone|dexamethasone|mesh-list
6651438|NCT01440582|Lenalidomide|lenalidomide|mesh-list
6651439|NCT01440582|Bortezomib|bortezomib|mesh-list
6651440|NCT01440582|Panobinostat|panobinostat|mesh-list
6651441|NCT01440582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6651442|NCT01440582|Antiemetics|antiemetics|mesh-ancestor
6651443|NCT01440582|Autonomic Agents|autonomic agents|mesh-ancestor
6651444|NCT01440582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6651445|NCT01440582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651446|NCT01440582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6651447|NCT01440582|Glucocorticoids|glucocorticoids|mesh-ancestor
6651448|NCT01440582|Hormones|hormones|mesh-ancestor
6651449|NCT01440582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6651450|NCT01440582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6651451|NCT01440582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6651452|NCT01440582|Immunologic Factors|immunologic factors|mesh-ancestor
6651453|NCT01440582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6651454|NCT01440582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6651455|NCT01440582|Growth Substances|growth substances|mesh-ancestor
6651456|NCT01440582|Growth Inhibitors|growth inhibitors|mesh-ancestor
6651457|NCT01440582|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6651458|NCT01440582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6651459|NCT01440582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651460|NCT01440608|Albendazole|albendazole|mesh-list
6651461|NCT01440608|Anthelmintics|anthelmintics|mesh-ancestor
6651462|NCT01440608|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6651463|NCT01440608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6651464|NCT01440608|Anticestodal Agents|anticestodal agents|mesh-ancestor
6651465|NCT01440608|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6651466|NCT01440608|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6651467|NCT01440608|Tubulin Modulators|tubulin modulators|mesh-ancestor
6651468|NCT01440608|Antimitotic Agents|antimitotic agents|mesh-ancestor
6651469|NCT01440608|Mitosis Modulators|mitosis modulators|mesh-ancestor
6651470|NCT01440608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651471|NCT01440608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6651472|NCT01440621|Pyridoxine|pyridoxine|mesh-list
6651473|NCT01440621|Modafinil|modafinil|mesh-list
6651474|NCT01440621|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6651475|NCT01440621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651476|NCT01440621|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6651477|NCT01440621|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6651478|NCT01440621|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6651479|NCT01440621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651480|NCT01440621|Vitamin B Complex|vitamin b complex|mesh-ancestor
6651481|NCT01440621|Vitamins|vitamins|mesh-ancestor
6651482|NCT01440621|Micronutrients|micronutrients|mesh-ancestor
5489011|NCT04484675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489012|NCT04484675|Protective Agents|protective agents|mesh-ancestor
5489013|NCT04484675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489014|NCT04483115|Tadalafil|tadalafil|mesh-list
5489015|NCT04483115|Vasodilator Agents|vasodilator agents|mesh-ancestor
5489016|NCT04483115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5489017|NCT04483115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5489018|NCT04483115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5489019|NCT04483115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489020|NCT04483115|Urological Agents|urological agents|mesh-ancestor
5489021|NCT04476277|Biotin|biotin|mesh-list
5489022|NCT04476277|Vitamin B Complex|vitamin b complex|mesh-ancestor
5489023|NCT04476277|Vitamins|vitamins|mesh-ancestor
5489024|NCT04476277|Micronutrients|micronutrients|mesh-ancestor
5489025|NCT04476277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489026|NCT04475939|Pembrolizumab|pembrolizumab|mesh-list
5489027|NCT04475939|Niraparib|niraparib|mesh-list
5489028|NCT04475939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5489029|NCT04475939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5489030|NCT04475939|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5489031|NCT04475939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5489032|NCT04475939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489033|NCT04452383|Ketamine|ketamine|mesh-list
5489034|NCT04452383|Propofol|propofol|mesh-list
5489035|NCT04452383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5489036|NCT04452383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5489037|NCT04452383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489038|NCT04452383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5489039|NCT04452383|Anesthetics, General|anesthetics, general|mesh-ancestor
5489040|NCT04452383|Anesthetics|anesthetics|mesh-ancestor
6651483|NCT01440673|Aprepitant|aprepitant|mesh-list
6651484|NCT01440673|Antiemetics|antiemetics|mesh-ancestor
6651485|NCT01440673|Autonomic Agents|autonomic agents|mesh-ancestor
6651486|NCT01440673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6651487|NCT01440673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651488|NCT01440673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6651489|NCT01440673|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6651490|NCT01440673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6651491|NCT01440673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651492|NCT01440725|Mitogens|mitogens|mesh-list
6651493|NCT01440725|Mitosis Modulators|mitosis modulators|mesh-ancestor
6651494|NCT01440725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651495|NCT01440751|Mitomycins|mitomycins|mesh-list
6651496|NCT01440751|Mitomycin|mitomycin|mesh-list
6651497|NCT01440751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6651498|NCT01440751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6651499|NCT01440751|Alkylating Agents|alkylating agents|mesh-ancestor
6651500|NCT01440751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651501|NCT01440751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6651502|NCT01440751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6651503|NCT01440790|Vitamins|vitamins|mesh-list
6651504|NCT01440790|Ascorbic Acid|ascorbic acid|mesh-list
6651505|NCT01440790|Micronutrients|micronutrients|mesh-ancestor
6651506|NCT01440790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651507|NCT01440790|Antioxidants|antioxidants|mesh-ancestor
6651508|NCT01440790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651509|NCT01440790|Protective Agents|protective agents|mesh-ancestor
6651510|NCT01440829|N-Methylaspartate|n-methylaspartate|mesh-list
6651511|NCT01440829|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
6651512|NCT01440829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6651513|NCT01440829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6651514|NCT01440829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651515|NCT01440829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651516|NCT01440842|Insulin|insulin|mesh-list
6651517|NCT01440842|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6651518|NCT01440842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6651519|NCT01440842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651520|NCT01440933|Magnesium Sulfate|magnesium sulfate|mesh-list
6651521|NCT01440933|Analgesics|analgesics|mesh-ancestor
5489041|NCT04452383|Analgesics|analgesics|mesh-ancestor
5489042|NCT04452383|Sensory System Agents|sensory system agents|mesh-ancestor
5489043|NCT04452383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5489044|NCT04452383|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5489045|NCT04452383|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5489046|NCT04452383|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6651522|NCT01440933|Sensory System Agents|sensory system agents|mesh-ancestor
6651523|NCT01440933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6651524|NCT01440933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651525|NCT01440933|Anesthetics|anesthetics|mesh-ancestor
6651526|NCT01440933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6651527|NCT01440933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6651528|NCT01440933|Anticonvulsants|anticonvulsants|mesh-ancestor
6651529|NCT01440933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6651530|NCT01440933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6651531|NCT01440933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651532|NCT01440933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6651533|NCT01440933|Tocolytic Agents|tocolytic agents|mesh-ancestor
6651534|NCT01440933|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6651535|NCT01440985|Nicotine|nicotine|mesh-list
6651536|NCT01440985|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6651537|NCT01440985|Autonomic Agents|autonomic agents|mesh-ancestor
6651538|NCT01440985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6651539|NCT01440985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651540|NCT01440985|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6651541|NCT01440985|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6651542|NCT01440985|Cholinergic Agents|cholinergic agents|mesh-ancestor
6651543|NCT01440985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6651544|NCT01440985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651545|NCT01440998|Paclitaxel|paclitaxel|mesh-list
6651546|NCT01440998|Carboplatin|carboplatin|mesh-list
6651547|NCT01440998|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6651548|NCT01440998|Dasatinib|dasatinib|mesh-list
6651549|NCT01440998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6651550|NCT01440998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5489047|NCT04452383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5489048|NCT04452383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489049|NCT04447755|Lenvatinib|lenvatinib|mesh-list
5489050|NCT04447755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5489051|NCT04447755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5489052|NCT04447755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5489053|NCT04447755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489054|NCT04438824|Palbociclib|palbociclib|mesh-list
5489055|NCT04438824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5489056|NCT04438824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5489057|NCT04438824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5489058|NCT04438824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502851|NCT04464005|Analgesics|analgesics|mesh-ancestor
6453795|NCT00421863|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6453796|NCT00421863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453797|NCT00421863|Vasodilator Agents|vasodilator agents|mesh-ancestor
6453798|NCT00421863|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6453799|NCT00421863|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6453800|NCT00421863|Analgesics|analgesics|mesh-ancestor
6453801|NCT00421863|Sensory System Agents|sensory system agents|mesh-ancestor
6453802|NCT00421863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6453803|NCT00421863|Sympatholytics|sympatholytics|mesh-ancestor
6453804|NCT00421863|Autonomic Agents|autonomic agents|mesh-ancestor
6453805|NCT00421863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6651551|NCT01440998|Tubulin Modulators|tubulin modulators|mesh-ancestor
6651552|NCT01440998|Antimitotic Agents|antimitotic agents|mesh-ancestor
6651553|NCT01440998|Mitosis Modulators|mitosis modulators|mesh-ancestor
6651554|NCT01440998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651555|NCT01440998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6651556|NCT01440998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6651557|NCT01441128|Crizotinib|crizotinib|mesh-list
6651558|NCT01441128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6651559|NCT01441128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6651560|NCT01441128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6651561|NCT01441128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651562|NCT01441193|Vaccines|vaccines|mesh-list
6651563|NCT01441193|Immunologic Factors|immunologic factors|mesh-ancestor
6651564|NCT01441193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489059|NCT04438512|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
5489060|NCT04438512|Hallucinogens|hallucinogens|mesh-ancestor
5489061|NCT04438512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489062|NCT04438512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5489063|NCT04438512|Serotonin Agents|serotonin agents|mesh-ancestor
5489064|NCT04438512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5489065|NCT04438512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489066|NCT04438512|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5489067|NCT04438512|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5489068|NCT04438512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5489069|NCT04438512|Adrenergic Agents|adrenergic agents|mesh-ancestor
5489070|NCT04418401|Antibodies|antibodies|mesh-list
5489071|NCT04418401|Immunologic Factors|immunologic factors|mesh-ancestor
6651565|NCT01441206|Rifampin|rifampin|mesh-list
6651566|NCT01441206|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6651567|NCT01441206|Antitubercular Agents|antitubercular agents|mesh-ancestor
6651568|NCT01441206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6651569|NCT01441206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6651570|NCT01441206|Leprostatic Agents|leprostatic agents|mesh-ancestor
6651571|NCT01441206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6651572|NCT01441206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6651573|NCT01441206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651574|NCT01441206|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6651575|NCT01441206|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6651576|NCT01441206|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6651577|NCT01441206|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6651578|NCT01441206|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6651579|NCT01441206|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6651580|NCT01441232|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6651581|NCT01441232|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
6651582|NCT01441232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6651583|NCT01441232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651584|NCT01441232|Incretins|incretins|mesh-ancestor
6651585|NCT01441232|Hormones|hormones|mesh-ancestor
6651586|NCT01441232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6651587|NCT01441232|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6651588|NCT01441232|Protease Inhibitors|protease inhibitors|mesh-ancestor
6651589|NCT01441232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6651590|NCT01441232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651591|NCT01441232|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6651592|NCT01441284|Pramipexole|pramipexole|mesh-list
6651593|NCT01441284|Antioxidants|antioxidants|mesh-ancestor
5489072|NCT04418401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489073|NCT04412018|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
5489074|NCT04412018|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5489075|NCT04412018|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5489076|NCT04409314|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
5489077|NCT04409314|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5489078|NCT04409314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489079|NCT04401904|Dapagliflozin|dapagliflozin|mesh-list
5489080|NCT04401904|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5489081|NCT04401904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489082|NCT04401904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5489083|NCT04401904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489084|NCT04363840|Aspirin|aspirin|mesh-list
5489085|NCT04363840|Vitamin D|vitamin d|mesh-list
5489086|NCT04363840|Vitamins|vitamins|mesh-ancestor
5489087|NCT04363840|Micronutrients|micronutrients|mesh-ancestor
6651594|NCT01441284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651595|NCT01441284|Protective Agents|protective agents|mesh-ancestor
6651596|NCT01441284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651597|NCT01441284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6651598|NCT01441284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6651599|NCT01441284|Dopamine Agonists|dopamine agonists|mesh-ancestor
6651600|NCT01441284|Dopamine Agents|dopamine agents|mesh-ancestor
6651601|NCT01441284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6651602|NCT01441297|Nintedanib|nintedanib|mesh-list
6651603|NCT01441297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6651604|NCT01441297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6651605|NCT01441297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6651606|NCT01441297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489088|NCT04363840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489089|NCT04363840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6651607|NCT01441349|Simvastatin|simvastatin|mesh-list
6651608|NCT01441349|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6651609|NCT01441349|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6651610|NCT01441349|Antimetabolites|antimetabolites|mesh-ancestor
6651611|NCT01441349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651612|NCT01441349|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6651613|NCT01441349|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6651614|NCT01441349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6651615|NCT01441388|Bevacizumab|bevacizumab|mesh-list
6453806|NCT00421863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6453807|NCT00421863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6453808|NCT00421863|Adrenergic Agents|adrenergic agents|mesh-ancestor
6453809|NCT00421863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6453810|NCT00421863|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6453811|NCT00421863|Protease Inhibitors|protease inhibitors|mesh-ancestor
6453812|NCT00421863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6453813|NCT00421915|Etanercept|etanercept|mesh-list
6453814|NCT00421915|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6453815|NCT00421915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6453816|NCT00421915|Analgesics|analgesics|mesh-ancestor
6453817|NCT00421915|Sensory System Agents|sensory system agents|mesh-ancestor
6453818|NCT00421915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6453819|NCT00421915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453820|NCT00421915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6453821|NCT00421915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6453822|NCT00421915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6453823|NCT00421915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6453824|NCT00421915|Immunologic Factors|immunologic factors|mesh-ancestor
6453825|NCT00421967|Ketorolac|ketorolac|mesh-list
6453826|NCT00421967|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6453827|NCT00421967|Epinephrine|epinephrine|mesh-list
6651616|NCT01441388|Sunitinib|sunitinib|mesh-list
6651617|NCT01441388|Sorafenib|sorafenib|mesh-list
6651618|NCT01441388|Axitinib|axitinib|mesh-list
6651619|NCT01441388|Crizotinib|crizotinib|mesh-list
6651620|NCT01441388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6651621|NCT01441388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6651622|NCT01441388|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6651623|NCT01441388|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6651624|NCT01441388|Growth Substances|growth substances|mesh-ancestor
6651625|NCT01441388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651626|NCT01441388|Growth Inhibitors|growth inhibitors|mesh-ancestor
6651627|NCT01441388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6651628|NCT01441388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6651629|NCT01441388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651630|NCT01441427|Lenograstim|lenograstim|mesh-list
6651631|NCT01441427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6651632|NCT01441427|Immunologic Factors|immunologic factors|mesh-ancestor
6651633|NCT01441427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651634|NCT01441505|Midazolam|midazolam|mesh-list
6651635|NCT01441505|Ketamine|ketamine|mesh-list
6651636|NCT01441505|Analgesics|analgesics|mesh-ancestor
6651637|NCT01441505|Sensory System Agents|sensory system agents|mesh-ancestor
6651638|NCT01441505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6651639|NCT01441505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651640|NCT01441505|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6651641|NCT01441505|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6651642|NCT01441505|Anesthetics, General|anesthetics, general|mesh-ancestor
6651643|NCT01441505|Anesthetics|anesthetics|mesh-ancestor
6453828|NCT00421967|Racepinephrine|racepinephrine|mesh-list
6651644|NCT01441505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6651645|NCT01441505|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6651646|NCT01441505|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6651647|NCT01441505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6651648|NCT01441505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651649|NCT01441505|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6651650|NCT01441505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6651651|NCT01441505|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6651652|NCT01441505|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6651653|NCT01441505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6651654|NCT01441505|GABA Modulators|gaba modulators|mesh-ancestor
6651655|NCT01441505|GABA Agents|gaba agents|mesh-ancestor
6651656|NCT01441531|Gabapentin|gabapentin|mesh-list
6651657|NCT01441531|Analgesics|analgesics|mesh-ancestor
6651658|NCT01441531|Sensory System Agents|sensory system agents|mesh-ancestor
6651659|NCT01441531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6651660|NCT01441531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651661|NCT01441531|Anticonvulsants|anticonvulsants|mesh-ancestor
6651662|NCT01441531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6651663|NCT01441531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5489090|NCT04363840|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5489091|NCT04363840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5489092|NCT04363840|Analgesics|analgesics|mesh-ancestor
5489093|NCT04363840|Sensory System Agents|sensory system agents|mesh-ancestor
5489094|NCT04363840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5489095|NCT04363840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5489096|NCT04363840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5489097|NCT04363840|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5489098|NCT04363840|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5489099|NCT04363840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489100|NCT04363840|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5489101|NCT04363840|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5489102|NCT04363840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5489103|NCT04363840|Antipyretics|antipyretics|mesh-ancestor
5502852|NCT04464005|Sensory System Agents|sensory system agents|mesh-ancestor
5502853|NCT04464005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5502854|NCT04464005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502855|NCT04464005|Anesthetics|anesthetics|mesh-ancestor
5502856|NCT04464005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5502857|NCT04464005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5502858|NCT04464005|Anticonvulsants|anticonvulsants|mesh-ancestor
5502859|NCT04464005|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5502860|NCT04464005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5502861|NCT04464005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502862|NCT04464005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5502863|NCT04464005|Tocolytic Agents|tocolytic agents|mesh-ancestor
5502864|NCT04464005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5502865|NCT04464174|Gemcitabine|gemcitabine|mesh-list
5502866|NCT04464174|Carboplatin|carboplatin|mesh-list
5502867|NCT04464174|Capecitabine|capecitabine|mesh-list
5502868|NCT04464174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5502869|NCT04464174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5502870|NCT04464174|Antimetabolites|antimetabolites|mesh-ancestor
5502871|NCT04464174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502872|NCT04464174|Antiviral Agents|antiviral agents|mesh-ancestor
5502873|NCT04464174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5502874|NCT04464174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5502875|NCT04464174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5502876|NCT04464174|Immunologic Factors|immunologic factors|mesh-ancestor
5502877|NCT04464174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502878|NCT04464122|Somatostatin|somatostatin|mesh-list
5502879|NCT04464122|Hormones|hormones|mesh-ancestor
5502880|NCT04464122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5502881|NCT04464122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502882|NCT04463875|Coenzyme Q10|coenzyme q10|mesh-list
5502883|NCT04463875|Riboflavin|riboflavin|mesh-list
5502884|NCT04463875|Ubiquinone|ubiquinone|mesh-list
5502885|NCT04463875|Andrographolide|andrographolide|mesh-list
5502886|NCT04463875|Vitamins|vitamins|mesh-ancestor
5502887|NCT04463875|Micronutrients|micronutrients|mesh-ancestor
5502888|NCT04463875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502889|NCT04463875|Vitamin B Complex|vitamin b complex|mesh-ancestor
5502890|NCT04463875|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5502891|NCT04463875|Dermatologic Agents|dermatologic agents|mesh-ancestor
5502892|NCT04463875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6021783|NCT00402103|Natriuretic Agents|natriuretic agents|mesh-ancestor
6651664|NCT01441531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6651665|NCT01441531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6651666|NCT01441531|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6651667|NCT01441531|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6651668|NCT01441531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6651669|NCT01441531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651670|NCT01441531|Antimanic Agents|antimanic agents|mesh-ancestor
6664378|NCT01511822|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6664379|NCT01511822|Hormone Antagonists|hormone antagonists|mesh-ancestor
6664380|NCT01511822|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6664381|NCT01511822|Diuretics|diuretics|mesh-ancestor
6664382|NCT01511822|Natriuretic Agents|natriuretic agents|mesh-ancestor
6664383|NCT01511835|Folic Acid|folic acid|mesh-list
6664384|NCT01511835|Vitamin B Complex|vitamin b complex|mesh-list
6664385|NCT01511835|Inositol|inositol|mesh-list
6664386|NCT01511835|Hematinics|hematinics|mesh-ancestor
6664387|NCT01511835|Vitamins|vitamins|mesh-ancestor
6664388|NCT01511835|Micronutrients|micronutrients|mesh-ancestor
6664389|NCT01511835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664390|NCT01511848|Deferasirox|deferasirox|mesh-list
6664391|NCT01511848|Deferiprone|deferiprone|mesh-list
6664392|NCT01511848|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6664393|NCT01511848|Chelating Agents|chelating agents|mesh-ancestor
6664394|NCT01511848|Sequestering Agents|sequestering agents|mesh-ancestor
6664395|NCT01511848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6664396|NCT01511874|Leuprolide|leuprolide|mesh-list
6664397|NCT01511874|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6664398|NCT01511874|Fertility Agents|fertility agents|mesh-ancestor
6664399|NCT01511874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6664400|NCT01511874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664401|NCT01511874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6664402|NCT01511874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6664403|NCT01511887|Ibuprofen|ibuprofen|mesh-list
6664404|NCT01511887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6664405|NCT01511887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6664406|NCT01511887|Analgesics|analgesics|mesh-ancestor
6664407|NCT01511887|Sensory System Agents|sensory system agents|mesh-ancestor
6664408|NCT01511887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6664409|NCT01511887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664410|NCT01511887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6664411|NCT01511887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6664412|NCT01511887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6664413|NCT01511887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6664414|NCT01511887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6664415|NCT01511991|Sevoflurane|sevoflurane|mesh-list
6664416|NCT01511991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6664417|NCT01511991|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6664418|NCT01511991|Anesthetics, General|anesthetics, general|mesh-ancestor
6664419|NCT01511991|Anesthetics|anesthetics|mesh-ancestor
6664420|NCT01511991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6664421|NCT01511991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664422|NCT01512004|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6664423|NCT01512004|Propiverine|propiverine|mesh-list
6664424|NCT01512004|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6664425|NCT01512004|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6664426|NCT01512004|Cholinergic Agents|cholinergic agents|mesh-ancestor
6664427|NCT01512004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6664428|NCT01512004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6664429|NCT01512004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664430|NCT01512004|Urological Agents|urological agents|mesh-ancestor
6664431|NCT01512004|Parasympatholytics|parasympatholytics|mesh-ancestor
6651671|NCT01441557|Amifampridine|amifampridine|mesh-list
6651672|NCT01441557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6651673|NCT01441557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6651674|NCT01441557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651675|NCT01441557|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6651676|NCT01441557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6651677|NCT01441557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651678|NCT01441700|Anesthetics|anesthetics|mesh-list
6651679|NCT01441700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6651680|NCT01441700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651681|NCT01441804|Ribavirin|ribavirin|mesh-list
6651682|NCT01441804|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6651683|NCT01441804|Interferon-alpha|interferon-alpha|mesh-list
6651684|NCT01441804|Antimetabolites|antimetabolites|mesh-ancestor
6651685|NCT01441804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651686|NCT01441804|Antiviral Agents|antiviral agents|mesh-ancestor
6651687|NCT01441804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6651688|NCT01441804|Immunologic Factors|immunologic factors|mesh-ancestor
6651689|NCT01441804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651690|NCT01441869|Metformin|metformin|mesh-list
6651691|NCT01441869|Saxagliptin|saxagliptin|mesh-list
6651692|NCT01441869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6651693|NCT01441869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651694|NCT01441869|Incretins|incretins|mesh-ancestor
6651695|NCT01441869|Hormones|hormones|mesh-ancestor
6651696|NCT01441869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6651697|NCT01441869|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6651698|NCT01441869|Protease Inhibitors|protease inhibitors|mesh-ancestor
6651699|NCT01441869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6651700|NCT01441869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651701|NCT01441908|Pravastatin|pravastatin|mesh-list
6651702|NCT01441908|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6651703|NCT01441908|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6651704|NCT01441908|Antimetabolites|antimetabolites|mesh-ancestor
6651705|NCT01441908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651706|NCT01441908|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6651707|NCT01441908|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6651708|NCT01441908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6651709|NCT01441934|Sildenafil Citrate|sildenafil citrate|mesh-list
6651710|NCT01441934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651711|NCT01441934|Vasodilator Agents|vasodilator agents|mesh-ancestor
6651712|NCT01441934|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6651713|NCT01441934|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6651714|NCT01441934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6651715|NCT01441934|Urological Agents|urological agents|mesh-ancestor
6651716|NCT01441947|Fulvestrant|fulvestrant|mesh-list
6651717|NCT01441947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6651718|NCT01441947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6651719|NCT01441947|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6651720|NCT01441947|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6651721|NCT01441947|Hormone Antagonists|hormone antagonists|mesh-ancestor
6651722|NCT01441947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6651723|NCT01441947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489104|NCT04337060|Lidocaine|lidocaine|mesh-list
5489105|NCT04337060|Morphine|morphine|mesh-list
5489106|NCT04337060|Bupivacaine|bupivacaine|mesh-list
5489107|NCT04337060|Anesthetics, Local|anesthetics, local|mesh-ancestor
5489108|NCT04337060|Anesthetics|anesthetics|mesh-ancestor
5489109|NCT04337060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5489110|NCT04337060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489111|NCT04337060|Sensory System Agents|sensory system agents|mesh-ancestor
5489112|NCT04337060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6651724|NCT01441986|Amantadine|amantadine|mesh-list
6651725|NCT01441986|Dextromethorphan|dextromethorphan|mesh-list
6651726|NCT01441986|Antitussive Agents|antitussive agents|mesh-ancestor
6651727|NCT01441986|Respiratory System Agents|respiratory system agents|mesh-ancestor
6651728|NCT01441986|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6651729|NCT01441986|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6651730|NCT01441986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6651731|NCT01441986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651732|NCT01441986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651733|NCT01441986|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5489113|NCT04337060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5489114|NCT04337060|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5489115|NCT04337060|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5489116|NCT04337060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5489117|NCT04337060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489118|NCT04337060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5489119|NCT04337060|Narcotics|narcotics|mesh-ancestor
5489120|NCT04337060|Analgesics|analgesics|mesh-ancestor
5489121|NCT04330183|Ketamine|ketamine|mesh-list
5489122|NCT04330183|Analgesics|analgesics|mesh-ancestor
5489123|NCT04330183|Sensory System Agents|sensory system agents|mesh-ancestor
6651734|NCT01441986|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6651735|NCT01441986|Antiviral Agents|antiviral agents|mesh-ancestor
6651736|NCT01441986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6651737|NCT01441986|Dopamine Agents|dopamine agents|mesh-ancestor
6651738|NCT01441986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5489124|NCT04330183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5489125|NCT04330183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489126|NCT04330183|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5489127|NCT04330183|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5489128|NCT04330183|Anesthetics, General|anesthetics, general|mesh-ancestor
5489129|NCT04330183|Anesthetics|anesthetics|mesh-ancestor
5489130|NCT04330183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5489131|NCT04330183|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5489132|NCT04330183|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5489133|NCT04330183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5489134|NCT04330183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489135|NCT04311723|Anesthetics|anesthetics|mesh-list
5489136|NCT04311723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5489137|NCT04311723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453829|NCT00421967|Ropivacaine|ropivacaine|mesh-list
6453830|NCT00421967|Epinephryl borate|epinephryl borate|mesh-list
6453831|NCT00421967|Anesthetics, Local|anesthetics, local|mesh-ancestor
6453832|NCT00421967|Anesthetics|anesthetics|mesh-ancestor
6453833|NCT00421967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6453834|NCT00421967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453835|NCT00421967|Sensory System Agents|sensory system agents|mesh-ancestor
6453836|NCT00421967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6453837|NCT00421967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6453838|NCT00421967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6651739|NCT01441986|Analgesics|analgesics|mesh-ancestor
6651740|NCT01441986|Sensory System Agents|sensory system agents|mesh-ancestor
6651741|NCT01441986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6651742|NCT01442025|Infliximab|infliximab|mesh-list
6651743|NCT01442025|Dermatologic Agents|dermatologic agents|mesh-ancestor
6651744|NCT01442025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6651745|NCT01442025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6651746|NCT01442168|Atovaquone|atovaquone|mesh-list
6651747|NCT01442168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6651748|NCT01442168|Antimalarials|antimalarials|mesh-ancestor
6651749|NCT01442168|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6453839|NCT00421967|Analgesics|analgesics|mesh-ancestor
6453840|NCT00421967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6453841|NCT00421967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6453842|NCT00421967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6453843|NCT00421967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6453844|NCT00421967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651750|NCT01442168|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6651751|NCT01442168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6651752|NCT01442168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651753|NCT01442246|Leuprolide|leuprolide|mesh-list
6651754|NCT01442246|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6651755|NCT01442246|Fertility Agents|fertility agents|mesh-ancestor
6651756|NCT01442246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6651757|NCT01442246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651758|NCT01442246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6651759|NCT01442246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6651760|NCT01442272|Calcifediol|calcifediol|mesh-list
6651761|NCT01442272|Vitamins|vitamins|mesh-ancestor
6651762|NCT01442272|Micronutrients|micronutrients|mesh-ancestor
6651763|NCT01442272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651764|NCT01442272|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6651765|NCT01442311|Interferons|interferons|mesh-list
6651766|NCT01442311|Ribavirin|ribavirin|mesh-list
6651767|NCT01442311|Interferon-alpha|interferon-alpha|mesh-list
6651768|NCT01442311|Interferon alpha-2|interferon alpha-2|mesh-list
6651769|NCT01442311|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6651770|NCT01442311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6651771|NCT01442311|Antiviral Agents|antiviral agents|mesh-ancestor
6651772|NCT01442311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6651773|NCT01442311|Antimetabolites|antimetabolites|mesh-ancestor
6651774|NCT01442311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651775|NCT01442311|Immunologic Factors|immunologic factors|mesh-ancestor
6651776|NCT01442311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651777|NCT01442428|Dexamethasone|dexamethasone|mesh-list
6651778|NCT01442428|Naproxen|naproxen|mesh-list
6651779|NCT01442428|Atorvastatin|atorvastatin|mesh-list
6651780|NCT01442428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6651781|NCT01442428|Antiemetics|antiemetics|mesh-ancestor
6651782|NCT01442428|Autonomic Agents|autonomic agents|mesh-ancestor
6651783|NCT01442428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6651784|NCT01442428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651785|NCT01442428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6651786|NCT01442428|Glucocorticoids|glucocorticoids|mesh-ancestor
6651787|NCT01442428|Hormones|hormones|mesh-ancestor
6651788|NCT01442428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6651789|NCT01442428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6651790|NCT01442428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6651791|NCT01442428|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6651792|NCT01442428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6651793|NCT01442428|Antimetabolites|antimetabolites|mesh-ancestor
6651794|NCT01442428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651795|NCT01442428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6651796|NCT01442428|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6651797|NCT01442428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6651798|NCT01442428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6651799|NCT01442428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6651800|NCT01442428|Analgesics|analgesics|mesh-ancestor
6651801|NCT01442428|Sensory System Agents|sensory system agents|mesh-ancestor
6651802|NCT01442428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6651803|NCT01442428|Gout Suppressants|gout suppressants|mesh-ancestor
6651804|NCT01442428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6651805|NCT01442519|Mitomycins|mitomycins|mesh-list
6651806|NCT01442519|Mitomycin|mitomycin|mesh-list
6651807|NCT01442519|BCG Vaccine|bcg vaccine|mesh-list
6651808|NCT01442519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6651809|NCT01442519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6651810|NCT01442519|Alkylating Agents|alkylating agents|mesh-ancestor
6651811|NCT01442519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651812|NCT01442519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6651813|NCT01442519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6651814|NCT01442519|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6651815|NCT01442519|Immunologic Factors|immunologic factors|mesh-ancestor
6651816|NCT01442519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651817|NCT01442532|Midazolam|midazolam|mesh-list
6651818|NCT01442532|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6651819|NCT01442532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6651820|NCT01442532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6651821|NCT01442532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651822|NCT01442532|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6651823|NCT01442532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6651824|NCT01442532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6651825|NCT01442532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6651826|NCT01442532|Anesthetics, General|anesthetics, general|mesh-ancestor
6651827|NCT01442532|Anesthetics|anesthetics|mesh-ancestor
6651828|NCT01442532|GABA Modulators|gaba modulators|mesh-ancestor
6651829|NCT01442532|GABA Agents|gaba agents|mesh-ancestor
6651830|NCT01442532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6651831|NCT01442532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651832|NCT01442558|Bupivacaine|bupivacaine|mesh-list
5489138|NCT04308304|Donepezil|donepezil|mesh-list
5489139|NCT04308304|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5489140|NCT04308304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5489141|NCT04308304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489142|NCT04308304|Cholinergic Agents|cholinergic agents|mesh-ancestor
5489143|NCT04308304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5489144|NCT04308304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489145|NCT04308304|Nootropic Agents|nootropic agents|mesh-ancestor
5489146|NCT04300595|Anesthetics|anesthetics|mesh-list
5489147|NCT04300595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5489148|NCT04300595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489149|NCT04297293|Ramosetron|ramosetron|mesh-list
6651833|NCT01442558|Anesthetics, Local|anesthetics, local|mesh-ancestor
5489150|NCT04297293|Antiemetics|antiemetics|mesh-ancestor
5489151|NCT04297293|Autonomic Agents|autonomic agents|mesh-ancestor
5489152|NCT04297293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5489153|NCT04297293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651834|NCT01442558|Anesthetics|anesthetics|mesh-ancestor
6651835|NCT01442558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6651836|NCT01442558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651837|NCT01442558|Sensory System Agents|sensory system agents|mesh-ancestor
6651838|NCT01442558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6651839|NCT01442571|Hyaluronic Acid|hyaluronic acid|mesh-list
6651840|NCT01442571|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6651841|NCT01442571|Immunologic Factors|immunologic factors|mesh-ancestor
6651842|NCT01442571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651843|NCT01442571|Viscosupplements|viscosupplements|mesh-ancestor
6651844|NCT01442571|Protective Agents|protective agents|mesh-ancestor
6651845|NCT01442610|Rasagiline|rasagiline|mesh-list
6651846|NCT01442610|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6651847|NCT01442610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6651848|NCT01442610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651849|NCT01442610|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6651850|NCT01442610|Protective Agents|protective agents|mesh-ancestor
6651851|NCT01442610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651852|NCT01442662|Gemcitabine|gemcitabine|mesh-list
6651853|NCT01442662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6651854|NCT01442662|Antimetabolites|antimetabolites|mesh-ancestor
6651855|NCT01442662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651856|NCT01442662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6651857|NCT01442662|Antiviral Agents|antiviral agents|mesh-ancestor
6651858|NCT01442662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6651859|NCT01442662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6651860|NCT01442662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6651861|NCT01442662|Immunologic Factors|immunologic factors|mesh-ancestor
6651862|NCT01442662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651863|NCT01442701|Triclosan|triclosan|mesh-list
6651864|NCT01442701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6651865|NCT01442701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6651866|NCT01442701|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6651867|NCT01442701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6651868|NCT01442701|Antimetabolites|antimetabolites|mesh-ancestor
6651869|NCT01442701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651870|NCT01442701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6651871|NCT01442727|Selenium|selenium|mesh-list
6651872|NCT01442727|Selenious Acid|selenious acid|mesh-list
6651873|NCT01442727|Sodium Selenite|sodium selenite|mesh-list
6651874|NCT01442727|Antioxidants|antioxidants|mesh-ancestor
6651875|NCT01442727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651876|NCT01442727|Protective Agents|protective agents|mesh-ancestor
6651877|NCT01442727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651878|NCT01442727|Trace Elements|trace elements|mesh-ancestor
6651879|NCT01442727|Micronutrients|micronutrients|mesh-ancestor
6651880|NCT01442766|Donepezil|donepezil|mesh-list
6651881|NCT01442766|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6651882|NCT01442766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6651883|NCT01442766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651884|NCT01442766|Cholinergic Agents|cholinergic agents|mesh-ancestor
6651885|NCT01442766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6651886|NCT01442766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651887|NCT01442766|Nootropic Agents|nootropic agents|mesh-ancestor
6651888|NCT01442792|Rivaroxaban|rivaroxaban|mesh-list
6651889|NCT01442792|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6651890|NCT01442792|Antithrombins|antithrombins|mesh-ancestor
6651891|NCT01442792|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6651892|NCT01442792|Protease Inhibitors|protease inhibitors|mesh-ancestor
6651893|NCT01442792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6651894|NCT01442792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651895|NCT01442792|Anticoagulants|anticoagulants|mesh-ancestor
6651896|NCT01442818|Hydromorphone|hydromorphone|mesh-list
6651897|NCT01442818|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6651898|NCT01442818|Narcotics|narcotics|mesh-ancestor
6651899|NCT01442818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6651900|NCT01442818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651901|NCT01442818|Analgesics|analgesics|mesh-ancestor
6651902|NCT01442818|Sensory System Agents|sensory system agents|mesh-ancestor
6651903|NCT01442818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6651904|NCT01442870|Metformin|metformin|mesh-list
6651905|NCT01442870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6651906|NCT01442870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489154|NCT04297293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5489155|NCT04297293|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5489156|NCT04297293|Serotonin Agents|serotonin agents|mesh-ancestor
5489157|NCT04297293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5489158|NCT04297293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489159|NCT04295863|Pembrolizumab|pembrolizumab|mesh-list
5489160|NCT04295863|Nivolumab|nivolumab|mesh-list
5489161|NCT04295863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5489162|NCT04295863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5489163|NCT04295863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5489164|NCT04295863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489165|NCT04292223|Pimavanserin|pimavanserin|mesh-list
5489166|NCT04292223|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5489167|NCT04292223|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5489168|NCT04292223|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5489169|NCT04292223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5489170|NCT04292223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5489171|NCT04292223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489172|NCT04292223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5489173|NCT04292223|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5489174|NCT04292223|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5489175|NCT04292223|Serotonin Agents|serotonin agents|mesh-ancestor
5489176|NCT04292223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5489177|NCT04292223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489178|NCT04266730|Pembrolizumab|pembrolizumab|mesh-list
6651907|NCT01442909|Docetaxel|docetaxel|mesh-list
6651908|NCT01442909|Pemetrexed|pemetrexed|mesh-list
6651909|NCT01442909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6651910|NCT01442909|Tubulin Modulators|tubulin modulators|mesh-ancestor
6651911|NCT01442909|Antimitotic Agents|antimitotic agents|mesh-ancestor
6651912|NCT01442909|Mitosis Modulators|mitosis modulators|mesh-ancestor
6651913|NCT01442909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651914|NCT01442909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6651915|NCT01442909|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6651916|NCT01442909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6651917|NCT01442935|Leucovorin|leucovorin|mesh-list
6651918|NCT01442935|Folic Acid|folic acid|mesh-list
6651919|NCT01442935|Bevacizumab|bevacizumab|mesh-list
6651920|NCT01442935|Cetuximab|cetuximab|mesh-list
6651921|NCT01442935|Oxaliplatin|oxaliplatin|mesh-list
6651922|NCT01442935|Irinotecan|irinotecan|mesh-list
5489179|NCT04266730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5489180|NCT04266730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5489181|NCT04260854|Bupivacaine|bupivacaine|mesh-list
5489182|NCT04260854|Anesthetics, Local|anesthetics, local|mesh-ancestor
5489183|NCT04260854|Anesthetics|anesthetics|mesh-ancestor
5489184|NCT04260854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5489185|NCT04260854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489186|NCT04260854|Sensory System Agents|sensory system agents|mesh-ancestor
5489187|NCT04260854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6651923|NCT01442935|Fluorouracil|fluorouracil|mesh-list
5489188|NCT04249297|Dydrogesterone|dydrogesterone|mesh-list
6651924|NCT01442935|Levoleucovorin|levoleucovorin|mesh-list
6651925|NCT01442935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5489189|NCT04249297|Progestins|progestins|mesh-ancestor
5489190|NCT04249297|Hormones|hormones|mesh-ancestor
5489191|NCT04249297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5489192|NCT04249297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489193|NCT04245514|Durvalumab|durvalumab|mesh-list
5489194|NCT04245514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5489195|NCT04245514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5489196|NCT04238390|Meropenem|meropenem|mesh-list
5489197|NCT04238390|Tazobactam|tazobactam|mesh-list
6651926|NCT01442935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6651927|NCT01442935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6651928|NCT01442935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5489198|NCT04238390|Ceftolozane|ceftolozane|mesh-list
5489199|NCT04238390|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
5489200|NCT04238390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5489201|NCT04238390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5489202|NCT04238390|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5489203|NCT04238390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5489204|NCT04238390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489205|NCT04238390|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5489206|NCT04238390|Renal Agents|renal agents|mesh-ancestor
6651929|NCT01442935|Growth Substances|growth substances|mesh-ancestor
6651930|NCT01442935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651931|NCT01442935|Growth Inhibitors|growth inhibitors|mesh-ancestor
6651932|NCT01442935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6651933|NCT01442935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6651934|NCT01442935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6651935|NCT01442935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651936|NCT01442935|Antidotes|antidotes|mesh-ancestor
6651937|NCT01442935|Protective Agents|protective agents|mesh-ancestor
6651938|NCT01442935|Vitamin B Complex|vitamin b complex|mesh-ancestor
6651939|NCT01442935|Vitamins|vitamins|mesh-ancestor
6651940|NCT01442935|Micronutrients|micronutrients|mesh-ancestor
6651941|NCT01442935|Hematinics|hematinics|mesh-ancestor
6651942|NCT01442935|Antimetabolites|antimetabolites|mesh-ancestor
6651943|NCT01442935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6651944|NCT01442935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6651945|NCT01442935|Immunologic Factors|immunologic factors|mesh-ancestor
6651946|NCT01442974|Gemcitabine|gemcitabine|mesh-list
6651947|NCT01442974|Paclitaxel|paclitaxel|mesh-list
6651948|NCT01442974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6651949|NCT01442974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6651950|NCT01442974|Tubulin Modulators|tubulin modulators|mesh-ancestor
6651951|NCT01442974|Antimitotic Agents|antimitotic agents|mesh-ancestor
6651952|NCT01442974|Mitosis Modulators|mitosis modulators|mesh-ancestor
6651953|NCT01442974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651954|NCT01442974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6651955|NCT01442974|Antimetabolites|antimetabolites|mesh-ancestor
6651956|NCT01442974|Antiviral Agents|antiviral agents|mesh-ancestor
6651957|NCT01442974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6651958|NCT01442974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6651959|NCT01442974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6651960|NCT01442974|Immunologic Factors|immunologic factors|mesh-ancestor
6651961|NCT01442974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651962|NCT01442987|Irbesartan|irbesartan|mesh-list
6651963|NCT01442987|Atorvastatin|atorvastatin|mesh-list
6651964|NCT01442987|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6651965|NCT01442987|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6651966|NCT01442987|Antimetabolites|antimetabolites|mesh-ancestor
6651967|NCT01442987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651968|NCT01442987|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6651969|NCT01442987|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6651970|NCT01442987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6651971|NCT01442987|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6651972|NCT01442987|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6651973|NCT01442987|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6651974|NCT01443065|Leucovorin|leucovorin|mesh-list
6651975|NCT01443065|Folic Acid|folic acid|mesh-list
6651976|NCT01443065|Oxaliplatin|oxaliplatin|mesh-list
6651977|NCT01443065|Panitumumab|panitumumab|mesh-list
6651978|NCT01443065|Fluorouracil|fluorouracil|mesh-list
6651979|NCT01443065|Rilotumumab|rilotumumab|mesh-list
6651980|NCT01443065|Levoleucovorin|levoleucovorin|mesh-list
6651981|NCT01443065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6651982|NCT01443065|Antidotes|antidotes|mesh-ancestor
6651983|NCT01443065|Protective Agents|protective agents|mesh-ancestor
6651984|NCT01443065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6651985|NCT01443065|Vitamin B Complex|vitamin b complex|mesh-ancestor
6651986|NCT01443065|Vitamins|vitamins|mesh-ancestor
6651987|NCT01443065|Micronutrients|micronutrients|mesh-ancestor
6651988|NCT01443065|Hematinics|hematinics|mesh-ancestor
6651989|NCT01443065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6651990|NCT01443065|Antimetabolites|antimetabolites|mesh-ancestor
6651991|NCT01443065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6651992|NCT01443065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6651993|NCT01443065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6651994|NCT01443065|Immunologic Factors|immunologic factors|mesh-ancestor
6651995|NCT01443104|Sirolimus|sirolimus|mesh-list
6651996|NCT01443104|Everolimus|everolimus|mesh-list
6651997|NCT01443104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6651998|NCT01443104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5489207|NCT04236830|Fluorides|fluorides|mesh-list
5489208|NCT04236830|Cariostatic Agents|cariostatic agents|mesh-ancestor
5489209|NCT04236830|Protective Agents|protective agents|mesh-ancestor
5489210|NCT04236830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489211|NCT04233216|Islatravir|islatravir|mesh-list
5489212|NCT04233216|Antiviral Agents|antiviral agents|mesh-ancestor
5489213|NCT04233216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5489214|NCT04233216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5489215|NCT04233216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489216|NCT04233216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5489217|NCT04233216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6651999|NCT01443104|Immunologic Factors|immunologic factors|mesh-ancestor
6652000|NCT01443104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652001|NCT01443104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6652002|NCT01443104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6652003|NCT01443104|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6652004|NCT01443104|Antifungal Agents|antifungal agents|mesh-ancestor
6652005|NCT01443117|Vaccines|vaccines|mesh-list
6652006|NCT01443117|Immunologic Factors|immunologic factors|mesh-ancestor
6652007|NCT01443117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652008|NCT01443169|Pregabalin|pregabalin|mesh-list
6652009|NCT01443169|Analgesics|analgesics|mesh-ancestor
6652010|NCT01443169|Sensory System Agents|sensory system agents|mesh-ancestor
6652011|NCT01443169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6652012|NCT01443169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652013|NCT01443169|Anticonvulsants|anticonvulsants|mesh-ancestor
6652014|NCT01443169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6652015|NCT01443169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6652016|NCT01443169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652017|NCT01443169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6652018|NCT01443169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6652019|NCT01443169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6652020|NCT01443169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6652021|NCT01443169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6652022|NCT01443195|Iron|iron|mesh-list
6652023|NCT01443195|Trace Elements|trace elements|mesh-ancestor
6652024|NCT01443195|Micronutrients|micronutrients|mesh-ancestor
6652025|NCT01443195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652026|NCT01443208|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6652027|NCT01443208|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6652028|NCT01443208|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5489218|NCT04233216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5489219|NCT04231708|Hydrocortisone|hydrocortisone|mesh-list
5489220|NCT04231708|Yohimbine|yohimbine|mesh-list
6652029|NCT01443208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6652030|NCT01443208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652031|NCT01443208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6652032|NCT01443208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652033|NCT01443208|Antidepressive Agents|antidepressive agents|mesh-ancestor
6652034|NCT01443208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5489221|NCT04231708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5489222|NCT04231708|Mydriatics|mydriatics|mesh-ancestor
5489223|NCT04231708|Autonomic Agents|autonomic agents|mesh-ancestor
5489224|NCT04231708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5489225|NCT04231708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489226|NCT04231708|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5489227|NCT04231708|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5489228|NCT04231708|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5489229|NCT04231708|Adrenergic Agents|adrenergic agents|mesh-ancestor
5489230|NCT04231708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6664432|NCT01512004|Autonomic Agents|autonomic agents|mesh-ancestor
6652035|NCT01443221|Metformin|metformin|mesh-list
6652036|NCT01443221|Mitiglinide|mitiglinide|mesh-list
6652037|NCT01443221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6652038|NCT01443221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652039|NCT01443247|gamma-Globulins|gamma-globulins|mesh-list
6652040|NCT01443247|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6652041|NCT01443247|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6652042|NCT01443247|Immunologic Factors|immunologic factors|mesh-ancestor
6652043|NCT01443247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652044|NCT01443325|Lidocaine|lidocaine|mesh-list
6652045|NCT01443325|Anesthetics, Local|anesthetics, local|mesh-ancestor
6652046|NCT01443325|Anesthetics|anesthetics|mesh-ancestor
6652047|NCT01443325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6652048|NCT01443325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652049|NCT01443325|Sensory System Agents|sensory system agents|mesh-ancestor
6652050|NCT01443325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6652051|NCT01443325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6652052|NCT01443325|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6652053|NCT01443325|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6652054|NCT01443325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6652055|NCT01443325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652056|NCT01443338|Acitretin|acitretin|mesh-list
6652057|NCT01443338|Keratolytic Agents|keratolytic agents|mesh-ancestor
6652058|NCT01443338|Dermatologic Agents|dermatologic agents|mesh-ancestor
6652059|NCT01443377|Panitumumab|panitumumab|mesh-list
6652060|NCT01443377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6652061|NCT01443377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6652062|NCT01443416|Vaccines|vaccines|mesh-list
6652063|NCT01443416|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6652064|NCT01443416|Immunologic Factors|immunologic factors|mesh-ancestor
6652065|NCT01443416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652066|NCT01443429|Beraprost|beraprost|mesh-list
6652067|NCT01443429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6652068|NCT01443429|Vasodilator Agents|vasodilator agents|mesh-ancestor
5489231|NCT04231708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652069|NCT01443520|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6652070|NCT01443520|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6652071|NCT01443520|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6652072|NCT01443520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6652073|NCT01443520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6652074|NCT01443520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652075|NCT01443520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6652076|NCT01443520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489232|NCT04231708|Urological Agents|urological agents|mesh-ancestor
5489233|NCT04226248|Rivastigmine|rivastigmine|mesh-list
5489234|NCT04226248|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5489235|NCT04226248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6652077|NCT01443520|Analgesics|analgesics|mesh-ancestor
6652078|NCT01443520|Sensory System Agents|sensory system agents|mesh-ancestor
6652079|NCT01443520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6652080|NCT01443520|Antidepressive Agents|antidepressive agents|mesh-ancestor
6652081|NCT01443520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6652082|NCT01443520|Dopamine Agents|dopamine agents|mesh-ancestor
6652083|NCT01443520|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6652084|NCT01443572|Sevoflurane|sevoflurane|mesh-list
6652085|NCT01443572|Desflurane|desflurane|mesh-list
6652086|NCT01443572|Anesthetics|anesthetics|mesh-list
6652087|NCT01443572|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6652088|NCT01443572|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6652089|NCT01443572|Anesthetics, General|anesthetics, general|mesh-ancestor
6652090|NCT01443572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6652091|NCT01443572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652092|NCT01443624|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6652093|NCT01443624|Hematinics|hematinics|mesh-ancestor
6652094|NCT01443676|Bevacizumab|bevacizumab|mesh-list
6652095|NCT01443676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6652096|NCT01443676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6652097|NCT01443676|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6652098|NCT01443676|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6652099|NCT01443676|Growth Substances|growth substances|mesh-ancestor
6652100|NCT01443676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652101|NCT01443676|Growth Inhibitors|growth inhibitors|mesh-ancestor
6652102|NCT01443741|Insulin|insulin|mesh-list
6652103|NCT01443741|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6652104|NCT01443741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6652105|NCT01443741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652106|NCT01443780|Selenium|selenium|mesh-list
6652107|NCT01443780|Antioxidants|antioxidants|mesh-ancestor
6652108|NCT01443780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652109|NCT01443780|Protective Agents|protective agents|mesh-ancestor
6652110|NCT01443780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652111|NCT01443780|Trace Elements|trace elements|mesh-ancestor
6652112|NCT01443780|Micronutrients|micronutrients|mesh-ancestor
6652113|NCT01443806|Oseltamivir|oseltamivir|mesh-list
6652114|NCT01443806|Antiviral Agents|antiviral agents|mesh-ancestor
6652115|NCT01443806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6652116|NCT01443806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6652117|NCT01443806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652118|NCT01443897|Vitamin D|vitamin d|mesh-list
6652119|NCT01443897|Ergocalciferols|ergocalciferols|mesh-list
6652120|NCT01443897|Vitamins|vitamins|mesh-list
6652121|NCT01443897|Micronutrients|micronutrients|mesh-ancestor
6652122|NCT01443897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652123|NCT01443897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6652124|NCT01443897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6652125|NCT01443936|Vaccines|vaccines|mesh-list
6652126|NCT01443936|Immunologic Factors|immunologic factors|mesh-ancestor
6652127|NCT01443936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652128|NCT01443988|Travoprost|travoprost|mesh-list
6652129|NCT01443988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6652130|NCT01444001|Vaccines|vaccines|mesh-list
6652131|NCT01444001|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6652132|NCT01444001|Immunologic Factors|immunologic factors|mesh-ancestor
6652133|NCT01444001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652134|NCT01444040|Travoprost|travoprost|mesh-list
6652135|NCT01444040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6652136|NCT01444118|Cyclophosphamide|cyclophosphamide|mesh-list
6652137|NCT01444118|Vaccines|vaccines|mesh-list
6652138|NCT01444118|Immunologic Factors|immunologic factors|mesh-ancestor
6652139|NCT01444118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652140|NCT01444118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6652141|NCT01444118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6652142|NCT01444118|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6652143|NCT01444118|Alkylating Agents|alkylating agents|mesh-ancestor
6652144|NCT01444118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652145|NCT01444118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6652146|NCT01444118|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6652147|NCT01444131|Nicotine|nicotine|mesh-list
6652148|NCT01444131|Varenicline|varenicline|mesh-list
6652149|NCT01444131|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6652150|NCT01444131|Autonomic Agents|autonomic agents|mesh-ancestor
6652151|NCT01444131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6652152|NCT01444131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652153|NCT01444131|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6652154|NCT01444131|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6652155|NCT01444131|Cholinergic Agents|cholinergic agents|mesh-ancestor
6652156|NCT01444131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6652157|NCT01444131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652158|NCT01444196|Desloratadine|desloratadine|mesh-list
6652159|NCT01444196|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6652160|NCT01444196|Cholinergic Agents|cholinergic agents|mesh-ancestor
5489236|NCT04226248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489237|NCT04226248|Cholinergic Agents|cholinergic agents|mesh-ancestor
5489238|NCT04226248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6652161|NCT01444196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6652162|NCT01444196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652163|NCT01444196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652164|NCT01444196|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6652165|NCT01444196|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6652166|NCT01444196|Histamine Antagonists|histamine antagonists|mesh-ancestor
6652167|NCT01444196|Histamine Agents|histamine agents|mesh-ancestor
6652168|NCT01444248|Metformin|metformin|mesh-list
5489239|NCT04226248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489240|NCT04226248|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5489241|NCT04226248|Protective Agents|protective agents|mesh-ancestor
5489242|NCT04214249|Cytarabine|cytarabine|mesh-list
5489243|NCT04214249|Pembrolizumab|pembrolizumab|mesh-list
5489244|NCT04214249|Daunorubicin|daunorubicin|mesh-list
5489245|NCT04214249|Idarubicin|idarubicin|mesh-list
6652169|NCT01444248|Glimepiride|glimepiride|mesh-list
6652170|NCT01444248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6652171|NCT01444248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652172|NCT01444248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6652173|NCT01444248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6652174|NCT01444248|Immunologic Factors|immunologic factors|mesh-ancestor
6652175|NCT01444339|Vaccines|vaccines|mesh-list
6453845|NCT00421967|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6453846|NCT00421967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6652176|NCT01444339|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6652177|NCT01444339|Immunologic Factors|immunologic factors|mesh-ancestor
6652178|NCT01444339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652179|NCT01444352|Vaccines|vaccines|mesh-list
6652180|NCT01444352|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6652181|NCT01444352|Immunologic Factors|immunologic factors|mesh-ancestor
6652182|NCT01444352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652183|NCT01444469|Azithromycin|azithromycin|mesh-list
6652184|NCT01444469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6652185|NCT01444469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6652186|NCT01444521|Irinotecan|irinotecan|mesh-list
6453847|NCT00421967|Adrenergic Agents|adrenergic agents|mesh-ancestor
6453848|NCT00421967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6453849|NCT00421967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6453850|NCT00421967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6453851|NCT00421967|Autonomic Agents|autonomic agents|mesh-ancestor
6453852|NCT00421967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6453853|NCT00421967|Respiratory System Agents|respiratory system agents|mesh-ancestor
6453854|NCT00421967|Mydriatics|mydriatics|mesh-ancestor
6453855|NCT00421967|Sympathomimetics|sympathomimetics|mesh-ancestor
6453856|NCT00421967|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6453857|NCT00421980|Etanercept|etanercept|mesh-list
6652187|NCT01444521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6652188|NCT01444521|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6652189|NCT01444521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6652190|NCT01444521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6652191|NCT01444521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652192|NCT01444547|Paclitaxel|paclitaxel|mesh-list
6652193|NCT01444547|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6652194|NCT01444547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6652195|NCT01444547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6453858|NCT00421980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6453859|NCT00421980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6652196|NCT01444547|Tubulin Modulators|tubulin modulators|mesh-ancestor
6652197|NCT01444547|Antimitotic Agents|antimitotic agents|mesh-ancestor
6652198|NCT01444547|Mitosis Modulators|mitosis modulators|mesh-ancestor
6652199|NCT01444547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652200|NCT01444586|Rivaroxaban|rivaroxaban|mesh-list
6652201|NCT01444586|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6652202|NCT01444586|Antithrombins|antithrombins|mesh-ancestor
6652203|NCT01444586|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6652204|NCT01444586|Protease Inhibitors|protease inhibitors|mesh-ancestor
6652205|NCT01444586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6652206|NCT01444586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652207|NCT01444586|Anticoagulants|anticoagulants|mesh-ancestor
6652208|NCT01444612|Heparin|heparin|mesh-list
6652209|NCT01444612|Calcium heparin|calcium heparin|mesh-list
5489246|NCT04214249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5489247|NCT04214249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6652210|NCT01444612|Enoxaparin|enoxaparin|mesh-list
6652211|NCT01444612|Dalteparin|dalteparin|mesh-list
6652212|NCT01444612|Tinzaparin|tinzaparin|mesh-list
6652213|NCT01444612|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6652214|NCT01444612|PENTA|penta|mesh-list
6652215|NCT01444612|Fondaparinux|fondaparinux|mesh-list
6652216|NCT01444612|Anticoagulants|anticoagulants|mesh-ancestor
6652217|NCT01444612|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6652218|NCT01444612|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6652219|NCT01444612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652220|NCT01444612|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6652221|NCT01444612|Antithrombins|antithrombins|mesh-ancestor
6652222|NCT01444612|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6652223|NCT01444612|Protease Inhibitors|protease inhibitors|mesh-ancestor
6652224|NCT01444612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6652225|NCT01444677|Beta-lapachone|beta-lapachone|mesh-list
6652226|NCT01444677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6652227|NCT01444677|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6652228|NCT01444677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6652229|NCT01444677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6652230|NCT01444677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652231|NCT01444677|Antiviral Agents|antiviral agents|mesh-ancestor
6652232|NCT01444703|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6652233|NCT01444807|Sorafenib|sorafenib|mesh-list
6652234|NCT01444807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6652235|NCT01444807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6652236|NCT01444807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6652237|NCT01444807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652238|NCT01444833|Candesartan|candesartan|mesh-list
6652239|NCT01444833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6652240|NCT01444833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6652241|NCT01444833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6652242|NCT01444833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652243|NCT01444846|Ebselen|ebselen|mesh-list
6652244|NCT01444846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6652245|NCT01444846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6652246|NCT01444846|Analgesics|analgesics|mesh-ancestor
6652247|NCT01444846|Sensory System Agents|sensory system agents|mesh-ancestor
6652248|NCT01444846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6652249|NCT01444846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652250|NCT01444846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6652251|NCT01444846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6652252|NCT01444846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6652253|NCT01444846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6652254|NCT01444846|Antioxidants|antioxidants|mesh-ancestor
6652255|NCT01444846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652256|NCT01444846|Protective Agents|protective agents|mesh-ancestor
6652257|NCT01444846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6652258|NCT01444846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6652259|NCT01444846|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6664433|NCT01512004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6664434|NCT01512017|Petrolatum|petrolatum|mesh-list
6664435|NCT01512017|Emollients|emollients|mesh-ancestor
6664436|NCT01512017|Dermatologic Agents|dermatologic agents|mesh-ancestor
6664437|NCT01512147|Dexmedetomidine|dexmedetomidine|mesh-list
6664438|NCT01512147|Propofol|propofol|mesh-list
6664439|NCT01512147|Isoflurane|isoflurane|mesh-list
6664440|NCT01512147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6664441|NCT01512147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6664442|NCT01512147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652260|NCT01444885|Amlodipine|amlodipine|mesh-list
6652261|NCT01444885|Nitroglycerin|nitroglycerin|mesh-list
6652262|NCT01444885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6652263|NCT01444885|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6652264|NCT01444885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6652265|NCT01444885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652266|NCT01444885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6652267|NCT01444885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652268|NCT01444885|Vasodilator Agents|vasodilator agents|mesh-ancestor
6652269|NCT01444976|Midazolam|midazolam|mesh-list
6652270|NCT01444976|Anesthetics|anesthetics|mesh-ancestor
6652271|NCT01444976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6652272|NCT01444976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652273|NCT01444976|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6652274|NCT01444976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6652275|NCT01444976|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6652276|NCT01444976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6652277|NCT01444976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6652278|NCT01444976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6652279|NCT01444976|Anesthetics, General|anesthetics, general|mesh-ancestor
6652280|NCT01444976|GABA Modulators|gaba modulators|mesh-ancestor
6652281|NCT01444976|GABA Agents|gaba agents|mesh-ancestor
6652282|NCT01444976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6652283|NCT01444976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652284|NCT01445067|Calcitonin|calcitonin|mesh-list
6652285|NCT01445067|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
6652286|NCT01445067|Katacalcin|katacalcin|mesh-list
6652287|NCT01445067|Vasodilator Agents|vasodilator agents|mesh-ancestor
6652288|NCT01445067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6652289|NCT01445067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652290|NCT01445067|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6652291|NCT01445106|Nelfinavir|nelfinavir|mesh-list
6652292|NCT01445106|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6652293|NCT01445106|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6652294|NCT01445106|Protease Inhibitors|protease inhibitors|mesh-ancestor
6652295|NCT01445106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6652296|NCT01445106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652297|NCT01445106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6652298|NCT01445106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6652299|NCT01445106|Antiviral Agents|antiviral agents|mesh-ancestor
6652300|NCT01445106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6652301|NCT01445119|Carboplatin|carboplatin|mesh-list
6652302|NCT01445119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6652303|NCT01445210|Ropivacaine|ropivacaine|mesh-list
6652304|NCT01445210|Anesthetics, Local|anesthetics, local|mesh-ancestor
6652305|NCT01445210|Anesthetics|anesthetics|mesh-ancestor
6652306|NCT01445210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6652307|NCT01445210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652308|NCT01445210|Sensory System Agents|sensory system agents|mesh-ancestor
6652309|NCT01445210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6652310|NCT01445223|Ritonavir|ritonavir|mesh-list
6652311|NCT01445223|Lopinavir|lopinavir|mesh-list
6652312|NCT01445223|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6652313|NCT01445223|Efavirenz|efavirenz|mesh-list
6652314|NCT01445223|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6652315|NCT01445223|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6652316|NCT01445223|Protease Inhibitors|protease inhibitors|mesh-ancestor
6652317|NCT01445223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6652318|NCT01445223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652319|NCT01445223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6652320|NCT01445223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6652321|NCT01445223|Antiviral Agents|antiviral agents|mesh-ancestor
6652322|NCT01445223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6652323|NCT01445223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6652324|NCT01445223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6652325|NCT01445223|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6652326|NCT01445223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6652327|NCT01445223|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6652328|NCT01445223|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6652329|NCT01445223|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6652330|NCT01445223|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6652331|NCT01445223|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6021784|NCT00402103|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6021785|NCT00402116|Temozolomide|temozolomide|mesh-list
6652332|NCT01445236|Cyclosporine|cyclosporine|mesh-list
6652333|NCT01445236|Tacrolimus|tacrolimus|mesh-list
6652334|NCT01445236|Cyclosporins|cyclosporins|mesh-list
6652335|NCT01445236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6652336|NCT01445236|Immunologic Factors|immunologic factors|mesh-ancestor
6652337|NCT01445236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652338|NCT01445236|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6652339|NCT01445236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5489248|NCT04214249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5489249|NCT04214249|Antimetabolites|antimetabolites|mesh-ancestor
5489250|NCT04214249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489251|NCT04214249|Antiviral Agents|antiviral agents|mesh-ancestor
5489252|NCT04214249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5489253|NCT04214249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5489254|NCT04214249|Immunologic Factors|immunologic factors|mesh-ancestor
5489255|NCT04214249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489256|NCT04214249|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5489257|NCT04214249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5489258|NCT04214249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5489259|NCT04214249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5489260|NCT04198922|Acalabrutinib|acalabrutinib|mesh-list
5489261|NCT04198922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5489262|NCT04198428|Analgesics, Opioid|analgesics, opioid|mesh-list
5489263|NCT04198428|Narcotics|narcotics|mesh-ancestor
5489264|NCT04198428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5489265|NCT04198428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489266|NCT04198428|Analgesics|analgesics|mesh-ancestor
5489267|NCT04198428|Sensory System Agents|sensory system agents|mesh-ancestor
5489268|NCT04198428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5489269|NCT04197687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5489270|NCT04197687|Trastuzumab|trastuzumab|mesh-list
6652340|NCT01445236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652341|NCT01445236|Antifungal Agents|antifungal agents|mesh-ancestor
6652342|NCT01445236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6652343|NCT01445236|Dermatologic Agents|dermatologic agents|mesh-ancestor
6652344|NCT01445236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6652345|NCT01445262|Levocetirizine|levocetirizine|mesh-list
6652346|NCT01445262|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6652347|NCT01445262|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6652348|NCT01445262|Histamine Antagonists|histamine antagonists|mesh-ancestor
6652349|NCT01445262|Histamine Agents|histamine agents|mesh-ancestor
6652350|NCT01445262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6652351|NCT01445262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652352|NCT01445262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652353|NCT01445340|Romidepsin|romidepsin|mesh-list
6652354|NCT01445340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6652355|NCT01445340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6652356|NCT01445379|Ipilimumab|ipilimumab|mesh-list
6652357|NCT01445379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6652358|NCT01445379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6652359|NCT01445379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6652360|NCT01445379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652361|NCT01445392|Pemetrexed|pemetrexed|mesh-list
6652362|NCT01445392|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6652363|NCT01445392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6652364|NCT01445392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6652365|NCT01445392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652366|NCT01445392|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6652367|NCT01445392|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6652368|NCT01445392|Immunologic Factors|immunologic factors|mesh-ancestor
6652369|NCT01445392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652370|NCT01445405|Cetuximab|cetuximab|mesh-list
6652371|NCT01445405|Bortezomib|bortezomib|mesh-list
6652372|NCT01445405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6652373|NCT01445405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6652374|NCT01445418|Carboplatin|carboplatin|mesh-list
6652375|NCT01445418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6652376|NCT01445431|Mineral Oil|mineral oil|mesh-list
6652377|NCT01445431|Emollients|emollients|mesh-ancestor
6652378|NCT01445431|Dermatologic Agents|dermatologic agents|mesh-ancestor
6652379|NCT01445522|Cyclophosphamide|cyclophosphamide|mesh-list
6652380|NCT01445522|Veliparib|veliparib|mesh-list
5489271|NCT04197687|Pertuzumab|pertuzumab|mesh-list
5489272|NCT04197687|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
5489273|NCT04197687|Maytansine|maytansine|mesh-list
5489274|NCT04197687|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
5489275|NCT04197687|Vaccines|vaccines|mesh-list
6652381|NCT01445522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6453860|NCT00421980|Analgesics|analgesics|mesh-ancestor
6453861|NCT00421980|Sensory System Agents|sensory system agents|mesh-ancestor
6453862|NCT00421980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6453863|NCT00421980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453864|NCT00421980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6453865|NCT00421980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6652382|NCT01445522|Immunologic Factors|immunologic factors|mesh-ancestor
6652383|NCT01445522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652384|NCT01445522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6652385|NCT01445522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6652386|NCT01445522|Alkylating Agents|alkylating agents|mesh-ancestor
6652387|NCT01445522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652388|NCT01445522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6652389|NCT01445522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6652390|NCT01445522|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6652391|NCT01445522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6652392|NCT01445561|Interleukin-2|interleukin-2|mesh-list
6652393|NCT01445561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6652394|NCT01445561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6652395|NCT01445561|Analgesics|analgesics|mesh-ancestor
6652396|NCT01445561|Sensory System Agents|sensory system agents|mesh-ancestor
6652397|NCT01445561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6652398|NCT01445561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652399|NCT01445587|Bortezomib|bortezomib|mesh-list
6652400|NCT01445587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6652401|NCT01445600|Retapamulin|retapamulin|mesh-list
6652402|NCT01445600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6652403|NCT01445600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6652404|NCT01445639|Dexmedetomidine|dexmedetomidine|mesh-list
6652405|NCT01445639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6652406|NCT01445639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6652407|NCT01445639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652408|NCT01445639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6652409|NCT01445639|Analgesics|analgesics|mesh-ancestor
6652410|NCT01445639|Sensory System Agents|sensory system agents|mesh-ancestor
6652411|NCT01445639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6652412|NCT01445639|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6652413|NCT01445639|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6652414|NCT01445639|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6453866|NCT00421980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6453867|NCT00421980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6453868|NCT00421980|Immunologic Factors|immunologic factors|mesh-ancestor
6453869|NCT00422123|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6453870|NCT00422123|Antidepressive Agents|antidepressive agents|mesh-ancestor
6453871|NCT00422123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6453872|NCT00422123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6652415|NCT01445639|Adrenergic Agents|adrenergic agents|mesh-ancestor
6652416|NCT01445639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6652417|NCT01445639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652418|NCT01445691|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6652419|NCT01445691|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6652420|NCT01445691|Dermatologic Agents|dermatologic agents|mesh-ancestor
6652421|NCT01445743|Vaccines|vaccines|mesh-list
6652422|NCT01445743|Immunologic Factors|immunologic factors|mesh-ancestor
6652423|NCT01445743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652424|NCT01445756|Lidocaine|lidocaine|mesh-list
6652425|NCT01445756|Anesthetics, Local|anesthetics, local|mesh-ancestor
6652426|NCT01445756|Anesthetics|anesthetics|mesh-ancestor
6652427|NCT01445756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6652428|NCT01445756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652429|NCT01445756|Sensory System Agents|sensory system agents|mesh-ancestor
5489276|NCT04197687|Antibodies|antibodies|mesh-list
5489277|NCT04197687|Immunoglobulins|immunoglobulins|mesh-list
5489278|NCT04197687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5489279|NCT04197687|Sargramostim|sargramostim|mesh-list
5489280|NCT04197687|Immunoconjugates|immunoconjugates|mesh-list
5489281|NCT04197687|Immunologic Factors|immunologic factors|mesh-ancestor
6652430|NCT01445756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6652431|NCT01445756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6652432|NCT01445756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6652433|NCT01445756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6652434|NCT01445756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6652435|NCT01445756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652436|NCT01445860|Simvastatin|simvastatin|mesh-list
6652437|NCT01445860|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6652438|NCT01445860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6652439|NCT01445860|Antimetabolites|antimetabolites|mesh-ancestor
6652440|NCT01445860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652441|NCT01445860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6652442|NCT01445860|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6652443|NCT01445860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6652444|NCT01445938|Lumefantrine|lumefantrine|mesh-list
6652445|NCT01445938|Antimalarials|antimalarials|mesh-ancestor
6652446|NCT01445938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6652447|NCT01445938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6652448|NCT01445938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6652449|NCT01445964|Atenolol|atenolol|mesh-list
6652450|NCT01445964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6652451|NCT01445964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6652452|NCT01445964|Sympatholytics|sympatholytics|mesh-ancestor
6652453|NCT01445964|Autonomic Agents|autonomic agents|mesh-ancestor
6652454|NCT01445964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6652455|NCT01445964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652456|NCT01445964|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6652457|NCT01445964|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6652458|NCT01445964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6652459|NCT01445964|Adrenergic Agents|adrenergic agents|mesh-ancestor
6652460|NCT01445964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6652461|NCT01445964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652462|NCT01446094|Regadenoson|regadenoson|mesh-list
6652463|NCT01446094|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
6652464|NCT01446094|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6652465|NCT01446094|Purinergic Agonists|purinergic agonists|mesh-ancestor
6652466|NCT01446094|Purinergic Agents|purinergic agents|mesh-ancestor
6652467|NCT01446094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6652468|NCT01446094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652469|NCT01446094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652470|NCT01446107|Fluorides|fluorides|mesh-list
6652471|NCT01446107|Fluorides, Topical|fluorides, topical|mesh-list
6652472|NCT01446107|Cariostatic Agents|cariostatic agents|mesh-ancestor
6652473|NCT01446107|Protective Agents|protective agents|mesh-ancestor
6652474|NCT01446107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652475|NCT01446120|Insulin|insulin|mesh-list
6652476|NCT01446120|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6652477|NCT01446120|Insulin, Isophane|insulin, isophane|mesh-list
6652478|NCT01446120|Isophane Insulin, Human|isophane insulin, human|mesh-list
6652479|NCT01446120|Isophane insulin, beef|isophane insulin, beef|mesh-list
6652480|NCT01446120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6652481|NCT01446120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652482|NCT01446211|Gusperimus|gusperimus|mesh-list
6652483|NCT01446211|Cyclophosphamide|cyclophosphamide|mesh-list
6652484|NCT01446211|Methotrexate|methotrexate|mesh-list
6652485|NCT01446211|Azathioprine|azathioprine|mesh-list
6652486|NCT01446211|Glucocorticoids|glucocorticoids|mesh-list
6652487|NCT01446211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6652488|NCT01446211|Immunologic Factors|immunologic factors|mesh-ancestor
5489282|NCT04197687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489283|NCT04197687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6652489|NCT01446211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652490|NCT01446211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6652491|NCT01446211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6652492|NCT01446211|Alkylating Agents|alkylating agents|mesh-ancestor
6652493|NCT01446211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652494|NCT01446211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6652495|NCT01446211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6652496|NCT01446211|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6652497|NCT01446211|Abortifacient Agents|abortifacient agents|mesh-ancestor
6652498|NCT01446211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6652499|NCT01446211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6652500|NCT01446211|Antimetabolites|antimetabolites|mesh-ancestor
6652501|NCT01446211|Dermatologic Agents|dermatologic agents|mesh-ancestor
6652502|NCT01446211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6652503|NCT01446211|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6652504|NCT01446211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6652505|NCT01446211|Hormones|hormones|mesh-ancestor
6652506|NCT01446211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6652507|NCT01446211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6652508|NCT01446211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6652509|NCT01446211|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6652510|NCT01446211|Protective Agents|protective agents|mesh-ancestor
6652511|NCT01446224|Bevacizumab|bevacizumab|mesh-list
6652512|NCT01446224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6652513|NCT01446224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6652514|NCT01446224|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6652515|NCT01446224|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6652516|NCT01446224|Growth Substances|growth substances|mesh-ancestor
6652517|NCT01446224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652518|NCT01446224|Growth Inhibitors|growth inhibitors|mesh-ancestor
6652519|NCT01446276|Resveratrol|resveratrol|mesh-list
6652520|NCT01446276|Antioxidants|antioxidants|mesh-ancestor
6652521|NCT01446276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652522|NCT01446276|Protective Agents|protective agents|mesh-ancestor
6652523|NCT01446276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652524|NCT01446276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6652525|NCT01446276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6652526|NCT01446328|Olanzapine|olanzapine|mesh-list
6652527|NCT01446328|Aripiprazole|aripiprazole|mesh-list
6652528|NCT01446328|Amisulpride|amisulpride|mesh-list
6652529|NCT01446328|Antiemetics|antiemetics|mesh-ancestor
6652530|NCT01446328|Autonomic Agents|autonomic agents|mesh-ancestor
6652531|NCT01446328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6652532|NCT01446328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652533|NCT01446328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6652534|NCT01446328|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6652535|NCT01446328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5489284|NCT04197687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5489285|NCT04197687|Tubulin Modulators|tubulin modulators|mesh-ancestor
5489286|NCT04197687|Antimitotic Agents|antimitotic agents|mesh-ancestor
6652536|NCT01446328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6652537|NCT01446328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6652538|NCT01446328|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6652539|NCT01446328|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6652540|NCT01446328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6652541|NCT01446328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652542|NCT01446328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6652543|NCT01446328|Serotonin Agents|serotonin agents|mesh-ancestor
6652544|NCT01446328|Antidepressive Agents|antidepressive agents|mesh-ancestor
6652545|NCT01446328|Dopamine Agonists|dopamine agonists|mesh-ancestor
6652546|NCT01446328|Dopamine Agents|dopamine agents|mesh-ancestor
6652547|NCT01446328|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6652548|NCT01446328|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6652549|NCT01446328|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6652550|NCT01446328|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6652551|NCT01446328|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6652552|NCT01446328|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6652553|NCT01446328|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6652554|NCT01446445|Valganciclovir|valganciclovir|mesh-list
6652555|NCT01446445|Ganciclovir|ganciclovir|mesh-list
6652556|NCT01446445|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6652557|NCT01446445|Antiviral Agents|antiviral agents|mesh-ancestor
6652558|NCT01446445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6652559|NCT01446445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6652560|NCT01446445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6652561|NCT01446445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652562|NCT01446458|Folfirinox|folfirinox|mesh-list
6652563|NCT01446458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6652564|NCT01446484|Cyclosporine|cyclosporine|mesh-list
6652565|NCT01446484|Sirolimus|sirolimus|mesh-list
6652566|NCT01446484|Mycophenolic Acid|mycophenolic acid|mesh-list
6652567|NCT01446484|Everolimus|everolimus|mesh-list
6652568|NCT01446484|Alemtuzumab|alemtuzumab|mesh-list
6652569|NCT01446484|Tacrolimus|tacrolimus|mesh-list
6652570|NCT01446484|Cyclosporins|cyclosporins|mesh-list
6652571|NCT01446484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6652572|NCT01446484|Immunologic Factors|immunologic factors|mesh-ancestor
6652573|NCT01446484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652574|NCT01446484|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6652575|NCT01446484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6652576|NCT01446484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652577|NCT01446484|Antifungal Agents|antifungal agents|mesh-ancestor
6652578|NCT01446484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6652579|NCT01446484|Dermatologic Agents|dermatologic agents|mesh-ancestor
6652580|NCT01446484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6652581|NCT01446484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6652582|NCT01446484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6652583|NCT01446484|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6652584|NCT01446484|Antitubercular Agents|antitubercular agents|mesh-ancestor
6652585|NCT01446484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6652586|NCT01446484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6652587|NCT01446497|Timolol|timolol|mesh-list
6652588|NCT01446497|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6652589|NCT01446497|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6652590|NCT01446497|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6652591|NCT01446497|Adrenergic Agents|adrenergic agents|mesh-ancestor
6652592|NCT01446497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6652593|NCT01446497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652594|NCT01446497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652595|NCT01446497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6652596|NCT01446497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6652597|NCT01446497|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6652598|NCT01446497|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6021786|NCT00402116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6021787|NCT00402116|Alkylating Agents|alkylating agents|mesh-ancestor
6053248|NCT00593957|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6453873|NCT00422123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6453874|NCT00422123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6453875|NCT00422123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652599|NCT01446497|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6652600|NCT01446523|Lactulose|lactulose|mesh-list
6652601|NCT01446523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6652602|NCT01446562|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6652603|NCT01446562|Immunologic Factors|immunologic factors|mesh-ancestor
6652604|NCT01446562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652605|NCT01446679|Atorvastatin|atorvastatin|mesh-list
6652606|NCT01446679|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6652607|NCT01446679|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6652608|NCT01446679|Antimetabolites|antimetabolites|mesh-ancestor
6652609|NCT01446679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652610|NCT01446679|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6652611|NCT01446679|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6652612|NCT01446679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6652613|NCT01446731|Docetaxel|docetaxel|mesh-list
6652614|NCT01446731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6652615|NCT01446731|Tubulin Modulators|tubulin modulators|mesh-ancestor
6453876|NCT00422175|Siponimod|siponimod|mesh-list
6453877|NCT00422175|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6453878|NCT00422175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453879|NCT00422175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6453880|NCT00422175|Immunologic Factors|immunologic factors|mesh-ancestor
6652616|NCT01446731|Antimitotic Agents|antimitotic agents|mesh-ancestor
6652617|NCT01446731|Mitosis Modulators|mitosis modulators|mesh-ancestor
6664443|NCT01512147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6652618|NCT01446731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652619|NCT01446783|Mecasermin|mecasermin|mesh-list
6652620|NCT01446783|Growth Substances|growth substances|mesh-ancestor
6652621|NCT01446783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664444|NCT01512147|Anesthetics, General|anesthetics, general|mesh-ancestor
6664445|NCT01512147|Anesthetics|anesthetics|mesh-ancestor
6664446|NCT01512147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6664447|NCT01512147|Analgesics|analgesics|mesh-ancestor
6664448|NCT01512147|Sensory System Agents|sensory system agents|mesh-ancestor
6664449|NCT01512147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6664450|NCT01512147|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6664451|NCT01512147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6664452|NCT01512147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6664453|NCT01512147|Adrenergic Agents|adrenergic agents|mesh-ancestor
6664454|NCT01512147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6664455|NCT01512147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489287|NCT04197687|Mitosis Modulators|mitosis modulators|mesh-ancestor
5489288|NCT04197687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489289|NCT04196257|Paclitaxel|paclitaxel|mesh-list
5489290|NCT04196257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5489291|NCT04196257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5489292|NCT04196257|Tubulin Modulators|tubulin modulators|mesh-ancestor
5489293|NCT04196257|Antimitotic Agents|antimitotic agents|mesh-ancestor
5489294|NCT04196257|Mitosis Modulators|mitosis modulators|mesh-ancestor
5489295|NCT04196257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489296|NCT04191928|Apixaban|apixaban|mesh-list
5489297|NCT04191928|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5489298|NCT04191928|Antithrombins|antithrombins|mesh-ancestor
6664456|NCT01512147|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6665094|NCT01515813|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6665095|NCT01515813|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6665096|NCT01515813|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6665097|NCT01515813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6665098|NCT01515813|Antimetabolites|antimetabolites|mesh-ancestor
6665099|NCT01515813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6665100|NCT01515813|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6665101|NCT01515826|Moxifloxacin|moxifloxacin|mesh-list
6665102|NCT01515826|Dexamethasone|dexamethasone|mesh-list
6665103|NCT01515826|Dexamethasone acetate|dexamethasone acetate|mesh-list
6665104|NCT01515826|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6665105|NCT01515826|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6665106|NCT01515826|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6665107|NCT01515826|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
6665108|NCT01515826|BB 1101|bb 1101|mesh-list
5489299|NCT04191928|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5489300|NCT04191928|Protease Inhibitors|protease inhibitors|mesh-ancestor
6652622|NCT01446900|Rituximab|rituximab|mesh-list
6652623|NCT01446900|Cladribine|cladribine|mesh-list
6652624|NCT01446900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6652625|NCT01446900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6652626|NCT01446900|Immunologic Factors|immunologic factors|mesh-ancestor
6652627|NCT01446900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652628|NCT01446900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6652629|NCT01446900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6652630|NCT01446926|Vaccines|vaccines|mesh-list
6652631|NCT01446926|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6652632|NCT01446926|Immunologic Factors|immunologic factors|mesh-ancestor
6652633|NCT01446926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652634|NCT01446952|Vitamin E|vitamin e|mesh-list
6652635|NCT01446952|Tocopherols|tocopherols|mesh-list
6652636|NCT01446952|Tocotrienols|tocotrienols|mesh-list
6652637|NCT01446952|Vitamins|vitamins|mesh-ancestor
6652638|NCT01446952|Micronutrients|micronutrients|mesh-ancestor
6652639|NCT01446952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652640|NCT01446952|Antioxidants|antioxidants|mesh-ancestor
6652641|NCT01446952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652642|NCT01446952|Protective Agents|protective agents|mesh-ancestor
6453881|NCT00422175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453882|NCT00422188|Deoxycholic Acid|deoxycholic acid|mesh-list
6453883|NCT00422188|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6652643|NCT01446978|Vaccines|vaccines|mesh-list
6652644|NCT01446978|Immunologic Factors|immunologic factors|mesh-ancestor
6652645|NCT01446978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652646|NCT01447043|Ranibizumab|ranibizumab|mesh-list
6652647|NCT01447043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6652648|NCT01447043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6652649|NCT01447043|Growth Substances|growth substances|mesh-ancestor
6652650|NCT01447043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652651|NCT01447043|Growth Inhibitors|growth inhibitors|mesh-ancestor
6652652|NCT01447043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6652653|NCT01447069|Albuterol|albuterol|mesh-list
6652654|NCT01447069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6652655|NCT01447069|Autonomic Agents|autonomic agents|mesh-ancestor
6652656|NCT01447069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6652657|NCT01447069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652658|NCT01447069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5489301|NCT04191928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5489302|NCT04191928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489303|NCT04191928|Anticoagulants|anticoagulants|mesh-ancestor
5489304|NCT04181515|Hydrocortisone|hydrocortisone|mesh-list
5489305|NCT04181515|Yohimbine|yohimbine|mesh-list
5489306|NCT04181515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5489307|NCT04181515|Mydriatics|mydriatics|mesh-ancestor
5489308|NCT04181515|Autonomic Agents|autonomic agents|mesh-ancestor
5489309|NCT04181515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5489310|NCT04181515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489311|NCT04181515|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5489312|NCT04181515|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5489313|NCT04181515|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6652659|NCT01447069|Respiratory System Agents|respiratory system agents|mesh-ancestor
6652660|NCT01447069|Tocolytic Agents|tocolytic agents|mesh-ancestor
6652661|NCT01447069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6652662|NCT01447069|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6652663|NCT01447069|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6652664|NCT01447069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6652665|NCT01447069|Adrenergic Agents|adrenergic agents|mesh-ancestor
5489314|NCT04181515|Adrenergic Agents|adrenergic agents|mesh-ancestor
5489315|NCT04181515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6453884|NCT00422188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6453885|NCT00422214|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6453886|NCT00422214|Antidepressive Agents|antidepressive agents|mesh-ancestor
6453887|NCT00422214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6453888|NCT00422214|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6453889|NCT00422214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6453890|NCT00422214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6453891|NCT00422214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489316|NCT04181515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489317|NCT04181515|Urological Agents|urological agents|mesh-ancestor
6652666|NCT01447069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6652667|NCT01447069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489318|NCT04180969|Hydrocortisone|hydrocortisone|mesh-list
5489319|NCT04180969|Yohimbine|yohimbine|mesh-list
5489320|NCT04180969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5489321|NCT04180969|Mydriatics|mydriatics|mesh-ancestor
5489322|NCT04180969|Autonomic Agents|autonomic agents|mesh-ancestor
5489323|NCT04180969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5489324|NCT04180969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489325|NCT04180969|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5489326|NCT04180969|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5489327|NCT04180969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5489328|NCT04180969|Adrenergic Agents|adrenergic agents|mesh-ancestor
5489329|NCT04180969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5489330|NCT04180969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489331|NCT04180969|Urological Agents|urological agents|mesh-ancestor
5489332|NCT04170348|Vitamin D|vitamin d|mesh-list
5489333|NCT04170348|Ergocalciferols|ergocalciferols|mesh-list
5489334|NCT04170348|Cholecalciferol|cholecalciferol|mesh-list
5489335|NCT04170348|Vitamins|vitamins|mesh-list
5489336|NCT04170348|Trientine|trientine|mesh-list
5489337|NCT04170348|Micronutrients|micronutrients|mesh-ancestor
5489338|NCT04170348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489339|NCT04170348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5489340|NCT04170348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5489341|NCT04170348|Chelating Agents|chelating agents|mesh-ancestor
5489342|NCT04170348|Sequestering Agents|sequestering agents|mesh-ancestor
5489343|NCT04170348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489344|NCT04167761|Ertugliflozin|ertugliflozin|mesh-list
5489345|NCT04167761|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
5489346|NCT04167761|Glipizide|glipizide|mesh-list
5489347|NCT04167761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489348|NCT04167761|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5489349|NCT04167761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489350|NCT04165239|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
5489351|NCT04165239|Antioxidants|antioxidants|mesh-ancestor
5489352|NCT04165239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489353|NCT04165239|Protective Agents|protective agents|mesh-ancestor
5489354|NCT04165239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489355|NCT04163900|Gemcitabine|gemcitabine|mesh-list
5489356|NCT04163900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5489357|NCT04163900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5489358|NCT04163900|Antimetabolites|antimetabolites|mesh-ancestor
5489359|NCT04163900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489360|NCT04163900|Antiviral Agents|antiviral agents|mesh-ancestor
5489361|NCT04163900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5489362|NCT04163900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5489363|NCT04163900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5489364|NCT04163900|Immunologic Factors|immunologic factors|mesh-ancestor
5489365|NCT04163900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489366|NCT04160052|Azacitidine|azacitidine|mesh-list
5489367|NCT04160052|Venetoclax|venetoclax|mesh-list
6652668|NCT01447095|Epoprostenol|epoprostenol|mesh-list
6652669|NCT01447095|Tezosentan|tezosentan|mesh-list
6652670|NCT01447095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6652671|NCT01447095|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6652672|NCT01447095|Vasodilator Agents|vasodilator agents|mesh-ancestor
5489368|NCT04160052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5489369|NCT04160052|Antimetabolites|antimetabolites|mesh-ancestor
5489370|NCT04160052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489371|NCT04160052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5489372|NCT04160052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5489373|NCT04156334|Anesthetics|anesthetics|mesh-list
5489374|NCT04156334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5489375|NCT04156334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489376|NCT04147546|Artenimol|artenimol|mesh-list
5489377|NCT04147546|Antimalarials|antimalarials|mesh-ancestor
5489378|NCT04147546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5489379|NCT04147546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5489380|NCT04147546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5489381|NCT04139304|Prednisone|prednisone|mesh-list
5489382|NCT04139304|Cortisone|cortisone|mesh-list
5489383|NCT04139304|Cyclophosphamide|cyclophosphamide|mesh-list
5489384|NCT04139304|Doxorubicin|doxorubicin|mesh-list
5489385|NCT04139304|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5489386|NCT04139304|Etoposide|etoposide|mesh-list
5489387|NCT04139304|Vincristine|vincristine|mesh-list
5489388|NCT04139304|Etoposide phosphate|etoposide phosphate|mesh-list
5489389|NCT04139304|Daunorubicin|daunorubicin|mesh-list
6652673|NCT01447160|Cortisone|cortisone|mesh-list
5489390|NCT04139304|Daratumumab|daratumumab|mesh-list
5489391|NCT04139304|Podophyllotoxin|podophyllotoxin|mesh-list
5489392|NCT04139304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5489393|NCT04139304|Immunologic Factors|immunologic factors|mesh-ancestor
5489394|NCT04139304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489395|NCT04139304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5489396|NCT04139304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5489397|NCT04139304|Alkylating Agents|alkylating agents|mesh-ancestor
5489398|NCT04139304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489399|NCT04139304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5489400|NCT04139304|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5489401|NCT04139304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5489402|NCT04139304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5489403|NCT04139304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6652674|NCT01447160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6652675|NCT01447173|Vitamin D|vitamin d|mesh-list
6652676|NCT01447173|Vitamins|vitamins|mesh-ancestor
6652677|NCT01447173|Micronutrients|micronutrients|mesh-ancestor
6652678|NCT01447173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652679|NCT01447173|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5489404|NCT04139304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5489405|NCT04139304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5489406|NCT04139304|Glucocorticoids|glucocorticoids|mesh-ancestor
5489407|NCT04139304|Hormones|hormones|mesh-ancestor
5489408|NCT04139304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6652680|NCT01447212|Hydromorphone|hydromorphone|mesh-list
6652681|NCT01447212|Heroin|heroin|mesh-list
6652682|NCT01447212|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6652683|NCT01447212|Narcotics|narcotics|mesh-ancestor
6652684|NCT01447212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6652685|NCT01447212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652686|NCT01447212|Analgesics|analgesics|mesh-ancestor
6652687|NCT01447212|Sensory System Agents|sensory system agents|mesh-ancestor
6652688|NCT01447212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6652689|NCT01447355|Vitamin D|vitamin d|mesh-list
6652690|NCT01447355|Cholecalciferol|cholecalciferol|mesh-list
6652691|NCT01447355|Vitamins|vitamins|mesh-ancestor
6652692|NCT01447355|Micronutrients|micronutrients|mesh-ancestor
6652693|NCT01447355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652694|NCT01447355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6652695|NCT01447355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6652696|NCT01447368|Cinacalcet|cinacalcet|mesh-list
6652697|NCT01447368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6652698|NCT01447368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652699|NCT01447368|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6652700|NCT01447368|Hormone Antagonists|hormone antagonists|mesh-ancestor
6652701|NCT01447368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6652702|NCT01447394|Interferons|interferons|mesh-list
6652703|NCT01447394|Ribavirin|ribavirin|mesh-list
6652704|NCT01447394|Interferon-alpha|interferon-alpha|mesh-list
6652705|NCT01447394|Interferon alpha-2|interferon alpha-2|mesh-list
6652706|NCT01447394|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6652707|NCT01447394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6652708|NCT01447394|Antiviral Agents|antiviral agents|mesh-ancestor
6453892|NCT00422240|Adapalene|adapalene|mesh-list
6453893|NCT00422240|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
6453894|NCT00422240|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6453895|NCT00422240|Dermatologic Agents|dermatologic agents|mesh-ancestor
6453896|NCT00422240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6453897|NCT00422240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6453898|NCT00422240|Analgesics|analgesics|mesh-ancestor
6453899|NCT00422240|Sensory System Agents|sensory system agents|mesh-ancestor
6453900|NCT00422240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6453901|NCT00422240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453902|NCT00422240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6453903|NCT00422240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6453904|NCT00422318|Benzbromarone|benzbromarone|mesh-list
6453905|NCT00422318|Uricosuric Agents|uricosuric agents|mesh-ancestor
5489409|NCT04139304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5489410|NCT04139304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5489411|NCT04139304|Tubulin Modulators|tubulin modulators|mesh-ancestor
5489412|NCT04139304|Antimitotic Agents|antimitotic agents|mesh-ancestor
5489413|NCT04139304|Mitosis Modulators|mitosis modulators|mesh-ancestor
5489414|NCT04139304|Keratolytic Agents|keratolytic agents|mesh-ancestor
5489415|NCT04139304|Dermatologic Agents|dermatologic agents|mesh-ancestor
5489416|NCT04134325|Pembrolizumab|pembrolizumab|mesh-list
5489417|NCT04134325|Nivolumab|nivolumab|mesh-list
5489418|NCT04134325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5489419|NCT04134325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5489420|NCT04134325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5489421|NCT04134325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489422|NCT04122170|Aspirin|aspirin|mesh-list
5489423|NCT04122170|Ticagrelor|ticagrelor|mesh-list
5489424|NCT04122170|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5489425|NCT04122170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5489426|NCT04122170|Analgesics|analgesics|mesh-ancestor
5489427|NCT04122170|Sensory System Agents|sensory system agents|mesh-ancestor
5489428|NCT04122170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5489429|NCT04122170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489430|NCT04122170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5489431|NCT04122170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6652709|NCT01447394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6652710|NCT01447394|Antimetabolites|antimetabolites|mesh-ancestor
6652711|NCT01447394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652712|NCT01447394|Immunologic Factors|immunologic factors|mesh-ancestor
6652713|NCT01447394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652714|NCT01447485|Valsartan|valsartan|mesh-list
6652715|NCT01447485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6652716|NCT01447485|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6652717|NCT01447485|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6652718|NCT01447485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652719|NCT01447550|Bosentan|bosentan|mesh-list
6652720|NCT01447550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6652721|NCT01447550|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6652722|NCT01447550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489432|NCT04122170|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5489433|NCT04122170|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5489434|NCT04122170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489435|NCT04122170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5489436|NCT04122170|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5489437|NCT04122170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5489438|NCT04122170|Antipyretics|antipyretics|mesh-ancestor
5489439|NCT04122170|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5489440|NCT04122170|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5489441|NCT04122170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5489442|NCT04122170|Purinergic Agents|purinergic agents|mesh-ancestor
5489443|NCT04122170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6652723|NCT01447563|Clopidogrel|clopidogrel|mesh-list
6652724|NCT01447563|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6652725|NCT01447563|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6652726|NCT01447563|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6652727|NCT01447563|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6652728|NCT01447563|Purinergic Agents|purinergic agents|mesh-ancestor
6453906|NCT00422318|Gout Suppressants|gout suppressants|mesh-ancestor
6453907|NCT00422318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6453908|NCT00422318|Renal Agents|renal agents|mesh-ancestor
6453909|NCT00422331|Lithium Carbonate|lithium carbonate|mesh-list
6453910|NCT00422331|Antidepressive Agents|antidepressive agents|mesh-ancestor
6453911|NCT00422331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6453912|NCT00422331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6453913|NCT00422331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453914|NCT00422331|Antimanic Agents|antimanic agents|mesh-ancestor
6453915|NCT00422331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6652729|NCT01447563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6652730|NCT01447563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652731|NCT01447563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652732|NCT01447589|Nelfinavir|nelfinavir|mesh-list
6652733|NCT01447589|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6652734|NCT01447589|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6652735|NCT01447589|Protease Inhibitors|protease inhibitors|mesh-ancestor
6652736|NCT01447589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6652737|NCT01447589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652738|NCT01447589|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6652739|NCT01447589|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6652740|NCT01447589|Antiviral Agents|antiviral agents|mesh-ancestor
6652741|NCT01447589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6652742|NCT01447654|Losartan|losartan|mesh-list
6652743|NCT01447654|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6652744|NCT01447654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6652745|NCT01447654|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6652746|NCT01447654|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6652747|NCT01447654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652748|NCT01447797|Irbesartan|irbesartan|mesh-list
6652749|NCT01447797|Atorvastatin|atorvastatin|mesh-list
6652750|NCT01447797|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6652751|NCT01447797|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6652752|NCT01447797|Antimetabolites|antimetabolites|mesh-ancestor
6652753|NCT01447797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652754|NCT01447797|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6652755|NCT01447797|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6652756|NCT01447797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6652757|NCT01447797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6652758|NCT01447797|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6652759|NCT01447797|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6652760|NCT01447862|Ibutilide|ibutilide|mesh-list
6652761|NCT01447862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6652762|NCT01447875|Propofol|propofol|mesh-list
6652763|NCT01447875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6652764|NCT01447875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6652765|NCT01447875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652766|NCT01447875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6652767|NCT01447875|Anesthetics, General|anesthetics, general|mesh-ancestor
6652768|NCT01447875|Anesthetics|anesthetics|mesh-ancestor
6652769|NCT01447979|Pancrelipase|pancrelipase|mesh-list
6652770|NCT01447979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6652771|NCT01447992|Pancrelipase|pancrelipase|mesh-list
6652772|NCT01447992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6652773|NCT01448018|Ranibizumab|ranibizumab|mesh-list
6652774|NCT01448018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6652775|NCT01448018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6652776|NCT01448018|Growth Substances|growth substances|mesh-ancestor
6652777|NCT01448018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652778|NCT01448018|Growth Inhibitors|growth inhibitors|mesh-ancestor
6652779|NCT01448018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6652780|NCT01448031|Esomeprazole|esomeprazole|mesh-list
6652781|NCT01448031|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6652782|NCT01448031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6652783|NCT01448031|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6652784|NCT01448031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6652785|NCT01448031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652786|NCT01448070|Insulin|insulin|mesh-list
6652787|NCT01448070|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6652788|NCT01448070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6652789|NCT01448070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652790|NCT01448096|Rituximab|rituximab|mesh-list
6652791|NCT01448096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6652792|NCT01448096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6652793|NCT01448096|Immunologic Factors|immunologic factors|mesh-ancestor
6652794|NCT01448096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652795|NCT01448096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6652796|NCT01448109|Hydrocortisone|hydrocortisone|mesh-list
6652797|NCT01448109|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6652798|NCT01448109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6652799|NCT01448174|Atorvastatin|atorvastatin|mesh-list
6652800|NCT01448174|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6652801|NCT01448174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6652802|NCT01448174|Antimetabolites|antimetabolites|mesh-ancestor
6652803|NCT01448174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489444|NCT04060758|Latanoprost|latanoprost|mesh-list
5489445|NCT04060758|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5489446|NCT04060758|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5489447|NCT04058990|Paclitaxel|paclitaxel|mesh-list
5489448|NCT04058990|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5489449|NCT04058990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5489450|NCT04058990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5489451|NCT04058990|Tubulin Modulators|tubulin modulators|mesh-ancestor
5489452|NCT04058990|Antimitotic Agents|antimitotic agents|mesh-ancestor
6652804|NCT01448174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6652805|NCT01448174|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6652806|NCT01448174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6652807|NCT01448239|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6652808|NCT01448239|Immunologic Factors|immunologic factors|mesh-ancestor
6652809|NCT01448239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652810|NCT01448252|Vaccines|vaccines|mesh-list
6652811|NCT01448252|Immunologic Factors|immunologic factors|mesh-ancestor
6652812|NCT01448252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652813|NCT01448291|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6652814|NCT01448291|Etonogestrel|etonogestrel|mesh-list
6652815|NCT01448291|NuvaRing|nuvaring|mesh-list
6652816|NCT01448291|Contraceptive Agents|contraceptive agents|mesh-list
6652817|NCT01448291|Estradiol|estradiol|mesh-list
6652818|NCT01448291|Estrogens|estrogens|mesh-ancestor
6652819|NCT01448291|Hormones|hormones|mesh-ancestor
6652820|NCT01448291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6652821|NCT01448291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652822|NCT01448291|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6652823|NCT01448291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6652824|NCT01448291|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6652825|NCT01448291|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6652826|NCT01448291|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6652827|NCT01448317|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6652828|NCT01448317|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6652829|NCT01448317|Immunologic Factors|immunologic factors|mesh-ancestor
6652830|NCT01448317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652831|NCT01448330|Aspirin|aspirin|mesh-list
6652832|NCT01448330|Clopidogrel|clopidogrel|mesh-list
6652833|NCT01448330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6652834|NCT01448330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6652835|NCT01448330|Analgesics|analgesics|mesh-ancestor
6652836|NCT01448330|Sensory System Agents|sensory system agents|mesh-ancestor
6652837|NCT01448330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6652838|NCT01448330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652839|NCT01448330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6652840|NCT01448330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6652841|NCT01448330|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6453916|NCT00422331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6453917|NCT00422331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453918|NCT00422344|Sunitinib|sunitinib|mesh-list
6652842|NCT01448330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6652843|NCT01448330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652844|NCT01448330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6652845|NCT01448330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6652846|NCT01448330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6652847|NCT01448330|Antipyretics|antipyretics|mesh-ancestor
6652848|NCT01448330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6652849|NCT01448330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6652850|NCT01448330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6652851|NCT01448330|Purinergic Agents|purinergic agents|mesh-ancestor
6652852|NCT01448330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6652853|NCT01448395|Avibactam|avibactam|mesh-list
5489453|NCT04058990|Mitosis Modulators|mitosis modulators|mesh-ancestor
6453919|NCT00422344|Everolimus|everolimus|mesh-list
6453920|NCT00422344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6453921|NCT00422344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6453922|NCT00422344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6453923|NCT00422344|Growth Substances|growth substances|mesh-ancestor
6453924|NCT00422344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453925|NCT00422344|Growth Inhibitors|growth inhibitors|mesh-ancestor
6453926|NCT00422344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6453927|NCT00422344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6453928|NCT00422344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453929|NCT00422344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6453930|NCT00422344|Immunologic Factors|immunologic factors|mesh-ancestor
6652854|NCT01448395|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6652855|NCT01448395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6652856|NCT01448395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652857|NCT01448395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6652858|NCT01448395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6652859|NCT01448434|Plasma-lyte 148|plasma-lyte 148|mesh-list
6652860|NCT01448434|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6652861|NCT01448434|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6664457|NCT01512173|Propranolol|propranolol|mesh-list
6664458|NCT01512173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6664459|NCT01512173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6664460|NCT01512173|Adrenergic Agents|adrenergic agents|mesh-ancestor
6664461|NCT01512173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6664462|NCT01512173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6664463|NCT01512173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664464|NCT01512173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6664465|NCT01512173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6664466|NCT01512173|Vasodilator Agents|vasodilator agents|mesh-ancestor
6664467|NCT01512199|Paclitaxel|paclitaxel|mesh-list
6664468|NCT01512199|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6664469|NCT01512199|Trastuzumab|trastuzumab|mesh-list
6664470|NCT01512199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6664471|NCT01512199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6664472|NCT01512199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6664473|NCT01512199|Tubulin Modulators|tubulin modulators|mesh-ancestor
6664474|NCT01512199|Antimitotic Agents|antimitotic agents|mesh-ancestor
6664475|NCT01512199|Mitosis Modulators|mitosis modulators|mesh-ancestor
6664476|NCT01512199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6664477|NCT01512199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6664478|NCT01512199|Immunologic Factors|immunologic factors|mesh-ancestor
6664479|NCT01512199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664480|NCT01512316|Cycloserine|cycloserine|mesh-list
6664481|NCT01512316|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5489454|NCT04058990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489455|NCT04055688|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5489456|NCT04055688|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5489457|NCT04055688|Dermatologic Agents|dermatologic agents|mesh-ancestor
5489458|NCT04055116|Lidocaine|lidocaine|mesh-list
5489459|NCT04055116|Anesthetics, Local|anesthetics, local|mesh-ancestor
5489460|NCT04055116|Anesthetics|anesthetics|mesh-ancestor
5489461|NCT04055116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5489462|NCT04055116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489463|NCT04055116|Sensory System Agents|sensory system agents|mesh-ancestor
5489464|NCT04055116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6664482|NCT01512316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6664483|NCT01512316|Renal Agents|renal agents|mesh-ancestor
6664484|NCT01512316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6664485|NCT01512316|Antitubercular Agents|antitubercular agents|mesh-ancestor
6664486|NCT01512316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6664487|NCT01512316|Antimetabolites|antimetabolites|mesh-ancestor
6664488|NCT01512316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6664489|NCT01512355|Dexmedetomidine|dexmedetomidine|mesh-list
6664490|NCT01512355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6664491|NCT01512355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6664492|NCT01512355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664493|NCT01512355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6664494|NCT01512355|Analgesics|analgesics|mesh-ancestor
6664495|NCT01512355|Sensory System Agents|sensory system agents|mesh-ancestor
6664496|NCT01512355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6664497|NCT01512355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6664498|NCT01512355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6664499|NCT01512355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6664500|NCT01512355|Adrenergic Agents|adrenergic agents|mesh-ancestor
6664501|NCT01512355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6664502|NCT01512355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6664503|NCT01512407|Ethiodized Oil|ethiodized oil|mesh-list
6664504|NCT01512407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6664505|NCT01512459|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6664506|NCT01512459|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6664507|NCT01512459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6664508|NCT01512459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6664509|NCT01512459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489465|NCT04055116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5489466|NCT04055116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5489467|NCT04055116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5489468|NCT04055116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5489469|NCT04055116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489470|NCT04047628|Alemtuzumab|alemtuzumab|mesh-list
5489471|NCT04047628|Ofatumumab|ofatumumab|mesh-list
5489472|NCT04047628|Cladribine|cladribine|mesh-list
5489473|NCT04047628|Ocrelizumab|ocrelizumab|mesh-list
5489474|NCT04047628|Natalizumab|natalizumab|mesh-list
5489475|NCT04047628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5489476|NCT04047628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5489477|NCT04047628|Immunologic Factors|immunologic factors|mesh-ancestor
5489478|NCT04047628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652862|NCT01448499|Clozapine|clozapine|mesh-list
6652863|NCT01448499|Amisulpride|amisulpride|mesh-list
6652864|NCT01448499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6652865|NCT01448499|Serotonin Agents|serotonin agents|mesh-ancestor
6652866|NCT01448499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6652867|NCT01448499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652868|NCT01448499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652869|NCT01448499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6652870|NCT01448499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6652871|NCT01448499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6652872|NCT01448499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6652873|NCT01448499|GABA Antagonists|gaba antagonists|mesh-ancestor
6652874|NCT01448499|GABA Agents|gaba agents|mesh-ancestor
6652875|NCT01448499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6652876|NCT01448499|Dopamine Agents|dopamine agents|mesh-ancestor
6652877|NCT01448499|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6652878|NCT01448499|Antidepressive Agents|antidepressive agents|mesh-ancestor
6652879|NCT01448538|Bevacizumab|bevacizumab|mesh-list
6652880|NCT01448538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6652881|NCT01448538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6652882|NCT01448538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6652883|NCT01448538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6652884|NCT01448538|Growth Substances|growth substances|mesh-ancestor
6652885|NCT01448538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489479|NCT04047628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5489480|NCT04047251|Topotecan|topotecan|mesh-list
5489481|NCT04047251|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5489482|NCT04047251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5489483|NCT04047251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5489484|NCT04047251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489485|NCT04047251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6652886|NCT01448538|Growth Inhibitors|growth inhibitors|mesh-ancestor
6652887|NCT01448642|Atorvastatin|atorvastatin|mesh-list
6652888|NCT01448642|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6652889|NCT01448642|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6652890|NCT01448642|Antimetabolites|antimetabolites|mesh-ancestor
6652891|NCT01448642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652892|NCT01448642|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6652893|NCT01448642|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6652894|NCT01448642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6652895|NCT01448720|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6652896|NCT01448720|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6652897|NCT01448720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6652898|NCT01448720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6652899|NCT01448720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652900|NCT01448720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6652901|NCT01448720|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6652902|NCT01448720|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6652903|NCT01448720|Serotonin Agents|serotonin agents|mesh-ancestor
6652904|NCT01448720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6652905|NCT01448720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652906|NCT01448720|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6652907|NCT01448720|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6652908|NCT01448720|Dopamine Agents|dopamine agents|mesh-ancestor
6652909|NCT01448733|Clindamycin|clindamycin|mesh-list
6652910|NCT01448733|Clindamycin palmitate|clindamycin palmitate|mesh-list
6652911|NCT01448733|Clindamycin phosphate|clindamycin phosphate|mesh-list
6652912|NCT01448733|Tretinoin|tretinoin|mesh-list
6652913|NCT01448733|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6652914|NCT01448733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6652915|NCT01448733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6652916|NCT01448733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6652917|NCT01448733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6652918|NCT01448733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652919|NCT01448733|Dermatologic Agents|dermatologic agents|mesh-ancestor
6652920|NCT01448733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6652921|NCT01448733|Keratolytic Agents|keratolytic agents|mesh-ancestor
6652922|NCT01448746|Heparin|heparin|mesh-list
6652923|NCT01448746|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6652924|NCT01448746|Tinzaparin|tinzaparin|mesh-list
6652925|NCT01448746|Dalteparin|dalteparin|mesh-list
6652926|NCT01448746|Anticoagulants|anticoagulants|mesh-ancestor
6652927|NCT01448746|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6652928|NCT01448746|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6652929|NCT01448746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652930|NCT01448772|Dronabinol|dronabinol|mesh-list
6652931|NCT01448772|Hallucinogens|hallucinogens|mesh-ancestor
6652932|NCT01448772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652933|NCT01448772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6652934|NCT01448772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6652935|NCT01448772|Analgesics|analgesics|mesh-ancestor
6652936|NCT01448772|Sensory System Agents|sensory system agents|mesh-ancestor
6652937|NCT01448772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6652938|NCT01448772|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6652939|NCT01448772|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6652940|NCT01448772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6652941|NCT01448772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652942|NCT01448772|Hormones|hormones|mesh-ancestor
6652943|NCT01448772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6652944|NCT01448798|Thrombin|thrombin|mesh-list
6652945|NCT01448798|Hemostatics|hemostatics|mesh-list
6652946|NCT01448798|Coagulants|coagulants|mesh-ancestor
6652947|NCT01448837|Timolol|timolol|mesh-list
6652948|NCT01448837|Bimatoprost|bimatoprost|mesh-list
6652949|NCT01448837|Latanoprost|latanoprost|mesh-list
6652950|NCT01448837|Cloprostenol|cloprostenol|mesh-list
6652951|NCT01448837|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6652952|NCT01448837|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6652953|NCT01448837|Adrenergic Agents|adrenergic agents|mesh-ancestor
6652954|NCT01448837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6652955|NCT01448837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652956|NCT01448837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652957|NCT01448837|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6652958|NCT01448837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6652959|NCT01448837|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6652960|NCT01448837|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6652961|NCT01448837|Luteolytic Agents|luteolytic agents|mesh-ancestor
6652962|NCT01448837|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6652963|NCT01448837|Contraceptive Agents|contraceptive agents|mesh-ancestor
6652964|NCT01448837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6652965|NCT01448837|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5489496|NCT04035837|Interferons|interferons|mesh-list
5489497|NCT04035837|Interferon-alpha|interferon-alpha|mesh-list
5489498|NCT04035837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5489499|NCT04035837|Antiviral Agents|antiviral agents|mesh-ancestor
5489500|NCT04035837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5489501|NCT04035837|Immunologic Factors|immunologic factors|mesh-ancestor
5489502|NCT04035837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489503|NCT04019327|Temozolomide|temozolomide|mesh-list
5489504|NCT04019327|Talazoparib|talazoparib|mesh-list
5489505|NCT04019327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5489506|NCT04019327|Alkylating Agents|alkylating agents|mesh-ancestor
6453931|NCT00422396|Fenofibrate|fenofibrate|mesh-list
6453932|NCT00422396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6453933|NCT00422396|Antimetabolites|antimetabolites|mesh-ancestor
6453934|NCT00422396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453935|NCT00422396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6453936|NCT00422435|Paclitaxel|paclitaxel|mesh-list
6453937|NCT00422435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6453938|NCT00422435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6453939|NCT00422435|Tubulin Modulators|tubulin modulators|mesh-ancestor
6453940|NCT00422435|Antimitotic Agents|antimitotic agents|mesh-ancestor
6453941|NCT00422435|Mitosis Modulators|mitosis modulators|mesh-ancestor
6453942|NCT00422435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453943|NCT00422526|Progesterone|progesterone|mesh-list
6453944|NCT00422526|Progestins|progestins|mesh-ancestor
6453945|NCT00422526|Hormones|hormones|mesh-ancestor
6453946|NCT00422526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6453947|NCT00422526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453948|NCT00422565|Sirolimus|sirolimus|mesh-list
6453949|NCT00422565|Paclitaxel|paclitaxel|mesh-list
6652966|NCT01448993|Azithromycin|azithromycin|mesh-list
6652967|NCT01448993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6652968|NCT01448993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6652969|NCT01449045|Lumefantrine|lumefantrine|mesh-list
6652970|NCT01449045|Artemether|artemether|mesh-list
6652971|NCT01449045|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6652972|NCT01449045|Antimalarials|antimalarials|mesh-ancestor
6652973|NCT01449045|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6453950|NCT00422565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6021788|NCT00402116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021789|NCT00402116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6021790|NCT00402168|Cyclosporine|cyclosporine|mesh-list
6453951|NCT00422565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6453952|NCT00422565|Tubulin Modulators|tubulin modulators|mesh-ancestor
6453953|NCT00422565|Antimitotic Agents|antimitotic agents|mesh-ancestor
6453954|NCT00422565|Mitosis Modulators|mitosis modulators|mesh-ancestor
6453955|NCT00422565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453956|NCT00422565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6453957|NCT00422565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6652974|NCT01449045|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6652975|NCT01449045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6652976|NCT01449110|Resveratrol|resveratrol|mesh-list
6652977|NCT01449110|Antioxidants|antioxidants|mesh-ancestor
6652978|NCT01449110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6652979|NCT01449110|Protective Agents|protective agents|mesh-ancestor
6652980|NCT01449110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652981|NCT01449110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6652982|NCT01449110|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6652983|NCT01449123|Mannitol|mannitol|mesh-list
6652984|NCT01449123|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6652985|NCT01449123|Diuretics|diuretics|mesh-ancestor
6652986|NCT01449123|Natriuretic Agents|natriuretic agents|mesh-ancestor
6652987|NCT01449123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6652988|NCT01449136|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6652989|NCT01449136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6652990|NCT01449188|Moxifloxacin|moxifloxacin|mesh-list
6652991|NCT01449188|Ondansetron|ondansetron|mesh-list
6652992|NCT01449188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6652993|NCT01449188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6652994|NCT01449188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6652995|NCT01449188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6652996|NCT01449188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6652997|NCT01449188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489507|NCT04019327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489508|NCT04019327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6652998|NCT01449188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6652999|NCT01449188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653000|NCT01449188|Antiemetics|antiemetics|mesh-ancestor
6653001|NCT01449188|Autonomic Agents|autonomic agents|mesh-ancestor
6653002|NCT01449188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6653003|NCT01449188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6653004|NCT01449188|Antipruritics|antipruritics|mesh-ancestor
6653005|NCT01449188|Dermatologic Agents|dermatologic agents|mesh-ancestor
6653006|NCT01449188|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6653007|NCT01449188|Serotonin Agents|serotonin agents|mesh-ancestor
6653008|NCT01449188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6653009|NCT01449188|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6653010|NCT01449188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6653011|NCT01449188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6653012|NCT01449188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6653013|NCT01449188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6653014|NCT01449253|Bosentan|bosentan|mesh-list
6653015|NCT01449253|Sildenafil Citrate|sildenafil citrate|mesh-list
6653016|NCT01449253|Vasodilator Agents|vasodilator agents|mesh-ancestor
6653017|NCT01449253|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6653018|NCT01449253|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6653019|NCT01449253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6653020|NCT01449253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653021|NCT01449253|Urological Agents|urological agents|mesh-ancestor
6653022|NCT01449253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6653023|NCT01449253|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6653024|NCT01449344|Cytarabine|cytarabine|mesh-list
6653025|NCT01449344|Dexamethasone|dexamethasone|mesh-list
6653026|NCT01449344|Dexamethasone acetate|dexamethasone acetate|mesh-list
6653027|NCT01449344|Rituximab|rituximab|mesh-list
6653028|NCT01449344|Bortezomib|bortezomib|mesh-list
6653029|NCT01449344|BB 1101|bb 1101|mesh-list
6653030|NCT01449344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6653031|NCT01449344|Antiemetics|antiemetics|mesh-ancestor
6653032|NCT01449344|Autonomic Agents|autonomic agents|mesh-ancestor
6653033|NCT01449344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6653034|NCT01449344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653035|NCT01449344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6653036|NCT01449344|Glucocorticoids|glucocorticoids|mesh-ancestor
6653037|NCT01449344|Hormones|hormones|mesh-ancestor
6653038|NCT01449344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6653039|NCT01449344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6653040|NCT01449344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5489509|NCT04019327|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5489510|NCT04019327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5489511|NCT04019288|Durvalumab|durvalumab|mesh-list
5489512|NCT04019288|Immunoglobulins|immunoglobulins|mesh-list
5489513|NCT04019288|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5489514|NCT04019288|Immunoglobulin G|immunoglobulin g|mesh-list
5489515|NCT04019288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6653041|NCT01449344|Protease Inhibitors|protease inhibitors|mesh-ancestor
6653042|NCT01449344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6653043|NCT01449344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653044|NCT01449344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6653045|NCT01449344|Immunologic Factors|immunologic factors|mesh-ancestor
6653046|NCT01449344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6653047|NCT01449344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6653048|NCT01449344|Antimetabolites|antimetabolites|mesh-ancestor
6653049|NCT01449344|Antiviral Agents|antiviral agents|mesh-ancestor
5489516|NCT04019288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5489517|NCT04019288|Immunologic Factors|immunologic factors|mesh-ancestor
5489518|NCT04019288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489519|NCT03991403|Paclitaxel|paclitaxel|mesh-list
5489520|NCT03991403|Bevacizumab|bevacizumab|mesh-list
5489521|NCT03991403|Carboplatin|carboplatin|mesh-list
6653050|NCT01449344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6653051|NCT01449344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6653052|NCT01449357|Zalutumumab|zalutumumab|mesh-list
6653053|NCT01449357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6653054|NCT01449357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5489522|NCT03991403|Pemetrexed|pemetrexed|mesh-list
5489523|NCT03991403|Atezolizumab|atezolizumab|mesh-list
5489524|NCT03991403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5489525|NCT03991403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5489526|NCT03991403|Tubulin Modulators|tubulin modulators|mesh-ancestor
6653055|NCT01449435|Methacholine Chloride|methacholine chloride|mesh-list
6653056|NCT01449435|Miotics|miotics|mesh-ancestor
6653057|NCT01449435|Autonomic Agents|autonomic agents|mesh-ancestor
6653058|NCT01449435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6653059|NCT01449435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653060|NCT01449435|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6653061|NCT01449435|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
6653062|NCT01449435|Respiratory System Agents|respiratory system agents|mesh-ancestor
6653063|NCT01449435|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6653064|NCT01449435|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6653065|NCT01449435|Cholinergic Agents|cholinergic agents|mesh-ancestor
6653066|NCT01449435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5489527|NCT03991403|Antimitotic Agents|antimitotic agents|mesh-ancestor
5489528|NCT03991403|Mitosis Modulators|mitosis modulators|mesh-ancestor
5489529|NCT03991403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489530|NCT03991403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5489531|NCT03991403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5489532|NCT03991403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5489533|NCT03991403|Growth Substances|growth substances|mesh-ancestor
6653067|NCT01449435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653068|NCT01449448|Triamcinolone|triamcinolone|mesh-list
6653069|NCT01449448|Ketorolac|ketorolac|mesh-list
6653070|NCT01449448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6653071|NCT01449448|Glucocorticoids|glucocorticoids|mesh-ancestor
6653072|NCT01449448|Hormones|hormones|mesh-ancestor
6653073|NCT01449448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6653074|NCT01449448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653075|NCT01449448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6653076|NCT01449448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653077|NCT01449448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6653078|NCT01449448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6653079|NCT01449448|Analgesics|analgesics|mesh-ancestor
6653080|NCT01449448|Sensory System Agents|sensory system agents|mesh-ancestor
6653081|NCT01449448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6653082|NCT01449448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6653083|NCT01449448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6653084|NCT01449552|Tranexamic Acid|tranexamic acid|mesh-list
6653085|NCT01449552|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6653086|NCT01449552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6653087|NCT01449552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653088|NCT01449552|Hemostatics|hemostatics|mesh-ancestor
6653089|NCT01449552|Coagulants|coagulants|mesh-ancestor
6653090|NCT01449565|Naltrexone|naltrexone|mesh-list
6653091|NCT01449565|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6653092|NCT01449565|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6653093|NCT01449565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653094|NCT01449565|Sensory System Agents|sensory system agents|mesh-ancestor
6653095|NCT01449565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6653096|NCT01449578|Pramipexole|pramipexole|mesh-list
6653097|NCT01449578|Antioxidants|antioxidants|mesh-ancestor
6653098|NCT01449578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653099|NCT01449578|Protective Agents|protective agents|mesh-ancestor
6653100|NCT01449578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653101|NCT01449578|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6653102|NCT01449578|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6653103|NCT01449578|Dopamine Agonists|dopamine agonists|mesh-ancestor
6653104|NCT01449578|Dopamine Agents|dopamine agents|mesh-ancestor
6653105|NCT01449578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5489534|NCT03991403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653106|NCT01449617|Aspirin|aspirin|mesh-list
6653107|NCT01449617|Clopidogrel|clopidogrel|mesh-list
6653108|NCT01449617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6653109|NCT01449617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6653110|NCT01449617|Analgesics|analgesics|mesh-ancestor
6653111|NCT01449617|Sensory System Agents|sensory system agents|mesh-ancestor
5489535|NCT03991403|Growth Inhibitors|growth inhibitors|mesh-ancestor
5489536|NCT03991403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5489537|NCT03991403|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5489538|NCT03991403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5489539|NCT03978091|Ceftazidime|ceftazidime|mesh-list
5489540|NCT03978091|Avibactam|avibactam|mesh-list
5489541|NCT03978091|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
5489542|NCT03978091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5489543|NCT03978091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5489544|NCT03978091|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5489545|NCT03978091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5489546|NCT03978091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021791|NCT00402168|Abatacept|abatacept|mesh-list
6021792|NCT00402168|Tacrolimus|tacrolimus|mesh-list
6653112|NCT01449617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6653113|NCT01449617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653114|NCT01449617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6653115|NCT01449617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6653116|NCT01449617|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6653117|NCT01449617|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6653118|NCT01449617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653119|NCT01449617|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6653120|NCT01449617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6653121|NCT01449617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6653122|NCT01449617|Antipyretics|antipyretics|mesh-ancestor
6653123|NCT01449617|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6653124|NCT01449617|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6653125|NCT01449617|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6653126|NCT01449617|Purinergic Agents|purinergic agents|mesh-ancestor
6653127|NCT01449617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6653128|NCT01449799|Fluticasone|fluticasone|mesh-list
6653129|NCT01449799|Xhance|xhance|mesh-list
6653130|NCT01449799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6653131|NCT01449799|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6653132|NCT01449799|Autonomic Agents|autonomic agents|mesh-ancestor
6653133|NCT01449799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6653134|NCT01449799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653135|NCT01449799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6653136|NCT01449799|Respiratory System Agents|respiratory system agents|mesh-ancestor
6653137|NCT01449799|Dermatologic Agents|dermatologic agents|mesh-ancestor
6653138|NCT01449799|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6653139|NCT01449825|Bevacizumab|bevacizumab|mesh-list
6653140|NCT01449825|Sunitinib|sunitinib|mesh-list
6653141|NCT01449825|Sorafenib|sorafenib|mesh-list
6653142|NCT01449825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6653143|NCT01449825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6653144|NCT01449825|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6653145|NCT01449825|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6653146|NCT01449825|Growth Substances|growth substances|mesh-ancestor
6653147|NCT01449825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653148|NCT01449825|Growth Inhibitors|growth inhibitors|mesh-ancestor
6653149|NCT01449825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6653150|NCT01449825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6653151|NCT01449825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653152|NCT01449877|Trimethoprim|trimethoprim|mesh-list
6653153|NCT01449877|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6653154|NCT01449877|Sulfamethoxazole|sulfamethoxazole|mesh-list
6653155|NCT01449877|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6653156|NCT01449877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6653157|NCT01449877|Renal Agents|renal agents|mesh-ancestor
6653158|NCT01449877|Antimalarials|antimalarials|mesh-ancestor
6653159|NCT01449877|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6653160|NCT01449877|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6653161|NCT01449877|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6653162|NCT01449877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6653163|NCT01449877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653164|NCT01449877|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6653165|NCT01449877|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6653166|NCT01449877|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6653167|NCT01449877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6021793|NCT00402168|Cyclosporins|cyclosporins|mesh-list
6021794|NCT00402168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6021795|NCT00402168|Immunologic Factors|immunologic factors|mesh-ancestor
6021796|NCT00402168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021797|NCT00402168|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6653168|NCT01450046|Vitamin E|vitamin e|mesh-list
6653169|NCT01450046|Tocopherols|tocopherols|mesh-list
6653170|NCT01450046|Tocotrienols|tocotrienols|mesh-list
6653171|NCT01450046|Vitamins|vitamins|mesh-ancestor
6653172|NCT01450046|Micronutrients|micronutrients|mesh-ancestor
6653173|NCT01450046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653174|NCT01450046|Antioxidants|antioxidants|mesh-ancestor
6653175|NCT01450046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653176|NCT01450046|Protective Agents|protective agents|mesh-ancestor
6653177|NCT01450111|Lacosamide|lacosamide|mesh-list
6653178|NCT01450111|Anticonvulsants|anticonvulsants|mesh-ancestor
6653179|NCT01450111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6653180|NCT01450111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6021798|NCT00402168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6021799|NCT00402168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489555|NCT03961204|Cladribine|cladribine|mesh-list
5489556|NCT03961204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5489557|NCT03961204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5489558|NCT03961204|Immunologic Factors|immunologic factors|mesh-ancestor
5489559|NCT03961204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489560|NCT03954041|Glyburide|glyburide|mesh-list
5489561|NCT03954041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5489562|NCT03954041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489563|NCT03945357|Gemcitabine|gemcitabine|mesh-list
6653181|NCT01450111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6653182|NCT01450111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653183|NCT01450124|Boswellic acid|boswellic acid|mesh-list
6653184|NCT01450124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6653185|NCT01450124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6653186|NCT01450124|Analgesics|analgesics|mesh-ancestor
6653187|NCT01450124|Sensory System Agents|sensory system agents|mesh-ancestor
5489564|NCT03945357|Clindamycin|clindamycin|mesh-list
5489565|NCT03945357|Clindamycin palmitate|clindamycin palmitate|mesh-list
5489566|NCT03945357|Clindamycin phosphate|clindamycin phosphate|mesh-list
5489567|NCT03945357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5489568|NCT03945357|Antimetabolites|antimetabolites|mesh-ancestor
5489569|NCT03945357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489570|NCT03945357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6653188|NCT01450124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6653189|NCT01450124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653190|NCT01450124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6653191|NCT01450124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6653192|NCT01450163|Oxaliplatin|oxaliplatin|mesh-list
6653193|NCT01450163|Pregabalin|pregabalin|mesh-list
6653194|NCT01450163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6653195|NCT01450163|Analgesics|analgesics|mesh-ancestor
6653196|NCT01450163|Sensory System Agents|sensory system agents|mesh-ancestor
6653197|NCT01450163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6653198|NCT01450163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653199|NCT01450163|Anticonvulsants|anticonvulsants|mesh-ancestor
6653200|NCT01450163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6653201|NCT01450163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6653202|NCT01450163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653203|NCT01450163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6021800|NCT00402168|Antifungal Agents|antifungal agents|mesh-ancestor
6653204|NCT01450163|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6653205|NCT01450163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5489571|NCT03945357|Antiviral Agents|antiviral agents|mesh-ancestor
5489572|NCT03945357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5489573|NCT03945357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5489574|NCT03945357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5489575|NCT03945357|Immunologic Factors|immunologic factors|mesh-ancestor
5489576|NCT03945357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653206|NCT01450163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6653207|NCT01450163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6653208|NCT01450176|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
6653209|NCT01450176|Bepotastine besilate|bepotastine besilate|mesh-list
6653210|NCT01450176|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6653211|NCT01450176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6653212|NCT01450176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6653213|NCT01450176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6653214|NCT01450176|Analgesics|analgesics|mesh-ancestor
6653215|NCT01450176|Sensory System Agents|sensory system agents|mesh-ancestor
6653216|NCT01450176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5489577|NCT03945357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5489578|NCT03945357|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5489579|NCT03943498|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
5489580|NCT03943498|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5489581|NCT03943498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489582|NCT03943498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5489583|NCT03943498|Immunologic Factors|immunologic factors|mesh-ancestor
5489584|NCT03943498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653217|NCT01450176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653218|NCT01450176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6653219|NCT01450176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6653220|NCT01450176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6653221|NCT01450176|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6653222|NCT01450176|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6653223|NCT01450176|Histamine Antagonists|histamine antagonists|mesh-ancestor
6653224|NCT01450176|Histamine Agents|histamine agents|mesh-ancestor
6653225|NCT01450176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6653226|NCT01450176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653227|NCT01450215|Lenalidomide|lenalidomide|mesh-list
6653228|NCT01450215|Immunologic Factors|immunologic factors|mesh-ancestor
6653229|NCT01450215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653230|NCT01450215|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6653231|NCT01450215|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6653232|NCT01450215|Growth Substances|growth substances|mesh-ancestor
5489585|NCT03934814|Rituximab|rituximab|mesh-list
5489586|NCT03934814|Pembrolizumab|pembrolizumab|mesh-list
5489587|NCT03934814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5489588|NCT03934814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5489589|NCT03934814|Immunologic Factors|immunologic factors|mesh-ancestor
5489590|NCT03934814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489591|NCT03934814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5489592|NCT03933215|Cladribine|cladribine|mesh-list
5489593|NCT03933215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5489594|NCT03933215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5489595|NCT03933215|Immunologic Factors|immunologic factors|mesh-ancestor
5489596|NCT03933215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489597|NCT03930771|Capecitabine|capecitabine|mesh-list
5489598|NCT03930771|Temozolomide|temozolomide|mesh-list
5489599|NCT03930771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6453958|NCT00422565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6453959|NCT00422565|Antifungal Agents|antifungal agents|mesh-ancestor
6453960|NCT00422565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6453961|NCT00422565|Immunologic Factors|immunologic factors|mesh-ancestor
6453962|NCT00422565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453963|NCT00422578|Tadalafil|tadalafil|mesh-list
6453964|NCT00422578|Vasodilator Agents|vasodilator agents|mesh-ancestor
6453965|NCT00422578|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6453966|NCT00422578|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6453967|NCT00422578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6453968|NCT00422578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453969|NCT00422578|Urological Agents|urological agents|mesh-ancestor
6453970|NCT00422604|Tiotropium Bromide|tiotropium bromide|mesh-list
6453971|NCT00422604|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6453972|NCT00422604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6453973|NCT00422604|Autonomic Agents|autonomic agents|mesh-ancestor
6453974|NCT00422604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6653233|NCT01450215|Growth Inhibitors|growth inhibitors|mesh-ancestor
6653234|NCT01450215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6664510|NCT01512459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6664511|NCT01512459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664512|NCT01512459|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6664513|NCT01512459|Antidepressive Agents|antidepressive agents|mesh-ancestor
6664514|NCT01512459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6664515|NCT01512485|Clopidogrel|clopidogrel|mesh-list
6664516|NCT01512485|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6664517|NCT01512485|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6664518|NCT01512485|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6664519|NCT01512485|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6664520|NCT01512485|Purinergic Agents|purinergic agents|mesh-ancestor
6664521|NCT01512485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5489600|NCT03930771|Antimetabolites|antimetabolites|mesh-ancestor
5489601|NCT03930771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489602|NCT03930771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5489603|NCT03930771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5489604|NCT03930771|Alkylating Agents|alkylating agents|mesh-ancestor
5489605|NCT03926624|Cytarabine|cytarabine|mesh-list
5489606|NCT03926624|Fludarabine|fludarabine|mesh-list
5489607|NCT03926624|Etoposide|etoposide|mesh-list
5489608|NCT03926624|Azacitidine|azacitidine|mesh-list
6664522|NCT01512485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6664523|NCT01512485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664524|NCT01512511|Nitrous Oxide|nitrous oxide|mesh-list
6664525|NCT01512511|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6664526|NCT01512511|Anesthetics, General|anesthetics, general|mesh-ancestor
6664527|NCT01512511|Anesthetics|anesthetics|mesh-ancestor
6664528|NCT01512511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5489609|NCT03926624|Decitabine|decitabine|mesh-list
5489610|NCT03926624|Venetoclax|venetoclax|mesh-list
5489611|NCT03926624|Mitoxantrone|mitoxantrone|mesh-list
5489612|NCT03926624|Idarubicin|idarubicin|mesh-list
5489613|NCT03926624|Cladribine|cladribine|mesh-list
5489614|NCT03926624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5489615|NCT03926624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5489616|NCT03926624|Antimetabolites|antimetabolites|mesh-ancestor
5489617|NCT03926624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489618|NCT03926624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5489619|NCT03926624|Immunologic Factors|immunologic factors|mesh-ancestor
5489620|NCT03926624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489621|NCT03926624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5489622|NCT03926624|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6664529|NCT01512511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664530|NCT01512511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6664531|NCT01512511|Analgesics|analgesics|mesh-ancestor
6664532|NCT01512511|Sensory System Agents|sensory system agents|mesh-ancestor
6664533|NCT01512511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6664534|NCT01512537|Vitamin D|vitamin d|mesh-list
6664535|NCT01512537|Ergocalciferols|ergocalciferols|mesh-list
6664536|NCT01512537|Vitamins|vitamins|mesh-list
6664537|NCT01512537|Calcium|calcium|mesh-list
6664538|NCT01512537|Micronutrients|micronutrients|mesh-ancestor
6664539|NCT01512537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664540|NCT01512537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6664541|NCT01512537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6664542|NCT01512628|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
6664543|NCT01512628|Plasma Substitutes|plasma substitutes|mesh-ancestor
6664544|NCT01512628|Blood Substitutes|blood substitutes|mesh-ancestor
6664545|NCT01512680|Insulin|insulin|mesh-list
6664546|NCT01512680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6664547|NCT01512680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664548|NCT01512784|Vaccines|vaccines|mesh-list
6664549|NCT01512784|Immunologic Factors|immunologic factors|mesh-ancestor
6664550|NCT01512784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664551|NCT01512862|Calcitriol|calcitriol|mesh-list
6664552|NCT01512862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6664553|NCT01512862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664554|NCT01512862|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6664555|NCT01512862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6664556|NCT01512862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6664557|NCT01512862|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6664558|NCT01512862|Vitamins|vitamins|mesh-ancestor
6664559|NCT01512862|Micronutrients|micronutrients|mesh-ancestor
5489623|NCT03926624|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6664560|NCT01512862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6653235|NCT01450241|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6653236|NCT01450241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6653237|NCT01450267|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6653238|NCT01450345|Pregabalin|pregabalin|mesh-list
6653239|NCT01450345|Analgesics|analgesics|mesh-ancestor
6653240|NCT01450345|Sensory System Agents|sensory system agents|mesh-ancestor
6653241|NCT01450345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6653242|NCT01450345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653243|NCT01450345|Anticonvulsants|anticonvulsants|mesh-ancestor
6653244|NCT01450345|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6653245|NCT01450345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6653246|NCT01450345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653247|NCT01450345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6653248|NCT01450345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6653249|NCT01450345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6653250|NCT01450345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6653251|NCT01450345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6653252|NCT01450358|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5489624|NCT03926624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5489625|NCT03926624|Antiviral Agents|antiviral agents|mesh-ancestor
5489626|NCT03926624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5489627|NCT03926624|Analgesics|analgesics|mesh-ancestor
6653253|NCT01450358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6653254|NCT01450384|Pemetrexed|pemetrexed|mesh-list
6653255|NCT01450384|Sorafenib|sorafenib|mesh-list
6653256|NCT01450384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6653257|NCT01450384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6653258|NCT01450384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653259|NCT01450384|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6653260|NCT01450384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6653261|NCT01450384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6653262|NCT01450410|Nicotinic Acids|nicotinic acids|mesh-list
6653263|NCT01450410|Niacin|niacin|mesh-list
6653264|NCT01450410|Niacinamide|niacinamide|mesh-list
6653265|NCT01450410|Vitamin B Complex|vitamin b complex|mesh-ancestor
6653266|NCT01450410|Vitamins|vitamins|mesh-ancestor
6653267|NCT01450410|Micronutrients|micronutrients|mesh-ancestor
6653268|NCT01450410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653269|NCT01450410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6653270|NCT01450410|Antimetabolites|antimetabolites|mesh-ancestor
6653271|NCT01450410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653272|NCT01450410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6653273|NCT01450410|Vasodilator Agents|vasodilator agents|mesh-ancestor
6453975|NCT00422604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453976|NCT00422604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6453977|NCT00422604|Respiratory System Agents|respiratory system agents|mesh-ancestor
6453978|NCT00422604|Parasympatholytics|parasympatholytics|mesh-ancestor
6453979|NCT00422604|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6453980|NCT00422604|Cholinergic Agents|cholinergic agents|mesh-ancestor
6453981|NCT00422604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6453982|NCT00422604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453983|NCT00422604|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6453984|NCT00422604|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6453985|NCT00422604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6453986|NCT00422604|Adrenergic Agents|adrenergic agents|mesh-ancestor
6453987|NCT00422617|Alefacept|alefacept|mesh-list
6453988|NCT00422617|Dermatologic Agents|dermatologic agents|mesh-ancestor
6453989|NCT00422617|Immunologic Factors|immunologic factors|mesh-ancestor
6453990|NCT00422617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453991|NCT00422643|Hyaluronic Acid|hyaluronic acid|mesh-list
6453992|NCT00422643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6453993|NCT00422643|Immunologic Factors|immunologic factors|mesh-ancestor
6653274|NCT01450462|Vitamin D|vitamin d|mesh-list
6653275|NCT01450462|Cholecalciferol|cholecalciferol|mesh-list
6653276|NCT01450462|Vitamins|vitamins|mesh-ancestor
6653277|NCT01450462|Micronutrients|micronutrients|mesh-ancestor
6653278|NCT01450462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653279|NCT01450462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6653280|NCT01450462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6653281|NCT01450514|Pipamperone|pipamperone|mesh-list
6653282|NCT01450514|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6653283|NCT01450514|Serotonin Agents|serotonin agents|mesh-ancestor
6653284|NCT01450514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6653285|NCT01450514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653286|NCT01450514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653287|NCT01450514|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6653288|NCT01450514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6653289|NCT01450514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6653290|NCT01450514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6653291|NCT01450566|Lidocaine|lidocaine|mesh-list
6653292|NCT01450566|Anesthetics, Local|anesthetics, local|mesh-ancestor
6653293|NCT01450566|Anesthetics|anesthetics|mesh-ancestor
6653294|NCT01450566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6653295|NCT01450566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653296|NCT01450566|Sensory System Agents|sensory system agents|mesh-ancestor
6653297|NCT01450566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6653298|NCT01450566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6653299|NCT01450566|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6653300|NCT01450566|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6653301|NCT01450566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6653302|NCT01450566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653303|NCT01450774|Beclomethasone|beclomethasone|mesh-list
5489628|NCT03926624|Sensory System Agents|sensory system agents|mesh-ancestor
5489629|NCT03926624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5489630|NCT03926624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5489631|NCT03905902|Vaccines|vaccines|mesh-list
5489632|NCT03905902|Immunologic Factors|immunologic factors|mesh-ancestor
5489633|NCT03905902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489634|NCT03889743|Dexamethasone|dexamethasone|mesh-list
5489635|NCT03889743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5489636|NCT03889743|Antiemetics|antiemetics|mesh-ancestor
5489637|NCT03889743|Autonomic Agents|autonomic agents|mesh-ancestor
5489638|NCT03889743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5489639|NCT03889743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489640|NCT03889743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5489641|NCT03889743|Glucocorticoids|glucocorticoids|mesh-ancestor
5489642|NCT03889743|Hormones|hormones|mesh-ancestor
5489643|NCT03889743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5489644|NCT03889743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5489645|NCT03889743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5489646|NCT03889275|Durvalumab|durvalumab|mesh-list
6653304|NCT01450774|Formoterol Fumarate|formoterol fumarate|mesh-list
6653305|NCT01450774|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6653306|NCT01450774|Autonomic Agents|autonomic agents|mesh-ancestor
6653307|NCT01450774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6653308|NCT01450774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653309|NCT01450774|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6653310|NCT01450774|Respiratory System Agents|respiratory system agents|mesh-ancestor
6653311|NCT01450774|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6653312|NCT01450774|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6653313|NCT01450774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6653314|NCT01450774|Adrenergic Agents|adrenergic agents|mesh-ancestor
6653315|NCT01450774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6653316|NCT01450774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653317|NCT01450774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6653318|NCT01450774|Glucocorticoids|glucocorticoids|mesh-ancestor
6653319|NCT01450774|Hormones|hormones|mesh-ancestor
6653320|NCT01450774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6653321|NCT01450865|Flupirtine|flupirtine|mesh-list
6653322|NCT01450865|Analgesics|analgesics|mesh-ancestor
6653323|NCT01450865|Sensory System Agents|sensory system agents|mesh-ancestor
6653324|NCT01450865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6653325|NCT01450865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653326|NCT01450930|Hydrocortisone|hydrocortisone|mesh-list
5489647|NCT03889275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5489648|NCT03889275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6653327|NCT01450930|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6653328|NCT01450930|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6653329|NCT01450930|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6653330|NCT01450930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6653331|NCT01450956|Sevoflurane|sevoflurane|mesh-list
5489649|NCT03878927|Gemtuzumab|gemtuzumab|mesh-list
5489650|NCT03878927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5489651|NCT03878927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5489652|NCT03869892|Trifluridine|trifluridine|mesh-list
5489653|NCT03869892|Bevacizumab|bevacizumab|mesh-list
5489654|NCT03869892|Capecitabine|capecitabine|mesh-list
5489655|NCT03869892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5489656|NCT03869892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5489657|NCT03869892|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5489658|NCT03869892|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5489659|NCT03869892|Growth Substances|growth substances|mesh-ancestor
5489660|NCT03869892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489661|NCT03869892|Growth Inhibitors|growth inhibitors|mesh-ancestor
5489662|NCT03869892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5489663|NCT03869892|Antimetabolites|antimetabolites|mesh-ancestor
5489664|NCT03869892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653332|NCT01450956|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6653333|NCT01450956|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6653334|NCT01450956|Anesthetics, General|anesthetics, general|mesh-ancestor
6653335|NCT01450956|Anesthetics|anesthetics|mesh-ancestor
6653336|NCT01450956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6653337|NCT01450956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653338|NCT01450995|Sumatriptan|sumatriptan|mesh-list
6653339|NCT01450995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6653340|NCT01450995|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6653341|NCT01450995|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6653342|NCT01450995|Serotonin Agents|serotonin agents|mesh-ancestor
6653343|NCT01450995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6653344|NCT01450995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6453994|NCT00422643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6453995|NCT00422643|Viscosupplements|viscosupplements|mesh-ancestor
6453996|NCT00422643|Protective Agents|protective agents|mesh-ancestor
6453997|NCT00422682|Gemcitabine|gemcitabine|mesh-list
6453998|NCT00422682|Paclitaxel|paclitaxel|mesh-list
6453999|NCT00422682|Carboplatin|carboplatin|mesh-list
6454000|NCT00422682|Temozolomide|temozolomide|mesh-list
6021801|NCT00402168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6021802|NCT00402168|Dermatologic Agents|dermatologic agents|mesh-ancestor
6021803|NCT00402168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6021804|NCT00402168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6021805|NCT00402168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6021806|NCT00402194|Losartan|losartan|mesh-list
6021807|NCT00402194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6021808|NCT00402194|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6021809|NCT00402194|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6021810|NCT00402194|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6021811|NCT00402194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021812|NCT00402233|Pramipexole|pramipexole|mesh-list
6021813|NCT00402233|Antioxidants|antioxidants|mesh-ancestor
6454001|NCT00422682|Topotecan|topotecan|mesh-list
6454002|NCT00422682|Iniparib|iniparib|mesh-list
5489665|NCT03869892|Antiviral Agents|antiviral agents|mesh-ancestor
6454003|NCT00422682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5489666|NCT03869892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6653345|NCT01450995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653346|NCT01451060|Ephedrine|ephedrine|mesh-list
6653347|NCT01451060|Metaraminol|metaraminol|mesh-list
5489667|NCT03867201|Erenumab|erenumab|mesh-list
5489668|NCT03867201|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
5489669|NCT03867201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653348|NCT01451060|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6653349|NCT01451060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653350|NCT01451060|Sympathomimetics|sympathomimetics|mesh-ancestor
6653351|NCT01451060|Autonomic Agents|autonomic agents|mesh-ancestor
6653352|NCT01451060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6653353|NCT01451060|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6653354|NCT01451060|Adrenergic Agents|adrenergic agents|mesh-ancestor
6653355|NCT01451060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6653356|NCT01451060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653357|NCT01451060|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6653358|NCT01451060|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6653359|NCT01451060|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6653360|NCT01451086|Vaccines|vaccines|mesh-list
6653361|NCT01451086|Immunologic Factors|immunologic factors|mesh-ancestor
6653362|NCT01451086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653363|NCT01451229|Higenamine|higenamine|mesh-list
6653364|NCT01451229|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6653365|NCT01451229|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6653366|NCT01451229|Adrenergic Agents|adrenergic agents|mesh-ancestor
6653367|NCT01451229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6653368|NCT01451229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653369|NCT01451229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653370|NCT01451229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6653371|NCT01451229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6653372|NCT01451229|Analgesics|analgesics|mesh-ancestor
5489670|NCT03867201|Analgesics|analgesics|mesh-ancestor
5489671|NCT03867201|Sensory System Agents|sensory system agents|mesh-ancestor
5489672|NCT03867201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5489673|NCT03867201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489674|NCT03858049|Dydrogesterone|dydrogesterone|mesh-list
5489675|NCT03858049|Progestins|progestins|mesh-ancestor
5489676|NCT03858049|Hormones|hormones|mesh-ancestor
5489677|NCT03858049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5489678|NCT03858049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489679|NCT03852888|Methotrexate|methotrexate|mesh-list
5489680|NCT03852888|7-hydroxymethotrexate|7-hydroxymethotrexate|mesh-list
5489681|NCT03852888|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5489682|NCT03852888|Abortifacient Agents|abortifacient agents|mesh-ancestor
5489683|NCT03852888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5489684|NCT03852888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489685|NCT03852888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5489686|NCT03852888|Antimetabolites|antimetabolites|mesh-ancestor
5489687|NCT03852888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489688|NCT03852888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5489689|NCT03852888|Dermatologic Agents|dermatologic agents|mesh-ancestor
6454004|NCT00422682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6454005|NCT00422682|Tubulin Modulators|tubulin modulators|mesh-ancestor
6454006|NCT00422682|Antimitotic Agents|antimitotic agents|mesh-ancestor
6454007|NCT00422682|Mitosis Modulators|mitosis modulators|mesh-ancestor
6454008|NCT00422682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489690|NCT03852888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5489691|NCT03852888|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5489692|NCT03852888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5489693|NCT03852888|Immunologic Factors|immunologic factors|mesh-ancestor
5489694|NCT03852888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5489695|NCT03852888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5489696|NCT03850418|Azacitidine|azacitidine|mesh-list
5489697|NCT03850418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5489698|NCT03850418|Antimetabolites|antimetabolites|mesh-ancestor
5489699|NCT03850418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489700|NCT03850418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5489701|NCT03850418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5489702|NCT03850379|Ciprofloxacin|ciprofloxacin|mesh-list
5489703|NCT03850379|Levofloxacin|levofloxacin|mesh-list
6454009|NCT00422682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6454010|NCT00422682|Antimetabolites|antimetabolites|mesh-ancestor
6454011|NCT00422682|Antiviral Agents|antiviral agents|mesh-ancestor
6653373|NCT01451229|Sensory System Agents|sensory system agents|mesh-ancestor
5489704|NCT03850379|Ofloxacin|ofloxacin|mesh-list
5489705|NCT03850379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5489706|NCT03850379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5489707|NCT03850379|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5489708|NCT03850379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5489709|NCT03850379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6653374|NCT01451229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6653375|NCT01451229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6653376|NCT01451229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6653377|NCT01451229|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6653378|NCT01451229|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6653379|NCT01451229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6653380|NCT01451229|Protective Agents|protective agents|mesh-ancestor
6653381|NCT01451268|Panobinostat|panobinostat|mesh-list
6653382|NCT01451268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6653383|NCT01451268|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6653384|NCT01451268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6653385|NCT01451268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653386|NCT01451294|Phenylephrine|phenylephrine|mesh-list
6653387|NCT01451294|Oxymetazoline|oxymetazoline|mesh-list
6653388|NCT01451294|Ephedrine|ephedrine|mesh-list
6653389|NCT01451294|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6653390|NCT01451294|Mydriatics|mydriatics|mesh-ancestor
6653391|NCT01451294|Autonomic Agents|autonomic agents|mesh-ancestor
6653392|NCT01451294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6653393|NCT01451294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653394|NCT01451294|Sympathomimetics|sympathomimetics|mesh-ancestor
6653395|NCT01451294|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6653396|NCT01451294|Nasal Decongestants|nasal decongestants|mesh-ancestor
6653397|NCT01451294|Respiratory System Agents|respiratory system agents|mesh-ancestor
6653398|NCT01451294|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6653399|NCT01451294|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6653400|NCT01451294|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6653401|NCT01451294|Adrenergic Agents|adrenergic agents|mesh-ancestor
6653402|NCT01451294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6653403|NCT01451294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653404|NCT01451294|Protective Agents|protective agents|mesh-ancestor
6653405|NCT01451294|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6653406|NCT01451320|Plasminogen|plasminogen|mesh-list
6653407|NCT01451320|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6653408|NCT01451320|Streptokinase|streptokinase|mesh-list
6653409|NCT01451320|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6653410|NCT01451320|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6653411|NCT01451320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489710|NCT03850379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489711|NCT03850379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5489712|NCT03850379|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5489713|NCT03850379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5489714|NCT03850379|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5489715|NCT03850379|Renal Agents|renal agents|mesh-ancestor
5502893|NCT04463875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5502894|NCT04463875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5502895|NCT04463875|Analgesics|analgesics|mesh-ancestor
5502896|NCT04463875|Sensory System Agents|sensory system agents|mesh-ancestor
5502897|NCT04463875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5502898|NCT04463875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5502899|NCT04463875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5502900|NCT04463875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5502901|NCT04463875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5502902|NCT04463875|Antiviral Agents|antiviral agents|mesh-ancestor
5502903|NCT04463875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5502904|NCT04463784|Efavirenz|efavirenz|mesh-list
5502905|NCT04463784|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5502906|NCT04463784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6454012|NCT00422682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6454013|NCT00422682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6454014|NCT00422682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6454015|NCT00422682|Immunologic Factors|immunologic factors|mesh-ancestor
6454016|NCT00422682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454017|NCT00422682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6454018|NCT00422682|Alkylating Agents|alkylating agents|mesh-ancestor
6454019|NCT00422682|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6454020|NCT00422682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6653412|NCT01451333|Efavirenz|efavirenz|mesh-list
6664561|NCT01512901|Betamethasone|betamethasone|mesh-list
5489716|NCT03850366|Cyclophosphamide|cyclophosphamide|mesh-list
5489717|NCT03850366|Bortezomib|bortezomib|mesh-list
5489718|NCT03850366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5489719|NCT03850366|Immunologic Factors|immunologic factors|mesh-ancestor
5489720|NCT03850366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489721|NCT03850366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5489722|NCT03850366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6653413|NCT01451333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6653414|NCT01451333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6653415|NCT01451333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6653416|NCT01451333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653417|NCT01451333|Antiviral Agents|antiviral agents|mesh-ancestor
6653418|NCT01451333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6653419|NCT01451333|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6653420|NCT01451333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6653421|NCT01451333|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6653422|NCT01451333|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6653423|NCT01451333|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6653424|NCT01451333|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6653425|NCT01451489|Cyclophosphamide|cyclophosphamide|mesh-list
6653426|NCT01451489|Tacrolimus|tacrolimus|mesh-list
6653427|NCT01451489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6653428|NCT01451489|Immunologic Factors|immunologic factors|mesh-ancestor
6653429|NCT01451489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653430|NCT01451489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6653431|NCT01451489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6653432|NCT01451489|Alkylating Agents|alkylating agents|mesh-ancestor
6653433|NCT01451489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653434|NCT01451489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6653435|NCT01451489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6653436|NCT01451489|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6653437|NCT01451489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6653438|NCT01451515|Cytarabine|cytarabine|mesh-list
6653439|NCT01451515|Dexamethasone|dexamethasone|mesh-list
6653440|NCT01451515|Prednisone|prednisone|mesh-list
6653441|NCT01451515|Prednisolone|prednisolone|mesh-list
6653442|NCT01451515|Hydrocortisone|hydrocortisone|mesh-list
6653443|NCT01451515|Cyclophosphamide|cyclophosphamide|mesh-list
6653444|NCT01451515|Doxorubicin|doxorubicin|mesh-list
6653445|NCT01451515|Methotrexate|methotrexate|mesh-list
6653446|NCT01451515|Etoposide|etoposide|mesh-list
6653447|NCT01451515|Vincristine|vincristine|mesh-list
6653448|NCT01451515|Daunorubicin|daunorubicin|mesh-list
6653449|NCT01451515|Asparaginase|asparaginase|mesh-list
6653450|NCT01451515|Mercaptopurine|mercaptopurine|mesh-list
6653451|NCT01451515|Clofarabine|clofarabine|mesh-list
6653452|NCT01451515|Pegaspargase|pegaspargase|mesh-list
6653453|NCT01451515|Thioguanine|thioguanine|mesh-list
6653454|NCT01451515|Antimetabolites|antimetabolites|mesh-list
6653455|NCT01451515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6653456|NCT01451515|Immunologic Factors|immunologic factors|mesh-ancestor
6653457|NCT01451515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653458|NCT01451515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6653459|NCT01451515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6653460|NCT01451515|Alkylating Agents|alkylating agents|mesh-ancestor
5489723|NCT03850366|Alkylating Agents|alkylating agents|mesh-ancestor
6653461|NCT01451515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653462|NCT01451515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6653463|NCT01451515|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6653464|NCT01451515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6653465|NCT01451515|Antiemetics|antiemetics|mesh-ancestor
6653466|NCT01451515|Autonomic Agents|autonomic agents|mesh-ancestor
6653467|NCT01451515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6653468|NCT01451515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6653469|NCT01451515|Glucocorticoids|glucocorticoids|mesh-ancestor
6653470|NCT01451515|Hormones|hormones|mesh-ancestor
6653471|NCT01451515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6653472|NCT01451515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6653473|NCT01451515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6653474|NCT01451515|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6653475|NCT01451515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6653476|NCT01451515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5489724|NCT03850366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489725|NCT03850366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5489726|NCT03850366|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5489727|NCT03849469|Pembrolizumab|pembrolizumab|mesh-list
5489728|NCT03849469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6653477|NCT01451515|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6653478|NCT01451515|Abortifacient Agents|abortifacient agents|mesh-ancestor
6653479|NCT01451515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6653480|NCT01451515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6653481|NCT01451515|Dermatologic Agents|dermatologic agents|mesh-ancestor
6653482|NCT01451515|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6653483|NCT01451515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6653484|NCT01451515|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6653485|NCT01451515|Antiviral Agents|antiviral agents|mesh-ancestor
6653486|NCT01451515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6653487|NCT01451515|Tubulin Modulators|tubulin modulators|mesh-ancestor
6653488|NCT01451515|Antimitotic Agents|antimitotic agents|mesh-ancestor
6653489|NCT01451515|Mitosis Modulators|mitosis modulators|mesh-ancestor
6653490|NCT01451580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6653491|NCT01451580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6653492|NCT01451580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6653493|NCT01451593|Phenytoin|phenytoin|mesh-list
6653494|NCT01451593|Anticonvulsants|anticonvulsants|mesh-ancestor
6653495|NCT01451593|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6653496|NCT01451593|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6653497|NCT01451593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6653498|NCT01451593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653499|NCT01451593|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5489729|NCT03849469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5489730|NCT03840148|Meropenem|meropenem|mesh-list
5489731|NCT03840148|Cefepime|cefepime|mesh-list
5489732|NCT03840148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5489733|NCT03840148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5489734|NCT03832127|Fludarabine|fludarabine|mesh-list
5489735|NCT03832127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5489736|NCT03824522|BAX 855|bax 855|mesh-list
5489737|NCT03824522|Coagulants|coagulants|mesh-ancestor
5489738|NCT03823365|Blinatumomab|blinatumomab|mesh-list
5489739|NCT03823365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5489740|NCT03819114|Levonorgestrel|levonorgestrel|mesh-list
5489741|NCT03819114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5489742|NCT03819114|Contraceptive Agents|contraceptive agents|mesh-ancestor
6021814|NCT00402233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021815|NCT00402233|Protective Agents|protective agents|mesh-ancestor
6021816|NCT00402233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021817|NCT00402233|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6454021|NCT00422682|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6454022|NCT00422708|Anesthetics|anesthetics|mesh-list
6454023|NCT00422708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6454024|NCT00422708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461905|NCT00456794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461906|NCT00456794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461907|NCT00456820|Bupropion|bupropion|mesh-list
6461908|NCT00456820|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6461909|NCT00456820|Antidepressive Agents|antidepressive agents|mesh-ancestor
6461910|NCT00456820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6461911|NCT00456820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6461912|NCT00456820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6653500|NCT01451593|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6653501|NCT01451658|Propranolol|propranolol|mesh-list
6653502|NCT01451658|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6653503|NCT01451658|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6653504|NCT01451658|Adrenergic Agents|adrenergic agents|mesh-ancestor
6653505|NCT01451658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6454025|NCT00422773|Cetuximab|cetuximab|mesh-list
6454026|NCT00422773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6454027|NCT00422773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6454028|NCT00422825|Imatinib Mesylate|imatinib mesylate|mesh-list
6454029|NCT00422825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6454030|NCT00422825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6454031|NCT00422825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6653506|NCT01451658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653507|NCT01451658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653508|NCT01451658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6653509|NCT01451658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6653510|NCT01451658|Vasodilator Agents|vasodilator agents|mesh-ancestor
6653511|NCT01451710|Prednisone|prednisone|mesh-list
6653512|NCT01451710|Prednisolone|prednisolone|mesh-list
6653513|NCT01451710|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6653514|NCT01451710|Methylprednisolone|methylprednisolone|mesh-list
6653515|NCT01451710|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6653516|NCT01451710|Prednisolone acetate|prednisolone acetate|mesh-list
6653517|NCT01451710|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6653518|NCT01451710|Prednisolone phosphate|prednisolone phosphate|mesh-list
6653519|NCT01451710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6653520|NCT01451710|Glucocorticoids|glucocorticoids|mesh-ancestor
6653521|NCT01451710|Hormones|hormones|mesh-ancestor
6653522|NCT01451710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6653523|NCT01451710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653524|NCT01451710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6653525|NCT01451710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6021818|NCT00402233|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6653526|NCT01451710|Antiemetics|antiemetics|mesh-ancestor
6653527|NCT01451710|Autonomic Agents|autonomic agents|mesh-ancestor
6653528|NCT01451710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6653529|NCT01451710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6021819|NCT00402233|Dopamine Agonists|dopamine agonists|mesh-ancestor
6021820|NCT00402233|Dopamine Agents|dopamine agents|mesh-ancestor
6021821|NCT00402233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6021822|NCT00402285|Lycopene|lycopene|mesh-list
6021823|NCT00402285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6021824|NCT00402285|Antioxidants|antioxidants|mesh-ancestor
6021825|NCT00402285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021826|NCT00402285|Protective Agents|protective agents|mesh-ancestor
6021827|NCT00402285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021828|NCT00402285|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6021829|NCT00402285|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6021830|NCT00402285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6021831|NCT00402298|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
6021832|NCT00402298|Hallucinogens|hallucinogens|mesh-ancestor
6021833|NCT00402298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021834|NCT00402298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6021835|NCT00402298|Serotonin Agents|serotonin agents|mesh-ancestor
6021836|NCT00402298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6021837|NCT00402298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021838|NCT00402298|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6021839|NCT00402298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6021840|NCT00402298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6021841|NCT00402298|Adrenergic Agents|adrenergic agents|mesh-ancestor
6021842|NCT00402324|Valproic Acid|valproic acid|mesh-list
6021843|NCT00402324|Olanzapine|olanzapine|mesh-list
6021844|NCT00402324|Antiemetics|antiemetics|mesh-ancestor
6021845|NCT00402324|Autonomic Agents|autonomic agents|mesh-ancestor
6021846|NCT00402324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6021847|NCT00402324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454032|NCT00422825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6454033|NCT00422864|Leucovorin|leucovorin|mesh-list
6653530|NCT01451710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6653531|NCT01451710|Protective Agents|protective agents|mesh-ancestor
6021848|NCT00402324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5489743|NCT03819114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6653532|NCT01451736|Risperidone|risperidone|mesh-list
6653533|NCT01451736|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6653534|NCT01451736|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6653535|NCT01451736|Serotonin Agents|serotonin agents|mesh-ancestor
6653536|NCT01451736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6653537|NCT01451736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653538|NCT01451736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653539|NCT01451736|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6653540|NCT01451736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6653541|NCT01451736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6653542|NCT01451736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6653543|NCT01451736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6653544|NCT01451736|Dopamine Agents|dopamine agents|mesh-ancestor
6653545|NCT01451736|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6653546|NCT01451736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6653547|NCT01451788|Thrombin|thrombin|mesh-list
6653548|NCT01451788|Hemostatics|hemostatics|mesh-ancestor
6653549|NCT01451788|Coagulants|coagulants|mesh-ancestor
6653550|NCT01451840|Lidocaine|lidocaine|mesh-list
6653551|NCT01451840|Remifentanil|remifentanil|mesh-list
6653552|NCT01451840|Anesthetics, Local|anesthetics, local|mesh-ancestor
6653553|NCT01451840|Anesthetics|anesthetics|mesh-ancestor
6653554|NCT01451840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6653555|NCT01451840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653556|NCT01451840|Sensory System Agents|sensory system agents|mesh-ancestor
6653557|NCT01451840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6653558|NCT01451840|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6653559|NCT01451840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6653560|NCT01451840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6653561|NCT01451840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6653562|NCT01451840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653563|NCT01451840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6653564|NCT01451840|Narcotics|narcotics|mesh-ancestor
6653565|NCT01451840|Analgesics|analgesics|mesh-ancestor
6653566|NCT01451853|Ebselen|ebselen|mesh-list
6653567|NCT01451853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6653568|NCT01451853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6653569|NCT01451853|Analgesics|analgesics|mesh-ancestor
6653570|NCT01451853|Sensory System Agents|sensory system agents|mesh-ancestor
6653571|NCT01451853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6653572|NCT01451853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653573|NCT01451853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6653574|NCT01451853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6653575|NCT01451853|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6653576|NCT01451853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6653577|NCT01451853|Antioxidants|antioxidants|mesh-ancestor
6653578|NCT01451853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653579|NCT01451853|Protective Agents|protective agents|mesh-ancestor
6653580|NCT01451853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6653581|NCT01451853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6653582|NCT01451853|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6653583|NCT01451879|Miglustat|miglustat|mesh-list
6653584|NCT01451879|Rituximab|rituximab|mesh-list
6653585|NCT01451879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6653586|NCT01451879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6653587|NCT01451879|Immunologic Factors|immunologic factors|mesh-ancestor
6653588|NCT01451879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653589|NCT01451879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6653590|NCT01451879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6653591|NCT01451879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653592|NCT01451879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6653593|NCT01451879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6653594|NCT01451879|Antiviral Agents|antiviral agents|mesh-ancestor
6653595|NCT01451879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5489744|NCT03819114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489745|NCT03819114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5489746|NCT03819114|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5489747|NCT03819114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5489748|NCT03815682|Pembrolizumab|pembrolizumab|mesh-list
5489749|NCT03815682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5489750|NCT03815682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5489751|NCT03808077|Rocuronium|rocuronium|mesh-list
5489752|NCT03808077|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5489753|NCT03808077|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5489754|NCT03808077|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5489755|NCT03808077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5489756|NCT03808077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489757|NCT03804268|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5489758|NCT03804268|Pilocarpine|pilocarpine|mesh-list
5489759|NCT03804268|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5489760|NCT03804268|Miotics|miotics|mesh-ancestor
5489761|NCT03804268|Autonomic Agents|autonomic agents|mesh-ancestor
5489762|NCT03804268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5489763|NCT03804268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489764|NCT03804268|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
5489765|NCT03804268|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5489766|NCT03804268|Cholinergic Agents|cholinergic agents|mesh-ancestor
5489767|NCT03804268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5489768|NCT03804268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489769|NCT03804138|Vaccines|vaccines|mesh-list
5489770|NCT03804138|Immunologic Factors|immunologic factors|mesh-ancestor
5489771|NCT03804138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489772|NCT03796273|Ketoconazole|ketoconazole|mesh-list
5489773|NCT03796273|Antifungal Agents|antifungal agents|mesh-ancestor
5489774|NCT03796273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5489775|NCT03796273|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5489776|NCT03796273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5489777|NCT03796273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5489778|NCT03796273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489779|NCT03796273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5489780|NCT03796273|Hormone Antagonists|hormone antagonists|mesh-ancestor
5489781|NCT03796273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5489782|NCT03796273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489783|NCT03796273|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5489784|NCT05239390|Dronabinol|dronabinol|mesh-list
5489785|NCT05239390|Hallucinogens|hallucinogens|mesh-ancestor
5489786|NCT05239390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653596|NCT01451879|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6653597|NCT01451879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6653598|NCT01451905|Liraglutide|liraglutide|mesh-list
6653599|NCT01451905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6653600|NCT01451905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653601|NCT01451905|Incretins|incretins|mesh-ancestor
6653602|NCT01451905|Hormones|hormones|mesh-ancestor
6653603|NCT01451905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6653604|NCT01451918|Resveratrol|resveratrol|mesh-list
6653605|NCT01451918|Antioxidants|antioxidants|mesh-ancestor
6653606|NCT01451918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653607|NCT01451918|Protective Agents|protective agents|mesh-ancestor
6653608|NCT01451918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653609|NCT01451918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6653610|NCT01451918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6653611|NCT01452009|Travoprost|travoprost|mesh-list
6653612|NCT01452009|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6653613|NCT01452009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6653614|NCT01452009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6664562|NCT01512901|Betamethasone Valerate|betamethasone valerate|mesh-list
6664563|NCT01512901|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
6664564|NCT01512901|Betamethasone benzoate|betamethasone benzoate|mesh-list
6664565|NCT01512901|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
6664566|NCT01512901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6664567|NCT01512901|Glucocorticoids|glucocorticoids|mesh-ancestor
6664568|NCT01512901|Hormones|hormones|mesh-ancestor
6664569|NCT01512901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6664570|NCT01512901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664571|NCT01512901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6664572|NCT01512901|Respiratory System Agents|respiratory system agents|mesh-ancestor
6664573|NCT01512914|Ropivacaine|ropivacaine|mesh-list
6653615|NCT01452100|Prednisone|prednisone|mesh-list
6653616|NCT01452100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6653617|NCT01452100|Glucocorticoids|glucocorticoids|mesh-ancestor
6653618|NCT01452100|Hormones|hormones|mesh-ancestor
6653619|NCT01452100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6653620|NCT01452100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653621|NCT01452100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6653622|NCT01452100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6653623|NCT01452113|Vildagliptin|vildagliptin|mesh-list
6653624|NCT01452113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6653625|NCT01452113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653626|NCT01452113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6653627|NCT01452113|Protease Inhibitors|protease inhibitors|mesh-ancestor
6653628|NCT01452113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6653629|NCT01452113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653630|NCT01452139|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6653631|NCT01452139|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6653632|NCT01452217|Secretin|secretin|mesh-list
6653633|NCT01452217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6653634|NCT01452217|Hormones|hormones|mesh-ancestor
6653635|NCT01452217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6653636|NCT01452217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653637|NCT01452243|Vitamin D|vitamin d|mesh-list
6653638|NCT01452243|Calcium|calcium|mesh-list
6653639|NCT01452243|Vitamins|vitamins|mesh-ancestor
6653640|NCT01452243|Micronutrients|micronutrients|mesh-ancestor
6653641|NCT01452243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653642|NCT01452243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6653643|NCT01452243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6653644|NCT01452256|Propofol|propofol|mesh-list
6653645|NCT01452256|Desflurane|desflurane|mesh-list
6653646|NCT01452256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6653647|NCT01452256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6653648|NCT01452256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653649|NCT01452256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6653650|NCT01452256|Anesthetics, General|anesthetics, general|mesh-ancestor
5489787|NCT05239390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5489788|NCT05239390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5489789|NCT05239390|Analgesics|analgesics|mesh-ancestor
5489790|NCT05239390|Sensory System Agents|sensory system agents|mesh-ancestor
5489791|NCT05239390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5489792|NCT05239390|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5489793|NCT05239390|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5489794|NCT05239390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5489795|NCT05239390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489796|NCT05239390|Hormones|hormones|mesh-ancestor
5489797|NCT05239390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5489798|NCT05239312|Anti-Infective Agents|anti-infective agents|mesh-list
5489799|NCT05239312|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5489800|NCT05239286|Anesthetics|anesthetics|mesh-list
5489801|NCT05239286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5489802|NCT05239286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489803|NCT05239169|Capecitabine|capecitabine|mesh-list
6653651|NCT01452256|Anesthetics|anesthetics|mesh-ancestor
6653652|NCT01452256|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6653653|NCT01452334|BMS-936559|bms-936559|mesh-list
6653654|NCT01452334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6653655|NCT01452334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6653656|NCT01452373|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
6653657|NCT01452373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6653658|NCT01452373|Immunologic Factors|immunologic factors|mesh-ancestor
6653659|NCT01452373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653660|NCT01452477|Tanshinone|tanshinone|mesh-list
6653661|NCT01452477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6653662|NCT01452477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6653663|NCT01452477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6653664|NCT01452477|Analgesics|analgesics|mesh-ancestor
6653665|NCT01452477|Sensory System Agents|sensory system agents|mesh-ancestor
6653666|NCT01452477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6653667|NCT01452477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653668|NCT01452477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6653669|NCT01452477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6653670|NCT01452477|Anticoagulants|anticoagulants|mesh-ancestor
6653671|NCT01452477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5489804|NCT05239169|Durvalumab|durvalumab|mesh-list
6653672|NCT01452477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6653673|NCT01452477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6653674|NCT01452477|Immunologic Factors|immunologic factors|mesh-ancestor
6653675|NCT01452542|Eliglustat|eliglustat|mesh-list
6653676|NCT01452542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6653677|NCT01452542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653678|NCT01452568|Aspirin|aspirin|mesh-list
6653679|NCT01452568|Salicylic Acid|salicylic acid|mesh-list
6653680|NCT01452568|Salicylates|salicylates|mesh-list
6653681|NCT01452568|Warfarin|warfarin|mesh-list
6653682|NCT01452568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6653683|NCT01452568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6653684|NCT01452568|Analgesics|analgesics|mesh-ancestor
6653685|NCT01452568|Sensory System Agents|sensory system agents|mesh-ancestor
6653686|NCT01452568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6653687|NCT01452568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653688|NCT01452568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6653689|NCT01452568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6653690|NCT01452568|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6653691|NCT01452568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6653692|NCT01452568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653693|NCT01452568|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6653694|NCT01452568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5489805|NCT05239169|Tremelimumab|tremelimumab|mesh-list
5489806|NCT05239169|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5489807|NCT05239169|Antimetabolites|antimetabolites|mesh-ancestor
5489808|NCT05239169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489809|NCT05239169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5489810|NCT05239169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5489811|NCT05239091|Lidocaine|lidocaine|mesh-list
5489812|NCT05239091|Anesthetics, Local|anesthetics, local|mesh-list
5489813|NCT05239091|Anesthetics|anesthetics|mesh-list
5489814|NCT05239091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5489815|NCT05239091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653695|NCT01452568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6653696|NCT01452568|Antipyretics|antipyretics|mesh-ancestor
6653697|NCT01452568|Anticoagulants|anticoagulants|mesh-ancestor
6653698|NCT01452568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6653699|NCT01452568|Antifungal Agents|antifungal agents|mesh-ancestor
6653700|NCT01452568|Keratolytic Agents|keratolytic agents|mesh-ancestor
6653701|NCT01452568|Dermatologic Agents|dermatologic agents|mesh-ancestor
6653702|NCT01452607|Ebselen|ebselen|mesh-list
6653703|NCT01452607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6653704|NCT01452607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6653705|NCT01452607|Analgesics|analgesics|mesh-ancestor
6653706|NCT01452607|Sensory System Agents|sensory system agents|mesh-ancestor
6653707|NCT01452607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6653708|NCT01452607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653709|NCT01452607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6653710|NCT01452607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6653711|NCT01452607|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6653712|NCT01452607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6653713|NCT01452607|Antioxidants|antioxidants|mesh-ancestor
6653714|NCT01452607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653715|NCT01452607|Protective Agents|protective agents|mesh-ancestor
6653716|NCT01452607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6653717|NCT01452607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6653718|NCT01452607|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6653719|NCT01452633|Bupivacaine|bupivacaine|mesh-list
6653720|NCT01452633|Anesthetics, Local|anesthetics, local|mesh-ancestor
6653721|NCT01452633|Anesthetics|anesthetics|mesh-ancestor
6653722|NCT01452633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6653723|NCT01452633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653724|NCT01452633|Sensory System Agents|sensory system agents|mesh-ancestor
6653725|NCT01452633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5489816|NCT05239091|Sensory System Agents|sensory system agents|mesh-ancestor
5489817|NCT05239091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5489818|NCT05239091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5489819|NCT05239091|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5489820|NCT05239091|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5489821|NCT05239091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5489822|NCT05239091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489823|NCT05239078|Anesthetics|anesthetics|mesh-list
6653726|NCT01452659|Relugolix|relugolix|mesh-list
6653727|NCT01452659|Androgen Antagonists|androgen antagonists|mesh-ancestor
6454034|NCT00422864|Fluorouracil|fluorouracil|mesh-list
6454035|NCT00422864|Oxaliplatin|oxaliplatin|mesh-list
6454036|NCT00422864|Antimetabolites|antimetabolites|mesh-ancestor
6454037|NCT00422864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6454038|NCT00422864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6454039|NCT00422864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5489824|NCT05239078|Anesthetics, Local|anesthetics, local|mesh-list
5489825|NCT05239078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5489826|NCT05239078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489827|NCT05239078|Sensory System Agents|sensory system agents|mesh-ancestor
5502907|NCT04463784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6653728|NCT01452659|Hormone Antagonists|hormone antagonists|mesh-ancestor
6653729|NCT01452659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6653730|NCT01452659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653731|NCT01452685|Leuprolide|leuprolide|mesh-list
6653732|NCT01452685|Relugolix|relugolix|mesh-list
6653733|NCT01452685|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6653734|NCT01452685|Fertility Agents|fertility agents|mesh-ancestor
6653735|NCT01452685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6653736|NCT01452685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653737|NCT01452685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6653738|NCT01452685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6653739|NCT01452685|Androgen Antagonists|androgen antagonists|mesh-ancestor
6653740|NCT01452685|Hormone Antagonists|hormone antagonists|mesh-ancestor
6653741|NCT01452685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6653742|NCT01452698|Lansoprazole|lansoprazole|mesh-list
6653743|NCT01452698|Dexlansoprazole|dexlansoprazole|mesh-list
6653744|NCT01452698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6653745|NCT01452698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6653746|NCT01452698|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6653747|NCT01452698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6653748|NCT01452698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653749|NCT01452711|Lansoprazole|lansoprazole|mesh-list
6653750|NCT01452711|Dexlansoprazole|dexlansoprazole|mesh-list
6653751|NCT01452711|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6653752|NCT01452711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6653753|NCT01452711|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6653754|NCT01452711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6653755|NCT01452711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653756|NCT01452724|Lansoprazole|lansoprazole|mesh-list
6653757|NCT01452724|Dexlansoprazole|dexlansoprazole|mesh-list
6653758|NCT01452724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6653759|NCT01452724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6653760|NCT01452724|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6653761|NCT01452724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6653762|NCT01452724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653763|NCT01452737|Bisacodyl|bisacodyl|mesh-list
6653764|NCT01452737|Cathartics|cathartics|mesh-ancestor
6653765|NCT01452737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6653766|NCT01452737|Laxatives|laxatives|mesh-ancestor
6653767|NCT01452750|Lansoprazole|lansoprazole|mesh-list
6653768|NCT01452750|Dexlansoprazole|dexlansoprazole|mesh-list
6653769|NCT01452750|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6653770|NCT01452750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6653771|NCT01452750|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6653772|NCT01452750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6653773|NCT01452750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653774|NCT01452763|Lansoprazole|lansoprazole|mesh-list
6653775|NCT01452763|Dexlansoprazole|dexlansoprazole|mesh-list
6653776|NCT01452763|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6653777|NCT01452763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6653778|NCT01452763|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6653779|NCT01452763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6653780|NCT01452763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653781|NCT01452828|Tedizolid phosphate|tedizolid phosphate|mesh-list
6653782|NCT01452828|Tedizolid|tedizolid|mesh-list
6653783|NCT01452828|Oxazolidinones|oxazolidinones|mesh-list
6454040|NCT00422864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6454041|NCT00422864|Immunologic Factors|immunologic factors|mesh-ancestor
6454042|NCT00422864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454043|NCT00422864|Antidotes|antidotes|mesh-ancestor
6454044|NCT00422864|Protective Agents|protective agents|mesh-ancestor
6454045|NCT00422864|Vitamin B Complex|vitamin b complex|mesh-ancestor
6454046|NCT00422864|Vitamins|vitamins|mesh-ancestor
6454047|NCT00422864|Micronutrients|micronutrients|mesh-ancestor
6454048|NCT00422955|Rosiglitazone|rosiglitazone|mesh-list
6653784|NCT01452828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6653785|NCT01452828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6653786|NCT01452828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6653787|NCT01452828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6653788|NCT01452828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653789|NCT01452867|Chlorhexidine|chlorhexidine|mesh-list
6653790|NCT01452867|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6653791|NCT01452867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6653792|NCT01452867|Disinfectants|disinfectants|mesh-ancestor
6653793|NCT01452880|Remifentanil|remifentanil|mesh-list
6653794|NCT01452880|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6653795|NCT01452880|Narcotics|narcotics|mesh-ancestor
6653796|NCT01452880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6653797|NCT01452880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653798|NCT01452880|Analgesics|analgesics|mesh-ancestor
6653799|NCT01452880|Sensory System Agents|sensory system agents|mesh-ancestor
6653800|NCT01452880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6653801|NCT01452906|Omeprazole|omeprazole|mesh-list
6653802|NCT01452906|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6653803|NCT01452906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6021849|NCT00402324|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6021850|NCT00402324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6021851|NCT00402324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6653804|NCT01452906|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6653805|NCT01452906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6653806|NCT01452906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653807|NCT01453062|Ofatumumab|ofatumumab|mesh-list
6653808|NCT01453062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6653809|NCT01453088|Bortezomib|bortezomib|mesh-list
6021852|NCT00402324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6021853|NCT00402324|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6021854|NCT00402324|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6021855|NCT00402324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6021856|NCT00402324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021857|NCT00402324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6021858|NCT00402324|Serotonin Agents|serotonin agents|mesh-ancestor
6021859|NCT00402324|Anticonvulsants|anticonvulsants|mesh-ancestor
6021860|NCT00402324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6653810|NCT01453088|Melphalan|melphalan|mesh-list
6653811|NCT01453088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6653812|NCT01453088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6653813|NCT01453088|Alkylating Agents|alkylating agents|mesh-ancestor
6653814|NCT01453088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653815|NCT01453088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6653816|NCT01453088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6653817|NCT01453088|Immunologic Factors|immunologic factors|mesh-ancestor
6653818|NCT01453088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653819|NCT01453101|Fludarabine|fludarabine|mesh-list
6021861|NCT00402324|GABA Agents|gaba agents|mesh-ancestor
6021862|NCT00402324|Antimanic Agents|antimanic agents|mesh-ancestor
6021863|NCT00402337|Linaclotide|linaclotide|mesh-list
6021864|NCT00402337|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
6021865|NCT00402337|Enzyme Activators|enzyme activators|mesh-ancestor
6053249|NCT00593957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6653820|NCT01453101|Fludarabine phosphate|fludarabine phosphate|mesh-list
6653821|NCT01453101|Bortezomib|bortezomib|mesh-list
6653822|NCT01453101|Melphalan|melphalan|mesh-list
6653823|NCT01453101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6653824|NCT01453101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6653825|NCT01453101|Antimetabolites|antimetabolites|mesh-ancestor
6653826|NCT01453101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653827|NCT01453101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6653828|NCT01453101|Immunologic Factors|immunologic factors|mesh-ancestor
6653829|NCT01453101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653830|NCT01453101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6653831|NCT01453101|Alkylating Agents|alkylating agents|mesh-ancestor
6653832|NCT01453101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6653833|NCT01453140|Sirolimus|sirolimus|mesh-list
6653834|NCT01453140|Cyclophosphamide|cyclophosphamide|mesh-list
6653835|NCT01453140|Interleukin-2|interleukin-2|mesh-list
6653836|NCT01453140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6653837|NCT01453140|Immunologic Factors|immunologic factors|mesh-ancestor
5489828|NCT05239078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5489829|NCT05239013|Nitroglycerin|nitroglycerin|mesh-list
5489830|NCT05239013|Vasodilator Agents|vasodilator agents|mesh-ancestor
5489831|NCT05238948|Midazolam|midazolam|mesh-list
5489832|NCT05238948|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5489833|NCT05238948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5489834|NCT05238948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5489835|NCT05238948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489836|NCT05238948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5489837|NCT05238948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5489838|NCT05238948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5489839|NCT05238948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5489840|NCT05238948|Anesthetics, General|anesthetics, general|mesh-ancestor
5489841|NCT05238948|Anesthetics|anesthetics|mesh-ancestor
5489842|NCT05238948|GABA Modulators|gaba modulators|mesh-ancestor
5489843|NCT05238948|GABA Agents|gaba agents|mesh-ancestor
6653838|NCT01453140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653839|NCT01453140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6653840|NCT01453140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6653841|NCT01453140|Alkylating Agents|alkylating agents|mesh-ancestor
6653842|NCT01453140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653843|NCT01453140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6653844|NCT01453140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6653845|NCT01453140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6653846|NCT01453140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6653847|NCT01453140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6653848|NCT01453140|Antifungal Agents|antifungal agents|mesh-ancestor
6653849|NCT01453140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6653850|NCT01453140|Analgesics|analgesics|mesh-ancestor
6653851|NCT01453140|Sensory System Agents|sensory system agents|mesh-ancestor
6653852|NCT01453140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6653853|NCT01453192|Raltegravir Potassium|raltegravir potassium|mesh-list
6653854|NCT01453192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6653855|NCT01453192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6653856|NCT01453192|Antiviral Agents|antiviral agents|mesh-ancestor
5489844|NCT05238948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5489845|NCT05238948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489846|NCT05238844|Tenofovir|tenofovir|mesh-list
5489847|NCT05238844|Antiviral Agents|antiviral agents|mesh-ancestor
5489848|NCT05238844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5489849|NCT05238844|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5489850|NCT05238844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5489851|NCT05238844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5489852|NCT05238844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489853|NCT05238844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5489854|NCT05238844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6021866|NCT00402337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021867|NCT00402337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6653857|NCT01453192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6653858|NCT01453192|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6653859|NCT01453192|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6653860|NCT01453192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6653861|NCT01453192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653862|NCT01453283|Trabectedin|trabectedin|mesh-list
6653863|NCT01453283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6653864|NCT01453283|Alkylating Agents|alkylating agents|mesh-ancestor
6653865|NCT01453283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653866|NCT01453283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6021868|NCT00402597|Rivaroxaban|rivaroxaban|mesh-list
6454049|NCT00422955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6454050|NCT00422955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454051|NCT00422994|Ropinirole|ropinirole|mesh-list
6454052|NCT00422994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6454053|NCT00422994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6454054|NCT00422994|Dopamine Agonists|dopamine agonists|mesh-ancestor
6454055|NCT00422994|Dopamine Agents|dopamine agents|mesh-ancestor
6454056|NCT00422994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6461913|NCT00456820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6653867|NCT01453400|Aspirin|aspirin|mesh-list
6653868|NCT01453400|Acetaminophen|acetaminophen|mesh-list
6653869|NCT01453400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6653870|NCT01453400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6653871|NCT01453400|Analgesics|analgesics|mesh-ancestor
6653872|NCT01453400|Sensory System Agents|sensory system agents|mesh-ancestor
6653873|NCT01453400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6653874|NCT01453400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653875|NCT01453400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6653876|NCT01453400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6653877|NCT01453400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6653878|NCT01453400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6653879|NCT01453400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653880|NCT01453400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6653881|NCT01453400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6653882|NCT01453400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6653883|NCT01453400|Antipyretics|antipyretics|mesh-ancestor
6653884|NCT01453426|Dimethyl Fumarate|dimethyl fumarate|mesh-list
6653885|NCT01453426|Dermatologic Agents|dermatologic agents|mesh-ancestor
6653886|NCT01453426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6653887|NCT01453426|Immunologic Factors|immunologic factors|mesh-ancestor
6653888|NCT01453426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653889|NCT01453504|Everolimus|everolimus|mesh-list
6653890|NCT01453504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6653891|NCT01453504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6653892|NCT01453504|Immunologic Factors|immunologic factors|mesh-ancestor
6653893|NCT01453504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653894|NCT01453530|Glycopyrrolate|glycopyrrolate|mesh-list
6653895|NCT01453530|Neostigmine|neostigmine|mesh-list
6653896|NCT01453530|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6653897|NCT01453530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6653898|NCT01453530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653899|NCT01453530|Cholinergic Agents|cholinergic agents|mesh-ancestor
6653900|NCT01453530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6653901|NCT01453530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653902|NCT01453530|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6653903|NCT01453530|Autonomic Agents|autonomic agents|mesh-ancestor
6653904|NCT01453530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6021869|NCT00402597|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6021870|NCT00402597|Antithrombins|antithrombins|mesh-ancestor
6021871|NCT00402597|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6021872|NCT00402597|Protease Inhibitors|protease inhibitors|mesh-ancestor
6021873|NCT00402597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6021874|NCT00402597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021875|NCT00402597|Anticoagulants|anticoagulants|mesh-ancestor
6653905|NCT01453530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6653906|NCT01453530|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6653907|NCT01453530|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6653908|NCT01453582|Propolis|propolis|mesh-list
6653909|NCT01453582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6653910|NCT01453660|Cisplatin|cisplatin|mesh-list
6653911|NCT01453660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6653912|NCT01453686|Hydrocortisone|hydrocortisone|mesh-list
6653913|NCT01453686|Clobetasol|clobetasol|mesh-list
6021876|NCT00402688|Levofloxacin|levofloxacin|mesh-list
6021877|NCT00402688|Ofloxacin|ofloxacin|mesh-list
6021878|NCT00402688|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6021879|NCT00402688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6021880|NCT00402688|Renal Agents|renal agents|mesh-ancestor
6021881|NCT00402688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6021882|NCT00402688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6021883|NCT00402688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6653914|NCT01453686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6653915|NCT01453686|Glucocorticoids|glucocorticoids|mesh-ancestor
6653916|NCT01453686|Hormones|hormones|mesh-ancestor
6664574|NCT01512914|Anesthetics, Local|anesthetics, local|mesh-ancestor
6653917|NCT01453686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6653918|NCT01453686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664575|NCT01512914|Anesthetics|anesthetics|mesh-ancestor
6664576|NCT01512914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6664577|NCT01512914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664578|NCT01512914|Sensory System Agents|sensory system agents|mesh-ancestor
6664579|NCT01512914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6664580|NCT01512953|Lansoprazole|lansoprazole|mesh-list
6664581|NCT01512953|Dexlansoprazole|dexlansoprazole|mesh-list
6664582|NCT01512953|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6664583|NCT01512953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6664584|NCT01512953|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6664585|NCT01512953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6664586|NCT01512953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6664587|NCT01512966|Aflibercept|aflibercept|mesh-list
6664588|NCT01512966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6664589|NCT01512966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6664590|NCT01512966|Growth Substances|growth substances|mesh-ancestor
6664591|NCT01512966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664592|NCT01512966|Growth Inhibitors|growth inhibitors|mesh-ancestor
6664593|NCT01512966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6664594|NCT01513044|Mycophenolic Acid|mycophenolic acid|mesh-list
6664595|NCT01513044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6664596|NCT01513044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6664597|NCT01513044|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6664598|NCT01513044|Antitubercular Agents|antitubercular agents|mesh-ancestor
6664599|NCT01513044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6664600|NCT01513044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6664601|NCT01513044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6664602|NCT01513044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6664603|NCT01513057|Mycophenolic Acid|mycophenolic acid|mesh-list
6664604|NCT01513057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6664605|NCT01513057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6664606|NCT01513057|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6664607|NCT01513057|Antitubercular Agents|antitubercular agents|mesh-ancestor
6664608|NCT01513057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6664609|NCT01513057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6021884|NCT00402688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6021885|NCT00402688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021886|NCT00402688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6021887|NCT00402688|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6454057|NCT00422994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6454058|NCT00422994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454059|NCT00423007|Bromfenac|bromfenac|mesh-list
6454060|NCT00423007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6454061|NCT00423007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6454062|NCT00423007|Analgesics|analgesics|mesh-ancestor
6454063|NCT00423007|Sensory System Agents|sensory system agents|mesh-ancestor
6021888|NCT00402688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6021889|NCT00402714|Pentostatin|pentostatin|mesh-list
6021890|NCT00402714|Methoxsalen|methoxsalen|mesh-list
6021891|NCT00402714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6021892|NCT00402714|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
6021893|NCT00402714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6021894|NCT00402714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021895|NCT00402714|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6021896|NCT00402714|Dermatologic Agents|dermatologic agents|mesh-ancestor
6021897|NCT00402727|Amoxicillin|amoxicillin|mesh-list
6021898|NCT00402727|Moxifloxacin|moxifloxacin|mesh-list
6021899|NCT00402727|Tazobactam|tazobactam|mesh-list
6021900|NCT00402727|Piperacillin|piperacillin|mesh-list
6021901|NCT00402727|Clavulanic Acids|clavulanic acids|mesh-list
6021902|NCT00402727|Clavulanic Acid|clavulanic acid|mesh-list
6454064|NCT00423007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6664610|NCT01513057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6454065|NCT00423007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454066|NCT00423007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6021903|NCT00402727|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
6021904|NCT00402727|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6021905|NCT00402727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6021906|NCT00402727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6021907|NCT00402727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6021908|NCT00402727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6021909|NCT00402727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6021910|NCT00402727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021911|NCT00402727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6021912|NCT00402727|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6021913|NCT00402727|Contraceptive Agents|contraceptive agents|mesh-ancestor
6021914|NCT00402727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6454067|NCT00423007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6454068|NCT00423020|Epoetin Alfa|epoetin alfa|mesh-list
6454069|NCT00423020|Hematinics|hematinics|mesh-ancestor
6454070|NCT00423059|Bevacizumab|bevacizumab|mesh-list
6454071|NCT00423059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6454072|NCT00423059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6454073|NCT00423059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6454074|NCT00423059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6454075|NCT00423059|Growth Substances|growth substances|mesh-ancestor
6454076|NCT00423059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454077|NCT00423059|Growth Inhibitors|growth inhibitors|mesh-ancestor
6454078|NCT00423163|Voriconazole|voriconazole|mesh-list
6653919|NCT01453738|Plasma-lyte 148|plasma-lyte 148|mesh-list
6653920|NCT01453738|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6653921|NCT01453738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6653922|NCT01453881|Beclomethasone|beclomethasone|mesh-list
6653923|NCT01453881|Formoterol Fumarate|formoterol fumarate|mesh-list
6653924|NCT01453881|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6653925|NCT01453881|Autonomic Agents|autonomic agents|mesh-ancestor
6653926|NCT01453881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6653927|NCT01453881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653928|NCT01453881|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6653929|NCT01453881|Respiratory System Agents|respiratory system agents|mesh-ancestor
6653930|NCT01453881|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6653931|NCT01453881|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6653932|NCT01453881|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6653933|NCT01453881|Adrenergic Agents|adrenergic agents|mesh-ancestor
6653934|NCT01453881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6653935|NCT01453881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653936|NCT01453881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6653937|NCT01453881|Glucocorticoids|glucocorticoids|mesh-ancestor
6653938|NCT01453881|Hormones|hormones|mesh-ancestor
6653939|NCT01453881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6653940|NCT01453920|Ranibizumab|ranibizumab|mesh-list
6653941|NCT01453920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6653942|NCT01453920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6653943|NCT01453920|Growth Substances|growth substances|mesh-ancestor
6653944|NCT01453920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653945|NCT01453920|Growth Inhibitors|growth inhibitors|mesh-ancestor
6653946|NCT01453920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6653947|NCT01453933|Raltegravir Potassium|raltegravir potassium|mesh-list
6653948|NCT01453933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6653949|NCT01453933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6653950|NCT01453933|Antiviral Agents|antiviral agents|mesh-ancestor
6653951|NCT01453933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6653952|NCT01453933|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6653953|NCT01453933|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6653954|NCT01453933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6653955|NCT01453933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653956|NCT01453959|Fludrocortisone|fludrocortisone|mesh-list
6653957|NCT01453959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6653958|NCT01454011|Methyltestosterone|methyltestosterone|mesh-list
6653959|NCT01454011|Testosterone|testosterone|mesh-list
6653960|NCT01454011|Testosterone undecanoate|testosterone undecanoate|mesh-list
6021915|NCT00402727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021916|NCT00402727|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6021917|NCT00402727|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6454079|NCT00423163|Micafungin|micafungin|mesh-list
6454080|NCT00423163|Antifungal Agents|antifungal agents|mesh-ancestor
6653961|NCT01454011|Testosterone enanthate|testosterone enanthate|mesh-list
6653962|NCT01454011|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6021918|NCT00402727|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6021919|NCT00402727|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6021920|NCT00402779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6021921|NCT00402779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6021922|NCT00402779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6021923|NCT00402779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6021924|NCT00402779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021925|NCT00402896|Mitogens|mitogens|mesh-list
6021926|NCT00402896|Endothelial Growth Factors|endothelial growth factors|mesh-list
6021927|NCT00402896|Mitosis Modulators|mitosis modulators|mesh-ancestor
6021928|NCT00402896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021929|NCT00402896|Growth Substances|growth substances|mesh-ancestor
6021930|NCT00402896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021931|NCT00402987|Celecoxib|celecoxib|mesh-list
6021932|NCT00402987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6021933|NCT00402987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6021934|NCT00402987|Analgesics|analgesics|mesh-ancestor
6021935|NCT00402987|Sensory System Agents|sensory system agents|mesh-ancestor
6021936|NCT00402987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6021937|NCT00402987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021938|NCT00402987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6021939|NCT00402987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6021940|NCT00402987|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6021941|NCT00402987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6021942|NCT00402987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6021943|NCT00402987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021944|NCT00403117|Naltrexone|naltrexone|mesh-list
6021945|NCT00403117|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6021946|NCT00403117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6021947|NCT00403117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021948|NCT00403117|Sensory System Agents|sensory system agents|mesh-ancestor
6454081|NCT00423163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6454082|NCT00423163|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6454083|NCT00423163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6454084|NCT00423163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6454085|NCT00423163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6454086|NCT00423163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6454087|NCT00423163|Hormone Antagonists|hormone antagonists|mesh-ancestor
6454088|NCT00423163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6454089|NCT00423163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454090|NCT00423163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6454091|NCT00423202|Ambrisentan|ambrisentan|mesh-list
6454092|NCT00423202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6454093|NCT00423215|Insulin Glargine|insulin glargine|mesh-list
6454094|NCT00423215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6454095|NCT00423215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454096|NCT00423228|Donepezil|donepezil|mesh-list
6454097|NCT00423228|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6454098|NCT00423228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6454099|NCT00423228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6454100|NCT00423228|Cholinergic Agents|cholinergic agents|mesh-ancestor
6454101|NCT00423228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6454102|NCT00423228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454103|NCT00423228|Nootropic Agents|nootropic agents|mesh-ancestor
6454104|NCT00423371|Hyaluronic Acid|hyaluronic acid|mesh-list
6454105|NCT00423371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6454106|NCT00423371|Immunologic Factors|immunologic factors|mesh-ancestor
6454107|NCT00423371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454108|NCT00423371|Viscosupplements|viscosupplements|mesh-ancestor
6454109|NCT00423371|Protective Agents|protective agents|mesh-ancestor
6454110|NCT00423384|Ibandronic Acid|ibandronic acid|mesh-list
6454111|NCT00423384|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6454112|NCT00423384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454113|NCT00423397|Interferons|interferons|mesh-list
6454114|NCT00423397|Interferon-alpha|interferon-alpha|mesh-list
6454115|NCT00423397|Interferon alpha-2|interferon alpha-2|mesh-list
6454116|NCT00423397|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6454117|NCT00423397|Gefitinib|gefitinib|mesh-list
6454118|NCT00423397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6454119|NCT00423397|Antiviral Agents|antiviral agents|mesh-ancestor
6454120|NCT00423397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6454121|NCT00423397|Immunologic Factors|immunologic factors|mesh-ancestor
6454122|NCT00423397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454123|NCT00423397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6454124|NCT00423397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6454125|NCT00423397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6454126|NCT00423475|Goserelin|goserelin|mesh-list
6653963|NCT01454011|Androgens|androgens|mesh-ancestor
6653964|NCT01454011|Hormones|hormones|mesh-ancestor
6653965|NCT01454011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6653966|NCT01454011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653967|NCT01454011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6653968|NCT01454011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6653969|NCT01454011|Anabolic Agents|anabolic agents|mesh-ancestor
6653970|NCT01454154|Glyburide|glyburide|mesh-list
6653971|NCT01454154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6653972|NCT01454154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653973|NCT01454180|Leucovorin|leucovorin|mesh-list
6653974|NCT01454180|Gemcitabine|gemcitabine|mesh-list
6653975|NCT01454180|Capecitabine|capecitabine|mesh-list
6653976|NCT01454180|Fluorouracil|fluorouracil|mesh-list
6653977|NCT01454180|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6653978|NCT01454180|Oxaliplatin|oxaliplatin|mesh-list
6653979|NCT01454180|Folfirinox|folfirinox|mesh-list
6653980|NCT01454180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6653981|NCT01454180|Antimetabolites|antimetabolites|mesh-ancestor
6653982|NCT01454180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6653983|NCT01454180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6653984|NCT01454180|Antiviral Agents|antiviral agents|mesh-ancestor
6653985|NCT01454180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6653986|NCT01454180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6653987|NCT01454180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6653988|NCT01454180|Immunologic Factors|immunologic factors|mesh-ancestor
6653989|NCT01454180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6653990|NCT01454180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6653991|NCT01454180|Antidotes|antidotes|mesh-ancestor
6653992|NCT01454180|Protective Agents|protective agents|mesh-ancestor
6653993|NCT01454180|Vitamin B Complex|vitamin b complex|mesh-ancestor
6653994|NCT01454180|Vitamins|vitamins|mesh-ancestor
6653995|NCT01454180|Micronutrients|micronutrients|mesh-ancestor
6653996|NCT01454440|Eptifibatide|eptifibatide|mesh-list
6653997|NCT01454440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6653998|NCT01454479|Lapatinib|lapatinib|mesh-list
6653999|NCT01454479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6654000|NCT01454479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6654001|NCT01454479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6654002|NCT01454479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654003|NCT01454518|Anesthetics|anesthetics|mesh-list
6654004|NCT01454518|Anesthetics, Local|anesthetics, local|mesh-list
6654005|NCT01454518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6654006|NCT01454518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654007|NCT01454518|Sensory System Agents|sensory system agents|mesh-ancestor
6654008|NCT01454518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6654009|NCT01454609|Clonidine|clonidine|mesh-list
6654010|NCT01454609|Bupivacaine|bupivacaine|mesh-list
6654011|NCT01454609|Anesthetics, Local|anesthetics, local|mesh-ancestor
6654012|NCT01454609|Anesthetics|anesthetics|mesh-ancestor
6654013|NCT01454609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6654014|NCT01454609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654015|NCT01454609|Sensory System Agents|sensory system agents|mesh-ancestor
6654016|NCT01454609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6654017|NCT01454609|Analgesics|analgesics|mesh-ancestor
6654018|NCT01454609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6654019|NCT01454609|Sympatholytics|sympatholytics|mesh-ancestor
6654020|NCT01454609|Autonomic Agents|autonomic agents|mesh-ancestor
6654021|NCT01454609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6654022|NCT01454609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6454127|NCT00423475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6654023|NCT01454609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6654024|NCT01454609|Adrenergic Agents|adrenergic agents|mesh-ancestor
6654025|NCT01454609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6654026|NCT01454609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654027|NCT01454622|Metformin|metformin|mesh-list
6654028|NCT01454622|Canagliflozin|canagliflozin|mesh-list
6654029|NCT01454622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6654030|NCT01454622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654031|NCT01454622|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6654032|NCT01454622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654033|NCT01454635|Sertraline|sertraline|mesh-list
6654034|NCT01454635|Antidepressive Agents|antidepressive agents|mesh-ancestor
6654035|NCT01454635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6021949|NCT00403117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6021950|NCT00403130|Gemcitabine|gemcitabine|mesh-list
6021951|NCT00403130|Paclitaxel|paclitaxel|mesh-list
6021952|NCT00403130|Bevacizumab|bevacizumab|mesh-list
6021953|NCT00403130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6021954|NCT00403130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6021955|NCT00403130|Tubulin Modulators|tubulin modulators|mesh-ancestor
6021956|NCT00403130|Antimitotic Agents|antimitotic agents|mesh-ancestor
6021957|NCT00403130|Mitosis Modulators|mitosis modulators|mesh-ancestor
6021958|NCT00403130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021959|NCT00403130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6654036|NCT01454635|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6654037|NCT01454635|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6654038|NCT01454635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6654039|NCT01454635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654040|NCT01454635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6654041|NCT01454635|Serotonin Agents|serotonin agents|mesh-ancestor
6654042|NCT01454635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654043|NCT01454700|Insulin|insulin|mesh-list
6654044|NCT01454700|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6654045|NCT01454700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6654046|NCT01454700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654047|NCT01454804|Trastuzumab|trastuzumab|mesh-list
6654048|NCT01454804|Lapatinib|lapatinib|mesh-list
6654049|NCT01454804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6654050|NCT01454804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6654051|NCT01454804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6654052|NCT01454804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6454128|NCT00423475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6021960|NCT00403130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6454129|NCT00423501|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6454130|NCT00423501|Incretins|incretins|mesh-ancestor
6454131|NCT00423501|Hormones|hormones|mesh-ancestor
6454132|NCT00423501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6454133|NCT00423501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454134|NCT00423514|Mycophenolic Acid|mycophenolic acid|mesh-list
6454135|NCT00423514|Melphalan|melphalan|mesh-list
6454136|NCT00423514|Thiotepa|thiotepa|mesh-list
6454137|NCT00423514|Clofarabine|clofarabine|mesh-list
6454138|NCT00423514|Tacrolimus|tacrolimus|mesh-list
6454139|NCT00423514|Immunologic Factors|immunologic factors|mesh-ancestor
6454140|NCT00423514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454141|NCT00423514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6454142|NCT00423514|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6454143|NCT00423514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6454144|NCT00423514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6454145|NCT00423514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6454146|NCT00423514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6454147|NCT00423514|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6454148|NCT00423514|Antitubercular Agents|antitubercular agents|mesh-ancestor
6454149|NCT00423514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6654053|NCT01454804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654054|NCT01454869|Heparin|heparin|mesh-list
6654055|NCT01454869|Anticoagulants|anticoagulants|mesh-ancestor
6654056|NCT01454869|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6654057|NCT01454869|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6654058|NCT01454869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654059|NCT01455025|Plerixafor|plerixafor|mesh-list
6654060|NCT01455025|Sargramostim|sargramostim|mesh-list
6654061|NCT01455025|Lenograstim|lenograstim|mesh-list
6654062|NCT01455025|Immunologic Factors|immunologic factors|mesh-ancestor
6021961|NCT00403130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6021962|NCT00403130|Growth Substances|growth substances|mesh-ancestor
6021963|NCT00403130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021964|NCT00403130|Growth Inhibitors|growth inhibitors|mesh-ancestor
6021965|NCT00403130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6021966|NCT00403130|Antimetabolites|antimetabolites|mesh-ancestor
6021967|NCT00403130|Antiviral Agents|antiviral agents|mesh-ancestor
6021968|NCT00403130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6021969|NCT00403130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6021970|NCT00403130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6021971|NCT00403130|Immunologic Factors|immunologic factors|mesh-ancestor
6021972|NCT00403234|Buprenorphine|buprenorphine|mesh-list
6021973|NCT00403234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6021974|NCT00403234|Narcotics|narcotics|mesh-ancestor
6021975|NCT00403234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6021976|NCT00403234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654063|NCT01455025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6021977|NCT00403234|Analgesics|analgesics|mesh-ancestor
6454150|NCT00423514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6454151|NCT00423514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6454152|NCT00423514|Alkylating Agents|alkylating agents|mesh-ancestor
6454153|NCT00423514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6021978|NCT00403234|Sensory System Agents|sensory system agents|mesh-ancestor
6021979|NCT00403234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6021980|NCT00403234|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6454154|NCT00423514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6454155|NCT00423514|Antimetabolites|antimetabolites|mesh-ancestor
6454156|NCT00423527|Levetiracetam|levetiracetam|mesh-list
6454157|NCT00423527|Anticonvulsants|anticonvulsants|mesh-ancestor
6454158|NCT00423527|Nootropic Agents|nootropic agents|mesh-ancestor
6021981|NCT00403260|Artesunate|artesunate|mesh-list
6021982|NCT00403260|Mefloquine|mefloquine|mesh-list
6021983|NCT00403260|Pyronaridine|pyronaridine|mesh-list
6021984|NCT00403260|Antimalarials|antimalarials|mesh-ancestor
6021985|NCT00403260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6021986|NCT00403260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6454159|NCT00423540|Magnesium Sulfate|magnesium sulfate|mesh-list
6454160|NCT00423540|Analgesics|analgesics|mesh-ancestor
6454161|NCT00423540|Sensory System Agents|sensory system agents|mesh-ancestor
6454162|NCT00423540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6454163|NCT00423540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454164|NCT00423540|Anesthetics|anesthetics|mesh-ancestor
6454165|NCT00423540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6454166|NCT00423540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6454167|NCT00423540|Anticonvulsants|anticonvulsants|mesh-ancestor
6454168|NCT00423540|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6454169|NCT00423540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6021987|NCT00403260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5489910|NCT05238727|Mepivacaine|mepivacaine|mesh-list
5489911|NCT05238727|Carticaine|carticaine|mesh-list
5489912|NCT05238727|Anesthetics, Local|anesthetics, local|mesh-ancestor
5489913|NCT05238727|Anesthetics|anesthetics|mesh-ancestor
5489914|NCT05238727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5489915|NCT05238727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489916|NCT05238727|Sensory System Agents|sensory system agents|mesh-ancestor
5489917|NCT05238727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6021988|NCT00403260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6021989|NCT00403260|Antiviral Agents|antiviral agents|mesh-ancestor
6021990|NCT00403260|Schistosomicides|schistosomicides|mesh-ancestor
6021991|NCT00403260|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6021992|NCT00403260|Anthelmintics|anthelmintics|mesh-ancestor
6021993|NCT00403273|Botulinum Toxins|botulinum toxins|mesh-list
6021994|NCT00403273|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6021995|NCT00403273|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6454170|NCT00423540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021996|NCT00403273|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6021997|NCT00403273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6654064|NCT01455025|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6654065|NCT01455025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6654066|NCT01455025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6654067|NCT01455025|Antiviral Agents|antiviral agents|mesh-ancestor
6654068|NCT01455025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6654069|NCT01455051|Ofatumumab|ofatumumab|mesh-list
6654070|NCT01455051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6654071|NCT01455103|BMS-936559|bms-936559|mesh-list
6654072|NCT01455103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6654073|NCT01455103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6654074|NCT01455103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6654075|NCT01455103|Immunologic Factors|immunologic factors|mesh-ancestor
6654076|NCT01455103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654077|NCT01455129|Tiotropium Bromide|tiotropium bromide|mesh-list
6654078|NCT01455129|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6654079|NCT01455129|Autonomic Agents|autonomic agents|mesh-ancestor
6654080|NCT01455129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6654081|NCT01455129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654082|NCT01455129|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6654083|NCT01455129|Respiratory System Agents|respiratory system agents|mesh-ancestor
6654084|NCT01455129|Parasympatholytics|parasympatholytics|mesh-ancestor
6654085|NCT01455129|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6654086|NCT01455129|Cholinergic Agents|cholinergic agents|mesh-ancestor
6654087|NCT01455129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6654088|NCT01455129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654089|NCT01455142|Insulin|insulin|mesh-list
6654090|NCT01455142|Insulin Aspart|insulin aspart|mesh-list
6654091|NCT01455142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6654092|NCT01455142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654093|NCT01455233|Moxifloxacin|moxifloxacin|mesh-list
6654094|NCT01455233|Besifloxacin|besifloxacin|mesh-list
6654095|NCT01455233|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6654096|NCT01455233|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6654097|NCT01455233|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6654098|NCT01455233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6654099|NCT01455233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6654100|NCT01455233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6654101|NCT01455233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6654102|NCT01455233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6654103|NCT01455233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654104|NCT01455233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6654105|NCT01455233|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6654106|NCT01455233|Contraceptive Agents|contraceptive agents|mesh-ancestor
6654107|NCT01455233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6654108|NCT01455233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654109|NCT01455233|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6654110|NCT01455233|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6654111|NCT01455233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6654112|NCT01455246|Meropenem|meropenem|mesh-list
6654113|NCT01455246|Daptomycin|daptomycin|mesh-list
6654114|NCT01455246|Ceftazidime|ceftazidime|mesh-list
6654115|NCT01455246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6654116|NCT01455246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6654117|NCT01455337|Prednisolone|prednisolone|mesh-list
6654118|NCT01455337|Pentoxifylline|pentoxifylline|mesh-list
6654119|NCT01455337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6654120|NCT01455337|Glucocorticoids|glucocorticoids|mesh-ancestor
6654121|NCT01455337|Hormones|hormones|mesh-ancestor
6654122|NCT01455337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6654123|NCT01455337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654124|NCT01455337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6654125|NCT01455337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6654126|NCT01455337|Protective Agents|protective agents|mesh-ancestor
6654127|NCT01455337|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6654128|NCT01455337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6654129|NCT01455337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654130|NCT01455337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6654131|NCT01455337|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6654132|NCT01455337|Vasodilator Agents|vasodilator agents|mesh-ancestor
6654133|NCT01455337|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6654134|NCT01455337|Antioxidants|antioxidants|mesh-ancestor
6654135|NCT01455350|Lidocaine|lidocaine|mesh-list
6654136|NCT01455350|Anesthetics, Local|anesthetics, local|mesh-ancestor
6654137|NCT01455350|Anesthetics|anesthetics|mesh-ancestor
6654138|NCT01455350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6654139|NCT01455350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654140|NCT01455350|Sensory System Agents|sensory system agents|mesh-ancestor
6654141|NCT01455350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6654142|NCT01455350|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6654143|NCT01455350|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6654144|NCT01455350|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6654145|NCT01455350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6654146|NCT01455350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654147|NCT01455389|Diphenhydramine|diphenhydramine|mesh-list
6654148|NCT01455389|Promethazine|promethazine|mesh-list
6654149|NCT01455389|Dexamethasone|dexamethasone|mesh-list
6654150|NCT01455389|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6654151|NCT01455389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6654152|NCT01455389|Antiemetics|antiemetics|mesh-ancestor
6654153|NCT01455389|Autonomic Agents|autonomic agents|mesh-ancestor
6654154|NCT01455389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5489918|NCT05238649|Vaccines|vaccines|mesh-list
5489919|NCT05238649|Immunologic Factors|immunologic factors|mesh-ancestor
5489920|NCT05238649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489921|NCT05238506|Lidocaine|lidocaine|mesh-list
5489922|NCT05238506|Anesthetics, Local|anesthetics, local|mesh-ancestor
5489923|NCT05238506|Anesthetics|anesthetics|mesh-ancestor
5489924|NCT05238506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5489925|NCT05238506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489926|NCT05238506|Sensory System Agents|sensory system agents|mesh-ancestor
5489927|NCT05238506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5489928|NCT05238506|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5489929|NCT05238506|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5489930|NCT05238506|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5489931|NCT05238506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5489932|NCT05238506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502908|NCT04463784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502909|NCT04463784|Antiviral Agents|antiviral agents|mesh-ancestor
5502910|NCT04463784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6654155|NCT01455389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654156|NCT01455389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6654157|NCT01455389|Glucocorticoids|glucocorticoids|mesh-ancestor
6654158|NCT01455389|Hormones|hormones|mesh-ancestor
6654159|NCT01455389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6654160|NCT01455389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6654161|NCT01455389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6654162|NCT01455389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6654163|NCT01455389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6654164|NCT01455389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654165|NCT01455389|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6654166|NCT01455389|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6654167|NCT01455389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6654168|NCT01455389|Anesthetics, Local|anesthetics, local|mesh-ancestor
6654169|NCT01455389|Anesthetics|anesthetics|mesh-ancestor
6654170|NCT01455389|Sensory System Agents|sensory system agents|mesh-ancestor
6654171|NCT01455389|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6654172|NCT01455389|Histamine Antagonists|histamine antagonists|mesh-ancestor
5502911|NCT04463784|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5502912|NCT04463784|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5502913|NCT04463784|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6021998|NCT00403273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6021999|NCT00403273|Cholinergic Agents|cholinergic agents|mesh-ancestor
6022000|NCT00403273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6022001|NCT00403273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022002|NCT00403273|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6022003|NCT00403273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6022004|NCT00403403|Bevacizumab|bevacizumab|mesh-list
6022005|NCT00403403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6022006|NCT00403403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6454171|NCT00423540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6454172|NCT00423540|Tocolytic Agents|tocolytic agents|mesh-ancestor
6454173|NCT00423540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6454174|NCT00423696|Leucovorin|leucovorin|mesh-list
6454175|NCT00423696|Bevacizumab|bevacizumab|mesh-list
6454176|NCT00423696|Fluorouracil|fluorouracil|mesh-list
6454177|NCT00423696|Capecitabine|capecitabine|mesh-list
6454178|NCT00423696|Irinotecan|irinotecan|mesh-list
6454179|NCT00423696|Calcium|calcium|mesh-list
6454180|NCT00423696|Levoleucovorin|levoleucovorin|mesh-list
6454181|NCT00423696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5489933|NCT05238467|Antibodies|antibodies|mesh-list
5489934|NCT05238467|Immunologic Factors|immunologic factors|mesh-ancestor
5489935|NCT05238467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489936|NCT05238363|Cetuximab|cetuximab|mesh-list
5489937|NCT05238363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5489938|NCT05238363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5489939|NCT05238233|Proxymetacaine|proxymetacaine|mesh-list
5489940|NCT05238233|Pilocarpine|pilocarpine|mesh-list
5489941|NCT05238233|Tropicamide|tropicamide|mesh-list
5489942|NCT05238233|Miotics|miotics|mesh-ancestor
5489943|NCT05238233|Autonomic Agents|autonomic agents|mesh-ancestor
5489944|NCT05238233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5489945|NCT05238233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489946|NCT05238233|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
5489947|NCT05238233|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5489948|NCT05238233|Cholinergic Agents|cholinergic agents|mesh-ancestor
5489949|NCT05238233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5489950|NCT05238233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654173|NCT01455389|Histamine Agents|histamine agents|mesh-ancestor
6654174|NCT01455389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6654175|NCT01455389|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6654176|NCT01455389|Antipruritics|antipruritics|mesh-ancestor
6654177|NCT01455389|Dermatologic Agents|dermatologic agents|mesh-ancestor
6454182|NCT00423696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6454183|NCT00423696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6454184|NCT00423696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6454185|NCT00423696|Growth Substances|growth substances|mesh-ancestor
6454186|NCT00423696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454187|NCT00423696|Growth Inhibitors|growth inhibitors|mesh-ancestor
6022007|NCT00403403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6022008|NCT00403403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6022009|NCT00403403|Growth Substances|growth substances|mesh-ancestor
6022010|NCT00403403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454188|NCT00423696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6454189|NCT00423696|Antimetabolites|antimetabolites|mesh-ancestor
6454190|NCT00423696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6454191|NCT00423696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6454192|NCT00423696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6454193|NCT00423696|Immunologic Factors|immunologic factors|mesh-ancestor
6454194|NCT00423696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6454195|NCT00423696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6454196|NCT00423696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6454197|NCT00423696|Antidotes|antidotes|mesh-ancestor
6454198|NCT00423696|Protective Agents|protective agents|mesh-ancestor
5489951|NCT05238233|Mydriatics|mydriatics|mesh-ancestor
6022011|NCT00403403|Growth Inhibitors|growth inhibitors|mesh-ancestor
6022012|NCT00403455|Paroxetine|paroxetine|mesh-list
6022013|NCT00403455|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6022014|NCT00403455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6022015|NCT00403455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5489952|NCT05238233|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5489953|NCT05238233|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5489954|NCT05238233|Anesthetics, Local|anesthetics, local|mesh-ancestor
5489955|NCT05238233|Anesthetics|anesthetics|mesh-ancestor
5489956|NCT05238233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5489957|NCT05238233|Sensory System Agents|sensory system agents|mesh-ancestor
5489958|NCT05238220|Valganciclovir|valganciclovir|mesh-list
5489959|NCT05238220|Antiviral Agents|antiviral agents|mesh-ancestor
5489960|NCT05238220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5489961|NCT05238207|Psyllium|psyllium|mesh-list
5489962|NCT05238207|Cathartics|cathartics|mesh-ancestor
5489963|NCT05238207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5489964|NCT05238155|Antimetabolites|antimetabolites|mesh-list
5489965|NCT05238155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489966|NCT05238142|Insulin|insulin|mesh-list
5489967|NCT05238142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5489968|NCT05238142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489969|NCT05238064|Cyclophosphamide|cyclophosphamide|mesh-list
6022016|NCT00403455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6022017|NCT00403455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6022018|NCT00403455|Serotonin Agents|serotonin agents|mesh-ancestor
6022019|NCT00403455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022020|NCT00403455|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6654178|NCT01455441|Liraglutide|liraglutide|mesh-list
5489970|NCT05238064|Doxorubicin|doxorubicin|mesh-list
5489971|NCT05238064|Vincristine|vincristine|mesh-list
5489972|NCT05238064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5489973|NCT05238064|Immunologic Factors|immunologic factors|mesh-ancestor
5489974|NCT05238064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489975|NCT05238064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5489976|NCT05238064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5489977|NCT05238064|Alkylating Agents|alkylating agents|mesh-ancestor
5489978|NCT05238064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654179|NCT01455441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6654180|NCT01455441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654181|NCT01455441|Incretins|incretins|mesh-ancestor
6654182|NCT01455441|Hormones|hormones|mesh-ancestor
6654183|NCT01455441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6664611|NCT01513057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6664612|NCT01513070|Aspirin|aspirin|mesh-list
6664613|NCT01513070|Isosorbide|isosorbide|mesh-list
6664614|NCT01513070|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
6664615|NCT01513070|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
6664616|NCT01513070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6664617|NCT01513070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6664618|NCT01513070|Analgesics|analgesics|mesh-ancestor
6664619|NCT01513070|Sensory System Agents|sensory system agents|mesh-ancestor
6664620|NCT01513070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6664621|NCT01513070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664622|NCT01513070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6664623|NCT01513070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6664624|NCT01513070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6664625|NCT01513070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5489979|NCT05238064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5489980|NCT05238064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5489981|NCT05238064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5489982|NCT05238064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6022021|NCT00403455|Antidepressive Agents|antidepressive agents|mesh-ancestor
6022022|NCT00403455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6022023|NCT00403455|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6022024|NCT00403455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6022025|NCT00403455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6022026|NCT00403481|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6022027|NCT00403481|Olmesartan|olmesartan|mesh-list
6022028|NCT00403481|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6022029|NCT00403481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6022030|NCT00403481|Diuretics|diuretics|mesh-ancestor
6022031|NCT00403481|Natriuretic Agents|natriuretic agents|mesh-ancestor
6022032|NCT00403481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022033|NCT00403481|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6022034|NCT00403481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6022035|NCT00403481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6022036|NCT00403481|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6022037|NCT00403481|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6022038|NCT00403494|Verapamil|verapamil|mesh-list
6022039|NCT00403494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6664626|NCT01513070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6664627|NCT01513070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6664628|NCT01513070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6664629|NCT01513070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6664630|NCT01513070|Antipyretics|antipyretics|mesh-ancestor
6664631|NCT01513070|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6664632|NCT01513070|Diuretics|diuretics|mesh-ancestor
6654184|NCT01455506|Fludarabine|fludarabine|mesh-list
6654185|NCT01455506|Busulfan|busulfan|mesh-list
6654186|NCT01455506|Decitabine|decitabine|mesh-list
6654187|NCT01455506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6654188|NCT01455506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6654189|NCT01455506|Antimetabolites|antimetabolites|mesh-ancestor
6654190|NCT01455506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654191|NCT01455506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6654192|NCT01455506|Immunologic Factors|immunologic factors|mesh-ancestor
6654193|NCT01455506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654194|NCT01455506|Alkylating Agents|alkylating agents|mesh-ancestor
6654195|NCT01455506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6654196|NCT01455506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6654197|NCT01455506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6654198|NCT01455532|Gemcitabine|gemcitabine|mesh-list
6654199|NCT01455532|Carboplatin|carboplatin|mesh-list
6654200|NCT01455532|Doxorubicin|doxorubicin|mesh-list
6654201|NCT01455532|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6654202|NCT01455532|Iniparib|iniparib|mesh-list
6654203|NCT01455532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6654204|NCT01455532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6654205|NCT01455532|Antimetabolites|antimetabolites|mesh-ancestor
6654206|NCT01455532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654207|NCT01455532|Antiviral Agents|antiviral agents|mesh-ancestor
6654208|NCT01455532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6654209|NCT01455532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6654210|NCT01455532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6654211|NCT01455532|Immunologic Factors|immunologic factors|mesh-ancestor
6654212|NCT01455532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489983|NCT05238064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6022040|NCT00403494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6022041|NCT00403494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6022042|NCT00403494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6022043|NCT00403494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6022044|NCT00403494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022045|NCT00403494|Vasodilator Agents|vasodilator agents|mesh-ancestor
6022046|NCT00403546|Ziprasidone|ziprasidone|mesh-list
6022047|NCT00403546|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6022048|NCT00403546|Serotonin Agents|serotonin agents|mesh-ancestor
6022049|NCT00403546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6022050|NCT00403546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489984|NCT05238064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5489985|NCT05238064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5489986|NCT05238064|Tubulin Modulators|tubulin modulators|mesh-ancestor
5489987|NCT05238064|Antimitotic Agents|antimitotic agents|mesh-ancestor
5489988|NCT05238064|Mitosis Modulators|mitosis modulators|mesh-ancestor
5489989|NCT05238012|Atorvastatin|atorvastatin|mesh-list
5489990|NCT05238012|Calcium|calcium|mesh-list
5489991|NCT05238012|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5489992|NCT05238012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5489993|NCT05238012|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5489994|NCT05238012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5489995|NCT05238012|Antimetabolites|antimetabolites|mesh-ancestor
5489996|NCT05238012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5489997|NCT05238012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5489998|NCT05238012|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5489999|NCT05238012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5490000|NCT05237960|Metformin|metformin|mesh-list
5490001|NCT05237960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5490002|NCT05237960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490003|NCT05237843|Aspirin|aspirin|mesh-list
5490004|NCT05237843|Hydroxychloroquine|hydroxychloroquine|mesh-list
6022051|NCT00403546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022052|NCT00403546|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6022053|NCT00403546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6022054|NCT00403546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6022055|NCT00403546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6022056|NCT00403546|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6022057|NCT00403546|Dopamine Agents|dopamine agents|mesh-ancestor
6022058|NCT00403585|Adefovir|adefovir|mesh-list
6022059|NCT00403585|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6022060|NCT00403585|Antiviral Agents|antiviral agents|mesh-ancestor
6022061|NCT00403585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5490005|NCT05237843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6654213|NCT01455532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6664633|NCT01513070|Natriuretic Agents|natriuretic agents|mesh-ancestor
6654214|NCT01455532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6654215|NCT01455532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6654216|NCT01455532|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6654217|NCT01455636|Micronutrients|micronutrients|mesh-list
6654218|NCT01455636|Trace Elements|trace elements|mesh-list
6654219|NCT01455636|Hand Sanitizers|hand sanitizers|mesh-list
6654220|NCT01455636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654221|NCT01455636|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6654222|NCT01455636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6654223|NCT01455636|Disinfectants|disinfectants|mesh-ancestor
6654224|NCT01455649|Cyclosporine|cyclosporine|mesh-list
6654225|NCT01455649|Everolimus|everolimus|mesh-list
6654226|NCT01455649|Tacrolimus|tacrolimus|mesh-list
6654227|NCT01455649|Cyclosporins|cyclosporins|mesh-list
6654228|NCT01455649|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
6654229|NCT01455649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6654230|NCT01455649|Immunologic Factors|immunologic factors|mesh-ancestor
6654231|NCT01455649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654232|NCT01455649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6654233|NCT01455649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654234|NCT01455649|Antifungal Agents|antifungal agents|mesh-ancestor
6654235|NCT01455649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6654236|NCT01455649|Dermatologic Agents|dermatologic agents|mesh-ancestor
6654237|NCT01455649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6654238|NCT01455649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6654239|NCT01455831|Tinzaparin|tinzaparin|mesh-list
6654240|NCT01455831|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6654241|NCT01455831|Dalteparin|dalteparin|mesh-list
6654242|NCT01455831|Anticoagulants|anticoagulants|mesh-ancestor
6654243|NCT01455831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6654244|NCT01455831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6654245|NCT01455831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654246|NCT01455883|Glimepiride|glimepiride|mesh-list
6654247|NCT01455883|Exenatide|exenatide|mesh-list
6654248|NCT01455883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6654249|NCT01455883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6654250|NCT01455883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654251|NCT01455883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6654252|NCT01455883|Immunologic Factors|immunologic factors|mesh-ancestor
6654253|NCT01455883|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6654254|NCT01455883|Incretins|incretins|mesh-ancestor
6654255|NCT01455883|Hormones|hormones|mesh-ancestor
6654256|NCT01455883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6654257|NCT01455909|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6654258|NCT01455909|Exenatide|exenatide|mesh-list
6654259|NCT01455909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6654260|NCT01455909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654261|NCT01455909|Incretins|incretins|mesh-ancestor
6654262|NCT01455909|Hormones|hormones|mesh-ancestor
6654263|NCT01455909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6654264|NCT01455909|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6654265|NCT01455909|Protease Inhibitors|protease inhibitors|mesh-ancestor
6654266|NCT01455909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6654267|NCT01455909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654268|NCT01455909|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6654269|NCT01455922|Glimepiride|glimepiride|mesh-list
6654270|NCT01455922|Exenatide|exenatide|mesh-list
6654271|NCT01455922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6654272|NCT01455922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6654273|NCT01455922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654274|NCT01455922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6654275|NCT01455922|Immunologic Factors|immunologic factors|mesh-ancestor
6654276|NCT01455922|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6654277|NCT01455922|Incretins|incretins|mesh-ancestor
6654278|NCT01455922|Hormones|hormones|mesh-ancestor
5490006|NCT05237843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5490007|NCT05237843|Analgesics|analgesics|mesh-ancestor
5490008|NCT05237843|Sensory System Agents|sensory system agents|mesh-ancestor
5490009|NCT05237843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6022062|NCT00403585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6022063|NCT00403585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6654279|NCT01455922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6654280|NCT01455935|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6654281|NCT01455935|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6654282|NCT01455935|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6654283|NCT01455935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654284|NCT01455974|Dialysis Solutions|dialysis solutions|mesh-list
6654285|NCT01455974|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6654286|NCT01456078|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
6654287|NCT01456078|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6654288|NCT01456078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654289|NCT01456117|Pioglitazone|pioglitazone|mesh-list
6654290|NCT01456117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6654291|NCT01456117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654292|NCT01456208|Norepinephrine|norepinephrine|mesh-list
6654293|NCT01456208|Angiotensin II|angiotensin ii|mesh-list
6654294|NCT01456208|Giapreza|giapreza|mesh-list
6654295|NCT01456208|Angiotensinogen|angiotensinogen|mesh-list
6654296|NCT01456208|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6654297|NCT01456208|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6654298|NCT01456208|Adrenergic Agents|adrenergic agents|mesh-ancestor
6654299|NCT01456208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5490010|NCT05237843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490011|NCT05237843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6022064|NCT00403585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6022065|NCT00403585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6022066|NCT00403754|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6022067|NCT00403754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6022068|NCT00403754|Autonomic Agents|autonomic agents|mesh-ancestor
6022069|NCT00403754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6454199|NCT00423696|Vitamin B Complex|vitamin b complex|mesh-ancestor
6454200|NCT00423696|Vitamins|vitamins|mesh-ancestor
6454201|NCT00423696|Micronutrients|micronutrients|mesh-ancestor
6454202|NCT00423709|Fludarabine|fludarabine|mesh-list
6454203|NCT00423709|Melphalan|melphalan|mesh-list
6022070|NCT00403754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022071|NCT00403754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6022072|NCT00403754|Respiratory System Agents|respiratory system agents|mesh-ancestor
6022073|NCT00403754|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6022074|NCT00403754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6022075|NCT00403754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6022076|NCT00403754|Adrenergic Agents|adrenergic agents|mesh-ancestor
6022077|NCT00403754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6022078|NCT00403754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6022079|NCT00403767|Warfarin|warfarin|mesh-list
6022080|NCT00403767|Rivaroxaban|rivaroxaban|mesh-list
6022081|NCT00403767|Anticoagulants|anticoagulants|mesh-ancestor
6454204|NCT00423709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6454205|NCT00423709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6454206|NCT00423709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6454207|NCT00423709|Immunologic Factors|immunologic factors|mesh-ancestor
6454208|NCT00423709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454209|NCT00423709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6454210|NCT00423709|Alkylating Agents|alkylating agents|mesh-ancestor
5490012|NCT05237843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5490013|NCT05237843|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5490014|NCT05237843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5490015|NCT05237843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490016|NCT05237843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5490017|NCT05237843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5490018|NCT05237843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5490019|NCT05237843|Antipyretics|antipyretics|mesh-ancestor
5490020|NCT05237843|Antimalarials|antimalarials|mesh-ancestor
5490021|NCT05237843|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5490022|NCT05237843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5490023|NCT05237843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5490024|NCT05237791|Magnesium Sulfate|magnesium sulfate|mesh-list
5490025|NCT05237791|Analgesics|analgesics|mesh-ancestor
5490026|NCT05237791|Sensory System Agents|sensory system agents|mesh-ancestor
5490027|NCT05237791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5490028|NCT05237791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490029|NCT05237791|Anesthetics|anesthetics|mesh-ancestor
5490030|NCT05237791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5490031|NCT05237791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5490032|NCT05237791|Anticonvulsants|anticonvulsants|mesh-ancestor
5490033|NCT05237791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5490034|NCT05237791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5490035|NCT05237791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490036|NCT05237791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6454211|NCT00423709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6654300|NCT01456208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6664634|NCT01513070|Vasodilator Agents|vasodilator agents|mesh-ancestor
6654301|NCT01456208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654302|NCT01456208|Sympathomimetics|sympathomimetics|mesh-ancestor
6654303|NCT01456208|Autonomic Agents|autonomic agents|mesh-ancestor
6654304|NCT01456208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6654305|NCT01456208|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6654306|NCT01456208|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6654307|NCT01456208|Protease Inhibitors|protease inhibitors|mesh-ancestor
6654308|NCT01456208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6654309|NCT01456234|Oseltamivir|oseltamivir|mesh-list
6654310|NCT01456234|Antiviral Agents|antiviral agents|mesh-ancestor
6654311|NCT01456234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6654312|NCT01456234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6654313|NCT01456234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654314|NCT01456247|Lansoprazole|lansoprazole|mesh-list
6654315|NCT01456247|Dexlansoprazole|dexlansoprazole|mesh-list
6654316|NCT01456247|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5490037|NCT05237791|Tocolytic Agents|tocolytic agents|mesh-ancestor
5490038|NCT05237791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5490039|NCT05237687|Sirolimus|sirolimus|mesh-list
5490040|NCT05237687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5490041|NCT05237687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5490042|NCT05237687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6454212|NCT00423748|Ambrisentan|ambrisentan|mesh-list
6454213|NCT00423748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6022082|NCT00403767|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6022083|NCT00403767|Antithrombins|antithrombins|mesh-ancestor
6022084|NCT00403767|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6022085|NCT00403767|Protease Inhibitors|protease inhibitors|mesh-ancestor
6022086|NCT00403767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6022087|NCT00403767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6022088|NCT00404066|Dexamethasone|dexamethasone|mesh-list
6022089|NCT00404066|Cyclophosphamide|cyclophosphamide|mesh-list
6022090|NCT00404066|Docetaxel|docetaxel|mesh-list
6022091|NCT00404066|Doxorubicin|doxorubicin|mesh-list
6022092|NCT00404066|Trastuzumab|trastuzumab|mesh-list
6022093|NCT00404066|Lapatinib|lapatinib|mesh-list
6022094|NCT00404066|Lenograstim|lenograstim|mesh-list
6022095|NCT00404066|Sargramostim|sargramostim|mesh-list
6454214|NCT00423761|Midazolam|midazolam|mesh-list
6454215|NCT00423761|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6022096|NCT00404066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6022097|NCT00404066|Immunologic Factors|immunologic factors|mesh-ancestor
6454216|NCT00423761|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6454217|NCT00423761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6454218|NCT00423761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454219|NCT00423761|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6454220|NCT00423761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6454221|NCT00423761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6454222|NCT00423761|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6454223|NCT00423761|Anesthetics, General|anesthetics, general|mesh-ancestor
6454224|NCT00423761|Anesthetics|anesthetics|mesh-ancestor
6454225|NCT00423761|GABA Modulators|gaba modulators|mesh-ancestor
6454226|NCT00423761|GABA Agents|gaba agents|mesh-ancestor
6454227|NCT00423761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5490043|NCT05237687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5490044|NCT05237687|Antifungal Agents|antifungal agents|mesh-ancestor
5490045|NCT05237687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5490046|NCT05237687|Immunologic Factors|immunologic factors|mesh-ancestor
6022098|NCT00404066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022099|NCT00404066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6022100|NCT00404066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6454228|NCT00423761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654317|NCT01456247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6654318|NCT01456247|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6654319|NCT01456247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6654320|NCT01456247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654321|NCT01456260|Lansoprazole|lansoprazole|mesh-list
6654322|NCT01456260|Dexlansoprazole|dexlansoprazole|mesh-list
6654323|NCT01456260|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6654324|NCT01456260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6654325|NCT01456260|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6654326|NCT01456260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6654327|NCT01456260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654328|NCT01456312|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6654329|NCT01456312|Entecavir|entecavir|mesh-list
6654330|NCT01456312|Antiviral Agents|antiviral agents|mesh-ancestor
6654331|NCT01456312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6654332|NCT01456325|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6654333|NCT01456325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6654334|NCT01456325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6654335|NCT01456325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6654336|NCT01456325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654337|NCT01456351|Rituximab|rituximab|mesh-list
6654338|NCT01456351|Fludarabine|fludarabine|mesh-list
6654339|NCT01456351|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6654340|NCT01456351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6654341|NCT01456351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6654342|NCT01456351|Immunologic Factors|immunologic factors|mesh-ancestor
6654343|NCT01456351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654344|NCT01456351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6654345|NCT01456351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654346|NCT01456351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6654347|NCT01456351|Alkylating Agents|alkylating agents|mesh-ancestor
6654348|NCT01456364|Ticagrelor|ticagrelor|mesh-list
6654349|NCT01456364|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6654350|NCT01456364|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6654351|NCT01456364|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6654352|NCT01456364|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6654353|NCT01456364|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6654354|NCT01456364|Purinergic Agents|purinergic agents|mesh-ancestor
6654355|NCT01456364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6454229|NCT00423826|Cytarabine|cytarabine|mesh-list
6454230|NCT00423826|Mycophenolic Acid|mycophenolic acid|mesh-list
6022101|NCT00404066|Alkylating Agents|alkylating agents|mesh-ancestor
6022102|NCT00404066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6022103|NCT00404066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6022104|NCT00404066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6454231|NCT00423826|Fludarabine|fludarabine|mesh-list
6454232|NCT00423826|Fludarabine phosphate|fludarabine phosphate|mesh-list
6454233|NCT00423826|Busulfan|busulfan|mesh-list
6454234|NCT00423826|Tacrolimus|tacrolimus|mesh-list
6454235|NCT00423826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6454236|NCT00423826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6454237|NCT00423826|Antimetabolites|antimetabolites|mesh-ancestor
6454238|NCT00423826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6454239|NCT00423826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6454240|NCT00423826|Immunologic Factors|immunologic factors|mesh-ancestor
6454241|NCT00423826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454242|NCT00423826|Antiviral Agents|antiviral agents|mesh-ancestor
6454243|NCT00423826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6454244|NCT00423826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6454245|NCT00423826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6454246|NCT00423826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6454247|NCT00423826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6454248|NCT00423826|Antitubercular Agents|antitubercular agents|mesh-ancestor
6454249|NCT00423826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6664635|NCT01513070|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5490047|NCT05237687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490048|NCT05237596|Acetaminophen|acetaminophen|mesh-list
5490049|NCT05237596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
5490050|NCT05237596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
5490051|NCT05237596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5490052|NCT05237596|Analgesics|analgesics|mesh-ancestor
5490053|NCT05237596|Sensory System Agents|sensory system agents|mesh-ancestor
5490054|NCT05237596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5490055|NCT05237596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490056|NCT05237596|Antipyretics|antipyretics|mesh-ancestor
5490057|NCT05237596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6454250|NCT00423826|Alkylating Agents|alkylating agents|mesh-ancestor
6654356|NCT01456364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654357|NCT01456364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654358|NCT01456468|Tretinoin|tretinoin|mesh-list
6654359|NCT01456468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6654360|NCT01456468|Keratolytic Agents|keratolytic agents|mesh-ancestor
6654361|NCT01456468|Dermatologic Agents|dermatologic agents|mesh-ancestor
6654362|NCT01456481|Midodrine|midodrine|mesh-list
6654363|NCT01456481|Sympathomimetics|sympathomimetics|mesh-ancestor
6654364|NCT01456481|Autonomic Agents|autonomic agents|mesh-ancestor
6654365|NCT01456481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6654366|NCT01456481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654367|NCT01456481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6654368|NCT01456481|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6654369|NCT01456481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6654370|NCT01456481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6654371|NCT01456481|Adrenergic Agents|adrenergic agents|mesh-ancestor
6654372|NCT01456481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6654373|NCT01456481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654374|NCT01456507|Naltrexone|naltrexone|mesh-list
6654375|NCT01456507|Oxycodone|oxycodone|mesh-list
6654376|NCT01456507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6654377|NCT01456507|Narcotics|narcotics|mesh-ancestor
6654378|NCT01456507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6654379|NCT01456507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654380|NCT01456507|Analgesics|analgesics|mesh-ancestor
6654381|NCT01456507|Sensory System Agents|sensory system agents|mesh-ancestor
6654382|NCT01456507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6654383|NCT01456507|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6654384|NCT01456507|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6654385|NCT01456546|Proguanil|proguanil|mesh-list
6654386|NCT01456546|Clopidogrel|clopidogrel|mesh-list
6654387|NCT01456546|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6654388|NCT01456546|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6654389|NCT01456546|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6654390|NCT01456546|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6654391|NCT01456546|Purinergic Agents|purinergic agents|mesh-ancestor
6654392|NCT01456546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6654393|NCT01456546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654394|NCT01456546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654395|NCT01456546|Antimalarials|antimalarials|mesh-ancestor
6654396|NCT01456546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6654397|NCT01456546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6654398|NCT01456546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6654399|NCT01456546|Antimetabolites|antimetabolites|mesh-ancestor
6654400|NCT01456585|Gemcitabine|gemcitabine|mesh-list
6654401|NCT01456585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6654402|NCT01456585|Antimetabolites|antimetabolites|mesh-ancestor
6654403|NCT01456585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654404|NCT01456585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6654405|NCT01456585|Antiviral Agents|antiviral agents|mesh-ancestor
6654406|NCT01456585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6654407|NCT01456585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6654408|NCT01456585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6654409|NCT01456585|Immunologic Factors|immunologic factors|mesh-ancestor
6654410|NCT01456585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654411|NCT01456611|Diclofenac|diclofenac|mesh-list
6022105|NCT00404066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6022106|NCT00404066|Antiemetics|antiemetics|mesh-ancestor
6454251|NCT00423826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6454252|NCT00423826|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6454253|NCT00423865|Everolimus|everolimus|mesh-list
6454254|NCT00423865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6454255|NCT00423865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6454256|NCT00423865|Immunologic Factors|immunologic factors|mesh-ancestor
6022107|NCT00404066|Autonomic Agents|autonomic agents|mesh-ancestor
6022108|NCT00404066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6022109|NCT00404066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6022110|NCT00404066|Glucocorticoids|glucocorticoids|mesh-ancestor
6454257|NCT00423865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454258|NCT00423969|Galantamine|galantamine|mesh-list
6454259|NCT00423969|Citalopram|citalopram|mesh-list
6454260|NCT00423969|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6654412|NCT01456611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6654413|NCT01456611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6654414|NCT01456611|Analgesics|analgesics|mesh-ancestor
6654415|NCT01456611|Sensory System Agents|sensory system agents|mesh-ancestor
6022111|NCT00404066|Hormones|hormones|mesh-ancestor
6654416|NCT01456611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6654417|NCT01456611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654418|NCT01456611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6654419|NCT01456611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6654420|NCT01456611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6654421|NCT01456611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6654422|NCT01456611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654423|NCT01456624|Megestrol Acetate|megestrol acetate|mesh-list
6654424|NCT01456624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6654425|NCT01456624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6654426|NCT01456624|Appetite Stimulants|appetite stimulants|mesh-ancestor
6654427|NCT01456624|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6654428|NCT01456624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654429|NCT01456650|Glyburide|glyburide|mesh-list
6654430|NCT01456650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6654431|NCT01456650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654432|NCT01456689|Midazolam|midazolam|mesh-list
6654433|NCT01456689|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6654434|NCT01456689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6654435|NCT01456689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6654436|NCT01456689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654437|NCT01456689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6654438|NCT01456689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6654439|NCT01456689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6654440|NCT01456689|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6654441|NCT01456689|Anesthetics, General|anesthetics, general|mesh-ancestor
6654442|NCT01456689|Anesthetics|anesthetics|mesh-ancestor
6654443|NCT01456689|GABA Modulators|gaba modulators|mesh-ancestor
6654444|NCT01456689|GABA Agents|gaba agents|mesh-ancestor
6654445|NCT01456689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6654446|NCT01456689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654447|NCT01456715|Vaccines|vaccines|mesh-list
6654448|NCT01456715|Immunologic Factors|immunologic factors|mesh-ancestor
6654449|NCT01456715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654450|NCT01457001|Vitamin D|vitamin d|mesh-list
6654451|NCT01457001|Vitamins|vitamins|mesh-list
6654452|NCT01457001|Micronutrients|micronutrients|mesh-ancestor
6654453|NCT01457001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654454|NCT01457001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6654455|NCT01457040|Etoposide|etoposide|mesh-list
6654456|NCT01457040|Etoposide phosphate|etoposide phosphate|mesh-list
6654457|NCT01457040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6654458|NCT01457040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6654459|NCT01457040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6654460|NCT01457040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6654461|NCT01457040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6654462|NCT01457040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6454261|NCT00423969|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6454262|NCT00423969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6454263|NCT00423969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6454264|NCT00423969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6454265|NCT00423969|Serotonin Agents|serotonin agents|mesh-ancestor
6454266|NCT00423969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454267|NCT00423969|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6454268|NCT00423969|Antidepressive Agents|antidepressive agents|mesh-ancestor
6454269|NCT00423969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6454270|NCT00423969|Autonomic Agents|autonomic agents|mesh-ancestor
6022112|NCT00404066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6022113|NCT00404066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6022114|NCT00404066|Tubulin Modulators|tubulin modulators|mesh-ancestor
6022115|NCT00404066|Antimitotic Agents|antimitotic agents|mesh-ancestor
6664636|NCT01513083|Trastuzumab|trastuzumab|mesh-list
6664637|NCT01513083|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
6654463|NCT01457131|Cyclophosphamide|cyclophosphamide|mesh-list
6654464|NCT01457131|Fludarabine|fludarabine|mesh-list
6654465|NCT01457131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6654466|NCT01457131|Immunologic Factors|immunologic factors|mesh-ancestor
6654467|NCT01457131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654468|NCT01457131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6654469|NCT01457131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6654470|NCT01457131|Alkylating Agents|alkylating agents|mesh-ancestor
6654471|NCT01457131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654472|NCT01457131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6654473|NCT01457131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6654474|NCT01457261|Albuterol|albuterol|mesh-list
6654475|NCT01457261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6654476|NCT01457261|Autonomic Agents|autonomic agents|mesh-ancestor
6654477|NCT01457261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6654478|NCT01457261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654479|NCT01457261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6654480|NCT01457261|Respiratory System Agents|respiratory system agents|mesh-ancestor
6654481|NCT01457261|Tocolytic Agents|tocolytic agents|mesh-ancestor
6654482|NCT01457261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6022116|NCT00404066|Mitosis Modulators|mitosis modulators|mesh-ancestor
6454271|NCT00423969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6454272|NCT00423969|Cholinergic Agents|cholinergic agents|mesh-ancestor
6454273|NCT00423969|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6454274|NCT00423969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6454275|NCT00423969|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6454276|NCT00423969|Nootropic Agents|nootropic agents|mesh-ancestor
6454277|NCT00423982|Vancomycin|vancomycin|mesh-list
6022117|NCT00404066|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6022118|NCT00404066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6022119|NCT00404066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6022120|NCT00404066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6022121|NCT00404066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6022122|NCT00404066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6022123|NCT00404066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6022124|NCT00404092|Caspofungin|caspofungin|mesh-list
6022125|NCT00404092|Antifungal Agents|antifungal agents|mesh-ancestor
6022126|NCT00404092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6022127|NCT00404092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6022128|NCT00404092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6022129|NCT00404235|Paclitaxel|paclitaxel|mesh-list
6022130|NCT00404235|Carboplatin|carboplatin|mesh-list
6022131|NCT00404235|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6022132|NCT00404235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6022133|NCT00404235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6022134|NCT00404235|Tubulin Modulators|tubulin modulators|mesh-ancestor
6454278|NCT00423982|Rifampin|rifampin|mesh-list
6454279|NCT00423982|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6454280|NCT00423982|Cloxacillin|cloxacillin|mesh-list
6454281|NCT00423982|Anti-Infective Agents|anti-infective agents|mesh-list
6454282|NCT00423982|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6454283|NCT00423982|Antitubercular Agents|antitubercular agents|mesh-ancestor
6454284|NCT00423982|Leprostatic Agents|leprostatic agents|mesh-ancestor
6022135|NCT00404235|Antimitotic Agents|antimitotic agents|mesh-ancestor
6022136|NCT00404235|Mitosis Modulators|mitosis modulators|mesh-ancestor
6022137|NCT00404235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6022138|NCT00404352|Interferon beta-1a|interferon beta-1a|mesh-list
6022139|NCT00404352|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6022140|NCT00404352|Immunologic Factors|immunologic factors|mesh-ancestor
6022141|NCT00404352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022142|NCT00404352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6022143|NCT00404352|Antiviral Agents|antiviral agents|mesh-ancestor
6022144|NCT00404352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6022145|NCT00404495|Irinotecan|irinotecan|mesh-list
6022146|NCT00404495|Temozolomide|temozolomide|mesh-list
6022147|NCT00404495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6022148|NCT00404495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6022149|NCT00404495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6022150|NCT00404495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6022151|NCT00404495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6022152|NCT00404495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6022153|NCT00404495|Alkylating Agents|alkylating agents|mesh-ancestor
6022154|NCT00404547|Ciclesonide|ciclesonide|mesh-list
6022155|NCT00404547|Glucocorticoids|glucocorticoids|mesh-ancestor
6022156|NCT00404547|Hormones|hormones|mesh-ancestor
6454285|NCT00423982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6664638|NCT01513083|Maytansine|maytansine|mesh-list
6654483|NCT01457261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6654484|NCT01457261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6654485|NCT01457261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6654486|NCT01457261|Adrenergic Agents|adrenergic agents|mesh-ancestor
6654487|NCT01457261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6654488|NCT01457261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490058|NCT05237492|Tramadol|tramadol|mesh-list
5490059|NCT05237492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5490060|NCT05237492|Narcotics|narcotics|mesh-ancestor
5490061|NCT05237492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5490062|NCT05237492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654489|NCT01457469|Nicotine|nicotine|mesh-list
6654490|NCT01457469|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6654491|NCT01457469|Autonomic Agents|autonomic agents|mesh-ancestor
6654492|NCT01457469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6654493|NCT01457469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490063|NCT05237492|Analgesics|analgesics|mesh-ancestor
5490064|NCT05237492|Sensory System Agents|sensory system agents|mesh-ancestor
5490065|NCT05237492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5490066|NCT05237349|Oxaliplatin|oxaliplatin|mesh-list
5490067|NCT05237349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5490068|NCT05237323|Mycophenolic Acid|mycophenolic acid|mesh-list
5490069|NCT05237323|Azathioprine|azathioprine|mesh-list
5490070|NCT05237323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5490071|NCT05237323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5490072|NCT05237323|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5490073|NCT05237323|Antitubercular Agents|antitubercular agents|mesh-ancestor
5490074|NCT05237323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5490075|NCT05237323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5490076|NCT05237323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5502914|NCT04463784|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6454286|NCT00423982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6454287|NCT00423982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6454288|NCT00423982|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6454289|NCT00423982|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6454290|NCT00423982|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6454291|NCT00423982|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6454292|NCT00423982|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6454293|NCT00423982|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6454294|NCT00424060|Sagopilone|sagopilone|mesh-list
6454295|NCT00424060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6454296|NCT00424086|Vaccines|vaccines|mesh-list
6454297|NCT00424086|Immunologic Factors|immunologic factors|mesh-ancestor
6454298|NCT00424086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454299|NCT00424138|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6454300|NCT00424138|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6454301|NCT00424138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6454302|NCT00424151|Rituximab|rituximab|mesh-list
6454303|NCT00424151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6454304|NCT00424151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6454305|NCT00424151|Immunologic Factors|immunologic factors|mesh-ancestor
6454306|NCT00424151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654494|NCT01457469|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6654495|NCT01457469|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6654496|NCT01457469|Cholinergic Agents|cholinergic agents|mesh-ancestor
6654497|NCT01457469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6654498|NCT01457469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654499|NCT01457495|Edetic Acid|edetic acid|mesh-list
6654500|NCT01457495|Pentetic Acid|pentetic acid|mesh-list
6654501|NCT01457495|Antidotes|antidotes|mesh-ancestor
6654502|NCT01457495|Protective Agents|protective agents|mesh-ancestor
6654503|NCT01457495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654504|NCT01457495|Chelating Agents|chelating agents|mesh-ancestor
6654505|NCT01457495|Sequestering Agents|sequestering agents|mesh-ancestor
6654506|NCT01457495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654507|NCT01457495|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6654508|NCT01457495|Anticoagulants|anticoagulants|mesh-ancestor
6654509|NCT01457495|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6654510|NCT01457508|Edetic Acid|edetic acid|mesh-list
6654511|NCT01457508|Pentetic Acid|pentetic acid|mesh-list
6654512|NCT01457508|Antidotes|antidotes|mesh-ancestor
6654513|NCT01457508|Protective Agents|protective agents|mesh-ancestor
5490077|NCT05237323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490078|NCT05237323|Antimetabolites|antimetabolites|mesh-ancestor
5490079|NCT05237323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5490080|NCT05237323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5490081|NCT05237323|Immunologic Factors|immunologic factors|mesh-ancestor
5490082|NCT05237323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490083|NCT05237323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5490084|NCT05237297|Celecoxib|celecoxib|mesh-list
5490085|NCT05237297|Naproxen|naproxen|mesh-list
5490086|NCT05237297|Aceclofenac|aceclofenac|mesh-list
5490087|NCT05237297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5490088|NCT05237297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5490089|NCT05237297|Analgesics|analgesics|mesh-ancestor
6454307|NCT00424151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6454308|NCT00424164|Tamoxifen|tamoxifen|mesh-list
6454309|NCT00424164|Lapatinib|lapatinib|mesh-list
6454310|NCT00424164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6454311|NCT00424164|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6454312|NCT00424164|Hormone Antagonists|hormone antagonists|mesh-ancestor
6454313|NCT00424164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6454314|NCT00424164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022157|NCT00404547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6022158|NCT00404547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022159|NCT00404547|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5490090|NCT05237297|Sensory System Agents|sensory system agents|mesh-ancestor
5490091|NCT05237297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6022160|NCT00404651|Vaccines|vaccines|mesh-list
6022161|NCT00404651|Immunologic Factors|immunologic factors|mesh-ancestor
6022162|NCT00404651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654514|NCT01457508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654515|NCT01457508|Chelating Agents|chelating agents|mesh-ancestor
5490092|NCT05237297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654516|NCT01457508|Sequestering Agents|sequestering agents|mesh-ancestor
5490093|NCT05237297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6654517|NCT01457508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654518|NCT01457508|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6654519|NCT01457508|Anticoagulants|anticoagulants|mesh-ancestor
6654520|NCT01457508|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6654521|NCT01457547|Edetic Acid|edetic acid|mesh-list
6654522|NCT01457547|Vaccines|vaccines|mesh-list
6654523|NCT01457547|Pentetic Acid|pentetic acid|mesh-list
6654524|NCT01457547|Immunologic Factors|immunologic factors|mesh-ancestor
6022163|NCT00404755|Citalopram|citalopram|mesh-list
6022164|NCT00404755|Bupropion|bupropion|mesh-list
6022165|NCT00404755|Imipramine|imipramine|mesh-list
6022166|NCT00404755|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6022167|NCT00404755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6022168|NCT00404755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6022169|NCT00404755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6022170|NCT00404755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6022171|NCT00404755|Serotonin Agents|serotonin agents|mesh-ancestor
6022172|NCT00404755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022173|NCT00404755|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6022174|NCT00404755|Antidepressive Agents|antidepressive agents|mesh-ancestor
6022175|NCT00404755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6022176|NCT00404755|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6022177|NCT00404755|Dopamine Agents|dopamine agents|mesh-ancestor
6022178|NCT00404755|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6022179|NCT00404755|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6022180|NCT00404755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6022181|NCT00404755|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6022182|NCT00404755|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6022183|NCT00404755|Adrenergic Agents|adrenergic agents|mesh-ancestor
6022184|NCT00404820|Vitamin D|vitamin d|mesh-list
6022185|NCT00404820|Zoledronic Acid|zoledronic acid|mesh-list
6022186|NCT00404820|Alendronate|alendronate|mesh-list
6454315|NCT00424164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6454316|NCT00424164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6454317|NCT00424164|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6454318|NCT00424164|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6454319|NCT00424164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6454320|NCT00424164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6454321|NCT00424164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5490094|NCT05237297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5490095|NCT05237297|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6022187|NCT00404820|Calcium|calcium|mesh-list
6454322|NCT00424203|Cyclophosphamide|cyclophosphamide|mesh-list
6022188|NCT00404820|Vitamins|vitamins|mesh-ancestor
6022189|NCT00404820|Micronutrients|micronutrients|mesh-ancestor
6454323|NCT00424203|Doxorubicin|doxorubicin|mesh-list
6454324|NCT00424203|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6454325|NCT00424203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6454326|NCT00424203|Immunologic Factors|immunologic factors|mesh-ancestor
6454327|NCT00424203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654525|NCT01457547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654526|NCT01457547|Antidotes|antidotes|mesh-ancestor
6654527|NCT01457547|Protective Agents|protective agents|mesh-ancestor
5490096|NCT05237297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5490097|NCT05237297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5490098|NCT05237297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490099|NCT05237297|Gout Suppressants|gout suppressants|mesh-ancestor
5502915|NCT04463784|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6022190|NCT00404820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022191|NCT00404820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6022192|NCT00404820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6022193|NCT00405067|Ezetimibe|ezetimibe|mesh-list
6022194|NCT00405067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6022195|NCT00405067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6022196|NCT00405067|Antimetabolites|antimetabolites|mesh-ancestor
6022197|NCT00405067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6022198|NCT00405067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6022199|NCT00405275|Hydroxychloroquine|hydroxychloroquine|mesh-list
6022200|NCT00405275|Sulfasalazine|sulfasalazine|mesh-list
6022201|NCT00405275|Etanercept|etanercept|mesh-list
6022202|NCT00405275|Methotrexate|methotrexate|mesh-list
6022203|NCT00405275|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6022204|NCT00405275|Abortifacient Agents|abortifacient agents|mesh-ancestor
6454328|NCT00424203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6454329|NCT00424203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6454330|NCT00424203|Alkylating Agents|alkylating agents|mesh-ancestor
6454331|NCT00424203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6454332|NCT00424203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6454333|NCT00424203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6454334|NCT00424203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6454335|NCT00424203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6454336|NCT00424203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6454337|NCT00424203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6454338|NCT00424229|Lenalidomide|lenalidomide|mesh-list
6454339|NCT00424229|Immunologic Factors|immunologic factors|mesh-ancestor
6454340|NCT00424229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454341|NCT00424229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6454342|NCT00424229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6454343|NCT00424229|Growth Substances|growth substances|mesh-ancestor
6454344|NCT00424229|Growth Inhibitors|growth inhibitors|mesh-ancestor
6454345|NCT00424229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6454346|NCT00424242|Pemetrexed|pemetrexed|mesh-list
6454347|NCT00424242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6454348|NCT00424242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6454349|NCT00424242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6454350|NCT00424242|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6454351|NCT00424242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6454352|NCT00424281|PENTA|penta|mesh-list
6454353|NCT00424281|Fondaparinux|fondaparinux|mesh-list
6454354|NCT00424281|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6454355|NCT00424281|Antithrombins|antithrombins|mesh-ancestor
6454356|NCT00424281|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6454357|NCT00424281|Protease Inhibitors|protease inhibitors|mesh-ancestor
6454358|NCT00424281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6454359|NCT00424281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6454360|NCT00424281|Anticoagulants|anticoagulants|mesh-ancestor
6454361|NCT00424281|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6454362|NCT00424281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6454363|NCT00424333|Insulin|insulin|mesh-list
6454364|NCT00424333|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6454365|NCT00424333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6454366|NCT00424333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454367|NCT00424411|Insulin|insulin|mesh-list
6454368|NCT00424411|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6454369|NCT00424411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6454370|NCT00424411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454371|NCT00424437|Insulin|insulin|mesh-list
6454372|NCT00424437|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6454373|NCT00424437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6454374|NCT00424437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454375|NCT00424580|Montelukast|montelukast|mesh-list
6454376|NCT00424580|Desloratadine|desloratadine|mesh-list
6454377|NCT00424580|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6454378|NCT00424580|Respiratory System Agents|respiratory system agents|mesh-ancestor
6654528|NCT01457547|Chelating Agents|chelating agents|mesh-ancestor
6654529|NCT01457547|Sequestering Agents|sequestering agents|mesh-ancestor
6654530|NCT01457547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654531|NCT01457547|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6654532|NCT01457547|Anticoagulants|anticoagulants|mesh-ancestor
6654533|NCT01457547|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6654534|NCT01457690|Tocopherols|tocopherols|mesh-list
6654535|NCT01457690|Vitamin E|vitamin e|mesh-list
6022205|NCT00405275|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6022206|NCT00405275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022207|NCT00405275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6022208|NCT00405275|Antimetabolites|antimetabolites|mesh-ancestor
6022209|NCT00405275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6022210|NCT00405275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6022211|NCT00405275|Dermatologic Agents|dermatologic agents|mesh-ancestor
6022212|NCT00405275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6022213|NCT00405275|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6022214|NCT00405275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6454379|NCT00424580|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6454380|NCT00424580|Hormone Antagonists|hormone antagonists|mesh-ancestor
6454381|NCT00424580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6454382|NCT00424580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454383|NCT00424580|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6454384|NCT00424580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6454385|NCT00424580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6454386|NCT00424580|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6454387|NCT00424580|Cholinergic Agents|cholinergic agents|mesh-ancestor
5490100|NCT05216328|Magnesium Hydroxide|magnesium hydroxide|mesh-list
5490101|NCT05216328|Antacids|antacids|mesh-ancestor
5490102|NCT05216328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490103|NCT05216328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5490104|NCT05215990|Metformin|metformin|mesh-list
5490105|NCT05215990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5490106|NCT05215990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490107|NCT05215834|Remifentanil|remifentanil|mesh-list
5490108|NCT05215834|Propofol|propofol|mesh-list
5490109|NCT05215834|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5490110|NCT05215834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5490111|NCT05215834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490112|NCT05215834|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5490113|NCT05215834|Anesthetics, General|anesthetics, general|mesh-ancestor
5490114|NCT05215834|Anesthetics|anesthetics|mesh-ancestor
5490115|NCT05215834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6454388|NCT00424580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6454389|NCT00424580|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6454390|NCT00424580|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6454391|NCT00424580|Histamine Antagonists|histamine antagonists|mesh-ancestor
6454392|NCT00424580|Histamine Agents|histamine agents|mesh-ancestor
6454393|NCT00424606|Docetaxel|docetaxel|mesh-list
6454394|NCT00424606|Epirubicin|epirubicin|mesh-list
6454395|NCT00424606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6454396|NCT00424606|Tubulin Modulators|tubulin modulators|mesh-ancestor
6454397|NCT00424606|Antimitotic Agents|antimitotic agents|mesh-ancestor
6454398|NCT00424606|Mitosis Modulators|mitosis modulators|mesh-ancestor
6454399|NCT00424606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6454400|NCT00424606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6454401|NCT00424606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6654536|NCT01457690|Tocotrienols|tocotrienols|mesh-list
6654537|NCT01457690|alpha-Tocopherol|alpha-tocopherol|mesh-list
5490116|NCT05215834|Narcotics|narcotics|mesh-ancestor
5490117|NCT05215834|Analgesics|analgesics|mesh-ancestor
6022215|NCT00405275|Immunologic Factors|immunologic factors|mesh-ancestor
6022216|NCT00405275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6022217|NCT00405275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6022218|NCT00405275|Antimalarials|antimalarials|mesh-ancestor
6022219|NCT00405275|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6654538|NCT01457690|Antioxidants|antioxidants|mesh-ancestor
6654539|NCT01457690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654540|NCT01457690|Protective Agents|protective agents|mesh-ancestor
6454402|NCT00424606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6454403|NCT00424606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6454404|NCT00424710|Ranibizumab|ranibizumab|mesh-list
6454405|NCT00424710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6454406|NCT00424710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6454407|NCT00424710|Growth Substances|growth substances|mesh-ancestor
6454408|NCT00424710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022220|NCT00405275|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6022221|NCT00405275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6022222|NCT00405275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6022223|NCT00405275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6022224|NCT00405275|Analgesics|analgesics|mesh-ancestor
6022225|NCT00405275|Sensory System Agents|sensory system agents|mesh-ancestor
6022226|NCT00405275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6022227|NCT00405275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6022228|NCT00405275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6022229|NCT00405288|Hydrocortisone|hydrocortisone|mesh-list
6022230|NCT00405288|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6022231|NCT00405288|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6022232|NCT00405288|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6022233|NCT00405288|Pramoxine|pramoxine|mesh-list
6454409|NCT00424710|Growth Inhibitors|growth inhibitors|mesh-ancestor
6454410|NCT00424710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6454411|NCT00424723|Pemetrexed|pemetrexed|mesh-list
6454412|NCT00424723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6454413|NCT00424723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6454414|NCT00424723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6454415|NCT00424723|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6454416|NCT00424723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6454417|NCT00424788|Natalizumab|natalizumab|mesh-list
6454418|NCT00424788|Immunologic Factors|immunologic factors|mesh-ancestor
6454419|NCT00424788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454420|NCT00424801|Nicorandil|nicorandil|mesh-list
6454421|NCT00424801|Valsartan|valsartan|mesh-list
6454422|NCT00424801|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6454423|NCT00424801|Doxazosin|doxazosin|mesh-list
6454424|NCT00424801|Lercanidipine|lercanidipine|mesh-list
6454425|NCT00424801|Pindolol|pindolol|mesh-list
6454426|NCT00424801|Moxonidine|moxonidine|mesh-list
6454427|NCT00424801|Amiloride|amiloride|mesh-list
6454428|NCT00424801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6454429|NCT00424801|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6454430|NCT00424801|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6454431|NCT00424801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6454432|NCT00424801|Diuretics|diuretics|mesh-ancestor
6454433|NCT00424801|Natriuretic Agents|natriuretic agents|mesh-ancestor
6454434|NCT00424801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454435|NCT00424801|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6454436|NCT00424801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6454437|NCT00424801|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
6454438|NCT00424801|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6454439|NCT00424801|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
6454440|NCT00424801|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6022234|NCT00405288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6022235|NCT00405288|Anesthetics, Local|anesthetics, local|mesh-ancestor
6022236|NCT00405288|Anesthetics|anesthetics|mesh-ancestor
6022237|NCT00405288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6654541|NCT01457690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654542|NCT01457690|Vitamins|vitamins|mesh-ancestor
6654543|NCT01457690|Micronutrients|micronutrients|mesh-ancestor
6654544|NCT01457716|Budesonide|budesonide|mesh-list
6654545|NCT01457716|Formoterol Fumarate|formoterol fumarate|mesh-list
6654546|NCT01457716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6654547|NCT01457716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6654548|NCT01457716|Autonomic Agents|autonomic agents|mesh-ancestor
6654549|NCT01457716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6654550|NCT01457716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654551|NCT01457716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6654552|NCT01457716|Respiratory System Agents|respiratory system agents|mesh-ancestor
6654553|NCT01457716|Glucocorticoids|glucocorticoids|mesh-ancestor
6654554|NCT01457716|Hormones|hormones|mesh-ancestor
6654555|NCT01457716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5490118|NCT05215834|Sensory System Agents|sensory system agents|mesh-ancestor
5490119|NCT05215834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5490120|NCT05215431|Antioxidants|antioxidants|mesh-list
5490121|NCT05215431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490122|NCT05215431|Protective Agents|protective agents|mesh-ancestor
5490123|NCT05215431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490124|NCT05214183|Rituximab|rituximab|mesh-list
5490125|NCT05214183|Acalabrutinib|acalabrutinib|mesh-list
5490126|NCT05214183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5490127|NCT05214183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5490128|NCT05214183|Immunologic Factors|immunologic factors|mesh-ancestor
6654556|NCT01457716|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5490129|NCT05214183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490130|NCT05214183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5490131|NCT05213208|Propofol|propofol|mesh-list
5490132|NCT05213208|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5490133|NCT05213208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5490134|NCT05213208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490135|NCT05213208|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5490136|NCT05213208|Anesthetics, General|anesthetics, general|mesh-ancestor
5490137|NCT05213208|Anesthetics|anesthetics|mesh-ancestor
5490138|NCT05200143|Nivolumab|nivolumab|mesh-list
5490139|NCT05200143|Ipilimumab|ipilimumab|mesh-list
5490140|NCT05200143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5490141|NCT05200143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6022238|NCT00405288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022239|NCT00405288|Sensory System Agents|sensory system agents|mesh-ancestor
6022240|NCT00405288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6022241|NCT00405353|Methyltestosterone|methyltestosterone|mesh-list
6022242|NCT00405353|Testosterone|testosterone|mesh-list
6022243|NCT00405353|Testosterone undecanoate|testosterone undecanoate|mesh-list
6022244|NCT00405353|Testosterone enanthate|testosterone enanthate|mesh-list
6022245|NCT00405353|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6022246|NCT00405353|Androgens|androgens|mesh-ancestor
6022247|NCT00405353|Hormones|hormones|mesh-ancestor
6022248|NCT00405353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6022249|NCT00405353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454441|NCT00424801|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6454442|NCT00424801|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6454443|NCT00424801|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6454444|NCT00424801|Adrenergic Agents|adrenergic agents|mesh-ancestor
6454445|NCT00424801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6454446|NCT00424801|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6454447|NCT00424801|Vasodilator Agents|vasodilator agents|mesh-ancestor
6454448|NCT00424801|Vitamin B Complex|vitamin b complex|mesh-ancestor
6454449|NCT00424801|Vitamins|vitamins|mesh-ancestor
6454450|NCT00424801|Micronutrients|micronutrients|mesh-ancestor
6454451|NCT00424801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6454452|NCT00424801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6454453|NCT00424801|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5490142|NCT05200143|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5490143|NCT05200143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490144|NCT05189509|Plasminogen|plasminogen|mesh-list
5490145|NCT05189509|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5490146|NCT05189509|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6454454|NCT00424801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6454455|NCT00424801|Serotonin Agents|serotonin agents|mesh-ancestor
6022250|NCT00405353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6022251|NCT00405353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6022252|NCT00405353|Anabolic Agents|anabolic agents|mesh-ancestor
6022253|NCT00405392|Ibandronic Acid|ibandronic acid|mesh-list
6022254|NCT00405392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6022255|NCT00405392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490147|NCT05189509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6654557|NCT01457716|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6654558|NCT01457716|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6654559|NCT01457716|Adrenergic Agents|adrenergic agents|mesh-ancestor
6654560|NCT01457716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6654561|NCT01457716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654562|NCT01457820|Allopurinol|allopurinol|mesh-list
6654563|NCT01457820|Antimetabolites|antimetabolites|mesh-ancestor
6654564|NCT01457820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654565|NCT01457820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6654566|NCT01457820|Gout Suppressants|gout suppressants|mesh-ancestor
6654567|NCT01457820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6654568|NCT01457820|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6654569|NCT01457820|Antioxidants|antioxidants|mesh-ancestor
5490148|NCT05189509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490149|NCT05188222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5490150|NCT05181527|Dextromethorphan|dextromethorphan|mesh-list
5490151|NCT05181527|Serotonin|serotonin|mesh-list
5490152|NCT05181527|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
6022256|NCT00405522|Remifentanil|remifentanil|mesh-list
6022257|NCT00405522|Propofol|propofol|mesh-list
6022258|NCT00405522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6022259|NCT00405522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6022260|NCT00405522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022261|NCT00405522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6022262|NCT00405522|Anesthetics, General|anesthetics, general|mesh-ancestor
6022263|NCT00405522|Anesthetics|anesthetics|mesh-ancestor
6022264|NCT00405522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6454456|NCT00424814|Ritonavir|ritonavir|mesh-list
6454457|NCT00424814|Lopinavir|lopinavir|mesh-list
6454458|NCT00424814|Lamivudine|lamivudine|mesh-list
6454459|NCT00424814|Zidovudine|zidovudine|mesh-list
6454460|NCT00424814|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6454461|NCT00424814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6454462|NCT00424814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6454463|NCT00424814|Protease Inhibitors|protease inhibitors|mesh-ancestor
6454464|NCT00424814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6454465|NCT00424814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6454466|NCT00424814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6454467|NCT00424814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6454468|NCT00424814|Antiviral Agents|antiviral agents|mesh-ancestor
6454469|NCT00424814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6454470|NCT00424814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6454471|NCT00424814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6454472|NCT00424814|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6454473|NCT00424814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6454474|NCT00424814|Antimetabolites|antimetabolites|mesh-ancestor
6454475|NCT00424853|Gemcitabine|gemcitabine|mesh-list
6454476|NCT00424853|Cisplatin|cisplatin|mesh-list
6022265|NCT00405522|Narcotics|narcotics|mesh-ancestor
6022266|NCT00405522|Analgesics|analgesics|mesh-ancestor
6022267|NCT00405522|Sensory System Agents|sensory system agents|mesh-ancestor
6022268|NCT00405522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6022269|NCT00405548|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6022270|NCT00405548|Natriuretic Agents|natriuretic agents|mesh-ancestor
6022271|NCT00405548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022272|NCT00405587|Vemurafenib|vemurafenib|mesh-list
6022273|NCT00405587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6022274|NCT00405587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6654570|NCT01457820|Protective Agents|protective agents|mesh-ancestor
5490153|NCT05181527|Antitussive Agents|antitussive agents|mesh-ancestor
5490154|NCT05181527|Respiratory System Agents|respiratory system agents|mesh-ancestor
5490155|NCT05181527|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5490156|NCT05181527|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5490157|NCT05181527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5490158|NCT05181527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490159|NCT05181527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490160|NCT05181527|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5490161|NCT05181527|Serotonin Agents|serotonin agents|mesh-ancestor
5490162|NCT05181527|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5490163|NCT05181527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5490164|NCT05168813|Vaccines|vaccines|mesh-list
5490165|NCT05168813|Immunologic Factors|immunologic factors|mesh-ancestor
6022275|NCT00405587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6054334|NCT00602459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454477|NCT00424853|Docetaxel|docetaxel|mesh-list
6454478|NCT00424853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6654571|NCT01457820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654572|NCT01457859|Triclosan|triclosan|mesh-list
6654573|NCT01457859|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6654574|NCT01457859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6654575|NCT01457859|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6654576|NCT01457859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6454479|NCT00424853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6454480|NCT00424853|Antimetabolites|antimetabolites|mesh-ancestor
6454481|NCT00424853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6454482|NCT00424853|Antiviral Agents|antiviral agents|mesh-ancestor
6454483|NCT00424853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6454484|NCT00424853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6454485|NCT00424853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6454486|NCT00424853|Immunologic Factors|immunologic factors|mesh-ancestor
6454487|NCT00424853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454488|NCT00424853|Tubulin Modulators|tubulin modulators|mesh-ancestor
6454489|NCT00424853|Antimitotic Agents|antimitotic agents|mesh-ancestor
6454490|NCT00424853|Mitosis Modulators|mitosis modulators|mesh-ancestor
6454491|NCT00424892|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6454492|NCT00424892|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6454493|NCT00424892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6454494|NCT00424892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6454495|NCT00424892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6454496|NCT00424892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6022276|NCT00405587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6022277|NCT00405639|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6022278|NCT00405639|Natriuretic Agents|natriuretic agents|mesh-ancestor
6022279|NCT00405639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490166|NCT05168813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490167|NCT05141708|Talazoparib|talazoparib|mesh-list
5490168|NCT05141708|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5490169|NCT05141708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5490170|NCT05141708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490171|NCT05141708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6022280|NCT00405652|Mycophenolic Acid|mycophenolic acid|mesh-list
6022281|NCT00405652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6022282|NCT00405652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6022283|NCT00405652|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6022284|NCT00405652|Antitubercular Agents|antitubercular agents|mesh-ancestor
6022285|NCT00405652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6022286|NCT00405652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6022287|NCT00405652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6454497|NCT00424892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454498|NCT00424892|Antidepressive Agents|antidepressive agents|mesh-ancestor
6454499|NCT00424892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6454500|NCT00424931|Modafinil|modafinil|mesh-list
6454501|NCT00424931|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6454502|NCT00424931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454503|NCT00424931|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6454504|NCT00424931|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6454505|NCT00424931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6454506|NCT00424931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461914|NCT00456820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461915|NCT00456820|Dopamine Agents|dopamine agents|mesh-ancestor
6461916|NCT00456820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6461917|NCT00456820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461918|NCT00456820|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6654577|NCT01457859|Antimetabolites|antimetabolites|mesh-ancestor
6654578|NCT01457859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490172|NCT05131204|Eculizumab|eculizumab|mesh-list
5490173|NCT05131204|Ravulizumab|ravulizumab|mesh-list
5490174|NCT05131204|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5490175|NCT05131204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5490176|NCT05131204|Immunologic Factors|immunologic factors|mesh-ancestor
5490177|NCT05131204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490178|NCT05097768|Dexamethasone|dexamethasone|mesh-list
5490179|NCT05097768|Ibuprofen|ibuprofen|mesh-list
5490180|NCT05097768|Ketorolac|ketorolac|mesh-list
5490181|NCT05097768|Meloxicam|meloxicam|mesh-list
6454507|NCT00424944|Vaccines|vaccines|mesh-list
6454508|NCT00424944|Immunologic Factors|immunologic factors|mesh-ancestor
6454509|NCT00424944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454510|NCT00424970|Acetazolamide|acetazolamide|mesh-list
6454511|NCT00424970|Anticonvulsants|anticonvulsants|mesh-ancestor
6022288|NCT00405652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6022289|NCT00405704|Trimethoprim|trimethoprim|mesh-list
6022290|NCT00405704|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6022291|NCT00405704|Sulfamethoxazole|sulfamethoxazole|mesh-list
6022292|NCT00405704|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6022293|NCT00405704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6022294|NCT00405704|Renal Agents|renal agents|mesh-ancestor
6022295|NCT00405704|Antimalarials|antimalarials|mesh-ancestor
6022296|NCT00405704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6022297|NCT00405704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6022298|NCT00405704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6022299|NCT00405704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6022300|NCT00405704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6022301|NCT00405704|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6022302|NCT00405704|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6022303|NCT00405704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6022304|NCT00405704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6022305|NCT00405756|Aspirin|aspirin|mesh-list
6022306|NCT00405756|Prednisone|prednisone|mesh-list
6022307|NCT00405756|Lenalidomide|lenalidomide|mesh-list
6022308|NCT00405756|Melphalan|melphalan|mesh-list
6022309|NCT00405756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6022310|NCT00405756|Glucocorticoids|glucocorticoids|mesh-ancestor
6022311|NCT00405756|Hormones|hormones|mesh-ancestor
6022312|NCT00405756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6022313|NCT00405756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022314|NCT00405756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6022315|NCT00405756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6022316|NCT00405756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6022317|NCT00405756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6022318|NCT00405756|Analgesics|analgesics|mesh-ancestor
6022319|NCT00405756|Sensory System Agents|sensory system agents|mesh-ancestor
6454512|NCT00424970|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6454513|NCT00424970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6454514|NCT00424970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6454515|NCT00424970|Diuretics|diuretics|mesh-ancestor
6454516|NCT00424970|Natriuretic Agents|natriuretic agents|mesh-ancestor
6454517|NCT00424970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454518|NCT00424983|Zoledronic Acid|zoledronic acid|mesh-list
6454519|NCT00424983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6454520|NCT00424983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454521|NCT00425009|Metformin|metformin|mesh-list
6454522|NCT00425009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6454523|NCT00425009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022320|NCT00405756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6454524|NCT00425035|Panitumumab|panitumumab|mesh-list
5490182|NCT05097768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5490183|NCT05097768|Antiemetics|antiemetics|mesh-ancestor
6022321|NCT00405756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6022322|NCT00405756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6022323|NCT00405756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6022324|NCT00405756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6022325|NCT00405756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6022326|NCT00405756|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6022327|NCT00405756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6022328|NCT00405756|Antipyretics|antipyretics|mesh-ancestor
6022329|NCT00405756|Immunologic Factors|immunologic factors|mesh-ancestor
6022330|NCT00405756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6022331|NCT00405756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5490184|NCT05097768|Autonomic Agents|autonomic agents|mesh-ancestor
5490185|NCT05097768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5490186|NCT05097768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490187|NCT05097768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5490188|NCT05097768|Glucocorticoids|glucocorticoids|mesh-ancestor
5490189|NCT05097768|Hormones|hormones|mesh-ancestor
5490190|NCT05097768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5490191|NCT05097768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5490192|NCT05097768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5490193|NCT05097768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5490194|NCT05097768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5490195|NCT05097768|Analgesics|analgesics|mesh-ancestor
5490196|NCT05097768|Sensory System Agents|sensory system agents|mesh-ancestor
5490197|NCT05097768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5490198|NCT05097768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5490199|NCT05097768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5490200|NCT05097768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490201|NCT05097768|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5490202|NCT05095376|Temozolomide|temozolomide|mesh-list
6022332|NCT00405756|Growth Substances|growth substances|mesh-ancestor
6022333|NCT00405756|Growth Inhibitors|growth inhibitors|mesh-ancestor
6022334|NCT00405756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6022335|NCT00405756|Alkylating Agents|alkylating agents|mesh-ancestor
6022336|NCT00405756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6022337|NCT00405756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6022338|NCT00405821|Acyclovir|acyclovir|mesh-list
6022339|NCT00405821|Antiviral Agents|antiviral agents|mesh-ancestor
6022340|NCT00405821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6022341|NCT00405938|Bevacizumab|bevacizumab|mesh-list
5490203|NCT05095376|Lomustine|lomustine|mesh-list
5490204|NCT05095376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5490205|NCT05095376|Alkylating Agents|alkylating agents|mesh-ancestor
5490206|NCT05095376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490207|NCT05095376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5490208|NCT05093582|Cromakalim|cromakalim|mesh-list
5490209|NCT05093582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5490210|NCT05093582|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5490211|NCT05093582|Autonomic Agents|autonomic agents|mesh-ancestor
5490212|NCT05093582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5490213|NCT05093582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490214|NCT05093582|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5490215|NCT05093582|Respiratory System Agents|respiratory system agents|mesh-ancestor
5490216|NCT05093582|Parasympatholytics|parasympatholytics|mesh-ancestor
5490217|NCT05093582|Vasodilator Agents|vasodilator agents|mesh-ancestor
5490218|NCT05073679|Naltrexone|naltrexone|mesh-list
5490219|NCT05073679|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5490220|NCT05073679|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5490221|NCT05073679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490222|NCT05073679|Sensory System Agents|sensory system agents|mesh-ancestor
5490223|NCT05073679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5490224|NCT05069831|Abrocitinib|abrocitinib|mesh-list
6022342|NCT00405938|Fulvestrant|fulvestrant|mesh-list
6022343|NCT00405938|Anastrozole|anastrozole|mesh-list
6022344|NCT00405938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6022345|NCT00405938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6022346|NCT00405938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6022347|NCT00405938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6454525|NCT00425035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6454526|NCT00425035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6454527|NCT00425074|Aspirin|aspirin|mesh-list
6454528|NCT00425074|Salicylic Acid|salicylic acid|mesh-list
6454529|NCT00425074|Salicylates|salicylates|mesh-list
6454530|NCT00425074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6454531|NCT00425074|Antifungal Agents|antifungal agents|mesh-ancestor
6454532|NCT00425074|Keratolytic Agents|keratolytic agents|mesh-ancestor
6454533|NCT00425074|Dermatologic Agents|dermatologic agents|mesh-ancestor
6454534|NCT00425074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6454535|NCT00425074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6454536|NCT00425074|Analgesics|analgesics|mesh-ancestor
6454537|NCT00425074|Sensory System Agents|sensory system agents|mesh-ancestor
6454538|NCT00425074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6454539|NCT00425074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022348|NCT00405938|Growth Substances|growth substances|mesh-ancestor
6022349|NCT00405938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022350|NCT00405938|Growth Inhibitors|growth inhibitors|mesh-ancestor
6454540|NCT00425074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6454541|NCT00425074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6454542|NCT00425074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6022351|NCT00405938|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6022352|NCT00405938|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6022353|NCT00405938|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6022354|NCT00405938|Hormone Antagonists|hormone antagonists|mesh-ancestor
6022355|NCT00405938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5490225|NCT05069831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5490226|NCT05069831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5490227|NCT05069831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490228|NCT05069350|Bupivacaine|bupivacaine|mesh-list
5490229|NCT05069350|Anesthetics, Local|anesthetics, local|mesh-ancestor
6022356|NCT00405938|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6022357|NCT00405938|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6454543|NCT00425074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6454544|NCT00425074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6454545|NCT00425074|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6454546|NCT00425074|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6454547|NCT00425074|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6454548|NCT00425074|Antipyretics|antipyretics|mesh-ancestor
6454549|NCT00425126|Epoetin Alfa|epoetin alfa|mesh-list
6454550|NCT00425126|Hematinics|hematinics|mesh-ancestor
6454551|NCT00425152|Leucovorin|leucovorin|mesh-list
6454552|NCT00425152|Levamisole|levamisole|mesh-list
6454553|NCT00425152|Fluorouracil|fluorouracil|mesh-list
6454554|NCT00425152|Calcium|calcium|mesh-list
6454555|NCT00425152|Levoleucovorin|levoleucovorin|mesh-list
6454556|NCT00425152|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6454557|NCT00425152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454558|NCT00425152|Antimetabolites|antimetabolites|mesh-ancestor
6454559|NCT00425152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6454560|NCT00425152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6454561|NCT00425152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6454562|NCT00425152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6454563|NCT00425152|Immunologic Factors|immunologic factors|mesh-ancestor
6454564|NCT00425152|Antidotes|antidotes|mesh-ancestor
6454565|NCT00425152|Protective Agents|protective agents|mesh-ancestor
6454566|NCT00425152|Vitamin B Complex|vitamin b complex|mesh-ancestor
6454567|NCT00425152|Vitamins|vitamins|mesh-ancestor
6454568|NCT00425152|Micronutrients|micronutrients|mesh-ancestor
6022358|NCT00405938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6022359|NCT00405938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6454569|NCT00425152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6454570|NCT00425152|Antinematodal Agents|antinematodal agents|mesh-ancestor
6454571|NCT00425152|Anthelmintics|anthelmintics|mesh-ancestor
6454572|NCT00425152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5490230|NCT05069350|Anesthetics|anesthetics|mesh-ancestor
5490231|NCT05069350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5490232|NCT05069350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490233|NCT05069350|Sensory System Agents|sensory system agents|mesh-ancestor
5490234|NCT05069350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5490235|NCT05067582|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
5490236|NCT05067582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5490237|NCT05067582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490238|NCT05065411|Everolimus|everolimus|mesh-list
5490239|NCT05065411|Fulvestrant|fulvestrant|mesh-list
5490240|NCT05065411|Exemestane|exemestane|mesh-list
5490241|NCT05065411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5490242|NCT05065411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5490243|NCT05065411|Immunologic Factors|immunologic factors|mesh-ancestor
5490244|NCT05065411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490245|NCT05065411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5490246|NCT05065411|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5490247|NCT05065411|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5490248|NCT05065411|Hormone Antagonists|hormone antagonists|mesh-ancestor
5490249|NCT05065411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5490250|NCT05065411|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5490251|NCT05065411|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6454573|NCT00425152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6454574|NCT00425152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6454575|NCT00425191|Gemcitabine|gemcitabine|mesh-list
6454576|NCT00425191|Docetaxel|docetaxel|mesh-list
6454577|NCT00425191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6454578|NCT00425191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6454579|NCT00425191|Antimetabolites|antimetabolites|mesh-ancestor
6454580|NCT00425191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6454581|NCT00425191|Antiviral Agents|antiviral agents|mesh-ancestor
6454582|NCT00425191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6454583|NCT00425191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6454584|NCT00425191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6454585|NCT00425191|Immunologic Factors|immunologic factors|mesh-ancestor
6454586|NCT00425191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454587|NCT00425191|Tubulin Modulators|tubulin modulators|mesh-ancestor
6454588|NCT00425191|Antimitotic Agents|antimitotic agents|mesh-ancestor
6454589|NCT00425191|Mitosis Modulators|mitosis modulators|mesh-ancestor
6454590|NCT00425204|Panitumumab|panitumumab|mesh-list
6454591|NCT00425204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6454592|NCT00425204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6454593|NCT00425217|Rituximab|rituximab|mesh-list
6454594|NCT00425217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6454595|NCT00425217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6454596|NCT00425217|Immunologic Factors|immunologic factors|mesh-ancestor
6454597|NCT00425217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454598|NCT00425217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6454599|NCT00425230|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6454600|NCT00425230|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6454601|NCT00425230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6454602|NCT00425230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6454603|NCT00425230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490252|NCT05065411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5490253|NCT05065411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490254|NCT05040282|Etonogestrel|etonogestrel|mesh-list
5490255|NCT05040282|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5490256|NCT05040282|Contraceptive Agents|contraceptive agents|mesh-ancestor
5490257|NCT05040282|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5490258|NCT05040282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490259|NCT05040282|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6454604|NCT00425230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6454605|NCT00425230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454606|NCT00425230|Analgesics|analgesics|mesh-ancestor
6454607|NCT00425230|Sensory System Agents|sensory system agents|mesh-ancestor
6454608|NCT00425230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6454609|NCT00425230|Antidepressive Agents|antidepressive agents|mesh-ancestor
6454610|NCT00425230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6454611|NCT00425230|Dopamine Agents|dopamine agents|mesh-ancestor
6454612|NCT00425243|Zolpidem|zolpidem|mesh-list
6454613|NCT00425243|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6454614|NCT00425243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6454615|NCT00425243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6454616|NCT00425243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454617|NCT00425243|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6454618|NCT00425243|GABA Agonists|gaba agonists|mesh-ancestor
6022360|NCT00406029|Levodopa|levodopa|mesh-list
6454619|NCT00425243|GABA Agents|gaba agents|mesh-ancestor
6454620|NCT00425243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6454621|NCT00425243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6454622|NCT00425334|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6454623|NCT00425347|Elotuzumab|elotuzumab|mesh-list
6454624|NCT00425347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6454625|NCT00425360|Gemcitabine|gemcitabine|mesh-list
6454626|NCT00425360|Capecitabine|capecitabine|mesh-list
6454627|NCT00425360|Sargramostim|sargramostim|mesh-list
6454628|NCT00425360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6454629|NCT00425360|Antimetabolites|antimetabolites|mesh-ancestor
6454630|NCT00425360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6454631|NCT00425360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6454632|NCT00425360|Antiviral Agents|antiviral agents|mesh-ancestor
6454633|NCT00425360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6454634|NCT00425360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6454635|NCT00425360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6454636|NCT00425360|Immunologic Factors|immunologic factors|mesh-ancestor
6454637|NCT00425360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454638|NCT00425425|Fluorouracil|fluorouracil|mesh-list
6454639|NCT00425425|Oxaliplatin|oxaliplatin|mesh-list
6454640|NCT00425425|Cetuximab|cetuximab|mesh-list
6454641|NCT00425425|Antimetabolites|antimetabolites|mesh-ancestor
6454642|NCT00425425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6454643|NCT00425425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6454644|NCT00425425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6454645|NCT00425425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6454646|NCT00425425|Immunologic Factors|immunologic factors|mesh-ancestor
6022361|NCT00406029|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6022362|NCT00406029|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6022363|NCT00406029|Dopamine Agents|dopamine agents|mesh-ancestor
6022364|NCT00406029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6022365|NCT00406029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6022366|NCT00406029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022367|NCT00406276|Docetaxel|docetaxel|mesh-list
6022368|NCT00406276|Everolimus|everolimus|mesh-list
6022369|NCT00406276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6022370|NCT00406276|Tubulin Modulators|tubulin modulators|mesh-ancestor
6022371|NCT00406276|Antimitotic Agents|antimitotic agents|mesh-ancestor
6022372|NCT00406276|Mitosis Modulators|mitosis modulators|mesh-ancestor
6454647|NCT00425425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022373|NCT00406276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6022374|NCT00406276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6454648|NCT00425425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6454649|NCT00425451|Chlorhexidine|chlorhexidine|mesh-list
6454650|NCT00425451|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6454651|NCT00425451|Flurbiprofen|flurbiprofen|mesh-list
6454652|NCT00425451|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6022375|NCT00406276|Immunologic Factors|immunologic factors|mesh-ancestor
6022376|NCT00406276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022377|NCT00406315|Ziprasidone|ziprasidone|mesh-list
6022378|NCT00406315|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6022379|NCT00406315|Serotonin Agents|serotonin agents|mesh-ancestor
6022380|NCT00406315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6022381|NCT00406315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6022382|NCT00406315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454653|NCT00425451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6454654|NCT00425451|Disinfectants|disinfectants|mesh-ancestor
6454655|NCT00425451|Dermatologic Agents|dermatologic agents|mesh-ancestor
6454656|NCT00425451|Analgesics|analgesics|mesh-ancestor
6454657|NCT00425451|Sensory System Agents|sensory system agents|mesh-ancestor
6454658|NCT00425451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6454659|NCT00425451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454660|NCT00425451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6454661|NCT00425451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6454662|NCT00425451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6454663|NCT00425451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6454664|NCT00425451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6454665|NCT00425451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6454666|NCT00425451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6454667|NCT00425490|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6454668|NCT00425490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6454669|NCT00425490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454670|NCT00425490|Incretins|incretins|mesh-ancestor
6022383|NCT00406315|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6022384|NCT00406315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6022385|NCT00406315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6022386|NCT00406315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6022387|NCT00406315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6022388|NCT00406315|Dopamine Agents|dopamine agents|mesh-ancestor
6022389|NCT00406354|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6022390|NCT00406354|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6022391|NCT00406354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6454671|NCT00425490|Hormones|hormones|mesh-ancestor
6454672|NCT00425490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6454673|NCT00425490|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6454674|NCT00425490|Protease Inhibitors|protease inhibitors|mesh-ancestor
6454675|NCT00425490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6454676|NCT00425490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6454677|NCT00425516|Cyclophosphamide|cyclophosphamide|mesh-list
6454678|NCT00425516|Docetaxel|docetaxel|mesh-list
6454679|NCT00425516|Fluorouracil|fluorouracil|mesh-list
6454680|NCT00425516|Epirubicin|epirubicin|mesh-list
6454681|NCT00425516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6454682|NCT00425516|Immunologic Factors|immunologic factors|mesh-ancestor
6454683|NCT00425516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454684|NCT00425516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6454685|NCT00425516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6454686|NCT00425516|Alkylating Agents|alkylating agents|mesh-ancestor
6454687|NCT00425516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6454688|NCT00425516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6454689|NCT00425516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6454690|NCT00425516|Tubulin Modulators|tubulin modulators|mesh-ancestor
6454691|NCT00425516|Antimitotic Agents|antimitotic agents|mesh-ancestor
6454692|NCT00425516|Mitosis Modulators|mitosis modulators|mesh-ancestor
6454693|NCT00425516|Antimetabolites|antimetabolites|mesh-ancestor
6454694|NCT00425516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6454695|NCT00425516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6454696|NCT00425516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6022392|NCT00406354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6022393|NCT00406354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6022394|NCT00406354|Adrenergic Agents|adrenergic agents|mesh-ancestor
6022395|NCT00406354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5490274|NCT05013229|Insulin|insulin|mesh-list
5490275|NCT05013229|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5490276|NCT05013229|Insulin Glargine|insulin glargine|mesh-list
5490277|NCT05013229|Insulin Aspart|insulin aspart|mesh-list
5490278|NCT05013229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5490279|NCT05013229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022396|NCT00406354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022397|NCT00406367|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
6022398|NCT00406367|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6022399|NCT00406367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6022400|NCT00406367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054335|NCT00602459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6022401|NCT00406367|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6022402|NCT00406367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6022403|NCT00406367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6022404|NCT00406367|Cholinergic Agents|cholinergic agents|mesh-ancestor
6022405|NCT00406367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6022406|NCT00406393|Sirolimus|sirolimus|mesh-list
6022407|NCT00406393|Methotrexate|methotrexate|mesh-list
6022408|NCT00406393|Tacrolimus|tacrolimus|mesh-list
6022409|NCT00406393|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6022410|NCT00406393|Abortifacient Agents|abortifacient agents|mesh-ancestor
6022411|NCT00406393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5490298|NCT05004038|BCG Vaccine|bcg vaccine|mesh-list
6022412|NCT00406393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022413|NCT00406393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6022414|NCT00406393|Antimetabolites|antimetabolites|mesh-ancestor
6022415|NCT00406393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6022416|NCT00406393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6022417|NCT00406393|Dermatologic Agents|dermatologic agents|mesh-ancestor
6022418|NCT00406393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6022419|NCT00406393|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6022420|NCT00406393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5490299|NCT05004038|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5490300|NCT05004038|Immunologic Factors|immunologic factors|mesh-ancestor
5490301|NCT05004038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490302|NCT04994535|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5490303|NCT04994535|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5490304|NCT04994535|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6022421|NCT00406393|Immunologic Factors|immunologic factors|mesh-ancestor
6022422|NCT00406393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6022423|NCT00406393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6022424|NCT00406393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6022425|NCT00406393|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6022426|NCT00406393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6022427|NCT00406393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6454697|NCT00425516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6454698|NCT00425516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6454699|NCT00425568|Testosterone|testosterone|mesh-list
6454700|NCT00425568|Androgens|androgens|mesh-ancestor
6454701|NCT00425568|Hormones|hormones|mesh-ancestor
6022428|NCT00406393|Antifungal Agents|antifungal agents|mesh-ancestor
6022429|NCT00406419|Methotrexate|methotrexate|mesh-list
6022430|NCT00406419|Ocrelizumab|ocrelizumab|mesh-list
6454702|NCT00425568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5490305|NCT04994535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5490306|NCT04994535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490307|NCT04994535|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5490308|NCT04994535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5490309|NCT04994535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490310|NCT04994535|Cholinergic Agents|cholinergic agents|mesh-ancestor
6022431|NCT00406419|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6022432|NCT00406419|Abortifacient Agents|abortifacient agents|mesh-ancestor
6022433|NCT00406419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6022434|NCT00406419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022435|NCT00406419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6022436|NCT00406419|Antimetabolites|antimetabolites|mesh-ancestor
6022437|NCT00406419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6022438|NCT00406419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6022439|NCT00406419|Dermatologic Agents|dermatologic agents|mesh-ancestor
5490311|NCT04994535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5490312|NCT04982172|Infliximab|infliximab|mesh-list
5490313|NCT04982172|Dermatologic Agents|dermatologic agents|mesh-ancestor
5490314|NCT04982172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5490315|NCT04982172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5502916|NCT04463784|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5502917|NCT04463966|Tranexamic Acid|tranexamic acid|mesh-list
5502918|NCT04463966|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5502919|NCT04463966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5502920|NCT04463966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502921|NCT04463966|Hemostatics|hemostatics|mesh-ancestor
6022440|NCT00406419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6022441|NCT00406419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6022442|NCT00406419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6022443|NCT00406419|Immunologic Factors|immunologic factors|mesh-ancestor
6022444|NCT00406419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6022445|NCT00406419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6022446|NCT00406640|Citalopram|citalopram|mesh-list
6022447|NCT00406640|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6454703|NCT00425568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454704|NCT00425594|Bisacodyl|bisacodyl|mesh-list
6454705|NCT00425594|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
6454706|NCT00425594|Cathartics|cathartics|mesh-ancestor
6454707|NCT00425594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6454708|NCT00425594|Laxatives|laxatives|mesh-ancestor
6022448|NCT00406640|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6022449|NCT00406640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6022450|NCT00406640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6022451|NCT00406640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6022452|NCT00406640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6022453|NCT00406640|Serotonin Agents|serotonin agents|mesh-ancestor
6022454|NCT00406640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022455|NCT00406640|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6022456|NCT00406640|Antidepressive Agents|antidepressive agents|mesh-ancestor
6022457|NCT00406640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6022458|NCT00406640|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6454709|NCT00425620|Amphotericin B|amphotericin b|mesh-list
6454710|NCT00425620|Amebicides|amebicides|mesh-ancestor
6454711|NCT00425620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6454712|NCT00425620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6654579|NCT01457859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6654580|NCT01457911|Metformin|metformin|mesh-list
6654581|NCT01457911|Glimepiride|glimepiride|mesh-list
6654582|NCT01457911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6654583|NCT01457911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654584|NCT01457911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6654585|NCT01457911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6654586|NCT01457911|Immunologic Factors|immunologic factors|mesh-ancestor
6654587|NCT01457937|Interferons|interferons|mesh-list
6454713|NCT00425620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6454714|NCT00425620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6454715|NCT00425620|Antifungal Agents|antifungal agents|mesh-ancestor
6454716|NCT00425646|Bevacizumab|bevacizumab|mesh-list
6454717|NCT00425646|Imatinib Mesylate|imatinib mesylate|mesh-list
6454718|NCT00425646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6454719|NCT00425646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6454720|NCT00425646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6454721|NCT00425646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6022459|NCT00406653|Abatacept|abatacept|mesh-list
6022460|NCT00406653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6022461|NCT00406653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6022462|NCT00406653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6454722|NCT00425646|Growth Substances|growth substances|mesh-ancestor
6454723|NCT00425646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454724|NCT00425646|Growth Inhibitors|growth inhibitors|mesh-ancestor
6654588|NCT01457937|Ribavirin|ribavirin|mesh-list
6022463|NCT00406653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6022464|NCT00406653|Immunologic Factors|immunologic factors|mesh-ancestor
6022465|NCT00406653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022466|NCT00406653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6022467|NCT00406692|Zonisamide|zonisamide|mesh-list
6022468|NCT00406692|Anticonvulsants|anticonvulsants|mesh-ancestor
6022469|NCT00406692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6022470|NCT00406692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6022471|NCT00406692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490316|NCT04978272|Piperaquine|piperaquine|mesh-list
5490317|NCT04978272|Artenimol|artenimol|mesh-list
5490318|NCT04978272|Antimalarials|antimalarials|mesh-ancestor
5490319|NCT04978272|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5490320|NCT04978272|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5490321|NCT04978272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5490322|NCT04952779|Insulin|insulin|mesh-list
5490323|NCT04952779|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5490324|NCT04952779|Liraglutide|liraglutide|mesh-list
5490325|NCT04952779|Insulin, Long-Acting|insulin, long-acting|mesh-list
5490326|NCT04952779|Xultophy|xultophy|mesh-list
5490327|NCT04952779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5490328|NCT04952779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490329|NCT04952779|Incretins|incretins|mesh-ancestor
5490330|NCT04952779|Hormones|hormones|mesh-ancestor
5490331|NCT04952779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6022472|NCT00406692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6022473|NCT00406692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022474|NCT00406848|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6022475|NCT00406848|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6022476|NCT00406848|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6454725|NCT00425646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6454726|NCT00425646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6454727|NCT00425646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6454728|NCT00425711|Acamprosate|acamprosate|mesh-list
6454729|NCT00425711|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6454730|NCT00425724|Cyclosporine|cyclosporine|mesh-list
6454731|NCT00425724|Prednisone|prednisone|mesh-list
6454732|NCT00425724|Methylprednisolone|methylprednisolone|mesh-list
6454733|NCT00425724|Cyclosporins|cyclosporins|mesh-list
6454734|NCT00425724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6454735|NCT00425724|Glucocorticoids|glucocorticoids|mesh-ancestor
6454736|NCT00425724|Hormones|hormones|mesh-ancestor
6454737|NCT00425724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6454738|NCT00425724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022477|NCT00406848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6022478|NCT00406848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6022479|NCT00406848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6022480|NCT00406848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490332|NCT04934800|Cladribine|cladribine|mesh-list
5490333|NCT04934800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5490334|NCT04934800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5490335|NCT04934800|Immunologic Factors|immunologic factors|mesh-ancestor
5490336|NCT04934800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490337|NCT04915144|Edotreotide|edotreotide|mesh-list
5490338|NCT04915144|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5490339|NCT04915144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490340|NCT04883645|Imiquimod|imiquimod|mesh-list
5490341|NCT04883645|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5490342|NCT04883645|Immunologic Factors|immunologic factors|mesh-ancestor
5490343|NCT04883645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490344|NCT04883645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5490345|NCT04883645|Interferon Inducers|interferon inducers|mesh-ancestor
5490346|NCT04874480|Decitabine|decitabine|mesh-list
5490347|NCT04874480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5490348|NCT04874480|Antimetabolites|antimetabolites|mesh-ancestor
6022481|NCT00406848|Analgesics|analgesics|mesh-ancestor
6022482|NCT00406848|Sensory System Agents|sensory system agents|mesh-ancestor
6022483|NCT00406848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6022484|NCT00406848|Antidepressive Agents|antidepressive agents|mesh-ancestor
6022485|NCT00406848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6022486|NCT00406848|Dopamine Agents|dopamine agents|mesh-ancestor
6022487|NCT00407030|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
6454739|NCT00425724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5490349|NCT04874480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490350|NCT04874480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6022488|NCT00407030|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6022489|NCT00407030|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6022490|NCT00407030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6454740|NCT00425724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6454741|NCT00425724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5490351|NCT04874480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5490352|NCT04861584|Gemcitabine|gemcitabine|mesh-list
5490353|NCT04861584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5490354|NCT04861584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5490355|NCT04861584|Antimetabolites|antimetabolites|mesh-ancestor
5490356|NCT04861584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490357|NCT04861584|Antiviral Agents|antiviral agents|mesh-ancestor
5490358|NCT04861584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5490359|NCT04861584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6454742|NCT00425724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490360|NCT04861584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5490361|NCT04861584|Immunologic Factors|immunologic factors|mesh-ancestor
6022491|NCT00407030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022492|NCT00407030|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5490362|NCT04861584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490363|NCT04859062|Lidocaine|lidocaine|mesh-list
5490364|NCT04859062|Anesthetics, Local|anesthetics, local|mesh-ancestor
5490365|NCT04859062|Anesthetics|anesthetics|mesh-ancestor
5490366|NCT04859062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5490367|NCT04859062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022493|NCT00407030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6022494|NCT00407030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6022495|NCT00407030|Cholinergic Agents|cholinergic agents|mesh-ancestor
6022496|NCT00407030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6022497|NCT00407355|Ranibizumab|ranibizumab|mesh-list
6022498|NCT00407355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6022499|NCT00407355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6022500|NCT00407355|Growth Substances|growth substances|mesh-ancestor
6022501|NCT00407355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022502|NCT00407355|Growth Inhibitors|growth inhibitors|mesh-ancestor
6022503|NCT00407355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6022504|NCT00407381|Ranibizumab|ranibizumab|mesh-list
6022505|NCT00407381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6022506|NCT00407381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6022507|NCT00407381|Growth Substances|growth substances|mesh-ancestor
6022508|NCT00407381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022509|NCT00407381|Growth Inhibitors|growth inhibitors|mesh-ancestor
6022510|NCT00407381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6022511|NCT00407485|Aflibercept|aflibercept|mesh-list
6022512|NCT00407485|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6022513|NCT00407485|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6022514|NCT00407485|Growth Substances|growth substances|mesh-ancestor
6022515|NCT00407485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022516|NCT00407485|Growth Inhibitors|growth inhibitors|mesh-ancestor
6022517|NCT00407485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6022518|NCT00407511|Pregabalin|pregabalin|mesh-list
6022519|NCT00407511|Analgesics|analgesics|mesh-ancestor
6022520|NCT00407511|Sensory System Agents|sensory system agents|mesh-ancestor
6022521|NCT00407511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6022522|NCT00407511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022523|NCT00407511|Anticonvulsants|anticonvulsants|mesh-ancestor
6022524|NCT00407511|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6022525|NCT00407511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6022526|NCT00407511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6022527|NCT00407511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6022528|NCT00407511|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6022529|NCT00407511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6022530|NCT00407511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6022531|NCT00407511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6022532|NCT00407537|Amlodipine|amlodipine|mesh-list
6022533|NCT00407537|Atorvastatin|atorvastatin|mesh-list
6022534|NCT00407537|Calcium|calcium|mesh-list
6022535|NCT00407537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6022536|NCT00407537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022537|NCT00407537|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6022538|NCT00407537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6022539|NCT00407537|Antimetabolites|antimetabolites|mesh-ancestor
6022540|NCT00407537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6022541|NCT00407537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6054336|NCT00602459|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6022542|NCT00407537|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6022543|NCT00407537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6022544|NCT00407537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5490368|NCT04859062|Sensory System Agents|sensory system agents|mesh-ancestor
5490369|NCT04859062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5490370|NCT04859062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6022545|NCT00407537|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6022546|NCT00407537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6022547|NCT00407537|Vasodilator Agents|vasodilator agents|mesh-ancestor
6022548|NCT00407550|Gemcitabine|gemcitabine|mesh-list
6022549|NCT00407550|Pemetrexed|pemetrexed|mesh-list
6022550|NCT00407550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6022551|NCT00407550|Antimetabolites|antimetabolites|mesh-ancestor
5490371|NCT04859062|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5490372|NCT04859062|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5490373|NCT04859062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5490374|NCT04859062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490375|NCT04848584|Vaccines|vaccines|mesh-list
5490376|NCT04848584|Immunologic Factors|immunologic factors|mesh-ancestor
5490377|NCT04848584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022552|NCT00407550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6022553|NCT00407550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6022554|NCT00407550|Antiviral Agents|antiviral agents|mesh-ancestor
6022555|NCT00407550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6022556|NCT00407550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6022557|NCT00407550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6022558|NCT00407550|Immunologic Factors|immunologic factors|mesh-ancestor
6022559|NCT00407550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022560|NCT00407550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6022561|NCT00407550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5490388|NCT04818229|Moxifloxacin|moxifloxacin|mesh-list
5490389|NCT04818229|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6022562|NCT00407563|Paclitaxel|paclitaxel|mesh-list
6022563|NCT00407563|Bevacizumab|bevacizumab|mesh-list
6022564|NCT00407563|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6454743|NCT00425724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6454744|NCT00425724|Immunologic Factors|immunologic factors|mesh-ancestor
6454745|NCT00425724|Antifungal Agents|antifungal agents|mesh-ancestor
6454746|NCT00425724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5490390|NCT04818229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5490391|NCT04818229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5490392|NCT04818229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6654589|NCT01457937|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6654590|NCT01457937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6654591|NCT01457937|Antiviral Agents|antiviral agents|mesh-ancestor
6654592|NCT01457937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6654593|NCT01457937|Antimetabolites|antimetabolites|mesh-ancestor
5490393|NCT04818229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6454747|NCT00425724|Dermatologic Agents|dermatologic agents|mesh-ancestor
6454748|NCT00425724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6454749|NCT00425724|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6454750|NCT00425724|Antiemetics|antiemetics|mesh-ancestor
6454751|NCT00425724|Autonomic Agents|autonomic agents|mesh-ancestor
6454752|NCT00425724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6454753|NCT00425724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6454754|NCT00425724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6454755|NCT00425724|Protective Agents|protective agents|mesh-ancestor
6454756|NCT00425841|Gemcitabine|gemcitabine|mesh-list
6454757|NCT00425841|Oxaliplatin|oxaliplatin|mesh-list
6454758|NCT00425841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6454759|NCT00425841|Antimetabolites|antimetabolites|mesh-ancestor
6454760|NCT00425841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6454761|NCT00425841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6454762|NCT00425841|Antiviral Agents|antiviral agents|mesh-ancestor
6022565|NCT00407563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6022566|NCT00407563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6022567|NCT00407563|Tubulin Modulators|tubulin modulators|mesh-ancestor
6022568|NCT00407563|Antimitotic Agents|antimitotic agents|mesh-ancestor
6022569|NCT00407563|Mitosis Modulators|mitosis modulators|mesh-ancestor
6022570|NCT00407563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6022571|NCT00407563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6022572|NCT00407563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6454763|NCT00425841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6454764|NCT00425841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6022573|NCT00407563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6654594|NCT01457937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654595|NCT01457989|Ezogabine|ezogabine|mesh-list
6654596|NCT01457989|Anticonvulsants|anticonvulsants|mesh-ancestor
6654597|NCT01457989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6654598|NCT01457989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654599|NCT01458015|Oxycodone|oxycodone|mesh-list
6654600|NCT01458015|Tapentadol|tapentadol|mesh-list
6654601|NCT01458015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6654602|NCT01458015|Narcotics|narcotics|mesh-ancestor
6654603|NCT01458015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6654604|NCT01458015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654605|NCT01458015|Analgesics|analgesics|mesh-ancestor
6022574|NCT00407563|Growth Substances|growth substances|mesh-ancestor
6022575|NCT00407563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022576|NCT00407563|Growth Inhibitors|growth inhibitors|mesh-ancestor
6022577|NCT00407654|Aflibercept|aflibercept|mesh-list
6022578|NCT00407654|Endothelial Growth Factors|endothelial growth factors|mesh-list
6022579|NCT00407654|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6022580|NCT00407654|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6022581|NCT00407654|Growth Substances|growth substances|mesh-ancestor
6022582|NCT00407654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490394|NCT04818229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5490395|NCT04818229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490396|NCT04818229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5490397|NCT04818229|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5490398|NCT04818229|Contraceptive Agents|contraceptive agents|mesh-ancestor
5490399|NCT04818229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5490400|NCT04818229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490401|NCT04818229|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5490402|NCT04818229|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5490403|NCT04818229|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5490404|NCT04817410|Naltrexone|naltrexone|mesh-list
5490405|NCT04817410|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5490406|NCT04817410|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6022583|NCT00407654|Growth Inhibitors|growth inhibitors|mesh-ancestor
6022584|NCT00407654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6022585|NCT00407745|Pregabalin|pregabalin|mesh-list
6022586|NCT00407745|Analgesics|analgesics|mesh-ancestor
6022587|NCT00407745|Sensory System Agents|sensory system agents|mesh-ancestor
6022588|NCT00407745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6022589|NCT00407745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022590|NCT00407745|Anticonvulsants|anticonvulsants|mesh-ancestor
6022591|NCT00407745|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6022592|NCT00407745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6454765|NCT00425841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6454766|NCT00425841|Immunologic Factors|immunologic factors|mesh-ancestor
6454767|NCT00425841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490407|NCT04817410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490408|NCT04817410|Sensory System Agents|sensory system agents|mesh-ancestor
6022593|NCT00407745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6454768|NCT00425906|Nicotine|nicotine|mesh-list
6454769|NCT00425906|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6454770|NCT00425906|Autonomic Agents|autonomic agents|mesh-ancestor
6454771|NCT00425906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6454772|NCT00425906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454773|NCT00425906|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6022594|NCT00407745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6022595|NCT00407745|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6022596|NCT00407745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6022597|NCT00407745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6022598|NCT00407745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6022599|NCT00407797|Pregabalin|pregabalin|mesh-list
6022600|NCT00407797|Analgesics|analgesics|mesh-ancestor
6022601|NCT00407797|Sensory System Agents|sensory system agents|mesh-ancestor
6022602|NCT00407797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6454774|NCT00425906|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6454775|NCT00425906|Cholinergic Agents|cholinergic agents|mesh-ancestor
6454776|NCT00425906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6454777|NCT00425906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6454778|NCT00425932|Rituximab|rituximab|mesh-list
6454779|NCT00425932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6454780|NCT00425932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6454781|NCT00425932|Immunologic Factors|immunologic factors|mesh-ancestor
6454782|NCT00425932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454783|NCT00425932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6454784|NCT00425997|Amlodipine|amlodipine|mesh-list
6454785|NCT00425997|Valsartan|valsartan|mesh-list
6454786|NCT00425997|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6454787|NCT00425997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6454788|NCT00425997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6454789|NCT00425997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6454790|NCT00425997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6454791|NCT00425997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6454792|NCT00425997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454793|NCT00425997|Vasodilator Agents|vasodilator agents|mesh-ancestor
6454794|NCT00425997|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6454795|NCT00425997|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6454796|NCT00425997|Diuretics|diuretics|mesh-ancestor
6454797|NCT00425997|Natriuretic Agents|natriuretic agents|mesh-ancestor
6454798|NCT00425997|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6454799|NCT00426010|Caffeine|caffeine|mesh-list
6454800|NCT00426010|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6454801|NCT00426010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454802|NCT00426010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6454803|NCT00426010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6454804|NCT00426010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6454805|NCT00426010|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6454806|NCT00426010|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6454807|NCT00426010|Purinergic Agents|purinergic agents|mesh-ancestor
6454808|NCT00426010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6454809|NCT00426023|Ketotifen|ketotifen|mesh-list
6454810|NCT00426023|Cyclosporine|cyclosporine|mesh-list
6454811|NCT00426023|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6454812|NCT00426023|Cyclosporins|cyclosporins|mesh-list
6454813|NCT00426023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6454814|NCT00426023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6454815|NCT00426023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6454816|NCT00426023|Immunologic Factors|immunologic factors|mesh-ancestor
6454817|NCT00426023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454818|NCT00426023|Antifungal Agents|antifungal agents|mesh-ancestor
6454819|NCT00426023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6454820|NCT00426023|Dermatologic Agents|dermatologic agents|mesh-ancestor
6022603|NCT00407797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022604|NCT00407797|Anticonvulsants|anticonvulsants|mesh-ancestor
6022605|NCT00407797|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6022606|NCT00407797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6022607|NCT00407797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6022608|NCT00407797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6022609|NCT00407797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6022610|NCT00407797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6454821|NCT00426023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6454822|NCT00426023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6454823|NCT00426023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6454824|NCT00426023|Antipruritics|antipruritics|mesh-ancestor
6454825|NCT00426023|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6454826|NCT00426023|Histamine Antagonists|histamine antagonists|mesh-ancestor
6454827|NCT00426023|Histamine Agents|histamine agents|mesh-ancestor
6454828|NCT00426023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6454829|NCT00426023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6454830|NCT00426049|Everolimus|everolimus|mesh-list
6454831|NCT00426049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6454832|NCT00426049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6022611|NCT00407797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6022612|NCT00407797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6053250|NCT00593957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053251|NCT00593957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053252|NCT00594165|Rotigotine|rotigotine|mesh-list
6053253|NCT00594165|Dopamine Agonists|dopamine agonists|mesh-ancestor
6053254|NCT00594165|Dopamine Agents|dopamine agents|mesh-ancestor
6053255|NCT00594165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6053256|NCT00594165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053257|NCT00594165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053258|NCT00594204|Varenicline|varenicline|mesh-list
6053259|NCT00594204|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6053260|NCT00594204|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6454833|NCT00426049|Immunologic Factors|immunologic factors|mesh-ancestor
6454834|NCT00426049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490409|NCT04817410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5490410|NCT04814368|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5490411|NCT04814368|Immunologic Factors|immunologic factors|mesh-ancestor
6022613|NCT00407888|Paclitaxel|paclitaxel|mesh-list
6022614|NCT00407888|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6022615|NCT00407888|Cyclophosphamide|cyclophosphamide|mesh-list
6022616|NCT00407888|Doxorubicin|doxorubicin|mesh-list
6022617|NCT00407888|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6022618|NCT00407888|Trastuzumab|trastuzumab|mesh-list
6022619|NCT00407888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5490412|NCT04814368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490413|NCT04809376|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
5490414|NCT04809376|Anticoagulants|anticoagulants|mesh-ancestor
5490415|NCT04808414|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5490416|NCT04808414|Polymyxins|polymyxins|mesh-list
5490417|NCT04808414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5490418|NCT04801849|Vitamin E|vitamin e|mesh-list
5490419|NCT04801849|Tocopherols|tocopherols|mesh-list
5490420|NCT04801849|Tocotrienols|tocotrienols|mesh-list
5490421|NCT04801849|alpha-Tocopherol|alpha-tocopherol|mesh-list
5490422|NCT04801849|Vitamins|vitamins|mesh-ancestor
5490423|NCT04801849|Micronutrients|micronutrients|mesh-ancestor
5490424|NCT04801849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490425|NCT04801849|Antioxidants|antioxidants|mesh-ancestor
5490426|NCT04801849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490427|NCT04801849|Protective Agents|protective agents|mesh-ancestor
5490428|NCT04795531|Insulin|insulin|mesh-list
5490429|NCT04795531|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5490430|NCT04795531|Insulin, Long-Acting|insulin, long-acting|mesh-list
5490431|NCT04795531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5490432|NCT04795531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490433|NCT04770012|Aspirin|aspirin|mesh-list
5490434|NCT04770012|Clopidogrel|clopidogrel|mesh-list
5490435|NCT04770012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5490436|NCT04770012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5490437|NCT04770012|Analgesics|analgesics|mesh-ancestor
5490438|NCT04770012|Sensory System Agents|sensory system agents|mesh-ancestor
5490439|NCT04770012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5490440|NCT04770012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490441|NCT04770012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5490442|NCT04770012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5490443|NCT04770012|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5490444|NCT04770012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5490445|NCT04770012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490446|NCT04770012|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6022620|NCT00407888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6022621|NCT00407888|Tubulin Modulators|tubulin modulators|mesh-ancestor
6022622|NCT00407888|Antimitotic Agents|antimitotic agents|mesh-ancestor
6022623|NCT00407888|Mitosis Modulators|mitosis modulators|mesh-ancestor
6022624|NCT00407888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6022625|NCT00407888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6022626|NCT00407888|Immunologic Factors|immunologic factors|mesh-ancestor
6022627|NCT00407888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022628|NCT00407888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6022629|NCT00407888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6022630|NCT00407888|Alkylating Agents|alkylating agents|mesh-ancestor
6022631|NCT00407888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5490447|NCT04770012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5490448|NCT04770012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5490449|NCT04770012|Antipyretics|antipyretics|mesh-ancestor
5490450|NCT04770012|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6022632|NCT00407888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6022633|NCT00407888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6022634|NCT00407888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6022635|NCT00407888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6022636|NCT00407888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6022637|NCT00407966|Cytarabine|cytarabine|mesh-list
6022638|NCT00407966|Mitoxantrone|mitoxantrone|mesh-list
6454835|NCT00426101|Cyclosporine|cyclosporine|mesh-list
6454836|NCT00426101|Dexamethasone|dexamethasone|mesh-list
5490451|NCT04770012|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6454837|NCT00426101|Etoposide|etoposide|mesh-list
6454838|NCT00426101|Cyclosporins|cyclosporins|mesh-list
6454839|NCT00426101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6454840|NCT00426101|Antiemetics|antiemetics|mesh-ancestor
5490452|NCT04770012|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5490453|NCT04770012|Purinergic Agents|purinergic agents|mesh-ancestor
6454841|NCT00426101|Autonomic Agents|autonomic agents|mesh-ancestor
6454842|NCT00426101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6454843|NCT00426101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454844|NCT00426101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6022639|NCT00407966|Alvocidib|alvocidib|mesh-list
6022640|NCT00407966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6022641|NCT00407966|Antimetabolites|antimetabolites|mesh-ancestor
6022642|NCT00407966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6022643|NCT00407966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6022644|NCT00407966|Antiviral Agents|antiviral agents|mesh-ancestor
6454845|NCT00426101|Glucocorticoids|glucocorticoids|mesh-ancestor
6454846|NCT00426101|Hormones|hormones|mesh-ancestor
6454847|NCT00426101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6454848|NCT00426101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6454849|NCT00426101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6454850|NCT00426101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6454851|NCT00426101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6454852|NCT00426101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6454853|NCT00426101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6454854|NCT00426101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6022645|NCT00407966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6022646|NCT00407966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6022647|NCT00407966|Immunologic Factors|immunologic factors|mesh-ancestor
5490454|NCT04770012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5490455|NCT04760626|Insulin|insulin|mesh-list
5490456|NCT04760626|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6454855|NCT00426101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6454856|NCT00426101|Immunologic Factors|immunologic factors|mesh-ancestor
6454857|NCT00426101|Antifungal Agents|antifungal agents|mesh-ancestor
6454858|NCT00426101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6454859|NCT00426101|Dermatologic Agents|dermatologic agents|mesh-ancestor
6454860|NCT00426101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6454861|NCT00426101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6454862|NCT00426140|Epothilone B|epothilone b|mesh-list
6454863|NCT00426140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6454864|NCT00426140|Tubulin Modulators|tubulin modulators|mesh-ancestor
6454865|NCT00426140|Antimitotic Agents|antimitotic agents|mesh-ancestor
6454866|NCT00426140|Mitosis Modulators|mitosis modulators|mesh-ancestor
6022648|NCT00407966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022649|NCT00407966|Analgesics|analgesics|mesh-ancestor
6022650|NCT00407966|Sensory System Agents|sensory system agents|mesh-ancestor
6022651|NCT00407966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6022652|NCT00407966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6022653|NCT00407966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6022654|NCT00407966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6022655|NCT00407966|Growth Inhibitors|growth inhibitors|mesh-ancestor
6022656|NCT00407966|Growth Substances|growth substances|mesh-ancestor
6022657|NCT00407966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6022658|NCT00408005|Calcium, Dietary|calcium, dietary|mesh-list
6022659|NCT00408005|Leucovorin|leucovorin|mesh-list
6022660|NCT00408005|Folic Acid|folic acid|mesh-list
6022661|NCT00408005|Cytarabine|cytarabine|mesh-list
6022662|NCT00408005|6-methoxypurine arabinoside|6-methoxypurine arabinoside|mesh-list
6022663|NCT00408005|Dexamethasone|dexamethasone|mesh-list
6022664|NCT00408005|Dexamethasone acetate|dexamethasone acetate|mesh-list
6022665|NCT00408005|Prednisone|prednisone|mesh-list
6022666|NCT00408005|Cortisone|cortisone|mesh-list
6022667|NCT00408005|Cyclophosphamide|cyclophosphamide|mesh-list
6022668|NCT00408005|Doxorubicin|doxorubicin|mesh-list
6022669|NCT00408005|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6454867|NCT00426140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6454868|NCT00426179|Imatinib Mesylate|imatinib mesylate|mesh-list
6454869|NCT00426179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6454870|NCT00426179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6454871|NCT00426179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6454872|NCT00426179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6454873|NCT00426192|Mannitol|mannitol|mesh-list
6454874|NCT00426192|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6454875|NCT00426192|Diuretics|diuretics|mesh-ancestor
6454876|NCT00426192|Natriuretic Agents|natriuretic agents|mesh-ancestor
6454877|NCT00426192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454878|NCT00426296|Ritonavir|ritonavir|mesh-list
6454879|NCT00426296|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6454880|NCT00426296|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5490457|NCT04760626|Insulin Glargine|insulin glargine|mesh-list
6022670|NCT00408005|Methotrexate|methotrexate|mesh-list
6022671|NCT00408005|Vincristine|vincristine|mesh-list
6022672|NCT00408005|Daunorubicin|daunorubicin|mesh-list
6022673|NCT00408005|Asparaginase|asparaginase|mesh-list
6454881|NCT00426296|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6022674|NCT00408005|Mercaptopurine|mercaptopurine|mesh-list
6022675|NCT00408005|Pegaspargase|pegaspargase|mesh-list
6022676|NCT00408005|Thioguanine|thioguanine|mesh-list
6022677|NCT00408005|BB 1101|bb 1101|mesh-list
6022678|NCT00408005|Calcium|calcium|mesh-list
6022679|NCT00408005|2-Aminopurine|2-aminopurine|mesh-list
6022680|NCT00408005|Levoleucovorin|levoleucovorin|mesh-list
6022681|NCT00408005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6022682|NCT00408005|Immunologic Factors|immunologic factors|mesh-ancestor
6022683|NCT00408005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022684|NCT00408005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6022685|NCT00408005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6022686|NCT00408005|Alkylating Agents|alkylating agents|mesh-ancestor
6022687|NCT00408005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6022688|NCT00408005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6022689|NCT00408005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6022690|NCT00408005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6022691|NCT00408005|Antiemetics|antiemetics|mesh-ancestor
6022692|NCT00408005|Autonomic Agents|autonomic agents|mesh-ancestor
6022693|NCT00408005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6022694|NCT00408005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6022695|NCT00408005|Glucocorticoids|glucocorticoids|mesh-ancestor
6022696|NCT00408005|Hormones|hormones|mesh-ancestor
6022697|NCT00408005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6022698|NCT00408005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6022699|NCT00408005|Protease Inhibitors|protease inhibitors|mesh-ancestor
6022700|NCT00408005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6022701|NCT00408005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6022702|NCT00408005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6022703|NCT00408005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6022704|NCT00408005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6022705|NCT00408005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6022706|NCT00408005|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6454882|NCT00426296|Protease Inhibitors|protease inhibitors|mesh-ancestor
6454883|NCT00426296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6454884|NCT00426296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6454885|NCT00426296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6454886|NCT00426296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6454887|NCT00426296|Antiviral Agents|antiviral agents|mesh-ancestor
6454888|NCT00426296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6454889|NCT00426296|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6454890|NCT00426296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6454891|NCT00426348|Valsartan|valsartan|mesh-list
6454892|NCT00426348|Probucol|probucol|mesh-list
6454893|NCT00426348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6454894|NCT00426348|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6454895|NCT00426348|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6022707|NCT00408005|Abortifacient Agents|abortifacient agents|mesh-ancestor
6022708|NCT00408005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6022709|NCT00408005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6022710|NCT00408005|Antimetabolites|antimetabolites|mesh-ancestor
6022711|NCT00408005|Dermatologic Agents|dermatologic agents|mesh-ancestor
6022712|NCT00408005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6022713|NCT00408005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6022714|NCT00408005|Antiviral Agents|antiviral agents|mesh-ancestor
6022715|NCT00408005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6022716|NCT00408005|Antidotes|antidotes|mesh-ancestor
6022717|NCT00408005|Protective Agents|protective agents|mesh-ancestor
6454896|NCT00426348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6454897|NCT00426348|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6454898|NCT00426348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6454899|NCT00426348|Antimetabolites|antimetabolites|mesh-ancestor
6454900|NCT00426348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6454901|NCT00426348|Antioxidants|antioxidants|mesh-ancestor
6022718|NCT00408005|Vitamin B Complex|vitamin b complex|mesh-ancestor
6022719|NCT00408005|Vitamins|vitamins|mesh-ancestor
6454902|NCT00426348|Protective Agents|protective agents|mesh-ancestor
6454903|NCT00426348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454904|NCT00426413|Pioglitazone|pioglitazone|mesh-list
6454905|NCT00426413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6454906|NCT00426413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454907|NCT00426439|Chloroquine|chloroquine|mesh-list
6454908|NCT00426439|Lumefantrine|lumefantrine|mesh-list
6454909|NCT00426439|Artemether|artemether|mesh-list
6454910|NCT00426439|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6454911|NCT00426439|Amebicides|amebicides|mesh-ancestor
6454912|NCT00426439|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6454913|NCT00426439|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6454914|NCT00426439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6454915|NCT00426439|Antimalarials|antimalarials|mesh-ancestor
6454916|NCT00426439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6454917|NCT00426452|Vatalanib|vatalanib|mesh-list
6454918|NCT00426452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6454919|NCT00426452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6454920|NCT00426452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6454921|NCT00426478|Amlodipine|amlodipine|mesh-list
6454922|NCT00426478|Valsartan|valsartan|mesh-list
6454923|NCT00426478|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6454924|NCT00426478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6454925|NCT00426478|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6454926|NCT00426478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6454927|NCT00426478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6454928|NCT00426478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6454929|NCT00426478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454930|NCT00426478|Vasodilator Agents|vasodilator agents|mesh-ancestor
6022720|NCT00408005|Micronutrients|micronutrients|mesh-ancestor
6022721|NCT00408005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6022722|NCT00408005|Tubulin Modulators|tubulin modulators|mesh-ancestor
6022723|NCT00408005|Antimitotic Agents|antimitotic agents|mesh-ancestor
6022724|NCT00408005|Mitosis Modulators|mitosis modulators|mesh-ancestor
6022725|NCT00408005|Hematinics|hematinics|mesh-ancestor
6022726|NCT00408070|Paclitaxel|paclitaxel|mesh-list
6022727|NCT00408070|Bevacizumab|bevacizumab|mesh-list
6022728|NCT00408070|Carboplatin|carboplatin|mesh-list
6022729|NCT00408070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6022730|NCT00408070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6022731|NCT00408070|Tubulin Modulators|tubulin modulators|mesh-ancestor
6022732|NCT00408070|Antimitotic Agents|antimitotic agents|mesh-ancestor
6454931|NCT00426478|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6454932|NCT00426478|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6454933|NCT00426478|Diuretics|diuretics|mesh-ancestor
6454934|NCT00426478|Natriuretic Agents|natriuretic agents|mesh-ancestor
6454935|NCT00426478|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6454936|NCT00426491|Misoprostol|misoprostol|mesh-list
6454937|NCT00426491|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6454938|NCT00426491|Abortifacient Agents|abortifacient agents|mesh-ancestor
6454939|NCT00426491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6454940|NCT00426491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454941|NCT00426491|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6454942|NCT00426491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6454943|NCT00426491|Oxytocics|oxytocics|mesh-ancestor
6454944|NCT00426530|Everolimus|everolimus|mesh-list
6454945|NCT00426530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6454946|NCT00426530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6454947|NCT00426530|Immunologic Factors|immunologic factors|mesh-ancestor
6454948|NCT00426530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454949|NCT00426543|Rituximab|rituximab|mesh-list
6454950|NCT00426543|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6454951|NCT00426543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6454952|NCT00426543|Immunologic Factors|immunologic factors|mesh-ancestor
6454953|NCT00426543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454954|NCT00426543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6454955|NCT00426582|Epothilone B|epothilone b|mesh-list
6454956|NCT00426582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6454957|NCT00426582|Tubulin Modulators|tubulin modulators|mesh-ancestor
6454958|NCT00426582|Antimitotic Agents|antimitotic agents|mesh-ancestor
6454959|NCT00426582|Mitosis Modulators|mitosis modulators|mesh-ancestor
6454960|NCT00426582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654606|NCT01458015|Sensory System Agents|sensory system agents|mesh-ancestor
6654607|NCT01458015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6654608|NCT01458015|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6022733|NCT00408070|Mitosis Modulators|mitosis modulators|mesh-ancestor
6454961|NCT00426595|Omeprazole|omeprazole|mesh-list
6454962|NCT00426595|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6454963|NCT00426595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6454964|NCT00426595|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6454965|NCT00426595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6454966|NCT00426595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490458|NCT04760626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5490459|NCT04760626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490460|NCT04755972|Acetylcysteine|acetylcysteine|mesh-list
5490461|NCT04755972|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5490462|NCT04755972|Antiviral Agents|antiviral agents|mesh-ancestor
5490463|NCT04755972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5490464|NCT04755972|Expectorants|expectorants|mesh-ancestor
5490465|NCT04755972|Respiratory System Agents|respiratory system agents|mesh-ancestor
5490466|NCT04755972|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5490467|NCT04755972|Antioxidants|antioxidants|mesh-ancestor
5490468|NCT04755972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490469|NCT04755972|Protective Agents|protective agents|mesh-ancestor
5490470|NCT04755972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490471|NCT04755972|Antidotes|antidotes|mesh-ancestor
5490472|NCT04747561|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5490473|NCT04747561|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5490474|NCT04747561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490475|NCT04745832|Prednisone|prednisone|mesh-list
5490476|NCT04745832|Cyclophosphamide|cyclophosphamide|mesh-list
5490477|NCT04745832|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5490478|NCT04745832|Rituximab|rituximab|mesh-list
5490479|NCT04745832|Vincristine|vincristine|mesh-list
5490480|NCT04745832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5490481|NCT04745832|Immunologic Factors|immunologic factors|mesh-ancestor
5490482|NCT04745832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490483|NCT04745832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5490484|NCT04745832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5490485|NCT04745832|Alkylating Agents|alkylating agents|mesh-ancestor
6454967|NCT00426608|Alprazolam|alprazolam|mesh-list
6454968|NCT00426608|Metyrapone|metyrapone|mesh-list
6454969|NCT00426608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6454970|NCT00426608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6454971|NCT00426608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454972|NCT00426608|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6454973|NCT00426608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6454974|NCT00426608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6454975|NCT00426608|GABA Modulators|gaba modulators|mesh-ancestor
6022734|NCT00408070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6022735|NCT00408070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6022736|NCT00408070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6022737|NCT00408070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6022738|NCT00408070|Growth Substances|growth substances|mesh-ancestor
6022739|NCT00408070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022740|NCT00408070|Growth Inhibitors|growth inhibitors|mesh-ancestor
6022741|NCT00408200|Sotalol|sotalol|mesh-list
6022742|NCT00408200|Flecainide|flecainide|mesh-list
6022743|NCT00408200|Propafenone|propafenone|mesh-list
6022744|NCT00408200|Dofetilide|dofetilide|mesh-list
6022745|NCT00408200|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6022746|NCT00408200|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6022747|NCT00408200|Adrenergic Agents|adrenergic agents|mesh-ancestor
6022748|NCT00408200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5490486|NCT04745832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6454976|NCT00426608|GABA Agents|gaba agents|mesh-ancestor
6022749|NCT00408200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6022750|NCT00408200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022751|NCT00408200|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6022752|NCT00408200|Sympatholytics|sympatholytics|mesh-ancestor
6022753|NCT00408200|Autonomic Agents|autonomic agents|mesh-ancestor
6022754|NCT00408200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6022755|NCT00408200|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6022756|NCT00408200|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6022757|NCT00408200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6022758|NCT00408200|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6022759|NCT00408317|Pancrelipase|pancrelipase|mesh-list
6022760|NCT00408317|Pancreatin|pancreatin|mesh-list
6022761|NCT00408317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6022762|NCT00408408|Gemcitabine|gemcitabine|mesh-list
6022763|NCT00408408|Cyclophosphamide|cyclophosphamide|mesh-list
6022764|NCT00408408|Bevacizumab|bevacizumab|mesh-list
6454977|NCT00426608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6454978|NCT00426608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6454979|NCT00426608|Antimetabolites|antimetabolites|mesh-ancestor
6454980|NCT00426608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6454981|NCT00426621|Diclofenac|diclofenac|mesh-list
6454982|NCT00426621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6454983|NCT00426621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6454984|NCT00426621|Analgesics|analgesics|mesh-ancestor
6454985|NCT00426621|Sensory System Agents|sensory system agents|mesh-ancestor
6022765|NCT00408408|Docetaxel|docetaxel|mesh-list
6454986|NCT00426621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6454987|NCT00426621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022766|NCT00408408|Doxorubicin|doxorubicin|mesh-list
6022767|NCT00408408|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6454988|NCT00426621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6454989|NCT00426621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6454990|NCT00426621|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6454991|NCT00426621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6454992|NCT00426621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6454993|NCT00426647|Buprenorphine|buprenorphine|mesh-list
6454994|NCT00426647|Tramadol|tramadol|mesh-list
6454995|NCT00426647|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6454996|NCT00426647|Narcotics|narcotics|mesh-ancestor
6454997|NCT00426647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6454998|NCT00426647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6454999|NCT00426647|Analgesics|analgesics|mesh-ancestor
6455000|NCT00426647|Sensory System Agents|sensory system agents|mesh-ancestor
6455001|NCT00426647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6455002|NCT00426647|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6455003|NCT00426673|Brivaracetam|brivaracetam|mesh-list
6455004|NCT00426673|Anticonvulsants|anticonvulsants|mesh-ancestor
6455005|NCT00426712|1018 oligonucleotide|1018 oligonucleotide|mesh-list
6455006|NCT00426712|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6455007|NCT00426712|Immunologic Factors|immunologic factors|mesh-ancestor
6455008|NCT00426712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461919|NCT00456820|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6461920|NCT00456820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6461921|NCT00456833|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6461922|NCT00456833|Everolimus|everolimus|mesh-list
6461923|NCT00456833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6461924|NCT00456833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6461925|NCT00456833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6461926|NCT00456833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461927|NCT00456833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6461928|NCT00456833|Immunologic Factors|immunologic factors|mesh-ancestor
6461929|NCT00456833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461930|NCT00456872|Lidocaine|lidocaine|mesh-list
6461931|NCT00456872|Anesthetics, Local|anesthetics, local|mesh-ancestor
6461932|NCT00456872|Anesthetics|anesthetics|mesh-ancestor
6455009|NCT00426777|Risedronic Acid|risedronic acid|mesh-list
6455010|NCT00426777|Etidronic Acid|etidronic acid|mesh-list
6455011|NCT00426777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6455012|NCT00426777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6455013|NCT00426777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455014|NCT00426777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6022768|NCT00408408|Capecitabine|capecitabine|mesh-list
6022769|NCT00408408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6022770|NCT00408408|Immunologic Factors|immunologic factors|mesh-ancestor
6022771|NCT00408408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022772|NCT00408408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6022773|NCT00408408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6022774|NCT00408408|Alkylating Agents|alkylating agents|mesh-ancestor
6022775|NCT00408408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6022776|NCT00408408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6022777|NCT00408408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6022778|NCT00408408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6022779|NCT00408408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6455015|NCT00426777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455016|NCT00426777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6455017|NCT00426829|Bevacizumab|bevacizumab|mesh-list
6455018|NCT00426829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6022780|NCT00408408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6022781|NCT00408408|Growth Substances|growth substances|mesh-ancestor
6022782|NCT00408408|Growth Inhibitors|growth inhibitors|mesh-ancestor
6455019|NCT00426829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6455020|NCT00426829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6455021|NCT00426829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6455022|NCT00426829|Growth Substances|growth substances|mesh-ancestor
6455023|NCT00426829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455024|NCT00426829|Growth Inhibitors|growth inhibitors|mesh-ancestor
6455025|NCT00426920|Insulin|insulin|mesh-list
6455026|NCT00426920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6455027|NCT00426920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455028|NCT00426933|Vancomycin|vancomycin|mesh-list
6455029|NCT00426933|Daptomycin|daptomycin|mesh-list
6455030|NCT00426933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6455031|NCT00426933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6455032|NCT00426946|Reboxetine|reboxetine|mesh-list
6455033|NCT00426946|Antidepressive Agents|antidepressive agents|mesh-ancestor
6455034|NCT00426946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6455035|NCT00426946|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6455036|NCT00426946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6455037|NCT00426946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6455038|NCT00426946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455039|NCT00426946|Adrenergic Agents|adrenergic agents|mesh-ancestor
6455040|NCT00426946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6455041|NCT00426946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455042|NCT00426972|Estradiol|estradiol|mesh-list
6455043|NCT00426972|Estrogens|estrogens|mesh-ancestor
6455044|NCT00426972|Hormones|hormones|mesh-ancestor
6455045|NCT00426972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6455046|NCT00426972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455047|NCT00426985|Ketoprofen|ketoprofen|mesh-list
6455048|NCT00426985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6455049|NCT00426985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6455050|NCT00426985|Analgesics|analgesics|mesh-ancestor
6455051|NCT00426985|Sensory System Agents|sensory system agents|mesh-ancestor
6455052|NCT00426985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6455053|NCT00426985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455054|NCT00426985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6455055|NCT00426985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6455056|NCT00426985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6455057|NCT00426985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6455058|NCT00426985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455059|NCT00426998|Bevacizumab|bevacizumab|mesh-list
6455060|NCT00426998|Verteporfin|verteporfin|mesh-list
6654609|NCT01458015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6455061|NCT00426998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6455062|NCT00426998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6455063|NCT00426998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6455064|NCT00426998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6455065|NCT00426998|Growth Substances|growth substances|mesh-ancestor
6455066|NCT00426998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455067|NCT00426998|Growth Inhibitors|growth inhibitors|mesh-ancestor
6455068|NCT00426998|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6455069|NCT00426998|Dermatologic Agents|dermatologic agents|mesh-ancestor
6455070|NCT00427076|Vancomycin|vancomycin|mesh-list
6455071|NCT00427076|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6455072|NCT00427076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6455073|NCT00427076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6455074|NCT00427076|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6455075|NCT00427076|Renal Agents|renal agents|mesh-ancestor
6455076|NCT00427076|Antimalarials|antimalarials|mesh-ancestor
6455077|NCT00427076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6455078|NCT00427076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6455079|NCT00427089|Ascorbic Acid|ascorbic acid|mesh-list
6455080|NCT00427089|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
6455081|NCT00427089|Antioxidants|antioxidants|mesh-ancestor
6455082|NCT00427089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455083|NCT00427089|Protective Agents|protective agents|mesh-ancestor
6455084|NCT00427089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455085|NCT00427089|Vitamins|vitamins|mesh-ancestor
6022783|NCT00408408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6022784|NCT00408408|Antimetabolites|antimetabolites|mesh-ancestor
6022785|NCT00408408|Antiviral Agents|antiviral agents|mesh-ancestor
6022786|NCT00408408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6022787|NCT00408408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6022788|NCT00408408|Tubulin Modulators|tubulin modulators|mesh-ancestor
6022789|NCT00408408|Antimitotic Agents|antimitotic agents|mesh-ancestor
6022790|NCT00408408|Mitosis Modulators|mitosis modulators|mesh-ancestor
6022791|NCT00408408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6022792|NCT00408408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6022793|NCT00408408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6022794|NCT00408421|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6022795|NCT00408421|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6455086|NCT00427089|Micronutrients|micronutrients|mesh-ancestor
6455087|NCT00427089|Laxatives|laxatives|mesh-ancestor
6455088|NCT00427089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6455089|NCT00427102|Cisplatin|cisplatin|mesh-list
6455090|NCT00427102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6455091|NCT00427128|Fluoxetine|fluoxetine|mesh-list
6455092|NCT00427128|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6455093|NCT00427128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6455094|NCT00427128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6455095|NCT00427128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455096|NCT00427128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6455097|NCT00427128|Serotonin Agents|serotonin agents|mesh-ancestor
6455098|NCT00427128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455099|NCT00427128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5490487|NCT04745832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5490488|NCT04745832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5490489|NCT04745832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5490490|NCT04745832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5490491|NCT04745832|Glucocorticoids|glucocorticoids|mesh-ancestor
5490492|NCT04745832|Hormones|hormones|mesh-ancestor
5490493|NCT04745832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5490494|NCT04745832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5490495|NCT04745832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5490496|NCT04745832|Tubulin Modulators|tubulin modulators|mesh-ancestor
5490497|NCT04745832|Antimitotic Agents|antimitotic agents|mesh-ancestor
5490498|NCT04745832|Mitosis Modulators|mitosis modulators|mesh-ancestor
5490499|NCT04711135|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
5490500|NCT04711135|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5490501|NCT04711135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490502|NCT04709250|Bupivacaine|bupivacaine|mesh-list
5490503|NCT04709250|Anesthetics, Local|anesthetics, local|mesh-ancestor
5490504|NCT04709250|Anesthetics|anesthetics|mesh-ancestor
5490505|NCT04709250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5490506|NCT04709250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490507|NCT04709250|Sensory System Agents|sensory system agents|mesh-ancestor
6455100|NCT00427128|Antidepressive Agents|antidepressive agents|mesh-ancestor
6455101|NCT00427128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5490508|NCT04709250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5490509|NCT04708418|Pembrolizumab|pembrolizumab|mesh-list
5490510|NCT04708418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5490511|NCT04708418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5490512|NCT04704154|Nivolumab|nivolumab|mesh-list
6455102|NCT00427128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6455103|NCT00427128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6455104|NCT00427128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6455105|NCT00427167|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6455106|NCT00427167|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6455107|NCT00427167|Immunologic Factors|immunologic factors|mesh-ancestor
6455108|NCT00427167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455109|NCT00427167|Antacids|antacids|mesh-ancestor
6455110|NCT00427167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6022796|NCT00408421|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6022797|NCT00408421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6022798|NCT00408421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6022799|NCT00408421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6022800|NCT00408421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022801|NCT00408421|Analgesics|analgesics|mesh-ancestor
6455111|NCT00427167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6455112|NCT00427206|Acetaminophen|acetaminophen|mesh-list
6455113|NCT00427206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6455114|NCT00427206|Analgesics|analgesics|mesh-ancestor
6455115|NCT00427206|Sensory System Agents|sensory system agents|mesh-ancestor
6455116|NCT00427206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6455117|NCT00427206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455118|NCT00427206|Antipyretics|antipyretics|mesh-ancestor
6455119|NCT00427232|BQ 788|bq 788|mesh-list
6455120|NCT00427232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6455121|NCT00427232|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6455122|NCT00427232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455123|NCT00427232|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
6455124|NCT00427245|Cyclophosphamide|cyclophosphamide|mesh-list
6455125|NCT00427245|Goserelin|goserelin|mesh-list
6455126|NCT00427245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6455127|NCT00427245|Immunologic Factors|immunologic factors|mesh-ancestor
6455128|NCT00427245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022802|NCT00408421|Sensory System Agents|sensory system agents|mesh-ancestor
6022803|NCT00408421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6022804|NCT00408421|Antidepressive Agents|antidepressive agents|mesh-ancestor
6022805|NCT00408421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6022806|NCT00408421|Dopamine Agents|dopamine agents|mesh-ancestor
6022807|NCT00408434|Efatutazone|efatutazone|mesh-list
6022808|NCT00408434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6022809|NCT00408460|Paclitaxel|paclitaxel|mesh-list
6455129|NCT00427245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6455130|NCT00427245|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6455131|NCT00427245|Alkylating Agents|alkylating agents|mesh-ancestor
6455132|NCT00427245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455133|NCT00427245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6455134|NCT00427245|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6455135|NCT00427245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6455136|NCT00427271|Aspirin|aspirin|mesh-list
6455137|NCT00427271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6455138|NCT00427271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6455139|NCT00427271|Analgesics|analgesics|mesh-ancestor
6455140|NCT00427271|Sensory System Agents|sensory system agents|mesh-ancestor
6455141|NCT00427271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6455142|NCT00427271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455143|NCT00427271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6455144|NCT00427271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6455145|NCT00427271|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6455146|NCT00427271|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5490513|NCT04704154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5490514|NCT04704154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5490515|NCT04704154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6455147|NCT00427271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455148|NCT00427271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6455149|NCT00427271|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6455150|NCT00427271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6455151|NCT00427271|Antipyretics|antipyretics|mesh-ancestor
6455152|NCT00427310|Fluorouracil|fluorouracil|mesh-list
6455153|NCT00427310|Heparin|heparin|mesh-list
6455154|NCT00427310|Calcium heparin|calcium heparin|mesh-list
6455155|NCT00427310|Antimetabolites|antimetabolites|mesh-ancestor
6455156|NCT00427310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455157|NCT00427310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6022810|NCT00408460|Imatinib Mesylate|imatinib mesylate|mesh-list
5490516|NCT04704154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490517|NCT04702022|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5490518|NCT04702022|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5490519|NCT04702022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455158|NCT00427310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6455159|NCT00427310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6455160|NCT00427310|Immunologic Factors|immunologic factors|mesh-ancestor
6455161|NCT00427310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455162|NCT00427310|Anticoagulants|anticoagulants|mesh-ancestor
6455163|NCT00427310|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6455164|NCT00427310|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6455165|NCT00427362|Adalimumab|adalimumab|mesh-list
6455166|NCT00427362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6455167|NCT00427362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6455168|NCT00427388|Methylprednisolone|methylprednisolone|mesh-list
6455169|NCT00427388|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6455170|NCT00427388|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6455171|NCT00427388|Prednisolone|prednisolone|mesh-list
6455172|NCT00427388|Prednisolone acetate|prednisolone acetate|mesh-list
6455173|NCT00427388|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6022811|NCT00408460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6022812|NCT00408460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6022813|NCT00408460|Tubulin Modulators|tubulin modulators|mesh-ancestor
6022814|NCT00408460|Antimitotic Agents|antimitotic agents|mesh-ancestor
6022815|NCT00408460|Mitosis Modulators|mitosis modulators|mesh-ancestor
6022816|NCT00408460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6022817|NCT00408460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6022818|NCT00408460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6022819|NCT00408499|Cetuximab|cetuximab|mesh-list
6022820|NCT00408499|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6022821|NCT00408499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6022822|NCT00408499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5490520|NCT04686305|Carboplatin|carboplatin|mesh-list
5490521|NCT04686305|Trastuzumab|trastuzumab|mesh-list
5490522|NCT04686305|Pemetrexed|pemetrexed|mesh-list
5490523|NCT04686305|Durvalumab|durvalumab|mesh-list
5490524|NCT04686305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5490525|NCT04686305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5490526|NCT04686305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5490527|NCT04686305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490528|NCT04686305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5490529|NCT04686305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5490530|NCT04661150|Capecitabine|capecitabine|mesh-list
5490531|NCT04661150|Oxaliplatin|oxaliplatin|mesh-list
5490532|NCT04661150|Trastuzumab|trastuzumab|mesh-list
5490533|NCT04661150|Atezolizumab|atezolizumab|mesh-list
5490534|NCT04661150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5490535|NCT04661150|Antimetabolites|antimetabolites|mesh-ancestor
5490536|NCT04661150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490537|NCT04661150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5490538|NCT04661150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5490539|NCT04652245|Fluticasone|fluticasone|mesh-list
5490540|NCT04652245|Xhance|xhance|mesh-list
5490541|NCT04652245|Azelastine|azelastine|mesh-list
5490542|NCT04652245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5490543|NCT04652245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5490544|NCT04652245|Autonomic Agents|autonomic agents|mesh-ancestor
6022823|NCT00408499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6022824|NCT00408499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6022825|NCT00408499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6022826|NCT00408564|Gemcitabine|gemcitabine|mesh-list
6022827|NCT00408564|Capecitabine|capecitabine|mesh-list
6022828|NCT00408564|Oxaliplatin|oxaliplatin|mesh-list
6022829|NCT00408564|Cetuximab|cetuximab|mesh-list
6022830|NCT00408564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6022831|NCT00408564|Antimetabolites|antimetabolites|mesh-ancestor
6022832|NCT00408564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6022833|NCT00408564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6022834|NCT00408564|Antiviral Agents|antiviral agents|mesh-ancestor
6022835|NCT00408564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6455174|NCT00427388|Prednisolone phosphate|prednisolone phosphate|mesh-list
6455175|NCT00427388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5490545|NCT04652245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5490546|NCT04652245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490547|NCT04652245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5490548|NCT04652245|Respiratory System Agents|respiratory system agents|mesh-ancestor
6022836|NCT00408564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6022837|NCT00408564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6022838|NCT00408564|Immunologic Factors|immunologic factors|mesh-ancestor
6022839|NCT00408564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022840|NCT00408564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6022841|NCT00408629|Adalimumab|adalimumab|mesh-list
6022842|NCT00408629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6022843|NCT00408629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6022844|NCT00408681|Lithium Carbonate|lithium carbonate|mesh-list
6022845|NCT00408681|Antidepressive Agents|antidepressive agents|mesh-ancestor
6022846|NCT00408681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6022847|NCT00408681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6022848|NCT00408681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6022849|NCT00408681|Antimanic Agents|antimanic agents|mesh-ancestor
6022850|NCT00408681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6022851|NCT00408681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6022852|NCT00408681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022853|NCT00408694|Bevacizumab|bevacizumab|mesh-list
6455176|NCT00427388|Antiemetics|antiemetics|mesh-ancestor
6455177|NCT00427388|Autonomic Agents|autonomic agents|mesh-ancestor
6455178|NCT00427388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6455179|NCT00427388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455180|NCT00427388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6455181|NCT00427388|Glucocorticoids|glucocorticoids|mesh-ancestor
6455182|NCT00427388|Hormones|hormones|mesh-ancestor
6455183|NCT00427388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6455184|NCT00427388|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6455185|NCT00427388|Protective Agents|protective agents|mesh-ancestor
6455186|NCT00427388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6455187|NCT00427388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6455188|NCT00427414|Daunorubicin|daunorubicin|mesh-list
6455189|NCT00427414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455190|NCT00427414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6455191|NCT00427414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6455192|NCT00427414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6455193|NCT00427414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6455194|NCT00427414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6455195|NCT00427427|Trastuzumab|trastuzumab|mesh-list
6455196|NCT00427427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6455197|NCT00427427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6455198|NCT00427466|Pemetrexed|pemetrexed|mesh-list
6455199|NCT00427466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6455200|NCT00427466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6455201|NCT00427466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455202|NCT00427466|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6455203|NCT00427466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6455204|NCT00427492|Magnesium Oxide|magnesium oxide|mesh-list
6455205|NCT00427492|Antacids|antacids|mesh-ancestor
6455206|NCT00427492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455207|NCT00427492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6455208|NCT00427505|Deferasirox|deferasirox|mesh-list
6455209|NCT00427505|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6455210|NCT00427505|Chelating Agents|chelating agents|mesh-ancestor
6455211|NCT00427505|Sequestering Agents|sequestering agents|mesh-ancestor
6455212|NCT00427505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455213|NCT00427570|Fluorouracil|fluorouracil|mesh-list
6455214|NCT00427570|Vincristine|vincristine|mesh-list
6455215|NCT00427570|Semustine|semustine|mesh-list
6455216|NCT00427570|BCG Vaccine|bcg vaccine|mesh-list
6455217|NCT00427570|Antimetabolites|antimetabolites|mesh-ancestor
6455218|NCT00427570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455219|NCT00427570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6455220|NCT00427570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6022854|NCT00408694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6022855|NCT00408694|Cisplatin|cisplatin|mesh-list
6022856|NCT00408694|Fluorouracil|fluorouracil|mesh-list
6022857|NCT00408694|Endothelial Growth Factors|endothelial growth factors|mesh-list
6022858|NCT00408694|Antibodies|antibodies|mesh-list
6022859|NCT00408694|Immunoglobulins|immunoglobulins|mesh-list
6022860|NCT00408694|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6022861|NCT00408694|Immunoglobulin G|immunoglobulin g|mesh-list
6022862|NCT00408694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6022863|NCT00408694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6022864|NCT00408694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6022865|NCT00408694|Growth Substances|growth substances|mesh-ancestor
6022866|NCT00408694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490549|NCT04652245|Dermatologic Agents|dermatologic agents|mesh-ancestor
5490550|NCT04652245|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5490551|NCT04652245|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
5490552|NCT04652245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5490553|NCT04652245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490554|NCT04652245|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5490555|NCT04652245|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5490556|NCT04652245|Histamine Antagonists|histamine antagonists|mesh-ancestor
5490557|NCT04652245|Histamine Agents|histamine agents|mesh-ancestor
5490558|NCT04652245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5490559|NCT04647643|Paclitaxel|paclitaxel|mesh-list
5490560|NCT04647643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5490561|NCT04647643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5490562|NCT04647643|Tubulin Modulators|tubulin modulators|mesh-ancestor
5490563|NCT04647643|Antimitotic Agents|antimitotic agents|mesh-ancestor
5490564|NCT04647643|Mitosis Modulators|mitosis modulators|mesh-ancestor
5490565|NCT04647643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490566|NCT04631536|Folic Acid|folic acid|mesh-list
5490567|NCT04631536|Vitamin B Complex|vitamin b complex|mesh-list
5490568|NCT04631536|Nicorandil|nicorandil|mesh-list
5490569|NCT04631536|Nebivolol|nebivolol|mesh-list
5490570|NCT04631536|Atorvastatin|atorvastatin|mesh-list
5490571|NCT04631536|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5490572|NCT04631536|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5490573|NCT04631536|Antimetabolites|antimetabolites|mesh-ancestor
5490574|NCT04631536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490575|NCT04631536|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5490576|NCT04631536|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5490577|NCT04631536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5490578|NCT04631536|Hematinics|hematinics|mesh-ancestor
5490579|NCT04631536|Vitamins|vitamins|mesh-ancestor
5490580|NCT04631536|Micronutrients|micronutrients|mesh-ancestor
5490581|NCT04631536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490582|NCT04631536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5490583|NCT04631536|Vasodilator Agents|vasodilator agents|mesh-ancestor
5490584|NCT04631536|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5490585|NCT04631536|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5490586|NCT04631536|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5490587|NCT04631536|Adrenergic Agents|adrenergic agents|mesh-ancestor
5490588|NCT04631536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5490589|NCT04631536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5490590|NCT04619004|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
5490591|NCT04619004|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6455221|NCT00427570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6455222|NCT00427570|Immunologic Factors|immunologic factors|mesh-ancestor
6022867|NCT00408694|Growth Inhibitors|growth inhibitors|mesh-ancestor
6022868|NCT00408694|Immunologic Factors|immunologic factors|mesh-ancestor
6022869|NCT00408694|Antimetabolites|antimetabolites|mesh-ancestor
6022870|NCT00408694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455223|NCT00427570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455224|NCT00427570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6455225|NCT00427570|Tubulin Modulators|tubulin modulators|mesh-ancestor
6455226|NCT00427570|Antimitotic Agents|antimitotic agents|mesh-ancestor
6455227|NCT00427570|Mitosis Modulators|mitosis modulators|mesh-ancestor
6455228|NCT00427570|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6455229|NCT00427570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6455230|NCT00427570|Alkylating Agents|alkylating agents|mesh-ancestor
6455231|NCT00427583|Imatinib Mesylate|imatinib mesylate|mesh-list
6455232|NCT00427583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6455233|NCT00427583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6455234|NCT00427583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6455235|NCT00427583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455236|NCT00427596|Solabegron|solabegron|mesh-list
6455237|NCT00427596|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6455238|NCT00427596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6455239|NCT00427596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6455240|NCT00427596|Adrenergic Agents|adrenergic agents|mesh-ancestor
6455241|NCT00427596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6654610|NCT01458015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6022871|NCT00408694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6022872|NCT00408694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6022873|NCT00408876|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6022874|NCT00408876|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5490592|NCT04619004|Immunologic Factors|immunologic factors|mesh-ancestor
5502922|NCT04463966|Coagulants|coagulants|mesh-ancestor
6455242|NCT00427596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455243|NCT00427596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455244|NCT00427609|Penicillin G Benzathine|penicillin g benzathine|mesh-list
6022875|NCT00408876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6022876|NCT00408876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6022877|NCT00408876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6022878|NCT00408876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6022879|NCT00408876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022880|NCT00408876|Analgesics|analgesics|mesh-ancestor
6022881|NCT00408876|Sensory System Agents|sensory system agents|mesh-ancestor
6022882|NCT00408876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6022883|NCT00408876|Antidepressive Agents|antidepressive agents|mesh-ancestor
6022884|NCT00408876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6022885|NCT00408876|Dopamine Agents|dopamine agents|mesh-ancestor
6022886|NCT00408928|Bortezomib|bortezomib|mesh-list
6022887|NCT00408928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6022888|NCT00408993|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6022889|NCT00408993|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6022890|NCT00408993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6022891|NCT00408993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6022892|NCT00408993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6022893|NCT00408993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6022894|NCT00408993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022895|NCT00408993|Analgesics|analgesics|mesh-ancestor
6022896|NCT00408993|Sensory System Agents|sensory system agents|mesh-ancestor
6022897|NCT00408993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6022898|NCT00408993|Antidepressive Agents|antidepressive agents|mesh-ancestor
6022899|NCT00408993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6455245|NCT00427609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6455246|NCT00427609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6455247|NCT00427713|Capecitabine|capecitabine|mesh-list
6455248|NCT00427713|Oxaliplatin|oxaliplatin|mesh-list
5490593|NCT04619004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490594|NCT04619004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5490595|NCT04619004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5502923|NCT04463953|Dexamethasone|dexamethasone|mesh-list
5502924|NCT04463953|Ixazomib|ixazomib|mesh-list
6455249|NCT00427713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6455250|NCT00427713|Antimetabolites|antimetabolites|mesh-ancestor
6455251|NCT00427713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455252|NCT00427713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6455253|NCT00427882|Alfuzosin|alfuzosin|mesh-list
6022900|NCT00408993|Dopamine Agents|dopamine agents|mesh-ancestor
6022901|NCT00409006|Pemetrexed|pemetrexed|mesh-list
6022902|NCT00409006|Gefitinib|gefitinib|mesh-list
6022903|NCT00409006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6022904|NCT00409006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6022905|NCT00409006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6022906|NCT00409006|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6022907|NCT00409006|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6022908|NCT00409006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6022909|NCT00409188|Cyclophosphamide|cyclophosphamide|mesh-list
6022910|NCT00409188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6022911|NCT00409188|Immunologic Factors|immunologic factors|mesh-ancestor
6022912|NCT00409188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022913|NCT00409188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6022914|NCT00409188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6022915|NCT00409188|Alkylating Agents|alkylating agents|mesh-ancestor
6022916|NCT00409188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6022917|NCT00409188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6022918|NCT00409188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6022919|NCT00409292|Everolimus|everolimus|mesh-list
6455254|NCT00427882|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6455255|NCT00427882|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6455256|NCT00427882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6455257|NCT00427882|Adrenergic Agents|adrenergic agents|mesh-ancestor
6455258|NCT00427882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6455259|NCT00427882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502925|NCT04463953|Zanubrutinib|zanubrutinib|mesh-list
5502926|NCT04463953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5502927|NCT04463953|Antiemetics|antiemetics|mesh-ancestor
5502928|NCT04463953|Autonomic Agents|autonomic agents|mesh-ancestor
5502929|NCT04463953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6455260|NCT00427882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455261|NCT00427882|Urological Agents|urological agents|mesh-ancestor
6455262|NCT00427947|Ropivacaine|ropivacaine|mesh-list
6455263|NCT00427947|Anesthetics, Local|anesthetics, local|mesh-ancestor
5490596|NCT04592809|Midazolam|midazolam|mesh-list
5490597|NCT04592809|Ketamine|ketamine|mesh-list
6022920|NCT00409292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6022921|NCT00409292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6022922|NCT00409292|Immunologic Factors|immunologic factors|mesh-ancestor
6022923|NCT00409292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022924|NCT00409565|Bevacizumab|bevacizumab|mesh-list
6022925|NCT00409565|Cetuximab|cetuximab|mesh-list
6022926|NCT00409565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6022927|NCT00409565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6022928|NCT00409565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6022929|NCT00409565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6022930|NCT00409565|Growth Substances|growth substances|mesh-ancestor
6022931|NCT00409565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022932|NCT00409565|Growth Inhibitors|growth inhibitors|mesh-ancestor
6022933|NCT00409578|Valsartan|valsartan|mesh-list
6022934|NCT00409578|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6053261|NCT00594204|Cholinergic Agents|cholinergic agents|mesh-ancestor
6455264|NCT00427947|Anesthetics|anesthetics|mesh-ancestor
6455265|NCT00427947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6455266|NCT00427947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455267|NCT00427947|Sensory System Agents|sensory system agents|mesh-ancestor
6455268|NCT00427947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6455269|NCT00428025|Diclofenac|diclofenac|mesh-list
6455270|NCT00428025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6455271|NCT00428025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6455272|NCT00428025|Analgesics|analgesics|mesh-ancestor
6455273|NCT00428025|Sensory System Agents|sensory system agents|mesh-ancestor
6455274|NCT00428025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6455275|NCT00428025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455276|NCT00428025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6455277|NCT00428025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6455278|NCT00428025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6455279|NCT00428025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6455280|NCT00428025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455281|NCT00428064|Cyclosporine|cyclosporine|mesh-list
6022935|NCT00409578|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6022936|NCT00409578|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6022937|NCT00409578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6022938|NCT00409617|Adalimumab|adalimumab|mesh-list
6022939|NCT00409617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6022940|NCT00409617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6022941|NCT00409682|Adalimumab|adalimumab|mesh-list
6022942|NCT00409682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6022943|NCT00409682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6022944|NCT00409708|Methylphenidate|methylphenidate|mesh-list
6022945|NCT00409708|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6022946|NCT00409708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455282|NCT00428064|Sirolimus|sirolimus|mesh-list
6455283|NCT00428064|Cyclosporins|cyclosporins|mesh-list
6455284|NCT00428064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6455285|NCT00428064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455286|NCT00428064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6455287|NCT00428064|Immunologic Factors|immunologic factors|mesh-ancestor
6455288|NCT00428064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455289|NCT00428064|Antifungal Agents|antifungal agents|mesh-ancestor
6455290|NCT00428064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6455291|NCT00428064|Dermatologic Agents|dermatologic agents|mesh-ancestor
6455292|NCT00428064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6455293|NCT00428064|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6455294|NCT00428064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5490598|NCT04592809|Analgesics|analgesics|mesh-ancestor
5490599|NCT04592809|Sensory System Agents|sensory system agents|mesh-ancestor
5490600|NCT04592809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5490601|NCT04592809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490602|NCT04592809|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5490603|NCT04592809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5490604|NCT04592809|Anesthetics, General|anesthetics, general|mesh-ancestor
5490605|NCT04592809|Anesthetics|anesthetics|mesh-ancestor
5490606|NCT04592809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6455295|NCT00428064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6455296|NCT00428064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6455297|NCT00428129|Plasminogen|plasminogen|mesh-list
6455298|NCT00428129|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6455299|NCT00428129|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6455300|NCT00428129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455301|NCT00428142|Prednisone|prednisone|mesh-list
6455302|NCT00428142|Cyclophosphamide|cyclophosphamide|mesh-list
6455303|NCT00428142|Rituximab|rituximab|mesh-list
6455304|NCT00428142|Vincristine|vincristine|mesh-list
6455305|NCT00428142|Bortezomib|bortezomib|mesh-list
6455306|NCT00428142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6455307|NCT00428142|Immunologic Factors|immunologic factors|mesh-ancestor
6455308|NCT00428142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455309|NCT00428142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6455310|NCT00428142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6455311|NCT00428142|Alkylating Agents|alkylating agents|mesh-ancestor
6455312|NCT00428142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490607|NCT04592809|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5490608|NCT04592809|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5490609|NCT04592809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5490610|NCT04592809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490611|NCT04592809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6455313|NCT00428142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6455314|NCT00428142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6455315|NCT00428142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6455316|NCT00428142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6455317|NCT00428142|Glucocorticoids|glucocorticoids|mesh-ancestor
6455318|NCT00428142|Hormones|hormones|mesh-ancestor
6455319|NCT00428142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6455320|NCT00428142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6455321|NCT00428142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6455322|NCT00428142|Tubulin Modulators|tubulin modulators|mesh-ancestor
6455323|NCT00428142|Antimitotic Agents|antimitotic agents|mesh-ancestor
6455324|NCT00428142|Mitosis Modulators|mitosis modulators|mesh-ancestor
6455325|NCT00428168|Betahistine|betahistine|mesh-list
6455326|NCT00428168|Vasodilator Agents|vasodilator agents|mesh-ancestor
6455327|NCT00428168|Histamine Agonists|histamine agonists|mesh-ancestor
6455328|NCT00428168|Histamine Agents|histamine agents|mesh-ancestor
5490612|NCT04592809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6455329|NCT00428168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5490613|NCT04592809|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5490614|NCT04592809|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5490615|NCT04592809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5490616|NCT04592809|GABA Modulators|gaba modulators|mesh-ancestor
5490617|NCT04592809|GABA Agents|gaba agents|mesh-ancestor
5490618|NCT04567992|Bupivacaine|bupivacaine|mesh-list
5490619|NCT04567992|Anesthetics, Local|anesthetics, local|mesh-ancestor
5490620|NCT04567992|Anesthetics|anesthetics|mesh-ancestor
5490621|NCT04567992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5490622|NCT04567992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455330|NCT00428168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455331|NCT00428168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455332|NCT00428181|Ethanol|ethanol|mesh-list
6455333|NCT00428181|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6455334|NCT00428181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6455335|NCT00428181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6455336|NCT00428181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455337|NCT00428194|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6455338|NCT00428194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6455339|NCT00428194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6455340|NCT00428194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6455341|NCT00428194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490623|NCT04567992|Sensory System Agents|sensory system agents|mesh-ancestor
5490624|NCT04567992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5490625|NCT04565600|Etoricoxib|etoricoxib|mesh-list
5490626|NCT04565600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5490627|NCT04565600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5490628|NCT04565600|Analgesics|analgesics|mesh-ancestor
5490629|NCT04565600|Sensory System Agents|sensory system agents|mesh-ancestor
5490630|NCT04565600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5490631|NCT04565600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490632|NCT04565600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5490633|NCT04565600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5490634|NCT04565600|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5490635|NCT04565600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5490636|NCT04565600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5490637|NCT04565600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6022947|NCT00409708|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6022948|NCT00409708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6022949|NCT00409708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6455342|NCT00428272|Interferons|interferons|mesh-list
6455343|NCT00428272|Interferon-gamma|interferon-gamma|mesh-list
6455344|NCT00428272|Lexatumumab|lexatumumab|mesh-list
6455345|NCT00428272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6022950|NCT00409708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6022951|NCT00409708|Dopamine Agents|dopamine agents|mesh-ancestor
6022952|NCT00409708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6022953|NCT00409747|Minocycline|minocycline|mesh-list
6022954|NCT00409747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6455346|NCT00428272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6022955|NCT00409747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5490642|NCT04526509|Cyclophosphamide|cyclophosphamide|mesh-list
5490643|NCT04526509|Fludarabine|fludarabine|mesh-list
6455347|NCT00428272|Antiviral Agents|antiviral agents|mesh-ancestor
6455348|NCT00428272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6455349|NCT00428272|Immunologic Factors|immunologic factors|mesh-ancestor
6455350|NCT00428272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455351|NCT00428311|Metformin|metformin|mesh-list
6022956|NCT00409825|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
6022957|NCT00409825|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
5490644|NCT04526509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5490645|NCT04526509|Immunologic Factors|immunologic factors|mesh-ancestor
5490646|NCT04526509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490647|NCT04526509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5490648|NCT04526509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5490649|NCT04526509|Alkylating Agents|alkylating agents|mesh-ancestor
6022958|NCT00409825|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6022959|NCT00409825|Hormone Antagonists|hormone antagonists|mesh-ancestor
6022960|NCT00409825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6022961|NCT00409825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022962|NCT00409825|Progestins|progestins|mesh-ancestor
6022963|NCT00409825|Hormones|hormones|mesh-ancestor
6022964|NCT00409838|Methotrexate|methotrexate|mesh-list
6022965|NCT00409838|Abatacept|abatacept|mesh-list
6022966|NCT00409838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6022967|NCT00409838|Abortifacient Agents|abortifacient agents|mesh-ancestor
6022968|NCT00409838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6022969|NCT00409838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490650|NCT04526509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490651|NCT04526509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5490652|NCT04526509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5490653|NCT04517396|Fenofibrate|fenofibrate|mesh-list
5490654|NCT04517396|Fenofibric acid|fenofibric acid|mesh-list
5490655|NCT04517396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5490656|NCT04517396|Antimetabolites|antimetabolites|mesh-ancestor
6022970|NCT00409838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6022971|NCT00409838|Antimetabolites|antimetabolites|mesh-ancestor
6022972|NCT00409838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6022973|NCT00409838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6022974|NCT00409838|Dermatologic Agents|dermatologic agents|mesh-ancestor
6455352|NCT00428311|Cyproterone Acetate|cyproterone acetate|mesh-list
6455353|NCT00428311|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6455354|NCT00428311|Estradiol|estradiol|mesh-list
6022975|NCT00409838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6022976|NCT00409838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6022977|NCT00409838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6022978|NCT00409838|Immunologic Factors|immunologic factors|mesh-ancestor
6022979|NCT00409838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6022980|NCT00409838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6022981|NCT00409838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6022982|NCT00410046|Etanercept|etanercept|mesh-list
6022983|NCT00410046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6022984|NCT00410046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6022985|NCT00410046|Analgesics|analgesics|mesh-ancestor
6022986|NCT00410046|Sensory System Agents|sensory system agents|mesh-ancestor
6455355|NCT00428311|Cyproterone|cyproterone|mesh-list
5490657|NCT04517396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455356|NCT00428311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6455357|NCT00428311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455358|NCT00428311|Estrogens|estrogens|mesh-ancestor
6455359|NCT00428311|Hormones|hormones|mesh-ancestor
6455360|NCT00428311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6455361|NCT00428311|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6455362|NCT00428311|Contraceptive Agents|contraceptive agents|mesh-ancestor
6455363|NCT00428311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6455364|NCT00428311|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6455365|NCT00428311|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6455366|NCT00428311|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6455367|NCT00428311|Androgen Antagonists|androgen antagonists|mesh-ancestor
6455368|NCT00428311|Hormone Antagonists|hormone antagonists|mesh-ancestor
6455369|NCT00428311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6455370|NCT00428311|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6022987|NCT00410046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6022988|NCT00410046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6022989|NCT00410046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6455371|NCT00428350|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6455372|NCT00428350|Antidepressive Agents|antidepressive agents|mesh-ancestor
6455373|NCT00428350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6455374|NCT00428350|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6455375|NCT00428350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6022990|NCT00410046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6022991|NCT00410046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6022992|NCT00410046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6022993|NCT00410046|Immunologic Factors|immunologic factors|mesh-ancestor
6022994|NCT00410059|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6022995|NCT00410059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6022996|NCT00410059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6022997|NCT00410059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6022998|NCT00410059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6022999|NCT00410072|Tenofovir|tenofovir|mesh-list
6023000|NCT00410072|Entecavir|entecavir|mesh-list
6023001|NCT00410072|Antiviral Agents|antiviral agents|mesh-ancestor
6023002|NCT00410072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6023003|NCT00410072|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6023004|NCT00410072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6023005|NCT00410072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6023006|NCT00410072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455376|NCT00428350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6455377|NCT00428350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455378|NCT00428428|Isoproterenol|isoproterenol|mesh-list
6455379|NCT00428428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6455380|NCT00428428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6455381|NCT00428428|Adrenergic Agents|adrenergic agents|mesh-ancestor
6455382|NCT00428428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6455383|NCT00428428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455384|NCT00428428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455385|NCT00428428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6455386|NCT00428428|Autonomic Agents|autonomic agents|mesh-ancestor
6455387|NCT00428428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6455388|NCT00428428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6023007|NCT00410072|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6023008|NCT00410072|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6023009|NCT00410124|Everolimus|everolimus|mesh-list
6023010|NCT00410124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6023011|NCT00410124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6023012|NCT00410124|Immunologic Factors|immunologic factors|mesh-ancestor
6023013|NCT00410124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023014|NCT00410150|Albuterol|albuterol|mesh-list
6023015|NCT00410150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6023016|NCT00410150|Autonomic Agents|autonomic agents|mesh-ancestor
6023017|NCT00410150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6455389|NCT00428428|Respiratory System Agents|respiratory system agents|mesh-ancestor
6455390|NCT00428428|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6455391|NCT00428428|Sympathomimetics|sympathomimetics|mesh-ancestor
6455392|NCT00428428|Protective Agents|protective agents|mesh-ancestor
6455393|NCT00428454|Sirolimus|sirolimus|mesh-list
6455394|NCT00428454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6455395|NCT00428454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6455396|NCT00428454|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6023018|NCT00410150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455397|NCT00428454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6455398|NCT00428454|Antifungal Agents|antifungal agents|mesh-ancestor
6455399|NCT00428454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6455400|NCT00428454|Immunologic Factors|immunologic factors|mesh-ancestor
6455401|NCT00428454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455402|NCT00428480|Methamphetamine|methamphetamine|mesh-list
6455403|NCT00428480|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6455404|NCT00428480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455405|NCT00428480|Sympathomimetics|sympathomimetics|mesh-ancestor
6455406|NCT00428480|Autonomic Agents|autonomic agents|mesh-ancestor
6455407|NCT00428480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6023019|NCT00410150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6023020|NCT00410150|Respiratory System Agents|respiratory system agents|mesh-ancestor
6023021|NCT00410150|Tocolytic Agents|tocolytic agents|mesh-ancestor
6023022|NCT00410150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6023023|NCT00410150|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6023024|NCT00410150|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6023025|NCT00410150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6023026|NCT00410150|Adrenergic Agents|adrenergic agents|mesh-ancestor
6023027|NCT00410150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6023028|NCT00410150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023029|NCT00410163|Cyclophosphamide|cyclophosphamide|mesh-list
6023030|NCT00410163|Fludarabine|fludarabine|mesh-list
6023031|NCT00410163|Ofatumumab|ofatumumab|mesh-list
6023032|NCT00410163|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6023033|NCT00410163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6023034|NCT00410163|Immunologic Factors|immunologic factors|mesh-ancestor
6023035|NCT00410163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023036|NCT00410163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6023037|NCT00410163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6023038|NCT00410163|Alkylating Agents|alkylating agents|mesh-ancestor
6023039|NCT00410163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490658|NCT04517396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5490659|NCT04517396|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5490660|NCT04501211|Granisetron|granisetron|mesh-list
5490661|NCT04501211|Antiemetics|antiemetics|mesh-ancestor
5490662|NCT04501211|Autonomic Agents|autonomic agents|mesh-ancestor
5490663|NCT04501211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5490664|NCT04501211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490665|NCT04501211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5490666|NCT04501211|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5490667|NCT04501211|Serotonin Agents|serotonin agents|mesh-ancestor
5490668|NCT04501211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5490669|NCT04501211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490670|NCT04493853|Abiraterone Acetate|abiraterone acetate|mesh-list
5490671|NCT04493853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5490672|NCT04493853|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5490673|NCT04493853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5490674|NCT04493853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490675|NCT04493853|Hormone Antagonists|hormone antagonists|mesh-ancestor
5490676|NCT04493853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5490677|NCT04493853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490678|NCT04493853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5490679|NCT04484818|Leuprolide|leuprolide|mesh-list
5490680|NCT04484818|Goserelin|goserelin|mesh-list
5490681|NCT04484818|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5490682|NCT04484818|Tryptophan|tryptophan|mesh-list
5490683|NCT04484818|Androgen Antagonists|androgen antagonists|mesh-list
5490684|NCT04484818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5490685|NCT04484818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490686|NCT04484818|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5490687|NCT04484818|Fertility Agents|fertility agents|mesh-ancestor
6023040|NCT00410163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6023041|NCT00410163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6023042|NCT00410202|Tenofovir|tenofovir|mesh-list
6023043|NCT00410202|Lamivudine|lamivudine|mesh-list
6023044|NCT00410202|Entecavir|entecavir|mesh-list
6023045|NCT00410202|Adefovir|adefovir|mesh-list
6023046|NCT00410202|Antiviral Agents|antiviral agents|mesh-ancestor
6023047|NCT00410202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6023048|NCT00410202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6023049|NCT00410202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6023050|NCT00410202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6455408|NCT00428480|Dopamine Agents|dopamine agents|mesh-ancestor
6455409|NCT00428480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6461933|NCT00456872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6053262|NCT00594204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6455410|NCT00428480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455411|NCT00428480|Adrenergic Agents|adrenergic agents|mesh-ancestor
6455412|NCT00428480|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6455413|NCT00428480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6455414|NCT00428480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6455415|NCT00428480|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6455416|NCT00428519|Aprepitant|aprepitant|mesh-list
6455417|NCT00428519|Fosaprepitant|fosaprepitant|mesh-list
6455418|NCT00428519|Antiemetics|antiemetics|mesh-ancestor
6455419|NCT00428519|Autonomic Agents|autonomic agents|mesh-ancestor
6455420|NCT00428519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6455421|NCT00428519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455422|NCT00428519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6455423|NCT00428519|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6455424|NCT00428519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6455425|NCT00428519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455426|NCT00428545|Bevacizumab|bevacizumab|mesh-list
6455427|NCT00428545|Bortezomib|bortezomib|mesh-list
6455428|NCT00428545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6455429|NCT00428545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6455430|NCT00428545|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6455431|NCT00428545|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6023051|NCT00410202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023052|NCT00410202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6023053|NCT00410202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6023054|NCT00410384|Belimumab|belimumab|mesh-list
6023055|NCT00410384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6023056|NCT00410384|Immunologic Factors|immunologic factors|mesh-ancestor
6023057|NCT00410384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023058|NCT00410410|Abatacept|abatacept|mesh-list
6455432|NCT00428545|Growth Substances|growth substances|mesh-ancestor
6455433|NCT00428545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455434|NCT00428545|Growth Inhibitors|growth inhibitors|mesh-ancestor
6455435|NCT00428558|Cytarabine|cytarabine|mesh-list
6455436|NCT00428558|Daunorubicin|daunorubicin|mesh-list
6455437|NCT00428558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6455438|NCT00428558|Antimetabolites|antimetabolites|mesh-ancestor
6455439|NCT00428558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455440|NCT00428558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6455441|NCT00428558|Antiviral Agents|antiviral agents|mesh-ancestor
6023059|NCT00410410|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6023060|NCT00410410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023061|NCT00410410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6023062|NCT00410410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6023063|NCT00410410|Immunologic Factors|immunologic factors|mesh-ancestor
6023064|NCT00410410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023065|NCT00410410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6023066|NCT00410423|Cytarabine|cytarabine|mesh-list
6023067|NCT00410423|Etoposide|etoposide|mesh-list
6023068|NCT00410423|Mitoxantrone|mitoxantrone|mesh-list
6023069|NCT00410423|Bortezomib|bortezomib|mesh-list
6023070|NCT00410423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6023071|NCT00410423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6023072|NCT00410423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6023073|NCT00410423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6023074|NCT00410423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6023075|NCT00410423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023076|NCT00410423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6023077|NCT00410423|Antimetabolites|antimetabolites|mesh-ancestor
6023078|NCT00410423|Antiviral Agents|antiviral agents|mesh-ancestor
6023079|NCT00410423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6023080|NCT00410423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6023081|NCT00410423|Immunologic Factors|immunologic factors|mesh-ancestor
6023082|NCT00410423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455442|NCT00428558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6455443|NCT00428558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6455444|NCT00428558|Immunologic Factors|immunologic factors|mesh-ancestor
6455445|NCT00428558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455446|NCT00428558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5490688|NCT04484818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5490689|NCT04484818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5490690|NCT04484818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6023083|NCT00410423|Analgesics|analgesics|mesh-ancestor
6023084|NCT00410423|Sensory System Agents|sensory system agents|mesh-ancestor
6455447|NCT00428558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6455448|NCT00428558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6455449|NCT00428558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6023085|NCT00410423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6023086|NCT00410488|Dexamethasone|dexamethasone|mesh-list
6023087|NCT00410488|Dexamethasone acetate|dexamethasone acetate|mesh-list
5490691|NCT04484818|Luteolytic Agents|luteolytic agents|mesh-ancestor
5490692|NCT04484818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5490693|NCT04484818|Contraceptive Agents|contraceptive agents|mesh-ancestor
5490694|NCT04484818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5490695|NCT04484818|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5490696|NCT04484818|Antidepressive Agents|antidepressive agents|mesh-ancestor
5490697|NCT04484818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5490698|NCT04484818|Hormone Antagonists|hormone antagonists|mesh-ancestor
5490699|NCT04482309|Trastuzumab|trastuzumab|mesh-list
5490700|NCT04482309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6023088|NCT00410488|Doxorubicin|doxorubicin|mesh-list
6023089|NCT00410488|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6023090|NCT00410488|Vincristine|vincristine|mesh-list
5490701|NCT04482309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5490702|NCT04460885|Insulin|insulin|mesh-list
5490703|NCT04460885|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5490704|NCT04460885|Insulin Glargine|insulin glargine|mesh-list
5490705|NCT04460885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5490706|NCT04460885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023091|NCT00410488|Ifosfamide|ifosfamide|mesh-list
6023092|NCT00410488|Dexrazoxane|dexrazoxane|mesh-list
6023093|NCT00410488|Palonosetron|palonosetron|mesh-list
6023094|NCT00410488|BB 1101|bb 1101|mesh-list
6023095|NCT00410488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6023096|NCT00410488|Antiemetics|antiemetics|mesh-ancestor
6023097|NCT00410488|Autonomic Agents|autonomic agents|mesh-ancestor
6023098|NCT00410488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6023099|NCT00410488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023100|NCT00410488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6023101|NCT00410488|Glucocorticoids|glucocorticoids|mesh-ancestor
6023102|NCT00410488|Hormones|hormones|mesh-ancestor
6023103|NCT00410488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6023104|NCT00410488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6023105|NCT00410488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6023106|NCT00410488|Protease Inhibitors|protease inhibitors|mesh-ancestor
5490707|NCT04458831|Dexamethasone|dexamethasone|mesh-list
5490708|NCT04458831|Pomalidomide|pomalidomide|mesh-list
5490709|NCT04458831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5490710|NCT04458831|Antiemetics|antiemetics|mesh-ancestor
5490711|NCT04458831|Autonomic Agents|autonomic agents|mesh-ancestor
5490712|NCT04458831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5490713|NCT04458831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490714|NCT04458831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5490715|NCT04458831|Glucocorticoids|glucocorticoids|mesh-ancestor
5490716|NCT04458831|Hormones|hormones|mesh-ancestor
5490717|NCT04458831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5490718|NCT04458831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5490719|NCT04458831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5490720|NCT04458831|Immunologic Factors|immunologic factors|mesh-ancestor
5490721|NCT04458831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5490722|NCT04458831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5490723|NCT04458831|Growth Substances|growth substances|mesh-ancestor
5490724|NCT04458831|Growth Inhibitors|growth inhibitors|mesh-ancestor
5490725|NCT04456296|Methyltestosterone|methyltestosterone|mesh-list
5490726|NCT04456296|Testosterone|testosterone|mesh-list
5490727|NCT04456296|Testosterone undecanoate|testosterone undecanoate|mesh-list
5490728|NCT04456296|Testosterone enanthate|testosterone enanthate|mesh-list
5490729|NCT04456296|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5490730|NCT04456296|Androgens|androgens|mesh-ancestor
5490731|NCT04456296|Hormones|hormones|mesh-ancestor
5490732|NCT04456296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5490733|NCT04456296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490734|NCT04456296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6023107|NCT00410488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6023108|NCT00410488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023109|NCT00410488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6023110|NCT00410488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5490735|NCT04456296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5490736|NCT04456296|Anabolic Agents|anabolic agents|mesh-ancestor
6023111|NCT00410488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5490737|NCT04435808|Hydroxychloroquine|hydroxychloroquine|mesh-list
6023112|NCT00410488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6023113|NCT00410488|Tubulin Modulators|tubulin modulators|mesh-ancestor
6023114|NCT00410488|Antimitotic Agents|antimitotic agents|mesh-ancestor
6023115|NCT00410488|Mitosis Modulators|mitosis modulators|mesh-ancestor
6023116|NCT00410488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6023117|NCT00410488|Alkylating Agents|alkylating agents|mesh-ancestor
6023118|NCT00410488|Protective Agents|protective agents|mesh-ancestor
6023119|NCT00410488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6023120|NCT00410488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6023121|NCT00410488|Serotonin Agents|serotonin agents|mesh-ancestor
6023122|NCT00410488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6023123|NCT00410488|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6023124|NCT00410514|Mirabegron|mirabegron|mesh-list
6023125|NCT00410514|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6023126|NCT00410514|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6023127|NCT00410514|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6023128|NCT00410514|Adrenergic Agents|adrenergic agents|mesh-ancestor
6023129|NCT00410514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6023130|NCT00410514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023131|NCT00410514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023132|NCT00410514|Urological Agents|urological agents|mesh-ancestor
6023133|NCT00410605|Dexamethasone|dexamethasone|mesh-list
6023134|NCT00410605|Bevacizumab|bevacizumab|mesh-list
6023135|NCT00410605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6023136|NCT00410605|Lenalidomide|lenalidomide|mesh-list
6023137|NCT00410605|Antibodies|antibodies|mesh-list
6023138|NCT00410605|Immunoglobulins|immunoglobulins|mesh-list
6023139|NCT00410605|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6023140|NCT00410605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6023141|NCT00410605|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6023142|NCT00410605|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5490738|NCT04435808|Antimalarials|antimalarials|mesh-ancestor
6023143|NCT00410605|Growth Substances|growth substances|mesh-ancestor
6023144|NCT00410605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023145|NCT00410605|Growth Inhibitors|growth inhibitors|mesh-ancestor
6023146|NCT00410605|Immunologic Factors|immunologic factors|mesh-ancestor
6023147|NCT00410605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6023148|NCT00410605|Antiemetics|antiemetics|mesh-ancestor
6023149|NCT00410605|Autonomic Agents|autonomic agents|mesh-ancestor
6023150|NCT00410605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6023151|NCT00410605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6023152|NCT00410605|Glucocorticoids|glucocorticoids|mesh-ancestor
6023153|NCT00410605|Hormones|hormones|mesh-ancestor
6023154|NCT00410605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6023155|NCT00410605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6023156|NCT00410813|Dasatinib|dasatinib|mesh-list
5490739|NCT04435808|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5490740|NCT04435808|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5490741|NCT04435808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6023157|NCT00410813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6023158|NCT00410813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6023159|NCT00410813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6054337|NCT00602459|Alkylating Agents|alkylating agents|mesh-ancestor
6023160|NCT00410813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023161|NCT00410826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6023162|NCT00410826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6455450|NCT00428649|Selenium|selenium|mesh-list
6455451|NCT00428649|Antioxidants|antioxidants|mesh-ancestor
6455452|NCT00428649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490742|NCT04435808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5490743|NCT04435808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490744|NCT04435808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5490745|NCT04409262|Remdesivir|remdesivir|mesh-list
5490746|NCT04409262|Antimetabolites|antimetabolites|mesh-ancestor
5490747|NCT04409262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490748|NCT04409262|Antiviral Agents|antiviral agents|mesh-ancestor
5490749|NCT04409262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5490750|NCT04408508|Amoxicillin|amoxicillin|mesh-list
5490751|NCT04408508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5490752|NCT04408508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5490753|NCT04394858|Temozolomide|temozolomide|mesh-list
5490754|NCT04394858|Olaparib|olaparib|mesh-list
5490755|NCT04394858|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
6455453|NCT00428649|Protective Agents|protective agents|mesh-ancestor
6455454|NCT00428649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455455|NCT00428649|Trace Elements|trace elements|mesh-ancestor
6455456|NCT00428649|Micronutrients|micronutrients|mesh-ancestor
6455457|NCT00428701|Esomeprazole|esomeprazole|mesh-list
5490756|NCT04394858|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6455458|NCT00428701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6455459|NCT00428701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6455460|NCT00428701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6455461|NCT00428701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6023163|NCT00410826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6023164|NCT00410826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6023165|NCT00410826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023166|NCT00410891|Gatifloxacin|gatifloxacin|mesh-list
6023167|NCT00410891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6023168|NCT00410891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6455462|NCT00428701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455463|NCT00428727|Nitric Oxide|nitric oxide|mesh-list
6455464|NCT00428727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6455465|NCT00428727|Autonomic Agents|autonomic agents|mesh-ancestor
6455466|NCT00428727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6455467|NCT00428727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455468|NCT00428727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6455469|NCT00428727|Respiratory System Agents|respiratory system agents|mesh-ancestor
6455470|NCT00428727|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6455471|NCT00428727|Antioxidants|antioxidants|mesh-ancestor
6455472|NCT00428727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490757|NCT04394858|Alkylating Agents|alkylating agents|mesh-ancestor
5490758|NCT04394858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490759|NCT04394858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5490760|NCT04394858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5490761|NCT04352439|Aspirin|aspirin|mesh-list
6455473|NCT00428727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6455474|NCT00428727|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6455475|NCT00428727|Vasodilator Agents|vasodilator agents|mesh-ancestor
6455476|NCT00428727|Gasotransmitters|gasotransmitters|mesh-ancestor
6455477|NCT00428727|Protective Agents|protective agents|mesh-ancestor
6455478|NCT00428766|Farletuzumab|farletuzumab|mesh-list
6023169|NCT00410891|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6455479|NCT00428766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6455480|NCT00428818|Doxycycline|doxycycline|mesh-list
6023170|NCT00410891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6023171|NCT00410891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6023172|NCT00410891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6023173|NCT00410891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6023174|NCT00410891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023175|NCT00410891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6023176|NCT00410904|Pemetrexed|pemetrexed|mesh-list
6023177|NCT00410904|Cediranib|cediranib|mesh-list
6023178|NCT00410904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6023179|NCT00410904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6023180|NCT00410904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023181|NCT00410904|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6455481|NCT00428818|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6455482|NCT00428818|Trimethoprim|trimethoprim|mesh-list
6455483|NCT00428818|Sulfamethoxazole|sulfamethoxazole|mesh-list
6023182|NCT00410904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6023183|NCT00410904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6023184|NCT00411086|Rituximab|rituximab|mesh-list
6023185|NCT00411086|Molgramostim|molgramostim|mesh-list
6023186|NCT00411086|Sargramostim|sargramostim|mesh-list
6023187|NCT00411086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6023188|NCT00411086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6023189|NCT00411086|Immunologic Factors|immunologic factors|mesh-ancestor
6023190|NCT00411086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023191|NCT00411086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6455484|NCT00428818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6455485|NCT00428818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6455486|NCT00428818|Antimalarials|antimalarials|mesh-ancestor
6455487|NCT00428818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6455488|NCT00428818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6455489|NCT00428818|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6455490|NCT00428818|Renal Agents|renal agents|mesh-ancestor
6455491|NCT00428818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6455492|NCT00428818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6455493|NCT00428818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455494|NCT00428818|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6455495|NCT00428818|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6455496|NCT00428818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6023192|NCT00411151|Sunitinib|sunitinib|mesh-list
6023193|NCT00411151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6023194|NCT00411151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6023195|NCT00411151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6023196|NCT00411151|Growth Substances|growth substances|mesh-ancestor
6023197|NCT00411151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654611|NCT01458015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654612|NCT01458015|Adrenergic Agents|adrenergic agents|mesh-ancestor
6654613|NCT01458015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6654614|NCT01458041|Iloprost|iloprost|mesh-list
6654615|NCT01458041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6654616|NCT01458041|Vasodilator Agents|vasodilator agents|mesh-ancestor
6654617|NCT01458054|Ritonavir|ritonavir|mesh-list
6654618|NCT01458054|Omeprazole|omeprazole|mesh-list
6654619|NCT01458054|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6023198|NCT00411151|Growth Inhibitors|growth inhibitors|mesh-ancestor
6023199|NCT00411151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6023200|NCT00411151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6455497|NCT00428883|Acetylcysteine|acetylcysteine|mesh-list
6455498|NCT00428883|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6455499|NCT00428883|Antiviral Agents|antiviral agents|mesh-ancestor
6455500|NCT00428883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6455501|NCT00428883|Expectorants|expectorants|mesh-ancestor
6455502|NCT00428883|Respiratory System Agents|respiratory system agents|mesh-ancestor
6654620|NCT01458054|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6023201|NCT00411151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023202|NCT00411398|Memantine|memantine|mesh-list
6023203|NCT00411398|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6023204|NCT00411398|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6023205|NCT00411398|Dopamine Agents|dopamine agents|mesh-ancestor
6023206|NCT00411398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6023207|NCT00411398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023208|NCT00411398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023209|NCT00411398|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6023210|NCT00411398|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6023211|NCT00411411|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6455503|NCT00428883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5490762|NCT04352439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5490763|NCT04352439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5490764|NCT04352439|Analgesics|analgesics|mesh-ancestor
5490765|NCT04352439|Sensory System Agents|sensory system agents|mesh-ancestor
5490766|NCT04352439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5490767|NCT04352439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490768|NCT04352439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5490769|NCT04352439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5490770|NCT04352439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5490771|NCT04352439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5490772|NCT04352439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490773|NCT04352439|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6023212|NCT00411411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6023213|NCT00411411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023214|NCT00411411|Incretins|incretins|mesh-ancestor
6023215|NCT00411411|Hormones|hormones|mesh-ancestor
6023216|NCT00411411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6023217|NCT00411411|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6023218|NCT00411411|Protease Inhibitors|protease inhibitors|mesh-ancestor
6023219|NCT00411411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6023220|NCT00411411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023221|NCT00411450|Panitumumab|panitumumab|mesh-list
6023222|NCT00411450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6023223|NCT00411450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6455504|NCT00428883|Antioxidants|antioxidants|mesh-ancestor
6455505|NCT00428883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455506|NCT00428883|Protective Agents|protective agents|mesh-ancestor
6455507|NCT00428883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455508|NCT00428883|Antidotes|antidotes|mesh-ancestor
6455509|NCT00428896|Gefitinib|gefitinib|mesh-list
6455510|NCT00428896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6455511|NCT00428896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6455512|NCT00428896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6455513|NCT00428896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455514|NCT00428909|Acetaminophen|acetaminophen|mesh-list
6455515|NCT00428909|Imatinib Mesylate|imatinib mesylate|mesh-list
6455516|NCT00428909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6455517|NCT00428909|Analgesics|analgesics|mesh-ancestor
6023224|NCT00411463|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6023225|NCT00411463|Antidepressive Agents|antidepressive agents|mesh-ancestor
6023226|NCT00411463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6023227|NCT00411463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6023228|NCT00411463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6023229|NCT00411463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6023230|NCT00411463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023231|NCT00411554|Inositol|inositol|mesh-list
6023232|NCT00411554|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6023233|NCT00411554|Voglibose|voglibose|mesh-list
6023234|NCT00411554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6023235|NCT00411554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023236|NCT00411554|Incretins|incretins|mesh-ancestor
6023237|NCT00411554|Hormones|hormones|mesh-ancestor
6023238|NCT00411554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6023239|NCT00411554|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6023240|NCT00411554|Protease Inhibitors|protease inhibitors|mesh-ancestor
6023241|NCT00411554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6023242|NCT00411554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023243|NCT00411554|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6023244|NCT00411554|Vitamin B Complex|vitamin b complex|mesh-ancestor
6023245|NCT00411554|Vitamins|vitamins|mesh-ancestor
6455518|NCT00428909|Sensory System Agents|sensory system agents|mesh-ancestor
6455519|NCT00428909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6455520|NCT00428909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455521|NCT00428909|Antipyretics|antipyretics|mesh-ancestor
6455522|NCT00428909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6455523|NCT00428909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6455524|NCT00428909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6455525|NCT00428909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455526|NCT00429065|Rituximab|rituximab|mesh-list
6023246|NCT00411554|Micronutrients|micronutrients|mesh-ancestor
6023247|NCT00411619|Everolimus|everolimus|mesh-list
6023248|NCT00411619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6023249|NCT00411619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6023250|NCT00411619|Immunologic Factors|immunologic factors|mesh-ancestor
6023251|NCT00411619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023252|NCT00411632|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6023253|NCT00411632|Bexarotene|bexarotene|mesh-list
6023254|NCT00411632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6023255|NCT00411632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6023256|NCT00411632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6023257|NCT00411632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023258|NCT00411645|Maribavir|maribavir|mesh-list
6023259|NCT00411645|Antiviral Agents|antiviral agents|mesh-ancestor
6023260|NCT00411645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6023261|NCT00411671|Sorafenib|sorafenib|mesh-list
6023262|NCT00411671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6023263|NCT00411671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6023264|NCT00411671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6023265|NCT00411671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023266|NCT00411684|Ulipristal acetate|ulipristal acetate|mesh-list
6023267|NCT00411684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6023268|NCT00411684|Contraceptive Agents|contraceptive agents|mesh-ancestor
6023269|NCT00411684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5490774|NCT04352439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5490775|NCT04352439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5490776|NCT04352439|Antipyretics|antipyretics|mesh-ancestor
6023270|NCT00411684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023271|NCT00411684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6023272|NCT00411762|Capecitabine|capecitabine|mesh-list
6023273|NCT00411762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6023274|NCT00411762|Antimetabolites|antimetabolites|mesh-ancestor
6023275|NCT00411762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023276|NCT00411762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6023277|NCT00411788|Sirolimus|sirolimus|mesh-list
6023278|NCT00411788|Trastuzumab|trastuzumab|mesh-list
6654621|NCT01458054|Protease Inhibitors|protease inhibitors|mesh-ancestor
6654622|NCT01458054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6023279|NCT00411788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6023280|NCT00411788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6023281|NCT00411788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6023282|NCT00411788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6023283|NCT00411788|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6023284|NCT00411788|Antifungal Agents|antifungal agents|mesh-ancestor
6023285|NCT00411788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6023286|NCT00411788|Immunologic Factors|immunologic factors|mesh-ancestor
6023287|NCT00411788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023288|NCT00412061|Everolimus|everolimus|mesh-list
6023289|NCT00412061|Octreotide|octreotide|mesh-list
6023290|NCT00412061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6455527|NCT00429065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6455528|NCT00429065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6455529|NCT00429065|Immunologic Factors|immunologic factors|mesh-ancestor
6455530|NCT00429065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455531|NCT00429065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6455532|NCT00429091|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6455533|NCT00429091|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6455534|NCT00429091|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6455535|NCT00429091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6455536|NCT00429091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455537|NCT00429091|Adrenergic Agents|adrenergic agents|mesh-ancestor
5490777|NCT04330430|Nivolumab|nivolumab|mesh-list
5490778|NCT04330430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5490779|NCT04330430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5490780|NCT04330430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5490781|NCT04330430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490782|NCT04315636|Pulmonary Surfactants|pulmonary surfactants|mesh-list
5490783|NCT04315636|Respiratory System Agents|respiratory system agents|mesh-ancestor
5490784|NCT04308785|Atezolizumab|atezolizumab|mesh-list
5490785|NCT04308785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5490786|NCT04267120|Pembrolizumab|pembrolizumab|mesh-list
5490787|NCT04267120|Lenvatinib|lenvatinib|mesh-list
5490788|NCT04267120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5490789|NCT04267120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5490790|NCT04267120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5490791|NCT04267120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5490792|NCT04267120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490793|NCT04249401|Warfarin|warfarin|mesh-list
6023291|NCT00412061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5490794|NCT04249401|Rivaroxaban|rivaroxaban|mesh-list
6455538|NCT00429091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5490795|NCT04249401|Dabigatran|dabigatran|mesh-list
5490796|NCT04249401|Apixaban|apixaban|mesh-list
5490797|NCT04249401|Anticoagulants|anticoagulants|mesh-ancestor
6023292|NCT00412061|Immunologic Factors|immunologic factors|mesh-ancestor
6455539|NCT00429091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455540|NCT00429208|Nicotine|nicotine|mesh-list
6023293|NCT00412061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023294|NCT00412061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6023295|NCT00412061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6023296|NCT00412074|Vitamin D|vitamin d|mesh-list
6023297|NCT00412074|Ergocalciferols|ergocalciferols|mesh-list
6023298|NCT00412074|Cholecalciferol|cholecalciferol|mesh-list
6023299|NCT00412074|Vitamins|vitamins|mesh-list
6023300|NCT00412074|Micronutrients|micronutrients|mesh-ancestor
6023301|NCT00412074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023302|NCT00412074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6455541|NCT00429208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6455542|NCT00429208|Autonomic Agents|autonomic agents|mesh-ancestor
6455543|NCT00429208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6455544|NCT00429208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455545|NCT00429208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6455546|NCT00429208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6455547|NCT00429208|Cholinergic Agents|cholinergic agents|mesh-ancestor
6455548|NCT00429208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6455549|NCT00429208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455550|NCT00429234|Gemcitabine|gemcitabine|mesh-list
6455551|NCT00429234|Dasatinib|dasatinib|mesh-list
6455552|NCT00429234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6455553|NCT00429234|Antimetabolites|antimetabolites|mesh-ancestor
6455554|NCT00429234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455555|NCT00429234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6455556|NCT00429234|Antiviral Agents|antiviral agents|mesh-ancestor
6455557|NCT00429234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6455558|NCT00429234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6455559|NCT00429234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6455560|NCT00429234|Immunologic Factors|immunologic factors|mesh-ancestor
6455561|NCT00429234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455562|NCT00429234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6455563|NCT00429247|Trastuzumab|trastuzumab|mesh-list
6455564|NCT00429247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6455565|NCT00429247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6023303|NCT00412074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6023304|NCT00412087|Vitamin D|vitamin d|mesh-list
6023305|NCT00412087|Ergocalciferols|ergocalciferols|mesh-list
6023306|NCT00412087|Cholecalciferol|cholecalciferol|mesh-list
6023307|NCT00412087|Vitamins|vitamins|mesh-list
6023308|NCT00412087|Micronutrients|micronutrients|mesh-ancestor
6023309|NCT00412087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023310|NCT00412087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6023311|NCT00412087|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6023312|NCT00412113|Calcium, Dietary|calcium, dietary|mesh-list
6023313|NCT00412113|Amlodipine|amlodipine|mesh-list
6023314|NCT00412113|Atorvastatin|atorvastatin|mesh-list
6023315|NCT00412113|Calcium|calcium|mesh-list
6023316|NCT00412113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6023317|NCT00412113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023318|NCT00412113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6455566|NCT00429377|Tacrolimus|tacrolimus|mesh-list
5490798|NCT04249401|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5490799|NCT04249401|Antithrombins|antithrombins|mesh-ancestor
5490800|NCT04249401|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5490801|NCT04249401|Protease Inhibitors|protease inhibitors|mesh-ancestor
5490802|NCT04249401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5490803|NCT04249401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490804|NCT04219540|Buprenorphine|buprenorphine|mesh-list
5490805|NCT04219540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5490806|NCT04219540|Narcotics|narcotics|mesh-ancestor
5490807|NCT04219540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5490808|NCT04219540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490809|NCT04219540|Analgesics|analgesics|mesh-ancestor
5490810|NCT04219540|Sensory System Agents|sensory system agents|mesh-ancestor
5490811|NCT04219540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5490812|NCT04219540|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5490813|NCT04146298|Cyclophosphamide|cyclophosphamide|mesh-list
6023319|NCT00412113|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6023320|NCT00412113|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6023321|NCT00412113|Antimetabolites|antimetabolites|mesh-ancestor
6023322|NCT00412113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023323|NCT00412113|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6023324|NCT00412113|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6023325|NCT00412113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6023326|NCT00412113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5490814|NCT04146298|Fludarabine|fludarabine|mesh-list
5490815|NCT04146298|Antibodies|antibodies|mesh-list
5490816|NCT04146298|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5490817|NCT04146298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5490818|NCT04146298|Immunologic Factors|immunologic factors|mesh-ancestor
5490819|NCT04146298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490820|NCT04146298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5490821|NCT04146298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5490822|NCT04146298|Alkylating Agents|alkylating agents|mesh-ancestor
5502930|NCT04463953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023327|NCT00412113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6023328|NCT00412113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6023329|NCT00412113|Vasodilator Agents|vasodilator agents|mesh-ancestor
6023330|NCT00412217|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6023331|NCT00412217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6023332|NCT00412217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6023333|NCT00412217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6023334|NCT00412217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023335|NCT00412243|Cyclophosphamide|cyclophosphamide|mesh-list
6023336|NCT00412243|Clofarabine|clofarabine|mesh-list
6023337|NCT00412243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6023338|NCT00412243|Immunologic Factors|immunologic factors|mesh-ancestor
6023339|NCT00412243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023340|NCT00412243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6023341|NCT00412243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6023342|NCT00412243|Alkylating Agents|alkylating agents|mesh-ancestor
6023343|NCT00412243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023344|NCT00412243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6023345|NCT00412243|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6023346|NCT00412243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6023347|NCT00412243|Antimetabolites|antimetabolites|mesh-ancestor
6023348|NCT00412360|Cyclosporine|cyclosporine|mesh-list
6023349|NCT00412360|Mycophenolic Acid|mycophenolic acid|mesh-list
6023350|NCT00412360|Cyclophosphamide|cyclophosphamide|mesh-list
6023351|NCT00412360|Fludarabine|fludarabine|mesh-list
6023352|NCT00412360|Cyclosporins|cyclosporins|mesh-list
6023353|NCT00412360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6023354|NCT00412360|Immunologic Factors|immunologic factors|mesh-ancestor
6023355|NCT00412360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023356|NCT00412360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6023357|NCT00412360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6023358|NCT00412360|Alkylating Agents|alkylating agents|mesh-ancestor
6023359|NCT00412360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023360|NCT00412360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6023361|NCT00412360|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6023362|NCT00412360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6023363|NCT00412360|Antifungal Agents|antifungal agents|mesh-ancestor
6023364|NCT00412360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6023365|NCT00412360|Dermatologic Agents|dermatologic agents|mesh-ancestor
6023366|NCT00412360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6023367|NCT00412360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6023368|NCT00412360|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6023369|NCT00412360|Antitubercular Agents|antitubercular agents|mesh-ancestor
6023370|NCT00412360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6023371|NCT00412373|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6023372|NCT00412373|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6023373|NCT00412373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6455567|NCT00429377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6455568|NCT00429377|Immunologic Factors|immunologic factors|mesh-ancestor
6455569|NCT00429377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455570|NCT00429377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6455571|NCT00429377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6455572|NCT00429377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455573|NCT00429442|Simvastatin|simvastatin|mesh-list
6455574|NCT00429442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6455575|NCT00429442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6455576|NCT00429442|Antimetabolites|antimetabolites|mesh-ancestor
6455577|NCT00429442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455578|NCT00429442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6455579|NCT00429442|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6023374|NCT00412373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6023375|NCT00412373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023376|NCT00412373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6023377|NCT00412373|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6455580|NCT00429442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6455581|NCT00429468|Acetaminophen|acetaminophen|mesh-list
6455582|NCT00429468|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
6455583|NCT00429468|Hydrocodone|hydrocodone|mesh-list
6455584|NCT00429468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6455585|NCT00429468|Analgesics|analgesics|mesh-ancestor
6455586|NCT00429468|Sensory System Agents|sensory system agents|mesh-ancestor
6455587|NCT00429468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6455588|NCT00429468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455589|NCT00429468|Antipyretics|antipyretics|mesh-ancestor
5490823|NCT04146298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490824|NCT04146298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6023378|NCT00412373|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6455590|NCT00429468|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6455591|NCT00429468|Narcotics|narcotics|mesh-ancestor
6023379|NCT00412373|Serotonin Agents|serotonin agents|mesh-ancestor
6023380|NCT00412373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6023381|NCT00412373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023382|NCT00412373|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6023383|NCT00412373|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6023384|NCT00412373|Dopamine Agents|dopamine agents|mesh-ancestor
6023385|NCT00412425|Palonosetron|palonosetron|mesh-list
6023386|NCT00412425|Antiemetics|antiemetics|mesh-ancestor
6023387|NCT00412425|Autonomic Agents|autonomic agents|mesh-ancestor
6023388|NCT00412425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6023389|NCT00412425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023390|NCT00412425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6023391|NCT00412425|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6023392|NCT00412425|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6023393|NCT00412425|Serotonin Agents|serotonin agents|mesh-ancestor
6023394|NCT00412425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6023395|NCT00412425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023396|NCT00412451|Plasminogen|plasminogen|mesh-list
6023397|NCT00412451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6023398|NCT00412451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6023399|NCT00412451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023400|NCT00412464|PENTA|penta|mesh-list
6023401|NCT00412464|Fondaparinux|fondaparinux|mesh-list
6023402|NCT00412464|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6023403|NCT00412464|Antithrombins|antithrombins|mesh-ancestor
6023404|NCT00412464|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6455592|NCT00429468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6455593|NCT00429468|Antitussive Agents|antitussive agents|mesh-ancestor
6455594|NCT00429468|Respiratory System Agents|respiratory system agents|mesh-ancestor
6455595|NCT00429468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6455596|NCT00429468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6455597|NCT00429468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6455598|NCT00429520|Hyaluronic Acid|hyaluronic acid|mesh-list
6455599|NCT00429520|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6455600|NCT00429520|Immunologic Factors|immunologic factors|mesh-ancestor
6455601|NCT00429520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455602|NCT00429520|Viscosupplements|viscosupplements|mesh-ancestor
6455603|NCT00429520|Protective Agents|protective agents|mesh-ancestor
6023405|NCT00412464|Protease Inhibitors|protease inhibitors|mesh-ancestor
6023406|NCT00412464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6023407|NCT00412464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023408|NCT00412464|Anticoagulants|anticoagulants|mesh-ancestor
6023409|NCT00412464|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6023410|NCT00412464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6023411|NCT00412529|Entecavir|entecavir|mesh-list
6023412|NCT00412529|Telbivudine|telbivudine|mesh-list
6455604|NCT00429533|Dapsone|dapsone|mesh-list
6455605|NCT00429533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6455606|NCT00429533|Antimalarials|antimalarials|mesh-ancestor
6455607|NCT00429533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6455608|NCT00429533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6455609|NCT00429533|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6455610|NCT00429533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6455611|NCT00429533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490825|NCT04146298|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5502931|NCT04463953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5502932|NCT04463953|Glucocorticoids|glucocorticoids|mesh-ancestor
5502933|NCT04463953|Hormones|hormones|mesh-ancestor
5502934|NCT04463953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5502935|NCT04463953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5502936|NCT04463953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5502937|NCT04463953|Protease Inhibitors|protease inhibitors|mesh-ancestor
5502938|NCT04463953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6455612|NCT00429533|Leprostatic Agents|leprostatic agents|mesh-ancestor
6455613|NCT00429533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6455614|NCT00429559|Gemcitabine|gemcitabine|mesh-list
6455615|NCT00429559|Topotecan|topotecan|mesh-list
6455616|NCT00429559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6455617|NCT00429559|Antimetabolites|antimetabolites|mesh-ancestor
6455618|NCT00429559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455619|NCT00429559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6455620|NCT00429559|Antiviral Agents|antiviral agents|mesh-ancestor
6455621|NCT00429559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6455622|NCT00429559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6455623|NCT00429559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5502939|NCT04463953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502940|NCT04463953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5502941|NCT04463901|Mitomycins|mitomycins|mesh-list
5502942|NCT04463901|Mitomycin|mitomycin|mesh-list
5502943|NCT04463901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5502944|NCT04463901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5502945|NCT04463901|Alkylating Agents|alkylating agents|mesh-ancestor
5502946|NCT04463901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502947|NCT04463901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5502948|NCT04463901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5502949|NCT04463368|Nivolumab|nivolumab|mesh-list
5502950|NCT04463368|Ipilimumab|ipilimumab|mesh-list
5502951|NCT04463368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5502952|NCT04463368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5502953|NCT04463368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5502954|NCT04463368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502955|NCT04463615|Leflunomide|leflunomide|mesh-list
5502956|NCT04463615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5502957|NCT04463615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502958|NCT04463615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5502959|NCT04463615|Immunologic Factors|immunologic factors|mesh-ancestor
5502960|NCT04463615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502961|NCT04463459|Vitamins|vitamins|mesh-list
5502962|NCT04463459|Ascorbic Acid|ascorbic acid|mesh-list
5502963|NCT04463459|Vitamin E|vitamin e|mesh-list
5502964|NCT04463459|Micronutrients|micronutrients|mesh-ancestor
5502965|NCT04463459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455624|NCT00429559|Immunologic Factors|immunologic factors|mesh-ancestor
6455625|NCT00429559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455626|NCT00429559|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5502966|NCT04463459|Antioxidants|antioxidants|mesh-ancestor
5502967|NCT04463459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502968|NCT04463459|Protective Agents|protective agents|mesh-ancestor
5502969|NCT04463342|Methamphetamine|methamphetamine|mesh-list
5502970|NCT04463342|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5502971|NCT04463342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502972|NCT04463342|Sympathomimetics|sympathomimetics|mesh-ancestor
6023413|NCT00412529|Antiviral Agents|antiviral agents|mesh-ancestor
6455627|NCT00429559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6023414|NCT00412529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6023415|NCT00412529|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6023416|NCT00412529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6023417|NCT00412529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023418|NCT00412542|Thalidomide|thalidomide|mesh-list
6023419|NCT00412542|Irinotecan|irinotecan|mesh-list
6023420|NCT00412542|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6023421|NCT00412542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6023422|NCT00412542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6023423|NCT00412542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023424|NCT00412542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6023425|NCT00412542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6023426|NCT00412542|Immunologic Factors|immunologic factors|mesh-ancestor
6023427|NCT00412542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023428|NCT00412542|Leprostatic Agents|leprostatic agents|mesh-ancestor
6023429|NCT00412542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6023430|NCT00412542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6023431|NCT00412542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6023432|NCT00412542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6023433|NCT00412542|Growth Substances|growth substances|mesh-ancestor
6023434|NCT00412542|Growth Inhibitors|growth inhibitors|mesh-ancestor
6023435|NCT00412737|Oseltamivir|oseltamivir|mesh-list
6023436|NCT00412737|Antiviral Agents|antiviral agents|mesh-ancestor
6023437|NCT00412737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6023438|NCT00412737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6023439|NCT00412737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023440|NCT00412750|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6455628|NCT00429624|Acetaminophen|acetaminophen|mesh-list
6455629|NCT00429624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6455630|NCT00429624|Analgesics|analgesics|mesh-ancestor
6455631|NCT00429624|Sensory System Agents|sensory system agents|mesh-ancestor
6455632|NCT00429624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6455633|NCT00429624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455634|NCT00429624|Antipyretics|antipyretics|mesh-ancestor
6455635|NCT00429676|Haloperidol|haloperidol|mesh-list
6455636|NCT00429676|Haloperidol decanoate|haloperidol decanoate|mesh-list
6455637|NCT00429676|Antiemetics|antiemetics|mesh-ancestor
6455638|NCT00429676|Autonomic Agents|autonomic agents|mesh-ancestor
6455639|NCT00429676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6455640|NCT00429676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455641|NCT00429676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6455642|NCT00429676|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6455643|NCT00429676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6455644|NCT00429676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6455645|NCT00429676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6455646|NCT00429676|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6455647|NCT00429676|Dopamine Agents|dopamine agents|mesh-ancestor
6455648|NCT00429676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6455649|NCT00429676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455650|NCT00429676|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6455651|NCT00429715|Aluminum sulfate|aluminum sulfate|mesh-list
6455652|NCT00429715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6455653|NCT00429715|Immunologic Factors|immunologic factors|mesh-ancestor
6455654|NCT00429715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455655|NCT00429754|Aprepitant|aprepitant|mesh-list
6455656|NCT00429754|Antiemetics|antiemetics|mesh-ancestor
6455657|NCT00429754|Autonomic Agents|autonomic agents|mesh-ancestor
6455658|NCT00429754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6455659|NCT00429754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023441|NCT00412750|Telbivudine|telbivudine|mesh-list
6455660|NCT00429754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6455661|NCT00429754|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6455662|NCT00429754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6455663|NCT00429754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455664|NCT00429780|Aluminum sulfate|aluminum sulfate|mesh-list
6455665|NCT00429780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6455666|NCT00429780|Immunologic Factors|immunologic factors|mesh-ancestor
6455667|NCT00429780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455668|NCT00429806|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
6455669|NCT00429806|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5490826|NCT04091386|Factor VIII|factor viii|mesh-list
5490827|NCT04091386|Coagulants|coagulants|mesh-ancestor
5490828|NCT04024436|Fulvestrant|fulvestrant|mesh-list
5490829|NCT04024436|Futibatinib|futibatinib|mesh-list
5490830|NCT04024436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5490831|NCT04024436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5490832|NCT04024436|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5490833|NCT04024436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5490834|NCT04024436|Hormone Antagonists|hormone antagonists|mesh-ancestor
6455670|NCT00429806|Immunologic Factors|immunologic factors|mesh-ancestor
6455671|NCT00429806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023442|NCT00412750|Antiviral Agents|antiviral agents|mesh-ancestor
6023443|NCT00412750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5490835|NCT04024436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5490836|NCT04024436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490837|NCT04016805|Venetoclax|venetoclax|mesh-list
5490838|NCT04016805|Acalabrutinib|acalabrutinib|mesh-list
5490839|NCT04016805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5490840|NCT04009681|Antibodies|antibodies|mesh-list
5490841|NCT04009681|Immunologic Factors|immunologic factors|mesh-ancestor
5490842|NCT04009681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490843|NCT04004611|Mirikizumab|mirikizumab|mesh-list
5490844|NCT04004611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5490845|NCT04004611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5490846|NCT04004611|Analgesics|analgesics|mesh-ancestor
5490847|NCT04004611|Sensory System Agents|sensory system agents|mesh-ancestor
5490848|NCT04004611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5490849|NCT04004611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490850|NCT04004611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5490851|NCT04004611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5490852|NCT04004611|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5490853|NCT04004611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5490854|NCT03994146|Remifentanil|remifentanil|mesh-list
5490855|NCT03994146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5490856|NCT03994146|Narcotics|narcotics|mesh-ancestor
5490857|NCT03994146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5490858|NCT03994146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490859|NCT03994146|Analgesics|analgesics|mesh-ancestor
5490860|NCT03994146|Sensory System Agents|sensory system agents|mesh-ancestor
5490861|NCT03994146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5490862|NCT03987919|Tirzepatide|tirzepatide|mesh-list
5490863|NCT03987919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5490864|NCT03987919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023444|NCT00412750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6023445|NCT00412750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6023446|NCT00412750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023447|NCT00412841|Atorvastatin|atorvastatin|mesh-list
6023448|NCT00412841|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6023449|NCT00412841|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6023450|NCT00412841|Antimetabolites|antimetabolites|mesh-ancestor
6023451|NCT00412841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023452|NCT00412841|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6023453|NCT00412841|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6023454|NCT00412841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6023455|NCT00412867|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6023456|NCT00412867|Plasminogen|plasminogen|mesh-list
6023457|NCT00412867|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6023458|NCT00412867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6455672|NCT00429832|Promethazine|promethazine|mesh-list
6455673|NCT00429832|Diphenhydramine|diphenhydramine|mesh-list
6455674|NCT00429832|Ondansetron|ondansetron|mesh-list
6455675|NCT00429832|Antiemetics|antiemetics|mesh-ancestor
6455676|NCT00429832|Autonomic Agents|autonomic agents|mesh-ancestor
6455677|NCT00429832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6455678|NCT00429832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455679|NCT00429832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6455680|NCT00429832|Antipruritics|antipruritics|mesh-ancestor
6455681|NCT00429832|Dermatologic Agents|dermatologic agents|mesh-ancestor
6455682|NCT00429832|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6455683|NCT00429832|Serotonin Agents|serotonin agents|mesh-ancestor
6455684|NCT00429832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5490865|NCT03987919|Incretins|incretins|mesh-ancestor
6023459|NCT00412867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023460|NCT00412893|Voriconazole|voriconazole|mesh-list
6455685|NCT00429832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490866|NCT03987919|Hormones|hormones|mesh-ancestor
6455686|NCT00429832|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6455687|NCT00429832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6455688|NCT00429832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6455689|NCT00429832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6455690|NCT00429832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5502973|NCT04463342|Autonomic Agents|autonomic agents|mesh-ancestor
6023461|NCT00412893|Isavuconazole|isavuconazole|mesh-list
6023462|NCT00412893|Antifungal Agents|antifungal agents|mesh-ancestor
6023463|NCT00412893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6023464|NCT00412893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6455691|NCT00429832|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6023465|NCT00412893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6023466|NCT00412893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6023467|NCT00412893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023468|NCT00412893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6023469|NCT00412893|Hormone Antagonists|hormone antagonists|mesh-ancestor
6023470|NCT00412893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6455692|NCT00429832|Histamine Antagonists|histamine antagonists|mesh-ancestor
6455693|NCT00429832|Histamine Agents|histamine agents|mesh-ancestor
6455694|NCT00429832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6455695|NCT00429832|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6455696|NCT00429832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6455697|NCT00429832|Anesthetics, Local|anesthetics, local|mesh-ancestor
6455698|NCT00429832|Anesthetics|anesthetics|mesh-ancestor
6455699|NCT00429832|Sensory System Agents|sensory system agents|mesh-ancestor
6455700|NCT00429871|Docetaxel|docetaxel|mesh-list
6455701|NCT00429871|Capecitabine|capecitabine|mesh-list
6455702|NCT00429871|Epirubicin|epirubicin|mesh-list
6455703|NCT00429871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6455704|NCT00429871|Tubulin Modulators|tubulin modulators|mesh-ancestor
6654623|NCT01458054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654624|NCT01458054|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6654625|NCT01458054|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6654626|NCT01458054|Antiviral Agents|antiviral agents|mesh-ancestor
6654627|NCT01458054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6654628|NCT01458054|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6654629|NCT01458054|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6654630|NCT01458054|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6654631|NCT01458054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6455705|NCT00429871|Antimitotic Agents|antimitotic agents|mesh-ancestor
6455706|NCT00429871|Mitosis Modulators|mitosis modulators|mesh-ancestor
6455707|NCT00429871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455708|NCT00429871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6455709|NCT00429871|Antimetabolites|antimetabolites|mesh-ancestor
6455710|NCT00429871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6455711|NCT00429871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6023471|NCT00412893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023472|NCT00412893|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6023473|NCT00412958|Plasminogen|plasminogen|mesh-list
6023474|NCT00412958|Fibrinolysin|fibrinolysin|mesh-list
6023475|NCT00412958|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6023476|NCT00412958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6023477|NCT00412958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023478|NCT00412984|Warfarin|warfarin|mesh-list
6023479|NCT00412984|Apixaban|apixaban|mesh-list
6023480|NCT00412984|Anticoagulants|anticoagulants|mesh-ancestor
6023481|NCT00412984|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6023482|NCT00412984|Antithrombins|antithrombins|mesh-ancestor
6023483|NCT00412984|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6023484|NCT00412984|Protease Inhibitors|protease inhibitors|mesh-ancestor
6023485|NCT00412984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6023486|NCT00412984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023487|NCT00413010|Pregabalin|pregabalin|mesh-list
6023488|NCT00413010|Analgesics|analgesics|mesh-ancestor
6023489|NCT00413010|Sensory System Agents|sensory system agents|mesh-ancestor
6455712|NCT00429871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6023490|NCT00413010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6023491|NCT00413010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455713|NCT00429871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6455714|NCT00429897|Bendroflumethiazide|bendroflumethiazide|mesh-list
6455715|NCT00429897|Amiloride|amiloride|mesh-list
6455716|NCT00429897|Spironolactone|spironolactone|mesh-list
6455717|NCT00429897|Furosemide|furosemide|mesh-list
6455718|NCT00429897|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6023492|NCT00413010|Anticonvulsants|anticonvulsants|mesh-ancestor
6023493|NCT00413010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6023494|NCT00413010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6023495|NCT00413010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023496|NCT00413010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6023497|NCT00413010|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6023498|NCT00413010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6023499|NCT00413010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6023500|NCT00413010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6023501|NCT00413036|Lenalidomide|lenalidomide|mesh-list
6023502|NCT00413036|Immunologic Factors|immunologic factors|mesh-ancestor
6023503|NCT00413036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023504|NCT00413036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6023505|NCT00413036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6023506|NCT00413036|Growth Substances|growth substances|mesh-ancestor
6023507|NCT00413036|Growth Inhibitors|growth inhibitors|mesh-ancestor
6023508|NCT00413036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6023509|NCT00413049|Amlodipine|amlodipine|mesh-list
6023510|NCT00413049|Valsartan|valsartan|mesh-list
6023511|NCT00413049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6023512|NCT00413049|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6023513|NCT00413049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6023514|NCT00413049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023515|NCT00413049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6023516|NCT00413049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023517|NCT00413049|Vasodilator Agents|vasodilator agents|mesh-ancestor
6023518|NCT00413049|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6023519|NCT00413049|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6053263|NCT00594204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455719|NCT00429897|Hormone Antagonists|hormone antagonists|mesh-ancestor
6455720|NCT00429897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6455721|NCT00429897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455722|NCT00429897|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6455723|NCT00429897|Diuretics|diuretics|mesh-ancestor
6053264|NCT00594204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053265|NCT00594230|Panobinostat|panobinostat|mesh-list
6053266|NCT00594230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6053267|NCT00594230|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6053268|NCT00594230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6455724|NCT00429897|Natriuretic Agents|natriuretic agents|mesh-ancestor
6455725|NCT00429897|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
6455726|NCT00429897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5490867|NCT03987919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5490868|NCT03987711|Warfarin|warfarin|mesh-list
5490869|NCT03987711|Apixaban|apixaban|mesh-list
6455727|NCT00429897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6455728|NCT00429897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455729|NCT00429897|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
6455730|NCT00429897|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5490870|NCT03987711|Anticoagulants|anticoagulants|mesh-ancestor
5490871|NCT03987711|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6455731|NCT00429897|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6455732|NCT00429897|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6455733|NCT00429936|Fenretinide|fenretinide|mesh-list
6455734|NCT00429936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6455735|NCT00429936|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6455736|NCT00429936|Protective Agents|protective agents|mesh-ancestor
6455737|NCT00429936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455738|NCT00429962|Ranibizumab|ranibizumab|mesh-list
6455739|NCT00429962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6455740|NCT00429962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6455741|NCT00429962|Growth Substances|growth substances|mesh-ancestor
6455742|NCT00429962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455743|NCT00429962|Growth Inhibitors|growth inhibitors|mesh-ancestor
6455744|NCT00429962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6455745|NCT00429975|Levofloxacin|levofloxacin|mesh-list
6455746|NCT00429975|Ofloxacin|ofloxacin|mesh-list
6455747|NCT00429975|Ceftriaxone|ceftriaxone|mesh-list
6455748|NCT00429975|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6455749|NCT00429975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6023520|NCT00413153|Ritonavir|ritonavir|mesh-list
6023521|NCT00413153|Lopinavir|lopinavir|mesh-list
6023522|NCT00413153|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6023523|NCT00413153|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6023524|NCT00413153|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6023525|NCT00413153|Protease Inhibitors|protease inhibitors|mesh-ancestor
6023526|NCT00413153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6023527|NCT00413153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023528|NCT00413153|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6023529|NCT00413153|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6023530|NCT00413153|Antiviral Agents|antiviral agents|mesh-ancestor
6023531|NCT00413153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6023532|NCT00413153|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6023533|NCT00413153|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6023534|NCT00413166|Idarubicin|idarubicin|mesh-list
6023535|NCT00413166|Tretinoin|tretinoin|mesh-list
6023536|NCT00413166|Arsenic Trioxide|arsenic trioxide|mesh-list
6023537|NCT00413166|Gemtuzumab|gemtuzumab|mesh-list
5490872|NCT03987711|Antithrombins|antithrombins|mesh-ancestor
5490873|NCT03987711|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5490874|NCT03987711|Protease Inhibitors|protease inhibitors|mesh-ancestor
5490875|NCT03987711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5490876|NCT03987711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490877|NCT03959085|Calcium, Dietary|calcium, dietary|mesh-list
5490878|NCT03959085|Leucovorin|leucovorin|mesh-list
5490879|NCT03959085|Folic Acid|folic acid|mesh-list
5490880|NCT03959085|Cytarabine|cytarabine|mesh-list
5490881|NCT03959085|Dexamethasone|dexamethasone|mesh-list
5490882|NCT03959085|Dexamethasone acetate|dexamethasone acetate|mesh-list
5490883|NCT03959085|Prednisolone|prednisolone|mesh-list
5490884|NCT03959085|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5490885|NCT03959085|Methylprednisolone|methylprednisolone|mesh-list
5490886|NCT03959085|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5490887|NCT03959085|Prednisolone acetate|prednisolone acetate|mesh-list
5490888|NCT03959085|Hydrocortisone|hydrocortisone|mesh-list
5490889|NCT03959085|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
5490890|NCT03959085|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
5490891|NCT03959085|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
5490892|NCT03959085|Cyclophosphamide|cyclophosphamide|mesh-list
6023538|NCT00413166|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6023539|NCT00413166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6023540|NCT00413166|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6023541|NCT00413166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6023542|NCT00413166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6023543|NCT00413166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023544|NCT00413166|Keratolytic Agents|keratolytic agents|mesh-ancestor
6023545|NCT00413166|Dermatologic Agents|dermatologic agents|mesh-ancestor
6023546|NCT00413166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6023547|NCT00413218|Voriconazole|voriconazole|mesh-list
6023548|NCT00413218|Caspofungin|caspofungin|mesh-list
6023549|NCT00413218|Isavuconazole|isavuconazole|mesh-list
6023550|NCT00413218|Antifungal Agents|antifungal agents|mesh-ancestor
6023551|NCT00413218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6023552|NCT00413218|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6023553|NCT00413218|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6023554|NCT00413218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5490893|NCT03959085|Doxorubicin|doxorubicin|mesh-list
5490894|NCT03959085|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6455750|NCT00429975|Renal Agents|renal agents|mesh-ancestor
6455751|NCT00429975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5490895|NCT03959085|Methotrexate|methotrexate|mesh-list
5490896|NCT03959085|Vincristine|vincristine|mesh-list
5490897|NCT03959085|Daunorubicin|daunorubicin|mesh-list
5490898|NCT03959085|Asparaginase|asparaginase|mesh-list
6455752|NCT00429975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6455753|NCT00429975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6455754|NCT00429975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6455755|NCT00429975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455756|NCT00429975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6455757|NCT00429975|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6455758|NCT00429975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6455759|NCT00430001|Docetaxel|docetaxel|mesh-list
6455760|NCT00430001|Trastuzumab|trastuzumab|mesh-list
6455761|NCT00430001|Vinorelbine|vinorelbine|mesh-list
6455762|NCT00430001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6455763|NCT00430001|Tubulin Modulators|tubulin modulators|mesh-ancestor
6455764|NCT00430001|Antimitotic Agents|antimitotic agents|mesh-ancestor
6455765|NCT00430001|Mitosis Modulators|mitosis modulators|mesh-ancestor
6455766|NCT00430001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455767|NCT00430001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6455768|NCT00430001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6455769|NCT00430040|Carvedilol|carvedilol|mesh-list
6455770|NCT00430040|Lisinopril|lisinopril|mesh-list
6455771|NCT00430040|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6455772|NCT00430040|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6455773|NCT00430040|Adrenergic Agents|adrenergic agents|mesh-ancestor
6455774|NCT00430040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6455775|NCT00430040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455776|NCT00430040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455777|NCT00430040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6455778|NCT00430040|Antioxidants|antioxidants|mesh-ancestor
6455779|NCT00430040|Protective Agents|protective agents|mesh-ancestor
6455780|NCT00430040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6455781|NCT00430040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6455782|NCT00430040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6455783|NCT00430040|Vasodilator Agents|vasodilator agents|mesh-ancestor
6455784|NCT00430040|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6455785|NCT00430040|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6455786|NCT00430040|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6455787|NCT00430040|Protease Inhibitors|protease inhibitors|mesh-ancestor
6455788|NCT00430040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6455789|NCT00430040|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6455790|NCT00430066|Imatinib Mesylate|imatinib mesylate|mesh-list
6455791|NCT00430066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6455792|NCT00430066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6455793|NCT00430066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6455794|NCT00430066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455795|NCT00430079|Etanidazole|etanidazole|mesh-list
6455796|NCT00430079|Imidazole|imidazole|mesh-list
6455797|NCT00430079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6455798|NCT00430079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455799|NCT00430079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6455800|NCT00430105|Cyclophosphamide|cyclophosphamide|mesh-list
5490899|NCT03959085|Mercaptopurine|mercaptopurine|mesh-list
5490900|NCT03959085|Pegaspargase|pegaspargase|mesh-list
5490901|NCT03959085|Thioguanine|thioguanine|mesh-list
5490902|NCT03959085|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
5490903|NCT03959085|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5490904|NCT03959085|Prednisolone phosphate|prednisolone phosphate|mesh-list
5490905|NCT03959085|BB 1101|bb 1101|mesh-list
5490906|NCT03959085|Calcium|calcium|mesh-list
5490907|NCT03959085|2-Aminopurine|2-aminopurine|mesh-list
5490908|NCT03959085|Levoleucovorin|levoleucovorin|mesh-list
5490909|NCT03959085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5490910|NCT03959085|Immunologic Factors|immunologic factors|mesh-ancestor
5490911|NCT03959085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490912|NCT03959085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5490913|NCT03959085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5490914|NCT03959085|Alkylating Agents|alkylating agents|mesh-ancestor
5490915|NCT03959085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490916|NCT03959085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5490917|NCT03959085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5490918|NCT03959085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5490919|NCT03959085|Antiemetics|antiemetics|mesh-ancestor
5490920|NCT03959085|Autonomic Agents|autonomic agents|mesh-ancestor
5490921|NCT03959085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5490922|NCT03959085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5490923|NCT03959085|Glucocorticoids|glucocorticoids|mesh-ancestor
5490924|NCT03959085|Hormones|hormones|mesh-ancestor
5490925|NCT03959085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5490926|NCT03959085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5490927|NCT03959085|Protease Inhibitors|protease inhibitors|mesh-ancestor
5490928|NCT03959085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5490929|NCT03959085|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5490930|NCT03959085|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6455801|NCT00430105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6455802|NCT00430105|Immunologic Factors|immunologic factors|mesh-ancestor
6455803|NCT00430105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455804|NCT00430105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6455805|NCT00430105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6455806|NCT00430105|Alkylating Agents|alkylating agents|mesh-ancestor
6455807|NCT00430105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490931|NCT03959085|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5490932|NCT03959085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5490933|NCT03959085|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5490934|NCT03959085|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5490935|NCT03959085|Abortifacient Agents|abortifacient agents|mesh-ancestor
5490936|NCT03959085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5490937|NCT03959085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5490938|NCT03959085|Antimetabolites|antimetabolites|mesh-ancestor
5490939|NCT03959085|Dermatologic Agents|dermatologic agents|mesh-ancestor
5490940|NCT03959085|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5490941|NCT03959085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5490942|NCT03959085|Antiviral Agents|antiviral agents|mesh-ancestor
5490943|NCT03959085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5490944|NCT03959085|Antidotes|antidotes|mesh-ancestor
5490945|NCT03959085|Protective Agents|protective agents|mesh-ancestor
5490946|NCT03959085|Vitamin B Complex|vitamin b complex|mesh-ancestor
5490947|NCT03959085|Vitamins|vitamins|mesh-ancestor
6455808|NCT00430105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6455809|NCT00430105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6455810|NCT00430118|Cytarabine|cytarabine|mesh-list
6455811|NCT00430118|Dexamethasone|dexamethasone|mesh-list
6455812|NCT00430118|Prednisone|prednisone|mesh-list
6455813|NCT00430118|Cyclophosphamide|cyclophosphamide|mesh-list
6455814|NCT00430118|Ifosfamide|ifosfamide|mesh-list
6455815|NCT00430118|Doxorubicin|doxorubicin|mesh-list
6455816|NCT00430118|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6455817|NCT00430118|Methotrexate|methotrexate|mesh-list
6455818|NCT00430118|Etoposide|etoposide|mesh-list
5490948|NCT03959085|Micronutrients|micronutrients|mesh-ancestor
5490949|NCT03959085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5490950|NCT03959085|Tubulin Modulators|tubulin modulators|mesh-ancestor
5490951|NCT03959085|Antimitotic Agents|antimitotic agents|mesh-ancestor
5490952|NCT03959085|Mitosis Modulators|mitosis modulators|mesh-ancestor
5490953|NCT03959085|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5490954|NCT03959085|Hematinics|hematinics|mesh-ancestor
5490955|NCT03959085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6023555|NCT00413218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023556|NCT00413218|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6023557|NCT00413218|Hormone Antagonists|hormone antagonists|mesh-ancestor
5490959|NCT03873818|Pembrolizumab|pembrolizumab|mesh-list
6455819|NCT00430118|Vincristine|vincristine|mesh-list
6455820|NCT00430118|Daunorubicin|daunorubicin|mesh-list
6455821|NCT00430118|Asparaginase|asparaginase|mesh-list
6455822|NCT00430118|Mercaptopurine|mercaptopurine|mesh-list
6455823|NCT00430118|Thioguanine|thioguanine|mesh-list
6455824|NCT00430118|Vindesine|vindesine|mesh-list
6455825|NCT00430118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6455826|NCT00430118|Immunologic Factors|immunologic factors|mesh-ancestor
6455827|NCT00430118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455828|NCT00430118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6455829|NCT00430118|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6455830|NCT00430118|Alkylating Agents|alkylating agents|mesh-ancestor
6455831|NCT00430118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023558|NCT00413218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6023559|NCT00413218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455832|NCT00430118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5490960|NCT03873818|Ipilimumab|ipilimumab|mesh-list
5490961|NCT03873818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5490962|NCT03873818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6455833|NCT00430118|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6023560|NCT00413218|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6023561|NCT00413244|Testosterone|testosterone|mesh-list
6023562|NCT00413244|Androgens|androgens|mesh-ancestor
6023563|NCT00413244|Hormones|hormones|mesh-ancestor
6023564|NCT00413244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6023565|NCT00413244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023566|NCT00413283|Gemcitabine|gemcitabine|mesh-list
6455834|NCT00430118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6455835|NCT00430118|Antiemetics|antiemetics|mesh-ancestor
6023567|NCT00413283|Carboplatin|carboplatin|mesh-list
6023568|NCT00413283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6023569|NCT00413283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6023570|NCT00413283|Antimetabolites|antimetabolites|mesh-ancestor
6023571|NCT00413283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023572|NCT00413283|Antiviral Agents|antiviral agents|mesh-ancestor
6023573|NCT00413283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6023574|NCT00413283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6023575|NCT00413283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6023576|NCT00413283|Immunologic Factors|immunologic factors|mesh-ancestor
6023577|NCT00413283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023578|NCT00413335|Rosiglitazone|rosiglitazone|mesh-list
6023579|NCT00413335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6023580|NCT00413335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023581|NCT00413374|Enoxaparin|enoxaparin|mesh-list
6023582|NCT00413374|Anticoagulants|anticoagulants|mesh-ancestor
6455836|NCT00430118|Autonomic Agents|autonomic agents|mesh-ancestor
6455837|NCT00430118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6455838|NCT00430118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6455839|NCT00430118|Glucocorticoids|glucocorticoids|mesh-ancestor
6455840|NCT00430118|Hormones|hormones|mesh-ancestor
6455841|NCT00430118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6455842|NCT00430118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6455843|NCT00430118|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6455844|NCT00430118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6455845|NCT00430118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6455846|NCT00430118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6455847|NCT00430118|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6455848|NCT00430118|Abortifacient Agents|abortifacient agents|mesh-ancestor
6455849|NCT00430118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6455850|NCT00430118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6455851|NCT00430118|Antimetabolites|antimetabolites|mesh-ancestor
6455852|NCT00430118|Dermatologic Agents|dermatologic agents|mesh-ancestor
6455853|NCT00430118|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6455854|NCT00430118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6455855|NCT00430118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6455856|NCT00430118|Antiviral Agents|antiviral agents|mesh-ancestor
5490963|NCT03873818|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5490964|NCT03873818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490965|NCT03861039|Tirzepatide|tirzepatide|mesh-list
5490966|NCT03861039|Hypoglycemic Agents|hypoglycemic agents|mesh-list
5490967|NCT03861039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490968|NCT03861039|Incretins|incretins|mesh-ancestor
5490969|NCT03861039|Hormones|hormones|mesh-ancestor
5490970|NCT03861039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5490971|NCT03813147|Cytarabine|cytarabine|mesh-list
5490972|NCT03813147|Hydrocortisone|hydrocortisone|mesh-list
5490973|NCT03813147|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
5490974|NCT03813147|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
5490975|NCT03813147|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
5490976|NCT03813147|Methotrexate|methotrexate|mesh-list
5490977|NCT03813147|Fludarabine phosphate|fludarabine phosphate|mesh-list
5490978|NCT03813147|Azacitidine|azacitidine|mesh-list
5490979|NCT03813147|Fludarabine|fludarabine|mesh-list
5490980|NCT03813147|Enzyme Inhibitors|enzyme inhibitors|mesh-list
5490981|NCT03813147|Pevonedistat|pevonedistat|mesh-list
5490982|NCT03813147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5490983|NCT03813147|Abortifacient Agents|abortifacient agents|mesh-ancestor
6023583|NCT00413374|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6455857|NCT00430118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6455858|NCT00430118|Tubulin Modulators|tubulin modulators|mesh-ancestor
6455859|NCT00430118|Antimitotic Agents|antimitotic agents|mesh-ancestor
6455860|NCT00430118|Mitosis Modulators|mitosis modulators|mesh-ancestor
6455861|NCT00430144|Belotecan|belotecan|mesh-list
6455862|NCT00430144|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6455863|NCT00430144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6455864|NCT00430144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6455865|NCT00430144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455866|NCT00430144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6455867|NCT00430157|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
6455868|NCT00430157|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6455869|NCT00430157|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6455870|NCT00430157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6455871|NCT00430157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455872|NCT00430170|Dipyridamole|dipyridamole|mesh-list
6455873|NCT00430170|Caffeine|caffeine|mesh-list
6455874|NCT00430170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6455875|NCT00430170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455876|NCT00430170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6455877|NCT00430170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6455878|NCT00430170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455879|NCT00430170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6455880|NCT00430170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6455881|NCT00430170|Purinergic Agents|purinergic agents|mesh-ancestor
6455882|NCT00430170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6455883|NCT00430170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6455884|NCT00430170|Vasodilator Agents|vasodilator agents|mesh-ancestor
6455885|NCT00430196|Tizanidine|tizanidine|mesh-list
6455886|NCT00430196|Analgesics|analgesics|mesh-ancestor
6455887|NCT00430196|Sensory System Agents|sensory system agents|mesh-ancestor
6455888|NCT00430196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6455889|NCT00430196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455890|NCT00430196|Anticonvulsants|anticonvulsants|mesh-ancestor
6455891|NCT00430196|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6455892|NCT00430196|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6455893|NCT00430196|Parasympatholytics|parasympatholytics|mesh-ancestor
6455894|NCT00430196|Autonomic Agents|autonomic agents|mesh-ancestor
6455895|NCT00430196|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6455896|NCT00430196|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6455897|NCT00430196|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6455898|NCT00430196|Adrenergic Agents|adrenergic agents|mesh-ancestor
6455899|NCT00430196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6455900|NCT00430196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455901|NCT00430235|Sorafenib|sorafenib|mesh-list
6455902|NCT00430235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6455903|NCT00430235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6455904|NCT00430235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6455905|NCT00430235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455906|NCT00430261|Sunitinib|sunitinib|mesh-list
6455907|NCT00430261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6455908|NCT00430261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6455909|NCT00430261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6455910|NCT00430261|Growth Substances|growth substances|mesh-ancestor
6455911|NCT00430261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023584|NCT00413374|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6023585|NCT00413374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023586|NCT00413400|Etanercept|etanercept|mesh-list
6023587|NCT00413400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6023588|NCT00413400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6023589|NCT00413400|Analgesics|analgesics|mesh-ancestor
6023590|NCT00413400|Sensory System Agents|sensory system agents|mesh-ancestor
6023591|NCT00413400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6023592|NCT00413400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023593|NCT00413400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6023594|NCT00413400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6023595|NCT00413400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6023596|NCT00413400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6023597|NCT00413400|Immunologic Factors|immunologic factors|mesh-ancestor
6023598|NCT00413413|Amlodipine|amlodipine|mesh-list
6023599|NCT00413413|Valsartan|valsartan|mesh-list
6023600|NCT00413413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5490984|NCT03813147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5490985|NCT03813147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5490986|NCT03813147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5490987|NCT03813147|Antimetabolites|antimetabolites|mesh-ancestor
5490988|NCT03813147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490989|NCT03813147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5490990|NCT03813147|Dermatologic Agents|dermatologic agents|mesh-ancestor
5490991|NCT03813147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6023601|NCT00413413|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6023602|NCT00413413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6023603|NCT00413413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023604|NCT00413413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6023605|NCT00413413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023606|NCT00413413|Vasodilator Agents|vasodilator agents|mesh-ancestor
6023607|NCT00413413|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6023608|NCT00413413|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6023609|NCT00413478|Azacitidine|azacitidine|mesh-list
6023610|NCT00413478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6023611|NCT00413478|Antimetabolites|antimetabolites|mesh-ancestor
6023612|NCT00413478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023613|NCT00413478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6023614|NCT00413478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6023615|NCT00413634|Anagrelide|anagrelide|mesh-list
6023616|NCT00413634|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6023617|NCT00413634|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6023618|NCT00413634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023619|NCT00413634|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6023620|NCT00413660|Tofacitinib|tofacitinib|mesh-list
6023621|NCT00413660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6023622|NCT00413660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6023623|NCT00413660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023624|NCT00413777|Tolvaptan|tolvaptan|mesh-list
6023625|NCT00413777|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6023626|NCT00413777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5490992|NCT03813147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5490993|NCT03813147|Immunologic Factors|immunologic factors|mesh-ancestor
5490994|NCT03813147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5490995|NCT03813147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5490996|NCT03813147|Antiviral Agents|antiviral agents|mesh-ancestor
5490997|NCT03813147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5490998|NCT03813147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5490999|NCT03801525|Venetoclax|venetoclax|mesh-list
5491000|NCT03801525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5491001|NCT03778073|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5491002|NCT03778073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5491003|NCT03778073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5491004|NCT03778073|Alkylating Agents|alkylating agents|mesh-ancestor
5491005|NCT03778073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491006|NCT03778073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5491007|NCT03778073|Immunologic Factors|immunologic factors|mesh-ancestor
5491008|NCT03778073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5491009|NCT03759587|Niraparib|niraparib|mesh-list
6023627|NCT00413777|Natriuretic Agents|natriuretic agents|mesh-ancestor
6023628|NCT00413777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023629|NCT00413894|Epoetin Alfa|epoetin alfa|mesh-list
6023630|NCT00413894|Hematinics|hematinics|mesh-ancestor
6023631|NCT00413920|Mycophenolic Acid|mycophenolic acid|mesh-list
6023632|NCT00413920|Prednisone|prednisone|mesh-list
6023633|NCT00413920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6023634|NCT00413920|Glucocorticoids|glucocorticoids|mesh-ancestor
6023635|NCT00413920|Hormones|hormones|mesh-ancestor
6023636|NCT00413920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6023637|NCT00413920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023638|NCT00413920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5491010|NCT03759587|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5491011|NCT03759587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5491012|NCT03759587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491013|NCT03759587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6023639|NCT00413920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6023640|NCT00413920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6023641|NCT00413920|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6455912|NCT00430261|Growth Inhibitors|growth inhibitors|mesh-ancestor
6023642|NCT00413920|Antitubercular Agents|antitubercular agents|mesh-ancestor
6023643|NCT00413920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6023644|NCT00413920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6023645|NCT00413920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6023646|NCT00413920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023647|NCT00413959|Dexamethasone|dexamethasone|mesh-list
6023648|NCT00413959|Cyclophosphamide|cyclophosphamide|mesh-list
6023649|NCT00413959|Rituximab|rituximab|mesh-list
6023650|NCT00413959|Bortezomib|bortezomib|mesh-list
6023651|NCT00413959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6023652|NCT00413959|Immunologic Factors|immunologic factors|mesh-ancestor
6023653|NCT00413959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023654|NCT00413959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6023655|NCT00413959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6023656|NCT00413959|Alkylating Agents|alkylating agents|mesh-ancestor
6023657|NCT00413959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023658|NCT00413959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6023659|NCT00413959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6023660|NCT00413959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6023661|NCT00413959|Antiemetics|antiemetics|mesh-ancestor
6023662|NCT00413959|Autonomic Agents|autonomic agents|mesh-ancestor
6023663|NCT00413959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6023664|NCT00413959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5491014|NCT03733314|Quetmolimab|quetmolimab|mesh-list
5491015|NCT03733314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5491016|NCT03730662|Insulin Glargine|insulin glargine|mesh-list
5491017|NCT03730662|Tirzepatide|tirzepatide|mesh-list
5491018|NCT03730662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5491019|NCT03730662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5491020|NCT03730662|Incretins|incretins|mesh-ancestor
6023665|NCT00413959|Glucocorticoids|glucocorticoids|mesh-ancestor
6023666|NCT00413959|Hormones|hormones|mesh-ancestor
6023667|NCT00413959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6023668|NCT00413959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6023669|NCT00413959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6023670|NCT00414011|Moxifloxacin|moxifloxacin|mesh-list
6023671|NCT00414011|Gatifloxacin|gatifloxacin|mesh-list
6023672|NCT00414011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6023673|NCT00414011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6023674|NCT00414011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6023675|NCT00414011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6023676|NCT00414011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5491021|NCT03730662|Hormones|hormones|mesh-ancestor
5491022|NCT03730662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6023677|NCT00414011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023678|NCT00414011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6023679|NCT00414011|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6023680|NCT00414011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6023681|NCT00414050|Vaccines|vaccines|mesh-list
6023682|NCT00414050|Immunologic Factors|immunologic factors|mesh-ancestor
6023683|NCT00414050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023684|NCT00414076|Letrozole|letrozole|mesh-list
6023685|NCT00414076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6023686|NCT00414076|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6023687|NCT00414076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5491023|NCT03717623|Posaconazole|posaconazole|mesh-list
5491024|NCT03717623|Antifungal Agents|antifungal agents|mesh-ancestor
5491025|NCT03717623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5491026|NCT03717623|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5491027|NCT03717623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5491028|NCT03717623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5491029|NCT03717623|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5491030|NCT03717623|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5491031|NCT03717623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5491032|NCT03717623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491033|NCT03717623|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5491034|NCT03717623|Hormone Antagonists|hormone antagonists|mesh-ancestor
5491035|NCT03717623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5491036|NCT03717623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023688|NCT00414076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6023689|NCT00414076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023690|NCT00414076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6023691|NCT00414076|Hormone Antagonists|hormone antagonists|mesh-ancestor
5491037|NCT03714308|Aflibercept|aflibercept|mesh-list
5491038|NCT03714308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5491039|NCT03714308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5491040|NCT03714308|Growth Substances|growth substances|mesh-ancestor
5491041|NCT03714308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5491042|NCT03714308|Growth Inhibitors|growth inhibitors|mesh-ancestor
5491043|NCT03714308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5491044|NCT03709706|Pembrolizumab|pembrolizumab|mesh-list
5491045|NCT03709706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6023692|NCT00414076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6023693|NCT00414076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023694|NCT00414167|Bupropion|bupropion|mesh-list
6023695|NCT00414167|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6023696|NCT00414167|Antidepressive Agents|antidepressive agents|mesh-ancestor
6023697|NCT00414167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6023698|NCT00414167|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6023699|NCT00414167|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6023700|NCT00414167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5491046|NCT03709706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5491047|NCT03701282|Venetoclax|venetoclax|mesh-list
5491048|NCT03701282|Obinutuzumab|obinutuzumab|mesh-list
5491049|NCT03701282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5491050|NCT03701282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5491051|NCT03683355|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5491052|NCT03683355|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5491053|NCT03683355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491054|NCT03673462|Vaccines|vaccines|mesh-list
5491055|NCT03673462|Immunologic Factors|immunologic factors|mesh-ancestor
5491056|NCT03673462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5491057|NCT03666273|Pembrolizumab|pembrolizumab|mesh-list
5491058|NCT03666273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5491059|NCT03666273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5491060|NCT03613506|Captopril|captopril|mesh-list
6023701|NCT00414167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023702|NCT00414167|Dopamine Agents|dopamine agents|mesh-ancestor
6023703|NCT00414167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6023704|NCT00414167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023705|NCT00414167|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6023706|NCT00414167|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6023707|NCT00414167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6023708|NCT00414206|Mecamylamine|mecamylamine|mesh-list
6023709|NCT00414206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6023710|NCT00414206|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
6023711|NCT00414206|Autonomic Agents|autonomic agents|mesh-ancestor
6023712|NCT00414206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6023713|NCT00414206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023714|NCT00414206|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
6023715|NCT00414206|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6023716|NCT00414206|Cholinergic Agents|cholinergic agents|mesh-ancestor
6023717|NCT00414206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6023718|NCT00414206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023719|NCT00414271|Docetaxel|docetaxel|mesh-list
6023720|NCT00414271|Capecitabine|capecitabine|mesh-list
6023721|NCT00414271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6023722|NCT00414271|Tubulin Modulators|tubulin modulators|mesh-ancestor
6023723|NCT00414271|Antimitotic Agents|antimitotic agents|mesh-ancestor
6023724|NCT00414271|Mitosis Modulators|mitosis modulators|mesh-ancestor
6023725|NCT00414271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023726|NCT00414271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6023727|NCT00414271|Antimetabolites|antimetabolites|mesh-ancestor
6023728|NCT00414310|Decitabine|decitabine|mesh-list
6023729|NCT00414310|Valproic Acid|valproic acid|mesh-list
6023730|NCT00414310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6023731|NCT00414310|Antimetabolites|antimetabolites|mesh-ancestor
6023732|NCT00414310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023733|NCT00414310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6023734|NCT00414310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6023735|NCT00414310|Anticonvulsants|anticonvulsants|mesh-ancestor
6023736|NCT00414310|GABA Agents|gaba agents|mesh-ancestor
6023737|NCT00414310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6023738|NCT00414310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023739|NCT00414310|Antimanic Agents|antimanic agents|mesh-ancestor
6023740|NCT00414310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6023741|NCT00414310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5491061|NCT03613506|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6023742|NCT00414310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5491062|NCT03613506|Protease Inhibitors|protease inhibitors|mesh-ancestor
5491063|NCT03613506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5491064|NCT03613506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491065|NCT03613506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5502974|NCT04463342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5502975|NCT04463342|Dopamine Agents|dopamine agents|mesh-ancestor
5502976|NCT04463342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5502977|NCT04463342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502978|NCT04463342|Adrenergic Agents|adrenergic agents|mesh-ancestor
5502979|NCT04463342|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5502980|NCT04463342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5502981|NCT04463342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6023743|NCT00414388|Sorafenib|sorafenib|mesh-list
6023744|NCT00414388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6023745|NCT00414388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6023746|NCT00414388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5502982|NCT04463342|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5502983|NCT04463030|Vitamins|vitamins|mesh-list
5502984|NCT04463030|Ascorbic Acid|ascorbic acid|mesh-list
5502985|NCT04463030|Micronutrients|micronutrients|mesh-ancestor
5502986|NCT04463030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502987|NCT04463030|Antioxidants|antioxidants|mesh-ancestor
5502988|NCT04463030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5502989|NCT04463030|Protective Agents|protective agents|mesh-ancestor
5502990|NCT04463264|Nitazoxanide|nitazoxanide|mesh-list
5502991|NCT04463264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5502992|NCT04463264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5502993|NCT04463056|Eculizumab|eculizumab|mesh-list
5502994|NCT04463056|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5502995|NCT04463056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5502996|NCT04463056|Immunologic Factors|immunologic factors|mesh-ancestor
5502997|NCT04463056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5502998|NCT04462939|Micronutrients|micronutrients|mesh-list
5502999|NCT04462939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503000|NCT04462757|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5503001|NCT04462757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5503002|NCT04462796|Magnesium citrate|magnesium citrate|mesh-list
6023747|NCT00414388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023748|NCT00414440|Everolimus|everolimus|mesh-list
6023749|NCT00414440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6023750|NCT00414440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6023751|NCT00414440|Immunologic Factors|immunologic factors|mesh-ancestor
6023752|NCT00414440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023753|NCT00414466|Gabapentin|gabapentin|mesh-list
6023754|NCT00414466|Analgesics|analgesics|mesh-ancestor
6023755|NCT00414466|Sensory System Agents|sensory system agents|mesh-ancestor
6023756|NCT00414466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6023757|NCT00414466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023758|NCT00414466|Anticonvulsants|anticonvulsants|mesh-ancestor
6023759|NCT00414466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6023760|NCT00414466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6023761|NCT00414466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6023762|NCT00414466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6023763|NCT00414466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6023764|NCT00414466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6023765|NCT00414466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6023766|NCT00414466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023767|NCT00414466|Antimanic Agents|antimanic agents|mesh-ancestor
6023768|NCT00414518|Ritonavir|ritonavir|mesh-list
6023769|NCT00414518|Lopinavir|lopinavir|mesh-list
6023770|NCT00414518|Tenofovir|tenofovir|mesh-list
6023771|NCT00414518|Emtricitabine|emtricitabine|mesh-list
6023772|NCT00414518|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6023773|NCT00414518|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6023774|NCT00414518|Protease Inhibitors|protease inhibitors|mesh-ancestor
6023775|NCT00414518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6455913|NCT00430261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6455914|NCT00430261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6455915|NCT00430261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455916|NCT00430365|Lenalidomide|lenalidomide|mesh-list
6455917|NCT00430365|Immunologic Factors|immunologic factors|mesh-ancestor
6455918|NCT00430365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455919|NCT00430365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6455920|NCT00430365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6455921|NCT00430365|Growth Substances|growth substances|mesh-ancestor
6023776|NCT00414518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023777|NCT00414518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6023778|NCT00414518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6023779|NCT00414518|Antiviral Agents|antiviral agents|mesh-ancestor
6023780|NCT00414518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6023781|NCT00414518|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6023782|NCT00414518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6023783|NCT00414518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6023784|NCT00414518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6023785|NCT00414661|Tofacitinib|tofacitinib|mesh-list
6023786|NCT00414661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6023787|NCT00414661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6023788|NCT00414661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023789|NCT00414765|Aldesleukin|aldesleukin|mesh-list
6023790|NCT00414765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6023791|NCT00414765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6023792|NCT00414765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6023793|NCT00414765|Antiviral Agents|antiviral agents|mesh-ancestor
6023794|NCT00414765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6023795|NCT00414908|Pancrelipase|pancrelipase|mesh-list
6023796|NCT00414908|Pancreatin|pancreatin|mesh-list
6023797|NCT00414908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6023798|NCT00414973|Teriparatide|teriparatide|mesh-list
6023799|NCT00414973|Calcitonin|calcitonin|mesh-list
6023800|NCT00414973|Salmon calcitonin|salmon calcitonin|mesh-list
6023801|NCT00414973|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
6023802|NCT00414973|Katacalcin|katacalcin|mesh-list
6023803|NCT00414973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6023804|NCT00414973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023805|NCT00414973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6023806|NCT00414973|Vasodilator Agents|vasodilator agents|mesh-ancestor
6023807|NCT00415168|Pemetrexed|pemetrexed|mesh-list
5491072|NCT03571633|Paclitaxel|paclitaxel|mesh-list
6023808|NCT00415168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6023809|NCT00415168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6023810|NCT00415168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023811|NCT00415168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6023812|NCT00415168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6023813|NCT00415194|Pemetrexed|pemetrexed|mesh-list
6023814|NCT00415194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5491073|NCT03571633|Trastuzumab|trastuzumab|mesh-list
5491074|NCT03571633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5491075|NCT03571633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5491076|NCT03571633|Tubulin Modulators|tubulin modulators|mesh-ancestor
5491077|NCT03571633|Antimitotic Agents|antimitotic agents|mesh-ancestor
5491078|NCT03571633|Mitosis Modulators|mitosis modulators|mesh-ancestor
5491079|NCT03571633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023815|NCT00415194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6023816|NCT00415194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023817|NCT00415194|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6023818|NCT00415194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6023819|NCT00415506|Rituximab|rituximab|mesh-list
6023820|NCT00415506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6023821|NCT00415506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6023822|NCT00415506|Immunologic Factors|immunologic factors|mesh-ancestor
6023823|NCT00415506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023824|NCT00415506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6023825|NCT00415519|Edaravone|edaravone|mesh-list
6023826|NCT00415519|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6023827|NCT00415519|Antioxidants|antioxidants|mesh-ancestor
6023828|NCT00415519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023829|NCT00415519|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6023830|NCT00415519|Protective Agents|protective agents|mesh-ancestor
6023831|NCT00415519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023832|NCT00415597|Naltrexone|naltrexone|mesh-list
6023833|NCT00415597|Morphine|morphine|mesh-list
6023834|NCT00415597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6023835|NCT00415597|Narcotics|narcotics|mesh-ancestor
6023836|NCT00415597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6023837|NCT00415597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023838|NCT00415597|Analgesics|analgesics|mesh-ancestor
6023839|NCT00415597|Sensory System Agents|sensory system agents|mesh-ancestor
6023840|NCT00415597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6023841|NCT00415597|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6023842|NCT00415597|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6023843|NCT00415610|Nicardipine|nicardipine|mesh-list
6023844|NCT00415610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6023845|NCT00415610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6023846|NCT00415610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6023847|NCT00415610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023848|NCT00415610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6023849|NCT00415610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023850|NCT00415610|Vasodilator Agents|vasodilator agents|mesh-ancestor
6023851|NCT00415636|Pemetrexed|pemetrexed|mesh-list
6023852|NCT00415636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6023853|NCT00415636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6023854|NCT00415636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023855|NCT00415636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6023856|NCT00415636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6023857|NCT00415857|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6023858|NCT00415857|Imatinib Mesylate|imatinib mesylate|mesh-list
6023859|NCT00415857|Vaccines|vaccines|mesh-list
6023860|NCT00415857|Sargramostim|sargramostim|mesh-list
6023861|NCT00415857|Immunologic Factors|immunologic factors|mesh-ancestor
6023862|NCT00415857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023863|NCT00415857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6023864|NCT00415857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5491080|NCT03571633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5491081|NCT03547271|Vaccines|vaccines|mesh-list
5491082|NCT03547271|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5491083|NCT03547271|Immunologic Factors|immunologic factors|mesh-ancestor
5491084|NCT03547271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5491085|NCT03544281|Dexamethasone|dexamethasone|mesh-list
5491086|NCT03544281|Lenalidomide|lenalidomide|mesh-list
5491087|NCT03544281|Bortezomib|bortezomib|mesh-list
5491088|NCT03544281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5491089|NCT03544281|Antiemetics|antiemetics|mesh-ancestor
5491090|NCT03544281|Autonomic Agents|autonomic agents|mesh-ancestor
5491091|NCT03544281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5491092|NCT03544281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023865|NCT00415857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6023866|NCT00415857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023867|NCT00415857|Antiviral Agents|antiviral agents|mesh-ancestor
6023868|NCT00415857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6023869|NCT00415909|Imatinib Mesylate|imatinib mesylate|mesh-list
6023870|NCT00415909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5491093|NCT03544281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5491094|NCT03544281|Glucocorticoids|glucocorticoids|mesh-ancestor
5491095|NCT03544281|Hormones|hormones|mesh-ancestor
5491096|NCT03544281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5491097|NCT03544281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5491098|NCT03544281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5491099|NCT03544281|Immunologic Factors|immunologic factors|mesh-ancestor
6023871|NCT00415909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6023872|NCT00415909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5491100|NCT03544281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6023873|NCT00415909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491101|NCT03544281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5491102|NCT03544281|Growth Substances|growth substances|mesh-ancestor
5491103|NCT03544281|Growth Inhibitors|growth inhibitors|mesh-ancestor
5491104|NCT03537833|Pemetrexed|pemetrexed|mesh-list
5491105|NCT03537833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5491106|NCT03537833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5491107|NCT03537833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491108|NCT03537833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5491109|NCT03537833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5491110|NCT03521570|Nivolumab|nivolumab|mesh-list
5491111|NCT03521570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6023874|NCT00416455|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6023875|NCT00416455|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6023876|NCT00416455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023877|NCT00416494|Bevacizumab|bevacizumab|mesh-list
6023878|NCT00416494|Capecitabine|capecitabine|mesh-list
6023879|NCT00416494|Oxaliplatin|oxaliplatin|mesh-list
6023880|NCT00416494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6023881|NCT00416494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6023882|NCT00416494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6023883|NCT00416494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6023884|NCT00416494|Growth Substances|growth substances|mesh-ancestor
6023885|NCT00416494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023886|NCT00416494|Growth Inhibitors|growth inhibitors|mesh-ancestor
6023887|NCT00416494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6023888|NCT00416494|Antimetabolites|antimetabolites|mesh-ancestor
6023889|NCT00416494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023890|NCT00416520|Sevelamer|sevelamer|mesh-list
6023891|NCT00416520|Chelating Agents|chelating agents|mesh-ancestor
6023892|NCT00416520|Sequestering Agents|sequestering agents|mesh-ancestor
6023893|NCT00416520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023894|NCT00416598|Cytarabine|cytarabine|mesh-list
6023895|NCT00416598|Etoposide|etoposide|mesh-list
6023896|NCT00416598|Podophyllotoxin|podophyllotoxin|mesh-list
6023897|NCT00416598|Daunorubicin|daunorubicin|mesh-list
6023898|NCT00416598|Etoposide phosphate|etoposide phosphate|mesh-list
6023899|NCT00416598|Busulfan|busulfan|mesh-list
6023900|NCT00416598|Decitabine|decitabine|mesh-list
6023901|NCT00416598|Lenograstim|lenograstim|mesh-list
6023902|NCT00416598|Sargramostim|sargramostim|mesh-list
6023903|NCT00416598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6023904|NCT00416598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6023905|NCT00416598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6023906|NCT00416598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6023907|NCT00416598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6023908|NCT00416598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023909|NCT00416598|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6023910|NCT00416598|Immunologic Factors|immunologic factors|mesh-ancestor
6023911|NCT00416598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023912|NCT00416598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6023913|NCT00416598|Antimetabolites|antimetabolites|mesh-ancestor
6023914|NCT00416598|Antiviral Agents|antiviral agents|mesh-ancestor
6023915|NCT00416598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6023916|NCT00416598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6023917|NCT00416598|Alkylating Agents|alkylating agents|mesh-ancestor
6023918|NCT00416598|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6023919|NCT00416598|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6023920|NCT00416598|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6023921|NCT00416598|Keratolytic Agents|keratolytic agents|mesh-ancestor
6023922|NCT00416598|Dermatologic Agents|dermatologic agents|mesh-ancestor
6023923|NCT00416598|Tubulin Modulators|tubulin modulators|mesh-ancestor
6023924|NCT00416598|Antimitotic Agents|antimitotic agents|mesh-ancestor
6023925|NCT00416598|Mitosis Modulators|mitosis modulators|mesh-ancestor
6023926|NCT00416624|Epoetin Alfa|epoetin alfa|mesh-list
6023927|NCT00416624|Darbepoetin alfa|darbepoetin alfa|mesh-list
6023928|NCT00416624|Hematinics|hematinics|mesh-ancestor
6023929|NCT00416715|Calcium, Dietary|calcium, dietary|mesh-list
6023930|NCT00416715|Vitamin D|vitamin d|mesh-list
6023931|NCT00416715|Cholecalciferol|cholecalciferol|mesh-list
6023932|NCT00416715|Letrozole|letrozole|mesh-list
6023933|NCT00416715|Calcium Carbonate|calcium carbonate|mesh-list
6023934|NCT00416715|Citric Acid|citric acid|mesh-list
6023935|NCT00416715|Sodium Citrate|sodium citrate|mesh-list
6023936|NCT00416715|Calcium|calcium|mesh-list
6023937|NCT00416715|Vitamins|vitamins|mesh-ancestor
6023938|NCT00416715|Micronutrients|micronutrients|mesh-ancestor
6023939|NCT00416715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023940|NCT00416715|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6023941|NCT00416715|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6023942|NCT00416715|Anticoagulants|anticoagulants|mesh-ancestor
6023943|NCT00416715|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6023944|NCT00416715|Chelating Agents|chelating agents|mesh-ancestor
6023945|NCT00416715|Sequestering Agents|sequestering agents|mesh-ancestor
6023946|NCT00416715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023947|NCT00416715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6023948|NCT00416715|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6023949|NCT00416715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6023950|NCT00416715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6023951|NCT00416715|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6023952|NCT00416715|Hormone Antagonists|hormone antagonists|mesh-ancestor
6023953|NCT00416715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6023954|NCT00416715|Antacids|antacids|mesh-ancestor
6023955|NCT00416715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6023956|NCT00416793|Carboplatin|carboplatin|mesh-list
6023957|NCT00416793|Bortezomib|bortezomib|mesh-list
6023958|NCT00416793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6023959|NCT00416884|Fludarabine|fludarabine|mesh-list
6023960|NCT00416884|Alemtuzumab|alemtuzumab|mesh-list
6023961|NCT00416884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6023962|NCT00416884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6023963|NCT00417079|Prednisone|prednisone|mesh-list
6023964|NCT00417079|Mitoxantrone|mitoxantrone|mesh-list
6023965|NCT00417079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6023966|NCT00417079|Glucocorticoids|glucocorticoids|mesh-ancestor
6023967|NCT00417079|Hormones|hormones|mesh-ancestor
6023968|NCT00417079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6023969|NCT00417079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023970|NCT00417079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6023971|NCT00417079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6023972|NCT00417079|Analgesics|analgesics|mesh-ancestor
6023973|NCT00417079|Sensory System Agents|sensory system agents|mesh-ancestor
6023974|NCT00417079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6023975|NCT00417079|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6023976|NCT00417079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6023977|NCT00417079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6023978|NCT00417079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023979|NCT00417170|Amlodipine|amlodipine|mesh-list
6023980|NCT00417170|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6023981|NCT00417170|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5491112|NCT03521570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5491113|NCT03521570|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5491114|NCT03521570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491115|NCT03489525|Antibodies|antibodies|mesh-list
5491116|NCT03489525|Immunoglobulins|immunoglobulins|mesh-list
5491117|NCT03489525|Immunoconjugates|immunoconjugates|mesh-list
5491118|NCT03489525|Immunologic Factors|immunologic factors|mesh-ancestor
5491119|NCT03489525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5491120|NCT03471364|Ketoconazole|ketoconazole|mesh-list
6023982|NCT00417170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6023983|NCT00417170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023984|NCT00417170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6023985|NCT00417170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6023986|NCT00417170|Vasodilator Agents|vasodilator agents|mesh-ancestor
6023987|NCT00417274|Quinacrine|quinacrine|mesh-list
6023988|NCT00417274|Anticestodal Agents|anticestodal agents|mesh-ancestor
6023989|NCT00417274|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6023990|NCT00417274|Anthelmintics|anthelmintics|mesh-ancestor
6023991|NCT00417274|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6023992|NCT00417274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6023993|NCT00417274|Antimalarials|antimalarials|mesh-ancestor
6023994|NCT00417274|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6023995|NCT00417274|Antinematodal Agents|antinematodal agents|mesh-ancestor
6023996|NCT00417274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6023997|NCT00417274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6023998|NCT00417274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6023999|NCT00417417|Rilonacept|rilonacept|mesh-list
6024000|NCT00417417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6024001|NCT00417482|Risperidone|risperidone|mesh-list
5491121|NCT03471364|Antifungal Agents|antifungal agents|mesh-ancestor
5491122|NCT03471364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5491123|NCT03471364|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5491124|NCT03471364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5491125|NCT03471364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5491126|NCT03471364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491127|NCT03471364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5491128|NCT03471364|Hormone Antagonists|hormone antagonists|mesh-ancestor
5491129|NCT03471364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5491130|NCT03471364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5491131|NCT03471364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5491132|NCT03446040|Nivolumab|nivolumab|mesh-list
5491133|NCT03446040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5491134|NCT03446040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5491135|NCT03446040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5491136|NCT03446040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6024002|NCT00417482|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6024003|NCT00417482|Serotonin Agents|serotonin agents|mesh-ancestor
6024004|NCT00417482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6024005|NCT00417482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6024006|NCT00417482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024007|NCT00417482|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5491137|NCT03439085|Durvalumab|durvalumab|mesh-list
5491138|NCT03439085|Interleukin-12|interleukin-12|mesh-list
5491139|NCT03439085|Vaccines|vaccines|mesh-list
5491140|NCT03439085|Immunoglobulins|immunoglobulins|mesh-list
5491141|NCT03439085|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5491142|NCT03439085|Immunoglobulin G|immunoglobulin g|mesh-list
5491143|NCT03439085|Immunologic Factors|immunologic factors|mesh-ancestor
6024008|NCT00417482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6024009|NCT00417482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6024010|NCT00417482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6024011|NCT00417482|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6024012|NCT00417482|Dopamine Agents|dopamine agents|mesh-ancestor
6024013|NCT00417885|Sunitinib|sunitinib|mesh-list
6024014|NCT00417885|Exemestane|exemestane|mesh-list
5491144|NCT03439085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5491145|NCT03439085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5491146|NCT03439085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5491147|NCT03439085|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5491148|NCT03439085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5491149|NCT03439085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6455922|NCT00430365|Growth Inhibitors|growth inhibitors|mesh-ancestor
6024015|NCT00417885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6024016|NCT00417885|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6024017|NCT00417885|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6024018|NCT00417885|Growth Substances|growth substances|mesh-ancestor
6024019|NCT00417885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024020|NCT00417885|Growth Inhibitors|growth inhibitors|mesh-ancestor
6024021|NCT00417885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6024022|NCT00417885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6024023|NCT00417885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6024024|NCT00417885|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6024025|NCT00417885|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6024026|NCT00417885|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6024027|NCT00417885|Hormone Antagonists|hormone antagonists|mesh-ancestor
6024028|NCT00417885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6024029|NCT00417976|Gemcitabine|gemcitabine|mesh-list
6024030|NCT00417976|Bevacizumab|bevacizumab|mesh-list
6024031|NCT00417976|Fluorouracil|fluorouracil|mesh-list
6024032|NCT00417976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6455923|NCT00430365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6455924|NCT00430443|Annamycin|annamycin|mesh-list
6455925|NCT00430443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6455926|NCT00430443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6461934|NCT00456872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461935|NCT00456872|Sensory System Agents|sensory system agents|mesh-ancestor
6461936|NCT00456872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6461937|NCT00456872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6461938|NCT00456872|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6461939|NCT00456872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6461940|NCT00456872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6461941|NCT00456872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461942|NCT00456898|Codeine|codeine|mesh-list
6461943|NCT00456898|Paroxetine|paroxetine|mesh-list
6461944|NCT00456898|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6024033|NCT00417976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6024034|NCT00417976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6024035|NCT00417976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6024036|NCT00417976|Growth Substances|growth substances|mesh-ancestor
6024037|NCT00417976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024038|NCT00417976|Growth Inhibitors|growth inhibitors|mesh-ancestor
6024039|NCT00417976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6024040|NCT00417976|Antimetabolites|antimetabolites|mesh-ancestor
6024041|NCT00417976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6024042|NCT00417976|Antiviral Agents|antiviral agents|mesh-ancestor
6024043|NCT00417976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6024044|NCT00417976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6024045|NCT00417976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6024046|NCT00417976|Immunologic Factors|immunologic factors|mesh-ancestor
6024047|NCT00418028|Capecitabine|capecitabine|mesh-list
6024048|NCT00418028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6024049|NCT00418028|Antimetabolites|antimetabolites|mesh-ancestor
6024050|NCT00418028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6024051|NCT00418028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6024052|NCT00418093|Gemcitabine|gemcitabine|mesh-list
6024053|NCT00418093|Bevacizumab|bevacizumab|mesh-list
6024054|NCT00418093|Oxaliplatin|oxaliplatin|mesh-list
6024055|NCT00418093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6024056|NCT00418093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6024057|NCT00418093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6024058|NCT00418093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6024059|NCT00418093|Growth Substances|growth substances|mesh-ancestor
6024060|NCT00418093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5491150|NCT03439085|Growth Substances|growth substances|mesh-ancestor
5491151|NCT03439085|Growth Inhibitors|growth inhibitors|mesh-ancestor
5491152|NCT03433183|Sirolimus|sirolimus|mesh-list
5491153|NCT03433183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5491154|NCT03433183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5491155|NCT03433183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5491156|NCT03433183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5491157|NCT03433183|Antifungal Agents|antifungal agents|mesh-ancestor
5491158|NCT03433183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5491159|NCT03433183|Immunologic Factors|immunologic factors|mesh-ancestor
5491160|NCT03433183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5491161|NCT03427736|Ketorolac|ketorolac|mesh-list
5491162|NCT03427736|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6024061|NCT00418093|Growth Inhibitors|growth inhibitors|mesh-ancestor
6024062|NCT00418093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6024063|NCT00418093|Antimetabolites|antimetabolites|mesh-ancestor
6024064|NCT00418093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6024065|NCT00418093|Antiviral Agents|antiviral agents|mesh-ancestor
6024066|NCT00418093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6024067|NCT00418093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5491163|NCT03427736|Morphine|morphine|mesh-list
5491164|NCT03427736|Oxycodone|oxycodone|mesh-list
5491165|NCT03427736|Hydromorphone|hydromorphone|mesh-list
5491166|NCT03427736|Ketamine|ketamine|mesh-list
5491167|NCT03427736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5491168|NCT03427736|Narcotics|narcotics|mesh-ancestor
5491169|NCT03427736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5491170|NCT03427736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5491171|NCT03427736|Analgesics|analgesics|mesh-ancestor
5491172|NCT03427736|Sensory System Agents|sensory system agents|mesh-ancestor
5491173|NCT03427736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5491174|NCT03427736|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5491175|NCT03427736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6024068|NCT00418093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6024069|NCT00418093|Immunologic Factors|immunologic factors|mesh-ancestor
6024070|NCT00418262|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6024071|NCT00418262|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6024072|NCT00418262|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6024073|NCT00418262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6024074|NCT00418262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6024075|NCT00418262|Adrenergic Agents|adrenergic agents|mesh-ancestor
6024076|NCT00418262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6024077|NCT00418262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024078|NCT00418379|Immunologic Factors|immunologic factors|mesh-list
6024079|NCT00418379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024080|NCT00418457|Anesthetics|anesthetics|mesh-list
6024081|NCT00418457|Propofol|propofol|mesh-list
6024082|NCT00418457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6024083|NCT00418457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024084|NCT00418457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6024085|NCT00418457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6024086|NCT00418457|Anesthetics, General|anesthetics, general|mesh-ancestor
6024087|NCT00418522|Insulin|insulin|mesh-list
6024088|NCT00418522|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6024089|NCT00418522|Insulin Glargine|insulin glargine|mesh-list
6024090|NCT00418522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6024091|NCT00418522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024092|NCT00418574|Abagovomab|abagovomab|mesh-list
6024093|NCT00418574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6024094|NCT00418574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6024095|NCT00418691|Methylphenidate|methylphenidate|mesh-list
6024096|NCT00418691|Modafinil|modafinil|mesh-list
6024097|NCT00418691|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5491176|NCT03427736|Anesthetics, General|anesthetics, general|mesh-ancestor
5491177|NCT03427736|Anesthetics|anesthetics|mesh-ancestor
6024098|NCT00418691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024099|NCT00418691|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6024100|NCT00418691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6024101|NCT00418691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6024102|NCT00418691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6024103|NCT00418691|Dopamine Agents|dopamine agents|mesh-ancestor
6024104|NCT00418691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6024105|NCT00418691|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6024106|NCT00418691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6024107|NCT00418691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5491178|NCT03427736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5491179|NCT03427736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6024108|NCT00418717|Etanercept|etanercept|mesh-list
5491180|NCT03427736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6024109|NCT00418717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6024110|NCT00418717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6024111|NCT00418717|Analgesics|analgesics|mesh-ancestor
6024112|NCT00418717|Sensory System Agents|sensory system agents|mesh-ancestor
5491181|NCT03427736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491182|NCT03427736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5491183|NCT03427736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5491184|NCT03427736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5491185|NCT03427736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5491186|NCT03427736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5491187|NCT03427736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5491188|NCT03421639|Leuprolide|leuprolide|mesh-list
5491189|NCT03421639|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
5491190|NCT03421639|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5491191|NCT03421639|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5491192|NCT03421639|Fertility Agents|fertility agents|mesh-ancestor
5491193|NCT03421639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5491194|NCT03421639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5491195|NCT03421639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6024113|NCT00418717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6024114|NCT00418717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024115|NCT00418717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6024116|NCT00418717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6024117|NCT00418717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6024118|NCT00418717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6024119|NCT00418717|Immunologic Factors|immunologic factors|mesh-ancestor
6024120|NCT00418886|Pemetrexed|pemetrexed|mesh-list
6024121|NCT00418886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6024122|NCT00418886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6024123|NCT00418886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6024124|NCT00418886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6024125|NCT00418886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6024126|NCT00418938|Leucovorin|leucovorin|mesh-list
6024127|NCT00418938|Bevacizumab|bevacizumab|mesh-list
6024128|NCT00418938|Panitumumab|panitumumab|mesh-list
6024129|NCT00418938|Fluorouracil|fluorouracil|mesh-list
6024130|NCT00418938|Irinotecan|irinotecan|mesh-list
6024131|NCT00418938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6024132|NCT00418938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6024133|NCT00418938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6024134|NCT00418938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6024135|NCT00418938|Growth Substances|growth substances|mesh-ancestor
6024136|NCT00418938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024137|NCT00418938|Growth Inhibitors|growth inhibitors|mesh-ancestor
6024138|NCT00418938|Antimetabolites|antimetabolites|mesh-ancestor
6024139|NCT00418938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6024140|NCT00418938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6024141|NCT00418938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6024142|NCT00418938|Immunologic Factors|immunologic factors|mesh-ancestor
6024143|NCT00418938|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6024144|NCT00418938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6024145|NCT00418938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6024146|NCT00418938|Antidotes|antidotes|mesh-ancestor
6024147|NCT00418938|Protective Agents|protective agents|mesh-ancestor
6024148|NCT00418938|Vitamin B Complex|vitamin b complex|mesh-ancestor
6024149|NCT00418938|Vitamins|vitamins|mesh-ancestor
6024150|NCT00418938|Micronutrients|micronutrients|mesh-ancestor
6024151|NCT00418951|Voriconazole|voriconazole|mesh-list
6024152|NCT00418951|Amphotericin B|amphotericin b|mesh-list
6024153|NCT00418951|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6024154|NCT00418951|Antifungal Agents|antifungal agents|mesh-ancestor
6024155|NCT00418951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6024156|NCT00418951|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6024157|NCT00418951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6024158|NCT00418951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6024159|NCT00418951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6024160|NCT00418951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6024161|NCT00418951|Hormone Antagonists|hormone antagonists|mesh-ancestor
6024162|NCT00418951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6024163|NCT00418951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024164|NCT00418951|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6024165|NCT00418951|Amebicides|amebicides|mesh-ancestor
6024166|NCT00418951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6024167|NCT00418951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6024168|NCT00418951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6053269|NCT00594230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053270|NCT00594256|Sodium Oxybate|sodium oxybate|mesh-list
6053271|NCT00594256|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6053272|NCT00594256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6053273|NCT00594256|Anesthetics, General|anesthetics, general|mesh-ancestor
6053274|NCT00594256|Anesthetics|anesthetics|mesh-ancestor
6053275|NCT00594256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6053276|NCT00594256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053277|NCT00594308|Cyclosporine|cyclosporine|mesh-list
6053278|NCT00594308|Mycophenolic Acid|mycophenolic acid|mesh-list
6053279|NCT00594308|Cyclophosphamide|cyclophosphamide|mesh-list
6053280|NCT00594308|Fludarabine|fludarabine|mesh-list
6053281|NCT00594308|Cyclosporins|cyclosporins|mesh-list
6455927|NCT00430469|Lactoferrin|lactoferrin|mesh-list
6455928|NCT00430469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6455929|NCT00430547|Carbimazole|carbimazole|mesh-list
6053282|NCT00594308|Basiliximab|basiliximab|mesh-list
6053283|NCT00594308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6053284|NCT00594308|Immunologic Factors|immunologic factors|mesh-ancestor
6053285|NCT00594308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053286|NCT00594308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6053287|NCT00594308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6053288|NCT00594308|Alkylating Agents|alkylating agents|mesh-ancestor
6053289|NCT00594308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053290|NCT00594308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6053291|NCT00594308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6053292|NCT00594308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6053293|NCT00594308|Antifungal Agents|antifungal agents|mesh-ancestor
6053294|NCT00594308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6053295|NCT00594308|Dermatologic Agents|dermatologic agents|mesh-ancestor
6053296|NCT00594308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6053297|NCT00594308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6053298|NCT00594308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6053299|NCT00594308|Antitubercular Agents|antitubercular agents|mesh-ancestor
6053300|NCT00594308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6053301|NCT00594386|Rotigotine|rotigotine|mesh-list
6053302|NCT00594386|Dopamine Agonists|dopamine agonists|mesh-ancestor
6053303|NCT00594386|Dopamine Agents|dopamine agents|mesh-ancestor
6053304|NCT00594386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6053305|NCT00594386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053306|NCT00594386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053307|NCT00594425|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6053308|NCT00594425|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
6053309|NCT00594425|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6053310|NCT00594425|Dermatologic Agents|dermatologic agents|mesh-ancestor
6053311|NCT00594464|Rotigotine|rotigotine|mesh-list
6053312|NCT00594464|Dopamine Agonists|dopamine agonists|mesh-ancestor
6053313|NCT00594464|Dopamine Agents|dopamine agents|mesh-ancestor
6053314|NCT00594464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6053315|NCT00594464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053316|NCT00594464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053317|NCT00594516|Tapentadol|tapentadol|mesh-list
6053318|NCT00594516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6053319|NCT00594516|Narcotics|narcotics|mesh-ancestor
6053320|NCT00594516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6053321|NCT00594516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053322|NCT00594516|Analgesics|analgesics|mesh-ancestor
6053323|NCT00594516|Sensory System Agents|sensory system agents|mesh-ancestor
6053324|NCT00594516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6053325|NCT00594516|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6053326|NCT00594516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6053327|NCT00594516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6053328|NCT00594516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053329|NCT00594516|Adrenergic Agents|adrenergic agents|mesh-ancestor
6053330|NCT00594516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6053331|NCT00594646|Tenofovir|tenofovir|mesh-list
6053332|NCT00594646|Emtricitabine|emtricitabine|mesh-list
6053333|NCT00594646|Raltegravir Potassium|raltegravir potassium|mesh-list
6053334|NCT00594646|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6053335|NCT00594646|Antiviral Agents|antiviral agents|mesh-ancestor
6455930|NCT00430547|Antithyroid Agents|antithyroid agents|mesh-ancestor
6053336|NCT00594646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6053337|NCT00594646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6455931|NCT00430547|Hormone Antagonists|hormone antagonists|mesh-ancestor
6455932|NCT00430547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6455933|NCT00430547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455934|NCT00430586|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
6024169|NCT00419003|Lamotrigine|lamotrigine|mesh-list
6024170|NCT00419003|Ketamine|ketamine|mesh-list
6024171|NCT00419003|Riluzole|riluzole|mesh-list
6024172|NCT00419003|Analgesics|analgesics|mesh-ancestor
6024173|NCT00419003|Sensory System Agents|sensory system agents|mesh-ancestor
6024174|NCT00419003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6024175|NCT00419003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024176|NCT00419003|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6024177|NCT00419003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6024178|NCT00419003|Anesthetics, General|anesthetics, general|mesh-ancestor
6024179|NCT00419003|Anesthetics|anesthetics|mesh-ancestor
6024180|NCT00419003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6024181|NCT00419003|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6024182|NCT00419003|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6024183|NCT00419003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6024184|NCT00419003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455935|NCT00430586|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6455936|NCT00430586|Botulinum Toxins|botulinum toxins|mesh-list
6024185|NCT00419003|Anticonvulsants|anticonvulsants|mesh-ancestor
6024186|NCT00419003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6024187|NCT00419003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6024188|NCT00419003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6024189|NCT00419003|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6024190|NCT00419003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6024191|NCT00419003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6024192|NCT00419003|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6024193|NCT00419003|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6024194|NCT00419003|Protective Agents|protective agents|mesh-ancestor
6024195|NCT00419094|Levetiracetam|levetiracetam|mesh-list
6024196|NCT00419094|Anticonvulsants|anticonvulsants|mesh-ancestor
6024197|NCT00419094|Nootropic Agents|nootropic agents|mesh-ancestor
6455937|NCT00430586|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6455938|NCT00430586|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6455939|NCT00430586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6455940|NCT00430586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024198|NCT00419159|Everolimus|everolimus|mesh-list
6024199|NCT00419159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6024200|NCT00419159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6024201|NCT00419159|Immunologic Factors|immunologic factors|mesh-ancestor
6024202|NCT00419159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455941|NCT00430586|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6455942|NCT00430586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6461945|NCT00456898|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5491196|NCT03421639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6024203|NCT00419263|Peramivir|peramivir|mesh-list
6024204|NCT00419263|Antiviral Agents|antiviral agents|mesh-ancestor
6024205|NCT00419263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6024206|NCT00419263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6024207|NCT00419263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6024208|NCT00419341|Immunoglobulins|immunoglobulins|mesh-list
6024209|NCT00419341|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6024210|NCT00419341|Antibodies|antibodies|mesh-list
6024211|NCT00419341|Immunologic Factors|immunologic factors|mesh-ancestor
6024212|NCT00419341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024213|NCT00419393|Levetiracetam|levetiracetam|mesh-list
6024214|NCT00419393|Anticonvulsants|anticonvulsants|mesh-ancestor
6024215|NCT00419393|Nootropic Agents|nootropic agents|mesh-ancestor
6024216|NCT00419445|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
6024217|NCT00419445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5491197|NCT03421639|Hormones|hormones|mesh-ancestor
5491198|NCT03421639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5491199|NCT03421639|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5491200|NCT03421639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5491201|NCT03421639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491202|NCT03421639|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5491203|NCT03421639|Hormone Antagonists|hormone antagonists|mesh-ancestor
5491204|NCT03379051|Lenalidomide|lenalidomide|mesh-list
5491205|NCT03379051|Venetoclax|venetoclax|mesh-list
5491206|NCT03379051|Immunologic Factors|immunologic factors|mesh-ancestor
5491207|NCT03379051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024218|NCT00419445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5503003|NCT04462796|Cathartics|cathartics|mesh-ancestor
6024219|NCT00419445|Cholinergic Agents|cholinergic agents|mesh-ancestor
6024220|NCT00419445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6024221|NCT00419445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6024222|NCT00419445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024223|NCT00419562|Insulin|insulin|mesh-list
6654632|NCT01458054|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6654633|NCT01458067|GSK2636771|gsk2636771|mesh-list
6654634|NCT01458067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5491208|NCT03379051|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6024224|NCT00419562|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6024225|NCT00419562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5491209|NCT03379051|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5491210|NCT03379051|Growth Substances|growth substances|mesh-ancestor
5491211|NCT03379051|Growth Inhibitors|growth inhibitors|mesh-ancestor
5491212|NCT03379051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5491213|NCT03367156|Dexamethasone|dexamethasone|mesh-list
5491214|NCT03367156|Dexamethasone acetate|dexamethasone acetate|mesh-list
5491215|NCT03367156|Ichthammol|ichthammol|mesh-list
5491216|NCT03367156|BB 1101|bb 1101|mesh-list
5491217|NCT03367156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5491218|NCT03367156|Antiemetics|antiemetics|mesh-ancestor
5491219|NCT03367156|Autonomic Agents|autonomic agents|mesh-ancestor
5491220|NCT03367156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5491221|NCT03367156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5491222|NCT03367156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5491223|NCT03367156|Glucocorticoids|glucocorticoids|mesh-ancestor
6024226|NCT00419666|Calcitriol|calcitriol|mesh-list
6024227|NCT00419666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6024228|NCT00419666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024229|NCT00419666|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6024230|NCT00419666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6024231|NCT00419666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6024232|NCT00419666|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6024233|NCT00419666|Vitamins|vitamins|mesh-ancestor
6024234|NCT00419666|Micronutrients|micronutrients|mesh-ancestor
6024235|NCT00419666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6024236|NCT00419744|Budesonide|budesonide|mesh-list
6024237|NCT00419744|Formoterol Fumarate|formoterol fumarate|mesh-list
6024238|NCT00419744|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6024239|NCT00419744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6024240|NCT00419744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6024241|NCT00419744|Autonomic Agents|autonomic agents|mesh-ancestor
6024242|NCT00419744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6024243|NCT00419744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024244|NCT00419744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6024245|NCT00419744|Respiratory System Agents|respiratory system agents|mesh-ancestor
6024246|NCT00419744|Glucocorticoids|glucocorticoids|mesh-ancestor
6024247|NCT00419744|Hormones|hormones|mesh-ancestor
6024248|NCT00419744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6024249|NCT00419744|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6024250|NCT00419744|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6024251|NCT00419744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6024252|NCT00419744|Adrenergic Agents|adrenergic agents|mesh-ancestor
6024253|NCT00419744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6024254|NCT00419744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6024255|NCT00419757|Budesonide|budesonide|mesh-list
6024256|NCT00419757|Formoterol Fumarate|formoterol fumarate|mesh-list
6024257|NCT00419757|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6024258|NCT00419757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6024259|NCT00419757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6024260|NCT00419757|Autonomic Agents|autonomic agents|mesh-ancestor
6024261|NCT00419757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5491224|NCT03367156|Hormones|hormones|mesh-ancestor
5491225|NCT03367156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5491226|NCT03367156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5491227|NCT03367156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5491228|NCT03367156|Protease Inhibitors|protease inhibitors|mesh-ancestor
5491229|NCT03367156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5491230|NCT03367156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491231|NCT03367156|Dermatologic Agents|dermatologic agents|mesh-ancestor
5491232|NCT03272347|Tenofovir|tenofovir|mesh-list
5491233|NCT03272347|Lamivudine|lamivudine|mesh-list
5491234|NCT03272347|Islatravir|islatravir|mesh-list
6654635|NCT01458067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5491235|NCT03272347|Antiviral Agents|antiviral agents|mesh-ancestor
5491236|NCT03272347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6024262|NCT00419757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024263|NCT00419757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6024264|NCT00419757|Respiratory System Agents|respiratory system agents|mesh-ancestor
6024265|NCT00419757|Glucocorticoids|glucocorticoids|mesh-ancestor
6024266|NCT00419757|Hormones|hormones|mesh-ancestor
6024267|NCT00419757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6024268|NCT00419757|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6024269|NCT00419757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6024270|NCT00419757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6024271|NCT00419757|Adrenergic Agents|adrenergic agents|mesh-ancestor
6024272|NCT00419757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6024273|NCT00419757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6024274|NCT00419770|Amphotericin B|amphotericin b|mesh-list
6024275|NCT00419770|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6024276|NCT00419770|Deferasirox|deferasirox|mesh-list
6024277|NCT00419770|Amebicides|amebicides|mesh-ancestor
6024278|NCT00419770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6024279|NCT00419770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6024280|NCT00419770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6024281|NCT00419770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6024282|NCT00419770|Antifungal Agents|antifungal agents|mesh-ancestor
6024283|NCT00419770|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6024284|NCT00419770|Chelating Agents|chelating agents|mesh-ancestor
6024285|NCT00419770|Sequestering Agents|sequestering agents|mesh-ancestor
6024286|NCT00419770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455943|NCT00430586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455944|NCT00430586|Cholinergic Agents|cholinergic agents|mesh-ancestor
6455945|NCT00430586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6455946|NCT00430651|Carboplatin|carboplatin|mesh-list
6024287|NCT00419926|Cyclosporine|cyclosporine|mesh-list
6024288|NCT00419926|Mycophenolic Acid|mycophenolic acid|mesh-list
6024289|NCT00419926|Prednisone|prednisone|mesh-list
6024290|NCT00419926|Cyclosporins|cyclosporins|mesh-list
6024291|NCT00419926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6024292|NCT00419926|Glucocorticoids|glucocorticoids|mesh-ancestor
6024293|NCT00419926|Hormones|hormones|mesh-ancestor
5491237|NCT03272347|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5491238|NCT03272347|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5491239|NCT03272347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5491240|NCT03272347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491241|NCT03272347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5491242|NCT03272347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6024294|NCT00419926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6024295|NCT00419926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024296|NCT00419926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6024297|NCT00419926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6024298|NCT00419926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6024299|NCT00419926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6024300|NCT00419926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6024301|NCT00419926|Immunologic Factors|immunologic factors|mesh-ancestor
6024302|NCT00419926|Antifungal Agents|antifungal agents|mesh-ancestor
6024303|NCT00419926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6024304|NCT00419926|Dermatologic Agents|dermatologic agents|mesh-ancestor
6024305|NCT00419926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6024306|NCT00419926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6024307|NCT00419926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6024308|NCT00419926|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6024309|NCT00419926|Antitubercular Agents|antitubercular agents|mesh-ancestor
6024310|NCT00419926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6024311|NCT00419952|Budesonide|budesonide|mesh-list
6024312|NCT00419952|Formoterol Fumarate|formoterol fumarate|mesh-list
6024313|NCT00419952|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6024314|NCT00419952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6024315|NCT00419952|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6024316|NCT00419952|Autonomic Agents|autonomic agents|mesh-ancestor
5491253|NCT03255434|Oxaliplatin|oxaliplatin|mesh-list
5491254|NCT03255434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6024317|NCT00419952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6024318|NCT00419952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024319|NCT00419952|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6024320|NCT00419952|Respiratory System Agents|respiratory system agents|mesh-ancestor
6024321|NCT00419952|Glucocorticoids|glucocorticoids|mesh-ancestor
6024322|NCT00419952|Hormones|hormones|mesh-ancestor
6455947|NCT00430651|Docetaxel|docetaxel|mesh-list
5491255|NCT03252925|Acetylcysteine|acetylcysteine|mesh-list
6024323|NCT00419952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6024324|NCT00419952|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6024325|NCT00419952|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6024326|NCT00419952|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6024327|NCT00419952|Adrenergic Agents|adrenergic agents|mesh-ancestor
6024328|NCT00419952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6024329|NCT00419952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6024330|NCT00420004|Citalopram|citalopram|mesh-list
6024331|NCT00420004|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6024332|NCT00420004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6024333|NCT00420004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6024334|NCT00420004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6024335|NCT00420004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6024336|NCT00420004|Serotonin Agents|serotonin agents|mesh-ancestor
6024337|NCT00420004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024338|NCT00420004|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6024339|NCT00420004|Antidepressive Agents|antidepressive agents|mesh-ancestor
6024340|NCT00420004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6024341|NCT00420017|Amiodarone|amiodarone|mesh-list
6024342|NCT00420017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6024343|NCT00420017|Vasodilator Agents|vasodilator agents|mesh-ancestor
6024344|NCT00420017|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6024345|NCT00420017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6024346|NCT00420017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6024347|NCT00420017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6024348|NCT00420017|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6024349|NCT00420017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6024350|NCT00420017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6024351|NCT00420017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6024352|NCT00420017|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6024353|NCT00420017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6024354|NCT00420056|Palbociclib|palbociclib|mesh-list
6024355|NCT00420056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6024356|NCT00420056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6024357|NCT00420056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6024358|NCT00420056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6024359|NCT00420095|Insulin|insulin|mesh-list
6024360|NCT00420095|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6024361|NCT00420095|Insulin Lispro|insulin lispro|mesh-list
6024362|NCT00420095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6024363|NCT00420095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024364|NCT00420199|Abatacept|abatacept|mesh-list
6024365|NCT00420199|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6024366|NCT00420199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6024367|NCT00420199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6024368|NCT00420199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6024369|NCT00420199|Immunologic Factors|immunologic factors|mesh-ancestor
6024370|NCT00420199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024371|NCT00420199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6024372|NCT00420212|Dimethyl Fumarate|dimethyl fumarate|mesh-list
6024373|NCT00420212|Dermatologic Agents|dermatologic agents|mesh-ancestor
6024374|NCT00420212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6024375|NCT00420212|Immunologic Factors|immunologic factors|mesh-ancestor
6024376|NCT00420212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024377|NCT00420238|Etanercept|etanercept|mesh-list
6024378|NCT00420238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6024379|NCT00420238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6024380|NCT00420238|Analgesics|analgesics|mesh-ancestor
6024381|NCT00420238|Sensory System Agents|sensory system agents|mesh-ancestor
6024382|NCT00420238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6024383|NCT00420238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024384|NCT00420238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5491256|NCT03252925|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5491257|NCT03252925|Antiviral Agents|antiviral agents|mesh-ancestor
6024385|NCT00420238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6024386|NCT00420238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6024387|NCT00420238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6024388|NCT00420238|Immunologic Factors|immunologic factors|mesh-ancestor
6024389|NCT00420290|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6024390|NCT00420290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6024391|NCT00420303|Etanercept|etanercept|mesh-list
6024392|NCT00420303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6024393|NCT00420303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6024394|NCT00420303|Analgesics|analgesics|mesh-ancestor
6024395|NCT00420303|Sensory System Agents|sensory system agents|mesh-ancestor
6024396|NCT00420303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6024397|NCT00420303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024398|NCT00420303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6024399|NCT00420303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6024400|NCT00420303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6024401|NCT00420303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6024402|NCT00420303|Immunologic Factors|immunologic factors|mesh-ancestor
6024403|NCT00420316|Vaccines|vaccines|mesh-list
6024404|NCT00420316|Immunologic Factors|immunologic factors|mesh-ancestor
6024405|NCT00420316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024406|NCT00420342|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6024407|NCT00420342|Drospirenone|drospirenone|mesh-list
6024408|NCT00420342|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6024409|NCT00420342|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6024410|NCT00420342|Medroxyprogesterone|medroxyprogesterone|mesh-list
6024411|NCT00420342|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6024412|NCT00420342|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
6024413|NCT00420342|Estradiol|estradiol|mesh-list
6024414|NCT00420342|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6024415|NCT00420342|Estrogens|estrogens|mesh-ancestor
6024416|NCT00420342|Hormones|hormones|mesh-ancestor
6024417|NCT00420342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6024418|NCT00420342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024419|NCT00420342|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6024420|NCT00420342|Contraceptive Agents|contraceptive agents|mesh-ancestor
6024421|NCT00420342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6024422|NCT00420342|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6024423|NCT00420342|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6024424|NCT00420342|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5491258|NCT03252925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5491259|NCT03252925|Expectorants|expectorants|mesh-ancestor
5491260|NCT03252925|Respiratory System Agents|respiratory system agents|mesh-ancestor
5491261|NCT03252925|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5491262|NCT03252925|Antioxidants|antioxidants|mesh-ancestor
5491263|NCT03252925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491264|NCT03252925|Protective Agents|protective agents|mesh-ancestor
5491265|NCT03252925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5491266|NCT03252925|Antidotes|antidotes|mesh-ancestor
5491267|NCT03217565|Tedizolid|tedizolid|mesh-list
5491268|NCT03217565|Tedizolid phosphate|tedizolid phosphate|mesh-list
5491269|NCT03217565|Oxazolidinones|oxazolidinones|mesh-list
5491270|NCT03217565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5491271|NCT03217565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5491272|NCT03217565|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5491273|NCT03217565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5491274|NCT03217565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491275|NCT03215511|Selitrectinib|selitrectinib|mesh-list
5491276|NCT03215511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5491277|NCT03215511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6024425|NCT00420342|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6024426|NCT00420342|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6024427|NCT00420342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6024428|NCT00420342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6024429|NCT00420342|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6024430|NCT00420342|Hormone Antagonists|hormone antagonists|mesh-ancestor
6024431|NCT00420342|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6024432|NCT00420342|Diuretics|diuretics|mesh-ancestor
6024433|NCT00420342|Natriuretic Agents|natriuretic agents|mesh-ancestor
6024434|NCT00420407|Vasopressins|vasopressins|mesh-list
6024435|NCT00420407|Arginine Vasopressin|arginine vasopressin|mesh-list
6024436|NCT00420407|Hemostatics|hemostatics|mesh-ancestor
6024437|NCT00420407|Coagulants|coagulants|mesh-ancestor
6024438|NCT00420407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6024439|NCT00420407|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6024440|NCT00420407|Natriuretic Agents|natriuretic agents|mesh-ancestor
6024441|NCT00420407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024442|NCT00420459|Aripiprazole|aripiprazole|mesh-list
6024443|NCT00420459|Antidepressive Agents|antidepressive agents|mesh-ancestor
6024444|NCT00420459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6654636|NCT01458067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6654637|NCT01458067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6024445|NCT00420459|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6024446|NCT00420459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6024447|NCT00420459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6024448|NCT00420459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024449|NCT00420459|Dopamine Agonists|dopamine agonists|mesh-ancestor
6024450|NCT00420459|Dopamine Agents|dopamine agents|mesh-ancestor
6024451|NCT00420459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6024452|NCT00420459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6024453|NCT00420459|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6024454|NCT00420459|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6024455|NCT00420459|Serotonin Agents|serotonin agents|mesh-ancestor
6024456|NCT00420459|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6024457|NCT00420459|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6024458|NCT00420459|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6024459|NCT00420459|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6024460|NCT00420511|Metformin|metformin|mesh-list
6024461|NCT00420511|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6024462|NCT00420511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6024463|NCT00420511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024464|NCT00420511|Incretins|incretins|mesh-ancestor
6024465|NCT00420511|Hormones|hormones|mesh-ancestor
6024466|NCT00420511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6024467|NCT00420511|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6024468|NCT00420511|Protease Inhibitors|protease inhibitors|mesh-ancestor
6024469|NCT00420511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6024470|NCT00420511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6024471|NCT00420628|Loteprednol Etabonate|loteprednol etabonate|mesh-list
6024472|NCT00420628|Tobramycin|tobramycin|mesh-list
6024473|NCT00420628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6024474|NCT00420628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6024475|NCT00420628|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6024476|NCT00420641|Paroxetine|paroxetine|mesh-list
6024477|NCT00420641|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6024478|NCT00420641|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6024479|NCT00420641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6024480|NCT00420641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6024481|NCT00420641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6024482|NCT00420641|Serotonin Agents|serotonin agents|mesh-ancestor
6024483|NCT00420641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024484|NCT00420641|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6024485|NCT00420641|Antidepressive Agents|antidepressive agents|mesh-ancestor
6024486|NCT00420641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6024487|NCT00420641|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6024488|NCT00420641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6024489|NCT00420641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6024490|NCT00420771|Gabapentin|gabapentin|mesh-list
6024491|NCT00420771|Analgesics|analgesics|mesh-ancestor
6024492|NCT00420771|Sensory System Agents|sensory system agents|mesh-ancestor
6024493|NCT00420771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6024494|NCT00420771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024495|NCT00420771|Anticonvulsants|anticonvulsants|mesh-ancestor
6024496|NCT00420771|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6024497|NCT00420771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6024498|NCT00420771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6024499|NCT00420771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6024500|NCT00420771|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6024501|NCT00420771|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6024502|NCT00420771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6024503|NCT00420771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6024504|NCT00420771|Antimanic Agents|antimanic agents|mesh-ancestor
6024505|NCT00420784|Interferons|interferons|mesh-list
5491302|NCT03092453|Cyclophosphamide|cyclophosphamide|mesh-list
5491303|NCT03092453|Pembrolizumab|pembrolizumab|mesh-list
5491304|NCT03092453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5491305|NCT03092453|Immunologic Factors|immunologic factors|mesh-ancestor
5491306|NCT03092453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5491307|NCT03092453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6455948|NCT00430651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6455949|NCT00430651|Tubulin Modulators|tubulin modulators|mesh-ancestor
6455950|NCT00430651|Antimitotic Agents|antimitotic agents|mesh-ancestor
6455951|NCT00430651|Mitosis Modulators|mitosis modulators|mesh-ancestor
6455952|NCT00430651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455953|NCT00430664|Povidone-Iodine|povidone-iodine|mesh-list
6455954|NCT00430664|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6024506|NCT00420784|Ribavirin|ribavirin|mesh-list
6024507|NCT00420784|Interferon-alpha|interferon-alpha|mesh-list
6024508|NCT00420784|Interferon alpha-2|interferon alpha-2|mesh-list
6024509|NCT00420784|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6024510|NCT00420784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6024511|NCT00420784|Antiviral Agents|antiviral agents|mesh-ancestor
6024512|NCT00420784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6024513|NCT00420784|Antimetabolites|antimetabolites|mesh-ancestor
6024514|NCT00420784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6024515|NCT00420784|Immunologic Factors|immunologic factors|mesh-ancestor
6024516|NCT00420784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024517|NCT00420849|Dexamethasone|dexamethasone|mesh-list
6024518|NCT00420849|Lenalidomide|lenalidomide|mesh-list
6024519|NCT00420849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6024520|NCT00420849|Antiemetics|antiemetics|mesh-ancestor
6024521|NCT00420849|Autonomic Agents|autonomic agents|mesh-ancestor
6024522|NCT00420849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6024523|NCT00420849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024524|NCT00420849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6024525|NCT00420849|Glucocorticoids|glucocorticoids|mesh-ancestor
6024526|NCT00420849|Hormones|hormones|mesh-ancestor
6024527|NCT00420849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6024528|NCT00420849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6024529|NCT00420849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6024530|NCT00420849|Immunologic Factors|immunologic factors|mesh-ancestor
6024531|NCT00420849|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6024532|NCT00420849|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6024533|NCT00420849|Growth Substances|growth substances|mesh-ancestor
6024534|NCT00420849|Growth Inhibitors|growth inhibitors|mesh-ancestor
6024535|NCT00420927|Adalimumab|adalimumab|mesh-list
6024536|NCT00420927|Methotrexate|methotrexate|mesh-list
6024537|NCT00420927|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6024538|NCT00420927|Abortifacient Agents|abortifacient agents|mesh-ancestor
6024539|NCT00420927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6024540|NCT00420927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024541|NCT00420927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6024542|NCT00420927|Antimetabolites|antimetabolites|mesh-ancestor
6024543|NCT00420927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6024544|NCT00420927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6024545|NCT00420927|Dermatologic Agents|dermatologic agents|mesh-ancestor
6024546|NCT00420927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6024547|NCT00420927|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6024548|NCT00420927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6024549|NCT00420927|Immunologic Factors|immunologic factors|mesh-ancestor
6024550|NCT00420927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6024551|NCT00420927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6024552|NCT00420927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6024553|NCT00420992|Naltrexone|naltrexone|mesh-list
6024554|NCT00420992|Morphine|morphine|mesh-list
6024555|NCT00420992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6024556|NCT00420992|Narcotics|narcotics|mesh-ancestor
6024557|NCT00420992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6024558|NCT00420992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024559|NCT00420992|Analgesics|analgesics|mesh-ancestor
6024560|NCT00420992|Sensory System Agents|sensory system agents|mesh-ancestor
6024561|NCT00420992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6024562|NCT00420992|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6024563|NCT00420992|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6024564|NCT00421148|Bromides|bromides|mesh-list
6024565|NCT00421148|Rocuronium|rocuronium|mesh-list
6024566|NCT00421148|Anticonvulsants|anticonvulsants|mesh-ancestor
6024567|NCT00421148|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6024568|NCT00421148|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6024569|NCT00421148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6024570|NCT00421148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6024571|NCT00421148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024572|NCT00421174|Methylprednisolone|methylprednisolone|mesh-list
6455955|NCT00430664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6024573|NCT00421174|Etanercept|etanercept|mesh-list
6024574|NCT00421174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6455956|NCT00430742|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
6024575|NCT00421174|Antiemetics|antiemetics|mesh-ancestor
6024576|NCT00421174|Autonomic Agents|autonomic agents|mesh-ancestor
6024577|NCT00421174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6024578|NCT00421174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024579|NCT00421174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6455957|NCT00430742|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6024580|NCT00421174|Glucocorticoids|glucocorticoids|mesh-ancestor
6024581|NCT00421174|Hormones|hormones|mesh-ancestor
5491308|NCT03092453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5491309|NCT03092453|Alkylating Agents|alkylating agents|mesh-ancestor
5491310|NCT03092453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491311|NCT03092453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5491312|NCT03092453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5491313|NCT03092453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6024582|NCT00421174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6024583|NCT00421174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6024584|NCT00421174|Protective Agents|protective agents|mesh-ancestor
6024585|NCT00421174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6024586|NCT00421174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6024587|NCT00421174|Analgesics|analgesics|mesh-ancestor
6024588|NCT00421174|Sensory System Agents|sensory system agents|mesh-ancestor
6024589|NCT00421174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6024590|NCT00421174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5491318|NCT02979873|Sirolimus|sirolimus|mesh-list
5491319|NCT02979873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5491320|NCT02979873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5491321|NCT02979873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5491322|NCT02979873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5491323|NCT02979873|Antifungal Agents|antifungal agents|mesh-ancestor
5491324|NCT02979873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5491325|NCT02979873|Immunologic Factors|immunologic factors|mesh-ancestor
5491326|NCT02979873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5491327|NCT02976337|Naloxone|naloxone|mesh-list
5491328|NCT02976337|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5491329|NCT02976337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5491330|NCT02976337|Sensory System Agents|sensory system agents|mesh-ancestor
5491331|NCT02976337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5491332|NCT02963714|Vaccines|vaccines|mesh-list
5491333|NCT02963714|Immunologic Factors|immunologic factors|mesh-ancestor
5491334|NCT02963714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5491335|NCT02959918|Sirolimus|sirolimus|mesh-list
5491336|NCT02959918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5491337|NCT02959918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5491338|NCT02959918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5491339|NCT02959918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5491340|NCT02959918|Antifungal Agents|antifungal agents|mesh-ancestor
5491341|NCT02959918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5491342|NCT02959918|Immunologic Factors|immunologic factors|mesh-ancestor
5491343|NCT02959918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5491344|NCT02918201|Tranexamic Acid|tranexamic acid|mesh-list
5491345|NCT02918201|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6024591|NCT00421174|Immunologic Factors|immunologic factors|mesh-ancestor
6024592|NCT00421343|Cholecalciferol|cholecalciferol|mesh-list
6024593|NCT00421343|Alendronate|alendronate|mesh-list
6024594|NCT00421343|Calcium Carbonate|calcium carbonate|mesh-list
6024595|NCT00421343|Calcium|calcium|mesh-list
6024596|NCT00421343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6024597|NCT00421343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024598|NCT00421343|Vitamins|vitamins|mesh-ancestor
6024599|NCT00421343|Micronutrients|micronutrients|mesh-ancestor
6024600|NCT00421343|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6024601|NCT00421343|Antacids|antacids|mesh-ancestor
6024602|NCT00421343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6024603|NCT00421343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6024604|NCT00421603|Topiramate|topiramate|mesh-list
6024605|NCT00421603|Adderall|adderall|mesh-list
6024606|NCT00421603|Anticonvulsants|anticonvulsants|mesh-ancestor
6024607|NCT00421603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6024608|NCT00421603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024609|NCT00421603|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6024610|NCT00421733|Ergocalciferols|ergocalciferols|mesh-list
5491346|NCT02918201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6024611|NCT00421733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6024612|NCT00421733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024613|NCT00421733|Vitamins|vitamins|mesh-ancestor
6024614|NCT00421733|Micronutrients|micronutrients|mesh-ancestor
5491347|NCT02918201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491348|NCT02918201|Hemostatics|hemostatics|mesh-ancestor
5491349|NCT02918201|Coagulants|coagulants|mesh-ancestor
5491350|NCT02859896|Calcitriol|calcitriol|mesh-list
5491351|NCT02859896|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
5491352|NCT02859896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5491353|NCT02859896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5491354|NCT02859896|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
5491355|NCT02859896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6024615|NCT00421733|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6024616|NCT00421889|Paclitaxel|paclitaxel|mesh-list
6024617|NCT00421889|Carboplatin|carboplatin|mesh-list
6455958|NCT00430742|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6455959|NCT00430742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6455960|NCT00430742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455961|NCT00430742|Hormones|hormones|mesh-ancestor
6455962|NCT00430742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6455963|NCT00430742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455964|NCT00430794|Spironolactone|spironolactone|mesh-list
6455965|NCT00430794|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6024618|NCT00421889|Belinostat|belinostat|mesh-list
6024619|NCT00421889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6024620|NCT00421889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6024621|NCT00421889|Tubulin Modulators|tubulin modulators|mesh-ancestor
6024622|NCT00421889|Antimitotic Agents|antimitotic agents|mesh-ancestor
6024623|NCT00421889|Mitosis Modulators|mitosis modulators|mesh-ancestor
6024624|NCT00421889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6024625|NCT00421889|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6024626|NCT00421889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6024627|NCT00421928|Oxycodone|oxycodone|mesh-list
6024628|NCT00421928|Tapentadol|tapentadol|mesh-list
6024629|NCT00421928|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6024630|NCT00421928|Narcotics|narcotics|mesh-ancestor
6024631|NCT00421928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6024632|NCT00421928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024633|NCT00421928|Analgesics|analgesics|mesh-ancestor
6024634|NCT00421928|Sensory System Agents|sensory system agents|mesh-ancestor
6024635|NCT00421928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6024636|NCT00421928|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6024637|NCT00421928|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6024638|NCT00421928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6024639|NCT00421928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6024640|NCT00421928|Adrenergic Agents|adrenergic agents|mesh-ancestor
6024641|NCT00421928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6024642|NCT00421993|Adapalene|adapalene|mesh-list
6024643|NCT00421993|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
6024644|NCT00421993|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6024645|NCT00421993|Dermatologic Agents|dermatologic agents|mesh-ancestor
6024646|NCT00421993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6024647|NCT00421993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6024648|NCT00421993|Analgesics|analgesics|mesh-ancestor
6024649|NCT00421993|Sensory System Agents|sensory system agents|mesh-ancestor
6024650|NCT00421993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6024651|NCT00421993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024652|NCT00421993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6024653|NCT00421993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6024654|NCT00422032|Clofarabine|clofarabine|mesh-list
6024655|NCT00422032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6024656|NCT00422032|Antimetabolites|antimetabolites|mesh-ancestor
6024657|NCT00422032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6024658|NCT00422032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6024659|NCT00422058|Liraglutide|liraglutide|mesh-list
6024660|NCT00422058|Orlistat|orlistat|mesh-list
6024661|NCT00422058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6024662|NCT00422058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024663|NCT00422058|Incretins|incretins|mesh-ancestor
6024664|NCT00422058|Hormones|hormones|mesh-ancestor
6024665|NCT00422058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6024666|NCT00422058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6024667|NCT00422058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6024668|NCT00422058|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6024669|NCT00422058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6024670|NCT00422084|Artesunate|artesunate|mesh-list
6024671|NCT00422084|Lumefantrine|lumefantrine|mesh-list
6024672|NCT00422084|Artemether|artemether|mesh-list
6024673|NCT00422084|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6024674|NCT00422084|Pyronaridine|pyronaridine|mesh-list
6024675|NCT00422084|Antimalarials|antimalarials|mesh-ancestor
6024676|NCT00422084|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6024677|NCT00422084|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5491356|NCT02859896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491357|NCT02859896|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5491358|NCT02859896|Vitamins|vitamins|mesh-ancestor
5491359|NCT02859896|Micronutrients|micronutrients|mesh-ancestor
5491360|NCT02859896|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5491361|NCT02855944|Gemcitabine|gemcitabine|mesh-list
5491362|NCT02855944|Paclitaxel|paclitaxel|mesh-list
5491363|NCT02855944|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5491364|NCT02855944|Cisplatin|cisplatin|mesh-list
5491365|NCT02855944|Carboplatin|carboplatin|mesh-list
5491366|NCT02855944|Rucaparib|rucaparib|mesh-list
5491367|NCT02855944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5491368|NCT02855944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5491369|NCT02855944|Tubulin Modulators|tubulin modulators|mesh-ancestor
5491370|NCT02855944|Antimitotic Agents|antimitotic agents|mesh-ancestor
5491371|NCT02855944|Mitosis Modulators|mitosis modulators|mesh-ancestor
5491372|NCT02855944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491373|NCT02855944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5491374|NCT02855944|Antimetabolites|antimetabolites|mesh-ancestor
5491375|NCT02855944|Antiviral Agents|antiviral agents|mesh-ancestor
5491376|NCT02855944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6024678|NCT00422084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6024679|NCT00422084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6024680|NCT00422084|Antiviral Agents|antiviral agents|mesh-ancestor
6024681|NCT00422084|Schistosomicides|schistosomicides|mesh-ancestor
6024682|NCT00422084|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6024683|NCT00422084|Anthelmintics|anthelmintics|mesh-ancestor
5491377|NCT02855944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5491378|NCT02855944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5491379|NCT02855944|Immunologic Factors|immunologic factors|mesh-ancestor
5491380|NCT02855944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5491381|NCT02855944|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5491382|NCT02823847|Carbon Monoxide|carbon monoxide|mesh-list
5491383|NCT02823847|Antimetabolites|antimetabolites|mesh-ancestor
5491384|NCT02823847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491385|NCT02823847|Gasotransmitters|gasotransmitters|mesh-ancestor
5491386|NCT02823847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5491387|NCT02823847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5491388|NCT02817789|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
5491389|NCT02817789|Clopidogrel|clopidogrel|mesh-list
5491390|NCT02817789|Ticagrelor|ticagrelor|mesh-list
5491391|NCT02817789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5491392|NCT02817789|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5491393|NCT02817789|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5491394|NCT02817789|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5491395|NCT02817789|Purinergic Agents|purinergic agents|mesh-ancestor
5491396|NCT02817789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5491397|NCT02817789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491398|NCT02817789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5491399|NCT02817789|Analgesics|analgesics|mesh-ancestor
5491400|NCT02817789|Sensory System Agents|sensory system agents|mesh-ancestor
5491401|NCT02817789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5491402|NCT02817789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5491403|NCT02817789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6024684|NCT00422097|Epothilones|epothilones|mesh-list
6024685|NCT00422097|Famotidine|famotidine|mesh-list
6024686|NCT00422097|Tubulin Modulators|tubulin modulators|mesh-ancestor
6024687|NCT00422097|Antimitotic Agents|antimitotic agents|mesh-ancestor
6024688|NCT00422097|Mitosis Modulators|mitosis modulators|mesh-ancestor
6024689|NCT00422097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6024690|NCT00422097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6024691|NCT00422097|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6024692|NCT00422097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6024693|NCT00422097|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6024694|NCT00422097|Histamine Antagonists|histamine antagonists|mesh-ancestor
6024695|NCT00422097|Histamine Agents|histamine agents|mesh-ancestor
6024696|NCT00422097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6455966|NCT00430794|Hormone Antagonists|hormone antagonists|mesh-ancestor
6024697|NCT00422097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024698|NCT00422162|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6024699|NCT00422162|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6024700|NCT00422162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6024701|NCT00422162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6024702|NCT00422162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6024703|NCT00422162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6024704|NCT00422162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024705|NCT00422162|Analgesics|analgesics|mesh-ancestor
6024706|NCT00422162|Sensory System Agents|sensory system agents|mesh-ancestor
6024707|NCT00422162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6024708|NCT00422162|Antidepressive Agents|antidepressive agents|mesh-ancestor
6024709|NCT00422162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6024710|NCT00422162|Dopamine Agents|dopamine agents|mesh-ancestor
6024711|NCT00422201|Mifepristone|mifepristone|mesh-list
6024712|NCT00422201|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6024713|NCT00422201|Abortifacient Agents|abortifacient agents|mesh-ancestor
6024714|NCT00422201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6024715|NCT00422201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024716|NCT00422201|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6024717|NCT00422201|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6024718|NCT00422201|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6024719|NCT00422201|Contraceptive Agents|contraceptive agents|mesh-ancestor
6024720|NCT00422201|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6024721|NCT00422201|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6024722|NCT00422201|Hormone Antagonists|hormone antagonists|mesh-ancestor
5491404|NCT02817789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5491405|NCT02817789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5491406|NCT02817789|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5491407|NCT02817789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5491408|NCT02813200|Tiotropium Bromide|tiotropium bromide|mesh-list
5491409|NCT02813200|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
5491410|NCT02813200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5491411|NCT02813200|Autonomic Agents|autonomic agents|mesh-ancestor
5491412|NCT02813200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5491413|NCT02813200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5491414|NCT02813200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6024723|NCT00422201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6024724|NCT00422201|Luteolytic Agents|luteolytic agents|mesh-ancestor
6024725|NCT00422201|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6024726|NCT00422201|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6024727|NCT00422227|Hydroxychloroquine|hydroxychloroquine|mesh-list
6024728|NCT00422227|Sulfasalazine|sulfasalazine|mesh-list
6024729|NCT00422227|Etanercept|etanercept|mesh-list
6024730|NCT00422227|Methotrexate|methotrexate|mesh-list
6024731|NCT00422227|Leflunomide|leflunomide|mesh-list
6024732|NCT00422227|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6024733|NCT00422227|Abortifacient Agents|abortifacient agents|mesh-ancestor
6024734|NCT00422227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6024735|NCT00422227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024736|NCT00422227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6024737|NCT00422227|Antimetabolites|antimetabolites|mesh-ancestor
6024738|NCT00422227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6024739|NCT00422227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6024740|NCT00422227|Dermatologic Agents|dermatologic agents|mesh-ancestor
6024741|NCT00422227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6024742|NCT00422227|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6024743|NCT00422227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6024744|NCT00422227|Immunologic Factors|immunologic factors|mesh-ancestor
6024745|NCT00422227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6024746|NCT00422227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6024747|NCT00422227|Antimalarials|antimalarials|mesh-ancestor
6024748|NCT00422227|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6024749|NCT00422227|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6024750|NCT00422227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6024751|NCT00422227|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6024752|NCT00422227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6024753|NCT00422227|Analgesics|analgesics|mesh-ancestor
6024754|NCT00422227|Sensory System Agents|sensory system agents|mesh-ancestor
6024755|NCT00422227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6024756|NCT00422227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6024757|NCT00422227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5491415|NCT02813200|Respiratory System Agents|respiratory system agents|mesh-ancestor
6024758|NCT00422292|Vaccines|vaccines|mesh-list
6024759|NCT00422292|Immunologic Factors|immunologic factors|mesh-ancestor
6024760|NCT00422292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024761|NCT00422383|Rituximab|rituximab|mesh-list
6024762|NCT00422383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6024763|NCT00422383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6024764|NCT00422383|Immunologic Factors|immunologic factors|mesh-ancestor
6024765|NCT00422383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024766|NCT00422383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6024767|NCT00422422|Brivaracetam|brivaracetam|mesh-list
6024768|NCT00422422|Anticonvulsants|anticonvulsants|mesh-ancestor
6024769|NCT00422513|Epoetin Alfa|epoetin alfa|mesh-list
6024770|NCT00422513|Hematinics|hematinics|mesh-ancestor
6024771|NCT00422591|Cytarabine|cytarabine|mesh-list
6024772|NCT00422591|Idarubicin|idarubicin|mesh-list
6024773|NCT00422591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6024774|NCT00422591|Antimetabolites|antimetabolites|mesh-ancestor
6024775|NCT00422591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6024776|NCT00422591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6024777|NCT00422591|Antiviral Agents|antiviral agents|mesh-ancestor
6024778|NCT00422591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6024779|NCT00422591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6024780|NCT00422591|Immunologic Factors|immunologic factors|mesh-ancestor
6024781|NCT00422591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024782|NCT00422591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6024783|NCT00422591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6024784|NCT00422591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6024785|NCT00422591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6024786|NCT00422734|Tadalafil|tadalafil|mesh-list
6024787|NCT00422734|Vasodilator Agents|vasodilator agents|mesh-ancestor
6024788|NCT00422734|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6024789|NCT00422734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6024790|NCT00422734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6024791|NCT00422734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6024792|NCT00422734|Urological Agents|urological agents|mesh-ancestor
6024793|NCT00422799|Rituximab|rituximab|mesh-list
6024794|NCT00422799|Bortezomib|bortezomib|mesh-list
6024795|NCT00422799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6024796|NCT00422799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6024797|NCT00422799|Immunologic Factors|immunologic factors|mesh-ancestor
6024798|NCT00422799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5491416|NCT02813200|Parasympatholytics|parasympatholytics|mesh-ancestor
5491417|NCT02813200|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5491418|NCT02813200|Cholinergic Agents|cholinergic agents|mesh-ancestor
5491419|NCT02813200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5491420|NCT02813200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491421|NCT02813200|Glucocorticoids|glucocorticoids|mesh-ancestor
5491422|NCT02813200|Hormones|hormones|mesh-ancestor
5491423|NCT02813200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5491424|NCT02813200|Sympathomimetics|sympathomimetics|mesh-ancestor
5491425|NCT02803437|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
5491426|NCT02803437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5491427|NCT02793583|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5491428|NCT02793583|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5491429|NCT02793583|Alkylating Agents|alkylating agents|mesh-ancestor
5491430|NCT02793583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491431|NCT02793583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5491432|NCT02744742|Cyclophosphamide|cyclophosphamide|mesh-list
5491433|NCT02744742|Busulfan|busulfan|mesh-list
5491434|NCT02744742|Decitabine|decitabine|mesh-list
5491435|NCT02744742|Sargramostim|sargramostim|mesh-list
5491436|NCT02744742|Lenograstim|lenograstim|mesh-list
5491437|NCT02744742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5491438|NCT02744742|Immunologic Factors|immunologic factors|mesh-ancestor
5491439|NCT02744742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5491440|NCT02744742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5491441|NCT02744742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5491442|NCT02744742|Alkylating Agents|alkylating agents|mesh-ancestor
5491443|NCT02744742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491444|NCT02744742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5491445|NCT02744742|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5491446|NCT02744742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5491447|NCT02744742|Antimetabolites|antimetabolites|mesh-ancestor
6024799|NCT00422799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6024800|NCT00422903|Letrozole|letrozole|mesh-list
6024801|NCT00422903|Lapatinib|lapatinib|mesh-list
6024802|NCT00422903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6024803|NCT00422903|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6024804|NCT00422903|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6024805|NCT00422903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6024806|NCT00422903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491448|NCT02744742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5491449|NCT02744742|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5491450|NCT02724579|Cyclophosphamide|cyclophosphamide|mesh-list
5491451|NCT02724579|Lomustine|lomustine|mesh-list
5491452|NCT02724579|Cisplatin|cisplatin|mesh-list
5491453|NCT02724579|Vincristine|vincristine|mesh-list
5491454|NCT02724579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5491455|NCT02724579|Immunologic Factors|immunologic factors|mesh-ancestor
5491456|NCT02724579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5491457|NCT02724579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5491458|NCT02724579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6024807|NCT00422903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6024808|NCT00422903|Hormone Antagonists|hormone antagonists|mesh-ancestor
6024809|NCT00422903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6024810|NCT00422903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024811|NCT00422903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6024812|NCT00423085|Rivastigmine|rivastigmine|mesh-list
6024813|NCT00423085|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6024814|NCT00423085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6024815|NCT00423085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6024816|NCT00423085|Cholinergic Agents|cholinergic agents|mesh-ancestor
6024817|NCT00423085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6024818|NCT00423085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024819|NCT00423085|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6024820|NCT00423085|Protective Agents|protective agents|mesh-ancestor
6024821|NCT00423098|Mycophenolic Acid|mycophenolic acid|mesh-list
6024822|NCT00423098|Prednisone|prednisone|mesh-list
6024823|NCT00423098|Methylprednisolone|methylprednisolone|mesh-list
6024824|NCT00423098|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6024825|NCT00423098|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6024826|NCT00423098|Prednisolone|prednisolone|mesh-list
6024827|NCT00423098|Prednisolone acetate|prednisolone acetate|mesh-list
6024828|NCT00423098|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6024829|NCT00423098|Prednisolone phosphate|prednisolone phosphate|mesh-list
6024830|NCT00423098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6024831|NCT00423098|Glucocorticoids|glucocorticoids|mesh-ancestor
6024832|NCT00423098|Hormones|hormones|mesh-ancestor
6024833|NCT00423098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6024834|NCT00423098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024835|NCT00423098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6024836|NCT00423098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6024837|NCT00423098|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6024838|NCT00423098|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6024839|NCT00423098|Antitubercular Agents|antitubercular agents|mesh-ancestor
6024840|NCT00423098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6024841|NCT00423098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6024842|NCT00423098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6024843|NCT00423098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6024844|NCT00423098|Antiemetics|antiemetics|mesh-ancestor
6024845|NCT00423098|Autonomic Agents|autonomic agents|mesh-ancestor
6024846|NCT00423098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6024847|NCT00423098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6024848|NCT00423098|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6024849|NCT00423098|Protective Agents|protective agents|mesh-ancestor
6024850|NCT00423150|Temozolomide|temozolomide|mesh-list
6024851|NCT00423150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6024852|NCT00423150|Alkylating Agents|alkylating agents|mesh-ancestor
6024853|NCT00423150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6024854|NCT00423150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6024855|NCT00423189|Ranibizumab|ranibizumab|mesh-list
6024856|NCT00423189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6024857|NCT00423189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6024858|NCT00423189|Growth Substances|growth substances|mesh-ancestor
6024859|NCT00423189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024860|NCT00423189|Growth Inhibitors|growth inhibitors|mesh-ancestor
6024861|NCT00423189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6024862|NCT00423267|Fluconazole|fluconazole|mesh-list
6024863|NCT00423267|Posaconazole|posaconazole|mesh-list
6024864|NCT00423267|Antifungal Agents|antifungal agents|mesh-ancestor
6024865|NCT00423267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5491459|NCT02724579|Alkylating Agents|alkylating agents|mesh-ancestor
6024866|NCT00423267|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6024867|NCT00423267|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6024868|NCT00423267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6024869|NCT00423267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6024870|NCT00423267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6024871|NCT00423267|Hormone Antagonists|hormone antagonists|mesh-ancestor
6024872|NCT00423267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6024873|NCT00423267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024874|NCT00423267|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6024875|NCT00423267|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6024876|NCT00423267|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6024877|NCT00423267|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6024878|NCT00423267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6024879|NCT00423293|Fluorouracil|fluorouracil|mesh-list
6024880|NCT00423293|Mitomycins|mitomycins|mesh-list
6024881|NCT00423293|Mitomycin|mitomycin|mesh-list
6024882|NCT00423293|Antimetabolites|antimetabolites|mesh-ancestor
6024883|NCT00423293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6024884|NCT00423293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6024885|NCT00423293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6024886|NCT00423293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6024887|NCT00423293|Immunologic Factors|immunologic factors|mesh-ancestor
6024888|NCT00423293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024889|NCT00423293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6024890|NCT00423293|Alkylating Agents|alkylating agents|mesh-ancestor
6024891|NCT00423293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6024892|NCT00423293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6024893|NCT00423319|Enoxaparin|enoxaparin|mesh-list
5491460|NCT02724579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491461|NCT02724579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5491462|NCT02724579|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5491463|NCT02724579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5491464|NCT02724579|Tubulin Modulators|tubulin modulators|mesh-ancestor
6024894|NCT00423319|Enoxaparin sodium|enoxaparin sodium|mesh-list
6024895|NCT00423319|Apixaban|apixaban|mesh-list
6024896|NCT00423319|Anticoagulants|anticoagulants|mesh-ancestor
6024897|NCT00423319|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6024898|NCT00423319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6024899|NCT00423319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6024900|NCT00423319|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6024901|NCT00423319|Antithrombins|antithrombins|mesh-ancestor
6024902|NCT00423319|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6024903|NCT00423319|Protease Inhibitors|protease inhibitors|mesh-ancestor
6024904|NCT00423319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6024905|NCT00423332|Cediranib|cediranib|mesh-list
6024906|NCT00423332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6024907|NCT00423332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6024908|NCT00423332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6024909|NCT00423332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6024910|NCT00423358|Vitamin D|vitamin d|mesh-list
6024911|NCT00423358|Ergocalciferols|ergocalciferols|mesh-list
6024912|NCT00423358|Vitamins|vitamins|mesh-ancestor
6024913|NCT00423358|Micronutrients|micronutrients|mesh-ancestor
6024914|NCT00423358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024915|NCT00423358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6024916|NCT00423358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6024917|NCT00423449|Gemcitabine|gemcitabine|mesh-list
6024918|NCT00423449|Vorinostat|vorinostat|mesh-list
6024919|NCT00423449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6024920|NCT00423449|Antimetabolites|antimetabolites|mesh-ancestor
6024921|NCT00423449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6024922|NCT00423449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6024923|NCT00423449|Antiviral Agents|antiviral agents|mesh-ancestor
6024924|NCT00423449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5491465|NCT02724579|Antimitotic Agents|antimitotic agents|mesh-ancestor
5491466|NCT02724579|Mitosis Modulators|mitosis modulators|mesh-ancestor
5491467|NCT02720068|Leucovorin|leucovorin|mesh-list
6455967|NCT00430794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6455968|NCT00430794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455969|NCT00430794|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6455970|NCT00430794|Diuretics|diuretics|mesh-ancestor
6455971|NCT00430794|Natriuretic Agents|natriuretic agents|mesh-ancestor
6455972|NCT00430807|Hydroxychloroquine|hydroxychloroquine|mesh-list
6455973|NCT00430807|Antimalarials|antimalarials|mesh-ancestor
6455974|NCT00430807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6024925|NCT00423449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6024926|NCT00423449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6024927|NCT00423449|Immunologic Factors|immunologic factors|mesh-ancestor
6024928|NCT00423449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024929|NCT00423449|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6024930|NCT00423592|Ambrisentan|ambrisentan|mesh-list
6024931|NCT00423592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6024932|NCT00423657|Vancomycin|vancomycin|mesh-list
6024933|NCT00423657|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
6024934|NCT00423657|Aztreonam|aztreonam|mesh-list
6024935|NCT00423657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6024936|NCT00423657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6024937|NCT00423670|Ribavirin|ribavirin|mesh-list
6024938|NCT00423670|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6024939|NCT00423670|Antimetabolites|antimetabolites|mesh-ancestor
6024940|NCT00423670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6024941|NCT00423670|Antiviral Agents|antiviral agents|mesh-ancestor
6024942|NCT00423670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6024943|NCT00423683|PENTA|penta|mesh-list
6024944|NCT00423683|Fondaparinux|fondaparinux|mesh-list
6024945|NCT00423683|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6024946|NCT00423683|Antithrombins|antithrombins|mesh-ancestor
6024947|NCT00423683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6024948|NCT00423683|Protease Inhibitors|protease inhibitors|mesh-ancestor
6024949|NCT00423683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6024950|NCT00423683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6024951|NCT00423683|Anticoagulants|anticoagulants|mesh-ancestor
6024952|NCT00423683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6024953|NCT00423683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6024954|NCT00423735|Dasatinib|dasatinib|mesh-list
6024955|NCT00423735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6024956|NCT00423735|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6024957|NCT00423735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6024958|NCT00423735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6024959|NCT00423800|Interferons|interferons|mesh-list
6024960|NCT00423800|Ribavirin|ribavirin|mesh-list
6024961|NCT00423800|Interferon-alpha|interferon-alpha|mesh-list
6024962|NCT00423800|Interferon alpha-2|interferon alpha-2|mesh-list
6024963|NCT00423800|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6024964|NCT00423800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6024965|NCT00423800|Antiviral Agents|antiviral agents|mesh-ancestor
6024966|NCT00423800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6024967|NCT00423800|Antimetabolites|antimetabolites|mesh-ancestor
6024968|NCT00423800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6024969|NCT00423800|Immunologic Factors|immunologic factors|mesh-ancestor
6024970|NCT00423800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024971|NCT00423852|Paclitaxel|paclitaxel|mesh-list
6024972|NCT00423852|Carboplatin|carboplatin|mesh-list
6024973|NCT00423852|Ifosfamide|ifosfamide|mesh-list
6024974|NCT00423852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6024975|NCT00423852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6024976|NCT00423852|Tubulin Modulators|tubulin modulators|mesh-ancestor
6024977|NCT00423852|Antimitotic Agents|antimitotic agents|mesh-ancestor
6024978|NCT00423852|Mitosis Modulators|mitosis modulators|mesh-ancestor
6024979|NCT00423852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6024980|NCT00423852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6024981|NCT00423852|Alkylating Agents|alkylating agents|mesh-ancestor
6024982|NCT00423878|Olanzapine|olanzapine|mesh-list
6024983|NCT00423878|Risperidone|risperidone|mesh-list
6024984|NCT00423878|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6455975|NCT00430807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5491468|NCT02720068|Fluorouracil|fluorouracil|mesh-list
5491469|NCT02720068|Pembrolizumab|pembrolizumab|mesh-list
6024985|NCT00423878|Aripiprazole|aripiprazole|mesh-list
6024986|NCT00423878|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6024987|NCT00423878|Serotonin Agents|serotonin agents|mesh-ancestor
6024988|NCT00423878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6024989|NCT00423878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6024990|NCT00423878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6024991|NCT00423878|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6024992|NCT00423878|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6024993|NCT00423878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6024994|NCT00423878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6455976|NCT00430807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6455977|NCT00430807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6024995|NCT00423878|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6455978|NCT00430807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455979|NCT00430807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6455980|NCT00430833|Candesartan|candesartan|mesh-list
6024996|NCT00423878|Dopamine Agents|dopamine agents|mesh-ancestor
6024997|NCT00423878|Antiemetics|antiemetics|mesh-ancestor
6024998|NCT00423878|Autonomic Agents|autonomic agents|mesh-ancestor
6024999|NCT00423878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6025000|NCT00423878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6025001|NCT00423878|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6025002|NCT00423878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6025003|NCT00423878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6025004|NCT00423878|Antidepressive Agents|antidepressive agents|mesh-ancestor
5491470|NCT02720068|Oxaliplatin|oxaliplatin|mesh-list
5491471|NCT02720068|Irinotecan|irinotecan|mesh-list
5491472|NCT02720068|Lenvatinib|lenvatinib|mesh-list
5491473|NCT02720068|Calcium|calcium|mesh-list
5491474|NCT02720068|Levoleucovorin|levoleucovorin|mesh-list
5491475|NCT02720068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5491476|NCT02720068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5491477|NCT02720068|Antimetabolites|antimetabolites|mesh-ancestor
5491478|NCT02720068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491479|NCT02720068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5491480|NCT02720068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5491481|NCT02720068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5491482|NCT02720068|Immunologic Factors|immunologic factors|mesh-ancestor
5491483|NCT02720068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5491484|NCT02720068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5491485|NCT02720068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5491486|NCT02720068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5491487|NCT02720068|Antidotes|antidotes|mesh-ancestor
5491488|NCT02720068|Protective Agents|protective agents|mesh-ancestor
5491489|NCT02720068|Vitamin B Complex|vitamin b complex|mesh-ancestor
6025005|NCT00423878|Dopamine Agonists|dopamine agonists|mesh-ancestor
6025006|NCT00423878|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6025007|NCT00423878|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6025008|NCT00423878|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6025009|NCT00423878|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6025010|NCT00423891|Entecavir|entecavir|mesh-list
6025011|NCT00423891|Antiviral Agents|antiviral agents|mesh-ancestor
6025012|NCT00423891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6053338|NCT00594646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6053339|NCT00594646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6053340|NCT00594646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053341|NCT00594646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6053342|NCT00594646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6053343|NCT00594646|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6053344|NCT00594646|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6053345|NCT00594815|Leucovorin|leucovorin|mesh-list
6053346|NCT00594815|Cytarabine|cytarabine|mesh-list
6053347|NCT00594815|Rituximab|rituximab|mesh-list
6053348|NCT00594815|Methotrexate|methotrexate|mesh-list
6053349|NCT00594815|Vincristine|vincristine|mesh-list
6455981|NCT00430833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6455982|NCT00430833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6455983|NCT00430833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5491490|NCT02720068|Vitamins|vitamins|mesh-ancestor
5491491|NCT02720068|Micronutrients|micronutrients|mesh-ancestor
5491492|NCT02720068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5491493|NCT02717455|Panobinostat|panobinostat|mesh-list
5491494|NCT02717455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5491495|NCT02717455|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5491496|NCT02717455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5491497|NCT02717455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491498|NCT02687386|Mitoxantrone|mitoxantrone|mesh-list
5491499|NCT02687386|Analgesics|analgesics|mesh-ancestor
6654638|NCT01458223|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5491500|NCT02687386|Sensory System Agents|sensory system agents|mesh-ancestor
5491501|NCT02687386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6053350|NCT00594815|Procarbazine|procarbazine|mesh-list
6455984|NCT00430833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6455985|NCT00430846|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6455986|NCT00430846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6455987|NCT00430846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6455988|NCT00430885|Immunoglobulins|immunoglobulins|mesh-list
6455989|NCT00430885|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6455990|NCT00430885|gamma-Globulins|gamma-globulins|mesh-list
6455991|NCT00430885|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6455992|NCT00430885|Immunologic Factors|immunologic factors|mesh-ancestor
6455993|NCT00430885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455994|NCT00430898|Basiliximab|basiliximab|mesh-list
6455995|NCT00430898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6455996|NCT00430898|Immunologic Factors|immunologic factors|mesh-ancestor
6455997|NCT00430898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6455998|NCT00430924|Eplerenone|eplerenone|mesh-list
6455999|NCT00430924|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6456000|NCT00430924|Hormone Antagonists|hormone antagonists|mesh-ancestor
6456001|NCT00430924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6456002|NCT00430924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456003|NCT00430924|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6456004|NCT00430924|Diuretics|diuretics|mesh-ancestor
6456005|NCT00430924|Natriuretic Agents|natriuretic agents|mesh-ancestor
6456006|NCT00430924|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6025013|NCT00423917|Bevacizumab|bevacizumab|mesh-list
6456007|NCT00430963|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
6025014|NCT00423917|Fulvestrant|fulvestrant|mesh-list
6025015|NCT00423917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6025016|NCT00423917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6025017|NCT00423917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6025018|NCT00423917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6025019|NCT00423917|Growth Substances|growth substances|mesh-ancestor
6025020|NCT00423917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025021|NCT00423917|Growth Inhibitors|growth inhibitors|mesh-ancestor
6025022|NCT00423917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6025023|NCT00423917|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6025024|NCT00423917|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6025025|NCT00423917|Hormone Antagonists|hormone antagonists|mesh-ancestor
6025026|NCT00423917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6025027|NCT00423930|Bevacizumab|bevacizumab|mesh-list
6025028|NCT00423930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6025029|NCT00423930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6025030|NCT00423930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6025031|NCT00423930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6025032|NCT00423930|Growth Substances|growth substances|mesh-ancestor
6025033|NCT00423930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025034|NCT00423930|Growth Inhibitors|growth inhibitors|mesh-ancestor
6025035|NCT00423943|Modafinil|modafinil|mesh-list
6025036|NCT00423943|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6025037|NCT00423943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025038|NCT00423943|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6025039|NCT00423943|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6025040|NCT00423943|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6025041|NCT00423943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025042|NCT00424021|Ambrisentan|ambrisentan|mesh-list
6025043|NCT00424021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6025044|NCT00424047|Dexamethasone|dexamethasone|mesh-list
6025045|NCT00424047|Dexamethasone acetate|dexamethasone acetate|mesh-list
6025046|NCT00424047|Lenalidomide|lenalidomide|mesh-list
6025047|NCT00424047|BB 1101|bb 1101|mesh-list
6025048|NCT00424047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6025049|NCT00424047|Antiemetics|antiemetics|mesh-ancestor
6025050|NCT00424047|Autonomic Agents|autonomic agents|mesh-ancestor
6025051|NCT00424047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6025052|NCT00424047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025053|NCT00424047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5491502|NCT02687386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5491503|NCT02687386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5491504|NCT02687386|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5491505|NCT02687386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5491506|NCT02687386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5491507|NCT02687386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491508|NCT02678143|Mycophenolic Acid|mycophenolic acid|mesh-list
5491509|NCT02678143|Sirolimus|sirolimus|mesh-list
5491510|NCT02678143|Cyclophosphamide|cyclophosphamide|mesh-list
5491511|NCT02678143|Fludarabine|fludarabine|mesh-list
5491512|NCT02678143|Alemtuzumab|alemtuzumab|mesh-list
5491513|NCT02678143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5491514|NCT02678143|Immunologic Factors|immunologic factors|mesh-ancestor
5491515|NCT02678143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5491516|NCT02678143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5491517|NCT02678143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5491518|NCT02678143|Alkylating Agents|alkylating agents|mesh-ancestor
5491519|NCT02678143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491520|NCT02678143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5491521|NCT02678143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5491522|NCT02678143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5491523|NCT02678143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5491524|NCT02678143|Antitubercular Agents|antitubercular agents|mesh-ancestor
5491525|NCT02678143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5491526|NCT02678143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5491527|NCT02678143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5491528|NCT02678143|Antifungal Agents|antifungal agents|mesh-ancestor
5491529|NCT02678143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5491530|NCT02660411|Propofol|propofol|mesh-list
5491531|NCT02660411|Sevoflurane|sevoflurane|mesh-list
5491532|NCT02660411|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5491533|NCT02660411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5491534|NCT02660411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5491535|NCT02660411|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5491536|NCT02660411|Anesthetics, General|anesthetics, general|mesh-ancestor
5491537|NCT02660411|Anesthetics|anesthetics|mesh-ancestor
5491538|NCT02660411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5491539|NCT02660411|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5491540|NCT02628405|Rituximab|rituximab|mesh-list
5491541|NCT02628405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5491542|NCT02628405|Carboplatin|carboplatin|mesh-list
5491543|NCT02628405|Etoposide|etoposide|mesh-list
5491544|NCT02628405|Lenalidomide|lenalidomide|mesh-list
5491545|NCT02628405|Etoposide phosphate|etoposide phosphate|mesh-list
5491546|NCT02628405|Ifosfamide|ifosfamide|mesh-list
5491547|NCT02628405|Isophosphamide mustard|isophosphamide mustard|mesh-list
5491548|NCT02628405|Podophyllotoxin|podophyllotoxin|mesh-list
5491549|NCT02628405|Antibodies|antibodies|mesh-list
5491550|NCT02628405|Immunoglobulins|immunoglobulins|mesh-list
5491551|NCT02628405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5491552|NCT02628405|Immunologic Factors|immunologic factors|mesh-ancestor
5491553|NCT02628405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5491554|NCT02628405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5491555|NCT02628405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5491556|NCT02628405|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5491557|NCT02628405|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5491558|NCT02628405|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5491559|NCT02628405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5491560|NCT02628405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491561|NCT02628405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5491562|NCT02628405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5491563|NCT02628405|Growth Substances|growth substances|mesh-ancestor
5491564|NCT02628405|Growth Inhibitors|growth inhibitors|mesh-ancestor
5491565|NCT02628405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5491566|NCT02628405|Alkylating Agents|alkylating agents|mesh-ancestor
5491567|NCT02628405|Keratolytic Agents|keratolytic agents|mesh-ancestor
5491568|NCT02628405|Dermatologic Agents|dermatologic agents|mesh-ancestor
5491569|NCT02628405|Tubulin Modulators|tubulin modulators|mesh-ancestor
5491570|NCT02628405|Antimitotic Agents|antimitotic agents|mesh-ancestor
5491571|NCT02628405|Mitosis Modulators|mitosis modulators|mesh-ancestor
5491572|NCT02612311|Obinutuzumab|obinutuzumab|mesh-list
5491573|NCT02612311|Chlorambucil|chlorambucil|mesh-list
6025054|NCT00424047|Glucocorticoids|glucocorticoids|mesh-ancestor
5491574|NCT02612311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5491575|NCT02612311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5491576|NCT02612311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5491577|NCT02612311|Alkylating Agents|alkylating agents|mesh-ancestor
6025055|NCT00424047|Hormones|hormones|mesh-ancestor
6025056|NCT00424047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6025057|NCT00424047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6025058|NCT00424047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6025059|NCT00424047|Protease Inhibitors|protease inhibitors|mesh-ancestor
6025060|NCT00424047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6025061|NCT00424047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025062|NCT00424047|Immunologic Factors|immunologic factors|mesh-ancestor
6025063|NCT00424047|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6025064|NCT00424047|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6025065|NCT00424047|Growth Substances|growth substances|mesh-ancestor
6025066|NCT00424047|Growth Inhibitors|growth inhibitors|mesh-ancestor
6025067|NCT00424190|Vancomycin|vancomycin|mesh-list
6025068|NCT00424190|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
6025069|NCT00424190|Aztreonam|aztreonam|mesh-list
6025070|NCT00424190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6025071|NCT00424190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6025072|NCT00424255|Lapatinib|lapatinib|mesh-list
6025073|NCT00424255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6025074|NCT00424255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6025075|NCT00424255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5491578|NCT02612311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503004|NCT04462796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5503005|NCT04462588|Metronidazole|metronidazole|mesh-list
5503006|NCT04462588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5503007|NCT04462588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5503008|NCT04462588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6025076|NCT00424255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025077|NCT00424294|Celecoxib|celecoxib|mesh-list
6025078|NCT00424294|Methotrexate|methotrexate|mesh-list
5503009|NCT04462588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5503010|NCT04462614|Heparin|heparin|mesh-list
5503011|NCT04462614|Anticoagulants|anticoagulants|mesh-ancestor
5503012|NCT04462614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5503013|NCT04462614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6025079|NCT00424294|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6025080|NCT00424294|Abortifacient Agents|abortifacient agents|mesh-ancestor
6025081|NCT00424294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6025082|NCT00424294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025083|NCT00424294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6025084|NCT00424294|Antimetabolites|antimetabolites|mesh-ancestor
6025085|NCT00424294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025086|NCT00424294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6025087|NCT00424294|Dermatologic Agents|dermatologic agents|mesh-ancestor
6025088|NCT00424294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6025089|NCT00424294|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6025090|NCT00424294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6025091|NCT00424294|Immunologic Factors|immunologic factors|mesh-ancestor
6025092|NCT00424294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6025093|NCT00424294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6025094|NCT00424294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6025095|NCT00424294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6025096|NCT00424294|Analgesics|analgesics|mesh-ancestor
6025097|NCT00424294|Sensory System Agents|sensory system agents|mesh-ancestor
6025098|NCT00424294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5503014|NCT04462614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503015|NCT04462822|Fluticasone|fluticasone|mesh-list
5503016|NCT04462822|Xhance|xhance|mesh-list
5503017|NCT04462822|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5503018|NCT04462822|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
5503019|NCT04462822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5503020|NCT04462822|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5503021|NCT04462822|Autonomic Agents|autonomic agents|mesh-ancestor
5503022|NCT04462822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5503023|NCT04462822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503024|NCT04462822|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5503025|NCT04462822|Respiratory System Agents|respiratory system agents|mesh-ancestor
6025099|NCT00424294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6025100|NCT00424294|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6025101|NCT00424294|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6025102|NCT00424372|Pregabalin|pregabalin|mesh-list
6025103|NCT00424372|Analgesics|analgesics|mesh-ancestor
6025104|NCT00424372|Sensory System Agents|sensory system agents|mesh-ancestor
5503026|NCT04462822|Dermatologic Agents|dermatologic agents|mesh-ancestor
6025105|NCT00424372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6025106|NCT00424372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025107|NCT00424372|Anticonvulsants|anticonvulsants|mesh-ancestor
6025108|NCT00424372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6025109|NCT00424372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6025110|NCT00424372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025111|NCT00424372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6025112|NCT00424372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6025113|NCT00424372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6025114|NCT00424372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6025115|NCT00424372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6025116|NCT00424385|Sorafenib|sorafenib|mesh-list
6025117|NCT00424385|Imatinib Mesylate|imatinib mesylate|mesh-list
6025118|NCT00424385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6025119|NCT00424385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6025120|NCT00424385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6025121|NCT00424385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025122|NCT00424398|Bepotastine besilate|bepotastine besilate|mesh-list
6025123|NCT00424398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6025124|NCT00424463|Edaravone|edaravone|mesh-list
6025125|NCT00424463|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6025126|NCT00424463|Antioxidants|antioxidants|mesh-ancestor
5491579|NCT02575404|Pembrolizumab|pembrolizumab|mesh-list
5491580|NCT02575404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5491581|NCT02575404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5491582|NCT02523040|Lenalidomide|lenalidomide|mesh-list
5491583|NCT02523040|Immunologic Factors|immunologic factors|mesh-ancestor
5491584|NCT02523040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5491585|NCT02523040|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5491586|NCT02523040|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5491587|NCT02523040|Growth Substances|growth substances|mesh-ancestor
5491588|NCT02523040|Growth Inhibitors|growth inhibitors|mesh-ancestor
5491589|NCT02523040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5491590|NCT02521493|Cytarabine|cytarabine|mesh-list
5491591|NCT02521493|Etoposide|etoposide|mesh-list
5491592|NCT02521493|Podophyllotoxin|podophyllotoxin|mesh-list
5491593|NCT02521493|Daunorubicin|daunorubicin|mesh-list
5491594|NCT02521493|Mitoxantrone|mitoxantrone|mesh-list
5491595|NCT02521493|Etoposide phosphate|etoposide phosphate|mesh-list
5491596|NCT02521493|Asparaginase|asparaginase|mesh-list
5491597|NCT02521493|Mercaptopurine|mercaptopurine|mesh-list
5491598|NCT02521493|Thioguanine|thioguanine|mesh-list
5491599|NCT02521493|2-Aminopurine|2-aminopurine|mesh-list
5491600|NCT02521493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5491601|NCT02521493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5491602|NCT02521493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5491603|NCT02521493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5491604|NCT02521493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5491605|NCT02521493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491606|NCT02521493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5491607|NCT02521493|Antimetabolites|antimetabolites|mesh-ancestor
5491608|NCT02521493|Antiviral Agents|antiviral agents|mesh-ancestor
5491609|NCT02521493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5491610|NCT02521493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5491611|NCT02521493|Immunologic Factors|immunologic factors|mesh-ancestor
5491612|NCT02521493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5491613|NCT02521493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5491614|NCT02521493|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5491615|NCT02521493|Analgesics|analgesics|mesh-ancestor
5491616|NCT02521493|Sensory System Agents|sensory system agents|mesh-ancestor
6025127|NCT00424463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025128|NCT00424463|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6025129|NCT00424463|Protective Agents|protective agents|mesh-ancestor
6025130|NCT00424463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025131|NCT00424476|Belimumab|belimumab|mesh-list
6025132|NCT00424476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6025133|NCT00424476|Immunologic Factors|immunologic factors|mesh-ancestor
6025134|NCT00424476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025135|NCT00424489|Methylprednisolone|methylprednisolone|mesh-list
6025136|NCT00424489|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6025137|NCT00424489|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6025138|NCT00424489|Prednisolone|prednisolone|mesh-list
6025139|NCT00424489|Prednisolone acetate|prednisolone acetate|mesh-list
5491617|NCT02521493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5491618|NCT02521493|Keratolytic Agents|keratolytic agents|mesh-ancestor
6025140|NCT00424489|Cyclophosphamide|cyclophosphamide|mesh-list
5491619|NCT02521493|Dermatologic Agents|dermatologic agents|mesh-ancestor
5491620|NCT02521493|Tubulin Modulators|tubulin modulators|mesh-ancestor
6025141|NCT00424489|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6025142|NCT00424489|Prednisolone phosphate|prednisolone phosphate|mesh-list
6025143|NCT00424489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6025144|NCT00424489|Immunologic Factors|immunologic factors|mesh-ancestor
6025145|NCT00424489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025146|NCT00424489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6025147|NCT00424489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6025148|NCT00424489|Alkylating Agents|alkylating agents|mesh-ancestor
6025149|NCT00424489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025150|NCT00424489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6025151|NCT00424489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6025152|NCT00424489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6025153|NCT00424489|Antiemetics|antiemetics|mesh-ancestor
6025154|NCT00424489|Autonomic Agents|autonomic agents|mesh-ancestor
6025155|NCT00424489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6025156|NCT00424489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6025157|NCT00424489|Glucocorticoids|glucocorticoids|mesh-ancestor
6025158|NCT00424489|Hormones|hormones|mesh-ancestor
6025159|NCT00424489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6025160|NCT00424489|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6025161|NCT00424489|Protective Agents|protective agents|mesh-ancestor
6025162|NCT00424489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6025163|NCT00424502|Rituximab|rituximab|mesh-list
6025164|NCT00424502|Methotrexate|methotrexate|mesh-list
6025165|NCT00424502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6025166|NCT00424502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6025167|NCT00424502|Immunologic Factors|immunologic factors|mesh-ancestor
6025168|NCT00424502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025169|NCT00424502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6025170|NCT00424502|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6025171|NCT00424502|Abortifacient Agents|abortifacient agents|mesh-ancestor
6025172|NCT00424502|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6025173|NCT00424502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6025174|NCT00424502|Antimetabolites|antimetabolites|mesh-ancestor
6025175|NCT00424502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025176|NCT00424502|Dermatologic Agents|dermatologic agents|mesh-ancestor
6025177|NCT00424502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6025178|NCT00424502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6025179|NCT00424502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6025180|NCT00424502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6025181|NCT00424515|Imatinib Mesylate|imatinib mesylate|mesh-list
6025182|NCT00424515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6025183|NCT00424515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6025184|NCT00424515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6025185|NCT00424515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025186|NCT00424528|Tiotropium Bromide|tiotropium bromide|mesh-list
6025187|NCT00424528|Formoterol Fumarate|formoterol fumarate|mesh-list
6025188|NCT00424528|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6025189|NCT00424528|Autonomic Agents|autonomic agents|mesh-ancestor
6025190|NCT00424528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6025191|NCT00424528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025192|NCT00424528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6025193|NCT00424528|Respiratory System Agents|respiratory system agents|mesh-ancestor
6025194|NCT00424528|Parasympatholytics|parasympatholytics|mesh-ancestor
6025195|NCT00424528|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6025196|NCT00424528|Cholinergic Agents|cholinergic agents|mesh-ancestor
6025197|NCT00424528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6025198|NCT00424528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025199|NCT00424528|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6025200|NCT00424528|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6025201|NCT00424528|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5491621|NCT02521493|Antimitotic Agents|antimitotic agents|mesh-ancestor
5491622|NCT02521493|Mitosis Modulators|mitosis modulators|mesh-ancestor
6025202|NCT00424528|Adrenergic Agents|adrenergic agents|mesh-ancestor
6025203|NCT00424554|Temozolomide|temozolomide|mesh-list
6025204|NCT00424554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6025205|NCT00424554|Alkylating Agents|alkylating agents|mesh-ancestor
6025206|NCT00424554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025207|NCT00424554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6025208|NCT00424593|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6025209|NCT00424593|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6025210|NCT00424593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6456008|NCT00430963|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6025211|NCT00424593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6025212|NCT00424593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491623|NCT02520778|Osimertinib|osimertinib|mesh-list
5491624|NCT02520778|Navitoclax|navitoclax|mesh-list
5491625|NCT02520778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5491626|NCT02520778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5491627|NCT02520778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5491628|NCT02520778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025213|NCT00424593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6025214|NCT00424593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025215|NCT00424593|Analgesics|analgesics|mesh-ancestor
6025216|NCT00424593|Sensory System Agents|sensory system agents|mesh-ancestor
6025217|NCT00424593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6025218|NCT00424593|Antidepressive Agents|antidepressive agents|mesh-ancestor
6025219|NCT00424593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6025220|NCT00424593|Dopamine Agents|dopamine agents|mesh-ancestor
6025221|NCT00424619|Vitamin D|vitamin d|mesh-list
6025222|NCT00424619|Ergocalciferols|ergocalciferols|mesh-list
6025223|NCT00424619|Vitamins|vitamins|mesh-list
6025224|NCT00424619|Micronutrients|micronutrients|mesh-ancestor
6025225|NCT00424619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025226|NCT00424619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6025227|NCT00424619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6025228|NCT00424749|Prednisone|prednisone|mesh-list
6025229|NCT00424749|Rituximab|rituximab|mesh-list
6025230|NCT00424749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6025231|NCT00424749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6025232|NCT00424749|Immunologic Factors|immunologic factors|mesh-ancestor
6025233|NCT00424749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025234|NCT00424749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6025235|NCT00424749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6025236|NCT00424749|Glucocorticoids|glucocorticoids|mesh-ancestor
6025237|NCT00424749|Hormones|hormones|mesh-ancestor
6025238|NCT00424749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6025239|NCT00424749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6025240|NCT00424762|Rosiglitazone|rosiglitazone|mesh-list
6025241|NCT00424762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6025242|NCT00424762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025243|NCT00424775|Vorinostat|vorinostat|mesh-list
6025244|NCT00424775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6025245|NCT00424775|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6025246|NCT00424775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6025247|NCT00424775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025248|NCT00424827|Gemcitabine|gemcitabine|mesh-list
6025249|NCT00424827|Fluorouracil|fluorouracil|mesh-list
6025250|NCT00424827|Cetuximab|cetuximab|mesh-list
6025251|NCT00424827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5491629|NCT02485691|Prednisone|prednisone|mesh-list
5491630|NCT02485691|Abiraterone Acetate|abiraterone acetate|mesh-list
5491631|NCT02485691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5491632|NCT02485691|Glucocorticoids|glucocorticoids|mesh-ancestor
5491633|NCT02485691|Hormones|hormones|mesh-ancestor
5491634|NCT02485691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5491635|NCT02485691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5491636|NCT02485691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5491637|NCT02485691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5491638|NCT02485691|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5491639|NCT02485691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5491640|NCT02485691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491641|NCT02485691|Hormone Antagonists|hormone antagonists|mesh-ancestor
5491642|NCT02485691|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5491643|NCT02479646|Lenograstim|lenograstim|mesh-list
5491644|NCT02479646|Sargramostim|sargramostim|mesh-list
5491645|NCT02479646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5491646|NCT02479646|Immunologic Factors|immunologic factors|mesh-ancestor
5491647|NCT02479646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5491648|NCT02472964|Paclitaxel|paclitaxel|mesh-list
5491649|NCT02472964|Docetaxel|docetaxel|mesh-list
5491650|NCT02472964|Trastuzumab|trastuzumab|mesh-list
6025252|NCT00424827|Antimetabolites|antimetabolites|mesh-ancestor
6025253|NCT00424827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025254|NCT00424827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6025255|NCT00424827|Antiviral Agents|antiviral agents|mesh-ancestor
6025256|NCT00424827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6025257|NCT00424827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5491651|NCT02472964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6025258|NCT00424827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6456009|NCT00430963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6456010|NCT00430963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456011|NCT00430963|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5491652|NCT02472964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5491653|NCT02472964|Tubulin Modulators|tubulin modulators|mesh-ancestor
5491654|NCT02472964|Antimitotic Agents|antimitotic agents|mesh-ancestor
5491655|NCT02472964|Mitosis Modulators|mitosis modulators|mesh-ancestor
5491656|NCT02472964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491657|NCT02472964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5491658|NCT02467868|Lenograstim|lenograstim|mesh-list
5491659|NCT02467868|Sargramostim|sargramostim|mesh-list
5491660|NCT02467868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5491661|NCT02467868|Immunologic Factors|immunologic factors|mesh-ancestor
6456012|NCT00430963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6456013|NCT00430963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456014|NCT00430963|Cholinergic Agents|cholinergic agents|mesh-ancestor
6456015|NCT00430963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6456016|NCT00431028|Ciprofloxacin|ciprofloxacin|mesh-list
6456017|NCT00431028|Triamcinolone|triamcinolone|mesh-list
6025259|NCT00424827|Immunologic Factors|immunologic factors|mesh-ancestor
6025260|NCT00424827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025261|NCT00424827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6025262|NCT00424840|Bevacizumab|bevacizumab|mesh-list
6025263|NCT00424840|Carboplatin|carboplatin|mesh-list
6025264|NCT00424840|Bortezomib|bortezomib|mesh-list
6025265|NCT00424840|Docetaxel|docetaxel|mesh-list
6025266|NCT00424840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6025267|NCT00424840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6025268|NCT00424840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6025269|NCT00424840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6025270|NCT00424840|Growth Substances|growth substances|mesh-ancestor
6025271|NCT00424840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025272|NCT00424840|Growth Inhibitors|growth inhibitors|mesh-ancestor
6025273|NCT00424840|Tubulin Modulators|tubulin modulators|mesh-ancestor
6025274|NCT00424840|Antimitotic Agents|antimitotic agents|mesh-ancestor
6025275|NCT00424840|Mitosis Modulators|mitosis modulators|mesh-ancestor
6025276|NCT00424840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025277|NCT00425113|Metronidazole|metronidazole|mesh-list
6025278|NCT00425113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6025279|NCT00425113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6025280|NCT00425113|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6025281|NCT00425113|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6025282|NCT00425308|Cyclosporine|cyclosporine|mesh-list
6025283|NCT00425308|Mycophenolic Acid|mycophenolic acid|mesh-list
6025284|NCT00425308|Everolimus|everolimus|mesh-list
6025285|NCT00425308|Cyclosporins|cyclosporins|mesh-list
6025286|NCT00425308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6025287|NCT00425308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025288|NCT00425308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6025289|NCT00425308|Immunologic Factors|immunologic factors|mesh-ancestor
6025290|NCT00425308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025291|NCT00425308|Antifungal Agents|antifungal agents|mesh-ancestor
6025292|NCT00425308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6025293|NCT00425308|Dermatologic Agents|dermatologic agents|mesh-ancestor
6025294|NCT00425308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6025295|NCT00425308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6025296|NCT00425308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6025297|NCT00425308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6025298|NCT00425308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6025299|NCT00425308|Antitubercular Agents|antitubercular agents|mesh-ancestor
6025300|NCT00425308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6025301|NCT00425373|Amlodipine|amlodipine|mesh-list
6025302|NCT00425373|Valsartan|valsartan|mesh-list
6025303|NCT00425373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6025304|NCT00425373|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6025305|NCT00425373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6025306|NCT00425373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025307|NCT00425373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6025308|NCT00425373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025309|NCT00425373|Vasodilator Agents|vasodilator agents|mesh-ancestor
6025310|NCT00425373|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6025311|NCT00425373|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5491662|NCT02467868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025312|NCT00425386|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6025313|NCT00425386|Sunitinib|sunitinib|mesh-list
6025314|NCT00425386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6025315|NCT00425386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6025316|NCT00425386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6025317|NCT00425386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025318|NCT00425386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6025319|NCT00425386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6025320|NCT00425386|Growth Substances|growth substances|mesh-ancestor
6025321|NCT00425386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456018|NCT00431028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6456019|NCT00431028|Glucocorticoids|glucocorticoids|mesh-ancestor
6456020|NCT00431028|Hormones|hormones|mesh-ancestor
6025322|NCT00425386|Growth Inhibitors|growth inhibitors|mesh-ancestor
6025323|NCT00425477|Bexarotene|bexarotene|mesh-list
6025324|NCT00425477|Sargramostim|sargramostim|mesh-list
6025325|NCT00425477|Immunologic Factors|immunologic factors|mesh-ancestor
6025326|NCT00425477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025327|NCT00425477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6025328|NCT00425503|Bortezomib|bortezomib|mesh-list
6025329|NCT00425503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6025330|NCT00425555|Panobinostat|panobinostat|mesh-list
6025331|NCT00425555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6025332|NCT00425555|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6025333|NCT00425555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6025334|NCT00425555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025335|NCT00425607|Lonafarnib|lonafarnib|mesh-list
6025336|NCT00425607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6025337|NCT00425607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025338|NCT00425672|Interleukin-2|interleukin-2|mesh-list
6025339|NCT00425672|Denileukin diftitox|denileukin diftitox|mesh-list
6025340|NCT00425672|Immunotoxins|immunotoxins|mesh-list
6025341|NCT00425672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6025342|NCT00425672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6025343|NCT00425672|Analgesics|analgesics|mesh-ancestor
6456021|NCT00431028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6456022|NCT00431028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456023|NCT00431028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6456024|NCT00431028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456025|NCT00431028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6456026|NCT00431028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6456027|NCT00431028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6456028|NCT00431028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5491663|NCT02421263|Psilocybin|psilocybin|mesh-list
5491664|NCT02421263|Hallucinogens|hallucinogens|mesh-ancestor
5491665|NCT02421263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5491666|NCT02421263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5491667|NCT02402920|Cisplatin|cisplatin|mesh-list
5491668|NCT02402920|Carboplatin|carboplatin|mesh-list
5491669|NCT02402920|Pembrolizumab|pembrolizumab|mesh-list
5491670|NCT02402920|Etoposide|etoposide|mesh-list
5491671|NCT02402920|Etoposide phosphate|etoposide phosphate|mesh-list
5491672|NCT02402920|Podophyllotoxin|podophyllotoxin|mesh-list
5491673|NCT02402920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6456029|NCT00431028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6025344|NCT00425672|Sensory System Agents|sensory system agents|mesh-ancestor
6025345|NCT00425672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6025346|NCT00425672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025347|NCT00425672|Immunologic Factors|immunologic factors|mesh-ancestor
6025348|NCT00425698|Epoetin Alfa|epoetin alfa|mesh-list
6025349|NCT00425698|Hematinics|hematinics|mesh-ancestor
6025350|NCT00425750|Docetaxel|docetaxel|mesh-list
6025351|NCT00425750|Bortezomib|bortezomib|mesh-list
6025352|NCT00425750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6025353|NCT00425750|Tubulin Modulators|tubulin modulators|mesh-ancestor
6025354|NCT00425750|Antimitotic Agents|antimitotic agents|mesh-ancestor
6025355|NCT00425750|Mitosis Modulators|mitosis modulators|mesh-ancestor
6025356|NCT00425750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025357|NCT00425802|Cyclosporine|cyclosporine|mesh-list
6025358|NCT00425802|Mycophenolic Acid|mycophenolic acid|mesh-list
6025359|NCT00425802|Cyclophosphamide|cyclophosphamide|mesh-list
6025360|NCT00425802|Rituximab|rituximab|mesh-list
6025361|NCT00425802|Fludarabine|fludarabine|mesh-list
6025362|NCT00425802|Fludarabine phosphate|fludarabine phosphate|mesh-list
6025363|NCT00425802|Cyclosporins|cyclosporins|mesh-list
5491674|NCT02402920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6025364|NCT00425802|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6025365|NCT00425802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6025366|NCT00425802|Immunologic Factors|immunologic factors|mesh-ancestor
6025367|NCT00425802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025368|NCT00425802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6025369|NCT00425802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6025370|NCT00425802|Alkylating Agents|alkylating agents|mesh-ancestor
6025371|NCT00425802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025372|NCT00425802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6025373|NCT00425802|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6025374|NCT00425802|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6025375|NCT00425802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6025376|NCT00425802|Antimetabolites|antimetabolites|mesh-ancestor
5491675|NCT02402920|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5491676|NCT02402920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5491677|NCT02402920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6025377|NCT00425802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6025378|NCT00425802|Antifungal Agents|antifungal agents|mesh-ancestor
6025379|NCT00425802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6025380|NCT00425802|Dermatologic Agents|dermatologic agents|mesh-ancestor
6025381|NCT00425802|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6025382|NCT00425802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6025383|NCT00425802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6025384|NCT00425802|Antitubercular Agents|antitubercular agents|mesh-ancestor
6025385|NCT00425802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6025386|NCT00425854|Afatinib|afatinib|mesh-list
6025387|NCT00425854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6025388|NCT00425854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6025389|NCT00425854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6025390|NCT00425854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025391|NCT00425945|Pycnogenols|pycnogenols|mesh-list
6025392|NCT00425945|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6025393|NCT00425945|Immunologic Factors|immunologic factors|mesh-ancestor
6025394|NCT00425945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025395|NCT00425945|Antioxidants|antioxidants|mesh-ancestor
6025396|NCT00425945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025397|NCT00425945|Protective Agents|protective agents|mesh-ancestor
6025398|NCT00425945|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6025399|NCT00426127|Docetaxel|docetaxel|mesh-list
6025400|NCT00426127|Doxorubicin|doxorubicin|mesh-list
6025401|NCT00426127|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6025402|NCT00426127|Enoxaparin|enoxaparin|mesh-list
6025403|NCT00426127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6025404|NCT00426127|Tubulin Modulators|tubulin modulators|mesh-ancestor
6025405|NCT00426127|Antimitotic Agents|antimitotic agents|mesh-ancestor
6025406|NCT00426127|Mitosis Modulators|mitosis modulators|mesh-ancestor
6025407|NCT00426127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025408|NCT00426127|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6025409|NCT00426127|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6025410|NCT00426127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6025411|NCT00426127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6025412|NCT00426127|Anticoagulants|anticoagulants|mesh-ancestor
6025413|NCT00426127|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6025414|NCT00426127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6025415|NCT00426153|Octreotide|octreotide|mesh-list
6025416|NCT00426153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6025417|NCT00426153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6025418|NCT00426153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6025419|NCT00426270|Immunoglobulins|immunoglobulins|mesh-list
5491678|NCT02402920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5491679|NCT02402920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491680|NCT02402920|Keratolytic Agents|keratolytic agents|mesh-ancestor
5491681|NCT02402920|Dermatologic Agents|dermatologic agents|mesh-ancestor
5491682|NCT02402920|Tubulin Modulators|tubulin modulators|mesh-ancestor
5491683|NCT02402920|Antimitotic Agents|antimitotic agents|mesh-ancestor
5491684|NCT02402920|Mitosis Modulators|mitosis modulators|mesh-ancestor
5491685|NCT02178722|Pembrolizumab|pembrolizumab|mesh-list
5491686|NCT02178722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5491687|NCT02178722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5491688|NCT02048813|Cyclophosphamide|cyclophosphamide|mesh-list
5491689|NCT02048813|Rituximab|rituximab|mesh-list
5491690|NCT02048813|Fludarabine|fludarabine|mesh-list
5491691|NCT02048813|Fludarabine phosphate|fludarabine phosphate|mesh-list
5491692|NCT02048813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5491693|NCT02048813|Antibodies|antibodies|mesh-list
5491694|NCT02048813|Immunoglobulins|immunoglobulins|mesh-list
5491695|NCT02048813|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5491696|NCT02048813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6025420|NCT00426270|Immunologic Factors|immunologic factors|mesh-ancestor
5491697|NCT02048813|Immunologic Factors|immunologic factors|mesh-ancestor
5491698|NCT02048813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5491699|NCT02048813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5491700|NCT02048813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5491701|NCT02048813|Alkylating Agents|alkylating agents|mesh-ancestor
5491702|NCT02048813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491703|NCT02048813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5491704|NCT02048813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5491705|NCT02048813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5724882|NCT03184480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6025421|NCT00426270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025422|NCT00426283|Fluticasone|fluticasone|mesh-list
6025423|NCT00426283|Xhance|xhance|mesh-list
6025424|NCT00426283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6025425|NCT00426283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6025426|NCT00426283|Autonomic Agents|autonomic agents|mesh-ancestor
6025427|NCT00426283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6025428|NCT00426283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025429|NCT00426283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6025430|NCT00426283|Respiratory System Agents|respiratory system agents|mesh-ancestor
6025431|NCT00426283|Dermatologic Agents|dermatologic agents|mesh-ancestor
6025432|NCT00426283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6025433|NCT00426361|Vaccines|vaccines|mesh-list
6025434|NCT00426361|Immunologic Factors|immunologic factors|mesh-ancestor
6025435|NCT00426361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025436|NCT00426517|Sirolimus|sirolimus|mesh-list
6025437|NCT00426517|Busulfan|busulfan|mesh-list
6025438|NCT00426517|Alemtuzumab|alemtuzumab|mesh-list
6025439|NCT00426517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6025440|NCT00426517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6025441|NCT00426517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6025442|NCT00426517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6025443|NCT00426517|Antifungal Agents|antifungal agents|mesh-ancestor
6025444|NCT00426517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6025445|NCT00426517|Immunologic Factors|immunologic factors|mesh-ancestor
6025446|NCT00426517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025447|NCT00426517|Alkylating Agents|alkylating agents|mesh-ancestor
6025448|NCT00426517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025449|NCT00426517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6025450|NCT00426517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6025451|NCT00426517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6025452|NCT00426556|Paclitaxel|paclitaxel|mesh-list
6025453|NCT00426556|Trastuzumab|trastuzumab|mesh-list
6025454|NCT00426556|Everolimus|everolimus|mesh-list
6025455|NCT00426556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6025456|NCT00426556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6025457|NCT00426556|Tubulin Modulators|tubulin modulators|mesh-ancestor
6025458|NCT00426556|Antimitotic Agents|antimitotic agents|mesh-ancestor
6025459|NCT00426556|Mitosis Modulators|mitosis modulators|mesh-ancestor
6025460|NCT00426556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025461|NCT00426556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6025462|NCT00426556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6025463|NCT00426556|Immunologic Factors|immunologic factors|mesh-ancestor
5724883|NCT03184480|Respiratory System Agents|respiratory system agents|mesh-ancestor
5724884|NCT03184480|Dermatologic Agents|dermatologic agents|mesh-ancestor
5724885|NCT03184480|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5724886|NCT03184493|Metformin|metformin|mesh-list
5724887|NCT03184493|Celecoxib|celecoxib|mesh-list
5724888|NCT03184493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5724889|NCT03184493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724890|NCT03184493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5724891|NCT03184493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5724892|NCT03184493|Analgesics|analgesics|mesh-ancestor
5724893|NCT03184493|Sensory System Agents|sensory system agents|mesh-ancestor
6025464|NCT00426556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025465|NCT00426660|Maraviroc|maraviroc|mesh-list
6025466|NCT00426660|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6025467|NCT00426660|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6025468|NCT00426660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025469|NCT00426660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6025470|NCT00426660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6025471|NCT00426660|Antiviral Agents|antiviral agents|mesh-ancestor
6025472|NCT00426660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6025473|NCT00426660|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6025474|NCT00426751|Abciximab|abciximab|mesh-list
6025475|NCT00426751|Eptifibatide|eptifibatide|mesh-list
6025476|NCT00426751|Anticoagulants|anticoagulants|mesh-ancestor
6025477|NCT00426751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6025478|NCT00426764|Romidepsin|romidepsin|mesh-list
6025479|NCT00426764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6025480|NCT00426764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6025481|NCT00426842|Midodrine|midodrine|mesh-list
6025482|NCT00426842|Sympathomimetics|sympathomimetics|mesh-ancestor
6025483|NCT00426842|Autonomic Agents|autonomic agents|mesh-ancestor
6025484|NCT00426842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6025485|NCT00426842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456030|NCT00431028|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6025486|NCT00426842|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6025487|NCT00426842|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6025488|NCT00426842|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6025489|NCT00426842|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6025490|NCT00426842|Adrenergic Agents|adrenergic agents|mesh-ancestor
6025491|NCT00426842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6025492|NCT00426842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025493|NCT00426855|Bortezomib|bortezomib|mesh-list
6025494|NCT00426855|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6025495|NCT00426855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6025496|NCT00426855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6025497|NCT00426855|Alkylating Agents|alkylating agents|mesh-ancestor
6025498|NCT00426855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025499|NCT00427037|Vitamin D|vitamin d|mesh-list
6025500|NCT00427037|Cholecalciferol|cholecalciferol|mesh-list
6025501|NCT00427037|Vitamins|vitamins|mesh-ancestor
6025502|NCT00427037|Micronutrients|micronutrients|mesh-ancestor
6025503|NCT00427037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025504|NCT00427037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6025505|NCT00427037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6025506|NCT00427297|Ritonavir|ritonavir|mesh-list
6025507|NCT00427297|Lopinavir|lopinavir|mesh-list
6025508|NCT00427297|Tenofovir|tenofovir|mesh-list
6025509|NCT00427297|Lamivudine|lamivudine|mesh-list
6025510|NCT00427297|Zidovudine|zidovudine|mesh-list
6025511|NCT00427297|Nevirapine|nevirapine|mesh-list
6025512|NCT00427297|Abacavir|abacavir|mesh-list
6025513|NCT00427297|Stavudine|stavudine|mesh-list
6025514|NCT00427297|Didanosine|didanosine|mesh-list
6025515|NCT00427297|Efavirenz|efavirenz|mesh-list
6025516|NCT00427297|Dideoxynucleosides|dideoxynucleosides|mesh-list
6025517|NCT00427297|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6025518|NCT00427297|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6025519|NCT00427297|Protease Inhibitors|protease inhibitors|mesh-ancestor
6025520|NCT00427297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6025521|NCT00427297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025522|NCT00427297|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6025523|NCT00427297|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6025524|NCT00427297|Antiviral Agents|antiviral agents|mesh-ancestor
6025525|NCT00427297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6025526|NCT00427297|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6025527|NCT00427297|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6025528|NCT00427297|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6025529|NCT00427297|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6025530|NCT00427297|Antimetabolites|antimetabolites|mesh-ancestor
6025531|NCT00427297|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6025532|NCT00427297|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6025533|NCT00427297|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6025534|NCT00427297|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6025535|NCT00427297|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6025536|NCT00427336|Vidarabine|vidarabine|mesh-list
6025537|NCT00427336|Cyclophosphamide|cyclophosphamide|mesh-list
6025538|NCT00427336|Fludarabine|fludarabine|mesh-list
6025539|NCT00427336|Fludarabine phosphate|fludarabine phosphate|mesh-list
6025540|NCT00427336|Thymoglobulin|thymoglobulin|mesh-list
5491706|NCT02048813|Antimetabolites|antimetabolites|mesh-ancestor
5491707|NCT01955499|Lenalidomide|lenalidomide|mesh-list
5491708|NCT01955499|Immunologic Factors|immunologic factors|mesh-ancestor
5491709|NCT01955499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5491710|NCT01955499|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5491711|NCT01955499|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5491712|NCT01955499|Growth Substances|growth substances|mesh-ancestor
5491713|NCT01955499|Growth Inhibitors|growth inhibitors|mesh-ancestor
5491714|NCT01955499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5491715|NCT01889303|Docetaxel|docetaxel|mesh-list
5491716|NCT01889303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5491717|NCT01889303|Tubulin Modulators|tubulin modulators|mesh-ancestor
5491718|NCT01889303|Antimitotic Agents|antimitotic agents|mesh-ancestor
5491719|NCT01889303|Mitosis Modulators|mitosis modulators|mesh-ancestor
5491720|NCT01889303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491721|NCT01829568|Rituximab|rituximab|mesh-list
5491722|NCT01829568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5491723|NCT01829568|Lenalidomide|lenalidomide|mesh-list
6025541|NCT00427336|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6025542|NCT00427336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6025543|NCT00427336|Immunologic Factors|immunologic factors|mesh-ancestor
6025544|NCT00427336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025545|NCT00427336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6025546|NCT00427336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6025547|NCT00427336|Alkylating Agents|alkylating agents|mesh-ancestor
5491724|NCT01829568|Antibodies|antibodies|mesh-list
5491725|NCT01829568|Immunoglobulins|immunoglobulins|mesh-list
5491726|NCT01829568|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5491727|NCT01829568|Immunologic Factors|immunologic factors|mesh-ancestor
5491728|NCT01829568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5491729|NCT01829568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5491730|NCT01829568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5491731|NCT01829568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6025548|NCT00427336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025549|NCT00427336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6025550|NCT00427336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6025551|NCT00427336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6025552|NCT00427336|Antimetabolites|antimetabolites|mesh-ancestor
6025553|NCT00427336|Antiviral Agents|antiviral agents|mesh-ancestor
6025554|NCT00427336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6025555|NCT00427349|Octreotide|octreotide|mesh-list
6025556|NCT00427349|Motesanib diphosphate|motesanib diphosphate|mesh-list
5491732|NCT01829568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5491733|NCT01829568|Growth Substances|growth substances|mesh-ancestor
5491734|NCT01829568|Growth Inhibitors|growth inhibitors|mesh-ancestor
5491735|NCT01787500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5491736|NCT01787500|Cetuximab|cetuximab|mesh-list
5491737|NCT01787500|Irinotecan|irinotecan|mesh-list
5491738|NCT01787500|Camptothecin|camptothecin|mesh-list
5491739|NCT01787500|Vemurafenib|vemurafenib|mesh-list
5491740|NCT01787500|Antibodies|antibodies|mesh-list
5491741|NCT01787500|Immunoglobulins|immunoglobulins|mesh-list
5491742|NCT01787500|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5491743|NCT01787500|Immunologic Factors|immunologic factors|mesh-ancestor
5491744|NCT01787500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5491745|NCT01787500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5491746|NCT01787500|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5491747|NCT01787500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5491748|NCT01787500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5491749|NCT01787500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491750|NCT01787500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5491751|NCT01787500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6025557|NCT00427349|Imetelstat|imetelstat|mesh-list
6025558|NCT00427349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6025559|NCT00427349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6025560|NCT00427349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6025561|NCT00427349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6025562|NCT00427349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6025563|NCT00427349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025564|NCT00427557|Vidarabine|vidarabine|mesh-list
6025565|NCT00427557|Rituximab|rituximab|mesh-list
6025566|NCT00427557|Fludarabine|fludarabine|mesh-list
5491760|NCT01353313|Hydrocortisone|hydrocortisone|mesh-list
5491761|NCT01353313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5491762|NCT01303341|Sorafenib|sorafenib|mesh-list
5491763|NCT01303341|Riluzole|riluzole|mesh-list
5491764|NCT01303341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6025567|NCT00427557|Fludarabine phosphate|fludarabine phosphate|mesh-list
6025568|NCT00427557|Melphalan|melphalan|mesh-list
6025569|NCT00427557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6456031|NCT00431028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6456032|NCT00431054|Docetaxel|docetaxel|mesh-list
6456033|NCT00431054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6456034|NCT00431054|Tubulin Modulators|tubulin modulators|mesh-ancestor
6456035|NCT00431054|Antimitotic Agents|antimitotic agents|mesh-ancestor
6456036|NCT00431054|Mitosis Modulators|mitosis modulators|mesh-ancestor
6456037|NCT00431054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456038|NCT00431080|Paclitaxel|paclitaxel|mesh-list
6456039|NCT00431080|Docetaxel|docetaxel|mesh-list
6456040|NCT00431080|Cyclophosphamide|cyclophosphamide|mesh-list
6456041|NCT00431080|Epirubicin|epirubicin|mesh-list
6456042|NCT00431080|Fluorouracil|fluorouracil|mesh-list
6456043|NCT00431080|Mitogens|mitogens|mesh-list
6456044|NCT00431080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6456045|NCT00431080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6456046|NCT00431080|Tubulin Modulators|tubulin modulators|mesh-ancestor
6456047|NCT00431080|Antimitotic Agents|antimitotic agents|mesh-ancestor
6456048|NCT00431080|Mitosis Modulators|mitosis modulators|mesh-ancestor
6456049|NCT00431080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456050|NCT00431080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6456051|NCT00431080|Immunologic Factors|immunologic factors|mesh-ancestor
6456052|NCT00431080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456053|NCT00431080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6456054|NCT00431080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6456055|NCT00431080|Alkylating Agents|alkylating agents|mesh-ancestor
6456056|NCT00431080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6456057|NCT00431080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6456058|NCT00431080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6456059|NCT00431080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6456060|NCT00431080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6456061|NCT00431080|Antimetabolites|antimetabolites|mesh-ancestor
5491765|NCT01303341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5491766|NCT01303341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6025570|NCT00427557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6025571|NCT00427557|Immunologic Factors|immunologic factors|mesh-ancestor
5491767|NCT01303341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491768|NCT01303341|Anticonvulsants|anticonvulsants|mesh-ancestor
5491769|NCT01303341|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5491770|NCT01303341|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5491771|NCT01303341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5491772|NCT01303341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025572|NCT00427557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025573|NCT00427557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6025574|NCT00427557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6025575|NCT00427557|Antimetabolites|antimetabolites|mesh-ancestor
6025576|NCT00427557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025577|NCT00427557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6025578|NCT00427557|Antiviral Agents|antiviral agents|mesh-ancestor
6025579|NCT00427557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6025580|NCT00427557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6025581|NCT00427557|Alkylating Agents|alkylating agents|mesh-ancestor
6025582|NCT00427557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6025583|NCT00427635|Esomeprazole|esomeprazole|mesh-list
6025584|NCT00427635|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6025585|NCT00427635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6025586|NCT00427635|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6025587|NCT00427635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6025588|NCT00427635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025589|NCT00427648|Lidocaine|lidocaine|mesh-list
6025590|NCT00427648|Anesthetics, Local|anesthetics, local|mesh-ancestor
6025591|NCT00427648|Anesthetics|anesthetics|mesh-ancestor
6025592|NCT00427648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6025593|NCT00427648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025594|NCT00427648|Sensory System Agents|sensory system agents|mesh-ancestor
6025595|NCT00427648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6025596|NCT00427648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6025597|NCT00427648|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6025598|NCT00427648|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6025599|NCT00427648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6025600|NCT00427648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025601|NCT00427661|Cyclosporine|cyclosporine|mesh-list
6456062|NCT00431080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6456063|NCT00431106|Gemcitabine|gemcitabine|mesh-list
6025602|NCT00427661|Fludarabine|fludarabine|mesh-list
6025603|NCT00427661|Busulfan|busulfan|mesh-list
6025604|NCT00427661|Cyclosporins|cyclosporins|mesh-list
6025605|NCT00427661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6025606|NCT00427661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025607|NCT00427661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6025608|NCT00427661|Immunologic Factors|immunologic factors|mesh-ancestor
6025609|NCT00427661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025610|NCT00427661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6025611|NCT00427661|Antifungal Agents|antifungal agents|mesh-ancestor
6025612|NCT00427661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6025613|NCT00427661|Dermatologic Agents|dermatologic agents|mesh-ancestor
6025614|NCT00427661|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6025615|NCT00427661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6025616|NCT00427661|Alkylating Agents|alkylating agents|mesh-ancestor
6025617|NCT00427661|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6025618|NCT00427661|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6025619|NCT00427700|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
6025620|NCT00427700|Clomiphene|clomiphene|mesh-list
6025621|NCT00427700|Enclomiphene|enclomiphene|mesh-list
6025622|NCT00427700|Zuclomiphene|zuclomiphene|mesh-list
6025623|NCT00427700|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6025624|NCT00427700|Hormone Antagonists|hormone antagonists|mesh-ancestor
6654639|NCT01458223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6654640|NCT01458223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6654641|NCT01458223|Antitubercular Agents|antitubercular agents|mesh-ancestor
6025625|NCT00427700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6025626|NCT00427700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025627|NCT00427700|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6025628|NCT00427700|Fertility Agents|fertility agents|mesh-ancestor
6025629|NCT00427700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5491773|NCT01303341|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5491774|NCT01303341|Protective Agents|protective agents|mesh-ancestor
5491775|NCT01258803|Mometasone Furoate|mometasone furoate|mesh-list
5491776|NCT01258803|Formoterol Fumarate|formoterol fumarate|mesh-list
5491777|NCT01258803|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5491778|NCT01258803|Autonomic Agents|autonomic agents|mesh-ancestor
5491779|NCT01258803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5491780|NCT01258803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5491781|NCT01258803|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5491782|NCT01258803|Respiratory System Agents|respiratory system agents|mesh-ancestor
5491783|NCT01258803|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5491784|NCT01258803|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5491785|NCT01258803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5491786|NCT01258803|Adrenergic Agents|adrenergic agents|mesh-ancestor
5491787|NCT01258803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5491788|NCT01258803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491789|NCT01258803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5491790|NCT01258803|Dermatologic Agents|dermatologic agents|mesh-ancestor
5491791|NCT01258803|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5491792|NCT01104922|Cetuximab|cetuximab|mesh-list
5491793|NCT01104922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5491794|NCT01104922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5491795|NCT00862251|Atorvastatin|atorvastatin|mesh-list
6025630|NCT00427700|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6025631|NCT00427700|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6025632|NCT00427700|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6025633|NCT00427765|Melphalan|melphalan|mesh-list
6025634|NCT00427765|Busulfan|busulfan|mesh-list
6025635|NCT00427765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6025636|NCT00427765|Alkylating Agents|alkylating agents|mesh-ancestor
6025637|NCT00427765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025638|NCT00427765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6025639|NCT00427765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6025640|NCT00427765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6025641|NCT00427765|Immunologic Factors|immunologic factors|mesh-ancestor
6025642|NCT00427765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025643|NCT00427791|Rituximab|rituximab|mesh-list
6025644|NCT00427791|Etoposide|etoposide|mesh-list
6025645|NCT00427791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6025646|NCT00427791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5491796|NCT00862251|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5491797|NCT00862251|Simvastatin|simvastatin|mesh-list
5491798|NCT00862251|Ezetimibe|ezetimibe|mesh-list
6025647|NCT00427791|Immunologic Factors|immunologic factors|mesh-ancestor
6025648|NCT00427791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025649|NCT00427791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6025650|NCT00427791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6025651|NCT00427791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6025652|NCT00427791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6025653|NCT00427791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6025654|NCT00427791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025655|NCT00427804|Calcitriol|calcitriol|mesh-list
6025656|NCT00427804|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6025657|NCT00427804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025658|NCT00427804|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6025659|NCT00427804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6025660|NCT00427804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025661|NCT00427804|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6025662|NCT00427804|Vitamins|vitamins|mesh-ancestor
6025663|NCT00427804|Micronutrients|micronutrients|mesh-ancestor
6025664|NCT00427804|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6025665|NCT00427895|Vaccines|vaccines|mesh-list
6025666|NCT00427895|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6025667|NCT00427895|Immunologic Factors|immunologic factors|mesh-ancestor
6025668|NCT00427895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025669|NCT00427921|Adalimumab|adalimumab|mesh-list
6025670|NCT00427921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6025671|NCT00427921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6025672|NCT00427934|Maraviroc|maraviroc|mesh-list
6025673|NCT00427934|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6025674|NCT00427934|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5491799|NCT00862251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5491800|NCT00862251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5491801|NCT00862251|Antimetabolites|antimetabolites|mesh-ancestor
5491802|NCT00862251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491803|NCT00862251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5491804|NCT00862251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6025675|NCT00427934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025676|NCT00427934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6025677|NCT00427934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6025678|NCT00427934|Antiviral Agents|antiviral agents|mesh-ancestor
6025679|NCT00427934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6025680|NCT00427934|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6025681|NCT00427960|Atorvastatin|atorvastatin|mesh-list
6025682|NCT00427960|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6025683|NCT00427960|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6025684|NCT00427960|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5491805|NCT00862251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5491806|NCT00783263|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5491807|NCT00783263|Ezetimibe|ezetimibe|mesh-list
5491808|NCT00783263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5491809|NCT00783263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5491810|NCT00783263|Antimetabolites|antimetabolites|mesh-ancestor
5491811|NCT00783263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491812|NCT00783263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6025685|NCT00427960|Antimetabolites|antimetabolites|mesh-ancestor
6025686|NCT00427960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025687|NCT00427960|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6025688|NCT00427960|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6025689|NCT00427960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6025690|NCT00427973|Cediranib|cediranib|mesh-list
6025691|NCT00427973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6025692|NCT00427973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025693|NCT00427973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6025694|NCT00427973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6025695|NCT00427999|Pioglitazone|pioglitazone|mesh-list
6025696|NCT00427999|Dexamethasone|dexamethasone|mesh-list
6025697|NCT00427999|Dexamethasone acetate|dexamethasone acetate|mesh-list
6025698|NCT00427999|Etoricoxib|etoricoxib|mesh-list
6025699|NCT00427999|Imatinib Mesylate|imatinib mesylate|mesh-list
6456064|NCT00431106|Capecitabine|capecitabine|mesh-list
6456065|NCT00431106|Vinorelbine|vinorelbine|mesh-list
6456066|NCT00431106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6456067|NCT00431106|Antimetabolites|antimetabolites|mesh-ancestor
6456068|NCT00431106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456069|NCT00431106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6456070|NCT00431106|Antiviral Agents|antiviral agents|mesh-ancestor
6456071|NCT00431106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6456072|NCT00431106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6025700|NCT00427999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6025701|NCT00427999|Antiemetics|antiemetics|mesh-ancestor
6025702|NCT00427999|Autonomic Agents|autonomic agents|mesh-ancestor
6025703|NCT00427999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6025704|NCT00427999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025705|NCT00427999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6456073|NCT00431106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6456074|NCT00431106|Immunologic Factors|immunologic factors|mesh-ancestor
6456075|NCT00431106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456076|NCT00431106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6456077|NCT00431106|Tubulin Modulators|tubulin modulators|mesh-ancestor
6456078|NCT00431106|Antimitotic Agents|antimitotic agents|mesh-ancestor
6456079|NCT00431106|Mitosis Modulators|mitosis modulators|mesh-ancestor
6456080|NCT00431119|Mycophenolic Acid|mycophenolic acid|mesh-list
6456081|NCT00431119|Azathioprine|azathioprine|mesh-list
6456082|NCT00431119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6456083|NCT00431119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5503027|NCT04462822|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6025706|NCT00427999|Glucocorticoids|glucocorticoids|mesh-ancestor
6025707|NCT00427999|Hormones|hormones|mesh-ancestor
6025708|NCT00427999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6025709|NCT00427999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6025710|NCT00427999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6456084|NCT00431119|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6456085|NCT00431119|Antitubercular Agents|antitubercular agents|mesh-ancestor
6456086|NCT00431119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6456087|NCT00431119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6025711|NCT00427999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6025712|NCT00427999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6025713|NCT00427999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6025714|NCT00427999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025715|NCT00427999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6025716|NCT00427999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6025717|NCT00427999|Analgesics|analgesics|mesh-ancestor
6025718|NCT00427999|Sensory System Agents|sensory system agents|mesh-ancestor
6025719|NCT00427999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6025720|NCT00427999|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6025721|NCT00427999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6025722|NCT00428090|Rosiglitazone|rosiglitazone|mesh-list
6025723|NCT00428090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6025724|NCT00428090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025725|NCT00428220|Sunitinib|sunitinib|mesh-list
6025726|NCT00428220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6025727|NCT00428220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6025728|NCT00428220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6025729|NCT00428220|Growth Substances|growth substances|mesh-ancestor
6025730|NCT00428220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025731|NCT00428220|Growth Inhibitors|growth inhibitors|mesh-ancestor
6025732|NCT00428220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6025733|NCT00428220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6025734|NCT00428220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025735|NCT00428298|Valacyclovir|valacyclovir|mesh-list
6025736|NCT00428298|Antiviral Agents|antiviral agents|mesh-ancestor
6025737|NCT00428298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6025738|NCT00428389|Rivastigmine|rivastigmine|mesh-list
6456088|NCT00431119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6456089|NCT00431119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456090|NCT00431119|Antimetabolites|antimetabolites|mesh-ancestor
5491813|NCT00783263|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5491814|NCT00783263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5491815|NCT00782184|Atorvastatin|atorvastatin|mesh-list
5491816|NCT00782184|Simvastatin|simvastatin|mesh-list
5491817|NCT00782184|Ezetimibe|ezetimibe|mesh-list
5491818|NCT00782184|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
5491819|NCT00782184|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5491820|NCT00782184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5491821|NCT00782184|Antimetabolites|antimetabolites|mesh-ancestor
5491822|NCT00782184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491823|NCT00782184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5491824|NCT00782184|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5491825|NCT00782184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5491826|NCT00664937|Montelukast|montelukast|mesh-list
5491827|NCT00664937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5491828|NCT00664937|Respiratory System Agents|respiratory system agents|mesh-ancestor
5491829|NCT00664937|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5491830|NCT00664937|Hormone Antagonists|hormone antagonists|mesh-ancestor
5491831|NCT00664937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5491832|NCT00664937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5491833|NCT00664937|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5491834|NCT00664937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5491835|NCT00664937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491836|NCT00635882|Mometasone Furoate|mometasone furoate|mesh-list
5491837|NCT00635882|Formoterol Fumarate|formoterol fumarate|mesh-list
5491838|NCT00635882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5491839|NCT00635882|Autonomic Agents|autonomic agents|mesh-ancestor
5491840|NCT00635882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5491841|NCT00635882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5491842|NCT00635882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5491843|NCT00635882|Respiratory System Agents|respiratory system agents|mesh-ancestor
5491844|NCT00635882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5491845|NCT00635882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5491846|NCT00635882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5491847|NCT00635882|Adrenergic Agents|adrenergic agents|mesh-ancestor
5491848|NCT00635882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5491849|NCT00635882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491850|NCT00635882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5491851|NCT00635882|Dermatologic Agents|dermatologic agents|mesh-ancestor
5491852|NCT00635882|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5491853|NCT00586391|Ipilimumab|ipilimumab|mesh-list
5491854|NCT00586391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5491855|NCT00586391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5491856|NCT00586391|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5491857|NCT00586391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025739|NCT00428389|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6025740|NCT00428389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5491858|NCT00545324|Fluticasone|fluticasone|mesh-list
5491859|NCT00545324|Montelukast|montelukast|mesh-list
5491860|NCT00545324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5491861|NCT00545324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5491862|NCT00545324|Autonomic Agents|autonomic agents|mesh-ancestor
5491863|NCT00545324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5491864|NCT00545324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5491865|NCT00545324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5491866|NCT00545324|Respiratory System Agents|respiratory system agents|mesh-ancestor
5491867|NCT00545324|Dermatologic Agents|dermatologic agents|mesh-ancestor
5491868|NCT00545324|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5491869|NCT00545324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491870|NCT00545324|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5491871|NCT00545324|Hormone Antagonists|hormone antagonists|mesh-ancestor
5491872|NCT00545324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6025741|NCT00428389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025742|NCT00428389|Cholinergic Agents|cholinergic agents|mesh-ancestor
6025743|NCT00428389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6025744|NCT00428389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5491873|NCT00545324|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5491874|NCT00545324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5491875|NCT00540839|Fluticasone|fluticasone|mesh-list
5491876|NCT00540839|Xhance|xhance|mesh-list
5491877|NCT00540839|Montelukast|montelukast|mesh-list
5491878|NCT00540839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6025745|NCT00428389|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6025746|NCT00428389|Protective Agents|protective agents|mesh-ancestor
6025747|NCT00428441|Warfarin|warfarin|mesh-list
6025748|NCT00428441|Anticoagulants|anticoagulants|mesh-ancestor
6025749|NCT00428584|Interferons|interferons|mesh-list
6025750|NCT00428584|Interferon-beta|interferon-beta|mesh-list
6025751|NCT00428584|Interferon beta-1a|interferon beta-1a|mesh-list
6025752|NCT00428584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6025753|NCT00428584|Antiviral Agents|antiviral agents|mesh-ancestor
6025754|NCT00428584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6025755|NCT00428584|Immunologic Factors|immunologic factors|mesh-ancestor
6025756|NCT00428584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025757|NCT00428584|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6025758|NCT00428597|Sunitinib|sunitinib|mesh-list
6025759|NCT00428597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6025760|NCT00428597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6025761|NCT00428597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6025762|NCT00428597|Growth Substances|growth substances|mesh-ancestor
5491879|NCT00540839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5491880|NCT00540839|Autonomic Agents|autonomic agents|mesh-ancestor
5491881|NCT00540839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5491882|NCT00540839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5491883|NCT00540839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5491884|NCT00540839|Respiratory System Agents|respiratory system agents|mesh-ancestor
5491885|NCT00540839|Dermatologic Agents|dermatologic agents|mesh-ancestor
5491886|NCT00540839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5491887|NCT00540839|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5491888|NCT00540839|Hormone Antagonists|hormone antagonists|mesh-ancestor
5491889|NCT00540839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5491890|NCT00540839|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5491891|NCT00540839|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5491892|NCT00540839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491893|NCT00535405|Atorvastatin|atorvastatin|mesh-list
6025763|NCT00428597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025764|NCT00428597|Growth Inhibitors|growth inhibitors|mesh-ancestor
6025765|NCT00428597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6025766|NCT00428597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6025767|NCT00428597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025768|NCT00428792|Methylphenidate|methylphenidate|mesh-list
6025769|NCT00428792|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6025770|NCT00428792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025771|NCT00428792|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6025772|NCT00428792|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6025773|NCT00428792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6025774|NCT00428792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025775|NCT00428792|Dopamine Agents|dopamine agents|mesh-ancestor
6025776|NCT00428792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6025777|NCT00428844|Vancomycin|vancomycin|mesh-list
6456091|NCT00431119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5491894|NCT00535405|Simvastatin|simvastatin|mesh-list
5491895|NCT00535405|Ezetimibe|ezetimibe|mesh-list
5491896|NCT00535405|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5491897|NCT00535405|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5491898|NCT00535405|Antimetabolites|antimetabolites|mesh-ancestor
5491899|NCT00535405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491900|NCT00535405|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5491901|NCT00535405|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5491902|NCT00535405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5491903|NCT00496730|Atorvastatin|atorvastatin|mesh-list
5491904|NCT00496730|Simvastatin|simvastatin|mesh-list
5491905|NCT00496730|Ezetimibe|ezetimibe|mesh-list
5491906|NCT00496730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6456092|NCT00431119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6456093|NCT00431119|Immunologic Factors|immunologic factors|mesh-ancestor
6456094|NCT00431119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456095|NCT00431119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6456096|NCT00431145|Niacin|niacin|mesh-list
6456097|NCT00431145|Niacinamide|niacinamide|mesh-list
5491907|NCT00496730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5491908|NCT00496730|Antimetabolites|antimetabolites|mesh-ancestor
5491909|NCT00496730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491910|NCT00496730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5491911|NCT00496730|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6025778|NCT00428844|Daptomycin|daptomycin|mesh-list
6456098|NCT00431145|Nicotinic Acids|nicotinic acids|mesh-list
6456099|NCT00431145|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6025779|NCT00428844|Teicoplanin|teicoplanin|mesh-list
6025780|NCT00428844|Floxacillin|floxacillin|mesh-list
6025781|NCT00428844|Oxacillin|oxacillin|mesh-list
6025782|NCT00428844|Nafcillin|nafcillin|mesh-list
6456100|NCT00431145|Antimetabolites|antimetabolites|mesh-ancestor
6456101|NCT00431145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456102|NCT00431145|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6456103|NCT00431145|Vasodilator Agents|vasodilator agents|mesh-ancestor
6456104|NCT00431145|Vitamin B Complex|vitamin b complex|mesh-ancestor
6456105|NCT00431145|Vitamins|vitamins|mesh-ancestor
6456106|NCT00431145|Micronutrients|micronutrients|mesh-ancestor
6456107|NCT00431145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5491912|NCT00496730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6025783|NCT00428844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6025784|NCT00428844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6025785|NCT00428922|Bevacizumab|bevacizumab|mesh-list
6025786|NCT00428922|Trastuzumab|trastuzumab|mesh-list
6025787|NCT00428922|Docetaxel|docetaxel|mesh-list
6025788|NCT00428922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6025789|NCT00428922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6025790|NCT00428922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6025791|NCT00428922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6025792|NCT00428922|Growth Substances|growth substances|mesh-ancestor
6025793|NCT00428922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025794|NCT00428922|Growth Inhibitors|growth inhibitors|mesh-ancestor
5491913|NCT00462748|Atorvastatin|atorvastatin|mesh-list
5491914|NCT00462748|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5491915|NCT00462748|Simvastatin|simvastatin|mesh-list
5491916|NCT00462748|Ezetimibe|ezetimibe|mesh-list
5491917|NCT00462748|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5491918|NCT00462748|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5491919|NCT00462748|Antimetabolites|antimetabolites|mesh-ancestor
5491920|NCT00462748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025795|NCT00428922|Tubulin Modulators|tubulin modulators|mesh-ancestor
6025796|NCT00428922|Antimitotic Agents|antimitotic agents|mesh-ancestor
6025797|NCT00428922|Mitosis Modulators|mitosis modulators|mesh-ancestor
6025798|NCT00428922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025799|NCT00428948|Tolvaptan|tolvaptan|mesh-list
6025800|NCT00428948|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6025801|NCT00428948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025802|NCT00428948|Natriuretic Agents|natriuretic agents|mesh-ancestor
6025803|NCT00428948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025804|NCT00429104|Trastuzumab|trastuzumab|mesh-list
6025805|NCT00429104|Sargramostim|sargramostim|mesh-list
6025806|NCT00429104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6025807|NCT00429104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6025808|NCT00429104|Immunologic Factors|immunologic factors|mesh-ancestor
6025809|NCT00429104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025810|NCT00429143|Mycophenolic Acid|mycophenolic acid|mesh-list
6025811|NCT00429143|Cyclophosphamide|cyclophosphamide|mesh-list
6025812|NCT00429143|Tacrolimus|tacrolimus|mesh-list
6025813|NCT00429143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6025814|NCT00429143|Immunologic Factors|immunologic factors|mesh-ancestor
6025815|NCT00429143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025816|NCT00429143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6025817|NCT00429143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6025818|NCT00429143|Alkylating Agents|alkylating agents|mesh-ancestor
6025819|NCT00429143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025820|NCT00429143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6025821|NCT00429143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6025822|NCT00429143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6025823|NCT00429143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6025824|NCT00429143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6025825|NCT00429143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6025826|NCT00429143|Antitubercular Agents|antitubercular agents|mesh-ancestor
6025827|NCT00429143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6025828|NCT00429143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6025829|NCT00429169|Bupropion|bupropion|mesh-list
6025830|NCT00429169|Paroxetine|paroxetine|mesh-list
6025831|NCT00429169|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6025832|NCT00429169|Antidepressive Agents|antidepressive agents|mesh-ancestor
6025833|NCT00429169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6025834|NCT00429169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6025835|NCT00429169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5491921|NCT00462748|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6456108|NCT00431171|Lithium Carbonate|lithium carbonate|mesh-list
6025836|NCT00429169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6025837|NCT00429169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025838|NCT00429169|Dopamine Agents|dopamine agents|mesh-ancestor
6025839|NCT00429169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6025840|NCT00429169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025841|NCT00429169|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6025842|NCT00429169|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6025843|NCT00429169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6025844|NCT00429169|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6025845|NCT00429169|Serotonin Agents|serotonin agents|mesh-ancestor
6053351|NCT00594815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6053352|NCT00594815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6053353|NCT00594815|Immunologic Factors|immunologic factors|mesh-ancestor
6053354|NCT00594815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053355|NCT00594815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6053356|NCT00594815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6053357|NCT00594815|Abortifacient Agents|abortifacient agents|mesh-ancestor
6053358|NCT00594815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6456109|NCT00431171|Antidepressive Agents|antidepressive agents|mesh-ancestor
6456110|NCT00431171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6456111|NCT00431171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6456112|NCT00431171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456113|NCT00431171|Antimanic Agents|antimanic agents|mesh-ancestor
6456114|NCT00431171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6456115|NCT00431171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6053359|NCT00594815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6053360|NCT00594815|Antimetabolites|antimetabolites|mesh-ancestor
6053361|NCT00594815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053362|NCT00594815|Dermatologic Agents|dermatologic agents|mesh-ancestor
6053363|NCT00594815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6053364|NCT00594815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6053365|NCT00594815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6053366|NCT00594815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6053367|NCT00594815|Antiviral Agents|antiviral agents|mesh-ancestor
6053368|NCT00594815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6053369|NCT00594815|Antidotes|antidotes|mesh-ancestor
6053370|NCT00594815|Protective Agents|protective agents|mesh-ancestor
6053371|NCT00594815|Vitamin B Complex|vitamin b complex|mesh-ancestor
6053372|NCT00594815|Vitamins|vitamins|mesh-ancestor
6053373|NCT00594815|Micronutrients|micronutrients|mesh-ancestor
6053374|NCT00594815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5491922|NCT00462748|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5491923|NCT00462748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5491924|NCT00446186|Montelukast|montelukast|mesh-list
5491925|NCT00446186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491926|NCT00446186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5491927|NCT00446186|Respiratory System Agents|respiratory system agents|mesh-ancestor
5491928|NCT00446186|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5491929|NCT00446186|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5491930|NCT00446186|Hormone Antagonists|hormone antagonists|mesh-ancestor
5491931|NCT00446186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5491932|NCT00446186|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5491933|NCT00446186|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5491934|NCT00445107|Montelukast|montelukast|mesh-list
5491935|NCT00445107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5491936|NCT00445107|Respiratory System Agents|respiratory system agents|mesh-ancestor
5491937|NCT00445107|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5491938|NCT00445107|Hormone Antagonists|hormone antagonists|mesh-ancestor
5491939|NCT00445107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5491940|NCT00445107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5491941|NCT00445107|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5491942|NCT00445107|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5491943|NCT00445107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491944|NCT00418834|Atorvastatin|atorvastatin|mesh-list
5491945|NCT00418834|Ezetimibe|ezetimibe|mesh-list
5491946|NCT00418834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5491947|NCT00418834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6053375|NCT00594815|Tubulin Modulators|tubulin modulators|mesh-ancestor
6053376|NCT00594815|Antimitotic Agents|antimitotic agents|mesh-ancestor
6053377|NCT00594815|Mitosis Modulators|mitosis modulators|mesh-ancestor
6456116|NCT00431171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456117|NCT00431197|Ketoconazole|ketoconazole|mesh-list
6025846|NCT00429182|Cyclophosphamide|cyclophosphamide|mesh-list
6025847|NCT00429182|Thiotepa|thiotepa|mesh-list
6025848|NCT00429182|Carboplatin|carboplatin|mesh-list
6025849|NCT00429182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6456118|NCT00431197|Testosterone|testosterone|mesh-list
6456119|NCT00431197|Antifungal Agents|antifungal agents|mesh-ancestor
6456120|NCT00431197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6025850|NCT00429182|Immunologic Factors|immunologic factors|mesh-ancestor
6025851|NCT00429182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025852|NCT00429182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6025853|NCT00429182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6025854|NCT00429182|Alkylating Agents|alkylating agents|mesh-ancestor
6025855|NCT00429182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025856|NCT00429182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6025857|NCT00429182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6025858|NCT00429273|Guanfacine|guanfacine|mesh-list
6025859|NCT00429273|Methylphenidate|methylphenidate|mesh-list
6025860|NCT00429273|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
6025861|NCT00429273|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6025862|NCT00429273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025863|NCT00429273|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6025864|NCT00429273|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6025865|NCT00429273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6025866|NCT00429273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025867|NCT00429273|Dopamine Agents|dopamine agents|mesh-ancestor
6025868|NCT00429273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6025869|NCT00429273|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6025870|NCT00429273|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6025871|NCT00429273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6025872|NCT00429273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6025873|NCT00429273|Adrenergic Agents|adrenergic agents|mesh-ancestor
6025874|NCT00429299|Paclitaxel|paclitaxel|mesh-list
6025875|NCT00429299|Cyclophosphamide|cyclophosphamide|mesh-list
6025876|NCT00429299|Fluorouracil|fluorouracil|mesh-list
6025877|NCT00429299|Trastuzumab|trastuzumab|mesh-list
6025878|NCT00429299|Lapatinib|lapatinib|mesh-list
6025879|NCT00429299|Epirubicin|epirubicin|mesh-list
6025880|NCT00429299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6025881|NCT00429299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6025882|NCT00429299|Tubulin Modulators|tubulin modulators|mesh-ancestor
6025883|NCT00429299|Antimitotic Agents|antimitotic agents|mesh-ancestor
6025884|NCT00429299|Mitosis Modulators|mitosis modulators|mesh-ancestor
6025885|NCT00429299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025886|NCT00429299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6025887|NCT00429299|Immunologic Factors|immunologic factors|mesh-ancestor
6025888|NCT00429299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025889|NCT00429299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6025890|NCT00429299|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6025891|NCT00429299|Alkylating Agents|alkylating agents|mesh-ancestor
6025892|NCT00429299|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6025893|NCT00429299|Antimetabolites|antimetabolites|mesh-ancestor
6025894|NCT00429299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6025895|NCT00429299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6025896|NCT00429299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6025897|NCT00429299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6025898|NCT00429299|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6025899|NCT00429299|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6025900|NCT00429299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6025901|NCT00429364|Losartan|losartan|mesh-list
6025902|NCT00429364|Atenolol|atenolol|mesh-list
6025903|NCT00429364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6025904|NCT00429364|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6025905|NCT00429364|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5491948|NCT00418834|Antimetabolites|antimetabolites|mesh-ancestor
6025906|NCT00429364|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6053378|NCT00594854|Diclofenac|diclofenac|mesh-list
5491949|NCT00418834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491950|NCT00418834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6025907|NCT00429364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025908|NCT00429364|Sympatholytics|sympatholytics|mesh-ancestor
6025909|NCT00429364|Autonomic Agents|autonomic agents|mesh-ancestor
6025910|NCT00429364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6025911|NCT00429364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025912|NCT00429364|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6025913|NCT00429364|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6025914|NCT00429364|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6025915|NCT00429364|Adrenergic Agents|adrenergic agents|mesh-ancestor
6025916|NCT00429364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6025917|NCT00429403|Goserelin|goserelin|mesh-list
6025918|NCT00429403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6025919|NCT00429403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6025920|NCT00429416|Cytarabine|cytarabine|mesh-list
6025921|NCT00429416|Cyclophosphamide|cyclophosphamide|mesh-list
6025922|NCT00429416|Fludarabine|fludarabine|mesh-list
6025923|NCT00429416|Fludarabine phosphate|fludarabine phosphate|mesh-list
6456121|NCT00431197|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6456122|NCT00431197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6456123|NCT00431197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6456124|NCT00431197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491951|NCT00418834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5491952|NCT00418834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6025924|NCT00429416|Molgramostim|molgramostim|mesh-list
6025925|NCT00429416|Tacrolimus|tacrolimus|mesh-list
6025926|NCT00429416|Sargramostim|sargramostim|mesh-list
6025927|NCT00429416|Mesna|mesna|mesh-list
6025928|NCT00429416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6025929|NCT00429416|Immunologic Factors|immunologic factors|mesh-ancestor
6025930|NCT00429416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025931|NCT00429416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5491953|NCT00409773|Atorvastatin|atorvastatin|mesh-list
5491954|NCT00409773|Simvastatin|simvastatin|mesh-list
5491955|NCT00409773|Ezetimibe|ezetimibe|mesh-list
5491956|NCT00409773|Calcium|calcium|mesh-list
5491957|NCT00409773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5491958|NCT00409773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5491959|NCT00409773|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5491960|NCT00409773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5491961|NCT00409773|Antimetabolites|antimetabolites|mesh-ancestor
5491962|NCT00409773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491963|NCT00409773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5491964|NCT00409773|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5491965|NCT00409773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5491966|NCT00398151|Montelukast|montelukast|mesh-list
6025932|NCT00429416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6025933|NCT00429416|Alkylating Agents|alkylating agents|mesh-ancestor
6025934|NCT00429416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025935|NCT00429416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6025936|NCT00429416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6025937|NCT00429416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6025938|NCT00429416|Antimetabolites|antimetabolites|mesh-ancestor
6025939|NCT00429416|Antiviral Agents|antiviral agents|mesh-ancestor
6025940|NCT00429416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6025941|NCT00429416|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6025942|NCT00429416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6025943|NCT00429416|Protective Agents|protective agents|mesh-ancestor
6025944|NCT00429494|Leuprolide|leuprolide|mesh-list
6025945|NCT00429494|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6025946|NCT00429494|Fertility Agents|fertility agents|mesh-ancestor
6025947|NCT00429494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6025948|NCT00429494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025949|NCT00429494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6025950|NCT00429494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6025951|NCT00429507|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
6025952|NCT00429507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6025953|NCT00429507|Analgesics|analgesics|mesh-ancestor
6025954|NCT00429507|Sensory System Agents|sensory system agents|mesh-ancestor
6025955|NCT00429507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6025956|NCT00429507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025957|NCT00429572|Fludarabine|fludarabine|mesh-list
6025958|NCT00429572|Melphalan|melphalan|mesh-list
6053379|NCT00594854|Arthrotec|arthrotec|mesh-list
5491967|NCT00398151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5491968|NCT00398151|Respiratory System Agents|respiratory system agents|mesh-ancestor
5491969|NCT00398151|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5491970|NCT00398151|Hormone Antagonists|hormone antagonists|mesh-ancestor
5491971|NCT00398151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5491972|NCT00398151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5491973|NCT00398151|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5491974|NCT00398151|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5491975|NCT00398151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491976|NCT00394160|Montelukast|montelukast|mesh-list
5491977|NCT00394160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5491978|NCT00394160|Respiratory System Agents|respiratory system agents|mesh-ancestor
5491979|NCT00394160|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5491980|NCT00394160|Hormone Antagonists|hormone antagonists|mesh-ancestor
5491981|NCT00394160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5491982|NCT00394160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5491983|NCT00394160|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6025959|NCT00429572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6025960|NCT00429572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025961|NCT00429572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6025962|NCT00429572|Immunologic Factors|immunologic factors|mesh-ancestor
6025963|NCT00429572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025964|NCT00429572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6025965|NCT00429572|Alkylating Agents|alkylating agents|mesh-ancestor
6025966|NCT00429572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6025967|NCT00429702|Diphenhydramine|diphenhydramine|mesh-list
6025968|NCT00429702|Promethazine|promethazine|mesh-list
6025969|NCT00429702|Dexamethasone|dexamethasone|mesh-list
6025970|NCT00429702|Lorazepam|lorazepam|mesh-list
5491984|NCT00394160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5491985|NCT00394160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025971|NCT00429702|Ondansetron|ondansetron|mesh-list
6025972|NCT00429702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6025973|NCT00429702|Antiemetics|antiemetics|mesh-ancestor
5491986|NCT00380705|Montelukast|montelukast|mesh-list
5491987|NCT00380705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5491988|NCT00380705|Respiratory System Agents|respiratory system agents|mesh-ancestor
6025974|NCT00429702|Autonomic Agents|autonomic agents|mesh-ancestor
6025975|NCT00429702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6025976|NCT00429702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6025977|NCT00429702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6025978|NCT00429702|Glucocorticoids|glucocorticoids|mesh-ancestor
6025979|NCT00429702|Hormones|hormones|mesh-ancestor
6025980|NCT00429702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6025981|NCT00429702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6025982|NCT00429702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5491989|NCT00380705|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5491990|NCT00380705|Hormone Antagonists|hormone antagonists|mesh-ancestor
5491991|NCT00380705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5491992|NCT00380705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5491993|NCT00380705|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5491994|NCT00380705|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5491995|NCT00380705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5491996|NCT00276484|Atorvastatin|atorvastatin|mesh-list
5491997|NCT00276484|Ezetimibe|ezetimibe|mesh-list
5491998|NCT00276484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5491999|NCT00276484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5492000|NCT00276484|Antimetabolites|antimetabolites|mesh-ancestor
5492001|NCT00276484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492002|NCT00276484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5492003|NCT00276484|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5492004|NCT00276484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5492005|NCT00276458|Atorvastatin|atorvastatin|mesh-list
5492006|NCT00276458|Ezetimibe|ezetimibe|mesh-list
5492007|NCT00276458|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5492008|NCT00276458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5492009|NCT00276458|Antimetabolites|antimetabolites|mesh-ancestor
5492010|NCT00276458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492011|NCT00276458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5492012|NCT00276458|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6025983|NCT00429702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6025984|NCT00429702|Antipruritics|antipruritics|mesh-ancestor
6025985|NCT00429702|Dermatologic Agents|dermatologic agents|mesh-ancestor
6025986|NCT00429702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6025987|NCT00429702|Serotonin Agents|serotonin agents|mesh-ancestor
6025988|NCT00429702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6025989|NCT00429702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6025990|NCT00429702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6025991|NCT00429702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6025992|NCT00429702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6025993|NCT00429702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6025994|NCT00429702|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6025995|NCT00429702|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6025996|NCT00429702|Anesthetics, Local|anesthetics, local|mesh-ancestor
6025997|NCT00429702|Anesthetics|anesthetics|mesh-ancestor
6025998|NCT00429702|Sensory System Agents|sensory system agents|mesh-ancestor
6025999|NCT00429702|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6026000|NCT00429702|Histamine Antagonists|histamine antagonists|mesh-ancestor
6026001|NCT00429702|Histamine Agents|histamine agents|mesh-ancestor
6026002|NCT00429702|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6026003|NCT00429702|Anticonvulsants|anticonvulsants|mesh-ancestor
6026004|NCT00429702|GABA Modulators|gaba modulators|mesh-ancestor
6026005|NCT00429702|GABA Agents|gaba agents|mesh-ancestor
5492013|NCT00276458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5492014|NCT00271817|Niacin|niacin|mesh-list
5492015|NCT00271817|Niacinamide|niacinamide|mesh-list
5492016|NCT00271817|Nicotinic Acids|nicotinic acids|mesh-list
5492017|NCT00271817|Simvastatin|simvastatin|mesh-list
5492018|NCT00271817|Ezetimibe|ezetimibe|mesh-list
5492019|NCT00271817|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
5492020|NCT00271817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5492021|NCT00271817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5492022|NCT00271817|Antimetabolites|antimetabolites|mesh-ancestor
5492023|NCT00271817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026006|NCT00429793|Sirolimus|sirolimus|mesh-list
6026007|NCT00429793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6026008|NCT00429793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6026009|NCT00429793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6026010|NCT00429793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6026011|NCT00429793|Antifungal Agents|antifungal agents|mesh-ancestor
6026012|NCT00429793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6026013|NCT00429793|Immunologic Factors|immunologic factors|mesh-ancestor
6026014|NCT00429793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026015|NCT00429949|Dasatinib|dasatinib|mesh-list
6026016|NCT00429949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6026017|NCT00429949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6026018|NCT00429949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6026019|NCT00429949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026020|NCT00430183|Docetaxel|docetaxel|mesh-list
6026021|NCT00430183|Leuprolide|leuprolide|mesh-list
6026022|NCT00430183|Goserelin|goserelin|mesh-list
6026023|NCT00430183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6026024|NCT00430183|Tubulin Modulators|tubulin modulators|mesh-ancestor
6026025|NCT00430183|Antimitotic Agents|antimitotic agents|mesh-ancestor
5492024|NCT00271817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5492025|NCT00271817|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5492026|NCT00271817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5492027|NCT00271817|Vasodilator Agents|vasodilator agents|mesh-ancestor
5492028|NCT00271817|Vitamin B Complex|vitamin b complex|mesh-ancestor
5492029|NCT00271817|Vitamins|vitamins|mesh-ancestor
5492030|NCT00271817|Micronutrients|micronutrients|mesh-ancestor
5492031|NCT00271817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492032|NCT00157937|Theophylline|theophylline|mesh-list
6026026|NCT00430183|Mitosis Modulators|mitosis modulators|mesh-ancestor
6026027|NCT00430183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492033|NCT00157937|Montelukast|montelukast|mesh-list
5492034|NCT00157937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5492035|NCT00157937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492036|NCT00157937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492037|NCT00157937|Autonomic Agents|autonomic agents|mesh-ancestor
5492038|NCT00157937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5492039|NCT00157937|Respiratory System Agents|respiratory system agents|mesh-ancestor
5492040|NCT00157937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5492041|NCT00157937|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5492042|NCT00157937|Hormone Antagonists|hormone antagonists|mesh-ancestor
6026028|NCT00430183|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6026029|NCT00430183|Fertility Agents|fertility agents|mesh-ancestor
6026030|NCT00430183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6026031|NCT00430183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492043|NCT00157937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6026032|NCT00430183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6026033|NCT00430248|Allopurinol|allopurinol|mesh-list
6026034|NCT00430248|Febuxostat|febuxostat|mesh-list
6026035|NCT00430248|Antimetabolites|antimetabolites|mesh-ancestor
6026036|NCT00430248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026037|NCT00430248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6026038|NCT00430248|Gout Suppressants|gout suppressants|mesh-ancestor
6026039|NCT00430248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6026040|NCT00430248|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6026041|NCT00430248|Antioxidants|antioxidants|mesh-ancestor
6026042|NCT00430248|Protective Agents|protective agents|mesh-ancestor
6026043|NCT00430248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026044|NCT00430352|Rituximab|rituximab|mesh-list
6456125|NCT00431197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6456126|NCT00431197|Hormone Antagonists|hormone antagonists|mesh-ancestor
6456127|NCT00431197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6456128|NCT00431197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456129|NCT00431197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6456130|NCT00431197|Androgens|androgens|mesh-ancestor
6456131|NCT00431197|Hormones|hormones|mesh-ancestor
6026045|NCT00430352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5492044|NCT00157937|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5492045|NCT00157937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5492046|NCT00157937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5492047|NCT00157937|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5492048|NCT00157937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5492049|NCT00157937|Vasodilator Agents|vasodilator agents|mesh-ancestor
5492050|NCT00157937|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5492051|NCT00157937|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5492052|NCT00157937|Purinergic Agents|purinergic agents|mesh-ancestor
5492053|NCT00127647|Montelukast|montelukast|mesh-list
5492054|NCT00127647|Pranlukast|pranlukast|mesh-list
5492055|NCT00127647|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5492056|NCT00127647|Respiratory System Agents|respiratory system agents|mesh-ancestor
5492057|NCT00127647|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6026046|NCT00430352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6026047|NCT00430352|Immunologic Factors|immunologic factors|mesh-ancestor
6026048|NCT00430352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026049|NCT00430352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6026050|NCT00430521|Vaccines|vaccines|mesh-list
6026051|NCT00430521|Immunologic Factors|immunologic factors|mesh-ancestor
6026052|NCT00430521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026053|NCT00430573|Cycloserine|cycloserine|mesh-list
6026054|NCT00430573|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6026055|NCT00430573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6026056|NCT00430573|Renal Agents|renal agents|mesh-ancestor
6026057|NCT00430573|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6026058|NCT00430573|Antitubercular Agents|antitubercular agents|mesh-ancestor
6026059|NCT00430573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6026060|NCT00430573|Antimetabolites|antimetabolites|mesh-ancestor
6026061|NCT00430573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026062|NCT00430638|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6026063|NCT00430638|Olmesartan|olmesartan|mesh-list
6026064|NCT00430638|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6026065|NCT00430638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6026066|NCT00430638|Diuretics|diuretics|mesh-ancestor
6026067|NCT00430638|Natriuretic Agents|natriuretic agents|mesh-ancestor
6026068|NCT00430638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026069|NCT00430638|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6026070|NCT00430638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6026071|NCT00430638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026072|NCT00430638|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6026073|NCT00430638|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6026074|NCT00430677|Mycophenolic Acid|mycophenolic acid|mesh-list
6026075|NCT00430677|Prednisone|prednisone|mesh-list
6026076|NCT00430677|Prednisolone|prednisolone|mesh-list
6026077|NCT00430677|Abatacept|abatacept|mesh-list
6026078|NCT00430677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6026079|NCT00430677|Glucocorticoids|glucocorticoids|mesh-ancestor
6026080|NCT00430677|Hormones|hormones|mesh-ancestor
6026081|NCT00430677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6026082|NCT00430677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026083|NCT00430677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6026084|NCT00430677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6026085|NCT00430677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6026086|NCT00430677|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6026087|NCT00430677|Antitubercular Agents|antitubercular agents|mesh-ancestor
6026088|NCT00430677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6026089|NCT00430677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6026090|NCT00430677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5492058|NCT00127647|Hormone Antagonists|hormone antagonists|mesh-ancestor
5492059|NCT00127647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5492060|NCT00127647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492061|NCT00127647|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5492062|NCT00127647|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5492063|NCT00127647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492064|NCT00092989|Montelukast|montelukast|mesh-list
5492065|NCT00092989|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5492066|NCT00092989|Respiratory System Agents|respiratory system agents|mesh-ancestor
6026091|NCT00430677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026092|NCT00430677|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6026093|NCT00430677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6026094|NCT00430677|Immunologic Factors|immunologic factors|mesh-ancestor
6026095|NCT00430677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6026096|NCT00430716|Sildenafil Citrate|sildenafil citrate|mesh-list
6026097|NCT00430716|Citric Acid|citric acid|mesh-list
6026098|NCT00430716|Sodium Citrate|sodium citrate|mesh-list
6026099|NCT00430716|Anticoagulants|anticoagulants|mesh-ancestor
6026100|NCT00430716|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6026101|NCT00430716|Chelating Agents|chelating agents|mesh-ancestor
6026102|NCT00430716|Sequestering Agents|sequestering agents|mesh-ancestor
6026103|NCT00430716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026104|NCT00430716|Vasodilator Agents|vasodilator agents|mesh-ancestor
6026105|NCT00430716|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6026106|NCT00430716|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6026107|NCT00430716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6026108|NCT00430716|Urological Agents|urological agents|mesh-ancestor
6026109|NCT00430781|Lapatinib|lapatinib|mesh-list
6026110|NCT00430781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6026111|NCT00430781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6026112|NCT00430781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6026113|NCT00430781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026114|NCT00430937|Vancomycin|vancomycin|mesh-list
6026115|NCT00430937|Daptomycin|daptomycin|mesh-list
6026116|NCT00430937|Teicoplanin|teicoplanin|mesh-list
6026117|NCT00430937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6026118|NCT00430937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6026119|NCT00430989|Nitrous Oxide|nitrous oxide|mesh-list
6026120|NCT00430989|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6026121|NCT00430989|Anesthetics, General|anesthetics, general|mesh-ancestor
6026122|NCT00430989|Anesthetics|anesthetics|mesh-ancestor
6026123|NCT00430989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6026124|NCT00430989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026125|NCT00430989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6026126|NCT00430989|Analgesics|analgesics|mesh-ancestor
6026127|NCT00430989|Sensory System Agents|sensory system agents|mesh-ancestor
6026128|NCT00430989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6026129|NCT00431041|Solifenacin Succinate|solifenacin succinate|mesh-list
6026130|NCT00431041|Oxybutynin|oxybutynin|mesh-list
6026131|NCT00431041|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6026132|NCT00431041|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6026133|NCT00431041|Cholinergic Agents|cholinergic agents|mesh-ancestor
6026134|NCT00431041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6026135|NCT00431041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026136|NCT00431041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026137|NCT00431041|Urological Agents|urological agents|mesh-ancestor
6026138|NCT00431041|Parasympatholytics|parasympatholytics|mesh-ancestor
6026139|NCT00431041|Autonomic Agents|autonomic agents|mesh-ancestor
6026140|NCT00431041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6026141|NCT00431067|Afatinib|afatinib|mesh-list
6026142|NCT00431067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6026143|NCT00431067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6026144|NCT00431067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6026145|NCT00431067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026146|NCT00431132|Estradiol|estradiol|mesh-list
6026147|NCT00431132|Estrogens|estrogens|mesh-ancestor
6026148|NCT00431132|Hormones|hormones|mesh-ancestor
6026149|NCT00431132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6026150|NCT00431132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026151|NCT00431184|Pentazocine|pentazocine|mesh-list
6026152|NCT00431184|Lorazepam|lorazepam|mesh-list
6026153|NCT00431184|Anticonvulsants|anticonvulsants|mesh-ancestor
6026154|NCT00431184|Antiemetics|antiemetics|mesh-ancestor
6026155|NCT00431184|Autonomic Agents|autonomic agents|mesh-ancestor
6026156|NCT00431184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6026157|NCT00431184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492067|NCT00092989|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5492068|NCT00092989|Hormone Antagonists|hormone antagonists|mesh-ancestor
5492069|NCT00092989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5492070|NCT00092989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026158|NCT00431184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6026159|NCT00431184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6026160|NCT00431184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6026161|NCT00431184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6026162|NCT00431184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6026163|NCT00431184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6026164|NCT00431184|GABA Modulators|gaba modulators|mesh-ancestor
6026165|NCT00431184|GABA Agents|gaba agents|mesh-ancestor
6026166|NCT00431184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6026167|NCT00431184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026168|NCT00431184|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6456132|NCT00431236|Dexamethasone|dexamethasone|mesh-list
6456133|NCT00431236|Ondansetron|ondansetron|mesh-list
6456134|NCT00431236|Casopitant|casopitant|mesh-list
6026169|NCT00431184|Narcotics|narcotics|mesh-ancestor
6026170|NCT00431184|Analgesics|analgesics|mesh-ancestor
6026171|NCT00431184|Sensory System Agents|sensory system agents|mesh-ancestor
6026172|NCT00431184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6026173|NCT00431184|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6456135|NCT00431236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6456136|NCT00431236|Antiemetics|antiemetics|mesh-ancestor
6456137|NCT00431236|Autonomic Agents|autonomic agents|mesh-ancestor
6456138|NCT00431236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6456139|NCT00431236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456140|NCT00431236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6456141|NCT00431236|Glucocorticoids|glucocorticoids|mesh-ancestor
6456142|NCT00431236|Hormones|hormones|mesh-ancestor
6456143|NCT00431236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6456144|NCT00431236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6456145|NCT00431236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6456146|NCT00431236|Antipruritics|antipruritics|mesh-ancestor
6456147|NCT00431236|Dermatologic Agents|dermatologic agents|mesh-ancestor
6456148|NCT00431236|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6456149|NCT00431236|Serotonin Agents|serotonin agents|mesh-ancestor
6456150|NCT00431236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6456151|NCT00431236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456152|NCT00431236|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6456153|NCT00431236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6456154|NCT00431236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6456155|NCT00431236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6456156|NCT00431236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6456157|NCT00431236|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6026174|NCT00431444|Zoledronic Acid|zoledronic acid|mesh-list
6456158|NCT00431249|Cilostazol|cilostazol|mesh-list
6456159|NCT00431249|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6026175|NCT00431444|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
6026176|NCT00431444|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6026177|NCT00431444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026178|NCT00431444|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6026179|NCT00431444|Hormone Antagonists|hormone antagonists|mesh-ancestor
6026180|NCT00431444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6026181|NCT00431444|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6026182|NCT00431444|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6026183|NCT00431496|Cinacalcet|cinacalcet|mesh-list
6026184|NCT00431496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6026185|NCT00431496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026186|NCT00431496|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6026187|NCT00431496|Hormone Antagonists|hormone antagonists|mesh-ancestor
6026188|NCT00431496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6026189|NCT00431626|Dutasteride|dutasteride|mesh-list
6026190|NCT00431626|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6026191|NCT00431626|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6456160|NCT00431249|Autonomic Agents|autonomic agents|mesh-ancestor
6456161|NCT00431249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6026192|NCT00431626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6026193|NCT00431626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026194|NCT00431626|Hormone Antagonists|hormone antagonists|mesh-ancestor
6026195|NCT00431626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6026196|NCT00431626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026197|NCT00431847|Anesthetics|anesthetics|mesh-list
6026198|NCT00431847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6026199|NCT00431847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026200|NCT00431964|Azithromycin|azithromycin|mesh-list
6026201|NCT00431964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6026202|NCT00431964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6026203|NCT00432172|Cyclophosphamide|cyclophosphamide|mesh-list
6026204|NCT00432172|Carboplatin|carboplatin|mesh-list
5492071|NCT00092989|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5492072|NCT00092989|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5492073|NCT00092989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492074|NCT00092144|Montelukast|montelukast|mesh-list
5492075|NCT00092144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492076|NCT00092144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492077|NCT00092144|Respiratory System Agents|respiratory system agents|mesh-ancestor
5492078|NCT00092144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5492079|NCT00092144|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6026205|NCT00432172|Docetaxel|docetaxel|mesh-list
6026206|NCT00432172|Epirubicin|epirubicin|mesh-list
6026207|NCT00432172|Exemestane|exemestane|mesh-list
6026208|NCT00432172|Goserelin|goserelin|mesh-list
6026209|NCT00432172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6026210|NCT00432172|Immunologic Factors|immunologic factors|mesh-ancestor
6026211|NCT00432172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026212|NCT00432172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6026213|NCT00432172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6026214|NCT00432172|Alkylating Agents|alkylating agents|mesh-ancestor
6026215|NCT00432172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026216|NCT00432172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6026217|NCT00432172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6026218|NCT00432172|Tubulin Modulators|tubulin modulators|mesh-ancestor
6026219|NCT00432172|Antimitotic Agents|antimitotic agents|mesh-ancestor
6026220|NCT00432172|Mitosis Modulators|mitosis modulators|mesh-ancestor
6026221|NCT00432172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6026222|NCT00432172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6026223|NCT00432172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6026224|NCT00432172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6026225|NCT00432172|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6026226|NCT00432172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6026227|NCT00432172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6026228|NCT00432172|Hormone Antagonists|hormone antagonists|mesh-ancestor
6026229|NCT00432172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6026230|NCT00432172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6026231|NCT00432276|Metformin|metformin|mesh-list
6026232|NCT00432276|Pioglitazone|pioglitazone|mesh-list
6026233|NCT00432276|Alogliptin|alogliptin|mesh-list
6026234|NCT00432276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6026235|NCT00432276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026236|NCT00432276|Incretins|incretins|mesh-ancestor
6026237|NCT00432276|Hormones|hormones|mesh-ancestor
6026238|NCT00432276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6026239|NCT00432276|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6026240|NCT00432276|Protease Inhibitors|protease inhibitors|mesh-ancestor
6026241|NCT00432276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6026242|NCT00432276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026243|NCT00432341|Botulinum Toxins|botulinum toxins|mesh-list
6026244|NCT00432341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6026245|NCT00432341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6026246|NCT00432341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6026247|NCT00432341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6026248|NCT00432341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026249|NCT00432341|Cholinergic Agents|cholinergic agents|mesh-ancestor
6026250|NCT00432341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6026251|NCT00432341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026252|NCT00432341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6026253|NCT00432341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6026254|NCT00432458|Zoledronic Acid|zoledronic acid|mesh-list
6026255|NCT00432458|Thalidomide|thalidomide|mesh-list
5492080|NCT00092144|Hormone Antagonists|hormone antagonists|mesh-ancestor
5492081|NCT00092144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5492082|NCT00092144|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5492083|NCT00092144|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6026256|NCT00432458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6026257|NCT00432458|Immunologic Factors|immunologic factors|mesh-ancestor
6026258|NCT00432458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026259|NCT00432458|Leprostatic Agents|leprostatic agents|mesh-ancestor
6026260|NCT00432458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6026261|NCT00432458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6026262|NCT00432458|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6026263|NCT00432458|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6026264|NCT00432458|Growth Substances|growth substances|mesh-ancestor
6026265|NCT00432458|Growth Inhibitors|growth inhibitors|mesh-ancestor
6026266|NCT00432458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6026267|NCT00432458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6026268|NCT00432562|Vinorelbine|vinorelbine|mesh-list
6026269|NCT00432562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6026270|NCT00432562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6026271|NCT00432562|Tubulin Modulators|tubulin modulators|mesh-ancestor
6026272|NCT00432562|Antimitotic Agents|antimitotic agents|mesh-ancestor
6026273|NCT00432562|Mitosis Modulators|mitosis modulators|mesh-ancestor
6026274|NCT00432562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026275|NCT00432666|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
6026276|NCT00432666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6026277|NCT00432666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6026278|NCT00432666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026279|NCT00432666|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6026280|NCT00432666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6026281|NCT00432666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026282|NCT00432666|Cholinergic Agents|cholinergic agents|mesh-ancestor
6026283|NCT00432666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6026284|NCT00432679|Rosiglitazone|rosiglitazone|mesh-list
6026285|NCT00432679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6026286|NCT00432679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026287|NCT00432991|Ephedrine|ephedrine|mesh-list
6026288|NCT00432991|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6026289|NCT00432991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026290|NCT00432991|Sympathomimetics|sympathomimetics|mesh-ancestor
6026291|NCT00432991|Autonomic Agents|autonomic agents|mesh-ancestor
6026292|NCT00432991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6026293|NCT00432991|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6026294|NCT00432991|Adrenergic Agents|adrenergic agents|mesh-ancestor
6026295|NCT00432991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6026296|NCT00432991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026297|NCT00433004|Levonorgestrel|levonorgestrel|mesh-list
6026298|NCT00433004|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6026299|NCT00433004|Contraceptive Agents|contraceptive agents|mesh-ancestor
6026300|NCT00433004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6026301|NCT00433004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026302|NCT00433004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6026303|NCT00433004|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6026304|NCT00433004|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6026305|NCT00433017|Ranibizumab|ranibizumab|mesh-list
6026306|NCT00433017|Verteporfin|verteporfin|mesh-list
6026307|NCT00433017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6026308|NCT00433017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6026309|NCT00433017|Growth Substances|growth substances|mesh-ancestor
6026310|NCT00433017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026311|NCT00433017|Growth Inhibitors|growth inhibitors|mesh-ancestor
6026312|NCT00433017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6026313|NCT00433017|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6026314|NCT00433017|Dermatologic Agents|dermatologic agents|mesh-ancestor
6026315|NCT00433160|Teriparatide|teriparatide|mesh-list
6026316|NCT00433160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6026317|NCT00433160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026318|NCT00433160|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6026319|NCT00433199|Testosterone|testosterone|mesh-list
6026320|NCT00433199|Androgens|androgens|mesh-ancestor
6026321|NCT00433199|Hormones|hormones|mesh-ancestor
6026322|NCT00433199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6026323|NCT00433199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026324|NCT00433290|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6026325|NCT00433290|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6026326|NCT00433290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6026327|NCT00433290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6026328|NCT00433290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026329|NCT00433290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6026330|NCT00433290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026331|NCT00433290|Analgesics|analgesics|mesh-ancestor
6026332|NCT00433290|Sensory System Agents|sensory system agents|mesh-ancestor
6026333|NCT00433290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6026334|NCT00433290|Antidepressive Agents|antidepressive agents|mesh-ancestor
6026335|NCT00433290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6026336|NCT00433290|Dopamine Agents|dopamine agents|mesh-ancestor
6026337|NCT00433329|Bosentan|bosentan|mesh-list
6026338|NCT00433329|Sildenafil Citrate|sildenafil citrate|mesh-list
6026339|NCT00433329|Vasodilator Agents|vasodilator agents|mesh-ancestor
6026340|NCT00433329|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6026341|NCT00433329|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6026342|NCT00433329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6026343|NCT00433329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026344|NCT00433329|Urological Agents|urological agents|mesh-ancestor
6026345|NCT00433329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6026346|NCT00433329|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6026347|NCT00433381|Bevacizumab|bevacizumab|mesh-list
6026348|NCT00433381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6026349|NCT00433381|Irinotecan|irinotecan|mesh-list
6026350|NCT00433381|Temozolomide|temozolomide|mesh-list
6026351|NCT00433381|Camptothecin|camptothecin|mesh-list
6026352|NCT00433381|Endothelial Growth Factors|endothelial growth factors|mesh-list
6026353|NCT00433381|Antibodies|antibodies|mesh-list
6456162|NCT00431249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456163|NCT00431249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6456164|NCT00431249|Respiratory System Agents|respiratory system agents|mesh-ancestor
6456165|NCT00431249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6456166|NCT00431249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6456167|NCT00431249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456168|NCT00431249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6456169|NCT00431249|Vasodilator Agents|vasodilator agents|mesh-ancestor
6026354|NCT00433381|Immunoglobulins|immunoglobulins|mesh-list
6026355|NCT00433381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6026356|NCT00433381|Immunoglobulin G|immunoglobulin g|mesh-list
6026357|NCT00433381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6026358|NCT00433381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6026359|NCT00433381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6026360|NCT00433381|Growth Substances|growth substances|mesh-ancestor
6026361|NCT00433381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026362|NCT00433381|Growth Inhibitors|growth inhibitors|mesh-ancestor
6026363|NCT00433381|Immunologic Factors|immunologic factors|mesh-ancestor
6026364|NCT00433381|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6026365|NCT00433381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6026366|NCT00433381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6026367|NCT00433381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026368|NCT00433381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6026369|NCT00433381|Alkylating Agents|alkylating agents|mesh-ancestor
6026370|NCT00433381|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6026371|NCT00433446|Siltuximab|siltuximab|mesh-list
6026372|NCT00433446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6026373|NCT00433537|Dexamethasone|dexamethasone|mesh-list
6026374|NCT00433537|Cyclophosphamide|cyclophosphamide|mesh-list
6026375|NCT00433537|Rituximab|rituximab|mesh-list
6026376|NCT00433537|Doxorubicin|doxorubicin|mesh-list
6026377|NCT00433537|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6026378|NCT00433537|Vincristine|vincristine|mesh-list
6026379|NCT00433537|Bortezomib|bortezomib|mesh-list
6026380|NCT00433537|Lenograstim|lenograstim|mesh-list
6026381|NCT00433537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6026382|NCT00433537|Immunologic Factors|immunologic factors|mesh-ancestor
6456170|NCT00431249|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6456171|NCT00431249|Protective Agents|protective agents|mesh-ancestor
6456172|NCT00431249|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6456173|NCT00431249|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6456174|NCT00431249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6456175|NCT00431262|Disulfiram|disulfiram|mesh-list
6456176|NCT00431262|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6456177|NCT00431262|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
6456178|NCT00431262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6654642|NCT01458236|Beraprost|beraprost|mesh-list
6026383|NCT00433537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026384|NCT00433537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6026385|NCT00433537|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6026386|NCT00433537|Alkylating Agents|alkylating agents|mesh-ancestor
6026387|NCT00433537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026388|NCT00433537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6026389|NCT00433537|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6026390|NCT00433537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6026391|NCT00433537|Antiemetics|antiemetics|mesh-ancestor
6026392|NCT00433537|Autonomic Agents|autonomic agents|mesh-ancestor
6026393|NCT00433537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5492114|NCT03770689|Capecitabine|capecitabine|mesh-list
5492115|NCT03770689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5492116|NCT03770689|Antimetabolites|antimetabolites|mesh-ancestor
5492117|NCT03770689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492118|NCT03770689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5492119|NCT03760523|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
5492120|NCT03760523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6026394|NCT00433537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6026395|NCT00433537|Glucocorticoids|glucocorticoids|mesh-ancestor
6026396|NCT00433537|Hormones|hormones|mesh-ancestor
6026397|NCT00433537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6026398|NCT00433537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6026399|NCT00433537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6026400|NCT00433537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6026401|NCT00433537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6026402|NCT00433537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6026403|NCT00433537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6026404|NCT00433537|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6026405|NCT00433537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6026406|NCT00433537|Tubulin Modulators|tubulin modulators|mesh-ancestor
6026407|NCT00433537|Antimitotic Agents|antimitotic agents|mesh-ancestor
6026408|NCT00433537|Mitosis Modulators|mitosis modulators|mesh-ancestor
6026409|NCT00433550|Capecitabine|capecitabine|mesh-list
6026410|NCT00433550|Oxaliplatin|oxaliplatin|mesh-list
6026411|NCT00433550|Irinotecan|irinotecan|mesh-list
6026412|NCT00433550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6026413|NCT00433550|Antimetabolites|antimetabolites|mesh-ancestor
6026414|NCT00433550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026415|NCT00433550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6026416|NCT00433550|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6026417|NCT00433550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6026418|NCT00433550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6026419|NCT00433745|Vaccines|vaccines|mesh-list
6026420|NCT00433745|Immunologic Factors|immunologic factors|mesh-ancestor
6026421|NCT00433745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026422|NCT00433836|Valsartan|valsartan|mesh-list
6026423|NCT00433836|Enalapril|enalapril|mesh-list
5492121|NCT03760523|Alkylating Agents|alkylating agents|mesh-ancestor
5492122|NCT03760523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492123|NCT03760523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5492124|NCT03754153|Atropine|atropine|mesh-list
5492125|NCT03754153|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5492126|NCT03754153|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5492127|NCT03754153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5492128|NCT03754153|Autonomic Agents|autonomic agents|mesh-ancestor
6026424|NCT00433836|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6026425|NCT00433836|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5492129|NCT03754153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6026426|NCT00433836|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6026427|NCT00433836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026428|NCT00433836|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6026429|NCT00433836|Protease Inhibitors|protease inhibitors|mesh-ancestor
6026430|NCT00433836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6026431|NCT00433914|Vaccines|vaccines|mesh-list
6026432|NCT00433914|Immunologic Factors|immunologic factors|mesh-ancestor
6026433|NCT00433914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026434|NCT00433966|Paclitaxel|paclitaxel|mesh-list
6026435|NCT00433966|Heparin|heparin|mesh-list
6026436|NCT00433966|Calcium heparin|calcium heparin|mesh-list
6026437|NCT00433966|Bivalirudin|bivalirudin|mesh-list
6026438|NCT00433966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6026439|NCT00433966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6026440|NCT00433966|Tubulin Modulators|tubulin modulators|mesh-ancestor
6026441|NCT00433966|Antimitotic Agents|antimitotic agents|mesh-ancestor
6026442|NCT00433966|Mitosis Modulators|mitosis modulators|mesh-ancestor
6026443|NCT00433966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026444|NCT00433966|Anticoagulants|anticoagulants|mesh-ancestor
6026445|NCT00433966|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6456179|NCT00431262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492130|NCT03754153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026446|NCT00433966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5492131|NCT03754153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5492132|NCT03754153|Respiratory System Agents|respiratory system agents|mesh-ancestor
5492133|NCT03754153|Mydriatics|mydriatics|mesh-ancestor
5492134|NCT03754153|Parasympatholytics|parasympatholytics|mesh-ancestor
5492135|NCT03754153|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5492136|NCT03754153|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5492137|NCT03754153|Cholinergic Agents|cholinergic agents|mesh-ancestor
5492138|NCT03754153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5492139|NCT03754153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492140|NCT03753074|Tenofovir|tenofovir|mesh-list
5492141|NCT03753074|Antiviral Agents|antiviral agents|mesh-ancestor
5492142|NCT03753074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6026447|NCT00433966|Antithrombins|antithrombins|mesh-ancestor
6026448|NCT00433966|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6026449|NCT00433966|Protease Inhibitors|protease inhibitors|mesh-ancestor
6026450|NCT00433966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6026451|NCT00434109|Sunitinib|sunitinib|mesh-list
6026452|NCT00434109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6026453|NCT00434109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6026454|NCT00434109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6026455|NCT00434109|Growth Substances|growth substances|mesh-ancestor
6026456|NCT00434109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026457|NCT00434109|Growth Inhibitors|growth inhibitors|mesh-ancestor
6026458|NCT00434109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6026459|NCT00434109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6026460|NCT00434109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026461|NCT00434148|Pasireotide|pasireotide|mesh-list
6026462|NCT00434148|Hormones|hormones|mesh-ancestor
6026463|NCT00434148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6026464|NCT00434148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026465|NCT00434213|Methylphenidate|methylphenidate|mesh-list
6026466|NCT00434213|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6026467|NCT00434213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492143|NCT03753074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5492144|NCT03753074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5492145|NCT03753074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5492146|NCT03753074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492147|NCT03753074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5492148|NCT03753074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5492149|NCT03748784|Aflibercept|aflibercept|mesh-list
5492150|NCT03748784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5492151|NCT03748784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5492152|NCT03748784|Growth Substances|growth substances|mesh-ancestor
5492153|NCT03748784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492154|NCT03748784|Growth Inhibitors|growth inhibitors|mesh-ancestor
5492155|NCT03748784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5492156|NCT03746301|Rivaroxaban|rivaroxaban|mesh-list
5492157|NCT03746301|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5492158|NCT03746301|Antithrombins|antithrombins|mesh-ancestor
5492159|NCT03746301|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6026468|NCT00434213|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6026469|NCT00434213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6026470|NCT00434213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6026471|NCT00434213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026472|NCT00434213|Dopamine Agents|dopamine agents|mesh-ancestor
6026473|NCT00434213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6026474|NCT00434252|Paclitaxel|paclitaxel|mesh-list
6026475|NCT00434252|Bevacizumab|bevacizumab|mesh-list
6026476|NCT00434252|Carboplatin|carboplatin|mesh-list
6026477|NCT00434252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6026478|NCT00434252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6026479|NCT00434252|Tubulin Modulators|tubulin modulators|mesh-ancestor
6456180|NCT00431275|Tremelimumab|tremelimumab|mesh-list
6456181|NCT00431275|Ipilimumab|ipilimumab|mesh-list
6456182|NCT00431275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6456183|NCT00431275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6026480|NCT00434252|Antimitotic Agents|antimitotic agents|mesh-ancestor
6026481|NCT00434252|Mitosis Modulators|mitosis modulators|mesh-ancestor
6026482|NCT00434252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026483|NCT00434252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6026484|NCT00434252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6026485|NCT00434252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6026486|NCT00434252|Growth Substances|growth substances|mesh-ancestor
6026487|NCT00434252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026488|NCT00434252|Growth Inhibitors|growth inhibitors|mesh-ancestor
6026489|NCT00434304|Ropinirole|ropinirole|mesh-list
6456184|NCT00431275|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5492160|NCT03746301|Protease Inhibitors|protease inhibitors|mesh-ancestor
5492161|NCT03746301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5492162|NCT03746301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492163|NCT03746301|Anticoagulants|anticoagulants|mesh-ancestor
5503028|NCT04462822|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5503029|NCT04462822|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5503030|NCT04462822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5503031|NCT04462822|Adrenergic Agents|adrenergic agents|mesh-ancestor
5503032|NCT04462822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5503033|NCT04462822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503034|NCT04462822|Glucocorticoids|glucocorticoids|mesh-ancestor
5503035|NCT04462822|Hormones|hormones|mesh-ancestor
5503036|NCT04462822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5503037|NCT04462822|Sympathomimetics|sympathomimetics|mesh-ancestor
5503038|NCT04462809|Talazoparib|talazoparib|mesh-list
5503039|NCT04462809|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5503040|NCT04462809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5503041|NCT04462809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503042|NCT04462809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5503043|NCT04462666|Etoricoxib|etoricoxib|mesh-list
5503044|NCT04462666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5503045|NCT04462666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5503046|NCT04462666|Analgesics|analgesics|mesh-ancestor
5503047|NCT04462666|Sensory System Agents|sensory system agents|mesh-ancestor
5503048|NCT04462666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5503049|NCT04462666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503050|NCT04462666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5503051|NCT04462666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5503052|NCT04462666|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5503053|NCT04462666|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5503054|NCT04462666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5724894|NCT03184493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5724895|NCT03184493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5724896|NCT03184493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5724897|NCT03184493|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5724898|NCT03184493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5724899|NCT03184493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5724900|NCT03184493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724901|NCT03184363|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5724902|NCT03184363|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5724903|NCT03184363|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5724904|NCT03184363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5724905|NCT03184363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026490|NCT00434304|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6026491|NCT00434304|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6026492|NCT00434304|Dopamine Agonists|dopamine agonists|mesh-ancestor
6026493|NCT00434304|Dopamine Agents|dopamine agents|mesh-ancestor
6026494|NCT00434304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6026495|NCT00434304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026496|NCT00434304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026497|NCT00434356|Paclitaxel|paclitaxel|mesh-list
6026498|NCT00434356|Bevacizumab|bevacizumab|mesh-list
6026499|NCT00434356|Sunitinib|sunitinib|mesh-list
6026500|NCT00434356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6026501|NCT00434356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6026502|NCT00434356|Tubulin Modulators|tubulin modulators|mesh-ancestor
6026503|NCT00434356|Antimitotic Agents|antimitotic agents|mesh-ancestor
6026504|NCT00434356|Mitosis Modulators|mitosis modulators|mesh-ancestor
6026505|NCT00434356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026506|NCT00434356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6026507|NCT00434356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6026508|NCT00434356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6026509|NCT00434356|Growth Substances|growth substances|mesh-ancestor
6026510|NCT00434356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026511|NCT00434356|Growth Inhibitors|growth inhibitors|mesh-ancestor
6026512|NCT00434356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6026513|NCT00434356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6026514|NCT00434434|Omalizumab|omalizumab|mesh-list
6026515|NCT00434434|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6026516|NCT00434434|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6026517|NCT00434434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6026518|NCT00434434|Respiratory System Agents|respiratory system agents|mesh-ancestor
6026519|NCT00434434|Immunologic Factors|immunologic factors|mesh-ancestor
6026520|NCT00434434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026521|NCT00434577|Vaccines|vaccines|mesh-list
6026522|NCT00434577|Immunologic Factors|immunologic factors|mesh-ancestor
6026523|NCT00434577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026524|NCT00434642|Gemcitabine|gemcitabine|mesh-list
6026525|NCT00434642|Bevacizumab|bevacizumab|mesh-list
6026526|NCT00434642|Carboplatin|carboplatin|mesh-list
6026527|NCT00434642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6026528|NCT00434642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6026529|NCT00434642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6026530|NCT00434642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6026531|NCT00434642|Growth Substances|growth substances|mesh-ancestor
6026532|NCT00434642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492164|NCT03731923|Liver Extracts|liver extracts|mesh-list
5492165|NCT03731923|Hematinics|hematinics|mesh-ancestor
5492166|NCT03727633|Idarubicin|idarubicin|mesh-list
5492167|NCT03727633|Ethiodized Oil|ethiodized oil|mesh-list
5492168|NCT03727633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5492169|NCT03727633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6026533|NCT00434642|Growth Inhibitors|growth inhibitors|mesh-ancestor
6026534|NCT00434642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6026535|NCT00434642|Antimetabolites|antimetabolites|mesh-ancestor
6026536|NCT00434642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026537|NCT00434642|Antiviral Agents|antiviral agents|mesh-ancestor
6026538|NCT00434642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6026539|NCT00434642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6026540|NCT00434642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6026541|NCT00434642|Immunologic Factors|immunologic factors|mesh-ancestor
6026542|NCT00434876|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6026543|NCT00434876|Antidepressive Agents|antidepressive agents|mesh-ancestor
6026544|NCT00434876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6026545|NCT00434876|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6026546|NCT00434876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6026547|NCT00434876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6456185|NCT00431275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492170|NCT03727633|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5492171|NCT03727633|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6026548|NCT00434876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456186|NCT00431340|Belinostat|belinostat|mesh-list
5492172|NCT03727633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6026549|NCT00434954|Insulin Aspart|insulin aspart|mesh-list
6026550|NCT00434954|Exenatide|exenatide|mesh-list
6026551|NCT00434954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6026552|NCT00434954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026553|NCT00434954|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6026554|NCT00434954|Incretins|incretins|mesh-ancestor
6026555|NCT00434954|Hormones|hormones|mesh-ancestor
6026556|NCT00434954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6026557|NCT00434967|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6026558|NCT00434967|Candesartan|candesartan|mesh-list
6026559|NCT00434967|Candesartan cilexetil|candesartan cilexetil|mesh-list
6026560|NCT00434967|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6026561|NCT00434967|Diuretics|diuretics|mesh-ancestor
6026562|NCT00434967|Natriuretic Agents|natriuretic agents|mesh-ancestor
6026563|NCT00434967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026564|NCT00434967|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6026565|NCT00434967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6026566|NCT00434967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026567|NCT00434967|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6026568|NCT00434967|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6026569|NCT00434993|Albuterol|albuterol|mesh-list
6026570|NCT00434993|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6026571|NCT00434993|Autonomic Agents|autonomic agents|mesh-ancestor
6026572|NCT00434993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6026573|NCT00434993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026574|NCT00434993|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6026575|NCT00434993|Respiratory System Agents|respiratory system agents|mesh-ancestor
6026576|NCT00434993|Tocolytic Agents|tocolytic agents|mesh-ancestor
6026577|NCT00434993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6026578|NCT00434993|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6026579|NCT00434993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6026580|NCT00434993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6026581|NCT00434993|Adrenergic Agents|adrenergic agents|mesh-ancestor
6026582|NCT00434993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6026583|NCT00434993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026584|NCT00435019|Insulin|insulin|mesh-list
6026585|NCT00435019|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6026586|NCT00435019|Insulin Aspart|insulin aspart|mesh-list
6456187|NCT00431340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6456188|NCT00431340|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6026587|NCT00435019|Insulin Detemir|insulin detemir|mesh-list
6026588|NCT00435019|Isophane Insulin, Human|isophane insulin, human|mesh-list
6026589|NCT00435019|Insulin, Isophane|insulin, isophane|mesh-list
6026590|NCT00435019|Isophane insulin, beef|isophane insulin, beef|mesh-list
6026591|NCT00435019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6026592|NCT00435019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053380|NCT00594854|Misoprostol|misoprostol|mesh-list
6053381|NCT00594854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6053382|NCT00594854|Abortifacient Agents|abortifacient agents|mesh-ancestor
6053383|NCT00594854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6053384|NCT00594854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053385|NCT00594854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6053386|NCT00594854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6053387|NCT00594854|Oxytocics|oxytocics|mesh-ancestor
6053388|NCT00594854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6053389|NCT00594854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6053390|NCT00594854|Analgesics|analgesics|mesh-ancestor
6053391|NCT00594854|Sensory System Agents|sensory system agents|mesh-ancestor
6053392|NCT00594854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6053393|NCT00594854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6053394|NCT00594854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6053395|NCT00594854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6053396|NCT00594854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6053397|NCT00594854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053398|NCT00594880|Interferons|interferons|mesh-list
6053399|NCT00594880|Interferon-alpha|interferon-alpha|mesh-list
6053400|NCT00594880|Interferon alpha-2|interferon alpha-2|mesh-list
6053401|NCT00594880|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6053402|NCT00594880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6053403|NCT00594880|Antiviral Agents|antiviral agents|mesh-ancestor
6053404|NCT00594880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6053405|NCT00594880|Immunologic Factors|immunologic factors|mesh-ancestor
6053406|NCT00594880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053407|NCT00594906|Teriparatide|teriparatide|mesh-list
6456189|NCT00431340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6456190|NCT00431340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456191|NCT00431353|Valganciclovir|valganciclovir|mesh-list
6456192|NCT00431353|Ganciclovir|ganciclovir|mesh-list
6456193|NCT00431353|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6456194|NCT00431353|Antiviral Agents|antiviral agents|mesh-ancestor
6456195|NCT00431353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6456196|NCT00431353|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6456197|NCT00431353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6456198|NCT00431353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456199|NCT00431379|Tenecteplase|tenecteplase|mesh-list
6456200|NCT00431379|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6026593|NCT00435045|Atorvastatin|atorvastatin|mesh-list
6026594|NCT00435045|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6026595|NCT00435045|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6026596|NCT00435045|Antimetabolites|antimetabolites|mesh-ancestor
6026597|NCT00435045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026598|NCT00435045|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6026599|NCT00435045|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5492173|NCT03727633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492174|NCT03713593|Pembrolizumab|pembrolizumab|mesh-list
5492175|NCT03713593|Lenvatinib|lenvatinib|mesh-list
5492176|NCT03713593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6026600|NCT00435045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6026601|NCT00435162|Valsartan|valsartan|mesh-list
6026602|NCT00435162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6026603|NCT00435162|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6026604|NCT00435162|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6026605|NCT00435162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026606|NCT00435370|Tropisetron|tropisetron|mesh-list
6026607|NCT00435370|Risperidone|risperidone|mesh-list
6026608|NCT00435370|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6026609|NCT00435370|Serotonin Agents|serotonin agents|mesh-ancestor
6026610|NCT00435370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6026611|NCT00435370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026612|NCT00435370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026613|NCT00435370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6026614|NCT00435370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6026615|NCT00435370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6026616|NCT00435370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6026617|NCT00435370|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6026618|NCT00435370|Dopamine Agents|dopamine agents|mesh-ancestor
6026619|NCT00435370|Antiemetics|antiemetics|mesh-ancestor
6026620|NCT00435370|Autonomic Agents|autonomic agents|mesh-ancestor
6026621|NCT00435370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6654643|NCT01458236|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6654644|NCT01458236|Vasodilator Agents|vasodilator agents|mesh-ancestor
6654645|NCT01458301|Leuprolide|leuprolide|mesh-list
5492177|NCT03713593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5492178|NCT03713593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5492179|NCT03713593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5492180|NCT03713593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492181|NCT03713086|Vaccines|vaccines|mesh-list
5492182|NCT03713086|Immunologic Factors|immunologic factors|mesh-ancestor
5492183|NCT03713086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492184|NCT03704298|Cyclophosphamide|cyclophosphamide|mesh-list
5492185|NCT03704298|Fludarabine|fludarabine|mesh-list
5492186|NCT03704298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5492187|NCT03704298|Immunologic Factors|immunologic factors|mesh-ancestor
5492188|NCT03704298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654646|NCT01458301|Relugolix|relugolix|mesh-list
6654647|NCT01458301|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6654648|NCT01458301|Fertility Agents|fertility agents|mesh-ancestor
6654649|NCT01458301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6654650|NCT01458301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654651|NCT01458301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6654652|NCT01458301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6654653|NCT01458301|Androgen Antagonists|androgen antagonists|mesh-ancestor
6654654|NCT01458301|Hormone Antagonists|hormone antagonists|mesh-ancestor
6654655|NCT01458301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6654656|NCT01458431|Anesthetics|anesthetics|mesh-list
6654657|NCT01458431|Levobupivacaine|levobupivacaine|mesh-list
6654658|NCT01458431|Anesthetics, Local|anesthetics, local|mesh-list
6654659|NCT01458431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6026622|NCT00435370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6026623|NCT00435370|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6026624|NCT00435409|Capecitabine|capecitabine|mesh-list
6026625|NCT00435409|Sunitinib|sunitinib|mesh-list
6026626|NCT00435409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6026627|NCT00435409|Antimetabolites|antimetabolites|mesh-ancestor
6026628|NCT00435409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492189|NCT03704298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5492190|NCT03704298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5492191|NCT03704298|Alkylating Agents|alkylating agents|mesh-ancestor
5492192|NCT03704298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492193|NCT03704298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5492194|NCT03704298|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6026629|NCT00435409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6026630|NCT00435409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6026631|NCT00435409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6026632|NCT00435409|Growth Substances|growth substances|mesh-ancestor
6026633|NCT00435409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026634|NCT00435409|Growth Inhibitors|growth inhibitors|mesh-ancestor
6026635|NCT00435409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6026636|NCT00435409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6026637|NCT00435461|Fluticasone|fluticasone|mesh-list
6026638|NCT00435461|Xhance|xhance|mesh-list
6026639|NCT00435461|Fexofenadine|fexofenadine|mesh-list
6026640|NCT00435461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6026641|NCT00435461|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5492195|NCT03699540|Ethanol|ethanol|mesh-list
5492196|NCT03699540|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5492197|NCT03699540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5492198|NCT03699540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5492199|NCT03699540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026642|NCT00435461|Autonomic Agents|autonomic agents|mesh-ancestor
6026643|NCT00435461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6026644|NCT00435461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026645|NCT00435461|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6026646|NCT00435461|Respiratory System Agents|respiratory system agents|mesh-ancestor
6026647|NCT00435461|Dermatologic Agents|dermatologic agents|mesh-ancestor
6026648|NCT00435461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6026649|NCT00435461|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6026650|NCT00435461|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5492200|NCT03697876|Hyaluronic Acid|hyaluronic acid|mesh-list
5492201|NCT03697876|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5492202|NCT03697876|Immunologic Factors|immunologic factors|mesh-ancestor
5492203|NCT03697876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492204|NCT03697876|Viscosupplements|viscosupplements|mesh-ancestor
5492205|NCT03697876|Protective Agents|protective agents|mesh-ancestor
5492206|NCT03690765|Dydrogesterone|dydrogesterone|mesh-list
5492207|NCT03690765|Progestins|progestins|mesh-ancestor
5492208|NCT03690765|Hormones|hormones|mesh-ancestor
5492209|NCT03690765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5492210|NCT03690765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492211|NCT03686813|Sildenafil Citrate|sildenafil citrate|mesh-list
5492212|NCT03686813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492213|NCT03686813|Vasodilator Agents|vasodilator agents|mesh-ancestor
5492214|NCT03686813|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5492215|NCT03686813|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5492216|NCT03686813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5492217|NCT03686813|Urological Agents|urological agents|mesh-ancestor
5492218|NCT03679624|Daratumumab|daratumumab|mesh-list
6026651|NCT00435461|Histamine Antagonists|histamine antagonists|mesh-ancestor
6026652|NCT00435461|Histamine Agents|histamine agents|mesh-ancestor
6026653|NCT00435461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6026654|NCT00435461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026655|NCT00435487|Heparin|heparin|mesh-list
6026656|NCT00435487|Calcium heparin|calcium heparin|mesh-list
6026657|NCT00435487|Dalteparin|dalteparin|mesh-list
6026658|NCT00435487|Tinzaparin|tinzaparin|mesh-list
6026659|NCT00435487|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6026660|NCT00435487|Anticoagulants|anticoagulants|mesh-ancestor
6026661|NCT00435487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6026662|NCT00435487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6026663|NCT00435487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026664|NCT00435539|Plasminogen|plasminogen|mesh-list
6026665|NCT00435539|Fibrinolysin|fibrinolysin|mesh-list
6026666|NCT00435539|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6026667|NCT00435539|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6026668|NCT00435539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026669|NCT00435591|Conivaptan|conivaptan|mesh-list
6026670|NCT00435591|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6026671|NCT00435591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492219|NCT03679624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5492220|NCT03658304|Mitomycins|mitomycins|mesh-list
5492221|NCT03658304|Mitomycin|mitomycin|mesh-list
5492222|NCT03658304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5492223|NCT03658304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5492224|NCT03658304|Alkylating Agents|alkylating agents|mesh-ancestor
5492225|NCT03658304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492226|NCT03658304|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5492227|NCT03658304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5492228|NCT03653247|Plerixafor|plerixafor|mesh-list
5492229|NCT03653247|Busulfan|busulfan|mesh-list
5492230|NCT03653247|Alkylating Agents|alkylating agents|mesh-ancestor
6026672|NCT00435591|Natriuretic Agents|natriuretic agents|mesh-ancestor
6026673|NCT00435591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026674|NCT00435812|Vaccines|vaccines|mesh-list
6026675|NCT00435812|Immunologic Factors|immunologic factors|mesh-ancestor
6026676|NCT00435812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026677|NCT00435825|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6026678|NCT00435825|Antiviral Agents|antiviral agents|mesh-ancestor
6026679|NCT00435825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6026680|NCT00435929|Ritonavir|ritonavir|mesh-list
5492231|NCT03653247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492232|NCT03653247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6026681|NCT00435929|Saquinavir|saquinavir|mesh-list
5492233|NCT03653247|Immunologic Factors|immunologic factors|mesh-ancestor
5492234|NCT03653247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492235|NCT03653247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5492236|NCT03653247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5492237|NCT03653247|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5492238|NCT03653247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5492239|NCT03653247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5492240|NCT03653247|Antiviral Agents|antiviral agents|mesh-ancestor
5492241|NCT03653247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5492242|NCT03642028|Suvorexant|suvorexant|mesh-list
5492243|NCT03642028|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5492244|NCT03642028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5492245|NCT03642028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5492246|NCT03642028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492247|NCT03642028|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
5492248|NCT03642028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5492249|NCT03642028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026682|NCT00435929|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6026683|NCT00435929|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6026684|NCT00435929|Protease Inhibitors|protease inhibitors|mesh-ancestor
6026685|NCT00435929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6026686|NCT00435929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026687|NCT00435929|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6026688|NCT00435929|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6026689|NCT00435929|Antiviral Agents|antiviral agents|mesh-ancestor
6026690|NCT00435929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6026691|NCT00435929|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6026692|NCT00435929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6026693|NCT00435994|Epinephrine|epinephrine|mesh-list
6026694|NCT00435994|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6026695|NCT00435994|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6026696|NCT00435994|Adrenergic Agents|adrenergic agents|mesh-ancestor
6026697|NCT00435994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5492250|NCT03636451|Lidocaine|lidocaine|mesh-list
5492251|NCT03636451|Anesthetics, Local|anesthetics, local|mesh-ancestor
5492252|NCT03636451|Anesthetics|anesthetics|mesh-ancestor
5492253|NCT03636451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5492254|NCT03636451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492255|NCT03636451|Sensory System Agents|sensory system agents|mesh-ancestor
5492256|NCT03636451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5492257|NCT03636451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5492258|NCT03636451|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5492259|NCT03636451|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5492260|NCT03636451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5492261|NCT03636451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492262|NCT03629340|Metformin|metformin|mesh-list
5492263|NCT03629340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5492264|NCT03629340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492265|NCT03629171|Cytarabine|cytarabine|mesh-list
5492266|NCT03629171|Daunorubicin|daunorubicin|mesh-list
5492267|NCT03629171|Venetoclax|venetoclax|mesh-list
5492268|NCT03629171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5492269|NCT03629171|Antimetabolites|antimetabolites|mesh-ancestor
5492270|NCT03629171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492271|NCT03629171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5492272|NCT03629171|Antiviral Agents|antiviral agents|mesh-ancestor
5492273|NCT03629171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5492274|NCT03629171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5492275|NCT03629171|Immunologic Factors|immunologic factors|mesh-ancestor
5492276|NCT03629171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492277|NCT03629171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5492278|NCT03629171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5492279|NCT03629171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5492280|NCT03629171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6026698|NCT00435994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026699|NCT00435994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026700|NCT00435994|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6026701|NCT00435994|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6026702|NCT00435994|Autonomic Agents|autonomic agents|mesh-ancestor
6026703|NCT00435994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6026704|NCT00435994|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6026705|NCT00435994|Respiratory System Agents|respiratory system agents|mesh-ancestor
6026706|NCT00435994|Mydriatics|mydriatics|mesh-ancestor
5492284|NCT03622775|Daratumumab|daratumumab|mesh-list
6026707|NCT00435994|Sympathomimetics|sympathomimetics|mesh-ancestor
6026708|NCT00435994|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5492285|NCT03622775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5492286|NCT03618134|Durvalumab|durvalumab|mesh-list
6026709|NCT00436007|Vaccines|vaccines|mesh-list
6026710|NCT00436007|Immunologic Factors|immunologic factors|mesh-ancestor
6026711|NCT00436007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492287|NCT03618134|Ipilimumab|ipilimumab|mesh-list
5492288|NCT03618134|Tremelimumab|tremelimumab|mesh-list
5492289|NCT03618134|Immunoglobulins|immunoglobulins|mesh-list
5492290|NCT03618134|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5492291|NCT03618134|Immunoglobulin G|immunoglobulin g|mesh-list
5492292|NCT03618134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5492293|NCT03618134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6026712|NCT00436046|Interferons|interferons|mesh-list
6026713|NCT00436046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6026714|NCT00436046|Antiviral Agents|antiviral agents|mesh-ancestor
6026715|NCT00436046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6026716|NCT00436163|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6026717|NCT00436163|Antiviral Agents|antiviral agents|mesh-ancestor
6026718|NCT00436163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6026719|NCT00436215|Bevacizumab|bevacizumab|mesh-list
6026720|NCT00436215|Sorafenib|sorafenib|mesh-list
6026721|NCT00436215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6026722|NCT00436215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6026723|NCT00436215|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6026724|NCT00436215|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6026725|NCT00436215|Growth Substances|growth substances|mesh-ancestor
5492294|NCT03618134|Immunologic Factors|immunologic factors|mesh-ancestor
5492295|NCT03618134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492296|NCT03618134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6026726|NCT00436215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026727|NCT00436215|Growth Inhibitors|growth inhibitors|mesh-ancestor
6026728|NCT00436215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6026729|NCT00436215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6026730|NCT00436215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026731|NCT00436280|Gemcitabine|gemcitabine|mesh-list
6026732|NCT00436280|Rituximab|rituximab|mesh-list
6026733|NCT00436280|Oxaliplatin|oxaliplatin|mesh-list
6026734|NCT00436280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6026735|NCT00436280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6026736|NCT00436280|Immunologic Factors|immunologic factors|mesh-ancestor
6026737|NCT00436280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026738|NCT00436280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5492297|NCT03618134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492298|NCT03603509|Vaccines|vaccines|mesh-list
5492299|NCT03603509|Immunologic Factors|immunologic factors|mesh-ancestor
6026739|NCT00436280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6026740|NCT00436280|Antimetabolites|antimetabolites|mesh-ancestor
6026741|NCT00436280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026742|NCT00436280|Antiviral Agents|antiviral agents|mesh-ancestor
6026743|NCT00436280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6026744|NCT00436280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6026745|NCT00436280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6026746|NCT00436332|Bevacizumab|bevacizumab|mesh-list
6026747|NCT00436332|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6026748|NCT00436332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6026749|NCT00436332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6026750|NCT00436332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6026751|NCT00436332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6026752|NCT00436332|Growth Substances|growth substances|mesh-ancestor
6026753|NCT00436332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026754|NCT00436332|Growth Inhibitors|growth inhibitors|mesh-ancestor
6026755|NCT00436332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6026756|NCT00436332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6026757|NCT00436332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026758|NCT00436345|Remifentanil|remifentanil|mesh-list
6026759|NCT00436345|Propofol|propofol|mesh-list
6026760|NCT00436345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6026761|NCT00436345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6026762|NCT00436345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026763|NCT00436345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6026764|NCT00436345|Anesthetics, General|anesthetics, general|mesh-ancestor
6026765|NCT00436345|Anesthetics|anesthetics|mesh-ancestor
6026766|NCT00436345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6026767|NCT00436345|Narcotics|narcotics|mesh-ancestor
5492300|NCT03603509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026768|NCT00436345|Analgesics|analgesics|mesh-ancestor
6026769|NCT00436345|Sensory System Agents|sensory system agents|mesh-ancestor
6026770|NCT00436345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6026771|NCT00436436|Temozolomide|temozolomide|mesh-list
6026772|NCT00436436|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
6026773|NCT00436436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6456201|NCT00431379|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6456202|NCT00431379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456203|NCT00431392|Atropine|atropine|mesh-list
6456204|NCT00431392|Propranolol|propranolol|mesh-list
6456205|NCT00431392|Phenylephrine|phenylephrine|mesh-list
6456206|NCT00431392|Oxymetazoline|oxymetazoline|mesh-list
6456207|NCT00431392|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
6456208|NCT00431392|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6456209|NCT00431392|Mydriatics|mydriatics|mesh-ancestor
6456210|NCT00431392|Autonomic Agents|autonomic agents|mesh-ancestor
6456211|NCT00431392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6456212|NCT00431392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456213|NCT00431392|Sympathomimetics|sympathomimetics|mesh-ancestor
6456214|NCT00431392|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6456215|NCT00431392|Nasal Decongestants|nasal decongestants|mesh-ancestor
6456216|NCT00431392|Respiratory System Agents|respiratory system agents|mesh-ancestor
6456217|NCT00431392|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6456218|NCT00431392|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6456219|NCT00431392|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6456220|NCT00431392|Adrenergic Agents|adrenergic agents|mesh-ancestor
6456221|NCT00431392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5492301|NCT03580161|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
5492302|NCT03580161|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
5492303|NCT03580161|Technetium Tc 99m Mertiatide|technetium tc 99m mertiatide|mesh-list
5492304|NCT03580161|Technetium Tc 99m Dimercaptosuccinic Acid|technetium tc 99m dimercaptosuccinic acid|mesh-list
5492305|NCT03580161|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5492306|NCT03580161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492307|NCT03574571|Docetaxel|docetaxel|mesh-list
5492308|NCT03574571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5492309|NCT03574571|Tubulin Modulators|tubulin modulators|mesh-ancestor
5492310|NCT03574571|Antimitotic Agents|antimitotic agents|mesh-ancestor
5492311|NCT03574571|Mitosis Modulators|mitosis modulators|mesh-ancestor
5492312|NCT03574571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492313|NCT03572049|Itraconazole|itraconazole|mesh-list
5492314|NCT03572049|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
5492315|NCT03572049|Antifungal Agents|antifungal agents|mesh-ancestor
5492316|NCT03572049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5492317|NCT03572049|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5492318|NCT03572049|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5492319|NCT03572049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5492320|NCT03572049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492321|NCT03572049|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5492322|NCT03572049|Hormone Antagonists|hormone antagonists|mesh-ancestor
5492323|NCT03572049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5492324|NCT03572049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492325|NCT03572049|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5492326|NCT03571334|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
5492327|NCT03571334|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5492328|NCT03571334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5492329|NCT03571334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026774|NCT00436436|Alkylating Agents|alkylating agents|mesh-ancestor
6456222|NCT00431392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456223|NCT00431392|Protective Agents|protective agents|mesh-ancestor
6456224|NCT00431392|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6456225|NCT00431392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6456226|NCT00431392|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6456227|NCT00431392|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6456228|NCT00431392|Parasympatholytics|parasympatholytics|mesh-ancestor
6456229|NCT00431392|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5492330|NCT03571334|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5492331|NCT03571334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5492332|NCT03571334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456230|NCT00431392|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6456231|NCT00431392|Cholinergic Agents|cholinergic agents|mesh-ancestor
6456232|NCT00431392|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6456233|NCT00431392|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6456234|NCT00431392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6456235|NCT00431392|Vasodilator Agents|vasodilator agents|mesh-ancestor
6456236|NCT00431392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6026775|NCT00436436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026776|NCT00436436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6026777|NCT00436436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6026778|NCT00436475|Calcium, Dietary|calcium, dietary|mesh-list
6026779|NCT00436475|Vitamin D|vitamin d|mesh-list
6026780|NCT00436475|Ergocalciferols|ergocalciferols|mesh-list
6026781|NCT00436475|Cholecalciferol|cholecalciferol|mesh-list
6026782|NCT00436475|Vitamins|vitamins|mesh-list
6026783|NCT00436475|Calcium Carbonate|calcium carbonate|mesh-list
6026784|NCT00436475|Calcium|calcium|mesh-list
6026785|NCT00436475|Micronutrients|micronutrients|mesh-ancestor
6026786|NCT00436475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026787|NCT00436475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6026788|NCT00436475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5492333|NCT03571334|Cholinergic Agents|cholinergic agents|mesh-ancestor
5492334|NCT03571334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5492335|NCT03570619|Nivolumab|nivolumab|mesh-list
5492336|NCT03570619|Ipilimumab|ipilimumab|mesh-list
5492337|NCT03570619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5492338|NCT03570619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5492339|NCT03570619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5492340|NCT03570619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492341|NCT03565783|Cemiplimab|cemiplimab|mesh-list
5492342|NCT03565783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5492343|NCT03565783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5492344|NCT03554473|Temozolomide|temozolomide|mesh-list
5492345|NCT03554473|Topotecan|topotecan|mesh-list
5492346|NCT03554473|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6026789|NCT00436475|Antacids|antacids|mesh-ancestor
6026790|NCT00436475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026791|NCT00436475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6026792|NCT00436501|Docetaxel|docetaxel|mesh-list
6026793|NCT00436501|Aflibercept|aflibercept|mesh-list
6026794|NCT00436501|Endothelial Growth Factors|endothelial growth factors|mesh-list
6026795|NCT00436501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6026796|NCT00436501|Tubulin Modulators|tubulin modulators|mesh-ancestor
6026797|NCT00436501|Antimitotic Agents|antimitotic agents|mesh-ancestor
6026798|NCT00436501|Mitosis Modulators|mitosis modulators|mesh-ancestor
6026799|NCT00436501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026800|NCT00436501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6026801|NCT00436501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6026802|NCT00436501|Growth Substances|growth substances|mesh-ancestor
5492347|NCT03554473|Alkylating Agents|alkylating agents|mesh-ancestor
5492348|NCT03554473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026803|NCT00436501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026804|NCT00436501|Growth Inhibitors|growth inhibitors|mesh-ancestor
6026805|NCT00436553|Ranibizumab|ranibizumab|mesh-list
6026806|NCT00436553|Verteporfin|verteporfin|mesh-list
6026807|NCT00436553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5492349|NCT03554473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5492350|NCT03554473|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5492351|NCT03554473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5492352|NCT03554473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5492353|NCT03530683|Dexamethasone|dexamethasone|mesh-list
5492354|NCT03530683|Azacitidine|azacitidine|mesh-list
5492355|NCT03530683|Venetoclax|venetoclax|mesh-list
5492356|NCT03530683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5492357|NCT03530683|Antiemetics|antiemetics|mesh-ancestor
5492358|NCT03530683|Autonomic Agents|autonomic agents|mesh-ancestor
5492359|NCT03530683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5492360|NCT03530683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492361|NCT03530683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6026808|NCT00436553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6026809|NCT00436553|Growth Substances|growth substances|mesh-ancestor
6026810|NCT00436553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492362|NCT03530683|Glucocorticoids|glucocorticoids|mesh-ancestor
5492363|NCT03530683|Hormones|hormones|mesh-ancestor
5492364|NCT03530683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5492365|NCT03530683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5492366|NCT03530683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5492367|NCT03530683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5492368|NCT03530683|Antimetabolites|antimetabolites|mesh-ancestor
5492369|NCT03530683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026811|NCT00436553|Growth Inhibitors|growth inhibitors|mesh-ancestor
6026812|NCT00436553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6026813|NCT00436553|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6026814|NCT00436553|Dermatologic Agents|dermatologic agents|mesh-ancestor
6026815|NCT00436566|Paclitaxel|paclitaxel|mesh-list
6026816|NCT00436566|Cyclophosphamide|cyclophosphamide|mesh-list
6026817|NCT00436566|Doxorubicin|doxorubicin|mesh-list
6026818|NCT00436566|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6026819|NCT00436566|Trastuzumab|trastuzumab|mesh-list
6026820|NCT00436566|Lapatinib|lapatinib|mesh-list
6026821|NCT00436566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6026822|NCT00436566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6026823|NCT00436566|Tubulin Modulators|tubulin modulators|mesh-ancestor
6026824|NCT00436566|Antimitotic Agents|antimitotic agents|mesh-ancestor
6026825|NCT00436566|Mitosis Modulators|mitosis modulators|mesh-ancestor
6026826|NCT00436566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026827|NCT00436566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6026828|NCT00436566|Immunologic Factors|immunologic factors|mesh-ancestor
6026829|NCT00436566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026830|NCT00436566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6026831|NCT00436566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6026832|NCT00436566|Alkylating Agents|alkylating agents|mesh-ancestor
6026833|NCT00436566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6026834|NCT00436566|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6026835|NCT00436566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6026836|NCT00436566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6026837|NCT00436566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6026838|NCT00436566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6456237|NCT00431418|Sildenafil Citrate|sildenafil citrate|mesh-list
6456238|NCT00431418|Vasodilator Agents|vasodilator agents|mesh-ancestor
6456239|NCT00431418|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6456240|NCT00431418|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6456241|NCT00431418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6456242|NCT00431418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456243|NCT00431418|Urological Agents|urological agents|mesh-ancestor
5492370|NCT03530683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6026839|NCT00436566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6026840|NCT00436605|Dasatinib|dasatinib|mesh-list
6026841|NCT00436605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6026842|NCT00436605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6026843|NCT00436605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6026844|NCT00436605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492371|NCT03520647|Cyclophosphamide|cyclophosphamide|mesh-list
5492372|NCT03520647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5492373|NCT03520647|Immunologic Factors|immunologic factors|mesh-ancestor
5492374|NCT03520647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492375|NCT03520647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5492376|NCT03520647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5492377|NCT03520647|Alkylating Agents|alkylating agents|mesh-ancestor
5492378|NCT03520647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492379|NCT03520647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5492380|NCT03520647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5492381|NCT03511196|Prednisone|prednisone|mesh-list
5492382|NCT03511196|Glucocorticoids|glucocorticoids|mesh-list
5492383|NCT03511196|Androgens|androgens|mesh-list
5492384|NCT03511196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5492385|NCT03511196|Hormones|hormones|mesh-ancestor
5492386|NCT03511196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5492387|NCT03511196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492388|NCT03511196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5492389|NCT03511196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6026845|NCT00436618|Everolimus|everolimus|mesh-list
6026846|NCT00436618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6026847|NCT00436618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6026848|NCT00436618|Immunologic Factors|immunologic factors|mesh-ancestor
6026849|NCT00436618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026850|NCT00436644|Topotecan|topotecan|mesh-list
6026851|NCT00436644|Lapatinib|lapatinib|mesh-list
6026852|NCT00436644|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6026853|NCT00436644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6026854|NCT00436644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6026855|NCT00436644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026856|NCT00436644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6026857|NCT00436644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6026858|NCT00436748|Darbepoetin alfa|darbepoetin alfa|mesh-list
6026859|NCT00436748|Hematinics|hematinics|mesh-ancestor
6026860|NCT00436904|Rituximab|rituximab|mesh-list
6026861|NCT00436904|Alemtuzumab|alemtuzumab|mesh-list
6026862|NCT00436904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6026863|NCT00436904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6026864|NCT00436904|Immunologic Factors|immunologic factors|mesh-ancestor
6026865|NCT00436904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026866|NCT00436904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6026867|NCT00436917|Zoledronic Acid|zoledronic acid|mesh-list
6026868|NCT00436917|Letrozole|letrozole|mesh-list
6026869|NCT00436917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6026870|NCT00436917|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6026871|NCT00436917|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6026872|NCT00436917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6026873|NCT00436917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026874|NCT00436917|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6026875|NCT00436917|Hormone Antagonists|hormone antagonists|mesh-ancestor
6026876|NCT00436917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6026877|NCT00436917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026878|NCT00436917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6026879|NCT00436956|Prednisone|prednisone|mesh-list
6026880|NCT00436956|Cediranib|cediranib|mesh-list
6026881|NCT00436956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6026882|NCT00436956|Glucocorticoids|glucocorticoids|mesh-ancestor
6026883|NCT00436956|Hormones|hormones|mesh-ancestor
6026884|NCT00436956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6026885|NCT00436956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026886|NCT00436956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6026887|NCT00436956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6026888|NCT00436956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6026889|NCT00436956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6026890|NCT00436956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026891|NCT00436969|Hyaluronic Acid|hyaluronic acid|mesh-list
6026892|NCT00436969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6026893|NCT00436969|Immunologic Factors|immunologic factors|mesh-ancestor
6026894|NCT00436969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026895|NCT00436969|Viscosupplements|viscosupplements|mesh-ancestor
6026896|NCT00436969|Protective Agents|protective agents|mesh-ancestor
6026897|NCT00437034|Aflibercept|aflibercept|mesh-list
6026898|NCT00437034|Endothelial Growth Factors|endothelial growth factors|mesh-list
6026899|NCT00437034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6026900|NCT00437034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6026901|NCT00437034|Growth Substances|growth substances|mesh-ancestor
6026902|NCT00437034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026903|NCT00437034|Growth Inhibitors|growth inhibitors|mesh-ancestor
6026904|NCT00437034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6026905|NCT00437073|Capecitabine|capecitabine|mesh-list
6026906|NCT00437073|Topotecan|topotecan|mesh-list
6026907|NCT00437073|Lapatinib|lapatinib|mesh-list
6026908|NCT00437073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6026909|NCT00437073|Antimetabolites|antimetabolites|mesh-ancestor
6026910|NCT00437073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026911|NCT00437073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6026912|NCT00437073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6456244|NCT00431522|Valproic Acid|valproic acid|mesh-list
6456245|NCT00431522|Anticonvulsants|anticonvulsants|mesh-ancestor
6026913|NCT00437073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6026914|NCT00437073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6026915|NCT00437073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6026916|NCT00437125|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6026917|NCT00437125|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6026918|NCT00437125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6026919|NCT00437125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6026920|NCT00437125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026921|NCT00437125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6456246|NCT00431522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6026922|NCT00437125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026923|NCT00437125|Analgesics|analgesics|mesh-ancestor
5492390|NCT03493126|Estradiol|estradiol|mesh-list
5492391|NCT03493126|Estrogens|estrogens|mesh-ancestor
5492392|NCT03493126|Hormones|hormones|mesh-ancestor
5492393|NCT03493126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5492394|NCT03493126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492395|NCT03483038|Irinotecan|irinotecan|mesh-list
6026924|NCT00437125|Sensory System Agents|sensory system agents|mesh-ancestor
6456247|NCT00431522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456248|NCT00431522|GABA Agents|gaba agents|mesh-ancestor
6456249|NCT00431522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6456250|NCT00431522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456251|NCT00431522|Antimanic Agents|antimanic agents|mesh-ancestor
6456252|NCT00431522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6456253|NCT00431522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6456254|NCT00431522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6456255|NCT00431561|Temozolomide|temozolomide|mesh-list
6026925|NCT00437125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6026926|NCT00437125|Antidepressive Agents|antidepressive agents|mesh-ancestor
6026927|NCT00437125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6456256|NCT00431561|Lomustine|lomustine|mesh-list
5492396|NCT03483038|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6026928|NCT00437125|Dopamine Agents|dopamine agents|mesh-ancestor
6026929|NCT00437203|Gemcitabine|gemcitabine|mesh-list
6026930|NCT00437203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6026931|NCT00437203|Antimetabolites|antimetabolites|mesh-ancestor
6026932|NCT00437203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026933|NCT00437203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6026934|NCT00437203|Antiviral Agents|antiviral agents|mesh-ancestor
6026935|NCT00437203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6026936|NCT00437203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6026937|NCT00437203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6026938|NCT00437203|Immunologic Factors|immunologic factors|mesh-ancestor
6026939|NCT00437203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026940|NCT00437268|Irinotecan|irinotecan|mesh-list
6026941|NCT00437268|Cetuximab|cetuximab|mesh-list
6026942|NCT00437268|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6026943|NCT00437268|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5492397|NCT03483038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5492398|NCT03483038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5492399|NCT03483038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492400|NCT03483038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5492401|NCT03483012|Atezolizumab|atezolizumab|mesh-list
5492402|NCT03483012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5492403|NCT03474029|Rifampin|rifampin|mesh-list
5492404|NCT03474029|Rifapentine|rifapentine|mesh-list
5492405|NCT03474029|Isoniazid|isoniazid|mesh-list
5492406|NCT03474029|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6026944|NCT00437268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6026945|NCT00437268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026946|NCT00437268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6026947|NCT00437268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6026948|NCT00437281|Pregabalin|pregabalin|mesh-list
6026949|NCT00437281|Analgesics|analgesics|mesh-ancestor
6026950|NCT00437281|Sensory System Agents|sensory system agents|mesh-ancestor
6026951|NCT00437281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6026952|NCT00437281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026953|NCT00437281|Anticonvulsants|anticonvulsants|mesh-ancestor
6026954|NCT00437281|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6026955|NCT00437281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6026956|NCT00437281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026957|NCT00437281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6026958|NCT00437281|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6026959|NCT00437281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6026960|NCT00437281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6026961|NCT00437281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6026962|NCT00437294|Capecitabine|capecitabine|mesh-list
6026963|NCT00437294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6026964|NCT00437294|Antimetabolites|antimetabolites|mesh-ancestor
6026965|NCT00437294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026966|NCT00437294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6026967|NCT00437489|Insulin|insulin|mesh-list
5492407|NCT03474029|Antitubercular Agents|antitubercular agents|mesh-ancestor
6026968|NCT00437489|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6026969|NCT00437489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6026970|NCT00437489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026971|NCT00437645|Amlodipine|amlodipine|mesh-list
6026972|NCT00437645|Valsartan|valsartan|mesh-list
6026973|NCT00437645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6026974|NCT00437645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6026975|NCT00437645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6026976|NCT00437645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026977|NCT00437645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6026978|NCT00437645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026979|NCT00437645|Vasodilator Agents|vasodilator agents|mesh-ancestor
6026980|NCT00437645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6026981|NCT00437645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6026982|NCT00437658|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6026983|NCT00437658|Medroxyprogesterone|medroxyprogesterone|mesh-list
6026984|NCT00437658|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6026985|NCT00437658|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6026986|NCT00437658|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6026987|NCT00437658|Contraceptive Agents|contraceptive agents|mesh-ancestor
6026988|NCT00437658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6026989|NCT00437658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6026990|NCT00437658|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6026991|NCT00437658|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6026992|NCT00437658|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6026993|NCT00437658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6026994|NCT00437658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6026995|NCT00438100|Capecitabine|capecitabine|mesh-list
6026996|NCT00438100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6026997|NCT00438100|Antimetabolites|antimetabolites|mesh-ancestor
6026998|NCT00438100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6026999|NCT00438100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6027000|NCT00438204|Gemcitabine|gemcitabine|mesh-list
6027001|NCT00438204|Bevacizumab|bevacizumab|mesh-list
6027002|NCT00438204|Pemetrexed|pemetrexed|mesh-list
6027003|NCT00438204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6027004|NCT00438204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6027005|NCT00438204|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6027006|NCT00438204|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6027007|NCT00438204|Growth Substances|growth substances|mesh-ancestor
6027008|NCT00438204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6027009|NCT00438204|Growth Inhibitors|growth inhibitors|mesh-ancestor
6027010|NCT00438204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6027011|NCT00438204|Antimetabolites|antimetabolites|mesh-ancestor
6027012|NCT00438204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027013|NCT00438204|Antiviral Agents|antiviral agents|mesh-ancestor
6027014|NCT00438204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6027015|NCT00438204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6027016|NCT00438204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6027017|NCT00438204|Immunologic Factors|immunologic factors|mesh-ancestor
6027018|NCT00438204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6027019|NCT00438204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6027020|NCT00438256|Capecitabine|capecitabine|mesh-list
6027021|NCT00438256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6456257|NCT00431561|Trabedersen|trabedersen|mesh-list
6456258|NCT00431561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6456259|NCT00431561|Alkylating Agents|alkylating agents|mesh-ancestor
6456260|NCT00431561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456261|NCT00431561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6456262|NCT00431613|Gemcitabine|gemcitabine|mesh-list
6456263|NCT00431613|Carboplatin|carboplatin|mesh-list
6456264|NCT00431613|Docetaxel|docetaxel|mesh-list
6456265|NCT00431613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6456266|NCT00431613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6456267|NCT00431613|Antimetabolites|antimetabolites|mesh-ancestor
6456268|NCT00431613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456269|NCT00431613|Antiviral Agents|antiviral agents|mesh-ancestor
6027022|NCT00438256|Antimetabolites|antimetabolites|mesh-ancestor
6027023|NCT00438256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027024|NCT00438256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6027025|NCT00438360|Cyclosporine|cyclosporine|mesh-list
6027026|NCT00438360|Cyclosporins|cyclosporins|mesh-list
6027027|NCT00438360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6027028|NCT00438360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027029|NCT00438360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6027030|NCT00438360|Immunologic Factors|immunologic factors|mesh-ancestor
6027031|NCT00438360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6027032|NCT00438360|Antifungal Agents|antifungal agents|mesh-ancestor
6027033|NCT00438360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6027034|NCT00438360|Dermatologic Agents|dermatologic agents|mesh-ancestor
6027035|NCT00438360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6027036|NCT00438360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6027037|NCT00438451|Lamotrigine|lamotrigine|mesh-list
6027038|NCT00438451|Carbamazepine|carbamazepine|mesh-list
6027039|NCT00438451|Levetiracetam|levetiracetam|mesh-list
6027040|NCT00438451|Anticonvulsants|anticonvulsants|mesh-ancestor
6027041|NCT00438451|Nootropic Agents|nootropic agents|mesh-ancestor
6027042|NCT00438451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5492408|NCT03474029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5492409|NCT03474029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5492410|NCT03474029|Leprostatic Agents|leprostatic agents|mesh-ancestor
5492411|NCT03474029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5492412|NCT03474029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5492413|NCT03474029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492414|NCT03474029|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5492415|NCT03474029|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6027043|NCT00438451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6027044|NCT00438451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027045|NCT00438451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6027046|NCT00438451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6027047|NCT00438451|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6027048|NCT00438451|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6027049|NCT00438451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6027050|NCT00438451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6027051|NCT00438451|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6027052|NCT00438451|Antimanic Agents|antimanic agents|mesh-ancestor
6027053|NCT00438451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6027054|NCT00438451|Analgesics|analgesics|mesh-ancestor
6027055|NCT00438451|Sensory System Agents|sensory system agents|mesh-ancestor
6027056|NCT00438451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6027057|NCT00438451|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6027058|NCT00438451|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6027059|NCT00438464|Finasteride|finasteride|mesh-list
6027060|NCT00438464|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6027061|NCT00438464|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6027062|NCT00438464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6027063|NCT00438464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027064|NCT00438464|Hormone Antagonists|hormone antagonists|mesh-ancestor
6456270|NCT00431613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6456271|NCT00431613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6027065|NCT00438464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6027066|NCT00438464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6027067|NCT00438464|Urological Agents|urological agents|mesh-ancestor
6027068|NCT00438659|Mometasone Furoate|mometasone furoate|mesh-list
6027069|NCT00438659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6027070|NCT00438659|Dermatologic Agents|dermatologic agents|mesh-ancestor
6027071|NCT00438659|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6027072|NCT00438672|Dexamethasone|dexamethasone|mesh-list
6027073|NCT00438672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6027074|NCT00438672|Antiemetics|antiemetics|mesh-ancestor
6027075|NCT00438672|Autonomic Agents|autonomic agents|mesh-ancestor
6027076|NCT00438672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6027077|NCT00438672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6027078|NCT00438672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6027079|NCT00438672|Glucocorticoids|glucocorticoids|mesh-ancestor
6027080|NCT00438672|Hormones|hormones|mesh-ancestor
6027081|NCT00438672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6027082|NCT00438672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6027083|NCT00438672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6027084|NCT00438802|Alefacept|alefacept|mesh-list
6027085|NCT00438802|Dermatologic Agents|dermatologic agents|mesh-ancestor
6027086|NCT00438802|Immunologic Factors|immunologic factors|mesh-ancestor
6027087|NCT00438802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6027088|NCT00438815|Complement C1s|complement c1s|mesh-list
6027089|NCT00438815|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
6027090|NCT00438815|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
6027091|NCT00438815|Immunologic Factors|immunologic factors|mesh-ancestor
6027092|NCT00438815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6027093|NCT00438815|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6027094|NCT00438815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6027095|NCT00438854|Dasatinib|dasatinib|mesh-list
6027096|NCT00438854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6027097|NCT00438854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6027098|NCT00438854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6027099|NCT00438854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027100|NCT00438880|Rituximab|rituximab|mesh-list
6027101|NCT00438880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6027102|NCT00438880|Antibodies|antibodies|mesh-list
6027103|NCT00438880|Immunoglobulins|immunoglobulins|mesh-list
6027104|NCT00438880|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6027105|NCT00438880|Immunologic Factors|immunologic factors|mesh-ancestor
6027106|NCT00438880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6027107|NCT00438880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6027108|NCT00438880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6027109|NCT00438971|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6027110|NCT00438971|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6027111|NCT00438971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6027112|NCT00438971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6027113|NCT00438971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027114|NCT00438971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6027115|NCT00438971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6027116|NCT00438971|Analgesics|analgesics|mesh-ancestor
6027117|NCT00438971|Sensory System Agents|sensory system agents|mesh-ancestor
6027118|NCT00438971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6027119|NCT00438971|Antidepressive Agents|antidepressive agents|mesh-ancestor
6027120|NCT00438971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6027121|NCT00438971|Dopamine Agents|dopamine agents|mesh-ancestor
6027122|NCT00439140|Botulinum Toxins|botulinum toxins|mesh-list
6027123|NCT00439140|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6027124|NCT00439140|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6027125|NCT00439140|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6027126|NCT00439140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6027127|NCT00439140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492416|NCT03474029|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5492417|NCT03474029|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5492418|NCT03474029|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5492419|NCT03474029|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5492420|NCT03474029|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5492421|NCT03474029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5492422|NCT03474029|Antimetabolites|antimetabolites|mesh-ancestor
5492423|NCT03474029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5492424|NCT03467789|Vitamin D|vitamin d|mesh-list
5492425|NCT03467789|Ergocalciferols|ergocalciferols|mesh-list
5492426|NCT03467789|Cholecalciferol|cholecalciferol|mesh-list
5492427|NCT03467789|Vitamins|vitamins|mesh-list
5492428|NCT03467789|Micronutrients|micronutrients|mesh-ancestor
5492429|NCT03467789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492430|NCT03467789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5492431|NCT03467789|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5492432|NCT03460015|Propofol|propofol|mesh-list
5492433|NCT03460015|Sevoflurane|sevoflurane|mesh-list
5492434|NCT03460015|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6027128|NCT00439140|Cholinergic Agents|cholinergic agents|mesh-ancestor
6027129|NCT00439140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6027130|NCT00439140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6027131|NCT00439140|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6027132|NCT00439140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6027133|NCT00439218|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
6027134|NCT00439218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6027135|NCT00439231|Lenalidomide|lenalidomide|mesh-list
6027136|NCT00439231|Immunologic Factors|immunologic factors|mesh-ancestor
6027137|NCT00439231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6027138|NCT00439231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6027139|NCT00439231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6027140|NCT00439231|Growth Substances|growth substances|mesh-ancestor
6027141|NCT00439231|Growth Inhibitors|growth inhibitors|mesh-ancestor
6027142|NCT00439231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6027143|NCT00439244|Zoledronic Acid|zoledronic acid|mesh-list
6027144|NCT00439244|Teriparatide|teriparatide|mesh-list
6027145|NCT00439244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6027146|NCT00439244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6027147|NCT00439244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6027148|NCT00439270|Docetaxel|docetaxel|mesh-list
6027149|NCT00439270|Dasatinib|dasatinib|mesh-list
6027150|NCT00439270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6027151|NCT00439270|Tubulin Modulators|tubulin modulators|mesh-ancestor
6027152|NCT00439270|Antimitotic Agents|antimitotic agents|mesh-ancestor
6027153|NCT00439270|Mitosis Modulators|mitosis modulators|mesh-ancestor
6027154|NCT00439270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027155|NCT00439270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6027156|NCT00439270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6027157|NCT00439296|Cytarabine|cytarabine|mesh-list
6027158|NCT00439296|Dexamethasone|dexamethasone|mesh-list
6027159|NCT00439296|Cyclophosphamide|cyclophosphamide|mesh-list
6027160|NCT00439296|Doxorubicin|doxorubicin|mesh-list
6027161|NCT00439296|Methotrexate|methotrexate|mesh-list
6027162|NCT00439296|Asparaginase|asparaginase|mesh-list
6027163|NCT00439296|Mercaptopurine|mercaptopurine|mesh-list
6027164|NCT00439296|Thioguanine|thioguanine|mesh-list
6027165|NCT00439296|Pegaspargase|pegaspargase|mesh-list
6027166|NCT00439296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6027167|NCT00439296|Immunologic Factors|immunologic factors|mesh-ancestor
6027168|NCT00439296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6027169|NCT00439296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6027170|NCT00439296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6027171|NCT00439296|Alkylating Agents|alkylating agents|mesh-ancestor
6027172|NCT00439296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456272|NCT00431613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6456273|NCT00431613|Immunologic Factors|immunologic factors|mesh-ancestor
6456274|NCT00431613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456275|NCT00431613|Tubulin Modulators|tubulin modulators|mesh-ancestor
6456276|NCT00431613|Antimitotic Agents|antimitotic agents|mesh-ancestor
6456277|NCT00431613|Mitosis Modulators|mitosis modulators|mesh-ancestor
6456278|NCT00431665|Heparin|heparin|mesh-list
5492435|NCT03460015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5492436|NCT03460015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456279|NCT00431665|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6027173|NCT00439296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6027174|NCT00439296|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6456280|NCT00431665|Somatostatin|somatostatin|mesh-list
6456281|NCT00431665|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
6456282|NCT00431665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456283|NCT00431665|Anticoagulants|anticoagulants|mesh-ancestor
6456284|NCT00431665|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6456285|NCT00431665|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5492437|NCT03460015|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5492438|NCT03460015|Anesthetics, General|anesthetics, general|mesh-ancestor
5492439|NCT03460015|Anesthetics|anesthetics|mesh-ancestor
5492440|NCT03460015|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5492441|NCT03460015|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5492442|NCT03459859|Cytarabine|cytarabine|mesh-list
5492443|NCT03459859|Pevonedistat|pevonedistat|mesh-list
5492444|NCT03459859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5492445|NCT03459859|Antimetabolites|antimetabolites|mesh-ancestor
5492446|NCT03459859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492447|NCT03459859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5492448|NCT03459859|Antiviral Agents|antiviral agents|mesh-ancestor
5492449|NCT03459859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5492450|NCT03459859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5492451|NCT03459859|Immunologic Factors|immunologic factors|mesh-ancestor
5492452|NCT03459859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492453|NCT03459859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5492454|NCT03452865|Esomeprazole|esomeprazole|mesh-list
5492455|NCT03452865|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5492456|NCT03452865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5492457|NCT03452865|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5492458|NCT03452865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5492459|NCT03452865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492460|NCT03452839|Meropenem|meropenem|mesh-list
5492461|NCT03452839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5492462|NCT03452839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6456286|NCT00431665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027175|NCT00439296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6027176|NCT00439296|Antiemetics|antiemetics|mesh-ancestor
6027177|NCT00439296|Autonomic Agents|autonomic agents|mesh-ancestor
6027178|NCT00439296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6027179|NCT00439296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6027180|NCT00439296|Glucocorticoids|glucocorticoids|mesh-ancestor
6027181|NCT00439296|Hormones|hormones|mesh-ancestor
6027182|NCT00439296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6027183|NCT00439296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6027184|NCT00439296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5492463|NCT03401710|Epoetin Alfa|epoetin alfa|mesh-list
5492464|NCT03401710|Hematinics|hematinics|mesh-ancestor
5492473|NCT03387917|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6027185|NCT00439296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6027186|NCT00439296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6027187|NCT00439296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6027188|NCT00439296|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6027189|NCT00439296|Abortifacient Agents|abortifacient agents|mesh-ancestor
6027190|NCT00439296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6027191|NCT00439296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6027192|NCT00439296|Antimetabolites|antimetabolites|mesh-ancestor
6027193|NCT00439296|Dermatologic Agents|dermatologic agents|mesh-ancestor
6027194|NCT00439296|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6027195|NCT00439296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6027196|NCT00439296|Antiviral Agents|antiviral agents|mesh-ancestor
6027197|NCT00439296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6027198|NCT00439309|Thrombin|thrombin|mesh-list
6027199|NCT00439309|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
6027200|NCT00439309|Hemostatics|hemostatics|mesh-ancestor
6027201|NCT00439309|Coagulants|coagulants|mesh-ancestor
6027202|NCT00439335|Vaccines|vaccines|mesh-list
6027203|NCT00439335|Immunologic Factors|immunologic factors|mesh-ancestor
6027204|NCT00439335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456287|NCT00431665|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
5492474|NCT03387917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5492475|NCT03387917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5492476|NCT03366142|Ustekinumab|ustekinumab|mesh-list
6027205|NCT00439374|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
6027206|NCT00439374|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
6027207|NCT00439374|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6027208|NCT00439374|Hormone Antagonists|hormone antagonists|mesh-ancestor
6027209|NCT00439374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6027210|NCT00439374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492477|NCT03366142|Dermatologic Agents|dermatologic agents|mesh-ancestor
5503055|NCT04462666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503056|NCT04462250|Analgesics, Opioid|analgesics, opioid|mesh-list
6027211|NCT00439374|Progestins|progestins|mesh-ancestor
6027212|NCT00439374|Hormones|hormones|mesh-ancestor
6027213|NCT00439413|Selegiline|selegiline|mesh-list
6027214|NCT00439413|Antidepressive Agents|antidepressive agents|mesh-ancestor
6027215|NCT00439413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6027216|NCT00439413|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6456288|NCT00431665|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6456289|NCT00431665|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5503057|NCT04462250|Narcotics|narcotics|mesh-ancestor
6027217|NCT00439413|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6027218|NCT00439413|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6027219|NCT00439413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6456290|NCT00431665|Hormones|hormones|mesh-ancestor
6456291|NCT00431665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6456292|NCT00431665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6456293|NCT00431678|Moxifloxacin|moxifloxacin|mesh-list
6456294|NCT00431678|Levofloxacin|levofloxacin|mesh-list
6456295|NCT00431678|Ofloxacin|ofloxacin|mesh-list
6456296|NCT00431678|Ceftriaxone|ceftriaxone|mesh-list
6456297|NCT00431678|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6456298|NCT00431678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6027220|NCT00439413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027221|NCT00439413|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6027222|NCT00439413|Protective Agents|protective agents|mesh-ancestor
6027223|NCT00439413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6027224|NCT00439517|Cetuximab|cetuximab|mesh-list
6027225|NCT00439517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6027226|NCT00439517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6027227|NCT00439556|Cytarabine|cytarabine|mesh-list
6027228|NCT00439556|Rituximab|rituximab|mesh-list
6456299|NCT00431678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6027229|NCT00439556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6027230|NCT00439556|Methotrexate|methotrexate|mesh-list
6027231|NCT00439556|Etoposide|etoposide|mesh-list
6027232|NCT00439556|Bortezomib|bortezomib|mesh-list
6027233|NCT00439556|Etoposide phosphate|etoposide phosphate|mesh-list
6027234|NCT00439556|Melphalan|melphalan|mesh-list
6027235|NCT00439556|Mechlorethamine|mechlorethamine|mesh-list
6027236|NCT00439556|Carmustine|carmustine|mesh-list
6027237|NCT00439556|Podophyllotoxin|podophyllotoxin|mesh-list
6027238|NCT00439556|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
6027239|NCT00439556|Antibodies|antibodies|mesh-list
6027240|NCT00439556|Immunoglobulins|immunoglobulins|mesh-list
6027241|NCT00439556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6027242|NCT00439556|Lenograstim|lenograstim|mesh-list
6027243|NCT00439556|Tacrolimus|tacrolimus|mesh-list
6027244|NCT00439556|Thymoglobulin|thymoglobulin|mesh-list
6027245|NCT00439556|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6027246|NCT00439556|Immunologic Factors|immunologic factors|mesh-ancestor
6027247|NCT00439556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6027248|NCT00439556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6027249|NCT00439556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6027250|NCT00439556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6027251|NCT00439556|Abortifacient Agents|abortifacient agents|mesh-ancestor
6456300|NCT00431678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6027252|NCT00439556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6027253|NCT00439556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6027254|NCT00439556|Antimetabolites|antimetabolites|mesh-ancestor
6027255|NCT00439556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027256|NCT00439556|Dermatologic Agents|dermatologic agents|mesh-ancestor
6027257|NCT00439556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6027258|NCT00439556|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6027259|NCT00439556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6027260|NCT00439556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6027261|NCT00439556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6027262|NCT00439556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6027263|NCT00439556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6027264|NCT00439556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6027265|NCT00439556|Antiviral Agents|antiviral agents|mesh-ancestor
6027266|NCT00439556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6027267|NCT00439556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6027268|NCT00439556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6027269|NCT00439556|Alkylating Agents|alkylating agents|mesh-ancestor
6027270|NCT00439556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6027271|NCT00439556|Keratolytic Agents|keratolytic agents|mesh-ancestor
6027272|NCT00439556|Tubulin Modulators|tubulin modulators|mesh-ancestor
6027273|NCT00439556|Antimitotic Agents|antimitotic agents|mesh-ancestor
6027274|NCT00439556|Mitosis Modulators|mitosis modulators|mesh-ancestor
5492478|NCT03358563|Docetaxel|docetaxel|mesh-list
5492479|NCT03358563|Bicalutamide|bicalutamide|mesh-list
5492480|NCT03358563|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
5492481|NCT03358563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6027275|NCT00439608|Paclitaxel|paclitaxel|mesh-list
6027276|NCT00439608|Carboplatin|carboplatin|mesh-list
6027277|NCT00439608|Cetuximab|cetuximab|mesh-list
6027278|NCT00439608|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6027279|NCT00439608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6027280|NCT00439608|Tubulin Modulators|tubulin modulators|mesh-ancestor
6027281|NCT00439608|Antimitotic Agents|antimitotic agents|mesh-ancestor
6027282|NCT00439608|Mitosis Modulators|mitosis modulators|mesh-ancestor
6027283|NCT00439608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027284|NCT00439608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6027285|NCT00439647|Zoledronic Acid|zoledronic acid|mesh-list
6027286|NCT00439647|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6027287|NCT00439647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6027288|NCT00439673|Azacitidine|azacitidine|mesh-list
6027289|NCT00439673|Valproic Acid|valproic acid|mesh-list
6027290|NCT00439673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6027291|NCT00439673|Antimetabolites|antimetabolites|mesh-ancestor
6027292|NCT00439673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027293|NCT00439673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6027294|NCT00439673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6027295|NCT00439673|Anticonvulsants|anticonvulsants|mesh-ancestor
6027296|NCT00439673|GABA Agents|gaba agents|mesh-ancestor
6027297|NCT00439673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6027298|NCT00439673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6027299|NCT00439673|Antimanic Agents|antimanic agents|mesh-ancestor
6027300|NCT00439673|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6027301|NCT00439673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6027302|NCT00439673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6027303|NCT00439725|Rivaroxaban|rivaroxaban|mesh-list
6027304|NCT00439725|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6027305|NCT00439725|Antithrombins|antithrombins|mesh-ancestor
6027306|NCT00439725|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6027307|NCT00439725|Protease Inhibitors|protease inhibitors|mesh-ancestor
6027308|NCT00439725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6027309|NCT00439725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027310|NCT00439725|Anticoagulants|anticoagulants|mesh-ancestor
5492482|NCT03358563|Tubulin Modulators|tubulin modulators|mesh-ancestor
6027311|NCT00439777|Enoxaparin|enoxaparin|mesh-list
6027312|NCT00439777|Rivaroxaban|rivaroxaban|mesh-list
6027313|NCT00439777|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5492483|NCT03358563|Antimitotic Agents|antimitotic agents|mesh-ancestor
6027314|NCT00439777|Antithrombins|antithrombins|mesh-ancestor
6027315|NCT00439777|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6027316|NCT00439777|Protease Inhibitors|protease inhibitors|mesh-ancestor
6027317|NCT00439777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6027318|NCT00439777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027319|NCT00439777|Anticoagulants|anticoagulants|mesh-ancestor
6027320|NCT00439777|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6027321|NCT00439777|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5492484|NCT03358563|Mitosis Modulators|mitosis modulators|mesh-ancestor
5492485|NCT03358563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492486|NCT03358563|Androgen Antagonists|androgen antagonists|mesh-ancestor
5492487|NCT03358563|Hormone Antagonists|hormone antagonists|mesh-ancestor
5492488|NCT03358563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5492489|NCT03358563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492490|NCT03358563|Hematinics|hematinics|mesh-ancestor
5492491|NCT03358563|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5492492|NCT03358563|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6027322|NCT00439946|Treprostinil|treprostinil|mesh-list
6027323|NCT00439946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6027324|NCT00440011|Bimatoprost|bimatoprost|mesh-list
6027325|NCT00440011|Travoprost|travoprost|mesh-list
6027326|NCT00440011|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6027327|NCT00440011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6027328|NCT00440011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6027329|NCT00440115|Bupropion|bupropion|mesh-list
6027330|NCT00440115|Nicotine|nicotine|mesh-list
6027331|NCT00440115|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6027332|NCT00440115|Autonomic Agents|autonomic agents|mesh-ancestor
6027333|NCT00440115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6027334|NCT00440115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6027335|NCT00440115|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6027336|NCT00440115|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6027337|NCT00440115|Cholinergic Agents|cholinergic agents|mesh-ancestor
6027338|NCT00440115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6027339|NCT00440115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027340|NCT00440115|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6027341|NCT00440115|Antidepressive Agents|antidepressive agents|mesh-ancestor
5492493|NCT03354728|Vaccines|vaccines|mesh-list
5492494|NCT03354728|Immunologic Factors|immunologic factors|mesh-ancestor
5492495|NCT03354728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492496|NCT03346135|Melphalan|melphalan|mesh-list
5492497|NCT03346135|Mechlorethamine|mechlorethamine|mesh-list
5492498|NCT03346135|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
5492499|NCT03346135|Daratumumab|daratumumab|mesh-list
5492500|NCT03346135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5492501|NCT03346135|Alkylating Agents|alkylating agents|mesh-ancestor
5492502|NCT03346135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492503|NCT03346135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5492504|NCT03346135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6027342|NCT00440115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6027343|NCT00440115|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6027344|NCT00440115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6027345|NCT00440115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6027346|NCT00440115|Dopamine Agents|dopamine agents|mesh-ancestor
6027347|NCT00440115|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6027348|NCT00440115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6027349|NCT00440115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6027350|NCT00440180|Anastrozole|anastrozole|mesh-list
6027351|NCT00440180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6027352|NCT00440180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6027353|NCT00440180|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6027354|NCT00440180|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6027355|NCT00440180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6027356|NCT00440180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027357|NCT00440180|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6027358|NCT00440180|Hormone Antagonists|hormone antagonists|mesh-ancestor
6027359|NCT00440180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6027360|NCT00440180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6027361|NCT00440193|Enoxaparin|enoxaparin|mesh-list
6027362|NCT00440193|Rivaroxaban|rivaroxaban|mesh-list
6027363|NCT00440193|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6027364|NCT00440193|Antithrombins|antithrombins|mesh-ancestor
5492505|NCT03346135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5492506|NCT03346135|Immunologic Factors|immunologic factors|mesh-ancestor
6027365|NCT00440193|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6027366|NCT00440193|Protease Inhibitors|protease inhibitors|mesh-ancestor
6027367|NCT00440193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6027368|NCT00440193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027369|NCT00440193|Anticoagulants|anticoagulants|mesh-ancestor
6027370|NCT00440193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6027371|NCT00440193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6027372|NCT00440232|Frovatriptan|frovatriptan|mesh-list
6027373|NCT00440232|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6027374|NCT00440232|Serotonin Agents|serotonin agents|mesh-ancestor
6027375|NCT00440232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6027376|NCT00440232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027377|NCT00440232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6027378|NCT00440310|Talaporfin|talaporfin|mesh-list
6027379|NCT00440310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6027380|NCT00440310|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6027381|NCT00440310|Dermatologic Agents|dermatologic agents|mesh-ancestor
6027382|NCT00440401|Thrombin|thrombin|mesh-list
6027383|NCT00440401|Hemostatics|hemostatics|mesh-list
6027384|NCT00440401|Coagulants|coagulants|mesh-ancestor
6027385|NCT00440466|Epoetin Alfa|epoetin alfa|mesh-list
6027386|NCT00440466|Hematinics|hematinics|mesh-ancestor
6027387|NCT00440505|Nicotine|nicotine|mesh-list
6027388|NCT00440505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6027389|NCT00440505|Autonomic Agents|autonomic agents|mesh-ancestor
6027390|NCT00440505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6027391|NCT00440505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6027392|NCT00440505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6027393|NCT00440505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6027394|NCT00440505|Cholinergic Agents|cholinergic agents|mesh-ancestor
6027395|NCT00440505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6027396|NCT00440505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027397|NCT00440518|Lacosamide|lacosamide|mesh-list
6027398|NCT00440518|Anticonvulsants|anticonvulsants|mesh-ancestor
6027399|NCT00440518|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6027400|NCT00440518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6027401|NCT00440518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6027402|NCT00440518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027403|NCT00440557|Epoetin Alfa|epoetin alfa|mesh-list
6027404|NCT00440557|Hematinics|hematinics|mesh-ancestor
6053408|NCT00594906|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6053409|NCT00594906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053410|NCT00594906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6053411|NCT00594932|Mycophenolic Acid|mycophenolic acid|mesh-list
6053412|NCT00594932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6053413|NCT00594932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6053414|NCT00594932|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6053415|NCT00594932|Antitubercular Agents|antitubercular agents|mesh-ancestor
6053416|NCT00594932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6053417|NCT00594932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6053418|NCT00594932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6053419|NCT00594932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492507|NCT03346135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492508|NCT03339284|Dexamethasone|dexamethasone|mesh-list
5492509|NCT03339284|Dexamethasone acetate|dexamethasone acetate|mesh-list
5492510|NCT03339284|Ropivacaine|ropivacaine|mesh-list
5492511|NCT03339284|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
5492512|NCT03339284|BB 1101|bb 1101|mesh-list
5492513|NCT03339284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5492514|NCT03339284|Antiemetics|antiemetics|mesh-ancestor
5492515|NCT03339284|Autonomic Agents|autonomic agents|mesh-ancestor
5492516|NCT03339284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5492517|NCT03339284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492518|NCT03339284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5492519|NCT03339284|Glucocorticoids|glucocorticoids|mesh-ancestor
5492520|NCT03339284|Hormones|hormones|mesh-ancestor
5492521|NCT03339284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5492522|NCT03339284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5492523|NCT03339284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5492524|NCT03339284|Anesthetics, Local|anesthetics, local|mesh-ancestor
5492525|NCT03339284|Anesthetics|anesthetics|mesh-ancestor
5492526|NCT03339284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5492527|NCT03339284|Sensory System Agents|sensory system agents|mesh-ancestor
6053420|NCT00594945|Clonazepam|clonazepam|mesh-list
5492528|NCT03339284|Protease Inhibitors|protease inhibitors|mesh-ancestor
5492529|NCT03339284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5492530|NCT03339284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492531|NCT03316586|Nivolumab|nivolumab|mesh-list
5492532|NCT03316586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5492533|NCT03316586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6027405|NCT00440726|Cytarabine|cytarabine|mesh-list
6027406|NCT00440726|Dexamethasone|dexamethasone|mesh-list
6027407|NCT00440726|Doxorubicin|doxorubicin|mesh-list
6027408|NCT00440726|Methotrexate|methotrexate|mesh-list
6027409|NCT00440726|Vincristine|vincristine|mesh-list
6027410|NCT00440726|Bortezomib|bortezomib|mesh-list
6027411|NCT00440726|Asparaginase|asparaginase|mesh-list
6027412|NCT00440726|Pegaspargase|pegaspargase|mesh-list
6027413|NCT00440726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6027414|NCT00440726|Antiemetics|antiemetics|mesh-ancestor
6027415|NCT00440726|Autonomic Agents|autonomic agents|mesh-ancestor
6027416|NCT00440726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6027417|NCT00440726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6027418|NCT00440726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6027419|NCT00440726|Glucocorticoids|glucocorticoids|mesh-ancestor
6027420|NCT00440726|Hormones|hormones|mesh-ancestor
6027421|NCT00440726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5492534|NCT03316586|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5492535|NCT03316586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492536|NCT03312400|Danazol|danazol|mesh-list
5492537|NCT03312400|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6027422|NCT00440726|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6027423|NCT00440726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6027424|NCT00440726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6027425|NCT00440726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6027426|NCT00440726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6456301|NCT00431678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6456302|NCT00431678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6456303|NCT00431678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456304|NCT00431678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6456305|NCT00431678|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6027427|NCT00440726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6027428|NCT00440726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027429|NCT00440726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6027430|NCT00440726|Abortifacient Agents|abortifacient agents|mesh-ancestor
6027431|NCT00440726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6027432|NCT00440726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6027433|NCT00440726|Antimetabolites|antimetabolites|mesh-ancestor
6027434|NCT00440726|Dermatologic Agents|dermatologic agents|mesh-ancestor
6027435|NCT00440726|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6027436|NCT00440726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6027437|NCT00440726|Immunologic Factors|immunologic factors|mesh-ancestor
6027438|NCT00440726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6027439|NCT00440726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6027440|NCT00440726|Antiviral Agents|antiviral agents|mesh-ancestor
6027441|NCT00440726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6027442|NCT00440726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6027443|NCT00440726|Tubulin Modulators|tubulin modulators|mesh-ancestor
6027444|NCT00440726|Antimitotic Agents|antimitotic agents|mesh-ancestor
6027445|NCT00440726|Mitosis Modulators|mitosis modulators|mesh-ancestor
6027446|NCT00440830|Nicotine|nicotine|mesh-list
6027447|NCT00440830|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6027448|NCT00440830|Autonomic Agents|autonomic agents|mesh-ancestor
6027449|NCT00440830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6027450|NCT00440830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6027451|NCT00440830|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6027452|NCT00440830|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6027453|NCT00440830|Cholinergic Agents|cholinergic agents|mesh-ancestor
6027454|NCT00440830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6027455|NCT00440830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027456|NCT00440947|Ritonavir|ritonavir|mesh-list
6027457|NCT00440947|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6027458|NCT00440947|Lamivudine|lamivudine|mesh-list
6027459|NCT00440947|Abacavir|abacavir|mesh-list
6027460|NCT00440947|Dideoxynucleosides|dideoxynucleosides|mesh-list
6027461|NCT00440947|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6027462|NCT00440947|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6027463|NCT00440947|Protease Inhibitors|protease inhibitors|mesh-ancestor
6027464|NCT00440947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6027465|NCT00440947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456306|NCT00431678|Contraceptive Agents|contraceptive agents|mesh-ancestor
6456307|NCT00431678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5492538|NCT03312400|Hormone Antagonists|hormone antagonists|mesh-ancestor
5492539|NCT03312400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5492540|NCT03312400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492541|NCT03301857|Denosumab|denosumab|mesh-list
5492542|NCT03301857|Immunoglobulins|immunoglobulins|mesh-list
5492543|NCT03301857|Immunoglobulin G|immunoglobulin g|mesh-list
5492544|NCT03301857|Immunologic Factors|immunologic factors|mesh-ancestor
5492545|NCT03301857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492546|NCT03301857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5492547|NCT03284385|Adavosertib|adavosertib|mesh-list
6027466|NCT00440947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6027467|NCT00440947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6027468|NCT00440947|Antiviral Agents|antiviral agents|mesh-ancestor
6027469|NCT00440947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6027470|NCT00440947|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6027471|NCT00440947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6027472|NCT00440947|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6027473|NCT00440947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6027474|NCT00440947|Antimetabolites|antimetabolites|mesh-ancestor
6027475|NCT00440999|Artesunate|artesunate|mesh-list
6027476|NCT00440999|Chloroquine|chloroquine|mesh-list
6027477|NCT00440999|Pyronaridine|pyronaridine|mesh-list
6027478|NCT00440999|Antimalarials|antimalarials|mesh-ancestor
6027479|NCT00440999|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6027480|NCT00440999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6027481|NCT00440999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6027482|NCT00440999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6027483|NCT00440999|Antiviral Agents|antiviral agents|mesh-ancestor
6027484|NCT00440999|Schistosomicides|schistosomicides|mesh-ancestor
6027485|NCT00440999|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6027486|NCT00440999|Anthelmintics|anthelmintics|mesh-ancestor
6027487|NCT00440999|Amebicides|amebicides|mesh-ancestor
6027488|NCT00440999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6027489|NCT00441103|Interferon beta-1a|interferon beta-1a|mesh-list
6027490|NCT00441103|Interferon-beta|interferon-beta|mesh-list
6027491|NCT00441103|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6027492|NCT00441103|Immunologic Factors|immunologic factors|mesh-ancestor
6027493|NCT00441103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6027494|NCT00441103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6027495|NCT00441103|Antiviral Agents|antiviral agents|mesh-ancestor
6027496|NCT00441103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6027497|NCT00441116|Dutasteride|dutasteride|mesh-list
6027498|NCT00441116|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6027499|NCT00441116|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6027500|NCT00441116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6027501|NCT00441116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027502|NCT00441116|Hormone Antagonists|hormone antagonists|mesh-ancestor
6027503|NCT00441116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6027504|NCT00441116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6027505|NCT00441129|Insulin|insulin|mesh-list
6456308|NCT00431678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456309|NCT00431678|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6456310|NCT00431678|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6456311|NCT00431678|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6027506|NCT00441129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6053421|NCT00594945|Anticonvulsants|anticonvulsants|mesh-ancestor
5492548|NCT03284385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5492549|NCT03284385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492550|NCT03277066|Diclofenac|diclofenac|mesh-list
5492551|NCT03277066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5492552|NCT03277066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5492553|NCT03277066|Analgesics|analgesics|mesh-ancestor
5492554|NCT03277066|Sensory System Agents|sensory system agents|mesh-ancestor
5492555|NCT03277066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5492556|NCT03277066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492557|NCT03277066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6456312|NCT00431678|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6456313|NCT00431678|Renal Agents|renal agents|mesh-ancestor
6456314|NCT00431678|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6456315|NCT00431678|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6456316|NCT00431691|Nitroglycerin|nitroglycerin|mesh-list
6456317|NCT00431691|Vasodilator Agents|vasodilator agents|mesh-ancestor
6456318|NCT00431704|Carboplatin|carboplatin|mesh-list
6027507|NCT00441129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6027508|NCT00441142|Temozolomide|temozolomide|mesh-list
6027509|NCT00441142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6027510|NCT00441142|Alkylating Agents|alkylating agents|mesh-ancestor
6027511|NCT00441142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027512|NCT00441142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6027513|NCT00441168|Dexamethasone|dexamethasone|mesh-list
6027514|NCT00441168|Vincristine|vincristine|mesh-list
6027515|NCT00441168|Doxorubicin|doxorubicin|mesh-list
6027516|NCT00441168|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5492558|NCT03277066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5492559|NCT03277066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5492560|NCT03277066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5492561|NCT03277066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492562|NCT03268811|Teduglutide|teduglutide|mesh-list
5492563|NCT03268811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5492564|NCT03268811|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5492565|NCT03268811|Protective Agents|protective agents|mesh-ancestor
5492566|NCT03268811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492567|NCT03267433|Rituximab|rituximab|mesh-list
5492568|NCT03267433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5492569|NCT03267433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5492570|NCT03267433|Immunologic Factors|immunologic factors|mesh-ancestor
5492571|NCT03267433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492572|NCT03267433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5492573|NCT03234686|Deferiprone|deferiprone|mesh-list
5492574|NCT03234686|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5492575|NCT03234686|Chelating Agents|chelating agents|mesh-ancestor
5492576|NCT03234686|Sequestering Agents|sequestering agents|mesh-ancestor
5492577|NCT03234686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492578|NCT03231085|Ferrous fumarate|ferrous fumarate|mesh-list
5492579|NCT03231085|Trace Elements|trace elements|mesh-ancestor
5492580|NCT03231085|Micronutrients|micronutrients|mesh-ancestor
5492581|NCT03231085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492582|NCT03207347|Niraparib|niraparib|mesh-list
5492583|NCT03207347|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5492584|NCT03207347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5492585|NCT03207347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492586|NCT03207347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5492587|NCT03199053|Dapagliflozin|dapagliflozin|mesh-list
5492588|NCT03199053|Saxagliptin|saxagliptin|mesh-list
5492589|NCT03199053|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5492590|NCT03199053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492591|NCT03199053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5492592|NCT03199053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492593|NCT03199053|Incretins|incretins|mesh-ancestor
5492594|NCT03199053|Hormones|hormones|mesh-ancestor
5492595|NCT03199053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5492596|NCT03199053|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5492597|NCT03199053|Protease Inhibitors|protease inhibitors|mesh-ancestor
5492598|NCT03199053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5492599|NCT03194893|Crizotinib|crizotinib|mesh-list
6027517|NCT00441168|Bortezomib|bortezomib|mesh-list
6027518|NCT00441168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6456319|NCT00431704|Trastuzumab|trastuzumab|mesh-list
5492600|NCT03194893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6027519|NCT00441168|Antiemetics|antiemetics|mesh-ancestor
6027520|NCT00441168|Autonomic Agents|autonomic agents|mesh-ancestor
6456320|NCT00431704|Vinorelbine|vinorelbine|mesh-list
5492601|NCT03194893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5492602|NCT03194893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5492603|NCT03194893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492604|NCT03193333|Timolol|timolol|mesh-list
5492605|NCT03193333|Brimonidine Tartrate|brimonidine tartrate|mesh-list
5492606|NCT03193333|Dorzolamide|dorzolamide|mesh-list
5492607|NCT03193333|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5492608|NCT03193333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5492609|NCT03193333|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5492610|NCT03193333|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5492611|NCT03193333|Adrenergic Agents|adrenergic agents|mesh-ancestor
5492612|NCT03193333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5492613|NCT03193333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492614|NCT03193333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492615|NCT03193333|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6027521|NCT00441168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6027522|NCT00441168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6027523|NCT00441168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6027524|NCT00441168|Glucocorticoids|glucocorticoids|mesh-ancestor
6027525|NCT00441168|Hormones|hormones|mesh-ancestor
6027526|NCT00441168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6027527|NCT00441168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6027528|NCT00441168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6027529|NCT00441168|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6027530|NCT00441168|Tubulin Modulators|tubulin modulators|mesh-ancestor
6027531|NCT00441168|Antimitotic Agents|antimitotic agents|mesh-ancestor
6027532|NCT00441168|Mitosis Modulators|mitosis modulators|mesh-ancestor
6027533|NCT00441168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027534|NCT00441168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6027535|NCT00441168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6027536|NCT00441168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6456321|NCT00431704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6456322|NCT00431704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6456323|NCT00431704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6027537|NCT00441168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6027538|NCT00441285|Albendazole|albendazole|mesh-list
6027539|NCT00441285|Praziquantel|praziquantel|mesh-list
6027540|NCT00441285|Anthelmintics|anthelmintics|mesh-ancestor
6027541|NCT00441285|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6027542|NCT00441285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6027543|NCT00441285|Anticestodal Agents|anticestodal agents|mesh-ancestor
5492616|NCT03193333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5492617|NCT03193333|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5492618|NCT03193333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5492619|NCT03193333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5492620|NCT03193333|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5492621|NCT03193333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5492622|NCT03177291|Pirfenidone|pirfenidone|mesh-list
5492623|NCT03177291|Paclitaxel|paclitaxel|mesh-list
5492624|NCT03177291|Carboplatin|carboplatin|mesh-list
5492625|NCT03177291|Pemetrexed|pemetrexed|mesh-list
5492626|NCT03177291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5492627|NCT03177291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5492628|NCT03177291|Tubulin Modulators|tubulin modulators|mesh-ancestor
5492629|NCT03177291|Antimitotic Agents|antimitotic agents|mesh-ancestor
5492630|NCT03177291|Mitosis Modulators|mitosis modulators|mesh-ancestor
5492631|NCT03177291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492632|NCT03177291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5492633|NCT03177291|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5492634|NCT03177291|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5492635|NCT03177291|Analgesics|analgesics|mesh-ancestor
5492636|NCT03177291|Sensory System Agents|sensory system agents|mesh-ancestor
5492637|NCT03177291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5492638|NCT03177291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492639|NCT03177291|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5492640|NCT03177291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5492641|NCT03177291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5492642|NCT03177291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5492643|NCT03142334|Pembrolizumab|pembrolizumab|mesh-list
5492644|NCT03142334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5492645|NCT03142334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5492646|NCT03141359|Paclitaxel|paclitaxel|mesh-list
5492647|NCT03141359|Etoposide|etoposide|mesh-list
5492648|NCT03141359|Carboplatin|carboplatin|mesh-list
6027544|NCT00441285|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6027545|NCT00441285|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6027546|NCT00441285|Tubulin Modulators|tubulin modulators|mesh-ancestor
6027547|NCT00441285|Antimitotic Agents|antimitotic agents|mesh-ancestor
6027548|NCT00441285|Mitosis Modulators|mitosis modulators|mesh-ancestor
6027549|NCT00441285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027550|NCT00441285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6027551|NCT00441337|Nivolumab|nivolumab|mesh-list
6027552|NCT00441337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6027553|NCT00441337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6027554|NCT00441337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6027555|NCT00441337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027556|NCT00441363|Bromocriptine|bromocriptine|mesh-list
6027557|NCT00441363|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6027558|NCT00441363|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6027559|NCT00441363|Hormone Antagonists|hormone antagonists|mesh-ancestor
6027560|NCT00441363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6027561|NCT00441363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6027562|NCT00441363|Dopamine Agonists|dopamine agonists|mesh-ancestor
6027563|NCT00441363|Dopamine Agents|dopamine agents|mesh-ancestor
5492649|NCT03141359|Durvalumab|durvalumab|mesh-list
5492650|NCT03141359|Cisplatin|cisplatin|mesh-list
5492651|NCT03141359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5492652|NCT03141359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5492653|NCT03141359|Tubulin Modulators|tubulin modulators|mesh-ancestor
6027564|NCT00441363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6027565|NCT00441363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027566|NCT00441441|Fluticasone|fluticasone|mesh-list
6027567|NCT00441441|Xhance|xhance|mesh-list
6027568|NCT00441441|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6027569|NCT00441441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6027570|NCT00441441|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6027571|NCT00441441|Autonomic Agents|autonomic agents|mesh-ancestor
6027572|NCT00441441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6027573|NCT00441441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6027574|NCT00441441|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6027575|NCT00441441|Respiratory System Agents|respiratory system agents|mesh-ancestor
6027576|NCT00441441|Dermatologic Agents|dermatologic agents|mesh-ancestor
6027577|NCT00441441|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6027578|NCT00441441|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6027579|NCT00441441|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6027580|NCT00441441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6027581|NCT00441441|Adrenergic Agents|adrenergic agents|mesh-ancestor
6027582|NCT00441441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6027583|NCT00441441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027584|NCT00441545|Sevelamer|sevelamer|mesh-list
6027585|NCT00441545|Chelating Agents|chelating agents|mesh-ancestor
6027586|NCT00441545|Sequestering Agents|sequestering agents|mesh-ancestor
6027587|NCT00441545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027588|NCT00441584|Ribavirin|ribavirin|mesh-list
6027589|NCT00441584|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6027590|NCT00441584|Interferon-alpha|interferon-alpha|mesh-list
6027591|NCT00441584|Antimetabolites|antimetabolites|mesh-ancestor
6654660|NCT01458431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654661|NCT01458431|Sensory System Agents|sensory system agents|mesh-ancestor
6654662|NCT01458431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6027592|NCT00441584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027593|NCT00441584|Antiviral Agents|antiviral agents|mesh-ancestor
6027594|NCT00441584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6027595|NCT00441584|Immunologic Factors|immunologic factors|mesh-ancestor
6027596|NCT00441584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6027597|NCT00441727|Esomeprazole|esomeprazole|mesh-list
6027598|NCT00441727|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6027599|NCT00441727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6027600|NCT00441727|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6027601|NCT00441727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6027602|NCT00441727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027603|NCT00441792|Midazolam|midazolam|mesh-list
6027604|NCT00441792|Etomidate|etomidate|mesh-list
6027605|NCT00441792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6027606|NCT00441792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6027607|NCT00441792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6027608|NCT00441792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6027609|NCT00441792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6027610|NCT00441792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6027611|NCT00441792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6027612|NCT00441792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6027613|NCT00441792|Anesthetics, General|anesthetics, general|mesh-ancestor
6027614|NCT00441792|Anesthetics|anesthetics|mesh-ancestor
6027615|NCT00441792|GABA Modulators|gaba modulators|mesh-ancestor
6027616|NCT00441792|GABA Agents|gaba agents|mesh-ancestor
6027617|NCT00441792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6027618|NCT00441792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027619|NCT00441883|Latanoprost|latanoprost|mesh-list
6027620|NCT00441883|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6027621|NCT00441883|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6027622|NCT00441974|Adefovir|adefovir|mesh-list
6456324|NCT00431704|Tubulin Modulators|tubulin modulators|mesh-ancestor
6456325|NCT00431704|Antimitotic Agents|antimitotic agents|mesh-ancestor
6456326|NCT00431704|Mitosis Modulators|mitosis modulators|mesh-ancestor
6456327|NCT00431704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456328|NCT00431769|Bortezomib|bortezomib|mesh-list
6456329|NCT00431769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6456330|NCT00431795|Doxorubicin|doxorubicin|mesh-list
6456331|NCT00431795|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6456332|NCT00431795|Epirubicin|epirubicin|mesh-list
6027623|NCT00441974|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6027624|NCT00441974|Antiviral Agents|antiviral agents|mesh-ancestor
6027625|NCT00441974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6027626|NCT00441974|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6027627|NCT00441974|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6027628|NCT00441974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6027629|NCT00441974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027630|NCT00442013|Lansoprazole|lansoprazole|mesh-list
6654663|NCT01458470|Memantine|memantine|mesh-list
6654664|NCT01458470|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6654665|NCT01458470|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6027631|NCT00442013|Dexlansoprazole|dexlansoprazole|mesh-list
6027632|NCT00442013|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6027633|NCT00442013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6027634|NCT00442013|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6027635|NCT00442013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6027636|NCT00442013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027637|NCT00442169|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6027638|NCT00442364|Polidocanol|polidocanol|mesh-list
6027639|NCT00442364|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
6027640|NCT00442364|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6027641|NCT00442416|Epoetin Alfa|epoetin alfa|mesh-list
6027642|NCT00442416|Hematinics|hematinics|mesh-ancestor
6027643|NCT00442507|Bevacizumab|bevacizumab|mesh-list
6027644|NCT00442507|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6027645|NCT00442507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6027646|NCT00442507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6027647|NCT00442507|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6027648|NCT00442507|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6027649|NCT00442507|Growth Substances|growth substances|mesh-ancestor
6027650|NCT00442507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6027651|NCT00442507|Growth Inhibitors|growth inhibitors|mesh-ancestor
6027652|NCT00442507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6027653|NCT00442507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6027654|NCT00442507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027655|NCT00442572|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6027656|NCT00442572|Antiviral Agents|antiviral agents|mesh-ancestor
6027657|NCT00442572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6027658|NCT00442611|Abatacept|abatacept|mesh-list
6027659|NCT00442611|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6027660|NCT00442611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027661|NCT00442611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6456333|NCT00431795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6456334|NCT00431795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6456335|NCT00431795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6456336|NCT00431795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6456337|NCT00431795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6027662|NCT00442611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6027663|NCT00442611|Immunologic Factors|immunologic factors|mesh-ancestor
6027664|NCT00442611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6027665|NCT00442611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6027666|NCT00442689|Flutamide|flutamide|mesh-list
6027667|NCT00442689|Drospirenone|drospirenone|mesh-list
6027668|NCT00442689|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6027669|NCT00442689|Estradiol|estradiol|mesh-list
6027670|NCT00442689|Estrogens|estrogens|mesh-ancestor
6027671|NCT00442689|Hormones|hormones|mesh-ancestor
6027672|NCT00442689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6027673|NCT00442689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6027674|NCT00442689|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5492654|NCT03141359|Antimitotic Agents|antimitotic agents|mesh-ancestor
5492655|NCT03141359|Mitosis Modulators|mitosis modulators|mesh-ancestor
6456338|NCT00431795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456339|NCT00431990|Dexamethasone|dexamethasone|mesh-list
6456340|NCT00431990|Bortezomib|bortezomib|mesh-list
6456341|NCT00431990|Romidepsin|romidepsin|mesh-list
6027675|NCT00442689|Contraceptive Agents|contraceptive agents|mesh-ancestor
6027676|NCT00442689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6027677|NCT00442689|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6027678|NCT00442689|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6027679|NCT00442689|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6027680|NCT00442689|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6027681|NCT00442689|Hormone Antagonists|hormone antagonists|mesh-ancestor
6027682|NCT00442689|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6027683|NCT00442689|Diuretics|diuretics|mesh-ancestor
6027684|NCT00442689|Natriuretic Agents|natriuretic agents|mesh-ancestor
5492656|NCT03141359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492657|NCT03141359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5492658|NCT03141359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5492659|NCT03141359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5492660|NCT03141359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5492661|NCT03110744|Palbociclib|palbociclib|mesh-list
6027685|NCT00442689|Androgen Antagonists|androgen antagonists|mesh-ancestor
6027686|NCT00442689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6027687|NCT00442689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6027688|NCT00442702|Darbepoetin alfa|darbepoetin alfa|mesh-list
6027689|NCT00442702|Hematinics|hematinics|mesh-ancestor
6027690|NCT00442767|Insulin|insulin|mesh-list
6027691|NCT00442767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6027692|NCT00442767|Pramlintide|pramlintide|mesh-list
6027693|NCT00442767|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
6027694|NCT00442767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6027695|NCT00442767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6027696|NCT00442767|Appetite Depressants|appetite depressants|mesh-ancestor
6027697|NCT00442767|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6027698|NCT00442767|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
6027699|NCT00442767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027700|NCT00442936|Oxazolidinones|oxazolidinones|mesh-list
6027701|NCT00442936|Zolmitriptan|zolmitriptan|mesh-list
6027702|NCT00442936|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5492662|NCT03110744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5492663|NCT03110744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5492664|NCT03110744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5492665|NCT03110744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492666|NCT03093246|Aspirin|aspirin|mesh-list
5492667|NCT03093246|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5492668|NCT03093246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5492669|NCT03093246|Analgesics|analgesics|mesh-ancestor
5492670|NCT03093246|Sensory System Agents|sensory system agents|mesh-ancestor
5492671|NCT03093246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5492672|NCT03093246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492673|NCT03093246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5492674|NCT03093246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6027703|NCT00442936|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6027704|NCT00442936|Serotonin Agents|serotonin agents|mesh-ancestor
6027705|NCT00442936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6027706|NCT00442936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027707|NCT00442936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6027708|NCT00442936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6456342|NCT00431990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6027709|NCT00442936|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6027710|NCT00442936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6456343|NCT00431990|Antiemetics|antiemetics|mesh-ancestor
6654666|NCT01458470|Dopamine Agents|dopamine agents|mesh-ancestor
6027711|NCT00442962|Tenofovir|tenofovir|mesh-list
5492675|NCT03093246|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5492676|NCT03093246|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5492677|NCT03093246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027712|NCT00442962|Emtricitabine|emtricitabine|mesh-list
6027713|NCT00442962|Efavirenz|efavirenz|mesh-list
6027714|NCT00442962|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6027715|NCT00442962|Antiviral Agents|antiviral agents|mesh-ancestor
6027716|NCT00442962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6027717|NCT00442962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6027718|NCT00442962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6027719|NCT00442962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6027720|NCT00442962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027721|NCT00442962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6027722|NCT00442962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6027723|NCT00442962|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6027724|NCT00442962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6027725|NCT00442962|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6027726|NCT00442962|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6027727|NCT00442962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6027728|NCT00442962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6027729|NCT00443053|PENTA|penta|mesh-list
6027730|NCT00443053|Fondaparinux|fondaparinux|mesh-list
6027731|NCT00443053|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6027732|NCT00443053|Antithrombins|antithrombins|mesh-ancestor
6027733|NCT00443053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6027734|NCT00443053|Protease Inhibitors|protease inhibitors|mesh-ancestor
6027735|NCT00443053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6027736|NCT00443053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027737|NCT00443053|Anticoagulants|anticoagulants|mesh-ancestor
6027738|NCT00443053|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5492678|NCT03093246|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5492679|NCT03093246|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5492680|NCT03093246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6027739|NCT00443053|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6456344|NCT00431990|Autonomic Agents|autonomic agents|mesh-ancestor
6456345|NCT00431990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6456346|NCT00431990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456347|NCT00431990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6456348|NCT00431990|Glucocorticoids|glucocorticoids|mesh-ancestor
6027740|NCT00443209|Rizatriptan|rizatriptan|mesh-list
6027741|NCT00443209|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6027742|NCT00443209|Serotonin Agents|serotonin agents|mesh-ancestor
6027743|NCT00443209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6027744|NCT00443209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027745|NCT00443209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6027746|NCT00443261|Azacitidine|azacitidine|mesh-list
6027747|NCT00443261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5492681|NCT03093246|Antipyretics|antipyretics|mesh-ancestor
6027748|NCT00443261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6027749|NCT00443261|Antimetabolites|antimetabolites|mesh-ancestor
6053422|NCT00594945|GABA Modulators|gaba modulators|mesh-ancestor
6456349|NCT00431990|Hormones|hormones|mesh-ancestor
6456350|NCT00431990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6456351|NCT00431990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6456352|NCT00431990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6456353|NCT00431990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6456354|NCT00432016|Zidovudine|zidovudine|mesh-list
6456355|NCT00432016|Antimetabolites|antimetabolites|mesh-ancestor
6456356|NCT00432016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456357|NCT00432016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6456358|NCT00432016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5492682|NCT03090997|Vitamins|vitamins|mesh-list
5492683|NCT03090997|Ascorbic Acid|ascorbic acid|mesh-list
5492684|NCT03090997|Resveratrol|resveratrol|mesh-list
6027750|NCT00443261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027751|NCT00443261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6027752|NCT00443352|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6027753|NCT00443352|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6027754|NCT00443352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6027755|NCT00443352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6027756|NCT00443352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027757|NCT00443352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6027758|NCT00443352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6027759|NCT00443352|Analgesics|analgesics|mesh-ancestor
6027760|NCT00443352|Sensory System Agents|sensory system agents|mesh-ancestor
6027761|NCT00443352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6027762|NCT00443352|Antidepressive Agents|antidepressive agents|mesh-ancestor
6027763|NCT00443352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6027764|NCT00443352|Dopamine Agents|dopamine agents|mesh-ancestor
6027765|NCT00443430|Prednisone|prednisone|mesh-list
6027766|NCT00443430|Prednisolone|prednisolone|mesh-list
6027767|NCT00443430|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6027768|NCT00443430|Methylprednisolone|methylprednisolone|mesh-list
6027769|NCT00443430|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6027770|NCT00443430|Prednisolone acetate|prednisolone acetate|mesh-list
6027771|NCT00443430|Etanercept|etanercept|mesh-list
6027772|NCT00443430|Methotrexate|methotrexate|mesh-list
6027773|NCT00443430|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6027774|NCT00443430|Prednisolone phosphate|prednisolone phosphate|mesh-list
6027775|NCT00443430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6027776|NCT00443430|Glucocorticoids|glucocorticoids|mesh-ancestor
6027777|NCT00443430|Hormones|hormones|mesh-ancestor
6027778|NCT00443430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6027779|NCT00443430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6027780|NCT00443430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6027781|NCT00443430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6027782|NCT00443430|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6027783|NCT00443430|Abortifacient Agents|abortifacient agents|mesh-ancestor
6027784|NCT00443430|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6027785|NCT00443430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6027786|NCT00443430|Antimetabolites|antimetabolites|mesh-ancestor
6027787|NCT00443430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027788|NCT00443430|Dermatologic Agents|dermatologic agents|mesh-ancestor
6027789|NCT00443430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6027790|NCT00443430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6027791|NCT00443430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6027792|NCT00443430|Immunologic Factors|immunologic factors|mesh-ancestor
6027793|NCT00443430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6027794|NCT00443430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6027795|NCT00443430|Antiemetics|antiemetics|mesh-ancestor
6027796|NCT00443430|Autonomic Agents|autonomic agents|mesh-ancestor
6027797|NCT00443430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6027798|NCT00443430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6027799|NCT00443430|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6027800|NCT00443430|Protective Agents|protective agents|mesh-ancestor
6027801|NCT00443430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6027802|NCT00443430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6027803|NCT00443430|Analgesics|analgesics|mesh-ancestor
6027804|NCT00443430|Sensory System Agents|sensory system agents|mesh-ancestor
6027805|NCT00443456|Amlodipine|amlodipine|mesh-list
6027806|NCT00443456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6027807|NCT00443456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6027808|NCT00443456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6027809|NCT00443456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027810|NCT00443456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6027811|NCT00443456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6027812|NCT00443456|Vasodilator Agents|vasodilator agents|mesh-ancestor
6027813|NCT00443534|Sunitinib|sunitinib|mesh-list
6027814|NCT00443534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6027815|NCT00443534|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6027816|NCT00443534|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6027817|NCT00443534|Growth Substances|growth substances|mesh-ancestor
6027818|NCT00443534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6027819|NCT00443534|Growth Inhibitors|growth inhibitors|mesh-ancestor
5492685|NCT03090997|Micronutrients|micronutrients|mesh-ancestor
6027820|NCT00443534|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6027821|NCT00443534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6027822|NCT00443534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027823|NCT00443560|Fentanyl|fentanyl|mesh-list
6027824|NCT00443560|Bupivacaine|bupivacaine|mesh-list
6027825|NCT00443560|Anesthetics, Local|anesthetics, local|mesh-ancestor
6027826|NCT00443560|Anesthetics|anesthetics|mesh-ancestor
6027827|NCT00443560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6027828|NCT00443560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6027829|NCT00443560|Sensory System Agents|sensory system agents|mesh-ancestor
6027830|NCT00443560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6027831|NCT00443560|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6027832|NCT00443560|Narcotics|narcotics|mesh-ancestor
6027833|NCT00443560|Analgesics|analgesics|mesh-ancestor
6027834|NCT00443560|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6027835|NCT00443560|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6027836|NCT00443560|Anesthetics, General|anesthetics, general|mesh-ancestor
6027837|NCT00443599|Insulin|insulin|mesh-list
6027838|NCT00443599|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6027839|NCT00443599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6027840|NCT00443599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6027841|NCT00443651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
6027842|NCT00443651|Rituximab|rituximab|mesh-list
6027843|NCT00443651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6027844|NCT00443651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6027845|NCT00443651|Immunologic Factors|immunologic factors|mesh-ancestor
6027846|NCT00443651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6027847|NCT00443651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6027848|NCT00443703|Ritonavir|ritonavir|mesh-list
6027849|NCT00443703|Lopinavir|lopinavir|mesh-list
6027850|NCT00443703|Raltegravir Potassium|raltegravir potassium|mesh-list
6027851|NCT00443703|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6027852|NCT00443703|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6027853|NCT00443703|Protease Inhibitors|protease inhibitors|mesh-ancestor
6027854|NCT00443703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6027855|NCT00443703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027856|NCT00443703|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6027857|NCT00443703|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6027858|NCT00443703|Antiviral Agents|antiviral agents|mesh-ancestor
6456359|NCT00432016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6456360|NCT00432016|Antiviral Agents|antiviral agents|mesh-ancestor
6456361|NCT00432016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6456362|NCT00432016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6456363|NCT00432016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6456364|NCT00432055|Botulinum Toxins|botulinum toxins|mesh-list
6456365|NCT00432055|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6456366|NCT00432055|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6027859|NCT00443703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6027860|NCT00443703|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6027861|NCT00443703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6027862|NCT00443703|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6027863|NCT00443703|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6027864|NCT00443729|Ritonavir|ritonavir|mesh-list
6027865|NCT00443729|Lopinavir|lopinavir|mesh-list
6027866|NCT00443729|Raltegravir Potassium|raltegravir potassium|mesh-list
6027867|NCT00443729|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6027868|NCT00443729|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6027869|NCT00443729|Protease Inhibitors|protease inhibitors|mesh-ancestor
6027870|NCT00443729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6027871|NCT00443729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027872|NCT00443729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6027873|NCT00443729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6027874|NCT00443729|Antiviral Agents|antiviral agents|mesh-ancestor
6027875|NCT00443729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6456367|NCT00432055|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6654667|NCT01458470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6456368|NCT00432055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6027876|NCT00443729|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6027877|NCT00443729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6027878|NCT00443729|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6027879|NCT00443729|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6027880|NCT00443755|Metformin|metformin|mesh-list
6027881|NCT00443755|Pioglitazone|pioglitazone|mesh-list
6027882|NCT00443755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6027883|NCT00443755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6027884|NCT00443781|Anesthetics|anesthetics|mesh-list
6027885|NCT00443781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6027886|NCT00443781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492686|NCT03090997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492687|NCT03090997|Antioxidants|antioxidants|mesh-ancestor
5492688|NCT03090997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492689|NCT03090997|Protective Agents|protective agents|mesh-ancestor
5492690|NCT03090997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5492691|NCT03090997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5492692|NCT03077542|Sirolimus|sirolimus|mesh-list
5492693|NCT03077542|Cyclophosphamide|cyclophosphamide|mesh-list
5492694|NCT03077542|Alemtuzumab|alemtuzumab|mesh-list
5492695|NCT03077542|Hydroxyurea|hydroxyurea|mesh-list
5492696|NCT03077542|Pentostatin|pentostatin|mesh-list
5492697|NCT03077542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5492698|NCT03077542|Immunologic Factors|immunologic factors|mesh-ancestor
5492699|NCT03077542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492700|NCT03077542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5492701|NCT03077542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5492702|NCT03077542|Alkylating Agents|alkylating agents|mesh-ancestor
6027887|NCT00443820|Terbinafine|terbinafine|mesh-list
6027888|NCT00443820|Antifungal Agents|antifungal agents|mesh-ancestor
6027889|NCT00443820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6027890|NCT00443820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6027891|NCT00443820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027892|NCT00443872|Selegiline|selegiline|mesh-list
6027893|NCT00443872|Antidepressive Agents|antidepressive agents|mesh-ancestor
6027894|NCT00443872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6027895|NCT00443872|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6027896|NCT00443872|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6027897|NCT00443872|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6027898|NCT00443872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6027899|NCT00443872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027900|NCT00443872|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6027901|NCT00443872|Protective Agents|protective agents|mesh-ancestor
6027902|NCT00443872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6027903|NCT00443898|Terbinafine|terbinafine|mesh-list
5492703|NCT03077542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492704|NCT03077542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5492705|NCT03077542|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6027904|NCT00443898|Antifungal Agents|antifungal agents|mesh-ancestor
6027905|NCT00443898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6027906|NCT00443898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6027907|NCT00443898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027908|NCT00444028|Loxapine|loxapine|mesh-list
6027909|NCT00444028|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6027910|NCT00444028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6027911|NCT00444028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6027912|NCT00444028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6027913|NCT00444028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6027914|NCT00444028|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6027915|NCT00444028|Dopamine Agents|dopamine agents|mesh-ancestor
6027916|NCT00444028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6027917|NCT00444028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027918|NCT00444106|Artesunate|artesunate|mesh-list
6027919|NCT00444106|Lumefantrine|lumefantrine|mesh-list
5492706|NCT03077542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5492707|NCT03077542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5492708|NCT03077542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5492709|NCT03077542|Antifungal Agents|antifungal agents|mesh-ancestor
5492710|NCT03077542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5492711|NCT03077542|Antisickling Agents|antisickling agents|mesh-ancestor
5492712|NCT03077542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5492713|NCT03077542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5492714|NCT03077542|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
6027920|NCT00444106|Artemether|artemether|mesh-list
6027921|NCT00444106|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6027922|NCT00444106|Mefloquine|mefloquine|mesh-list
6027923|NCT00444106|Atovaquone|atovaquone|mesh-list
6027924|NCT00444106|Proguanil|proguanil|mesh-list
6027925|NCT00444106|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
6027926|NCT00444106|Antimalarials|antimalarials|mesh-ancestor
6027927|NCT00444106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6027928|NCT00444106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6027929|NCT00444106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6027930|NCT00444106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6027931|NCT00444106|Antiviral Agents|antiviral agents|mesh-ancestor
6027932|NCT00444106|Schistosomicides|schistosomicides|mesh-ancestor
6027933|NCT00444106|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6027934|NCT00444106|Anthelmintics|anthelmintics|mesh-ancestor
6027935|NCT00444106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6027936|NCT00444106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027937|NCT00444106|Antimetabolites|antimetabolites|mesh-ancestor
6027938|NCT00444145|Lansoprazole|lansoprazole|mesh-list
6027939|NCT00444145|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6027940|NCT00444145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6027941|NCT00444145|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6027942|NCT00444145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6027943|NCT00444145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027944|NCT00444275|Esomeprazole|esomeprazole|mesh-list
6027945|NCT00444275|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6027946|NCT00444275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6027947|NCT00444275|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6027948|NCT00444275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6027949|NCT00444275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027950|NCT00444457|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6027951|NCT00444457|Immunologic Factors|immunologic factors|mesh-ancestor
6027952|NCT00444457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6027953|NCT00444535|Bevacizumab|bevacizumab|mesh-list
6027954|NCT00444535|Lapatinib|lapatinib|mesh-list
6027955|NCT00444535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6027956|NCT00444535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6027957|NCT00444535|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6027958|NCT00444535|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6027959|NCT00444535|Growth Substances|growth substances|mesh-ancestor
6027960|NCT00444535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6027961|NCT00444535|Growth Inhibitors|growth inhibitors|mesh-ancestor
6027962|NCT00444535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6027963|NCT00444535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6027964|NCT00444535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027965|NCT00444587|Trastuzumab|trastuzumab|mesh-list
6027966|NCT00444587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6027967|NCT00444587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6027968|NCT00444600|Triamcinolone|triamcinolone|mesh-list
6027969|NCT00444600|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6027970|NCT00444600|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6027971|NCT00444600|Bevacizumab|bevacizumab|mesh-list
6027972|NCT00444600|Ranibizumab|ranibizumab|mesh-list
6027973|NCT00444600|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6027974|NCT00444600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6027975|NCT00444600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6027976|NCT00444600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6027977|NCT00444600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6027978|NCT00444600|Growth Substances|growth substances|mesh-ancestor
6027979|NCT00444600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6027980|NCT00444600|Growth Inhibitors|growth inhibitors|mesh-ancestor
6027981|NCT00444600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6027982|NCT00444600|Glucocorticoids|glucocorticoids|mesh-ancestor
6027983|NCT00444600|Hormones|hormones|mesh-ancestor
6027984|NCT00444600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6027985|NCT00444600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6027986|NCT00444600|Immunologic Factors|immunologic factors|mesh-ancestor
6027987|NCT00444600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5492715|NCT03030235|Dapagliflozin|dapagliflozin|mesh-list
5492716|NCT03030235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6027988|NCT00444600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6027989|NCT00444626|Lidocaine|lidocaine|mesh-list
6027990|NCT00444626|Prilocaine|prilocaine|mesh-list
6027991|NCT00444626|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
6027992|NCT00444626|Hyaluronic Acid|hyaluronic acid|mesh-list
5503058|NCT04462250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6027993|NCT00444626|Anesthetics, Local|anesthetics, local|mesh-ancestor
6027994|NCT00444626|Anesthetics|anesthetics|mesh-ancestor
6027995|NCT00444626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6027996|NCT00444626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6027997|NCT00444626|Sensory System Agents|sensory system agents|mesh-ancestor
6027998|NCT00444626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6027999|NCT00444626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6028000|NCT00444626|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6028001|NCT00444626|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6028002|NCT00444626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6028003|NCT00444626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028004|NCT00444626|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6028005|NCT00444626|Immunologic Factors|immunologic factors|mesh-ancestor
6028006|NCT00444626|Viscosupplements|viscosupplements|mesh-ancestor
6028007|NCT00444626|Protective Agents|protective agents|mesh-ancestor
6028008|NCT00444626|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
6028009|NCT00444678|Capecitabine|capecitabine|mesh-list
6028010|NCT00444678|Oxaliplatin|oxaliplatin|mesh-list
6028011|NCT00444678|Cetuximab|cetuximab|mesh-list
6028012|NCT00444678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6028013|NCT00444678|Antimetabolites|antimetabolites|mesh-ancestor
6028014|NCT00444678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028015|NCT00444678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6028016|NCT00444678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6028017|NCT00444795|Sunitinib|sunitinib|mesh-list
6456369|NCT00432055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456370|NCT00432055|Cholinergic Agents|cholinergic agents|mesh-ancestor
6456371|NCT00432055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6456372|NCT00432055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456373|NCT00432055|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6456374|NCT00432055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6456375|NCT00432068|Octreotide|octreotide|mesh-list
6456376|NCT00432068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5492717|NCT03030235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492718|NCT03030235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6456377|NCT00432068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6456378|NCT00432068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6456379|NCT00432081|Indomethacin|indomethacin|mesh-list
6456380|NCT00432081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6456381|NCT00432081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6456382|NCT00432081|Analgesics|analgesics|mesh-ancestor
6456383|NCT00432081|Sensory System Agents|sensory system agents|mesh-ancestor
5492719|NCT03030235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492720|NCT02991599|Vaccines|vaccines|mesh-list
5492721|NCT02991599|Immunologic Factors|immunologic factors|mesh-ancestor
5492722|NCT02991599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456384|NCT00432081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6456385|NCT00432081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028018|NCT00444795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6028019|NCT00444795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6028020|NCT00444795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6028021|NCT00444795|Growth Substances|growth substances|mesh-ancestor
6053423|NCT00594945|GABA Agents|gaba agents|mesh-ancestor
5492723|NCT02983578|Durvalumab|durvalumab|mesh-list
5492724|NCT02983578|Immunoglobulins|immunoglobulins|mesh-list
5492725|NCT02983578|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6028022|NCT00444795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028023|NCT00444795|Growth Inhibitors|growth inhibitors|mesh-ancestor
6028024|NCT00444795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6028025|NCT00444795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6028026|NCT00444795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028027|NCT00444912|Plerixafor|plerixafor|mesh-list
6028028|NCT00444912|Rituximab|rituximab|mesh-list
6028029|NCT00444912|Lenograstim|lenograstim|mesh-list
6028030|NCT00444912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6028031|NCT00444912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6028032|NCT00444912|Immunologic Factors|immunologic factors|mesh-ancestor
6028033|NCT00444912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028034|NCT00444912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6028035|NCT00444912|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6028036|NCT00444912|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6028037|NCT00444912|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6028038|NCT00444912|Antiviral Agents|antiviral agents|mesh-ancestor
6028039|NCT00444912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6028040|NCT00444925|Fesoterodine|fesoterodine|mesh-list
6028041|NCT00444925|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6028042|NCT00444925|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6028043|NCT00444925|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6028044|NCT00444925|Cholinergic Agents|cholinergic agents|mesh-ancestor
6028045|NCT00444925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6028046|NCT00444925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492726|NCT02983578|Immunoglobulin G|immunoglobulin g|mesh-list
5492727|NCT02983578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5492728|NCT02983578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5492729|NCT02983578|Immunologic Factors|immunologic factors|mesh-ancestor
5492730|NCT02983578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028047|NCT00444925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028048|NCT00444925|Urological Agents|urological agents|mesh-ancestor
6028049|NCT00444951|Vaccines|vaccines|mesh-list
6028050|NCT00444951|Immunologic Factors|immunologic factors|mesh-ancestor
6028051|NCT00444951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028052|NCT00444964|Hormones|hormones|mesh-list
6028053|NCT00444964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6028054|NCT00444964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028055|NCT00445003|Triamcinolone|triamcinolone|mesh-list
6028056|NCT00445003|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6028057|NCT00445003|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6028058|NCT00445003|Ranibizumab|ranibizumab|mesh-list
6028059|NCT00445003|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6028060|NCT00445003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6028061|NCT00445003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6028062|NCT00445003|Growth Substances|growth substances|mesh-ancestor
6028063|NCT00445003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028064|NCT00445003|Growth Inhibitors|growth inhibitors|mesh-ancestor
6028065|NCT00445003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6028066|NCT00445003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6028067|NCT00445003|Glucocorticoids|glucocorticoids|mesh-ancestor
6028068|NCT00445003|Hormones|hormones|mesh-ancestor
6028069|NCT00445003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6028070|NCT00445003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6028071|NCT00445003|Immunologic Factors|immunologic factors|mesh-ancestor
6456386|NCT00432081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6456387|NCT00432081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6028072|NCT00445003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6028073|NCT00445003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028074|NCT00445068|Panobinostat|panobinostat|mesh-list
6028075|NCT00445068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6028076|NCT00445068|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6028077|NCT00445068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6028078|NCT00445068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028079|NCT00445146|Elvitegravir|elvitegravir|mesh-list
6028080|NCT00445146|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6028081|NCT00445146|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6028082|NCT00445146|Antiviral Agents|antiviral agents|mesh-ancestor
6028083|NCT00445146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6028084|NCT00445146|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6028085|NCT00445146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6028086|NCT00445146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028087|NCT00445211|Heparin|heparin|mesh-list
6028088|NCT00445211|Calcium heparin|calcium heparin|mesh-list
6456388|NCT00432081|Gout Suppressants|gout suppressants|mesh-ancestor
5492731|NCT02970500|Methylphenidate|methylphenidate|mesh-list
6028089|NCT00445211|Anticoagulants|anticoagulants|mesh-ancestor
6028090|NCT00445211|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6028091|NCT00445211|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6028092|NCT00445211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028093|NCT00445263|Tirofiban|tirofiban|mesh-list
6028094|NCT00445263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6028095|NCT00445263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6028096|NCT00445263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028097|NCT00445263|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6028098|NCT00445302|Plerixafor|plerixafor|mesh-list
6028099|NCT00445302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6028100|NCT00445302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6028101|NCT00445302|Antiviral Agents|antiviral agents|mesh-ancestor
6028102|NCT00445302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6028103|NCT00445328|Heparin|heparin|mesh-list
6028104|NCT00445328|Calcium heparin|calcium heparin|mesh-list
6028105|NCT00445328|Dalteparin|dalteparin|mesh-list
6028106|NCT00445328|Tinzaparin|tinzaparin|mesh-list
6028107|NCT00445328|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6028108|NCT00445328|Anticoagulants|anticoagulants|mesh-ancestor
6028109|NCT00445328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6028110|NCT00445328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6028111|NCT00445328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492732|NCT02970500|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5492733|NCT02970500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492734|NCT02970500|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5492735|NCT02970500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5492736|NCT02970500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5492737|NCT02970500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492738|NCT02970500|Dopamine Agents|dopamine agents|mesh-ancestor
5492739|NCT02970500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5492740|NCT02969928|Amoxicillin|amoxicillin|mesh-list
6028112|NCT00445341|Alvocidib|alvocidib|mesh-list
6028113|NCT00445341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6028114|NCT00445341|Growth Inhibitors|growth inhibitors|mesh-ancestor
6028115|NCT00445341|Growth Substances|growth substances|mesh-ancestor
6028116|NCT00445341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028117|NCT00445341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6028118|NCT00445341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6028119|NCT00445341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028120|NCT00445432|Adalimumab|adalimumab|mesh-list
6654668|NCT01458470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654669|NCT01458470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654670|NCT01458470|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6654671|NCT01458470|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6654672|NCT01458548|Rituximab|rituximab|mesh-list
6654673|NCT01458548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6654674|NCT01458548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6654675|NCT01458548|Immunologic Factors|immunologic factors|mesh-ancestor
6654676|NCT01458548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654677|NCT01458548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6654678|NCT01458600|Diclofenac|diclofenac|mesh-list
6654679|NCT01458600|Propranolol|propranolol|mesh-list
6654680|NCT01458600|Metoprolol|metoprolol|mesh-list
6654681|NCT01458600|Methimazole|methimazole|mesh-list
6028121|NCT00445432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6028122|NCT00445432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6028123|NCT00445458|Paclitaxel|paclitaxel|mesh-list
6028124|NCT00445458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6028125|NCT00445458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6028126|NCT00445458|Tubulin Modulators|tubulin modulators|mesh-ancestor
6028127|NCT00445458|Antimitotic Agents|antimitotic agents|mesh-ancestor
6028128|NCT00445458|Mitosis Modulators|mitosis modulators|mesh-ancestor
6028129|NCT00445458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028130|NCT00445484|Lenalidomide|lenalidomide|mesh-list
6028131|NCT00445484|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6028132|NCT00445484|Immunologic Factors|immunologic factors|mesh-ancestor
6028133|NCT00445484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028134|NCT00445484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6028135|NCT00445484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6028136|NCT00445484|Growth Substances|growth substances|mesh-ancestor
6028137|NCT00445484|Growth Inhibitors|growth inhibitors|mesh-ancestor
6028138|NCT00445484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6028139|NCT00445588|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6028140|NCT00445588|Sorafenib|sorafenib|mesh-list
6028141|NCT00445588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6028142|NCT00445588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6028143|NCT00445588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6028144|NCT00445588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053424|NCT00594945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6053425|NCT00594945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053426|NCT00594945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053427|NCT00594958|Vaccines|vaccines|mesh-list
6053428|NCT00594958|Immunologic Factors|immunologic factors|mesh-ancestor
6053429|NCT00594958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053430|NCT00595101|Latanoprost|latanoprost|mesh-list
6053431|NCT00595101|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6053432|NCT00595101|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6053433|NCT00595127|Cyclophosphamide|cyclophosphamide|mesh-list
6053434|NCT00595127|Fludarabine|fludarabine|mesh-list
6053435|NCT00595127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6053436|NCT00595127|Immunologic Factors|immunologic factors|mesh-ancestor
6053437|NCT00595127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053438|NCT00595127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6053439|NCT00595127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6053440|NCT00595127|Alkylating Agents|alkylating agents|mesh-ancestor
6053441|NCT00595127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053442|NCT00595127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6053443|NCT00595127|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5492741|NCT02969928|Metronidazole|metronidazole|mesh-list
5492742|NCT02969928|Clarithromycin|clarithromycin|mesh-list
5492743|NCT02969928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5492744|NCT02969928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5492745|NCT02969928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5492746|NCT02969928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6053444|NCT00595153|Budesonide|budesonide|mesh-list
6053445|NCT00595153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6053446|NCT00595153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6053447|NCT00595153|Autonomic Agents|autonomic agents|mesh-ancestor
6053448|NCT00595153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6053449|NCT00595153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053450|NCT00595153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6053451|NCT00595153|Respiratory System Agents|respiratory system agents|mesh-ancestor
6053452|NCT00595153|Glucocorticoids|glucocorticoids|mesh-ancestor
6053453|NCT00595153|Hormones|hormones|mesh-ancestor
6053454|NCT00595153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6053455|NCT00595231|Rufinamide|rufinamide|mesh-list
6053456|NCT00595231|Anticonvulsants|anticonvulsants|mesh-ancestor
6053457|NCT00595231|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6053458|NCT00595231|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6053459|NCT00595231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6053460|NCT00595231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053461|NCT00595270|Vaccines|vaccines|mesh-list
6053462|NCT00595270|Immunologic Factors|immunologic factors|mesh-ancestor
6053463|NCT00595270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053464|NCT00595335|Methylprednisolone|methylprednisolone|mesh-list
6053465|NCT00595335|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6053466|NCT00595335|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6053467|NCT00595335|Prednisolone|prednisolone|mesh-list
6053468|NCT00595335|Prednisolone acetate|prednisolone acetate|mesh-list
6053469|NCT00595335|Rituximab|rituximab|mesh-list
6053470|NCT00595335|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6053471|NCT00595335|Prednisolone phosphate|prednisolone phosphate|mesh-list
6053472|NCT00595335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6053473|NCT00595335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6053474|NCT00595335|Immunologic Factors|immunologic factors|mesh-ancestor
6053475|NCT00595335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053476|NCT00595335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5492747|NCT02969928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5492748|NCT02969928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5492749|NCT02969928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492750|NCT02969928|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6053477|NCT00595335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6053478|NCT00595335|Antiemetics|antiemetics|mesh-ancestor
6053479|NCT00595335|Autonomic Agents|autonomic agents|mesh-ancestor
6053480|NCT00595335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6053481|NCT00595335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6053482|NCT00595335|Glucocorticoids|glucocorticoids|mesh-ancestor
6053483|NCT00595335|Hormones|hormones|mesh-ancestor
6028145|NCT00445601|Gemcitabine|gemcitabine|mesh-list
6028146|NCT00445601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6028147|NCT00445601|Antimetabolites|antimetabolites|mesh-ancestor
6028148|NCT00445601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028149|NCT00445601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6028150|NCT00445601|Antiviral Agents|antiviral agents|mesh-ancestor
6028151|NCT00445601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6028152|NCT00445601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6028153|NCT00445601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6028154|NCT00445601|Immunologic Factors|immunologic factors|mesh-ancestor
6028155|NCT00445601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028156|NCT00445679|Paroxetine|paroxetine|mesh-list
6028157|NCT00445679|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6028158|NCT00445679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6028159|NCT00445679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6028160|NCT00445679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028161|NCT00445679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6028162|NCT00445679|Serotonin Agents|serotonin agents|mesh-ancestor
6028163|NCT00445679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028164|NCT00445679|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6028165|NCT00445679|Antidepressive Agents|antidepressive agents|mesh-ancestor
6028166|NCT00445679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6028167|NCT00445679|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6028168|NCT00445679|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6028169|NCT00445679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6028170|NCT00445692|Clarithromycin|clarithromycin|mesh-list
6028171|NCT00445692|Dexamethasone|dexamethasone|mesh-list
6028172|NCT00445692|Dexamethasone acetate|dexamethasone acetate|mesh-list
6028173|NCT00445692|Lenalidomide|lenalidomide|mesh-list
6028174|NCT00445692|Ichthammol|ichthammol|mesh-list
6028175|NCT00445692|BB 1101|bb 1101|mesh-list
6028176|NCT00445692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6028177|NCT00445692|Antiemetics|antiemetics|mesh-ancestor
6028178|NCT00445692|Autonomic Agents|autonomic agents|mesh-ancestor
6028179|NCT00445692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6028180|NCT00445692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028181|NCT00445692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6028182|NCT00445692|Glucocorticoids|glucocorticoids|mesh-ancestor
6028183|NCT00445692|Hormones|hormones|mesh-ancestor
6028184|NCT00445692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6028185|NCT00445692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6028186|NCT00445692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5492751|NCT02969928|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5492752|NCT02968446|Vitamin D|vitamin d|mesh-list
5492753|NCT02968446|Cholecalciferol|cholecalciferol|mesh-list
5492754|NCT02968446|Mechlorethamine|mechlorethamine|mesh-list
5492755|NCT02968446|Vitamins|vitamins|mesh-ancestor
5492756|NCT02968446|Micronutrients|micronutrients|mesh-ancestor
5492757|NCT02968446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028187|NCT00445692|Immunologic Factors|immunologic factors|mesh-ancestor
6028188|NCT00445692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6028189|NCT00445692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6028190|NCT00445692|Growth Substances|growth substances|mesh-ancestor
6028191|NCT00445692|Growth Inhibitors|growth inhibitors|mesh-ancestor
6028192|NCT00445692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6028193|NCT00445692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6028194|NCT00445692|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6028195|NCT00445692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6028196|NCT00445692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028197|NCT00445692|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6028198|NCT00445692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6028199|NCT00445692|Protease Inhibitors|protease inhibitors|mesh-ancestor
6028200|NCT00445692|Dermatologic Agents|dermatologic agents|mesh-ancestor
6028201|NCT00445744|Cyclophosphamide|cyclophosphamide|mesh-list
6028202|NCT00445744|Busulfan|busulfan|mesh-list
6028203|NCT00445744|Methotrexate|methotrexate|mesh-list
6028204|NCT00445744|Tacrolimus|tacrolimus|mesh-list
5492758|NCT02968446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5492759|NCT02968446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5492760|NCT02968446|Alkylating Agents|alkylating agents|mesh-ancestor
5492761|NCT02968446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492762|NCT02968446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5492763|NCT02968446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6028205|NCT00445744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6456389|NCT00432081|Tocolytic Agents|tocolytic agents|mesh-ancestor
6028206|NCT00445744|Immunologic Factors|immunologic factors|mesh-ancestor
6028207|NCT00445744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028208|NCT00445744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6028209|NCT00445744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6028210|NCT00445744|Alkylating Agents|alkylating agents|mesh-ancestor
6028211|NCT00445744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028212|NCT00445744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6028213|NCT00445744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6028214|NCT00445744|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6028215|NCT00445744|Abortifacient Agents|abortifacient agents|mesh-ancestor
6028216|NCT00445744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6028217|NCT00445744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6028218|NCT00445744|Antimetabolites|antimetabolites|mesh-ancestor
6028219|NCT00445744|Dermatologic Agents|dermatologic agents|mesh-ancestor
6028220|NCT00445744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6028221|NCT00445744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6028222|NCT00445744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6028223|NCT00445744|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6028224|NCT00445770|Etanercept|etanercept|mesh-list
6028225|NCT00445770|Methotrexate|methotrexate|mesh-list
6028226|NCT00445770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6028227|NCT00445770|Abortifacient Agents|abortifacient agents|mesh-ancestor
6028228|NCT00445770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6028229|NCT00445770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028230|NCT00445770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6028231|NCT00445770|Antimetabolites|antimetabolites|mesh-ancestor
6028232|NCT00445770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028233|NCT00445770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6028234|NCT00445770|Dermatologic Agents|dermatologic agents|mesh-ancestor
6028235|NCT00445770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6028236|NCT00445770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6028237|NCT00445770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6028238|NCT00445770|Immunologic Factors|immunologic factors|mesh-ancestor
6028239|NCT00445770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6028240|NCT00445770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6028241|NCT00445770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6028242|NCT00445770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6028243|NCT00445770|Analgesics|analgesics|mesh-ancestor
6028244|NCT00445770|Sensory System Agents|sensory system agents|mesh-ancestor
6028245|NCT00445770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6028246|NCT00445770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6028247|NCT00445770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6028248|NCT00445848|Bevacizumab|bevacizumab|mesh-list
6028249|NCT00445848|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6028250|NCT00445848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6028251|NCT00445848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6028252|NCT00445848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6028253|NCT00445848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6028254|NCT00445848|Growth Substances|growth substances|mesh-ancestor
6028255|NCT00445848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028256|NCT00445848|Growth Inhibitors|growth inhibitors|mesh-ancestor
6028257|NCT00445848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6028258|NCT00445848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6028259|NCT00445848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028260|NCT00445887|Levonorgestrel|levonorgestrel|mesh-list
6028261|NCT00445887|Norgestrel|norgestrel|mesh-list
6028262|NCT00445887|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6028263|NCT00445887|Contraceptive Agents|contraceptive agents|mesh-ancestor
6028264|NCT00445887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6028265|NCT00445887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028266|NCT00445887|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6028267|NCT00445887|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6028268|NCT00445887|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6028269|NCT00445887|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6028270|NCT00445939|Adalimumab|adalimumab|mesh-list
6028271|NCT00445939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6028272|NCT00445939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6028273|NCT00445978|Verapamil|verapamil|mesh-list
6028274|NCT00445978|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6028275|NCT00445978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6028276|NCT00445978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6028277|NCT00445978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028278|NCT00445978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6456390|NCT00432081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6456391|NCT00432081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6456392|NCT00432081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6456393|NCT00432081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456394|NCT00432094|Paclitaxel|paclitaxel|mesh-list
6456395|NCT00432094|Etoposide|etoposide|mesh-list
6456396|NCT00432094|Carboplatin|carboplatin|mesh-list
6028279|NCT00445978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028280|NCT00445978|Vasodilator Agents|vasodilator agents|mesh-ancestor
6028281|NCT00446030|Cyclophosphamide|cyclophosphamide|mesh-list
6028282|NCT00446030|Bevacizumab|bevacizumab|mesh-list
6028283|NCT00446030|Carboplatin|carboplatin|mesh-list
6028284|NCT00446030|Docetaxel|docetaxel|mesh-list
6028285|NCT00446030|Doxorubicin|doxorubicin|mesh-list
6028286|NCT00446030|Trastuzumab|trastuzumab|mesh-list
6028287|NCT00446030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6028288|NCT00446030|Immunologic Factors|immunologic factors|mesh-ancestor
6028289|NCT00446030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028290|NCT00446030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6028291|NCT00446030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6028292|NCT00446030|Alkylating Agents|alkylating agents|mesh-ancestor
6028293|NCT00446030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028294|NCT00446030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6028295|NCT00446030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6028296|NCT00446030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6028297|NCT00446030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6028298|NCT00446030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6028299|NCT00446030|Growth Substances|growth substances|mesh-ancestor
6028300|NCT00446030|Growth Inhibitors|growth inhibitors|mesh-ancestor
6028301|NCT00446030|Tubulin Modulators|tubulin modulators|mesh-ancestor
6028302|NCT00446030|Antimitotic Agents|antimitotic agents|mesh-ancestor
6028303|NCT00446030|Mitosis Modulators|mitosis modulators|mesh-ancestor
6028304|NCT00446030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6028305|NCT00446030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6028306|NCT00446030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6028307|NCT00446030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6028308|NCT00446134|Ribavirin|ribavirin|mesh-list
6028309|NCT00446134|Taribavirin|taribavirin|mesh-list
6028310|NCT00446134|Antimetabolites|antimetabolites|mesh-ancestor
6028311|NCT00446134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028312|NCT00446134|Antiviral Agents|antiviral agents|mesh-ancestor
6028313|NCT00446134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6028314|NCT00446147|Pyridoxine|pyridoxine|mesh-list
6028315|NCT00446147|Vitamin B Complex|vitamin b complex|mesh-ancestor
6028316|NCT00446147|Vitamins|vitamins|mesh-ancestor
6028317|NCT00446147|Micronutrients|micronutrients|mesh-ancestor
6028318|NCT00446147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028319|NCT00446199|Drospirenone|drospirenone|mesh-list
6028320|NCT00446199|Estradiol|estradiol|mesh-list
6028321|NCT00446199|Estrogens|estrogens|mesh-ancestor
5492778|NCT02955758|Pembrolizumab|pembrolizumab|mesh-list
5492779|NCT02955758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5492780|NCT02955758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5492781|NCT02954874|Pembrolizumab|pembrolizumab|mesh-list
5492782|NCT02954874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5492783|NCT02954874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6028322|NCT00446199|Hormones|hormones|mesh-ancestor
6028323|NCT00446199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6028324|NCT00446199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028325|NCT00446199|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6028326|NCT00446199|Hormone Antagonists|hormone antagonists|mesh-ancestor
6028327|NCT00446199|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6028328|NCT00446199|Diuretics|diuretics|mesh-ancestor
6028329|NCT00446199|Natriuretic Agents|natriuretic agents|mesh-ancestor
6028330|NCT00446251|Mycophenolic Acid|mycophenolic acid|mesh-list
6028331|NCT00446251|Rituximab|rituximab|mesh-list
6456397|NCT00432094|Ifosfamide|ifosfamide|mesh-list
6456398|NCT00432094|Thiotepa|thiotepa|mesh-list
6028332|NCT00446251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6028333|NCT00446251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6028334|NCT00446251|Immunologic Factors|immunologic factors|mesh-ancestor
6028335|NCT00446251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028336|NCT00446251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6028337|NCT00446251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6028338|NCT00446251|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6028339|NCT00446251|Antitubercular Agents|antitubercular agents|mesh-ancestor
6028340|NCT00446251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6028341|NCT00446251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6028342|NCT00446251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6028343|NCT00446251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028344|NCT00446264|Sirolimus|sirolimus|mesh-list
6028345|NCT00446264|Tacrolimus|tacrolimus|mesh-list
6028346|NCT00446264|Daclizumab|daclizumab|mesh-list
6028347|NCT00446264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6028348|NCT00446264|Immunologic Factors|immunologic factors|mesh-ancestor
6654682|NCT01458600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6654683|NCT01458600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6654684|NCT01458600|Analgesics|analgesics|mesh-ancestor
6654685|NCT01458600|Sensory System Agents|sensory system agents|mesh-ancestor
6654686|NCT01458600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6654687|NCT01458600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654688|NCT01458600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6654689|NCT01458600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6654690|NCT01458600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5492784|NCT02939183|Dexamethasone|dexamethasone|mesh-list
6028349|NCT00446264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028350|NCT00446264|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6028351|NCT00446264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6028352|NCT00446264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028353|NCT00446264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6028354|NCT00446264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6028355|NCT00446264|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6028356|NCT00446264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6028357|NCT00446264|Antifungal Agents|antifungal agents|mesh-ancestor
6028358|NCT00446290|Docetaxel|docetaxel|mesh-list
6028359|NCT00446290|Capecitabine|capecitabine|mesh-list
6028360|NCT00446290|Oxaliplatin|oxaliplatin|mesh-list
6028361|NCT00446290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6028362|NCT00446290|Tubulin Modulators|tubulin modulators|mesh-ancestor
5492785|NCT02939183|Pomalidomide|pomalidomide|mesh-list
5492786|NCT02939183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5492787|NCT02939183|Antiemetics|antiemetics|mesh-ancestor
5492788|NCT02939183|Autonomic Agents|autonomic agents|mesh-ancestor
5492789|NCT02939183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5492790|NCT02939183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492791|NCT02939183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5492792|NCT02939183|Glucocorticoids|glucocorticoids|mesh-ancestor
5492793|NCT02939183|Hormones|hormones|mesh-ancestor
5492794|NCT02939183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5492795|NCT02939183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5492796|NCT02939183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5492797|NCT02939183|Immunologic Factors|immunologic factors|mesh-ancestor
6028363|NCT00446290|Antimitotic Agents|antimitotic agents|mesh-ancestor
6028364|NCT00446290|Mitosis Modulators|mitosis modulators|mesh-ancestor
6028365|NCT00446290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028366|NCT00446290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6028367|NCT00446290|Antimetabolites|antimetabolites|mesh-ancestor
6028368|NCT00446446|Panitumumab|panitumumab|mesh-list
6028369|NCT00446446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6028370|NCT00446446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6028371|NCT00446459|Mycophenolic Acid|mycophenolic acid|mesh-list
6028372|NCT00446459|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6028373|NCT00446459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6028374|NCT00446459|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6028375|NCT00446459|Antitubercular Agents|antitubercular agents|mesh-ancestor
6028376|NCT00446459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6028377|NCT00446459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6028378|NCT00446459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6028379|NCT00446459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028380|NCT00446511|Valsartan|valsartan|mesh-list
6028381|NCT00446511|Enalapril|enalapril|mesh-list
6028382|NCT00446511|Enalaprilat|enalaprilat|mesh-list
6028383|NCT00446511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5492798|NCT02939183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5492799|NCT02939183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5492800|NCT02939183|Growth Substances|growth substances|mesh-ancestor
5492801|NCT02939183|Growth Inhibitors|growth inhibitors|mesh-ancestor
5492802|NCT02935309|Capecitabine|capecitabine|mesh-list
5492803|NCT02935309|Lenvatinib|lenvatinib|mesh-list
5492804|NCT02935309|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5492805|NCT02935309|Antimetabolites|antimetabolites|mesh-ancestor
5492806|NCT02935309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492807|NCT02935309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5492808|NCT02935309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5492809|NCT02935309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5503059|NCT04462250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503060|NCT04462250|Analgesics|analgesics|mesh-ancestor
5503061|NCT04462250|Sensory System Agents|sensory system agents|mesh-ancestor
5503062|NCT04462250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5503636|NCT04457089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503637|NCT04457089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5503638|NCT04457089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5503639|NCT04457089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6028384|NCT00446511|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6028385|NCT00446511|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6028386|NCT00446511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028387|NCT00446511|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6028388|NCT00446511|Protease Inhibitors|protease inhibitors|mesh-ancestor
6028389|NCT00446511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6028390|NCT00446563|Losartan|losartan|mesh-list
6028391|NCT00446563|Amlodipine|amlodipine|mesh-list
6028392|NCT00446563|Valsartan|valsartan|mesh-list
6028393|NCT00446563|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6028394|NCT00446563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6028395|NCT00446563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6028396|NCT00446563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6028397|NCT00446563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028398|NCT00446563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6028399|NCT00446563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028400|NCT00446563|Vasodilator Agents|vasodilator agents|mesh-ancestor
6028401|NCT00446563|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6028402|NCT00446563|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6028403|NCT00446563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6028404|NCT00446563|Diuretics|diuretics|mesh-ancestor
6028405|NCT00446563|Natriuretic Agents|natriuretic agents|mesh-ancestor
6028406|NCT00446563|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6028407|NCT00446641|Cilostazol|cilostazol|mesh-list
6028408|NCT00446641|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6028409|NCT00446641|Autonomic Agents|autonomic agents|mesh-ancestor
6028410|NCT00446641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5503640|NCT04457284|Nivolumab|nivolumab|mesh-list
5503641|NCT04457284|Temozolomide|temozolomide|mesh-list
5503642|NCT04457284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5503643|NCT04457284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6028411|NCT00446641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028412|NCT00446641|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6028413|NCT00446641|Respiratory System Agents|respiratory system agents|mesh-ancestor
6028414|NCT00446641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6028415|NCT00446641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6028416|NCT00446641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028417|NCT00446641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6028418|NCT00446641|Vasodilator Agents|vasodilator agents|mesh-ancestor
6028419|NCT00446641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6028420|NCT00446641|Protective Agents|protective agents|mesh-ancestor
6028421|NCT00446641|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6028422|NCT00446641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6028423|NCT00446641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6028424|NCT00446797|Celecoxib|celecoxib|mesh-list
6028425|NCT00446797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6028426|NCT00446797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6028427|NCT00446797|Analgesics|analgesics|mesh-ancestor
6456399|NCT00432094|Mesna|mesna|mesh-list
5503644|NCT04457284|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5503645|NCT04457284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503646|NCT04457284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5503647|NCT04457284|Alkylating Agents|alkylating agents|mesh-ancestor
5503648|NCT04456985|Folic Acid|folic acid|mesh-list
6028428|NCT00446797|Sensory System Agents|sensory system agents|mesh-ancestor
6028429|NCT00446797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6028430|NCT00446797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028431|NCT00446797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6028432|NCT00446797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6028433|NCT00446797|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6028434|NCT00446797|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6028435|NCT00446797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6028436|NCT00446797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028437|NCT00446849|Mesalamine|mesalamine|mesh-list
6028438|NCT00446849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6028439|NCT00446849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6028440|NCT00446849|Analgesics|analgesics|mesh-ancestor
6028441|NCT00446849|Sensory System Agents|sensory system agents|mesh-ancestor
6028442|NCT00446849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6028443|NCT00446849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492810|NCT02908685|Risdiplam|risdiplam|mesh-list
5492811|NCT02908685|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5492812|NCT02908685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5492813|NCT02908685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492814|NCT02907996|Sofosbuvir|sofosbuvir|mesh-list
5492815|NCT02907996|Antiviral Agents|antiviral agents|mesh-ancestor
5492816|NCT02907996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5492817|NCT02857426|Nivolumab|nivolumab|mesh-list
6028444|NCT00446849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6028445|NCT00446849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6028446|NCT00446992|Olanzapine|olanzapine|mesh-list
6028447|NCT00446992|Antiemetics|antiemetics|mesh-ancestor
6028448|NCT00446992|Autonomic Agents|autonomic agents|mesh-ancestor
6028449|NCT00446992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6028450|NCT00446992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028451|NCT00446992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6028452|NCT00446992|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6028453|NCT00446992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6028454|NCT00446992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6028455|NCT00446992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6028456|NCT00446992|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6028457|NCT00446992|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6028458|NCT00446992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6028459|NCT00446992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028460|NCT00446992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6028461|NCT00446992|Serotonin Agents|serotonin agents|mesh-ancestor
6028462|NCT00447005|Axitinib|axitinib|mesh-list
6028463|NCT00447005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6028464|NCT00447005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6028465|NCT00447005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6028466|NCT00447005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028467|NCT00447057|Pemetrexed|pemetrexed|mesh-list
6028468|NCT00447057|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6028469|NCT00447057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6028470|NCT00447057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6028471|NCT00447057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028472|NCT00447057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6028473|NCT00447057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6028474|NCT00447057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6028475|NCT00447122|Gemcitabine|gemcitabine|mesh-list
6028476|NCT00447122|Lapatinib|lapatinib|mesh-list
6028477|NCT00447122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6456400|NCT00432094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6456401|NCT00432094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6456402|NCT00432094|Tubulin Modulators|tubulin modulators|mesh-ancestor
6028478|NCT00447122|Antimetabolites|antimetabolites|mesh-ancestor
6028479|NCT00447122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028480|NCT00447122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6028481|NCT00447122|Antiviral Agents|antiviral agents|mesh-ancestor
6028482|NCT00447122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6028483|NCT00447122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6028484|NCT00447122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6028485|NCT00447122|Immunologic Factors|immunologic factors|mesh-ancestor
6028486|NCT00447122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028487|NCT00447122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6028488|NCT00447226|Lapatinib|lapatinib|mesh-list
6028489|NCT00447226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6028490|NCT00447226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6028491|NCT00447226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6028492|NCT00447226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028493|NCT00447265|Etanercept|etanercept|mesh-list
6028494|NCT00447265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6028495|NCT00447265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6028496|NCT00447265|Analgesics|analgesics|mesh-ancestor
6028497|NCT00447265|Sensory System Agents|sensory system agents|mesh-ancestor
6028498|NCT00447265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6028499|NCT00447265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028500|NCT00447265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6028501|NCT00447265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6028502|NCT00447265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6028503|NCT00447265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6028504|NCT00447265|Immunologic Factors|immunologic factors|mesh-ancestor
6028505|NCT00447278|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6028506|NCT00447278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6028507|NCT00447278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6028508|NCT00447278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6028509|NCT00447278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028510|NCT00447278|Adrenergic Agents|adrenergic agents|mesh-ancestor
6028511|NCT00447278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6028512|NCT00447278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028513|NCT00447330|Bevacizumab|bevacizumab|mesh-list
6028514|NCT00447330|Capecitabine|capecitabine|mesh-list
6028515|NCT00447330|Oxaliplatin|oxaliplatin|mesh-list
6028516|NCT00447330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6028517|NCT00447330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6028518|NCT00447330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6028519|NCT00447330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6028520|NCT00447330|Growth Substances|growth substances|mesh-ancestor
6028521|NCT00447330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028522|NCT00447330|Growth Inhibitors|growth inhibitors|mesh-ancestor
6028523|NCT00447330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6028524|NCT00447330|Antimetabolites|antimetabolites|mesh-ancestor
6028525|NCT00447330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028526|NCT00447382|Insulin|insulin|mesh-list
6028527|NCT00447382|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6028528|NCT00447382|Insulin Aspart|insulin aspart|mesh-list
6028529|NCT00447382|Insulin Detemir|insulin detemir|mesh-list
5492818|NCT02857426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5492819|NCT02857426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5492820|NCT02857426|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5492821|NCT02857426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492822|NCT02845297|Pembrolizumab|pembrolizumab|mesh-list
6028530|NCT00447382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6028531|NCT00447382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028532|NCT00447499|Lanreotide|lanreotide|mesh-list
6028533|NCT00447499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6028534|NCT00447694|Deferasirox|deferasirox|mesh-list
6028535|NCT00447694|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6028536|NCT00447694|Chelating Agents|chelating agents|mesh-ancestor
6028537|NCT00447694|Sequestering Agents|sequestering agents|mesh-ancestor
6028538|NCT00447694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028539|NCT00447772|Botulinum Toxins|botulinum toxins|mesh-list
6028540|NCT00447772|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6028541|NCT00447772|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6028542|NCT00447772|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6028543|NCT00447772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6028544|NCT00447772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028545|NCT00447772|Cholinergic Agents|cholinergic agents|mesh-ancestor
6028546|NCT00447772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6028547|NCT00447772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028548|NCT00447772|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6028549|NCT00447772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6028550|NCT00447876|Botulinum Toxins|botulinum toxins|mesh-list
6028551|NCT00447876|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6028552|NCT00447876|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6028553|NCT00447876|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6028554|NCT00447876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6028555|NCT00447876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028556|NCT00447876|Cholinergic Agents|cholinergic agents|mesh-ancestor
6028557|NCT00447876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6028558|NCT00447876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028559|NCT00447876|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6028560|NCT00447876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6028561|NCT00447902|Ritonavir|ritonavir|mesh-list
6028562|NCT00447902|Tipranavir|tipranavir|mesh-list
6028563|NCT00447902|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6028564|NCT00447902|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6028565|NCT00447902|Protease Inhibitors|protease inhibitors|mesh-ancestor
6028566|NCT00447902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6028567|NCT00447902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028568|NCT00447902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6028569|NCT00447902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6028570|NCT00447902|Antiviral Agents|antiviral agents|mesh-ancestor
6028571|NCT00447902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6028572|NCT00447902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6028573|NCT00447902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6028574|NCT00448019|Vidarabine|vidarabine|mesh-list
6028575|NCT00448019|Cyclophosphamide|cyclophosphamide|mesh-list
6028576|NCT00448019|Bevacizumab|bevacizumab|mesh-list
6028577|NCT00448019|Rituximab|rituximab|mesh-list
6028578|NCT00448019|Fludarabine|fludarabine|mesh-list
6028579|NCT00448019|Fludarabine phosphate|fludarabine phosphate|mesh-list
6028580|NCT00448019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6028581|NCT00448019|Immunologic Factors|immunologic factors|mesh-ancestor
6028582|NCT00448019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028583|NCT00448019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6028584|NCT00448019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6028585|NCT00448019|Alkylating Agents|alkylating agents|mesh-ancestor
6028586|NCT00448019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028587|NCT00448019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6028588|NCT00448019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6028589|NCT00448019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6028590|NCT00448019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6028591|NCT00448019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6028592|NCT00448019|Growth Substances|growth substances|mesh-ancestor
6028593|NCT00448019|Growth Inhibitors|growth inhibitors|mesh-ancestor
6028594|NCT00448019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6028595|NCT00448019|Antimetabolites|antimetabolites|mesh-ancestor
6028596|NCT00448019|Antiviral Agents|antiviral agents|mesh-ancestor
6028597|NCT00448019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6028598|NCT00448123|Tamsulosin|tamsulosin|mesh-list
6028599|NCT00448123|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6028600|NCT00448123|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6028601|NCT00448123|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6028602|NCT00448123|Adrenergic Agents|adrenergic agents|mesh-ancestor
6028603|NCT00448123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6028604|NCT00448123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028605|NCT00448123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028606|NCT00448123|Urological Agents|urological agents|mesh-ancestor
6028607|NCT00448136|Bevacizumab|bevacizumab|mesh-list
6028608|NCT00448136|Streptozocin|streptozocin|mesh-list
6028609|NCT00448136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6028610|NCT00448136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6028611|NCT00448136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6028612|NCT00448136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6028613|NCT00448136|Growth Substances|growth substances|mesh-ancestor
5492823|NCT02845297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5492824|NCT02845297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5492825|NCT02831764|Tenofovir|tenofovir|mesh-list
5492826|NCT02831764|Lamivudine|lamivudine|mesh-list
5492827|NCT02831764|Emtricitabine|emtricitabine|mesh-list
5492828|NCT02831764|Dolutegravir|dolutegravir|mesh-list
5492829|NCT02831764|Antiviral Agents|antiviral agents|mesh-ancestor
6456403|NCT00432094|Antimitotic Agents|antimitotic agents|mesh-ancestor
6028614|NCT00448136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028615|NCT00448136|Growth Inhibitors|growth inhibitors|mesh-ancestor
6028616|NCT00448136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6028617|NCT00448175|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6028618|NCT00448175|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6028619|NCT00448175|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6028620|NCT00448175|Cholinergic Agents|cholinergic agents|mesh-ancestor
6028621|NCT00448175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6028622|NCT00448175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028623|NCT00448175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028624|NCT00448175|Urological Agents|urological agents|mesh-ancestor
6028625|NCT00448201|Methotrexate|methotrexate|mesh-list
6028626|NCT00448201|Fludarabine phosphate|fludarabine phosphate|mesh-list
6028627|NCT00448201|Fludarabine|fludarabine|mesh-list
6028628|NCT00448201|Busulfan|busulfan|mesh-list
6028629|NCT00448201|Tacrolimus|tacrolimus|mesh-list
5492830|NCT02831764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5492831|NCT02831764|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5492832|NCT02831764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5492833|NCT02831764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5492834|NCT02831764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492835|NCT02831764|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5492836|NCT02831764|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6028630|NCT00448201|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6028631|NCT00448201|Sargramostim|sargramostim|mesh-list
6028632|NCT00448201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6028633|NCT00448201|Abortifacient Agents|abortifacient agents|mesh-ancestor
6028634|NCT00448201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6028635|NCT00448201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028636|NCT00448201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6028637|NCT00448201|Antimetabolites|antimetabolites|mesh-ancestor
6028638|NCT00448201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028639|NCT00448201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6028640|NCT00448201|Dermatologic Agents|dermatologic agents|mesh-ancestor
6028641|NCT00448201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6028642|NCT00448201|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6028643|NCT00448201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6028644|NCT00448201|Immunologic Factors|immunologic factors|mesh-ancestor
6028645|NCT00448201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6456404|NCT00432094|Mitosis Modulators|mitosis modulators|mesh-ancestor
6456405|NCT00432094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456406|NCT00432094|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6028646|NCT00448201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6028647|NCT00448201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6028648|NCT00448201|Alkylating Agents|alkylating agents|mesh-ancestor
6028649|NCT00448201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6028650|NCT00448201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6028651|NCT00448227|Famciclovir|famciclovir|mesh-list
6456407|NCT00432094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6456408|NCT00432094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6456409|NCT00432094|Immunologic Factors|immunologic factors|mesh-ancestor
6456410|NCT00432094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456411|NCT00432094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6456412|NCT00432094|Alkylating Agents|alkylating agents|mesh-ancestor
6028652|NCT00448227|Antiviral Agents|antiviral agents|mesh-ancestor
6028653|NCT00448227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6028654|NCT00448227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6028655|NCT00448227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6028656|NCT00448227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028657|NCT00448279|Trastuzumab|trastuzumab|mesh-list
6028658|NCT00448279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6028659|NCT00448279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6028660|NCT00448357|Methotrexate|methotrexate|mesh-list
6028661|NCT00448357|Fludarabine phosphate|fludarabine phosphate|mesh-list
6028662|NCT00448357|Fludarabine|fludarabine|mesh-list
6028663|NCT00448357|Busulfan|busulfan|mesh-list
6028664|NCT00448357|Tacrolimus|tacrolimus|mesh-list
6028665|NCT00448357|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6028666|NCT00448357|Thymoglobulin|thymoglobulin|mesh-list
6456413|NCT00432094|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6456414|NCT00432094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6456415|NCT00432094|Protective Agents|protective agents|mesh-ancestor
6456416|NCT00432120|Clopidogrel|clopidogrel|mesh-list
6456417|NCT00432120|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6456418|NCT00432120|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5492837|NCT02831764|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5492838|NCT02831764|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5492839|NCT02823002|Lidocaine|lidocaine|mesh-list
5492840|NCT02823002|Anesthetics, Local|anesthetics, local|mesh-ancestor
5492841|NCT02823002|Anesthetics|anesthetics|mesh-ancestor
6028667|NCT00448357|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6028668|NCT00448357|Abortifacient Agents|abortifacient agents|mesh-ancestor
6028669|NCT00448357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6028670|NCT00448357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028671|NCT00448357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6028672|NCT00448357|Antimetabolites|antimetabolites|mesh-ancestor
6028673|NCT00448357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028674|NCT00448357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6028675|NCT00448357|Dermatologic Agents|dermatologic agents|mesh-ancestor
6028676|NCT00448357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6028677|NCT00448357|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6028678|NCT00448357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6028679|NCT00448357|Immunologic Factors|immunologic factors|mesh-ancestor
6028680|NCT00448357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6028681|NCT00448357|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6028682|NCT00448357|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6028683|NCT00448357|Alkylating Agents|alkylating agents|mesh-ancestor
6028684|NCT00448357|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6028685|NCT00448357|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6028686|NCT00448435|Fluticasone|fluticasone|mesh-list
6028687|NCT00448435|Xhance|xhance|mesh-list
6028688|NCT00448435|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6028689|NCT00448435|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6028690|NCT00448435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6028691|NCT00448435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6028692|NCT00448435|Autonomic Agents|autonomic agents|mesh-ancestor
6028693|NCT00448435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6028694|NCT00448435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028695|NCT00448435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6028696|NCT00448435|Respiratory System Agents|respiratory system agents|mesh-ancestor
6028697|NCT00448435|Dermatologic Agents|dermatologic agents|mesh-ancestor
6028698|NCT00448435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6028699|NCT00448435|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6028700|NCT00448435|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6028701|NCT00448435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6028702|NCT00448435|Adrenergic Agents|adrenergic agents|mesh-ancestor
6028703|NCT00448435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6028704|NCT00448435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028705|NCT00448435|Glucocorticoids|glucocorticoids|mesh-ancestor
6028706|NCT00448435|Hormones|hormones|mesh-ancestor
6028707|NCT00448435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6028708|NCT00448435|Sympathomimetics|sympathomimetics|mesh-ancestor
6028709|NCT00448539|Rufinamide|rufinamide|mesh-list
6028710|NCT00448539|Anticonvulsants|anticonvulsants|mesh-ancestor
6028711|NCT00448539|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6028712|NCT00448539|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6028713|NCT00448539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6028714|NCT00448539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028715|NCT00448591|Bevacizumab|bevacizumab|mesh-list
6028716|NCT00448591|Taxane|taxane|mesh-list
6028717|NCT00448591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6028718|NCT00448591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6028719|NCT00448591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6028720|NCT00448591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6028721|NCT00448591|Growth Substances|growth substances|mesh-ancestor
6028722|NCT00448591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028723|NCT00448591|Growth Inhibitors|growth inhibitors|mesh-ancestor
6028724|NCT00448669|Tenofovir|tenofovir|mesh-list
6028725|NCT00448669|Emtricitabine|emtricitabine|mesh-list
6028726|NCT00448669|Antiviral Agents|antiviral agents|mesh-ancestor
6028727|NCT00448669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6028728|NCT00448669|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6028729|NCT00448669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6028730|NCT00448669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6028731|NCT00448669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028732|NCT00448669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5492842|NCT02823002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5492843|NCT02823002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028733|NCT00448669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5492844|NCT02823002|Sensory System Agents|sensory system agents|mesh-ancestor
5492845|NCT02823002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5492846|NCT02823002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5492847|NCT02823002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5492848|NCT02823002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5492849|NCT02823002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5492850|NCT02823002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492851|NCT02807493|Salicylic Acid|salicylic acid|mesh-list
5492852|NCT02807493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5492853|NCT02807493|Antifungal Agents|antifungal agents|mesh-ancestor
5492854|NCT02807493|Keratolytic Agents|keratolytic agents|mesh-ancestor
5492855|NCT02807493|Dermatologic Agents|dermatologic agents|mesh-ancestor
5492856|NCT02777385|Pembrolizumab|pembrolizumab|mesh-list
5492857|NCT02777385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5492858|NCT02777385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5492859|NCT02728752|gamma-Globulins|gamma-globulins|mesh-list
5492860|NCT02728752|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5492861|NCT02728752|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5492862|NCT02728752|Immunologic Factors|immunologic factors|mesh-ancestor
5492863|NCT02728752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492864|NCT02710331|Ethanol|ethanol|mesh-list
5492865|NCT02710331|Dronabinol|dronabinol|mesh-list
5492866|NCT02710331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5492867|NCT02710331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5492868|NCT02710331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5492869|NCT02710331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492870|NCT02710331|Hallucinogens|hallucinogens|mesh-ancestor
5492871|NCT02710331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5492872|NCT02710331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5492873|NCT02710331|Analgesics|analgesics|mesh-ancestor
5492874|NCT02710331|Sensory System Agents|sensory system agents|mesh-ancestor
5492875|NCT02710331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5492876|NCT02710331|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5492877|NCT02710331|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5492878|NCT02710331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5492879|NCT02710331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492880|NCT02710331|Hormones|hormones|mesh-ancestor
5492881|NCT02710331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5492882|NCT02705300|Leucovorin|leucovorin|mesh-list
5492883|NCT02705300|Tocotrienols|tocotrienols|mesh-list
5492884|NCT02705300|Vitamin E|vitamin e|mesh-list
6028734|NCT00448708|Paclitaxel|paclitaxel|mesh-list
6028735|NCT00448708|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6028736|NCT00448708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6028737|NCT00448708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6028738|NCT00448708|Tubulin Modulators|tubulin modulators|mesh-ancestor
6028739|NCT00448708|Antimitotic Agents|antimitotic agents|mesh-ancestor
6028740|NCT00448708|Mitosis Modulators|mitosis modulators|mesh-ancestor
6028741|NCT00448708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028742|NCT00448760|Leucovorin|leucovorin|mesh-list
5492885|NCT02705300|Tocopherols|tocopherols|mesh-list
5492886|NCT02705300|Fluorouracil|fluorouracil|mesh-list
5492887|NCT02705300|Oxaliplatin|oxaliplatin|mesh-list
5492888|NCT02705300|Irinotecan|irinotecan|mesh-list
5492889|NCT02705300|Levoleucovorin|levoleucovorin|mesh-list
5492890|NCT02705300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028743|NCT00448760|Docetaxel|docetaxel|mesh-list
6028744|NCT00448760|Oxaliplatin|oxaliplatin|mesh-list
6028745|NCT00448760|Floxuridine|floxuridine|mesh-list
6028746|NCT00448760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6028747|NCT00448760|Tubulin Modulators|tubulin modulators|mesh-ancestor
6028748|NCT00448760|Antimitotic Agents|antimitotic agents|mesh-ancestor
6028749|NCT00448760|Mitosis Modulators|mitosis modulators|mesh-ancestor
6028750|NCT00448760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492891|NCT02705300|Antimetabolites|antimetabolites|mesh-ancestor
5492892|NCT02705300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492893|NCT02705300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5492894|NCT02705300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5492895|NCT02705300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5492896|NCT02705300|Immunologic Factors|immunologic factors|mesh-ancestor
5492897|NCT02705300|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5492898|NCT02705300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5492899|NCT02705300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5492900|NCT02705300|Antidotes|antidotes|mesh-ancestor
6028751|NCT00448760|Antidotes|antidotes|mesh-ancestor
6028752|NCT00448760|Protective Agents|protective agents|mesh-ancestor
6654691|NCT01458600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6028753|NCT00448760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028754|NCT00448760|Vitamin B Complex|vitamin b complex|mesh-ancestor
6028755|NCT00448760|Vitamins|vitamins|mesh-ancestor
6028756|NCT00448760|Micronutrients|micronutrients|mesh-ancestor
6028757|NCT00448760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6028758|NCT00448760|Antimetabolites|antimetabolites|mesh-ancestor
6028759|NCT00448864|Ecallantide|ecallantide|mesh-list
6028760|NCT00448864|Analgesics|analgesics|mesh-ancestor
6028761|NCT00448864|Sensory System Agents|sensory system agents|mesh-ancestor
6028762|NCT00448864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6028763|NCT00448864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028764|NCT00448864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6028765|NCT00448864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6028766|NCT00448864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6028767|NCT00448864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6028768|NCT00448916|Pregabalin|pregabalin|mesh-list
6028769|NCT00448916|Analgesics|analgesics|mesh-ancestor
6028770|NCT00448916|Sensory System Agents|sensory system agents|mesh-ancestor
6028771|NCT00448916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6028772|NCT00448916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028773|NCT00448916|Anticonvulsants|anticonvulsants|mesh-ancestor
6028774|NCT00448916|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6028775|NCT00448916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6028776|NCT00448916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028777|NCT00448916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6028778|NCT00448916|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6028779|NCT00448916|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6028780|NCT00448916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6028781|NCT00448916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6028782|NCT00449007|Bupropion|bupropion|mesh-list
6028783|NCT00449007|Fluoxetine|fluoxetine|mesh-list
6028784|NCT00449007|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6028785|NCT00449007|Antidepressive Agents|antidepressive agents|mesh-ancestor
6028786|NCT00449007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6028787|NCT00449007|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6028788|NCT00449007|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6028789|NCT00449007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6028790|NCT00449007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028791|NCT00449007|Dopamine Agents|dopamine agents|mesh-ancestor
6028792|NCT00449007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6028793|NCT00449007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028794|NCT00449007|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6028795|NCT00449007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6028796|NCT00449007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5492901|NCT02705300|Protective Agents|protective agents|mesh-ancestor
5492902|NCT02705300|Vitamin B Complex|vitamin b complex|mesh-ancestor
5492903|NCT02705300|Vitamins|vitamins|mesh-ancestor
5492904|NCT02705300|Micronutrients|micronutrients|mesh-ancestor
5492905|NCT02705300|Antioxidants|antioxidants|mesh-ancestor
5492906|NCT02678533|Plerixafor|plerixafor|mesh-list
5492907|NCT02678533|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5492908|NCT02678533|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5492909|NCT02678533|Antiviral Agents|antiviral agents|mesh-ancestor
5492910|NCT02678533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5492911|NCT02593123|Mycophenolic Acid|mycophenolic acid|mesh-list
5492912|NCT02593123|Molgramostim|molgramostim|mesh-list
5492913|NCT02593123|Lenograstim|lenograstim|mesh-list
5492914|NCT02593123|Sargramostim|sargramostim|mesh-list
5492915|NCT02593123|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5492916|NCT02593123|Immunologic Factors|immunologic factors|mesh-ancestor
5492917|NCT02593123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492918|NCT02593123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6028797|NCT00449007|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6028798|NCT00449007|Serotonin Agents|serotonin agents|mesh-ancestor
6028799|NCT00449033|Gemcitabine|gemcitabine|mesh-list
6028800|NCT00449033|Sorafenib|sorafenib|mesh-list
6028801|NCT00449033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6028802|NCT00449033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6028803|NCT00449033|Antimetabolites|antimetabolites|mesh-ancestor
6028804|NCT00449033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028805|NCT00449033|Antiviral Agents|antiviral agents|mesh-ancestor
6028806|NCT00449033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6028807|NCT00449033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5492919|NCT02593123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5492920|NCT02593123|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6028808|NCT00449033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5492921|NCT02593123|Antitubercular Agents|antitubercular agents|mesh-ancestor
5492922|NCT02593123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5492923|NCT02593123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5492924|NCT02593123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5492925|NCT02593123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492926|NCT02591147|Fluorides|fluorides|mesh-list
5492927|NCT02591147|Cariostatic Agents|cariostatic agents|mesh-ancestor
5492928|NCT02591147|Protective Agents|protective agents|mesh-ancestor
5492929|NCT02591147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492930|NCT02574455|Gemcitabine|gemcitabine|mesh-list
5492931|NCT02574455|Capecitabine|capecitabine|mesh-list
5492932|NCT02574455|Vinorelbine|vinorelbine|mesh-list
5492933|NCT02574455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6028809|NCT00449033|Immunologic Factors|immunologic factors|mesh-ancestor
6028810|NCT00449033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028811|NCT00449033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6028812|NCT00449046|Fluticasone|fluticasone|mesh-list
6028813|NCT00449046|Xhance|xhance|mesh-list
6028814|NCT00449046|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6028815|NCT00449046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6028816|NCT00449046|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6028817|NCT00449046|Autonomic Agents|autonomic agents|mesh-ancestor
6028818|NCT00449046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6028819|NCT00449046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028820|NCT00449046|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6028821|NCT00449046|Respiratory System Agents|respiratory system agents|mesh-ancestor
6028822|NCT00449046|Dermatologic Agents|dermatologic agents|mesh-ancestor
6028823|NCT00449046|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6028824|NCT00449046|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6028825|NCT00449046|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6028826|NCT00449046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6028827|NCT00449046|Adrenergic Agents|adrenergic agents|mesh-ancestor
6028828|NCT00449046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6028829|NCT00449046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028830|NCT00449072|Loratadine|loratadine|mesh-list
6028831|NCT00449072|Antipruritics|antipruritics|mesh-ancestor
6028832|NCT00449072|Dermatologic Agents|dermatologic agents|mesh-ancestor
6028833|NCT00449072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6028834|NCT00449072|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6028835|NCT00449072|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6028836|NCT00449072|Histamine Antagonists|histamine antagonists|mesh-ancestor
6028837|NCT00449072|Histamine Agents|histamine agents|mesh-ancestor
6028838|NCT00449072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6028839|NCT00449072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028840|NCT00449072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028841|NCT00449150|Cetrorelix|cetrorelix|mesh-list
6028842|NCT00449150|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6028843|NCT00449150|Fertility Agents|fertility agents|mesh-ancestor
6028844|NCT00449150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6028845|NCT00449150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028846|NCT00449150|Hormone Antagonists|hormone antagonists|mesh-ancestor
6028847|NCT00449150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6028848|NCT00449163|Leucovorin|leucovorin|mesh-list
6028849|NCT00449163|Bevacizumab|bevacizumab|mesh-list
6028850|NCT00449163|Irinotecan|irinotecan|mesh-list
6028851|NCT00449163|Floxuridine|floxuridine|mesh-list
6028852|NCT00449163|Levoleucovorin|levoleucovorin|mesh-list
6028853|NCT00449163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6028854|NCT00449163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6028855|NCT00449163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6028856|NCT00449163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6028857|NCT00449163|Growth Substances|growth substances|mesh-ancestor
6028858|NCT00449163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028859|NCT00449163|Growth Inhibitors|growth inhibitors|mesh-ancestor
6028860|NCT00449163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6028861|NCT00449163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6028862|NCT00449163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6028863|NCT00449163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028864|NCT00449163|Antidotes|antidotes|mesh-ancestor
6028865|NCT00449163|Protective Agents|protective agents|mesh-ancestor
6028866|NCT00449163|Vitamin B Complex|vitamin b complex|mesh-ancestor
6028867|NCT00449163|Vitamins|vitamins|mesh-ancestor
6028868|NCT00449163|Micronutrients|micronutrients|mesh-ancestor
6028869|NCT00449163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6028870|NCT00449163|Antimetabolites|antimetabolites|mesh-ancestor
6028871|NCT00449176|Oxycodone|oxycodone|mesh-list
6028872|NCT00449176|Tapentadol|tapentadol|mesh-list
6028873|NCT00449176|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6028874|NCT00449176|Narcotics|narcotics|mesh-ancestor
6028875|NCT00449176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5492934|NCT02574455|Antimetabolites|antimetabolites|mesh-ancestor
5492935|NCT02574455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492936|NCT02574455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5492937|NCT02574455|Antiviral Agents|antiviral agents|mesh-ancestor
5492938|NCT02574455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5492939|NCT02574455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5492940|NCT02574455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5492941|NCT02574455|Immunologic Factors|immunologic factors|mesh-ancestor
5492942|NCT02574455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492943|NCT02574455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5492944|NCT02574455|Tubulin Modulators|tubulin modulators|mesh-ancestor
5492945|NCT02574455|Antimitotic Agents|antimitotic agents|mesh-ancestor
5492946|NCT02574455|Mitosis Modulators|mitosis modulators|mesh-ancestor
5492947|NCT02527798|Furosemide|furosemide|mesh-list
5492948|NCT02527798|Diuretics|diuretics|mesh-ancestor
5492949|NCT02527798|Natriuretic Agents|natriuretic agents|mesh-ancestor
5492950|NCT02527798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492951|NCT02527798|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5492952|NCT02527798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5492953|NCT02527798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492954|NCT02457598|Obinutuzumab|obinutuzumab|mesh-list
5492955|NCT02457598|Idelalisib|idelalisib|mesh-list
5492956|NCT02457598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5492957|NCT02457598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5492958|NCT02457598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5492959|NCT02457598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492960|NCT02451982|Cyclophosphamide|cyclophosphamide|mesh-list
6028876|NCT00449176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028877|NCT00449176|Analgesics|analgesics|mesh-ancestor
6028878|NCT00449176|Sensory System Agents|sensory system agents|mesh-ancestor
6028879|NCT00449176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6028880|NCT00449176|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6028881|NCT00449176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6028882|NCT00449176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6028883|NCT00449176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028884|NCT00449176|Adrenergic Agents|adrenergic agents|mesh-ancestor
6028885|NCT00449176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6028886|NCT00449644|Bedaquiline|bedaquiline|mesh-list
6028887|NCT00449644|Antitubercular Agents|antitubercular agents|mesh-ancestor
6028888|NCT00449644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6028889|NCT00449644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6028890|NCT00449670|Vaccines|vaccines|mesh-list
6028891|NCT00449670|Immunologic Factors|immunologic factors|mesh-ancestor
6028892|NCT00449670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028893|NCT00449748|Everolimus|everolimus|mesh-list
6028894|NCT00449748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6028895|NCT00449748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6028896|NCT00449748|Immunologic Factors|immunologic factors|mesh-ancestor
6028897|NCT00449748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028898|NCT00449761|Panobinostat|panobinostat|mesh-list
6028899|NCT00449761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6028900|NCT00449761|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6028901|NCT00449761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6028902|NCT00449761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028903|NCT00449787|Naproxen|naproxen|mesh-list
6028904|NCT00449787|Sumatriptan|sumatriptan|mesh-list
6028905|NCT00449787|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6028906|NCT00449787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6028907|NCT00449787|Analgesics|analgesics|mesh-ancestor
6028908|NCT00449787|Sensory System Agents|sensory system agents|mesh-ancestor
6028909|NCT00449787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6028910|NCT00449787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028911|NCT00449787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5492961|NCT02451982|Nivolumab|nivolumab|mesh-list
5492962|NCT02451982|Immunologic Factors|immunologic factors|mesh-ancestor
5492963|NCT02451982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492964|NCT02451982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5492965|NCT02451982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5492966|NCT02451982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6028912|NCT00449787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6028913|NCT00449787|Gout Suppressants|gout suppressants|mesh-ancestor
6028914|NCT00449787|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6028915|NCT00449787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6028916|NCT00449787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028917|NCT00449787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6028918|NCT00449787|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6028919|NCT00449787|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6028920|NCT00449787|Serotonin Agents|serotonin agents|mesh-ancestor
6028921|NCT00449787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6028922|NCT00449930|Metformin|metformin|mesh-list
6028923|NCT00449930|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6028924|NCT00449930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6028925|NCT00449930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028926|NCT00449930|Incretins|incretins|mesh-ancestor
6028927|NCT00449930|Hormones|hormones|mesh-ancestor
6028928|NCT00449930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6028929|NCT00449930|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6028930|NCT00449930|Protease Inhibitors|protease inhibitors|mesh-ancestor
6028931|NCT00449930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6028932|NCT00449930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028933|NCT00449956|Timolol|timolol|mesh-list
6028934|NCT00449956|Dorzolamide|dorzolamide|mesh-list
6028935|NCT00449956|Maleic acid|maleic acid|mesh-list
6028936|NCT00449956|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6028937|NCT00449956|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6028938|NCT00449956|Adrenergic Agents|adrenergic agents|mesh-ancestor
6028939|NCT00449956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6028940|NCT00449956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028941|NCT00449956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028942|NCT00449956|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6028943|NCT00449956|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6028944|NCT00449956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6028945|NCT00449956|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6028946|NCT00450073|Vitamin D|vitamin d|mesh-list
6028947|NCT00450073|Ergocalciferols|ergocalciferols|mesh-list
6028948|NCT00450073|Cholecalciferol|cholecalciferol|mesh-list
6028949|NCT00450073|Vitamins|vitamins|mesh-list
6028950|NCT00450073|Micronutrients|micronutrients|mesh-ancestor
6028951|NCT00450073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028952|NCT00450073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6028953|NCT00450073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6028954|NCT00450216|Ibuprofen|ibuprofen|mesh-list
6028955|NCT00450216|Famotidine|famotidine|mesh-list
6028956|NCT00450216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6028957|NCT00450216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6028958|NCT00450216|Analgesics|analgesics|mesh-ancestor
6028959|NCT00450216|Sensory System Agents|sensory system agents|mesh-ancestor
6028960|NCT00450216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6028961|NCT00450216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028962|NCT00450216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6028963|NCT00450216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6028964|NCT00450216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6028965|NCT00450216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6028966|NCT00450216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028967|NCT00450216|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6028968|NCT00450216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6028969|NCT00450216|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6028970|NCT00450216|Histamine Antagonists|histamine antagonists|mesh-ancestor
5492967|NCT02451982|Alkylating Agents|alkylating agents|mesh-ancestor
5492968|NCT02451982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492969|NCT02451982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5492970|NCT02451982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5492971|NCT02451982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6028971|NCT00450216|Histamine Agents|histamine agents|mesh-ancestor
6028972|NCT00450216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6028973|NCT00450242|Lidocaine|lidocaine|mesh-list
6028974|NCT00450242|Anesthetics, Local|anesthetics, local|mesh-ancestor
6028975|NCT00450242|Anesthetics|anesthetics|mesh-ancestor
6028976|NCT00450242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6028977|NCT00450242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028978|NCT00450242|Sensory System Agents|sensory system agents|mesh-ancestor
6028979|NCT00450242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6028980|NCT00450242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6028981|NCT00450242|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6028982|NCT00450242|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6028983|NCT00450242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6028984|NCT00450242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6028985|NCT00450255|Aflibercept|aflibercept|mesh-list
6028986|NCT00450255|Endothelial Growth Factors|endothelial growth factors|mesh-list
6028987|NCT00450255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6028988|NCT00450255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6028989|NCT00450255|Growth Substances|growth substances|mesh-ancestor
6028990|NCT00450255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6028991|NCT00450255|Growth Inhibitors|growth inhibitors|mesh-ancestor
6028992|NCT00450255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6028993|NCT00450385|Prednisone|prednisone|mesh-list
6028994|NCT00450385|Cyclophosphamide|cyclophosphamide|mesh-list
6028995|NCT00450385|Rituximab|rituximab|mesh-list
6028996|NCT00450385|Doxorubicin|doxorubicin|mesh-list
6028997|NCT00450385|Vincristine|vincristine|mesh-list
6028998|NCT00450385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6028999|NCT00450385|Immunologic Factors|immunologic factors|mesh-ancestor
6029000|NCT00450385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029001|NCT00450385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6029002|NCT00450385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6029003|NCT00450385|Alkylating Agents|alkylating agents|mesh-ancestor
6029004|NCT00450385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029005|NCT00450385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6029006|NCT00450385|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6029007|NCT00450385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6029008|NCT00450385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6029009|NCT00450385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6029010|NCT00450385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6029011|NCT00450385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6029012|NCT00450385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6029013|NCT00450385|Glucocorticoids|glucocorticoids|mesh-ancestor
6029014|NCT00450385|Hormones|hormones|mesh-ancestor
6029015|NCT00450385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6029016|NCT00450385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6029017|NCT00450385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6029018|NCT00450385|Tubulin Modulators|tubulin modulators|mesh-ancestor
6029019|NCT00450385|Antimitotic Agents|antimitotic agents|mesh-ancestor
6029020|NCT00450385|Mitosis Modulators|mitosis modulators|mesh-ancestor
6029021|NCT00450450|Lenograstim|lenograstim|mesh-list
6029022|NCT00450450|Sargramostim|sargramostim|mesh-list
6029023|NCT00450450|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6029024|NCT00450450|Immunologic Factors|immunologic factors|mesh-ancestor
6029025|NCT00450450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029026|NCT00450463|Metronidazole|metronidazole|mesh-list
6029027|NCT00450463|Molgramostim|molgramostim|mesh-list
6029028|NCT00450463|Flutamide|flutamide|mesh-list
6029029|NCT00450463|Sargramostim|sargramostim|mesh-list
6029030|NCT00450463|Immunologic Factors|immunologic factors|mesh-ancestor
6029031|NCT00450463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029032|NCT00450463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6029033|NCT00450463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6029034|NCT00450463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6029035|NCT00450463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6029036|NCT00450463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6029037|NCT00450463|Androgen Antagonists|androgen antagonists|mesh-ancestor
6029038|NCT00450463|Hormone Antagonists|hormone antagonists|mesh-ancestor
6456419|NCT00432120|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6029039|NCT00450463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6029040|NCT00450463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6029041|NCT00450580|Ritonavir|ritonavir|mesh-list
6029042|NCT00450580|Fosamprenavir|fosamprenavir|mesh-list
6029043|NCT00450580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6029044|NCT00450580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6029045|NCT00450580|Protease Inhibitors|protease inhibitors|mesh-ancestor
6029046|NCT00450580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6029047|NCT00450580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029048|NCT00450580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6029049|NCT00450580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5492972|NCT02451982|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5492973|NCT02422641|Methotrexate|methotrexate|mesh-list
5492974|NCT02422641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5492975|NCT02422641|Abortifacient Agents|abortifacient agents|mesh-ancestor
5492976|NCT02422641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5492977|NCT02422641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5492978|NCT02422641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5492979|NCT02422641|Antimetabolites|antimetabolites|mesh-ancestor
5492980|NCT02422641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029050|NCT00450580|Antiviral Agents|antiviral agents|mesh-ancestor
6029051|NCT00450580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6029052|NCT00450580|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6029053|NCT00450580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6029054|NCT00450619|Metronidazole|metronidazole|mesh-list
6029055|NCT00450619|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
6029056|NCT00450619|Vaccines|vaccines|mesh-list
6029057|NCT00450619|Sargramostim|sargramostim|mesh-list
6029058|NCT00450619|Immunologic Factors|immunologic factors|mesh-ancestor
6029059|NCT00450619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029060|NCT00450619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6029061|NCT00450619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6029062|NCT00450619|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6029063|NCT00450619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6029064|NCT00450619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6029065|NCT00450619|Analgesics|analgesics|mesh-ancestor
6029066|NCT00450619|Sensory System Agents|sensory system agents|mesh-ancestor
6029067|NCT00450619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6029068|NCT00450658|Ibuprofen|ibuprofen|mesh-list
6029069|NCT00450658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6029070|NCT00450658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6029071|NCT00450658|Analgesics|analgesics|mesh-ancestor
6029072|NCT00450658|Sensory System Agents|sensory system agents|mesh-ancestor
6029073|NCT00450658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6029074|NCT00450658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456420|NCT00432120|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6456421|NCT00432120|Purinergic Agents|purinergic agents|mesh-ancestor
6029075|NCT00450658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6029076|NCT00450658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6029077|NCT00450658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6029078|NCT00450658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6029079|NCT00450658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053484|NCT00595335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6053485|NCT00595335|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6053486|NCT00595335|Protective Agents|protective agents|mesh-ancestor
6053487|NCT00595335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6053488|NCT00595361|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6053489|NCT00595361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6053490|NCT00595361|Autonomic Agents|autonomic agents|mesh-ancestor
6053491|NCT00595361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6053492|NCT00595361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053493|NCT00595361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6053494|NCT00595361|Respiratory System Agents|respiratory system agents|mesh-ancestor
6053495|NCT00595361|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6053496|NCT00595361|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6053497|NCT00595361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6053498|NCT00595361|Adrenergic Agents|adrenergic agents|mesh-ancestor
6053499|NCT00595361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6053500|NCT00595361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053501|NCT00595413|Adalimumab|adalimumab|mesh-list
6053502|NCT00595413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6053503|NCT00595413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6053504|NCT00595517|Esomeprazole|esomeprazole|mesh-list
6029080|NCT00450723|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
6029081|NCT00450723|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6029082|NCT00450723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029083|NCT00450749|Lycopene|lycopene|mesh-list
6029084|NCT00450749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6029085|NCT00450749|Antioxidants|antioxidants|mesh-ancestor
6029086|NCT00450749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029087|NCT00450749|Protective Agents|protective agents|mesh-ancestor
6029088|NCT00450749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029089|NCT00450749|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6029090|NCT00450749|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6029091|NCT00450749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5492981|NCT02422641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5492982|NCT02422641|Dermatologic Agents|dermatologic agents|mesh-ancestor
5492983|NCT02422641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5492984|NCT02422641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5492985|NCT02422641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5492986|NCT02422641|Immunologic Factors|immunologic factors|mesh-ancestor
5492987|NCT02422641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5492988|NCT02422641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5492989|NCT02383992|Hydrogen Peroxide|hydrogen peroxide|mesh-list
5492990|NCT02383992|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5492991|NCT02383992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5492992|NCT02346630|Levodopa|levodopa|mesh-list
5492993|NCT02346630|Carbidopa|carbidopa|mesh-list
5492994|NCT02346630|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5492995|NCT02346630|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5492996|NCT02346630|Dopamine Agents|dopamine agents|mesh-ancestor
5492997|NCT02346630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5492998|NCT02346630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5492999|NCT02346630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493000|NCT02346630|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5493001|NCT02346630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5493002|NCT02112526|Acalabrutinib|acalabrutinib|mesh-list
5493003|NCT02112526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5493004|NCT02097121|Botulinum Toxins|botulinum toxins|mesh-list
5493005|NCT02097121|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5493006|NCT02097121|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5493007|NCT02097121|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5493008|NCT02097121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5493009|NCT02097121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493010|NCT02097121|Cholinergic Agents|cholinergic agents|mesh-ancestor
5493011|NCT02097121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5493012|NCT02097121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029092|NCT00450801|Leucovorin|leucovorin|mesh-list
6029093|NCT00450801|Cytarabine|cytarabine|mesh-list
6029094|NCT00450801|Thalidomide|thalidomide|mesh-list
6029095|NCT00450801|Cyclophosphamide|cyclophosphamide|mesh-list
6029096|NCT00450801|Ifosfamide|ifosfamide|mesh-list
6029097|NCT00450801|Rituximab|rituximab|mesh-list
6029098|NCT00450801|Doxorubicin|doxorubicin|mesh-list
6029099|NCT00450801|Methotrexate|methotrexate|mesh-list
6029100|NCT00450801|Etoposide|etoposide|mesh-list
6029101|NCT00450801|Vincristine|vincristine|mesh-list
6029102|NCT00450801|Granisetron|granisetron|mesh-list
6029103|NCT00450801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6029104|NCT00450801|Immunologic Factors|immunologic factors|mesh-ancestor
6029105|NCT00450801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493013|NCT02097121|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5493014|NCT02097121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6029106|NCT00450801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6029107|NCT00450801|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6029108|NCT00450801|Alkylating Agents|alkylating agents|mesh-ancestor
6029109|NCT00450801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029110|NCT00450801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6029111|NCT00450801|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6029112|NCT00450801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6029113|NCT00450801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6029114|NCT00450801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6029115|NCT00450801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6029116|NCT00450801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6029117|NCT00450801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6029118|NCT00450801|Abortifacient Agents|abortifacient agents|mesh-ancestor
6029119|NCT00450801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6029120|NCT00450801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6029121|NCT00450801|Antimetabolites|antimetabolites|mesh-ancestor
5493015|NCT02067975|Tryptophan|tryptophan|mesh-list
5493016|NCT02067975|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5493017|NCT02067975|Antidepressive Agents|antidepressive agents|mesh-ancestor
5493018|NCT02067975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5493019|NCT02035137|Irinotecan|irinotecan|mesh-list
6029122|NCT00450801|Dermatologic Agents|dermatologic agents|mesh-ancestor
6029123|NCT00450801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6029124|NCT00450801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6029125|NCT00450801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6029126|NCT00450801|Antiviral Agents|antiviral agents|mesh-ancestor
6029127|NCT00450801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6029128|NCT00450801|Antidotes|antidotes|mesh-ancestor
6029129|NCT00450801|Protective Agents|protective agents|mesh-ancestor
6029130|NCT00450801|Vitamin B Complex|vitamin b complex|mesh-ancestor
6029131|NCT00450801|Vitamins|vitamins|mesh-ancestor
6029132|NCT00450801|Micronutrients|micronutrients|mesh-ancestor
6029133|NCT00450801|Tubulin Modulators|tubulin modulators|mesh-ancestor
6029134|NCT00450801|Antimitotic Agents|antimitotic agents|mesh-ancestor
6029135|NCT00450801|Mitosis Modulators|mitosis modulators|mesh-ancestor
6029136|NCT00450801|Antiemetics|antiemetics|mesh-ancestor
6029137|NCT00450801|Autonomic Agents|autonomic agents|mesh-ancestor
6456422|NCT00432120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6029138|NCT00450801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6029139|NCT00450801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6029140|NCT00450801|Leprostatic Agents|leprostatic agents|mesh-ancestor
6029141|NCT00450801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6029142|NCT00450801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6029143|NCT00450801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6029144|NCT00450801|Growth Substances|growth substances|mesh-ancestor
6029145|NCT00450801|Growth Inhibitors|growth inhibitors|mesh-ancestor
6029146|NCT00450801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6029147|NCT00450801|Serotonin Agents|serotonin agents|mesh-ancestor
6029148|NCT00450801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6029149|NCT00450814|Cyclophosphamide|cyclophosphamide|mesh-list
6029150|NCT00450814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6029151|NCT00450814|Immunologic Factors|immunologic factors|mesh-ancestor
6029152|NCT00450814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029153|NCT00450814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6029154|NCT00450814|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6029155|NCT00450814|Alkylating Agents|alkylating agents|mesh-ancestor
6029156|NCT00450814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029157|NCT00450814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6029158|NCT00450814|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6029159|NCT00450866|Epothilones|epothilones|mesh-list
6029160|NCT00450866|Epothilone B|epothilone b|mesh-list
6029161|NCT00450866|Tubulin Modulators|tubulin modulators|mesh-ancestor
6029162|NCT00450866|Antimitotic Agents|antimitotic agents|mesh-ancestor
6029163|NCT00450866|Mitosis Modulators|mitosis modulators|mesh-ancestor
6029164|NCT00450866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029165|NCT00450866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6029166|NCT00450983|Methotrexate|methotrexate|mesh-list
6029167|NCT00450983|Fludarabine phosphate|fludarabine phosphate|mesh-list
6029168|NCT00450983|Fludarabine|fludarabine|mesh-list
6029169|NCT00450983|Thiotepa|thiotepa|mesh-list
6029170|NCT00450983|Muromonab-CD3|muromonab-cd3|mesh-list
6029171|NCT00450983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6029172|NCT00450983|Abortifacient Agents|abortifacient agents|mesh-ancestor
6029173|NCT00450983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6029174|NCT00450983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029175|NCT00450983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6029176|NCT00450983|Antimetabolites|antimetabolites|mesh-ancestor
6029177|NCT00450983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029178|NCT00450983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6029179|NCT00450983|Dermatologic Agents|dermatologic agents|mesh-ancestor
6029180|NCT00450983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6029181|NCT00450983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6029182|NCT00450983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6029183|NCT00450983|Immunologic Factors|immunologic factors|mesh-ancestor
6029184|NCT00450983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6029185|NCT00450983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6029186|NCT00450983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6029187|NCT00450983|Alkylating Agents|alkylating agents|mesh-ancestor
5493020|NCT02035137|Vincristine|vincristine|mesh-list
6029188|NCT00450983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5493021|NCT02035137|Vorinostat|vorinostat|mesh-list
6029189|NCT00451035|Panobinostat|panobinostat|mesh-list
6029190|NCT00451035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5493022|NCT02035137|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
6029191|NCT00451035|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6029192|NCT00451035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6029193|NCT00451035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029194|NCT00451048|Sunitinib|sunitinib|mesh-list
6029195|NCT00451048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6029196|NCT00451048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6029197|NCT00451048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6029198|NCT00451048|Growth Substances|growth substances|mesh-ancestor
6029199|NCT00451048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029200|NCT00451048|Growth Inhibitors|growth inhibitors|mesh-ancestor
6029201|NCT00451048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6029202|NCT00451048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5493023|NCT02035137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5493024|NCT02035137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5493025|NCT02035137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5493026|NCT02035137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493027|NCT02035137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5493028|NCT02035137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5493029|NCT02035137|Tubulin Modulators|tubulin modulators|mesh-ancestor
5493030|NCT02035137|Antimitotic Agents|antimitotic agents|mesh-ancestor
5493031|NCT02035137|Mitosis Modulators|mitosis modulators|mesh-ancestor
5493032|NCT02035137|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5493033|NCT02035137|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6029203|NCT00451048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029204|NCT00451178|Prednisone|prednisone|mesh-list
6029205|NCT00451178|Cyclophosphamide|cyclophosphamide|mesh-list
6029206|NCT00451178|Rituximab|rituximab|mesh-list
6456423|NCT00432120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456424|NCT00432120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493034|NCT01999179|Heparin|heparin|mesh-list
6029207|NCT00451178|Doxorubicin|doxorubicin|mesh-list
6029208|NCT00451178|Vincristine|vincristine|mesh-list
6029209|NCT00451178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6029210|NCT00451178|Immunologic Factors|immunologic factors|mesh-ancestor
5493035|NCT01999179|Enoxaparin|enoxaparin|mesh-list
5493036|NCT01999179|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5493037|NCT01999179|Tinzaparin|tinzaparin|mesh-list
5493038|NCT01999179|Dalteparin|dalteparin|mesh-list
5493039|NCT01999179|Rivaroxaban|rivaroxaban|mesh-list
5493040|NCT01999179|Dabigatran|dabigatran|mesh-list
5493041|NCT01999179|Apixaban|apixaban|mesh-list
5493042|NCT01999179|Edoxaban|edoxaban|mesh-list
5493043|NCT01999179|Anticoagulants|anticoagulants|mesh-list
5493044|NCT01999179|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5493045|NCT01999179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5493046|NCT01999179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493047|NCT01999179|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5493048|NCT01999179|Antithrombins|antithrombins|mesh-ancestor
5493049|NCT01999179|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5493050|NCT01999179|Protease Inhibitors|protease inhibitors|mesh-ancestor
5493051|NCT01999179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5493052|NCT01964807|Nicotine|nicotine|mesh-list
5493053|NCT01964807|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5493054|NCT01964807|Autonomic Agents|autonomic agents|mesh-ancestor
5493055|NCT01964807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5493056|NCT01964807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029211|NCT00451178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029212|NCT00451178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6029213|NCT00451178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6029214|NCT00451178|Alkylating Agents|alkylating agents|mesh-ancestor
6029215|NCT00451178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029216|NCT00451178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6029217|NCT00451178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6029218|NCT00451178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6029219|NCT00451178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6029220|NCT00451178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6029221|NCT00451178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6029222|NCT00451178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6029223|NCT00451178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6029224|NCT00451178|Glucocorticoids|glucocorticoids|mesh-ancestor
6029225|NCT00451178|Hormones|hormones|mesh-ancestor
6029226|NCT00451178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5493057|NCT01964807|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5493058|NCT01964807|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6053505|NCT00595517|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6029227|NCT00451178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6029228|NCT00451178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6029229|NCT00451178|Tubulin Modulators|tubulin modulators|mesh-ancestor
6029230|NCT00451178|Antimitotic Agents|antimitotic agents|mesh-ancestor
6029231|NCT00451178|Mitosis Modulators|mitosis modulators|mesh-ancestor
6029232|NCT00451191|Botulinum Toxins|botulinum toxins|mesh-list
6029233|NCT00451191|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6029234|NCT00451191|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6456425|NCT00432146|Lugol's solution|lugol's solution|mesh-list
6456426|NCT00432146|Hemostatics|hemostatics|mesh-ancestor
6456427|NCT00432146|Coagulants|coagulants|mesh-ancestor
6456428|NCT00432198|Zolpidem|zolpidem|mesh-list
6456429|NCT00432198|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6456430|NCT00432198|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6456431|NCT00432198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6456432|NCT00432198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456433|NCT00432198|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6456434|NCT00432198|GABA Agonists|gaba agonists|mesh-ancestor
6456435|NCT00432198|GABA Agents|gaba agents|mesh-ancestor
6456436|NCT00432198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6456437|NCT00432198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461946|NCT00456898|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6029235|NCT00451191|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6029236|NCT00451191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6029237|NCT00451191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029238|NCT00451191|Cholinergic Agents|cholinergic agents|mesh-ancestor
6029239|NCT00451191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6029240|NCT00451191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029241|NCT00451191|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6029242|NCT00451191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6029243|NCT00451204|Glatiramer Acetate|glatiramer acetate|mesh-list
6029244|NCT00451204|Estrogens|estrogens|mesh-list
6029245|NCT00451204|(T,G)-A-L|(t,g)-a-l|mesh-list
6029246|NCT00451204|Hormones|hormones|mesh-ancestor
6029247|NCT00451204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6029248|NCT00451204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029249|NCT00451204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6029250|NCT00451204|Immunologic Factors|immunologic factors|mesh-ancestor
6029251|NCT00451204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6029252|NCT00451204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6029253|NCT00451217|Glycopyrrolate|glycopyrrolate|mesh-list
6029254|NCT00451217|Neostigmine|neostigmine|mesh-list
6029255|NCT00451217|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6029256|NCT00451217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6029257|NCT00451217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029258|NCT00451217|Cholinergic Agents|cholinergic agents|mesh-ancestor
6029259|NCT00451217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6029260|NCT00451217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029261|NCT00451217|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6029262|NCT00451217|Autonomic Agents|autonomic agents|mesh-ancestor
6029263|NCT00451217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6029264|NCT00451217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6029265|NCT00451217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6029266|NCT00451217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6029267|NCT00451451|Glatiramer Acetate|glatiramer acetate|mesh-list
6029268|NCT00451451|Dimethyl Fumarate|dimethyl fumarate|mesh-list
6029269|NCT00451451|(T,G)-A-L|(t,g)-a-l|mesh-list
6029270|NCT00451451|Dermatologic Agents|dermatologic agents|mesh-ancestor
6029271|NCT00451451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6029272|NCT00451451|Immunologic Factors|immunologic factors|mesh-ancestor
6029273|NCT00451451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029274|NCT00451451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6029275|NCT00451451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6029276|NCT00451555|Fulvestrant|fulvestrant|mesh-list
6029277|NCT00451555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6654692|NCT01458600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654693|NCT01458600|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6654694|NCT01458600|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6654695|NCT01458600|Adrenergic Agents|adrenergic agents|mesh-ancestor
6654696|NCT01458600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6654697|NCT01458600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6654698|NCT01458600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6654699|NCT01458600|Vasodilator Agents|vasodilator agents|mesh-ancestor
5493059|NCT01964807|Cholinergic Agents|cholinergic agents|mesh-ancestor
6029278|NCT00451555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6029279|NCT00451555|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6029280|NCT00451555|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6029281|NCT00451555|Hormone Antagonists|hormone antagonists|mesh-ancestor
6029282|NCT00451555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6029283|NCT00451555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029284|NCT00451698|Epoetin Alfa|epoetin alfa|mesh-list
6029285|NCT00451698|Hematinics|hematinics|mesh-ancestor
6029286|NCT00451906|Bevacizumab|bevacizumab|mesh-list
6029287|NCT00451906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6029288|NCT00451906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6029289|NCT00451906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6029290|NCT00451906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6029291|NCT00451906|Growth Substances|growth substances|mesh-ancestor
6029292|NCT00451906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029293|NCT00451906|Growth Inhibitors|growth inhibitors|mesh-ancestor
6029294|NCT00451958|Leuprolide|leuprolide|mesh-list
6029295|NCT00451958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6029296|NCT00451958|Fertility Agents|fertility agents|mesh-ancestor
6029297|NCT00451958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6029298|NCT00451958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029299|NCT00451958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6029300|NCT00451958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6029301|NCT00452335|Lubiprostone|lubiprostone|mesh-list
6029302|NCT00452335|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6029303|NCT00452335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6029304|NCT00452335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029305|NCT00452348|Fluticasone|fluticasone|mesh-list
6029306|NCT00452348|Xhance|xhance|mesh-list
6029307|NCT00452348|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6029308|NCT00452348|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6029309|NCT00452348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6029310|NCT00452348|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6029311|NCT00452348|Autonomic Agents|autonomic agents|mesh-ancestor
6029312|NCT00452348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6029313|NCT00452348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029314|NCT00452348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6029315|NCT00452348|Respiratory System Agents|respiratory system agents|mesh-ancestor
6029316|NCT00452348|Dermatologic Agents|dermatologic agents|mesh-ancestor
6029317|NCT00452348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6029318|NCT00452348|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6029319|NCT00452348|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6029320|NCT00452348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6029321|NCT00452348|Adrenergic Agents|adrenergic agents|mesh-ancestor
6029322|NCT00452348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6029323|NCT00452348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029324|NCT00452348|Glucocorticoids|glucocorticoids|mesh-ancestor
6029325|NCT00452348|Hormones|hormones|mesh-ancestor
6029326|NCT00452348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6029327|NCT00452348|Sympathomimetics|sympathomimetics|mesh-ancestor
6029328|NCT00452374|Vidarabine|vidarabine|mesh-list
6029329|NCT00452374|Cytarabine|cytarabine|mesh-list
6029330|NCT00452374|Rituximab|rituximab|mesh-list
6029331|NCT00452374|Oxaliplatin|oxaliplatin|mesh-list
6029332|NCT00452374|Fludarabine|fludarabine|mesh-list
6029333|NCT00452374|Fludarabine phosphate|fludarabine phosphate|mesh-list
6029334|NCT00452374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6029335|NCT00452374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6029336|NCT00452374|Immunologic Factors|immunologic factors|mesh-ancestor
6029337|NCT00452374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029338|NCT00452374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6029339|NCT00452374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6029340|NCT00452374|Antimetabolites|antimetabolites|mesh-ancestor
6029341|NCT00452374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029342|NCT00452374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6654700|NCT01458600|Sympatholytics|sympatholytics|mesh-ancestor
6654701|NCT01458600|Autonomic Agents|autonomic agents|mesh-ancestor
5493060|NCT01964807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5503063|NCT04462627|Antibodies|antibodies|mesh-list
6029343|NCT00452374|Antiviral Agents|antiviral agents|mesh-ancestor
5493061|NCT01964807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493062|NCT01941446|Moxifloxacin|moxifloxacin|mesh-list
5493063|NCT01941446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5493064|NCT01941446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5493065|NCT01941446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5493066|NCT01941446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5493067|NCT01941446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5493068|NCT01941446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493069|NCT01941446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5503064|NCT04462627|Immunologic Factors|immunologic factors|mesh-ancestor
5503065|NCT04462627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503066|NCT04462406|Pembrolizumab|pembrolizumab|mesh-list
5503067|NCT04462406|Nivolumab|nivolumab|mesh-list
5503068|NCT04462406|Ipilimumab|ipilimumab|mesh-list
5503069|NCT04462406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5503070|NCT04462406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5503071|NCT04462406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6029344|NCT00452374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6029345|NCT00452387|Prednisone|prednisone|mesh-list
6029346|NCT00452387|Sorafenib|sorafenib|mesh-list
6029347|NCT00452387|Mitoxantrone|mitoxantrone|mesh-list
6029348|NCT00452387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6029349|NCT00452387|Glucocorticoids|glucocorticoids|mesh-ancestor
6029350|NCT00452387|Hormones|hormones|mesh-ancestor
6029351|NCT00452387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6029352|NCT00452387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029353|NCT00452387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6029354|NCT00452387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6029355|NCT00452387|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6029356|NCT00452387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6029357|NCT00452387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029358|NCT00452387|Analgesics|analgesics|mesh-ancestor
6029359|NCT00452387|Sensory System Agents|sensory system agents|mesh-ancestor
6029360|NCT00452387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6029361|NCT00452387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6029362|NCT00452387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6029363|NCT00452400|Olodaterol|olodaterol|mesh-list
6029364|NCT00452400|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6029365|NCT00452400|Autonomic Agents|autonomic agents|mesh-ancestor
6029366|NCT00452400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6029367|NCT00452400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029368|NCT00452400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6029369|NCT00452400|Respiratory System Agents|respiratory system agents|mesh-ancestor
6029370|NCT00452413|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6029371|NCT00452413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6029372|NCT00452413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5503072|NCT04462406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503073|NCT04462315|Cobalt|cobalt|mesh-list
5503074|NCT04462315|Chromium|chromium|mesh-list
5503075|NCT04462315|Everolimus|everolimus|mesh-list
5503076|NCT04462315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5503077|NCT04462315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5503078|NCT04462315|Immunologic Factors|immunologic factors|mesh-ancestor
6029373|NCT00452413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6029374|NCT00452413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029375|NCT00452426|Analgesics, Opioid|analgesics, opioid|mesh-list
6029376|NCT00452426|Narcotics|narcotics|mesh-ancestor
6029377|NCT00452426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6029378|NCT00452426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029379|NCT00452426|Analgesics|analgesics|mesh-ancestor
6029380|NCT00452426|Sensory System Agents|sensory system agents|mesh-ancestor
6029381|NCT00452426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6029382|NCT00452439|Vitamin D|vitamin d|mesh-list
6029383|NCT00452439|Risedronic Acid|risedronic acid|mesh-list
6029384|NCT00452439|Etidronic Acid|etidronic acid|mesh-list
6029385|NCT00452439|Calcium|calcium|mesh-list
6029386|NCT00452439|Vitamins|vitamins|mesh-ancestor
6029387|NCT00452439|Micronutrients|micronutrients|mesh-ancestor
6029388|NCT00452439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029389|NCT00452439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6029390|NCT00452439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6029391|NCT00452439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6029392|NCT00452439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6456438|NCT00432302|Sagopilone|sagopilone|mesh-list
5503079|NCT04462315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029393|NCT00452439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029394|NCT00452452|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6029395|NCT00452452|Immunologic Factors|immunologic factors|mesh-ancestor
6654702|NCT01458600|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6654703|NCT01458600|Antithyroid Agents|antithyroid agents|mesh-ancestor
6654704|NCT01458600|Hormone Antagonists|hormone antagonists|mesh-ancestor
6029396|NCT00452452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029397|NCT00452530|Enoxaparin|enoxaparin|mesh-list
6029398|NCT00452530|Enoxaparin sodium|enoxaparin sodium|mesh-list
6029399|NCT00452530|Apixaban|apixaban|mesh-list
6029400|NCT00452530|Anticoagulants|anticoagulants|mesh-ancestor
6029401|NCT00452530|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6029402|NCT00452530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6029403|NCT00452530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029404|NCT00452530|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6029405|NCT00452530|Antithrombins|antithrombins|mesh-ancestor
6029406|NCT00452530|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6029407|NCT00452530|Protease Inhibitors|protease inhibitors|mesh-ancestor
6029408|NCT00452530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6029409|NCT00452543|Acamprosate|acamprosate|mesh-list
6029410|NCT00452543|Dexetimide|dexetimide|mesh-list
6029411|NCT00452543|Citalopram|citalopram|mesh-list
6456439|NCT00432302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6456440|NCT00432315|Docetaxel|docetaxel|mesh-list
6456441|NCT00432315|Cisplatin|cisplatin|mesh-list
6456442|NCT00432315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6456443|NCT00432315|Tubulin Modulators|tubulin modulators|mesh-ancestor
6456444|NCT00432315|Antimitotic Agents|antimitotic agents|mesh-ancestor
6456445|NCT00432315|Mitosis Modulators|mitosis modulators|mesh-ancestor
6456446|NCT00432315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456447|NCT00432354|Atorvastatin|atorvastatin|mesh-list
6456448|NCT00432354|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6029412|NCT00452543|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6029413|NCT00452543|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6029414|NCT00452543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6029415|NCT00452543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029416|NCT00452543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6029417|NCT00452543|Serotonin Agents|serotonin agents|mesh-ancestor
6029418|NCT00452543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029419|NCT00452543|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6029420|NCT00452543|Antidepressive Agents|antidepressive agents|mesh-ancestor
6029421|NCT00452543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6029422|NCT00452543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6029423|NCT00452543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6029424|NCT00452543|Parasympatholytics|parasympatholytics|mesh-ancestor
6029425|NCT00452543|Autonomic Agents|autonomic agents|mesh-ancestor
6029426|NCT00452543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6029427|NCT00452543|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6029428|NCT00452543|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6029429|NCT00452543|Cholinergic Agents|cholinergic agents|mesh-ancestor
6029430|NCT00452543|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6029431|NCT00452673|Capecitabine|capecitabine|mesh-list
6029432|NCT00452673|Dasatinib|dasatinib|mesh-list
6029433|NCT00452673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6029434|NCT00452673|Antimetabolites|antimetabolites|mesh-ancestor
6029435|NCT00452673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029436|NCT00452673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6029437|NCT00452673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6029438|NCT00452673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6029439|NCT00452699|Fluticasone|fluticasone|mesh-list
6029440|NCT00452699|Xhance|xhance|mesh-list
6029441|NCT00452699|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6029442|NCT00452699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6029443|NCT00452699|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6029444|NCT00452699|Autonomic Agents|autonomic agents|mesh-ancestor
6029445|NCT00452699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6029446|NCT00452699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029447|NCT00452699|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6456449|NCT00432354|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6029448|NCT00452699|Respiratory System Agents|respiratory system agents|mesh-ancestor
6029449|NCT00452699|Dermatologic Agents|dermatologic agents|mesh-ancestor
6029450|NCT00452699|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6029451|NCT00452699|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6029452|NCT00452699|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6029453|NCT00452699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6029454|NCT00452699|Adrenergic Agents|adrenergic agents|mesh-ancestor
5493070|NCT01940809|Nivolumab|nivolumab|mesh-list
5493071|NCT01940809|Ipilimumab|ipilimumab|mesh-list
5493072|NCT01940809|Trametinib|trametinib|mesh-list
5493073|NCT01940809|Dabrafenib|dabrafenib|mesh-list
5493074|NCT01940809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5493075|NCT01940809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5493076|NCT01940809|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5493077|NCT01940809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493078|NCT01940809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5493079|NCT01940809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5493080|NCT01921335|Trastuzumab|trastuzumab|mesh-list
5493081|NCT01921335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6029455|NCT00452699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6029456|NCT00452699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029457|NCT00452790|Vaccines|vaccines|mesh-list
6029458|NCT00452790|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6029459|NCT00452790|Immunologic Factors|immunologic factors|mesh-ancestor
6029460|NCT00452790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493082|NCT01921335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5493083|NCT01907360|Methylphenidate|methylphenidate|mesh-list
5493084|NCT01907360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5493085|NCT01907360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493086|NCT01907360|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5493087|NCT01907360|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5493088|NCT01907360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5493089|NCT01907360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493090|NCT01907360|Dopamine Agents|dopamine agents|mesh-ancestor
5493091|NCT01907360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5493092|NCT01886872|Rituximab|rituximab|mesh-list
5493093|NCT01886872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5493094|NCT01886872|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5493095|NCT01886872|Antibodies|antibodies|mesh-list
5493096|NCT01886872|Immunoglobulins|immunoglobulins|mesh-list
5493097|NCT01886872|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5493098|NCT01886872|Immunologic Factors|immunologic factors|mesh-ancestor
5493099|NCT01886872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493100|NCT01886872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5493101|NCT01886872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5493102|NCT01886872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5493103|NCT01886872|Alkylating Agents|alkylating agents|mesh-ancestor
6029461|NCT00452868|Donepezil|donepezil|mesh-list
6029462|NCT00452868|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5493104|NCT01886872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493105|NCT01873170|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
5493106|NCT01873170|Contraceptive Agents|contraceptive agents|mesh-list
5493107|NCT01873170|Levonorgestrel|levonorgestrel|mesh-list
5493108|NCT01873170|Etonogestrel|etonogestrel|mesh-list
5493109|NCT01873170|Desogestrel|desogestrel|mesh-list
5493110|NCT01873170|Contraceptives, Oral|contraceptives, oral|mesh-list
5493111|NCT01873170|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
6029463|NCT00452868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5493112|NCT01873170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5493113|NCT01873170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493114|NCT01873170|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5493115|NCT01873170|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5493116|NCT01873170|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5493117|NCT01873170|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5493118|NCT01873170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5493119|NCT01873170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5493120|NCT01873170|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5493121|NCT01873170|Progestins|progestins|mesh-ancestor
5493122|NCT01873170|Hormones|hormones|mesh-ancestor
5493123|NCT01873170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5493124|NCT01835041|Leucovorin|leucovorin|mesh-list
5493125|NCT01835041|Thioctic Acid|thioctic acid|mesh-list
5493126|NCT01835041|Fluorouracil|fluorouracil|mesh-list
5493127|NCT01835041|Oxaliplatin|oxaliplatin|mesh-list
5493128|NCT01835041|Irinotecan|irinotecan|mesh-list
6029464|NCT00452868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029465|NCT00452868|Cholinergic Agents|cholinergic agents|mesh-ancestor
6029466|NCT00452868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6029467|NCT00452868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029468|NCT00452868|Nootropic Agents|nootropic agents|mesh-ancestor
6029469|NCT00453102|Rituximab|rituximab|mesh-list
6029470|NCT00453102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6029471|NCT00453102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6029472|NCT00453102|Immunologic Factors|immunologic factors|mesh-ancestor
6029473|NCT00453102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029474|NCT00453102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6029475|NCT00453154|Cisplatin|cisplatin|mesh-list
6029476|NCT00453154|Carboplatin|carboplatin|mesh-list
6654705|NCT01458600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6654706|NCT01458626|Mirtazapine|mirtazapine|mesh-list
6654707|NCT01458626|Paroxetine|paroxetine|mesh-list
6654708|NCT01458626|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6654709|NCT01458626|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6654710|NCT01458626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6654711|NCT01458626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654712|NCT01458626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6654713|NCT01458626|Serotonin Agents|serotonin agents|mesh-ancestor
6654714|NCT01458626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654715|NCT01458626|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6029477|NCT00453154|Etoposide|etoposide|mesh-list
6029478|NCT00453154|Etoposide phosphate|etoposide phosphate|mesh-list
6029479|NCT00453154|Sunitinib|sunitinib|mesh-list
6029480|NCT00453154|Podophyllotoxin|podophyllotoxin|mesh-list
6029481|NCT00453154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6029482|NCT00453154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6029483|NCT00453154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6029484|NCT00453154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6029485|NCT00453154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6029486|NCT00453154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029487|NCT00453154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6029488|NCT00453154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6029489|NCT00453154|Growth Substances|growth substances|mesh-ancestor
6029490|NCT00453154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029491|NCT00453154|Growth Inhibitors|growth inhibitors|mesh-ancestor
6029492|NCT00453154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6029493|NCT00453154|Keratolytic Agents|keratolytic agents|mesh-ancestor
6029494|NCT00453154|Dermatologic Agents|dermatologic agents|mesh-ancestor
6029495|NCT00453154|Tubulin Modulators|tubulin modulators|mesh-ancestor
6029496|NCT00453154|Antimitotic Agents|antimitotic agents|mesh-ancestor
6029497|NCT00453154|Mitosis Modulators|mitosis modulators|mesh-ancestor
6029498|NCT00453180|Acetylcysteine|acetylcysteine|mesh-list
6029499|NCT00453180|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6029500|NCT00453180|Antiviral Agents|antiviral agents|mesh-ancestor
6029501|NCT00453180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6029502|NCT00453180|Expectorants|expectorants|mesh-ancestor
6029503|NCT00453180|Respiratory System Agents|respiratory system agents|mesh-ancestor
6029504|NCT00453180|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6029505|NCT00453180|Antioxidants|antioxidants|mesh-ancestor
6029506|NCT00453180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029507|NCT00453180|Protective Agents|protective agents|mesh-ancestor
6029508|NCT00453180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029509|NCT00453180|Antidotes|antidotes|mesh-ancestor
6029510|NCT00453193|Alemtuzumab|alemtuzumab|mesh-list
6029511|NCT00453193|Pentostatin|pentostatin|mesh-list
6029512|NCT00453193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6029513|NCT00453193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6029514|NCT00453193|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
6029515|NCT00453193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6029516|NCT00453193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029517|NCT00453310|Sunitinib|sunitinib|mesh-list
6029518|NCT00453310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6029519|NCT00453310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6029520|NCT00453310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6029521|NCT00453310|Growth Substances|growth substances|mesh-ancestor
6029522|NCT00453310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029523|NCT00453310|Growth Inhibitors|growth inhibitors|mesh-ancestor
6029524|NCT00453310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6029525|NCT00453310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6029526|NCT00453310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029527|NCT00453336|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
6029528|NCT00453336|Trioxsalen|trioxsalen|mesh-list
6029529|NCT00453336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6029530|NCT00453336|Dermatologic Agents|dermatologic agents|mesh-ancestor
6029531|NCT00453336|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6029532|NCT00453349|Moxifloxacin|moxifloxacin|mesh-list
6029533|NCT00453349|Metronidazole|metronidazole|mesh-list
6029534|NCT00453349|Levofloxacin|levofloxacin|mesh-list
6029535|NCT00453349|Ofloxacin|ofloxacin|mesh-list
6029536|NCT00453349|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6029537|NCT00453349|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6029538|NCT00453349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6029539|NCT00453349|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6029540|NCT00453349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6029541|NCT00453349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6029542|NCT00453349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029543|NCT00453349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6029544|NCT00453349|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6029545|NCT00453349|Contraceptive Agents|contraceptive agents|mesh-ancestor
6029546|NCT00453349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6029547|NCT00453349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029548|NCT00453349|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6029549|NCT00453349|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6029550|NCT00453349|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6029551|NCT00453349|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6029552|NCT00453349|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6029553|NCT00453349|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6029554|NCT00453349|Renal Agents|renal agents|mesh-ancestor
6456450|NCT00432354|Antimetabolites|antimetabolites|mesh-ancestor
6456451|NCT00432354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456452|NCT00432354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6456453|NCT00432354|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6456454|NCT00432354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6456455|NCT00432367|Artesunate|artesunate|mesh-list
6456456|NCT00432367|Pyrimethamine|pyrimethamine|mesh-list
6456457|NCT00432367|Sulfadoxine|sulfadoxine|mesh-list
6029555|NCT00453349|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6029556|NCT00453349|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6029557|NCT00453362|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6029558|NCT00453362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6029559|NCT00453362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6029560|NCT00453362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6029561|NCT00453362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029562|NCT00453388|Cyclosporine|cyclosporine|mesh-list
6029563|NCT00453388|Mycophenolic Acid|mycophenolic acid|mesh-list
6029564|NCT00453388|Cyclophosphamide|cyclophosphamide|mesh-list
6029565|NCT00453388|Fludarabine|fludarabine|mesh-list
6029566|NCT00453388|Fludarabine phosphate|fludarabine phosphate|mesh-list
6029567|NCT00453388|Cyclosporins|cyclosporins|mesh-list
6029568|NCT00453388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5493129|NCT01835041|Calcium|calcium|mesh-list
5493130|NCT01835041|Levoleucovorin|levoleucovorin|mesh-list
5493131|NCT01835041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5493132|NCT01835041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493133|NCT01835041|Antimetabolites|antimetabolites|mesh-ancestor
5493134|NCT01835041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029569|NCT00453388|Immunologic Factors|immunologic factors|mesh-ancestor
6029570|NCT00453388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029571|NCT00453388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6029572|NCT00453388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6029573|NCT00453388|Alkylating Agents|alkylating agents|mesh-ancestor
6029574|NCT00453388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029575|NCT00453388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6029576|NCT00453388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6029577|NCT00453388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6029578|NCT00453388|Antimetabolites|antimetabolites|mesh-ancestor
6029579|NCT00453388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6029580|NCT00453388|Antifungal Agents|antifungal agents|mesh-ancestor
6029581|NCT00453388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6029582|NCT00453388|Dermatologic Agents|dermatologic agents|mesh-ancestor
6029583|NCT00453388|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6029584|NCT00453388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5503080|NCT04462315|Trace Elements|trace elements|mesh-ancestor
6029585|NCT00453388|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6029586|NCT00453388|Antitubercular Agents|antitubercular agents|mesh-ancestor
6029587|NCT00453388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6029588|NCT00453895|Sunitinib|sunitinib|mesh-list
6029589|NCT00453895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6029590|NCT00453895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6029591|NCT00453895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6029592|NCT00453895|Growth Substances|growth substances|mesh-ancestor
6029593|NCT00453895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029594|NCT00453895|Growth Inhibitors|growth inhibitors|mesh-ancestor
6029595|NCT00453895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6029596|NCT00453895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6029597|NCT00453895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029598|NCT00453921|Methylphenidate|methylphenidate|mesh-list
6029599|NCT00453921|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6029600|NCT00453921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029601|NCT00453921|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6029602|NCT00453921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6029603|NCT00453921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6029604|NCT00453921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029605|NCT00453921|Dopamine Agents|dopamine agents|mesh-ancestor
6029606|NCT00453921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6029607|NCT00453999|Oseltamivir|oseltamivir|mesh-list
6029608|NCT00453999|Peramivir|peramivir|mesh-list
6029609|NCT00453999|Antiviral Agents|antiviral agents|mesh-ancestor
6029610|NCT00453999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6456458|NCT00432367|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6456459|NCT00432367|Amodiaquine|amodiaquine|mesh-list
6029611|NCT00453999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6029612|NCT00453999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029613|NCT00454051|Omalizumab|omalizumab|mesh-list
6029614|NCT00454051|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6029615|NCT00454051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6029616|NCT00454051|Respiratory System Agents|respiratory system agents|mesh-ancestor
6029617|NCT00454181|Interferons|interferons|mesh-list
6029618|NCT00454181|Interferon-alpha|interferon-alpha|mesh-list
6029619|NCT00454181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6029620|NCT00454181|Antiviral Agents|antiviral agents|mesh-ancestor
6029621|NCT00454181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6029622|NCT00454181|Immunologic Factors|immunologic factors|mesh-ancestor
6029623|NCT00454181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029624|NCT00454194|Pemetrexed|pemetrexed|mesh-list
6029625|NCT00454194|Sorafenib|sorafenib|mesh-list
6029626|NCT00454194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6029627|NCT00454194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6029628|NCT00454194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029629|NCT00454194|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6029630|NCT00454194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6029631|NCT00454194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6029632|NCT00454207|Sildenafil Citrate|sildenafil citrate|mesh-list
6029633|NCT00454207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029634|NCT00454207|Vasodilator Agents|vasodilator agents|mesh-ancestor
6029635|NCT00454207|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6029636|NCT00454207|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6029637|NCT00454207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6029638|NCT00454207|Urological Agents|urological agents|mesh-ancestor
6029639|NCT00454246|Epoetin Alfa|epoetin alfa|mesh-list
6029640|NCT00454246|Darbepoetin alfa|darbepoetin alfa|mesh-list
6029641|NCT00454246|Hematinics|hematinics|mesh-ancestor
6029642|NCT00454324|Paclitaxel|paclitaxel|mesh-list
6456460|NCT00432367|Antimalarials|antimalarials|mesh-ancestor
6456461|NCT00432367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6456462|NCT00432367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6456463|NCT00432367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6456464|NCT00432367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6456465|NCT00432367|Antiviral Agents|antiviral agents|mesh-ancestor
6456466|NCT00432367|Schistosomicides|schistosomicides|mesh-ancestor
6456467|NCT00432367|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6456468|NCT00432367|Anthelmintics|anthelmintics|mesh-ancestor
6456469|NCT00432367|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6456470|NCT00432367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5493135|NCT01835041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5493136|NCT01835041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6029643|NCT00454324|Carboplatin|carboplatin|mesh-list
6029644|NCT00454324|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6029645|NCT00454324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5493137|NCT01835041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5493138|NCT01835041|Immunologic Factors|immunologic factors|mesh-ancestor
5493139|NCT01835041|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5493140|NCT01835041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5493141|NCT01835041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5493142|NCT01835041|Antidotes|antidotes|mesh-ancestor
5493143|NCT01835041|Protective Agents|protective agents|mesh-ancestor
5493144|NCT01835041|Vitamin B Complex|vitamin b complex|mesh-ancestor
5493145|NCT01835041|Vitamins|vitamins|mesh-ancestor
5493146|NCT01835041|Micronutrients|micronutrients|mesh-ancestor
5493147|NCT01835041|Antioxidants|antioxidants|mesh-ancestor
5493148|NCT01808820|Imiquimod|imiquimod|mesh-list
5493149|NCT01808820|Vaccines|vaccines|mesh-list
5493150|NCT01808820|Immunologic Factors|immunologic factors|mesh-ancestor
5493151|NCT01808820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493152|NCT01808820|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5493153|NCT01808820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5493154|NCT01808820|Interferon Inducers|interferon inducers|mesh-ancestor
5493155|NCT01609790|Bevacizumab|bevacizumab|mesh-list
5493156|NCT01609790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5493157|NCT01609790|Trebananib|trebananib|mesh-list
5493158|NCT01609790|Endothelial Growth Factors|endothelial growth factors|mesh-list
5493159|NCT01609790|Antibodies|antibodies|mesh-list
5493160|NCT01609790|Immunoglobulins|immunoglobulins|mesh-list
5493161|NCT01609790|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5493162|NCT01609790|Immunoglobulin G|immunoglobulin g|mesh-list
5493163|NCT01609790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5493164|NCT01609790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5493165|NCT01609790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5493166|NCT01609790|Growth Substances|growth substances|mesh-ancestor
5493167|NCT01609790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493168|NCT01609790|Growth Inhibitors|growth inhibitors|mesh-ancestor
5493169|NCT01609790|Immunologic Factors|immunologic factors|mesh-ancestor
5493170|NCT01572506|Biotin|biotin|mesh-list
5493171|NCT01572506|Vitamin B Complex|vitamin b complex|mesh-ancestor
5493172|NCT01572506|Vitamins|vitamins|mesh-ancestor
5493173|NCT01572506|Micronutrients|micronutrients|mesh-ancestor
5493174|NCT01572506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493175|NCT01481272|Leucovorin|leucovorin|mesh-list
5493176|NCT01481272|Cytarabine|cytarabine|mesh-list
5493177|NCT01481272|Methotrexate|methotrexate|mesh-list
6029646|NCT00454324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6029647|NCT00454324|Tubulin Modulators|tubulin modulators|mesh-ancestor
5493178|NCT01481272|Etoposide|etoposide|mesh-list
5493179|NCT01481272|Ofatumumab|ofatumumab|mesh-list
5493180|NCT01481272|Lenograstim|lenograstim|mesh-list
5493181|NCT01481272|Sargramostim|sargramostim|mesh-list
5493182|NCT01481272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5493183|NCT01481272|Abortifacient Agents|abortifacient agents|mesh-ancestor
5493184|NCT01481272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5493185|NCT01481272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493186|NCT01481272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5493187|NCT01481272|Antimetabolites|antimetabolites|mesh-ancestor
5493188|NCT01481272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029648|NCT00454324|Antimitotic Agents|antimitotic agents|mesh-ancestor
6029649|NCT00454324|Mitosis Modulators|mitosis modulators|mesh-ancestor
6029650|NCT00454324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029651|NCT00454584|Etanercept|etanercept|mesh-list
6029652|NCT00454584|Ustekinumab|ustekinumab|mesh-list
5493189|NCT01481272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5493190|NCT01481272|Dermatologic Agents|dermatologic agents|mesh-ancestor
5493191|NCT01481272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5493192|NCT01481272|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5493193|NCT01481272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5493194|NCT01481272|Immunologic Factors|immunologic factors|mesh-ancestor
5493195|NCT01481272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5493196|NCT01481272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5493197|NCT01481272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5493198|NCT01481272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6029653|NCT00454584|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6029654|NCT00454584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6029655|NCT00454584|Analgesics|analgesics|mesh-ancestor
5493199|NCT01481272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5493200|NCT01481272|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5493201|NCT01481272|Antiviral Agents|antiviral agents|mesh-ancestor
5493202|NCT01481272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5493203|NCT01481272|Antidotes|antidotes|mesh-ancestor
5493204|NCT01481272|Protective Agents|protective agents|mesh-ancestor
5493205|NCT01481272|Vitamin B Complex|vitamin b complex|mesh-ancestor
5493206|NCT01481272|Vitamins|vitamins|mesh-ancestor
6029656|NCT00454584|Sensory System Agents|sensory system agents|mesh-ancestor
6029657|NCT00454584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6029658|NCT00454584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029659|NCT00454584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6029660|NCT00454584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6029661|NCT00454584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6029662|NCT00454584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6029663|NCT00454584|Immunologic Factors|immunologic factors|mesh-ancestor
6029664|NCT00454584|Dermatologic Agents|dermatologic agents|mesh-ancestor
6029665|NCT00454636|Cisplatin|cisplatin|mesh-list
6029666|NCT00454636|Docetaxel|docetaxel|mesh-list
6029667|NCT00454636|Capecitabine|capecitabine|mesh-list
6029668|NCT00454636|Oxaliplatin|oxaliplatin|mesh-list
6029669|NCT00454636|Epirubicin|epirubicin|mesh-list
6029670|NCT00454636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6029671|NCT00454636|Tubulin Modulators|tubulin modulators|mesh-ancestor
6029672|NCT00454636|Antimitotic Agents|antimitotic agents|mesh-ancestor
6029673|NCT00454636|Mitosis Modulators|mitosis modulators|mesh-ancestor
6029674|NCT00454636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029675|NCT00454636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6029676|NCT00454636|Antimetabolites|antimetabolites|mesh-ancestor
6029677|NCT00454636|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6029678|NCT00454636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6029679|NCT00454636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6029680|NCT00454636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6029681|NCT00454649|Gemcitabine|gemcitabine|mesh-list
6029682|NCT00454649|Paclitaxel|paclitaxel|mesh-list
6029683|NCT00454649|Docetaxel|docetaxel|mesh-list
6029684|NCT00454649|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6029685|NCT00454649|Cisplatin|cisplatin|mesh-list
6029686|NCT00454649|Carboplatin|carboplatin|mesh-list
6029687|NCT00454649|Capecitabine|capecitabine|mesh-list
6029688|NCT00454649|Pemetrexed|pemetrexed|mesh-list
6029689|NCT00454649|Axitinib|axitinib|mesh-list
6029690|NCT00454649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6029691|NCT00454649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6029692|NCT00454649|Tubulin Modulators|tubulin modulators|mesh-ancestor
6029693|NCT00454649|Antimitotic Agents|antimitotic agents|mesh-ancestor
6029694|NCT00454649|Mitosis Modulators|mitosis modulators|mesh-ancestor
6029695|NCT00454649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029696|NCT00454649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6029697|NCT00454649|Antimetabolites|antimetabolites|mesh-ancestor
6029698|NCT00454649|Antiviral Agents|antiviral agents|mesh-ancestor
6029699|NCT00454649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6029700|NCT00454649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6029701|NCT00454649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6029702|NCT00454649|Immunologic Factors|immunologic factors|mesh-ancestor
6029703|NCT00454649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029704|NCT00454649|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6029705|NCT00454649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6029706|NCT00454649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6029707|NCT00454779|Cisplatin|cisplatin|mesh-list
6029708|NCT00454779|Docetaxel|docetaxel|mesh-list
6029709|NCT00454779|Panitumumab|panitumumab|mesh-list
6029710|NCT00454779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6029711|NCT00454779|Tubulin Modulators|tubulin modulators|mesh-ancestor
6029712|NCT00454779|Antimitotic Agents|antimitotic agents|mesh-ancestor
6029713|NCT00454779|Mitosis Modulators|mitosis modulators|mesh-ancestor
6029714|NCT00454779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029715|NCT00454779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6029716|NCT00454805|Fulvestrant|fulvestrant|mesh-list
6029717|NCT00454805|Cediranib|cediranib|mesh-list
6029718|NCT00454805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6029719|NCT00454805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6029720|NCT00454805|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6029721|NCT00454805|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6029722|NCT00454805|Hormone Antagonists|hormone antagonists|mesh-ancestor
6029723|NCT00454805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6029724|NCT00454805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029725|NCT00454805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6029726|NCT00454805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6029727|NCT00454805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029728|NCT00455013|Mycophenolic Acid|mycophenolic acid|mesh-list
6029729|NCT00455013|Sirolimus|sirolimus|mesh-list
6029730|NCT00455013|Abatacept|abatacept|mesh-list
6029731|NCT00455013|Tacrolimus|tacrolimus|mesh-list
6029732|NCT00455013|Thymoglobulin|thymoglobulin|mesh-list
6029733|NCT00455013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6029734|NCT00455013|Immunologic Factors|immunologic factors|mesh-ancestor
6029735|NCT00455013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029736|NCT00455013|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6029737|NCT00455013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6029738|NCT00455013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029739|NCT00455013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6029740|NCT00455013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6029741|NCT00455013|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6029742|NCT00455013|Antitubercular Agents|antitubercular agents|mesh-ancestor
6029743|NCT00455013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6029744|NCT00455013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6029745|NCT00455013|Antifungal Agents|antifungal agents|mesh-ancestor
6029746|NCT00455013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6029747|NCT00455013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6029748|NCT00455312|Methylprednisolone|methylprednisolone|mesh-list
6029749|NCT00455312|Cyclophosphamide|cyclophosphamide|mesh-list
6029750|NCT00455312|Fludarabine|fludarabine|mesh-list
6029751|NCT00455312|Alemtuzumab|alemtuzumab|mesh-list
6029752|NCT00455312|Thymoglobulin|thymoglobulin|mesh-list
6029753|NCT00455312|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6029754|NCT00455312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6029755|NCT00455312|Immunologic Factors|immunologic factors|mesh-ancestor
6029756|NCT00455312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029757|NCT00455312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6029758|NCT00455312|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6029759|NCT00455312|Alkylating Agents|alkylating agents|mesh-ancestor
6029760|NCT00455312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029761|NCT00455312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6029762|NCT00455312|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6029763|NCT00455312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5493207|NCT01481272|Micronutrients|micronutrients|mesh-ancestor
5493208|NCT01434316|Veliparib|veliparib|mesh-list
5493209|NCT01434316|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5493210|NCT01434316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5493211|NCT01434316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493212|NCT01434316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5493213|NCT01380028|Prednisone|prednisone|mesh-list
5493214|NCT01380028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5493215|NCT01380028|Glucocorticoids|glucocorticoids|mesh-ancestor
5493216|NCT01380028|Hormones|hormones|mesh-ancestor
5493217|NCT01380028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5493218|NCT01380028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029764|NCT00455312|Antiemetics|antiemetics|mesh-ancestor
6029765|NCT00455312|Autonomic Agents|autonomic agents|mesh-ancestor
6029766|NCT00455312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6029767|NCT00455312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6029768|NCT00455312|Glucocorticoids|glucocorticoids|mesh-ancestor
6029769|NCT00455312|Hormones|hormones|mesh-ancestor
6029770|NCT00455312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6029771|NCT00455312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6029772|NCT00455312|Protective Agents|protective agents|mesh-ancestor
6029773|NCT00455312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6029774|NCT00455455|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6029775|NCT00455520|Tapentadol|tapentadol|mesh-list
5493219|NCT01380028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5493220|NCT01380028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5493221|NCT01305460|Azacitidine|azacitidine|mesh-list
5493222|NCT01305460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5493223|NCT01305460|Antimetabolites|antimetabolites|mesh-ancestor
5493224|NCT01305460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493225|NCT01305460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5493226|NCT01305460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5493227|NCT01300143|Chlorotrianisene|chlorotrianisene|mesh-list
5493228|NCT01300143|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
5493229|NCT01300143|Estrogens|estrogens|mesh-ancestor
5493230|NCT01300143|Hormones|hormones|mesh-ancestor
5493231|NCT01300143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5493232|NCT01300143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493233|NCT01300143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6029776|NCT00455520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6029777|NCT00455520|Narcotics|narcotics|mesh-ancestor
6029778|NCT00455520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6029779|NCT00455520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029780|NCT00455520|Analgesics|analgesics|mesh-ancestor
6029781|NCT00455520|Sensory System Agents|sensory system agents|mesh-ancestor
6029782|NCT00455520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6029783|NCT00455520|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6029784|NCT00455520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6029785|NCT00455520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6029786|NCT00455520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029787|NCT00455520|Adrenergic Agents|adrenergic agents|mesh-ancestor
6029788|NCT00455520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6029789|NCT00455533|Paclitaxel|paclitaxel|mesh-list
6029790|NCT00455533|Epothilones|epothilones|mesh-list
6029791|NCT00455533|Cyclophosphamide|cyclophosphamide|mesh-list
6029792|NCT00455533|Doxorubicin|doxorubicin|mesh-list
6029793|NCT00455533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6029794|NCT00455533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6029795|NCT00455533|Tubulin Modulators|tubulin modulators|mesh-ancestor
6029796|NCT00455533|Antimitotic Agents|antimitotic agents|mesh-ancestor
6029797|NCT00455533|Mitosis Modulators|mitosis modulators|mesh-ancestor
6029798|NCT00455533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029799|NCT00455533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6029800|NCT00455533|Immunologic Factors|immunologic factors|mesh-ancestor
6029801|NCT00455533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029802|NCT00455533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6029803|NCT00455533|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6029804|NCT00455533|Alkylating Agents|alkylating agents|mesh-ancestor
6029805|NCT00455533|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6029806|NCT00455533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6029807|NCT00455533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6029808|NCT00455533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6029809|NCT00455533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6029810|NCT00455650|Mecamylamine|mecamylamine|mesh-list
6029811|NCT00455650|Varenicline|varenicline|mesh-list
6029812|NCT00455650|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6029813|NCT00455650|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6029814|NCT00455650|Cholinergic Agents|cholinergic agents|mesh-ancestor
6029815|NCT00455650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6029816|NCT00455650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029817|NCT00455650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029818|NCT00455650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6029819|NCT00455650|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
6029820|NCT00455650|Autonomic Agents|autonomic agents|mesh-ancestor
6029821|NCT00455650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6029822|NCT00455650|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
6029823|NCT00455650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6029824|NCT00455689|Leuprolide|leuprolide|mesh-list
6029825|NCT00455689|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6029826|NCT00455689|Fertility Agents|fertility agents|mesh-ancestor
6029827|NCT00455689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6029828|NCT00455689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029829|NCT00455689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6029830|NCT00455689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6029831|NCT00455702|Cycloserine|cycloserine|mesh-list
6029832|NCT00455702|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6029833|NCT00455702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6029834|NCT00455702|Renal Agents|renal agents|mesh-ancestor
6029835|NCT00455702|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6029836|NCT00455702|Antitubercular Agents|antitubercular agents|mesh-ancestor
6029837|NCT00455702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6029838|NCT00455702|Antimetabolites|antimetabolites|mesh-ancestor
6029839|NCT00455702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029840|NCT00455741|Estradiol|estradiol|mesh-list
6029841|NCT00455741|Progesterone|progesterone|mesh-list
5493234|NCT01300143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5493235|NCT01295944|Bevacizumab|bevacizumab|mesh-list
5493236|NCT01295944|Carboplatin|carboplatin|mesh-list
5493237|NCT01295944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5493238|NCT01295944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5493239|NCT01295944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5493240|NCT01295944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5493241|NCT01295944|Growth Substances|growth substances|mesh-ancestor
5493242|NCT01295944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493243|NCT01295944|Growth Inhibitors|growth inhibitors|mesh-ancestor
5493244|NCT01269424|Temozolomide|temozolomide|mesh-list
6029842|NCT00455741|Estrogens|estrogens|mesh-ancestor
6029843|NCT00455741|Hormones|hormones|mesh-ancestor
6029844|NCT00455741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6029845|NCT00455741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029846|NCT00455741|Progestins|progestins|mesh-ancestor
6029847|NCT00455858|Insulin Detemir|insulin detemir|mesh-list
6029848|NCT00455858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6029849|NCT00455858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029850|NCT00455923|Fluticasone|fluticasone|mesh-list
6029851|NCT00455923|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6029852|NCT00455923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6029853|NCT00455923|Autonomic Agents|autonomic agents|mesh-ancestor
6029854|NCT00455923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6029855|NCT00455923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029856|NCT00455923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6029857|NCT00455923|Respiratory System Agents|respiratory system agents|mesh-ancestor
6029858|NCT00455923|Glucocorticoids|glucocorticoids|mesh-ancestor
6029859|NCT00455923|Hormones|hormones|mesh-ancestor
6029860|NCT00455923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6029861|NCT00455923|Sympathomimetics|sympathomimetics|mesh-ancestor
6029862|NCT00455923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6029863|NCT00455923|Dermatologic Agents|dermatologic agents|mesh-ancestor
6029864|NCT00455923|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6029865|NCT00455962|Estradiol|estradiol|mesh-list
6029866|NCT00455962|Progesterone|progesterone|mesh-list
6029867|NCT00455962|Estrogens|estrogens|mesh-ancestor
6029868|NCT00455962|Hormones|hormones|mesh-ancestor
6029869|NCT00455962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6029870|NCT00455962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029871|NCT00455962|Progestins|progestins|mesh-ancestor
6029872|NCT00455975|Bevacizumab|bevacizumab|mesh-list
6029873|NCT00455975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6029874|NCT00455975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6029875|NCT00455975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6029876|NCT00455975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6029877|NCT00455975|Growth Substances|growth substances|mesh-ancestor
6029878|NCT00455975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029879|NCT00455975|Growth Inhibitors|growth inhibitors|mesh-ancestor
6029880|NCT00456014|Citalopram|citalopram|mesh-list
6029881|NCT00456014|Desipramine|desipramine|mesh-list
6029882|NCT00456014|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5493245|NCT01269424|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
6029883|NCT00456014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6029884|NCT00456014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6029885|NCT00456014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029886|NCT00456014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6029887|NCT00456014|Serotonin Agents|serotonin agents|mesh-ancestor
6029888|NCT00456014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029889|NCT00456014|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6029890|NCT00456014|Antidepressive Agents|antidepressive agents|mesh-ancestor
6029891|NCT00456014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6029892|NCT00456014|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6029893|NCT00456014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6029894|NCT00456014|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6029895|NCT00456014|Adrenergic Agents|adrenergic agents|mesh-ancestor
6029896|NCT00456092|Apremilast|apremilast|mesh-list
6029897|NCT00456092|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6029898|NCT00456092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6029899|NCT00456092|Analgesics|analgesics|mesh-ancestor
6029900|NCT00456092|Sensory System Agents|sensory system agents|mesh-ancestor
6029901|NCT00456092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6029902|NCT00456092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029903|NCT00456092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6029904|NCT00456092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6029905|NCT00456092|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6029906|NCT00456092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6029907|NCT00456092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6029908|NCT00456092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029909|NCT00456261|Gemcitabine|gemcitabine|mesh-list
6029910|NCT00456261|Bevacizumab|bevacizumab|mesh-list
6029911|NCT00456261|Carboplatin|carboplatin|mesh-list
6029912|NCT00456261|Pemetrexed|pemetrexed|mesh-list
6029913|NCT00456261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6029914|NCT00456261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5493246|NCT01269424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5493247|NCT01269424|Alkylating Agents|alkylating agents|mesh-ancestor
5503081|NCT04462315|Micronutrients|micronutrients|mesh-ancestor
6029915|NCT00456261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6456471|NCT00432367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456472|NCT00432367|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6456473|NCT00432367|Renal Agents|renal agents|mesh-ancestor
6456474|NCT00432393|Levodopa|levodopa|mesh-list
6456475|NCT00432393|Carbidopa|carbidopa|mesh-list
6456476|NCT00432393|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
6456477|NCT00432393|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6456478|NCT00432393|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6456479|NCT00432393|Dopamine Agents|dopamine agents|mesh-ancestor
6456480|NCT00432393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6456481|NCT00432393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456482|NCT00432393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456483|NCT00432393|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6456484|NCT00432393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6029916|NCT00456261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6029917|NCT00456261|Growth Substances|growth substances|mesh-ancestor
6029918|NCT00456261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029919|NCT00456261|Growth Inhibitors|growth inhibitors|mesh-ancestor
6029920|NCT00456261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6029921|NCT00456261|Antimetabolites|antimetabolites|mesh-ancestor
6029922|NCT00456261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029923|NCT00456261|Antiviral Agents|antiviral agents|mesh-ancestor
6029924|NCT00456261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6029925|NCT00456261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6029926|NCT00456261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6029927|NCT00456261|Immunologic Factors|immunologic factors|mesh-ancestor
6029928|NCT00456261|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6029929|NCT00456261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6029930|NCT00456300|Exenatide|exenatide|mesh-list
6029931|NCT00456300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6029932|NCT00456300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029933|NCT00456300|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6029934|NCT00456300|Incretins|incretins|mesh-ancestor
6029935|NCT00456300|Hormones|hormones|mesh-ancestor
6029936|NCT00456300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6029937|NCT00456365|Pravastatin|pravastatin|mesh-list
6029938|NCT00456365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6029939|NCT00456365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6029940|NCT00456365|Antimetabolites|antimetabolites|mesh-ancestor
6029941|NCT00456365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029942|NCT00456365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6029943|NCT00456365|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6029944|NCT00456365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6029945|NCT00456495|Ranibizumab|ranibizumab|mesh-list
6029946|NCT00456495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6029947|NCT00456495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6029948|NCT00456495|Growth Substances|growth substances|mesh-ancestor
6029949|NCT00456495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029950|NCT00456495|Growth Inhibitors|growth inhibitors|mesh-ancestor
6029951|NCT00456495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6029952|NCT00456508|Ecallantide|ecallantide|mesh-list
6029953|NCT00456508|Analgesics|analgesics|mesh-ancestor
6029954|NCT00456508|Sensory System Agents|sensory system agents|mesh-ancestor
6029955|NCT00456508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6029956|NCT00456508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029957|NCT00456508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6029958|NCT00456508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6029959|NCT00456508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6029960|NCT00456508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6029961|NCT00456521|Naltrexone|naltrexone|mesh-list
6029962|NCT00456521|Bupropion|bupropion|mesh-list
6029963|NCT00456521|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6029964|NCT00456521|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6029965|NCT00456521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029966|NCT00456521|Sensory System Agents|sensory system agents|mesh-ancestor
6029967|NCT00456521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6029968|NCT00456521|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6029969|NCT00456521|Antidepressive Agents|antidepressive agents|mesh-ancestor
6029970|NCT00456521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6029971|NCT00456521|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6029972|NCT00456521|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6029973|NCT00456521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6029974|NCT00456521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029975|NCT00456521|Dopamine Agents|dopamine agents|mesh-ancestor
6029976|NCT00456521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6029977|NCT00456521|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6029978|NCT00456521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6029979|NCT00456521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6029980|NCT00456599|Gemcitabine|gemcitabine|mesh-list
6029981|NCT00456599|Oxaliplatin|oxaliplatin|mesh-list
6029982|NCT00456599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6029983|NCT00456599|Antimetabolites|antimetabolites|mesh-ancestor
6029984|NCT00456599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6029985|NCT00456599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6029986|NCT00456599|Antiviral Agents|antiviral agents|mesh-ancestor
6029987|NCT00456599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6029988|NCT00456599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6029989|NCT00456599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6029990|NCT00456599|Immunologic Factors|immunologic factors|mesh-ancestor
6029991|NCT00456599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029992|NCT00456625|Vaccines|vaccines|mesh-list
5493248|NCT01269424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493249|NCT01269424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5493250|NCT01269424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5493251|NCT01199302|Brodalumab|brodalumab|mesh-list
5493252|NCT01199302|Dermatologic Agents|dermatologic agents|mesh-ancestor
5493253|NCT01192568|Oxybutynin|oxybutynin|mesh-list
5493254|NCT01192568|Parasympatholytics|parasympatholytics|mesh-ancestor
5493255|NCT01192568|Autonomic Agents|autonomic agents|mesh-ancestor
5493256|NCT01192568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5493257|NCT01192568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493258|NCT01192568|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5493259|NCT01192568|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5493260|NCT01192568|Cholinergic Agents|cholinergic agents|mesh-ancestor
5493261|NCT01192568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5493262|NCT01192568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493263|NCT01192568|Urological Agents|urological agents|mesh-ancestor
5493264|NCT01164995|Carboplatin|carboplatin|mesh-list
5493265|NCT01164995|Adavosertib|adavosertib|mesh-list
5493266|NCT01164995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5493267|NCT01164995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6029993|NCT00456625|Immunologic Factors|immunologic factors|mesh-ancestor
6029994|NCT00456625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029995|NCT00456807|Vaccines|vaccines|mesh-list
6029996|NCT00456807|Immunologic Factors|immunologic factors|mesh-ancestor
6029997|NCT00456807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6029998|NCT00456846|Paclitaxel|paclitaxel|mesh-list
6029999|NCT00456846|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6030000|NCT00456846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6030001|NCT00456846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6030002|NCT00456846|Tubulin Modulators|tubulin modulators|mesh-ancestor
6030003|NCT00456846|Antimitotic Agents|antimitotic agents|mesh-ancestor
6030004|NCT00456846|Mitosis Modulators|mitosis modulators|mesh-ancestor
6030005|NCT00456846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053506|NCT00595517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6053507|NCT00595517|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6053508|NCT00595517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6053509|NCT00595517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053510|NCT00595530|Ketamine|ketamine|mesh-list
6053511|NCT00595530|Analgesics|analgesics|mesh-ancestor
6053512|NCT00595530|Sensory System Agents|sensory system agents|mesh-ancestor
5493268|NCT01164995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493269|NCT01123707|Aripiprazole|aripiprazole|mesh-list
5493270|NCT01123707|Citalopram|citalopram|mesh-list
5493271|NCT01123707|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5493272|NCT01123707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6053513|NCT00595530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6053514|NCT00595530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053515|NCT00595530|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6053516|NCT00595530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6053517|NCT00595530|Anesthetics, General|anesthetics, general|mesh-ancestor
6053518|NCT00595530|Anesthetics|anesthetics|mesh-ancestor
6053519|NCT00595530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6053520|NCT00595530|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6053521|NCT00595530|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6053522|NCT00595530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6053523|NCT00595530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053524|NCT00595556|Zonisamide|zonisamide|mesh-list
6053525|NCT00595556|Anticonvulsants|anticonvulsants|mesh-ancestor
6053526|NCT00595556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6053527|NCT00595556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6053528|NCT00595556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053529|NCT00595556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6053530|NCT00595556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053531|NCT00595790|Vaccines|vaccines|mesh-list
6053532|NCT00595790|Immunologic Factors|immunologic factors|mesh-ancestor
6053533|NCT00595790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053534|NCT00595868|Varenicline|varenicline|mesh-list
6053535|NCT00595868|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6053536|NCT00595868|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6053537|NCT00595868|Cholinergic Agents|cholinergic agents|mesh-ancestor
6053538|NCT00595868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6053539|NCT00595868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053540|NCT00595868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053541|NCT00595946|Lubiprostone|lubiprostone|mesh-list
6053542|NCT00595946|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6053543|NCT00595946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6053544|NCT00595946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053545|NCT00596167|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6053546|NCT00596167|Vancomycin|vancomycin|mesh-list
5493273|NCT01123707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6030006|NCT00456885|Exenatide|exenatide|mesh-list
6030007|NCT00456885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6030008|NCT00456885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030009|NCT00456885|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6030010|NCT00456885|Incretins|incretins|mesh-ancestor
6030011|NCT00456885|Hormones|hormones|mesh-ancestor
6030012|NCT00456885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6030013|NCT00457002|Enoxaparin|enoxaparin|mesh-list
6030014|NCT00457002|Apixaban|apixaban|mesh-list
5493274|NCT01123707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493275|NCT01123707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5493276|NCT01123707|Serotonin Agents|serotonin agents|mesh-ancestor
5493277|NCT01123707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493278|NCT01123707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5493279|NCT01123707|Antidepressive Agents|antidepressive agents|mesh-ancestor
6030015|NCT00457002|Anticoagulants|anticoagulants|mesh-ancestor
6030016|NCT00457002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6030017|NCT00457002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5493280|NCT01123707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5493281|NCT01123707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5493282|NCT01123707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5493283|NCT01123707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5493284|NCT01123707|Dopamine Agonists|dopamine agonists|mesh-ancestor
5493285|NCT01123707|Dopamine Agents|dopamine agents|mesh-ancestor
5493286|NCT01123707|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6030018|NCT00457002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030019|NCT00457002|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6030020|NCT00457002|Antithrombins|antithrombins|mesh-ancestor
6030021|NCT00457002|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6030022|NCT00457002|Protease Inhibitors|protease inhibitors|mesh-ancestor
6030023|NCT00457002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6030024|NCT00457015|Ecallantide|ecallantide|mesh-list
6030025|NCT00457015|Analgesics|analgesics|mesh-ancestor
6030026|NCT00457015|Sensory System Agents|sensory system agents|mesh-ancestor
6030027|NCT00457015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6030028|NCT00457015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030029|NCT00457015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6030030|NCT00457015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6030031|NCT00457015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6030032|NCT00457015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6030033|NCT00457197|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6030034|NCT00457197|Antidepressive Agents|antidepressive agents|mesh-ancestor
6030035|NCT00457197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6030036|NCT00457197|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5493287|NCT01123707|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5493288|NCT01123707|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5493289|NCT01123707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5493290|NCT01123707|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5493291|NCT01123707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5493292|NCT00999401|Roscovitine|roscovitine|mesh-list
5493293|NCT00999401|Sapacitabine|sapacitabine|mesh-list
5493294|NCT00999401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5493295|NCT00999401|Antiviral Agents|antiviral agents|mesh-ancestor
5493296|NCT00999401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5493297|NCT00999401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5493298|NCT00999401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5493299|NCT00999401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493300|NCT00885963|Sapacitabine|sapacitabine|mesh-list
5493301|NCT00885963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5493302|NCT00725127|Aspirin|aspirin|mesh-list
5493303|NCT00725127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5493304|NCT00725127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5493305|NCT00725127|Analgesics|analgesics|mesh-ancestor
5493306|NCT00725127|Sensory System Agents|sensory system agents|mesh-ancestor
5493307|NCT00725127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5493308|NCT00725127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493309|NCT00725127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5493310|NCT00725127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5493311|NCT00725127|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5493312|NCT00725127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5493313|NCT00725127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493314|NCT00725127|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6030037|NCT00457197|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6030038|NCT00457197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5493315|NCT00725127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5493316|NCT00725127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5493317|NCT00725127|Antipyretics|antipyretics|mesh-ancestor
6456485|NCT00432393|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6456486|NCT00432393|Immunologic Factors|immunologic factors|mesh-ancestor
6456487|NCT00432393|Dopamine Agonists|dopamine agonists|mesh-ancestor
6456488|NCT00432406|Etanercept|etanercept|mesh-list
6456489|NCT00432406|Infliximab|infliximab|mesh-list
6456490|NCT00432406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6456491|NCT00432406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6456492|NCT00432406|Analgesics|analgesics|mesh-ancestor
6456493|NCT00432406|Sensory System Agents|sensory system agents|mesh-ancestor
6456494|NCT00432406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6654716|NCT01458626|Antidepressive Agents|antidepressive agents|mesh-ancestor
6654717|NCT01458626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6654718|NCT01458626|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6654719|NCT01458626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6654720|NCT01458626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6654721|NCT01458626|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6654722|NCT01458626|Histamine Antagonists|histamine antagonists|mesh-ancestor
6654723|NCT01458626|Histamine Agents|histamine agents|mesh-ancestor
6654724|NCT01458626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6654725|NCT01458626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6654726|NCT01458626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6456495|NCT00432406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456496|NCT00432406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6456497|NCT00432406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6456498|NCT00432406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6456499|NCT00432406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6456500|NCT00432406|Immunologic Factors|immunologic factors|mesh-ancestor
6456501|NCT00432406|Dermatologic Agents|dermatologic agents|mesh-ancestor
6456502|NCT00432432|Infliximab|infliximab|mesh-list
6456503|NCT00432432|Dermatologic Agents|dermatologic agents|mesh-ancestor
6456504|NCT00432432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6456505|NCT00432432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6456506|NCT00432510|Complement C1s|complement c1s|mesh-list
6456507|NCT00432510|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
6456508|NCT00432510|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
6456509|NCT00432510|Immunologic Factors|immunologic factors|mesh-ancestor
6456510|NCT00432510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456511|NCT00432510|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6456512|NCT00432510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6030039|NCT00457197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030040|NCT00457366|Lorazepam|lorazepam|mesh-list
6030041|NCT00457366|Haloperidol|haloperidol|mesh-list
6030042|NCT00457366|Benztropine|benztropine|mesh-list
6030043|NCT00457366|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6030044|NCT00457366|Haloperidol decanoate|haloperidol decanoate|mesh-list
6030045|NCT00457366|Antidepressive Agents|antidepressive agents|mesh-ancestor
6030046|NCT00457366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6030047|NCT00457366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6030048|NCT00457366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6030049|NCT00457366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6030050|NCT00457366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030051|NCT00457366|Antiemetics|antiemetics|mesh-ancestor
6030052|NCT00457366|Autonomic Agents|autonomic agents|mesh-ancestor
6030053|NCT00457366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6030054|NCT00457366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6030055|NCT00457366|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6030056|NCT00457366|Dopamine Agents|dopamine agents|mesh-ancestor
6030057|NCT00457366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6030058|NCT00457366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030059|NCT00457366|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6030060|NCT00457366|Anticonvulsants|anticonvulsants|mesh-ancestor
6030061|NCT00457366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6030062|NCT00457366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6030063|NCT00457366|GABA Modulators|gaba modulators|mesh-ancestor
6030064|NCT00457366|GABA Agents|gaba agents|mesh-ancestor
6030065|NCT00457366|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6030066|NCT00457366|Parasympatholytics|parasympatholytics|mesh-ancestor
6030067|NCT00457366|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6030068|NCT00457366|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6030069|NCT00457366|Cholinergic Agents|cholinergic agents|mesh-ancestor
6030070|NCT00457366|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6053547|NCT00596167|Levofloxacin|levofloxacin|mesh-list
6456513|NCT00432549|Topiramate|topiramate|mesh-list
6456514|NCT00432549|Almotriptan|almotriptan|mesh-list
6456515|NCT00432549|Anticonvulsants|anticonvulsants|mesh-ancestor
6030071|NCT00457366|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6030072|NCT00457366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6030073|NCT00457392|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6030074|NCT00457392|Sunitinib|sunitinib|mesh-list
6030075|NCT00457392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6030076|NCT00457392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6030077|NCT00457392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6030078|NCT00457392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030079|NCT00457392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6030080|NCT00457392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6030081|NCT00457392|Growth Substances|growth substances|mesh-ancestor
6030082|NCT00457392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030083|NCT00457392|Growth Inhibitors|growth inhibitors|mesh-ancestor
6030084|NCT00457418|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6030085|NCT00457418|Antiviral Agents|antiviral agents|mesh-ancestor
6030086|NCT00457418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6030087|NCT00457626|Valsartan|valsartan|mesh-list
6030088|NCT00457626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6030089|NCT00457626|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6030090|NCT00457626|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6030091|NCT00457626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030092|NCT00457639|Cholic Acids|cholic acids|mesh-list
6030093|NCT00457639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6030094|NCT00457665|Efavirenz|efavirenz|mesh-list
6030095|NCT00457665|Nelfinavir|nelfinavir|mesh-list
6030096|NCT00457665|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6030097|NCT00457665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6030098|NCT00457665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6030099|NCT00457665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030100|NCT00457665|Antiviral Agents|antiviral agents|mesh-ancestor
6030101|NCT00457665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6030102|NCT00457665|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6030103|NCT00457665|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6030104|NCT00457665|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6030105|NCT00457665|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6030106|NCT00457665|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6030107|NCT00457665|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6030108|NCT00457665|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6030109|NCT00457665|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6030110|NCT00457665|Protease Inhibitors|protease inhibitors|mesh-ancestor
6030111|NCT00457665|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6030112|NCT00457665|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6030113|NCT00457691|Leucovorin|leucovorin|mesh-list
6030114|NCT00457691|Fluorouracil|fluorouracil|mesh-list
6030115|NCT00457691|Irinotecan|irinotecan|mesh-list
6030116|NCT00457691|Sunitinib|sunitinib|mesh-list
6030117|NCT00457691|Levoleucovorin|levoleucovorin|mesh-list
6030118|NCT00457691|Antimetabolites|antimetabolites|mesh-ancestor
6030119|NCT00457691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030120|NCT00457691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6030121|NCT00457691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6030122|NCT00457691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6030123|NCT00457691|Immunologic Factors|immunologic factors|mesh-ancestor
6030124|NCT00457691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030125|NCT00457691|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6030126|NCT00457691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6030127|NCT00457691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6030128|NCT00457691|Antidotes|antidotes|mesh-ancestor
6030129|NCT00457691|Protective Agents|protective agents|mesh-ancestor
6030130|NCT00457691|Vitamin B Complex|vitamin b complex|mesh-ancestor
6030131|NCT00457691|Vitamins|vitamins|mesh-ancestor
6030132|NCT00457691|Micronutrients|micronutrients|mesh-ancestor
6030133|NCT00457691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6030134|NCT00457691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6030135|NCT00457691|Growth Substances|growth substances|mesh-ancestor
6030136|NCT00457691|Growth Inhibitors|growth inhibitors|mesh-ancestor
6030137|NCT00457691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6030138|NCT00457730|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6030139|NCT00457730|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6030140|NCT00457730|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6030141|NCT00457730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6030142|NCT00457730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030143|NCT00457730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6053548|NCT00596167|Gentamicins|gentamicins|mesh-list
6030144|NCT00457730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030145|NCT00457730|Analgesics|analgesics|mesh-ancestor
6030146|NCT00457730|Sensory System Agents|sensory system agents|mesh-ancestor
6030147|NCT00457730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6030148|NCT00457730|Antidepressive Agents|antidepressive agents|mesh-ancestor
5493318|NCT00476554|Sapacitabine|sapacitabine|mesh-list
5493319|NCT00476554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5493320|NCT00462943|Homoharringtonine|homoharringtonine|mesh-list
5493321|NCT00462943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5493322|NCT00462943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5493323|NCT00462943|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5493324|NCT00462943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6030149|NCT00457730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6030150|NCT00457730|Dopamine Agents|dopamine agents|mesh-ancestor
6030151|NCT00457743|Sunitinib|sunitinib|mesh-list
5493325|NCT00462943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493326|NCT00454753|Dasatinib|dasatinib|mesh-list
5493327|NCT00454753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6030152|NCT00457743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6030153|NCT00457743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6030154|NCT00457743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6030155|NCT00457743|Growth Substances|growth substances|mesh-ancestor
6030156|NCT00457743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030157|NCT00457743|Growth Inhibitors|growth inhibitors|mesh-ancestor
6030158|NCT00457743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6030159|NCT00457743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5493328|NCT00454753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5493329|NCT00454753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5493330|NCT00454753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493331|NCT00372073|Roscovitine|roscovitine|mesh-list
5493332|NCT00372073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5493333|NCT00372073|Antiviral Agents|antiviral agents|mesh-ancestor
6030160|NCT00457743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030161|NCT00457795|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6030162|NCT00457795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6030163|NCT00457795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6030164|NCT00457795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6030165|NCT00457795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6030166|NCT00457795|Adrenergic Agents|adrenergic agents|mesh-ancestor
6030167|NCT00457795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6030168|NCT00457795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030169|NCT00457795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030170|NCT00457821|Ivacaftor|ivacaftor|mesh-list
6030171|NCT00457821|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6030172|NCT00457821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6030173|NCT00457821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030174|NCT00457977|Vaccines|vaccines|mesh-list
6030175|NCT00457977|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6030176|NCT00457977|Immunologic Factors|immunologic factors|mesh-ancestor
6030177|NCT00457977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030178|NCT00458211|Ziprasidone|ziprasidone|mesh-list
6030179|NCT00458211|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6030180|NCT00458211|Serotonin Agents|serotonin agents|mesh-ancestor
6030181|NCT00458211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6030182|NCT00458211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030183|NCT00458211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030184|NCT00458211|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6030185|NCT00458211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6030186|NCT00458211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6030187|NCT00458211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6030188|NCT00458211|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6030189|NCT00458211|Dopamine Agents|dopamine agents|mesh-ancestor
6030190|NCT00458237|Trastuzumab|trastuzumab|mesh-list
6030191|NCT00458237|Everolimus|everolimus|mesh-list
6030192|NCT00458237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6030193|NCT00458237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6030194|NCT00458237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6030195|NCT00458237|Immunologic Factors|immunologic factors|mesh-ancestor
6030196|NCT00458237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030197|NCT00458302|Darunavir|darunavir|mesh-list
6030198|NCT00458302|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6030199|NCT00458302|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6030200|NCT00458302|Protease Inhibitors|protease inhibitors|mesh-ancestor
6030201|NCT00458302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6030202|NCT00458302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030203|NCT00458302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6030204|NCT00458302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6030205|NCT00458302|Antiviral Agents|antiviral agents|mesh-ancestor
6030206|NCT00458302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6030207|NCT00458393|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6030208|NCT00458393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6030209|NCT00458393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6030210|NCT00458393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6030211|NCT00458393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493334|NCT00372073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5493335|NCT00372073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5493336|NCT00372073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5493337|NCT00372073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493338|NCT00364637|Anesthetics|anesthetics|mesh-list
5493339|NCT00364637|Sevoflurane|sevoflurane|mesh-list
5493340|NCT00364637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5493341|NCT00364637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493342|NCT00364637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5493343|NCT00364637|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5493344|NCT00364637|Anesthetics, General|anesthetics, general|mesh-ancestor
5493345|NCT00280761|Fluorouracil|fluorouracil|mesh-list
5493346|NCT00280761|Capecitabine|capecitabine|mesh-list
5493347|NCT00280761|Antimetabolites|antimetabolites|mesh-ancestor
5493348|NCT00280761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493349|NCT00280761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5493350|NCT00280761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5493351|NCT00280761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5493352|NCT00280761|Immunologic Factors|immunologic factors|mesh-ancestor
6030212|NCT00458393|Antiviral Agents|antiviral agents|mesh-ancestor
6030213|NCT00458393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6030214|NCT00458393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6030215|NCT00458393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6030216|NCT00458705|Thalidomide|thalidomide|mesh-list
6030217|NCT00458705|Dexamethasone|dexamethasone|mesh-list
6030218|NCT00458705|Doxorubicin|doxorubicin|mesh-list
6030219|NCT00458705|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6030220|NCT00458705|Bortezomib|bortezomib|mesh-list
6030221|NCT00458705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6030222|NCT00458705|Antiemetics|antiemetics|mesh-ancestor
6030223|NCT00458705|Autonomic Agents|autonomic agents|mesh-ancestor
6030224|NCT00458705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6030225|NCT00458705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030226|NCT00458705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6030227|NCT00458705|Glucocorticoids|glucocorticoids|mesh-ancestor
6030228|NCT00458705|Hormones|hormones|mesh-ancestor
6030229|NCT00458705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6030230|NCT00458705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6030231|NCT00458705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6030232|NCT00458705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6030233|NCT00458705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6030234|NCT00458705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6030235|NCT00458705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6030236|NCT00458705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030237|NCT00458705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6030238|NCT00458705|Immunologic Factors|immunologic factors|mesh-ancestor
6030239|NCT00458705|Leprostatic Agents|leprostatic agents|mesh-ancestor
6030240|NCT00458705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6030241|NCT00458705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6456516|NCT00432549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5493353|NCT00280761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030242|NCT00458705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6030243|NCT00458705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6030244|NCT00458705|Growth Substances|growth substances|mesh-ancestor
6030245|NCT00458705|Growth Inhibitors|growth inhibitors|mesh-ancestor
6030246|NCT00458822|Dexamethasone|dexamethasone|mesh-list
6030247|NCT00458822|Bortezomib|bortezomib|mesh-list
6030248|NCT00458822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6030249|NCT00458822|Antiemetics|antiemetics|mesh-ancestor
6030250|NCT00458822|Autonomic Agents|autonomic agents|mesh-ancestor
6030251|NCT00458822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6030252|NCT00458822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030253|NCT00458822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6030254|NCT00458822|Glucocorticoids|glucocorticoids|mesh-ancestor
6030255|NCT00458822|Hormones|hormones|mesh-ancestor
6030256|NCT00458822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6030257|NCT00458822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6030258|NCT00458822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6030259|NCT00458848|Prednisone|prednisone|mesh-list
6030260|NCT00458848|Methylprednisolone|methylprednisolone|mesh-list
6030261|NCT00458848|Methotrexate|methotrexate|mesh-list
6030262|NCT00458848|Etoposide|etoposide|mesh-list
6030263|NCT00458848|Vincristine|vincristine|mesh-list
6030264|NCT00458848|Imatinib Mesylate|imatinib mesylate|mesh-list
6030265|NCT00458848|Daunorubicin|daunorubicin|mesh-list
6030266|NCT00458848|Asparaginase|asparaginase|mesh-list
6030267|NCT00458848|Mercaptopurine|mercaptopurine|mesh-list
6030268|NCT00458848|Mitoxantrone|mitoxantrone|mesh-list
6030269|NCT00458848|Idarubicin|idarubicin|mesh-list
6030270|NCT00458848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6030271|NCT00458848|Glucocorticoids|glucocorticoids|mesh-ancestor
6030272|NCT00458848|Hormones|hormones|mesh-ancestor
6030273|NCT00458848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6030274|NCT00458848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030275|NCT00458848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6030276|NCT00458848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6030277|NCT00458848|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6030278|NCT00458848|Abortifacient Agents|abortifacient agents|mesh-ancestor
6030279|NCT00458848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6030280|NCT00458848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6030281|NCT00458848|Antimetabolites|antimetabolites|mesh-ancestor
6030282|NCT00458848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030283|NCT00458848|Dermatologic Agents|dermatologic agents|mesh-ancestor
6030284|NCT00458848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6030285|NCT00458848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6030286|NCT00458848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6030287|NCT00458848|Immunologic Factors|immunologic factors|mesh-ancestor
6030288|NCT00458848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6030289|NCT00458848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6030290|NCT00458848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6030291|NCT00458848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6030292|NCT00458848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6030293|NCT00458848|Tubulin Modulators|tubulin modulators|mesh-ancestor
6030294|NCT00458848|Antimitotic Agents|antimitotic agents|mesh-ancestor
6030295|NCT00458848|Mitosis Modulators|mitosis modulators|mesh-ancestor
6030296|NCT00458848|Antiemetics|antiemetics|mesh-ancestor
6030297|NCT00458848|Autonomic Agents|autonomic agents|mesh-ancestor
6030298|NCT00458848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6030299|NCT00458848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6030300|NCT00458848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6030301|NCT00458848|Protective Agents|protective agents|mesh-ancestor
6030302|NCT00458848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6030303|NCT00458848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6030304|NCT00458848|Analgesics|analgesics|mesh-ancestor
6030305|NCT00458848|Sensory System Agents|sensory system agents|mesh-ancestor
5493354|NCT00248287|Carboplatin|carboplatin|mesh-list
5493355|NCT00248287|Irinotecan|irinotecan|mesh-list
5493356|NCT00248287|Cetuximab|cetuximab|mesh-list
5493357|NCT00248287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5493358|NCT00248287|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5493359|NCT00248287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5493360|NCT00248287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5493361|NCT00248287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493362|NCT00248287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5493363|NCT00225095|Hyaluronic Acid|hyaluronic acid|mesh-list
5493364|NCT00225095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6030306|NCT00458952|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
6030307|NCT00458952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6030308|NCT00458952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6030309|NCT00458952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030310|NCT00458952|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6030311|NCT00459043|Docetaxel|docetaxel|mesh-list
6030312|NCT00459043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6030313|NCT00459043|Tubulin Modulators|tubulin modulators|mesh-ancestor
6030314|NCT00459043|Antimitotic Agents|antimitotic agents|mesh-ancestor
6030315|NCT00459043|Mitosis Modulators|mitosis modulators|mesh-ancestor
6030316|NCT00459043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030317|NCT00459056|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6030318|NCT00459056|Carvedilol|carvedilol|mesh-list
6030319|NCT00459056|Lisinopril|lisinopril|mesh-list
6030320|NCT00459056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6030321|NCT00459056|Diuretics|diuretics|mesh-ancestor
6030322|NCT00459056|Natriuretic Agents|natriuretic agents|mesh-ancestor
6030323|NCT00459056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030324|NCT00459056|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6030325|NCT00459056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6030326|NCT00459056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030327|NCT00459056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6030328|NCT00459056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6030329|NCT00459056|Adrenergic Agents|adrenergic agents|mesh-ancestor
5493365|NCT00225095|Immunologic Factors|immunologic factors|mesh-ancestor
6030330|NCT00459056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6030331|NCT00459056|Antioxidants|antioxidants|mesh-ancestor
6030332|NCT00459056|Protective Agents|protective agents|mesh-ancestor
6030333|NCT00459056|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6030334|NCT00459056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6030335|NCT00459056|Vasodilator Agents|vasodilator agents|mesh-ancestor
6030336|NCT00459056|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6030337|NCT00459056|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6030338|NCT00459056|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6030339|NCT00459056|Protease Inhibitors|protease inhibitors|mesh-ancestor
6030340|NCT00459056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6030341|NCT00459056|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6030342|NCT00459108|Dasatinib|dasatinib|mesh-list
6030343|NCT00459108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6030344|NCT00459108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6654727|NCT01458626|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6654728|NCT01458626|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6654729|NCT01458626|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6030345|NCT00459108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6030346|NCT00459108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030347|NCT00459186|Prednisone|prednisone|mesh-list
5493366|NCT00225095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493367|NCT00225095|Viscosupplements|viscosupplements|mesh-ancestor
5493368|NCT00225095|Protective Agents|protective agents|mesh-ancestor
5493369|NCT00038727|Metformin|metformin|mesh-list
5493370|NCT00038727|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5493371|NCT00038727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493372|NCT05174351|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
5493373|NCT05174351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6030348|NCT00459186|Docetaxel|docetaxel|mesh-list
6030349|NCT00459186|Everolimus|everolimus|mesh-list
6030350|NCT00459186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6030351|NCT00459186|Tubulin Modulators|tubulin modulators|mesh-ancestor
6030352|NCT00459186|Antimitotic Agents|antimitotic agents|mesh-ancestor
6030353|NCT00459186|Mitosis Modulators|mitosis modulators|mesh-ancestor
6030354|NCT00459186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030355|NCT00459186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6456517|NCT00432549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456518|NCT00432549|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6456519|NCT00432549|Serotonin Agents|serotonin agents|mesh-ancestor
6456520|NCT00432549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6456521|NCT00432549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456522|NCT00432575|Surinabant|surinabant|mesh-list
6456523|NCT00432575|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
6030356|NCT00459186|Glucocorticoids|glucocorticoids|mesh-ancestor
6030357|NCT00459186|Hormones|hormones|mesh-ancestor
6030358|NCT00459186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6030359|NCT00459186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030360|NCT00459186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6030361|NCT00459186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6030362|NCT00459186|Immunologic Factors|immunologic factors|mesh-ancestor
6030363|NCT00459290|Mifepristone|mifepristone|mesh-list
6030364|NCT00459290|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5493374|NCT05174351|Adrenergic Agents|adrenergic agents|mesh-ancestor
5493375|NCT05174351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5493376|NCT05174351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493377|NCT05174351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493378|NCT05174312|Diuretics|diuretics|mesh-list
5493379|NCT05174312|Natriuretic Agents|natriuretic agents|mesh-ancestor
5493380|NCT05174312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493381|NCT05174195|Desogestrel|desogestrel|mesh-list
5493382|NCT05174195|Etonogestrel|etonogestrel|mesh-list
5493383|NCT05174195|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5493384|NCT05174195|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5493385|NCT05174195|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5493386|NCT05174195|Contraceptive Agents|contraceptive agents|mesh-ancestor
5493387|NCT05174195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5493388|NCT05174195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493389|NCT05174195|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5493390|NCT05174195|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5493391|NCT05174195|Progestins|progestins|mesh-ancestor
5493392|NCT05174195|Hormones|hormones|mesh-ancestor
5493393|NCT05174195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6030365|NCT00459290|Abortifacient Agents|abortifacient agents|mesh-ancestor
6030366|NCT00459290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5493394|NCT05174156|Paclitaxel|paclitaxel|mesh-list
5493395|NCT05174156|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6030367|NCT00459290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030368|NCT00459290|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6030369|NCT00459290|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6030370|NCT00459290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6030371|NCT00459290|Contraceptive Agents|contraceptive agents|mesh-ancestor
6030372|NCT00459290|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6030373|NCT00459290|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5493396|NCT05174156|Cisplatin|cisplatin|mesh-list
5493397|NCT05174156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5493398|NCT05174156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5493399|NCT05174156|Tubulin Modulators|tubulin modulators|mesh-ancestor
6030374|NCT00459290|Hormone Antagonists|hormone antagonists|mesh-ancestor
6030375|NCT00459290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6030376|NCT00459290|Luteolytic Agents|luteolytic agents|mesh-ancestor
6030377|NCT00459290|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6030378|NCT00459290|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6030379|NCT00459342|Dasatinib|dasatinib|mesh-list
6030380|NCT00459342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6030381|NCT00459342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6030382|NCT00459342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6030383|NCT00459342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030384|NCT00459537|Terbinafine|terbinafine|mesh-list
6030385|NCT00459537|Amorolfine|amorolfine|mesh-list
5493400|NCT05174156|Antimitotic Agents|antimitotic agents|mesh-ancestor
5493401|NCT05174156|Mitosis Modulators|mitosis modulators|mesh-ancestor
5493402|NCT05174156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503082|NCT04462276|Atezolizumab|atezolizumab|mesh-list
5503083|NCT04462276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5503084|NCT04462328|Durvalumab|durvalumab|mesh-list
5503085|NCT04462328|Acalabrutinib|acalabrutinib|mesh-list
5503086|NCT04462328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5503087|NCT04462328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5503088|NCT04462523|Prednisolone|prednisolone|mesh-list
5503089|NCT04462523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5503090|NCT04462523|Glucocorticoids|glucocorticoids|mesh-ancestor
5503091|NCT04462523|Hormones|hormones|mesh-ancestor
5503092|NCT04462523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5503093|NCT04462523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503094|NCT04462523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5503095|NCT04462523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5503096|NCT04462094|Ketamine|ketamine|mesh-list
5503097|NCT04462094|Anesthetics|anesthetics|mesh-ancestor
5503098|NCT04462094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5503099|NCT04462094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503100|NCT04462094|Analgesics|analgesics|mesh-ancestor
5503101|NCT04462094|Sensory System Agents|sensory system agents|mesh-ancestor
5503102|NCT04462094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5503103|NCT04462094|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5503104|NCT04462094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5503105|NCT04462094|Anesthetics, General|anesthetics, general|mesh-ancestor
5503106|NCT04462094|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5503107|NCT04462094|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5503108|NCT04462094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5503109|NCT04462094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503110|NCT04462003|Enoxaparin|enoxaparin|mesh-list
5503111|NCT04462003|Apixaban|apixaban|mesh-list
5503112|NCT04462003|Anticoagulants|anticoagulants|mesh-ancestor
5503113|NCT04462003|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5503114|NCT04462003|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5503115|NCT04462003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030386|NCT00459537|Antifungal Agents|antifungal agents|mesh-ancestor
6030387|NCT00459537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6030388|NCT00459537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6030389|NCT00459537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030390|NCT00459667|Interferons|interferons|mesh-list
6030391|NCT00459667|Interferon-beta|interferon-beta|mesh-list
6030392|NCT00459667|Interferon beta-1b|interferon beta-1b|mesh-list
6030393|NCT00459667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6030394|NCT00459667|Antiviral Agents|antiviral agents|mesh-ancestor
6030395|NCT00459667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5503116|NCT04462003|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5503117|NCT04462003|Antithrombins|antithrombins|mesh-ancestor
5503118|NCT04462003|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5503119|NCT04462003|Protease Inhibitors|protease inhibitors|mesh-ancestor
6030396|NCT00459667|Immunologic Factors|immunologic factors|mesh-ancestor
6030397|NCT00459667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030398|NCT00459667|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6030399|NCT00459706|Etanercept|etanercept|mesh-list
6030400|NCT00459706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6030401|NCT00459706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6030402|NCT00459706|Analgesics|analgesics|mesh-ancestor
6030403|NCT00459706|Sensory System Agents|sensory system agents|mesh-ancestor
6030404|NCT00459706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6030405|NCT00459706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030406|NCT00459706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6030407|NCT00459706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6030408|NCT00459706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6030409|NCT00459706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6030410|NCT00459706|Immunologic Factors|immunologic factors|mesh-ancestor
6030411|NCT00459732|Zinc|zinc|mesh-list
6030412|NCT00459732|Zinc Sulfate|zinc sulfate|mesh-list
6030413|NCT00459732|Trace Elements|trace elements|mesh-ancestor
6030414|NCT00459732|Micronutrients|micronutrients|mesh-ancestor
6030415|NCT00459732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030416|NCT00459732|Astringents|astringents|mesh-ancestor
6030417|NCT00459732|Dermatologic Agents|dermatologic agents|mesh-ancestor
6030418|NCT00459810|Paclitaxel|paclitaxel|mesh-list
6030419|NCT00459810|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
6030420|NCT00459810|Estradiol|estradiol|mesh-list
6030421|NCT00459810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6030422|NCT00459810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6030423|NCT00459810|Tubulin Modulators|tubulin modulators|mesh-ancestor
6030424|NCT00459810|Antimitotic Agents|antimitotic agents|mesh-ancestor
5493403|NCT05174065|Apremilast|apremilast|mesh-list
5493404|NCT05174065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5493405|NCT05174065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5493406|NCT05174065|Analgesics|analgesics|mesh-ancestor
5493407|NCT05174065|Sensory System Agents|sensory system agents|mesh-ancestor
5493408|NCT05174065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5493409|NCT05174065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493410|NCT05174065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5493411|NCT05174065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5493412|NCT05174065|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5493413|NCT05174065|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6030425|NCT00459810|Mitosis Modulators|mitosis modulators|mesh-ancestor
6030426|NCT00459810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030427|NCT00459810|Estrogens|estrogens|mesh-ancestor
6030428|NCT00459810|Hormones|hormones|mesh-ancestor
6030429|NCT00459810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6030430|NCT00459810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030431|NCT00459875|Sunitinib|sunitinib|mesh-list
6030432|NCT00459875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6030433|NCT00459875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6030434|NCT00459875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6030435|NCT00459875|Growth Substances|growth substances|mesh-ancestor
6030436|NCT00459875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030437|NCT00459875|Growth Inhibitors|growth inhibitors|mesh-ancestor
6030438|NCT00459875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6030439|NCT00459875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6030440|NCT00459875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030441|NCT00459953|Nicotine|nicotine|mesh-list
6030442|NCT00459953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6030443|NCT00459953|Autonomic Agents|autonomic agents|mesh-ancestor
6030444|NCT00459953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6030445|NCT00459953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030446|NCT00459953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6030447|NCT00459953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6030448|NCT00459953|Cholinergic Agents|cholinergic agents|mesh-ancestor
6030449|NCT00459953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6030450|NCT00459953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456524|NCT00432575|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6456525|NCT00432575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6456526|NCT00432575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456527|NCT00432575|Hormones|hormones|mesh-ancestor
6456528|NCT00432575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6456529|NCT00432575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456530|NCT00432588|Misoprostol|misoprostol|mesh-list
6456531|NCT00432588|Dinoprostone|dinoprostone|mesh-list
6456532|NCT00432588|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6030451|NCT00459979|Sunitinib|sunitinib|mesh-list
6030452|NCT00459979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6030453|NCT00459979|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6030454|NCT00459979|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6030455|NCT00459979|Growth Substances|growth substances|mesh-ancestor
6030456|NCT00459979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030457|NCT00459979|Growth Inhibitors|growth inhibitors|mesh-ancestor
6030458|NCT00459979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6030459|NCT00459979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6030460|NCT00459979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030461|NCT00460031|Ketoconazole|ketoconazole|mesh-list
6030462|NCT00460031|Hydrocortisone|hydrocortisone|mesh-list
6030463|NCT00460031|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6030464|NCT00460031|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6030465|NCT00460031|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
5493414|NCT05174065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5493415|NCT05174065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493416|NCT05174052|Dapagliflozin|dapagliflozin|mesh-list
5493417|NCT05174052|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5493418|NCT05174052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493419|NCT05174052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5493420|NCT05174052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493421|NCT05174026|Deoxyglucose|deoxyglucose|mesh-list
5493422|NCT05174026|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5493423|NCT05174026|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5493424|NCT05174026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493425|NCT05174026|Antimetabolites|antimetabolites|mesh-ancestor
5493426|NCT05174026|Antiviral Agents|antiviral agents|mesh-ancestor
5493427|NCT05174026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5493428|NCT05173896|Tadalafil|tadalafil|mesh-list
5493429|NCT05173896|Vasodilator Agents|vasodilator agents|mesh-ancestor
5493430|NCT05173896|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6030466|NCT00460031|Lenalidomide|lenalidomide|mesh-list
6030467|NCT00460031|Immunologic Factors|immunologic factors|mesh-ancestor
6030468|NCT00460031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030469|NCT00460031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6030470|NCT00460031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6030471|NCT00460031|Growth Substances|growth substances|mesh-ancestor
6030472|NCT00460031|Growth Inhibitors|growth inhibitors|mesh-ancestor
6030473|NCT00460031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6030474|NCT00460031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6030475|NCT00460031|Antifungal Agents|antifungal agents|mesh-ancestor
6030476|NCT00460031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6030477|NCT00460031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6030478|NCT00460031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5493431|NCT05173896|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5493432|NCT05173896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5493433|NCT05173896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493434|NCT05173896|Urological Agents|urological agents|mesh-ancestor
5493435|NCT05173831|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
5493436|NCT05173831|Hallucinogens|hallucinogens|mesh-ancestor
5493437|NCT05173831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493438|NCT05173831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5493439|NCT05173831|Serotonin Agents|serotonin agents|mesh-ancestor
5493440|NCT05173831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6030479|NCT00460031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6030480|NCT00460031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030481|NCT00460031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6030482|NCT00460031|Hormone Antagonists|hormone antagonists|mesh-ancestor
6030483|NCT00460031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6030484|NCT00460031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6030485|NCT00460109|Rituximab|rituximab|mesh-list
5503120|NCT04462003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5493441|NCT05173831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493442|NCT05173831|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5493443|NCT05173831|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5493444|NCT05173831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5493445|NCT05173831|Adrenergic Agents|adrenergic agents|mesh-ancestor
5493446|NCT05173688|Propofol|propofol|mesh-list
5493447|NCT05173688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5493448|NCT05173688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5493449|NCT05173688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493450|NCT05173688|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5493451|NCT05173688|Anesthetics, General|anesthetics, general|mesh-ancestor
5493452|NCT05173688|Anesthetics|anesthetics|mesh-ancestor
5493453|NCT05173584|Albuterol|albuterol|mesh-list
5493454|NCT05173584|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5493455|NCT05173584|Autonomic Agents|autonomic agents|mesh-ancestor
5493456|NCT05173584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5493457|NCT05173584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493458|NCT05173584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5493459|NCT05173584|Respiratory System Agents|respiratory system agents|mesh-ancestor
5493460|NCT05173584|Tocolytic Agents|tocolytic agents|mesh-ancestor
5493461|NCT05173584|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5493462|NCT05173584|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5493463|NCT05173584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5493464|NCT05173584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5493465|NCT05173584|Adrenergic Agents|adrenergic agents|mesh-ancestor
5493466|NCT05173584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5493467|NCT05173584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493468|NCT05173545|Mitoxantrone|mitoxantrone|mesh-list
5493469|NCT05173545|Analgesics|analgesics|mesh-ancestor
5493470|NCT05173545|Sensory System Agents|sensory system agents|mesh-ancestor
6030486|NCT00460109|Denileukin diftitox|denileukin diftitox|mesh-list
6030487|NCT00460109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6030488|NCT00460109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6030489|NCT00460109|Immunologic Factors|immunologic factors|mesh-ancestor
6030490|NCT00460109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030491|NCT00460109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6030492|NCT00460239|Morphine|morphine|mesh-list
6030493|NCT00460239|Buprenorphine|buprenorphine|mesh-list
6030494|NCT00460239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6030495|NCT00460239|Narcotics|narcotics|mesh-ancestor
6030496|NCT00460239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6030497|NCT00460239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030498|NCT00460239|Analgesics|analgesics|mesh-ancestor
6030499|NCT00460239|Sensory System Agents|sensory system agents|mesh-ancestor
6030500|NCT00460239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6030501|NCT00460239|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6030502|NCT00460551|Zalutumumab|zalutumumab|mesh-list
6030503|NCT00460551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6030504|NCT00460551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6030505|NCT00460577|Bromides|bromides|mesh-list
6030506|NCT00460577|Fenoterol|fenoterol|mesh-list
6030507|NCT00460577|Formoterol Fumarate|formoterol fumarate|mesh-list
6030508|NCT00460577|Ipratropium|ipratropium|mesh-list
6030509|NCT00460577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6030510|NCT00460577|Autonomic Agents|autonomic agents|mesh-ancestor
6030511|NCT00460577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6030512|NCT00460577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030513|NCT00460577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6030514|NCT00460577|Respiratory System Agents|respiratory system agents|mesh-ancestor
5493471|NCT05173545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5493472|NCT05173545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493473|NCT05173545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5493474|NCT05173545|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5493475|NCT05173545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5493476|NCT05173545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5493477|NCT05173545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493478|NCT05173493|Amoxicillin|amoxicillin|mesh-list
5493479|NCT05173493|Levofloxacin|levofloxacin|mesh-list
5493480|NCT05173493|Ofloxacin|ofloxacin|mesh-list
5493481|NCT05173493|Tetracycline|tetracycline|mesh-list
5493482|NCT05173493|Furazolidone|furazolidone|mesh-list
5503121|NCT04461587|Pirfenidone|pirfenidone|mesh-list
6030515|NCT00460577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6030516|NCT00460577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6030517|NCT00460577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6030518|NCT00460577|Adrenergic Agents|adrenergic agents|mesh-ancestor
6030519|NCT00460577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6030520|NCT00460577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030521|NCT00460577|Anticonvulsants|anticonvulsants|mesh-ancestor
6030522|NCT00460577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6030523|NCT00460577|Cholinergic Agents|cholinergic agents|mesh-ancestor
6030524|NCT00460577|Sympathomimetics|sympathomimetics|mesh-ancestor
6030525|NCT00460577|Tocolytic Agents|tocolytic agents|mesh-ancestor
6030526|NCT00460577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6030527|NCT00460603|Bevacizumab|bevacizumab|mesh-list
6030528|NCT00460603|Axitinib|axitinib|mesh-list
6030529|NCT00460603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6030530|NCT00460603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6030531|NCT00460603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6030532|NCT00460603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6030533|NCT00460603|Growth Substances|growth substances|mesh-ancestor
6030534|NCT00460603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030535|NCT00460603|Growth Inhibitors|growth inhibitors|mesh-ancestor
6030536|NCT00460603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6030537|NCT00460603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6030538|NCT00460603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030539|NCT00460746|Ritonavir|ritonavir|mesh-list
6030540|NCT00460746|Darunavir|darunavir|mesh-list
6030541|NCT00460746|Etravirine|etravirine|mesh-list
6030542|NCT00460746|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6030543|NCT00460746|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6030544|NCT00460746|Protease Inhibitors|protease inhibitors|mesh-ancestor
6030545|NCT00460746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6030546|NCT00460746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030547|NCT00460746|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6030548|NCT00460746|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6030549|NCT00460746|Antiviral Agents|antiviral agents|mesh-ancestor
6030550|NCT00460746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6030551|NCT00460746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6030552|NCT00460746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6456533|NCT00432588|Abortifacient Agents|abortifacient agents|mesh-ancestor
6456534|NCT00432588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6456535|NCT00432588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456536|NCT00432588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6456537|NCT00432588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6030553|NCT00460746|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6030554|NCT00460746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6030555|NCT00460798|Sunitinib|sunitinib|mesh-list
6030556|NCT00460798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6030557|NCT00460798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6030558|NCT00460798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6030559|NCT00460798|Growth Substances|growth substances|mesh-ancestor
6030560|NCT00460798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030561|NCT00460798|Growth Inhibitors|growth inhibitors|mesh-ancestor
6030562|NCT00460798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6030563|NCT00460798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6030564|NCT00460798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030565|NCT00460811|Linaclotide|linaclotide|mesh-list
6030566|NCT00460811|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
6030567|NCT00460811|Enzyme Activators|enzyme activators|mesh-ancestor
6030568|NCT00460811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030569|NCT00460811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6030570|NCT00460993|Eszopiclone|eszopiclone|mesh-list
6030571|NCT00460993|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5493483|NCT05173493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5493484|NCT05173493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5493485|NCT05173493|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5493486|NCT05173493|Renal Agents|renal agents|mesh-ancestor
5493487|NCT05173493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5493488|NCT05173493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5493489|NCT05173493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5493490|NCT05173493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493491|NCT05173493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5493492|NCT05173493|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5493493|NCT05173493|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5493494|NCT05173493|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5493495|NCT05173493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6030572|NCT00460993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6030573|NCT00460993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493496|NCT05173493|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
5493497|NCT05173493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5493498|NCT05173493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5493499|NCT05173493|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
5493500|NCT05173337|Nefopam|nefopam|mesh-list
5493501|NCT05173337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5493502|NCT05173337|Analgesics|analgesics|mesh-ancestor
5493503|NCT05173337|Sensory System Agents|sensory system agents|mesh-ancestor
5493504|NCT05173337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5493505|NCT05173337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493506|NCT05173246|Paclitaxel|paclitaxel|mesh-list
5493507|NCT05173246|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5493508|NCT05173246|Cisplatin|cisplatin|mesh-list
5493509|NCT05173246|Carboplatin|carboplatin|mesh-list
5493510|NCT05173246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5493511|NCT05173246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6030574|NCT00461123|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6030575|NCT00461123|Vasodilator Agents|vasodilator agents|mesh-ancestor
6030576|NCT00461123|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6030577|NCT00461123|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6030578|NCT00461123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6030579|NCT00461123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030580|NCT00461123|Urological Agents|urological agents|mesh-ancestor
6030581|NCT00461253|Copper|copper|mesh-list
6030582|NCT00461253|Levonorgestrel|levonorgestrel|mesh-list
6030583|NCT00461253|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6030584|NCT00461253|Contraceptive Agents|contraceptive agents|mesh-ancestor
6030585|NCT00461253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6030586|NCT00461253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030587|NCT00461253|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6030588|NCT00461253|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6030589|NCT00461253|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6030590|NCT00461253|Trace Elements|trace elements|mesh-ancestor
6030591|NCT00461253|Micronutrients|micronutrients|mesh-ancestor
6030592|NCT00461292|Botulinum Toxins|botulinum toxins|mesh-list
6030593|NCT00461292|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6030594|NCT00461292|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5493512|NCT05173246|Tubulin Modulators|tubulin modulators|mesh-ancestor
5493513|NCT05173246|Antimitotic Agents|antimitotic agents|mesh-ancestor
5493514|NCT05173246|Mitosis Modulators|mitosis modulators|mesh-ancestor
6030595|NCT00461292|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6030596|NCT00461292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6030597|NCT00461292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493515|NCT05173246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493516|NCT05173090|Ropivacaine|ropivacaine|mesh-list
5493517|NCT05173090|Anesthetics, Local|anesthetics, local|mesh-ancestor
5493518|NCT05173090|Anesthetics|anesthetics|mesh-ancestor
5493519|NCT05173090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5493520|NCT05173090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493521|NCT05173090|Sensory System Agents|sensory system agents|mesh-ancestor
5493522|NCT05173090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5493523|NCT05172934|Tenecteplase|tenecteplase|mesh-list
5493524|NCT05172934|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5493525|NCT05172934|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5493526|NCT05172934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030598|NCT00461292|Cholinergic Agents|cholinergic agents|mesh-ancestor
6030599|NCT00461292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6030600|NCT00461292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030601|NCT00461292|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6030602|NCT00461292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6030603|NCT00461305|Drospirenone|drospirenone|mesh-list
6030604|NCT00461305|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6030605|NCT00461305|Hormone Antagonists|hormone antagonists|mesh-ancestor
6030606|NCT00461305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6030607|NCT00461305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030608|NCT00461305|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6030609|NCT00461305|Diuretics|diuretics|mesh-ancestor
6030610|NCT00461305|Natriuretic Agents|natriuretic agents|mesh-ancestor
6030611|NCT00461331|Insulin|insulin|mesh-list
5493527|NCT05172817|Adalimumab|adalimumab|mesh-list
5493528|NCT05172817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5493529|NCT05172817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5493530|NCT05172791|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5493531|NCT05172791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5493532|NCT05172739|Analgesics, Opioid|analgesics, opioid|mesh-list
6030612|NCT00461331|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6030613|NCT00461331|Insulin Aspart|insulin aspart|mesh-list
6030614|NCT00461331|Insulin, Long-Acting|insulin, long-acting|mesh-list
6030615|NCT00461331|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6030616|NCT00461331|Insulin Lispro|insulin lispro|mesh-list
6030617|NCT00461331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6030618|NCT00461331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030619|NCT00461500|Fluticasone|fluticasone|mesh-list
6030620|NCT00461500|Xhance|xhance|mesh-list
6030621|NCT00461500|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6030622|NCT00461500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6030623|NCT00461500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6030624|NCT00461500|Autonomic Agents|autonomic agents|mesh-ancestor
6030625|NCT00461500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6030626|NCT00461500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030627|NCT00461500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6030628|NCT00461500|Respiratory System Agents|respiratory system agents|mesh-ancestor
6030629|NCT00461500|Dermatologic Agents|dermatologic agents|mesh-ancestor
6030630|NCT00461500|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6030631|NCT00461500|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6030632|NCT00461500|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6030633|NCT00461500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6030634|NCT00461500|Adrenergic Agents|adrenergic agents|mesh-ancestor
6030635|NCT00461500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6030636|NCT00461500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030637|NCT00461591|Apaziquone|apaziquone|mesh-list
6030638|NCT00461591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6030639|NCT00461630|Niacin|niacin|mesh-list
6030640|NCT00461630|Simvastatin|simvastatin|mesh-list
6030641|NCT00461630|Ezetimibe|ezetimibe|mesh-list
6030642|NCT00461630|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
6030643|NCT00461630|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6030644|NCT00461630|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6030645|NCT00461630|Antimetabolites|antimetabolites|mesh-ancestor
6030646|NCT00461630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030647|NCT00461630|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6030648|NCT00461630|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5493533|NCT05172739|Anesthetics|anesthetics|mesh-list
5493534|NCT05172739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6030649|NCT00461630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6030650|NCT00461630|Vasodilator Agents|vasodilator agents|mesh-ancestor
6030651|NCT00461630|Vitamin B Complex|vitamin b complex|mesh-ancestor
6030652|NCT00461630|Vitamins|vitamins|mesh-ancestor
6030653|NCT00461630|Micronutrients|micronutrients|mesh-ancestor
6030654|NCT00461630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030655|NCT00461708|Gemcitabine|gemcitabine|mesh-list
6030656|NCT00461708|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6030657|NCT00461708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6030658|NCT00461708|Antimetabolites|antimetabolites|mesh-ancestor
6030659|NCT00461708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030660|NCT00461708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6030661|NCT00461708|Antiviral Agents|antiviral agents|mesh-ancestor
6030662|NCT00461708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6030663|NCT00461708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6030664|NCT00461708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6030665|NCT00461708|Immunologic Factors|immunologic factors|mesh-ancestor
6030666|NCT00461708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030667|NCT00461708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6030668|NCT00461773|Bevacizumab|bevacizumab|mesh-list
6030669|NCT00461773|Letrozole|letrozole|mesh-list
6030670|NCT00461773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6030671|NCT00461773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5493535|NCT05172739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493536|NCT05172739|Narcotics|narcotics|mesh-ancestor
5493537|NCT05172739|Analgesics|analgesics|mesh-ancestor
5493538|NCT05172739|Sensory System Agents|sensory system agents|mesh-ancestor
5493539|NCT05172739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5493540|NCT05172570|Gabapentin|gabapentin|mesh-list
5493541|NCT05172570|Analgesics|analgesics|mesh-ancestor
5493542|NCT05172570|Sensory System Agents|sensory system agents|mesh-ancestor
5493543|NCT05172570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5493544|NCT05172570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493545|NCT05172570|Anticonvulsants|anticonvulsants|mesh-ancestor
5493546|NCT05172570|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5493547|NCT05172570|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5493548|NCT05172570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5493549|NCT05172570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6030672|NCT00461773|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6030673|NCT00461773|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6030674|NCT00461773|Growth Substances|growth substances|mesh-ancestor
6030675|NCT00461773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030676|NCT00461773|Growth Inhibitors|growth inhibitors|mesh-ancestor
6030677|NCT00461773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6030678|NCT00461773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6456538|NCT00432588|Oxytocics|oxytocics|mesh-ancestor
6456539|NCT00432614|Citalopram|citalopram|mesh-list
6456540|NCT00432614|Amibegron|amibegron|mesh-list
6456541|NCT00432614|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6456542|NCT00432614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6456543|NCT00432614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6456544|NCT00432614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456545|NCT00432614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6030679|NCT00461773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6030680|NCT00461773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030681|NCT00461773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6030682|NCT00461773|Hormone Antagonists|hormone antagonists|mesh-ancestor
6030683|NCT00461773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6030684|NCT00461786|Pemetrexed|pemetrexed|mesh-list
6030685|NCT00461786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6030686|NCT00461786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6030687|NCT00461786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030688|NCT00461786|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6030689|NCT00461786|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6030690|NCT00461851|Gemcitabine|gemcitabine|mesh-list
6030691|NCT00461851|Carboplatin|carboplatin|mesh-list
6030692|NCT00461851|Sorafenib|sorafenib|mesh-list
6030693|NCT00461851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6030694|NCT00461851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6030695|NCT00461851|Antimetabolites|antimetabolites|mesh-ancestor
6030696|NCT00461851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030697|NCT00461851|Antiviral Agents|antiviral agents|mesh-ancestor
6030698|NCT00461851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5493550|NCT05172570|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5493551|NCT05172570|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5493552|NCT05172570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5493553|NCT05172570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030699|NCT00461851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6030700|NCT00461851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6030701|NCT00461851|Immunologic Factors|immunologic factors|mesh-ancestor
6030702|NCT00461851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030703|NCT00461851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6030704|NCT00461981|Vaccines|vaccines|mesh-list
6030705|NCT00461981|Immunologic Factors|immunologic factors|mesh-ancestor
6030706|NCT00461981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030707|NCT00462020|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5493554|NCT05172570|Antimanic Agents|antimanic agents|mesh-ancestor
5493555|NCT05172531|Cisatracurium|cisatracurium|mesh-list
5493556|NCT05172531|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5493557|NCT05172531|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5493558|NCT05172531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5493559|NCT05172531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493560|NCT05172518|Capecitabine|capecitabine|mesh-list
5493561|NCT05172518|Taxane|taxane|mesh-list
5493562|NCT05172518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5493563|NCT05172518|Antimetabolites|antimetabolites|mesh-ancestor
5493564|NCT05172518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030708|NCT00462020|Metronidazole|metronidazole|mesh-list
6030709|NCT00462020|Ceftriaxone|ceftriaxone|mesh-list
6030710|NCT00462020|Ampicillin|ampicillin|mesh-list
6030711|NCT00462020|Clavulanic Acids|clavulanic acids|mesh-list
6030712|NCT00462020|Clavulanic Acid|clavulanic acid|mesh-list
6030713|NCT00462020|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6030714|NCT00462020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6030715|NCT00462020|Antitubercular Agents|antitubercular agents|mesh-ancestor
6030716|NCT00462020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6030717|NCT00462020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6030718|NCT00462020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6030719|NCT00462020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030720|NCT00462020|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6030721|NCT00462072|Infliximab|infliximab|mesh-list
6030722|NCT00462072|Dermatologic Agents|dermatologic agents|mesh-ancestor
6030723|NCT00462072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6030724|NCT00462072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6030725|NCT00462228|Memantine|memantine|mesh-list
6030726|NCT00462228|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6030727|NCT00462228|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6030728|NCT00462228|Dopamine Agents|dopamine agents|mesh-ancestor
6030729|NCT00462228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6456546|NCT00432614|Serotonin Agents|serotonin agents|mesh-ancestor
6456547|NCT00432614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456548|NCT00432614|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5493565|NCT05172518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5493566|NCT05172440|Axitinib|axitinib|mesh-list
5493567|NCT05172440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5493568|NCT05172440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5493569|NCT05172440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5493570|NCT05172440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493571|NCT05172401|Triamcinolone|triamcinolone|mesh-list
5493572|NCT05172401|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5493573|NCT05172401|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5493574|NCT05172401|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5493575|NCT05172401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5493576|NCT05172401|Glucocorticoids|glucocorticoids|mesh-ancestor
5493577|NCT05172401|Hormones|hormones|mesh-ancestor
5493578|NCT05172401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5493579|NCT05172401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493580|NCT05172401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5493581|NCT05172401|Immunologic Factors|immunologic factors|mesh-ancestor
5493582|NCT05172401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5493583|NCT05172401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493584|NCT05172310|FAPI-46|fapi-46|mesh-list
5493585|NCT05172310|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5493586|NCT05172310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503122|NCT04461587|Analgesics|analgesics|mesh-ancestor
5503123|NCT04461587|Sensory System Agents|sensory system agents|mesh-ancestor
5503124|NCT04461587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5503125|NCT04461587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503126|NCT04461587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5503127|NCT04461587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6456549|NCT00432614|Antidepressive Agents|antidepressive agents|mesh-ancestor
6456550|NCT00432614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6456551|NCT00432614|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6456552|NCT00432614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6456553|NCT00432614|Adrenergic Agents|adrenergic agents|mesh-ancestor
6456554|NCT00432627|Deferasirox|deferasirox|mesh-list
6456555|NCT00432627|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6456556|NCT00432627|Chelating Agents|chelating agents|mesh-ancestor
6456557|NCT00432627|Sequestering Agents|sequestering agents|mesh-ancestor
6030730|NCT00462228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030731|NCT00462228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030732|NCT00462228|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6030733|NCT00462228|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6030734|NCT00462280|Lovastatin|lovastatin|mesh-list
6030735|NCT00462280|L 647318|l 647318|mesh-list
6030736|NCT00462280|Dihydromevinolin|dihydromevinolin|mesh-list
6030737|NCT00462280|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6030738|NCT00462280|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6030739|NCT00462280|Antimetabolites|antimetabolites|mesh-ancestor
6456558|NCT00432627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503128|NCT04461587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5503129|NCT04461587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6030740|NCT00462280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030741|NCT00462280|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6030742|NCT00462280|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6030743|NCT00462280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6030744|NCT00462332|Vidarabine|vidarabine|mesh-list
6030745|NCT00462332|Fludarabine|fludarabine|mesh-list
6030746|NCT00462332|Fludarabine phosphate|fludarabine phosphate|mesh-list
6030747|NCT00462332|Alemtuzumab|alemtuzumab|mesh-list
6030748|NCT00462332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6030749|NCT00462332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6030750|NCT00462332|Antimetabolites|antimetabolites|mesh-ancestor
6030751|NCT00462332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030752|NCT00462332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6030753|NCT00462332|Immunologic Factors|immunologic factors|mesh-ancestor
6030754|NCT00462332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030755|NCT00462332|Antiviral Agents|antiviral agents|mesh-ancestor
6456559|NCT00432653|Rituximab|rituximab|mesh-list
6456560|NCT00432653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6456561|NCT00432653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6456562|NCT00432653|Immunologic Factors|immunologic factors|mesh-ancestor
6456563|NCT00432653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456564|NCT00432653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6456565|NCT00432757|Ketotifen|ketotifen|mesh-list
6456566|NCT00432757|Antipruritics|antipruritics|mesh-ancestor
6456567|NCT00432757|Dermatologic Agents|dermatologic agents|mesh-ancestor
6456568|NCT00432757|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6456569|NCT00432757|Histamine Antagonists|histamine antagonists|mesh-ancestor
6030756|NCT00462332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6030757|NCT00462332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6030758|NCT00462345|Rituximab|rituximab|mesh-list
6030759|NCT00462345|Methotrexate|methotrexate|mesh-list
6030760|NCT00462345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6030761|NCT00462345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6030762|NCT00462345|Immunologic Factors|immunologic factors|mesh-ancestor
6030763|NCT00462345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030764|NCT00462345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6030765|NCT00462345|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6030766|NCT00462345|Abortifacient Agents|abortifacient agents|mesh-ancestor
6030767|NCT00462345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6030768|NCT00462345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6030769|NCT00462345|Antimetabolites|antimetabolites|mesh-ancestor
6030770|NCT00462345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030771|NCT00462345|Dermatologic Agents|dermatologic agents|mesh-ancestor
6030772|NCT00462345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6030773|NCT00462345|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6030774|NCT00462345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6030775|NCT00462345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6030776|NCT00462384|Epoetin Alfa|epoetin alfa|mesh-list
6030777|NCT00462384|Hematinics|hematinics|mesh-ancestor
6030778|NCT00462423|Bevacizumab|bevacizumab|mesh-list
6030779|NCT00462423|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6030780|NCT00462423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6030781|NCT00462423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6030782|NCT00462423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6030783|NCT00462423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6030784|NCT00462423|Growth Substances|growth substances|mesh-ancestor
6030785|NCT00462423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030786|NCT00462423|Growth Inhibitors|growth inhibitors|mesh-ancestor
6030787|NCT00462462|Ethanol|ethanol|mesh-list
6030788|NCT00462462|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6030789|NCT00462462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6030790|NCT00462462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6030791|NCT00462462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053549|NCT00596167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6053550|NCT00596167|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6053551|NCT00596167|Renal Agents|renal agents|mesh-ancestor
6053552|NCT00596167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6053553|NCT00596167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5493587|NCT05172167|Antibodies|antibodies|mesh-list
5493588|NCT05172167|Immunologic Factors|immunologic factors|mesh-ancestor
5493589|NCT05172167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493590|NCT05172115|Heparin|heparin|mesh-list
6053554|NCT00596167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6053555|NCT00596167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456570|NCT00432757|Histamine Agents|histamine agents|mesh-ancestor
6456571|NCT00432757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5493591|NCT05172115|Enoxaparin|enoxaparin|mesh-list
6030792|NCT00462501|Leucovorin|leucovorin|mesh-list
6030793|NCT00462501|Bevacizumab|bevacizumab|mesh-list
6030794|NCT00462501|Fluorouracil|fluorouracil|mesh-list
6030795|NCT00462501|Oxaliplatin|oxaliplatin|mesh-list
6030796|NCT00462501|Calcium|calcium|mesh-list
6030797|NCT00462501|Levoleucovorin|levoleucovorin|mesh-list
6030798|NCT00462501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6030799|NCT00462501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6030800|NCT00462501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6030801|NCT00462501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6030802|NCT00462501|Growth Substances|growth substances|mesh-ancestor
6030803|NCT00462501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030804|NCT00462501|Growth Inhibitors|growth inhibitors|mesh-ancestor
6030805|NCT00462501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6030806|NCT00462501|Antimetabolites|antimetabolites|mesh-ancestor
6030807|NCT00462501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030808|NCT00462501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6030809|NCT00462501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6030810|NCT00462501|Immunologic Factors|immunologic factors|mesh-ancestor
6030811|NCT00462501|Antidotes|antidotes|mesh-ancestor
6030812|NCT00462501|Protective Agents|protective agents|mesh-ancestor
6030813|NCT00462501|Vitamin B Complex|vitamin b complex|mesh-ancestor
6030814|NCT00462501|Vitamins|vitamins|mesh-ancestor
6030815|NCT00462501|Micronutrients|micronutrients|mesh-ancestor
6030816|NCT00462605|Entinostat|entinostat|mesh-list
6030817|NCT00462605|Sargramostim|sargramostim|mesh-list
6030818|NCT00462605|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
6030819|NCT00462605|Immunologic Factors|immunologic factors|mesh-ancestor
6030820|NCT00462605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493592|NCT05172115|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5493593|NCT05172115|Tinzaparin|tinzaparin|mesh-list
6030821|NCT00462605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6456572|NCT00432757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456573|NCT00432757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456574|NCT00432757|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6456575|NCT00432796|Dalteparin|dalteparin|mesh-list
6030822|NCT00462605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6030823|NCT00462605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030824|NCT00462644|Fentanyl|fentanyl|mesh-list
6030825|NCT00462644|Midazolam|midazolam|mesh-list
6030826|NCT00462644|Etomidate|etomidate|mesh-list
6030827|NCT00462644|Succinylcholine|succinylcholine|mesh-list
6030828|NCT00462644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6030829|NCT00462644|Narcotics|narcotics|mesh-ancestor
6030830|NCT00462644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6030831|NCT00462644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030832|NCT00462644|Analgesics|analgesics|mesh-ancestor
6030833|NCT00462644|Sensory System Agents|sensory system agents|mesh-ancestor
6030834|NCT00462644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6030835|NCT00462644|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6030836|NCT00462644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6030837|NCT00462644|Anesthetics, General|anesthetics, general|mesh-ancestor
6030838|NCT00462644|Anesthetics|anesthetics|mesh-ancestor
6030839|NCT00462644|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6030840|NCT00462644|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6030841|NCT00462644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6030842|NCT00462644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6030843|NCT00462644|GABA Modulators|gaba modulators|mesh-ancestor
6030844|NCT00462644|GABA Agents|gaba agents|mesh-ancestor
6030845|NCT00462644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6030846|NCT00462644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030847|NCT00462644|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
6030848|NCT00462644|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6030849|NCT00462644|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6030850|NCT00462670|Tolvaptan|tolvaptan|mesh-list
6030851|NCT00462670|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6030852|NCT00462670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030853|NCT00462670|Natriuretic Agents|natriuretic agents|mesh-ancestor
6030854|NCT00462670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030855|NCT00462709|Complement C1s|complement c1s|mesh-list
6030856|NCT00462709|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
6030857|NCT00462709|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
6030858|NCT00462709|Immunologic Factors|immunologic factors|mesh-ancestor
6030859|NCT00462709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456576|NCT00432796|Tinzaparin|tinzaparin|mesh-list
6030860|NCT00462709|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6030861|NCT00462709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6030862|NCT00462722|Ibuprofen|ibuprofen|mesh-list
6030863|NCT00462722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6030864|NCT00462722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6030865|NCT00462722|Analgesics|analgesics|mesh-ancestor
6030866|NCT00462722|Sensory System Agents|sensory system agents|mesh-ancestor
6030867|NCT00462722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6030868|NCT00462722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030869|NCT00462722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6030870|NCT00462722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6030871|NCT00462722|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6030872|NCT00462722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6030873|NCT00462722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030874|NCT00462735|Fluorouracil|fluorouracil|mesh-list
6030875|NCT00462735|Cetuximab|cetuximab|mesh-list
6030876|NCT00462735|Hydroxyurea|hydroxyurea|mesh-list
6030877|NCT00462735|Antimetabolites|antimetabolites|mesh-ancestor
6030878|NCT00462735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493594|NCT05172115|Dalteparin|dalteparin|mesh-list
5493595|NCT05172115|Plasminogen|plasminogen|mesh-list
5493596|NCT05172115|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5493597|NCT05172115|Anticoagulants|anticoagulants|mesh-ancestor
5493598|NCT05172115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5493599|NCT05172115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5493600|NCT05172115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493601|NCT05171985|Dexmedetomidine|dexmedetomidine|mesh-list
5493602|NCT05171985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5493603|NCT05171985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5493604|NCT05171985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030879|NCT00462735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6030880|NCT00462735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6030881|NCT00462735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6030882|NCT00462735|Immunologic Factors|immunologic factors|mesh-ancestor
6030883|NCT00462735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030884|NCT00462735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6030885|NCT00462735|Antisickling Agents|antisickling agents|mesh-ancestor
6030886|NCT00462735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6030887|NCT00462735|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6030888|NCT00462826|Aflibercept|aflibercept|mesh-list
6030889|NCT00462826|Endothelial Growth Factors|endothelial growth factors|mesh-list
6030890|NCT00462826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6030891|NCT00462826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6030892|NCT00462826|Growth Substances|growth substances|mesh-ancestor
6030893|NCT00462826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030894|NCT00462826|Growth Inhibitors|growth inhibitors|mesh-ancestor
6030895|NCT00462826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6030896|NCT00462865|Gemcitabine|gemcitabine|mesh-list
6030897|NCT00462865|Bevacizumab|bevacizumab|mesh-list
6030898|NCT00462865|Capecitabine|capecitabine|mesh-list
6030899|NCT00462865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6030900|NCT00462865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6030901|NCT00462865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6030902|NCT00462865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6030903|NCT00462865|Growth Substances|growth substances|mesh-ancestor
6030904|NCT00462865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030905|NCT00462865|Growth Inhibitors|growth inhibitors|mesh-ancestor
6030906|NCT00462865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6030907|NCT00462865|Antimetabolites|antimetabolites|mesh-ancestor
6030908|NCT00462865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030909|NCT00462865|Antiviral Agents|antiviral agents|mesh-ancestor
6030910|NCT00462865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6030911|NCT00462865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6030912|NCT00462865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6030913|NCT00462865|Immunologic Factors|immunologic factors|mesh-ancestor
6030914|NCT00462982|Sunitinib|sunitinib|mesh-list
6030915|NCT00462982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6030916|NCT00462982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6030917|NCT00462982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6030918|NCT00462982|Growth Substances|growth substances|mesh-ancestor
6030919|NCT00462982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030920|NCT00462982|Growth Inhibitors|growth inhibitors|mesh-ancestor
6030921|NCT00462982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6030922|NCT00462982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6030923|NCT00462982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030924|NCT00463047|Fentanyl|fentanyl|mesh-list
6030925|NCT00463047|Oxycodone|oxycodone|mesh-list
6030926|NCT00463047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6030927|NCT00463047|Narcotics|narcotics|mesh-ancestor
6030928|NCT00463047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6030929|NCT00463047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493605|NCT05171985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5493606|NCT05171985|Analgesics|analgesics|mesh-ancestor
5493607|NCT05171985|Sensory System Agents|sensory system agents|mesh-ancestor
5493608|NCT05171985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5493609|NCT05171985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5493610|NCT05171985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5493611|NCT05171985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5493612|NCT05171985|Adrenergic Agents|adrenergic agents|mesh-ancestor
5493613|NCT05171985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5493614|NCT05171985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493615|NCT05171946|Vaccines|vaccines|mesh-list
6030930|NCT00463047|Analgesics|analgesics|mesh-ancestor
6030931|NCT00463047|Sensory System Agents|sensory system agents|mesh-ancestor
6030932|NCT00463047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6030933|NCT00463047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6030934|NCT00463047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6030935|NCT00463047|Anesthetics, General|anesthetics, general|mesh-ancestor
6456577|NCT00432796|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6456578|NCT00432796|Anticoagulants|anticoagulants|mesh-ancestor
6456579|NCT00432796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6456580|NCT00432796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5493616|NCT05171946|Immunologic Factors|immunologic factors|mesh-ancestor
5493617|NCT05171946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493618|NCT05171751|Octreotide|octreotide|mesh-list
5493619|NCT05171751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5493620|NCT05171751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5493621|NCT05171751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5493622|NCT05171660|Capecitabine|capecitabine|mesh-list
6456581|NCT00432796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456582|NCT00432861|Pancrelipase|pancrelipase|mesh-list
6456583|NCT00432861|Pancreatin|pancreatin|mesh-list
5493623|NCT05171660|Oxaliplatin|oxaliplatin|mesh-list
5493624|NCT05171660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5493625|NCT05171660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5493626|NCT05171660|Antimetabolites|antimetabolites|mesh-ancestor
5493627|NCT05171660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493628|NCT05171530|Lenvatinib|lenvatinib|mesh-list
5493629|NCT05171530|Taxane|taxane|mesh-list
5493630|NCT05171530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6030936|NCT00463047|Anesthetics|anesthetics|mesh-ancestor
6030937|NCT00463060|Sunitinib|sunitinib|mesh-list
6030938|NCT00463060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6030939|NCT00463060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6030940|NCT00463060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6030941|NCT00463060|Growth Substances|growth substances|mesh-ancestor
6030942|NCT00463060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030943|NCT00463060|Growth Inhibitors|growth inhibitors|mesh-ancestor
6030944|NCT00463060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6030945|NCT00463060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6030946|NCT00463060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030947|NCT00463151|Rebamipide|rebamipide|mesh-list
6030948|NCT00463151|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6030949|NCT00463151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6030950|NCT00463151|Antioxidants|antioxidants|mesh-ancestor
6030951|NCT00463151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030952|NCT00463151|Protective Agents|protective agents|mesh-ancestor
5493631|NCT05171530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5493632|NCT05171530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5493633|NCT05171530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493634|NCT05164653|Valsartan|valsartan|mesh-list
5493635|NCT05164653|Angiotensin II|angiotensin ii|mesh-list
5493636|NCT05164653|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5493637|NCT05164653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
5493638|NCT05164653|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
5493639|NCT05164653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5493640|NCT05164653|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5493641|NCT05164653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493642|NCT05164653|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5493643|NCT05164653|Protease Inhibitors|protease inhibitors|mesh-ancestor
5493644|NCT05164653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5493645|NCT05155293|Aflibercept|aflibercept|mesh-list
5493646|NCT05155293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5493647|NCT05155293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5493648|NCT05155293|Growth Substances|growth substances|mesh-ancestor
5493649|NCT05155293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493650|NCT05155293|Growth Inhibitors|growth inhibitors|mesh-ancestor
5493651|NCT05155293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5493652|NCT05151848|Adalimumab|adalimumab|mesh-list
5493653|NCT05151848|Tofacitinib|tofacitinib|mesh-list
5493654|NCT05151848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5493655|NCT05151848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5493656|NCT05151848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5493657|NCT05151848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5493658|NCT05151848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030953|NCT00463151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030954|NCT00463151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6030955|NCT00463346|Acamprosate|acamprosate|mesh-list
6030956|NCT00463346|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6030957|NCT00463385|Thalidomide|thalidomide|mesh-list
6030958|NCT00463385|Prednisone|prednisone|mesh-list
6030959|NCT00463385|Pomalidomide|pomalidomide|mesh-list
6030960|NCT00463385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6030961|NCT00463385|Glucocorticoids|glucocorticoids|mesh-ancestor
6030962|NCT00463385|Hormones|hormones|mesh-ancestor
6030963|NCT00463385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6030964|NCT00463385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030965|NCT00463385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6030966|NCT00463385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6030967|NCT00463385|Immunologic Factors|immunologic factors|mesh-ancestor
6030968|NCT00463385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6030969|NCT00463385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6030970|NCT00463385|Growth Substances|growth substances|mesh-ancestor
6030971|NCT00463385|Growth Inhibitors|growth inhibitors|mesh-ancestor
6030972|NCT00463385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6030973|NCT00463385|Leprostatic Agents|leprostatic agents|mesh-ancestor
6030974|NCT00463385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6030975|NCT00463385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6456584|NCT00432861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6456585|NCT00432887|Caffeine|caffeine|mesh-list
6456586|NCT00432887|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6456587|NCT00432887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456588|NCT00432887|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6456589|NCT00432887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5493659|NCT05151588|Docetaxel|docetaxel|mesh-list
6030976|NCT00463437|Vaccines|vaccines|mesh-list
6030977|NCT00463437|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6030978|NCT00463437|Immunologic Factors|immunologic factors|mesh-ancestor
6030979|NCT00463437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030980|NCT00463567|Formoterol Fumarate|formoterol fumarate|mesh-list
5493660|NCT05151588|Fluorouracil|fluorouracil|mesh-list
6030981|NCT00463567|Tiotropium Bromide|tiotropium bromide|mesh-list
6030982|NCT00463567|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6030983|NCT00463567|Autonomic Agents|autonomic agents|mesh-ancestor
6030984|NCT00463567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6030985|NCT00463567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6030986|NCT00463567|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6030987|NCT00463567|Respiratory System Agents|respiratory system agents|mesh-ancestor
6030988|NCT00463567|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6030989|NCT00463567|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6030990|NCT00463567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6654730|NCT01458626|Adrenergic Agents|adrenergic agents|mesh-ancestor
6030991|NCT00463567|Adrenergic Agents|adrenergic agents|mesh-ancestor
6030992|NCT00463567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6030993|NCT00463567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030994|NCT00463567|Parasympatholytics|parasympatholytics|mesh-ancestor
6030995|NCT00463567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6030996|NCT00463567|Cholinergic Agents|cholinergic agents|mesh-ancestor
6030997|NCT00463580|Infliximab|infliximab|mesh-list
5493661|NCT05151588|Cisplatin|cisplatin|mesh-list
5493662|NCT05151588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5493663|NCT05151588|Tubulin Modulators|tubulin modulators|mesh-ancestor
5493664|NCT05151588|Antimitotic Agents|antimitotic agents|mesh-ancestor
5493665|NCT05151588|Mitosis Modulators|mitosis modulators|mesh-ancestor
5493666|NCT05151588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6030998|NCT00463580|Dermatologic Agents|dermatologic agents|mesh-ancestor
6030999|NCT00463580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6031000|NCT00463580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6031001|NCT00463606|Calcium, Dietary|calcium, dietary|mesh-list
6031002|NCT00463606|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6031003|NCT00463606|Fenofibric acid|fenofibric acid|mesh-list
6031004|NCT00463606|Calcium|calcium|mesh-list
6031005|NCT00463606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6031006|NCT00463606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031007|NCT00463606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6031008|NCT00463606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6031009|NCT00463606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6031010|NCT00463606|Antimetabolites|antimetabolites|mesh-ancestor
6031011|NCT00463606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031012|NCT00463606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6031013|NCT00463606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6031014|NCT00463606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6031015|NCT00463684|Vaccines|vaccines|mesh-list
6031016|NCT00463684|Immunologic Factors|immunologic factors|mesh-ancestor
6031017|NCT00463684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031018|NCT00463788|Cisplatin|cisplatin|mesh-list
6031019|NCT00463788|Cetuximab|cetuximab|mesh-list
6031020|NCT00463788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6031021|NCT00463788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6031022|NCT00463801|Daptomycin|daptomycin|mesh-list
6031023|NCT00463801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6031024|NCT00463801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6031025|NCT00463840|Fluorouracil|fluorouracil|mesh-list
6031026|NCT00463840|Oxaliplatin|oxaliplatin|mesh-list
6456590|NCT00432887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493667|NCT05151588|Antimetabolites|antimetabolites|mesh-ancestor
5493668|NCT05151588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5493669|NCT05151588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5493670|NCT05151588|Immunologic Factors|immunologic factors|mesh-ancestor
5493671|NCT05151588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493672|NCT05145348|Vaccines|vaccines|mesh-list
6031027|NCT00463840|Antimetabolites|antimetabolites|mesh-ancestor
6456591|NCT00432887|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6456592|NCT00432887|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6456593|NCT00432887|Purinergic Agents|purinergic agents|mesh-ancestor
6456594|NCT00432887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6456595|NCT00432978|Bosentan|bosentan|mesh-list
6456596|NCT00432978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6456597|NCT00432978|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6456598|NCT00432978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456599|NCT00433043|Metoprolol|metoprolol|mesh-list
6031028|NCT00463840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031029|NCT00463840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6031030|NCT00463840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6031031|NCT00463840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6031032|NCT00463840|Immunologic Factors|immunologic factors|mesh-ancestor
6031033|NCT00463840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031034|NCT00463866|Budesonide|budesonide|mesh-list
6031035|NCT00463866|Formoterol Fumarate|formoterol fumarate|mesh-list
6031036|NCT00463866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6031037|NCT00463866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6031038|NCT00463866|Autonomic Agents|autonomic agents|mesh-ancestor
6031039|NCT00463866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6031040|NCT00463866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031041|NCT00463866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6031042|NCT00463866|Respiratory System Agents|respiratory system agents|mesh-ancestor
6031043|NCT00463866|Glucocorticoids|glucocorticoids|mesh-ancestor
6031044|NCT00463866|Hormones|hormones|mesh-ancestor
5493673|NCT05145348|Immunologic Factors|immunologic factors|mesh-ancestor
5493674|NCT05145348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493675|NCT05142969|Chlorhexidine|chlorhexidine|mesh-list
5493676|NCT05142969|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5493677|NCT05142969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5493678|NCT05142969|Disinfectants|disinfectants|mesh-ancestor
5493679|NCT05142267|Oxycodone|oxycodone|mesh-list
5493680|NCT05142267|Naloxone|naloxone|mesh-list
5493681|NCT05142267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5493682|NCT05142267|Narcotics|narcotics|mesh-ancestor
5493683|NCT05142267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5493684|NCT05142267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493685|NCT05142267|Analgesics|analgesics|mesh-ancestor
5493686|NCT05142267|Sensory System Agents|sensory system agents|mesh-ancestor
5493687|NCT05142267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5493688|NCT05142267|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5493689|NCT05137938|Ketamine|ketamine|mesh-list
5493690|NCT05137938|Analgesics|analgesics|mesh-ancestor
5493691|NCT05137938|Sensory System Agents|sensory system agents|mesh-ancestor
5493692|NCT05137938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5493693|NCT05137938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493694|NCT05137938|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5493695|NCT05137938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5493696|NCT05137938|Anesthetics, General|anesthetics, general|mesh-ancestor
5493697|NCT05137938|Anesthetics|anesthetics|mesh-ancestor
5493698|NCT05137938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5493699|NCT05137938|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5493700|NCT05137938|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5493701|NCT05137938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5493702|NCT05137938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493703|NCT05133804|Methylphenidate|methylphenidate|mesh-list
5493704|NCT05133804|Reboxetine|reboxetine|mesh-list
5493705|NCT05133804|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5493706|NCT05133804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031045|NCT00463866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6031046|NCT00463866|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6031047|NCT00463866|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6456600|NCT00433043|Carvedilol|carvedilol|mesh-list
6456601|NCT00433043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
6456602|NCT00433043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6456603|NCT00433043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6456604|NCT00433043|Sympatholytics|sympatholytics|mesh-ancestor
6456605|NCT00433043|Autonomic Agents|autonomic agents|mesh-ancestor
6031048|NCT00463866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6031049|NCT00463866|Adrenergic Agents|adrenergic agents|mesh-ancestor
6031050|NCT00463866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6031051|NCT00463866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031052|NCT00464087|Heparin|heparin|mesh-list
6031053|NCT00464087|Calcium heparin|calcium heparin|mesh-list
6031054|NCT00464087|PENTA|penta|mesh-list
6031055|NCT00464087|Bivalirudin|bivalirudin|mesh-list
6031056|NCT00464087|Fondaparinux|fondaparinux|mesh-list
6031057|NCT00464087|Anticoagulants|anticoagulants|mesh-ancestor
6031058|NCT00464087|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6031059|NCT00464087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6031060|NCT00464087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456606|NCT00433043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6456607|NCT00433043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456608|NCT00433043|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6456609|NCT00433043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6456610|NCT00433043|Adrenergic Agents|adrenergic agents|mesh-ancestor
6456611|NCT00433043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6456612|NCT00433043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031061|NCT00464087|Antithrombins|antithrombins|mesh-ancestor
6031062|NCT00464087|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6031063|NCT00464087|Protease Inhibitors|protease inhibitors|mesh-ancestor
6031064|NCT00464087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6031065|NCT00464087|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6031066|NCT00464204|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
6031067|NCT00464204|Plasma Substitutes|plasma substitutes|mesh-ancestor
6031068|NCT00464204|Blood Substitutes|blood substitutes|mesh-ancestor
6031069|NCT00464269|Brivaracetam|brivaracetam|mesh-list
6031070|NCT00464269|Anticonvulsants|anticonvulsants|mesh-ancestor
6031071|NCT00464308|Esomeprazole|esomeprazole|mesh-list
6031072|NCT00464308|Rabeprazole|rabeprazole|mesh-list
6031073|NCT00464308|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5493707|NCT05133804|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5493708|NCT05133804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5493709|NCT05133804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5493710|NCT05133804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493711|NCT05133804|Dopamine Agents|dopamine agents|mesh-ancestor
5493712|NCT05133804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6031074|NCT00464308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6031075|NCT00464308|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6031076|NCT00464308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6031077|NCT00464308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031078|NCT00464438|Moxifloxacin|moxifloxacin|mesh-list
6031079|NCT00464438|Gatifloxacin|gatifloxacin|mesh-list
6031080|NCT00464438|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6031081|NCT00464438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6031082|NCT00464438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6031083|NCT00464438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6031084|NCT00464438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6031085|NCT00464438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6031086|NCT00464438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031087|NCT00464438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6031088|NCT00464438|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6031089|NCT00464490|Dexmedetomidine|dexmedetomidine|mesh-list
6031090|NCT00464490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6031091|NCT00464490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6031092|NCT00464490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031093|NCT00464490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6031094|NCT00464490|Analgesics|analgesics|mesh-ancestor
6031095|NCT00464490|Sensory System Agents|sensory system agents|mesh-ancestor
6031096|NCT00464490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6031097|NCT00464490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6031098|NCT00464490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6031099|NCT00464490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6031100|NCT00464490|Adrenergic Agents|adrenergic agents|mesh-ancestor
5493713|NCT05133804|Antidepressive Agents|antidepressive agents|mesh-ancestor
5493714|NCT05133804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5493715|NCT05133804|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5493716|NCT05133804|Adrenergic Agents|adrenergic agents|mesh-ancestor
5493717|NCT05117307|Bupivacaine|bupivacaine|mesh-list
5493718|NCT05117307|Anesthetics, Local|anesthetics, local|mesh-ancestor
5493719|NCT05117307|Anesthetics|anesthetics|mesh-ancestor
5493720|NCT05117307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5493721|NCT05117307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493722|NCT05117307|Sensory System Agents|sensory system agents|mesh-ancestor
5493723|NCT05117307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5493724|NCT05105633|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5493725|NCT05105633|Tenecteplase|tenecteplase|mesh-list
5493726|NCT05105633|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5493727|NCT05105633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5493728|NCT05105633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503130|NCT04461587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5503131|NCT04461925|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5503132|NCT04461925|Azithromycin|azithromycin|mesh-list
5503133|NCT04461925|Ceftriaxone|ceftriaxone|mesh-list
5503134|NCT04461925|Dexamethasone|dexamethasone|mesh-list
5503135|NCT04461925|Enoxaparin|enoxaparin|mesh-list
5503136|NCT04461925|Anticoagulants|anticoagulants|mesh-list
5503137|NCT04461925|Hormones|hormones|mesh-list
5503138|NCT04461925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5503139|NCT04461925|Antiemetics|antiemetics|mesh-ancestor
5503140|NCT04461925|Autonomic Agents|autonomic agents|mesh-ancestor
5503141|NCT04461925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5503142|NCT04461925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503143|NCT04461925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5503144|NCT04461925|Glucocorticoids|glucocorticoids|mesh-ancestor
6031101|NCT00464490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6031102|NCT00464490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031103|NCT00464542|Metronidazole|metronidazole|mesh-list
6031104|NCT00464542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6031105|NCT00464542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6031106|NCT00464542|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6031107|NCT00464542|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6031108|NCT00464568|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
6031109|NCT00464568|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5503649|NCT04456985|Vitamin B 12|vitamin b 12|mesh-list
6031110|NCT00464568|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6031111|NCT00464568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6031112|NCT00464568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456613|NCT00433043|Antioxidants|antioxidants|mesh-ancestor
6456614|NCT00433043|Protective Agents|protective agents|mesh-ancestor
6456615|NCT00433043|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6456616|NCT00433043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6456617|NCT00433043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6456618|NCT00433043|Vasodilator Agents|vasodilator agents|mesh-ancestor
6456619|NCT00433043|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6456620|NCT00433043|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6031113|NCT00464620|Dasatinib|dasatinib|mesh-list
6031114|NCT00464620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6031115|NCT00464620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6031116|NCT00464620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6031117|NCT00464620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031118|NCT00464646|Cyclophosphamide|cyclophosphamide|mesh-list
6031119|NCT00464646|Bevacizumab|bevacizumab|mesh-list
6031120|NCT00464646|Docetaxel|docetaxel|mesh-list
6031121|NCT00464646|Trastuzumab|trastuzumab|mesh-list
6031122|NCT00464646|Epirubicin|epirubicin|mesh-list
6031123|NCT00464646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6031124|NCT00464646|Immunologic Factors|immunologic factors|mesh-ancestor
6031125|NCT00464646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031126|NCT00464646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6031127|NCT00464646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6031128|NCT00464646|Alkylating Agents|alkylating agents|mesh-ancestor
6031129|NCT00464646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031130|NCT00464646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6031131|NCT00464646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6031132|NCT00464646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6031133|NCT00464646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6031134|NCT00464646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6031135|NCT00464646|Growth Substances|growth substances|mesh-ancestor
6031136|NCT00464646|Growth Inhibitors|growth inhibitors|mesh-ancestor
6031137|NCT00464646|Tubulin Modulators|tubulin modulators|mesh-ancestor
6031138|NCT00464646|Antimitotic Agents|antimitotic agents|mesh-ancestor
6031139|NCT00464646|Mitosis Modulators|mitosis modulators|mesh-ancestor
6031140|NCT00464646|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5493729|NCT05085054|Osimertinib|osimertinib|mesh-list
5493730|NCT05085054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5503650|NCT04456985|Hydroxocobalamin|hydroxocobalamin|mesh-list
6031141|NCT00464646|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6031142|NCT00464646|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6031143|NCT00464646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6031144|NCT00464672|Vaccines|vaccines|mesh-list
6031145|NCT00464672|Immunologic Factors|immunologic factors|mesh-ancestor
6031146|NCT00464672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031147|NCT00464685|Dexamethasone|dexamethasone|mesh-list
6031148|NCT00464685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6031149|NCT00464685|Antiemetics|antiemetics|mesh-ancestor
6031150|NCT00464685|Autonomic Agents|autonomic agents|mesh-ancestor
6456621|NCT00433069|Pioglitazone|pioglitazone|mesh-list
6031151|NCT00464685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6031152|NCT00464685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031153|NCT00464685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6031154|NCT00464685|Glucocorticoids|glucocorticoids|mesh-ancestor
6031155|NCT00464685|Hormones|hormones|mesh-ancestor
6031156|NCT00464685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6031157|NCT00464685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6031158|NCT00464685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6031159|NCT00464698|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6031160|NCT00464698|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6031161|NCT00464698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6031162|NCT00464698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6031163|NCT00464698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031164|NCT00464698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6031165|NCT00464698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031166|NCT00464698|Analgesics|analgesics|mesh-ancestor
6031167|NCT00464698|Sensory System Agents|sensory system agents|mesh-ancestor
6031168|NCT00464698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6031169|NCT00464698|Antidepressive Agents|antidepressive agents|mesh-ancestor
6031170|NCT00464698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6031171|NCT00464698|Dopamine Agents|dopamine agents|mesh-ancestor
6031172|NCT00464711|Citalopram|citalopram|mesh-list
6031173|NCT00464711|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6031174|NCT00464711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6031175|NCT00464711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6031176|NCT00464711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031177|NCT00464711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6031178|NCT00464711|Serotonin Agents|serotonin agents|mesh-ancestor
6031179|NCT00464711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031180|NCT00464711|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6031181|NCT00464711|Antidepressive Agents|antidepressive agents|mesh-ancestor
6031182|NCT00464711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6031183|NCT00464737|Rotigotine|rotigotine|mesh-list
6031184|NCT00464737|Dopamine Agonists|dopamine agonists|mesh-ancestor
6031185|NCT00464737|Dopamine Agents|dopamine agents|mesh-ancestor
6031186|NCT00464737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6031187|NCT00464737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031188|NCT00464737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031189|NCT00464945|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6031190|NCT00464945|Immunologic Factors|immunologic factors|mesh-ancestor
6031191|NCT00464945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031192|NCT00465088|Niacin|niacin|mesh-list
6031193|NCT00465088|Niacinamide|niacinamide|mesh-list
6031194|NCT00465088|Nicotinic Acids|nicotinic acids|mesh-list
6031195|NCT00465088|Atorvastatin|atorvastatin|mesh-list
6031196|NCT00465088|Simvastatin|simvastatin|mesh-list
6031197|NCT00465088|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6031198|NCT00465088|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6031199|NCT00465088|Antimetabolites|antimetabolites|mesh-ancestor
6031200|NCT00465088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031201|NCT00465088|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6031202|NCT00465088|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6031203|NCT00465088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6031204|NCT00465088|Vasodilator Agents|vasodilator agents|mesh-ancestor
6031205|NCT00465088|Vitamin B Complex|vitamin b complex|mesh-ancestor
6031206|NCT00465088|Vitamins|vitamins|mesh-ancestor
6031207|NCT00465088|Micronutrients|micronutrients|mesh-ancestor
6031208|NCT00465088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031209|NCT00465179|Sunitinib|sunitinib|mesh-list
6031210|NCT00465179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6031211|NCT00465179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6031212|NCT00465179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6031213|NCT00465179|Growth Substances|growth substances|mesh-ancestor
6031214|NCT00465179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031215|NCT00465179|Growth Inhibitors|growth inhibitors|mesh-ancestor
6031216|NCT00465179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6031217|NCT00465179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6031218|NCT00465179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031219|NCT00465530|Gentamicins|gentamicins|mesh-list
6031220|NCT00465530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6031221|NCT00465530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6031222|NCT00465530|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6031223|NCT00465530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6031224|NCT00465530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031225|NCT00465595|Psilocybin|psilocybin|mesh-list
6031226|NCT00465595|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
6031227|NCT00465595|Hallucinogens|hallucinogens|mesh-ancestor
6031228|NCT00465595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031229|NCT00465595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6031230|NCT00465595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6031231|NCT00465595|Serotonin Agents|serotonin agents|mesh-ancestor
6031232|NCT00465595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6031233|NCT00465595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031234|NCT00465595|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6031235|NCT00465647|Hydromorphone|hydromorphone|mesh-list
6031236|NCT00465647|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6031237|NCT00465647|Narcotics|narcotics|mesh-ancestor
6031238|NCT00465647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5493731|NCT05085054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5493732|NCT05085054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5493733|NCT05085054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493734|NCT05077332|Celecoxib|celecoxib|mesh-list
5493735|NCT05077332|Famotidine|famotidine|mesh-list
5493736|NCT05077332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5493737|NCT05077332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5493738|NCT05077332|Analgesics|analgesics|mesh-ancestor
5493739|NCT05077332|Sensory System Agents|sensory system agents|mesh-ancestor
5493740|NCT05077332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5493741|NCT05077332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493742|NCT05077332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6031239|NCT00465647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031240|NCT00465647|Analgesics|analgesics|mesh-ancestor
6031241|NCT00465647|Sensory System Agents|sensory system agents|mesh-ancestor
6031242|NCT00465647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6031243|NCT00465738|Botulinum Toxins|botulinum toxins|mesh-list
6031244|NCT00465738|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6031245|NCT00465738|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6031246|NCT00465738|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
6031247|NCT00465738|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6031248|NCT00465738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5493743|NCT05077332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5493744|NCT05077332|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5493745|NCT05077332|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5493746|NCT05077332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5493747|NCT05077332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493748|NCT05077332|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5493749|NCT05077332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5493750|NCT05077332|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5493751|NCT05077332|Histamine Antagonists|histamine antagonists|mesh-ancestor
5493752|NCT05077332|Histamine Agents|histamine agents|mesh-ancestor
5493753|NCT05077332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5493754|NCT05054374|Fulvestrant|fulvestrant|mesh-list
5493755|NCT05054374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5493756|NCT05054374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6031249|NCT00465738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031250|NCT00465738|Cholinergic Agents|cholinergic agents|mesh-ancestor
6031251|NCT00465738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6031252|NCT00465738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031253|NCT00465738|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6031254|NCT00465738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6031255|NCT00465894|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6031256|NCT00465894|Estradiol|estradiol|mesh-list
6031257|NCT00465894|Estrogens|estrogens|mesh-ancestor
6031258|NCT00465894|Hormones|hormones|mesh-ancestor
6031259|NCT00465894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6031260|NCT00465894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031261|NCT00465894|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6031262|NCT00465894|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6031263|NCT00465894|Cholinergic Agents|cholinergic agents|mesh-ancestor
6031264|NCT00465894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6031265|NCT00465894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031266|NCT00465894|Urological Agents|urological agents|mesh-ancestor
6031267|NCT00465972|Doxepin|doxepin|mesh-list
5493757|NCT05054374|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5493758|NCT05054374|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6031268|NCT00465972|Temazepam|temazepam|mesh-list
6456622|NCT00433069|Interferons|interferons|mesh-list
6031269|NCT00465972|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6031270|NCT00465972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6031271|NCT00465972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6031272|NCT00465972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031273|NCT00465972|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6031274|NCT00465972|Antidepressive Agents|antidepressive agents|mesh-ancestor
6031275|NCT00465972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6031276|NCT00465972|Histamine Antagonists|histamine antagonists|mesh-ancestor
6031277|NCT00465972|Histamine Agents|histamine agents|mesh-ancestor
6031278|NCT00465972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6031279|NCT00465972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031280|NCT00465972|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6031281|NCT00465972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6031282|NCT00465972|GABA Modulators|gaba modulators|mesh-ancestor
6031283|NCT00465972|GABA Agents|gaba agents|mesh-ancestor
6031284|NCT00466167|Pramipexole|pramipexole|mesh-list
6031285|NCT00466167|Antioxidants|antioxidants|mesh-ancestor
6031286|NCT00466167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031287|NCT00466167|Protective Agents|protective agents|mesh-ancestor
6031288|NCT00466167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031289|NCT00466167|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6031290|NCT00466167|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6031291|NCT00466167|Dopamine Agonists|dopamine agonists|mesh-ancestor
6031292|NCT00466167|Dopamine Agents|dopamine agents|mesh-ancestor
6031293|NCT00466167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6031294|NCT00466193|Zolpidem|zolpidem|mesh-list
6031295|NCT00466193|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6031296|NCT00466193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6031297|NCT00466193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6031298|NCT00466193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031299|NCT00466193|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6031300|NCT00466193|GABA Agonists|gaba agonists|mesh-ancestor
6031301|NCT00466193|GABA Agents|gaba agents|mesh-ancestor
6031302|NCT00466193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6031303|NCT00466193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031304|NCT00466310|Risperidone|risperidone|mesh-list
6031305|NCT00466310|Aripiprazole|aripiprazole|mesh-list
6031306|NCT00466310|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6031307|NCT00466310|Serotonin Agents|serotonin agents|mesh-ancestor
6031308|NCT00466310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6031309|NCT00466310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031310|NCT00466310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031311|NCT00466310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6031312|NCT00466310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6031313|NCT00466310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6031314|NCT00466310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6031315|NCT00466310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6031316|NCT00466310|Dopamine Agents|dopamine agents|mesh-ancestor
5493759|NCT05054374|Hormone Antagonists|hormone antagonists|mesh-ancestor
5493760|NCT05054374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5493761|NCT05054374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493762|NCT05054179|Ropivacaine|ropivacaine|mesh-list
5493763|NCT05054179|Anesthetics, Local|anesthetics, local|mesh-ancestor
5493764|NCT05054179|Anesthetics|anesthetics|mesh-ancestor
5493765|NCT05054179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5493766|NCT05054179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493767|NCT05054179|Sensory System Agents|sensory system agents|mesh-ancestor
6031317|NCT00466310|Antidepressive Agents|antidepressive agents|mesh-ancestor
6031318|NCT00466310|Dopamine Agonists|dopamine agonists|mesh-ancestor
6031319|NCT00466310|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6031320|NCT00466310|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6031321|NCT00466310|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6031322|NCT00466310|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6031323|NCT00466440|Prednisone|prednisone|mesh-list
6031324|NCT00466440|Docetaxel|docetaxel|mesh-list
6031325|NCT00466440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6031326|NCT00466440|Tubulin Modulators|tubulin modulators|mesh-ancestor
6031327|NCT00466440|Antimitotic Agents|antimitotic agents|mesh-ancestor
6031328|NCT00466440|Mitosis Modulators|mitosis modulators|mesh-ancestor
6031329|NCT00466440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031330|NCT00466440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6031331|NCT00466440|Glucocorticoids|glucocorticoids|mesh-ancestor
6031332|NCT00466440|Hormones|hormones|mesh-ancestor
6031333|NCT00466440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5493768|NCT05054179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5493769|NCT05030272|Nicotine|nicotine|mesh-list
5493770|NCT05030272|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5493771|NCT05030272|Autonomic Agents|autonomic agents|mesh-ancestor
5493772|NCT05030272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5493773|NCT05030272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493774|NCT05030272|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5493775|NCT05030272|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5493776|NCT05030272|Cholinergic Agents|cholinergic agents|mesh-ancestor
5493777|NCT05030272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5493778|NCT05030272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493779|NCT05027425|Durvalumab|durvalumab|mesh-list
5493780|NCT05027425|Tremelimumab|tremelimumab|mesh-list
5493781|NCT05027425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5493782|NCT05027425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5493783|NCT05024513|Fluorouracil|fluorouracil|mesh-list
5493784|NCT05024513|Oxaliplatin|oxaliplatin|mesh-list
5493785|NCT05024513|Antimetabolites|antimetabolites|mesh-ancestor
5493786|NCT05024513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493787|NCT05024513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5493788|NCT05024513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5493789|NCT05024513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5493790|NCT05024513|Immunologic Factors|immunologic factors|mesh-ancestor
5493791|NCT05024513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493792|NCT04995003|Cyclophosphamide|cyclophosphamide|mesh-list
5493793|NCT04995003|Pembrolizumab|pembrolizumab|mesh-list
6031334|NCT00466440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031335|NCT00466440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6031336|NCT00466505|Celecoxib|celecoxib|mesh-list
6031337|NCT00466505|Cetuximab|cetuximab|mesh-list
6031338|NCT00466505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6031339|NCT00466505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6031340|NCT00466505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6031341|NCT00466505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6031342|NCT00466505|Analgesics|analgesics|mesh-ancestor
6031343|NCT00466505|Sensory System Agents|sensory system agents|mesh-ancestor
6031344|NCT00466505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6031345|NCT00466505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031346|NCT00466505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6031347|NCT00466505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6031348|NCT00466505|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6031349|NCT00466505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6031350|NCT00466505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6031351|NCT00466505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031352|NCT00466661|Acamprosate|acamprosate|mesh-list
6031353|NCT00466661|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6031354|NCT00466687|Bevacizumab|bevacizumab|mesh-list
6031355|NCT00466687|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6031356|NCT00466687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6031357|NCT00466687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6031358|NCT00466687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6031359|NCT00466687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6031360|NCT00466687|Growth Substances|growth substances|mesh-ancestor
6031361|NCT00466687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031362|NCT00466687|Growth Inhibitors|growth inhibitors|mesh-ancestor
6031363|NCT00466687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6031364|NCT00466687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6456623|NCT00433069|Ribavirin|ribavirin|mesh-list
6456624|NCT00433069|Interferon-alpha|interferon-alpha|mesh-list
6456625|NCT00433069|Interferon alpha-2|interferon alpha-2|mesh-list
6456626|NCT00433069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6456627|NCT00433069|Antiviral Agents|antiviral agents|mesh-ancestor
6031365|NCT00466687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031366|NCT00466726|Sargramostim|sargramostim|mesh-list
6031367|NCT00466726|Immunologic Factors|immunologic factors|mesh-ancestor
6456628|NCT00433069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6456629|NCT00433069|Antimetabolites|antimetabolites|mesh-ancestor
6456630|NCT00433069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456631|NCT00433069|Immunologic Factors|immunologic factors|mesh-ancestor
6456632|NCT00433069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456633|NCT00433069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6456634|NCT00433095|Trastuzumab|trastuzumab|mesh-list
6456635|NCT00433095|Vinorelbine|vinorelbine|mesh-list
6456636|NCT00433095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6456637|NCT00433095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5493794|NCT04995003|Nivolumab|nivolumab|mesh-list
5493795|NCT04995003|Fludarabine|fludarabine|mesh-list
5493796|NCT04995003|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5493797|NCT04995003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5493798|NCT04995003|Immunologic Factors|immunologic factors|mesh-ancestor
5493799|NCT04995003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493800|NCT04995003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5493801|NCT04995003|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5493802|NCT04995003|Alkylating Agents|alkylating agents|mesh-ancestor
5493803|NCT04995003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031368|NCT00466726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456638|NCT00433095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6456639|NCT00433095|Tubulin Modulators|tubulin modulators|mesh-ancestor
6456640|NCT00433095|Antimitotic Agents|antimitotic agents|mesh-ancestor
6031369|NCT00466752|Sorafenib|sorafenib|mesh-list
6031370|NCT00466752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6031371|NCT00466752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6031372|NCT00466752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6031373|NCT00466752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031374|NCT00466817|Valganciclovir|valganciclovir|mesh-list
6031375|NCT00466817|Antiviral Agents|antiviral agents|mesh-ancestor
6031376|NCT00466817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6031377|NCT00466921|Lenalidomide|lenalidomide|mesh-list
6031378|NCT00466921|Immunologic Factors|immunologic factors|mesh-ancestor
6031379|NCT00466921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031380|NCT00466921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6031381|NCT00466921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6031382|NCT00466921|Growth Substances|growth substances|mesh-ancestor
6031383|NCT00466921|Growth Inhibitors|growth inhibitors|mesh-ancestor
6031384|NCT00466921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6031385|NCT00466947|Vaccines|vaccines|mesh-list
6031386|NCT00466947|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6031387|NCT00466947|Immunologic Factors|immunologic factors|mesh-ancestor
6031388|NCT00466947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031389|NCT00466960|Paclitaxel|paclitaxel|mesh-list
6031390|NCT00466960|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6031391|NCT00466960|Sargramostim|sargramostim|mesh-list
6031392|NCT00466960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6031393|NCT00466960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6031394|NCT00466960|Tubulin Modulators|tubulin modulators|mesh-ancestor
6031395|NCT00466960|Antimitotic Agents|antimitotic agents|mesh-ancestor
6031396|NCT00466960|Mitosis Modulators|mitosis modulators|mesh-ancestor
6031397|NCT00466960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031398|NCT00466960|Immunologic Factors|immunologic factors|mesh-ancestor
6031399|NCT00466960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031400|NCT00467051|Paclitaxel|paclitaxel|mesh-list
6031401|NCT00467051|Carboplatin|carboplatin|mesh-list
6031402|NCT00467051|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6031403|NCT00467051|Ifosfamide|ifosfamide|mesh-list
6031404|NCT00467051|Isophosphamide mustard|isophosphamide mustard|mesh-list
6031405|NCT00467051|Lenograstim|lenograstim|mesh-list
6031406|NCT00467051|Sargramostim|sargramostim|mesh-list
6031407|NCT00467051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6031408|NCT00467051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6031409|NCT00467051|Tubulin Modulators|tubulin modulators|mesh-ancestor
6031410|NCT00467051|Antimitotic Agents|antimitotic agents|mesh-ancestor
6031411|NCT00467051|Mitosis Modulators|mitosis modulators|mesh-ancestor
6031412|NCT00467051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456641|NCT00433095|Mitosis Modulators|mitosis modulators|mesh-ancestor
6456642|NCT00433095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456643|NCT00433121|Olanzapine|olanzapine|mesh-list
6456644|NCT00433121|Risperidone|risperidone|mesh-list
6456645|NCT00433121|Citalopram|citalopram|mesh-list
6456646|NCT00433121|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6456647|NCT00433121|Serotonin Agents|serotonin agents|mesh-ancestor
6456648|NCT00433121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6456649|NCT00433121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031413|NCT00467051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6031414|NCT00467051|Immunologic Factors|immunologic factors|mesh-ancestor
6031415|NCT00467051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031416|NCT00467051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6031417|NCT00467051|Alkylating Agents|alkylating agents|mesh-ancestor
6031418|NCT00467077|Interferons|interferons|mesh-list
6031419|NCT00467077|Interferon-alpha|interferon-alpha|mesh-list
6031420|NCT00467077|Interferon alpha-2|interferon alpha-2|mesh-list
6031421|NCT00467077|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6031422|NCT00467077|Gefitinib|gefitinib|mesh-list
6031423|NCT00467077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6031424|NCT00467077|Antiviral Agents|antiviral agents|mesh-ancestor
6031425|NCT00467077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6031426|NCT00467077|Immunologic Factors|immunologic factors|mesh-ancestor
6031427|NCT00467077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031428|NCT00467077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6031429|NCT00467077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6031430|NCT00467077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031431|NCT00467259|Testosterone|testosterone|mesh-list
6031432|NCT00467259|Androgens|androgens|mesh-ancestor
6031433|NCT00467259|Hormones|hormones|mesh-ancestor
6031434|NCT00467259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5493804|NCT04995003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5493805|NCT04995003|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5493806|NCT04995003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5493807|NCT04994561|Niacinamide|niacinamide|mesh-list
5493808|NCT04994561|Metformin|metformin|mesh-list
5493809|NCT04994561|Dasatinib|dasatinib|mesh-list
5493810|NCT04994561|Resveratrol|resveratrol|mesh-list
5493811|NCT04994561|Quercetin|quercetin|mesh-list
6031435|NCT00467259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031436|NCT00467272|Daptomycin|daptomycin|mesh-list
6031437|NCT00467272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6031438|NCT00467272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6031439|NCT00467350|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
6031440|NCT00467350|Laxatives|laxatives|mesh-ancestor
6031441|NCT00467350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6031442|NCT00467363|Aspirin|aspirin|mesh-list
5493812|NCT04994561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5493813|NCT04994561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493814|NCT04994561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5493815|NCT04994561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5493816|NCT04994561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5493817|NCT04994561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493818|NCT04994561|Antioxidants|antioxidants|mesh-ancestor
6031443|NCT00467363|Folic Acid|folic acid|mesh-list
6031444|NCT00467363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6031445|NCT00467363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6031446|NCT00467363|Analgesics|analgesics|mesh-ancestor
6031447|NCT00467363|Sensory System Agents|sensory system agents|mesh-ancestor
6031448|NCT00467363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6031449|NCT00467363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031450|NCT00467363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6031451|NCT00467363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6031452|NCT00467363|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6031453|NCT00467363|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6031454|NCT00467363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031455|NCT00467363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6031456|NCT00467363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6031457|NCT00467363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6031458|NCT00467363|Antipyretics|antipyretics|mesh-ancestor
6031459|NCT00467363|Hematinics|hematinics|mesh-ancestor
6031460|NCT00467363|Vitamin B Complex|vitamin b complex|mesh-ancestor
6031461|NCT00467363|Vitamins|vitamins|mesh-ancestor
6031462|NCT00467363|Micronutrients|micronutrients|mesh-ancestor
6031463|NCT00467389|Donepezil|donepezil|mesh-list
6031464|NCT00467389|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6031465|NCT00467389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6031466|NCT00467389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031467|NCT00467389|Cholinergic Agents|cholinergic agents|mesh-ancestor
6031468|NCT00467389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6031469|NCT00467389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031470|NCT00467389|Nootropic Agents|nootropic agents|mesh-ancestor
6031471|NCT00467558|Naltrexone|naltrexone|mesh-list
6031472|NCT00467558|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6031473|NCT00467558|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5493819|NCT04994561|Protective Agents|protective agents|mesh-ancestor
6031474|NCT00467558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031475|NCT00467558|Sensory System Agents|sensory system agents|mesh-ancestor
6031476|NCT00467558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6031477|NCT00467584|Aspirin|aspirin|mesh-list
5493820|NCT04994561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5493821|NCT04994561|Vitamin B Complex|vitamin b complex|mesh-ancestor
6031478|NCT00467584|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6031479|NCT00467584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6031480|NCT00467584|Analgesics|analgesics|mesh-ancestor
6031481|NCT00467584|Sensory System Agents|sensory system agents|mesh-ancestor
6031482|NCT00467584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6031483|NCT00467584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031484|NCT00467584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6031485|NCT00467584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6031486|NCT00467584|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6031487|NCT00467584|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6031488|NCT00467584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031489|NCT00467584|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6031490|NCT00467584|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6031491|NCT00467584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6031492|NCT00467584|Antipyretics|antipyretics|mesh-ancestor
6031493|NCT00467597|Levodopa|levodopa|mesh-list
6031494|NCT00467597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6031495|NCT00467597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6031496|NCT00467597|Dopamine Agents|dopamine agents|mesh-ancestor
6031497|NCT00467597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6031498|NCT00467597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031499|NCT00467597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031500|NCT00467649|Insulin|insulin|mesh-list
6031501|NCT00467649|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6031502|NCT00467649|Insulin Glargine|insulin glargine|mesh-list
6031503|NCT00467649|Insulin Aspart|insulin aspart|mesh-list
6031504|NCT00467649|Insulin Lispro|insulin lispro|mesh-list
6031505|NCT00467649|Insulin Detemir|insulin detemir|mesh-list
6031506|NCT00467649|Insulin glulisine|insulin glulisine|mesh-list
6031507|NCT00467649|Pramlintide|pramlintide|mesh-list
6031508|NCT00467649|Insulin, Short-Acting|insulin, short-acting|mesh-list
6031509|NCT00467649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6031510|NCT00467649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031511|NCT00467740|Olodaterol|olodaterol|mesh-list
6031512|NCT00467740|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6031513|NCT00467740|Autonomic Agents|autonomic agents|mesh-ancestor
6031514|NCT00467740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6031515|NCT00467740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031516|NCT00467740|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6031517|NCT00467740|Respiratory System Agents|respiratory system agents|mesh-ancestor
6031518|NCT00467779|Midazolam|midazolam|mesh-list
6031519|NCT00467779|Dextromethorphan|dextromethorphan|mesh-list
6031520|NCT00467779|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6031521|NCT00467779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6031522|NCT00467779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6031523|NCT00467779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031524|NCT00467779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6031525|NCT00467779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6031526|NCT00467779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6031527|NCT00467779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6031528|NCT00467779|Anesthetics, General|anesthetics, general|mesh-ancestor
6031529|NCT00467779|Anesthetics|anesthetics|mesh-ancestor
6031530|NCT00467779|GABA Modulators|gaba modulators|mesh-ancestor
6031531|NCT00467779|GABA Agents|gaba agents|mesh-ancestor
6031532|NCT00467779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5493822|NCT04994561|Vitamins|vitamins|mesh-ancestor
5493823|NCT04994561|Micronutrients|micronutrients|mesh-ancestor
5493824|NCT04991662|Phenylephrine|phenylephrine|mesh-list
6031533|NCT00467779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031534|NCT00467779|Antitussive Agents|antitussive agents|mesh-ancestor
6031535|NCT00467779|Respiratory System Agents|respiratory system agents|mesh-ancestor
6031536|NCT00467779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6031537|NCT00467779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6031538|NCT00467831|Acetylcysteine|acetylcysteine|mesh-list
6031539|NCT00467831|Erythromycin|erythromycin|mesh-list
6031540|NCT00467831|Erythromycin Estolate|erythromycin estolate|mesh-list
6031541|NCT00467831|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
6031542|NCT00467831|Erythromycin stearate|erythromycin stearate|mesh-list
6031543|NCT00467831|Zileuton|zileuton|mesh-list
6031544|NCT00467831|Losartan|losartan|mesh-list
6031545|NCT00467831|Pravastatin|pravastatin|mesh-list
5493825|NCT04991662|Oxymetazoline|oxymetazoline|mesh-list
6031546|NCT00467831|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6031547|NCT00467831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6031548|NCT00467831|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6031549|NCT00467831|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6031550|NCT00467831|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6031551|NCT00467831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031552|NCT00467831|Antiviral Agents|antiviral agents|mesh-ancestor
6031553|NCT00467831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6031554|NCT00467831|Expectorants|expectorants|mesh-ancestor
6031555|NCT00467831|Respiratory System Agents|respiratory system agents|mesh-ancestor
6031556|NCT00467831|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6031557|NCT00467831|Antioxidants|antioxidants|mesh-ancestor
6031558|NCT00467831|Protective Agents|protective agents|mesh-ancestor
6031559|NCT00467831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031560|NCT00467831|Antidotes|antidotes|mesh-ancestor
5493826|NCT04991662|Norepinephrine|norepinephrine|mesh-list
5493827|NCT04991662|Metaraminol|metaraminol|mesh-list
5493828|NCT04991662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5493829|NCT04991662|Mydriatics|mydriatics|mesh-ancestor
5493830|NCT04991662|Autonomic Agents|autonomic agents|mesh-ancestor
5493831|NCT04991662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5493832|NCT04991662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493833|NCT04991662|Sympathomimetics|sympathomimetics|mesh-ancestor
5493834|NCT04991662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5493835|NCT04991662|Nasal Decongestants|nasal decongestants|mesh-ancestor
5493836|NCT04991662|Respiratory System Agents|respiratory system agents|mesh-ancestor
5493837|NCT04991662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5493838|NCT04991662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5493839|NCT04991662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5493840|NCT04991662|Adrenergic Agents|adrenergic agents|mesh-ancestor
6031561|NCT00467831|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6031562|NCT00467831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6031563|NCT00467831|Antimetabolites|antimetabolites|mesh-ancestor
6031564|NCT00467831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6031565|NCT00467831|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6031566|NCT00467831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6031567|NCT00467831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6031568|NCT00467831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6031569|NCT00467831|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6031570|NCT00467831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6031571|NCT00467831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6031572|NCT00467831|Analgesics|analgesics|mesh-ancestor
5493841|NCT04991662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5493842|NCT04991662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493843|NCT04991662|Protective Agents|protective agents|mesh-ancestor
5493844|NCT04969120|Metoclopramide|metoclopramide|mesh-list
5493845|NCT04969120|Antiemetics|antiemetics|mesh-ancestor
5493846|NCT04969120|Autonomic Agents|autonomic agents|mesh-ancestor
5493847|NCT04969120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5493848|NCT04969120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493849|NCT04969120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6031573|NCT00467831|Sensory System Agents|sensory system agents|mesh-ancestor
6031574|NCT00467831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6031575|NCT00467831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6031576|NCT00467831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6031577|NCT00467831|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6031578|NCT00467831|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6031579|NCT00467831|Hormone Antagonists|hormone antagonists|mesh-ancestor
6031580|NCT00467831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6053556|NCT00596167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6053557|NCT00596167|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6456650|NCT00433121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456651|NCT00433121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6456652|NCT00433121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6053558|NCT00596167|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6053559|NCT00596167|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6053560|NCT00596271|Vaccines|vaccines|mesh-list
6053561|NCT00596271|Immunologic Factors|immunologic factors|mesh-ancestor
6053562|NCT00596271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053563|NCT00596362|Bevacizumab|bevacizumab|mesh-list
6456653|NCT00433121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6456654|NCT00433121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6456655|NCT00433121|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6456656|NCT00433121|Dopamine Agents|dopamine agents|mesh-ancestor
5493850|NCT04969120|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5493851|NCT04969120|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6456657|NCT00433121|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6456658|NCT00433121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6456659|NCT00433121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6456660|NCT00433121|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6456661|NCT00433121|Antidepressive Agents|antidepressive agents|mesh-ancestor
6456662|NCT00433121|Autonomic Agents|autonomic agents|mesh-ancestor
6031581|NCT00467870|Methyltestosterone|methyltestosterone|mesh-list
6031582|NCT00467870|Testosterone|testosterone|mesh-list
6031583|NCT00467870|Testosterone undecanoate|testosterone undecanoate|mesh-list
6031584|NCT00467870|Testosterone enanthate|testosterone enanthate|mesh-list
6031585|NCT00467870|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6031586|NCT00467870|Androgens|androgens|mesh-ancestor
6031587|NCT00467870|Hormones|hormones|mesh-ancestor
6031588|NCT00467870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6031589|NCT00467870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031590|NCT00467870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6031591|NCT00467870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6031592|NCT00467870|Anabolic Agents|anabolic agents|mesh-ancestor
6031593|NCT00467896|Iloprost|iloprost|mesh-list
6031594|NCT00467896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6031595|NCT00467896|Vasodilator Agents|vasodilator agents|mesh-ancestor
6031596|NCT00468052|Fentanyl|fentanyl|mesh-list
6031597|NCT00468052|Dexmedetomidine|dexmedetomidine|mesh-list
6031598|NCT00468052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6031599|NCT00468052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6031600|NCT00468052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031601|NCT00468052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6031602|NCT00468052|Analgesics|analgesics|mesh-ancestor
6031603|NCT00468052|Sensory System Agents|sensory system agents|mesh-ancestor
6031604|NCT00468052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6031605|NCT00468052|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6031606|NCT00468052|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6031607|NCT00468052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6031608|NCT00468052|Adrenergic Agents|adrenergic agents|mesh-ancestor
6031609|NCT00468052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6031610|NCT00468052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031611|NCT00468052|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6031612|NCT00468052|Narcotics|narcotics|mesh-ancestor
6031613|NCT00468052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6031614|NCT00468052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6031615|NCT00468052|Anesthetics, General|anesthetics, general|mesh-ancestor
6031616|NCT00468052|Anesthetics|anesthetics|mesh-ancestor
6031617|NCT00468104|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6031618|NCT00468104|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6031619|NCT00468104|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6031620|NCT00468104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031621|NCT00468143|Adderall|adderall|mesh-list
6031622|NCT00468143|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6031623|NCT00468143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031624|NCT00468169|Cetuximab|cetuximab|mesh-list
6031625|NCT00468169|Hydroxyurea|hydroxyurea|mesh-list
6031626|NCT00468169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6031627|NCT00468169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6031628|NCT00468169|Antisickling Agents|antisickling agents|mesh-ancestor
6031629|NCT00468169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6031630|NCT00468169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031631|NCT00468169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6031632|NCT00468208|Abatacept|abatacept|mesh-list
6031633|NCT00468208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6031634|NCT00468208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031635|NCT00468208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6031636|NCT00468208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6031637|NCT00468208|Immunologic Factors|immunologic factors|mesh-ancestor
6031638|NCT00468208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031639|NCT00468208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6031640|NCT00468299|Misoprostol|misoprostol|mesh-list
6031641|NCT00468299|Mifepristone|mifepristone|mesh-list
6031642|NCT00468299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6031643|NCT00468299|Abortifacient Agents|abortifacient agents|mesh-ancestor
6031644|NCT00468299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6031645|NCT00468299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031646|NCT00468299|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6031647|NCT00468299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6031648|NCT00468299|Oxytocics|oxytocics|mesh-ancestor
6031649|NCT00468299|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6031650|NCT00468299|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6031651|NCT00468299|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6031652|NCT00468299|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6031653|NCT00468299|Contraceptive Agents|contraceptive agents|mesh-ancestor
6031654|NCT00468299|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6031655|NCT00468299|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6031656|NCT00468299|Hormone Antagonists|hormone antagonists|mesh-ancestor
6031657|NCT00468299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6031658|NCT00468299|Luteolytic Agents|luteolytic agents|mesh-ancestor
6031659|NCT00468299|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6031660|NCT00468299|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6031661|NCT00468481|Drospirenone|drospirenone|mesh-list
6031662|NCT00468481|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6031663|NCT00468481|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
6031664|NCT00468481|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6031665|NCT00468481|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6031666|NCT00468481|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6031667|NCT00468481|Contraceptive Agents|contraceptive agents|mesh-ancestor
6031668|NCT00468481|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6031669|NCT00468481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031670|NCT00468481|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5493852|NCT04969120|Dopamine Agents|dopamine agents|mesh-ancestor
5493853|NCT04969120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5493854|NCT04969120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493855|NCT04947072|Anesthetics|anesthetics|mesh-list
5493856|NCT04947072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6031671|NCT00468481|Estrogens|estrogens|mesh-ancestor
6031672|NCT00468481|Hormones|hormones|mesh-ancestor
6031673|NCT00468481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6031674|NCT00468481|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6031675|NCT00468481|Hormone Antagonists|hormone antagonists|mesh-ancestor
6031676|NCT00468481|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6031677|NCT00468481|Diuretics|diuretics|mesh-ancestor
6031678|NCT00468481|Natriuretic Agents|natriuretic agents|mesh-ancestor
6031679|NCT00468546|Methotrexate|methotrexate|mesh-list
6031680|NCT00468546|Rituximab|rituximab|mesh-list
6031681|NCT00468546|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6031682|NCT00468546|Abortifacient Agents|abortifacient agents|mesh-ancestor
5493857|NCT04947072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493858|NCT04942158|Eugenol|eugenol|mesh-list
5493859|NCT04942158|Zinc Oxide|zinc oxide|mesh-list
5493860|NCT04942158|Dermatologic Agents|dermatologic agents|mesh-ancestor
5493861|NCT04942158|Sunscreening Agents|sunscreening agents|mesh-ancestor
5493862|NCT04942158|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5493863|NCT04942158|Protective Agents|protective agents|mesh-ancestor
5493864|NCT04942158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493865|NCT04942158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5493866|NCT04941703|Magnesium citrate|magnesium citrate|mesh-list
5493867|NCT04941703|Cathartics|cathartics|mesh-ancestor
6031683|NCT00468546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6031684|NCT00468546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031685|NCT00468546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6031686|NCT00468546|Antimetabolites|antimetabolites|mesh-ancestor
5493868|NCT04941703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5493869|NCT04911166|Atezolizumab|atezolizumab|mesh-list
5493870|NCT04911166|Interleukin-12|interleukin-12|mesh-list
5493871|NCT04911166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5493872|NCT04911166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5493873|NCT04911166|Immunologic Factors|immunologic factors|mesh-ancestor
6031687|NCT00468546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031688|NCT00468546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6031689|NCT00468546|Dermatologic Agents|dermatologic agents|mesh-ancestor
6031690|NCT00468546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6031691|NCT00468546|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6031692|NCT00468546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6031693|NCT00468546|Immunologic Factors|immunologic factors|mesh-ancestor
6031694|NCT00468546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6031695|NCT00468546|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6031696|NCT00468546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6031697|NCT00468559|Esomeprazole|esomeprazole|mesh-list
6031698|NCT00468559|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6031699|NCT00468559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6031700|NCT00468559|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6031701|NCT00468559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6031702|NCT00468559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031703|NCT00468585|Bevacizumab|bevacizumab|mesh-list
6031704|NCT00468585|Capecitabine|capecitabine|mesh-list
6031705|NCT00468585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5493874|NCT04911166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493875|NCT04911166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5493876|NCT04911166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6031706|NCT00468585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6031707|NCT00468585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6031708|NCT00468585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6031709|NCT00468585|Growth Substances|growth substances|mesh-ancestor
6031710|NCT00468585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031711|NCT00468585|Growth Inhibitors|growth inhibitors|mesh-ancestor
6031712|NCT00468585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6031713|NCT00468585|Antimetabolites|antimetabolites|mesh-ancestor
6031714|NCT00468585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493877|NCT04911166|Growth Substances|growth substances|mesh-ancestor
5493878|NCT04911166|Growth Inhibitors|growth inhibitors|mesh-ancestor
5493879|NCT04827836|Povidone-Iodine|povidone-iodine|mesh-list
5493880|NCT04827836|Povidone|povidone|mesh-list
6031715|NCT00468650|Sildenafil Citrate|sildenafil citrate|mesh-list
6031716|NCT00468650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031717|NCT00468650|Vasodilator Agents|vasodilator agents|mesh-ancestor
6031718|NCT00468650|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6031719|NCT00468650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6031720|NCT00468650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6031721|NCT00468650|Urological Agents|urological agents|mesh-ancestor
6031722|NCT00468728|Vancomycin|vancomycin|mesh-list
6031723|NCT00468728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6031724|NCT00468728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6031725|NCT00468845|Pregabalin|pregabalin|mesh-list
6031726|NCT00468845|Analgesics|analgesics|mesh-ancestor
6031727|NCT00468845|Sensory System Agents|sensory system agents|mesh-ancestor
6031728|NCT00468845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6031729|NCT00468845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493881|NCT04827836|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5493882|NCT04827836|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5493883|NCT04827836|Plasma Substitutes|plasma substitutes|mesh-ancestor
5493884|NCT04827836|Blood Substitutes|blood substitutes|mesh-ancestor
6031730|NCT00468845|Anticonvulsants|anticonvulsants|mesh-ancestor
6031731|NCT00468845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6031732|NCT00468845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6031733|NCT00468845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493885|NCT04827836|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5493886|NCT04827836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5493887|NCT04810208|Docetaxel|docetaxel|mesh-list
5493888|NCT04810208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5493889|NCT04810208|Tubulin Modulators|tubulin modulators|mesh-ancestor
5493890|NCT04810208|Antimitotic Agents|antimitotic agents|mesh-ancestor
5493891|NCT04810208|Mitosis Modulators|mitosis modulators|mesh-ancestor
5493892|NCT04810208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493893|NCT04802161|Cytarabine|cytarabine|mesh-list
5493894|NCT04802161|Daunorubicin|daunorubicin|mesh-list
5493895|NCT04802161|Pomalidomide|pomalidomide|mesh-list
5493896|NCT04802161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5493897|NCT04802161|Antimetabolites|antimetabolites|mesh-ancestor
5493898|NCT04802161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493899|NCT04802161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5493900|NCT04802161|Antiviral Agents|antiviral agents|mesh-ancestor
5493901|NCT04802161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5493902|NCT04802161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5493903|NCT04802161|Immunologic Factors|immunologic factors|mesh-ancestor
5493904|NCT04802161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493905|NCT04802161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5493906|NCT04802161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5493907|NCT04802161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5493908|NCT04802161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5493909|NCT04802161|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5493910|NCT04802161|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5493911|NCT04802161|Growth Substances|growth substances|mesh-ancestor
5493912|NCT04802161|Growth Inhibitors|growth inhibitors|mesh-ancestor
6031734|NCT00468845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6031735|NCT00468845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6031736|NCT00468845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6031737|NCT00468845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6031738|NCT00468845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6031739|NCT00468910|Aspirin|aspirin|mesh-list
6031740|NCT00468910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6031741|NCT00468910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6031742|NCT00468910|Analgesics|analgesics|mesh-ancestor
6031743|NCT00468910|Sensory System Agents|sensory system agents|mesh-ancestor
6031744|NCT00468910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6031745|NCT00468910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031746|NCT00468910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6031747|NCT00468910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6031748|NCT00468910|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6031749|NCT00468910|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6031750|NCT00468910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031751|NCT00468910|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6031752|NCT00468910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6031753|NCT00468910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6031754|NCT00468910|Antipyretics|antipyretics|mesh-ancestor
6031755|NCT00469014|Vidarabine|vidarabine|mesh-list
6031756|NCT00469014|Fludarabine|fludarabine|mesh-list
6031757|NCT00469014|Fludarabine phosphate|fludarabine phosphate|mesh-list
6031758|NCT00469014|Busulfan|busulfan|mesh-list
6031759|NCT00469014|Clofarabine|clofarabine|mesh-list
6031760|NCT00469014|Thymoglobulin|thymoglobulin|mesh-list
6031761|NCT00469014|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6031762|NCT00469014|Lenograstim|lenograstim|mesh-list
6031763|NCT00469014|Sargramostim|sargramostim|mesh-list
6031764|NCT00469014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5503145|NCT04461925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5503146|NCT04461925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5503147|NCT04461925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6031765|NCT00469014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6031766|NCT00469014|Antimetabolites|antimetabolites|mesh-ancestor
6031767|NCT00469014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031768|NCT00469014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6031769|NCT00469014|Immunologic Factors|immunologic factors|mesh-ancestor
6031770|NCT00469014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031771|NCT00469014|Antiviral Agents|antiviral agents|mesh-ancestor
6031772|NCT00469014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5503148|NCT04461925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503149|NCT04461925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5503150|NCT04461925|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5503151|NCT04461925|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5503152|NCT04461795|Erenumab|erenumab|mesh-list
5503153|NCT04461795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5503154|NCT04461795|Immunologic Factors|immunologic factors|mesh-ancestor
5503155|NCT04461795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503156|NCT04461795|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
5503651|NCT04456985|Vitamins|vitamins|mesh-ancestor
6031773|NCT00469014|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6031774|NCT00469014|Alkylating Agents|alkylating agents|mesh-ancestor
6031775|NCT00469014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6031776|NCT00469014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6031777|NCT00469079|Nicotine|nicotine|mesh-list
6031778|NCT00469079|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6031779|NCT00469079|Autonomic Agents|autonomic agents|mesh-ancestor
6031780|NCT00469079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6031781|NCT00469079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031782|NCT00469079|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6031783|NCT00469079|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6031784|NCT00469079|Cholinergic Agents|cholinergic agents|mesh-ancestor
6031785|NCT00469079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6031786|NCT00469079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031787|NCT00469092|Insulin|insulin|mesh-list
6031788|NCT00469092|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6031789|NCT00469092|Metformin|metformin|mesh-list
6031790|NCT00469092|Insulin Glargine|insulin glargine|mesh-list
6031791|NCT00469092|Insulin Aspart|insulin aspart|mesh-list
6031792|NCT00469092|Glimepiride|glimepiride|mesh-list
6031793|NCT00469092|Biphasic Insulins|biphasic insulins|mesh-list
6031794|NCT00469092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6031795|NCT00469092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031796|NCT00469092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6031797|NCT00469092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6031798|NCT00469092|Immunologic Factors|immunologic factors|mesh-ancestor
6031799|NCT00469144|Fludarabine|fludarabine|mesh-list
6031800|NCT00469144|Busulfan|busulfan|mesh-list
6031801|NCT00469144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6031802|NCT00469144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031803|NCT00469144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6031804|NCT00469144|Immunologic Factors|immunologic factors|mesh-ancestor
6031805|NCT00469144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031806|NCT00469144|Alkylating Agents|alkylating agents|mesh-ancestor
6031807|NCT00469144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6031808|NCT00469144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6031809|NCT00469209|Ascorbic Acid|ascorbic acid|mesh-list
6031810|NCT00469209|Bortezomib|bortezomib|mesh-list
5493913|NCT04787835|Anesthetics|anesthetics|mesh-list
5493914|NCT04787835|Anesthetics, Local|anesthetics, local|mesh-list
5493915|NCT04787835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6031811|NCT00469209|Melphalan|melphalan|mesh-list
6031812|NCT00469209|Arsenic Trioxide|arsenic trioxide|mesh-list
6031813|NCT00469209|Vitamins|vitamins|mesh-ancestor
6031814|NCT00469209|Micronutrients|micronutrients|mesh-ancestor
6031815|NCT00469209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031816|NCT00469209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6031817|NCT00469209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6031818|NCT00469209|Alkylating Agents|alkylating agents|mesh-ancestor
6031819|NCT00469209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031820|NCT00469209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6031821|NCT00469209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6031822|NCT00469209|Immunologic Factors|immunologic factors|mesh-ancestor
6031823|NCT00469209|Antioxidants|antioxidants|mesh-ancestor
6031824|NCT00469209|Protective Agents|protective agents|mesh-ancestor
6031825|NCT00469274|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6031826|NCT00469274|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6031827|NCT00469274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6031828|NCT00469274|Antitubercular Agents|antitubercular agents|mesh-ancestor
5503652|NCT04456985|Micronutrients|micronutrients|mesh-ancestor
6031829|NCT00469456|Memantine|memantine|mesh-list
6031830|NCT00469456|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6031831|NCT00469456|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6031832|NCT00469456|Dopamine Agents|dopamine agents|mesh-ancestor
6031833|NCT00469456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6031834|NCT00469456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031835|NCT00469456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031836|NCT00469456|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6031837|NCT00469456|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6031838|NCT00469508|Modafinil|modafinil|mesh-list
6031839|NCT00469508|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6031840|NCT00469508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493916|NCT04787835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493917|NCT04787835|Sensory System Agents|sensory system agents|mesh-ancestor
5493918|NCT04787835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6031841|NCT00469508|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6031842|NCT00469508|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6031843|NCT00469508|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6031844|NCT00469508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031845|NCT00469833|Insulin|insulin|mesh-list
6031846|NCT00469833|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6031847|NCT00469833|Insulin Glargine|insulin glargine|mesh-list
6031848|NCT00469833|Insulin, Long-Acting|insulin, long-acting|mesh-list
6031849|NCT00469833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6031850|NCT00469833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031851|NCT00469859|Cytarabine|cytarabine|mesh-list
6031852|NCT00469859|Idarubicin|idarubicin|mesh-list
6031853|NCT00469859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6031854|NCT00469859|Antimetabolites|antimetabolites|mesh-ancestor
6031855|NCT00469859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031856|NCT00469859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6031857|NCT00469859|Antiviral Agents|antiviral agents|mesh-ancestor
6031858|NCT00469859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6031859|NCT00469859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6031860|NCT00469859|Immunologic Factors|immunologic factors|mesh-ancestor
6031861|NCT00469859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031862|NCT00469859|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6031863|NCT00469859|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6031864|NCT00469859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6031865|NCT00469859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6031866|NCT00469898|Carboplatin|carboplatin|mesh-list
6031867|NCT00469898|Irinotecan|irinotecan|mesh-list
6031868|NCT00469898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6031869|NCT00469898|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6031870|NCT00469898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6031871|NCT00469898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6031872|NCT00469898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031873|NCT00470054|Dasatinib|dasatinib|mesh-list
6031874|NCT00470054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6031875|NCT00470054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6031876|NCT00470054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6031877|NCT00470054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031878|NCT00470093|Interferons|interferons|mesh-list
6031879|NCT00470093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6031880|NCT00470093|Antiviral Agents|antiviral agents|mesh-ancestor
6031881|NCT00470093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6031882|NCT00470158|Iron|iron|mesh-list
6031883|NCT00470158|Zinc|zinc|mesh-list
6031884|NCT00470158|Trace Elements|trace elements|mesh-ancestor
6031885|NCT00470158|Micronutrients|micronutrients|mesh-ancestor
6031886|NCT00470158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031887|NCT00470184|Capecitabine|capecitabine|mesh-list
6031888|NCT00470184|Oxaliplatin|oxaliplatin|mesh-list
6031889|NCT00470184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6031890|NCT00470184|Antimetabolites|antimetabolites|mesh-ancestor
6031891|NCT00470184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031892|NCT00470184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6031893|NCT00470262|Pioglitazone|pioglitazone|mesh-list
6031894|NCT00470262|Fenofibrate|fenofibrate|mesh-list
6031895|NCT00470262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6031896|NCT00470262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031897|NCT00470262|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6031898|NCT00470262|Antimetabolites|antimetabolites|mesh-ancestor
6031899|NCT00470262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031900|NCT00470262|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6031901|NCT00470275|Cytarabine|cytarabine|mesh-list
6031902|NCT00470275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6031903|NCT00470275|Antimetabolites|antimetabolites|mesh-ancestor
6031904|NCT00470275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031905|NCT00470275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6031906|NCT00470275|Antiviral Agents|antiviral agents|mesh-ancestor
6031907|NCT00470275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6031908|NCT00470275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6031909|NCT00470275|Immunologic Factors|immunologic factors|mesh-ancestor
6031910|NCT00470275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031911|NCT00470301|Paclitaxel|paclitaxel|mesh-list
6031912|NCT00470301|Cyclophosphamide|cyclophosphamide|mesh-list
6031913|NCT00470301|Doxorubicin|doxorubicin|mesh-list
6031914|NCT00470301|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6031915|NCT00470301|Tipifarnib|tipifarnib|mesh-list
6031916|NCT00470301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6031917|NCT00470301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6031918|NCT00470301|Tubulin Modulators|tubulin modulators|mesh-ancestor
6031919|NCT00470301|Antimitotic Agents|antimitotic agents|mesh-ancestor
6031920|NCT00470301|Mitosis Modulators|mitosis modulators|mesh-ancestor
6031921|NCT00470301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031922|NCT00470301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6031923|NCT00470301|Immunologic Factors|immunologic factors|mesh-ancestor
6031924|NCT00470301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031925|NCT00470301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6031926|NCT00470301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6031927|NCT00470301|Alkylating Agents|alkylating agents|mesh-ancestor
6031928|NCT00470301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6031929|NCT00470301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6031930|NCT00470301|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6031931|NCT00470301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6031932|NCT00470301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6031933|NCT00470366|Paclitaxel|paclitaxel|mesh-list
6031934|NCT00470366|Ifosfamide|ifosfamide|mesh-list
6031935|NCT00470366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6031936|NCT00470366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6031937|NCT00470366|Tubulin Modulators|tubulin modulators|mesh-ancestor
6031938|NCT00470366|Antimitotic Agents|antimitotic agents|mesh-ancestor
6031939|NCT00470366|Mitosis Modulators|mitosis modulators|mesh-ancestor
6031940|NCT00470366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031941|NCT00470366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6031942|NCT00470366|Alkylating Agents|alkylating agents|mesh-ancestor
6031943|NCT00470392|Clobetasol|clobetasol|mesh-list
6031944|NCT00470392|Imiquimod|imiquimod|mesh-list
6031945|NCT00470392|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6031946|NCT00470392|Immunologic Factors|immunologic factors|mesh-ancestor
6031947|NCT00470392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031948|NCT00470392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6031949|NCT00470392|Interferon Inducers|interferon inducers|mesh-ancestor
6031950|NCT00470392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6031951|NCT00470392|Glucocorticoids|glucocorticoids|mesh-ancestor
6031952|NCT00470392|Hormones|hormones|mesh-ancestor
6031953|NCT00470392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6031954|NCT00470470|Imatinib Mesylate|imatinib mesylate|mesh-list
6031955|NCT00470470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6031956|NCT00470470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6031957|NCT00470470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6031958|NCT00470470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031959|NCT00470535|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6031960|NCT00470535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6031961|NCT00470535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6031962|NCT00470535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6031963|NCT00470535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031964|NCT00470548|Paclitaxel|paclitaxel|mesh-list
6031965|NCT00470548|Pemetrexed|pemetrexed|mesh-list
6031966|NCT00470548|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6031967|NCT00470548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6031968|NCT00470548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6031969|NCT00470548|Tubulin Modulators|tubulin modulators|mesh-ancestor
6031970|NCT00470548|Antimitotic Agents|antimitotic agents|mesh-ancestor
6031971|NCT00470548|Mitosis Modulators|mitosis modulators|mesh-ancestor
6031972|NCT00470548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493929|NCT04752826|Pembrolizumab|pembrolizumab|mesh-list
5493930|NCT04752826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5493931|NCT04752826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5493932|NCT04745559|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5493933|NCT04745559|Immunologic Factors|immunologic factors|mesh-ancestor
6031973|NCT00470548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5493934|NCT04745559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031974|NCT00470548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6031975|NCT00470548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6031976|NCT00470600|Ibuprofen|ibuprofen|mesh-list
5493935|NCT04742010|Zoledronic Acid|zoledronic acid|mesh-list
5493936|NCT04742010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5493937|NCT04742010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493938|NCT04741997|Nivolumab|nivolumab|mesh-list
5493939|NCT04741997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5493940|NCT04741997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5493941|NCT04741997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6031977|NCT00470600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6031978|NCT00470600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6031979|NCT00470600|Analgesics|analgesics|mesh-ancestor
6031980|NCT00470600|Sensory System Agents|sensory system agents|mesh-ancestor
6031981|NCT00470600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6031982|NCT00470600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031983|NCT00470600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6031984|NCT00470600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6031985|NCT00470600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6031986|NCT00470600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6031987|NCT00470600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031988|NCT00470834|Bicalutamide|bicalutamide|mesh-list
6031989|NCT00470834|Dutasteride|dutasteride|mesh-list
5493942|NCT04741997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493943|NCT04710030|Valacyclovir|valacyclovir|mesh-list
5493944|NCT04710030|Antiviral Agents|antiviral agents|mesh-ancestor
5493945|NCT04710030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5493946|NCT04708054|Fludarabine|fludarabine|mesh-list
5493947|NCT04708054|Fludarabine phosphate|fludarabine phosphate|mesh-list
5493948|NCT04708054|Busulfan|busulfan|mesh-list
5493949|NCT04708054|Venetoclax|venetoclax|mesh-list
5493950|NCT04708054|Thiotepa|thiotepa|mesh-list
5493951|NCT04708054|Cladribine|cladribine|mesh-list
5493952|NCT04708054|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
5493953|NCT04708054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5493954|NCT04708054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5493955|NCT04708054|Antimetabolites|antimetabolites|mesh-ancestor
5493956|NCT04708054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493957|NCT04708054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5493958|NCT04708054|Immunologic Factors|immunologic factors|mesh-ancestor
5493959|NCT04708054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493960|NCT04708054|Alkylating Agents|alkylating agents|mesh-ancestor
5493961|NCT04708054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5493962|NCT04708054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5493963|NCT04703621|Daratumumab|daratumumab|mesh-list
6031990|NCT00470834|Androgen Antagonists|androgen antagonists|mesh-ancestor
6031991|NCT00470834|Hormone Antagonists|hormone antagonists|mesh-ancestor
6031992|NCT00470834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5493964|NCT04703621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5493965|NCT04691804|Prednisone|prednisone|mesh-list
6031993|NCT00470834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6031994|NCT00470834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6031995|NCT00470834|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6031996|NCT00470834|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6031997|NCT00470834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6031998|NCT00470834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6031999|NCT00470847|Trastuzumab|trastuzumab|mesh-list
6032000|NCT00470847|Lapatinib|lapatinib|mesh-list
6032001|NCT00470847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6032002|NCT00470847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6032003|NCT00470847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6032004|NCT00470847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6032005|NCT00470847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6032006|NCT00471068|Timolol|timolol|mesh-list
6032007|NCT00471068|Travoprost|travoprost|mesh-list
6032008|NCT00471068|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6032009|NCT00471068|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6032010|NCT00471068|Adrenergic Agents|adrenergic agents|mesh-ancestor
6032011|NCT00471068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6032012|NCT00471068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6032013|NCT00471068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032014|NCT00471068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5493966|NCT04691804|Abiraterone Acetate|abiraterone acetate|mesh-list
5493967|NCT04691804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6032015|NCT00471068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6032016|NCT00471146|Gemcitabine|gemcitabine|mesh-list
6032017|NCT00471146|Axitinib|axitinib|mesh-list
6032018|NCT00471146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6032019|NCT00471146|Antimetabolites|antimetabolites|mesh-ancestor
6032020|NCT00471146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6032021|NCT00471146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6032022|NCT00471146|Antiviral Agents|antiviral agents|mesh-ancestor
6032023|NCT00471146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6032024|NCT00471146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6032025|NCT00471146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6032026|NCT00471146|Immunologic Factors|immunologic factors|mesh-ancestor
6032027|NCT00471146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032028|NCT00471146|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6032029|NCT00471237|Alendronate|alendronate|mesh-list
6032030|NCT00471237|Teriparatide|teriparatide|mesh-list
6032031|NCT00471237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6032032|NCT00471237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032033|NCT00471237|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6032034|NCT00471276|Sunitinib|sunitinib|mesh-list
6032035|NCT00471276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6032036|NCT00471276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6032037|NCT00471276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6032038|NCT00471276|Growth Substances|growth substances|mesh-ancestor
6032039|NCT00471276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032040|NCT00471276|Growth Inhibitors|growth inhibitors|mesh-ancestor
6032041|NCT00471276|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6032042|NCT00471276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6032043|NCT00471276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6032044|NCT00471315|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6032045|NCT00471315|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6032046|NCT00471315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6032047|NCT00471315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6456663|NCT00433121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6456664|NCT00433121|Antiemetics|antiemetics|mesh-ancestor
6456665|NCT00433121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6456666|NCT00433173|Anastrozole|anastrozole|mesh-list
5493968|NCT04691804|Glucocorticoids|glucocorticoids|mesh-ancestor
6032048|NCT00471315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6032049|NCT00471315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6032050|NCT00471315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032051|NCT00471315|Analgesics|analgesics|mesh-ancestor
6032052|NCT00471315|Sensory System Agents|sensory system agents|mesh-ancestor
6032053|NCT00471315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6032054|NCT00471315|Antidepressive Agents|antidepressive agents|mesh-ancestor
6032055|NCT00471315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6032056|NCT00471315|Dopamine Agents|dopamine agents|mesh-ancestor
6032057|NCT00471328|Sunitinib|sunitinib|mesh-list
6032058|NCT00471328|Imatinib Mesylate|imatinib mesylate|mesh-list
6032059|NCT00471328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6032060|NCT00471328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6032061|NCT00471328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6032062|NCT00471328|Growth Substances|growth substances|mesh-ancestor
6032063|NCT00471328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032064|NCT00471328|Growth Inhibitors|growth inhibitors|mesh-ancestor
6032065|NCT00471328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6032066|NCT00471328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6032067|NCT00471328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6032068|NCT00471354|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6032069|NCT00471354|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6032070|NCT00471354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6032071|NCT00471354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6032072|NCT00471354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6032073|NCT00471354|Adrenergic Agents|adrenergic agents|mesh-ancestor
6032074|NCT00471354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6032075|NCT00471354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032076|NCT00471380|Timolol|timolol|mesh-list
6032077|NCT00471380|Travoprost|travoprost|mesh-list
6032078|NCT00471380|Dorzolamide|dorzolamide|mesh-list
6032079|NCT00471380|Brinzolamide|brinzolamide|mesh-list
5493969|NCT04691804|Hormones|hormones|mesh-ancestor
5493970|NCT04691804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6456667|NCT00433173|Goserelin|goserelin|mesh-list
6456668|NCT00433173|Testosterone|testosterone|mesh-list
6032080|NCT00471380|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6032081|NCT00471380|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5493971|NCT04691804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493972|NCT04691804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5493973|NCT04691804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5493974|NCT04691804|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6032082|NCT00471380|Adrenergic Agents|adrenergic agents|mesh-ancestor
6032083|NCT00471380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6032084|NCT00471380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6032085|NCT00471380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032086|NCT00471380|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6032087|NCT00471380|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6032088|NCT00471380|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6032089|NCT00471380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6032090|NCT00471445|Ketamine|ketamine|mesh-list
6032091|NCT00471445|Amitriptyline|amitriptyline|mesh-list
6032092|NCT00471445|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6032093|NCT00471445|Analgesics|analgesics|mesh-ancestor
6032094|NCT00471445|Sensory System Agents|sensory system agents|mesh-ancestor
6032095|NCT00471445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6032096|NCT00471445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032097|NCT00471445|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6032098|NCT00471445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6032099|NCT00471445|Anesthetics, General|anesthetics, general|mesh-ancestor
6032100|NCT00471445|Anesthetics|anesthetics|mesh-ancestor
6032101|NCT00471445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6032102|NCT00471445|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6032103|NCT00471445|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6032104|NCT00471445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6032105|NCT00471445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6032106|NCT00471445|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6032107|NCT00471445|Antidepressive Agents|antidepressive agents|mesh-ancestor
6032108|NCT00471445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6032109|NCT00471445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6032110|NCT00471445|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6032111|NCT00471445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6032112|NCT00471445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6032113|NCT00471445|Adrenergic Agents|adrenergic agents|mesh-ancestor
6032114|NCT00471445|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6456669|NCT00433173|Androgens|androgens|mesh-ancestor
6456670|NCT00433173|Hormones|hormones|mesh-ancestor
6456671|NCT00433173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6456672|NCT00433173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456673|NCT00433173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6456674|NCT00433173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6456675|NCT00433173|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6456676|NCT00433173|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6456677|NCT00433173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6456678|NCT00433173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456679|NCT00433173|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6456680|NCT00433173|Hormone Antagonists|hormone antagonists|mesh-ancestor
6456681|NCT00433186|Mycophenolic Acid|mycophenolic acid|mesh-list
5493975|NCT04691804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5493976|NCT04691804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493977|NCT04691804|Hormone Antagonists|hormone antagonists|mesh-ancestor
5493978|NCT04691804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5493979|NCT04671030|Glycopyrrolate|glycopyrrolate|mesh-list
5493980|NCT04671030|Neostigmine|neostigmine|mesh-list
5493981|NCT04671030|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5493982|NCT04671030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6032115|NCT00471445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6032116|NCT00471497|Imatinib Mesylate|imatinib mesylate|mesh-list
6032117|NCT00471497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6032118|NCT00471497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6032119|NCT00471497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6032120|NCT00471497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6032121|NCT00471705|Miltefosine|miltefosine|mesh-list
6032122|NCT00471705|Meglumine Antimoniate|meglumine antimoniate|mesh-list
6032123|NCT00471705|Antifungal Agents|antifungal agents|mesh-ancestor
6032124|NCT00471705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6032125|NCT00471705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6032126|NCT00471705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6032127|NCT00471705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6032128|NCT00471848|Thymoglobulin|thymoglobulin|mesh-list
6032129|NCT00471848|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6032130|NCT00471848|Immunologic Factors|immunologic factors|mesh-ancestor
6032131|NCT00471848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032132|NCT00471848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6032133|NCT00471887|Tremelimumab|tremelimumab|mesh-list
6032134|NCT00471887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6032135|NCT00472030|Omalizumab|omalizumab|mesh-list
6032136|NCT00472030|Prednisone|prednisone|mesh-list
6032137|NCT00472030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6032138|NCT00472030|Glucocorticoids|glucocorticoids|mesh-ancestor
6032139|NCT00472030|Hormones|hormones|mesh-ancestor
6032140|NCT00472030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6032141|NCT00472030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032142|NCT00472030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6032143|NCT00472030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6032144|NCT00472030|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6032145|NCT00472030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6032146|NCT00472030|Respiratory System Agents|respiratory system agents|mesh-ancestor
5493983|NCT04671030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5493984|NCT04671030|Cholinergic Agents|cholinergic agents|mesh-ancestor
5493985|NCT04671030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5493986|NCT04671030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5493987|NCT04671030|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5493988|NCT04671030|Autonomic Agents|autonomic agents|mesh-ancestor
5493989|NCT04671030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5493990|NCT04671030|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5493991|NCT04671030|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5493992|NCT04671030|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6032147|NCT00472056|Cytarabine|cytarabine|mesh-list
6032148|NCT00472056|Rituximab|rituximab|mesh-list
6032149|NCT00472056|Etoposide|etoposide|mesh-list
6032150|NCT00472056|Melphalan|melphalan|mesh-list
6032151|NCT00472056|Carmustine|carmustine|mesh-list
6032152|NCT00472056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6032153|NCT00472056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6032154|NCT00472056|Immunologic Factors|immunologic factors|mesh-ancestor
6032155|NCT00472056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032156|NCT00472056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6032157|NCT00472056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6032158|NCT00472056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6032159|NCT00472056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6032160|NCT00472056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6032161|NCT00472056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6032162|NCT00472056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6032163|NCT00472056|Antimetabolites|antimetabolites|mesh-ancestor
6032164|NCT00472056|Antiviral Agents|antiviral agents|mesh-ancestor
6032165|NCT00472056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6032166|NCT00472056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6032167|NCT00472056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6032168|NCT00472056|Alkylating Agents|alkylating agents|mesh-ancestor
6032169|NCT00472056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6032170|NCT00472199|Pramipexole|pramipexole|mesh-list
6032171|NCT00472199|Antioxidants|antioxidants|mesh-ancestor
6032172|NCT00472199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6032173|NCT00472199|Protective Agents|protective agents|mesh-ancestor
6032174|NCT00472199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032175|NCT00472199|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6032176|NCT00472199|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6032177|NCT00472199|Dopamine Agonists|dopamine agonists|mesh-ancestor
6032178|NCT00472199|Dopamine Agents|dopamine agents|mesh-ancestor
6032179|NCT00472199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6032180|NCT00472303|Morphine|morphine|mesh-list
6032181|NCT00472303|Tapentadol|tapentadol|mesh-list
6032182|NCT00472303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6032183|NCT00472303|Narcotics|narcotics|mesh-ancestor
6032184|NCT00472303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6032185|NCT00472303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032186|NCT00472303|Analgesics|analgesics|mesh-ancestor
6032187|NCT00472303|Sensory System Agents|sensory system agents|mesh-ancestor
6032188|NCT00472303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6032189|NCT00472303|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6032190|NCT00472303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6032191|NCT00472303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6032192|NCT00472303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6032193|NCT00472303|Adrenergic Agents|adrenergic agents|mesh-ancestor
5493993|NCT04660890|Moxifloxacin|moxifloxacin|mesh-list
5493994|NCT04660890|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
5493995|NCT04660890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5493996|NCT04660890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5493997|NCT04660890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6032194|NCT00472303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6032195|NCT00472420|Rituximab|rituximab|mesh-list
6032196|NCT00472420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6032197|NCT00472420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6032198|NCT00472420|Immunologic Factors|immunologic factors|mesh-ancestor
6032199|NCT00472420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032200|NCT00472420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6032201|NCT00472641|Ziprasidone|ziprasidone|mesh-list
6032202|NCT00472641|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6032203|NCT00472641|Serotonin Agents|serotonin agents|mesh-ancestor
6032204|NCT00472641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6032205|NCT00472641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6032206|NCT00472641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032207|NCT00472641|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6032208|NCT00472641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6032209|NCT00472641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6032210|NCT00472641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5493998|NCT04660890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5493999|NCT04660890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5494000|NCT04660890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494001|NCT04660890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6032211|NCT00472641|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6032212|NCT00472641|Dopamine Agents|dopamine agents|mesh-ancestor
6032213|NCT00472797|Interferon beta-1a|interferon beta-1a|mesh-list
6032214|NCT00472797|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6032215|NCT00472797|Immunologic Factors|immunologic factors|mesh-ancestor
6032216|NCT00472797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032217|NCT00472797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5494002|NCT04660890|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5494003|NCT04660890|Contraceptive Agents|contraceptive agents|mesh-ancestor
5494004|NCT04660890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5494005|NCT04660890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494006|NCT04660890|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5494007|NCT04660890|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5494008|NCT04660890|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5494009|NCT04652206|Gemcitabine|gemcitabine|mesh-list
5494010|NCT04652206|Paclitaxel|paclitaxel|mesh-list
5494011|NCT04652206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5494012|NCT04652206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5494013|NCT04652206|Tubulin Modulators|tubulin modulators|mesh-ancestor
5494014|NCT04652206|Antimitotic Agents|antimitotic agents|mesh-ancestor
5494015|NCT04652206|Mitosis Modulators|mitosis modulators|mesh-ancestor
6032218|NCT00472797|Antiviral Agents|antiviral agents|mesh-ancestor
6032219|NCT00472797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6032220|NCT00472849|Cytarabine|cytarabine|mesh-list
6032221|NCT00472849|Rituximab|rituximab|mesh-list
6032222|NCT00472849|Oxaliplatin|oxaliplatin|mesh-list
6032223|NCT00472849|Fludarabine|fludarabine|mesh-list
6032224|NCT00472849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6032225|NCT00472849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6032226|NCT00472849|Immunologic Factors|immunologic factors|mesh-ancestor
6032227|NCT00472849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032228|NCT00472849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6032229|NCT00472849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6032230|NCT00472849|Antimetabolites|antimetabolites|mesh-ancestor
6032231|NCT00472849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6032232|NCT00472849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6032233|NCT00472849|Antiviral Agents|antiviral agents|mesh-ancestor
6032234|NCT00472849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6032235|NCT00473083|Minocycline|minocycline|mesh-list
6032236|NCT00473083|Clindamycin|clindamycin|mesh-list
6032237|NCT00473083|Clindamycin palmitate|clindamycin palmitate|mesh-list
6032238|NCT00473083|Clindamycin phosphate|clindamycin phosphate|mesh-list
6032239|NCT00473083|Triamcinolone|triamcinolone|mesh-list
6032240|NCT00473083|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6032241|NCT00473083|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6032242|NCT00473083|Hydrocortisone|hydrocortisone|mesh-list
6032243|NCT00473083|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6032244|NCT00473083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6032245|NCT00473083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6032246|NCT00473083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6032247|NCT00473083|Glucocorticoids|glucocorticoids|mesh-ancestor
5494016|NCT04652206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494017|NCT04652206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6032248|NCT00473083|Hormones|hormones|mesh-ancestor
6032249|NCT00473083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6032250|NCT00473083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032251|NCT00473083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6032252|NCT00473083|Immunologic Factors|immunologic factors|mesh-ancestor
6032253|NCT00473083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6032254|NCT00473083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6032255|NCT00473083|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6032256|NCT00473265|Teriparatide|teriparatide|mesh-list
6032257|NCT00473265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6032258|NCT00473265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032259|NCT00473265|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6032260|NCT00473330|Ranibizumab|ranibizumab|mesh-list
6032261|NCT00473330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6032262|NCT00473330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6032263|NCT00473330|Growth Substances|growth substances|mesh-ancestor
6032264|NCT00473330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032265|NCT00473330|Growth Inhibitors|growth inhibitors|mesh-ancestor
6032266|NCT00473330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6032267|NCT00473382|Ranibizumab|ranibizumab|mesh-list
6032268|NCT00473382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6032269|NCT00473382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6032270|NCT00473382|Growth Substances|growth substances|mesh-ancestor
6032271|NCT00473382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032272|NCT00473382|Growth Inhibitors|growth inhibitors|mesh-ancestor
6032273|NCT00473382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6032274|NCT00473434|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6032275|NCT00473434|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6032276|NCT00473434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6032277|NCT00473434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6032278|NCT00473434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032279|NCT00473434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6032280|NCT00473434|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6032281|NCT00473434|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6032282|NCT00473434|Serotonin Agents|serotonin agents|mesh-ancestor
6032283|NCT00473434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6032284|NCT00473434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6032285|NCT00473434|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6032286|NCT00473434|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6032287|NCT00473434|Dopamine Agents|dopamine agents|mesh-ancestor
6032288|NCT00473512|Dexamethasone|dexamethasone|mesh-list
6032289|NCT00473512|Abiraterone Acetate|abiraterone acetate|mesh-list
6032290|NCT00473512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6032291|NCT00473512|Antiemetics|antiemetics|mesh-ancestor
6032292|NCT00473512|Autonomic Agents|autonomic agents|mesh-ancestor
6032293|NCT00473512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6032294|NCT00473512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032295|NCT00473512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6032296|NCT00473512|Glucocorticoids|glucocorticoids|mesh-ancestor
6032297|NCT00473512|Hormones|hormones|mesh-ancestor
6032298|NCT00473512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6032299|NCT00473512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6032300|NCT00473512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6032301|NCT00473512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6032302|NCT00473512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6032303|NCT00473512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6032304|NCT00473512|Hormone Antagonists|hormone antagonists|mesh-ancestor
6032305|NCT00473512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6032306|NCT00473590|Bevacizumab|bevacizumab|mesh-list
6032307|NCT00473590|Bortezomib|bortezomib|mesh-list
6032308|NCT00473590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6032309|NCT00473590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6032310|NCT00473590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6032311|NCT00473590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6032312|NCT00473590|Growth Substances|growth substances|mesh-ancestor
6032313|NCT00473590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032314|NCT00473590|Growth Inhibitors|growth inhibitors|mesh-ancestor
6032315|NCT00473642|Ranibizumab|ranibizumab|mesh-list
6032316|NCT00473642|Verteporfin|verteporfin|mesh-list
6032317|NCT00473642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6032318|NCT00473642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6032319|NCT00473642|Growth Substances|growth substances|mesh-ancestor
6032320|NCT00473642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032321|NCT00473642|Growth Inhibitors|growth inhibitors|mesh-ancestor
6032322|NCT00473642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6032323|NCT00473642|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6032324|NCT00473642|Dermatologic Agents|dermatologic agents|mesh-ancestor
6032325|NCT00473655|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6032326|NCT00473655|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6032327|NCT00473655|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6032328|NCT00473655|Antimetabolites|antimetabolites|mesh-ancestor
6032329|NCT00473655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6032330|NCT00473655|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6032331|NCT00473655|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6032332|NCT00473655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5494018|NCT04652206|Antimetabolites|antimetabolites|mesh-ancestor
5494019|NCT04652206|Antiviral Agents|antiviral agents|mesh-ancestor
5494020|NCT04652206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5494021|NCT04652206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5494022|NCT04652206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6032333|NCT00473694|Glycopyrrolate|glycopyrrolate|mesh-list
6032334|NCT00473694|Rocuronium|rocuronium|mesh-list
6032335|NCT00473694|Vecuronium Bromide|vecuronium bromide|mesh-list
6032336|NCT00473694|Neostigmine|neostigmine|mesh-list
6032337|NCT00473694|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6032338|NCT00473694|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6032339|NCT00473694|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6032340|NCT00473694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6032341|NCT00473694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032342|NCT00473694|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6032343|NCT00473694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6032344|NCT00473694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6032345|NCT00473694|Cholinergic Agents|cholinergic agents|mesh-ancestor
6032346|NCT00473694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6032347|NCT00473694|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6032348|NCT00473694|Autonomic Agents|autonomic agents|mesh-ancestor
6032349|NCT00473694|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6032350|NCT00473694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6032351|NCT00473694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6032352|NCT00473694|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
6032353|NCT00473746|Dexamethasone|dexamethasone|mesh-list
6032354|NCT00473746|Prednisone|prednisone|mesh-list
6032355|NCT00473746|Prednisolone|prednisolone|mesh-list
6456682|NCT00433186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6456683|NCT00433186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6456684|NCT00433186|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6456685|NCT00433186|Antitubercular Agents|antitubercular agents|mesh-ancestor
6456686|NCT00433186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6456687|NCT00433186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6456688|NCT00433186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6456689|NCT00433186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456690|NCT00433225|Gatifloxacin|gatifloxacin|mesh-list
6456691|NCT00433225|Prednisolone|prednisolone|mesh-list
6456692|NCT00433225|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6456693|NCT00433225|Methylprednisolone|methylprednisolone|mesh-list
6456694|NCT00433225|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6456695|NCT00433225|Prednisolone acetate|prednisolone acetate|mesh-list
6456696|NCT00433225|Ketorolac|ketorolac|mesh-list
6456697|NCT00433225|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5494023|NCT04652206|Immunologic Factors|immunologic factors|mesh-ancestor
6032356|NCT00473746|Abiraterone Acetate|abiraterone acetate|mesh-list
6032357|NCT00473746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6456698|NCT00433225|Prednisolone phosphate|prednisolone phosphate|mesh-list
6456699|NCT00433225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6456700|NCT00433225|Glucocorticoids|glucocorticoids|mesh-ancestor
6456701|NCT00433225|Hormones|hormones|mesh-ancestor
6456702|NCT00433225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6456703|NCT00433225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456704|NCT00433225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6456705|NCT00433225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5494024|NCT04652206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032358|NCT00473746|Antiemetics|antiemetics|mesh-ancestor
6032359|NCT00473746|Autonomic Agents|autonomic agents|mesh-ancestor
6032360|NCT00473746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6032361|NCT00473746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032362|NCT00473746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6032363|NCT00473746|Glucocorticoids|glucocorticoids|mesh-ancestor
6032364|NCT00473746|Hormones|hormones|mesh-ancestor
6032365|NCT00473746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6032366|NCT00473746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6032367|NCT00473746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6032368|NCT00473746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6032369|NCT00473746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6032370|NCT00473746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6032371|NCT00473746|Hormone Antagonists|hormone antagonists|mesh-ancestor
6032372|NCT00473746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6032373|NCT00473824|Immunoglobulins|immunoglobulins|mesh-list
6032374|NCT00473824|Antibodies|antibodies|mesh-list
6032375|NCT00473824|gamma-Globulins|gamma-globulins|mesh-list
6032376|NCT00473824|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6032377|NCT00473824|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6032378|NCT00473824|Immunologic Factors|immunologic factors|mesh-ancestor
6032379|NCT00473824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032380|NCT00473837|Chloroquine|chloroquine|mesh-list
6032381|NCT00473837|Amebicides|amebicides|mesh-ancestor
6032382|NCT00473837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6032383|NCT00473837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6032384|NCT00473837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5494025|NCT04647903|Amphetamine|amphetamine|mesh-list
5494026|NCT04647903|Dextroamphetamine|dextroamphetamine|mesh-list
5494027|NCT04647903|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5494028|NCT04647903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494029|NCT04647903|Sympathomimetics|sympathomimetics|mesh-ancestor
5494030|NCT04647903|Autonomic Agents|autonomic agents|mesh-ancestor
5494031|NCT04647903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5494032|NCT04647903|Dopamine Agents|dopamine agents|mesh-ancestor
5494033|NCT04647903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5494034|NCT04647903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494035|NCT04647903|Adrenergic Agents|adrenergic agents|mesh-ancestor
6032385|NCT00473837|Antimalarials|antimalarials|mesh-ancestor
6032386|NCT00473837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6032387|NCT00473876|Metformin|metformin|mesh-list
6032388|NCT00473876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6032389|NCT00473876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032390|NCT00473889|Paclitaxel|paclitaxel|mesh-list
6032391|NCT00473889|Carboplatin|carboplatin|mesh-list
6032392|NCT00473889|Vorinostat|vorinostat|mesh-list
6032393|NCT00473889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6032394|NCT00473889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6032395|NCT00473889|Tubulin Modulators|tubulin modulators|mesh-ancestor
6032396|NCT00473889|Antimitotic Agents|antimitotic agents|mesh-ancestor
6032397|NCT00473889|Mitosis Modulators|mitosis modulators|mesh-ancestor
6032398|NCT00473889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6032399|NCT00473889|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6032400|NCT00473889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6053564|NCT00596362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6053565|NCT00596362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6053566|NCT00596362|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6032401|NCT00474045|Insulin|insulin|mesh-list
6032402|NCT00474045|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5494036|NCT04647903|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5494037|NCT04647903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5494038|NCT04647903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5494039|NCT04647903|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5494040|NCT04642378|Insulin|insulin|mesh-list
6032403|NCT00474045|Insulin Aspart|insulin aspart|mesh-list
6032404|NCT00474045|Insulin Detemir|insulin detemir|mesh-list
6032405|NCT00474045|Insulin, Isophane|insulin, isophane|mesh-list
6032406|NCT00474045|Isophane Insulin, Human|isophane insulin, human|mesh-list
6032407|NCT00474045|Isophane insulin, beef|isophane insulin, beef|mesh-list
6032408|NCT00474045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6032409|NCT00474045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032410|NCT00474058|Rotigotine|rotigotine|mesh-list
6032411|NCT00474058|Dopamine Agonists|dopamine agonists|mesh-ancestor
6032412|NCT00474058|Dopamine Agents|dopamine agents|mesh-ancestor
6032413|NCT00474058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6032414|NCT00474058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6032415|NCT00474058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032416|NCT00474123|Simvastatin|simvastatin|mesh-list
6032417|NCT00474123|Ezetimibe|ezetimibe|mesh-list
6032418|NCT00474123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6032419|NCT00474123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6032420|NCT00474123|Antimetabolites|antimetabolites|mesh-ancestor
6032421|NCT00474123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6032422|NCT00474123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6032423|NCT00474123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6032424|NCT00474123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6032425|NCT00474175|Benzocaine|benzocaine|mesh-list
6032426|NCT00474175|Anesthetics, Local|anesthetics, local|mesh-ancestor
6032427|NCT00474175|Anesthetics|anesthetics|mesh-ancestor
6032428|NCT00474175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6032429|NCT00474175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032430|NCT00474175|Sensory System Agents|sensory system agents|mesh-ancestor
6032431|NCT00474175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6032432|NCT00474201|Ritonavir|ritonavir|mesh-list
6032433|NCT00474201|Lopinavir|lopinavir|mesh-list
6032434|NCT00474201|Gemfibrozil|gemfibrozil|mesh-list
6032435|NCT00474201|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6032436|NCT00474201|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6032437|NCT00474201|Protease Inhibitors|protease inhibitors|mesh-ancestor
6032438|NCT00474201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6032439|NCT00474201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456706|NCT00433225|Antiemetics|antiemetics|mesh-ancestor
6456707|NCT00433225|Autonomic Agents|autonomic agents|mesh-ancestor
6456708|NCT00433225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6456709|NCT00433225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6456710|NCT00433225|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6032440|NCT00474201|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6032441|NCT00474201|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6032442|NCT00474201|Antiviral Agents|antiviral agents|mesh-ancestor
6032443|NCT00474201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6032444|NCT00474201|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6032445|NCT00474201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6032446|NCT00474201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6032447|NCT00474201|Antimetabolites|antimetabolites|mesh-ancestor
6032448|NCT00474201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6032449|NCT00474201|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6032450|NCT00474240|Atorvastatin|atorvastatin|mesh-list
6032451|NCT00474240|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6032452|NCT00474240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6032453|NCT00474240|Antimetabolites|antimetabolites|mesh-ancestor
6032454|NCT00474240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6032455|NCT00474240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6032456|NCT00474240|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6032457|NCT00474240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6032458|NCT00474253|Rocuronium|rocuronium|mesh-list
6032459|NCT00474253|Succinylcholine|succinylcholine|mesh-list
6032460|NCT00474253|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6032461|NCT00474253|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6032462|NCT00474253|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6032463|NCT00474253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6032464|NCT00474253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456711|NCT00433225|Protective Agents|protective agents|mesh-ancestor
5494041|NCT04642378|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6032465|NCT00474253|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
6032466|NCT00474383|Abiraterone Acetate|abiraterone acetate|mesh-list
6032467|NCT00474383|Glucocorticoids|glucocorticoids|mesh-list
6032468|NCT00474383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6032469|NCT00474383|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6032470|NCT00474383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6032471|NCT00474383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6032472|NCT00474383|Hormone Antagonists|hormone antagonists|mesh-ancestor
6032473|NCT00474383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6032474|NCT00474383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032475|NCT00474383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6032476|NCT00474383|Hormones|hormones|mesh-ancestor
6032477|NCT00474487|Vaccines|vaccines|mesh-list
6032478|NCT00474487|Immunologic Factors|immunologic factors|mesh-ancestor
6032479|NCT00474487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032480|NCT00474526|Vaccines|vaccines|mesh-list
6032481|NCT00474526|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6032482|NCT00474526|Immunologic Factors|immunologic factors|mesh-ancestor
6032483|NCT00474526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032484|NCT00474539|Vaccines|vaccines|mesh-list
6032485|NCT00474539|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6032486|NCT00474539|Immunologic Factors|immunologic factors|mesh-ancestor
6032487|NCT00474539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032488|NCT00474630|Naltrexone|naltrexone|mesh-list
6032489|NCT00474630|Bupropion|bupropion|mesh-list
6032490|NCT00474630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6032491|NCT00474630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6032492|NCT00474630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032493|NCT00474630|Sensory System Agents|sensory system agents|mesh-ancestor
6032494|NCT00474630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6032495|NCT00474630|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6032496|NCT00474630|Antidepressive Agents|antidepressive agents|mesh-ancestor
6032497|NCT00474630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6032498|NCT00474630|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6032499|NCT00474630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5494042|NCT04642378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5494043|NCT04642378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494044|NCT04632264|Oxytocin|oxytocin|mesh-list
5494045|NCT04632264|Oxytocics|oxytocics|mesh-ancestor
5494046|NCT04632264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5494047|NCT04632264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032500|NCT00474630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6032501|NCT00474630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6032502|NCT00474630|Dopamine Agents|dopamine agents|mesh-ancestor
6032503|NCT00474630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6032504|NCT00474630|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6032505|NCT00474630|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6032506|NCT00474630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6032507|NCT00474708|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6032508|NCT00474708|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6032509|NCT00474708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5494048|NCT04629872|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
5494049|NCT04629872|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5494050|NCT04629872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494051|NCT04629872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5494052|NCT04629872|Immunologic Factors|immunologic factors|mesh-ancestor
5494053|NCT04629872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494054|NCT04616248|Poly I-C|poly i-c|mesh-list
5494055|NCT04616248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5494056|NCT04616248|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6032510|NCT00474708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6032511|NCT00474708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6032512|NCT00474708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6032513|NCT00474708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032514|NCT00474708|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6032515|NCT00474708|Antidepressive Agents|antidepressive agents|mesh-ancestor
6032516|NCT00474708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6032517|NCT00474786|Sirolimus|sirolimus|mesh-list
6032518|NCT00474786|Sorafenib|sorafenib|mesh-list
6032519|NCT00474786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6032520|NCT00474786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6032521|NCT00474786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6032522|NCT00474786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6032523|NCT00474786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6032524|NCT00474786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6032525|NCT00474786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6032526|NCT00474786|Antifungal Agents|antifungal agents|mesh-ancestor
6032527|NCT00474786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6032528|NCT00474786|Immunologic Factors|immunologic factors|mesh-ancestor
6032529|NCT00474786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032530|NCT00474812|Dasatinib|dasatinib|mesh-list
6032531|NCT00474812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6032532|NCT00474812|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6032533|NCT00474812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6032534|NCT00474812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6032535|NCT00474851|Norethindrone|norethindrone|mesh-list
6032536|NCT00474851|Norethindrone Acetate|norethindrone acetate|mesh-list
6032537|NCT00474851|Estrogens|estrogens|mesh-list
6032538|NCT00474851|Hormones|hormones|mesh-ancestor
6032539|NCT00474851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6032540|NCT00474851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032541|NCT00474851|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6032542|NCT00474851|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6032543|NCT00474851|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6032544|NCT00474851|Contraceptive Agents|contraceptive agents|mesh-ancestor
6032545|NCT00474851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6032546|NCT00474851|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5494057|NCT04616248|Antibodies|antibodies|mesh-list
5494058|NCT04616248|Immunoglobulins|immunoglobulins|mesh-list
5494059|NCT04616248|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5494060|NCT04616248|Poly ICLC|poly iclc|mesh-list
6032547|NCT00474851|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6032548|NCT00474903|Aspirin|aspirin|mesh-list
6032549|NCT00474903|Esomeprazole|esomeprazole|mesh-list
6032550|NCT00474903|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6032551|NCT00474903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6032552|NCT00474903|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6032553|NCT00474903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6032554|NCT00474903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6032555|NCT00474903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6032556|NCT00474903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6032557|NCT00474903|Analgesics|analgesics|mesh-ancestor
6032558|NCT00474903|Sensory System Agents|sensory system agents|mesh-ancestor
6032559|NCT00474903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6032560|NCT00474903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032561|NCT00474903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6032562|NCT00474903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6032563|NCT00474903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6032564|NCT00474903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6032565|NCT00474903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6032566|NCT00474903|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6032567|NCT00474903|Antipyretics|antipyretics|mesh-ancestor
6032568|NCT00474929|Everolimus|everolimus|mesh-list
6032569|NCT00474929|Sorafenib|sorafenib|mesh-list
6032570|NCT00474929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6032571|NCT00474929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5494061|NCT04616248|Flt3 ligand protein|flt3 ligand protein|mesh-list
6032572|NCT00474929|Immunologic Factors|immunologic factors|mesh-ancestor
6032573|NCT00474929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032574|NCT00474929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6032575|NCT00474929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6032576|NCT00474929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6032577|NCT00474955|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6032578|NCT00474955|Antiviral Agents|antiviral agents|mesh-ancestor
6032579|NCT00474955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6032580|NCT00474994|Sunitinib|sunitinib|mesh-list
6032581|NCT00474994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6032582|NCT00474994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6032583|NCT00474994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6032584|NCT00474994|Growth Substances|growth substances|mesh-ancestor
6032585|NCT00474994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032586|NCT00474994|Growth Inhibitors|growth inhibitors|mesh-ancestor
6032587|NCT00474994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6032588|NCT00474994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6032589|NCT00474994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6032590|NCT00475020|Vidarabine|vidarabine|mesh-list
6032591|NCT00475020|Fludarabine|fludarabine|mesh-list
6032592|NCT00475020|Fludarabine phosphate|fludarabine phosphate|mesh-list
6032593|NCT00475020|Busulfan|busulfan|mesh-list
6032594|NCT00475020|Thymoglobulin|thymoglobulin|mesh-list
6032595|NCT00475020|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6032596|NCT00475020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6032597|NCT00475020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6032598|NCT00475020|Antimetabolites|antimetabolites|mesh-ancestor
6032599|NCT00475020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6032600|NCT00475020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6032601|NCT00475020|Immunologic Factors|immunologic factors|mesh-ancestor
6032602|NCT00475020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032603|NCT00475020|Antiviral Agents|antiviral agents|mesh-ancestor
6032604|NCT00475020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6032605|NCT00475020|Alkylating Agents|alkylating agents|mesh-ancestor
6032606|NCT00475020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6032607|NCT00475020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6032608|NCT00475033|Vaccines|vaccines|mesh-list
6032609|NCT00475033|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6032610|NCT00475033|Immunologic Factors|immunologic factors|mesh-ancestor
6032611|NCT00475033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032612|NCT00475085|Dexamethasone|dexamethasone|mesh-list
6032613|NCT00475085|Aprepitant|aprepitant|mesh-list
6032614|NCT00475085|Palonosetron|palonosetron|mesh-list
6032615|NCT00475085|Granisetron|granisetron|mesh-list
6032616|NCT00475085|Prochlorperazine|prochlorperazine|mesh-list
6032617|NCT00475085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6032618|NCT00475085|Antiemetics|antiemetics|mesh-ancestor
6032619|NCT00475085|Autonomic Agents|autonomic agents|mesh-ancestor
6032620|NCT00475085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6032621|NCT00475085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032622|NCT00475085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6032623|NCT00475085|Glucocorticoids|glucocorticoids|mesh-ancestor
6032624|NCT00475085|Hormones|hormones|mesh-ancestor
6032625|NCT00475085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6032626|NCT00475085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6032627|NCT00475085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6032628|NCT00475085|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6032629|NCT00475085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6032630|NCT00475085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6032631|NCT00475085|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6032632|NCT00475085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6032633|NCT00475085|Serotonin Agents|serotonin agents|mesh-ancestor
6032634|NCT00475085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6032635|NCT00475085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6032636|NCT00475085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6032637|NCT00475085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6032638|NCT00475085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6032639|NCT00475085|Dopamine Agents|dopamine agents|mesh-ancestor
6032640|NCT00475150|Cediranib|cediranib|mesh-list
6032641|NCT00475150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6032642|NCT00475150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6032643|NCT00475150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6032644|NCT00475150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6032645|NCT00475176|Ribavirin|ribavirin|mesh-list
6032646|NCT00475176|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6032647|NCT00475176|Antimetabolites|antimetabolites|mesh-ancestor
5494062|NCT04616248|Immunologic Factors|immunologic factors|mesh-ancestor
5494063|NCT04616248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494064|NCT04616248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5494065|NCT04616248|Interferon Inducers|interferon inducers|mesh-ancestor
5494066|NCT04616248|Laxatives|laxatives|mesh-ancestor
5494067|NCT04616248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5494068|NCT04616248|Antiviral Agents|antiviral agents|mesh-ancestor
5494069|NCT04616248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5494070|NCT04616248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5494071|NCT04616248|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5494072|NCT04616248|Protective Agents|protective agents|mesh-ancestor
6032648|NCT00475176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6032649|NCT00475176|Antiviral Agents|antiviral agents|mesh-ancestor
6032650|NCT00475176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6032651|NCT00475215|Rocuronium|rocuronium|mesh-list
6032652|NCT00475215|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6032653|NCT00475215|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6032654|NCT00475215|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6032655|NCT00475215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6032656|NCT00475215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032657|NCT00475228|Levonorgestrel|levonorgestrel|mesh-list
6032658|NCT00475228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6032659|NCT00475228|Contraceptive Agents|contraceptive agents|mesh-ancestor
6032660|NCT00475228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6032661|NCT00475228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032662|NCT00475228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6032663|NCT00475228|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6032664|NCT00475228|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6032665|NCT00475306|Diphenhydramine|diphenhydramine|mesh-list
6032666|NCT00475306|Promethazine|promethazine|mesh-list
6032667|NCT00475306|Metoclopramide|metoclopramide|mesh-list
6032668|NCT00475306|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6032669|NCT00475306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6032670|NCT00475306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6032671|NCT00475306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032672|NCT00475306|Anesthetics, Local|anesthetics, local|mesh-ancestor
6032673|NCT00475306|Anesthetics|anesthetics|mesh-ancestor
6032674|NCT00475306|Sensory System Agents|sensory system agents|mesh-ancestor
6032675|NCT00475306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6032676|NCT00475306|Antiemetics|antiemetics|mesh-ancestor
6032677|NCT00475306|Autonomic Agents|autonomic agents|mesh-ancestor
6032678|NCT00475306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6032679|NCT00475306|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6032680|NCT00475306|Histamine Antagonists|histamine antagonists|mesh-ancestor
6032681|NCT00475306|Histamine Agents|histamine agents|mesh-ancestor
6032682|NCT00475306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6032683|NCT00475306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6032684|NCT00475306|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6032685|NCT00475306|Antipruritics|antipruritics|mesh-ancestor
6032686|NCT00475306|Dermatologic Agents|dermatologic agents|mesh-ancestor
6032687|NCT00475306|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6032688|NCT00475306|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6032689|NCT00475306|Dopamine Agents|dopamine agents|mesh-ancestor
6032690|NCT00475319|Rebamipide|rebamipide|mesh-list
6032691|NCT00475319|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6032692|NCT00475319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6032693|NCT00475319|Antioxidants|antioxidants|mesh-ancestor
6032694|NCT00475319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6032695|NCT00475319|Protective Agents|protective agents|mesh-ancestor
6032696|NCT00475319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032697|NCT00475319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6032698|NCT00475423|Rituximab|rituximab|mesh-list
6032699|NCT00475423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6032700|NCT00475423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6456712|NCT00433225|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6456713|NCT00433225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6456714|NCT00433225|Analgesics|analgesics|mesh-ancestor
5494073|NCT04607928|Pirfenidone|pirfenidone|mesh-list
6032701|NCT00475423|Immunologic Factors|immunologic factors|mesh-ancestor
5494074|NCT04607928|Analgesics|analgesics|mesh-ancestor
5494075|NCT04607928|Sensory System Agents|sensory system agents|mesh-ancestor
5494076|NCT04607928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5494077|NCT04607928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032702|NCT00475423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032703|NCT00475423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6456715|NCT00433225|Sensory System Agents|sensory system agents|mesh-ancestor
6032704|NCT00475501|Methyltestosterone|methyltestosterone|mesh-list
6032705|NCT00475501|Finasteride|finasteride|mesh-list
6032706|NCT00475501|Testosterone|testosterone|mesh-list
6032707|NCT00475501|Testosterone undecanoate|testosterone undecanoate|mesh-list
6032708|NCT00475501|Testosterone enanthate|testosterone enanthate|mesh-list
6032709|NCT00475501|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6032710|NCT00475501|Androgens|androgens|mesh-ancestor
6032711|NCT00475501|Hormones|hormones|mesh-ancestor
6032712|NCT00475501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6032713|NCT00475501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032714|NCT00475501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6456716|NCT00433225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6456717|NCT00433225|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6456718|NCT00433225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6456719|NCT00433225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456720|NCT00433225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6456721|NCT00433225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6456722|NCT00433225|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6032715|NCT00475501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6032716|NCT00475501|Anabolic Agents|anabolic agents|mesh-ancestor
6032717|NCT00475501|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6032718|NCT00475501|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6032719|NCT00475501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6032720|NCT00475501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6032721|NCT00475501|Hormone Antagonists|hormone antagonists|mesh-ancestor
6032722|NCT00475501|Urological Agents|urological agents|mesh-ancestor
6032723|NCT00475670|Paclitaxel|paclitaxel|mesh-list
6032724|NCT00475670|Docetaxel|docetaxel|mesh-list
6032725|NCT00475670|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6032726|NCT00475670|Trastuzumab|trastuzumab|mesh-list
6032727|NCT00475670|Taxane|taxane|mesh-list
6032728|NCT00475670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6032729|NCT00475670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6032730|NCT00475670|Tubulin Modulators|tubulin modulators|mesh-ancestor
6032731|NCT00475670|Antimitotic Agents|antimitotic agents|mesh-ancestor
6032732|NCT00475670|Mitosis Modulators|mitosis modulators|mesh-ancestor
6032733|NCT00475670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6032734|NCT00475670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6032735|NCT00475735|Methylphenidate|methylphenidate|mesh-list
6032736|NCT00475735|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6032737|NCT00475735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032738|NCT00475735|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6032739|NCT00475735|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6032740|NCT00475735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6032741|NCT00475735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6032742|NCT00475735|Dopamine Agents|dopamine agents|mesh-ancestor
6032743|NCT00475735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6032744|NCT00475852|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6032745|NCT00475852|Natriuretic Agents|natriuretic agents|mesh-ancestor
6032746|NCT00475852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032747|NCT00475865|Teriflunomide|teriflunomide|mesh-list
6032748|NCT00475865|Glatiramer Acetate|glatiramer acetate|mesh-list
6032749|NCT00475865|(T,G)-A-L|(t,g)-a-l|mesh-list
6032750|NCT00475865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6032751|NCT00475865|Immunologic Factors|immunologic factors|mesh-ancestor
6032752|NCT00475865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032753|NCT00475865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6032754|NCT00475865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6032755|NCT00475865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6032756|NCT00475865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6456723|NCT00433225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6456724|NCT00433225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6456725|NCT00433225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6456726|NCT00433277|Cyclosporine|cyclosporine|mesh-list
6456727|NCT00433277|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6456728|NCT00433277|Cyclosporins|cyclosporins|mesh-list
6456729|NCT00433277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6456730|NCT00433277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456731|NCT00433277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6456732|NCT00433277|Immunologic Factors|immunologic factors|mesh-ancestor
6456733|NCT00433277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456734|NCT00433277|Antifungal Agents|antifungal agents|mesh-ancestor
6456735|NCT00433277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6032757|NCT00475865|Analgesics|analgesics|mesh-ancestor
6456736|NCT00433277|Dermatologic Agents|dermatologic agents|mesh-ancestor
6032758|NCT00475865|Sensory System Agents|sensory system agents|mesh-ancestor
6032759|NCT00475865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6032760|NCT00475865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6032761|NCT00475878|Citalopram|citalopram|mesh-list
6032762|NCT00475878|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6032763|NCT00475878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6032764|NCT00475878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6032765|NCT00475878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6032766|NCT00475878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6032767|NCT00475878|Serotonin Agents|serotonin agents|mesh-ancestor
6032768|NCT00475878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032769|NCT00475878|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6032770|NCT00475878|Antidepressive Agents|antidepressive agents|mesh-ancestor
6032771|NCT00475878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6032772|NCT00475904|Gabapentin|gabapentin|mesh-list
6032773|NCT00475904|Analgesics|analgesics|mesh-ancestor
6032774|NCT00475904|Sensory System Agents|sensory system agents|mesh-ancestor
6032775|NCT00475904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5494078|NCT04607928|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5494079|NCT04607928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5494080|NCT04607928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5494081|NCT04607928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5494082|NCT04607928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6032776|NCT00475904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032777|NCT00475904|Anticonvulsants|anticonvulsants|mesh-ancestor
6032778|NCT00475904|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6032779|NCT00475904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6032780|NCT00475904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6032781|NCT00475904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6032782|NCT00475904|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6032783|NCT00475904|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6032784|NCT00475904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6032785|NCT00475904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6032786|NCT00475904|Antimanic Agents|antimanic agents|mesh-ancestor
6032787|NCT00476008|Memantine|memantine|mesh-list
6032788|NCT00476008|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6032789|NCT00476008|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6032790|NCT00476008|Dopamine Agents|dopamine agents|mesh-ancestor
6032791|NCT00476008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6032792|NCT00476008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6032793|NCT00476008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032794|NCT00476008|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6032795|NCT00476008|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6032796|NCT00476021|Levonorgestrel|levonorgestrel|mesh-list
6032797|NCT00476021|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6032798|NCT00476021|Contraceptive Agents|contraceptive agents|mesh-ancestor
6032799|NCT00476021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6032800|NCT00476021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032801|NCT00476021|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6032802|NCT00476021|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6032803|NCT00476021|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6032804|NCT00476047|Tositumomab I-131|tositumomab i-131|mesh-list
6032805|NCT00476047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6032806|NCT00476086|Gemcitabine|gemcitabine|mesh-list
6032807|NCT00476086|Oxaliplatin|oxaliplatin|mesh-list
6032808|NCT00476086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6456737|NCT00433277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6456738|NCT00433277|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6456739|NCT00433277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6456740|NCT00433316|Ropivacaine|ropivacaine|mesh-list
6456741|NCT00433316|Anesthetics, Local|anesthetics, local|mesh-ancestor
6456742|NCT00433316|Anesthetics|anesthetics|mesh-ancestor
6456743|NCT00433316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6456744|NCT00433316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456745|NCT00433316|Sensory System Agents|sensory system agents|mesh-ancestor
6456746|NCT00433316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6032809|NCT00476086|Antimetabolites|antimetabolites|mesh-ancestor
6032810|NCT00476086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6032811|NCT00476086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6032812|NCT00476086|Antiviral Agents|antiviral agents|mesh-ancestor
6032813|NCT00476086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6032814|NCT00476086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6032815|NCT00476086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6456747|NCT00433342|Floxacillin|floxacillin|mesh-list
6032816|NCT00476086|Immunologic Factors|immunologic factors|mesh-ancestor
6032817|NCT00476086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032818|NCT00476151|Ketamine|ketamine|mesh-list
6032819|NCT00476151|Amitriptyline|amitriptyline|mesh-list
6032820|NCT00476151|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6032821|NCT00476151|Analgesics|analgesics|mesh-ancestor
6032822|NCT00476151|Sensory System Agents|sensory system agents|mesh-ancestor
6032823|NCT00476151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6032824|NCT00476151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032825|NCT00476151|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6032826|NCT00476151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6032827|NCT00476151|Anesthetics, General|anesthetics, general|mesh-ancestor
6032828|NCT00476151|Anesthetics|anesthetics|mesh-ancestor
6032829|NCT00476151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6032830|NCT00476151|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6032831|NCT00476151|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6032832|NCT00476151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6032833|NCT00476151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6032834|NCT00476151|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6032835|NCT00476151|Antidepressive Agents|antidepressive agents|mesh-ancestor
6032836|NCT00476151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6032837|NCT00476151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6032838|NCT00476151|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6032839|NCT00476151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6032840|NCT00476151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6032841|NCT00476151|Adrenergic Agents|adrenergic agents|mesh-ancestor
6032842|NCT00476151|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6032843|NCT00476151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6032844|NCT00476229|Rituximab|rituximab|mesh-list
6032845|NCT00476229|Thymoglobulin|thymoglobulin|mesh-list
6032846|NCT00476229|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6032847|NCT00476229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6032848|NCT00476229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6032849|NCT00476229|Immunologic Factors|immunologic factors|mesh-ancestor
6032850|NCT00476229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032851|NCT00476229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6032852|NCT00476229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6032853|NCT00476242|Naltrexone|naltrexone|mesh-list
6032854|NCT00476242|Memantine|memantine|mesh-list
6032855|NCT00476242|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6032856|NCT00476242|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6032857|NCT00476242|Dopamine Agents|dopamine agents|mesh-ancestor
6032858|NCT00476242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6032859|NCT00476242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6032860|NCT00476242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032861|NCT00476242|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6032862|NCT00476242|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6032863|NCT00476242|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6032864|NCT00476242|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6032865|NCT00476242|Sensory System Agents|sensory system agents|mesh-ancestor
6032866|NCT00476242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6032867|NCT00476476|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6032868|NCT00476476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6032869|NCT00476476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6032870|NCT00476476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6032871|NCT00476476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6032872|NCT00476593|Dexamethasone|dexamethasone|mesh-list
6032873|NCT00476593|Diclofenac|diclofenac|mesh-list
5494083|NCT04564846|Insulin|insulin|mesh-list
5494084|NCT04564846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5494085|NCT04564846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494086|NCT04552223|Nivolumab|nivolumab|mesh-list
5494087|NCT04552223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5494088|NCT04552223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5494089|NCT04552223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5494090|NCT04552223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494091|NCT04539366|Cyclophosphamide|cyclophosphamide|mesh-list
6032874|NCT00476593|Lactitol|lactitol|mesh-list
6032875|NCT00476593|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6032876|NCT00476593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6032877|NCT00476593|Antiemetics|antiemetics|mesh-ancestor
6032878|NCT00476593|Autonomic Agents|autonomic agents|mesh-ancestor
6032879|NCT00476593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6032880|NCT00476593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456748|NCT00433342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6032881|NCT00476593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6032882|NCT00476593|Glucocorticoids|glucocorticoids|mesh-ancestor
6032883|NCT00476593|Hormones|hormones|mesh-ancestor
6032884|NCT00476593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6032885|NCT00476593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6032886|NCT00476593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6032887|NCT00476593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6032888|NCT00476593|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6032889|NCT00476593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6032890|NCT00476593|Analgesics|analgesics|mesh-ancestor
6032891|NCT00476593|Sensory System Agents|sensory system agents|mesh-ancestor
6032892|NCT00476593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6032893|NCT00476593|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6032894|NCT00476593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6032895|NCT00476593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6032896|NCT00476593|Cathartics|cathartics|mesh-ancestor
6032897|NCT00476645|Fulvestrant|fulvestrant|mesh-list
6032898|NCT00476645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6032899|NCT00476645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6032900|NCT00476645|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6032901|NCT00476645|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6032902|NCT00476645|Hormone Antagonists|hormone antagonists|mesh-ancestor
6032903|NCT00476645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6032904|NCT00476645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032905|NCT00476788|Insulin|insulin|mesh-list
6032906|NCT00476788|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6032907|NCT00476788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6032908|NCT00476788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032909|NCT00476957|Sirolimus|sirolimus|mesh-list
6032910|NCT00476957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6032911|NCT00476957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6032912|NCT00476957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6032913|NCT00476957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6032914|NCT00476957|Antifungal Agents|antifungal agents|mesh-ancestor
6032915|NCT00476957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6032916|NCT00476957|Immunologic Factors|immunologic factors|mesh-ancestor
6032917|NCT00476957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032918|NCT00476996|Methotrexate|methotrexate|mesh-list
6032919|NCT00476996|Leflunomide|leflunomide|mesh-list
6032920|NCT00476996|Ocrelizumab|ocrelizumab|mesh-list
6032921|NCT00476996|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6032922|NCT00476996|Abortifacient Agents|abortifacient agents|mesh-ancestor
6032923|NCT00476996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6032924|NCT00476996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032925|NCT00476996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6032926|NCT00476996|Antimetabolites|antimetabolites|mesh-ancestor
6032927|NCT00476996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6032928|NCT00476996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6032929|NCT00476996|Dermatologic Agents|dermatologic agents|mesh-ancestor
6032930|NCT00476996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6032931|NCT00476996|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6032932|NCT00476996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6032933|NCT00476996|Immunologic Factors|immunologic factors|mesh-ancestor
6032934|NCT00476996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6032935|NCT00476996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6032936|NCT00477087|Molgramostim|molgramostim|mesh-list
6032937|NCT00477087|Mitoxantrone|mitoxantrone|mesh-list
6032938|NCT00477087|Sargramostim|sargramostim|mesh-list
6032939|NCT00477087|Immunologic Factors|immunologic factors|mesh-ancestor
6032940|NCT00477087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032941|NCT00477087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6032942|NCT00477087|Analgesics|analgesics|mesh-ancestor
6032943|NCT00477087|Sensory System Agents|sensory system agents|mesh-ancestor
6032944|NCT00477087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6032945|NCT00477087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6032946|NCT00477087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6032947|NCT00477087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6032948|NCT00477087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6032949|NCT00477165|Citalopram|citalopram|mesh-list
6032950|NCT00477165|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6032951|NCT00477165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6032952|NCT00477165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6032953|NCT00477165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6032954|NCT00477165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6032955|NCT00477165|Serotonin Agents|serotonin agents|mesh-ancestor
6032956|NCT00477165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032957|NCT00477165|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6032958|NCT00477165|Antidepressive Agents|antidepressive agents|mesh-ancestor
6032959|NCT00477165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6032960|NCT00477191|Etanercept|etanercept|mesh-list
5494092|NCT04539366|Fludarabine|fludarabine|mesh-list
5494093|NCT04539366|Fludarabine phosphate|fludarabine phosphate|mesh-list
5494094|NCT04539366|Immunologic Factors|immunologic factors|mesh-ancestor
5494095|NCT04539366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494096|NCT04539366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5494097|NCT04539366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5494098|NCT04539366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5494099|NCT04539366|Alkylating Agents|alkylating agents|mesh-ancestor
5494100|NCT04539366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494101|NCT04539366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5494102|NCT04539366|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6032961|NCT00477191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6032962|NCT00477191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6032963|NCT00477191|Analgesics|analgesics|mesh-ancestor
6032964|NCT00477191|Sensory System Agents|sensory system agents|mesh-ancestor
6032965|NCT00477191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6032966|NCT00477191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032967|NCT00477191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6032968|NCT00477191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6032969|NCT00477191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6032970|NCT00477191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6032971|NCT00477191|Immunologic Factors|immunologic factors|mesh-ancestor
6032972|NCT00477204|Simvastatin|simvastatin|mesh-list
6032973|NCT00477204|Ezetimibe|ezetimibe|mesh-list
6032974|NCT00477204|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
6032975|NCT00477204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6032976|NCT00477204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6032977|NCT00477204|Antimetabolites|antimetabolites|mesh-ancestor
6032978|NCT00477204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6032979|NCT00477204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6032980|NCT00477204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6032981|NCT00477204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6032982|NCT00477269|Imatinib Mesylate|imatinib mesylate|mesh-list
6032983|NCT00477269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6032984|NCT00477269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6032985|NCT00477269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6032986|NCT00477269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6032987|NCT00477295|Carbamazepine|carbamazepine|mesh-list
6032988|NCT00477295|Zonisamide|zonisamide|mesh-list
6032989|NCT00477295|Anticonvulsants|anticonvulsants|mesh-ancestor
6032990|NCT00477295|Antimanic Agents|antimanic agents|mesh-ancestor
6032991|NCT00477295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6032992|NCT00477295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6032993|NCT00477295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6032994|NCT00477295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6032995|NCT00477295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6032996|NCT00477295|Analgesics|analgesics|mesh-ancestor
6032997|NCT00477295|Sensory System Agents|sensory system agents|mesh-ancestor
6032998|NCT00477295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6032999|NCT00477295|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6033000|NCT00477295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6033001|NCT00477295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033002|NCT00477295|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6033003|NCT00477295|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6033004|NCT00477295|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6053567|NCT00596362|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6033005|NCT00477295|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6033006|NCT00477334|Famciclovir|famciclovir|mesh-list
6033007|NCT00477334|Antiviral Agents|antiviral agents|mesh-ancestor
6033008|NCT00477334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6033009|NCT00477334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6033010|NCT00477334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6033011|NCT00477334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033012|NCT00477386|Decitabine|decitabine|mesh-list
6033013|NCT00477386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6033014|NCT00477386|Antimetabolites|antimetabolites|mesh-ancestor
6033015|NCT00477386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033016|NCT00477386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5494103|NCT04539366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5494104|NCT04539366|Antimetabolites|antimetabolites|mesh-ancestor
5494105|NCT04537026|Dexamethasone|dexamethasone|mesh-list
5494106|NCT04537026|Dexamethasone acetate|dexamethasone acetate|mesh-list
5494107|NCT04537026|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
5494108|NCT04537026|BB 1101|bb 1101|mesh-list
5494109|NCT04537026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5494110|NCT04537026|Antiemetics|antiemetics|mesh-ancestor
5494111|NCT04537026|Autonomic Agents|autonomic agents|mesh-ancestor
5494112|NCT04537026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5494113|NCT04537026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494114|NCT04537026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5494115|NCT04537026|Glucocorticoids|glucocorticoids|mesh-ancestor
5494116|NCT04537026|Hormones|hormones|mesh-ancestor
5494117|NCT04537026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5494118|NCT04537026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5494119|NCT04537026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5494120|NCT04537026|Protease Inhibitors|protease inhibitors|mesh-ancestor
5494121|NCT04537026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5494122|NCT04537026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494123|NCT04526730|Nivolumab|nivolumab|mesh-list
5494124|NCT04526730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5494125|NCT04526730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5494126|NCT04526730|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5494127|NCT04526730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494128|NCT04506086|Blinatumomab|blinatumomab|mesh-list
5494129|NCT04506086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5494130|NCT04498780|Valsartan|valsartan|mesh-list
5494131|NCT04498780|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5494132|NCT04498780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5494133|NCT04498780|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5494134|NCT04498780|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6033017|NCT00477386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6033018|NCT00477451|Alprazolam|alprazolam|mesh-list
6033019|NCT00477451|Doxapram|doxapram|mesh-list
6033020|NCT00477451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6033021|NCT00477451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6033022|NCT00477451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6033023|NCT00477451|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6033024|NCT00477451|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6033025|NCT00477451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6033026|NCT00477451|GABA Modulators|gaba modulators|mesh-ancestor
6033027|NCT00477451|GABA Agents|gaba agents|mesh-ancestor
5494135|NCT04498780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494136|NCT04448717|Antibodies|antibodies|mesh-list
5494137|NCT04448717|Immunologic Factors|immunologic factors|mesh-ancestor
5494138|NCT04448717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494139|NCT04436965|Cisplatin|cisplatin|mesh-list
5494140|NCT04436965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5494141|NCT04424641|Antibodies|antibodies|mesh-list
5494142|NCT04424641|Antibodies, Bispecific|antibodies, bispecific|mesh-list
6033028|NCT00477451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6033029|NCT00477451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033030|NCT00477451|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6033031|NCT00477451|Respiratory System Agents|respiratory system agents|mesh-ancestor
6033032|NCT00477464|Capecitabine|capecitabine|mesh-list
6033033|NCT00477464|Lapatinib|lapatinib|mesh-list
6033034|NCT00477464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6033035|NCT00477464|Antimetabolites|antimetabolites|mesh-ancestor
6033036|NCT00477464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033037|NCT00477464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6033038|NCT00477464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6033039|NCT00477464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6033040|NCT00477490|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
6033041|NCT00477490|Hemostatics|hemostatics|mesh-ancestor
6033042|NCT00477490|Coagulants|coagulants|mesh-ancestor
6033043|NCT00477490|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6033044|NCT00477490|Natriuretic Agents|natriuretic agents|mesh-ancestor
6033045|NCT00477490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6033046|NCT00477594|Mipomersen|mipomersen|mesh-list
6033047|NCT00477594|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6033048|NCT00477594|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6033049|NCT00477594|Antimetabolites|antimetabolites|mesh-ancestor
6033050|NCT00477594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033051|NCT00477594|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6033052|NCT00477607|Thioctic Acid|thioctic acid|mesh-list
6033053|NCT00477607|Antioxidants|antioxidants|mesh-ancestor
6033054|NCT00477607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033055|NCT00477607|Protective Agents|protective agents|mesh-ancestor
6033056|NCT00477607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6033057|NCT00477607|Vitamin B Complex|vitamin b complex|mesh-ancestor
6033058|NCT00477607|Vitamins|vitamins|mesh-ancestor
6033059|NCT00477607|Micronutrients|micronutrients|mesh-ancestor
6033060|NCT00477633|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6033061|NCT00477633|Norethindrone|norethindrone|mesh-list
6033062|NCT00477633|Norethindrone Acetate|norethindrone acetate|mesh-list
6033063|NCT00477633|Estradiol|estradiol|mesh-list
6033064|NCT00477633|Estrogens|estrogens|mesh-ancestor
6033065|NCT00477633|Hormones|hormones|mesh-ancestor
6033066|NCT00477633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6033067|NCT00477633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6033068|NCT00477633|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6033069|NCT00477633|Contraceptive Agents|contraceptive agents|mesh-ancestor
6033070|NCT00477633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6033071|NCT00477633|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5494143|NCT04424641|Immunologic Factors|immunologic factors|mesh-ancestor
5494144|NCT04424641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494145|NCT04420741|Iloprost|iloprost|mesh-list
5494146|NCT04420741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5494147|NCT04420741|Vasodilator Agents|vasodilator agents|mesh-ancestor
5494148|NCT04409041|Naltrexone|naltrexone|mesh-list
5494149|NCT04409041|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5494150|NCT04409041|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5494151|NCT04409041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494152|NCT04409041|Sensory System Agents|sensory system agents|mesh-ancestor
5494153|NCT04409041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5503157|NCT04461795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503158|NCT04461795|Analgesics|analgesics|mesh-ancestor
5503159|NCT04461795|Sensory System Agents|sensory system agents|mesh-ancestor
5503160|NCT04461795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5503161|NCT04461665|Vitamin D|vitamin d|mesh-list
5503162|NCT04461665|Ergocalciferols|ergocalciferols|mesh-list
5503163|NCT04461665|Vitamins|vitamins|mesh-list
5503164|NCT04461665|Micronutrients|micronutrients|mesh-ancestor
6033072|NCT00477633|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6033073|NCT00477633|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6033074|NCT00477633|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6033075|NCT00477659|Donepezil|donepezil|mesh-list
6033076|NCT00477659|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5503165|NCT04461665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503166|NCT04461665|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6033077|NCT00477659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6033078|NCT00477659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033079|NCT00477659|Cholinergic Agents|cholinergic agents|mesh-ancestor
6033080|NCT00477659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6033081|NCT00477659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6033082|NCT00477659|Nootropic Agents|nootropic agents|mesh-ancestor
6033083|NCT00477672|Pimavanserin|pimavanserin|mesh-list
6033084|NCT00477672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6033085|NCT00477672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6033086|NCT00477672|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6033087|NCT00477672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6033088|NCT00477672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6033089|NCT00477672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6033090|NCT00477672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6033091|NCT00477672|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6033092|NCT00477672|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5503167|NCT04461665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6033093|NCT00477672|Serotonin Agents|serotonin agents|mesh-ancestor
6033094|NCT00477672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6033095|NCT00477672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033096|NCT00477750|Prednisone|prednisone|mesh-list
6033097|NCT00477750|Lenalidomide|lenalidomide|mesh-list
6033098|NCT00477750|Melphalan|melphalan|mesh-list
6033099|NCT00477750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6033100|NCT00477750|Glucocorticoids|glucocorticoids|mesh-ancestor
6033101|NCT00477750|Hormones|hormones|mesh-ancestor
6033102|NCT00477750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5494154|NCT04407286|Vitamin D|vitamin d|mesh-list
5494155|NCT04407286|Cholecalciferol|cholecalciferol|mesh-list
5494156|NCT04407286|Vitamins|vitamins|mesh-ancestor
5494157|NCT04407286|Micronutrients|micronutrients|mesh-ancestor
5494158|NCT04407286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494159|NCT04407286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5494160|NCT04407286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5494161|NCT04388839|Dactinomycin|dactinomycin|mesh-list
5494162|NCT04388839|Cyclophosphamide|cyclophosphamide|mesh-list
5494163|NCT04388839|Vincristine|vincristine|mesh-list
5494164|NCT04388839|Vinorelbine|vinorelbine|mesh-list
5494165|NCT04388839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5494166|NCT04388839|Immunologic Factors|immunologic factors|mesh-ancestor
5494167|NCT04388839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494168|NCT04388839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6033103|NCT00477750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456749|NCT00433342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6456750|NCT00433368|N-Methylaspartate|n-methylaspartate|mesh-list
6456751|NCT00433368|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
6456752|NCT00433368|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6033104|NCT00477750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6033105|NCT00477750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6033106|NCT00477750|Immunologic Factors|immunologic factors|mesh-ancestor
6033107|NCT00477750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6033108|NCT00477750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6033109|NCT00477750|Growth Substances|growth substances|mesh-ancestor
6033110|NCT00477750|Growth Inhibitors|growth inhibitors|mesh-ancestor
6033111|NCT00477750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6033112|NCT00477750|Alkylating Agents|alkylating agents|mesh-ancestor
6033113|NCT00477750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033114|NCT00477750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6033115|NCT00477750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6033116|NCT00477971|Dexamethasone|dexamethasone|mesh-list
6033117|NCT00477971|Melphalan|melphalan|mesh-list
6033118|NCT00477971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6033119|NCT00477971|Antiemetics|antiemetics|mesh-ancestor
6033120|NCT00477971|Autonomic Agents|autonomic agents|mesh-ancestor
6033121|NCT00477971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6033122|NCT00477971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6033123|NCT00477971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5494169|NCT04388839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5494170|NCT04388839|Alkylating Agents|alkylating agents|mesh-ancestor
5494171|NCT04388839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494172|NCT04388839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5494173|NCT04388839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5494174|NCT04388839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5494175|NCT04388839|Tubulin Modulators|tubulin modulators|mesh-ancestor
5494176|NCT04388839|Antimitotic Agents|antimitotic agents|mesh-ancestor
5494177|NCT04388839|Mitosis Modulators|mitosis modulators|mesh-ancestor
5494178|NCT04388839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5494179|NCT04388839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5494180|NCT04388839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5494181|NCT04388839|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5494182|NCT04388839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5494183|NCT04388839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5494184|NCT04382885|Cariprazine|cariprazine|mesh-list
5494185|NCT04382885|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5494186|NCT04382885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5494187|NCT04382885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5494188|NCT04382885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494189|NCT04382885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5494190|NCT04373369|Atezolizumab|atezolizumab|mesh-list
5494191|NCT04373369|Vorolanib|vorolanib|mesh-list
5494192|NCT04373369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6033124|NCT00477971|Glucocorticoids|glucocorticoids|mesh-ancestor
6033125|NCT00477971|Hormones|hormones|mesh-ancestor
6033126|NCT00477971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6033127|NCT00477971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6033128|NCT00477971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6033129|NCT00477971|Immunologic Factors|immunologic factors|mesh-ancestor
6033130|NCT00477971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6033131|NCT00477971|Alkylating Agents|alkylating agents|mesh-ancestor
6033132|NCT00477971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033133|NCT00477971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6033134|NCT00477971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6033135|NCT00478023|Morphine|morphine|mesh-list
6033136|NCT00478023|Tapentadol|tapentadol|mesh-list
6033137|NCT00478023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6033138|NCT00478023|Narcotics|narcotics|mesh-ancestor
6033139|NCT00478023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6033140|NCT00478023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6033141|NCT00478023|Analgesics|analgesics|mesh-ancestor
6033142|NCT00478023|Sensory System Agents|sensory system agents|mesh-ancestor
6033143|NCT00478023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6033144|NCT00478023|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6033145|NCT00478023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6033146|NCT00478023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6033147|NCT00478023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033148|NCT00478023|Adrenergic Agents|adrenergic agents|mesh-ancestor
6033149|NCT00478023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6033150|NCT00478036|Prednisolone|prednisolone|mesh-list
6033151|NCT00478036|Prednisolone acetate|prednisolone acetate|mesh-list
6033152|NCT00478036|Ketorolac|ketorolac|mesh-list
6033153|NCT00478036|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6033154|NCT00478036|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6033155|NCT00478036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6033156|NCT00478036|Glucocorticoids|glucocorticoids|mesh-ancestor
6033157|NCT00478036|Hormones|hormones|mesh-ancestor
6033158|NCT00478036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6033159|NCT00478036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6033160|NCT00478036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6033161|NCT00478036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6033162|NCT00478036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6033163|NCT00478036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6033164|NCT00478036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6033165|NCT00478036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6033166|NCT00478036|Analgesics|analgesics|mesh-ancestor
6033167|NCT00478036|Sensory System Agents|sensory system agents|mesh-ancestor
6033168|NCT00478036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6033169|NCT00478036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6033170|NCT00478036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6033171|NCT00478036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033172|NCT00478036|Laxatives|laxatives|mesh-ancestor
6033173|NCT00478140|Trastuzumab|trastuzumab|mesh-list
6033174|NCT00478140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6033175|NCT00478140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6033176|NCT00478192|Conivaptan|conivaptan|mesh-list
6033177|NCT00478192|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6033178|NCT00478192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033179|NCT00478192|Natriuretic Agents|natriuretic agents|mesh-ancestor
6033180|NCT00478192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6033181|NCT00478205|Donepezil|donepezil|mesh-list
6033182|NCT00478205|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6033183|NCT00478205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6033184|NCT00478205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033185|NCT00478205|Cholinergic Agents|cholinergic agents|mesh-ancestor
6033186|NCT00478205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6033187|NCT00478205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6033188|NCT00478205|Nootropic Agents|nootropic agents|mesh-ancestor
6033189|NCT00478218|Dexamethasone|dexamethasone|mesh-list
6033190|NCT00478218|Cyclophosphamide|cyclophosphamide|mesh-list
6033191|NCT00478218|Lenalidomide|lenalidomide|mesh-list
6033192|NCT00478218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6033193|NCT00478218|Immunologic Factors|immunologic factors|mesh-ancestor
6033194|NCT00478218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6033195|NCT00478218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6033196|NCT00478218|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6033197|NCT00478218|Alkylating Agents|alkylating agents|mesh-ancestor
6033198|NCT00478218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494193|NCT04373369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5494194|NCT04373369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5494195|NCT04373369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494196|NCT04366713|Capecitabine|capecitabine|mesh-list
5494197|NCT04366713|Loperamide|loperamide|mesh-list
5494198|NCT04366713|Antidiarrheals|antidiarrheals|mesh-list
5494199|NCT04366713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5494200|NCT04366713|Antimetabolites|antimetabolites|mesh-ancestor
5494201|NCT04366713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494202|NCT04366713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5494203|NCT04366713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6033199|NCT00478218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6033200|NCT00478218|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6033201|NCT00478218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6033202|NCT00478218|Antiemetics|antiemetics|mesh-ancestor
6033203|NCT00478218|Autonomic Agents|autonomic agents|mesh-ancestor
6033204|NCT00478218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6033205|NCT00478218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6033206|NCT00478218|Glucocorticoids|glucocorticoids|mesh-ancestor
6033207|NCT00478218|Hormones|hormones|mesh-ancestor
6033208|NCT00478218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6033209|NCT00478218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6033210|NCT00478218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6033211|NCT00478218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6033212|NCT00478218|Growth Substances|growth substances|mesh-ancestor
6033213|NCT00478218|Growth Inhibitors|growth inhibitors|mesh-ancestor
6033214|NCT00478231|Maraviroc|maraviroc|mesh-list
6033215|NCT00478231|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6033216|NCT00478231|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6033217|NCT00478231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033218|NCT00478231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6033219|NCT00478231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6033220|NCT00478231|Antiviral Agents|antiviral agents|mesh-ancestor
6033221|NCT00478231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6033222|NCT00478231|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6033223|NCT00478244|Vidarabine|vidarabine|mesh-list
6033224|NCT00478244|Cyclophosphamide|cyclophosphamide|mesh-list
6033225|NCT00478244|Busulfan|busulfan|mesh-list
6033226|NCT00478244|Fludarabine|fludarabine|mesh-list
6033227|NCT00478244|Fludarabine phosphate|fludarabine phosphate|mesh-list
6033228|NCT00478244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6033229|NCT00478244|Immunologic Factors|immunologic factors|mesh-ancestor
6033230|NCT00478244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6033231|NCT00478244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6033232|NCT00478244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6033233|NCT00478244|Alkylating Agents|alkylating agents|mesh-ancestor
6033234|NCT00478244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033235|NCT00478244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6033236|NCT00478244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6033237|NCT00478244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6033238|NCT00478244|Antimetabolites|antimetabolites|mesh-ancestor
6033239|NCT00478244|Antiviral Agents|antiviral agents|mesh-ancestor
6033240|NCT00478244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6033241|NCT00478335|Calcitonin|calcitonin|mesh-list
6033242|NCT00478335|Salmon calcitonin|salmon calcitonin|mesh-list
5494204|NCT04356599|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6033243|NCT00478335|Indomethacin|indomethacin|mesh-list
6033244|NCT00478335|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6033245|NCT00478335|Amiloride|amiloride|mesh-list
6033246|NCT00478335|Sildenafil Citrate|sildenafil citrate|mesh-list
6033247|NCT00478335|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
6033248|NCT00478335|Katacalcin|katacalcin|mesh-list
6033249|NCT00478335|Vasodilator Agents|vasodilator agents|mesh-ancestor
6033250|NCT00478335|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6033251|NCT00478335|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6033252|NCT00478335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6033253|NCT00478335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033254|NCT00478335|Urological Agents|urological agents|mesh-ancestor
6033255|NCT00478335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6033256|NCT00478335|Diuretics|diuretics|mesh-ancestor
6033257|NCT00478335|Natriuretic Agents|natriuretic agents|mesh-ancestor
6033258|NCT00478335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6033259|NCT00478335|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6033260|NCT00478335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6033261|NCT00478335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6033262|NCT00478335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6033263|NCT00478335|Analgesics|analgesics|mesh-ancestor
6033264|NCT00478335|Sensory System Agents|sensory system agents|mesh-ancestor
6033265|NCT00478335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6033266|NCT00478335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6033267|NCT00478335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6033268|NCT00478335|Gout Suppressants|gout suppressants|mesh-ancestor
6033269|NCT00478335|Tocolytic Agents|tocolytic agents|mesh-ancestor
6033270|NCT00478335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6033271|NCT00478335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6033272|NCT00478335|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
6033273|NCT00478335|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6033274|NCT00478335|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
6033275|NCT00478335|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6033276|NCT00478335|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6033277|NCT00478335|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6033278|NCT00478361|Gemcitabine|gemcitabine|mesh-list
6033279|NCT00478361|Paclitaxel|paclitaxel|mesh-list
6033280|NCT00478361|Doxorubicin|doxorubicin|mesh-list
6033281|NCT00478361|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6033282|NCT00478361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6033283|NCT00478361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6033284|NCT00478361|Tubulin Modulators|tubulin modulators|mesh-ancestor
6033285|NCT00478361|Antimitotic Agents|antimitotic agents|mesh-ancestor
6033286|NCT00478361|Mitosis Modulators|mitosis modulators|mesh-ancestor
6033287|NCT00478361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033288|NCT00478361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6033289|NCT00478361|Antimetabolites|antimetabolites|mesh-ancestor
6033290|NCT00478361|Antiviral Agents|antiviral agents|mesh-ancestor
6033291|NCT00478361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6033292|NCT00478361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6033293|NCT00478361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6033294|NCT00478361|Immunologic Factors|immunologic factors|mesh-ancestor
6033295|NCT00478361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6033296|NCT00478361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6033297|NCT00478361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6033298|NCT00478361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6033299|NCT00478426|Sunitinib|sunitinib|mesh-list
6033300|NCT00478426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6033301|NCT00478426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6033302|NCT00478426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6033303|NCT00478426|Growth Substances|growth substances|mesh-ancestor
6033304|NCT00478426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6033305|NCT00478426|Growth Inhibitors|growth inhibitors|mesh-ancestor
6033306|NCT00478426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6033307|NCT00478426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6033308|NCT00478426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033309|NCT00478569|Hormones|hormones|mesh-list
6033310|NCT00478569|Parathyroid Hormone|parathyroid hormone|mesh-list
6033311|NCT00478569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6033312|NCT00478569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6033313|NCT00478569|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6033314|NCT00478608|Sirolimus|sirolimus|mesh-list
6033315|NCT00478608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6033316|NCT00478608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6033317|NCT00478608|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6033318|NCT00478608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6033319|NCT00478608|Antifungal Agents|antifungal agents|mesh-ancestor
6033320|NCT00478608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6033321|NCT00478608|Immunologic Factors|immunologic factors|mesh-ancestor
6033322|NCT00478608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6033323|NCT00478777|Dexamethasone|dexamethasone|mesh-list
6033324|NCT00478777|Lenalidomide|lenalidomide|mesh-list
6033325|NCT00478777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6033326|NCT00478777|Antiemetics|antiemetics|mesh-ancestor
6033327|NCT00478777|Autonomic Agents|autonomic agents|mesh-ancestor
6033328|NCT00478777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6033329|NCT00478777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6033330|NCT00478777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6033331|NCT00478777|Glucocorticoids|glucocorticoids|mesh-ancestor
6033332|NCT00478777|Hormones|hormones|mesh-ancestor
6033333|NCT00478777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6033334|NCT00478777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6033335|NCT00478777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6033336|NCT00478777|Immunologic Factors|immunologic factors|mesh-ancestor
6033337|NCT00478777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6033338|NCT00478777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6033339|NCT00478777|Growth Substances|growth substances|mesh-ancestor
6033340|NCT00478777|Growth Inhibitors|growth inhibitors|mesh-ancestor
6033341|NCT00478881|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6033342|NCT00478881|Vasodilator Agents|vasodilator agents|mesh-ancestor
6033343|NCT00478881|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6033344|NCT00478881|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6033345|NCT00478881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6033346|NCT00478881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033347|NCT00478881|Urological Agents|urological agents|mesh-ancestor
5494205|NCT04356599|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5494206|NCT04356599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494207|NCT04317404|Triamcinolone|triamcinolone|mesh-list
5494208|NCT04317404|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5494209|NCT04317404|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5494210|NCT04317404|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5494211|NCT04317404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5494212|NCT04317404|Glucocorticoids|glucocorticoids|mesh-ancestor
5494213|NCT04317404|Hormones|hormones|mesh-ancestor
5494214|NCT04317404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5494215|NCT04317404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494216|NCT04317404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5494217|NCT04317404|Immunologic Factors|immunologic factors|mesh-ancestor
5494218|NCT04317404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5724906|NCT03184363|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5724907|NCT03184363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5724908|NCT03184363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724909|NCT03184363|Cholinergic Agents|cholinergic agents|mesh-ancestor
5724910|NCT03184363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5724911|NCT03184766|Ibuprofen|ibuprofen|mesh-list
5724912|NCT03184766|Pseudoephedrine|pseudoephedrine|mesh-list
5724913|NCT03184766|Ephedrine|ephedrine|mesh-list
5724914|NCT03184766|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6053568|NCT00596362|Growth Substances|growth substances|mesh-ancestor
6053569|NCT00596362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053570|NCT00596362|Growth Inhibitors|growth inhibitors|mesh-ancestor
6053571|NCT00596427|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
6053572|NCT00596427|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6053573|NCT00596427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6053574|NCT00596427|Antimetabolites|antimetabolites|mesh-ancestor
6053575|NCT00596427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724915|NCT03184766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5724916|NCT03184766|Analgesics|analgesics|mesh-ancestor
5724917|NCT03184766|Sensory System Agents|sensory system agents|mesh-ancestor
5724918|NCT03184766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6033348|NCT00479037|Strontium ranelate|strontium ranelate|mesh-list
6033349|NCT00479037|Hormones|hormones|mesh-list
6033350|NCT00479037|Parathyroid Hormone|parathyroid hormone|mesh-list
6033351|NCT00479037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6033352|NCT00479037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6033353|NCT00479037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6033354|NCT00479037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6033355|NCT00479089|Dexamethasone|dexamethasone|mesh-list
6033356|NCT00479089|Docetaxel|docetaxel|mesh-list
6033357|NCT00479089|Gefitinib|gefitinib|mesh-list
6033358|NCT00479089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6033359|NCT00479089|Antiemetics|antiemetics|mesh-ancestor
6033360|NCT00479089|Autonomic Agents|autonomic agents|mesh-ancestor
6033361|NCT00479089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6033362|NCT00479089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6033363|NCT00479089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6033364|NCT00479089|Glucocorticoids|glucocorticoids|mesh-ancestor
6033365|NCT00479089|Hormones|hormones|mesh-ancestor
6033366|NCT00479089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6033367|NCT00479089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6033368|NCT00479089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6033369|NCT00479089|Tubulin Modulators|tubulin modulators|mesh-ancestor
6033370|NCT00479089|Antimitotic Agents|antimitotic agents|mesh-ancestor
6456753|NCT00433368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6456754|NCT00433368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456755|NCT00433368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456756|NCT00433407|Trastuzumab|trastuzumab|mesh-list
6456757|NCT00433407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6456758|NCT00433407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6456759|NCT00433420|Paclitaxel|paclitaxel|mesh-list
6456760|NCT00433420|Cyclophosphamide|cyclophosphamide|mesh-list
6456761|NCT00433420|Fluorouracil|fluorouracil|mesh-list
6456762|NCT00433420|Epirubicin|epirubicin|mesh-list
6456763|NCT00433420|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6033371|NCT00479089|Mitosis Modulators|mitosis modulators|mesh-ancestor
6033372|NCT00479089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033373|NCT00479089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6033374|NCT00479089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6033375|NCT00479115|Plerixafor|plerixafor|mesh-list
6033376|NCT00479115|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6033377|NCT00479115|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6033378|NCT00479115|Antiviral Agents|antiviral agents|mesh-ancestor
6033379|NCT00479115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6033380|NCT00479154|Botulinum Toxins|botulinum toxins|mesh-list
6033381|NCT00479154|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6033382|NCT00479154|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6033383|NCT00479154|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6033384|NCT00479154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6654731|NCT01458626|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6654732|NCT01458626|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6654733|NCT01458626|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6033385|NCT00479154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033386|NCT00479154|Cholinergic Agents|cholinergic agents|mesh-ancestor
6033387|NCT00479154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6033388|NCT00479154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6033389|NCT00479154|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6033390|NCT00479154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6033391|NCT00479232|Decitabine|decitabine|mesh-list
6033392|NCT00479232|Vorinostat|vorinostat|mesh-list
6033393|NCT00479232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6033394|NCT00479232|Antimetabolites|antimetabolites|mesh-ancestor
6033395|NCT00479232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033396|NCT00479232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6033397|NCT00479232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6033398|NCT00479232|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6033399|NCT00479336|Tolvaptan|tolvaptan|mesh-list
6033400|NCT00479336|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6033401|NCT00479336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033402|NCT00479336|Natriuretic Agents|natriuretic agents|mesh-ancestor
6033403|NCT00479336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6033404|NCT00479388|Niacin|niacin|mesh-list
6033405|NCT00479388|Atorvastatin|atorvastatin|mesh-list
6033406|NCT00479388|Simvastatin|simvastatin|mesh-list
6033407|NCT00479388|Calcium|calcium|mesh-list
6033408|NCT00479388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6033409|NCT00479388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6033410|NCT00479388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6033411|NCT00479388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6033412|NCT00479388|Antimetabolites|antimetabolites|mesh-ancestor
6033413|NCT00479388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033414|NCT00479388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6033415|NCT00479388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6033416|NCT00479388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6033417|NCT00479388|Vasodilator Agents|vasodilator agents|mesh-ancestor
6033418|NCT00479388|Vitamin B Complex|vitamin b complex|mesh-ancestor
6033419|NCT00479388|Vitamins|vitamins|mesh-ancestor
6033420|NCT00479388|Micronutrients|micronutrients|mesh-ancestor
6033421|NCT00479401|Pramipexole|pramipexole|mesh-list
6033422|NCT00479401|Antioxidants|antioxidants|mesh-ancestor
6033423|NCT00479401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033424|NCT00479401|Protective Agents|protective agents|mesh-ancestor
6033425|NCT00479401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6033426|NCT00479401|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6033427|NCT00479401|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6033428|NCT00479401|Dopamine Agonists|dopamine agonists|mesh-ancestor
6033429|NCT00479401|Dopamine Agents|dopamine agents|mesh-ancestor
6033430|NCT00479401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6033431|NCT00479466|Metformin|metformin|mesh-list
6033432|NCT00479466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6033433|NCT00479466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6033434|NCT00479557|Saponin QA-21V1|saponin qa-21v1|mesh-list
6033435|NCT00479557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5494219|NCT04317404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494220|NCT04282239|Lidocaine|lidocaine|mesh-list
5494221|NCT04282239|Epinephrine|epinephrine|mesh-list
5494222|NCT04282239|Dexmedetomidine|dexmedetomidine|mesh-list
5494223|NCT04282239|Ropivacaine|ropivacaine|mesh-list
5494224|NCT04282239|Anesthetics, Local|anesthetics, local|mesh-ancestor
5494225|NCT04282239|Anesthetics|anesthetics|mesh-ancestor
5494226|NCT04282239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5494227|NCT04282239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494228|NCT04282239|Sensory System Agents|sensory system agents|mesh-ancestor
5494229|NCT04282239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5494230|NCT04282239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6033436|NCT00479557|Immunologic Factors|immunologic factors|mesh-ancestor
6033437|NCT00479557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6033438|NCT00479674|Paclitaxel|paclitaxel|mesh-list
6033439|NCT00479674|Bevacizumab|bevacizumab|mesh-list
6033440|NCT00479674|Carboplatin|carboplatin|mesh-list
6033441|NCT00479674|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6033442|NCT00479674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6033443|NCT00479674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6033444|NCT00479674|Tubulin Modulators|tubulin modulators|mesh-ancestor
6033445|NCT00479674|Antimitotic Agents|antimitotic agents|mesh-ancestor
6033446|NCT00479674|Mitosis Modulators|mitosis modulators|mesh-ancestor
6033447|NCT00479674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033448|NCT00479674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6033449|NCT00479674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6033450|NCT00479674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6033451|NCT00479674|Growth Substances|growth substances|mesh-ancestor
6033452|NCT00479674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6033453|NCT00479674|Growth Inhibitors|growth inhibitors|mesh-ancestor
6033454|NCT00479687|Hyaluronic Acid|hyaluronic acid|mesh-list
6033455|NCT00479687|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6033456|NCT00479687|Immunologic Factors|immunologic factors|mesh-ancestor
6033457|NCT00479687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6033458|NCT00479687|Viscosupplements|viscosupplements|mesh-ancestor
6033459|NCT00479687|Protective Agents|protective agents|mesh-ancestor
6033460|NCT00479765|Paclitaxel|paclitaxel|mesh-list
6033461|NCT00479765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6033462|NCT00479765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6033463|NCT00479765|Tubulin Modulators|tubulin modulators|mesh-ancestor
6033464|NCT00479765|Antimitotic Agents|antimitotic agents|mesh-ancestor
6033465|NCT00479765|Mitosis Modulators|mitosis modulators|mesh-ancestor
6033466|NCT00479765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033467|NCT00479856|Paclitaxel|paclitaxel|mesh-list
6033468|NCT00479856|Docetaxel|docetaxel|mesh-list
6033469|NCT00479856|Capecitabine|capecitabine|mesh-list
6033470|NCT00479856|Lapatinib|lapatinib|mesh-list
6033471|NCT00479856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6033472|NCT00479856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6033473|NCT00479856|Tubulin Modulators|tubulin modulators|mesh-ancestor
6033474|NCT00479856|Antimitotic Agents|antimitotic agents|mesh-ancestor
6033475|NCT00479856|Mitosis Modulators|mitosis modulators|mesh-ancestor
6033476|NCT00479856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033477|NCT00479856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6033478|NCT00479856|Antimetabolites|antimetabolites|mesh-ancestor
6033479|NCT00479856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6033480|NCT00479856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6033481|NCT00479882|Simvastatin|simvastatin|mesh-list
6033482|NCT00479882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6033483|NCT00479882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6033484|NCT00479882|Antimetabolites|antimetabolites|mesh-ancestor
6033485|NCT00479882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033486|NCT00479882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6033487|NCT00479882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6033488|NCT00479882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6033489|NCT00480441|Dronabinol|dronabinol|mesh-list
6456764|NCT00433420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6456765|NCT00433420|Tubulin Modulators|tubulin modulators|mesh-ancestor
6456766|NCT00433420|Antimitotic Agents|antimitotic agents|mesh-ancestor
6456767|NCT00433420|Mitosis Modulators|mitosis modulators|mesh-ancestor
6456768|NCT00433420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456769|NCT00433420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6456770|NCT00433420|Immunologic Factors|immunologic factors|mesh-ancestor
6456771|NCT00433420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6033490|NCT00480441|Hallucinogens|hallucinogens|mesh-ancestor
6033491|NCT00480441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6033492|NCT00480441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6033493|NCT00480441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6033494|NCT00480441|Analgesics|analgesics|mesh-ancestor
6033495|NCT00480441|Sensory System Agents|sensory system agents|mesh-ancestor
6033496|NCT00480441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6033497|NCT00480441|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6033498|NCT00480441|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6033499|NCT00480441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6033500|NCT00480441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033501|NCT00480441|Hormones|hormones|mesh-ancestor
6033502|NCT00480441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6033503|NCT00480532|Doxycycline|doxycycline|mesh-list
6033504|NCT00480532|Levonorgestrel|levonorgestrel|mesh-list
6033505|NCT00480532|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6033506|NCT00480532|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
6033507|NCT00480532|Estradiol|estradiol|mesh-list
6033508|NCT00480532|Estrogens|estrogens|mesh-ancestor
6033509|NCT00480532|Hormones|hormones|mesh-ancestor
6033510|NCT00480532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6033511|NCT00480532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6033512|NCT00480532|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6033513|NCT00480532|Contraceptive Agents|contraceptive agents|mesh-ancestor
6033514|NCT00480532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6033515|NCT00480532|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6033516|NCT00480532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6033517|NCT00480532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6033518|NCT00480532|Antimalarials|antimalarials|mesh-ancestor
6033519|NCT00480532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6033520|NCT00480532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6033521|NCT00480532|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6033522|NCT00480532|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6033523|NCT00480532|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6033524|NCT00480532|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6033525|NCT00480636|Dalteparin|dalteparin|mesh-list
6033526|NCT00480636|Tinzaparin|tinzaparin|mesh-list
6033527|NCT00480636|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6033528|NCT00480636|Anticoagulants|anticoagulants|mesh-ancestor
6033529|NCT00480636|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6033530|NCT00480636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6033531|NCT00480636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033532|NCT00480740|Dexmedetomidine|dexmedetomidine|mesh-list
6033533|NCT00480740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6033534|NCT00480740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6033535|NCT00480740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6033536|NCT00480740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6033537|NCT00480740|Analgesics|analgesics|mesh-ancestor
6033538|NCT00480740|Sensory System Agents|sensory system agents|mesh-ancestor
6033539|NCT00480740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5494231|NCT04282239|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5494232|NCT04282239|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6033540|NCT00480740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6033541|NCT00480740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6033542|NCT00480740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6033543|NCT00480740|Adrenergic Agents|adrenergic agents|mesh-ancestor
6033544|NCT00480740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6033545|NCT00480740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033546|NCT00480857|Docetaxel|docetaxel|mesh-list
6033547|NCT00480857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6033548|NCT00480857|Tubulin Modulators|tubulin modulators|mesh-ancestor
6033549|NCT00480857|Antimitotic Agents|antimitotic agents|mesh-ancestor
6033550|NCT00480857|Mitosis Modulators|mitosis modulators|mesh-ancestor
6033551|NCT00480857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033552|NCT00480987|Vidarabine|vidarabine|mesh-list
6033553|NCT00480987|Cytarabine|cytarabine|mesh-list
6033554|NCT00480987|Oxaliplatin|oxaliplatin|mesh-list
6033555|NCT00480987|Fludarabine|fludarabine|mesh-list
6033556|NCT00480987|Fludarabine phosphate|fludarabine phosphate|mesh-list
6033557|NCT00480987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6033558|NCT00480987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6033559|NCT00480987|Antimetabolites|antimetabolites|mesh-ancestor
6033560|NCT00480987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033561|NCT00480987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6033562|NCT00480987|Immunologic Factors|immunologic factors|mesh-ancestor
6033563|NCT00480987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6033564|NCT00480987|Antiviral Agents|antiviral agents|mesh-ancestor
6033565|NCT00480987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6033566|NCT00481065|MF59 oil emulsion|mf59 oil emulsion|mesh-list
6033567|NCT00481065|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6033568|NCT00481065|Immunologic Factors|immunologic factors|mesh-ancestor
6033569|NCT00481065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6033570|NCT00481078|Paclitaxel|paclitaxel|mesh-list
5494233|NCT04282239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5494234|NCT04282239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494235|NCT04282239|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5494236|NCT04282239|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5494237|NCT04282239|Analgesics|analgesics|mesh-ancestor
5494238|NCT04282239|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5494239|NCT04282239|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5494240|NCT04282239|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5494241|NCT04282239|Adrenergic Agents|adrenergic agents|mesh-ancestor
5494242|NCT04282239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5494243|NCT04282239|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5494244|NCT04282239|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5494245|NCT04282239|Autonomic Agents|autonomic agents|mesh-ancestor
6033571|NCT00481078|Carboplatin|carboplatin|mesh-list
6033572|NCT00481078|Vorinostat|vorinostat|mesh-list
6033573|NCT00481078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6033574|NCT00481078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6033575|NCT00481078|Tubulin Modulators|tubulin modulators|mesh-ancestor
6033576|NCT00481078|Antimitotic Agents|antimitotic agents|mesh-ancestor
6033577|NCT00481078|Mitosis Modulators|mitosis modulators|mesh-ancestor
6033578|NCT00481078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033579|NCT00481078|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6033580|NCT00481078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6033581|NCT00481195|Modafinil|modafinil|mesh-list
6033582|NCT00481195|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6033583|NCT00481195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6033584|NCT00481195|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6033585|NCT00481195|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6033586|NCT00481195|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6033587|NCT00481195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033588|NCT00481247|Imatinib Mesylate|imatinib mesylate|mesh-list
6033589|NCT00481247|Dasatinib|dasatinib|mesh-list
6033590|NCT00481247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6033591|NCT00481247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6033592|NCT00481247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6033593|NCT00481247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033594|NCT00481351|Simvastatin|simvastatin|mesh-list
6456772|NCT00433420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6033595|NCT00481351|Ezetimibe|ezetimibe|mesh-list
6033596|NCT00481351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6033597|NCT00481351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6033598|NCT00481351|Antimetabolites|antimetabolites|mesh-ancestor
6033599|NCT00481351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033600|NCT00481351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6033601|NCT00481351|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5494246|NCT04282239|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5494247|NCT04282239|Respiratory System Agents|respiratory system agents|mesh-ancestor
5494248|NCT04282239|Mydriatics|mydriatics|mesh-ancestor
5494249|NCT04282239|Sympathomimetics|sympathomimetics|mesh-ancestor
5494250|NCT04282239|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6033602|NCT00481351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6033603|NCT00481676|Omalizumab|omalizumab|mesh-list
6033604|NCT00481676|Loratadine|loratadine|mesh-list
6033605|NCT00481676|Clemastine|clemastine|mesh-list
6033606|NCT00481676|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6033607|NCT00481676|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6033608|NCT00481676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6033609|NCT00481676|Respiratory System Agents|respiratory system agents|mesh-ancestor
6033610|NCT00481676|Immunologic Factors|immunologic factors|mesh-ancestor
6033611|NCT00481676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6033612|NCT00481676|Antipruritics|antipruritics|mesh-ancestor
6033613|NCT00481676|Dermatologic Agents|dermatologic agents|mesh-ancestor
6033614|NCT00481676|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6033615|NCT00481676|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6033616|NCT00481676|Histamine Antagonists|histamine antagonists|mesh-ancestor
6033617|NCT00481676|Histamine Agents|histamine agents|mesh-ancestor
6033618|NCT00481676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6033619|NCT00481676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033620|NCT00481767|Vaccines|vaccines|mesh-list
6033621|NCT00481767|Immunologic Factors|immunologic factors|mesh-ancestor
6033622|NCT00481767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6033623|NCT00481832|Cyclosporine|cyclosporine|mesh-list
6033624|NCT00481832|Mycophenolic Acid|mycophenolic acid|mesh-list
6033625|NCT00481832|Methylprednisolone|methylprednisolone|mesh-list
6033626|NCT00481832|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6033627|NCT00481832|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6033628|NCT00481832|Prednisolone|prednisolone|mesh-list
6033629|NCT00481832|Prednisolone acetate|prednisolone acetate|mesh-list
6033630|NCT00481832|Cyclophosphamide|cyclophosphamide|mesh-list
6033631|NCT00481832|Carmustine|carmustine|mesh-list
6033632|NCT00481832|Rituximab|rituximab|mesh-list
6033633|NCT00481832|Etoposide|etoposide|mesh-list
6033634|NCT00481832|Cyclosporins|cyclosporins|mesh-list
6033635|NCT00481832|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6033636|NCT00481832|Lenograstim|lenograstim|mesh-list
6033637|NCT00481832|Sargramostim|sargramostim|mesh-list
6033638|NCT00481832|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6033639|NCT00481832|Prednisolone phosphate|prednisolone phosphate|mesh-list
6033640|NCT00481832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6033641|NCT00481832|Immunologic Factors|immunologic factors|mesh-ancestor
6033642|NCT00481832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6033643|NCT00481832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6033644|NCT00481832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6033645|NCT00481832|Alkylating Agents|alkylating agents|mesh-ancestor
6033646|NCT00481832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033647|NCT00481832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6033648|NCT00481832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6033649|NCT00481832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6033650|NCT00481832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6033651|NCT00481832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6033652|NCT00481832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6033653|NCT00481832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6033654|NCT00481832|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6033655|NCT00481832|Antifungal Agents|antifungal agents|mesh-ancestor
5494251|NCT04242238|Avelumab|avelumab|mesh-list
6033656|NCT00481832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5494252|NCT04242238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5494253|NCT04242238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5494254|NCT04232072|Ibuprofen|ibuprofen|mesh-list
5494255|NCT04232072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5494256|NCT04232072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5724919|NCT03184766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6033657|NCT00481832|Dermatologic Agents|dermatologic agents|mesh-ancestor
6033658|NCT00481832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6033659|NCT00481832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6033660|NCT00481832|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6033661|NCT00481832|Antitubercular Agents|antitubercular agents|mesh-ancestor
6033662|NCT00481832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6033663|NCT00481832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6033664|NCT00481832|Antiemetics|antiemetics|mesh-ancestor
6033665|NCT00481832|Autonomic Agents|autonomic agents|mesh-ancestor
6033666|NCT00481832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6033667|NCT00481832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6033668|NCT00481832|Glucocorticoids|glucocorticoids|mesh-ancestor
6033669|NCT00481832|Hormones|hormones|mesh-ancestor
6033670|NCT00481832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6033671|NCT00481832|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6033672|NCT00481832|Protective Agents|protective agents|mesh-ancestor
6033673|NCT00481832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6033674|NCT00481845|Anastrozole|anastrozole|mesh-list
6033675|NCT00481845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6033676|NCT00481845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6033677|NCT00481845|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6033678|NCT00481845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6033679|NCT00481845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6033680|NCT00481845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033681|NCT00481845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6033682|NCT00481845|Hormone Antagonists|hormone antagonists|mesh-ancestor
6033683|NCT00481845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6033684|NCT00481845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6033685|NCT00481871|Vitamins|vitamins|mesh-list
6033686|NCT00481871|Folic Acid|folic acid|mesh-list
6033687|NCT00481871|Vitamin B 12|vitamin b 12|mesh-list
6033688|NCT00481871|Hydroxocobalamin|hydroxocobalamin|mesh-list
6033689|NCT00481871|Vitamin B Complex|vitamin b complex|mesh-list
6033690|NCT00481871|Gemcitabine|gemcitabine|mesh-list
6033691|NCT00481871|10-deazaaminopterin|10-deazaaminopterin|mesh-list
6033692|NCT00481871|Aminopterin|aminopterin|mesh-list
6033693|NCT00481871|Micronutrients|micronutrients|mesh-ancestor
5724920|NCT03184766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5724921|NCT03184766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5724922|NCT03184766|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5724923|NCT03184766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5724924|NCT03184766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724925|NCT03184766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5724926|NCT03184766|Autonomic Agents|autonomic agents|mesh-ancestor
5724927|NCT03184766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5724928|NCT03184766|Respiratory System Agents|respiratory system agents|mesh-ancestor
5724929|NCT03184766|Nasal Decongestants|nasal decongestants|mesh-ancestor
5724930|NCT03184766|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5724931|NCT03184766|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5724932|NCT03184766|Sympathomimetics|sympathomimetics|mesh-ancestor
5724933|NCT03184766|Adrenergic Agents|adrenergic agents|mesh-ancestor
5724934|NCT03184766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5724935|NCT03184324|Esomeprazole|esomeprazole|mesh-list
5724936|NCT03184324|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5724937|NCT03184324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5724938|NCT03184324|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5724939|NCT03184324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5724940|NCT03184324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724941|NCT03184103|Complement System Proteins|complement system proteins|mesh-list
5724942|NCT03184103|Antistreptolysin|antistreptolysin|mesh-list
5724943|NCT03184103|Immunologic Factors|immunologic factors|mesh-ancestor
5724944|NCT03184103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724945|NCT03184090|Palbociclib|palbociclib|mesh-list
5724946|NCT03184090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5724947|NCT03184090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5724948|NCT03184090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5724949|NCT03184090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724950|NCT03184194|Cyclophosphamide|cyclophosphamide|mesh-list
6456773|NCT00433420|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6456774|NCT00433420|Alkylating Agents|alkylating agents|mesh-ancestor
6456775|NCT00433420|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6456776|NCT00433420|Antimetabolites|antimetabolites|mesh-ancestor
6033694|NCT00481871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494257|NCT04232072|Analgesics|analgesics|mesh-ancestor
5494258|NCT04232072|Sensory System Agents|sensory system agents|mesh-ancestor
5494259|NCT04232072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5494260|NCT04232072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494261|NCT04232072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5494262|NCT04232072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5494263|NCT04232072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5494264|NCT04232072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5494265|NCT04232072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494266|NCT04219254|Pembrolizumab|pembrolizumab|mesh-list
5494267|NCT04219254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5494268|NCT04219254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5494269|NCT04201197|Dronabinol|dronabinol|mesh-list
5494270|NCT04201197|Hallucinogens|hallucinogens|mesh-ancestor
5494271|NCT04201197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494272|NCT04201197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5494273|NCT04201197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5494274|NCT04201197|Analgesics|analgesics|mesh-ancestor
5494275|NCT04201197|Sensory System Agents|sensory system agents|mesh-ancestor
5494276|NCT04201197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5494277|NCT04201197|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6033695|NCT00481871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6033696|NCT00481871|Antimetabolites|antimetabolites|mesh-ancestor
6033697|NCT00481871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033698|NCT00481871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6033699|NCT00481871|Antiviral Agents|antiviral agents|mesh-ancestor
6033700|NCT00481871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6033701|NCT00481871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6033702|NCT00481871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6033703|NCT00481871|Immunologic Factors|immunologic factors|mesh-ancestor
6033704|NCT00481871|Hematinics|hematinics|mesh-ancestor
6033705|NCT00481871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6033706|NCT00482001|Donepezil|donepezil|mesh-list
6033707|NCT00482001|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5494278|NCT04201197|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5494279|NCT04201197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5494280|NCT04201197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494281|NCT04201197|Hormones|hormones|mesh-ancestor
5494282|NCT04201197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5494283|NCT04182633|Vancomycin|vancomycin|mesh-list
5494284|NCT04182633|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
5494285|NCT04182633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5494286|NCT04182633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5494287|NCT04182633|Laxatives|laxatives|mesh-ancestor
5494288|NCT04182633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5494289|NCT04179864|Prednisone|prednisone|mesh-list
5494290|NCT04179864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6033708|NCT00482001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6033709|NCT00482001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033710|NCT00482001|Cholinergic Agents|cholinergic agents|mesh-ancestor
6033711|NCT00482001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6033712|NCT00482001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6033713|NCT00482001|Nootropic Agents|nootropic agents|mesh-ancestor
6033714|NCT00482014|Carboplatin|carboplatin|mesh-list
6033715|NCT00482014|Pemetrexed|pemetrexed|mesh-list
6033716|NCT00482014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6033717|NCT00482014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6033718|NCT00482014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494291|NCT04179864|Glucocorticoids|glucocorticoids|mesh-ancestor
5494292|NCT04179864|Hormones|hormones|mesh-ancestor
5503168|NCT04461535|Hormones|hormones|mesh-list
6033719|NCT00482014|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6033720|NCT00482014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6033721|NCT00482053|Acetaminophen|acetaminophen|mesh-list
6033722|NCT00482053|Diphenhydramine|diphenhydramine|mesh-list
6033723|NCT00482053|Promethazine|promethazine|mesh-list
6033724|NCT00482053|Cyclosporine|cyclosporine|mesh-list
6033725|NCT00482053|Mycophenolic Acid|mycophenolic acid|mesh-list
6033726|NCT00482053|Methylprednisolone|methylprednisolone|mesh-list
6033727|NCT00482053|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6033728|NCT00482053|Hydrocortisone|hydrocortisone|mesh-list
6033729|NCT00482053|Cyclophosphamide|cyclophosphamide|mesh-list
6033730|NCT00482053|Carmustine|carmustine|mesh-list
6033731|NCT00482053|Rituximab|rituximab|mesh-list
6033732|NCT00482053|Etoposide|etoposide|mesh-list
6033733|NCT00482053|Cyclosporins|cyclosporins|mesh-list
6033734|NCT00482053|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6033735|NCT00482053|Lenograstim|lenograstim|mesh-list
6033736|NCT00482053|Sargramostim|sargramostim|mesh-list
6033737|NCT00482053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6033738|NCT00482053|Immunologic Factors|immunologic factors|mesh-ancestor
6033739|NCT00482053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6033740|NCT00482053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6033741|NCT00482053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6033742|NCT00482053|Alkylating Agents|alkylating agents|mesh-ancestor
6033743|NCT00482053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033744|NCT00482053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5494293|NCT04179864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5494294|NCT04179864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494295|NCT04179864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5494296|NCT04179864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5494297|NCT04148430|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5494298|NCT04148430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5494299|NCT04143477|Peficitinib|peficitinib|mesh-list
5494300|NCT04143477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5494301|NCT04143477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494302|NCT04143477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6033745|NCT00482053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6033746|NCT00482053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6033747|NCT00482053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6033748|NCT00482053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6033749|NCT00482053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6033750|NCT00482053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6033751|NCT00482053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6033752|NCT00482053|Antifungal Agents|antifungal agents|mesh-ancestor
6033753|NCT00482053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6033754|NCT00482053|Dermatologic Agents|dermatologic agents|mesh-ancestor
6033755|NCT00482053|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6033756|NCT00482053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6033757|NCT00482053|Analgesics|analgesics|mesh-ancestor
6033758|NCT00482053|Sensory System Agents|sensory system agents|mesh-ancestor
6033759|NCT00482053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6033760|NCT00482053|Antipyretics|antipyretics|mesh-ancestor
6033761|NCT00482053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6033762|NCT00482053|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6033763|NCT00482053|Antitubercular Agents|antitubercular agents|mesh-ancestor
6033764|NCT00482053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6033765|NCT00482053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5494303|NCT04143477|Immunologic Factors|immunologic factors|mesh-ancestor
5494304|NCT04143477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494305|NCT04132427|Vancomycin|vancomycin|mesh-list
5494306|NCT04132427|Magnesium citrate|magnesium citrate|mesh-list
5494307|NCT04132427|Citric Acid|citric acid|mesh-list
6033766|NCT00482053|Antiemetics|antiemetics|mesh-ancestor
6033767|NCT00482053|Autonomic Agents|autonomic agents|mesh-ancestor
6033768|NCT00482053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6033769|NCT00482053|Glucocorticoids|glucocorticoids|mesh-ancestor
6033770|NCT00482053|Hormones|hormones|mesh-ancestor
6033771|NCT00482053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6033772|NCT00482053|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6033773|NCT00482053|Protective Agents|protective agents|mesh-ancestor
6033774|NCT00482053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5494308|NCT04132427|Sodium Citrate|sodium citrate|mesh-list
5494309|NCT04132427|Anticoagulants|anticoagulants|mesh-ancestor
5494310|NCT04132427|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6033775|NCT00482053|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6033776|NCT00482053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6033777|NCT00482053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6033778|NCT00482053|Anesthetics, Local|anesthetics, local|mesh-ancestor
6033779|NCT00482053|Anesthetics|anesthetics|mesh-ancestor
6033780|NCT00482053|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6033781|NCT00482053|Histamine Antagonists|histamine antagonists|mesh-ancestor
6033782|NCT00482053|Histamine Agents|histamine agents|mesh-ancestor
6033783|NCT00482053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6033784|NCT00482053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6033785|NCT00482053|Antipruritics|antipruritics|mesh-ancestor
6033786|NCT00482170|Etanercept|etanercept|mesh-list
6033787|NCT00482170|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6033788|NCT00482170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6033789|NCT00482170|Analgesics|analgesics|mesh-ancestor
6033790|NCT00482170|Sensory System Agents|sensory system agents|mesh-ancestor
6033791|NCT00482170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6033792|NCT00482170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6033793|NCT00482170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6033794|NCT00482170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6033795|NCT00482170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6033796|NCT00482170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6033797|NCT00482170|Immunologic Factors|immunologic factors|mesh-ancestor
5494311|NCT04132427|Chelating Agents|chelating agents|mesh-ancestor
5494312|NCT04132427|Sequestering Agents|sequestering agents|mesh-ancestor
5494313|NCT04132427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494314|NCT04132427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5494315|NCT04132427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5494316|NCT04132427|Cathartics|cathartics|mesh-ancestor
5494317|NCT04132427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6033798|NCT00482274|Docetaxel|docetaxel|mesh-list
6033799|NCT00482274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6033800|NCT00482274|Tubulin Modulators|tubulin modulators|mesh-ancestor
6033801|NCT00482274|Antimitotic Agents|antimitotic agents|mesh-ancestor
6033802|NCT00482274|Mitosis Modulators|mitosis modulators|mesh-ancestor
6033803|NCT00482274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033804|NCT00482391|Paclitaxel|paclitaxel|mesh-list
6033805|NCT00482391|Cyclophosphamide|cyclophosphamide|mesh-list
6033806|NCT00482391|Doxorubicin|doxorubicin|mesh-list
6033807|NCT00482391|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6033808|NCT00482391|Trastuzumab|trastuzumab|mesh-list
6033809|NCT00482391|Lapatinib|lapatinib|mesh-list
6033810|NCT00482391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6033811|NCT00482391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6033812|NCT00482391|Tubulin Modulators|tubulin modulators|mesh-ancestor
6033813|NCT00482391|Antimitotic Agents|antimitotic agents|mesh-ancestor
6033814|NCT00482391|Mitosis Modulators|mitosis modulators|mesh-ancestor
6033815|NCT00482391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033816|NCT00482391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6033817|NCT00482391|Immunologic Factors|immunologic factors|mesh-ancestor
6033818|NCT00482391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6033819|NCT00482391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6033820|NCT00482391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6033821|NCT00482391|Alkylating Agents|alkylating agents|mesh-ancestor
6033822|NCT00482391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6033823|NCT00482391|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6033824|NCT00482391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6033825|NCT00482391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6033826|NCT00482391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6033827|NCT00482391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6033828|NCT00482391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6033829|NCT00482612|Mirtazapine|mirtazapine|mesh-list
6033830|NCT00482612|Antidepressive Agents|antidepressive agents|mesh-ancestor
6033831|NCT00482612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6033832|NCT00482612|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6033833|NCT00482612|Histamine Antagonists|histamine antagonists|mesh-ancestor
6033834|NCT00482612|Histamine Agents|histamine agents|mesh-ancestor
6033835|NCT00482612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6033836|NCT00482612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033837|NCT00482612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6033838|NCT00482612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6033839|NCT00482612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6033840|NCT00482612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6033841|NCT00482612|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6033842|NCT00482612|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6033843|NCT00482612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6033844|NCT00482612|Adrenergic Agents|adrenergic agents|mesh-ancestor
5494318|NCT04122755|Buprenorphine|buprenorphine|mesh-list
6033845|NCT00482612|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6033846|NCT00482612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6033847|NCT00482612|Serotonin Agents|serotonin agents|mesh-ancestor
6033848|NCT00482612|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6033849|NCT00482625|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6033850|NCT00482625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6033851|NCT00482625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6033852|NCT00482625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6033853|NCT00482625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033854|NCT00482677|Temozolomide|temozolomide|mesh-list
6033855|NCT00482677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6033856|NCT00482677|Alkylating Agents|alkylating agents|mesh-ancestor
6033857|NCT00482677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456777|NCT00433420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6456778|NCT00433420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6456779|NCT00433420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6033858|NCT00482677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6033859|NCT00482703|Dasatinib|dasatinib|mesh-list
6033860|NCT00482703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6033861|NCT00482703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6033862|NCT00482703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6033863|NCT00482703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033864|NCT00482729|Metformin|metformin|mesh-list
6033865|NCT00482729|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6033866|NCT00482729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6033867|NCT00482729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6033868|NCT00482729|Incretins|incretins|mesh-ancestor
6033869|NCT00482729|Hormones|hormones|mesh-ancestor
6033870|NCT00482729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6033871|NCT00482729|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6033872|NCT00482729|Protease Inhibitors|protease inhibitors|mesh-ancestor
6033873|NCT00482729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6033874|NCT00482729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033875|NCT00482911|Cyclophosphamide|cyclophosphamide|mesh-list
6033876|NCT00482911|Lenalidomide|lenalidomide|mesh-list
6033877|NCT00482911|Sunitinib|sunitinib|mesh-list
6033878|NCT00482911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6033879|NCT00482911|Immunologic Factors|immunologic factors|mesh-ancestor
6033880|NCT00482911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6033881|NCT00482911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6033882|NCT00482911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6033883|NCT00482911|Alkylating Agents|alkylating agents|mesh-ancestor
5494319|NCT04122755|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5494320|NCT04122755|Narcotics|narcotics|mesh-ancestor
5494321|NCT04122755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5494322|NCT04122755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494323|NCT04122755|Analgesics|analgesics|mesh-ancestor
6033884|NCT00482911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033885|NCT00482911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6033886|NCT00482911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6033887|NCT00482911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6033888|NCT00482911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6033889|NCT00482911|Growth Substances|growth substances|mesh-ancestor
6033890|NCT00482911|Growth Inhibitors|growth inhibitors|mesh-ancestor
6033891|NCT00482911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6033892|NCT00482911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6033893|NCT00483002|Varenicline|varenicline|mesh-list
6033894|NCT00483002|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6033895|NCT00483002|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6033896|NCT00483002|Cholinergic Agents|cholinergic agents|mesh-ancestor
6033897|NCT00483002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6033898|NCT00483002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033899|NCT00483002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6033900|NCT00483223|Carboplatin|carboplatin|mesh-list
6033901|NCT00483223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6033902|NCT00483262|Bortezomib|bortezomib|mesh-list
6033903|NCT00483262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6033904|NCT00483327|Megestrol|megestrol|mesh-list
6033905|NCT00483327|Megestrol Acetate|megestrol acetate|mesh-list
6033906|NCT00483327|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6033907|NCT00483327|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6033908|NCT00483327|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6033909|NCT00483327|Contraceptive Agents|contraceptive agents|mesh-ancestor
6033910|NCT00483327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5494324|NCT04122755|Sensory System Agents|sensory system agents|mesh-ancestor
6033911|NCT00483327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6033912|NCT00483327|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6033913|NCT00483327|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6033914|NCT00483327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6033915|NCT00483327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6033916|NCT00483327|Appetite Stimulants|appetite stimulants|mesh-ancestor
6033917|NCT00483327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6033918|NCT00483405|Capecitabine|capecitabine|mesh-list
6033919|NCT00483405|Oxaliplatin|oxaliplatin|mesh-list
6033920|NCT00483405|Cetuximab|cetuximab|mesh-list
6033921|NCT00483405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6033922|NCT00483405|Antimetabolites|antimetabolites|mesh-ancestor
6033923|NCT00483405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033924|NCT00483405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6033925|NCT00483405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6033926|NCT00483496|Titanium dioxide|titanium dioxide|mesh-list
6033927|NCT00483496|Sunscreening Agents|sunscreening agents|mesh-ancestor
6033928|NCT00483496|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6033929|NCT00483496|Protective Agents|protective agents|mesh-ancestor
6033930|NCT00483496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6033931|NCT00483496|Dermatologic Agents|dermatologic agents|mesh-ancestor
6033932|NCT00483496|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6033933|NCT00483509|Doxorubicin|doxorubicin|mesh-list
6033934|NCT00483509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5494325|NCT04122755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5494326|NCT04122755|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5494327|NCT04099836|Bevacizumab|bevacizumab|mesh-list
5494328|NCT04099836|Atezolizumab|atezolizumab|mesh-list
5494329|NCT04099836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5494330|NCT04099836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5494331|NCT04099836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5494332|NCT04099836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5494333|NCT04099836|Growth Substances|growth substances|mesh-ancestor
5494334|NCT04099836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494335|NCT04099836|Growth Inhibitors|growth inhibitors|mesh-ancestor
5494336|NCT04097470|Decitabine|decitabine|mesh-list
5494337|NCT04097470|Midostaurin|midostaurin|mesh-list
5494338|NCT04097470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5494339|NCT04097470|Antimetabolites|antimetabolites|mesh-ancestor
5494340|NCT04097470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033935|NCT00483509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6033936|NCT00483509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6033937|NCT00483509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6033938|NCT00483509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6033939|NCT00483509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033940|NCT00483548|Ziprasidone|ziprasidone|mesh-list
6033941|NCT00483548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5724951|NCT03184194|Nivolumab|nivolumab|mesh-list
5724952|NCT03184194|Daratumumab|daratumumab|mesh-list
5724953|NCT03184194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5724954|NCT03184194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6033942|NCT00483548|Serotonin Agents|serotonin agents|mesh-ancestor
6033943|NCT00483548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6033944|NCT00483548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033945|NCT00483548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6033946|NCT00483548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6033947|NCT00483548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6033948|NCT00483548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6033949|NCT00483548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6033950|NCT00483548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6033951|NCT00483548|Dopamine Agents|dopamine agents|mesh-ancestor
6033952|NCT00483561|Etoposide|etoposide|mesh-list
6033953|NCT00483561|Gefitinib|gefitinib|mesh-list
6033954|NCT00483561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6033955|NCT00483561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6033956|NCT00483561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6033957|NCT00483561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6033958|NCT00483561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6033959|NCT00483561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033960|NCT00483561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6033961|NCT00483574|Vaccines|vaccines|mesh-list
6033962|NCT00483574|Immunologic Factors|immunologic factors|mesh-ancestor
6033963|NCT00483574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494341|NCT04097470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5494342|NCT04097470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6033964|NCT00483652|4-Aminopyridine|4-aminopyridine|mesh-list
6033965|NCT00483652|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6033966|NCT00483652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6033967|NCT00483652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456780|NCT00433420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6456781|NCT00433420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6456782|NCT00433433|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6456783|NCT00433433|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6456784|NCT00433433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456785|NCT00433459|Prednisone|prednisone|mesh-list
6456786|NCT00433459|Prednisolone|prednisolone|mesh-list
6456787|NCT00433459|Cyclophosphamide|cyclophosphamide|mesh-list
6456788|NCT00433459|Dacarbazine|dacarbazine|mesh-list
6033968|NCT00483717|Ketorolac|ketorolac|mesh-list
6033969|NCT00483717|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6033970|NCT00483717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6033971|NCT00483717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6456789|NCT00433459|Vincristine|vincristine|mesh-list
6456790|NCT00433459|Procarbazine|procarbazine|mesh-list
6456791|NCT00433459|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6456792|NCT00433459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6456793|NCT00433459|Immunologic Factors|immunologic factors|mesh-ancestor
6456794|NCT00433459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456795|NCT00433459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6456796|NCT00433459|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6456797|NCT00433459|Alkylating Agents|alkylating agents|mesh-ancestor
6456798|NCT00433459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456799|NCT00433459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6456800|NCT00433459|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6456801|NCT00433459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6456802|NCT00433459|Glucocorticoids|glucocorticoids|mesh-ancestor
6456803|NCT00433459|Hormones|hormones|mesh-ancestor
6456804|NCT00433459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6456805|NCT00433459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6456806|NCT00433459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6456807|NCT00433459|Tubulin Modulators|tubulin modulators|mesh-ancestor
6456808|NCT00433459|Antimitotic Agents|antimitotic agents|mesh-ancestor
6654734|NCT01458743|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
6654735|NCT01458743|Cephalosporins|cephalosporins|mesh-list
6654736|NCT01458743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6654737|NCT01458743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6654738|NCT01458769|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6654739|NCT01458769|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6654740|NCT01458769|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6654741|NCT01458769|Protease Inhibitors|protease inhibitors|mesh-ancestor
6033972|NCT00483717|Analgesics|analgesics|mesh-ancestor
6033973|NCT00483717|Sensory System Agents|sensory system agents|mesh-ancestor
6033974|NCT00483717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6033975|NCT00483717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6033976|NCT00483717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6033977|NCT00483717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6033978|NCT00483717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6033979|NCT00483717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6456809|NCT00433459|Mitosis Modulators|mitosis modulators|mesh-ancestor
6456810|NCT00433459|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6456811|NCT00433485|Sirolimus|sirolimus|mesh-list
6456812|NCT00433485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6456813|NCT00433485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6456814|NCT00433485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6456815|NCT00433485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6456816|NCT00433485|Antifungal Agents|antifungal agents|mesh-ancestor
6654742|NCT01458769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6654743|NCT01458769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033980|NCT00483717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033981|NCT00483756|Cyclosporine|cyclosporine|mesh-list
6456817|NCT00433485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6654744|NCT01458769|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6654745|NCT01458769|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6654746|NCT01458769|Antiviral Agents|antiviral agents|mesh-ancestor
6654747|NCT01458769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6654748|NCT01458808|Dialysis Solutions|dialysis solutions|mesh-list
6654749|NCT01458808|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6654750|NCT01458847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6664639|NCT01513083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6456818|NCT00433485|Immunologic Factors|immunologic factors|mesh-ancestor
6654751|NCT01458964|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6456819|NCT00433485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456820|NCT00433498|Carboplatin|carboplatin|mesh-list
6456821|NCT00433498|Etoposide|etoposide|mesh-list
6456822|NCT00433498|Etoposide phosphate|etoposide phosphate|mesh-list
6456823|NCT00433498|Pravastatin|pravastatin|mesh-list
6456824|NCT00433498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6033982|NCT00483756|Cyclosporins|cyclosporins|mesh-list
6033983|NCT00483756|Tofacitinib|tofacitinib|mesh-list
6033984|NCT00483756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6033985|NCT00483756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6033986|NCT00483756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6033987|NCT00483756|Immunologic Factors|immunologic factors|mesh-ancestor
6033988|NCT00483756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6033989|NCT00483756|Antifungal Agents|antifungal agents|mesh-ancestor
6033990|NCT00483756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6033991|NCT00483756|Dermatologic Agents|dermatologic agents|mesh-ancestor
6033992|NCT00483756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6456825|NCT00433498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6456826|NCT00433498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6456827|NCT00433498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6456828|NCT00433498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6456829|NCT00433498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456830|NCT00433498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6456831|NCT00433498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6456832|NCT00433498|Antimetabolites|antimetabolites|mesh-ancestor
6456833|NCT00433498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6456834|NCT00433498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6456835|NCT00433576|Resveratrol|resveratrol|mesh-list
6456836|NCT00433576|Antioxidants|antioxidants|mesh-ancestor
6456837|NCT00433576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456838|NCT00433576|Protective Agents|protective agents|mesh-ancestor
6456839|NCT00433576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456840|NCT00433576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6456841|NCT00433576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6456842|NCT00433589|Docetaxel|docetaxel|mesh-list
6456843|NCT00433589|Capecitabine|capecitabine|mesh-list
6456844|NCT00433589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6456845|NCT00433589|Tubulin Modulators|tubulin modulators|mesh-ancestor
6456846|NCT00433589|Antimitotic Agents|antimitotic agents|mesh-ancestor
6456847|NCT00433589|Mitosis Modulators|mitosis modulators|mesh-ancestor
6456848|NCT00433589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456849|NCT00433589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6033993|NCT00483756|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6033994|NCT00483756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6033995|NCT00483938|Interferons|interferons|mesh-list
6033996|NCT00483938|Ribavirin|ribavirin|mesh-list
6033997|NCT00483938|Interferon-alpha|interferon-alpha|mesh-list
6033998|NCT00483938|Interferon alpha-2|interferon alpha-2|mesh-list
6033999|NCT00483938|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6034000|NCT00483938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6456850|NCT00433589|Antimetabolites|antimetabolites|mesh-ancestor
6456851|NCT00433615|Epoetin Alfa|epoetin alfa|mesh-list
6456852|NCT00433615|Hematinics|hematinics|mesh-ancestor
6456853|NCT00433641|Sibutramine|sibutramine|mesh-list
6456854|NCT00433641|Antidepressive Agents|antidepressive agents|mesh-ancestor
6456855|NCT00433641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6034001|NCT00483938|Antiviral Agents|antiviral agents|mesh-ancestor
6034002|NCT00483938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6034003|NCT00483938|Antimetabolites|antimetabolites|mesh-ancestor
6034004|NCT00483938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034005|NCT00483938|Immunologic Factors|immunologic factors|mesh-ancestor
6034006|NCT00483938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034007|NCT00484094|Sirolimus|sirolimus|mesh-list
6034008|NCT00484094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6456856|NCT00433641|Appetite Depressants|appetite depressants|mesh-ancestor
6034009|NCT00484094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6034010|NCT00484094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6034011|NCT00484094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6034012|NCT00484094|Antifungal Agents|antifungal agents|mesh-ancestor
6034013|NCT00484094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6034014|NCT00484094|Immunologic Factors|immunologic factors|mesh-ancestor
6034015|NCT00484094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034016|NCT00484159|Lidocaine|lidocaine|mesh-list
6034017|NCT00484159|Bupivacaine|bupivacaine|mesh-list
6034018|NCT00484159|Anesthetics, Local|anesthetics, local|mesh-ancestor
6034019|NCT00484159|Anesthetics|anesthetics|mesh-ancestor
6034020|NCT00484159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6034021|NCT00484159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034022|NCT00484159|Sensory System Agents|sensory system agents|mesh-ancestor
6034023|NCT00484159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6034024|NCT00484159|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6034025|NCT00484159|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6034026|NCT00484159|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5494343|NCT04097470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5494344|NCT04061746|Plasma-lyte 148|plasma-lyte 148|mesh-list
5494345|NCT04061746|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5494346|NCT04061746|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5494347|NCT04054999|Hydroxocobalamin|hydroxocobalamin|mesh-list
5494348|NCT04054999|Vitamin B 12|vitamin b 12|mesh-list
6034027|NCT00484159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6034028|NCT00484159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034029|NCT00484198|Pioglitazone|pioglitazone|mesh-list
6034030|NCT00484198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6034031|NCT00484198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034032|NCT00484289|Abatacept|abatacept|mesh-list
6034033|NCT00484289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6034034|NCT00484289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034035|NCT00484289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6034036|NCT00484289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6034037|NCT00484289|Immunologic Factors|immunologic factors|mesh-ancestor
6034038|NCT00484289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034039|NCT00484289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6034040|NCT00484315|Paclitaxel|paclitaxel|mesh-list
6034041|NCT00484315|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6034042|NCT00484315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6034043|NCT00484315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6034044|NCT00484315|Tubulin Modulators|tubulin modulators|mesh-ancestor
6034045|NCT00484315|Antimitotic Agents|antimitotic agents|mesh-ancestor
6034046|NCT00484315|Mitosis Modulators|mitosis modulators|mesh-ancestor
6034047|NCT00484315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456857|NCT00433641|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6456858|NCT00433719|Efavirenz|efavirenz|mesh-list
6456859|NCT00433719|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6456860|NCT00433719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6034048|NCT00484393|Tetracaine|tetracaine|mesh-list
6034049|NCT00484393|Anesthetics, Local|anesthetics, local|mesh-ancestor
6034050|NCT00484393|Anesthetics|anesthetics|mesh-ancestor
6034051|NCT00484393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6034052|NCT00484393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034053|NCT00484393|Sensory System Agents|sensory system agents|mesh-ancestor
6034054|NCT00484393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6034055|NCT00484679|Triamcinolone|triamcinolone|mesh-list
6034056|NCT00484679|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6034057|NCT00484679|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6034058|NCT00484679|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6034059|NCT00484679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6034060|NCT00484679|Glucocorticoids|glucocorticoids|mesh-ancestor
5494349|NCT04054999|Methylene Blue|methylene blue|mesh-list
5494350|NCT04054999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6034061|NCT00484679|Hormones|hormones|mesh-ancestor
6034062|NCT00484679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6034063|NCT00484679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034064|NCT00484679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6034065|NCT00484679|Immunologic Factors|immunologic factors|mesh-ancestor
5494351|NCT04054999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494352|NCT04054999|Hematinics|hematinics|mesh-ancestor
5494353|NCT04054999|Vitamin B Complex|vitamin b complex|mesh-ancestor
5494354|NCT04054999|Vitamins|vitamins|mesh-ancestor
5494355|NCT04054999|Micronutrients|micronutrients|mesh-ancestor
5494356|NCT04054999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494357|NCT04041232|Glycerol|glycerol|mesh-list
5494358|NCT04041232|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
5494359|NCT04041232|Protective Agents|protective agents|mesh-ancestor
5494360|NCT04041232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494361|NCT03947385|Crizotinib|crizotinib|mesh-list
5494362|NCT03947385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5494363|NCT03947385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5494364|NCT03947385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5494365|NCT03947385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503169|NCT04461535|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
5503170|NCT04461535|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
6034066|NCT00484679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6034067|NCT00484679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034068|NCT00484874|Tositumomab I-131|tositumomab i-131|mesh-list
6034069|NCT00484874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6034070|NCT00484939|Bevacizumab|bevacizumab|mesh-list
6034071|NCT00484939|Capecitabine|capecitabine|mesh-list
6034072|NCT00484939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6034073|NCT00484939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6034074|NCT00484939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6034075|NCT00484939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6034076|NCT00484939|Growth Substances|growth substances|mesh-ancestor
6034077|NCT00484939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034078|NCT00484939|Growth Inhibitors|growth inhibitors|mesh-ancestor
6034079|NCT00484939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6034080|NCT00484939|Antimetabolites|antimetabolites|mesh-ancestor
6034081|NCT00484939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034082|NCT00485069|Levodopa|levodopa|mesh-list
6034083|NCT00485069|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6034084|NCT00485069|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6034085|NCT00485069|Dopamine Agents|dopamine agents|mesh-ancestor
6034086|NCT00485069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6034087|NCT00485069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034088|NCT00485069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034089|NCT00485134|Vaccines|vaccines|mesh-list
6034090|NCT00485134|Immunologic Factors|immunologic factors|mesh-ancestor
6034091|NCT00485134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034092|NCT00485264|Raltegravir Potassium|raltegravir potassium|mesh-list
6034093|NCT00485264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5503171|NCT04461535|beta-Endorphin|beta-endorphin|mesh-list
5503172|NCT04461535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5503173|NCT04461535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503174|NCT04461535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5503175|NCT04461535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503176|NCT04461249|Travoprost|travoprost|mesh-list
5503177|NCT04461249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5503178|NCT04461249|Latanoprost|latanoprost|mesh-list
5503179|NCT04461249|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5503180|NCT04461249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5503181|NCT04461353|Hydroxychloroquine|hydroxychloroquine|mesh-list
5503182|NCT04461353|Antimalarials|antimalarials|mesh-ancestor
5503183|NCT04461353|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5503184|NCT04461353|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5503185|NCT04461353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5503186|NCT04461353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5503187|NCT04461353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503188|NCT04461353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6034094|NCT00485264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6034095|NCT00485264|Antiviral Agents|antiviral agents|mesh-ancestor
6034096|NCT00485264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6034097|NCT00485264|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5503189|NCT04461418|Glucocorticoids|glucocorticoids|mesh-list
5503190|NCT04461418|Hormones|hormones|mesh-ancestor
6034098|NCT00485264|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6034099|NCT00485264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6034100|NCT00485264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034101|NCT00485303|Prednisone|prednisone|mesh-list
6034102|NCT00485303|Abiraterone Acetate|abiraterone acetate|mesh-list
6034103|NCT00485303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6034104|NCT00485303|Glucocorticoids|glucocorticoids|mesh-ancestor
6034105|NCT00485303|Hormones|hormones|mesh-ancestor
6034106|NCT00485303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6034107|NCT00485303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034108|NCT00485303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6034109|NCT00485303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6654752|NCT01458964|Antidepressive Agents|antidepressive agents|mesh-ancestor
6654753|NCT01458964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6654754|NCT01458964|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6654755|NCT01458964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6654756|NCT01458964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6654757|NCT01458964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654758|NCT01458977|Tenofovir|tenofovir|mesh-list
6654759|NCT01458977|Emtricitabine|emtricitabine|mesh-list
6654760|NCT01458977|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6654761|NCT01458977|Antiviral Agents|antiviral agents|mesh-ancestor
6654762|NCT01458977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6654763|NCT01458977|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6654764|NCT01458977|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6654765|NCT01458977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6654766|NCT01458977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654767|NCT01458977|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6654768|NCT01458977|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6654769|NCT01459081|Zanamivir|zanamivir|mesh-list
5494366|NCT03896984|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
6456861|NCT00433719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6456862|NCT00433719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6456863|NCT00433719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494367|NCT03896984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5494368|NCT03857542|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5494369|NCT03857542|Pilocarpine|pilocarpine|mesh-list
5494370|NCT03857542|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5494371|NCT03857542|Miotics|miotics|mesh-ancestor
5494372|NCT03857542|Autonomic Agents|autonomic agents|mesh-ancestor
5494373|NCT03857542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5494374|NCT03857542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494375|NCT03857542|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
5494376|NCT03857542|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6456864|NCT00433719|Antiviral Agents|antiviral agents|mesh-ancestor
6456865|NCT00433719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6034110|NCT00485303|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6034111|NCT00485303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6034112|NCT00485303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034113|NCT00485303|Hormone Antagonists|hormone antagonists|mesh-ancestor
6034114|NCT00485303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6034115|NCT00485433|Epinephrine|epinephrine|mesh-list
6034116|NCT00485433|Bupivacaine|bupivacaine|mesh-list
6034117|NCT00485433|Anesthetics, Local|anesthetics, local|mesh-ancestor
6034118|NCT00485433|Anesthetics|anesthetics|mesh-ancestor
5494377|NCT03857542|Cholinergic Agents|cholinergic agents|mesh-ancestor
5494378|NCT03857542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5494379|NCT03857542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494380|NCT03848832|Cannabidiol|cannabidiol|mesh-list
5494381|NCT03848832|Anticonvulsants|anticonvulsants|mesh-ancestor
5494382|NCT03835013|Exenatide|exenatide|mesh-list
6034119|NCT00485433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6034120|NCT00485433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034121|NCT00485433|Sensory System Agents|sensory system agents|mesh-ancestor
6034122|NCT00485433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6034123|NCT00485433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6034124|NCT00485433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6456866|NCT00433719|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6456867|NCT00433719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6456868|NCT00433719|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6456869|NCT00433719|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6456870|NCT00433719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6456871|NCT00433719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5494383|NCT03835013|Glucagon|glucagon|mesh-list
6456872|NCT00433719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6456873|NCT00433719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6456874|NCT00433732|Naproxen|naproxen|mesh-list
6456875|NCT00433732|Sumatriptan|sumatriptan|mesh-list
6456876|NCT00433732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6456877|NCT00433732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6456878|NCT00433732|Analgesics|analgesics|mesh-ancestor
6456879|NCT00433732|Sensory System Agents|sensory system agents|mesh-ancestor
6456880|NCT00433732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6456881|NCT00433732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456882|NCT00433732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6456883|NCT00433732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6456884|NCT00433732|Gout Suppressants|gout suppressants|mesh-ancestor
6456885|NCT00433732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6456886|NCT00433732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6456887|NCT00433732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456888|NCT00433732|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6456889|NCT00433732|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6456890|NCT00433732|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6456891|NCT00433732|Serotonin Agents|serotonin agents|mesh-ancestor
6456892|NCT00433732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6456893|NCT00433784|Clopidogrel|clopidogrel|mesh-list
6456894|NCT00433784|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6456895|NCT00433784|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5494384|NCT03835013|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5494385|NCT03835013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5494386|NCT03835013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494387|NCT03835013|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5494388|NCT03835013|Incretins|incretins|mesh-ancestor
5494389|NCT03835013|Hormones|hormones|mesh-ancestor
5494390|NCT03835013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5494391|NCT03835013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5494392|NCT03810807|Osimertinib|osimertinib|mesh-list
5494393|NCT03810807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6034125|NCT00485433|Adrenergic Agents|adrenergic agents|mesh-ancestor
6456896|NCT00433784|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6456897|NCT00433784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6456898|NCT00433784|Purinergic Agents|purinergic agents|mesh-ancestor
6456899|NCT00433784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6456900|NCT00433784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456901|NCT00433784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456902|NCT00433823|Atorvastatin|atorvastatin|mesh-list
6456903|NCT00433823|Ezetimibe|ezetimibe|mesh-list
6456904|NCT00433823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6456905|NCT00433823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6456906|NCT00433823|Antimetabolites|antimetabolites|mesh-ancestor
6456907|NCT00433823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456908|NCT00433823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6456909|NCT00433823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6456910|NCT00433823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6456911|NCT00433927|Leucovorin|leucovorin|mesh-list
6456912|NCT00433927|Folic Acid|folic acid|mesh-list
6456913|NCT00433927|Bevacizumab|bevacizumab|mesh-list
6456914|NCT00433927|Cetuximab|cetuximab|mesh-list
6456915|NCT00433927|Irinotecan|irinotecan|mesh-list
6456916|NCT00433927|Levoleucovorin|levoleucovorin|mesh-list
6456917|NCT00433927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6456918|NCT00433927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6456919|NCT00433927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6456920|NCT00433927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6456921|NCT00433927|Growth Substances|growth substances|mesh-ancestor
6456922|NCT00433927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456923|NCT00433927|Growth Inhibitors|growth inhibitors|mesh-ancestor
6034126|NCT00485433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6034127|NCT00485433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034128|NCT00485433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6034129|NCT00485433|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6034130|NCT00485433|Autonomic Agents|autonomic agents|mesh-ancestor
6034131|NCT00485433|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6034132|NCT00485433|Respiratory System Agents|respiratory system agents|mesh-ancestor
6034133|NCT00485433|Mydriatics|mydriatics|mesh-ancestor
6034134|NCT00485433|Sympathomimetics|sympathomimetics|mesh-ancestor
6034135|NCT00485433|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6034136|NCT00485472|Lacosamide|lacosamide|mesh-list
6456924|NCT00433927|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6456925|NCT00433927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6034137|NCT00485472|Anticonvulsants|anticonvulsants|mesh-ancestor
6034138|NCT00485472|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6034139|NCT00485472|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6034140|NCT00485472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6034141|NCT00485472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034142|NCT00485485|Docetaxel|docetaxel|mesh-list
6456926|NCT00433927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6456927|NCT00433927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456928|NCT00433927|Antidotes|antidotes|mesh-ancestor
6456929|NCT00433927|Protective Agents|protective agents|mesh-ancestor
6034143|NCT00485485|Imatinib Mesylate|imatinib mesylate|mesh-list
6034144|NCT00485485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6034145|NCT00485485|Tubulin Modulators|tubulin modulators|mesh-ancestor
6034146|NCT00485485|Antimitotic Agents|antimitotic agents|mesh-ancestor
6034147|NCT00485485|Mitosis Modulators|mitosis modulators|mesh-ancestor
6034148|NCT00485485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034149|NCT00485485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6034150|NCT00485485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6456930|NCT00433927|Vitamin B Complex|vitamin b complex|mesh-ancestor
6456931|NCT00433927|Vitamins|vitamins|mesh-ancestor
6456932|NCT00433927|Micronutrients|micronutrients|mesh-ancestor
6034151|NCT00485589|Methotrexate|methotrexate|mesh-list
5494394|NCT03810807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5494395|NCT03810807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5494396|NCT03810807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494397|NCT03794388|Pregabalin|pregabalin|mesh-list
5494398|NCT03794388|Capsaicin|capsaicin|mesh-list
5494399|NCT03794388|Analgesics|analgesics|mesh-ancestor
6034152|NCT00485589|Ocrelizumab|ocrelizumab|mesh-list
6034153|NCT00485589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6456933|NCT00433927|Hematinics|hematinics|mesh-ancestor
6456934|NCT00433940|Prednisolone|prednisolone|mesh-list
6456935|NCT00433940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6456936|NCT00433940|Glucocorticoids|glucocorticoids|mesh-ancestor
6456937|NCT00433940|Hormones|hormones|mesh-ancestor
6456938|NCT00433940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6456939|NCT00433940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456940|NCT00433940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6456941|NCT00433940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6456942|NCT00433953|Mycophenolic Acid|mycophenolic acid|mesh-list
6456943|NCT00433953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6456944|NCT00433953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6456945|NCT00433953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6456946|NCT00433953|Antitubercular Agents|antitubercular agents|mesh-ancestor
6456947|NCT00433953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6456948|NCT00433953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6456949|NCT00433953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6456950|NCT00433953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456951|NCT00433979|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6456952|NCT00433979|Antiviral Agents|antiviral agents|mesh-ancestor
6456953|NCT00433979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6461947|NCT00456898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6461948|NCT00456898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461949|NCT00456898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6461950|NCT00456898|Serotonin Agents|serotonin agents|mesh-ancestor
5494400|NCT03794388|Sensory System Agents|sensory system agents|mesh-ancestor
6461951|NCT00456898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461952|NCT00456898|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6461953|NCT00456898|Antidepressive Agents|antidepressive agents|mesh-ancestor
6461954|NCT00456898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6461955|NCT00456898|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5494401|NCT03794388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5494402|NCT03794388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494403|NCT03794388|Anticonvulsants|anticonvulsants|mesh-ancestor
5494404|NCT03794388|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5494405|NCT03794388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5494406|NCT03794388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034154|NCT00485589|Abortifacient Agents|abortifacient agents|mesh-ancestor
6461956|NCT00456898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6461957|NCT00456898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6034155|NCT00485589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6034156|NCT00485589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034157|NCT00485589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6034158|NCT00485589|Antimetabolites|antimetabolites|mesh-ancestor
6034159|NCT00485589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034160|NCT00485589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6034161|NCT00485589|Dermatologic Agents|dermatologic agents|mesh-ancestor
6034162|NCT00485589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6034163|NCT00485589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6034164|NCT00485589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5494407|NCT03794388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5494408|NCT03794388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5724955|NCT03184194|Immunologic Factors|immunologic factors|mesh-ancestor
6034165|NCT00485589|Immunologic Factors|immunologic factors|mesh-ancestor
6034166|NCT00485589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6034167|NCT00485589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6034168|NCT00485693|Epinephrine|epinephrine|mesh-list
6034169|NCT00485693|Bupivacaine|bupivacaine|mesh-list
6034170|NCT00485693|Anesthetics, Local|anesthetics, local|mesh-ancestor
6034171|NCT00485693|Anesthetics|anesthetics|mesh-ancestor
6034172|NCT00485693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6034173|NCT00485693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034174|NCT00485693|Sensory System Agents|sensory system agents|mesh-ancestor
6034175|NCT00485693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6034176|NCT00485693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5724956|NCT03184194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724957|NCT03184194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6034177|NCT00485693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6456954|NCT00434005|Acetylcysteine|acetylcysteine|mesh-list
6456955|NCT00434005|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6034178|NCT00485693|Adrenergic Agents|adrenergic agents|mesh-ancestor
6034179|NCT00485693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6034180|NCT00485693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034181|NCT00485693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6034182|NCT00485693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6034183|NCT00485693|Autonomic Agents|autonomic agents|mesh-ancestor
6034184|NCT00485693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6034185|NCT00485693|Respiratory System Agents|respiratory system agents|mesh-ancestor
6034186|NCT00485693|Mydriatics|mydriatics|mesh-ancestor
6034187|NCT00485693|Sympathomimetics|sympathomimetics|mesh-ancestor
6034188|NCT00485693|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6034189|NCT00485732|Vaccines|vaccines|mesh-list
6034190|NCT00485732|Immunologic Factors|immunologic factors|mesh-ancestor
6034191|NCT00485732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034192|NCT00485758|Niacin|niacin|mesh-list
6034193|NCT00485758|Niacinamide|niacinamide|mesh-list
6034194|NCT00485758|Nicotinic Acids|nicotinic acids|mesh-list
6034195|NCT00485758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6034196|NCT00485758|Antimetabolites|antimetabolites|mesh-ancestor
6034197|NCT00485758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034198|NCT00485758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6034199|NCT00485758|Vasodilator Agents|vasodilator agents|mesh-ancestor
6034200|NCT00485758|Vitamin B Complex|vitamin b complex|mesh-ancestor
6034201|NCT00485758|Vitamins|vitamins|mesh-ancestor
6034202|NCT00485758|Micronutrients|micronutrients|mesh-ancestor
6034203|NCT00485758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034204|NCT00485836|Ranibizumab|ranibizumab|mesh-list
6034205|NCT00485836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6034206|NCT00485836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6034207|NCT00485836|Growth Substances|growth substances|mesh-ancestor
6034208|NCT00485836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034209|NCT00485836|Growth Inhibitors|growth inhibitors|mesh-ancestor
6034210|NCT00485836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6034211|NCT00485953|Risedronic Acid|risedronic acid|mesh-list
6034212|NCT00485953|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6034213|NCT00485953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6456956|NCT00434005|Antiviral Agents|antiviral agents|mesh-ancestor
6456957|NCT00434005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6456958|NCT00434005|Expectorants|expectorants|mesh-ancestor
6456959|NCT00434005|Respiratory System Agents|respiratory system agents|mesh-ancestor
6456960|NCT00434005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6456961|NCT00434005|Antioxidants|antioxidants|mesh-ancestor
6456962|NCT00434005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6456963|NCT00434005|Protective Agents|protective agents|mesh-ancestor
6456964|NCT00434005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456965|NCT00434005|Antidotes|antidotes|mesh-ancestor
6456966|NCT00434031|Cyclophosphamide|cyclophosphamide|mesh-list
6456967|NCT00434031|Docetaxel|docetaxel|mesh-list
6456968|NCT00434031|Doxorubicin|doxorubicin|mesh-list
6456969|NCT00434031|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6456970|NCT00434031|Trastuzumab|trastuzumab|mesh-list
6456971|NCT00434031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5494409|NCT03794388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5494410|NCT03794388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5494411|NCT03794388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5494412|NCT03794388|Antipruritics|antipruritics|mesh-ancestor
5494413|NCT03794388|Dermatologic Agents|dermatologic agents|mesh-ancestor
5494414|NCT03712943|Nivolumab|nivolumab|mesh-list
5494415|NCT03712943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5494416|NCT03712943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5494417|NCT03712943|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5494418|NCT03712943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494419|NCT03700541|Morphine|morphine|mesh-list
5494420|NCT03700541|Pirinitramide|pirinitramide|mesh-list
6456972|NCT00434031|Immunologic Factors|immunologic factors|mesh-ancestor
6456973|NCT00434031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456974|NCT00434031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6456975|NCT00434031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6456976|NCT00434031|Alkylating Agents|alkylating agents|mesh-ancestor
6456977|NCT00434031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494421|NCT03700541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6456978|NCT00434031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6456979|NCT00434031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6456980|NCT00434031|Tubulin Modulators|tubulin modulators|mesh-ancestor
6456981|NCT00434031|Antimitotic Agents|antimitotic agents|mesh-ancestor
6456982|NCT00434031|Mitosis Modulators|mitosis modulators|mesh-ancestor
6456983|NCT00434031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6456984|NCT00434031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6456985|NCT00434031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6456986|NCT00434031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6456987|NCT00434031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6456988|NCT00434044|Etanercept|etanercept|mesh-list
6456989|NCT00434044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6456990|NCT00434044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6456991|NCT00434044|Analgesics|analgesics|mesh-ancestor
6456992|NCT00434044|Sensory System Agents|sensory system agents|mesh-ancestor
6456993|NCT00434044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6456994|NCT00434044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6456995|NCT00434044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6456996|NCT00434044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6456997|NCT00434044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6456998|NCT00434044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6456999|NCT00434044|Immunologic Factors|immunologic factors|mesh-ancestor
6457000|NCT00434083|Naproxen|naproxen|mesh-list
6457001|NCT00434083|Sumatriptan|sumatriptan|mesh-list
6457002|NCT00434083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6457003|NCT00434083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6457004|NCT00434083|Analgesics|analgesics|mesh-ancestor
6034214|NCT00485953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034215|NCT00485953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6034216|NCT00485953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494422|NCT03700541|Narcotics|narcotics|mesh-ancestor
6034217|NCT00485953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6034218|NCT00486018|Ranibizumab|ranibizumab|mesh-list
6034219|NCT00486018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6034220|NCT00486018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6034221|NCT00486018|Growth Substances|growth substances|mesh-ancestor
6034222|NCT00486018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034223|NCT00486018|Growth Inhibitors|growth inhibitors|mesh-ancestor
6034224|NCT00486018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6034225|NCT00486031|Balsalazide|balsalazide|mesh-list
6034226|NCT00486031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6034227|NCT00486031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6034228|NCT00486031|Analgesics|analgesics|mesh-ancestor
6034229|NCT00486031|Sensory System Agents|sensory system agents|mesh-ancestor
6034230|NCT00486031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6034231|NCT00486031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034232|NCT00486031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6034233|NCT00486031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6034234|NCT00486031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6034235|NCT00486044|Simvastatin|simvastatin|mesh-list
6034236|NCT00486044|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6034237|NCT00486044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6034238|NCT00486044|Antimetabolites|antimetabolites|mesh-ancestor
6457005|NCT00434083|Sensory System Agents|sensory system agents|mesh-ancestor
5494423|NCT03700541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5494424|NCT03700541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494425|NCT03700541|Analgesics|analgesics|mesh-ancestor
5494426|NCT03700541|Sensory System Agents|sensory system agents|mesh-ancestor
6034239|NCT00486044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034240|NCT00486044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6034241|NCT00486044|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6034242|NCT00486044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6053576|NCT00596427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6053577|NCT00596440|Nicotine|nicotine|mesh-list
6053578|NCT00596440|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6053579|NCT00596440|Autonomic Agents|autonomic agents|mesh-ancestor
6053580|NCT00596440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6053581|NCT00596440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053582|NCT00596440|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6053583|NCT00596440|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6053584|NCT00596440|Cholinergic Agents|cholinergic agents|mesh-ancestor
6053585|NCT00596440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6053586|NCT00596440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053587|NCT00596453|Ciprofloxacin|ciprofloxacin|mesh-list
6053588|NCT00596453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6053589|NCT00596453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6053590|NCT00596453|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6053591|NCT00596453|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6053592|NCT00596453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6053593|NCT00596453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053594|NCT00596453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6457006|NCT00434083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6457007|NCT00434083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457008|NCT00434083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6457009|NCT00434083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6457010|NCT00434083|Gout Suppressants|gout suppressants|mesh-ancestor
6457011|NCT00434083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6457012|NCT00434083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6457013|NCT00434083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654770|NCT01459081|Antiviral Agents|antiviral agents|mesh-ancestor
6654771|NCT01459081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6654772|NCT01459081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6654773|NCT01459081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654774|NCT01459133|Insulin|insulin|mesh-list
6654775|NCT01459133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6654776|NCT01459133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654777|NCT01459146|Lumefantrine|lumefantrine|mesh-list
6654778|NCT01459146|Artemether|artemether|mesh-list
6654779|NCT01459146|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6654780|NCT01459146|Albendazole|albendazole|mesh-list
6654781|NCT01459146|Praziquantel|praziquantel|mesh-list
6654782|NCT01459146|Antimalarials|antimalarials|mesh-ancestor
6654783|NCT01459146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6654784|NCT01459146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6654785|NCT01459146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6053595|NCT00596453|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6053596|NCT00596453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6053597|NCT00596466|Pregabalin|pregabalin|mesh-list
6053598|NCT00596466|Analgesics|analgesics|mesh-ancestor
6053599|NCT00596466|Sensory System Agents|sensory system agents|mesh-ancestor
6053600|NCT00596466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6053601|NCT00596466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053602|NCT00596466|Anticonvulsants|anticonvulsants|mesh-ancestor
6053603|NCT00596466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6053604|NCT00596466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6053605|NCT00596466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053606|NCT00596466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6053607|NCT00596466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6053608|NCT00596466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6654786|NCT01459146|Anthelmintics|anthelmintics|mesh-ancestor
5494427|NCT03700541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5494428|NCT03700411|Morphine|morphine|mesh-list
5494429|NCT03700411|Pirinitramide|pirinitramide|mesh-list
5494430|NCT03700411|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5494431|NCT03700411|Narcotics|narcotics|mesh-ancestor
5494432|NCT03700411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5494433|NCT03700411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494434|NCT03700411|Analgesics|analgesics|mesh-ancestor
5494435|NCT03700411|Sensory System Agents|sensory system agents|mesh-ancestor
5494436|NCT03700411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5494437|NCT03691051|Capecitabine|capecitabine|mesh-list
6034243|NCT00486330|Ritonavir|ritonavir|mesh-list
6034244|NCT00486330|Tipranavir|tipranavir|mesh-list
6034245|NCT00486330|Buprenorphine|buprenorphine|mesh-list
6034246|NCT00486330|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6034247|NCT00486330|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6034248|NCT00486330|Protease Inhibitors|protease inhibitors|mesh-ancestor
6034249|NCT00486330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6034250|NCT00486330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034251|NCT00486330|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6034252|NCT00486330|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6034253|NCT00486330|Antiviral Agents|antiviral agents|mesh-ancestor
6034254|NCT00486330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6034255|NCT00486330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6034256|NCT00486330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6457014|NCT00434083|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6457015|NCT00434083|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6457016|NCT00434083|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6457017|NCT00434083|Serotonin Agents|serotonin agents|mesh-ancestor
6457018|NCT00434083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6457019|NCT00434096|Rimonabant|rimonabant|mesh-list
6457020|NCT00434096|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6457021|NCT00434096|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
6457022|NCT00434096|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6457023|NCT00434096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6457024|NCT00434096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457025|NCT00434096|Hormones|hormones|mesh-ancestor
6457026|NCT00434096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6457027|NCT00434096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457028|NCT00434135|Gemcitabine|gemcitabine|mesh-list
6034257|NCT00486330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6034258|NCT00486330|Narcotics|narcotics|mesh-ancestor
6034259|NCT00486330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6034260|NCT00486330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034261|NCT00486330|Analgesics|analgesics|mesh-ancestor
6034262|NCT00486330|Sensory System Agents|sensory system agents|mesh-ancestor
6034263|NCT00486330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6034264|NCT00486330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6034265|NCT00486434|Calcitonin|calcitonin|mesh-list
6034266|NCT00486434|Salmon calcitonin|salmon calcitonin|mesh-list
6034267|NCT00486434|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
6034268|NCT00486434|Katacalcin|katacalcin|mesh-list
6034269|NCT00486434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6034270|NCT00486434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034271|NCT00486434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6034272|NCT00486434|Vasodilator Agents|vasodilator agents|mesh-ancestor
6034273|NCT00486603|Hydroxychloroquine|hydroxychloroquine|mesh-list
6034274|NCT00486603|Temozolomide|temozolomide|mesh-list
6034275|NCT00486603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6034276|NCT00486603|Alkylating Agents|alkylating agents|mesh-ancestor
6034277|NCT00486603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034278|NCT00486603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6034279|NCT00486603|Antimalarials|antimalarials|mesh-ancestor
6034280|NCT00486603|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6034281|NCT00486603|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6034282|NCT00486603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6034283|NCT00486603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6034284|NCT00486603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6034285|NCT00486642|Bicalutamide|bicalutamide|mesh-list
6034286|NCT00486642|Androgen Antagonists|androgen antagonists|mesh-ancestor
6034287|NCT00486642|Hormone Antagonists|hormone antagonists|mesh-ancestor
6034288|NCT00486642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6034289|NCT00486642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034290|NCT00486642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6034291|NCT00486720|Vorinostat|vorinostat|mesh-list
6034292|NCT00486720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5494438|NCT03691051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5494439|NCT03691051|Antimetabolites|antimetabolites|mesh-ancestor
5494440|NCT03691051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034293|NCT00486720|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6034294|NCT00486720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6034295|NCT00486720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034296|NCT00486759|Bevacizumab|bevacizumab|mesh-list
6457029|NCT00434135|Paclitaxel|paclitaxel|mesh-list
6034297|NCT00486759|Rituximab|rituximab|mesh-list
6034298|NCT00486759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6034299|NCT00486759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5494441|NCT03691051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5494442|NCT03688802|Varenicline|varenicline|mesh-list
5494443|NCT03688802|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5494444|NCT03688802|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5494445|NCT03688802|Cholinergic Agents|cholinergic agents|mesh-ancestor
5494446|NCT03688802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5494447|NCT03688802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494448|NCT03688802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494449|NCT03656068|Nitazoxanide|nitazoxanide|mesh-list
5494450|NCT03656068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5494451|NCT03656068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5494452|NCT03630666|Hormones|hormones|mesh-list
5494453|NCT03630666|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
5494454|NCT03630666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5494455|NCT03630666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494456|NCT03625648|Pentoxifylline|pentoxifylline|mesh-list
5494457|NCT03625648|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5494458|NCT03625648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5494459|NCT03625648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494460|NCT03625648|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5494461|NCT03625648|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5494462|NCT03625648|Protective Agents|protective agents|mesh-ancestor
5494463|NCT03625648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494464|NCT03625648|Vasodilator Agents|vasodilator agents|mesh-ancestor
5494465|NCT03625648|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5494466|NCT03625648|Antioxidants|antioxidants|mesh-ancestor
5494467|NCT03616418|Antihypertensive Agents|antihypertensive agents|mesh-list
5494468|NCT03616418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
6034300|NCT00486759|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6034301|NCT00486759|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6034302|NCT00486759|Growth Substances|growth substances|mesh-ancestor
6034303|NCT00486759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034304|NCT00486759|Growth Inhibitors|growth inhibitors|mesh-ancestor
6034305|NCT00486759|Immunologic Factors|immunologic factors|mesh-ancestor
6034306|NCT00486759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6034307|NCT00486811|Oxycodone|oxycodone|mesh-list
6034308|NCT00486811|Tapentadol|tapentadol|mesh-list
6034309|NCT00486811|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6034310|NCT00486811|Narcotics|narcotics|mesh-ancestor
6034311|NCT00486811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6034312|NCT00486811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034313|NCT00486811|Analgesics|analgesics|mesh-ancestor
6034314|NCT00486811|Sensory System Agents|sensory system agents|mesh-ancestor
6034315|NCT00486811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6457030|NCT00434135|Pemetrexed|pemetrexed|mesh-list
6457031|NCT00434135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6457032|NCT00434135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5494469|NCT03602612|Cyclophosphamide|cyclophosphamide|mesh-list
5494470|NCT03602612|Fludarabine|fludarabine|mesh-list
5494471|NCT03602612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5494472|NCT03602612|Immunologic Factors|immunologic factors|mesh-ancestor
5494473|NCT03602612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494474|NCT03602612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5494475|NCT03602612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5494476|NCT03602612|Alkylating Agents|alkylating agents|mesh-ancestor
5494477|NCT03602612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457033|NCT00434135|Tubulin Modulators|tubulin modulators|mesh-ancestor
5494478|NCT03602612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6457034|NCT00434135|Antimitotic Agents|antimitotic agents|mesh-ancestor
6457035|NCT00434135|Mitosis Modulators|mitosis modulators|mesh-ancestor
6457036|NCT00434135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457037|NCT00434135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6457038|NCT00434135|Antimetabolites|antimetabolites|mesh-ancestor
6457039|NCT00434135|Antiviral Agents|antiviral agents|mesh-ancestor
6457040|NCT00434135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6457041|NCT00434135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6457042|NCT00434135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6457043|NCT00434135|Immunologic Factors|immunologic factors|mesh-ancestor
6457044|NCT00434135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457045|NCT00434135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6034316|NCT00486811|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6034317|NCT00486811|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6457046|NCT00434135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6457047|NCT00434174|Pemetrexed|pemetrexed|mesh-list
6457048|NCT00434174|Everolimus|everolimus|mesh-list
6457049|NCT00434174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6457050|NCT00434174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6457051|NCT00434174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457052|NCT00434174|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6457053|NCT00434174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6457054|NCT00434174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6457055|NCT00434174|Immunologic Factors|immunologic factors|mesh-ancestor
6457056|NCT00434174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457057|NCT00434239|Lenalidomide|lenalidomide|mesh-list
6457058|NCT00434239|Immunologic Factors|immunologic factors|mesh-ancestor
6457059|NCT00434239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457060|NCT00434239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6457061|NCT00434239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6457062|NCT00434239|Growth Substances|growth substances|mesh-ancestor
6457063|NCT00434239|Growth Inhibitors|growth inhibitors|mesh-ancestor
6457064|NCT00434239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6457065|NCT00434317|Zoledronic Acid|zoledronic acid|mesh-list
6457066|NCT00434317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6457067|NCT00434317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457068|NCT00434382|Fentanyl|fentanyl|mesh-list
6457069|NCT00434382|Sufentanil|sufentanil|mesh-list
6457070|NCT00434382|Remifentanil|remifentanil|mesh-list
6457071|NCT00434382|Alfentanil|alfentanil|mesh-list
6457072|NCT00434382|Propofol|propofol|mesh-list
6457073|NCT00434382|Sevoflurane|sevoflurane|mesh-list
6457074|NCT00434382|Desflurane|desflurane|mesh-list
6457075|NCT00434382|Isoflurane|isoflurane|mesh-list
6457076|NCT00434382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6457077|NCT00434382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6457078|NCT00434382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457079|NCT00434382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6457080|NCT00434382|Anesthetics, General|anesthetics, general|mesh-ancestor
6457081|NCT00434382|Anesthetics|anesthetics|mesh-ancestor
6457082|NCT00434382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6457083|NCT00434382|Narcotics|narcotics|mesh-ancestor
6457084|NCT00434382|Analgesics|analgesics|mesh-ancestor
6457085|NCT00434382|Sensory System Agents|sensory system agents|mesh-ancestor
6457086|NCT00434382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6457087|NCT00434382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6457088|NCT00434382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6457089|NCT00434382|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6457090|NCT00434447|Zoledronic Acid|zoledronic acid|mesh-list
6457091|NCT00434447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6457092|NCT00434447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457093|NCT00434629|Tositumomab I-131|tositumomab i-131|mesh-list
6457094|NCT00434629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6457095|NCT00434668|Cisplatin|cisplatin|mesh-list
5494479|NCT03602612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5494480|NCT03595917|Prednisone|prednisone|mesh-list
5494481|NCT03595917|Dasatinib|dasatinib|mesh-list
5494482|NCT03595917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5494483|NCT03595917|Glucocorticoids|glucocorticoids|mesh-ancestor
5494484|NCT03595917|Hormones|hormones|mesh-ancestor
5494485|NCT03595917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5494486|NCT03595917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494487|NCT03595917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5494488|NCT03595917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6457096|NCT00434668|Docetaxel|docetaxel|mesh-list
6457097|NCT00434668|Vinorelbine|vinorelbine|mesh-list
6457098|NCT00434668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6457099|NCT00434668|Tubulin Modulators|tubulin modulators|mesh-ancestor
6457100|NCT00434668|Antimitotic Agents|antimitotic agents|mesh-ancestor
6457101|NCT00434668|Mitosis Modulators|mitosis modulators|mesh-ancestor
6457102|NCT00434668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654787|NCT01459146|Anticestodal Agents|anticestodal agents|mesh-ancestor
6654788|NCT01459146|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6654789|NCT01459146|Tubulin Modulators|tubulin modulators|mesh-ancestor
6654790|NCT01459146|Antimitotic Agents|antimitotic agents|mesh-ancestor
6654791|NCT01459146|Mitosis Modulators|mitosis modulators|mesh-ancestor
6654792|NCT01459146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034318|NCT00486811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6034319|NCT00486811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034320|NCT00486811|Adrenergic Agents|adrenergic agents|mesh-ancestor
6034321|NCT00486811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6034322|NCT00486824|Indomethacin|indomethacin|mesh-list
6034323|NCT00486824|Nifedipine|nifedipine|mesh-list
6034324|NCT00486824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6034325|NCT00486824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6034326|NCT00486824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034327|NCT00486824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6034328|NCT00486824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034329|NCT00486824|Vasodilator Agents|vasodilator agents|mesh-ancestor
6034330|NCT00486824|Tocolytic Agents|tocolytic agents|mesh-ancestor
6034331|NCT00486824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6034332|NCT00486824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6654793|NCT01459146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6654794|NCT01459198|Vaccines|vaccines|mesh-list
6654795|NCT01459198|Immunologic Factors|immunologic factors|mesh-ancestor
6654796|NCT01459198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654797|NCT01459211|Dexamethasone|dexamethasone|mesh-list
6654798|NCT01459211|Lenalidomide|lenalidomide|mesh-list
6654799|NCT01459211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6654800|NCT01459211|Antiemetics|antiemetics|mesh-ancestor
6654801|NCT01459211|Autonomic Agents|autonomic agents|mesh-ancestor
6654802|NCT01459211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6654803|NCT01459211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654804|NCT01459211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6654805|NCT01459211|Glucocorticoids|glucocorticoids|mesh-ancestor
6654806|NCT01459211|Hormones|hormones|mesh-ancestor
6654807|NCT01459211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6654808|NCT01459211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6654809|NCT01459211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6654810|NCT01459211|Immunologic Factors|immunologic factors|mesh-ancestor
6654811|NCT01459211|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6654812|NCT01459211|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5494489|NCT03595917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6654813|NCT01459211|Growth Substances|growth substances|mesh-ancestor
6654814|NCT01459211|Growth Inhibitors|growth inhibitors|mesh-ancestor
6654815|NCT01459250|S 20098|s 20098|mesh-list
6654816|NCT01459250|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6654817|NCT01459250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6654818|NCT01459250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654819|NCT01459276|Vaccines|vaccines|mesh-list
6034333|NCT00486824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6034334|NCT00486824|Analgesics|analgesics|mesh-ancestor
6034335|NCT00486824|Sensory System Agents|sensory system agents|mesh-ancestor
6034336|NCT00486824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6034337|NCT00486824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6034338|NCT00486824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6034339|NCT00486824|Gout Suppressants|gout suppressants|mesh-ancestor
6034340|NCT00486824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6034341|NCT00486824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6034342|NCT00486837|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
6034343|NCT00486837|Protease Inhibitors|protease inhibitors|mesh-list
6034344|NCT00486837|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6034345|NCT00486837|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6034346|NCT00486837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6034347|NCT00486837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457103|NCT00434668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6457104|NCT00434681|Acetaminophen|acetaminophen|mesh-list
6457105|NCT00434681|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6457106|NCT00434681|Analgesics|analgesics|mesh-ancestor
6457107|NCT00434681|Sensory System Agents|sensory system agents|mesh-ancestor
6457108|NCT00434681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6654820|NCT01459276|Immunologic Factors|immunologic factors|mesh-ancestor
6034348|NCT00486863|Praziquantel|praziquantel|mesh-list
6034349|NCT00486863|Anthelmintics|anthelmintics|mesh-ancestor
6034350|NCT00486863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6034351|NCT00486863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6034352|NCT00486902|Ketamine|ketamine|mesh-list
6034353|NCT00486902|N-Methylaspartate|n-methylaspartate|mesh-list
6034354|NCT00486902|Analgesics|analgesics|mesh-ancestor
6034355|NCT00486902|Sensory System Agents|sensory system agents|mesh-ancestor
6034356|NCT00486902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6034357|NCT00486902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034358|NCT00486902|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6034359|NCT00486902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6034360|NCT00486902|Anesthetics, General|anesthetics, general|mesh-ancestor
6034361|NCT00486902|Anesthetics|anesthetics|mesh-ancestor
6034362|NCT00486902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6034363|NCT00486902|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6034364|NCT00486902|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6034365|NCT00486902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6034366|NCT00486902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034367|NCT00486902|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
6034368|NCT00486954|Paclitaxel|paclitaxel|mesh-list
6034369|NCT00486954|Lapatinib|lapatinib|mesh-list
6034370|NCT00486954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6034371|NCT00486954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6034372|NCT00486954|Tubulin Modulators|tubulin modulators|mesh-ancestor
6654821|NCT01459276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494490|NCT03595917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5494491|NCT03595917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494492|NCT03562195|Albuterol|albuterol|mesh-list
5494493|NCT03562195|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5494494|NCT03562195|Autonomic Agents|autonomic agents|mesh-ancestor
5494495|NCT03562195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5494496|NCT03562195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654822|NCT01459315|Dolutegravir|dolutegravir|mesh-list
6654823|NCT01459315|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5494497|NCT03562195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5494498|NCT03562195|Respiratory System Agents|respiratory system agents|mesh-ancestor
5494499|NCT03562195|Tocolytic Agents|tocolytic agents|mesh-ancestor
5494500|NCT03562195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5494501|NCT03562195|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6034373|NCT00486954|Antimitotic Agents|antimitotic agents|mesh-ancestor
6034374|NCT00486954|Mitosis Modulators|mitosis modulators|mesh-ancestor
6034375|NCT00486954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034376|NCT00486954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6034377|NCT00486954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6034378|NCT00487084|Lidocaine|lidocaine|mesh-list
6034379|NCT00487084|Morphine|morphine|mesh-list
6034380|NCT00487084|Anesthetics, Local|anesthetics, local|mesh-ancestor
5494502|NCT03562195|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5494503|NCT03562195|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5494504|NCT03562195|Adrenergic Agents|adrenergic agents|mesh-ancestor
5494505|NCT03562195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5494506|NCT03562195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494507|NCT03541083|Blinatumomab|blinatumomab|mesh-list
5494508|NCT03541083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5494509|NCT03510598|Deoxycholic Acid|deoxycholic acid|mesh-list
5494510|NCT03510598|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5494511|NCT03510598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5494512|NCT03465111|Hormones|hormones|mesh-list
5494513|NCT03465111|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
5494514|NCT03465111|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
5494515|NCT03465111|beta-Endorphin|beta-endorphin|mesh-list
5494516|NCT03465111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5494517|NCT03465111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494518|NCT03465111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5494519|NCT03465111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494520|NCT03448393|Cyclophosphamide|cyclophosphamide|mesh-list
6034381|NCT00487084|Anesthetics|anesthetics|mesh-ancestor
6034382|NCT00487084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6034383|NCT00487084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457109|NCT00434681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457110|NCT00434681|Antipyretics|antipyretics|mesh-ancestor
6457111|NCT00434746|Fezakinumab|fezakinumab|mesh-list
6457112|NCT00434746|Dermatologic Agents|dermatologic agents|mesh-ancestor
6457113|NCT00434772|Glucagon|glucagon|mesh-list
6034384|NCT00487084|Sensory System Agents|sensory system agents|mesh-ancestor
6034385|NCT00487084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6034386|NCT00487084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6034387|NCT00487084|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6034388|NCT00487084|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6034389|NCT00487084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6034390|NCT00487084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034391|NCT00487084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6034392|NCT00487084|Narcotics|narcotics|mesh-ancestor
6034393|NCT00487084|Analgesics|analgesics|mesh-ancestor
6034394|NCT00487188|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6034395|NCT00487188|Enfuvirtide|enfuvirtide|mesh-list
6034396|NCT00487188|Antiviral Agents|antiviral agents|mesh-ancestor
6034397|NCT00487188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6034398|NCT00487188|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6034399|NCT00487188|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6034400|NCT00487188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034401|NCT00487188|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6034402|NCT00487240|Insulin|insulin|mesh-list
6034403|NCT00487240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6034404|NCT00487240|Insulin Lispro|insulin lispro|mesh-list
6034405|NCT00487240|Insulin Detemir|insulin detemir|mesh-list
6034406|NCT00487240|Protamines|protamines|mesh-list
6034407|NCT00487240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6034408|NCT00487240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034409|NCT00487240|Heparin Antagonists|heparin antagonists|mesh-ancestor
6034410|NCT00487240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034411|NCT00487240|Coagulants|coagulants|mesh-ancestor
6034412|NCT00487435|Tapentadol|tapentadol|mesh-list
6034413|NCT00487435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6034414|NCT00487435|Narcotics|narcotics|mesh-ancestor
6034415|NCT00487435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6034416|NCT00487435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034417|NCT00487435|Analgesics|analgesics|mesh-ancestor
6034418|NCT00487435|Sensory System Agents|sensory system agents|mesh-ancestor
6034419|NCT00487435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6034420|NCT00487435|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6034421|NCT00487435|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6034422|NCT00487435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6034423|NCT00487435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457114|NCT00434772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6457115|NCT00434772|Hormones|hormones|mesh-ancestor
6457116|NCT00434772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6457117|NCT00434772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457118|NCT00434824|Methyltestosterone|methyltestosterone|mesh-list
6457119|NCT00434824|Testosterone|testosterone|mesh-list
6457120|NCT00434824|Testosterone undecanoate|testosterone undecanoate|mesh-list
6457121|NCT00434824|Testosterone enanthate|testosterone enanthate|mesh-list
6457122|NCT00434824|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6457123|NCT00434824|Androgens|androgens|mesh-ancestor
6457124|NCT00434824|Hormones|hormones|mesh-ancestor
6457125|NCT00434824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6034424|NCT00487435|Adrenergic Agents|adrenergic agents|mesh-ancestor
6034425|NCT00487435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6034426|NCT00487539|Golimumab|golimumab|mesh-list
6034427|NCT00487539|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6034428|NCT00487539|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6034429|NCT00487539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6457126|NCT00434824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457127|NCT00434824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6457128|NCT00434824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6457129|NCT00434824|Anabolic Agents|anabolic agents|mesh-ancestor
6457130|NCT00434863|Botulinum Toxins|botulinum toxins|mesh-list
6457131|NCT00434863|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6457132|NCT00434863|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6457133|NCT00434863|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6457134|NCT00434863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6457135|NCT00434863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457136|NCT00434863|Cholinergic Agents|cholinergic agents|mesh-ancestor
6457137|NCT00434863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6034430|NCT00487539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6034431|NCT00487539|Immunologic Factors|immunologic factors|mesh-ancestor
6034432|NCT00487539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034433|NCT00487669|Paclitaxel|paclitaxel|mesh-list
6034434|NCT00487669|Pemetrexed|pemetrexed|mesh-list
6034435|NCT00487669|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
6034436|NCT00487669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6034437|NCT00487669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6034438|NCT00487669|Tubulin Modulators|tubulin modulators|mesh-ancestor
6034439|NCT00487669|Antimitotic Agents|antimitotic agents|mesh-ancestor
6034440|NCT00487669|Mitosis Modulators|mitosis modulators|mesh-ancestor
6034441|NCT00487669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034442|NCT00487669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5494521|NCT03448393|Fludarabine|fludarabine|mesh-list
5494522|NCT03448393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5494523|NCT03448393|Immunologic Factors|immunologic factors|mesh-ancestor
5494524|NCT03448393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494525|NCT03448393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5494526|NCT03448393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5494527|NCT03448393|Alkylating Agents|alkylating agents|mesh-ancestor
5494528|NCT03448393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494529|NCT03448393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5494530|NCT03448393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5494531|NCT03446612|Nitroprusside|nitroprusside|mesh-list
5494532|NCT03446612|Acetylcholine|acetylcholine|mesh-list
5494533|NCT03446612|Darbepoetin alfa|darbepoetin alfa|mesh-list
5494534|NCT03446612|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
5494535|NCT03446612|Hematinics|hematinics|mesh-ancestor
5494536|NCT03446612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5494537|NCT03446612|Vasodilator Agents|vasodilator agents|mesh-ancestor
5494538|NCT03446612|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6034443|NCT00487669|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6034444|NCT00487669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6034445|NCT00487721|Silymarin|silymarin|mesh-list
6034446|NCT00487721|Antioxidants|antioxidants|mesh-ancestor
6034447|NCT00487721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034448|NCT00487721|Protective Agents|protective agents|mesh-ancestor
6034449|NCT00487721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034450|NCT00487747|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6034451|NCT00487747|Antiviral Agents|antiviral agents|mesh-ancestor
6034452|NCT00487747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6034453|NCT00487825|Methotrexate|methotrexate|mesh-list
6034454|NCT00487825|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6034455|NCT00487825|Abortifacient Agents|abortifacient agents|mesh-ancestor
6034456|NCT00487825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6034457|NCT00487825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034458|NCT00487825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6034459|NCT00487825|Antimetabolites|antimetabolites|mesh-ancestor
6034460|NCT00487825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034461|NCT00487825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6034462|NCT00487825|Dermatologic Agents|dermatologic agents|mesh-ancestor
6034463|NCT00487825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6034464|NCT00487825|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6034465|NCT00487825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6034466|NCT00487825|Immunologic Factors|immunologic factors|mesh-ancestor
6034467|NCT00487825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6034468|NCT00487825|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6034469|NCT00487942|Modafinil|modafinil|mesh-list
6034470|NCT00487942|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6034471|NCT00487942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034472|NCT00487942|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6034473|NCT00487942|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6034474|NCT00487942|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6034475|NCT00487942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034476|NCT00488059|Enfuvirtide|enfuvirtide|mesh-list
6034477|NCT00488059|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
6034478|NCT00488059|Integrase Inhibitors|integrase inhibitors|mesh-list
6034479|NCT00488059|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6034480|NCT00488059|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6034481|NCT00488059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034482|NCT00488059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6034483|NCT00488059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6034484|NCT00488059|Antiviral Agents|antiviral agents|mesh-ancestor
6034485|NCT00488059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6034486|NCT00488059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6034487|NCT00488319|Paliperidone Palmitate|paliperidone palmitate|mesh-list
5494539|NCT03446612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494540|NCT03446612|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6034488|NCT00488319|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6034489|NCT00488319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6034490|NCT00488319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6034491|NCT00488319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034492|NCT00488319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6654824|NCT01459315|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6654825|NCT01459315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6457138|NCT00434863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457139|NCT00434863|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6457140|NCT00434863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6457141|NCT00434941|Capecitabine|capecitabine|mesh-list
6457142|NCT00434941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6457143|NCT00434941|Antimetabolites|antimetabolites|mesh-ancestor
6457144|NCT00434941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457145|NCT00434941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6457146|NCT00435058|Timolol|timolol|mesh-list
6457147|NCT00435058|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6457148|NCT00435058|Travoprost|travoprost|mesh-list
6457149|NCT00435058|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6457150|NCT00435058|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6457151|NCT00435058|Adrenergic Agents|adrenergic agents|mesh-ancestor
6457152|NCT00435058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6457153|NCT00435058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457154|NCT00435058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457155|NCT00435058|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6457156|NCT00435058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6457157|NCT00435058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6457158|NCT00435058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6457159|NCT00435058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5494541|NCT03446612|Cholinergic Agents|cholinergic agents|mesh-ancestor
5494542|NCT03446612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5494543|NCT03446612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494544|NCT03446612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5494545|NCT03436433|Lacosamide|lacosamide|mesh-list
5494546|NCT03436433|Levetiracetam|levetiracetam|mesh-list
5494547|NCT03436433|Anticonvulsants|anticonvulsants|mesh-ancestor
5494548|NCT03436433|Nootropic Agents|nootropic agents|mesh-ancestor
5494549|NCT03436433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5494550|NCT03436433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5494551|NCT03436433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5494552|NCT03436433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494553|NCT03434379|Bevacizumab|bevacizumab|mesh-list
5494554|NCT03434379|Sorafenib|sorafenib|mesh-list
5494555|NCT03434379|Atezolizumab|atezolizumab|mesh-list
5494556|NCT03434379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5494557|NCT03434379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5494558|NCT03434379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6457160|NCT00435175|Estradiol|estradiol|mesh-list
6457161|NCT00435175|Estrogens|estrogens|mesh-ancestor
5494559|NCT03434379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6664640|NCT01513083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6034493|NCT00488319|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6034494|NCT00488319|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6034495|NCT00488319|Serotonin Agents|serotonin agents|mesh-ancestor
6034496|NCT00488319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6034497|NCT00488319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034498|NCT00488319|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6034499|NCT00488319|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6034500|NCT00488319|Dopamine Agents|dopamine agents|mesh-ancestor
6034501|NCT00488345|Tigecycline|tigecycline|mesh-list
6034502|NCT00488345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6034503|NCT00488345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6034504|NCT00488345|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6034505|NCT00488345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6034506|NCT00488345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034507|NCT00488475|Etanercept|etanercept|mesh-list
6034508|NCT00488475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6034509|NCT00488475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6034510|NCT00488475|Analgesics|analgesics|mesh-ancestor
6034511|NCT00488475|Sensory System Agents|sensory system agents|mesh-ancestor
6034512|NCT00488475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6034513|NCT00488475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034514|NCT00488475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6457162|NCT00435175|Hormones|hormones|mesh-ancestor
6461958|NCT00456898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5494560|NCT03434379|Growth Substances|growth substances|mesh-ancestor
6034515|NCT00488475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6034516|NCT00488475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6034517|NCT00488475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6034518|NCT00488475|Immunologic Factors|immunologic factors|mesh-ancestor
6034519|NCT00488488|Tigecycline|tigecycline|mesh-list
6034520|NCT00488488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6034521|NCT00488488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6034522|NCT00488488|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6034523|NCT00488488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6034524|NCT00488488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034525|NCT00488514|Naproxen|naproxen|mesh-list
6034526|NCT00488514|Sumatriptan|sumatriptan|mesh-list
6034527|NCT00488514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6654826|NCT01459315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654827|NCT01459315|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6654828|NCT01459315|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6654829|NCT01459315|Antiviral Agents|antiviral agents|mesh-ancestor
6654830|NCT01459315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6654831|NCT01459367|Lansoprazole|lansoprazole|mesh-list
6654832|NCT01459367|Dexlansoprazole|dexlansoprazole|mesh-list
6654833|NCT01459367|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6654834|NCT01459367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6654835|NCT01459367|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6654836|NCT01459367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6654837|NCT01459367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654838|NCT01459380|Bevacizumab|bevacizumab|mesh-list
6654839|NCT01459380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6654840|NCT01459380|Carboplatin|carboplatin|mesh-list
6654841|NCT01459380|Doxorubicin|doxorubicin|mesh-list
6654842|NCT01459380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6034528|NCT00488514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6034529|NCT00488514|Analgesics|analgesics|mesh-ancestor
6034530|NCT00488514|Sensory System Agents|sensory system agents|mesh-ancestor
6034531|NCT00488514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6034532|NCT00488514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034533|NCT00488514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6034534|NCT00488514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6034535|NCT00488514|Gout Suppressants|gout suppressants|mesh-ancestor
6034536|NCT00488514|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6034537|NCT00488514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6034538|NCT00488514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034539|NCT00488514|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6034540|NCT00488514|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6034541|NCT00488514|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6034542|NCT00488514|Serotonin Agents|serotonin agents|mesh-ancestor
6034543|NCT00488514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6034544|NCT00488592|Molgramostim|molgramostim|mesh-list
6034545|NCT00488592|Sargramostim|sargramostim|mesh-list
6034546|NCT00488592|Immunologic Factors|immunologic factors|mesh-ancestor
6034547|NCT00488592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034548|NCT00488592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6034549|NCT00488618|Cariprazine|cariprazine|mesh-list
6034550|NCT00488618|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6034551|NCT00488618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6034552|NCT00488618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6034553|NCT00488618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034554|NCT00488618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6457163|NCT00435175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6457164|NCT00435175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457165|NCT00435279|Eszopiclone|eszopiclone|mesh-list
6457166|NCT00435279|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6457167|NCT00435279|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6457168|NCT00435279|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6457169|NCT00435279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6457170|NCT00435279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457171|NCT00435279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6461959|NCT00456898|Narcotics|narcotics|mesh-ancestor
6654843|NCT01459380|Veliparib|veliparib|mesh-list
6034555|NCT00488631|Golimumab|golimumab|mesh-list
6034556|NCT00488631|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6034557|NCT00488631|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6034558|NCT00488631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6034559|NCT00488631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6034560|NCT00488631|Immunologic Factors|immunologic factors|mesh-ancestor
6654844|NCT01459380|Endothelial Growth Factors|endothelial growth factors|mesh-list
6034561|NCT00488631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034562|NCT00488683|Vaccines|vaccines|mesh-list
6034563|NCT00488683|Immunologic Factors|immunologic factors|mesh-ancestor
6034564|NCT00488683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034565|NCT00488774|Golimumab|golimumab|mesh-list
6034566|NCT00488774|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6034567|NCT00488774|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6034568|NCT00488774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6034569|NCT00488774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6034570|NCT00488774|Immunologic Factors|immunologic factors|mesh-ancestor
6034571|NCT00488774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034572|NCT00488826|Vaccines|vaccines|mesh-list
6034573|NCT00488826|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6034574|NCT00488826|Immunologic Factors|immunologic factors|mesh-ancestor
6034575|NCT00488826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034576|NCT00488982|Docetaxel|docetaxel|mesh-list
6034577|NCT00488982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6034578|NCT00488982|Tubulin Modulators|tubulin modulators|mesh-ancestor
6034579|NCT00488982|Antimitotic Agents|antimitotic agents|mesh-ancestor
5494561|NCT03434379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494562|NCT03434379|Growth Inhibitors|growth inhibitors|mesh-ancestor
6034580|NCT00488982|Mitosis Modulators|mitosis modulators|mesh-ancestor
6034581|NCT00488982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034582|NCT00489086|Tazarotene|tazarotene|mesh-list
6034583|NCT00489086|Dermatologic Agents|dermatologic agents|mesh-ancestor
6034584|NCT00489086|Keratolytic Agents|keratolytic agents|mesh-ancestor
6034585|NCT00489281|Mycophenolic Acid|mycophenolic acid|mesh-list
6034586|NCT00489281|Sirolimus|sirolimus|mesh-list
6034587|NCT00489281|Cyclophosphamide|cyclophosphamide|mesh-list
6034588|NCT00489281|Fludarabine|fludarabine|mesh-list
6034589|NCT00489281|Levetiracetam|levetiracetam|mesh-list
6034590|NCT00489281|Thymoglobulin|thymoglobulin|mesh-list
6034591|NCT00489281|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6034592|NCT00489281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6034593|NCT00489281|Immunologic Factors|immunologic factors|mesh-ancestor
6457172|NCT00435279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457173|NCT00435279|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6457174|NCT00435279|Antidepressive Agents|antidepressive agents|mesh-ancestor
6034594|NCT00489281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034595|NCT00489281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6034596|NCT00489281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6034597|NCT00489281|Alkylating Agents|alkylating agents|mesh-ancestor
6034598|NCT00489281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034599|NCT00489281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6034600|NCT00489281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6034601|NCT00489281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6034602|NCT00489281|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6034603|NCT00489281|Antitubercular Agents|antitubercular agents|mesh-ancestor
6034604|NCT00489281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6034605|NCT00489281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6034606|NCT00489281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6034607|NCT00489281|Antifungal Agents|antifungal agents|mesh-ancestor
6034608|NCT00489281|Anticonvulsants|anticonvulsants|mesh-ancestor
6034609|NCT00489281|Nootropic Agents|nootropic agents|mesh-ancestor
6034610|NCT00489359|Carboplatin|carboplatin|mesh-list
6034611|NCT00489359|Pemetrexed|pemetrexed|mesh-list
6034612|NCT00489359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6034613|NCT00489359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6034614|NCT00489359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034615|NCT00489359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6034616|NCT00489359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6034617|NCT00489411|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6034618|NCT00489411|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6034619|NCT00489411|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6034620|NCT00489411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6034621|NCT00489411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034622|NCT00489411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6034623|NCT00489411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457175|NCT00435279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6457176|NCT00435279|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6457177|NCT00435279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6457178|NCT00435292|Naproxen|naproxen|mesh-list
6457179|NCT00435292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6457180|NCT00435292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6457181|NCT00435292|Analgesics|analgesics|mesh-ancestor
6457182|NCT00435292|Sensory System Agents|sensory system agents|mesh-ancestor
6457183|NCT00435292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6457184|NCT00435292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457185|NCT00435292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6457186|NCT00435292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6457187|NCT00435292|Gout Suppressants|gout suppressants|mesh-ancestor
6457188|NCT00435292|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6457189|NCT00435292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6457190|NCT00435292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457191|NCT00435305|Vancomycin|vancomycin|mesh-list
6457192|NCT00435305|Meropenem|meropenem|mesh-list
6457193|NCT00435305|Tazobactam|tazobactam|mesh-list
6457194|NCT00435305|Linezolid|linezolid|mesh-list
6457195|NCT00435305|Piperacillin|piperacillin|mesh-list
6457196|NCT00435305|Ceftazidime|ceftazidime|mesh-list
6457197|NCT00435305|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
6457198|NCT00435305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6457199|NCT00435305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6457200|NCT00435305|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6457201|NCT00435305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6457202|NCT00435305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654845|NCT01459380|Antibodies|antibodies|mesh-list
6654846|NCT01459380|Immunoglobulins|immunoglobulins|mesh-list
6654847|NCT01459380|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6034624|NCT00489411|Analgesics|analgesics|mesh-ancestor
6034625|NCT00489411|Sensory System Agents|sensory system agents|mesh-ancestor
6034626|NCT00489411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6034627|NCT00489411|Antidepressive Agents|antidepressive agents|mesh-ancestor
6654848|NCT01459380|Immunoglobulin G|immunoglobulin g|mesh-list
6654849|NCT01459380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6654850|NCT01459380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6654851|NCT01459380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6654852|NCT01459380|Growth Substances|growth substances|mesh-ancestor
6654853|NCT01459380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654854|NCT01459380|Growth Inhibitors|growth inhibitors|mesh-ancestor
6654855|NCT01459380|Immunologic Factors|immunologic factors|mesh-ancestor
6654856|NCT01459380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6654857|NCT01459380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6654858|NCT01459380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6654859|NCT01459380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6654860|NCT01459380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034628|NCT00489411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6034629|NCT00489411|Dopamine Agents|dopamine agents|mesh-ancestor
6034630|NCT00489424|Acetaminophen|acetaminophen|mesh-list
6034631|NCT00489424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6034632|NCT00489424|Analgesics|analgesics|mesh-ancestor
6034633|NCT00489424|Sensory System Agents|sensory system agents|mesh-ancestor
6034634|NCT00489424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6034635|NCT00489424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034636|NCT00489424|Antipyretics|antipyretics|mesh-ancestor
6034637|NCT00489476|Loxapine|loxapine|mesh-list
6034638|NCT00489476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6034639|NCT00489476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6034640|NCT00489476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6034641|NCT00489476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034642|NCT00489476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6654861|NCT01459380|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6654862|NCT01459406|Levan|levan|mesh-list
6654863|NCT01459406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6654864|NCT01459419|Antibodies|antibodies|mesh-list
6654865|NCT01459419|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6654866|NCT01459419|Immunologic Factors|immunologic factors|mesh-ancestor
6654867|NCT01459419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457203|NCT00435305|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6457204|NCT00435331|Verapamil|verapamil|mesh-list
6457205|NCT00435331|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6457206|NCT00435331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6457207|NCT00435331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6034643|NCT00489476|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6034644|NCT00489476|Dopamine Agents|dopamine agents|mesh-ancestor
6034645|NCT00489476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6034646|NCT00489476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034647|NCT00489489|Interferons|interferons|mesh-list
6034648|NCT00489489|Interferon-beta|interferon-beta|mesh-list
6034649|NCT00489489|Teriflunomide|teriflunomide|mesh-list
6654868|NCT01459445|Metformin|metformin|mesh-list
6654869|NCT01459445|Drospirenone|drospirenone|mesh-list
6654870|NCT01459445|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6034650|NCT00489489|Interferon beta-1b|interferon beta-1b|mesh-list
6034651|NCT00489489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6034652|NCT00489489|Antiviral Agents|antiviral agents|mesh-ancestor
6034653|NCT00489489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6034654|NCT00489489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6034655|NCT00489489|Immunologic Factors|immunologic factors|mesh-ancestor
6034656|NCT00489489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034657|NCT00489489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6034658|NCT00489489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6034659|NCT00489489|Analgesics|analgesics|mesh-ancestor
6034660|NCT00489489|Sensory System Agents|sensory system agents|mesh-ancestor
6034661|NCT00489489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5724958|NCT03184194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5724959|NCT03184194|Alkylating Agents|alkylating agents|mesh-ancestor
5724960|NCT03184194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724961|NCT03184194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5724962|NCT03184194|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5724963|NCT03184194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5724964|NCT03184194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5724965|NCT03183752|Metformin|metformin|mesh-list
5724966|NCT03183752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6034662|NCT00489489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6034663|NCT00489489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6034664|NCT00489489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6034665|NCT00489541|Paclitaxel|paclitaxel|mesh-list
6034666|NCT00489541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6034667|NCT00489541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6034668|NCT00489541|Tubulin Modulators|tubulin modulators|mesh-ancestor
6034669|NCT00489541|Antimitotic Agents|antimitotic agents|mesh-ancestor
6034670|NCT00489541|Mitosis Modulators|mitosis modulators|mesh-ancestor
6034671|NCT00489541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034672|NCT00489554|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6034673|NCT00489554|Immunologic Factors|immunologic factors|mesh-ancestor
5494563|NCT03434379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5494564|NCT03434379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5494565|NCT03434379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494566|NCT03408886|Vancomycin|vancomycin|mesh-list
6034674|NCT00489554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034675|NCT00489736|Amiodarone|amiodarone|mesh-list
6034676|NCT00489736|Dronedarone|dronedarone|mesh-list
6034677|NCT00489736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6034678|NCT00489736|Vasodilator Agents|vasodilator agents|mesh-ancestor
6034679|NCT00489736|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6034680|NCT00489736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6034681|NCT00489736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034682|NCT00489736|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6034683|NCT00489736|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6034684|NCT00489736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5494567|NCT03408886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5494568|NCT03408886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5494569|NCT03387774|Urinastatin|urinastatin|mesh-list
5494570|NCT03387774|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6034685|NCT00489736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6034686|NCT00489736|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6034687|NCT00489736|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6034688|NCT00489736|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6034689|NCT00489853|Budesonide|budesonide|mesh-list
6034690|NCT00489853|Formoterol Fumarate|formoterol fumarate|mesh-list
6034691|NCT00489853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6034692|NCT00489853|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6034693|NCT00489853|Autonomic Agents|autonomic agents|mesh-ancestor
6034694|NCT00489853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6034695|NCT00489853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034696|NCT00489853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6034697|NCT00489853|Respiratory System Agents|respiratory system agents|mesh-ancestor
6034698|NCT00489853|Glucocorticoids|glucocorticoids|mesh-ancestor
6034699|NCT00489853|Hormones|hormones|mesh-ancestor
6457208|NCT00435331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457209|NCT00435331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6457210|NCT00435331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457211|NCT00435331|Vasodilator Agents|vasodilator agents|mesh-ancestor
6457212|NCT00435435|Disulfiram|disulfiram|mesh-list
5494571|NCT03387774|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6457213|NCT00435435|Acamprosate|acamprosate|mesh-list
6457214|NCT00435435|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6457215|NCT00435435|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
6457216|NCT00435435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6457217|NCT00435435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457218|NCT00435448|Lonidamine|lonidamine|mesh-list
6457219|NCT00435448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6034700|NCT00489853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6034701|NCT00489853|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6034702|NCT00489853|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6034703|NCT00489853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6034704|NCT00489853|Adrenergic Agents|adrenergic agents|mesh-ancestor
6034705|NCT00489853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6034706|NCT00489853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034707|NCT00489866|Aripiprazole|aripiprazole|mesh-list
6034708|NCT00489866|Antidepressive Agents|antidepressive agents|mesh-ancestor
6034709|NCT00489866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6034710|NCT00489866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6034711|NCT00489866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6034712|NCT00489866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6034713|NCT00489866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034714|NCT00489866|Dopamine Agonists|dopamine agonists|mesh-ancestor
6034715|NCT00489866|Dopamine Agents|dopamine agents|mesh-ancestor
5494572|NCT03387774|Protease Inhibitors|protease inhibitors|mesh-ancestor
5494573|NCT03387774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5494574|NCT03387774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494575|NCT03387579|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
5494576|NCT03387579|SMOFlipid|smoflipid|mesh-list
5494577|NCT03387579|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
5494578|NCT03387579|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5494579|NCT03387579|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6034716|NCT00489866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6654871|NCT01459445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6654872|NCT01459445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654873|NCT01459445|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6654874|NCT01459445|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6654875|NCT01459445|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6654876|NCT01459445|Contraceptive Agents|contraceptive agents|mesh-ancestor
6654877|NCT01459445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6654878|NCT01459445|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6654879|NCT01459445|Estrogens|estrogens|mesh-ancestor
6654880|NCT01459445|Hormones|hormones|mesh-ancestor
6654881|NCT01459445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6034717|NCT00489866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457220|NCT00435448|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
6457221|NCT00435448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457222|NCT00435448|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6457223|NCT00435448|Contraceptive Agents|contraceptive agents|mesh-ancestor
6457224|NCT00435448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6457225|NCT00435448|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6457226|NCT00435448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6034718|NCT00489866|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6034719|NCT00489866|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6034720|NCT00489866|Serotonin Agents|serotonin agents|mesh-ancestor
6034721|NCT00489866|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6034722|NCT00489866|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6034723|NCT00489866|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6034724|NCT00489866|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6034725|NCT00489918|Teriparatide|teriparatide|mesh-list
6034726|NCT00489918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6034727|NCT00489918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034728|NCT00489918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6034729|NCT00490009|Acetaminophen|acetaminophen|mesh-list
6034730|NCT00490009|Iodine|iodine|mesh-list
6034731|NCT00490009|Diphenhydramine|diphenhydramine|mesh-list
6034732|NCT00490009|Promethazine|promethazine|mesh-list
6034733|NCT00490009|Cadexomer iodine|cadexomer iodine|mesh-list
6034734|NCT00490009|Tositumomab I-131|tositumomab i-131|mesh-list
6034735|NCT00490009|Lugol's solution|lugol's solution|mesh-list
6034736|NCT00490009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6034737|NCT00490009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6034738|NCT00490009|Analgesics|analgesics|mesh-ancestor
6457227|NCT00435448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6034739|NCT00490009|Sensory System Agents|sensory system agents|mesh-ancestor
5494580|NCT03332498|Pembrolizumab|pembrolizumab|mesh-list
5494581|NCT03332498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5494582|NCT03332498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5494583|NCT03290079|Pembrolizumab|pembrolizumab|mesh-list
5494584|NCT03290079|Lenvatinib|lenvatinib|mesh-list
5494585|NCT03290079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5494586|NCT03290079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5494587|NCT03290079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5494588|NCT03290079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5494589|NCT03290079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494590|NCT03260504|Aldesleukin|aldesleukin|mesh-list
5494591|NCT03260504|Pembrolizumab|pembrolizumab|mesh-list
5494592|NCT03260504|Interleukin-2|interleukin-2|mesh-list
5494593|NCT03260504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5494594|NCT03260504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5494595|NCT03260504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5494596|NCT03260504|Analgesics|analgesics|mesh-ancestor
5494597|NCT03260504|Sensory System Agents|sensory system agents|mesh-ancestor
5494598|NCT03260504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5494599|NCT03260504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494600|NCT03260504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5494601|NCT03260504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5494602|NCT03260504|Antiviral Agents|antiviral agents|mesh-ancestor
5494603|NCT03260504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5494604|NCT03255512|Isosorbide|isosorbide|mesh-list
5494605|NCT03255512|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
5494606|NCT03255512|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
5494607|NCT03255512|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5494608|NCT03255512|Diuretics|diuretics|mesh-ancestor
5494609|NCT03255512|Natriuretic Agents|natriuretic agents|mesh-ancestor
5494610|NCT03255512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494611|NCT03255512|Vasodilator Agents|vasodilator agents|mesh-ancestor
5494612|NCT03255512|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5494613|NCT03255512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503191|NCT04461418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5503192|NCT04461418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503193|NCT04461379|Vaccines|vaccines|mesh-list
5503194|NCT04461379|BCG Vaccine|bcg vaccine|mesh-list
5503195|NCT04461379|Immunologic Factors|immunologic factors|mesh-ancestor
5503196|NCT04461379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503197|NCT04461379|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5503198|NCT04461288|Nicotine|nicotine|mesh-list
5503199|NCT04461288|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5503200|NCT04461288|Autonomic Agents|autonomic agents|mesh-ancestor
5503201|NCT04461288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5503202|NCT04461288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034740|NCT00490009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6034741|NCT00490009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034742|NCT00490009|Antipyretics|antipyretics|mesh-ancestor
6034743|NCT00490009|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6034744|NCT00490009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6034745|NCT00490009|Trace Elements|trace elements|mesh-ancestor
6034746|NCT00490009|Micronutrients|micronutrients|mesh-ancestor
6034747|NCT00490009|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6034748|NCT00490009|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6034749|NCT00490009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6034750|NCT00490009|Anesthetics, Local|anesthetics, local|mesh-ancestor
6034751|NCT00490009|Anesthetics|anesthetics|mesh-ancestor
6034752|NCT00490009|Antiemetics|antiemetics|mesh-ancestor
6034753|NCT00490009|Autonomic Agents|autonomic agents|mesh-ancestor
6654882|NCT01459445|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6654883|NCT01459445|Hormone Antagonists|hormone antagonists|mesh-ancestor
6654884|NCT01459445|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6654885|NCT01459445|Diuretics|diuretics|mesh-ancestor
6654886|NCT01459445|Natriuretic Agents|natriuretic agents|mesh-ancestor
5503203|NCT04461288|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5503204|NCT04461288|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5503205|NCT04461288|Cholinergic Agents|cholinergic agents|mesh-ancestor
5503206|NCT04461288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5503207|NCT04461288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503208|NCT04461340|Sirolimus|sirolimus|mesh-list
5503209|NCT04461340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5503210|NCT04461340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5503211|NCT04461340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6034754|NCT00490009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6654887|NCT01459484|Cisplatin|cisplatin|mesh-list
6034755|NCT00490009|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6034756|NCT00490009|Histamine Antagonists|histamine antagonists|mesh-ancestor
6034757|NCT00490009|Histamine Agents|histamine agents|mesh-ancestor
6034758|NCT00490009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6034759|NCT00490009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034760|NCT00490009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6034761|NCT00490009|Antipruritics|antipruritics|mesh-ancestor
6034762|NCT00490009|Dermatologic Agents|dermatologic agents|mesh-ancestor
6034763|NCT00490009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6034764|NCT00490009|Hemostatics|hemostatics|mesh-ancestor
6034765|NCT00490009|Coagulants|coagulants|mesh-ancestor
6034766|NCT00490022|Dihydrotestosterone|dihydrotestosterone|mesh-list
6034767|NCT00490022|Androgens|androgens|mesh-ancestor
6034768|NCT00490022|Hormones|hormones|mesh-ancestor
6034769|NCT00490022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6034770|NCT00490022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034771|NCT00490035|Brivaracetam|brivaracetam|mesh-list
6034772|NCT00490035|Anticonvulsants|anticonvulsants|mesh-ancestor
6034773|NCT00490061|Lapatinib|lapatinib|mesh-list
6034774|NCT00490061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6034775|NCT00490061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6034776|NCT00490061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6034777|NCT00490061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034778|NCT00490100|Mecasermin|mecasermin|mesh-list
6034779|NCT00490100|Growth Substances|growth substances|mesh-ancestor
6034780|NCT00490100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034781|NCT00490139|Trastuzumab|trastuzumab|mesh-list
6034782|NCT00490139|Lapatinib|lapatinib|mesh-list
6034783|NCT00490139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6034784|NCT00490139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6034785|NCT00490139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6034786|NCT00490139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6034787|NCT00490139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034788|NCT00490269|Dronabinol|dronabinol|mesh-list
6034789|NCT00490269|Hallucinogens|hallucinogens|mesh-ancestor
6034790|NCT00490269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034791|NCT00490269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6034792|NCT00490269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6034793|NCT00490269|Analgesics|analgesics|mesh-ancestor
6034794|NCT00490269|Sensory System Agents|sensory system agents|mesh-ancestor
6034795|NCT00490269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6034796|NCT00490269|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6034797|NCT00490269|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6034798|NCT00490269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6034799|NCT00490269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034800|NCT00490269|Hormones|hormones|mesh-ancestor
6034801|NCT00490269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6034802|NCT00490477|Polymyxins|polymyxins|mesh-list
6034803|NCT00490477|Polymyxin B|polymyxin b|mesh-list
6034804|NCT00490477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6034805|NCT00490477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6034806|NCT00490490|Iodine|iodine|mesh-list
6034807|NCT00490490|Lugol's solution|lugol's solution|mesh-list
6034808|NCT00490490|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6034809|NCT00490490|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6034810|NCT00490490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6457228|NCT00435448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6457229|NCT00435500|Fluorides|fluorides|mesh-list
6457230|NCT00435500|Fluorides, Topical|fluorides, topical|mesh-list
6457231|NCT00435500|Cariostatic Agents|cariostatic agents|mesh-ancestor
6457232|NCT00435500|Protective Agents|protective agents|mesh-ancestor
6457233|NCT00435500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494614|NCT03236935|Pembrolizumab|pembrolizumab|mesh-list
5494615|NCT03236935|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
5494616|NCT03236935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5494617|NCT03236935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5494618|NCT03236935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5494619|NCT03236935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494620|NCT03230266|Insulin|insulin|mesh-list
5494621|NCT03230266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5494622|NCT03230266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494623|NCT03193216|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
5494624|NCT03193216|Antacids|antacids|mesh-ancestor
6034811|NCT00490490|Trace Elements|trace elements|mesh-ancestor
6457234|NCT00435747|Parecoxib|parecoxib|mesh-list
6457235|NCT00435747|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6457236|NCT00435747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6457237|NCT00435747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6457238|NCT00435747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457239|NCT00435747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6457240|NCT00435747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6457241|NCT00435747|Analgesics|analgesics|mesh-ancestor
6034812|NCT00490490|Micronutrients|micronutrients|mesh-ancestor
5494625|NCT03193216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494626|NCT03193216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5494627|NCT03112590|Interferons|interferons|mesh-list
5494628|NCT03112590|Interferon-gamma|interferon-gamma|mesh-list
5494629|NCT03112590|Paclitaxel|paclitaxel|mesh-list
5494630|NCT03112590|Trastuzumab|trastuzumab|mesh-list
5494631|NCT03112590|Pertuzumab|pertuzumab|mesh-list
5494632|NCT03112590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5494633|NCT03112590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5494634|NCT03112590|Tubulin Modulators|tubulin modulators|mesh-ancestor
5494635|NCT03112590|Antimitotic Agents|antimitotic agents|mesh-ancestor
5494636|NCT03112590|Mitosis Modulators|mitosis modulators|mesh-ancestor
5494637|NCT03112590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494638|NCT03112590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5494639|NCT03112590|Antiviral Agents|antiviral agents|mesh-ancestor
5494640|NCT03112590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5494641|NCT03111212|Iloprost|iloprost|mesh-list
5494642|NCT03111212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5494643|NCT03111212|Vasodilator Agents|vasodilator agents|mesh-ancestor
5494644|NCT03099863|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
5494645|NCT03099863|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6034813|NCT00490490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034814|NCT00490490|Hemostatics|hemostatics|mesh-ancestor
6034815|NCT00490490|Coagulants|coagulants|mesh-ancestor
6034816|NCT00490529|Cyclophosphamide|cyclophosphamide|mesh-list
6034817|NCT00490529|Rituximab|rituximab|mesh-list
6034818|NCT00490529|Vaccines|vaccines|mesh-list
6034819|NCT00490529|Immunologic Factors|immunologic factors|mesh-ancestor
5494646|NCT03099863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5494647|NCT03099863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5494648|NCT03063021|Acetylcysteine|acetylcysteine|mesh-list
5494649|NCT03063021|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5494650|NCT03063021|Antiviral Agents|antiviral agents|mesh-ancestor
5494651|NCT03063021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5494652|NCT03063021|Expectorants|expectorants|mesh-ancestor
5494653|NCT03063021|Respiratory System Agents|respiratory system agents|mesh-ancestor
5494654|NCT03063021|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5494655|NCT03063021|Antioxidants|antioxidants|mesh-ancestor
5494656|NCT03063021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494657|NCT03063021|Protective Agents|protective agents|mesh-ancestor
6034820|NCT00490529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034821|NCT00490529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6034822|NCT00490529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6034823|NCT00490529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6034824|NCT00490529|Alkylating Agents|alkylating agents|mesh-ancestor
6034825|NCT00490529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034826|NCT00490529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6034827|NCT00490529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6034828|NCT00490529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6034829|NCT00490542|Ziprasidone|ziprasidone|mesh-list
6034830|NCT00490542|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6034831|NCT00490542|Serotonin Agents|serotonin agents|mesh-ancestor
6034832|NCT00490542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6034833|NCT00490542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034834|NCT00490542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034835|NCT00490542|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6034836|NCT00490542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6034837|NCT00490542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6034838|NCT00490542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6457242|NCT00435747|Sensory System Agents|sensory system agents|mesh-ancestor
6457243|NCT00435747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6457244|NCT00435747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457245|NCT00435747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6457246|NCT00435747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6034839|NCT00490542|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6034840|NCT00490542|Dopamine Agents|dopamine agents|mesh-ancestor
5494658|NCT03063021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494659|NCT03063021|Antidotes|antidotes|mesh-ancestor
6034841|NCT00490555|Methyltestosterone|methyltestosterone|mesh-list
6457247|NCT00435760|Bromides|bromides|mesh-list
6457248|NCT00435760|Tiotropium Bromide|tiotropium bromide|mesh-list
6034842|NCT00490555|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6034843|NCT00490555|Medroxyprogesterone|medroxyprogesterone|mesh-list
6034844|NCT00490555|Testosterone|testosterone|mesh-list
6034845|NCT00490555|Testosterone undecanoate|testosterone undecanoate|mesh-list
6034846|NCT00490555|Testosterone enanthate|testosterone enanthate|mesh-list
6034847|NCT00490555|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6034848|NCT00490555|Dutasteride|dutasteride|mesh-list
6034849|NCT00490555|Androgens|androgens|mesh-ancestor
6034850|NCT00490555|Hormones|hormones|mesh-ancestor
6034851|NCT00490555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6034852|NCT00490555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034853|NCT00490555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6654888|NCT01459484|Doxorubicin|doxorubicin|mesh-list
6654889|NCT01459484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6654890|NCT01459484|Methotrexate|methotrexate|mesh-list
6654891|NCT01459484|Ifosfamide|ifosfamide|mesh-list
6654892|NCT01459484|Mifamurtide|mifamurtide|mesh-list
6654893|NCT01459484|Acetylmuramyl-Alanyl-Isoglutamine|acetylmuramyl-alanyl-isoglutamine|mesh-list
6654894|NCT01459484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6654895|NCT01459484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6654896|NCT01459484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6654897|NCT01459484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6654898|NCT01459484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6034854|NCT00490555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6034855|NCT00490555|Anabolic Agents|anabolic agents|mesh-ancestor
6034856|NCT00490555|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6034857|NCT00490555|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5494660|NCT02997358|Doxorubicin|doxorubicin|mesh-list
5494661|NCT02997358|Trabectedin|trabectedin|mesh-list
5494662|NCT02997358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5494663|NCT02997358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5494664|NCT02997358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5494665|NCT02997358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5494666|NCT02997358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5494667|NCT02997358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494668|NCT02997358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5494669|NCT02997358|Alkylating Agents|alkylating agents|mesh-ancestor
5494670|NCT02963610|Pembrolizumab|pembrolizumab|mesh-list
5494671|NCT02963610|Lenalidomide|lenalidomide|mesh-list
5494672|NCT02963610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6034858|NCT00490555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6034859|NCT00490555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034860|NCT00490555|Hormone Antagonists|hormone antagonists|mesh-ancestor
6457249|NCT00435760|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6457250|NCT00435760|Autonomic Agents|autonomic agents|mesh-ancestor
6457251|NCT00435760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6457252|NCT00435760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457253|NCT00435760|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5494673|NCT02963610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5494674|NCT02963610|Immunologic Factors|immunologic factors|mesh-ancestor
5494675|NCT02963610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494676|NCT02963610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5494677|NCT02963610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5494678|NCT02963610|Growth Substances|growth substances|mesh-ancestor
5494679|NCT02963610|Growth Inhibitors|growth inhibitors|mesh-ancestor
5494680|NCT02945800|Gemcitabine|gemcitabine|mesh-list
5494681|NCT02945800|Paclitaxel|paclitaxel|mesh-list
5494682|NCT02945800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5494683|NCT02945800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6034861|NCT00490555|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6457254|NCT00435760|Respiratory System Agents|respiratory system agents|mesh-ancestor
6457255|NCT00435760|Parasympatholytics|parasympatholytics|mesh-ancestor
6457256|NCT00435760|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6457257|NCT00435760|Cholinergic Agents|cholinergic agents|mesh-ancestor
6457258|NCT00435760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6457259|NCT00435760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457260|NCT00435760|Anticonvulsants|anticonvulsants|mesh-ancestor
6461960|NCT00456898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6461961|NCT00456898|Analgesics|analgesics|mesh-ancestor
6461962|NCT00456898|Sensory System Agents|sensory system agents|mesh-ancestor
6461963|NCT00456898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6654899|NCT01459484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034862|NCT00490555|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6034863|NCT00490555|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6034864|NCT00490555|Contraceptive Agents|contraceptive agents|mesh-ancestor
6034865|NCT00490555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6034866|NCT00490555|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6034867|NCT00490555|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6034868|NCT00490555|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6654900|NCT01459484|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6654901|NCT01459484|Abortifacient Agents|abortifacient agents|mesh-ancestor
6654902|NCT01459484|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5494684|NCT02945800|Tubulin Modulators|tubulin modulators|mesh-ancestor
5494685|NCT02945800|Antimitotic Agents|antimitotic agents|mesh-ancestor
5494686|NCT02945800|Mitosis Modulators|mitosis modulators|mesh-ancestor
5494687|NCT02945800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034869|NCT00490568|Rosiglitazone|rosiglitazone|mesh-list
6034870|NCT00490568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6034871|NCT00490568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034872|NCT00490646|Docetaxel|docetaxel|mesh-list
6034873|NCT00490646|Trastuzumab|trastuzumab|mesh-list
6034874|NCT00490646|Epothilones|epothilones|mesh-list
6034875|NCT00490646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6034876|NCT00490646|Tubulin Modulators|tubulin modulators|mesh-ancestor
6034877|NCT00490646|Antimitotic Agents|antimitotic agents|mesh-ancestor
6034878|NCT00490646|Mitosis Modulators|mitosis modulators|mesh-ancestor
6034879|NCT00490646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034880|NCT00490646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6034881|NCT00490698|Zoledronic Acid|zoledronic acid|mesh-list
6034882|NCT00490698|Atorvastatin|atorvastatin|mesh-list
6034883|NCT00490698|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6034884|NCT00490698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6034885|NCT00490698|Antimetabolites|antimetabolites|mesh-ancestor
6034886|NCT00490698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034887|NCT00490698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6034888|NCT00490698|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6034889|NCT00490698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6034890|NCT00490698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6034891|NCT00490698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034892|NCT00490724|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6654903|NCT01459484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654904|NCT01459484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5494688|NCT02945800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5494689|NCT02945800|Antimetabolites|antimetabolites|mesh-ancestor
5494690|NCT02945800|Antiviral Agents|antiviral agents|mesh-ancestor
6457261|NCT00435799|Riboflavin|riboflavin|mesh-list
6457262|NCT00435799|Dextrans|dextrans|mesh-list
6457263|NCT00435799|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6457264|NCT00435799|Vitamin B Complex|vitamin b complex|mesh-ancestor
6457265|NCT00435799|Vitamins|vitamins|mesh-ancestor
6034893|NCT00490724|Natriuretic Agents|natriuretic agents|mesh-ancestor
5494691|NCT02945800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5494692|NCT02945800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5494693|NCT02945800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5494694|NCT02945800|Immunologic Factors|immunologic factors|mesh-ancestor
5494695|NCT02945800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494696|NCT02903160|Prednisone|prednisone|mesh-list
5494697|NCT02903160|Carboplatin|carboplatin|mesh-list
5494698|NCT02903160|Abiraterone Acetate|abiraterone acetate|mesh-list
6034894|NCT00490724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034895|NCT00490802|Oxytocin|oxytocin|mesh-list
6034896|NCT00490802|Oxytocics|oxytocics|mesh-ancestor
6034897|NCT00490802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6034898|NCT00490802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034899|NCT00490815|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
6034900|NCT00490815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6034901|NCT00490815|Glucocorticoids|glucocorticoids|mesh-ancestor
6034902|NCT00490815|Hormones|hormones|mesh-ancestor
6034903|NCT00490815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6034904|NCT00490815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034905|NCT00490919|Buprenorphine|buprenorphine|mesh-list
6034906|NCT00490919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6457266|NCT00435799|Micronutrients|micronutrients|mesh-ancestor
6457267|NCT00435799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457268|NCT00435799|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6457269|NCT00435799|Dermatologic Agents|dermatologic agents|mesh-ancestor
6034907|NCT00490919|Narcotics|narcotics|mesh-ancestor
6457270|NCT00435799|Anticoagulants|anticoagulants|mesh-ancestor
6654905|NCT01459484|Antimetabolites|antimetabolites|mesh-ancestor
5494699|NCT02903160|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
5494700|NCT02903160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5494701|NCT02903160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5494702|NCT02903160|Glucocorticoids|glucocorticoids|mesh-ancestor
5494703|NCT02903160|Hormones|hormones|mesh-ancestor
5494704|NCT02903160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5494705|NCT02903160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494706|NCT02903160|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5494707|NCT02903160|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5494708|NCT02903160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5494709|NCT02903160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034908|NCT00490919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6034909|NCT00490919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034910|NCT00490919|Analgesics|analgesics|mesh-ancestor
6034911|NCT00490919|Sensory System Agents|sensory system agents|mesh-ancestor
6034912|NCT00490919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6034913|NCT00490919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6034914|NCT00490971|Olanzapine|olanzapine|mesh-list
6034915|NCT00490971|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6034916|NCT00490971|Antiemetics|antiemetics|mesh-ancestor
6034917|NCT00490971|Autonomic Agents|autonomic agents|mesh-ancestor
6034918|NCT00490971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6034919|NCT00490971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034920|NCT00490971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6034921|NCT00490971|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6034922|NCT00490971|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6034923|NCT00490971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6034924|NCT00490971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6034925|NCT00490971|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6034926|NCT00490971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6034927|NCT00490971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6034928|NCT00490971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034929|NCT00490971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6034930|NCT00490971|Serotonin Agents|serotonin agents|mesh-ancestor
6457271|NCT00435799|Plasma Substitutes|plasma substitutes|mesh-ancestor
6457272|NCT00435799|Blood Substitutes|blood substitutes|mesh-ancestor
6457273|NCT00435799|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6457274|NCT00435851|Hormones|hormones|mesh-list
6457275|NCT00435851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5494710|NCT02903160|Hormone Antagonists|hormone antagonists|mesh-ancestor
5494711|NCT02903160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5494712|NCT02875223|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
5494713|NCT02875223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5494714|NCT02875223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5494715|NCT02875223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494716|NCT02836925|Sofosbuvir|sofosbuvir|mesh-list
5494717|NCT02836925|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
5494718|NCT02836925|Ledipasvir|ledipasvir|mesh-list
5494719|NCT02836925|Velpatasvir|velpatasvir|mesh-list
5494720|NCT02836925|Antiviral Agents|antiviral agents|mesh-ancestor
5494721|NCT02836925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5494722|NCT02814695|Ascorbic Acid|ascorbic acid|mesh-list
5494723|NCT02814695|Antioxidants|antioxidants|mesh-ancestor
5494724|NCT02814695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494725|NCT02814695|Protective Agents|protective agents|mesh-ancestor
5494726|NCT02814695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034931|NCT00490971|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6034932|NCT00490971|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6034933|NCT00490971|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6034934|NCT00490971|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6034935|NCT00490971|Dopamine Agents|dopamine agents|mesh-ancestor
6034936|NCT00491075|Gemcitabine|gemcitabine|mesh-list
5494727|NCT02814695|Vitamins|vitamins|mesh-ancestor
5494728|NCT02814695|Micronutrients|micronutrients|mesh-ancestor
5494729|NCT02798536|Paclitaxel|paclitaxel|mesh-list
5494730|NCT02798536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5494731|NCT02798536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5494732|NCT02798536|Tubulin Modulators|tubulin modulators|mesh-ancestor
6034937|NCT00491075|Pemetrexed|pemetrexed|mesh-list
6034938|NCT00491075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6034939|NCT00491075|Antimetabolites|antimetabolites|mesh-ancestor
5494733|NCT02798536|Antimitotic Agents|antimitotic agents|mesh-ancestor
5494734|NCT02798536|Mitosis Modulators|mitosis modulators|mesh-ancestor
5494735|NCT02798536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494736|NCT02771249|Pyridoxine|pyridoxine|mesh-list
5494737|NCT02771249|Darunavir|darunavir|mesh-list
5494738|NCT02771249|Cobicistat|cobicistat|mesh-list
5494739|NCT02771249|Isoniazid|isoniazid|mesh-list
5494740|NCT02771249|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5494741|NCT02771249|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5494742|NCT02771249|Protease Inhibitors|protease inhibitors|mesh-ancestor
5494743|NCT02771249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5494744|NCT02771249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034940|NCT00491075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034941|NCT00491075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6034942|NCT00491075|Antiviral Agents|antiviral agents|mesh-ancestor
6034943|NCT00491075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6034944|NCT00491075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6034945|NCT00491075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6034946|NCT00491075|Immunologic Factors|immunologic factors|mesh-ancestor
6034947|NCT00491075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034948|NCT00491075|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6034949|NCT00491075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6034950|NCT00491179|Interferons|interferons|mesh-list
6034951|NCT00491179|Ribavirin|ribavirin|mesh-list
6034952|NCT00491179|Interferon-alpha|interferon-alpha|mesh-list
6034953|NCT00491179|Interferon alpha-2|interferon alpha-2|mesh-list
6034954|NCT00491179|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6034955|NCT00491179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6034956|NCT00491179|Antiviral Agents|antiviral agents|mesh-ancestor
6034957|NCT00491179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6034958|NCT00491179|Antimetabolites|antimetabolites|mesh-ancestor
6034959|NCT00491179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034960|NCT00491179|Immunologic Factors|immunologic factors|mesh-ancestor
6034961|NCT00491179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034962|NCT00491244|Interferons|interferons|mesh-list
6034963|NCT00491244|Ribavirin|ribavirin|mesh-list
6034964|NCT00491244|Interferon-alpha|interferon-alpha|mesh-list
6654906|NCT01459484|Dermatologic Agents|dermatologic agents|mesh-ancestor
6654907|NCT01459484|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6654908|NCT01459484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6654909|NCT01459484|Immunologic Factors|immunologic factors|mesh-ancestor
6654910|NCT01459484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6654911|NCT01459484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6654912|NCT01459484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6654913|NCT01459484|Alkylating Agents|alkylating agents|mesh-ancestor
6654914|NCT01459484|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6457276|NCT00435851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457277|NCT00435955|Rituximab|rituximab|mesh-list
6457278|NCT00435955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6457279|NCT00435955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6457280|NCT00435955|Immunologic Factors|immunologic factors|mesh-ancestor
6457281|NCT00435955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457282|NCT00435955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6457283|NCT00435981|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6457284|NCT00435981|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6457285|NCT00435981|Immunologic Factors|immunologic factors|mesh-ancestor
6457286|NCT00435981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457287|NCT00435981|Antacids|antacids|mesh-ancestor
6654915|NCT01459601|Cabergoline|cabergoline|mesh-list
6654916|NCT01459601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6654917|NCT01459601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6654918|NCT01459601|Dopamine Agonists|dopamine agonists|mesh-ancestor
6654919|NCT01459601|Dopamine Agents|dopamine agents|mesh-ancestor
6654920|NCT01459601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6654921|NCT01459601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654922|NCT01459601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654923|NCT01459627|Ticagrelor|ticagrelor|mesh-list
6034965|NCT00491244|Interferon alpha-2|interferon alpha-2|mesh-list
6034966|NCT00491244|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6034967|NCT00491244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6034968|NCT00491244|Antiviral Agents|antiviral agents|mesh-ancestor
6654924|NCT01459627|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6654925|NCT01459627|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6654926|NCT01459627|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6654927|NCT01459627|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5494745|NCT02771249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5494746|NCT02771249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6034969|NCT00491244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6034970|NCT00491244|Antimetabolites|antimetabolites|mesh-ancestor
6461964|NCT00456898|Antitussive Agents|antitussive agents|mesh-ancestor
6654928|NCT01459627|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6654929|NCT01459627|Purinergic Agents|purinergic agents|mesh-ancestor
5494747|NCT02771249|Antiviral Agents|antiviral agents|mesh-ancestor
5494748|NCT02771249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5494749|NCT02771249|Antitubercular Agents|antitubercular agents|mesh-ancestor
5494750|NCT02771249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5494751|NCT02771249|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5494752|NCT02771249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5494753|NCT02771249|Antimetabolites|antimetabolites|mesh-ancestor
5494754|NCT02771249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5494755|NCT02771249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6654930|NCT01459627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6654931|NCT01459627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654932|NCT01459627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654933|NCT01459640|Hyaluronic Acid|hyaluronic acid|mesh-list
6654934|NCT01459640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6654935|NCT01459640|Immunologic Factors|immunologic factors|mesh-ancestor
6034971|NCT00491244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034972|NCT00491244|Immunologic Factors|immunologic factors|mesh-ancestor
6034973|NCT00491244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034974|NCT00491322|Ergocalciferols|ergocalciferols|mesh-list
6034975|NCT00491322|Vitamin D|vitamin d|mesh-list
6034976|NCT00491322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6034977|NCT00491322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034978|NCT00491322|Vitamins|vitamins|mesh-ancestor
6654936|NCT01459640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654937|NCT01459640|Viscosupplements|viscosupplements|mesh-ancestor
5494756|NCT02771249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5494757|NCT02771249|Vitamin B Complex|vitamin b complex|mesh-ancestor
5494758|NCT02771249|Vitamins|vitamins|mesh-ancestor
5494759|NCT02771249|Micronutrients|micronutrients|mesh-ancestor
5494760|NCT02771249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494761|NCT02766335|Docetaxel|docetaxel|mesh-list
5494762|NCT02766335|Durvalumab|durvalumab|mesh-list
5494763|NCT02766335|Immunoglobulins|immunoglobulins|mesh-list
5494764|NCT02766335|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5494765|NCT02766335|Immunoglobulin G|immunoglobulin g|mesh-list
5494766|NCT02766335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5494767|NCT02766335|Tubulin Modulators|tubulin modulators|mesh-ancestor
5494768|NCT02766335|Antimitotic Agents|antimitotic agents|mesh-ancestor
5494769|NCT02766335|Mitosis Modulators|mitosis modulators|mesh-ancestor
6654938|NCT01459640|Protective Agents|protective agents|mesh-ancestor
6654939|NCT01459666|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6654940|NCT01459666|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6654941|NCT01459666|Hemagglutinins|hemagglutinins|mesh-list
6034979|NCT00491322|Micronutrients|micronutrients|mesh-ancestor
6034980|NCT00491322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6034981|NCT00491374|Mometasone Furoate|mometasone furoate|mesh-list
6034982|NCT00491374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6034983|NCT00491374|Dermatologic Agents|dermatologic agents|mesh-ancestor
6034984|NCT00491374|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6034985|NCT00491530|Calcium, Dietary|calcium, dietary|mesh-list
6034986|NCT00491530|Atorvastatin|atorvastatin|mesh-list
6034987|NCT00491530|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6034988|NCT00491530|Simvastatin|simvastatin|mesh-list
6034989|NCT00491530|Fenofibric acid|fenofibric acid|mesh-list
6034990|NCT00491530|Calcium|calcium|mesh-list
6034991|NCT00491530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6034992|NCT00491530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6034993|NCT00491530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6034994|NCT00491530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6034995|NCT00491530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6034996|NCT00491530|Antimetabolites|antimetabolites|mesh-ancestor
6034997|NCT00491530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6034998|NCT00491530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6034999|NCT00491530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6035000|NCT00491530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6035001|NCT00491556|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6035002|NCT00491556|Antiviral Agents|antiviral agents|mesh-ancestor
6035003|NCT00491556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6053609|NCT00596466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6053610|NCT00596466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6053611|NCT00596622|Lithium Carbonate|lithium carbonate|mesh-list
6654942|NCT01459666|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5494770|NCT02766335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494771|NCT02766335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6035004|NCT00491751|Ascorbic Acid|ascorbic acid|mesh-list
6035005|NCT00491751|Atorvastatin|atorvastatin|mesh-list
6035006|NCT00491751|Vitamins|vitamins|mesh-ancestor
6035007|NCT00491751|Micronutrients|micronutrients|mesh-ancestor
6035008|NCT00491751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035009|NCT00491751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6035010|NCT00491751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6035011|NCT00491751|Antimetabolites|antimetabolites|mesh-ancestor
6035012|NCT00491751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035013|NCT00491751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6035014|NCT00491751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6035015|NCT00491751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6035016|NCT00491751|Antioxidants|antioxidants|mesh-ancestor
6035017|NCT00491751|Protective Agents|protective agents|mesh-ancestor
5494772|NCT02766335|Immunologic Factors|immunologic factors|mesh-ancestor
5494773|NCT02766335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035018|NCT00491764|Posaconazole|posaconazole|mesh-list
6035019|NCT00491764|Terbinafine|terbinafine|mesh-list
6035020|NCT00491764|Antifungal Agents|antifungal agents|mesh-ancestor
6035021|NCT00491764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6035022|NCT00491764|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6035023|NCT00491764|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6035024|NCT00491764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6035025|NCT00491764|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6035026|NCT00491764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6035027|NCT00491764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6035028|NCT00491764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035029|NCT00491764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6457288|NCT00435981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457289|NCT00435981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6457290|NCT00436033|Milnacipran|milnacipran|mesh-list
6457291|NCT00436033|Levomilnacipran|levomilnacipran|mesh-list
6457292|NCT00436033|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6457293|NCT00436033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6457294|NCT00436033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6457295|NCT00436033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457296|NCT00436033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6457297|NCT00436033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457298|NCT00436033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6457299|NCT00436033|Analgesics|analgesics|mesh-ancestor
6457300|NCT00436033|Sensory System Agents|sensory system agents|mesh-ancestor
6457301|NCT00436033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6457302|NCT00436033|Antidepressive Agents|antidepressive agents|mesh-ancestor
6457303|NCT00436033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6457304|NCT00436059|Bortezomib|bortezomib|mesh-list
6457305|NCT00436059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6457306|NCT00436072|Irinotecan|irinotecan|mesh-list
6457307|NCT00436072|Cetuximab|cetuximab|mesh-list
6457308|NCT00436072|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6457309|NCT00436072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6457310|NCT00436072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6457311|NCT00436072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457312|NCT00436072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6654943|NCT01459666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6035030|NCT00491764|Hormone Antagonists|hormone antagonists|mesh-ancestor
6035031|NCT00491764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6035032|NCT00491764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035033|NCT00491894|Glycopyrrolate|glycopyrrolate|mesh-list
6035034|NCT00491894|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6035035|NCT00491894|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6035036|NCT00491894|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6035037|NCT00491894|Cholinergic Agents|cholinergic agents|mesh-ancestor
6035038|NCT00491894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6035039|NCT00491894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035040|NCT00491894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035041|NCT00492024|Moxifloxacin|moxifloxacin|mesh-list
6035042|NCT00492024|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6035043|NCT00492024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6035044|NCT00492024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6035045|NCT00492024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6035046|NCT00492024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6035047|NCT00492024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6053612|NCT00596622|Antidepressive Agents|antidepressive agents|mesh-ancestor
6457313|NCT00436072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6457314|NCT00436124|Oseltamivir|oseltamivir|mesh-list
6457315|NCT00436124|Antiviral Agents|antiviral agents|mesh-ancestor
6457316|NCT00436124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6457317|NCT00436124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6457318|NCT00436124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457319|NCT00436241|Capecitabine|capecitabine|mesh-list
6457320|NCT00436241|Oxaliplatin|oxaliplatin|mesh-list
6035048|NCT00492024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035049|NCT00492024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6035050|NCT00492024|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6035051|NCT00492024|Contraceptive Agents|contraceptive agents|mesh-ancestor
6035052|NCT00492024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6035053|NCT00492024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654944|NCT01459666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654945|NCT01459666|Cholinergic Agents|cholinergic agents|mesh-ancestor
6654946|NCT01459666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6654947|NCT01459666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654948|NCT01459666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6654949|NCT01459666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6654950|NCT01459666|Agglutinins|agglutinins|mesh-ancestor
6654951|NCT01459666|Immunologic Factors|immunologic factors|mesh-ancestor
6654952|NCT01459809|Metformin|metformin|mesh-list
6654953|NCT01459809|Glimepiride|glimepiride|mesh-list
6654954|NCT01459809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6654955|NCT01459809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654956|NCT01459809|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6654957|NCT01459809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6654958|NCT01459809|Immunologic Factors|immunologic factors|mesh-ancestor
6654959|NCT01459887|Prednisone|prednisone|mesh-list
6654960|NCT01459887|Cyclophosphamide|cyclophosphamide|mesh-list
6654961|NCT01459887|Doxorubicin|doxorubicin|mesh-list
6654962|NCT01459887|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6035054|NCT00492024|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6035055|NCT00492024|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5494783|NCT02736422|Xenon|xenon|mesh-list
5494784|NCT02736422|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5494785|NCT02736422|Anesthetics, General|anesthetics, general|mesh-ancestor
5494786|NCT02736422|Anesthetics|anesthetics|mesh-ancestor
5494787|NCT02736422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5494788|NCT02736422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494789|NCT02710643|Ofatumumab|ofatumumab|mesh-list
5494790|NCT02710643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5494791|NCT02675439|Ipilimumab|ipilimumab|mesh-list
5494792|NCT02675439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5494793|NCT02675439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5494794|NCT02675439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5494795|NCT02675439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6654963|NCT01459887|Vincristine|vincristine|mesh-list
6654964|NCT01459887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6654965|NCT01459887|Immunologic Factors|immunologic factors|mesh-ancestor
6654966|NCT01459887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654967|NCT01459887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6654968|NCT01459887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6654969|NCT01459887|Alkylating Agents|alkylating agents|mesh-ancestor
6654970|NCT01459887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035056|NCT00492024|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6035057|NCT00492063|Vaccines|vaccines|mesh-list
6035058|NCT00492063|Immunologic Factors|immunologic factors|mesh-ancestor
6035059|NCT00492063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457321|NCT00436241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6035060|NCT00492089|Bevacizumab|bevacizumab|mesh-list
6035061|NCT00492089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6035062|NCT00492089|Antibodies|antibodies|mesh-list
6035063|NCT00492089|Immunoglobulins|immunoglobulins|mesh-list
6457322|NCT00436241|Antimetabolites|antimetabolites|mesh-ancestor
6457323|NCT00436241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457324|NCT00436241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6457325|NCT00436254|Molgramostim|molgramostim|mesh-list
6457326|NCT00436254|Sargramostim|sargramostim|mesh-list
6035064|NCT00492089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6035065|NCT00492089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6035066|NCT00492089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6035067|NCT00492089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6035068|NCT00492089|Growth Substances|growth substances|mesh-ancestor
6035069|NCT00492089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035070|NCT00492089|Growth Inhibitors|growth inhibitors|mesh-ancestor
6035071|NCT00492089|Immunologic Factors|immunologic factors|mesh-ancestor
6035072|NCT00492206|Cetuximab|cetuximab|mesh-list
6035073|NCT00492206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6035074|NCT00492206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6035075|NCT00492232|Zolpidem|zolpidem|mesh-list
6035076|NCT00492232|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6035077|NCT00492232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6035078|NCT00492232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6035079|NCT00492232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035080|NCT00492232|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6457327|NCT00436254|Immunologic Factors|immunologic factors|mesh-ancestor
6457328|NCT00436254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457329|NCT00436254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6035081|NCT00492232|GABA Agonists|gaba agonists|mesh-ancestor
6035082|NCT00492232|GABA Agents|gaba agents|mesh-ancestor
6035083|NCT00492232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6035084|NCT00492232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035085|NCT00492284|Dexamethasone|dexamethasone|mesh-list
6035086|NCT00492284|Ranibizumab|ranibizumab|mesh-list
6035087|NCT00492284|Verteporfin|verteporfin|mesh-list
6035088|NCT00492284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6035089|NCT00492284|Antiemetics|antiemetics|mesh-ancestor
6035090|NCT00492284|Autonomic Agents|autonomic agents|mesh-ancestor
5494796|NCT02651740|Rifaximin|rifaximin|mesh-list
5494797|NCT02651740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5494798|NCT02651740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5494799|NCT02651740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5494800|NCT02617550|Nitroglycerin|nitroglycerin|mesh-list
5494801|NCT02617550|Vasodilator Agents|vasodilator agents|mesh-ancestor
5494802|NCT02606136|Mitogens|mitogens|mesh-list
5494803|NCT02606136|Mitosis Modulators|mitosis modulators|mesh-ancestor
6035091|NCT00492284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6654971|NCT01459887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6654972|NCT01459887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6654973|NCT01459887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6654974|NCT01459887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6654975|NCT01459887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6654976|NCT01459887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6654977|NCT01459887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6654978|NCT01459887|Glucocorticoids|glucocorticoids|mesh-ancestor
6654979|NCT01459887|Hormones|hormones|mesh-ancestor
6654980|NCT01459887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6654981|NCT01459887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6654982|NCT01459887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6035092|NCT00492284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035093|NCT00492284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6035094|NCT00492284|Glucocorticoids|glucocorticoids|mesh-ancestor
6035095|NCT00492284|Hormones|hormones|mesh-ancestor
6035096|NCT00492284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6035097|NCT00492284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6035098|NCT00492284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6035099|NCT00492284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6035100|NCT00492284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6654983|NCT01459887|Tubulin Modulators|tubulin modulators|mesh-ancestor
6654984|NCT01459887|Antimitotic Agents|antimitotic agents|mesh-ancestor
6654985|NCT01459887|Mitosis Modulators|mitosis modulators|mesh-ancestor
6654986|NCT01460030|Cinacalcet|cinacalcet|mesh-list
6654987|NCT01460030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6035101|NCT00492284|Growth Substances|growth substances|mesh-ancestor
5503212|NCT04461340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5494804|NCT02606136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035102|NCT00492284|Growth Inhibitors|growth inhibitors|mesh-ancestor
6035103|NCT00492284|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6035104|NCT00492284|Dermatologic Agents|dermatologic agents|mesh-ancestor
6035105|NCT00492297|Sorafenib|sorafenib|mesh-list
6035106|NCT00492297|Dacarbazine|dacarbazine|mesh-list
6035107|NCT00492297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6035108|NCT00492297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5494805|NCT02535078|Durvalumab|durvalumab|mesh-list
5494806|NCT02535078|Tremelimumab|tremelimumab|mesh-list
5494807|NCT02535078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5494808|NCT02535078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5494809|NCT02496585|Prednisone|prednisone|mesh-list
5494810|NCT02496585|Nintedanib|nintedanib|mesh-list
5494811|NCT02496585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5494812|NCT02496585|Glucocorticoids|glucocorticoids|mesh-ancestor
5494813|NCT02496585|Hormones|hormones|mesh-ancestor
6035109|NCT00492297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6035110|NCT00492297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035111|NCT00492297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6035112|NCT00492297|Alkylating Agents|alkylating agents|mesh-ancestor
6035113|NCT00492336|Rasagiline|rasagiline|mesh-list
6035114|NCT00492336|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6035115|NCT00492336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6035116|NCT00492336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457330|NCT00436267|Fluorouracil|fluorouracil|mesh-list
6457331|NCT00436267|Antimetabolites|antimetabolites|mesh-ancestor
6457332|NCT00436267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457333|NCT00436267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6457334|NCT00436267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6457335|NCT00436267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6035117|NCT00492336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6035118|NCT00492336|Protective Agents|protective agents|mesh-ancestor
6035119|NCT00492336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035120|NCT00492401|Decitabine|decitabine|mesh-list
5494814|NCT02496585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5494815|NCT02496585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494816|NCT02496585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5494817|NCT02496585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5494818|NCT02496585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5494819|NCT02496585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5494820|NCT02496585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494821|NCT02494141|Curcumin|curcumin|mesh-list
5494822|NCT02494141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5503213|NCT04461340|Antifungal Agents|antifungal agents|mesh-ancestor
6035121|NCT00492401|Azacitidine|azacitidine|mesh-list
6035122|NCT00492401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6035123|NCT00492401|Antimetabolites|antimetabolites|mesh-ancestor
6035124|NCT00492401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035125|NCT00492401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6035126|NCT00492401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6035127|NCT00492531|Sildenafil Citrate|sildenafil citrate|mesh-list
6035128|NCT00492531|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
6035129|NCT00492531|Vasodilator Agents|vasodilator agents|mesh-ancestor
6035130|NCT00492531|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6035131|NCT00492531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6035132|NCT00492531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035133|NCT00492531|Urological Agents|urological agents|mesh-ancestor
6035134|NCT00492544|Vaccines|vaccines|mesh-list
6035135|NCT00492544|Immunologic Factors|immunologic factors|mesh-ancestor
6035136|NCT00492544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035137|NCT00492557|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6035138|NCT00492557|Immunologic Factors|immunologic factors|mesh-ancestor
6035139|NCT00492557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035140|NCT00492622|Omeprazole|omeprazole|mesh-list
6035141|NCT00492622|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6035142|NCT00492622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6035143|NCT00492622|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6035144|NCT00492622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6035145|NCT00492622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035146|NCT00492726|Moxifloxacin|moxifloxacin|mesh-list
6035147|NCT00492726|Ertapenem|ertapenem|mesh-list
6035148|NCT00492726|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6035149|NCT00492726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6035150|NCT00492726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6035151|NCT00492726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6035152|NCT00492726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6035153|NCT00492726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6035154|NCT00492726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035155|NCT00492726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6035156|NCT00492726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6035157|NCT00492726|Contraceptive Agents|contraceptive agents|mesh-ancestor
6035158|NCT00492726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6035159|NCT00492726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035160|NCT00492726|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6035161|NCT00492726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6035162|NCT00492726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6035163|NCT00492752|Sorafenib|sorafenib|mesh-list
6035164|NCT00492752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6035165|NCT00492752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6035166|NCT00492752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6035167|NCT00492752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457336|NCT00436267|Immunologic Factors|immunologic factors|mesh-ancestor
6457337|NCT00436267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457338|NCT00436293|Docetaxel|docetaxel|mesh-list
6457339|NCT00436293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6457340|NCT00436293|Tubulin Modulators|tubulin modulators|mesh-ancestor
6457341|NCT00436293|Antimitotic Agents|antimitotic agents|mesh-ancestor
6457342|NCT00436293|Mitosis Modulators|mitosis modulators|mesh-ancestor
6457343|NCT00436293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457344|NCT00436306|Contraceptive Agents|contraceptive agents|mesh-list
6457345|NCT00436306|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6457346|NCT00436306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035168|NCT00492856|Methotrexate|methotrexate|mesh-list
6035169|NCT00492856|Mercaptopurine|mercaptopurine|mesh-list
6035170|NCT00492856|Tretinoin|tretinoin|mesh-list
6035171|NCT00492856|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6035172|NCT00492856|Abortifacient Agents|abortifacient agents|mesh-ancestor
6035173|NCT00492856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6035174|NCT00492856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035175|NCT00492856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6035176|NCT00492856|Antimetabolites|antimetabolites|mesh-ancestor
5494823|NCT02494141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5494824|NCT02494141|Analgesics|analgesics|mesh-ancestor
5494825|NCT02494141|Sensory System Agents|sensory system agents|mesh-ancestor
6035177|NCT00492856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035178|NCT00492856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6035179|NCT00492856|Dermatologic Agents|dermatologic agents|mesh-ancestor
6457347|NCT00436371|Amisulpride|amisulpride|mesh-list
6654988|NCT01460030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654989|NCT01460030|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6654990|NCT01460030|Hormone Antagonists|hormone antagonists|mesh-ancestor
6654991|NCT01460030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6654992|NCT01460069|Liraglutide|liraglutide|mesh-list
6654993|NCT01460069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6654994|NCT01460069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654995|NCT01460069|Incretins|incretins|mesh-ancestor
6654996|NCT01460069|Hormones|hormones|mesh-ancestor
6654997|NCT01460069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6457348|NCT00436371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6457349|NCT00436371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6457350|NCT00436371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6457351|NCT00436371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457352|NCT00436371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6457353|NCT00436371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6457354|NCT00436371|Dopamine Agents|dopamine agents|mesh-ancestor
6457355|NCT00436371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6457356|NCT00436371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457357|NCT00436371|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6457358|NCT00436371|Antidepressive Agents|antidepressive agents|mesh-ancestor
6457359|NCT00436423|Gemcitabine|gemcitabine|mesh-list
6457360|NCT00436423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6457361|NCT00436423|Antimetabolites|antimetabolites|mesh-ancestor
6461965|NCT00456898|Respiratory System Agents|respiratory system agents|mesh-ancestor
6654998|NCT01460134|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5494826|NCT02494141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5494827|NCT02494141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6654999|NCT01460134|Immunologic Factors|immunologic factors|mesh-ancestor
6655000|NCT01460134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494828|NCT02494141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5494829|NCT02494141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5494830|NCT02494141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6655001|NCT01460212|Fluvoxamine|fluvoxamine|mesh-list
6655002|NCT01460212|Citalopram|citalopram|mesh-list
6655003|NCT01460212|Fluoxetine|fluoxetine|mesh-list
6655004|NCT01460212|Paroxetine|paroxetine|mesh-list
6655005|NCT01460212|Sertraline|sertraline|mesh-list
6655006|NCT01460212|Antidepressive Agents|antidepressive agents|mesh-list
6655007|NCT01460212|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6655008|NCT01460212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6655009|NCT01460212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6655010|NCT01460212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655011|NCT01460212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6655012|NCT01460212|Serotonin Agents|serotonin agents|mesh-ancestor
6035180|NCT00492856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6035181|NCT00492856|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6035182|NCT00492856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6035183|NCT00492856|Immunologic Factors|immunologic factors|mesh-ancestor
6035184|NCT00492856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6035185|NCT00492856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6035186|NCT00492856|Keratolytic Agents|keratolytic agents|mesh-ancestor
6035187|NCT00492921|Cyclophosphamide|cyclophosphamide|mesh-list
6035188|NCT00492921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6035189|NCT00492921|Immunologic Factors|immunologic factors|mesh-ancestor
6035190|NCT00492921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035191|NCT00492921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6035192|NCT00492921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6035193|NCT00492921|Alkylating Agents|alkylating agents|mesh-ancestor
6035194|NCT00492921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035195|NCT00492921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6035196|NCT00492921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6035197|NCT00492973|Cefuroxime|cefuroxime|mesh-list
6035198|NCT00492973|Methylprednisolone|methylprednisolone|mesh-list
6035199|NCT00492973|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6035200|NCT00492973|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6035201|NCT00492973|Prednisolone|prednisolone|mesh-list
6035202|NCT00492973|Prednisolone acetate|prednisolone acetate|mesh-list
6457362|NCT00436423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457363|NCT00436423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6457364|NCT00436423|Antiviral Agents|antiviral agents|mesh-ancestor
6457365|NCT00436423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6457366|NCT00436423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6457367|NCT00436423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6457368|NCT00436423|Immunologic Factors|immunologic factors|mesh-ancestor
6035203|NCT00492973|Clonidine|clonidine|mesh-list
6035204|NCT00492973|Epinephrine|epinephrine|mesh-list
5494831|NCT02494141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5503214|NCT04461340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5724967|NCT03183752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724968|NCT03183843|Warfarin|warfarin|mesh-list
5724969|NCT03183843|Dabigatran|dabigatran|mesh-list
5724970|NCT03183843|Anticoagulants|anticoagulants|mesh-ancestor
5724971|NCT03183843|Antithrombins|antithrombins|mesh-ancestor
5724972|NCT03183843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5724973|NCT03183843|Protease Inhibitors|protease inhibitors|mesh-ancestor
5724974|NCT03183843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5724975|NCT03183843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724976|NCT03183674|Oxytocin|oxytocin|mesh-list
5724977|NCT03183674|Oxytocics|oxytocics|mesh-ancestor
5724978|NCT03183674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6035205|NCT00492973|Morphine|morphine|mesh-list
6035206|NCT00492973|Bupivacaine|bupivacaine|mesh-list
6035207|NCT00492973|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6457369|NCT00436423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457370|NCT00436527|Metronidazole|metronidazole|mesh-list
6457371|NCT00436527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6035208|NCT00492973|Prednisolone phosphate|prednisolone phosphate|mesh-list
6035209|NCT00492973|Anesthetics, Local|anesthetics, local|mesh-ancestor
6035210|NCT00492973|Anesthetics|anesthetics|mesh-ancestor
5494832|NCT02494141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035211|NCT00492973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6655013|NCT01460212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655014|NCT01460212|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6655015|NCT01460212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6655016|NCT01460212|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6655017|NCT01460212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5494833|NCT02493426|Oxytocin|oxytocin|mesh-list
6035212|NCT00492973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035213|NCT00492973|Sensory System Agents|sensory system agents|mesh-ancestor
6035214|NCT00492973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6035215|NCT00492973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5494834|NCT02493426|Oxytocics|oxytocics|mesh-ancestor
5494835|NCT02493426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5494836|NCT02493426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494837|NCT02432378|Celecoxib|celecoxib|mesh-list
5494838|NCT02432378|Cisplatin|cisplatin|mesh-list
5494839|NCT02432378|Vaccines|vaccines|mesh-list
5494840|NCT02432378|Immunologic Factors|immunologic factors|mesh-ancestor
5494841|NCT02432378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494842|NCT02432378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5494843|NCT02432378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5494844|NCT02432378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5494845|NCT02432378|Analgesics|analgesics|mesh-ancestor
5494846|NCT02432378|Sensory System Agents|sensory system agents|mesh-ancestor
5494847|NCT02432378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5494848|NCT02432378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5494849|NCT02432378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5494850|NCT02432378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6035216|NCT00492973|Narcotics|narcotics|mesh-ancestor
6035217|NCT00492973|Analgesics|analgesics|mesh-ancestor
6035218|NCT00492973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6035219|NCT00492973|Antiemetics|antiemetics|mesh-ancestor
6035220|NCT00492973|Autonomic Agents|autonomic agents|mesh-ancestor
6035221|NCT00492973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6035222|NCT00492973|Glucocorticoids|glucocorticoids|mesh-ancestor
6035223|NCT00492973|Hormones|hormones|mesh-ancestor
6035224|NCT00492973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6035225|NCT00492973|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6035226|NCT00492973|Protective Agents|protective agents|mesh-ancestor
6035227|NCT00492973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6035228|NCT00492973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6035229|NCT00492973|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6035230|NCT00492973|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6035231|NCT00492973|Adrenergic Agents|adrenergic agents|mesh-ancestor
6457372|NCT00436527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6457373|NCT00436527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6457374|NCT00436527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6457375|NCT00436540|Clobetasol|clobetasol|mesh-list
6457376|NCT00436540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6457377|NCT00436540|Glucocorticoids|glucocorticoids|mesh-ancestor
6457378|NCT00436540|Hormones|hormones|mesh-ancestor
6457379|NCT00436540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6655018|NCT01460212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6457380|NCT00436540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457381|NCT00436579|Sorafenib|sorafenib|mesh-list
6457382|NCT00436579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6457383|NCT00436579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6457384|NCT00436579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6457385|NCT00436579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457386|NCT00436657|Cisplatin|cisplatin|mesh-list
6457387|NCT00436657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6457388|NCT00436709|Paclitaxel|paclitaxel|mesh-list
6457389|NCT00436709|Cyclophosphamide|cyclophosphamide|mesh-list
6457390|NCT00436709|Bevacizumab|bevacizumab|mesh-list
6035232|NCT00492973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6035233|NCT00492973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035234|NCT00492973|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6035235|NCT00492973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6035236|NCT00492973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6035237|NCT00492973|Respiratory System Agents|respiratory system agents|mesh-ancestor
6035238|NCT00492973|Mydriatics|mydriatics|mesh-ancestor
6035239|NCT00492973|Sympathomimetics|sympathomimetics|mesh-ancestor
6035240|NCT00492973|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6035241|NCT00492973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5494851|NCT02432378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5494852|NCT02432378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5494853|NCT02432378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494854|NCT02285192|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6035242|NCT00492973|Sympatholytics|sympatholytics|mesh-ancestor
6035243|NCT00492973|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6035244|NCT00492973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6655019|NCT01460212|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6655020|NCT01460212|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6655021|NCT01460212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6655022|NCT01460212|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6655023|NCT01460212|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6655024|NCT01460355|Botulinum Toxins|botulinum toxins|mesh-list
6035245|NCT00492973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6035246|NCT00493012|Vitamin D|vitamin d|mesh-list
6035247|NCT00493012|Vitamins|vitamins|mesh-ancestor
6035248|NCT00493012|Micronutrients|micronutrients|mesh-ancestor
6035249|NCT00493012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035250|NCT00493012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6035251|NCT00493038|Amoxicillin|amoxicillin|mesh-list
6035252|NCT00493038|Moxifloxacin|moxifloxacin|mesh-list
6035253|NCT00493038|Clavulanic Acid|clavulanic acid|mesh-list
6035254|NCT00493038|Clavulanic Acids|clavulanic acids|mesh-list
6035255|NCT00493038|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6035256|NCT00493038|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6655025|NCT01460355|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6655026|NCT01460355|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6655027|NCT01460355|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6655028|NCT01460355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6655029|NCT01460355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655030|NCT01460355|Cholinergic Agents|cholinergic agents|mesh-ancestor
6655031|NCT01460355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6655032|NCT01460355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655033|NCT01460355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6655034|NCT01460355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6655035|NCT01460420|Lenalidomide|lenalidomide|mesh-list
6655036|NCT01460420|Bortezomib|bortezomib|mesh-list
6655037|NCT01460420|Immunologic Factors|immunologic factors|mesh-ancestor
6655038|NCT01460420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655039|NCT01460420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6655040|NCT01460420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6655041|NCT01460420|Growth Substances|growth substances|mesh-ancestor
6655042|NCT01460420|Growth Inhibitors|growth inhibitors|mesh-ancestor
6035257|NCT00493038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6035258|NCT00493038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6035259|NCT00493038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6035260|NCT00493038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6035261|NCT00493038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6035262|NCT00493038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035263|NCT00493038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6035264|NCT00493038|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6457391|NCT00436709|Doxorubicin|doxorubicin|mesh-list
6655043|NCT01460420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6655044|NCT01460498|Azacitidine|azacitidine|mesh-list
6035265|NCT00493038|Contraceptive Agents|contraceptive agents|mesh-ancestor
6035266|NCT00493038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6457392|NCT00436709|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6457393|NCT00436709|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6457394|NCT00436709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6035267|NCT00493038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035268|NCT00493038|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6035269|NCT00493038|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6035270|NCT00493038|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6035271|NCT00493038|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6035272|NCT00493064|Niacin|niacin|mesh-list
6035273|NCT00493064|Nicotinic Acids|nicotinic acids|mesh-list
6035274|NCT00493064|Niacinamide|niacinamide|mesh-list
6655045|NCT01460498|Decitabine|decitabine|mesh-list
6655046|NCT01460498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6655047|NCT01460498|Antimetabolites|antimetabolites|mesh-ancestor
6655048|NCT01460498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457395|NCT00436709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6457396|NCT00436709|Tubulin Modulators|tubulin modulators|mesh-ancestor
5494855|NCT02285192|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5494856|NCT02285192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494857|NCT02211755|Bortezomib|bortezomib|mesh-list
5494858|NCT02211755|Clofarabine|clofarabine|mesh-list
5494859|NCT02211755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5494860|NCT02211755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6457397|NCT00436709|Antimitotic Agents|antimitotic agents|mesh-ancestor
6457398|NCT00436709|Mitosis Modulators|mitosis modulators|mesh-ancestor
6457399|NCT00436709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494861|NCT02211755|Antimetabolites|antimetabolites|mesh-ancestor
5494862|NCT02211755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494863|NCT02090998|Lidocaine|lidocaine|mesh-list
5494864|NCT02090998|Amitriptyline|amitriptyline|mesh-list
5494865|NCT02090998|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
5494866|NCT02090998|Anesthetics, Local|anesthetics, local|mesh-ancestor
5494867|NCT02090998|Anesthetics|anesthetics|mesh-ancestor
5494868|NCT02090998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5494869|NCT02090998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494870|NCT02090998|Sensory System Agents|sensory system agents|mesh-ancestor
5494871|NCT02090998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5494872|NCT02090998|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6457400|NCT00436709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6457401|NCT00436709|Immunologic Factors|immunologic factors|mesh-ancestor
6035275|NCT00493064|Prednisolone|prednisolone|mesh-list
6035276|NCT00493064|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6035277|NCT00493064|Methylprednisolone|methylprednisolone|mesh-list
6035278|NCT00493064|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6035279|NCT00493064|Prednisolone acetate|prednisolone acetate|mesh-list
6035280|NCT00493064|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6035281|NCT00493064|Prednisolone phosphate|prednisolone phosphate|mesh-list
6035282|NCT00493064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6035283|NCT00493064|Glucocorticoids|glucocorticoids|mesh-ancestor
6035284|NCT00493064|Hormones|hormones|mesh-ancestor
6035285|NCT00493064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6035286|NCT00493064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035287|NCT00493064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6035288|NCT00493064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6035289|NCT00493064|Antiemetics|antiemetics|mesh-ancestor
6035290|NCT00493064|Autonomic Agents|autonomic agents|mesh-ancestor
6035291|NCT00493064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6035292|NCT00493064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6035293|NCT00493064|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6035294|NCT00493064|Protective Agents|protective agents|mesh-ancestor
6035295|NCT00493064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6035296|NCT00493064|Antimetabolites|antimetabolites|mesh-ancestor
6035297|NCT00493064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035298|NCT00493064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6035299|NCT00493064|Vasodilator Agents|vasodilator agents|mesh-ancestor
6035300|NCT00493064|Vitamin B Complex|vitamin b complex|mesh-ancestor
6035301|NCT00493064|Vitamins|vitamins|mesh-ancestor
6035302|NCT00493064|Micronutrients|micronutrients|mesh-ancestor
6035303|NCT00493181|Oprelvekin|oprelvekin|mesh-list
6035304|NCT00493181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6035305|NCT00493220|Ceftriaxone|ceftriaxone|mesh-list
5503215|NCT04461340|Immunologic Factors|immunologic factors|mesh-ancestor
6035306|NCT00493220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6035307|NCT00493220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6035308|NCT00493246|Acetaminophen|acetaminophen|mesh-list
6035309|NCT00493246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6035310|NCT00493246|Analgesics|analgesics|mesh-ancestor
6035311|NCT00493246|Sensory System Agents|sensory system agents|mesh-ancestor
6035312|NCT00493246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6035313|NCT00493246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035314|NCT00493246|Antipyretics|antipyretics|mesh-ancestor
6035315|NCT00493311|Acetaminophen|acetaminophen|mesh-list
6035316|NCT00493311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6035317|NCT00493311|Analgesics|analgesics|mesh-ancestor
6035318|NCT00493311|Sensory System Agents|sensory system agents|mesh-ancestor
6457402|NCT00436709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457403|NCT00436709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6457404|NCT00436709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6457405|NCT00436709|Alkylating Agents|alkylating agents|mesh-ancestor
6457406|NCT00436709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6457407|NCT00436709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6457408|NCT00436709|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6457409|NCT00436709|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6457410|NCT00436709|Growth Substances|growth substances|mesh-ancestor
6457411|NCT00436709|Growth Inhibitors|growth inhibitors|mesh-ancestor
6457412|NCT00436709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6035319|NCT00493311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6035320|NCT00493311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035321|NCT00493311|Antipyretics|antipyretics|mesh-ancestor
6035322|NCT00493454|Rituximab|rituximab|mesh-list
6035323|NCT00493454|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6035324|NCT00493454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6035325|NCT00493454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6035326|NCT00493454|Immunologic Factors|immunologic factors|mesh-ancestor
6035327|NCT00493454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035328|NCT00493454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6035329|NCT00493467|Rituximab|rituximab|mesh-list
6035330|NCT00493467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6035331|NCT00493467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6035332|NCT00493467|Immunologic Factors|immunologic factors|mesh-ancestor
6035333|NCT00493467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035334|NCT00493467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6035335|NCT00493636|Gemcitabine|gemcitabine|mesh-list
6035336|NCT00493636|Capecitabine|capecitabine|mesh-list
6035337|NCT00493636|Sorafenib|sorafenib|mesh-list
6035338|NCT00493636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6035339|NCT00493636|Antimetabolites|antimetabolites|mesh-ancestor
6035340|NCT00493636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035341|NCT00493636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6035342|NCT00493636|Antiviral Agents|antiviral agents|mesh-ancestor
6035343|NCT00493636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6035344|NCT00493636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6035345|NCT00493636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6035346|NCT00493636|Immunologic Factors|immunologic factors|mesh-ancestor
6035347|NCT00493636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035348|NCT00493636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6035349|NCT00493649|Cyclophosphamide|cyclophosphamide|mesh-list
6035350|NCT00493649|Docetaxel|docetaxel|mesh-list
6035351|NCT00493649|Trastuzumab|trastuzumab|mesh-list
6035352|NCT00493649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6035353|NCT00493649|Immunologic Factors|immunologic factors|mesh-ancestor
6035354|NCT00493649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035355|NCT00493649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6035356|NCT00493649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6035357|NCT00493649|Alkylating Agents|alkylating agents|mesh-ancestor
6035358|NCT00493649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035359|NCT00493649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6035360|NCT00493649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6035361|NCT00493649|Tubulin Modulators|tubulin modulators|mesh-ancestor
6035362|NCT00493649|Antimitotic Agents|antimitotic agents|mesh-ancestor
6035363|NCT00493649|Mitosis Modulators|mitosis modulators|mesh-ancestor
6655049|NCT01460498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6655050|NCT01460498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6655051|NCT01460537|Gemcitabine|gemcitabine|mesh-list
6655052|NCT01460537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6035364|NCT00493649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6035365|NCT00493805|Interferons|interferons|mesh-list
6035366|NCT00493805|Ribavirin|ribavirin|mesh-list
6035367|NCT00493805|Interferon-alpha|interferon-alpha|mesh-list
6035368|NCT00493805|Interferon alpha-2|interferon alpha-2|mesh-list
6035369|NCT00493805|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6035370|NCT00493805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6035371|NCT00493805|Antiviral Agents|antiviral agents|mesh-ancestor
6035372|NCT00493805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6035373|NCT00493805|Antimetabolites|antimetabolites|mesh-ancestor
6035374|NCT00493805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035375|NCT00493805|Immunologic Factors|immunologic factors|mesh-ancestor
6035376|NCT00493805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035377|NCT00493974|Zileuton|zileuton|mesh-list
6035378|NCT00493974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6035379|NCT00493974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6035380|NCT00493974|Analgesics|analgesics|mesh-ancestor
6035381|NCT00493974|Sensory System Agents|sensory system agents|mesh-ancestor
6035382|NCT00493974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6035383|NCT00493974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035384|NCT00493974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6035385|NCT00493974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6035386|NCT00493974|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6457413|NCT00436709|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6457414|NCT00436709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6457415|NCT00436709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6457416|NCT00436722|Immunoglobulins|immunoglobulins|mesh-list
6457417|NCT00436722|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6457418|NCT00436722|Immunologic Factors|immunologic factors|mesh-ancestor
6457419|NCT00436722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457420|NCT00436722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6457421|NCT00436761|Cyclosporine|cyclosporine|mesh-list
6457422|NCT00436761|Methylprednisolone|methylprednisolone|mesh-list
6035387|NCT00493974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5494873|NCT02090998|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5494874|NCT02090998|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6035388|NCT00493974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035389|NCT00493974|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6035390|NCT00493974|Hormone Antagonists|hormone antagonists|mesh-ancestor
6035391|NCT00493974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6035392|NCT00494013|Insulin Lispro|insulin lispro|mesh-list
6035393|NCT00494013|Protamines|protamines|mesh-list
6035394|NCT00494013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6035395|NCT00494013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035396|NCT00494013|Heparin Antagonists|heparin antagonists|mesh-ancestor
6035397|NCT00494013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035398|NCT00494013|Coagulants|coagulants|mesh-ancestor
6035399|NCT00494026|Carboplatin|carboplatin|mesh-list
6035400|NCT00494026|Pemetrexed|pemetrexed|mesh-list
6035401|NCT00494026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6035402|NCT00494026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6035403|NCT00494026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494875|NCT02090998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5494876|NCT02090998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494877|NCT02090998|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5494878|NCT02090998|Antidepressive Agents|antidepressive agents|mesh-ancestor
5494879|NCT02090998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5494880|NCT02090998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5494881|NCT02090998|Analgesics|analgesics|mesh-ancestor
5494882|NCT02090998|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6457423|NCT00436761|Melphalan|melphalan|mesh-list
6457424|NCT00436761|Busulfan|busulfan|mesh-list
5494883|NCT02090998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5494884|NCT02090998|Adrenergic Agents|adrenergic agents|mesh-ancestor
5494885|NCT02090998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5494886|NCT02090998|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5494887|NCT02090998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5494888|NCT02063685|Prednisone|prednisone|mesh-list
5494889|NCT02063685|Cyclophosphamide|cyclophosphamide|mesh-list
5494890|NCT02063685|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5494891|NCT02063685|Rituximab|rituximab|mesh-list
5494892|NCT02063685|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5494893|NCT02063685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5494894|NCT02063685|Immunologic Factors|immunologic factors|mesh-ancestor
5494895|NCT02063685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494896|NCT02063685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5494897|NCT02063685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5494898|NCT02063685|Alkylating Agents|alkylating agents|mesh-ancestor
5494899|NCT02063685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494900|NCT02063685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5494901|NCT02063685|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5494902|NCT02063685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5494903|NCT02063685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5494904|NCT02063685|Glucocorticoids|glucocorticoids|mesh-ancestor
5494905|NCT02063685|Hormones|hormones|mesh-ancestor
5494906|NCT02063685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5494907|NCT02063685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5494908|NCT02051309|Guanfacine|guanfacine|mesh-list
6035404|NCT00494026|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6035405|NCT00494026|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6035406|NCT00494091|Sirolimus|sirolimus|mesh-list
6035407|NCT00494091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6035408|NCT00494091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5494909|NCT02051309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5494910|NCT02051309|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5494911|NCT02051309|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5494912|NCT02051309|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5494913|NCT02051309|Adrenergic Agents|adrenergic agents|mesh-ancestor
5494914|NCT02051309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5494915|NCT02051309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494916|NCT02051309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494917|NCT02001623|Tisotumab vedotin|tisotumab vedotin|mesh-list
5494918|NCT02001623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5494919|NCT02001623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6035409|NCT00494091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6035410|NCT00494091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6035411|NCT00494091|Antifungal Agents|antifungal agents|mesh-ancestor
6035412|NCT00494091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6035413|NCT00494091|Immunologic Factors|immunologic factors|mesh-ancestor
6035414|NCT00494091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035415|NCT00494221|Leucovorin|leucovorin|mesh-list
6035416|NCT00494221|Fluorouracil|fluorouracil|mesh-list
6035417|NCT00494221|Oxaliplatin|oxaliplatin|mesh-list
6035418|NCT00494221|Cediranib|cediranib|mesh-list
6035419|NCT00494221|Levoleucovorin|levoleucovorin|mesh-list
6035420|NCT00494221|Antimetabolites|antimetabolites|mesh-ancestor
6035421|NCT00494221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035422|NCT00494221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6035423|NCT00494221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6035424|NCT00494221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6035425|NCT00494221|Immunologic Factors|immunologic factors|mesh-ancestor
6035426|NCT00494221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035427|NCT00494221|Antidotes|antidotes|mesh-ancestor
6035428|NCT00494221|Protective Agents|protective agents|mesh-ancestor
6035429|NCT00494221|Vitamin B Complex|vitamin b complex|mesh-ancestor
5494920|NCT01900002|Sorafenib|sorafenib|mesh-list
5494921|NCT01900002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5494922|NCT01900002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5494923|NCT01900002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5494924|NCT01900002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494925|NCT01595061|Gemcitabine|gemcitabine|mesh-list
5494926|NCT01595061|Cisplatin|cisplatin|mesh-list
5494927|NCT01595061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5494928|NCT01595061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5494929|NCT01595061|Antimetabolites|antimetabolites|mesh-ancestor
5494930|NCT01595061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035430|NCT00494221|Vitamins|vitamins|mesh-ancestor
6035431|NCT00494221|Micronutrients|micronutrients|mesh-ancestor
6035432|NCT00494221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6035433|NCT00494221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6035434|NCT00494234|Olaparib|olaparib|mesh-list
6035435|NCT00494234|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
6035436|NCT00494234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6035437|NCT00494234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035438|NCT00494234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6035439|NCT00494299|Sorafenib|sorafenib|mesh-list
6035440|NCT00494299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6035441|NCT00494299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6035442|NCT00494299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6035443|NCT00494299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035444|NCT00494442|Olaparib|olaparib|mesh-list
6035445|NCT00494442|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
6035446|NCT00494442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6035447|NCT00494442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035448|NCT00494442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6035449|NCT00494481|Docetaxel|docetaxel|mesh-list
6035450|NCT00494481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6035451|NCT00494481|Tubulin Modulators|tubulin modulators|mesh-ancestor
6035452|NCT00494481|Antimitotic Agents|antimitotic agents|mesh-ancestor
6035453|NCT00494481|Mitosis Modulators|mitosis modulators|mesh-ancestor
6035454|NCT00494481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035455|NCT00494494|Nepafenac|nepafenac|mesh-list
6035456|NCT00494494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6035457|NCT00494494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6035458|NCT00494494|Analgesics|analgesics|mesh-ancestor
6035459|NCT00494494|Sensory System Agents|sensory system agents|mesh-ancestor
6035460|NCT00494494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6035461|NCT00494494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035462|NCT00494494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6035463|NCT00494494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6035464|NCT00494507|Dichlorphenamide|dichlorphenamide|mesh-list
6035465|NCT00494507|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6035466|NCT00494507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5494931|NCT01595061|Antiviral Agents|antiviral agents|mesh-ancestor
5494932|NCT01595061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5494933|NCT01595061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5494934|NCT01595061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5494935|NCT01595061|Immunologic Factors|immunologic factors|mesh-ancestor
5494936|NCT01595061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494937|NCT01587352|Vorinostat|vorinostat|mesh-list
6035467|NCT00494507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035468|NCT00494676|Methamphetamine|methamphetamine|mesh-list
6035469|NCT00494676|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6035470|NCT00494676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035471|NCT00494676|Sympathomimetics|sympathomimetics|mesh-ancestor
6035472|NCT00494676|Autonomic Agents|autonomic agents|mesh-ancestor
6035473|NCT00494676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6035474|NCT00494676|Dopamine Agents|dopamine agents|mesh-ancestor
6035475|NCT00494676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6035476|NCT00494676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035477|NCT00494676|Adrenergic Agents|adrenergic agents|mesh-ancestor
6035478|NCT00494676|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6035479|NCT00494676|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6035480|NCT00494676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6035481|NCT00494676|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6035482|NCT00494780|Prednisone|prednisone|mesh-list
6035483|NCT00494780|Prednisolone|prednisolone|mesh-list
6035484|NCT00494780|Cyclophosphamide|cyclophosphamide|mesh-list
6035485|NCT00494780|Doxorubicin|doxorubicin|mesh-list
6035486|NCT00494780|Vincristine|vincristine|mesh-list
6035487|NCT00494780|Ofatumumab|ofatumumab|mesh-list
5494938|NCT01587352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5494939|NCT01587352|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5494940|NCT01587352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5494941|NCT01587352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494942|NCT01572480|Dexamethasone|dexamethasone|mesh-list
5494943|NCT01572480|Lenalidomide|lenalidomide|mesh-list
5494944|NCT01572480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5494945|NCT01572480|Antiemetics|antiemetics|mesh-ancestor
5494946|NCT01572480|Autonomic Agents|autonomic agents|mesh-ancestor
5494947|NCT01572480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5494948|NCT01572480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035488|NCT00494780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6035489|NCT00494780|Immunologic Factors|immunologic factors|mesh-ancestor
6035490|NCT00494780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035491|NCT00494780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6035492|NCT00494780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6035493|NCT00494780|Alkylating Agents|alkylating agents|mesh-ancestor
6035494|NCT00494780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035495|NCT00494780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6035496|NCT00494780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6035497|NCT00494780|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6035498|NCT00494780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6035499|NCT00494780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6035500|NCT00494780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6035501|NCT00494780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6457425|NCT00436761|Cyclosporins|cyclosporins|mesh-list
6457426|NCT00436761|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6457427|NCT00436761|Sargramostim|sargramostim|mesh-list
6457428|NCT00436761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6457429|NCT00436761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457430|NCT00436761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6457431|NCT00436761|Immunologic Factors|immunologic factors|mesh-ancestor
6457432|NCT00436761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457433|NCT00436761|Antifungal Agents|antifungal agents|mesh-ancestor
6457434|NCT00436761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6457435|NCT00436761|Dermatologic Agents|dermatologic agents|mesh-ancestor
6457436|NCT00436761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6457437|NCT00436761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6457438|NCT00436761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6457439|NCT00436761|Alkylating Agents|alkylating agents|mesh-ancestor
6655053|NCT01460537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6035502|NCT00494780|Glucocorticoids|glucocorticoids|mesh-ancestor
6035503|NCT00494780|Hormones|hormones|mesh-ancestor
6035504|NCT00494780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6035505|NCT00494780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6035506|NCT00494780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6035507|NCT00494780|Tubulin Modulators|tubulin modulators|mesh-ancestor
6035508|NCT00494780|Antimitotic Agents|antimitotic agents|mesh-ancestor
6035509|NCT00494780|Mitosis Modulators|mitosis modulators|mesh-ancestor
6035510|NCT00494871|Warfarin|warfarin|mesh-list
6035511|NCT00494871|Rivaroxaban|rivaroxaban|mesh-list
6035512|NCT00494871|Anticoagulants|anticoagulants|mesh-ancestor
6035513|NCT00494871|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6035514|NCT00494871|Antithrombins|antithrombins|mesh-ancestor
6035515|NCT00494871|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6035516|NCT00494871|Protease Inhibitors|protease inhibitors|mesh-ancestor
6035517|NCT00494871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6035518|NCT00494871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035519|NCT00495079|Vincristine|vincristine|mesh-list
6035520|NCT00495079|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6035521|NCT00495079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6035522|NCT00495079|Tubulin Modulators|tubulin modulators|mesh-ancestor
6035523|NCT00495079|Antimitotic Agents|antimitotic agents|mesh-ancestor
6035524|NCT00495079|Mitosis Modulators|mitosis modulators|mesh-ancestor
6035525|NCT00495079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035526|NCT00495170|Paclitaxel|paclitaxel|mesh-list
6035527|NCT00495170|Carboplatin|carboplatin|mesh-list
6035528|NCT00495170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6035529|NCT00495170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6035530|NCT00495170|Tubulin Modulators|tubulin modulators|mesh-ancestor
6035531|NCT00495170|Antimitotic Agents|antimitotic agents|mesh-ancestor
6035532|NCT00495170|Mitosis Modulators|mitosis modulators|mesh-ancestor
6035533|NCT00495170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655054|NCT01460537|Antimetabolites|antimetabolites|mesh-ancestor
6655055|NCT01460537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035534|NCT00495391|Ribavirin|ribavirin|mesh-list
6457440|NCT00436761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6655056|NCT01460537|Antiviral Agents|antiviral agents|mesh-ancestor
6655057|NCT01460537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6655058|NCT01460537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6655059|NCT01460537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6655060|NCT01460537|Immunologic Factors|immunologic factors|mesh-ancestor
6655061|NCT01460537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664641|NCT01513083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6664642|NCT01513083|Tubulin Modulators|tubulin modulators|mesh-ancestor
6664643|NCT01513083|Antimitotic Agents|antimitotic agents|mesh-ancestor
6664644|NCT01513083|Mitosis Modulators|mitosis modulators|mesh-ancestor
6664645|NCT01513083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6664646|NCT01513174|Olaparib|olaparib|mesh-list
6664647|NCT01513174|Gefitinib|gefitinib|mesh-list
6035535|NCT00495391|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6035536|NCT00495391|Nitazoxanide|nitazoxanide|mesh-list
6035537|NCT00495391|Antimetabolites|antimetabolites|mesh-ancestor
6457441|NCT00436761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6457442|NCT00436761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6457443|NCT00436761|Antiemetics|antiemetics|mesh-ancestor
6457444|NCT00436761|Autonomic Agents|autonomic agents|mesh-ancestor
6457445|NCT00436761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6457446|NCT00436761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6035538|NCT00495391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035539|NCT00495391|Antiviral Agents|antiviral agents|mesh-ancestor
6035540|NCT00495391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6035541|NCT00495391|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6035542|NCT00495521|Aminosalicylic Acid|aminosalicylic acid|mesh-list
6035543|NCT00495521|Antitubercular Agents|antitubercular agents|mesh-ancestor
6035544|NCT00495521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6035545|NCT00495521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6035546|NCT00495586|Amoxicillin|amoxicillin|mesh-list
6035547|NCT00495586|Clavulanic Acids|clavulanic acids|mesh-list
6035548|NCT00495586|Clavulanic Acid|clavulanic acid|mesh-list
6035549|NCT00495586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6035550|NCT00495586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6035551|NCT00495586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6035552|NCT00495586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035553|NCT00495586|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6035554|NCT00495612|Omalizumab|omalizumab|mesh-list
6035555|NCT00495612|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6035556|NCT00495612|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6035557|NCT00495612|Respiratory System Agents|respiratory system agents|mesh-ancestor
6035558|NCT00495625|Sunitinib|sunitinib|mesh-list
6035559|NCT00495625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6035560|NCT00495625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6035561|NCT00495625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6035562|NCT00495625|Growth Substances|growth substances|mesh-ancestor
6035563|NCT00495625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035564|NCT00495625|Growth Inhibitors|growth inhibitors|mesh-ancestor
6035565|NCT00495625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6035566|NCT00495625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6035567|NCT00495625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035568|NCT00495677|PF 232798|pf 232798|mesh-list
6035569|NCT00495677|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6035570|NCT00495677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035571|NCT00495677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6035572|NCT00495677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6035573|NCT00495677|Antiviral Agents|antiviral agents|mesh-ancestor
6457447|NCT00436761|Glucocorticoids|glucocorticoids|mesh-ancestor
6664648|NCT01513174|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6664649|NCT01513174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6664650|NCT01513174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6664651|NCT01513174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6457448|NCT00436761|Hormones|hormones|mesh-ancestor
6457449|NCT00436761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6457450|NCT00436761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6457451|NCT00436761|Protective Agents|protective agents|mesh-ancestor
6457452|NCT00436787|PENTA|penta|mesh-list
6457453|NCT00436787|Fondaparinux|fondaparinux|mesh-list
6457454|NCT00436787|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6457455|NCT00436787|Antithrombins|antithrombins|mesh-ancestor
6457456|NCT00436787|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6457457|NCT00436787|Protease Inhibitors|protease inhibitors|mesh-ancestor
6457458|NCT00436787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6457459|NCT00436787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655062|NCT01460563|Magnesium Sulfate|magnesium sulfate|mesh-list
6655063|NCT01460563|Analgesics|analgesics|mesh-ancestor
6655064|NCT01460563|Sensory System Agents|sensory system agents|mesh-ancestor
6655065|NCT01460563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6655066|NCT01460563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655067|NCT01460563|Anesthetics|anesthetics|mesh-ancestor
6655068|NCT01460563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6655069|NCT01460563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6035574|NCT00495677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6035575|NCT00495755|Alemtuzumab|alemtuzumab|mesh-list
6035576|NCT00495755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6035577|NCT00495755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6035578|NCT00495820|Methylphenidate|methylphenidate|mesh-list
6035579|NCT00495820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6035580|NCT00495820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035581|NCT00495820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6035582|NCT00495820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6035583|NCT00495820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6035584|NCT00495820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035585|NCT00495820|Dopamine Agents|dopamine agents|mesh-ancestor
6035586|NCT00495820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6035587|NCT00496015|Acetaminophen|acetaminophen|mesh-list
6035588|NCT00496015|Vaccines|vaccines|mesh-list
6035589|NCT00496015|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6035590|NCT00496015|Immunologic Factors|immunologic factors|mesh-ancestor
6035591|NCT00496015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035592|NCT00496015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6035593|NCT00496015|Analgesics|analgesics|mesh-ancestor
6035594|NCT00496015|Sensory System Agents|sensory system agents|mesh-ancestor
6035595|NCT00496015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6655070|NCT01460563|Anticonvulsants|anticonvulsants|mesh-ancestor
6655071|NCT01460563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6655072|NCT01460563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6655073|NCT01460563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655074|NCT01460563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6655075|NCT01460563|Tocolytic Agents|tocolytic agents|mesh-ancestor
5494949|NCT01572480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5494950|NCT01572480|Glucocorticoids|glucocorticoids|mesh-ancestor
5494951|NCT01572480|Hormones|hormones|mesh-ancestor
5494952|NCT01572480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5494953|NCT01572480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5494954|NCT01572480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5494955|NCT01572480|Immunologic Factors|immunologic factors|mesh-ancestor
5494956|NCT01572480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5494957|NCT01572480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5494958|NCT01572480|Growth Substances|growth substances|mesh-ancestor
5494959|NCT01572480|Growth Inhibitors|growth inhibitors|mesh-ancestor
5503216|NCT04461340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503217|NCT04461041|Empagliflozin|empagliflozin|mesh-list
5503218|NCT04461041|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6655076|NCT01460563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6655077|NCT01460602|Rituximab|rituximab|mesh-list
6655078|NCT01460602|Bortezomib|bortezomib|mesh-list
6655079|NCT01460602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6655080|NCT01460602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6655081|NCT01460602|Immunologic Factors|immunologic factors|mesh-ancestor
6655082|NCT01460602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655083|NCT01460602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6655084|NCT01460615|Hydrocortisone|hydrocortisone|mesh-list
6655085|NCT01460615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6655086|NCT01460654|Alendronate|alendronate|mesh-list
6457460|NCT00436787|Anticoagulants|anticoagulants|mesh-ancestor
6457461|NCT00436787|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6655087|NCT01460654|Methyltestosterone|methyltestosterone|mesh-list
6655088|NCT01460654|Testosterone|testosterone|mesh-list
6655089|NCT01460654|Testosterone undecanoate|testosterone undecanoate|mesh-list
6655090|NCT01460654|Testosterone enanthate|testosterone enanthate|mesh-list
6655091|NCT01460654|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6655092|NCT01460654|Androgens|androgens|mesh-ancestor
6457462|NCT00436787|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6457463|NCT00436800|Gemcitabine|gemcitabine|mesh-list
6457464|NCT00436800|Oxaliplatin|oxaliplatin|mesh-list
6457465|NCT00436800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6457466|NCT00436800|Antimetabolites|antimetabolites|mesh-ancestor
6457467|NCT00436800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457468|NCT00436800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6457469|NCT00436800|Antiviral Agents|antiviral agents|mesh-ancestor
6457470|NCT00436800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6457471|NCT00436800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6457472|NCT00436800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6457473|NCT00436800|Immunologic Factors|immunologic factors|mesh-ancestor
6457474|NCT00436800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457475|NCT00436826|Interferons|interferons|mesh-list
6457476|NCT00436826|Interferon-beta|interferon-beta|mesh-list
6457477|NCT00436826|Cladribine|cladribine|mesh-list
6457478|NCT00436826|Interferon beta-1b|interferon beta-1b|mesh-list
6457479|NCT00436826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6457480|NCT00436826|Antiviral Agents|antiviral agents|mesh-ancestor
6457481|NCT00436826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6457482|NCT00436826|Immunologic Factors|immunologic factors|mesh-ancestor
5494960|NCT00902044|Cyclophosphamide|cyclophosphamide|mesh-list
5494961|NCT00902044|Fludarabine|fludarabine|mesh-list
5494962|NCT00902044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5494963|NCT00902044|Immunologic Factors|immunologic factors|mesh-ancestor
5494964|NCT00902044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494965|NCT00902044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6457483|NCT00436826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457484|NCT00436826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6457485|NCT00436826|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6035596|NCT00496015|Antipyretics|antipyretics|mesh-ancestor
6035597|NCT00496054|Vaccines|vaccines|mesh-list
6035598|NCT00496054|Immunologic Factors|immunologic factors|mesh-ancestor
6035599|NCT00496054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035600|NCT00496197|Fluconazole|fluconazole|mesh-list
6035601|NCT00496197|Voriconazole|voriconazole|mesh-list
6035602|NCT00496197|Anidulafungin|anidulafungin|mesh-list
6035603|NCT00496197|Antifungal Agents|antifungal agents|mesh-ancestor
6035604|NCT00496197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6035605|NCT00496197|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6035606|NCT00496197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6035607|NCT00496197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6035608|NCT00496197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035609|NCT00496197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6035610|NCT00496197|Hormone Antagonists|hormone antagonists|mesh-ancestor
6035611|NCT00496197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6035612|NCT00496197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035613|NCT00496197|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6035614|NCT00496197|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6035615|NCT00496197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6035616|NCT00496340|Rituximab|rituximab|mesh-list
6035617|NCT00496340|Busulfan|busulfan|mesh-list
6035618|NCT00496340|Pentostatin|pentostatin|mesh-list
6035619|NCT00496340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6035620|NCT00496340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6035621|NCT00496340|Immunologic Factors|immunologic factors|mesh-ancestor
6035622|NCT00496340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035623|NCT00496340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6035624|NCT00496340|Alkylating Agents|alkylating agents|mesh-ancestor
6035625|NCT00496340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457486|NCT00436839|Prednisone|prednisone|mesh-list
5494966|NCT00902044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5494967|NCT00902044|Alkylating Agents|alkylating agents|mesh-ancestor
5494968|NCT00902044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494969|NCT00902044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5494970|NCT00902044|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5494971|NCT00165724|Donepezil|donepezil|mesh-list
5494972|NCT00165724|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5494973|NCT00165724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5494974|NCT00165724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494975|NCT00165724|Cholinergic Agents|cholinergic agents|mesh-ancestor
5494976|NCT00165724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5494977|NCT00165724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5494978|NCT00165724|Nootropic Agents|nootropic agents|mesh-ancestor
5494979|NCT00097474|Hydrocortisone|hydrocortisone|mesh-list
5494980|NCT00097474|Melatonin|melatonin|mesh-list
5494981|NCT00097474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5494982|NCT00097474|Antioxidants|antioxidants|mesh-ancestor
5494983|NCT00097474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494984|NCT00097474|Protective Agents|protective agents|mesh-ancestor
5494985|NCT00097474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457487|NCT00436839|Docetaxel|docetaxel|mesh-list
6035626|NCT00496340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6035627|NCT00496340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6035628|NCT00496340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6035629|NCT00496340|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
6035630|NCT00496340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6035631|NCT00496366|Capecitabine|capecitabine|mesh-list
6035632|NCT00496366|Lapatinib|lapatinib|mesh-list
6035633|NCT00496366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6035634|NCT00496366|Antimetabolites|antimetabolites|mesh-ancestor
6035635|NCT00496366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035636|NCT00496366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6035637|NCT00496366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6035638|NCT00496366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6035639|NCT00496379|Epothilones|epothilones|mesh-list
5494986|NCT00097474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6035640|NCT00496379|Sagopilone|sagopilone|mesh-list
6035641|NCT00496379|Tubulin Modulators|tubulin modulators|mesh-ancestor
6035642|NCT00496379|Antimitotic Agents|antimitotic agents|mesh-ancestor
6035643|NCT00496379|Mitosis Modulators|mitosis modulators|mesh-ancestor
6035644|NCT00496379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035645|NCT00496379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6035646|NCT00496470|Budesonide|budesonide|mesh-list
6035647|NCT00496470|Bromides|bromides|mesh-list
6035648|NCT00496470|Formoterol Fumarate|formoterol fumarate|mesh-list
6035649|NCT00496470|Tiotropium Bromide|tiotropium bromide|mesh-list
6035650|NCT00496470|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
5494987|NCT04527042|Rivaroxaban|rivaroxaban|mesh-list
5494988|NCT04527042|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5494989|NCT04527042|Antithrombins|antithrombins|mesh-ancestor
5494990|NCT04527042|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5494991|NCT04527042|Protease Inhibitors|protease inhibitors|mesh-ancestor
5494992|NCT04527042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5494993|NCT04527042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5494994|NCT04527042|Anticoagulants|anticoagulants|mesh-ancestor
5494995|NCT04527133|Aprotinin|aprotinin|mesh-list
5494996|NCT04527133|Hemostatics|hemostatics|mesh-ancestor
6035651|NCT00496470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6035652|NCT00496470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6035653|NCT00496470|Autonomic Agents|autonomic agents|mesh-ancestor
6035654|NCT00496470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6035655|NCT00496470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035656|NCT00496470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6035657|NCT00496470|Respiratory System Agents|respiratory system agents|mesh-ancestor
6035658|NCT00496470|Glucocorticoids|glucocorticoids|mesh-ancestor
6035659|NCT00496470|Hormones|hormones|mesh-ancestor
6035660|NCT00496470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6035661|NCT00496470|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6035662|NCT00496470|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6035663|NCT00496470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6035664|NCT00496470|Adrenergic Agents|adrenergic agents|mesh-ancestor
6035665|NCT00496470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6035666|NCT00496470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035667|NCT00496470|Parasympatholytics|parasympatholytics|mesh-ancestor
6035668|NCT00496470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6035669|NCT00496470|Cholinergic Agents|cholinergic agents|mesh-ancestor
6035670|NCT00496470|Anticonvulsants|anticonvulsants|mesh-ancestor
6035671|NCT00496483|Tacrolimus|tacrolimus|mesh-list
6035672|NCT00496483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6035673|NCT00496483|Immunologic Factors|immunologic factors|mesh-ancestor
6035674|NCT00496483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035675|NCT00496483|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6035676|NCT00496483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5494997|NCT04527133|Coagulants|coagulants|mesh-ancestor
6053613|NCT00596622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6035677|NCT00496483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035678|NCT00496587|Gemcitabine|gemcitabine|mesh-list
6035679|NCT00496587|Bevacizumab|bevacizumab|mesh-list
6035680|NCT00496587|Capecitabine|capecitabine|mesh-list
6035681|NCT00496587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6035682|NCT00496587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6035683|NCT00496587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6035684|NCT00496587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6035685|NCT00496587|Growth Substances|growth substances|mesh-ancestor
5494998|NCT04527133|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5494999|NCT04527133|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5495000|NCT04527133|Protease Inhibitors|protease inhibitors|mesh-ancestor
5495001|NCT04527133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5495002|NCT04527133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495003|NCT04527055|Metronidazole|metronidazole|mesh-list
5495004|NCT04527055|Tetracycline|tetracycline|mesh-list
5495005|NCT04527055|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
5495006|NCT04527055|Esomeprazole|esomeprazole|mesh-list
5495007|NCT04527055|Bismuth|bismuth|mesh-list
5495008|NCT04527055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5495009|NCT04527055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6035686|NCT00496587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035687|NCT00496587|Growth Inhibitors|growth inhibitors|mesh-ancestor
6035688|NCT00496587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6035689|NCT00496587|Antimetabolites|antimetabolites|mesh-ancestor
6035690|NCT00496587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035691|NCT00496587|Antiviral Agents|antiviral agents|mesh-ancestor
6035692|NCT00496587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6035693|NCT00496587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6035694|NCT00496587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6035695|NCT00496587|Immunologic Factors|immunologic factors|mesh-ancestor
6035696|NCT00496769|Aspirin|aspirin|mesh-list
6035697|NCT00496769|Apixaban|apixaban|mesh-list
6035698|NCT00496769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6035699|NCT00496769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6035700|NCT00496769|Analgesics|analgesics|mesh-ancestor
6035701|NCT00496769|Sensory System Agents|sensory system agents|mesh-ancestor
6035702|NCT00496769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6035703|NCT00496769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035704|NCT00496769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6035705|NCT00496769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6035706|NCT00496769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6457488|NCT00436839|Mitoxantrone|mitoxantrone|mesh-list
6457489|NCT00436839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6457490|NCT00436839|Tubulin Modulators|tubulin modulators|mesh-ancestor
6457491|NCT00436839|Antimitotic Agents|antimitotic agents|mesh-ancestor
6457492|NCT00436839|Mitosis Modulators|mitosis modulators|mesh-ancestor
6457493|NCT00436839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457494|NCT00436839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6457495|NCT00436839|Glucocorticoids|glucocorticoids|mesh-ancestor
6457496|NCT00436839|Hormones|hormones|mesh-ancestor
6457497|NCT00436839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6457498|NCT00436839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457499|NCT00436839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6457500|NCT00436839|Analgesics|analgesics|mesh-ancestor
6457501|NCT00436839|Sensory System Agents|sensory system agents|mesh-ancestor
6457502|NCT00436839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6457503|NCT00436839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6457504|NCT00436839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6457505|NCT00436839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6457506|NCT00436930|Sargramostim|sargramostim|mesh-list
6457507|NCT00436930|Immunologic Factors|immunologic factors|mesh-ancestor
6457508|NCT00436930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457509|NCT00436943|Bupropion|bupropion|mesh-list
6457510|NCT00436943|Nicotine|nicotine|mesh-list
6457511|NCT00436943|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6457512|NCT00436943|Autonomic Agents|autonomic agents|mesh-ancestor
6457513|NCT00436943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6457514|NCT00436943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457515|NCT00436943|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6457516|NCT00436943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6457517|NCT00436943|Cholinergic Agents|cholinergic agents|mesh-ancestor
6457518|NCT00436943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6457519|NCT00436943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655093|NCT01460654|Hormones|hormones|mesh-ancestor
5495010|NCT04527055|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5495011|NCT04527055|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5495012|NCT04527055|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5495013|NCT04527055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5495014|NCT04527055|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5495015|NCT04527055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5495016|NCT04527055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495017|NCT04527055|Antacids|antacids|mesh-ancestor
5495018|NCT04527055|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5495019|NCT04526951|Aspirin|aspirin|mesh-list
5495020|NCT04526951|Tenecteplase|tenecteplase|mesh-list
5495021|NCT04526951|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5495022|NCT04526951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5495023|NCT04526951|Analgesics|analgesics|mesh-ancestor
5495024|NCT04526951|Sensory System Agents|sensory system agents|mesh-ancestor
5495025|NCT04526951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5495026|NCT04526951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495027|NCT04526951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5495028|NCT04526951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6457520|NCT00436943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6457521|NCT00436943|Antidepressive Agents|antidepressive agents|mesh-ancestor
6457522|NCT00436943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6457523|NCT00436943|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6457524|NCT00436943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6457525|NCT00436943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6457526|NCT00436943|Dopamine Agents|dopamine agents|mesh-ancestor
6457527|NCT00436943|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6457528|NCT00436943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6457529|NCT00436943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6457530|NCT00436995|Darbepoetin alfa|darbepoetin alfa|mesh-list
6457531|NCT00436995|Hematinics|hematinics|mesh-ancestor
6457532|NCT00437008|Benphothiamine|benphothiamine|mesh-list
6457533|NCT00437008|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5495029|NCT04526951|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5495030|NCT04526951|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5495031|NCT04526951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495032|NCT04526951|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5495033|NCT04526951|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5495034|NCT04526951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5495035|NCT04526951|Antipyretics|antipyretics|mesh-ancestor
5495036|NCT04527068|Bevacizumab|bevacizumab|mesh-list
5495037|NCT04527068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5495038|NCT04527068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5495039|NCT04527068|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5495040|NCT04527068|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5495041|NCT04527068|Growth Substances|growth substances|mesh-ancestor
5495042|NCT04527068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495043|NCT04527068|Growth Inhibitors|growth inhibitors|mesh-ancestor
5495044|NCT04526782|Docetaxel|docetaxel|mesh-list
5495045|NCT04526782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5495046|NCT04526782|Tubulin Modulators|tubulin modulators|mesh-ancestor
5495047|NCT04526782|Antimitotic Agents|antimitotic agents|mesh-ancestor
5495048|NCT04526782|Mitosis Modulators|mitosis modulators|mesh-ancestor
5495049|NCT04526782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495050|NCT04526470|Paclitaxel|paclitaxel|mesh-list
5495051|NCT04526470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6457534|NCT00437008|Immunologic Factors|immunologic factors|mesh-ancestor
6457535|NCT00437008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457536|NCT00437008|Chelating Agents|chelating agents|mesh-ancestor
6457537|NCT00437008|Sequestering Agents|sequestering agents|mesh-ancestor
6457538|NCT00437008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457539|NCT00437086|Bortezomib|bortezomib|mesh-list
6457540|NCT00437086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6457541|NCT00437164|Insulin|insulin|mesh-list
6457542|NCT00437164|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6457543|NCT00437164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6457544|NCT00437164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035707|NCT00496769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6035708|NCT00496769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035709|NCT00496769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6035710|NCT00496769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6035711|NCT00496769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6035712|NCT00496769|Antipyretics|antipyretics|mesh-ancestor
6457545|NCT00437177|Apomorphine|apomorphine|mesh-list
5495052|NCT04526470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6457546|NCT00437177|Emetics|emetics|mesh-ancestor
6457547|NCT00437177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457548|NCT00437177|Autonomic Agents|autonomic agents|mesh-ancestor
6035713|NCT00496769|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6035714|NCT00496769|Antithrombins|antithrombins|mesh-ancestor
6035715|NCT00496769|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5495053|NCT04526470|Tubulin Modulators|tubulin modulators|mesh-ancestor
5495054|NCT04526470|Antimitotic Agents|antimitotic agents|mesh-ancestor
5495055|NCT04526470|Mitosis Modulators|mitosis modulators|mesh-ancestor
5495056|NCT04526470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035716|NCT00496769|Protease Inhibitors|protease inhibitors|mesh-ancestor
6035717|NCT00496769|Anticoagulants|anticoagulants|mesh-ancestor
6035718|NCT00496808|Trastuzumab|trastuzumab|mesh-list
6035719|NCT00496808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6035720|NCT00496808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6035721|NCT00496873|Cyclophosphamide|cyclophosphamide|mesh-list
6035722|NCT00496873|Rituximab|rituximab|mesh-list
6035723|NCT00496873|Pentostatin|pentostatin|mesh-list
6457549|NCT00437177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6457550|NCT00437177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6457551|NCT00437177|Dopamine Agonists|dopamine agonists|mesh-ancestor
6457552|NCT00437177|Dopamine Agents|dopamine agents|mesh-ancestor
6457553|NCT00437177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6457554|NCT00437177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457555|NCT00437216|Clobetasol|clobetasol|mesh-list
6457556|NCT00437216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6457557|NCT00437216|Glucocorticoids|glucocorticoids|mesh-ancestor
6457558|NCT00437216|Hormones|hormones|mesh-ancestor
6457559|NCT00437216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6457560|NCT00437216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457561|NCT00437229|Dexamethasone|dexamethasone|mesh-list
6035724|NCT00496873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6035725|NCT00496873|Immunologic Factors|immunologic factors|mesh-ancestor
6035726|NCT00496873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035727|NCT00496873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6035728|NCT00496873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6035729|NCT00496873|Alkylating Agents|alkylating agents|mesh-ancestor
6035730|NCT00496873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035731|NCT00496873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6035732|NCT00496873|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6035733|NCT00496873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6035734|NCT00496873|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
6035735|NCT00496873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6035736|NCT00496964|Botulinum Toxins|botulinum toxins|mesh-list
6035737|NCT00496964|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6035738|NCT00496964|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6035739|NCT00496964|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6035740|NCT00496964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6035741|NCT00496964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035742|NCT00496964|Cholinergic Agents|cholinergic agents|mesh-ancestor
6035743|NCT00496964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6035744|NCT00496964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035745|NCT00496964|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6035746|NCT00496964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6035747|NCT00497055|Aripiprazole|aripiprazole|mesh-list
6035748|NCT00497055|Antidepressive Agents|antidepressive agents|mesh-ancestor
6035749|NCT00497055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6035750|NCT00497055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6035751|NCT00497055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6035752|NCT00497055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6035753|NCT00497055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035754|NCT00497055|Dopamine Agonists|dopamine agonists|mesh-ancestor
6035755|NCT00497055|Dopamine Agents|dopamine agents|mesh-ancestor
6035756|NCT00497055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6035757|NCT00497055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035758|NCT00497055|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6035759|NCT00497055|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6035760|NCT00497055|Serotonin Agents|serotonin agents|mesh-ancestor
6035761|NCT00497055|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6035762|NCT00497055|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6035763|NCT00497055|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6035764|NCT00497055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6035765|NCT00497081|Mirtazapine|mirtazapine|mesh-list
6457562|NCT00437229|Dexamethasone acetate|dexamethasone acetate|mesh-list
6035766|NCT00497081|Antidepressive Agents|antidepressive agents|mesh-ancestor
6035767|NCT00497081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6035768|NCT00497081|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6035769|NCT00497081|Histamine Antagonists|histamine antagonists|mesh-ancestor
6035770|NCT00497081|Histamine Agents|histamine agents|mesh-ancestor
6035771|NCT00497081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6035772|NCT00497081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035773|NCT00497081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035774|NCT00497081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6035775|NCT00497081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6035776|NCT00497081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6035777|NCT00497081|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6035778|NCT00497081|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6035779|NCT00497081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6035780|NCT00497081|Adrenergic Agents|adrenergic agents|mesh-ancestor
6035781|NCT00497081|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6035782|NCT00497081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6035783|NCT00497081|Serotonin Agents|serotonin agents|mesh-ancestor
6035784|NCT00497081|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6035785|NCT00497198|Bile Acids and Salts|bile acids and salts|mesh-list
6035786|NCT00497198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6035787|NCT00497770|Pemetrexed|pemetrexed|mesh-list
6035788|NCT00497770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6035789|NCT00497770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6035790|NCT00497770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035791|NCT00497770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6035792|NCT00497770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6035793|NCT00497796|Ganciclovir|ganciclovir|mesh-list
6035794|NCT00497796|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6035795|NCT00497796|Maribavir|maribavir|mesh-list
6035796|NCT00497796|Antiviral Agents|antiviral agents|mesh-ancestor
6035797|NCT00497796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6035798|NCT00497796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6035799|NCT00497796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6035800|NCT00497796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035801|NCT00498173|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6035802|NCT00498173|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6035803|NCT00498173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6457563|NCT00437229|Ondansetron|ondansetron|mesh-list
6457564|NCT00437229|Casopitant|casopitant|mesh-list
6457565|NCT00437229|BB 1101|bb 1101|mesh-list
6457566|NCT00437229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6457567|NCT00437229|Antiemetics|antiemetics|mesh-ancestor
6457568|NCT00437229|Autonomic Agents|autonomic agents|mesh-ancestor
6457569|NCT00437229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6457570|NCT00437229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495057|NCT04526353|Oxybutynin|oxybutynin|mesh-list
5495058|NCT04526353|Parasympatholytics|parasympatholytics|mesh-ancestor
5495059|NCT04526353|Autonomic Agents|autonomic agents|mesh-ancestor
5495060|NCT04526353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5495061|NCT04526353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495062|NCT04526353|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5495063|NCT04526353|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5495064|NCT04526353|Cholinergic Agents|cholinergic agents|mesh-ancestor
5495065|NCT04526353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5495066|NCT04526353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495067|NCT04526353|Urological Agents|urological agents|mesh-ancestor
5495068|NCT04526210|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
5495069|NCT04526210|Choline|choline|mesh-list
6457571|NCT00437229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6457572|NCT00437229|Glucocorticoids|glucocorticoids|mesh-ancestor
6457573|NCT00437229|Hormones|hormones|mesh-ancestor
6457574|NCT00437229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6457575|NCT00437229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6457576|NCT00437229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6457577|NCT00437229|Protease Inhibitors|protease inhibitors|mesh-ancestor
6457578|NCT00437229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6457579|NCT00437229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457580|NCT00437229|Antipruritics|antipruritics|mesh-ancestor
6457581|NCT00437229|Dermatologic Agents|dermatologic agents|mesh-ancestor
6457582|NCT00437229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6457583|NCT00437229|Serotonin Agents|serotonin agents|mesh-ancestor
6457584|NCT00437229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5495070|NCT04526210|Bupropion|bupropion|mesh-list
5495071|NCT04526210|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6457585|NCT00437229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6457586|NCT00437229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6457587|NCT00437229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6457588|NCT00437229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6457589|NCT00437229|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6035804|NCT00498173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6035805|NCT00498173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035806|NCT00498173|Adrenergic Agents|adrenergic agents|mesh-ancestor
6035807|NCT00498173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6035808|NCT00498173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035809|NCT00498186|Rotigotine|rotigotine|mesh-list
6035810|NCT00498186|Dopamine Agonists|dopamine agonists|mesh-ancestor
6035811|NCT00498186|Dopamine Agents|dopamine agents|mesh-ancestor
6035812|NCT00498186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6035813|NCT00498186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035814|NCT00498186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035815|NCT00498355|Ranibizumab|ranibizumab|mesh-list
6035816|NCT00498355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6035817|NCT00498355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6035818|NCT00498355|Growth Substances|growth substances|mesh-ancestor
6035819|NCT00498355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035820|NCT00498355|Growth Inhibitors|growth inhibitors|mesh-ancestor
6035821|NCT00498355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6053614|NCT00596622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6053615|NCT00596622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495072|NCT04526210|Antidepressive Agents|antidepressive agents|mesh-ancestor
5495073|NCT04526210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5495074|NCT04526210|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5495075|NCT04526210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5495076|NCT04526210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5495077|NCT04526210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053616|NCT00596622|Antimanic Agents|antimanic agents|mesh-ancestor
6053617|NCT00596622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6053618|NCT00596622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6053619|NCT00596622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053620|NCT00596687|Insulin|insulin|mesh-list
6053621|NCT00596687|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6457590|NCT00437229|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6457591|NCT00437255|Betamethasone|betamethasone|mesh-list
6457592|NCT00437255|Betamethasone Valerate|betamethasone valerate|mesh-list
6457593|NCT00437255|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
6457594|NCT00437255|Betamethasone benzoate|betamethasone benzoate|mesh-list
6457595|NCT00437255|Clobetasol|clobetasol|mesh-list
6457596|NCT00437255|Calcipotriene|calcipotriene|mesh-list
6457597|NCT00437255|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
6457598|NCT00437255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6457599|NCT00437255|Glucocorticoids|glucocorticoids|mesh-ancestor
6457600|NCT00437255|Hormones|hormones|mesh-ancestor
6457601|NCT00437255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5495078|NCT04526210|Dopamine Agents|dopamine agents|mesh-ancestor
5495079|NCT04526210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6457602|NCT00437255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457603|NCT00437255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6457604|NCT00437255|Respiratory System Agents|respiratory system agents|mesh-ancestor
6457605|NCT00437255|Dermatologic Agents|dermatologic agents|mesh-ancestor
6053622|NCT00596687|Insulin Glargine|insulin glargine|mesh-list
6053623|NCT00596687|Insulin glulisine|insulin glulisine|mesh-list
6053624|NCT00596687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6053625|NCT00596687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053626|NCT00596752|Alprostadil|alprostadil|mesh-list
6053627|NCT00596752|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6053628|NCT00596752|Vasodilator Agents|vasodilator agents|mesh-ancestor
6053629|NCT00596752|Urological Agents|urological agents|mesh-ancestor
6053630|NCT00596817|Vortioxetine|vortioxetine|mesh-list
6053631|NCT00596817|Antidepressive Agents|antidepressive agents|mesh-ancestor
6053632|NCT00596817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6457606|NCT00437307|Topotecan|topotecan|mesh-list
5495080|NCT04526210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495081|NCT04526210|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5495082|NCT04526210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5495083|NCT04526210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5495084|NCT04526210|Lipotropic Agents|lipotropic agents|mesh-ancestor
5495085|NCT04526210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5495086|NCT04526210|Antimetabolites|antimetabolites|mesh-ancestor
6457607|NCT00437307|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6035822|NCT00498368|Rituximab|rituximab|mesh-list
6035823|NCT00498368|Angiotensin II|angiotensin ii|mesh-list
6035824|NCT00498368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6035825|NCT00498368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6035826|NCT00498368|Immunologic Factors|immunologic factors|mesh-ancestor
6035827|NCT00498368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035828|NCT00498368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6035829|NCT00498368|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6035830|NCT00498433|Amlodipine|amlodipine|mesh-list
5495087|NCT04526210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5495088|NCT04526210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5495089|NCT04526210|Nootropic Agents|nootropic agents|mesh-ancestor
5495090|NCT04526210|Chelating Agents|chelating agents|mesh-ancestor
5495091|NCT04526210|Sequestering Agents|sequestering agents|mesh-ancestor
5495092|NCT04526210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5495093|NCT04526210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5495094|NCT04526210|Growth Substances|growth substances|mesh-ancestor
6035831|NCT00498433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6035832|NCT00498433|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6035833|NCT00498433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6035834|NCT00498433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035835|NCT00498433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6035836|NCT00498433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035837|NCT00498433|Vasodilator Agents|vasodilator agents|mesh-ancestor
6035838|NCT00498485|Sodium Oxybate|sodium oxybate|mesh-list
6035839|NCT00498485|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6035840|NCT00498485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6035841|NCT00498485|Anesthetics, General|anesthetics, general|mesh-ancestor
6035842|NCT00498485|Anesthetics|anesthetics|mesh-ancestor
6035843|NCT00498485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6035844|NCT00498485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035845|NCT00498550|Clozapine|clozapine|mesh-list
6035846|NCT00498550|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6035847|NCT00498550|Serotonin Agents|serotonin agents|mesh-ancestor
6035848|NCT00498550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6035849|NCT00498550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035850|NCT00498550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035851|NCT00498550|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6035852|NCT00498550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6035853|NCT00498550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6035854|NCT00498550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6035855|NCT00498550|GABA Antagonists|gaba antagonists|mesh-ancestor
6035856|NCT00498550|GABA Agents|gaba agents|mesh-ancestor
6035857|NCT00498602|Saponin QA-21V1|saponin qa-21v1|mesh-list
6035858|NCT00498602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5495095|NCT04526210|Growth Inhibitors|growth inhibitors|mesh-ancestor
5495096|NCT04526210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5495097|NCT04526028|Fulvestrant|fulvestrant|mesh-list
5495098|NCT04526028|Palbociclib|palbociclib|mesh-list
5495099|NCT04526028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6035859|NCT00498602|Immunologic Factors|immunologic factors|mesh-ancestor
6035860|NCT00498602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035861|NCT00498615|Fasudil|fasudil|mesh-list
6035862|NCT00498615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6035863|NCT00498615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6035864|NCT00498615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035865|NCT00498615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6035866|NCT00498615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035867|NCT00498615|Vasodilator Agents|vasodilator agents|mesh-ancestor
6035868|NCT00498615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6035869|NCT00498615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6035870|NCT00498628|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6035871|NCT00498628|Antidepressive Agents|antidepressive agents|mesh-ancestor
6035872|NCT00498628|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6035873|NCT00498628|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6035874|NCT00498628|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6035875|NCT00498628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6035876|NCT00498628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035877|NCT00498797|Prednisolone|prednisolone|mesh-list
6035878|NCT00498797|Docetaxel|docetaxel|mesh-list
6035879|NCT00498797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6035880|NCT00498797|Tubulin Modulators|tubulin modulators|mesh-ancestor
6035881|NCT00498797|Antimitotic Agents|antimitotic agents|mesh-ancestor
6035882|NCT00498797|Mitosis Modulators|mitosis modulators|mesh-ancestor
6053633|NCT00596817|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5495100|NCT04526028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5495101|NCT04526028|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5495102|NCT04526028|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5495103|NCT04526028|Hormone Antagonists|hormone antagonists|mesh-ancestor
5495104|NCT04526028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5495105|NCT04526028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495106|NCT04526028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5495107|NCT04526028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5495108|NCT04526028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495109|NCT04526119|Z 338|z 338|mesh-list
5495110|NCT04526119|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5495111|NCT04526119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5495112|NCT04526119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495113|NCT04526119|Cholinergic Agents|cholinergic agents|mesh-ancestor
6035883|NCT00498797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035884|NCT00498797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6035885|NCT00498797|Glucocorticoids|glucocorticoids|mesh-ancestor
6035886|NCT00498797|Hormones|hormones|mesh-ancestor
6035887|NCT00498797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6035888|NCT00498797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035889|NCT00498797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6035890|NCT00498927|Temozolomide|temozolomide|mesh-list
6035891|NCT00498927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6035892|NCT00498927|Alkylating Agents|alkylating agents|mesh-ancestor
6035893|NCT00498927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035894|NCT00498927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6035895|NCT00499031|Cetuximab|cetuximab|mesh-list
6035896|NCT00499031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6035897|NCT00499031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6035898|NCT00499083|Tamoxifen|tamoxifen|mesh-list
6035899|NCT00499083|Paclitaxel|paclitaxel|mesh-list
6035900|NCT00499083|Cyclophosphamide|cyclophosphamide|mesh-list
6035901|NCT00499083|Doxorubicin|doxorubicin|mesh-list
6035902|NCT00499083|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6035903|NCT00499083|Aromatase Inhibitors|aromatase inhibitors|mesh-list
6035904|NCT00499083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5495114|NCT04526119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5495115|NCT04526119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495116|NCT04526119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5495117|NCT04526236|Methadone|methadone|mesh-list
5495118|NCT04526236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5495119|NCT04526236|Narcotics|narcotics|mesh-ancestor
5495120|NCT04526236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6035905|NCT00499083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6035906|NCT00499083|Tubulin Modulators|tubulin modulators|mesh-ancestor
6035907|NCT00499083|Antimitotic Agents|antimitotic agents|mesh-ancestor
6035908|NCT00499083|Mitosis Modulators|mitosis modulators|mesh-ancestor
6035909|NCT00499083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035910|NCT00499083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6035911|NCT00499083|Immunologic Factors|immunologic factors|mesh-ancestor
6035912|NCT00499083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035913|NCT00499083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6035914|NCT00499083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6035915|NCT00499083|Alkylating Agents|alkylating agents|mesh-ancestor
6035916|NCT00499083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6035917|NCT00499083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6035918|NCT00499083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6035919|NCT00499083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6035920|NCT00499083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6035921|NCT00499083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6035922|NCT00499083|Hormone Antagonists|hormone antagonists|mesh-ancestor
6035923|NCT00499083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6035924|NCT00499083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6035925|NCT00499083|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6035926|NCT00499083|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6035927|NCT00499083|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6035928|NCT00499083|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6035929|NCT00499109|Gemcitabine|gemcitabine|mesh-list
6035930|NCT00499109|Carboplatin|carboplatin|mesh-list
6035931|NCT00499109|Docetaxel|docetaxel|mesh-list
6035932|NCT00499109|Vinorelbine|vinorelbine|mesh-list
6035933|NCT00499109|Antineoplastic Agents|antineoplastic agents|mesh-list
6035934|NCT00499109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6035935|NCT00499109|Antimetabolites|antimetabolites|mesh-ancestor
5495121|NCT04526236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495122|NCT04526236|Analgesics|analgesics|mesh-ancestor
5495123|NCT04526236|Sensory System Agents|sensory system agents|mesh-ancestor
5495124|NCT04526236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5495125|NCT04526236|Antitussive Agents|antitussive agents|mesh-ancestor
5495126|NCT04526236|Respiratory System Agents|respiratory system agents|mesh-ancestor
5495127|NCT04526288|Cytarabine|cytarabine|mesh-list
6035936|NCT00499109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035937|NCT00499109|Antiviral Agents|antiviral agents|mesh-ancestor
6035938|NCT00499109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6035939|NCT00499109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6035940|NCT00499109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6035941|NCT00499109|Immunologic Factors|immunologic factors|mesh-ancestor
6035942|NCT00499109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035943|NCT00499109|Tubulin Modulators|tubulin modulators|mesh-ancestor
6035944|NCT00499109|Antimitotic Agents|antimitotic agents|mesh-ancestor
6035945|NCT00499109|Mitosis Modulators|mitosis modulators|mesh-ancestor
6035946|NCT00499109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6035947|NCT00499122|Cyclophosphamide|cyclophosphamide|mesh-list
6035948|NCT00499122|Docetaxel|docetaxel|mesh-list
6035949|NCT00499122|Doxorubicin|doxorubicin|mesh-list
6035950|NCT00499122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6035951|NCT00499122|Immunologic Factors|immunologic factors|mesh-ancestor
6035952|NCT00499122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035953|NCT00499122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6035954|NCT00499122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6035955|NCT00499122|Alkylating Agents|alkylating agents|mesh-ancestor
6035956|NCT00499122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035957|NCT00499122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6035958|NCT00499122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6035959|NCT00499122|Tubulin Modulators|tubulin modulators|mesh-ancestor
6035960|NCT00499122|Antimitotic Agents|antimitotic agents|mesh-ancestor
6035961|NCT00499122|Mitosis Modulators|mitosis modulators|mesh-ancestor
6035962|NCT00499122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6035963|NCT00499122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6035964|NCT00499122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6035965|NCT00499122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6035966|NCT00499252|Paclitaxel|paclitaxel|mesh-list
6035967|NCT00499252|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6035968|NCT00499252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6035969|NCT00499252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6035970|NCT00499252|Tubulin Modulators|tubulin modulators|mesh-ancestor
6035971|NCT00499252|Antimitotic Agents|antimitotic agents|mesh-ancestor
6035972|NCT00499252|Mitosis Modulators|mitosis modulators|mesh-ancestor
6035973|NCT00499252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035974|NCT00499343|Rituximab|rituximab|mesh-list
6035975|NCT00499343|Etoposide|etoposide|mesh-list
6035976|NCT00499343|Ifosfamide|ifosfamide|mesh-list
6035977|NCT00499343|Sargramostim|sargramostim|mesh-list
6035978|NCT00499343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6035979|NCT00499343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6035980|NCT00499343|Immunologic Factors|immunologic factors|mesh-ancestor
6035981|NCT00499343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035982|NCT00499343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6035983|NCT00499343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6035984|NCT00499343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5495128|NCT04526288|Daunorubicin|daunorubicin|mesh-list
5495129|NCT04526288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5495130|NCT04526288|Antimetabolites|antimetabolites|mesh-ancestor
5495131|NCT04526288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495132|NCT04526288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5495133|NCT04526288|Antiviral Agents|antiviral agents|mesh-ancestor
5495134|NCT04526288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5495135|NCT04526288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5495136|NCT04526288|Immunologic Factors|immunologic factors|mesh-ancestor
5495137|NCT04526288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495138|NCT04526288|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5495139|NCT04526288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5495140|NCT04526288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6035985|NCT00499343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6035986|NCT00499343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6035987|NCT00499343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6035988|NCT00499343|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5495141|NCT04526288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6035989|NCT00499343|Alkylating Agents|alkylating agents|mesh-ancestor
5495142|NCT04525820|Vitamin D|vitamin d|mesh-list
5495143|NCT04525820|Ergocalciferols|ergocalciferols|mesh-list
5495144|NCT04525820|Cholecalciferol|cholecalciferol|mesh-list
5495145|NCT04525820|Vitamins|vitamins|mesh-list
5495146|NCT04525820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5495147|NCT04525820|Micronutrients|micronutrients|mesh-ancestor
6035990|NCT00499369|Leucovorin|leucovorin|mesh-list
6457608|NCT00437307|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6457609|NCT00437307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6457610|NCT00437307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457611|NCT00437307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6457612|NCT00437320|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
6457613|NCT00437320|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6457614|NCT00437320|Dermatologic Agents|dermatologic agents|mesh-ancestor
6457615|NCT00437333|Metformin|metformin|mesh-list
6457616|NCT00437333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6457617|NCT00437333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457618|NCT00437359|Toremifene|toremifene|mesh-list
6457619|NCT00437359|Anastrozole|anastrozole|mesh-list
6457620|NCT00437359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457621|NCT00437359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6457622|NCT00437359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6457623|NCT00437359|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6457624|NCT00437359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6035991|NCT00499369|Bevacizumab|bevacizumab|mesh-list
6035992|NCT00499369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6035993|NCT00499369|Cetuximab|cetuximab|mesh-list
6035994|NCT00499369|Fluorouracil|fluorouracil|mesh-list
6035995|NCT00499369|Irinotecan|irinotecan|mesh-list
6035996|NCT00499369|Antibodies|antibodies|mesh-list
5495148|NCT04525820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6035997|NCT00499369|Immunoglobulins|immunoglobulins|mesh-list
6035998|NCT00499369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6035999|NCT00499369|Levoleucovorin|levoleucovorin|mesh-list
6036000|NCT00499369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6036001|NCT00499369|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6036002|NCT00499369|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6036003|NCT00499369|Growth Substances|growth substances|mesh-ancestor
6036004|NCT00499369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036005|NCT00499369|Growth Inhibitors|growth inhibitors|mesh-ancestor
6036006|NCT00499369|Immunologic Factors|immunologic factors|mesh-ancestor
6036007|NCT00499369|Antimetabolites|antimetabolites|mesh-ancestor
6036008|NCT00499369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6036009|NCT00499369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6036010|NCT00499369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6036011|NCT00499369|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6036012|NCT00499369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6036013|NCT00499369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6036014|NCT00499369|Antidotes|antidotes|mesh-ancestor
6036015|NCT00499369|Protective Agents|protective agents|mesh-ancestor
6036016|NCT00499369|Vitamin B Complex|vitamin b complex|mesh-ancestor
6036017|NCT00499369|Vitamins|vitamins|mesh-ancestor
6036018|NCT00499369|Micronutrients|micronutrients|mesh-ancestor
6036019|NCT00499408|Vitamin D|vitamin d|mesh-list
6036020|NCT00499408|Cholecalciferol|cholecalciferol|mesh-list
6036021|NCT00499408|Vitamins|vitamins|mesh-ancestor
6036022|NCT00499408|Micronutrients|micronutrients|mesh-ancestor
6036023|NCT00499408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036024|NCT00499408|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6036025|NCT00499408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6036026|NCT00499460|Oxycodone|oxycodone|mesh-list
6036027|NCT00499460|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6036028|NCT00499460|Narcotics|narcotics|mesh-ancestor
6036029|NCT00499460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6036030|NCT00499460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495149|NCT04525820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6036031|NCT00499460|Analgesics|analgesics|mesh-ancestor
6036032|NCT00499460|Sensory System Agents|sensory system agents|mesh-ancestor
6036033|NCT00499460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6036034|NCT00499473|Sunitinib|sunitinib|mesh-list
6036035|NCT00499473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6036036|NCT00499473|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6036037|NCT00499473|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6036038|NCT00499473|Growth Substances|growth substances|mesh-ancestor
6036039|NCT00499473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036040|NCT00499473|Growth Inhibitors|growth inhibitors|mesh-ancestor
6036041|NCT00499473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6036042|NCT00499473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6036043|NCT00499473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6036044|NCT00499486|Sirolimus|sirolimus|mesh-list
6036045|NCT00499486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6036046|NCT00499486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6036047|NCT00499486|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6036048|NCT00499486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6036049|NCT00499486|Antifungal Agents|antifungal agents|mesh-ancestor
6036050|NCT00499486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6036051|NCT00499486|Immunologic Factors|immunologic factors|mesh-ancestor
6036052|NCT00499486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036053|NCT00499603|Paclitaxel|paclitaxel|mesh-list
6036054|NCT00499603|Cyclophosphamide|cyclophosphamide|mesh-list
6036055|NCT00499603|Fluorouracil|fluorouracil|mesh-list
6036056|NCT00499603|Epirubicin|epirubicin|mesh-list
6036057|NCT00499603|Everolimus|everolimus|mesh-list
6036058|NCT00499603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6036059|NCT00499603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6036060|NCT00499603|Tubulin Modulators|tubulin modulators|mesh-ancestor
6036061|NCT00499603|Antimitotic Agents|antimitotic agents|mesh-ancestor
6036062|NCT00499603|Mitosis Modulators|mitosis modulators|mesh-ancestor
6036063|NCT00499603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6036064|NCT00499603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6036065|NCT00499603|Immunologic Factors|immunologic factors|mesh-ancestor
6036066|NCT00499603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036067|NCT00499603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6036068|NCT00499603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6036069|NCT00499603|Alkylating Agents|alkylating agents|mesh-ancestor
6036070|NCT00499603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6036071|NCT00499603|Antimetabolites|antimetabolites|mesh-ancestor
6036072|NCT00499603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6036073|NCT00499603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6036074|NCT00499603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6036075|NCT00499603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6036076|NCT00499603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6036077|NCT00499616|Cyclophosphamide|cyclophosphamide|mesh-list
6036078|NCT00499616|Carboplatin|carboplatin|mesh-list
6036079|NCT00499616|Doxorubicin|doxorubicin|mesh-list
6036080|NCT00499616|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6036081|NCT00499616|Etoposide|etoposide|mesh-list
6036082|NCT00499616|Topotecan|topotecan|mesh-list
6036083|NCT00499616|Isotretinoin|isotretinoin|mesh-list
6036084|NCT00499616|Lenograstim|lenograstim|mesh-list
6036085|NCT00499616|Sargramostim|sargramostim|mesh-list
6036086|NCT00499616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6036087|NCT00499616|Immunologic Factors|immunologic factors|mesh-ancestor
6036088|NCT00499616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036089|NCT00499616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6036090|NCT00499616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6036091|NCT00499616|Alkylating Agents|alkylating agents|mesh-ancestor
6036092|NCT00499616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6036093|NCT00499616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6036094|NCT00499616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6036095|NCT00499616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6036096|NCT00499616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6036097|NCT00499616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6036098|NCT00499616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6036099|NCT00499616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6036100|NCT00499616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6036101|NCT00499616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6036102|NCT00499616|Dermatologic Agents|dermatologic agents|mesh-ancestor
6036103|NCT00499655|Celecoxib|celecoxib|mesh-list
6036104|NCT00499655|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6036105|NCT00499655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6036106|NCT00499655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6036107|NCT00499655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6036108|NCT00499655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6036109|NCT00499655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6036110|NCT00499655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6036111|NCT00499655|Analgesics|analgesics|mesh-ancestor
6036112|NCT00499655|Sensory System Agents|sensory system agents|mesh-ancestor
6036113|NCT00499655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6036114|NCT00499655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036115|NCT00499655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6036116|NCT00499655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6036117|NCT00499655|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6036118|NCT00499655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6036119|NCT00499681|Letrozole|letrozole|mesh-list
6036120|NCT00499681|Lapatinib|lapatinib|mesh-list
6036121|NCT00499681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6036122|NCT00499681|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6036123|NCT00499681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6036124|NCT00499681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6036125|NCT00499681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6036126|NCT00499681|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6036127|NCT00499681|Hormone Antagonists|hormone antagonists|mesh-ancestor
6036128|NCT00499681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6036129|NCT00499681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036130|NCT00499681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6036131|NCT00499694|Bevacizumab|bevacizumab|mesh-list
6036132|NCT00499694|Satraplatin|satraplatin|mesh-list
6036133|NCT00499694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6036134|NCT00499694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6036135|NCT00499694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6036136|NCT00499694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6036137|NCT00499694|Growth Substances|growth substances|mesh-ancestor
6036138|NCT00499694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036139|NCT00499694|Growth Inhibitors|growth inhibitors|mesh-ancestor
6036140|NCT00499746|Tramadol|tramadol|mesh-list
6036141|NCT00499746|Hydromorphone|hydromorphone|mesh-list
6036142|NCT00499746|Methylphenidate|methylphenidate|mesh-list
6036143|NCT00499746|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6036144|NCT00499746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036145|NCT00499746|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6036146|NCT00499746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5495150|NCT04525820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5495151|NCT04525664|Amoxicillin|amoxicillin|mesh-list
5495152|NCT04525664|Clarithromycin|clarithromycin|mesh-list
5495153|NCT04525664|Omeprazole|omeprazole|mesh-list
5495154|NCT04525664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5495155|NCT04525664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6036147|NCT00499746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6036148|NCT00499746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6036149|NCT00499746|Dopamine Agents|dopamine agents|mesh-ancestor
6036150|NCT00499746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6036151|NCT00499746|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6036152|NCT00499746|Narcotics|narcotics|mesh-ancestor
6036153|NCT00499746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6036154|NCT00499746|Analgesics|analgesics|mesh-ancestor
6036155|NCT00499746|Sensory System Agents|sensory system agents|mesh-ancestor
6036156|NCT00499746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6036157|NCT00499863|Methylphenidate|methylphenidate|mesh-list
6036158|NCT00499863|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6036159|NCT00499863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036160|NCT00499863|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6036161|NCT00499863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6036162|NCT00499863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6036163|NCT00499863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6036164|NCT00499863|Dopamine Agents|dopamine agents|mesh-ancestor
6036165|NCT00499863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6036166|NCT00499889|Vidarabine|vidarabine|mesh-list
6036167|NCT00499889|Methotrexate|methotrexate|mesh-list
6036168|NCT00499889|Fludarabine phosphate|fludarabine phosphate|mesh-list
6036169|NCT00499889|Fludarabine|fludarabine|mesh-list
6036170|NCT00499889|Busulfan|busulfan|mesh-list
6036171|NCT00499889|Imatinib Mesylate|imatinib mesylate|mesh-list
6036172|NCT00499889|Tacrolimus|tacrolimus|mesh-list
6036173|NCT00499889|Thymoglobulin|thymoglobulin|mesh-list
6036174|NCT00499889|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6036175|NCT00499889|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6036176|NCT00499889|Abortifacient Agents|abortifacient agents|mesh-ancestor
6036177|NCT00499889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5495156|NCT04525664|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5495157|NCT04525664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6053634|NCT00596817|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5495158|NCT04525664|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5495159|NCT04525664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5495160|NCT04525664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495161|NCT04525664|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5495162|NCT04525664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5495163|NCT04525664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5495164|NCT04525729|Rituximab|rituximab|mesh-list
5495165|NCT04525729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5495166|NCT04525729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6036178|NCT00499889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036179|NCT00499889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6036180|NCT00499889|Antimetabolites|antimetabolites|mesh-ancestor
6036181|NCT00499889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6036182|NCT00499889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6036183|NCT00499889|Dermatologic Agents|dermatologic agents|mesh-ancestor
6036184|NCT00499889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6036185|NCT00499889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6036186|NCT00499889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6036187|NCT00499889|Immunologic Factors|immunologic factors|mesh-ancestor
6036188|NCT00499889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6036189|NCT00499889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6036190|NCT00499889|Antiviral Agents|antiviral agents|mesh-ancestor
6036191|NCT00499889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6036192|NCT00499889|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6036193|NCT00499889|Alkylating Agents|alkylating agents|mesh-ancestor
6036194|NCT00499889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6036195|NCT00499889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6036196|NCT00499889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6036197|NCT00500071|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6036198|NCT00500071|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5495167|NCT04525729|Immunologic Factors|immunologic factors|mesh-ancestor
5495168|NCT04525729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495169|NCT04525729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5495170|NCT04525755|Nicotine|nicotine|mesh-list
5495171|NCT04525755|Varenicline|varenicline|mesh-list
5495172|NCT04525755|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5495173|NCT04525755|Autonomic Agents|autonomic agents|mesh-ancestor
5495174|NCT04525755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5495175|NCT04525755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495176|NCT04525755|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5495177|NCT04525755|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5495178|NCT04525755|Cholinergic Agents|cholinergic agents|mesh-ancestor
5495179|NCT04525755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5495180|NCT04525755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495181|NCT04525521|Hand Sanitizers|hand sanitizers|mesh-list
5495182|NCT04525521|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6036199|NCT00500071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036200|NCT00500071|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6036201|NCT00500071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6036202|NCT00500071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6036203|NCT00500071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6036204|NCT00500071|Dopamine Agents|dopamine agents|mesh-ancestor
6036205|NCT00500071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6036206|NCT00500110|Docetaxel|docetaxel|mesh-list
6036207|NCT00500110|Imatinib Mesylate|imatinib mesylate|mesh-list
6036208|NCT00500110|Leuprolide|leuprolide|mesh-list
6036209|NCT00500110|Goserelin|goserelin|mesh-list
6036210|NCT00500110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6036211|NCT00500110|Tubulin Modulators|tubulin modulators|mesh-ancestor
6036212|NCT00500110|Antimitotic Agents|antimitotic agents|mesh-ancestor
6036213|NCT00500110|Mitosis Modulators|mitosis modulators|mesh-ancestor
6036214|NCT00500110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6036215|NCT00500110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6036216|NCT00500110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6036217|NCT00500110|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6036218|NCT00500110|Fertility Agents|fertility agents|mesh-ancestor
5495183|NCT04525521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5495184|NCT04525521|Disinfectants|disinfectants|mesh-ancestor
5495185|NCT04525495|Dopamine|dopamine|mesh-list
5495186|NCT04525495|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5495187|NCT04525495|Sympathomimetics|sympathomimetics|mesh-ancestor
5495188|NCT04525495|Autonomic Agents|autonomic agents|mesh-ancestor
5495189|NCT04525495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5495190|NCT04525495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036219|NCT00500110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6036220|NCT00500110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036221|NCT00500110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6036222|NCT00500149|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6036223|NCT00500149|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6036224|NCT00500149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036225|NCT00500149|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6036226|NCT00500149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6036227|NCT00500149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6036228|NCT00500149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6036229|NCT00500149|Dopamine Agents|dopamine agents|mesh-ancestor
6036230|NCT00500149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6036231|NCT00500240|Insulin|insulin|mesh-list
6036232|NCT00500240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6036233|NCT00500240|Insulin Glargine|insulin glargine|mesh-list
6036234|NCT00500240|Insulin Aspart|insulin aspart|mesh-list
6036235|NCT00500240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6036236|NCT00500240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036237|NCT00500266|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6036238|NCT00500266|Immunologic Factors|immunologic factors|mesh-ancestor
6036239|NCT00500266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036240|NCT00500292|Leucovorin|leucovorin|mesh-list
6036241|NCT00500292|Folic Acid|folic acid|mesh-list
6036242|NCT00500292|Fluorouracil|fluorouracil|mesh-list
6036243|NCT00500292|Oxaliplatin|oxaliplatin|mesh-list
6036244|NCT00500292|Levoleucovorin|levoleucovorin|mesh-list
6036245|NCT00500292|Antimetabolites|antimetabolites|mesh-ancestor
6036246|NCT00500292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6036247|NCT00500292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6036248|NCT00500292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6036249|NCT00500292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6036250|NCT00500292|Immunologic Factors|immunologic factors|mesh-ancestor
6036251|NCT00500292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036252|NCT00500292|Antidotes|antidotes|mesh-ancestor
6036253|NCT00500292|Protective Agents|protective agents|mesh-ancestor
6036254|NCT00500292|Vitamin B Complex|vitamin b complex|mesh-ancestor
6036255|NCT00500292|Vitamins|vitamins|mesh-ancestor
6036256|NCT00500292|Micronutrients|micronutrients|mesh-ancestor
6036257|NCT00500292|Hematinics|hematinics|mesh-ancestor
6036258|NCT00500318|Bromides|bromides|mesh-list
6036259|NCT00500318|Anticonvulsants|anticonvulsants|mesh-ancestor
6036260|NCT00500331|Pioglitazone|pioglitazone|mesh-list
6036261|NCT00500331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6036262|NCT00500331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036263|NCT00500357|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6036264|NCT00500357|Immunologic Factors|immunologic factors|mesh-ancestor
6036265|NCT00500357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036266|NCT00500370|Exenatide|exenatide|mesh-list
6036267|NCT00500370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6036268|NCT00500370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036269|NCT00500370|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6036270|NCT00500370|Incretins|incretins|mesh-ancestor
6036271|NCT00500370|Hormones|hormones|mesh-ancestor
6036272|NCT00500370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6036273|NCT00500539|Omalizumab|omalizumab|mesh-list
6036274|NCT00500539|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6036275|NCT00500539|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6036276|NCT00500539|Respiratory System Agents|respiratory system agents|mesh-ancestor
6036277|NCT00500578|Ribavirin|ribavirin|mesh-list
6036278|NCT00500578|Antimetabolites|antimetabolites|mesh-ancestor
6036279|NCT00500578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6036280|NCT00500578|Antiviral Agents|antiviral agents|mesh-ancestor
6036281|NCT00500578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6036282|NCT00500656|Icatibant|icatibant|mesh-list
6036283|NCT00500656|Tranexamic Acid|tranexamic acid|mesh-list
6036284|NCT00500656|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6036285|NCT00500656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6036286|NCT00500656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6036287|NCT00500656|Hemostatics|hemostatics|mesh-ancestor
6036288|NCT00500656|Coagulants|coagulants|mesh-ancestor
6036289|NCT00500656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6036290|NCT00500656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6036291|NCT00500656|Analgesics|analgesics|mesh-ancestor
6036292|NCT00500656|Sensory System Agents|sensory system agents|mesh-ancestor
6036293|NCT00500656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6036294|NCT00500656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036295|NCT00500656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6036296|NCT00500656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6036297|NCT00500656|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
6036298|NCT00500656|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
6036299|NCT00500656|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6036300|NCT00500656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6036301|NCT00500656|Immunologic Factors|immunologic factors|mesh-ancestor
6036302|NCT00500760|Panitumumab|panitumumab|mesh-list
6036303|NCT00500760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6036304|NCT00500760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6036305|NCT00501059|Aspirin|aspirin|mesh-list
6036306|NCT00501059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6036307|NCT00501059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6036308|NCT00501059|Analgesics|analgesics|mesh-ancestor
6036309|NCT00501059|Sensory System Agents|sensory system agents|mesh-ancestor
6036310|NCT00501059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6036311|NCT00501059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495191|NCT04525495|Dopamine Agents|dopamine agents|mesh-ancestor
5495192|NCT04525495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5495193|NCT04525495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495194|NCT04525495|Protective Agents|protective agents|mesh-ancestor
5503219|NCT04461041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503220|NCT04461041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5503221|NCT04461041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503222|NCT04460963|Adrenomedullin|adrenomedullin|mesh-list
5503223|NCT04460963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6036312|NCT00501059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6036313|NCT00501059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6036314|NCT00501059|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6036315|NCT00501059|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6036316|NCT00501059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6036317|NCT00501059|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6036318|NCT00501059|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6036319|NCT00501059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6036320|NCT00501059|Antipyretics|antipyretics|mesh-ancestor
6036321|NCT00501293|Methylphenidate|methylphenidate|mesh-list
6036322|NCT00501293|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6036323|NCT00501293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503224|NCT04460963|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5503225|NCT04460963|Autonomic Agents|autonomic agents|mesh-ancestor
5503226|NCT04460963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6036324|NCT00501293|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6036325|NCT00501293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6036326|NCT00501293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6036327|NCT00501293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6036328|NCT00501293|Dopamine Agents|dopamine agents|mesh-ancestor
6036329|NCT00501293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6036330|NCT00501540|Lithium Carbonate|lithium carbonate|mesh-list
6036331|NCT00501540|Antidepressive Agents|antidepressive agents|mesh-ancestor
6036332|NCT00501540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6036333|NCT00501540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6036334|NCT00501540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503227|NCT04460963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503228|NCT04460963|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5503229|NCT04460963|Respiratory System Agents|respiratory system agents|mesh-ancestor
5503230|NCT04460963|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6036335|NCT00501540|Antimanic Agents|antimanic agents|mesh-ancestor
6036336|NCT00501540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6036337|NCT00501540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6036338|NCT00501540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036339|NCT00501631|Naltrexone|naltrexone|mesh-list
6036340|NCT00501631|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6036341|NCT00501631|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6036342|NCT00501631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036343|NCT00501631|Sensory System Agents|sensory system agents|mesh-ancestor
6036344|NCT00501631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6036345|NCT00501644|Interferons|interferons|mesh-list
6036346|NCT00501644|Interferon-gamma|interferon-gamma|mesh-list
6036347|NCT00501644|Carboplatin|carboplatin|mesh-list
6036348|NCT00501644|Molgramostim|molgramostim|mesh-list
6036349|NCT00501644|Sargramostim|sargramostim|mesh-list
6036350|NCT00501644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6036351|NCT00501644|Antiviral Agents|antiviral agents|mesh-ancestor
6457625|NCT00437359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5503231|NCT04460963|Vasodilator Agents|vasodilator agents|mesh-ancestor
5495195|NCT04525638|Nivolumab|nivolumab|mesh-list
5495196|NCT04525638|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
5495197|NCT04525638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5495198|NCT04525638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5495199|NCT04525638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5495200|NCT04525638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495201|NCT04525638|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6036352|NCT00501644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6036353|NCT00501644|Immunologic Factors|immunologic factors|mesh-ancestor
6036354|NCT00501644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036355|NCT00501852|Glycopyrrolate|glycopyrrolate|mesh-list
6036356|NCT00501852|Tiotropium Bromide|tiotropium bromide|mesh-list
6036357|NCT00501852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6036358|NCT00501852|Autonomic Agents|autonomic agents|mesh-ancestor
6036359|NCT00501852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6036360|NCT00501852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036361|NCT00501852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6036362|NCT00501852|Respiratory System Agents|respiratory system agents|mesh-ancestor
6036363|NCT00501852|Parasympatholytics|parasympatholytics|mesh-ancestor
6036364|NCT00501852|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6036365|NCT00501852|Cholinergic Agents|cholinergic agents|mesh-ancestor
6036366|NCT00501852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6036367|NCT00501852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6036368|NCT00501852|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6036369|NCT00501852|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6036370|NCT00501891|Bevacizumab|bevacizumab|mesh-list
6036371|NCT00501891|Temozolomide|temozolomide|mesh-list
6036372|NCT00501891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6036373|NCT00501891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6036374|NCT00501891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6036375|NCT00501891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6036376|NCT00501891|Growth Substances|growth substances|mesh-ancestor
6036377|NCT00501891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036378|NCT00501891|Growth Inhibitors|growth inhibitors|mesh-ancestor
5495202|NCT04525066|Hyaluronic Acid|hyaluronic acid|mesh-list
5495203|NCT04525066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5495204|NCT04525066|Immunologic Factors|immunologic factors|mesh-ancestor
5495205|NCT04525066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495206|NCT04525066|Viscosupplements|viscosupplements|mesh-ancestor
5495207|NCT04525066|Protective Agents|protective agents|mesh-ancestor
6036379|NCT00501891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6036380|NCT00501891|Alkylating Agents|alkylating agents|mesh-ancestor
6036381|NCT00501891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495211|NCT04525235|Tolbutamide|tolbutamide|mesh-list
5495212|NCT04525235|Rifampin|rifampin|mesh-list
5495213|NCT04525235|Digoxin|digoxin|mesh-list
5495214|NCT04525235|Midazolam|midazolam|mesh-list
5495215|NCT04525235|Dextromethorphan|dextromethorphan|mesh-list
5495216|NCT04525235|Caffeine|caffeine|mesh-list
5495217|NCT04525235|Omeprazole|omeprazole|mesh-list
5495218|NCT04525235|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5495219|NCT04525235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5495220|NCT04525235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5495221|NCT04525235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495222|NCT04525235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5495223|NCT04525235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5495224|NCT04525235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5495225|NCT04525235|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5495226|NCT04525235|Anesthetics, General|anesthetics, general|mesh-ancestor
5495227|NCT04525235|Anesthetics|anesthetics|mesh-ancestor
5495228|NCT04525235|GABA Modulators|gaba modulators|mesh-ancestor
6036382|NCT00501943|Interferons|interferons|mesh-list
6036383|NCT00501943|Interferon-beta|interferon-beta|mesh-list
6036384|NCT00501943|Interferon beta-1a|interferon beta-1a|mesh-list
6036385|NCT00501943|Riluzole|riluzole|mesh-list
6036386|NCT00501943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6036387|NCT00501943|Antiviral Agents|antiviral agents|mesh-ancestor
6036388|NCT00501943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6036389|NCT00501943|Immunologic Factors|immunologic factors|mesh-ancestor
6036390|NCT00501943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036391|NCT00501943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6036392|NCT00501943|Anticonvulsants|anticonvulsants|mesh-ancestor
5495229|NCT04525235|GABA Agents|gaba agents|mesh-ancestor
5495230|NCT04525235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5495231|NCT04525235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495232|NCT04525235|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6036393|NCT00501943|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6036394|NCT00501943|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6036395|NCT00501943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6036396|NCT00501943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6036397|NCT00501943|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6036398|NCT00501943|Protective Agents|protective agents|mesh-ancestor
6036399|NCT00501969|Rotigotine|rotigotine|mesh-list
6036400|NCT00501969|Dopamine Agonists|dopamine agonists|mesh-ancestor
6036401|NCT00501969|Dopamine Agents|dopamine agents|mesh-ancestor
6036402|NCT00501969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6036403|NCT00501969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6036404|NCT00501969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036405|NCT00501995|Cyclophosphamide|cyclophosphamide|mesh-list
6036406|NCT00501995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6036407|NCT00501995|Immunologic Factors|immunologic factors|mesh-ancestor
6036408|NCT00501995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036409|NCT00501995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6036410|NCT00501995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6036411|NCT00501995|Alkylating Agents|alkylating agents|mesh-ancestor
6036412|NCT00501995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6036413|NCT00501995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6036414|NCT00501995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6036415|NCT00502203|Paclitaxel|paclitaxel|mesh-list
6036416|NCT00502203|Carboplatin|carboplatin|mesh-list
6036417|NCT00502203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6036418|NCT00502203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6036419|NCT00502203|Tubulin Modulators|tubulin modulators|mesh-ancestor
6036420|NCT00502203|Antimitotic Agents|antimitotic agents|mesh-ancestor
6036421|NCT00502203|Mitosis Modulators|mitosis modulators|mesh-ancestor
6036422|NCT00502203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6036423|NCT00502216|Naltrexone|naltrexone|mesh-list
6036424|NCT00502216|Varenicline|varenicline|mesh-list
6036425|NCT00502216|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6036426|NCT00502216|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6036427|NCT00502216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036428|NCT00502216|Sensory System Agents|sensory system agents|mesh-ancestor
6036429|NCT00502216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6036430|NCT00502216|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6036431|NCT00502216|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6036432|NCT00502216|Cholinergic Agents|cholinergic agents|mesh-ancestor
6036433|NCT00502216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6036434|NCT00502216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6036435|NCT00502242|Ramipril|ramipril|mesh-list
6036436|NCT00502242|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6036437|NCT00502242|Protease Inhibitors|protease inhibitors|mesh-ancestor
6036438|NCT00502242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6036439|NCT00502242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6036440|NCT00502242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6036441|NCT00502671|Capecitabine|capecitabine|mesh-list
6036442|NCT00502671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6036443|NCT00502671|Antimetabolites|antimetabolites|mesh-ancestor
6036444|NCT00502671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6036445|NCT00502671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6036446|NCT00502775|Fluticasone|fluticasone|mesh-list
6036447|NCT00502775|Xhance|xhance|mesh-list
6036448|NCT00502775|Fexofenadine|fexofenadine|mesh-list
6036449|NCT00502775|Terfenadine|terfenadine|mesh-list
6036450|NCT00502775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6036451|NCT00502775|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6036452|NCT00502775|Autonomic Agents|autonomic agents|mesh-ancestor
6036453|NCT00502775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6036454|NCT00502775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036455|NCT00502775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6036456|NCT00502775|Respiratory System Agents|respiratory system agents|mesh-ancestor
6036457|NCT00502775|Dermatologic Agents|dermatologic agents|mesh-ancestor
6036458|NCT00502775|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6036459|NCT00502775|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6036460|NCT00502775|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6036461|NCT00502775|Histamine Antagonists|histamine antagonists|mesh-ancestor
6036462|NCT00502775|Histamine Agents|histamine agents|mesh-ancestor
6036463|NCT00502775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6036464|NCT00502775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6036465|NCT00502801|Doripenem|doripenem|mesh-list
6036466|NCT00502801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6036467|NCT00502801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6036468|NCT00502840|Rituximab|rituximab|mesh-list
6036469|NCT00502840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6036470|NCT00502840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6036471|NCT00502840|Immunologic Factors|immunologic factors|mesh-ancestor
6036472|NCT00502840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036473|NCT00502840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6036474|NCT00502853|Rituximab|rituximab|mesh-list
6036475|NCT00502853|Methotrexate|methotrexate|mesh-list
6036476|NCT00502853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6036477|NCT00502853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6036478|NCT00502853|Immunologic Factors|immunologic factors|mesh-ancestor
5495233|NCT04525235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5495234|NCT04525235|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5495235|NCT04525235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5495236|NCT04525235|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5495237|NCT04525235|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5495238|NCT04525235|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5495239|NCT04525235|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5495240|NCT04525235|Purinergic Agents|purinergic agents|mesh-ancestor
5495241|NCT04525235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5495242|NCT04525235|Antitubercular Agents|antitubercular agents|mesh-ancestor
5495243|NCT04525235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5495244|NCT04525235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5495245|NCT04525235|Leprostatic Agents|leprostatic agents|mesh-ancestor
5495246|NCT04525235|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5495247|NCT04525235|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5495248|NCT04525235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5495249|NCT04525235|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5495250|NCT04525235|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5495251|NCT04525235|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5495252|NCT04525235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5495253|NCT04525235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5495254|NCT04525235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5495255|NCT04525235|Protective Agents|protective agents|mesh-ancestor
5495256|NCT04525235|Antitussive Agents|antitussive agents|mesh-ancestor
5495257|NCT04525235|Respiratory System Agents|respiratory system agents|mesh-ancestor
5495258|NCT04525235|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6036479|NCT00502853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036480|NCT00502853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6036481|NCT00502853|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6036482|NCT00502853|Abortifacient Agents|abortifacient agents|mesh-ancestor
6036483|NCT00502853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6036484|NCT00502853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6036485|NCT00502853|Antimetabolites|antimetabolites|mesh-ancestor
6036486|NCT00502853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6036487|NCT00502853|Dermatologic Agents|dermatologic agents|mesh-ancestor
6036488|NCT00502853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6036489|NCT00502853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6036490|NCT00502853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6036491|NCT00502853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6036492|NCT00502905|Vidarabine|vidarabine|mesh-list
6036493|NCT00502905|Fludarabine|fludarabine|mesh-list
5495259|NCT04525235|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5495260|NCT04525235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5495261|NCT04525274|Dexmedetomidine|dexmedetomidine|mesh-list
5495262|NCT04525274|Ketamine|ketamine|mesh-list
5495263|NCT04525274|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5495264|NCT04525274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5495265|NCT04525274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036494|NCT00502905|Fludarabine phosphate|fludarabine phosphate|mesh-list
6036495|NCT00502905|Busulfan|busulfan|mesh-list
6036496|NCT00502905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6036497|NCT00502905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6036498|NCT00502905|Antimetabolites|antimetabolites|mesh-ancestor
6036499|NCT00502905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6036500|NCT00502905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6036501|NCT00502905|Immunologic Factors|immunologic factors|mesh-ancestor
6036502|NCT00502905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036503|NCT00502905|Antiviral Agents|antiviral agents|mesh-ancestor
6036504|NCT00502905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6036505|NCT00502905|Alkylating Agents|alkylating agents|mesh-ancestor
6036506|NCT00502905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6036507|NCT00502905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6036508|NCT00502996|Rituximab|rituximab|mesh-list
6036509|NCT00502996|Methotrexate|methotrexate|mesh-list
6036510|NCT00502996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6036511|NCT00502996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6036512|NCT00502996|Immunologic Factors|immunologic factors|mesh-ancestor
6036513|NCT00502996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036514|NCT00502996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6036515|NCT00502996|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6036516|NCT00502996|Abortifacient Agents|abortifacient agents|mesh-ancestor
6036517|NCT00502996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6036518|NCT00502996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6036519|NCT00502996|Antimetabolites|antimetabolites|mesh-ancestor
6036520|NCT00502996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6036521|NCT00502996|Dermatologic Agents|dermatologic agents|mesh-ancestor
6036522|NCT00502996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6036523|NCT00502996|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6036524|NCT00502996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6036525|NCT00502996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6036526|NCT00503113|Alendronate|alendronate|mesh-list
6036527|NCT00503113|Ibandronic Acid|ibandronic acid|mesh-list
6036528|NCT00503113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6036529|NCT00503113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036530|NCT00503139|Etanercept|etanercept|mesh-list
6036531|NCT00503139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6036532|NCT00503139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6036533|NCT00503139|Analgesics|analgesics|mesh-ancestor
6036534|NCT00503139|Sensory System Agents|sensory system agents|mesh-ancestor
6036535|NCT00503139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6036536|NCT00503139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036537|NCT00503139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6036538|NCT00503139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6036539|NCT00503139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6036540|NCT00503139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6036541|NCT00503139|Immunologic Factors|immunologic factors|mesh-ancestor
6036542|NCT00503399|Teriparatide|teriparatide|mesh-list
6036543|NCT00503399|Risedronic Acid|risedronic acid|mesh-list
6036544|NCT00503399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6036545|NCT00503399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036546|NCT00503399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6036547|NCT00503399|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6036548|NCT00503399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6036549|NCT00503399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6036550|NCT00503425|Rituximab|rituximab|mesh-list
6036551|NCT00503425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6036552|NCT00503425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6036553|NCT00503425|Immunologic Factors|immunologic factors|mesh-ancestor
6036554|NCT00503425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036555|NCT00503425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5495266|NCT04525274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5495267|NCT04525274|Analgesics|analgesics|mesh-ancestor
5495268|NCT04525274|Sensory System Agents|sensory system agents|mesh-ancestor
5495269|NCT04525274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5495270|NCT04525274|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6036556|NCT00503685|Cetuximab|cetuximab|mesh-list
6036557|NCT00503685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6036558|NCT00503685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6036559|NCT00503750|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6036560|NCT00503750|Vinorelbine|vinorelbine|mesh-list
5495271|NCT04525274|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5495272|NCT04525274|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6036561|NCT00503750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6036562|NCT00503750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6036563|NCT00503750|Tubulin Modulators|tubulin modulators|mesh-ancestor
6036564|NCT00503750|Antimitotic Agents|antimitotic agents|mesh-ancestor
6036565|NCT00503750|Mitosis Modulators|mitosis modulators|mesh-ancestor
6036566|NCT00503750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6036567|NCT00503776|Amifostine|amifostine|mesh-list
6036568|NCT00503776|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6036569|NCT00503776|Protective Agents|protective agents|mesh-ancestor
6036570|NCT00503776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036571|NCT00503906|Gemcitabine|gemcitabine|mesh-list
6036572|NCT00503906|Paclitaxel|paclitaxel|mesh-list
6036573|NCT00503906|Bevacizumab|bevacizumab|mesh-list
6036574|NCT00503906|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6457626|NCT00437359|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6457627|NCT00437359|Hormone Antagonists|hormone antagonists|mesh-ancestor
6457628|NCT00437359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6457629|NCT00437359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457630|NCT00437359|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5495273|NCT04525274|Adrenergic Agents|adrenergic agents|mesh-ancestor
6036575|NCT00503906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6036576|NCT00503906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6036577|NCT00503906|Tubulin Modulators|tubulin modulators|mesh-ancestor
6036578|NCT00503906|Antimitotic Agents|antimitotic agents|mesh-ancestor
6036579|NCT00503906|Mitosis Modulators|mitosis modulators|mesh-ancestor
6036580|NCT00503906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6036581|NCT00503906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6036582|NCT00503906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5495274|NCT04525274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5495275|NCT04525274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495276|NCT04525274|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5495277|NCT04525274|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5495278|NCT04525274|Anesthetics, General|anesthetics, general|mesh-ancestor
5495279|NCT04525274|Anesthetics|anesthetics|mesh-ancestor
5495280|NCT04525274|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5495281|NCT04525274|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5495282|NCT04525326|Bevacizumab|bevacizumab|mesh-list
5495283|NCT04525326|Cetuximab|cetuximab|mesh-list
5495284|NCT04525326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5495285|NCT04525326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5495286|NCT04525326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5495287|NCT04525326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5495288|NCT04525326|Growth Substances|growth substances|mesh-ancestor
5495289|NCT04525326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495290|NCT04525326|Growth Inhibitors|growth inhibitors|mesh-ancestor
5495291|NCT04525300|Liraglutide|liraglutide|mesh-list
5495292|NCT04525300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5495293|NCT04525300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495294|NCT04525300|Incretins|incretins|mesh-ancestor
5495295|NCT04525300|Hormones|hormones|mesh-ancestor
5495296|NCT04525300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5495297|NCT04524702|Gemcitabine|gemcitabine|mesh-list
5495298|NCT04524702|Hydroxychloroquine|hydroxychloroquine|mesh-list
5495299|NCT04524702|Paclitaxel|paclitaxel|mesh-list
5495300|NCT04524702|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5495301|NCT04524702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5495302|NCT04524702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5495303|NCT04524702|Tubulin Modulators|tubulin modulators|mesh-ancestor
5495304|NCT04524702|Antimitotic Agents|antimitotic agents|mesh-ancestor
5495305|NCT04524702|Mitosis Modulators|mitosis modulators|mesh-ancestor
5495306|NCT04524702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495307|NCT04524702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5495308|NCT04524702|Antimetabolites|antimetabolites|mesh-ancestor
5495309|NCT04524702|Antiviral Agents|antiviral agents|mesh-ancestor
5495310|NCT04524702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5495311|NCT04524702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5495312|NCT04524702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5495313|NCT04524702|Immunologic Factors|immunologic factors|mesh-ancestor
5495314|NCT04524702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495315|NCT04524702|Antimalarials|antimalarials|mesh-ancestor
5495316|NCT04524702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5495317|NCT04524702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6036583|NCT00503906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5495318|NCT04524702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6036584|NCT00503906|Growth Substances|growth substances|mesh-ancestor
6036585|NCT00503906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036586|NCT00503906|Growth Inhibitors|growth inhibitors|mesh-ancestor
6036587|NCT00503906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6036588|NCT00503906|Antimetabolites|antimetabolites|mesh-ancestor
6036589|NCT00503906|Antiviral Agents|antiviral agents|mesh-ancestor
5495319|NCT04524728|Letrozole|letrozole|mesh-list
5495320|NCT04524728|Fulvestrant|fulvestrant|mesh-list
5495321|NCT04524728|Palbociclib|palbociclib|mesh-list
5495322|NCT04524728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5495323|NCT04524728|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5495324|NCT04524728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5495325|NCT04524728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5495326|NCT04524728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495327|NCT04524728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5495328|NCT04524728|Hormone Antagonists|hormone antagonists|mesh-ancestor
5495329|NCT04524728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6036590|NCT00503906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6036591|NCT00503906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6036592|NCT00503906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6036593|NCT00503906|Immunologic Factors|immunologic factors|mesh-ancestor
6036594|NCT00503984|Prednisone|prednisone|mesh-list
6036595|NCT00503984|Docetaxel|docetaxel|mesh-list
6036596|NCT00503984|Azacitidine|azacitidine|mesh-list
6036597|NCT00503984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6036598|NCT00503984|Tubulin Modulators|tubulin modulators|mesh-ancestor
6036599|NCT00503984|Antimitotic Agents|antimitotic agents|mesh-ancestor
6036600|NCT00503984|Mitosis Modulators|mitosis modulators|mesh-ancestor
6036601|NCT00503984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6036602|NCT00503984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6036603|NCT00503984|Glucocorticoids|glucocorticoids|mesh-ancestor
6036604|NCT00503984|Hormones|hormones|mesh-ancestor
6036605|NCT00503984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6036606|NCT00503984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036607|NCT00503984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6036608|NCT00503984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6036609|NCT00503984|Antimetabolites|antimetabolites|mesh-ancestor
6036610|NCT00503984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6036611|NCT00503997|Oxaliplatin|oxaliplatin|mesh-list
5495330|NCT04524728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495331|NCT04524728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5495332|NCT04524728|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5495333|NCT04524728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5495334|NCT04524897|Triamcinolone|triamcinolone|mesh-list
5495335|NCT04524897|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5495336|NCT04524897|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5495337|NCT04524897|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5495338|NCT04524897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5495339|NCT04524897|Glucocorticoids|glucocorticoids|mesh-ancestor
5495340|NCT04524897|Hormones|hormones|mesh-ancestor
5495341|NCT04524897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5495342|NCT04524897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495343|NCT04524897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6036612|NCT00503997|Pemetrexed|pemetrexed|mesh-list
6036613|NCT00503997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6036614|NCT00503997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6036615|NCT00503997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495344|NCT04524897|Immunologic Factors|immunologic factors|mesh-ancestor
5495345|NCT04524897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5495346|NCT04524897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495347|NCT04524663|Camostat|camostat|mesh-list
5495348|NCT04524663|Protease Inhibitors|protease inhibitors|mesh-ancestor
5495349|NCT04524663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5495350|NCT04524663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495351|NCT04524663|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5495352|NCT04524663|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5495353|NCT04524260|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5495354|NCT04524169|Thymalfasin|thymalfasin|mesh-list
5495355|NCT04524169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5495356|NCT04524169|Immunologic Factors|immunologic factors|mesh-ancestor
5495357|NCT04524169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495358|NCT04523987|Ciprofloxacin|ciprofloxacin|mesh-list
5495359|NCT04523987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5495360|NCT04523987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5495361|NCT04523987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5495362|NCT04523987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6036616|NCT00503997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6036617|NCT00503997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6036618|NCT00504023|Imiquimod|imiquimod|mesh-list
6036619|NCT00504023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6036620|NCT00504023|Immunologic Factors|immunologic factors|mesh-ancestor
6036621|NCT00504023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457631|NCT00437359|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6457632|NCT00437359|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6457633|NCT00437372|Sunitinib|sunitinib|mesh-list
6457634|NCT00437372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6457635|NCT00437372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6457636|NCT00437372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6457637|NCT00437372|Growth Substances|growth substances|mesh-ancestor
6457638|NCT00437372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036622|NCT00504023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6036623|NCT00504023|Interferon Inducers|interferon inducers|mesh-ancestor
6036624|NCT00504075|Immunoglobulins|immunoglobulins|mesh-list
6036625|NCT00504075|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6036626|NCT00504075|Antibodies|antibodies|mesh-list
6036627|NCT00504075|gamma-Globulins|gamma-globulins|mesh-list
6036628|NCT00504075|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6036629|NCT00504075|Immunologic Factors|immunologic factors|mesh-ancestor
6036630|NCT00504075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036631|NCT00504153|Dasatinib|dasatinib|mesh-list
6036632|NCT00504153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5495363|NCT04523987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5495364|NCT04523987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495365|NCT04523987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5495366|NCT04523987|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6036633|NCT00504153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6036634|NCT00504153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6036635|NCT00504153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6036636|NCT00504166|Alendronate|alendronate|mesh-list
6036637|NCT00504166|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6036638|NCT00504166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036639|NCT00504257|Bevacizumab|bevacizumab|mesh-list
6036640|NCT00504257|Docetaxel|docetaxel|mesh-list
6036641|NCT00504257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6036642|NCT00504257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6036643|NCT00504257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6036644|NCT00504257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6036645|NCT00504257|Growth Substances|growth substances|mesh-ancestor
6036646|NCT00504257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036647|NCT00504257|Growth Inhibitors|growth inhibitors|mesh-ancestor
6036648|NCT00504257|Tubulin Modulators|tubulin modulators|mesh-ancestor
6036649|NCT00504257|Antimitotic Agents|antimitotic agents|mesh-ancestor
6036650|NCT00504257|Mitosis Modulators|mitosis modulators|mesh-ancestor
6036651|NCT00504257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053635|NCT00596817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6053636|NCT00596817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053637|NCT00596817|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6053638|NCT00596817|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6053639|NCT00596817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6457639|NCT00437372|Growth Inhibitors|growth inhibitors|mesh-ancestor
5503232|NCT04460963|Protective Agents|protective agents|mesh-ancestor
6036652|NCT00504348|Tacrolimus|tacrolimus|mesh-list
6036653|NCT00504348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6036654|NCT00504348|Immunologic Factors|immunologic factors|mesh-ancestor
6036655|NCT00504348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036656|NCT00504348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6036657|NCT00504348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6036658|NCT00504348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6036659|NCT00504504|Rituximab|rituximab|mesh-list
6036660|NCT00504504|Doxorubicin|doxorubicin|mesh-list
6036661|NCT00504504|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6036662|NCT00504504|Dacarbazine|dacarbazine|mesh-list
6036663|NCT00504504|Bleomycin|bleomycin|mesh-list
6036664|NCT00504504|Vinblastine|vinblastine|mesh-list
6036665|NCT00504504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5495367|NCT04523987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5495368|NCT04524026|Letrozole|letrozole|mesh-list
5495369|NCT04524026|Aromatase Inhibitors|aromatase inhibitors|mesh-list
6036666|NCT00504504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6036667|NCT00504504|Immunologic Factors|immunologic factors|mesh-ancestor
6036668|NCT00504504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036669|NCT00504504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6457640|NCT00437372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6457641|NCT00437372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6457642|NCT00437372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457643|NCT00437385|Lithium Carbonate|lithium carbonate|mesh-list
6457644|NCT00437385|Antidepressive Agents|antidepressive agents|mesh-ancestor
6036670|NCT00504504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6036671|NCT00504504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6036672|NCT00504504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6036673|NCT00504504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6036674|NCT00504504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6036675|NCT00504504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6036676|NCT00504504|Alkylating Agents|alkylating agents|mesh-ancestor
6036677|NCT00504504|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6036678|NCT00504504|Tubulin Modulators|tubulin modulators|mesh-ancestor
6036679|NCT00504504|Antimitotic Agents|antimitotic agents|mesh-ancestor
6036680|NCT00504504|Mitosis Modulators|mitosis modulators|mesh-ancestor
6036681|NCT00504556|Warfarin|warfarin|mesh-list
6036682|NCT00504556|Edoxaban|edoxaban|mesh-list
5495370|NCT04524026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5495371|NCT04524026|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5495372|NCT04524026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5495373|NCT04524026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495374|NCT04524026|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5495375|NCT04524026|Hormone Antagonists|hormone antagonists|mesh-ancestor
5495376|NCT04524026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6036683|NCT00504556|Anticoagulants|anticoagulants|mesh-ancestor
6036684|NCT00504556|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6036685|NCT00504556|Antithrombins|antithrombins|mesh-ancestor
6036686|NCT00504556|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6036687|NCT00504556|Protease Inhibitors|protease inhibitors|mesh-ancestor
6036688|NCT00504556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6036689|NCT00504556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6036690|NCT00504582|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6036691|NCT00504582|Hemostatics|hemostatics|mesh-ancestor
6036692|NCT00504582|Coagulants|coagulants|mesh-ancestor
6036693|NCT00504660|Celecoxib|celecoxib|mesh-list
6036694|NCT00504660|Capecitabine|capecitabine|mesh-list
6036695|NCT00504660|Thioguanine|thioguanine|mesh-list
6036696|NCT00504660|Temozolomide|temozolomide|mesh-list
6036697|NCT00504660|Lomustine|lomustine|mesh-list
6036698|NCT00504660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6036699|NCT00504660|Antimetabolites|antimetabolites|mesh-ancestor
6036700|NCT00504660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6036701|NCT00504660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6036702|NCT00504660|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6036703|NCT00504660|Alkylating Agents|alkylating agents|mesh-ancestor
6036704|NCT00504660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6036705|NCT00504660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6036706|NCT00504660|Analgesics|analgesics|mesh-ancestor
6457645|NCT00437385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6457646|NCT00437385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6036707|NCT00504660|Sensory System Agents|sensory system agents|mesh-ancestor
6036708|NCT00504660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6457647|NCT00437385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6036709|NCT00504660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036710|NCT00504660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6036711|NCT00504660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6036712|NCT00504660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6036713|NCT00504660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6036714|NCT00504660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6036715|NCT00504725|Ketamine|ketamine|mesh-list
6036716|NCT00504725|Analgesics|analgesics|mesh-ancestor
6036717|NCT00504725|Sensory System Agents|sensory system agents|mesh-ancestor
6036718|NCT00504725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6036719|NCT00504725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036720|NCT00504725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6036721|NCT00504725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6036722|NCT00504725|Anesthetics, General|anesthetics, general|mesh-ancestor
6036723|NCT00504725|Anesthetics|anesthetics|mesh-ancestor
6036724|NCT00504725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6036725|NCT00504725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6036726|NCT00504725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6036727|NCT00504725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6036728|NCT00504725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6036729|NCT00504751|Dexamethasone|dexamethasone|mesh-list
6036730|NCT00504751|Rituximab|rituximab|mesh-list
6036731|NCT00504751|Etoposide|etoposide|mesh-list
6036732|NCT00504751|Bortezomib|bortezomib|mesh-list
6036733|NCT00504751|Ifosfamide|ifosfamide|mesh-list
6036734|NCT00504751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6036735|NCT00504751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6036736|NCT00504751|Antiemetics|antiemetics|mesh-ancestor
6036737|NCT00504751|Autonomic Agents|autonomic agents|mesh-ancestor
5495377|NCT04524026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495378|NCT04524130|Lidocaine|lidocaine|mesh-list
5495379|NCT04524130|Ketamine|ketamine|mesh-list
5495380|NCT04524130|Anesthetics, Local|anesthetics, local|mesh-ancestor
5495381|NCT04524130|Anesthetics|anesthetics|mesh-ancestor
5495382|NCT04524130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5495383|NCT04524130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495384|NCT04524130|Sensory System Agents|sensory system agents|mesh-ancestor
5495385|NCT04524130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5495386|NCT04524130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5495387|NCT04524130|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5495388|NCT04524130|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5495389|NCT04524130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5495390|NCT04524130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495391|NCT04524130|Analgesics|analgesics|mesh-ancestor
5495392|NCT04524130|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5495393|NCT04524130|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5495394|NCT04524130|Anesthetics, General|anesthetics, general|mesh-ancestor
5495395|NCT04524130|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5495396|NCT04524130|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5495397|NCT04524130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5495398|NCT04523844|Brimonidine Tartrate|brimonidine tartrate|mesh-list
5495399|NCT04523844|Brinzolamide|brinzolamide|mesh-list
5495400|NCT04523844|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5495401|NCT04523844|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5495402|NCT04523844|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5495403|NCT04523844|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5495404|NCT04523844|Adrenergic Agents|adrenergic agents|mesh-ancestor
5495405|NCT04523844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5495406|NCT04523844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495407|NCT04523844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495408|NCT04523844|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5495409|NCT04523844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5495410|NCT04523818|Fluorouracil|fluorouracil|mesh-list
5495411|NCT04523818|Capecitabine|capecitabine|mesh-list
5495412|NCT04523818|Antimetabolites|antimetabolites|mesh-ancestor
5495413|NCT04523818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495414|NCT04523818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5495415|NCT04523818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5495416|NCT04523818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5495417|NCT04523818|Immunologic Factors|immunologic factors|mesh-ancestor
5495418|NCT04523818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495419|NCT04523792|Buprenorphine|buprenorphine|mesh-list
5495420|NCT04523792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6036738|NCT00504751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6664652|NCT01513174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6036739|NCT00504751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036740|NCT00504751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6036741|NCT00504751|Glucocorticoids|glucocorticoids|mesh-ancestor
6036742|NCT00504751|Hormones|hormones|mesh-ancestor
6036743|NCT00504751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6036744|NCT00504751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6036745|NCT00504751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6036746|NCT00504751|Immunologic Factors|immunologic factors|mesh-ancestor
6036747|NCT00504751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6036748|NCT00504751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6036749|NCT00504751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6036750|NCT00504751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6036751|NCT00504751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6036752|NCT00504751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6036753|NCT00504751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6036754|NCT00504751|Alkylating Agents|alkylating agents|mesh-ancestor
6036755|NCT00504777|Rituximab|rituximab|mesh-list
5495421|NCT04523792|Narcotics|narcotics|mesh-ancestor
5495422|NCT04523792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5495423|NCT04523792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495424|NCT04523792|Analgesics|analgesics|mesh-ancestor
5495425|NCT04523792|Sensory System Agents|sensory system agents|mesh-ancestor
6036756|NCT00504777|Methotrexate|methotrexate|mesh-list
6036757|NCT00504777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6036758|NCT00504777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6036759|NCT00504777|Immunologic Factors|immunologic factors|mesh-ancestor
6036760|NCT00504777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036761|NCT00504777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6036762|NCT00504777|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5495426|NCT04523792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5495427|NCT04523792|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5495428|NCT04523740|Acetaminophen|acetaminophen|mesh-list
5495429|NCT04523740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5495430|NCT04523740|Analgesics|analgesics|mesh-ancestor
5495431|NCT04523740|Sensory System Agents|sensory system agents|mesh-ancestor
5495432|NCT04523740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5495433|NCT04523740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495434|NCT04523740|Antipyretics|antipyretics|mesh-ancestor
5495435|NCT04523623|Ibuprofen|ibuprofen|mesh-list
5495436|NCT04523623|Oxycodone|oxycodone|mesh-list
5495437|NCT04523623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5495438|NCT04523623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5495439|NCT04523623|Analgesics|analgesics|mesh-ancestor
5495440|NCT04523623|Sensory System Agents|sensory system agents|mesh-ancestor
5495441|NCT04523623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5495442|NCT04523623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495443|NCT04523623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5495444|NCT04523623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5495445|NCT04523623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5495446|NCT04523623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6036763|NCT00504777|Abortifacient Agents|abortifacient agents|mesh-ancestor
6036764|NCT00504777|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6036765|NCT00504777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6036766|NCT00504777|Antimetabolites|antimetabolites|mesh-ancestor
6036767|NCT00504777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6036768|NCT00504777|Dermatologic Agents|dermatologic agents|mesh-ancestor
6036769|NCT00504777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6036770|NCT00504777|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6036771|NCT00504777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6036772|NCT00504777|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6036773|NCT00504829|Atorvastatin|atorvastatin|mesh-list
6036774|NCT00504829|Fenofibrate|fenofibrate|mesh-list
6036775|NCT00504829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6036776|NCT00504829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6036777|NCT00504829|Antimetabolites|antimetabolites|mesh-ancestor
6036778|NCT00504829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6036779|NCT00504829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6036780|NCT00504829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6036781|NCT00504829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6036782|NCT00504881|Brivaracetam|brivaracetam|mesh-list
6036783|NCT00504881|Anticonvulsants|anticonvulsants|mesh-ancestor
6036784|NCT00504894|Thiopental|thiopental|mesh-list
5495447|NCT04523623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495448|NCT04523623|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6036785|NCT00504894|Propofol|propofol|mesh-list
6036786|NCT00504894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6036787|NCT00504894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6036788|NCT00504894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036789|NCT00504894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6036790|NCT00504894|Anesthetics, General|anesthetics, general|mesh-ancestor
6036791|NCT00504894|Anesthetics|anesthetics|mesh-ancestor
6036792|NCT00504894|Anticonvulsants|anticonvulsants|mesh-ancestor
6036793|NCT00504894|GABA Modulators|gaba modulators|mesh-ancestor
6036794|NCT00504894|GABA Agents|gaba agents|mesh-ancestor
6036795|NCT00504894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6036796|NCT00504894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6036797|NCT00505375|Abatacept|abatacept|mesh-list
6036798|NCT00505375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6036799|NCT00505375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6036800|NCT00505375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6036801|NCT00505375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6457648|NCT00437385|Antimanic Agents|antimanic agents|mesh-ancestor
6457649|NCT00437385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6457650|NCT00437385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6457651|NCT00437385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457652|NCT00437450|Epoetin Alfa|epoetin alfa|mesh-list
6457653|NCT00437450|Hematinics|hematinics|mesh-ancestor
6036802|NCT00505375|Immunologic Factors|immunologic factors|mesh-ancestor
6036803|NCT00505375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036804|NCT00505375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6036805|NCT00505414|Morphine|morphine|mesh-list
6036806|NCT00505414|Tapentadol|tapentadol|mesh-list
6036807|NCT00505414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6036808|NCT00505414|Narcotics|narcotics|mesh-ancestor
6036809|NCT00505414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6036810|NCT00505414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036811|NCT00505414|Analgesics|analgesics|mesh-ancestor
6036812|NCT00505414|Sensory System Agents|sensory system agents|mesh-ancestor
6036813|NCT00505414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6036814|NCT00505414|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6036815|NCT00505414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6036816|NCT00505414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6036817|NCT00505414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6036818|NCT00505414|Adrenergic Agents|adrenergic agents|mesh-ancestor
6036819|NCT00505414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6036820|NCT00505518|Psychotropic Drugs|psychotropic drugs|mesh-list
6036821|NCT00505635|Interferons|interferons|mesh-list
6036822|NCT00505635|Interferon-alpha|interferon-alpha|mesh-list
6036823|NCT00505635|Interferon alpha-2|interferon alpha-2|mesh-list
6036824|NCT00505635|Thalidomide|thalidomide|mesh-list
6036825|NCT00505635|Cisplatin|cisplatin|mesh-list
6036826|NCT00505635|Temozolomide|temozolomide|mesh-list
6036827|NCT00505635|Interleukin-2|interleukin-2|mesh-list
6036828|NCT00505635|Vinblastine|vinblastine|mesh-list
6036829|NCT00505635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6036830|NCT00505635|Antiviral Agents|antiviral agents|mesh-ancestor
6036831|NCT00505635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6036832|NCT00505635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6036833|NCT00505635|Alkylating Agents|alkylating agents|mesh-ancestor
6036834|NCT00505635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495449|NCT04523623|Narcotics|narcotics|mesh-ancestor
5495450|NCT04523623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5495451|NCT04523662|Apatinib|apatinib|mesh-list
5495452|NCT04523662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5495453|NCT04523662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5495454|NCT04523662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5495455|NCT04523662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6036835|NCT00505635|Immunologic Factors|immunologic factors|mesh-ancestor
6036836|NCT00505635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036837|NCT00505635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6036838|NCT00505635|Analgesics|analgesics|mesh-ancestor
6036839|NCT00505635|Sensory System Agents|sensory system agents|mesh-ancestor
6036840|NCT00505635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6036841|NCT00505635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6036842|NCT00505635|Leprostatic Agents|leprostatic agents|mesh-ancestor
6036843|NCT00505635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6036844|NCT00505635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6036845|NCT00505635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5495456|NCT04523493|Lenvatinib|lenvatinib|mesh-list
6036846|NCT00505635|Growth Substances|growth substances|mesh-ancestor
6457654|NCT00437463|Ramipril|ramipril|mesh-list
6036847|NCT00505635|Growth Inhibitors|growth inhibitors|mesh-ancestor
6036848|NCT00505635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6036849|NCT00505635|Tubulin Modulators|tubulin modulators|mesh-ancestor
6036850|NCT00505635|Antimitotic Agents|antimitotic agents|mesh-ancestor
5495457|NCT04523493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5495458|NCT04523493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5495459|NCT04523493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6036851|NCT00505635|Mitosis Modulators|mitosis modulators|mesh-ancestor
6036852|NCT00505661|Letrozole|letrozole|mesh-list
6036853|NCT00505661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6036854|NCT00505661|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6036855|NCT00505661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6036856|NCT00505661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6036857|NCT00505661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6036858|NCT00505661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6036859|NCT00505661|Hormone Antagonists|hormone antagonists|mesh-ancestor
6036860|NCT00505661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6036861|NCT00505661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036862|NCT00505687|Rotigotine|rotigotine|mesh-list
6036863|NCT00505687|Dopamine Agonists|dopamine agonists|mesh-ancestor
6036864|NCT00505687|Dopamine Agents|dopamine agents|mesh-ancestor
6036865|NCT00505687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6036866|NCT00505687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6036867|NCT00505687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036868|NCT00505752|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6036869|NCT00505752|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6036870|NCT00505752|Hormones|hormones|mesh-ancestor
6036871|NCT00505752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6036872|NCT00505752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036873|NCT00505752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6036874|NCT00505778|Mesalamine|mesalamine|mesh-list
5495460|NCT04523493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495461|NCT04523675|Acetylcysteine|acetylcysteine|mesh-list
5495462|NCT04523675|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5495463|NCT04523675|Antiviral Agents|antiviral agents|mesh-ancestor
5495464|NCT04523675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5495465|NCT04523675|Expectorants|expectorants|mesh-ancestor
6036875|NCT00505778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6036876|NCT00505778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6036877|NCT00505778|Analgesics|analgesics|mesh-ancestor
6036878|NCT00505778|Sensory System Agents|sensory system agents|mesh-ancestor
6036879|NCT00505778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6036880|NCT00505778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036881|NCT00505778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6036882|NCT00505778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6036883|NCT00505895|Vidarabine|vidarabine|mesh-list
6036884|NCT00505895|Rituximab|rituximab|mesh-list
6036885|NCT00505895|Fludarabine|fludarabine|mesh-list
6036886|NCT00505895|Fludarabine phosphate|fludarabine phosphate|mesh-list
6036887|NCT00505895|Melphalan|melphalan|mesh-list
6036888|NCT00505895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6036889|NCT00505895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6036890|NCT00505895|Immunologic Factors|immunologic factors|mesh-ancestor
6036891|NCT00505895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036892|NCT00505895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6036893|NCT00505895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6036894|NCT00505895|Antimetabolites|antimetabolites|mesh-ancestor
6036895|NCT00505895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6036896|NCT00505895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6036897|NCT00505895|Antiviral Agents|antiviral agents|mesh-ancestor
6036898|NCT00505895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6036899|NCT00505895|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6036900|NCT00505895|Alkylating Agents|alkylating agents|mesh-ancestor
6036901|NCT00505895|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6036902|NCT00505921|Cytarabine|cytarabine|mesh-list
6036903|NCT00505921|Cyclophosphamide|cyclophosphamide|mesh-list
6036904|NCT00505921|Melphalan|melphalan|mesh-list
6036905|NCT00505921|Carmustine|carmustine|mesh-list
6036906|NCT00505921|Fludarabine|fludarabine|mesh-list
6036907|NCT00505921|Fludarabine phosphate|fludarabine phosphate|mesh-list
6036908|NCT00505921|Etoposide|etoposide|mesh-list
6036909|NCT00505921|Etoposide phosphate|etoposide phosphate|mesh-list
6036910|NCT00505921|Molgramostim|molgramostim|mesh-list
5495466|NCT04523675|Respiratory System Agents|respiratory system agents|mesh-ancestor
6036911|NCT00505921|Alemtuzumab|alemtuzumab|mesh-list
6036912|NCT00505921|Lenograstim|lenograstim|mesh-list
6036913|NCT00505921|Sargramostim|sargramostim|mesh-list
6036914|NCT00505921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6036915|NCT00505921|Immunologic Factors|immunologic factors|mesh-ancestor
6036916|NCT00505921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036917|NCT00505921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6036918|NCT00505921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6036919|NCT00505921|Alkylating Agents|alkylating agents|mesh-ancestor
6036920|NCT00505921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6036921|NCT00505921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6036922|NCT00505921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6036923|NCT00505921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6036924|NCT00505921|Antimetabolites|antimetabolites|mesh-ancestor
5495467|NCT04523675|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5495468|NCT04523675|Antioxidants|antioxidants|mesh-ancestor
5495469|NCT04523675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495470|NCT04523675|Protective Agents|protective agents|mesh-ancestor
6036925|NCT00505921|Antiviral Agents|antiviral agents|mesh-ancestor
6036926|NCT00505921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6036927|NCT00505921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6036928|NCT00505921|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6036929|NCT00505921|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6036930|NCT00505921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5495471|NCT04523675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495472|NCT04523675|Antidotes|antidotes|mesh-ancestor
5495473|NCT04523701|SMOFlipid|smoflipid|mesh-list
5495474|NCT04523701|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
5495475|NCT04523701|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6036931|NCT00505921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6036932|NCT00505921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6036933|NCT00505934|Levetiracetam|levetiracetam|mesh-list
6036934|NCT00505934|Anticonvulsants|anticonvulsants|mesh-ancestor
6036935|NCT00505934|Nootropic Agents|nootropic agents|mesh-ancestor
6036936|NCT00506129|Vidarabine|vidarabine|mesh-list
6036937|NCT00506129|Fludarabine|fludarabine|mesh-list
6036938|NCT00506129|Fludarabine phosphate|fludarabine phosphate|mesh-list
6036939|NCT00506129|Melphalan|melphalan|mesh-list
6036940|NCT00506129|Thymoglobulin|thymoglobulin|mesh-list
6036941|NCT00506129|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6036942|NCT00506129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6036943|NCT00506129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6036944|NCT00506129|Antimetabolites|antimetabolites|mesh-ancestor
6036945|NCT00506129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6036946|NCT00506129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6036947|NCT00506129|Immunologic Factors|immunologic factors|mesh-ancestor
6036948|NCT00506129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036949|NCT00506129|Antiviral Agents|antiviral agents|mesh-ancestor
6036950|NCT00506129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6036951|NCT00506129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6036952|NCT00506129|Alkylating Agents|alkylating agents|mesh-ancestor
6036953|NCT00506129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6036954|NCT00506142|Vincristine|vincristine|mesh-list
6036955|NCT00506142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6036956|NCT00506142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6036957|NCT00506142|Tubulin Modulators|tubulin modulators|mesh-ancestor
6036958|NCT00506142|Antimitotic Agents|antimitotic agents|mesh-ancestor
6036959|NCT00506142|Mitosis Modulators|mitosis modulators|mesh-ancestor
6036960|NCT00506142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6036961|NCT00506155|Bevacizumab|bevacizumab|mesh-list
6036962|NCT00506155|Cisplatin|cisplatin|mesh-list
6036963|NCT00506155|Doxorubicin|doxorubicin|mesh-list
6036964|NCT00506155|Methotrexate|methotrexate|mesh-list
6036965|NCT00506155|Vinblastine|vinblastine|mesh-list
6036966|NCT00506155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6036967|NCT00506155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6036968|NCT00506155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6036969|NCT00506155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6036970|NCT00506155|Growth Substances|growth substances|mesh-ancestor
6036971|NCT00506155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036972|NCT00506155|Growth Inhibitors|growth inhibitors|mesh-ancestor
6036973|NCT00506155|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6036974|NCT00506155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6036975|NCT00506155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6036976|NCT00506155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6036977|NCT00506155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6036978|NCT00506155|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5495476|NCT04523701|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6036979|NCT00506155|Abortifacient Agents|abortifacient agents|mesh-ancestor
6036980|NCT00506155|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6036981|NCT00506155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6036982|NCT00506155|Antimetabolites|antimetabolites|mesh-ancestor
6036983|NCT00506155|Dermatologic Agents|dermatologic agents|mesh-ancestor
6036984|NCT00506155|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6036985|NCT00506155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6036986|NCT00506155|Immunologic Factors|immunologic factors|mesh-ancestor
6036987|NCT00506155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6036988|NCT00506155|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6036989|NCT00506155|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6036990|NCT00506155|Tubulin Modulators|tubulin modulators|mesh-ancestor
5495477|NCT04524000|Fulvestrant|fulvestrant|mesh-list
5495478|NCT04524000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5495479|NCT04524000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5495480|NCT04524000|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5495481|NCT04524000|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5495482|NCT04524000|Hormone Antagonists|hormone antagonists|mesh-ancestor
6036991|NCT00506155|Antimitotic Agents|antimitotic agents|mesh-ancestor
6036992|NCT00506155|Mitosis Modulators|mitosis modulators|mesh-ancestor
6036993|NCT00506285|Methylphenidate|methylphenidate|mesh-list
6036994|NCT00506285|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6036995|NCT00506285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6036996|NCT00506285|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6036997|NCT00506285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6036998|NCT00506285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6036999|NCT00506285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037000|NCT00506285|Dopamine Agents|dopamine agents|mesh-ancestor
6037001|NCT00506285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6037002|NCT00506350|Vaccines|vaccines|mesh-list
6037003|NCT00506350|Immunologic Factors|immunologic factors|mesh-ancestor
6037004|NCT00506350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6037005|NCT00506389|Mirtazapine|mirtazapine|mesh-list
6037006|NCT00506389|Antidepressive Agents|antidepressive agents|mesh-ancestor
6037007|NCT00506389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6037008|NCT00506389|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5495483|NCT04524000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5495484|NCT04524000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495485|NCT04523688|Temozolomide|temozolomide|mesh-list
5495486|NCT04523688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5495487|NCT04523688|Alkylating Agents|alkylating agents|mesh-ancestor
5495488|NCT04523688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495489|NCT04523688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5495490|NCT04523467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
5724979|NCT03183674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724980|NCT03183596|Dexamethasone|dexamethasone|mesh-list
6037009|NCT00506389|Histamine Antagonists|histamine antagonists|mesh-ancestor
6037010|NCT00506389|Histamine Agents|histamine agents|mesh-ancestor
6037011|NCT00506389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6037012|NCT00506389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037013|NCT00506389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6037014|NCT00506389|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6037015|NCT00506389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6037016|NCT00506389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6037017|NCT00506389|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6037018|NCT00506389|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6037019|NCT00506389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6037020|NCT00506389|Adrenergic Agents|adrenergic agents|mesh-ancestor
6457655|NCT00437463|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6457656|NCT00437463|Protease Inhibitors|protease inhibitors|mesh-ancestor
6457657|NCT00437463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6457658|NCT00437463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457659|NCT00437463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6457660|NCT00437476|Ribavirin|ribavirin|mesh-list
6457661|NCT00437476|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6457662|NCT00437476|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
6457663|NCT00437476|Antimetabolites|antimetabolites|mesh-ancestor
5724981|NCT03183596|Bupivacaine|bupivacaine|mesh-list
5724982|NCT03183596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5724983|NCT03183596|Antiemetics|antiemetics|mesh-ancestor
5724984|NCT03183596|Autonomic Agents|autonomic agents|mesh-ancestor
5724985|NCT03183596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5724986|NCT03183596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495491|NCT04523467|Ginsenoside Rg3|ginsenoside rg3|mesh-list
5495492|NCT04523467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5495493|NCT04523467|Growth Substances|growth substances|mesh-ancestor
5495494|NCT04523467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495495|NCT04523467|Growth Inhibitors|growth inhibitors|mesh-ancestor
5495496|NCT04523467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5495497|NCT04523467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5495498|NCT04523506|Botulinum Toxins|botulinum toxins|mesh-list
5495499|NCT04523506|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5495500|NCT04523506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5495501|NCT04523506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495502|NCT04523506|Cholinergic Agents|cholinergic agents|mesh-ancestor
5495503|NCT04523506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5495504|NCT04523506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495505|NCT04523233|Vitamins|vitamins|mesh-list
5495506|NCT04523233|Micronutrients|micronutrients|mesh-ancestor
5495507|NCT04523233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503233|NCT04460781|Vaccines|vaccines|mesh-list
5503234|NCT04460781|Immunologic Factors|immunologic factors|mesh-ancestor
5503235|NCT04460781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503236|NCT04460820|Doxorubicin|doxorubicin|mesh-list
5503237|NCT04460820|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5503238|NCT04460820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5503239|NCT04460820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5503240|NCT04460820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6037021|NCT00506389|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6037022|NCT00506389|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6037023|NCT00506389|Serotonin Agents|serotonin agents|mesh-ancestor
6037024|NCT00506389|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6037025|NCT00506415|Rivastigmine|rivastigmine|mesh-list
6037026|NCT00506415|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6037027|NCT00506415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5503241|NCT04460820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5503242|NCT04460820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5503243|NCT04460820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503244|NCT04460924|Integrase Inhibitors|integrase inhibitors|mesh-list
5503245|NCT04460924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5503246|NCT04460924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503653|NCT04456985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503654|NCT04456985|Hematinics|hematinics|mesh-ancestor
5503655|NCT04456985|Vitamin B Complex|vitamin b complex|mesh-ancestor
5503656|NCT04456803|Sevelamer|sevelamer|mesh-list
5503657|NCT04456803|Chelating Agents|chelating agents|mesh-ancestor
5503658|NCT04456803|Sequestering Agents|sequestering agents|mesh-ancestor
5503659|NCT04456803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503660|NCT04456946|Salicylic Acid|salicylic acid|mesh-list
5503661|NCT04456946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5503662|NCT04456946|Antifungal Agents|antifungal agents|mesh-ancestor
5503663|NCT04456946|Keratolytic Agents|keratolytic agents|mesh-ancestor
6037028|NCT00506415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037029|NCT00506415|Cholinergic Agents|cholinergic agents|mesh-ancestor
6037030|NCT00506415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6037031|NCT00506415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6037032|NCT00506415|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6037033|NCT00506415|Protective Agents|protective agents|mesh-ancestor
6037034|NCT00506519|Antithrombins|antithrombins|mesh-list
6037035|NCT00506519|Antithrombin III|antithrombin iii|mesh-list
6037036|NCT00506519|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6037037|NCT00506519|Protease Inhibitors|protease inhibitors|mesh-ancestor
6037038|NCT00506519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6037039|NCT00506519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037040|NCT00506519|Anticoagulants|anticoagulants|mesh-ancestor
6037041|NCT00506597|Asparaginase|asparaginase|mesh-list
6037042|NCT00506597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6037043|NCT00506662|Insulin|insulin|mesh-list
6037044|NCT00506662|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6037045|NCT00506662|Insulin Detemir|insulin detemir|mesh-list
6037046|NCT00506662|Isophane Insulin, Human|isophane insulin, human|mesh-list
6037047|NCT00506662|Insulin, Isophane|insulin, isophane|mesh-list
6037048|NCT00506662|Isophane insulin, beef|isophane insulin, beef|mesh-list
6037049|NCT00506662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6037050|NCT00506662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6037051|NCT00506675|Atropine|atropine|mesh-list
6037052|NCT00506675|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5503664|NCT04456946|Dermatologic Agents|dermatologic agents|mesh-ancestor
5503665|NCT04456829|Resveratrol|resveratrol|mesh-list
5495508|NCT04523428|Venetoclax|venetoclax|mesh-list
5495509|NCT04523428|Acalabrutinib|acalabrutinib|mesh-list
5495510|NCT04523428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5495511|NCT04523272|Sunitinib|sunitinib|mesh-list
5495512|NCT04523272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5495513|NCT04523272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5495514|NCT04523272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5495515|NCT04523272|Growth Substances|growth substances|mesh-ancestor
5495516|NCT04523272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495517|NCT04523272|Growth Inhibitors|growth inhibitors|mesh-ancestor
5495518|NCT04523272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5495519|NCT04523272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6037053|NCT00506675|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6037054|NCT00506675|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6037055|NCT00506675|Autonomic Agents|autonomic agents|mesh-ancestor
6037056|NCT00506675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6037057|NCT00506675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6037058|NCT00506675|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6037059|NCT00506675|Respiratory System Agents|respiratory system agents|mesh-ancestor
6037060|NCT00506675|Mydriatics|mydriatics|mesh-ancestor
6037061|NCT00506675|Parasympatholytics|parasympatholytics|mesh-ancestor
6037062|NCT00506675|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6037063|NCT00506675|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6037064|NCT00506675|Cholinergic Agents|cholinergic agents|mesh-ancestor
6037065|NCT00506675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6037066|NCT00506675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037067|NCT00506779|Paclitaxel|paclitaxel|mesh-list
6037068|NCT00506779|Imatinib Mesylate|imatinib mesylate|mesh-list
6037069|NCT00506779|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6037070|NCT00506779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6037071|NCT00506779|Tubulin Modulators|tubulin modulators|mesh-ancestor
6037072|NCT00506779|Antimitotic Agents|antimitotic agents|mesh-ancestor
6037073|NCT00506779|Mitosis Modulators|mitosis modulators|mesh-ancestor
6037074|NCT00506779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037075|NCT00506779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6037076|NCT00506779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6037077|NCT00506831|Imatinib Mesylate|imatinib mesylate|mesh-list
6037078|NCT00506831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6037079|NCT00506831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5495520|NCT04523272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495521|NCT04523077|Antibodies|antibodies|mesh-list
5495522|NCT04523077|Hormones|hormones|mesh-list
5495523|NCT04523077|Immunologic Factors|immunologic factors|mesh-ancestor
5495524|NCT04523077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495525|NCT04523077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5495526|NCT04523142|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5495527|NCT04523142|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5495528|NCT04523090|Nitazoxanide|nitazoxanide|mesh-list
5495529|NCT04523090|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5495530|NCT04523090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5495531|NCT04522882|Insulin|insulin|mesh-list
5495532|NCT04522882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5495533|NCT04522882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495534|NCT04523064|Empagliflozin|empagliflozin|mesh-list
5495535|NCT04523064|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5495536|NCT04523064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495537|NCT04523064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5495538|NCT04523064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6037080|NCT00506831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6037081|NCT00506831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037082|NCT00506857|Vidarabine|vidarabine|mesh-list
6037083|NCT00506857|Fludarabine|fludarabine|mesh-list
6037084|NCT00506857|Fludarabine phosphate|fludarabine phosphate|mesh-list
6037085|NCT00506857|Busulfan|busulfan|mesh-list
6037086|NCT00506857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6037087|NCT00506857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6037088|NCT00506857|Antimetabolites|antimetabolites|mesh-ancestor
6037089|NCT00506857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037090|NCT00506857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6037091|NCT00506857|Immunologic Factors|immunologic factors|mesh-ancestor
6037092|NCT00506857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6037093|NCT00506857|Antiviral Agents|antiviral agents|mesh-ancestor
6037094|NCT00506857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6037095|NCT00506857|Alkylating Agents|alkylating agents|mesh-ancestor
5495539|NCT04522661|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5503247|NCT04460807|Exemestane|exemestane|mesh-list
6037096|NCT00506857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6037097|NCT00506857|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6037098|NCT00506883|Colchicine|colchicine|mesh-list
6037099|NCT00506883|Gout Suppressants|gout suppressants|mesh-ancestor
6037100|NCT00506883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6037101|NCT00506883|Tubulin Modulators|tubulin modulators|mesh-ancestor
6037102|NCT00506883|Antimitotic Agents|antimitotic agents|mesh-ancestor
6037103|NCT00506883|Mitosis Modulators|mitosis modulators|mesh-ancestor
6037104|NCT00506883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037105|NCT00506883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6037106|NCT00506922|Methotrexate|methotrexate|mesh-list
6037107|NCT00506922|Pentostatin|pentostatin|mesh-list
6037108|NCT00506922|Tacrolimus|tacrolimus|mesh-list
6037109|NCT00506922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6037110|NCT00506922|Abortifacient Agents|abortifacient agents|mesh-ancestor
6037111|NCT00506922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6037112|NCT00506922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6037113|NCT00506922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6037114|NCT00506922|Antimetabolites|antimetabolites|mesh-ancestor
6037115|NCT00506922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037116|NCT00506922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6037117|NCT00506922|Dermatologic Agents|dermatologic agents|mesh-ancestor
6037118|NCT00506922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6037119|NCT00506922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5495540|NCT04522661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5495541|NCT04522739|Spironolactone|spironolactone|mesh-list
5495542|NCT04522739|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5495543|NCT04522739|Hormone Antagonists|hormone antagonists|mesh-ancestor
5495544|NCT04522739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5495545|NCT04522739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6037120|NCT00506922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6037121|NCT00506922|Immunologic Factors|immunologic factors|mesh-ancestor
6037122|NCT00506922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6037123|NCT00506922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6037124|NCT00506922|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6037125|NCT00506922|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
6037126|NCT00506948|Mycophenolic Acid|mycophenolic acid|mesh-list
6037127|NCT00506948|Sirolimus|sirolimus|mesh-list
6037128|NCT00506948|Thymoglobulin|thymoglobulin|mesh-list
6037129|NCT00506948|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6037130|NCT00506948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6037131|NCT00506948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6037132|NCT00506948|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6037133|NCT00506948|Antitubercular Agents|antitubercular agents|mesh-ancestor
6037134|NCT00506948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6037135|NCT00506948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6037136|NCT00506948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6037137|NCT00506948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037138|NCT00506948|Antifungal Agents|antifungal agents|mesh-ancestor
6037139|NCT00506948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6037140|NCT00506948|Immunologic Factors|immunologic factors|mesh-ancestor
6037141|NCT00506948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495546|NCT04522739|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5495547|NCT04522739|Diuretics|diuretics|mesh-ancestor
5495548|NCT04522739|Natriuretic Agents|natriuretic agents|mesh-ancestor
6037142|NCT00507026|Diclofenac|diclofenac|mesh-list
6037143|NCT00507026|Ketorolac|ketorolac|mesh-list
6037144|NCT00507026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6037145|NCT00507026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6037146|NCT00507026|Analgesics|analgesics|mesh-ancestor
6037147|NCT00507026|Sensory System Agents|sensory system agents|mesh-ancestor
6037148|NCT00507026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6037149|NCT00507026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6037150|NCT00507026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6037151|NCT00507026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5495549|NCT04522622|Teriparatide|teriparatide|mesh-list
5495550|NCT04522622|Listerine|listerine|mesh-list
5495551|NCT04522622|Fluorides|fluorides|mesh-list
5495552|NCT04522622|Sodium Fluoride|sodium fluoride|mesh-list
5495553|NCT04522622|Cariostatic Agents|cariostatic agents|mesh-ancestor
5495554|NCT04522622|Protective Agents|protective agents|mesh-ancestor
5495555|NCT04522622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495556|NCT04522622|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6037152|NCT00507026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6037153|NCT00507026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6462221|NCT00458185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6037154|NCT00507026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037155|NCT00507416|Thalidomide|thalidomide|mesh-list
6037156|NCT00507416|Dexamethasone|dexamethasone|mesh-list
6037157|NCT00507416|Prednisone|prednisone|mesh-list
6037158|NCT00507416|Bortezomib|bortezomib|mesh-list
6037159|NCT00507416|Melphalan|melphalan|mesh-list
6037160|NCT00507416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6037161|NCT00507416|Antiemetics|antiemetics|mesh-ancestor
6037162|NCT00507416|Autonomic Agents|autonomic agents|mesh-ancestor
6037163|NCT00507416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5495557|NCT04522622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5495558|NCT04522622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5495559|NCT04522622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5495560|NCT04522544|Durvalumab|durvalumab|mesh-list
5495561|NCT04522544|Tremelimumab|tremelimumab|mesh-list
5495562|NCT04522544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5495563|NCT04522544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6037164|NCT00507416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6037165|NCT00507416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6457664|NCT00437476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457665|NCT00437476|Antiviral Agents|antiviral agents|mesh-ancestor
6457666|NCT00437476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6457667|NCT00437476|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6457668|NCT00437476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5495564|NCT04522336|Docetaxel|docetaxel|mesh-list
5495565|NCT04522336|Fluorouracil|fluorouracil|mesh-list
5495566|NCT04522336|Pembrolizumab|pembrolizumab|mesh-list
5495567|NCT04522336|Oxaliplatin|oxaliplatin|mesh-list
5495568|NCT04522336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5495569|NCT04522336|Tubulin Modulators|tubulin modulators|mesh-ancestor
5495570|NCT04522336|Antimitotic Agents|antimitotic agents|mesh-ancestor
5495571|NCT04522336|Mitosis Modulators|mitosis modulators|mesh-ancestor
5495572|NCT04522336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495573|NCT04522336|Antimetabolites|antimetabolites|mesh-ancestor
5495574|NCT04522336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5495575|NCT04522336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5495576|NCT04522336|Immunologic Factors|immunologic factors|mesh-ancestor
5495577|NCT04522336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457669|NCT00437502|Vaccines|vaccines|mesh-list
5495578|NCT04522336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5495579|NCT04522466|Hydroxychloroquine|hydroxychloroquine|mesh-list
5495580|NCT04522466|Antimalarials|antimalarials|mesh-ancestor
5495581|NCT04522466|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5495582|NCT04522466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5495583|NCT04522466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5495584|NCT04522466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5495585|NCT04522466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495586|NCT04522466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5495587|NCT04522297|Octreotide|octreotide|mesh-list
5495588|NCT04522297|Epinephrine|epinephrine|mesh-list
5495589|NCT04522297|Midodrine|midodrine|mesh-list
5495590|NCT04522297|Norepinephrine|norepinephrine|mesh-list
5495591|NCT04522297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5495592|NCT04522297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5495593|NCT04522297|Adrenergic Agents|adrenergic agents|mesh-ancestor
5495594|NCT04522297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5495595|NCT04522297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495596|NCT04522297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495597|NCT04522297|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5495598|NCT04522297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5495599|NCT04522297|Autonomic Agents|autonomic agents|mesh-ancestor
5495600|NCT04522297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5495601|NCT04522297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5495602|NCT04522297|Respiratory System Agents|respiratory system agents|mesh-ancestor
5495603|NCT04522297|Mydriatics|mydriatics|mesh-ancestor
5495604|NCT04522297|Sympathomimetics|sympathomimetics|mesh-ancestor
5495605|NCT04522297|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5495606|NCT04522297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5495607|NCT04522297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5495608|NCT04522297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5495609|NCT04522297|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5495610|NCT04522206|Oxycodone|oxycodone|mesh-list
5495611|NCT04522206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5495612|NCT04522206|Narcotics|narcotics|mesh-ancestor
5495613|NCT04522206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6037166|NCT00507416|Glucocorticoids|glucocorticoids|mesh-ancestor
6037167|NCT00507416|Hormones|hormones|mesh-ancestor
6457670|NCT00437502|Immunologic Factors|immunologic factors|mesh-ancestor
6037168|NCT00507416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6037169|NCT00507416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6037170|NCT00507416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6037171|NCT00507416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6037172|NCT00507416|Alkylating Agents|alkylating agents|mesh-ancestor
6037173|NCT00507416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037174|NCT00507416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6037175|NCT00507416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6037176|NCT00507416|Immunologic Factors|immunologic factors|mesh-ancestor
6037177|NCT00507416|Leprostatic Agents|leprostatic agents|mesh-ancestor
6037178|NCT00507416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6037179|NCT00507416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6037180|NCT00507416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5495614|NCT04522206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495615|NCT04522206|Analgesics|analgesics|mesh-ancestor
5495616|NCT04522206|Sensory System Agents|sensory system agents|mesh-ancestor
6037181|NCT00507416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6037182|NCT00507416|Growth Substances|growth substances|mesh-ancestor
6037183|NCT00507416|Growth Inhibitors|growth inhibitors|mesh-ancestor
6037184|NCT00507429|Paclitaxel|paclitaxel|mesh-list
6037185|NCT00507429|Fosbretabulin|fosbretabulin|mesh-list
6037186|NCT00507429|Combretastatin|combretastatin|mesh-list
6037187|NCT00507429|Carboplatin|carboplatin|mesh-list
6037188|NCT00507429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6037189|NCT00507429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6037190|NCT00507429|Tubulin Modulators|tubulin modulators|mesh-ancestor
6037191|NCT00507429|Antimitotic Agents|antimitotic agents|mesh-ancestor
6037192|NCT00507429|Mitosis Modulators|mitosis modulators|mesh-ancestor
6037193|NCT00507429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037194|NCT00507442|Dexamethasone|dexamethasone|mesh-list
6037195|NCT00507442|Cyclophosphamide|cyclophosphamide|mesh-list
6037196|NCT00507442|Lenalidomide|lenalidomide|mesh-list
6037197|NCT00507442|Bortezomib|bortezomib|mesh-list
6037198|NCT00507442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6037199|NCT00507442|Immunologic Factors|immunologic factors|mesh-ancestor
6037200|NCT00507442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6037201|NCT00507442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6037202|NCT00507442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6037203|NCT00507442|Alkylating Agents|alkylating agents|mesh-ancestor
6037204|NCT00507442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037205|NCT00507442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6037206|NCT00507442|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6037207|NCT00507442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6037208|NCT00507442|Antiemetics|antiemetics|mesh-ancestor
6037209|NCT00507442|Autonomic Agents|autonomic agents|mesh-ancestor
6037210|NCT00507442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6037211|NCT00507442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5495617|NCT04522206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5495618|NCT04521868|Sulforaphane|sulforaphane|mesh-list
5495619|NCT04521868|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5495620|NCT04521868|Protective Agents|protective agents|mesh-ancestor
5495621|NCT04521868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6037212|NCT00507442|Glucocorticoids|glucocorticoids|mesh-ancestor
6037213|NCT00507442|Hormones|hormones|mesh-ancestor
6037214|NCT00507442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6037215|NCT00507442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6037216|NCT00507442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6037217|NCT00507442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6037218|NCT00507442|Growth Substances|growth substances|mesh-ancestor
6037219|NCT00507442|Growth Inhibitors|growth inhibitors|mesh-ancestor
6037220|NCT00507455|Tamsulosin|tamsulosin|mesh-list
6457671|NCT00437502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457672|NCT00437554|Glimepiride|glimepiride|mesh-list
6457673|NCT00437554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6037221|NCT00507455|Solifenacin Succinate|solifenacin succinate|mesh-list
6037222|NCT00507455|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6037223|NCT00507455|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6037224|NCT00507455|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6037225|NCT00507455|Adrenergic Agents|adrenergic agents|mesh-ancestor
6037226|NCT00507455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6037227|NCT00507455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037228|NCT00507455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6037229|NCT00507455|Urological Agents|urological agents|mesh-ancestor
6037230|NCT00507455|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6037231|NCT00507455|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6037232|NCT00507455|Cholinergic Agents|cholinergic agents|mesh-ancestor
6037233|NCT00507507|Tenofovir|tenofovir|mesh-list
6037234|NCT00507507|Antiviral Agents|antiviral agents|mesh-ancestor
6037235|NCT00507507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5495622|NCT04521868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5495623|NCT04522050|Gemcitabine|gemcitabine|mesh-list
5495624|NCT04522050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5495625|NCT04522050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5495626|NCT04522050|Antimetabolites|antimetabolites|mesh-ancestor
5495627|NCT04522050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495628|NCT04522050|Antiviral Agents|antiviral agents|mesh-ancestor
5495629|NCT04522050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5495630|NCT04522050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5495631|NCT04522050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5495632|NCT04522050|Immunologic Factors|immunologic factors|mesh-ancestor
5495633|NCT04522050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495634|NCT04521946|Mycophenolic Acid|mycophenolic acid|mesh-list
5495635|NCT04521946|Fludarabine|fludarabine|mesh-list
5495636|NCT04521946|Fludarabine phosphate|fludarabine phosphate|mesh-list
5495637|NCT04521946|Etoposide|etoposide|mesh-list
5495638|NCT04521946|Etoposide phosphate|etoposide phosphate|mesh-list
5495639|NCT04521946|Melphalan|melphalan|mesh-list
5495640|NCT04521946|Mechlorethamine|mechlorethamine|mesh-list
5495641|NCT04521946|Thiotepa|thiotepa|mesh-list
5495642|NCT04521946|Podophyllotoxin|podophyllotoxin|mesh-list
5495643|NCT04521946|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
5495644|NCT04521946|Tacrolimus|tacrolimus|mesh-list
5495645|NCT04521946|Thymoglobulin|thymoglobulin|mesh-list
5495646|NCT04521946|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5495647|NCT04521946|Immunoglobulins|immunoglobulins|mesh-list
5495648|NCT04521946|Antibodies|antibodies|mesh-list
5495649|NCT04521946|gamma-Globulins|gamma-globulins|mesh-list
5495650|NCT04521946|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5495651|NCT04521946|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5495652|NCT04521946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5495653|NCT04521946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5495654|NCT04521946|Antimetabolites|antimetabolites|mesh-ancestor
5495655|NCT04521946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495656|NCT04521946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5495657|NCT04521946|Immunologic Factors|immunologic factors|mesh-ancestor
5495658|NCT04521946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495659|NCT04521946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5495660|NCT04521946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5495661|NCT04521946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6037236|NCT00507507|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6037237|NCT00507507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6037238|NCT00507507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6037239|NCT00507507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037240|NCT00507507|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6037241|NCT00507507|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6037242|NCT00507689|Immunoglobulins|immunoglobulins|mesh-list
6037243|NCT00507689|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6037244|NCT00507689|Antibodies|antibodies|mesh-list
6037245|NCT00507689|Immunologic Factors|immunologic factors|mesh-ancestor
6037246|NCT00507689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6037247|NCT00507728|Bupropion|bupropion|mesh-list
6037248|NCT00507728|Varenicline|varenicline|mesh-list
6037249|NCT00507728|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6037250|NCT00507728|Antidepressive Agents|antidepressive agents|mesh-ancestor
6037251|NCT00507728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6037252|NCT00507728|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6037253|NCT00507728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5495662|NCT04521946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6457674|NCT00437554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6037254|NCT00507728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6037255|NCT00507728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037256|NCT00507728|Dopamine Agents|dopamine agents|mesh-ancestor
6037257|NCT00507728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6037258|NCT00507728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6037259|NCT00507728|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6457675|NCT00437554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457676|NCT00437554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6457677|NCT00437554|Immunologic Factors|immunologic factors|mesh-ancestor
6457678|NCT00437606|Ethanol|ethanol|mesh-list
6457679|NCT00437606|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6457680|NCT00437606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6457681|NCT00437606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6457682|NCT00437606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457683|NCT00437619|Calcipotriene|calcipotriene|mesh-list
6457684|NCT00437619|Dermatologic Agents|dermatologic agents|mesh-ancestor
6457685|NCT00437632|Caffeine|caffeine|mesh-list
6457686|NCT00437632|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6037260|NCT00507728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6037261|NCT00507728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6037262|NCT00507728|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6037263|NCT00507728|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6037264|NCT00507728|Cholinergic Agents|cholinergic agents|mesh-ancestor
6037265|NCT00507767|Dasatinib|dasatinib|mesh-list
6037266|NCT00507767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6037267|NCT00507767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6037268|NCT00507767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6037269|NCT00507767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037270|NCT00507819|Sildenafil Citrate|sildenafil citrate|mesh-list
6037271|NCT00507819|Vasodilator Agents|vasodilator agents|mesh-ancestor
6037272|NCT00507819|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6037273|NCT00507819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6037274|NCT00507819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6037275|NCT00507819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037276|NCT00507819|Urological Agents|urological agents|mesh-ancestor
6037277|NCT00508027|Simvastatin|simvastatin|mesh-list
6037278|NCT00508027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6037279|NCT00508027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6037280|NCT00508027|Antimetabolites|antimetabolites|mesh-ancestor
6037281|NCT00508027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037282|NCT00508027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6037283|NCT00508027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6457687|NCT00437632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457688|NCT00437632|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5495663|NCT04521946|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6037284|NCT00508027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5495664|NCT04521946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5495665|NCT04521946|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5495666|NCT04521946|Antitubercular Agents|antitubercular agents|mesh-ancestor
5495667|NCT04521946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5495668|NCT04521946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6037285|NCT00508118|Nicardipine|nicardipine|mesh-list
6037286|NCT00508118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6037287|NCT00508118|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6037288|NCT00508118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6037289|NCT00508118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037290|NCT00508118|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6037291|NCT00508118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6037292|NCT00508118|Vasodilator Agents|vasodilator agents|mesh-ancestor
6037293|NCT00508144|Pemetrexed|pemetrexed|mesh-list
6037294|NCT00508144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6037295|NCT00508144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6037296|NCT00508144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037297|NCT00508144|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6037298|NCT00508144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6037299|NCT00508157|Olanzapine|olanzapine|mesh-list
6037300|NCT00508157|Risperidone|risperidone|mesh-list
6037301|NCT00508157|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6037302|NCT00508157|Aripiprazole|aripiprazole|mesh-list
6037303|NCT00508157|Antipsychotic Agents|antipsychotic agents|mesh-list
6037304|NCT00508157|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6037305|NCT00508157|Serotonin Agents|serotonin agents|mesh-ancestor
6037306|NCT00508157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6037307|NCT00508157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037308|NCT00508157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6037309|NCT00508157|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6037310|NCT00508157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6037311|NCT00508157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6037312|NCT00508157|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6037313|NCT00508157|Dopamine Agents|dopamine agents|mesh-ancestor
6037314|NCT00508157|Antiemetics|antiemetics|mesh-ancestor
6037315|NCT00508157|Autonomic Agents|autonomic agents|mesh-ancestor
6037316|NCT00508157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6037317|NCT00508157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6037318|NCT00508157|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6037319|NCT00508157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6037320|NCT00508157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6037321|NCT00508157|Antidepressive Agents|antidepressive agents|mesh-ancestor
6037322|NCT00508157|Dopamine Agonists|dopamine agonists|mesh-ancestor
6037323|NCT00508157|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6037324|NCT00508157|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6037325|NCT00508157|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6037326|NCT00508157|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6037327|NCT00508274|Capecitabine|capecitabine|mesh-list
6037328|NCT00508274|Lapatinib|lapatinib|mesh-list
6037329|NCT00508274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6037330|NCT00508274|Antimetabolites|antimetabolites|mesh-ancestor
6037331|NCT00508274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037332|NCT00508274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6037333|NCT00508274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6037334|NCT00508274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6037335|NCT00508404|Panitumumab|panitumumab|mesh-list
6037336|NCT00508404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6037337|NCT00508404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6037338|NCT00508469|Timolol|timolol|mesh-list
6037339|NCT00508469|Travoprost|travoprost|mesh-list
6037340|NCT00508469|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6037341|NCT00508469|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6037342|NCT00508469|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6037343|NCT00508469|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6037344|NCT00508469|Adrenergic Agents|adrenergic agents|mesh-ancestor
6037345|NCT00508469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6037346|NCT00508469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037347|NCT00508469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6037348|NCT00508469|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6037349|NCT00508469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6457689|NCT00437632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6457690|NCT00437632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457691|NCT00437632|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6037350|NCT00508482|Lactulose|lactulose|mesh-list
6037351|NCT00508482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6037352|NCT00508742|Vaccines|vaccines|mesh-list
6457692|NCT00437632|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6457693|NCT00437632|Purinergic Agents|purinergic agents|mesh-ancestor
6457694|NCT00437632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6037353|NCT00508742|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6037354|NCT00508742|Immunologic Factors|immunologic factors|mesh-ancestor
6037355|NCT00508742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6037356|NCT00508924|Heparin|heparin|mesh-list
6037357|NCT00508924|Argatroban|argatroban|mesh-list
6037358|NCT00508924|Anticoagulants|anticoagulants|mesh-ancestor
6037359|NCT00508924|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6037360|NCT00508924|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6037361|NCT00508924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037362|NCT00508924|Antithrombins|antithrombins|mesh-ancestor
6037363|NCT00508924|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6037364|NCT00508924|Protease Inhibitors|protease inhibitors|mesh-ancestor
6037365|NCT00508924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6037366|NCT00508924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6037367|NCT00509002|Gefitinib|gefitinib|mesh-list
6037368|NCT00509002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6037369|NCT00509002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6037370|NCT00509002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6037371|NCT00509002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037372|NCT00509028|Budesonide|budesonide|mesh-list
6037373|NCT00509028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6037374|NCT00509028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6037375|NCT00509028|Autonomic Agents|autonomic agents|mesh-ancestor
6037376|NCT00509028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6037377|NCT00509028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6037378|NCT00509028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6037379|NCT00509028|Respiratory System Agents|respiratory system agents|mesh-ancestor
6037380|NCT00509028|Glucocorticoids|glucocorticoids|mesh-ancestor
6037381|NCT00509028|Hormones|hormones|mesh-ancestor
6037382|NCT00509028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6037383|NCT00509041|Dasatinib|dasatinib|mesh-list
6037384|NCT00509041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6037385|NCT00509041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6037386|NCT00509041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6037387|NCT00509041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037388|NCT00509067|Olanzapine|olanzapine|mesh-list
6037389|NCT00509067|Risperidone|risperidone|mesh-list
6037390|NCT00509067|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6037391|NCT00509067|Aripiprazole|aripiprazole|mesh-list
6037392|NCT00509067|Ziprasidone|ziprasidone|mesh-list
6037393|NCT00509067|Choline|choline|mesh-list
6037394|NCT00509067|Galantamine|galantamine|mesh-list
6037395|NCT00509067|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
6037396|NCT00509067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6037397|NCT00509067|Serotonin Agents|serotonin agents|mesh-ancestor
6037398|NCT00509067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6037399|NCT00509067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037400|NCT00509067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6037401|NCT00509067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6037402|NCT00509067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6037403|NCT00509067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6037404|NCT00509067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6037405|NCT00509067|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6037406|NCT00509067|Dopamine Agents|dopamine agents|mesh-ancestor
6037407|NCT00509067|Antiemetics|antiemetics|mesh-ancestor
6037408|NCT00509067|Autonomic Agents|autonomic agents|mesh-ancestor
6037409|NCT00509067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6037410|NCT00509067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6037411|NCT00509067|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6037412|NCT00509067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6037413|NCT00509067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6037414|NCT00509067|Antidepressive Agents|antidepressive agents|mesh-ancestor
6037415|NCT00509067|Dopamine Agonists|dopamine agonists|mesh-ancestor
6037416|NCT00509067|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6037417|NCT00509067|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6037418|NCT00509067|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6037419|NCT00509067|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6037420|NCT00509067|Lipotropic Agents|lipotropic agents|mesh-ancestor
6037421|NCT00509067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5495669|NCT04521946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5495670|NCT04521946|Alkylating Agents|alkylating agents|mesh-ancestor
5495671|NCT04521946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5495672|NCT04521946|Keratolytic Agents|keratolytic agents|mesh-ancestor
5495673|NCT04521946|Dermatologic Agents|dermatologic agents|mesh-ancestor
5495674|NCT04521946|Tubulin Modulators|tubulin modulators|mesh-ancestor
5495675|NCT04521946|Antimitotic Agents|antimitotic agents|mesh-ancestor
5495676|NCT04521946|Mitosis Modulators|mitosis modulators|mesh-ancestor
5495677|NCT04522037|Morphine|morphine|mesh-list
5495678|NCT04522037|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5495679|NCT04522037|Narcotics|narcotics|mesh-ancestor
5495680|NCT04522037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5495681|NCT04522037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495682|NCT04522037|Analgesics|analgesics|mesh-ancestor
5495683|NCT04522037|Sensory System Agents|sensory system agents|mesh-ancestor
5495684|NCT04522037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5495685|NCT04521400|Interferons|interferons|mesh-list
5495686|NCT04521400|Ritonavir|ritonavir|mesh-list
5495687|NCT04521400|Lopinavir|lopinavir|mesh-list
5495688|NCT04521400|Interferon-beta|interferon-beta|mesh-list
5495689|NCT04521400|Interferon beta-1a|interferon beta-1a|mesh-list
5495690|NCT04521400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5495691|NCT04521400|Antiviral Agents|antiviral agents|mesh-ancestor
5495692|NCT04521400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6037422|NCT00509067|Antimetabolites|antimetabolites|mesh-ancestor
6037423|NCT00509067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6037424|NCT00509067|Nootropic Agents|nootropic agents|mesh-ancestor
6037425|NCT00509067|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6037426|NCT00509067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6037427|NCT00509067|Cholinergic Agents|cholinergic agents|mesh-ancestor
6037428|NCT00509067|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6037429|NCT00509093|Imatinib Mesylate|imatinib mesylate|mesh-list
6037430|NCT00509093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6037431|NCT00509093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6037432|NCT00509093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6037433|NCT00509093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037434|NCT00509106|Ceftriaxone|ceftriaxone|mesh-list
6037435|NCT00509106|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
5495693|NCT04521400|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5495694|NCT04521400|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5495695|NCT04521400|Protease Inhibitors|protease inhibitors|mesh-ancestor
6037436|NCT00509106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6037437|NCT00509106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6037438|NCT00509197|Fluticasone|fluticasone|mesh-list
6037439|NCT00509197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6037440|NCT00509197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6037441|NCT00509197|Autonomic Agents|autonomic agents|mesh-ancestor
6037442|NCT00509197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5495696|NCT04521400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5495697|NCT04521400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495698|NCT04521400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5495699|NCT04521400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5495700|NCT04521400|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6037443|NCT00509197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6037444|NCT00509197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6037445|NCT00509197|Respiratory System Agents|respiratory system agents|mesh-ancestor
6037446|NCT00509197|Dermatologic Agents|dermatologic agents|mesh-ancestor
6037447|NCT00509197|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6037448|NCT00509236|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6037449|NCT00509236|Glipizide|glipizide|mesh-list
6037450|NCT00509236|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6037451|NCT00509236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6037452|NCT00509236|Incretins|incretins|mesh-ancestor
6037453|NCT00509236|Hormones|hormones|mesh-ancestor
6037454|NCT00509236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6037455|NCT00509236|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5495701|NCT04521400|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5495702|NCT04521400|Immunologic Factors|immunologic factors|mesh-ancestor
5495703|NCT04521400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495704|NCT04521400|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5495705|NCT04521569|Regadenoson|regadenoson|mesh-list
5503666|NCT04456829|Antioxidants|antioxidants|mesh-ancestor
6037456|NCT00509236|Protease Inhibitors|protease inhibitors|mesh-ancestor
6037457|NCT00509236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6037458|NCT00509236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053640|NCT00596817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053641|NCT00596817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6053642|NCT00596817|Serotonin Agents|serotonin agents|mesh-ancestor
6053643|NCT00596817|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6053644|NCT00596817|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6053645|NCT00596817|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6053646|NCT00596817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6053647|NCT00596830|Paclitaxel|paclitaxel|mesh-list
6053648|NCT00596830|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6053649|NCT00596830|Carboplatin|carboplatin|mesh-list
6053650|NCT00596830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6053651|NCT00596830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6053652|NCT00596830|Tubulin Modulators|tubulin modulators|mesh-ancestor
6053653|NCT00596830|Antimitotic Agents|antimitotic agents|mesh-ancestor
6053654|NCT00596830|Mitosis Modulators|mitosis modulators|mesh-ancestor
6053655|NCT00596830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053656|NCT00597038|Dasatinib|dasatinib|mesh-list
6053657|NCT00597038|Dacarbazine|dacarbazine|mesh-list
6053658|NCT00597038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6053659|NCT00597038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6053660|NCT00597038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6053661|NCT00597038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053662|NCT00597038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6053663|NCT00597038|Alkylating Agents|alkylating agents|mesh-ancestor
5495706|NCT04521569|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
5495707|NCT04521569|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5495708|NCT04521569|Purinergic Agonists|purinergic agonists|mesh-ancestor
5495709|NCT04521569|Purinergic Agents|purinergic agents|mesh-ancestor
5495710|NCT04521569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5495711|NCT04521569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495712|NCT04521569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495713|NCT04521556|Morphine|morphine|mesh-list
5495714|NCT04521556|Tramadol|tramadol|mesh-list
5495715|NCT04521556|Anesthetics|anesthetics|mesh-list
5495716|NCT04521556|Ropivacaine|ropivacaine|mesh-list
5495717|NCT04521556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5495718|NCT04521556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495719|NCT04521556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5495720|NCT04521556|Narcotics|narcotics|mesh-ancestor
5495721|NCT04521556|Analgesics|analgesics|mesh-ancestor
5495722|NCT04521556|Sensory System Agents|sensory system agents|mesh-ancestor
5495723|NCT04521556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5495724|NCT04521556|Anesthetics, Local|anesthetics, local|mesh-ancestor
6457695|NCT00437671|Immunoglobulins|immunoglobulins|mesh-list
6457696|NCT00437671|Antibodies|antibodies|mesh-list
6457697|NCT00437671|gamma-Globulins|gamma-globulins|mesh-list
6457698|NCT00437671|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6457699|NCT00437671|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6037459|NCT00509249|Aflibercept|aflibercept|mesh-list
6037460|NCT00509249|Endothelial Growth Factors|endothelial growth factors|mesh-list
6037461|NCT00509249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6037462|NCT00509249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6037463|NCT00509249|Growth Substances|growth substances|mesh-ancestor
6037464|NCT00509249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6037465|NCT00509249|Growth Inhibitors|growth inhibitors|mesh-ancestor
6037466|NCT00509249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6037467|NCT00509262|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6037468|NCT00509262|Glipizide|glipizide|mesh-list
6037469|NCT00509262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6037470|NCT00509262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6037471|NCT00509262|Incretins|incretins|mesh-ancestor
6037472|NCT00509262|Hormones|hormones|mesh-ancestor
6457700|NCT00437671|Immunologic Factors|immunologic factors|mesh-ancestor
6457701|NCT00437671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457702|NCT00437684|Ribavirin|ribavirin|mesh-list
6457703|NCT00437684|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6457704|NCT00437684|Antimetabolites|antimetabolites|mesh-ancestor
6457705|NCT00437684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457706|NCT00437684|Antiviral Agents|antiviral agents|mesh-ancestor
6457707|NCT00437684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6457708|NCT00437697|Dalteparin|dalteparin|mesh-list
6457709|NCT00437697|Tinzaparin|tinzaparin|mesh-list
6457710|NCT00437697|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6457711|NCT00437697|Anticoagulants|anticoagulants|mesh-ancestor
6457712|NCT00437697|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6457713|NCT00437697|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6457714|NCT00437697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461966|NCT00456898|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6461967|NCT00456937|Citalopram|citalopram|mesh-list
6461968|NCT00456937|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6461969|NCT00456937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6461970|NCT00456937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6461971|NCT00456937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461972|NCT00456937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6461973|NCT00456937|Serotonin Agents|serotonin agents|mesh-ancestor
6461974|NCT00456937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461975|NCT00456937|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6461976|NCT00456937|Antidepressive Agents|antidepressive agents|mesh-ancestor
6461977|NCT00456937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6461978|NCT00456963|Losartan|losartan|mesh-list
6461979|NCT00456963|Enalapril|enalapril|mesh-list
6461980|NCT00456963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6461981|NCT00456963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6461982|NCT00456963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6461983|NCT00456963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6037473|NCT00509262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6037474|NCT00509262|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6462222|NCT00458185|Immunologic Factors|immunologic factors|mesh-ancestor
5495725|NCT04521582|Amlodipine|amlodipine|mesh-list
5495726|NCT04521582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6037475|NCT00509262|Protease Inhibitors|protease inhibitors|mesh-ancestor
6037476|NCT00509262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6037477|NCT00509262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037478|NCT00509288|Aldesleukin|aldesleukin|mesh-list
6037479|NCT00509288|Cyclophosphamide|cyclophosphamide|mesh-list
6037480|NCT00509288|Fludarabine|fludarabine|mesh-list
6037481|NCT00509288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6037482|NCT00509288|Immunologic Factors|immunologic factors|mesh-ancestor
6037483|NCT00509288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6037484|NCT00509288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6037485|NCT00509288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6037486|NCT00509288|Alkylating Agents|alkylating agents|mesh-ancestor
6037487|NCT00509288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037488|NCT00509288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6037489|NCT00509288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6037490|NCT00509288|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6037491|NCT00509288|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6037492|NCT00509288|Antiviral Agents|antiviral agents|mesh-ancestor
6037493|NCT00509288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6037494|NCT00509366|Gemcitabine|gemcitabine|mesh-list
6037495|NCT00509366|Cisplatin|cisplatin|mesh-list
6037496|NCT00509366|Docetaxel|docetaxel|mesh-list
6037497|NCT00509366|Pemetrexed|pemetrexed|mesh-list
6037498|NCT00509366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6037499|NCT00509366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6037500|NCT00509366|Antimetabolites|antimetabolites|mesh-ancestor
5495727|NCT04521582|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5495728|NCT04521582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5495729|NCT04521582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495730|NCT04521582|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5495731|NCT04521582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495732|NCT04521582|Vasodilator Agents|vasodilator agents|mesh-ancestor
5503248|NCT04460807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6037501|NCT00509366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037502|NCT00509366|Antiviral Agents|antiviral agents|mesh-ancestor
6037503|NCT00509366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6037504|NCT00509366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6037505|NCT00509366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6037506|NCT00509366|Immunologic Factors|immunologic factors|mesh-ancestor
6037507|NCT00509366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457715|NCT00437723|Epoetin Alfa|epoetin alfa|mesh-list
6457716|NCT00437723|Hematinics|hematinics|mesh-ancestor
6457717|NCT00437762|Botulinum Toxins|botulinum toxins|mesh-list
6457718|NCT00437762|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6457719|NCT00437762|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6457720|NCT00437762|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6457721|NCT00437762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6037508|NCT00509366|Tubulin Modulators|tubulin modulators|mesh-ancestor
6037509|NCT00509366|Antimitotic Agents|antimitotic agents|mesh-ancestor
6037510|NCT00509366|Mitosis Modulators|mitosis modulators|mesh-ancestor
6037511|NCT00509366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6037512|NCT00509366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6457722|NCT00437762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457723|NCT00437762|Cholinergic Agents|cholinergic agents|mesh-ancestor
6457724|NCT00437762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6457725|NCT00437762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457726|NCT00437762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6457727|NCT00437762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6457728|NCT00437814|Ketamine|ketamine|mesh-list
6037513|NCT00509496|Aldesleukin|aldesleukin|mesh-list
6037514|NCT00509496|Cyclophosphamide|cyclophosphamide|mesh-list
6037515|NCT00509496|Fludarabine|fludarabine|mesh-list
6037516|NCT00509496|Fludarabine phosphate|fludarabine phosphate|mesh-list
6037517|NCT00509496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6037518|NCT00509496|Immunologic Factors|immunologic factors|mesh-ancestor
6037519|NCT00509496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6037520|NCT00509496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6037521|NCT00509496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6037522|NCT00509496|Alkylating Agents|alkylating agents|mesh-ancestor
6037523|NCT00509496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037524|NCT00509496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6037525|NCT00509496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6037526|NCT00509496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6037527|NCT00509496|Antimetabolites|antimetabolites|mesh-ancestor
6037528|NCT00509496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6037529|NCT00509496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6037530|NCT00509496|Antiviral Agents|antiviral agents|mesh-ancestor
6037531|NCT00509496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6037532|NCT00509665|Gemcitabine|gemcitabine|mesh-list
6037533|NCT00509665|Doxorubicin|doxorubicin|mesh-list
6037534|NCT00509665|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6037535|NCT00509665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6037536|NCT00509665|Antimetabolites|antimetabolites|mesh-ancestor
5495733|NCT04521647|Nicotine|nicotine|mesh-list
6037537|NCT00509665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037538|NCT00509665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6037539|NCT00509665|Antiviral Agents|antiviral agents|mesh-ancestor
6037540|NCT00509665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6037541|NCT00509665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6037542|NCT00509665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6037543|NCT00509665|Immunologic Factors|immunologic factors|mesh-ancestor
6037544|NCT00509665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6037545|NCT00509665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6037546|NCT00509665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6037547|NCT00509665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6037548|NCT00509769|Trastuzumab|trastuzumab|mesh-list
6037549|NCT00509769|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
6037550|NCT00509769|Maytansine|maytansine|mesh-list
6037551|NCT00509769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6037552|NCT00509769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6037553|NCT00509769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6037554|NCT00509769|Tubulin Modulators|tubulin modulators|mesh-ancestor
6037555|NCT00509769|Antimitotic Agents|antimitotic agents|mesh-ancestor
6037556|NCT00509769|Mitosis Modulators|mitosis modulators|mesh-ancestor
6037557|NCT00509769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037558|NCT00509795|Ranibizumab|ranibizumab|mesh-list
6037559|NCT00509795|Aflibercept|aflibercept|mesh-list
6037560|NCT00509795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6037561|NCT00509795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6037562|NCT00509795|Growth Substances|growth substances|mesh-ancestor
6037563|NCT00509795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6037564|NCT00509795|Growth Inhibitors|growth inhibitors|mesh-ancestor
6037565|NCT00509795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6037566|NCT00509873|Gatifloxacin|gatifloxacin|mesh-list
6037567|NCT00509873|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6037568|NCT00509873|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6037569|NCT00509873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6037570|NCT00509873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6037571|NCT00509873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6037572|NCT00509873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6037573|NCT00509873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6037574|NCT00509873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037575|NCT00509873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6037576|NCT00509925|Insulin|insulin|mesh-list
6037577|NCT00509925|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6037578|NCT00509925|Insulin Aspart|insulin aspart|mesh-list
6037579|NCT00509925|Insulin Detemir|insulin detemir|mesh-list
6037580|NCT00509925|Isophane Insulin, Human|isophane insulin, human|mesh-list
6037581|NCT00509925|Insulin, Isophane|insulin, isophane|mesh-list
6037582|NCT00509925|Isophane insulin, beef|isophane insulin, beef|mesh-list
6037583|NCT00509925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6037584|NCT00509925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6037585|NCT00510068|Everolimus|everolimus|mesh-list
6037586|NCT00510068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6037587|NCT00510068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6037588|NCT00510068|Immunologic Factors|immunologic factors|mesh-ancestor
6037589|NCT00510068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6037590|NCT00510146|Olanzapine|olanzapine|mesh-list
6037591|NCT00510146|Antiemetics|antiemetics|mesh-ancestor
6037592|NCT00510146|Autonomic Agents|autonomic agents|mesh-ancestor
6037593|NCT00510146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6037594|NCT00510146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6037595|NCT00510146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6037596|NCT00510146|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6037597|NCT00510146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6037598|NCT00510146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6037599|NCT00510146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6037600|NCT00510146|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6037601|NCT00510146|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6037602|NCT00510146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6053664|NCT00597116|Vinorelbine|vinorelbine|mesh-list
5503249|NCT04460807|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6037603|NCT00510146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037604|NCT00510146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6037605|NCT00510146|Serotonin Agents|serotonin agents|mesh-ancestor
6037606|NCT00510224|Octreotide|octreotide|mesh-list
6037607|NCT00510224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6037608|NCT00510224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6037609|NCT00510224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6037610|NCT00510276|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6037611|NCT00510276|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6037612|NCT00510276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5495734|NCT04521647|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5495735|NCT04521647|Autonomic Agents|autonomic agents|mesh-ancestor
6037613|NCT00510276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6037614|NCT00510276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037615|NCT00510276|Adrenergic Agents|adrenergic agents|mesh-ancestor
6037616|NCT00510276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6037617|NCT00510276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6037618|NCT00510289|Sorafenib|sorafenib|mesh-list
6037619|NCT00510289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6037620|NCT00510289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6037621|NCT00510289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6037622|NCT00510289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037623|NCT00510484|Pancrelipase|pancrelipase|mesh-list
6037624|NCT00510484|Pancreatin|pancreatin|mesh-list
6037625|NCT00510484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6037626|NCT00510510|Glycopyrrolate|glycopyrrolate|mesh-list
6037627|NCT00510510|Bromides|bromides|mesh-list
6037628|NCT00510510|Anticonvulsants|anticonvulsants|mesh-ancestor
6037629|NCT00510510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6037630|NCT00510510|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6037631|NCT00510510|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6037632|NCT00510510|Cholinergic Agents|cholinergic agents|mesh-ancestor
6037633|NCT00510510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6037634|NCT00510510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037635|NCT00510510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6037636|NCT00510653|Imatinib Mesylate|imatinib mesylate|mesh-list
6037637|NCT00510653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6037638|NCT00510653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5495736|NCT04521647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5495737|NCT04521647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495738|NCT04521647|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5495739|NCT04521647|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5495740|NCT04521647|Cholinergic Agents|cholinergic agents|mesh-ancestor
5495741|NCT04521647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5495742|NCT04521647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037639|NCT00510653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6037640|NCT00510653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037641|NCT00510783|Phenytoin|phenytoin|mesh-list
6037642|NCT00510783|Fosphenytoin|fosphenytoin|mesh-list
6037643|NCT00510783|Levetiracetam|levetiracetam|mesh-list
6037644|NCT00510783|Anticonvulsants|anticonvulsants|mesh-ancestor
6037645|NCT00510783|Nootropic Agents|nootropic agents|mesh-ancestor
6037646|NCT00510783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6037647|NCT00510783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6037648|NCT00510783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6037649|NCT00510783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037650|NCT00510783|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6037651|NCT00510783|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6037652|NCT00510809|Ethanol|ethanol|mesh-list
6037653|NCT00510809|Policosanol|policosanol|mesh-list
6037654|NCT00510809|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
6037655|NCT00510809|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6037656|NCT00510809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6037657|NCT00510809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6037658|NCT00510809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6037659|NCT00510809|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6037660|NCT00510809|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6037661|NCT00510809|Antimetabolites|antimetabolites|mesh-ancestor
6037662|NCT00510809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037663|NCT00510809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6037664|NCT00510809|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6037665|NCT00510809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6037666|NCT00510887|Dexamethasone|dexamethasone|mesh-list
6037667|NCT00510887|Rituximab|rituximab|mesh-list
6037668|NCT00510887|Fludarabine|fludarabine|mesh-list
6037669|NCT00510887|Bortezomib|bortezomib|mesh-list
6037670|NCT00510887|Mitoxantrone|mitoxantrone|mesh-list
6037671|NCT00510887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6037672|NCT00510887|Antiemetics|antiemetics|mesh-ancestor
6037673|NCT00510887|Autonomic Agents|autonomic agents|mesh-ancestor
6037674|NCT00510887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6037675|NCT00510887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6037676|NCT00510887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6037677|NCT00510887|Glucocorticoids|glucocorticoids|mesh-ancestor
6037678|NCT00510887|Hormones|hormones|mesh-ancestor
5495743|NCT04521751|Acarbose|acarbose|mesh-list
5495744|NCT04521751|Orlistat|orlistat|mesh-list
5495745|NCT04521751|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
5495746|NCT04521751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5495747|NCT04521751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495748|NCT04521751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5495749|NCT04521751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495750|NCT04521751|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5495751|NCT04521751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5495752|NCT04521517|Imidacloprid|imidacloprid|mesh-list
5495753|NCT04521517|Cholinergic Agents|cholinergic agents|mesh-ancestor
5495754|NCT04521517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5495755|NCT04521517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495756|NCT04521517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495757|NCT04521491|Leucovorin|leucovorin|mesh-list
5495758|NCT04521491|Fluorouracil|fluorouracil|mesh-list
5495759|NCT04521491|Oxaliplatin|oxaliplatin|mesh-list
5495760|NCT04521491|Antimetabolites|antimetabolites|mesh-ancestor
5495761|NCT04521491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495762|NCT04521491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5495763|NCT04521491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5495764|NCT04521491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5495765|NCT04521491|Immunologic Factors|immunologic factors|mesh-ancestor
5495766|NCT04521491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495767|NCT04521491|Antidotes|antidotes|mesh-ancestor
6037679|NCT00510887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6037680|NCT00510887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6037681|NCT00510887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6037682|NCT00510887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6037683|NCT00510887|Immunologic Factors|immunologic factors|mesh-ancestor
6037684|NCT00510887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6037685|NCT00510887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037686|NCT00510887|Analgesics|analgesics|mesh-ancestor
6037687|NCT00510887|Sensory System Agents|sensory system agents|mesh-ancestor
6037688|NCT00510887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6037689|NCT00510887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6037690|NCT00510887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6037691|NCT00510952|Insulin|insulin|mesh-list
6037692|NCT00510952|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6037693|NCT00510952|Insulin Glargine|insulin glargine|mesh-list
6037694|NCT00510952|Insulin Lispro|insulin lispro|mesh-list
6037695|NCT00510952|Protamines|protamines|mesh-list
6037696|NCT00510952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6457729|NCT00437814|Analgesics|analgesics|mesh-ancestor
6457730|NCT00437814|Sensory System Agents|sensory system agents|mesh-ancestor
6457731|NCT00437814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6457732|NCT00437814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457733|NCT00437814|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6457734|NCT00437814|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6457735|NCT00437814|Anesthetics, General|anesthetics, general|mesh-ancestor
6457736|NCT00437814|Anesthetics|anesthetics|mesh-ancestor
5495768|NCT04521491|Protective Agents|protective agents|mesh-ancestor
6037697|NCT00510952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6037698|NCT00510952|Heparin Antagonists|heparin antagonists|mesh-ancestor
6037699|NCT00510952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037700|NCT00510952|Coagulants|coagulants|mesh-ancestor
6037701|NCT00511004|Albendazole|albendazole|mesh-list
6037702|NCT00511004|Diethylcarbamazine|diethylcarbamazine|mesh-list
6037703|NCT00511004|Anthelmintics|anthelmintics|mesh-ancestor
6037704|NCT00511004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6037705|NCT00511004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6037706|NCT00511004|Anticestodal Agents|anticestodal agents|mesh-ancestor
6037707|NCT00511004|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6037708|NCT00511004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6037709|NCT00511004|Tubulin Modulators|tubulin modulators|mesh-ancestor
6037710|NCT00511004|Antimitotic Agents|antimitotic agents|mesh-ancestor
6037711|NCT00511004|Mitosis Modulators|mitosis modulators|mesh-ancestor
6037712|NCT00511004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037713|NCT00511004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6037714|NCT00511004|Filaricides|filaricides|mesh-ancestor
6037715|NCT00511004|Antinematodal Agents|antinematodal agents|mesh-ancestor
6037716|NCT00511004|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6037717|NCT00511004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5495769|NCT04521491|Vitamin B Complex|vitamin b complex|mesh-ancestor
5495770|NCT04521491|Vitamins|vitamins|mesh-ancestor
5495771|NCT04521491|Micronutrients|micronutrients|mesh-ancestor
5495772|NCT04521387|Hyaluronic Acid|hyaluronic acid|mesh-list
5495773|NCT04521387|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5495774|NCT04521387|Immunologic Factors|immunologic factors|mesh-ancestor
5495775|NCT04521387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495776|NCT04521387|Viscosupplements|viscosupplements|mesh-ancestor
5495777|NCT04521387|Protective Agents|protective agents|mesh-ancestor
5495778|NCT04521075|Nivolumab|nivolumab|mesh-list
6037718|NCT00511108|Pioglitazone|pioglitazone|mesh-list
6037719|NCT00511108|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6037720|NCT00511108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6037721|NCT00511108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6037722|NCT00511108|Incretins|incretins|mesh-ancestor
6037723|NCT00511108|Hormones|hormones|mesh-ancestor
6037724|NCT00511108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6037725|NCT00511108|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6037726|NCT00511108|Protease Inhibitors|protease inhibitors|mesh-ancestor
6037727|NCT00511108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6037728|NCT00511108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037729|NCT00511134|Eszopiclone|eszopiclone|mesh-list
6037730|NCT00511134|Bupropion|bupropion|mesh-list
6037731|NCT00511134|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6037732|NCT00511134|Antidepressive Agents|antidepressive agents|mesh-ancestor
6037733|NCT00511134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6037734|NCT00511134|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6037735|NCT00511134|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6037736|NCT00511134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6037737|NCT00511134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037738|NCT00511134|Dopamine Agents|dopamine agents|mesh-ancestor
6037739|NCT00511134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6037740|NCT00511134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6037741|NCT00511134|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6037742|NCT00511134|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6037743|NCT00511134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6037744|NCT00511134|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6037745|NCT00511134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6037746|NCT00511147|Immunoglobulins|immunoglobulins|mesh-list
6037747|NCT00511147|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6037748|NCT00511147|gamma-Globulins|gamma-globulins|mesh-list
6037749|NCT00511147|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6037750|NCT00511147|Immunologic Factors|immunologic factors|mesh-ancestor
6037751|NCT00511147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6037752|NCT00511173|Warfarin|warfarin|mesh-list
6037753|NCT00511173|Anticoagulants|anticoagulants|mesh-ancestor
6037754|NCT00511472|Insulin Glargine|insulin glargine|mesh-list
6037755|NCT00511472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6037756|NCT00511472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6037757|NCT00511706|Dexamethasone|dexamethasone|mesh-list
6037758|NCT00511706|Ranibizumab|ranibizumab|mesh-list
6037759|NCT00511706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6037760|NCT00511706|Antiemetics|antiemetics|mesh-ancestor
6037761|NCT00511706|Autonomic Agents|autonomic agents|mesh-ancestor
6037762|NCT00511706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6037763|NCT00511706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6037764|NCT00511706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6037765|NCT00511706|Glucocorticoids|glucocorticoids|mesh-ancestor
6037766|NCT00511706|Hormones|hormones|mesh-ancestor
6037767|NCT00511706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6037768|NCT00511706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6037769|NCT00511706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6037770|NCT00511706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6037771|NCT00511706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6037772|NCT00511706|Growth Substances|growth substances|mesh-ancestor
6037773|NCT00511706|Growth Inhibitors|growth inhibitors|mesh-ancestor
5495779|NCT04521075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6037774|NCT00511836|Naltrexone|naltrexone|mesh-list
6037775|NCT00511836|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6037776|NCT00511836|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6037777|NCT00511836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6037778|NCT00511836|Sensory System Agents|sensory system agents|mesh-ancestor
6037779|NCT00511836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6037780|NCT00511875|Doxycycline|doxycycline|mesh-list
6037781|NCT00511875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6037782|NCT00511875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6037783|NCT00511875|Antimalarials|antimalarials|mesh-ancestor
6037784|NCT00511875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6037785|NCT00511875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6037786|NCT00511901|Epoetin Alfa|epoetin alfa|mesh-list
6037787|NCT00511901|Hematinics|hematinics|mesh-ancestor
6037788|NCT00511992|Paclitaxel|paclitaxel|mesh-list
6037789|NCT00511992|Bevacizumab|bevacizumab|mesh-list
6037790|NCT00511992|Cisplatin|cisplatin|mesh-list
6037791|NCT00511992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6037792|NCT00511992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6037793|NCT00511992|Tubulin Modulators|tubulin modulators|mesh-ancestor
6037794|NCT00511992|Antimitotic Agents|antimitotic agents|mesh-ancestor
6037795|NCT00511992|Mitosis Modulators|mitosis modulators|mesh-ancestor
6037796|NCT00511992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037797|NCT00511992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6037798|NCT00511992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6037799|NCT00511992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6037800|NCT00511992|Growth Substances|growth substances|mesh-ancestor
6037801|NCT00511992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6037802|NCT00511992|Growth Inhibitors|growth inhibitors|mesh-ancestor
6037803|NCT00512096|Paclitaxel|paclitaxel|mesh-list
5495780|NCT04521075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5495781|NCT04521075|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5495782|NCT04521075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495783|NCT04521335|Copper|copper|mesh-list
5495784|NCT04521335|Disulfiram|disulfiram|mesh-list
6037804|NCT00512096|Cisplatin|cisplatin|mesh-list
6037805|NCT00512096|Ifosfamide|ifosfamide|mesh-list
6037806|NCT00512096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6037807|NCT00512096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6037808|NCT00512096|Tubulin Modulators|tubulin modulators|mesh-ancestor
6037809|NCT00512096|Antimitotic Agents|antimitotic agents|mesh-ancestor
6037810|NCT00512096|Mitosis Modulators|mitosis modulators|mesh-ancestor
6037811|NCT00512096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037812|NCT00512096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6037813|NCT00512096|Alkylating Agents|alkylating agents|mesh-ancestor
6037814|NCT00512135|Botulinum Toxins|botulinum toxins|mesh-list
6037815|NCT00512135|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6037816|NCT00512135|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6037817|NCT00512135|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
6037818|NCT00512135|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6037819|NCT00512135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6037820|NCT00512135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037821|NCT00512135|Cholinergic Agents|cholinergic agents|mesh-ancestor
6037822|NCT00512135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6037823|NCT00512135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6037824|NCT00512135|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6037825|NCT00512135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6037826|NCT00512252|Cytarabine|cytarabine|mesh-list
6037827|NCT00512252|Plerixafor|plerixafor|mesh-list
6037828|NCT00512252|Etoposide|etoposide|mesh-list
6037829|NCT00512252|Mitoxantrone|mitoxantrone|mesh-list
6037830|NCT00512252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6037831|NCT00512252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6037832|NCT00512252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6037833|NCT00512252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6037834|NCT00512252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6037835|NCT00512252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037836|NCT00512252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5495785|NCT04521335|Trace Elements|trace elements|mesh-ancestor
5495786|NCT04521335|Micronutrients|micronutrients|mesh-ancestor
6037837|NCT00512252|Antimetabolites|antimetabolites|mesh-ancestor
6037838|NCT00512252|Antiviral Agents|antiviral agents|mesh-ancestor
6037839|NCT00512252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6037840|NCT00512252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6037841|NCT00512252|Immunologic Factors|immunologic factors|mesh-ancestor
6037842|NCT00512252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6037843|NCT00512252|Analgesics|analgesics|mesh-ancestor
6037844|NCT00512252|Sensory System Agents|sensory system agents|mesh-ancestor
6037845|NCT00512252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6037846|NCT00512252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6037847|NCT00512252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6037848|NCT00512278|Infliximab|infliximab|mesh-list
6037849|NCT00512278|Dermatologic Agents|dermatologic agents|mesh-ancestor
6037850|NCT00512278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6037851|NCT00512278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6037852|NCT00512707|Sildenafil Citrate|sildenafil citrate|mesh-list
6037853|NCT00512707|Testosterone|testosterone|mesh-list
6037854|NCT00512707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037855|NCT00512707|Androgens|androgens|mesh-ancestor
6037856|NCT00512707|Hormones|hormones|mesh-ancestor
6037857|NCT00512707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6037858|NCT00512707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6037859|NCT00512707|Vasodilator Agents|vasodilator agents|mesh-ancestor
6037860|NCT00512707|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6037861|NCT00512707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6037862|NCT00512707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6037863|NCT00512707|Urological Agents|urological agents|mesh-ancestor
6037864|NCT00512798|Bortezomib|bortezomib|mesh-list
6037865|NCT00512798|Temozolomide|temozolomide|mesh-list
6037866|NCT00512798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6037867|NCT00512798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6037868|NCT00512798|Alkylating Agents|alkylating agents|mesh-ancestor
6037869|NCT00512798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037870|NCT00512876|Bevacizumab|bevacizumab|mesh-list
6037871|NCT00512876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6037872|NCT00512876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6037873|NCT00512876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6037874|NCT00512876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6037875|NCT00512876|Growth Substances|growth substances|mesh-ancestor
6037876|NCT00512876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6037877|NCT00512876|Growth Inhibitors|growth inhibitors|mesh-ancestor
6037878|NCT00512902|Imatinib Mesylate|imatinib mesylate|mesh-list
6037879|NCT00512902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6037880|NCT00512902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6037881|NCT00512902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6655094|NCT01460654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5495787|NCT04521335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495788|NCT04521335|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5495789|NCT04521335|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
5495790|NCT04521335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5495791|NCT04521335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495792|NCT04521140|Dexamethasone|dexamethasone|mesh-list
5495793|NCT04521140|Prednisolone|prednisolone|mesh-list
5495794|NCT04521140|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5495795|NCT04521140|Methylprednisolone|methylprednisolone|mesh-list
5495796|NCT04521140|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6655095|NCT01460654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655096|NCT01460654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5495797|NCT04521140|Prednisolone acetate|prednisolone acetate|mesh-list
6037882|NCT00512902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495798|NCT04521140|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5495799|NCT04521140|Prednisolone phosphate|prednisolone phosphate|mesh-list
5495800|NCT04521140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5495801|NCT04521140|Antiemetics|antiemetics|mesh-ancestor
5495802|NCT04521140|Autonomic Agents|autonomic agents|mesh-ancestor
5495803|NCT04521140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6037883|NCT00513019|Lamotrigine|lamotrigine|mesh-list
6037884|NCT00513019|Anticonvulsants|anticonvulsants|mesh-list
6037885|NCT00513019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6037886|NCT00513019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6037887|NCT00513019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037888|NCT00513019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6037889|NCT00513019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6037890|NCT00513019|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6037891|NCT00513019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5495804|NCT04521140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495805|NCT04521140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5495806|NCT04521140|Glucocorticoids|glucocorticoids|mesh-ancestor
5495807|NCT04521140|Hormones|hormones|mesh-ancestor
5495808|NCT04521140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5495809|NCT04521140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5495810|NCT04521140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5495811|NCT04521140|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5495812|NCT04521140|Protective Agents|protective agents|mesh-ancestor
5495813|NCT04521348|Antibodies|antibodies|mesh-list
5495814|NCT04521348|Immunoglobulins|immunoglobulins|mesh-list
5495815|NCT04521348|Immunologic Factors|immunologic factors|mesh-ancestor
5495816|NCT04521348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495817|NCT04521309|Antibodies|antibodies|mesh-list
5495818|NCT04521309|Immunologic Factors|immunologic factors|mesh-ancestor
5495819|NCT04521309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495820|NCT04521153|Apatinib|apatinib|mesh-list
5495821|NCT04521153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5495822|NCT04521153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5495823|NCT04521153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5495824|NCT04521153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495825|NCT04521049|Saxagliptin|saxagliptin|mesh-list
5495826|NCT04521049|Incretins|incretins|mesh-ancestor
5495827|NCT04521049|Hormones|hormones|mesh-ancestor
5495828|NCT04521049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5495829|NCT04521049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495830|NCT04521049|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5495831|NCT04521049|Protease Inhibitors|protease inhibitors|mesh-ancestor
5495832|NCT04521049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5495833|NCT04521049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495834|NCT04521049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5495835|NCT04520646|Empagliflozin|empagliflozin|mesh-list
5495836|NCT04520646|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5495837|NCT04520646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495838|NCT04520646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5495839|NCT04520646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495840|NCT04520620|Enoxaparin|enoxaparin|mesh-list
5495841|NCT04520620|Anticoagulants|anticoagulants|mesh-ancestor
5495842|NCT04520620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5495843|NCT04520620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6037892|NCT00513019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6037893|NCT00513019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6037894|NCT00513019|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6037895|NCT00513071|Saracatinib|saracatinib|mesh-list
6037896|NCT00513071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6037897|NCT00513071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6037898|NCT00513071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037899|NCT00513240|Epoetin Alfa|epoetin alfa|mesh-list
6037900|NCT00513240|Hematinics|hematinics|mesh-ancestor
6037901|NCT00513292|Paclitaxel|paclitaxel|mesh-list
6037902|NCT00513292|Cyclophosphamide|cyclophosphamide|mesh-list
6037903|NCT00513292|Trastuzumab|trastuzumab|mesh-list
6037904|NCT00513292|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6037905|NCT00513292|Epirubicin|epirubicin|mesh-list
6037906|NCT00513292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5495844|NCT04520620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495845|NCT04520880|Antibodies|antibodies|mesh-list
6037907|NCT00513292|Antibodies|antibodies|mesh-list
6037908|NCT00513292|Immunoglobulins|immunoglobulins|mesh-list
5495846|NCT04520880|Immunoglobulins|immunoglobulins|mesh-list
5495847|NCT04520880|Antibodies, Blocking|antibodies, blocking|mesh-list
5495848|NCT04520880|Immunologic Factors|immunologic factors|mesh-ancestor
5495849|NCT04520880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495850|NCT04520919|Anesthetics|anesthetics|mesh-list
5495851|NCT04520919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5495852|NCT04520919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495853|NCT04520503|Propofol|propofol|mesh-list
5495854|NCT04520503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5495855|NCT04520503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6037909|NCT00513292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6037910|NCT00513292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6037911|NCT00513292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6037912|NCT00513292|Tubulin Modulators|tubulin modulators|mesh-ancestor
6037913|NCT00513292|Antimitotic Agents|antimitotic agents|mesh-ancestor
6037914|NCT00513292|Mitosis Modulators|mitosis modulators|mesh-ancestor
6037915|NCT00513292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037916|NCT00513292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6037917|NCT00513292|Immunologic Factors|immunologic factors|mesh-ancestor
6037918|NCT00513292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6037919|NCT00513292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6037920|NCT00513292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6037921|NCT00513292|Alkylating Agents|alkylating agents|mesh-ancestor
6037922|NCT00513292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6037923|NCT00513292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6037924|NCT00513292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6037925|NCT00513292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5495856|NCT04520503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495857|NCT04520503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5495858|NCT04520503|Anesthetics, General|anesthetics, general|mesh-ancestor
5495859|NCT04520503|Anesthetics|anesthetics|mesh-ancestor
5495860|NCT04520230|Budesonide|budesonide|mesh-list
5495861|NCT04520230|Formoterol Fumarate|formoterol fumarate|mesh-list
5495862|NCT04520230|Tiotropium Bromide|tiotropium bromide|mesh-list
5495863|NCT04520230|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
5495864|NCT04520230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5495865|NCT04520230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5495866|NCT04520230|Autonomic Agents|autonomic agents|mesh-ancestor
5495867|NCT04520230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5495868|NCT04520230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495869|NCT04520230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6037926|NCT00513292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6037927|NCT00513305|Cytarabine|cytarabine|mesh-list
6037928|NCT00513305|Arsenic Trioxide|arsenic trioxide|mesh-list
6037929|NCT00513305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6037930|NCT00513305|Antimetabolites|antimetabolites|mesh-ancestor
6037931|NCT00513305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037932|NCT00513305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6037933|NCT00513305|Antiviral Agents|antiviral agents|mesh-ancestor
6037934|NCT00513305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6037935|NCT00513305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6037936|NCT00513305|Immunologic Factors|immunologic factors|mesh-ancestor
6037937|NCT00513305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6037938|NCT00513357|Melatonin|melatonin|mesh-list
6037939|NCT00513357|Antioxidants|antioxidants|mesh-ancestor
6037940|NCT00513357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037941|NCT00513357|Protective Agents|protective agents|mesh-ancestor
6037942|NCT00513357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6037943|NCT00513357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6037944|NCT00513370|Adalimumab|adalimumab|mesh-list
6037945|NCT00513370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6037946|NCT00513370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6037947|NCT00513435|Saracatinib|saracatinib|mesh-list
6457737|NCT00437814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6457738|NCT00437814|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6457739|NCT00437814|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6457740|NCT00437814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6457741|NCT00437814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457742|NCT00437853|Anastrozole|anastrozole|mesh-list
6457743|NCT00437853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6457744|NCT00437853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6457745|NCT00437853|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6457746|NCT00437853|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6037948|NCT00513435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6457747|NCT00437853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6457748|NCT00437853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457749|NCT00437853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6457750|NCT00437853|Hormone Antagonists|hormone antagonists|mesh-ancestor
6457751|NCT00437853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6457752|NCT00437853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457753|NCT00437892|Atorvastatin|atorvastatin|mesh-list
6457754|NCT00437892|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6457755|NCT00437892|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6457756|NCT00437892|Antimetabolites|antimetabolites|mesh-ancestor
6457757|NCT00437892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457758|NCT00437892|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6457759|NCT00437892|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6457760|NCT00437892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6457761|NCT00437918|Acarbose|acarbose|mesh-list
6457762|NCT00437918|Nateglinide|nateglinide|mesh-list
6457763|NCT00437918|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6457764|NCT00437918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6457765|NCT00437918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457766|NCT00437918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5495870|NCT04520230|Respiratory System Agents|respiratory system agents|mesh-ancestor
5495871|NCT04520230|Glucocorticoids|glucocorticoids|mesh-ancestor
6037949|NCT00513435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6037950|NCT00513435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037951|NCT00513474|Cyclosporine|cyclosporine|mesh-list
6037952|NCT00513474|Sirolimus|sirolimus|mesh-list
6037953|NCT00513474|Cyclophosphamide|cyclophosphamide|mesh-list
6037954|NCT00513474|Busulfan|busulfan|mesh-list
6037955|NCT00513474|Methotrexate|methotrexate|mesh-list
6037956|NCT00513474|Fludarabine|fludarabine|mesh-list
6037957|NCT00513474|Etoposide|etoposide|mesh-list
6037958|NCT00513474|Allopurinol|allopurinol|mesh-list
6037959|NCT00513474|Rasburicase|rasburicase|mesh-list
6037960|NCT00513474|Tacrolimus|tacrolimus|mesh-list
6037961|NCT00513474|Cyclosporins|cyclosporins|mesh-list
6037962|NCT00513474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6037963|NCT00513474|Immunologic Factors|immunologic factors|mesh-ancestor
6037964|NCT00513474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6037965|NCT00513474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6037966|NCT00513474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6037967|NCT00513474|Alkylating Agents|alkylating agents|mesh-ancestor
6037968|NCT00513474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6037969|NCT00513474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6037970|NCT00513474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6037971|NCT00513474|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6037972|NCT00513474|Abortifacient Agents|abortifacient agents|mesh-ancestor
6037973|NCT00513474|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6037974|NCT00513474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6037975|NCT00513474|Antimetabolites|antimetabolites|mesh-ancestor
6037976|NCT00513474|Dermatologic Agents|dermatologic agents|mesh-ancestor
6037977|NCT00513474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6037978|NCT00513474|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6037979|NCT00513474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6037980|NCT00513474|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6037981|NCT00513474|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6037982|NCT00513474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6037983|NCT00513474|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6037984|NCT00513474|Antifungal Agents|antifungal agents|mesh-ancestor
5495872|NCT04520230|Hormones|hormones|mesh-ancestor
5495873|NCT04520230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5495874|NCT04520230|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5495875|NCT04520230|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5495876|NCT04520230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5495877|NCT04520230|Adrenergic Agents|adrenergic agents|mesh-ancestor
5495878|NCT04520230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5495879|NCT04520230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495880|NCT04520230|Parasympatholytics|parasympatholytics|mesh-ancestor
5495881|NCT04520230|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5495882|NCT04520230|Cholinergic Agents|cholinergic agents|mesh-ancestor
5495883|NCT04520490|Exenatide|exenatide|mesh-list
6037985|NCT00513474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6037986|NCT00513474|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6037987|NCT00513474|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6037988|NCT00513474|Gout Suppressants|gout suppressants|mesh-ancestor
6462223|NCT00458250|Cyclosporine|cyclosporine|mesh-list
6037989|NCT00513474|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6037990|NCT00513474|Antioxidants|antioxidants|mesh-ancestor
6037991|NCT00513474|Protective Agents|protective agents|mesh-ancestor
6655097|NCT01460654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5495884|NCT04520490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5495885|NCT04520490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495886|NCT04520490|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5495887|NCT04520490|Incretins|incretins|mesh-ancestor
6037992|NCT00513500|Amoxicillin|amoxicillin|mesh-list
6037993|NCT00513500|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6037994|NCT00513500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6037995|NCT00513500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6037996|NCT00513500|Antimalarials|antimalarials|mesh-ancestor
6037997|NCT00513500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6037998|NCT00513500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6037999|NCT00513526|Vaccines|vaccines|mesh-list
6038000|NCT00513526|Immunologic Factors|immunologic factors|mesh-ancestor
6038001|NCT00513526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038002|NCT00513604|Aldesleukin|aldesleukin|mesh-list
6038003|NCT00513604|Cyclophosphamide|cyclophosphamide|mesh-list
6038004|NCT00513604|Fludarabine|fludarabine|mesh-list
6038005|NCT00513604|Fludarabine phosphate|fludarabine phosphate|mesh-list
6038006|NCT00513604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6038007|NCT00513604|Immunologic Factors|immunologic factors|mesh-ancestor
6038008|NCT00513604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038009|NCT00513604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6038010|NCT00513604|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6038011|NCT00513604|Alkylating Agents|alkylating agents|mesh-ancestor
6038012|NCT00513604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6038013|NCT00513604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6038014|NCT00513604|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6038015|NCT00513604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6038016|NCT00513604|Antimetabolites|antimetabolites|mesh-ancestor
6038017|NCT00513604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6038018|NCT00513604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6038019|NCT00513604|Antiviral Agents|antiviral agents|mesh-ancestor
6038020|NCT00513604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6038021|NCT00513682|Pancrelipase|pancrelipase|mesh-list
6038022|NCT00513682|Pancreatin|pancreatin|mesh-list
6038023|NCT00513682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6038024|NCT00513695|Paclitaxel|paclitaxel|mesh-list
6038025|NCT00513695|Cyclophosphamide|cyclophosphamide|mesh-list
6038026|NCT00513695|Doxorubicin|doxorubicin|mesh-list
6038027|NCT00513695|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6038028|NCT00513695|Sunitinib|sunitinib|mesh-list
6038029|NCT00513695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6038030|NCT00513695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6038031|NCT00513695|Tubulin Modulators|tubulin modulators|mesh-ancestor
6038032|NCT00513695|Antimitotic Agents|antimitotic agents|mesh-ancestor
6038033|NCT00513695|Mitosis Modulators|mitosis modulators|mesh-ancestor
6462224|NCT00458250|Cyclophosphamide|cyclophosphamide|mesh-list
6462225|NCT00458250|Busulfan|busulfan|mesh-list
6462226|NCT00458250|Methotrexate|methotrexate|mesh-list
6462227|NCT00458250|Alemtuzumab|alemtuzumab|mesh-list
6462228|NCT00458250|Cyclosporins|cyclosporins|mesh-list
6462229|NCT00458250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6462230|NCT00458250|Immunologic Factors|immunologic factors|mesh-ancestor
6462231|NCT00458250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462232|NCT00458250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6462233|NCT00458250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6462234|NCT00458250|Alkylating Agents|alkylating agents|mesh-ancestor
6462235|NCT00458250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462236|NCT00458250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6462237|NCT00458250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6462238|NCT00458250|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6462239|NCT00458250|Abortifacient Agents|abortifacient agents|mesh-ancestor
6462240|NCT00458250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5495888|NCT04520490|Hormones|hormones|mesh-ancestor
5495889|NCT04520490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5495890|NCT04520074|Cyclophosphamide|cyclophosphamide|mesh-list
5495891|NCT04520074|Carboplatin|carboplatin|mesh-list
5495892|NCT04520074|Etoposide|etoposide|mesh-list
5495893|NCT04520074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5495894|NCT04520074|Immunologic Factors|immunologic factors|mesh-ancestor
6038034|NCT00513695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6038035|NCT00513695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6038036|NCT00513695|Immunologic Factors|immunologic factors|mesh-ancestor
6038037|NCT00513695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038038|NCT00513695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6038039|NCT00513695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6038040|NCT00513695|Alkylating Agents|alkylating agents|mesh-ancestor
6038041|NCT00513695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6038042|NCT00513695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6038043|NCT00513695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6038044|NCT00513695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6038045|NCT00513695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6038046|NCT00513695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6038047|NCT00513695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6038048|NCT00513695|Growth Substances|growth substances|mesh-ancestor
6038049|NCT00513695|Growth Inhibitors|growth inhibitors|mesh-ancestor
6038050|NCT00513695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6038051|NCT00513747|Rituximab|rituximab|mesh-list
6038052|NCT00513747|Fludarabine|fludarabine|mesh-list
6038053|NCT00513747|Fludarabine phosphate|fludarabine phosphate|mesh-list
6038054|NCT00513747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6038055|NCT00513747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6038056|NCT00513747|Immunologic Factors|immunologic factors|mesh-ancestor
6038057|NCT00513747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495895|NCT04520074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495896|NCT04520074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5495897|NCT04520074|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5495898|NCT04520074|Alkylating Agents|alkylating agents|mesh-ancestor
5495899|NCT04520074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495900|NCT04520074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5495901|NCT04520074|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5495902|NCT04520074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5495903|NCT04520074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5495904|NCT04520074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5495905|NCT04520074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5495906|NCT04520451|Prednisone|prednisone|mesh-list
5495907|NCT04520451|Prednisolone|prednisolone|mesh-list
5495908|NCT04520451|Glucocorticoids|glucocorticoids|mesh-list
5495909|NCT04520451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5495910|NCT04520451|Hormones|hormones|mesh-ancestor
5495911|NCT04520451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5495912|NCT04520451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495913|NCT04520451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5495914|NCT04520451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5495915|NCT04520048|Acetylcholine|acetylcholine|mesh-list
5495916|NCT04520048|Vasodilator Agents|vasodilator agents|mesh-ancestor
5495917|NCT04520048|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5495918|NCT04520048|Cholinergic Agents|cholinergic agents|mesh-ancestor
5495919|NCT04520048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5495920|NCT04520048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6038058|NCT00513747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6038059|NCT00513747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6038060|NCT00513747|Antimetabolites|antimetabolites|mesh-ancestor
6038061|NCT00513747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6038062|NCT00513747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6038063|NCT00513799|Chlorhexidine|chlorhexidine|mesh-list
6038064|NCT00513799|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6038065|NCT00513799|Mupirocin|mupirocin|mesh-list
6038066|NCT00513799|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6038067|NCT00513799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6038068|NCT00513799|Disinfectants|disinfectants|mesh-ancestor
5495921|NCT04520048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038069|NCT00513799|Dermatologic Agents|dermatologic agents|mesh-ancestor
6038070|NCT00513799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6038071|NCT00513799|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6038072|NCT00513799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6038073|NCT00513799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655098|NCT01460654|Anabolic Agents|anabolic agents|mesh-ancestor
6655099|NCT01460654|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6655100|NCT01460667|Acetaminophen|acetaminophen|mesh-list
6655101|NCT01460667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6655102|NCT01460667|Analgesics|analgesics|mesh-ancestor
6655103|NCT01460667|Sensory System Agents|sensory system agents|mesh-ancestor
6655104|NCT01460667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6664653|NCT01513187|Interferons|interferons|mesh-list
6038074|NCT00514020|Leucovorin|leucovorin|mesh-list
6038075|NCT00514020|Fluorouracil|fluorouracil|mesh-list
6038076|NCT00514020|Oxaliplatin|oxaliplatin|mesh-list
6038077|NCT00514020|Calcium|calcium|mesh-list
6038078|NCT00514020|Levoleucovorin|levoleucovorin|mesh-list
6038079|NCT00514020|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6038080|NCT00514020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038081|NCT00514020|Antimetabolites|antimetabolites|mesh-ancestor
6038082|NCT00514020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6038083|NCT00514020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6038084|NCT00514020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6038085|NCT00514020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6038086|NCT00514020|Immunologic Factors|immunologic factors|mesh-ancestor
5495922|NCT04520178|Carbidopa|carbidopa|mesh-list
5495923|NCT04520178|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
5495924|NCT04520178|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6038087|NCT00514020|Antidotes|antidotes|mesh-ancestor
6038088|NCT00514020|Protective Agents|protective agents|mesh-ancestor
6038089|NCT00514020|Vitamin B Complex|vitamin b complex|mesh-ancestor
6038090|NCT00514020|Vitamins|vitamins|mesh-ancestor
6038091|NCT00514020|Micronutrients|micronutrients|mesh-ancestor
6038092|NCT00514137|Sunitinib|sunitinib|mesh-list
6038093|NCT00514137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6038094|NCT00514137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6457767|NCT00437918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457768|NCT00437957|Temozolomide|temozolomide|mesh-list
6457769|NCT00437957|Valproic Acid|valproic acid|mesh-list
6457770|NCT00437957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6457771|NCT00437957|Alkylating Agents|alkylating agents|mesh-ancestor
6457772|NCT00437957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457773|NCT00437957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6038095|NCT00514137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6038096|NCT00514137|Growth Substances|growth substances|mesh-ancestor
6038097|NCT00514137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495925|NCT04520178|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5495926|NCT04520178|Dopamine Agents|dopamine agents|mesh-ancestor
5495927|NCT04520178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5495928|NCT04520178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6038098|NCT00514137|Growth Inhibitors|growth inhibitors|mesh-ancestor
6038099|NCT00514137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6038100|NCT00514137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6038101|NCT00514137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6038102|NCT00514215|Molgramostim|molgramostim|mesh-list
6038103|NCT00514215|Sargramostim|sargramostim|mesh-list
6038104|NCT00514215|Immunologic Factors|immunologic factors|mesh-ancestor
6038105|NCT00514215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038106|NCT00514215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6038107|NCT00514449|Valacyclovir|valacyclovir|mesh-list
6038108|NCT00514449|Antiviral Agents|antiviral agents|mesh-ancestor
6038109|NCT00514449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6038110|NCT00514514|Cyclosporine|cyclosporine|mesh-list
6038111|NCT00514514|Mycophenolic Acid|mycophenolic acid|mesh-list
6038112|NCT00514514|Everolimus|everolimus|mesh-list
6038113|NCT00514514|Cyclosporins|cyclosporins|mesh-list
6038114|NCT00514514|Basiliximab|basiliximab|mesh-list
6038115|NCT00514514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6038116|NCT00514514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6038117|NCT00514514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6038118|NCT00514514|Immunologic Factors|immunologic factors|mesh-ancestor
6038119|NCT00514514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038120|NCT00514514|Antifungal Agents|antifungal agents|mesh-ancestor
6038121|NCT00514514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6038122|NCT00514514|Dermatologic Agents|dermatologic agents|mesh-ancestor
6038123|NCT00514514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5495929|NCT04520178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495930|NCT04520178|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5495931|NCT04520178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6038124|NCT00514514|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6038125|NCT00514514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6457774|NCT00437957|Anticonvulsants|anticonvulsants|mesh-ancestor
5495932|NCT04520178|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5495933|NCT04520178|Antidepressive Agents|antidepressive agents|mesh-ancestor
5495934|NCT04520178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5495935|NCT04520126|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
5495936|NCT04520126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5495937|NCT04520126|Antioxidants|antioxidants|mesh-ancestor
5495938|NCT04520126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495939|NCT04520126|Protective Agents|protective agents|mesh-ancestor
5495940|NCT04520126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495941|NCT04520126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5495942|NCT04520139|Acetylcysteine|acetylcysteine|mesh-list
5495943|NCT04520139|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5495944|NCT04520139|Antiviral Agents|antiviral agents|mesh-ancestor
5495945|NCT04520139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5495946|NCT04520139|Expectorants|expectorants|mesh-ancestor
6038126|NCT00514514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6038127|NCT00514514|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6038128|NCT00514514|Antitubercular Agents|antitubercular agents|mesh-ancestor
6038129|NCT00514514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6038130|NCT00514540|Carboplatin|carboplatin|mesh-list
6038131|NCT00514540|Docetaxel|docetaxel|mesh-list
6038132|NCT00514540|Etoposide|etoposide|mesh-list
6038133|NCT00514540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6038134|NCT00514540|Tubulin Modulators|tubulin modulators|mesh-ancestor
6038135|NCT00514540|Antimitotic Agents|antimitotic agents|mesh-ancestor
6038136|NCT00514540|Mitosis Modulators|mitosis modulators|mesh-ancestor
6038137|NCT00514540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6038138|NCT00514540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6038139|NCT00514540|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6038140|NCT00514540|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6038141|NCT00514540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6038142|NCT00514683|Nintedanib|nintedanib|mesh-list
6038143|NCT00514683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6038144|NCT00514683|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6038145|NCT00514683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6038146|NCT00514683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6038147|NCT00514709|Vaccines|vaccines|mesh-list
6038148|NCT00514709|Immunologic Factors|immunologic factors|mesh-ancestor
6038149|NCT00514709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038150|NCT00514735|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
6038151|NCT00514852|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6038152|NCT00514852|Lubricant Eye Drops|lubricant eye drops|mesh-list
6038153|NCT00514852|Glycerol|glycerol|mesh-list
6038154|NCT00514852|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6038155|NCT00514852|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6038156|NCT00514852|Laxatives|laxatives|mesh-ancestor
6038157|NCT00514852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6038158|NCT00514852|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6038159|NCT00514852|Protective Agents|protective agents|mesh-ancestor
6038160|NCT00514852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038161|NCT00514904|Vaccines|vaccines|mesh-list
6038162|NCT00514904|Immunologic Factors|immunologic factors|mesh-ancestor
6038163|NCT00514904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038164|NCT00514917|Docetaxel|docetaxel|mesh-list
6038165|NCT00514917|Leuprolide|leuprolide|mesh-list
6038166|NCT00514917|Bicalutamide|bicalutamide|mesh-list
6038167|NCT00514917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6038168|NCT00514917|Tubulin Modulators|tubulin modulators|mesh-ancestor
6038169|NCT00514917|Antimitotic Agents|antimitotic agents|mesh-ancestor
6038170|NCT00514917|Mitosis Modulators|mitosis modulators|mesh-ancestor
6038171|NCT00514917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6038172|NCT00514917|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6038173|NCT00514917|Fertility Agents|fertility agents|mesh-ancestor
6038174|NCT00514917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6038175|NCT00514917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038176|NCT00514917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6038177|NCT00514917|Androgen Antagonists|androgen antagonists|mesh-ancestor
6038178|NCT00514917|Hormone Antagonists|hormone antagonists|mesh-ancestor
6038179|NCT00514917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6038180|NCT00514943|Cetuximab|cetuximab|mesh-list
6038181|NCT00514943|Afatinib|afatinib|mesh-list
6038182|NCT00514943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6038183|NCT00514943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6038184|NCT00514943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5495947|NCT04520139|Respiratory System Agents|respiratory system agents|mesh-ancestor
6038185|NCT00514943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6457775|NCT00437957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6038186|NCT00514943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6038187|NCT00515021|Eplerenone|eplerenone|mesh-list
6038188|NCT00515021|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6038189|NCT00515021|Hormone Antagonists|hormone antagonists|mesh-ancestor
6038190|NCT00515021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6038191|NCT00515021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038192|NCT00515021|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6038193|NCT00515021|Diuretics|diuretics|mesh-ancestor
6038194|NCT00515021|Natriuretic Agents|natriuretic agents|mesh-ancestor
6038195|NCT00515021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6038196|NCT00515034|Imipenem|imipenem|mesh-list
6038197|NCT00515034|Doripenem|doripenem|mesh-list
6038198|NCT00515034|Cilastatin|cilastatin|mesh-list
6038199|NCT00515034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6038200|NCT00515034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6038201|NCT00515034|Protease Inhibitors|protease inhibitors|mesh-ancestor
6038202|NCT00515034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6038203|NCT00515034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053665|NCT00597116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6053666|NCT00597116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6053667|NCT00597116|Tubulin Modulators|tubulin modulators|mesh-ancestor
5495948|NCT04520139|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5495949|NCT04520139|Antioxidants|antioxidants|mesh-ancestor
5495950|NCT04520139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495951|NCT04520139|Protective Agents|protective agents|mesh-ancestor
5495952|NCT04520139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495953|NCT04520139|Antidotes|antidotes|mesh-ancestor
5495954|NCT04519983|Osimertinib|osimertinib|mesh-list
5495955|NCT04519983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5495956|NCT04519983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5495957|NCT04519983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5495958|NCT04519983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495959|NCT04520035|Paclitaxel|paclitaxel|mesh-list
5495960|NCT04520035|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5495961|NCT04520035|Cisplatin|cisplatin|mesh-list
5495962|NCT04520035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5495963|NCT04520035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6053668|NCT00597116|Antimitotic Agents|antimitotic agents|mesh-ancestor
6053669|NCT00597116|Mitosis Modulators|mitosis modulators|mesh-ancestor
6053670|NCT00597116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053671|NCT00597402|Bevacizumab|bevacizumab|mesh-list
6053672|NCT00597402|Irinotecan|irinotecan|mesh-list
6053673|NCT00597402|Temozolomide|temozolomide|mesh-list
6053674|NCT00597402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6053675|NCT00597402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6053676|NCT00597402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6053677|NCT00597402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6053678|NCT00597402|Growth Substances|growth substances|mesh-ancestor
6053679|NCT00597402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053680|NCT00597402|Growth Inhibitors|growth inhibitors|mesh-ancestor
6053681|NCT00597402|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6053682|NCT00597402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6053683|NCT00597402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6053684|NCT00597402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053685|NCT00597402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6053686|NCT00597402|Alkylating Agents|alkylating agents|mesh-ancestor
6053687|NCT00597428|Lubiprostone|lubiprostone|mesh-list
6053688|NCT00597428|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6053689|NCT00597428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6053690|NCT00597428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053691|NCT00597493|Temozolomide|temozolomide|mesh-list
6053692|NCT00597493|Sorafenib|sorafenib|mesh-list
6053693|NCT00597493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5495964|NCT04520035|Tubulin Modulators|tubulin modulators|mesh-ancestor
5495965|NCT04520035|Antimitotic Agents|antimitotic agents|mesh-ancestor
5495966|NCT04520035|Mitosis Modulators|mitosis modulators|mesh-ancestor
5495967|NCT04520035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503250|NCT04460807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5503251|NCT04460807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5503252|NCT04460807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053694|NCT00597493|Alkylating Agents|alkylating agents|mesh-ancestor
6053695|NCT00597493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503253|NCT04460807|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6038204|NCT00515073|Diphenhydramine|diphenhydramine|mesh-list
6038205|NCT00515073|Promethazine|promethazine|mesh-list
6038206|NCT00515073|Dexamethasone|dexamethasone|mesh-list
5495968|NCT04519944|Edoxaban|edoxaban|mesh-list
5495969|NCT04519944|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5495970|NCT04519944|Antithrombins|antithrombins|mesh-ancestor
5495971|NCT04519944|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5495972|NCT04519944|Protease Inhibitors|protease inhibitors|mesh-ancestor
5495973|NCT04519944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5495974|NCT04519944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5495975|NCT04519944|Anticoagulants|anticoagulants|mesh-ancestor
5495976|NCT04519476|Methylprednisolone|methylprednisolone|mesh-list
5495977|NCT04519476|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5495978|NCT04519476|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5495979|NCT04519476|Prednisolone|prednisolone|mesh-list
5495980|NCT04519476|Prednisolone acetate|prednisolone acetate|mesh-list
5495981|NCT04519476|Lenalidomide|lenalidomide|mesh-list
5495982|NCT04519476|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6038207|NCT00515073|Paclitaxel|paclitaxel|mesh-list
6038208|NCT00515073|Cimetidine|cimetidine|mesh-list
6038209|NCT00515073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6038210|NCT00515073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6038211|NCT00515073|Tubulin Modulators|tubulin modulators|mesh-ancestor
6038212|NCT00515073|Antimitotic Agents|antimitotic agents|mesh-ancestor
6038213|NCT00515073|Mitosis Modulators|mitosis modulators|mesh-ancestor
6038214|NCT00515073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6038215|NCT00515073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6038216|NCT00515073|Antiemetics|antiemetics|mesh-ancestor
6038217|NCT00515073|Autonomic Agents|autonomic agents|mesh-ancestor
6038218|NCT00515073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6038219|NCT00515073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038220|NCT00515073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6038221|NCT00515073|Glucocorticoids|glucocorticoids|mesh-ancestor
6038222|NCT00515073|Hormones|hormones|mesh-ancestor
6038223|NCT00515073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6038224|NCT00515073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6038225|NCT00515073|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6038226|NCT00515073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6038227|NCT00515073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6038228|NCT00515073|Anesthetics, Local|anesthetics, local|mesh-ancestor
6038229|NCT00515073|Anesthetics|anesthetics|mesh-ancestor
6038230|NCT00515073|Sensory System Agents|sensory system agents|mesh-ancestor
6038231|NCT00515073|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6038232|NCT00515073|Histamine Antagonists|histamine antagonists|mesh-ancestor
6038233|NCT00515073|Histamine Agents|histamine agents|mesh-ancestor
6038234|NCT00515073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6038235|NCT00515073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6038236|NCT00515073|Antipruritics|antipruritics|mesh-ancestor
6038237|NCT00515073|Dermatologic Agents|dermatologic agents|mesh-ancestor
6038238|NCT00515073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6038239|NCT00515073|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6038240|NCT00515073|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6038241|NCT00515073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6038242|NCT00515073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6038243|NCT00515086|Everolimus|everolimus|mesh-list
6038244|NCT00515086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6038245|NCT00515086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5495983|NCT04519476|Prednisolone phosphate|prednisolone phosphate|mesh-list
5495984|NCT04519476|Immunologic Factors|immunologic factors|mesh-ancestor
5495985|NCT04519476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038246|NCT00515086|Immunologic Factors|immunologic factors|mesh-ancestor
6038247|NCT00515086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038248|NCT00515099|Thymoglobulin|thymoglobulin|mesh-list
6038249|NCT00515099|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6038250|NCT00515099|Immunologic Factors|immunologic factors|mesh-ancestor
6038251|NCT00515099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038252|NCT00515099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6038253|NCT00515177|Eszopiclone|eszopiclone|mesh-list
6038254|NCT00515177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6038255|NCT00515177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6038256|NCT00515177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038257|NCT00515216|Leucovorin|leucovorin|mesh-list
6038258|NCT00515216|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
6038259|NCT00515216|Tetrahydrofolates|tetrahydrofolates|mesh-list
6038260|NCT00515216|Fluorouracil|fluorouracil|mesh-list
6038261|NCT00515216|Oxaliplatin|oxaliplatin|mesh-list
6038262|NCT00515216|Levoleucovorin|levoleucovorin|mesh-list
6038263|NCT00515216|Antimetabolites|antimetabolites|mesh-ancestor
6038264|NCT00515216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6038265|NCT00515216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6038266|NCT00515216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6038267|NCT00515216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5495986|NCT04519476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5495987|NCT04519476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5495988|NCT04519476|Growth Substances|growth substances|mesh-ancestor
5495989|NCT04519476|Growth Inhibitors|growth inhibitors|mesh-ancestor
6038268|NCT00515216|Immunologic Factors|immunologic factors|mesh-ancestor
6038269|NCT00515216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038270|NCT00515216|Antidotes|antidotes|mesh-ancestor
6038271|NCT00515216|Protective Agents|protective agents|mesh-ancestor
6038272|NCT00515216|Vitamin B Complex|vitamin b complex|mesh-ancestor
6038273|NCT00515216|Vitamins|vitamins|mesh-ancestor
6038274|NCT00515216|Micronutrients|micronutrients|mesh-ancestor
6038275|NCT00515294|Caffeine|caffeine|mesh-list
6038276|NCT00515294|Methamphetamine|methamphetamine|mesh-list
6038277|NCT00515294|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6038278|NCT00515294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038279|NCT00515294|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6038280|NCT00515294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6038281|NCT00515294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6038282|NCT00515294|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6038283|NCT00515294|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6038284|NCT00515294|Purinergic Agents|purinergic agents|mesh-ancestor
6038285|NCT00515294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6038286|NCT00515294|Sympathomimetics|sympathomimetics|mesh-ancestor
6038287|NCT00515294|Autonomic Agents|autonomic agents|mesh-ancestor
6038288|NCT00515294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6038289|NCT00515294|Dopamine Agents|dopamine agents|mesh-ancestor
6457776|NCT00437957|GABA Agents|gaba agents|mesh-ancestor
6457777|NCT00437957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6457778|NCT00437957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5495990|NCT04519476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6038290|NCT00515294|Adrenergic Agents|adrenergic agents|mesh-ancestor
6038291|NCT00515294|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6038292|NCT00515294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5495991|NCT04519476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5495992|NCT04519476|Antiemetics|antiemetics|mesh-ancestor
5495993|NCT04519476|Autonomic Agents|autonomic agents|mesh-ancestor
5495994|NCT04519476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5495995|NCT04519476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5495996|NCT04519476|Glucocorticoids|glucocorticoids|mesh-ancestor
5495997|NCT04519476|Hormones|hormones|mesh-ancestor
5503254|NCT04460807|Hormone Antagonists|hormone antagonists|mesh-ancestor
6038293|NCT00515294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6038294|NCT00515294|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6038295|NCT00515411|Leucovorin|leucovorin|mesh-list
6038296|NCT00515411|Cisplatin|cisplatin|mesh-list
6038297|NCT00515411|Docetaxel|docetaxel|mesh-list
6038298|NCT00515411|Fluorouracil|fluorouracil|mesh-list
6038299|NCT00515411|Trastuzumab|trastuzumab|mesh-list
6038300|NCT00515411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6038301|NCT00515411|Tubulin Modulators|tubulin modulators|mesh-ancestor
6038302|NCT00515411|Antimitotic Agents|antimitotic agents|mesh-ancestor
6038303|NCT00515411|Mitosis Modulators|mitosis modulators|mesh-ancestor
6038304|NCT00515411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6038305|NCT00515411|Antimetabolites|antimetabolites|mesh-ancestor
6038306|NCT00515411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6457779|NCT00437957|Antimanic Agents|antimanic agents|mesh-ancestor
6038307|NCT00515411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6038308|NCT00515411|Immunologic Factors|immunologic factors|mesh-ancestor
6038309|NCT00515411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038310|NCT00515411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6038311|NCT00515411|Antidotes|antidotes|mesh-ancestor
6038312|NCT00515411|Protective Agents|protective agents|mesh-ancestor
6038313|NCT00515411|Vitamin B Complex|vitamin b complex|mesh-ancestor
6038314|NCT00515411|Vitamins|vitamins|mesh-ancestor
6038315|NCT00515411|Micronutrients|micronutrients|mesh-ancestor
6038316|NCT00515437|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
6038317|NCT00515437|Botulinum Toxins|botulinum toxins|mesh-list
6038318|NCT00515437|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6038319|NCT00515437|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6038320|NCT00515437|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6038321|NCT00515437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6038322|NCT00515437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6038323|NCT00515437|Cholinergic Agents|cholinergic agents|mesh-ancestor
6038324|NCT00515437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6038325|NCT00515437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038326|NCT00515437|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6038327|NCT00515437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6038328|NCT00515437|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6038329|NCT00515463|Denosumab|denosumab|mesh-list
6038330|NCT00515463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6038331|NCT00515463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038332|NCT00515502|Tiotropium Bromide|tiotropium bromide|mesh-list
6038333|NCT00515502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6038334|NCT00515502|Autonomic Agents|autonomic agents|mesh-ancestor
6038335|NCT00515502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6038336|NCT00515502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038337|NCT00515502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6038338|NCT00515502|Respiratory System Agents|respiratory system agents|mesh-ancestor
6038339|NCT00515502|Parasympatholytics|parasympatholytics|mesh-ancestor
6038340|NCT00515502|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6038341|NCT00515502|Cholinergic Agents|cholinergic agents|mesh-ancestor
6038342|NCT00515502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6038343|NCT00515502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6038344|NCT00515619|Lacosamide|lacosamide|mesh-list
6038345|NCT00515619|Anticonvulsants|anticonvulsants|mesh-ancestor
6038346|NCT00515619|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6038347|NCT00515619|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6038348|NCT00515619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6038349|NCT00515619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6038350|NCT00515697|Ramucirumab|ramucirumab|mesh-list
6038351|NCT00515697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6038352|NCT00515723|Olanzapine|olanzapine|mesh-list
6038353|NCT00515723|Risperidone|risperidone|mesh-list
6038354|NCT00515723|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6038355|NCT00515723|Ziprasidone|ziprasidone|mesh-list
6038356|NCT00515723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6038357|NCT00515723|Serotonin Agents|serotonin agents|mesh-ancestor
6038358|NCT00515723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6038359|NCT00515723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6038360|NCT00515723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038361|NCT00515723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6038362|NCT00515723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6038363|NCT00515723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6038364|NCT00515723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6038365|NCT00515723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6038366|NCT00515723|Dopamine Agents|dopamine agents|mesh-ancestor
6038367|NCT00515723|Antiemetics|antiemetics|mesh-ancestor
6038368|NCT00515723|Autonomic Agents|autonomic agents|mesh-ancestor
6038369|NCT00515723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6038370|NCT00515723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6038371|NCT00515723|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6457780|NCT00437957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6457781|NCT00437957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6457782|NCT00437957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6457783|NCT00437970|Metformin|metformin|mesh-list
6457784|NCT00437970|Pioglitazone|pioglitazone|mesh-list
6457785|NCT00437970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6457786|NCT00437970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457787|NCT00437996|Clonidine|clonidine|mesh-list
6457788|NCT00437996|Sufentanil|sufentanil|mesh-list
6457789|NCT00437996|Levobupivacaine|levobupivacaine|mesh-list
6457790|NCT00437996|Anesthetics, Local|anesthetics, local|mesh-ancestor
6457791|NCT00437996|Anesthetics|anesthetics|mesh-ancestor
6457792|NCT00437996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6457793|NCT00437996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457794|NCT00437996|Sensory System Agents|sensory system agents|mesh-ancestor
6457795|NCT00437996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6457796|NCT00437996|Analgesics|analgesics|mesh-ancestor
6457797|NCT00437996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6457798|NCT00437996|Sympatholytics|sympatholytics|mesh-ancestor
6457799|NCT00437996|Autonomic Agents|autonomic agents|mesh-ancestor
6457800|NCT00437996|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6457801|NCT00437996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6457802|NCT00437996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6038372|NCT00515723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6038373|NCT00515723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6038374|NCT00515723|Antidepressive Agents|antidepressive agents|mesh-ancestor
6038375|NCT00515827|Raltegravir Potassium|raltegravir potassium|mesh-list
6038376|NCT00515827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6038377|NCT00515827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6038378|NCT00515827|Antiviral Agents|antiviral agents|mesh-ancestor
6038379|NCT00515827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6038380|NCT00515827|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6038381|NCT00515827|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6038382|NCT00515827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6038383|NCT00515827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6038384|NCT00515879|Cycloserine|cycloserine|mesh-list
6038385|NCT00515879|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6038386|NCT00515879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6038387|NCT00515879|Renal Agents|renal agents|mesh-ancestor
6038388|NCT00515879|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6038389|NCT00515879|Antitubercular Agents|antitubercular agents|mesh-ancestor
6038390|NCT00515879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6038391|NCT00515879|Antimetabolites|antimetabolites|mesh-ancestor
6038392|NCT00515879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6038393|NCT00516048|Exenatide|exenatide|mesh-list
6038394|NCT00516048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6038395|NCT00516048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038396|NCT00516048|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6038397|NCT00516048|Incretins|incretins|mesh-ancestor
6038398|NCT00516048|Hormones|hormones|mesh-ancestor
6038399|NCT00516048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6038400|NCT00516074|Exenatide|exenatide|mesh-list
6038401|NCT00516074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6038402|NCT00516074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038403|NCT00516074|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6038404|NCT00516074|Incretins|incretins|mesh-ancestor
6038405|NCT00516074|Hormones|hormones|mesh-ancestor
6457803|NCT00437996|Adrenergic Agents|adrenergic agents|mesh-ancestor
6457804|NCT00437996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6457805|NCT00437996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6038406|NCT00516074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6038407|NCT00516139|Lamotrigine|lamotrigine|mesh-list
6038408|NCT00516139|Anticonvulsants|anticonvulsants|mesh-ancestor
6038409|NCT00516139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6038410|NCT00516139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6038411|NCT00516139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6038412|NCT00516139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6038413|NCT00516139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038414|NCT00516139|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6038415|NCT00516139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6038416|NCT00516139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6038417|NCT00516139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6038418|NCT00516139|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6038419|NCT00516165|Everolimus|everolimus|mesh-list
6038420|NCT00516165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6038421|NCT00516165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6038422|NCT00516165|Immunologic Factors|immunologic factors|mesh-ancestor
6038423|NCT00516165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038424|NCT00516217|Galiximab|galiximab|mesh-list
6038425|NCT00516217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6038426|NCT00516217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6038427|NCT00516269|Methylphenidate|methylphenidate|mesh-list
6038428|NCT00516269|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6038429|NCT00516269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038430|NCT00516269|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6038431|NCT00516269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6038432|NCT00516269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5495998|NCT04519476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5495999|NCT04519476|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6038433|NCT00516269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6038434|NCT00516269|Dopamine Agents|dopamine agents|mesh-ancestor
6038435|NCT00516269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6038436|NCT00516295|Cyclophosphamide|cyclophosphamide|mesh-list
6038437|NCT00516295|Bevacizumab|bevacizumab|mesh-list
6038438|NCT00516295|Vincristine|vincristine|mesh-list
6038439|NCT00516295|Topotecan|topotecan|mesh-list
6038440|NCT00516295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6038441|NCT00516295|Antibodies|antibodies|mesh-list
6038442|NCT00516295|Immunoglobulins|immunoglobulins|mesh-list
6038443|NCT00516295|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6038444|NCT00516295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6038445|NCT00516295|Immunologic Factors|immunologic factors|mesh-ancestor
6038446|NCT00516295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038447|NCT00516295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6038448|NCT00516295|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6038449|NCT00516295|Alkylating Agents|alkylating agents|mesh-ancestor
6038450|NCT00516295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6038451|NCT00516295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6038452|NCT00516295|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6038453|NCT00516295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6038454|NCT00516295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6038455|NCT00516295|Growth Substances|growth substances|mesh-ancestor
6038456|NCT00516295|Growth Inhibitors|growth inhibitors|mesh-ancestor
6038457|NCT00516295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6038458|NCT00516295|Tubulin Modulators|tubulin modulators|mesh-ancestor
5496000|NCT04519476|Protective Agents|protective agents|mesh-ancestor
5496001|NCT04519476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5496002|NCT04519463|Lidocaine|lidocaine|mesh-list
5496003|NCT04519463|Anesthetics, Local|anesthetics, local|mesh-ancestor
5496004|NCT04519463|Anesthetics|anesthetics|mesh-ancestor
5496005|NCT04519463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5496006|NCT04519463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496007|NCT04519463|Sensory System Agents|sensory system agents|mesh-ancestor
5496008|NCT04519463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5496009|NCT04519463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5496010|NCT04519463|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5496011|NCT04519463|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5496012|NCT04519463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5496013|NCT04519463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496014|NCT04519762|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6038459|NCT00516295|Antimitotic Agents|antimitotic agents|mesh-ancestor
6038460|NCT00516295|Mitosis Modulators|mitosis modulators|mesh-ancestor
6457806|NCT00437996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6038461|NCT00516295|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6038462|NCT00516295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6038463|NCT00516295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6038464|NCT00516386|Mecasermin|mecasermin|mesh-list
6038465|NCT00516386|Growth Substances|growth substances|mesh-ancestor
6038466|NCT00516386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038467|NCT00516503|Ketamine|ketamine|mesh-list
6038468|NCT00516503|Amitriptyline|amitriptyline|mesh-list
6038469|NCT00516503|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6038470|NCT00516503|Baclofen|baclofen|mesh-list
6038471|NCT00516503|Analgesics|analgesics|mesh-ancestor
6038472|NCT00516503|Sensory System Agents|sensory system agents|mesh-ancestor
6038473|NCT00516503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6038474|NCT00516503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038475|NCT00516503|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6038476|NCT00516503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6038477|NCT00516503|Anesthetics, General|anesthetics, general|mesh-ancestor
6038478|NCT00516503|Anesthetics|anesthetics|mesh-ancestor
6038479|NCT00516503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6038480|NCT00516503|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6038481|NCT00516503|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6038482|NCT00516503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6038483|NCT00516503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496015|NCT04519762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5496016|NCT04519710|Rituximab|rituximab|mesh-list
5496017|NCT04519710|Ocrelizumab|ocrelizumab|mesh-list
5496018|NCT04519710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5496019|NCT04519710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5496020|NCT04519710|Immunologic Factors|immunologic factors|mesh-ancestor
5496021|NCT04519710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496022|NCT04519710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5496023|NCT04519164|Eplerenone|eplerenone|mesh-list
5496024|NCT04519164|Chlorthalidone|chlorthalidone|mesh-list
5496025|NCT04519164|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5496026|NCT04519164|Hormone Antagonists|hormone antagonists|mesh-ancestor
5496027|NCT04519164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5496028|NCT04519164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496029|NCT04519164|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5496030|NCT04519164|Diuretics|diuretics|mesh-ancestor
5496031|NCT04519164|Natriuretic Agents|natriuretic agents|mesh-ancestor
5496032|NCT04519164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5496033|NCT04519164|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5496034|NCT04519164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5496035|NCT04519164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496036|NCT04519125|Tenofovir|tenofovir|mesh-list
5496037|NCT04519125|Emtricitabine|emtricitabine|mesh-list
5496038|NCT04519125|Antiviral Agents|antiviral agents|mesh-ancestor
5496039|NCT04519125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5496040|NCT04519125|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5496041|NCT04519125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5496042|NCT04519125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5496043|NCT04519125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496044|NCT04519125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6038484|NCT00516503|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6038485|NCT00516503|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6038486|NCT00516503|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6038487|NCT00516503|GABA Agonists|gaba agonists|mesh-ancestor
6038488|NCT00516503|GABA Agents|gaba agents|mesh-ancestor
6038489|NCT00516503|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6038490|NCT00516503|Antidepressive Agents|antidepressive agents|mesh-ancestor
6038491|NCT00516503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6038492|NCT00516503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6038493|NCT00516503|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6038494|NCT00516503|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6038495|NCT00516503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6038496|NCT00516503|Adrenergic Agents|adrenergic agents|mesh-ancestor
6038497|NCT00516503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6038498|NCT00516503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6038499|NCT00516893|Natalizumab|natalizumab|mesh-list
6038500|NCT00516893|Immunologic Factors|immunologic factors|mesh-ancestor
6038501|NCT00516893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038502|NCT00516906|Chlorhexidine|chlorhexidine|mesh-list
6038503|NCT00516906|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6038504|NCT00516906|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6038505|NCT00516906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6038506|NCT00516906|Disinfectants|disinfectants|mesh-ancestor
5496045|NCT04519125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5496046|NCT04519151|Pembrolizumab|pembrolizumab|mesh-list
5496047|NCT04519151|Lenvatinib|lenvatinib|mesh-list
5496048|NCT04519151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5496049|NCT04519151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5496050|NCT04519151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6038507|NCT00516906|Dermatologic Agents|dermatologic agents|mesh-ancestor
6038508|NCT00516919|Orlistat|orlistat|mesh-list
6038509|NCT00516919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6038510|NCT00516919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6038511|NCT00516919|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6038512|NCT00516919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6038513|NCT00517010|Ranibizumab|ranibizumab|mesh-list
6038514|NCT00517010|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6038515|NCT00517010|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6038516|NCT00517010|Growth Substances|growth substances|mesh-ancestor
6038517|NCT00517010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038518|NCT00517010|Growth Inhibitors|growth inhibitors|mesh-ancestor
6038519|NCT00517010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6038520|NCT00517296|Adalimumab|adalimumab|mesh-list
6038521|NCT00517296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6038522|NCT00517296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6038523|NCT00517413|Epoetin Alfa|epoetin alfa|mesh-list
6038524|NCT00517413|Hematinics|hematinics|mesh-ancestor
6038525|NCT00517530|Obinutuzumab|obinutuzumab|mesh-list
6038526|NCT00517530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6038527|NCT00517530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6038528|NCT00517556|Contraceptive Agents|contraceptive agents|mesh-list
6038529|NCT00517556|Contraceptives, Oral|contraceptives, oral|mesh-list
6038530|NCT00517556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6038531|NCT00517556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038532|NCT00517556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6038533|NCT00517595|Gemcitabine|gemcitabine|mesh-list
6038534|NCT00517595|Bevacizumab|bevacizumab|mesh-list
6038535|NCT00517595|Pemetrexed|pemetrexed|mesh-list
6038536|NCT00517595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6038537|NCT00517595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6038538|NCT00517595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6038539|NCT00517595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6038540|NCT00517595|Growth Substances|growth substances|mesh-ancestor
6038541|NCT00517595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457807|NCT00437996|Narcotics|narcotics|mesh-ancestor
6457808|NCT00437996|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6457809|NCT00437996|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6457810|NCT00437996|Anesthetics, General|anesthetics, general|mesh-ancestor
6457811|NCT00438048|Pilocarpine|pilocarpine|mesh-list
6457812|NCT00438048|Miotics|miotics|mesh-ancestor
6457813|NCT00438048|Autonomic Agents|autonomic agents|mesh-ancestor
6457814|NCT00438048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6457815|NCT00438048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457816|NCT00438048|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
5496051|NCT04519151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5496052|NCT04519151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496053|NCT04519281|Ascorbic Acid|ascorbic acid|mesh-list
5496054|NCT04519281|Vitamins|vitamins|mesh-ancestor
5496055|NCT04519281|Micronutrients|micronutrients|mesh-ancestor
5496056|NCT04519281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496057|NCT04519281|Antioxidants|antioxidants|mesh-ancestor
5496058|NCT04519281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496059|NCT04519281|Protective Agents|protective agents|mesh-ancestor
5496060|NCT04519385|Dexamethasone|dexamethasone|mesh-list
5496061|NCT04519385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5496062|NCT04519385|Antiemetics|antiemetics|mesh-ancestor
6457817|NCT00438048|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6457818|NCT00438048|Cholinergic Agents|cholinergic agents|mesh-ancestor
6457819|NCT00438048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6457820|NCT00438048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457821|NCT00438087|Methylprednisolone|methylprednisolone|mesh-list
6038542|NCT00517595|Growth Inhibitors|growth inhibitors|mesh-ancestor
6038543|NCT00517595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6038544|NCT00517595|Antimetabolites|antimetabolites|mesh-ancestor
6038545|NCT00517595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6038546|NCT00517595|Antiviral Agents|antiviral agents|mesh-ancestor
6457822|NCT00438087|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5496063|NCT04519385|Autonomic Agents|autonomic agents|mesh-ancestor
5496064|NCT04519385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6457823|NCT00438087|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6457824|NCT00438087|Prednisolone|prednisolone|mesh-list
6457825|NCT00438087|Prednisolone acetate|prednisolone acetate|mesh-list
6457826|NCT00438087|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6457827|NCT00438087|Prednisolone phosphate|prednisolone phosphate|mesh-list
6457828|NCT00438087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6457829|NCT00438087|Antiemetics|antiemetics|mesh-ancestor
6457830|NCT00438087|Autonomic Agents|autonomic agents|mesh-ancestor
6038547|NCT00517595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6038548|NCT00517595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6038549|NCT00517595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6038550|NCT00517595|Immunologic Factors|immunologic factors|mesh-ancestor
6038551|NCT00517595|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6038552|NCT00517595|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6038553|NCT00517829|Docetaxel|docetaxel|mesh-list
6038554|NCT00517829|Oxaliplatin|oxaliplatin|mesh-list
6038555|NCT00517829|Cetuximab|cetuximab|mesh-list
6038556|NCT00517829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6038557|NCT00517829|Tubulin Modulators|tubulin modulators|mesh-ancestor
6038558|NCT00517829|Antimitotic Agents|antimitotic agents|mesh-ancestor
6038559|NCT00517829|Mitosis Modulators|mitosis modulators|mesh-ancestor
6038560|NCT00517829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6038561|NCT00517829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6038562|NCT00517881|Epoetin Alfa|epoetin alfa|mesh-list
6038563|NCT00517881|Hematinics|hematinics|mesh-ancestor
6038564|NCT00517933|Sildenafil Citrate|sildenafil citrate|mesh-list
6038565|NCT00517933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6038566|NCT00517933|Vasodilator Agents|vasodilator agents|mesh-ancestor
6038567|NCT00517933|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6038568|NCT00517933|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6038569|NCT00517933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5496065|NCT04519385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496066|NCT04519385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5496067|NCT04519385|Glucocorticoids|glucocorticoids|mesh-ancestor
5496068|NCT04519385|Hormones|hormones|mesh-ancestor
5496069|NCT04519385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5496070|NCT04519385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6038570|NCT00517933|Urological Agents|urological agents|mesh-ancestor
6038571|NCT00518011|Gemcitabine|gemcitabine|mesh-list
6038572|NCT00518011|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6038573|NCT00518011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6038574|NCT00518011|Antimetabolites|antimetabolites|mesh-ancestor
6038575|NCT00518011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6038576|NCT00518011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6038577|NCT00518011|Antiviral Agents|antiviral agents|mesh-ancestor
6038578|NCT00518011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6038579|NCT00518011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6038580|NCT00518011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6038581|NCT00518011|Immunologic Factors|immunologic factors|mesh-ancestor
6038582|NCT00518011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038583|NCT00518011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6038584|NCT00518089|Gatifloxacin|gatifloxacin|mesh-list
6038585|NCT00518089|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6038586|NCT00518089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6038587|NCT00518089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6038588|NCT00518089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6038589|NCT00518089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6038590|NCT00518089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6457831|NCT00438087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6038591|NCT00518089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6038592|NCT00518089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6038593|NCT00518089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6038594|NCT00518115|Exenatide|exenatide|mesh-list
6038595|NCT00518115|rGLP-1 protein|rglp-1 protein|mesh-list
6038596|NCT00518115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6038597|NCT00518115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038598|NCT00518115|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6038599|NCT00518115|Incretins|incretins|mesh-ancestor
6038600|NCT00518115|Hormones|hormones|mesh-ancestor
6038601|NCT00518115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6038602|NCT00518154|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
6038603|NCT00518154|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6038604|NCT00518154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6038605|NCT00518154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6038606|NCT00518154|Cholinergic Agents|cholinergic agents|mesh-ancestor
6038607|NCT00518154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6038608|NCT00518154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038609|NCT00518180|Lactitol|lactitol|mesh-list
6038610|NCT00518180|Vaccines|vaccines|mesh-list
6038611|NCT00518180|Immunologic Factors|immunologic factors|mesh-ancestor
6038612|NCT00518180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038613|NCT00518180|Cathartics|cathartics|mesh-ancestor
6038614|NCT00518180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6038615|NCT00518206|Cyclophosphamide|cyclophosphamide|mesh-list
6038616|NCT00518206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6038617|NCT00518206|Immunologic Factors|immunologic factors|mesh-ancestor
6038618|NCT00518206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038619|NCT00518206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6038620|NCT00518206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6038621|NCT00518206|Alkylating Agents|alkylating agents|mesh-ancestor
6038622|NCT00518206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6038623|NCT00518206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6038624|NCT00518206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6038625|NCT00518284|Paclitaxel|paclitaxel|mesh-list
6038626|NCT00518284|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6038627|NCT00518284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6038628|NCT00518284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6038629|NCT00518284|Tubulin Modulators|tubulin modulators|mesh-ancestor
6038630|NCT00518284|Antimitotic Agents|antimitotic agents|mesh-ancestor
6038631|NCT00518284|Mitosis Modulators|mitosis modulators|mesh-ancestor
6038632|NCT00518284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6038633|NCT00518323|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6038634|NCT00518323|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6038635|NCT00518323|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6038636|NCT00518323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6038637|NCT00518323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038638|NCT00518323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6038639|NCT00518323|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6038640|NCT00518323|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6038641|NCT00518323|Serotonin Agents|serotonin agents|mesh-ancestor
6038642|NCT00518323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6038643|NCT00518323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6038644|NCT00518323|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6038645|NCT00518323|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6038646|NCT00518323|Dopamine Agents|dopamine agents|mesh-ancestor
6038647|NCT00518531|Denosumab|denosumab|mesh-list
6038648|NCT00518531|Alendronate|alendronate|mesh-list
6038649|NCT00518531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6038650|NCT00518531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457832|NCT00438087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457833|NCT00438087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6457834|NCT00438087|Glucocorticoids|glucocorticoids|mesh-ancestor
6457835|NCT00438087|Hormones|hormones|mesh-ancestor
6038651|NCT00518687|Vaccines|vaccines|mesh-list
6038652|NCT00518687|Immunologic Factors|immunologic factors|mesh-ancestor
6038653|NCT00518687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038654|NCT00518713|Clobazam|clobazam|mesh-list
6038655|NCT00518713|Anticonvulsants|anticonvulsants|mesh-ancestor
6038656|NCT00518713|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5496071|NCT04519385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5496072|NCT04518852|Sorafenib|sorafenib|mesh-list
5496073|NCT04518852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5496074|NCT04518852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5496075|NCT04518852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5496076|NCT04518852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496077|NCT04518735|Anticoagulants|anticoagulants|mesh-list
5496078|NCT04518618|Fentanyl|fentanyl|mesh-list
5496079|NCT04518618|Naloxone|naloxone|mesh-list
5496080|NCT04518618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6038657|NCT00518713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6038658|NCT00518713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6038659|NCT00518713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038660|NCT00518713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6038661|NCT00518713|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6038662|NCT00518713|GABA Agonists|gaba agonists|mesh-ancestor
6038663|NCT00518713|GABA Agents|gaba agents|mesh-ancestor
6038664|NCT00518713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6038665|NCT00518713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6038666|NCT00518882|Liraglutide|liraglutide|mesh-list
6038667|NCT00518882|Exenatide|exenatide|mesh-list
6038668|NCT00518882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6038669|NCT00518882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038670|NCT00518882|Incretins|incretins|mesh-ancestor
6038671|NCT00518882|Hormones|hormones|mesh-ancestor
6038672|NCT00518882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6038673|NCT00518882|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6038674|NCT00518973|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6038675|NCT00518973|Antidepressive Agents|antidepressive agents|mesh-ancestor
6038676|NCT00518973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6038677|NCT00518973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6038678|NCT00518973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6038679|NCT00518973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6038680|NCT00518973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038681|NCT00518986|Modafinil|modafinil|mesh-list
6038682|NCT00518986|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6038683|NCT00518986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038684|NCT00518986|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6038685|NCT00518986|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6038686|NCT00518986|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6038687|NCT00518986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6038688|NCT00519077|Gefitinib|gefitinib|mesh-list
6038689|NCT00519077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6038690|NCT00519077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6038691|NCT00519077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6038692|NCT00519077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6038693|NCT00519285|Prednisone|prednisone|mesh-list
6038694|NCT00519285|Prednisolone|prednisolone|mesh-list
6038695|NCT00519285|Docetaxel|docetaxel|mesh-list
6038696|NCT00519285|Aflibercept|aflibercept|mesh-list
6038697|NCT00519285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6038698|NCT00519285|Tubulin Modulators|tubulin modulators|mesh-ancestor
6038699|NCT00519285|Antimitotic Agents|antimitotic agents|mesh-ancestor
6038700|NCT00519285|Mitosis Modulators|mitosis modulators|mesh-ancestor
6038701|NCT00519285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6038702|NCT00519285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6038703|NCT00519285|Glucocorticoids|glucocorticoids|mesh-ancestor
6038704|NCT00519285|Hormones|hormones|mesh-ancestor
6038705|NCT00519285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6038706|NCT00519285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038707|NCT00519285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6038708|NCT00519285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6038709|NCT00519285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6038710|NCT00519285|Growth Substances|growth substances|mesh-ancestor
6038711|NCT00519285|Growth Inhibitors|growth inhibitors|mesh-ancestor
6038712|NCT00519428|Dexetimide|dexetimide|mesh-list
6038713|NCT00519428|Citalopram|citalopram|mesh-list
5496081|NCT04518618|Narcotics|narcotics|mesh-ancestor
6038714|NCT00519428|Bupropion|bupropion|mesh-list
6038715|NCT00519428|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6038716|NCT00519428|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6038717|NCT00519428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6038718|NCT00519428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6038719|NCT00519428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6038720|NCT00519428|Serotonin Agents|serotonin agents|mesh-ancestor
6038721|NCT00519428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038722|NCT00519428|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6038723|NCT00519428|Antidepressive Agents|antidepressive agents|mesh-ancestor
6038724|NCT00519428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6038725|NCT00519428|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6038726|NCT00519428|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6038727|NCT00519428|Parasympatholytics|parasympatholytics|mesh-ancestor
6038728|NCT00519428|Autonomic Agents|autonomic agents|mesh-ancestor
6038729|NCT00519428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6038730|NCT00519428|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6038731|NCT00519428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6038732|NCT00519428|Cholinergic Agents|cholinergic agents|mesh-ancestor
6038733|NCT00519428|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6038734|NCT00519428|Dopamine Agents|dopamine agents|mesh-ancestor
6038735|NCT00519428|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6038736|NCT00519428|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6038737|NCT00519428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6038738|NCT00519532|Rotigotine|rotigotine|mesh-list
6038739|NCT00519532|Dopamine Agonists|dopamine agonists|mesh-ancestor
6038740|NCT00519532|Dopamine Agents|dopamine agents|mesh-ancestor
6038741|NCT00519532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6038742|NCT00519532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6038743|NCT00519532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038744|NCT00519584|Bupivacaine|bupivacaine|mesh-list
6038745|NCT00519584|Ropivacaine|ropivacaine|mesh-list
6038746|NCT00519584|Anesthetics, Local|anesthetics, local|mesh-ancestor
6038747|NCT00519584|Anesthetics|anesthetics|mesh-ancestor
6038748|NCT00519584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6038749|NCT00519584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038750|NCT00519584|Sensory System Agents|sensory system agents|mesh-ancestor
6038751|NCT00519584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6038752|NCT00519623|Insulin|insulin|mesh-list
6038753|NCT00519623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6038754|NCT00519623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496082|NCT04518618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5496083|NCT04518618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496084|NCT04518618|Analgesics|analgesics|mesh-ancestor
5496085|NCT04518618|Sensory System Agents|sensory system agents|mesh-ancestor
5496086|NCT04518618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5496087|NCT04518618|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5496088|NCT04518618|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5496089|NCT04518618|Anesthetics, General|anesthetics, general|mesh-ancestor
5496090|NCT04518618|Anesthetics|anesthetics|mesh-ancestor
5496091|NCT04518618|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5496092|NCT04518982|Lenalidomide|lenalidomide|mesh-list
5496093|NCT04518982|Immunologic Factors|immunologic factors|mesh-ancestor
5496094|NCT04518982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496095|NCT04518982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5496096|NCT04518982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5496097|NCT04518982|Growth Substances|growth substances|mesh-ancestor
5496098|NCT04518982|Growth Inhibitors|growth inhibitors|mesh-ancestor
5496099|NCT04518982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5496100|NCT04518280|Capecitabine|capecitabine|mesh-list
5496101|NCT04518280|Oxaliplatin|oxaliplatin|mesh-list
6038755|NCT00519636|Fluticasone|fluticasone|mesh-list
6038756|NCT00519636|Xhance|xhance|mesh-list
6038757|NCT00519636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6038758|NCT00519636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6038759|NCT00519636|Autonomic Agents|autonomic agents|mesh-ancestor
6038760|NCT00519636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6038761|NCT00519636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038762|NCT00519636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6038763|NCT00519636|Respiratory System Agents|respiratory system agents|mesh-ancestor
6038764|NCT00519636|Dermatologic Agents|dermatologic agents|mesh-ancestor
6038765|NCT00519636|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6038766|NCT00519818|Hydrocortisone|hydrocortisone|mesh-list
6038767|NCT00519818|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6038768|NCT00519818|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6038769|NCT00519818|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6038770|NCT00519818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6038771|NCT00519831|Cetuximab|cetuximab|mesh-list
5496102|NCT04518280|Antibodies|antibodies|mesh-list
5496103|NCT04518280|Immunologic Factors|immunologic factors|mesh-ancestor
5496104|NCT04518280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496105|NCT04518280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5496106|NCT04518280|Antimetabolites|antimetabolites|mesh-ancestor
5496107|NCT04518280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496108|NCT04518280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6038772|NCT00519831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6038773|NCT00519831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6038774|NCT00519896|Sunitinib|sunitinib|mesh-list
6038775|NCT00519896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6038776|NCT00519896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6038777|NCT00519896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6038778|NCT00519896|Growth Substances|growth substances|mesh-ancestor
6038779|NCT00519896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496109|NCT04518319|Olanzapine|olanzapine|mesh-list
5496110|NCT04518319|Antiemetics|antiemetics|mesh-ancestor
5496111|NCT04518319|Autonomic Agents|autonomic agents|mesh-ancestor
5496112|NCT04518319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5496113|NCT04518319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496114|NCT04518319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5496115|NCT04518319|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5496116|NCT04518319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5496117|NCT04518319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5496118|NCT04518319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5496119|NCT04518319|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5496120|NCT04518319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5496121|NCT04518319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5496122|NCT04518319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496123|NCT04518319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5496124|NCT04518319|Serotonin Agents|serotonin agents|mesh-ancestor
5496125|NCT04518553|Antiviral Agents|antiviral agents|mesh-list
5496126|NCT04518553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5496127|NCT04518540|Thioctic Acid|thioctic acid|mesh-list
5496128|NCT04518540|Antioxidants|antioxidants|mesh-ancestor
5496129|NCT04518540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496130|NCT04518540|Protective Agents|protective agents|mesh-ancestor
6038780|NCT00519896|Growth Inhibitors|growth inhibitors|mesh-ancestor
6038781|NCT00519896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6038782|NCT00519896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6038783|NCT00519896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6038784|NCT00520013|Paclitaxel|paclitaxel|mesh-list
6038785|NCT00520013|Bevacizumab|bevacizumab|mesh-list
6038786|NCT00520013|Carboplatin|carboplatin|mesh-list
6038787|NCT00520013|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6038788|NCT00520013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6038789|NCT00520013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6038790|NCT00520013|Tubulin Modulators|tubulin modulators|mesh-ancestor
6038791|NCT00520013|Antimitotic Agents|antimitotic agents|mesh-ancestor
6038792|NCT00520013|Mitosis Modulators|mitosis modulators|mesh-ancestor
6038793|NCT00520013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6038794|NCT00520013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6038795|NCT00520013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6038796|NCT00520013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6038797|NCT00520013|Growth Substances|growth substances|mesh-ancestor
6038798|NCT00520013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038799|NCT00520013|Growth Inhibitors|growth inhibitors|mesh-ancestor
6038800|NCT00520013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6038801|NCT00520013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6038802|NCT00520130|Cytarabine|cytarabine|mesh-list
6038803|NCT00520130|Cyclosporine|cyclosporine|mesh-list
6038804|NCT00520130|Rituximab|rituximab|mesh-list
6038805|NCT00520130|Alemtuzumab|alemtuzumab|mesh-list
6038806|NCT00520130|Fludarabine|fludarabine|mesh-list
6038807|NCT00520130|Cyclosporins|cyclosporins|mesh-list
6038808|NCT00520130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6038809|NCT00520130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6038810|NCT00520130|Immunologic Factors|immunologic factors|mesh-ancestor
6038811|NCT00520130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038812|NCT00520130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6038813|NCT00520130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6038814|NCT00520130|Antimetabolites|antimetabolites|mesh-ancestor
6457836|NCT00438087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6457837|NCT00438087|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6457838|NCT00438087|Protective Agents|protective agents|mesh-ancestor
6664654|NCT01513187|Interferon-alpha|interferon-alpha|mesh-list
6038815|NCT00520130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6038816|NCT00520130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6038817|NCT00520130|Antiviral Agents|antiviral agents|mesh-ancestor
6038818|NCT00520130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6038819|NCT00520130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6038820|NCT00520130|Antifungal Agents|antifungal agents|mesh-ancestor
6457839|NCT00438087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6457840|NCT00438087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6457841|NCT00438113|Atenolol|atenolol|mesh-list
6457842|NCT00438113|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6457843|NCT00438113|Terazosin|terazosin|mesh-list
6457844|NCT00438113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6457845|NCT00438113|Diuretics|diuretics|mesh-ancestor
6457846|NCT00438113|Natriuretic Agents|natriuretic agents|mesh-ancestor
6038821|NCT00520130|Dermatologic Agents|dermatologic agents|mesh-ancestor
6038822|NCT00520130|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6038823|NCT00520234|Caspofungin|caspofungin|mesh-list
6038824|NCT00520234|Antifungal Agents|antifungal agents|mesh-ancestor
6038825|NCT00520234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6038826|NCT00520234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6038827|NCT00520234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6038828|NCT00520286|Modafinil|modafinil|mesh-list
6038829|NCT00520286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6038830|NCT00520286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038831|NCT00520286|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6038832|NCT00520286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6038833|NCT00520286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6038834|NCT00520286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6038835|NCT00520403|Interferons|interferons|mesh-list
6038836|NCT00520403|Interferon-alpha|interferon-alpha|mesh-list
6038837|NCT00520403|Interferon alpha-2|interferon alpha-2|mesh-list
6655105|NCT01460667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655106|NCT01460667|Antipyretics|antipyretics|mesh-ancestor
6655107|NCT01460693|Imatinib Mesylate|imatinib mesylate|mesh-list
6655108|NCT01460693|Dasatinib|dasatinib|mesh-list
6655109|NCT01460693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6038838|NCT00520403|Bevacizumab|bevacizumab|mesh-list
6038839|NCT00520403|Vinblastine|vinblastine|mesh-list
6038840|NCT00520403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6038841|NCT00520403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6038842|NCT00520403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6038843|NCT00520403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6038844|NCT00520403|Growth Substances|growth substances|mesh-ancestor
6038845|NCT00520403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038846|NCT00520403|Growth Inhibitors|growth inhibitors|mesh-ancestor
6038847|NCT00520403|Antiviral Agents|antiviral agents|mesh-ancestor
6038848|NCT00520403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6038849|NCT00520403|Immunologic Factors|immunologic factors|mesh-ancestor
6038850|NCT00520403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6038851|NCT00520403|Tubulin Modulators|tubulin modulators|mesh-ancestor
6038852|NCT00520403|Antimitotic Agents|antimitotic agents|mesh-ancestor
6038853|NCT00520403|Mitosis Modulators|mitosis modulators|mesh-ancestor
6038854|NCT00520403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6038855|NCT00520468|Cyclosporine|cyclosporine|mesh-list
6038856|NCT00520468|Prednisone|prednisone|mesh-list
6038857|NCT00520468|Epoetin Alfa|epoetin alfa|mesh-list
6038858|NCT00520468|Darbepoetin alfa|darbepoetin alfa|mesh-list
6038859|NCT00520468|Cyclosporins|cyclosporins|mesh-list
6038860|NCT00520468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6038861|NCT00520468|Glucocorticoids|glucocorticoids|mesh-ancestor
6038862|NCT00520468|Hormones|hormones|mesh-ancestor
6038863|NCT00520468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6038864|NCT00520468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038865|NCT00520468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6038866|NCT00520468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6038867|NCT00520468|Immunologic Factors|immunologic factors|mesh-ancestor
6038868|NCT00520468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6053696|NCT00597493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6457847|NCT00438113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6664655|NCT01513187|Interferon alpha-2|interferon alpha-2|mesh-list
6038869|NCT00520468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6038870|NCT00520468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6038871|NCT00520468|Antifungal Agents|antifungal agents|mesh-ancestor
6038872|NCT00520468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6038873|NCT00520468|Dermatologic Agents|dermatologic agents|mesh-ancestor
6038874|NCT00520468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6038875|NCT00520468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6038876|NCT00520468|Hematinics|hematinics|mesh-ancestor
6038877|NCT00520481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6038878|NCT00520481|Immunologic Factors|immunologic factors|mesh-ancestor
6038879|NCT00520481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038880|NCT00520533|Sunitinib|sunitinib|mesh-list
6038881|NCT00520533|Antibodies|antibodies|mesh-list
6038882|NCT00520533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6038883|NCT00520533|Immunologic Factors|immunologic factors|mesh-ancestor
6038884|NCT00520533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496131|NCT04518540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496132|NCT04518540|Vitamin B Complex|vitamin b complex|mesh-ancestor
5496133|NCT04518540|Vitamins|vitamins|mesh-ancestor
5496134|NCT04518540|Micronutrients|micronutrients|mesh-ancestor
5496135|NCT04518475|Rituximab|rituximab|mesh-list
5496136|NCT04518475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5496137|NCT04518475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5496138|NCT04518475|Immunologic Factors|immunologic factors|mesh-ancestor
5496139|NCT04518475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496140|NCT04518475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6038885|NCT00520533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6038886|NCT00520533|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6038887|NCT00520533|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6038888|NCT00520533|Growth Substances|growth substances|mesh-ancestor
6038889|NCT00520533|Growth Inhibitors|growth inhibitors|mesh-ancestor
6038890|NCT00520533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6038891|NCT00520533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6038892|NCT00520533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496141|NCT04518462|Bupivacaine|bupivacaine|mesh-list
5496142|NCT04518462|Anesthetics, Local|anesthetics, local|mesh-ancestor
5496143|NCT04518462|Anesthetics|anesthetics|mesh-ancestor
5496144|NCT04518462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5496145|NCT04518462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038893|NCT00520572|Etanercept|etanercept|mesh-list
6038894|NCT00520572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6038895|NCT00520572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6038896|NCT00520572|Analgesics|analgesics|mesh-ancestor
6038897|NCT00520572|Sensory System Agents|sensory system agents|mesh-ancestor
6038898|NCT00520572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6038899|NCT00520572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038900|NCT00520572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6038901|NCT00520572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6038902|NCT00520572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6038903|NCT00520572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6038904|NCT00520572|Immunologic Factors|immunologic factors|mesh-ancestor
6038905|NCT00520676|Carboplatin|carboplatin|mesh-list
6038906|NCT00520676|Docetaxel|docetaxel|mesh-list
6038907|NCT00520676|Pemetrexed|pemetrexed|mesh-list
6038908|NCT00520676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6038909|NCT00520676|Tubulin Modulators|tubulin modulators|mesh-ancestor
6038910|NCT00520676|Antimitotic Agents|antimitotic agents|mesh-ancestor
6038911|NCT00520676|Mitosis Modulators|mitosis modulators|mesh-ancestor
6038912|NCT00520676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6038913|NCT00520676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6038914|NCT00520676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6038915|NCT00520676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6038916|NCT00520741|Lacosamide|lacosamide|mesh-list
6038917|NCT00520741|Anticonvulsants|anticonvulsants|mesh-ancestor
6038918|NCT00520741|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6038919|NCT00520741|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6038920|NCT00520741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6038921|NCT00520741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6038922|NCT00520767|Dexamethasone|dexamethasone|mesh-list
6038923|NCT00520767|Dexamethasone acetate|dexamethasone acetate|mesh-list
6038924|NCT00520767|Bortezomib|bortezomib|mesh-list
6038925|NCT00520767|Melphalan|melphalan|mesh-list
6038926|NCT00520767|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
6038927|NCT00520767|BB 1101|bb 1101|mesh-list
5496146|NCT04518462|Sensory System Agents|sensory system agents|mesh-ancestor
6038928|NCT00520767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6038929|NCT00520767|Antiemetics|antiemetics|mesh-ancestor
6038930|NCT00520767|Autonomic Agents|autonomic agents|mesh-ancestor
6038931|NCT00520767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6038932|NCT00520767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038933|NCT00520767|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6038934|NCT00520767|Glucocorticoids|glucocorticoids|mesh-ancestor
6038935|NCT00520767|Hormones|hormones|mesh-ancestor
6038936|NCT00520767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6038937|NCT00520767|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6038938|NCT00520767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6038939|NCT00520767|Protease Inhibitors|protease inhibitors|mesh-ancestor
6038940|NCT00520767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6038941|NCT00520767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6038942|NCT00520767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5496147|NCT04518462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5496148|NCT04518202|Lidocaine|lidocaine|mesh-list
5496149|NCT04518202|Anesthetics, Local|anesthetics, local|mesh-ancestor
6038943|NCT00520767|Alkylating Agents|alkylating agents|mesh-ancestor
6038944|NCT00520767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6038945|NCT00520767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6038946|NCT00520767|Immunologic Factors|immunologic factors|mesh-ancestor
6038947|NCT00520845|Celecoxib|celecoxib|mesh-list
6038948|NCT00520845|Docetaxel|docetaxel|mesh-list
6038949|NCT00520845|Pemetrexed|pemetrexed|mesh-list
6038950|NCT00520845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6038951|NCT00520845|Tubulin Modulators|tubulin modulators|mesh-ancestor
6038952|NCT00520845|Antimitotic Agents|antimitotic agents|mesh-ancestor
6038953|NCT00520845|Mitosis Modulators|mitosis modulators|mesh-ancestor
6038954|NCT00520845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6038955|NCT00520845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6038956|NCT00520845|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6038957|NCT00520845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6038958|NCT00520845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6038959|NCT00520845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6038960|NCT00520845|Analgesics|analgesics|mesh-ancestor
6038961|NCT00520845|Sensory System Agents|sensory system agents|mesh-ancestor
6038962|NCT00520845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6038963|NCT00520845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038964|NCT00520845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6038965|NCT00520845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6038966|NCT00520845|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6038967|NCT00520845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6038968|NCT00520936|Pemetrexed|pemetrexed|mesh-list
6038969|NCT00520936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6038970|NCT00520936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6038971|NCT00520936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6038972|NCT00520936|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6038973|NCT00520936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6038974|NCT00520975|Paclitaxel|paclitaxel|mesh-list
6038975|NCT00520975|Bevacizumab|bevacizumab|mesh-list
6038976|NCT00520975|Carboplatin|carboplatin|mesh-list
6038977|NCT00520975|Trastuzumab|trastuzumab|mesh-list
6038978|NCT00520975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6038979|NCT00520975|Antibodies|antibodies|mesh-list
6038980|NCT00520975|Immunoglobulins|immunoglobulins|mesh-list
6038981|NCT00520975|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6038982|NCT00520975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6038983|NCT00520975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6038984|NCT00520975|Tubulin Modulators|tubulin modulators|mesh-ancestor
6038985|NCT00520975|Antimitotic Agents|antimitotic agents|mesh-ancestor
6038986|NCT00520975|Mitosis Modulators|mitosis modulators|mesh-ancestor
6038987|NCT00520975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6038988|NCT00520975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6038989|NCT00520975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6038990|NCT00520975|Growth Substances|growth substances|mesh-ancestor
6038991|NCT00520975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6038992|NCT00520975|Growth Inhibitors|growth inhibitors|mesh-ancestor
5496150|NCT04518202|Anesthetics|anesthetics|mesh-ancestor
6038993|NCT00520975|Immunologic Factors|immunologic factors|mesh-ancestor
6038994|NCT00521001|Everolimus|everolimus|mesh-list
6038995|NCT00521001|Temozolomide|temozolomide|mesh-list
6038996|NCT00521001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6038997|NCT00521001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5496151|NCT04518202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5496152|NCT04518202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496153|NCT04518202|Sensory System Agents|sensory system agents|mesh-ancestor
6038998|NCT00521001|Immunologic Factors|immunologic factors|mesh-ancestor
6038999|NCT00521001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039000|NCT00521001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6039001|NCT00521001|Alkylating Agents|alkylating agents|mesh-ancestor
6039002|NCT00521001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039003|NCT00521014|Cytarabine|cytarabine|mesh-list
6039004|NCT00521014|Rituximab|rituximab|mesh-list
6039005|NCT00521014|Etoposide|etoposide|mesh-list
6039006|NCT00521014|Melphalan|melphalan|mesh-list
6039007|NCT00521014|Carmustine|carmustine|mesh-list
6039008|NCT00521014|Sargramostim|sargramostim|mesh-list
6039009|NCT00521014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6039010|NCT00521014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6039011|NCT00521014|Immunologic Factors|immunologic factors|mesh-ancestor
6039012|NCT00521014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039013|NCT00521014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6039014|NCT00521014|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6039015|NCT00521014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6039016|NCT00521014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6039017|NCT00521014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6039018|NCT00521014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039019|NCT00521014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6039020|NCT00521014|Antimetabolites|antimetabolites|mesh-ancestor
6039021|NCT00521014|Antiviral Agents|antiviral agents|mesh-ancestor
6039022|NCT00521014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6039023|NCT00521014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6039024|NCT00521014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6039025|NCT00521014|Alkylating Agents|alkylating agents|mesh-ancestor
6039026|NCT00521014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6039027|NCT00521144|Topotecan|topotecan|mesh-list
6039028|NCT00521144|Obatoclax|obatoclax|mesh-list
6039029|NCT00521144|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6039030|NCT00521144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6039031|NCT00521144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6039032|NCT00521144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039033|NCT00521144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6053697|NCT00597493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6053698|NCT00597493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6053699|NCT00597506|Bevacizumab|bevacizumab|mesh-list
6053700|NCT00597506|Everolimus|everolimus|mesh-list
6053701|NCT00597506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6053702|NCT00597506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6053703|NCT00597506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6053704|NCT00597506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6053705|NCT00597506|Growth Substances|growth substances|mesh-ancestor
6053706|NCT00597506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053707|NCT00597506|Growth Inhibitors|growth inhibitors|mesh-ancestor
6039034|NCT00521339|Apremilast|apremilast|mesh-list
6039035|NCT00521339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6039036|NCT00521339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6039037|NCT00521339|Analgesics|analgesics|mesh-ancestor
6039038|NCT00521339|Sensory System Agents|sensory system agents|mesh-ancestor
6039039|NCT00521339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6039040|NCT00521339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496154|NCT04518202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5496155|NCT04518202|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5496156|NCT04518202|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5496157|NCT04518202|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5496158|NCT04518202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5496159|NCT04518202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496160|NCT04518189|Lidocaine|lidocaine|mesh-list
5496161|NCT04518189|Anesthetics, Local|anesthetics, local|mesh-ancestor
5496162|NCT04518189|Anesthetics|anesthetics|mesh-ancestor
6039041|NCT00521339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6039042|NCT00521339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6039043|NCT00521339|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6039044|NCT00521339|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6039045|NCT00521339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6039046|NCT00521339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039047|NCT00521365|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6039048|NCT00521365|Antidepressive Agents|antidepressive agents|mesh-ancestor
6039049|NCT00521365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6039050|NCT00521365|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6039051|NCT00521365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6039052|NCT00521365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6039053|NCT00521365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039054|NCT00521404|Gemcitabine|gemcitabine|mesh-list
6039055|NCT00521404|Antibodies|antibodies|mesh-list
6039056|NCT00521404|Immunologic Factors|immunologic factors|mesh-ancestor
6039057|NCT00521404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039058|NCT00521404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6039059|NCT00521404|Antimetabolites|antimetabolites|mesh-ancestor
6039060|NCT00521404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039061|NCT00521404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6039062|NCT00521404|Antiviral Agents|antiviral agents|mesh-ancestor
6039063|NCT00521404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6039064|NCT00521404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6039065|NCT00521404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6457848|NCT00438113|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6457849|NCT00438113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6457850|NCT00438113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457851|NCT00438113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6457852|NCT00438113|Sympatholytics|sympatholytics|mesh-ancestor
6457853|NCT00438113|Autonomic Agents|autonomic agents|mesh-ancestor
6457854|NCT00438113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6039066|NCT00521456|Ketorolac|ketorolac|mesh-list
6039067|NCT00521456|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6039068|NCT00521456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6039069|NCT00521456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6039070|NCT00521456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6039071|NCT00521456|Analgesics|analgesics|mesh-ancestor
6039072|NCT00521456|Sensory System Agents|sensory system agents|mesh-ancestor
6039073|NCT00521456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6039074|NCT00521456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039075|NCT00521456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6039076|NCT00521456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6039077|NCT00521456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6039078|NCT00521456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6039079|NCT00521456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039080|NCT00521586|Vaccines|vaccines|mesh-list
6039081|NCT00521586|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6039082|NCT00521586|Immunologic Factors|immunologic factors|mesh-ancestor
6039083|NCT00521586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039084|NCT00521989|Prednisolone|prednisolone|mesh-list
6039085|NCT00521989|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6039086|NCT00521989|Methylprednisolone|methylprednisolone|mesh-list
6039087|NCT00521989|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6039088|NCT00521989|Prednisolone acetate|prednisolone acetate|mesh-list
6039089|NCT00521989|Dipyridamole|dipyridamole|mesh-list
6039090|NCT00521989|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6039091|NCT00521989|Prednisolone phosphate|prednisolone phosphate|mesh-list
6039092|NCT00521989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6039093|NCT00521989|Glucocorticoids|glucocorticoids|mesh-ancestor
6039094|NCT00521989|Hormones|hormones|mesh-ancestor
6039095|NCT00521989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6039096|NCT00521989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039097|NCT00521989|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6039098|NCT00521989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6039099|NCT00521989|Antiemetics|antiemetics|mesh-ancestor
6039100|NCT00521989|Autonomic Agents|autonomic agents|mesh-ancestor
6039101|NCT00521989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6039102|NCT00521989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6039103|NCT00521989|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6039104|NCT00521989|Protective Agents|protective agents|mesh-ancestor
6039105|NCT00521989|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6039106|NCT00521989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6039107|NCT00521989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496163|NCT04518189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5496164|NCT04518189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496165|NCT04518189|Sensory System Agents|sensory system agents|mesh-ancestor
5496166|NCT04518189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5496167|NCT04518189|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5496168|NCT04518189|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5496169|NCT04518189|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5496170|NCT04518189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5496171|NCT04518189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496172|NCT04517799|Cannabidiol|cannabidiol|mesh-list
6039108|NCT00521989|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6039109|NCT00521989|Vasodilator Agents|vasodilator agents|mesh-ancestor
6039110|NCT00522041|Nitroglycerin|nitroglycerin|mesh-list
6039111|NCT00522041|Vasodilator Agents|vasodilator agents|mesh-ancestor
6039112|NCT00522275|Lacosamide|lacosamide|mesh-list
6039113|NCT00522275|Anticonvulsants|anticonvulsants|mesh-ancestor
6039114|NCT00522275|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6039115|NCT00522275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6039116|NCT00522275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6039117|NCT00522275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039118|NCT00522379|Rotigotine|rotigotine|mesh-list
6039119|NCT00522379|Dopamine Agonists|dopamine agonists|mesh-ancestor
6039120|NCT00522379|Dopamine Agents|dopamine agents|mesh-ancestor
5496173|NCT04517799|Anticonvulsants|anticonvulsants|mesh-ancestor
5496174|NCT04517890|Lidocaine|lidocaine|mesh-list
5496175|NCT04517890|Anesthetics, Local|anesthetics, local|mesh-ancestor
5496176|NCT04517890|Anesthetics|anesthetics|mesh-ancestor
5496177|NCT04517890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5496178|NCT04517890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496179|NCT04517890|Sensory System Agents|sensory system agents|mesh-ancestor
5496180|NCT04517890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5496181|NCT04517890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5496182|NCT04517890|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5496183|NCT04517890|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6039121|NCT00522379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6039122|NCT00522379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039123|NCT00522379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039124|NCT00522392|Dexamethasone|dexamethasone|mesh-list
6039125|NCT00522392|Lenalidomide|lenalidomide|mesh-list
6039126|NCT00522392|Bortezomib|bortezomib|mesh-list
6039127|NCT00522392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6039128|NCT00522392|Antiemetics|antiemetics|mesh-ancestor
6039129|NCT00522392|Autonomic Agents|autonomic agents|mesh-ancestor
6039130|NCT00522392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6039131|NCT00522392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496184|NCT04517890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5496185|NCT04517890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496186|NCT04518176|Oxytocin|oxytocin|mesh-list
5496187|NCT04518176|Oxytocics|oxytocics|mesh-ancestor
5496188|NCT04518176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5496189|NCT04518176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496190|NCT04517851|Elotuzumab|elotuzumab|mesh-list
5496191|NCT04517851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5503255|NCT04460807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5503256|NCT04460807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503257|NCT04460651|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
5503258|NCT04460651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5503259|NCT04460651|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5503260|NCT04460872|Methyltestosterone|methyltestosterone|mesh-list
5503261|NCT04460872|Testosterone|testosterone|mesh-list
5503262|NCT04460872|Testosterone undecanoate|testosterone undecanoate|mesh-list
5503263|NCT04460872|Testosterone enanthate|testosterone enanthate|mesh-list
5503264|NCT04460872|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5503265|NCT04460872|Androgens|androgens|mesh-ancestor
5503266|NCT04460872|Hormones|hormones|mesh-ancestor
5503267|NCT04460872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5503268|NCT04460872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503269|NCT04460872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6039132|NCT00522392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6039133|NCT00522392|Glucocorticoids|glucocorticoids|mesh-ancestor
6039134|NCT00522392|Hormones|hormones|mesh-ancestor
6039135|NCT00522392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6039136|NCT00522392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6039137|NCT00522392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6039138|NCT00522392|Immunologic Factors|immunologic factors|mesh-ancestor
6039139|NCT00522392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6039140|NCT00522392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6039141|NCT00522392|Growth Substances|growth substances|mesh-ancestor
6039142|NCT00522392|Growth Inhibitors|growth inhibitors|mesh-ancestor
6039143|NCT00522431|Testosterone|testosterone|mesh-list
6039144|NCT00522431|Androgens|androgens|mesh-ancestor
6039145|NCT00522431|Hormones|hormones|mesh-ancestor
6039146|NCT00522431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6039147|NCT00522431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039148|NCT00522548|Mycophenolic Acid|mycophenolic acid|mesh-list
6039149|NCT00522548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6039150|NCT00522548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6039151|NCT00522548|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6039152|NCT00522548|Antitubercular Agents|antitubercular agents|mesh-ancestor
6039153|NCT00522548|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6039154|NCT00522548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6039155|NCT00522548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6039156|NCT00522548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039157|NCT00522795|Paclitaxel|paclitaxel|mesh-list
6039158|NCT00522795|Cisplatin|cisplatin|mesh-list
6039159|NCT00522795|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
6039160|NCT00522795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6039161|NCT00522795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6039162|NCT00522795|Tubulin Modulators|tubulin modulators|mesh-ancestor
6039163|NCT00522795|Antimitotic Agents|antimitotic agents|mesh-ancestor
6039164|NCT00522795|Mitosis Modulators|mitosis modulators|mesh-ancestor
6039165|NCT00522795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039166|NCT00523237|Raltegravir Potassium|raltegravir potassium|mesh-list
6039167|NCT00523237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6039168|NCT00523237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6039169|NCT00523237|Antiviral Agents|antiviral agents|mesh-ancestor
6039170|NCT00523237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6039171|NCT00523237|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6039172|NCT00523237|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6039173|NCT00523237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6039174|NCT00523237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039175|NCT00523341|Denosumab|denosumab|mesh-list
6039176|NCT00523341|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6039177|NCT00523341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039178|NCT00523419|Pemetrexed|pemetrexed|mesh-list
6039179|NCT00523419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6039180|NCT00523419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6039181|NCT00523419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039182|NCT00523419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6039183|NCT00523419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6039184|NCT00523549|Amlodipine|amlodipine|mesh-list
6039185|NCT00523549|Valsartan|valsartan|mesh-list
6039186|NCT00523549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6039187|NCT00523549|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6039188|NCT00523549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6039189|NCT00523549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039190|NCT00523549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6039191|NCT00523549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039192|NCT00523549|Vasodilator Agents|vasodilator agents|mesh-ancestor
6039193|NCT00523549|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6039194|NCT00523549|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6039195|NCT00523640|Gemcitabine|gemcitabine|mesh-list
6039196|NCT00523640|Bevacizumab|bevacizumab|mesh-list
6039197|NCT00523640|Capecitabine|capecitabine|mesh-list
6039198|NCT00523640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6039199|NCT00523640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6039200|NCT00523640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6039201|NCT00523640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6039202|NCT00523640|Growth Substances|growth substances|mesh-ancestor
6039203|NCT00523640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039204|NCT00523640|Growth Inhibitors|growth inhibitors|mesh-ancestor
6039205|NCT00523640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6039206|NCT00523640|Antimetabolites|antimetabolites|mesh-ancestor
6039207|NCT00523640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039208|NCT00523640|Antiviral Agents|antiviral agents|mesh-ancestor
6039209|NCT00523640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6039210|NCT00523640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6039211|NCT00523640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6039212|NCT00523640|Immunologic Factors|immunologic factors|mesh-ancestor
6039213|NCT00523705|Citalopram|citalopram|mesh-list
6039214|NCT00523705|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6039215|NCT00523705|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6039216|NCT00523705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6039217|NCT00523705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039218|NCT00523705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6039219|NCT00523705|Serotonin Agents|serotonin agents|mesh-ancestor
6039220|NCT00523705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039221|NCT00523705|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6039222|NCT00523705|Antidepressive Agents|antidepressive agents|mesh-ancestor
6039223|NCT00523705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6039224|NCT00523718|Riluzole|riluzole|mesh-list
6039225|NCT00523718|Anticonvulsants|anticonvulsants|mesh-ancestor
6039226|NCT00523718|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6039227|NCT00523718|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6039228|NCT00523718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6039229|NCT00523718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039230|NCT00523718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039231|NCT00523718|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6039232|NCT00523718|Protective Agents|protective agents|mesh-ancestor
6039233|NCT00523744|Amlodipine|amlodipine|mesh-list
6039234|NCT00523744|Valsartan|valsartan|mesh-list
6039235|NCT00523744|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6039236|NCT00523744|Olmesartan|olmesartan|mesh-list
6039237|NCT00523744|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6039238|NCT00523744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6039239|NCT00523744|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6039240|NCT00523744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5496192|NCT04518163|Tranexamic Acid|tranexamic acid|mesh-list
5496193|NCT04518163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5496194|NCT04518163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5496195|NCT04518163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496196|NCT04518163|Hemostatics|hemostatics|mesh-ancestor
5496197|NCT04518163|Coagulants|coagulants|mesh-ancestor
5496198|NCT04517747|Ramucirumab|ramucirumab|mesh-list
5496199|NCT04517747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6039241|NCT00523744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039242|NCT00523744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6039243|NCT00523744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039244|NCT00523744|Vasodilator Agents|vasodilator agents|mesh-ancestor
6039245|NCT00523744|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6039246|NCT00523744|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6039247|NCT00523744|Diuretics|diuretics|mesh-ancestor
6039248|NCT00523744|Natriuretic Agents|natriuretic agents|mesh-ancestor
6039249|NCT00523744|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6039250|NCT00523848|Thalidomide|thalidomide|mesh-list
6039251|NCT00523848|Doxorubicin|doxorubicin|mesh-list
6039252|NCT00523848|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6039253|NCT00523848|Bortezomib|bortezomib|mesh-list
6039254|NCT00523848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6039255|NCT00523848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6039256|NCT00523848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6039257|NCT00523848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5496200|NCT04517526|Bevacizumab|bevacizumab|mesh-list
5496201|NCT04517526|Durvalumab|durvalumab|mesh-list
6039258|NCT00523848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6039259|NCT00523848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039260|NCT00523848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6039261|NCT00523848|Immunologic Factors|immunologic factors|mesh-ancestor
6039262|NCT00523848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039263|NCT00523848|Leprostatic Agents|leprostatic agents|mesh-ancestor
6039264|NCT00523848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6039265|NCT00523848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6039266|NCT00523848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6039267|NCT00523848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6039268|NCT00523848|Growth Substances|growth substances|mesh-ancestor
6039269|NCT00523848|Growth Inhibitors|growth inhibitors|mesh-ancestor
6039270|NCT00523978|Sotalol|sotalol|mesh-list
6655110|NCT01460693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6655111|NCT01460693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6655112|NCT01460693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655113|NCT01460706|Edotreotide|edotreotide|mesh-list
6039271|NCT00523978|Flecainide|flecainide|mesh-list
6039272|NCT00523978|Propafenone|propafenone|mesh-list
6039273|NCT00523978|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6039274|NCT00523978|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6039275|NCT00523978|Adrenergic Agents|adrenergic agents|mesh-ancestor
6039276|NCT00523978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6039277|NCT00523978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039278|NCT00523978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039279|NCT00523978|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6039280|NCT00523978|Sympatholytics|sympatholytics|mesh-ancestor
6039281|NCT00523978|Autonomic Agents|autonomic agents|mesh-ancestor
6039282|NCT00523978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6039283|NCT00523978|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6039284|NCT00523978|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6039285|NCT00523978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6039286|NCT00523991|Tiotropium Bromide|tiotropium bromide|mesh-list
6039287|NCT00523991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6039288|NCT00523991|Autonomic Agents|autonomic agents|mesh-ancestor
6039289|NCT00523991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6039290|NCT00523991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496202|NCT04517526|Carboplatin|carboplatin|mesh-list
5496203|NCT04517526|Pemetrexed|pemetrexed|mesh-list
6039291|NCT00523991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6039292|NCT00523991|Respiratory System Agents|respiratory system agents|mesh-ancestor
6039293|NCT00523991|Parasympatholytics|parasympatholytics|mesh-ancestor
6039294|NCT00523991|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6039295|NCT00523991|Cholinergic Agents|cholinergic agents|mesh-ancestor
6039296|NCT00523991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6039297|NCT00523991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039298|NCT00524017|Cetuximab|cetuximab|mesh-list
6039299|NCT00524017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6039300|NCT00524017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6039301|NCT00524030|Pregabalin|pregabalin|mesh-list
6039302|NCT00524030|Analgesics|analgesics|mesh-ancestor
5496204|NCT04517526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5496205|NCT04517526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5496206|NCT04517526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5496207|NCT04517526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5496208|NCT04517526|Growth Substances|growth substances|mesh-ancestor
5496209|NCT04517526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496210|NCT04517526|Growth Inhibitors|growth inhibitors|mesh-ancestor
5496211|NCT04517526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6039303|NCT00524030|Sensory System Agents|sensory system agents|mesh-ancestor
6039304|NCT00524030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6039305|NCT00524030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039306|NCT00524030|Anticonvulsants|anticonvulsants|mesh-ancestor
6039307|NCT00524030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6039308|NCT00524030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6039309|NCT00524030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039310|NCT00524030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6039311|NCT00524030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6039312|NCT00524030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6039313|NCT00524030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6039314|NCT00524030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6039315|NCT00524043|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6039316|NCT00524043|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6039317|NCT00524043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6039318|NCT00524043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6039319|NCT00524043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039320|NCT00524043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6039321|NCT00524043|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6039322|NCT00524043|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6039323|NCT00524043|Serotonin Agents|serotonin agents|mesh-ancestor
6039324|NCT00524043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6039325|NCT00524043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039326|NCT00524043|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6039327|NCT00524043|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6039328|NCT00524043|Dopamine Agents|dopamine agents|mesh-ancestor
6039329|NCT00524121|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6039330|NCT00524121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6039331|NCT00524121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6039332|NCT00524121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6039333|NCT00524121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039334|NCT00524173|Tenofovir|tenofovir|mesh-list
6039335|NCT00524173|Emtricitabine|emtricitabine|mesh-list
6039336|NCT00524173|Antiviral Agents|antiviral agents|mesh-ancestor
5496212|NCT04517526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496213|NCT04517526|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5496214|NCT04517526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5496215|NCT04517292|Gemcitabine|gemcitabine|mesh-list
5496216|NCT04517292|Cisplatin|cisplatin|mesh-list
5496217|NCT04517292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5496218|NCT04517292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5496219|NCT04517292|Antimetabolites|antimetabolites|mesh-ancestor
5496220|NCT04517292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496221|NCT04517292|Antiviral Agents|antiviral agents|mesh-ancestor
5496222|NCT04517292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5496223|NCT04517292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5496224|NCT04517292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5496225|NCT04517292|Immunologic Factors|immunologic factors|mesh-ancestor
5496226|NCT04517292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039337|NCT00524173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5496227|NCT04517227|Durvalumab|durvalumab|mesh-list
5496228|NCT04517227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5496229|NCT04517227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5496230|NCT04517214|Gemcitabine|gemcitabine|mesh-list
5496231|NCT04517214|Capecitabine|capecitabine|mesh-list
6039338|NCT00524173|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6039339|NCT00524173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6039340|NCT00524173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6039341|NCT00524173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039342|NCT00524173|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6039343|NCT00524173|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6039344|NCT00524225|Oprelvekin|oprelvekin|mesh-list
6039345|NCT00524225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6039346|NCT00524264|Ketorolac|ketorolac|mesh-list
6039347|NCT00524264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6039348|NCT00524264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6039349|NCT00524264|Analgesics|analgesics|mesh-ancestor
6039350|NCT00524264|Sensory System Agents|sensory system agents|mesh-ancestor
6039351|NCT00524264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6039352|NCT00524264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039353|NCT00524264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6039354|NCT00524264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6039355|NCT00524264|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6039356|NCT00524264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6039357|NCT00524264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039358|NCT00524303|Paclitaxel|paclitaxel|mesh-list
6039359|NCT00524303|Trastuzumab|trastuzumab|mesh-list
6039360|NCT00524303|Lapatinib|lapatinib|mesh-list
6039361|NCT00524303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6039362|NCT00524303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6039363|NCT00524303|Tubulin Modulators|tubulin modulators|mesh-ancestor
6039364|NCT00524303|Antimitotic Agents|antimitotic agents|mesh-ancestor
6039365|NCT00524303|Mitosis Modulators|mitosis modulators|mesh-ancestor
6039366|NCT00524303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039367|NCT00524303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6039368|NCT00524303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6039369|NCT00524303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6039370|NCT00524316|Doxorubicin|doxorubicin|mesh-list
6039371|NCT00524316|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5496232|NCT04517214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5496233|NCT04517214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5496234|NCT04517214|Antimetabolites|antimetabolites|mesh-ancestor
5496235|NCT04517214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496236|NCT04517214|Antiviral Agents|antiviral agents|mesh-ancestor
6039372|NCT00524316|Sunitinib|sunitinib|mesh-list
6039373|NCT00524316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6039374|NCT00524316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6039375|NCT00524316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6039376|NCT00524316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6039377|NCT00524316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6039378|NCT00524316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039379|NCT00524316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6039380|NCT00524316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6039381|NCT00524316|Growth Substances|growth substances|mesh-ancestor
6039382|NCT00524316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039383|NCT00524316|Growth Inhibitors|growth inhibitors|mesh-ancestor
6039384|NCT00524316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6039385|NCT00524342|Oprelvekin|oprelvekin|mesh-list
6039386|NCT00524342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6039387|NCT00524368|Ritonavir|ritonavir|mesh-list
6039388|NCT00524368|Darunavir|darunavir|mesh-list
6039389|NCT00524368|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6039390|NCT00524368|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6039391|NCT00524368|Protease Inhibitors|protease inhibitors|mesh-ancestor
6039392|NCT00524368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6039393|NCT00524368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039394|NCT00524368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6039395|NCT00524368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6039396|NCT00524368|Antiviral Agents|antiviral agents|mesh-ancestor
6039397|NCT00524368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6039398|NCT00524368|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6655114|NCT01460706|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5496237|NCT04517214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5496238|NCT04517214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5496239|NCT04517214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5496240|NCT04517214|Immunologic Factors|immunologic factors|mesh-ancestor
5496241|NCT04517214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496242|NCT04517201|Insulin|insulin|mesh-list
5496243|NCT04517201|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5496244|NCT04517201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5496245|NCT04517201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496246|NCT04517110|Pregabalin|pregabalin|mesh-list
5496247|NCT04517110|Analgesics|analgesics|mesh-ancestor
5496248|NCT04517110|Sensory System Agents|sensory system agents|mesh-ancestor
5496249|NCT04517110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5496250|NCT04517110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496251|NCT04517110|Anticonvulsants|anticonvulsants|mesh-ancestor
5496252|NCT04517110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5496253|NCT04517110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5496254|NCT04517110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496255|NCT04517110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6039399|NCT00524368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6039400|NCT00524472|Insulin|insulin|mesh-list
5496256|NCT04517110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6039401|NCT00524472|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6039402|NCT00524472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6039403|NCT00524472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039404|NCT00524576|Vaccines|vaccines|mesh-list
6039405|NCT00524576|Immunologic Factors|immunologic factors|mesh-ancestor
6039406|NCT00524576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039407|NCT00524589|Calcitriol|calcitriol|mesh-list
6039408|NCT00524589|Dexamethasone|dexamethasone|mesh-list
6039409|NCT00524589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6039410|NCT00524589|Antiemetics|antiemetics|mesh-ancestor
6039411|NCT00524589|Autonomic Agents|autonomic agents|mesh-ancestor
6039412|NCT00524589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6039413|NCT00524589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039414|NCT00524589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6039415|NCT00524589|Glucocorticoids|glucocorticoids|mesh-ancestor
6039416|NCT00524589|Hormones|hormones|mesh-ancestor
6039417|NCT00524589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6039418|NCT00524589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6039419|NCT00524589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6039420|NCT00524589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6039421|NCT00524589|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6039422|NCT00524589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6039423|NCT00524589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039424|NCT00524589|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6039425|NCT00524589|Vitamins|vitamins|mesh-ancestor
6039426|NCT00524589|Micronutrients|micronutrients|mesh-ancestor
6039427|NCT00524589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6039428|NCT00524680|Cholecalciferol|cholecalciferol|mesh-list
6039429|NCT00524680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6039430|NCT00524680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039431|NCT00524680|Vitamins|vitamins|mesh-ancestor
6039432|NCT00524680|Micronutrients|micronutrients|mesh-ancestor
6039433|NCT00524680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6039434|NCT00525031|Interferons|interferons|mesh-list
6039435|NCT00525031|Interferon-alpha|interferon-alpha|mesh-list
6039436|NCT00525031|Interferon alpha-2|interferon alpha-2|mesh-list
6039437|NCT00525031|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6039438|NCT00525031|Temozolomide|temozolomide|mesh-list
6039439|NCT00525031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6039440|NCT00525031|Antiviral Agents|antiviral agents|mesh-ancestor
6039441|NCT00525031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6039442|NCT00525031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6039443|NCT00525031|Alkylating Agents|alkylating agents|mesh-ancestor
6053708|NCT00597506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5496257|NCT04517110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6039444|NCT00525031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039445|NCT00525031|Immunologic Factors|immunologic factors|mesh-ancestor
6039446|NCT00525031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039447|NCT00525044|Ambroxol|ambroxol|mesh-list
6039448|NCT00525044|Expectorants|expectorants|mesh-ancestor
6039449|NCT00525044|Respiratory System Agents|respiratory system agents|mesh-ancestor
6039450|NCT00525057|Dalteparin|dalteparin|mesh-list
6039451|NCT00525057|Tinzaparin|tinzaparin|mesh-list
6039452|NCT00525057|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6039453|NCT00525057|Anticoagulants|anticoagulants|mesh-ancestor
6039454|NCT00525057|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6039455|NCT00525057|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6039456|NCT00525057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039457|NCT00525135|Valproic Acid|valproic acid|mesh-list
6039458|NCT00525135|Anticonvulsants|anticonvulsants|mesh-ancestor
6039459|NCT00525135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6039460|NCT00525135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039461|NCT00525135|GABA Agents|gaba agents|mesh-ancestor
6039462|NCT00525135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6039463|NCT00525135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039464|NCT00525135|Antimanic Agents|antimanic agents|mesh-ancestor
6039465|NCT00525135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6039466|NCT00525135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6039467|NCT00525135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6039468|NCT00525148|Afatinib|afatinib|mesh-list
6039469|NCT00525148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6039470|NCT00525148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6039471|NCT00525148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6039472|NCT00525148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039473|NCT00525161|Sorafenib|sorafenib|mesh-list
6039474|NCT00525161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6039475|NCT00525161|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6039476|NCT00525161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6039477|NCT00525161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039478|NCT00525265|Tolvaptan|tolvaptan|mesh-list
6039479|NCT00525265|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6039480|NCT00525265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039481|NCT00525265|Natriuretic Agents|natriuretic agents|mesh-ancestor
6039482|NCT00525265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039483|NCT00525421|Curcumin|curcumin|mesh-list
6039484|NCT00525421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5496258|NCT04517110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5496259|NCT04517110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5496260|NCT04517188|Iodine|iodine|mesh-list
5496261|NCT04517188|Povidone-Iodine|povidone-iodine|mesh-list
5496262|NCT04517188|Povidone|povidone|mesh-list
5496263|NCT04517188|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5496264|NCT04517188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5496265|NCT04517188|Trace Elements|trace elements|mesh-ancestor
5496266|NCT04517188|Micronutrients|micronutrients|mesh-ancestor
6039485|NCT00525421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6039486|NCT00525421|Analgesics|analgesics|mesh-ancestor
6039487|NCT00525421|Sensory System Agents|sensory system agents|mesh-ancestor
6039488|NCT00525421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6039489|NCT00525421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039490|NCT00525421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6039491|NCT00525421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6039492|NCT00525421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6039493|NCT00525421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6039494|NCT00525421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039495|NCT00525499|Androgens|androgens|mesh-list
6039496|NCT00525499|Hormones|hormones|mesh-ancestor
6039497|NCT00525499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6039498|NCT00525499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039499|NCT00525512|Tiotropium Bromide|tiotropium bromide|mesh-list
5496267|NCT04517188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039500|NCT00525512|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6039501|NCT00525512|Autonomic Agents|autonomic agents|mesh-ancestor
6039502|NCT00525512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6039503|NCT00525512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039504|NCT00525512|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5496268|NCT04517188|Plasma Substitutes|plasma substitutes|mesh-ancestor
5496269|NCT04517188|Blood Substitutes|blood substitutes|mesh-ancestor
5496270|NCT04516902|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
5496271|NCT04516902|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
5496272|NCT04516902|Hallucinogens|hallucinogens|mesh-ancestor
5496273|NCT04516902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496274|NCT04516902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5496275|NCT04516902|Serotonin Agents|serotonin agents|mesh-ancestor
5496276|NCT04516902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5496277|NCT04516902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496278|NCT04516902|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5496279|NCT04516902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5496280|NCT04516902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5496281|NCT04516902|Adrenergic Agents|adrenergic agents|mesh-ancestor
5496282|NCT04516902|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5496283|NCT04516902|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6039505|NCT00525512|Respiratory System Agents|respiratory system agents|mesh-ancestor
6039506|NCT00525512|Parasympatholytics|parasympatholytics|mesh-ancestor
6039507|NCT00525512|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6039508|NCT00525512|Cholinergic Agents|cholinergic agents|mesh-ancestor
6039509|NCT00525512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6039510|NCT00525512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039511|NCT00525525|Bevacizumab|bevacizumab|mesh-list
6039512|NCT00525525|Temozolomide|temozolomide|mesh-list
6039513|NCT00525525|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6039514|NCT00525525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6039515|NCT00525525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6039516|NCT00525525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6039517|NCT00525525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6039518|NCT00525525|Growth Substances|growth substances|mesh-ancestor
6039519|NCT00525525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039520|NCT00525525|Growth Inhibitors|growth inhibitors|mesh-ancestor
6039521|NCT00525525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6039522|NCT00525525|Alkylating Agents|alkylating agents|mesh-ancestor
6039523|NCT00525525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039524|NCT00525525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6039525|NCT00525525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6039526|NCT00525590|Carmustine|carmustine|mesh-list
6039527|NCT00525590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6039528|NCT00525590|Alkylating Agents|alkylating agents|mesh-ancestor
6039529|NCT00525590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039530|NCT00525590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6039531|NCT00525603|Vidarabine|vidarabine|mesh-list
6039532|NCT00525603|Cyclophosphamide|cyclophosphamide|mesh-list
6039533|NCT00525603|Rituximab|rituximab|mesh-list
6039534|NCT00525603|Fludarabine|fludarabine|mesh-list
6039535|NCT00525603|Fludarabine phosphate|fludarabine phosphate|mesh-list
6039536|NCT00525603|Alemtuzumab|alemtuzumab|mesh-list
6039537|NCT00525603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6039538|NCT00525603|Immunologic Factors|immunologic factors|mesh-ancestor
6039539|NCT00525603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039540|NCT00525603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6039541|NCT00525603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6039542|NCT00525603|Alkylating Agents|alkylating agents|mesh-ancestor
6039543|NCT00525603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457855|NCT00438113|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6457856|NCT00438113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6457857|NCT00438113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6457858|NCT00438113|Adrenergic Agents|adrenergic agents|mesh-ancestor
6457859|NCT00438113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6039544|NCT00525603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6039545|NCT00525603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6039546|NCT00525603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6039547|NCT00525603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6039548|NCT00525603|Antimetabolites|antimetabolites|mesh-ancestor
6039549|NCT00525603|Antiviral Agents|antiviral agents|mesh-ancestor
6039550|NCT00525603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6039551|NCT00525733|Ritonavir|ritonavir|mesh-list
6039552|NCT00525733|Darunavir|darunavir|mesh-list
6039553|NCT00525733|Raltegravir Potassium|raltegravir potassium|mesh-list
6039554|NCT00525733|Maraviroc|maraviroc|mesh-list
6039555|NCT00525733|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6039556|NCT00525733|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6039557|NCT00525733|Protease Inhibitors|protease inhibitors|mesh-ancestor
6039558|NCT00525733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6039559|NCT00525733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039560|NCT00525733|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6039561|NCT00525733|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6039562|NCT00525733|Antiviral Agents|antiviral agents|mesh-ancestor
6039563|NCT00525733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6039564|NCT00525733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6039565|NCT00525733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6039566|NCT00525733|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6039567|NCT00525733|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6039568|NCT00525733|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6039569|NCT00525733|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6039570|NCT00525733|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6039571|NCT00525785|Leucovorin|leucovorin|mesh-list
6039572|NCT00525785|Folic Acid|folic acid|mesh-list
6039573|NCT00525785|Fluorouracil|fluorouracil|mesh-list
6039574|NCT00525785|Oxaliplatin|oxaliplatin|mesh-list
6039575|NCT00525785|Levoleucovorin|levoleucovorin|mesh-list
6039576|NCT00525785|Antimetabolites|antimetabolites|mesh-ancestor
6039577|NCT00525785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039578|NCT00525785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6039579|NCT00525785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5496284|NCT04516941|Colchicine|colchicine|mesh-list
5496285|NCT04516941|Edoxaban|edoxaban|mesh-list
5496286|NCT04516941|Gout Suppressants|gout suppressants|mesh-ancestor
5496287|NCT04516941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5496288|NCT04516941|Tubulin Modulators|tubulin modulators|mesh-ancestor
5496289|NCT04516941|Antimitotic Agents|antimitotic agents|mesh-ancestor
5496290|NCT04516941|Mitosis Modulators|mitosis modulators|mesh-ancestor
5496291|NCT04516941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496292|NCT04516941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6039580|NCT00525785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6039581|NCT00525785|Immunologic Factors|immunologic factors|mesh-ancestor
6039582|NCT00525785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039583|NCT00525785|Antidotes|antidotes|mesh-ancestor
6039584|NCT00525785|Protective Agents|protective agents|mesh-ancestor
6039585|NCT00525785|Vitamin B Complex|vitamin b complex|mesh-ancestor
6039586|NCT00525785|Vitamins|vitamins|mesh-ancestor
6039587|NCT00525785|Micronutrients|micronutrients|mesh-ancestor
6039588|NCT00525785|Hematinics|hematinics|mesh-ancestor
6039589|NCT00525798|Calcitonin|calcitonin|mesh-list
6039590|NCT00525798|Salmon calcitonin|salmon calcitonin|mesh-list
6039591|NCT00525798|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
5496293|NCT04516941|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5496294|NCT04516941|Antithrombins|antithrombins|mesh-ancestor
5496295|NCT04516941|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5496296|NCT04516941|Protease Inhibitors|protease inhibitors|mesh-ancestor
5496297|NCT04516941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5496298|NCT04516941|Anticoagulants|anticoagulants|mesh-ancestor
5496299|NCT04516915|Oseltamivir|oseltamivir|mesh-list
5496300|NCT04516915|Antiviral Agents|antiviral agents|mesh-ancestor
6039592|NCT00525798|Katacalcin|katacalcin|mesh-list
6039593|NCT00525798|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6039594|NCT00525798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039595|NCT00525798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6039596|NCT00525798|Vasodilator Agents|vasodilator agents|mesh-ancestor
6039597|NCT00525824|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6039598|NCT00525824|Simvastatin|simvastatin|mesh-list
6039599|NCT00525824|Ezetimibe|ezetimibe|mesh-list
6039600|NCT00525824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6039601|NCT00525824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6039602|NCT00525824|Antimetabolites|antimetabolites|mesh-ancestor
6039603|NCT00525824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039604|NCT00525824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6039605|NCT00525824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6039606|NCT00525824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6039607|NCT00525837|Varenicline|varenicline|mesh-list
5496301|NCT04516915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6039608|NCT00525837|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6039609|NCT00525837|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6039610|NCT00525837|Cholinergic Agents|cholinergic agents|mesh-ancestor
5496302|NCT04516915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6039611|NCT00525837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6039612|NCT00525837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039613|NCT00525837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039614|NCT00525876|Vidarabine|vidarabine|mesh-list
6039615|NCT00525876|Cyclophosphamide|cyclophosphamide|mesh-list
6039616|NCT00525876|Rituximab|rituximab|mesh-list
6039617|NCT00525876|Fludarabine|fludarabine|mesh-list
6039618|NCT00525876|Fludarabine phosphate|fludarabine phosphate|mesh-list
6039619|NCT00525876|Alemtuzumab|alemtuzumab|mesh-list
6039620|NCT00525876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6039621|NCT00525876|Immunologic Factors|immunologic factors|mesh-ancestor
6039622|NCT00525876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039623|NCT00525876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6039624|NCT00525876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6039625|NCT00525876|Alkylating Agents|alkylating agents|mesh-ancestor
6039626|NCT00525876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039627|NCT00525876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6039628|NCT00525876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6039629|NCT00525876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6039630|NCT00525876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5496303|NCT04516915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496304|NCT04517162|Povidone|povidone|mesh-list
6655115|NCT01460706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655116|NCT01460797|Metformin|metformin|mesh-list
6655117|NCT01460797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6655118|NCT01460797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655119|NCT01460836|Tobramycin|tobramycin|mesh-list
6655120|NCT01460836|Aztreonam|aztreonam|mesh-list
6655121|NCT01460836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6655122|NCT01460836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6655123|NCT01460888|Olaparib|olaparib|mesh-list
6655124|NCT01460888|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6655125|NCT01460888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6655126|NCT01460888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655127|NCT01460888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6655128|NCT01460979|Sirolimus|sirolimus|mesh-list
6655129|NCT01460979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6039631|NCT00525876|Antimetabolites|antimetabolites|mesh-ancestor
6039632|NCT00525876|Antiviral Agents|antiviral agents|mesh-ancestor
6039633|NCT00525876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6039634|NCT00525902|Adalimumab|adalimumab|mesh-list
6039635|NCT00525902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6039636|NCT00525902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6039637|NCT00525915|Fluorouracil|fluorouracil|mesh-list
6039638|NCT00525915|Oxaliplatin|oxaliplatin|mesh-list
6039639|NCT00525915|Antimetabolites|antimetabolites|mesh-ancestor
6039640|NCT00525915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039641|NCT00525915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6039642|NCT00525915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6039643|NCT00525915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6039644|NCT00525915|Immunologic Factors|immunologic factors|mesh-ancestor
6039645|NCT00525915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039646|NCT00526058|Clotrimazole|clotrimazole|mesh-list
6039647|NCT00526058|Miconazole|miconazole|mesh-list
6039648|NCT00526058|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6039649|NCT00526058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6039650|NCT00526058|Antifungal Agents|antifungal agents|mesh-ancestor
6039651|NCT00526058|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6457860|NCT00438113|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6039652|NCT00526058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6039653|NCT00526058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6457861|NCT00438113|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6457862|NCT00438113|Urological Agents|urological agents|mesh-ancestor
6655130|NCT01460979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5496305|NCT04517162|Plasma Substitutes|plasma substitutes|mesh-ancestor
5496306|NCT04517162|Blood Substitutes|blood substitutes|mesh-ancestor
5496307|NCT04516616|Paclitaxel|paclitaxel|mesh-list
5496308|NCT04516616|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5496309|NCT04516616|Cisplatin|cisplatin|mesh-list
5496310|NCT04516616|Antibodies|antibodies|mesh-list
6053709|NCT00597506|Immunologic Factors|immunologic factors|mesh-ancestor
6457863|NCT00438139|Dronabinol|dronabinol|mesh-list
6457864|NCT00438139|Hallucinogens|hallucinogens|mesh-ancestor
6457865|NCT00438139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457866|NCT00438139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6457867|NCT00438139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5496311|NCT04516616|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6655131|NCT01460979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6039654|NCT00526058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039655|NCT00526058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6039656|NCT00526058|Hormone Antagonists|hormone antagonists|mesh-ancestor
5496312|NCT04516616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5496313|NCT04516616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5496314|NCT04516616|Tubulin Modulators|tubulin modulators|mesh-ancestor
5496315|NCT04516616|Antimitotic Agents|antimitotic agents|mesh-ancestor
5496316|NCT04516616|Mitosis Modulators|mitosis modulators|mesh-ancestor
5496317|NCT04516616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496318|NCT04516616|Immunologic Factors|immunologic factors|mesh-ancestor
5496319|NCT04516616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496320|NCT04516681|Ascorbic Acid|ascorbic acid|mesh-list
5496321|NCT04516681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496322|NCT04516681|Vitamins|vitamins|mesh-ancestor
5496323|NCT04516681|Micronutrients|micronutrients|mesh-ancestor
6039657|NCT00526058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6039658|NCT00526058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039659|NCT00526058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6039660|NCT00526058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6039661|NCT00526097|Bisacodyl|bisacodyl|mesh-list
6039662|NCT00526097|Cathartics|cathartics|mesh-ancestor
6039663|NCT00526097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6039664|NCT00526097|Laxatives|laxatives|mesh-ancestor
6039665|NCT00526110|Docetaxel|docetaxel|mesh-list
6039666|NCT00526110|Fluorouracil|fluorouracil|mesh-list
6039667|NCT00526110|Oxaliplatin|oxaliplatin|mesh-list
6457868|NCT00438139|Analgesics|analgesics|mesh-ancestor
6457869|NCT00438139|Sensory System Agents|sensory system agents|mesh-ancestor
6457870|NCT00438139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6457871|NCT00438139|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6457872|NCT00438139|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6457873|NCT00438139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6457874|NCT00438139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039668|NCT00526110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6039669|NCT00526110|Tubulin Modulators|tubulin modulators|mesh-ancestor
6039670|NCT00526110|Antimitotic Agents|antimitotic agents|mesh-ancestor
6039671|NCT00526110|Mitosis Modulators|mitosis modulators|mesh-ancestor
6039672|NCT00526110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496324|NCT04516681|Antioxidants|antioxidants|mesh-ancestor
5496325|NCT04516681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496326|NCT04516681|Protective Agents|protective agents|mesh-ancestor
5496327|NCT04516655|Rituximab|rituximab|mesh-list
5496328|NCT04516655|Methotrexate|methotrexate|mesh-list
5496329|NCT04516655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5496330|NCT04516655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5496331|NCT04516655|Immunologic Factors|immunologic factors|mesh-ancestor
5496332|NCT04516655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496333|NCT04516655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5496334|NCT04516655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5496335|NCT04516655|Abortifacient Agents|abortifacient agents|mesh-ancestor
5496336|NCT04516655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5496337|NCT04516655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5496338|NCT04516655|Antimetabolites|antimetabolites|mesh-ancestor
5496339|NCT04516655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496340|NCT04516655|Dermatologic Agents|dermatologic agents|mesh-ancestor
5496341|NCT04516655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5496342|NCT04516655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5496343|NCT04516655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5496344|NCT04516655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5496345|NCT04516603|4-Aminopyridine|4-aminopyridine|mesh-list
5496346|NCT04516603|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5496347|NCT04516603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5496348|NCT04516603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496349|NCT04516304|Equol|equol|mesh-list
5496350|NCT04516304|Phytoestrogens|phytoestrogens|mesh-ancestor
5496351|NCT04516304|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
5496352|NCT04516304|Estrogens|estrogens|mesh-ancestor
5496353|NCT04516304|Hormones|hormones|mesh-ancestor
5496354|NCT04516304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5496355|NCT04516304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457875|NCT00438139|Hormones|hormones|mesh-ancestor
6457876|NCT00438139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6457877|NCT00438152|Ritonavir|ritonavir|mesh-list
6039673|NCT00526110|Antimetabolites|antimetabolites|mesh-ancestor
6039674|NCT00526110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6039675|NCT00526110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6039676|NCT00526110|Immunologic Factors|immunologic factors|mesh-ancestor
6039677|NCT00526110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039678|NCT00526292|Cyclophosphamide|cyclophosphamide|mesh-list
6039679|NCT00526292|Fludarabine|fludarabine|mesh-list
6039680|NCT00526292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6039681|NCT00526292|Immunologic Factors|immunologic factors|mesh-ancestor
6039682|NCT00526292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039683|NCT00526292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6039684|NCT00526292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6039685|NCT00526292|Alkylating Agents|alkylating agents|mesh-ancestor
6039686|NCT00526292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039687|NCT00526292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6039688|NCT00526292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6039689|NCT00526474|Vorapaxar|vorapaxar|mesh-list
6039690|NCT00526474|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6039691|NCT00526591|Everolimus|everolimus|mesh-list
6039692|NCT00526591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6039693|NCT00526591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6039694|NCT00526591|Immunologic Factors|immunologic factors|mesh-ancestor
6039695|NCT00526591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039696|NCT00526630|Methylphenidate|methylphenidate|mesh-list
6039697|NCT00526630|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6039698|NCT00526630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496356|NCT04516174|Dexmedetomidine|dexmedetomidine|mesh-list
5496357|NCT04516174|Ropivacaine|ropivacaine|mesh-list
5496358|NCT04516174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5496359|NCT04516174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5496360|NCT04516174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496361|NCT04516174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5496362|NCT04516174|Analgesics|analgesics|mesh-ancestor
6039699|NCT00526630|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6039700|NCT00526630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6039701|NCT00526630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6039702|NCT00526630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039703|NCT00526630|Dopamine Agents|dopamine agents|mesh-ancestor
6039704|NCT00526630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6039705|NCT00526656|Sunitinib|sunitinib|mesh-list
6039706|NCT00526656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6039707|NCT00526656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6039708|NCT00526656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6039709|NCT00526656|Growth Substances|growth substances|mesh-ancestor
6039710|NCT00526656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039711|NCT00526656|Growth Inhibitors|growth inhibitors|mesh-ancestor
6039712|NCT00526656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6039713|NCT00526656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6039714|NCT00526656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039715|NCT00526669|Capecitabine|capecitabine|mesh-list
6039716|NCT00526669|Lapatinib|lapatinib|mesh-list
6039717|NCT00526669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6039718|NCT00526669|Antimetabolites|antimetabolites|mesh-ancestor
6039719|NCT00526669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039720|NCT00526669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6039721|NCT00526669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6039722|NCT00526669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6039723|NCT00526799|Sorafenib|sorafenib|mesh-list
6039724|NCT00526799|Topotecan|topotecan|mesh-list
6039725|NCT00526799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6039726|NCT00526799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6039727|NCT00526799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6039728|NCT00526799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039729|NCT00526799|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6039730|NCT00526799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6039731|NCT00526890|Selenium|selenium|mesh-list
6039732|NCT00526890|Paclitaxel|paclitaxel|mesh-list
6039733|NCT00526890|Carboplatin|carboplatin|mesh-list
6457878|NCT00438152|Lopinavir|lopinavir|mesh-list
6655132|NCT01460979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5496363|NCT04516174|Sensory System Agents|sensory system agents|mesh-ancestor
5496364|NCT04516174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5496365|NCT04516174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5496366|NCT04516174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6457879|NCT00438152|Saquinavir|saquinavir|mesh-list
5496367|NCT04516174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5496368|NCT04516174|Adrenergic Agents|adrenergic agents|mesh-ancestor
5496369|NCT04516174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5496370|NCT04516174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496371|NCT04516174|Anesthetics, Local|anesthetics, local|mesh-ancestor
5496372|NCT04516174|Anesthetics|anesthetics|mesh-ancestor
5496373|NCT04516161|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
6457880|NCT00438152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6457881|NCT00438152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6457882|NCT00438152|Protease Inhibitors|protease inhibitors|mesh-ancestor
6457883|NCT00438152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6655133|NCT01460979|Antifungal Agents|antifungal agents|mesh-ancestor
6039734|NCT00526890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6039735|NCT00526890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6039736|NCT00526890|Tubulin Modulators|tubulin modulators|mesh-ancestor
6039737|NCT00526890|Antimitotic Agents|antimitotic agents|mesh-ancestor
6039738|NCT00526890|Mitosis Modulators|mitosis modulators|mesh-ancestor
6039739|NCT00526890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039740|NCT00526890|Antioxidants|antioxidants|mesh-ancestor
6039741|NCT00526890|Protective Agents|protective agents|mesh-ancestor
6039742|NCT00526890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039743|NCT00526890|Trace Elements|trace elements|mesh-ancestor
6039744|NCT00526890|Micronutrients|micronutrients|mesh-ancestor
6039745|NCT00527072|Infliximab|infliximab|mesh-list
6039746|NCT00527072|Dermatologic Agents|dermatologic agents|mesh-ancestor
6039747|NCT00527072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6039748|NCT00527072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6039749|NCT00527111|Fluorouracil|fluorouracil|mesh-list
6039750|NCT00527111|Cetuximab|cetuximab|mesh-list
6039751|NCT00527111|Antimetabolites|antimetabolites|mesh-ancestor
6039752|NCT00527111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039753|NCT00527111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6039754|NCT00527111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6039755|NCT00527111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6039756|NCT00527111|Immunologic Factors|immunologic factors|mesh-ancestor
6039757|NCT00527111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039758|NCT00527111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6039759|NCT00527124|Prednisone|prednisone|mesh-list
6039760|NCT00527124|Docetaxel|docetaxel|mesh-list
6039761|NCT00527124|Cediranib|cediranib|mesh-list
6039762|NCT00527124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6039763|NCT00527124|Tubulin Modulators|tubulin modulators|mesh-ancestor
6039764|NCT00527124|Antimitotic Agents|antimitotic agents|mesh-ancestor
6039765|NCT00527124|Mitosis Modulators|mitosis modulators|mesh-ancestor
6039766|NCT00527124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039767|NCT00527124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6039768|NCT00527124|Glucocorticoids|glucocorticoids|mesh-ancestor
6039769|NCT00527124|Hormones|hormones|mesh-ancestor
6039770|NCT00527124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6039771|NCT00527124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496374|NCT04516161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5496375|NCT04516395|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5496376|NCT04516395|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5496377|NCT04516395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5496378|NCT04516395|Antitubercular Agents|antitubercular agents|mesh-ancestor
5496379|NCT04516148|Clindamycin|clindamycin|mesh-list
5496380|NCT04516148|Clindamycin palmitate|clindamycin palmitate|mesh-list
5496381|NCT04516148|Clindamycin phosphate|clindamycin phosphate|mesh-list
6039772|NCT00527124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6039773|NCT00527124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6039774|NCT00527124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6039775|NCT00527332|Fentanyl|fentanyl|mesh-list
6039776|NCT00527332|Morphine|morphine|mesh-list
6039777|NCT00527332|Bupivacaine|bupivacaine|mesh-list
6039778|NCT00527332|Propofol|propofol|mesh-list
6039779|NCT00527332|Anesthetics, Local|anesthetics, local|mesh-ancestor
6039780|NCT00527332|Anesthetics|anesthetics|mesh-ancestor
6039781|NCT00527332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6039782|NCT00527332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039783|NCT00527332|Sensory System Agents|sensory system agents|mesh-ancestor
6039784|NCT00527332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6039785|NCT00527332|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5496382|NCT04516148|Cefazolin|cefazolin|mesh-list
6039786|NCT00527332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6039787|NCT00527332|Anesthetics, General|anesthetics, general|mesh-ancestor
5496383|NCT04516148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6039788|NCT00527332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6039789|NCT00527332|Narcotics|narcotics|mesh-ancestor
5496384|NCT04516148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5496385|NCT04516148|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5496386|NCT04516148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5496387|NCT04516148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496388|NCT04516317|Artesunate|artesunate|mesh-list
5496389|NCT04516317|Quinine|quinine|mesh-list
5496390|NCT04516317|Antimalarials|antimalarials|mesh-ancestor
5496391|NCT04516317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5496392|NCT04516317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5496393|NCT04516317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5496394|NCT04516317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5496395|NCT04516317|Antiviral Agents|antiviral agents|mesh-ancestor
5496396|NCT04516317|Schistosomicides|schistosomicides|mesh-ancestor
5496397|NCT04516317|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5496398|NCT04516317|Anthelmintics|anthelmintics|mesh-ancestor
5496399|NCT04516317|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5496400|NCT04516317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496401|NCT04516317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5496402|NCT04516317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5496403|NCT04516317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5496404|NCT04516317|Analgesics|analgesics|mesh-ancestor
5496405|NCT04516317|Sensory System Agents|sensory system agents|mesh-ancestor
5496406|NCT04516226|Chlorhexidine|chlorhexidine|mesh-list
5496407|NCT04516226|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5496408|NCT04516226|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5496409|NCT04516226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5496410|NCT04516226|Disinfectants|disinfectants|mesh-ancestor
5496411|NCT04516226|Dermatologic Agents|dermatologic agents|mesh-ancestor
5496412|NCT04515966|Methylprednisolone|methylprednisolone|mesh-list
5496413|NCT04515966|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6039790|NCT00527332|Analgesics|analgesics|mesh-ancestor
6039791|NCT00527332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6053710|NCT00597519|Cyclophosphamide|cyclophosphamide|mesh-list
6053711|NCT00597519|Fludarabine|fludarabine|mesh-list
6053712|NCT00597519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6053713|NCT00597519|Immunologic Factors|immunologic factors|mesh-ancestor
5496414|NCT04515966|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5496415|NCT04515966|Prednisolone|prednisolone|mesh-list
5496416|NCT04515966|Prednisolone acetate|prednisolone acetate|mesh-list
5496417|NCT04515966|Lidocaine|lidocaine|mesh-list
5496418|NCT04515966|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5496419|NCT04515966|Prednisolone phosphate|prednisolone phosphate|mesh-list
5496420|NCT04515966|Anesthetics, Local|anesthetics, local|mesh-ancestor
5496421|NCT04515966|Anesthetics|anesthetics|mesh-ancestor
5496422|NCT04515966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5496423|NCT04515966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496424|NCT04515966|Sensory System Agents|sensory system agents|mesh-ancestor
5496425|NCT04515966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5496426|NCT04515966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5496427|NCT04515966|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5496428|NCT04515966|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5496429|NCT04515966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5496430|NCT04515966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496431|NCT04515966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5496432|NCT04515966|Antiemetics|antiemetics|mesh-ancestor
5496433|NCT04515966|Autonomic Agents|autonomic agents|mesh-ancestor
5496434|NCT04515966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5496435|NCT04515966|Glucocorticoids|glucocorticoids|mesh-ancestor
5496436|NCT04515966|Hormones|hormones|mesh-ancestor
5496437|NCT04515966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5496438|NCT04515966|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5496439|NCT04515966|Protective Agents|protective agents|mesh-ancestor
5496440|NCT04515966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5496441|NCT04515966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5503270|NCT04460872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5503271|NCT04460872|Anabolic Agents|anabolic agents|mesh-ancestor
5503272|NCT04460352|Leucovorin|leucovorin|mesh-list
5503273|NCT04460352|Paclitaxel|paclitaxel|mesh-list
5503274|NCT04460352|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5503275|NCT04460352|Carboplatin|carboplatin|mesh-list
5503276|NCT04460352|Fluorouracil|fluorouracil|mesh-list
6053714|NCT00597519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053715|NCT00597519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6053716|NCT00597519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6053717|NCT00597519|Alkylating Agents|alkylating agents|mesh-ancestor
5503277|NCT04460352|Oxaliplatin|oxaliplatin|mesh-list
5503278|NCT04460352|Calcium|calcium|mesh-list
5503279|NCT04460352|Levoleucovorin|levoleucovorin|mesh-list
6039792|NCT00527397|Insulin|insulin|mesh-list
6039793|NCT00527397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6039794|NCT00527397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039795|NCT00527423|Aflibercept|aflibercept|mesh-list
6039796|NCT00527423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6039797|NCT00527423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6039798|NCT00527423|Growth Substances|growth substances|mesh-ancestor
6039799|NCT00527423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039800|NCT00527423|Growth Inhibitors|growth inhibitors|mesh-ancestor
6039801|NCT00527423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6039802|NCT00527475|Ranibizumab|ranibizumab|mesh-list
6039803|NCT00527475|Verteporfin|verteporfin|mesh-list
6039804|NCT00527475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6039805|NCT00527475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6039806|NCT00527475|Growth Substances|growth substances|mesh-ancestor
6039807|NCT00527475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039808|NCT00527475|Growth Inhibitors|growth inhibitors|mesh-ancestor
6039809|NCT00527475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6039810|NCT00527475|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6039811|NCT00527475|Dermatologic Agents|dermatologic agents|mesh-ancestor
6039812|NCT00527514|Amlodipine|amlodipine|mesh-list
5496442|NCT04515719|Belimumab|belimumab|mesh-list
5496443|NCT04515719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5496444|NCT04515719|Immunologic Factors|immunologic factors|mesh-ancestor
5496445|NCT04515719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496446|NCT04515979|Pembrolizumab|pembrolizumab|mesh-list
6039813|NCT00527514|Olmesartan|olmesartan|mesh-list
6039814|NCT00527514|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6039815|NCT00527514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6039816|NCT00527514|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6039817|NCT00527514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6039818|NCT00527514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039819|NCT00527514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6039820|NCT00527514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039821|NCT00527514|Vasodilator Agents|vasodilator agents|mesh-ancestor
6039822|NCT00527514|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6039823|NCT00527514|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6039824|NCT00527592|Travoprost|travoprost|mesh-list
6039825|NCT00527592|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6039826|NCT00527592|Latanoprost|latanoprost|mesh-list
6039827|NCT00527592|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6039828|NCT00527592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6039829|NCT00527605|Dutasteride|dutasteride|mesh-list
6039830|NCT00527605|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6039831|NCT00527605|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6039832|NCT00527605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6039833|NCT00527605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039834|NCT00527605|Hormone Antagonists|hormone antagonists|mesh-ancestor
6039835|NCT00527605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6039836|NCT00527605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039837|NCT00527618|Valacyclovir|valacyclovir|mesh-list
6039838|NCT00527618|Acyclovir|acyclovir|mesh-list
6039839|NCT00527618|Antiviral Agents|antiviral agents|mesh-ancestor
6039840|NCT00527618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6039841|NCT00527644|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6039842|NCT00527644|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
6039843|NCT00527644|beta-Endorphin|beta-endorphin|mesh-list
6039844|NCT00527644|Hormones|hormones|mesh-ancestor
5496447|NCT04515979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5496448|NCT04515979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6039845|NCT00527644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6039846|NCT00527644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039847|NCT00527644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6039848|NCT00527644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039849|NCT00527735|Paclitaxel|paclitaxel|mesh-list
6039850|NCT00527735|Carboplatin|carboplatin|mesh-list
6039851|NCT00527735|Ipilimumab|ipilimumab|mesh-list
6039852|NCT00527735|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6039853|NCT00527735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6039854|NCT00527735|Tubulin Modulators|tubulin modulators|mesh-ancestor
6039855|NCT00527735|Antimitotic Agents|antimitotic agents|mesh-ancestor
6039856|NCT00527735|Mitosis Modulators|mitosis modulators|mesh-ancestor
6039857|NCT00527735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039858|NCT00527735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6039859|NCT00527735|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6039860|NCT00527787|Naproxen|naproxen|mesh-list
6039861|NCT00527787|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6039862|NCT00527787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6039863|NCT00527787|Analgesics|analgesics|mesh-ancestor
6039864|NCT00527787|Sensory System Agents|sensory system agents|mesh-ancestor
6039865|NCT00527787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6039866|NCT00527787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039867|NCT00527787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6039868|NCT00527787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6039869|NCT00527787|Gout Suppressants|gout suppressants|mesh-ancestor
6039870|NCT00527787|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6039871|NCT00527787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6039872|NCT00527787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039873|NCT00527826|Fluticasone|fluticasone|mesh-list
6039874|NCT00527826|Xhance|xhance|mesh-list
6039875|NCT00527826|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6039876|NCT00527826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6039877|NCT00527826|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6039878|NCT00527826|Autonomic Agents|autonomic agents|mesh-ancestor
6039879|NCT00527826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6039880|NCT00527826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039881|NCT00527826|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6039882|NCT00527826|Respiratory System Agents|respiratory system agents|mesh-ancestor
6039883|NCT00527826|Dermatologic Agents|dermatologic agents|mesh-ancestor
6039884|NCT00527826|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6039885|NCT00527826|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6039886|NCT00527826|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6039887|NCT00527826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6039888|NCT00527826|Adrenergic Agents|adrenergic agents|mesh-ancestor
6039889|NCT00527826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6039890|NCT00527826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039891|NCT00527878|Ranitidine|ranitidine|mesh-list
5496449|NCT04515836|Olaparib|olaparib|mesh-list
5496450|NCT04515836|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5496451|NCT04515836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5496452|NCT04515836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496453|NCT04515836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5496454|NCT04515368|Vaccines|vaccines|mesh-list
5496455|NCT04515368|Immunologic Factors|immunologic factors|mesh-ancestor
5496456|NCT04515368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496457|NCT04515732|Apremilast|apremilast|mesh-list
5496458|NCT04515732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5496459|NCT04515732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5496460|NCT04515732|Analgesics|analgesics|mesh-ancestor
5496461|NCT04515732|Sensory System Agents|sensory system agents|mesh-ancestor
6039892|NCT00527878|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
6039893|NCT00527878|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6039894|NCT00527878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6039895|NCT00527878|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6039896|NCT00527878|Histamine Antagonists|histamine antagonists|mesh-ancestor
6039897|NCT00527878|Histamine Agents|histamine agents|mesh-ancestor
6039898|NCT00527878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6039899|NCT00527878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039900|NCT00527878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039901|NCT00527904|Naproxen|naproxen|mesh-list
6039902|NCT00527904|Esomeprazole|esomeprazole|mesh-list
6039903|NCT00527904|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6039904|NCT00527904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6039905|NCT00527904|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6039906|NCT00527904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6039907|NCT00527904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039908|NCT00527904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6039909|NCT00527904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6039910|NCT00527904|Analgesics|analgesics|mesh-ancestor
6039911|NCT00527904|Sensory System Agents|sensory system agents|mesh-ancestor
6039912|NCT00527904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6039913|NCT00527904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039914|NCT00527904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6039915|NCT00527904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6039916|NCT00527904|Gout Suppressants|gout suppressants|mesh-ancestor
6039917|NCT00527904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6039918|NCT00527943|Vorapaxar|vorapaxar|mesh-list
6039919|NCT00527943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6039920|NCT00528190|Itraconazole|itraconazole|mesh-list
6039921|NCT00528190|Antifungal Agents|antifungal agents|mesh-ancestor
6039922|NCT00528190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6039923|NCT00528190|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6039924|NCT00528190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6039925|NCT00528190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6039926|NCT00528190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039927|NCT00528190|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5496462|NCT04515732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5496463|NCT04515732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496464|NCT04515732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5496465|NCT04515732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5496466|NCT04515732|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5496467|NCT04515732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5496468|NCT04515732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5496469|NCT04515732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496470|NCT04515420|Norepinephrine|norepinephrine|mesh-list
5496471|NCT04515420|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5496472|NCT04515420|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6039928|NCT00528190|Hormone Antagonists|hormone antagonists|mesh-ancestor
6039929|NCT00528190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6039930|NCT00528190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039931|NCT00528190|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6039932|NCT00528268|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
6039933|NCT00528268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6039934|NCT00528372|Metformin|metformin|mesh-list
6039935|NCT00528372|Dapagliflozin|dapagliflozin|mesh-list
6039936|NCT00528372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6039937|NCT00528372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039938|NCT00528372|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6039939|NCT00528372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039940|NCT00528398|Cytarabine|cytarabine|mesh-list
6039941|NCT00528398|Idarubicin|idarubicin|mesh-list
6039942|NCT00528398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6039943|NCT00528398|Antimetabolites|antimetabolites|mesh-ancestor
6039944|NCT00528398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039945|NCT00528398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6039946|NCT00528398|Antiviral Agents|antiviral agents|mesh-ancestor
6039947|NCT00528398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6039948|NCT00528398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6039949|NCT00528398|Immunologic Factors|immunologic factors|mesh-ancestor
6039950|NCT00528398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039951|NCT00528398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6039952|NCT00528398|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6039953|NCT00528398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6039954|NCT00528398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6039955|NCT00528411|Aspirin|aspirin|mesh-list
6039956|NCT00528411|Clopidogrel|clopidogrel|mesh-list
6039957|NCT00528411|Ticagrelor|ticagrelor|mesh-list
6039958|NCT00528411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6039959|NCT00528411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6039960|NCT00528411|Analgesics|analgesics|mesh-ancestor
6039961|NCT00528411|Sensory System Agents|sensory system agents|mesh-ancestor
6039962|NCT00528411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6039963|NCT00528411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6039964|NCT00528411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6039965|NCT00528411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6039966|NCT00528411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6039967|NCT00528411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6039968|NCT00528411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039969|NCT00528411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6039970|NCT00528411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6039971|NCT00528411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6039972|NCT00528411|Antipyretics|antipyretics|mesh-ancestor
6039973|NCT00528411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6039974|NCT00528411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6039975|NCT00528411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6457884|NCT00438152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457885|NCT00438152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5496473|NCT04515420|Adrenergic Agents|adrenergic agents|mesh-ancestor
6039976|NCT00528411|Purinergic Agents|purinergic agents|mesh-ancestor
6039977|NCT00528411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6039978|NCT00528450|Idarubicin|idarubicin|mesh-list
6039979|NCT00528450|Arsenic Trioxide|arsenic trioxide|mesh-list
6039980|NCT00528450|Tretinoin|tretinoin|mesh-list
6039981|NCT00528450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6039982|NCT00528450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6039983|NCT00528450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6039984|NCT00528450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6039985|NCT00528450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6039986|NCT00528450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039987|NCT00528450|Keratolytic Agents|keratolytic agents|mesh-ancestor
6039988|NCT00528450|Dermatologic Agents|dermatologic agents|mesh-ancestor
6039989|NCT00528528|Ribavirin|ribavirin|mesh-list
6039990|NCT00528528|Interferon-alpha|interferon-alpha|mesh-list
6039991|NCT00528528|Interferon alpha-2|interferon alpha-2|mesh-list
6039992|NCT00528528|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
6039993|NCT00528528|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6039994|NCT00528528|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6039995|NCT00528528|Antimetabolites|antimetabolites|mesh-ancestor
6039996|NCT00528528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6039997|NCT00528528|Antiviral Agents|antiviral agents|mesh-ancestor
6039998|NCT00528528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6039999|NCT00528528|Immunologic Factors|immunologic factors|mesh-ancestor
6040000|NCT00528528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040001|NCT00528528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6040002|NCT00528541|Botulinum Toxins|botulinum toxins|mesh-list
6040003|NCT00528541|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6040004|NCT00528541|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6040005|NCT00528541|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5496474|NCT04515420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5496475|NCT04515420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496476|NCT04515420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496477|NCT04515420|Sympathomimetics|sympathomimetics|mesh-ancestor
5496478|NCT04515420|Autonomic Agents|autonomic agents|mesh-ancestor
5496479|NCT04515420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5496480|NCT04515420|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5496481|NCT04515641|Islatravir|islatravir|mesh-list
5496482|NCT04515641|Antiviral Agents|antiviral agents|mesh-ancestor
5496483|NCT04515641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5496484|NCT04515641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5496485|NCT04515641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496486|NCT04515641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5496487|NCT04515641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6040006|NCT00528541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6040007|NCT00528541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040008|NCT00528541|Cholinergic Agents|cholinergic agents|mesh-ancestor
6040009|NCT00528541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6040010|NCT00528541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457886|NCT00438152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6040011|NCT00528541|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6040012|NCT00528541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6040013|NCT00528567|Bevacizumab|bevacizumab|mesh-list
6040014|NCT00528567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6040015|NCT00528567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6040016|NCT00528567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6040017|NCT00528567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5496488|NCT04515641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5496489|NCT04515576|Dulaglutide|dulaglutide|mesh-list
5496490|NCT04515576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5496491|NCT04515576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496492|NCT04515628|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5496493|NCT04515628|Branebrutinib|branebrutinib|mesh-list
5496494|NCT04515628|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5496495|NCT04515628|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5496496|NCT04515628|Antimetabolites|antimetabolites|mesh-ancestor
5496497|NCT04515628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496498|NCT04515628|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5496499|NCT04515628|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5496500|NCT04515628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6040018|NCT00528567|Growth Substances|growth substances|mesh-ancestor
6040019|NCT00528567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040020|NCT00528567|Growth Inhibitors|growth inhibitors|mesh-ancestor
6040021|NCT00528580|Simvastatin|simvastatin|mesh-list
6040022|NCT00528580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6040023|NCT00528580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6040024|NCT00528580|Antimetabolites|antimetabolites|mesh-ancestor
6040025|NCT00528580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040026|NCT00528580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6040027|NCT00528580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6040028|NCT00528580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6040029|NCT00528645|Saracatinib|saracatinib|mesh-list
6040030|NCT00528645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6040031|NCT00528645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6040032|NCT00528645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040033|NCT00528788|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
6040034|NCT00528788|Vitamins|vitamins|mesh-ancestor
6040035|NCT00528788|Micronutrients|micronutrients|mesh-ancestor
6040036|NCT00528788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040037|NCT00528788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5496501|NCT04515628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5496502|NCT04515797|Antiviral Agents|antiviral agents|mesh-list
5496503|NCT04515797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5496504|NCT04515238|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5496505|NCT04515238|Venetoclax|venetoclax|mesh-list
5496506|NCT04515238|Obinutuzumab|obinutuzumab|mesh-list
5496507|NCT04515238|Zanubrutinib|zanubrutinib|mesh-list
6040038|NCT00528866|Docetaxel|docetaxel|mesh-list
6040039|NCT00528866|Bicalutamide|bicalutamide|mesh-list
6040040|NCT00528866|Flutamide|flutamide|mesh-list
6040041|NCT00528866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6040042|NCT00528866|Tubulin Modulators|tubulin modulators|mesh-ancestor
6040043|NCT00528866|Antimitotic Agents|antimitotic agents|mesh-ancestor
6040044|NCT00528866|Mitosis Modulators|mitosis modulators|mesh-ancestor
6040045|NCT00528866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040046|NCT00528866|Androgen Antagonists|androgen antagonists|mesh-ancestor
6040047|NCT00528866|Hormone Antagonists|hormone antagonists|mesh-ancestor
6040048|NCT00528866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6040049|NCT00528866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040050|NCT00528866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6040051|NCT00528879|Metformin|metformin|mesh-list
6040052|NCT00528879|Dapagliflozin|dapagliflozin|mesh-list
6040053|NCT00528879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6040054|NCT00528879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040055|NCT00528879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6040056|NCT00528879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040057|NCT00528957|Tenofovir|tenofovir|mesh-list
6040058|NCT00528957|Zidovudine|zidovudine|mesh-list
6040059|NCT00528957|Stavudine|stavudine|mesh-list
6040060|NCT00528957|Antiviral Agents|antiviral agents|mesh-ancestor
6040061|NCT00528957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6040062|NCT00528957|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6040063|NCT00528957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6040064|NCT00528957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5496508|NCT04515238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6040065|NCT00528957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040066|NCT00528957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6040067|NCT00528957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6040068|NCT00528957|Antimetabolites|antimetabolites|mesh-ancestor
6040069|NCT00528970|Methylnaltrexone|methylnaltrexone|mesh-list
6040070|NCT00528970|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6040071|NCT00528970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040072|NCT00528970|Sensory System Agents|sensory system agents|mesh-ancestor
6040073|NCT00528970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6040074|NCT00528996|Bromides|bromides|mesh-list
6040075|NCT00528996|Tiotropium Bromide|tiotropium bromide|mesh-list
6040076|NCT00528996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6040077|NCT00528996|Autonomic Agents|autonomic agents|mesh-ancestor
6040078|NCT00528996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6040079|NCT00528996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040080|NCT00528996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6040081|NCT00528996|Respiratory System Agents|respiratory system agents|mesh-ancestor
6040082|NCT00528996|Parasympatholytics|parasympatholytics|mesh-ancestor
6040083|NCT00528996|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6040084|NCT00528996|Cholinergic Agents|cholinergic agents|mesh-ancestor
6040085|NCT00528996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6040086|NCT00528996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040087|NCT00528996|Anticonvulsants|anticonvulsants|mesh-ancestor
6040088|NCT00529035|Interleukin-2|interleukin-2|mesh-list
6040089|NCT00529035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6040090|NCT00529035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6040091|NCT00529035|Analgesics|analgesics|mesh-ancestor
6040092|NCT00529035|Sensory System Agents|sensory system agents|mesh-ancestor
6040093|NCT00529035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6040094|NCT00529035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040095|NCT00529087|Bromides|bromides|mesh-list
5496509|NCT04515238|Alkylating Agents|alkylating agents|mesh-ancestor
5496510|NCT04515238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496511|NCT04515238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5496512|NCT04515238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5496513|NCT04515238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5496514|NCT04515238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5496515|NCT04514835|Capecitabine|capecitabine|mesh-list
5496516|NCT04514835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5496517|NCT04514835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5496518|NCT04514835|Antimetabolites|antimetabolites|mesh-ancestor
5496519|NCT04514835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496520|NCT04514770|Misoprostol|misoprostol|mesh-list
5496521|NCT04514770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6040096|NCT00529087|Methylnaltrexone|methylnaltrexone|mesh-list
6040097|NCT00529087|Anticonvulsants|anticonvulsants|mesh-ancestor
6040098|NCT00529087|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6040099|NCT00529087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040100|NCT00529087|Sensory System Agents|sensory system agents|mesh-ancestor
6040101|NCT00529087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6040102|NCT00529100|Cisplatin|cisplatin|mesh-list
6040103|NCT00529100|Pemetrexed|pemetrexed|mesh-list
6040104|NCT00529100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6040105|NCT00529100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6040106|NCT00529100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040107|NCT00529100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6040108|NCT00529100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6040109|NCT00529126|Epinephrine|epinephrine|mesh-list
6040110|NCT00529126|Bupivacaine|bupivacaine|mesh-list
6040111|NCT00529126|Anesthetics, Local|anesthetics, local|mesh-ancestor
6040112|NCT00529126|Anesthetics|anesthetics|mesh-ancestor
6040113|NCT00529126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6040114|NCT00529126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040115|NCT00529126|Sensory System Agents|sensory system agents|mesh-ancestor
6040116|NCT00529126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6040117|NCT00529126|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6040118|NCT00529126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6040119|NCT00529126|Adrenergic Agents|adrenergic agents|mesh-ancestor
6040120|NCT00529126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6040121|NCT00529126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040122|NCT00529126|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6040123|NCT00529126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6040124|NCT00529126|Autonomic Agents|autonomic agents|mesh-ancestor
6040125|NCT00529126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6040126|NCT00529126|Respiratory System Agents|respiratory system agents|mesh-ancestor
6040127|NCT00529126|Mydriatics|mydriatics|mesh-ancestor
6040128|NCT00529126|Sympathomimetics|sympathomimetics|mesh-ancestor
6040129|NCT00529126|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6040130|NCT00529191|Atorvastatin|atorvastatin|mesh-list
6040131|NCT00529191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6040132|NCT00529191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6040133|NCT00529191|Antimetabolites|antimetabolites|mesh-ancestor
6040134|NCT00529191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496522|NCT04514770|Abortifacient Agents|abortifacient agents|mesh-ancestor
5496523|NCT04514770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5496524|NCT04514770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496525|NCT04514770|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5496526|NCT04514770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5496527|NCT04514770|Oxytocics|oxytocics|mesh-ancestor
5496528|NCT04514731|Magnesium Sulfate|magnesium sulfate|mesh-list
5496529|NCT04514731|Analgesics|analgesics|mesh-ancestor
5496530|NCT04514731|Sensory System Agents|sensory system agents|mesh-ancestor
5496531|NCT04514731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5496532|NCT04514731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496533|NCT04514731|Anesthetics|anesthetics|mesh-ancestor
5496534|NCT04514731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5496535|NCT04514731|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6040135|NCT00529191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6040136|NCT00529191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6040137|NCT00529191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5496536|NCT04514731|Anticonvulsants|anticonvulsants|mesh-ancestor
5496537|NCT04514731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5496538|NCT04514731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5496539|NCT04514731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496540|NCT04514731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5496541|NCT04514731|Tocolytic Agents|tocolytic agents|mesh-ancestor
5496542|NCT04514731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5496543|NCT04514796|Adalimumab|adalimumab|mesh-list
5496544|NCT04514796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5496545|NCT04514796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5496546|NCT04514419|Docetaxel|docetaxel|mesh-list
5496547|NCT04514419|Trastuzumab|trastuzumab|mesh-list
5496548|NCT04514419|Pertuzumab|pertuzumab|mesh-list
5496549|NCT04514419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5496550|NCT04514419|Tubulin Modulators|tubulin modulators|mesh-ancestor
5496551|NCT04514419|Antimitotic Agents|antimitotic agents|mesh-ancestor
5496552|NCT04514419|Mitosis Modulators|mitosis modulators|mesh-ancestor
5496553|NCT04514419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496554|NCT04514419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5496555|NCT04514588|Caffeine|caffeine|mesh-list
5496556|NCT04514588|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5496557|NCT04514588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496558|NCT04514588|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5496559|NCT04514588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5496560|NCT04514588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496561|NCT04514588|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5496562|NCT04514588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5496563|NCT04514588|Purinergic Agents|purinergic agents|mesh-ancestor
5496564|NCT04514588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5496565|NCT04514328|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6040138|NCT00529204|Exenatide|exenatide|mesh-list
6040139|NCT00529204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6040140|NCT00529204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040141|NCT00529204|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6457887|NCT00438152|Antiviral Agents|antiviral agents|mesh-ancestor
6457888|NCT00438152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6457889|NCT00438152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5496566|NCT04514328|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6040142|NCT00529204|Incretins|incretins|mesh-ancestor
6457890|NCT00438152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6457891|NCT00438178|Obatoclax|obatoclax|mesh-list
6457892|NCT00438178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5496567|NCT04514328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496568|NCT04514094|Fluorides|fluorides|mesh-list
5496569|NCT04514094|Cariostatic Agents|cariostatic agents|mesh-ancestor
5496570|NCT04514094|Protective Agents|protective agents|mesh-ancestor
5496571|NCT04514094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496572|NCT04514393|Methotrexate|methotrexate|mesh-list
5496573|NCT04514393|Temozolomide|temozolomide|mesh-list
5496574|NCT04514393|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6457893|NCT00438178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457894|NCT00438217|Leuprolide|leuprolide|mesh-list
6457895|NCT00438217|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6457896|NCT00438217|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
6457897|NCT00438217|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6457898|NCT00438217|Fertility Agents|fertility agents|mesh-ancestor
6457899|NCT00438217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6457900|NCT00438217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457901|NCT00438217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6040143|NCT00529204|Hormones|hormones|mesh-ancestor
6040144|NCT00529204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6040145|NCT00529243|Raltegravir Potassium|raltegravir potassium|mesh-list
6040146|NCT00529243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6040147|NCT00529243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6040148|NCT00529243|Antiviral Agents|antiviral agents|mesh-ancestor
6040149|NCT00529243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5496575|NCT04514393|Abortifacient Agents|abortifacient agents|mesh-ancestor
5496576|NCT04514393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5496577|NCT04514393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496578|NCT04514393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6040150|NCT00529243|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6040151|NCT00529243|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6040152|NCT00529243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6040153|NCT00529243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040154|NCT00529373|Calcium, Dietary|calcium, dietary|mesh-list
6040155|NCT00529373|Vitamin D|vitamin d|mesh-list
6040156|NCT00529373|Cholecalciferol|cholecalciferol|mesh-list
6040157|NCT00529373|Calcium Carbonate|calcium carbonate|mesh-list
6040158|NCT00529373|Calcium|calcium|mesh-list
6040159|NCT00529373|Vitamins|vitamins|mesh-ancestor
6040160|NCT00529373|Micronutrients|micronutrients|mesh-ancestor
6040161|NCT00529373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040162|NCT00529373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6040163|NCT00529373|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6040164|NCT00529373|Antacids|antacids|mesh-ancestor
6040165|NCT00529373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040166|NCT00529373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6040167|NCT00529399|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6040168|NCT00529399|Aluminum sulfate|aluminum sulfate|mesh-list
6040169|NCT00529399|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6040170|NCT00529399|Immunologic Factors|immunologic factors|mesh-ancestor
6040171|NCT00529399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040172|NCT00529399|Antacids|antacids|mesh-ancestor
6040173|NCT00529399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496579|NCT04514393|Antimetabolites|antimetabolites|mesh-ancestor
6040174|NCT00529399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6040175|NCT00529451|Ramipril|ramipril|mesh-list
6040176|NCT00529451|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6040177|NCT00529451|Protease Inhibitors|protease inhibitors|mesh-ancestor
6040178|NCT00529451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6040179|NCT00529451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040180|NCT00529451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6040181|NCT00529529|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5496580|NCT04514393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496581|NCT04514393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5496582|NCT04514393|Dermatologic Agents|dermatologic agents|mesh-ancestor
6040182|NCT00529529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6040183|NCT00529529|Autonomic Agents|autonomic agents|mesh-ancestor
6040184|NCT00529529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6040185|NCT00529529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040186|NCT00529529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6040187|NCT00529529|Respiratory System Agents|respiratory system agents|mesh-ancestor
6040188|NCT00529529|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6040189|NCT00529529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6040190|NCT00529529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6040191|NCT00529529|Adrenergic Agents|adrenergic agents|mesh-ancestor
6040192|NCT00529529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6040193|NCT00529529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496583|NCT04514393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5496584|NCT04514393|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5496585|NCT04514393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5496586|NCT04514393|Immunologic Factors|immunologic factors|mesh-ancestor
5496587|NCT04514393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5496588|NCT04514393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5496589|NCT04514393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5496590|NCT04514393|Alkylating Agents|alkylating agents|mesh-ancestor
5496591|NCT04514029|Dexamethasone|dexamethasone|mesh-list
5496592|NCT04514029|Simvastatin|simvastatin|mesh-list
5496593|NCT04514029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5496594|NCT04514029|Antiemetics|antiemetics|mesh-ancestor
5496595|NCT04514029|Autonomic Agents|autonomic agents|mesh-ancestor
5496596|NCT04514029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5496597|NCT04514029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496598|NCT04514029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5496599|NCT04514029|Glucocorticoids|glucocorticoids|mesh-ancestor
5496600|NCT04514029|Hormones|hormones|mesh-ancestor
6040194|NCT00529542|Atorvastatin|atorvastatin|mesh-list
6040195|NCT00529542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5496601|NCT04514029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5496602|NCT04514029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5496603|NCT04514029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5496604|NCT04514029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5496605|NCT04514029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5496606|NCT04514029|Antimetabolites|antimetabolites|mesh-ancestor
6040196|NCT00529542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6040197|NCT00529542|Antimetabolites|antimetabolites|mesh-ancestor
6040198|NCT00529542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040199|NCT00529542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6040200|NCT00529542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6040201|NCT00529542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6040202|NCT00529555|Minocycline|minocycline|mesh-list
6040203|NCT00529555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6040204|NCT00529555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6040205|NCT00529633|Thalidomide|thalidomide|mesh-list
6040206|NCT00529633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6040207|NCT00529633|Immunologic Factors|immunologic factors|mesh-ancestor
6040208|NCT00529633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040209|NCT00529633|Leprostatic Agents|leprostatic agents|mesh-ancestor
6040210|NCT00529633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6040211|NCT00529633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6040212|NCT00529633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6040213|NCT00529633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6040214|NCT00529633|Growth Substances|growth substances|mesh-ancestor
6040215|NCT00529633|Growth Inhibitors|growth inhibitors|mesh-ancestor
6040216|NCT00529633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6040217|NCT00529789|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6040218|NCT00529789|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6040219|NCT00529789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6040220|NCT00529789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6040221|NCT00529789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040222|NCT00529789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6040223|NCT00529789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040224|NCT00529789|Analgesics|analgesics|mesh-ancestor
6040225|NCT00529789|Sensory System Agents|sensory system agents|mesh-ancestor
6040226|NCT00529789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6040227|NCT00529789|Antidepressive Agents|antidepressive agents|mesh-ancestor
6040228|NCT00529789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6040229|NCT00529789|Dopamine Agents|dopamine agents|mesh-ancestor
6040230|NCT00529802|Everolimus|everolimus|mesh-list
6040231|NCT00529802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6040232|NCT00529802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6040233|NCT00529802|Immunologic Factors|immunologic factors|mesh-ancestor
6040234|NCT00529802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040235|NCT00530023|Insulin|insulin|mesh-list
6040236|NCT00530023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6040237|NCT00530023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040238|NCT00530075|Gusperimus|gusperimus|mesh-list
6040239|NCT00530075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6040240|NCT00530075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6040241|NCT00530075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6040242|NCT00530075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040243|NCT00530075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6040244|NCT00530075|Immunologic Factors|immunologic factors|mesh-ancestor
6040245|NCT00530075|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6040246|NCT00530075|Protective Agents|protective agents|mesh-ancestor
6040247|NCT00530088|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
6040248|NCT00530088|Trioxsalen|trioxsalen|mesh-list
6040249|NCT00530088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6040250|NCT00530088|Dermatologic Agents|dermatologic agents|mesh-ancestor
6040251|NCT00530088|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6040252|NCT00530218|Ganciclovir|ganciclovir|mesh-list
6040253|NCT00530218|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6040254|NCT00530218|Antiviral Agents|antiviral agents|mesh-ancestor
6040255|NCT00530218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6040256|NCT00530218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6040257|NCT00530218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6040258|NCT00530218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040259|NCT00530257|Methylphenidate|methylphenidate|mesh-list
6040260|NCT00530257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6040261|NCT00530257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040262|NCT00530257|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6040263|NCT00530257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6040264|NCT00530257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6040265|NCT00530257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040266|NCT00530257|Dopamine Agents|dopamine agents|mesh-ancestor
6040267|NCT00530257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6040268|NCT00530270|Dexamethasone|dexamethasone|mesh-list
6040269|NCT00530270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6040270|NCT00530270|Antiemetics|antiemetics|mesh-ancestor
6040271|NCT00530270|Autonomic Agents|autonomic agents|mesh-ancestor
6040272|NCT00530270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6040273|NCT00530270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040274|NCT00530270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6040275|NCT00530270|Glucocorticoids|glucocorticoids|mesh-ancestor
6040276|NCT00530270|Hormones|hormones|mesh-ancestor
6040277|NCT00530270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6040278|NCT00530270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6040279|NCT00530270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6040280|NCT00530335|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6040281|NCT00530335|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6040282|NCT00530335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6040283|NCT00530335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5496607|NCT04514029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496608|NCT04514029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5496609|NCT04514029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5496610|NCT04514029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5496611|NCT04514289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5496612|NCT04514081|Decitabine|decitabine|mesh-list
5496613|NCT04514081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5496614|NCT04514081|Antimetabolites|antimetabolites|mesh-ancestor
5496615|NCT04514081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496616|NCT04514081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5496617|NCT04514081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5503280|NCT04460352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5503281|NCT04460352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5503282|NCT04460352|Tubulin Modulators|tubulin modulators|mesh-ancestor
5503283|NCT04460352|Antimitotic Agents|antimitotic agents|mesh-ancestor
6040284|NCT00530335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040285|NCT00530335|Adrenergic Agents|adrenergic agents|mesh-ancestor
6040286|NCT00530335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6040287|NCT00530335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040288|NCT00530348|Interferons|interferons|mesh-list
6040289|NCT00530348|Interferon-beta|interferon-beta|mesh-list
6040290|NCT00530348|Interferon beta-1a|interferon beta-1a|mesh-list
6040291|NCT00530348|Alemtuzumab|alemtuzumab|mesh-list
6040292|NCT00530348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6040293|NCT00530348|Antiviral Agents|antiviral agents|mesh-ancestor
6040294|NCT00530348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6040295|NCT00530348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6040296|NCT00530348|Immunologic Factors|immunologic factors|mesh-ancestor
6040297|NCT00530348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040298|NCT00530348|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6040299|NCT00530621|Pemetrexed|pemetrexed|mesh-list
6040300|NCT00530621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6040301|NCT00530621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6040302|NCT00530621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040303|NCT00530621|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5503284|NCT04460352|Mitosis Modulators|mitosis modulators|mesh-ancestor
5503285|NCT04460352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503286|NCT04460352|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6040304|NCT00530621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6040305|NCT00530634|Gemcitabine|gemcitabine|mesh-list
6040306|NCT00530634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6040307|NCT00530634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6040308|NCT00530634|Antimetabolites|antimetabolites|mesh-ancestor
6040309|NCT00530634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040310|NCT00530634|Antiviral Agents|antiviral agents|mesh-ancestor
6040311|NCT00530634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6040312|NCT00530634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6040313|NCT00530634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5503287|NCT04460352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503288|NCT04460352|Antimetabolites|antimetabolites|mesh-ancestor
5503289|NCT04460352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6040314|NCT00530634|Immunologic Factors|immunologic factors|mesh-ancestor
6040315|NCT00530634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040316|NCT00530764|Nabiximols|nabiximols|mesh-list
6040317|NCT00530764|Dronabinol|dronabinol|mesh-list
6040318|NCT00530764|Cannabidiol|cannabidiol|mesh-list
6040319|NCT00530764|Analgesics|analgesics|mesh-ancestor
6040320|NCT00530764|Sensory System Agents|sensory system agents|mesh-ancestor
6040321|NCT00530764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6040322|NCT00530764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040323|NCT00530764|Anticonvulsants|anticonvulsants|mesh-ancestor
6040324|NCT00530764|Hallucinogens|hallucinogens|mesh-ancestor
6040325|NCT00530764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6040326|NCT00530764|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6040327|NCT00530764|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6040328|NCT00530764|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6040329|NCT00530764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6040330|NCT00530764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040331|NCT00530764|Hormones|hormones|mesh-ancestor
6040332|NCT00530764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5496618|NCT04513821|Ethanol|ethanol|mesh-list
5496619|NCT04513821|Minocycline|minocycline|mesh-list
5496620|NCT04513821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5496621|NCT04513821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5496622|NCT04513821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5496623|NCT04513821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496624|NCT04513821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5496625|NCT04513808|Anesthetics|anesthetics|mesh-list
5496626|NCT04513808|Propofol|propofol|mesh-list
5496627|NCT04513808|Sevoflurane|sevoflurane|mesh-list
5496628|NCT04513808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5496629|NCT04513808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040333|NCT00530777|Valacyclovir|valacyclovir|mesh-list
6040334|NCT00530777|Antiviral Agents|antiviral agents|mesh-ancestor
6040335|NCT00530777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6040336|NCT00530790|Ropinirole|ropinirole|mesh-list
6040337|NCT00530790|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6040338|NCT00530790|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6040339|NCT00530790|Dopamine Agonists|dopamine agonists|mesh-ancestor
6040340|NCT00530790|Dopamine Agents|dopamine agents|mesh-ancestor
6040341|NCT00530790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6040342|NCT00530790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040343|NCT00530790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040344|NCT00530803|Lidocaine|lidocaine|mesh-list
6040345|NCT00530803|Tetracaine|tetracaine|mesh-list
6040346|NCT00530803|Prilocaine|prilocaine|mesh-list
6040347|NCT00530803|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
6040348|NCT00530803|Anesthetics, Local|anesthetics, local|mesh-ancestor
6040349|NCT00530803|Anesthetics|anesthetics|mesh-ancestor
6040350|NCT00530803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6040351|NCT00530803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040352|NCT00530803|Sensory System Agents|sensory system agents|mesh-ancestor
6040353|NCT00530803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6040354|NCT00530803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6040355|NCT00530803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6040356|NCT00530803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6040357|NCT00530803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6040358|NCT00530803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040359|NCT00530803|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
6040360|NCT00530842|Fluticasone|fluticasone|mesh-list
6040361|NCT00530842|Tiotropium Bromide|tiotropium bromide|mesh-list
6040362|NCT00530842|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5496630|NCT04513808|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5496631|NCT04513808|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5496632|NCT04513808|Anesthetics, General|anesthetics, general|mesh-ancestor
5496633|NCT04513808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5496634|NCT04513808|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5496635|NCT04513652|Carticaine|carticaine|mesh-list
5496636|NCT04513652|Anesthetics, Local|anesthetics, local|mesh-ancestor
5496637|NCT04513652|Anesthetics|anesthetics|mesh-ancestor
5496638|NCT04513652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6040363|NCT00530842|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6040364|NCT00530842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6040365|NCT00530842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6040366|NCT00530842|Autonomic Agents|autonomic agents|mesh-ancestor
6040367|NCT00530842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6040368|NCT00530842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040369|NCT00530842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6040370|NCT00530842|Respiratory System Agents|respiratory system agents|mesh-ancestor
6040371|NCT00530842|Dermatologic Agents|dermatologic agents|mesh-ancestor
6040372|NCT00530842|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6040373|NCT00530842|Parasympatholytics|parasympatholytics|mesh-ancestor
6040374|NCT00530842|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6040375|NCT00530842|Cholinergic Agents|cholinergic agents|mesh-ancestor
6040376|NCT00530842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6040377|NCT00530842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040378|NCT00530842|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6040379|NCT00530842|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6040380|NCT00530842|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6040381|NCT00530842|Adrenergic Agents|adrenergic agents|mesh-ancestor
6040382|NCT00530842|Glucocorticoids|glucocorticoids|mesh-ancestor
6040383|NCT00530842|Hormones|hormones|mesh-ancestor
6040384|NCT00530842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6040385|NCT00530842|Sympathomimetics|sympathomimetics|mesh-ancestor
6040386|NCT00530855|Lacosamide|lacosamide|mesh-list
5496639|NCT04513652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040387|NCT00530855|Anticonvulsants|anticonvulsants|mesh-ancestor
6040388|NCT00530855|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6040389|NCT00530855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6040390|NCT00530855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6040391|NCT00530855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040392|NCT00530920|Ritonavir|ritonavir|mesh-list
6040393|NCT00530920|Tipranavir|tipranavir|mesh-list
6040394|NCT00530920|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6040395|NCT00530920|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6040396|NCT00530920|Protease Inhibitors|protease inhibitors|mesh-ancestor
6040397|NCT00530920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6040398|NCT00530920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040399|NCT00530920|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6040400|NCT00530920|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6040401|NCT00530920|Antiviral Agents|antiviral agents|mesh-ancestor
6040402|NCT00530920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6040403|NCT00530920|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6040404|NCT00530920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6040405|NCT00530946|Amlodipine|amlodipine|mesh-list
6040406|NCT00530946|Atorvastatin|atorvastatin|mesh-list
6040407|NCT00530946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6040408|NCT00530946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6040409|NCT00530946|Antimetabolites|antimetabolites|mesh-ancestor
6040410|NCT00530946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040411|NCT00530946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6457902|NCT00438217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6457903|NCT00438217|Hormones|hormones|mesh-ancestor
6457904|NCT00438217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6040412|NCT00530946|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6040413|NCT00530946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6040414|NCT00530946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6040415|NCT00530946|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6040416|NCT00530946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6040417|NCT00530946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6040418|NCT00530946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040419|NCT00530946|Vasodilator Agents|vasodilator agents|mesh-ancestor
6040420|NCT00531011|Paclitaxel|paclitaxel|mesh-list
6040421|NCT00531011|Everolimus|everolimus|mesh-list
6040422|NCT00531011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5496640|NCT04513652|Sensory System Agents|sensory system agents|mesh-ancestor
5496641|NCT04513652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5496642|NCT04513639|Dexamethasone|dexamethasone|mesh-list
5496643|NCT04513639|Dexamethasone acetate|dexamethasone acetate|mesh-list
5496644|NCT04513639|Daratumumab|daratumumab|mesh-list
5496645|NCT04513639|BB 1101|bb 1101|mesh-list
5496646|NCT04513639|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5496647|NCT04513639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5496648|NCT04513639|Antiemetics|antiemetics|mesh-ancestor
5496649|NCT04513639|Autonomic Agents|autonomic agents|mesh-ancestor
5496650|NCT04513639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5496651|NCT04513639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496652|NCT04513639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5496653|NCT04513639|Glucocorticoids|glucocorticoids|mesh-ancestor
5496654|NCT04513639|Hormones|hormones|mesh-ancestor
5496655|NCT04513639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5496656|NCT04513639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5496657|NCT04513639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5496658|NCT04513639|Protease Inhibitors|protease inhibitors|mesh-ancestor
5496659|NCT04513639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5496660|NCT04513639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496661|NCT04513639|Immunologic Factors|immunologic factors|mesh-ancestor
5496662|NCT04513509|Propranolol|propranolol|mesh-list
5496663|NCT04513509|Metoprolol|metoprolol|mesh-list
5496664|NCT04513509|Digoxin|digoxin|mesh-list
5496665|NCT04513509|Atenolol|atenolol|mesh-list
5496666|NCT04513509|Verapamil|verapamil|mesh-list
5496667|NCT04513509|Nebivolol|nebivolol|mesh-list
5496668|NCT04513509|Diltiazem|diltiazem|mesh-list
5496669|NCT04513509|Bisoprolol|bisoprolol|mesh-list
6040423|NCT00531011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6040424|NCT00531011|Tubulin Modulators|tubulin modulators|mesh-ancestor
6040425|NCT00531011|Antimitotic Agents|antimitotic agents|mesh-ancestor
6457905|NCT00438217|Luteolytic Agents|luteolytic agents|mesh-ancestor
5496670|NCT04513509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5496671|NCT04513509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5496672|NCT04513509|Adrenergic Agents|adrenergic agents|mesh-ancestor
5496673|NCT04513509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6040426|NCT00531011|Mitosis Modulators|mitosis modulators|mesh-ancestor
6040427|NCT00531011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040428|NCT00531011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6040429|NCT00531011|Immunologic Factors|immunologic factors|mesh-ancestor
6040430|NCT00531011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040431|NCT00531050|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6040432|NCT00531050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6040433|NCT00531050|Autonomic Agents|autonomic agents|mesh-ancestor
6040434|NCT00531050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6040435|NCT00531050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040436|NCT00531050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6040437|NCT00531050|Respiratory System Agents|respiratory system agents|mesh-ancestor
6040438|NCT00531050|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6040439|NCT00531050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6040440|NCT00531050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6040441|NCT00531050|Adrenergic Agents|adrenergic agents|mesh-ancestor
6040442|NCT00531050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6040443|NCT00531050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040444|NCT00531206|Ritonavir|ritonavir|mesh-list
6040445|NCT00531206|Tipranavir|tipranavir|mesh-list
6040446|NCT00531206|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6040447|NCT00531206|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6040448|NCT00531206|Protease Inhibitors|protease inhibitors|mesh-ancestor
6040449|NCT00531206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6040450|NCT00531206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040451|NCT00531206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6040452|NCT00531206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6040453|NCT00531206|Antiviral Agents|antiviral agents|mesh-ancestor
6040454|NCT00531206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6040455|NCT00531206|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6040456|NCT00531206|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6040457|NCT00531232|Clofarabine|clofarabine|mesh-list
6040458|NCT00531232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6040459|NCT00531232|Antimetabolites|antimetabolites|mesh-ancestor
6040460|NCT00531232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040461|NCT00531232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6040462|NCT00531284|Dexamethasone|dexamethasone|mesh-list
6040463|NCT00531284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6040464|NCT00531284|Antiemetics|antiemetics|mesh-ancestor
6040465|NCT00531284|Autonomic Agents|autonomic agents|mesh-ancestor
6040466|NCT00531284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6040467|NCT00531284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040468|NCT00531284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6040469|NCT00531284|Glucocorticoids|glucocorticoids|mesh-ancestor
6040470|NCT00531284|Hormones|hormones|mesh-ancestor
6040471|NCT00531284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6040472|NCT00531284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6040473|NCT00531284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6040474|NCT00531427|Buprenorphine|buprenorphine|mesh-list
6040475|NCT00531427|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6040476|NCT00531427|Narcotics|narcotics|mesh-ancestor
6040477|NCT00531427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6040478|NCT00531427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040479|NCT00531427|Analgesics|analgesics|mesh-ancestor
6040480|NCT00531427|Sensory System Agents|sensory system agents|mesh-ancestor
6040481|NCT00531427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6040482|NCT00531427|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6040483|NCT00531453|Thalidomide|thalidomide|mesh-list
6040484|NCT00531453|Dexamethasone|dexamethasone|mesh-list
6040485|NCT00531453|Dexamethasone acetate|dexamethasone acetate|mesh-list
6040486|NCT00531453|Cyclophosphamide|cyclophosphamide|mesh-list
6040487|NCT00531453|Bortezomib|bortezomib|mesh-list
6040488|NCT00531453|BB 1101|bb 1101|mesh-list
6040489|NCT00531453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6040490|NCT00531453|Immunologic Factors|immunologic factors|mesh-ancestor
6040491|NCT00531453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040492|NCT00531453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6040493|NCT00531453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6040494|NCT00531453|Alkylating Agents|alkylating agents|mesh-ancestor
6040495|NCT00531453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040496|NCT00531453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6040497|NCT00531453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6040498|NCT00531453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6040499|NCT00531453|Antiemetics|antiemetics|mesh-ancestor
6040500|NCT00531453|Autonomic Agents|autonomic agents|mesh-ancestor
6040501|NCT00531453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6040502|NCT00531453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6040503|NCT00531453|Glucocorticoids|glucocorticoids|mesh-ancestor
6040504|NCT00531453|Hormones|hormones|mesh-ancestor
6040505|NCT00531453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6040506|NCT00531453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6040507|NCT00531453|Protease Inhibitors|protease inhibitors|mesh-ancestor
6040508|NCT00531453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6040509|NCT00531453|Leprostatic Agents|leprostatic agents|mesh-ancestor
6040510|NCT00531453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6040511|NCT00531453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6040512|NCT00531453|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6040513|NCT00531453|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6040514|NCT00531453|Growth Substances|growth substances|mesh-ancestor
6040515|NCT00531453|Growth Inhibitors|growth inhibitors|mesh-ancestor
6040516|NCT00531479|Voriconazole|voriconazole|mesh-list
6040517|NCT00531479|Anidulafungin|anidulafungin|mesh-list
6040518|NCT00531479|Antifungal Agents|antifungal agents|mesh-ancestor
6040519|NCT00531479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6040520|NCT00531479|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6040521|NCT00531479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6040522|NCT00531479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6040523|NCT00531479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040524|NCT00531479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6040525|NCT00531479|Hormone Antagonists|hormone antagonists|mesh-ancestor
6040526|NCT00531479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6040527|NCT00531479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040528|NCT00531479|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6040529|NCT00531518|Lamotrigine|lamotrigine|mesh-list
6040530|NCT00531518|Aripiprazole|aripiprazole|mesh-list
6040531|NCT00531518|Bupropion|bupropion|mesh-list
6040532|NCT00531518|Fluoxetine|fluoxetine|mesh-list
6040533|NCT00531518|Sertraline|sertraline|mesh-list
6040534|NCT00531518|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6040535|NCT00531518|Antidepressive Agents|antidepressive agents|mesh-ancestor
6040536|NCT00531518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6040537|NCT00531518|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6040538|NCT00531518|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6040539|NCT00531518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6040540|NCT00531518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040541|NCT00531518|Dopamine Agents|dopamine agents|mesh-ancestor
6040542|NCT00531518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6040543|NCT00531518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040544|NCT00531518|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6040545|NCT00531518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6040546|NCT00531518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6040547|NCT00531518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6040548|NCT00531518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6040549|NCT00531518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6040550|NCT00531518|Dopamine Agonists|dopamine agonists|mesh-ancestor
6040551|NCT00531518|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6040552|NCT00531518|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6040553|NCT00531518|Serotonin Agents|serotonin agents|mesh-ancestor
6040554|NCT00531518|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6040555|NCT00531518|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6040556|NCT00531518|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6040557|NCT00531518|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6040558|NCT00531518|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6457906|NCT00438217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6040559|NCT00531518|Anticonvulsants|anticonvulsants|mesh-ancestor
6040560|NCT00531518|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6040561|NCT00531518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6040562|NCT00531518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6040563|NCT00531843|PENTA|penta|mesh-list
5496674|NCT04513509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496675|NCT04513509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496676|NCT04513509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5496677|NCT04513509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5496678|NCT04513509|Vasodilator Agents|vasodilator agents|mesh-ancestor
5496679|NCT04513509|Sympatholytics|sympatholytics|mesh-ancestor
5496680|NCT04513509|Autonomic Agents|autonomic agents|mesh-ancestor
5496681|NCT04513509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5496682|NCT04513509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5496683|NCT04513509|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5496684|NCT04513509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5496685|NCT04513509|Protective Agents|protective agents|mesh-ancestor
5496686|NCT04513509|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5496687|NCT04513509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5496688|NCT04513509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5496689|NCT04513509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5496690|NCT04513509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5496691|NCT04513509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5496692|NCT04513626|Raltegravir Potassium|raltegravir potassium|mesh-list
5496693|NCT04513626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5496694|NCT04513626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6040564|NCT00531843|Fondaparinux|fondaparinux|mesh-list
6040565|NCT00531843|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6040566|NCT00531843|Antithrombins|antithrombins|mesh-ancestor
6457907|NCT00438217|Contraceptive Agents|contraceptive agents|mesh-ancestor
6457908|NCT00438217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6457909|NCT00438230|Warfarin|warfarin|mesh-list
6457910|NCT00438230|Anticoagulants|anticoagulants|mesh-ancestor
6457911|NCT00438243|Bromfenac|bromfenac|mesh-list
6457912|NCT00438243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6457913|NCT00438243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6457914|NCT00438243|Analgesics|analgesics|mesh-ancestor
6457915|NCT00438243|Sensory System Agents|sensory system agents|mesh-ancestor
6457916|NCT00438243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6457917|NCT00438243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457918|NCT00438243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6457919|NCT00438243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6457920|NCT00438269|Metronidazole|metronidazole|mesh-list
6457921|NCT00438269|Ciprofloxacin|ciprofloxacin|mesh-list
6457922|NCT00438269|Meropenem|meropenem|mesh-list
6457923|NCT00438269|Cefazolin|cefazolin|mesh-list
6457924|NCT00438269|Tazobactam|tazobactam|mesh-list
6457925|NCT00438269|Piperacillin|piperacillin|mesh-list
6457926|NCT00438269|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
6457927|NCT00438269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6457928|NCT00438269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6457929|NCT00438269|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5496695|NCT04513626|Antiviral Agents|antiviral agents|mesh-ancestor
5496696|NCT04513626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5496697|NCT04513626|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5496698|NCT04513626|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5496699|NCT04513626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5496700|NCT04513626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496701|NCT04513457|Liver Extracts|liver extracts|mesh-list
5496702|NCT04513457|Hematinics|hematinics|mesh-ancestor
5496703|NCT04513340|Levodopa|levodopa|mesh-list
5496704|NCT04513340|Carbidopa|carbidopa|mesh-list
5496705|NCT04513340|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5496706|NCT04513340|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5496707|NCT04513340|Dopamine Agents|dopamine agents|mesh-ancestor
5496708|NCT04513340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5496709|NCT04513340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496710|NCT04513340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496711|NCT04513340|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6457930|NCT00438269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6457931|NCT00438269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6457932|NCT00438269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6457933|NCT00438269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6040567|NCT00531843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6457934|NCT00438269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040568|NCT00531843|Protease Inhibitors|protease inhibitors|mesh-ancestor
6040569|NCT00531843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6040570|NCT00531843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040571|NCT00531843|Anticoagulants|anticoagulants|mesh-ancestor
6040572|NCT00531843|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6040573|NCT00531843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6053718|NCT00597519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053719|NCT00597519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6053720|NCT00597519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6053721|NCT00597584|Epoetin Alfa|epoetin alfa|mesh-list
6053722|NCT00597584|Hematinics|hematinics|mesh-ancestor
6053723|NCT00597701|Lorazepam|lorazepam|mesh-list
6053724|NCT00597701|Baclofen|baclofen|mesh-list
6053725|NCT00597701|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6053726|NCT00597701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053727|NCT00597701|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6053728|NCT00597701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6053729|NCT00597701|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6053730|NCT00597701|GABA Agonists|gaba agonists|mesh-ancestor
6053731|NCT00597701|GABA Agents|gaba agents|mesh-ancestor
6053732|NCT00597701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6053733|NCT00597701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053734|NCT00597701|Anticonvulsants|anticonvulsants|mesh-ancestor
6053735|NCT00597701|Antiemetics|antiemetics|mesh-ancestor
6053736|NCT00597701|Autonomic Agents|autonomic agents|mesh-ancestor
6053737|NCT00597701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6053738|NCT00597701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6053739|NCT00597701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6053740|NCT00597701|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6053741|NCT00597701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6053742|NCT00597701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6053743|NCT00597701|GABA Modulators|gaba modulators|mesh-ancestor
6053744|NCT00597727|Glycerol|glycerol|mesh-list
6053745|NCT00597727|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6053746|NCT00597727|Protective Agents|protective agents|mesh-ancestor
6053747|NCT00597727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053748|NCT00597753|Epoetin Alfa|epoetin alfa|mesh-list
6053749|NCT00597753|Hematinics|hematinics|mesh-ancestor
6053750|NCT00597766|Triamcinolone|triamcinolone|mesh-list
6053751|NCT00597766|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6053752|NCT00597766|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6053753|NCT00597766|Lidocaine|lidocaine|mesh-list
6053754|NCT00597766|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6053755|NCT00597766|Anesthetics, Local|anesthetics, local|mesh-ancestor
6053756|NCT00597766|Anesthetics|anesthetics|mesh-ancestor
6053757|NCT00597766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6053758|NCT00597766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053759|NCT00597766|Sensory System Agents|sensory system agents|mesh-ancestor
6053760|NCT00597766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6053761|NCT00597766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6053762|NCT00597766|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6053763|NCT00597766|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6053764|NCT00597766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6053765|NCT00597766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053766|NCT00597766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6053767|NCT00597766|Glucocorticoids|glucocorticoids|mesh-ancestor
6053768|NCT00597766|Hormones|hormones|mesh-ancestor
6053769|NCT00597766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6053770|NCT00597766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6053771|NCT00597766|Immunologic Factors|immunologic factors|mesh-ancestor
6053772|NCT00597766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6053773|NCT00597818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
6053774|NCT00597818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
6053775|NCT00597818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6053776|NCT00597818|Analgesics|analgesics|mesh-ancestor
6053777|NCT00597818|Sensory System Agents|sensory system agents|mesh-ancestor
6053778|NCT00597818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6053779|NCT00597818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053780|NCT00597818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6053781|NCT00597896|Pramipexole|pramipexole|mesh-list
6053782|NCT00597896|Antioxidants|antioxidants|mesh-ancestor
5496712|NCT04513340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5496719|NCT04513379|Efavirenz|efavirenz|mesh-list
5496720|NCT04513379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5496721|NCT04513379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5496722|NCT04513379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5496723|NCT04513379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496724|NCT04513379|Antiviral Agents|antiviral agents|mesh-ancestor
5496725|NCT04513379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6040574|NCT00531882|Pioglitazone|pioglitazone|mesh-list
6040575|NCT00531882|Ibuprofen|ibuprofen|mesh-list
6040576|NCT00531882|Simvastatin|simvastatin|mesh-list
6040577|NCT00531882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6040578|NCT00531882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6040579|NCT00531882|Analgesics|analgesics|mesh-ancestor
6040580|NCT00531882|Sensory System Agents|sensory system agents|mesh-ancestor
6040581|NCT00531882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6040582|NCT00531882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040583|NCT00531882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6040584|NCT00531882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6040585|NCT00531882|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6040586|NCT00531882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6040587|NCT00531882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040588|NCT00531882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5496726|NCT04513379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5496727|NCT04513379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5496728|NCT04513379|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5496729|NCT04513379|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5496730|NCT04513379|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5496731|NCT04513379|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5496732|NCT04513015|Antioxidants|antioxidants|mesh-list
5496733|NCT04513015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496734|NCT04513015|Protective Agents|protective agents|mesh-ancestor
6040589|NCT00531882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6040590|NCT00531882|Antimetabolites|antimetabolites|mesh-ancestor
6040591|NCT00531882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6040592|NCT00531882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6040593|NCT00531882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5496735|NCT04513015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496736|NCT04513184|Dexamethasone|dexamethasone|mesh-list
5496737|NCT04513184|Dexamethasone acetate|dexamethasone acetate|mesh-list
5496738|NCT04513184|BB 1101|bb 1101|mesh-list
5496739|NCT04513184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5496740|NCT04513184|Antiemetics|antiemetics|mesh-ancestor
5496741|NCT04513184|Autonomic Agents|autonomic agents|mesh-ancestor
5496742|NCT04513184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5496743|NCT04513184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496744|NCT04513184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6040594|NCT00531934|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6040595|NCT00531934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6040596|NCT00531934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6040597|NCT00531934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6040598|NCT00531934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040599|NCT00531947|Selegiline|selegiline|mesh-list
6040600|NCT00531947|Antidepressive Agents|antidepressive agents|mesh-ancestor
6040601|NCT00531947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6040602|NCT00531947|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6040603|NCT00531947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6040604|NCT00531947|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6040605|NCT00531947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6040606|NCT00531947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040607|NCT00531947|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6040608|NCT00531947|Protective Agents|protective agents|mesh-ancestor
5496745|NCT04513184|Glucocorticoids|glucocorticoids|mesh-ancestor
5496746|NCT04513184|Hormones|hormones|mesh-ancestor
5496747|NCT04513184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5496748|NCT04513184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5496749|NCT04513184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5496750|NCT04513184|Protease Inhibitors|protease inhibitors|mesh-ancestor
5496751|NCT04513184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5496752|NCT04513184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496753|NCT04513145|Ropivacaine|ropivacaine|mesh-list
5496754|NCT04513145|Anesthetics, Local|anesthetics, local|mesh-ancestor
5496755|NCT04513145|Anesthetics|anesthetics|mesh-ancestor
5496756|NCT04513145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6040609|NCT00531947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040610|NCT00531960|Bevacizumab|bevacizumab|mesh-list
6040611|NCT00531960|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6040612|NCT00531960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6040613|NCT00531960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6040614|NCT00531960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6040615|NCT00531960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6040616|NCT00531960|Growth Substances|growth substances|mesh-ancestor
6040617|NCT00531960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040618|NCT00531960|Growth Inhibitors|growth inhibitors|mesh-ancestor
6040619|NCT00531960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6040620|NCT00531960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6040621|NCT00531960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457935|NCT00438269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6457936|NCT00438269|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6457937|NCT00438269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6457938|NCT00438269|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6457939|NCT00438321|Anastrozole|anastrozole|mesh-list
6457940|NCT00438321|Goserelin|goserelin|mesh-list
6457941|NCT00438321|Testosterone|testosterone|mesh-list
6040622|NCT00532129|Rituximab|rituximab|mesh-list
6040623|NCT00532129|Chlorambucil|chlorambucil|mesh-list
6040624|NCT00532129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6040625|NCT00532129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6040626|NCT00532129|Immunologic Factors|immunologic factors|mesh-ancestor
6040627|NCT00532129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040628|NCT00532129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6040629|NCT00532129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6040630|NCT00532129|Alkylating Agents|alkylating agents|mesh-ancestor
6040631|NCT00532129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040632|NCT00532155|Dexamethasone|dexamethasone|mesh-list
6040633|NCT00532155|Docetaxel|docetaxel|mesh-list
6040634|NCT00532155|Aflibercept|aflibercept|mesh-list
6040635|NCT00532155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6040636|NCT00532155|Antiemetics|antiemetics|mesh-ancestor
6040637|NCT00532155|Autonomic Agents|autonomic agents|mesh-ancestor
6040638|NCT00532155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6040639|NCT00532155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040640|NCT00532155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6040641|NCT00532155|Glucocorticoids|glucocorticoids|mesh-ancestor
6040642|NCT00532155|Hormones|hormones|mesh-ancestor
6040643|NCT00532155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6040644|NCT00532155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6040645|NCT00532155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6040646|NCT00532155|Tubulin Modulators|tubulin modulators|mesh-ancestor
6040647|NCT00532155|Antimitotic Agents|antimitotic agents|mesh-ancestor
6040648|NCT00532155|Mitosis Modulators|mitosis modulators|mesh-ancestor
6040649|NCT00532155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040650|NCT00532155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6040651|NCT00532155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6040652|NCT00532155|Growth Substances|growth substances|mesh-ancestor
6040653|NCT00532155|Growth Inhibitors|growth inhibitors|mesh-ancestor
6040654|NCT00532259|Pidilizumab|pidilizumab|mesh-list
6040655|NCT00532259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6040656|NCT00532259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6040657|NCT00532298|Vaccines|vaccines|mesh-list
6040658|NCT00532298|Immunologic Factors|immunologic factors|mesh-ancestor
6040659|NCT00532298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040660|NCT00532441|Docetaxel|docetaxel|mesh-list
6040661|NCT00532441|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6040662|NCT00532441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6040663|NCT00532441|Tubulin Modulators|tubulin modulators|mesh-ancestor
6040664|NCT00532441|Antimitotic Agents|antimitotic agents|mesh-ancestor
6040665|NCT00532441|Mitosis Modulators|mitosis modulators|mesh-ancestor
6040666|NCT00532441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040667|NCT00532441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6040668|NCT00532441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6457942|NCT00438321|Androgens|androgens|mesh-ancestor
6040669|NCT00532480|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6040670|NCT00532480|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6040671|NCT00532480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6040672|NCT00532480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6040673|NCT00532480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040674|NCT00532480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6040675|NCT00532480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040676|NCT00532480|Analgesics|analgesics|mesh-ancestor
6040677|NCT00532480|Sensory System Agents|sensory system agents|mesh-ancestor
6040678|NCT00532480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6040679|NCT00532480|Antidepressive Agents|antidepressive agents|mesh-ancestor
6040680|NCT00532480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6040681|NCT00532480|Dopamine Agents|dopamine agents|mesh-ancestor
6040682|NCT00532493|Prazosin|prazosin|mesh-list
6040683|NCT00532493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6040684|NCT00532493|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6040685|NCT00532493|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6040686|NCT00532493|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6040687|NCT00532493|Adrenergic Agents|adrenergic agents|mesh-ancestor
6040688|NCT00532493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6040689|NCT00532493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040690|NCT00532493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040691|NCT00532779|Naltrexone|naltrexone|mesh-list
6040692|NCT00532779|Bupropion|bupropion|mesh-list
6040693|NCT00532779|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6040694|NCT00532779|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6040695|NCT00532779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040696|NCT00532779|Sensory System Agents|sensory system agents|mesh-ancestor
6040697|NCT00532779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6040698|NCT00532779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6040699|NCT00532779|Antidepressive Agents|antidepressive agents|mesh-ancestor
6040700|NCT00532779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6040701|NCT00532779|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6040702|NCT00532779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6040703|NCT00532779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6040704|NCT00532779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040705|NCT00532779|Dopamine Agents|dopamine agents|mesh-ancestor
6040706|NCT00532779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6040707|NCT00532779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6040708|NCT00532779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6040709|NCT00532779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6040710|NCT00532844|Vitamins|vitamins|mesh-list
6040711|NCT00532844|Ascorbic Acid|ascorbic acid|mesh-list
6040712|NCT00532844|Verapamil|verapamil|mesh-list
6040713|NCT00532844|Micronutrients|micronutrients|mesh-ancestor
6040714|NCT00532844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040715|NCT00532844|Antioxidants|antioxidants|mesh-ancestor
6040716|NCT00532844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040717|NCT00532844|Protective Agents|protective agents|mesh-ancestor
6040718|NCT00532844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6040719|NCT00532844|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6040720|NCT00532844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6040721|NCT00532844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6040722|NCT00532844|Vasodilator Agents|vasodilator agents|mesh-ancestor
6040723|NCT00532883|Hydroxyurea|hydroxyurea|mesh-list
6040724|NCT00532883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6040725|NCT00532883|Antisickling Agents|antisickling agents|mesh-ancestor
6040726|NCT00532883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6040727|NCT00532883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040728|NCT00532883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6040729|NCT00532935|Metformin|metformin|mesh-list
6040730|NCT00532935|Pioglitazone|pioglitazone|mesh-list
6040731|NCT00532935|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6040732|NCT00532935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6040733|NCT00532935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040734|NCT00532935|Incretins|incretins|mesh-ancestor
6040735|NCT00532935|Hormones|hormones|mesh-ancestor
6040736|NCT00532935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6040737|NCT00532935|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6040738|NCT00532935|Protease Inhibitors|protease inhibitors|mesh-ancestor
6040739|NCT00532935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6040740|NCT00532935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040741|NCT00532948|Capecitabine|capecitabine|mesh-list
6040742|NCT00532948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6040743|NCT00532948|Antimetabolites|antimetabolites|mesh-ancestor
6040744|NCT00532948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040745|NCT00532948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6040746|NCT00533117|Fluoxetine|fluoxetine|mesh-list
6040747|NCT00533117|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6040748|NCT00533117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6040749|NCT00533117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6040750|NCT00533117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040751|NCT00533117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6040752|NCT00533117|Serotonin Agents|serotonin agents|mesh-ancestor
6040753|NCT00533117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040754|NCT00533117|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6040755|NCT00533117|Antidepressive Agents|antidepressive agents|mesh-ancestor
6040756|NCT00533117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6040757|NCT00533117|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6040758|NCT00533117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6040759|NCT00533117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6040760|NCT00533429|Bevacizumab|bevacizumab|mesh-list
6040761|NCT00533429|Carboplatin|carboplatin|mesh-list
6040762|NCT00533429|Pemetrexed|pemetrexed|mesh-list
6040763|NCT00533429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6040764|NCT00533429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6040765|NCT00533429|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6040766|NCT00533429|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6040767|NCT00533429|Growth Substances|growth substances|mesh-ancestor
6040768|NCT00533429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040769|NCT00533429|Growth Inhibitors|growth inhibitors|mesh-ancestor
6040770|NCT00533429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6040771|NCT00533429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040772|NCT00533429|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6040773|NCT00533429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6040774|NCT00533442|Mycophenolic Acid|mycophenolic acid|mesh-list
6040775|NCT00533442|Sirolimus|sirolimus|mesh-list
6040776|NCT00533442|Tacrolimus|tacrolimus|mesh-list
6040777|NCT00533442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6040778|NCT00533442|Immunologic Factors|immunologic factors|mesh-ancestor
5496757|NCT04513145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496758|NCT04513145|Sensory System Agents|sensory system agents|mesh-ancestor
5496759|NCT04513145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5496760|NCT04512911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
5496761|NCT04512872|Denosumab|denosumab|mesh-list
5496762|NCT04512872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5496763|NCT04512872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496764|NCT04512638|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5496765|NCT04512638|Amoxicillin|amoxicillin|mesh-list
5496766|NCT04512638|Chlorhexidine|chlorhexidine|mesh-list
6040779|NCT00533442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040780|NCT00533442|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6040781|NCT00533442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6040782|NCT00533442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040783|NCT00533442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6040784|NCT00533442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6040785|NCT00533442|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6040786|NCT00533442|Antitubercular Agents|antitubercular agents|mesh-ancestor
6040787|NCT00533442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6040788|NCT00533442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6040789|NCT00533442|Antifungal Agents|antifungal agents|mesh-ancestor
6040790|NCT00533507|Vaccines|vaccines|mesh-list
6040791|NCT00533507|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6040792|NCT00533507|Immunologic Factors|immunologic factors|mesh-ancestor
6040793|NCT00533507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040794|NCT00533546|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
6040795|NCT00533546|Protein C|protein c|mesh-list
6040796|NCT00533546|Anticoagulants|anticoagulants|mesh-ancestor
6040797|NCT00533546|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6040798|NCT00533546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6040799|NCT00533546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040800|NCT00533546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6040801|NCT00533702|Dacarbazine|dacarbazine|mesh-list
6040802|NCT00533702|Ramucirumab|ramucirumab|mesh-list
6040803|NCT00533702|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6040804|NCT00533702|Imidazole|imidazole|mesh-list
6457943|NCT00438321|Hormones|hormones|mesh-ancestor
5496767|NCT04512638|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5496768|NCT04512638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5496769|NCT04512638|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5496770|NCT04512638|Disinfectants|disinfectants|mesh-ancestor
6040805|NCT00533702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6040806|NCT00533702|Alkylating Agents|alkylating agents|mesh-ancestor
6040807|NCT00533702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040808|NCT00533702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6040809|NCT00533702|Immunologic Factors|immunologic factors|mesh-ancestor
6040810|NCT00533702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040811|NCT00533702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6040812|NCT00533845|Bupivacaine|bupivacaine|mesh-list
6040813|NCT00533845|Anesthetics, Local|anesthetics, local|mesh-ancestor
6040814|NCT00533845|Anesthetics|anesthetics|mesh-ancestor
6040815|NCT00533845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6040816|NCT00533845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040817|NCT00533845|Sensory System Agents|sensory system agents|mesh-ancestor
6040818|NCT00533845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6040819|NCT00533897|Abatacept|abatacept|mesh-list
6040820|NCT00533897|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6040821|NCT00533897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040822|NCT00533897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5496771|NCT04512638|Dermatologic Agents|dermatologic agents|mesh-ancestor
5496772|NCT04512404|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
5496773|NCT04512404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5496774|NCT04512404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5496775|NCT04512404|Antimetabolites|antimetabolites|mesh-ancestor
6040823|NCT00533897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6040824|NCT00533897|Immunologic Factors|immunologic factors|mesh-ancestor
6040825|NCT00533897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040826|NCT00533897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6040827|NCT00533910|Rifaximin|rifaximin|mesh-list
5496776|NCT04512404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040828|NCT00533910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6040829|NCT00533910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6040830|NCT00533910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6040831|NCT00533949|Paclitaxel|paclitaxel|mesh-list
6040832|NCT00533949|Carboplatin|carboplatin|mesh-list
6040833|NCT00533949|Cetuximab|cetuximab|mesh-list
6040834|NCT00533949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6040835|NCT00533949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6040836|NCT00533949|Tubulin Modulators|tubulin modulators|mesh-ancestor
5724987|NCT03183596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5724988|NCT03183596|Glucocorticoids|glucocorticoids|mesh-ancestor
5724989|NCT03183596|Hormones|hormones|mesh-ancestor
5724990|NCT03183596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5724991|NCT03183596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5724992|NCT03183596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5724993|NCT03183596|Anesthetics, Local|anesthetics, local|mesh-ancestor
5724994|NCT03183596|Anesthetics|anesthetics|mesh-ancestor
5724995|NCT03183596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5724996|NCT03183596|Sensory System Agents|sensory system agents|mesh-ancestor
5724997|NCT03183557|Vitamin D|vitamin d|mesh-list
5724998|NCT03183557|Zoledronic Acid|zoledronic acid|mesh-list
5724999|NCT03183557|Alfacalcidol|alfacalcidol|mesh-list
5725000|NCT03183557|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
6040837|NCT00533949|Antimitotic Agents|antimitotic agents|mesh-ancestor
6040838|NCT00533949|Mitosis Modulators|mitosis modulators|mesh-ancestor
6040839|NCT00533949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040840|NCT00533949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6040841|NCT00534001|Bupropion|bupropion|mesh-list
6040842|NCT00534001|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6040843|NCT00534001|Antidepressive Agents|antidepressive agents|mesh-ancestor
6040844|NCT00534001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6040845|NCT00534001|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6040846|NCT00534001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6040847|NCT00534001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6040848|NCT00534001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040849|NCT00534001|Dopamine Agents|dopamine agents|mesh-ancestor
6040850|NCT00534001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6040851|NCT00534001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040852|NCT00534001|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6040853|NCT00534001|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5496777|NCT04512404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5725001|NCT03183557|Vitamins|vitamins|mesh-ancestor
6040854|NCT00534001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6040855|NCT00534313|Abatacept|abatacept|mesh-list
6040856|NCT00534313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6040857|NCT00534313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040858|NCT00534313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6040859|NCT00534313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6040860|NCT00534313|Immunologic Factors|immunologic factors|mesh-ancestor
6040861|NCT00534313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040862|NCT00534313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6040863|NCT00534352|Ritonavir|ritonavir|mesh-list
6040864|NCT00534352|Darunavir|darunavir|mesh-list
6040865|NCT00534352|Etravirine|etravirine|mesh-list
6040866|NCT00534352|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6040867|NCT00534352|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6040868|NCT00534352|Protease Inhibitors|protease inhibitors|mesh-ancestor
6040869|NCT00534352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6040870|NCT00534352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040871|NCT00534352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6040872|NCT00534352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6040873|NCT00534352|Antiviral Agents|antiviral agents|mesh-ancestor
6040874|NCT00534352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6040875|NCT00534352|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6040876|NCT00534352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6040877|NCT00534352|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6040878|NCT00534352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6040879|NCT00534404|Nicotine|nicotine|mesh-list
6040880|NCT00534404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6040881|NCT00534404|Autonomic Agents|autonomic agents|mesh-ancestor
6040882|NCT00534404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6040883|NCT00534404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040884|NCT00534404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6040885|NCT00534404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6040886|NCT00534404|Cholinergic Agents|cholinergic agents|mesh-ancestor
6040887|NCT00534404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6040888|NCT00534404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040889|NCT00534417|Capecitabine|capecitabine|mesh-list
6040890|NCT00534417|Fulvestrant|fulvestrant|mesh-list
6040891|NCT00534417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6040892|NCT00534417|Antimetabolites|antimetabolites|mesh-ancestor
6040893|NCT00534417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040894|NCT00534417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6040895|NCT00534417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6040896|NCT00534417|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6040897|NCT00534417|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6040898|NCT00534417|Hormone Antagonists|hormone antagonists|mesh-ancestor
6040899|NCT00534417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6040900|NCT00534417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496778|NCT04512404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5496779|NCT04512313|Rocuronium|rocuronium|mesh-list
5496780|NCT04512313|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6040901|NCT00534495|Rilonacept|rilonacept|mesh-list
6040902|NCT00534495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6040903|NCT00534599|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6040904|NCT00534599|Antidepressive Agents|antidepressive agents|mesh-ancestor
6040905|NCT00534599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6040906|NCT00534599|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6040907|NCT00534599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6040908|NCT00534599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6040909|NCT00534599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040910|NCT00534794|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
6040911|NCT00534794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6040912|NCT00534794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6040913|NCT00534794|Analgesics|analgesics|mesh-ancestor
6040914|NCT00534794|Sensory System Agents|sensory system agents|mesh-ancestor
5496781|NCT04512313|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5496782|NCT04512313|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5496783|NCT04512313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5496784|NCT04512313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496785|NCT04512105|Venetoclax|venetoclax|mesh-list
5496786|NCT04512105|Pitavastatin|pitavastatin|mesh-list
5496787|NCT04512105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5496788|NCT04512105|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5496789|NCT04512105|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5496790|NCT04512105|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6040915|NCT00534794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6040916|NCT00534794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040917|NCT00534794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6040918|NCT00534794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6040919|NCT00534794|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6040920|NCT00534794|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6040921|NCT00534794|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6040922|NCT00534794|Histamine Antagonists|histamine antagonists|mesh-ancestor
6040923|NCT00534794|Histamine Agents|histamine agents|mesh-ancestor
6040924|NCT00534794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6040925|NCT00534794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040926|NCT00534833|Vaccines|vaccines|mesh-list
6040927|NCT00534833|Immunologic Factors|immunologic factors|mesh-ancestor
6040928|NCT00534833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040929|NCT00535002|Yohimbine|yohimbine|mesh-list
6040930|NCT00535002|Mydriatics|mydriatics|mesh-ancestor
6040931|NCT00535002|Autonomic Agents|autonomic agents|mesh-ancestor
6040932|NCT00535002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6040933|NCT00535002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040934|NCT00535002|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6040935|NCT00535002|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6040936|NCT00535002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6040937|NCT00535002|Adrenergic Agents|adrenergic agents|mesh-ancestor
6040938|NCT00535002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6040939|NCT00535002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496791|NCT04512105|Antimetabolites|antimetabolites|mesh-ancestor
5496792|NCT04512105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496793|NCT04512105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5496794|NCT04512105|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5496795|NCT04512365|Dronabinol|dronabinol|mesh-list
5496796|NCT04512365|Hallucinogens|hallucinogens|mesh-ancestor
5496797|NCT04512365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040940|NCT00535002|Urological Agents|urological agents|mesh-ancestor
6040941|NCT00535132|Risperidone|risperidone|mesh-list
6040942|NCT00535132|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6040943|NCT00535132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6040944|NCT00535132|Serotonin Agents|serotonin agents|mesh-ancestor
6040945|NCT00535132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6040946|NCT00535132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040947|NCT00535132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040948|NCT00535132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6040949|NCT00535132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6040950|NCT00535132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6040951|NCT00535132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6040952|NCT00535132|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6040953|NCT00535132|Dopamine Agents|dopamine agents|mesh-ancestor
6040954|NCT00535132|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6040955|NCT00535132|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6040956|NCT00535145|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6040957|NCT00535145|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6040958|NCT00535145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6040959|NCT00535145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6040960|NCT00535145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040961|NCT00535145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6040962|NCT00535145|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6040963|NCT00535145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6040964|NCT00535145|Serotonin Agents|serotonin agents|mesh-ancestor
6040965|NCT00535145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6040966|NCT00535145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040967|NCT00535145|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6040968|NCT00535145|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5496798|NCT04512365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6040969|NCT00535145|Dopamine Agents|dopamine agents|mesh-ancestor
6040970|NCT00535288|Mirtazapine|mirtazapine|mesh-list
6040971|NCT00535288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040972|NCT00535288|Antidepressive Agents|antidepressive agents|mesh-ancestor
6040973|NCT00535288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6040974|NCT00535288|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6040975|NCT00535288|Histamine Antagonists|histamine antagonists|mesh-ancestor
6040976|NCT00535288|Histamine Agents|histamine agents|mesh-ancestor
6040977|NCT00535288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6040978|NCT00535288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6040979|NCT00535288|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6040980|NCT00535288|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6040981|NCT00535288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6040982|NCT00535288|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6040983|NCT00535288|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6040984|NCT00535288|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6040985|NCT00535288|Adrenergic Agents|adrenergic agents|mesh-ancestor
6040986|NCT00535288|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6040987|NCT00535288|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6040988|NCT00535288|Serotonin Agents|serotonin agents|mesh-ancestor
6040989|NCT00535288|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6040990|NCT00535392|Levetiracetam|levetiracetam|mesh-list
6040991|NCT00535392|Anticonvulsants|anticonvulsants|mesh-ancestor
6040992|NCT00535392|Nootropic Agents|nootropic agents|mesh-ancestor
6040993|NCT00535587|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
6040994|NCT00535587|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6040995|NCT00535587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6040996|NCT00535587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6040997|NCT00535587|Cholinergic Agents|cholinergic agents|mesh-ancestor
6040998|NCT00535587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6040999|NCT00535587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041000|NCT00535613|Propofol|propofol|mesh-list
6041001|NCT00535613|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6041002|NCT00535613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6041003|NCT00535613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041004|NCT00535613|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6041005|NCT00535613|Anesthetics, General|anesthetics, general|mesh-ancestor
6041006|NCT00535613|Anesthetics|anesthetics|mesh-ancestor
6041007|NCT00535652|Ertapenem|ertapenem|mesh-list
6041008|NCT00535652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6041009|NCT00535652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6041010|NCT00535730|Vaccines|vaccines|mesh-list
6041011|NCT00535730|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6041012|NCT00535730|Immunologic Factors|immunologic factors|mesh-ancestor
6041013|NCT00535730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041014|NCT00535743|Bromides|bromides|mesh-list
6041015|NCT00535743|Rocuronium|rocuronium|mesh-list
6041016|NCT00535743|Anticonvulsants|anticonvulsants|mesh-ancestor
6041017|NCT00535743|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6041018|NCT00535743|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6041019|NCT00535743|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6041020|NCT00535743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6041021|NCT00535743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041022|NCT00535782|Methotrexate|methotrexate|mesh-list
6041023|NCT00535782|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6041024|NCT00535782|Abortifacient Agents|abortifacient agents|mesh-ancestor
6041025|NCT00535782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6041026|NCT00535782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041027|NCT00535782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6041028|NCT00535782|Antimetabolites|antimetabolites|mesh-ancestor
6041029|NCT00535782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6041030|NCT00535782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6041031|NCT00535782|Dermatologic Agents|dermatologic agents|mesh-ancestor
6041032|NCT00535782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6041033|NCT00535782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6041034|NCT00535782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6041035|NCT00535782|Immunologic Factors|immunologic factors|mesh-ancestor
6041036|NCT00535782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6041037|NCT00535782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6041038|NCT00535847|Interferons|interferons|mesh-list
6041039|NCT00535847|Ribavirin|ribavirin|mesh-list
6041040|NCT00535847|Interferon-alpha|interferon-alpha|mesh-list
6041041|NCT00535847|Interferon alpha-2|interferon alpha-2|mesh-list
6041042|NCT00535847|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6041043|NCT00535847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6041044|NCT00535847|Antiviral Agents|antiviral agents|mesh-ancestor
6041045|NCT00535847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6041046|NCT00535847|Antimetabolites|antimetabolites|mesh-ancestor
6041047|NCT00535847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6041048|NCT00535847|Immunologic Factors|immunologic factors|mesh-ancestor
6041049|NCT00535847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041050|NCT00535873|Lenalidomide|lenalidomide|mesh-list
6041051|NCT00535873|Immunologic Factors|immunologic factors|mesh-ancestor
6041052|NCT00535873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041053|NCT00535873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6041054|NCT00535873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6041055|NCT00535873|Growth Substances|growth substances|mesh-ancestor
6041056|NCT00535873|Growth Inhibitors|growth inhibitors|mesh-ancestor
6041057|NCT00535873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6041058|NCT00535925|Aspirin|aspirin|mesh-list
6041059|NCT00535925|Atenolol|atenolol|mesh-list
6041060|NCT00535925|Amlodipine|amlodipine|mesh-list
6041061|NCT00535925|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6041062|NCT00535925|Clonidine|clonidine|mesh-list
6041063|NCT00535925|Ramipril|ramipril|mesh-list
6041064|NCT00535925|Irbesartan|irbesartan|mesh-list
6041065|NCT00535925|Doxazosin|doxazosin|mesh-list
6041066|NCT00535925|Furosemide|furosemide|mesh-list
6041067|NCT00535925|Epoetin Alfa|epoetin alfa|mesh-list
6041068|NCT00535925|Simvastatin|simvastatin|mesh-list
6041069|NCT00535925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041070|NCT00535925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6041071|NCT00535925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6041072|NCT00535925|Analgesics|analgesics|mesh-ancestor
6041073|NCT00535925|Sensory System Agents|sensory system agents|mesh-ancestor
6041074|NCT00535925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6041075|NCT00535925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6041076|NCT00535925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6041077|NCT00535925|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6041078|NCT00535925|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6041079|NCT00535925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6041080|NCT00535925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6041081|NCT00535925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6041082|NCT00535925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6041083|NCT00535925|Antipyretics|antipyretics|mesh-ancestor
6041084|NCT00535925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6041085|NCT00535925|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6041086|NCT00535925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6041087|NCT00535925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6041088|NCT00535925|Vasodilator Agents|vasodilator agents|mesh-ancestor
6041089|NCT00535925|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6041090|NCT00535925|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6041091|NCT00535925|Antimetabolites|antimetabolites|mesh-ancestor
6041092|NCT00535925|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6041093|NCT00535925|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6041094|NCT00535925|Diuretics|diuretics|mesh-ancestor
6041095|NCT00535925|Natriuretic Agents|natriuretic agents|mesh-ancestor
6041096|NCT00535925|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6041097|NCT00535925|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6041098|NCT00535925|Sympatholytics|sympatholytics|mesh-ancestor
6041099|NCT00535925|Autonomic Agents|autonomic agents|mesh-ancestor
6041100|NCT00535925|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6041101|NCT00535925|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6041102|NCT00535925|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6041103|NCT00535925|Adrenergic Agents|adrenergic agents|mesh-ancestor
6041104|NCT00535925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6041105|NCT00535925|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6041106|NCT00535925|Protease Inhibitors|protease inhibitors|mesh-ancestor
6041107|NCT00535925|Hematinics|hematinics|mesh-ancestor
6041108|NCT00535925|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6041109|NCT00535925|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6041110|NCT00535925|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6041111|NCT00535925|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6041112|NCT00535925|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6041113|NCT00535925|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6041114|NCT00535925|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6041115|NCT00535925|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6041116|NCT00535938|Botulinum Toxins|botulinum toxins|mesh-list
6041117|NCT00535938|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6041118|NCT00535938|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6041119|NCT00535938|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6041120|NCT00535938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6041121|NCT00535938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6041122|NCT00535938|Cholinergic Agents|cholinergic agents|mesh-ancestor
6041123|NCT00535938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6041124|NCT00535938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041125|NCT00535938|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6041126|NCT00535938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6041127|NCT00536107|Docetaxel|docetaxel|mesh-list
6041128|NCT00536107|Gefitinib|gefitinib|mesh-list
6041129|NCT00536107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6041130|NCT00536107|Tubulin Modulators|tubulin modulators|mesh-ancestor
6041131|NCT00536107|Antimitotic Agents|antimitotic agents|mesh-ancestor
6041132|NCT00536107|Mitosis Modulators|mitosis modulators|mesh-ancestor
6041133|NCT00536107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6041134|NCT00536107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6041135|NCT00536107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6041136|NCT00536120|Natalizumab|natalizumab|mesh-list
6041137|NCT00536120|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
6041138|NCT00536120|Immunologic Factors|immunologic factors|mesh-ancestor
6041139|NCT00536120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041140|NCT00536120|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6041141|NCT00536172|Citalopram|citalopram|mesh-list
6041142|NCT00536172|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6041143|NCT00536172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6041144|NCT00536172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6041145|NCT00536172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6041146|NCT00536172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6041147|NCT00536172|Serotonin Agents|serotonin agents|mesh-ancestor
6041148|NCT00536172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041149|NCT00536172|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6041150|NCT00536172|Antidepressive Agents|antidepressive agents|mesh-ancestor
6041151|NCT00536172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6041152|NCT00536198|Sertraline|sertraline|mesh-list
6041153|NCT00536198|Antidepressive Agents|antidepressive agents|mesh-ancestor
6041154|NCT00536198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6041155|NCT00536198|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6041156|NCT00536198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6041157|NCT00536198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6041158|NCT00536198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6041159|NCT00536198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6041160|NCT00536198|Serotonin Agents|serotonin agents|mesh-ancestor
6041161|NCT00536198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041162|NCT00536263|Interferons|interferons|mesh-list
6041163|NCT00536263|Interferon-alpha|interferon-alpha|mesh-list
6041164|NCT00536263|Interferon alpha-2|interferon alpha-2|mesh-list
5496799|NCT04512365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5496800|NCT04512365|Analgesics|analgesics|mesh-ancestor
5496801|NCT04512365|Sensory System Agents|sensory system agents|mesh-ancestor
5496802|NCT04512365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5496803|NCT04512365|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5496804|NCT04512365|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5496805|NCT04512365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5496806|NCT04512365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496807|NCT04512365|Hormones|hormones|mesh-ancestor
5496808|NCT04512365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5503290|NCT04460352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5503291|NCT04460352|Immunologic Factors|immunologic factors|mesh-ancestor
5503292|NCT04460352|Antidotes|antidotes|mesh-ancestor
5503293|NCT04460352|Protective Agents|protective agents|mesh-ancestor
5503294|NCT04460352|Vitamin B Complex|vitamin b complex|mesh-ancestor
5503295|NCT04460352|Vitamins|vitamins|mesh-ancestor
5503296|NCT04460352|Micronutrients|micronutrients|mesh-ancestor
5503297|NCT04460547|Interferons|interferons|mesh-list
5503298|NCT04460547|Interferon-beta|interferon-beta|mesh-list
5503299|NCT04460547|Interferon beta-1a|interferon beta-1a|mesh-list
5503300|NCT04460547|Hydroxychloroquine|hydroxychloroquine|mesh-list
5503301|NCT04460547|Ivermectin|ivermectin|mesh-list
5503302|NCT04460547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5503303|NCT04460547|Antiviral Agents|antiviral agents|mesh-ancestor
5503304|NCT04460547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5503305|NCT04460547|Antimalarials|antimalarials|mesh-ancestor
5503306|NCT04460547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5503307|NCT04460547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5503308|NCT04460547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5503309|NCT04460547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503310|NCT04460547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5496809|NCT04511975|Azacitidine|azacitidine|mesh-list
5496810|NCT04511975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5496811|NCT04511975|Antimetabolites|antimetabolites|mesh-ancestor
5496812|NCT04511975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496813|NCT04511975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5496814|NCT04511975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5496815|NCT04511832|Diclofenac|diclofenac|mesh-list
5496816|NCT04511832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5496817|NCT04511832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5496818|NCT04511832|Analgesics|analgesics|mesh-ancestor
5496819|NCT04511832|Sensory System Agents|sensory system agents|mesh-ancestor
5496820|NCT04511832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5496821|NCT04511832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496822|NCT04511832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5496823|NCT04511832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5496824|NCT04511832|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5496825|NCT04511832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5496826|NCT04511832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496827|NCT04511715|Bevacizumab|bevacizumab|mesh-list
5496828|NCT04511715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6041165|NCT00536263|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6041166|NCT00536263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6041167|NCT00536263|Antiviral Agents|antiviral agents|mesh-ancestor
6041168|NCT00536263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6041169|NCT00536263|Immunologic Factors|immunologic factors|mesh-ancestor
6041170|NCT00536263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041171|NCT00536341|Rituximab|rituximab|mesh-list
6041172|NCT00536341|Fludarabine|fludarabine|mesh-list
6041173|NCT00536341|Lenalidomide|lenalidomide|mesh-list
6041174|NCT00536341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5496829|NCT04511715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5496830|NCT04511715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5496831|NCT04511715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5496832|NCT04511715|Growth Substances|growth substances|mesh-ancestor
5503311|NCT04460547|Immunologic Factors|immunologic factors|mesh-ancestor
6041175|NCT00536341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6041176|NCT00536341|Immunologic Factors|immunologic factors|mesh-ancestor
6041177|NCT00536341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041178|NCT00536341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6041179|NCT00536341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6041180|NCT00536341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6041181|NCT00536341|Growth Substances|growth substances|mesh-ancestor
6457944|NCT00438321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6041182|NCT00536341|Growth Inhibitors|growth inhibitors|mesh-ancestor
6041183|NCT00536471|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6041184|NCT00536471|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6041185|NCT00536471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6041186|NCT00536471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6041187|NCT00536471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6041188|NCT00536471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6041189|NCT00536471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041190|NCT00536471|Analgesics|analgesics|mesh-ancestor
6041191|NCT00536471|Sensory System Agents|sensory system agents|mesh-ancestor
6041192|NCT00536471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6041193|NCT00536471|Antidepressive Agents|antidepressive agents|mesh-ancestor
6041194|NCT00536471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6041195|NCT00536471|Dopamine Agents|dopamine agents|mesh-ancestor
6655134|NCT01460979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5496833|NCT04511715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496834|NCT04511715|Growth Inhibitors|growth inhibitors|mesh-ancestor
5496835|NCT04511897|Expectorants|expectorants|mesh-list
5496836|NCT04511897|Respiratory System Agents|respiratory system agents|mesh-ancestor
5496837|NCT04511650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5496838|NCT04511728|Propofol|propofol|mesh-list
5496839|NCT04511728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5496840|NCT04511728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5496841|NCT04511728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496842|NCT04511728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5496843|NCT04511728|Anesthetics, General|anesthetics, general|mesh-ancestor
5496844|NCT04511728|Anesthetics|anesthetics|mesh-ancestor
5496845|NCT04511923|Heparin|heparin|mesh-list
5496846|NCT04511923|Anticoagulants|anticoagulants|mesh-ancestor
5496847|NCT04511923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6655135|NCT01460979|Immunologic Factors|immunologic factors|mesh-ancestor
6655136|NCT01460979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655137|NCT01461018|Immunoglobulins|immunoglobulins|mesh-list
6655138|NCT01461018|Antibodies|antibodies|mesh-list
6655139|NCT01461018|gamma-Globulins|gamma-globulins|mesh-list
6655140|NCT01461018|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6655141|NCT01461018|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6655142|NCT01461018|Immunologic Factors|immunologic factors|mesh-ancestor
6041196|NCT00536484|Fesoterodine|fesoterodine|mesh-list
6041197|NCT00536484|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6041198|NCT00536484|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6041199|NCT00536484|Cholinergic Agents|cholinergic agents|mesh-ancestor
6041200|NCT00536484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5496848|NCT04511923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5496849|NCT04511923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496850|NCT04511637|Rivaroxaban|rivaroxaban|mesh-list
5496851|NCT04511637|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5496852|NCT04511637|Antithrombins|antithrombins|mesh-ancestor
5496853|NCT04511637|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5496854|NCT04511637|Protease Inhibitors|protease inhibitors|mesh-ancestor
5496855|NCT04511637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5496856|NCT04511637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496857|NCT04511637|Anticoagulants|anticoagulants|mesh-ancestor
5496858|NCT04511468|Ascorbic Acid|ascorbic acid|mesh-list
5496859|NCT04511468|Copper|copper|mesh-list
5496860|NCT04511468|Chromium|chromium|mesh-list
5496861|NCT04511468|Vitamins|vitamins|mesh-ancestor
5496862|NCT04511468|Micronutrients|micronutrients|mesh-ancestor
5496863|NCT04511468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496864|NCT04511468|Antioxidants|antioxidants|mesh-ancestor
5496865|NCT04511468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6041201|NCT00536484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6041202|NCT00536484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041203|NCT00536484|Urological Agents|urological agents|mesh-ancestor
6041204|NCT00536510|Niacin|niacin|mesh-list
5496866|NCT04511468|Protective Agents|protective agents|mesh-ancestor
5496867|NCT04511468|Trace Elements|trace elements|mesh-ancestor
5496868|NCT04511416|Metformin|metformin|mesh-list
6041205|NCT00536510|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6041206|NCT00536510|Antimetabolites|antimetabolites|mesh-ancestor
6041207|NCT00536510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6041208|NCT00536510|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6041209|NCT00536510|Vasodilator Agents|vasodilator agents|mesh-ancestor
6041210|NCT00536510|Vitamin B Complex|vitamin b complex|mesh-ancestor
6041211|NCT00536510|Vitamins|vitamins|mesh-ancestor
6041212|NCT00536510|Micronutrients|micronutrients|mesh-ancestor
6041213|NCT00536510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041214|NCT00536575|Bortezomib|bortezomib|mesh-list
6041215|NCT00536575|Sorafenib|sorafenib|mesh-list
6041216|NCT00536575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6041217|NCT00536575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6041218|NCT00536575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6041219|NCT00536575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655143|NCT01461018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496869|NCT04511416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5496870|NCT04511416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655144|NCT01461031|Nefopam|nefopam|mesh-list
5496871|NCT04511611|Rivaroxaban|rivaroxaban|mesh-list
5496872|NCT04511611|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5496873|NCT04511611|Antithrombins|antithrombins|mesh-ancestor
6041220|NCT00536601|Cyclophosphamide|cyclophosphamide|mesh-list
6041221|NCT00536601|Melphalan|melphalan|mesh-list
6041222|NCT00536601|Busulfan|busulfan|mesh-list
6655145|NCT01461031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5496874|NCT04511611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5496875|NCT04511611|Protease Inhibitors|protease inhibitors|mesh-ancestor
5496876|NCT04511611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5496877|NCT04511611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496878|NCT04511611|Anticoagulants|anticoagulants|mesh-ancestor
5496879|NCT04511299|SMOFlipid|smoflipid|mesh-list
5496880|NCT04511299|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
5496881|NCT04511299|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5496882|NCT04511299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5496883|NCT04511000|Atorvastatin|atorvastatin|mesh-list
5496884|NCT04511000|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5496885|NCT04511000|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5496886|NCT04511000|Antimetabolites|antimetabolites|mesh-ancestor
5496887|NCT04511000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496888|NCT04511000|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5496889|NCT04511000|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5496890|NCT04511000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5496891|NCT04510935|Anesthetics|anesthetics|mesh-list
6041223|NCT00536601|Thiotepa|thiotepa|mesh-list
6041224|NCT00536601|Carmustine|carmustine|mesh-list
6041225|NCT00536601|Carboplatin|carboplatin|mesh-list
6041226|NCT00536601|Etoposide|etoposide|mesh-list
6041227|NCT00536601|Etoposide phosphate|etoposide phosphate|mesh-list
6041228|NCT00536601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6041229|NCT00536601|Immunologic Factors|immunologic factors|mesh-ancestor
6041230|NCT00536601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041231|NCT00536601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6041232|NCT00536601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6041233|NCT00536601|Alkylating Agents|alkylating agents|mesh-ancestor
6041234|NCT00536601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6041235|NCT00536601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6041236|NCT00536601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6041237|NCT00536601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6041238|NCT00536601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6041239|NCT00536601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6041240|NCT00536601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6041241|NCT00536731|Budesonide|budesonide|mesh-list
6041242|NCT00536731|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6041243|NCT00536731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6041244|NCT00536731|Respiratory System Agents|respiratory system agents|mesh-ancestor
6041245|NCT00536731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6041246|NCT00536731|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6041247|NCT00536731|Autonomic Agents|autonomic agents|mesh-ancestor
6041248|NCT00536731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6041249|NCT00536731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041250|NCT00536731|Glucocorticoids|glucocorticoids|mesh-ancestor
6041251|NCT00536731|Hormones|hormones|mesh-ancestor
6041252|NCT00536731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6041253|NCT00536809|Capecitabine|capecitabine|mesh-list
6041254|NCT00536809|Oxaliplatin|oxaliplatin|mesh-list
6041255|NCT00536809|Lapatinib|lapatinib|mesh-list
6041256|NCT00536809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6041257|NCT00536809|Antimetabolites|antimetabolites|mesh-ancestor
6041258|NCT00536809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6041259|NCT00536809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6041260|NCT00536809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6041261|NCT00536809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6041262|NCT00536874|Gemcitabine|gemcitabine|mesh-list
6041263|NCT00536874|Oxaliplatin|oxaliplatin|mesh-list
6041264|NCT00536874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6041265|NCT00536874|Antimetabolites|antimetabolites|mesh-ancestor
6041266|NCT00536874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6041267|NCT00536874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6041268|NCT00536874|Antiviral Agents|antiviral agents|mesh-ancestor
6041269|NCT00536874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6041270|NCT00536874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6041271|NCT00536874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6041272|NCT00536874|Immunologic Factors|immunologic factors|mesh-ancestor
6041273|NCT00536874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041274|NCT00536913|Budesonide|budesonide|mesh-list
6041275|NCT00536913|Formoterol Fumarate|formoterol fumarate|mesh-list
6041276|NCT00536913|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
5496892|NCT04510935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6041277|NCT00536913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6041278|NCT00536913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6041279|NCT00536913|Autonomic Agents|autonomic agents|mesh-ancestor
6041280|NCT00536913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6041281|NCT00536913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041282|NCT00536913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6041283|NCT00536913|Respiratory System Agents|respiratory system agents|mesh-ancestor
6041284|NCT00536913|Glucocorticoids|glucocorticoids|mesh-ancestor
6041285|NCT00536913|Hormones|hormones|mesh-ancestor
6041286|NCT00536913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6041287|NCT00536913|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6041288|NCT00536913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6041289|NCT00536913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6041290|NCT00536913|Adrenergic Agents|adrenergic agents|mesh-ancestor
6041291|NCT00536913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5496893|NCT04510935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496894|NCT04510844|Evolocumab|evolocumab|mesh-list
5496895|NCT04510844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5496896|NCT04510844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5496897|NCT04510844|Antimetabolites|antimetabolites|mesh-ancestor
5496898|NCT04510844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6041292|NCT00536913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6041293|NCT00536939|Paclitaxel|paclitaxel|mesh-list
6041294|NCT00536939|Bevacizumab|bevacizumab|mesh-list
6041295|NCT00536939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6041296|NCT00536939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6041297|NCT00536939|Tubulin Modulators|tubulin modulators|mesh-ancestor
6041298|NCT00536939|Antimitotic Agents|antimitotic agents|mesh-ancestor
6041299|NCT00536939|Mitosis Modulators|mitosis modulators|mesh-ancestor
6041300|NCT00536939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6041301|NCT00536939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6041302|NCT00536939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6041303|NCT00536939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6041304|NCT00536939|Growth Substances|growth substances|mesh-ancestor
6041305|NCT00536939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041306|NCT00536939|Growth Inhibitors|growth inhibitors|mesh-ancestor
6041307|NCT00536991|Calcitriol|calcitriol|mesh-list
5496899|NCT04510844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5496900|NCT04511039|Trifluridine|trifluridine|mesh-list
5496901|NCT04511039|Talazoparib|talazoparib|mesh-list
5496902|NCT04511039|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5496903|NCT04511039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6041308|NCT00536991|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
6041309|NCT00536991|Ketoconazole|ketoconazole|mesh-list
6041310|NCT00536991|Hydrocortisone|hydrocortisone|mesh-list
6041311|NCT00536991|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6041312|NCT00536991|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6041313|NCT00536991|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6041314|NCT00536991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6041315|NCT00536991|Antifungal Agents|antifungal agents|mesh-ancestor
6041316|NCT00536991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6041317|NCT00536991|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6041318|NCT00536991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6041319|NCT00536991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6041320|NCT00536991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6041321|NCT00536991|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6041322|NCT00536991|Hormone Antagonists|hormone antagonists|mesh-ancestor
6041323|NCT00536991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6041324|NCT00536991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041325|NCT00536991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6655146|NCT01461031|Analgesics|analgesics|mesh-ancestor
5496904|NCT04511039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496905|NCT04511039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6041326|NCT00536991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6041327|NCT00536991|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
5496906|NCT04511039|Antimetabolites|antimetabolites|mesh-ancestor
5496907|NCT04511039|Antiviral Agents|antiviral agents|mesh-ancestor
5496908|NCT04511039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5496909|NCT04511195|Diclofenac|diclofenac|mesh-list
5496910|NCT04511195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5496911|NCT04511195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5496912|NCT04511195|Analgesics|analgesics|mesh-ancestor
5496913|NCT04511195|Sensory System Agents|sensory system agents|mesh-ancestor
5496914|NCT04511195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5496915|NCT04511195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496916|NCT04511195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5496917|NCT04511195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5496918|NCT04511195|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6041328|NCT00536991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6041329|NCT00536991|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6041330|NCT00536991|Vitamins|vitamins|mesh-ancestor
6041331|NCT00536991|Micronutrients|micronutrients|mesh-ancestor
6041332|NCT00536991|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6041333|NCT00537017|Levodopa|levodopa|mesh-list
6041334|NCT00537017|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6041335|NCT00537017|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6041336|NCT00537017|Dopamine Agents|dopamine agents|mesh-ancestor
6041337|NCT00537017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6041338|NCT00537017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6041339|NCT00537017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041340|NCT00537030|Asparaginase|asparaginase|mesh-list
6041341|NCT00537030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6041342|NCT00537056|Sunitinib|sunitinib|mesh-list
6041343|NCT00537056|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6041344|NCT00537056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6041345|NCT00537056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6041346|NCT00537056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6041347|NCT00537056|Growth Substances|growth substances|mesh-ancestor
6041348|NCT00537056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041349|NCT00537056|Growth Inhibitors|growth inhibitors|mesh-ancestor
6041350|NCT00537056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6041351|NCT00537056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6041352|NCT00537056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6041353|NCT00537056|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6041354|NCT00537082|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6041355|NCT00537082|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6041356|NCT00537082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6041357|NCT00537082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6041358|NCT00537082|Immunologic Factors|immunologic factors|mesh-ancestor
6041359|NCT00537082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041360|NCT00537238|Pregabalin|pregabalin|mesh-list
6041361|NCT00537238|Levetiracetam|levetiracetam|mesh-list
6041362|NCT00537238|Analgesics|analgesics|mesh-ancestor
6041363|NCT00537238|Sensory System Agents|sensory system agents|mesh-ancestor
6041364|NCT00537238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6041365|NCT00537238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041366|NCT00537238|Anticonvulsants|anticonvulsants|mesh-ancestor
6041367|NCT00537238|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6041368|NCT00537238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6041369|NCT00537238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6041370|NCT00537238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6041371|NCT00537238|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6041372|NCT00537238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6041373|NCT00537238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6041374|NCT00537238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6041375|NCT00537238|Nootropic Agents|nootropic agents|mesh-ancestor
6041376|NCT00537277|Insulin Aspart|insulin aspart|mesh-list
6041377|NCT00537277|Biphasic Insulins|biphasic insulins|mesh-list
6041378|NCT00537277|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6041379|NCT00537277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6041380|NCT00537277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041381|NCT00537290|Rituximab|rituximab|mesh-list
6041382|NCT00537290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6041383|NCT00537290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6041384|NCT00537290|Immunologic Factors|immunologic factors|mesh-ancestor
6041385|NCT00537290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496919|NCT04511195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5496920|NCT04511195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496921|NCT04510870|Ferric Compounds|ferric compounds|mesh-list
5496922|NCT04510870|Hematinics|hematinics|mesh-ancestor
5496923|NCT04510922|Droxidopa|droxidopa|mesh-list
5496924|NCT04510922|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5496925|NCT04510922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6041386|NCT00537290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6041387|NCT00537303|Insulin|insulin|mesh-list
6041388|NCT00537303|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6041389|NCT00537303|Insulin Aspart|insulin aspart|mesh-list
6041390|NCT00537303|Insulin, Long-Acting|insulin, long-acting|mesh-list
6041391|NCT00537303|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6041392|NCT00537303|Insulin Detemir|insulin detemir|mesh-list
6041393|NCT00537303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6041394|NCT00537303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041395|NCT00537316|Azathioprine|azathioprine|mesh-list
6041396|NCT00537316|Infliximab|infliximab|mesh-list
6041397|NCT00537316|Dermatologic Agents|dermatologic agents|mesh-ancestor
6041398|NCT00537316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6041399|NCT00537316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6041400|NCT00537316|Antimetabolites|antimetabolites|mesh-ancestor
6041401|NCT00537316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6041402|NCT00537316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6041403|NCT00537316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6041404|NCT00537316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6041405|NCT00537316|Immunologic Factors|immunologic factors|mesh-ancestor
6041406|NCT00537316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041407|NCT00537329|Anidulafungin|anidulafungin|mesh-list
6041408|NCT00537329|Antifungal Agents|antifungal agents|mesh-ancestor
6041409|NCT00537329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6041410|NCT00537381|Prednisone|prednisone|mesh-list
6041411|NCT00537381|Docetaxel|docetaxel|mesh-list
6041412|NCT00537381|Intetumumab|intetumumab|mesh-list
6041413|NCT00537381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6041414|NCT00537381|Tubulin Modulators|tubulin modulators|mesh-ancestor
6041415|NCT00537381|Antimitotic Agents|antimitotic agents|mesh-ancestor
6041416|NCT00537381|Mitosis Modulators|mitosis modulators|mesh-ancestor
6041417|NCT00537381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6041418|NCT00537381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6041419|NCT00537381|Glucocorticoids|glucocorticoids|mesh-ancestor
6041420|NCT00537381|Hormones|hormones|mesh-ancestor
6041421|NCT00537381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6041422|NCT00537381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041423|NCT00537381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6041424|NCT00537381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6041425|NCT00537394|Raltegravir Potassium|raltegravir potassium|mesh-list
6041426|NCT00537394|Maraviroc|maraviroc|mesh-list
6041427|NCT00537394|Darunavir|darunavir|mesh-list
6041428|NCT00537394|Tipranavir|tipranavir|mesh-list
6041429|NCT00537394|Enfuvirtide|enfuvirtide|mesh-list
6041430|NCT00537394|Etravirine|etravirine|mesh-list
6041431|NCT00537394|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6041432|NCT00537394|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6041433|NCT00537394|Antiviral Agents|antiviral agents|mesh-ancestor
6041434|NCT00537394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6041435|NCT00537394|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6041436|NCT00537394|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6041437|NCT00537394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6041438|NCT00537394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6041439|NCT00537394|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6041440|NCT00537394|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6041441|NCT00537394|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6041442|NCT00537394|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6041443|NCT00537394|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6041444|NCT00537394|Protease Inhibitors|protease inhibitors|mesh-ancestor
6041445|NCT00537394|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6041446|NCT00537394|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6041447|NCT00537407|Ribavirin|ribavirin|mesh-list
6041448|NCT00537407|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6041449|NCT00537407|Antimetabolites|antimetabolites|mesh-ancestor
6041450|NCT00537407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6041451|NCT00537407|Antiviral Agents|antiviral agents|mesh-ancestor
6041452|NCT00537407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6053783|NCT00597896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496926|NCT04510623|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6053784|NCT00597896|Protective Agents|protective agents|mesh-ancestor
6041453|NCT00537511|Etoposide|etoposide|mesh-list
6041454|NCT00537511|Etoposide phosphate|etoposide phosphate|mesh-list
6041455|NCT00537511|Pomalidomide|pomalidomide|mesh-list
6041456|NCT00537511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6041457|NCT00537511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6041458|NCT00537511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6041459|NCT00537511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6041460|NCT00537511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6041461|NCT00537511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6041462|NCT00537511|Immunologic Factors|immunologic factors|mesh-ancestor
6041463|NCT00537511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041464|NCT00537511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6041465|NCT00537511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6041466|NCT00537511|Growth Substances|growth substances|mesh-ancestor
6041467|NCT00537511|Growth Inhibitors|growth inhibitors|mesh-ancestor
6041468|NCT00537680|Ubiquinone|ubiquinone|mesh-list
6041469|NCT00537680|Idebenone|idebenone|mesh-list
6041470|NCT00537680|Antioxidants|antioxidants|mesh-ancestor
6041471|NCT00537680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6041472|NCT00537680|Protective Agents|protective agents|mesh-ancestor
6041473|NCT00537680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041474|NCT00537680|Micronutrients|micronutrients|mesh-ancestor
6041475|NCT00537745|Naltrexone|naltrexone|mesh-list
6041476|NCT00537745|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6041477|NCT00537745|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6041478|NCT00537745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041479|NCT00537745|Sensory System Agents|sensory system agents|mesh-ancestor
6041480|NCT00537745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6041481|NCT00537771|Tamoxifen|tamoxifen|mesh-list
6041482|NCT00537771|Anastrozole|anastrozole|mesh-list
6041483|NCT00537771|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6041484|NCT00537771|Hormone Antagonists|hormone antagonists|mesh-ancestor
6457945|NCT00438321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457946|NCT00438321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6457947|NCT00438321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6041485|NCT00537771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6041486|NCT00537771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041487|NCT00537771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6041488|NCT00537771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6041489|NCT00537771|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6041490|NCT00537771|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6041491|NCT00537771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6041492|NCT00537771|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6041493|NCT00537771|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6041494|NCT00537771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6041495|NCT00537771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6041496|NCT00537810|Sibutramine|sibutramine|mesh-list
6041497|NCT00537810|Antidepressive Agents|antidepressive agents|mesh-ancestor
6041498|NCT00537810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6041499|NCT00537810|Appetite Depressants|appetite depressants|mesh-ancestor
6041500|NCT00537810|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6041501|NCT00537823|Leucovorin|leucovorin|mesh-list
6041502|NCT00537823|Bevacizumab|bevacizumab|mesh-list
6041503|NCT00537823|Cetuximab|cetuximab|mesh-list
6041504|NCT00537823|Fluorouracil|fluorouracil|mesh-list
6041505|NCT00537823|Oxaliplatin|oxaliplatin|mesh-list
6041506|NCT00537823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6041507|NCT00537823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5496927|NCT04510623|Protease Inhibitors|protease inhibitors|mesh-ancestor
5496928|NCT04510623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5496929|NCT04510623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496930|NCT04510649|Rifampin|rifampin|mesh-list
5496931|NCT04510649|Rabeprazole|rabeprazole|mesh-list
5496932|NCT04510649|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5496933|NCT04510649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6041508|NCT00537823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6457948|NCT00438321|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5496934|NCT04510649|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5496935|NCT04510649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6041509|NCT00537823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6041510|NCT00537823|Growth Substances|growth substances|mesh-ancestor
6041511|NCT00537823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041512|NCT00537823|Growth Inhibitors|growth inhibitors|mesh-ancestor
6041513|NCT00537823|Antimetabolites|antimetabolites|mesh-ancestor
6041514|NCT00537823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6041515|NCT00537823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6041516|NCT00537823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6041517|NCT00537823|Immunologic Factors|immunologic factors|mesh-ancestor
6041518|NCT00537823|Antidotes|antidotes|mesh-ancestor
6041519|NCT00537823|Protective Agents|protective agents|mesh-ancestor
6041520|NCT00537823|Vitamin B Complex|vitamin b complex|mesh-ancestor
6041521|NCT00537823|Vitamins|vitamins|mesh-ancestor
6041522|NCT00537823|Micronutrients|micronutrients|mesh-ancestor
6041523|NCT00537940|Pregabalin|pregabalin|mesh-list
6041524|NCT00537940|Gabapentin|gabapentin|mesh-list
6041525|NCT00537940|Analgesics|analgesics|mesh-ancestor
6041526|NCT00537940|Sensory System Agents|sensory system agents|mesh-ancestor
6041527|NCT00537940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6041528|NCT00537940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496936|NCT04510649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496937|NCT04510649|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5496938|NCT04510649|Antitubercular Agents|antitubercular agents|mesh-ancestor
5496939|NCT04510649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5496940|NCT04510649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5496941|NCT04510649|Leprostatic Agents|leprostatic agents|mesh-ancestor
5496942|NCT04510649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5496943|NCT04510649|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5496944|NCT04510649|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5496945|NCT04510649|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5496946|NCT04510649|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5496947|NCT04510649|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5496948|NCT04510649|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5496949|NCT04510818|Capecitabine|capecitabine|mesh-list
5496950|NCT04510818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6041529|NCT00537940|Anticonvulsants|anticonvulsants|mesh-ancestor
6041530|NCT00537940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6041531|NCT00537940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6041532|NCT00537940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6041533|NCT00537940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6041534|NCT00537940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6041535|NCT00537940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6041536|NCT00537940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6041537|NCT00537940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6041538|NCT00537940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6041539|NCT00537940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6041540|NCT00537940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6041541|NCT00537940|Antimanic Agents|antimanic agents|mesh-ancestor
6041542|NCT00537979|Ergocalciferols|ergocalciferols|mesh-list
6041543|NCT00537979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6041544|NCT00537979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041545|NCT00537979|Vitamins|vitamins|mesh-ancestor
6041546|NCT00537979|Micronutrients|micronutrients|mesh-ancestor
6041547|NCT00537979|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6041548|NCT00538291|Capecitabine|capecitabine|mesh-list
6041549|NCT00538291|Cetuximab|cetuximab|mesh-list
5496951|NCT04510818|Antimetabolites|antimetabolites|mesh-ancestor
5496952|NCT04510818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496953|NCT04510818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5496954|NCT04510610|Decitabine|decitabine|mesh-list
5496955|NCT04510610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5496956|NCT04510610|Antimetabolites|antimetabolites|mesh-ancestor
5496957|NCT04510610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496958|NCT04510610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5496959|NCT04510610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5496960|NCT04510662|Telmisartan|telmisartan|mesh-list
5496961|NCT04510662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5496962|NCT04510662|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5496963|NCT04510662|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6041550|NCT00538291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6041551|NCT00538291|Antimetabolites|antimetabolites|mesh-ancestor
6041552|NCT00538291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6041553|NCT00538291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6041554|NCT00538291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6041555|NCT00538304|Bimatoprost|bimatoprost|mesh-list
6041556|NCT00538304|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6041557|NCT00538304|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6041558|NCT00538304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6041559|NCT00538434|Reslizumab|reslizumab|mesh-list
6041560|NCT00538434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6041561|NCT00538434|Respiratory System Agents|respiratory system agents|mesh-ancestor
6041562|NCT00538590|Mitomycins|mitomycins|mesh-list
6041563|NCT00538590|Mitomycin|mitomycin|mesh-list
6041564|NCT00538590|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6041565|NCT00538590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6041566|NCT00538590|Alkylating Agents|alkylating agents|mesh-ancestor
6041567|NCT00538590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6041568|NCT00538590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6041569|NCT00538590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6041570|NCT00538616|Dexmedetomidine|dexmedetomidine|mesh-list
6041571|NCT00538616|Propofol|propofol|mesh-list
6041572|NCT00538616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6041573|NCT00538616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6041574|NCT00538616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041575|NCT00538616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6041576|NCT00538616|Anesthetics, General|anesthetics, general|mesh-ancestor
6041577|NCT00538616|Anesthetics|anesthetics|mesh-ancestor
6041578|NCT00538616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6041579|NCT00538616|Analgesics|analgesics|mesh-ancestor
6041580|NCT00538616|Sensory System Agents|sensory system agents|mesh-ancestor
6041581|NCT00538616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6041582|NCT00538616|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6041583|NCT00538616|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6041584|NCT00538616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6041585|NCT00538616|Adrenergic Agents|adrenergic agents|mesh-ancestor
6041586|NCT00538616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6041587|NCT00538616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6041588|NCT00538642|Ziprasidone|ziprasidone|mesh-list
6041589|NCT00538642|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6041590|NCT00538642|Serotonin Agents|serotonin agents|mesh-ancestor
6041591|NCT00538642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6041592|NCT00538642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6041593|NCT00538642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041594|NCT00538642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6041595|NCT00538642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6655147|NCT01461031|Sensory System Agents|sensory system agents|mesh-ancestor
5496964|NCT04510662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5496965|NCT04510285|Pembrolizumab|pembrolizumab|mesh-list
5496966|NCT04510285|Trastuzumab|trastuzumab|mesh-list
5496967|NCT04510285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5496968|NCT04510285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5496969|NCT04510428|Immunoglobulins|immunoglobulins|mesh-list
5496970|NCT04510428|Antibodies|antibodies|mesh-list
6041596|NCT00538642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6041597|NCT00538642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6041598|NCT00538642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6041599|NCT00538642|Dopamine Agents|dopamine agents|mesh-ancestor
6041600|NCT00538681|Pemetrexed|pemetrexed|mesh-list
6041601|NCT00538681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6041602|NCT00538681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6041603|NCT00538681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6041604|NCT00538681|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6041605|NCT00538681|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6041606|NCT00538733|Clarithromycin|clarithromycin|mesh-list
6041607|NCT00538733|Thalidomide|thalidomide|mesh-list
6041608|NCT00538733|Dexamethasone|dexamethasone|mesh-list
6041609|NCT00538733|Lenalidomide|lenalidomide|mesh-list
6041610|NCT00538733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6041611|NCT00538733|Antiemetics|antiemetics|mesh-ancestor
6041612|NCT00538733|Autonomic Agents|autonomic agents|mesh-ancestor
6041613|NCT00538733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6041614|NCT00538733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041615|NCT00538733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6041616|NCT00538733|Glucocorticoids|glucocorticoids|mesh-ancestor
6041617|NCT00538733|Hormones|hormones|mesh-ancestor
6041618|NCT00538733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6041619|NCT00538733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6041620|NCT00538733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6041621|NCT00538733|Immunologic Factors|immunologic factors|mesh-ancestor
6041622|NCT00538733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6041623|NCT00538733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6041624|NCT00538733|Growth Substances|growth substances|mesh-ancestor
6041625|NCT00538733|Growth Inhibitors|growth inhibitors|mesh-ancestor
6041626|NCT00538733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6041627|NCT00538733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6041628|NCT00538733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6041629|NCT00538733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6041630|NCT00538733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6041631|NCT00538733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6041632|NCT00538733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6041633|NCT00538733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6041634|NCT00538733|Leprostatic Agents|leprostatic agents|mesh-ancestor
5496971|NCT04510428|gamma-Globulins|gamma-globulins|mesh-list
5496972|NCT04510428|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5496973|NCT04510428|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5496974|NCT04510428|Immunologic Factors|immunologic factors|mesh-ancestor
5496975|NCT04510428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041635|NCT00538785|Palivizumab|palivizumab|mesh-list
6041636|NCT00538785|Antiviral Agents|antiviral agents|mesh-ancestor
6041637|NCT00538785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6041638|NCT00538824|Thalidomide|thalidomide|mesh-list
6041639|NCT00538824|Dexamethasone|dexamethasone|mesh-list
6041640|NCT00538824|Lenalidomide|lenalidomide|mesh-list
6041641|NCT00538824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6041642|NCT00538824|Antiemetics|antiemetics|mesh-ancestor
6041643|NCT00538824|Autonomic Agents|autonomic agents|mesh-ancestor
6041644|NCT00538824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6041645|NCT00538824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041646|NCT00538824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6041647|NCT00538824|Glucocorticoids|glucocorticoids|mesh-ancestor
6041648|NCT00538824|Hormones|hormones|mesh-ancestor
6041649|NCT00538824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6041650|NCT00538824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6041651|NCT00538824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6041652|NCT00538824|Immunologic Factors|immunologic factors|mesh-ancestor
6041653|NCT00538824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6041654|NCT00538824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6041655|NCT00538824|Growth Substances|growth substances|mesh-ancestor
6041656|NCT00538824|Growth Inhibitors|growth inhibitors|mesh-ancestor
6041657|NCT00538824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6041658|NCT00538824|Leprostatic Agents|leprostatic agents|mesh-ancestor
6041659|NCT00538824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6041660|NCT00538824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6041661|NCT00538850|Fentanyl|fentanyl|mesh-list
6041662|NCT00538850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6041663|NCT00538850|Narcotics|narcotics|mesh-ancestor
6041664|NCT00538850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6041665|NCT00538850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041666|NCT00538850|Analgesics|analgesics|mesh-ancestor
6041667|NCT00538850|Sensory System Agents|sensory system agents|mesh-ancestor
5496976|NCT04510220|Ofatumumab|ofatumumab|mesh-list
5496977|NCT04510220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5496978|NCT04510337|Magnesium Sulfate|magnesium sulfate|mesh-list
5496979|NCT04510337|Rocuronium|rocuronium|mesh-list
5496980|NCT04510337|Analgesics|analgesics|mesh-ancestor
5496981|NCT04510337|Sensory System Agents|sensory system agents|mesh-ancestor
5496982|NCT04510337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5496983|NCT04510337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5496984|NCT04510337|Anesthetics|anesthetics|mesh-ancestor
5496985|NCT04510337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5496986|NCT04510337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5496987|NCT04510337|Anticonvulsants|anticonvulsants|mesh-ancestor
5496988|NCT04510337|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5496989|NCT04510337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5496990|NCT04510337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6041668|NCT00538850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6041669|NCT00538850|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6041670|NCT00538850|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6041671|NCT00538850|Anesthetics, General|anesthetics, general|mesh-ancestor
6041672|NCT00538850|Anesthetics|anesthetics|mesh-ancestor
6041673|NCT00538863|Fentanyl|fentanyl|mesh-list
6041674|NCT00538863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6041675|NCT00538863|Narcotics|narcotics|mesh-ancestor
6041676|NCT00538863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6041677|NCT00538863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041678|NCT00538863|Analgesics|analgesics|mesh-ancestor
6041679|NCT00538863|Sensory System Agents|sensory system agents|mesh-ancestor
6041680|NCT00538863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6041681|NCT00538863|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6041682|NCT00538863|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6041683|NCT00538863|Anesthetics, General|anesthetics, general|mesh-ancestor
6041684|NCT00538863|Anesthetics|anesthetics|mesh-ancestor
6041685|NCT00538902|Adalimumab|adalimumab|mesh-list
6041686|NCT00538902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5496991|NCT04510337|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5496992|NCT04510337|Tocolytic Agents|tocolytic agents|mesh-ancestor
5496993|NCT04510337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5496994|NCT04510337|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5496995|NCT04510337|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5496996|NCT04510337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5503312|NCT04460547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503313|NCT04460547|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5503314|NCT04460248|Rituximab|rituximab|mesh-list
5503315|NCT04460248|Lenalidomide|lenalidomide|mesh-list
5503316|NCT04460248|Zanubrutinib|zanubrutinib|mesh-list
5503317|NCT04460248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5503318|NCT04460248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5503319|NCT04460248|Immunologic Factors|immunologic factors|mesh-ancestor
5503320|NCT04460248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041687|NCT00538902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6041688|NCT00538915|Immunoglobulins|immunoglobulins|mesh-list
6041689|NCT00538915|Antibodies|antibodies|mesh-list
6041690|NCT00538915|gamma-Globulins|gamma-globulins|mesh-list
6041691|NCT00538915|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6041692|NCT00538915|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6041693|NCT00538915|Immunologic Factors|immunologic factors|mesh-ancestor
6041694|NCT00538915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041695|NCT00539006|Fluticasone|fluticasone|mesh-list
6041696|NCT00539006|Xhance|xhance|mesh-list
6041697|NCT00539006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6041698|NCT00539006|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6041699|NCT00539006|Autonomic Agents|autonomic agents|mesh-ancestor
6041700|NCT00539006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6041701|NCT00539006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041702|NCT00539006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6041703|NCT00539006|Respiratory System Agents|respiratory system agents|mesh-ancestor
6041704|NCT00539006|Dermatologic Agents|dermatologic agents|mesh-ancestor
6041705|NCT00539006|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6041706|NCT00539032|Vaccines|vaccines|mesh-list
6041707|NCT00539032|Immunologic Factors|immunologic factors|mesh-ancestor
6041708|NCT00539032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041709|NCT00539188|Acetylcysteine|acetylcysteine|mesh-list
6041710|NCT00539188|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6041711|NCT00539188|Antiviral Agents|antiviral agents|mesh-ancestor
5503321|NCT04460248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5503322|NCT04460248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6041712|NCT00539188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6041713|NCT00539188|Expectorants|expectorants|mesh-ancestor
6041714|NCT00539188|Respiratory System Agents|respiratory system agents|mesh-ancestor
5496997|NCT04510233|Ivermectin|ivermectin|mesh-list
5496998|NCT04510233|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5496999|NCT04510233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5497000|NCT04510051|Cyclophosphamide|cyclophosphamide|mesh-list
5497001|NCT04510051|Fludarabine|fludarabine|mesh-list
5497002|NCT04510051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6041715|NCT00539188|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6041716|NCT00539188|Antioxidants|antioxidants|mesh-ancestor
6041717|NCT00539188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6041718|NCT00539188|Protective Agents|protective agents|mesh-ancestor
6041719|NCT00539188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041720|NCT00539188|Antidotes|antidotes|mesh-ancestor
6041721|NCT00539240|Antidepressive Agents|antidepressive agents|mesh-list
6041722|NCT00539240|Nortriptyline|nortriptyline|mesh-list
6041723|NCT00539240|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
6041724|NCT00539240|Rabeprazole|rabeprazole|mesh-list
6041725|NCT00539240|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6041726|NCT00539240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5497003|NCT04510051|Immunologic Factors|immunologic factors|mesh-ancestor
5497004|NCT04510051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497005|NCT04510051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5497006|NCT04510051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5497007|NCT04510051|Alkylating Agents|alkylating agents|mesh-ancestor
5497008|NCT04510051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5497009|NCT04510051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5497010|NCT04510051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6041727|NCT00539240|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6041728|NCT00539240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6041729|NCT00539240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6041730|NCT00539240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6041731|NCT00539240|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6041732|NCT00539240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6041733|NCT00539240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6041734|NCT00539240|Adrenergic Agents|adrenergic agents|mesh-ancestor
6041735|NCT00539240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6041736|NCT00539240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041737|NCT00539305|Methyltestosterone|methyltestosterone|mesh-list
6041738|NCT00539305|Testosterone|testosterone|mesh-list
6041739|NCT00539305|Testosterone undecanoate|testosterone undecanoate|mesh-list
6041740|NCT00539305|Testosterone enanthate|testosterone enanthate|mesh-list
6041741|NCT00539305|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6041742|NCT00539305|Androgens|androgens|mesh-ancestor
6041743|NCT00539305|Hormones|hormones|mesh-ancestor
6041744|NCT00539305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6041745|NCT00539305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041746|NCT00539305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6041747|NCT00539305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6041748|NCT00539305|Anabolic Agents|anabolic agents|mesh-ancestor
6041749|NCT00539500|Carboplatin|carboplatin|mesh-list
6041750|NCT00539500|Etoposide|etoposide|mesh-list
6457949|NCT00438321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6457950|NCT00438321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6457951|NCT00438321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457952|NCT00438321|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6457953|NCT00438321|Hormone Antagonists|hormone antagonists|mesh-ancestor
6457954|NCT00438386|Aripiprazole|aripiprazole|mesh-list
6457955|NCT00438386|Antidepressive Agents|antidepressive agents|mesh-ancestor
6457956|NCT00438386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6457957|NCT00438386|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6457958|NCT00438386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6041751|NCT00539500|Melphalan|melphalan|mesh-list
6041752|NCT00539500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6041753|NCT00539500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6041754|NCT00539500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6041755|NCT00539500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6041756|NCT00539500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6041757|NCT00539500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6041758|NCT00539500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6041759|NCT00539500|Alkylating Agents|alkylating agents|mesh-ancestor
6041760|NCT00539500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6041761|NCT00539500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6457959|NCT00438386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5497011|NCT04510402|Povidone-Iodine|povidone-iodine|mesh-list
5497012|NCT04510402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6041762|NCT00539500|Immunologic Factors|immunologic factors|mesh-ancestor
5497013|NCT04510402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6041763|NCT00539500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041764|NCT00539513|Acetylcysteine|acetylcysteine|mesh-list
6041765|NCT00539513|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6041766|NCT00539513|Antiviral Agents|antiviral agents|mesh-ancestor
6041767|NCT00539513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6041768|NCT00539513|Expectorants|expectorants|mesh-ancestor
6041769|NCT00539513|Respiratory System Agents|respiratory system agents|mesh-ancestor
6041770|NCT00539513|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6041771|NCT00539513|Antioxidants|antioxidants|mesh-ancestor
6041772|NCT00539513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6041773|NCT00539513|Protective Agents|protective agents|mesh-ancestor
6041774|NCT00539513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041775|NCT00539513|Antidotes|antidotes|mesh-ancestor
6041776|NCT00539526|Bimatoprost|bimatoprost|mesh-list
6041777|NCT00539526|Travoprost|travoprost|mesh-list
6041778|NCT00539526|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6041779|NCT00539526|Latanoprost|latanoprost|mesh-list
6041780|NCT00539526|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6041781|NCT00539526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6041782|NCT00539591|Interferons|interferons|mesh-list
6041783|NCT00539591|Interferon-alpha|interferon-alpha|mesh-list
6041784|NCT00539591|Interferon alpha-2|interferon alpha-2|mesh-list
6041785|NCT00539591|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6041786|NCT00539591|Temozolomide|temozolomide|mesh-list
6041787|NCT00539591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6041788|NCT00539591|Antiviral Agents|antiviral agents|mesh-ancestor
6041789|NCT00539591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6041790|NCT00539591|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6041791|NCT00539591|Alkylating Agents|alkylating agents|mesh-ancestor
6041792|NCT00539591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6041793|NCT00539591|Immunologic Factors|immunologic factors|mesh-ancestor
6041794|NCT00539591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041795|NCT00539695|Aldesleukin|aldesleukin|mesh-list
6041796|NCT00539695|Interleukin-2|interleukin-2|mesh-list
6041797|NCT00539695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6041798|NCT00539695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6041799|NCT00539695|Analgesics|analgesics|mesh-ancestor
6041800|NCT00539695|Sensory System Agents|sensory system agents|mesh-ancestor
6041801|NCT00539695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6041802|NCT00539695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041803|NCT00539695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6041804|NCT00539695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6041805|NCT00539695|Antiviral Agents|antiviral agents|mesh-ancestor
6041806|NCT00539695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6041807|NCT00539734|Ranibizumab|ranibizumab|mesh-list
6041808|NCT00539734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6041809|NCT00539734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6655148|NCT01461031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6655149|NCT01461031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655150|NCT01461174|Memantine|memantine|mesh-list
6655151|NCT01461174|Modafinil|modafinil|mesh-list
6655152|NCT01461174|Donepezil|donepezil|mesh-list
6655153|NCT01461174|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6655154|NCT01461174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6655155|NCT01461174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655156|NCT01461174|Cholinergic Agents|cholinergic agents|mesh-ancestor
6041810|NCT00539734|Growth Substances|growth substances|mesh-ancestor
6041811|NCT00539734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041812|NCT00539734|Growth Inhibitors|growth inhibitors|mesh-ancestor
6041813|NCT00539734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6041814|NCT00539864|Vaccines|vaccines|mesh-list
6041815|NCT00539864|Hemagglutinins|hemagglutinins|mesh-list
6041816|NCT00539864|Immunologic Factors|immunologic factors|mesh-ancestor
6041817|NCT00539864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041818|NCT00539864|Agglutinins|agglutinins|mesh-ancestor
6041819|NCT00539942|PENTA|penta|mesh-list
6041820|NCT00539942|Fondaparinux|fondaparinux|mesh-list
6041821|NCT00539942|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6041822|NCT00539942|Antithrombins|antithrombins|mesh-ancestor
6041823|NCT00539942|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6041824|NCT00539942|Protease Inhibitors|protease inhibitors|mesh-ancestor
6041825|NCT00539942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6041826|NCT00539942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6041827|NCT00539942|Anticoagulants|anticoagulants|mesh-ancestor
6041828|NCT00539942|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6041829|NCT00539942|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6041830|NCT00539981|Hemagglutinins|hemagglutinins|mesh-list
6655157|NCT01461174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6041831|NCT00539981|Immunologic Factors|immunologic factors|mesh-ancestor
6041832|NCT00539981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041833|NCT00539981|Agglutinins|agglutinins|mesh-ancestor
6041834|NCT00539994|Retapamulin|retapamulin|mesh-list
6041835|NCT00539994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6041836|NCT00539994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6041837|NCT00540007|Lenalidomide|lenalidomide|mesh-list
6041838|NCT00540007|Immunologic Factors|immunologic factors|mesh-ancestor
6041839|NCT00540007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041840|NCT00540007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6041841|NCT00540007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6041842|NCT00540007|Growth Substances|growth substances|mesh-ancestor
6041843|NCT00540007|Growth Inhibitors|growth inhibitors|mesh-ancestor
6041844|NCT00540007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6041845|NCT00540046|Copper|copper|mesh-list
6041846|NCT00540046|Trace Elements|trace elements|mesh-ancestor
5497026|NCT04510012|Complement System Proteins|complement system proteins|mesh-list
5497027|NCT04510012|Immunologic Factors|immunologic factors|mesh-ancestor
5497028|NCT04510012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497029|NCT04510038|Colchicine|colchicine|mesh-list
5497030|NCT04510038|Gout Suppressants|gout suppressants|mesh-ancestor
5497031|NCT04510038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5497032|NCT04510038|Tubulin Modulators|tubulin modulators|mesh-ancestor
5497033|NCT04510038|Antimitotic Agents|antimitotic agents|mesh-ancestor
5497034|NCT04510038|Mitosis Modulators|mitosis modulators|mesh-ancestor
5497035|NCT04510038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6041847|NCT00540046|Micronutrients|micronutrients|mesh-ancestor
6041848|NCT00540046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041849|NCT00540124|Tadalafil|tadalafil|mesh-list
6041850|NCT00540124|Tamsulosin|tamsulosin|mesh-list
6041851|NCT00540124|Vasodilator Agents|vasodilator agents|mesh-ancestor
6041852|NCT00540124|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6041853|NCT00540124|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6041854|NCT00540124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6041855|NCT00540124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6041856|NCT00540124|Urological Agents|urological agents|mesh-ancestor
6041857|NCT00540124|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6041858|NCT00540124|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6041859|NCT00540124|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6041860|NCT00540124|Adrenergic Agents|adrenergic agents|mesh-ancestor
6457960|NCT00438386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457961|NCT00438386|Dopamine Agonists|dopamine agonists|mesh-ancestor
6457962|NCT00438386|Dopamine Agents|dopamine agents|mesh-ancestor
6457963|NCT00438386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6457964|NCT00438386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457965|NCT00438386|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6457966|NCT00438386|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5497036|NCT04510038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6041861|NCT00540124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6041862|NCT00540124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041863|NCT00540293|Atorvastatin|atorvastatin|mesh-list
6041864|NCT00540293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6041865|NCT00540293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6041866|NCT00540293|Antimetabolites|antimetabolites|mesh-ancestor
6041867|NCT00540293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6041868|NCT00540293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6041869|NCT00540293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6041870|NCT00540293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6041871|NCT00540436|Ambrisentan|ambrisentan|mesh-list
6041872|NCT00540436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6041873|NCT00540449|Efavirenz|efavirenz|mesh-list
6041874|NCT00540449|Rilpivirine|rilpivirine|mesh-list
6041875|NCT00540449|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6041876|NCT00540449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6041877|NCT00540449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6041878|NCT00540449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6041879|NCT00540449|Antiviral Agents|antiviral agents|mesh-ancestor
6041880|NCT00540449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6041881|NCT00540449|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6041882|NCT00540449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6041883|NCT00540449|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6041884|NCT00540449|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6041885|NCT00540449|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6041886|NCT00540449|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6041887|NCT00540449|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6041888|NCT00540449|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6041889|NCT00540514|Paclitaxel|paclitaxel|mesh-list
6041890|NCT00540514|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6041891|NCT00540514|Carboplatin|carboplatin|mesh-list
6041892|NCT00540514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6041893|NCT00540514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6041894|NCT00540514|Tubulin Modulators|tubulin modulators|mesh-ancestor
6041895|NCT00540514|Antimitotic Agents|antimitotic agents|mesh-ancestor
6041896|NCT00540514|Mitosis Modulators|mitosis modulators|mesh-ancestor
6041897|NCT00540514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6041898|NCT00540579|Gemcitabine|gemcitabine|mesh-list
6041899|NCT00540579|Pomalidomide|pomalidomide|mesh-list
6041900|NCT00540579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6041901|NCT00540579|Antimetabolites|antimetabolites|mesh-ancestor
6041902|NCT00540579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6041903|NCT00540579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6041904|NCT00540579|Antiviral Agents|antiviral agents|mesh-ancestor
6041905|NCT00540579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6041906|NCT00540579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6041907|NCT00540579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6041908|NCT00540579|Immunologic Factors|immunologic factors|mesh-ancestor
6041909|NCT00540579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041910|NCT00540579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6041911|NCT00540579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6041912|NCT00540579|Growth Substances|growth substances|mesh-ancestor
6041913|NCT00540579|Growth Inhibitors|growth inhibitors|mesh-ancestor
6041914|NCT00540644|Prednisone|prednisone|mesh-list
6041915|NCT00540644|Cyclophosphamide|cyclophosphamide|mesh-list
6041916|NCT00540644|Lenalidomide|lenalidomide|mesh-list
6041917|NCT00540644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6041918|NCT00540644|Immunologic Factors|immunologic factors|mesh-ancestor
6041919|NCT00540644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041920|NCT00540644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6041921|NCT00540644|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6041922|NCT00540644|Alkylating Agents|alkylating agents|mesh-ancestor
6041923|NCT00540644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6041924|NCT00540644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6041925|NCT00540644|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6041926|NCT00540644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6041927|NCT00540644|Glucocorticoids|glucocorticoids|mesh-ancestor
6041928|NCT00540644|Hormones|hormones|mesh-ancestor
6041929|NCT00540644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6041930|NCT00540644|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6041931|NCT00540644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6041932|NCT00540644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6041933|NCT00540644|Growth Substances|growth substances|mesh-ancestor
6041934|NCT00540644|Growth Inhibitors|growth inhibitors|mesh-ancestor
6041935|NCT00540722|Acetic Acid|acetic acid|mesh-list
6041936|NCT00540722|Retinol acetate|retinol acetate|mesh-list
6041937|NCT00540722|Gossypol acetic acid|gossypol acetic acid|mesh-list
6041938|NCT00540722|Gossypol|gossypol|mesh-list
6041939|NCT00540722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6041940|NCT00540722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6041941|NCT00540722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6041942|NCT00540722|Immunologic Factors|immunologic factors|mesh-ancestor
6041943|NCT00540722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041944|NCT00540722|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6041945|NCT00540722|Protective Agents|protective agents|mesh-ancestor
6041946|NCT00540722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6041947|NCT00540722|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6041948|NCT00540722|Contraceptive Agents|contraceptive agents|mesh-ancestor
6041949|NCT00540722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6041950|NCT00540722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6041951|NCT00540722|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6041952|NCT00540722|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
6041953|NCT00540722|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
6041954|NCT00540982|Vinorelbine|vinorelbine|mesh-list
6655158|NCT01461174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041955|NCT00540982|Lidocaine|lidocaine|mesh-list
6041956|NCT00540982|Anesthetics, Local|anesthetics, local|mesh-ancestor
6041957|NCT00540982|Anesthetics|anesthetics|mesh-ancestor
6041958|NCT00540982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6041959|NCT00540982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041960|NCT00540982|Sensory System Agents|sensory system agents|mesh-ancestor
6041961|NCT00540982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6041962|NCT00540982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6041963|NCT00540982|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6041964|NCT00540982|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6041965|NCT00540982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6041966|NCT00540982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6041967|NCT00540982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6041968|NCT00540982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6041969|NCT00540982|Tubulin Modulators|tubulin modulators|mesh-ancestor
6041970|NCT00540982|Antimitotic Agents|antimitotic agents|mesh-ancestor
6041971|NCT00540982|Mitosis Modulators|mitosis modulators|mesh-ancestor
6041972|NCT00540995|Etoposide|etoposide|mesh-list
6041973|NCT00540995|Podophyllotoxin|podophyllotoxin|mesh-list
6041974|NCT00540995|Etoposide phosphate|etoposide phosphate|mesh-list
6041975|NCT00540995|Busulfan|busulfan|mesh-list
6041976|NCT00540995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6041977|NCT00540995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6041978|NCT00540995|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6041979|NCT00540995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5497037|NCT04509999|Bicalutamide|bicalutamide|mesh-list
5497038|NCT04509999|Androgen Antagonists|androgen antagonists|mesh-ancestor
5497039|NCT04509999|Hormone Antagonists|hormone antagonists|mesh-ancestor
5497040|NCT04509999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5497041|NCT04509999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497042|NCT04509999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6041980|NCT00540995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6041981|NCT00540995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6041982|NCT00540995|Alkylating Agents|alkylating agents|mesh-ancestor
6041983|NCT00540995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6041984|NCT00540995|Immunologic Factors|immunologic factors|mesh-ancestor
6041985|NCT00540995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041986|NCT00540995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6041987|NCT00540995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6041988|NCT00540995|Keratolytic Agents|keratolytic agents|mesh-ancestor
6041989|NCT00540995|Dermatologic Agents|dermatologic agents|mesh-ancestor
6041990|NCT00540995|Tubulin Modulators|tubulin modulators|mesh-ancestor
6041991|NCT00540995|Antimitotic Agents|antimitotic agents|mesh-ancestor
6041992|NCT00540995|Mitosis Modulators|mitosis modulators|mesh-ancestor
6041993|NCT00541034|Cyclophosphamide|cyclophosphamide|mesh-list
6041994|NCT00541034|Rituximab|rituximab|mesh-list
6041995|NCT00541034|Pentostatin|pentostatin|mesh-list
6041996|NCT00541034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6041997|NCT00541034|Immunologic Factors|immunologic factors|mesh-ancestor
6041998|NCT00541034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6041999|NCT00541034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6042000|NCT00541034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6042001|NCT00541034|Alkylating Agents|alkylating agents|mesh-ancestor
6042002|NCT00541034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042003|NCT00541034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6457967|NCT00438386|Serotonin Agents|serotonin agents|mesh-ancestor
6457968|NCT00438386|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6457969|NCT00438386|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6457970|NCT00438386|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6457971|NCT00438386|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6655159|NCT01461174|Nootropic Agents|nootropic agents|mesh-ancestor
6457972|NCT00438477|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
6457973|NCT00438477|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6042004|NCT00541034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6042005|NCT00541034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6042006|NCT00541034|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
6042007|NCT00541034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6042008|NCT00541099|Bevacizumab|bevacizumab|mesh-list
6042009|NCT00541099|Docetaxel|docetaxel|mesh-list
6042010|NCT00541099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6042011|NCT00541099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6042012|NCT00541099|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6042013|NCT00541099|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5497043|NCT04509466|Mitoxantrone|mitoxantrone|mesh-list
5497044|NCT04509466|Pegaspargase|pegaspargase|mesh-list
5497045|NCT04509466|Asparaginase|asparaginase|mesh-list
5497046|NCT04509466|Analgesics|analgesics|mesh-ancestor
5497047|NCT04509466|Sensory System Agents|sensory system agents|mesh-ancestor
5497048|NCT04509466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5497049|NCT04509466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497050|NCT04509466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5497051|NCT04509466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5497052|NCT04509466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5497053|NCT04509466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5497054|NCT04509466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042014|NCT00541099|Growth Substances|growth substances|mesh-ancestor
6042015|NCT00541099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042016|NCT00541099|Growth Inhibitors|growth inhibitors|mesh-ancestor
6042017|NCT00541099|Tubulin Modulators|tubulin modulators|mesh-ancestor
6042018|NCT00541099|Antimitotic Agents|antimitotic agents|mesh-ancestor
6042019|NCT00541099|Mitosis Modulators|mitosis modulators|mesh-ancestor
6042020|NCT00541099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042021|NCT00541229|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6042022|NCT00541229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6042023|NCT00541229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042024|NCT00541229|Incretins|incretins|mesh-ancestor
6042025|NCT00541229|Hormones|hormones|mesh-ancestor
6042026|NCT00541229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6042027|NCT00541229|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6042028|NCT00541229|Protease Inhibitors|protease inhibitors|mesh-ancestor
6042029|NCT00541229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5497055|NCT04509583|Vitamin E|vitamin e|mesh-list
5497056|NCT04509583|Vitamins|vitamins|mesh-ancestor
5497057|NCT04509583|Micronutrients|micronutrients|mesh-ancestor
5497058|NCT04509583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497059|NCT04509583|Antioxidants|antioxidants|mesh-ancestor
5497060|NCT04509583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5497061|NCT04509583|Protective Agents|protective agents|mesh-ancestor
5497062|NCT04509622|Cytarabine|cytarabine|mesh-list
5497063|NCT04509622|Venetoclax|venetoclax|mesh-list
5497064|NCT04509622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5497065|NCT04509622|Antimetabolites|antimetabolites|mesh-ancestor
5497066|NCT04509622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042030|NCT00541229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042031|NCT00541242|Bimatoprost|bimatoprost|mesh-list
6042032|NCT00541242|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5497067|NCT04509622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5497068|NCT04509622|Antiviral Agents|antiviral agents|mesh-ancestor
5497069|NCT04509622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5497070|NCT04509622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5497071|NCT04509622|Immunologic Factors|immunologic factors|mesh-ancestor
5497072|NCT04509622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497073|NCT04509661|Bronchodilator Agents|bronchodilator agents|mesh-list
5497074|NCT04509661|Autonomic Agents|autonomic agents|mesh-ancestor
5497075|NCT04509661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5497076|NCT04509661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042033|NCT00541242|Latanoprost|latanoprost|mesh-list
6042034|NCT00541242|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6042035|NCT00541242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6042036|NCT00541307|Heparin|heparin|mesh-list
6042037|NCT00541307|Anticoagulants|anticoagulants|mesh-ancestor
6042038|NCT00541307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6042039|NCT00541307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5497077|NCT04509661|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5497078|NCT04509661|Respiratory System Agents|respiratory system agents|mesh-ancestor
5497079|NCT04509596|Capecitabine|capecitabine|mesh-list
5497080|NCT04509596|Trastuzumab|trastuzumab|mesh-list
6042040|NCT00541307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042041|NCT00541346|Methylphenidate|methylphenidate|mesh-list
6042042|NCT00541346|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6042043|NCT00541346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042044|NCT00541346|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6042045|NCT00541346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6042046|NCT00541346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6042047|NCT00541346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042048|NCT00541346|Dopamine Agents|dopamine agents|mesh-ancestor
6042049|NCT00541346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6042050|NCT00541385|Artesunate|artesunate|mesh-list
6042051|NCT00541385|Lumefantrine|lumefantrine|mesh-list
6042052|NCT00541385|Pyronaridine|pyronaridine|mesh-list
6042053|NCT00541385|Antimalarials|antimalarials|mesh-ancestor
6042054|NCT00541385|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6042055|NCT00541385|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6042056|NCT00541385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6042057|NCT00541385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6042058|NCT00541385|Antiviral Agents|antiviral agents|mesh-ancestor
6042059|NCT00541385|Schistosomicides|schistosomicides|mesh-ancestor
6042060|NCT00541385|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6042061|NCT00541385|Anthelmintics|anthelmintics|mesh-ancestor
6042062|NCT00541450|Metformin|metformin|mesh-list
6042063|NCT00541450|Pioglitazone|pioglitazone|mesh-list
6042064|NCT00541450|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6042065|NCT00541450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6042066|NCT00541450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497081|NCT04509596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5497082|NCT04509596|Antimetabolites|antimetabolites|mesh-ancestor
5497083|NCT04509596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042067|NCT00541450|Incretins|incretins|mesh-ancestor
6042068|NCT00541450|Hormones|hormones|mesh-ancestor
6042069|NCT00541450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6042070|NCT00541450|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5497084|NCT04509596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5497085|NCT04509596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5497086|NCT04509635|Cetuximab|cetuximab|mesh-list
5497087|NCT04509635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5497088|NCT04509635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5497089|NCT04509440|Triamcinolone|triamcinolone|mesh-list
5497090|NCT04509440|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5497091|NCT04509440|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5497092|NCT04509440|Anesthetics|anesthetics|mesh-list
5497093|NCT04509440|Mepivacaine|mepivacaine|mesh-list
5497094|NCT04509440|Anesthetics, Local|anesthetics, local|mesh-list
5497095|NCT04509440|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5497096|NCT04509440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5497097|NCT04509440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497098|NCT04509440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5497099|NCT04509440|Glucocorticoids|glucocorticoids|mesh-ancestor
5497100|NCT04509440|Hormones|hormones|mesh-ancestor
5497101|NCT04509440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5497102|NCT04509440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5497103|NCT04509440|Immunologic Factors|immunologic factors|mesh-ancestor
5497104|NCT04509440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5497105|NCT04509440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5497106|NCT04509440|Sensory System Agents|sensory system agents|mesh-ancestor
5497107|NCT04509440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5497108|NCT04509414|Midazolam|midazolam|mesh-list
5497109|NCT04509414|Dexmedetomidine|dexmedetomidine|mesh-list
6042071|NCT00541450|Protease Inhibitors|protease inhibitors|mesh-ancestor
6042072|NCT00541450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5497110|NCT04509414|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5497111|NCT04509414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5497112|NCT04509414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497113|NCT04509414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5497114|NCT04509414|Analgesics|analgesics|mesh-ancestor
5497115|NCT04509414|Sensory System Agents|sensory system agents|mesh-ancestor
5497116|NCT04509414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5497117|NCT04509414|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5497118|NCT04509414|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5497119|NCT04509414|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6042073|NCT00541450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042074|NCT00541658|Risedronic Acid|risedronic acid|mesh-list
6042075|NCT00541658|Etidronic Acid|etidronic acid|mesh-list
6042076|NCT00541658|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6042077|NCT00541658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6042078|NCT00541658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042079|NCT00541658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6042080|NCT00541658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042081|NCT00541658|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6042082|NCT00541671|Promethazine|promethazine|mesh-list
6042083|NCT00541671|Antipruritics|antipruritics|mesh-ancestor
6042084|NCT00541671|Dermatologic Agents|dermatologic agents|mesh-ancestor
6042085|NCT00541671|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6042086|NCT00541671|Histamine Antagonists|histamine antagonists|mesh-ancestor
6042087|NCT00541671|Histamine Agents|histamine agents|mesh-ancestor
6042088|NCT00541671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6042089|NCT00541671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042090|NCT00541671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042091|NCT00541671|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6042092|NCT00541775|Metformin|metformin|mesh-list
6042093|NCT00541775|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6042094|NCT00541775|Rosiglitazone|rosiglitazone|mesh-list
6042095|NCT00541775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6042096|NCT00541775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042097|NCT00541775|Incretins|incretins|mesh-ancestor
5497120|NCT04509414|Adrenergic Agents|adrenergic agents|mesh-ancestor
5497121|NCT04509414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5497122|NCT04509414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5497123|NCT04509414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5497124|NCT04509414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5497125|NCT04509414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5497126|NCT04509414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5497127|NCT04509414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5497128|NCT04509414|Anesthetics, General|anesthetics, general|mesh-ancestor
5497129|NCT04509414|Anesthetics|anesthetics|mesh-ancestor
5497130|NCT04509414|GABA Modulators|gaba modulators|mesh-ancestor
5497131|NCT04509414|GABA Agents|gaba agents|mesh-ancestor
5497132|NCT04509336|Orphenadrine|orphenadrine|mesh-list
5497133|NCT04509336|Baclofen|baclofen|mesh-list
5497134|NCT04509336|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5497135|NCT04509336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497136|NCT04509336|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5497137|NCT04509336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6042098|NCT00541775|Hormones|hormones|mesh-ancestor
6042099|NCT00541775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6042100|NCT00541775|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6042101|NCT00541775|Protease Inhibitors|protease inhibitors|mesh-ancestor
6042102|NCT00541775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6042103|NCT00541775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042104|NCT00541866|Cytarabine|cytarabine|mesh-list
6042105|NCT00541866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6042106|NCT00541866|Antimetabolites|antimetabolites|mesh-ancestor
6042107|NCT00541866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042108|NCT00541866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6042109|NCT00541866|Antiviral Agents|antiviral agents|mesh-ancestor
6042110|NCT00541866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6042111|NCT00541866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6042112|NCT00541866|Immunologic Factors|immunologic factors|mesh-ancestor
6042113|NCT00541866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042114|NCT00541970|Vaccines|vaccines|mesh-list
6042115|NCT00541970|Immunologic Factors|immunologic factors|mesh-ancestor
6042116|NCT00541970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497138|NCT04509336|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
5497139|NCT04509336|GABA Agonists|gaba agonists|mesh-ancestor
6042117|NCT00542178|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6042118|NCT00542178|Simvastatin|simvastatin|mesh-list
6462241|NCT00458250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5497140|NCT04509336|GABA Agents|gaba agents|mesh-ancestor
5497141|NCT04509336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5497142|NCT04509336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5497143|NCT04509336|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5497144|NCT04509336|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5497145|NCT04509336|Parasympatholytics|parasympatholytics|mesh-ancestor
5497146|NCT04509336|Autonomic Agents|autonomic agents|mesh-ancestor
5497147|NCT04509336|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5497148|NCT04509336|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5497149|NCT04509336|Cholinergic Agents|cholinergic agents|mesh-ancestor
5497150|NCT04509336|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
5497151|NCT04509336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5497152|NCT04509336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5497153|NCT04509102|Adderall|adderall|mesh-list
5497154|NCT04509102|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5497155|NCT04509102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497156|NCT04509323|Huperzine A|huperzine a|mesh-list
5497157|NCT04509323|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5497158|NCT04509323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5497159|NCT04509323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5497160|NCT04509323|Cholinergic Agents|cholinergic agents|mesh-ancestor
5497161|NCT04509323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5497162|NCT04509323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497163|NCT04509323|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5497164|NCT04509323|Protective Agents|protective agents|mesh-ancestor
5497165|NCT04508946|Ascorbic Acid|ascorbic acid|mesh-list
5497166|NCT04508946|Thiamine|thiamine|mesh-list
5497167|NCT04508946|Hydrocortisone|hydrocortisone|mesh-list
5497168|NCT04508946|Vitamins|vitamins|mesh-ancestor
5497169|NCT04508946|Micronutrients|micronutrients|mesh-ancestor
5497170|NCT04508946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497171|NCT04508946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5497172|NCT04508946|Antioxidants|antioxidants|mesh-ancestor
5497173|NCT04508946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5497174|NCT04508946|Protective Agents|protective agents|mesh-ancestor
5497175|NCT04508946|Vitamin B Complex|vitamin b complex|mesh-ancestor
5497176|NCT04509219|Methylprednisolone|methylprednisolone|mesh-list
5497177|NCT04509219|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5497178|NCT04509219|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5497179|NCT04509219|Prednisolone|prednisolone|mesh-list
5497180|NCT04509219|Prednisolone acetate|prednisolone acetate|mesh-list
5497181|NCT04509219|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5497182|NCT04509219|Prednisolone phosphate|prednisolone phosphate|mesh-list
5497183|NCT04509219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5497184|NCT04509219|Antiemetics|antiemetics|mesh-ancestor
5497185|NCT04509219|Autonomic Agents|autonomic agents|mesh-ancestor
5497186|NCT04509219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5497187|NCT04509219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497188|NCT04509219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5497189|NCT04509219|Glucocorticoids|glucocorticoids|mesh-ancestor
5497190|NCT04509219|Hormones|hormones|mesh-ancestor
5497191|NCT04509219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5497192|NCT04509219|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5497193|NCT04509219|Protective Agents|protective agents|mesh-ancestor
5497194|NCT04509219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5497195|NCT04509219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5497196|NCT04509232|Fluorides|fluorides|mesh-list
5497197|NCT04509232|Cariostatic Agents|cariostatic agents|mesh-ancestor
6655160|NCT01461174|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6042119|NCT00542178|Fenofibrate|fenofibrate|mesh-list
6042120|NCT00542178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6042121|NCT00542178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6042122|NCT00542178|Antimetabolites|antimetabolites|mesh-ancestor
6042123|NCT00542178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042124|NCT00542178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6042125|NCT00542178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6042126|NCT00542178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6042127|NCT00542178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042128|NCT00542191|Paclitaxel|paclitaxel|mesh-list
5497198|NCT04509232|Protective Agents|protective agents|mesh-ancestor
5497199|NCT04509232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497200|NCT04509258|Acetylcarnitine|acetylcarnitine|mesh-list
6042129|NCT00542191|Cyclophosphamide|cyclophosphamide|mesh-list
5497201|NCT04509258|Acetylcysteine|acetylcysteine|mesh-list
5497202|NCT04509258|Ondansetron|ondansetron|mesh-list
5497203|NCT04509258|Mineral Oil|mineral oil|mesh-list
5497204|NCT04509258|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5497205|NCT04509258|Antiemetics|antiemetics|mesh-ancestor
6042130|NCT00542191|Carboplatin|carboplatin|mesh-list
6042131|NCT00542191|Doxorubicin|doxorubicin|mesh-list
6042132|NCT00542191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6042133|NCT00542191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6042134|NCT00542191|Tubulin Modulators|tubulin modulators|mesh-ancestor
6042135|NCT00542191|Antimitotic Agents|antimitotic agents|mesh-ancestor
6042136|NCT00542191|Mitosis Modulators|mitosis modulators|mesh-ancestor
6042137|NCT00542191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042138|NCT00542191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6042139|NCT00542191|Immunologic Factors|immunologic factors|mesh-ancestor
6042140|NCT00542191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042141|NCT00542191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6042142|NCT00542191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6042143|NCT00542191|Alkylating Agents|alkylating agents|mesh-ancestor
6042144|NCT00542191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6042145|NCT00542191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6042146|NCT00542191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6042147|NCT00542191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6042148|NCT00542191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6042149|NCT00542269|Amlodipine|amlodipine|mesh-list
6042150|NCT00542269|Ramipril|ramipril|mesh-list
6042151|NCT00542269|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6042152|NCT00542269|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6042153|NCT00542269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6042154|NCT00542269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042155|NCT00542269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6042156|NCT00542269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042157|NCT00542269|Vasodilator Agents|vasodilator agents|mesh-ancestor
6042158|NCT00542269|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6042159|NCT00542269|Protease Inhibitors|protease inhibitors|mesh-ancestor
6042160|NCT00542269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6042161|NCT00542308|Zalutumumab|zalutumumab|mesh-list
6042162|NCT00542308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6042163|NCT00542308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6042164|NCT00542425|Teriparatide|teriparatide|mesh-list
6042165|NCT00542425|Abaloparatide|abaloparatide|mesh-list
6042166|NCT00542425|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
6042167|NCT00542425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6042168|NCT00542425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042169|NCT00542425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6042170|NCT00542620|Insulin|insulin|mesh-list
6042171|NCT00542620|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6042172|NCT00542620|Insulin Aspart|insulin aspart|mesh-list
6042173|NCT00542620|Insulin, Long-Acting|insulin, long-acting|mesh-list
6042174|NCT00542620|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6042175|NCT00542620|Insulin Detemir|insulin detemir|mesh-list
6042176|NCT00542620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6042177|NCT00542620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042178|NCT00542750|Acetylcysteine|acetylcysteine|mesh-list
6042179|NCT00542750|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6042180|NCT00542750|Antiviral Agents|antiviral agents|mesh-ancestor
6042181|NCT00542750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6042182|NCT00542750|Expectorants|expectorants|mesh-ancestor
6042183|NCT00542750|Respiratory System Agents|respiratory system agents|mesh-ancestor
6042184|NCT00542750|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6042185|NCT00542750|Antioxidants|antioxidants|mesh-ancestor
6042186|NCT00542750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042187|NCT00542750|Protective Agents|protective agents|mesh-ancestor
6042188|NCT00542750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042189|NCT00542750|Antidotes|antidotes|mesh-ancestor
6042190|NCT00542789|Esomeprazole|esomeprazole|mesh-list
6042191|NCT00542789|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6042192|NCT00542789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6655161|NCT01461174|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6655162|NCT01461174|Dopamine Agents|dopamine agents|mesh-ancestor
6655163|NCT01461174|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6655164|NCT01461174|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6655165|NCT01461174|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6655166|NCT01461174|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6655167|NCT01461174|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5497206|NCT04509258|Autonomic Agents|autonomic agents|mesh-ancestor
6655168|NCT01461174|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6655169|NCT01461460|Moxifloxacin|moxifloxacin|mesh-list
6655170|NCT01461460|Tedizolid phosphate|tedizolid phosphate|mesh-list
6655171|NCT01461460|Tedizolid|tedizolid|mesh-list
6655172|NCT01461460|Oxazolidinones|oxazolidinones|mesh-list
6655173|NCT01461460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6655174|NCT01461460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6655175|NCT01461460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6457974|NCT00438477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6457975|NCT00438568|Insulin|insulin|mesh-list
6457976|NCT00438568|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6457977|NCT00438568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6457978|NCT00438568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457979|NCT00438581|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6457980|NCT00438581|Immunologic Factors|immunologic factors|mesh-ancestor
6457981|NCT00438581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457982|NCT00438607|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
6457983|NCT00438607|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
6457984|NCT00438607|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6457985|NCT00438607|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6457986|NCT00438607|Purinergic Agents|purinergic agents|mesh-ancestor
6457987|NCT00438607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6457988|NCT00438607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042193|NCT00542789|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6042194|NCT00542789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6042195|NCT00542789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042196|NCT00542815|Sevelamer|sevelamer|mesh-list
6042197|NCT00542815|Chelating Agents|chelating agents|mesh-ancestor
6042198|NCT00542815|Sequestering Agents|sequestering agents|mesh-ancestor
6042199|NCT00542815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042200|NCT00542828|Immunoglobulins|immunoglobulins|mesh-list
6042201|NCT00542828|Thymoglobulin|thymoglobulin|mesh-list
6042202|NCT00542828|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6042203|NCT00542828|Immunologic Factors|immunologic factors|mesh-ancestor
6042204|NCT00542828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497207|NCT04509258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5497208|NCT04509258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497209|NCT04509258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5497210|NCT04509258|Antipruritics|antipruritics|mesh-ancestor
6042205|NCT00542828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6042206|NCT00542880|Fluticasone|fluticasone|mesh-list
6042207|NCT00542880|Budesonide|budesonide|mesh-list
6042208|NCT00542880|Formoterol Fumarate|formoterol fumarate|mesh-list
6042209|NCT00542880|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6042210|NCT00542880|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6042211|NCT00542880|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6042212|NCT00542880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6042213|NCT00542880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6042214|NCT00542880|Autonomic Agents|autonomic agents|mesh-ancestor
6655176|NCT01461460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6655177|NCT01461460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6655178|NCT01461460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655179|NCT01461460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6042215|NCT00542880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6042216|NCT00542880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042217|NCT00542880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6042218|NCT00542880|Respiratory System Agents|respiratory system agents|mesh-ancestor
6042219|NCT00542880|Dermatologic Agents|dermatologic agents|mesh-ancestor
6042220|NCT00542880|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6042221|NCT00542880|Glucocorticoids|glucocorticoids|mesh-ancestor
6042222|NCT00542880|Hormones|hormones|mesh-ancestor
6042223|NCT00542880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6042224|NCT00542880|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6042225|NCT00542880|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6042226|NCT00542880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6042227|NCT00542880|Adrenergic Agents|adrenergic agents|mesh-ancestor
6457989|NCT00438607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457990|NCT00438737|Leucovorin|leucovorin|mesh-list
6457991|NCT00438737|Bevacizumab|bevacizumab|mesh-list
6457992|NCT00438737|Cetuximab|cetuximab|mesh-list
6457993|NCT00438737|Fluorouracil|fluorouracil|mesh-list
6655180|NCT01461460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6655181|NCT01461577|Insulin Glargine|insulin glargine|mesh-list
6655182|NCT01461577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6042228|NCT00542880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6042229|NCT00542880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042230|NCT00542880|Sympathomimetics|sympathomimetics|mesh-ancestor
6042231|NCT00542971|Cytarabine|cytarabine|mesh-list
6042232|NCT00542971|Sorafenib|sorafenib|mesh-list
6042233|NCT00542971|Idarubicin|idarubicin|mesh-list
6042234|NCT00542971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6042235|NCT00542971|Antimetabolites|antimetabolites|mesh-ancestor
6042236|NCT00542971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042237|NCT00542971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6042238|NCT00542971|Antiviral Agents|antiviral agents|mesh-ancestor
6042239|NCT00542971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6042240|NCT00542971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6042241|NCT00542971|Immunologic Factors|immunologic factors|mesh-ancestor
6457994|NCT00438737|Oxaliplatin|oxaliplatin|mesh-list
6457995|NCT00438737|Calcium|calcium|mesh-list
6655183|NCT01461577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042242|NCT00542971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042243|NCT00542971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6042244|NCT00542971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6042245|NCT00542971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6042246|NCT00542971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6042247|NCT00542971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6042248|NCT00542997|Immunoglobulins|immunoglobulins|mesh-list
6042249|NCT00542997|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6042250|NCT00542997|Antibodies|antibodies|mesh-list
6042251|NCT00542997|Immunologic Factors|immunologic factors|mesh-ancestor
6042252|NCT00542997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042253|NCT00543062|Moxifloxacin|moxifloxacin|mesh-list
6042254|NCT00543062|Prochlorperazine|prochlorperazine|mesh-list
6042255|NCT00543062|Loxapine|loxapine|mesh-list
6042256|NCT00543062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6042257|NCT00543062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6042258|NCT00543062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6042259|NCT00543062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6042260|NCT00543062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6042261|NCT00543062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042262|NCT00543062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6042263|NCT00543062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042264|NCT00543062|Antiemetics|antiemetics|mesh-ancestor
6042265|NCT00543062|Autonomic Agents|autonomic agents|mesh-ancestor
6042266|NCT00543062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6042267|NCT00543062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6042268|NCT00543062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6042269|NCT00543062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6042270|NCT00543062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6042271|NCT00543062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6042272|NCT00543062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6042273|NCT00543062|Dopamine Agents|dopamine agents|mesh-ancestor
6042274|NCT00543062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6042275|NCT00543101|Darunavir|darunavir|mesh-list
6042276|NCT00543101|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6042277|NCT00543101|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6042278|NCT00543101|Protease Inhibitors|protease inhibitors|mesh-ancestor
6042279|NCT00543101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6042280|NCT00543101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042281|NCT00543101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6042282|NCT00543101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6042283|NCT00543101|Antiviral Agents|antiviral agents|mesh-ancestor
6042284|NCT00543101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6042285|NCT00543127|Fulvestrant|fulvestrant|mesh-list
6042286|NCT00543127|Anastrozole|anastrozole|mesh-list
6042287|NCT00543127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5497211|NCT04509258|Dermatologic Agents|dermatologic agents|mesh-ancestor
5497212|NCT04509258|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5497213|NCT04509258|Serotonin Agents|serotonin agents|mesh-ancestor
5497214|NCT04509258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5497215|NCT04509258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5497216|NCT04509258|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5497217|NCT04509258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5497218|NCT04509258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6042288|NCT00543127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6042289|NCT00543127|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6042290|NCT00543127|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6042291|NCT00543127|Hormone Antagonists|hormone antagonists|mesh-ancestor
6053785|NCT00597896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6457996|NCT00438737|Levoleucovorin|levoleucovorin|mesh-list
5497219|NCT04509258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5497220|NCT04509258|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5497221|NCT04509258|Antiviral Agents|antiviral agents|mesh-ancestor
5497222|NCT04509258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5497223|NCT04509258|Expectorants|expectorants|mesh-ancestor
5497224|NCT04509258|Respiratory System Agents|respiratory system agents|mesh-ancestor
5497225|NCT04509258|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5497226|NCT04509258|Antioxidants|antioxidants|mesh-ancestor
5497227|NCT04509258|Protective Agents|protective agents|mesh-ancestor
5497228|NCT04509258|Antidotes|antidotes|mesh-ancestor
5497229|NCT04509258|Vitamin B Complex|vitamin b complex|mesh-ancestor
5497230|NCT04509258|Vitamins|vitamins|mesh-ancestor
5497231|NCT04509258|Micronutrients|micronutrients|mesh-ancestor
5497232|NCT04509258|Nootropic Agents|nootropic agents|mesh-ancestor
5497233|NCT04509258|Emollients|emollients|mesh-ancestor
5497234|NCT04509193|Warfarin|warfarin|mesh-list
5497235|NCT04509193|Rivaroxaban|rivaroxaban|mesh-list
5497236|NCT04509193|Anticoagulants|anticoagulants|mesh-ancestor
5497237|NCT04509193|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6042292|NCT00543127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6042293|NCT00543127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042294|NCT00543127|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6042295|NCT00543127|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6042296|NCT00543127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6042297|NCT00543127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053786|NCT00597896|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6053787|NCT00597896|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6053788|NCT00597896|Dopamine Agonists|dopamine agonists|mesh-ancestor
5497238|NCT04509193|Antithrombins|antithrombins|mesh-ancestor
5497239|NCT04509193|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5497240|NCT04509193|Protease Inhibitors|protease inhibitors|mesh-ancestor
5497241|NCT04509193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5497242|NCT04509193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5497243|NCT04508803|Trastuzumab|trastuzumab|mesh-list
5497244|NCT04508803|Niraparib|niraparib|mesh-list
5497245|NCT04508803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5497246|NCT04508803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5497247|NCT04508803|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5497248|NCT04508803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5497249|NCT04508803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5497250|NCT04508829|Cetuximab|cetuximab|mesh-list
5497251|NCT04508829|Antibodies|antibodies|mesh-list
5497252|NCT04508829|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5497253|NCT04508829|Immunologic Factors|immunologic factors|mesh-ancestor
5497254|NCT04508829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497255|NCT04508829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5497256|NCT04508829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5497257|NCT04508816|Cetuximab|cetuximab|mesh-list
5497258|NCT04508816|Nimotuzumab|nimotuzumab|mesh-list
5497259|NCT04508816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5497260|NCT04508816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5497261|NCT04508894|Dexmedetomidine|dexmedetomidine|mesh-list
5497262|NCT04508894|Ketamine|ketamine|mesh-list
5497263|NCT04508894|Bupivacaine|bupivacaine|mesh-list
5497264|NCT04508894|Anesthetics, Local|anesthetics, local|mesh-ancestor
6053789|NCT00597896|Dopamine Agents|dopamine agents|mesh-ancestor
6053790|NCT00597896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6053791|NCT00598078|Sodium Oxybate|sodium oxybate|mesh-list
6053792|NCT00598078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6053793|NCT00598078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6053794|NCT00598078|Anesthetics, General|anesthetics, general|mesh-ancestor
6053795|NCT00598078|Anesthetics|anesthetics|mesh-ancestor
6053796|NCT00598078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6053797|NCT00598078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053798|NCT00598273|Darbepoetin alfa|darbepoetin alfa|mesh-list
6053799|NCT00598273|Hematinics|hematinics|mesh-ancestor
6053800|NCT00598442|Darbepoetin alfa|darbepoetin alfa|mesh-list
6053801|NCT00598442|Hematinics|hematinics|mesh-ancestor
6053802|NCT00598481|Busulfan|busulfan|mesh-list
6053803|NCT00598481|Alkylating Agents|alkylating agents|mesh-ancestor
6053804|NCT00598481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053805|NCT00598481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6053806|NCT00598481|Immunologic Factors|immunologic factors|mesh-ancestor
5497265|NCT04508894|Anesthetics|anesthetics|mesh-ancestor
5497266|NCT04508894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5497267|NCT04508894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497268|NCT04508894|Sensory System Agents|sensory system agents|mesh-ancestor
5497269|NCT04508894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6042298|NCT00543296|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
6042299|NCT00543296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6042300|NCT00543296|Glucocorticoids|glucocorticoids|mesh-ancestor
6042301|NCT00543296|Hormones|hormones|mesh-ancestor
6042302|NCT00543296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6042303|NCT00543296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042304|NCT00543309|Milrinone|milrinone|mesh-list
6042305|NCT00543309|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6042306|NCT00543309|Natriuretic Agents|natriuretic agents|mesh-ancestor
6042307|NCT00543309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042308|NCT00543309|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6042309|NCT00543309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6042310|NCT00543309|Vasodilator Agents|vasodilator agents|mesh-ancestor
6042311|NCT00543309|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6042312|NCT00543309|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6042313|NCT00543309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6042314|NCT00543309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042315|NCT00543309|Protective Agents|protective agents|mesh-ancestor
6042316|NCT00543387|Docetaxel|docetaxel|mesh-list
6042317|NCT00543387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6042318|NCT00543387|Tubulin Modulators|tubulin modulators|mesh-ancestor
6042319|NCT00543387|Antimitotic Agents|antimitotic agents|mesh-ancestor
6042320|NCT00543387|Mitosis Modulators|mitosis modulators|mesh-ancestor
6042321|NCT00543387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042322|NCT00543400|Heparin|heparin|mesh-list
6042323|NCT00543400|Calcium heparin|calcium heparin|mesh-list
6042324|NCT00543400|Anticoagulants|anticoagulants|mesh-ancestor
6042325|NCT00543400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6042326|NCT00543400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6042327|NCT00543400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042328|NCT00543439|Factor VIII|factor viii|mesh-list
6042329|NCT00543439|Coagulants|coagulants|mesh-ancestor
6042330|NCT00543569|Mycophenolic Acid|mycophenolic acid|mesh-list
6042331|NCT00543569|Alefacept|alefacept|mesh-list
6042332|NCT00543569|Tacrolimus|tacrolimus|mesh-list
6042333|NCT00543569|Basiliximab|basiliximab|mesh-list
6042334|NCT00543569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6042335|NCT00543569|Immunologic Factors|immunologic factors|mesh-ancestor
6042336|NCT00543569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042337|NCT00543569|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6042338|NCT00543569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6042339|NCT00543569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042340|NCT00543569|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6042341|NCT00543569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6042342|NCT00543569|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6042343|NCT00543569|Antitubercular Agents|antitubercular agents|mesh-ancestor
6042344|NCT00543569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6042345|NCT00543569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6042346|NCT00543569|Dermatologic Agents|dermatologic agents|mesh-ancestor
6042347|NCT00543725|Efavirenz|efavirenz|mesh-list
6042348|NCT00543725|Rilpivirine|rilpivirine|mesh-list
6042349|NCT00543725|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6042350|NCT00543725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6042351|NCT00543725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6042352|NCT00543725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042353|NCT00543725|Antiviral Agents|antiviral agents|mesh-ancestor
6042354|NCT00543725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6042355|NCT00543725|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6042356|NCT00543725|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6042357|NCT00543725|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6042358|NCT00543725|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6042359|NCT00543725|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6042360|NCT00543725|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6042361|NCT00543725|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6042362|NCT00543725|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6042363|NCT00543855|Donepezil|donepezil|mesh-list
6042364|NCT00543855|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6042365|NCT00543855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6042366|NCT00543855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042367|NCT00543855|Cholinergic Agents|cholinergic agents|mesh-ancestor
6042368|NCT00543855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6042369|NCT00543855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042370|NCT00543855|Nootropic Agents|nootropic agents|mesh-ancestor
6042371|NCT00544076|Sildenafil Citrate|sildenafil citrate|mesh-list
6042372|NCT00544076|Alprostadil|alprostadil|mesh-list
6042373|NCT00544076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042374|NCT00544076|Vasodilator Agents|vasodilator agents|mesh-ancestor
6042375|NCT00544076|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6042376|NCT00544076|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6042377|NCT00544076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6042378|NCT00544076|Urological Agents|urological agents|mesh-ancestor
6042379|NCT00544076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6655184|NCT01461616|Insulin|insulin|mesh-list
6655185|NCT01461616|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6655186|NCT01461616|Insulin Glargine|insulin glargine|mesh-list
6042380|NCT00544167|Paclitaxel|paclitaxel|mesh-list
6042381|NCT00544167|Cyclophosphamide|cyclophosphamide|mesh-list
6042382|NCT00544167|Doxorubicin|doxorubicin|mesh-list
6042383|NCT00544167|Sorafenib|sorafenib|mesh-list
6042384|NCT00544167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6042385|NCT00544167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6042386|NCT00544167|Tubulin Modulators|tubulin modulators|mesh-ancestor
6042387|NCT00544167|Antimitotic Agents|antimitotic agents|mesh-ancestor
6042388|NCT00544167|Mitosis Modulators|mitosis modulators|mesh-ancestor
6042389|NCT00544167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042390|NCT00544167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6042391|NCT00544167|Immunologic Factors|immunologic factors|mesh-ancestor
6042392|NCT00544167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042393|NCT00544167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6042394|NCT00544167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6042395|NCT00544167|Alkylating Agents|alkylating agents|mesh-ancestor
6042396|NCT00544167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5497270|NCT04508894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5497271|NCT04508894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5497272|NCT04508894|Analgesics|analgesics|mesh-ancestor
5497273|NCT04508894|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5497274|NCT04508894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5497275|NCT04508894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5497276|NCT04508894|Adrenergic Agents|adrenergic agents|mesh-ancestor
5497277|NCT04508894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5497278|NCT04508894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5497279|NCT04508894|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5497280|NCT04508894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5497281|NCT04508894|Anesthetics, General|anesthetics, general|mesh-ancestor
6042397|NCT00544167|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6042398|NCT00544167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6042399|NCT00544167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6042400|NCT00544167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6042401|NCT00544167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6042402|NCT00544440|Prednisone|prednisone|mesh-list
6042403|NCT00544440|Abiraterone Acetate|abiraterone acetate|mesh-list
6042404|NCT00544440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6042405|NCT00544440|Glucocorticoids|glucocorticoids|mesh-ancestor
6042406|NCT00544440|Hormones|hormones|mesh-ancestor
6042407|NCT00544440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6042408|NCT00544440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042409|NCT00544440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6042410|NCT00544440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6042411|NCT00544440|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6042412|NCT00544440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6042413|NCT00544440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042414|NCT00544440|Hormone Antagonists|hormone antagonists|mesh-ancestor
6042415|NCT00544440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6042416|NCT00544544|Riluzole|riluzole|mesh-list
6042417|NCT00544544|Anticonvulsants|anticonvulsants|mesh-ancestor
6042418|NCT00544544|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6655187|NCT01461616|Insulin Detemir|insulin detemir|mesh-list
6655188|NCT01461616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6042419|NCT00544544|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6042420|NCT00544544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6042421|NCT00544544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042422|NCT00544544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042423|NCT00544544|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6042424|NCT00544544|Protective Agents|protective agents|mesh-ancestor
6042425|NCT00544557|Etanercept|etanercept|mesh-list
6042426|NCT00544557|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6042427|NCT00544557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6042428|NCT00544557|Analgesics|analgesics|mesh-ancestor
6042429|NCT00544557|Sensory System Agents|sensory system agents|mesh-ancestor
6042430|NCT00544557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5497282|NCT04508894|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5497283|NCT04508894|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5497284|NCT04508686|Capecitabine|capecitabine|mesh-list
5497285|NCT04508686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5497286|NCT04508686|Antimetabolites|antimetabolites|mesh-ancestor
6042431|NCT00544557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042432|NCT00544557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6042433|NCT00544557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6042434|NCT00544557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6042435|NCT00544557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6042436|NCT00544557|Immunologic Factors|immunologic factors|mesh-ancestor
6042437|NCT00544648|Paclitaxel|paclitaxel|mesh-list
6042438|NCT00544648|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6042439|NCT00544648|Carboplatin|carboplatin|mesh-list
6042440|NCT00544648|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6042441|NCT00544648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6042442|NCT00544648|Tubulin Modulators|tubulin modulators|mesh-ancestor
6042443|NCT00544648|Antimitotic Agents|antimitotic agents|mesh-ancestor
6042444|NCT00544648|Mitosis Modulators|mitosis modulators|mesh-ancestor
6042445|NCT00544648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042446|NCT00544713|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6042447|NCT00544713|Lubricant Eye Drops|lubricant eye drops|mesh-list
6042448|NCT00544713|Glycerol|glycerol|mesh-list
6042449|NCT00544713|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6042450|NCT00544713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6042451|NCT00544713|Laxatives|laxatives|mesh-ancestor
6042452|NCT00544713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6042453|NCT00544713|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6042454|NCT00544713|Protective Agents|protective agents|mesh-ancestor
6042455|NCT00544713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042456|NCT00544778|Doxorubicin|doxorubicin|mesh-list
6042457|NCT00544778|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6042458|NCT00544778|Dexrazoxane|dexrazoxane|mesh-list
6042459|NCT00544778|Irinotecan|irinotecan|mesh-list
6042460|NCT00544778|Ifosfamide|ifosfamide|mesh-list
6042461|NCT00544778|Razoxane|razoxane|mesh-list
6042462|NCT00544778|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6042463|NCT00544778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6042464|NCT00544778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6042465|NCT00544778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6042466|NCT00544778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6042467|NCT00544778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042468|NCT00544778|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6042469|NCT00544778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042470|NCT00544778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6042471|NCT00544778|Alkylating Agents|alkylating agents|mesh-ancestor
6042472|NCT00544778|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6042473|NCT00544778|Protective Agents|protective agents|mesh-ancestor
6042474|NCT00544778|Antimitotic Agents|antimitotic agents|mesh-ancestor
5497287|NCT04508686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5497288|NCT04508686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5503323|NCT04460248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6042475|NCT00544778|Mitosis Modulators|mitosis modulators|mesh-ancestor
6042476|NCT00544817|Temozolomide|temozolomide|mesh-list
6042477|NCT00544817|Sorafenib|sorafenib|mesh-list
6042478|NCT00544817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6042479|NCT00544817|Alkylating Agents|alkylating agents|mesh-ancestor
6042480|NCT00544817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042481|NCT00544817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6042482|NCT00544817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6042483|NCT00544817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6042484|NCT00544869|Tolvaptan|tolvaptan|mesh-list
6042485|NCT00544869|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
5497289|NCT04508439|Heparin|heparin|mesh-list
5497290|NCT04508439|Enoxaparin|enoxaparin|mesh-list
5497291|NCT04508439|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5497292|NCT04508439|Tinzaparin|tinzaparin|mesh-list
5497293|NCT04508439|Dalteparin|dalteparin|mesh-list
5497294|NCT04508439|Anticoagulants|anticoagulants|mesh-ancestor
5497295|NCT04508439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5497296|NCT04508439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5497297|NCT04508439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5497298|NCT04508400|Dexamethasone|dexamethasone|mesh-list
5497299|NCT04508400|Dexamethasone acetate|dexamethasone acetate|mesh-list
5497300|NCT04508400|Ondansetron|ondansetron|mesh-list
5497301|NCT04508400|Fosaprepitant|fosaprepitant|mesh-list
5497302|NCT04508400|Aprepitant|aprepitant|mesh-list
5497303|NCT04508400|BB 1101|bb 1101|mesh-list
5497304|NCT04508400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5497305|NCT04508400|Antiemetics|antiemetics|mesh-ancestor
5497306|NCT04508400|Autonomic Agents|autonomic agents|mesh-ancestor
5497307|NCT04508400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5497308|NCT04508400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497309|NCT04508400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5497310|NCT04508400|Glucocorticoids|glucocorticoids|mesh-ancestor
5497311|NCT04508400|Hormones|hormones|mesh-ancestor
5497312|NCT04508400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5497313|NCT04508400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5497314|NCT04508400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5497315|NCT04508400|Protease Inhibitors|protease inhibitors|mesh-ancestor
5497316|NCT04508400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5497317|NCT04508400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042486|NCT00544869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042487|NCT00544869|Natriuretic Agents|natriuretic agents|mesh-ancestor
6042488|NCT00544869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042489|NCT00544882|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6042490|NCT00544882|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6042491|NCT00544882|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6042492|NCT00544882|Desogestrel|desogestrel|mesh-list
6042493|NCT00544882|Oviol|oviol|mesh-list
6042494|NCT00544882|Estradiol|estradiol|mesh-list
6042495|NCT00544882|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6042496|NCT00544882|Estrogens|estrogens|mesh-ancestor
6042497|NCT00544882|Hormones|hormones|mesh-ancestor
6042498|NCT00544882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6042499|NCT00544882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042500|NCT00544882|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6042501|NCT00544882|Contraceptive Agents|contraceptive agents|mesh-ancestor
6042502|NCT00544882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6042503|NCT00544882|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6042504|NCT00544882|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6042505|NCT00544882|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6042506|NCT00544882|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6042507|NCT00544882|Progestins|progestins|mesh-ancestor
6042508|NCT00544882|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6042509|NCT00544908|Dasatinib|dasatinib|mesh-list
6042510|NCT00544908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6042511|NCT00544908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6042512|NCT00544908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6042513|NCT00544908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042514|NCT00545051|Ibandronic Acid|ibandronic acid|mesh-list
6042515|NCT00545051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6042516|NCT00545051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042517|NCT00545064|Timolol|timolol|mesh-list
6042518|NCT00545064|Dorzolamide|dorzolamide|mesh-list
6042519|NCT00545064|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6042520|NCT00545064|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6042521|NCT00545064|Adrenergic Agents|adrenergic agents|mesh-ancestor
6042522|NCT00545064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5497318|NCT04508400|Antipruritics|antipruritics|mesh-ancestor
5497319|NCT04508400|Dermatologic Agents|dermatologic agents|mesh-ancestor
5497320|NCT04508400|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6042523|NCT00545064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042524|NCT00545064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042525|NCT00545064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6042526|NCT00545064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6042527|NCT00545064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6042528|NCT00545064|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6042529|NCT00545077|Bevacizumab|bevacizumab|mesh-list
6042530|NCT00545077|Letrozole|letrozole|mesh-list
5497321|NCT04508400|Serotonin Agents|serotonin agents|mesh-ancestor
5497322|NCT04508400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5497323|NCT04508400|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5497324|NCT04508400|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5497325|NCT04508400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5497326|NCT04508400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5497327|NCT04508400|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5497328|NCT04508400|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5497329|NCT04508452|Bevacizumab|bevacizumab|mesh-list
5497330|NCT04508452|Capecitabine|capecitabine|mesh-list
6042531|NCT00545077|Fulvestrant|fulvestrant|mesh-list
6042532|NCT00545077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6042533|NCT00545077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6042534|NCT00545077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6042535|NCT00545077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6042536|NCT00545077|Growth Substances|growth substances|mesh-ancestor
6042537|NCT00545077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042538|NCT00545077|Growth Inhibitors|growth inhibitors|mesh-ancestor
6042539|NCT00545077|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6042540|NCT00545077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6042541|NCT00545077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6042542|NCT00545077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042543|NCT00545077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6042544|NCT00545077|Hormone Antagonists|hormone antagonists|mesh-ancestor
6042545|NCT00545077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6042546|NCT00545077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6042547|NCT00545077|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6042548|NCT00545103|Mesalamine|mesalamine|mesh-list
6042549|NCT00545103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6042550|NCT00545103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6042551|NCT00545103|Analgesics|analgesics|mesh-ancestor
6042552|NCT00545103|Sensory System Agents|sensory system agents|mesh-ancestor
6042553|NCT00545103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6042554|NCT00545103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042555|NCT00545103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6042556|NCT00545103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6042557|NCT00545168|Permethrin|permethrin|mesh-list
6042558|NCT00545168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6042559|NCT00545168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042560|NCT00545181|Metronidazole|metronidazole|mesh-list
6042561|NCT00545181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6042562|NCT00545181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6042563|NCT00545181|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6042564|NCT00545181|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6042565|NCT00545233|Pioglitazone|pioglitazone|mesh-list
6042566|NCT00545233|Ribavirin|ribavirin|mesh-list
6042567|NCT00545233|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6042568|NCT00545233|Antimetabolites|antimetabolites|mesh-ancestor
6042569|NCT00545233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042570|NCT00545233|Antiviral Agents|antiviral agents|mesh-ancestor
6042571|NCT00545233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6042572|NCT00545233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6042573|NCT00545233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042574|NCT00545272|Formoterol Fumarate|formoterol fumarate|mesh-list
6042575|NCT00545272|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6042576|NCT00545272|Autonomic Agents|autonomic agents|mesh-ancestor
6042577|NCT00545272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6042578|NCT00545272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042579|NCT00545272|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6042580|NCT00545272|Respiratory System Agents|respiratory system agents|mesh-ancestor
6042581|NCT00545272|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6042582|NCT00545272|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6042583|NCT00545272|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6042584|NCT00545272|Adrenergic Agents|adrenergic agents|mesh-ancestor
6042585|NCT00545272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6042586|NCT00545272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5497331|NCT04508452|Oxaliplatin|oxaliplatin|mesh-list
5497332|NCT04508452|Irinotecan|irinotecan|mesh-list
5497333|NCT04508452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5497334|NCT04508452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5497335|NCT04508452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5497336|NCT04508452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5497337|NCT04508452|Growth Substances|growth substances|mesh-ancestor
5497338|NCT04508452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497339|NCT04508452|Growth Inhibitors|growth inhibitors|mesh-ancestor
6042587|NCT00545298|Nitric Oxide|nitric oxide|mesh-list
6042588|NCT00545298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6042589|NCT00545298|Autonomic Agents|autonomic agents|mesh-ancestor
6042590|NCT00545298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5497340|NCT04508452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6042591|NCT00545298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042592|NCT00545298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6042593|NCT00545298|Respiratory System Agents|respiratory system agents|mesh-ancestor
6042594|NCT00545298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6042595|NCT00545298|Antioxidants|antioxidants|mesh-ancestor
6042596|NCT00545298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042597|NCT00545298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6042598|NCT00545298|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6042599|NCT00545298|Vasodilator Agents|vasodilator agents|mesh-ancestor
6042600|NCT00545298|Gasotransmitters|gasotransmitters|mesh-ancestor
6042601|NCT00545298|Protective Agents|protective agents|mesh-ancestor
6042602|NCT00545363|Ibandronic Acid|ibandronic acid|mesh-list
6042603|NCT00545363|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6042604|NCT00545363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042605|NCT00545402|Mycophenolic Acid|mycophenolic acid|mesh-list
6042606|NCT00545402|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6042607|NCT00545402|Tacrolimus|tacrolimus|mesh-list
6042608|NCT00545402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6042609|NCT00545402|Immunologic Factors|immunologic factors|mesh-ancestor
6042610|NCT00545402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042611|NCT00545402|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6042612|NCT00545402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6042613|NCT00545402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042614|NCT00545402|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6042615|NCT00545402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6042616|NCT00545402|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6042617|NCT00545402|Antitubercular Agents|antitubercular agents|mesh-ancestor
6042618|NCT00545402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6042619|NCT00545402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6042620|NCT00545402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6042621|NCT00545402|Glucocorticoids|glucocorticoids|mesh-ancestor
6042622|NCT00545402|Hormones|hormones|mesh-ancestor
6042623|NCT00545402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6042624|NCT00545402|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6042625|NCT00545402|Protective Agents|protective agents|mesh-ancestor
6042626|NCT00545402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6042627|NCT00545532|Oseltamivir|oseltamivir|mesh-list
6042628|NCT00545532|Antiviral Agents|antiviral agents|mesh-ancestor
6042629|NCT00545532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5497341|NCT04508452|Antimetabolites|antimetabolites|mesh-ancestor
5497342|NCT04508452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5497343|NCT04508452|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5497344|NCT04508452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5497345|NCT04508452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5497346|NCT04508504|Ropivacaine|ropivacaine|mesh-list
5497347|NCT04508504|Anesthetics, Local|anesthetics, local|mesh-ancestor
5497348|NCT04508504|Anesthetics|anesthetics|mesh-ancestor
5497349|NCT04508504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5497350|NCT04508504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497351|NCT04508504|Sensory System Agents|sensory system agents|mesh-ancestor
5497352|NCT04508504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5497353|NCT04508166|Sodium Oxybate|sodium oxybate|mesh-list
5497354|NCT04508166|Dexmedetomidine|dexmedetomidine|mesh-list
5497355|NCT04508166|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5497356|NCT04508166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5497357|NCT04508166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042630|NCT00545532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6042631|NCT00545532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042632|NCT00545571|Epoetin Alfa|epoetin alfa|mesh-list
6042633|NCT00545571|Hematinics|hematinics|mesh-ancestor
6042634|NCT00545584|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6042635|NCT00545584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6042636|NCT00545584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042637|NCT00545584|Incretins|incretins|mesh-ancestor
6457997|NCT00438737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6457998|NCT00438737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6457999|NCT00438737|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6042638|NCT00545584|Hormones|hormones|mesh-ancestor
6042639|NCT00545584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6042640|NCT00545584|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6042641|NCT00545584|Protease Inhibitors|protease inhibitors|mesh-ancestor
6042642|NCT00545584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6042643|NCT00545584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042644|NCT00545662|Choline|choline|mesh-list
6042645|NCT00545662|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
6042646|NCT00545662|Lipotropic Agents|lipotropic agents|mesh-ancestor
6042647|NCT00545662|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5497358|NCT04508166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5497359|NCT04508166|Analgesics|analgesics|mesh-ancestor
5497360|NCT04508166|Sensory System Agents|sensory system agents|mesh-ancestor
5497361|NCT04508166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5497362|NCT04508166|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5497363|NCT04508166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5497364|NCT04508166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6042648|NCT00545662|Antimetabolites|antimetabolites|mesh-ancestor
6042649|NCT00545662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042650|NCT00545662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6042651|NCT00545662|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6042652|NCT00545662|Nootropic Agents|nootropic agents|mesh-ancestor
6042653|NCT00545688|Docetaxel|docetaxel|mesh-list
6042654|NCT00545688|Trastuzumab|trastuzumab|mesh-list
6042655|NCT00545688|Pertuzumab|pertuzumab|mesh-list
6042656|NCT00545688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6042657|NCT00545688|Tubulin Modulators|tubulin modulators|mesh-ancestor
6042658|NCT00545688|Antimitotic Agents|antimitotic agents|mesh-ancestor
6042659|NCT00545688|Mitosis Modulators|mitosis modulators|mesh-ancestor
6042660|NCT00545688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042661|NCT00545688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6042662|NCT00545714|Cyclophosphamide|cyclophosphamide|mesh-list
6042663|NCT00545714|Rituximab|rituximab|mesh-list
6042664|NCT00545714|Fludarabine|fludarabine|mesh-list
6042665|NCT00545714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6042666|NCT00545714|Immunologic Factors|immunologic factors|mesh-ancestor
6042667|NCT00545714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042668|NCT00545714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6042669|NCT00545714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6042670|NCT00545714|Alkylating Agents|alkylating agents|mesh-ancestor
5497365|NCT04508166|Adrenergic Agents|adrenergic agents|mesh-ancestor
6042671|NCT00545714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042672|NCT00545714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6042673|NCT00545714|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5497366|NCT04508166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5497367|NCT04508166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5497368|NCT04508166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5497369|NCT04508166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5497370|NCT04508166|Anesthetics, General|anesthetics, general|mesh-ancestor
5497371|NCT04508166|Anesthetics|anesthetics|mesh-ancestor
5497372|NCT04508140|Pembrolizumab|pembrolizumab|mesh-list
5497373|NCT04508140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5497374|NCT04508140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5497375|NCT04508244|Propranolol|propranolol|mesh-list
5497376|NCT04508244|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5497377|NCT04508244|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5497378|NCT04508244|Adrenergic Agents|adrenergic agents|mesh-ancestor
5497379|NCT04508244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5497380|NCT04508244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5497381|NCT04508244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497382|NCT04508244|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5497383|NCT04508244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5497384|NCT04508244|Vasodilator Agents|vasodilator agents|mesh-ancestor
5497385|NCT04508036|Fibrin fragment D|fibrin fragment d|mesh-list
5497386|NCT04508036|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5497387|NCT04508036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5497388|NCT04508036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042674|NCT00545714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6042675|NCT00545740|Mesalamine|mesalamine|mesh-list
6042676|NCT00545740|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6042677|NCT00545740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6042678|NCT00545740|Analgesics|analgesics|mesh-ancestor
6042679|NCT00545740|Sensory System Agents|sensory system agents|mesh-ancestor
6042680|NCT00545740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6042681|NCT00545740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042682|NCT00545740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6042683|NCT00545740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6042684|NCT00545753|Permethrin|permethrin|mesh-list
6042685|NCT00545753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6042686|NCT00545753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042687|NCT00545779|Ibandronic Acid|ibandronic acid|mesh-list
6042688|NCT00545779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6042689|NCT00545779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042690|NCT00545792|Bevacizumab|bevacizumab|mesh-list
6042691|NCT00545792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6042692|NCT00545792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6042693|NCT00545792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6042694|NCT00545792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6042695|NCT00545792|Growth Substances|growth substances|mesh-ancestor
6042696|NCT00545792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042697|NCT00545792|Growth Inhibitors|growth inhibitors|mesh-ancestor
6042698|NCT00545948|Cisplatin|cisplatin|mesh-list
6042699|NCT00545948|Pemetrexed|pemetrexed|mesh-list
6042700|NCT00545948|Vinorelbine|vinorelbine|mesh-list
6042701|NCT00545948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6042702|NCT00545948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6042703|NCT00545948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042704|NCT00545948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6042705|NCT00545948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6042706|NCT00545948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6042707|NCT00545948|Tubulin Modulators|tubulin modulators|mesh-ancestor
6042708|NCT00545948|Antimitotic Agents|antimitotic agents|mesh-ancestor
6042709|NCT00545948|Mitosis Modulators|mitosis modulators|mesh-ancestor
6042710|NCT00545974|Memantine|memantine|mesh-list
6042711|NCT00545974|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6042712|NCT00545974|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6042713|NCT00545974|Dopamine Agents|dopamine agents|mesh-ancestor
6042714|NCT00545974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6042715|NCT00545974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042716|NCT00545974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042717|NCT00545974|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6042718|NCT00545974|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6042719|NCT00546000|Fluticasone|fluticasone|mesh-list
6042720|NCT00546000|Xhance|xhance|mesh-list
6042721|NCT00546000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5497389|NCT04508036|Hemostatics|hemostatics|mesh-ancestor
5497390|NCT04508036|Coagulants|coagulants|mesh-ancestor
6042722|NCT00546000|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6042723|NCT00546000|Autonomic Agents|autonomic agents|mesh-ancestor
6042724|NCT00546000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6042725|NCT00546000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042726|NCT00546000|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6042727|NCT00546000|Respiratory System Agents|respiratory system agents|mesh-ancestor
6042728|NCT00546000|Dermatologic Agents|dermatologic agents|mesh-ancestor
6042729|NCT00546000|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6042730|NCT00546078|Vaccines|vaccines|mesh-list
6042731|NCT00546078|Immunologic Factors|immunologic factors|mesh-ancestor
6655189|NCT01461616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655190|NCT01461746|Docetaxel|docetaxel|mesh-list
6655191|NCT01461746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6655192|NCT01461746|Tubulin Modulators|tubulin modulators|mesh-ancestor
6655193|NCT01461746|Antimitotic Agents|antimitotic agents|mesh-ancestor
6655194|NCT01461746|Mitosis Modulators|mitosis modulators|mesh-ancestor
6655195|NCT01461746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655196|NCT01461759|Cisplatin|cisplatin|mesh-list
6655197|NCT01461759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6655198|NCT01461772|Carboplatin|carboplatin|mesh-list
6655199|NCT01461772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6655200|NCT01461876|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6042732|NCT00546078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042733|NCT00546104|Dasatinib|dasatinib|mesh-list
6042734|NCT00546104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6042735|NCT00546104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6042736|NCT00546104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6042737|NCT00546104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042738|NCT00546117|Lansoprazole|lansoprazole|mesh-list
6042739|NCT00546117|Dexlansoprazole|dexlansoprazole|mesh-list
6042740|NCT00546117|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6042741|NCT00546117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6042742|NCT00546117|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6042743|NCT00546117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6042744|NCT00546117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042745|NCT00546156|Paclitaxel|paclitaxel|mesh-list
6042746|NCT00546156|Cyclophosphamide|cyclophosphamide|mesh-list
6042747|NCT00546156|Bevacizumab|bevacizumab|mesh-list
6042748|NCT00546156|Doxorubicin|doxorubicin|mesh-list
6042749|NCT00546156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6042750|NCT00546156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6042751|NCT00546156|Tubulin Modulators|tubulin modulators|mesh-ancestor
6042752|NCT00546156|Antimitotic Agents|antimitotic agents|mesh-ancestor
6042753|NCT00546156|Mitosis Modulators|mitosis modulators|mesh-ancestor
6042754|NCT00546156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458000|NCT00438737|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6458001|NCT00438737|Growth Substances|growth substances|mesh-ancestor
6458002|NCT00438737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458003|NCT00438737|Growth Inhibitors|growth inhibitors|mesh-ancestor
6458004|NCT00438737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6458005|NCT00438737|Antimetabolites|antimetabolites|mesh-ancestor
6458006|NCT00438737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458007|NCT00438737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6458008|NCT00438737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6458009|NCT00438737|Immunologic Factors|immunologic factors|mesh-ancestor
6458010|NCT00438737|Antidotes|antidotes|mesh-ancestor
6458011|NCT00438737|Protective Agents|protective agents|mesh-ancestor
6458012|NCT00438737|Vitamin B Complex|vitamin b complex|mesh-ancestor
6458013|NCT00438737|Vitamins|vitamins|mesh-ancestor
6042755|NCT00546156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6042756|NCT00546156|Immunologic Factors|immunologic factors|mesh-ancestor
6042757|NCT00546156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042758|NCT00546156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6042759|NCT00546156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6042760|NCT00546156|Alkylating Agents|alkylating agents|mesh-ancestor
6042761|NCT00546156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6042762|NCT00546156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6042763|NCT00546156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6042764|NCT00546156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6042765|NCT00546156|Growth Substances|growth substances|mesh-ancestor
6042766|NCT00546156|Growth Inhibitors|growth inhibitors|mesh-ancestor
6042767|NCT00546156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6458014|NCT00438737|Micronutrients|micronutrients|mesh-ancestor
6655201|NCT01461876|Antiviral Agents|antiviral agents|mesh-ancestor
6655202|NCT01461876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6042768|NCT00546156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6042769|NCT00546156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6042770|NCT00546156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6042771|NCT00546351|Lacosamide|lacosamide|mesh-list
6042772|NCT00546351|Anticonvulsants|anticonvulsants|mesh-ancestor
6042773|NCT00546351|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6042774|NCT00546351|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6042775|NCT00546351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6042776|NCT00546351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042777|NCT00546364|Docetaxel|docetaxel|mesh-list
6042778|NCT00546364|Capecitabine|capecitabine|mesh-list
6042779|NCT00546364|Epothilones|epothilones|mesh-list
6042780|NCT00546364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6042781|NCT00546364|Tubulin Modulators|tubulin modulators|mesh-ancestor
6042782|NCT00546364|Antimitotic Agents|antimitotic agents|mesh-ancestor
6042783|NCT00546364|Mitosis Modulators|mitosis modulators|mesh-ancestor
6042784|NCT00546364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042785|NCT00546364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6042786|NCT00546364|Antimetabolites|antimetabolites|mesh-ancestor
6042787|NCT00546377|Cyclophosphamide|cyclophosphamide|mesh-list
6042788|NCT00546377|Rituximab|rituximab|mesh-list
6042789|NCT00546377|Mitoxantrone|mitoxantrone|mesh-list
6042790|NCT00546377|Pentostatin|pentostatin|mesh-list
6042791|NCT00546377|Sargramostim|sargramostim|mesh-list
6042792|NCT00546377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6042793|NCT00546377|Immunologic Factors|immunologic factors|mesh-ancestor
6042794|NCT00546377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042795|NCT00546377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6042796|NCT00546377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6042797|NCT00546377|Alkylating Agents|alkylating agents|mesh-ancestor
6042798|NCT00546377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042799|NCT00546377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6042800|NCT00546377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6042801|NCT00546377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6042802|NCT00546377|Analgesics|analgesics|mesh-ancestor
6042803|NCT00546377|Sensory System Agents|sensory system agents|mesh-ancestor
6042804|NCT00546377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6042805|NCT00546377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5497391|NCT04507906|Nivolumab|nivolumab|mesh-list
5497392|NCT04507906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5497393|NCT04507906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5497394|NCT04507906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5497395|NCT04507906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5497396|NCT04508231|Hormones|hormones|mesh-list
5497397|NCT04508231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5497398|NCT04508231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497399|NCT04507919|Dabrafenib|dabrafenib|mesh-list
5497400|NCT04507919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5497401|NCT04507919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5497402|NCT04507919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5497403|NCT04507919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5497404|NCT04507607|Tenofovir|tenofovir|mesh-list
6042806|NCT00546377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6042807|NCT00546377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6042808|NCT00546377|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
6042809|NCT00546481|Epoetin Alfa|epoetin alfa|mesh-list
6042810|NCT00546481|Hematinics|hematinics|mesh-ancestor
6042811|NCT00546572|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6042812|NCT00546572|Immunologic Factors|immunologic factors|mesh-ancestor
6042813|NCT00546572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042814|NCT00546637|Fesoterodine|fesoterodine|mesh-list
6042815|NCT00546637|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6042816|NCT00546637|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6042817|NCT00546637|Cholinergic Agents|cholinergic agents|mesh-ancestor
6042818|NCT00546637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6042819|NCT00546637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042820|NCT00546637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042821|NCT00546637|Urological Agents|urological agents|mesh-ancestor
5497405|NCT04507607|Antiviral Agents|antiviral agents|mesh-ancestor
5497406|NCT04507607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5497407|NCT04507607|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5497408|NCT04507607|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5497409|NCT04507607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6042822|NCT00546728|Metformin|metformin|mesh-list
6042823|NCT00546728|Exenatide|exenatide|mesh-list
6042824|NCT00546728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6042825|NCT00546728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042826|NCT00546728|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6042827|NCT00546728|Incretins|incretins|mesh-ancestor
6042828|NCT00546728|Hormones|hormones|mesh-ancestor
6042829|NCT00546728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6042830|NCT00546871|Immunoglobulins|immunoglobulins|mesh-list
6042831|NCT00546871|Antibodies|antibodies|mesh-list
6042832|NCT00546871|gamma-Globulins|gamma-globulins|mesh-list
6042833|NCT00546871|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6042834|NCT00546871|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6042835|NCT00546871|Immunologic Factors|immunologic factors|mesh-ancestor
6042836|NCT00546871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042837|NCT00546897|Lenalidomide|lenalidomide|mesh-list
6042838|NCT00546897|Immunologic Factors|immunologic factors|mesh-ancestor
6042839|NCT00546897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042840|NCT00546897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6042841|NCT00546897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6042842|NCT00546897|Growth Substances|growth substances|mesh-ancestor
6042843|NCT00546897|Growth Inhibitors|growth inhibitors|mesh-ancestor
6042844|NCT00546897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6042845|NCT00546910|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6042846|NCT00546910|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6042847|NCT00546910|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6042848|NCT00546910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6042849|NCT00546910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042850|NCT00546910|Adrenergic Agents|adrenergic agents|mesh-ancestor
6042851|NCT00546910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6042852|NCT00546910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042853|NCT00547105|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6042854|NCT00547105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6042855|NCT00547105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6042856|NCT00547105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6042857|NCT00547105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042858|NCT00547118|Rimonabant|rimonabant|mesh-list
6042859|NCT00547118|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6042860|NCT00547118|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
6042861|NCT00547118|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6042862|NCT00547118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6042863|NCT00547118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042864|NCT00547118|Hormones|hormones|mesh-ancestor
6042865|NCT00547118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6042866|NCT00547118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042867|NCT00547157|Cisplatin|cisplatin|mesh-list
6042868|NCT00547157|Panitumumab|panitumumab|mesh-list
6042869|NCT00547157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6042870|NCT00547157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6042871|NCT00547248|Vaccines|vaccines|mesh-list
6042872|NCT00547248|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6042873|NCT00547248|Immunologic Factors|immunologic factors|mesh-ancestor
6042874|NCT00547248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042875|NCT00547365|Immunoglobulins|immunoglobulins|mesh-list
6042876|NCT00547365|Antibodies|antibodies|mesh-list
5497410|NCT04507607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5497411|NCT04507607|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5497412|NCT04507607|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5497413|NCT04507477|Rituximab|rituximab|mesh-list
5497414|NCT04507477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6042877|NCT00547365|gamma-Globulins|gamma-globulins|mesh-list
6042878|NCT00547365|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6042879|NCT00547365|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6042880|NCT00547365|Immunologic Factors|immunologic factors|mesh-ancestor
6042881|NCT00547365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042882|NCT00547521|Methotrexate|methotrexate|mesh-list
6042883|NCT00547521|Abatacept|abatacept|mesh-list
6042884|NCT00547521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6042885|NCT00547521|Abortifacient Agents|abortifacient agents|mesh-ancestor
6042886|NCT00547521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6042887|NCT00547521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042888|NCT00547521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6042889|NCT00547521|Antimetabolites|antimetabolites|mesh-ancestor
6042890|NCT00547521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042891|NCT00547521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6042892|NCT00547521|Dermatologic Agents|dermatologic agents|mesh-ancestor
6042893|NCT00547521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6042894|NCT00547521|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5497415|NCT04507477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5497416|NCT04507477|Immunologic Factors|immunologic factors|mesh-ancestor
5497417|NCT04507477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497418|NCT04507477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5497419|NCT04507750|Apatinib|apatinib|mesh-list
5497420|NCT04507750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5497421|NCT04507750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5497422|NCT04507750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5497423|NCT04507750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5497424|NCT04507412|Dexamethasone|dexamethasone|mesh-list
5497425|NCT04507412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5497426|NCT04507412|Antiemetics|antiemetics|mesh-ancestor
5497427|NCT04507412|Autonomic Agents|autonomic agents|mesh-ancestor
5497428|NCT04507412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5497429|NCT04507412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497430|NCT04507412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6042895|NCT00547521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6042896|NCT00547521|Immunologic Factors|immunologic factors|mesh-ancestor
6042897|NCT00547521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6042898|NCT00547521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6042899|NCT00547521|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6042900|NCT00547534|Rituximab|rituximab|mesh-list
6042901|NCT00547534|Bortezomib|bortezomib|mesh-list
6042902|NCT00547534|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6042903|NCT00547534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6042904|NCT00547534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6042905|NCT00547534|Immunologic Factors|immunologic factors|mesh-ancestor
6042906|NCT00547534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458015|NCT00438776|Olanzapine|olanzapine|mesh-list
6458016|NCT00438776|Antiemetics|antiemetics|mesh-ancestor
6458017|NCT00438776|Autonomic Agents|autonomic agents|mesh-ancestor
6458018|NCT00438776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6458019|NCT00438776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458020|NCT00438776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6042907|NCT00547534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6042908|NCT00547534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6042909|NCT00547534|Alkylating Agents|alkylating agents|mesh-ancestor
6042910|NCT00547534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042911|NCT00547586|Bromides|bromides|mesh-list
6042912|NCT00547586|Methylnaltrexone|methylnaltrexone|mesh-list
6042913|NCT00547586|Anticonvulsants|anticonvulsants|mesh-ancestor
6042914|NCT00547586|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6042915|NCT00547586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042916|NCT00547586|Sensory System Agents|sensory system agents|mesh-ancestor
6042917|NCT00547586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6042918|NCT00547703|Nortriptyline|nortriptyline|mesh-list
6042919|NCT00547703|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6042920|NCT00547703|Antidepressive Agents|antidepressive agents|mesh-ancestor
6042921|NCT00547703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6042922|NCT00547703|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6042923|NCT00547703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6042924|NCT00547703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6042925|NCT00547703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458021|NCT00438776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5497431|NCT04507412|Glucocorticoids|glucocorticoids|mesh-ancestor
5497432|NCT04507412|Hormones|hormones|mesh-ancestor
5497433|NCT04507412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5497434|NCT04507412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5497435|NCT04507412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5497436|NCT04507217|Carboplatin|carboplatin|mesh-list
6042926|NCT00547703|Adrenergic Agents|adrenergic agents|mesh-ancestor
6042927|NCT00547703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6042928|NCT00547703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042929|NCT00547911|Carbidopa|carbidopa|mesh-list
6042930|NCT00547911|Entacapone|entacapone|mesh-list
6042931|NCT00547911|Droxidopa|droxidopa|mesh-list
6042932|NCT00547911|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6042933|NCT00547911|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6458022|NCT00438776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6458023|NCT00438776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6458024|NCT00438776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6458025|NCT00438776|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6042934|NCT00547911|Dopamine Agents|dopamine agents|mesh-ancestor
6042935|NCT00547911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6042936|NCT00547911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042937|NCT00547911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042938|NCT00547911|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6042939|NCT00547911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5497437|NCT04507217|Pemetrexed|pemetrexed|mesh-list
5497438|NCT04507217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5497439|NCT04507217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5497440|NCT04507217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5497441|NCT04507217|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5497442|NCT04507217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5497443|NCT04507165|Analgesics, Opioid|analgesics, opioid|mesh-list
5497444|NCT04507165|Anesthetics|anesthetics|mesh-list
5497445|NCT04507165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5497446|NCT04507165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497447|NCT04507165|Narcotics|narcotics|mesh-ancestor
5497448|NCT04507165|Analgesics|analgesics|mesh-ancestor
5497449|NCT04507165|Sensory System Agents|sensory system agents|mesh-ancestor
5497450|NCT04507165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5497451|NCT04507178|Nadroparin|nadroparin|mesh-list
5497452|NCT04507178|Anticoagulants|anticoagulants|mesh-ancestor
5497453|NCT04507178|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5497454|NCT04507178|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5497455|NCT04507178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5497456|NCT04506827|Hyaluronic Acid|hyaluronic acid|mesh-list
5497457|NCT04506827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5497458|NCT04506827|Immunologic Factors|immunologic factors|mesh-ancestor
5497459|NCT04506827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497460|NCT04506827|Viscosupplements|viscosupplements|mesh-ancestor
5497461|NCT04506827|Protective Agents|protective agents|mesh-ancestor
5497462|NCT04507022|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5497463|NCT04507022|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5497464|NCT04507022|Estradiol|estradiol|mesh-list
5497465|NCT04507022|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5497466|NCT04507022|Progesterone|progesterone|mesh-list
5497467|NCT04507022|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5497468|NCT04507022|Estrogens|estrogens|mesh-ancestor
5497469|NCT04507022|Hormones|hormones|mesh-ancestor
5497470|NCT04507022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5497471|NCT04507022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497472|NCT04507022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5497473|NCT04507022|Contraceptive Agents|contraceptive agents|mesh-ancestor
5497474|NCT04507022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6042940|NCT00547911|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6042941|NCT00548132|Chlorhexidine|chlorhexidine|mesh-list
6042942|NCT00548132|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6042943|NCT00548132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6042944|NCT00548132|Disinfectants|disinfectants|mesh-ancestor
6042945|NCT00548145|Ezetimibe|ezetimibe|mesh-list
6042946|NCT00548145|Pitavastatin|pitavastatin|mesh-list
6042947|NCT00548145|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6042948|NCT00548145|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6042949|NCT00548145|Antimetabolites|antimetabolites|mesh-ancestor
6042950|NCT00548145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042951|NCT00548145|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6042952|NCT00548145|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6042953|NCT00548145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6042954|NCT00548184|Trastuzumab|trastuzumab|mesh-list
6042955|NCT00548184|Lapatinib|lapatinib|mesh-list
6042956|NCT00548184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6042957|NCT00548184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6042958|NCT00548184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6042959|NCT00548184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6042960|NCT00548184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042961|NCT00548197|Bevacizumab|bevacizumab|mesh-list
6042962|NCT00548197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6042963|NCT00548197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6042964|NCT00548197|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6042965|NCT00548197|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6042966|NCT00548197|Growth Substances|growth substances|mesh-ancestor
6042967|NCT00548197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497475|NCT04507022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5497476|NCT04507022|Progestins|progestins|mesh-ancestor
5497477|NCT04507022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5497478|NCT04507022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5497479|NCT04507022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5497480|NCT04507022|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5497481|NCT04507022|Hormone Antagonists|hormone antagonists|mesh-ancestor
5497482|NCT04506554|Nivolumab|nivolumab|mesh-list
5497483|NCT04506554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5497484|NCT04506554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5497485|NCT04506554|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5497486|NCT04506554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503324|NCT04460248|Growth Substances|growth substances|mesh-ancestor
5503325|NCT04460248|Growth Inhibitors|growth inhibitors|mesh-ancestor
5503326|NCT04460248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5503327|NCT04460248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5503328|NCT04460248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503329|NCT04460443|Sofosbuvir|sofosbuvir|mesh-list
5503330|NCT04460443|Antiviral Agents|antiviral agents|mesh-ancestor
5503331|NCT04460443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5503332|NCT04460521|Acetylcysteine|acetylcysteine|mesh-list
5503333|NCT04460521|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5503334|NCT04460521|Antiviral Agents|antiviral agents|mesh-ancestor
6042968|NCT00548197|Growth Inhibitors|growth inhibitors|mesh-ancestor
6042969|NCT00548249|Iron|iron|mesh-list
6042970|NCT00548249|Trace Elements|trace elements|mesh-ancestor
6042971|NCT00548249|Micronutrients|micronutrients|mesh-ancestor
6042972|NCT00548249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042973|NCT00548262|Voriconazole|voriconazole|mesh-list
6042974|NCT00548262|Anidulafungin|anidulafungin|mesh-list
6042975|NCT00548262|Antifungal Agents|antifungal agents|mesh-ancestor
6042976|NCT00548262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6042977|NCT00548262|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6042978|NCT00548262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6042979|NCT00548262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6042980|NCT00548262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6042981|NCT00548262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6042982|NCT00548262|Hormone Antagonists|hormone antagonists|mesh-ancestor
6042983|NCT00548262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6042984|NCT00548262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042985|NCT00548262|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5503335|NCT04460521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5503336|NCT04460521|Expectorants|expectorants|mesh-ancestor
5503337|NCT04460521|Respiratory System Agents|respiratory system agents|mesh-ancestor
5503338|NCT04460521|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6042986|NCT00548405|Interferons|interferons|mesh-list
6042987|NCT00548405|Interferon-beta|interferon-beta|mesh-list
6042988|NCT00548405|Interferon beta-1a|interferon beta-1a|mesh-list
6042989|NCT00548405|Alemtuzumab|alemtuzumab|mesh-list
6042990|NCT00548405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6042991|NCT00548405|Antiviral Agents|antiviral agents|mesh-ancestor
6042992|NCT00548405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6042993|NCT00548405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6042994|NCT00548405|Immunologic Factors|immunologic factors|mesh-ancestor
6042995|NCT00548405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6042996|NCT00548405|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6053807|NCT00598481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053808|NCT00598481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6053809|NCT00598481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6053810|NCT00598481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6053811|NCT00598507|Sagopilone|sagopilone|mesh-list
6053812|NCT00598507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6054268|NCT00602043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054269|NCT00602225|Cytarabine|cytarabine|mesh-list
6054270|NCT00602225|Clofarabine|clofarabine|mesh-list
6054271|NCT00602225|Immunologic Factors|immunologic factors|mesh-ancestor
6054272|NCT00602225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054273|NCT00602225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6054274|NCT00602225|Antimetabolites|antimetabolites|mesh-ancestor
6054275|NCT00602225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054276|NCT00602225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6054277|NCT00602225|Antiviral Agents|antiviral agents|mesh-ancestor
6054278|NCT00602225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6054279|NCT00602225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6054280|NCT00602290|Methylphenidate|methylphenidate|mesh-list
6054281|NCT00602290|Citalopram|citalopram|mesh-list
6054282|NCT00602290|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6054283|NCT00602290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054284|NCT00602290|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6054285|NCT00602290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6054286|NCT00602290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6054287|NCT00602290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054288|NCT00602290|Dopamine Agents|dopamine agents|mesh-ancestor
6054289|NCT00602290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6054290|NCT00602290|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6054291|NCT00602290|Serotonin Agents|serotonin agents|mesh-ancestor
6054292|NCT00602290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6054293|NCT00602290|Antidepressive Agents|antidepressive agents|mesh-ancestor
6054294|NCT00602290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6054295|NCT00602355|Sertraline|sertraline|mesh-list
6054296|NCT00602355|Antidepressive Agents|antidepressive agents|mesh-ancestor
6054297|NCT00602355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6054298|NCT00602355|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6054299|NCT00602355|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6054300|NCT00602355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6054301|NCT00602355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054302|NCT00602355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6054303|NCT00602355|Serotonin Agents|serotonin agents|mesh-ancestor
6054304|NCT00602355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054305|NCT00602420|Naproxen|naproxen|mesh-list
6054306|NCT00602420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6054307|NCT00602420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6054308|NCT00602420|Analgesics|analgesics|mesh-ancestor
6054309|NCT00602420|Sensory System Agents|sensory system agents|mesh-ancestor
6054310|NCT00602420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6054311|NCT00602420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054312|NCT00602420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6054313|NCT00602420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6054314|NCT00602420|Gout Suppressants|gout suppressants|mesh-ancestor
6054315|NCT00602420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6054316|NCT00602420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6054317|NCT00602420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054318|NCT00602446|Deferasirox|deferasirox|mesh-list
6054319|NCT00602446|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6054320|NCT00602446|Chelating Agents|chelating agents|mesh-ancestor
6054321|NCT00602446|Sequestering Agents|sequestering agents|mesh-ancestor
6054322|NCT00602446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054323|NCT00602459|Cyclophosphamide|cyclophosphamide|mesh-list
6054324|NCT00602459|Rituximab|rituximab|mesh-list
6042997|NCT00548418|Bevacizumab|bevacizumab|mesh-list
6042998|NCT00548418|Topotecan|topotecan|mesh-list
6042999|NCT00548418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6043000|NCT00548418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6043001|NCT00548418|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6043002|NCT00548418|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6043003|NCT00548418|Growth Substances|growth substances|mesh-ancestor
6043004|NCT00548418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043005|NCT00548418|Growth Inhibitors|growth inhibitors|mesh-ancestor
6043006|NCT00548418|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6043007|NCT00548418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6043008|NCT00548418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6043009|NCT00548418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043010|NCT00548431|Mercaptopurine|mercaptopurine|mesh-list
6043011|NCT00548431|Antimetabolites|antimetabolites|mesh-ancestor
6043012|NCT00548431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043013|NCT00548431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6043014|NCT00548431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6043015|NCT00548431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6043016|NCT00548431|Immunologic Factors|immunologic factors|mesh-ancestor
6043017|NCT00548431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043018|NCT00548431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6043019|NCT00548431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6043020|NCT00548470|Varenicline|varenicline|mesh-list
6043021|NCT00548470|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6043022|NCT00548470|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6043023|NCT00548470|Cholinergic Agents|cholinergic agents|mesh-ancestor
6043024|NCT00548470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6043025|NCT00548470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043026|NCT00548470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043027|NCT00548548|Bevacizumab|bevacizumab|mesh-list
6043028|NCT00548548|Fluorouracil|fluorouracil|mesh-list
6043029|NCT00548548|Capecitabine|capecitabine|mesh-list
6458026|NCT00438776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6458027|NCT00438776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6458028|NCT00438776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458029|NCT00438776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6458030|NCT00438776|Serotonin Agents|serotonin agents|mesh-ancestor
6458031|NCT00438789|Eculizumab|eculizumab|mesh-list
6458032|NCT00438789|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5497487|NCT04507711|Palonosetron|palonosetron|mesh-list
6043030|NCT00548548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6043031|NCT00548548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6043032|NCT00548548|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6043033|NCT00548548|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6043034|NCT00548548|Growth Substances|growth substances|mesh-ancestor
6043035|NCT00548548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043036|NCT00548548|Growth Inhibitors|growth inhibitors|mesh-ancestor
6043037|NCT00548548|Antimetabolites|antimetabolites|mesh-ancestor
6043038|NCT00548548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043039|NCT00548548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6043040|NCT00548548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6043041|NCT00548548|Immunologic Factors|immunologic factors|mesh-ancestor
6043042|NCT00548717|Mycophenolic Acid|mycophenolic acid|mesh-list
6043043|NCT00548717|Sirolimus|sirolimus|mesh-list
6043044|NCT00548717|Bortezomib|bortezomib|mesh-list
6043045|NCT00548717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6043046|NCT00548717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6043047|NCT00548717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6043048|NCT00548717|Antitubercular Agents|antitubercular agents|mesh-ancestor
6043049|NCT00548717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6043050|NCT00548717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6043051|NCT00548717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5497488|NCT04507711|Antiemetics|antiemetics|mesh-ancestor
5497489|NCT04507711|Autonomic Agents|autonomic agents|mesh-ancestor
5497490|NCT04507711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5497491|NCT04507711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497492|NCT04507711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5497493|NCT04507711|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5497494|NCT04507711|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5497495|NCT04507711|Serotonin Agents|serotonin agents|mesh-ancestor
6043052|NCT00548717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043053|NCT00548717|Antifungal Agents|antifungal agents|mesh-ancestor
6043054|NCT00548717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5497496|NCT04507711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5497497|NCT04507711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5497498|NCT04506567|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5497499|NCT04506567|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5497500|NCT04506567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5497501|NCT04506450|Anesthetics|anesthetics|mesh-list
5497502|NCT04506450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5497503|NCT04506450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497504|NCT04506034|Lidocaine|lidocaine|mesh-list
5497505|NCT04506034|Anesthetics, Local|anesthetics, local|mesh-ancestor
6043055|NCT00548717|Immunologic Factors|immunologic factors|mesh-ancestor
6043056|NCT00548717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043057|NCT00548808|Insulin|insulin|mesh-list
6043058|NCT00548808|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6043059|NCT00548808|Insulin Glargine|insulin glargine|mesh-list
6043060|NCT00548808|Insulin Lispro|insulin lispro|mesh-list
6043061|NCT00548808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6043062|NCT00548808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043063|NCT00548847|Interferons|interferons|mesh-list
6043064|NCT00548847|Interferon-alpha|interferon-alpha|mesh-list
6043065|NCT00548847|Interferon alpha-2|interferon alpha-2|mesh-list
6043066|NCT00548847|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6043067|NCT00548847|Molgramostim|molgramostim|mesh-list
6043068|NCT00548847|Sargramostim|sargramostim|mesh-list
6043069|NCT00548847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6043070|NCT00548847|Antiviral Agents|antiviral agents|mesh-ancestor
6043071|NCT00548847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6043072|NCT00548847|Immunologic Factors|immunologic factors|mesh-ancestor
6043073|NCT00548847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043074|NCT00549042|Hydromorphone|hydromorphone|mesh-list
6043075|NCT00549042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6043076|NCT00549042|Narcotics|narcotics|mesh-ancestor
6043077|NCT00549042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6043078|NCT00549042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497506|NCT04506034|Anesthetics|anesthetics|mesh-ancestor
5497507|NCT04506034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5497508|NCT04506034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497509|NCT04506034|Sensory System Agents|sensory system agents|mesh-ancestor
5497510|NCT04506034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5497511|NCT04506034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5497512|NCT04506034|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5497513|NCT04506034|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5497514|NCT04506034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5497515|NCT04506034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5497516|NCT04506242|Apatinib|apatinib|mesh-list
5497517|NCT04506242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5497518|NCT04506242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5497519|NCT04506242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5497520|NCT04506242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5497521|NCT04505930|Vaccines|vaccines|mesh-list
5497522|NCT04505930|Immunologic Factors|immunologic factors|mesh-ancestor
5497523|NCT04505930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497524|NCT04505904|Oxytocin|oxytocin|mesh-list
5497525|NCT04505904|Oxytocics|oxytocics|mesh-ancestor
5497526|NCT04505904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5497527|NCT04505904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497528|NCT04505943|Isoniazid|isoniazid|mesh-list
5497529|NCT04505943|Misoprostol|misoprostol|mesh-list
5497530|NCT04505943|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5497531|NCT04505943|Abortifacient Agents|abortifacient agents|mesh-ancestor
5497532|NCT04505943|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5497533|NCT04505943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497534|NCT04505943|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5497535|NCT04505943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5497536|NCT04505943|Oxytocics|oxytocics|mesh-ancestor
5497537|NCT04505943|Antitubercular Agents|antitubercular agents|mesh-ancestor
5497538|NCT04505943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5497539|NCT04505943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5497540|NCT04505943|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5497541|NCT04505943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5497542|NCT04505943|Antimetabolites|antimetabolites|mesh-ancestor
5497543|NCT04505943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043079|NCT00549042|Analgesics|analgesics|mesh-ancestor
6043080|NCT00549042|Sensory System Agents|sensory system agents|mesh-ancestor
6043081|NCT00549042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6043082|NCT00549198|Tenofovir|tenofovir|mesh-list
6043083|NCT00549198|Lamivudine|lamivudine|mesh-list
6043084|NCT00549198|Emtricitabine|emtricitabine|mesh-list
6043085|NCT00549198|Efavirenz|efavirenz|mesh-list
6043086|NCT00549198|Abacavir|abacavir|mesh-list
6043087|NCT00549198|Antiviral Agents|antiviral agents|mesh-ancestor
6043088|NCT00549198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6043089|NCT00549198|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6043090|NCT00549198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6043091|NCT00549198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6043092|NCT00549198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043093|NCT00549198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6043094|NCT00549198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6043095|NCT00549198|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6043096|NCT00549198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6043097|NCT00549198|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6043098|NCT00549198|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6043099|NCT00549198|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6043100|NCT00549198|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6043101|NCT00549302|Tadalafil|tadalafil|mesh-list
6043102|NCT00549302|Vasodilator Agents|vasodilator agents|mesh-ancestor
6043103|NCT00549302|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6043104|NCT00549302|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6043105|NCT00549302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6043106|NCT00549302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043107|NCT00549302|Urological Agents|urological agents|mesh-ancestor
6043108|NCT00549393|Chlorhexidine|chlorhexidine|mesh-list
6043109|NCT00549393|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6043110|NCT00549393|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6043111|NCT00549393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6043112|NCT00549393|Disinfectants|disinfectants|mesh-ancestor
6043113|NCT00549393|Dermatologic Agents|dermatologic agents|mesh-ancestor
6043114|NCT00549445|Azithromycin|azithromycin|mesh-list
6043115|NCT00549445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6043116|NCT00549445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6043117|NCT00549549|Celecoxib|celecoxib|mesh-list
6043118|NCT00549549|Indomethacin|indomethacin|mesh-list
6043119|NCT00549549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6043120|NCT00549549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6043121|NCT00549549|Analgesics|analgesics|mesh-ancestor
6043122|NCT00549549|Sensory System Agents|sensory system agents|mesh-ancestor
6458033|NCT00438789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6458034|NCT00438789|Immunologic Factors|immunologic factors|mesh-ancestor
6458035|NCT00438789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043123|NCT00549549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6043124|NCT00549549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497544|NCT04505943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5497545|NCT04505995|Azacitidine|azacitidine|mesh-list
5497546|NCT04505995|Homoharringtonine|homoharringtonine|mesh-list
5497547|NCT04505995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5497548|NCT04505995|Antimetabolites|antimetabolites|mesh-ancestor
5497549|NCT04505995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5497550|NCT04505995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5497551|NCT04505995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5497552|NCT04505995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5497553|NCT04505995|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5497554|NCT04505514|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
5497555|NCT04505514|Hematinics|hematinics|mesh-ancestor
6043125|NCT00549549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6043126|NCT00549549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6655203|NCT01462006|Sirolimus|sirolimus|mesh-list
5497556|NCT04505644|Lidocaine|lidocaine|mesh-list
5497557|NCT04505644|Anesthetics, Local|anesthetics, local|mesh-ancestor
6458036|NCT00438828|Dexamethasone|dexamethasone|mesh-list
6043127|NCT00549549|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6043128|NCT00549549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6043129|NCT00549549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6043130|NCT00549549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043131|NCT00549549|Gout Suppressants|gout suppressants|mesh-ancestor
6043132|NCT00549549|Tocolytic Agents|tocolytic agents|mesh-ancestor
6043133|NCT00549549|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6043134|NCT00549562|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6043135|NCT00549562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6043136|NCT00549562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6043137|NCT00549562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6043138|NCT00549562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043139|NCT00549562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6043140|NCT00549562|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6043141|NCT00549562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6043142|NCT00549562|Serotonin Agents|serotonin agents|mesh-ancestor
6043143|NCT00549562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6043144|NCT00549562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043145|NCT00549562|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6043146|NCT00549562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6043147|NCT00549562|Dopamine Agents|dopamine agents|mesh-ancestor
6043148|NCT00549601|Rivastigmine|rivastigmine|mesh-list
6043149|NCT00549601|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6043150|NCT00549601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6043151|NCT00549601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043152|NCT00549601|Cholinergic Agents|cholinergic agents|mesh-ancestor
6043153|NCT00549601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6043154|NCT00549601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043155|NCT00549601|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6043156|NCT00549601|Protective Agents|protective agents|mesh-ancestor
6043157|NCT00549640|Methylphenidate|methylphenidate|mesh-list
6043158|NCT00549640|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5497558|NCT04505644|Anesthetics|anesthetics|mesh-ancestor
5497559|NCT04505644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5497560|NCT04505644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497561|NCT04505644|Sensory System Agents|sensory system agents|mesh-ancestor
5497562|NCT04505644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5497563|NCT04505644|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5497564|NCT04505644|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5497565|NCT04505644|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5497566|NCT04505644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5497567|NCT04505644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043159|NCT00549640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043160|NCT00549640|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6043161|NCT00549640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6043162|NCT00549640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6043163|NCT00549640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043164|NCT00549640|Dopamine Agents|dopamine agents|mesh-ancestor
6043165|NCT00549640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6043166|NCT00549718|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
6043167|NCT00549718|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6043168|NCT00549718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6043169|NCT00549718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6043170|NCT00549718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043171|NCT00549718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6043172|NCT00549718|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6043173|NCT00549718|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6043174|NCT00549718|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6043175|NCT00549718|Adrenergic Agents|adrenergic agents|mesh-ancestor
6043176|NCT00549718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6043177|NCT00549718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043178|NCT00549718|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6043179|NCT00549718|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6043180|NCT00549718|Serotonin Agents|serotonin agents|mesh-ancestor
6043181|NCT00549718|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6043182|NCT00549718|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6043183|NCT00549718|Dopamine Agents|dopamine agents|mesh-ancestor
6043184|NCT00549770|Valsartan|valsartan|mesh-list
6043185|NCT00549770|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
6043186|NCT00549770|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6053813|NCT00598559|Acetaminophen|acetaminophen|mesh-list
6043187|NCT00549770|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6043188|NCT00549770|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6458037|NCT00438828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6458038|NCT00438828|Antiemetics|antiemetics|mesh-ancestor
6458039|NCT00438828|Autonomic Agents|autonomic agents|mesh-ancestor
6458040|NCT00438828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6458041|NCT00438828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458042|NCT00438828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6458043|NCT00438828|Glucocorticoids|glucocorticoids|mesh-ancestor
6458044|NCT00438828|Hormones|hormones|mesh-ancestor
6458045|NCT00438828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5497568|NCT04505475|Hemostatics|hemostatics|mesh-list
5497569|NCT04505475|Coagulants|coagulants|mesh-ancestor
5497570|NCT04505800|Tryptophan|tryptophan|mesh-list
5497571|NCT04505800|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5497572|NCT04505800|Antidepressive Agents|antidepressive agents|mesh-ancestor
5497573|NCT04505800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6458046|NCT00438828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6043189|NCT00549770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043190|NCT00549783|Botulinum Toxins|botulinum toxins|mesh-list
6043191|NCT00549783|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6043192|NCT00549783|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6043193|NCT00549783|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5497574|NCT04505917|Misoprostol|misoprostol|mesh-list
5497575|NCT04505917|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5497576|NCT04505917|Abortifacient Agents|abortifacient agents|mesh-ancestor
5497577|NCT04505917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5497578|NCT04505917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497579|NCT04505917|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6043194|NCT00549783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6043195|NCT00549783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043196|NCT00549783|Cholinergic Agents|cholinergic agents|mesh-ancestor
6043197|NCT00549783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6043198|NCT00549783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043199|NCT00549783|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6043200|NCT00549783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6043201|NCT00549822|Letrozole|letrozole|mesh-list
6043202|NCT00549822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6043203|NCT00549822|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6043204|NCT00549822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6458047|NCT00438828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6458048|NCT00438841|Thalidomide|thalidomide|mesh-list
6458049|NCT00438841|Dexamethasone|dexamethasone|mesh-list
6458050|NCT00438841|Cyclophosphamide|cyclophosphamide|mesh-list
6458051|NCT00438841|Bortezomib|bortezomib|mesh-list
6458052|NCT00438841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6458053|NCT00438841|Immunologic Factors|immunologic factors|mesh-ancestor
6043205|NCT00549822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6043206|NCT00549822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043207|NCT00549822|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6043208|NCT00549822|Hormone Antagonists|hormone antagonists|mesh-ancestor
6458054|NCT00438841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458055|NCT00438841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6458056|NCT00438841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6043209|NCT00549822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6043210|NCT00549822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043211|NCT00549900|Vaccines|vaccines|mesh-list
6043212|NCT00549900|Immunologic Factors|immunologic factors|mesh-ancestor
6043213|NCT00549900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043214|NCT00549939|Alfuzosin|alfuzosin|mesh-list
6043215|NCT00549939|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6043216|NCT00549939|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6043217|NCT00549939|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5497580|NCT04505917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5497581|NCT04505917|Oxytocics|oxytocics|mesh-ancestor
5497582|NCT04505592|Tenecteplase|tenecteplase|mesh-list
5497583|NCT04505592|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5497584|NCT04505592|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5497585|NCT04505592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5497586|NCT04505683|Ertapenem|ertapenem|mesh-list
5497587|NCT04505683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5497588|NCT04505683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5497589|NCT04505657|Celecoxib|celecoxib|mesh-list
6043218|NCT00549939|Adrenergic Agents|adrenergic agents|mesh-ancestor
6043219|NCT00549939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6043220|NCT00549939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043221|NCT00549939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043222|NCT00549939|Urological Agents|urological agents|mesh-ancestor
6043223|NCT00550147|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6043224|NCT00550147|Methylphenidate|methylphenidate|mesh-list
6043225|NCT00550147|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6043226|NCT00550147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043227|NCT00550147|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6043228|NCT00550147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6043229|NCT00550147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6043230|NCT00550147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043231|NCT00550147|Dopamine Agents|dopamine agents|mesh-ancestor
6043232|NCT00550147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6043233|NCT00550147|Antidepressive Agents|antidepressive agents|mesh-ancestor
6043234|NCT00550147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6043235|NCT00550147|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6043236|NCT00550147|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6043237|NCT00550147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6043238|NCT00550173|Pemetrexed|pemetrexed|mesh-list
6043239|NCT00550173|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6043240|NCT00550173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5497590|NCT04505657|Lidocaine|lidocaine|mesh-list
5497591|NCT04505657|Anesthetics, Local|anesthetics, local|mesh-ancestor
5497592|NCT04505657|Anesthetics|anesthetics|mesh-ancestor
5497593|NCT04505657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5497594|NCT04505657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497595|NCT04505657|Sensory System Agents|sensory system agents|mesh-ancestor
5497596|NCT04505657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5497597|NCT04505657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5497598|NCT04505657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5497599|NCT04505657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5497600|NCT04505657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6043241|NCT00550173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6043242|NCT00550173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043243|NCT00550173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6043244|NCT00550173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6043245|NCT00550173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6043246|NCT00550238|Pimavanserin|pimavanserin|mesh-list
6043247|NCT00550238|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6043248|NCT00550238|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6043249|NCT00550238|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5497601|NCT04505657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5497602|NCT04505657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6043250|NCT00550238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6043251|NCT00550238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6043252|NCT00550238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043253|NCT00550238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6043254|NCT00550238|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6043255|NCT00550238|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6043256|NCT00550238|Serotonin Agents|serotonin agents|mesh-ancestor
6043257|NCT00550238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6043258|NCT00550238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043259|NCT00550277|Panobinostat|panobinostat|mesh-list
6043260|NCT00550277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6043261|NCT00550277|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6043262|NCT00550277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6043263|NCT00550277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043264|NCT00550290|Cefazolin|cefazolin|mesh-list
6043265|NCT00550290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6043266|NCT00550290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6043267|NCT00550394|Topiramate|topiramate|mesh-list
6043268|NCT00550394|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6043269|NCT00550394|Antidepressive Agents|antidepressive agents|mesh-ancestor
6043270|NCT00550394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6043271|NCT00550394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6043272|NCT00550394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6043273|NCT00550394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6043274|NCT00550394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043275|NCT00550394|Anticonvulsants|anticonvulsants|mesh-ancestor
6043276|NCT00550394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6043277|NCT00550407|Lamotrigine|lamotrigine|mesh-list
6043278|NCT00550407|Anticonvulsants|anticonvulsants|mesh-ancestor
6043279|NCT00550407|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6043280|NCT00550407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6043281|NCT00550407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043282|NCT00550407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6043283|NCT00550407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043284|NCT00550407|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6043285|NCT00550407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6043286|NCT00550407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6043287|NCT00550407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6043288|NCT00550407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6043289|NCT00550420|Rosiglitazone|rosiglitazone|mesh-list
6043290|NCT00550420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6043291|NCT00550420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043292|NCT00550446|Adalimumab|adalimumab|mesh-list
6043293|NCT00550446|Tofacitinib|tofacitinib|mesh-list
6043294|NCT00550446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6043295|NCT00550446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6043296|NCT00550446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6043297|NCT00550446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6043298|NCT00550446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043299|NCT00550459|Tolvaptan|tolvaptan|mesh-list
6043300|NCT00550459|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6043301|NCT00550459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043302|NCT00550459|Natriuretic Agents|natriuretic agents|mesh-ancestor
6043303|NCT00550459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043304|NCT00550537|Paclitaxel|paclitaxel|mesh-list
6043305|NCT00550537|Bevacizumab|bevacizumab|mesh-list
6043306|NCT00550537|Carboplatin|carboplatin|mesh-list
6043307|NCT00550537|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5497603|NCT04505657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5497604|NCT04505657|Analgesics|analgesics|mesh-ancestor
5497605|NCT04505657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5497606|NCT04505657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5497607|NCT04505657|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6043308|NCT00550537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6043309|NCT00550537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6043310|NCT00550537|Tubulin Modulators|tubulin modulators|mesh-ancestor
6043311|NCT00550537|Antimitotic Agents|antimitotic agents|mesh-ancestor
6043312|NCT00550537|Mitosis Modulators|mitosis modulators|mesh-ancestor
6043313|NCT00550537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043314|NCT00550537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6043315|NCT00550537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6043316|NCT00550537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6043317|NCT00550537|Growth Substances|growth substances|mesh-ancestor
6043318|NCT00550537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043319|NCT00550537|Growth Inhibitors|growth inhibitors|mesh-ancestor
6043320|NCT00550537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6043321|NCT00550537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6043322|NCT00550550|Fluticasone|fluticasone|mesh-list
6043323|NCT00550550|Mometasone Furoate|mometasone furoate|mesh-list
6458057|NCT00438841|Alkylating Agents|alkylating agents|mesh-ancestor
6458058|NCT00438841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458059|NCT00438841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6458060|NCT00438841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6458061|NCT00438841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6458062|NCT00438841|Antiemetics|antiemetics|mesh-ancestor
6458063|NCT00438841|Autonomic Agents|autonomic agents|mesh-ancestor
6458064|NCT00438841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6458065|NCT00438841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6458066|NCT00438841|Glucocorticoids|glucocorticoids|mesh-ancestor
6458067|NCT00438841|Hormones|hormones|mesh-ancestor
6458068|NCT00438841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6458069|NCT00438841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6458070|NCT00438841|Leprostatic Agents|leprostatic agents|mesh-ancestor
6458071|NCT00438841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6043324|NCT00550550|Loratadine|loratadine|mesh-list
6043325|NCT00550550|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
6043326|NCT00550550|Prednisone|prednisone|mesh-list
6043327|NCT00550550|Albuterol|albuterol|mesh-list
6043328|NCT00550550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6043329|NCT00550550|Glucocorticoids|glucocorticoids|mesh-ancestor
6043330|NCT00550550|Hormones|hormones|mesh-ancestor
6043331|NCT00550550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6043332|NCT00550550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043333|NCT00550550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6043334|NCT00550550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6043335|NCT00550550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6043336|NCT00550550|Autonomic Agents|autonomic agents|mesh-ancestor
6043337|NCT00550550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6043338|NCT00550550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6043339|NCT00550550|Respiratory System Agents|respiratory system agents|mesh-ancestor
6043340|NCT00550550|Dermatologic Agents|dermatologic agents|mesh-ancestor
6043341|NCT00550550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6043342|NCT00550550|Tocolytic Agents|tocolytic agents|mesh-ancestor
6043343|NCT00550550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6043344|NCT00550550|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6043345|NCT00550550|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6043346|NCT00550550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6043347|NCT00550550|Adrenergic Agents|adrenergic agents|mesh-ancestor
6043348|NCT00550550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6043349|NCT00550550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043350|NCT00550550|Antipruritics|antipruritics|mesh-ancestor
6043351|NCT00550550|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6043352|NCT00550550|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6043353|NCT00550550|Histamine Antagonists|histamine antagonists|mesh-ancestor
6043354|NCT00550550|Histamine Agents|histamine agents|mesh-ancestor
6458072|NCT00438841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6458073|NCT00438841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6458074|NCT00438841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6458075|NCT00438841|Growth Substances|growth substances|mesh-ancestor
6043355|NCT00550550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6043356|NCT00550550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6043357|NCT00550550|Analgesics|analgesics|mesh-ancestor
6043358|NCT00550550|Sensory System Agents|sensory system agents|mesh-ancestor
6043359|NCT00550550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6043360|NCT00550589|Cidofovir|cidofovir|mesh-list
6043361|NCT00550589|Antiviral Agents|antiviral agents|mesh-ancestor
6043362|NCT00550589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6043363|NCT00550589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6043364|NCT00550589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043365|NCT00550615|Dasatinib|dasatinib|mesh-list
6043366|NCT00550615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6043367|NCT00550615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6043368|NCT00550615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6043369|NCT00550615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458076|NCT00438841|Growth Inhibitors|growth inhibitors|mesh-ancestor
6458077|NCT00438906|Secretin|secretin|mesh-list
6458078|NCT00438906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6458079|NCT00438906|Hormones|hormones|mesh-ancestor
6043370|NCT00550680|Epoetin Alfa|epoetin alfa|mesh-list
6043371|NCT00550680|Hematinics|hematinics|mesh-ancestor
6043372|NCT00550732|Posaconazole|posaconazole|mesh-list
6043373|NCT00550732|Antifungal Agents|antifungal agents|mesh-ancestor
6043374|NCT00550732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6043375|NCT00550732|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6043376|NCT00550732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6043377|NCT00550732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6043378|NCT00550732|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6043379|NCT00550732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6043380|NCT00550732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6043381|NCT00550732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043382|NCT00550732|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6043383|NCT00550732|Hormone Antagonists|hormone antagonists|mesh-ancestor
5497608|NCT04505657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5497609|NCT04505657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6043384|NCT00550732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6043385|NCT00550732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043386|NCT00550771|Paclitaxel|paclitaxel|mesh-list
6043387|NCT00550771|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6043388|NCT00550771|Cyclophosphamide|cyclophosphamide|mesh-list
6043389|NCT00550771|Doxorubicin|doxorubicin|mesh-list
6043390|NCT00550771|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6043391|NCT00550771|Trastuzumab|trastuzumab|mesh-list
6043392|NCT00550771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6043393|NCT00550771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6043394|NCT00550771|Tubulin Modulators|tubulin modulators|mesh-ancestor
6043395|NCT00550771|Antimitotic Agents|antimitotic agents|mesh-ancestor
6043396|NCT00550771|Mitosis Modulators|mitosis modulators|mesh-ancestor
6043397|NCT00550771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043398|NCT00550771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6043399|NCT00550771|Immunologic Factors|immunologic factors|mesh-ancestor
6043400|NCT00550771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043401|NCT00550771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6043402|NCT00550771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6043403|NCT00550771|Alkylating Agents|alkylating agents|mesh-ancestor
6043404|NCT00550771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6043405|NCT00550771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6043406|NCT00550771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6043407|NCT00550771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6043408|NCT00550771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6043409|NCT00550771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6043410|NCT00550836|Gemcitabine|gemcitabine|mesh-list
6043411|NCT00550836|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6043412|NCT00550836|Panitumumab|panitumumab|mesh-list
6043413|NCT00550836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6043414|NCT00550836|Antimetabolites|antimetabolites|mesh-ancestor
6043415|NCT00550836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043416|NCT00550836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6043417|NCT00550836|Antiviral Agents|antiviral agents|mesh-ancestor
6043418|NCT00550836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6043419|NCT00550836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6043420|NCT00550836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6043421|NCT00550836|Immunologic Factors|immunologic factors|mesh-ancestor
6043422|NCT00550836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043423|NCT00550836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6043424|NCT00550836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6043425|NCT00550862|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
6043426|NCT00550862|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6043427|NCT00550862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6043428|NCT00550953|Amlodipine|amlodipine|mesh-list
6043429|NCT00550953|Telmisartan|telmisartan|mesh-list
6043430|NCT00550953|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
6043431|NCT00550953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6043432|NCT00550953|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6043433|NCT00550953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6043434|NCT00550953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043435|NCT00550953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6043436|NCT00550953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043437|NCT00550953|Vasodilator Agents|vasodilator agents|mesh-ancestor
6458080|NCT00438906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5497610|NCT04505189|Psilocybin|psilocybin|mesh-list
6043438|NCT00550953|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6043439|NCT00550953|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6043440|NCT00551031|Vaccines|vaccines|mesh-list
6043441|NCT00551031|Immunologic Factors|immunologic factors|mesh-ancestor
6043442|NCT00551031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043443|NCT00551135|Pregabalin|pregabalin|mesh-list
6043444|NCT00551135|Analgesics|analgesics|mesh-ancestor
6043445|NCT00551135|Sensory System Agents|sensory system agents|mesh-ancestor
6043446|NCT00551135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6043447|NCT00551135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043448|NCT00551135|Anticonvulsants|anticonvulsants|mesh-ancestor
6043449|NCT00551135|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6043450|NCT00551135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6043451|NCT00551135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043452|NCT00551135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6043453|NCT00551135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6043454|NCT00551135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6043455|NCT00551135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6043456|NCT00551135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6043457|NCT00551161|Memantine|memantine|mesh-list
6043458|NCT00551161|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6043459|NCT00551161|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6043460|NCT00551161|Dopamine Agents|dopamine agents|mesh-ancestor
6043461|NCT00551161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6043462|NCT00551161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043463|NCT00551161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043464|NCT00551161|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6043465|NCT00551161|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6043466|NCT00551174|Ibandronic Acid|ibandronic acid|mesh-list
6043467|NCT00551174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6043468|NCT00551174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043469|NCT00551200|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
6043470|NCT00551200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6043471|NCT00551213|Capecitabine|capecitabine|mesh-list
6043472|NCT00551213|Irinotecan|irinotecan|mesh-list
6043473|NCT00551213|Cetuximab|cetuximab|mesh-list
6043474|NCT00551213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6043475|NCT00551213|Antimetabolites|antimetabolites|mesh-ancestor
6043476|NCT00551213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043477|NCT00551213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6043478|NCT00551213|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6043479|NCT00551213|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6043480|NCT00551213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6043481|NCT00551213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6043482|NCT00551291|Mycophenolic Acid|mycophenolic acid|mesh-list
5497611|NCT04505189|Hallucinogens|hallucinogens|mesh-ancestor
5497612|NCT04505189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497613|NCT04505189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5497614|NCT04505202|Chlorhexidine|chlorhexidine|mesh-list
5497615|NCT04505202|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5497616|NCT04505202|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5497617|NCT04505202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5497618|NCT04505202|Disinfectants|disinfectants|mesh-ancestor
5497619|NCT04505202|Dermatologic Agents|dermatologic agents|mesh-ancestor
5497620|NCT04505410|Tofacitinib|tofacitinib|mesh-list
5497621|NCT04505410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5497622|NCT04505410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5497623|NCT04505410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5497624|NCT04505228|Atropine|atropine|mesh-list
5497625|NCT04505228|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5497626|NCT04505228|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5497627|NCT04505228|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5497628|NCT04505228|Autonomic Agents|autonomic agents|mesh-ancestor
5497629|NCT04505228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6043483|NCT00551291|Prednisone|prednisone|mesh-list
6043484|NCT00551291|Epoetin Alfa|epoetin alfa|mesh-list
6043485|NCT00551291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6043486|NCT00551291|Glucocorticoids|glucocorticoids|mesh-ancestor
6043487|NCT00551291|Hormones|hormones|mesh-ancestor
6043488|NCT00551291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6043489|NCT00551291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043490|NCT00551291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6043491|NCT00551291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6043492|NCT00551291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6054325|NCT00602459|Fludarabine|fludarabine|mesh-list
5497630|NCT04505228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497631|NCT04505228|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5497632|NCT04505228|Respiratory System Agents|respiratory system agents|mesh-ancestor
5497633|NCT04505228|Mydriatics|mydriatics|mesh-ancestor
5497634|NCT04505228|Parasympatholytics|parasympatholytics|mesh-ancestor
5497635|NCT04505228|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5497636|NCT04505228|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5497637|NCT04505228|Cholinergic Agents|cholinergic agents|mesh-ancestor
5497638|NCT04505228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5497639|NCT04505228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5497640|NCT04505280|Lidocaine|lidocaine|mesh-list
5497641|NCT04505280|Anesthetics, Local|anesthetics, local|mesh-ancestor
5497642|NCT04505280|Anesthetics|anesthetics|mesh-ancestor
5497643|NCT04505280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5497644|NCT04505280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043493|NCT00551291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6043494|NCT00551291|Antitubercular Agents|antitubercular agents|mesh-ancestor
6043495|NCT00551291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6043496|NCT00551291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6043497|NCT00551291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6043498|NCT00551291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043499|NCT00551291|Hematinics|hematinics|mesh-ancestor
6043500|NCT00551421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6043501|NCT00551421|Cetuximab|cetuximab|mesh-list
6043502|NCT00551421|Pertuzumab|pertuzumab|mesh-list
6043503|NCT00551421|Irinotecan|irinotecan|mesh-list
6043504|NCT00551421|Antibodies|antibodies|mesh-list
6043505|NCT00551421|Immunoglobulins|immunoglobulins|mesh-list
6043506|NCT00551421|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6043507|NCT00551421|Immunologic Factors|immunologic factors|mesh-ancestor
6043508|NCT00551421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043509|NCT00551421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6043510|NCT00551421|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6043511|NCT00551421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6043512|NCT00551421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6043513|NCT00551421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043514|NCT00551460|Methotrexate|methotrexate|mesh-list
6043515|NCT00551460|Mercaptopurine|mercaptopurine|mesh-list
6043516|NCT00551460|Arsenic Trioxide|arsenic trioxide|mesh-list
6043517|NCT00551460|Tretinoin|tretinoin|mesh-list
6043518|NCT00551460|Gemtuzumab|gemtuzumab|mesh-list
6043519|NCT00551460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6043520|NCT00551460|Abortifacient Agents|abortifacient agents|mesh-ancestor
6043521|NCT00551460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6043522|NCT00551460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043523|NCT00551460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6043524|NCT00551460|Antimetabolites|antimetabolites|mesh-ancestor
6043525|NCT00551460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043526|NCT00551460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6043527|NCT00551460|Dermatologic Agents|dermatologic agents|mesh-ancestor
6043528|NCT00551460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6043529|NCT00551460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6043530|NCT00551460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6043531|NCT00551460|Immunologic Factors|immunologic factors|mesh-ancestor
6043532|NCT00551460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6043533|NCT00551460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6043534|NCT00551460|Keratolytic Agents|keratolytic agents|mesh-ancestor
6043535|NCT00551460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6043536|NCT00551525|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
6043537|NCT00551525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6043538|NCT00551525|Analgesics|analgesics|mesh-ancestor
6043539|NCT00551525|Sensory System Agents|sensory system agents|mesh-ancestor
6043540|NCT00551525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6043541|NCT00551525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043542|NCT00551642|Nitric Oxide|nitric oxide|mesh-list
6043543|NCT00551642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6043544|NCT00551642|Autonomic Agents|autonomic agents|mesh-ancestor
6054326|NCT00602459|Fludarabine phosphate|fludarabine phosphate|mesh-list
5497645|NCT04505280|Sensory System Agents|sensory system agents|mesh-ancestor
6043545|NCT00551642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6043546|NCT00551642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043547|NCT00551642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6043548|NCT00551642|Respiratory System Agents|respiratory system agents|mesh-ancestor
6043549|NCT00551642|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6043550|NCT00551642|Antioxidants|antioxidants|mesh-ancestor
6043551|NCT00551642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043552|NCT00551642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6043553|NCT00551642|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6043554|NCT00551642|Vasodilator Agents|vasodilator agents|mesh-ancestor
6043555|NCT00551642|Gasotransmitters|gasotransmitters|mesh-ancestor
6043556|NCT00551642|Protective Agents|protective agents|mesh-ancestor
6043557|NCT00551707|Prednisolone|prednisolone|mesh-list
6043558|NCT00551707|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6043559|NCT00551707|Methylprednisolone|methylprednisolone|mesh-list
6043560|NCT00551707|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6043561|NCT00551707|Prednisolone acetate|prednisolone acetate|mesh-list
6043562|NCT00551707|Dipyridamole|dipyridamole|mesh-list
6043563|NCT00551707|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6043564|NCT00551707|Prednisolone phosphate|prednisolone phosphate|mesh-list
6043565|NCT00551707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6043566|NCT00551707|Glucocorticoids|glucocorticoids|mesh-ancestor
6043567|NCT00551707|Hormones|hormones|mesh-ancestor
6043568|NCT00551707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6043569|NCT00551707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043570|NCT00551707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6043571|NCT00551707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6043572|NCT00551707|Antiemetics|antiemetics|mesh-ancestor
6043573|NCT00551707|Autonomic Agents|autonomic agents|mesh-ancestor
6043574|NCT00551707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5497646|NCT04505280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5497647|NCT04505280|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5497648|NCT04505280|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5497649|NCT04505280|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5497650|NCT04505280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5497651|NCT04505280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5497652|NCT04504877|Cannabidiol|cannabidiol|mesh-list
5497653|NCT04504877|Anticonvulsants|anticonvulsants|mesh-ancestor
5497654|NCT04504851|Rifampin|rifampin|mesh-list
5497655|NCT04504851|Isoniazid|isoniazid|mesh-list
5497656|NCT04504851|Pyrazinamide|pyrazinamide|mesh-list
5497657|NCT04504851|Ethambutol|ethambutol|mesh-list
5497658|NCT04504851|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5497659|NCT04504851|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5497660|NCT04504851|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5497661|NCT04504851|Antimetabolites|antimetabolites|mesh-ancestor
5497662|NCT04504851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043575|NCT00551707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6043576|NCT00551707|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6043577|NCT00551707|Protective Agents|protective agents|mesh-ancestor
6043578|NCT00551707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6043579|NCT00551707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6043580|NCT00551707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043581|NCT00551707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6043582|NCT00551707|Vasodilator Agents|vasodilator agents|mesh-ancestor
6043583|NCT00551759|Docetaxel|docetaxel|mesh-list
6043584|NCT00551759|Fluorouracil|fluorouracil|mesh-list
6043585|NCT00551759|Oxaliplatin|oxaliplatin|mesh-list
6043586|NCT00551759|Cetuximab|cetuximab|mesh-list
6043587|NCT00551759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6043588|NCT00551759|Tubulin Modulators|tubulin modulators|mesh-ancestor
6043589|NCT00551759|Antimitotic Agents|antimitotic agents|mesh-ancestor
6043590|NCT00551759|Mitosis Modulators|mitosis modulators|mesh-ancestor
6043591|NCT00551759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043592|NCT00551759|Antimetabolites|antimetabolites|mesh-ancestor
6043593|NCT00551759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6043594|NCT00551759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6043595|NCT00551759|Immunologic Factors|immunologic factors|mesh-ancestor
6043596|NCT00551759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043597|NCT00551759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6043598|NCT00552058|Certolizumab Pegol|certolizumab pegol|mesh-list
6043599|NCT00552058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6043600|NCT00552058|Immunologic Factors|immunologic factors|mesh-ancestor
5497663|NCT04504851|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5497664|NCT04504851|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5497665|NCT04504851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5497666|NCT04504851|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5497667|NCT04504851|Antitubercular Agents|antitubercular agents|mesh-ancestor
5497668|NCT04504851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5497669|NCT04504851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5497670|NCT04504851|Leprostatic Agents|leprostatic agents|mesh-ancestor
5497671|NCT04504851|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6043601|NCT00552058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043602|NCT00552058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6043603|NCT00552071|Octreotide|octreotide|mesh-list
6043604|NCT00552071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6043605|NCT00552071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6043606|NCT00552071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6043607|NCT00552110|Mometasone Furoate|mometasone furoate|mesh-list
6043608|NCT00552110|Phenylephrine|phenylephrine|mesh-list
6043609|NCT00552110|Oxymetazoline|oxymetazoline|mesh-list
6043610|NCT00552110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6043611|NCT00552110|Dermatologic Agents|dermatologic agents|mesh-ancestor
6043612|NCT00552110|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6043613|NCT00552110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6043614|NCT00552110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6043615|NCT00552110|Adrenergic Agents|adrenergic agents|mesh-ancestor
6043616|NCT00552110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6043617|NCT00552110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043618|NCT00552110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043619|NCT00552110|Sympathomimetics|sympathomimetics|mesh-ancestor
6043620|NCT00552110|Autonomic Agents|autonomic agents|mesh-ancestor
6043621|NCT00552110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6043622|NCT00552110|Nasal Decongestants|nasal decongestants|mesh-ancestor
6043623|NCT00552110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6043624|NCT00552110|Respiratory System Agents|respiratory system agents|mesh-ancestor
6043625|NCT00552110|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6043626|NCT00552110|Mydriatics|mydriatics|mesh-ancestor
6043627|NCT00552110|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6043628|NCT00552110|Protective Agents|protective agents|mesh-ancestor
6043629|NCT00552175|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6043630|NCT00552175|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6043631|NCT00552175|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6043632|NCT00552175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6043633|NCT00552175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043634|NCT00552175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6043635|NCT00552175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043636|NCT00552175|Analgesics|analgesics|mesh-ancestor
6043637|NCT00552175|Sensory System Agents|sensory system agents|mesh-ancestor
6043638|NCT00552175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6043639|NCT00552175|Antidepressive Agents|antidepressive agents|mesh-ancestor
6043640|NCT00552175|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6043641|NCT00552175|Dopamine Agents|dopamine agents|mesh-ancestor
6043642|NCT00552188|Atreleuton|atreleuton|mesh-list
6043643|NCT00552188|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6043644|NCT00552188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6043645|NCT00552188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043646|NCT00552240|Ritonavir|ritonavir|mesh-list
6043647|NCT00552240|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6043648|NCT00552240|Tenofovir|tenofovir|mesh-list
6043649|NCT00552240|Emtricitabine|emtricitabine|mesh-list
6043650|NCT00552240|Nevirapine|nevirapine|mesh-list
6043651|NCT00552240|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6043652|NCT00552240|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6043653|NCT00552240|Protease Inhibitors|protease inhibitors|mesh-ancestor
6043654|NCT00552240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6043655|NCT00552240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043656|NCT00552240|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6043657|NCT00552240|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6043658|NCT00552240|Antiviral Agents|antiviral agents|mesh-ancestor
6043659|NCT00552240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6043660|NCT00552240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6043661|NCT00552240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6043662|NCT00552240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6043663|NCT00552240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5497672|NCT04504851|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6043664|NCT00552240|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6043665|NCT00552240|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6043666|NCT00552279|Vaccines|vaccines|mesh-list
6043667|NCT00552279|Immunologic Factors|immunologic factors|mesh-ancestor
6043668|NCT00552279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043669|NCT00552305|Lacosamide|lacosamide|mesh-list
6043670|NCT00552305|Anticonvulsants|anticonvulsants|mesh-ancestor
6043671|NCT00552305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6043672|NCT00552305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6043673|NCT00552305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6043674|NCT00552305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043675|NCT00552344|Certolizumab Pegol|certolizumab pegol|mesh-list
6043676|NCT00552344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6043677|NCT00552344|Immunologic Factors|immunologic factors|mesh-ancestor
6043678|NCT00552344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043679|NCT00552344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6043680|NCT00552409|Cholecalciferol|cholecalciferol|mesh-list
6043681|NCT00552409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6043682|NCT00552409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043683|NCT00552409|Vitamins|vitamins|mesh-ancestor
6043684|NCT00552409|Micronutrients|micronutrients|mesh-ancestor
6043685|NCT00552409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6043686|NCT00552422|Domperidone|domperidone|mesh-list
6043687|NCT00552422|Antiemetics|antiemetics|mesh-ancestor
6043688|NCT00552422|Autonomic Agents|autonomic agents|mesh-ancestor
6043689|NCT00552422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6043690|NCT00552422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043691|NCT00552422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6043692|NCT00552422|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6043693|NCT00552422|Dopamine Agents|dopamine agents|mesh-ancestor
6043694|NCT00552422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6043695|NCT00552422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5497673|NCT04504851|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5497674|NCT04504851|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5497675|NCT04504851|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5497676|NCT04504851|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5497677|NCT04504851|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5497678|NCT04504851|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5497679|NCT04504552|Avelumab|avelumab|mesh-list
5497680|NCT04504552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5497681|NCT04504552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6043696|NCT00552578|Buprenorphine|buprenorphine|mesh-list
6043697|NCT00552578|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6043698|NCT00552578|Naloxone|naloxone|mesh-list
6043699|NCT00552578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6043700|NCT00552578|Narcotics|narcotics|mesh-ancestor
6043701|NCT00552578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6043702|NCT00552578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043703|NCT00552578|Analgesics|analgesics|mesh-ancestor
6043704|NCT00552578|Sensory System Agents|sensory system agents|mesh-ancestor
6043705|NCT00552578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6043706|NCT00552578|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6043707|NCT00552617|Rocuronium|rocuronium|mesh-list
6043708|NCT00552617|Vecuronium Bromide|vecuronium bromide|mesh-list
6043709|NCT00552617|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6043710|NCT00552617|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6043711|NCT00552617|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6043712|NCT00552617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6043713|NCT00552617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043714|NCT00552617|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
6043715|NCT00552617|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5497682|NCT04504110|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5497683|NCT04504110|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5497684|NCT04504110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5497685|NCT04504318|Enoxaparin|enoxaparin|mesh-list
5497686|NCT04504318|Apixaban|apixaban|mesh-list
5497687|NCT04504318|Anticoagulants|anticoagulants|mesh-ancestor
5497688|NCT04504318|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5497689|NCT04504318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5497690|NCT04504318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5497691|NCT04504318|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6043716|NCT00552617|Cholinergic Agents|cholinergic agents|mesh-ancestor
6043717|NCT00552617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6043718|NCT00552617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043719|NCT00552669|Sirolimus|sirolimus|mesh-list
6043720|NCT00552669|Paclitaxel|paclitaxel|mesh-list
6043721|NCT00552669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6043722|NCT00552669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6043723|NCT00552669|Tubulin Modulators|tubulin modulators|mesh-ancestor
6043724|NCT00552669|Antimitotic Agents|antimitotic agents|mesh-ancestor
6043725|NCT00552669|Mitosis Modulators|mitosis modulators|mesh-ancestor
6043726|NCT00552669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043727|NCT00552669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6043728|NCT00552669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6043729|NCT00552669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6043730|NCT00552669|Antifungal Agents|antifungal agents|mesh-ancestor
6043731|NCT00552669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6043732|NCT00552669|Immunologic Factors|immunologic factors|mesh-ancestor
6043733|NCT00552669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043734|NCT00552695|Lidocaine|lidocaine|mesh-list
6043735|NCT00552695|Tetracaine|tetracaine|mesh-list
6043736|NCT00552695|Anesthetics, Local|anesthetics, local|mesh-ancestor
6043737|NCT00552695|Anesthetics|anesthetics|mesh-ancestor
6043738|NCT00552695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6043739|NCT00552695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043740|NCT00552695|Sensory System Agents|sensory system agents|mesh-ancestor
6043741|NCT00552695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6043742|NCT00552695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6043743|NCT00552695|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6043744|NCT00552695|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6043745|NCT00552695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6043746|NCT00552695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043747|NCT00552786|Acetylcysteine|acetylcysteine|mesh-list
6043748|NCT00552786|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6043749|NCT00552786|Antiviral Agents|antiviral agents|mesh-ancestor
6043750|NCT00552786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6043751|NCT00552786|Expectorants|expectorants|mesh-ancestor
6043752|NCT00552786|Respiratory System Agents|respiratory system agents|mesh-ancestor
6043753|NCT00552786|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6043754|NCT00552786|Antioxidants|antioxidants|mesh-ancestor
6043755|NCT00552786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043756|NCT00552786|Protective Agents|protective agents|mesh-ancestor
6054327|NCT00602459|Lenalidomide|lenalidomide|mesh-list
6458081|NCT00438906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458082|NCT00438945|Eprosartan|eprosartan|mesh-list
6458083|NCT00438945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6458084|NCT00438945|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
6458085|NCT00438945|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6458086|NCT00438945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458087|NCT00438958|Lenograstim|lenograstim|mesh-list
6458088|NCT00438958|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6458089|NCT00438958|Immunologic Factors|immunologic factors|mesh-ancestor
6458090|NCT00438958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458091|NCT00438984|Aldesleukin|aldesleukin|mesh-list
6458092|NCT00438984|Cyclophosphamide|cyclophosphamide|mesh-list
6458093|NCT00438984|Interleukin-2|interleukin-2|mesh-list
6458094|NCT00438984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6458095|NCT00438984|Immunologic Factors|immunologic factors|mesh-ancestor
6458096|NCT00438984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458097|NCT00438984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6458098|NCT00438984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6458099|NCT00438984|Alkylating Agents|alkylating agents|mesh-ancestor
6458100|NCT00438984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458101|NCT00438984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6458102|NCT00438984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5497692|NCT04504318|Antithrombins|antithrombins|mesh-ancestor
6043757|NCT00552786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043758|NCT00552786|Antidotes|antidotes|mesh-ancestor
6043759|NCT00553059|Dexamethasone|dexamethasone|mesh-list
6043760|NCT00553059|Dronabinol|dronabinol|mesh-list
6043761|NCT00553059|Palonosetron|palonosetron|mesh-list
6043762|NCT00553059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5497693|NCT04504318|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5497694|NCT04504318|Protease Inhibitors|protease inhibitors|mesh-ancestor
5497695|NCT04504318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5497696|NCT04504123|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5497697|NCT04504123|Doxycycline|doxycycline|mesh-list
5497698|NCT04504123|Tetracycline|tetracycline|mesh-list
5497699|NCT04504123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5497700|NCT04504123|Antimalarials|antimalarials|mesh-ancestor
5497701|NCT04504123|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5497702|NCT04504123|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6043763|NCT00553059|Antiemetics|antiemetics|mesh-ancestor
6043764|NCT00553059|Autonomic Agents|autonomic agents|mesh-ancestor
6043765|NCT00553059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6043766|NCT00553059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043767|NCT00553059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6043768|NCT00553059|Glucocorticoids|glucocorticoids|mesh-ancestor
6043769|NCT00553059|Hormones|hormones|mesh-ancestor
6043770|NCT00553059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6043771|NCT00553059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6043772|NCT00553059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6043773|NCT00553059|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6043774|NCT00553059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6043775|NCT00553059|Serotonin Agents|serotonin agents|mesh-ancestor
6043776|NCT00553059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6043777|NCT00553059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043778|NCT00553059|Hallucinogens|hallucinogens|mesh-ancestor
6043779|NCT00553059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6043780|NCT00553059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6043781|NCT00553059|Analgesics|analgesics|mesh-ancestor
6043782|NCT00553059|Sensory System Agents|sensory system agents|mesh-ancestor
5497703|NCT04504123|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5497704|NCT04504123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5497705|NCT04504123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5497706|NCT04504045|Metformin|metformin|mesh-list
5497707|NCT04504045|Efavirenz|efavirenz|mesh-list
5497708|NCT04504045|Losartan|losartan|mesh-list
5497709|NCT04504045|Metoprolol|metoprolol|mesh-list
5497710|NCT04504045|Midazolam|midazolam|mesh-list
5497711|NCT04504045|Caffeine|caffeine|mesh-list
5497712|NCT04504045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5497713|NCT04504045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497714|NCT04504045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5497715|NCT04504045|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5497716|NCT04504045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5497717|NCT04504045|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6043783|NCT00553059|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6043784|NCT00553059|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6043785|NCT00553098|Cyclosporine|cyclosporine|mesh-list
6043786|NCT00553098|Mycophenolic Acid|mycophenolic acid|mesh-list
6043787|NCT00553098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6043788|NCT00553098|Alemtuzumab|alemtuzumab|mesh-list
6043789|NCT00553098|Fludarabine|fludarabine|mesh-list
6043790|NCT00553098|Fludarabine phosphate|fludarabine phosphate|mesh-list
6043791|NCT00553098|Antibodies|antibodies|mesh-list
6043792|NCT00553098|Immunoglobulins|immunoglobulins|mesh-list
6043793|NCT00553098|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6043794|NCT00553098|Cyclosporins|cyclosporins|mesh-list
6043795|NCT00553098|Immunologic Factors|immunologic factors|mesh-ancestor
5497718|NCT04504045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5497719|NCT04504045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6043796|NCT00553098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043797|NCT00553098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6043798|NCT00553098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6043799|NCT00553098|Antimetabolites|antimetabolites|mesh-ancestor
6043800|NCT00553098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043801|NCT00553098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6043802|NCT00553098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5497720|NCT04504045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5497721|NCT04504045|Anesthetics, General|anesthetics, general|mesh-ancestor
5497722|NCT04504045|Anesthetics|anesthetics|mesh-ancestor
5497723|NCT04504045|GABA Modulators|gaba modulators|mesh-ancestor
5497724|NCT04504045|GABA Agents|gaba agents|mesh-ancestor
5497725|NCT04504045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5497726|NCT04504045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043803|NCT00553098|Antifungal Agents|antifungal agents|mesh-ancestor
6043804|NCT00553098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6043805|NCT00553098|Dermatologic Agents|dermatologic agents|mesh-ancestor
6043806|NCT00553098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6043807|NCT00553098|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6043808|NCT00553098|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6043809|NCT00553098|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6043810|NCT00553098|Antitubercular Agents|antitubercular agents|mesh-ancestor
6043811|NCT00553098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6043812|NCT00553150|Everolimus|everolimus|mesh-list
6043813|NCT00553150|Temozolomide|temozolomide|mesh-list
6043814|NCT00553150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6043815|NCT00553150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6043816|NCT00553150|Immunologic Factors|immunologic factors|mesh-ancestor
6043817|NCT00553150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043818|NCT00553150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6043819|NCT00553150|Alkylating Agents|alkylating agents|mesh-ancestor
6043820|NCT00553150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043821|NCT00553202|Cyclosporine|cyclosporine|mesh-list
6043822|NCT00553202|Methylprednisolone|methylprednisolone|mesh-list
6043823|NCT00553202|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6043824|NCT00553202|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6043825|NCT00553202|Prednisolone|prednisolone|mesh-list
6043826|NCT00553202|Prednisolone acetate|prednisolone acetate|mesh-list
6043827|NCT00553202|Cyclophosphamide|cyclophosphamide|mesh-list
6043828|NCT00553202|Busulfan|busulfan|mesh-list
6043829|NCT00553202|Methotrexate|methotrexate|mesh-list
6043830|NCT00553202|Tacrolimus|tacrolimus|mesh-list
6043831|NCT00553202|Cyclosporins|cyclosporins|mesh-list
6043832|NCT00553202|Thymoglobulin|thymoglobulin|mesh-list
6043833|NCT00553202|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6043834|NCT00553202|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6043835|NCT00553202|Prednisolone phosphate|prednisolone phosphate|mesh-list
6043836|NCT00553202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6043837|NCT00553202|Immunologic Factors|immunologic factors|mesh-ancestor
6043838|NCT00553202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043839|NCT00553202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6043840|NCT00553202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6043841|NCT00553202|Alkylating Agents|alkylating agents|mesh-ancestor
6043842|NCT00553202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043843|NCT00553202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6043844|NCT00553202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6043845|NCT00553202|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6043846|NCT00553202|Abortifacient Agents|abortifacient agents|mesh-ancestor
6043847|NCT00553202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6043848|NCT00553202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6043849|NCT00553202|Antimetabolites|antimetabolites|mesh-ancestor
6043850|NCT00553202|Dermatologic Agents|dermatologic agents|mesh-ancestor
6043851|NCT00553202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6043852|NCT00553202|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6043853|NCT00553202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6043854|NCT00553202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6043855|NCT00553202|Antifungal Agents|antifungal agents|mesh-ancestor
6043856|NCT00553202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6043857|NCT00553202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6043858|NCT00553202|Antiemetics|antiemetics|mesh-ancestor
6043859|NCT00553202|Autonomic Agents|autonomic agents|mesh-ancestor
6043860|NCT00553202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6043861|NCT00553202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6043862|NCT00553202|Glucocorticoids|glucocorticoids|mesh-ancestor
6043863|NCT00553202|Hormones|hormones|mesh-ancestor
5497727|NCT04504045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5503339|NCT04460521|Antioxidants|antioxidants|mesh-ancestor
6053814|NCT00598559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6043864|NCT00553202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6043865|NCT00553202|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6043866|NCT00553202|Protective Agents|protective agents|mesh-ancestor
6043867|NCT00553202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6043868|NCT00553267|Amlodipine|amlodipine|mesh-list
6043869|NCT00553267|Telmisartan|telmisartan|mesh-list
6043870|NCT00553267|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
6043871|NCT00553267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5497728|NCT04504045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5497729|NCT04504045|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5497730|NCT04504045|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5497731|NCT04504045|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5497732|NCT04504045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5497733|NCT04504045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6043872|NCT00553267|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6043873|NCT00553267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6043874|NCT00553267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043875|NCT00553267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6043876|NCT00553267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043877|NCT00553267|Vasodilator Agents|vasodilator agents|mesh-ancestor
6043878|NCT00553267|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6043879|NCT00553267|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6043880|NCT00553280|Pregabalin|pregabalin|mesh-list
6043881|NCT00553280|Analgesics|analgesics|mesh-ancestor
6043882|NCT00553280|Sensory System Agents|sensory system agents|mesh-ancestor
6043883|NCT00553280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6043884|NCT00553280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043885|NCT00553280|Anticonvulsants|anticonvulsants|mesh-ancestor
6043886|NCT00553280|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6043887|NCT00553280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6043888|NCT00553280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043889|NCT00553280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6043890|NCT00553280|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6043891|NCT00553280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6043892|NCT00553280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6043893|NCT00553280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6043894|NCT00553319|Amphetamine|amphetamine|mesh-list
6043895|NCT00553319|Adderall|adderall|mesh-list
5497734|NCT04504045|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5497735|NCT04504045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5497736|NCT04504045|Purinergic Agents|purinergic agents|mesh-ancestor
5497737|NCT04504045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5497738|NCT04504045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5497739|NCT04504045|Antiviral Agents|antiviral agents|mesh-ancestor
5497740|NCT04504045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5497741|NCT04504045|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5497742|NCT04504045|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5497743|NCT04504045|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5497744|NCT04504045|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5497745|NCT04504045|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5497746|NCT04504045|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5497747|NCT04504045|Sympatholytics|sympatholytics|mesh-ancestor
5497748|NCT04504045|Autonomic Agents|autonomic agents|mesh-ancestor
6043896|NCT00553319|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6043897|NCT00553319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043898|NCT00553319|Sympathomimetics|sympathomimetics|mesh-ancestor
6043899|NCT00553319|Autonomic Agents|autonomic agents|mesh-ancestor
6043900|NCT00553319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6043901|NCT00553319|Dopamine Agents|dopamine agents|mesh-ancestor
6043902|NCT00553319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6043903|NCT00553319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458103|NCT00438984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6458104|NCT00438984|Analgesics|analgesics|mesh-ancestor
6458105|NCT00438984|Sensory System Agents|sensory system agents|mesh-ancestor
6458106|NCT00438984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6458107|NCT00438984|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6458108|NCT00438984|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6458109|NCT00438984|Antiviral Agents|antiviral agents|mesh-ancestor
6458110|NCT00438984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6458111|NCT00439049|Naltrexone|naltrexone|mesh-list
6458112|NCT00439049|Modafinil|modafinil|mesh-list
6458113|NCT00439049|Amphetamine|amphetamine|mesh-list
5497749|NCT04504045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5497750|NCT04504045|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5497751|NCT04504045|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5497752|NCT04504045|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5497753|NCT04504045|Adrenergic Agents|adrenergic agents|mesh-ancestor
5497754|NCT04503915|Estrogens|estrogens|mesh-list
5497755|NCT04503915|Hormones|hormones|mesh-ancestor
5497756|NCT04503915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5497757|NCT04503915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497758|NCT04503967|Nivolumab|nivolumab|mesh-list
5497759|NCT04503967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6043904|NCT00553319|Adrenergic Agents|adrenergic agents|mesh-ancestor
6043905|NCT00553319|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6043906|NCT00553319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6043907|NCT00553319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6043908|NCT00553319|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6458114|NCT00439049|Dextroamphetamine|dextroamphetamine|mesh-list
6458115|NCT00439049|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6458116|NCT00439049|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6458117|NCT00439049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053815|NCT00598559|Analgesics|analgesics|mesh-ancestor
6053816|NCT00598559|Sensory System Agents|sensory system agents|mesh-ancestor
6053817|NCT00598559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6053818|NCT00598559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053819|NCT00598559|Antipyretics|antipyretics|mesh-ancestor
6053820|NCT00598585|Sildenafil Citrate|sildenafil citrate|mesh-list
6053821|NCT00598585|Vasodilator Agents|vasodilator agents|mesh-ancestor
6053822|NCT00598585|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6053823|NCT00598585|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6053824|NCT00598585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6053825|NCT00598585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053826|NCT00598585|Urological Agents|urological agents|mesh-ancestor
6053827|NCT00598650|Donepezil|donepezil|mesh-list
6053828|NCT00598650|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6053829|NCT00598650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6053830|NCT00598650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053831|NCT00598650|Cholinergic Agents|cholinergic agents|mesh-ancestor
6053832|NCT00598650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6053833|NCT00598650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053834|NCT00598650|Nootropic Agents|nootropic agents|mesh-ancestor
6053835|NCT00598663|Insulin|insulin|mesh-list
6458118|NCT00439049|Sensory System Agents|sensory system agents|mesh-ancestor
6458119|NCT00439049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6458120|NCT00439049|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6458121|NCT00439049|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6458122|NCT00439049|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6458123|NCT00439049|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6458124|NCT00439049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458125|NCT00439049|Sympathomimetics|sympathomimetics|mesh-ancestor
6053836|NCT00598663|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6053837|NCT00598663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6053838|NCT00598663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053839|NCT00598702|Acetaminophen|acetaminophen|mesh-list
6053840|NCT00598702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6053841|NCT00598702|Analgesics|analgesics|mesh-ancestor
6053842|NCT00598702|Sensory System Agents|sensory system agents|mesh-ancestor
6053843|NCT00598702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6053844|NCT00598702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053845|NCT00598702|Antipyretics|antipyretics|mesh-ancestor
5497760|NCT04503967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5497761|NCT04503967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6053846|NCT00598806|Apaziquone|apaziquone|mesh-list
6053847|NCT00598806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6053848|NCT00598832|Adapalene|adapalene|mesh-list
6053849|NCT00598832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6053850|NCT00598832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6053851|NCT00598832|Analgesics|analgesics|mesh-ancestor
6053852|NCT00598832|Sensory System Agents|sensory system agents|mesh-ancestor
6053853|NCT00598832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6053854|NCT00598832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053855|NCT00598832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6053856|NCT00598832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6053857|NCT00598832|Dermatologic Agents|dermatologic agents|mesh-ancestor
6053858|NCT00598871|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6458126|NCT00439049|Autonomic Agents|autonomic agents|mesh-ancestor
6458127|NCT00439049|Dopamine Agents|dopamine agents|mesh-ancestor
6458128|NCT00439049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6458129|NCT00439049|Adrenergic Agents|adrenergic agents|mesh-ancestor
6458130|NCT00439049|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6458131|NCT00439049|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6458132|NCT00439049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6458133|NCT00439049|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6458134|NCT00439062|Roxithromycin|roxithromycin|mesh-list
6458135|NCT00439062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6458136|NCT00439062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5497762|NCT04503967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043909|NCT00553358|Paclitaxel|paclitaxel|mesh-list
6043910|NCT00553358|Trastuzumab|trastuzumab|mesh-list
6043911|NCT00553358|Lapatinib|lapatinib|mesh-list
6043912|NCT00553358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6043913|NCT00553358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6043914|NCT00553358|Tubulin Modulators|tubulin modulators|mesh-ancestor
6043915|NCT00553358|Antimitotic Agents|antimitotic agents|mesh-ancestor
6043916|NCT00553358|Mitosis Modulators|mitosis modulators|mesh-ancestor
6043917|NCT00553358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043918|NCT00553358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6043919|NCT00553358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6043920|NCT00553358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6043921|NCT00553410|Letrozole|letrozole|mesh-list
6043922|NCT00553410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6043923|NCT00553410|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6043924|NCT00553410|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6043925|NCT00553410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6043926|NCT00553410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043927|NCT00553410|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6043928|NCT00553410|Hormone Antagonists|hormone antagonists|mesh-ancestor
6043929|NCT00553410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6043930|NCT00553410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043931|NCT00553462|Paclitaxel|paclitaxel|mesh-list
6043932|NCT00553462|Carboplatin|carboplatin|mesh-list
6043933|NCT00553462|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6043934|NCT00553462|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6043935|NCT00553462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6043936|NCT00553462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6043937|NCT00553462|Tubulin Modulators|tubulin modulators|mesh-ancestor
6043938|NCT00553462|Antimitotic Agents|antimitotic agents|mesh-ancestor
6043939|NCT00553462|Mitosis Modulators|mitosis modulators|mesh-ancestor
6043940|NCT00553462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043941|NCT00553462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6043942|NCT00553462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6043943|NCT00553475|Pregabalin|pregabalin|mesh-list
6043944|NCT00553475|Analgesics|analgesics|mesh-ancestor
6043945|NCT00553475|Sensory System Agents|sensory system agents|mesh-ancestor
6043946|NCT00553475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6043947|NCT00553475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043948|NCT00553475|Anticonvulsants|anticonvulsants|mesh-ancestor
6043949|NCT00553475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6043950|NCT00553475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6043951|NCT00553475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043952|NCT00553475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5497763|NCT04503850|Mirabegron|mirabegron|mesh-list
5497764|NCT04503850|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
5497765|NCT04503850|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
5497766|NCT04503850|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5497767|NCT04503850|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5497768|NCT04503850|Adrenergic Agents|adrenergic agents|mesh-ancestor
5497769|NCT04503850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5497770|NCT04503850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5497771|NCT04503850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497772|NCT04503850|Urological Agents|urological agents|mesh-ancestor
5497773|NCT04503850|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5497774|NCT04503616|Cyclophosphamide|cyclophosphamide|mesh-list
5497775|NCT04503616|Abatacept|abatacept|mesh-list
5497776|NCT04503616|Tacrolimus|tacrolimus|mesh-list
5497777|NCT04503616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5497778|NCT04503616|Immunologic Factors|immunologic factors|mesh-ancestor
5497779|NCT04503616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497780|NCT04503616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6043953|NCT00553475|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6043954|NCT00553475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6043955|NCT00553475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6043956|NCT00553475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6043957|NCT00553501|Rituximab|rituximab|mesh-list
6043958|NCT00553501|Epratuzumab|epratuzumab|mesh-list
6043959|NCT00553501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6043960|NCT00553501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6043961|NCT00553501|Immunologic Factors|immunologic factors|mesh-ancestor
6043962|NCT00553501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043963|NCT00553501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6043964|NCT00553514|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6043965|NCT00553514|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6043966|NCT00553514|Hormones|hormones|mesh-ancestor
6043967|NCT00553514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6043968|NCT00553514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043969|NCT00553514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6043970|NCT00553605|Ketoprofen|ketoprofen|mesh-list
6043971|NCT00553605|Parecoxib|parecoxib|mesh-list
6043972|NCT00553605|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6043973|NCT00553605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6043974|NCT00553605|Analgesics|analgesics|mesh-ancestor
6043975|NCT00553605|Sensory System Agents|sensory system agents|mesh-ancestor
6043976|NCT00553605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6043977|NCT00553605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043978|NCT00553605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6043979|NCT00553605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6043980|NCT00553605|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6043981|NCT00553605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6043982|NCT00553605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6043983|NCT00553605|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6043984|NCT00553644|Lenalidomide|lenalidomide|mesh-list
6043985|NCT00553644|Bortezomib|bortezomib|mesh-list
6043986|NCT00553644|Immunologic Factors|immunologic factors|mesh-ancestor
6043987|NCT00553644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043988|NCT00553644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6043989|NCT00553644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6043990|NCT00553644|Growth Substances|growth substances|mesh-ancestor
6043991|NCT00553644|Growth Inhibitors|growth inhibitors|mesh-ancestor
6043992|NCT00553644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6043993|NCT00553696|Sunitinib|sunitinib|mesh-list
6043994|NCT00553696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6043995|NCT00553696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6043996|NCT00553696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6043997|NCT00553696|Growth Substances|growth substances|mesh-ancestor
6043998|NCT00553696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6043999|NCT00553696|Growth Inhibitors|growth inhibitors|mesh-ancestor
6044000|NCT00553696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6044001|NCT00553696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6044002|NCT00553696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044003|NCT00553735|Cyclosporine|cyclosporine|mesh-list
6044004|NCT00553735|Lubricant Eye Drops|lubricant eye drops|mesh-list
6044005|NCT00553735|Cyclosporins|cyclosporins|mesh-list
6044006|NCT00553735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6044007|NCT00553735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044008|NCT00553735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6044009|NCT00553735|Immunologic Factors|immunologic factors|mesh-ancestor
6044010|NCT00553735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044011|NCT00553735|Antifungal Agents|antifungal agents|mesh-ancestor
6044012|NCT00553735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6044013|NCT00553735|Dermatologic Agents|dermatologic agents|mesh-ancestor
6044014|NCT00553735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6044015|NCT00553735|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6044016|NCT00553735|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6044017|NCT00553735|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6044018|NCT00553839|Ketamine|ketamine|mesh-list
6044019|NCT00553839|Analgesics|analgesics|mesh-ancestor
6044020|NCT00553839|Sensory System Agents|sensory system agents|mesh-ancestor
6044021|NCT00553839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6044022|NCT00553839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044023|NCT00553839|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6044024|NCT00553839|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6044025|NCT00553839|Anesthetics, General|anesthetics, general|mesh-ancestor
6044026|NCT00553839|Anesthetics|anesthetics|mesh-ancestor
6044027|NCT00553839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6044028|NCT00553839|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6044029|NCT00553839|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6044030|NCT00553839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6044031|NCT00553839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044032|NCT00553969|Carvedilol|carvedilol|mesh-list
6044033|NCT00553969|Lisinopril|lisinopril|mesh-list
6044034|NCT00553969|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6044035|NCT00553969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6044036|NCT00553969|Adrenergic Agents|adrenergic agents|mesh-ancestor
6044037|NCT00553969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6044038|NCT00553969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044039|NCT00553969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044040|NCT00553969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6044041|NCT00553969|Antioxidants|antioxidants|mesh-ancestor
6044042|NCT00553969|Protective Agents|protective agents|mesh-ancestor
6044043|NCT00553969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6044044|NCT00553969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6044045|NCT00553969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6044046|NCT00553969|Vasodilator Agents|vasodilator agents|mesh-ancestor
6044047|NCT00553969|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6044048|NCT00553969|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6044049|NCT00553969|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6044050|NCT00553969|Protease Inhibitors|protease inhibitors|mesh-ancestor
6044051|NCT00553969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6044052|NCT00553969|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6044053|NCT00554099|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6044054|NCT00554099|Mesalamine|mesalamine|mesh-list
6044055|NCT00554099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6044056|NCT00554099|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6044057|NCT00554099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6044058|NCT00554099|Analgesics|analgesics|mesh-ancestor
6044059|NCT00554099|Sensory System Agents|sensory system agents|mesh-ancestor
6044060|NCT00554099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6044061|NCT00554099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044062|NCT00554099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6044063|NCT00554099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6044064|NCT00554216|Topiramate|topiramate|mesh-list
6044065|NCT00554216|Phentermine|phentermine|mesh-list
6044066|NCT00554216|Anticonvulsants|anticonvulsants|mesh-ancestor
6044067|NCT00554216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5497781|NCT04503616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5497782|NCT04503616|Alkylating Agents|alkylating agents|mesh-ancestor
5497783|NCT04503616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5497784|NCT04503616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5497785|NCT04503616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5497786|NCT04503616|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5497787|NCT04503616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5497788|NCT04503616|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5497789|NCT04503694|Nivolumab|nivolumab|mesh-list
5497790|NCT04503694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5497791|NCT04503694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6044068|NCT00554216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044069|NCT00554216|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6044070|NCT00554216|Appetite Depressants|appetite depressants|mesh-ancestor
6044071|NCT00554216|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6044072|NCT00554216|Sympathomimetics|sympathomimetics|mesh-ancestor
6044073|NCT00554216|Autonomic Agents|autonomic agents|mesh-ancestor
6044074|NCT00554216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6044075|NCT00554216|Adrenergic Agents|adrenergic agents|mesh-ancestor
6044076|NCT00554216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6044077|NCT00554216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044078|NCT00554463|Etoposide|etoposide|mesh-list
6044079|NCT00554463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6044080|NCT00554463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6044081|NCT00554463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6044082|NCT00554463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6044083|NCT00554463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6044084|NCT00554463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044085|NCT00554515|Aldesleukin|aldesleukin|mesh-list
6044086|NCT00554515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6044087|NCT00554515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6044088|NCT00554515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6044089|NCT00554515|Antiviral Agents|antiviral agents|mesh-ancestor
6044090|NCT00554515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6044091|NCT00554788|Cyclophosphamide|cyclophosphamide|mesh-list
6044092|NCT00554788|Thiotepa|thiotepa|mesh-list
6044093|NCT00554788|Cisplatin|cisplatin|mesh-list
6044094|NCT00554788|Carboplatin|carboplatin|mesh-list
6044095|NCT00554788|Etoposide|etoposide|mesh-list
6044096|NCT00554788|Vincristine|vincristine|mesh-list
6044097|NCT00554788|Etoposide phosphate|etoposide phosphate|mesh-list
6044098|NCT00554788|Podophyllotoxin|podophyllotoxin|mesh-list
6044099|NCT00554788|Lenograstim|lenograstim|mesh-list
6044100|NCT00554788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6044101|NCT00554788|Immunologic Factors|immunologic factors|mesh-ancestor
6044102|NCT00554788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044103|NCT00554788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6044104|NCT00554788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6044105|NCT00554788|Alkylating Agents|alkylating agents|mesh-ancestor
6044106|NCT00554788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044107|NCT00554788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6044108|NCT00554788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6044109|NCT00554788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6044110|NCT00554788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6044111|NCT00554788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6044112|NCT00554788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6044113|NCT00554788|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6044114|NCT00554788|Tubulin Modulators|tubulin modulators|mesh-ancestor
6044115|NCT00554788|Antimitotic Agents|antimitotic agents|mesh-ancestor
6044116|NCT00554788|Mitosis Modulators|mitosis modulators|mesh-ancestor
6044117|NCT00554788|Keratolytic Agents|keratolytic agents|mesh-ancestor
6044118|NCT00554788|Dermatologic Agents|dermatologic agents|mesh-ancestor
6044119|NCT00554840|Varenicline|varenicline|mesh-list
6044120|NCT00554840|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6044121|NCT00554840|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6044122|NCT00554840|Cholinergic Agents|cholinergic agents|mesh-ancestor
6044123|NCT00554840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6458137|NCT00439166|Doxycycline|doxycycline|mesh-list
6458138|NCT00439166|Rifampin|rifampin|mesh-list
6458139|NCT00439166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6044124|NCT00554840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044125|NCT00554840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044126|NCT00554853|Pioglitazone|pioglitazone|mesh-list
6044127|NCT00554853|Nitroglycerin|nitroglycerin|mesh-list
6044128|NCT00554853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6044129|NCT00554853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044130|NCT00554853|Vasodilator Agents|vasodilator agents|mesh-ancestor
6044131|NCT00554970|Budesonide|budesonide|mesh-list
6044132|NCT00554970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6044133|NCT00554970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6044134|NCT00554970|Autonomic Agents|autonomic agents|mesh-ancestor
6044135|NCT00554970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6044136|NCT00554970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044137|NCT00554970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6044138|NCT00554970|Respiratory System Agents|respiratory system agents|mesh-ancestor
6044139|NCT00554970|Glucocorticoids|glucocorticoids|mesh-ancestor
6044140|NCT00554970|Hormones|hormones|mesh-ancestor
6044141|NCT00554970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6044142|NCT00555048|Cyclophosphamide|cyclophosphamide|mesh-list
6044143|NCT00555048|Busulfan|busulfan|mesh-list
6044144|NCT00555048|Methotrexate|methotrexate|mesh-list
6044145|NCT00555048|Alemtuzumab|alemtuzumab|mesh-list
6044146|NCT00555048|Tacrolimus|tacrolimus|mesh-list
6044147|NCT00555048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6044148|NCT00555048|Immunologic Factors|immunologic factors|mesh-ancestor
6044149|NCT00555048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044150|NCT00555048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6044151|NCT00555048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6044152|NCT00555048|Alkylating Agents|alkylating agents|mesh-ancestor
6044153|NCT00555048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044154|NCT00555048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6044155|NCT00555048|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6044156|NCT00555048|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6044157|NCT00555048|Abortifacient Agents|abortifacient agents|mesh-ancestor
6044158|NCT00555048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6044159|NCT00555048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6044160|NCT00555048|Antimetabolites|antimetabolites|mesh-ancestor
6044161|NCT00555048|Dermatologic Agents|dermatologic agents|mesh-ancestor
6044162|NCT00555048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6044163|NCT00555048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6044164|NCT00555048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6458140|NCT00439166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6044165|NCT00555048|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6044166|NCT00555048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6044167|NCT00555061|Retapamulin|retapamulin|mesh-list
6044168|NCT00555061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6044169|NCT00555061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6044170|NCT00555152|Lapatinib|lapatinib|mesh-list
6044171|NCT00555152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6044172|NCT00555152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6044173|NCT00555152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6044174|NCT00555152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458141|NCT00439166|Antimalarials|antimalarials|mesh-ancestor
6458142|NCT00439166|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6458143|NCT00439166|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6458144|NCT00439166|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6458145|NCT00439166|Antitubercular Agents|antitubercular agents|mesh-ancestor
6458146|NCT00439166|Leprostatic Agents|leprostatic agents|mesh-ancestor
6458147|NCT00439166|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5497792|NCT04503694|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6044175|NCT00555217|Losartan|losartan|mesh-list
6044176|NCT00555217|Lisinopril|lisinopril|mesh-list
6044177|NCT00555217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6044178|NCT00555217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5497793|NCT04503694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5497794|NCT04503629|Rabeprazole|rabeprazole|mesh-list
5497795|NCT04503629|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5497796|NCT04503629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5497797|NCT04503629|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5497798|NCT04503629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5497799|NCT04503629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5497800|NCT04503460|Fluticasone|fluticasone|mesh-list
5497801|NCT04503460|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6044179|NCT00555217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6044180|NCT00555217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6044181|NCT00555217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044182|NCT00555217|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6044183|NCT00555217|Protease Inhibitors|protease inhibitors|mesh-ancestor
6044184|NCT00555217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6044185|NCT00555217|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6044186|NCT00555217|Protective Agents|protective agents|mesh-ancestor
6044187|NCT00555217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044188|NCT00555321|Mycophenolic Acid|mycophenolic acid|mesh-list
6044189|NCT00555321|Abatacept|abatacept|mesh-list
6044190|NCT00555321|Tacrolimus|tacrolimus|mesh-list
6044191|NCT00555321|Basiliximab|basiliximab|mesh-list
6044192|NCT00555321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6044193|NCT00555321|Immunologic Factors|immunologic factors|mesh-ancestor
6044194|NCT00555321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044195|NCT00555321|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6044196|NCT00555321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6044197|NCT00555321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044198|NCT00555321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6044199|NCT00555321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6044200|NCT00555321|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6044201|NCT00555321|Antitubercular Agents|antitubercular agents|mesh-ancestor
6044202|NCT00555321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5497802|NCT04503460|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6044203|NCT00555321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6044204|NCT00555321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6044205|NCT00555321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6044206|NCT00555425|Buprenorphine|buprenorphine|mesh-list
6044207|NCT00555425|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6044208|NCT00555425|Naloxone|naloxone|mesh-list
6044209|NCT00555425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6044210|NCT00555425|Narcotics|narcotics|mesh-ancestor
6044211|NCT00555425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6044212|NCT00555425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044213|NCT00555425|Analgesics|analgesics|mesh-ancestor
5497803|NCT04503460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5497804|NCT04503460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5497805|NCT04503460|Autonomic Agents|autonomic agents|mesh-ancestor
6044214|NCT00555425|Sensory System Agents|sensory system agents|mesh-ancestor
6044215|NCT00555425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6044216|NCT00555425|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6044217|NCT00555438|PENTA|penta|mesh-list
6044218|NCT00555438|Fondaparinux|fondaparinux|mesh-list
6044219|NCT00555438|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6044220|NCT00555438|Antithrombins|antithrombins|mesh-ancestor
6044221|NCT00555438|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6044222|NCT00555438|Protease Inhibitors|protease inhibitors|mesh-ancestor
6044223|NCT00555438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6044224|NCT00555438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044225|NCT00555438|Anticoagulants|anticoagulants|mesh-ancestor
6044226|NCT00555438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6044227|NCT00555438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6044228|NCT00555464|Prednisone|prednisone|mesh-list
6044229|NCT00555464|Prednisolone|prednisolone|mesh-list
6044230|NCT00555464|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6044231|NCT00555464|Methylprednisolone|methylprednisolone|mesh-list
6044232|NCT00555464|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6044233|NCT00555464|Prednisolone acetate|prednisolone acetate|mesh-list
6044234|NCT00555464|Vincristine|vincristine|mesh-list
6044235|NCT00555464|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6044236|NCT00555464|Prednisolone phosphate|prednisolone phosphate|mesh-list
6044237|NCT00555464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6044238|NCT00555464|Glucocorticoids|glucocorticoids|mesh-ancestor
6044239|NCT00555464|Hormones|hormones|mesh-ancestor
6044240|NCT00555464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6044241|NCT00555464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044242|NCT00555464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6044243|NCT00555464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6044244|NCT00555464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6044245|NCT00555464|Tubulin Modulators|tubulin modulators|mesh-ancestor
6044246|NCT00555464|Antimitotic Agents|antimitotic agents|mesh-ancestor
6044247|NCT00555464|Mitosis Modulators|mitosis modulators|mesh-ancestor
6044248|NCT00555464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044249|NCT00555464|Antiemetics|antiemetics|mesh-ancestor
6044250|NCT00555464|Autonomic Agents|autonomic agents|mesh-ancestor
6044251|NCT00555464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6044252|NCT00555464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6044253|NCT00555464|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6044254|NCT00555464|Protective Agents|protective agents|mesh-ancestor
6044255|NCT00555477|Anastrozole|anastrozole|mesh-list
6044256|NCT00555477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6044257|NCT00555477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6044258|NCT00555477|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6044259|NCT00555477|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6044260|NCT00555477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6044261|NCT00555477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044262|NCT00555477|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6044263|NCT00555477|Hormone Antagonists|hormone antagonists|mesh-ancestor
6044264|NCT00555477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6044265|NCT00555477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044266|NCT00555581|Imatinib Mesylate|imatinib mesylate|mesh-list
6044267|NCT00555581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6044268|NCT00555581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6044269|NCT00555581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6044270|NCT00555581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044271|NCT00555620|Capecitabine|capecitabine|mesh-list
6044272|NCT00555620|Oxaliplatin|oxaliplatin|mesh-list
6044273|NCT00555620|Sunitinib|sunitinib|mesh-list
6044274|NCT00555620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6044275|NCT00555620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6044276|NCT00555620|Antimetabolites|antimetabolites|mesh-ancestor
6044277|NCT00555620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044278|NCT00555620|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5497806|NCT04503460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6458148|NCT00439166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6044279|NCT00555620|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6044280|NCT00555620|Growth Substances|growth substances|mesh-ancestor
6655204|NCT01462006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6655205|NCT01462006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6655206|NCT01462006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6655207|NCT01462006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6655208|NCT01462006|Antifungal Agents|antifungal agents|mesh-ancestor
6655209|NCT01462006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6655210|NCT01462006|Immunologic Factors|immunologic factors|mesh-ancestor
6655211|NCT01462006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655212|NCT01462058|Vitamin D|vitamin d|mesh-list
6655213|NCT01462058|Cholecalciferol|cholecalciferol|mesh-list
6655214|NCT01462058|Vitamins|vitamins|mesh-ancestor
6655215|NCT01462058|Micronutrients|micronutrients|mesh-ancestor
6655216|NCT01462058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655217|NCT01462058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6655218|NCT01462058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6655219|NCT01462149|Carboplatin|carboplatin|mesh-list
6655220|NCT01462149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6655221|NCT01462214|Everolimus|everolimus|mesh-list
6044281|NCT00555620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044282|NCT00555620|Growth Inhibitors|growth inhibitors|mesh-ancestor
6044283|NCT00555620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6044284|NCT00555620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6044285|NCT00555672|Fluorouracil|fluorouracil|mesh-list
6044286|NCT00555672|Sunitinib|sunitinib|mesh-list
6044287|NCT00555672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6044288|NCT00555672|Antimetabolites|antimetabolites|mesh-ancestor
6044289|NCT00555672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044290|NCT00555672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6044291|NCT00555672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6044292|NCT00555672|Immunologic Factors|immunologic factors|mesh-ancestor
6044293|NCT00555672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044294|NCT00555672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6044295|NCT00555672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6044296|NCT00555672|Growth Substances|growth substances|mesh-ancestor
6458149|NCT00439166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458150|NCT00439166|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6458151|NCT00439166|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6458152|NCT00439166|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6458153|NCT00439166|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6458154|NCT00439166|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6458155|NCT00439166|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6458156|NCT00439192|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6458157|NCT00439192|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6458158|NCT00439192|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6458159|NCT00439192|Cholinergic Agents|cholinergic agents|mesh-ancestor
6458160|NCT00439192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6458161|NCT00439192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458162|NCT00439192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458163|NCT00439192|Urological Agents|urological agents|mesh-ancestor
6655222|NCT01462214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6655223|NCT01462214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6044297|NCT00555672|Growth Inhibitors|growth inhibitors|mesh-ancestor
6044298|NCT00555672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6044299|NCT00555672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6044300|NCT00555750|Eszopiclone|eszopiclone|mesh-list
6044301|NCT00555750|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6044302|NCT00555750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5725002|NCT03183557|Micronutrients|micronutrients|mesh-ancestor
5725003|NCT03183557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725004|NCT03183557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5725005|NCT03183375|Hydroxyurea|hydroxyurea|mesh-list
5725006|NCT03183375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5725007|NCT03183375|Antisickling Agents|antisickling agents|mesh-ancestor
6044303|NCT00555750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044304|NCT00555880|Midodrine|midodrine|mesh-list
6044305|NCT00555880|Sympathomimetics|sympathomimetics|mesh-ancestor
6044306|NCT00555880|Autonomic Agents|autonomic agents|mesh-ancestor
6044307|NCT00555880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6044308|NCT00555880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044309|NCT00555880|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6044310|NCT00555880|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6044311|NCT00555880|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6044312|NCT00555880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6044313|NCT00555880|Adrenergic Agents|adrenergic agents|mesh-ancestor
6044314|NCT00555880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6044315|NCT00555880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044316|NCT00555893|Oseltamivir|oseltamivir|mesh-list
6044317|NCT00555893|Antiviral Agents|antiviral agents|mesh-ancestor
6044318|NCT00555893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6044319|NCT00555893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6044320|NCT00555893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044321|NCT00555906|Dexamethasone|dexamethasone|mesh-list
6044322|NCT00555906|Bortezomib|bortezomib|mesh-list
6044323|NCT00555906|Palbociclib|palbociclib|mesh-list
6044324|NCT00555906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6044325|NCT00555906|Antiemetics|antiemetics|mesh-ancestor
6044326|NCT00555906|Autonomic Agents|autonomic agents|mesh-ancestor
6044327|NCT00555906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6044328|NCT00555906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044329|NCT00555906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6044330|NCT00555906|Glucocorticoids|glucocorticoids|mesh-ancestor
6044331|NCT00555906|Hormones|hormones|mesh-ancestor
6044332|NCT00555906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6044333|NCT00555906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6044334|NCT00555906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6044335|NCT00555906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6044336|NCT00555906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6044337|NCT00555906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044338|NCT00555971|Omalizumab|omalizumab|mesh-list
6044339|NCT00555971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6044340|NCT00555971|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6044341|NCT00555971|Respiratory System Agents|respiratory system agents|mesh-ancestor
6044342|NCT00555997|Ziprasidone|ziprasidone|mesh-list
6044343|NCT00555997|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6044344|NCT00555997|Serotonin Agents|serotonin agents|mesh-ancestor
6044345|NCT00555997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6044346|NCT00555997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044347|NCT00555997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044348|NCT00555997|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6044349|NCT00555997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6044350|NCT00555997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6044351|NCT00555997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6044352|NCT00555997|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6044353|NCT00555997|Dopamine Agents|dopamine agents|mesh-ancestor
6044354|NCT00556049|Gemcitabine|gemcitabine|mesh-list
6044355|NCT00556049|Sunitinib|sunitinib|mesh-list
6044356|NCT00556049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6044357|NCT00556049|Antimetabolites|antimetabolites|mesh-ancestor
6044358|NCT00556049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044359|NCT00556049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6044360|NCT00556049|Antiviral Agents|antiviral agents|mesh-ancestor
6044361|NCT00556049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6044362|NCT00556049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6044363|NCT00556049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6044364|NCT00556049|Immunologic Factors|immunologic factors|mesh-ancestor
6044365|NCT00556049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044366|NCT00556049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6044367|NCT00556049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6044368|NCT00556049|Growth Substances|growth substances|mesh-ancestor
6044369|NCT00556049|Growth Inhibitors|growth inhibitors|mesh-ancestor
6044370|NCT00556049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6044371|NCT00556140|Aripiprazole|aripiprazole|mesh-list
6044372|NCT00556140|Antidepressive Agents|antidepressive agents|mesh-ancestor
6044373|NCT00556140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6044374|NCT00556140|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6044375|NCT00556140|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6044376|NCT00556140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6044377|NCT00556140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044378|NCT00556140|Dopamine Agonists|dopamine agonists|mesh-ancestor
6044379|NCT00556140|Dopamine Agents|dopamine agents|mesh-ancestor
6044380|NCT00556140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6044381|NCT00556140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044382|NCT00556140|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6044383|NCT00556140|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6044384|NCT00556140|Serotonin Agents|serotonin agents|mesh-ancestor
5497807|NCT04503460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044385|NCT00556140|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6044386|NCT00556140|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6044387|NCT00556140|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6044388|NCT00556140|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6044389|NCT00556322|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6044390|NCT00556322|Docetaxel|docetaxel|mesh-list
6044391|NCT00556322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6044392|NCT00556322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6044393|NCT00556322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6044394|NCT00556322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044395|NCT00556322|Tubulin Modulators|tubulin modulators|mesh-ancestor
6044396|NCT00556322|Antimitotic Agents|antimitotic agents|mesh-ancestor
6044397|NCT00556322|Mitosis Modulators|mitosis modulators|mesh-ancestor
6044398|NCT00556374|Zoledronic Acid|zoledronic acid|mesh-list
6044399|NCT00556374|Denosumab|denosumab|mesh-list
6044400|NCT00556374|Aromatase Inhibitors|aromatase inhibitors|mesh-list
6044401|NCT00556374|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6044402|NCT00556374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044403|NCT00556374|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6044404|NCT00556374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6044405|NCT00556374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044406|NCT00556374|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6044407|NCT00556374|Hormone Antagonists|hormone antagonists|mesh-ancestor
6044408|NCT00556374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6044409|NCT00556439|Abatacept|abatacept|mesh-list
6044410|NCT00556439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6044411|NCT00556439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044412|NCT00556439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6044413|NCT00556439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6044414|NCT00556439|Immunologic Factors|immunologic factors|mesh-ancestor
6044415|NCT00556439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044416|NCT00556439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6044417|NCT00556452|Busulfan|busulfan|mesh-list
6044418|NCT00556452|Clofarabine|clofarabine|mesh-list
6044419|NCT00556452|Alkylating Agents|alkylating agents|mesh-ancestor
6044420|NCT00556452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044421|NCT00556452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6044422|NCT00556452|Immunologic Factors|immunologic factors|mesh-ancestor
6044423|NCT00556452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044424|NCT00556452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6044425|NCT00556452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6044426|NCT00556452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6044427|NCT00556452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6044428|NCT00556452|Antimetabolites|antimetabolites|mesh-ancestor
6044429|NCT00556478|Lidocaine|lidocaine|mesh-list
6044430|NCT00556478|Prilocaine|prilocaine|mesh-list
6044431|NCT00556478|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
6044432|NCT00556478|Anesthetics, Local|anesthetics, local|mesh-ancestor
6044433|NCT00556478|Anesthetics|anesthetics|mesh-ancestor
6044434|NCT00556478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6044435|NCT00556478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044436|NCT00556478|Sensory System Agents|sensory system agents|mesh-ancestor
6044437|NCT00556478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6044438|NCT00556478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6044439|NCT00556478|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6044440|NCT00556478|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6044441|NCT00556478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6044442|NCT00556478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044443|NCT00556478|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
6044444|NCT00556491|Minocycline|minocycline|mesh-list
6044445|NCT00556491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6044446|NCT00556491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6044447|NCT00556504|Ribavirin|ribavirin|mesh-list
6044448|NCT00556504|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6044449|NCT00556504|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6044450|NCT00556504|Antimetabolites|antimetabolites|mesh-ancestor
6053859|NCT00598871|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6044451|NCT00556504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044452|NCT00556504|Antiviral Agents|antiviral agents|mesh-ancestor
6044453|NCT00556504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6044454|NCT00556673|Fluticasone|fluticasone|mesh-list
6044455|NCT00556673|Mometasone Furoate|mometasone furoate|mesh-list
6044456|NCT00556673|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6044457|NCT00556673|Maleic acid|maleic acid|mesh-list
6044458|NCT00556673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6044459|NCT00556673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6044460|NCT00556673|Autonomic Agents|autonomic agents|mesh-ancestor
6044461|NCT00556673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6044462|NCT00556673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044463|NCT00556673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6044464|NCT00556673|Respiratory System Agents|respiratory system agents|mesh-ancestor
6044465|NCT00556673|Dermatologic Agents|dermatologic agents|mesh-ancestor
6044466|NCT00556673|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6044467|NCT00556673|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6458164|NCT00439283|Methotrexate|methotrexate|mesh-list
6458165|NCT00439283|Infliximab|infliximab|mesh-list
6458166|NCT00439283|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6458167|NCT00439283|Abortifacient Agents|abortifacient agents|mesh-ancestor
6458168|NCT00439283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6458169|NCT00439283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458170|NCT00439283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6458171|NCT00439283|Antimetabolites|antimetabolites|mesh-ancestor
6458172|NCT00439283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458173|NCT00439283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6458174|NCT00439283|Dermatologic Agents|dermatologic agents|mesh-ancestor
6458175|NCT00439283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6458176|NCT00439283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6458177|NCT00439283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6458178|NCT00439283|Immunologic Factors|immunologic factors|mesh-ancestor
6458179|NCT00439283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6458180|NCT00439283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6458181|NCT00439283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5497808|NCT04503460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6044468|NCT00556673|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6044469|NCT00556673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6044470|NCT00556673|Adrenergic Agents|adrenergic agents|mesh-ancestor
6044471|NCT00556673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6044472|NCT00556673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044473|NCT00556673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6044474|NCT00556712|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5497809|NCT04503460|Respiratory System Agents|respiratory system agents|mesh-ancestor
5497810|NCT04503460|Dermatologic Agents|dermatologic agents|mesh-ancestor
5497811|NCT04503460|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5497812|NCT04503460|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5497813|NCT04503460|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6044475|NCT00556712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6044476|NCT00556712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6044477|NCT00556712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6044478|NCT00556712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044479|NCT00556933|Mycophenolic Acid|mycophenolic acid|mesh-list
6044480|NCT00556933|Sirolimus|sirolimus|mesh-list
6044481|NCT00556933|Tacrolimus|tacrolimus|mesh-list
6044482|NCT00556933|Thymoglobulin|thymoglobulin|mesh-list
6044483|NCT00556933|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6044484|NCT00556933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6044485|NCT00556933|Immunologic Factors|immunologic factors|mesh-ancestor
6044486|NCT00556933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044487|NCT00556933|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6044488|NCT00556933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6044489|NCT00556933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044490|NCT00556933|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6044491|NCT00556933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6044492|NCT00556933|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6044493|NCT00556933|Antitubercular Agents|antitubercular agents|mesh-ancestor
6044494|NCT00556933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6044495|NCT00556933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6044496|NCT00556933|Antifungal Agents|antifungal agents|mesh-ancestor
6044497|NCT00556998|Voriconazole|voriconazole|mesh-list
6044498|NCT00556998|Antifungal Agents|antifungal agents|mesh-ancestor
6044499|NCT00556998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6044500|NCT00556998|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6458182|NCT00439361|Carboplatin|carboplatin|mesh-list
6044501|NCT00556998|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6044502|NCT00556998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6044503|NCT00556998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044504|NCT00556998|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6044505|NCT00556998|Hormone Antagonists|hormone antagonists|mesh-ancestor
6044506|NCT00556998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6044507|NCT00556998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044508|NCT00556998|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6044509|NCT00557193|Calcium, Dietary|calcium, dietary|mesh-list
6044510|NCT00557193|Leucovorin|leucovorin|mesh-list
6044511|NCT00557193|Folic Acid|folic acid|mesh-list
6044512|NCT00557193|Cytarabine|cytarabine|mesh-list
6044513|NCT00557193|Dexamethasone|dexamethasone|mesh-list
6044514|NCT00557193|Prednisone|prednisone|mesh-list
6044515|NCT00557193|Methylprednisolone|methylprednisolone|mesh-list
6044516|NCT00557193|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6044517|NCT00557193|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6044518|NCT00557193|Prednisolone|prednisolone|mesh-list
6044519|NCT00557193|Prednisolone acetate|prednisolone acetate|mesh-list
6044520|NCT00557193|Hydrocortisone|hydrocortisone|mesh-list
6044521|NCT00557193|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6044522|NCT00557193|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6044523|NCT00557193|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6044524|NCT00557193|Dexamethasone acetate|dexamethasone acetate|mesh-list
6044525|NCT00557193|Cortisone|cortisone|mesh-list
6044526|NCT00557193|Cyclophosphamide|cyclophosphamide|mesh-list
6044527|NCT00557193|Methotrexate|methotrexate|mesh-list
6044528|NCT00557193|Etoposide|etoposide|mesh-list
6044529|NCT00557193|Vincristine|vincristine|mesh-list
6044530|NCT00557193|Etoposide phosphate|etoposide phosphate|mesh-list
6044531|NCT00557193|Daunorubicin|daunorubicin|mesh-list
6044532|NCT00557193|Asparaginase|asparaginase|mesh-list
6044533|NCT00557193|Mercaptopurine|mercaptopurine|mesh-list
6044534|NCT00557193|Podophyllotoxin|podophyllotoxin|mesh-list
6044535|NCT00557193|Pegaspargase|pegaspargase|mesh-list
6044536|NCT00557193|Lenograstim|lenograstim|mesh-list
6044537|NCT00557193|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6044538|NCT00557193|Prednisolone phosphate|prednisolone phosphate|mesh-list
6044539|NCT00557193|Calcium|calcium|mesh-list
6044540|NCT00557193|BB 1101|bb 1101|mesh-list
6044541|NCT00557193|Levoleucovorin|levoleucovorin|mesh-list
6044542|NCT00557193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6044543|NCT00557193|Immunologic Factors|immunologic factors|mesh-ancestor
6044544|NCT00557193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044545|NCT00557193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6044546|NCT00557193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6044547|NCT00557193|Alkylating Agents|alkylating agents|mesh-ancestor
6044548|NCT00557193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044549|NCT00557193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6044550|NCT00557193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6044551|NCT00557193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6044552|NCT00557193|Antiemetics|antiemetics|mesh-ancestor
6044553|NCT00557193|Autonomic Agents|autonomic agents|mesh-ancestor
6044554|NCT00557193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6044555|NCT00557193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6044556|NCT00557193|Glucocorticoids|glucocorticoids|mesh-ancestor
6044557|NCT00557193|Hormones|hormones|mesh-ancestor
6044558|NCT00557193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6044559|NCT00557193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6044560|NCT00557193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6044561|NCT00557193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6044562|NCT00557193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6044563|NCT00557193|Abortifacient Agents|abortifacient agents|mesh-ancestor
6044564|NCT00557193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6044565|NCT00557193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6044566|NCT00557193|Antimetabolites|antimetabolites|mesh-ancestor
6044567|NCT00557193|Dermatologic Agents|dermatologic agents|mesh-ancestor
6044568|NCT00557193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6044569|NCT00557193|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6044570|NCT00557193|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6044571|NCT00557193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6044572|NCT00557193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6044573|NCT00557193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6044574|NCT00557193|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6044575|NCT00557193|Antiviral Agents|antiviral agents|mesh-ancestor
6044576|NCT00557193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6044577|NCT00557193|Antidotes|antidotes|mesh-ancestor
6044578|NCT00557193|Protective Agents|protective agents|mesh-ancestor
6044579|NCT00557193|Vitamin B Complex|vitamin b complex|mesh-ancestor
6044580|NCT00557193|Vitamins|vitamins|mesh-ancestor
6044581|NCT00557193|Micronutrients|micronutrients|mesh-ancestor
6044582|NCT00557193|Tubulin Modulators|tubulin modulators|mesh-ancestor
6044583|NCT00557193|Antimitotic Agents|antimitotic agents|mesh-ancestor
6044584|NCT00557193|Mitosis Modulators|mitosis modulators|mesh-ancestor
6044585|NCT00557193|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6044586|NCT00557193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6044587|NCT00557193|Hematinics|hematinics|mesh-ancestor
6044588|NCT00557193|Protease Inhibitors|protease inhibitors|mesh-ancestor
6044589|NCT00557193|Keratolytic Agents|keratolytic agents|mesh-ancestor
6044590|NCT00557245|Tenofovir|tenofovir|mesh-list
6044591|NCT00557245|Emtricitabine|emtricitabine|mesh-list
6044592|NCT00557245|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6044593|NCT00557245|Antiviral Agents|antiviral agents|mesh-ancestor
6044594|NCT00557245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6044595|NCT00557245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6044596|NCT00557245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6044597|NCT00557245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6044598|NCT00557245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044599|NCT00557245|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6044600|NCT00557245|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6044601|NCT00557284|Montelukast|montelukast|mesh-list
6044602|NCT00557284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6044603|NCT00557284|Respiratory System Agents|respiratory system agents|mesh-ancestor
6044604|NCT00557284|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6044605|NCT00557284|Hormone Antagonists|hormone antagonists|mesh-ancestor
6044606|NCT00557284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6044607|NCT00557284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044608|NCT00557284|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6044609|NCT00557284|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6044610|NCT00557284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044611|NCT00557310|Teriparatide|teriparatide|mesh-list
6044612|NCT00557310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6044613|NCT00557310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044614|NCT00557310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6044615|NCT00557349|Omeprazole|omeprazole|mesh-list
6044616|NCT00557349|Famotidine|famotidine|mesh-list
6044617|NCT00557349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6044618|NCT00557349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6044619|NCT00557349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6044620|NCT00557349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6044621|NCT00557349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044622|NCT00557349|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6044623|NCT00557349|Histamine Antagonists|histamine antagonists|mesh-ancestor
6044624|NCT00557349|Histamine Agents|histamine agents|mesh-ancestor
6044625|NCT00557349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6044626|NCT00557349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044627|NCT00557362|Voriconazole|voriconazole|mesh-list
6044628|NCT00557362|Natamycin|natamycin|mesh-list
6044629|NCT00557362|Antifungal Agents|antifungal agents|mesh-ancestor
6044630|NCT00557362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6044631|NCT00557362|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6044632|NCT00557362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6044633|NCT00557362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6044634|NCT00557362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044635|NCT00557362|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6044636|NCT00557362|Hormone Antagonists|hormone antagonists|mesh-ancestor
6044637|NCT00557362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6044638|NCT00557362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044639|NCT00557362|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6044640|NCT00557362|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6044641|NCT00557362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6044642|NCT00557440|Fluticasone|fluticasone|mesh-list
6044643|NCT00557440|Xhance|xhance|mesh-list
6044644|NCT00557440|Mometasone Furoate|mometasone furoate|mesh-list
6044645|NCT00557440|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6044646|NCT00557440|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6044647|NCT00557440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6044648|NCT00557440|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6044649|NCT00557440|Autonomic Agents|autonomic agents|mesh-ancestor
6044650|NCT00557440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6044651|NCT00557440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044652|NCT00557440|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6044653|NCT00557440|Respiratory System Agents|respiratory system agents|mesh-ancestor
6044654|NCT00557440|Dermatologic Agents|dermatologic agents|mesh-ancestor
6044655|NCT00557440|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6044656|NCT00557440|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6044657|NCT00557440|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6044658|NCT00557440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6044659|NCT00557440|Adrenergic Agents|adrenergic agents|mesh-ancestor
6044660|NCT00557440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6044661|NCT00557440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044662|NCT00557440|Glucocorticoids|glucocorticoids|mesh-ancestor
6044663|NCT00557440|Hormones|hormones|mesh-ancestor
6044664|NCT00557440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6044665|NCT00557440|Sympathomimetics|sympathomimetics|mesh-ancestor
6044666|NCT00557466|Formoterol Fumarate|formoterol fumarate|mesh-list
6044667|NCT00557466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6458183|NCT00439361|Etoposide|etoposide|mesh-list
5497814|NCT04503460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5497815|NCT04503460|Adrenergic Agents|adrenergic agents|mesh-ancestor
5497816|NCT04503460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5497817|NCT04503460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5497818|NCT04503460|Glucocorticoids|glucocorticoids|mesh-ancestor
5497819|NCT04503460|Hormones|hormones|mesh-ancestor
6458184|NCT00439361|Bortezomib|bortezomib|mesh-list
6458185|NCT00439361|Ifosfamide|ifosfamide|mesh-list
6458186|NCT00439361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6458187|NCT00439361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6458188|NCT00439361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6458189|NCT00439361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6458190|NCT00439361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6458191|NCT00439361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458192|NCT00439361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6458193|NCT00439361|Alkylating Agents|alkylating agents|mesh-ancestor
6458194|NCT00439400|Doxycycline|doxycycline|mesh-list
6458195|NCT00439400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6458196|NCT00439400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6458197|NCT00439400|Antimalarials|antimalarials|mesh-ancestor
6458198|NCT00439400|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6458199|NCT00439400|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6044668|NCT00557466|Autonomic Agents|autonomic agents|mesh-ancestor
6044669|NCT00557466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6044670|NCT00557466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044671|NCT00557466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6044672|NCT00557466|Respiratory System Agents|respiratory system agents|mesh-ancestor
6044673|NCT00557466|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6044674|NCT00557466|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6044675|NCT00557466|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6044676|NCT00557466|Adrenergic Agents|adrenergic agents|mesh-ancestor
6044677|NCT00557466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6044678|NCT00557466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044679|NCT00557492|Gemcitabine|gemcitabine|mesh-list
6044680|NCT00557492|Bevacizumab|bevacizumab|mesh-list
6044681|NCT00557492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6458200|NCT00439426|Capecitabine|capecitabine|mesh-list
6044682|NCT00557492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6044683|NCT00557492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6044684|NCT00557492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6044685|NCT00557492|Growth Substances|growth substances|mesh-ancestor
6044686|NCT00557492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044687|NCT00557492|Growth Inhibitors|growth inhibitors|mesh-ancestor
6044688|NCT00557492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6044689|NCT00557492|Antimetabolites|antimetabolites|mesh-ancestor
6044690|NCT00557492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044691|NCT00557492|Antiviral Agents|antiviral agents|mesh-ancestor
6044692|NCT00557492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6044693|NCT00557492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6044694|NCT00557492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6044695|NCT00557492|Immunologic Factors|immunologic factors|mesh-ancestor
6044696|NCT00557622|Paroxetine|paroxetine|mesh-list
6044697|NCT00557622|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6044698|NCT00557622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6044699|NCT00557622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6044700|NCT00557622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044701|NCT00557622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6044702|NCT00557622|Serotonin Agents|serotonin agents|mesh-ancestor
6458201|NCT00439426|Oxaliplatin|oxaliplatin|mesh-list
6458202|NCT00439426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6458203|NCT00439426|Antimetabolites|antimetabolites|mesh-ancestor
6458204|NCT00439426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458205|NCT00439426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6461984|NCT00456963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6461985|NCT00456963|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6461986|NCT00456963|Protease Inhibitors|protease inhibitors|mesh-ancestor
6044703|NCT00557622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044704|NCT00557622|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6044705|NCT00557622|Antidepressive Agents|antidepressive agents|mesh-ancestor
6044706|NCT00557622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6044707|NCT00557622|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6044708|NCT00557622|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6044709|NCT00557622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6044710|NCT00557830|Sorafenib|sorafenib|mesh-list
6044711|NCT00557830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6044712|NCT00557830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6044713|NCT00557830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6044714|NCT00557830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044715|NCT00558012|Vitamin D|vitamin d|mesh-list
6044716|NCT00558012|Zoledronic Acid|zoledronic acid|mesh-list
6044717|NCT00558012|Calcium|calcium|mesh-list
6044718|NCT00558012|Vitamins|vitamins|mesh-ancestor
6044719|NCT00558012|Micronutrients|micronutrients|mesh-ancestor
6044720|NCT00558012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044721|NCT00558012|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6044722|NCT00558012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6044723|NCT00558025|Pramipexole|pramipexole|mesh-list
6044724|NCT00558025|Antioxidants|antioxidants|mesh-ancestor
6044725|NCT00558025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044726|NCT00558025|Protective Agents|protective agents|mesh-ancestor
6044727|NCT00558025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044728|NCT00558025|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6044729|NCT00558025|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6044730|NCT00558025|Dopamine Agonists|dopamine agonists|mesh-ancestor
6044731|NCT00558025|Dopamine Agents|dopamine agents|mesh-ancestor
6044732|NCT00558025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6044733|NCT00558064|Amlodipine|amlodipine|mesh-list
6044734|NCT00558064|Telmisartan|telmisartan|mesh-list
6044735|NCT00558064|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
6044736|NCT00558064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6044737|NCT00558064|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5497820|NCT04503460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5497821|NCT04503460|Sympathomimetics|sympathomimetics|mesh-ancestor
5497822|NCT04503252|Cefazolin|cefazolin|mesh-list
5497823|NCT04503252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5497824|NCT04503252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5497825|NCT04503161|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5497826|NCT04503161|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5497827|NCT04503161|Estradiol|estradiol|mesh-list
6044738|NCT00558064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5497828|NCT04503161|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6044739|NCT00558064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044740|NCT00558064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6044741|NCT00558064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044742|NCT00558064|Vasodilator Agents|vasodilator agents|mesh-ancestor
6044743|NCT00558064|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6044744|NCT00558064|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6044745|NCT00558103|Lapatinib|lapatinib|mesh-list
6044746|NCT00558103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6044747|NCT00558103|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6044748|NCT00558103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6044749|NCT00558103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044750|NCT00558259|Dabigatran|dabigatran|mesh-list
6044751|NCT00558259|Antithrombins|antithrombins|mesh-ancestor
6044752|NCT00558259|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6044753|NCT00558259|Protease Inhibitors|protease inhibitors|mesh-ancestor
6044754|NCT00558259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6044755|NCT00558259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044756|NCT00558259|Anticoagulants|anticoagulants|mesh-ancestor
6044757|NCT00558272|Zoledronic Acid|zoledronic acid|mesh-list
6044758|NCT00558272|Saracatinib|saracatinib|mesh-list
6044759|NCT00558272|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6044760|NCT00558272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044761|NCT00558272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6044762|NCT00558272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6044763|NCT00558272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044764|NCT00558285|Glycopyrrolate|glycopyrrolate|mesh-list
6044765|NCT00558285|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6044766|NCT00558285|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6044767|NCT00558285|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6044768|NCT00558285|Cholinergic Agents|cholinergic agents|mesh-ancestor
6044769|NCT00558285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6044770|NCT00558285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044771|NCT00558285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044772|NCT00558363|Dutasteride|dutasteride|mesh-list
6044773|NCT00558363|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6044774|NCT00558363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6655224|NCT01462214|Immunologic Factors|immunologic factors|mesh-ancestor
6655225|NCT01462214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655226|NCT01462422|Misoprostol|misoprostol|mesh-list
6655227|NCT01462422|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6655228|NCT01462422|Abortifacient Agents|abortifacient agents|mesh-ancestor
6044775|NCT00558363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6044776|NCT00558363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044777|NCT00558363|Hormone Antagonists|hormone antagonists|mesh-ancestor
6044778|NCT00558363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6044779|NCT00558363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044780|NCT00558428|Amlodipine|amlodipine|mesh-list
6044781|NCT00558428|Telmisartan|telmisartan|mesh-list
6044782|NCT00558428|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
6044783|NCT00558428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6044784|NCT00558428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6044785|NCT00558428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5497829|NCT04503161|Estrogens|estrogens|mesh-ancestor
5497830|NCT04503161|Hormones|hormones|mesh-ancestor
5497831|NCT04503161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5497832|NCT04503161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497833|NCT04503161|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5497834|NCT04503161|Contraceptive Agents|contraceptive agents|mesh-ancestor
5497835|NCT04503161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5497836|NCT04503161|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5497837|NCT04502966|Immunologic Factors|immunologic factors|mesh-list
5497838|NCT04502966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5497839|NCT04502966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497840|NCT04502771|Antifungal Agents|antifungal agents|mesh-list
5497841|NCT04502771|Clotrimazole|clotrimazole|mesh-list
5497842|NCT04502771|Miconazole|miconazole|mesh-list
5497843|NCT04502771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5497844|NCT04502771|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6044786|NCT00558428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044787|NCT00558428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6044788|NCT00558428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044789|NCT00558428|Vasodilator Agents|vasodilator agents|mesh-ancestor
6044790|NCT00558428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6044791|NCT00558428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6044792|NCT00558467|Pramipexole|pramipexole|mesh-list
6044793|NCT00558467|Antioxidants|antioxidants|mesh-ancestor
6044794|NCT00558467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044795|NCT00558467|Protective Agents|protective agents|mesh-ancestor
6044796|NCT00558467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044797|NCT00558467|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6044798|NCT00558467|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6044799|NCT00558467|Dopamine Agonists|dopamine agonists|mesh-ancestor
6044800|NCT00558467|Dopamine Agents|dopamine agents|mesh-ancestor
6044801|NCT00558467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6044802|NCT00558519|Cytarabine|cytarabine|mesh-list
6044803|NCT00558519|Dexamethasone|dexamethasone|mesh-list
6044804|NCT00558519|Cyclophosphamide|cyclophosphamide|mesh-list
6044805|NCT00558519|Doxorubicin|doxorubicin|mesh-list
6044806|NCT00558519|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6044807|NCT00558519|Methotrexate|methotrexate|mesh-list
6044808|NCT00558519|Vincristine|vincristine|mesh-list
6044809|NCT00558519|Daunorubicin|daunorubicin|mesh-list
6044810|NCT00558519|Mercaptopurine|mercaptopurine|mesh-list
6044811|NCT00558519|Pegaspargase|pegaspargase|mesh-list
6044812|NCT00558519|Thioguanine|thioguanine|mesh-list
6044813|NCT00558519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6044814|NCT00558519|Immunologic Factors|immunologic factors|mesh-ancestor
6044815|NCT00558519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044816|NCT00558519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6044817|NCT00558519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6044818|NCT00558519|Alkylating Agents|alkylating agents|mesh-ancestor
6044819|NCT00558519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044820|NCT00558519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6044821|NCT00558519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6044822|NCT00558519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6044823|NCT00558519|Antiemetics|antiemetics|mesh-ancestor
6044824|NCT00558519|Autonomic Agents|autonomic agents|mesh-ancestor
6044825|NCT00558519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6044826|NCT00558519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6044827|NCT00558519|Glucocorticoids|glucocorticoids|mesh-ancestor
6044828|NCT00558519|Hormones|hormones|mesh-ancestor
6044829|NCT00558519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6044830|NCT00558519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6044831|NCT00558519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6044832|NCT00558519|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6044833|NCT00558519|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6044834|NCT00558519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6044835|NCT00558519|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6044836|NCT00558519|Abortifacient Agents|abortifacient agents|mesh-ancestor
6044837|NCT00558519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6044838|NCT00558519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6044839|NCT00558519|Antimetabolites|antimetabolites|mesh-ancestor
6044840|NCT00558519|Dermatologic Agents|dermatologic agents|mesh-ancestor
6044841|NCT00558519|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6044842|NCT00558519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6044843|NCT00558519|Antiviral Agents|antiviral agents|mesh-ancestor
6044844|NCT00558519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6044845|NCT00558519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6044846|NCT00558519|Tubulin Modulators|tubulin modulators|mesh-ancestor
6044847|NCT00558519|Antimitotic Agents|antimitotic agents|mesh-ancestor
6044848|NCT00558519|Mitosis Modulators|mitosis modulators|mesh-ancestor
6053860|NCT00598975|Irinotecan|irinotecan|mesh-list
6053861|NCT00598975|Cetuximab|cetuximab|mesh-list
6053862|NCT00598975|Etirinotecan pegol|etirinotecan pegol|mesh-list
6053863|NCT00598975|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6053864|NCT00598975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6053865|NCT00598975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6053866|NCT00598975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5497845|NCT04502771|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5497846|NCT04502771|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5497847|NCT04502771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5497848|NCT04502771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5497849|NCT04502771|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5497850|NCT04502771|Hormone Antagonists|hormone antagonists|mesh-ancestor
6053867|NCT00598975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6053868|NCT00598975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6053869|NCT00598975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6053870|NCT00599053|Azithromycin|azithromycin|mesh-list
6044849|NCT00558571|Empagliflozin|empagliflozin|mesh-list
6044850|NCT00558571|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6044851|NCT00558571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044852|NCT00558571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6044853|NCT00558571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044854|NCT00558636|Paclitaxel|paclitaxel|mesh-list
6044855|NCT00558636|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6044856|NCT00558636|Carboplatin|carboplatin|mesh-list
6044857|NCT00558636|Sorafenib|sorafenib|mesh-list
6044858|NCT00558636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6044859|NCT00558636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6044860|NCT00558636|Tubulin Modulators|tubulin modulators|mesh-ancestor
6044861|NCT00558636|Antimitotic Agents|antimitotic agents|mesh-ancestor
6044862|NCT00558636|Mitosis Modulators|mitosis modulators|mesh-ancestor
6044863|NCT00558636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044864|NCT00558636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6044865|NCT00558636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6044866|NCT00558753|Pregabalin|pregabalin|mesh-list
6044867|NCT00558753|Analgesics|analgesics|mesh-ancestor
6044868|NCT00558753|Sensory System Agents|sensory system agents|mesh-ancestor
6044869|NCT00558753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6044870|NCT00558753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497851|NCT04502771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5497852|NCT04502771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497853|NCT04502771|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5497854|NCT04502771|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5497855|NCT04502849|Vitamin E|vitamin e|mesh-list
5497856|NCT04502849|Tocopherols|tocopherols|mesh-list
5497857|NCT04502849|alpha-Tocopherol|alpha-tocopherol|mesh-list
5497858|NCT04502849|Vitamins|vitamins|mesh-ancestor
5497859|NCT04502849|Micronutrients|micronutrients|mesh-ancestor
5497860|NCT04502849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497861|NCT04502849|Antioxidants|antioxidants|mesh-ancestor
5497862|NCT04502849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5497863|NCT04502849|Protective Agents|protective agents|mesh-ancestor
5497864|NCT04502667|Vitamin D|vitamin d|mesh-list
5497865|NCT04502667|Cholecalciferol|cholecalciferol|mesh-list
5497866|NCT04502667|Vitamins|vitamins|mesh-ancestor
5497867|NCT04502667|Micronutrients|micronutrients|mesh-ancestor
5497868|NCT04502667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497869|NCT04502667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5497870|NCT04502667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5503340|NCT04460521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503341|NCT04460521|Protective Agents|protective agents|mesh-ancestor
5503342|NCT04460521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503343|NCT04460521|Antidotes|antidotes|mesh-ancestor
5503344|NCT04460001|Triamcinolone|triamcinolone|mesh-list
5503345|NCT04460001|Ranibizumab|ranibizumab|mesh-list
5503346|NCT04460001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5503347|NCT04460001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5503348|NCT04460001|Growth Substances|growth substances|mesh-ancestor
5503349|NCT04460001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503350|NCT04460001|Growth Inhibitors|growth inhibitors|mesh-ancestor
5503351|NCT04460001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5503352|NCT04460001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5503353|NCT04460001|Glucocorticoids|glucocorticoids|mesh-ancestor
5503354|NCT04460001|Hormones|hormones|mesh-ancestor
5503355|NCT04460001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5503356|NCT04460066|Paclitaxel|paclitaxel|mesh-list
5503357|NCT04460066|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5503358|NCT04460066|Antibodies|antibodies|mesh-list
5503359|NCT04460066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5503360|NCT04460066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5503361|NCT04460066|Tubulin Modulators|tubulin modulators|mesh-ancestor
5503362|NCT04460066|Antimitotic Agents|antimitotic agents|mesh-ancestor
5503363|NCT04460066|Mitosis Modulators|mitosis modulators|mesh-ancestor
5503364|NCT04460066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503365|NCT04460066|Immunologic Factors|immunologic factors|mesh-ancestor
5503366|NCT04460066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503367|NCT04460092|Insulin|insulin|mesh-list
5503368|NCT04460092|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5503369|NCT04460092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5503370|NCT04460092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503371|NCT04460079|Lenograstim|lenograstim|mesh-list
6044871|NCT00558753|Anticonvulsants|anticonvulsants|mesh-ancestor
6044872|NCT00558753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6044873|NCT00558753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6044874|NCT00558753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044875|NCT00558753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6655229|NCT01462422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6655230|NCT01462422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044876|NCT00558753|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6044877|NCT00558753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6044878|NCT00558753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6044879|NCT00558753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6044880|NCT00558831|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6044881|NCT00558831|Dermatologic Agents|dermatologic agents|mesh-ancestor
6044882|NCT00558896|Dexamethasone|dexamethasone|mesh-list
6044883|NCT00558896|Pomalidomide|pomalidomide|mesh-list
6044884|NCT00558896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6044885|NCT00558896|Antiemetics|antiemetics|mesh-ancestor
6044886|NCT00558896|Autonomic Agents|autonomic agents|mesh-ancestor
6044887|NCT00558896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6044888|NCT00558896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044889|NCT00558896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6044890|NCT00558896|Glucocorticoids|glucocorticoids|mesh-ancestor
6044891|NCT00558896|Hormones|hormones|mesh-ancestor
6044892|NCT00558896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6044893|NCT00558896|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6044894|NCT00558896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6044895|NCT00558896|Immunologic Factors|immunologic factors|mesh-ancestor
6044896|NCT00558896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6044897|NCT00558896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6044898|NCT00558896|Growth Substances|growth substances|mesh-ancestor
6044899|NCT00558896|Growth Inhibitors|growth inhibitors|mesh-ancestor
6044900|NCT00559104|Cyclophosphamide|cyclophosphamide|mesh-list
6044901|NCT00559104|Carmustine|carmustine|mesh-list
6044902|NCT00559104|Etoposide|etoposide|mesh-list
6044903|NCT00559104|Sargramostim|sargramostim|mesh-list
6044904|NCT00559104|Lenograstim|lenograstim|mesh-list
6044905|NCT00559104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6044906|NCT00559104|Immunologic Factors|immunologic factors|mesh-ancestor
6044907|NCT00559104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044908|NCT00559104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6044909|NCT00559104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6044910|NCT00559104|Alkylating Agents|alkylating agents|mesh-ancestor
6044911|NCT00559104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044912|NCT00559104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6044913|NCT00559104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6044914|NCT00559104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6044915|NCT00559104|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6044916|NCT00559104|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6044917|NCT00559104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6044918|NCT00559104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6044919|NCT00559273|Darbepoetin alfa|darbepoetin alfa|mesh-list
6044920|NCT00559273|Hematinics|hematinics|mesh-ancestor
6044921|NCT00559364|Omeprazole|omeprazole|mesh-list
6044922|NCT00559364|Pancrelipase|pancrelipase|mesh-list
6044923|NCT00559364|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
6044924|NCT00559364|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6044925|NCT00559364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6044926|NCT00559364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6044927|NCT00559364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044928|NCT00559377|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6044929|NCT00559377|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6044930|NCT00559377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044931|NCT00559468|Bromides|bromides|mesh-list
6044932|NCT00559468|Propofol|propofol|mesh-list
6044933|NCT00559468|Sevoflurane|sevoflurane|mesh-list
6044934|NCT00559468|Rocuronium|rocuronium|mesh-list
6044935|NCT00559468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6044936|NCT00559468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6044937|NCT00559468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044938|NCT00559468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6044939|NCT00559468|Anesthetics, General|anesthetics, general|mesh-ancestor
5497871|NCT04502641|Docetaxel|docetaxel|mesh-list
5497872|NCT04502641|Fluorouracil|fluorouracil|mesh-list
5497873|NCT04502641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5497874|NCT04502641|Tubulin Modulators|tubulin modulators|mesh-ancestor
6044940|NCT00559468|Anesthetics|anesthetics|mesh-ancestor
6458206|NCT00439504|Lobeline|lobeline|mesh-list
5497875|NCT04502641|Antimitotic Agents|antimitotic agents|mesh-ancestor
6458207|NCT00439504|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6044941|NCT00559468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6044942|NCT00559468|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6044943|NCT00559468|Anticonvulsants|anticonvulsants|mesh-ancestor
6044944|NCT00559468|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6044945|NCT00559468|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6044946|NCT00559468|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6044947|NCT00559468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6044948|NCT00559507|Saracatinib|saracatinib|mesh-list
6044949|NCT00559507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6044950|NCT00559507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6044951|NCT00559507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044952|NCT00559585|Abatacept|abatacept|mesh-list
6044953|NCT00559585|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6044954|NCT00559585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044955|NCT00559585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6044956|NCT00559585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6044957|NCT00559585|Immunologic Factors|immunologic factors|mesh-ancestor
6044958|NCT00559585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044959|NCT00559585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6044960|NCT00559637|Epoetin Alfa|epoetin alfa|mesh-list
6044961|NCT00559637|Hematinics|hematinics|mesh-ancestor
6044962|NCT00559754|Bevacizumab|bevacizumab|mesh-list
6044963|NCT00559754|Docetaxel|docetaxel|mesh-list
6044964|NCT00559754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6044965|NCT00559754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6044966|NCT00559754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6044967|NCT00559754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6044968|NCT00559754|Growth Substances|growth substances|mesh-ancestor
6044969|NCT00559754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044970|NCT00559754|Growth Inhibitors|growth inhibitors|mesh-ancestor
6044971|NCT00559754|Tubulin Modulators|tubulin modulators|mesh-ancestor
5497876|NCT04502641|Mitosis Modulators|mitosis modulators|mesh-ancestor
5497877|NCT04502641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5497878|NCT04502641|Antimetabolites|antimetabolites|mesh-ancestor
6044972|NCT00559754|Antimitotic Agents|antimitotic agents|mesh-ancestor
6044973|NCT00559754|Mitosis Modulators|mitosis modulators|mesh-ancestor
6044974|NCT00559754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044975|NCT00559845|Paclitaxel|paclitaxel|mesh-list
6044976|NCT00559845|Cyclophosphamide|cyclophosphamide|mesh-list
6044977|NCT00559845|Bevacizumab|bevacizumab|mesh-list
6044978|NCT00559845|Fluorouracil|fluorouracil|mesh-list
6044979|NCT00559845|Epirubicin|epirubicin|mesh-list
6044980|NCT00559845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6044981|NCT00559845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6044982|NCT00559845|Tubulin Modulators|tubulin modulators|mesh-ancestor
6044983|NCT00559845|Antimitotic Agents|antimitotic agents|mesh-ancestor
6044984|NCT00559845|Mitosis Modulators|mitosis modulators|mesh-ancestor
6044985|NCT00559845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6044986|NCT00559845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6044987|NCT00559845|Immunologic Factors|immunologic factors|mesh-ancestor
6044988|NCT00559845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6044989|NCT00559845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6044990|NCT00559845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6044991|NCT00559845|Alkylating Agents|alkylating agents|mesh-ancestor
6044992|NCT00559845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6044993|NCT00559845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6044994|NCT00559845|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6044995|NCT00559845|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6044996|NCT00559845|Growth Substances|growth substances|mesh-ancestor
6044997|NCT00559845|Growth Inhibitors|growth inhibitors|mesh-ancestor
6044998|NCT00559845|Antimetabolites|antimetabolites|mesh-ancestor
6044999|NCT00559845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6045000|NCT00559845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6045001|NCT00559845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6045002|NCT00559845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6045003|NCT00559845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5497879|NCT04502641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5497880|NCT04502641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5497881|NCT04502641|Immunologic Factors|immunologic factors|mesh-ancestor
5497882|NCT04502641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497883|NCT04502537|Epoetin Alfa|epoetin alfa|mesh-list
5497884|NCT04502537|Hematinics|hematinics|mesh-ancestor
5497885|NCT04502589|Disulfiram|disulfiram|mesh-list
6045004|NCT00559936|Bevacizumab|bevacizumab|mesh-list
6045005|NCT00559936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6045006|NCT00559936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6045007|NCT00559936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6045008|NCT00559936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6045009|NCT00559936|Growth Substances|growth substances|mesh-ancestor
6045010|NCT00559936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045011|NCT00559936|Growth Inhibitors|growth inhibitors|mesh-ancestor
6045012|NCT00559962|Atorvastatin|atorvastatin|mesh-list
6045013|NCT00559962|Ezetimibe|ezetimibe|mesh-list
6045014|NCT00559962|Fenofibrate|fenofibrate|mesh-list
6045015|NCT00559962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6045016|NCT00559962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6045017|NCT00559962|Antimetabolites|antimetabolites|mesh-ancestor
6045018|NCT00559962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045019|NCT00559962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6045020|NCT00559962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6045021|NCT00559962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6045022|NCT00560066|Vaccines|vaccines|mesh-list
6045023|NCT00560066|Immunologic Factors|immunologic factors|mesh-ancestor
6045024|NCT00560066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045025|NCT00560352|Dexamethasone|dexamethasone|mesh-list
6045026|NCT00560352|Bortezomib|bortezomib|mesh-list
6045027|NCT00560352|Dasatinib|dasatinib|mesh-list
6045028|NCT00560352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6045029|NCT00560352|Antiemetics|antiemetics|mesh-ancestor
6045030|NCT00560352|Autonomic Agents|autonomic agents|mesh-ancestor
6045031|NCT00560352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6045032|NCT00560352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045033|NCT00560352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6045034|NCT00560352|Glucocorticoids|glucocorticoids|mesh-ancestor
6045035|NCT00560352|Hormones|hormones|mesh-ancestor
6045036|NCT00560352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5497886|NCT04502589|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5497887|NCT04502589|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
5497888|NCT04502589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5497889|NCT04502589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5497890|NCT04502602|Niraparib|niraparib|mesh-list
5497891|NCT04502602|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5497892|NCT04502602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6045037|NCT00560352|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6045038|NCT00560352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6045039|NCT00560352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6045040|NCT00560352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5497893|NCT04502602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5497894|NCT04502602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5497895|NCT04502264|Botulinum Toxins|botulinum toxins|mesh-list
5497896|NCT04502264|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5497897|NCT04502264|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5497898|NCT04502264|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5497899|NCT04502264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5497900|NCT04502264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5497901|NCT04502264|Cholinergic Agents|cholinergic agents|mesh-ancestor
6045041|NCT00560352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045042|NCT00560391|Dexamethasone|dexamethasone|mesh-list
6045043|NCT00560391|Dexamethasone acetate|dexamethasone acetate|mesh-list
6045044|NCT00560391|Lenalidomide|lenalidomide|mesh-list
6045045|NCT00560391|Dasatinib|dasatinib|mesh-list
5497902|NCT04502264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5497903|NCT04502264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497904|NCT04502264|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5497905|NCT04502264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5497906|NCT04502303|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5497907|NCT04502303|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5497908|NCT04502303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5497909|NCT04502277|Fluconazole|fluconazole|mesh-list
5497910|NCT04502277|Antifungal Agents|antifungal agents|mesh-ancestor
5497911|NCT04502277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5497912|NCT04502277|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6045046|NCT00560391|BB 1101|bb 1101|mesh-list
6045047|NCT00560391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6045048|NCT00560391|Antiemetics|antiemetics|mesh-ancestor
6045049|NCT00560391|Autonomic Agents|autonomic agents|mesh-ancestor
6045050|NCT00560391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6045051|NCT00560391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045052|NCT00560391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6045053|NCT00560391|Glucocorticoids|glucocorticoids|mesh-ancestor
6045054|NCT00560391|Hormones|hormones|mesh-ancestor
6045055|NCT00560391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6045056|NCT00560391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6045057|NCT00560391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6045058|NCT00560391|Protease Inhibitors|protease inhibitors|mesh-ancestor
6045059|NCT00560391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6045060|NCT00560391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045061|NCT00560391|Immunologic Factors|immunologic factors|mesh-ancestor
6045062|NCT00560391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6045063|NCT00560391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6045064|NCT00560391|Growth Substances|growth substances|mesh-ancestor
6045065|NCT00560391|Growth Inhibitors|growth inhibitors|mesh-ancestor
6045066|NCT00560391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6045067|NCT00560404|Epoetin Alfa|epoetin alfa|mesh-list
6045068|NCT00560404|Hematinics|hematinics|mesh-ancestor
6045069|NCT00560417|Insulin|insulin|mesh-list
6045070|NCT00560417|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6045071|NCT00560417|Insulin Glargine|insulin glargine|mesh-list
6045072|NCT00560417|Insulin Lispro|insulin lispro|mesh-list
6045073|NCT00560417|Protamines|protamines|mesh-list
6045074|NCT00560417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6045075|NCT00560417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045076|NCT00560417|Heparin Antagonists|heparin antagonists|mesh-ancestor
6045077|NCT00560417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045078|NCT00560417|Coagulants|coagulants|mesh-ancestor
6045079|NCT00560508|Pramipexole|pramipexole|mesh-list
6045080|NCT00560508|Antioxidants|antioxidants|mesh-ancestor
6045081|NCT00560508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045082|NCT00560508|Protective Agents|protective agents|mesh-ancestor
6045083|NCT00560508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045084|NCT00560508|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6045085|NCT00560508|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6045086|NCT00560508|Dopamine Agonists|dopamine agonists|mesh-ancestor
6045087|NCT00560508|Dopamine Agents|dopamine agents|mesh-ancestor
6045088|NCT00560508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5497913|NCT04502277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5497914|NCT04502277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5497915|NCT04502277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5497916|NCT04502277|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5497917|NCT04502277|Hormone Antagonists|hormone antagonists|mesh-ancestor
5497918|NCT04502277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5497919|NCT04502277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497920|NCT04502277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5497921|NCT04502277|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5497922|NCT04502251|Naltrexone|naltrexone|mesh-list
6045089|NCT00560573|Gemcitabine|gemcitabine|mesh-list
6045090|NCT00560573|Pemetrexed|pemetrexed|mesh-list
6045091|NCT00560573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6045092|NCT00560573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6458208|NCT00439504|Autonomic Agents|autonomic agents|mesh-ancestor
6458209|NCT00439504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6458210|NCT00439504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458211|NCT00439504|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6458212|NCT00439504|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6458213|NCT00439504|Cholinergic Agents|cholinergic agents|mesh-ancestor
6458214|NCT00439504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6045093|NCT00560573|Antimetabolites|antimetabolites|mesh-ancestor
6045094|NCT00560573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045095|NCT00560573|Antiviral Agents|antiviral agents|mesh-ancestor
6045096|NCT00560573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6045097|NCT00560573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6045098|NCT00560573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6045099|NCT00560573|Immunologic Factors|immunologic factors|mesh-ancestor
6045100|NCT00560573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045101|NCT00560573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6045102|NCT00560573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6045103|NCT00560612|Paroxetine|paroxetine|mesh-list
6045104|NCT00560612|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6045105|NCT00560612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6045106|NCT00560612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6045107|NCT00560612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045108|NCT00560612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6045109|NCT00560612|Serotonin Agents|serotonin agents|mesh-ancestor
6461987|NCT00456963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6045110|NCT00560612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045111|NCT00560612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6045112|NCT00560612|Antidepressive Agents|antidepressive agents|mesh-ancestor
6045113|NCT00560612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6045114|NCT00560612|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6045115|NCT00560612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6045116|NCT00560612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6045117|NCT00560703|Doxycycline|doxycycline|mesh-list
6045118|NCT00560703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6045119|NCT00560703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6045120|NCT00560703|Antimalarials|antimalarials|mesh-ancestor
6045121|NCT00560703|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6045122|NCT00560703|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6045123|NCT00560794|Blinatumomab|blinatumomab|mesh-list
6045124|NCT00560794|Antibodies, Bispecific|antibodies, bispecific|mesh-list
6045125|NCT00560794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5497923|NCT04502251|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5497924|NCT04502251|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5497925|NCT04502251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497926|NCT04502251|Sensory System Agents|sensory system agents|mesh-ancestor
5497927|NCT04502251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5497928|NCT04502017|Clopidogrel|clopidogrel|mesh-list
5497929|NCT04502017|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5497930|NCT04502017|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5497931|NCT04502017|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5497932|NCT04502017|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5497933|NCT04502017|Purinergic Agents|purinergic agents|mesh-ancestor
5497934|NCT04502017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5497935|NCT04502017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5497936|NCT04502017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497937|NCT04501965|Azithromycin|azithromycin|mesh-list
5497938|NCT04501965|Hydroxychloroquine|hydroxychloroquine|mesh-list
6045126|NCT00560794|Immunologic Factors|immunologic factors|mesh-ancestor
6045127|NCT00560794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045128|NCT00560833|Mirtazapine|mirtazapine|mesh-list
6045129|NCT00560833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045130|NCT00560833|Antidepressive Agents|antidepressive agents|mesh-ancestor
6045131|NCT00560833|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6045132|NCT00560833|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6045133|NCT00560833|Histamine Antagonists|histamine antagonists|mesh-ancestor
6045134|NCT00560833|Histamine Agents|histamine agents|mesh-ancestor
6045135|NCT00560833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6045136|NCT00560833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045137|NCT00560833|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5497939|NCT04501965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5497940|NCT04501965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5497941|NCT04501965|Antimalarials|antimalarials|mesh-ancestor
5497942|NCT04501965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5497943|NCT04501965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5497944|NCT04501965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5497945|NCT04501965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045138|NCT00560833|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6045139|NCT00560833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6045140|NCT00560833|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6045141|NCT00560833|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6045142|NCT00560833|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6045143|NCT00560833|Adrenergic Agents|adrenergic agents|mesh-ancestor
6045144|NCT00560833|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6045145|NCT00560833|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6045146|NCT00560833|Serotonin Agents|serotonin agents|mesh-ancestor
6045147|NCT00560833|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6045148|NCT00560950|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6045149|NCT00560950|Immunologic Factors|immunologic factors|mesh-ancestor
6045150|NCT00560950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045151|NCT00561002|Vaccines|vaccines|mesh-list
6045152|NCT00561002|Immunologic Factors|immunologic factors|mesh-ancestor
6045153|NCT00561002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045154|NCT00561015|Ribavirin|ribavirin|mesh-list
6045155|NCT00561015|Interferon alpha-2|interferon alpha-2|mesh-list
6045156|NCT00561015|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6045157|NCT00561015|Antimetabolites|antimetabolites|mesh-ancestor
6045158|NCT00561015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045159|NCT00561015|Antiviral Agents|antiviral agents|mesh-ancestor
6045160|NCT00561015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5497946|NCT04501965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5497947|NCT04502095|Levofloxacin|levofloxacin|mesh-list
5497948|NCT04502095|Ofloxacin|ofloxacin|mesh-list
5497949|NCT04502095|Trimethoprim|trimethoprim|mesh-list
5497950|NCT04502095|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
5497951|NCT04502095|Nitrofurantoin|nitrofurantoin|mesh-list
5497952|NCT04502095|Clindamycin|clindamycin|mesh-list
5497953|NCT04502095|Ertapenem|ertapenem|mesh-list
5497954|NCT04502095|Sulfamethoxazole|sulfamethoxazole|mesh-list
5497955|NCT04502095|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5497956|NCT04502095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5497957|NCT04502095|Renal Agents|renal agents|mesh-ancestor
5497958|NCT04502095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5497959|NCT04502095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5497960|NCT04502095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5497961|NCT04502095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5497962|NCT04502095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5497963|NCT04502095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6045161|NCT00561015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6045162|NCT00561080|Vaccines|vaccines|mesh-list
6045163|NCT00561080|Immunologic Factors|immunologic factors|mesh-ancestor
6045164|NCT00561080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045165|NCT00561353|Ribavirin|ribavirin|mesh-list
6045166|NCT00561353|Simeprevir|simeprevir|mesh-list
6045167|NCT00561353|Antimetabolites|antimetabolites|mesh-ancestor
5497964|NCT04502095|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5497965|NCT04502095|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5497966|NCT04502095|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5497967|NCT04502095|Antimalarials|antimalarials|mesh-ancestor
5497968|NCT04502095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5497969|NCT04502095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5497970|NCT04502095|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5497971|NCT04502095|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5497972|NCT04502095|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
5497973|NCT04501991|Hypoglycemic Agents|hypoglycemic agents|mesh-list
5497974|NCT04501991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497975|NCT04501900|Clopidogrel|clopidogrel|mesh-list
5497976|NCT04501900|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5497977|NCT04501900|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5497978|NCT04501900|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5497979|NCT04501900|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5497980|NCT04501900|Purinergic Agents|purinergic agents|mesh-ancestor
5497981|NCT04501900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5497982|NCT04501900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725008|NCT03183375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6045168|NCT00561353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045169|NCT00561353|Antiviral Agents|antiviral agents|mesh-ancestor
6045170|NCT00561353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6045171|NCT00561353|Protease Inhibitors|protease inhibitors|mesh-ancestor
6045172|NCT00561353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6045173|NCT00561392|Rivastigmine|rivastigmine|mesh-list
6045174|NCT00561392|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6045175|NCT00561392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6045176|NCT00561392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045177|NCT00561392|Cholinergic Agents|cholinergic agents|mesh-ancestor
6045178|NCT00561392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6045179|NCT00561392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045180|NCT00561392|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6045181|NCT00561392|Protective Agents|protective agents|mesh-ancestor
6045182|NCT00561418|Vorinostat|vorinostat|mesh-list
6461988|NCT00456976|Selegiline|selegiline|mesh-list
5725009|NCT03183375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725010|NCT03183375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5725011|NCT03183297|Fexofenadine|fexofenadine|mesh-list
5725012|NCT03183297|Naproxen|naproxen|mesh-list
5725013|NCT03183297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5725014|NCT03183297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5725015|NCT03183297|Analgesics|analgesics|mesh-ancestor
5725016|NCT03183297|Sensory System Agents|sensory system agents|mesh-ancestor
5725017|NCT03183297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5725018|NCT03183297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725019|NCT03183297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5725020|NCT03183297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5725021|NCT03183297|Gout Suppressants|gout suppressants|mesh-ancestor
6045183|NCT00561418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6045184|NCT00561418|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6045185|NCT00561418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6045186|NCT00561418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045187|NCT00561470|Leucovorin|leucovorin|mesh-list
6045188|NCT00561470|Fluorouracil|fluorouracil|mesh-list
6045189|NCT00561470|Irinotecan|irinotecan|mesh-list
6045190|NCT00561470|Aflibercept|aflibercept|mesh-list
6045191|NCT00561470|Levoleucovorin|levoleucovorin|mesh-list
6045192|NCT00561470|Antimetabolites|antimetabolites|mesh-ancestor
6045193|NCT00561470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045194|NCT00561470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5497983|NCT04501900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497984|NCT04501809|Misoprostol|misoprostol|mesh-list
5497985|NCT04501809|Oxytocin|oxytocin|mesh-list
5497986|NCT04501809|Oxytocics|oxytocics|mesh-ancestor
5497987|NCT04501809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5497988|NCT04501809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5497989|NCT04501809|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5497990|NCT04501809|Abortifacient Agents|abortifacient agents|mesh-ancestor
5497991|NCT04501809|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5497992|NCT04501809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5497993|NCT04501783|Favipiravir|favipiravir|mesh-list
5497994|NCT04501783|Antiviral Agents|antiviral agents|mesh-ancestor
5497995|NCT04501783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5497996|NCT04501523|Capecitabine|capecitabine|mesh-list
5497997|NCT04501523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5497998|NCT04501523|Antimetabolites|antimetabolites|mesh-ancestor
5497999|NCT04501523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498000|NCT04501523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6045195|NCT00561470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6045196|NCT00561470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6045197|NCT00561470|Immunologic Factors|immunologic factors|mesh-ancestor
6045198|NCT00561470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045199|NCT00561470|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6045200|NCT00561470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6045201|NCT00561470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6045202|NCT00561470|Antidotes|antidotes|mesh-ancestor
6045203|NCT00561470|Protective Agents|protective agents|mesh-ancestor
6045204|NCT00561470|Vitamin B Complex|vitamin b complex|mesh-ancestor
6045205|NCT00561470|Vitamins|vitamins|mesh-ancestor
6045206|NCT00561470|Micronutrients|micronutrients|mesh-ancestor
6045207|NCT00561470|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6045208|NCT00561470|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6045209|NCT00561470|Growth Substances|growth substances|mesh-ancestor
6045210|NCT00561470|Growth Inhibitors|growth inhibitors|mesh-ancestor
6045211|NCT00561574|Mirtazapine|mirtazapine|mesh-list
6045212|NCT00561574|Antidepressive Agents|antidepressive agents|mesh-ancestor
6045213|NCT00561574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6045214|NCT00561574|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6045215|NCT00561574|Histamine Antagonists|histamine antagonists|mesh-ancestor
6045216|NCT00561574|Histamine Agents|histamine agents|mesh-ancestor
6045217|NCT00561574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6045218|NCT00561574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045219|NCT00561574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045220|NCT00561574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6045221|NCT00561574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6045222|NCT00561574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6045223|NCT00561574|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6045224|NCT00561574|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6045225|NCT00561574|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6045226|NCT00561574|Adrenergic Agents|adrenergic agents|mesh-ancestor
6045227|NCT00561574|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6045228|NCT00561574|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6045229|NCT00561574|Serotonin Agents|serotonin agents|mesh-ancestor
6045230|NCT00561574|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6045231|NCT00561678|Dexmedetomidine|dexmedetomidine|mesh-list
6045232|NCT00561678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6045233|NCT00561678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6045234|NCT00561678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045235|NCT00561678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6045236|NCT00561678|Analgesics|analgesics|mesh-ancestor
6045237|NCT00561678|Sensory System Agents|sensory system agents|mesh-ancestor
5498001|NCT04501224|Tenofovir|tenofovir|mesh-list
5498002|NCT04501224|Entecavir|entecavir|mesh-list
5498003|NCT04501224|Antiviral Agents|antiviral agents|mesh-ancestor
6045238|NCT00561678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6045239|NCT00561678|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5498004|NCT04501224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5498005|NCT04501224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5498006|NCT04501224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5498007|NCT04501224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5498008|NCT04501224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498009|NCT04501224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6045240|NCT00561678|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6045241|NCT00561678|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6045242|NCT00561678|Adrenergic Agents|adrenergic agents|mesh-ancestor
6045243|NCT00561678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6045244|NCT00561678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045245|NCT00561730|Pantoprazole|pantoprazole|mesh-list
6045246|NCT00561730|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6045247|NCT00561730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6045248|NCT00561730|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6045249|NCT00561730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6045250|NCT00561730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045251|NCT00561821|Mirtazapine|mirtazapine|mesh-list
6045252|NCT00561821|Antidepressive Agents|antidepressive agents|mesh-ancestor
6045253|NCT00561821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6045254|NCT00561821|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6045255|NCT00561821|Histamine Antagonists|histamine antagonists|mesh-ancestor
6045256|NCT00561821|Histamine Agents|histamine agents|mesh-ancestor
6045257|NCT00561821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6045258|NCT00561821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045259|NCT00561821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045260|NCT00561821|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6045261|NCT00561821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6045262|NCT00561821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6045263|NCT00561821|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6045264|NCT00561821|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6045265|NCT00561821|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6045266|NCT00561821|Adrenergic Agents|adrenergic agents|mesh-ancestor
6045267|NCT00561821|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6045268|NCT00561821|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6045269|NCT00561821|Serotonin Agents|serotonin agents|mesh-ancestor
6045270|NCT00561821|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6045271|NCT00561834|Ranibizumab|ranibizumab|mesh-list
6045272|NCT00561834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6045273|NCT00561834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6045274|NCT00561834|Growth Substances|growth substances|mesh-ancestor
6045275|NCT00561834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045276|NCT00561834|Growth Inhibitors|growth inhibitors|mesh-ancestor
6045277|NCT00561834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6045278|NCT00561925|Nevirapine|nevirapine|mesh-list
6045279|NCT00561925|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6045280|NCT00561925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6045281|NCT00561925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6045282|NCT00561925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045283|NCT00561925|Antiviral Agents|antiviral agents|mesh-ancestor
6045284|NCT00561925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6045285|NCT00561925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6045286|NCT00561925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6045287|NCT00561925|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6045288|NCT00561925|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6045289|NCT00561951|Fesoterodine|fesoterodine|mesh-list
6045290|NCT00561951|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6045291|NCT00561951|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6045292|NCT00561951|Cholinergic Agents|cholinergic agents|mesh-ancestor
6045293|NCT00561951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6045294|NCT00561951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045295|NCT00561951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045296|NCT00561951|Urological Agents|urological agents|mesh-ancestor
6045297|NCT00562094|Pantoprazole|pantoprazole|mesh-list
6045298|NCT00562094|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6045299|NCT00562094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6045300|NCT00562094|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6045301|NCT00562094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6045302|NCT00562094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045303|NCT00562120|Fexofenadine|fexofenadine|mesh-list
6045304|NCT00562120|Terfenadine|terfenadine|mesh-list
6045305|NCT00562120|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6045306|NCT00562120|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6045307|NCT00562120|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6045308|NCT00562120|Histamine Antagonists|histamine antagonists|mesh-ancestor
6045309|NCT00562120|Histamine Agents|histamine agents|mesh-ancestor
6045310|NCT00562120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6045311|NCT00562120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045312|NCT00562120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045313|NCT00562159|Fluticasone|fluticasone|mesh-list
6045314|NCT00562159|Xhance|xhance|mesh-list
6045315|NCT00562159|Mometasone Furoate|mometasone furoate|mesh-list
6045316|NCT00562159|Loratadine|loratadine|mesh-list
6045317|NCT00562159|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
6045318|NCT00562159|Prednisone|prednisone|mesh-list
6045319|NCT00562159|Albuterol|albuterol|mesh-list
6045320|NCT00562159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6045321|NCT00562159|Glucocorticoids|glucocorticoids|mesh-ancestor
6045322|NCT00562159|Hormones|hormones|mesh-ancestor
6045323|NCT00562159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6045324|NCT00562159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045325|NCT00562159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6045326|NCT00562159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6045327|NCT00562159|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6045328|NCT00562159|Autonomic Agents|autonomic agents|mesh-ancestor
6045329|NCT00562159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6045330|NCT00562159|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6045331|NCT00562159|Respiratory System Agents|respiratory system agents|mesh-ancestor
6045332|NCT00562159|Dermatologic Agents|dermatologic agents|mesh-ancestor
6045333|NCT00562159|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6045334|NCT00562159|Tocolytic Agents|tocolytic agents|mesh-ancestor
6045335|NCT00562159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6045336|NCT00562159|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6045337|NCT00562159|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6045338|NCT00562159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6045339|NCT00562159|Adrenergic Agents|adrenergic agents|mesh-ancestor
6045340|NCT00562159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6045341|NCT00562159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045342|NCT00562159|Antipruritics|antipruritics|mesh-ancestor
6045343|NCT00562159|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6045344|NCT00562159|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6045345|NCT00562159|Histamine Antagonists|histamine antagonists|mesh-ancestor
6045346|NCT00562159|Histamine Agents|histamine agents|mesh-ancestor
6045347|NCT00562159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6045348|NCT00562159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6045349|NCT00562159|Analgesics|analgesics|mesh-ancestor
6045350|NCT00562159|Sensory System Agents|sensory system agents|mesh-ancestor
6045351|NCT00562159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6045352|NCT00562328|Rituximab|rituximab|mesh-list
6045353|NCT00562328|Alemtuzumab|alemtuzumab|mesh-list
6045354|NCT00562328|Sargramostim|sargramostim|mesh-list
6045355|NCT00562328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6045356|NCT00562328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6045357|NCT00562328|Immunologic Factors|immunologic factors|mesh-ancestor
6045358|NCT00562328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045359|NCT00562328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6045360|NCT00562588|Dipyridamole|dipyridamole|mesh-list
6045361|NCT00562588|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
6045362|NCT00562588|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6045363|NCT00562588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6045364|NCT00562588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045365|NCT00562588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6045366|NCT00562588|Vasodilator Agents|vasodilator agents|mesh-ancestor
6045367|NCT00562627|Ketorolac|ketorolac|mesh-list
6045368|NCT00562627|Epinephrine|epinephrine|mesh-list
6045369|NCT00562627|Racepinephrine|racepinephrine|mesh-list
6045370|NCT00562627|Fentanyl|fentanyl|mesh-list
6045371|NCT00562627|Morphine|morphine|mesh-list
6045372|NCT00562627|Bupivacaine|bupivacaine|mesh-list
6045373|NCT00562627|Ropivacaine|ropivacaine|mesh-list
5498010|NCT04501224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5498011|NCT04501289|Magnesium Sulfate|magnesium sulfate|mesh-list
5498012|NCT04501289|Analgesics|analgesics|mesh-ancestor
5498013|NCT04501289|Sensory System Agents|sensory system agents|mesh-ancestor
5498014|NCT04501289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5498015|NCT04501289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498016|NCT04501289|Anesthetics|anesthetics|mesh-ancestor
5498017|NCT04501289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5498018|NCT04501289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5498019|NCT04501289|Anticonvulsants|anticonvulsants|mesh-ancestor
5498020|NCT04501289|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5498021|NCT04501289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5498022|NCT04501289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498023|NCT04501289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5498024|NCT04501289|Tocolytic Agents|tocolytic agents|mesh-ancestor
5498025|NCT04501289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5498026|NCT04501380|Rifamycins|rifamycins|mesh-list
6045374|NCT00562627|Epinephryl borate|epinephryl borate|mesh-list
6045375|NCT00562627|Anesthetics, Local|anesthetics, local|mesh-ancestor
6045376|NCT00562627|Anesthetics|anesthetics|mesh-ancestor
6045377|NCT00562627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6045378|NCT00562627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045379|NCT00562627|Sensory System Agents|sensory system agents|mesh-ancestor
6045380|NCT00562627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6045381|NCT00562627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6045382|NCT00562627|Narcotics|narcotics|mesh-ancestor
6045383|NCT00562627|Analgesics|analgesics|mesh-ancestor
6045384|NCT00562627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6045385|NCT00562627|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6045386|NCT00562627|Anesthetics, General|anesthetics, general|mesh-ancestor
6045387|NCT00562627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6045388|NCT00562627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6045389|NCT00562627|Adrenergic Agents|adrenergic agents|mesh-ancestor
6045390|NCT00562627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6045391|NCT00562627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045392|NCT00562627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6045393|NCT00562627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6045394|NCT00562627|Autonomic Agents|autonomic agents|mesh-ancestor
6045395|NCT00562627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6045396|NCT00562627|Respiratory System Agents|respiratory system agents|mesh-ancestor
6045397|NCT00562627|Mydriatics|mydriatics|mesh-ancestor
6045398|NCT00562627|Sympathomimetics|sympathomimetics|mesh-ancestor
6045399|NCT00562627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6045400|NCT00562627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6045401|NCT00562627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6045402|NCT00562627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6045403|NCT00562627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6045404|NCT00562627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6045405|NCT00562627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6045406|NCT00562718|Capecitabine|capecitabine|mesh-list
6045407|NCT00562718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6045408|NCT00562718|Antimetabolites|antimetabolites|mesh-ancestor
6045409|NCT00562718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045410|NCT00562718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6045411|NCT00562861|Lamotrigine|lamotrigine|mesh-list
6045412|NCT00562861|Carbamazepine|carbamazepine|mesh-list
6045413|NCT00562861|Valproic Acid|valproic acid|mesh-list
6045414|NCT00562861|Citalopram|citalopram|mesh-list
6045415|NCT00562861|Anticonvulsants|anticonvulsants|mesh-ancestor
6045416|NCT00562861|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6045417|NCT00562861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6045418|NCT00562861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045419|NCT00562861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6045420|NCT00562861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045421|NCT00562861|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6045422|NCT00562861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6045423|NCT00562861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6045424|NCT00562861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6045425|NCT00562861|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5498027|NCT04501380|Rifamycin SV|rifamycin sv|mesh-list
6045426|NCT00562861|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6462242|NCT00458250|Antimetabolites|antimetabolites|mesh-ancestor
5498028|NCT04501380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5498029|NCT04501380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5498030|NCT04501380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5498031|NCT04501367|Dexamethasone|dexamethasone|mesh-list
5498032|NCT04501367|Dexamethasone acetate|dexamethasone acetate|mesh-list
5498033|NCT04501367|Prednisone|prednisone|mesh-list
5498034|NCT04501367|BB 1101|bb 1101|mesh-list
5498035|NCT04501367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5498036|NCT04501367|Antiemetics|antiemetics|mesh-ancestor
5498037|NCT04501367|Autonomic Agents|autonomic agents|mesh-ancestor
5498038|NCT04501367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5498039|NCT04501367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498040|NCT04501367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5498041|NCT04501367|Glucocorticoids|glucocorticoids|mesh-ancestor
5498042|NCT04501367|Hormones|hormones|mesh-ancestor
5498043|NCT04501367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5498044|NCT04501367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5498045|NCT04501367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5498046|NCT04501367|Protease Inhibitors|protease inhibitors|mesh-ancestor
5498047|NCT04501367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5498048|NCT04501367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498049|NCT04501107|Insulin|insulin|mesh-list
5498050|NCT04501107|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5498051|NCT04501107|Insulin Lispro|insulin lispro|mesh-list
5498052|NCT04501107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5498053|NCT04501107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498054|NCT04501250|Insulin|insulin|mesh-list
5498055|NCT04501250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5498056|NCT04501250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5498057|NCT04501250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498058|NCT04500899|Phenylephrine|phenylephrine|mesh-list
5498059|NCT04500899|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5498060|NCT04500899|Mydriatics|mydriatics|mesh-ancestor
5498061|NCT04500899|Autonomic Agents|autonomic agents|mesh-ancestor
6045427|NCT00562861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6045428|NCT00562861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6045429|NCT00562861|Serotonin Agents|serotonin agents|mesh-ancestor
6045430|NCT00562861|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6045431|NCT00562861|Antidepressive Agents|antidepressive agents|mesh-ancestor
6045432|NCT00562861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6045433|NCT00562861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6045434|NCT00562861|GABA Agents|gaba agents|mesh-ancestor
6045435|NCT00562861|Antimanic Agents|antimanic agents|mesh-ancestor
6045436|NCT00562861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6045437|NCT00562861|Analgesics|analgesics|mesh-ancestor
6045438|NCT00562861|Sensory System Agents|sensory system agents|mesh-ancestor
6045439|NCT00562861|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6045440|NCT00562861|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6045441|NCT00562965|Dexamethasone|dexamethasone|mesh-list
6045442|NCT00562965|Prednisone|prednisone|mesh-list
6045443|NCT00562965|Prednisolone|prednisolone|mesh-list
6045444|NCT00562965|Cyclophosphamide|cyclophosphamide|mesh-list
6045445|NCT00562965|Rituximab|rituximab|mesh-list
6045446|NCT00562965|Fludarabine|fludarabine|mesh-list
6045447|NCT00562965|Vincristine|vincristine|mesh-list
6045448|NCT00562965|Mitoxantrone|mitoxantrone|mesh-list
6045449|NCT00562965|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
6045450|NCT00562965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6045451|NCT00562965|Immunologic Factors|immunologic factors|mesh-ancestor
6045452|NCT00562965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045453|NCT00562965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6045454|NCT00562965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6045455|NCT00562965|Alkylating Agents|alkylating agents|mesh-ancestor
6045456|NCT00562965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045457|NCT00562965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6045458|NCT00562965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6045459|NCT00562965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6045460|NCT00562965|Antiemetics|antiemetics|mesh-ancestor
6045461|NCT00562965|Autonomic Agents|autonomic agents|mesh-ancestor
6045462|NCT00562965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6045463|NCT00562965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6045464|NCT00562965|Glucocorticoids|glucocorticoids|mesh-ancestor
6045465|NCT00562965|Hormones|hormones|mesh-ancestor
6045466|NCT00562965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6045467|NCT00562965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5498062|NCT04500899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5498063|NCT04500899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498064|NCT04500899|Sympathomimetics|sympathomimetics|mesh-ancestor
6045468|NCT00562965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6045469|NCT00562965|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6045470|NCT00562965|Tubulin Modulators|tubulin modulators|mesh-ancestor
6045471|NCT00562965|Antimitotic Agents|antimitotic agents|mesh-ancestor
6045472|NCT00562965|Mitosis Modulators|mitosis modulators|mesh-ancestor
6045473|NCT00562965|Analgesics|analgesics|mesh-ancestor
6045474|NCT00562965|Sensory System Agents|sensory system agents|mesh-ancestor
6045475|NCT00562965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6045476|NCT00562965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6045477|NCT00562965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6045478|NCT00562965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6045479|NCT00562978|Cyclophosphamide|cyclophosphamide|mesh-list
6045480|NCT00562978|Etoposide|etoposide|mesh-list
6045481|NCT00562978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6045482|NCT00562978|Immunologic Factors|immunologic factors|mesh-ancestor
6045483|NCT00562978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045484|NCT00562978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6045485|NCT00562978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6045486|NCT00562978|Alkylating Agents|alkylating agents|mesh-ancestor
6045487|NCT00562978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045488|NCT00562978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6045489|NCT00562978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6045490|NCT00562978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5498065|NCT04500899|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5498066|NCT04500899|Nasal Decongestants|nasal decongestants|mesh-ancestor
5498067|NCT04500899|Respiratory System Agents|respiratory system agents|mesh-ancestor
5498068|NCT04500899|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5498069|NCT04500899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5498070|NCT04500899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5498071|NCT04500899|Adrenergic Agents|adrenergic agents|mesh-ancestor
5498072|NCT04500899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5498073|NCT04500899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498074|NCT04500899|Protective Agents|protective agents|mesh-ancestor
5498075|NCT04500860|Tadalafil|tadalafil|mesh-list
5498076|NCT04500860|Vasodilator Agents|vasodilator agents|mesh-ancestor
5498077|NCT04500860|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5498078|NCT04500860|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5498079|NCT04500860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5498080|NCT04500860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045491|NCT00562978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6045492|NCT00562978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6045493|NCT00562978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6045494|NCT00563290|Dasatinib|dasatinib|mesh-list
6045495|NCT00563290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6045496|NCT00563290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6045497|NCT00563290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6045498|NCT00563290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045499|NCT00563316|Irinotecan|irinotecan|mesh-list
6045500|NCT00563316|Panitumumab|panitumumab|mesh-list
6045501|NCT00563316|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6045502|NCT00563316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6045503|NCT00563316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6045504|NCT00563316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045505|NCT00563316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6045506|NCT00563316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6045507|NCT00563368|Topiramate|topiramate|mesh-list
6045508|NCT00563368|Phentermine|phentermine|mesh-list
6045509|NCT00563368|Anticonvulsants|anticonvulsants|mesh-ancestor
6045510|NCT00563368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6045511|NCT00563368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045512|NCT00563368|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6045513|NCT00563368|Appetite Depressants|appetite depressants|mesh-ancestor
6045514|NCT00563368|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6045515|NCT00563368|Sympathomimetics|sympathomimetics|mesh-ancestor
6045516|NCT00563368|Autonomic Agents|autonomic agents|mesh-ancestor
6045517|NCT00563368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6045518|NCT00563368|Adrenergic Agents|adrenergic agents|mesh-ancestor
6045519|NCT00563368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6045520|NCT00563368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045521|NCT00563381|Bromides|bromides|mesh-list
6045522|NCT00563381|Tiotropium Bromide|tiotropium bromide|mesh-list
6045523|NCT00563381|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6462243|NCT00458250|Dermatologic Agents|dermatologic agents|mesh-ancestor
5498081|NCT04500860|Urological Agents|urological agents|mesh-ancestor
6045524|NCT00563381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6045525|NCT00563381|Autonomic Agents|autonomic agents|mesh-ancestor
6045526|NCT00563381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6045527|NCT00563381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045528|NCT00563381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6045529|NCT00563381|Respiratory System Agents|respiratory system agents|mesh-ancestor
6045530|NCT00563381|Parasympatholytics|parasympatholytics|mesh-ancestor
6045531|NCT00563381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6045532|NCT00563381|Cholinergic Agents|cholinergic agents|mesh-ancestor
6045533|NCT00563381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6045534|NCT00563381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045535|NCT00563381|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6045536|NCT00563381|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5498082|NCT04501406|Pioglitazone|pioglitazone|mesh-list
5498083|NCT04501406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5498084|NCT04501406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498085|NCT04500808|Macitentan|macitentan|mesh-list
5498086|NCT04500808|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
5498087|NCT04500808|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5498088|NCT04500808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498089|NCT04500808|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
5503372|NCT04460079|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6045537|NCT00563381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6045538|NCT00563381|Adrenergic Agents|adrenergic agents|mesh-ancestor
6458215|NCT00439504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458216|NCT00439504|Respiratory System Agents|respiratory system agents|mesh-ancestor
6458217|NCT00439530|Oseltamivir|oseltamivir|mesh-list
6458218|NCT00439530|Probenecid|probenecid|mesh-list
6458219|NCT00439530|Antiviral Agents|antiviral agents|mesh-ancestor
6458220|NCT00439530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6458221|NCT00439530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5503373|NCT04460079|Immunologic Factors|immunologic factors|mesh-ancestor
6045539|NCT00563381|Anticonvulsants|anticonvulsants|mesh-ancestor
6045540|NCT00563706|Risperidone|risperidone|mesh-list
5503374|NCT04460079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503375|NCT04459598|Efavirenz|efavirenz|mesh-list
5503376|NCT04459598|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6045541|NCT00563706|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6045542|NCT00563706|Serotonin Agents|serotonin agents|mesh-ancestor
6045543|NCT00563706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6045544|NCT00563706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045545|NCT00563706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045546|NCT00563706|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6045547|NCT00563706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6045548|NCT00563706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6045549|NCT00563706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6045550|NCT00563706|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6045551|NCT00563706|Dopamine Agents|dopamine agents|mesh-ancestor
6045552|NCT00563784|Paclitaxel|paclitaxel|mesh-list
6045553|NCT00563784|Carboplatin|carboplatin|mesh-list
6045554|NCT00563784|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6045555|NCT00563784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6045556|NCT00563784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6045557|NCT00563784|Tubulin Modulators|tubulin modulators|mesh-ancestor
6045558|NCT00563784|Antimitotic Agents|antimitotic agents|mesh-ancestor
6045559|NCT00563784|Mitosis Modulators|mitosis modulators|mesh-ancestor
6045560|NCT00563784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045561|NCT00563784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6045562|NCT00563784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6045563|NCT00563797|Mecamylamine|mecamylamine|mesh-list
6045564|NCT00563797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6045565|NCT00563797|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
6045566|NCT00563797|Autonomic Agents|autonomic agents|mesh-ancestor
6045567|NCT00563797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6045568|NCT00563797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045569|NCT00563797|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
6045570|NCT00563797|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6045571|NCT00563797|Cholinergic Agents|cholinergic agents|mesh-ancestor
5503377|NCT04459598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5503378|NCT04459598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5503379|NCT04459598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503380|NCT04459598|Antiviral Agents|antiviral agents|mesh-ancestor
6045572|NCT00563797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6045573|NCT00563797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462244|NCT00458250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6045574|NCT00564018|Insulin Detemir|insulin detemir|mesh-list
6045575|NCT00564018|Protamines|protamines|mesh-list
6045576|NCT00564018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6045577|NCT00564018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045578|NCT00564018|Heparin Antagonists|heparin antagonists|mesh-ancestor
6045579|NCT00564018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045580|NCT00564018|Coagulants|coagulants|mesh-ancestor
6045581|NCT00564278|Antidepressive Agents|antidepressive agents|mesh-list
6045582|NCT00564278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6045583|NCT00564395|Insulin|insulin|mesh-list
6045584|NCT00564395|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6045585|NCT00564395|Insulin Detemir|insulin detemir|mesh-list
6045586|NCT00564395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6045587|NCT00564395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045588|NCT00564447|Azithromycin|azithromycin|mesh-list
6045589|NCT00564447|Moxifloxacin|moxifloxacin|mesh-list
6045590|NCT00564447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6045591|NCT00564447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6045592|NCT00564447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6045593|NCT00564447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6045594|NCT00564447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6045595|NCT00564447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045596|NCT00564447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6045597|NCT00564486|Acetaminophen|acetaminophen|mesh-list
6045598|NCT00564486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6045599|NCT00564486|Analgesics|analgesics|mesh-ancestor
6045600|NCT00564486|Sensory System Agents|sensory system agents|mesh-ancestor
6045601|NCT00564486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6045602|NCT00564486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045603|NCT00564486|Antipyretics|antipyretics|mesh-ancestor
6045604|NCT00564629|Acetaminophen|acetaminophen|mesh-list
6045605|NCT00564629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6045606|NCT00564629|Analgesics|analgesics|mesh-ancestor
6045607|NCT00564629|Sensory System Agents|sensory system agents|mesh-ancestor
6045608|NCT00564629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6045609|NCT00564629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045610|NCT00564629|Antipyretics|antipyretics|mesh-ancestor
6045611|NCT00564681|Botulinum Toxins|botulinum toxins|mesh-list
6045612|NCT00564681|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6045613|NCT00564681|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6045614|NCT00564681|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6045615|NCT00564681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6045616|NCT00564681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045617|NCT00564681|Cholinergic Agents|cholinergic agents|mesh-ancestor
6045618|NCT00564681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6045619|NCT00564681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045620|NCT00564681|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6045621|NCT00564681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6045622|NCT00564733|Gemcitabine|gemcitabine|mesh-list
6045623|NCT00564733|Paclitaxel|paclitaxel|mesh-list
6045624|NCT00564733|Docetaxel|docetaxel|mesh-list
6045625|NCT00564733|Carboplatin|carboplatin|mesh-list
6045626|NCT00564733|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6458222|NCT00439530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458223|NCT00439530|Uricosuric Agents|uricosuric agents|mesh-ancestor
6458224|NCT00439530|Gout Suppressants|gout suppressants|mesh-ancestor
5498090|NCT04500574|Latanoprost|latanoprost|mesh-list
5498091|NCT04500574|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5498092|NCT04500574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5498093|NCT04500717|Carboplatin|carboplatin|mesh-list
5498094|NCT04500717|Pemetrexed|pemetrexed|mesh-list
5498095|NCT04500717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6045627|NCT00564733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6045628|NCT00564733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5498096|NCT04500717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6045629|NCT00564733|Tubulin Modulators|tubulin modulators|mesh-ancestor
6045630|NCT00564733|Antimitotic Agents|antimitotic agents|mesh-ancestor
6045631|NCT00564733|Mitosis Modulators|mitosis modulators|mesh-ancestor
6045632|NCT00564733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045633|NCT00564733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6045634|NCT00564733|Antimetabolites|antimetabolites|mesh-ancestor
6045635|NCT00564733|Antiviral Agents|antiviral agents|mesh-ancestor
6045636|NCT00564733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6045637|NCT00564733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6045638|NCT00564733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6045639|NCT00564733|Immunologic Factors|immunologic factors|mesh-ancestor
6045640|NCT00564733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045641|NCT00564733|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6045642|NCT00564850|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6045643|NCT00564850|Luteolytic Agents|luteolytic agents|mesh-ancestor
6045644|NCT00564850|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6045645|NCT00564850|Contraceptive Agents|contraceptive agents|mesh-ancestor
6045646|NCT00564850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6045647|NCT00564850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045648|NCT00564850|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6045649|NCT00564850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6045650|NCT00564850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6045651|NCT00564889|Dexamethasone|dexamethasone|mesh-list
6045652|NCT00564889|Cyclophosphamide|cyclophosphamide|mesh-list
6045653|NCT00564889|Lenalidomide|lenalidomide|mesh-list
6045654|NCT00564889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6045655|NCT00564889|Immunologic Factors|immunologic factors|mesh-ancestor
6045656|NCT00564889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498097|NCT04500717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498098|NCT04500717|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5498099|NCT04500717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5498100|NCT04500496|Isoniazid|isoniazid|mesh-list
5498101|NCT04500496|Dinoprostone|dinoprostone|mesh-list
6045657|NCT00564889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6045658|NCT00564889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6045659|NCT00564889|Alkylating Agents|alkylating agents|mesh-ancestor
6045660|NCT00564889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045661|NCT00564889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6045662|NCT00564889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6045663|NCT00564889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6045664|NCT00564889|Antiemetics|antiemetics|mesh-ancestor
6045665|NCT00564889|Autonomic Agents|autonomic agents|mesh-ancestor
6045666|NCT00564889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6045667|NCT00564889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6045668|NCT00564889|Glucocorticoids|glucocorticoids|mesh-ancestor
6045669|NCT00564889|Hormones|hormones|mesh-ancestor
6045670|NCT00564889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6045671|NCT00564889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6045672|NCT00564889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6045673|NCT00564889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6045674|NCT00564889|Growth Substances|growth substances|mesh-ancestor
6045675|NCT00564889|Growth Inhibitors|growth inhibitors|mesh-ancestor
6045676|NCT00564954|Methylphenidate|methylphenidate|mesh-list
6045677|NCT00564954|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
6045678|NCT00564954|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6045679|NCT00564954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045680|NCT00564954|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6045681|NCT00564954|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6045682|NCT00564954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6045683|NCT00564954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045684|NCT00564954|Dopamine Agents|dopamine agents|mesh-ancestor
6045685|NCT00564954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6053871|NCT00599053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6053872|NCT00599053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6053873|NCT00599196|Rotigotine|rotigotine|mesh-list
6053874|NCT00599196|Dopamine Agonists|dopamine agonists|mesh-ancestor
6053875|NCT00599196|Dopamine Agents|dopamine agents|mesh-ancestor
6053876|NCT00599196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6053877|NCT00599196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053878|NCT00599196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053879|NCT00599313|Sunitinib|sunitinib|mesh-list
6053880|NCT00599313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6053881|NCT00599313|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6053882|NCT00599313|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5498102|NCT04500496|Oxytocics|oxytocics|mesh-ancestor
6045686|NCT00565084|Ibuprofen|ibuprofen|mesh-list
6045687|NCT00565084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6045688|NCT00565084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6045689|NCT00565084|Analgesics|analgesics|mesh-ancestor
6045690|NCT00565084|Sensory System Agents|sensory system agents|mesh-ancestor
6045691|NCT00565084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6045692|NCT00565084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045693|NCT00565084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6045694|NCT00565084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6045695|NCT00565084|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6045696|NCT00565084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6045697|NCT00565084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045698|NCT00565266|Beclomethasone|beclomethasone|mesh-list
6045699|NCT00565266|Bromides|bromides|mesh-list
6045700|NCT00565266|Tiotropium Bromide|tiotropium bromide|mesh-list
6045701|NCT00565266|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6045702|NCT00565266|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6045703|NCT00565266|Autonomic Agents|autonomic agents|mesh-ancestor
6045704|NCT00565266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6045705|NCT00565266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045706|NCT00565266|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6045707|NCT00565266|Respiratory System Agents|respiratory system agents|mesh-ancestor
6045708|NCT00565266|Parasympatholytics|parasympatholytics|mesh-ancestor
6045709|NCT00565266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6045710|NCT00565266|Cholinergic Agents|cholinergic agents|mesh-ancestor
6045711|NCT00565266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6045712|NCT00565266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045713|NCT00565266|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6045714|NCT00565266|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6045715|NCT00565266|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6045716|NCT00565266|Adrenergic Agents|adrenergic agents|mesh-ancestor
6045717|NCT00565266|Anticonvulsants|anticonvulsants|mesh-ancestor
6045718|NCT00565266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6045719|NCT00565266|Glucocorticoids|glucocorticoids|mesh-ancestor
6045720|NCT00565266|Hormones|hormones|mesh-ancestor
6045721|NCT00565266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6045722|NCT00565370|Capecitabine|capecitabine|mesh-list
6045723|NCT00565370|Sorafenib|sorafenib|mesh-list
6045724|NCT00565370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6045725|NCT00565370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6045726|NCT00565370|Antimetabolites|antimetabolites|mesh-ancestor
6045727|NCT00565370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045728|NCT00565370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6458225|NCT00439530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6458226|NCT00439530|Renal Agents|renal agents|mesh-ancestor
6045729|NCT00565370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6045730|NCT00565409|Etanercept|etanercept|mesh-list
6045731|NCT00565409|Methotrexate|methotrexate|mesh-list
6045732|NCT00565409|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6045733|NCT00565409|Abortifacient Agents|abortifacient agents|mesh-ancestor
6045734|NCT00565409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6045735|NCT00565409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045736|NCT00565409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6045737|NCT00565409|Antimetabolites|antimetabolites|mesh-ancestor
6045738|NCT00565409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045739|NCT00565409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6045740|NCT00565409|Dermatologic Agents|dermatologic agents|mesh-ancestor
6045741|NCT00565409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6045742|NCT00565409|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6045743|NCT00565409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6045744|NCT00565409|Immunologic Factors|immunologic factors|mesh-ancestor
6045745|NCT00565409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6045746|NCT00565409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6045747|NCT00565409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6045748|NCT00565409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6045749|NCT00565409|Analgesics|analgesics|mesh-ancestor
6045750|NCT00565409|Sensory System Agents|sensory system agents|mesh-ancestor
6045751|NCT00565409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6045752|NCT00565409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6045753|NCT00565409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6458227|NCT00439543|Iloprost|iloprost|mesh-list
5498103|NCT04500496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6045754|NCT00565448|Docetaxel|docetaxel|mesh-list
6045755|NCT00565448|Fluorouracil|fluorouracil|mesh-list
6045756|NCT00565448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6045757|NCT00565448|Tubulin Modulators|tubulin modulators|mesh-ancestor
6045758|NCT00565448|Antimitotic Agents|antimitotic agents|mesh-ancestor
6045759|NCT00565448|Mitosis Modulators|mitosis modulators|mesh-ancestor
6045760|NCT00565448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045761|NCT00565448|Antimetabolites|antimetabolites|mesh-ancestor
6045762|NCT00565448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6045763|NCT00565448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6045764|NCT00565448|Immunologic Factors|immunologic factors|mesh-ancestor
6045765|NCT00565448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045766|NCT00565643|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6045767|NCT00565643|Hyaluronic Acid|hyaluronic acid|mesh-list
6045768|NCT00565643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6045769|NCT00565643|Immunologic Factors|immunologic factors|mesh-ancestor
6045770|NCT00565643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045771|NCT00565643|Viscosupplements|viscosupplements|mesh-ancestor
6045772|NCT00565643|Protective Agents|protective agents|mesh-ancestor
6458228|NCT00439543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5498104|NCT04500496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498105|NCT04500496|Antitubercular Agents|antitubercular agents|mesh-ancestor
5498106|NCT04500496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6458229|NCT00439543|Vasodilator Agents|vasodilator agents|mesh-ancestor
6458230|NCT00439699|Memantine|memantine|mesh-list
6458231|NCT00439699|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6458232|NCT00439699|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6458233|NCT00439699|Dopamine Agents|dopamine agents|mesh-ancestor
6458234|NCT00439699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6458235|NCT00439699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458236|NCT00439699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458237|NCT00439699|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6458238|NCT00439699|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6458239|NCT00439712|Levocetirizine|levocetirizine|mesh-list
6458240|NCT00439712|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6458241|NCT00439712|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6458242|NCT00439712|Histamine Antagonists|histamine antagonists|mesh-ancestor
6458243|NCT00439712|Histamine Agents|histamine agents|mesh-ancestor
6458244|NCT00439712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6458245|NCT00439712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458246|NCT00439712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458247|NCT00439751|Goserelin|goserelin|mesh-list
6458248|NCT00439751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5498107|NCT04500496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5498108|NCT04500496|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5498109|NCT04500496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5498110|NCT04500496|Antimetabolites|antimetabolites|mesh-ancestor
5498111|NCT04500496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498112|NCT04500496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5498113|NCT04500704|Carboplatin|carboplatin|mesh-list
5498114|NCT04500704|Pemetrexed|pemetrexed|mesh-list
5498115|NCT04500704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5498116|NCT04500704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5498117|NCT04500704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498118|NCT04500704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5498119|NCT04500704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5498120|NCT04500743|Leuprolide|leuprolide|mesh-list
5498121|NCT04500743|Dienogest|dienogest|mesh-list
5498122|NCT04500743|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5498123|NCT04500743|Fertility Agents|fertility agents|mesh-ancestor
5498124|NCT04500743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5498125|NCT04500743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498126|NCT04500743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5498127|NCT04500743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5498128|NCT04500743|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5498129|NCT04500743|Contraceptive Agents|contraceptive agents|mesh-ancestor
5498130|NCT04500743|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5498131|NCT04500743|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5498132|NCT04500743|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6045773|NCT00565643|Laxatives|laxatives|mesh-ancestor
6458249|NCT00439751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6458250|NCT00439829|Cetrorelix|cetrorelix|mesh-list
6458251|NCT00439829|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5498133|NCT04500743|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6458252|NCT00439829|Fertility Agents|fertility agents|mesh-ancestor
6458253|NCT00439829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6045774|NCT00565643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6045775|NCT00565669|Cyclosporine|cyclosporine|mesh-list
6045776|NCT00565669|Cyclosporins|cyclosporins|mesh-list
6045777|NCT00565669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6045778|NCT00565669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045779|NCT00565669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6045780|NCT00565669|Immunologic Factors|immunologic factors|mesh-ancestor
6045781|NCT00565669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045782|NCT00565669|Antifungal Agents|antifungal agents|mesh-ancestor
6045783|NCT00565669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6045784|NCT00565669|Dermatologic Agents|dermatologic agents|mesh-ancestor
6045785|NCT00565669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6045786|NCT00565669|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6045787|NCT00565773|Sirolimus|sirolimus|mesh-list
6045788|NCT00565773|Alemtuzumab|alemtuzumab|mesh-list
6045789|NCT00565773|Abatacept|abatacept|mesh-list
6045790|NCT00565773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6045791|NCT00565773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6045792|NCT00565773|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6045793|NCT00565773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6045794|NCT00565773|Antifungal Agents|antifungal agents|mesh-ancestor
6045795|NCT00565773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6045796|NCT00565773|Immunologic Factors|immunologic factors|mesh-ancestor
6045797|NCT00565773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045798|NCT00565773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6045799|NCT00565773|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6045800|NCT00565773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045801|NCT00565773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6045802|NCT00565916|Estradiol|estradiol|mesh-list
6045803|NCT00565916|Estrogens|estrogens|mesh-list
6045804|NCT00565916|Progesterone|progesterone|mesh-list
6045805|NCT00565916|Hormones|hormones|mesh-ancestor
6045806|NCT00565916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6045807|NCT00565916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458254|NCT00439829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458255|NCT00439829|Hormone Antagonists|hormone antagonists|mesh-ancestor
6458256|NCT00439829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6458257|NCT00439855|Heparin|heparin|mesh-list
6458258|NCT00439855|Enoxaparin|enoxaparin|mesh-list
6458259|NCT00439855|Calcium heparin|calcium heparin|mesh-list
6458260|NCT00439855|Anticoagulants|anticoagulants|mesh-ancestor
6458261|NCT00439855|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6458262|NCT00439855|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6458263|NCT00439855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458264|NCT00439972|Moxifloxacin|moxifloxacin|mesh-list
6458265|NCT00439972|Ortho Evra|ortho evra|mesh-list
6458266|NCT00439972|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6458267|NCT00439972|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6458268|NCT00439972|Contraceptive Agents|contraceptive agents|mesh-ancestor
6458269|NCT00439972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6458270|NCT00439972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458271|NCT00439972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6458272|NCT00439972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6458273|NCT00439972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6458274|NCT00439972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6458275|NCT00439972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6045808|NCT00565916|Progestins|progestins|mesh-ancestor
6045809|NCT00566020|Lamotrigine|lamotrigine|mesh-list
6458276|NCT00439972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458277|NCT00439972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6458278|NCT00439972|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6458279|NCT00439972|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6458280|NCT00439972|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6458281|NCT00440024|Tazarotene|tazarotene|mesh-list
6458282|NCT00440024|Dermatologic Agents|dermatologic agents|mesh-ancestor
6458283|NCT00440024|Keratolytic Agents|keratolytic agents|mesh-ancestor
6045810|NCT00566020|Anticonvulsants|anticonvulsants|mesh-ancestor
6045811|NCT00566020|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6045812|NCT00566020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6045813|NCT00566020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498134|NCT04500743|Hormone Antagonists|hormone antagonists|mesh-ancestor
5498135|NCT04500743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5498136|NCT04500522|Isoniazid|isoniazid|mesh-list
5498137|NCT04500522|Antitubercular Agents|antitubercular agents|mesh-ancestor
5498138|NCT04500522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5498139|NCT04500522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5498140|NCT04500522|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5498141|NCT04500522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6045814|NCT00566020|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6045815|NCT00566020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045816|NCT00566020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6045817|NCT00566020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6045818|NCT00566020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6045819|NCT00566020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6045820|NCT00566020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6045821|NCT00566098|Melphalan|melphalan|mesh-list
6045822|NCT00566098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6045823|NCT00566098|Alkylating Agents|alkylating agents|mesh-ancestor
6045824|NCT00566098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045825|NCT00566098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6045826|NCT00566098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6045827|NCT00566098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6045828|NCT00566098|Immunologic Factors|immunologic factors|mesh-ancestor
6045829|NCT00566098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045830|NCT00566111|Ceftriaxone|ceftriaxone|mesh-list
6045831|NCT00566111|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6045832|NCT00566111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6045833|NCT00566150|Levetiracetam|levetiracetam|mesh-list
6045834|NCT00566150|Anticonvulsants|anticonvulsants|mesh-ancestor
6045835|NCT00566150|Nootropic Agents|nootropic agents|mesh-ancestor
6045836|NCT00566254|Zonisamide|zonisamide|mesh-list
6045837|NCT00566254|Anticonvulsants|anticonvulsants|mesh-ancestor
6458284|NCT00440063|Epoetin Alfa|epoetin alfa|mesh-list
6458285|NCT00440063|Hematinics|hematinics|mesh-ancestor
6458286|NCT00440076|Bortezomib|bortezomib|mesh-list
6458287|NCT00440076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6458288|NCT00440102|Ketamine|ketamine|mesh-list
6458289|NCT00440102|Etomidate|etomidate|mesh-list
6458290|NCT00440102|Analgesics|analgesics|mesh-ancestor
6458291|NCT00440102|Sensory System Agents|sensory system agents|mesh-ancestor
6045838|NCT00566254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6045839|NCT00566254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6045840|NCT00566254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045841|NCT00566254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6045842|NCT00566254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045843|NCT00566501|Donepezil|donepezil|mesh-list
6045844|NCT00566501|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6045845|NCT00566501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6045846|NCT00566501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045847|NCT00566501|Cholinergic Agents|cholinergic agents|mesh-ancestor
6045848|NCT00566501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6045849|NCT00566501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045850|NCT00566501|Nootropic Agents|nootropic agents|mesh-ancestor
6045851|NCT00566540|Paclitaxel|paclitaxel|mesh-list
6045852|NCT00566540|Cisplatin|cisplatin|mesh-list
6045853|NCT00566540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6045854|NCT00566540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5498142|NCT04500522|Antimetabolites|antimetabolites|mesh-ancestor
5498143|NCT04500522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498144|NCT04500522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5498145|NCT04500561|Gemcitabine|gemcitabine|mesh-list
5498146|NCT04500561|Oxaliplatin|oxaliplatin|mesh-list
5498147|NCT04500561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6045855|NCT00566540|Tubulin Modulators|tubulin modulators|mesh-ancestor
6045856|NCT00566540|Antimitotic Agents|antimitotic agents|mesh-ancestor
6045857|NCT00566540|Mitosis Modulators|mitosis modulators|mesh-ancestor
6655231|NCT01462422|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6458292|NCT00440102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5498148|NCT04500561|Antimetabolites|antimetabolites|mesh-ancestor
5498149|NCT04500561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498150|NCT04500561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5498151|NCT04500561|Antiviral Agents|antiviral agents|mesh-ancestor
5498152|NCT04500561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5498153|NCT04500561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5498154|NCT04500561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5498155|NCT04500561|Immunologic Factors|immunologic factors|mesh-ancestor
5498156|NCT04500561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498157|NCT04500236|Anesthetics|anesthetics|mesh-list
5498158|NCT04500236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5498159|NCT04500236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498160|NCT04500275|Vancomycin|vancomycin|mesh-list
6045858|NCT00566540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045859|NCT00566631|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6045860|NCT00566631|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6045861|NCT00566631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6045862|NCT00566631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6045863|NCT00566631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045864|NCT00566631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6045865|NCT00566631|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6045866|NCT00566631|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6045867|NCT00566631|Serotonin Agents|serotonin agents|mesh-ancestor
6045868|NCT00566631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6045869|NCT00566631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045870|NCT00566631|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6045871|NCT00566631|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6045872|NCT00566631|Dopamine Agents|dopamine agents|mesh-ancestor
6045873|NCT00566696|Mycophenolic Acid|mycophenolic acid|mesh-list
6045874|NCT00566696|Cyclophosphamide|cyclophosphamide|mesh-list
6045875|NCT00566696|Melphalan|melphalan|mesh-list
6045876|NCT00566696|Mechlorethamine|mechlorethamine|mesh-list
6045877|NCT00566696|Thiotepa|thiotepa|mesh-list
6045878|NCT00566696|Rituximab|rituximab|mesh-list
6045879|NCT00566696|Fludarabine|fludarabine|mesh-list
6045880|NCT00566696|Alemtuzumab|alemtuzumab|mesh-list
6045881|NCT00566696|Thymoglobulin|thymoglobulin|mesh-list
6045882|NCT00566696|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6045883|NCT00566696|Muromonab-CD3|muromonab-cd3|mesh-list
6045884|NCT00566696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6045885|NCT00566696|Immunologic Factors|immunologic factors|mesh-ancestor
6045886|NCT00566696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045887|NCT00566696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6045888|NCT00566696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6045889|NCT00566696|Alkylating Agents|alkylating agents|mesh-ancestor
6045890|NCT00566696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045891|NCT00566696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6045892|NCT00566696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6045893|NCT00566696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6045894|NCT00566696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6045895|NCT00566696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6045896|NCT00566696|Antitubercular Agents|antitubercular agents|mesh-ancestor
6045897|NCT00566696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6045898|NCT00566696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6045899|NCT00566696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6045900|NCT00566722|Adalimumab|adalimumab|mesh-list
6045901|NCT00566722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6045902|NCT00566722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6045903|NCT00566735|Galantamine|galantamine|mesh-list
6045904|NCT00566735|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6045905|NCT00566735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6045906|NCT00566735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498161|NCT04500275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5498162|NCT04500275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5498163|NCT04500756|Metformin|metformin|mesh-list
5498164|NCT04500756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5498165|NCT04500756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498166|NCT04499989|Isoniazid|isoniazid|mesh-list
5498167|NCT04499989|Antitubercular Agents|antitubercular agents|mesh-ancestor
6045907|NCT00566735|Cholinergic Agents|cholinergic agents|mesh-ancestor
6045908|NCT00566735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6045909|NCT00566735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045910|NCT00566735|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6045911|NCT00566735|Autonomic Agents|autonomic agents|mesh-ancestor
5498168|NCT04499989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5498169|NCT04499989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5498170|NCT04499989|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5498171|NCT04499989|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5498172|NCT04499989|Antimetabolites|antimetabolites|mesh-ancestor
5498173|NCT04499989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498174|NCT04499989|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5498175|NCT04500067|Immunoglobulins|immunoglobulins|mesh-list
5498176|NCT04500067|Immunologic Factors|immunologic factors|mesh-ancestor
5498177|NCT04500067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498178|NCT04500613|Dexamethasone|dexamethasone|mesh-list
5498179|NCT04500613|Dexamethasone acetate|dexamethasone acetate|mesh-list
5498180|NCT04500613|Bupivacaine|bupivacaine|mesh-list
5498181|NCT04500613|BB 1101|bb 1101|mesh-list
6045912|NCT00566735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6045913|NCT00566735|Nootropic Agents|nootropic agents|mesh-ancestor
6045914|NCT00566813|Exenatide|exenatide|mesh-list
6045915|NCT00566813|Etanercept|etanercept|mesh-list
6045916|NCT00566813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6045917|NCT00566813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6045918|NCT00566813|Analgesics|analgesics|mesh-ancestor
6045919|NCT00566813|Sensory System Agents|sensory system agents|mesh-ancestor
6045920|NCT00566813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6045921|NCT00566813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045922|NCT00566813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6045923|NCT00566813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6045924|NCT00566813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6045925|NCT00566813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6045926|NCT00566813|Immunologic Factors|immunologic factors|mesh-ancestor
6045927|NCT00566813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6045928|NCT00566813|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6458293|NCT00440102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458294|NCT00440102|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6458295|NCT00440102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6458296|NCT00440102|Anesthetics, General|anesthetics, general|mesh-ancestor
6458297|NCT00440102|Anesthetics|anesthetics|mesh-ancestor
6045929|NCT00566813|Incretins|incretins|mesh-ancestor
6045930|NCT00566813|Hormones|hormones|mesh-ancestor
6045931|NCT00566813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6045932|NCT00566852|Memantine|memantine|mesh-list
6045933|NCT00566852|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6045934|NCT00566852|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6045935|NCT00566852|Dopamine Agents|dopamine agents|mesh-ancestor
6045936|NCT00566852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6045937|NCT00566852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045938|NCT00566852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045939|NCT00566852|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6045940|NCT00566852|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6045941|NCT00566969|Carvedilol|carvedilol|mesh-list
6045942|NCT00566969|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6045943|NCT00566969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6045944|NCT00566969|Adrenergic Agents|adrenergic agents|mesh-ancestor
6045945|NCT00566969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6045946|NCT00566969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045947|NCT00566969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045948|NCT00566969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6045949|NCT00566969|Antioxidants|antioxidants|mesh-ancestor
6045950|NCT00566969|Protective Agents|protective agents|mesh-ancestor
6045951|NCT00566969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6045952|NCT00566969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6045953|NCT00566969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6045954|NCT00566969|Vasodilator Agents|vasodilator agents|mesh-ancestor
6045955|NCT00566969|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6045956|NCT00566969|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6045957|NCT00567008|Varenicline|varenicline|mesh-list
6045958|NCT00567008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6045959|NCT00567008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6045960|NCT00567008|Cholinergic Agents|cholinergic agents|mesh-ancestor
6045961|NCT00567008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6045962|NCT00567008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045963|NCT00567008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045964|NCT00567164|Drospirenone|drospirenone|mesh-list
5498182|NCT04500613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5498183|NCT04500613|Antiemetics|antiemetics|mesh-ancestor
5498184|NCT04500613|Autonomic Agents|autonomic agents|mesh-ancestor
5498185|NCT04500613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5498186|NCT04500613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498187|NCT04500613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5498188|NCT04500613|Glucocorticoids|glucocorticoids|mesh-ancestor
5498189|NCT04500613|Hormones|hormones|mesh-ancestor
5498190|NCT04500613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5498191|NCT04500613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5498192|NCT04500613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5498193|NCT04500613|Protease Inhibitors|protease inhibitors|mesh-ancestor
5498194|NCT04500613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5498195|NCT04500613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498196|NCT04500613|Anesthetics, Local|anesthetics, local|mesh-ancestor
5498197|NCT04500613|Anesthetics|anesthetics|mesh-ancestor
5498198|NCT04500613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5498199|NCT04500613|Sensory System Agents|sensory system agents|mesh-ancestor
5498200|NCT04500678|Metformin|metformin|mesh-list
5498201|NCT04500678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5498202|NCT04500678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498203|NCT04500002|Isoniazid|isoniazid|mesh-list
5498204|NCT04500002|Misoprostol|misoprostol|mesh-list
5498205|NCT04500002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5498206|NCT04500002|Abortifacient Agents|abortifacient agents|mesh-ancestor
5498207|NCT04500002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5498208|NCT04500002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498209|NCT04500002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5498210|NCT04500002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5498211|NCT04500002|Oxytocics|oxytocics|mesh-ancestor
5498212|NCT04500002|Antitubercular Agents|antitubercular agents|mesh-ancestor
5498213|NCT04500002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5498214|NCT04500002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5498215|NCT04500002|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5498216|NCT04500002|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5498217|NCT04500002|Antimetabolites|antimetabolites|mesh-ancestor
5498218|NCT04500002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498219|NCT04500002|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5498220|NCT04500158|Lidocaine|lidocaine|mesh-list
5498221|NCT04500158|Anesthetics, Local|anesthetics, local|mesh-ancestor
5498222|NCT04500158|Anesthetics|anesthetics|mesh-ancestor
5498223|NCT04500158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5498224|NCT04500158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498225|NCT04500158|Sensory System Agents|sensory system agents|mesh-ancestor
5498226|NCT04500158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5498227|NCT04500158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5498228|NCT04500158|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5498229|NCT04500158|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5498230|NCT04500158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5498231|NCT04500158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498232|NCT04500418|Cenicriviroc|cenicriviroc|mesh-list
5498233|NCT04500418|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
5498234|NCT04500418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498235|NCT04500418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6045965|NCT00567164|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6045966|NCT00567164|Hormone Antagonists|hormone antagonists|mesh-ancestor
6045967|NCT00567164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6045968|NCT00567164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045969|NCT00567164|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6045970|NCT00567164|Diuretics|diuretics|mesh-ancestor
6045971|NCT00567164|Natriuretic Agents|natriuretic agents|mesh-ancestor
6045972|NCT00567190|Docetaxel|docetaxel|mesh-list
6045973|NCT00567190|Trastuzumab|trastuzumab|mesh-list
6045974|NCT00567190|Pertuzumab|pertuzumab|mesh-list
6045975|NCT00567190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6045976|NCT00567190|Tubulin Modulators|tubulin modulators|mesh-ancestor
6045977|NCT00567190|Antimitotic Agents|antimitotic agents|mesh-ancestor
6045978|NCT00567190|Mitosis Modulators|mitosis modulators|mesh-ancestor
6045979|NCT00567190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6045980|NCT00567190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6045981|NCT00567229|Rituximab|rituximab|mesh-list
6045982|NCT00567229|Lenalidomide|lenalidomide|mesh-list
6045983|NCT00567229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6045984|NCT00567229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6045985|NCT00567229|Immunologic Factors|immunologic factors|mesh-ancestor
6045986|NCT00567229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045987|NCT00567229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6045988|NCT00567229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6045989|NCT00567229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6045990|NCT00567229|Growth Substances|growth substances|mesh-ancestor
6045991|NCT00567229|Growth Inhibitors|growth inhibitors|mesh-ancestor
5498236|NCT04500418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6045992|NCT00567255|Naltrexone|naltrexone|mesh-list
6045993|NCT00567255|Bupropion|bupropion|mesh-list
6045994|NCT00567255|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6045995|NCT00567255|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6045996|NCT00567255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6045997|NCT00567255|Sensory System Agents|sensory system agents|mesh-ancestor
6045998|NCT00567255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6045999|NCT00567255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6046000|NCT00567255|Antidepressive Agents|antidepressive agents|mesh-ancestor
6046001|NCT00567255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6046002|NCT00567255|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5498237|NCT04500418|Antiviral Agents|antiviral agents|mesh-ancestor
5498238|NCT04500418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5498239|NCT04499742|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
5498240|NCT04499742|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5498241|NCT04499742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498242|NCT04499898|Carvedilol|carvedilol|mesh-list
5498243|NCT04499898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5498244|NCT04499898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5498245|NCT04499898|Adrenergic Agents|adrenergic agents|mesh-ancestor
5498246|NCT04499898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6046003|NCT00567255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6046004|NCT00567255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6046005|NCT00567255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046006|NCT00567255|Dopamine Agents|dopamine agents|mesh-ancestor
6046007|NCT00567255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6046008|NCT00567255|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6046009|NCT00567255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6046010|NCT00567255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6046011|NCT00567268|Gabapentin|gabapentin|mesh-list
6046012|NCT00567268|Analgesics|analgesics|mesh-ancestor
6046013|NCT00567268|Sensory System Agents|sensory system agents|mesh-ancestor
6046014|NCT00567268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6046015|NCT00567268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046016|NCT00567268|Anticonvulsants|anticonvulsants|mesh-ancestor
6046017|NCT00567268|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6046018|NCT00567268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5498247|NCT04499898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725022|NCT03183297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5725023|NCT03183297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5725024|NCT03183297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725025|NCT03183297|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5725026|NCT03183297|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5725027|NCT03183297|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5725028|NCT03183297|Histamine Antagonists|histamine antagonists|mesh-ancestor
6053883|NCT00599313|Growth Substances|growth substances|mesh-ancestor
6046019|NCT00567268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6046020|NCT00567268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6046021|NCT00567268|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6046022|NCT00567268|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6046023|NCT00567268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6046024|NCT00567268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046025|NCT00567268|Antimanic Agents|antimanic agents|mesh-ancestor
6046026|NCT00567320|Varenicline|varenicline|mesh-list
6046027|NCT00567320|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6046028|NCT00567320|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6046029|NCT00567320|Cholinergic Agents|cholinergic agents|mesh-ancestor
6046030|NCT00567320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6046031|NCT00567320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046032|NCT00567320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046033|NCT00567359|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6046034|NCT00567359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6046035|NCT00567359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6046036|NCT00567359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5498248|NCT04499898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498249|NCT04499898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5498250|NCT04499898|Antioxidants|antioxidants|mesh-ancestor
5498251|NCT04499898|Protective Agents|protective agents|mesh-ancestor
5498252|NCT04499898|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5498253|NCT04499898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5498254|NCT04499898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5498255|NCT04499898|Vasodilator Agents|vasodilator agents|mesh-ancestor
5498256|NCT04499898|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5498257|NCT04499898|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5498258|NCT04499885|Mineral Oil|mineral oil|mesh-list
5498259|NCT04499885|Emollients|emollients|mesh-ancestor
6046037|NCT00567359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046038|NCT00567398|Icodextrin|icodextrin|mesh-list
6046039|NCT00567398|Dialysis Solutions|dialysis solutions|mesh-ancestor
6046040|NCT00567398|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6046041|NCT00567476|Omalizumab|omalizumab|mesh-list
6046042|NCT00567476|Terbutaline|terbutaline|mesh-list
6046043|NCT00567476|Adrenergic Agents|adrenergic agents|mesh-list
6046044|NCT00567476|Adrenergic Agonists|adrenergic agonists|mesh-list
6046045|NCT00567476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6046046|NCT00567476|Autonomic Agents|autonomic agents|mesh-ancestor
6046047|NCT00567476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6046048|NCT00567476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046049|NCT00567476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6046050|NCT00567476|Respiratory System Agents|respiratory system agents|mesh-ancestor
6046051|NCT00567476|Tocolytic Agents|tocolytic agents|mesh-ancestor
6046052|NCT00567476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6046053|NCT00567476|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6046054|NCT00567476|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6046055|NCT00567476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6046056|NCT00567476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046057|NCT00567476|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6046058|NCT00567476|Sympathomimetics|sympathomimetics|mesh-ancestor
6046059|NCT00567489|Icodextrin|icodextrin|mesh-list
6046060|NCT00567489|Dialysis Solutions|dialysis solutions|mesh-ancestor
6046061|NCT00567489|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6046062|NCT00567593|Rosiglitazone|rosiglitazone|mesh-list
6046063|NCT00567593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6046064|NCT00567593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046065|NCT00567879|Trastuzumab|trastuzumab|mesh-list
6046066|NCT00567879|Panobinostat|panobinostat|mesh-list
6046067|NCT00567879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6046068|NCT00567879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6046069|NCT00567879|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6046070|NCT00567879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6046071|NCT00567879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046072|NCT00567996|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6046073|NCT00567996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6046074|NCT00567996|Autonomic Agents|autonomic agents|mesh-ancestor
6046075|NCT00567996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6046076|NCT00567996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046077|NCT00567996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6046078|NCT00567996|Respiratory System Agents|respiratory system agents|mesh-ancestor
6046079|NCT00567996|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6458298|NCT00440102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6046080|NCT00567996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6046081|NCT00567996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6046082|NCT00567996|Adrenergic Agents|adrenergic agents|mesh-ancestor
6046083|NCT00567996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6046084|NCT00567996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046085|NCT00568022|Capecitabine|capecitabine|mesh-list
6046086|NCT00568022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6046087|NCT00568022|Antimetabolites|antimetabolites|mesh-ancestor
6046088|NCT00568022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046089|NCT00568022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6046090|NCT00568061|Nitric Oxide|nitric oxide|mesh-list
6046091|NCT00568061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6046092|NCT00568061|Autonomic Agents|autonomic agents|mesh-ancestor
6046093|NCT00568061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6046094|NCT00568061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046095|NCT00568061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6046096|NCT00568061|Respiratory System Agents|respiratory system agents|mesh-ancestor
6046097|NCT00568061|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6046098|NCT00568061|Antioxidants|antioxidants|mesh-ancestor
6046099|NCT00568061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046100|NCT00568061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6046101|NCT00568061|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6046102|NCT00568061|Vasodilator Agents|vasodilator agents|mesh-ancestor
6046103|NCT00568061|Gasotransmitters|gasotransmitters|mesh-ancestor
6046104|NCT00568061|Protective Agents|protective agents|mesh-ancestor
6046105|NCT00568087|Acetylcysteine|acetylcysteine|mesh-list
6046106|NCT00568087|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6046107|NCT00568087|Antiviral Agents|antiviral agents|mesh-ancestor
6046108|NCT00568087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6046109|NCT00568087|Expectorants|expectorants|mesh-ancestor
6046110|NCT00568087|Respiratory System Agents|respiratory system agents|mesh-ancestor
6046111|NCT00568087|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6046112|NCT00568087|Antioxidants|antioxidants|mesh-ancestor
6046113|NCT00568087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046114|NCT00568087|Protective Agents|protective agents|mesh-ancestor
6046115|NCT00568087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046116|NCT00568087|Antidotes|antidotes|mesh-ancestor
6046117|NCT00568321|Tanezumab|tanezumab|mesh-list
6046118|NCT00568321|Analgesics|analgesics|mesh-ancestor
6046119|NCT00568321|Sensory System Agents|sensory system agents|mesh-ancestor
6046120|NCT00568321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6046121|NCT00568321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046122|NCT00568386|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6046123|NCT00568386|Lubricant Eye Drops|lubricant eye drops|mesh-list
6046124|NCT00568386|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6046125|NCT00568399|Sodium thiosulfate|sodium thiosulfate|mesh-list
6046126|NCT00568399|Antidotes|antidotes|mesh-ancestor
6046127|NCT00568399|Protective Agents|protective agents|mesh-ancestor
6046128|NCT00568399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046129|NCT00568399|Antioxidants|antioxidants|mesh-ancestor
6046130|NCT00568399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498260|NCT04499885|Dermatologic Agents|dermatologic agents|mesh-ancestor
5498261|NCT04499586|Irinotecan|irinotecan|mesh-list
5498262|NCT04499586|Raltitrexed|raltitrexed|mesh-list
5498263|NCT04499586|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5498264|NCT04499586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5498265|NCT04499586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6046131|NCT00568399|Antitubercular Agents|antitubercular agents|mesh-ancestor
6046132|NCT00568399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6046133|NCT00568399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6046134|NCT00568399|Chelating Agents|chelating agents|mesh-ancestor
6046135|NCT00568399|Sequestering Agents|sequestering agents|mesh-ancestor
6046136|NCT00568451|Paclitaxel|paclitaxel|mesh-list
6046137|NCT00568451|Carboplatin|carboplatin|mesh-list
6046138|NCT00568451|Temozolomide|temozolomide|mesh-list
6046139|NCT00568451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6046140|NCT00568451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6046141|NCT00568451|Tubulin Modulators|tubulin modulators|mesh-ancestor
6046142|NCT00568451|Antimitotic Agents|antimitotic agents|mesh-ancestor
6046143|NCT00568451|Mitosis Modulators|mitosis modulators|mesh-ancestor
6046144|NCT00568451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046145|NCT00568451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6046146|NCT00568451|Alkylating Agents|alkylating agents|mesh-ancestor
5498266|NCT04499586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498267|NCT04499586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5498268|NCT04499586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5498269|NCT04499586|Antimetabolites|antimetabolites|mesh-ancestor
5498270|NCT04499586|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5498271|NCT04499859|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5498272|NCT04499859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5498273|NCT04499859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5498274|NCT04499859|Antimetabolites|antimetabolites|mesh-ancestor
5498275|NCT04499859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498276|NCT04499859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6046147|NCT00568555|Naltrexone|naltrexone|mesh-list
6046148|NCT00568555|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6046149|NCT00568555|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6046150|NCT00568555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046151|NCT00568555|Sensory System Agents|sensory system agents|mesh-ancestor
6046152|NCT00568555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6046153|NCT00568633|Cyclosporine|cyclosporine|mesh-list
6046154|NCT00568633|Mycophenolic Acid|mycophenolic acid|mesh-list
6046155|NCT00568633|Methylprednisolone|methylprednisolone|mesh-list
6046156|NCT00568633|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6046157|NCT00568633|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6046158|NCT00568633|Prednisolone|prednisolone|mesh-list
6046159|NCT00568633|Prednisolone acetate|prednisolone acetate|mesh-list
5498277|NCT04499859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5498278|NCT04499859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5498279|NCT04499573|Cytarabine|cytarabine|mesh-list
5498280|NCT04499573|Dexamethasone|dexamethasone|mesh-list
5498281|NCT04499573|Cyclophosphamide|cyclophosphamide|mesh-list
5498282|NCT04499573|Fludarabine|fludarabine|mesh-list
5498283|NCT04499573|Etoposide|etoposide|mesh-list
6046160|NCT00568633|Cyclosporins|cyclosporins|mesh-list
6046161|NCT00568633|Thymoglobulin|thymoglobulin|mesh-list
6046162|NCT00568633|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6046163|NCT00568633|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6046164|NCT00568633|Prednisolone phosphate|prednisolone phosphate|mesh-list
6046165|NCT00568633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6046166|NCT00568633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046167|NCT00568633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6046168|NCT00568633|Immunologic Factors|immunologic factors|mesh-ancestor
6046169|NCT00568633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046170|NCT00568633|Antifungal Agents|antifungal agents|mesh-ancestor
6046171|NCT00568633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6046172|NCT00568633|Dermatologic Agents|dermatologic agents|mesh-ancestor
6046173|NCT00568633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6046174|NCT00568633|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6046175|NCT00568633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6046176|NCT00568633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6046177|NCT00568633|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6046178|NCT00568633|Antitubercular Agents|antitubercular agents|mesh-ancestor
6046179|NCT00568633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6046180|NCT00568633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6046181|NCT00568633|Antiemetics|antiemetics|mesh-ancestor
6046182|NCT00568633|Autonomic Agents|autonomic agents|mesh-ancestor
6046183|NCT00568633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6046184|NCT00568633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6046185|NCT00568633|Glucocorticoids|glucocorticoids|mesh-ancestor
6046186|NCT00568633|Hormones|hormones|mesh-ancestor
6046187|NCT00568633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6046188|NCT00568633|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6046189|NCT00568633|Protective Agents|protective agents|mesh-ancestor
6046190|NCT00568633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6046191|NCT00568685|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6046192|NCT00568685|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6046193|NCT00568685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6046194|NCT00568685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6046195|NCT00568685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046196|NCT00568685|Adrenergic Agents|adrenergic agents|mesh-ancestor
6046197|NCT00568685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5498284|NCT04499573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6046198|NCT00568685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046199|NCT00568776|Inositol|inositol|mesh-list
6046200|NCT00568776|Vitamin B Complex|vitamin b complex|mesh-ancestor
6046201|NCT00568776|Vitamins|vitamins|mesh-ancestor
6046202|NCT00568776|Micronutrients|micronutrients|mesh-ancestor
6046203|NCT00568776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046204|NCT00568958|Naltrexone|naltrexone|mesh-list
6046205|NCT00568958|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6046206|NCT00568958|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6046207|NCT00568958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046208|NCT00568958|Sensory System Agents|sensory system agents|mesh-ancestor
6046209|NCT00568958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6046210|NCT00569010|Cytarabine|cytarabine|mesh-list
6046211|NCT00569010|Azacitidine|azacitidine|mesh-list
6046212|NCT00569010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6046213|NCT00569010|Antimetabolites|antimetabolites|mesh-ancestor
6458299|NCT00440102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6458300|NCT00440102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6458301|NCT00440102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5498285|NCT04499573|Immunologic Factors|immunologic factors|mesh-ancestor
5498286|NCT04499573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498287|NCT04499573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5498288|NCT04499573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5498289|NCT04499573|Alkylating Agents|alkylating agents|mesh-ancestor
5498290|NCT04499573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498291|NCT04499573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5498292|NCT04499573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5498293|NCT04499573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6046214|NCT00569010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046215|NCT00569010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6046216|NCT00569010|Antiviral Agents|antiviral agents|mesh-ancestor
6046217|NCT00569010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6046218|NCT00569010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6046219|NCT00569010|Immunologic Factors|immunologic factors|mesh-ancestor
6046220|NCT00569010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046221|NCT00569010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6046222|NCT00569127|Interferons|interferons|mesh-list
6046223|NCT00569127|Interferon-alpha|interferon-alpha|mesh-list
6046224|NCT00569127|Interferon alpha-2|interferon alpha-2|mesh-list
6046225|NCT00569127|Bevacizumab|bevacizumab|mesh-list
6046226|NCT00569127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6046227|NCT00569127|Octreotide|octreotide|mesh-list
6046228|NCT00569127|Endothelial Growth Factors|endothelial growth factors|mesh-list
6046229|NCT00569127|Antibodies|antibodies|mesh-list
6046230|NCT00569127|Immunoglobulins|immunoglobulins|mesh-list
6458302|NCT00440102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458303|NCT00440102|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6458304|NCT00440128|Docetaxel|docetaxel|mesh-list
6458305|NCT00440128|Casopitant|casopitant|mesh-list
6458306|NCT00440128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6458307|NCT00440128|Tubulin Modulators|tubulin modulators|mesh-ancestor
6458308|NCT00440128|Antimitotic Agents|antimitotic agents|mesh-ancestor
6458309|NCT00440128|Mitosis Modulators|mitosis modulators|mesh-ancestor
6458310|NCT00440128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458311|NCT00440128|Antiemetics|antiemetics|mesh-ancestor
6458312|NCT00440128|Autonomic Agents|autonomic agents|mesh-ancestor
6458313|NCT00440128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6458314|NCT00440128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458315|NCT00440128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6458316|NCT00440128|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6458317|NCT00440128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6046231|NCT00569127|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6046232|NCT00569127|Immunoglobulin G|immunoglobulin g|mesh-list
6046233|NCT00569127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6046234|NCT00569127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6046235|NCT00569127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6046236|NCT00569127|Growth Substances|growth substances|mesh-ancestor
6046237|NCT00569127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046238|NCT00569127|Growth Inhibitors|growth inhibitors|mesh-ancestor
6046239|NCT00569127|Immunologic Factors|immunologic factors|mesh-ancestor
6046240|NCT00569127|Antiviral Agents|antiviral agents|mesh-ancestor
6046241|NCT00569127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6046242|NCT00569127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6046243|NCT00569127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6046244|NCT00569309|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6046245|NCT00569309|Immunologic Factors|immunologic factors|mesh-ancestor
6046246|NCT00569309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046247|NCT00569374|Modafinil|modafinil|mesh-list
5498294|NCT04499573|Antiemetics|antiemetics|mesh-ancestor
5498295|NCT04499573|Autonomic Agents|autonomic agents|mesh-ancestor
5498296|NCT04499573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5498297|NCT04499573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5498298|NCT04499573|Glucocorticoids|glucocorticoids|mesh-ancestor
5498299|NCT04499573|Hormones|hormones|mesh-ancestor
5498300|NCT04499573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5498301|NCT04499573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6046248|NCT00569374|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6046249|NCT00569374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046250|NCT00569374|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6046251|NCT00569374|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6046252|NCT00569374|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6046253|NCT00569374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046254|NCT00569530|Calfactant|calfactant|mesh-list
6046255|NCT00569530|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
6046256|NCT00569530|Respiratory System Agents|respiratory system agents|mesh-ancestor
6046257|NCT00569582|Mifepristone|mifepristone|mesh-list
6046258|NCT00569582|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6046259|NCT00569582|Abortifacient Agents|abortifacient agents|mesh-ancestor
6046260|NCT00569582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6046261|NCT00569582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046262|NCT00569582|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6046263|NCT00569582|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6046264|NCT00569582|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6046265|NCT00569582|Contraceptive Agents|contraceptive agents|mesh-ancestor
6046266|NCT00569582|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6046267|NCT00569582|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6046268|NCT00569582|Hormone Antagonists|hormone antagonists|mesh-ancestor
6046269|NCT00569582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6046270|NCT00569582|Luteolytic Agents|luteolytic agents|mesh-ancestor
6046271|NCT00569582|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6046272|NCT00569582|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6046273|NCT00569660|Azacitidine|azacitidine|mesh-list
6046274|NCT00569660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6046275|NCT00569660|Antimetabolites|antimetabolites|mesh-ancestor
6046276|NCT00569660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046277|NCT00569660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6046278|NCT00569660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6046279|NCT00569673|Docetaxel|docetaxel|mesh-list
6655232|NCT01462422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6655233|NCT01462422|Oxytocics|oxytocics|mesh-ancestor
6655234|NCT01462474|Cisplatin|cisplatin|mesh-list
6655235|NCT01462474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6655236|NCT01462487|Zanamivir|zanamivir|mesh-list
6655237|NCT01462487|Antiviral Agents|antiviral agents|mesh-ancestor
6655238|NCT01462487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6655239|NCT01462487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6046280|NCT00569673|Trabectedin|trabectedin|mesh-list
6046281|NCT00569673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6046282|NCT00569673|Tubulin Modulators|tubulin modulators|mesh-ancestor
6046283|NCT00569673|Antimitotic Agents|antimitotic agents|mesh-ancestor
6046284|NCT00569673|Mitosis Modulators|mitosis modulators|mesh-ancestor
6046285|NCT00569673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046286|NCT00569673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6655240|NCT01462487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046287|NCT00569673|Alkylating Agents|alkylating agents|mesh-ancestor
6046288|NCT00569777|Ketotifen|ketotifen|mesh-list
6046289|NCT00569777|Antipruritics|antipruritics|mesh-ancestor
6046290|NCT00569777|Dermatologic Agents|dermatologic agents|mesh-ancestor
6046291|NCT00569777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6046292|NCT00569777|Histamine Antagonists|histamine antagonists|mesh-ancestor
6046293|NCT00569777|Histamine Agents|histamine agents|mesh-ancestor
6046294|NCT00569777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6046295|NCT00569777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046296|NCT00569777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046297|NCT00569777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6046298|NCT00569803|Abatacept|abatacept|mesh-list
6046299|NCT00569803|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6046300|NCT00569803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046301|NCT00569803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6046302|NCT00569803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6046303|NCT00569803|Immunologic Factors|immunologic factors|mesh-ancestor
6046304|NCT00569803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046305|NCT00569803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6046306|NCT00569855|Phenoxybenzamine|phenoxybenzamine|mesh-list
6046307|NCT00569855|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6046308|NCT00569855|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6046309|NCT00569855|Adrenergic Agents|adrenergic agents|mesh-ancestor
6046310|NCT00569855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6046311|NCT00569855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046312|NCT00569855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046313|NCT00569855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6046314|NCT00569855|Vasodilator Agents|vasodilator agents|mesh-ancestor
6046315|NCT00569946|Axitinib|axitinib|mesh-list
6046316|NCT00569946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6046317|NCT00569946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6046318|NCT00569946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6046319|NCT00569946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046320|NCT00570089|Ranolazine|ranolazine|mesh-list
6046321|NCT00570089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6046322|NCT00570089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6046323|NCT00570089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046324|NCT00570128|Donepezil|donepezil|mesh-list
6046325|NCT00570128|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6046326|NCT00570128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6046327|NCT00570128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046328|NCT00570128|Cholinergic Agents|cholinergic agents|mesh-ancestor
6046329|NCT00570128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6046330|NCT00570128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046331|NCT00570128|Nootropic Agents|nootropic agents|mesh-ancestor
6046332|NCT00570232|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6046333|NCT00570232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6046334|NCT00570232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6046335|NCT00570232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6046336|NCT00570232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046337|NCT00570310|Pregabalin|pregabalin|mesh-list
6046338|NCT00570310|Analgesics|analgesics|mesh-ancestor
6046339|NCT00570310|Sensory System Agents|sensory system agents|mesh-ancestor
5498302|NCT04499573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5498303|NCT04499573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5498304|NCT04499573|Antimetabolites|antimetabolites|mesh-ancestor
5498305|NCT04499573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5498306|NCT04499573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5498307|NCT04499573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5498308|NCT04499573|Antiviral Agents|antiviral agents|mesh-ancestor
5498309|NCT04499573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5498310|NCT04499976|Misoprostol|misoprostol|mesh-list
5498311|NCT04499976|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5498312|NCT04499976|Abortifacient Agents|abortifacient agents|mesh-ancestor
5498313|NCT04499976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6046340|NCT00570310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6046341|NCT00570310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046342|NCT00570310|Anticonvulsants|anticonvulsants|mesh-ancestor
6046343|NCT00570310|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5498314|NCT04499976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498315|NCT04499976|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5498316|NCT04499976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5498317|NCT04499976|Oxytocics|oxytocics|mesh-ancestor
5498318|NCT04499053|Durvalumab|durvalumab|mesh-list
6458318|NCT00440141|Brimonidine Tartrate|brimonidine tartrate|mesh-list
5498319|NCT04499053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5498320|NCT04499053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5498321|NCT04499118|Paclitaxel|paclitaxel|mesh-list
5498322|NCT04499118|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5498323|NCT04499118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5498324|NCT04499118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5498325|NCT04499118|Tubulin Modulators|tubulin modulators|mesh-ancestor
5498326|NCT04499118|Antimitotic Agents|antimitotic agents|mesh-ancestor
5498327|NCT04499118|Mitosis Modulators|mitosis modulators|mesh-ancestor
5498328|NCT04499118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498329|NCT04499313|Dexamethasone|dexamethasone|mesh-list
5498330|NCT04499313|Methylprednisolone|methylprednisolone|mesh-list
5498331|NCT04499313|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5498332|NCT04499313|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5498333|NCT04499313|Prednisolone|prednisolone|mesh-list
6046344|NCT00570310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6046345|NCT00570310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046346|NCT00570310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6046347|NCT00570310|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6046348|NCT00570310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6046349|NCT00570310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6046350|NCT00570310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6046351|NCT00570323|Fulvestrant|fulvestrant|mesh-list
6458319|NCT00440141|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6458320|NCT00440141|Latanoprost|latanoprost|mesh-list
6458321|NCT00440141|Brinzolamide|brinzolamide|mesh-list
6458322|NCT00440141|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6458323|NCT00440141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5498334|NCT04499313|Prednisolone acetate|prednisolone acetate|mesh-list
5498335|NCT04499313|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5498336|NCT04499313|Prednisolone phosphate|prednisolone phosphate|mesh-list
5498337|NCT04499313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5498338|NCT04499313|Antiemetics|antiemetics|mesh-ancestor
5498339|NCT04499313|Autonomic Agents|autonomic agents|mesh-ancestor
5498340|NCT04499313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5498341|NCT04499313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498342|NCT04499313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5498343|NCT04499313|Glucocorticoids|glucocorticoids|mesh-ancestor
5498344|NCT04499313|Hormones|hormones|mesh-ancestor
5498345|NCT04499313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5498346|NCT04499313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5498347|NCT04499313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5498348|NCT04499313|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5498349|NCT04499313|Protective Agents|protective agents|mesh-ancestor
5498350|NCT04499235|Mometasone Furoate|mometasone furoate|mesh-list
5498351|NCT04499235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5498352|NCT04499235|Dermatologic Agents|dermatologic agents|mesh-ancestor
5498353|NCT04499235|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5498354|NCT04499196|Glucocorticoids|glucocorticoids|mesh-list
6458324|NCT00440141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6458325|NCT00440141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5498355|NCT04499196|Hormones|hormones|mesh-ancestor
6046352|NCT00570323|Anastrozole|anastrozole|mesh-list
6046353|NCT00570323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6046354|NCT00570323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6046355|NCT00570323|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6046356|NCT00570323|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6046357|NCT00570323|Hormone Antagonists|hormone antagonists|mesh-ancestor
6046358|NCT00570323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6046359|NCT00570323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046360|NCT00570323|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5498356|NCT04499196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5498357|NCT04499196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503381|NCT04459598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5503382|NCT04459598|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5503383|NCT04459598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5503384|NCT04459598|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6046361|NCT00570323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6046362|NCT00570323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6046363|NCT00570323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053884|NCT00599313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053885|NCT00599313|Growth Inhibitors|growth inhibitors|mesh-ancestor
6458326|NCT00440141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6046364|NCT00570349|Nitric Oxide|nitric oxide|mesh-list
6046365|NCT00570349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6046366|NCT00570349|Autonomic Agents|autonomic agents|mesh-ancestor
5498358|NCT04499274|Ondansetron|ondansetron|mesh-list
5498359|NCT04499274|Antiemetics|antiemetics|mesh-ancestor
5498360|NCT04499274|Autonomic Agents|autonomic agents|mesh-ancestor
5498361|NCT04499274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5498362|NCT04499274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498363|NCT04499274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5498364|NCT04499274|Antipruritics|antipruritics|mesh-ancestor
5498365|NCT04499274|Dermatologic Agents|dermatologic agents|mesh-ancestor
5498366|NCT04499274|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5498367|NCT04499274|Serotonin Agents|serotonin agents|mesh-ancestor
5498368|NCT04499274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5498369|NCT04499274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498370|NCT04499274|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5498371|NCT04499274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6046367|NCT00570349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6046368|NCT00570349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046369|NCT00570349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6046370|NCT00570349|Respiratory System Agents|respiratory system agents|mesh-ancestor
6046371|NCT00570349|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6046372|NCT00570349|Antioxidants|antioxidants|mesh-ancestor
6046373|NCT00570349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046374|NCT00570349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6046375|NCT00570349|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6046376|NCT00570349|Vasodilator Agents|vasodilator agents|mesh-ancestor
6046377|NCT00570349|Gasotransmitters|gasotransmitters|mesh-ancestor
6046378|NCT00570349|Protective Agents|protective agents|mesh-ancestor
6046379|NCT00570401|Dasatinib|dasatinib|mesh-list
6046380|NCT00570401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6046381|NCT00570401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6046382|NCT00570401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6046383|NCT00570401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046384|NCT00570492|Fluticasone|fluticasone|mesh-list
6046385|NCT00570492|Xhance|xhance|mesh-list
6046386|NCT00570492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6046387|NCT00570492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6046388|NCT00570492|Autonomic Agents|autonomic agents|mesh-ancestor
6046389|NCT00570492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6046390|NCT00570492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046391|NCT00570492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6046392|NCT00570492|Respiratory System Agents|respiratory system agents|mesh-ancestor
6046393|NCT00570492|Dermatologic Agents|dermatologic agents|mesh-ancestor
6046394|NCT00570492|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6046395|NCT00570661|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
6046396|NCT00570661|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
6046397|NCT00570661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6046398|NCT00570661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046399|NCT00570674|Paclitaxel|paclitaxel|mesh-list
6046400|NCT00570674|Carboplatin|carboplatin|mesh-list
6046401|NCT00570674|Cetuximab|cetuximab|mesh-list
6046402|NCT00570674|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6046403|NCT00570674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6046404|NCT00570674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6046405|NCT00570674|Tubulin Modulators|tubulin modulators|mesh-ancestor
6046406|NCT00570674|Antimitotic Agents|antimitotic agents|mesh-ancestor
6046407|NCT00570674|Mitosis Modulators|mitosis modulators|mesh-ancestor
6046408|NCT00570674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046409|NCT00570674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6046410|NCT00570687|Insulin|insulin|mesh-list
6046411|NCT00570687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6046412|NCT00570687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046413|NCT00570700|Dasatinib|dasatinib|mesh-list
6046414|NCT00570700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6046415|NCT00570700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6046416|NCT00570700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6046417|NCT00570700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046418|NCT00570713|Gemcitabine|gemcitabine|mesh-list
6046419|NCT00570713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6046420|NCT00570713|Antimetabolites|antimetabolites|mesh-ancestor
6046421|NCT00570713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046422|NCT00570713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6046423|NCT00570713|Antiviral Agents|antiviral agents|mesh-ancestor
5498372|NCT04499274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6046424|NCT00570713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6046425|NCT00570713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6046426|NCT00570713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6046427|NCT00570713|Immunologic Factors|immunologic factors|mesh-ancestor
6046428|NCT00570713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046429|NCT00570739|Metformin|metformin|mesh-list
6046430|NCT00570739|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
6046431|NCT00570739|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6046432|NCT00570739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046433|NCT00570739|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6046434|NCT00570739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6046435|NCT00570739|Antimetabolites|antimetabolites|mesh-ancestor
6046436|NCT00570739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046437|NCT00570739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6046438|NCT00570765|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
6046439|NCT00570765|Cathartics|cathartics|mesh-ancestor
6046440|NCT00570765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6046441|NCT00570778|Glycopyrrolate|glycopyrrolate|mesh-list
6046442|NCT00570778|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6046443|NCT00570778|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6046444|NCT00570778|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6046445|NCT00570778|Cholinergic Agents|cholinergic agents|mesh-ancestor
6046446|NCT00570778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6046447|NCT00570778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046448|NCT00570778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046449|NCT00570908|Capecitabine|capecitabine|mesh-list
6046450|NCT00570908|Sunitinib|sunitinib|mesh-list
6046451|NCT00570908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6046452|NCT00570908|Antimetabolites|antimetabolites|mesh-ancestor
6046453|NCT00570908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046454|NCT00570908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6046455|NCT00570908|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6046456|NCT00570908|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6046457|NCT00570908|Growth Substances|growth substances|mesh-ancestor
5498373|NCT04499274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5498374|NCT04499274|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5498375|NCT04499209|Naproxen|naproxen|mesh-list
5498376|NCT04499209|Pregabalin|pregabalin|mesh-list
5498377|NCT04499209|Analgesics|analgesics|mesh-ancestor
5498378|NCT04499209|Sensory System Agents|sensory system agents|mesh-ancestor
5498379|NCT04499209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5498380|NCT04499209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498381|NCT04499209|Anticonvulsants|anticonvulsants|mesh-ancestor
5498382|NCT04499209|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5498383|NCT04499209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5498384|NCT04499209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498385|NCT04499209|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5498386|NCT04499209|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5498387|NCT04499209|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5498388|NCT04499209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5498389|NCT04499209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5725029|NCT03183297|Histamine Agents|histamine agents|mesh-ancestor
6046458|NCT00570908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046459|NCT00570908|Growth Inhibitors|growth inhibitors|mesh-ancestor
6046460|NCT00570908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6046461|NCT00570908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6046462|NCT00570921|Everolimus|everolimus|mesh-list
6046463|NCT00570921|Fulvestrant|fulvestrant|mesh-list
6046464|NCT00570921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6046465|NCT00570921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6046466|NCT00570921|Immunologic Factors|immunologic factors|mesh-ancestor
6046467|NCT00570921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046468|NCT00570921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6046469|NCT00570921|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6046470|NCT00570921|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6046471|NCT00570921|Hormone Antagonists|hormone antagonists|mesh-ancestor
6046472|NCT00570921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6046473|NCT00570960|Dextrans|dextrans|mesh-list
6046474|NCT00570960|Anticoagulants|anticoagulants|mesh-ancestor
6046475|NCT00570960|Plasma Substitutes|plasma substitutes|mesh-ancestor
6046476|NCT00570960|Blood Substitutes|blood substitutes|mesh-ancestor
6046477|NCT00571064|Donepezil|donepezil|mesh-list
6046478|NCT00571064|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6046479|NCT00571064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6046480|NCT00571064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046481|NCT00571064|Cholinergic Agents|cholinergic agents|mesh-ancestor
6046482|NCT00571064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6046483|NCT00571064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046484|NCT00571064|Nootropic Agents|nootropic agents|mesh-ancestor
6046485|NCT00571103|Acamprosate|acamprosate|mesh-list
6046486|NCT00571103|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6046487|NCT00571259|Gentamicins|gentamicins|mesh-list
6046488|NCT00571259|Heparin|heparin|mesh-list
5498390|NCT04499209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5498391|NCT04499209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5498392|NCT04499209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5498393|NCT04499209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5498394|NCT04499209|Gout Suppressants|gout suppressants|mesh-ancestor
5498395|NCT04499209|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5498396|NCT04499209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5498397|NCT04498936|Sofosbuvir|sofosbuvir|mesh-list
6046489|NCT00571259|Citric Acid|citric acid|mesh-list
6046490|NCT00571259|Sodium Citrate|sodium citrate|mesh-list
6046491|NCT00571259|Anticoagulants|anticoagulants|mesh-ancestor
6046492|NCT00571259|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6046493|NCT00571259|Chelating Agents|chelating agents|mesh-ancestor
6046494|NCT00571259|Sequestering Agents|sequestering agents|mesh-ancestor
6046495|NCT00571259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046496|NCT00571259|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6046497|NCT00571259|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6046498|NCT00571259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6046499|NCT00571259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6046500|NCT00571259|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6046501|NCT00571259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6046502|NCT00571428|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6046503|NCT00571428|Formoterol Fumarate|formoterol fumarate|mesh-list
6046504|NCT00571428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6046505|NCT00571428|Autonomic Agents|autonomic agents|mesh-ancestor
6046506|NCT00571428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6046507|NCT00571428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046508|NCT00571428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6046509|NCT00571428|Respiratory System Agents|respiratory system agents|mesh-ancestor
6046510|NCT00571428|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6046511|NCT00571428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6046512|NCT00571428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6046513|NCT00571428|Adrenergic Agents|adrenergic agents|mesh-ancestor
6046514|NCT00571428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6046515|NCT00571428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046516|NCT00571493|Cytarabine|cytarabine|mesh-list
6046517|NCT00571493|Etoposide|etoposide|mesh-list
6046518|NCT00571493|Bortezomib|bortezomib|mesh-list
6046519|NCT00571493|Melphalan|melphalan|mesh-list
6046520|NCT00571493|Carmustine|carmustine|mesh-list
6046521|NCT00571493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6046522|NCT00571493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6046523|NCT00571493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6046524|NCT00571493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6046525|NCT00571493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6046526|NCT00571493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046527|NCT00571493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6046528|NCT00571493|Antimetabolites|antimetabolites|mesh-ancestor
6046529|NCT00571493|Antiviral Agents|antiviral agents|mesh-ancestor
6046530|NCT00571493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6046531|NCT00571493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6046532|NCT00571493|Immunologic Factors|immunologic factors|mesh-ancestor
5498398|NCT04498936|Ledipasvir|ledipasvir|mesh-list
5498399|NCT04498936|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
5498400|NCT04498936|Nitazoxanide|nitazoxanide|mesh-list
5498401|NCT04498936|Antiviral Agents|antiviral agents|mesh-ancestor
5498402|NCT04498936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5498403|NCT04498936|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5498404|NCT04498923|Dexamethasone|dexamethasone|mesh-list
5498405|NCT04498923|Epinephrine|epinephrine|mesh-list
5498406|NCT04498923|Bupivacaine|bupivacaine|mesh-list
5498407|NCT04498923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5498408|NCT04498923|Antiemetics|antiemetics|mesh-ancestor
5498409|NCT04498923|Autonomic Agents|autonomic agents|mesh-ancestor
5498410|NCT04498923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5498411|NCT04498923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498412|NCT04498923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6046533|NCT00571493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046534|NCT00571493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6046535|NCT00571493|Alkylating Agents|alkylating agents|mesh-ancestor
6046536|NCT00571493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6458327|NCT00440141|Adrenergic Agents|adrenergic agents|mesh-ancestor
6458328|NCT00440141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6458329|NCT00440141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458330|NCT00440141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458331|NCT00440141|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6458332|NCT00440141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6458333|NCT00440154|Ezetimibe|ezetimibe|mesh-list
6458334|NCT00440154|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6458335|NCT00440154|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6458336|NCT00440154|Antimetabolites|antimetabolites|mesh-ancestor
6458337|NCT00440154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458338|NCT00440154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6458339|NCT00440167|Gemcitabine|gemcitabine|mesh-list
6458340|NCT00440167|Capecitabine|capecitabine|mesh-list
6458341|NCT00440167|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6458342|NCT00440167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6458343|NCT00440167|Antimetabolites|antimetabolites|mesh-ancestor
6046537|NCT00571519|Metformin|metformin|mesh-list
6046538|NCT00571519|Pioglitazone|pioglitazone|mesh-list
6046539|NCT00571519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5498413|NCT04498923|Glucocorticoids|glucocorticoids|mesh-ancestor
5498414|NCT04498923|Hormones|hormones|mesh-ancestor
5498415|NCT04498923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5498416|NCT04498923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5498417|NCT04498923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5498418|NCT04498923|Anesthetics, Local|anesthetics, local|mesh-ancestor
5498419|NCT04498923|Anesthetics|anesthetics|mesh-ancestor
5498420|NCT04498923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6046540|NCT00571519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046541|NCT00571649|Enoxaparin|enoxaparin|mesh-list
6046542|NCT00571649|Rivaroxaban|rivaroxaban|mesh-list
6046543|NCT00571649|Enoxaparin sodium|enoxaparin sodium|mesh-list
6046544|NCT00571649|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6046545|NCT00571649|Antithrombins|antithrombins|mesh-ancestor
6046546|NCT00571649|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6046547|NCT00571649|Protease Inhibitors|protease inhibitors|mesh-ancestor
6046548|NCT00571649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6046549|NCT00571649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046550|NCT00571649|Anticoagulants|anticoagulants|mesh-ancestor
6046551|NCT00571649|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6046552|NCT00571649|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6046553|NCT00571662|Cyclosporine|cyclosporine|mesh-list
6046554|NCT00571662|Mycophenolic Acid|mycophenolic acid|mesh-list
6046555|NCT00571662|Pentostatin|pentostatin|mesh-list
6046556|NCT00571662|Cyclosporins|cyclosporins|mesh-list
6046557|NCT00571662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6046558|NCT00571662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046559|NCT00571662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6046560|NCT00571662|Immunologic Factors|immunologic factors|mesh-ancestor
6046561|NCT00571662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046562|NCT00571662|Antifungal Agents|antifungal agents|mesh-ancestor
6046563|NCT00571662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6046564|NCT00571662|Dermatologic Agents|dermatologic agents|mesh-ancestor
6046565|NCT00571662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6046566|NCT00571662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6046567|NCT00571662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6046568|NCT00571662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6046569|NCT00571662|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6046570|NCT00571662|Antitubercular Agents|antitubercular agents|mesh-ancestor
6046571|NCT00571662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6046572|NCT00571662|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
6046573|NCT00571688|Risperidone|risperidone|mesh-list
6046574|NCT00571688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6046575|NCT00571688|Serotonin Agents|serotonin agents|mesh-ancestor
6046576|NCT00571688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6046577|NCT00571688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046578|NCT00571688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046579|NCT00571688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6046580|NCT00571688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6046581|NCT00571688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6046582|NCT00571688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6046583|NCT00571688|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6046584|NCT00571688|Dopamine Agents|dopamine agents|mesh-ancestor
6046585|NCT00571701|Celecoxib|celecoxib|mesh-list
6046586|NCT00571701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6046587|NCT00571701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6046588|NCT00571701|Analgesics|analgesics|mesh-ancestor
6046589|NCT00571701|Sensory System Agents|sensory system agents|mesh-ancestor
6046590|NCT00571701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6046591|NCT00571701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046592|NCT00571701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6046593|NCT00571701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6046594|NCT00571701|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6046595|NCT00571701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6046596|NCT00571701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6046597|NCT00571701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046598|NCT00571961|Ritonavir|ritonavir|mesh-list
6046599|NCT00571961|Lopinavir|lopinavir|mesh-list
6046600|NCT00571961|Buprenorphine|buprenorphine|mesh-list
6046601|NCT00571961|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6046602|NCT00571961|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6046603|NCT00571961|Protease Inhibitors|protease inhibitors|mesh-ancestor
6046604|NCT00571961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6046605|NCT00571961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046606|NCT00571961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6046607|NCT00571961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6046608|NCT00571961|Antiviral Agents|antiviral agents|mesh-ancestor
6046609|NCT00571961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6046610|NCT00571961|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6046611|NCT00571961|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6046612|NCT00571961|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6046613|NCT00571961|Narcotics|narcotics|mesh-ancestor
6046614|NCT00571961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6046615|NCT00571961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046616|NCT00571961|Analgesics|analgesics|mesh-ancestor
6046617|NCT00571961|Sensory System Agents|sensory system agents|mesh-ancestor
6046618|NCT00571961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6046619|NCT00571961|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6046620|NCT00571974|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6046621|NCT00571974|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6046622|NCT00571974|Dermatologic Agents|dermatologic agents|mesh-ancestor
6046623|NCT00572117|Topiramate|topiramate|mesh-list
6458344|NCT00440167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458345|NCT00440167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6458346|NCT00440167|Antiviral Agents|antiviral agents|mesh-ancestor
6458347|NCT00440167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6458348|NCT00440167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6046624|NCT00572117|Anticonvulsants|anticonvulsants|mesh-ancestor
6046625|NCT00572117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6046626|NCT00572117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046627|NCT00572156|Mecasermin|mecasermin|mesh-list
6046628|NCT00572156|Growth Substances|growth substances|mesh-ancestor
6046629|NCT00572156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046630|NCT00572234|Bupropion|bupropion|mesh-list
6046631|NCT00572234|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6046632|NCT00572234|Antidepressive Agents|antidepressive agents|mesh-ancestor
6046633|NCT00572234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6046634|NCT00572234|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6046635|NCT00572234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6046636|NCT00572234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6046637|NCT00572234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046638|NCT00572234|Dopamine Agents|dopamine agents|mesh-ancestor
6046639|NCT00572234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6046640|NCT00572234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046641|NCT00572234|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6046642|NCT00572234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6046643|NCT00572234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6046644|NCT00572455|Latanoprost|latanoprost|mesh-list
6046645|NCT00572455|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6046646|NCT00572455|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6046647|NCT00572468|Simvastatin|simvastatin|mesh-list
6046648|NCT00572468|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6046649|NCT00572468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6046650|NCT00572468|Antimetabolites|antimetabolites|mesh-ancestor
6046651|NCT00572468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046652|NCT00572468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6046653|NCT00572468|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6046654|NCT00572468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6046655|NCT00572572|Aprepitant|aprepitant|mesh-list
6046656|NCT00572572|Antiemetics|antiemetics|mesh-ancestor
6046657|NCT00572572|Autonomic Agents|autonomic agents|mesh-ancestor
6046658|NCT00572572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6046659|NCT00572572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046660|NCT00572572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6046661|NCT00572572|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6046662|NCT00572572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6046663|NCT00572572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046664|NCT00572728|Alovudine|alovudine|mesh-list
6046665|NCT00572728|Dideoxynucleosides|dideoxynucleosides|mesh-list
6046666|NCT00572728|Antiviral Agents|antiviral agents|mesh-ancestor
6046667|NCT00572728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6046668|NCT00572728|Antimetabolites|antimetabolites|mesh-ancestor
6046669|NCT00572728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046670|NCT00572728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6046671|NCT00572728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6046672|NCT00572728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6046673|NCT00572832|Vaccines|vaccines|mesh-list
6046674|NCT00572832|Immunologic Factors|immunologic factors|mesh-ancestor
6046675|NCT00572832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458349|NCT00440167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6458350|NCT00440167|Immunologic Factors|immunologic factors|mesh-ancestor
6458351|NCT00440167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458352|NCT00440167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6458353|NCT00440219|Prednisone|prednisone|mesh-list
6458354|NCT00440219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5498421|NCT04498923|Sensory System Agents|sensory system agents|mesh-ancestor
5498422|NCT04498923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5498423|NCT04498923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5498424|NCT04498923|Adrenergic Agents|adrenergic agents|mesh-ancestor
5498425|NCT04498923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5498426|NCT04498923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498427|NCT04498923|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5498428|NCT04498923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5498429|NCT04498923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5498430|NCT04498923|Respiratory System Agents|respiratory system agents|mesh-ancestor
5498431|NCT04498923|Mydriatics|mydriatics|mesh-ancestor
5498432|NCT04498923|Sympathomimetics|sympathomimetics|mesh-ancestor
6458355|NCT00440219|Glucocorticoids|glucocorticoids|mesh-ancestor
6458356|NCT00440219|Hormones|hormones|mesh-ancestor
6458357|NCT00440219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6458358|NCT00440219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046676|NCT00572897|Fludarabine|fludarabine|mesh-list
6046677|NCT00572897|Melphalan|melphalan|mesh-list
6046678|NCT00572897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6046679|NCT00572897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046680|NCT00572897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6458359|NCT00440219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5498433|NCT04498923|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5498434|NCT04498897|Acamprosate|acamprosate|mesh-list
5498435|NCT04498897|Vortioxetine|vortioxetine|mesh-list
5498436|NCT04498897|Antidepressive Agents|antidepressive agents|mesh-ancestor
5498437|NCT04498897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5498438|NCT04498897|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5498439|NCT04498897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5498440|NCT04498897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5498441|NCT04498897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498442|NCT04498897|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5498443|NCT04498897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5498444|NCT04498897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5498445|NCT04498897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498446|NCT04498897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6046681|NCT00572897|Immunologic Factors|immunologic factors|mesh-ancestor
6046682|NCT00572897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046683|NCT00572897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6046684|NCT00572897|Alkylating Agents|alkylating agents|mesh-ancestor
6046685|NCT00572897|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6046686|NCT00572936|Timolol|timolol|mesh-list
6046687|NCT00572936|Dorzolamide|dorzolamide|mesh-list
6046688|NCT00572936|Latanoprost|latanoprost|mesh-list
6046689|NCT00572936|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6046690|NCT00572936|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6046691|NCT00572936|Adrenergic Agents|adrenergic agents|mesh-ancestor
6046692|NCT00572936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6046693|NCT00572936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046694|NCT00572936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046695|NCT00572936|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6046696|NCT00572936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6046697|NCT00572936|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6046698|NCT00572936|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6046699|NCT00572936|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6046700|NCT00572936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6046701|NCT00573066|Dexmedetomidine|dexmedetomidine|mesh-list
6046702|NCT00573066|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6046703|NCT00573066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6046704|NCT00573066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046705|NCT00573066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6046706|NCT00573066|Analgesics|analgesics|mesh-ancestor
6046707|NCT00573066|Sensory System Agents|sensory system agents|mesh-ancestor
6046708|NCT00573066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6046709|NCT00573066|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6046710|NCT00573066|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6046711|NCT00573066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6046712|NCT00573066|Adrenergic Agents|adrenergic agents|mesh-ancestor
6046713|NCT00573066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6046714|NCT00573066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046715|NCT00573131|Paclitaxel|paclitaxel|mesh-list
6046716|NCT00573131|Cisplatin|cisplatin|mesh-list
6046717|NCT00573131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6046718|NCT00573131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6046719|NCT00573131|Tubulin Modulators|tubulin modulators|mesh-ancestor
6046720|NCT00573131|Antimitotic Agents|antimitotic agents|mesh-ancestor
6046721|NCT00573131|Mitosis Modulators|mitosis modulators|mesh-ancestor
6046722|NCT00573131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046723|NCT00573144|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6046724|NCT00573144|Natriuretic Agents|natriuretic agents|mesh-ancestor
6046725|NCT00573144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046726|NCT00573248|Nicotine|nicotine|mesh-list
6046727|NCT00573248|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6046728|NCT00573248|Autonomic Agents|autonomic agents|mesh-ancestor
5498447|NCT04498897|Serotonin Agents|serotonin agents|mesh-ancestor
5498448|NCT04498897|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5498449|NCT04498897|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5498450|NCT04498897|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5498451|NCT04498897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5498452|NCT04498897|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5498453|NCT04498689|Gemcitabine|gemcitabine|mesh-list
6046729|NCT00573248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6046730|NCT00573248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046731|NCT00573248|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6046732|NCT00573248|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6046733|NCT00573248|Cholinergic Agents|cholinergic agents|mesh-ancestor
6046734|NCT00573248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6046735|NCT00573248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046736|NCT00573261|Pregabalin|pregabalin|mesh-list
6046737|NCT00573261|Analgesics|analgesics|mesh-ancestor
6046738|NCT00573261|Sensory System Agents|sensory system agents|mesh-ancestor
6046739|NCT00573261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6458360|NCT00440219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6458361|NCT00440245|Albuterol|albuterol|mesh-list
6458362|NCT00440245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6458363|NCT00440245|Autonomic Agents|autonomic agents|mesh-ancestor
6458364|NCT00440245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6458365|NCT00440245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458366|NCT00440245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6458367|NCT00440245|Respiratory System Agents|respiratory system agents|mesh-ancestor
6458368|NCT00440245|Tocolytic Agents|tocolytic agents|mesh-ancestor
5498454|NCT04498689|Paclitaxel|paclitaxel|mesh-list
5498455|NCT04498689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5498456|NCT04498689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5498457|NCT04498689|Tubulin Modulators|tubulin modulators|mesh-ancestor
5498458|NCT04498689|Antimitotic Agents|antimitotic agents|mesh-ancestor
5498459|NCT04498689|Mitosis Modulators|mitosis modulators|mesh-ancestor
5498460|NCT04498689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498461|NCT04498689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6046740|NCT00573261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046741|NCT00573261|Anticonvulsants|anticonvulsants|mesh-ancestor
6046742|NCT00573261|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6046743|NCT00573261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6046744|NCT00573261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046745|NCT00573261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6046746|NCT00573261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6046747|NCT00573261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6046748|NCT00573261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6046749|NCT00573261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6046750|NCT00573287|Risperidone|risperidone|mesh-list
6046751|NCT00573287|Clozapine|clozapine|mesh-list
6046752|NCT00573287|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6046753|NCT00573287|Serotonin Agents|serotonin agents|mesh-ancestor
6046754|NCT00573287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6046755|NCT00573287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046756|NCT00573287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046757|NCT00573287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6046758|NCT00573287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6046759|NCT00573287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6046760|NCT00573287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6046761|NCT00573287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6046762|NCT00573287|Dopamine Agents|dopamine agents|mesh-ancestor
6046763|NCT00573287|GABA Antagonists|gaba antagonists|mesh-ancestor
6046764|NCT00573287|GABA Agents|gaba agents|mesh-ancestor
6046765|NCT00573430|Candesartan|candesartan|mesh-list
6046766|NCT00573430|Candesartan cilexetil|candesartan cilexetil|mesh-list
6046767|NCT00573430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6046768|NCT00573430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6046769|NCT00573430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6046770|NCT00573430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046771|NCT00573443|Quinidine|quinidine|mesh-list
6046772|NCT00573443|Quinidine gluconate|quinidine gluconate|mesh-list
6458369|NCT00440245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6458370|NCT00440245|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6458371|NCT00440245|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6458372|NCT00440245|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6458373|NCT00440245|Adrenergic Agents|adrenergic agents|mesh-ancestor
6458374|NCT00440245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6458375|NCT00440245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046773|NCT00573443|Dextromethorphan|dextromethorphan|mesh-list
6046774|NCT00573443|Antitussive Agents|antitussive agents|mesh-ancestor
6046775|NCT00573443|Respiratory System Agents|respiratory system agents|mesh-ancestor
6046776|NCT00573443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6046777|NCT00573443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6046778|NCT00573443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5498462|NCT04498689|Antimetabolites|antimetabolites|mesh-ancestor
5498463|NCT04498689|Antiviral Agents|antiviral agents|mesh-ancestor
5498464|NCT04498689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5498465|NCT04498689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5498466|NCT04498689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5498467|NCT04498689|Immunologic Factors|immunologic factors|mesh-ancestor
5498468|NCT04498689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046779|NCT00573443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046780|NCT00573443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046781|NCT00573443|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6046782|NCT00573443|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6046783|NCT00573443|Adrenergic Agents|adrenergic agents|mesh-ancestor
6046784|NCT00573443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6046785|NCT00573443|Antimalarials|antimalarials|mesh-ancestor
6046786|NCT00573443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6046787|NCT00573443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6046788|NCT00573443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6046789|NCT00573443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6046790|NCT00573443|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6458376|NCT00440258|Cabergoline|cabergoline|mesh-list
6046791|NCT00573443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6046792|NCT00573443|Cholinergic Agents|cholinergic agents|mesh-ancestor
6046793|NCT00573443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6046794|NCT00573443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6046795|NCT00573443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6046796|NCT00573443|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6046797|NCT00573443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6046798|NCT00573508|Solifenacin Succinate|solifenacin succinate|mesh-list
6046799|NCT00573508|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6046800|NCT00573508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6046801|NCT00573508|Cholinergic Agents|cholinergic agents|mesh-ancestor
6046802|NCT00573508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6046803|NCT00573508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046804|NCT00573508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046805|NCT00573508|Urological Agents|urological agents|mesh-ancestor
6046806|NCT00573534|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6046807|NCT00573534|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6046808|NCT00573534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046809|NCT00573534|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6046810|NCT00573534|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6046811|NCT00573534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6046812|NCT00573534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046813|NCT00573534|Dopamine Agents|dopamine agents|mesh-ancestor
6046814|NCT00573534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6046815|NCT00573755|Sorafenib|sorafenib|mesh-list
6046816|NCT00573755|Letrozole|letrozole|mesh-list
6046817|NCT00573755|Anastrozole|anastrozole|mesh-list
6046818|NCT00573755|Exemestane|exemestane|mesh-list
6046819|NCT00573755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6046820|NCT00573755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6046821|NCT00573755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6046822|NCT00573755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046823|NCT00573755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6046824|NCT00573755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6046825|NCT00573755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6046826|NCT00573755|Hormone Antagonists|hormone antagonists|mesh-ancestor
6046827|NCT00573755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6046828|NCT00573755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046829|NCT00573755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6046830|NCT00573768|Diclofenac|diclofenac|mesh-list
6046831|NCT00573768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6046832|NCT00573768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6046833|NCT00573768|Analgesics|analgesics|mesh-ancestor
6046834|NCT00573768|Sensory System Agents|sensory system agents|mesh-ancestor
6046835|NCT00573768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6046836|NCT00573768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046837|NCT00573768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6046838|NCT00573768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6046839|NCT00573768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6046840|NCT00573768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6046841|NCT00573768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046842|NCT00573794|Adalimumab|adalimumab|mesh-list
6046843|NCT00573794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6046844|NCT00573794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6046845|NCT00573859|Methylphenidate|methylphenidate|mesh-list
6046846|NCT00573859|Amphetamine|amphetamine|mesh-list
6046847|NCT00573859|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6046848|NCT00573859|Dextroamphetamine|dextroamphetamine|mesh-list
6046849|NCT00573859|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6046850|NCT00573859|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6046851|NCT00573859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046852|NCT00573859|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6046853|NCT00573859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6046854|NCT00573859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6046855|NCT00573859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498469|NCT04498793|Paclitaxel|paclitaxel|mesh-list
5498470|NCT04498793|Cyclophosphamide|cyclophosphamide|mesh-list
5498471|NCT04498793|Doxorubicin|doxorubicin|mesh-list
5498472|NCT04498793|Epirubicin|epirubicin|mesh-list
5498473|NCT04498793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5498474|NCT04498793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5498475|NCT04498793|Tubulin Modulators|tubulin modulators|mesh-ancestor
5498476|NCT04498793|Antimitotic Agents|antimitotic agents|mesh-ancestor
6046856|NCT00573859|Dopamine Agents|dopamine agents|mesh-ancestor
6046857|NCT00573859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6046858|NCT00573859|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6046859|NCT00573859|Adrenergic Agents|adrenergic agents|mesh-ancestor
6046860|NCT00573859|Sympathomimetics|sympathomimetics|mesh-ancestor
6046861|NCT00573859|Autonomic Agents|autonomic agents|mesh-ancestor
6046862|NCT00573859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6046863|NCT00573989|Pemetrexed|pemetrexed|mesh-list
6046864|NCT00573989|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6046865|NCT00573989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6046866|NCT00573989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6046867|NCT00573989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046868|NCT00573989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6046869|NCT00573989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6046870|NCT00573989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6046871|NCT00574067|Buprenorphine|buprenorphine|mesh-list
6046872|NCT00574067|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6046873|NCT00574067|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6046874|NCT00574067|Narcotics|narcotics|mesh-ancestor
6046875|NCT00574067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6046876|NCT00574067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046877|NCT00574067|Analgesics|analgesics|mesh-ancestor
6046878|NCT00574067|Sensory System Agents|sensory system agents|mesh-ancestor
6046879|NCT00574067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6046880|NCT00574067|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6046881|NCT00574119|Spironolactone|spironolactone|mesh-list
6046882|NCT00574119|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6046883|NCT00574119|Hormone Antagonists|hormone antagonists|mesh-ancestor
6046884|NCT00574119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6046885|NCT00574119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046886|NCT00574119|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6046887|NCT00574119|Diuretics|diuretics|mesh-ancestor
6046888|NCT00574119|Natriuretic Agents|natriuretic agents|mesh-ancestor
6046889|NCT00574171|Capecitabine|capecitabine|mesh-list
6046890|NCT00574171|Lapatinib|lapatinib|mesh-list
6046891|NCT00574171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6046892|NCT00574171|Antimetabolites|antimetabolites|mesh-ancestor
6458377|NCT00440258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6458378|NCT00440258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6458379|NCT00440258|Dopamine Agonists|dopamine agonists|mesh-ancestor
6458380|NCT00440258|Dopamine Agents|dopamine agents|mesh-ancestor
6458381|NCT00440258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6458382|NCT00440258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458383|NCT00440258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458384|NCT00440284|Insulin|insulin|mesh-list
6458385|NCT00440284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6458386|NCT00440284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458387|NCT00440323|Zolpidem|zolpidem|mesh-list
6046893|NCT00574171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046894|NCT00574171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6046895|NCT00574171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6046896|NCT00574171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6046897|NCT00574197|Mycophenolic Acid|mycophenolic acid|mesh-list
6046898|NCT00574197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6046899|NCT00574197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6046900|NCT00574197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6046901|NCT00574197|Antitubercular Agents|antitubercular agents|mesh-ancestor
6046902|NCT00574197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6046903|NCT00574197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6046904|NCT00574197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6046905|NCT00574197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046906|NCT00574236|Doxorubicin|doxorubicin|mesh-list
6046907|NCT00574236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6046908|NCT00574236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6046909|NCT00574236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6046910|NCT00574236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6046911|NCT00574236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6046912|NCT00574236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046913|NCT00574249|Adalimumab|adalimumab|mesh-list
6046914|NCT00574249|Betamethasone|betamethasone|mesh-list
6046915|NCT00574249|Calcipotriene|calcipotriene|mesh-list
6046916|NCT00574249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6046917|NCT00574249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6046918|NCT00574249|Glucocorticoids|glucocorticoids|mesh-ancestor
6458388|NCT00440323|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5498477|NCT04498793|Mitosis Modulators|mitosis modulators|mesh-ancestor
5498478|NCT04498793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498479|NCT04498793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5498480|NCT04498793|Immunologic Factors|immunologic factors|mesh-ancestor
5498481|NCT04498793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498482|NCT04498793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6046919|NCT00574249|Hormones|hormones|mesh-ancestor
6046920|NCT00574249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6046921|NCT00574249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046922|NCT00574249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6046923|NCT00574249|Respiratory System Agents|respiratory system agents|mesh-ancestor
6046924|NCT00574249|Dermatologic Agents|dermatologic agents|mesh-ancestor
6046925|NCT00574275|Gemcitabine|gemcitabine|mesh-list
6046926|NCT00574275|Aflibercept|aflibercept|mesh-list
6046927|NCT00574275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6046928|NCT00574275|Antimetabolites|antimetabolites|mesh-ancestor
6046929|NCT00574275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046930|NCT00574275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6046931|NCT00574275|Antiviral Agents|antiviral agents|mesh-ancestor
6046932|NCT00574275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6046933|NCT00574275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6046934|NCT00574275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6046935|NCT00574275|Immunologic Factors|immunologic factors|mesh-ancestor
6046936|NCT00574275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046937|NCT00574275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6046938|NCT00574275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6046939|NCT00574275|Growth Substances|growth substances|mesh-ancestor
6046940|NCT00574275|Growth Inhibitors|growth inhibitors|mesh-ancestor
6046941|NCT00574288|Dexamethasone|dexamethasone|mesh-list
6046942|NCT00574288|Methylprednisolone|methylprednisolone|mesh-list
6046943|NCT00574288|Daratumumab|daratumumab|mesh-list
6046944|NCT00574288|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6046945|NCT00574288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6046946|NCT00574288|Antiemetics|antiemetics|mesh-ancestor
6046947|NCT00574288|Autonomic Agents|autonomic agents|mesh-ancestor
6046948|NCT00574288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6046949|NCT00574288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046950|NCT00574288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6046951|NCT00574288|Glucocorticoids|glucocorticoids|mesh-ancestor
6046952|NCT00574288|Hormones|hormones|mesh-ancestor
6046953|NCT00574288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6046954|NCT00574288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6046955|NCT00574288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6046956|NCT00574288|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6046957|NCT00574288|Protective Agents|protective agents|mesh-ancestor
6046958|NCT00574288|Immunologic Factors|immunologic factors|mesh-ancestor
6046959|NCT00574340|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6046960|NCT00574340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046961|NCT00574405|Insulin|insulin|mesh-list
6046962|NCT00574405|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6046963|NCT00574405|Insulin Lispro|insulin lispro|mesh-list
6046964|NCT00574405|Insulin Aspart|insulin aspart|mesh-list
6046965|NCT00574405|Insulin, Isophane|insulin, isophane|mesh-list
6046966|NCT00574405|Isophane Insulin, Human|isophane insulin, human|mesh-list
6046967|NCT00574405|Isophane insulin, beef|isophane insulin, beef|mesh-list
6046968|NCT00574405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6046969|NCT00574405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046970|NCT00574548|Vaccines|vaccines|mesh-list
6046971|NCT00574548|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6046972|NCT00574548|Immunologic Factors|immunologic factors|mesh-ancestor
6046973|NCT00574548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046974|NCT00574587|Paclitaxel|paclitaxel|mesh-list
6046975|NCT00574587|Cyclophosphamide|cyclophosphamide|mesh-list
6046976|NCT00574587|Doxorubicin|doxorubicin|mesh-list
6046977|NCT00574587|Trastuzumab|trastuzumab|mesh-list
6046978|NCT00574587|Vorinostat|vorinostat|mesh-list
6046979|NCT00574587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6046980|NCT00574587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6046981|NCT00574587|Tubulin Modulators|tubulin modulators|mesh-ancestor
6046982|NCT00574587|Antimitotic Agents|antimitotic agents|mesh-ancestor
6046983|NCT00574587|Mitosis Modulators|mitosis modulators|mesh-ancestor
6046984|NCT00574587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6046985|NCT00574587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6046986|NCT00574587|Immunologic Factors|immunologic factors|mesh-ancestor
6046987|NCT00574587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6046988|NCT00574587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6655241|NCT01462500|Miltefosine|miltefosine|mesh-list
6046989|NCT00574587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6458389|NCT00440323|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6458390|NCT00440323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6458391|NCT00440323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458392|NCT00440323|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6458393|NCT00440323|GABA Agonists|gaba agonists|mesh-ancestor
5498483|NCT04498793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5498484|NCT04498793|Alkylating Agents|alkylating agents|mesh-ancestor
6046990|NCT00574587|Alkylating Agents|alkylating agents|mesh-ancestor
6046991|NCT00574587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6046992|NCT00574587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6046993|NCT00574587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6046994|NCT00574587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6046995|NCT00574587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6046996|NCT00574587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6046997|NCT00574587|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6046998|NCT00574834|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6046999|NCT00574834|Ramipril|ramipril|mesh-list
6047000|NCT00574834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6047001|NCT00574834|Diuretics|diuretics|mesh-ancestor
6047002|NCT00574834|Natriuretic Agents|natriuretic agents|mesh-ancestor
6047003|NCT00574834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047004|NCT00574834|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6047005|NCT00574834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6047006|NCT00574834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047007|NCT00574834|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6047008|NCT00574834|Protease Inhibitors|protease inhibitors|mesh-ancestor
6047009|NCT00574834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6047010|NCT00574847|Citalopram|citalopram|mesh-list
6047011|NCT00574847|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6047012|NCT00574847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6047013|NCT00574847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6047014|NCT00574847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047015|NCT00574847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6047016|NCT00574847|Serotonin Agents|serotonin agents|mesh-ancestor
6047017|NCT00574847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047018|NCT00574847|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6047019|NCT00574847|Antidepressive Agents|antidepressive agents|mesh-ancestor
6047020|NCT00574847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6047021|NCT00574873|Imatinib Mesylate|imatinib mesylate|mesh-list
6047022|NCT00574873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6047023|NCT00574873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6047024|NCT00574873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6047025|NCT00574873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047026|NCT00574912|Insulin|insulin|mesh-list
6047027|NCT00574912|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6047028|NCT00574912|Insulin Glargine|insulin glargine|mesh-list
6047029|NCT00574912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6047030|NCT00574912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047031|NCT00574951|Motesanib diphosphate|motesanib diphosphate|mesh-list
6047032|NCT00574951|Imetelstat|imetelstat|mesh-list
6047033|NCT00574951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6047034|NCT00574951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6047035|NCT00574951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047036|NCT00575016|Botulinum Toxins|botulinum toxins|mesh-list
6047037|NCT00575016|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5498485|NCT04498793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5498486|NCT04498793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5498487|NCT04498793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5498488|NCT04498793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5498489|NCT04498793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5498490|NCT04498884|Insulin|insulin|mesh-list
5498491|NCT04498884|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5498492|NCT04498884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5498493|NCT04498884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047038|NCT00575016|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6047039|NCT00575016|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6047040|NCT00575016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6047041|NCT00575016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047042|NCT00575016|Cholinergic Agents|cholinergic agents|mesh-ancestor
6047043|NCT00575016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6047044|NCT00575016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458394|NCT00440323|GABA Agents|gaba agents|mesh-ancestor
6047045|NCT00575016|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6047046|NCT00575016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6047047|NCT00575029|Megestrol|megestrol|mesh-list
6047048|NCT00575029|Megestrol Acetate|megestrol acetate|mesh-list
6047049|NCT00575029|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6047050|NCT00575029|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6047051|NCT00575029|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6047052|NCT00575029|Contraceptive Agents|contraceptive agents|mesh-ancestor
6047053|NCT00575029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6047054|NCT00575029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047055|NCT00575029|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6047056|NCT00575029|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6047057|NCT00575029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6047058|NCT00575029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5498494|NCT04498325|Antibodies|antibodies|mesh-list
5498495|NCT04498325|Immunologic Factors|immunologic factors|mesh-ancestor
5498496|NCT04498325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498497|NCT04498286|Antibodies|antibodies|mesh-list
5498498|NCT04498286|Immunologic Factors|immunologic factors|mesh-ancestor
5498499|NCT04498286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498500|NCT04498520|Fulvestrant|fulvestrant|mesh-list
5498501|NCT04498520|Palbociclib|palbociclib|mesh-list
5498502|NCT04498520|Abexinostat|abexinostat|mesh-list
5498503|NCT04498520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5498504|NCT04498520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5498505|NCT04498520|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5498506|NCT04498520|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5498507|NCT04498520|Hormone Antagonists|hormone antagonists|mesh-ancestor
5498508|NCT04498520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5498509|NCT04498520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498510|NCT04498520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5498511|NCT04498520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5498512|NCT04498520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047059|NCT00575029|Appetite Stimulants|appetite stimulants|mesh-ancestor
6047060|NCT00575029|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6047061|NCT00575042|Fenofibrate|fenofibrate|mesh-list
6047062|NCT00575042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6047063|NCT00575042|Antimetabolites|antimetabolites|mesh-ancestor
6047064|NCT00575042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047065|NCT00575042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6047066|NCT00575094|Tigecycline|tigecycline|mesh-list
6047067|NCT00575094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6047068|NCT00575094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6047069|NCT00575094|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6047070|NCT00575094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6047071|NCT00575094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047072|NCT00575367|Azithromycin|azithromycin|mesh-list
6047073|NCT00575367|Moxifloxacin|moxifloxacin|mesh-list
6047074|NCT00575367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6047075|NCT00575367|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6047076|NCT00575367|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6047077|NCT00575367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6047078|NCT00575367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6047079|NCT00575367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6047080|NCT00575367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6047081|NCT00575367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6047082|NCT00575367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047083|NCT00575367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6047084|NCT00575367|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6047085|NCT00575367|Contraceptive Agents|contraceptive agents|mesh-ancestor
6047086|NCT00575367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5498513|NCT04498520|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5498514|NCT04498234|Bupivacaine|bupivacaine|mesh-list
5498515|NCT04498234|Anesthetics, Local|anesthetics, local|mesh-ancestor
5498516|NCT04498234|Anesthetics|anesthetics|mesh-ancestor
5498517|NCT04498234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5498518|NCT04498234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498519|NCT04498234|Sensory System Agents|sensory system agents|mesh-ancestor
5498520|NCT04498234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5498521|NCT04498260|Triamcinolone|triamcinolone|mesh-list
5498522|NCT04498260|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5498523|NCT04498260|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5498524|NCT04498260|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5498525|NCT04498260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5498526|NCT04498260|Glucocorticoids|glucocorticoids|mesh-ancestor
5498527|NCT04498260|Hormones|hormones|mesh-ancestor
5498528|NCT04498260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5498529|NCT04498260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498530|NCT04498260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5498531|NCT04498260|Immunologic Factors|immunologic factors|mesh-ancestor
5498532|NCT04498260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5498533|NCT04498260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498534|NCT04498351|Magnesium Sulfate|magnesium sulfate|mesh-list
5498535|NCT04498351|Dexmedetomidine|dexmedetomidine|mesh-list
5498536|NCT04498351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6047087|NCT00575367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047088|NCT00575367|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6047089|NCT00575367|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6047090|NCT00575367|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6047091|NCT00575380|Azithromycin|azithromycin|mesh-list
6047092|NCT00575380|Moxifloxacin|moxifloxacin|mesh-list
6047093|NCT00575380|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6047094|NCT00575380|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6047095|NCT00575380|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6047096|NCT00575380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6047097|NCT00575380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6047098|NCT00575380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6047099|NCT00575380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6047100|NCT00575380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6047101|NCT00575380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047102|NCT00575380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6047103|NCT00575380|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6047104|NCT00575380|Contraceptive Agents|contraceptive agents|mesh-ancestor
6047105|NCT00575380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6047106|NCT00575380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047107|NCT00575380|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6047108|NCT00575380|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6047109|NCT00575380|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6053886|NCT00599313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6053887|NCT00599313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6053888|NCT00599313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053889|NCT00599326|Deferasirox|deferasirox|mesh-list
6053890|NCT00599326|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6053891|NCT00599326|Chelating Agents|chelating agents|mesh-ancestor
6053892|NCT00599326|Sequestering Agents|sequestering agents|mesh-ancestor
6053893|NCT00599326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053894|NCT00599521|Adapalene|adapalene|mesh-list
6053895|NCT00599521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6053896|NCT00599521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6053897|NCT00599521|Analgesics|analgesics|mesh-ancestor
6053898|NCT00599521|Sensory System Agents|sensory system agents|mesh-ancestor
6053899|NCT00599521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6053900|NCT00599521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498537|NCT04498351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6053901|NCT00599521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6053902|NCT00599521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6053903|NCT00599521|Dermatologic Agents|dermatologic agents|mesh-ancestor
6053904|NCT00599638|Pregabalin|pregabalin|mesh-list
6053905|NCT00599638|Analgesics|analgesics|mesh-ancestor
6053906|NCT00599638|Sensory System Agents|sensory system agents|mesh-ancestor
6053907|NCT00599638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6053908|NCT00599638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053909|NCT00599638|Anticonvulsants|anticonvulsants|mesh-ancestor
6053910|NCT00599638|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6053911|NCT00599638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6053912|NCT00599638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053913|NCT00599638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6053914|NCT00599638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6053915|NCT00599638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6053916|NCT00599638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6053917|NCT00599638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6053918|NCT00599755|Gemcitabine|gemcitabine|mesh-list
6053919|NCT00599755|Carboplatin|carboplatin|mesh-list
6053920|NCT00599755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6053921|NCT00599755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6053922|NCT00599755|Antimetabolites|antimetabolites|mesh-ancestor
6655242|NCT01462500|Antifungal Agents|antifungal agents|mesh-ancestor
6047110|NCT00575588|Metformin|metformin|mesh-list
6047111|NCT00575588|Saxagliptin|saxagliptin|mesh-list
6047112|NCT00575588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6047113|NCT00575588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047114|NCT00575588|Incretins|incretins|mesh-ancestor
6047115|NCT00575588|Hormones|hormones|mesh-ancestor
6047116|NCT00575588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6047117|NCT00575588|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6047118|NCT00575588|Protease Inhibitors|protease inhibitors|mesh-ancestor
6047119|NCT00575588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6047120|NCT00575588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047121|NCT00575666|Insulin|insulin|mesh-list
6047122|NCT00575666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6047123|NCT00575666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047124|NCT00575887|Temozolomide|temozolomide|mesh-list
6047125|NCT00575887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6047126|NCT00575887|Alkylating Agents|alkylating agents|mesh-ancestor
6047127|NCT00575887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047128|NCT00575887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6047129|NCT00575965|Simvastatin|simvastatin|mesh-list
6047130|NCT00575965|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6047131|NCT00575965|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6047132|NCT00575965|Antimetabolites|antimetabolites|mesh-ancestor
6047133|NCT00575965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047134|NCT00575965|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6047135|NCT00575965|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6047136|NCT00575965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6047137|NCT00576056|Sorafenib|sorafenib|mesh-list
6047138|NCT00576056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6047139|NCT00576056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6047140|NCT00576056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6047141|NCT00576056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047142|NCT00576199|Bevacizumab|bevacizumab|mesh-list
6047143|NCT00576199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6047144|NCT00576199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6047145|NCT00576199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6047146|NCT00576199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6047147|NCT00576199|Growth Substances|growth substances|mesh-ancestor
6047148|NCT00576199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047149|NCT00576199|Growth Inhibitors|growth inhibitors|mesh-ancestor
6047150|NCT00576251|Tobramycin|tobramycin|mesh-list
6047151|NCT00576251|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
6047152|NCT00576251|Dexamethasone|dexamethasone|mesh-list
6047153|NCT00576251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6047154|NCT00576251|Antiemetics|antiemetics|mesh-ancestor
6047155|NCT00576251|Autonomic Agents|autonomic agents|mesh-ancestor
6047156|NCT00576251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6047157|NCT00576251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047158|NCT00576251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6047159|NCT00576251|Glucocorticoids|glucocorticoids|mesh-ancestor
6047160|NCT00576251|Hormones|hormones|mesh-ancestor
6047161|NCT00576251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6047162|NCT00576251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6047163|NCT00576251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6047164|NCT00576251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6047165|NCT00576251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6047166|NCT00576251|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6047167|NCT00576251|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6047168|NCT00576303|Epoetin Alfa|epoetin alfa|mesh-list
6047169|NCT00576303|Hematinics|hematinics|mesh-ancestor
6047170|NCT00576316|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6047171|NCT00576316|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6047172|NCT00576316|Respiratory System Agents|respiratory system agents|mesh-ancestor
6047173|NCT00576381|Dexmedetomidine|dexmedetomidine|mesh-list
6047174|NCT00576381|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6047175|NCT00576381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6047176|NCT00576381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047177|NCT00576381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6047178|NCT00576381|Analgesics|analgesics|mesh-ancestor
6047179|NCT00576381|Sensory System Agents|sensory system agents|mesh-ancestor
6047180|NCT00576381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6047181|NCT00576381|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6047182|NCT00576381|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6047183|NCT00576381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6047184|NCT00576381|Adrenergic Agents|adrenergic agents|mesh-ancestor
6047185|NCT00576381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6047186|NCT00576381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047187|NCT00576472|Methylphenidate|methylphenidate|mesh-list
6047188|NCT00576472|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6047189|NCT00576472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047190|NCT00576472|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6047191|NCT00576472|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6047192|NCT00576472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6047193|NCT00576472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047194|NCT00576472|Dopamine Agents|dopamine agents|mesh-ancestor
6047195|NCT00576472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6047196|NCT00576576|Atorvastatin|atorvastatin|mesh-list
6047197|NCT00576576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6047198|NCT00576576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6047199|NCT00576576|Antimetabolites|antimetabolites|mesh-ancestor
6047200|NCT00576576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047201|NCT00576576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6047202|NCT00576576|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6047203|NCT00576576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6047204|NCT00576628|Epoetin Alfa|epoetin alfa|mesh-list
5498538|NCT04498351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047205|NCT00576628|Hematinics|hematinics|mesh-ancestor
6047206|NCT00576680|Temozolomide|temozolomide|mesh-list
6047207|NCT00576680|Everolimus|everolimus|mesh-list
6047208|NCT00576680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6047209|NCT00576680|Alkylating Agents|alkylating agents|mesh-ancestor
6047210|NCT00576680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047211|NCT00576680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6047212|NCT00576680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6047213|NCT00576680|Immunologic Factors|immunologic factors|mesh-ancestor
6047214|NCT00576680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047215|NCT00576732|Risperidone|risperidone|mesh-list
6047216|NCT00576732|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6047217|NCT00576732|Serotonin Agents|serotonin agents|mesh-ancestor
6047218|NCT00576732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6047219|NCT00576732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047220|NCT00576732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047221|NCT00576732|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6047222|NCT00576732|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6047223|NCT00576732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6047224|NCT00576732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6047225|NCT00576732|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6047226|NCT00576732|Dopamine Agents|dopamine agents|mesh-ancestor
6047227|NCT00576758|Rituximab|rituximab|mesh-list
6047228|NCT00576758|Obinutuzumab|obinutuzumab|mesh-list
6047229|NCT00576758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6047230|NCT00576758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6047231|NCT00576758|Immunologic Factors|immunologic factors|mesh-ancestor
6047232|NCT00576758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047233|NCT00576758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6047234|NCT00576823|Alfuzosin|alfuzosin|mesh-list
6047235|NCT00576823|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6047236|NCT00576823|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6047237|NCT00576823|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6047238|NCT00576823|Adrenergic Agents|adrenergic agents|mesh-ancestor
6047239|NCT00576823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6047240|NCT00576823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047241|NCT00576823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047242|NCT00576823|Urological Agents|urological agents|mesh-ancestor
6047243|NCT00576836|Parathyroid Hormone|parathyroid hormone|mesh-list
6047244|NCT00576836|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6047245|NCT00576836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047246|NCT00576901|Bevacizumab|bevacizumab|mesh-list
6047247|NCT00576901|Docetaxel|docetaxel|mesh-list
6047248|NCT00576901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6047249|NCT00576901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6047250|NCT00576901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6047251|NCT00576901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6047252|NCT00576901|Growth Substances|growth substances|mesh-ancestor
6047253|NCT00576901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047254|NCT00576901|Growth Inhibitors|growth inhibitors|mesh-ancestor
6047255|NCT00576901|Tubulin Modulators|tubulin modulators|mesh-ancestor
6047256|NCT00576901|Antimitotic Agents|antimitotic agents|mesh-ancestor
6047257|NCT00576901|Mitosis Modulators|mitosis modulators|mesh-ancestor
6047258|NCT00576901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047259|NCT00577005|Levetiracetam|levetiracetam|mesh-list
6047260|NCT00577005|Anticonvulsants|anticonvulsants|mesh-ancestor
6047261|NCT00577005|Nootropic Agents|nootropic agents|mesh-ancestor
6047262|NCT00577031|Bevacizumab|bevacizumab|mesh-list
6047263|NCT00577031|Oxaliplatin|oxaliplatin|mesh-list
6047264|NCT00577031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6047265|NCT00577031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6047266|NCT00577031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6047267|NCT00577031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6047268|NCT00577031|Growth Substances|growth substances|mesh-ancestor
6047269|NCT00577031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655243|NCT01462500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6655244|NCT01462500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6655245|NCT01462500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6655246|NCT01462500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6655247|NCT01462617|Nemiralisib|nemiralisib|mesh-list
6655248|NCT01462617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6655249|NCT01462617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6047270|NCT00577031|Growth Inhibitors|growth inhibitors|mesh-ancestor
6047271|NCT00577096|Thalidomide|thalidomide|mesh-list
6047272|NCT00577096|Dexamethasone|dexamethasone|mesh-list
6047273|NCT00577096|Cyclophosphamide|cyclophosphamide|mesh-list
6047274|NCT00577096|Melphalan|melphalan|mesh-list
6047275|NCT00577096|Cisplatin|cisplatin|mesh-list
6047276|NCT00577096|Doxorubicin|doxorubicin|mesh-list
6047277|NCT00577096|Etoposide|etoposide|mesh-list
6047278|NCT00577096|Vincristine|vincristine|mesh-list
6047279|NCT00577096|Heparin|heparin|mesh-list
6047280|NCT00577096|Calcium heparin|calcium heparin|mesh-list
6047281|NCT00577096|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6047282|NCT00577096|Tinzaparin|tinzaparin|mesh-list
6047283|NCT00577096|Dalteparin|dalteparin|mesh-list
6047284|NCT00577096|Epoetin Alfa|epoetin alfa|mesh-list
6047285|NCT00577096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6047286|NCT00577096|Immunologic Factors|immunologic factors|mesh-ancestor
6047287|NCT00577096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047288|NCT00577096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6458395|NCT00440323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6458396|NCT00440323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458397|NCT00440336|Latanoprost|latanoprost|mesh-list
6458398|NCT00440336|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6458399|NCT00440336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6458400|NCT00440349|Tamoxifen|tamoxifen|mesh-list
6458401|NCT00440349|Prednisone|prednisone|mesh-list
6458402|NCT00440349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6458403|NCT00440349|Glucocorticoids|glucocorticoids|mesh-ancestor
6458404|NCT00440349|Hormones|hormones|mesh-ancestor
6458405|NCT00440349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6458406|NCT00440349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458407|NCT00440349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6458408|NCT00440349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6458409|NCT00440349|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6664656|NCT01513187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6458410|NCT00440349|Hormone Antagonists|hormone antagonists|mesh-ancestor
6458411|NCT00440349|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6458412|NCT00440349|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6047289|NCT00577096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6047290|NCT00577096|Alkylating Agents|alkylating agents|mesh-ancestor
6047291|NCT00577096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047292|NCT00577096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6047293|NCT00577096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6047294|NCT00577096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6047295|NCT00577096|Antiemetics|antiemetics|mesh-ancestor
6047296|NCT00577096|Autonomic Agents|autonomic agents|mesh-ancestor
6047297|NCT00577096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6047298|NCT00577096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6047299|NCT00577096|Glucocorticoids|glucocorticoids|mesh-ancestor
6047300|NCT00577096|Hormones|hormones|mesh-ancestor
6047301|NCT00577096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6047302|NCT00577096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6047303|NCT00577096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6047304|NCT00577096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6047305|NCT00577096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6047306|NCT00577096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6047307|NCT00577096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6047308|NCT00577096|Tubulin Modulators|tubulin modulators|mesh-ancestor
6047309|NCT00577096|Antimitotic Agents|antimitotic agents|mesh-ancestor
6047310|NCT00577096|Mitosis Modulators|mitosis modulators|mesh-ancestor
5498539|NCT04498351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5498540|NCT04498351|Analgesics|analgesics|mesh-ancestor
5498541|NCT04498351|Sensory System Agents|sensory system agents|mesh-ancestor
5498542|NCT04498351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5498543|NCT04498351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5498544|NCT04498351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5498545|NCT04498351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5498546|NCT04498351|Adrenergic Agents|adrenergic agents|mesh-ancestor
5498547|NCT04498351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5498548|NCT04498351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498549|NCT04498351|Anesthetics|anesthetics|mesh-ancestor
5498550|NCT04498351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5498551|NCT04498351|Anticonvulsants|anticonvulsants|mesh-ancestor
5498552|NCT04498351|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5498553|NCT04498351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5498554|NCT04498351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5498555|NCT04498351|Tocolytic Agents|tocolytic agents|mesh-ancestor
6047311|NCT00577096|Anticoagulants|anticoagulants|mesh-ancestor
6047312|NCT00577096|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6047313|NCT00577096|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6047314|NCT00577096|Hematinics|hematinics|mesh-ancestor
6047315|NCT00577096|Leprostatic Agents|leprostatic agents|mesh-ancestor
6047316|NCT00577096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6047317|NCT00577096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6047318|NCT00577096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6047319|NCT00577096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6047320|NCT00577096|Growth Substances|growth substances|mesh-ancestor
6047321|NCT00577096|Growth Inhibitors|growth inhibitors|mesh-ancestor
6047322|NCT00577122|Cyclophosphamide|cyclophosphamide|mesh-list
6047323|NCT00577122|Methotrexate|methotrexate|mesh-list
6047324|NCT00577122|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
5498556|NCT04498351|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5498557|NCT04497831|Morphine|morphine|mesh-list
5498558|NCT04497831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5498559|NCT04497831|Narcotics|narcotics|mesh-ancestor
5498560|NCT04497831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5498561|NCT04497831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498562|NCT04497831|Analgesics|analgesics|mesh-ancestor
5498563|NCT04497831|Sensory System Agents|sensory system agents|mesh-ancestor
5498564|NCT04497831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5498565|NCT04497766|Magnesium Sulfate|magnesium sulfate|mesh-list
5498566|NCT04497766|Analgesics|analgesics|mesh-ancestor
5498567|NCT04497766|Sensory System Agents|sensory system agents|mesh-ancestor
5498568|NCT04497766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5498569|NCT04497766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498570|NCT04497766|Anesthetics|anesthetics|mesh-ancestor
5498571|NCT04497766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5498572|NCT04497766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6047325|NCT00577122|Medroxyprogesterone|medroxyprogesterone|mesh-list
5498573|NCT04497766|Anticonvulsants|anticonvulsants|mesh-ancestor
6047326|NCT00577122|Progesterone|progesterone|mesh-list
6047327|NCT00577122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6047328|NCT00577122|Immunologic Factors|immunologic factors|mesh-ancestor
6047329|NCT00577122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047330|NCT00577122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6047331|NCT00577122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6047332|NCT00577122|Alkylating Agents|alkylating agents|mesh-ancestor
6047333|NCT00577122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047334|NCT00577122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6047335|NCT00577122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6047336|NCT00577122|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6047337|NCT00577122|Abortifacient Agents|abortifacient agents|mesh-ancestor
6047338|NCT00577122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6047339|NCT00577122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6047340|NCT00577122|Antimetabolites|antimetabolites|mesh-ancestor
6047341|NCT00577122|Dermatologic Agents|dermatologic agents|mesh-ancestor
6047342|NCT00577122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6047343|NCT00577122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6047344|NCT00577122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6655250|NCT01462617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655251|NCT01462630|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6655252|NCT01462630|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6047345|NCT00577122|Progestins|progestins|mesh-ancestor
6047346|NCT00577122|Hormones|hormones|mesh-ancestor
6047347|NCT00577122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6458413|NCT00440349|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5498574|NCT04497766|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5498575|NCT04497766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5498576|NCT04497766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498577|NCT04497766|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5498578|NCT04497766|Tocolytic Agents|tocolytic agents|mesh-ancestor
5498579|NCT04497766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5498580|NCT04497792|Metformin|metformin|mesh-list
5498581|NCT04497792|Empagliflozin|empagliflozin|mesh-list
5498582|NCT04497792|Hypoglycemic Agents|hypoglycemic agents|mesh-list
5498583|NCT04497792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498584|NCT04497792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5498585|NCT04497792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498586|NCT04497649|Sofosbuvir|sofosbuvir|mesh-list
5498587|NCT04497649|Antiviral Agents|antiviral agents|mesh-ancestor
5498588|NCT04497649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5498589|NCT04497012|Iron|iron|mesh-list
5498590|NCT04497012|Trace Elements|trace elements|mesh-ancestor
5498591|NCT04497012|Micronutrients|micronutrients|mesh-ancestor
5498592|NCT04497012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503385|NCT04459598|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5503386|NCT04459598|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5503387|NCT04459598|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5503388|NCT04459663|Axitinib|axitinib|mesh-list
5503389|NCT04459663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5503390|NCT04459663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5503391|NCT04459663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5503392|NCT04459663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503393|NCT04459702|Ritonavir|ritonavir|mesh-list
5503394|NCT04459702|Lopinavir|lopinavir|mesh-list
5503395|NCT04459702|Azithromycin|azithromycin|mesh-list
5503396|NCT04459702|Hydroxychloroquine|hydroxychloroquine|mesh-list
5503397|NCT04459702|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5503398|NCT04459702|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5503399|NCT04459702|Protease Inhibitors|protease inhibitors|mesh-ancestor
5503400|NCT04459702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5503401|NCT04459702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503402|NCT04459702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6458414|NCT00440375|Rosiglitazone|rosiglitazone|mesh-list
6458415|NCT00440375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6458416|NCT00440375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458417|NCT00440414|Pemetrexed|pemetrexed|mesh-list
6458418|NCT00440414|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6458419|NCT00440414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6458420|NCT00440414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6458421|NCT00440414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458422|NCT00440414|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6458423|NCT00440414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6047348|NCT00577122|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6047349|NCT00577122|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6047350|NCT00577122|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6047351|NCT00577122|Contraceptive Agents|contraceptive agents|mesh-ancestor
6047352|NCT00577122|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6047353|NCT00577122|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6047354|NCT00577122|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6047355|NCT00577122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6047356|NCT00577135|Furosemide|furosemide|mesh-list
6047357|NCT00577135|Diuretics|diuretics|mesh-list
6047358|NCT00577135|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
6047359|NCT00577135|Natriuretic Agents|natriuretic agents|mesh-ancestor
6047360|NCT00577135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047361|NCT00577135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6047362|NCT00577135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047363|NCT00577382|Sunitinib|sunitinib|mesh-list
6047364|NCT00577382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6047365|NCT00577382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6047366|NCT00577382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6047367|NCT00577382|Growth Substances|growth substances|mesh-ancestor
6047368|NCT00577382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047369|NCT00577382|Growth Inhibitors|growth inhibitors|mesh-ancestor
6047370|NCT00577382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6047371|NCT00577382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6047372|NCT00577382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047373|NCT00577408|Naltrexone|naltrexone|mesh-list
6047374|NCT00577408|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6047375|NCT00577408|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6047376|NCT00577408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047377|NCT00577408|Sensory System Agents|sensory system agents|mesh-ancestor
6047378|NCT00577408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6047379|NCT00577460|Pramipexole|pramipexole|mesh-list
6047380|NCT00577460|Antioxidants|antioxidants|mesh-ancestor
6047381|NCT00577460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047382|NCT00577460|Protective Agents|protective agents|mesh-ancestor
6047383|NCT00577460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047384|NCT00577460|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6047385|NCT00577460|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6047386|NCT00577460|Dopamine Agonists|dopamine agonists|mesh-ancestor
6047387|NCT00577460|Dopamine Agents|dopamine agents|mesh-ancestor
6458424|NCT00440414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6458425|NCT00440427|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6458426|NCT00440427|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6458427|NCT00440427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6458428|NCT00440427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6458429|NCT00440427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458430|NCT00440427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6458431|NCT00440427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458432|NCT00440427|Antidepressive Agents|antidepressive agents|mesh-ancestor
6458433|NCT00440427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6047388|NCT00577460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6047389|NCT00577473|Mesalamine|mesalamine|mesh-list
6047390|NCT00577473|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6047391|NCT00577473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6047392|NCT00577473|Analgesics|analgesics|mesh-ancestor
6047393|NCT00577473|Sensory System Agents|sensory system agents|mesh-ancestor
6047394|NCT00577473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6047395|NCT00577473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047396|NCT00577473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6047397|NCT00577473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6047398|NCT00577590|Metformin|metformin|mesh-list
6047399|NCT00577590|Rosiglitazone|rosiglitazone|mesh-list
6047400|NCT00577590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6047401|NCT00577590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047402|NCT00577629|Cytarabine|cytarabine|mesh-list
6047403|NCT00577629|Cyclophosphamide|cyclophosphamide|mesh-list
6047404|NCT00577629|Rituximab|rituximab|mesh-list
6047405|NCT00577629|Doxorubicin|doxorubicin|mesh-list
6047406|NCT00577629|Etoposide|etoposide|mesh-list
6047407|NCT00577629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6047408|NCT00577629|Immunologic Factors|immunologic factors|mesh-ancestor
6047409|NCT00577629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047410|NCT00577629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6047411|NCT00577629|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6047412|NCT00577629|Alkylating Agents|alkylating agents|mesh-ancestor
6047413|NCT00577629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047414|NCT00577629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6047415|NCT00577629|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6047416|NCT00577629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6047417|NCT00577629|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6047418|NCT00577629|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6047419|NCT00577629|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6047420|NCT00577629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6047421|NCT00577629|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6047422|NCT00577629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6047423|NCT00577629|Antimetabolites|antimetabolites|mesh-ancestor
6047424|NCT00577629|Antiviral Agents|antiviral agents|mesh-ancestor
6047425|NCT00577629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6047426|NCT00577642|Zoledronic Acid|zoledronic acid|mesh-list
6047427|NCT00577642|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6047428|NCT00577642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047429|NCT00577655|Albuterol|albuterol|mesh-list
6047430|NCT00577655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6047431|NCT00577655|Autonomic Agents|autonomic agents|mesh-ancestor
6047432|NCT00577655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6047433|NCT00577655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047434|NCT00577655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6047435|NCT00577655|Respiratory System Agents|respiratory system agents|mesh-ancestor
6047436|NCT00577655|Tocolytic Agents|tocolytic agents|mesh-ancestor
6047437|NCT00577655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6047438|NCT00577655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6047439|NCT00577655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6047440|NCT00577655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6047441|NCT00577655|Adrenergic Agents|adrenergic agents|mesh-ancestor
6047442|NCT00577655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6047443|NCT00577655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047444|NCT00577707|Pemetrexed|pemetrexed|mesh-list
6047445|NCT00577707|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6047446|NCT00577707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6047447|NCT00577707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6047448|NCT00577707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047449|NCT00577707|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6047450|NCT00577707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6047451|NCT00577707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5498593|NCT04497142|Levetiracetam|levetiracetam|mesh-list
5498594|NCT04497142|Anticonvulsants|anticonvulsants|mesh-ancestor
5498595|NCT04497142|Nootropic Agents|nootropic agents|mesh-ancestor
5498596|NCT04497168|Citalopram|citalopram|mesh-list
5498597|NCT04497168|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5498598|NCT04497168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6047452|NCT00577720|Risedronic Acid|risedronic acid|mesh-list
6047453|NCT00577720|Etidronic Acid|etidronic acid|mesh-list
6047454|NCT00577720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6047455|NCT00577720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6047456|NCT00577720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047457|NCT00577720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6047458|NCT00577720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047459|NCT00577720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6047460|NCT00577824|Exenatide|exenatide|mesh-list
6047461|NCT00577824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6047462|NCT00577824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047463|NCT00577824|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6047464|NCT00577824|Incretins|incretins|mesh-ancestor
6047465|NCT00577824|Hormones|hormones|mesh-ancestor
6047466|NCT00577824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6047467|NCT00577863|Teriparatide|teriparatide|mesh-list
6047468|NCT00577863|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6047469|NCT00577863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498599|NCT04497168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5498600|NCT04497168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498601|NCT04497168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5498602|NCT04497168|Serotonin Agents|serotonin agents|mesh-ancestor
5498603|NCT04497168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498604|NCT04497168|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5498605|NCT04497168|Antidepressive Agents|antidepressive agents|mesh-ancestor
5498606|NCT04497168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5498607|NCT04496921|Vitamins|vitamins|mesh-list
6047470|NCT00577863|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6047471|NCT00577889|Gemcitabine|gemcitabine|mesh-list
6047472|NCT00577889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6047473|NCT00577889|Antimetabolites|antimetabolites|mesh-ancestor
6047474|NCT00577889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047475|NCT00577889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6047476|NCT00577889|Antiviral Agents|antiviral agents|mesh-ancestor
6047477|NCT00577889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6047478|NCT00577889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6047479|NCT00577889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6047480|NCT00577889|Immunologic Factors|immunologic factors|mesh-ancestor
6047481|NCT00577889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047482|NCT00577993|Interferons|interferons|mesh-list
6047483|NCT00577993|Interferon-alpha|interferon-alpha|mesh-list
6047484|NCT00577993|Interferon alpha-2|interferon alpha-2|mesh-list
6047485|NCT00577993|Dexamethasone|dexamethasone|mesh-list
6047486|NCT00577993|Prednisone|prednisone|mesh-list
6047487|NCT00577993|Prednisolone|prednisolone|mesh-list
6047488|NCT00577993|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6047489|NCT00577993|Methylprednisolone|methylprednisolone|mesh-list
6047490|NCT00577993|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6047491|NCT00577993|Prednisolone acetate|prednisolone acetate|mesh-list
6047492|NCT00577993|Cyclophosphamide|cyclophosphamide|mesh-list
6047493|NCT00577993|Rituximab|rituximab|mesh-list
6047494|NCT00577993|Doxorubicin|doxorubicin|mesh-list
6047495|NCT00577993|Fludarabine|fludarabine|mesh-list
6047496|NCT00577993|Etoposide|etoposide|mesh-list
6047497|NCT00577993|Vincristine|vincristine|mesh-list
6047498|NCT00577993|Mitoxantrone|mitoxantrone|mesh-list
6047499|NCT00577993|Bleomycin|bleomycin|mesh-list
6047500|NCT00577993|Procarbazine|procarbazine|mesh-list
6047501|NCT00577993|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6047502|NCT00577993|Prednisolone phosphate|prednisolone phosphate|mesh-list
6047503|NCT00577993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6047504|NCT00577993|Immunologic Factors|immunologic factors|mesh-ancestor
6047505|NCT00577993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047506|NCT00577993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6047507|NCT00577993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6047508|NCT00577993|Alkylating Agents|alkylating agents|mesh-ancestor
6047509|NCT00577993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047510|NCT00577993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6047511|NCT00577993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6047512|NCT00577993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6047513|NCT00577993|Antiemetics|antiemetics|mesh-ancestor
6047514|NCT00577993|Autonomic Agents|autonomic agents|mesh-ancestor
6047515|NCT00577993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6047516|NCT00577993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6047517|NCT00577993|Glucocorticoids|glucocorticoids|mesh-ancestor
6047518|NCT00577993|Hormones|hormones|mesh-ancestor
6047519|NCT00577993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6047520|NCT00577993|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6047521|NCT00577993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6047522|NCT00577993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6047523|NCT00577993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6047524|NCT00577993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6047525|NCT00577993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6047526|NCT00577993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6047527|NCT00577993|Antiviral Agents|antiviral agents|mesh-ancestor
6047528|NCT00577993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6047529|NCT00577993|Tubulin Modulators|tubulin modulators|mesh-ancestor
6047530|NCT00577993|Antimitotic Agents|antimitotic agents|mesh-ancestor
6047531|NCT00577993|Mitosis Modulators|mitosis modulators|mesh-ancestor
6047532|NCT00577993|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6047533|NCT00577993|Protective Agents|protective agents|mesh-ancestor
6047534|NCT00577993|Analgesics|analgesics|mesh-ancestor
6047535|NCT00577993|Sensory System Agents|sensory system agents|mesh-ancestor
6047536|NCT00578071|Capecitabine|capecitabine|mesh-list
6047537|NCT00578071|Oxaliplatin|oxaliplatin|mesh-list
6047538|NCT00578071|Panitumumab|panitumumab|mesh-list
6047539|NCT00578071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6047540|NCT00578071|Antimetabolites|antimetabolites|mesh-ancestor
6047541|NCT00578071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047542|NCT00578071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6047543|NCT00578071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6047544|NCT00578136|Bupivacaine|bupivacaine|mesh-list
6047545|NCT00578136|Anesthetics, Local|anesthetics, local|mesh-ancestor
6047546|NCT00578136|Anesthetics|anesthetics|mesh-ancestor
6047547|NCT00578136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6047548|NCT00578136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047549|NCT00578136|Sensory System Agents|sensory system agents|mesh-ancestor
6047550|NCT00578136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6047551|NCT00578175|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6047552|NCT00578175|Immunologic Factors|immunologic factors|mesh-ancestor
6047553|NCT00578175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047554|NCT00578214|Midazolam|midazolam|mesh-list
6047555|NCT00578214|Anesthetics|anesthetics|mesh-ancestor
6047556|NCT00578214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6047557|NCT00578214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047558|NCT00578214|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6047559|NCT00578214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6047560|NCT00578214|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6047561|NCT00578214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6047562|NCT00578214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6047563|NCT00578214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6047564|NCT00578214|Anesthetics, General|anesthetics, general|mesh-ancestor
6047565|NCT00578214|GABA Modulators|gaba modulators|mesh-ancestor
6047566|NCT00578214|GABA Agents|gaba agents|mesh-ancestor
6047567|NCT00578214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6047568|NCT00578214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047569|NCT00578227|Vaccines|vaccines|mesh-list
6047570|NCT00578227|Immunologic Factors|immunologic factors|mesh-ancestor
6047571|NCT00578227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047572|NCT00578292|Cyclophosphamide|cyclophosphamide|mesh-list
6047573|NCT00578292|Busulfan|busulfan|mesh-list
6047574|NCT00578292|Fludarabine|fludarabine|mesh-list
6047575|NCT00578292|Alemtuzumab|alemtuzumab|mesh-list
6047576|NCT00578292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6047577|NCT00578292|Immunologic Factors|immunologic factors|mesh-ancestor
6047578|NCT00578292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047579|NCT00578292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6047580|NCT00578292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6047581|NCT00578292|Alkylating Agents|alkylating agents|mesh-ancestor
6047582|NCT00578292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047583|NCT00578292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6047584|NCT00578292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6047585|NCT00578292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6047586|NCT00578305|Folic Acid|folic acid|mesh-list
6047587|NCT00578305|Methylprednisolone|methylprednisolone|mesh-list
6047588|NCT00578305|Rituximab|rituximab|mesh-list
6047589|NCT00578305|Methotrexate|methotrexate|mesh-list
6047590|NCT00578305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6047591|NCT00578305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6047592|NCT00578305|Immunologic Factors|immunologic factors|mesh-ancestor
6047593|NCT00578305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047594|NCT00578305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6047595|NCT00578305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6047596|NCT00578305|Abortifacient Agents|abortifacient agents|mesh-ancestor
6047597|NCT00578305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6047598|NCT00578305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6047599|NCT00578305|Antimetabolites|antimetabolites|mesh-ancestor
6047600|NCT00578305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047601|NCT00578305|Dermatologic Agents|dermatologic agents|mesh-ancestor
6047602|NCT00578305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6047603|NCT00578305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6047604|NCT00578305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6047605|NCT00578305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6047606|NCT00578305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6047607|NCT00578305|Antiemetics|antiemetics|mesh-ancestor
6047608|NCT00578305|Autonomic Agents|autonomic agents|mesh-ancestor
6047609|NCT00578305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6047610|NCT00578305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6047611|NCT00578305|Glucocorticoids|glucocorticoids|mesh-ancestor
6047612|NCT00578305|Hormones|hormones|mesh-ancestor
6047613|NCT00578305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6047614|NCT00578305|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6047615|NCT00578305|Protective Agents|protective agents|mesh-ancestor
6047616|NCT00578305|Hematinics|hematinics|mesh-ancestor
6047617|NCT00578305|Vitamin B Complex|vitamin b complex|mesh-ancestor
5498608|NCT04496921|Vitamin K|vitamin k|mesh-list
5498609|NCT04496921|Micronutrients|micronutrients|mesh-ancestor
5498610|NCT04496921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047618|NCT00578305|Vitamins|vitamins|mesh-ancestor
6047619|NCT00578305|Micronutrients|micronutrients|mesh-ancestor
6047620|NCT00578331|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
6047621|NCT00578331|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6047622|NCT00578331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6047623|NCT00578331|Analgesics|analgesics|mesh-ancestor
6047624|NCT00578331|Sensory System Agents|sensory system agents|mesh-ancestor
6047625|NCT00578331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6047626|NCT00578331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047627|NCT00578331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6047628|NCT00578331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6047629|NCT00578331|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6458434|NCT00440440|Testosterone|testosterone|mesh-list
6458435|NCT00440440|Androgens|androgens|mesh-ancestor
6458436|NCT00440440|Hormones|hormones|mesh-ancestor
6458437|NCT00440440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6047630|NCT00578331|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6047631|NCT00578331|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6047632|NCT00578331|Histamine Antagonists|histamine antagonists|mesh-ancestor
6047633|NCT00578331|Histamine Agents|histamine agents|mesh-ancestor
6458438|NCT00440440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655253|NCT01462630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047634|NCT00578331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6047635|NCT00578331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047636|NCT00578344|Cyclophosphamide|cyclophosphamide|mesh-list
6047637|NCT00578344|Busulfan|busulfan|mesh-list
6047638|NCT00578344|Alemtuzumab|alemtuzumab|mesh-list
6047639|NCT00578344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6047640|NCT00578344|Immunologic Factors|immunologic factors|mesh-ancestor
6047641|NCT00578344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047642|NCT00578344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6047643|NCT00578344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6047644|NCT00578344|Alkylating Agents|alkylating agents|mesh-ancestor
6047645|NCT00578344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047646|NCT00578344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6047647|NCT00578344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6655254|NCT01462669|Ezogabine|ezogabine|mesh-list
6655255|NCT01462669|Anticonvulsants|anticonvulsants|mesh-ancestor
6655256|NCT01462669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5498611|NCT04496921|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6047648|NCT00578344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6047649|NCT00578448|Abatacept|abatacept|mesh-list
6047650|NCT00578448|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6047651|NCT00578448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047652|NCT00578448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6047653|NCT00578448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6047654|NCT00578448|Immunologic Factors|immunologic factors|mesh-ancestor
6047655|NCT00578448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047656|NCT00578448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6047657|NCT00578461|Cytarabine|cytarabine|mesh-list
6047658|NCT00578461|Cyclophosphamide|cyclophosphamide|mesh-list
6047659|NCT00578461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6047660|NCT00578461|Immunologic Factors|immunologic factors|mesh-ancestor
6047661|NCT00578461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047662|NCT00578461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6047663|NCT00578461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5498612|NCT04496921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5498613|NCT04496921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498614|NCT04496921|Hemostatics|hemostatics|mesh-ancestor
5498615|NCT04496921|Coagulants|coagulants|mesh-ancestor
5498616|NCT04496882|Tenofovir|tenofovir|mesh-list
5498617|NCT04496882|Antiviral Agents|antiviral agents|mesh-ancestor
5498618|NCT04496882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5498619|NCT04496882|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5498620|NCT04496882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5498621|NCT04496882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5498622|NCT04496882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498623|NCT04496882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6047664|NCT00578461|Alkylating Agents|alkylating agents|mesh-ancestor
6047665|NCT00578461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047666|NCT00578461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6047667|NCT00578461|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6047668|NCT00578461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6047669|NCT00578461|Antimetabolites|antimetabolites|mesh-ancestor
6047670|NCT00578461|Antiviral Agents|antiviral agents|mesh-ancestor
6047671|NCT00578461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6047672|NCT00578539|Cytarabine|cytarabine|mesh-list
6047673|NCT00578539|Cyclophosphamide|cyclophosphamide|mesh-list
6047674|NCT00578539|Alemtuzumab|alemtuzumab|mesh-list
6047675|NCT00578539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6047676|NCT00578539|Immunologic Factors|immunologic factors|mesh-ancestor
6047677|NCT00578539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047678|NCT00578539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6047679|NCT00578539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6047680|NCT00578539|Alkylating Agents|alkylating agents|mesh-ancestor
6047681|NCT00578539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655257|NCT01462669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655258|NCT01462890|Paclitaxel|paclitaxel|mesh-list
6655259|NCT01462890|Bevacizumab|bevacizumab|mesh-list
6655260|NCT01462890|Carboplatin|carboplatin|mesh-list
6655261|NCT01462890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6655262|NCT01462890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6655263|NCT01462890|Tubulin Modulators|tubulin modulators|mesh-ancestor
6655264|NCT01462890|Antimitotic Agents|antimitotic agents|mesh-ancestor
6655265|NCT01462890|Mitosis Modulators|mitosis modulators|mesh-ancestor
6655266|NCT01462890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655267|NCT01462890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6655268|NCT01462890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6655269|NCT01462890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6655270|NCT01462890|Growth Substances|growth substances|mesh-ancestor
6655271|NCT01462890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655272|NCT01462890|Growth Inhibitors|growth inhibitors|mesh-ancestor
6655273|NCT01462968|Heparin|heparin|mesh-list
6655274|NCT01462968|Anticoagulants|anticoagulants|mesh-ancestor
6655275|NCT01462968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6655276|NCT01462968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6655277|NCT01462968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655278|NCT01463046|Cytarabine|cytarabine|mesh-list
6655279|NCT01463046|Daunorubicin|daunorubicin|mesh-list
6655280|NCT01463046|Panobinostat|panobinostat|mesh-list
6655281|NCT01463046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6655282|NCT01463046|Antimetabolites|antimetabolites|mesh-ancestor
6655283|NCT01463046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498624|NCT04496882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5498625|NCT04496245|Broncho-Vaxom|broncho-vaxom|mesh-list
5498626|NCT04496245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5498627|NCT04496245|Immunologic Factors|immunologic factors|mesh-ancestor
5498628|NCT04496245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498629|NCT04496401|Tacrolimus|tacrolimus|mesh-list
5498630|NCT04496401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5498631|NCT04496401|Immunologic Factors|immunologic factors|mesh-ancestor
5498632|NCT04496401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498633|NCT04496401|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5498634|NCT04496401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5498635|NCT04496401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498636|NCT04496453|Vaccines|vaccines|mesh-list
5498637|NCT04496453|Immunologic Factors|immunologic factors|mesh-ancestor
5498638|NCT04496453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498639|NCT04496492|Tocotrienols|tocotrienols|mesh-list
5498640|NCT04496492|Vitamin E|vitamin e|mesh-list
5498641|NCT04496492|Tocopherols|tocopherols|mesh-list
5498642|NCT04496492|Antioxidants|antioxidants|mesh-ancestor
5498643|NCT04496492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498644|NCT04496492|Protective Agents|protective agents|mesh-ancestor
5498645|NCT04496492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498646|NCT04496492|Vitamins|vitamins|mesh-ancestor
5498647|NCT04496492|Micronutrients|micronutrients|mesh-ancestor
5498648|NCT04496141|Antibodies|antibodies|mesh-list
5498649|NCT04496141|Immunologic Factors|immunologic factors|mesh-ancestor
5498650|NCT04496141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498651|NCT04496037|Rituximab|rituximab|mesh-list
6655284|NCT01463046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6655285|NCT01463046|Antiviral Agents|antiviral agents|mesh-ancestor
6655286|NCT01463046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6655287|NCT01463046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6655288|NCT01463046|Immunologic Factors|immunologic factors|mesh-ancestor
5498652|NCT04496037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5498653|NCT04496037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6047682|NCT00578539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6047683|NCT00578539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6047684|NCT00578539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6047685|NCT00578539|Antimetabolites|antimetabolites|mesh-ancestor
6655289|NCT01463046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047686|NCT00578539|Antiviral Agents|antiviral agents|mesh-ancestor
6047687|NCT00578539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6047688|NCT00578539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6047689|NCT00578552|Gabapentin|gabapentin|mesh-list
6047690|NCT00578552|Analgesics|analgesics|mesh-ancestor
6047691|NCT00578552|Sensory System Agents|sensory system agents|mesh-ancestor
6047692|NCT00578552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6047693|NCT00578552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047694|NCT00578552|Anticonvulsants|anticonvulsants|mesh-ancestor
6047695|NCT00578552|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6047696|NCT00578552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6047697|NCT00578552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6047698|NCT00578552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6047699|NCT00578552|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6458439|NCT00440479|Bortezomib|bortezomib|mesh-list
6458440|NCT00440479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6458441|NCT00440609|Ranibizumab|ranibizumab|mesh-list
6458442|NCT00440609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6458443|NCT00440609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6458444|NCT00440609|Growth Substances|growth substances|mesh-ancestor
6458445|NCT00440609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458446|NCT00440609|Growth Inhibitors|growth inhibitors|mesh-ancestor
6047700|NCT00578552|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6047701|NCT00578552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5498654|NCT04496037|Immunologic Factors|immunologic factors|mesh-ancestor
5498655|NCT04496037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498656|NCT04496037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5498657|NCT04496050|Alprostadil|alprostadil|mesh-list
5498658|NCT04496050|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5498659|NCT04496050|Vasodilator Agents|vasodilator agents|mesh-ancestor
5498660|NCT04496050|Urological Agents|urological agents|mesh-ancestor
5498661|NCT04495894|Ketorolac|ketorolac|mesh-list
5498662|NCT04495894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5498663|NCT04495894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5498664|NCT04495894|Analgesics|analgesics|mesh-ancestor
5498665|NCT04495894|Sensory System Agents|sensory system agents|mesh-ancestor
5498666|NCT04495894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5498667|NCT04495894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498668|NCT04495894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5498669|NCT04495894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5498670|NCT04495894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5498671|NCT04495894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5498672|NCT04495894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498673|NCT04495881|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5498674|NCT04495881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5498675|NCT04495881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498676|NCT04495881|Incretins|incretins|mesh-ancestor
5498677|NCT04495881|Hormones|hormones|mesh-ancestor
5498678|NCT04495881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5498679|NCT04495881|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5498680|NCT04495881|Protease Inhibitors|protease inhibitors|mesh-ancestor
6047702|NCT00578552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047703|NCT00578552|Antimanic Agents|antimanic agents|mesh-ancestor
6047704|NCT00578565|Rituximab|rituximab|mesh-list
6047705|NCT00578565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6047706|NCT00578565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6047707|NCT00578565|Immunologic Factors|immunologic factors|mesh-ancestor
6047708|NCT00578565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047709|NCT00578565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6047710|NCT00578617|Amiodarone|amiodarone|mesh-list
6047711|NCT00578617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047712|NCT00578617|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6047713|NCT00578617|Vasodilator Agents|vasodilator agents|mesh-ancestor
6047714|NCT00578617|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6047715|NCT00578617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6047716|NCT00578617|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6047717|NCT00578617|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6047718|NCT00578617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6047719|NCT00578617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6047720|NCT00578617|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6047721|NCT00578617|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6047722|NCT00578617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6458447|NCT00440609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6458448|NCT00440622|Gemcitabine|gemcitabine|mesh-list
6047723|NCT00578643|Cyclosporine|cyclosporine|mesh-list
6047724|NCT00578643|Cyclophosphamide|cyclophosphamide|mesh-list
6047725|NCT00578643|Busulfan|busulfan|mesh-list
6047726|NCT00578643|Fludarabine|fludarabine|mesh-list
6047727|NCT00578643|Alemtuzumab|alemtuzumab|mesh-list
6047728|NCT00578643|Cyclosporins|cyclosporins|mesh-list
6047729|NCT00578643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6047730|NCT00578643|Immunologic Factors|immunologic factors|mesh-ancestor
6047731|NCT00578643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047732|NCT00578643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6047733|NCT00578643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6047734|NCT00578643|Alkylating Agents|alkylating agents|mesh-ancestor
6047735|NCT00578643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047736|NCT00578643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6047737|NCT00578643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6047738|NCT00578643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5498681|NCT04495881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5498682|NCT04495881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498683|NCT04496063|Ustekinumab|ustekinumab|mesh-list
5498684|NCT04496063|Dermatologic Agents|dermatologic agents|mesh-ancestor
5498685|NCT04495933|Vaccines|vaccines|mesh-list
5498686|NCT04495933|MF59 oil emulsion|mf59 oil emulsion|mesh-list
5498687|NCT04495933|Immunologic Factors|immunologic factors|mesh-ancestor
5498688|NCT04495933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498689|NCT04495933|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5498690|NCT04495608|Fluconazole|fluconazole|mesh-list
5498691|NCT04495608|Antifungal Agents|antifungal agents|mesh-ancestor
5498692|NCT04495608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5498693|NCT04495608|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5498694|NCT04495608|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5498695|NCT04495608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5498696|NCT04495608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498697|NCT04495608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5498698|NCT04495608|Hormone Antagonists|hormone antagonists|mesh-ancestor
5498699|NCT04495608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5498700|NCT04495608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498701|NCT04495608|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5498702|NCT04495608|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5498703|NCT04496024|Ofloxacin|ofloxacin|mesh-list
5498704|NCT04496024|Levofloxacin|levofloxacin|mesh-list
5498705|NCT04496024|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5498706|NCT04496024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6047739|NCT00578643|Antifungal Agents|antifungal agents|mesh-ancestor
6047740|NCT00578643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6047741|NCT00578643|Dermatologic Agents|dermatologic agents|mesh-ancestor
5498707|NCT04496024|Renal Agents|renal agents|mesh-ancestor
5498708|NCT04496024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5498709|NCT04496024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5498710|NCT04496024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5498711|NCT04496024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5498712|NCT04496024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498713|NCT04496024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5498714|NCT04496024|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5498715|NCT04496024|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5498716|NCT04495569|Antibodies|antibodies|mesh-list
6047742|NCT00578643|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6047743|NCT00578643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6047744|NCT00578669|Fluoxetine|fluoxetine|mesh-list
6047745|NCT00578669|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6047746|NCT00578669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6047747|NCT00578669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6047748|NCT00578669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047749|NCT00578669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6047750|NCT00578669|Serotonin Agents|serotonin agents|mesh-ancestor
6047751|NCT00578669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047752|NCT00578669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6047753|NCT00578669|Antidepressive Agents|antidepressive agents|mesh-ancestor
6047754|NCT00578669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6047755|NCT00578669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6047756|NCT00578669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5498717|NCT04495569|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5498718|NCT04495569|Immunologic Factors|immunologic factors|mesh-ancestor
6047757|NCT00578669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5498719|NCT04495569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498720|NCT04495478|Ramucirumab|ramucirumab|mesh-list
5498721|NCT04495478|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5498722|NCT04495478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5498723|NCT04495478|Immunologic Factors|immunologic factors|mesh-ancestor
5498724|NCT04495478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498725|NCT04495504|Ropivacaine|ropivacaine|mesh-list
5498726|NCT04495504|Anesthetics, Local|anesthetics, local|mesh-ancestor
5498727|NCT04495504|Anesthetics|anesthetics|mesh-ancestor
5498728|NCT04495504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6047758|NCT00578734|Pulmonary Surfactants|pulmonary surfactants|mesh-list
6047759|NCT00578734|Respiratory System Agents|respiratory system agents|mesh-ancestor
6047760|NCT00578786|Ambrisentan|ambrisentan|mesh-list
6047761|NCT00578786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6047762|NCT00578864|Cyclophosphamide|cyclophosphamide|mesh-list
6047763|NCT00578864|Doxorubicin|doxorubicin|mesh-list
6047764|NCT00578864|Etoposide|etoposide|mesh-list
6047765|NCT00578864|Etoposide phosphate|etoposide phosphate|mesh-list
6047766|NCT00578864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6047767|NCT00578864|Immunologic Factors|immunologic factors|mesh-ancestor
6047768|NCT00578864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047769|NCT00578864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6047770|NCT00578864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6047771|NCT00578864|Alkylating Agents|alkylating agents|mesh-ancestor
6047772|NCT00578864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047773|NCT00578864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6047774|NCT00578864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6047775|NCT00578864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6047776|NCT00578864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6047777|NCT00578864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6047778|NCT00578864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6047779|NCT00578864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6458449|NCT00440622|Capecitabine|capecitabine|mesh-list
6458450|NCT00440622|Trastuzumab|trastuzumab|mesh-list
6458451|NCT00440622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6458452|NCT00440622|Antimetabolites|antimetabolites|mesh-ancestor
6458453|NCT00440622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458454|NCT00440622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6458455|NCT00440622|Antiviral Agents|antiviral agents|mesh-ancestor
6047780|NCT00578877|Nonoxynol|nonoxynol|mesh-list
6047781|NCT00578877|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
6047782|NCT00578877|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
6047783|NCT00578877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047784|NCT00578877|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6047785|NCT00578877|Contraceptive Agents|contraceptive agents|mesh-ancestor
6047786|NCT00578877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5498729|NCT04495504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498730|NCT04495504|Sensory System Agents|sensory system agents|mesh-ancestor
5498731|NCT04495504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5498732|NCT04495868|Lidocaine|lidocaine|mesh-list
5498733|NCT04495868|Anesthetics, Local|anesthetics, local|mesh-ancestor
5498734|NCT04495868|Anesthetics|anesthetics|mesh-ancestor
5498735|NCT04495868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5498736|NCT04495868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498737|NCT04495868|Sensory System Agents|sensory system agents|mesh-ancestor
5498738|NCT04495868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5498739|NCT04495868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5498740|NCT04495868|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5498741|NCT04495868|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5498742|NCT04495868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5498743|NCT04495868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503403|NCT04459702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5503404|NCT04459702|Antiviral Agents|antiviral agents|mesh-ancestor
5503405|NCT04459702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5503406|NCT04459702|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5503407|NCT04459702|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5503408|NCT04459702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5503409|NCT04459702|Antimalarials|antimalarials|mesh-ancestor
5503410|NCT04459702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5503411|NCT04459702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5503412|NCT04459702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5503413|NCT04459676|Mitogens|mitogens|mesh-list
5503414|NCT04459676|Mitosis Modulators|mitosis modulators|mesh-ancestor
6458456|NCT00440622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5503415|NCT04459676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047787|NCT00578877|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6047788|NCT00578903|Cyclophosphamide|cyclophosphamide|mesh-list
6047789|NCT00578903|Methotrexate|methotrexate|mesh-list
6047790|NCT00578903|Alemtuzumab|alemtuzumab|mesh-list
6047791|NCT00578903|Tacrolimus|tacrolimus|mesh-list
6047792|NCT00578903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6047793|NCT00578903|Immunologic Factors|immunologic factors|mesh-ancestor
6047794|NCT00578903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047795|NCT00578903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6047796|NCT00578903|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6047797|NCT00578903|Alkylating Agents|alkylating agents|mesh-ancestor
6047798|NCT00578903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047799|NCT00578903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6047800|NCT00578903|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6047801|NCT00578903|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6047802|NCT00578903|Abortifacient Agents|abortifacient agents|mesh-ancestor
5498744|NCT04495101|Protease Inhibitors|protease inhibitors|mesh-list
5498745|NCT04495101|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
5498746|NCT04495101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5498747|NCT04495101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498748|NCT04495101|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5498749|NCT04495101|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6047803|NCT00578903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6047804|NCT00578903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6047805|NCT00578903|Antimetabolites|antimetabolites|mesh-ancestor
6047806|NCT00578903|Dermatologic Agents|dermatologic agents|mesh-ancestor
6047807|NCT00578903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6047808|NCT00578903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6047809|NCT00578903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6047810|NCT00578903|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6047811|NCT00578903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6047812|NCT00578929|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
6047813|NCT00578929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6047814|NCT00578929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6047815|NCT00578929|Analgesics|analgesics|mesh-ancestor
6047816|NCT00578929|Sensory System Agents|sensory system agents|mesh-ancestor
6047817|NCT00578929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6047818|NCT00578929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498750|NCT04494958|Palbociclib|palbociclib|mesh-list
5498751|NCT04494958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5498752|NCT04494958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5498753|NCT04494958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6047819|NCT00578929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6458457|NCT00440622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6458458|NCT00440622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6458459|NCT00440622|Immunologic Factors|immunologic factors|mesh-ancestor
6458460|NCT00440622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458461|NCT00440622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6458462|NCT00440635|Bortezomib|bortezomib|mesh-list
5498754|NCT04494958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498755|NCT04495010|Nivolumab|nivolumab|mesh-list
5498756|NCT04495010|Ipilimumab|ipilimumab|mesh-list
5498757|NCT04495010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5498758|NCT04495010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5498759|NCT04495010|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5498760|NCT04495010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498761|NCT04494880|Bupivacaine|bupivacaine|mesh-list
5498762|NCT04494880|Anesthetics, Local|anesthetics, local|mesh-ancestor
5498763|NCT04494880|Anesthetics|anesthetics|mesh-ancestor
5498764|NCT04494880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5498765|NCT04494880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498766|NCT04494880|Sensory System Agents|sensory system agents|mesh-ancestor
5498767|NCT04494880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5498768|NCT04494659|Rifampin|rifampin|mesh-list
6458463|NCT00440635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6458464|NCT00440648|Sevelamer|sevelamer|mesh-list
6458465|NCT00440648|Chelating Agents|chelating agents|mesh-ancestor
5498769|NCT04494659|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6458466|NCT00440648|Sequestering Agents|sequestering agents|mesh-ancestor
5498770|NCT04494659|Antitubercular Agents|antitubercular agents|mesh-ancestor
5498771|NCT04494659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5498772|NCT04494659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5498773|NCT04494659|Leprostatic Agents|leprostatic agents|mesh-ancestor
5498774|NCT04494659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5498775|NCT04494659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5498776|NCT04494659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498777|NCT04494659|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6047820|NCT00578929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6047821|NCT00578929|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6047822|NCT00578929|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6047823|NCT00578929|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6047824|NCT00578929|Histamine Antagonists|histamine antagonists|mesh-ancestor
6047825|NCT00578929|Histamine Agents|histamine agents|mesh-ancestor
6047826|NCT00578929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5498778|NCT04494659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5498779|NCT04494659|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5498780|NCT04494659|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5498781|NCT04494659|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5498782|NCT04494659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5498783|NCT04494763|Propranolol|propranolol|mesh-list
5498784|NCT04494763|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5498785|NCT04494763|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5498786|NCT04494763|Adrenergic Agents|adrenergic agents|mesh-ancestor
5498787|NCT04494763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5498788|NCT04494763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498789|NCT04494763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498790|NCT04494763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5498791|NCT04494763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5498792|NCT04494763|Vasodilator Agents|vasodilator agents|mesh-ancestor
5498793|NCT04494828|Dexmedetomidine|dexmedetomidine|mesh-list
5498794|NCT04494828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5498795|NCT04494828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5498796|NCT04494828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498797|NCT04494828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5498798|NCT04494828|Analgesics|analgesics|mesh-ancestor
6047827|NCT00578929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047828|NCT00578942|Alemtuzumab|alemtuzumab|mesh-list
6047829|NCT00578942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6047830|NCT00578942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6047831|NCT00578968|Tiotropium Bromide|tiotropium bromide|mesh-list
6047832|NCT00578968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6047833|NCT00578968|Autonomic Agents|autonomic agents|mesh-ancestor
6047834|NCT00578968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6047835|NCT00578968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047836|NCT00578968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6047837|NCT00578968|Respiratory System Agents|respiratory system agents|mesh-ancestor
6047838|NCT00578968|Parasympatholytics|parasympatholytics|mesh-ancestor
6047839|NCT00578968|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6047840|NCT00578968|Cholinergic Agents|cholinergic agents|mesh-ancestor
6047841|NCT00578968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6047842|NCT00578968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047843|NCT00579098|Atorvastatin|atorvastatin|mesh-list
6047844|NCT00579098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6047845|NCT00579098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5498799|NCT04494828|Sensory System Agents|sensory system agents|mesh-ancestor
5498800|NCT04494828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5498801|NCT04494828|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5498802|NCT04494828|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5498803|NCT04494828|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5498804|NCT04494828|Adrenergic Agents|adrenergic agents|mesh-ancestor
5498805|NCT04494828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5498806|NCT04494828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498807|NCT04494529|Betamethasone|betamethasone|mesh-list
5498808|NCT04494529|Betamethasone Valerate|betamethasone valerate|mesh-list
5498809|NCT04494529|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
6047846|NCT00579098|Antimetabolites|antimetabolites|mesh-ancestor
6047847|NCT00579098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047848|NCT00579098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6047849|NCT00579098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6047850|NCT00579098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6047851|NCT00579111|Fludarabine|fludarabine|mesh-list
6047852|NCT00579111|Busulfan|busulfan|mesh-list
6047853|NCT00579111|Alemtuzumab|alemtuzumab|mesh-list
6047854|NCT00579111|Tacrolimus|tacrolimus|mesh-list
6047855|NCT00579111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6047856|NCT00579111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047857|NCT00579111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5498810|NCT04494529|Betamethasone benzoate|betamethasone benzoate|mesh-list
5498811|NCT04494529|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
5498812|NCT04494529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5498813|NCT04494529|Glucocorticoids|glucocorticoids|mesh-ancestor
5498814|NCT04494529|Hormones|hormones|mesh-ancestor
5498815|NCT04494529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5498816|NCT04494529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498817|NCT04494529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5498818|NCT04494529|Respiratory System Agents|respiratory system agents|mesh-ancestor
5498819|NCT04494789|Fludrocortisone|fludrocortisone|mesh-list
5498820|NCT04494789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5498821|NCT04494503|Rituximab|rituximab|mesh-list
5498822|NCT04494503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5498823|NCT04494503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5498824|NCT04494503|Immunologic Factors|immunologic factors|mesh-ancestor
5498825|NCT04494503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498826|NCT04494503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5498827|NCT04494321|Budesonide|budesonide|mesh-list
5498828|NCT04494321|Formoterol Fumarate|formoterol fumarate|mesh-list
5498829|NCT04494321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5498830|NCT04494321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5498831|NCT04494321|Autonomic Agents|autonomic agents|mesh-ancestor
5498832|NCT04494321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5498833|NCT04494321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498834|NCT04494321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5498835|NCT04494321|Respiratory System Agents|respiratory system agents|mesh-ancestor
5498836|NCT04494321|Glucocorticoids|glucocorticoids|mesh-ancestor
5498837|NCT04494321|Hormones|hormones|mesh-ancestor
5498838|NCT04494321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5498839|NCT04494321|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5498840|NCT04494321|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5498841|NCT04494321|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5498842|NCT04494321|Adrenergic Agents|adrenergic agents|mesh-ancestor
5498843|NCT04494321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5498844|NCT04494321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498845|NCT04494100|Lidocaine|lidocaine|mesh-list
5498846|NCT04494100|Epinephrine|epinephrine|mesh-list
5498847|NCT04494100|Ropivacaine|ropivacaine|mesh-list
5498848|NCT04494100|Anesthetics, Local|anesthetics, local|mesh-ancestor
5498849|NCT04494100|Anesthetics|anesthetics|mesh-ancestor
5498850|NCT04494100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5498851|NCT04494100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498852|NCT04494100|Sensory System Agents|sensory system agents|mesh-ancestor
6047858|NCT00579111|Immunologic Factors|immunologic factors|mesh-ancestor
6047859|NCT00579111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047860|NCT00579111|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6047861|NCT00579111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6047862|NCT00579111|Alkylating Agents|alkylating agents|mesh-ancestor
6047863|NCT00579111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6047864|NCT00579111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6047865|NCT00579111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6047866|NCT00579137|Fludarabine|fludarabine|mesh-list
6047867|NCT00579137|Alemtuzumab|alemtuzumab|mesh-list
6047868|NCT00579137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6047869|NCT00579137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6047870|NCT00579280|Valproic Acid|valproic acid|mesh-list
6047871|NCT00579280|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6047872|NCT00579280|Antidepressive Agents|antidepressive agents|mesh-ancestor
6047873|NCT00579280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6047874|NCT00579280|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6047875|NCT00579280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6047876|NCT00579280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6047877|NCT00579280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047878|NCT00579280|Anticonvulsants|anticonvulsants|mesh-ancestor
6047879|NCT00579280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6047880|NCT00579280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047881|NCT00579280|GABA Agents|gaba agents|mesh-ancestor
6047882|NCT00579280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6047883|NCT00579280|Antimanic Agents|antimanic agents|mesh-ancestor
6047884|NCT00579345|Vaccines|vaccines|mesh-list
6047885|NCT00579345|Immunologic Factors|immunologic factors|mesh-ancestor
6047886|NCT00579345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047887|NCT00579501|Dexamethasone|dexamethasone|mesh-list
6047888|NCT00579501|Trabectedin|trabectedin|mesh-list
6047889|NCT00579501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6047890|NCT00579501|Antiemetics|antiemetics|mesh-ancestor
6047891|NCT00579501|Autonomic Agents|autonomic agents|mesh-ancestor
6047892|NCT00579501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6047893|NCT00579501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047894|NCT00579501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6047895|NCT00579501|Glucocorticoids|glucocorticoids|mesh-ancestor
6047896|NCT00579501|Hormones|hormones|mesh-ancestor
6047897|NCT00579501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6047898|NCT00579501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6047899|NCT00579501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6047900|NCT00579501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6047901|NCT00579501|Alkylating Agents|alkylating agents|mesh-ancestor
6047902|NCT00579501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047903|NCT00579527|Cyclosporine|cyclosporine|mesh-list
6047904|NCT00579527|Mycophenolic Acid|mycophenolic acid|mesh-list
6047905|NCT00579527|Methylprednisolone|methylprednisolone|mesh-list
6047906|NCT00579527|Prednisolone|prednisolone|mesh-list
6047907|NCT00579527|Tacrolimus|tacrolimus|mesh-list
6047908|NCT00579527|Cyclosporins|cyclosporins|mesh-list
6047909|NCT00579527|Thymoglobulin|thymoglobulin|mesh-list
6047910|NCT00579527|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6047911|NCT00579527|Daclizumab|daclizumab|mesh-list
6047912|NCT00579527|Parathyroid Hormone|parathyroid hormone|mesh-list
6047913|NCT00579527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6047914|NCT00579527|Immunologic Factors|immunologic factors|mesh-ancestor
6047915|NCT00579527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047916|NCT00579527|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6047917|NCT00579527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6047918|NCT00579527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047919|NCT00579527|Antifungal Agents|antifungal agents|mesh-ancestor
6047920|NCT00579527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6047921|NCT00579527|Dermatologic Agents|dermatologic agents|mesh-ancestor
6047922|NCT00579527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6047923|NCT00579527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6047924|NCT00579527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6047925|NCT00579527|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6047926|NCT00579527|Antitubercular Agents|antitubercular agents|mesh-ancestor
6047927|NCT00579527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6047928|NCT00579527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6047929|NCT00579527|Antiemetics|antiemetics|mesh-ancestor
6047930|NCT00579527|Autonomic Agents|autonomic agents|mesh-ancestor
6047931|NCT00579527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6047932|NCT00579527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6047933|NCT00579527|Glucocorticoids|glucocorticoids|mesh-ancestor
6047934|NCT00579527|Hormones|hormones|mesh-ancestor
6047935|NCT00579527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6047936|NCT00579527|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6047937|NCT00579527|Protective Agents|protective agents|mesh-ancestor
6047938|NCT00579527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6047939|NCT00579527|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5498853|NCT04494100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5498854|NCT04494100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5498855|NCT04494100|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5498856|NCT04494100|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6047940|NCT00579553|Progesterone|progesterone|mesh-list
6047941|NCT00579553|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
6047942|NCT00579553|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
6047943|NCT00579553|Progestins|progestins|mesh-ancestor
6047944|NCT00579553|Hormones|hormones|mesh-ancestor
6047945|NCT00579553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6047946|NCT00579553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047947|NCT00579553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6047948|NCT00579553|Hormone Antagonists|hormone antagonists|mesh-ancestor
6047949|NCT00579670|Ziprasidone|ziprasidone|mesh-list
6047950|NCT00579670|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6047951|NCT00579670|Serotonin Agents|serotonin agents|mesh-ancestor
6047952|NCT00579670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6047953|NCT00579670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047954|NCT00579670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047955|NCT00579670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6047956|NCT00579670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6047957|NCT00579670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6047958|NCT00579670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6047959|NCT00579670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6047960|NCT00579670|Dopamine Agents|dopamine agents|mesh-ancestor
6047961|NCT00579813|Pioglitazone|pioglitazone|mesh-list
6047962|NCT00579813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6047963|NCT00579813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047964|NCT00579878|Hydroxychloroquine|hydroxychloroquine|mesh-list
6047965|NCT00579878|Sulfasalazine|sulfasalazine|mesh-list
6047966|NCT00579878|Methotrexate|methotrexate|mesh-list
6047967|NCT00579878|Leflunomide|leflunomide|mesh-list
6047968|NCT00579878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6047969|NCT00579878|Abortifacient Agents|abortifacient agents|mesh-ancestor
6047970|NCT00579878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6047971|NCT00579878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6047972|NCT00579878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6047973|NCT00579878|Antimetabolites|antimetabolites|mesh-ancestor
6047974|NCT00579878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047975|NCT00579878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6047976|NCT00579878|Dermatologic Agents|dermatologic agents|mesh-ancestor
6047977|NCT00579878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6047978|NCT00579878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6047979|NCT00579878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6047980|NCT00579878|Immunologic Factors|immunologic factors|mesh-ancestor
6047981|NCT00579878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6047982|NCT00579878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5498857|NCT04494100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5498858|NCT04494100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498859|NCT04494100|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5498860|NCT04494100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5498861|NCT04494100|Adrenergic Agents|adrenergic agents|mesh-ancestor
5498862|NCT04494100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5498863|NCT04494100|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5498864|NCT04494100|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5498865|NCT04494100|Autonomic Agents|autonomic agents|mesh-ancestor
6047983|NCT00579878|Antimalarials|antimalarials|mesh-ancestor
6047984|NCT00579878|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6047985|NCT00579878|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6047986|NCT00579878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6047987|NCT00579878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6047988|NCT00579878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6047989|NCT00579878|Analgesics|analgesics|mesh-ancestor
6047990|NCT00579878|Sensory System Agents|sensory system agents|mesh-ancestor
6047991|NCT00579878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6047992|NCT00579878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6047993|NCT00579878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6047994|NCT00579982|Lamotrigine|lamotrigine|mesh-list
6047995|NCT00579982|Anticonvulsants|anticonvulsants|mesh-ancestor
6047996|NCT00579982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6047997|NCT00579982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6047998|NCT00579982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6047999|NCT00579982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6048000|NCT00579982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048001|NCT00579982|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5498866|NCT04494100|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5498867|NCT04494100|Respiratory System Agents|respiratory system agents|mesh-ancestor
5498868|NCT04494100|Mydriatics|mydriatics|mesh-ancestor
5498869|NCT04494100|Sympathomimetics|sympathomimetics|mesh-ancestor
5498870|NCT04494100|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5498871|NCT04494438|Rituximab|rituximab|mesh-list
5498872|NCT04494438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5498873|NCT04494438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5498874|NCT04494438|Immunologic Factors|immunologic factors|mesh-ancestor
5498875|NCT04494438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498876|NCT04494438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6048002|NCT00579982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6048003|NCT00579982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6048004|NCT00579982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6458467|NCT00440648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458468|NCT00440661|Diacetylrhein|diacetylrhein|mesh-list
6458469|NCT00440661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6458470|NCT00440674|Paclitaxel|paclitaxel|mesh-list
6458471|NCT00440674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6458472|NCT00440674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6458473|NCT00440674|Tubulin Modulators|tubulin modulators|mesh-ancestor
5498877|NCT04494243|Rabeprazole|rabeprazole|mesh-list
5498878|NCT04494243|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5498879|NCT04494243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5498880|NCT04494243|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5498881|NCT04494243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5498882|NCT04494243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498883|NCT04494399|Interferons|interferons|mesh-list
5498884|NCT04494399|Ribavirin|ribavirin|mesh-list
5498885|NCT04494399|Interferon-beta|interferon-beta|mesh-list
5498886|NCT04494399|Interferon beta-1b|interferon beta-1b|mesh-list
5498887|NCT04494399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5498888|NCT04494399|Antiviral Agents|antiviral agents|mesh-ancestor
5498889|NCT04494399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5498890|NCT04494399|Antimetabolites|antimetabolites|mesh-ancestor
5498891|NCT04494399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498892|NCT04494399|Immunologic Factors|immunologic factors|mesh-ancestor
5498893|NCT04494399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498894|NCT04494399|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5498895|NCT04494126|Tranexamic Acid|tranexamic acid|mesh-list
5498896|NCT04494126|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5498897|NCT04494126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5498898|NCT04494126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498899|NCT04494126|Hemostatics|hemostatics|mesh-ancestor
5498900|NCT04494126|Coagulants|coagulants|mesh-ancestor
5498901|NCT04493931|Rifampin|rifampin|mesh-list
5498902|NCT04493931|Digoxin|digoxin|mesh-list
5498903|NCT04493931|Midazolam|midazolam|mesh-list
5498904|NCT04493931|Cimetidine|cimetidine|mesh-list
5498905|NCT04493931|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6048005|NCT00579982|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6048006|NCT00580034|Alemtuzumab|alemtuzumab|mesh-list
6048007|NCT00580034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6048008|NCT00580034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5498906|NCT04493931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5498907|NCT04493931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6048009|NCT00580047|Calcium, Dietary|calcium, dietary|mesh-list
6048010|NCT00580047|Vitamin D|vitamin d|mesh-list
6048011|NCT00580047|Zoledronic Acid|zoledronic acid|mesh-list
6048012|NCT00580047|Alendronate|alendronate|mesh-list
6048013|NCT00580047|Calcium Carbonate|calcium carbonate|mesh-list
6048014|NCT00580047|Calcium|calcium|mesh-list
6048015|NCT00580047|Vitamins|vitamins|mesh-ancestor
6048016|NCT00580047|Micronutrients|micronutrients|mesh-ancestor
6048017|NCT00580047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048018|NCT00580047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6048019|NCT00580047|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6048020|NCT00580047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048021|NCT00580047|Antacids|antacids|mesh-ancestor
6048022|NCT00580047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6048023|NCT00580073|Leucovorin|leucovorin|mesh-list
6048024|NCT00580073|Fluorouracil|fluorouracil|mesh-list
6048025|NCT00580073|Oxaliplatin|oxaliplatin|mesh-list
6048026|NCT00580073|Cetuximab|cetuximab|mesh-list
6048027|NCT00580073|Antimetabolites|antimetabolites|mesh-ancestor
6048028|NCT00580073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048029|NCT00580073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6048030|NCT00580073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6048031|NCT00580073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6048032|NCT00580073|Immunologic Factors|immunologic factors|mesh-ancestor
6048033|NCT00580073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048034|NCT00580073|Antidotes|antidotes|mesh-ancestor
6048035|NCT00580073|Protective Agents|protective agents|mesh-ancestor
5498908|NCT04493931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498909|NCT04493931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5498910|NCT04493931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5498911|NCT04493931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5498912|NCT04493931|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5498913|NCT04493931|Anesthetics, General|anesthetics, general|mesh-ancestor
5498914|NCT04493931|Anesthetics|anesthetics|mesh-ancestor
6048036|NCT00580073|Vitamin B Complex|vitamin b complex|mesh-ancestor
6048037|NCT00580073|Vitamins|vitamins|mesh-ancestor
6048038|NCT00580073|Micronutrients|micronutrients|mesh-ancestor
6048039|NCT00580073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6048040|NCT00580151|Clonidine|clonidine|mesh-list
6048041|NCT00580151|Analgesics|analgesics|mesh-ancestor
6048042|NCT00580151|Sensory System Agents|sensory system agents|mesh-ancestor
6048043|NCT00580151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6048044|NCT00580151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048045|NCT00580151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6048046|NCT00580151|Sympatholytics|sympatholytics|mesh-ancestor
6048047|NCT00580151|Autonomic Agents|autonomic agents|mesh-ancestor
6048048|NCT00580151|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5498915|NCT04493931|GABA Modulators|gaba modulators|mesh-ancestor
5498916|NCT04493931|GABA Agents|gaba agents|mesh-ancestor
5498917|NCT04493931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5498918|NCT04493931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498919|NCT04493931|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5498920|NCT04493931|Antitubercular Agents|antitubercular agents|mesh-ancestor
5498921|NCT04493931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5498922|NCT04493931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5498923|NCT04493931|Leprostatic Agents|leprostatic agents|mesh-ancestor
6048049|NCT00580151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6048050|NCT00580151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5498924|NCT04493931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5498925|NCT04493931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6048051|NCT00580151|Adrenergic Agents|adrenergic agents|mesh-ancestor
6048052|NCT00580151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6048053|NCT00580151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048054|NCT00580229|Prednisone|prednisone|mesh-list
6048055|NCT00580229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6048056|NCT00580229|Glucocorticoids|glucocorticoids|mesh-ancestor
6048057|NCT00580229|Hormones|hormones|mesh-ancestor
6048058|NCT00580229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6048059|NCT00580229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048060|NCT00580229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6048061|NCT00580229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6048062|NCT00580294|Oxymorphone|oxymorphone|mesh-list
6048063|NCT00580294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6048064|NCT00580294|Narcotics|narcotics|mesh-ancestor
6048065|NCT00580294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6048066|NCT00580294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048067|NCT00580294|Analgesics|analgesics|mesh-ancestor
6048068|NCT00580294|Sensory System Agents|sensory system agents|mesh-ancestor
6048069|NCT00580294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6048070|NCT00580294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6048071|NCT00580333|Paclitaxel|paclitaxel|mesh-list
6048072|NCT00580333|Cyclophosphamide|cyclophosphamide|mesh-list
6048073|NCT00580333|Bevacizumab|bevacizumab|mesh-list
6048074|NCT00580333|Doxorubicin|doxorubicin|mesh-list
6048075|NCT00580333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6048076|NCT00580333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5498926|NCT04493931|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5498927|NCT04493931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5498928|NCT04493931|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5498929|NCT04493931|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5498930|NCT04493931|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5498931|NCT04493931|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5498932|NCT04493931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5498933|NCT04493931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5498934|NCT04493931|Protective Agents|protective agents|mesh-ancestor
5498935|NCT04493931|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5498936|NCT04493931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5498937|NCT04493931|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5498938|NCT04493931|Histamine Antagonists|histamine antagonists|mesh-ancestor
5498939|NCT04493931|Histamine Agents|histamine agents|mesh-ancestor
5498940|NCT04493931|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5503416|NCT04459988|Ocrelizumab|ocrelizumab|mesh-list
5498941|NCT04493931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5498942|NCT04493619|Carboplatin|carboplatin|mesh-list
5498943|NCT04493619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5498944|NCT04493554|Vasopressins|vasopressins|mesh-list
6048077|NCT00580333|Tubulin Modulators|tubulin modulators|mesh-ancestor
6048078|NCT00580333|Antimitotic Agents|antimitotic agents|mesh-ancestor
6048079|NCT00580333|Mitosis Modulators|mitosis modulators|mesh-ancestor
6048080|NCT00580333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048081|NCT00580333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6048082|NCT00580333|Immunologic Factors|immunologic factors|mesh-ancestor
6048083|NCT00580333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048084|NCT00580333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6048085|NCT00580333|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6048086|NCT00580333|Alkylating Agents|alkylating agents|mesh-ancestor
6048087|NCT00580333|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6048088|NCT00580333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6048089|NCT00580333|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6048090|NCT00580333|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6048091|NCT00580333|Growth Substances|growth substances|mesh-ancestor
6048092|NCT00580333|Growth Inhibitors|growth inhibitors|mesh-ancestor
6048093|NCT00580333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6048094|NCT00580333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6048095|NCT00580333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6048096|NCT00580333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6048097|NCT00580372|Cyclophosphamide|cyclophosphamide|mesh-list
6048098|NCT00580372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6048099|NCT00580372|Immunologic Factors|immunologic factors|mesh-ancestor
6048100|NCT00580372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048101|NCT00580372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6048102|NCT00580372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6048103|NCT00580372|Alkylating Agents|alkylating agents|mesh-ancestor
6048104|NCT00580372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048105|NCT00580372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6048106|NCT00580372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6048107|NCT00580398|Varenicline|varenicline|mesh-list
6048108|NCT00580398|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5498945|NCT04493554|Arginine Vasopressin|arginine vasopressin|mesh-list
6048109|NCT00580398|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6048110|NCT00580398|Cholinergic Agents|cholinergic agents|mesh-ancestor
6048111|NCT00580398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6048112|NCT00580398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048113|NCT00580398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048114|NCT00580606|Glycerol|glycerol|mesh-list
6048115|NCT00580606|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6048116|NCT00580606|Protective Agents|protective agents|mesh-ancestor
6048117|NCT00580606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053923|NCT00599755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053924|NCT00599755|Antiviral Agents|antiviral agents|mesh-ancestor
6053925|NCT00599755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6053926|NCT00599755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6053927|NCT00599755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6053928|NCT00599755|Immunologic Factors|immunologic factors|mesh-ancestor
6053929|NCT00599755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053930|NCT00599924|Leucovorin|leucovorin|mesh-list
6053931|NCT00599924|Sunitinib|sunitinib|mesh-list
6053932|NCT00599924|Fluorouracil|fluorouracil|mesh-list
6053933|NCT00599924|Oxaliplatin|oxaliplatin|mesh-list
6053934|NCT00599924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6053935|NCT00599924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6053936|NCT00599924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6053937|NCT00599924|Growth Substances|growth substances|mesh-ancestor
6053938|NCT00599924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498946|NCT04493554|Hemostatics|hemostatics|mesh-ancestor
5498947|NCT04493554|Coagulants|coagulants|mesh-ancestor
5498948|NCT04493554|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6048118|NCT00580645|Varenicline|varenicline|mesh-list
6048119|NCT00580645|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6048120|NCT00580645|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6048121|NCT00580645|Cholinergic Agents|cholinergic agents|mesh-ancestor
6048122|NCT00580645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6048123|NCT00580645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048124|NCT00580645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048125|NCT00580788|Parathyroid Hormone|parathyroid hormone|mesh-list
6048126|NCT00580788|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
6048127|NCT00580788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048128|NCT00580788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6048129|NCT00580801|Interferons|interferons|mesh-list
6048130|NCT00580801|Ribavirin|ribavirin|mesh-list
6048131|NCT00580801|Interferon-alpha|interferon-alpha|mesh-list
6048132|NCT00580801|Interferon alpha-2|interferon alpha-2|mesh-list
6048133|NCT00580801|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6048134|NCT00580801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6048135|NCT00580801|Antiviral Agents|antiviral agents|mesh-ancestor
6048136|NCT00580801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6048137|NCT00580801|Antimetabolites|antimetabolites|mesh-ancestor
6048138|NCT00580801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048139|NCT00580801|Immunologic Factors|immunologic factors|mesh-ancestor
6048140|NCT00580801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048141|NCT00580840|Certolizumab Pegol|certolizumab pegol|mesh-list
5498949|NCT04493554|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5498950|NCT04493554|Natriuretic Agents|natriuretic agents|mesh-ancestor
5498951|NCT04493554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498952|NCT04493515|Oxytocin|oxytocin|mesh-list
5498953|NCT04493515|Oxytocics|oxytocics|mesh-ancestor
5498954|NCT04493515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5498955|NCT04493515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498956|NCT04493489|Propranolol|propranolol|mesh-list
5498957|NCT04493489|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5498958|NCT04493489|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5498959|NCT04493489|Adrenergic Agents|adrenergic agents|mesh-ancestor
5498960|NCT04493489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5498961|NCT04493489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048142|NCT00580840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6048143|NCT00580840|Immunologic Factors|immunologic factors|mesh-ancestor
6048144|NCT00580840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048145|NCT00580840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6048146|NCT00580853|Bupropion|bupropion|mesh-list
6048147|NCT00580853|Varenicline|varenicline|mesh-list
5498962|NCT04493489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498963|NCT04493489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5498964|NCT04493489|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6048148|NCT00580853|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6048149|NCT00580853|Antidepressive Agents|antidepressive agents|mesh-ancestor
6048150|NCT00580853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6048151|NCT00580853|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6048152|NCT00580853|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6048153|NCT00580853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6048154|NCT00580853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048155|NCT00580853|Dopamine Agents|dopamine agents|mesh-ancestor
6048156|NCT00580853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6048157|NCT00580853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048158|NCT00580853|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6048159|NCT00580853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6048160|NCT00580853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6048161|NCT00580853|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5498965|NCT04493489|Vasodilator Agents|vasodilator agents|mesh-ancestor
5503417|NCT04459988|Immunologic Factors|immunologic factors|mesh-ancestor
5503418|NCT04459988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503419|NCT04459312|Antibodies|antibodies|mesh-list
5503420|NCT04459312|Immunologic Factors|immunologic factors|mesh-ancestor
5503421|NCT04459312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503422|NCT04459078|Apatinib|apatinib|mesh-list
5503423|NCT04459078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5503424|NCT04459078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5503425|NCT04459078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5503426|NCT04459078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5503427|NCT04459078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048162|NCT00580853|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6048163|NCT00580853|Cholinergic Agents|cholinergic agents|mesh-ancestor
6048164|NCT00580957|Trimethaphan|trimethaphan|mesh-list
6048165|NCT00580957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6048166|NCT00580957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6048167|NCT00580957|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
6048168|NCT00580957|Autonomic Agents|autonomic agents|mesh-ancestor
6048169|NCT00580957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6048170|NCT00580957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048171|NCT00580957|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
6048172|NCT00580957|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6048173|NCT00580957|Cholinergic Agents|cholinergic agents|mesh-ancestor
6048174|NCT00580957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6048175|NCT00580957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048176|NCT00580970|Lovastatin|lovastatin|mesh-list
6048177|NCT00580970|L 647318|l 647318|mesh-list
6048178|NCT00580970|Dihydromevinolin|dihydromevinolin|mesh-list
6048179|NCT00580970|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6048180|NCT00580970|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6048181|NCT00580970|Antimetabolites|antimetabolites|mesh-ancestor
6048182|NCT00580970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048183|NCT00580970|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6048184|NCT00580970|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6048185|NCT00580970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6048186|NCT00580983|Paclitaxel|paclitaxel|mesh-list
6048187|NCT00580983|Carboplatin|carboplatin|mesh-list
6048188|NCT00580983|Fluorouracil|fluorouracil|mesh-list
6048189|NCT00580983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6048190|NCT00580983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6048191|NCT00580983|Tubulin Modulators|tubulin modulators|mesh-ancestor
6048192|NCT00580983|Antimitotic Agents|antimitotic agents|mesh-ancestor
5498966|NCT04493528|Lidocaine|lidocaine|mesh-list
5498967|NCT04493528|Anesthetics, Local|anesthetics, local|mesh-ancestor
5498968|NCT04493528|Anesthetics|anesthetics|mesh-ancestor
5498969|NCT04493528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5498970|NCT04493528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498971|NCT04493528|Sensory System Agents|sensory system agents|mesh-ancestor
5498972|NCT04493528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5498973|NCT04493528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6048193|NCT00580983|Mitosis Modulators|mitosis modulators|mesh-ancestor
6048194|NCT00580983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048195|NCT00580983|Antimetabolites|antimetabolites|mesh-ancestor
6048196|NCT00580983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6048197|NCT00580983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6048198|NCT00580983|Immunologic Factors|immunologic factors|mesh-ancestor
6048199|NCT00580983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048200|NCT00581048|Vitamin E|vitamin e|mesh-list
6048201|NCT00581048|Tocopherols|tocopherols|mesh-list
6048202|NCT00581048|alpha-Tocopherol|alpha-tocopherol|mesh-list
6048203|NCT00581048|Vitamins|vitamins|mesh-ancestor
6048204|NCT00581048|Micronutrients|micronutrients|mesh-ancestor
6048205|NCT00581048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048206|NCT00581048|Antioxidants|antioxidants|mesh-ancestor
6048207|NCT00581048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048208|NCT00581048|Protective Agents|protective agents|mesh-ancestor
6048209|NCT00581061|Solifenacin Succinate|solifenacin succinate|mesh-list
6048210|NCT00581061|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6048211|NCT00581061|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6048212|NCT00581061|Cholinergic Agents|cholinergic agents|mesh-ancestor
6048213|NCT00581061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6048214|NCT00581061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048215|NCT00581061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048216|NCT00581061|Urological Agents|urological agents|mesh-ancestor
6048217|NCT00581100|Etanercept|etanercept|mesh-list
6048218|NCT00581100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6048219|NCT00581100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6048220|NCT00581100|Analgesics|analgesics|mesh-ancestor
6048221|NCT00581100|Sensory System Agents|sensory system agents|mesh-ancestor
6048222|NCT00581100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6048223|NCT00581100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048224|NCT00581100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6048225|NCT00581100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6048226|NCT00581100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6048227|NCT00581100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6048228|NCT00581100|Immunologic Factors|immunologic factors|mesh-ancestor
6048229|NCT00581360|Doxorubicin|doxorubicin|mesh-list
6048230|NCT00581360|Bortezomib|bortezomib|mesh-list
6048231|NCT00581360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6048232|NCT00581360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6048233|NCT00581360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6048234|NCT00581360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6048235|NCT00581360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6048236|NCT00581360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048237|NCT00581542|Moxifloxacin|moxifloxacin|mesh-list
6048238|NCT00581542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6048239|NCT00581542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5498974|NCT04493528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5498975|NCT04493528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5498976|NCT04493528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5498977|NCT04493528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498978|NCT04493333|Calcium polycarbophil|calcium polycarbophil|mesh-list
5498979|NCT04493333|Psyllium|psyllium|mesh-list
5498980|NCT04493333|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
5498981|NCT04493333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5498982|NCT04493333|Immunologic Factors|immunologic factors|mesh-ancestor
5498983|NCT04493333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498984|NCT04493333|Antidiarrheals|antidiarrheals|mesh-ancestor
5498985|NCT04493333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5498986|NCT04493333|Cathartics|cathartics|mesh-ancestor
5498987|NCT04493229|Oxytocin|oxytocin|mesh-list
5498988|NCT04493229|Oxytocics|oxytocics|mesh-ancestor
5498989|NCT04493229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5498990|NCT04493229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5498991|NCT04493203|Nivolumab|nivolumab|mesh-list
5498992|NCT04493203|Axitinib|axitinib|mesh-list
5498993|NCT04493203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5498994|NCT04493203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5498995|NCT04493203|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5498996|NCT04493203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5498997|NCT04493203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5498998|NCT04493203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5498999|NCT04493125|Mosapride|mosapride|mesh-list
5499000|NCT04493125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499001|NCT04493125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5499002|NCT04493125|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5499003|NCT04493125|Serotonin Agents|serotonin agents|mesh-ancestor
5499004|NCT04493125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6048240|NCT00581542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6048241|NCT00581542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6048242|NCT00581542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6048243|NCT00581542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048244|NCT00581542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6048245|NCT00581555|Etanercept|etanercept|mesh-list
5499005|NCT04493125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499006|NCT04493151|Imipenem|imipenem|mesh-list
5499007|NCT04493151|Relebactam|relebactam|mesh-list
5499008|NCT04493151|Cilastatin|cilastatin|mesh-list
5499009|NCT04493151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5499010|NCT04493151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5499011|NCT04493151|Protease Inhibitors|protease inhibitors|mesh-ancestor
5499012|NCT04493151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6048246|NCT00581555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6048247|NCT00581555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6048248|NCT00581555|Analgesics|analgesics|mesh-ancestor
6048249|NCT00581555|Sensory System Agents|sensory system agents|mesh-ancestor
6048250|NCT00581555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6048251|NCT00581555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048252|NCT00581555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6048253|NCT00581555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6048254|NCT00581555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6048255|NCT00581555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6048256|NCT00581555|Immunologic Factors|immunologic factors|mesh-ancestor
6048257|NCT00581776|Dexamethasone|dexamethasone|mesh-list
6048258|NCT00581776|Cyclophosphamide|cyclophosphamide|mesh-list
6048259|NCT00581776|Rituximab|rituximab|mesh-list
6048260|NCT00581776|Doxorubicin|doxorubicin|mesh-list
6048261|NCT00581776|Vincristine|vincristine|mesh-list
6048262|NCT00581776|Bortezomib|bortezomib|mesh-list
6048263|NCT00581776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6048264|NCT00581776|Immunologic Factors|immunologic factors|mesh-ancestor
6048265|NCT00581776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048266|NCT00581776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6048267|NCT00581776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6048268|NCT00581776|Alkylating Agents|alkylating agents|mesh-ancestor
6048269|NCT00581776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048270|NCT00581776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6048271|NCT00581776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6048272|NCT00581776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6048273|NCT00581776|Antiemetics|antiemetics|mesh-ancestor
6048274|NCT00581776|Autonomic Agents|autonomic agents|mesh-ancestor
5499013|NCT04493151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499014|NCT04493151|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5499015|NCT04493398|Erythritol|erythritol|mesh-list
5499016|NCT04493398|Vasodilator Agents|vasodilator agents|mesh-ancestor
5499017|NCT04493463|Methylprednisolone|methylprednisolone|mesh-list
5499018|NCT04493463|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5499019|NCT04493463|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5499020|NCT04493463|Prednisolone|prednisolone|mesh-list
5499021|NCT04493463|Prednisolone acetate|prednisolone acetate|mesh-list
5499022|NCT04493463|Ropivacaine|ropivacaine|mesh-list
5499023|NCT04493463|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5499024|NCT04493463|Prednisolone phosphate|prednisolone phosphate|mesh-list
5499025|NCT04493463|Anesthetics, Local|anesthetics, local|mesh-ancestor
5499026|NCT04493463|Anesthetics|anesthetics|mesh-ancestor
5499027|NCT04493463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5499028|NCT04493463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048275|NCT00581776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6048276|NCT00581776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6048277|NCT00581776|Glucocorticoids|glucocorticoids|mesh-ancestor
6048278|NCT00581776|Hormones|hormones|mesh-ancestor
6048279|NCT00581776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6048280|NCT00581776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6048281|NCT00581776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6048282|NCT00581776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6048283|NCT00581776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6048284|NCT00581776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6048285|NCT00581776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6048286|NCT00581776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6048287|NCT00581776|Tubulin Modulators|tubulin modulators|mesh-ancestor
6048288|NCT00581776|Antimitotic Agents|antimitotic agents|mesh-ancestor
6048289|NCT00581776|Mitosis Modulators|mitosis modulators|mesh-ancestor
5499029|NCT04493463|Sensory System Agents|sensory system agents|mesh-ancestor
5499030|NCT04493463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5499031|NCT04493463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5499032|NCT04493463|Antiemetics|antiemetics|mesh-ancestor
5499033|NCT04493463|Autonomic Agents|autonomic agents|mesh-ancestor
6048290|NCT00581828|Vitamin D|vitamin d|mesh-list
6048291|NCT00581828|Ergocalciferols|ergocalciferols|mesh-list
6048292|NCT00581828|Vitamins|vitamins|mesh-list
6048293|NCT00581828|Micronutrients|micronutrients|mesh-ancestor
6048294|NCT00581828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048295|NCT00581828|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6048296|NCT00581828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6048297|NCT00581867|Insulin|insulin|mesh-list
6048298|NCT00581867|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6048299|NCT00581867|Insulin Aspart|insulin aspart|mesh-list
6048300|NCT00581867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6048301|NCT00581867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048302|NCT00581893|Phenytoin|phenytoin|mesh-list
6048303|NCT00581893|Anticonvulsants|anticonvulsants|mesh-ancestor
6048304|NCT00581893|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6048305|NCT00581893|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6048306|NCT00581893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6048307|NCT00581893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048308|NCT00581893|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6048309|NCT00581893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6048310|NCT00581919|Acetylcarnitine|acetylcarnitine|mesh-list
6048311|NCT00581919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048312|NCT00581919|Vitamin B Complex|vitamin b complex|mesh-ancestor
6048313|NCT00581919|Vitamins|vitamins|mesh-ancestor
6048314|NCT00581919|Micronutrients|micronutrients|mesh-ancestor
6048315|NCT00581919|Nootropic Agents|nootropic agents|mesh-ancestor
6048316|NCT00581971|Celecoxib|celecoxib|mesh-list
6048317|NCT00581971|Paclitaxel|paclitaxel|mesh-list
6048318|NCT00581971|Carboplatin|carboplatin|mesh-list
6048319|NCT00581971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6048320|NCT00581971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6048321|NCT00581971|Tubulin Modulators|tubulin modulators|mesh-ancestor
5499034|NCT04493463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5499035|NCT04493463|Glucocorticoids|glucocorticoids|mesh-ancestor
5499036|NCT04493463|Hormones|hormones|mesh-ancestor
5499037|NCT04493463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5499038|NCT04493463|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5499039|NCT04493463|Protective Agents|protective agents|mesh-ancestor
5499040|NCT04493463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5499041|NCT04493463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5499042|NCT04493281|Edaravone|edaravone|mesh-list
5499043|NCT04493281|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6048322|NCT00581971|Antimitotic Agents|antimitotic agents|mesh-ancestor
6048323|NCT00581971|Mitosis Modulators|mitosis modulators|mesh-ancestor
6048324|NCT00581971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048325|NCT00581971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6048326|NCT00581971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6048327|NCT00581971|Analgesics|analgesics|mesh-ancestor
6048328|NCT00581971|Sensory System Agents|sensory system agents|mesh-ancestor
6048329|NCT00581971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6048330|NCT00581971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048331|NCT00581971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6048332|NCT00581971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6048333|NCT00581971|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6048334|NCT00581971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6048335|NCT00581971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6048336|NCT00582010|Nitric Oxide|nitric oxide|mesh-list
6048337|NCT00582010|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6048338|NCT00582010|Autonomic Agents|autonomic agents|mesh-ancestor
6048339|NCT00582010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6048340|NCT00582010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048341|NCT00582010|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6048342|NCT00582010|Respiratory System Agents|respiratory system agents|mesh-ancestor
6048343|NCT00582010|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6048344|NCT00582010|Antioxidants|antioxidants|mesh-ancestor
6655290|NCT01463046|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6655291|NCT01463046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6655292|NCT01463046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6655293|NCT01463046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6655294|NCT01463046|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6655295|NCT01463072|Paclitaxel|paclitaxel|mesh-list
6655296|NCT01463072|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6655297|NCT01463072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6048345|NCT00582010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048346|NCT00582010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6048347|NCT00582010|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6048348|NCT00582010|Vasodilator Agents|vasodilator agents|mesh-ancestor
6048349|NCT00582010|Gasotransmitters|gasotransmitters|mesh-ancestor
6048350|NCT00582010|Protective Agents|protective agents|mesh-ancestor
6048351|NCT00582075|Temozolomide|temozolomide|mesh-list
6048352|NCT00582075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6048353|NCT00582075|Alkylating Agents|alkylating agents|mesh-ancestor
6048354|NCT00582075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048355|NCT00582075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6048356|NCT00582114|Atenolol|atenolol|mesh-list
6048357|NCT00582114|Lisinopril|lisinopril|mesh-list
6048358|NCT00582114|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6048359|NCT00582114|Protease Inhibitors|protease inhibitors|mesh-ancestor
6048360|NCT00582114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6048361|NCT00582114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048362|NCT00582114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6048363|NCT00582114|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6048364|NCT00582114|Protective Agents|protective agents|mesh-ancestor
6048365|NCT00582114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048366|NCT00582114|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6048367|NCT00582114|Sympatholytics|sympatholytics|mesh-ancestor
6048368|NCT00582114|Autonomic Agents|autonomic agents|mesh-ancestor
6048369|NCT00582114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6048370|NCT00582114|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6048371|NCT00582114|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6048372|NCT00582114|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6048373|NCT00582114|Adrenergic Agents|adrenergic agents|mesh-ancestor
6048374|NCT00582114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6048375|NCT00582166|Rituximab|rituximab|mesh-list
6048376|NCT00582166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6048377|NCT00582166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6048378|NCT00582166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6048379|NCT00582166|Immunologic Factors|immunologic factors|mesh-ancestor
5499044|NCT04493281|Antioxidants|antioxidants|mesh-ancestor
5499045|NCT04493281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499046|NCT04493281|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5499047|NCT04493281|Protective Agents|protective agents|mesh-ancestor
5499048|NCT04493281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499049|NCT04493099|Decitabine|decitabine|mesh-list
5499050|NCT04493099|Venetoclax|venetoclax|mesh-list
5499051|NCT04493099|Alvocidib|alvocidib|mesh-list
6048380|NCT00582166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048381|NCT00582166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6048382|NCT00582205|Paclitaxel|paclitaxel|mesh-list
6048383|NCT00582205|Cisplatin|cisplatin|mesh-list
6048384|NCT00582205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6048385|NCT00582205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6048386|NCT00582205|Tubulin Modulators|tubulin modulators|mesh-ancestor
6048387|NCT00582205|Antimitotic Agents|antimitotic agents|mesh-ancestor
6048388|NCT00582205|Mitosis Modulators|mitosis modulators|mesh-ancestor
6048389|NCT00582205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048390|NCT00582309|Insulin|insulin|mesh-list
6048391|NCT00582309|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6048392|NCT00582309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6048393|NCT00582309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048394|NCT00582400|Arsenic Trioxide|arsenic trioxide|mesh-list
6048395|NCT00582400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6048396|NCT00582426|Octreotide|octreotide|mesh-list
6048397|NCT00582426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6048398|NCT00582426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6048399|NCT00582426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6048400|NCT00582491|Modafinil|modafinil|mesh-list
6048401|NCT00582491|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6048402|NCT00582491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048403|NCT00582491|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6048404|NCT00582491|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6048405|NCT00582491|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6048406|NCT00582491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048407|NCT00582556|Zoledronic Acid|zoledronic acid|mesh-list
6048408|NCT00582556|Leuprolide|leuprolide|mesh-list
6048409|NCT00582556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6048410|NCT00582556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048411|NCT00582556|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6048412|NCT00582556|Fertility Agents|fertility agents|mesh-ancestor
6048413|NCT00582556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6048414|NCT00582556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6048415|NCT00582556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6048416|NCT00582608|N-(2-aminoethyl)-5-isoquinolinesulfonamide|n-(2-aminoethyl)-5-isoquinolinesulfonamide|mesh-list
6048417|NCT00582608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6048418|NCT00582608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6048419|NCT00582608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048420|NCT00582660|Celecoxib|celecoxib|mesh-list
6048421|NCT00582660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6048422|NCT00582660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6048423|NCT00582660|Analgesics|analgesics|mesh-ancestor
6048424|NCT00582660|Sensory System Agents|sensory system agents|mesh-ancestor
6048425|NCT00582660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6048426|NCT00582660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048427|NCT00582660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6048428|NCT00582660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6048429|NCT00582660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6048430|NCT00582660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6048431|NCT00582660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6048432|NCT00582660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048433|NCT00582738|Everolimus|everolimus|mesh-list
6048434|NCT00582738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6048435|NCT00582738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5499052|NCT04493099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5499053|NCT04493099|Antimetabolites|antimetabolites|mesh-ancestor
5499054|NCT04493099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499055|NCT04493099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5499056|NCT04493099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5499057|NCT04493099|Growth Inhibitors|growth inhibitors|mesh-ancestor
5499058|NCT04493099|Growth Substances|growth substances|mesh-ancestor
5499059|NCT04493099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499060|NCT04493099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5499061|NCT04493164|Cytarabine|cytarabine|mesh-list
5499062|NCT04493164|Daunorubicin|daunorubicin|mesh-list
5499063|NCT04493164|Ivosidenib|ivosidenib|mesh-list
5499064|NCT04493164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5499065|NCT04493164|Antimetabolites|antimetabolites|mesh-ancestor
5499066|NCT04493164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499067|NCT04493164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5499068|NCT04493164|Antiviral Agents|antiviral agents|mesh-ancestor
5499069|NCT04493164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5499070|NCT04493164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5499071|NCT04493164|Immunologic Factors|immunologic factors|mesh-ancestor
5499072|NCT04493164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499073|NCT04493164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5499074|NCT04493164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5499075|NCT04493164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5499076|NCT04493164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5499077|NCT04493073|Mitomycins|mitomycins|mesh-list
5499078|NCT04493073|Mitomycin|mitomycin|mesh-list
5499079|NCT04493073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5499080|NCT04493073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5499081|NCT04493073|Alkylating Agents|alkylating agents|mesh-ancestor
5499082|NCT04493073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499083|NCT04493073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5499084|NCT04493073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5499085|NCT04493060|Niraparib|niraparib|mesh-list
5499086|NCT04493060|Immunoglobulins|immunoglobulins|mesh-list
5499087|NCT04493060|Immunoglobulin G|immunoglobulin g|mesh-list
5499088|NCT04493060|Immunologic Factors|immunologic factors|mesh-ancestor
5499089|NCT04493060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499090|NCT04493060|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5499091|NCT04493060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5499092|NCT04493060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499093|NCT04493060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5499094|NCT04492774|Dexamethasone|dexamethasone|mesh-list
5499095|NCT04492774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5499096|NCT04492774|Antiemetics|antiemetics|mesh-ancestor
5499097|NCT04492774|Autonomic Agents|autonomic agents|mesh-ancestor
5499098|NCT04492774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5499099|NCT04492774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499100|NCT04492774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5499101|NCT04492774|Glucocorticoids|glucocorticoids|mesh-ancestor
5499102|NCT04492774|Hormones|hormones|mesh-ancestor
5499103|NCT04492774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5499104|NCT04492774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5499105|NCT04492774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5499106|NCT04492813|Remifentanil|remifentanil|mesh-list
5499107|NCT04492813|Propofol|propofol|mesh-list
5499108|NCT04492813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5499109|NCT04492813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5499110|NCT04492813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499111|NCT04492813|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5499112|NCT04492813|Anesthetics, General|anesthetics, general|mesh-ancestor
5499113|NCT04492813|Anesthetics|anesthetics|mesh-ancestor
5499114|NCT04492813|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5499115|NCT04492813|Narcotics|narcotics|mesh-ancestor
5499116|NCT04492813|Analgesics|analgesics|mesh-ancestor
6048436|NCT00582738|Immunologic Factors|immunologic factors|mesh-ancestor
6048437|NCT00582738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048438|NCT00582790|Zoledronic Acid|zoledronic acid|mesh-list
6048439|NCT00582790|Interleukin-2|interleukin-2|mesh-list
6048440|NCT00582790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6048441|NCT00582790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6048442|NCT00582790|Analgesics|analgesics|mesh-ancestor
6048443|NCT00582790|Sensory System Agents|sensory system agents|mesh-ancestor
6048444|NCT00582790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6048445|NCT00582790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048446|NCT00582790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6048447|NCT00582894|Fludarabine|fludarabine|mesh-list
6048448|NCT00582894|Alemtuzumab|alemtuzumab|mesh-list
6048449|NCT00582894|Busulfan|busulfan|mesh-list
6048450|NCT00582894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6048451|NCT00582894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048452|NCT00582894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6048453|NCT00582894|Immunologic Factors|immunologic factors|mesh-ancestor
6048454|NCT00582894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048455|NCT00582894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6458474|NCT00440674|Antimitotic Agents|antimitotic agents|mesh-ancestor
6458475|NCT00440674|Mitosis Modulators|mitosis modulators|mesh-ancestor
5499117|NCT04492813|Sensory System Agents|sensory system agents|mesh-ancestor
5499118|NCT04492813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6048456|NCT00582894|Alkylating Agents|alkylating agents|mesh-ancestor
6048457|NCT00582894|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6048458|NCT00582894|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6048459|NCT00582907|Rilonacept|rilonacept|mesh-list
6048460|NCT00582907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6048461|NCT00582933|Vidarabine|vidarabine|mesh-list
6048462|NCT00582933|Fludarabine|fludarabine|mesh-list
6048463|NCT00582933|Fludarabine phosphate|fludarabine phosphate|mesh-list
6048464|NCT00582933|Melphalan|melphalan|mesh-list
6048465|NCT00582933|Busulfan|busulfan|mesh-list
6048466|NCT00582933|Lenograstim|lenograstim|mesh-list
6048467|NCT00582933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6048468|NCT00582933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6048469|NCT00582933|Antimetabolites|antimetabolites|mesh-ancestor
6048470|NCT00582933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048471|NCT00582933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6048472|NCT00582933|Immunologic Factors|immunologic factors|mesh-ancestor
6048473|NCT00582933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499119|NCT04492709|Midazolam|midazolam|mesh-list
5499120|NCT04492709|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5499121|NCT04492709|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5499122|NCT04492709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5499123|NCT04492709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499124|NCT04492709|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5499125|NCT04492709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5499126|NCT04492709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6048474|NCT00582933|Antiviral Agents|antiviral agents|mesh-ancestor
6048475|NCT00582933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6048476|NCT00582933|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6048477|NCT00582933|Alkylating Agents|alkylating agents|mesh-ancestor
6048478|NCT00582933|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6048479|NCT00582933|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6048480|NCT00582972|Omeprazole|omeprazole|mesh-list
6048481|NCT00582972|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6048482|NCT00582972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6048483|NCT00582972|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6048484|NCT00582972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6048485|NCT00582972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499127|NCT04492709|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5499128|NCT04492709|Anesthetics, General|anesthetics, general|mesh-ancestor
5499129|NCT04492709|Anesthetics|anesthetics|mesh-ancestor
5499130|NCT04492709|GABA Modulators|gaba modulators|mesh-ancestor
5499131|NCT04492709|GABA Agents|gaba agents|mesh-ancestor
5499132|NCT04492709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5499133|NCT04492709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499134|NCT04492514|Mavrilimumab|mavrilimumab|mesh-list
5499135|NCT04492514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5499136|NCT04492319|Neostigmine|neostigmine|mesh-list
5499137|NCT04492319|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5499138|NCT04492319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5499139|NCT04492319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499140|NCT04492319|Cholinergic Agents|cholinergic agents|mesh-ancestor
5499141|NCT04492319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5499142|NCT04492319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499143|NCT04492319|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5499144|NCT04492319|Autonomic Agents|autonomic agents|mesh-ancestor
5499145|NCT04492319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5499146|NCT04492280|Hydrocortisone|hydrocortisone|mesh-list
5499147|NCT04492280|Fludrocortisone|fludrocortisone|mesh-list
6048486|NCT00583011|Anesthetics|anesthetics|mesh-list
6048487|NCT00583011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5499148|NCT04492280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5499149|NCT04492254|Enoxaparin|enoxaparin|mesh-list
5499150|NCT04492254|Anticoagulants|anticoagulants|mesh-ancestor
5499151|NCT04492254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5499152|NCT04492254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5499153|NCT04492254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499154|NCT04492566|Pancrelipase|pancrelipase|mesh-list
5499155|NCT04492566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5499156|NCT04492553|Testosterone|testosterone|mesh-list
5499157|NCT04492553|Androgens|androgens|mesh-ancestor
5499158|NCT04492553|Hormones|hormones|mesh-ancestor
5499159|NCT04492553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5499160|NCT04492553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499161|NCT04492358|Prednisone|prednisone|mesh-list
5499162|NCT04492358|Colchicine|colchicine|mesh-list
5499163|NCT04492358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5499164|NCT04492358|Glucocorticoids|glucocorticoids|mesh-ancestor
5499165|NCT04492358|Hormones|hormones|mesh-ancestor
5499166|NCT04492358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5499167|NCT04492358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499168|NCT04492358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5499169|NCT04492358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5499170|NCT04492358|Gout Suppressants|gout suppressants|mesh-ancestor
5499171|NCT04492358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5499172|NCT04492358|Tubulin Modulators|tubulin modulators|mesh-ancestor
6048488|NCT00583011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048489|NCT00583102|Cytarabine|cytarabine|mesh-list
6048490|NCT00583102|Lovastatin|lovastatin|mesh-list
6048491|NCT00583102|L 647318|l 647318|mesh-list
6048492|NCT00583102|Dihydromevinolin|dihydromevinolin|mesh-list
6048493|NCT00583102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6048494|NCT00583102|Antimetabolites|antimetabolites|mesh-ancestor
6048495|NCT00583102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048496|NCT00583102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6048497|NCT00583102|Antiviral Agents|antiviral agents|mesh-ancestor
6048498|NCT00583102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6048499|NCT00583102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6048500|NCT00583102|Immunologic Factors|immunologic factors|mesh-ancestor
6048501|NCT00583102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048502|NCT00583102|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6048503|NCT00583102|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6048504|NCT00583102|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6048505|NCT00583102|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6048506|NCT00583102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6048507|NCT00583219|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6048508|NCT00583219|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5499173|NCT04492358|Antimitotic Agents|antimitotic agents|mesh-ancestor
5499174|NCT04492358|Mitosis Modulators|mitosis modulators|mesh-ancestor
5499175|NCT04492358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499176|NCT04492501|Remdesivir|remdesivir|mesh-list
5499177|NCT04492501|Antimetabolites|antimetabolites|mesh-ancestor
5499178|NCT04492501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499179|NCT04492501|Antiviral Agents|antiviral agents|mesh-ancestor
5499180|NCT04492501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5499181|NCT04492072|Misoprostol|misoprostol|mesh-list
5499182|NCT04492072|Oxytocin|oxytocin|mesh-list
6048509|NCT00583219|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
6048510|NCT00583219|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6048511|NCT00583219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6048512|NCT00583219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048513|NCT00583219|Cholinergic Agents|cholinergic agents|mesh-ancestor
6048514|NCT00583219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6048515|NCT00583219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048516|NCT00583219|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6048517|NCT00583219|Protective Agents|protective agents|mesh-ancestor
6048518|NCT00583219|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6048519|NCT00583219|Antioxidants|antioxidants|mesh-ancestor
5499183|NCT04492072|Oxytocics|oxytocics|mesh-ancestor
5499184|NCT04492072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5499185|NCT04492072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499186|NCT04492072|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5499187|NCT04492072|Abortifacient Agents|abortifacient agents|mesh-ancestor
5499188|NCT04492072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5499189|NCT04492072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5499190|NCT04492033|Paclitaxel|paclitaxel|mesh-list
6664657|NCT01513187|Antiviral Agents|antiviral agents|mesh-ancestor
5499191|NCT04492033|Irinotecan|irinotecan|mesh-list
5499192|NCT04492033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5499193|NCT04492033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5499194|NCT04492033|Tubulin Modulators|tubulin modulators|mesh-ancestor
6048520|NCT00583219|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6048521|NCT00583219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6048522|NCT00583362|Belimumab|belimumab|mesh-list
6048523|NCT00583362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6048524|NCT00583362|Immunologic Factors|immunologic factors|mesh-ancestor
6048525|NCT00583362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048526|NCT00583453|Celecoxib|celecoxib|mesh-list
6048527|NCT00583453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6048528|NCT00583453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6048529|NCT00583453|Analgesics|analgesics|mesh-ancestor
6048530|NCT00583453|Sensory System Agents|sensory system agents|mesh-ancestor
6048531|NCT00583453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6048532|NCT00583453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048533|NCT00583453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6048534|NCT00583453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6048535|NCT00583453|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6048536|NCT00583453|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6048537|NCT00583453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6048538|NCT00583453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048539|NCT00583557|Belimumab|belimumab|mesh-list
6048540|NCT00583557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6048541|NCT00583557|Immunologic Factors|immunologic factors|mesh-ancestor
6048542|NCT00583557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048543|NCT00583622|Gemcitabine|gemcitabine|mesh-list
6048544|NCT00583622|Bevacizumab|bevacizumab|mesh-list
6048545|NCT00583622|Carboplatin|carboplatin|mesh-list
6048546|NCT00583622|Docetaxel|docetaxel|mesh-list
6048547|NCT00583622|Melphalan|melphalan|mesh-list
6048548|NCT00583622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6048549|NCT00583622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6048550|NCT00583622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6048551|NCT00583622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6048552|NCT00583622|Growth Substances|growth substances|mesh-ancestor
6048553|NCT00583622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048554|NCT00583622|Growth Inhibitors|growth inhibitors|mesh-ancestor
6048555|NCT00583622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6048556|NCT00583622|Antimetabolites|antimetabolites|mesh-ancestor
6048557|NCT00583622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048558|NCT00583622|Antiviral Agents|antiviral agents|mesh-ancestor
6048559|NCT00583622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6048560|NCT00583622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6048561|NCT00583622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6048562|NCT00583622|Immunologic Factors|immunologic factors|mesh-ancestor
6048563|NCT00583622|Tubulin Modulators|tubulin modulators|mesh-ancestor
6048564|NCT00583622|Antimitotic Agents|antimitotic agents|mesh-ancestor
6048565|NCT00583622|Mitosis Modulators|mitosis modulators|mesh-ancestor
6048566|NCT00583622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6048567|NCT00583622|Alkylating Agents|alkylating agents|mesh-ancestor
6048568|NCT00583622|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6048569|NCT00583700|Vitamin E|vitamin e|mesh-list
6048570|NCT00583700|Pentoxifylline|pentoxifylline|mesh-list
6048571|NCT00583700|Vitamins|vitamins|mesh-ancestor
6048572|NCT00583700|Micronutrients|micronutrients|mesh-ancestor
6048573|NCT00583700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048574|NCT00583700|Antioxidants|antioxidants|mesh-ancestor
6048575|NCT00583700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048576|NCT00583700|Protective Agents|protective agents|mesh-ancestor
6048577|NCT00583700|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6048578|NCT00583700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6048579|NCT00583700|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6048580|NCT00583700|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6048581|NCT00583700|Vasodilator Agents|vasodilator agents|mesh-ancestor
6048582|NCT00583700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6048583|NCT00583947|Albuterol|albuterol|mesh-list
6048584|NCT00583947|Formoterol Fumarate|formoterol fumarate|mesh-list
6048585|NCT00583947|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6048586|NCT00583947|Autonomic Agents|autonomic agents|mesh-ancestor
6048587|NCT00583947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6048588|NCT00583947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048589|NCT00583947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6048590|NCT00583947|Respiratory System Agents|respiratory system agents|mesh-ancestor
6048591|NCT00583947|Tocolytic Agents|tocolytic agents|mesh-ancestor
6048592|NCT00583947|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6048593|NCT00583947|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6048594|NCT00583947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6048595|NCT00583947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6048596|NCT00583947|Adrenergic Agents|adrenergic agents|mesh-ancestor
6048597|NCT00583947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6048598|NCT00583947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048599|NCT00584701|Risperidone|risperidone|mesh-list
6048600|NCT00584701|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6048601|NCT00584701|Serotonin Agents|serotonin agents|mesh-ancestor
6048602|NCT00584701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5499195|NCT04492033|Antimitotic Agents|antimitotic agents|mesh-ancestor
5499196|NCT04492033|Mitosis Modulators|mitosis modulators|mesh-ancestor
5499197|NCT04492033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499198|NCT04492033|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5499199|NCT04492033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5499200|NCT04492033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5499201|NCT04491773|Tadalafil|tadalafil|mesh-list
5499202|NCT04491773|Vasodilator Agents|vasodilator agents|mesh-ancestor
5499203|NCT04491773|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5499204|NCT04491773|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5499205|NCT04491773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5499206|NCT04491773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499207|NCT04491773|Urological Agents|urological agents|mesh-ancestor
5499208|NCT04491786|Gabapentin|gabapentin|mesh-list
5499209|NCT04491786|Nefopam|nefopam|mesh-list
5499210|NCT04491786|Analgesics|analgesics|mesh-ancestor
6048603|NCT00584701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048604|NCT00584701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048605|NCT00584701|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6048606|NCT00584701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6048607|NCT00584701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6048608|NCT00584701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6048609|NCT00584701|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6048610|NCT00584701|Dopamine Agents|dopamine agents|mesh-ancestor
6048611|NCT00584857|Paclitaxel|paclitaxel|mesh-list
6048612|NCT00584857|Carboplatin|carboplatin|mesh-list
6048613|NCT00584857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6048614|NCT00584857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6048615|NCT00584857|Tubulin Modulators|tubulin modulators|mesh-ancestor
6048616|NCT00584857|Antimitotic Agents|antimitotic agents|mesh-ancestor
6048617|NCT00584857|Mitosis Modulators|mitosis modulators|mesh-ancestor
6048618|NCT00584857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499211|NCT04491786|Sensory System Agents|sensory system agents|mesh-ancestor
5499212|NCT04491786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5499213|NCT04491786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499214|NCT04491786|Anticonvulsants|anticonvulsants|mesh-ancestor
5499215|NCT04491786|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5499216|NCT04491786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5499217|NCT04491786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6048619|NCT00584870|Naproxen|naproxen|mesh-list
6048620|NCT00584870|Tanezumab|tanezumab|mesh-list
6048621|NCT00584870|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6048622|NCT00584870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6048623|NCT00584870|Analgesics|analgesics|mesh-ancestor
6048624|NCT00584870|Sensory System Agents|sensory system agents|mesh-ancestor
6048625|NCT00584870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6048626|NCT00584870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048627|NCT00584870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6048628|NCT00584870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6048629|NCT00584870|Gout Suppressants|gout suppressants|mesh-ancestor
6048630|NCT00584870|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6048631|NCT00584870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6048632|NCT00584870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048633|NCT00584909|Paclitaxel|paclitaxel|mesh-list
6048634|NCT00584909|Carboplatin|carboplatin|mesh-list
6048635|NCT00584909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6048636|NCT00584909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6048637|NCT00584909|Tubulin Modulators|tubulin modulators|mesh-ancestor
6048638|NCT00584909|Antimitotic Agents|antimitotic agents|mesh-ancestor
6048639|NCT00584909|Mitosis Modulators|mitosis modulators|mesh-ancestor
6048640|NCT00584909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048641|NCT00584948|Memantine|memantine|mesh-list
6048642|NCT00584948|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6048643|NCT00584948|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6048644|NCT00584948|Dopamine Agents|dopamine agents|mesh-ancestor
6048645|NCT00584948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6048646|NCT00584948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048647|NCT00584948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048648|NCT00584948|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6048649|NCT00584948|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6048650|NCT00584987|Fluticasone|fluticasone|mesh-list
6048651|NCT00584987|Xhance|xhance|mesh-list
6048652|NCT00584987|Phenylephrine|phenylephrine|mesh-list
6048653|NCT00584987|Oxymetazoline|oxymetazoline|mesh-list
6048654|NCT00584987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6048655|NCT00584987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6048656|NCT00584987|Autonomic Agents|autonomic agents|mesh-ancestor
6048657|NCT00584987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5499218|NCT04491786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5499219|NCT04491786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5499220|NCT04491786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5499221|NCT04491786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5499222|NCT04491786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499223|NCT04491786|Antimanic Agents|antimanic agents|mesh-ancestor
5499224|NCT04491786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5499225|NCT04491695|Tirofiban|tirofiban|mesh-list
5499226|NCT04491695|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5499227|NCT04491695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5499228|NCT04491695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499229|NCT04491695|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5503428|NCT04458948|Azithromycin|azithromycin|mesh-list
5503429|NCT04458948|Hydroxychloroquine|hydroxychloroquine|mesh-list
5503430|NCT04458948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5503431|NCT04458948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5503432|NCT04458948|Antimalarials|antimalarials|mesh-ancestor
5503433|NCT04458948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5503434|NCT04458948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5503435|NCT04458948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5503436|NCT04458948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503437|NCT04458948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5503438|NCT04459377|Ketamine|ketamine|mesh-list
6048658|NCT00584987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048659|NCT00584987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6048660|NCT00584987|Respiratory System Agents|respiratory system agents|mesh-ancestor
6048661|NCT00584987|Dermatologic Agents|dermatologic agents|mesh-ancestor
6048662|NCT00584987|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6048663|NCT00584987|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6048664|NCT00584987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6048665|NCT00584987|Adrenergic Agents|adrenergic agents|mesh-ancestor
6048666|NCT00584987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6048667|NCT00584987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048668|NCT00584987|Sympathomimetics|sympathomimetics|mesh-ancestor
6048669|NCT00584987|Nasal Decongestants|nasal decongestants|mesh-ancestor
6048670|NCT00584987|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6048671|NCT00584987|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6048672|NCT00584987|Mydriatics|mydriatics|mesh-ancestor
6048673|NCT00584987|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6048674|NCT00584987|Protective Agents|protective agents|mesh-ancestor
6458476|NCT00440674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458477|NCT00440687|Fluticasone|fluticasone|mesh-list
6458478|NCT00440687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6458479|NCT00440687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6458480|NCT00440687|Autonomic Agents|autonomic agents|mesh-ancestor
6458481|NCT00440687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6458482|NCT00440687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655298|NCT01463072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6655299|NCT01463072|Tubulin Modulators|tubulin modulators|mesh-ancestor
6655300|NCT01463072|Antimitotic Agents|antimitotic agents|mesh-ancestor
6655301|NCT01463072|Mitosis Modulators|mitosis modulators|mesh-ancestor
6655302|NCT01463072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655303|NCT01463150|Clopidogrel|clopidogrel|mesh-list
6655304|NCT01463150|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6655305|NCT01463150|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6655306|NCT01463150|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6655307|NCT01463150|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6655308|NCT01463150|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5503439|NCT04459377|Esketamine|esketamine|mesh-list
6048675|NCT00585013|Nitric Oxide|nitric oxide|mesh-list
5503440|NCT04459377|Analgesics|analgesics|mesh-ancestor
6048676|NCT00585013|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6048677|NCT00585013|Autonomic Agents|autonomic agents|mesh-ancestor
6048678|NCT00585013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6048679|NCT00585013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048680|NCT00585013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6048681|NCT00585013|Respiratory System Agents|respiratory system agents|mesh-ancestor
6048682|NCT00585013|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6048683|NCT00585013|Antioxidants|antioxidants|mesh-ancestor
6458483|NCT00440687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6458484|NCT00440687|Respiratory System Agents|respiratory system agents|mesh-ancestor
6458485|NCT00440687|Dermatologic Agents|dermatologic agents|mesh-ancestor
6458486|NCT00440687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6458487|NCT00440713|Aripiprazole|aripiprazole|mesh-list
6458488|NCT00440713|Antidepressive Agents|antidepressive agents|mesh-ancestor
6458489|NCT00440713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6458490|NCT00440713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6458491|NCT00440713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6458492|NCT00440713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6458493|NCT00440713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458494|NCT00440713|Dopamine Agonists|dopamine agonists|mesh-ancestor
6458495|NCT00440713|Dopamine Agents|dopamine agents|mesh-ancestor
6458496|NCT00440713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6458497|NCT00440713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048684|NCT00585013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048685|NCT00585013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6048686|NCT00585013|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6048687|NCT00585013|Vasodilator Agents|vasodilator agents|mesh-ancestor
6048688|NCT00585013|Gasotransmitters|gasotransmitters|mesh-ancestor
6048689|NCT00585013|Protective Agents|protective agents|mesh-ancestor
6048690|NCT00585039|Albuterol|albuterol|mesh-list
6048691|NCT00585039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6048692|NCT00585039|Autonomic Agents|autonomic agents|mesh-ancestor
6048693|NCT00585039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6048694|NCT00585039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048695|NCT00585039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6048696|NCT00585039|Respiratory System Agents|respiratory system agents|mesh-ancestor
6048697|NCT00585039|Tocolytic Agents|tocolytic agents|mesh-ancestor
5499230|NCT04491682|Megestrol|megestrol|mesh-list
5499231|NCT04491682|Megestrol Acetate|megestrol acetate|mesh-list
5499232|NCT04491682|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5499233|NCT04491682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5499234|NCT04491682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5499235|NCT04491682|Antimetabolites|antimetabolites|mesh-ancestor
5499236|NCT04491682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499237|NCT04491682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5499238|NCT04491682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5499239|NCT04491682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5499240|NCT04491682|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5499241|NCT04491682|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5499242|NCT04491682|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5499243|NCT04491682|Contraceptive Agents|contraceptive agents|mesh-ancestor
5499244|NCT04491682|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5499245|NCT04491682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499246|NCT04491682|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5499247|NCT04491682|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5499248|NCT04491682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5499249|NCT04491682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6048698|NCT00585039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6048699|NCT00585039|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6048700|NCT00585039|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6048701|NCT00585039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6048702|NCT00585039|Adrenergic Agents|adrenergic agents|mesh-ancestor
6048703|NCT00585039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6048704|NCT00585039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048705|NCT00585052|Paclitaxel|paclitaxel|mesh-list
6048706|NCT00585052|Lovastatin|lovastatin|mesh-list
6048707|NCT00585052|L 647318|l 647318|mesh-list
6048708|NCT00585052|Dihydromevinolin|dihydromevinolin|mesh-list
6048709|NCT00585052|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6048710|NCT00585052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6048711|NCT00585052|Tubulin Modulators|tubulin modulators|mesh-ancestor
6048712|NCT00585052|Antimitotic Agents|antimitotic agents|mesh-ancestor
6048713|NCT00585052|Mitosis Modulators|mitosis modulators|mesh-ancestor
6048714|NCT00585052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048715|NCT00585052|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6048716|NCT00585052|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6048717|NCT00585052|Antimetabolites|antimetabolites|mesh-ancestor
6048718|NCT00585052|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6048719|NCT00585052|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6048720|NCT00585052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6048721|NCT00585078|Capecitabine|capecitabine|mesh-list
6048722|NCT00585078|Oxaliplatin|oxaliplatin|mesh-list
6048723|NCT00585078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6048724|NCT00585078|Antimetabolites|antimetabolites|mesh-ancestor
6048725|NCT00585078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048726|NCT00585078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6053939|NCT00599924|Growth Inhibitors|growth inhibitors|mesh-ancestor
6053940|NCT00599924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6053941|NCT00599924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6053942|NCT00599924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053943|NCT00599924|Antimetabolites|antimetabolites|mesh-ancestor
6053944|NCT00599924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6053945|NCT00599924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6053946|NCT00599924|Immunologic Factors|immunologic factors|mesh-ancestor
6053947|NCT00599924|Antidotes|antidotes|mesh-ancestor
6053948|NCT00599924|Protective Agents|protective agents|mesh-ancestor
6053949|NCT00599924|Vitamin B Complex|vitamin b complex|mesh-ancestor
6053950|NCT00599924|Vitamins|vitamins|mesh-ancestor
6053951|NCT00599924|Micronutrients|micronutrients|mesh-ancestor
6053952|NCT00600015|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6053953|NCT00600015|Sorafenib|sorafenib|mesh-list
6053954|NCT00600015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6053955|NCT00600015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6053956|NCT00600015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6053957|NCT00600015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053958|NCT00600028|Thalidomide|thalidomide|mesh-list
6053959|NCT00600028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6053960|NCT00600028|Immunologic Factors|immunologic factors|mesh-ancestor
6053961|NCT00600028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053962|NCT00600028|Leprostatic Agents|leprostatic agents|mesh-ancestor
6053963|NCT00600028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6053964|NCT00600028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6053965|NCT00600028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6053966|NCT00600028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6053967|NCT00600028|Growth Substances|growth substances|mesh-ancestor
6053968|NCT00600028|Growth Inhibitors|growth inhibitors|mesh-ancestor
6053969|NCT00600028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6053970|NCT00600067|Topiramate|topiramate|mesh-list
6053971|NCT00600067|Phentermine|phentermine|mesh-list
6053972|NCT00600067|Anticonvulsants|anticonvulsants|mesh-ancestor
6053973|NCT00600067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6053974|NCT00600067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053975|NCT00600067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6053976|NCT00600067|Appetite Depressants|appetite depressants|mesh-ancestor
6053977|NCT00600067|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6053978|NCT00600067|Sympathomimetics|sympathomimetics|mesh-ancestor
6053979|NCT00600067|Autonomic Agents|autonomic agents|mesh-ancestor
6053980|NCT00600067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6053981|NCT00600067|Adrenergic Agents|adrenergic agents|mesh-ancestor
6053982|NCT00600067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6053983|NCT00600067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053984|NCT00600119|Naloxegol|naloxegol|mesh-list
6053985|NCT00600119|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6053986|NCT00600119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053987|NCT00600119|Sensory System Agents|sensory system agents|mesh-ancestor
6053988|NCT00600119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6053989|NCT00600340|Paclitaxel|paclitaxel|mesh-list
6053990|NCT00600340|Bevacizumab|bevacizumab|mesh-list
6053991|NCT00600340|Capecitabine|capecitabine|mesh-list
6053992|NCT00600340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6053993|NCT00600340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6053994|NCT00600340|Tubulin Modulators|tubulin modulators|mesh-ancestor
6053995|NCT00600340|Antimitotic Agents|antimitotic agents|mesh-ancestor
6053996|NCT00600340|Mitosis Modulators|mitosis modulators|mesh-ancestor
6053997|NCT00600340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053998|NCT00600340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6053999|NCT00600340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6054000|NCT00600340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6054001|NCT00600340|Growth Substances|growth substances|mesh-ancestor
6054002|NCT00600340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054003|NCT00600340|Growth Inhibitors|growth inhibitors|mesh-ancestor
5499250|NCT04491682|Appetite Stimulants|appetite stimulants|mesh-ancestor
5499251|NCT04491682|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5499252|NCT04491474|Lidocaine|lidocaine|mesh-list
5499253|NCT04491474|Anesthetics, Local|anesthetics, local|mesh-ancestor
5499254|NCT04491474|Anesthetics|anesthetics|mesh-ancestor
5499255|NCT04491474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5499256|NCT04491474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499257|NCT04491474|Sensory System Agents|sensory system agents|mesh-ancestor
5499258|NCT04491474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5499259|NCT04491474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5499260|NCT04491474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5499261|NCT04491474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5499262|NCT04491474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5499263|NCT04491474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499264|NCT04491383|Tocovid|tocovid|mesh-list
5499265|NCT04491383|Vitamins|vitamins|mesh-ancestor
6048727|NCT00585104|Simendan|simendan|mesh-list
6048728|NCT00585104|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6048729|NCT00585104|Vasodilator Agents|vasodilator agents|mesh-ancestor
6048730|NCT00585104|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6048731|NCT00585104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6048732|NCT00585104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6048733|NCT00585104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048734|NCT00585104|Protective Agents|protective agents|mesh-ancestor
6048735|NCT00585104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048736|NCT00585169|Memantine|memantine|mesh-list
6048737|NCT00585169|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6048738|NCT00585169|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6048739|NCT00585169|Dopamine Agents|dopamine agents|mesh-ancestor
6048740|NCT00585169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6048741|NCT00585169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048742|NCT00585169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048743|NCT00585169|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6048744|NCT00585169|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6048745|NCT00585182|Enoxaparin|enoxaparin|mesh-list
6048746|NCT00585182|Anticoagulants|anticoagulants|mesh-ancestor
6048747|NCT00585182|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6048748|NCT00585182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6048749|NCT00585182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499266|NCT04491383|Micronutrients|micronutrients|mesh-ancestor
5499267|NCT04491383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499268|NCT04491643|Megestrol|megestrol|mesh-list
5499269|NCT04491643|Megestrol Acetate|megestrol acetate|mesh-list
5499270|NCT04491643|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5499271|NCT04491643|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5499272|NCT04491643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5499273|NCT04491643|Antimetabolites|antimetabolites|mesh-ancestor
5499274|NCT04491643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499275|NCT04491643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5499276|NCT04491643|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5499277|NCT04491643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5499278|NCT04491643|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5499279|NCT04491643|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5499280|NCT04491643|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5499281|NCT04491643|Contraceptive Agents|contraceptive agents|mesh-ancestor
5499282|NCT04491643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5499283|NCT04491643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499284|NCT04491643|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5499285|NCT04491643|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5499286|NCT04491643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5499287|NCT04491643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5499288|NCT04491643|Appetite Stimulants|appetite stimulants|mesh-ancestor
5499289|NCT04491643|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5499290|NCT04491084|Antibodies|antibodies|mesh-list
5499291|NCT04491084|Flt3 ligand protein|flt3 ligand protein|mesh-list
5499292|NCT04491084|Immunologic Factors|immunologic factors|mesh-ancestor
5499293|NCT04491084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499294|NCT04491084|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5499295|NCT04491084|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5499296|NCT04491084|Protective Agents|protective agents|mesh-ancestor
5499297|NCT04491357|Calcium, Dietary|calcium, dietary|mesh-list
5499298|NCT04491357|Calcium|calcium|mesh-list
5499299|NCT04491357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5499300|NCT04491357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499301|NCT04491357|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5499302|NCT04491032|Anesthetics|anesthetics|mesh-list
5499303|NCT04491032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5499304|NCT04491032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499305|NCT04490967|Salicylic Acid|salicylic acid|mesh-list
5499306|NCT04490967|Salicylates|salicylates|mesh-list
6048777|NCT00585247|Imiquimod|imiquimod|mesh-list
5499307|NCT04490967|Silybin|silybin|mesh-list
5499308|NCT04490967|Silymarin|silymarin|mesh-list
5499309|NCT04490967|Antioxidants|antioxidants|mesh-ancestor
5499310|NCT04490967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499311|NCT04490967|Protective Agents|protective agents|mesh-ancestor
5499312|NCT04490967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499313|NCT04490967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5499314|NCT04490967|Antifungal Agents|antifungal agents|mesh-ancestor
5499315|NCT04490967|Keratolytic Agents|keratolytic agents|mesh-ancestor
5499316|NCT04490967|Dermatologic Agents|dermatologic agents|mesh-ancestor
5499317|NCT04490967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5499318|NCT04490967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5499319|NCT04490967|Analgesics|analgesics|mesh-ancestor
5499320|NCT04490967|Sensory System Agents|sensory system agents|mesh-ancestor
5499321|NCT04490967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5499322|NCT04490967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5499323|NCT04490967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5499324|NCT04490967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5499325|NCT04490967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5499326|NCT04490967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5499327|NCT04490967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6048778|NCT00585247|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6048779|NCT00585247|Immunologic Factors|immunologic factors|mesh-ancestor
6048780|NCT00585247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048781|NCT00585247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6048782|NCT00585247|Interferon Inducers|interferon inducers|mesh-ancestor
6048783|NCT00585312|Celecoxib|celecoxib|mesh-list
6048784|NCT00585312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6048785|NCT00585312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6048786|NCT00585312|Analgesics|analgesics|mesh-ancestor
6048787|NCT00585312|Sensory System Agents|sensory system agents|mesh-ancestor
6048788|NCT00585312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6048789|NCT00585312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458498|NCT00440713|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6458499|NCT00440713|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6458500|NCT00440713|Serotonin Agents|serotonin agents|mesh-ancestor
6458501|NCT00440713|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5499328|NCT04490837|Antibodies|antibodies|mesh-list
5499329|NCT04490837|Immunologic Factors|immunologic factors|mesh-ancestor
6458502|NCT00440713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6458503|NCT00440713|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5499330|NCT04490837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048790|NCT00585312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6048791|NCT00585312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6048792|NCT00585312|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6048793|NCT00585312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6048794|NCT00585312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6048795|NCT00585312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048796|NCT00585325|Lidocaine|lidocaine|mesh-list
6048797|NCT00585325|Anesthetics, Local|anesthetics, local|mesh-ancestor
6048798|NCT00585325|Anesthetics|anesthetics|mesh-ancestor
6048799|NCT00585325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6048800|NCT00585325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048801|NCT00585325|Sensory System Agents|sensory system agents|mesh-ancestor
6048802|NCT00585325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6048803|NCT00585325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6048804|NCT00585325|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6048805|NCT00585325|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6048806|NCT00585325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6048807|NCT00585325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048808|NCT00585351|Ranitidine|ranitidine|mesh-list
6048809|NCT00585351|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
6048810|NCT00585351|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6048811|NCT00585351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6048812|NCT00585351|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6048813|NCT00585351|Histamine Antagonists|histamine antagonists|mesh-ancestor
6048814|NCT00585351|Histamine Agents|histamine agents|mesh-ancestor
6048815|NCT00585351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6048816|NCT00585351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048817|NCT00585351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048818|NCT00585377|Bevacizumab|bevacizumab|mesh-list
6048819|NCT00585377|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6048820|NCT00585377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6048821|NCT00585377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6048822|NCT00585377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6048823|NCT00585377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6048824|NCT00585377|Growth Substances|growth substances|mesh-ancestor
6048825|NCT00585377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048826|NCT00585377|Growth Inhibitors|growth inhibitors|mesh-ancestor
6048827|NCT00585377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6048828|NCT00585377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6048829|NCT00585377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048830|NCT00585468|Mycophenolic Acid|mycophenolic acid|mesh-list
6048831|NCT00585468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5499331|NCT04490681|Ertugliflozin|ertugliflozin|mesh-list
5499332|NCT04490681|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5499333|NCT04490681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499334|NCT04490681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5499335|NCT04490681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499336|NCT04490980|Butorphanol|butorphanol|mesh-list
5499337|NCT04490980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5499338|NCT04490980|Narcotics|narcotics|mesh-ancestor
5499339|NCT04490980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5499340|NCT04490980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499341|NCT04490980|Analgesics|analgesics|mesh-ancestor
5499342|NCT04490980|Sensory System Agents|sensory system agents|mesh-ancestor
5499343|NCT04490980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5499344|NCT04490980|Antitussive Agents|antitussive agents|mesh-ancestor
5499345|NCT04490980|Respiratory System Agents|respiratory system agents|mesh-ancestor
5499346|NCT04490980|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5499347|NCT04490707|Lenalidomide|lenalidomide|mesh-list
5499348|NCT04490707|Azacitidine|azacitidine|mesh-list
5499349|NCT04490707|Immunologic Factors|immunologic factors|mesh-ancestor
5499350|NCT04490707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499351|NCT04490707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5499352|NCT04490707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5499353|NCT04490707|Growth Substances|growth substances|mesh-ancestor
5499354|NCT04490707|Growth Inhibitors|growth inhibitors|mesh-ancestor
5499355|NCT04490707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5499356|NCT04490707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5499357|NCT04490707|Antimetabolites|antimetabolites|mesh-ancestor
6458504|NCT00440713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6048832|NCT00585468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6048833|NCT00585468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6048834|NCT00585468|Antitubercular Agents|antitubercular agents|mesh-ancestor
6048835|NCT00585468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6048836|NCT00585468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6048837|NCT00585468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6048838|NCT00585468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048839|NCT00585533|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5499358|NCT04490707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048840|NCT00585533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6048841|NCT00585533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6048842|NCT00585533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6048843|NCT00585533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048844|NCT00585546|Clenbuterol|clenbuterol|mesh-list
6048845|NCT00585546|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6048846|NCT00585546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6048847|NCT00585546|Adrenergic Agents|adrenergic agents|mesh-ancestor
6048848|NCT00585546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6048849|NCT00585546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048850|NCT00585546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048851|NCT00585546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6048852|NCT00585546|Autonomic Agents|autonomic agents|mesh-ancestor
6048853|NCT00585546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6048854|NCT00585546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6048855|NCT00585546|Respiratory System Agents|respiratory system agents|mesh-ancestor
6048856|NCT00585546|Sympathomimetics|sympathomimetics|mesh-ancestor
6048857|NCT00585637|Vitamin D|vitamin d|mesh-list
6048858|NCT00585637|Vitamins|vitamins|mesh-ancestor
6048859|NCT00585637|Micronutrients|micronutrients|mesh-ancestor
6048860|NCT00585637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048861|NCT00585637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6048862|NCT00585650|Etanercept|etanercept|mesh-list
6048863|NCT00585650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6048864|NCT00585650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6048865|NCT00585650|Analgesics|analgesics|mesh-ancestor
6048866|NCT00585650|Sensory System Agents|sensory system agents|mesh-ancestor
6048867|NCT00585650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6048868|NCT00585650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048869|NCT00585650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6048870|NCT00585650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6048871|NCT00585650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6048872|NCT00585650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6048873|NCT00585650|Immunologic Factors|immunologic factors|mesh-ancestor
6048874|NCT00585689|Gemcitabine|gemcitabine|mesh-list
6048875|NCT00585689|Carboplatin|carboplatin|mesh-list
6048876|NCT00585689|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6048877|NCT00585689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6048878|NCT00585689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6048879|NCT00585689|Antimetabolites|antimetabolites|mesh-ancestor
6048880|NCT00585689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048881|NCT00585689|Antiviral Agents|antiviral agents|mesh-ancestor
6048882|NCT00585689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6048883|NCT00585689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6048884|NCT00585689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6048885|NCT00585689|Immunologic Factors|immunologic factors|mesh-ancestor
6048886|NCT00585689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048887|NCT00585780|Prazosin|prazosin|mesh-list
6048888|NCT00585780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6048889|NCT00585780|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6048890|NCT00585780|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6048891|NCT00585780|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6048892|NCT00585780|Adrenergic Agents|adrenergic agents|mesh-ancestor
6048893|NCT00585780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6048894|NCT00585780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048895|NCT00585780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048896|NCT00585910|Methylphenidate|methylphenidate|mesh-list
6048897|NCT00585910|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6048898|NCT00585910|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6048899|NCT00585910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048900|NCT00585910|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6048901|NCT00585910|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6048902|NCT00585910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6048903|NCT00585910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048904|NCT00585910|Dopamine Agents|dopamine agents|mesh-ancestor
6048905|NCT00585910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6048906|NCT00585910|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6048907|NCT00585910|Adrenergic Agents|adrenergic agents|mesh-ancestor
6048908|NCT00585975|Bromfenac|bromfenac|mesh-list
6048909|NCT00585975|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6048910|NCT00585975|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6048911|NCT00585975|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6048912|NCT00585975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6048913|NCT00585975|Analgesics|analgesics|mesh-ancestor
6048914|NCT00585975|Sensory System Agents|sensory system agents|mesh-ancestor
6048915|NCT00585975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6048916|NCT00585975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048917|NCT00585975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6458505|NCT00440739|Etoricoxib|etoricoxib|mesh-list
6458506|NCT00440739|Flavoxate|flavoxate|mesh-list
6458507|NCT00440739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6458508|NCT00440739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6458509|NCT00440739|Analgesics|analgesics|mesh-ancestor
6458510|NCT00440739|Sensory System Agents|sensory system agents|mesh-ancestor
6458511|NCT00440739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6458512|NCT00440739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458513|NCT00440739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6458514|NCT00440739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6458515|NCT00440739|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6458516|NCT00440739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6048918|NCT00585975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6048919|NCT00586066|Memantine|memantine|mesh-list
6048920|NCT00586066|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6048921|NCT00586066|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6048922|NCT00586066|Dopamine Agents|dopamine agents|mesh-ancestor
6048923|NCT00586066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6048924|NCT00586066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048925|NCT00586066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048926|NCT00586066|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6048927|NCT00586066|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6048928|NCT00586105|Sorafenib|sorafenib|mesh-list
6048929|NCT00586105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6048930|NCT00586105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6048931|NCT00586105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6054004|NCT00600340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6655309|NCT01463150|Purinergic Agents|purinergic agents|mesh-ancestor
6048932|NCT00586105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048933|NCT00586157|Methylphenidate|methylphenidate|mesh-list
6048934|NCT00586157|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6048935|NCT00586157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048936|NCT00586157|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6048937|NCT00586157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6048938|NCT00586157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6048939|NCT00586157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048940|NCT00586157|Dopamine Agents|dopamine agents|mesh-ancestor
6048941|NCT00586157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6048942|NCT00586196|Donepezil|donepezil|mesh-list
6048943|NCT00586196|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6048944|NCT00586196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6048945|NCT00586196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048946|NCT00586196|Cholinergic Agents|cholinergic agents|mesh-ancestor
6048947|NCT00586196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6048948|NCT00586196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048949|NCT00586196|Nootropic Agents|nootropic agents|mesh-ancestor
6048950|NCT00586261|Pioglitazone|pioglitazone|mesh-list
6048951|NCT00586261|Nitroglycerin|nitroglycerin|mesh-list
6048952|NCT00586261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6048953|NCT00586261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048954|NCT00586261|Vasodilator Agents|vasodilator agents|mesh-ancestor
6048955|NCT00586482|Nicotine|nicotine|mesh-list
6048956|NCT00586482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6048957|NCT00586482|Autonomic Agents|autonomic agents|mesh-ancestor
5499359|NCT04490707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5499360|NCT04490694|Lenvatinib|lenvatinib|mesh-list
5499361|NCT04490694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5499362|NCT04490694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5499363|NCT04490694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5499364|NCT04490694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499365|NCT04490590|Etoposide|etoposide|mesh-list
5499366|NCT04490590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5499367|NCT04490590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5499368|NCT04490590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5499369|NCT04490590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5499370|NCT04490590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5499371|NCT04490590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499372|NCT04490434|Celecoxib|celecoxib|mesh-list
5499373|NCT04490434|Naproxen|naproxen|mesh-list
6048958|NCT00586482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6048959|NCT00586482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048960|NCT00586482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6048961|NCT00586482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6048962|NCT00586482|Cholinergic Agents|cholinergic agents|mesh-ancestor
6048963|NCT00586482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6048964|NCT00586482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048965|NCT00586495|Sorafenib|sorafenib|mesh-list
6048966|NCT00586495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6048967|NCT00586495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6048968|NCT00586495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6048969|NCT00586495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048970|NCT00586508|Bevacizumab|bevacizumab|mesh-list
6048971|NCT00586508|Anticonvulsants|anticonvulsants|mesh-list
6048972|NCT00586508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5499374|NCT04490434|Meloxicam|meloxicam|mesh-list
5499375|NCT04490434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5499376|NCT04490434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5499377|NCT04490434|Analgesics|analgesics|mesh-ancestor
5499378|NCT04490434|Sensory System Agents|sensory system agents|mesh-ancestor
5499379|NCT04490434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5499380|NCT04490434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499381|NCT04490434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5499382|NCT04490434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5499383|NCT04490434|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5499384|NCT04490434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5499385|NCT04490434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5499386|NCT04490434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499387|NCT04490434|Gout Suppressants|gout suppressants|mesh-ancestor
5499388|NCT04489979|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5499389|NCT04489979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5499390|NCT04490421|Etoposide|etoposide|mesh-list
5499391|NCT04490421|Apatinib|apatinib|mesh-list
5499392|NCT04490421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5499393|NCT04490421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5499394|NCT04490421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5499395|NCT04490421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5499396|NCT04490421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5499397|NCT04490421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499398|NCT04490421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5499399|NCT04490031|Ketamine|ketamine|mesh-list
5499400|NCT04490031|Analgesics|analgesics|mesh-ancestor
5499401|NCT04490031|Sensory System Agents|sensory system agents|mesh-ancestor
5499402|NCT04490031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5499403|NCT04490031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499404|NCT04490031|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5499405|NCT04490031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5499406|NCT04490031|Anesthetics, General|anesthetics, general|mesh-ancestor
5499407|NCT04490031|Anesthetics|anesthetics|mesh-ancestor
5499408|NCT04490031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5499409|NCT04490031|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5499410|NCT04490031|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5499411|NCT04490031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5499412|NCT04490031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503441|NCT04459377|Sensory System Agents|sensory system agents|mesh-ancestor
5503442|NCT04459377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5503443|NCT04459377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048973|NCT00586508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6048974|NCT00586508|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6048975|NCT00586508|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6048976|NCT00586508|Growth Substances|growth substances|mesh-ancestor
6048977|NCT00586508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048978|NCT00586508|Growth Inhibitors|growth inhibitors|mesh-ancestor
6048979|NCT00586521|Factor VIII|factor viii|mesh-list
6048980|NCT00586521|Coagulants|coagulants|mesh-ancestor
6048981|NCT00586573|Memantine|memantine|mesh-list
6048982|NCT00586573|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6048983|NCT00586573|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6048984|NCT00586573|Dopamine Agents|dopamine agents|mesh-ancestor
6048985|NCT00586573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6048986|NCT00586573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6048987|NCT00586573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048988|NCT00586573|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5503444|NCT04459377|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5503445|NCT04459377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5503446|NCT04459377|Anesthetics, General|anesthetics, general|mesh-ancestor
5503447|NCT04459377|Anesthetics|anesthetics|mesh-ancestor
5503448|NCT04459377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5503449|NCT04459377|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5503450|NCT04459377|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5503451|NCT04459377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5503452|NCT04459377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503453|NCT04459377|Antidepressive Agents|antidepressive agents|mesh-ancestor
5503454|NCT04459377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5503455|NCT04459273|FAPI-46|fapi-46|mesh-list
5503456|NCT04459273|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5503457|NCT04459273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503458|NCT04459065|Nimotuzumab|nimotuzumab|mesh-list
5503459|NCT04459065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5503460|NCT04459065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5503667|NCT04456829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503668|NCT04456829|Protective Agents|protective agents|mesh-ancestor
5503669|NCT04456829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503670|NCT04456829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5503671|NCT04456829|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5503672|NCT04456777|Vortioxetine|vortioxetine|mesh-list
5503673|NCT04456777|Antidepressive Agents|antidepressive agents|mesh-ancestor
5503674|NCT04456777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5503675|NCT04456777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5503676|NCT04456777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5503677|NCT04456777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5503678|NCT04456777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503679|NCT04456777|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5503680|NCT04456777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6048989|NCT00586573|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5499413|NCT04490057|Bupropion|bupropion|mesh-list
6048990|NCT00586612|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6048991|NCT00586612|Immunologic Factors|immunologic factors|mesh-ancestor
6048992|NCT00586612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6048993|NCT00586625|Bepotastine besilate|bepotastine besilate|mesh-list
6048994|NCT00586625|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6048995|NCT00586664|Bepotastine besilate|bepotastine besilate|mesh-list
6048996|NCT00586664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6048997|NCT00586664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6048998|NCT00586664|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6048999|NCT00586690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6049000|NCT00586690|Antibodies|antibodies|mesh-list
6049001|NCT00586690|Immunoglobulins|immunoglobulins|mesh-list
6049002|NCT00586690|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6049003|NCT00586690|Immunologic Factors|immunologic factors|mesh-ancestor
6049004|NCT00586690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049005|NCT00586690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6049006|NCT00586729|Mafenide|mafenide|mesh-list
6049007|NCT00586729|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6049008|NCT00586729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6049009|NCT00586729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6049010|NCT00586729|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6049011|NCT00586729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6049012|NCT00586729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049013|NCT00586820|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
6049014|NCT00586820|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6049015|NCT00586820|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6049016|NCT00586820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049017|NCT00586846|Doxorubicin|doxorubicin|mesh-list
6049018|NCT00586846|Methotrexate|methotrexate|mesh-list
6049019|NCT00586846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6049020|NCT00586846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6049021|NCT00586846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6049022|NCT00586846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6049023|NCT00586846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6049024|NCT00586846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049025|NCT00586846|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6049026|NCT00586846|Abortifacient Agents|abortifacient agents|mesh-ancestor
6049027|NCT00586846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6049028|NCT00586846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049029|NCT00586846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6049030|NCT00586846|Antimetabolites|antimetabolites|mesh-ancestor
6049031|NCT00586846|Dermatologic Agents|dermatologic agents|mesh-ancestor
6049032|NCT00586846|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6049033|NCT00586846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6049034|NCT00586846|Immunologic Factors|immunologic factors|mesh-ancestor
6049035|NCT00586846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6049036|NCT00586846|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6049037|NCT00586898|Ketoconazole|ketoconazole|mesh-list
6049038|NCT00586898|Bicalutamide|bicalutamide|mesh-list
6049039|NCT00586898|Testosterone|testosterone|mesh-list
6049040|NCT00586898|Estrogens|estrogens|mesh-list
6049041|NCT00586898|Androgens|androgens|mesh-ancestor
6049042|NCT00586898|Hormones|hormones|mesh-ancestor
6049043|NCT00586898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6049044|NCT00586898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049045|NCT00586898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6049046|NCT00586898|Antifungal Agents|antifungal agents|mesh-ancestor
6049047|NCT00586898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6049048|NCT00586898|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6049049|NCT00586898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6049050|NCT00586898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6049051|NCT00586898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054005|NCT00600340|Antimetabolites|antimetabolites|mesh-ancestor
5499414|NCT04490057|Nicotine|nicotine|mesh-list
5499415|NCT04490057|Varenicline|varenicline|mesh-list
5499416|NCT04490057|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5499417|NCT04490057|Autonomic Agents|autonomic agents|mesh-ancestor
5499418|NCT04490057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5499419|NCT04490057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499420|NCT04490057|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5499421|NCT04490057|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5499422|NCT04490057|Cholinergic Agents|cholinergic agents|mesh-ancestor
5499423|NCT04490057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5499424|NCT04490057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499425|NCT04490057|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5499426|NCT04490057|Antidepressive Agents|antidepressive agents|mesh-ancestor
5499427|NCT04490057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5499428|NCT04490057|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6049052|NCT00586898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6049053|NCT00586898|Hormone Antagonists|hormone antagonists|mesh-ancestor
6049054|NCT00586898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6049055|NCT00586898|Androgen Antagonists|androgen antagonists|mesh-ancestor
6049056|NCT00587067|Floxuridine|floxuridine|mesh-list
6049057|NCT00587067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6049058|NCT00587067|Antimetabolites|antimetabolites|mesh-ancestor
6049059|NCT00587067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049060|NCT00587067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6049061|NCT00587132|Secretin|secretin|mesh-list
6049062|NCT00587132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6049063|NCT00587132|Hormones|hormones|mesh-ancestor
6049064|NCT00587132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6049065|NCT00587132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049066|NCT00587288|Reslizumab|reslizumab|mesh-list
6049067|NCT00587288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6049068|NCT00587288|Respiratory System Agents|respiratory system agents|mesh-ancestor
6049069|NCT00587431|Docetaxel|docetaxel|mesh-list
6049070|NCT00587431|Leuprolide|leuprolide|mesh-list
6049071|NCT00587431|Testosterone|testosterone|mesh-list
6049072|NCT00587431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6049073|NCT00587431|Tubulin Modulators|tubulin modulators|mesh-ancestor
6049074|NCT00587431|Antimitotic Agents|antimitotic agents|mesh-ancestor
6049075|NCT00587431|Mitosis Modulators|mitosis modulators|mesh-ancestor
5499429|NCT04490057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5499430|NCT04490057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5499431|NCT04490057|Dopamine Agents|dopamine agents|mesh-ancestor
5499432|NCT04490057|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5499433|NCT04490057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5499434|NCT04490057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5499435|NCT04490213|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
5499436|NCT04490213|Laxatives|laxatives|mesh-ancestor
5499437|NCT04490213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5499438|NCT04489706|Arsenic Trioxide|arsenic trioxide|mesh-list
5499439|NCT04489706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5499440|NCT04489589|Midodrine|midodrine|mesh-list
5499441|NCT04489589|Sympathomimetics|sympathomimetics|mesh-ancestor
5499442|NCT04489589|Autonomic Agents|autonomic agents|mesh-ancestor
5499443|NCT04489589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5499444|NCT04489589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049076|NCT00587431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049077|NCT00587431|Androgens|androgens|mesh-ancestor
6049078|NCT00587431|Hormones|hormones|mesh-ancestor
6049079|NCT00587431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6049080|NCT00587431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049081|NCT00587431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6049082|NCT00587431|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6049083|NCT00587431|Fertility Agents|fertility agents|mesh-ancestor
6049084|NCT00587431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6049085|NCT00587457|Immunotoxin HA22|immunotoxin ha22|mesh-list
6049086|NCT00587457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6049087|NCT00587483|Lidocaine|lidocaine|mesh-list
6049088|NCT00587483|Amiodarone|amiodarone|mesh-list
6049089|NCT00587483|Anesthetics, Local|anesthetics, local|mesh-ancestor
6049090|NCT00587483|Anesthetics|anesthetics|mesh-ancestor
6049091|NCT00587483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6049092|NCT00587483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049093|NCT00587483|Sensory System Agents|sensory system agents|mesh-ancestor
6458517|NCT00440739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6458518|NCT00440739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458519|NCT00440739|Parasympatholytics|parasympatholytics|mesh-ancestor
6458520|NCT00440739|Autonomic Agents|autonomic agents|mesh-ancestor
6458521|NCT00440739|Urological Agents|urological agents|mesh-ancestor
6458522|NCT00440765|Bortezomib|bortezomib|mesh-list
5499445|NCT04489589|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5499446|NCT04489589|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5499447|NCT04489589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5499448|NCT04489589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5499449|NCT04489589|Adrenergic Agents|adrenergic agents|mesh-ancestor
5499450|NCT04489589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6049094|NCT00587483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5499451|NCT04489589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499452|NCT04489745|Androgens|androgens|mesh-list
5499453|NCT04489745|Hormones|hormones|mesh-ancestor
5499454|NCT04489745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5499455|NCT04489745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499456|NCT04489797|Acalabrutinib|acalabrutinib|mesh-list
5499457|NCT04489797|Rabeprazole|rabeprazole|mesh-list
5499458|NCT04489797|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5499459|NCT04489797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5499460|NCT04489797|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5499461|NCT04489797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5499462|NCT04489797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499463|NCT04489797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6458523|NCT00440765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6458524|NCT00440778|Abciximab|abciximab|mesh-list
6458525|NCT00440778|Anticoagulants|anticoagulants|mesh-ancestor
6458526|NCT00440778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6458527|NCT00440804|Ibuprofen|ibuprofen|mesh-list
6458528|NCT00440804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6458529|NCT00440804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6458530|NCT00440804|Analgesics|analgesics|mesh-ancestor
6458531|NCT00440804|Sensory System Agents|sensory system agents|mesh-ancestor
6458532|NCT00440804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6458533|NCT00440804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458534|NCT00440804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6458535|NCT00440804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6458536|NCT00440804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6458537|NCT00440804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6458538|NCT00440804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458539|NCT00440843|Olanzapine|olanzapine|mesh-list
6458540|NCT00440843|Antiemetics|antiemetics|mesh-ancestor
6458541|NCT00440843|Autonomic Agents|autonomic agents|mesh-ancestor
6049095|NCT00587483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6049096|NCT00587483|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6049097|NCT00587483|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6049098|NCT00587483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6049099|NCT00587483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049100|NCT00587483|Vasodilator Agents|vasodilator agents|mesh-ancestor
6049101|NCT00587483|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6049102|NCT00587483|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6049103|NCT00587483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6049104|NCT00587483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6049105|NCT00587483|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6049106|NCT00587483|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6049107|NCT00587483|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6049108|NCT00587678|Simvastatin|simvastatin|mesh-list
6049109|NCT00587678|Ezetimibe|ezetimibe|mesh-list
6049110|NCT00587678|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6049111|NCT00587678|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6049112|NCT00587678|Antimetabolites|antimetabolites|mesh-ancestor
6049113|NCT00587678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049114|NCT00587678|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6049115|NCT00587678|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6049116|NCT00587678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6049117|NCT00587769|Bupropion|bupropion|mesh-list
6049118|NCT00587769|Varenicline|varenicline|mesh-list
6049119|NCT00587769|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6049120|NCT00587769|Antidepressive Agents|antidepressive agents|mesh-ancestor
6049121|NCT00587769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6049122|NCT00587769|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6049123|NCT00587769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6049124|NCT00587769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6054006|NCT00600353|Dexamethasone|dexamethasone|mesh-list
6655310|NCT01463150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5499464|NCT04489849|Apixaban|apixaban|mesh-list
5499465|NCT04489849|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5499466|NCT04489849|Antithrombins|antithrombins|mesh-ancestor
5499467|NCT04489849|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5499468|NCT04489849|Protease Inhibitors|protease inhibitors|mesh-ancestor
5499469|NCT04489849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5499470|NCT04489849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499471|NCT04489849|Anticoagulants|anticoagulants|mesh-ancestor
5499472|NCT04489459|Meropenem|meropenem|mesh-list
5499473|NCT04489459|Colistin|colistin|mesh-list
6049125|NCT00587769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049126|NCT00587769|Dopamine Agents|dopamine agents|mesh-ancestor
6049127|NCT00587769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6049128|NCT00587769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049129|NCT00587769|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6049130|NCT00587769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6049131|NCT00587769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6049132|NCT00587769|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6049133|NCT00587769|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6049134|NCT00587769|Cholinergic Agents|cholinergic agents|mesh-ancestor
6049135|NCT00587847|Alemtuzumab|alemtuzumab|mesh-list
6049136|NCT00587847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6049137|NCT00587847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6049138|NCT05247424|Heparin|heparin|mesh-list
6049139|NCT05247424|Calcium heparin|calcium heparin|mesh-list
6049140|NCT05247424|Anticoagulants|anticoagulants|mesh-ancestor
6049141|NCT05247424|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6049142|NCT05247424|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6049143|NCT05247424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049144|NCT05247385|Ticagrelor|ticagrelor|mesh-list
5499474|NCT04489459|Tigecycline|tigecycline|mesh-list
5499475|NCT04489459|Polymyxins|polymyxins|mesh-list
5499476|NCT04489459|Polymyxin B|polymyxin b|mesh-list
5499477|NCT04489459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5499478|NCT04489459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5499479|NCT04489459|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5499480|NCT04489459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5499481|NCT04489459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499482|NCT04489446|Sildenafil Citrate|sildenafil citrate|mesh-list
5499483|NCT04489446|Vasodilator Agents|vasodilator agents|mesh-ancestor
5499484|NCT04489446|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5499485|NCT04489446|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5499486|NCT04489446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5499487|NCT04489446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049145|NCT05247385|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6049146|NCT05247385|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6049147|NCT05247385|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6049148|NCT05247385|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6049149|NCT05247385|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6049150|NCT05247385|Purinergic Agents|purinergic agents|mesh-ancestor
6049151|NCT05247385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6049152|NCT05247385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499488|NCT04489446|Urological Agents|urological agents|mesh-ancestor
5499489|NCT04489147|Metformin|metformin|mesh-list
5499490|NCT04489147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5499491|NCT04489147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499492|NCT04489121|Omalizumab|omalizumab|mesh-list
5499493|NCT04489121|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5499494|NCT04489121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5499495|NCT04489121|Respiratory System Agents|respiratory system agents|mesh-ancestor
6049153|NCT05247385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049154|NCT05247320|Sotalol|sotalol|mesh-list
6049155|NCT05247320|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6049156|NCT05247320|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6049157|NCT05247320|Adrenergic Agents|adrenergic agents|mesh-ancestor
6049158|NCT05247320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6049159|NCT05247320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049160|NCT05247320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049161|NCT05247320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6049162|NCT05247320|Sympatholytics|sympatholytics|mesh-ancestor
6049163|NCT05247320|Autonomic Agents|autonomic agents|mesh-ancestor
6049164|NCT05247320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6049165|NCT05247268|Letrozole|letrozole|mesh-list
6049166|NCT05247268|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6049167|NCT05247268|Megestrol|megestrol|mesh-list
6049168|NCT05247268|Megestrol Acetate|megestrol acetate|mesh-list
6049169|NCT05247268|Medroxyprogesterone|medroxyprogesterone|mesh-list
6049170|NCT05247268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6049171|NCT05247268|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6049172|NCT05247268|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6049173|NCT05247268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6049174|NCT05247268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049175|NCT05247268|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6049176|NCT05247268|Hormone Antagonists|hormone antagonists|mesh-ancestor
5499496|NCT04489381|Nitazoxanide|nitazoxanide|mesh-list
6049177|NCT05247268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6049178|NCT05247268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655311|NCT01463150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655312|NCT01463150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655313|NCT01463163|Ticagrelor|ticagrelor|mesh-list
6655314|NCT01463163|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6655315|NCT01463163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5499497|NCT04489381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5499498|NCT04489381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5499499|NCT04489160|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
5499500|NCT04489160|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5499501|NCT04489160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5499502|NCT04489160|Immunologic Factors|immunologic factors|mesh-ancestor
5499503|NCT04489160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049179|NCT05247268|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6049180|NCT05247268|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6049181|NCT05247268|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6049182|NCT05247268|Contraceptive Agents|contraceptive agents|mesh-ancestor
6049183|NCT05247268|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6049184|NCT05247268|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6049185|NCT05247268|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6049186|NCT05247268|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5499504|NCT04489173|Trifluridine|trifluridine|mesh-list
5499505|NCT04489173|Antimetabolites|antimetabolites|mesh-ancestor
5499506|NCT04489173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049187|NCT05247268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6049188|NCT05247268|Appetite Stimulants|appetite stimulants|mesh-ancestor
6049189|NCT05247268|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6049190|NCT05247177|Dexmedetomidine|dexmedetomidine|mesh-list
6049191|NCT05247177|Ketamine|ketamine|mesh-list
6049192|NCT05247177|Anesthetics|anesthetics|mesh-list
6049193|NCT05247177|Sevoflurane|sevoflurane|mesh-list
6049194|NCT05247177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6049195|NCT05247177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049196|NCT05247177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6049197|NCT05247177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6049198|NCT05247177|Analgesics|analgesics|mesh-ancestor
6049199|NCT05247177|Sensory System Agents|sensory system agents|mesh-ancestor
6049200|NCT05247177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6049201|NCT05247177|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6049202|NCT05247177|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5499507|NCT04489173|Antiviral Agents|antiviral agents|mesh-ancestor
5499508|NCT04489173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5499509|NCT04488978|Amlodipine|amlodipine|mesh-list
5499510|NCT04488978|Irbesartan|irbesartan|mesh-list
5499511|NCT04488978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5499512|NCT04488978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5499513|NCT04488978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5499514|NCT04488978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049203|NCT05247177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6049204|NCT05247177|Adrenergic Agents|adrenergic agents|mesh-ancestor
6049205|NCT05247177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6049206|NCT05247177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049207|NCT05247177|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6049208|NCT05247177|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5499515|NCT04488978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5499516|NCT04488978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499517|NCT04488978|Vasodilator Agents|vasodilator agents|mesh-ancestor
5499518|NCT04488978|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5499519|NCT04488978|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5499520|NCT04488705|Albuterol|albuterol|mesh-list
5499521|NCT04488705|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5499522|NCT04488705|Autonomic Agents|autonomic agents|mesh-ancestor
5499523|NCT04488705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5499524|NCT04488705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499525|NCT04488705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5499526|NCT04488705|Respiratory System Agents|respiratory system agents|mesh-ancestor
5499527|NCT04488705|Tocolytic Agents|tocolytic agents|mesh-ancestor
5499528|NCT04488705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5499529|NCT04488705|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6049209|NCT05247177|Anesthetics, General|anesthetics, general|mesh-ancestor
6655316|NCT01463163|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6049210|NCT05247177|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6049211|NCT05247177|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6049212|NCT05247177|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6049213|NCT05247177|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6049214|NCT05247151|Oxytocin|oxytocin|mesh-list
6049215|NCT05247151|Oxytocics|oxytocics|mesh-ancestor
6049216|NCT05247151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6049217|NCT05247151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049218|NCT05247125|Melatonin|melatonin|mesh-list
6049219|NCT05247125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049220|NCT05247125|Antioxidants|antioxidants|mesh-ancestor
6049221|NCT05247125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049222|NCT05247125|Protective Agents|protective agents|mesh-ancestor
6049223|NCT05247125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6054007|NCT00600353|Aprepitant|aprepitant|mesh-list
6054008|NCT00600353|Palonosetron|palonosetron|mesh-list
6054009|NCT00600353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6054010|NCT00600353|Antiemetics|antiemetics|mesh-ancestor
6054011|NCT00600353|Autonomic Agents|autonomic agents|mesh-ancestor
6054012|NCT00600353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6054013|NCT00600353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054014|NCT00600353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6054015|NCT00600353|Glucocorticoids|glucocorticoids|mesh-ancestor
6054016|NCT00600353|Hormones|hormones|mesh-ancestor
6054017|NCT00600353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6054018|NCT00600353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6054019|NCT00600353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6054020|NCT00600353|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6054021|NCT00600353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6054022|NCT00600353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054023|NCT00600353|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6054024|NCT00600353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6054025|NCT00600353|Serotonin Agents|serotonin agents|mesh-ancestor
6054026|NCT00600756|Risperidone|risperidone|mesh-list
6054027|NCT00600756|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6054028|NCT00600756|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6054029|NCT00600756|Serotonin Agents|serotonin agents|mesh-ancestor
6054030|NCT00600756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5499530|NCT04488705|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5499531|NCT04488705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5499532|NCT04488705|Adrenergic Agents|adrenergic agents|mesh-ancestor
5499533|NCT04488705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5499534|NCT04488705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499535|NCT04488744|Nicotine|nicotine|mesh-list
5499536|NCT04488744|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5499537|NCT04488744|Autonomic Agents|autonomic agents|mesh-ancestor
5499538|NCT04488744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5499539|NCT04488744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499540|NCT04488744|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5499541|NCT04488744|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5499542|NCT04488744|Cholinergic Agents|cholinergic agents|mesh-ancestor
6054031|NCT00600756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054032|NCT00600756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054033|NCT00600756|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6054034|NCT00600756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6054035|NCT00600756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6054036|NCT00600756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6054037|NCT00600756|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6054038|NCT00600756|Dopamine Agents|dopamine agents|mesh-ancestor
6054039|NCT00600756|Antidepressive Agents|antidepressive agents|mesh-ancestor
6054040|NCT00600821|Paclitaxel|paclitaxel|mesh-list
6054041|NCT00600821|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6054042|NCT00600821|Bevacizumab|bevacizumab|mesh-list
6054043|NCT00600821|Carboplatin|carboplatin|mesh-list
6054044|NCT00600821|Axitinib|axitinib|mesh-list
6054045|NCT00600821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5499543|NCT04488744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5499544|NCT04488744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499545|NCT04488614|Zoledronic Acid|zoledronic acid|mesh-list
5499546|NCT04488614|Estrogens|estrogens|mesh-list
5499547|NCT04488614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5499548|NCT04488614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499549|NCT04488614|Hormones|hormones|mesh-ancestor
5499550|NCT04488614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6054046|NCT00600821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6049224|NCT05246982|Capecitabine|capecitabine|mesh-list
6049225|NCT05246982|Oxaliplatin|oxaliplatin|mesh-list
6049226|NCT05246982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6049227|NCT05246982|Antimetabolites|antimetabolites|mesh-ancestor
6049228|NCT05246982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049229|NCT05246982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6049230|NCT05246943|Fibrin fragment D|fibrin fragment d|mesh-list
6049231|NCT05246943|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6049232|NCT05246943|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6049233|NCT05246943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049234|NCT05246943|Hemostatics|hemostatics|mesh-ancestor
6049235|NCT05246943|Coagulants|coagulants|mesh-ancestor
6049236|NCT05246865|Androgens|androgens|mesh-list
6049237|NCT05246865|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
6049238|NCT05246865|Hormones|hormones|mesh-ancestor
6049239|NCT05246865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6049240|NCT05246865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049241|NCT05246865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6049242|NCT05246865|Immunologic Factors|immunologic factors|mesh-ancestor
6049243|NCT05246670|Palmidrol|palmidrol|mesh-list
6049244|NCT05246670|Analgesics|analgesics|mesh-ancestor
6049245|NCT05246670|Sensory System Agents|sensory system agents|mesh-ancestor
6049246|NCT05246670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6049247|NCT05246670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049248|NCT05246670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6049249|NCT05246670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6049250|NCT05246670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6049251|NCT05246670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6049252|NCT05246670|Antiviral Agents|antiviral agents|mesh-ancestor
6049253|NCT05246670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6049254|NCT05246670|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6049255|NCT05246670|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6049256|NCT05246670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6049257|NCT05246670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049258|NCT05246670|Hormones|hormones|mesh-ancestor
6049259|NCT05246670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6049260|NCT05246644|Acetaminophen|acetaminophen|mesh-list
6049261|NCT05246644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6049262|NCT05246644|Analgesics|analgesics|mesh-ancestor
6049263|NCT05246644|Sensory System Agents|sensory system agents|mesh-ancestor
6049264|NCT05246644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6049265|NCT05246644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049266|NCT05246644|Antipyretics|antipyretics|mesh-ancestor
6049267|NCT05246631|Dexamethasone|dexamethasone|mesh-list
6049268|NCT05246631|Dexamethasone acetate|dexamethasone acetate|mesh-list
6049269|NCT05246631|Haloperidol|haloperidol|mesh-list
6049270|NCT05246631|Haloperidol decanoate|haloperidol decanoate|mesh-list
6049271|NCT05246631|BB 1101|bb 1101|mesh-list
6049272|NCT05246631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6049273|NCT05246631|Antiemetics|antiemetics|mesh-ancestor
6049274|NCT05246631|Autonomic Agents|autonomic agents|mesh-ancestor
6049275|NCT05246631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6049276|NCT05246631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499551|NCT04488926|Palmidrol|palmidrol|mesh-list
5499552|NCT04488926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5499553|NCT04488926|Analgesics|analgesics|mesh-ancestor
5499554|NCT04488926|Sensory System Agents|sensory system agents|mesh-ancestor
5499555|NCT04488926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5499556|NCT04488926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499557|NCT04488926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5499558|NCT04488926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5499559|NCT04488926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5499560|NCT04488926|Antiviral Agents|antiviral agents|mesh-ancestor
5499561|NCT04488926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5499562|NCT04488926|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5499563|NCT04488926|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5499564|NCT04488926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5499565|NCT04488926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499566|NCT04488926|Hormones|hormones|mesh-ancestor
5499567|NCT04488926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5499568|NCT04488952|Anesthetics|anesthetics|mesh-list
5499569|NCT04488952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5499570|NCT04488952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499571|NCT04488874|Mannitol|mannitol|mesh-list
6049277|NCT05246631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6049278|NCT05246631|Glucocorticoids|glucocorticoids|mesh-ancestor
6049279|NCT05246631|Hormones|hormones|mesh-ancestor
6049280|NCT05246631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6049281|NCT05246631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5499572|NCT04488874|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6049282|NCT05246631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6049283|NCT05246631|Protease Inhibitors|protease inhibitors|mesh-ancestor
6049284|NCT05246631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6049285|NCT05246631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049286|NCT05246631|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6049287|NCT05246631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6049288|NCT05246631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6049289|NCT05246631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6049290|NCT05246631|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6049291|NCT05246631|Dopamine Agents|dopamine agents|mesh-ancestor
5499573|NCT04488874|Diuretics|diuretics|mesh-ancestor
5499574|NCT04488874|Natriuretic Agents|natriuretic agents|mesh-ancestor
5499575|NCT04488874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499576|NCT04488601|Sirolimus|sirolimus|mesh-list
5499577|NCT04488601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5499578|NCT04488601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5499579|NCT04488601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5499580|NCT04488601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5499581|NCT04488601|Antifungal Agents|antifungal agents|mesh-ancestor
5499582|NCT04488601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5499583|NCT04488601|Immunologic Factors|immunologic factors|mesh-ancestor
5499584|NCT04488601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499585|NCT04488315|Dexamethasone|dexamethasone|mesh-list
5499586|NCT04488315|Dexamethasone acetate|dexamethasone acetate|mesh-list
6049292|NCT05246631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6049293|NCT05246631|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6049294|NCT05246514|Trastuzumab|trastuzumab|mesh-list
6049295|NCT05246514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6049296|NCT05246514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6049297|NCT05246371|Dexmedetomidine|dexmedetomidine|mesh-list
6049298|NCT05246371|Propofol|propofol|mesh-list
6049299|NCT05246371|Desflurane|desflurane|mesh-list
6049300|NCT05246371|Anesthetics|anesthetics|mesh-ancestor
6049301|NCT05246371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6049302|NCT05246371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049303|NCT05246371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6049304|NCT05246371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6049305|NCT05246371|Anesthetics, General|anesthetics, general|mesh-ancestor
6049306|NCT05246371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6049307|NCT05246371|Analgesics|analgesics|mesh-ancestor
6049308|NCT05246371|Sensory System Agents|sensory system agents|mesh-ancestor
6049309|NCT05246371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6049310|NCT05246371|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6049311|NCT05246371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6049312|NCT05246371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6049313|NCT05246371|Adrenergic Agents|adrenergic agents|mesh-ancestor
6049314|NCT05246371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6458542|NCT00440843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6458543|NCT00440843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458544|NCT00440843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6458545|NCT00440843|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6458546|NCT00440843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5499587|NCT04488315|Ropivacaine|ropivacaine|mesh-list
5499588|NCT04488315|BB 1101|bb 1101|mesh-list
5499589|NCT04488315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5499590|NCT04488315|Antiemetics|antiemetics|mesh-ancestor
5499591|NCT04488315|Autonomic Agents|autonomic agents|mesh-ancestor
5499592|NCT04488315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5499593|NCT04488315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499594|NCT04488315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5499595|NCT04488315|Glucocorticoids|glucocorticoids|mesh-ancestor
5499596|NCT04488315|Hormones|hormones|mesh-ancestor
5499597|NCT04488315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6049315|NCT05246371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049316|NCT05246371|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6049317|NCT05246293|Tofacitinib|tofacitinib|mesh-list
6049318|NCT05246293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6049319|NCT05246293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6049320|NCT05246293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499598|NCT04488315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5499599|NCT04488315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5499600|NCT04488315|Protease Inhibitors|protease inhibitors|mesh-ancestor
5499601|NCT04488315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5499602|NCT04488315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499603|NCT04488315|Anesthetics, Local|anesthetics, local|mesh-ancestor
5499604|NCT04488315|Anesthetics|anesthetics|mesh-ancestor
6049321|NCT05246111|Topotecan|topotecan|mesh-list
6049322|NCT05246111|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6049323|NCT05246111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6049324|NCT05246111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6049325|NCT05246111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049326|NCT05246111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6049327|NCT05246085|Hydrocortisone|hydrocortisone|mesh-list
6049328|NCT05246085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6049329|NCT05246072|Ivermectin|ivermectin|mesh-list
6049330|NCT05246072|Colchicine|colchicine|mesh-list
6049331|NCT05246072|Gout Suppressants|gout suppressants|mesh-ancestor
6049332|NCT05246072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6049333|NCT05246072|Tubulin Modulators|tubulin modulators|mesh-ancestor
6049334|NCT05246072|Antimitotic Agents|antimitotic agents|mesh-ancestor
6049335|NCT05246072|Mitosis Modulators|mitosis modulators|mesh-ancestor
6049336|NCT05246072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049337|NCT05246072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6049338|NCT05246072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6049339|NCT05246072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6049340|NCT05246007|Dexmedetomidine|dexmedetomidine|mesh-list
6049341|NCT05246007|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6049342|NCT05246007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6049343|NCT05246007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049344|NCT05246007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6049345|NCT05246007|Analgesics|analgesics|mesh-ancestor
6049346|NCT05246007|Sensory System Agents|sensory system agents|mesh-ancestor
6049347|NCT05246007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6049348|NCT05246007|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6049349|NCT05246007|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6049350|NCT05246007|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6049351|NCT05246007|Adrenergic Agents|adrenergic agents|mesh-ancestor
6049352|NCT05246007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6049353|NCT05246007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049354|NCT05245994|Carboplatin|carboplatin|mesh-list
6049355|NCT05245994|Etoposide|etoposide|mesh-list
6049356|NCT05245994|Durvalumab|durvalumab|mesh-list
6049357|NCT05245994|Olaparib|olaparib|mesh-list
6049358|NCT05245994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6049359|NCT05245994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6049360|NCT05245994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6049361|NCT05245994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6049362|NCT05245994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6049363|NCT05245994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049364|NCT05245994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6049365|NCT05245994|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6049366|NCT05245968|Sunitinib|sunitinib|mesh-list
6049367|NCT05245968|Imatinib Mesylate|imatinib mesylate|mesh-list
6049368|NCT05245968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6049369|NCT05245968|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6049370|NCT05245968|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6049371|NCT05245968|Growth Substances|growth substances|mesh-ancestor
6049372|NCT05245968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049373|NCT05245968|Growth Inhibitors|growth inhibitors|mesh-ancestor
6049374|NCT05245968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6049375|NCT05245968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6049376|NCT05245968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049377|NCT05245916|Rituximab|rituximab|mesh-list
6054047|NCT00600821|Tubulin Modulators|tubulin modulators|mesh-ancestor
5499605|NCT04488315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5499606|NCT04488315|Sensory System Agents|sensory system agents|mesh-ancestor
5499607|NCT04488159|Leucovorin|leucovorin|mesh-list
5499608|NCT04488159|Fluorouracil|fluorouracil|mesh-list
5499609|NCT04488159|Capecitabine|capecitabine|mesh-list
5499610|NCT04488159|Oxaliplatin|oxaliplatin|mesh-list
5499611|NCT04488159|Antimetabolites|antimetabolites|mesh-ancestor
5499612|NCT04488159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499613|NCT04488159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5499614|NCT04488159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5499615|NCT04488159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5499616|NCT04488159|Immunologic Factors|immunologic factors|mesh-ancestor
5499617|NCT04488159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499618|NCT04488159|Antidotes|antidotes|mesh-ancestor
5499619|NCT04488159|Protective Agents|protective agents|mesh-ancestor
5499620|NCT04488159|Vitamin B Complex|vitamin b complex|mesh-ancestor
5499621|NCT04488159|Vitamins|vitamins|mesh-ancestor
5499622|NCT04488159|Micronutrients|micronutrients|mesh-ancestor
5499623|NCT04488107|Letrozole|letrozole|mesh-list
5499624|NCT04488107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5499625|NCT04488107|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5499626|NCT04488107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5499627|NCT04488107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5499628|NCT04488107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499629|NCT04488107|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5499630|NCT04488107|Hormone Antagonists|hormone antagonists|mesh-ancestor
5499631|NCT04488107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5499632|NCT04488107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499633|NCT04488367|Tranexamic Acid|tranexamic acid|mesh-list
5499634|NCT04488367|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5499635|NCT04488367|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5499636|NCT04488367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499637|NCT04488367|Hemostatics|hemostatics|mesh-ancestor
5499638|NCT04488367|Coagulants|coagulants|mesh-ancestor
5499639|NCT04488081|Cyclosporine|cyclosporine|mesh-list
5499640|NCT04488081|Remdesivir|remdesivir|mesh-list
5499641|NCT04488081|Celecoxib|celecoxib|mesh-list
5499642|NCT04488081|Famotidine|famotidine|mesh-list
5499643|NCT04488081|Cyclosporins|cyclosporins|mesh-list
5499644|NCT04488081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5499645|NCT04488081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499646|NCT04488081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5499647|NCT04488081|Immunologic Factors|immunologic factors|mesh-ancestor
5499648|NCT04488081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049378|NCT05245916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6049379|NCT05245916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6049380|NCT05245916|Immunologic Factors|immunologic factors|mesh-ancestor
6049381|NCT05245916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049382|NCT05245916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6049383|NCT05245877|Enoxaparin|enoxaparin|mesh-list
6049384|NCT05245877|Dalteparin|dalteparin|mesh-list
5499649|NCT04488081|Antifungal Agents|antifungal agents|mesh-ancestor
5499650|NCT04488081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5499651|NCT04488081|Dermatologic Agents|dermatologic agents|mesh-ancestor
5499652|NCT04488081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6049385|NCT05245877|Tinzaparin|tinzaparin|mesh-list
6049386|NCT05245877|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6049387|NCT05245877|Anticoagulants|anticoagulants|mesh-ancestor
6049388|NCT05245877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6049389|NCT05245877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6049390|NCT05245877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049391|NCT05245786|Copper|copper|mesh-list
6049392|NCT05245786|Antibodies|antibodies|mesh-list
6049393|NCT05245786|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6049394|NCT05245786|Immunologic Factors|immunologic factors|mesh-ancestor
6049395|NCT05245786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049396|NCT05245786|Trace Elements|trace elements|mesh-ancestor
6049397|NCT05245786|Micronutrients|micronutrients|mesh-ancestor
6049398|NCT05245734|Immunoglobulins|immunoglobulins|mesh-list
6049399|NCT05245734|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6049400|NCT05245734|Antibodies|antibodies|mesh-list
6049401|NCT05245734|gamma-Globulins|gamma-globulins|mesh-list
6049402|NCT05245734|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6049403|NCT05245734|Immunologic Factors|immunologic factors|mesh-ancestor
6049404|NCT05245734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458547|NCT00440843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5499653|NCT04488081|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5499654|NCT04488081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5499655|NCT04488081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6049405|NCT05245721|Nalbuphine|nalbuphine|mesh-list
5499656|NCT04488081|Analgesics|analgesics|mesh-ancestor
5499657|NCT04488081|Sensory System Agents|sensory system agents|mesh-ancestor
5499658|NCT04488081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5499659|NCT04488081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6049406|NCT05245721|Bupivacaine|bupivacaine|mesh-list
6049407|NCT05245721|Anesthetics, Local|anesthetics, local|mesh-ancestor
6049408|NCT05245721|Anesthetics|anesthetics|mesh-ancestor
6049409|NCT05245721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6049410|NCT05245721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049411|NCT05245721|Sensory System Agents|sensory system agents|mesh-ancestor
6049412|NCT05245721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6049413|NCT05245721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6049414|NCT05245721|Narcotics|narcotics|mesh-ancestor
6049415|NCT05245721|Analgesics|analgesics|mesh-ancestor
6049416|NCT05245708|Oxytocin|oxytocin|mesh-list
6049417|NCT05245708|Oxytocics|oxytocics|mesh-ancestor
6049418|NCT05245708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6049419|NCT05245708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049420|NCT05245669|Denosumab|denosumab|mesh-list
6049421|NCT05245669|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6049422|NCT05245669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054048|NCT00600821|Antimitotic Agents|antimitotic agents|mesh-ancestor
6054049|NCT00600821|Mitosis Modulators|mitosis modulators|mesh-ancestor
6054050|NCT00600821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054051|NCT00600821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6054052|NCT00600821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6054053|NCT00600821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6054054|NCT00600821|Growth Substances|growth substances|mesh-ancestor
6054055|NCT00600821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054056|NCT00600821|Growth Inhibitors|growth inhibitors|mesh-ancestor
6054057|NCT00600821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6054058|NCT00600821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6054059|NCT00600886|Octreotide|octreotide|mesh-list
6054060|NCT00600886|Pasireotide|pasireotide|mesh-list
6054061|NCT00600886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6054062|NCT00600886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6054063|NCT00600886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6054064|NCT00600886|Hormones|hormones|mesh-ancestor
6054065|NCT00600886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6054066|NCT00600886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054067|NCT00600925|Gentamicins|gentamicins|mesh-list
6054068|NCT00600925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6054069|NCT00600925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6054070|NCT00600925|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6054071|NCT00600925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6054072|NCT00600925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054073|NCT00600938|Deferasirox|deferasirox|mesh-list
6054074|NCT00600938|Deferoxamine|deferoxamine|mesh-list
6054075|NCT00600938|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6054076|NCT00600938|Chelating Agents|chelating agents|mesh-ancestor
6458548|NCT00440843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5499660|NCT04488081|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5499661|NCT04488081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5499662|NCT04488081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6049423|NCT05245604|Cyclosporine|cyclosporine|mesh-list
6049424|NCT05245604|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6049425|NCT05245604|Cyclosporins|cyclosporins|mesh-list
6049426|NCT05245604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6049427|NCT05245604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049428|NCT05245604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6049429|NCT05245604|Immunologic Factors|immunologic factors|mesh-ancestor
6049430|NCT05245604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049431|NCT05245604|Antifungal Agents|antifungal agents|mesh-ancestor
5499663|NCT04488081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5499664|NCT04488081|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5499665|NCT04488081|Histamine Antagonists|histamine antagonists|mesh-ancestor
5499666|NCT04488081|Histamine Agents|histamine agents|mesh-ancestor
5499667|NCT04488081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5499668|NCT04488081|Antimetabolites|antimetabolites|mesh-ancestor
5499669|NCT04488081|Antiviral Agents|antiviral agents|mesh-ancestor
5503461|NCT04459026|Ropivacaine|ropivacaine|mesh-list
5503462|NCT04459026|Anesthetics, Local|anesthetics, local|mesh-ancestor
5503463|NCT04459026|Anesthetics|anesthetics|mesh-ancestor
5503464|NCT04459026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5503465|NCT04459026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049432|NCT05245604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6049433|NCT05245604|Dermatologic Agents|dermatologic agents|mesh-ancestor
6049434|NCT05245604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6049435|NCT05245604|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6049436|NCT05245604|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6049437|NCT05245591|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
6049438|NCT05245591|Anticoagulants|anticoagulants|mesh-ancestor
6049439|NCT05245552|Vaccines|vaccines|mesh-list
6049440|NCT05245552|Immunologic Factors|immunologic factors|mesh-ancestor
6049441|NCT05245552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049442|NCT05245474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5503466|NCT04459026|Sensory System Agents|sensory system agents|mesh-ancestor
5503467|NCT04459026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5503468|NCT04459234|Ketamine|ketamine|mesh-list
5503469|NCT04459234|Analgesics|analgesics|mesh-ancestor
5503470|NCT04459234|Sensory System Agents|sensory system agents|mesh-ancestor
5503471|NCT04459234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5503472|NCT04459234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503473|NCT04459234|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5503474|NCT04459234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5503475|NCT04459234|Anesthetics, General|anesthetics, general|mesh-ancestor
5503476|NCT04459234|Anesthetics|anesthetics|mesh-ancestor
6049443|NCT05245474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049444|NCT05245474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6049445|NCT05245448|Tetrandrine|tetrandrine|mesh-list
6049446|NCT05245448|Antimalarials|antimalarials|mesh-ancestor
6049447|NCT05245448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5503477|NCT04459234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5503478|NCT04459234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5503479|NCT04459234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5503480|NCT04459234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5503481|NCT04459234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503482|NCT04458454|Methocarbamol|methocarbamol|mesh-list
5503483|NCT04458454|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5503484|NCT04458454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503485|NCT04458454|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5503486|NCT04458454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5503487|NCT04458558|Mifepristone|mifepristone|mesh-list
6049448|NCT05245448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6049449|NCT05245448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6049450|NCT05245448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6049451|NCT05245448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6049452|NCT05245448|Antiviral Agents|antiviral agents|mesh-ancestor
6049453|NCT05245448|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6049454|NCT05245448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6049455|NCT05245448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049456|NCT05245448|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6049457|NCT05245448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049458|NCT05245448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6049459|NCT05245448|Immunologic Factors|immunologic factors|mesh-ancestor
6049460|NCT05245071|Maytansine|maytansine|mesh-list
5499670|NCT04488172|Vitamins|vitamins|mesh-list
5499671|NCT04488172|Micronutrients|micronutrients|mesh-ancestor
5499672|NCT04488172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499673|NCT04487990|Heparin|heparin|mesh-list
5499674|NCT04487990|Calcium heparin|calcium heparin|mesh-list
5499675|NCT04487990|Anticoagulants|anticoagulants|mesh-ancestor
5499676|NCT04487990|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5499677|NCT04487990|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5499678|NCT04487990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499679|NCT04487951|Vitamin D|vitamin d|mesh-list
6049461|NCT05245071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6049462|NCT05245071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6049463|NCT05245071|Tubulin Modulators|tubulin modulators|mesh-ancestor
6049464|NCT05245071|Antimitotic Agents|antimitotic agents|mesh-ancestor
6049465|NCT05245071|Mitosis Modulators|mitosis modulators|mesh-ancestor
6049466|NCT05245071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049467|NCT05243823|Estradiol|estradiol|mesh-list
6049468|NCT05243823|Estrogens|estrogens|mesh-ancestor
6049469|NCT05243823|Hormones|hormones|mesh-ancestor
6049470|NCT05243823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6049471|NCT05243823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049472|NCT05220917|Insulin|insulin|mesh-list
6049473|NCT05220917|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6049474|NCT05220917|Metformin|metformin|mesh-list
6458549|NCT00440843|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6458550|NCT00440843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6458551|NCT00440843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6458552|NCT00440843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458553|NCT00440843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6458554|NCT00440843|Serotonin Agents|serotonin agents|mesh-ancestor
6458555|NCT00440869|Acetylcysteine|acetylcysteine|mesh-list
5499680|NCT04487951|Vitamins|vitamins|mesh-ancestor
5499681|NCT04487951|Micronutrients|micronutrients|mesh-ancestor
5499682|NCT04487951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499683|NCT04487951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5499684|NCT04487743|Liraglutide|liraglutide|mesh-list
5499685|NCT04487743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6458556|NCT00440869|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6458557|NCT00440869|Antiviral Agents|antiviral agents|mesh-ancestor
6458558|NCT00440869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6458559|NCT00440869|Expectorants|expectorants|mesh-ancestor
6458560|NCT00440869|Respiratory System Agents|respiratory system agents|mesh-ancestor
6458561|NCT00440869|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6458562|NCT00440869|Antioxidants|antioxidants|mesh-ancestor
6458563|NCT00440869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049475|NCT05220917|Insulin Glargine|insulin glargine|mesh-list
6049476|NCT05220917|Pioglitazone|pioglitazone|mesh-list
6049477|NCT05220917|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6655317|NCT01463163|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6655318|NCT01463163|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6655319|NCT01463163|Purinergic Agents|purinergic agents|mesh-ancestor
6049478|NCT05220917|Liraglutide|liraglutide|mesh-list
6049479|NCT05220917|Dapagliflozin|dapagliflozin|mesh-list
6049480|NCT05220917|Empagliflozin|empagliflozin|mesh-list
6049481|NCT05220917|Exenatide|exenatide|mesh-list
6049482|NCT05220917|Glimepiride|glimepiride|mesh-list
6049483|NCT05220917|Rosiglitazone|rosiglitazone|mesh-list
6049484|NCT05220917|Linagliptin|linagliptin|mesh-list
6049485|NCT05220917|Saxagliptin|saxagliptin|mesh-list
6049486|NCT05220917|Canagliflozin|canagliflozin|mesh-list
6458564|NCT00440869|Protective Agents|protective agents|mesh-ancestor
6458565|NCT00440869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458566|NCT00440869|Antidotes|antidotes|mesh-ancestor
6458567|NCT00440895|Abciximab|abciximab|mesh-list
5499686|NCT04487743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499687|NCT04487743|Incretins|incretins|mesh-ancestor
6049487|NCT05220917|Alogliptin|alogliptin|mesh-list
6049488|NCT05220917|Glyburide|glyburide|mesh-list
6049489|NCT05220917|Dulaglutide|dulaglutide|mesh-list
6049490|NCT05220917|Ertugliflozin|ertugliflozin|mesh-list
6458568|NCT00440895|Anticoagulants|anticoagulants|mesh-ancestor
6458569|NCT00440895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6049491|NCT05220917|Lixisenatide|lixisenatide|mesh-list
6049492|NCT05220917|Glipizide|glipizide|mesh-list
6049493|NCT05220917|Xultophy|xultophy|mesh-list
6049494|NCT05220917|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
6049495|NCT05220917|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
6049496|NCT05220917|Simvastatin|simvastatin|mesh-list
6049497|NCT05220917|rGLP-1 protein|rglp-1 protein|mesh-list
6049498|NCT05220917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6049499|NCT05220917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049500|NCT05220917|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6049501|NCT05220917|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6049502|NCT05220917|Antimetabolites|antimetabolites|mesh-ancestor
6049503|NCT05220917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049504|NCT05220917|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6049505|NCT05220917|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6049506|NCT05220917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6049507|NCT05220917|Incretins|incretins|mesh-ancestor
6049508|NCT05220917|Hormones|hormones|mesh-ancestor
6049509|NCT05220917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6049510|NCT05220917|Protease Inhibitors|protease inhibitors|mesh-ancestor
6049511|NCT05220917|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6049512|NCT05220917|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6049513|NCT05220917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6049514|NCT05220917|Immunologic Factors|immunologic factors|mesh-ancestor
6049515|NCT05220826|Ethanol|ethanol|mesh-list
6049516|NCT05220826|Ethylene|ethylene|mesh-list
5499688|NCT04487743|Hormones|hormones|mesh-ancestor
5499689|NCT04487743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5499690|NCT04487834|Simethicone|simethicone|mesh-list
5499691|NCT04487834|Antifoaming Agents|antifoaming agents|mesh-ancestor
6049517|NCT05220826|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6049518|NCT05220826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6049519|NCT05220826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6049520|NCT05220826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049521|NCT05220826|Plant Growth Regulators|plant growth regulators|mesh-ancestor
6049522|NCT05220826|Growth Substances|growth substances|mesh-ancestor
5499692|NCT04487834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499693|NCT04487834|Emollients|emollients|mesh-ancestor
5499694|NCT04487834|Dermatologic Agents|dermatologic agents|mesh-ancestor
5499695|NCT04487652|Coenzyme Q10|coenzyme q10|mesh-list
5499696|NCT04487652|Vitamins|vitamins|mesh-ancestor
5499697|NCT04487652|Micronutrients|micronutrients|mesh-ancestor
5499698|NCT04487652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499699|NCT04487756|Carboplatin|carboplatin|mesh-list
5499700|NCT04487756|Atezolizumab|atezolizumab|mesh-list
5499701|NCT04487756|Vaccines|vaccines|mesh-list
5499702|NCT04487756|Immunologic Factors|immunologic factors|mesh-ancestor
5499703|NCT04487756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049523|NCT05220046|Psilocybin|psilocybin|mesh-list
6049524|NCT05220046|Hallucinogens|hallucinogens|mesh-ancestor
6049525|NCT05220046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049526|NCT05220046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6049527|NCT05219877|Levofloxacin|levofloxacin|mesh-list
6049528|NCT05219877|Ofloxacin|ofloxacin|mesh-list
6049529|NCT05219877|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6049530|NCT05219877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5499704|NCT04487756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5499705|NCT04487587|Olaparib|olaparib|mesh-list
5499706|NCT04487587|Cediranib|cediranib|mesh-list
5499707|NCT04487587|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5499708|NCT04487587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5499709|NCT04487587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499710|NCT04487587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5499711|NCT04487587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5499712|NCT04487236|Capecitabine|capecitabine|mesh-list
5499713|NCT04487236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6049531|NCT05219877|Renal Agents|renal agents|mesh-ancestor
6049532|NCT05219877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6049533|NCT05219877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6458570|NCT00440921|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6458571|NCT00440921|Hemostatics|hemostatics|mesh-ancestor
6458572|NCT00440921|Coagulants|coagulants|mesh-ancestor
6458573|NCT00440960|Lidocaine|lidocaine|mesh-list
6458574|NCT00440960|Midazolam|midazolam|mesh-list
5499714|NCT04487236|Antimetabolites|antimetabolites|mesh-ancestor
6049534|NCT05219877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6049535|NCT05219877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6458575|NCT00440960|Alfentanil|alfentanil|mesh-list
6049536|NCT05219877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049537|NCT05219877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6049538|NCT05219877|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6049539|NCT05219877|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6049540|NCT05216432|Fulvestrant|fulvestrant|mesh-list
6049541|NCT05216432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6049542|NCT05216432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6049543|NCT05216432|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6049544|NCT05216432|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6049545|NCT05216432|Hormone Antagonists|hormone antagonists|mesh-ancestor
6049546|NCT05216432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6049547|NCT05216432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049548|NCT05214287|Nitrox|nitrox|mesh-list
6049549|NCT05214287|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6049550|NCT05214287|Protective Agents|protective agents|mesh-ancestor
6049551|NCT05214287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049552|NCT05213481|Tepotinib|tepotinib|mesh-list
6049553|NCT05213481|Carbamazepine|carbamazepine|mesh-list
6049554|NCT05213481|Anticonvulsants|anticonvulsants|mesh-ancestor
6049555|NCT05213481|Antimanic Agents|antimanic agents|mesh-ancestor
6049556|NCT05213481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6049557|NCT05213481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6049558|NCT05213481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049559|NCT05213481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6049560|NCT05213481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6049561|NCT05213481|Analgesics|analgesics|mesh-ancestor
6049562|NCT05213481|Sensory System Agents|sensory system agents|mesh-ancestor
6049563|NCT05213481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5499715|NCT04487236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499716|NCT04487236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5499717|NCT04487444|Thymalfasin|thymalfasin|mesh-list
6049564|NCT05213481|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6049565|NCT05213481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6049566|NCT05213481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049567|NCT05213481|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6049568|NCT05213481|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6049569|NCT05213481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6049570|NCT05208710|Vaccines|vaccines|mesh-list
6049571|NCT05208710|Immunologic Factors|immunologic factors|mesh-ancestor
6049572|NCT05208710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049573|NCT05204563|Imipenem|imipenem|mesh-list
6049574|NCT05204563|Relebactam|relebactam|mesh-list
6049575|NCT05204563|Cilastatin|cilastatin|mesh-list
6049576|NCT05204563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6049577|NCT05204563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6049578|NCT05204563|Protease Inhibitors|protease inhibitors|mesh-ancestor
6049579|NCT05204563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6049580|NCT05204563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049581|NCT05204563|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6049582|NCT05204368|Meropenem|meropenem|mesh-list
6049583|NCT05204368|Imipenem|imipenem|mesh-list
6049584|NCT05204368|Cilastatin|cilastatin|mesh-list
6049585|NCT05204368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6049586|NCT05204368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6049587|NCT05204368|Protease Inhibitors|protease inhibitors|mesh-ancestor
6049588|NCT05204368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6049589|NCT05204368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049590|NCT05194488|Botulinum Toxins|botulinum toxins|mesh-list
6049591|NCT05194488|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6049592|NCT05194488|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6049593|NCT05194488|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6049594|NCT05194488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6049595|NCT05194488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458576|NCT00440960|Propofol|propofol|mesh-list
6458577|NCT00440960|Anesthetics, Local|anesthetics, local|mesh-ancestor
6458578|NCT00440960|Anesthetics|anesthetics|mesh-ancestor
6458579|NCT00440960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6458580|NCT00440960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458581|NCT00440960|Sensory System Agents|sensory system agents|mesh-ancestor
6458582|NCT00440960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6458583|NCT00440960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6458584|NCT00440960|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6458585|NCT00440960|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6049596|NCT05194488|Cholinergic Agents|cholinergic agents|mesh-ancestor
6049597|NCT05194488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6049598|NCT05194488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049599|NCT05194488|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6049600|NCT05194488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6049601|NCT05189457|Docetaxel|docetaxel|mesh-list
6049602|NCT05189457|Leuprolide|leuprolide|mesh-list
6049603|NCT05189457|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6049604|NCT05189457|Hormones|hormones|mesh-list
6049605|NCT05189457|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
6049606|NCT05189457|Relugolix|relugolix|mesh-list
6049607|NCT05189457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6049608|NCT05189457|Tubulin Modulators|tubulin modulators|mesh-ancestor
5499718|NCT04487444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5499719|NCT04487444|Immunologic Factors|immunologic factors|mesh-ancestor
5499720|NCT04487444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499721|NCT04487392|Estrogens|estrogens|mesh-list
5499722|NCT04487392|Hormones|hormones|mesh-ancestor
5499723|NCT04487392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5499724|NCT04487392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499725|NCT04487106|Azacitidine|azacitidine|mesh-list
5499726|NCT04487106|Venetoclax|venetoclax|mesh-list
5499727|NCT04487106|Trametinib|trametinib|mesh-list
5499728|NCT04487106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5499729|NCT04487106|Antimetabolites|antimetabolites|mesh-ancestor
5499730|NCT04487106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499731|NCT04487106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5499732|NCT04487106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6049609|NCT05189457|Antimitotic Agents|antimitotic agents|mesh-ancestor
6049610|NCT05189457|Mitosis Modulators|mitosis modulators|mesh-ancestor
6049611|NCT05189457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049612|NCT05189457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6049613|NCT05189457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049614|NCT05189457|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6049615|NCT05189457|Fertility Agents|fertility agents|mesh-ancestor
6049616|NCT05189457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6049617|NCT05189457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6049618|NCT05189457|Luteolytic Agents|luteolytic agents|mesh-ancestor
5499733|NCT04487106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5499734|NCT04487093|Vaccines|vaccines|mesh-list
5499735|NCT04487093|Immunologic Factors|immunologic factors|mesh-ancestor
5499736|NCT04487093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499737|NCT04486911|Letrozole|letrozole|mesh-list
5499738|NCT04486911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5499739|NCT04486911|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5499740|NCT04486911|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5499741|NCT04486911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5499742|NCT04486911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499743|NCT04486911|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5499744|NCT04486911|Hormone Antagonists|hormone antagonists|mesh-ancestor
5499745|NCT04486911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5499746|NCT04486911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499747|NCT04487145|Piperaquine|piperaquine|mesh-list
5499748|NCT04487145|Artenimol|artenimol|mesh-list
6049619|NCT05189457|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6049620|NCT05189457|Contraceptive Agents|contraceptive agents|mesh-ancestor
6049621|NCT05189457|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6049622|NCT05189457|Androgen Antagonists|androgen antagonists|mesh-ancestor
6049623|NCT05189457|Hormone Antagonists|hormone antagonists|mesh-ancestor
6049624|NCT05183984|Bevacizumab|bevacizumab|mesh-list
6049625|NCT05183984|Niraparib|niraparib|mesh-list
6049626|NCT05183984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6049627|NCT05183984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6049628|NCT05183984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6049629|NCT05183984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6049630|NCT05183984|Growth Substances|growth substances|mesh-ancestor
6049631|NCT05183984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049632|NCT05183984|Growth Inhibitors|growth inhibitors|mesh-ancestor
6049633|NCT05183984|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6049634|NCT05183984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6049635|NCT05183984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049636|NCT05175768|Niacinamide|niacinamide|mesh-list
6049637|NCT05175768|Niacin|niacin|mesh-list
5499749|NCT04487145|Antimalarials|antimalarials|mesh-ancestor
6049638|NCT05175768|Nicotinic Acids|nicotinic acids|mesh-list
6049639|NCT05175768|Vitamin B Complex|vitamin b complex|mesh-ancestor
6049640|NCT05175768|Vitamins|vitamins|mesh-ancestor
6049641|NCT05175768|Micronutrients|micronutrients|mesh-ancestor
6049642|NCT05175768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049643|NCT05175768|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6049644|NCT05175768|Antimetabolites|antimetabolites|mesh-ancestor
6049645|NCT05175768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049646|NCT05175768|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6049647|NCT05175768|Vasodilator Agents|vasodilator agents|mesh-ancestor
6049648|NCT05168618|Atezolizumab|atezolizumab|mesh-list
6049649|NCT05168618|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6049650|NCT05168618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6049651|NCT05168618|Immunologic Factors|immunologic factors|mesh-ancestor
6049652|NCT05168618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049653|NCT05166616|Osimertinib|osimertinib|mesh-list
6049654|NCT05166616|Triptolide|triptolide|mesh-list
5499750|NCT04487145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5499751|NCT04487145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5499752|NCT04487145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5499753|NCT04486690|Ketamine|ketamine|mesh-list
5499754|NCT04486690|Propofol|propofol|mesh-list
5499755|NCT04486690|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5499756|NCT04486690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5499757|NCT04486690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499758|NCT04486690|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5499759|NCT04486690|Anesthetics, General|anesthetics, general|mesh-ancestor
5499760|NCT04486690|Anesthetics|anesthetics|mesh-ancestor
5499761|NCT04486690|Analgesics|analgesics|mesh-ancestor
5499762|NCT04486690|Sensory System Agents|sensory system agents|mesh-ancestor
5499763|NCT04486690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6049655|NCT05166616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6458586|NCT00440960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6458587|NCT00440960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458588|NCT00440960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6458589|NCT00440960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6458590|NCT00440960|Anesthetics, General|anesthetics, general|mesh-ancestor
6049656|NCT05166616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6049657|NCT05166616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6049658|NCT05166616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049659|NCT05166616|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
6049660|NCT05166616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049661|NCT05166616|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5499764|NCT04486690|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5499765|NCT04486690|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5499766|NCT04486690|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5499767|NCT04486690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5499768|NCT04486690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499769|NCT04486651|Irinotecan|irinotecan|mesh-list
5499770|NCT04486651|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5499771|NCT04486651|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5499772|NCT04486651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5499773|NCT04486651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499774|NCT04486651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5499775|NCT04486508|Heparin|heparin|mesh-list
5499776|NCT04486508|Calcium heparin|calcium heparin|mesh-list
5499777|NCT04486508|Enoxaparin|enoxaparin|mesh-list
5499778|NCT04486508|Enoxaparin sodium|enoxaparin sodium|mesh-list
5499779|NCT04486508|Atorvastatin|atorvastatin|mesh-list
5499780|NCT04486508|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
5499781|NCT04486508|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6049662|NCT05166616|Contraceptive Agents|contraceptive agents|mesh-ancestor
6049663|NCT05166616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6049664|NCT05166616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6049665|NCT05166616|Immunologic Factors|immunologic factors|mesh-ancestor
6049666|NCT05166616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6049667|NCT05166616|Alkylating Agents|alkylating agents|mesh-ancestor
6049671|NCT05153226|Cyclophosphamide|cyclophosphamide|mesh-list
6049672|NCT05153226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6049673|NCT05153226|Immunologic Factors|immunologic factors|mesh-ancestor
6049674|NCT05153226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049675|NCT05153226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6049676|NCT05153226|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6049677|NCT05153226|Alkylating Agents|alkylating agents|mesh-ancestor
5499782|NCT04486508|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5499783|NCT04486508|Antimetabolites|antimetabolites|mesh-ancestor
5499784|NCT04486508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499785|NCT04486508|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5499786|NCT04486508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5499787|NCT04486508|Anticoagulants|anticoagulants|mesh-ancestor
5499788|NCT04486508|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5499789|NCT04486508|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5499790|NCT04486781|Pembrolizumab|pembrolizumab|mesh-list
5499791|NCT04486781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5499792|NCT04486781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5499793|NCT04486612|Anesthetics|anesthetics|mesh-list
5499794|NCT04486612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5499795|NCT04486612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499796|NCT04486430|Salicylates|salicylates|mesh-list
5499797|NCT04486430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5499798|NCT04486430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5499799|NCT04486430|Analgesics|analgesics|mesh-ancestor
5499800|NCT04486430|Sensory System Agents|sensory system agents|mesh-ancestor
5499801|NCT04486430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5499802|NCT04486430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499803|NCT04486430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5499804|NCT04486430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5499805|NCT04486430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5499806|NCT04486430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5499807|NCT04486430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499808|NCT04486521|Siltuximab|siltuximab|mesh-list
6049678|NCT05153226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049679|NCT05153226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6049680|NCT05153226|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6049681|NCT05145010|Infigratinib|infigratinib|mesh-list
6049682|NCT05145010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6049683|NCT05139043|Dexamethasone|dexamethasone|mesh-list
6049684|NCT05139043|Dexamethasone acetate|dexamethasone acetate|mesh-list
6049685|NCT05139043|Ichthammol|ichthammol|mesh-list
6049686|NCT05139043|BB 1101|bb 1101|mesh-list
6049687|NCT05139043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6049688|NCT05139043|Antiemetics|antiemetics|mesh-ancestor
6049689|NCT05139043|Autonomic Agents|autonomic agents|mesh-ancestor
6049690|NCT05139043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6049691|NCT05139043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049692|NCT05139043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6049693|NCT05139043|Glucocorticoids|glucocorticoids|mesh-ancestor
6049694|NCT05139043|Hormones|hormones|mesh-ancestor
6049695|NCT05139043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6049696|NCT05139043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6049697|NCT05139043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5499809|NCT04486521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5503488|NCT04458558|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5503489|NCT04458558|Abortifacient Agents|abortifacient agents|mesh-ancestor
5503490|NCT04458558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5503491|NCT04458558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503492|NCT04458558|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5503493|NCT04458558|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5503494|NCT04458558|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5503495|NCT04458558|Contraceptive Agents|contraceptive agents|mesh-ancestor
5503496|NCT04458558|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5503497|NCT04458558|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5503498|NCT04458558|Hormone Antagonists|hormone antagonists|mesh-ancestor
5503499|NCT04458558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5503500|NCT04458558|Luteolytic Agents|luteolytic agents|mesh-ancestor
5503501|NCT04458558|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5503502|NCT04458558|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5503503|NCT04458610|Rituximab|rituximab|mesh-list
5503504|NCT04458610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5503505|NCT04458610|Zanubrutinib|zanubrutinib|mesh-list
5503506|NCT04458610|Antibodies|antibodies|mesh-list
5503507|NCT04458610|Immunoglobulins|immunoglobulins|mesh-list
5503508|NCT04458610|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5503509|NCT04458610|Immunologic Factors|immunologic factors|mesh-ancestor
5503510|NCT04458610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503511|NCT04458610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6049698|NCT05139043|Protease Inhibitors|protease inhibitors|mesh-ancestor
6049699|NCT05139043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6054077|NCT00600938|Sequestering Agents|sequestering agents|mesh-ancestor
6049700|NCT05139043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049701|NCT05139043|Dermatologic Agents|dermatologic agents|mesh-ancestor
6049702|NCT05139004|Fludarabine|fludarabine|mesh-list
6049703|NCT05139004|Fludarabine phosphate|fludarabine phosphate|mesh-list
6049704|NCT05139004|Melphalan|melphalan|mesh-list
6049705|NCT05139004|Mechlorethamine|mechlorethamine|mesh-list
6049706|NCT05139004|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
6049707|NCT05139004|Basiliximab|basiliximab|mesh-list
6049708|NCT05139004|Mitogens|mitogens|mesh-list
6049709|NCT05139004|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
6049710|NCT05139004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6049711|NCT05139004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6049712|NCT05139004|Antimetabolites|antimetabolites|mesh-ancestor
6049713|NCT05139004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049714|NCT05139004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6049715|NCT05139004|Immunologic Factors|immunologic factors|mesh-ancestor
6049716|NCT05139004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049717|NCT05139004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6049718|NCT05139004|Alkylating Agents|alkylating agents|mesh-ancestor
6049719|NCT05139004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6049720|NCT05139004|Mitosis Modulators|mitosis modulators|mesh-ancestor
6049721|NCT05139004|Chelating Agents|chelating agents|mesh-ancestor
6049722|NCT05139004|Sequestering Agents|sequestering agents|mesh-ancestor
6049723|NCT05136196|Nivolumab|nivolumab|mesh-list
6049724|NCT05136196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6049725|NCT05136196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6049726|NCT05136196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6049727|NCT05136196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049728|NCT05132153|Milrinone|milrinone|mesh-list
6049729|NCT05132153|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6049730|NCT05132153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6049731|NCT05132153|Vasodilator Agents|vasodilator agents|mesh-ancestor
6049732|NCT05132153|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6049733|NCT05132153|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6049734|NCT05132153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6049735|NCT05132153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049736|NCT05132153|Protective Agents|protective agents|mesh-ancestor
6049737|NCT05132153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049738|NCT05121350|Epirubicin|epirubicin|mesh-list
6049739|NCT05121350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6049740|NCT05121350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6049741|NCT05121350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5499810|NCT04486092|Valproic Acid|valproic acid|mesh-list
5499811|NCT04486092|Anticonvulsants|anticonvulsants|mesh-ancestor
5499812|NCT04486092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5499813|NCT04486092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499814|NCT04486092|GABA Agents|gaba agents|mesh-ancestor
5499815|NCT04486092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6049742|NCT05121350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6049743|NCT05121350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6049744|NCT05121350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054078|NCT00600938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054079|NCT00600938|Siderophores|siderophores|mesh-ancestor
6054080|NCT00601107|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
6054081|NCT00601107|Vitamins|vitamins|mesh-ancestor
6054082|NCT00601107|Micronutrients|micronutrients|mesh-ancestor
6054083|NCT00601107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054084|NCT00601107|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6054085|NCT00601172|Dexamethasone|dexamethasone|mesh-list
6054086|NCT00601172|Ondansetron|ondansetron|mesh-list
6054087|NCT00601172|Casopitant|casopitant|mesh-list
6054088|NCT00601172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6054089|NCT00601172|Antiemetics|antiemetics|mesh-ancestor
6054090|NCT00601172|Autonomic Agents|autonomic agents|mesh-ancestor
6054091|NCT00601172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6054092|NCT00601172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054093|NCT00601172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6054094|NCT00601172|Glucocorticoids|glucocorticoids|mesh-ancestor
6054095|NCT00601172|Hormones|hormones|mesh-ancestor
6054096|NCT00601172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6054097|NCT00601172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6054098|NCT00601172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6054099|NCT00601172|Antipruritics|antipruritics|mesh-ancestor
6054100|NCT00601172|Dermatologic Agents|dermatologic agents|mesh-ancestor
5503512|NCT04458610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5499816|NCT04486092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499817|NCT04486092|Antimanic Agents|antimanic agents|mesh-ancestor
5499818|NCT04486092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5499819|NCT04486092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5499820|NCT04486092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5499821|NCT04485845|Metformin|metformin|mesh-list
5499822|NCT04485845|Vildagliptin|vildagliptin|mesh-list
5499823|NCT04485845|Captopril|captopril|mesh-list
5499824|NCT04485845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5499825|NCT04485845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499826|NCT04485845|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5499827|NCT04485845|Protease Inhibitors|protease inhibitors|mesh-ancestor
5499828|NCT04485845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5499829|NCT04485845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499830|NCT04485845|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5499831|NCT04485845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5499832|NCT04485988|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
5499833|NCT04485988|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5499834|NCT04485988|Adrenergic Agents|adrenergic agents|mesh-ancestor
5499835|NCT04485988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5499836|NCT04485988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499837|NCT04485988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499838|NCT04485949|Temozolomide|temozolomide|mesh-list
5499839|NCT04485949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5499840|NCT04485949|Alkylating Agents|alkylating agents|mesh-ancestor
5499841|NCT04485949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499842|NCT04485949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5499843|NCT04485780|Botulinum Toxins|botulinum toxins|mesh-list
5499844|NCT04485780|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5499845|NCT04485780|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5499846|NCT04485780|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6049745|NCT05115110|Risdiplam|risdiplam|mesh-list
6049746|NCT05115110|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6049747|NCT05115110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6049748|NCT05115110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049749|NCT05098457|Lidocaine|lidocaine|mesh-list
6049750|NCT05098457|Anesthetics, Local|anesthetics, local|mesh-ancestor
6049751|NCT05098457|Anesthetics|anesthetics|mesh-ancestor
6049752|NCT05098457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6049753|NCT05098457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049754|NCT05098457|Sensory System Agents|sensory system agents|mesh-ancestor
6049755|NCT05098457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6049756|NCT05098457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6049757|NCT05098457|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6049758|NCT05098457|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6049759|NCT05098457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6049760|NCT05098457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049761|NCT05097846|Amoxicillin|amoxicillin|mesh-list
6049762|NCT05097846|Doxycycline|doxycycline|mesh-list
6049763|NCT05097846|Furazolidone|furazolidone|mesh-list
6049764|NCT05097846|Esomeprazole|esomeprazole|mesh-list
6049765|NCT05097846|Bismuth|bismuth|mesh-list
6049766|NCT05097846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6049767|NCT05097846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6049768|NCT05097846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6049769|NCT05097846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6049770|NCT05097846|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6049771|NCT05097846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6049772|NCT05097846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049773|NCT05097846|Antimalarials|antimalarials|mesh-ancestor
6049774|NCT05097846|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6049775|NCT05097846|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6049776|NCT05097846|Antacids|antacids|mesh-ancestor
6049777|NCT05097846|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5499847|NCT04485780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5499848|NCT04485780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499849|NCT04485780|Cholinergic Agents|cholinergic agents|mesh-ancestor
5499850|NCT04485780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5499851|NCT04485780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499852|NCT04485780|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5499853|NCT04485780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6049778|NCT05097846|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6049779|NCT05097846|Renal Agents|renal agents|mesh-ancestor
6049780|NCT05097846|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
5499854|NCT04485702|Midazolam|midazolam|mesh-list
5499855|NCT04485702|Ketamine|ketamine|mesh-list
5499856|NCT04485702|Analgesics|analgesics|mesh-ancestor
5499857|NCT04485702|Sensory System Agents|sensory system agents|mesh-ancestor
5499858|NCT04485702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5499859|NCT04485702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499860|NCT04485702|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5499861|NCT04485702|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5499862|NCT04485702|Anesthetics, General|anesthetics, general|mesh-ancestor
5499863|NCT04485702|Anesthetics|anesthetics|mesh-ancestor
5499864|NCT04485702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5499865|NCT04485702|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5499866|NCT04485702|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5499867|NCT04485702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5499868|NCT04485702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499869|NCT04485702|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5499870|NCT04485702|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5499871|NCT04485702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5499872|NCT04485702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5499873|NCT04485702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5499874|NCT04485702|GABA Modulators|gaba modulators|mesh-ancestor
5499875|NCT04485702|GABA Agents|gaba agents|mesh-ancestor
6049781|NCT05097846|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6049782|NCT05092958|Avelumab|avelumab|mesh-list
6049783|NCT05092958|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6049784|NCT05092958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6049785|NCT05092958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6049786|NCT05092958|Immunologic Factors|immunologic factors|mesh-ancestor
6049787|NCT05092958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049788|NCT05085496|Atezolizumab|atezolizumab|mesh-list
5499876|NCT04485585|Tamsulosin|tamsulosin|mesh-list
5499877|NCT04485585|Mirabegron|mirabegron|mesh-list
5499878|NCT04485585|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5499879|NCT04485585|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6049789|NCT05085496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6049790|NCT05085496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6049791|NCT05085496|Immunologic Factors|immunologic factors|mesh-ancestor
6049792|NCT05085496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049793|NCT05084222|Budesonide|budesonide|mesh-list
6049794|NCT05084222|Albuterol|albuterol|mesh-list
6049795|NCT05084222|Formoterol Fumarate|formoterol fumarate|mesh-list
6049796|NCT05084222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6049797|NCT05084222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6049798|NCT05084222|Autonomic Agents|autonomic agents|mesh-ancestor
6049799|NCT05084222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6049800|NCT05084222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049801|NCT05084222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6049802|NCT05084222|Respiratory System Agents|respiratory system agents|mesh-ancestor
6049803|NCT05084222|Glucocorticoids|glucocorticoids|mesh-ancestor
6049804|NCT05084222|Hormones|hormones|mesh-ancestor
6049805|NCT05084222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6049806|NCT05084222|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6049807|NCT05084222|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6049808|NCT05084222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6049809|NCT05084222|Adrenergic Agents|adrenergic agents|mesh-ancestor
6049810|NCT05084222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6049811|NCT05084222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049812|NCT05084222|Tocolytic Agents|tocolytic agents|mesh-ancestor
6049813|NCT05084222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6049814|NCT05077904|Alprazolam|alprazolam|mesh-list
6049815|NCT05077904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6049816|NCT05077904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6049817|NCT05077904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049818|NCT05077904|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6049819|NCT05077904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6049820|NCT05077904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6049821|NCT05077904|GABA Modulators|gaba modulators|mesh-ancestor
6049822|NCT05077904|GABA Agents|gaba agents|mesh-ancestor
6049823|NCT05077904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6049824|NCT05077904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049825|NCT05069051|Belimumab|belimumab|mesh-list
6049826|NCT05069051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6049827|NCT05069051|Immunologic Factors|immunologic factors|mesh-ancestor
6049828|NCT05069051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049829|NCT05065372|Metformin|metformin|mesh-list
6049830|NCT05065372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6049831|NCT05065372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049832|NCT05059470|Pembrolizumab|pembrolizumab|mesh-list
6458591|NCT00440960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6458592|NCT00440960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6458593|NCT00440960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6458594|NCT00440960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6458595|NCT00440960|GABA Modulators|gaba modulators|mesh-ancestor
6458596|NCT00440960|GABA Agents|gaba agents|mesh-ancestor
6458597|NCT00440960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6458598|NCT00440960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6458599|NCT00440960|Narcotics|narcotics|mesh-ancestor
6458600|NCT00440960|Analgesics|analgesics|mesh-ancestor
6458601|NCT00440973|Bevacizumab|bevacizumab|mesh-list
6458602|NCT00440973|Interleukin-2|interleukin-2|mesh-list
6458603|NCT00440973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5499880|NCT04485585|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5499881|NCT04485585|Adrenergic Agents|adrenergic agents|mesh-ancestor
5499882|NCT04485585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5499883|NCT04485585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499884|NCT04485585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499885|NCT04485585|Urological Agents|urological agents|mesh-ancestor
6049833|NCT05059470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6049834|NCT05059470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6049835|NCT05058651|Cisplatin|cisplatin|mesh-list
6458604|NCT00440973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6458605|NCT00440973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6049836|NCT05058651|Carboplatin|carboplatin|mesh-list
6049837|NCT05058651|Etoposide|etoposide|mesh-list
6049838|NCT05058651|Etoposide phosphate|etoposide phosphate|mesh-list
6049839|NCT05058651|Atezolizumab|atezolizumab|mesh-list
6049840|NCT05058651|Podophyllotoxin|podophyllotoxin|mesh-list
6049841|NCT05058651|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6049842|NCT05058651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6049843|NCT05058651|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6049844|NCT05058651|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6049845|NCT05058651|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6049846|NCT05058651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6049847|NCT05058651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049848|NCT05058651|Immunologic Factors|immunologic factors|mesh-ancestor
6049849|NCT05058651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049850|NCT05058651|Keratolytic Agents|keratolytic agents|mesh-ancestor
6049851|NCT05058651|Dermatologic Agents|dermatologic agents|mesh-ancestor
6049852|NCT05058651|Tubulin Modulators|tubulin modulators|mesh-ancestor
6049853|NCT05058651|Antimitotic Agents|antimitotic agents|mesh-ancestor
6049854|NCT05058651|Mitosis Modulators|mitosis modulators|mesh-ancestor
6049855|NCT05057494|Venetoclax|venetoclax|mesh-list
6049856|NCT05057494|Obinutuzumab|obinutuzumab|mesh-list
6458606|NCT00440973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6458607|NCT00440973|Growth Substances|growth substances|mesh-ancestor
6458608|NCT00440973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049857|NCT05057494|Acalabrutinib|acalabrutinib|mesh-list
6049858|NCT05057494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6049859|NCT05057494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6049860|NCT05038735|Fulvestrant|fulvestrant|mesh-list
6049861|NCT05038735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6049862|NCT05038735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6049863|NCT05038735|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6049864|NCT05038735|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6049865|NCT05038735|Hormone Antagonists|hormone antagonists|mesh-ancestor
6049866|NCT05038735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6049867|NCT05038735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049868|NCT05036408|Coal Tar|coal tar|mesh-list
6049869|NCT05036408|Keratolytic Agents|keratolytic agents|mesh-ancestor
6049870|NCT05036408|Dermatologic Agents|dermatologic agents|mesh-ancestor
6049871|NCT05032183|Leucovorin|leucovorin|mesh-list
6049872|NCT05032183|Cytarabine|cytarabine|mesh-list
6049873|NCT05032183|Dexamethasone|dexamethasone|mesh-list
6049874|NCT05032183|Dexamethasone acetate|dexamethasone acetate|mesh-list
6049875|NCT05032183|Prednisone|prednisone|mesh-list
6049876|NCT05032183|Cortisone|cortisone|mesh-list
6049877|NCT05032183|Cyclophosphamide|cyclophosphamide|mesh-list
6049878|NCT05032183|Rituximab|rituximab|mesh-list
6049879|NCT05032183|Methotrexate|methotrexate|mesh-list
6049880|NCT05032183|Vincristine|vincristine|mesh-list
6049881|NCT05032183|Mercaptopurine|mercaptopurine|mesh-list
6049882|NCT05032183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6049883|NCT05032183|Antibodies|antibodies|mesh-list
6049884|NCT05032183|Immunoglobulins|immunoglobulins|mesh-list
6049885|NCT05032183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6049886|NCT05032183|Lenograstim|lenograstim|mesh-list
6049887|NCT05032183|BB 1101|bb 1101|mesh-list
6049888|NCT05032183|Mesna|mesna|mesh-list
6049889|NCT05032183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6049890|NCT05032183|Immunologic Factors|immunologic factors|mesh-ancestor
5499886|NCT04485585|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
5499887|NCT04485585|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5499888|NCT04485585|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5499889|NCT04485689|Capsaicin|capsaicin|mesh-list
5499890|NCT04485689|Antipruritics|antipruritics|mesh-ancestor
5499891|NCT04485689|Dermatologic Agents|dermatologic agents|mesh-ancestor
5499892|NCT04485689|Sensory System Agents|sensory system agents|mesh-ancestor
6049891|NCT05032183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049892|NCT05032183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6049893|NCT05032183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6049894|NCT05032183|Alkylating Agents|alkylating agents|mesh-ancestor
6049895|NCT05032183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049896|NCT05032183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6049897|NCT05032183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6049898|NCT05032183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6049899|NCT05032183|Antiemetics|antiemetics|mesh-ancestor
6049900|NCT05032183|Autonomic Agents|autonomic agents|mesh-ancestor
6049901|NCT05032183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6049902|NCT05032183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6049903|NCT05032183|Glucocorticoids|glucocorticoids|mesh-ancestor
6049904|NCT05032183|Hormones|hormones|mesh-ancestor
6049905|NCT05032183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6049906|NCT05032183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6049907|NCT05032183|Protease Inhibitors|protease inhibitors|mesh-ancestor
6049908|NCT05032183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6049909|NCT05032183|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6049910|NCT05032183|Abortifacient Agents|abortifacient agents|mesh-ancestor
6049911|NCT05032183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6049912|NCT05032183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6049913|NCT05032183|Antimetabolites|antimetabolites|mesh-ancestor
6049914|NCT05032183|Dermatologic Agents|dermatologic agents|mesh-ancestor
6049915|NCT05032183|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6049916|NCT05032183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6049917|NCT05032183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6049918|NCT05032183|Antiviral Agents|antiviral agents|mesh-ancestor
6049919|NCT05032183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6049920|NCT05032183|Antidotes|antidotes|mesh-ancestor
6049921|NCT05032183|Protective Agents|protective agents|mesh-ancestor
6049922|NCT05032183|Vitamin B Complex|vitamin b complex|mesh-ancestor
5499893|NCT04485689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5499894|NCT04485689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499895|NCT04485520|Chlorhexidine|chlorhexidine|mesh-list
5499896|NCT04485520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6049923|NCT05032183|Vitamins|vitamins|mesh-ancestor
6049924|NCT05032183|Micronutrients|micronutrients|mesh-ancestor
6049925|NCT05032183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6049926|NCT05032183|Tubulin Modulators|tubulin modulators|mesh-ancestor
6049927|NCT05032183|Antimitotic Agents|antimitotic agents|mesh-ancestor
6049928|NCT05032183|Mitosis Modulators|mitosis modulators|mesh-ancestor
6049929|NCT05023993|Niacinamide|niacinamide|mesh-list
6049930|NCT05023993|Niacin|niacin|mesh-list
6049931|NCT05023993|Nicotinic Acids|nicotinic acids|mesh-list
6049932|NCT05023993|Vitamin B Complex|vitamin b complex|mesh-ancestor
6049933|NCT05023993|Vitamins|vitamins|mesh-ancestor
6049934|NCT05023993|Micronutrients|micronutrients|mesh-ancestor
6049935|NCT05023993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049936|NCT05023993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6049937|NCT05023993|Antimetabolites|antimetabolites|mesh-ancestor
6049938|NCT05023993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049939|NCT05023993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6049940|NCT05023993|Vasodilator Agents|vasodilator agents|mesh-ancestor
6049941|NCT05017025|Osimertinib|osimertinib|mesh-list
6049942|NCT05017025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6049943|NCT05017025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6049944|NCT05017025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6049945|NCT05017025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049946|NCT05014646|Cholestyramine Resin|cholestyramine resin|mesh-list
6049947|NCT05014646|Leflunomide|leflunomide|mesh-list
6049948|NCT05014646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6049949|NCT05014646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049950|NCT05014646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6049951|NCT05014646|Immunologic Factors|immunologic factors|mesh-ancestor
6049952|NCT05014646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049953|NCT05014646|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6049954|NCT05014646|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6049955|NCT05014646|Antimetabolites|antimetabolites|mesh-ancestor
6049956|NCT05014646|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6049957|NCT05012371|Everolimus|everolimus|mesh-list
5499897|NCT04485520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5499898|NCT04485520|Disinfectants|disinfectants|mesh-ancestor
5499899|NCT04485429|Methylprednisolone|methylprednisolone|mesh-list
5499900|NCT04485429|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5499901|NCT04485429|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5499902|NCT04485429|Prednisolone|prednisolone|mesh-list
5499903|NCT04485429|Prednisolone acetate|prednisolone acetate|mesh-list
5499904|NCT04485429|Heparin|heparin|mesh-list
5499905|NCT04485429|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5499906|NCT04485429|Prednisolone phosphate|prednisolone phosphate|mesh-list
6049958|NCT05012371|Lenvatinib|lenvatinib|mesh-list
6049959|NCT05012371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6049960|NCT05012371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6049961|NCT05012371|Immunologic Factors|immunologic factors|mesh-ancestor
6049962|NCT05012371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049963|NCT05012371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6049964|NCT05012371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6049965|NCT05012371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049966|NCT05008926|Naloxegol|naloxegol|mesh-list
6049967|NCT05008926|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6049968|NCT05008926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049969|NCT05008926|Sensory System Agents|sensory system agents|mesh-ancestor
6049970|NCT05008926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6049971|NCT04996004|Doxorubicin|doxorubicin|mesh-list
6049972|NCT04996004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6049973|NCT04996004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6049974|NCT04996004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6049975|NCT04996004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6049976|NCT04996004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5499907|NCT04485429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5499908|NCT04485429|Antiemetics|antiemetics|mesh-ancestor
5499909|NCT04485429|Autonomic Agents|autonomic agents|mesh-ancestor
5499910|NCT04485429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6049977|NCT04996004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049978|NCT04948333|Niacinamide|niacinamide|mesh-list
6049979|NCT04948333|Vitamin B Complex|vitamin b complex|mesh-ancestor
6049980|NCT04948333|Vitamins|vitamins|mesh-ancestor
5499911|NCT04485429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049981|NCT04948333|Micronutrients|micronutrients|mesh-ancestor
5499912|NCT04485429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5499913|NCT04485429|Glucocorticoids|glucocorticoids|mesh-ancestor
5499914|NCT04485429|Hormones|hormones|mesh-ancestor
5499915|NCT04485429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5499916|NCT04485429|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5499917|NCT04485429|Protective Agents|protective agents|mesh-ancestor
5499918|NCT04485429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5499919|NCT04485429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6049982|NCT04948333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049983|NCT04941144|Vaccines|vaccines|mesh-list
5499920|NCT04485429|Anticoagulants|anticoagulants|mesh-ancestor
5499921|NCT04485429|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5499922|NCT04485429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5499923|NCT04485429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499924|NCT04485130|Disulfiram|disulfiram|mesh-list
5499925|NCT04485130|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5499926|NCT04485130|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
5499927|NCT04485130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5499928|NCT04485130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499929|NCT04485273|Anesthetics|anesthetics|mesh-list
5499930|NCT04485273|Sevoflurane|sevoflurane|mesh-list
5499931|NCT04485273|Bupivacaine|bupivacaine|mesh-list
5499932|NCT04485273|Anesthetics, Local|anesthetics, local|mesh-list
5499933|NCT04485273|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5499934|NCT04485273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5499935|NCT04485273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499936|NCT04485273|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5499937|NCT04485273|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5499938|NCT04485273|Anesthetics, General|anesthetics, general|mesh-ancestor
5499939|NCT04485273|Sensory System Agents|sensory system agents|mesh-ancestor
5499940|NCT04485273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5499941|NCT04485299|Listerine|listerine|mesh-list
5499942|NCT04485299|Fluorides|fluorides|mesh-list
5499943|NCT04485299|Sodium Fluoride|sodium fluoride|mesh-list
6049984|NCT04941144|Immunologic Factors|immunologic factors|mesh-ancestor
6049985|NCT04941144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6049986|NCT04940052|Trametinib|trametinib|mesh-list
6049987|NCT04940052|Dabrafenib|dabrafenib|mesh-list
6049988|NCT04940052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6049989|NCT04940052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6049990|NCT04940052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5499944|NCT04485299|Fluorides, Topical|fluorides, topical|mesh-list
5499945|NCT04485299|Cariostatic Agents|cariostatic agents|mesh-ancestor
5499946|NCT04485299|Protective Agents|protective agents|mesh-ancestor
6049991|NCT04940052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6049995|NCT04929392|Paclitaxel|paclitaxel|mesh-list
6049996|NCT04929392|Carboplatin|carboplatin|mesh-list
6049997|NCT04929392|Pembrolizumab|pembrolizumab|mesh-list
5499947|NCT04485299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499948|NCT04485299|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6049998|NCT04929392|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6049999|NCT04929392|Lenvatinib|lenvatinib|mesh-list
6050000|NCT04929392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6050001|NCT04929392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6050002|NCT04929392|Tubulin Modulators|tubulin modulators|mesh-ancestor
6050003|NCT04929392|Antimitotic Agents|antimitotic agents|mesh-ancestor
6050004|NCT04929392|Mitosis Modulators|mitosis modulators|mesh-ancestor
5499949|NCT04485299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6050005|NCT04929392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6050006|NCT04929392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6050007|NCT04929392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6050008|NCT04929392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6050009|NCT04919226|Leucovorin|leucovorin|mesh-list
6050010|NCT04919226|Folic Acid|folic acid|mesh-list
6050011|NCT04919226|Fluorouracil|fluorouracil|mesh-list
6050012|NCT04919226|Capecitabine|capecitabine|mesh-list
6050013|NCT04919226|Oxaliplatin|oxaliplatin|mesh-list
6050014|NCT04919226|Everolimus|everolimus|mesh-list
6050015|NCT04919226|Temozolomide|temozolomide|mesh-list
6050016|NCT04919226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6050017|NCT04919226|Levoleucovorin|levoleucovorin|mesh-list
6050018|NCT04919226|Edotreotide|edotreotide|mesh-list
6050019|NCT04919226|Antimetabolites|antimetabolites|mesh-ancestor
6050020|NCT04919226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6050021|NCT04919226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6050022|NCT04919226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6050023|NCT04919226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6050024|NCT04919226|Immunologic Factors|immunologic factors|mesh-ancestor
6050025|NCT04919226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050026|NCT04919226|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5499950|NCT04485403|Ibuprofen|ibuprofen|mesh-list
5499951|NCT04485403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5499952|NCT04485403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5499953|NCT04485403|Analgesics|analgesics|mesh-ancestor
5499954|NCT04485403|Sensory System Agents|sensory system agents|mesh-ancestor
5499955|NCT04485403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5499956|NCT04485403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499957|NCT04485403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5499958|NCT04485403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5499959|NCT04485403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5499960|NCT04485403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5499961|NCT04485403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499962|NCT04485312|Chlorhexidine|chlorhexidine|mesh-list
5499963|NCT04485312|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5499964|NCT04485312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5499965|NCT04485312|Disinfectants|disinfectants|mesh-ancestor
5499966|NCT04485195|Procainamide|procainamide|mesh-list
5499967|NCT04485195|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5499968|NCT04485195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5499969|NCT04485195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6050027|NCT04919226|Alkylating Agents|alkylating agents|mesh-ancestor
6050028|NCT04919226|Antidotes|antidotes|mesh-ancestor
6050029|NCT04919226|Protective Agents|protective agents|mesh-ancestor
6050030|NCT04919226|Vitamin B Complex|vitamin b complex|mesh-ancestor
6050031|NCT04919226|Vitamins|vitamins|mesh-ancestor
6050032|NCT04919226|Micronutrients|micronutrients|mesh-ancestor
5499970|NCT04485195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5499971|NCT04485195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499972|NCT04485325|Etanercept|etanercept|mesh-list
5499973|NCT04485325|Tofacitinib|tofacitinib|mesh-list
5499974|NCT04485325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5499975|NCT04485325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5499976|NCT04485325|Analgesics|analgesics|mesh-ancestor
5499977|NCT04485325|Sensory System Agents|sensory system agents|mesh-ancestor
5499978|NCT04485325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5499979|NCT04485325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499980|NCT04485325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5499981|NCT04485325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6050033|NCT04919226|Hematinics|hematinics|mesh-ancestor
6050034|NCT04919226|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6050035|NCT04913337|Pembrolizumab|pembrolizumab|mesh-list
6050036|NCT04913337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6050037|NCT04913337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6050038|NCT04906213|Dapagliflozin|dapagliflozin|mesh-list
6050039|NCT04906213|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6050040|NCT04906213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6050041|NCT04906213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6050042|NCT04906213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050043|NCT04892888|Vaccines|vaccines|mesh-list
6050044|NCT04892888|Immunologic Factors|immunologic factors|mesh-ancestor
6050045|NCT04892888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050046|NCT04887194|Nivolumab|nivolumab|mesh-list
6050047|NCT04887194|Digoxin|digoxin|mesh-list
6050048|NCT04887194|Midazolam|midazolam|mesh-list
6050049|NCT04887194|Dextromethorphan|dextromethorphan|mesh-list
6050050|NCT04887194|Warfarin|warfarin|mesh-list
6050051|NCT04887194|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6050052|NCT04887194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5499982|NCT04485325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5499983|NCT04485325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6050053|NCT04887194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6050054|NCT04887194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6050055|NCT04887194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6050056|NCT04887194|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6050057|NCT04887194|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6050058|NCT04887194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6050059|NCT04887194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050060|NCT04887194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6050061|NCT04887194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6050062|NCT04887194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6050063|NCT04887194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6050064|NCT04887194|Anesthetics, General|anesthetics, general|mesh-ancestor
6050065|NCT04887194|Anesthetics|anesthetics|mesh-ancestor
6050066|NCT04887194|GABA Modulators|gaba modulators|mesh-ancestor
6050067|NCT04887194|GABA Agents|gaba agents|mesh-ancestor
6050068|NCT04887194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5499984|NCT04485325|Immunologic Factors|immunologic factors|mesh-ancestor
5499985|NCT04485325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5499986|NCT04485325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5499987|NCT04485325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5499988|NCT04485117|Anesthetics|anesthetics|mesh-list
5499989|NCT04485117|Propofol|propofol|mesh-list
5499990|NCT04485117|Sevoflurane|sevoflurane|mesh-list
6050069|NCT04887194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6050070|NCT04887194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6050071|NCT04887194|Antimetabolites|antimetabolites|mesh-ancestor
6050072|NCT04887194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5499991|NCT04485117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5499992|NCT04485117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5499993|NCT04485117|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5499994|NCT04485117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5499995|NCT04485117|Anesthetics, General|anesthetics, general|mesh-ancestor
5499996|NCT04485117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5499997|NCT04485117|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5499998|NCT04485156|Rifampin|rifampin|mesh-list
5499999|NCT04485156|Isoniazid|isoniazid|mesh-list
5500000|NCT04485156|Pyrazinamide|pyrazinamide|mesh-list
5500001|NCT04485156|Ethambutol|ethambutol|mesh-list
5500002|NCT04485156|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5500003|NCT04485156|Antitubercular Agents|antitubercular agents|mesh-ancestor
5500004|NCT04485156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5500005|NCT04485156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5500006|NCT04485156|Leprostatic Agents|leprostatic agents|mesh-ancestor
5500007|NCT04485156|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5500008|NCT04485156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5500009|NCT04485156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500010|NCT04485156|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5500011|NCT04485156|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5500012|NCT04485156|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6050073|NCT04887194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6050074|NCT04887194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6050075|NCT04887194|Anticoagulants|anticoagulants|mesh-ancestor
6050076|NCT04887194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6050077|NCT04887194|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6050078|NCT04887194|Protective Agents|protective agents|mesh-ancestor
6050079|NCT04887194|Antitussive Agents|antitussive agents|mesh-ancestor
6050080|NCT04887194|Respiratory System Agents|respiratory system agents|mesh-ancestor
6050081|NCT04887194|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6050082|NCT04887194|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6050083|NCT04877457|Ocrelizumab|ocrelizumab|mesh-list
6050084|NCT04877457|Immunologic Factors|immunologic factors|mesh-ancestor
6050085|NCT04877457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050086|NCT04871607|Cytarabine|cytarabine|mesh-list
6050087|NCT04871607|Etoposide|etoposide|mesh-list
6050088|NCT04871607|Podophyllotoxin|podophyllotoxin|mesh-list
6050089|NCT04871607|Etoposide phosphate|etoposide phosphate|mesh-list
6050090|NCT04871607|Carmustine|carmustine|mesh-list
6050091|NCT04871607|Basiliximab|basiliximab|mesh-list
5500013|NCT04485156|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5500014|NCT04485156|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5500015|NCT04485156|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6050092|NCT04871607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6050093|NCT04871607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6050094|NCT04871607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6050095|NCT04871607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6050096|NCT04871607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6050097|NCT04871607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6050098|NCT04871607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6050099|NCT04871607|Antimetabolites|antimetabolites|mesh-ancestor
6050100|NCT04871607|Antiviral Agents|antiviral agents|mesh-ancestor
6050101|NCT04871607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6050102|NCT04871607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6050103|NCT04871607|Immunologic Factors|immunologic factors|mesh-ancestor
6050104|NCT04871607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500016|NCT04485156|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5500017|NCT04485156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5500018|NCT04485156|Antimetabolites|antimetabolites|mesh-ancestor
5500019|NCT04485156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5500020|NCT04485065|Azacitidine|azacitidine|mesh-list
5500021|NCT04485065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5500022|NCT04485065|Antimetabolites|antimetabolites|mesh-ancestor
6050105|NCT04871607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6050106|NCT04871607|Alkylating Agents|alkylating agents|mesh-ancestor
6050107|NCT04871607|Keratolytic Agents|keratolytic agents|mesh-ancestor
6050108|NCT04871607|Dermatologic Agents|dermatologic agents|mesh-ancestor
6050109|NCT04871607|Tubulin Modulators|tubulin modulators|mesh-ancestor
6050110|NCT04871607|Antimitotic Agents|antimitotic agents|mesh-ancestor
6050111|NCT04871607|Mitosis Modulators|mitosis modulators|mesh-ancestor
6050112|NCT04865419|Voriconazole|voriconazole|mesh-list
6050113|NCT04865419|Antifungal Agents|antifungal agents|mesh-ancestor
6050114|NCT04865419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5500023|NCT04485065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500024|NCT04485065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5500025|NCT04485065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6050115|NCT04865419|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6050116|NCT04865419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6050117|NCT04865419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6050118|NCT04865419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6050119|NCT04865419|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6050120|NCT04865419|Hormone Antagonists|hormone antagonists|mesh-ancestor
6050121|NCT04865419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6050122|NCT04865419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050123|NCT04865419|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6050124|NCT04856228|Lidocaine|lidocaine|mesh-list
6050125|NCT04856228|Anesthetics, Local|anesthetics, local|mesh-ancestor
6050126|NCT04856228|Anesthetics|anesthetics|mesh-ancestor
6050127|NCT04856228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6050128|NCT04856228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050129|NCT04856228|Sensory System Agents|sensory system agents|mesh-ancestor
6050130|NCT04856228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6050131|NCT04856228|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6050132|NCT04856228|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6050133|NCT04856228|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6050134|NCT04856228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6050135|NCT04856228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500026|NCT04485052|Azacitidine|azacitidine|mesh-list
5500027|NCT04485052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5500028|NCT04485052|Antimetabolites|antimetabolites|mesh-ancestor
5500029|NCT04485052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500030|NCT04485052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5500031|NCT04485052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5500032|NCT04484688|Bisoprolol|bisoprolol|mesh-list
5500033|NCT04484688|Perindopril|perindopril|mesh-list
5500034|NCT04484688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5500035|NCT04484688|Sympatholytics|sympatholytics|mesh-ancestor
5500036|NCT04484688|Autonomic Agents|autonomic agents|mesh-ancestor
5500037|NCT04484688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5500038|NCT04484688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500039|NCT04484688|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5500040|NCT04484688|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5500041|NCT04484688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5500042|NCT04484688|Adrenergic Agents|adrenergic agents|mesh-ancestor
5500043|NCT04484688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5500044|NCT04484688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500045|NCT04484688|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5500046|NCT04484688|Protease Inhibitors|protease inhibitors|mesh-ancestor
5500047|NCT04484688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5500048|NCT04484779|Insulin|insulin|mesh-list
5500049|NCT04484779|Insulin Glargine|insulin glargine|mesh-list
5500050|NCT04484779|Insulin Lispro|insulin lispro|mesh-list
5500051|NCT04484779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5500052|NCT04484779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500053|NCT04484844|Listerine|listerine|mesh-list
5500054|NCT04484844|Fluorides|fluorides|mesh-list
5500055|NCT04484844|Sodium Fluoride|sodium fluoride|mesh-list
5500056|NCT04484844|Cariostatic Agents|cariostatic agents|mesh-ancestor
5500057|NCT04484844|Protective Agents|protective agents|mesh-ancestor
6054101|NCT00601172|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6054102|NCT00601172|Serotonin Agents|serotonin agents|mesh-ancestor
6054103|NCT00601172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6054104|NCT00601172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054105|NCT00601172|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6054106|NCT00601172|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6054107|NCT00601172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6054108|NCT00601172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6054109|NCT00601172|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6054110|NCT00601172|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6054111|NCT00601250|Linagliptin|linagliptin|mesh-list
6054112|NCT00601250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6054113|NCT00601250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054114|NCT00601250|Incretins|incretins|mesh-ancestor
6054115|NCT00601250|Hormones|hormones|mesh-ancestor
6054116|NCT00601250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6054117|NCT00601250|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6054118|NCT00601250|Protease Inhibitors|protease inhibitors|mesh-ancestor
6054119|NCT00601250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6054120|NCT00601250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054121|NCT00601354|Orlistat|orlistat|mesh-list
6054122|NCT00601354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6054123|NCT00601354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054124|NCT00601354|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6054125|NCT00601354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6054126|NCT00601458|Naproxen|naproxen|mesh-list
6054127|NCT00601458|Pregabalin|pregabalin|mesh-list
6054128|NCT00601458|Analgesics|analgesics|mesh-ancestor
6054129|NCT00601458|Sensory System Agents|sensory system agents|mesh-ancestor
6054130|NCT00601458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6054131|NCT00601458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054132|NCT00601458|Anticonvulsants|anticonvulsants|mesh-ancestor
6054133|NCT00601458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5500058|NCT04484844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500059|NCT04484844|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6050160|NCT04847063|Sodium thiosulfate|sodium thiosulfate|mesh-list
6050161|NCT04847063|Doxorubicin|doxorubicin|mesh-list
6050162|NCT04847063|Fluorouracil|fluorouracil|mesh-list
6050163|NCT04847063|Oxaliplatin|oxaliplatin|mesh-list
6050164|NCT04847063|Mitomycins|mitomycins|mesh-list
6050165|NCT04847063|Mitomycin|mitomycin|mesh-list
6050166|NCT04847063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6050167|NCT04847063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6050168|NCT04847063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6050169|NCT04847063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6050170|NCT04847063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6050171|NCT04847063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6050172|NCT04847063|Antimetabolites|antimetabolites|mesh-ancestor
6050173|NCT04847063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6050174|NCT04847063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6050175|NCT04847063|Immunologic Factors|immunologic factors|mesh-ancestor
6050176|NCT04847063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050177|NCT04847063|Alkylating Agents|alkylating agents|mesh-ancestor
6050178|NCT04847063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6050179|NCT04847063|Antidotes|antidotes|mesh-ancestor
6050180|NCT04847063|Protective Agents|protective agents|mesh-ancestor
6050181|NCT04847063|Antioxidants|antioxidants|mesh-ancestor
6050182|NCT04847063|Antitubercular Agents|antitubercular agents|mesh-ancestor
6050183|NCT04847063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6050184|NCT04847063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6050185|NCT04847063|Chelating Agents|chelating agents|mesh-ancestor
6050186|NCT04847063|Sequestering Agents|sequestering agents|mesh-ancestor
6050187|NCT04842604|Azacitidine|azacitidine|mesh-list
6050188|NCT04842604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6050189|NCT04842604|Antimetabolites|antimetabolites|mesh-ancestor
6050190|NCT04842604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6050191|NCT04842604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6050192|NCT04842604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6050193|NCT04835805|Atezolizumab|atezolizumab|mesh-list
6050194|NCT04835805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6458609|NCT00440973|Growth Inhibitors|growth inhibitors|mesh-ancestor
6458610|NCT00440973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5500060|NCT04484844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6050195|NCT04820023|Cetuximab|cetuximab|mesh-list
6050196|NCT04820023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6050197|NCT04820023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6050198|NCT04816214|Carboplatin|carboplatin|mesh-list
6050199|NCT04816214|Pemetrexed|pemetrexed|mesh-list
6050200|NCT04816214|Osimertinib|osimertinib|mesh-list
6050201|NCT04816214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6050202|NCT04816214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6050203|NCT04816214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6050204|NCT04816214|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6050205|NCT04816214|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6050206|NCT04816214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6050207|NCT04810546|Lactoferrin|lactoferrin|mesh-list
6050208|NCT04810546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6050209|NCT04799275|Prednisone|prednisone|mesh-list
6050210|NCT04799275|Cortisone|cortisone|mesh-list
6050211|NCT04799275|Cyclophosphamide|cyclophosphamide|mesh-list
6050212|NCT04799275|Rituximab|rituximab|mesh-list
6050213|NCT04799275|Doxorubicin|doxorubicin|mesh-list
6050214|NCT04799275|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6050215|NCT04799275|Vincristine|vincristine|mesh-list
6050216|NCT04799275|Azacitidine|azacitidine|mesh-list
5500061|NCT04484493|Mometasone Furoate|mometasone furoate|mesh-list
5500062|NCT04484493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5500063|NCT04484493|Dermatologic Agents|dermatologic agents|mesh-ancestor
5500064|NCT04484493|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5500065|NCT04484506|Prednisone|prednisone|mesh-list
5500066|NCT04484506|Cyclophosphamide|cyclophosphamide|mesh-list
5500067|NCT04484506|Etoposide|etoposide|mesh-list
5500068|NCT04484506|Vincristine|vincristine|mesh-list
5500069|NCT04484506|Pegaspargase|pegaspargase|mesh-list
5500070|NCT04484506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5500071|NCT04484506|Immunologic Factors|immunologic factors|mesh-ancestor
6050217|NCT04799275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6050218|NCT04799275|Antibodies|antibodies|mesh-list
5500072|NCT04484506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050219|NCT04799275|Immunoglobulins|immunoglobulins|mesh-list
6050220|NCT04799275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6050221|NCT04799275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6050222|NCT04799275|Immunologic Factors|immunologic factors|mesh-ancestor
6050223|NCT04799275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050224|NCT04799275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6458611|NCT00440973|Analgesics|analgesics|mesh-ancestor
5500073|NCT04484506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5500074|NCT04484506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5500075|NCT04484506|Alkylating Agents|alkylating agents|mesh-ancestor
5500076|NCT04484506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500077|NCT04484506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5500078|NCT04484506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6050225|NCT04799275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6050226|NCT04799275|Alkylating Agents|alkylating agents|mesh-ancestor
6050227|NCT04799275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6050228|NCT04799275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6050229|NCT04799275|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6050230|NCT04799275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6050231|NCT04799275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6050232|NCT04799275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6050233|NCT04799275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6050234|NCT04799275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6050235|NCT04799275|Glucocorticoids|glucocorticoids|mesh-ancestor
6050236|NCT04799275|Hormones|hormones|mesh-ancestor
6050237|NCT04799275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6050238|NCT04799275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6050239|NCT04799275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6050240|NCT04799275|Tubulin Modulators|tubulin modulators|mesh-ancestor
6050241|NCT04799275|Antimitotic Agents|antimitotic agents|mesh-ancestor
6050242|NCT04799275|Mitosis Modulators|mitosis modulators|mesh-ancestor
6050243|NCT04799275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6050244|NCT04799275|Antimetabolites|antimetabolites|mesh-ancestor
6050257|NCT04784052|Cyclophosphamide|cyclophosphamide|mesh-list
6050258|NCT04784052|Rituximab|rituximab|mesh-list
6050259|NCT04784052|Fludarabine|fludarabine|mesh-list
6050260|NCT04784052|Thymoglobulin|thymoglobulin|mesh-list
6050261|NCT04784052|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6050262|NCT04784052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6050263|NCT04784052|Immunologic Factors|immunologic factors|mesh-ancestor
6050264|NCT04784052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050265|NCT04784052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6050266|NCT04784052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6050267|NCT04784052|Alkylating Agents|alkylating agents|mesh-ancestor
6050268|NCT04784052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6050269|NCT04784052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6050270|NCT04784052|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6050271|NCT04784052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6050272|NCT04778410|Cytarabine|cytarabine|mesh-list
6050273|NCT04778410|Etoposide|etoposide|mesh-list
6050274|NCT04778410|Mitoxantrone|mitoxantrone|mesh-list
6050275|NCT04778410|Azacitidine|azacitidine|mesh-list
6050276|NCT04778410|Venetoclax|venetoclax|mesh-list
6050277|NCT04778410|Cc-486|cc-486|mesh-list
6050278|NCT04778410|Magrolimab|magrolimab|mesh-list
6050279|NCT04778410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6050280|NCT04778410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6050281|NCT04778410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6050282|NCT04778410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6050283|NCT04778410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6050284|NCT04778410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6050285|NCT04778410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6050286|NCT04778410|Antimetabolites|antimetabolites|mesh-ancestor
6050287|NCT04778410|Antiviral Agents|antiviral agents|mesh-ancestor
6050288|NCT04778410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6050289|NCT04778410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6050290|NCT04778410|Immunologic Factors|immunologic factors|mesh-ancestor
6050291|NCT04778410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050292|NCT04778410|Analgesics|analgesics|mesh-ancestor
6050293|NCT04778410|Sensory System Agents|sensory system agents|mesh-ancestor
6050294|NCT04778410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6050295|NCT04778410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6050296|NCT04771871|Paclitaxel|paclitaxel|mesh-list
6050297|NCT04771871|Cyclophosphamide|cyclophosphamide|mesh-list
6050298|NCT04771871|Carboplatin|carboplatin|mesh-list
6050299|NCT04771871|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6050300|NCT04771871|Epirubicin|epirubicin|mesh-list
6050301|NCT04771871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6050302|NCT04771871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6050303|NCT04771871|Tubulin Modulators|tubulin modulators|mesh-ancestor
6050304|NCT04771871|Antimitotic Agents|antimitotic agents|mesh-ancestor
6050305|NCT04771871|Mitosis Modulators|mitosis modulators|mesh-ancestor
6050306|NCT04771871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6050307|NCT04771871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6050308|NCT04771871|Immunologic Factors|immunologic factors|mesh-ancestor
6050309|NCT04771871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050310|NCT04771871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6050311|NCT04771871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6050312|NCT04771871|Alkylating Agents|alkylating agents|mesh-ancestor
6050313|NCT04771871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6050314|NCT04771871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6050315|NCT04771871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6050316|NCT04771871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6050317|NCT04771871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6050318|NCT04762069|Lomustine|lomustine|mesh-list
6050319|NCT04762069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6050320|NCT04762069|Alkylating Agents|alkylating agents|mesh-ancestor
6050321|NCT04762069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6050322|NCT04762069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6050323|NCT04756232|Mecamylamine|mecamylamine|mesh-list
6050324|NCT04756232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6050325|NCT04756232|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
6050326|NCT04756232|Autonomic Agents|autonomic agents|mesh-ancestor
6050327|NCT04756232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6050328|NCT04756232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050329|NCT04756232|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
6050330|NCT04756232|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6050331|NCT04756232|Cholinergic Agents|cholinergic agents|mesh-ancestor
6050332|NCT04756232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6050333|NCT04756232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6050334|NCT04752566|Eculizumab|eculizumab|mesh-list
6050335|NCT04752566|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6050336|NCT04752566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6050337|NCT04752566|Immunologic Factors|immunologic factors|mesh-ancestor
6050338|NCT04752566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050339|NCT04745910|Rasburicase|rasburicase|mesh-list
6050340|NCT04745910|Uric Acid|uric acid|mesh-list
6050341|NCT04745910|Gout Suppressants|gout suppressants|mesh-ancestor
6050342|NCT04745910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6050343|NCT04745910|Antioxidants|antioxidants|mesh-ancestor
6050344|NCT04745910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6050345|NCT04745910|Protective Agents|protective agents|mesh-ancestor
6050346|NCT04745910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050347|NCT04740905|Aflibercept|aflibercept|mesh-list
6050348|NCT04740905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6050349|NCT04740905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6050350|NCT04740905|Growth Substances|growth substances|mesh-ancestor
6050351|NCT04740905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050352|NCT04740905|Growth Inhibitors|growth inhibitors|mesh-ancestor
6050353|NCT04740905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6458612|NCT00440973|Sensory System Agents|sensory system agents|mesh-ancestor
6050354|NCT04740814|Certolizumab Pegol|certolizumab pegol|mesh-list
6050355|NCT04740814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6050356|NCT04740814|Immunologic Factors|immunologic factors|mesh-ancestor
6050357|NCT04740814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050358|NCT04740814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5500079|NCT04484506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5500080|NCT04484506|Glucocorticoids|glucocorticoids|mesh-ancestor
5500081|NCT04484506|Hormones|hormones|mesh-ancestor
5500082|NCT04484506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5500083|NCT04484506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5500084|NCT04484506|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5500085|NCT04484506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5500086|NCT04484506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5500087|NCT04484506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5500088|NCT04484506|Tubulin Modulators|tubulin modulators|mesh-ancestor
5500089|NCT04484506|Antimitotic Agents|antimitotic agents|mesh-ancestor
5500090|NCT04484506|Mitosis Modulators|mitosis modulators|mesh-ancestor
5503513|NCT04458610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5503514|NCT04458610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5503515|NCT04458610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503516|NCT04458545|Heroin|heroin|mesh-list
5503517|NCT04458545|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5503518|NCT04458545|Narcotics|narcotics|mesh-ancestor
5503519|NCT04458545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5503520|NCT04458545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503521|NCT04458545|Analgesics|analgesics|mesh-ancestor
5503522|NCT04458545|Sensory System Agents|sensory system agents|mesh-ancestor
5503523|NCT04458545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5503524|NCT04458636|Prednisolone|prednisolone|mesh-list
5503525|NCT04458636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5503526|NCT04458636|Glucocorticoids|glucocorticoids|mesh-ancestor
5503527|NCT04458636|Hormones|hormones|mesh-ancestor
5503528|NCT04458636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5503529|NCT04458636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503530|NCT04458636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5500091|NCT04484532|Vaccines|vaccines|mesh-list
5500092|NCT04484532|Immunologic Factors|immunologic factors|mesh-ancestor
5500093|NCT04484532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500094|NCT04484610|Analgesics, Opioid|analgesics, opioid|mesh-list
5500095|NCT04484610|Narcotics|narcotics|mesh-ancestor
5500096|NCT04484610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5500097|NCT04484610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500098|NCT04484610|Analgesics|analgesics|mesh-ancestor
5500099|NCT04484610|Sensory System Agents|sensory system agents|mesh-ancestor
5500100|NCT04484610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5500101|NCT04484558|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5500102|NCT04484558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5500103|NCT04484558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6050387|NCT04729387|Paclitaxel|paclitaxel|mesh-list
6050388|NCT04729387|Doxorubicin|doxorubicin|mesh-list
6050389|NCT04729387|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5500104|NCT04484558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500105|NCT04484467|Menthol|menthol|mesh-list
5500106|NCT04484467|Antipruritics|antipruritics|mesh-ancestor
5500107|NCT04484467|Dermatologic Agents|dermatologic agents|mesh-ancestor
5500108|NCT04484623|Dexamethasone|dexamethasone|mesh-list
5500109|NCT04484623|Bortezomib|bortezomib|mesh-list
5500110|NCT04484623|Pomalidomide|pomalidomide|mesh-list
5500111|NCT04484623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5500112|NCT04484623|Antiemetics|antiemetics|mesh-ancestor
5500113|NCT04484623|Autonomic Agents|autonomic agents|mesh-ancestor
5500114|NCT04484623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5500115|NCT04484623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500116|NCT04484623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5500117|NCT04484623|Glucocorticoids|glucocorticoids|mesh-ancestor
5500118|NCT04484623|Hormones|hormones|mesh-ancestor
5500119|NCT04484623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5500120|NCT04484623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5500121|NCT04484623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5500122|NCT04484623|Immunologic Factors|immunologic factors|mesh-ancestor
5500123|NCT04484623|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5500124|NCT04484623|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6050390|NCT04729387|Olaparib|olaparib|mesh-list
6050391|NCT04729387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6655320|NCT01463163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6655321|NCT01463163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655322|NCT01463163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655323|NCT01463215|Ambroxol|ambroxol|mesh-list
6655324|NCT01463215|Expectorants|expectorants|mesh-ancestor
6655325|NCT01463215|Respiratory System Agents|respiratory system agents|mesh-ancestor
6655326|NCT01463228|Metformin|metformin|mesh-list
6655327|NCT01463228|Canagliflozin|canagliflozin|mesh-list
6655328|NCT01463228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6655329|NCT01463228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655330|NCT01463228|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5500125|NCT04484623|Growth Substances|growth substances|mesh-ancestor
5500126|NCT04484623|Growth Inhibitors|growth inhibitors|mesh-ancestor
5500127|NCT04484428|Menthol|menthol|mesh-list
5500128|NCT04484428|Antipruritics|antipruritics|mesh-ancestor
5500129|NCT04484428|Dermatologic Agents|dermatologic agents|mesh-ancestor
5500130|NCT04484350|Enalapril|enalapril|mesh-list
5500131|NCT04484350|Hydralazine|hydralazine|mesh-list
5500132|NCT04484350|Labetalol|labetalol|mesh-list
5500133|NCT04484350|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6050392|NCT04729387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6655331|NCT01463228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6655332|NCT01463280|Lidocaine|lidocaine|mesh-list
6655333|NCT01463280|Anesthetics, Local|anesthetics, local|mesh-ancestor
6050393|NCT04729387|Tubulin Modulators|tubulin modulators|mesh-ancestor
6655334|NCT01463280|Anesthetics|anesthetics|mesh-ancestor
6050394|NCT04729387|Antimitotic Agents|antimitotic agents|mesh-ancestor
6050395|NCT04729387|Mitosis Modulators|mitosis modulators|mesh-ancestor
6050396|NCT04729387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6050397|NCT04729387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6050398|NCT04729387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6050399|NCT04729387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6050400|NCT04729387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6050401|NCT04729387|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6050402|NCT04692077|Tenofovir|tenofovir|mesh-list
6050403|NCT04692077|Emtricitabine|emtricitabine|mesh-list
6050404|NCT04692077|Cabotegravir|cabotegravir|mesh-list
6050405|NCT04692077|Antiviral Agents|antiviral agents|mesh-ancestor
6050406|NCT04692077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6050407|NCT04692077|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6050408|NCT04692077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6050409|NCT04692077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6050410|NCT04692077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6050411|NCT04692077|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6050412|NCT04692077|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6050413|NCT04692077|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6050414|NCT04692077|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6050415|NCT04671667|Cisplatin|cisplatin|mesh-list
6050416|NCT04671667|Carboplatin|carboplatin|mesh-list
5500134|NCT04484350|Protease Inhibitors|protease inhibitors|mesh-ancestor
5500135|NCT04484350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5500136|NCT04484350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500137|NCT04484350|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5500138|NCT04484350|Vasodilator Agents|vasodilator agents|mesh-ancestor
5500139|NCT04484350|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5500140|NCT04484350|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5500141|NCT04484350|Adrenergic Agents|adrenergic agents|mesh-ancestor
5500142|NCT04484350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5500143|NCT04484350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500144|NCT04484350|Sympathomimetics|sympathomimetics|mesh-ancestor
5500145|NCT04484350|Autonomic Agents|autonomic agents|mesh-ancestor
6050417|NCT04671667|Pembrolizumab|pembrolizumab|mesh-list
6050418|NCT04671667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6050419|NCT04671667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6050420|NCT04659044|Rituximab|rituximab|mesh-list
6050421|NCT04659044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6050422|NCT04659044|Venetoclax|venetoclax|mesh-list
6050423|NCT04659044|Antibodies|antibodies|mesh-list
6050424|NCT04659044|Immunoglobulins|immunoglobulins|mesh-list
6050425|NCT04659044|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6050426|NCT04659044|Immunoconjugates|immunoconjugates|mesh-list
6050427|NCT04659044|Immunologic Factors|immunologic factors|mesh-ancestor
6050428|NCT04659044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458613|NCT00440973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5500146|NCT04484350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5500147|NCT04484350|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5500148|NCT04484350|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5500149|NCT04484272|Analgesics, Opioid|analgesics, opioid|mesh-list
5500150|NCT04484272|Narcotics|narcotics|mesh-ancestor
5500151|NCT04484272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5500152|NCT04484272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500153|NCT04484272|Analgesics|analgesics|mesh-ancestor
6050429|NCT04659044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6050430|NCT04659044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6458614|NCT00441025|Alemtuzumab|alemtuzumab|mesh-list
6458615|NCT00441025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6458616|NCT00441025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6458617|NCT00441051|Diclofenac|diclofenac|mesh-list
6458618|NCT00441051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6458619|NCT00441051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6458620|NCT00441051|Analgesics|analgesics|mesh-ancestor
6050431|NCT04603391|Cannabidiol|cannabidiol|mesh-list
6050432|NCT04603391|Methylphenidate|methylphenidate|mesh-list
6050433|NCT04603391|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6050434|NCT04603391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050435|NCT04603391|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6050436|NCT04603391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6050437|NCT04603391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6050438|NCT04603391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6050439|NCT04603391|Dopamine Agents|dopamine agents|mesh-ancestor
6050440|NCT04603391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6050441|NCT04603391|Anticonvulsants|anticonvulsants|mesh-ancestor
6050442|NCT04599790|Lenvatinib|lenvatinib|mesh-list
6050443|NCT04599790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6050444|NCT04599790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6050445|NCT04599790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6050446|NCT04599790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6050447|NCT04575857|Atorvastatin|atorvastatin|mesh-list
6050448|NCT04575857|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6050449|NCT04575857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6050450|NCT04575857|Antimetabolites|antimetabolites|mesh-ancestor
6050451|NCT04575857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6050452|NCT04575857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6050453|NCT04575857|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6050454|NCT04575857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6050455|NCT04561206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6050456|NCT04561206|Nivolumab|nivolumab|mesh-list
6050457|NCT04561206|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6050458|NCT04561206|Antibodies|antibodies|mesh-list
6050459|NCT04561206|Immunoglobulins|immunoglobulins|mesh-list
6050460|NCT04561206|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6050461|NCT04561206|Immunoconjugates|immunoconjugates|mesh-list
6050462|NCT04561206|Immunologic Factors|immunologic factors|mesh-ancestor
6050463|NCT04561206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050464|NCT04561206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6050465|NCT04561206|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6050466|NCT04561206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6050467|NCT04545554|Vitamin D|vitamin d|mesh-list
5500154|NCT04484272|Sensory System Agents|sensory system agents|mesh-ancestor
5500155|NCT04484272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5500156|NCT04484259|Aspirin|aspirin|mesh-list
5500157|NCT04484259|Clopidogrel|clopidogrel|mesh-list
5500158|NCT04484259|Ticagrelor|ticagrelor|mesh-list
5500159|NCT04484259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5500160|NCT04484259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5500161|NCT04484259|Analgesics|analgesics|mesh-ancestor
5500162|NCT04484259|Sensory System Agents|sensory system agents|mesh-ancestor
5500163|NCT04484259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5500164|NCT04484259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050468|NCT04545554|Calcium|calcium|mesh-list
6050469|NCT04545554|Vitamins|vitamins|mesh-ancestor
6050470|NCT04545554|Micronutrients|micronutrients|mesh-ancestor
6050471|NCT04545554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050472|NCT04545554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6050473|NCT04545554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6050474|NCT04545008|Acetylcysteine|acetylcysteine|mesh-list
6050475|NCT04545008|Famotidine|famotidine|mesh-list
6050476|NCT04545008|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6050477|NCT04545008|Antiviral Agents|antiviral agents|mesh-ancestor
6050478|NCT04545008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6050479|NCT04545008|Expectorants|expectorants|mesh-ancestor
6050480|NCT04545008|Respiratory System Agents|respiratory system agents|mesh-ancestor
6050481|NCT04545008|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6050482|NCT04545008|Antioxidants|antioxidants|mesh-ancestor
6050483|NCT04545008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6050484|NCT04545008|Protective Agents|protective agents|mesh-ancestor
6050485|NCT04545008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050486|NCT04545008|Antidotes|antidotes|mesh-ancestor
6050487|NCT04545008|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6050488|NCT04545008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6050489|NCT04545008|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6050490|NCT04545008|Histamine Antagonists|histamine antagonists|mesh-ancestor
6050491|NCT04545008|Histamine Agents|histamine agents|mesh-ancestor
6050492|NCT04545008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6050493|NCT04527770|Dexamethasone|dexamethasone|mesh-list
6050494|NCT04527770|Midazolam|midazolam|mesh-list
6050495|NCT04527770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6050496|NCT04527770|Antiemetics|antiemetics|mesh-ancestor
6050497|NCT04527770|Autonomic Agents|autonomic agents|mesh-ancestor
6050498|NCT04527770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6050499|NCT04527770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050500|NCT04527770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6050501|NCT04527770|Glucocorticoids|glucocorticoids|mesh-ancestor
6050502|NCT04527770|Hormones|hormones|mesh-ancestor
6050503|NCT04527770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6050504|NCT04527770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6050505|NCT04527770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6050506|NCT04527770|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6050507|NCT04527770|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6050508|NCT04527770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6050509|NCT04527770|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6050510|NCT04527770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6050511|NCT04527770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6050512|NCT04527770|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6050513|NCT04527770|Anesthetics, General|anesthetics, general|mesh-ancestor
6050514|NCT04527770|Anesthetics|anesthetics|mesh-ancestor
6050515|NCT04527770|GABA Modulators|gaba modulators|mesh-ancestor
6050516|NCT04527770|GABA Agents|gaba agents|mesh-ancestor
6050517|NCT04527770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6050518|NCT04527770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6050519|NCT04527380|Adalimumab|adalimumab|mesh-list
6050520|NCT04527380|Ixekizumab|ixekizumab|mesh-list
6050521|NCT04527380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6050522|NCT04527380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6050523|NCT04527380|Dermatologic Agents|dermatologic agents|mesh-ancestor
6050524|NCT04514497|Irinotecan|irinotecan|mesh-list
6050525|NCT04514497|Topotecan|topotecan|mesh-list
6050526|NCT04514497|Camptothecin|camptothecin|mesh-list
6050527|NCT04514497|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6050528|NCT04514497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6050529|NCT04514497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6050530|NCT04514497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6050531|NCT04514497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6050532|NCT04514497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6050533|NCT04514211|Propofol|propofol|mesh-list
6050534|NCT04514211|Sevoflurane|sevoflurane|mesh-list
6050535|NCT04514211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6050536|NCT04514211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6050537|NCT04514211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050538|NCT04514211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6050539|NCT04514211|Anesthetics, General|anesthetics, general|mesh-ancestor
6050540|NCT04514211|Anesthetics|anesthetics|mesh-ancestor
6050541|NCT04514211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6050542|NCT04514211|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6054134|NCT00601458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6054135|NCT00601458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054136|NCT00601458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6054137|NCT00601458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6054138|NCT00601458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5500165|NCT04484259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5500166|NCT04484259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5500167|NCT04484259|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5500168|NCT04484259|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5500169|NCT04484259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500170|NCT04484259|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5500171|NCT04484259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5500172|NCT04484259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5500173|NCT04484259|Antipyretics|antipyretics|mesh-ancestor
5500174|NCT04484259|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5500175|NCT04484259|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5500176|NCT04484259|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5500177|NCT04484259|Purinergic Agents|purinergic agents|mesh-ancestor
5500178|NCT04484259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5500179|NCT04483830|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
5500180|NCT04483830|Anticoagulants|anticoagulants|mesh-ancestor
5500181|NCT04483830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5500182|NCT04483830|Antimetabolites|antimetabolites|mesh-ancestor
5500183|NCT04483830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500184|NCT04483830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5500185|NCT04483830|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5500186|NCT04483830|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5500187|NCT04483830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6050543|NCT04507503|Futibatinib|futibatinib|mesh-list
6050544|NCT04507503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6050545|NCT04507204|Methylphenidate|methylphenidate|mesh-list
6050546|NCT04507204|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6050547|NCT04507204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050548|NCT04507204|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6050549|NCT04507204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6050550|NCT04507204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6050551|NCT04507204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6050552|NCT04507204|Dopamine Agents|dopamine agents|mesh-ancestor
6050553|NCT04507204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6050554|NCT04505566|Ketorolac|ketorolac|mesh-list
6050555|NCT04505566|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6050556|NCT04505566|Lubricant Eye Drops|lubricant eye drops|mesh-list
6050557|NCT04505566|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6050558|NCT04505566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6050559|NCT04505566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6050560|NCT04505566|Analgesics|analgesics|mesh-ancestor
5500188|NCT04483830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500189|NCT04483960|Nafamostat|nafamostat|mesh-list
5500190|NCT04483960|Enoxaparin|enoxaparin|mesh-list
5500191|NCT04483960|Dalteparin|dalteparin|mesh-list
5500192|NCT04483960|Tinzaparin|tinzaparin|mesh-list
6050561|NCT04505566|Sensory System Agents|sensory system agents|mesh-ancestor
6050562|NCT04505566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6050563|NCT04505566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050564|NCT04505566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6050565|NCT04505566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6050566|NCT04505566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6050567|NCT04505566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6050568|NCT04505566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6050569|NCT04504331|Tamoxifen|tamoxifen|mesh-list
6050570|NCT04504331|Infigratinib|infigratinib|mesh-list
6050571|NCT04504331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6050572|NCT04504331|Hormone Antagonists|hormone antagonists|mesh-ancestor
6050573|NCT04504331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6050574|NCT04504331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050575|NCT04504331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6050576|NCT04504331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6050577|NCT04504331|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6050578|NCT04504331|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6050579|NCT04504331|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6050580|NCT04497298|Vaccines|vaccines|mesh-list
6458621|NCT00441051|Sensory System Agents|sensory system agents|mesh-ancestor
6458622|NCT00441051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6458623|NCT00441051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458624|NCT00441051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6458625|NCT00441051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6050581|NCT04497298|Immunologic Factors|immunologic factors|mesh-ancestor
6050582|NCT04497298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050583|NCT04494425|Paclitaxel|paclitaxel|mesh-list
6050584|NCT04494425|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6050585|NCT04494425|Capecitabine|capecitabine|mesh-list
6050586|NCT04494425|Trastuzumab|trastuzumab|mesh-list
6050587|NCT04494425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6050588|NCT04494425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6458626|NCT00441051|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6458627|NCT00441051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6458628|NCT00441051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458629|NCT00441155|Imatinib Mesylate|imatinib mesylate|mesh-list
6458630|NCT00441155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6458631|NCT00441155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6458632|NCT00441155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6458633|NCT00441155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458634|NCT00441181|Travoprost|travoprost|mesh-list
6458635|NCT00441181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6458636|NCT00441207|Ascorbic Acid|ascorbic acid|mesh-list
6458637|NCT00441207|Antioxidants|antioxidants|mesh-ancestor
6458638|NCT00441207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458639|NCT00441207|Protective Agents|protective agents|mesh-ancestor
6458640|NCT00441207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458641|NCT00441207|Vitamins|vitamins|mesh-ancestor
5500193|NCT04483960|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6458642|NCT00441207|Micronutrients|micronutrients|mesh-ancestor
5500194|NCT04483960|Anticoagulants|anticoagulants|mesh-ancestor
6458643|NCT00441246|Phenylpropanolamine|phenylpropanolamine|mesh-list
6458644|NCT00441246|Pseudoephedrine|pseudoephedrine|mesh-list
6458645|NCT00441246|Ephedrine|ephedrine|mesh-list
6458646|NCT00441246|Guaifenesin|guaifenesin|mesh-list
6458647|NCT00441246|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
6458648|NCT00441246|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6458649|NCT00441246|Autonomic Agents|autonomic agents|mesh-ancestor
6458650|NCT00441246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6458651|NCT00441246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458652|NCT00441246|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6458653|NCT00441246|Respiratory System Agents|respiratory system agents|mesh-ancestor
6458654|NCT00441246|Nasal Decongestants|nasal decongestants|mesh-ancestor
6458655|NCT00441246|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6458656|NCT00441246|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6458657|NCT00441246|Sympathomimetics|sympathomimetics|mesh-ancestor
6458658|NCT00441246|Adrenergic Agents|adrenergic agents|mesh-ancestor
6458659|NCT00441246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6458660|NCT00441246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458661|NCT00441246|Expectorants|expectorants|mesh-ancestor
6458662|NCT00441246|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6050589|NCT04494425|Tubulin Modulators|tubulin modulators|mesh-ancestor
6050590|NCT04494425|Antimitotic Agents|antimitotic agents|mesh-ancestor
6050591|NCT04494425|Mitosis Modulators|mitosis modulators|mesh-ancestor
6050592|NCT04494425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6050593|NCT04494425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6050594|NCT04494425|Antimetabolites|antimetabolites|mesh-ancestor
6050595|NCT04494425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6050596|NCT04483102|Liver Extracts|liver extracts|mesh-list
6458663|NCT00441246|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6458664|NCT00441246|Appetite Depressants|appetite depressants|mesh-ancestor
6458665|NCT00441246|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6458666|NCT00441298|Tenofovir|tenofovir|mesh-list
6458667|NCT00441298|Antiviral Agents|antiviral agents|mesh-ancestor
6458668|NCT00441298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6458669|NCT00441298|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6458670|NCT00441298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5500195|NCT04483960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6050597|NCT04483102|Hematinics|hematinics|mesh-ancestor
6050598|NCT04482244|Cannabidiol|cannabidiol|mesh-list
6050599|NCT04482244|Anticonvulsants|anticonvulsants|mesh-ancestor
6050600|NCT04473482|Ethanol|ethanol|mesh-list
6050601|NCT04473482|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6050602|NCT04473482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6050603|NCT04473482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6050604|NCT04473482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050605|NCT04459715|Cisplatin|cisplatin|mesh-list
6050606|NCT04459715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6050607|NCT04459117|Acetaminophen|acetaminophen|mesh-list
6050608|NCT04459117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6050609|NCT04459117|Analgesics|analgesics|mesh-ancestor
6050610|NCT04459117|Sensory System Agents|sensory system agents|mesh-ancestor
6050611|NCT04459117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6050612|NCT04459117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050613|NCT04459117|Antipyretics|antipyretics|mesh-ancestor
6050614|NCT04457557|Ropivacaine|ropivacaine|mesh-list
6050615|NCT04457557|Anesthetics, Local|anesthetics, local|mesh-list
6050616|NCT04457557|Anesthetics|anesthetics|mesh-list
6050617|NCT04457557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6050618|NCT04457557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050619|NCT04457557|Sensory System Agents|sensory system agents|mesh-ancestor
6050620|NCT04457557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5500196|NCT04483960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5500197|NCT04483960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500198|NCT04483960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5500199|NCT04483960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5500200|NCT04483960|Analgesics|analgesics|mesh-ancestor
5500201|NCT04483960|Sensory System Agents|sensory system agents|mesh-ancestor
5500202|NCT04483960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5500203|NCT04483960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500204|NCT04483960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5500205|NCT04483960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5500206|NCT04483960|Protease Inhibitors|protease inhibitors|mesh-ancestor
5500207|NCT04483960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6050621|NCT04444921|Paclitaxel|paclitaxel|mesh-list
6050622|NCT04444921|Carboplatin|carboplatin|mesh-list
6050623|NCT04444921|Nivolumab|nivolumab|mesh-list
6050624|NCT04444921|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6050625|NCT04444921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6050626|NCT04444921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6050627|NCT04444921|Tubulin Modulators|tubulin modulators|mesh-ancestor
6050628|NCT04444921|Antimitotic Agents|antimitotic agents|mesh-ancestor
6050629|NCT04444921|Mitosis Modulators|mitosis modulators|mesh-ancestor
5500208|NCT04483960|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5500209|NCT04483960|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5500210|NCT04483960|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5500211|NCT04483960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5500212|NCT04483960|Immunologic Factors|immunologic factors|mesh-ancestor
5500213|NCT04484012|Acalabrutinib|acalabrutinib|mesh-list
5500214|NCT04484012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5500215|NCT04483765|Anesthetics|anesthetics|mesh-list
5500216|NCT04483765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5500217|NCT04483765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500218|NCT04483596|Melatonin|melatonin|mesh-list
5500219|NCT04483596|Antioxidants|antioxidants|mesh-ancestor
5500220|NCT04483596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500221|NCT04483596|Protective Agents|protective agents|mesh-ancestor
5500222|NCT04483596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500223|NCT04483596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5500224|NCT04483427|Ketorolac|ketorolac|mesh-list
5500225|NCT04483427|Nalbuphine|nalbuphine|mesh-list
5500226|NCT04483427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5500227|NCT04483427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5500228|NCT04483427|Analgesics|analgesics|mesh-ancestor
5500229|NCT04483427|Sensory System Agents|sensory system agents|mesh-ancestor
5500230|NCT04483427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5500231|NCT04483427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050630|NCT04444921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6050631|NCT04444921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6050632|NCT04444921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6050633|NCT04432623|Benserazide|benserazide|mesh-list
6050634|NCT04432623|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6050635|NCT04432623|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6050636|NCT04432623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6050637|NCT04432623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6050638|NCT04432623|Dopamine Agents|dopamine agents|mesh-ancestor
6050639|NCT04432623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6050640|NCT04432623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050641|NCT04430036|Gemcitabine|gemcitabine|mesh-list
6050642|NCT04430036|Cisplatin|cisplatin|mesh-list
6050643|NCT04430036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6050644|NCT04430036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6050645|NCT04430036|Antimetabolites|antimetabolites|mesh-ancestor
6050646|NCT04430036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6050647|NCT04430036|Antiviral Agents|antiviral agents|mesh-ancestor
6050648|NCT04430036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6050649|NCT04430036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6050650|NCT04430036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6050651|NCT04430036|Immunologic Factors|immunologic factors|mesh-ancestor
6050652|NCT04430036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050653|NCT04427072|Docetaxel|docetaxel|mesh-list
6050654|NCT04427072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6050655|NCT04427072|Tubulin Modulators|tubulin modulators|mesh-ancestor
6050656|NCT04427072|Antimitotic Agents|antimitotic agents|mesh-ancestor
6050657|NCT04427072|Mitosis Modulators|mitosis modulators|mesh-ancestor
6050658|NCT04427072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6050659|NCT04421963|Olaparib|olaparib|mesh-list
6050660|NCT04421963|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6050661|NCT04421963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6050662|NCT04421963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6050663|NCT04421963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6050664|NCT04417569|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6050665|NCT04417569|Estradiol|estradiol|mesh-list
6050666|NCT04417569|Progesterone|progesterone|mesh-list
6050667|NCT04417569|Hormones|hormones|mesh-ancestor
6050668|NCT04417569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6050669|NCT04417569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050670|NCT04417569|Estrogens|estrogens|mesh-ancestor
6050671|NCT04417569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6050672|NCT04417569|Progestins|progestins|mesh-ancestor
6050673|NCT04411680|Sargramostim|sargramostim|mesh-list
6458671|NCT00441298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5500232|NCT04483427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5500233|NCT04483427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5500234|NCT04483427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5500235|NCT04483427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5500236|NCT04483427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500237|NCT04483427|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5500238|NCT04483427|Narcotics|narcotics|mesh-ancestor
5500239|NCT04483427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5500240|NCT04483635|Vitamin D|vitamin d|mesh-list
5500241|NCT04483635|Cholecalciferol|cholecalciferol|mesh-list
6050674|NCT04411680|Immunologic Factors|immunologic factors|mesh-ancestor
6050675|NCT04411680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050676|NCT04405908|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6050677|NCT04405908|Aluminum sulfate|aluminum sulfate|mesh-list
6050678|NCT04405908|1018 oligonucleotide|1018 oligonucleotide|mesh-list
6050679|NCT04405908|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6050680|NCT04405908|Immunologic Factors|immunologic factors|mesh-ancestor
6050681|NCT04405908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050682|NCT04405908|Antacids|antacids|mesh-ancestor
6050683|NCT04405908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6050684|NCT04405908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6050685|NCT04404283|Rituximab|rituximab|mesh-list
6050686|NCT04404283|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6050687|NCT04404283|Lenalidomide|lenalidomide|mesh-list
6050688|NCT04404283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6050689|NCT04404283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6050690|NCT04404283|Immunologic Factors|immunologic factors|mesh-ancestor
6050691|NCT04404283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050692|NCT04404283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6050693|NCT04404283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6050694|NCT04404283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6050695|NCT04404283|Growth Substances|growth substances|mesh-ancestor
6050696|NCT04404283|Growth Inhibitors|growth inhibitors|mesh-ancestor
6050697|NCT04388163|Gentian Violet|gentian violet|mesh-list
6050698|NCT04388163|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6050699|NCT04388163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6050700|NCT04380831|Cyclophosphamide|cyclophosphamide|mesh-list
6050701|NCT04380831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6050702|NCT04380831|Immunologic Factors|immunologic factors|mesh-ancestor
6050703|NCT04380831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050704|NCT04380831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6050705|NCT04380831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6050706|NCT04380831|Alkylating Agents|alkylating agents|mesh-ancestor
6050707|NCT04380831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6050708|NCT04380831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6050709|NCT04380831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6050710|NCT04364984|Enzyme Inhibitors|enzyme inhibitors|mesh-list
6050711|NCT04364984|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6050712|NCT04364984|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
6050713|NCT04364984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6050714|NCT04364984|Protease Inhibitors|protease inhibitors|mesh-ancestor
6050715|NCT04363437|Colchicine|colchicine|mesh-list
6050716|NCT04363437|Gout Suppressants|gout suppressants|mesh-ancestor
6050717|NCT04363437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6050718|NCT04363437|Tubulin Modulators|tubulin modulators|mesh-ancestor
6050719|NCT04363437|Antimitotic Agents|antimitotic agents|mesh-ancestor
6050720|NCT04363437|Mitosis Modulators|mitosis modulators|mesh-ancestor
6050721|NCT04363437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500242|NCT04483635|Vitamins|vitamins|mesh-ancestor
5500243|NCT04483635|Micronutrients|micronutrients|mesh-ancestor
5500244|NCT04483635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500245|NCT04483635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5500246|NCT04483635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5500247|NCT04483466|Methotrexate|methotrexate|mesh-list
5500248|NCT04483466|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5500249|NCT04483466|Abortifacient Agents|abortifacient agents|mesh-ancestor
5500250|NCT04483466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5500251|NCT04483466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500252|NCT04483466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5500253|NCT04483466|Antimetabolites|antimetabolites|mesh-ancestor
5500254|NCT04483466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500255|NCT04483466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6050722|NCT04363437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6050723|NCT04362839|Nivolumab|nivolumab|mesh-list
5500256|NCT04483466|Dermatologic Agents|dermatologic agents|mesh-ancestor
6050724|NCT04362839|Ipilimumab|ipilimumab|mesh-list
6050725|NCT04362839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6050726|NCT04362839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6050727|NCT04362839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6050728|NCT04362839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6050729|NCT04346654|Dexamethasone|dexamethasone|mesh-list
6050730|NCT04346654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6050731|NCT04346654|Antiemetics|antiemetics|mesh-ancestor
6050732|NCT04346654|Autonomic Agents|autonomic agents|mesh-ancestor
5500257|NCT04483466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5500258|NCT04483466|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5500259|NCT04483466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5500260|NCT04483466|Immunologic Factors|immunologic factors|mesh-ancestor
5500261|NCT04483466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5500262|NCT04483466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5500263|NCT04483739|Dexamethasone|dexamethasone|mesh-list
6050733|NCT04346654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6050734|NCT04346654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050735|NCT04346654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6050736|NCT04346654|Glucocorticoids|glucocorticoids|mesh-ancestor
6050737|NCT04346654|Hormones|hormones|mesh-ancestor
6050738|NCT04346654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6050739|NCT04346654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6050740|NCT04346654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6050741|NCT04333459|Vaccines|vaccines|mesh-list
6050742|NCT04333459|Immunologic Factors|immunologic factors|mesh-ancestor
6050743|NCT04333459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500264|NCT04483739|Dexamethasone acetate|dexamethasone acetate|mesh-list
5500265|NCT04483739|Lenalidomide|lenalidomide|mesh-list
5500266|NCT04483739|BB 1101|bb 1101|mesh-list
5500267|NCT04483739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5500268|NCT04483739|Antiemetics|antiemetics|mesh-ancestor
5500269|NCT04483739|Autonomic Agents|autonomic agents|mesh-ancestor
5500270|NCT04483739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5500271|NCT04483739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500272|NCT04483739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5500273|NCT04483739|Glucocorticoids|glucocorticoids|mesh-ancestor
5500274|NCT04483739|Hormones|hormones|mesh-ancestor
6050744|NCT04331496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6050745|NCT04323436|Spartalizumab|spartalizumab|mesh-list
6050746|NCT04323436|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6050747|NCT04323436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6050748|NCT04323436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6050749|NCT04304274|Morphine|morphine|mesh-list
6050750|NCT04304274|Ropivacaine|ropivacaine|mesh-list
6050751|NCT04304274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6050752|NCT04304274|Narcotics|narcotics|mesh-ancestor
6050753|NCT04304274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6050754|NCT04304274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050755|NCT04304274|Analgesics|analgesics|mesh-ancestor
6050756|NCT04304274|Sensory System Agents|sensory system agents|mesh-ancestor
6050757|NCT04304274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6050758|NCT04304274|Anesthetics, Local|anesthetics, local|mesh-ancestor
6050759|NCT04304274|Anesthetics|anesthetics|mesh-ancestor
6050760|NCT04298853|Morphine|morphine|mesh-list
6050761|NCT04298853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6050762|NCT04298853|Narcotics|narcotics|mesh-ancestor
6050763|NCT04298853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6050764|NCT04298853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050765|NCT04298853|Analgesics|analgesics|mesh-ancestor
6050766|NCT04298853|Sensory System Agents|sensory system agents|mesh-ancestor
6050767|NCT04298853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6050768|NCT04292080|Dimethyl Fumarate|dimethyl fumarate|mesh-list
6050769|NCT04292080|Dermatologic Agents|dermatologic agents|mesh-ancestor
6050770|NCT04292080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6050771|NCT04292080|Immunologic Factors|immunologic factors|mesh-ancestor
6050772|NCT04292080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500275|NCT04483739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6050786|NCT04233567|Infigratinib|infigratinib|mesh-list
6050787|NCT04233567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6050788|NCT04224740|Cisplatin|cisplatin|mesh-list
6458672|NCT00441298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458673|NCT00441298|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6458674|NCT00441298|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6461989|NCT00456976|Antidepressive Agents|antidepressive agents|mesh-ancestor
6461990|NCT00456976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6461991|NCT00456976|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6461992|NCT00456976|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6461993|NCT00456976|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6461994|NCT00456976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6461995|NCT00456976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6050789|NCT04224740|Carboplatin|carboplatin|mesh-list
5500276|NCT04483739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5500277|NCT04483739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5500278|NCT04483739|Protease Inhibitors|protease inhibitors|mesh-ancestor
5500279|NCT04483739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5500280|NCT04483739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6050790|NCT04224740|Pembrolizumab|pembrolizumab|mesh-list
6050791|NCT04224740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6050792|NCT04224740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6050793|NCT04220684|Cytarabine|cytarabine|mesh-list
6050794|NCT04220684|Fludarabine|fludarabine|mesh-list
6050795|NCT04220684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6050796|NCT04220684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6050797|NCT04220684|Antimetabolites|antimetabolites|mesh-ancestor
6050798|NCT04220684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6050799|NCT04220684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6050800|NCT04220684|Immunologic Factors|immunologic factors|mesh-ancestor
6050801|NCT04220684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050802|NCT04220684|Antiviral Agents|antiviral agents|mesh-ancestor
6050803|NCT04220684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6050809|NCT04159974|Durvalumab|durvalumab|mesh-list
6050810|NCT04159974|Tremelimumab|tremelimumab|mesh-list
6050811|NCT04159974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6050812|NCT04159974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6050813|NCT04157725|Clomiphene|clomiphene|mesh-list
5500281|NCT04483739|Immunologic Factors|immunologic factors|mesh-ancestor
5500282|NCT04483739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6050814|NCT04157725|Enclomiphene|enclomiphene|mesh-list
6050815|NCT04157725|Zuclomiphene|zuclomiphene|mesh-list
6050816|NCT04157725|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6050817|NCT04157725|Hormone Antagonists|hormone antagonists|mesh-ancestor
6050818|NCT04157725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6050819|NCT04157725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050820|NCT04157725|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6050821|NCT04157725|Fertility Agents|fertility agents|mesh-ancestor
6050822|NCT04157725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6050823|NCT04157725|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6050824|NCT04157725|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6461996|NCT00456976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6461997|NCT00456976|Protective Agents|protective agents|mesh-ancestor
6461998|NCT00456976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6461999|NCT00457054|Lithium Carbonate|lithium carbonate|mesh-list
6050841|NCT04145349|Cyclophosphamide|cyclophosphamide|mesh-list
6050842|NCT04145349|Vinorelbine|vinorelbine|mesh-list
6050843|NCT04145349|Ramucirumab|ramucirumab|mesh-list
6050844|NCT04145349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6050845|NCT04145349|Immunologic Factors|immunologic factors|mesh-ancestor
6050846|NCT04145349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050847|NCT04145349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6050848|NCT04145349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6050849|NCT04145349|Alkylating Agents|alkylating agents|mesh-ancestor
6050850|NCT04145349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6050851|NCT04145349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6050852|NCT04145349|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6050853|NCT04145349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6050854|NCT04145349|Tubulin Modulators|tubulin modulators|mesh-ancestor
6050855|NCT04145349|Antimitotic Agents|antimitotic agents|mesh-ancestor
6050856|NCT04145349|Mitosis Modulators|mitosis modulators|mesh-ancestor
6050857|NCT04142502|Dexmedetomidine|dexmedetomidine|mesh-list
6050858|NCT04142502|Propofol|propofol|mesh-list
6050859|NCT04142502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6050860|NCT04142502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6458675|NCT00441415|Adapalene|adapalene|mesh-list
6458676|NCT00441415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6458677|NCT00441415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6458678|NCT00441415|Analgesics|analgesics|mesh-ancestor
6458679|NCT00441415|Sensory System Agents|sensory system agents|mesh-ancestor
6458680|NCT00441415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6458681|NCT00441415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458682|NCT00441415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6458683|NCT00441415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6458684|NCT00441415|Dermatologic Agents|dermatologic agents|mesh-ancestor
6458685|NCT00441428|Solifenacin Succinate|solifenacin succinate|mesh-list
6458686|NCT00441428|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6458687|NCT00441428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6458688|NCT00441428|Cholinergic Agents|cholinergic agents|mesh-ancestor
6458689|NCT00441428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5500283|NCT04483739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5500284|NCT04483739|Growth Substances|growth substances|mesh-ancestor
5500285|NCT04483739|Growth Inhibitors|growth inhibitors|mesh-ancestor
5500286|NCT04483674|Tenofovir|tenofovir|mesh-list
5500287|NCT04483674|Emtricitabine|emtricitabine|mesh-list
5500288|NCT04483674|Antiviral Agents|antiviral agents|mesh-ancestor
5500289|NCT04483674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5500290|NCT04483674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5500291|NCT04483674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5500292|NCT04483674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5500293|NCT04483674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500294|NCT04483674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5500295|NCT04483674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5500296|NCT04483492|Caffeine|caffeine|mesh-list
5500297|NCT04483492|Caffeine citrate|caffeine citrate|mesh-list
5500298|NCT04483492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500299|NCT04483492|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5500300|NCT04483492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050861|NCT04142502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050862|NCT04142502|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6050863|NCT04142502|Anesthetics, General|anesthetics, general|mesh-ancestor
6050864|NCT04142502|Anesthetics|anesthetics|mesh-ancestor
6050865|NCT04142502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6050866|NCT04142502|Analgesics|analgesics|mesh-ancestor
6050867|NCT04142502|Sensory System Agents|sensory system agents|mesh-ancestor
6050868|NCT04142502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6050869|NCT04142502|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6050870|NCT04142502|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6050871|NCT04142502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6050872|NCT04142502|Adrenergic Agents|adrenergic agents|mesh-ancestor
6050873|NCT04142502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5500301|NCT04483492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5500302|NCT04483492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6458690|NCT00441428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6050874|NCT04142502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6050875|NCT04123795|Certolizumab Pegol|certolizumab pegol|mesh-list
5500303|NCT04483492|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5500304|NCT04483492|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5500305|NCT04483492|Purinergic Agents|purinergic agents|mesh-ancestor
5500306|NCT04483492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5500307|NCT04483258|Sevoflurane|sevoflurane|mesh-list
6050876|NCT04123795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6050877|NCT04123795|Immunologic Factors|immunologic factors|mesh-ancestor
6050878|NCT04123795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050879|NCT04123795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6050880|NCT04118166|Nivolumab|nivolumab|mesh-list
6050881|NCT04118166|Ipilimumab|ipilimumab|mesh-list
6050882|NCT04118166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6050883|NCT04118166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6050884|NCT04118166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6050885|NCT04118166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6050886|NCT04117581|Vitamin D|vitamin d|mesh-list
6050887|NCT04117581|Cholecalciferol|cholecalciferol|mesh-list
6050888|NCT04117581|Vitamins|vitamins|mesh-ancestor
5500308|NCT04483258|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5500309|NCT04483258|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5500310|NCT04483258|Anesthetics, General|anesthetics, general|mesh-ancestor
5500311|NCT04483258|Anesthetics|anesthetics|mesh-ancestor
5500312|NCT04483258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5500313|NCT04483258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500314|NCT04483206|Melphalan|melphalan|mesh-list
5500315|NCT04483206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5500316|NCT04483206|Alkylating Agents|alkylating agents|mesh-ancestor
5500317|NCT04483206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500318|NCT04483206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5500319|NCT04483206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5500320|NCT04483206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5500321|NCT04483206|Immunologic Factors|immunologic factors|mesh-ancestor
5500322|NCT04483206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050889|NCT04117581|Micronutrients|micronutrients|mesh-ancestor
6050890|NCT04117581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050891|NCT04117581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6050892|NCT04117581|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6050893|NCT04113616|Cytarabine|cytarabine|mesh-list
6050894|NCT04113616|Decitabine|decitabine|mesh-list
6050895|NCT04113616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6050896|NCT04113616|Antimetabolites|antimetabolites|mesh-ancestor
6050897|NCT04113616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6050898|NCT04113616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5500323|NCT04483284|Chlorotrianisene|chlorotrianisene|mesh-list
5500324|NCT04483284|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
5500325|NCT04483284|Estrogens|estrogens|mesh-ancestor
6050899|NCT04113616|Antiviral Agents|antiviral agents|mesh-ancestor
6050900|NCT04113616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6050901|NCT04113616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6050902|NCT04113616|Immunologic Factors|immunologic factors|mesh-ancestor
6050903|NCT04113616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050904|NCT04113616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6054139|NCT00601458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6054140|NCT00601458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6054141|NCT00601458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6054142|NCT00601458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6054143|NCT00601458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6054144|NCT00601458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6054145|NCT00601458|Gout Suppressants|gout suppressants|mesh-ancestor
6054146|NCT00601458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6054147|NCT00601458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5500326|NCT04483284|Hormones|hormones|mesh-ancestor
5500327|NCT04483284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6054148|NCT00601484|Tanezumab|tanezumab|mesh-list
6054149|NCT00601484|Analgesics|analgesics|mesh-ancestor
6054150|NCT00601484|Sensory System Agents|sensory system agents|mesh-ancestor
6050915|NCT04086745|Adalimumab|adalimumab|mesh-list
6050916|NCT04086745|Etanercept|etanercept|mesh-list
6050917|NCT04086745|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
6050918|NCT04086745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6050919|NCT04086745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6050920|NCT04086745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6050921|NCT04086745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6050922|NCT04086745|Analgesics|analgesics|mesh-ancestor
6050923|NCT04086745|Sensory System Agents|sensory system agents|mesh-ancestor
6050924|NCT04086745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6050925|NCT04086745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050926|NCT04086745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6050927|NCT04086745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6050928|NCT04086745|Immunologic Factors|immunologic factors|mesh-ancestor
6050929|NCT04066725|Aspirin|aspirin|mesh-list
6050930|NCT04066725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6050931|NCT04066725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6050932|NCT04066725|Analgesics|analgesics|mesh-ancestor
6050933|NCT04066725|Sensory System Agents|sensory system agents|mesh-ancestor
6050934|NCT04066725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6050935|NCT04066725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050936|NCT04066725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6050937|NCT04066725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6050938|NCT04066725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6050939|NCT04066725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6050940|NCT04066725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6050941|NCT04066725|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6050942|NCT04066725|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6050943|NCT04066725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6050944|NCT04066725|Antipyretics|antipyretics|mesh-ancestor
6050945|NCT04062032|Aspirin|aspirin|mesh-list
6050946|NCT04062032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6050947|NCT04062032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6050948|NCT04062032|Analgesics|analgesics|mesh-ancestor
6050949|NCT04062032|Sensory System Agents|sensory system agents|mesh-ancestor
6050950|NCT04062032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6050951|NCT04062032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050952|NCT04062032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6050953|NCT04062032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6050954|NCT04062032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6050955|NCT04062032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6050956|NCT04062032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6050957|NCT04062032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6050958|NCT04062032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6050959|NCT04062032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6050960|NCT04062032|Antipyretics|antipyretics|mesh-ancestor
6050961|NCT04059484|Tamoxifen|tamoxifen|mesh-list
6050962|NCT04059484|Letrozole|letrozole|mesh-list
6050963|NCT04059484|Fulvestrant|fulvestrant|mesh-list
6050964|NCT04059484|Anastrozole|anastrozole|mesh-list
6050965|NCT04059484|Exemestane|exemestane|mesh-list
6050966|NCT04059484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6050967|NCT04059484|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6050968|NCT04059484|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6050969|NCT04059484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6050970|NCT04059484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6050971|NCT04059484|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6050972|NCT04059484|Hormone Antagonists|hormone antagonists|mesh-ancestor
6050973|NCT04059484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6050974|NCT04059484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050975|NCT04059484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6050976|NCT04059484|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6050977|NCT04059484|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6050978|NCT04059484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6050979|NCT04059484|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6050980|NCT04055844|Decitabine|decitabine|mesh-list
6050981|NCT04055844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5500328|NCT04483284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500329|NCT04483284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6050982|NCT04055844|Antimetabolites|antimetabolites|mesh-ancestor
6050983|NCT04055844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6050984|NCT04055844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6050985|NCT04055844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6050986|NCT04053881|Certolizumab Pegol|certolizumab pegol|mesh-list
5500330|NCT04483284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6050987|NCT04053881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6050988|NCT04053881|Immunologic Factors|immunologic factors|mesh-ancestor
6050989|NCT04053881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6050990|NCT04053881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6050991|NCT04052698|Factor VIII|factor viii|mesh-list
6050992|NCT04052698|Coagulants|coagulants|mesh-ancestor
6050993|NCT04033991|Sunitinib|sunitinib|mesh-list
6050994|NCT04033991|Axitinib|axitinib|mesh-list
6050995|NCT04033991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6050996|NCT04033991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6050997|NCT04033991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6050998|NCT04033991|Growth Substances|growth substances|mesh-ancestor
6050999|NCT04033991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051000|NCT04033991|Growth Inhibitors|growth inhibitors|mesh-ancestor
6051001|NCT04033991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6051002|NCT04033991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6051003|NCT04033991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051004|NCT04027361|Amphetamine|amphetamine|mesh-list
6051005|NCT04027361|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6051006|NCT04027361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051007|NCT04027361|Sympathomimetics|sympathomimetics|mesh-ancestor
6051008|NCT04027361|Autonomic Agents|autonomic agents|mesh-ancestor
6051009|NCT04027361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6051010|NCT04027361|Dopamine Agents|dopamine agents|mesh-ancestor
6051011|NCT04027361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6051012|NCT04027361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051013|NCT04027361|Adrenergic Agents|adrenergic agents|mesh-ancestor
6051014|NCT04027361|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6051015|NCT04027361|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6051016|NCT04027361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6051017|NCT04027361|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6051018|NCT04011839|Levobupivacaine|levobupivacaine|mesh-list
6051019|NCT04011839|Anesthetics, Local|anesthetics, local|mesh-ancestor
6051020|NCT04011839|Anesthetics|anesthetics|mesh-ancestor
6051021|NCT04011839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6051022|NCT04011839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051023|NCT04011839|Sensory System Agents|sensory system agents|mesh-ancestor
6051024|NCT04011839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6051025|NCT04000529|Spartalizumab|spartalizumab|mesh-list
6051026|NCT04000529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6051027|NCT04000529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051028|NCT04000529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6051029|NCT03994627|Olaratumab|olaratumab|mesh-list
6051030|NCT03994627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5500331|NCT04483219|Antibodies|antibodies|mesh-list
5500332|NCT04483219|Immunologic Factors|immunologic factors|mesh-ancestor
5500333|NCT04483219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051031|NCT03992404|Botulinum Toxins|botulinum toxins|mesh-list
6051032|NCT03992404|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6051033|NCT03992404|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6051034|NCT03992404|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
6051035|NCT03992404|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6051036|NCT03992404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6051037|NCT03992404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051038|NCT03992404|Cholinergic Agents|cholinergic agents|mesh-ancestor
6051039|NCT03992404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6051040|NCT03992404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051041|NCT03992404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6051042|NCT03992404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5500334|NCT04483063|Chlorhexidine|chlorhexidine|mesh-list
5500335|NCT04483063|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5500336|NCT04483063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5500337|NCT04483063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6051043|NCT03991091|Oxytocin|oxytocin|mesh-list
6051044|NCT03991091|Oxytocics|oxytocics|mesh-ancestor
6051045|NCT03991091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6051046|NCT03991091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051047|NCT03986424|Memantine|memantine|mesh-list
6051048|NCT03986424|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6051049|NCT03986424|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6051050|NCT03986424|Dopamine Agents|dopamine agents|mesh-ancestor
6051051|NCT03986424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6051052|NCT03986424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500338|NCT04483063|Disinfectants|disinfectants|mesh-ancestor
6051053|NCT03986424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051054|NCT03986424|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6051055|NCT03986424|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6051056|NCT03973229|Estradiol|estradiol|mesh-list
6051057|NCT03973229|Estrogens|estrogens|mesh-ancestor
6051058|NCT03973229|Hormones|hormones|mesh-ancestor
6051059|NCT03973229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6051060|NCT03973229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051061|NCT03934840|Prednisone|prednisone|mesh-list
6051062|NCT03934840|Carboplatin|carboplatin|mesh-list
6051063|NCT03934840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6051064|NCT03934840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5500339|NCT04483063|Dermatologic Agents|dermatologic agents|mesh-ancestor
5500340|NCT04482907|Hormones|hormones|mesh-list
5500341|NCT04482907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5500342|NCT04482907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503531|NCT04458636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5503532|NCT04458688|Ocrelizumab|ocrelizumab|mesh-list
5503533|NCT04458688|Immunologic Factors|immunologic factors|mesh-ancestor
5503534|NCT04458688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503535|NCT04458324|Buspirone|buspirone|mesh-list
5503536|NCT04458324|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5503537|NCT04458324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5503538|NCT04458324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5503539|NCT04458324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503540|NCT04458324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5503541|NCT04458324|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5503542|NCT04458324|Serotonin Agents|serotonin agents|mesh-ancestor
5503543|NCT04458324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5503544|NCT04458324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503545|NCT04458285|Valsartan|valsartan|mesh-list
5503546|NCT04458285|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5503547|NCT04458285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5503548|NCT04458285|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5503549|NCT04458285|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5503550|NCT04458285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503551|NCT04458311|Abiraterone Acetate|abiraterone acetate|mesh-list
5503552|NCT04458311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5503553|NCT04458311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5503554|NCT04458311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6051065|NCT03934840|Glucocorticoids|glucocorticoids|mesh-ancestor
6051066|NCT03934840|Hormones|hormones|mesh-ancestor
6051067|NCT03934840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6051068|NCT03934840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051069|NCT03934840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6051070|NCT03930732|Cholinergic Agents|cholinergic agents|mesh-list
6051071|NCT03930732|Muscarinic Antagonists|muscarinic antagonists|mesh-list
6051072|NCT03930732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6051073|NCT03930732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051074|NCT03930732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051075|NCT03930732|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6051076|NCT03927157|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6051077|NCT03927157|Immunologic Factors|immunologic factors|mesh-ancestor
6051078|NCT03927157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051079|NCT03896659|Hydrocortisone|hydrocortisone|mesh-list
6051080|NCT03896659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6051081|NCT03879629|Carvedilol|carvedilol|mesh-list
6051082|NCT03879629|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6051083|NCT03879629|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6051084|NCT03879629|Adrenergic Agents|adrenergic agents|mesh-ancestor
6051085|NCT03879629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6051086|NCT03879629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051087|NCT03879629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051088|NCT03879629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6051089|NCT03879629|Antioxidants|antioxidants|mesh-ancestor
6051090|NCT03879629|Protective Agents|protective agents|mesh-ancestor
6051091|NCT03879629|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6051092|NCT03879629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6051093|NCT03879629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6051094|NCT03879629|Vasodilator Agents|vasodilator agents|mesh-ancestor
6051095|NCT03879629|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6051096|NCT03879629|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6051097|NCT03869866|Vaccines|vaccines|mesh-list
6051098|NCT03869866|Immunologic Factors|immunologic factors|mesh-ancestor
6051099|NCT03869866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051100|NCT03839823|Gemcitabine|gemcitabine|mesh-list
6051101|NCT03839823|Paclitaxel|paclitaxel|mesh-list
6051102|NCT03839823|Vinorelbine|vinorelbine|mesh-list
6051103|NCT03839823|Docetaxel|docetaxel|mesh-list
6051104|NCT03839823|Capecitabine|capecitabine|mesh-list
6051105|NCT03839823|Letrozole|letrozole|mesh-list
6051106|NCT03839823|Anastrozole|anastrozole|mesh-list
6051107|NCT03839823|Goserelin|goserelin|mesh-list
6051108|NCT03839823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6051109|NCT03839823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6051110|NCT03839823|Tubulin Modulators|tubulin modulators|mesh-ancestor
6051111|NCT03839823|Antimitotic Agents|antimitotic agents|mesh-ancestor
6051112|NCT03839823|Mitosis Modulators|mitosis modulators|mesh-ancestor
6051113|NCT03839823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051114|NCT03839823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6051115|NCT03839823|Antimetabolites|antimetabolites|mesh-ancestor
6051116|NCT03839823|Antiviral Agents|antiviral agents|mesh-ancestor
6051117|NCT03839823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6051118|NCT03839823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6051119|NCT03839823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6051120|NCT03839823|Immunologic Factors|immunologic factors|mesh-ancestor
6051121|NCT03839823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051122|NCT03839823|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6051123|NCT03839823|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6051124|NCT03839823|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6051125|NCT03839823|Hormone Antagonists|hormone antagonists|mesh-ancestor
6051126|NCT03839823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6051127|NCT03839823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6051128|NCT03793439|Prednisone|prednisone|mesh-list
6051129|NCT03793439|Tofacitinib|tofacitinib|mesh-list
6051130|NCT03793439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6051131|NCT03793439|Glucocorticoids|glucocorticoids|mesh-ancestor
6051132|NCT03793439|Hormones|hormones|mesh-ancestor
6051133|NCT03793439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6051134|NCT03793439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051135|NCT03793439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6051136|NCT03793439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5500343|NCT04482842|Warfarin|warfarin|mesh-list
5500344|NCT04482842|Anticoagulants|anticoagulants|mesh-ancestor
5500345|NCT04482959|Carbetocin|carbetocin|mesh-list
5500346|NCT04482959|Oxytocics|oxytocics|mesh-ancestor
5500347|NCT04482959|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5500348|NCT04482959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500349|NCT04482881|Isosorbide|isosorbide|mesh-list
5500350|NCT04482881|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
5500351|NCT04482881|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
5500352|NCT04482881|Misoprostol|misoprostol|mesh-list
5500353|NCT04482881|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6458691|NCT00441428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458692|NCT00441428|Urological Agents|urological agents|mesh-ancestor
6458693|NCT00441506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
6458694|NCT00441506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5500354|NCT04482881|Abortifacient Agents|abortifacient agents|mesh-ancestor
5500355|NCT04482881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5500356|NCT04482881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500357|NCT04482881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5500358|NCT04482881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5500359|NCT04482881|Oxytocics|oxytocics|mesh-ancestor
5500360|NCT04482881|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5500361|NCT04482881|Diuretics|diuretics|mesh-ancestor
5500362|NCT04482881|Natriuretic Agents|natriuretic agents|mesh-ancestor
5500363|NCT04482881|Vasodilator Agents|vasodilator agents|mesh-ancestor
5500364|NCT04482881|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5500365|NCT04482881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500366|NCT04482985|Meclizine|meclizine|mesh-list
5500367|NCT04482985|Antiemetics|antiemetics|mesh-ancestor
5500368|NCT04482985|Autonomic Agents|autonomic agents|mesh-ancestor
5500369|NCT04482985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5500370|NCT04482985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500371|NCT04482985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5500372|NCT04482985|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5500373|NCT04482985|Histamine Antagonists|histamine antagonists|mesh-ancestor
6051137|NCT03793439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5500374|NCT04482985|Histamine Agents|histamine agents|mesh-ancestor
6051138|NCT03793439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6458695|NCT00441506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458696|NCT00441519|Aspirin|aspirin|mesh-list
6458697|NCT00441519|Omeprazole|omeprazole|mesh-list
6458698|NCT00441519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6458699|NCT00441519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6458700|NCT00441519|Analgesics|analgesics|mesh-ancestor
6458701|NCT00441519|Sensory System Agents|sensory system agents|mesh-ancestor
6458702|NCT00441519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6458703|NCT00441519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458704|NCT00441519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6051139|NCT03793439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051140|NCT03755518|Luspatercept|luspatercept|mesh-list
6051141|NCT03755518|Hematinics|hematinics|mesh-ancestor
5500375|NCT04482985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5500376|NCT04482985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500377|NCT04482985|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5500378|NCT04482504|Vitamin D|vitamin d|mesh-list
5500379|NCT04482504|Vitamins|vitamins|mesh-ancestor
5500380|NCT04482504|Micronutrients|micronutrients|mesh-ancestor
5500381|NCT04482504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500382|NCT04482504|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5500389|NCT04482803|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
5500390|NCT04482803|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
5500391|NCT04482803|beta-Endorphin|beta-endorphin|mesh-list
5500392|NCT04482803|Hormones|hormones|mesh-ancestor
5500393|NCT04482803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6051154|NCT03729401|Aspirin|aspirin|mesh-list
6051155|NCT03729401|Clopidogrel|clopidogrel|mesh-list
6051156|NCT03729401|Ticagrelor|ticagrelor|mesh-list
6051157|NCT03729401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6051158|NCT03729401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6051159|NCT03729401|Analgesics|analgesics|mesh-ancestor
6051160|NCT03729401|Sensory System Agents|sensory system agents|mesh-ancestor
6051161|NCT03729401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6051162|NCT03729401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051163|NCT03729401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6051164|NCT03729401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6051165|NCT03729401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6051166|NCT03729401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6051167|NCT03729401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051168|NCT03729401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6051169|NCT03729401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6051170|NCT03729401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6051171|NCT03729401|Antipyretics|antipyretics|mesh-ancestor
6051172|NCT03729401|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6051173|NCT03729401|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6051174|NCT03729401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6051175|NCT03729401|Purinergic Agents|purinergic agents|mesh-ancestor
6051176|NCT03729401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6051177|NCT03725436|Paclitaxel|paclitaxel|mesh-list
6051178|NCT03725436|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6458705|NCT00441519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6051179|NCT03725436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6051180|NCT03725436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6051181|NCT03725436|Tubulin Modulators|tubulin modulators|mesh-ancestor
6051182|NCT03725436|Antimitotic Agents|antimitotic agents|mesh-ancestor
6051183|NCT03725436|Mitosis Modulators|mitosis modulators|mesh-ancestor
6051184|NCT03725436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051185|NCT03722966|Nicotine|nicotine|mesh-list
6051186|NCT03722966|Varenicline|varenicline|mesh-list
6051187|NCT03722966|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6051188|NCT03722966|Autonomic Agents|autonomic agents|mesh-ancestor
6051189|NCT03722966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6051190|NCT03722966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051191|NCT03722966|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6051192|NCT03722966|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6051193|NCT03722966|Cholinergic Agents|cholinergic agents|mesh-ancestor
6051194|NCT03722966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6051195|NCT03722966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051196|NCT03708354|Tocotrienols|tocotrienols|mesh-list
6051197|NCT03708354|Vitamin E|vitamin e|mesh-list
6051198|NCT03708354|Tocopherols|tocopherols|mesh-list
6051199|NCT03708354|Antioxidants|antioxidants|mesh-ancestor
6051200|NCT03708354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051201|NCT03708354|Protective Agents|protective agents|mesh-ancestor
6051202|NCT03708354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051203|NCT03708354|Vitamins|vitamins|mesh-ancestor
6051204|NCT03708354|Micronutrients|micronutrients|mesh-ancestor
6051205|NCT03706365|Prednisone|prednisone|mesh-list
6051206|NCT03706365|Abiraterone Acetate|abiraterone acetate|mesh-list
6051207|NCT03706365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6051208|NCT03706365|Glucocorticoids|glucocorticoids|mesh-ancestor
6051209|NCT03706365|Hormones|hormones|mesh-ancestor
6051210|NCT03706365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6051211|NCT03706365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051212|NCT03706365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6051213|NCT03706365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6051214|NCT03706365|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6051215|NCT03706365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6051216|NCT03706365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051217|NCT03706365|Hormone Antagonists|hormone antagonists|mesh-ancestor
6051218|NCT03706365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6051219|NCT03691610|Vaccines|vaccines|mesh-list
6051220|NCT03691610|Immunoglobulins|immunoglobulins|mesh-list
6051221|NCT03691610|Immunologic Factors|immunologic factors|mesh-ancestor
6051222|NCT03691610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051223|NCT03656536|Gemcitabine|gemcitabine|mesh-list
6051224|NCT03656536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6051225|NCT03656536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6051226|NCT03656536|Antimetabolites|antimetabolites|mesh-ancestor
6051227|NCT03656536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051228|NCT03656536|Antiviral Agents|antiviral agents|mesh-ancestor
6051229|NCT03656536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6051230|NCT03656536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6051231|NCT03656536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6051232|NCT03656536|Immunologic Factors|immunologic factors|mesh-ancestor
6051233|NCT03656536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051234|NCT03655691|Botulinum Toxins|botulinum toxins|mesh-list
6051235|NCT03655691|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6051236|NCT03655691|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6051237|NCT03655691|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6051238|NCT03655691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6051239|NCT03655691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051240|NCT03655691|Cholinergic Agents|cholinergic agents|mesh-ancestor
6051241|NCT03655691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6051242|NCT03655691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051243|NCT03655691|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6051244|NCT03655691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6051245|NCT03622788|Cyclophosphamide|cyclophosphamide|mesh-list
6051246|NCT03622788|Fludarabine|fludarabine|mesh-list
6051247|NCT03622788|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6051248|NCT03622788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6051249|NCT03622788|Immunologic Factors|immunologic factors|mesh-ancestor
6051250|NCT03622788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051251|NCT03622788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6051252|NCT03622788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6051253|NCT03622788|Alkylating Agents|alkylating agents|mesh-ancestor
6051254|NCT03622788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500394|NCT04482803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500395|NCT04482803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5500396|NCT04482803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500397|NCT04482712|Sirolimus|sirolimus|mesh-list
6051255|NCT03622788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6051256|NCT03622788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6051257|NCT03604991|Paclitaxel|paclitaxel|mesh-list
6051258|NCT03604991|Carboplatin|carboplatin|mesh-list
6051259|NCT03604991|Nivolumab|nivolumab|mesh-list
6051260|NCT03604991|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6051261|NCT03604991|Ipilimumab|ipilimumab|mesh-list
6051262|NCT03604991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6051263|NCT03604991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6051264|NCT03604991|Tubulin Modulators|tubulin modulators|mesh-ancestor
6051265|NCT03604991|Antimitotic Agents|antimitotic agents|mesh-ancestor
6051266|NCT03604991|Mitosis Modulators|mitosis modulators|mesh-ancestor
6051267|NCT03604991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051268|NCT03604991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6051269|NCT03604991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6051270|NCT03571191|Denosumab|denosumab|mesh-list
6051271|NCT03571191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6051272|NCT03571191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051273|NCT03568656|Abiraterone Acetate|abiraterone acetate|mesh-list
6051274|NCT03568656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6051275|NCT03568656|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6051276|NCT03568656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6051277|NCT03568656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051278|NCT03568656|Hormone Antagonists|hormone antagonists|mesh-ancestor
6051279|NCT03568656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6051280|NCT03568656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458706|NCT00441519|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6458707|NCT00441519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6051281|NCT03568656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5500398|NCT04482712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5500399|NCT04482712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5500400|NCT04482712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5500401|NCT04482712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5500402|NCT04482712|Antifungal Agents|antifungal agents|mesh-ancestor
5500403|NCT04482712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5500404|NCT04482712|Immunologic Factors|immunologic factors|mesh-ancestor
5500405|NCT04482712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500406|NCT04482764|Valproic Acid|valproic acid|mesh-list
5500407|NCT04482764|Anticonvulsants|anticonvulsants|mesh-ancestor
5500408|NCT04482764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5500409|NCT04482764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500410|NCT04482764|GABA Agents|gaba agents|mesh-ancestor
5500411|NCT04482764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5500412|NCT04482764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500413|NCT04482764|Antimanic Agents|antimanic agents|mesh-ancestor
5500414|NCT04482764|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5500415|NCT04482764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5500416|NCT04482764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5500417|NCT04482543|Methotrexate|methotrexate|mesh-list
5500418|NCT04482543|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5500419|NCT04482543|Abortifacient Agents|abortifacient agents|mesh-ancestor
5500420|NCT04482543|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5500421|NCT04482543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500422|NCT04482543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5500423|NCT04482543|Antimetabolites|antimetabolites|mesh-ancestor
5500424|NCT04482543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500425|NCT04482543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5500426|NCT04482543|Dermatologic Agents|dermatologic agents|mesh-ancestor
5500427|NCT04482543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5500428|NCT04482543|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6051282|NCT03537508|Vaccines|vaccines|mesh-list
6051283|NCT03537508|Immunologic Factors|immunologic factors|mesh-ancestor
6051284|NCT03537508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500429|NCT04482543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5500430|NCT04482543|Immunologic Factors|immunologic factors|mesh-ancestor
5500431|NCT04482543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5500432|NCT04482543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5500433|NCT04482413|Donepezil|donepezil|mesh-list
5500434|NCT04482413|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5500435|NCT04482413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6051285|NCT03527472|Memantine|memantine|mesh-list
5500436|NCT04482413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500437|NCT04482413|Cholinergic Agents|cholinergic agents|mesh-ancestor
5500438|NCT04482413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5500439|NCT04482413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500440|NCT04482413|Nootropic Agents|nootropic agents|mesh-ancestor
5500441|NCT04482296|Zinc Sulfate|zinc sulfate|mesh-list
5500442|NCT04482296|Astringents|astringents|mesh-ancestor
5500443|NCT04482296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500444|NCT04482296|Dermatologic Agents|dermatologic agents|mesh-ancestor
6051286|NCT03527472|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6051287|NCT03527472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6051288|NCT03527472|Dopamine Agents|dopamine agents|mesh-ancestor
6051289|NCT03527472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6051290|NCT03527472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051291|NCT03527472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500445|NCT04482257|Irinotecan|irinotecan|mesh-list
5500446|NCT04482257|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5500447|NCT04482257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5500448|NCT04482257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5500449|NCT04482257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500450|NCT04482257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5500451|NCT04481802|Acemannan|acemannan|mesh-list
5500452|NCT04481802|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5500453|NCT04481802|Immunologic Factors|immunologic factors|mesh-ancestor
5500454|NCT04481802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500455|NCT04481802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5500456|NCT04481802|Antiviral Agents|antiviral agents|mesh-ancestor
5500457|NCT04481802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5500458|NCT04481802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5500459|NCT04481815|Rituximab|rituximab|mesh-list
5500460|NCT04481815|Methotrexate|methotrexate|mesh-list
5500461|NCT04481815|Lenalidomide|lenalidomide|mesh-list
5500462|NCT04481815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5500463|NCT04481815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5500464|NCT04481815|Immunologic Factors|immunologic factors|mesh-ancestor
5500465|NCT04481815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500466|NCT04481815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5500467|NCT04481815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5500468|NCT04481815|Abortifacient Agents|abortifacient agents|mesh-ancestor
5500469|NCT04481815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5500470|NCT04481815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5500471|NCT04481815|Antimetabolites|antimetabolites|mesh-ancestor
5500472|NCT04481815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051292|NCT03527472|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6051293|NCT03527472|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6051294|NCT03498066|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
6051295|NCT03498066|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6051296|NCT03498066|Adrenergic Agents|adrenergic agents|mesh-ancestor
6051297|NCT03498066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6051298|NCT03498066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051299|NCT03498066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051300|NCT03497975|Nalbuphine|nalbuphine|mesh-list
6051301|NCT03497975|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6051302|NCT03497975|Narcotics|narcotics|mesh-ancestor
6051303|NCT03497975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6051304|NCT03497975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051305|NCT03497975|Analgesics|analgesics|mesh-ancestor
6051306|NCT03497975|Sensory System Agents|sensory system agents|mesh-ancestor
6051307|NCT03497975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6051308|NCT03480971|Tempol|tempol|mesh-list
6051309|NCT03480971|TEMPO|tempo|mesh-list
6051310|NCT03480971|Antioxidants|antioxidants|mesh-ancestor
6051311|NCT03480971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051312|NCT03480971|Protective Agents|protective agents|mesh-ancestor
6051313|NCT03480971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051314|NCT03480971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6051315|NCT03480971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6051316|NCT03480971|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6051317|NCT03480971|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6054151|NCT00601484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6054152|NCT00601484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054153|NCT00601523|Pramipexole|pramipexole|mesh-list
6054154|NCT00601523|Antioxidants|antioxidants|mesh-ancestor
6054155|NCT00601523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054156|NCT00601523|Protective Agents|protective agents|mesh-ancestor
6054157|NCT00601523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054158|NCT00601523|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6054159|NCT00601523|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6054160|NCT00601523|Dopamine Agonists|dopamine agonists|mesh-ancestor
6054161|NCT00601523|Dopamine Agents|dopamine agents|mesh-ancestor
6054162|NCT00601523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6054163|NCT00601627|Gemcitabine|gemcitabine|mesh-list
6054164|NCT00601627|Fluorouracil|fluorouracil|mesh-list
6054165|NCT00601627|Capecitabine|capecitabine|mesh-list
5500473|NCT04481815|Dermatologic Agents|dermatologic agents|mesh-ancestor
5500474|NCT04481815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5500475|NCT04481815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5500476|NCT04481815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5500477|NCT04481815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5500478|NCT04481815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5500479|NCT04481815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5500480|NCT04481815|Growth Substances|growth substances|mesh-ancestor
6054166|NCT00601627|Panitumumab|panitumumab|mesh-list
6054167|NCT00601627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6054168|NCT00601627|Antimetabolites|antimetabolites|mesh-ancestor
6054169|NCT00601627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054170|NCT00601627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5500481|NCT04481815|Growth Inhibitors|growth inhibitors|mesh-ancestor
5500482|NCT04481841|Vitamins|vitamins|mesh-list
5500483|NCT04481841|Vitamin E|vitamin e|mesh-list
5500484|NCT04481841|Riboflavin|riboflavin|mesh-list
6054171|NCT00601627|Antiviral Agents|antiviral agents|mesh-ancestor
6054172|NCT00601627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6054173|NCT00601627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6054174|NCT00601627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6054175|NCT00601627|Immunologic Factors|immunologic factors|mesh-ancestor
6054176|NCT00601627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054177|NCT00601627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6054178|NCT00601640|Eflornithine|eflornithine|mesh-list
5500485|NCT04481841|Micronutrients|micronutrients|mesh-ancestor
5500486|NCT04481841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500487|NCT04481841|Vitamin B Complex|vitamin b complex|mesh-ancestor
5500488|NCT04481841|Antioxidants|antioxidants|mesh-ancestor
5500489|NCT04481841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500490|NCT04481841|Protective Agents|protective agents|mesh-ancestor
5500491|NCT04481841|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5500492|NCT04481841|Dermatologic Agents|dermatologic agents|mesh-ancestor
6054179|NCT00601640|Diclofenac|diclofenac|mesh-list
5500493|NCT04481724|Evening primrose oil|evening primrose oil|mesh-list
5500494|NCT04481724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5500495|NCT04481724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5500496|NCT04481724|Analgesics|analgesics|mesh-ancestor
5500497|NCT04481724|Sensory System Agents|sensory system agents|mesh-ancestor
5500498|NCT04481724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5500499|NCT04481724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500500|NCT04481724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5500501|NCT04481724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5500502|NCT04481724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5500503|NCT04481724|Antimetabolites|antimetabolites|mesh-ancestor
5500504|NCT04481724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500505|NCT04481724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5500506|NCT04481724|Dermatologic Agents|dermatologic agents|mesh-ancestor
5500507|NCT04481971|Prednisolone|prednisolone|mesh-list
5500508|NCT04481971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5500509|NCT04481971|Glucocorticoids|glucocorticoids|mesh-ancestor
5500510|NCT04481971|Hormones|hormones|mesh-ancestor
6054180|NCT00601640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5500511|NCT04481971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6051318|NCT03433833|Digoxin|digoxin|mesh-list
6051319|NCT03433833|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6051320|NCT03433833|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6051321|NCT03433833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6051322|NCT03433833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051323|NCT03433833|Protective Agents|protective agents|mesh-ancestor
6051324|NCT03433833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051325|NCT03399773|Cyclophosphamide|cyclophosphamide|mesh-list
6051326|NCT03399773|Thiotepa|thiotepa|mesh-list
6051327|NCT03399773|Fludarabine|fludarabine|mesh-list
6051328|NCT03399773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6051329|NCT03399773|Immunologic Factors|immunologic factors|mesh-ancestor
6051330|NCT03399773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051331|NCT03399773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6051332|NCT03399773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6051333|NCT03399773|Alkylating Agents|alkylating agents|mesh-ancestor
6051334|NCT03399773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051335|NCT03399773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6051336|NCT03399773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6051337|NCT03376646|Paclitaxel|paclitaxel|mesh-list
6051338|NCT03376646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6051339|NCT03376646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6051340|NCT03376646|Tubulin Modulators|tubulin modulators|mesh-ancestor
6051341|NCT03376646|Antimitotic Agents|antimitotic agents|mesh-ancestor
6051342|NCT03376646|Mitosis Modulators|mitosis modulators|mesh-ancestor
6051343|NCT03376646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051344|NCT03375307|Olaparib|olaparib|mesh-list
6051345|NCT03375307|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
6051346|NCT03375307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6051347|NCT03375307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051348|NCT03375307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6051349|NCT03359811|Bupivacaine|bupivacaine|mesh-list
6051350|NCT03359811|Anesthetics, Local|anesthetics, local|mesh-list
6051351|NCT03359811|Anesthetics|anesthetics|mesh-list
6051352|NCT03359811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6051353|NCT03359811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051354|NCT03359811|Sensory System Agents|sensory system agents|mesh-ancestor
6051355|NCT03359811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6051356|NCT03297684|Aflibercept|aflibercept|mesh-list
6051357|NCT03297684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6051358|NCT03297684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6051359|NCT03297684|Growth Substances|growth substances|mesh-ancestor
6051360|NCT03297684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051361|NCT03297684|Growth Inhibitors|growth inhibitors|mesh-ancestor
6051362|NCT03297684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6051363|NCT03262662|Varenicline|varenicline|mesh-list
6051364|NCT03262662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6051365|NCT03262662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6051366|NCT03262662|Cholinergic Agents|cholinergic agents|mesh-ancestor
6051367|NCT03262662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6054181|NCT00601640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6458708|NCT00441519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500512|NCT04481971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500513|NCT04481971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5500514|NCT04481971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5500515|NCT04481555|Azithromycin|azithromycin|mesh-list
5500516|NCT04481555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5500517|NCT04481555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5500518|NCT04481750|Edaravone|edaravone|mesh-list
5500519|NCT04481750|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5500520|NCT04481750|Antioxidants|antioxidants|mesh-ancestor
5500521|NCT04481750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500522|NCT04481750|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5500523|NCT04481750|Protective Agents|protective agents|mesh-ancestor
5500524|NCT04481750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500525|NCT04481789|Furosemide|furosemide|mesh-list
5500526|NCT04481789|Sildenafil Citrate|sildenafil citrate|mesh-list
5500527|NCT04481789|Edaravone|edaravone|mesh-list
5500528|NCT04481789|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5500529|NCT04481789|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6458709|NCT00441519|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6458710|NCT00441519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6458711|NCT00441519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6458712|NCT00441519|Antipyretics|antipyretics|mesh-ancestor
6458713|NCT00441519|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6458714|NCT00441519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6458715|NCT00441519|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6458716|NCT00441532|Lidocaine|lidocaine|mesh-list
6458717|NCT00441532|Anesthetics, Local|anesthetics, local|mesh-ancestor
6458718|NCT00441532|Anesthetics|anesthetics|mesh-ancestor
6051368|NCT03262662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051369|NCT03262662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051370|NCT03249714|Ofatumumab|ofatumumab|mesh-list
6051371|NCT03249714|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6051372|NCT03249714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5500530|NCT04481789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5500531|NCT04481789|Antimetabolites|antimetabolites|mesh-ancestor
5500532|NCT04481789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051373|NCT03249714|Immunologic Factors|immunologic factors|mesh-ancestor
6051374|NCT03249714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051375|NCT03179163|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6051376|NCT03179163|Enalapril|enalapril|mesh-list
6051377|NCT03179163|Captopril|captopril|mesh-list
6051378|NCT03179163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6051379|NCT03179163|Diuretics|diuretics|mesh-ancestor
6051380|NCT03179163|Natriuretic Agents|natriuretic agents|mesh-ancestor
6051381|NCT03179163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051382|NCT03179163|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6051383|NCT03179163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6051384|NCT03179163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051385|NCT03179163|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6051386|NCT03179163|Protease Inhibitors|protease inhibitors|mesh-ancestor
6051387|NCT03179163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6051388|NCT03177122|Inositol|inositol|mesh-list
6051389|NCT03177122|Vitamin B Complex|vitamin b complex|mesh-ancestor
6051390|NCT03177122|Vitamins|vitamins|mesh-ancestor
6051391|NCT03177122|Micronutrients|micronutrients|mesh-ancestor
6051392|NCT03177122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051393|NCT03176277|Venetoclax|venetoclax|mesh-list
6051394|NCT03176277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6051395|NCT03173950|Nivolumab|nivolumab|mesh-list
6051396|NCT03173950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6051397|NCT03173950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6051398|NCT03173950|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6051399|NCT03173950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051400|NCT03096834|Erenumab|erenumab|mesh-list
6051401|NCT03096834|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
6051402|NCT03096834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051403|NCT03096834|Analgesics|analgesics|mesh-ancestor
6051404|NCT03096834|Sensory System Agents|sensory system agents|mesh-ancestor
6051405|NCT03096834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6051406|NCT03096834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051407|NCT03030378|Pembrolizumab|pembrolizumab|mesh-list
6051408|NCT03030378|Interleukin-12|interleukin-12|mesh-list
6051409|NCT03030378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6051410|NCT03030378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6051411|NCT03030378|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6051412|NCT03030378|Immunologic Factors|immunologic factors|mesh-ancestor
6051413|NCT03030378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051414|NCT03030378|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6051415|NCT03030378|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6051416|NCT03030378|Growth Substances|growth substances|mesh-ancestor
6051417|NCT03030378|Growth Inhibitors|growth inhibitors|mesh-ancestor
6051418|NCT03004443|Infliximab|infliximab|mesh-list
6051419|NCT03004443|Dermatologic Agents|dermatologic agents|mesh-ancestor
6051420|NCT03004443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6051421|NCT03004443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5500533|NCT04481789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5500534|NCT04481789|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5500535|NCT04481789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5500536|NCT04481789|Vasodilator Agents|vasodilator agents|mesh-ancestor
5500537|NCT04481789|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5500538|NCT04481789|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5500539|NCT04481789|Urological Agents|urological agents|mesh-ancestor
5500540|NCT04481789|Diuretics|diuretics|mesh-ancestor
6051422|NCT02959775|Vaccines|vaccines|mesh-list
6051423|NCT02959775|Immunologic Factors|immunologic factors|mesh-ancestor
6051424|NCT02959775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458719|NCT00441532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6458720|NCT00441532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051425|NCT02954406|Gemcitabine|gemcitabine|mesh-list
6051426|NCT02954406|Rituximab|rituximab|mesh-list
6051427|NCT02954406|Lenalidomide|lenalidomide|mesh-list
6051428|NCT02954406|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6051429|NCT02954406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6051430|NCT02954406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6051431|NCT02954406|Immunologic Factors|immunologic factors|mesh-ancestor
6051432|NCT02954406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051433|NCT02954406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6051434|NCT02954406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6051435|NCT02954406|Antimetabolites|antimetabolites|mesh-ancestor
6051436|NCT02954406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051437|NCT02954406|Antiviral Agents|antiviral agents|mesh-ancestor
6051438|NCT02954406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6051439|NCT02954406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6051440|NCT02954406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6051441|NCT02954406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6051442|NCT02954406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6051443|NCT02954406|Growth Substances|growth substances|mesh-ancestor
6051444|NCT02954406|Growth Inhibitors|growth inhibitors|mesh-ancestor
6051445|NCT02954406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5500541|NCT04481789|Natriuretic Agents|natriuretic agents|mesh-ancestor
5500542|NCT04481789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500543|NCT04481789|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5500544|NCT04481789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5500545|NCT04481789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5500546|NCT04481789|Antioxidants|antioxidants|mesh-ancestor
6051446|NCT02954406|Alkylating Agents|alkylating agents|mesh-ancestor
6051447|NCT02938923|Testosterone|testosterone|mesh-list
6051448|NCT02938923|Androgens|androgens|mesh-ancestor
6051449|NCT02938923|Hormones|hormones|mesh-ancestor
6051450|NCT02938923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6051451|NCT02938923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500547|NCT04481789|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5500548|NCT04481789|Protective Agents|protective agents|mesh-ancestor
5500549|NCT04481932|Trastuzumab|trastuzumab|mesh-list
5500550|NCT04481932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5500551|NCT04481932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5500552|NCT04481243|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5500553|NCT04481243|Immunologic Factors|immunologic factors|mesh-ancestor
5500554|NCT04481243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725030|NCT03183297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5725031|NCT03183310|Chlorpromazine|chlorpromazine|mesh-list
6655335|NCT01463280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6655336|NCT01463280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6655337|NCT01463280|Sensory System Agents|sensory system agents|mesh-ancestor
6655338|NCT01463280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6655339|NCT01463280|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6655340|NCT01463280|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6655341|NCT01463280|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6655342|NCT01463280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6655343|NCT01463280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725032|NCT03183310|Antiemetics|antiemetics|mesh-ancestor
5725033|NCT03183310|Autonomic Agents|autonomic agents|mesh-ancestor
5725034|NCT03183310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5725035|NCT03183310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725036|NCT03183310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5725037|NCT03183310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5725038|NCT03183310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6051457|NCT02924714|Imatinib Mesylate|imatinib mesylate|mesh-list
6051458|NCT02924714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6051459|NCT02924714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6051460|NCT02924714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6051461|NCT02924714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051462|NCT02910583|Venetoclax|venetoclax|mesh-list
6458721|NCT00441532|Sensory System Agents|sensory system agents|mesh-ancestor
6458722|NCT00441532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6458723|NCT00441532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6051463|NCT02910583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6051464|NCT02829268|Dantrolene|dantrolene|mesh-list
6051465|NCT02829268|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6051466|NCT02829268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051467|NCT02829268|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6051468|NCT02829268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6051469|NCT02784535|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6051470|NCT02784535|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6051471|NCT02784535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6051472|NCT02784535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6051473|NCT02784535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051474|NCT02784535|Adrenergic Agents|adrenergic agents|mesh-ancestor
6051475|NCT02784535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6051476|NCT02784535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051477|NCT02776605|Prednisone|prednisone|mesh-list
6051478|NCT02776605|Methotrexate|methotrexate|mesh-list
6051479|NCT02776605|Vincristine|vincristine|mesh-list
6051480|NCT02776605|Daunorubicin|daunorubicin|mesh-list
6051481|NCT02776605|Mercaptopurine|mercaptopurine|mesh-list
6051482|NCT02776605|Ponatinib|ponatinib|mesh-list
6051483|NCT02776605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6051484|NCT02776605|Glucocorticoids|glucocorticoids|mesh-ancestor
6051485|NCT02776605|Hormones|hormones|mesh-ancestor
6051486|NCT02776605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6051487|NCT02776605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051488|NCT02776605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6051489|NCT02776605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6051490|NCT02776605|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6051491|NCT02776605|Abortifacient Agents|abortifacient agents|mesh-ancestor
6051492|NCT02776605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6051493|NCT02776605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6051494|NCT02776605|Antimetabolites|antimetabolites|mesh-ancestor
6051495|NCT02776605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051496|NCT02776605|Dermatologic Agents|dermatologic agents|mesh-ancestor
6051497|NCT02776605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6051498|NCT02776605|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6051499|NCT02776605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6051500|NCT02776605|Immunologic Factors|immunologic factors|mesh-ancestor
6051501|NCT02776605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6051502|NCT02776605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6051503|NCT02776605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6051504|NCT02776605|Tubulin Modulators|tubulin modulators|mesh-ancestor
6051505|NCT02776605|Antimitotic Agents|antimitotic agents|mesh-ancestor
6051506|NCT02776605|Mitosis Modulators|mitosis modulators|mesh-ancestor
6051507|NCT02776605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6051508|NCT02776605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6051509|NCT02776605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6051510|NCT02776605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6051511|NCT02721537|Niacinamide|niacinamide|mesh-list
6051512|NCT02721537|Niacin|niacin|mesh-list
6051513|NCT02721537|Nicotinic Acids|nicotinic acids|mesh-list
5500555|NCT04481282|Terbutaline|terbutaline|mesh-list
5500556|NCT04481282|Danazol|danazol|mesh-list
5500557|NCT04481282|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5500558|NCT04481282|Autonomic Agents|autonomic agents|mesh-ancestor
5500559|NCT04481282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5500560|NCT04481282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051514|NCT02721537|Vitamin B Complex|vitamin b complex|mesh-ancestor
6051515|NCT02721537|Vitamins|vitamins|mesh-ancestor
6051516|NCT02721537|Micronutrients|micronutrients|mesh-ancestor
5500561|NCT04481282|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5500562|NCT04481282|Respiratory System Agents|respiratory system agents|mesh-ancestor
5500563|NCT04481282|Sympathomimetics|sympathomimetics|mesh-ancestor
5500564|NCT04481282|Tocolytic Agents|tocolytic agents|mesh-ancestor
6655344|NCT01463332|Dexmedetomidine|dexmedetomidine|mesh-list
6051517|NCT02721537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051518|NCT02721537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6051519|NCT02721537|Antimetabolites|antimetabolites|mesh-ancestor
6051520|NCT02721537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051521|NCT02721537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6051522|NCT02721537|Vasodilator Agents|vasodilator agents|mesh-ancestor
5500565|NCT04481282|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5500566|NCT04481282|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5500567|NCT04481282|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5500568|NCT04481282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5500569|NCT04481282|Adrenergic Agents|adrenergic agents|mesh-ancestor
5500570|NCT04481282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5500571|NCT04481282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500572|NCT04481282|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5500573|NCT04481282|Hormone Antagonists|hormone antagonists|mesh-ancestor
5500574|NCT04481282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5500575|NCT04481204|Leucovorin|leucovorin|mesh-list
5500576|NCT04481204|Gemcitabine|gemcitabine|mesh-list
5500577|NCT04481204|Paclitaxel|paclitaxel|mesh-list
5500578|NCT04481204|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5500579|NCT04481204|Cisplatin|cisplatin|mesh-list
5500580|NCT04481204|Fluorouracil|fluorouracil|mesh-list
5500581|NCT04481204|Oxaliplatin|oxaliplatin|mesh-list
5500582|NCT04481204|Irinotecan|irinotecan|mesh-list
6051523|NCT02697227|Nicotine|nicotine|mesh-list
6051524|NCT02697227|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6051525|NCT02697227|Autonomic Agents|autonomic agents|mesh-ancestor
5500583|NCT04481204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5500584|NCT04481204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5500585|NCT04481204|Tubulin Modulators|tubulin modulators|mesh-ancestor
5500586|NCT04481204|Antimitotic Agents|antimitotic agents|mesh-ancestor
5500587|NCT04481204|Mitosis Modulators|mitosis modulators|mesh-ancestor
5500588|NCT04481204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500589|NCT04481204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5500590|NCT04481204|Antimetabolites|antimetabolites|mesh-ancestor
5500591|NCT04481204|Antiviral Agents|antiviral agents|mesh-ancestor
5500592|NCT04481204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5500593|NCT04481204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5500594|NCT04481204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5500595|NCT04481204|Immunologic Factors|immunologic factors|mesh-ancestor
5500596|NCT04481204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500597|NCT04481204|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5500598|NCT04481204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5500599|NCT04481204|Antidotes|antidotes|mesh-ancestor
5500600|NCT04481204|Protective Agents|protective agents|mesh-ancestor
5500601|NCT04481204|Vitamin B Complex|vitamin b complex|mesh-ancestor
6051526|NCT02697227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6051527|NCT02697227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051528|NCT02697227|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6051529|NCT02697227|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6051530|NCT02697227|Cholinergic Agents|cholinergic agents|mesh-ancestor
6051531|NCT02697227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6051532|NCT02697227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051533|NCT02668562|Ticagrelor|ticagrelor|mesh-list
6051534|NCT02668562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6051535|NCT02668562|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6051536|NCT02668562|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6051537|NCT02668562|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6051538|NCT02668562|Purinergic Agents|purinergic agents|mesh-ancestor
6051539|NCT02668562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6051540|NCT02668562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051541|NCT02668562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051542|NCT02664155|Vitamin K|vitamin k|mesh-list
6051543|NCT02664155|Heparin|heparin|mesh-list
6051544|NCT02664155|Rivaroxaban|rivaroxaban|mesh-list
6051545|NCT02664155|Apixaban|apixaban|mesh-list
6051546|NCT02664155|Vitamins|vitamins|mesh-ancestor
6458724|NCT00441532|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6458725|NCT00441532|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6458726|NCT00441532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6458727|NCT00441532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458728|NCT00441597|Atorvastatin|atorvastatin|mesh-list
6051547|NCT02664155|Micronutrients|micronutrients|mesh-ancestor
5500602|NCT04481204|Vitamins|vitamins|mesh-ancestor
5500603|NCT04481204|Micronutrients|micronutrients|mesh-ancestor
5500604|NCT04481412|Cetirizine|cetirizine|mesh-list
5500605|NCT04481412|Ethanol|ethanol|mesh-list
5500606|NCT04481412|Minoxidil|minoxidil|mesh-list
6458729|NCT00441597|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6458730|NCT00441597|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6051548|NCT02664155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051549|NCT02664155|Anticoagulants|anticoagulants|mesh-ancestor
6051550|NCT02664155|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6051551|NCT02664155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6051552|NCT02664155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051553|NCT02664155|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6051554|NCT02664155|Antithrombins|antithrombins|mesh-ancestor
6051555|NCT02664155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6051556|NCT02664155|Protease Inhibitors|protease inhibitors|mesh-ancestor
6051557|NCT02664155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6051558|NCT02664155|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6051559|NCT02664155|Hemostatics|hemostatics|mesh-ancestor
5500607|NCT04481412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5500608|NCT04481412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6051560|NCT02664155|Coagulants|coagulants|mesh-ancestor
6051561|NCT02625480|Cyclophosphamide|cyclophosphamide|mesh-list
6051562|NCT02625480|Fludarabine|fludarabine|mesh-list
6051563|NCT02625480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6051564|NCT02625480|Immunologic Factors|immunologic factors|mesh-ancestor
6051565|NCT02625480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051566|NCT02625480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6051567|NCT02625480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6051568|NCT02625480|Alkylating Agents|alkylating agents|mesh-ancestor
6051569|NCT02625480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051570|NCT02625480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6051571|NCT02625480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6051572|NCT02592356|Lenvatinib|lenvatinib|mesh-list
6051573|NCT02592356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6051574|NCT02592356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5500609|NCT04481412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5500610|NCT04481412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500611|NCT04481412|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5500612|NCT04481412|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6051575|NCT02592356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6458731|NCT00441597|Antimetabolites|antimetabolites|mesh-ancestor
6051576|NCT02592356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051577|NCT02506933|Vaccines|vaccines|mesh-list
6051578|NCT02506933|Immunologic Factors|immunologic factors|mesh-ancestor
6051579|NCT02506933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051580|NCT02493751|Avelumab|avelumab|mesh-list
6051581|NCT02493751|Axitinib|axitinib|mesh-list
6051582|NCT02493751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6051583|NCT02493751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6051584|NCT02493751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6051585|NCT02493751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6051586|NCT02493751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051587|NCT02461537|Mitoxantrone|mitoxantrone|mesh-list
6051588|NCT02461537|Analgesics|analgesics|mesh-ancestor
6051589|NCT02461537|Sensory System Agents|sensory system agents|mesh-ancestor
6051590|NCT02461537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6051591|NCT02461537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051592|NCT02461537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6051593|NCT02461537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6051594|NCT02461537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6051595|NCT02461537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6051596|NCT02461537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500613|NCT04481412|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5500614|NCT04481412|Histamine Antagonists|histamine antagonists|mesh-ancestor
5500615|NCT04481412|Histamine Agents|histamine agents|mesh-ancestor
6051597|NCT02446964|Mycophenolic Acid|mycophenolic acid|mesh-list
6051598|NCT02446964|Cyclophosphamide|cyclophosphamide|mesh-list
6051599|NCT02446964|Fludarabine|fludarabine|mesh-list
6051600|NCT02446964|Fludarabine phosphate|fludarabine phosphate|mesh-list
6051601|NCT02446964|Tacrolimus|tacrolimus|mesh-list
6051602|NCT02446964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6051603|NCT02446964|Immunologic Factors|immunologic factors|mesh-ancestor
6051604|NCT02446964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051605|NCT02446964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6051606|NCT02446964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5500616|NCT04481412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5500617|NCT04481412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500618|NCT04481412|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5500619|NCT04481412|Vasodilator Agents|vasodilator agents|mesh-ancestor
5500620|NCT04481451|Ropivacaine|ropivacaine|mesh-list
5500621|NCT04481451|Anesthetics, Local|anesthetics, local|mesh-ancestor
5500622|NCT04481451|Anesthetics|anesthetics|mesh-ancestor
5500623|NCT04481451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5500624|NCT04481451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500625|NCT04481451|Sensory System Agents|sensory system agents|mesh-ancestor
5500626|NCT04481451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5500627|NCT04481256|Paclitaxel|paclitaxel|mesh-list
5500628|NCT04481256|Carboplatin|carboplatin|mesh-list
5500629|NCT04481256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5500630|NCT04481256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5500631|NCT04481256|Tubulin Modulators|tubulin modulators|mesh-ancestor
5500632|NCT04481256|Antimitotic Agents|antimitotic agents|mesh-ancestor
5500633|NCT04481256|Mitosis Modulators|mitosis modulators|mesh-ancestor
5500634|NCT04481256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500635|NCT04481100|Itraconazole|itraconazole|mesh-list
5500636|NCT04481100|Antifungal Agents|antifungal agents|mesh-ancestor
5500637|NCT04481100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6051607|NCT02446964|Alkylating Agents|alkylating agents|mesh-ancestor
6051608|NCT02446964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051609|NCT02446964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6051610|NCT02446964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6051611|NCT02446964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6051612|NCT02446964|Antimetabolites|antimetabolites|mesh-ancestor
6051613|NCT02446964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6051614|NCT02446964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6051615|NCT02446964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6051616|NCT02446964|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6051617|NCT02446964|Antitubercular Agents|antitubercular agents|mesh-ancestor
6051618|NCT02446964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6051619|NCT02446964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6051620|NCT02394834|Calcium, Dietary|calcium, dietary|mesh-list
6051621|NCT02394834|Leucovorin|leucovorin|mesh-list
6051622|NCT02394834|Bevacizumab|bevacizumab|mesh-list
6051623|NCT02394834|Panitumumab|panitumumab|mesh-list
6051624|NCT02394834|Oxaliplatin|oxaliplatin|mesh-list
6051625|NCT02394834|Fluorouracil|fluorouracil|mesh-list
6051626|NCT02394834|Calcium|calcium|mesh-list
6051627|NCT02394834|Levoleucovorin|levoleucovorin|mesh-list
5500638|NCT04481100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6051628|NCT02394834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6051629|NCT02394834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6051630|NCT02394834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6051631|NCT02394834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6051632|NCT02394834|Growth Substances|growth substances|mesh-ancestor
6051633|NCT02394834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051634|NCT02394834|Growth Inhibitors|growth inhibitors|mesh-ancestor
6051635|NCT02394834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6051636|NCT02394834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6051637|NCT02394834|Antimetabolites|antimetabolites|mesh-ancestor
6051638|NCT02394834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051639|NCT02394834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6051640|NCT02394834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6051641|NCT02394834|Immunologic Factors|immunologic factors|mesh-ancestor
6051642|NCT02394834|Antidotes|antidotes|mesh-ancestor
6051643|NCT02394834|Protective Agents|protective agents|mesh-ancestor
6051644|NCT02394834|Vitamin B Complex|vitamin b complex|mesh-ancestor
6051645|NCT02394834|Vitamins|vitamins|mesh-ancestor
6051646|NCT02394834|Micronutrients|micronutrients|mesh-ancestor
6051647|NCT02394795|Calcium, Dietary|calcium, dietary|mesh-list
6051648|NCT02394795|Leucovorin|leucovorin|mesh-list
6051649|NCT02394795|Bevacizumab|bevacizumab|mesh-list
6051650|NCT02394795|Panitumumab|panitumumab|mesh-list
6051651|NCT02394795|Oxaliplatin|oxaliplatin|mesh-list
6051652|NCT02394795|Fluorouracil|fluorouracil|mesh-list
6051653|NCT02394795|Calcium|calcium|mesh-list
6051654|NCT02394795|Levoleucovorin|levoleucovorin|mesh-list
6051655|NCT02394795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5500639|NCT04481100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5500640|NCT04481100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5500641|NCT04481100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500642|NCT04481100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5500643|NCT04481100|Hormone Antagonists|hormone antagonists|mesh-ancestor
5500644|NCT04481100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6051656|NCT02394795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6051657|NCT02394795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6051658|NCT02394795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6051659|NCT02394795|Growth Substances|growth substances|mesh-ancestor
6051660|NCT02394795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051661|NCT02394795|Growth Inhibitors|growth inhibitors|mesh-ancestor
6051662|NCT02394795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6051663|NCT02394795|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6051664|NCT02394795|Antimetabolites|antimetabolites|mesh-ancestor
6051665|NCT02394795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051666|NCT02394795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6051667|NCT02394795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6051668|NCT02394795|Immunologic Factors|immunologic factors|mesh-ancestor
6051669|NCT02394795|Antidotes|antidotes|mesh-ancestor
6051670|NCT02394795|Protective Agents|protective agents|mesh-ancestor
6051671|NCT02394795|Vitamin B Complex|vitamin b complex|mesh-ancestor
6051672|NCT02394795|Vitamins|vitamins|mesh-ancestor
6051673|NCT02394795|Micronutrients|micronutrients|mesh-ancestor
6051680|NCT02285166|Hypolipidemic Agents|hypolipidemic agents|mesh-list
6051681|NCT02285166|Antimetabolites|antimetabolites|mesh-ancestor
6051682|NCT02285166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051683|NCT02285166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6051684|NCT02278120|Tamoxifen|tamoxifen|mesh-list
6051685|NCT02278120|Letrozole|letrozole|mesh-list
6051686|NCT02278120|Anastrozole|anastrozole|mesh-list
6051687|NCT02278120|Goserelin|goserelin|mesh-list
6051688|NCT02278120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6051689|NCT02278120|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6051690|NCT02278120|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6051691|NCT02278120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6051692|NCT02278120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051693|NCT02278120|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6051694|NCT02278120|Hormone Antagonists|hormone antagonists|mesh-ancestor
6051695|NCT02278120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6051696|NCT02278120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051697|NCT02278120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6051698|NCT02278120|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6051699|NCT02278120|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6051700|NCT02278120|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6051701|NCT02202772|Gemcitabine|gemcitabine|mesh-list
6051702|NCT02202772|Cisplatin|cisplatin|mesh-list
6051703|NCT02202772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6051704|NCT02202772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6051705|NCT02202772|Antimetabolites|antimetabolites|mesh-ancestor
6051706|NCT02202772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051707|NCT02202772|Antiviral Agents|antiviral agents|mesh-ancestor
6051708|NCT02202772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6051709|NCT02202772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6051710|NCT02202772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6051711|NCT02202772|Immunologic Factors|immunologic factors|mesh-ancestor
6051712|NCT02202772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051713|NCT02192359|Irinotecan|irinotecan|mesh-list
6051714|NCT02192359|Camptothecin|camptothecin|mesh-list
6051715|NCT02192359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6051716|NCT02192359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6051717|NCT02192359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6051718|NCT02192359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051719|NCT02192359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6051720|NCT02192359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6051721|NCT02174822|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6051722|NCT02174822|Paroxetine|paroxetine|mesh-list
6051723|NCT02174822|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6051724|NCT02174822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6051725|NCT02174822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6051726|NCT02174822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051727|NCT02174822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6051728|NCT02174822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051729|NCT02174822|Analgesics|analgesics|mesh-ancestor
5500645|NCT04481100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500646|NCT04481100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5500647|NCT04480918|Ketamine|ketamine|mesh-list
5500648|NCT04480918|Esketamine|esketamine|mesh-list
5500649|NCT04480918|Analgesics|analgesics|mesh-ancestor
5500650|NCT04480918|Sensory System Agents|sensory system agents|mesh-ancestor
5500651|NCT04480918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5500652|NCT04480918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500653|NCT04480918|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5500654|NCT04480918|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5500655|NCT04480918|Anesthetics, General|anesthetics, general|mesh-ancestor
5500656|NCT04480918|Anesthetics|anesthetics|mesh-ancestor
5500657|NCT04480918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5500658|NCT04480918|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5500659|NCT04480918|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5500660|NCT04480918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5500661|NCT04480918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500662|NCT04480918|Antidepressive Agents|antidepressive agents|mesh-ancestor
5500663|NCT04480918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6051730|NCT02174822|Sensory System Agents|sensory system agents|mesh-ancestor
6051731|NCT02174822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6051732|NCT02174822|Antidepressive Agents|antidepressive agents|mesh-ancestor
6051733|NCT02174822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6051734|NCT02174822|Dopamine Agents|dopamine agents|mesh-ancestor
6051735|NCT02174822|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6051736|NCT02174822|Serotonin Agents|serotonin agents|mesh-ancestor
6051737|NCT02174822|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6051738|NCT02174822|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6051739|NCT02174822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6051740|NCT02174822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6051741|NCT02139397|Eflornithine|eflornithine|mesh-list
6051742|NCT02139397|Bortezomib|bortezomib|mesh-list
6051743|NCT02139397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6051744|NCT02139397|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6051745|NCT02139397|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6051746|NCT02139397|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6051747|NCT02139397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6051748|NCT02139397|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
6051749|NCT02139397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6051750|NCT02139397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054182|NCT00601640|Analgesics|analgesics|mesh-ancestor
6054183|NCT00601640|Sensory System Agents|sensory system agents|mesh-ancestor
6054184|NCT00601640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6054185|NCT00601640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054186|NCT00601640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6054187|NCT00601640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5500664|NCT04480827|Cholic Acids|cholic acids|mesh-list
5500665|NCT04480827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5503555|NCT04458311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503556|NCT04458311|Hormone Antagonists|hormone antagonists|mesh-ancestor
5503557|NCT04458311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5503558|NCT04458311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503559|NCT04458311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5503560|NCT04458116|Curcumin|curcumin|mesh-list
6054188|NCT00601640|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6054189|NCT00601640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6054190|NCT00601640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054191|NCT00601640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6054192|NCT00601640|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6054193|NCT00601640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6054194|NCT00601640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6054195|NCT00601640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6054196|NCT00601640|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
6054197|NCT00601705|Fluorouracil|fluorouracil|mesh-list
6054198|NCT00601705|Oxaliplatin|oxaliplatin|mesh-list
6054199|NCT00601705|Epirubicin|epirubicin|mesh-list
6054200|NCT00601705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6054201|NCT00601705|Antimetabolites|antimetabolites|mesh-ancestor
6054202|NCT00601705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054203|NCT00601705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6054204|NCT00601705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6054205|NCT00601705|Immunologic Factors|immunologic factors|mesh-ancestor
6054206|NCT00601705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054207|NCT00601705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6054208|NCT00601705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6054209|NCT00601705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6054210|NCT00601705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6054211|NCT00601718|Rituximab|rituximab|mesh-list
6054212|NCT00601718|Carboplatin|carboplatin|mesh-list
6054213|NCT00601718|Etoposide|etoposide|mesh-list
6054214|NCT00601718|Etoposide phosphate|etoposide phosphate|mesh-list
6054215|NCT00601718|Ifosfamide|ifosfamide|mesh-list
6054216|NCT00601718|Vorinostat|vorinostat|mesh-list
6054217|NCT00601718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6054218|NCT00601718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6054219|NCT00601718|Immunologic Factors|immunologic factors|mesh-ancestor
6054220|NCT00601718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054221|NCT00601718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6054222|NCT00601718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6054223|NCT00601718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6054224|NCT00601718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6054225|NCT00601718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6054226|NCT00601718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054227|NCT00601718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6054228|NCT00601718|Alkylating Agents|alkylating agents|mesh-ancestor
6054229|NCT00601718|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6054230|NCT00601796|Cyclophosphamide|cyclophosphamide|mesh-list
6054231|NCT00601796|Tretinoin|tretinoin|mesh-list
6054232|NCT00601796|Vaccines|vaccines|mesh-list
6054233|NCT00601796|Immunologic Factors|immunologic factors|mesh-ancestor
6054234|NCT00601796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054235|NCT00601796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6054236|NCT00601796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6054237|NCT00601796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6051751|NCT02015013|Plerixafor|plerixafor|mesh-list
6051752|NCT02015013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6051753|NCT02015013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6051754|NCT02015013|Antiviral Agents|antiviral agents|mesh-ancestor
6051755|NCT02015013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6051756|NCT01993719|Aldesleukin|aldesleukin|mesh-list
6051757|NCT01993719|Cyclophosphamide|cyclophosphamide|mesh-list
6051758|NCT01993719|Pembrolizumab|pembrolizumab|mesh-list
6051759|NCT01993719|Fludarabine|fludarabine|mesh-list
6051760|NCT01993719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6051761|NCT01993719|Immunologic Factors|immunologic factors|mesh-ancestor
6051762|NCT01993719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051763|NCT01993719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6051764|NCT01993719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6051765|NCT01993719|Alkylating Agents|alkylating agents|mesh-ancestor
6051766|NCT01993719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051767|NCT01993719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6051768|NCT01993719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6051769|NCT01993719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6051770|NCT01993719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6051771|NCT01993719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6051772|NCT01993719|Antiviral Agents|antiviral agents|mesh-ancestor
6051773|NCT01993719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6051774|NCT01961063|Busulfan|busulfan|mesh-list
6051775|NCT01961063|Alkylating Agents|alkylating agents|mesh-ancestor
6051776|NCT01961063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051777|NCT01961063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6051778|NCT01961063|Immunologic Factors|immunologic factors|mesh-ancestor
6051779|NCT01961063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051780|NCT01961063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6051781|NCT01961063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6051782|NCT01961063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6051783|NCT01909245|Immunosuppressive Agents|immunosuppressive agents|mesh-list
6051784|NCT01909245|Gastrins|gastrins|mesh-list
6051785|NCT01909245|Immunologic Factors|immunologic factors|mesh-ancestor
6051786|NCT01909245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051787|NCT01909245|Hormones|hormones|mesh-ancestor
6051788|NCT01909245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6051789|NCT01885689|Sirolimus|sirolimus|mesh-list
6051790|NCT01885689|Melphalan|melphalan|mesh-list
6051791|NCT01885689|Clofarabine|clofarabine|mesh-list
6051792|NCT01885689|Tacrolimus|tacrolimus|mesh-list
6051793|NCT01885689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6051794|NCT01885689|Immunologic Factors|immunologic factors|mesh-ancestor
6051795|NCT01885689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500678|NCT04480775|Methylprednisolone|methylprednisolone|mesh-list
5500679|NCT04480775|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5500680|NCT04480775|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5500681|NCT04480775|Prednisolone|prednisolone|mesh-list
5500682|NCT04480775|Prednisolone acetate|prednisolone acetate|mesh-list
5500683|NCT04480775|Triamcinolone|triamcinolone|mesh-list
5500684|NCT04480775|Bupivacaine|bupivacaine|mesh-list
6051796|NCT01885689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6051797|NCT01885689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6051798|NCT01885689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051799|NCT01885689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6051800|NCT01885689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6051801|NCT01885689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6051802|NCT01885689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6051803|NCT01885689|Antifungal Agents|antifungal agents|mesh-ancestor
6051804|NCT01885689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6051805|NCT01885689|Alkylating Agents|alkylating agents|mesh-ancestor
6051806|NCT01885689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6051807|NCT01885689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6051808|NCT01885689|Antimetabolites|antimetabolites|mesh-ancestor
6051809|NCT01872260|Letrozole|letrozole|mesh-list
6051810|NCT01872260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6051811|NCT01872260|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6051812|NCT01872260|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6051813|NCT01872260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6051814|NCT01872260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051815|NCT01872260|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6051816|NCT01872260|Hormone Antagonists|hormone antagonists|mesh-ancestor
6051817|NCT01872260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6051818|NCT01872260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500685|NCT04480775|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6051819|NCT01740648|Fluorouracil|fluorouracil|mesh-list
6051820|NCT01740648|Trametinib|trametinib|mesh-list
6051821|NCT01740648|Antimetabolites|antimetabolites|mesh-ancestor
6051822|NCT01740648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051823|NCT01740648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6051824|NCT01740648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6051825|NCT01740648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6051826|NCT01740648|Immunologic Factors|immunologic factors|mesh-ancestor
6051827|NCT01740648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051828|NCT01740648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6051829|NCT01740648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6051830|NCT01712620|Spironolactone|spironolactone|mesh-list
6051831|NCT01712620|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6051832|NCT01712620|Hormone Antagonists|hormone antagonists|mesh-ancestor
6051833|NCT01712620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6458732|NCT00441597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458733|NCT00441597|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6458734|NCT00441597|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6458735|NCT00441597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6458736|NCT00441649|Methylphenidate|methylphenidate|mesh-list
6458737|NCT00441649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6458738|NCT00441649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458739|NCT00441649|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6458740|NCT00441649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6051834|NCT01712620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051835|NCT01712620|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6051836|NCT01712620|Diuretics|diuretics|mesh-ancestor
5500686|NCT04480775|Prednisolone phosphate|prednisolone phosphate|mesh-list
5500687|NCT04480775|Anesthetics, Local|anesthetics, local|mesh-ancestor
5500688|NCT04480775|Anesthetics|anesthetics|mesh-ancestor
5500689|NCT04480775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5500690|NCT04480775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500691|NCT04480775|Sensory System Agents|sensory system agents|mesh-ancestor
5500692|NCT04480775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5500693|NCT04480775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5500694|NCT04480775|Antiemetics|antiemetics|mesh-ancestor
6051837|NCT01712620|Natriuretic Agents|natriuretic agents|mesh-ancestor
6051838|NCT01685424|Etoricoxib|etoricoxib|mesh-list
6051839|NCT01685424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6051840|NCT01685424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6051841|NCT01685424|Analgesics|analgesics|mesh-ancestor
6051842|NCT01685424|Sensory System Agents|sensory system agents|mesh-ancestor
6051843|NCT01685424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6051844|NCT01685424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051845|NCT01685424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6051846|NCT01685424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6051847|NCT01685424|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6051848|NCT01685424|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6051849|NCT01685424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6051850|NCT01685424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051851|NCT01587235|Simvastatin|simvastatin|mesh-list
6051852|NCT01587235|Ezetimibe|ezetimibe|mesh-list
6051853|NCT01587235|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
6051854|NCT01587235|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6051855|NCT01587235|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6051856|NCT01587235|Antimetabolites|antimetabolites|mesh-ancestor
6051857|NCT01587235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051858|NCT01587235|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6051859|NCT01587235|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6051860|NCT01587235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6051861|NCT01583322|Nintedanib|nintedanib|mesh-list
6051862|NCT01583322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6051863|NCT01583322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6051864|NCT01583322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6051865|NCT01583322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051866|NCT01571128|Tenofovir|tenofovir|mesh-list
6051867|NCT01571128|Emtricitabine|emtricitabine|mesh-list
6051868|NCT01571128|Antiviral Agents|antiviral agents|mesh-ancestor
6051869|NCT01571128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6051870|NCT01571128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6051871|NCT01571128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5500695|NCT04480775|Autonomic Agents|autonomic agents|mesh-ancestor
6051872|NCT01571128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6051873|NCT01571128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051874|NCT01571128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6051875|NCT01571128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6051876|NCT01494662|Capecitabine|capecitabine|mesh-list
6051877|NCT01494662|Trastuzumab|trastuzumab|mesh-list
6051878|NCT01494662|Maytansine|maytansine|mesh-list
6051879|NCT01494662|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
6051880|NCT01494662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6051881|NCT01494662|Antimetabolites|antimetabolites|mesh-ancestor
6051882|NCT01494662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051883|NCT01494662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6051884|NCT01494662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6051885|NCT01494662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6051886|NCT01494662|Tubulin Modulators|tubulin modulators|mesh-ancestor
6051887|NCT01494662|Antimitotic Agents|antimitotic agents|mesh-ancestor
6051888|NCT01494662|Mitosis Modulators|mitosis modulators|mesh-ancestor
6051889|NCT01429168|Etoricoxib|etoricoxib|mesh-list
6051890|NCT01429168|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6051891|NCT01429168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6051892|NCT01429168|Analgesics|analgesics|mesh-ancestor
6458741|NCT00441649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6458742|NCT00441649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458743|NCT00441649|Dopamine Agents|dopamine agents|mesh-ancestor
6051893|NCT01429168|Sensory System Agents|sensory system agents|mesh-ancestor
6051894|NCT01429168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6051895|NCT01429168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051896|NCT01429168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6051897|NCT01429168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6051898|NCT01429168|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5500696|NCT04480775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5500697|NCT04480775|Glucocorticoids|glucocorticoids|mesh-ancestor
5500698|NCT04480775|Hormones|hormones|mesh-ancestor
5500699|NCT04480775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6051899|NCT01429168|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6051900|NCT01429168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6051901|NCT01429168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051902|NCT01415882|Dexamethasone|dexamethasone|mesh-list
6051903|NCT01415882|Dexamethasone acetate|dexamethasone acetate|mesh-list
6051904|NCT01415882|Cyclophosphamide|cyclophosphamide|mesh-list
6051905|NCT01415882|Daratumumab|daratumumab|mesh-list
6051906|NCT01415882|Ixazomib|ixazomib|mesh-list
6051907|NCT01415882|Ichthammol|ichthammol|mesh-list
6051908|NCT01415882|BB 1101|bb 1101|mesh-list
6051909|NCT01415882|Glycine|glycine|mesh-list
6051910|NCT01415882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6051911|NCT01415882|Immunologic Factors|immunologic factors|mesh-ancestor
6051912|NCT01415882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051913|NCT01415882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6051914|NCT01415882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6051915|NCT01415882|Alkylating Agents|alkylating agents|mesh-ancestor
6051916|NCT01415882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051917|NCT01415882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6051918|NCT01415882|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6051919|NCT01415882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6051920|NCT01415882|Antiemetics|antiemetics|mesh-ancestor
6051921|NCT01415882|Autonomic Agents|autonomic agents|mesh-ancestor
6051922|NCT01415882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6051923|NCT01415882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6051924|NCT01415882|Glucocorticoids|glucocorticoids|mesh-ancestor
6051925|NCT01415882|Hormones|hormones|mesh-ancestor
6051926|NCT01415882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6051927|NCT01415882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6051928|NCT01415882|Protease Inhibitors|protease inhibitors|mesh-ancestor
6051929|NCT01415882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6051930|NCT01415882|Dermatologic Agents|dermatologic agents|mesh-ancestor
6051931|NCT01415882|Glycine Agents|glycine agents|mesh-ancestor
6051932|NCT01415882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6051933|NCT01327638|Etoricoxib|etoricoxib|mesh-list
6051934|NCT01327638|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
6051935|NCT01327638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6051936|NCT01327638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6051937|NCT01327638|Analgesics|analgesics|mesh-ancestor
6051938|NCT01327638|Sensory System Agents|sensory system agents|mesh-ancestor
6051939|NCT01327638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6051940|NCT01327638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051941|NCT01327638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6051942|NCT01327638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6051943|NCT01327638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6051944|NCT01327638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6051945|NCT01327638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051946|NCT01077843|Etoricoxib|etoricoxib|mesh-list
6051947|NCT01077843|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
6051948|NCT01077843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
6458744|NCT00441649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6458745|NCT00441662|Triamcinolone|triamcinolone|mesh-list
6458746|NCT00441662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6051949|NCT01077843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6051950|NCT01077843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6051951|NCT01077843|Analgesics|analgesics|mesh-ancestor
6051952|NCT01077843|Sensory System Agents|sensory system agents|mesh-ancestor
6051953|NCT01077843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6051954|NCT01077843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051955|NCT01077843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6051956|NCT01077843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6051957|NCT01077843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5500700|NCT04480775|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5500701|NCT04480775|Protective Agents|protective agents|mesh-ancestor
5500702|NCT04480775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5500703|NCT04480775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5500704|NCT04480853|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
5500705|NCT04480853|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6051958|NCT01077843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051959|NCT00771160|Montelukast|montelukast|mesh-list
6051960|NCT00771160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6051961|NCT00771160|Respiratory System Agents|respiratory system agents|mesh-ancestor
6051962|NCT00771160|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6051963|NCT00771160|Hormone Antagonists|hormone antagonists|mesh-ancestor
6051964|NCT00771160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6051965|NCT00771160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051966|NCT00771160|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6051967|NCT00771160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6051968|NCT00771160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051969|NCT00756418|Theophylline|theophylline|mesh-list
6051970|NCT00756418|Montelukast|montelukast|mesh-list
6051971|NCT00756418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6051972|NCT00756418|Respiratory System Agents|respiratory system agents|mesh-ancestor
6051973|NCT00756418|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6051974|NCT00756418|Hormone Antagonists|hormone antagonists|mesh-ancestor
6051975|NCT00756418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6051976|NCT00756418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051977|NCT00756418|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6051978|NCT00756418|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6051979|NCT00756418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6051980|NCT00756418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5500706|NCT04480853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500707|NCT04480853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5500708|NCT04480853|Immunologic Factors|immunologic factors|mesh-ancestor
5500709|NCT04480853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500710|NCT04480593|Propolis|propolis|mesh-list
5500711|NCT04480593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6051981|NCT00756418|Autonomic Agents|autonomic agents|mesh-ancestor
6051982|NCT00756418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6051983|NCT00756418|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6051984|NCT00756418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6051985|NCT00756418|Vasodilator Agents|vasodilator agents|mesh-ancestor
6051986|NCT00756418|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6051987|NCT00756418|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6051988|NCT00756418|Purinergic Agents|purinergic agents|mesh-ancestor
6051989|NCT00756418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6051990|NCT00755794|Montelukast|montelukast|mesh-list
6051991|NCT00755794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6051992|NCT00755794|Respiratory System Agents|respiratory system agents|mesh-ancestor
6051993|NCT00755794|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6051994|NCT00755794|Hormone Antagonists|hormone antagonists|mesh-ancestor
6051995|NCT00755794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6051996|NCT00755794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6051997|NCT00755794|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6051998|NCT00755794|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6051999|NCT00755794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052000|NCT00700661|Montelukast|montelukast|mesh-list
6052001|NCT00700661|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6052002|NCT00700661|Respiratory System Agents|respiratory system agents|mesh-ancestor
6052003|NCT00700661|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6052004|NCT00700661|Hormone Antagonists|hormone antagonists|mesh-ancestor
6052005|NCT00700661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6052006|NCT00700661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6052007|NCT00700661|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6052008|NCT00700661|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6052009|NCT00700661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052010|NCT00659711|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6052011|NCT00659711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6052012|NCT00659711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6052013|NCT00659711|Incretins|incretins|mesh-ancestor
6052014|NCT00659711|Hormones|hormones|mesh-ancestor
6052015|NCT00659711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6052016|NCT00659711|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6052017|NCT00659711|Protease Inhibitors|protease inhibitors|mesh-ancestor
6052018|NCT00659711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6052019|NCT00659711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052020|NCT00653276|Cyclosporine|cyclosporine|mesh-list
6052021|NCT00653276|Ezetimibe|ezetimibe|mesh-list
6052022|NCT00653276|Cyclosporins|cyclosporins|mesh-list
6052023|NCT00653276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6052024|NCT00653276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052025|NCT00653276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6052026|NCT00653276|Immunologic Factors|immunologic factors|mesh-ancestor
6052027|NCT00653276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6052028|NCT00653276|Antifungal Agents|antifungal agents|mesh-ancestor
5500712|NCT04481035|Acetylcysteine|acetylcysteine|mesh-list
5500713|NCT04481035|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5500714|NCT04481035|Antiviral Agents|antiviral agents|mesh-ancestor
5500715|NCT04481035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5500716|NCT04481035|Expectorants|expectorants|mesh-ancestor
5500717|NCT04481035|Respiratory System Agents|respiratory system agents|mesh-ancestor
5500718|NCT04481035|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5500719|NCT04481035|Antioxidants|antioxidants|mesh-ancestor
5500720|NCT04481035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500721|NCT04481035|Protective Agents|protective agents|mesh-ancestor
5500722|NCT04481035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500723|NCT04481035|Antidotes|antidotes|mesh-ancestor
5500724|NCT04480502|Ipilimumab|ipilimumab|mesh-list
5500725|NCT04480502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5500726|NCT04480502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5500727|NCT04480502|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5500728|NCT04480502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500729|NCT04480450|Rituximab|rituximab|mesh-list
5500730|NCT04480450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5500731|NCT04480450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5500732|NCT04480450|Immunologic Factors|immunologic factors|mesh-ancestor
5500733|NCT04480450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500734|NCT04480450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5500735|NCT04480190|Gemcitabine|gemcitabine|mesh-list
5500736|NCT04480190|Fluorouracil|fluorouracil|mesh-list
5500737|NCT04480190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5500738|NCT04480190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5500739|NCT04480190|Antimetabolites|antimetabolites|mesh-ancestor
5500740|NCT04480190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500741|NCT04480190|Antiviral Agents|antiviral agents|mesh-ancestor
5500742|NCT04480190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5500743|NCT04480190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5500744|NCT04480190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5500745|NCT04480190|Immunologic Factors|immunologic factors|mesh-ancestor
5500746|NCT04480190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500747|NCT04480086|Navitoclax|navitoclax|mesh-list
6052029|NCT00653276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6052030|NCT00653276|Dermatologic Agents|dermatologic agents|mesh-ancestor
6052031|NCT00653276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6052032|NCT00653276|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6052033|NCT00653276|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5500748|NCT04480086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6052034|NCT00653276|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6052035|NCT00653276|Antimetabolites|antimetabolites|mesh-ancestor
6052036|NCT00653276|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6052037|NCT00652847|Ezetimibe|ezetimibe|mesh-list
6052038|NCT00652847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6052039|NCT00652847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6052040|NCT00652847|Antimetabolites|antimetabolites|mesh-ancestor
5500749|NCT04480281|Lidocaine|lidocaine|mesh-list
6052041|NCT00652847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052042|NCT00652847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6052043|NCT00652717|Simvastatin|simvastatin|mesh-list
6052044|NCT00652717|Ezetimibe|ezetimibe|mesh-list
6052045|NCT00652717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6052046|NCT00652717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6052047|NCT00652717|Antimetabolites|antimetabolites|mesh-ancestor
6052048|NCT00652717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500750|NCT04480281|Anesthetics, Local|anesthetics, local|mesh-ancestor
5500751|NCT04480281|Anesthetics|anesthetics|mesh-ancestor
5500752|NCT04480281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5500753|NCT04480281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500754|NCT04480281|Sensory System Agents|sensory system agents|mesh-ancestor
5500755|NCT04480281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5500756|NCT04480281|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5500757|NCT04480281|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5500758|NCT04480281|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5500759|NCT04480281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5500760|NCT04480281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500761|NCT04480268|Gemcitabine|gemcitabine|mesh-list
5500762|NCT04480268|Paclitaxel|paclitaxel|mesh-list
5500763|NCT04480268|Capecitabine|capecitabine|mesh-list
5500764|NCT04480268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5500765|NCT04480268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5500766|NCT04480268|Tubulin Modulators|tubulin modulators|mesh-ancestor
5500767|NCT04480268|Antimitotic Agents|antimitotic agents|mesh-ancestor
5500768|NCT04480268|Mitosis Modulators|mitosis modulators|mesh-ancestor
5500769|NCT04480268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500770|NCT04480268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5500771|NCT04480268|Antimetabolites|antimetabolites|mesh-ancestor
5500772|NCT04480268|Antiviral Agents|antiviral agents|mesh-ancestor
5500773|NCT04480268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5500774|NCT04480268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5500775|NCT04480268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5500776|NCT04480268|Immunologic Factors|immunologic factors|mesh-ancestor
5500777|NCT04480268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500778|NCT04480463|Aflibercept|aflibercept|mesh-list
5500779|NCT04480463|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5500780|NCT04480463|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5500781|NCT04480463|Growth Substances|growth substances|mesh-ancestor
5500782|NCT04480463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500783|NCT04480463|Growth Inhibitors|growth inhibitors|mesh-ancestor
5500784|NCT04480463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5500785|NCT04480333|Antiviral Agents|antiviral agents|mesh-list
5500786|NCT04480333|Remdesivir|remdesivir|mesh-list
5500787|NCT04480333|Neuroprotective Agents|neuroprotective agents|mesh-list
5500788|NCT04480333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5500789|NCT04480333|Antimetabolites|antimetabolites|mesh-ancestor
5500790|NCT04480333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052049|NCT00652717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6052050|NCT00652717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6052051|NCT00652717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5500791|NCT04480333|Protective Agents|protective agents|mesh-ancestor
5500792|NCT04480333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500793|NCT04480372|Gemcitabine|gemcitabine|mesh-list
5500794|NCT04480372|Atezolizumab|atezolizumab|mesh-list
5500795|NCT04480372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5500796|NCT04480372|Antimetabolites|antimetabolites|mesh-ancestor
5500797|NCT04480372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052052|NCT00652444|Simvastatin|simvastatin|mesh-list
6052053|NCT00652444|Ezetimibe|ezetimibe|mesh-list
6052054|NCT00652444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6052055|NCT00652444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6052056|NCT00652444|Antimetabolites|antimetabolites|mesh-ancestor
6052057|NCT00652444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052058|NCT00652444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6052059|NCT00652444|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6052060|NCT00652444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6052061|NCT00652301|Simvastatin|simvastatin|mesh-list
6052062|NCT00652301|Ezetimibe|ezetimibe|mesh-list
6052063|NCT00652301|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6052064|NCT00652301|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6052065|NCT00652301|Antimetabolites|antimetabolites|mesh-ancestor
6052066|NCT00652301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052067|NCT00652301|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6054238|NCT00601796|Alkylating Agents|alkylating agents|mesh-ancestor
5500798|NCT04480372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5500799|NCT04480372|Antiviral Agents|antiviral agents|mesh-ancestor
5500800|NCT04480372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5500801|NCT04480372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5500802|NCT04480372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5500803|NCT04480372|Immunologic Factors|immunologic factors|mesh-ancestor
5500804|NCT04480372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500805|NCT04480125|Azacitidine|azacitidine|mesh-list
5500806|NCT04480125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5500807|NCT04480125|Antimetabolites|antimetabolites|mesh-ancestor
6052068|NCT00652301|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6052069|NCT00652301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6052070|NCT00651963|Ezetimibe|ezetimibe|mesh-list
6052071|NCT00651963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6052072|NCT00651963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6052073|NCT00651963|Antimetabolites|antimetabolites|mesh-ancestor
6052074|NCT00651963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052075|NCT00651963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6052076|NCT00651560|Simvastatin|simvastatin|mesh-list
6052077|NCT00651560|Ezetimibe|ezetimibe|mesh-list
6052078|NCT00651560|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6052079|NCT00651560|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6052080|NCT00651560|Antimetabolites|antimetabolites|mesh-ancestor
6052081|NCT00651560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052082|NCT00651560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6052083|NCT00651560|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6052084|NCT00651560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6052085|NCT00601003|Nifurtimox|nifurtimox|mesh-list
6052086|NCT00601003|Cyclophosphamide|cyclophosphamide|mesh-list
6052087|NCT00601003|Topotecan|topotecan|mesh-list
6052088|NCT00601003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6052089|NCT00601003|Immunologic Factors|immunologic factors|mesh-ancestor
6052090|NCT00601003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6052091|NCT00601003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6052092|NCT00601003|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6052093|NCT00601003|Alkylating Agents|alkylating agents|mesh-ancestor
6052094|NCT00601003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052095|NCT00601003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6052096|NCT00601003|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6052097|NCT00601003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6052098|NCT00601003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6052099|NCT00601003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6052100|NCT00601003|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6052101|NCT00601003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6052102|NCT00601003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5500808|NCT04480125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500809|NCT04480125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5500810|NCT04480125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5500811|NCT04480138|Interferons|interferons|mesh-list
5500812|NCT04480138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5500813|NCT04480138|Antiviral Agents|antiviral agents|mesh-ancestor
6052103|NCT00601003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6052104|NCT00553891|Mometasone Furoate|mometasone furoate|mesh-list
6052105|NCT00553891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6052106|NCT00553891|Dermatologic Agents|dermatologic agents|mesh-ancestor
6052107|NCT00553891|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6052108|NCT00551876|Simvastatin|simvastatin|mesh-list
6052109|NCT00551876|Ezetimibe|ezetimibe|mesh-list
6052110|NCT00551876|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6052111|NCT00551876|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6052112|NCT00551876|Antimetabolites|antimetabolites|mesh-ancestor
6052113|NCT00551876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052114|NCT00551876|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6052115|NCT00551876|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6052116|NCT00551876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6052117|NCT00551447|Simvastatin|simvastatin|mesh-list
6052118|NCT00551447|Ezetimibe|ezetimibe|mesh-list
6052119|NCT00551447|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6052120|NCT00551447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6052121|NCT00551447|Antimetabolites|antimetabolites|mesh-ancestor
6052122|NCT00551447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052123|NCT00551447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6052124|NCT00551447|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6052125|NCT00551447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6052126|NCT00542087|Diclofenac|diclofenac|mesh-list
5500814|NCT04480138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5500815|NCT04480359|Meloxicam|meloxicam|mesh-list
5500816|NCT04480359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5500817|NCT04480359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5500818|NCT04480359|Analgesics|analgesics|mesh-ancestor
6052127|NCT00542087|Etoricoxib|etoricoxib|mesh-list
6052128|NCT00542087|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6052129|NCT00542087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6052130|NCT00542087|Analgesics|analgesics|mesh-ancestor
6052131|NCT00542087|Sensory System Agents|sensory system agents|mesh-ancestor
6052132|NCT00542087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6052133|NCT00542087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6052134|NCT00542087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6052135|NCT00542087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6052136|NCT00542087|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6052137|NCT00542087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6052138|NCT00542087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052139|NCT00542087|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6052140|NCT00541697|Atorvastatin|atorvastatin|mesh-list
6052141|NCT00541697|Simvastatin|simvastatin|mesh-list
6052142|NCT00541697|Ezetimibe|ezetimibe|mesh-list
6052143|NCT00541697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6052144|NCT00541697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6052145|NCT00541697|Antimetabolites|antimetabolites|mesh-ancestor
6052146|NCT00541697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052147|NCT00541697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6052148|NCT00541697|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6052149|NCT00541697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6052150|NCT00489346|Fluticasone|fluticasone|mesh-list
6052151|NCT00489346|Xhance|xhance|mesh-list
6052152|NCT00489346|Montelukast|montelukast|mesh-list
6052153|NCT00489346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6052154|NCT00489346|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6052155|NCT00489346|Autonomic Agents|autonomic agents|mesh-ancestor
6052156|NCT00489346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6052157|NCT00489346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6052158|NCT00489346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6052159|NCT00489346|Respiratory System Agents|respiratory system agents|mesh-ancestor
6052160|NCT00489346|Dermatologic Agents|dermatologic agents|mesh-ancestor
6052161|NCT00489346|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6052162|NCT00489346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052163|NCT00489346|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6052164|NCT00489346|Hormone Antagonists|hormone antagonists|mesh-ancestor
6052165|NCT00489346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6052166|NCT00489346|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6052167|NCT00489346|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6052168|NCT00395603|Atorvastatin|atorvastatin|mesh-list
6052169|NCT00395603|Simvastatin|simvastatin|mesh-list
6052170|NCT00395603|Ezetimibe|ezetimibe|mesh-list
6052171|NCT00395603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6052172|NCT00395603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6458747|NCT00441662|Glucocorticoids|glucocorticoids|mesh-ancestor
5500819|NCT04480359|Sensory System Agents|sensory system agents|mesh-ancestor
5500820|NCT04480359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5500821|NCT04480359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500822|NCT04480359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6052173|NCT00395603|Antimetabolites|antimetabolites|mesh-ancestor
6052174|NCT00395603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052175|NCT00395603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6052176|NCT00395603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6052177|NCT00395603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6052178|NCT00395473|Ezetimibe|ezetimibe|mesh-list
6052179|NCT00395473|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6052180|NCT00395473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6052181|NCT00395473|Antimetabolites|antimetabolites|mesh-ancestor
6052182|NCT00395473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052183|NCT00395473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6052184|NCT00393354|Etoricoxib|etoricoxib|mesh-list
6052185|NCT00393354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052186|NCT00393354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6052187|NCT00393354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6052188|NCT00393354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6052189|NCT00393354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6052190|NCT00393354|Analgesics|analgesics|mesh-ancestor
6052191|NCT00393354|Sensory System Agents|sensory system agents|mesh-ancestor
6052192|NCT00393354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6052193|NCT00393354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6458748|NCT00441662|Hormones|hormones|mesh-ancestor
6458749|NCT00441662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6052194|NCT00393354|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6052195|NCT00393354|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6052196|NCT00393354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6052197|NCT00393211|Etoricoxib|etoricoxib|mesh-list
6458750|NCT00441662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458751|NCT00441740|Gemcitabine|gemcitabine|mesh-list
6458752|NCT00441740|Docetaxel|docetaxel|mesh-list
6458753|NCT00441740|Vinorelbine|vinorelbine|mesh-list
6458754|NCT00441740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6458755|NCT00441740|Antimetabolites|antimetabolites|mesh-ancestor
6458756|NCT00441740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458757|NCT00441740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6052198|NCT00393211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052199|NCT00393211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6052200|NCT00393211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6052201|NCT00393211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6052202|NCT00393211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6052203|NCT00393211|Analgesics|analgesics|mesh-ancestor
6052204|NCT00393211|Sensory System Agents|sensory system agents|mesh-ancestor
6052205|NCT00393211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6052206|NCT00393211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6052207|NCT00393211|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6052208|NCT00393211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6052209|NCT00393211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6052210|NCT00328523|Ezetimibe|ezetimibe|mesh-list
6052211|NCT00328523|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6052212|NCT00328523|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6052213|NCT00328523|Antimetabolites|antimetabolites|mesh-ancestor
6052214|NCT00328523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052215|NCT00328523|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6052216|NCT00269191|Ibuprofen|ibuprofen|mesh-list
6052217|NCT00269191|Etoricoxib|etoricoxib|mesh-list
6052218|NCT00269191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6052219|NCT00269191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6052220|NCT00269191|Analgesics|analgesics|mesh-ancestor
6052221|NCT00269191|Sensory System Agents|sensory system agents|mesh-ancestor
6052222|NCT00269191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6052223|NCT00269191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6052224|NCT00269191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6052225|NCT00269191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6052226|NCT00269191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6052227|NCT00269191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5500823|NCT04480359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5500824|NCT04480359|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5500825|NCT04480359|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5500826|NCT04480359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5500827|NCT04480359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500828|NCT04479748|Dexamethasone|dexamethasone|mesh-list
5500829|NCT04479748|Prednisolone|prednisolone|mesh-list
5500830|NCT04479748|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6052228|NCT00269191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052229|NCT00269191|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6052230|NCT00251576|Heparin|heparin|mesh-list
6052231|NCT00251576|Calcium heparin|calcium heparin|mesh-list
6052232|NCT00251576|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6052233|NCT00251576|Tinzaparin|tinzaparin|mesh-list
6052234|NCT00251576|Dalteparin|dalteparin|mesh-list
6052235|NCT00251576|Tirofiban|tirofiban|mesh-list
6052236|NCT00251576|Simvastatin|simvastatin|mesh-list
6052237|NCT00251576|Anticoagulants|anticoagulants|mesh-ancestor
6052238|NCT00251576|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6052239|NCT00251576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6052240|NCT00251576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052241|NCT00251576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6052242|NCT00251576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6052243|NCT00251576|Antimetabolites|antimetabolites|mesh-ancestor
6052244|NCT00251576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6052245|NCT00251576|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6052246|NCT00251576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6052247|NCT00251576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6052248|NCT00250445|Diclofenac|diclofenac|mesh-list
6052249|NCT00250445|Etoricoxib|etoricoxib|mesh-list
6052250|NCT00250445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6052251|NCT00250445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6052252|NCT00250445|Analgesics|analgesics|mesh-ancestor
6052253|NCT00250445|Sensory System Agents|sensory system agents|mesh-ancestor
6052254|NCT00250445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6052255|NCT00250445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6052256|NCT00250445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6052257|NCT00250445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6052258|NCT00250445|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6052259|NCT00250445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6052260|NCT00250445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052261|NCT00250445|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6052262|NCT00242489|Diclofenac|diclofenac|mesh-list
6052263|NCT00242489|Etoricoxib|etoricoxib|mesh-list
6052264|NCT00242489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6052265|NCT00242489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6052266|NCT00242489|Analgesics|analgesics|mesh-ancestor
6052267|NCT00242489|Sensory System Agents|sensory system agents|mesh-ancestor
6052268|NCT00242489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6052269|NCT00242489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6052270|NCT00242489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6052271|NCT00242489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6052272|NCT00242489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6052273|NCT00242489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6052274|NCT00242489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052275|NCT00242489|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6052276|NCT00166530|Atorvastatin|atorvastatin|mesh-list
6052277|NCT00166530|Simvastatin|simvastatin|mesh-list
6052278|NCT00166530|Ezetimibe|ezetimibe|mesh-list
6052279|NCT00166530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6052280|NCT00166530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6052281|NCT00166530|Antimetabolites|antimetabolites|mesh-ancestor
6052282|NCT00166530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052283|NCT00166530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6052284|NCT00166530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5500831|NCT04479748|Methylprednisolone|methylprednisolone|mesh-list
5500832|NCT04479748|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5500833|NCT04479748|Prednisolone acetate|prednisolone acetate|mesh-list
5500834|NCT04479748|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5500835|NCT04479748|Prednisolone phosphate|prednisolone phosphate|mesh-list
5500836|NCT04479748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5500837|NCT04479748|Antiemetics|antiemetics|mesh-ancestor
5500838|NCT04479748|Autonomic Agents|autonomic agents|mesh-ancestor
5500839|NCT04479748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5500840|NCT04479748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500841|NCT04479748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5500842|NCT04479748|Glucocorticoids|glucocorticoids|mesh-ancestor
6052285|NCT00166530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6052286|NCT00092833|Ezetimibe|ezetimibe|mesh-list
6052287|NCT00092833|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5500843|NCT04479748|Hormones|hormones|mesh-ancestor
6052288|NCT00092833|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6052289|NCT00092833|Antimetabolites|antimetabolites|mesh-ancestor
6052290|NCT00092833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052291|NCT00092833|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6052292|NCT00092716|Atorvastatin|atorvastatin|mesh-list
6052293|NCT00092716|Ezetimibe|ezetimibe|mesh-list
6052294|NCT00092716|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6052295|NCT00092716|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6052296|NCT00092716|Antimetabolites|antimetabolites|mesh-ancestor
6052297|NCT00092716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052298|NCT00092716|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6052299|NCT00092716|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6052300|NCT00092716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6052301|NCT00071708|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6052302|NCT00071708|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6052303|NCT00071708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6052304|NCT00071708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6052305|NCT00071708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052306|NCT00071708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6052307|NCT00071708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6052308|NCT00071708|Analgesics|analgesics|mesh-ancestor
6052309|NCT00071708|Sensory System Agents|sensory system agents|mesh-ancestor
6052310|NCT00071708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6052311|NCT00071708|Antidepressive Agents|antidepressive agents|mesh-ancestor
6052312|NCT00071708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6052313|NCT00071708|Dopamine Agents|dopamine agents|mesh-ancestor
6052314|NCT00588094|Rituximab|rituximab|mesh-list
6052315|NCT00588094|Carboplatin|carboplatin|mesh-list
6052316|NCT00588094|Etoposide|etoposide|mesh-list
6052317|NCT00588094|Ifosfamide|ifosfamide|mesh-list
6052318|NCT00588094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6052319|NCT00588094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6052320|NCT00588094|Immunologic Factors|immunologic factors|mesh-ancestor
6052321|NCT00588094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500844|NCT04479748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5500845|NCT04479748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5500846|NCT04479748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6052322|NCT00588094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6052323|NCT00588094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6052324|NCT00588094|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6052325|NCT00588094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6052326|NCT00588094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6052327|NCT00588094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052328|NCT00588094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6052329|NCT00588094|Alkylating Agents|alkylating agents|mesh-ancestor
6052330|NCT00588159|Diphenhydramine|diphenhydramine|mesh-list
6052331|NCT00588159|Promethazine|promethazine|mesh-list
6052332|NCT00588159|Gabapentin|gabapentin|mesh-list
5500847|NCT04479748|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5500848|NCT04479748|Protective Agents|protective agents|mesh-ancestor
5500849|NCT04479657|Cefuroxime|cefuroxime|mesh-list
5500850|NCT04479657|Cefuroxime axetil|cefuroxime axetil|mesh-list
5500851|NCT04479657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5500852|NCT04479657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5500853|NCT04479865|Donepezil|donepezil|mesh-list
5500854|NCT04479865|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5500855|NCT04479865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5500856|NCT04479865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500857|NCT04479865|Cholinergic Agents|cholinergic agents|mesh-ancestor
5500858|NCT04479865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5500859|NCT04479865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500860|NCT04479865|Nootropic Agents|nootropic agents|mesh-ancestor
5500861|NCT04479891|Itraconazole|itraconazole|mesh-list
5500862|NCT04479891|Antifungal Agents|antifungal agents|mesh-ancestor
6052333|NCT00588159|Analgesics|analgesics|mesh-ancestor
6052334|NCT00588159|Sensory System Agents|sensory system agents|mesh-ancestor
6052335|NCT00588159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6052336|NCT00588159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6052337|NCT00588159|Anticonvulsants|anticonvulsants|mesh-ancestor
6052338|NCT00588159|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6052339|NCT00588159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6052340|NCT00588159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6052341|NCT00588159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5500863|NCT04479891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6052342|NCT00588159|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6052343|NCT00588159|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6052344|NCT00588159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6052345|NCT00588159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052346|NCT00588159|Antimanic Agents|antimanic agents|mesh-ancestor
6052347|NCT00588159|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6052348|NCT00588159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6052349|NCT00588159|Anesthetics, Local|anesthetics, local|mesh-ancestor
6052350|NCT00588159|Anesthetics|anesthetics|mesh-ancestor
6052351|NCT00588159|Antiemetics|antiemetics|mesh-ancestor
5500864|NCT04479891|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5500865|NCT04479891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5500866|NCT04479891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5500867|NCT04479891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500868|NCT04479891|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5500869|NCT04479891|Hormone Antagonists|hormone antagonists|mesh-ancestor
5500870|NCT04479891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5500871|NCT04479891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500872|NCT04479891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5500873|NCT04479813|Moxonidine|moxonidine|mesh-list
5500874|NCT04479813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5500875|NCT04479527|Apatinib|apatinib|mesh-list
5500876|NCT04479527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5500877|NCT04479527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5500878|NCT04479527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5500879|NCT04479527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500880|NCT04479202|Bentonite|bentonite|mesh-list
5500881|NCT04479202|Antidotes|antidotes|mesh-ancestor
5500882|NCT04479202|Protective Agents|protective agents|mesh-ancestor
5500883|NCT04479202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500884|NCT04479306|Osimertinib|osimertinib|mesh-list
5500885|NCT04479306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5500886|NCT04479306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6052352|NCT00588159|Autonomic Agents|autonomic agents|mesh-ancestor
6052353|NCT00588159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6052354|NCT00588159|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6052355|NCT00588159|Histamine Antagonists|histamine antagonists|mesh-ancestor
6052356|NCT00588159|Histamine Agents|histamine agents|mesh-ancestor
6052357|NCT00588159|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6052358|NCT00588159|Antipruritics|antipruritics|mesh-ancestor
6052359|NCT00588159|Dermatologic Agents|dermatologic agents|mesh-ancestor
6052360|NCT00588237|Paclitaxel|paclitaxel|mesh-list
6052361|NCT00588237|Bevacizumab|bevacizumab|mesh-list
6052362|NCT00588237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6052363|NCT00588237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6052364|NCT00588237|Tubulin Modulators|tubulin modulators|mesh-ancestor
6052365|NCT00588237|Antimitotic Agents|antimitotic agents|mesh-ancestor
6052366|NCT00588237|Mitosis Modulators|mitosis modulators|mesh-ancestor
6052367|NCT00588237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052368|NCT00588237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6052369|NCT00588237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6052370|NCT00588237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6052371|NCT00588237|Growth Substances|growth substances|mesh-ancestor
6052372|NCT00588237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6052373|NCT00588237|Growth Inhibitors|growth inhibitors|mesh-ancestor
6052374|NCT00588341|Temozolomide|temozolomide|mesh-list
6052375|NCT00588341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6052376|NCT00588341|Alkylating Agents|alkylating agents|mesh-ancestor
6052377|NCT00588341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052378|NCT00588341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6052379|NCT00588354|Triamcinolone|triamcinolone|mesh-list
6052380|NCT00588354|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6052381|NCT00588354|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6052382|NCT00588354|Lidocaine|lidocaine|mesh-list
6052383|NCT00588354|Clonidine|clonidine|mesh-list
6052384|NCT00588354|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6052385|NCT00588354|Anesthetics, Local|anesthetics, local|mesh-ancestor
6052386|NCT00588354|Anesthetics|anesthetics|mesh-ancestor
6052387|NCT00588354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6052388|NCT00588354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6052389|NCT00588354|Sensory System Agents|sensory system agents|mesh-ancestor
6052390|NCT00588354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6052391|NCT00588354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6052392|NCT00588354|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6052393|NCT00588354|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6052394|NCT00588354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6052395|NCT00588354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052396|NCT00588354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6052397|NCT00588354|Glucocorticoids|glucocorticoids|mesh-ancestor
6052398|NCT00588354|Hormones|hormones|mesh-ancestor
6052399|NCT00588354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6052400|NCT00588354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6052401|NCT00588354|Immunologic Factors|immunologic factors|mesh-ancestor
5500887|NCT04479306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5500888|NCT04479306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500889|NCT04479371|Bupivacaine|bupivacaine|mesh-list
5500890|NCT04479371|Anesthetics, Local|anesthetics, local|mesh-ancestor
5500891|NCT04479371|Anesthetics|anesthetics|mesh-ancestor
5500892|NCT04479371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5500893|NCT04479371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500894|NCT04479371|Sensory System Agents|sensory system agents|mesh-ancestor
5500895|NCT04479371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5500896|NCT04479449|Otaplimastat|otaplimastat|mesh-list
5500897|NCT04479449|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5500898|NCT04479449|Protective Agents|protective agents|mesh-ancestor
5500899|NCT04479449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503561|NCT04458116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5503562|NCT04458116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5503563|NCT04458116|Analgesics|analgesics|mesh-ancestor
5503564|NCT04458116|Sensory System Agents|sensory system agents|mesh-ancestor
5503565|NCT04458116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5503566|NCT04458116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503567|NCT04458116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6052402|NCT00588354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6052403|NCT00588354|Analgesics|analgesics|mesh-ancestor
6052404|NCT00588354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5503568|NCT04458116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5503569|NCT04458116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5503570|NCT04458116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6052405|NCT00588354|Sympatholytics|sympatholytics|mesh-ancestor
6052406|NCT00588354|Autonomic Agents|autonomic agents|mesh-ancestor
6052407|NCT00588354|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6052408|NCT00588354|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6052409|NCT00588354|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6052410|NCT00588354|Adrenergic Agents|adrenergic agents|mesh-ancestor
6052411|NCT00588354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6052412|NCT00588406|Prednisone|prednisone|mesh-list
6052413|NCT00588406|Budesonide|budesonide|mesh-list
6052414|NCT00588406|Bromides|bromides|mesh-list
6052415|NCT00588406|Albuterol|albuterol|mesh-list
6052416|NCT00588406|Ipratropium|ipratropium|mesh-list
5503571|NCT04458116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503572|NCT04457609|Azithromycin|azithromycin|mesh-list
5503573|NCT04457609|Oseltamivir|oseltamivir|mesh-list
5503574|NCT04457609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6052417|NCT00588406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6052418|NCT00588406|Glucocorticoids|glucocorticoids|mesh-ancestor
5500900|NCT04479072|Aspirin|aspirin|mesh-list
5500901|NCT04479072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5500902|NCT04479072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5500903|NCT04479072|Analgesics|analgesics|mesh-ancestor
5500904|NCT04479072|Sensory System Agents|sensory system agents|mesh-ancestor
6052419|NCT00588406|Hormones|hormones|mesh-ancestor
6052420|NCT00588406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6052421|NCT00588406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458758|NCT00441740|Antiviral Agents|antiviral agents|mesh-ancestor
6458759|NCT00441740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6458760|NCT00441740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6458761|NCT00441740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5500905|NCT04479072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5500906|NCT04479072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500907|NCT04479072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5500908|NCT04479072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5500909|NCT04479072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5500910|NCT04479072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5500911|NCT04479072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500912|NCT04479072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5500913|NCT04479072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5500914|NCT04479072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5500915|NCT04479072|Antipyretics|antipyretics|mesh-ancestor
5500916|NCT04478838|Olanzapine|olanzapine|mesh-list
5500917|NCT04478838|Risperidone|risperidone|mesh-list
6458762|NCT00441740|Immunologic Factors|immunologic factors|mesh-ancestor
6458763|NCT00441740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458764|NCT00441740|Tubulin Modulators|tubulin modulators|mesh-ancestor
5500918|NCT04478838|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5500919|NCT04478838|Serotonin Agents|serotonin agents|mesh-ancestor
5500920|NCT04478838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5500921|NCT04478838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500922|NCT04478838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500923|NCT04478838|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6458765|NCT00441740|Antimitotic Agents|antimitotic agents|mesh-ancestor
6458766|NCT00441740|Mitosis Modulators|mitosis modulators|mesh-ancestor
6458767|NCT00441740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6458768|NCT00441844|Simvastatin|simvastatin|mesh-list
6458769|NCT00441844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6458770|NCT00441844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6458771|NCT00441844|Antimetabolites|antimetabolites|mesh-ancestor
6052422|NCT00588406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6052423|NCT00588406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6052424|NCT00588406|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6052425|NCT00588406|Autonomic Agents|autonomic agents|mesh-ancestor
6052426|NCT00588406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6052427|NCT00588406|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6052428|NCT00588406|Respiratory System Agents|respiratory system agents|mesh-ancestor
6052429|NCT00588406|Anticonvulsants|anticonvulsants|mesh-ancestor
6052430|NCT00588406|Tocolytic Agents|tocolytic agents|mesh-ancestor
6052431|NCT00588406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6052432|NCT00588406|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5500924|NCT04478838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5500925|NCT04478838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5500926|NCT04478838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5500927|NCT04478838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5500928|NCT04478838|Dopamine Agents|dopamine agents|mesh-ancestor
5500929|NCT04478838|Antiemetics|antiemetics|mesh-ancestor
5500930|NCT04478838|Autonomic Agents|autonomic agents|mesh-ancestor
6052433|NCT00588406|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6052434|NCT00588406|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6052435|NCT00588406|Adrenergic Agents|adrenergic agents|mesh-ancestor
6052436|NCT00588406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6052437|NCT00588406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052438|NCT00588406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6462000|NCT00457054|Antidepressive Agents|antidepressive agents|mesh-ancestor
5500931|NCT04478838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5500932|NCT04478838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5500933|NCT04478838|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5500934|NCT04478838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5500935|NCT04478838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5500936|NCT04478617|Metronidazole|metronidazole|mesh-list
5500937|NCT04478617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5500938|NCT04478617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5500939|NCT04478617|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6052439|NCT00588406|Cholinergic Agents|cholinergic agents|mesh-ancestor
6052440|NCT00588445|Gefitinib|gefitinib|mesh-list
6052441|NCT00588445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6052442|NCT00588445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6052443|NCT00588445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6052444|NCT00588445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052445|NCT00588536|Leucovorin|leucovorin|mesh-list
6052446|NCT00588536|Methotrexate|methotrexate|mesh-list
6052447|NCT00588536|Thioguanine|thioguanine|mesh-list
6052448|NCT00588536|Calcium|calcium|mesh-list
6052449|NCT00588536|Levoleucovorin|levoleucovorin|mesh-list
6052450|NCT00588536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6052451|NCT00588536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6052452|NCT00588536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6052453|NCT00588536|Abortifacient Agents|abortifacient agents|mesh-ancestor
6052454|NCT00588536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6052455|NCT00588536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6052456|NCT00588536|Antimetabolites|antimetabolites|mesh-ancestor
6052457|NCT00588536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052458|NCT00588536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6052459|NCT00588536|Dermatologic Agents|dermatologic agents|mesh-ancestor
6052460|NCT00588536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6052461|NCT00588536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6052462|NCT00588536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6052463|NCT00588536|Immunologic Factors|immunologic factors|mesh-ancestor
6052464|NCT00588536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6052465|NCT00588536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6052466|NCT00588536|Antidotes|antidotes|mesh-ancestor
6052467|NCT00588536|Protective Agents|protective agents|mesh-ancestor
6052468|NCT00588536|Vitamin B Complex|vitamin b complex|mesh-ancestor
6052469|NCT00588536|Vitamins|vitamins|mesh-ancestor
6052470|NCT00588536|Micronutrients|micronutrients|mesh-ancestor
6052471|NCT00588640|Methadone|methadone|mesh-list
6052472|NCT00588640|D-methadone|d-methadone|mesh-list
6052473|NCT00588640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6052474|NCT00588640|Narcotics|narcotics|mesh-ancestor
6052475|NCT00588640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6052476|NCT00588640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6052477|NCT00588640|Analgesics|analgesics|mesh-ancestor
6052478|NCT00588640|Sensory System Agents|sensory system agents|mesh-ancestor
6052479|NCT00588640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6052480|NCT00588640|Antitussive Agents|antitussive agents|mesh-ancestor
6052481|NCT00588640|Respiratory System Agents|respiratory system agents|mesh-ancestor
6052482|NCT00588640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6052483|NCT00588666|Gemcitabine|gemcitabine|mesh-list
6052484|NCT00588666|Bevacizumab|bevacizumab|mesh-list
6052485|NCT00588666|Carboplatin|carboplatin|mesh-list
5500940|NCT04478617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5500941|NCT04478448|Favipiravir|favipiravir|mesh-list
5500942|NCT04478448|Antiviral Agents|antiviral agents|mesh-ancestor
5500943|NCT04478448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5500944|NCT04478461|Antibodies|antibodies|mesh-list
5500945|NCT04478461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5500946|NCT04478461|Immunologic Factors|immunologic factors|mesh-ancestor
5500947|NCT04478461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500948|NCT04478526|Norepinephrine|norepinephrine|mesh-list
5500949|NCT04478526|Serotonin|serotonin|mesh-list
5500950|NCT04478526|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
5500951|NCT04478526|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
5500952|NCT04478526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5500953|NCT04478526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5500954|NCT04478526|Adrenergic Agents|adrenergic agents|mesh-ancestor
5500955|NCT04478526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5500956|NCT04478526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500957|NCT04478526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6052486|NCT00588666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6052487|NCT00588666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6052488|NCT00588666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6052489|NCT00588666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6052490|NCT00588666|Growth Substances|growth substances|mesh-ancestor
6052491|NCT00588666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6052492|NCT00588666|Growth Inhibitors|growth inhibitors|mesh-ancestor
6052493|NCT00588666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6052494|NCT00588666|Antimetabolites|antimetabolites|mesh-ancestor
6052495|NCT00588666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500958|NCT04478526|Sympathomimetics|sympathomimetics|mesh-ancestor
5500959|NCT04478526|Autonomic Agents|autonomic agents|mesh-ancestor
6052496|NCT00588666|Antiviral Agents|antiviral agents|mesh-ancestor
6052497|NCT00588666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6052498|NCT00588666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6052499|NCT00588666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6052500|NCT00588666|Immunologic Factors|immunologic factors|mesh-ancestor
6052501|NCT00588731|Cannabidiol|cannabidiol|mesh-list
6052502|NCT00588731|Anticonvulsants|anticonvulsants|mesh-ancestor
6052503|NCT00588822|Rituximab|rituximab|mesh-list
6052504|NCT00588822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6052505|NCT00588822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6052506|NCT00588822|Immunologic Factors|immunologic factors|mesh-ancestor
6052507|NCT00588822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6052508|NCT00588822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6052509|NCT00588900|Irinotecan|irinotecan|mesh-list
6052510|NCT00588900|Cediranib|cediranib|mesh-list
6052511|NCT00588900|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6052512|NCT00588900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6052513|NCT00588900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6052514|NCT00588900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052515|NCT00588900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6052516|NCT00588900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6052517|NCT00588952|Ketamine|ketamine|mesh-list
6052518|NCT00588952|Analgesics|analgesics|mesh-ancestor
6052519|NCT00588952|Sensory System Agents|sensory system agents|mesh-ancestor
6052520|NCT00588952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6052521|NCT00588952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6052522|NCT00588952|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6052523|NCT00588952|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6052524|NCT00588952|Anesthetics, General|anesthetics, general|mesh-ancestor
6052525|NCT00588952|Anesthetics|anesthetics|mesh-ancestor
6052526|NCT00588952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6052527|NCT00588952|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6052528|NCT00588952|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6052529|NCT00588952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6052530|NCT00588952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052531|NCT00588965|Propranolol|propranolol|mesh-list
6052532|NCT00588965|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6052533|NCT00588965|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6052534|NCT00588965|Adrenergic Agents|adrenergic agents|mesh-ancestor
6052535|NCT00588965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6052536|NCT00588965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052537|NCT00588965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6052538|NCT00588965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6052539|NCT00588965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6052540|NCT00588965|Vasodilator Agents|vasodilator agents|mesh-ancestor
6052541|NCT00589056|Nelfinavir|nelfinavir|mesh-list
6052542|NCT00589056|Etoposide|etoposide|mesh-list
6052543|NCT00589056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6052544|NCT00589056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6052545|NCT00589056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6052546|NCT00589056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6052547|NCT00589056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6052548|NCT00589056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052549|NCT00589056|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6052550|NCT00589056|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6052551|NCT00589056|Protease Inhibitors|protease inhibitors|mesh-ancestor
6052552|NCT00589056|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6052553|NCT00589056|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6052554|NCT00589056|Antiviral Agents|antiviral agents|mesh-ancestor
6052555|NCT00589056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6052556|NCT00589290|Belinostat|belinostat|mesh-list
6052557|NCT00589290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6052558|NCT00589290|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6052559|NCT00589290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6052560|NCT00589290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052561|NCT00589303|Metoprolol|metoprolol|mesh-list
6052562|NCT00589303|Amiodarone|amiodarone|mesh-list
6052563|NCT00589303|Verapamil|verapamil|mesh-list
6052564|NCT00589303|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6052565|NCT00589303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6052566|NCT00589303|Sympatholytics|sympatholytics|mesh-ancestor
6052567|NCT00589303|Autonomic Agents|autonomic agents|mesh-ancestor
6052568|NCT00589303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6052569|NCT00589303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6052570|NCT00589303|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6052571|NCT00589303|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6052572|NCT00589303|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6052573|NCT00589303|Adrenergic Agents|adrenergic agents|mesh-ancestor
6052574|NCT00589303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6052575|NCT00589303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052576|NCT00589303|Vasodilator Agents|vasodilator agents|mesh-ancestor
6052577|NCT00589303|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6052578|NCT00589303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6052579|NCT00589303|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6052580|NCT00589303|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6052581|NCT00589303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6052582|NCT00589303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6052583|NCT00589303|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6052584|NCT00589303|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6052585|NCT00589303|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6052586|NCT00589303|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6052587|NCT00589303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6054239|NCT00601796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054240|NCT00601796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6054241|NCT00601796|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6054242|NCT00601796|Keratolytic Agents|keratolytic agents|mesh-ancestor
6054243|NCT00601796|Dermatologic Agents|dermatologic agents|mesh-ancestor
6054244|NCT00601835|Vaccines|vaccines|mesh-list
6054245|NCT00601835|Immunologic Factors|immunologic factors|mesh-ancestor
5500960|NCT04478526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5500961|NCT04478526|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5500962|NCT04478526|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5500963|NCT04478526|Serotonin Agents|serotonin agents|mesh-ancestor
5500964|NCT04478526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5500965|NCT04478526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5500966|NCT04478357|Fesoterodine|fesoterodine|mesh-list
5500967|NCT04478357|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5500968|NCT04478357|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5500969|NCT04478357|Cholinergic Agents|cholinergic agents|mesh-ancestor
5500970|NCT04478357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5500971|NCT04478357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500972|NCT04478357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500973|NCT04478357|Urological Agents|urological agents|mesh-ancestor
5500974|NCT04478474|Ganciclovir|ganciclovir|mesh-list
5500975|NCT04478474|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
5500976|NCT04478474|Antiviral Agents|antiviral agents|mesh-ancestor
5500977|NCT04478474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5500978|NCT04478474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5500979|NCT04478474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5500980|NCT04478474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500981|NCT04478292|Sodium thiosulfate|sodium thiosulfate|mesh-list
5500982|NCT04478292|Cisplatin|cisplatin|mesh-list
5500983|NCT04478292|Carboplatin|carboplatin|mesh-list
5500984|NCT04478292|Doxorubicin|doxorubicin|mesh-list
6054246|NCT00601835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054247|NCT00601926|Bevacizumab|bevacizumab|mesh-list
6054248|NCT00601926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6054249|NCT00601926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6054250|NCT00601926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6054251|NCT00601926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6054252|NCT00601926|Growth Substances|growth substances|mesh-ancestor
6054253|NCT00601926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054254|NCT00601926|Growth Inhibitors|growth inhibitors|mesh-ancestor
6054255|NCT00601965|Citalopram|citalopram|mesh-list
6054256|NCT00601965|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6054257|NCT00601965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6054258|NCT00601965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6054259|NCT00601965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054260|NCT00601965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6054261|NCT00601965|Serotonin Agents|serotonin agents|mesh-ancestor
6054262|NCT00601965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5500985|NCT04478292|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5500986|NCT04478292|Fluorouracil|fluorouracil|mesh-list
5500987|NCT04478292|Irinotecan|irinotecan|mesh-list
5500988|NCT04478292|Vincristine|vincristine|mesh-list
5500989|NCT04478292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5500990|NCT04478292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5500991|NCT04478292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5500992|NCT04478292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5500993|NCT04478292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5500994|NCT04478292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5500995|NCT04478292|Antimetabolites|antimetabolites|mesh-ancestor
5500996|NCT04478292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5500997|NCT04478292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5500998|NCT04478292|Immunologic Factors|immunologic factors|mesh-ancestor
5500999|NCT04478292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6052588|NCT00589329|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6052589|NCT00589329|Metronidazole|metronidazole|mesh-list
6052590|NCT00589329|Erythromycin|erythromycin|mesh-list
6052591|NCT00589329|Erythromycin Estolate|erythromycin estolate|mesh-list
6052592|NCT00589329|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
6052593|NCT00589329|Erythromycin stearate|erythromycin stearate|mesh-list
6052594|NCT00589329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6052595|NCT00589329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6052596|NCT00589329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6052597|NCT00589329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6052598|NCT00589329|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6052599|NCT00589329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6052600|NCT00589329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052601|NCT00589472|Vorinostat|vorinostat|mesh-list
6052602|NCT00589472|Leuprolide|leuprolide|mesh-list
6052603|NCT00589472|Goserelin|goserelin|mesh-list
6052604|NCT00589472|Bicalutamide|bicalutamide|mesh-list
6052605|NCT00589472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6052606|NCT00589472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6052607|NCT00589472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6052608|NCT00589472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052609|NCT00589472|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6052610|NCT00589472|Fertility Agents|fertility agents|mesh-ancestor
6052611|NCT00589472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6052612|NCT00589472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6052613|NCT00589472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6052614|NCT00589472|Androgen Antagonists|androgen antagonists|mesh-ancestor
6052615|NCT00589472|Hormone Antagonists|hormone antagonists|mesh-ancestor
6052616|NCT00589472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6052617|NCT00589563|Sirolimus|sirolimus|mesh-list
6052618|NCT00589563|Cyclophosphamide|cyclophosphamide|mesh-list
6052619|NCT00589563|Melphalan|melphalan|mesh-list
6052620|NCT00589563|Methotrexate|methotrexate|mesh-list
6052621|NCT00589563|Fludarabine|fludarabine|mesh-list
6458772|NCT00441844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501000|NCT04478292|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5501001|NCT04478292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5501002|NCT04478292|Tubulin Modulators|tubulin modulators|mesh-ancestor
5501003|NCT04478292|Antimitotic Agents|antimitotic agents|mesh-ancestor
5501004|NCT04478292|Mitosis Modulators|mitosis modulators|mesh-ancestor
5501005|NCT04478292|Antidotes|antidotes|mesh-ancestor
5501006|NCT04478292|Protective Agents|protective agents|mesh-ancestor
5501007|NCT04478292|Antioxidants|antioxidants|mesh-ancestor
5501008|NCT04478292|Antitubercular Agents|antitubercular agents|mesh-ancestor
5501009|NCT04478292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5501010|NCT04478292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5501011|NCT04478292|Chelating Agents|chelating agents|mesh-ancestor
5501012|NCT04478292|Sequestering Agents|sequestering agents|mesh-ancestor
5501013|NCT04478513|Fluvoxamine|fluvoxamine|mesh-list
5501014|NCT04478513|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5501015|NCT04478513|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5501016|NCT04478513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5501017|NCT04478513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501018|NCT04478513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5501019|NCT04478513|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5501020|NCT04478513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5501021|NCT04478513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5501022|NCT04478513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501023|NCT04478513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5501024|NCT04478513|Serotonin Agents|serotonin agents|mesh-ancestor
6052622|NCT00589563|Fludarabine phosphate|fludarabine phosphate|mesh-list
6052623|NCT00589563|Etoposide|etoposide|mesh-list
6052624|NCT00589563|Tacrolimus|tacrolimus|mesh-list
6052625|NCT00589563|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6052626|NCT00589563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6052627|NCT00589563|Immunologic Factors|immunologic factors|mesh-ancestor
6052628|NCT00589563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6052629|NCT00589563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6052630|NCT00589563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6052631|NCT00589563|Alkylating Agents|alkylating agents|mesh-ancestor
6052632|NCT00589563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052633|NCT00589563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6052634|NCT00589563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6052635|NCT00589563|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6052636|NCT00589563|Abortifacient Agents|abortifacient agents|mesh-ancestor
6052637|NCT00589563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6052638|NCT00589563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6052639|NCT00589563|Antimetabolites|antimetabolites|mesh-ancestor
6052640|NCT00589563|Dermatologic Agents|dermatologic agents|mesh-ancestor
6052641|NCT00589563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6052642|NCT00589563|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6052643|NCT00589563|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6052644|NCT00589563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6052645|NCT00589563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6052646|NCT00589563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6052647|NCT00589563|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6052648|NCT00589563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6052649|NCT00589563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6052650|NCT00589563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6052651|NCT00589563|Antifungal Agents|antifungal agents|mesh-ancestor
6052652|NCT00589628|Infliximab|infliximab|mesh-list
6052653|NCT00589628|Dermatologic Agents|dermatologic agents|mesh-ancestor
6052654|NCT00589628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6052655|NCT00589628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6052656|NCT00589667|Gemcitabine|gemcitabine|mesh-list
6052657|NCT00589667|Pemetrexed|pemetrexed|mesh-list
6052658|NCT00589667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6052659|NCT00589667|Antimetabolites|antimetabolites|mesh-ancestor
6052660|NCT00589667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052661|NCT00589667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6052662|NCT00589667|Antiviral Agents|antiviral agents|mesh-ancestor
6052663|NCT00589667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6052664|NCT00589667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6052665|NCT00589667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6052666|NCT00589667|Immunologic Factors|immunologic factors|mesh-ancestor
6052667|NCT00589667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6052668|NCT00589667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6052669|NCT00589667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6052670|NCT00589693|Imipenem|imipenem|mesh-list
6052671|NCT00589693|Doripenem|doripenem|mesh-list
6052672|NCT00589693|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
6052673|NCT00589693|Cilastatin|cilastatin|mesh-list
6052674|NCT00589693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6052675|NCT00589693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6052676|NCT00589693|Protease Inhibitors|protease inhibitors|mesh-ancestor
6052677|NCT00589693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6052678|NCT00589693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052679|NCT00589784|Sunitinib|sunitinib|mesh-list
6052680|NCT00589784|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-list
6052681|NCT00589784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6052682|NCT00589784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6052683|NCT00589784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6052684|NCT00589784|Growth Substances|growth substances|mesh-ancestor
6052685|NCT00589784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6052686|NCT00589784|Growth Inhibitors|growth inhibitors|mesh-ancestor
6052687|NCT00589784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6052688|NCT00589784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6052689|NCT00589784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052690|NCT00589784|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6052691|NCT00589888|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6052692|NCT00589888|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6052693|NCT00589888|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6458773|NCT00441844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6458774|NCT00441844|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6458775|NCT00441844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6458776|NCT00441870|Folic Acid|folic acid|mesh-list
6458777|NCT00441870|Vitamin B Complex|vitamin b complex|mesh-list
6458778|NCT00441870|Hematinics|hematinics|mesh-ancestor
5501025|NCT04478513|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5501026|NCT04478513|Antidepressive Agents|antidepressive agents|mesh-ancestor
6052694|NCT00589888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6052695|NCT00589914|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6052696|NCT00589914|Risperidone|risperidone|mesh-list
6052697|NCT00589914|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6052698|NCT00589914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6052699|NCT00589914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6052700|NCT00589914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6052701|NCT00589914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6052702|NCT00589914|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5501027|NCT04478513|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5501028|NCT04478513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5501029|NCT04478513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5501030|NCT04478513|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5501031|NCT04478500|Minocycline|minocycline|mesh-list
5501032|NCT04478500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5501033|NCT04478500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5501034|NCT04477993|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
5501035|NCT04477993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5501036|NCT04477993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5501037|NCT04477993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501038|NCT04477772|Antibodies|antibodies|mesh-list
5501039|NCT04477772|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5501040|NCT04477772|Immunologic Factors|immunologic factors|mesh-ancestor
6052703|NCT00589914|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6052704|NCT00589914|Serotonin Agents|serotonin agents|mesh-ancestor
6052705|NCT00589914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6052706|NCT00589914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052707|NCT00589914|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6052708|NCT00589914|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6052709|NCT00589914|Dopamine Agents|dopamine agents|mesh-ancestor
5501041|NCT04477772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6052710|NCT00589979|Lidocaine|lidocaine|mesh-list
6052711|NCT00589979|Anesthetics, Local|anesthetics, local|mesh-ancestor
6052712|NCT00589979|Anesthetics|anesthetics|mesh-ancestor
6052713|NCT00589979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6052714|NCT00589979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6052715|NCT00589979|Sensory System Agents|sensory system agents|mesh-ancestor
6052716|NCT00589979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6052717|NCT00589979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6052718|NCT00589979|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6052719|NCT00589979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6052720|NCT00589979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6052721|NCT00589979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052722|NCT00590018|Hydrocortisone|hydrocortisone|mesh-list
6052723|NCT00590018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6052724|NCT00590031|Irinotecan|irinotecan|mesh-list
6052725|NCT00590031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6052726|NCT00590031|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6052727|NCT00590031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6052728|NCT00590031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6052729|NCT00590031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052730|NCT00590044|Insulin|insulin|mesh-list
6052731|NCT00590044|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6052732|NCT00590044|Insulin Glargine|insulin glargine|mesh-list
6458779|NCT00441870|Vitamins|vitamins|mesh-ancestor
6052733|NCT00590044|Insulin, Isophane|insulin, isophane|mesh-list
6052734|NCT00590044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6052735|NCT00590044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6052736|NCT00590161|Pentoxifylline|pentoxifylline|mesh-list
6052737|NCT00590161|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6052738|NCT00590161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6052739|NCT00590161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052740|NCT00590161|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6052741|NCT00590161|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6052742|NCT00590161|Protective Agents|protective agents|mesh-ancestor
6052743|NCT00590161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6052744|NCT00590161|Vasodilator Agents|vasodilator agents|mesh-ancestor
5501042|NCT04477629|Mycophenolic Acid|mycophenolic acid|mesh-list
5501043|NCT04477629|Abatacept|abatacept|mesh-list
5501044|NCT04477629|Tacrolimus|tacrolimus|mesh-list
5501045|NCT04477629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6052745|NCT00590161|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6052746|NCT00590161|Antioxidants|antioxidants|mesh-ancestor
6052747|NCT00590226|Insulin|insulin|mesh-list
6052748|NCT00590226|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6052749|NCT00590226|Insulin Aspart|insulin aspart|mesh-list
6052750|NCT00590226|Insulin, Isophane|insulin, isophane|mesh-list
6052751|NCT00590226|Isophane Insulin, Human|isophane insulin, human|mesh-list
6052752|NCT00590226|Isophane insulin, beef|isophane insulin, beef|mesh-list
6458780|NCT00441870|Micronutrients|micronutrients|mesh-ancestor
6458781|NCT00441870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458782|NCT00441909|UC-781|uc-781|mesh-list
6458783|NCT00441909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6458784|NCT00441909|Antiviral Agents|antiviral agents|mesh-ancestor
6458785|NCT00441909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6458786|NCT00441922|Docetaxel|docetaxel|mesh-list
6458787|NCT00441922|Vinorelbine|vinorelbine|mesh-list
6458788|NCT00441922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6052753|NCT00590226|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6052754|NCT00590226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6052755|NCT00590317|Ondansetron|ondansetron|mesh-list
6052756|NCT00590317|Prochlorperazine|prochlorperazine|mesh-list
6052757|NCT00590317|Antiemetics|antiemetics|mesh-ancestor
6052758|NCT00590317|Autonomic Agents|autonomic agents|mesh-ancestor
6052759|NCT00590317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6052760|NCT00590317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6052761|NCT00590317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6052762|NCT00590317|Antipruritics|antipruritics|mesh-ancestor
6052763|NCT00590317|Dermatologic Agents|dermatologic agents|mesh-ancestor
6052764|NCT00590317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6052765|NCT00590317|Serotonin Agents|serotonin agents|mesh-ancestor
5501046|NCT04477629|Immunologic Factors|immunologic factors|mesh-ancestor
5501047|NCT04477629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501048|NCT04477629|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5501049|NCT04477629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5501050|NCT04477629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501051|NCT04477629|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5501052|NCT04477629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6052766|NCT00590317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6052767|NCT00590317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052768|NCT00590317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6052769|NCT00590317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6458789|NCT00441922|Tubulin Modulators|tubulin modulators|mesh-ancestor
5501053|NCT04477629|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5501054|NCT04477629|Antitubercular Agents|antitubercular agents|mesh-ancestor
5501055|NCT04477629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5501056|NCT04477629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5501057|NCT04477629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5501058|NCT04477629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5501059|NCT04477642|Abatacept|abatacept|mesh-list
5501060|NCT04477642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5501061|NCT04477642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501062|NCT04477642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5501063|NCT04477642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5501064|NCT04477642|Immunologic Factors|immunologic factors|mesh-ancestor
5501065|NCT04477642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501066|NCT04477642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5501067|NCT04477811|Vitamins|vitamins|mesh-list
5501068|NCT04477811|Vitamin K|vitamin k|mesh-list
5501069|NCT04477811|Vitamin K 2|vitamin k 2|mesh-list
5501070|NCT04477811|Vitamin K 1|vitamin k 1|mesh-list
5501071|NCT04477811|Micronutrients|micronutrients|mesh-ancestor
6052770|NCT00590317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6052771|NCT00590317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6052772|NCT00590317|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6052773|NCT00590317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6052774|NCT00590317|Dopamine Agents|dopamine agents|mesh-ancestor
6052775|NCT00590395|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6052776|NCT00590395|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
6052777|NCT00590395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052778|NCT00590460|Fludarabine|fludarabine|mesh-list
6052779|NCT00590460|Alemtuzumab|alemtuzumab|mesh-list
6052780|NCT00590460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5501072|NCT04477811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501073|NCT04477811|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5501074|NCT04477811|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6052781|NCT00590460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6052782|NCT00590577|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6052783|NCT00590577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6052784|NCT00590577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6052785|NCT00590577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6052786|NCT00590577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6052787|NCT00590577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6052788|NCT00590577|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6052789|NCT00590577|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6052790|NCT00590577|Serotonin Agents|serotonin agents|mesh-ancestor
6052791|NCT00590577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6052792|NCT00590577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052793|NCT00590577|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6052794|NCT00590577|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6052795|NCT00590577|Dopamine Agents|dopamine agents|mesh-ancestor
6052796|NCT00590590|Diphenhydramine|diphenhydramine|mesh-list
6052797|NCT00590590|Promethazine|promethazine|mesh-list
6052798|NCT00590590|Lidocaine|lidocaine|mesh-list
6052799|NCT00590590|Anesthetics, Local|anesthetics, local|mesh-ancestor
6052800|NCT00590590|Anesthetics|anesthetics|mesh-ancestor
6052801|NCT00590590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6052802|NCT00590590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6052803|NCT00590590|Sensory System Agents|sensory system agents|mesh-ancestor
6052804|NCT00590590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6052805|NCT00590590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6052806|NCT00590590|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6052807|NCT00590590|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6052808|NCT00590590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6052809|NCT00590590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052810|NCT00590590|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5501075|NCT04477811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501076|NCT04477811|Hemostatics|hemostatics|mesh-ancestor
5501077|NCT04477811|Coagulants|coagulants|mesh-ancestor
5501078|NCT04477590|Metformin|metformin|mesh-list
5501079|NCT04477590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5501080|NCT04477590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501081|NCT04477525|Bupivacaine|bupivacaine|mesh-list
5501082|NCT04477525|Anesthetics, Local|anesthetics, local|mesh-ancestor
5501083|NCT04477525|Anesthetics|anesthetics|mesh-ancestor
5501084|NCT04477525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5501085|NCT04477525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501086|NCT04477525|Sensory System Agents|sensory system agents|mesh-ancestor
5501087|NCT04477525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5501088|NCT04477317|Epinephrine|epinephrine|mesh-list
5501089|NCT04477317|Racepinephrine|racepinephrine|mesh-list
5501090|NCT04477317|Nordefrin|nordefrin|mesh-list
5501091|NCT04477317|Mepivacaine|mepivacaine|mesh-list
5501092|NCT04477317|Carticaine|carticaine|mesh-list
6052811|NCT00590590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6052812|NCT00590590|Antiemetics|antiemetics|mesh-ancestor
6052813|NCT00590590|Autonomic Agents|autonomic agents|mesh-ancestor
6052814|NCT00590590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6052815|NCT00590590|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6052816|NCT00590590|Histamine Antagonists|histamine antagonists|mesh-ancestor
6052817|NCT00590590|Histamine Agents|histamine agents|mesh-ancestor
6052818|NCT00590590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6052819|NCT00590590|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6052820|NCT00590590|Antipruritics|antipruritics|mesh-ancestor
6052821|NCT00590590|Dermatologic Agents|dermatologic agents|mesh-ancestor
6052822|NCT00590681|Bevacizumab|bevacizumab|mesh-list
5501093|NCT04477317|Epinephryl borate|epinephryl borate|mesh-list
5501094|NCT04477317|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6052823|NCT00590681|Temozolomide|temozolomide|mesh-list
6052824|NCT00590681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6052825|NCT00590681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6052826|NCT00590681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6052827|NCT00590681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6052828|NCT00590681|Growth Substances|growth substances|mesh-ancestor
6052829|NCT00590681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6052830|NCT00590681|Growth Inhibitors|growth inhibitors|mesh-ancestor
6052831|NCT00590681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6052832|NCT00590681|Alkylating Agents|alkylating agents|mesh-ancestor
6052833|NCT00590681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052834|NCT00590772|Montelukast|montelukast|mesh-list
6052835|NCT00590772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6052836|NCT00590772|Respiratory System Agents|respiratory system agents|mesh-ancestor
6052837|NCT00590772|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6052838|NCT00590772|Hormone Antagonists|hormone antagonists|mesh-ancestor
6052839|NCT00590772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6052840|NCT00590772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6052841|NCT00590772|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6052842|NCT00590772|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6052843|NCT00590772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052844|NCT00590824|Interleukin-2|interleukin-2|mesh-list
6052845|NCT00590824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6052846|NCT00590824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6052847|NCT00590824|Analgesics|analgesics|mesh-ancestor
6052848|NCT00590824|Sensory System Agents|sensory system agents|mesh-ancestor
6052849|NCT00590824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6052850|NCT00590824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6052851|NCT00590863|Dexetimide|dexetimide|mesh-list
6052852|NCT00590863|Mirtazapine|mirtazapine|mesh-list
6052853|NCT00590863|Citalopram|citalopram|mesh-list
6052854|NCT00590863|Bupropion|bupropion|mesh-list
6052855|NCT00590863|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6052856|NCT00590863|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6052857|NCT00590863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6052858|NCT00590863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6052859|NCT00590863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052860|NCT00590863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6052861|NCT00590863|Serotonin Agents|serotonin agents|mesh-ancestor
6052862|NCT00590863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6052863|NCT00590863|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6052864|NCT00590863|Antidepressive Agents|antidepressive agents|mesh-ancestor
6052865|NCT00590863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6052866|NCT00590863|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6052867|NCT00590863|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6052868|NCT00590863|Parasympatholytics|parasympatholytics|mesh-ancestor
6052869|NCT00590863|Autonomic Agents|autonomic agents|mesh-ancestor
6052870|NCT00590863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6052871|NCT00590863|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6052872|NCT00590863|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6052873|NCT00590863|Cholinergic Agents|cholinergic agents|mesh-ancestor
6052874|NCT00590863|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6052875|NCT00590863|Dopamine Agents|dopamine agents|mesh-ancestor
6052876|NCT00590863|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6052877|NCT00590863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6052878|NCT00590863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6052879|NCT00590863|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6052880|NCT00590863|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6052881|NCT00590863|Histamine Antagonists|histamine antagonists|mesh-ancestor
6052882|NCT00590863|Histamine Agents|histamine agents|mesh-ancestor
6052883|NCT00590863|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6052884|NCT00590863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6052885|NCT00590863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6052886|NCT00590863|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6052887|NCT00590863|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6052888|NCT00590863|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6052889|NCT00590863|Adrenergic Agents|adrenergic agents|mesh-ancestor
6052890|NCT00590863|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6052891|NCT00590863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6052892|NCT00590863|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6052893|NCT00590902|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6052894|NCT00590902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6052895|NCT00590902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6052896|NCT00590902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6052897|NCT00590902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052898|NCT00590967|Cisplatin|cisplatin|mesh-list
6458790|NCT00441922|Antimitotic Agents|antimitotic agents|mesh-ancestor
6458791|NCT00441922|Mitosis Modulators|mitosis modulators|mesh-ancestor
6458792|NCT00441922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458793|NCT00441922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6458794|NCT00441961|Methotrexate|methotrexate|mesh-list
6458795|NCT00441961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6458796|NCT00441961|Abortifacient Agents|abortifacient agents|mesh-ancestor
6458797|NCT00441961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6458798|NCT00441961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458799|NCT00441961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6458800|NCT00441961|Antimetabolites|antimetabolites|mesh-ancestor
6458801|NCT00441961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458802|NCT00441961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6458803|NCT00441961|Dermatologic Agents|dermatologic agents|mesh-ancestor
6458804|NCT00441961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6458805|NCT00441961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6458806|NCT00441961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6458807|NCT00441961|Immunologic Factors|immunologic factors|mesh-ancestor
6458808|NCT00441961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6458809|NCT00441961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6458810|NCT00442026|Gemcitabine|gemcitabine|mesh-list
6458811|NCT00442026|Docetaxel|docetaxel|mesh-list
6458812|NCT00442026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6458813|NCT00442026|Antimetabolites|antimetabolites|mesh-ancestor
6458814|NCT00442026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6458815|NCT00442026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6458816|NCT00442026|Antiviral Agents|antiviral agents|mesh-ancestor
6458817|NCT00442026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6458818|NCT00442026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6458819|NCT00442026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6458820|NCT00442026|Immunologic Factors|immunologic factors|mesh-ancestor
6458821|NCT00442026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458822|NCT00442026|Tubulin Modulators|tubulin modulators|mesh-ancestor
6458823|NCT00442026|Antimitotic Agents|antimitotic agents|mesh-ancestor
6458824|NCT00442026|Mitosis Modulators|mitosis modulators|mesh-ancestor
6458825|NCT00442052|Aspirin|aspirin|mesh-list
6458826|NCT00442052|Omeprazole|omeprazole|mesh-list
6458827|NCT00442052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6052899|NCT00590967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6052900|NCT00591006|Hydrocortisone|hydrocortisone|mesh-list
6052901|NCT00591006|Phenytoin|phenytoin|mesh-list
6052902|NCT00591006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6052903|NCT00591006|Anticonvulsants|anticonvulsants|mesh-ancestor
6052904|NCT00591006|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6052905|NCT00591006|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6052906|NCT00591006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6052907|NCT00591006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052908|NCT00591006|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6052909|NCT00591006|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6052910|NCT00591019|Modafinil|modafinil|mesh-list
6052911|NCT00591019|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6052912|NCT00591019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6052913|NCT00591019|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6052914|NCT00591019|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6052915|NCT00591019|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6052916|NCT00591019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052917|NCT00591123|Leucovorin|leucovorin|mesh-list
6052918|NCT00591123|Fluorouracil|fluorouracil|mesh-list
6052919|NCT00591123|Oxaliplatin|oxaliplatin|mesh-list
6052920|NCT00591123|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6052921|NCT00591123|Levoleucovorin|levoleucovorin|mesh-list
6052922|NCT00591123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6458828|NCT00442052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5501095|NCT04477317|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5501096|NCT04477317|Adrenergic Agents|adrenergic agents|mesh-ancestor
5501097|NCT04477317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5501098|NCT04477317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501099|NCT04477317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501100|NCT04477317|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5501101|NCT04477317|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5501102|NCT04477317|Autonomic Agents|autonomic agents|mesh-ancestor
5501103|NCT04477317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5501104|NCT04477317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5501105|NCT04477317|Respiratory System Agents|respiratory system agents|mesh-ancestor
5501106|NCT04477317|Mydriatics|mydriatics|mesh-ancestor
5501107|NCT04477317|Sympathomimetics|sympathomimetics|mesh-ancestor
5501108|NCT04477317|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5501109|NCT04477317|Anesthetics, Local|anesthetics, local|mesh-ancestor
5501110|NCT04477317|Anesthetics|anesthetics|mesh-ancestor
5501111|NCT04477317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5501112|NCT04477317|Sensory System Agents|sensory system agents|mesh-ancestor
5501113|NCT04477304|Analgesics, Opioid|analgesics, opioid|mesh-list
6052923|NCT00591123|Antimetabolites|antimetabolites|mesh-ancestor
6052924|NCT00591123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052925|NCT00591123|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6052926|NCT00591123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6052927|NCT00591123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6052928|NCT00591123|Immunologic Factors|immunologic factors|mesh-ancestor
6052929|NCT00591123|Antidotes|antidotes|mesh-ancestor
6052930|NCT00591123|Protective Agents|protective agents|mesh-ancestor
6052931|NCT00591123|Vitamin B Complex|vitamin b complex|mesh-ancestor
6052932|NCT00591123|Vitamins|vitamins|mesh-ancestor
6052933|NCT00591123|Micronutrients|micronutrients|mesh-ancestor
6052934|NCT00591123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6052935|NCT00591123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6052936|NCT00591149|Docetaxel|docetaxel|mesh-list
6052937|NCT00591149|Oxaliplatin|oxaliplatin|mesh-list
6052938|NCT00591149|Cetuximab|cetuximab|mesh-list
6052939|NCT00591149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6052940|NCT00591149|Tubulin Modulators|tubulin modulators|mesh-ancestor
6052941|NCT00591149|Antimitotic Agents|antimitotic agents|mesh-ancestor
6052942|NCT00591149|Mitosis Modulators|mitosis modulators|mesh-ancestor
5501114|NCT04477304|Narcotics|narcotics|mesh-ancestor
5501115|NCT04477304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5501116|NCT04477304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6052943|NCT00591149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052944|NCT00591149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6052945|NCT00591253|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
6052946|NCT00591253|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6052947|NCT00591253|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5501117|NCT04477304|Analgesics|analgesics|mesh-ancestor
5501118|NCT04477304|Sensory System Agents|sensory system agents|mesh-ancestor
5501119|NCT04477304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5501120|NCT04477096|Emtricitabine|emtricitabine|mesh-list
5501121|NCT04477096|Antiviral Agents|antiviral agents|mesh-ancestor
5501122|NCT04477096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5501123|NCT04477096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5501124|NCT04477096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5501125|NCT04477096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5501126|NCT04477096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501127|NCT04477096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5501128|NCT04477096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5501129|NCT04476979|Dexamethasone|dexamethasone|mesh-list
5501130|NCT04476979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5501131|NCT04476979|Antiemetics|antiemetics|mesh-ancestor
5501132|NCT04476979|Autonomic Agents|autonomic agents|mesh-ancestor
5501133|NCT04476979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6052948|NCT00591253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052949|NCT00591266|Amlodipine|amlodipine|mesh-list
6052950|NCT00591266|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
6052951|NCT00591266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6052952|NCT00591266|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6052953|NCT00591266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6052954|NCT00591266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501134|NCT04476979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501135|NCT04476979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5501136|NCT04476979|Glucocorticoids|glucocorticoids|mesh-ancestor
5501137|NCT04476979|Hormones|hormones|mesh-ancestor
6052955|NCT00591266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6052956|NCT00591266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6052957|NCT00591266|Vasodilator Agents|vasodilator agents|mesh-ancestor
6052958|NCT00591266|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6052959|NCT00591266|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6052960|NCT00591305|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
6052961|NCT00591305|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6052962|NCT00591305|Protective Agents|protective agents|mesh-ancestor
6052963|NCT00591305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6052964|NCT00591305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6052965|NCT00591370|Temozolomide|temozolomide|mesh-list
6052966|NCT00591370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6052967|NCT00591370|Alkylating Agents|alkylating agents|mesh-ancestor
6052968|NCT00591370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052969|NCT00591370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6052970|NCT00591565|Acamprosate|acamprosate|mesh-list
6052971|NCT00591565|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6052972|NCT00591578|Valsartan|valsartan|mesh-list
6052973|NCT00591578|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
6052974|NCT00591578|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6052975|NCT00591578|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6052976|NCT00591578|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6052977|NCT00591578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052978|NCT00591630|Cytarabine|cytarabine|mesh-list
6052979|NCT00591630|Rituximab|rituximab|mesh-list
6052980|NCT00591630|Etoposide|etoposide|mesh-list
6052981|NCT00591630|Melphalan|melphalan|mesh-list
6052982|NCT00591630|Carmustine|carmustine|mesh-list
6052983|NCT00591630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6052984|NCT00591630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6052985|NCT00591630|Immunologic Factors|immunologic factors|mesh-ancestor
6052986|NCT00591630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6052987|NCT00591630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6052988|NCT00591630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6052989|NCT00591630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5501138|NCT04476979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5501139|NCT04476979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5501140|NCT04476979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5501141|NCT04476966|Mirabegron|mirabegron|mesh-list
5501142|NCT04476966|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
5501143|NCT04476966|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5501144|NCT04476966|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5501145|NCT04476966|Adrenergic Agents|adrenergic agents|mesh-ancestor
5501146|NCT04476966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5501147|NCT04476966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501148|NCT04476966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501149|NCT04476966|Urological Agents|urological agents|mesh-ancestor
5501150|NCT04477083|Hydroxychloroquine|hydroxychloroquine|mesh-list
5501151|NCT04477083|Antimalarials|antimalarials|mesh-ancestor
5501152|NCT04477083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5501153|NCT04477083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5501154|NCT04477083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5501155|NCT04477083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5501156|NCT04477083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5501157|NCT04477083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5503575|NCT04457609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5503576|NCT04457609|Antiviral Agents|antiviral agents|mesh-ancestor
5503577|NCT04457609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5503578|NCT04457609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503579|NCT04457648|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5503580|NCT04457648|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5503581|NCT04457765|Povidone-Iodine|povidone-iodine|mesh-list
5503582|NCT04457765|Povidone|povidone|mesh-list
6052990|NCT00591630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6052991|NCT00591630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6052992|NCT00591630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6052993|NCT00591630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6052994|NCT00591630|Antimetabolites|antimetabolites|mesh-ancestor
6052995|NCT00591630|Antiviral Agents|antiviral agents|mesh-ancestor
6052996|NCT00591630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6052997|NCT00591630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6052998|NCT00591630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6052999|NCT00591630|Alkylating Agents|alkylating agents|mesh-ancestor
5503583|NCT04457765|Plasma Substitutes|plasma substitutes|mesh-ancestor
6053000|NCT00591630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6053001|NCT00591734|Bevacizumab|bevacizumab|mesh-list
6053002|NCT00591734|Everolimus|everolimus|mesh-list
6053003|NCT00591734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6053004|NCT00591734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6053005|NCT00591734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6053006|NCT00591734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6053007|NCT00591734|Growth Substances|growth substances|mesh-ancestor
6053008|NCT00591734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053009|NCT00591734|Growth Inhibitors|growth inhibitors|mesh-ancestor
6053010|NCT00591734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6053011|NCT00591734|Immunologic Factors|immunologic factors|mesh-ancestor
6053012|NCT00591773|Chlorthalidone|chlorthalidone|mesh-list
6053013|NCT00591773|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
6053014|NCT00591773|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6053015|NCT00591773|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6053016|NCT00591773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053017|NCT00591773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6053018|NCT00591773|Diuretics|diuretics|mesh-ancestor
6053019|NCT00591773|Natriuretic Agents|natriuretic agents|mesh-ancestor
6053020|NCT00591773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053021|NCT00591773|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6053022|NCT00591773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6053023|NCT00591825|Cycloserine|cycloserine|mesh-list
6053024|NCT00591825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6053025|NCT00591825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6053026|NCT00591825|Renal Agents|renal agents|mesh-ancestor
6053027|NCT00591825|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6053028|NCT00591825|Antitubercular Agents|antitubercular agents|mesh-ancestor
6053029|NCT00591825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6053030|NCT00591825|Antimetabolites|antimetabolites|mesh-ancestor
5501158|NCT04477018|Ascorbic Acid|ascorbic acid|mesh-list
5501159|NCT04477018|Iron|iron|mesh-list
5501160|NCT04477018|Chelating Agents|chelating agents|mesh-list
5501161|NCT04477018|Vitamins|vitamins|mesh-ancestor
5501162|NCT04477018|Micronutrients|micronutrients|mesh-ancestor
5501163|NCT04477018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5501164|NCT04477018|Trace Elements|trace elements|mesh-ancestor
5501165|NCT04477018|Antioxidants|antioxidants|mesh-ancestor
5503584|NCT04457765|Blood Substitutes|blood substitutes|mesh-ancestor
6053031|NCT00591825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053032|NCT00591851|Paclitaxel|paclitaxel|mesh-list
6053033|NCT00591851|Cyclophosphamide|cyclophosphamide|mesh-list
6053034|NCT00591851|Doxorubicin|doxorubicin|mesh-list
6053035|NCT00591851|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6053036|NCT00591851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6053037|NCT00591851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6053038|NCT00591851|Tubulin Modulators|tubulin modulators|mesh-ancestor
6053039|NCT00591851|Antimitotic Agents|antimitotic agents|mesh-ancestor
6053040|NCT00591851|Mitosis Modulators|mitosis modulators|mesh-ancestor
6053041|NCT00591851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053042|NCT00591851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6053043|NCT00591851|Immunologic Factors|immunologic factors|mesh-ancestor
6053044|NCT00591851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053045|NCT00591851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6053046|NCT00591851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6053047|NCT00591851|Alkylating Agents|alkylating agents|mesh-ancestor
6053048|NCT00591851|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6053049|NCT00591851|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6053050|NCT00591851|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6053051|NCT00591851|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6053052|NCT00591851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6053053|NCT00592072|Decanoic acid|decanoic acid|mesh-list
6053054|NCT00592072|Antifungal Agents|antifungal agents|mesh-ancestor
6053055|NCT00592072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5501166|NCT04477018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053056|NCT00592124|Tenofovir|tenofovir|mesh-list
6053057|NCT00592124|Antiviral Agents|antiviral agents|mesh-ancestor
6053058|NCT00592124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6053059|NCT00592124|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6053060|NCT00592124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6053061|NCT00592124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6053062|NCT00592124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053063|NCT00592124|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6053064|NCT00592124|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6053065|NCT00592176|Bevacizumab|bevacizumab|mesh-list
6053066|NCT00592176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6053067|NCT00592176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6053068|NCT00592176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6053069|NCT00592176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6053070|NCT00592176|Growth Substances|growth substances|mesh-ancestor
6053071|NCT00592176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053072|NCT00592176|Growth Inhibitors|growth inhibitors|mesh-ancestor
6053073|NCT00592319|Celecoxib|celecoxib|mesh-list
6053074|NCT00592319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6053075|NCT00592319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6053076|NCT00592319|Analgesics|analgesics|mesh-ancestor
6053077|NCT00592319|Sensory System Agents|sensory system agents|mesh-ancestor
6053078|NCT00592319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6053079|NCT00592319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053080|NCT00592319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6053081|NCT00592319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6053082|NCT00592319|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6053083|NCT00592319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6053084|NCT00592319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6053085|NCT00592319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053086|NCT00592358|Paliperidone Palmitate|paliperidone palmitate|mesh-list
5501167|NCT04477018|Protective Agents|protective agents|mesh-ancestor
5501168|NCT04477018|Sequestering Agents|sequestering agents|mesh-ancestor
5501169|NCT04476992|Nitric Oxide|nitric oxide|mesh-list
5501170|NCT04476992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6053087|NCT00592358|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6053088|NCT00592358|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6053089|NCT00592358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6053090|NCT00592358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053091|NCT00592358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6053092|NCT00592358|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6053093|NCT00592358|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6053094|NCT00592358|Serotonin Agents|serotonin agents|mesh-ancestor
6053095|NCT00592358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6053096|NCT00592358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053097|NCT00592358|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6053098|NCT00592358|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6053099|NCT00592358|Dopamine Agents|dopamine agents|mesh-ancestor
6053100|NCT00592384|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
5501171|NCT04476992|Autonomic Agents|autonomic agents|mesh-ancestor
5501172|NCT04476992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5501173|NCT04476992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053101|NCT00592384|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6053102|NCT00592384|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6053103|NCT00592384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6053104|NCT00592384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053105|NCT00592384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6053106|NCT00592384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053107|NCT00592384|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6053108|NCT00592384|Antidepressive Agents|antidepressive agents|mesh-ancestor
6053109|NCT00592384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6053110|NCT00592475|Conivaptan|conivaptan|mesh-list
6053111|NCT00592475|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6053112|NCT00592475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053113|NCT00592475|Natriuretic Agents|natriuretic agents|mesh-ancestor
6053114|NCT00592475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053115|NCT00592488|Acetylcarnitine|acetylcarnitine|mesh-list
6053116|NCT00592488|Vitamin B Complex|vitamin b complex|mesh-ancestor
6053117|NCT00592488|Vitamins|vitamins|mesh-ancestor
6053118|NCT00592488|Micronutrients|micronutrients|mesh-ancestor
6053119|NCT00592488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053120|NCT00592488|Nootropic Agents|nootropic agents|mesh-ancestor
6053121|NCT00592501|Fluorouracil|fluorouracil|mesh-list
6053122|NCT00592501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6053123|NCT00592501|Antimetabolites|antimetabolites|mesh-ancestor
6053124|NCT00592501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053125|NCT00592501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5501174|NCT04476992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5501175|NCT04476992|Respiratory System Agents|respiratory system agents|mesh-ancestor
6053126|NCT00592501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6053127|NCT00592501|Immunologic Factors|immunologic factors|mesh-ancestor
6053128|NCT00592501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053129|NCT00592683|Aripiprazole|aripiprazole|mesh-list
6053130|NCT00592683|Antidepressive Agents|antidepressive agents|mesh-ancestor
6053131|NCT00592683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6053132|NCT00592683|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6053133|NCT00592683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6053134|NCT00592683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6053135|NCT00592683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053136|NCT00592683|Dopamine Agonists|dopamine agonists|mesh-ancestor
6053137|NCT00592683|Dopamine Agents|dopamine agents|mesh-ancestor
6053138|NCT00592683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6053139|NCT00592683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053140|NCT00592683|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6053141|NCT00592683|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6053142|NCT00592683|Serotonin Agents|serotonin agents|mesh-ancestor
6053143|NCT00592683|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6053144|NCT00592683|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6053145|NCT00592683|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6053146|NCT00592683|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6053147|NCT00592839|Estrogens|estrogens|mesh-list
6053148|NCT00592839|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6053149|NCT00592839|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
6053150|NCT00592839|Estrogens, conjugated synthetic B|estrogens, conjugated synthetic b|mesh-list
6053151|NCT00592839|Hormones|hormones|mesh-ancestor
6053152|NCT00592839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6053153|NCT00592839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053154|NCT00592852|Fluoxetine|fluoxetine|mesh-list
6053155|NCT00592852|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6053156|NCT00592852|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6053157|NCT00592852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6053158|NCT00592852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053159|NCT00592852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6053160|NCT00592852|Serotonin Agents|serotonin agents|mesh-ancestor
6053161|NCT00592852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053162|NCT00592852|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6053163|NCT00592852|Antidepressive Agents|antidepressive agents|mesh-ancestor
6053164|NCT00592852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6053165|NCT00592852|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6053166|NCT00592852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6053167|NCT00592852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6053168|NCT00592943|Modafinil|modafinil|mesh-list
6053169|NCT00592943|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6053170|NCT00592943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053171|NCT00592943|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6053172|NCT00592943|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6053173|NCT00592943|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6053174|NCT00592943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053175|NCT00593112|Methylphenidate|methylphenidate|mesh-list
6053176|NCT00593112|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6053177|NCT00593112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053178|NCT00593112|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6053179|NCT00593112|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6053180|NCT00593112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6053181|NCT00593112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053182|NCT00593112|Dopamine Agents|dopamine agents|mesh-ancestor
6053183|NCT00593112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6053184|NCT00593450|Bevacizumab|bevacizumab|mesh-list
6053185|NCT00593450|Ranibizumab|ranibizumab|mesh-list
6053186|NCT00593450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6053187|NCT00593450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6053188|NCT00593450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6053189|NCT00593450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6053190|NCT00593450|Growth Substances|growth substances|mesh-ancestor
6053191|NCT00593450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053192|NCT00593450|Growth Inhibitors|growth inhibitors|mesh-ancestor
6053193|NCT00593489|Insulin|insulin|mesh-list
6053194|NCT00593489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6053195|NCT00593489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6053196|NCT00593554|Fludarabine|fludarabine|mesh-list
6053197|NCT00593554|Thiotepa|thiotepa|mesh-list
6053198|NCT00593554|Thymoglobulin|thymoglobulin|mesh-list
6053199|NCT00593554|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6053200|NCT00593554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6053201|NCT00593554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6053202|NCT00593554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6053203|NCT00593554|Immunologic Factors|immunologic factors|mesh-ancestor
5503687|NCT04456777|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5503688|NCT04456777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5503689|NCT04456712|Ciprofloxacin|ciprofloxacin|mesh-list
5503690|NCT04456712|Levofloxacin|levofloxacin|mesh-list
5503691|NCT04456712|Ofloxacin|ofloxacin|mesh-list
5503692|NCT04456712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5503693|NCT04456712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5503694|NCT04456712|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5503695|NCT04456712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6054338|NCT00602459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054339|NCT00602459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6054340|NCT00602459|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6054341|NCT00602459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6054342|NCT00602459|Antimetabolites|antimetabolites|mesh-ancestor
6054343|NCT00602459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6054344|NCT00602459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6054345|NCT00602459|Growth Substances|growth substances|mesh-ancestor
6054346|NCT00602459|Growth Inhibitors|growth inhibitors|mesh-ancestor
6054347|NCT00602472|Linagliptin|linagliptin|mesh-list
6054348|NCT00602472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6054349|NCT00602472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054350|NCT00602472|Incretins|incretins|mesh-ancestor
6054351|NCT00602472|Hormones|hormones|mesh-ancestor
6054352|NCT00602472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6054353|NCT00602472|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6054354|NCT00602472|Protease Inhibitors|protease inhibitors|mesh-ancestor
6054355|NCT00602472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6054356|NCT00602472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054357|NCT00602537|Lithium Carbonate|lithium carbonate|mesh-list
6054358|NCT00602537|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6054359|NCT00602537|Antidepressive Agents|antidepressive agents|mesh-ancestor
6054360|NCT00602537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6054361|NCT00602537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6054362|NCT00602537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054363|NCT00602537|Antimanic Agents|antimanic agents|mesh-ancestor
6054364|NCT00602537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6054365|NCT00602537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6054366|NCT00602537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054367|NCT00602537|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6054368|NCT00602537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6054369|NCT00602537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6054370|NCT00602537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6054371|NCT00602537|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6054372|NCT00602771|Etoposide|etoposide|mesh-list
6054373|NCT00602771|Etoposide phosphate|etoposide phosphate|mesh-list
6054374|NCT00602771|Tipifarnib|tipifarnib|mesh-list
6054375|NCT00602771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6054376|NCT00602771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6054377|NCT00602771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6054378|NCT00602771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6054379|NCT00602771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6054380|NCT00602771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054381|NCT00602797|Paclitaxel|paclitaxel|mesh-list
6054382|NCT00602797|Vinorelbine|vinorelbine|mesh-list
6054383|NCT00602797|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6054384|NCT00602797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6054385|NCT00602797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6054386|NCT00602797|Tubulin Modulators|tubulin modulators|mesh-ancestor
6054387|NCT00602797|Antimitotic Agents|antimitotic agents|mesh-ancestor
6054388|NCT00602797|Mitosis Modulators|mitosis modulators|mesh-ancestor
6054389|NCT00602797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054390|NCT00602836|Cyclophosphamide|cyclophosphamide|mesh-list
6054391|NCT00602836|Rituximab|rituximab|mesh-list
6054392|NCT00602836|Lenalidomide|lenalidomide|mesh-list
6054393|NCT00602836|Pentostatin|pentostatin|mesh-list
6054394|NCT00602836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5503696|NCT04456712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5503697|NCT04456712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503698|NCT04456712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5503699|NCT04456712|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5503700|NCT04456712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5503701|NCT04456712|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5600045|NCT03715023|PC-786|pc-786|mesh-list
6054395|NCT00602836|Immunologic Factors|immunologic factors|mesh-ancestor
6054396|NCT00602836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054397|NCT00602836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6054398|NCT00602836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6054399|NCT00602836|Alkylating Agents|alkylating agents|mesh-ancestor
6054400|NCT00602836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054401|NCT00602836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6054402|NCT00602836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6054403|NCT00602836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6054404|NCT00602836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6054405|NCT00602836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6054406|NCT00602836|Growth Substances|growth substances|mesh-ancestor
6054407|NCT00602836|Growth Inhibitors|growth inhibitors|mesh-ancestor
6054408|NCT00602836|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
6054409|NCT00602836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6054410|NCT00602927|Varenicline|varenicline|mesh-list
6054411|NCT00602927|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6054412|NCT00602927|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6054413|NCT00602927|Cholinergic Agents|cholinergic agents|mesh-ancestor
6054414|NCT00602927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6054415|NCT00602927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054416|NCT00602927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054417|NCT00603018|Fluoxetine|fluoxetine|mesh-list
6054418|NCT00603018|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6054419|NCT00603018|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6054420|NCT00603018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6054421|NCT00603018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054422|NCT00603018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6054423|NCT00603018|Serotonin Agents|serotonin agents|mesh-ancestor
6054424|NCT00603018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054425|NCT00603018|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6054426|NCT00603018|Antidepressive Agents|antidepressive agents|mesh-ancestor
6054427|NCT00603018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6054428|NCT00603018|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6054429|NCT00603018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6054430|NCT00603018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6054431|NCT00603044|Fluticasone|fluticasone|mesh-list
6054432|NCT00603044|Xhance|xhance|mesh-list
5503702|NCT04456712|Renal Agents|renal agents|mesh-ancestor
5503703|NCT04456439|Diphenhydramine|diphenhydramine|mesh-list
5503704|NCT04456439|Promethazine|promethazine|mesh-list
5503705|NCT04456439|Remestemcel-l|remestemcel-l|mesh-list
5503706|NCT04456439|Hydrocortisone|hydrocortisone|mesh-list
5503707|NCT04456439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5503708|NCT04456439|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5503709|NCT04456439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6054433|NCT00603044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6054434|NCT00603044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6054435|NCT00603044|Autonomic Agents|autonomic agents|mesh-ancestor
6054436|NCT00603044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6054437|NCT00603044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054438|NCT00603044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5503710|NCT04456439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5503711|NCT04456439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503712|NCT04456439|Anesthetics, Local|anesthetics, local|mesh-ancestor
5503713|NCT04456439|Anesthetics|anesthetics|mesh-ancestor
5503714|NCT04456439|Sensory System Agents|sensory system agents|mesh-ancestor
5503715|NCT04456439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5503716|NCT04456439|Antiemetics|antiemetics|mesh-ancestor
6054439|NCT00603044|Respiratory System Agents|respiratory system agents|mesh-ancestor
6054440|NCT00603044|Dermatologic Agents|dermatologic agents|mesh-ancestor
6054441|NCT00603044|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6054442|NCT00603187|Acyline|acyline|mesh-list
6054443|NCT00603187|Hormone Antagonists|hormone antagonists|mesh-ancestor
5503717|NCT04456439|Autonomic Agents|autonomic agents|mesh-ancestor
6054444|NCT00603187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6054445|NCT00603187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462246|NCT00458250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6462247|NCT00458250|Antifungal Agents|antifungal agents|mesh-ancestor
6462248|NCT00458250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6462249|NCT00458250|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6462250|NCT00458250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5503718|NCT04456439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6054446|NCT00603239|Exenatide|exenatide|mesh-list
6054447|NCT00603239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6054448|NCT00603239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054449|NCT00603239|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6054450|NCT00603239|Incretins|incretins|mesh-ancestor
5503719|NCT04456439|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5503720|NCT04456439|Histamine Antagonists|histamine antagonists|mesh-ancestor
5503721|NCT04456439|Histamine Agents|histamine agents|mesh-ancestor
5503722|NCT04456439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5503723|NCT04456439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054451|NCT00603239|Hormones|hormones|mesh-ancestor
6054452|NCT00603239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6054453|NCT00603265|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6054454|NCT00603265|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6054455|NCT00603265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6054456|NCT00603265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6054457|NCT00603265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054458|NCT00603265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6054459|NCT00603265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054460|NCT00603265|Analgesics|analgesics|mesh-ancestor
6054461|NCT00603265|Sensory System Agents|sensory system agents|mesh-ancestor
6054462|NCT00603265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6054463|NCT00603265|Antidepressive Agents|antidepressive agents|mesh-ancestor
6054464|NCT00603265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6054465|NCT00603265|Dopamine Agents|dopamine agents|mesh-ancestor
6054466|NCT00603304|Saw palmetto extract|saw palmetto extract|mesh-list
6054467|NCT00603304|Urological Agents|urological agents|mesh-ancestor
6054468|NCT00603408|Cisplatin|cisplatin|mesh-list
6054469|NCT00603408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6054470|NCT00603447|Dexamethasone|dexamethasone|mesh-list
6054471|NCT00603447|Lenalidomide|lenalidomide|mesh-list
6054472|NCT00603447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6054473|NCT00603447|Antiemetics|antiemetics|mesh-ancestor
6054474|NCT00603447|Autonomic Agents|autonomic agents|mesh-ancestor
6054475|NCT00603447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6054476|NCT00603447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054477|NCT00603447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6054478|NCT00603447|Glucocorticoids|glucocorticoids|mesh-ancestor
6054479|NCT00603447|Hormones|hormones|mesh-ancestor
6054480|NCT00603447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6054481|NCT00603447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6054482|NCT00603447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6054483|NCT00603447|Immunologic Factors|immunologic factors|mesh-ancestor
6054484|NCT00603447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5503724|NCT04456439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5503725|NCT04456439|Antipruritics|antipruritics|mesh-ancestor
5503726|NCT04456439|Dermatologic Agents|dermatologic agents|mesh-ancestor
5503727|NCT04456439|Antiviral Agents|antiviral agents|mesh-ancestor
6054485|NCT00603447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6054486|NCT00603447|Growth Substances|growth substances|mesh-ancestor
6054487|NCT00603447|Growth Inhibitors|growth inhibitors|mesh-ancestor
6054488|NCT00603473|Gabapentin|gabapentin|mesh-list
5503728|NCT04456439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5503729|NCT04456608|Aspirin|aspirin|mesh-list
5503730|NCT04456608|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5503731|NCT04456608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5503732|NCT04456608|Analgesics|analgesics|mesh-ancestor
6054489|NCT00603473|Analgesics|analgesics|mesh-ancestor
6054490|NCT00603473|Sensory System Agents|sensory system agents|mesh-ancestor
6054491|NCT00603473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5503733|NCT04456608|Sensory System Agents|sensory system agents|mesh-ancestor
5503734|NCT04456608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5503735|NCT04456608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054492|NCT00603473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503736|NCT04456608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5503737|NCT04456608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6054493|NCT00603473|Anticonvulsants|anticonvulsants|mesh-ancestor
6054494|NCT00603473|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6054495|NCT00603473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6054496|NCT00603473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6054497|NCT00603473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6054498|NCT00603473|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6054499|NCT00603473|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6054500|NCT00603473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6054501|NCT00603473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054502|NCT00603473|Antimanic Agents|antimanic agents|mesh-ancestor
6054503|NCT00603512|Tofacitinib|tofacitinib|mesh-list
6054504|NCT00603512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6054505|NCT00603512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6054506|NCT00603512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054507|NCT00603525|Ofatumumab|ofatumumab|mesh-list
6054508|NCT00603525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6054509|NCT00603538|Paclitaxel|paclitaxel|mesh-list
6054510|NCT00603538|Carboplatin|carboplatin|mesh-list
6054511|NCT00603538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6054512|NCT00603538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6054513|NCT00603538|Tubulin Modulators|tubulin modulators|mesh-ancestor
6054514|NCT00603538|Antimitotic Agents|antimitotic agents|mesh-ancestor
6054515|NCT00603538|Mitosis Modulators|mitosis modulators|mesh-ancestor
6054516|NCT00603538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054517|NCT00603720|Phenylephrine|phenylephrine|mesh-list
6054518|NCT00603720|Oxymetazoline|oxymetazoline|mesh-list
6054519|NCT00603720|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
6054520|NCT00603720|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6054521|NCT00603720|Mydriatics|mydriatics|mesh-ancestor
6054522|NCT00603720|Autonomic Agents|autonomic agents|mesh-ancestor
6054523|NCT00603720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6054524|NCT00603720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054525|NCT00603720|Sympathomimetics|sympathomimetics|mesh-ancestor
6054526|NCT00603720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6054527|NCT00603720|Nasal Decongestants|nasal decongestants|mesh-ancestor
6054528|NCT00603720|Respiratory System Agents|respiratory system agents|mesh-ancestor
6054529|NCT00603720|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6054530|NCT00603720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6054531|NCT00603720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6054532|NCT00603720|Adrenergic Agents|adrenergic agents|mesh-ancestor
6054533|NCT00603720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6054534|NCT00603720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054535|NCT00603720|Protective Agents|protective agents|mesh-ancestor
6054536|NCT00603720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6054537|NCT00603733|Mesalamine|mesalamine|mesh-list
6054538|NCT00603733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6054539|NCT00603733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6054540|NCT00603733|Analgesics|analgesics|mesh-ancestor
6054541|NCT00603733|Sensory System Agents|sensory system agents|mesh-ancestor
6054542|NCT00603733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6054543|NCT00603733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054544|NCT00603733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6054545|NCT00603733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6054546|NCT00603798|Imiquimod|imiquimod|mesh-list
6054547|NCT00603798|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6054548|NCT00603798|Immunologic Factors|immunologic factors|mesh-ancestor
6054549|NCT00603798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054550|NCT00603798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6054551|NCT00603798|Interferon Inducers|interferon inducers|mesh-ancestor
6201921|NCT02033369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6054552|NCT00603915|Gemcitabine|gemcitabine|mesh-list
6054553|NCT00603915|Carboplatin|carboplatin|mesh-list
6054554|NCT00603915|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6054555|NCT00603915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6054556|NCT00603915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6054557|NCT00603915|Antimetabolites|antimetabolites|mesh-ancestor
6054558|NCT00603915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054559|NCT00603915|Antiviral Agents|antiviral agents|mesh-ancestor
6054560|NCT00603915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6054561|NCT00603915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6054562|NCT00603915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6054563|NCT00603915|Immunologic Factors|immunologic factors|mesh-ancestor
6054564|NCT00603915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054565|NCT00603915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6054566|NCT00603941|Paclitaxel|paclitaxel|mesh-list
6054567|NCT00603941|Efatutazone|efatutazone|mesh-list
6054568|NCT00603941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6054569|NCT00603941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6054570|NCT00603941|Tubulin Modulators|tubulin modulators|mesh-ancestor
6054571|NCT00603941|Antimitotic Agents|antimitotic agents|mesh-ancestor
6054572|NCT00603941|Mitosis Modulators|mitosis modulators|mesh-ancestor
6054573|NCT00603941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054574|NCT00603980|Alprazolam|alprazolam|mesh-list
6054575|NCT00603980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6054576|NCT00603980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6054577|NCT00603980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054578|NCT00603980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6054579|NCT00603980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6054580|NCT00603980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6054581|NCT00603980|GABA Modulators|gaba modulators|mesh-ancestor
6054582|NCT00603980|GABA Agents|gaba agents|mesh-ancestor
6054583|NCT00603980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6054584|NCT00603980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054585|NCT00603993|Adalimumab|adalimumab|mesh-list
6054586|NCT00603993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6054587|NCT00603993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6054588|NCT00604019|Dopamine|dopamine|mesh-list
6054589|NCT00604019|Norepinephrine|norepinephrine|mesh-list
5503738|NCT04456608|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5503739|NCT04456608|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5503740|NCT04456608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503741|NCT04456608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5503742|NCT04456608|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5503743|NCT04456608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5503744|NCT04456608|Antipyretics|antipyretics|mesh-ancestor
5503745|NCT04456387|Factor VIII|factor viii|mesh-list
5503746|NCT04456387|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
5503747|NCT04456387|Coagulants|coagulants|mesh-ancestor
5503748|NCT04456387|Immunologic Factors|immunologic factors|mesh-ancestor
5503749|NCT04456387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054590|NCT00604019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6054591|NCT00604019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6054592|NCT00604019|Adrenergic Agents|adrenergic agents|mesh-ancestor
6054593|NCT00604019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6054594|NCT00604019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054595|NCT00604019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054596|NCT00604019|Sympathomimetics|sympathomimetics|mesh-ancestor
6054597|NCT00604019|Autonomic Agents|autonomic agents|mesh-ancestor
6054598|NCT00604019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6054599|NCT00604019|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6054600|NCT00604019|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6054601|NCT00604019|Dopamine Agents|dopamine agents|mesh-ancestor
6054602|NCT00604019|Protective Agents|protective agents|mesh-ancestor
6054603|NCT00604188|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6054604|NCT00604188|Buprenorphine|buprenorphine|mesh-list
6054605|NCT00604188|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6054606|NCT00604188|Narcotics|narcotics|mesh-ancestor
6054607|NCT00604188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6054608|NCT00604188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054609|NCT00604188|Analgesics|analgesics|mesh-ancestor
6054610|NCT00604188|Sensory System Agents|sensory system agents|mesh-ancestor
6054611|NCT00604188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6054612|NCT00604188|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6054613|NCT00604214|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
5503750|NCT04455932|Liver Extracts|liver extracts|mesh-list
6054614|NCT00604214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6054615|NCT00604279|Risperidone|risperidone|mesh-list
6054616|NCT00604279|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6054617|NCT00604279|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6054618|NCT00604279|Serotonin Agents|serotonin agents|mesh-ancestor
6054619|NCT00604279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6054620|NCT00604279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054621|NCT00604279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054622|NCT00604279|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6054623|NCT00604279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6054624|NCT00604279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6054625|NCT00604279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6054626|NCT00604279|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6054627|NCT00604279|Dopamine Agents|dopamine agents|mesh-ancestor
6054628|NCT00604279|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6054629|NCT00604279|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6054630|NCT00604383|Ruboxistaurin|ruboxistaurin|mesh-list
6054631|NCT00604383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6054632|NCT00604383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054633|NCT00604461|Bevacizumab|bevacizumab|mesh-list
6054634|NCT00604461|Carboplatin|carboplatin|mesh-list
6054635|NCT00604461|Pemetrexed|pemetrexed|mesh-list
6054636|NCT00604461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6054637|NCT00604461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6054638|NCT00604461|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6054639|NCT00604461|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6054640|NCT00604461|Growth Substances|growth substances|mesh-ancestor
6054641|NCT00604461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054642|NCT00604461|Growth Inhibitors|growth inhibitors|mesh-ancestor
6054643|NCT00604461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6054644|NCT00604461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054645|NCT00604461|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5503751|NCT04455932|Hematinics|hematinics|mesh-ancestor
5503752|NCT04455802|Morphine|morphine|mesh-list
5503753|NCT04455802|Buprenorphine|buprenorphine|mesh-list
5503754|NCT04455802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5503755|NCT04455802|Narcotics|narcotics|mesh-ancestor
5503756|NCT04455802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5503757|NCT04455802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503758|NCT04455802|Analgesics|analgesics|mesh-ancestor
5503759|NCT04455802|Sensory System Agents|sensory system agents|mesh-ancestor
5503760|NCT04455802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5503761|NCT04455802|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5503762|NCT04456088|Nitric Oxide|nitric oxide|mesh-list
5503763|NCT04456088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5503764|NCT04456088|Autonomic Agents|autonomic agents|mesh-ancestor
5503765|NCT04456088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5503766|NCT04456088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201922|NCT02033369|Dopamine Agonists|dopamine agonists|mesh-ancestor
5503767|NCT04456088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5503768|NCT04456088|Respiratory System Agents|respiratory system agents|mesh-ancestor
5503769|NCT04456088|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5503770|NCT04456088|Antioxidants|antioxidants|mesh-ancestor
5503771|NCT04456088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503772|NCT04456088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5503773|NCT04456088|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5503774|NCT04456088|Vasodilator Agents|vasodilator agents|mesh-ancestor
5503775|NCT04456088|Gasotransmitters|gasotransmitters|mesh-ancestor
5503776|NCT04456088|Protective Agents|protective agents|mesh-ancestor
5503777|NCT04455711|Lidocaine|lidocaine|mesh-list
5503778|NCT04455711|Remifentanil|remifentanil|mesh-list
5503779|NCT04455711|Anesthetics, Local|anesthetics, local|mesh-ancestor
5503780|NCT04455711|Anesthetics|anesthetics|mesh-ancestor
5503781|NCT04455711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5503782|NCT04455711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503783|NCT04455711|Sensory System Agents|sensory system agents|mesh-ancestor
6054646|NCT00604461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6054647|NCT00604695|Tenecteplase|tenecteplase|mesh-list
6054648|NCT00604695|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6054649|NCT00604695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6054650|NCT00604695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054651|NCT00604708|Vaccines|vaccines|mesh-list
6054652|NCT00604708|Immunologic Factors|immunologic factors|mesh-ancestor
6054653|NCT00604708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054654|NCT00604786|Omalizumab|omalizumab|mesh-list
6054655|NCT00604786|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6054656|NCT00604786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6054657|NCT00604786|Respiratory System Agents|respiratory system agents|mesh-ancestor
6054658|NCT00604825|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6054659|NCT00604825|Estrogens|estrogens|mesh-ancestor
6054660|NCT00604825|Hormones|hormones|mesh-ancestor
6054661|NCT00604825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6054662|NCT00604825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054663|NCT00604968|Doxorubicin|doxorubicin|mesh-list
6054664|NCT00604968|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6054665|NCT00604968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6054666|NCT00604968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6054667|NCT00604968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6054668|NCT00604968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6054669|NCT00604968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6054670|NCT00604968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054671|NCT00605033|Buprenorphine|buprenorphine|mesh-list
6054672|NCT00605033|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6054673|NCT00605033|Naloxone|naloxone|mesh-list
6054674|NCT00605033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6054675|NCT00605033|Narcotics|narcotics|mesh-ancestor
6054676|NCT00605033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6054677|NCT00605033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054678|NCT00605033|Analgesics|analgesics|mesh-ancestor
6054679|NCT00605033|Sensory System Agents|sensory system agents|mesh-ancestor
6665149|NCT01515839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6665150|NCT01515839|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6665151|NCT01515839|Antiviral Agents|antiviral agents|mesh-ancestor
6665152|NCT01515839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6665153|NCT01515839|Expectorants|expectorants|mesh-ancestor
6054680|NCT00605033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6054681|NCT00605033|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6054682|NCT00605072|Metoprolol|metoprolol|mesh-list
6054683|NCT00605072|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6054684|NCT00605072|Candesartan|candesartan|mesh-list
6054685|NCT00605072|Lisinopril|lisinopril|mesh-list
6054686|NCT00605072|Nifedipine|nifedipine|mesh-list
6054687|NCT00605072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6054688|NCT00605072|Diuretics|diuretics|mesh-ancestor
6054689|NCT00605072|Natriuretic Agents|natriuretic agents|mesh-ancestor
6054690|NCT00605072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054691|NCT00605072|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6054692|NCT00605072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6054693|NCT00605072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054694|NCT00605072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6054695|NCT00605072|Sympatholytics|sympatholytics|mesh-ancestor
6054696|NCT00605072|Autonomic Agents|autonomic agents|mesh-ancestor
6054697|NCT00605072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6054698|NCT00605072|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6054699|NCT00605072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6054700|NCT00605072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6054701|NCT00605072|Adrenergic Agents|adrenergic agents|mesh-ancestor
6054702|NCT00605072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6054703|NCT00605072|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6054704|NCT00605072|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6054705|NCT00605072|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6054706|NCT00605072|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6054707|NCT00605072|Vasodilator Agents|vasodilator agents|mesh-ancestor
6054708|NCT00605072|Tocolytic Agents|tocolytic agents|mesh-ancestor
6054709|NCT00605072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6054710|NCT00605072|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6665154|NCT01515839|Respiratory System Agents|respiratory system agents|mesh-ancestor
6054711|NCT00605072|Protease Inhibitors|protease inhibitors|mesh-ancestor
6054712|NCT00605072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6054713|NCT00605072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6054714|NCT00605072|Protective Agents|protective agents|mesh-ancestor
6054715|NCT00605176|Imiquimod|imiquimod|mesh-list
6054716|NCT00605176|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6054717|NCT00605176|Immunologic Factors|immunologic factors|mesh-ancestor
6054718|NCT00605176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054719|NCT00605176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6054720|NCT00605176|Interferon Inducers|interferon inducers|mesh-ancestor
5503784|NCT04455711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5503785|NCT04455711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5503786|NCT04455711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5503787|NCT04455711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5503788|NCT04455711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5503789|NCT04455711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503790|NCT04455711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6054721|NCT00605202|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6054722|NCT00605202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6054723|NCT00605202|Diuretics|diuretics|mesh-ancestor
6054724|NCT00605202|Natriuretic Agents|natriuretic agents|mesh-ancestor
6054725|NCT00605202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054726|NCT00605202|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6054727|NCT00605202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6054728|NCT00605202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054729|NCT00605267|Tamoxifen|tamoxifen|mesh-list
6054730|NCT00605267|Goserelin|goserelin|mesh-list
6054731|NCT00605267|Anastrozole|anastrozole|mesh-list
6054732|NCT00605267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6054733|NCT00605267|Hormone Antagonists|hormone antagonists|mesh-ancestor
6054734|NCT00605267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6054735|NCT00605267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054736|NCT00605267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6054737|NCT00605267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6054738|NCT00605267|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6054739|NCT00605267|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6054740|NCT00605267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6054741|NCT00605267|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6054742|NCT00605267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6054743|NCT00605267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6054744|NCT00605267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054745|NCT00605293|Epoetin Alfa|epoetin alfa|mesh-list
6054746|NCT00605293|Hematinics|hematinics|mesh-ancestor
6054747|NCT00605306|Mometasone Furoate|mometasone furoate|mesh-list
6054748|NCT00605306|Maleic acid|maleic acid|mesh-list
6054749|NCT00605306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6054750|NCT00605306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054751|NCT00605306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6054752|NCT00605306|Dermatologic Agents|dermatologic agents|mesh-ancestor
6054753|NCT00605306|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6054754|NCT00605319|Fesoterodine|fesoterodine|mesh-list
6054755|NCT00605319|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6054756|NCT00605319|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6054757|NCT00605319|Cholinergic Agents|cholinergic agents|mesh-ancestor
6054758|NCT00605319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6054759|NCT00605319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054760|NCT00605319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054761|NCT00605319|Urological Agents|urological agents|mesh-ancestor
6054762|NCT00605345|Darbepoetin alfa|darbepoetin alfa|mesh-list
6054763|NCT00605345|Hematinics|hematinics|mesh-ancestor
6054764|NCT00605384|Tenofovir|tenofovir|mesh-list
6054765|NCT00605384|Lamivudine|lamivudine|mesh-list
6054766|NCT00605384|Entecavir|entecavir|mesh-list
6054767|NCT00605384|Adefovir|adefovir|mesh-list
6054768|NCT00605384|Antiviral Agents|antiviral agents|mesh-ancestor
6054769|NCT00605384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6054770|NCT00605384|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6054771|NCT00605384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6054772|NCT00605384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6054773|NCT00605384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054774|NCT00605384|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6054775|NCT00605384|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6054776|NCT00605423|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
6054777|NCT00605423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6054778|NCT00605423|Glucocorticoids|glucocorticoids|mesh-ancestor
6054779|NCT00605423|Hormones|hormones|mesh-ancestor
6054780|NCT00605423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6054781|NCT00605423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054782|NCT00605475|Metformin|metformin|mesh-list
6054783|NCT00605475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6054784|NCT00605475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054785|NCT00605566|Cyclophosphamide|cyclophosphamide|mesh-list
5503791|NCT04455711|Narcotics|narcotics|mesh-ancestor
5503792|NCT04455711|Analgesics|analgesics|mesh-ancestor
5503793|NCT04455555|Rotigotine|rotigotine|mesh-list
5503794|NCT04455555|Dopamine Agonists|dopamine agonists|mesh-ancestor
5503795|NCT04455555|Dopamine Agents|dopamine agents|mesh-ancestor
5503796|NCT04455555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5503797|NCT04455555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503798|NCT04455555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503799|NCT04455477|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
5503800|NCT04455477|Natriuretic Agents|natriuretic agents|mesh-ancestor
5503801|NCT04455477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600046|NCT03715023|Antiviral Agents|antiviral agents|mesh-ancestor
5600047|NCT03715023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5600048|NCT03715023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6054786|NCT00605566|Sorafenib|sorafenib|mesh-list
6054787|NCT00605566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6054788|NCT00605566|Immunologic Factors|immunologic factors|mesh-ancestor
6054789|NCT00605566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054790|NCT00605566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6054791|NCT00605566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6054792|NCT00605566|Alkylating Agents|alkylating agents|mesh-ancestor
6054793|NCT00605566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054794|NCT00605566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6054795|NCT00605566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6054796|NCT00605566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6054797|NCT00605566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6054798|NCT00605657|Valproic Acid|valproic acid|mesh-list
6054799|NCT00605657|Anticonvulsants|anticonvulsants|mesh-ancestor
6054800|NCT00605657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5600049|NCT03715023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600050|NCT03714958|Trametinib|trametinib|mesh-list
5600051|NCT03714958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5600052|NCT03714958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6054801|NCT00605657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054802|NCT00605657|GABA Agents|gaba agents|mesh-ancestor
6054803|NCT00605657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6054804|NCT00605657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054805|NCT00605657|Antimanic Agents|antimanic agents|mesh-ancestor
6054806|NCT00605657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6054807|NCT00605657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6054808|NCT00605657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6054809|NCT00605696|Insulin|insulin|mesh-list
6054810|NCT00605696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6054811|NCT00605696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054812|NCT00605722|Bevacizumab|bevacizumab|mesh-list
6054813|NCT00605722|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6054814|NCT00605722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6054815|NCT00605722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6054816|NCT00605722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6054817|NCT00605722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6054818|NCT00605722|Growth Substances|growth substances|mesh-ancestor
6054819|NCT00605722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054820|NCT00605722|Growth Inhibitors|growth inhibitors|mesh-ancestor
6054821|NCT00605722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6054822|NCT00605722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5600053|NCT03714958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6054823|NCT00605722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054824|NCT00605813|Sertraline|sertraline|mesh-list
5503802|NCT04455594|Carboplatin|carboplatin|mesh-list
5503803|NCT04455594|Pemetrexed|pemetrexed|mesh-list
6054825|NCT00605813|Antidepressive Agents|antidepressive agents|mesh-ancestor
6054826|NCT00605813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6054827|NCT00605813|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6054828|NCT00605813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6054829|NCT00605813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6054830|NCT00605813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054831|NCT00605813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6054832|NCT00605813|Serotonin Agents|serotonin agents|mesh-ancestor
6054833|NCT00605813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054834|NCT00605865|Sertraline|sertraline|mesh-list
6054835|NCT00605865|Antidepressive Agents|antidepressive agents|mesh-ancestor
6054836|NCT00605865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6054837|NCT00605865|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6054838|NCT00605865|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6054839|NCT00605865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6054840|NCT00605865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054841|NCT00605865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6054842|NCT00605865|Serotonin Agents|serotonin agents|mesh-ancestor
6054843|NCT00605865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054844|NCT00605904|Acamprosate|acamprosate|mesh-list
6054845|NCT00605904|Yohimbine|yohimbine|mesh-list
6054846|NCT00605904|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6054847|NCT00605904|Mydriatics|mydriatics|mesh-ancestor
6054848|NCT00605904|Autonomic Agents|autonomic agents|mesh-ancestor
6054849|NCT00605904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6054850|NCT00605904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054851|NCT00605904|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6054852|NCT00605904|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6054853|NCT00605904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6054854|NCT00605904|Adrenergic Agents|adrenergic agents|mesh-ancestor
6054855|NCT00605904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6054856|NCT00605904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054857|NCT00605904|Urological Agents|urological agents|mesh-ancestor
6054858|NCT00605917|Sertraline|sertraline|mesh-list
6054859|NCT00605917|Antidepressive Agents|antidepressive agents|mesh-ancestor
6054860|NCT00605917|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6054861|NCT00605917|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6054862|NCT00605917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6054863|NCT00605917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6054864|NCT00605917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054865|NCT00605917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6462251|NCT00458263|Hormones|hormones|mesh-list
6462252|NCT00458263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5503804|NCT04455594|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6462253|NCT00458263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462254|NCT00458315|Gemcitabine|gemcitabine|mesh-list
6462255|NCT00458315|Paclitaxel|paclitaxel|mesh-list
6462256|NCT00458315|Bevacizumab|bevacizumab|mesh-list
6462257|NCT00458315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5503805|NCT04455594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5503806|NCT04455594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5503807|NCT04455594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503808|NCT04455594|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5503809|NCT04455594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5503810|NCT04455594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5503811|NCT04455958|Ritonavir|ritonavir|mesh-list
5503812|NCT04455958|Lopinavir|lopinavir|mesh-list
5503813|NCT04455958|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5503814|NCT04455958|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5503815|NCT04455958|Protease Inhibitors|protease inhibitors|mesh-ancestor
5503816|NCT04455958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5503817|NCT04455958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503818|NCT04455958|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5503819|NCT04455958|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5503820|NCT04455958|Antiviral Agents|antiviral agents|mesh-ancestor
5503821|NCT04455958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5503822|NCT04455958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5503823|NCT04455958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5503824|NCT04455126|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5503825|NCT04455126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5503826|NCT04455243|Acetylcysteine|acetylcysteine|mesh-list
5503827|NCT04455243|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5503828|NCT04455243|Antiviral Agents|antiviral agents|mesh-ancestor
5503829|NCT04455243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6462258|NCT00458315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6462259|NCT00458315|Tubulin Modulators|tubulin modulators|mesh-ancestor
6462260|NCT00458315|Antimitotic Agents|antimitotic agents|mesh-ancestor
6462261|NCT00458315|Mitosis Modulators|mitosis modulators|mesh-ancestor
6462262|NCT00458315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462263|NCT00458315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6462264|NCT00458315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6462265|NCT00458315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6054866|NCT00605917|Serotonin Agents|serotonin agents|mesh-ancestor
6054867|NCT00605917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054868|NCT00606008|Sunitinib|sunitinib|mesh-list
6054869|NCT00606008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6054870|NCT00606008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6054871|NCT00606008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6054872|NCT00606008|Growth Substances|growth substances|mesh-ancestor
6462266|NCT00458315|Growth Substances|growth substances|mesh-ancestor
6462267|NCT00458315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462268|NCT00458315|Growth Inhibitors|growth inhibitors|mesh-ancestor
6462269|NCT00458315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6462270|NCT00458315|Antimetabolites|antimetabolites|mesh-ancestor
6054873|NCT00606008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054874|NCT00606008|Growth Inhibitors|growth inhibitors|mesh-ancestor
6054875|NCT00606008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6054876|NCT00606008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6054877|NCT00606008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054878|NCT00606021|Pemetrexed|pemetrexed|mesh-list
6054879|NCT00606021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6054880|NCT00606021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6054881|NCT00606021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503830|NCT04455243|Expectorants|expectorants|mesh-ancestor
5503831|NCT04455243|Respiratory System Agents|respiratory system agents|mesh-ancestor
5503832|NCT04455243|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5503833|NCT04455243|Antioxidants|antioxidants|mesh-ancestor
5503834|NCT04455243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503835|NCT04455243|Protective Agents|protective agents|mesh-ancestor
5503836|NCT04455243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503837|NCT04455243|Antidotes|antidotes|mesh-ancestor
6054882|NCT00606021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6054883|NCT00606021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6054884|NCT00606034|Insulin|insulin|mesh-list
6054885|NCT00606034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6054886|NCT00606034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054887|NCT00606086|Interferons|interferons|mesh-list
6054888|NCT00606086|Ribavirin|ribavirin|mesh-list
6054889|NCT00606086|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6054890|NCT00606086|Interferon-alpha|interferon-alpha|mesh-list
6054891|NCT00606086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6462271|NCT00458315|Antiviral Agents|antiviral agents|mesh-ancestor
6462272|NCT00458315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6054892|NCT00606086|Antiviral Agents|antiviral agents|mesh-ancestor
5503838|NCT04454775|Protein C|protein c|mesh-list
5503839|NCT04454775|Antithrombins|antithrombins|mesh-list
6054893|NCT00606086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6054894|NCT00606086|Antimetabolites|antimetabolites|mesh-ancestor
6054895|NCT00606086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054896|NCT00606086|Immunologic Factors|immunologic factors|mesh-ancestor
6054897|NCT00606086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054898|NCT00606138|Ranibizumab|ranibizumab|mesh-list
6054899|NCT00606138|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6054900|NCT00606138|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6054901|NCT00606138|Growth Substances|growth substances|mesh-ancestor
6054902|NCT00606138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054903|NCT00606138|Growth Inhibitors|growth inhibitors|mesh-ancestor
5503840|NCT04454775|Antithrombin III|antithrombin iii|mesh-list
5503841|NCT04454775|Protein S|protein s|mesh-list
5503842|NCT04454775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5503843|NCT04454775|Protease Inhibitors|protease inhibitors|mesh-ancestor
5503844|NCT04454775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5503845|NCT04454775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503846|NCT04454775|Anticoagulants|anticoagulants|mesh-ancestor
5503847|NCT04454775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5503848|NCT04454775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5503849|NCT04454840|Riluzole|riluzole|mesh-list
6462273|NCT00458315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6462274|NCT00458315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6462275|NCT00458315|Immunologic Factors|immunologic factors|mesh-ancestor
6054904|NCT00606138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6054905|NCT00606177|Aripiprazole|aripiprazole|mesh-list
6054906|NCT00606177|Antidepressive Agents|antidepressive agents|mesh-ancestor
6054907|NCT00606177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6054908|NCT00606177|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6054909|NCT00606177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6054910|NCT00606177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6054911|NCT00606177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054912|NCT00606177|Dopamine Agonists|dopamine agonists|mesh-ancestor
6054913|NCT00606177|Dopamine Agents|dopamine agents|mesh-ancestor
6054914|NCT00606177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6054915|NCT00606177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054916|NCT00606177|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6054917|NCT00606177|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6054918|NCT00606177|Serotonin Agents|serotonin agents|mesh-ancestor
6054919|NCT00606177|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6054920|NCT00606177|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6054921|NCT00606177|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6054922|NCT00606177|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6054923|NCT00606229|Aripiprazole|aripiprazole|mesh-list
6054924|NCT00606229|Antidepressive Agents|antidepressive agents|mesh-ancestor
6054925|NCT00606229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6054926|NCT00606229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6054927|NCT00606229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6054928|NCT00606229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6054929|NCT00606229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054930|NCT00606229|Dopamine Agonists|dopamine agonists|mesh-ancestor
6054931|NCT00606229|Dopamine Agents|dopamine agents|mesh-ancestor
6054932|NCT00606229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6054933|NCT00606229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054934|NCT00606229|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6054935|NCT00606229|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6054936|NCT00606229|Serotonin Agents|serotonin agents|mesh-ancestor
6054937|NCT00606229|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6054938|NCT00606229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5503850|NCT04454840|Anticonvulsants|anticonvulsants|mesh-ancestor
6054939|NCT00606229|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6054940|NCT00606229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6462276|NCT00458328|Z 338|z 338|mesh-list
6054941|NCT00606281|Aripiprazole|aripiprazole|mesh-list
6054942|NCT00606281|Antidepressive Agents|antidepressive agents|mesh-ancestor
6054943|NCT00606281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6054944|NCT00606281|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6054945|NCT00606281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6054946|NCT00606281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6054947|NCT00606281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054948|NCT00606281|Dopamine Agonists|dopamine agonists|mesh-ancestor
6054949|NCT00606281|Dopamine Agents|dopamine agents|mesh-ancestor
6054950|NCT00606281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6054951|NCT00606281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054952|NCT00606281|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6054953|NCT00606281|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6054954|NCT00606281|Serotonin Agents|serotonin agents|mesh-ancestor
6054955|NCT00606281|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6054956|NCT00606281|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6054957|NCT00606281|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6054958|NCT00606281|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6054959|NCT00606294|Misonidazole|misonidazole|mesh-list
6054960|NCT00606294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6054961|NCT00606294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6054962|NCT00606294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6054963|NCT00606294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6054964|NCT00606307|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
6054965|NCT00606307|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6054966|NCT00606307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6054967|NCT00606307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054968|NCT00606320|Aripiprazole|aripiprazole|mesh-list
6054969|NCT00606320|Antidepressive Agents|antidepressive agents|mesh-ancestor
6054970|NCT00606320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6054971|NCT00606320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6054972|NCT00606320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6054973|NCT00606320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6054974|NCT00606320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054975|NCT00606320|Dopamine Agonists|dopamine agonists|mesh-ancestor
6054976|NCT00606320|Dopamine Agents|dopamine agents|mesh-ancestor
6054977|NCT00606320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6054978|NCT00606320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054979|NCT00606320|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6054980|NCT00606320|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6054981|NCT00606320|Serotonin Agents|serotonin agents|mesh-ancestor
6054982|NCT00606320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6054983|NCT00606320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6054984|NCT00606320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6054985|NCT00606320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6054986|NCT00606489|Ibuprofen|ibuprofen|mesh-list
6054987|NCT00606489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6054988|NCT00606489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6054989|NCT00606489|Analgesics|analgesics|mesh-ancestor
6054990|NCT00606489|Sensory System Agents|sensory system agents|mesh-ancestor
6054991|NCT00606489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6054992|NCT00606489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6054993|NCT00606489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6054994|NCT00606489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6054995|NCT00606489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6054996|NCT00606489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6054997|NCT00606489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6054998|NCT00606502|Vitamins|vitamins|mesh-list
6054999|NCT00606502|Folic Acid|folic acid|mesh-list
6055000|NCT00606502|Vitamin B 12|vitamin b 12|mesh-list
6055001|NCT00606502|Hydroxocobalamin|hydroxocobalamin|mesh-list
6055002|NCT00606502|Vitamin B Complex|vitamin b complex|mesh-list
6055003|NCT00606502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6055004|NCT00606502|10-deazaaminopterin|10-deazaaminopterin|mesh-list
6055005|NCT00606502|Micronutrients|micronutrients|mesh-ancestor
6055006|NCT00606502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055007|NCT00606502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6055008|NCT00606502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6055009|NCT00606502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6055010|NCT00606502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503851|NCT04454840|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5503852|NCT04454840|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5503853|NCT04454840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5503854|NCT04454840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503855|NCT04454840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055011|NCT00606502|Hematinics|hematinics|mesh-ancestor
6055012|NCT00606502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6055013|NCT00606580|Paromomycin|paromomycin|mesh-list
6055014|NCT00606580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6055015|NCT00606580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6055016|NCT00606580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6055017|NCT00606580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6055018|NCT00606801|Galantamine|galantamine|mesh-list
6055019|NCT00606801|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6055020|NCT00606801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6055021|NCT00606801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6055022|NCT00606801|Cholinergic Agents|cholinergic agents|mesh-ancestor
6055023|NCT00606801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6055024|NCT00606801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055025|NCT00606801|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6055026|NCT00606801|Autonomic Agents|autonomic agents|mesh-ancestor
6055027|NCT00606801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6055028|NCT00606801|Nootropic Agents|nootropic agents|mesh-ancestor
6055029|NCT00606892|Nicotine|nicotine|mesh-list
6055030|NCT00606892|Varenicline|varenicline|mesh-list
6055031|NCT00606892|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6055032|NCT00606892|Autonomic Agents|autonomic agents|mesh-ancestor
6055033|NCT00606892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6055034|NCT00606892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055035|NCT00606892|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6055036|NCT00606892|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6055037|NCT00606892|Cholinergic Agents|cholinergic agents|mesh-ancestor
6055038|NCT00606892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6055039|NCT00606892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6055040|NCT00606905|Immunoglobulins|immunoglobulins|mesh-list
6055041|NCT00606905|gamma-Globulins|gamma-globulins|mesh-list
6055042|NCT00606905|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6055043|NCT00606905|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6055044|NCT00606905|Immunologic Factors|immunologic factors|mesh-ancestor
6055045|NCT00606905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055046|NCT00607048|Paclitaxel|paclitaxel|mesh-list
6055047|NCT00607048|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6055048|NCT00607048|Carboplatin|carboplatin|mesh-list
6055049|NCT00607048|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6055050|NCT00607048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6055051|NCT00607048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6055052|NCT00607048|Tubulin Modulators|tubulin modulators|mesh-ancestor
6055053|NCT00607048|Antimitotic Agents|antimitotic agents|mesh-ancestor
6055054|NCT00607048|Mitosis Modulators|mitosis modulators|mesh-ancestor
6055055|NCT00607048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6055056|NCT00607048|Immunologic Factors|immunologic factors|mesh-ancestor
6055057|NCT00607048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055058|NCT00607087|Insulin|insulin|mesh-list
6055059|NCT00607087|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6055060|NCT00607087|Insulin Aspart|insulin aspart|mesh-list
6055061|NCT00607087|Insulin Lispro|insulin lispro|mesh-list
6055062|NCT00607087|Insulin glulisine|insulin glulisine|mesh-list
6055063|NCT00607087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6055064|NCT00607087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055065|NCT00607113|Bevacizumab|bevacizumab|mesh-list
6055066|NCT00607113|Everolimus|everolimus|mesh-list
6055067|NCT00607113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6055068|NCT00607113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6055069|NCT00607113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6055070|NCT00607113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6055071|NCT00607113|Growth Substances|growth substances|mesh-ancestor
6055072|NCT00607113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055073|NCT00607113|Growth Inhibitors|growth inhibitors|mesh-ancestor
6055074|NCT00607113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6055075|NCT00607113|Immunologic Factors|immunologic factors|mesh-ancestor
6055076|NCT00607373|Mipomersen|mipomersen|mesh-list
6055077|NCT00607373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6055078|NCT00607373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6055079|NCT00607373|Antimetabolites|antimetabolites|mesh-ancestor
6055080|NCT00607373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6055081|NCT00607373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6055082|NCT00607594|Saracatinib|saracatinib|mesh-list
6055083|NCT00607594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6055084|NCT00607594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6055085|NCT00607594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503856|NCT04454840|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5503857|NCT04454840|Protective Agents|protective agents|mesh-ancestor
5503858|NCT04454788|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5503859|NCT04454788|Tenecteplase|tenecteplase|mesh-list
5503860|NCT04454788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5503861|NCT04454788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5503862|NCT04454788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503863|NCT04454515|Dexmedetomidine|dexmedetomidine|mesh-list
6055086|NCT00607672|Candesartan|candesartan|mesh-list
6055087|NCT00607672|Ramipril|ramipril|mesh-list
6055088|NCT00607672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6055089|NCT00607672|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6055090|NCT00607672|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5503864|NCT04454515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5503865|NCT04454515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5503866|NCT04454515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503867|NCT04454515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5503868|NCT04454515|Analgesics|analgesics|mesh-ancestor
6055091|NCT00607672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6055092|NCT00607672|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6055093|NCT00607672|Protease Inhibitors|protease inhibitors|mesh-ancestor
6055094|NCT00607672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6055095|NCT00607789|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6055096|NCT00607789|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6055097|NCT00607789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6055098|NCT00607789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6055099|NCT00607789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6055100|NCT00607789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6055101|NCT00607789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055102|NCT00607789|Analgesics|analgesics|mesh-ancestor
6055103|NCT00607789|Sensory System Agents|sensory system agents|mesh-ancestor
6055104|NCT00607789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6055105|NCT00607789|Antidepressive Agents|antidepressive agents|mesh-ancestor
6055106|NCT00607789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6055107|NCT00607789|Dopamine Agents|dopamine agents|mesh-ancestor
6055108|NCT00607919|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6055109|NCT00607919|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6055110|NCT00607919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6055111|NCT00607919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6201923|NCT02033369|Dopamine Agents|dopamine agents|mesh-ancestor
6665155|NCT01515839|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6665156|NCT01515839|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6665157|NCT01515839|Vasodilator Agents|vasodilator agents|mesh-ancestor
6665158|NCT01515852|Anesthetics|anesthetics|mesh-list
6665159|NCT01515852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6665160|NCT01515852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665161|NCT01515917|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
6665162|NCT01515917|Nootropic Agents|nootropic agents|mesh-ancestor
6665163|NCT01515969|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5503869|NCT04454515|Sensory System Agents|sensory system agents|mesh-ancestor
5503870|NCT04454515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5503871|NCT04454515|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5503872|NCT04454515|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5503873|NCT04454515|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5503874|NCT04454515|Adrenergic Agents|adrenergic agents|mesh-ancestor
5503875|NCT04454515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5503876|NCT04454515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503877|NCT04454619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5503878|NCT04454580|Azacitidine|azacitidine|mesh-list
5503879|NCT04454580|Decitabine|decitabine|mesh-list
5503880|NCT04454580|Venetoclax|venetoclax|mesh-list
5503881|NCT04454580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5503882|NCT04454580|Antimetabolites|antimetabolites|mesh-ancestor
5503883|NCT04454580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665164|NCT01515969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6665165|NCT01515969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6055112|NCT00607919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503884|NCT04454580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5503885|NCT04454580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5503886|NCT04454567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
5503887|NCT04454567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6055113|NCT00607919|Adrenergic Agents|adrenergic agents|mesh-ancestor
6055114|NCT00607919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6055115|NCT00607919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055116|NCT00608023|Tesamorelin|tesamorelin|mesh-list
6055117|NCT00608023|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
6055118|NCT00608023|Growth Substances|growth substances|mesh-ancestor
6055119|NCT00608023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055120|NCT00608023|Hormones|hormones|mesh-ancestor
6055121|NCT00608023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6055122|NCT00608062|Estradiol|estradiol|mesh-list
6055123|NCT00608062|Ganirelix|ganirelix|mesh-list
6055124|NCT00608062|Estrogens|estrogens|mesh-ancestor
6055125|NCT00608062|Hormones|hormones|mesh-ancestor
6055126|NCT00608062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6055127|NCT00608062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503888|NCT04454567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6055128|NCT00608062|Hormone Antagonists|hormone antagonists|mesh-ancestor
6201924|NCT02033369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6201925|NCT02033876|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
6201926|NCT02033876|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6201927|NCT02033876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6201928|NCT02033889|Insulin|insulin|mesh-list
6201929|NCT02033889|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6201930|NCT02033889|Metformin|metformin|mesh-list
6201931|NCT02033889|Insulin Glargine|insulin glargine|mesh-list
6201932|NCT02033889|Glimepiride|glimepiride|mesh-list
6201933|NCT02033889|Insulin Detemir|insulin detemir|mesh-list
6201934|NCT02033889|Ertugliflozin|ertugliflozin|mesh-list
6201935|NCT02033889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6201936|NCT02033889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201937|NCT02033889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6201938|NCT02033889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6201939|NCT02033889|Immunologic Factors|immunologic factors|mesh-ancestor
6201940|NCT02033889|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6201941|NCT02033889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201942|NCT02033993|Paclitaxel|paclitaxel|mesh-list
6201943|NCT02033993|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6201944|NCT02033993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6201945|NCT02033993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6201946|NCT02033993|Tubulin Modulators|tubulin modulators|mesh-ancestor
6201947|NCT02033993|Antimitotic Agents|antimitotic agents|mesh-ancestor
6201948|NCT02033993|Mitosis Modulators|mitosis modulators|mesh-ancestor
6201949|NCT02033993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201950|NCT02034006|Ranibizumab|ranibizumab|mesh-list
6201951|NCT02034006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6201952|NCT02034006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6201953|NCT02034006|Growth Substances|growth substances|mesh-ancestor
6201954|NCT02034006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201955|NCT02034006|Growth Inhibitors|growth inhibitors|mesh-ancestor
5503889|NCT04454567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503890|NCT04454567|Antiviral Agents|antiviral agents|mesh-ancestor
5503891|NCT04454567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5503892|NCT04454307|Tramadol|tramadol|mesh-list
5503893|NCT04454307|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5503894|NCT04454307|Narcotics|narcotics|mesh-ancestor
5503895|NCT04454307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5503896|NCT04454307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503897|NCT04454307|Analgesics|analgesics|mesh-ancestor
5503898|NCT04454307|Sensory System Agents|sensory system agents|mesh-ancestor
5503899|NCT04454307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5503900|NCT04454151|Azithromycin|azithromycin|mesh-list
5503901|NCT04454151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5503902|NCT04454151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5503903|NCT04454203|Anesthetics|anesthetics|mesh-list
5503904|NCT04454203|Mepivacaine|mepivacaine|mesh-list
5503905|NCT04454203|Anesthetics, Local|anesthetics, local|mesh-list
5503906|NCT04454203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5503907|NCT04454203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503908|NCT04454203|Sensory System Agents|sensory system agents|mesh-ancestor
5503909|NCT04454203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5503910|NCT04454281|Naloxone|naloxone|mesh-list
5503911|NCT04454281|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5503912|NCT04454281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503913|NCT04454281|Sensory System Agents|sensory system agents|mesh-ancestor
6055129|NCT00608205|Fluorouracil|fluorouracil|mesh-list
6055130|NCT00608205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6055131|NCT00608205|Antimetabolites|antimetabolites|mesh-ancestor
6055132|NCT00608205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6055133|NCT00608205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6055134|NCT00608205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6055135|NCT00608205|Immunologic Factors|immunologic factors|mesh-ancestor
6055136|NCT00608205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055137|NCT00608244|Tacrolimus|tacrolimus|mesh-list
6055138|NCT00608244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6055139|NCT00608244|Immunologic Factors|immunologic factors|mesh-ancestor
6055140|NCT00608244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055141|NCT00608244|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6055142|NCT00608244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6055143|NCT00608244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6055144|NCT00608322|Nitric Oxide|nitric oxide|mesh-list
6055145|NCT00608322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6055146|NCT00608322|Autonomic Agents|autonomic agents|mesh-ancestor
6055147|NCT00608322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6055148|NCT00608322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055149|NCT00608322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6055150|NCT00608322|Respiratory System Agents|respiratory system agents|mesh-ancestor
6055151|NCT00608322|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6055152|NCT00608322|Antioxidants|antioxidants|mesh-ancestor
6055153|NCT00608322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6055154|NCT00608322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6055155|NCT00608322|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6055156|NCT00608322|Vasodilator Agents|vasodilator agents|mesh-ancestor
6055157|NCT00608322|Gasotransmitters|gasotransmitters|mesh-ancestor
6055158|NCT00608322|Protective Agents|protective agents|mesh-ancestor
6055159|NCT00608517|Methylprednisolone|methylprednisolone|mesh-list
6055160|NCT00608517|Cyclophosphamide|cyclophosphamide|mesh-list
6055161|NCT00608517|Fludarabine|fludarabine|mesh-list
6055162|NCT00608517|Fludarabine phosphate|fludarabine phosphate|mesh-list
6055163|NCT00608517|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6055164|NCT00608517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6055165|NCT00608517|Immunologic Factors|immunologic factors|mesh-ancestor
6055166|NCT00608517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055167|NCT00608517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6055168|NCT00608517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6055169|NCT00608517|Alkylating Agents|alkylating agents|mesh-ancestor
6055170|NCT00608517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6055171|NCT00608517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6055172|NCT00608517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6055173|NCT00608517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6055174|NCT00608517|Antimetabolites|antimetabolites|mesh-ancestor
6055175|NCT00608517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6055176|NCT00608517|Antiemetics|antiemetics|mesh-ancestor
6055177|NCT00608517|Autonomic Agents|autonomic agents|mesh-ancestor
5503914|NCT04454281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5503915|NCT04454229|Penicillins|penicillins|mesh-list
5503916|NCT04454229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5503917|NCT04454229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6055178|NCT00608517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6055179|NCT00608517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6055180|NCT00608517|Glucocorticoids|glucocorticoids|mesh-ancestor
6055181|NCT00608517|Hormones|hormones|mesh-ancestor
6055182|NCT00608517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6055183|NCT00608517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6055184|NCT00608517|Protective Agents|protective agents|mesh-ancestor
6055185|NCT00608543|Aripiprazole|aripiprazole|mesh-list
6055186|NCT00608543|Antidepressive Agents|antidepressive agents|mesh-ancestor
6055187|NCT00608543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6055188|NCT00608543|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5503918|NCT04453930|Irinotecan|irinotecan|mesh-list
5503919|NCT04453930|Apatinib|apatinib|mesh-list
5503920|NCT04453930|Antibodies|antibodies|mesh-list
5503921|NCT04453930|Immunologic Factors|immunologic factors|mesh-ancestor
5503922|NCT04453930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055189|NCT00608543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6055190|NCT00608543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6055191|NCT00608543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055192|NCT00608543|Dopamine Agonists|dopamine agonists|mesh-ancestor
6055193|NCT00608543|Dopamine Agents|dopamine agents|mesh-ancestor
6055194|NCT00608543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6055195|NCT00608543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6055196|NCT00608543|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6055197|NCT00608543|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6055198|NCT00608543|Serotonin Agents|serotonin agents|mesh-ancestor
6055199|NCT00608543|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6055200|NCT00608543|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6055201|NCT00608543|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6055202|NCT00608543|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6055203|NCT00608569|Ritonavir|ritonavir|mesh-list
6055204|NCT00608569|Lopinavir|lopinavir|mesh-list
6055205|NCT00608569|Tenofovir|tenofovir|mesh-list
6055206|NCT00608569|Zidovudine|zidovudine|mesh-list
6055207|NCT00608569|Emtricitabine|emtricitabine|mesh-list
6055208|NCT00608569|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6055209|NCT00608569|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6055210|NCT00608569|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6055211|NCT00608569|Protease Inhibitors|protease inhibitors|mesh-ancestor
6055212|NCT00608569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6055213|NCT00608569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503923|NCT04453930|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5503924|NCT04453930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5503925|NCT04453930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5503926|NCT04453930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503927|NCT04453930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5503928|NCT04453930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5503929|NCT04453852|Vaccines|vaccines|mesh-list
5503930|NCT04453852|Immunologic Factors|immunologic factors|mesh-ancestor
6055214|NCT00608569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5503931|NCT04453852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055215|NCT00608569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6055216|NCT00608569|Antiviral Agents|antiviral agents|mesh-ancestor
6055217|NCT00608569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6055218|NCT00608569|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6055219|NCT00608569|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6055220|NCT00608569|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6055221|NCT00608569|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6055222|NCT00608569|Antimetabolites|antimetabolites|mesh-ancestor
6055223|NCT00608634|Perillyl alcohol|perillyl alcohol|mesh-list
6055224|NCT00608634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6055225|NCT00608634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6055226|NCT00608634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6055227|NCT00608842|Deoxycholic Acid|deoxycholic acid|mesh-list
6055228|NCT00608842|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6055229|NCT00608842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6055230|NCT00608868|Gefitinib|gefitinib|mesh-list
6055231|NCT00608868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6055232|NCT00608868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6055233|NCT00608868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6055234|NCT00608868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6055235|NCT00608881|Ubiquinone|ubiquinone|mesh-list
6055236|NCT00608881|Coenzyme Q10|coenzyme q10|mesh-list
6055237|NCT00608881|Micronutrients|micronutrients|mesh-ancestor
6055238|NCT00608881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055239|NCT00608881|Vitamins|vitamins|mesh-ancestor
6055240|NCT00608894|Prednisone|prednisone|mesh-list
6055241|NCT00608894|Azathioprine|azathioprine|mesh-list
6055242|NCT00608894|Tacrolimus|tacrolimus|mesh-list
6055243|NCT00608894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6055244|NCT00608894|Glucocorticoids|glucocorticoids|mesh-ancestor
6055245|NCT00608894|Hormones|hormones|mesh-ancestor
6055246|NCT00608894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6055247|NCT00608894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055248|NCT00608894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6055249|NCT00608894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6055250|NCT00608894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5503932|NCT04453735|Atorvastatin|atorvastatin|mesh-list
5503933|NCT04453735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5503934|NCT04453735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5503935|NCT04453735|Antimetabolites|antimetabolites|mesh-ancestor
6055251|NCT00608894|Immunologic Factors|immunologic factors|mesh-ancestor
6055252|NCT00608894|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6055253|NCT00608894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6055254|NCT00608894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6055255|NCT00608894|Antimetabolites|antimetabolites|mesh-ancestor
6055256|NCT00608894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6055257|NCT00608894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6055258|NCT00608907|Rifampin|rifampin|mesh-list
6055259|NCT00608907|Dexamethasone|dexamethasone|mesh-list
6055260|NCT00608907|Dexamethasone acetate|dexamethasone acetate|mesh-list
6055261|NCT00608907|Bortezomib|bortezomib|mesh-list
6055262|NCT00608907|BB 1101|bb 1101|mesh-list
6055263|NCT00608907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6055264|NCT00608907|Antiemetics|antiemetics|mesh-ancestor
6055265|NCT00608907|Autonomic Agents|autonomic agents|mesh-ancestor
6055266|NCT00608907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6055267|NCT00608907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462277|NCT00458328|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5503936|NCT04453735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503937|NCT04453735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5503938|NCT04453735|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6055268|NCT00608907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6055269|NCT00608907|Glucocorticoids|glucocorticoids|mesh-ancestor
6055270|NCT00608907|Hormones|hormones|mesh-ancestor
6201956|NCT02034006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6055271|NCT00608907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6055272|NCT00608907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6055273|NCT00608907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6055274|NCT00608907|Protease Inhibitors|protease inhibitors|mesh-ancestor
6055275|NCT00608907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6055276|NCT00608907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6055277|NCT00608907|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6055278|NCT00608907|Antitubercular Agents|antitubercular agents|mesh-ancestor
6055279|NCT00608907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6055280|NCT00608907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6055281|NCT00608907|Leprostatic Agents|leprostatic agents|mesh-ancestor
6055282|NCT00608907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6055283|NCT00608907|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6055284|NCT00608907|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6055285|NCT00608907|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6055286|NCT00608907|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6055287|NCT00608907|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6055288|NCT00608907|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6055289|NCT00608959|Chlorhexidine|chlorhexidine|mesh-list
6055290|NCT00608959|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6055291|NCT00608959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6665166|NCT01515969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6665167|NCT01515969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665168|NCT01516060|Efavirenz|efavirenz|mesh-list
6665169|NCT01516060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6665170|NCT01516060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6665171|NCT01516060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6665172|NCT01516060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665173|NCT01516060|Antiviral Agents|antiviral agents|mesh-ancestor
6665174|NCT01516060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6665175|NCT01516060|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6672632|NCT01557335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5503939|NCT04453735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6055292|NCT00608959|Disinfectants|disinfectants|mesh-ancestor
6055293|NCT00608985|Zolpidem|zolpidem|mesh-list
6055294|NCT00608985|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6055295|NCT00608985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6055296|NCT00608985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6055297|NCT00608985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055298|NCT00608985|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6055299|NCT00608985|GABA Agonists|gaba agonists|mesh-ancestor
6055300|NCT00608985|GABA Agents|gaba agents|mesh-ancestor
6055301|NCT00608985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6055302|NCT00608985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6055303|NCT00609128|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
6055304|NCT00609128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6055305|NCT00609128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6055306|NCT00609128|Analgesics|analgesics|mesh-ancestor
6055307|NCT00609128|Sensory System Agents|sensory system agents|mesh-ancestor
6055308|NCT00609128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6055309|NCT00609128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055310|NCT00609128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5503940|NCT04453761|Vitamin B Complex|vitamin b complex|mesh-list
5503941|NCT04453761|Vitamins|vitamins|mesh-ancestor
5503942|NCT04453761|Micronutrients|micronutrients|mesh-ancestor
5503943|NCT04453761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503944|NCT04454528|Pembrolizumab|pembrolizumab|mesh-list
5503945|NCT04454528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5503946|NCT04454528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5600054|NCT03714958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600055|NCT03714880|Mifepristone|mifepristone|mesh-list
5600056|NCT03714880|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6055311|NCT00609128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6055312|NCT00609128|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6055313|NCT00609128|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6055314|NCT00609128|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6055315|NCT00609128|Histamine Antagonists|histamine antagonists|mesh-ancestor
6055316|NCT00609128|Histamine Agents|histamine agents|mesh-ancestor
6055317|NCT00609128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6055318|NCT00609128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6055319|NCT00609167|Dexamethasone|dexamethasone|mesh-list
6055320|NCT00609167|Cyclophosphamide|cyclophosphamide|mesh-list
6055321|NCT00609167|Bortezomib|bortezomib|mesh-list
6055322|NCT00609167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6055323|NCT00609167|Immunologic Factors|immunologic factors|mesh-ancestor
6055324|NCT00609167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055325|NCT00609167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6055326|NCT00609167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6055327|NCT00609167|Alkylating Agents|alkylating agents|mesh-ancestor
5503947|NCT04453280|Antibodies|antibodies|mesh-list
5503948|NCT04453280|Immunologic Factors|immunologic factors|mesh-ancestor
5503949|NCT04453280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503950|NCT04453423|Carboplatin|carboplatin|mesh-list
5503951|NCT04453423|Pemetrexed|pemetrexed|mesh-list
5503952|NCT04453423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5503953|NCT04453423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5503954|NCT04453423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503955|NCT04453423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5503956|NCT04453423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5503957|NCT04453306|Topiramate|topiramate|mesh-list
5503958|NCT04453306|Anticonvulsants|anticonvulsants|mesh-ancestor
5503959|NCT04453306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5503960|NCT04453306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503961|NCT04453371|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5503962|NCT04453371|Plasminogen|plasminogen|mesh-list
6055328|NCT00609167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6055329|NCT00609167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6055330|NCT00609167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6055331|NCT00609167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6055332|NCT00609167|Antiemetics|antiemetics|mesh-ancestor
6055333|NCT00609167|Autonomic Agents|autonomic agents|mesh-ancestor
6055334|NCT00609167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6055335|NCT00609167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6055336|NCT00609167|Glucocorticoids|glucocorticoids|mesh-ancestor
6055337|NCT00609167|Hormones|hormones|mesh-ancestor
6055338|NCT00609167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6055339|NCT00609167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6055340|NCT00609245|Valproic Acid|valproic acid|mesh-list
6055341|NCT00609245|Anticonvulsants|anticonvulsants|mesh-ancestor
6055342|NCT00609245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6055343|NCT00609245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6055344|NCT00609245|GABA Agents|gaba agents|mesh-ancestor
6055345|NCT00609245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6055346|NCT00609245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055347|NCT00609245|Antimanic Agents|antimanic agents|mesh-ancestor
6055348|NCT00609245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6055349|NCT00609245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6055350|NCT00609245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6055351|NCT00609336|Gemcitabine|gemcitabine|mesh-list
6055352|NCT00609336|Capecitabine|capecitabine|mesh-list
6055353|NCT00609336|Docetaxel|docetaxel|mesh-list
6055354|NCT00609336|Oxaliplatin|oxaliplatin|mesh-list
6055355|NCT00609336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6055356|NCT00609336|Antimetabolites|antimetabolites|mesh-ancestor
6055357|NCT00609336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6055358|NCT00609336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6055359|NCT00609336|Antiviral Agents|antiviral agents|mesh-ancestor
6055360|NCT00609336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6055361|NCT00609336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6055362|NCT00609336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6055363|NCT00609336|Immunologic Factors|immunologic factors|mesh-ancestor
6055364|NCT00609336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055365|NCT00609336|Tubulin Modulators|tubulin modulators|mesh-ancestor
6055366|NCT00609336|Antimitotic Agents|antimitotic agents|mesh-ancestor
6055367|NCT00609336|Mitosis Modulators|mitosis modulators|mesh-ancestor
6055368|NCT00609362|Rosiglitazone|rosiglitazone|mesh-list
6055369|NCT00609362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6055370|NCT00609362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055371|NCT00609466|Morphine|morphine|mesh-list
5503963|NCT04453371|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5503964|NCT04453371|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5503965|NCT04453371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503966|NCT04453345|Thalidomide|thalidomide|mesh-list
5503967|NCT04453345|Prednisone|prednisone|mesh-list
5503968|NCT04453345|Methotrexate|methotrexate|mesh-list
5503969|NCT04453345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6055372|NCT00609466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6055373|NCT00609466|Narcotics|narcotics|mesh-ancestor
5503970|NCT04453345|Glucocorticoids|glucocorticoids|mesh-ancestor
5503971|NCT04453345|Hormones|hormones|mesh-ancestor
6055374|NCT00609466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6055375|NCT00609466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055376|NCT00609466|Analgesics|analgesics|mesh-ancestor
6055377|NCT00609466|Sensory System Agents|sensory system agents|mesh-ancestor
6055378|NCT00609466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6055379|NCT00609492|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6055380|NCT00609492|Immunologic Factors|immunologic factors|mesh-ancestor
6055381|NCT00609492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055382|NCT00609518|Folic Acid|folic acid|mesh-list
6055383|NCT00609518|Vitamin B 12|vitamin b 12|mesh-list
6055384|NCT00609518|Hydroxocobalamin|hydroxocobalamin|mesh-list
6055385|NCT00609518|Vitamin B Complex|vitamin b complex|mesh-list
6055386|NCT00609518|Dexamethasone|dexamethasone|mesh-list
6055387|NCT00609518|Dexamethasone acetate|dexamethasone acetate|mesh-list
6055388|NCT00609518|Pemetrexed|pemetrexed|mesh-list
6055389|NCT00609518|BB 1101|bb 1101|mesh-list
6055390|NCT00609518|Vitamins|vitamins|mesh-ancestor
6055391|NCT00609518|Micronutrients|micronutrients|mesh-ancestor
6055392|NCT00609518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055393|NCT00609518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6055394|NCT00609518|Antiemetics|antiemetics|mesh-ancestor
6055395|NCT00609518|Autonomic Agents|autonomic agents|mesh-ancestor
6055396|NCT00609518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6055397|NCT00609518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6055398|NCT00609518|Glucocorticoids|glucocorticoids|mesh-ancestor
6055399|NCT00609518|Hormones|hormones|mesh-ancestor
6055400|NCT00609518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6055401|NCT00609518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6055402|NCT00609518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6055403|NCT00609518|Protease Inhibitors|protease inhibitors|mesh-ancestor
6055404|NCT00609518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6055405|NCT00609518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6055406|NCT00609518|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6055407|NCT00609518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6055408|NCT00609518|Hematinics|hematinics|mesh-ancestor
6055409|NCT00609609|Methylprednisolone|methylprednisolone|mesh-list
6055410|NCT00609609|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6055411|NCT00609609|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6055412|NCT00609609|Prednisolone|prednisolone|mesh-list
6055413|NCT00609609|Prednisolone acetate|prednisolone acetate|mesh-list
6055414|NCT00609609|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6055415|NCT00609609|Prednisolone phosphate|prednisolone phosphate|mesh-list
6055416|NCT00609609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6055417|NCT00609609|Antiemetics|antiemetics|mesh-ancestor
6055418|NCT00609609|Autonomic Agents|autonomic agents|mesh-ancestor
6055419|NCT00609609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6055420|NCT00609609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055421|NCT00609609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6055422|NCT00609609|Glucocorticoids|glucocorticoids|mesh-ancestor
6055423|NCT00609609|Hormones|hormones|mesh-ancestor
6055424|NCT00609609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6055425|NCT00609609|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6055426|NCT00609609|Protective Agents|protective agents|mesh-ancestor
6055427|NCT00609609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6055428|NCT00609609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6055429|NCT00609622|Bevacizumab|bevacizumab|mesh-list
6055430|NCT00609622|Sunitinib|sunitinib|mesh-list
6055431|NCT00609622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6055432|NCT00609622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6055433|NCT00609622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6055434|NCT00609622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6055435|NCT00609622|Growth Substances|growth substances|mesh-ancestor
6055436|NCT00609622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055437|NCT00609622|Growth Inhibitors|growth inhibitors|mesh-ancestor
6055438|NCT00609622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6055439|NCT00609622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6055440|NCT00609622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6055441|NCT00609674|Fluticasone|fluticasone|mesh-list
6055442|NCT00609674|Xhance|xhance|mesh-list
6055443|NCT00609674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6055444|NCT00609674|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6055445|NCT00609674|Autonomic Agents|autonomic agents|mesh-ancestor
6055446|NCT00609674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6055447|NCT00609674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055448|NCT00609674|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6055449|NCT00609674|Respiratory System Agents|respiratory system agents|mesh-ancestor
6055450|NCT00609674|Dermatologic Agents|dermatologic agents|mesh-ancestor
6055451|NCT00609674|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6055452|NCT00609739|Cytarabine|cytarabine|mesh-list
6055453|NCT00609739|Cyclosporine|cyclosporine|mesh-list
6055454|NCT00609739|Methylprednisolone|methylprednisolone|mesh-list
6055455|NCT00609739|Methotrexate|methotrexate|mesh-list
6055456|NCT00609739|Mitoxantrone|mitoxantrone|mesh-list
6055457|NCT00609739|Tretinoin|tretinoin|mesh-list
6055458|NCT00609739|Isotretinoin|isotretinoin|mesh-list
6055459|NCT00609739|Cyclosporins|cyclosporins|mesh-list
6055460|NCT00609739|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6055461|NCT00609739|Abortifacient Agents|abortifacient agents|mesh-ancestor
6055462|NCT00609739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6055463|NCT00609739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055464|NCT00609739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6055465|NCT00609739|Antimetabolites|antimetabolites|mesh-ancestor
6055466|NCT00609739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6055467|NCT00609739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6055468|NCT00609739|Dermatologic Agents|dermatologic agents|mesh-ancestor
6055469|NCT00609739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6055470|NCT00609739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6055471|NCT00609739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6055472|NCT00609739|Immunologic Factors|immunologic factors|mesh-ancestor
6055473|NCT00609739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6055474|NCT00609739|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6055475|NCT00609739|Antiviral Agents|antiviral agents|mesh-ancestor
6055476|NCT00609739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6055477|NCT00609739|Antifungal Agents|antifungal agents|mesh-ancestor
6055478|NCT00609739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6055479|NCT00609739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6055480|NCT00609739|Antiemetics|antiemetics|mesh-ancestor
6055481|NCT00609739|Autonomic Agents|autonomic agents|mesh-ancestor
6055482|NCT00609739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6055483|NCT00609739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6055484|NCT00609739|Glucocorticoids|glucocorticoids|mesh-ancestor
6055485|NCT00609739|Hormones|hormones|mesh-ancestor
5503972|NCT04453345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5503973|NCT04453345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5503974|NCT04453345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5503975|NCT04453345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5503976|NCT04453345|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5503977|NCT04453345|Abortifacient Agents|abortifacient agents|mesh-ancestor
5503978|NCT04453345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5503979|NCT04453345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5503980|NCT04453345|Antimetabolites|antimetabolites|mesh-ancestor
5503981|NCT04453345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503982|NCT04453345|Dermatologic Agents|dermatologic agents|mesh-ancestor
6055486|NCT00609739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6055487|NCT00609739|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6055488|NCT00609739|Protective Agents|protective agents|mesh-ancestor
6055489|NCT00609739|Analgesics|analgesics|mesh-ancestor
6055490|NCT00609739|Sensory System Agents|sensory system agents|mesh-ancestor
6055491|NCT00609739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6055492|NCT00609739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6055493|NCT00609739|Keratolytic Agents|keratolytic agents|mesh-ancestor
6055494|NCT00609804|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6055495|NCT00609804|Sorafenib|sorafenib|mesh-list
6055496|NCT00609804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6055497|NCT00609804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6055498|NCT00609804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6055499|NCT00609804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6055500|NCT00609869|Rituximab|rituximab|mesh-list
6055501|NCT00609869|Lenalidomide|lenalidomide|mesh-list
6055502|NCT00609869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6055503|NCT00609869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6055504|NCT00609869|Immunologic Factors|immunologic factors|mesh-ancestor
6055505|NCT00609869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055506|NCT00609869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6055507|NCT00609869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6055508|NCT00609869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6055509|NCT00609869|Growth Substances|growth substances|mesh-ancestor
6055510|NCT00609869|Growth Inhibitors|growth inhibitors|mesh-ancestor
6055511|NCT00609973|Ciprofloxacin|ciprofloxacin|mesh-list
6055512|NCT00609973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6055513|NCT00609973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6055514|NCT00609973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6055515|NCT00609973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6055516|NCT00609973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6055517|NCT00609973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6055518|NCT00609973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6055519|NCT00609973|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6055520|NCT00609973|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6055521|NCT00609986|Insulin|insulin|mesh-list
6055522|NCT00609986|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6055523|NCT00609986|Insulin Glargine|insulin glargine|mesh-list
6055524|NCT00609986|Insulin, Isophane|insulin, isophane|mesh-list
6055525|NCT00609986|Isophane Insulin, Human|isophane insulin, human|mesh-list
6055526|NCT00609986|Isophane insulin, beef|isophane insulin, beef|mesh-list
6055527|NCT00609986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6055528|NCT00609986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055529|NCT00610155|Pregabalin|pregabalin|mesh-list
6055530|NCT00610155|Tramadol|tramadol|mesh-list
6055531|NCT00610155|Analgesics|analgesics|mesh-ancestor
6055532|NCT00610155|Sensory System Agents|sensory system agents|mesh-ancestor
6055533|NCT00610155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5503983|NCT04453345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5503984|NCT04453345|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5503985|NCT04453345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5503986|NCT04453345|Immunologic Factors|immunologic factors|mesh-ancestor
5503987|NCT04453345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5503988|NCT04453345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5503989|NCT04453345|Leprostatic Agents|leprostatic agents|mesh-ancestor
5503990|NCT04453345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5503991|NCT04453345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6055534|NCT00610155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055535|NCT00610155|Anticonvulsants|anticonvulsants|mesh-ancestor
6055536|NCT00610155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6055537|NCT00610155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5503992|NCT04453345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5503993|NCT04453345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6201957|NCT02034019|Dexamethasone|dexamethasone|mesh-list
6055538|NCT00610155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6055539|NCT00610155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6055540|NCT00610155|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6055541|NCT00610155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6055542|NCT00610155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6055543|NCT00610155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6055544|NCT00610155|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6055545|NCT00610155|Narcotics|narcotics|mesh-ancestor
6055546|NCT00610168|Vaccines|vaccines|mesh-list
6055547|NCT00610168|Immunologic Factors|immunologic factors|mesh-ancestor
5503994|NCT04453345|Growth Substances|growth substances|mesh-ancestor
5503995|NCT04453345|Growth Inhibitors|growth inhibitors|mesh-ancestor
5503996|NCT04453436|Tenofovir|tenofovir|mesh-list
6055548|NCT00610168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055549|NCT00610311|Aldesleukin|aldesleukin|mesh-list
6055550|NCT00610311|Cyclophosphamide|cyclophosphamide|mesh-list
6055551|NCT00610311|Fludarabine|fludarabine|mesh-list
6055552|NCT00610311|Fludarabine phosphate|fludarabine phosphate|mesh-list
6055553|NCT00610311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6055554|NCT00610311|Immunologic Factors|immunologic factors|mesh-ancestor
6055555|NCT00610311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055556|NCT00610311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6055557|NCT00610311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6055558|NCT00610311|Alkylating Agents|alkylating agents|mesh-ancestor
6055559|NCT00610311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6055560|NCT00610311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6055561|NCT00610311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6055562|NCT00610311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6055563|NCT00610311|Antimetabolites|antimetabolites|mesh-ancestor
6055564|NCT00610311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6055565|NCT00610311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6055566|NCT00610311|Antiviral Agents|antiviral agents|mesh-ancestor
6055567|NCT00610311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5503997|NCT04453436|Lamivudine|lamivudine|mesh-list
5503998|NCT04453436|Dolutegravir|dolutegravir|mesh-list
6055568|NCT00610363|Rilonacept|rilonacept|mesh-list
6055569|NCT00610363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6055570|NCT00610428|Prochlorperazine|prochlorperazine|mesh-list
6055571|NCT00610428|Antiemetics|antiemetics|mesh-ancestor
6055572|NCT00610428|Autonomic Agents|autonomic agents|mesh-ancestor
6055573|NCT00610428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6055574|NCT00610428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055575|NCT00610428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6055576|NCT00610428|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6055577|NCT00610428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6055578|NCT00610428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6055579|NCT00610428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6055580|NCT00610428|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6055581|NCT00610428|Dopamine Agents|dopamine agents|mesh-ancestor
6055582|NCT00610428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6055583|NCT00610428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5503999|NCT04453436|Antiviral Agents|antiviral agents|mesh-ancestor
6055584|NCT00610675|Mirtazapine|mirtazapine|mesh-list
6055585|NCT00610675|Antidepressive Agents|antidepressive agents|mesh-ancestor
6055586|NCT00610675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6055587|NCT00610675|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6462278|NCT00458328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6462279|NCT00458328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462280|NCT00458328|Cholinergic Agents|cholinergic agents|mesh-ancestor
6462281|NCT00458328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6462282|NCT00458328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462283|NCT00458328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6462284|NCT00458367|Risperidone|risperidone|mesh-list
6462285|NCT00458367|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6462286|NCT00458367|Serotonin Agents|serotonin agents|mesh-ancestor
6462287|NCT00458367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6462288|NCT00458367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462289|NCT00458367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055588|NCT00610675|Histamine Antagonists|histamine antagonists|mesh-ancestor
6055589|NCT00610675|Histamine Agents|histamine agents|mesh-ancestor
6055590|NCT00610675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6055591|NCT00610675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6055592|NCT00610675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055593|NCT00610675|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6055594|NCT00610675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6055595|NCT00610675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6055596|NCT00610675|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6055597|NCT00610675|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6055598|NCT00610675|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6055599|NCT00610675|Adrenergic Agents|adrenergic agents|mesh-ancestor
6055600|NCT00610675|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6055601|NCT00610675|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6055602|NCT00610675|Serotonin Agents|serotonin agents|mesh-ancestor
6055603|NCT00610675|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6055604|NCT00610688|Vitamin D|vitamin d|mesh-list
6055605|NCT00610688|Ergocalciferols|ergocalciferols|mesh-list
6055606|NCT00610688|Cholecalciferol|cholecalciferol|mesh-list
6055607|NCT00610688|Vitamins|vitamins|mesh-list
6055608|NCT00610688|Micronutrients|micronutrients|mesh-ancestor
6055609|NCT00610688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055610|NCT00610688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6055611|NCT00610688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6055612|NCT00610714|Paclitaxel|paclitaxel|mesh-list
6055613|NCT00610714|Carboplatin|carboplatin|mesh-list
6055614|NCT00610714|Saracatinib|saracatinib|mesh-list
6055615|NCT00610714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6055616|NCT00610714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6055617|NCT00610714|Tubulin Modulators|tubulin modulators|mesh-ancestor
6055618|NCT00610714|Antimitotic Agents|antimitotic agents|mesh-ancestor
6055619|NCT00610714|Mitosis Modulators|mitosis modulators|mesh-ancestor
6055620|NCT00610714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6055621|NCT00610714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6055622|NCT00610727|Prochlorperazine|prochlorperazine|mesh-list
6462290|NCT00458367|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6462291|NCT00458367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6462292|NCT00458367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6462293|NCT00458367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6462294|NCT00458367|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6462295|NCT00458367|Dopamine Agents|dopamine agents|mesh-ancestor
6462296|NCT00458419|Naloxone|naloxone|mesh-list
6462297|NCT00458419|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6462298|NCT00458419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462299|NCT00458419|Sensory System Agents|sensory system agents|mesh-ancestor
6055623|NCT00610727|Antiemetics|antiemetics|mesh-ancestor
6055624|NCT00610727|Autonomic Agents|autonomic agents|mesh-ancestor
6055625|NCT00610727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6055626|NCT00610727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055627|NCT00610727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6055628|NCT00610727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6055629|NCT00610727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6055630|NCT00610727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6055631|NCT00610727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6055632|NCT00610727|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6055633|NCT00610727|Dopamine Agents|dopamine agents|mesh-ancestor
6055634|NCT00610727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6055635|NCT00610727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462300|NCT00458419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6055636|NCT00610740|Gemcitabine|gemcitabine|mesh-list
6055637|NCT00610740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6055638|NCT00610740|Antimetabolites|antimetabolites|mesh-ancestor
6055639|NCT00610740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6055640|NCT00610740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6055641|NCT00610740|Antiviral Agents|antiviral agents|mesh-ancestor
6055642|NCT00610740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6055643|NCT00610740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6055644|NCT00610740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6055645|NCT00610740|Immunologic Factors|immunologic factors|mesh-ancestor
6055646|NCT00610740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055647|NCT00610857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6055648|NCT00610857|Antibodies|antibodies|mesh-list
6055649|NCT00610857|Immunoglobulins|immunoglobulins|mesh-list
6055650|NCT00610857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6055651|NCT00610857|Immunologic Factors|immunologic factors|mesh-ancestor
6055652|NCT00610857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055653|NCT00610857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6055654|NCT00610883|Cyclophosphamide|cyclophosphamide|mesh-list
6055655|NCT00610883|Methotrexate|methotrexate|mesh-list
6055656|NCT00610883|Asparaginase|asparaginase|mesh-list
6055657|NCT00610883|Daunorubicin|daunorubicin|mesh-list
6055658|NCT00610883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6055659|NCT00610883|Immunologic Factors|immunologic factors|mesh-ancestor
6055660|NCT00610883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055661|NCT00610883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6055662|NCT00610883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6055663|NCT00610883|Alkylating Agents|alkylating agents|mesh-ancestor
6055664|NCT00610883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6055665|NCT00610883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6055666|NCT00610883|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6055667|NCT00610883|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6055668|NCT00610883|Abortifacient Agents|abortifacient agents|mesh-ancestor
6055669|NCT00610883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6055670|NCT00610883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6055671|NCT00610883|Antimetabolites|antimetabolites|mesh-ancestor
6055672|NCT00610883|Dermatologic Agents|dermatologic agents|mesh-ancestor
6055673|NCT00610883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6055674|NCT00610883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6055675|NCT00610883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6055676|NCT00610883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6055677|NCT00610883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6055678|NCT00610883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6055679|NCT00610935|Peramivir|peramivir|mesh-list
6055680|NCT00610935|Antiviral Agents|antiviral agents|mesh-ancestor
6055681|NCT00610935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6055682|NCT00610935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6055683|NCT00610935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504000|NCT04453436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5725044|NCT03183310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725045|NCT03183492|Vaccines|vaccines|mesh-list
5725046|NCT03183492|Immunologic Factors|immunologic factors|mesh-ancestor
5725047|NCT03183492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725687|NCT03178656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5725688|NCT03178656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5725689|NCT03178656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5725690|NCT03178656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725691|NCT03178721|Calcium|calcium|mesh-list
5725692|NCT03178721|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5725693|NCT03178721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725694|NCT03178643|Piperaquine|piperaquine|mesh-list
5725695|NCT03178643|Sulfadoxine|sulfadoxine|mesh-list
5725696|NCT03178643|Amodiaquine|amodiaquine|mesh-list
5725697|NCT03178643|Artenimol|artenimol|mesh-list
5725698|NCT03178643|Proguanil|proguanil|mesh-list
5725699|NCT03178643|Antimalarials|antimalarials|mesh-ancestor
5725700|NCT03178643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5725701|NCT03178643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5725702|NCT03178643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5725703|NCT03178643|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5725704|NCT03178643|Renal Agents|renal agents|mesh-ancestor
5725705|NCT03178643|Antimetabolites|antimetabolites|mesh-ancestor
5725706|NCT03178643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725707|NCT03178747|Methylene Blue|methylene blue|mesh-list
5725708|NCT03178747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5504001|NCT04453436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5504002|NCT04453436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5504003|NCT04453436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5504004|NCT04453436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504005|NCT04453436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5504006|NCT04453436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5504007|NCT04453436|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5504008|NCT04453436|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5504009|NCT04453332|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5504010|NCT04453332|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5504011|NCT04453332|Hormones|hormones|mesh-list
5504012|NCT04453332|Estradiol|estradiol|mesh-list
5504013|NCT04453332|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5504014|NCT04453332|Progesterone|progesterone|mesh-list
5504015|NCT04453332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5504016|NCT04453332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504017|NCT04453332|Estrogens|estrogens|mesh-ancestor
5504018|NCT04453332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5504019|NCT04453332|Contraceptive Agents|contraceptive agents|mesh-ancestor
5504020|NCT04453332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6055684|NCT00610987|Cefazolin|cefazolin|mesh-list
6055685|NCT00610987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6055686|NCT00610987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6055687|NCT00611026|Fesoterodine|fesoterodine|mesh-list
6055688|NCT00611026|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6055689|NCT00611026|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6055690|NCT00611026|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6055691|NCT00611026|Cholinergic Agents|cholinergic agents|mesh-ancestor
6055692|NCT00611026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6055693|NCT00611026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6055694|NCT00611026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055695|NCT00611026|Urological Agents|urological agents|mesh-ancestor
6055696|NCT00611130|Vigabatrin|vigabatrin|mesh-list
6055697|NCT00611130|Anticonvulsants|anticonvulsants|mesh-ancestor
6055698|NCT00611130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6055699|NCT00611130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6055700|NCT00611130|GABA Agents|gaba agents|mesh-ancestor
6055701|NCT00611130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6665176|NCT01516060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6665177|NCT01516060|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6055702|NCT00611130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055703|NCT00611247|Temozolomide|temozolomide|mesh-list
6055704|NCT00611247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6055705|NCT00611247|Alkylating Agents|alkylating agents|mesh-ancestor
6055706|NCT00611247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6055707|NCT00611247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6055708|NCT00611325|Bevacizumab|bevacizumab|mesh-list
6055709|NCT00611325|Bortezomib|bortezomib|mesh-list
6055710|NCT00611325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6462301|NCT00458458|Leuprolide|leuprolide|mesh-list
6462302|NCT00458458|Norethindrone|norethindrone|mesh-list
6462303|NCT00458458|Norethindrone Acetate|norethindrone acetate|mesh-list
6462304|NCT00458458|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6462305|NCT00458458|Fertility Agents|fertility agents|mesh-ancestor
6462306|NCT00458458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6462307|NCT00458458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462308|NCT00458458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6462309|NCT00458458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6462310|NCT00458458|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6462311|NCT00458458|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6462312|NCT00458458|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6462313|NCT00458458|Contraceptive Agents|contraceptive agents|mesh-ancestor
6462314|NCT00458458|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6055711|NCT00611325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6055712|NCT00611325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6055713|NCT00611325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6055714|NCT00611325|Growth Substances|growth substances|mesh-ancestor
6055715|NCT00611325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055716|NCT00611325|Growth Inhibitors|growth inhibitors|mesh-ancestor
6055717|NCT00611351|Mycophenolic Acid|mycophenolic acid|mesh-list
6055718|NCT00611351|Cyclophosphamide|cyclophosphamide|mesh-list
6055719|NCT00611351|Busulfan|busulfan|mesh-list
6055720|NCT00611351|Tacrolimus|tacrolimus|mesh-list
6055721|NCT00611351|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6055722|NCT00611351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5504021|NCT04453332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5504022|NCT04453332|Progestins|progestins|mesh-ancestor
5504023|NCT04453449|Midazolam|midazolam|mesh-list
5504024|NCT04453449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5504025|NCT04453449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5504026|NCT04453449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5504027|NCT04453449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504028|NCT04453449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6055723|NCT00611351|Immunologic Factors|immunologic factors|mesh-ancestor
6055724|NCT00611351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055725|NCT00611351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6055726|NCT00611351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6055727|NCT00611351|Alkylating Agents|alkylating agents|mesh-ancestor
6055728|NCT00611351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6055729|NCT00611351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6055730|NCT00611351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6055731|NCT00611351|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6055732|NCT00611351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6055733|NCT00611351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6055734|NCT00611351|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6055735|NCT00611351|Antitubercular Agents|antitubercular agents|mesh-ancestor
6055736|NCT00611351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6055737|NCT00611351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6055738|NCT00611403|Cyclosporine|cyclosporine|mesh-list
6055739|NCT00611403|Lubricant Eye Drops|lubricant eye drops|mesh-list
6055740|NCT00611403|Cyclosporins|cyclosporins|mesh-list
6055741|NCT00611403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6055742|NCT00611403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6055743|NCT00611403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6055744|NCT00611403|Immunologic Factors|immunologic factors|mesh-ancestor
6055745|NCT00611403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055746|NCT00611403|Antifungal Agents|antifungal agents|mesh-ancestor
6055747|NCT00611403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6055748|NCT00611403|Dermatologic Agents|dermatologic agents|mesh-ancestor
6055749|NCT00611403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6055750|NCT00611403|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6055751|NCT00611403|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6055752|NCT00611403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6055753|NCT00611442|Lubiprostone|lubiprostone|mesh-list
6055754|NCT00611442|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6055755|NCT00611442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6055756|NCT00611442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6055757|NCT00611455|Ofatumumab|ofatumumab|mesh-list
6055758|NCT00611455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6055759|NCT00611468|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6055760|NCT00611468|Topotecan|topotecan|mesh-list
6055761|NCT00611468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6055762|NCT00611468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6055763|NCT00611468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6055764|NCT00611468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6055765|NCT00611468|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6055766|NCT00611468|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6055767|NCT00611533|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6055768|NCT00611533|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6055769|NCT00611533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6055770|NCT00611533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6201958|NCT02034019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5504029|NCT04453449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6055771|NCT00611533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6055772|NCT00611533|Adrenergic Agents|adrenergic agents|mesh-ancestor
6055773|NCT00611533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6055774|NCT00611533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055775|NCT00611559|PENTA|penta|mesh-list
6055776|NCT00611559|Anticoagulants|anticoagulants|mesh-ancestor
6055777|NCT00611559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6055778|NCT00611559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6055779|NCT00611559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6055780|NCT00611715|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6055781|NCT00611715|Letrozole|letrozole|mesh-list
6055782|NCT00611715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6055783|NCT00611715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6055784|NCT00611715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6055785|NCT00611715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6055786|NCT00611715|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6055787|NCT00611715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6055788|NCT00611715|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6055789|NCT00611715|Hormone Antagonists|hormone antagonists|mesh-ancestor
6055790|NCT00611715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6055791|NCT00611715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055792|NCT00611767|Thiopental|thiopental|mesh-list
6055793|NCT00611767|Anticonvulsants|anticonvulsants|mesh-ancestor
6055794|NCT00611767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6055795|NCT00611767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6055796|NCT00611767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055797|NCT00611767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6055798|NCT00611767|Anesthetics, General|anesthetics, general|mesh-ancestor
6055799|NCT00611767|Anesthetics|anesthetics|mesh-ancestor
6055800|NCT00611767|GABA Modulators|gaba modulators|mesh-ancestor
6055801|NCT00611767|GABA Agents|gaba agents|mesh-ancestor
6055802|NCT00611767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6055803|NCT00611767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6055804|NCT00611806|Folic Acid|folic acid|mesh-list
5504030|NCT04453449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5504031|NCT04453449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5504032|NCT04453449|Anesthetics, General|anesthetics, general|mesh-ancestor
5504033|NCT04453449|Anesthetics|anesthetics|mesh-ancestor
5504034|NCT04453449|GABA Modulators|gaba modulators|mesh-ancestor
5504035|NCT04453449|GABA Agents|gaba agents|mesh-ancestor
5504036|NCT04453449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5504037|NCT04453449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504038|NCT04453189|Lansoprazole|lansoprazole|mesh-list
5504039|NCT04453189|Dexlansoprazole|dexlansoprazole|mesh-list
5504040|NCT04453189|Famotidine|famotidine|mesh-list
5504041|NCT04453189|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5504042|NCT04453189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5504043|NCT04453189|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5504044|NCT04453189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5504045|NCT04453189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6055805|NCT00611806|Vitamin B 12|vitamin b 12|mesh-list
6055806|NCT00611806|Hematinics|hematinics|mesh-ancestor
6055807|NCT00611806|Vitamin B Complex|vitamin b complex|mesh-ancestor
6055808|NCT00611806|Vitamins|vitamins|mesh-ancestor
6055809|NCT00611806|Micronutrients|micronutrients|mesh-ancestor
6055810|NCT00611806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504046|NCT04453189|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5504047|NCT04453189|Histamine Antagonists|histamine antagonists|mesh-ancestor
5504048|NCT04453189|Histamine Agents|histamine agents|mesh-ancestor
5504049|NCT04453189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5504050|NCT04453189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504051|NCT04453124|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
5504052|NCT04453124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5504053|NCT04453111|Hyaluronic Acid|hyaluronic acid|mesh-list
5504054|NCT04453111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5504055|NCT04453111|Immunologic Factors|immunologic factors|mesh-ancestor
5504056|NCT04453111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504057|NCT04453111|Viscosupplements|viscosupplements|mesh-ancestor
5504058|NCT04453111|Protective Agents|protective agents|mesh-ancestor
5504059|NCT04452838|Fesoterodine|fesoterodine|mesh-list
5504060|NCT04452838|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5504061|NCT04452838|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5504062|NCT04452838|Cholinergic Agents|cholinergic agents|mesh-ancestor
5504063|NCT04452838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5504064|NCT04452838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504065|NCT04452838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504066|NCT04452838|Urological Agents|urological agents|mesh-ancestor
5504067|NCT04453046|Pembrolizumab|pembrolizumab|mesh-list
5504068|NCT04453046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5504069|NCT04453046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5504070|NCT04452929|Calcitonin|calcitonin|mesh-list
5504071|NCT04452929|Salmon calcitonin|salmon calcitonin|mesh-list
5504072|NCT04452929|Cilostazol|cilostazol|mesh-list
5504073|NCT04452929|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
5504074|NCT04452929|Erenumab|erenumab|mesh-list
5504075|NCT04452929|Katacalcin|katacalcin|mesh-list
5504076|NCT04452929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5504077|NCT04452929|Autonomic Agents|autonomic agents|mesh-ancestor
5504078|NCT04452929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5504079|NCT04452929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504080|NCT04452929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5504081|NCT04452929|Respiratory System Agents|respiratory system agents|mesh-ancestor
5504082|NCT04452929|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5504083|NCT04452929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5504084|NCT04452929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504085|NCT04452929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5504086|NCT04452929|Vasodilator Agents|vasodilator agents|mesh-ancestor
5504087|NCT04452929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5504088|NCT04452929|Protective Agents|protective agents|mesh-ancestor
5504089|NCT04452929|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5504090|NCT04452929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5504091|NCT04452929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5504092|NCT04452929|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
5504093|NCT04452929|Analgesics|analgesics|mesh-ancestor
5504094|NCT04452929|Sensory System Agents|sensory system agents|mesh-ancestor
5504095|NCT04452929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5504096|NCT04452929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5504097|NCT04452669|Epoprostenol|epoprostenol|mesh-list
5504098|NCT04452669|Tezosentan|tezosentan|mesh-list
5504099|NCT04452669|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5504100|NCT04452669|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5504101|NCT04452669|Vasodilator Agents|vasodilator agents|mesh-ancestor
5504102|NCT04452370|Etoposide|etoposide|mesh-list
5504103|NCT04452370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5504104|NCT04452370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5504105|NCT04452370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5504106|NCT04452370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5504107|NCT04452370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6055811|NCT00611858|Fluorouracil|fluorouracil|mesh-list
6055812|NCT00611858|Cetuximab|cetuximab|mesh-list
6055813|NCT00611858|Antimetabolites|antimetabolites|mesh-ancestor
6055814|NCT00611858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6055815|NCT00611858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6055816|NCT00611858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6055817|NCT00611858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6055818|NCT00611858|Immunologic Factors|immunologic factors|mesh-ancestor
6055819|NCT00611858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055820|NCT00611858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6055821|NCT00611884|Insulin|insulin|mesh-list
6055822|NCT00611884|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5504108|NCT04452370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504109|NCT04452461|Leucovorin|leucovorin|mesh-list
6055823|NCT00611884|Metformin|metformin|mesh-list
6055824|NCT00611884|Insulin Glargine|insulin glargine|mesh-list
6055825|NCT00611884|Insulin, Long-Acting|insulin, long-acting|mesh-list
6055826|NCT00611884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6055827|NCT00611884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055828|NCT00611897|Acetylcysteine|acetylcysteine|mesh-list
6055829|NCT00611897|Ketamine|ketamine|mesh-list
6055830|NCT00611897|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6055831|NCT00611897|Analgesics|analgesics|mesh-ancestor
6055832|NCT00611897|Sensory System Agents|sensory system agents|mesh-ancestor
6055833|NCT00611897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6055834|NCT00611897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055835|NCT00611897|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6055836|NCT00611897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6055837|NCT00611897|Anesthetics, General|anesthetics, general|mesh-ancestor
6055838|NCT00611897|Anesthetics|anesthetics|mesh-ancestor
6055839|NCT00611897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5504110|NCT04452461|Gemcitabine|gemcitabine|mesh-list
5504111|NCT04452461|Paclitaxel|paclitaxel|mesh-list
5504112|NCT04452461|Oxaliplatin|oxaliplatin|mesh-list
5504113|NCT04452461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5504114|NCT04452461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5504115|NCT04452461|Tubulin Modulators|tubulin modulators|mesh-ancestor
5504116|NCT04452461|Antimitotic Agents|antimitotic agents|mesh-ancestor
5504117|NCT04452461|Mitosis Modulators|mitosis modulators|mesh-ancestor
5504118|NCT04452461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504119|NCT04452461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5504120|NCT04452461|Antimetabolites|antimetabolites|mesh-ancestor
5504121|NCT04452461|Antiviral Agents|antiviral agents|mesh-ancestor
6055840|NCT00611897|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6055841|NCT00611897|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6055842|NCT00611897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6055843|NCT00611897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6055844|NCT00611897|Antiviral Agents|antiviral agents|mesh-ancestor
6055845|NCT00611897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6055846|NCT00611897|Expectorants|expectorants|mesh-ancestor
6055847|NCT00611897|Respiratory System Agents|respiratory system agents|mesh-ancestor
6055848|NCT00611897|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6055849|NCT00611897|Antioxidants|antioxidants|mesh-ancestor
6055850|NCT00611897|Protective Agents|protective agents|mesh-ancestor
6055851|NCT00611897|Antidotes|antidotes|mesh-ancestor
6055852|NCT00611923|Flutamide|flutamide|mesh-list
6055853|NCT00611923|Androgen Antagonists|androgen antagonists|mesh-ancestor
6055854|NCT00611923|Hormone Antagonists|hormone antagonists|mesh-ancestor
6055855|NCT00611923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6055856|NCT00611923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055857|NCT00611923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6055858|NCT00611923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6055859|NCT00611975|Bupropion|bupropion|mesh-list
6055860|NCT00611975|Fluoxetine|fluoxetine|mesh-list
6055861|NCT00611975|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6055862|NCT00611975|Antidepressive Agents|antidepressive agents|mesh-ancestor
6055863|NCT00611975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6055864|NCT00611975|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6201959|NCT02034019|Antiemetics|antiemetics|mesh-ancestor
5504122|NCT04452461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6055865|NCT00611975|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6055866|NCT00611975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6055867|NCT00611975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6055868|NCT00611975|Dopamine Agents|dopamine agents|mesh-ancestor
6055869|NCT00611975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6055870|NCT00611975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055871|NCT00611975|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6055872|NCT00611975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6055873|NCT00611975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6055874|NCT00611975|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6055875|NCT00611975|Serotonin Agents|serotonin agents|mesh-ancestor
6055876|NCT00612040|Insulin|insulin|mesh-list
6055877|NCT00612040|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6055878|NCT00612040|Insulin Glargine|insulin glargine|mesh-list
6055879|NCT00612040|Insulin Aspart|insulin aspart|mesh-list
6055880|NCT00612040|Insulin, Long-Acting|insulin, long-acting|mesh-list
6055881|NCT00612040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6055882|NCT00612040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055883|NCT00612066|Rosiglitazone|rosiglitazone|mesh-list
6055884|NCT00612066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6055885|NCT00612066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055886|NCT00612105|Ezogabine|ezogabine|mesh-list
6055887|NCT00612105|Anticonvulsants|anticonvulsants|mesh-ancestor
6055888|NCT00612105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6055889|NCT00612105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6055890|NCT00612222|Aldesleukin|aldesleukin|mesh-list
6055891|NCT00612222|Cyclophosphamide|cyclophosphamide|mesh-list
6055892|NCT00612222|Fludarabine|fludarabine|mesh-list
6055893|NCT00612222|Fludarabine phosphate|fludarabine phosphate|mesh-list
6055894|NCT00612222|Interleukin-2|interleukin-2|mesh-list
6055895|NCT00612222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6055896|NCT00612222|Immunologic Factors|immunologic factors|mesh-ancestor
6055897|NCT00612222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462315|NCT00458458|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6462316|NCT00458510|Fentanyl|fentanyl|mesh-list
6462317|NCT00458510|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6462318|NCT00458510|Narcotics|narcotics|mesh-ancestor
6462319|NCT00458510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6462320|NCT00458510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462321|NCT00458510|Analgesics|analgesics|mesh-ancestor
6055898|NCT00612222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6055899|NCT00612222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6055900|NCT00612222|Alkylating Agents|alkylating agents|mesh-ancestor
6055901|NCT00612222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6055902|NCT00612222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6055903|NCT00612222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6055904|NCT00612222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6055905|NCT00612222|Antimetabolites|antimetabolites|mesh-ancestor
6055906|NCT00612222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6055907|NCT00612222|Analgesics|analgesics|mesh-ancestor
6055908|NCT00612222|Sensory System Agents|sensory system agents|mesh-ancestor
6055909|NCT00612222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6462322|NCT00458510|Sensory System Agents|sensory system agents|mesh-ancestor
6055910|NCT00612222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6055911|NCT00612222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6055912|NCT00612222|Antiviral Agents|antiviral agents|mesh-ancestor
6055913|NCT00612222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6055914|NCT00612235|Lamotrigine|lamotrigine|mesh-list
6055915|NCT00612235|Carbamazepine|carbamazepine|mesh-list
6055916|NCT00612235|Levetiracetam|levetiracetam|mesh-list
6055917|NCT00612235|Anticonvulsants|anticonvulsants|mesh-ancestor
6055918|NCT00612235|Nootropic Agents|nootropic agents|mesh-ancestor
6055919|NCT00612235|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6055920|NCT00612235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6055921|NCT00612235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6055922|NCT00612235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6055923|NCT00612235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055924|NCT00612235|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6055925|NCT00612235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6055926|NCT00612235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6055927|NCT00612235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6055928|NCT00612235|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6055929|NCT00612235|Antimanic Agents|antimanic agents|mesh-ancestor
6055930|NCT00612235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6055931|NCT00612235|Analgesics|analgesics|mesh-ancestor
5504123|NCT04452461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5504124|NCT04452461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5504125|NCT04452461|Immunologic Factors|immunologic factors|mesh-ancestor
5504126|NCT04452461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504127|NCT04452461|Antidotes|antidotes|mesh-ancestor
5504128|NCT04452461|Protective Agents|protective agents|mesh-ancestor
5504129|NCT04452461|Vitamin B Complex|vitamin b complex|mesh-ancestor
5504130|NCT04452461|Vitamins|vitamins|mesh-ancestor
5504131|NCT04452461|Micronutrients|micronutrients|mesh-ancestor
5504132|NCT04452214|Pembrolizumab|pembrolizumab|mesh-list
6055932|NCT00612235|Sensory System Agents|sensory system agents|mesh-ancestor
6055933|NCT00612235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6055934|NCT00612235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6055935|NCT00612235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6055936|NCT00612313|Fluoxetine|fluoxetine|mesh-list
6055937|NCT00612313|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6055938|NCT00612313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6055939|NCT00612313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6055940|NCT00612313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6055941|NCT00612313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6055942|NCT00612313|Serotonin Agents|serotonin agents|mesh-ancestor
6055943|NCT00612313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055944|NCT00612313|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6055945|NCT00612313|Antidepressive Agents|antidepressive agents|mesh-ancestor
6055946|NCT00612313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6055947|NCT00612313|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6055948|NCT00612313|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6055949|NCT00612313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6055950|NCT00612339|Bevacizumab|bevacizumab|mesh-list
6055951|NCT00612339|Temozolomide|temozolomide|mesh-list
6055952|NCT00612339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6055953|NCT00612339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6055954|NCT00612339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5504133|NCT04452214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5504134|NCT04452214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5504135|NCT04451746|Contraceptive Agents|contraceptive agents|mesh-list
5504136|NCT04451746|Contraceptives, Oral|contraceptives, oral|mesh-list
5504137|NCT04451746|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
5504138|NCT04451746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5504139|NCT04451746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504140|NCT04451746|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5600057|NCT03714880|Abortifacient Agents|abortifacient agents|mesh-ancestor
6055955|NCT00612339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6055956|NCT00612339|Growth Substances|growth substances|mesh-ancestor
6055957|NCT00612339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055958|NCT00612339|Growth Inhibitors|growth inhibitors|mesh-ancestor
6055959|NCT00612339|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6055960|NCT00612339|Alkylating Agents|alkylating agents|mesh-ancestor
6055961|NCT00612339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6055962|NCT00612352|Ethanol|ethanol|mesh-list
6055963|NCT00612352|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6055964|NCT00612352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6055965|NCT00612352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6055966|NCT00612352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055967|NCT00612430|Bevacizumab|bevacizumab|mesh-list
6055968|NCT00612430|Etoposide|etoposide|mesh-list
6055969|NCT00612430|Etoposide phosphate|etoposide phosphate|mesh-list
6055970|NCT00612430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6055971|NCT00612430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6055972|NCT00612430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6055973|NCT00612430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6055974|NCT00612430|Growth Substances|growth substances|mesh-ancestor
6055975|NCT00612430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055976|NCT00612430|Growth Inhibitors|growth inhibitors|mesh-ancestor
6055977|NCT00612430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6055978|NCT00612430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6055979|NCT00612430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6055980|NCT00612430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6055981|NCT00612430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6055982|NCT00612508|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6462323|NCT00458510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6462324|NCT00458510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6462325|NCT00458510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6462326|NCT00458510|Anesthetics, General|anesthetics, general|mesh-ancestor
6462327|NCT00458510|Anesthetics|anesthetics|mesh-ancestor
6462328|NCT00458523|Alemtuzumab|alemtuzumab|mesh-list
6462329|NCT00458523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6055983|NCT00612508|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6055984|NCT00612508|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6055985|NCT00612508|Etonogestrel|etonogestrel|mesh-list
6055986|NCT00612508|Desogestrel|desogestrel|mesh-list
6055987|NCT00612508|NuvaRing|nuvaring|mesh-list
6055988|NCT00612508|Estradiol|estradiol|mesh-list
6055989|NCT00612508|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6055990|NCT00612508|Estrogens|estrogens|mesh-ancestor
6055991|NCT00612508|Hormones|hormones|mesh-ancestor
6055992|NCT00612508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6055993|NCT00612508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462330|NCT00458523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6055994|NCT00612508|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5504141|NCT04451837|Dapagliflozin|dapagliflozin|mesh-list
5504142|NCT04451837|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5504143|NCT04451837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504144|NCT04451837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5504145|NCT04451837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504146|NCT04451655|Insulin|insulin|mesh-list
5504147|NCT04451655|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5504148|NCT04451655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504149|NCT04451395|Micronutrients|micronutrients|mesh-list
5504150|NCT04451395|Trace Elements|trace elements|mesh-list
5504151|NCT04451395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504152|NCT04451447|SMOFlipid|smoflipid|mesh-list
5504153|NCT04451447|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
5504154|NCT04451447|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5504155|NCT04451447|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5504156|NCT04451200|Busulfan|busulfan|mesh-list
5504157|NCT04451200|Alkylating Agents|alkylating agents|mesh-ancestor
5504158|NCT04451200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504159|NCT04451200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5504160|NCT04451200|Immunologic Factors|immunologic factors|mesh-ancestor
5504161|NCT04451200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504162|NCT04451200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5504163|NCT04451200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5504164|NCT04451200|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5504165|NCT04451239|Cyclosporine|cyclosporine|mesh-list
5504166|NCT04451239|Cyclosporins|cyclosporins|mesh-list
5504167|NCT04451239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5504168|NCT04451239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504169|NCT04451239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5504170|NCT04451239|Immunologic Factors|immunologic factors|mesh-ancestor
5504171|NCT04451239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504172|NCT04451239|Antifungal Agents|antifungal agents|mesh-ancestor
5504173|NCT04451239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5504174|NCT04451239|Dermatologic Agents|dermatologic agents|mesh-ancestor
5504175|NCT04451239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5504176|NCT04451239|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5504177|NCT04451382|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5504178|NCT04451382|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5504179|NCT04451382|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5504180|NCT04451382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5504181|NCT04451382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6055995|NCT00612508|Contraceptive Agents|contraceptive agents|mesh-ancestor
6055996|NCT00612508|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6055997|NCT00612508|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6055998|NCT00612508|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6055999|NCT00612508|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6056000|NCT00612508|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6056001|NCT00612508|Progestins|progestins|mesh-ancestor
6056002|NCT00612534|Sufentanil|sufentanil|mesh-list
6056003|NCT00612534|Dsuvia|dsuvia|mesh-list
6056004|NCT00612534|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6056005|NCT00612534|Narcotics|narcotics|mesh-ancestor
6056006|NCT00612534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6056007|NCT00612534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056008|NCT00612534|Analgesics|analgesics|mesh-ancestor
6056009|NCT00612534|Sensory System Agents|sensory system agents|mesh-ancestor
6056010|NCT00612534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6056011|NCT00612534|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6056012|NCT00612534|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6056013|NCT00612534|Anesthetics, General|anesthetics, general|mesh-ancestor
6056014|NCT00612534|Anesthetics|anesthetics|mesh-ancestor
6056015|NCT00612560|Anastrozole|anastrozole|mesh-list
6056016|NCT00612560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6056017|NCT00612560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6056018|NCT00612560|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6056019|NCT00612560|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6056020|NCT00612560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6056021|NCT00612560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056022|NCT00612560|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6056023|NCT00612560|Hormone Antagonists|hormone antagonists|mesh-ancestor
6056024|NCT00612560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6056025|NCT00612560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056026|NCT00612573|Doxycycline|doxycycline|mesh-list
6056027|NCT00612573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6056028|NCT00612573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5504182|NCT04451382|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5504183|NCT04451382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5504184|NCT04451382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504185|NCT04451382|Cholinergic Agents|cholinergic agents|mesh-ancestor
5504186|NCT04451382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5504187|NCT04451330|Doxycycline|doxycycline|mesh-list
5504188|NCT04451330|Trifarotene|trifarotene|mesh-list
5504189|NCT04451330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5504190|NCT04451330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5504191|NCT04451330|Antimalarials|antimalarials|mesh-ancestor
5504192|NCT04451330|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5504193|NCT04451330|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5504194|NCT04451330|Dermatologic Agents|dermatologic agents|mesh-ancestor
5504195|NCT04451174|Prednisone|prednisone|mesh-list
5504196|NCT04451174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5504197|NCT04451174|Glucocorticoids|glucocorticoids|mesh-ancestor
5504198|NCT04451174|Hormones|hormones|mesh-ancestor
5504199|NCT04451174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6056029|NCT00612573|Antimalarials|antimalarials|mesh-ancestor
6056030|NCT00612573|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6056031|NCT00612573|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6056032|NCT00612586|Leucovorin|leucovorin|mesh-list
6056033|NCT00612586|Bevacizumab|bevacizumab|mesh-list
6056034|NCT00612586|Fluorouracil|fluorouracil|mesh-list
6056035|NCT00612586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6056036|NCT00612586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6056037|NCT00612586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6056038|NCT00612586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6056039|NCT00612586|Growth Substances|growth substances|mesh-ancestor
6056040|NCT00612586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056041|NCT00612586|Growth Inhibitors|growth inhibitors|mesh-ancestor
6056042|NCT00612586|Antimetabolites|antimetabolites|mesh-ancestor
6056043|NCT00612586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056044|NCT00612586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6056045|NCT00612586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6056046|NCT00612586|Immunologic Factors|immunologic factors|mesh-ancestor
6056047|NCT00612586|Antidotes|antidotes|mesh-ancestor
6056048|NCT00612586|Protective Agents|protective agents|mesh-ancestor
6056049|NCT00612586|Vitamin B Complex|vitamin b complex|mesh-ancestor
6056050|NCT00612586|Vitamins|vitamins|mesh-ancestor
6056051|NCT00612586|Micronutrients|micronutrients|mesh-ancestor
6056052|NCT00612716|Cyclophosphamide|cyclophosphamide|mesh-list
5725048|NCT03183115|Lugol's solution|lugol's solution|mesh-list
6056053|NCT00612716|Busulfan|busulfan|mesh-list
6056054|NCT00612716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6056055|NCT00612716|Immunologic Factors|immunologic factors|mesh-ancestor
6056056|NCT00612716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056057|NCT00612716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6056058|NCT00612716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6056059|NCT00612716|Alkylating Agents|alkylating agents|mesh-ancestor
6056060|NCT00612716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056061|NCT00612716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6056062|NCT00612716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6056063|NCT00612807|Tranylcypromine|tranylcypromine|mesh-list
6056064|NCT00612807|Bupropion|bupropion|mesh-list
6056065|NCT00612807|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6056066|NCT00612807|Sertraline|sertraline|mesh-list
6056067|NCT00612807|Nortriptyline|nortriptyline|mesh-list
6056068|NCT00612807|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6056069|NCT00612807|Antidepressive Agents|antidepressive agents|mesh-ancestor
6056070|NCT00612807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6056071|NCT00612807|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6056072|NCT00612807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6056073|NCT00612807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6056074|NCT00612807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056075|NCT00612807|Dopamine Agents|dopamine agents|mesh-ancestor
6056076|NCT00612807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6056077|NCT00612807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504200|NCT04451174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504201|NCT04451174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5504202|NCT04451174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5504203|NCT04451122|Tea Tree Oil|tea tree oil|mesh-list
6056078|NCT00612807|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6056079|NCT00612807|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6056080|NCT00612807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6056081|NCT00612807|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6056082|NCT00612807|Serotonin Agents|serotonin agents|mesh-ancestor
6056083|NCT00612807|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6056084|NCT00612807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6056085|NCT00612807|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6056086|NCT00612807|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6056087|NCT00612807|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6056088|NCT00612807|Adrenergic Agents|adrenergic agents|mesh-ancestor
6056089|NCT00612807|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6056090|NCT00612807|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6056091|NCT00613015|Guanfacine|guanfacine|mesh-list
6056092|NCT00613015|Modafinil|modafinil|mesh-list
6056093|NCT00613015|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6056094|NCT00613015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056095|NCT00613015|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6056096|NCT00613015|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6056097|NCT00613015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6056098|NCT00613015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056099|NCT00613015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6056100|NCT00613015|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6056101|NCT00613015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6056102|NCT00613015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6056103|NCT00613015|Adrenergic Agents|adrenergic agents|mesh-ancestor
6056104|NCT00613015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6056105|NCT00613028|Bevacizumab|bevacizumab|mesh-list
6056106|NCT00613028|Etoposide|etoposide|mesh-list
6056107|NCT00613028|Temozolomide|temozolomide|mesh-list
6056108|NCT00613028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6056109|NCT00613028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6056110|NCT00613028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6056111|NCT00613028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6056112|NCT00613028|Growth Substances|growth substances|mesh-ancestor
6056113|NCT00613028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056114|NCT00613028|Growth Inhibitors|growth inhibitors|mesh-ancestor
6056115|NCT00613028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6056116|NCT00613028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6056117|NCT00613028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6056118|NCT00613028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6056119|NCT00613028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056120|NCT00613028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6056121|NCT00613028|Alkylating Agents|alkylating agents|mesh-ancestor
6201960|NCT02034019|Autonomic Agents|autonomic agents|mesh-ancestor
6201961|NCT02034019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6201962|NCT02034019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201963|NCT02034019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6201964|NCT02034019|Glucocorticoids|glucocorticoids|mesh-ancestor
6201965|NCT02034019|Hormones|hormones|mesh-ancestor
6201966|NCT02034019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6201967|NCT02034019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6201968|NCT02034019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6201969|NCT02034162|Mebendazole|mebendazole|mesh-list
6201970|NCT02034162|Piperazine|piperazine|mesh-list
6201971|NCT02034162|Piperazine citrate|piperazine citrate|mesh-list
6201972|NCT02034162|DMP 777|dmp 777|mesh-list
6201973|NCT02034162|Antinematodal Agents|antinematodal agents|mesh-ancestor
6201974|NCT02034162|Anthelmintics|anthelmintics|mesh-ancestor
6201975|NCT02034162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6201976|NCT02034162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6201977|NCT02034162|Tubulin Modulators|tubulin modulators|mesh-ancestor
6201978|NCT02034162|Antimitotic Agents|antimitotic agents|mesh-ancestor
6201979|NCT02034162|Mitosis Modulators|mitosis modulators|mesh-ancestor
6201980|NCT02034162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201981|NCT02034162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6201982|NCT02034162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6201983|NCT02034435|Amlodipine|amlodipine|mesh-list
6201984|NCT02034435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6201985|NCT02034435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6201986|NCT02034435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6201987|NCT02034435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201988|NCT02034435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6201989|NCT02034435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201990|NCT02034435|Vasodilator Agents|vasodilator agents|mesh-ancestor
6201991|NCT02034513|Insulin|insulin|mesh-list
6201992|NCT02034513|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6201993|NCT02034513|Insulin Glargine|insulin glargine|mesh-list
6201994|NCT02034513|Insulin Aspart|insulin aspart|mesh-list
6201995|NCT02034513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6056122|NCT00613080|Leucovorin|leucovorin|mesh-list
6056123|NCT00613080|Fluorouracil|fluorouracil|mesh-list
6056124|NCT00613080|Capecitabine|capecitabine|mesh-list
6056125|NCT00613080|Oxaliplatin|oxaliplatin|mesh-list
6056126|NCT00613080|Antimetabolites|antimetabolites|mesh-ancestor
6056127|NCT00613080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056128|NCT00613080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6056129|NCT00613080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6056130|NCT00613080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6056131|NCT00613080|Immunologic Factors|immunologic factors|mesh-ancestor
6056132|NCT00613080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056133|NCT00613080|Antidotes|antidotes|mesh-ancestor
6056134|NCT00613080|Protective Agents|protective agents|mesh-ancestor
6056135|NCT00613080|Vitamin B Complex|vitamin b complex|mesh-ancestor
6056136|NCT00613080|Vitamins|vitamins|mesh-ancestor
6056137|NCT00613080|Micronutrients|micronutrients|mesh-ancestor
6056138|NCT00613106|Ibuprofen|ibuprofen|mesh-list
6056139|NCT00613106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6056140|NCT00613106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6056141|NCT00613106|Analgesics|analgesics|mesh-ancestor
6056142|NCT00613106|Sensory System Agents|sensory system agents|mesh-ancestor
5504204|NCT04451122|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6056143|NCT00613106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5725049|NCT03183115|Hemostatics|hemostatics|mesh-ancestor
6056144|NCT00613106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056145|NCT00613106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6056146|NCT00613106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6056147|NCT00613106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6056148|NCT00613106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6056149|NCT00613106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056150|NCT00613171|Imatinib Mesylate|imatinib mesylate|mesh-list
6056151|NCT00613171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6056152|NCT00613171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6056153|NCT00613171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6056154|NCT00613171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056155|NCT00613327|Oxybutynin|oxybutynin|mesh-list
6056156|NCT00613327|Parasympatholytics|parasympatholytics|mesh-ancestor
6056157|NCT00613327|Autonomic Agents|autonomic agents|mesh-ancestor
6056158|NCT00613327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6056159|NCT00613327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056160|NCT00613327|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6056161|NCT00613327|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6056162|NCT00613327|Cholinergic Agents|cholinergic agents|mesh-ancestor
6056163|NCT00613327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6056164|NCT00613327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056165|NCT00613327|Urological Agents|urological agents|mesh-ancestor
6056166|NCT00613366|Misoprostol|misoprostol|mesh-list
6056167|NCT00613366|Magnesium Oxide|magnesium oxide|mesh-list
6056168|NCT00613366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6056169|NCT00613366|Abortifacient Agents|abortifacient agents|mesh-ancestor
6056170|NCT00613366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6056171|NCT00613366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056172|NCT00613366|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5504205|NCT04451122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5504206|NCT04451083|Camostat|camostat|mesh-list
5504207|NCT04451083|Protease Inhibitors|protease inhibitors|mesh-ancestor
5504208|NCT04451083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5504209|NCT04451083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504210|NCT04451083|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5504211|NCT04451083|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5504212|NCT04450836|Trifluridine|trifluridine|mesh-list
5504213|NCT04450836|Antimetabolites|antimetabolites|mesh-ancestor
5504214|NCT04450836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504215|NCT04450836|Antiviral Agents|antiviral agents|mesh-ancestor
5504216|NCT04450836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5504217|NCT04450680|Lactams|lactams|mesh-list
5504218|NCT04450680|beta-Lactams|beta-lactams|mesh-list
5504219|NCT04450680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5504220|NCT04450680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5504221|NCT04450446|Heparin|heparin|mesh-list
5504222|NCT04450446|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5504223|NCT04450446|Tinzaparin|tinzaparin|mesh-list
6462331|NCT00458614|Lansoprazole|lansoprazole|mesh-list
6462332|NCT00458614|Dexlansoprazole|dexlansoprazole|mesh-list
5504224|NCT04450446|Dalteparin|dalteparin|mesh-list
5504225|NCT04450446|Anticoagulants|anticoagulants|mesh-ancestor
5504226|NCT04450446|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5504227|NCT04450446|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5504228|NCT04450446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504229|NCT04450160|Temozolomide|temozolomide|mesh-list
5504230|NCT04450160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5504231|NCT04450160|Alkylating Agents|alkylating agents|mesh-ancestor
5504232|NCT04450160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504233|NCT04450160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5504234|NCT04450173|Venetoclax|venetoclax|mesh-list
6056173|NCT00613366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6056174|NCT00613366|Oxytocics|oxytocics|mesh-ancestor
6056175|NCT00613366|Antacids|antacids|mesh-ancestor
6462333|NCT00458614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6462334|NCT00458614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6462335|NCT00458614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6462336|NCT00458614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6462337|NCT00458614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462338|NCT00458718|Rimonabant|rimonabant|mesh-list
6462339|NCT00458718|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6462340|NCT00458718|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
6462341|NCT00458718|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6462342|NCT00458718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6462343|NCT00458718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462344|NCT00458718|Hormones|hormones|mesh-ancestor
6462345|NCT00458718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6665178|NCT01516060|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6056176|NCT00613366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056177|NCT00613379|Leronlimab|leronlimab|mesh-list
6056178|NCT00613379|HIV Antibodies|hiv antibodies|mesh-list
6056179|NCT00613379|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6056180|NCT00613379|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6056181|NCT00613379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056182|NCT00613379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6056183|NCT00613379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6056184|NCT00613379|Antiviral Agents|antiviral agents|mesh-ancestor
6056185|NCT00613379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6056186|NCT00613379|Immunologic Factors|immunologic factors|mesh-ancestor
6056187|NCT00613379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056188|NCT00613509|Interferons|interferons|mesh-list
6056189|NCT00613509|Interferon-alpha|interferon-alpha|mesh-list
6056190|NCT00613509|Vaccines|vaccines|mesh-list
6056191|NCT00613509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6056192|NCT00613509|Antiviral Agents|antiviral agents|mesh-ancestor
6056193|NCT00613509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6056194|NCT00613509|Immunologic Factors|immunologic factors|mesh-ancestor
6056195|NCT00613509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056196|NCT00613574|Bromides|bromides|mesh-list
6056197|NCT00613574|Tiotropium Bromide|tiotropium bromide|mesh-list
6056198|NCT00613574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6056199|NCT00613574|Autonomic Agents|autonomic agents|mesh-ancestor
6056200|NCT00613574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6056201|NCT00613574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056202|NCT00613574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6056203|NCT00613574|Respiratory System Agents|respiratory system agents|mesh-ancestor
6056204|NCT00613574|Parasympatholytics|parasympatholytics|mesh-ancestor
6056205|NCT00613574|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6056206|NCT00613574|Cholinergic Agents|cholinergic agents|mesh-ancestor
6056207|NCT00613574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6056208|NCT00613574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056209|NCT00613574|Anticonvulsants|anticonvulsants|mesh-ancestor
6056210|NCT00613626|Etoposide|etoposide|mesh-list
6056211|NCT00613626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6056212|NCT00613626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6056213|NCT00613626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6056214|NCT00613626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6056215|NCT00613626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6056216|NCT00613626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056217|NCT00613821|Lidocaine|lidocaine|mesh-list
6056218|NCT00613821|Anesthetics, Local|anesthetics, local|mesh-ancestor
5504235|NCT04450173|Obinutuzumab|obinutuzumab|mesh-list
5504236|NCT04450173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5504237|NCT04450173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5504238|NCT04450134|Fexofenadine|fexofenadine|mesh-list
5504239|NCT04450134|Famotidine|famotidine|mesh-list
5504240|NCT04450134|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5504241|NCT04450134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5504242|NCT04450134|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5504243|NCT04450134|Histamine Antagonists|histamine antagonists|mesh-ancestor
5504244|NCT04450134|Histamine Agents|histamine agents|mesh-ancestor
5504245|NCT04450134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5504246|NCT04450134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504247|NCT04450134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504248|NCT04450134|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6056219|NCT00613821|Anesthetics|anesthetics|mesh-ancestor
6056220|NCT00613821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6056221|NCT00613821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056222|NCT00613821|Sensory System Agents|sensory system agents|mesh-ancestor
6056223|NCT00613821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6056224|NCT00613821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6056225|NCT00613821|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6056226|NCT00613821|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6056227|NCT00613821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6056228|NCT00613821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056229|NCT00613834|Lidocaine|lidocaine|mesh-list
6056230|NCT00613834|Anesthetics, Local|anesthetics, local|mesh-ancestor
6056231|NCT00613834|Anesthetics|anesthetics|mesh-ancestor
6056232|NCT00613834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6056233|NCT00613834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056234|NCT00613834|Sensory System Agents|sensory system agents|mesh-ancestor
6056235|NCT00613834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6056236|NCT00613834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6056237|NCT00613834|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5504249|NCT04450134|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5504250|NCT04450134|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5504251|NCT04450212|Vitamin K|vitamin k|mesh-list
6056238|NCT00613834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6056239|NCT00613834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6056240|NCT00613834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056241|NCT00613938|Oxycodone|oxycodone|mesh-list
6056242|NCT00613938|Tapentadol|tapentadol|mesh-list
6056243|NCT00613938|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6056244|NCT00613938|Narcotics|narcotics|mesh-ancestor
6056245|NCT00613938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6056246|NCT00613938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056247|NCT00613938|Analgesics|analgesics|mesh-ancestor
6056248|NCT00613938|Sensory System Agents|sensory system agents|mesh-ancestor
6056249|NCT00613938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6056250|NCT00613938|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6056251|NCT00613938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6056252|NCT00613938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6056253|NCT00613938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056254|NCT00613938|Adrenergic Agents|adrenergic agents|mesh-ancestor
6056255|NCT00613938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6056256|NCT00613951|Insulin|insulin|mesh-list
6056257|NCT00613951|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6056258|NCT00613951|Metformin|metformin|mesh-list
6056259|NCT00613951|Insulin Aspart|insulin aspart|mesh-list
6056260|NCT00613951|Insulin, Long-Acting|insulin, long-acting|mesh-list
6056261|NCT00613951|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
5504252|NCT04450212|Vitamins|vitamins|mesh-ancestor
5504253|NCT04450212|Micronutrients|micronutrients|mesh-ancestor
5504254|NCT04450212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504255|NCT04450212|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5504256|NCT04450212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5504257|NCT04450212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462346|NCT00458718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462347|NCT00458731|Bevacizumab|bevacizumab|mesh-list
6462348|NCT00458731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6462349|NCT00458731|Cediranib|cediranib|mesh-list
6462350|NCT00458731|Antibodies|antibodies|mesh-list
6462351|NCT00458731|Immunoglobulins|immunoglobulins|mesh-list
6462352|NCT00458731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6462353|NCT00458731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6462354|NCT00458731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6462355|NCT00458731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5504258|NCT04450212|Hemostatics|hemostatics|mesh-ancestor
5504259|NCT04450212|Coagulants|coagulants|mesh-ancestor
6056262|NCT00613951|Biphasic Insulins|biphasic insulins|mesh-list
6056263|NCT00613951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6056264|NCT00613951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056265|NCT00614055|Insulin|insulin|mesh-list
6056266|NCT00614055|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6056267|NCT00614055|Metformin|metformin|mesh-list
6056268|NCT00614055|Insulin Glargine|insulin glargine|mesh-list
6056269|NCT00614055|Insulin Aspart|insulin aspart|mesh-list
6056270|NCT00614055|Insulin, Long-Acting|insulin, long-acting|mesh-list
6056271|NCT00614055|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6056272|NCT00614055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6056273|NCT00614055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056274|NCT00614120|Metformin|metformin|mesh-list
6056275|NCT00614120|Liraglutide|liraglutide|mesh-list
6056276|NCT00614120|Glimepiride|glimepiride|mesh-list
6056277|NCT00614120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6056278|NCT00614120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056279|NCT00614120|Incretins|incretins|mesh-ancestor
6056280|NCT00614120|Hormones|hormones|mesh-ancestor
6056281|NCT00614120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6056282|NCT00614120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6056283|NCT00614120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6056284|NCT00614120|Immunologic Factors|immunologic factors|mesh-ancestor
6056285|NCT00614198|Caseins|caseins|mesh-list
6056286|NCT00614198|Chelating Agents|chelating agents|mesh-ancestor
6056287|NCT00614198|Sequestering Agents|sequestering agents|mesh-ancestor
6056288|NCT00614198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504260|NCT04450095|Ambrisentan|ambrisentan|mesh-list
5504261|NCT04450095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5504262|NCT04450329|Aflibercept|aflibercept|mesh-list
5504263|NCT04450329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5504264|NCT04450329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5504265|NCT04450329|Growth Substances|growth substances|mesh-ancestor
5504266|NCT04450329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504267|NCT04450329|Growth Inhibitors|growth inhibitors|mesh-ancestor
5504268|NCT04450329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5504269|NCT04450316|Naltrexone|naltrexone|mesh-list
5504270|NCT04450316|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5504271|NCT04450316|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5504272|NCT04450316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504273|NCT04450316|Sensory System Agents|sensory system agents|mesh-ancestor
5504274|NCT04450316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5600058|NCT03714880|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6056289|NCT00614380|Amlodipine|amlodipine|mesh-list
6056290|NCT00614380|Telmisartan|telmisartan|mesh-list
5600059|NCT03714880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056291|NCT00614380|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
6056292|NCT00614380|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6056293|NCT00614380|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6056294|NCT00614380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6056295|NCT00614380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056296|NCT00614380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5504275|NCT04449965|Povidone-Iodine|povidone-iodine|mesh-list
5504276|NCT04449965|Povidone|povidone|mesh-list
5504277|NCT04449965|Plasma Substitutes|plasma substitutes|mesh-ancestor
5504278|NCT04449965|Blood Substitutes|blood substitutes|mesh-ancestor
6056297|NCT00614380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056298|NCT00614380|Vasodilator Agents|vasodilator agents|mesh-ancestor
6056299|NCT00614380|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6056300|NCT00614380|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6056301|NCT00614393|Irinotecan|irinotecan|mesh-list
6056302|NCT00614393|Cetuximab|cetuximab|mesh-list
6056303|NCT00614393|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6056304|NCT00614393|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6056305|NCT00614393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6056306|NCT00614393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6056307|NCT00614393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056308|NCT00614393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6056309|NCT00614393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6056310|NCT00614393|Immunologic Factors|immunologic factors|mesh-ancestor
6056311|NCT00614393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056312|NCT00614406|Celecoxib|celecoxib|mesh-list
6056313|NCT00614406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6056314|NCT00614406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6056315|NCT00614406|Analgesics|analgesics|mesh-ancestor
6056316|NCT00614406|Sensory System Agents|sensory system agents|mesh-ancestor
6462356|NCT00458731|Growth Substances|growth substances|mesh-ancestor
5504279|NCT04449965|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5504280|NCT04449965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5504281|NCT04449952|Listerine|listerine|mesh-list
5504282|NCT04449952|Sodium Fluoride|sodium fluoride|mesh-list
5504283|NCT04449952|Cariostatic Agents|cariostatic agents|mesh-ancestor
5504284|NCT04449952|Protective Agents|protective agents|mesh-ancestor
5504285|NCT04449952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504286|NCT04449952|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6056317|NCT00614406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6056318|NCT00614406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056319|NCT00614406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6056320|NCT00614406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6056321|NCT00614406|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6056322|NCT00614406|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6056323|NCT00614406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6056324|NCT00614406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056325|NCT00614445|Pyridoxine|pyridoxine|mesh-list
6056326|NCT00614445|Vitamin B 6|vitamin b 6|mesh-list
6056327|NCT00614445|Doxylamine|doxylamine|mesh-list
6056328|NCT00614445|Doxylamine succinate|doxylamine succinate|mesh-list
6056329|NCT00614445|Vitamin B Complex|vitamin b complex|mesh-ancestor
6056330|NCT00614445|Vitamins|vitamins|mesh-ancestor
6056331|NCT00614445|Micronutrients|micronutrients|mesh-ancestor
6056332|NCT00614445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056333|NCT00614445|Antiemetics|antiemetics|mesh-ancestor
6056334|NCT00614445|Autonomic Agents|autonomic agents|mesh-ancestor
6462357|NCT00458731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462358|NCT00458731|Growth Inhibitors|growth inhibitors|mesh-ancestor
6462359|NCT00458731|Immunologic Factors|immunologic factors|mesh-ancestor
6462360|NCT00458731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6462361|NCT00458731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462362|NCT00458731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6462363|NCT00458796|Zoledronic Acid|zoledronic acid|mesh-list
6462364|NCT00458796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6462365|NCT00458796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462366|NCT00458809|Oxaliplatin|oxaliplatin|mesh-list
6462367|NCT00458809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6462368|NCT00458835|Ciclesonide|ciclesonide|mesh-list
6462369|NCT00458835|Glucocorticoids|glucocorticoids|mesh-ancestor
6462370|NCT00458835|Hormones|hormones|mesh-ancestor
6462371|NCT00458835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6056335|NCT00614445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5504287|NCT04449952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5504288|NCT04449757|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5504289|NCT04449718|Vitamin D|vitamin d|mesh-list
5504290|NCT04449718|Vitamins|vitamins|mesh-ancestor
5504291|NCT04449718|Micronutrients|micronutrients|mesh-ancestor
5504292|NCT04449718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504293|NCT04449718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5504294|NCT04450199|Vitamin D|vitamin d|mesh-list
6056336|NCT00614445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6056337|NCT00614445|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6056338|NCT00614445|Histamine Antagonists|histamine antagonists|mesh-ancestor
6056339|NCT00614445|Histamine Agents|histamine agents|mesh-ancestor
6056340|NCT00614445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6056341|NCT00614445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056342|NCT00614458|Raltegravir Potassium|raltegravir potassium|mesh-list
6056343|NCT00614458|Valproic Acid|valproic acid|mesh-list
6462372|NCT00458835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462373|NCT00458835|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6462374|NCT00458900|Moxifloxacin|moxifloxacin|mesh-list
6462375|NCT00458900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6462376|NCT00458900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5504295|NCT04450199|Ergocalciferols|ergocalciferols|mesh-list
5504296|NCT04450199|Vitamins|vitamins|mesh-list
5504297|NCT04450199|Micronutrients|micronutrients|mesh-ancestor
5504298|NCT04450199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504299|NCT04450199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5504300|NCT04450199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5504301|NCT04450355|Nefopam|nefopam|mesh-list
5504302|NCT04450355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5504303|NCT04450355|Analgesics|analgesics|mesh-ancestor
5504304|NCT04450355|Sensory System Agents|sensory system agents|mesh-ancestor
5504305|NCT04450355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5504306|NCT04450355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504307|NCT04449536|Mesna|mesna|mesh-list
5504308|NCT04449536|Protective Agents|protective agents|mesh-ancestor
5504309|NCT04449536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504310|NCT04449198|Resveratrol|resveratrol|mesh-list
5504311|NCT04449198|Antioxidants|antioxidants|mesh-ancestor
5504312|NCT04449198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504313|NCT04449198|Protective Agents|protective agents|mesh-ancestor
5504314|NCT04449198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504315|NCT04449198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5504316|NCT04449198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5504317|NCT04449224|Etanercept|etanercept|mesh-list
5504318|NCT04449224|Abatacept|abatacept|mesh-list
6462377|NCT00458900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6665179|NCT01516060|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6665180|NCT01516060|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6665181|NCT01516138|Insulin|insulin|mesh-list
6665182|NCT01516138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6665183|NCT01516138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665184|NCT01516216|Vitamin D|vitamin d|mesh-list
6665185|NCT01516216|Ergocalciferols|ergocalciferols|mesh-list
5504319|NCT04449224|Tofacitinib|tofacitinib|mesh-list
5504320|NCT04449224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5504321|NCT04449224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6462378|NCT00458900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6462379|NCT00458900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6488391|NCT00583869|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6056344|NCT00614458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6056345|NCT00614458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6056346|NCT00614458|Antiviral Agents|antiviral agents|mesh-ancestor
6056347|NCT00614458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6056348|NCT00614458|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6056349|NCT00614458|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6056350|NCT00614458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6056351|NCT00614458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056352|NCT00614458|Anticonvulsants|anticonvulsants|mesh-ancestor
6056353|NCT00614458|GABA Agents|gaba agents|mesh-ancestor
6056354|NCT00614458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6056355|NCT00614458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056356|NCT00614458|Antimanic Agents|antimanic agents|mesh-ancestor
6056357|NCT00614458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5504322|NCT04449224|Analgesics|analgesics|mesh-ancestor
5504323|NCT04449224|Sensory System Agents|sensory system agents|mesh-ancestor
5504324|NCT04449224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6056358|NCT00614458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6056359|NCT00614458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6056360|NCT00614484|Paclitaxel|paclitaxel|mesh-list
6056361|NCT00614484|Carboplatin|carboplatin|mesh-list
6056362|NCT00614484|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6056363|NCT00614484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6056364|NCT00614484|Tubulin Modulators|tubulin modulators|mesh-ancestor
6056365|NCT00614484|Antimitotic Agents|antimitotic agents|mesh-ancestor
5504325|NCT04449224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504326|NCT04449224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5504327|NCT04449224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5504328|NCT04449224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5504329|NCT04449224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5504330|NCT04449224|Immunologic Factors|immunologic factors|mesh-ancestor
5504331|NCT04449224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5504332|NCT04449224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504333|NCT04449224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5504334|NCT04449224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5504335|NCT04449224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5504336|NCT04449289|Lidocaine|lidocaine|mesh-list
5504337|NCT04449289|Ropivacaine|ropivacaine|mesh-list
5504338|NCT04449289|Anesthetics, Local|anesthetics, local|mesh-ancestor
5504339|NCT04449289|Anesthetics|anesthetics|mesh-ancestor
5504340|NCT04449289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5504341|NCT04449289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504342|NCT04449289|Sensory System Agents|sensory system agents|mesh-ancestor
6056366|NCT00614484|Mitosis Modulators|mitosis modulators|mesh-ancestor
6056367|NCT00614484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056368|NCT00614614|Vaccines|vaccines|mesh-list
6056369|NCT00614614|Immunologic Factors|immunologic factors|mesh-ancestor
6056370|NCT00614614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056371|NCT00614822|Bevacizumab|bevacizumab|mesh-list
6056372|NCT00614822|Carboplatin|carboplatin|mesh-list
6056373|NCT00614822|Pemetrexed|pemetrexed|mesh-list
6056374|NCT00614822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6056375|NCT00614822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6056376|NCT00614822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6056377|NCT00614822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6056378|NCT00614822|Growth Substances|growth substances|mesh-ancestor
6056379|NCT00614822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056380|NCT00614822|Growth Inhibitors|growth inhibitors|mesh-ancestor
6056381|NCT00614822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6056382|NCT00614822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056383|NCT00614822|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6056384|NCT00614822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6056385|NCT00614874|Rosiglitazone|rosiglitazone|mesh-list
6056386|NCT00614874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6056387|NCT00614874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056388|NCT00614926|Modafinil|modafinil|mesh-list
6056389|NCT00614926|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6056390|NCT00614926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056391|NCT00614926|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6056392|NCT00614926|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6056393|NCT00614926|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6056394|NCT00614926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665186|NCT01516216|Vitamins|vitamins|mesh-list
5504343|NCT04449289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5504344|NCT04449289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5504345|NCT04449289|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5504346|NCT04449289|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5504347|NCT04449289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6056395|NCT00614939|Saxagliptin|saxagliptin|mesh-list
6056396|NCT00614939|Incretins|incretins|mesh-ancestor
6056397|NCT00614939|Hormones|hormones|mesh-ancestor
6056398|NCT00614939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6056399|NCT00614939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056400|NCT00614939|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6056401|NCT00614939|Protease Inhibitors|protease inhibitors|mesh-ancestor
6056402|NCT00614939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6056403|NCT00614939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056404|NCT00614939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6056405|NCT00614991|Ritonavir|ritonavir|mesh-list
6056406|NCT00614991|Fosamprenavir|fosamprenavir|mesh-list
6056407|NCT00614991|Raltegravir Potassium|raltegravir potassium|mesh-list
6056408|NCT00614991|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6056409|NCT00614991|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6056410|NCT00614991|Protease Inhibitors|protease inhibitors|mesh-ancestor
6056411|NCT00614991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6056412|NCT00614991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056413|NCT00614991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6056414|NCT00614991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6056415|NCT00614991|Antiviral Agents|antiviral agents|mesh-ancestor
6056416|NCT00614991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6056417|NCT00614991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6056418|NCT00614991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6056419|NCT00614991|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6056420|NCT00614991|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6056421|NCT00615030|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6056422|NCT00615030|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6056423|NCT00615030|Autonomic Agents|autonomic agents|mesh-ancestor
6056424|NCT00615030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5504348|NCT04449289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504349|NCT04449471|Naproxen|naproxen|mesh-list
5504350|NCT04449471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6056425|NCT00615030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056426|NCT00615030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6056427|NCT00615030|Respiratory System Agents|respiratory system agents|mesh-ancestor
6056428|NCT00615030|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6056429|NCT00615030|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6056430|NCT00615030|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6056431|NCT00615030|Adrenergic Agents|adrenergic agents|mesh-ancestor
6056432|NCT00615030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6056433|NCT00615030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056434|NCT00615056|Leucovorin|leucovorin|mesh-list
6056435|NCT00615056|Bevacizumab|bevacizumab|mesh-list
6056436|NCT00615056|Fluorouracil|fluorouracil|mesh-list
6056437|NCT00615056|Oxaliplatin|oxaliplatin|mesh-list
6056438|NCT00615056|Irinotecan|irinotecan|mesh-list
6056439|NCT00615056|Axitinib|axitinib|mesh-list
6056440|NCT00615056|Levoleucovorin|levoleucovorin|mesh-list
6056441|NCT00615056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6056442|NCT00615056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6056443|NCT00615056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6056444|NCT00615056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6056445|NCT00615056|Growth Substances|growth substances|mesh-ancestor
6056446|NCT00615056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056447|NCT00615056|Growth Inhibitors|growth inhibitors|mesh-ancestor
6056448|NCT00615056|Antimetabolites|antimetabolites|mesh-ancestor
5504351|NCT04449471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5504352|NCT04449471|Analgesics|analgesics|mesh-ancestor
5504353|NCT04449471|Sensory System Agents|sensory system agents|mesh-ancestor
5504354|NCT04449471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5504355|NCT04449471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504356|NCT04449471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5504357|NCT04449471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5504358|NCT04449471|Gout Suppressants|gout suppressants|mesh-ancestor
6056449|NCT00615056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056450|NCT00615056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6056451|NCT00615056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6056452|NCT00615056|Immunologic Factors|immunologic factors|mesh-ancestor
6056453|NCT00615056|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6056454|NCT00615056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6056455|NCT00615056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6056456|NCT00615056|Antidotes|antidotes|mesh-ancestor
6056457|NCT00615056|Protective Agents|protective agents|mesh-ancestor
6056458|NCT00615056|Vitamin B Complex|vitamin b complex|mesh-ancestor
6056459|NCT00615056|Vitamins|vitamins|mesh-ancestor
6056460|NCT00615056|Micronutrients|micronutrients|mesh-ancestor
6056461|NCT00615056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6056462|NCT00615199|Tofacitinib|tofacitinib|mesh-list
6056463|NCT00615199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6056464|NCT00615199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6056465|NCT00615199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056466|NCT00615290|Tipranavir|tipranavir|mesh-list
6056467|NCT00615290|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6056468|NCT00615290|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6056469|NCT00615290|Antiviral Agents|antiviral agents|mesh-ancestor
6056470|NCT00615290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5504359|NCT04449471|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5504360|NCT04449471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5504361|NCT04449471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504362|NCT04449185|Amoxicillin|amoxicillin|mesh-list
5504363|NCT04449185|Clarithromycin|clarithromycin|mesh-list
5504364|NCT04449185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5504365|NCT04449185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5504366|NCT04449185|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5504367|NCT04449185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5504368|NCT04449185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504369|NCT04449185|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5504370|NCT04449185|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5504371|NCT04449380|Interferons|interferons|mesh-list
5504372|NCT04449380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5504373|NCT04449380|Antiviral Agents|antiviral agents|mesh-ancestor
5504374|NCT04449380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5504375|NCT04448873|Sirolimus|sirolimus|mesh-list
5504376|NCT04448873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5504377|NCT04448873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5504378|NCT04448873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5504379|NCT04448873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5504380|NCT04448873|Antifungal Agents|antifungal agents|mesh-ancestor
5504381|NCT04448873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5504382|NCT04448873|Immunologic Factors|immunologic factors|mesh-ancestor
5504383|NCT04448873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504384|NCT04448821|Metformin|metformin|mesh-list
5504385|NCT04448821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5504386|NCT04448821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504387|NCT04448977|Ocrelizumab|ocrelizumab|mesh-list
5504388|NCT04448977|Immunologic Factors|immunologic factors|mesh-ancestor
5504389|NCT04448977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504390|NCT04448587|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5504391|NCT04448587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5504392|NCT04448587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504393|NCT04448587|Incretins|incretins|mesh-ancestor
5504394|NCT04448587|Hormones|hormones|mesh-ancestor
5504395|NCT04448587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5504396|NCT04448587|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5504397|NCT04448587|Protease Inhibitors|protease inhibitors|mesh-ancestor
5504398|NCT04448587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5504399|NCT04448587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504400|NCT04448496|Dexamethasone|dexamethasone|mesh-list
5504401|NCT04448496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5504402|NCT04448496|Antiemetics|antiemetics|mesh-ancestor
5504403|NCT04448496|Autonomic Agents|autonomic agents|mesh-ancestor
5504404|NCT04448496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5504405|NCT04448496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504406|NCT04448496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5504407|NCT04448496|Glucocorticoids|glucocorticoids|mesh-ancestor
5504408|NCT04448496|Hormones|hormones|mesh-ancestor
5504409|NCT04448496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5504410|NCT04448496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5504411|NCT04448496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5504412|NCT04448457|Sufentanil|sufentanil|mesh-list
5504413|NCT04448457|Oxycodone|oxycodone|mesh-list
5504414|NCT04448457|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6056471|NCT00615433|Olanzapine|olanzapine|mesh-list
5504415|NCT04448457|Narcotics|narcotics|mesh-ancestor
6056472|NCT00615433|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
6056473|NCT00615433|Antiemetics|antiemetics|mesh-ancestor
6056474|NCT00615433|Autonomic Agents|autonomic agents|mesh-ancestor
6462380|NCT00458900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504416|NCT04448457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5504417|NCT04448457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504418|NCT04448457|Analgesics|analgesics|mesh-ancestor
5504419|NCT04448457|Sensory System Agents|sensory system agents|mesh-ancestor
5504420|NCT04448457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6056475|NCT00615433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6056476|NCT00615433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056477|NCT00615433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6056478|NCT00615433|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6056479|NCT00615433|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6056480|NCT00615433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6056481|NCT00615433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6056482|NCT00615433|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6056483|NCT00615433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6056484|NCT00615433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6056485|NCT00615433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056486|NCT00615433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6056487|NCT00615433|Serotonin Agents|serotonin agents|mesh-ancestor
6056488|NCT00615433|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6056489|NCT00615433|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6056490|NCT00615433|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5504421|NCT04448457|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5504422|NCT04448457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5504423|NCT04448457|Anesthetics, General|anesthetics, general|mesh-ancestor
5504424|NCT04448457|Anesthetics|anesthetics|mesh-ancestor
6056491|NCT00615433|Adrenergic Agents|adrenergic agents|mesh-ancestor
6056492|NCT00615433|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6056493|NCT00615433|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6056494|NCT00615433|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6056495|NCT00615433|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6056496|NCT00615433|Dopamine Agents|dopamine agents|mesh-ancestor
6056497|NCT00615459|Tiotropium Bromide|tiotropium bromide|mesh-list
6056498|NCT00615459|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6056499|NCT00615459|Autonomic Agents|autonomic agents|mesh-ancestor
6056500|NCT00615459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6056501|NCT00615459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056502|NCT00615459|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6056503|NCT00615459|Respiratory System Agents|respiratory system agents|mesh-ancestor
6056504|NCT00615459|Parasympatholytics|parasympatholytics|mesh-ancestor
6056505|NCT00615459|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6056506|NCT00615459|Cholinergic Agents|cholinergic agents|mesh-ancestor
6056507|NCT00615459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6056508|NCT00615459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056509|NCT00615472|Remifentanil|remifentanil|mesh-list
6056510|NCT00615472|Propofol|propofol|mesh-list
6056511|NCT00615472|Isoflurane|isoflurane|mesh-list
6056512|NCT00615472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6056513|NCT00615472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6056514|NCT00615472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504425|NCT04448379|Afatinib|afatinib|mesh-list
5504426|NCT04448379|Osimertinib|osimertinib|mesh-list
5504427|NCT04448379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5504428|NCT04448379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5504429|NCT04448379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5504430|NCT04448379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600060|NCT03714880|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5600061|NCT03714880|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5600062|NCT03714880|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5600063|NCT03714880|Contraceptive Agents|contraceptive agents|mesh-ancestor
5600064|NCT03714880|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5725050|NCT03183115|Coagulants|coagulants|mesh-ancestor
6056515|NCT00615472|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6056516|NCT00615472|Anesthetics, General|anesthetics, general|mesh-ancestor
6056517|NCT00615472|Anesthetics|anesthetics|mesh-ancestor
6056518|NCT00615472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6056519|NCT00615472|Narcotics|narcotics|mesh-ancestor
6056520|NCT00615472|Analgesics|analgesics|mesh-ancestor
6056521|NCT00615472|Sensory System Agents|sensory system agents|mesh-ancestor
6056522|NCT00615472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6056523|NCT00615472|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6056524|NCT00615550|Progesterone|progesterone|mesh-list
6056525|NCT00615550|Progestins|progestins|mesh-ancestor
6056526|NCT00615550|Hormones|hormones|mesh-ancestor
6056527|NCT00615550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6056528|NCT00615550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056529|NCT00615589|Fludarabine|fludarabine|mesh-list
6056530|NCT00615589|Busulfan|busulfan|mesh-list
6056531|NCT00615589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6056532|NCT00615589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056533|NCT00615589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6056534|NCT00615589|Immunologic Factors|immunologic factors|mesh-ancestor
6056535|NCT00615589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056536|NCT00615589|Alkylating Agents|alkylating agents|mesh-ancestor
6056537|NCT00615589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6056538|NCT00615589|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6056539|NCT00615784|Bexarotene|bexarotene|mesh-list
6056540|NCT00615784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6056541|NCT00615836|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
6056542|NCT00615836|Hemostatics|hemostatics|mesh-ancestor
6056543|NCT00615836|Coagulants|coagulants|mesh-ancestor
6056544|NCT00615836|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6056545|NCT00615836|Natriuretic Agents|natriuretic agents|mesh-ancestor
6056546|NCT00615836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056547|NCT00615901|Cyclophosphamide|cyclophosphamide|mesh-list
6056548|NCT00615901|Fluorouracil|fluorouracil|mesh-list
6056549|NCT00615901|Methotrexate|methotrexate|mesh-list
6056550|NCT00615901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6056551|NCT00615901|Immunologic Factors|immunologic factors|mesh-ancestor
6056552|NCT00615901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056553|NCT00615901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6056554|NCT00615901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6056555|NCT00615901|Alkylating Agents|alkylating agents|mesh-ancestor
6056556|NCT00615901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056557|NCT00615901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6056558|NCT00615901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6056559|NCT00615901|Antimetabolites|antimetabolites|mesh-ancestor
6056560|NCT00615901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6056561|NCT00615901|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6056562|NCT00615901|Abortifacient Agents|abortifacient agents|mesh-ancestor
6056563|NCT00615901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6056564|NCT00615901|Dermatologic Agents|dermatologic agents|mesh-ancestor
5504431|NCT04448392|Valacyclovir|valacyclovir|mesh-list
5504432|NCT04448392|Antiviral Agents|antiviral agents|mesh-ancestor
5504433|NCT04448392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5504434|NCT04448223|Latanoprost|latanoprost|mesh-list
5504435|NCT04448223|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5504436|NCT04448223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5504437|NCT04448119|Favipiravir|favipiravir|mesh-list
5504438|NCT04448119|Antiviral Agents|antiviral agents|mesh-ancestor
5504439|NCT04448119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5504440|NCT04448015|Analgesics, Opioid|analgesics, opioid|mesh-list
5504441|NCT04448015|Narcotics|narcotics|mesh-ancestor
5504442|NCT04448015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5504443|NCT04448015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504444|NCT04448015|Analgesics|analgesics|mesh-ancestor
5504445|NCT04448015|Sensory System Agents|sensory system agents|mesh-ancestor
5504446|NCT04448015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5504447|NCT04447989|Sildenafil Citrate|sildenafil citrate|mesh-list
5504448|NCT04447989|Vasodilator Agents|vasodilator agents|mesh-ancestor
5504449|NCT04447989|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5504450|NCT04447989|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6056565|NCT00615901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6056566|NCT00615901|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6056567|NCT00615901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6056568|NCT00615927|Imatinib Mesylate|imatinib mesylate|mesh-list
6056569|NCT00615927|Hydroxyurea|hydroxyurea|mesh-list
5504451|NCT04447989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5504452|NCT04447989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504453|NCT04447989|Urological Agents|urological agents|mesh-ancestor
5504454|NCT04447781|Citric Acid|citric acid|mesh-list
6056570|NCT00615927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5504455|NCT04447781|Sodium Citrate|sodium citrate|mesh-list
5504456|NCT04447781|Anticoagulants|anticoagulants|mesh-ancestor
5504457|NCT04447781|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5504458|NCT04447781|Chelating Agents|chelating agents|mesh-ancestor
5504459|NCT04447781|Sequestering Agents|sequestering agents|mesh-ancestor
5504460|NCT04447781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504461|NCT04447716|Rituximab|rituximab|mesh-list
6056571|NCT00615927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6056572|NCT00615927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6056573|NCT00615927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056574|NCT00615927|Antisickling Agents|antisickling agents|mesh-ancestor
6056575|NCT00615927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6056576|NCT00615992|Tiotropium Bromide|tiotropium bromide|mesh-list
6056577|NCT00615992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5504462|NCT04447716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5504463|NCT04447716|Lenalidomide|lenalidomide|mesh-list
5504464|NCT04447716|Venetoclax|venetoclax|mesh-list
5504465|NCT04447716|Piperidine|piperidine|mesh-list
5504466|NCT04447716|Antibodies|antibodies|mesh-list
5504467|NCT04447716|Immunoglobulins|immunoglobulins|mesh-list
5504468|NCT04447716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5504469|NCT04447716|Immunologic Factors|immunologic factors|mesh-ancestor
5504470|NCT04447716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504471|NCT04447716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6056578|NCT00615992|Autonomic Agents|autonomic agents|mesh-ancestor
6056579|NCT00615992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6056580|NCT00615992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056581|NCT00615992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6056582|NCT00615992|Respiratory System Agents|respiratory system agents|mesh-ancestor
6056583|NCT00615992|Parasympatholytics|parasympatholytics|mesh-ancestor
6056584|NCT00615992|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5504472|NCT04447716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5504473|NCT04447716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5504474|NCT04447716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5504475|NCT04447716|Growth Substances|growth substances|mesh-ancestor
5504476|NCT04447716|Growth Inhibitors|growth inhibitors|mesh-ancestor
5504477|NCT04447716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504478|NCT04447716|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6056585|NCT00615992|Cholinergic Agents|cholinergic agents|mesh-ancestor
6056586|NCT00615992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6056587|NCT00615992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056588|NCT00616018|Acetaminophen|acetaminophen|mesh-list
6056589|NCT00616018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6056590|NCT00616018|Analgesics|analgesics|mesh-ancestor
6056591|NCT00616018|Sensory System Agents|sensory system agents|mesh-ancestor
6056592|NCT00616018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6056593|NCT00616018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504479|NCT04447716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5504480|NCT04447716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5504481|NCT04448028|Esomeprazole|esomeprazole|mesh-list
5504482|NCT04448028|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
5504483|NCT04448028|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5504484|NCT04448028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5504485|NCT04448028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5504486|NCT04448028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056594|NCT00616018|Antipyretics|antipyretics|mesh-ancestor
6056595|NCT00616109|Sunitinib|sunitinib|mesh-list
6056596|NCT00616109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6056597|NCT00616109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6056598|NCT00616109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6056599|NCT00616109|Growth Substances|growth substances|mesh-ancestor
6665187|NCT01516216|Leucovorin|leucovorin|mesh-list
5504487|NCT04447911|Empagliflozin|empagliflozin|mesh-list
5504488|NCT04447911|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5504489|NCT04447911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504490|NCT04447911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6056600|NCT00616109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056601|NCT00616109|Growth Inhibitors|growth inhibitors|mesh-ancestor
6056602|NCT00616109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6056603|NCT00616109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6056604|NCT00616109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056605|NCT00616122|Cyclophosphamide|cyclophosphamide|mesh-list
6056606|NCT00616122|Methotrexate|methotrexate|mesh-list
6056607|NCT00616122|Sunitinib|sunitinib|mesh-list
6056608|NCT00616122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6056609|NCT00616122|Immunologic Factors|immunologic factors|mesh-ancestor
6056610|NCT00616122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056611|NCT00616122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6056612|NCT00616122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6056613|NCT00616122|Alkylating Agents|alkylating agents|mesh-ancestor
6056614|NCT00616122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056615|NCT00616122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5504491|NCT04447911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504492|NCT04447612|Gemcitabine|gemcitabine|mesh-list
5504493|NCT04447612|Durvalumab|durvalumab|mesh-list
5504494|NCT04447612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5504495|NCT04447612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5504496|NCT04447612|Antimetabolites|antimetabolites|mesh-ancestor
5504497|NCT04447612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504498|NCT04447612|Antiviral Agents|antiviral agents|mesh-ancestor
5504499|NCT04447612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5504500|NCT04447612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5504501|NCT04447612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6056616|NCT00616122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6056617|NCT00616122|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6056618|NCT00616122|Abortifacient Agents|abortifacient agents|mesh-ancestor
6056619|NCT00616122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6056620|NCT00616122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6056621|NCT00616122|Antimetabolites|antimetabolites|mesh-ancestor
6056622|NCT00616122|Dermatologic Agents|dermatologic agents|mesh-ancestor
6056623|NCT00616122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6056624|NCT00616122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6056625|NCT00616122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6056626|NCT00616122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6056627|NCT00616122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6056628|NCT00616122|Growth Substances|growth substances|mesh-ancestor
6056629|NCT00616122|Growth Inhibitors|growth inhibitors|mesh-ancestor
6056630|NCT00616122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6056631|NCT00616239|Salicylic Acid|salicylic acid|mesh-list
6056632|NCT00616239|Salicylates|salicylates|mesh-list
6056633|NCT00616239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6056634|NCT00616239|Antifungal Agents|antifungal agents|mesh-ancestor
6056635|NCT00616239|Keratolytic Agents|keratolytic agents|mesh-ancestor
6056636|NCT00616239|Dermatologic Agents|dermatologic agents|mesh-ancestor
6056637|NCT00616239|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6056638|NCT00616239|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6056639|NCT00616239|Analgesics|analgesics|mesh-ancestor
6056640|NCT00616239|Sensory System Agents|sensory system agents|mesh-ancestor
6056641|NCT00616239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6056642|NCT00616239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056643|NCT00616239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6056644|NCT00616239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6056645|NCT00616239|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6056646|NCT00616239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6056647|NCT00616239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056648|NCT00616434|Interferons|interferons|mesh-list
6056649|NCT00616434|Interferon-beta|interferon-beta|mesh-list
6056650|NCT00616434|Interferon beta-1a|interferon beta-1a|mesh-list
6056651|NCT00616434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6056652|NCT00616434|Antiviral Agents|antiviral agents|mesh-ancestor
6056653|NCT00616434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6056654|NCT00616434|Immunologic Factors|immunologic factors|mesh-ancestor
6056655|NCT00616434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056656|NCT00616434|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6056657|NCT00616655|Eszopiclone|eszopiclone|mesh-list
6056658|NCT00616655|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6056659|NCT00616655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6056660|NCT00616655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056661|NCT00616772|Choline|choline|mesh-list
6056662|NCT00616772|Atorvastatin|atorvastatin|mesh-list
6056663|NCT00616772|Fenofibric acid|fenofibric acid|mesh-list
6056664|NCT00616772|Fenofibrate|fenofibrate|mesh-list
6056665|NCT00616772|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6056666|NCT00616772|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6056667|NCT00616772|Antimetabolites|antimetabolites|mesh-ancestor
6056668|NCT00616772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056669|NCT00616772|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6056670|NCT00616772|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6056671|NCT00616772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6056672|NCT00616772|Lipotropic Agents|lipotropic agents|mesh-ancestor
6056673|NCT00616772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6056674|NCT00616772|Nootropic Agents|nootropic agents|mesh-ancestor
6056675|NCT00616902|Ergocalciferols|ergocalciferols|mesh-list
6056676|NCT00616902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6056677|NCT00616902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056678|NCT00616902|Vitamins|vitamins|mesh-ancestor
6056679|NCT00616902|Micronutrients|micronutrients|mesh-ancestor
6056680|NCT00616902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6056681|NCT00616941|Poly ICLC|poly iclc|mesh-list
6056682|NCT00616941|Interferon Inducers|interferon inducers|mesh-ancestor
6056683|NCT00616941|Immunologic Factors|immunologic factors|mesh-ancestor
6056684|NCT00616941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056685|NCT00617058|Metformin|metformin|mesh-list
6056686|NCT00617058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6056687|NCT00617058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056688|NCT00617084|Everolimus|everolimus|mesh-list
6056689|NCT00617084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6056690|NCT00617084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6665188|NCT01516216|Bevacizumab|bevacizumab|mesh-list
6665189|NCT01516216|Fluorouracil|fluorouracil|mesh-list
6665190|NCT01516216|Oxaliplatin|oxaliplatin|mesh-list
6665191|NCT01516216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6665192|NCT01516216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6665193|NCT01516216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6665194|NCT01516216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6665195|NCT01516216|Growth Substances|growth substances|mesh-ancestor
6462381|NCT00458900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6462382|NCT00458913|Bortezomib|bortezomib|mesh-list
6462383|NCT00458913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6462384|NCT00458991|Dextromethorphan|dextromethorphan|mesh-list
6462385|NCT00458991|Caffeine|caffeine|mesh-list
6462386|NCT00458991|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6462387|NCT00458991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462388|NCT00458991|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6462389|NCT00458991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6462390|NCT00458991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056691|NCT00617084|Immunologic Factors|immunologic factors|mesh-ancestor
6056692|NCT00617084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056693|NCT00617097|Ketorolac|ketorolac|mesh-list
6056694|NCT00617097|Lidocaine|lidocaine|mesh-list
6056695|NCT00617097|Anesthetics, Local|anesthetics, local|mesh-ancestor
6056696|NCT00617097|Anesthetics|anesthetics|mesh-ancestor
6056697|NCT00617097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6056698|NCT00617097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056699|NCT00617097|Sensory System Agents|sensory system agents|mesh-ancestor
6056700|NCT00617097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6056701|NCT00617097|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6056702|NCT00617097|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6056703|NCT00617097|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6056704|NCT00617097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6056705|NCT00617097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056706|NCT00617097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6056707|NCT00617097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6056708|NCT00617097|Analgesics|analgesics|mesh-ancestor
6056709|NCT00617097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6056710|NCT00617097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6056711|NCT00617097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6056712|NCT00617097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6056713|NCT00617123|Vorapaxar|vorapaxar|mesh-list
6056714|NCT00617123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6056715|NCT00617188|Fulvestrant|fulvestrant|mesh-list
6056716|NCT00617188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6056717|NCT00617188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6056718|NCT00617188|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6056719|NCT00617188|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6462391|NCT00458991|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6056720|NCT00617188|Hormone Antagonists|hormone antagonists|mesh-ancestor
6056721|NCT00617188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6056722|NCT00617188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056723|NCT00617201|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6056724|NCT00617201|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6056725|NCT00617201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6056726|NCT00617201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6056727|NCT00617201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056728|NCT00617201|Adrenergic Agents|adrenergic agents|mesh-ancestor
6056729|NCT00617201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6056730|NCT00617201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056731|NCT00617240|Metformin|metformin|mesh-list
6056732|NCT00617240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6056733|NCT00617240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056734|NCT00617305|Ambrisentan|ambrisentan|mesh-list
6056735|NCT00617305|Sildenafil Citrate|sildenafil citrate|mesh-list
6056736|NCT00617305|Tadalafil|tadalafil|mesh-list
6056737|NCT00617305|Vasodilator Agents|vasodilator agents|mesh-ancestor
6056738|NCT00617305|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6056739|NCT00617305|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6056740|NCT00617305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6056741|NCT00617305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462392|NCT00458991|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6462393|NCT00458991|Purinergic Agents|purinergic agents|mesh-ancestor
5504502|NCT04447612|Immunologic Factors|immunologic factors|mesh-ancestor
5504503|NCT04447612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725051|NCT03183076|Anticonvulsants|anticonvulsants|mesh-list
6056742|NCT00617305|Urological Agents|urological agents|mesh-ancestor
6056743|NCT00617305|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6056744|NCT00617344|Vaccines|vaccines|mesh-list
6056745|NCT00617344|Immunologic Factors|immunologic factors|mesh-ancestor
6056746|NCT00617344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056747|NCT00617396|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6056748|NCT00617396|Antidepressive Agents|antidepressive agents|mesh-ancestor
6056749|NCT00617396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6056750|NCT00617396|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6056751|NCT00617396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6056752|NCT00617396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6056753|NCT00617396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056754|NCT00617409|Paclitaxel|paclitaxel|mesh-list
6056755|NCT00617409|Tretinoin|tretinoin|mesh-list
6056756|NCT00617409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6056757|NCT00617409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6056758|NCT00617409|Tubulin Modulators|tubulin modulators|mesh-ancestor
6056759|NCT00617409|Antimitotic Agents|antimitotic agents|mesh-ancestor
6056760|NCT00617409|Mitosis Modulators|mitosis modulators|mesh-ancestor
6056761|NCT00617409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056762|NCT00617409|Keratolytic Agents|keratolytic agents|mesh-ancestor
6056763|NCT00617409|Dermatologic Agents|dermatologic agents|mesh-ancestor
6056764|NCT00617461|Gabapentin|gabapentin|mesh-list
6056765|NCT00617461|Analgesics|analgesics|mesh-ancestor
6056766|NCT00617461|Sensory System Agents|sensory system agents|mesh-ancestor
6056767|NCT00617461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6056768|NCT00617461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056769|NCT00617461|Anticonvulsants|anticonvulsants|mesh-ancestor
6056770|NCT00617461|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6056771|NCT00617461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6056772|NCT00617461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6056773|NCT00617461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6056774|NCT00617461|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6462394|NCT00458991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6462395|NCT00458991|Antitussive Agents|antitussive agents|mesh-ancestor
6462396|NCT00458991|Respiratory System Agents|respiratory system agents|mesh-ancestor
6462397|NCT00458991|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6462398|NCT00458991|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6462399|NCT00459004|Rimonabant|rimonabant|mesh-list
6462400|NCT00459004|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5504504|NCT04447612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5504505|NCT04447469|Mavrilimumab|mavrilimumab|mesh-list
5504506|NCT04447469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5504507|NCT04447352|Leucovorin|leucovorin|mesh-list
5504508|NCT04447352|Docetaxel|docetaxel|mesh-list
5504509|NCT04447352|Fluorouracil|fluorouracil|mesh-list
6056775|NCT00617461|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6056776|NCT00617461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6056777|NCT00617461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056778|NCT00617461|Antimanic Agents|antimanic agents|mesh-ancestor
6056779|NCT00617539|Irinotecan|irinotecan|mesh-list
6056780|NCT00617539|Temozolomide|temozolomide|mesh-list
6056781|NCT00617539|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6056782|NCT00617539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6056783|NCT00617539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6056784|NCT00617539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056785|NCT00617539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6056786|NCT00617539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6056787|NCT00617539|Alkylating Agents|alkylating agents|mesh-ancestor
6056788|NCT00617591|Dexamethasone|dexamethasone|mesh-list
6056789|NCT00617591|Doxorubicin|doxorubicin|mesh-list
6056790|NCT00617591|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6056791|NCT00617591|Lenalidomide|lenalidomide|mesh-list
5504510|NCT04447352|Oxaliplatin|oxaliplatin|mesh-list
5504511|NCT04447352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5504512|NCT04447352|Tubulin Modulators|tubulin modulators|mesh-ancestor
5504513|NCT04447352|Antimitotic Agents|antimitotic agents|mesh-ancestor
5504514|NCT04447352|Mitosis Modulators|mitosis modulators|mesh-ancestor
5504515|NCT04447352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504516|NCT04447352|Antimetabolites|antimetabolites|mesh-ancestor
5504517|NCT04447352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6056792|NCT00617591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6056793|NCT00617591|Antiemetics|antiemetics|mesh-ancestor
6056794|NCT00617591|Autonomic Agents|autonomic agents|mesh-ancestor
6056795|NCT00617591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6056796|NCT00617591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056797|NCT00617591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6056798|NCT00617591|Glucocorticoids|glucocorticoids|mesh-ancestor
6056799|NCT00617591|Hormones|hormones|mesh-ancestor
6056800|NCT00617591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6056801|NCT00617591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6056802|NCT00617591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6462401|NCT00459004|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
6665196|NCT01516216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056803|NCT00617591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6056804|NCT00617591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6056805|NCT00617591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6056806|NCT00617591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5504518|NCT04447352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5504519|NCT04447352|Immunologic Factors|immunologic factors|mesh-ancestor
5504520|NCT04447352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504521|NCT04447352|Antidotes|antidotes|mesh-ancestor
5504522|NCT04447352|Protective Agents|protective agents|mesh-ancestor
6056807|NCT00617591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056808|NCT00617591|Immunologic Factors|immunologic factors|mesh-ancestor
6056809|NCT00617591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6056810|NCT00617591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6056811|NCT00617591|Growth Substances|growth substances|mesh-ancestor
6056812|NCT00617591|Growth Inhibitors|growth inhibitors|mesh-ancestor
6056813|NCT00617604|Mycophenolic Acid|mycophenolic acid|mesh-list
6056814|NCT00617604|Alefacept|alefacept|mesh-list
6056815|NCT00617604|Tacrolimus|tacrolimus|mesh-list
6056816|NCT00617604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6056817|NCT00617604|Immunologic Factors|immunologic factors|mesh-ancestor
6056818|NCT00617604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056819|NCT00617604|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6056820|NCT00617604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6056821|NCT00617604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056822|NCT00617604|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6056823|NCT00617604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6056824|NCT00617604|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6056825|NCT00617604|Antitubercular Agents|antitubercular agents|mesh-ancestor
6056826|NCT00617604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6056827|NCT00617604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5504523|NCT04447352|Vitamin B Complex|vitamin b complex|mesh-ancestor
5504524|NCT04447352|Vitamins|vitamins|mesh-ancestor
6056828|NCT00617604|Dermatologic Agents|dermatologic agents|mesh-ancestor
6056829|NCT00617669|Docetaxel|docetaxel|mesh-list
6056830|NCT00617669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6056831|NCT00617669|Tubulin Modulators|tubulin modulators|mesh-ancestor
6056832|NCT00617669|Antimitotic Agents|antimitotic agents|mesh-ancestor
6056833|NCT00617669|Mitosis Modulators|mitosis modulators|mesh-ancestor
6056834|NCT00617669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056835|NCT00617734|Cetuximab|cetuximab|mesh-list
6056836|NCT00617734|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6056837|NCT00617734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6056838|NCT00617734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6056839|NCT00617734|Immunologic Factors|immunologic factors|mesh-ancestor
6056840|NCT00617734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056841|NCT00617851|Vaccines|vaccines|mesh-list
6056842|NCT00617851|Immunologic Factors|immunologic factors|mesh-ancestor
6056843|NCT00617851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056844|NCT00617890|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6056845|NCT00617890|Immunologic Factors|immunologic factors|mesh-ancestor
6056846|NCT00617890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056847|NCT00617903|Azelaic acid|azelaic acid|mesh-list
6056848|NCT00617903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6056849|NCT00617903|Dermatologic Agents|dermatologic agents|mesh-ancestor
6056850|NCT00617929|Rituximab|rituximab|mesh-list
6056851|NCT00617929|Clofarabine|clofarabine|mesh-list
6056852|NCT00617929|Thymoglobulin|thymoglobulin|mesh-list
6056853|NCT00617929|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6056854|NCT00617929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6056855|NCT00617929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6056856|NCT00617929|Immunologic Factors|immunologic factors|mesh-ancestor
6056857|NCT00617929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056858|NCT00617929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6056859|NCT00617929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6056860|NCT00617929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6056861|NCT00617929|Antimetabolites|antimetabolites|mesh-ancestor
6056862|NCT00617929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056863|NCT00617942|Paclitaxel|paclitaxel|mesh-list
6056864|NCT00617942|Carboplatin|carboplatin|mesh-list
6056865|NCT00617942|Trastuzumab|trastuzumab|mesh-list
6056866|NCT00617942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6056867|NCT00617942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6056868|NCT00617942|Tubulin Modulators|tubulin modulators|mesh-ancestor
6056869|NCT00617942|Antimitotic Agents|antimitotic agents|mesh-ancestor
6056870|NCT00617942|Mitosis Modulators|mitosis modulators|mesh-ancestor
6056871|NCT00617942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056872|NCT00617942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6056873|NCT00618072|Metformin|metformin|mesh-list
6056874|NCT00618072|Rosiglitazone|rosiglitazone|mesh-list
6056875|NCT00618072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6056876|NCT00618072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201996|NCT02034513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201997|NCT02034552|Prednisone|prednisone|mesh-list
6201998|NCT02034552|Abiraterone Acetate|abiraterone acetate|mesh-list
6201999|NCT02034552|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
6202000|NCT02034552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6202001|NCT02034552|Glucocorticoids|glucocorticoids|mesh-ancestor
6202002|NCT02034552|Hormones|hormones|mesh-ancestor
6202003|NCT02034552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6202004|NCT02034552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202005|NCT02034552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6202006|NCT02034552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6202007|NCT02034552|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6202008|NCT02034552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6202009|NCT02034552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202010|NCT02034552|Hormone Antagonists|hormone antagonists|mesh-ancestor
6202011|NCT02034552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6202012|NCT02034565|Apixaban|apixaban|mesh-list
6202013|NCT02034565|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6202014|NCT02034565|Antithrombins|antithrombins|mesh-ancestor
6202015|NCT02034565|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6202016|NCT02034565|Protease Inhibitors|protease inhibitors|mesh-ancestor
6202017|NCT02034565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6202018|NCT02034565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202019|NCT02034565|Anticoagulants|anticoagulants|mesh-ancestor
6202020|NCT02034578|Apixaban|apixaban|mesh-list
6202021|NCT02034578|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6202022|NCT02034578|Antithrombins|antithrombins|mesh-ancestor
6665197|NCT01516216|Growth Inhibitors|growth inhibitors|mesh-ancestor
6056877|NCT00618332|Mometasone Furoate|mometasone furoate|mesh-list
6056878|NCT00618332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6056879|NCT00618332|Dermatologic Agents|dermatologic agents|mesh-ancestor
6056880|NCT00618332|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6056881|NCT00618371|Raltegravir Potassium|raltegravir potassium|mesh-list
6056882|NCT00618371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6056883|NCT00618371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5504525|NCT04447352|Micronutrients|micronutrients|mesh-ancestor
5504526|NCT04447534|Chloroquine|chloroquine|mesh-list
5504527|NCT04447534|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
5504528|NCT04447534|Amebicides|amebicides|mesh-ancestor
5504529|NCT04447534|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5504530|NCT04447534|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5504531|NCT04447534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5504532|NCT04447534|Antimalarials|antimalarials|mesh-ancestor
5504533|NCT04447534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5504534|NCT04447534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5504535|NCT04447534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5504536|NCT04447534|Analgesics|analgesics|mesh-ancestor
5504537|NCT04447534|Sensory System Agents|sensory system agents|mesh-ancestor
5504538|NCT04447534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5504539|NCT04447534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504540|NCT04447534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6056884|NCT00618371|Antiviral Agents|antiviral agents|mesh-ancestor
6056885|NCT00618371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6056886|NCT00618371|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6056887|NCT00618371|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6056888|NCT00618371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6056889|NCT00618371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056890|NCT00618436|Phenytoin|phenytoin|mesh-list
6056891|NCT00618436|Levetiracetam|levetiracetam|mesh-list
6056892|NCT00618436|Anticonvulsants|anticonvulsants|mesh-ancestor
6056893|NCT00618436|Nootropic Agents|nootropic agents|mesh-ancestor
6056894|NCT00618436|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6056895|NCT00618436|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6056896|NCT00618436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6056897|NCT00618436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056898|NCT00618436|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6056899|NCT00618436|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6056900|NCT00618449|Azithromycin|azithromycin|mesh-list
6056901|NCT00618449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6056902|NCT00618449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6056903|NCT00618540|Fludarabine|fludarabine|mesh-list
6056904|NCT00618540|Fludarabine phosphate|fludarabine phosphate|mesh-list
6056905|NCT00618540|Melphalan|melphalan|mesh-list
6056906|NCT00618540|Alemtuzumab|alemtuzumab|mesh-list
6056907|NCT00618540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6056908|NCT00618540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6056909|NCT00618540|Antimetabolites|antimetabolites|mesh-ancestor
6056910|NCT00618540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056911|NCT00618540|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6056912|NCT00618540|Immunologic Factors|immunologic factors|mesh-ancestor
5504541|NCT04447534|Filaricides|filaricides|mesh-ancestor
5504542|NCT04447534|Antinematodal Agents|antinematodal agents|mesh-ancestor
5504543|NCT04447534|Anthelmintics|anthelmintics|mesh-ancestor
5504544|NCT04447326|Endostar protein|endostar protein|mesh-list
5504545|NCT04447326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5504546|NCT04447326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6056913|NCT00618540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056914|NCT00618540|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6056915|NCT00618540|Alkylating Agents|alkylating agents|mesh-ancestor
6056916|NCT00618540|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6056917|NCT00618540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6056918|NCT00618618|Deoxycholic Acid|deoxycholic acid|mesh-list
6056919|NCT00618618|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6056920|NCT00618618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6056921|NCT00618722|Deoxycholic Acid|deoxycholic acid|mesh-list
6056922|NCT00618722|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6056923|NCT00618722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6056924|NCT00618748|Olanzapine|olanzapine|mesh-list
6056925|NCT00618748|Antiemetics|antiemetics|mesh-ancestor
6056926|NCT00618748|Autonomic Agents|autonomic agents|mesh-ancestor
6056927|NCT00618748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5504547|NCT04447326|Growth Substances|growth substances|mesh-ancestor
5504548|NCT04447326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056928|NCT00618748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056929|NCT00618748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6056930|NCT00618748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6056931|NCT00618748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6056932|NCT00618748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6056933|NCT00618748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6056934|NCT00618748|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6056935|NCT00618748|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6056936|NCT00618748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6056937|NCT00618748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056938|NCT00618748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6056939|NCT00618748|Serotonin Agents|serotonin agents|mesh-ancestor
6056940|NCT00618774|Amlodipine|amlodipine|mesh-list
6056941|NCT00618774|Telmisartan|telmisartan|mesh-list
6056942|NCT00618774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6056943|NCT00618774|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6056944|NCT00618774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6056945|NCT00618774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056946|NCT00618774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6056947|NCT00618774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056948|NCT00618774|Vasodilator Agents|vasodilator agents|mesh-ancestor
6056949|NCT00618774|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6056950|NCT00618774|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6056951|NCT00618813|Cyclophosphamide|cyclophosphamide|mesh-list
6056952|NCT00618813|Ifosfamide|ifosfamide|mesh-list
6056953|NCT00618813|Doxorubicin|doxorubicin|mesh-list
6056954|NCT00618813|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6056955|NCT00618813|Etoposide|etoposide|mesh-list
6056956|NCT00618813|Vincristine|vincristine|mesh-list
6056957|NCT00618813|Etoposide phosphate|etoposide phosphate|mesh-list
6056958|NCT00618813|Topotecan|topotecan|mesh-list
6056959|NCT00618813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6056960|NCT00618813|Immunologic Factors|immunologic factors|mesh-ancestor
6056961|NCT00618813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056962|NCT00618813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6056963|NCT00618813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6056964|NCT00618813|Alkylating Agents|alkylating agents|mesh-ancestor
6056965|NCT00618813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504549|NCT04447326|Growth Inhibitors|growth inhibitors|mesh-ancestor
6056966|NCT00618813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6056967|NCT00618813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6056968|NCT00618813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6056969|NCT00618813|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6056970|NCT00618813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6056971|NCT00618813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6056972|NCT00618813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6056973|NCT00618813|Tubulin Modulators|tubulin modulators|mesh-ancestor
6056974|NCT00618813|Antimitotic Agents|antimitotic agents|mesh-ancestor
6056975|NCT00618813|Mitosis Modulators|mitosis modulators|mesh-ancestor
6056976|NCT00618813|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6056977|NCT00618826|Gemcitabine|gemcitabine|mesh-list
6056978|NCT00618826|Paclitaxel|paclitaxel|mesh-list
6056979|NCT00618826|Bevacizumab|bevacizumab|mesh-list
6056980|NCT00618826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6056981|NCT00618826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6056982|NCT00618826|Tubulin Modulators|tubulin modulators|mesh-ancestor
6056983|NCT00618826|Antimitotic Agents|antimitotic agents|mesh-ancestor
6056984|NCT00618826|Mitosis Modulators|mitosis modulators|mesh-ancestor
6056985|NCT00618826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6056986|NCT00618826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6056987|NCT00618826|Antimetabolites|antimetabolites|mesh-ancestor
6056988|NCT00618826|Antiviral Agents|antiviral agents|mesh-ancestor
6056989|NCT00618826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6056990|NCT00618826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6056991|NCT00618826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6056992|NCT00618826|Immunologic Factors|immunologic factors|mesh-ancestor
6056993|NCT00618826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6056994|NCT00618826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6056995|NCT00618826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6056996|NCT00618826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6056997|NCT00618826|Growth Substances|growth substances|mesh-ancestor
6056998|NCT00618826|Growth Inhibitors|growth inhibitors|mesh-ancestor
6056999|NCT00618917|Manganese|manganese|mesh-list
6057000|NCT00618917|Paclitaxel|paclitaxel|mesh-list
6057001|NCT00618917|Carboplatin|carboplatin|mesh-list
6057002|NCT00618917|Superoxide Dismutase|superoxide dismutase|mesh-list
6057003|NCT00618917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6057004|NCT00618917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6057005|NCT00618917|Tubulin Modulators|tubulin modulators|mesh-ancestor
6057006|NCT00618917|Antimitotic Agents|antimitotic agents|mesh-ancestor
5504550|NCT04447326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5504551|NCT04447274|Apatinib|apatinib|mesh-list
5504552|NCT04447274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5504553|NCT04447274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5504554|NCT04447274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6057007|NCT00618917|Mitosis Modulators|mitosis modulators|mesh-ancestor
6057008|NCT00618917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057009|NCT00618917|Trace Elements|trace elements|mesh-ancestor
6057010|NCT00618917|Micronutrients|micronutrients|mesh-ancestor
6057011|NCT00618917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057012|NCT00618917|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6057013|NCT00618917|Antioxidants|antioxidants|mesh-ancestor
6057014|NCT00618917|Protective Agents|protective agents|mesh-ancestor
6462402|NCT00459004|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6462403|NCT00459004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6488392|NCT00583869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5504555|NCT04447274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504556|NCT04447443|Loperamide|loperamide|mesh-list
5504557|NCT04447443|Antidiarrheals|antidiarrheals|mesh-list
5504558|NCT04447443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5504559|NCT04447235|Ivermectin|ivermectin|mesh-list
5504560|NCT04447235|Losartan|losartan|mesh-list
5504561|NCT04447235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5504562|NCT04447235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5504563|NCT04447235|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6057015|NCT00618956|Milnacipran|milnacipran|mesh-list
6057016|NCT00618956|Levomilnacipran|levomilnacipran|mesh-list
6057017|NCT00618956|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6057018|NCT00618956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6057019|NCT00618956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6057020|NCT00618956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057021|NCT00618956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6057022|NCT00618956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057023|NCT00618956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6057024|NCT00618956|Analgesics|analgesics|mesh-ancestor
6057025|NCT00618956|Sensory System Agents|sensory system agents|mesh-ancestor
6057026|NCT00618956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6057027|NCT00618956|Antidepressive Agents|antidepressive agents|mesh-ancestor
5504564|NCT04447235|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5504565|NCT04447235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504566|NCT04447235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5504567|NCT04447235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5504568|NCT04447560|Bupivacaine|bupivacaine|mesh-list
5504569|NCT04447560|Anesthetics, Local|anesthetics, local|mesh-ancestor
5504570|NCT04447560|Anesthetics|anesthetics|mesh-ancestor
5504571|NCT04447560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5504572|NCT04447560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504573|NCT04447560|Sensory System Agents|sensory system agents|mesh-ancestor
5504574|NCT04447560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5504575|NCT04447092|Leucovorin|leucovorin|mesh-list
5504576|NCT04447092|Gemcitabine|gemcitabine|mesh-list
5504577|NCT04447092|Paclitaxel|paclitaxel|mesh-list
5504578|NCT04447092|Pembrolizumab|pembrolizumab|mesh-list
5504579|NCT04447092|Oxaliplatin|oxaliplatin|mesh-list
5504580|NCT04447092|Irinotecan|irinotecan|mesh-list
5504581|NCT04447092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5504582|NCT04447092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5504583|NCT04447092|Tubulin Modulators|tubulin modulators|mesh-ancestor
5504584|NCT04447092|Antimitotic Agents|antimitotic agents|mesh-ancestor
5504585|NCT04447092|Mitosis Modulators|mitosis modulators|mesh-ancestor
5504586|NCT04447092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504587|NCT04447092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6057028|NCT00618956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6057029|NCT00618982|Sorafenib|sorafenib|mesh-list
6057030|NCT00618982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6057031|NCT00618982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6057032|NCT00618982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6057033|NCT00618982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057034|NCT00618995|Niacin|niacin|mesh-list
6057035|NCT00618995|Niacinamide|niacinamide|mesh-list
6057036|NCT00618995|Nicotinic Acids|nicotinic acids|mesh-list
6057037|NCT00618995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6057038|NCT00618995|Antimetabolites|antimetabolites|mesh-ancestor
6057039|NCT00618995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057040|NCT00618995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6057041|NCT00618995|Vasodilator Agents|vasodilator agents|mesh-ancestor
6057042|NCT00618995|Vitamin B Complex|vitamin b complex|mesh-ancestor
6057043|NCT00618995|Vitamins|vitamins|mesh-ancestor
6057044|NCT00618995|Micronutrients|micronutrients|mesh-ancestor
6057045|NCT00618995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057046|NCT00619060|Niacin|niacin|mesh-list
6057047|NCT00619060|Nicotinic Acids|nicotinic acids|mesh-list
6057048|NCT00619060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6057049|NCT00619060|Antimetabolites|antimetabolites|mesh-ancestor
6057050|NCT00619060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057051|NCT00619060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6057052|NCT00619060|Vasodilator Agents|vasodilator agents|mesh-ancestor
6057053|NCT00619060|Vitamin B Complex|vitamin b complex|mesh-ancestor
6057054|NCT00619060|Vitamins|vitamins|mesh-ancestor
6057055|NCT00619060|Micronutrients|micronutrients|mesh-ancestor
6057056|NCT00619060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504588|NCT04447092|Antimetabolites|antimetabolites|mesh-ancestor
5504589|NCT04447092|Antiviral Agents|antiviral agents|mesh-ancestor
5504590|NCT04447092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5504591|NCT04447092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5504592|NCT04447092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5504593|NCT04447092|Immunologic Factors|immunologic factors|mesh-ancestor
5504594|NCT04447092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504595|NCT04447092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6057057|NCT00619073|Aspirin|aspirin|mesh-list
6057058|NCT00619073|Clopidogrel|clopidogrel|mesh-list
6057059|NCT00619073|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6057060|NCT00619073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6057061|NCT00619073|Analgesics|analgesics|mesh-ancestor
6057062|NCT00619073|Sensory System Agents|sensory system agents|mesh-ancestor
6057063|NCT00619073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6057064|NCT00619073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057065|NCT00619073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6057066|NCT00619073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6057067|NCT00619073|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5504596|NCT04447092|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5504597|NCT04447092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5504598|NCT04447092|Antidotes|antidotes|mesh-ancestor
6057068|NCT00619073|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6057069|NCT00619073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057070|NCT00619073|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6057071|NCT00619073|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6057072|NCT00619073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6057073|NCT00619073|Antipyretics|antipyretics|mesh-ancestor
6057074|NCT00619073|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6057075|NCT00619073|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6057076|NCT00619073|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6057077|NCT00619073|Purinergic Agents|purinergic agents|mesh-ancestor
6057078|NCT00619073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6057079|NCT00619099|Decitabine|decitabine|mesh-list
6057080|NCT00619099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6057081|NCT00619099|Antimetabolites|antimetabolites|mesh-ancestor
6057082|NCT00619099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504599|NCT04447092|Protective Agents|protective agents|mesh-ancestor
5504600|NCT04447092|Vitamin B Complex|vitamin b complex|mesh-ancestor
5504601|NCT04447092|Vitamins|vitamins|mesh-ancestor
6057083|NCT00619099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6057084|NCT00619099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6057085|NCT00619112|Temozolomide|temozolomide|mesh-list
6057086|NCT00619112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6057087|NCT00619112|Alkylating Agents|alkylating agents|mesh-ancestor
6057088|NCT00619112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057089|NCT00619112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5504602|NCT04447092|Micronutrients|micronutrients|mesh-ancestor
5504603|NCT04447378|PENTA|penta|mesh-list
5504604|NCT04447378|Fondaparinux|fondaparinux|mesh-list
5504605|NCT04447378|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5504606|NCT04447378|Antithrombins|antithrombins|mesh-ancestor
5504607|NCT04447378|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5504608|NCT04447378|Protease Inhibitors|protease inhibitors|mesh-ancestor
5504609|NCT04447378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5504610|NCT04447378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504611|NCT04447378|Anticoagulants|anticoagulants|mesh-ancestor
5504612|NCT04447378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5504613|NCT04447378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5504614|NCT04447625|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5504615|NCT04447625|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5504616|NCT04447625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5504617|NCT04447625|Antitubercular Agents|antitubercular agents|mesh-ancestor
5504618|NCT04447105|Anesthetics|anesthetics|mesh-list
5504619|NCT04447105|Propofol|propofol|mesh-list
5504620|NCT04447105|Desflurane|desflurane|mesh-list
5504621|NCT04447105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5504622|NCT04447105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504623|NCT04447105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5504624|NCT04447105|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5504625|NCT04447105|Anesthetics, General|anesthetics, general|mesh-ancestor
5504626|NCT04447105|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5504627|NCT04446923|Propranolol|propranolol|mesh-list
5504628|NCT04446923|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5504629|NCT04446923|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5504630|NCT04446923|Adrenergic Agents|adrenergic agents|mesh-ancestor
5504631|NCT04446923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5504632|NCT04446923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504633|NCT04446923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504634|NCT04446923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5504635|NCT04446923|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5504636|NCT04446923|Vasodilator Agents|vasodilator agents|mesh-ancestor
5504637|NCT04447040|Acetaminophen|acetaminophen|mesh-list
5504638|NCT04447040|Naproxen|naproxen|mesh-list
5504639|NCT04447040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6057090|NCT00619190|Aripiprazole|aripiprazole|mesh-list
6057091|NCT00619190|Antidepressive Agents|antidepressive agents|mesh-ancestor
6057092|NCT00619190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6057093|NCT00619190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6057094|NCT00619190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6057095|NCT00619190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6057096|NCT00619190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057097|NCT00619190|Dopamine Agonists|dopamine agonists|mesh-ancestor
6057098|NCT00619190|Dopamine Agents|dopamine agents|mesh-ancestor
6057099|NCT00619190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6057100|NCT00619190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057101|NCT00619190|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6057102|NCT00619190|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6057103|NCT00619190|Serotonin Agents|serotonin agents|mesh-ancestor
6057104|NCT00619190|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6057105|NCT00619190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6057106|NCT00619190|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6057107|NCT00619190|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6057108|NCT00619229|Alprostadil|alprostadil|mesh-list
6057109|NCT00619229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6057110|NCT00619229|Vasodilator Agents|vasodilator agents|mesh-ancestor
5504640|NCT04447040|Analgesics|analgesics|mesh-ancestor
5504641|NCT04447040|Sensory System Agents|sensory system agents|mesh-ancestor
5504642|NCT04447040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5504643|NCT04447040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504644|NCT04447040|Antipyretics|antipyretics|mesh-ancestor
6057111|NCT00619229|Urological Agents|urological agents|mesh-ancestor
6057112|NCT00619307|Interferon beta-1a|interferon beta-1a|mesh-list
6057113|NCT00619307|Ibuprofen|ibuprofen|mesh-list
6057114|NCT00619307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6057115|NCT00619307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6057116|NCT00619307|Analgesics|analgesics|mesh-ancestor
6057117|NCT00619307|Sensory System Agents|sensory system agents|mesh-ancestor
6057118|NCT00619307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6057119|NCT00619307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057120|NCT00619307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6057121|NCT00619307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6057122|NCT00619307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5504645|NCT04447040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5504646|NCT04447040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6462404|NCT00459004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462405|NCT00459004|Hormones|hormones|mesh-ancestor
6462406|NCT00459004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6462407|NCT00459004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504647|NCT04447040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6057123|NCT00619307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6057124|NCT00619307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057125|NCT00619307|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6057126|NCT00619307|Immunologic Factors|immunologic factors|mesh-ancestor
6057127|NCT00619307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6057128|NCT00619307|Antiviral Agents|antiviral agents|mesh-ancestor
6057129|NCT00619307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6057130|NCT00619359|Dexamethasone|dexamethasone|mesh-list
6057131|NCT00619359|Dexamethasone acetate|dexamethasone acetate|mesh-list
5504648|NCT04447040|Gout Suppressants|gout suppressants|mesh-ancestor
5504649|NCT04447040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5504650|NCT04447040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5504651|NCT04447040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504652|NCT04446871|Methylene Blue|methylene blue|mesh-list
5504653|NCT04446871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5504654|NCT04446871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504655|NCT04446663|Paclitaxel|paclitaxel|mesh-list
5504656|NCT04446663|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5504657|NCT04446663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5504658|NCT04446663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5504659|NCT04446663|Tubulin Modulators|tubulin modulators|mesh-ancestor
5504660|NCT04446663|Antimitotic Agents|antimitotic agents|mesh-ancestor
5504661|NCT04446663|Mitosis Modulators|mitosis modulators|mesh-ancestor
5504662|NCT04446663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504663|NCT04446715|Sufentanil|sufentanil|mesh-list
5504664|NCT04446715|Meperidine|meperidine|mesh-list
5504665|NCT04446715|Bupivacaine|bupivacaine|mesh-list
5504666|NCT04446715|Anesthetics, Local|anesthetics, local|mesh-ancestor
5504667|NCT04446715|Anesthetics|anesthetics|mesh-ancestor
5504668|NCT04446715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5504669|NCT04446715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504670|NCT04446715|Sensory System Agents|sensory system agents|mesh-ancestor
5504671|NCT04446715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5504672|NCT04446715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5504673|NCT04446715|Narcotics|narcotics|mesh-ancestor
5504674|NCT04446715|Analgesics|analgesics|mesh-ancestor
5504675|NCT04446715|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5504676|NCT04446715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5504677|NCT04446715|Anesthetics, General|anesthetics, general|mesh-ancestor
5504678|NCT04446598|Tadalafil|tadalafil|mesh-list
5504679|NCT04446598|Vasodilator Agents|vasodilator agents|mesh-ancestor
5504680|NCT04446598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5504681|NCT04446598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5504682|NCT04446598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5504683|NCT04446598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504684|NCT04446598|Urological Agents|urological agents|mesh-ancestor
5504685|NCT04446533|Chlorhexidine|chlorhexidine|mesh-list
5504686|NCT04446533|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5504687|NCT04446533|Hydrogen Peroxide|hydrogen peroxide|mesh-list
5504688|NCT04446533|Hyaluronic Acid|hyaluronic acid|mesh-list
5504689|NCT04446533|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5504690|NCT04446533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5504691|NCT04446533|Disinfectants|disinfectants|mesh-ancestor
5504692|NCT04446533|Dermatologic Agents|dermatologic agents|mesh-ancestor
5504693|NCT04446533|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5504694|NCT04446533|Immunologic Factors|immunologic factors|mesh-ancestor
5504695|NCT04446533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504696|NCT04446533|Viscosupplements|viscosupplements|mesh-ancestor
5504697|NCT04446533|Protective Agents|protective agents|mesh-ancestor
5504698|NCT04446637|Albuterol|albuterol|mesh-list
5504699|NCT04446637|Ipratropium|ipratropium|mesh-list
5504700|NCT04446637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5504701|NCT04446637|Autonomic Agents|autonomic agents|mesh-ancestor
5504702|NCT04446637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5504703|NCT04446637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504704|NCT04446637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5504705|NCT04446637|Respiratory System Agents|respiratory system agents|mesh-ancestor
5504706|NCT04446637|Tocolytic Agents|tocolytic agents|mesh-ancestor
5504707|NCT04446637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5504708|NCT04446637|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5504709|NCT04446637|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5504710|NCT04446637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5504711|NCT04446637|Adrenergic Agents|adrenergic agents|mesh-ancestor
5504712|NCT04446637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5504713|NCT04446637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504714|NCT04446637|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5504715|NCT04446637|Cholinergic Agents|cholinergic agents|mesh-ancestor
5504716|NCT04446416|Bevacizumab|bevacizumab|mesh-list
5504717|NCT04446416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5504718|NCT04446416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5504719|NCT04446416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5504720|NCT04446416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5504721|NCT04446416|Growth Substances|growth substances|mesh-ancestor
5504722|NCT04446416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504723|NCT04446416|Growth Inhibitors|growth inhibitors|mesh-ancestor
6057132|NCT00619359|Ondansetron|ondansetron|mesh-list
6057133|NCT00619359|Aprepitant|aprepitant|mesh-list
6057134|NCT00619359|Fosaprepitant|fosaprepitant|mesh-list
6057135|NCT00619359|BB 1101|bb 1101|mesh-list
6057136|NCT00619359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6057137|NCT00619359|Antiemetics|antiemetics|mesh-ancestor
6057138|NCT00619359|Autonomic Agents|autonomic agents|mesh-ancestor
6057139|NCT00619359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6057140|NCT00619359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057141|NCT00619359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6057142|NCT00619359|Glucocorticoids|glucocorticoids|mesh-ancestor
6057143|NCT00619359|Hormones|hormones|mesh-ancestor
6057144|NCT00619359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6057145|NCT00619359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6057146|NCT00619359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6057147|NCT00619359|Protease Inhibitors|protease inhibitors|mesh-ancestor
6057148|NCT00619359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6057149|NCT00619359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057150|NCT00619359|Antipruritics|antipruritics|mesh-ancestor
6057151|NCT00619359|Dermatologic Agents|dermatologic agents|mesh-ancestor
6057152|NCT00619359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6057153|NCT00619359|Serotonin Agents|serotonin agents|mesh-ancestor
6057154|NCT00619359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6057155|NCT00619359|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6057156|NCT00619359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6057157|NCT00619359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6057158|NCT00619359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6057159|NCT00619359|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6057160|NCT00619359|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6057161|NCT00619476|Gabapentin|gabapentin|mesh-list
6057162|NCT00619476|Analgesics|analgesics|mesh-ancestor
6057163|NCT00619476|Sensory System Agents|sensory system agents|mesh-ancestor
6057164|NCT00619476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6057165|NCT00619476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057166|NCT00619476|Anticonvulsants|anticonvulsants|mesh-ancestor
6057167|NCT00619476|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6057168|NCT00619476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6057169|NCT00619476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6057170|NCT00619476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6057171|NCT00619476|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6057172|NCT00619476|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6057173|NCT00619476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6057174|NCT00619476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057175|NCT00619476|Antimanic Agents|antimanic agents|mesh-ancestor
6057176|NCT00619489|Vedolizumab|vedolizumab|mesh-list
6057177|NCT00619489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6057178|NCT00619619|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6057179|NCT00619619|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6057180|NCT00619619|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6057181|NCT00619619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6057182|NCT00619619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057183|NCT00619619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6057184|NCT00619619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057185|NCT00619619|Antidepressive Agents|antidepressive agents|mesh-ancestor
6057186|NCT00619619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6057187|NCT00619645|Cyclosporine|cyclosporine|mesh-list
5600065|NCT03714880|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5600066|NCT03714880|Hormone Antagonists|hormone antagonists|mesh-ancestor
5600067|NCT03714880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6057188|NCT00619645|Mycophenolic Acid|mycophenolic acid|mesh-list
6057189|NCT00619645|Fludarabine|fludarabine|mesh-list
6057190|NCT00619645|Fludarabine phosphate|fludarabine phosphate|mesh-list
6057191|NCT00619645|Busulfan|busulfan|mesh-list
6057192|NCT00619645|Cyclosporins|cyclosporins|mesh-list
6057193|NCT00619645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6057194|NCT00619645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6057195|NCT00619645|Antimetabolites|antimetabolites|mesh-ancestor
6057196|NCT00619645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057197|NCT00619645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6057198|NCT00619645|Immunologic Factors|immunologic factors|mesh-ancestor
6057199|NCT00619645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057200|NCT00619645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6057201|NCT00619645|Antifungal Agents|antifungal agents|mesh-ancestor
6057202|NCT00619645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6057203|NCT00619645|Dermatologic Agents|dermatologic agents|mesh-ancestor
6057204|NCT00619645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6057205|NCT00619645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6057206|NCT00619645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6057207|NCT00619645|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6057208|NCT00619645|Antitubercular Agents|antitubercular agents|mesh-ancestor
6057209|NCT00619645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6057210|NCT00619645|Alkylating Agents|alkylating agents|mesh-ancestor
6057211|NCT00619645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6057212|NCT00619645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6057213|NCT00619684|Lenalidomide|lenalidomide|mesh-list
6057214|NCT00619684|Immunologic Factors|immunologic factors|mesh-ancestor
6057215|NCT00619684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057216|NCT00619684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6057217|NCT00619684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6057218|NCT00619684|Growth Substances|growth substances|mesh-ancestor
6057219|NCT00619684|Growth Inhibitors|growth inhibitors|mesh-ancestor
6057220|NCT00619684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6057221|NCT00619723|Choline|choline|mesh-list
6057222|NCT00619723|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
6057223|NCT00619723|Lipotropic Agents|lipotropic agents|mesh-ancestor
6057224|NCT00619723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6057225|NCT00619723|Antimetabolites|antimetabolites|mesh-ancestor
6057226|NCT00619723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057227|NCT00619723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6057228|NCT00619723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6057229|NCT00619723|Nootropic Agents|nootropic agents|mesh-ancestor
6057230|NCT00619801|Levocetirizine|levocetirizine|mesh-list
6057231|NCT00619801|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6057232|NCT00619801|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6057233|NCT00619801|Histamine Antagonists|histamine antagonists|mesh-ancestor
6057234|NCT00619801|Histamine Agents|histamine agents|mesh-ancestor
6057235|NCT00619801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6057236|NCT00619801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057237|NCT00619801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057238|NCT00619892|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6057239|NCT00619892|Antidepressive Agents|antidepressive agents|mesh-ancestor
6057240|NCT00619892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6057241|NCT00619892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6057242|NCT00619892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6057243|NCT00619892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6057244|NCT00619892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057245|NCT00619957|Risedronic Acid|risedronic acid|mesh-list
6057246|NCT00619957|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6057247|NCT00619957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6057248|NCT00619957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057249|NCT00619957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6057250|NCT00619957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057251|NCT00619957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6057252|NCT00619970|Rifaximin|rifaximin|mesh-list
6057253|NCT00619970|Lactulose|lactulose|mesh-list
6057254|NCT00619970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6057255|NCT00619970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6057256|NCT00619970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6057257|NCT00619983|Gabapentin|gabapentin|mesh-list
6057258|NCT00619983|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6057259|NCT00619983|Donepezil|donepezil|mesh-list
6057260|NCT00619983|Analgesics|analgesics|mesh-ancestor
6057261|NCT00619983|Sensory System Agents|sensory system agents|mesh-ancestor
6057262|NCT00619983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6057263|NCT00619983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057264|NCT00619983|Anticonvulsants|anticonvulsants|mesh-ancestor
6057265|NCT00619983|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6057266|NCT00619983|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6057267|NCT00619983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6057268|NCT00619983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6057269|NCT00619983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6057270|NCT00619983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6057271|NCT00619983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6057272|NCT00619983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057273|NCT00619983|Antimanic Agents|antimanic agents|mesh-ancestor
6057274|NCT00619983|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6057275|NCT00619983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6057276|NCT00619983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6057277|NCT00619983|Antidepressive Agents|antidepressive agents|mesh-ancestor
6057278|NCT00619983|Dopamine Agents|dopamine agents|mesh-ancestor
6057279|NCT00619983|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6057280|NCT00619983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6057281|NCT00619983|Cholinergic Agents|cholinergic agents|mesh-ancestor
6057282|NCT00619983|Nootropic Agents|nootropic agents|mesh-ancestor
6057283|NCT00620061|Lubiprostone|lubiprostone|mesh-list
6057284|NCT00620061|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6057285|NCT00620061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6057286|NCT00620061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057287|NCT00620074|Voriconazole|voriconazole|mesh-list
6057288|NCT00620074|Anidulafungin|anidulafungin|mesh-list
6057289|NCT00620074|Antifungal Agents|antifungal agents|mesh-ancestor
6057290|NCT00620074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6057291|NCT00620074|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6057292|NCT00620074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6057293|NCT00620074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6057294|NCT00620074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057295|NCT00620074|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6057296|NCT00620074|Hormone Antagonists|hormone antagonists|mesh-ancestor
6057297|NCT00620074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6057298|NCT00620074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057299|NCT00620074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6057300|NCT00620113|Vitamin D|vitamin d|mesh-list
6057301|NCT00620113|Cholecalciferol|cholecalciferol|mesh-list
6057302|NCT00620113|Calcium Carbonate|calcium carbonate|mesh-list
6057303|NCT00620113|Calcium|calcium|mesh-list
6057304|NCT00620113|Vitamins|vitamins|mesh-ancestor
6057305|NCT00620113|Micronutrients|micronutrients|mesh-ancestor
6057306|NCT00620113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057307|NCT00620113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6057308|NCT00620113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6057309|NCT00620113|Antacids|antacids|mesh-ancestor
6057310|NCT00620113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057311|NCT00620113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6057312|NCT00620191|Metformin|metformin|mesh-list
6057313|NCT00620191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6057314|NCT00620191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057315|NCT00620282|Liraglutide|liraglutide|mesh-list
6057316|NCT00620282|Glimepiride|glimepiride|mesh-list
6057317|NCT00620282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6057318|NCT00620282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057319|NCT00620282|Incretins|incretins|mesh-ancestor
6057320|NCT00620282|Hormones|hormones|mesh-ancestor
6057321|NCT00620282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6057322|NCT00620282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6057323|NCT00620282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6057324|NCT00620282|Immunologic Factors|immunologic factors|mesh-ancestor
6057325|NCT00620321|Cytarabine|cytarabine|mesh-list
6057326|NCT00620321|Idarubicin|idarubicin|mesh-list
6057327|NCT00620321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6057328|NCT00620321|Antimetabolites|antimetabolites|mesh-ancestor
6057329|NCT00620321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057330|NCT00620321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6057331|NCT00620321|Antiviral Agents|antiviral agents|mesh-ancestor
6057332|NCT00620321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6057333|NCT00620321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6057334|NCT00620321|Immunologic Factors|immunologic factors|mesh-ancestor
6057335|NCT00620321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504724|NCT04446403|Anesthetics|anesthetics|mesh-list
5504725|NCT04446403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5504726|NCT04446403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504727|NCT04446338|Antibodies|antibodies|mesh-list
5504728|NCT04446338|Immunologic Factors|immunologic factors|mesh-ancestor
5504729|NCT04446338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504730|NCT04446364|Disinfectants|disinfectants|mesh-list
5504731|NCT04446364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5504732|NCT04445922|Anastrozole|anastrozole|mesh-list
5504733|NCT04445922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6057336|NCT00620321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6057337|NCT00620321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6057338|NCT00620321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6057339|NCT00620321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6057340|NCT00620373|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
6057341|NCT00620373|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6057342|NCT00620373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057343|NCT00620425|Sumatriptan|sumatriptan|mesh-list
6057344|NCT00620425|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6057345|NCT00620425|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6057346|NCT00620425|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6462408|NCT00459160|Antihypertensive Agents|antihypertensive agents|mesh-list
6462409|NCT00459173|Rimonabant|rimonabant|mesh-list
6462410|NCT00459173|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6462411|NCT00459173|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
6462412|NCT00459173|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5504734|NCT04445922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5504735|NCT04445922|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6462413|NCT00459173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6462414|NCT00459173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462415|NCT00459173|Hormones|hormones|mesh-ancestor
6462416|NCT00459173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6462417|NCT00459173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462418|NCT00459264|Folic Acid|folic acid|mesh-list
6462419|NCT00459264|Hematinics|hematinics|mesh-ancestor
6462420|NCT00459264|Vitamin B Complex|vitamin b complex|mesh-ancestor
6462421|NCT00459264|Vitamins|vitamins|mesh-ancestor
6462422|NCT00459264|Micronutrients|micronutrients|mesh-ancestor
6462423|NCT00459264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462424|NCT00459407|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
6462425|NCT00459407|Antioxidants|antioxidants|mesh-ancestor
6462426|NCT00459407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462427|NCT00459407|Protective Agents|protective agents|mesh-ancestor
6462428|NCT00459407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462429|NCT00459407|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
6462430|NCT00459407|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6462431|NCT00459407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6462432|NCT00459407|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6462433|NCT00459420|Caffeine|caffeine|mesh-list
6462434|NCT00459420|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6462435|NCT00459420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462436|NCT00459420|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6462437|NCT00459420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6462438|NCT00459420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462439|NCT00459420|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6462440|NCT00459420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6462441|NCT00459420|Purinergic Agents|purinergic agents|mesh-ancestor
6057347|NCT00620425|Serotonin Agents|serotonin agents|mesh-ancestor
6057348|NCT00620425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6057349|NCT00620425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057350|NCT00620425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057351|NCT00620542|Atorvastatin|atorvastatin|mesh-list
6057352|NCT00620542|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6057353|NCT00620542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6057354|NCT00620542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6057355|NCT00620542|Antimetabolites|antimetabolites|mesh-ancestor
6057356|NCT00620542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057357|NCT00620542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6057358|NCT00620542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6462442|NCT00459420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5504736|NCT04445922|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5504737|NCT04445922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5504738|NCT04445922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504739|NCT04445922|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5504740|NCT04445922|Hormone Antagonists|hormone antagonists|mesh-ancestor
5504741|NCT04445922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6462443|NCT00459485|Zinc Sulfate|zinc sulfate|mesh-list
6057359|NCT00620542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6057360|NCT00620555|Gabapentin|gabapentin|mesh-list
6057361|NCT00620555|Analgesics|analgesics|mesh-ancestor
6057362|NCT00620555|Sensory System Agents|sensory system agents|mesh-ancestor
6057363|NCT00620555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6057364|NCT00620555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057365|NCT00620555|Anticonvulsants|anticonvulsants|mesh-ancestor
5504742|NCT04445922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504743|NCT04446234|Risperidone|risperidone|mesh-list
5504744|NCT04446234|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6057366|NCT00620555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6057367|NCT00620555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6057368|NCT00620555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6057369|NCT00620555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6057370|NCT00620555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6057371|NCT00620555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6057372|NCT00620555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6057373|NCT00620555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057374|NCT00620555|Antimanic Agents|antimanic agents|mesh-ancestor
6057375|NCT00620659|Modafinil|modafinil|mesh-list
6057376|NCT00620659|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6057377|NCT00620659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057378|NCT00620659|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6057379|NCT00620659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6057380|NCT00620659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6057381|NCT00620659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057382|NCT00620750|Naltrexone|naltrexone|mesh-list
6057383|NCT00620750|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6057384|NCT00620750|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6057385|NCT00620750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057386|NCT00620750|Sensory System Agents|sensory system agents|mesh-ancestor
6057387|NCT00620750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5504745|NCT04446234|Aripiprazole|aripiprazole|mesh-list
5504746|NCT04446234|Ziprasidone|ziprasidone|mesh-list
5504747|NCT04446234|Amisulpride|amisulpride|mesh-list
5504748|NCT04446234|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5504749|NCT04446234|Serotonin Agents|serotonin agents|mesh-ancestor
5504750|NCT04446234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5504751|NCT04446234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504752|NCT04446234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504753|NCT04446234|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5504754|NCT04446234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5504755|NCT04446234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5504756|NCT04446234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6057388|NCT00620776|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6057389|NCT00620776|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6057390|NCT00620776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5504757|NCT04446234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5504758|NCT04446234|Dopamine Agents|dopamine agents|mesh-ancestor
5504759|NCT04446234|Antidepressive Agents|antidepressive agents|mesh-ancestor
5504760|NCT04446234|Dopamine Agonists|dopamine agonists|mesh-ancestor
5504761|NCT04446234|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5504762|NCT04446234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5504763|NCT04446234|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5504764|NCT04446234|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6057391|NCT00620776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6057392|NCT00620776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057393|NCT00620776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6057394|NCT00620776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057395|NCT00620776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6057396|NCT00620776|Antidepressive Agents|antidepressive agents|mesh-ancestor
6057397|NCT00620776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6057398|NCT00620815|Vaccines|vaccines|mesh-list
6057399|NCT00620815|MF59 oil emulsion|mf59 oil emulsion|mesh-list
6057400|NCT00620815|Immunologic Factors|immunologic factors|mesh-ancestor
6057401|NCT00620815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057402|NCT00620815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6057403|NCT00620854|Calcitonin|calcitonin|mesh-list
6057404|NCT00620854|Salmon calcitonin|salmon calcitonin|mesh-list
6057405|NCT00620854|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
5504765|NCT04446234|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5504766|NCT04446065|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
5504767|NCT04446065|Antioxidants|antioxidants|mesh-ancestor
5504768|NCT04446065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504769|NCT04446065|Protective Agents|protective agents|mesh-ancestor
5504770|NCT04446065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504771|NCT04446065|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
5504772|NCT04446065|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5504773|NCT04446065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5504774|NCT04446065|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5504775|NCT04445948|Amoxicillin|amoxicillin|mesh-list
5504776|NCT04445948|Metronidazole|metronidazole|mesh-list
5504777|NCT04445948|Clarithromycin|clarithromycin|mesh-list
5504778|NCT04445948|Lactoferrin|lactoferrin|mesh-list
5504779|NCT04445948|Esomeprazole|esomeprazole|mesh-list
5504780|NCT04445948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5504781|NCT04445948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5504782|NCT04445948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5504783|NCT04445948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5504784|NCT04445948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5504785|NCT04445948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5504786|NCT04445948|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5504787|NCT04445948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5504788|NCT04445948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504789|NCT04445948|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5504790|NCT04445948|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5504791|NCT04445948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5504792|NCT04446039|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6462444|NCT00459485|Astringents|astringents|mesh-ancestor
6462445|NCT00459485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462446|NCT00459485|Dermatologic Agents|dermatologic agents|mesh-ancestor
6462447|NCT00459511|Hydrocortisone|hydrocortisone|mesh-list
6462448|NCT00459511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6462449|NCT00459563|Vitamin D|vitamin d|mesh-list
6057406|NCT00620854|Katacalcin|katacalcin|mesh-list
6057407|NCT00620854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6057408|NCT00620854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504793|NCT04446039|Vortioxetine|vortioxetine|mesh-list
5504794|NCT04446039|Mirtazapine|mirtazapine|mesh-list
5504795|NCT04446039|Citalopram|citalopram|mesh-list
6057409|NCT00620854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6057410|NCT00620854|Vasodilator Agents|vasodilator agents|mesh-ancestor
6057411|NCT00620945|Phenoxybenzamine|phenoxybenzamine|mesh-list
6057412|NCT00620945|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6057413|NCT00620945|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6057414|NCT00620945|Adrenergic Agents|adrenergic agents|mesh-ancestor
6057415|NCT00620945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6057416|NCT00620945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057417|NCT00620945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462450|NCT00459563|Calcitriol|calcitriol|mesh-list
5504796|NCT04446039|Bupropion|bupropion|mesh-list
6462451|NCT00459563|Vitamins|vitamins|mesh-ancestor
5504797|NCT04446039|Fluoxetine|fluoxetine|mesh-list
5504798|NCT04446039|Paroxetine|paroxetine|mesh-list
6462452|NCT00459563|Micronutrients|micronutrients|mesh-ancestor
6057418|NCT00620945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6057419|NCT00620945|Vasodilator Agents|vasodilator agents|mesh-ancestor
6057420|NCT00621023|Ascorbic Acid|ascorbic acid|mesh-list
6057421|NCT00621023|Decitabine|decitabine|mesh-list
6057422|NCT00621023|Arsenic Trioxide|arsenic trioxide|mesh-list
6057423|NCT00621023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6057424|NCT00621023|Antimetabolites|antimetabolites|mesh-ancestor
6057425|NCT00621023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057426|NCT00621023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6057427|NCT00621023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6057428|NCT00621023|Antioxidants|antioxidants|mesh-ancestor
6057429|NCT00621023|Protective Agents|protective agents|mesh-ancestor
6057430|NCT00621023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057431|NCT00621023|Vitamins|vitamins|mesh-ancestor
6057432|NCT00621023|Micronutrients|micronutrients|mesh-ancestor
6057433|NCT00621049|Bevacizumab|bevacizumab|mesh-list
6057434|NCT00621049|Carboplatin|carboplatin|mesh-list
6057435|NCT00621049|Docetaxel|docetaxel|mesh-list
6057436|NCT00621049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6057437|NCT00621049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6057438|NCT00621049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6057439|NCT00621049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6057440|NCT00621049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6057441|NCT00621049|Growth Substances|growth substances|mesh-ancestor
6057442|NCT00621049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057443|NCT00621049|Growth Inhibitors|growth inhibitors|mesh-ancestor
6057444|NCT00621049|Tubulin Modulators|tubulin modulators|mesh-ancestor
6057445|NCT00621049|Antimitotic Agents|antimitotic agents|mesh-ancestor
6057446|NCT00621049|Mitosis Modulators|mitosis modulators|mesh-ancestor
6057447|NCT00621049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057448|NCT00621049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6057449|NCT00621049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6057450|NCT00621140|Linagliptin|linagliptin|mesh-list
6057451|NCT00621140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6057452|NCT00621140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057453|NCT00621140|Incretins|incretins|mesh-ancestor
6057454|NCT00621140|Hormones|hormones|mesh-ancestor
6057455|NCT00621140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6057456|NCT00621140|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6057457|NCT00621140|Protease Inhibitors|protease inhibitors|mesh-ancestor
6057458|NCT00621140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6057459|NCT00621140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057460|NCT00621153|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6057461|NCT00621153|Candesartan|candesartan|mesh-list
6057462|NCT00621153|Candesartan cilexetil|candesartan cilexetil|mesh-list
6057463|NCT00621153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6057464|NCT00621153|Diuretics|diuretics|mesh-ancestor
6057465|NCT00621153|Natriuretic Agents|natriuretic agents|mesh-ancestor
6057466|NCT00621153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057467|NCT00621153|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6057468|NCT00621153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6057469|NCT00621153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057470|NCT00621153|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6057471|NCT00621153|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6057472|NCT00621179|Leuprolide|leuprolide|mesh-list
6057473|NCT00621179|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6057474|NCT00621179|Fertility Agents|fertility agents|mesh-ancestor
6057475|NCT00621179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6057476|NCT00621179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057477|NCT00621179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6057478|NCT00621179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6057479|NCT00621192|Meropenem|meropenem|mesh-list
6057480|NCT00621192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6057481|NCT00621192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6057482|NCT00621244|Panobinostat|panobinostat|mesh-list
6057483|NCT00621244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6057484|NCT00621244|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6057485|NCT00621244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6057486|NCT00621244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057487|NCT00621257|Vitamin D|vitamin d|mesh-list
6057488|NCT00621257|Ergocalciferols|ergocalciferols|mesh-list
6057489|NCT00621257|Cholecalciferol|cholecalciferol|mesh-list
5600068|NCT03714880|Luteolytic Agents|luteolytic agents|mesh-ancestor
6057490|NCT00621257|Vitamins|vitamins|mesh-list
6057491|NCT00621257|Micronutrients|micronutrients|mesh-ancestor
6057492|NCT00621257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057493|NCT00621257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6057494|NCT00621257|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6057495|NCT00621309|Rifampin|rifampin|mesh-list
6057496|NCT00621309|Rifamycins|rifamycins|mesh-list
6057497|NCT00621309|Sulforaphane|sulforaphane|mesh-list
6057498|NCT00621309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6057499|NCT00621309|Antitubercular Agents|antitubercular agents|mesh-ancestor
6057500|NCT00621309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6057501|NCT00621309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6057502|NCT00621309|Leprostatic Agents|leprostatic agents|mesh-ancestor
6057503|NCT00621309|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6057504|NCT00621309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6057505|NCT00621309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057506|NCT00621309|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6057507|NCT00621309|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6057508|NCT00621309|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6057509|NCT00621309|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6057510|NCT00621309|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6057511|NCT00621309|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6057512|NCT00621309|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6057513|NCT00621309|Protective Agents|protective agents|mesh-ancestor
6057514|NCT00621309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057515|NCT00621309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6057516|NCT00621322|Vaccines|vaccines|mesh-list
6057517|NCT00621322|Immunologic Factors|immunologic factors|mesh-ancestor
6057518|NCT00621322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057519|NCT00621504|Clarithromycin|clarithromycin|mesh-list
6057520|NCT00621504|Ceftriaxone|ceftriaxone|mesh-list
6057521|NCT00621504|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
6057522|NCT00621504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6057523|NCT00621504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6057524|NCT00621504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6057525|NCT00621504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6057526|NCT00621504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057527|NCT00621504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6057528|NCT00621504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6057529|NCT00621517|Bupropion|bupropion|mesh-list
6057530|NCT00621517|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6057531|NCT00621517|Antidepressive Agents|antidepressive agents|mesh-ancestor
6057532|NCT00621517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6057533|NCT00621517|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6057534|NCT00621517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6057535|NCT00621517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6057536|NCT00621517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057537|NCT00621517|Dopamine Agents|dopamine agents|mesh-ancestor
6057538|NCT00621517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6057539|NCT00621517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057540|NCT00621517|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6057541|NCT00621517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6057542|NCT00621517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6057543|NCT00621530|Ketorolac|ketorolac|mesh-list
6057544|NCT00621530|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6057545|NCT00621530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6057546|NCT00621530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6057547|NCT00621530|Analgesics|analgesics|mesh-ancestor
6057548|NCT00621530|Sensory System Agents|sensory system agents|mesh-ancestor
6057549|NCT00621530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6057550|NCT00621530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057551|NCT00621530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6057552|NCT00621530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6057553|NCT00621530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6057554|NCT00621530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6057555|NCT00621530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057556|NCT00621543|Copper|copper|mesh-list
6057557|NCT00621543|Levonorgestrel|levonorgestrel|mesh-list
6057558|NCT00621543|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6057559|NCT00621543|Contraceptive Agents|contraceptive agents|mesh-ancestor
6057560|NCT00621543|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5725052|NCT03182894|Pembrolizumab|pembrolizumab|mesh-list
5504799|NCT04446039|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
5504800|NCT04446039|Sertraline|sertraline|mesh-list
5504801|NCT04446039|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
5504802|NCT04446039|Tianeptine|tianeptine|mesh-list
5504803|NCT04446039|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5504804|NCT04446039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5504805|NCT04446039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5504806|NCT04446039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504807|NCT04446039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5504808|NCT04446039|Serotonin Agents|serotonin agents|mesh-ancestor
5504809|NCT04446039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057561|NCT00621543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057562|NCT00621543|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6057563|NCT00621543|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6057564|NCT00621543|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6057565|NCT00621543|Trace Elements|trace elements|mesh-ancestor
6057566|NCT00621543|Micronutrients|micronutrients|mesh-ancestor
6057567|NCT00621686|Bevacizumab|bevacizumab|mesh-list
6057568|NCT00621686|Sorafenib|sorafenib|mesh-list
6057569|NCT00621686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6057570|NCT00621686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6057571|NCT00621686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6057572|NCT00621686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6057573|NCT00621686|Growth Substances|growth substances|mesh-ancestor
6057574|NCT00621686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057575|NCT00621686|Growth Inhibitors|growth inhibitors|mesh-ancestor
6057576|NCT00621686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6057577|NCT00621686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6057578|NCT00621686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057579|NCT00621751|Carbamazepine|carbamazepine|mesh-list
6057580|NCT00621751|Anticonvulsants|anticonvulsants|mesh-ancestor
6057581|NCT00621751|Antimanic Agents|antimanic agents|mesh-ancestor
6057582|NCT00621751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6057583|NCT00621751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6057584|NCT00621751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057585|NCT00621751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6057586|NCT00621751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6057587|NCT00621751|Analgesics|analgesics|mesh-ancestor
6057588|NCT00621751|Sensory System Agents|sensory system agents|mesh-ancestor
6057589|NCT00621751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6057590|NCT00621751|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6057591|NCT00621751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6057592|NCT00621751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057593|NCT00621751|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6057594|NCT00621751|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6057595|NCT00621764|Vaccines|vaccines|mesh-list
6057596|NCT00621764|Immunologic Factors|immunologic factors|mesh-ancestor
6057597|NCT00621764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057598|NCT00621777|Varenicline|varenicline|mesh-list
6057599|NCT00621777|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6057600|NCT00621777|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6057601|NCT00621777|Cholinergic Agents|cholinergic agents|mesh-ancestor
6057602|NCT00621777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6057603|NCT00621777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057604|NCT00621777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057605|NCT00621842|Lamotrigine|lamotrigine|mesh-list
6057606|NCT00621842|Anticonvulsants|anticonvulsants|mesh-list
6057607|NCT00621842|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6057608|NCT00621842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6057609|NCT00621842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057610|NCT00621842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6057611|NCT00621842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057612|NCT00621842|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6057613|NCT00621842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6057614|NCT00621842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6057615|NCT00621842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6462453|NCT00459563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504810|NCT04446039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5504811|NCT04446039|Antidepressive Agents|antidepressive agents|mesh-ancestor
5504812|NCT04446039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5504813|NCT04446039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5504814|NCT04446039|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5504815|NCT04446039|Dopamine Agents|dopamine agents|mesh-ancestor
6057616|NCT00621842|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6057617|NCT00621855|Dabigatran|dabigatran|mesh-list
6057618|NCT00621855|Antithrombins|antithrombins|mesh-ancestor
6057619|NCT00621855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6057620|NCT00621855|Protease Inhibitors|protease inhibitors|mesh-ancestor
6057621|NCT00621855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6057622|NCT00621855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057623|NCT00621855|Anticoagulants|anticoagulants|mesh-ancestor
6057624|NCT00621946|Dexetimide|dexetimide|mesh-list
6057625|NCT00621946|Citalopram|citalopram|mesh-list
6057626|NCT00621946|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6057627|NCT00621946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6057628|NCT00621946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6057629|NCT00621946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057630|NCT00621946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6057631|NCT00621946|Serotonin Agents|serotonin agents|mesh-ancestor
6057632|NCT00621946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057633|NCT00621946|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6057634|NCT00621946|Antidepressive Agents|antidepressive agents|mesh-ancestor
6057635|NCT00621946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6057636|NCT00621946|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6057637|NCT00621946|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6057638|NCT00621946|Parasympatholytics|parasympatholytics|mesh-ancestor
6057639|NCT00621946|Autonomic Agents|autonomic agents|mesh-ancestor
6057640|NCT00621946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6462454|NCT00459563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6462455|NCT00459563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6462456|NCT00459563|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6462457|NCT00459563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6462458|NCT00459563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462459|NCT00459563|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6462460|NCT00459615|Artesunate|artesunate|mesh-list
6462461|NCT00459615|Antimalarials|antimalarials|mesh-ancestor
6057641|NCT00621946|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6057642|NCT00621946|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6057643|NCT00621946|Cholinergic Agents|cholinergic agents|mesh-ancestor
6057644|NCT00621959|Levocetirizine|levocetirizine|mesh-list
6057645|NCT00621959|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6462462|NCT00459615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6462463|NCT00459615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6462464|NCT00459615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6462465|NCT00459615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6462466|NCT00459615|Antiviral Agents|antiviral agents|mesh-ancestor
6462467|NCT00459615|Schistosomicides|schistosomicides|mesh-ancestor
6462468|NCT00459615|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6462469|NCT00459615|Anthelmintics|anthelmintics|mesh-ancestor
6462470|NCT00459654|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
6462471|NCT00459654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6462472|NCT00459719|Tacrolimus|tacrolimus|mesh-list
6462473|NCT00459719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6462474|NCT00459719|Immunologic Factors|immunologic factors|mesh-ancestor
6462475|NCT00459719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462476|NCT00459719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6462477|NCT00459719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6462478|NCT00459719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462479|NCT00459771|Candesartan|candesartan|mesh-list
6462480|NCT00459771|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6462481|NCT00459771|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6462482|NCT00459771|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6462483|NCT00459771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462484|NCT00459836|Gemcitabine|gemcitabine|mesh-list
6462485|NCT00459836|Docetaxel|docetaxel|mesh-list
6462486|NCT00459836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6057646|NCT00621959|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6057647|NCT00621959|Histamine Antagonists|histamine antagonists|mesh-ancestor
6057648|NCT00621959|Histamine Agents|histamine agents|mesh-ancestor
6057649|NCT00621959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6057650|NCT00621959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057651|NCT00621959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057652|NCT00621985|Dexamethasone|dexamethasone|mesh-list
6057653|NCT00621985|Hydrocortisone|hydrocortisone|mesh-list
6057654|NCT00621985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6057655|NCT00621985|Antiemetics|antiemetics|mesh-ancestor
6057656|NCT00621985|Autonomic Agents|autonomic agents|mesh-ancestor
6057657|NCT00621985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6057658|NCT00621985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057659|NCT00621985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6057660|NCT00621985|Glucocorticoids|glucocorticoids|mesh-ancestor
6057661|NCT00621985|Hormones|hormones|mesh-ancestor
6057662|NCT00621985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5504816|NCT04446039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5504817|NCT04446039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5504818|NCT04446039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5504819|NCT04446039|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5504820|NCT04446039|Analgesics|analgesics|mesh-ancestor
5504821|NCT04446039|Sensory System Agents|sensory system agents|mesh-ancestor
5504822|NCT04446039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5504823|NCT04446039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5504824|NCT04446039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5504825|NCT04446039|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5504826|NCT04446039|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5504827|NCT04446039|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5504828|NCT04446039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5504829|NCT04446039|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6057663|NCT00621985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6057664|NCT00621985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6057665|NCT00622284|Glimepiride|glimepiride|mesh-list
6057666|NCT00622284|Linagliptin|linagliptin|mesh-list
6057667|NCT00622284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6057668|NCT00622284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6057669|NCT00622284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057670|NCT00622284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6057671|NCT00622284|Immunologic Factors|immunologic factors|mesh-ancestor
6057672|NCT00622284|Incretins|incretins|mesh-ancestor
6057673|NCT00622284|Hormones|hormones|mesh-ancestor
6057674|NCT00622284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6057675|NCT00622284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6057676|NCT00622284|Protease Inhibitors|protease inhibitors|mesh-ancestor
6057677|NCT00622284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6057678|NCT00622284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057679|NCT00622336|Lenalidomide|lenalidomide|mesh-list
6057680|NCT00622336|Immunologic Factors|immunologic factors|mesh-ancestor
6057681|NCT00622336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057682|NCT00622336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6057683|NCT00622336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6057684|NCT00622336|Growth Substances|growth substances|mesh-ancestor
6057685|NCT00622336|Growth Inhibitors|growth inhibitors|mesh-ancestor
6057686|NCT00622336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6202023|NCT02034578|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6202024|NCT02034578|Protease Inhibitors|protease inhibitors|mesh-ancestor
6202025|NCT02034578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6202026|NCT02034578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202027|NCT02034578|Anticoagulants|anticoagulants|mesh-ancestor
6202028|NCT02034591|Apixaban|apixaban|mesh-list
6202029|NCT02034591|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6202030|NCT02034591|Antithrombins|antithrombins|mesh-ancestor
6202031|NCT02034591|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6202032|NCT02034591|Protease Inhibitors|protease inhibitors|mesh-ancestor
6202033|NCT02034591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6202034|NCT02034591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504830|NCT04446039|Histamine Antagonists|histamine antagonists|mesh-ancestor
6057687|NCT00622388|Ofatumumab|ofatumumab|mesh-list
6057688|NCT00622388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6057689|NCT00622401|Interleukin-12|interleukin-12|mesh-list
6057690|NCT00622401|Vaccines|vaccines|mesh-list
6057691|NCT00622401|Immunologic Factors|immunologic factors|mesh-ancestor
6057692|NCT00622401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057693|NCT00622401|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6057694|NCT00622401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6057695|NCT00622401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6057696|NCT00622401|Growth Substances|growth substances|mesh-ancestor
6057697|NCT00622401|Growth Inhibitors|growth inhibitors|mesh-ancestor
6057698|NCT00622401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6057699|NCT00622466|Paclitaxel|paclitaxel|mesh-list
6057700|NCT00622466|Sorafenib|sorafenib|mesh-list
6057701|NCT00622466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6057702|NCT00622466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6057703|NCT00622466|Tubulin Modulators|tubulin modulators|mesh-ancestor
6057704|NCT00622466|Antimitotic Agents|antimitotic agents|mesh-ancestor
6057705|NCT00622466|Mitosis Modulators|mitosis modulators|mesh-ancestor
6057706|NCT00622466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057707|NCT00622466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6057708|NCT00622466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6057709|NCT00622505|Zoledronic Acid|zoledronic acid|mesh-list
6057710|NCT00622505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6057711|NCT00622505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057712|NCT00622635|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6057713|NCT00622635|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6057714|NCT00622635|Autonomic Agents|autonomic agents|mesh-ancestor
6057715|NCT00622635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6057716|NCT00622635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057717|NCT00622635|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6057718|NCT00622635|Respiratory System Agents|respiratory system agents|mesh-ancestor
6057719|NCT00622635|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6057720|NCT00622635|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6057721|NCT00622635|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6057722|NCT00622635|Adrenergic Agents|adrenergic agents|mesh-ancestor
6057723|NCT00622635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6057724|NCT00622635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057725|NCT00622700|Teriflunomide|teriflunomide|mesh-list
6057726|NCT00622700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6057727|NCT00622700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6057728|NCT00622700|Analgesics|analgesics|mesh-ancestor
6057729|NCT00622700|Sensory System Agents|sensory system agents|mesh-ancestor
6057730|NCT00622700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6057731|NCT00622700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057732|NCT00622700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6057733|NCT00622700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6057734|NCT00622700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6057735|NCT00622700|Immunologic Factors|immunologic factors|mesh-ancestor
6057736|NCT00622713|Rivastigmine|rivastigmine|mesh-list
6057737|NCT00622713|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6057738|NCT00622713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6057739|NCT00622713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057740|NCT00622713|Cholinergic Agents|cholinergic agents|mesh-ancestor
6057741|NCT00622713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6057742|NCT00622713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057743|NCT00622713|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6057744|NCT00622713|Protective Agents|protective agents|mesh-ancestor
6057745|NCT00622726|Bevacizumab|bevacizumab|mesh-list
6057746|NCT00622726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6057747|NCT00622726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6057748|NCT00622726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6057749|NCT00622726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6057750|NCT00622726|Growth Substances|growth substances|mesh-ancestor
6057751|NCT00622726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057752|NCT00622726|Growth Inhibitors|growth inhibitors|mesh-ancestor
6057753|NCT00622739|Ziprasidone|ziprasidone|mesh-list
6057754|NCT00622739|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6057755|NCT00622739|Serotonin Agents|serotonin agents|mesh-ancestor
5504831|NCT04446039|Histamine Agents|histamine agents|mesh-ancestor
5504832|NCT04446039|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5504833|NCT04446039|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5504834|NCT04446039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6057756|NCT00622739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6057757|NCT00622739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057758|NCT00622739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057759|NCT00622739|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6057760|NCT00622739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6057761|NCT00622739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6057762|NCT00622739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6057763|NCT00622739|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6057764|NCT00622739|Dopamine Agents|dopamine agents|mesh-ancestor
6057765|NCT00622869|Everolimus|everolimus|mesh-list
6057766|NCT00622869|Tacrolimus|tacrolimus|mesh-list
6057767|NCT00622869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6057768|NCT00622869|Immunologic Factors|immunologic factors|mesh-ancestor
6057769|NCT00622869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057770|NCT00622869|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6057771|NCT00622869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6057772|NCT00622869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057773|NCT00622869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6057774|NCT00622895|Mycophenolic Acid|mycophenolic acid|mesh-list
6057775|NCT00622895|Fludarabine|fludarabine|mesh-list
6057776|NCT00622895|Fludarabine phosphate|fludarabine phosphate|mesh-list
6057777|NCT00622895|Tacrolimus|tacrolimus|mesh-list
6057778|NCT00622895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6057779|NCT00622895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6057780|NCT00622895|Antimetabolites|antimetabolites|mesh-ancestor
6057781|NCT00622895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057782|NCT00622895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6057783|NCT00622895|Immunologic Factors|immunologic factors|mesh-ancestor
6057784|NCT00622895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504835|NCT04446039|Adrenergic Agents|adrenergic agents|mesh-ancestor
5504836|NCT04446039|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5504837|NCT04446039|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6057785|NCT00622895|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6057786|NCT00622895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6057787|NCT00622895|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5504838|NCT04446091|Irinotecan|irinotecan|mesh-list
5504839|NCT04446091|Apatinib|apatinib|mesh-list
5504840|NCT04446091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
5504841|NCT04446091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5504842|NCT04446091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5504843|NCT04446091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5504844|NCT04446091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504845|NCT04446091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5725053|NCT03182894|Azacitidine|azacitidine|mesh-list
6057788|NCT00622895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6057789|NCT00622895|Antitubercular Agents|antitubercular agents|mesh-ancestor
6057790|NCT00622895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6057791|NCT00622895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6057792|NCT00622908|Besifloxacin|besifloxacin|mesh-list
6057793|NCT00622908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6057794|NCT00622908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6057795|NCT00622908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6057796|NCT00622908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6057797|NCT00622908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6057798|NCT00622908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057799|NCT00622908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6057800|NCT00623012|Sirolimus|sirolimus|mesh-list
6057801|NCT00623012|Tacrolimus|tacrolimus|mesh-list
6057802|NCT00623012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6057803|NCT00623012|Immunologic Factors|immunologic factors|mesh-ancestor
6057804|NCT00623012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057805|NCT00623012|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6057806|NCT00623012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6057807|NCT00623012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057808|NCT00623012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6057809|NCT00623012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6057810|NCT00623012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6057811|NCT00623012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6057812|NCT00623012|Antifungal Agents|antifungal agents|mesh-ancestor
6057813|NCT00623103|Rivastigmine|rivastigmine|mesh-list
6057814|NCT00623103|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6057815|NCT00623103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6057816|NCT00623103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057817|NCT00623103|Cholinergic Agents|cholinergic agents|mesh-ancestor
6057818|NCT00623103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6057819|NCT00623103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504846|NCT04446091|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5504847|NCT04446091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5504848|NCT04446091|Growth Substances|growth substances|mesh-ancestor
5504849|NCT04446091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504850|NCT04446091|Growth Inhibitors|growth inhibitors|mesh-ancestor
5504851|NCT04446104|Ascorbic Acid|ascorbic acid|mesh-list
5504852|NCT04446104|Hydroxychloroquine|hydroxychloroquine|mesh-list
5504853|NCT04446104|Ivermectin|ivermectin|mesh-list
5504854|NCT04446104|Povidone-Iodine|povidone-iodine|mesh-list
5504855|NCT04446104|Povidone|povidone|mesh-list
5504856|NCT04446104|Vitamins|vitamins|mesh-ancestor
5504857|NCT04446104|Micronutrients|micronutrients|mesh-ancestor
5504858|NCT04446104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504859|NCT04446104|Antimalarials|antimalarials|mesh-ancestor
5504860|NCT04446104|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5504861|NCT04446104|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5504862|NCT04446104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5504863|NCT04446104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5504864|NCT04446104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504865|NCT04446104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5504866|NCT04446104|Antioxidants|antioxidants|mesh-ancestor
5504867|NCT04446104|Protective Agents|protective agents|mesh-ancestor
5504868|NCT04446104|Plasma Substitutes|plasma substitutes|mesh-ancestor
6057820|NCT00623103|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6057821|NCT00623103|Protective Agents|protective agents|mesh-ancestor
6057822|NCT00623181|Vaccines|vaccines|mesh-list
6057823|NCT00623181|Immunologic Factors|immunologic factors|mesh-ancestor
6057824|NCT00623181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057825|NCT00623194|Insulin|insulin|mesh-list
6057826|NCT00623194|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6057827|NCT00623194|Insulin Aspart|insulin aspart|mesh-list
6057828|NCT00623194|Insulin Detemir|insulin detemir|mesh-list
6057829|NCT00623194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6057830|NCT00623194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057831|NCT00623233|Gemcitabine|gemcitabine|mesh-list
6057832|NCT00623233|Bevacizumab|bevacizumab|mesh-list
6057833|NCT00623233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6057834|NCT00623233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6057835|NCT00623233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6057836|NCT00623233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6057837|NCT00623233|Growth Substances|growth substances|mesh-ancestor
6057838|NCT00623233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057839|NCT00623233|Growth Inhibitors|growth inhibitors|mesh-ancestor
6057840|NCT00623233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6057841|NCT00623233|Antimetabolites|antimetabolites|mesh-ancestor
6057842|NCT00623233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057843|NCT00623233|Antiviral Agents|antiviral agents|mesh-ancestor
6057844|NCT00623233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6057845|NCT00623233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6057846|NCT00623233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6057847|NCT00623233|Immunologic Factors|immunologic factors|mesh-ancestor
5504869|NCT04446104|Blood Substitutes|blood substitutes|mesh-ancestor
5504870|NCT04446104|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5504871|NCT04445935|Bivalirudin|bivalirudin|mesh-list
5504872|NCT04445935|Antithrombins|antithrombins|mesh-ancestor
5504873|NCT04445935|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5504874|NCT04445935|Protease Inhibitors|protease inhibitors|mesh-ancestor
5504875|NCT04445935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5504876|NCT04445935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504877|NCT04445935|Anticoagulants|anticoagulants|mesh-ancestor
5504878|NCT04446130|Decitabine|decitabine|mesh-list
5504879|NCT04446130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5504880|NCT04446130|Antimetabolites|antimetabolites|mesh-ancestor
6057848|NCT00623363|Piclozotan|piclozotan|mesh-list
6202035|NCT02034591|Anticoagulants|anticoagulants|mesh-ancestor
6057849|NCT00623363|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6057850|NCT00623363|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6057851|NCT00623363|Serotonin Agents|serotonin agents|mesh-ancestor
6057852|NCT00623363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6057853|NCT00623363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057854|NCT00623363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057855|NCT00623428|Ribavirin|ribavirin|mesh-list
6057856|NCT00623428|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6057857|NCT00623428|Antimetabolites|antimetabolites|mesh-ancestor
6057858|NCT00623428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057859|NCT00623428|Antiviral Agents|antiviral agents|mesh-ancestor
6057860|NCT00623428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6057861|NCT00623480|Factor VIII|factor viii|mesh-list
6057862|NCT00623480|Coagulants|coagulants|mesh-ancestor
6057863|NCT00623545|Exenatide|exenatide|mesh-list
6057864|NCT00623545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6057865|NCT00623545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057866|NCT00623545|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6057867|NCT00623545|Incretins|incretins|mesh-ancestor
6057868|NCT00623545|Hormones|hormones|mesh-ancestor
6057869|NCT00623545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6057870|NCT00623597|Ritonavir|ritonavir|mesh-list
5504881|NCT04446130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504882|NCT04446130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5504883|NCT04446130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5504884|NCT04445857|Calcitonin|calcitonin|mesh-list
5504885|NCT04445857|Salmon calcitonin|salmon calcitonin|mesh-list
5504886|NCT04445857|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
5504887|NCT04445857|Katacalcin|katacalcin|mesh-list
5504888|NCT04445857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5504889|NCT04445857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504890|NCT04445857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5504891|NCT04445857|Vasodilator Agents|vasodilator agents|mesh-ancestor
5504892|NCT04445727|Ascorbic Acid|ascorbic acid|mesh-list
5504893|NCT04445727|Vitamins|vitamins|mesh-ancestor
5504894|NCT04445727|Micronutrients|micronutrients|mesh-ancestor
5504895|NCT04445727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504896|NCT04445727|Antioxidants|antioxidants|mesh-ancestor
5504897|NCT04445727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504898|NCT04445727|Protective Agents|protective agents|mesh-ancestor
5504899|NCT04445779|Ubiquinone|ubiquinone|mesh-list
5504900|NCT04445779|Coenzyme Q10|coenzyme q10|mesh-list
5504901|NCT04445779|Micronutrients|micronutrients|mesh-ancestor
5504902|NCT04445779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504903|NCT04445779|Vitamins|vitamins|mesh-ancestor
6057871|NCT00623597|Saquinavir|saquinavir|mesh-list
6057872|NCT00623597|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6057873|NCT00623597|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6057874|NCT00623597|Protease Inhibitors|protease inhibitors|mesh-ancestor
6057875|NCT00623597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6057876|NCT00623597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057877|NCT00623597|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6057878|NCT00623597|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6057879|NCT00623597|Antiviral Agents|antiviral agents|mesh-ancestor
6057880|NCT00623597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6057881|NCT00623597|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6057882|NCT00623597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5504904|NCT04445519|Latanoprost|latanoprost|mesh-list
5504905|NCT04445519|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5504906|NCT04445519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5504907|NCT04445467|Favipiravir|favipiravir|mesh-list
5504908|NCT04445467|Antiviral Agents|antiviral agents|mesh-ancestor
5504909|NCT04445467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5504910|NCT04445571|Pulmonary Surfactants|pulmonary surfactants|mesh-list
5504911|NCT04445571|Respiratory System Agents|respiratory system agents|mesh-ancestor
5504912|NCT04445636|Dexmedetomidine|dexmedetomidine|mesh-list
5504913|NCT04445636|Morphine|morphine|mesh-list
5504914|NCT04445636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5504915|NCT04445636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5504916|NCT04445636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504917|NCT04445636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5504918|NCT04445636|Analgesics|analgesics|mesh-ancestor
5504919|NCT04445636|Sensory System Agents|sensory system agents|mesh-ancestor
5504920|NCT04445636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5504921|NCT04445636|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6057883|NCT00623623|Enoxaparin|enoxaparin|mesh-list
5504922|NCT04445636|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6057884|NCT00623623|Tenecteplase|tenecteplase|mesh-list
6057885|NCT00623623|Clopidogrel|clopidogrel|mesh-list
6057886|NCT00623623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6057887|NCT00623623|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6057888|NCT00623623|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6057889|NCT00623623|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6057890|NCT00623623|Purinergic Agents|purinergic agents|mesh-ancestor
6057891|NCT00623623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6057892|NCT00623623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057893|NCT00623623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057894|NCT00623623|Anticoagulants|anticoagulants|mesh-ancestor
6057895|NCT00623623|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6057896|NCT00623623|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6057897|NCT00623714|Fluticasone|fluticasone|mesh-list
6057898|NCT00623714|Xhance|xhance|mesh-list
6057899|NCT00623714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6057900|NCT00623714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6057901|NCT00623714|Autonomic Agents|autonomic agents|mesh-ancestor
5504923|NCT04445636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5504924|NCT04445636|Adrenergic Agents|adrenergic agents|mesh-ancestor
5504925|NCT04445636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5504926|NCT04445636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504927|NCT04445636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5504928|NCT04445636|Narcotics|narcotics|mesh-ancestor
5504929|NCT04445506|Dexamethasone|dexamethasone|mesh-list
6057902|NCT00623714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6057903|NCT00623714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057904|NCT00623714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6057905|NCT00623714|Respiratory System Agents|respiratory system agents|mesh-ancestor
6057906|NCT00623714|Dermatologic Agents|dermatologic agents|mesh-ancestor
6057907|NCT00623714|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6057908|NCT00623727|Factor VIII|factor viii|mesh-list
6057909|NCT00623727|Coagulants|coagulants|mesh-ancestor
6057910|NCT00623766|Dexamethasone|dexamethasone|mesh-list
6057911|NCT00623766|Prednisone|prednisone|mesh-list
6057912|NCT00623766|Methylprednisolone|methylprednisolone|mesh-list
6057913|NCT00623766|Prednisolone|prednisolone|mesh-list
6057914|NCT00623766|Triamcinolone|triamcinolone|mesh-list
6057915|NCT00623766|Hydrocortisone|hydrocortisone|mesh-list
6057916|NCT00623766|Betamethasone|betamethasone|mesh-list
6057917|NCT00623766|Fludrocortisone|fludrocortisone|mesh-list
6057918|NCT00623766|Ipilimumab|ipilimumab|mesh-list
6057919|NCT00623766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6057920|NCT00623766|Antiemetics|antiemetics|mesh-ancestor
6057921|NCT00623766|Autonomic Agents|autonomic agents|mesh-ancestor
5504930|NCT04445506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5504931|NCT04445506|Antiemetics|antiemetics|mesh-ancestor
5504932|NCT04445506|Autonomic Agents|autonomic agents|mesh-ancestor
5504933|NCT04445506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5504934|NCT04445506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504935|NCT04445506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5504936|NCT04445506|Glucocorticoids|glucocorticoids|mesh-ancestor
5504937|NCT04445506|Hormones|hormones|mesh-ancestor
5504938|NCT04445506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5504939|NCT04445506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5504940|NCT04445506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5504941|NCT04445623|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
5504942|NCT04445623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5504943|NCT04445311|Ivermectin|ivermectin|mesh-list
5504944|NCT04445311|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5504945|NCT04445311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5504946|NCT04445194|Vaccines|vaccines|mesh-list
6057922|NCT00623766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6057923|NCT00623766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057924|NCT00623766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6057925|NCT00623766|Glucocorticoids|glucocorticoids|mesh-ancestor
6057926|NCT00623766|Hormones|hormones|mesh-ancestor
6057927|NCT00623766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6057928|NCT00623766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6057929|NCT00623766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6057930|NCT00623766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6057931|NCT00623766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6057932|NCT00623766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057933|NCT00623766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6057934|NCT00623766|Protective Agents|protective agents|mesh-ancestor
6057935|NCT00623766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6462487|NCT00459836|Antimetabolites|antimetabolites|mesh-ancestor
5504947|NCT04445194|Immunologic Factors|immunologic factors|mesh-ancestor
5504948|NCT04445194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504949|NCT04445246|Iloprost|iloprost|mesh-list
5504950|NCT04445246|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5504951|NCT04445246|Vasodilator Agents|vasodilator agents|mesh-ancestor
5504952|NCT04445025|Leuprolide|leuprolide|mesh-list
5504953|NCT04445025|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5504954|NCT04445025|Fertility Agents|fertility agents|mesh-ancestor
6057936|NCT00623766|Respiratory System Agents|respiratory system agents|mesh-ancestor
6057937|NCT00623779|Aspirin|aspirin|mesh-list
6057938|NCT00623779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6057939|NCT00623779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6057940|NCT00623779|Analgesics|analgesics|mesh-ancestor
5504955|NCT04445025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5504956|NCT04445025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504957|NCT04445025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5504958|NCT04445025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5504959|NCT04444986|Favipiravir|favipiravir|mesh-list
5504960|NCT04444986|Antiviral Agents|antiviral agents|mesh-ancestor
5504961|NCT04444986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5504962|NCT04444843|Mycophenolic Acid|mycophenolic acid|mesh-list
5504963|NCT04444843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5504964|NCT04444843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5504965|NCT04444843|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5504966|NCT04444843|Antitubercular Agents|antitubercular agents|mesh-ancestor
5504967|NCT04444843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5504968|NCT04444843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5504969|NCT04444843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5504970|NCT04444843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504971|NCT04444804|Rivaroxaban|rivaroxaban|mesh-list
6057941|NCT00623779|Sensory System Agents|sensory system agents|mesh-ancestor
6057942|NCT00623779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6057943|NCT00623779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057944|NCT00623779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6057945|NCT00623779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6057946|NCT00623779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6057947|NCT00623779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6057948|NCT00623779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057949|NCT00623779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6057950|NCT00623779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6057951|NCT00623779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6057952|NCT00623779|Antipyretics|antipyretics|mesh-ancestor
5504972|NCT04444804|Phenprocoumon|phenprocoumon|mesh-list
5504973|NCT04444804|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5504974|NCT04444804|Antithrombins|antithrombins|mesh-ancestor
6057953|NCT00623805|Bevacizumab|bevacizumab|mesh-list
6057954|NCT00623805|Capecitabine|capecitabine|mesh-list
6057955|NCT00623805|Oxaliplatin|oxaliplatin|mesh-list
6057956|NCT00623805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6057957|NCT00623805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6057958|NCT00623805|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6057959|NCT00623805|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6057960|NCT00623805|Growth Substances|growth substances|mesh-ancestor
6057961|NCT00623805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057962|NCT00623805|Growth Inhibitors|growth inhibitors|mesh-ancestor
6057963|NCT00623805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6057964|NCT00623805|Antimetabolites|antimetabolites|mesh-ancestor
6057965|NCT00623805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057966|NCT00623935|Fludarabine|fludarabine|mesh-list
6057967|NCT00623935|Busulfan|busulfan|mesh-list
6057968|NCT00623935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6057969|NCT00623935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057970|NCT00623935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6057971|NCT00623935|Immunologic Factors|immunologic factors|mesh-ancestor
6057972|NCT00623935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057973|NCT00623935|Alkylating Agents|alkylating agents|mesh-ancestor
6057974|NCT00623935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5504975|NCT04444804|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5504976|NCT04444804|Protease Inhibitors|protease inhibitors|mesh-ancestor
5504977|NCT04444804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5504978|NCT04444804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5504979|NCT04444804|Anticoagulants|anticoagulants|mesh-ancestor
5504980|NCT04444635|Fentanyl|fentanyl|mesh-list
5504981|NCT04444635|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5504982|NCT04444635|Narcotics|narcotics|mesh-ancestor
6057975|NCT00623935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6057976|NCT00624013|Sertraline|sertraline|mesh-list
6057977|NCT00624013|Antidepressive Agents|antidepressive agents|mesh-ancestor
6057978|NCT00624013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6057979|NCT00624013|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6057980|NCT00624013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6057981|NCT00624013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6057982|NCT00624013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057983|NCT00624013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6057984|NCT00624013|Serotonin Agents|serotonin agents|mesh-ancestor
6057985|NCT00624013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057986|NCT00624052|Amlodipine|amlodipine|mesh-list
6057987|NCT00624052|Telmisartan|telmisartan|mesh-list
6057988|NCT00624052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6057989|NCT00624052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6057990|NCT00624052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6057991|NCT00624052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6057992|NCT00624052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6057993|NCT00624052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6057994|NCT00624052|Vasodilator Agents|vasodilator agents|mesh-ancestor
6057995|NCT00624052|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6057996|NCT00624052|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6057997|NCT00624065|Carvedilol|carvedilol|mesh-list
6057998|NCT00624065|Lisinopril|lisinopril|mesh-list
6057999|NCT00624065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6058000|NCT00624065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6058001|NCT00624065|Adrenergic Agents|adrenergic agents|mesh-ancestor
6058002|NCT00624065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6058003|NCT00624065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6058004|NCT00624065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058005|NCT00624065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6058006|NCT00624065|Antioxidants|antioxidants|mesh-ancestor
6058007|NCT00624065|Protective Agents|protective agents|mesh-ancestor
6058008|NCT00624065|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6058009|NCT00624065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6058010|NCT00624065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6058011|NCT00624065|Vasodilator Agents|vasodilator agents|mesh-ancestor
6058012|NCT00624065|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6058013|NCT00624065|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6058014|NCT00624065|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6058015|NCT00624065|Protease Inhibitors|protease inhibitors|mesh-ancestor
6058016|NCT00624065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6058017|NCT00624065|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6058018|NCT00624195|Etravirine|etravirine|mesh-list
6058019|NCT00624195|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6058020|NCT00624195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6058021|NCT00624195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6058022|NCT00624195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6058023|NCT00624195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6058024|NCT00624195|Antiviral Agents|antiviral agents|mesh-ancestor
6058025|NCT00624195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6058026|NCT00624377|Tiotropium Bromide|tiotropium bromide|mesh-list
6058027|NCT00624377|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6058028|NCT00624377|Autonomic Agents|autonomic agents|mesh-ancestor
5504983|NCT04444635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5504984|NCT04444635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504985|NCT04444635|Analgesics|analgesics|mesh-ancestor
5504986|NCT04444635|Sensory System Agents|sensory system agents|mesh-ancestor
5504987|NCT04444635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5504988|NCT04444635|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5504989|NCT04444635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5504990|NCT04444635|Anesthetics, General|anesthetics, general|mesh-ancestor
6058029|NCT00624377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6058030|NCT00624377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058031|NCT00624377|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6058032|NCT00624377|Respiratory System Agents|respiratory system agents|mesh-ancestor
6058033|NCT00624377|Parasympatholytics|parasympatholytics|mesh-ancestor
6058034|NCT00624377|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6058035|NCT00624377|Cholinergic Agents|cholinergic agents|mesh-ancestor
6058036|NCT00624377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6058037|NCT00624377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6058038|NCT00624416|Prednisolone|prednisolone|mesh-list
6058039|NCT00624416|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6058040|NCT00624416|Methylprednisolone|methylprednisolone|mesh-list
6058041|NCT00624416|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6058042|NCT00624416|Prednisolone acetate|prednisolone acetate|mesh-list
6058043|NCT00624416|Cortisone|cortisone|mesh-list
6058044|NCT00624416|Isoproterenol|isoproterenol|mesh-list
6058045|NCT00624416|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6058046|NCT00624416|Prednisolone phosphate|prednisolone phosphate|mesh-list
6058047|NCT00624416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6058048|NCT00624416|Glucocorticoids|glucocorticoids|mesh-ancestor
6058049|NCT00624416|Hormones|hormones|mesh-ancestor
6058050|NCT00624416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6058051|NCT00624416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058052|NCT00624416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6058053|NCT00624416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6058054|NCT00624416|Antiemetics|antiemetics|mesh-ancestor
6058055|NCT00624416|Autonomic Agents|autonomic agents|mesh-ancestor
6058056|NCT00624416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6058057|NCT00624416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6058058|NCT00624416|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6058059|NCT00624416|Protective Agents|protective agents|mesh-ancestor
6058060|NCT00624416|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6058061|NCT00624416|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6058062|NCT00624416|Adrenergic Agents|adrenergic agents|mesh-ancestor
6058063|NCT00624416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6058064|NCT00624416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6058065|NCT00624416|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6058066|NCT00624416|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6058067|NCT00624416|Respiratory System Agents|respiratory system agents|mesh-ancestor
6058068|NCT00624416|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6058069|NCT00624416|Sympathomimetics|sympathomimetics|mesh-ancestor
6058070|NCT00624559|Celecoxib|celecoxib|mesh-list
6058071|NCT00624559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6058072|NCT00624559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6058073|NCT00624559|Analgesics|analgesics|mesh-ancestor
6058074|NCT00624559|Sensory System Agents|sensory system agents|mesh-ancestor
6058075|NCT00624559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6058076|NCT00624559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058077|NCT00624559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6058078|NCT00624559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6058079|NCT00624559|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6058080|NCT00624559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6058081|NCT00624559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6058082|NCT00624559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6058083|NCT00624585|Dasatinib|dasatinib|mesh-list
6058084|NCT00624585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6058085|NCT00624585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6058086|NCT00624585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6058087|NCT00624585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6058088|NCT00624780|Pregabalin|pregabalin|mesh-list
6058089|NCT00624780|Lorazepam|lorazepam|mesh-list
6058090|NCT00624780|Analgesics|analgesics|mesh-ancestor
6058091|NCT00624780|Sensory System Agents|sensory system agents|mesh-ancestor
6058092|NCT00624780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6058093|NCT00624780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058094|NCT00624780|Anticonvulsants|anticonvulsants|mesh-ancestor
6058095|NCT00624780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6058096|NCT00624780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6058097|NCT00624780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6058098|NCT00624780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6058099|NCT00624780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6058100|NCT00624780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6058101|NCT00624780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6058102|NCT00624780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6058103|NCT00624780|Antiemetics|antiemetics|mesh-ancestor
6058104|NCT00624780|Autonomic Agents|autonomic agents|mesh-ancestor
6058105|NCT00624780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6058106|NCT00624780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6058107|NCT00624780|GABA Modulators|gaba modulators|mesh-ancestor
6058108|NCT00624780|GABA Agents|gaba agents|mesh-ancestor
6058109|NCT00624780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6058110|NCT00624819|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6058111|NCT00624819|Immunologic Factors|immunologic factors|mesh-ancestor
6058112|NCT00624819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058113|NCT00624832|Omalizumab|omalizumab|mesh-list
6058114|NCT00624832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6058115|NCT00624832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6058116|NCT00624832|Respiratory System Agents|respiratory system agents|mesh-ancestor
6058117|NCT00624910|Bupivacaine|bupivacaine|mesh-list
6058118|NCT00624910|Anesthetics, Local|anesthetics, local|mesh-ancestor
6058119|NCT00624910|Anesthetics|anesthetics|mesh-ancestor
6058120|NCT00624910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6058121|NCT00624910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058122|NCT00624910|Sensory System Agents|sensory system agents|mesh-ancestor
6058123|NCT00624910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6058124|NCT00624923|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
6058125|NCT00624923|Sodium Salicylate|sodium salicylate|mesh-list
6058126|NCT00624923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6058127|NCT00624923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6058128|NCT00624923|Analgesics|analgesics|mesh-ancestor
6058129|NCT00624923|Sensory System Agents|sensory system agents|mesh-ancestor
6058130|NCT00624923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6058131|NCT00624923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058132|NCT00624923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6058133|NCT00624923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6058134|NCT00624923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6058135|NCT00624923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6058136|NCT00624923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6058137|NCT00625131|Bupropion|bupropion|mesh-list
6058138|NCT00625131|Nicotine|nicotine|mesh-list
6058139|NCT00625131|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5504991|NCT04444635|Anesthetics|anesthetics|mesh-ancestor
5600069|NCT03714880|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5600070|NCT03714880|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5600071|NCT03714867|Pregabalin|pregabalin|mesh-list
5600072|NCT03714867|Analgesics|analgesics|mesh-ancestor
6058140|NCT00625131|Autonomic Agents|autonomic agents|mesh-ancestor
6058141|NCT00625131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6058142|NCT00625131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058143|NCT00625131|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6058144|NCT00625131|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6058145|NCT00625131|Cholinergic Agents|cholinergic agents|mesh-ancestor
6058146|NCT00625131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6058147|NCT00625131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6058148|NCT00625131|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6058149|NCT00625131|Antidepressive Agents|antidepressive agents|mesh-ancestor
6058150|NCT00625131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6058151|NCT00625131|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6058152|NCT00625131|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6058153|NCT00625131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6058154|NCT00625131|Dopamine Agents|dopamine agents|mesh-ancestor
6058155|NCT00625131|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6058156|NCT00625131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6058157|NCT00625131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6058158|NCT00625183|Selenium|selenium|mesh-list
6058159|NCT00625183|Capecitabine|capecitabine|mesh-list
6058160|NCT00625183|Oxaliplatin|oxaliplatin|mesh-list
6462488|NCT00459836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462489|NCT00459836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6462490|NCT00459836|Antiviral Agents|antiviral agents|mesh-ancestor
6462491|NCT00459836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6462492|NCT00459836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6462493|NCT00459836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6462494|NCT00459836|Immunologic Factors|immunologic factors|mesh-ancestor
6462495|NCT00459836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462496|NCT00459836|Tubulin Modulators|tubulin modulators|mesh-ancestor
6462497|NCT00459836|Antimitotic Agents|antimitotic agents|mesh-ancestor
6462498|NCT00459836|Mitosis Modulators|mitosis modulators|mesh-ancestor
6462499|NCT00459901|Capecitabine|capecitabine|mesh-list
6462500|NCT00459901|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6462501|NCT00459901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6058161|NCT00625183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6058162|NCT00625183|Antimetabolites|antimetabolites|mesh-ancestor
6058163|NCT00625183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6058164|NCT00625183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6058165|NCT00625183|Antioxidants|antioxidants|mesh-ancestor
6058166|NCT00625183|Protective Agents|protective agents|mesh-ancestor
6058167|NCT00625183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058168|NCT00625183|Trace Elements|trace elements|mesh-ancestor
6058169|NCT00625183|Micronutrients|micronutrients|mesh-ancestor
6058170|NCT00625404|Tenofovir|tenofovir|mesh-list
6058171|NCT00625404|Emtricitabine|emtricitabine|mesh-list
6058172|NCT00625404|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6058173|NCT00625404|Antiviral Agents|antiviral agents|mesh-ancestor
6058174|NCT00625404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5504992|NCT04444726|Betamethasone|betamethasone|mesh-list
5504993|NCT04444726|Betamethasone Valerate|betamethasone valerate|mesh-list
5504994|NCT04444726|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5504995|NCT04444726|Betamethasone benzoate|betamethasone benzoate|mesh-list
5504996|NCT04444726|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
5504997|NCT04444726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5504998|NCT04444726|Glucocorticoids|glucocorticoids|mesh-ancestor
6058175|NCT00625404|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6058176|NCT00625404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6058177|NCT00625404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6058178|NCT00625404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6058179|NCT00625404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6058180|NCT00625404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6058181|NCT00625729|Aldesleukin|aldesleukin|mesh-list
6058182|NCT00625729|Cyclophosphamide|cyclophosphamide|mesh-list
6058183|NCT00625729|Rituximab|rituximab|mesh-list
6058184|NCT00625729|Fludarabine|fludarabine|mesh-list
6058185|NCT00625729|Fludarabine phosphate|fludarabine phosphate|mesh-list
6058186|NCT00625729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6058187|NCT00625729|Immunologic Factors|immunologic factors|mesh-ancestor
6058188|NCT00625729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5504999|NCT04444726|Hormones|hormones|mesh-ancestor
5505000|NCT04444726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5505001|NCT04444726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505002|NCT04444726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5505003|NCT04444726|Respiratory System Agents|respiratory system agents|mesh-ancestor
5505004|NCT04444830|Ketorolac|ketorolac|mesh-list
5505005|NCT04444830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5505006|NCT04444830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5505007|NCT04444830|Analgesics|analgesics|mesh-ancestor
5505008|NCT04444830|Sensory System Agents|sensory system agents|mesh-ancestor
5505009|NCT04444830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5505010|NCT04444830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505011|NCT04444830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5505012|NCT04444830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6058189|NCT00625729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6462502|NCT00459901|Antimetabolites|antimetabolites|mesh-ancestor
6462503|NCT00459901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462504|NCT00459901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6462505|NCT00459901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6462506|NCT00459901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6462507|NCT00459940|Pioglitazone|pioglitazone|mesh-list
6058190|NCT00625729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6058191|NCT00625729|Alkylating Agents|alkylating agents|mesh-ancestor
6058192|NCT00625729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6058193|NCT00625729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6058194|NCT00625729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6058195|NCT00625729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6058196|NCT00625729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6058197|NCT00625729|Antimetabolites|antimetabolites|mesh-ancestor
6058198|NCT00625729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6058199|NCT00625729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6058200|NCT00625729|Antiviral Agents|antiviral agents|mesh-ancestor
6058201|NCT00625729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6058202|NCT00625820|Ascorbic Acid|ascorbic acid|mesh-list
6058203|NCT00625820|Vitamins|vitamins|mesh-ancestor
6058204|NCT00625820|Micronutrients|micronutrients|mesh-ancestor
6058205|NCT00625820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058206|NCT00625820|Antioxidants|antioxidants|mesh-ancestor
6058207|NCT00625820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6058208|NCT00625820|Protective Agents|protective agents|mesh-ancestor
6058209|NCT00626028|Nitric Oxide|nitric oxide|mesh-list
6058210|NCT00626028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6462508|NCT00459940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6058211|NCT00626028|Autonomic Agents|autonomic agents|mesh-ancestor
6058212|NCT00626028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6058213|NCT00626028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058214|NCT00626028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6058215|NCT00626028|Respiratory System Agents|respiratory system agents|mesh-ancestor
6058216|NCT00626028|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6058217|NCT00626028|Antioxidants|antioxidants|mesh-ancestor
6058218|NCT00626028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6058219|NCT00626028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6058220|NCT00626028|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6058221|NCT00626028|Vasodilator Agents|vasodilator agents|mesh-ancestor
6058222|NCT00626028|Gasotransmitters|gasotransmitters|mesh-ancestor
6058223|NCT00626028|Protective Agents|protective agents|mesh-ancestor
6058224|NCT00626197|Mycophenolic Acid|mycophenolic acid|mesh-list
6058225|NCT00626197|Cyclophosphamide|cyclophosphamide|mesh-list
6058226|NCT00626197|Azathioprine|azathioprine|mesh-list
6058227|NCT00626197|Ocrelizumab|ocrelizumab|mesh-list
6058228|NCT00626197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6058229|NCT00626197|Immunologic Factors|immunologic factors|mesh-ancestor
6058230|NCT00626197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058231|NCT00626197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6058232|NCT00626197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6058233|NCT00626197|Alkylating Agents|alkylating agents|mesh-ancestor
6058234|NCT00626197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6058235|NCT00626197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6058236|NCT00626197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6058237|NCT00626197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6058238|NCT00626197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6058239|NCT00626197|Antitubercular Agents|antitubercular agents|mesh-ancestor
6058240|NCT00626197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6058241|NCT00626197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6058242|NCT00626197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6058243|NCT00626197|Antimetabolites|antimetabolites|mesh-ancestor
6058244|NCT00626197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6058245|NCT00626210|Modafinil|modafinil|mesh-list
6058246|NCT00626210|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6058247|NCT00626210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058248|NCT00626210|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6058249|NCT00626210|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6058250|NCT00626210|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6058251|NCT00626210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505013|NCT04444830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5505014|NCT04444830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5505015|NCT04444830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505016|NCT04444817|Tacrolimus|tacrolimus|mesh-list
5505017|NCT04444817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5505018|NCT04444817|Immunologic Factors|immunologic factors|mesh-ancestor
5505019|NCT04444817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505020|NCT04444817|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5505021|NCT04444817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5505022|NCT04444817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505023|NCT04444167|Lenvatinib|lenvatinib|mesh-list
6058252|NCT00626275|Naproxen|naproxen|mesh-list
6058253|NCT00626275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6058254|NCT00626275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6058255|NCT00626275|Analgesics|analgesics|mesh-ancestor
6058256|NCT00626275|Sensory System Agents|sensory system agents|mesh-ancestor
6058257|NCT00626275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6058258|NCT00626275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058259|NCT00626275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6058260|NCT00626275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6058261|NCT00626275|Gout Suppressants|gout suppressants|mesh-ancestor
6058262|NCT00626275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6058263|NCT00626275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6058264|NCT00626275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6058265|NCT00626340|Fluoxetine|fluoxetine|mesh-list
6058266|NCT00626340|Estrogens|estrogens|mesh-list
6058267|NCT00626340|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6058268|NCT00626340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6058269|NCT00626340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6058270|NCT00626340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6058271|NCT00626340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6058272|NCT00626340|Serotonin Agents|serotonin agents|mesh-ancestor
6058273|NCT00626340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058274|NCT00626340|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6058275|NCT00626340|Antidepressive Agents|antidepressive agents|mesh-ancestor
6058276|NCT00626340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6058277|NCT00626340|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6058278|NCT00626340|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6058279|NCT00626340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6058280|NCT00626340|Hormones|hormones|mesh-ancestor
6058281|NCT00626340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6058282|NCT00626392|Aspirin|aspirin|mesh-list
6058283|NCT00626392|Niacin|niacin|mesh-list
6058284|NCT00626392|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6058285|NCT00626392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6058286|NCT00626392|Analgesics|analgesics|mesh-ancestor
6058287|NCT00626392|Sensory System Agents|sensory system agents|mesh-ancestor
6058288|NCT00626392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6058289|NCT00626392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058290|NCT00626392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6058291|NCT00626392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6058292|NCT00626392|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6058293|NCT00626392|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6058294|NCT00626392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6058295|NCT00626392|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6058296|NCT00626392|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6058297|NCT00626392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6058298|NCT00626392|Antipyretics|antipyretics|mesh-ancestor
6058299|NCT00626392|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6058300|NCT00626392|Antimetabolites|antimetabolites|mesh-ancestor
6058301|NCT00626392|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6058302|NCT00626392|Vasodilator Agents|vasodilator agents|mesh-ancestor
6058303|NCT00626392|Vitamin B Complex|vitamin b complex|mesh-ancestor
6058304|NCT00626392|Vitamins|vitamins|mesh-ancestor
6058305|NCT00626392|Micronutrients|micronutrients|mesh-ancestor
6058306|NCT00626405|Paclitaxel|paclitaxel|mesh-list
6058307|NCT00626405|Bevacizumab|bevacizumab|mesh-list
6058308|NCT00626405|Carboplatin|carboplatin|mesh-list
6058309|NCT00626405|Temozolomide|temozolomide|mesh-list
6058310|NCT00626405|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6058311|NCT00626405|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6058312|NCT00626405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6058313|NCT00626405|Tubulin Modulators|tubulin modulators|mesh-ancestor
6058314|NCT00626405|Antimitotic Agents|antimitotic agents|mesh-ancestor
6058315|NCT00626405|Mitosis Modulators|mitosis modulators|mesh-ancestor
6058316|NCT00626405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505024|NCT04444167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6058317|NCT00626405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6058318|NCT00626405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6058319|NCT00626405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6058320|NCT00626405|Growth Substances|growth substances|mesh-ancestor
6058321|NCT00626405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058322|NCT00626405|Growth Inhibitors|growth inhibitors|mesh-ancestor
6058323|NCT00626405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6058324|NCT00626405|Alkylating Agents|alkylating agents|mesh-ancestor
6058325|NCT00626431|Leuprolide|leuprolide|mesh-list
6058326|NCT00626431|Hormones|hormones|mesh-list
6058327|NCT00626431|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
6058328|NCT00626431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6058329|NCT00626431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058330|NCT00626431|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6058331|NCT00626431|Fertility Agents|fertility agents|mesh-ancestor
6058332|NCT00626431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6058333|NCT00626431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6058334|NCT00626431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6058335|NCT00626522|Bromides|bromides|mesh-list
6058336|NCT00626522|Formoterol Fumarate|formoterol fumarate|mesh-list
6058337|NCT00626522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6058338|NCT00626522|Autonomic Agents|autonomic agents|mesh-ancestor
6058339|NCT00626522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6058340|NCT00626522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058341|NCT00626522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6058342|NCT00626522|Respiratory System Agents|respiratory system agents|mesh-ancestor
6058343|NCT00626522|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6058344|NCT00626522|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6058345|NCT00626522|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6058346|NCT00626522|Adrenergic Agents|adrenergic agents|mesh-ancestor
6058347|NCT00626522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6058348|NCT00626522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6058349|NCT00626522|Anticonvulsants|anticonvulsants|mesh-ancestor
6058350|NCT00626574|Epoetin Alfa|epoetin alfa|mesh-list
6058351|NCT00626574|Hematinics|hematinics|mesh-ancestor
6058352|NCT00626626|Alemtuzumab|alemtuzumab|mesh-list
6058353|NCT00626626|Clofarabine|clofarabine|mesh-list
6058354|NCT00626626|Cyclophosphamide|cyclophosphamide|mesh-list
6058355|NCT00626626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6058356|NCT00626626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6462509|NCT00459940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488393|NCT00583869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488394|NCT00583869|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6488395|NCT00583869|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6488396|NCT00583869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6488397|NCT00583869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6488398|NCT00583869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5505025|NCT04444167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5505026|NCT04444167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5505027|NCT04444167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505028|NCT04444349|Ubiquinone|ubiquinone|mesh-list
5505029|NCT04444349|Coenzyme Q10|coenzyme q10|mesh-list
5505030|NCT04444349|Micronutrients|micronutrients|mesh-ancestor
6489040|NCT00588926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6489041|NCT00588926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489042|NCT00588926|Analgesics|analgesics|mesh-ancestor
6489043|NCT00588926|Sensory System Agents|sensory system agents|mesh-ancestor
6489044|NCT00588926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6489045|NCT00589082|Daunorubicin|daunorubicin|mesh-list
6489046|NCT00589082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6489047|NCT00589082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6489048|NCT00589082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6058357|NCT00626626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6058358|NCT00626626|Antimetabolites|antimetabolites|mesh-ancestor
6058359|NCT00626626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6058360|NCT00626626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6058361|NCT00626626|Immunologic Factors|immunologic factors|mesh-ancestor
6058362|NCT00626626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058363|NCT00626626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6058364|NCT00626626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6058365|NCT00626626|Alkylating Agents|alkylating agents|mesh-ancestor
6058366|NCT00626626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6058367|NCT00626639|Cisplatin|cisplatin|mesh-list
6058368|NCT00626639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6058369|NCT00626743|Amlodipine|amlodipine|mesh-list
6058370|NCT00626743|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6058371|NCT00626743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6058372|NCT00626743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6058373|NCT00626743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6058374|NCT00626743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6058375|NCT00626743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058376|NCT00626743|Vasodilator Agents|vasodilator agents|mesh-ancestor
6058377|NCT00626782|Ranibizumab|ranibizumab|mesh-list
6058378|NCT00626782|Mitomycins|mitomycins|mesh-list
6058379|NCT00626782|Mitomycin|mitomycin|mesh-list
6058380|NCT00626782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6058381|NCT00626782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6058382|NCT00626782|Growth Substances|growth substances|mesh-ancestor
6058383|NCT00626782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058384|NCT00626782|Growth Inhibitors|growth inhibitors|mesh-ancestor
6058385|NCT00626782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6058386|NCT00626782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6058387|NCT00626782|Alkylating Agents|alkylating agents|mesh-ancestor
6058388|NCT00626782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6058389|NCT00626782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6058390|NCT00626782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6058391|NCT00626795|Mupirocin|mupirocin|mesh-list
6058392|NCT00626795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6058393|NCT00626795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6058394|NCT00626795|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6058395|NCT00626795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6058396|NCT00626795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6058397|NCT00626886|Bupivacaine|bupivacaine|mesh-list
6058398|NCT00626886|Anesthetics, Local|anesthetics, local|mesh-ancestor
6058399|NCT00626886|Anesthetics|anesthetics|mesh-ancestor
5505031|NCT04444349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505032|NCT04444349|Vitamins|vitamins|mesh-ancestor
5505033|NCT04444284|Vaccines|vaccines|mesh-list
5505034|NCT04444284|Immunologic Factors|immunologic factors|mesh-ancestor
5505035|NCT04444284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505036|NCT04444440|Ciprofloxacin|ciprofloxacin|mesh-list
5505037|NCT04444440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5505038|NCT04444440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5505039|NCT04444440|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5505040|NCT04444440|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5505041|NCT04444440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5505042|NCT04444440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505043|NCT04444440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5505044|NCT04444440|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5505045|NCT04444440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5505046|NCT04444193|Durvalumab|durvalumab|mesh-list
5505047|NCT04444193|Lenvatinib|lenvatinib|mesh-list
5505048|NCT04444193|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6058400|NCT00626886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6058401|NCT00626886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058402|NCT00626886|Sensory System Agents|sensory system agents|mesh-ancestor
6058403|NCT00626886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6058404|NCT00626925|Topiramate|topiramate|mesh-list
6058405|NCT00626925|Anticonvulsants|anticonvulsants|mesh-ancestor
6058406|NCT00626925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6058407|NCT00626925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058408|NCT00627016|Dexlansoprazole|dexlansoprazole|mesh-list
6058409|NCT00627016|Lansoprazole|lansoprazole|mesh-list
6058410|NCT00627016|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6058411|NCT00627016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6058412|NCT00627016|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6058413|NCT00627016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6058414|NCT00627016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6058415|NCT00627042|Ramucirumab|ramucirumab|mesh-list
6058416|NCT00627042|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6058417|NCT00627042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6058418|NCT00627042|Immunologic Factors|immunologic factors|mesh-ancestor
6058419|NCT00627042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058420|NCT00627367|Hydromorphone|hydromorphone|mesh-list
6058421|NCT00627367|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6058422|NCT00627367|Narcotics|narcotics|mesh-ancestor
6058423|NCT00627367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6058424|NCT00627367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058425|NCT00627367|Analgesics|analgesics|mesh-ancestor
6058426|NCT00627367|Sensory System Agents|sensory system agents|mesh-ancestor
6058427|NCT00627367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6058428|NCT00627393|Anti-Infective Agents|anti-infective agents|mesh-list
6058429|NCT00627393|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6058430|NCT00627393|Dexamethasone|dexamethasone|mesh-list
6058431|NCT00627393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6058432|NCT00627393|Antiemetics|antiemetics|mesh-ancestor
6058433|NCT00627393|Autonomic Agents|autonomic agents|mesh-ancestor
6058434|NCT00627393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6058435|NCT00627393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058436|NCT00627393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6058437|NCT00627393|Glucocorticoids|glucocorticoids|mesh-ancestor
6058438|NCT00627393|Hormones|hormones|mesh-ancestor
6058439|NCT00627393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6058440|NCT00627393|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6058441|NCT00627393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6202036|NCT02034799|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6202037|NCT02034799|Hemostatics|hemostatics|mesh-ancestor
6202038|NCT02034799|Coagulants|coagulants|mesh-ancestor
6202039|NCT02034877|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6202040|NCT02034877|Immunologic Factors|immunologic factors|mesh-ancestor
6202041|NCT02034877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202042|NCT02034916|Talazoparib|talazoparib|mesh-list
5505049|NCT04444193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5505050|NCT04444193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5505051|NCT04444193|Immunologic Factors|immunologic factors|mesh-ancestor
5505052|NCT04444193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505053|NCT04444193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5505054|NCT04444193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5505055|NCT04444193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202043|NCT02034916|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5505056|NCT04444492|Ranibizumab|ranibizumab|mesh-list
5505057|NCT04444492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5505058|NCT04444492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5505059|NCT04444492|Growth Substances|growth substances|mesh-ancestor
5505060|NCT04444492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505061|NCT04444492|Growth Inhibitors|growth inhibitors|mesh-ancestor
5505062|NCT04444492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5505063|NCT04443920|Tranexamic Acid|tranexamic acid|mesh-list
5505064|NCT04443920|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5505065|NCT04443920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6058442|NCT00627406|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6058443|NCT00627406|Buserelin|buserelin|mesh-list
6058444|NCT00627406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6058445|NCT00627406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058446|NCT00627406|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6058447|NCT00627406|Fertility Agents|fertility agents|mesh-ancestor
6058448|NCT00627445|Insulin|insulin|mesh-list
6058449|NCT00627445|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6058450|NCT00627445|Metformin|metformin|mesh-list
6058451|NCT00627445|Insulin Aspart|insulin aspart|mesh-list
6058452|NCT00627445|Insulin, Long-Acting|insulin, long-acting|mesh-list
6058453|NCT00627445|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6058454|NCT00627445|Biphasic Insulins|biphasic insulins|mesh-list
6058455|NCT00627445|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6058456|NCT00627445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6058457|NCT00627445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058458|NCT00627458|Vaccines|vaccines|mesh-list
5505066|NCT04443920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505067|NCT04443920|Hemostatics|hemostatics|mesh-ancestor
5505068|NCT04443920|Coagulants|coagulants|mesh-ancestor
5505069|NCT04443946|Sufentanil|sufentanil|mesh-list
5505070|NCT04443946|Propofol|propofol|mesh-list
5505071|NCT04443946|Sevoflurane|sevoflurane|mesh-list
5505072|NCT04443946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5505073|NCT04443946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5505074|NCT04443946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505075|NCT04443946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5505076|NCT04443946|Anesthetics, General|anesthetics, general|mesh-ancestor
5505077|NCT04443946|Anesthetics|anesthetics|mesh-ancestor
5505078|NCT04443946|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5505079|NCT04443946|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5505080|NCT04443946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5505081|NCT04443946|Narcotics|narcotics|mesh-ancestor
5505082|NCT04443946|Analgesics|analgesics|mesh-ancestor
5505083|NCT04443946|Sensory System Agents|sensory system agents|mesh-ancestor
5505084|NCT04443946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5505085|NCT04443946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5505086|NCT04443725|Hydroxychloroquine|hydroxychloroquine|mesh-list
5505087|NCT04443725|Sofosbuvir|sofosbuvir|mesh-list
5505088|NCT04443725|Antimalarials|antimalarials|mesh-ancestor
5505089|NCT04443725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5505090|NCT04443725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5505091|NCT04443725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5505092|NCT04443725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5505093|NCT04443725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505094|NCT04443725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5505095|NCT04443725|Antiviral Agents|antiviral agents|mesh-ancestor
5505096|NCT04443868|Nitric Oxide|nitric oxide|mesh-list
5505097|NCT04443868|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5505098|NCT04443868|Autonomic Agents|autonomic agents|mesh-ancestor
5505099|NCT04443868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5505100|NCT04443868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058459|NCT00627458|Immunologic Factors|immunologic factors|mesh-ancestor
6058460|NCT00627458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058461|NCT00627679|Budesonide|budesonide|mesh-list
6058462|NCT00627679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6058463|NCT00627679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6058464|NCT00627679|Autonomic Agents|autonomic agents|mesh-ancestor
6058465|NCT00627679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6058466|NCT00627679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058467|NCT00627679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6058468|NCT00627679|Respiratory System Agents|respiratory system agents|mesh-ancestor
6058469|NCT00627679|Glucocorticoids|glucocorticoids|mesh-ancestor
6058470|NCT00627679|Hormones|hormones|mesh-ancestor
6058471|NCT00627679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6058472|NCT00627705|Acetylcysteine|acetylcysteine|mesh-list
6058473|NCT00627705|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5505101|NCT04443868|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5505102|NCT04443868|Respiratory System Agents|respiratory system agents|mesh-ancestor
5505103|NCT04443868|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5505104|NCT04443868|Antioxidants|antioxidants|mesh-ancestor
5505105|NCT04443868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505106|NCT04443868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5505107|NCT04443868|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5505108|NCT04443868|Vasodilator Agents|vasodilator agents|mesh-ancestor
5505109|NCT04443868|Gasotransmitters|gasotransmitters|mesh-ancestor
5505110|NCT04443868|Protective Agents|protective agents|mesh-ancestor
6058474|NCT00627705|Antiviral Agents|antiviral agents|mesh-ancestor
6058475|NCT00627705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6058476|NCT00627705|Expectorants|expectorants|mesh-ancestor
6058477|NCT00627705|Respiratory System Agents|respiratory system agents|mesh-ancestor
6058478|NCT00627705|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6058479|NCT00627705|Antioxidants|antioxidants|mesh-ancestor
6058480|NCT00627705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6058481|NCT00627705|Protective Agents|protective agents|mesh-ancestor
6058482|NCT00627705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058483|NCT00627705|Antidotes|antidotes|mesh-ancestor
6058484|NCT00627861|Metoprolol|metoprolol|mesh-list
6058485|NCT00627861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6058486|NCT00627861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6058487|NCT00627861|Sympatholytics|sympatholytics|mesh-ancestor
6058488|NCT00627861|Autonomic Agents|autonomic agents|mesh-ancestor
6058489|NCT00627861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6058490|NCT00627861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058491|NCT00627861|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6058492|NCT00627861|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6058493|NCT00627861|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6058494|NCT00627861|Adrenergic Agents|adrenergic agents|mesh-ancestor
6058495|NCT00627861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6058496|NCT00627861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6058497|NCT00627926|Interferons|interferons|mesh-list
6058498|NCT00627926|Ribavirin|ribavirin|mesh-list
6058499|NCT00627926|Interferon-alpha|interferon-alpha|mesh-list
6058500|NCT00627926|Interferon alpha-2|interferon alpha-2|mesh-list
6058501|NCT00627926|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6058502|NCT00627926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6058503|NCT00627926|Antiviral Agents|antiviral agents|mesh-ancestor
6058504|NCT00627926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6058505|NCT00627926|Antimetabolites|antimetabolites|mesh-ancestor
6058506|NCT00627926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505111|NCT04443556|Tramadol|tramadol|mesh-list
5505112|NCT04443556|Anesthetics|anesthetics|mesh-list
5505113|NCT04443556|Anesthetics, Local|anesthetics, local|mesh-list
5505114|NCT04443556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5505115|NCT04443556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505116|NCT04443556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5505117|NCT04443556|Narcotics|narcotics|mesh-ancestor
5505118|NCT04443556|Analgesics|analgesics|mesh-ancestor
5505119|NCT04443556|Sensory System Agents|sensory system agents|mesh-ancestor
5505120|NCT04443556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6058507|NCT00627926|Immunologic Factors|immunologic factors|mesh-ancestor
6058508|NCT00627926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058509|NCT00628108|Levocetirizine|levocetirizine|mesh-list
6058510|NCT00628108|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6058511|NCT00628108|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6058512|NCT00628108|Histamine Antagonists|histamine antagonists|mesh-ancestor
6058513|NCT00628108|Histamine Agents|histamine agents|mesh-ancestor
6058514|NCT00628108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5505121|NCT04443634|Bupivacaine|bupivacaine|mesh-list
5505122|NCT04443634|Anesthetics, Local|anesthetics, local|mesh-ancestor
5505123|NCT04443634|Anesthetics|anesthetics|mesh-ancestor
5505124|NCT04443634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5505125|NCT04443634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505126|NCT04443634|Sensory System Agents|sensory system agents|mesh-ancestor
5505127|NCT04443634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5505128|NCT04443673|Glycine|glycine|mesh-list
5505129|NCT04443673|Glycine Agents|glycine agents|mesh-ancestor
5505130|NCT04443673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5505131|NCT04443673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505132|NCT04443673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505133|NCT04443517|Propofol|propofol|mesh-list
5505134|NCT04443517|Anesthetics|anesthetics|mesh-ancestor
6058515|NCT00628108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6058516|NCT00628108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058517|NCT00628134|Calfactant|calfactant|mesh-list
6058518|NCT00628134|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
6058519|NCT00628134|Respiratory System Agents|respiratory system agents|mesh-ancestor
6058520|NCT00628251|Doxorubicin|doxorubicin|mesh-list
6058521|NCT00628251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6058522|NCT00628251|Olaparib|olaparib|mesh-list
6058523|NCT00628251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6058524|NCT00628251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6058525|NCT00628251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6058526|NCT00628251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6058527|NCT00628251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6058528|NCT00628251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6058529|NCT00628251|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6058530|NCT00628355|Lidocaine|lidocaine|mesh-list
5505135|NCT04443517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5505136|NCT04443517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505137|NCT04443517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5505138|NCT04443517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5505139|NCT04443517|Anesthetics, General|anesthetics, general|mesh-ancestor
5505140|NCT04444011|Amoxicillin|amoxicillin|mesh-list
6058531|NCT00628355|Anesthetics, Local|anesthetics, local|mesh-ancestor
6058532|NCT00628355|Anesthetics|anesthetics|mesh-ancestor
6058533|NCT00628355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6058534|NCT00628355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058535|NCT00628355|Sensory System Agents|sensory system agents|mesh-ancestor
6058536|NCT00628355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6058537|NCT00628355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6058538|NCT00628355|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6058539|NCT00628355|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6058540|NCT00628355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6058541|NCT00628355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6058542|NCT00628394|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6058543|NCT00628394|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6058544|NCT00628394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6058545|NCT00628394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6058546|NCT00628394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505141|NCT04444011|Clarithromycin|clarithromycin|mesh-list
5505142|NCT04444011|Bismuth|bismuth|mesh-list
5505143|NCT04444011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5505144|NCT04444011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5505145|NCT04444011|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5505146|NCT04444011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5505147|NCT04444011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505148|NCT04444011|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5505149|NCT04444011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5505150|NCT04444011|Antacids|antacids|mesh-ancestor
6058547|NCT00628394|Adrenergic Agents|adrenergic agents|mesh-ancestor
6058548|NCT00628394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6058549|NCT00628394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058550|NCT00628498|Defibrotide|defibrotide|mesh-list
6058551|NCT00628498|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5505151|NCT04444011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5505152|NCT04443647|Oxytocin|oxytocin|mesh-list
5505153|NCT04443647|Oxytocics|oxytocics|mesh-ancestor
5505154|NCT04443647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5505155|NCT04443647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505156|NCT04443881|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5505157|NCT04443881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6058552|NCT00628498|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6058553|NCT00628498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6058554|NCT00628498|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6058555|NCT00628589|Loxapine|loxapine|mesh-list
6058556|NCT00628589|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6058557|NCT00628589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6058558|NCT00628589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6058559|NCT00628589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058560|NCT00628589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6058561|NCT00628589|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6058562|NCT00628589|Dopamine Agents|dopamine agents|mesh-ancestor
6058563|NCT00628589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6058564|NCT00628589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505158|NCT04443387|Vitamin D|vitamin d|mesh-list
6058565|NCT00628628|Rasburicase|rasburicase|mesh-list
6058566|NCT00628628|Gout Suppressants|gout suppressants|mesh-ancestor
6058567|NCT00628628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6058568|NCT00628758|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6058569|NCT00628758|Formoterol Fumarate|formoterol fumarate|mesh-list
6058570|NCT00628758|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6058571|NCT00628758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6058572|NCT00628758|Respiratory System Agents|respiratory system agents|mesh-ancestor
6058573|NCT00628758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6058574|NCT00628758|Autonomic Agents|autonomic agents|mesh-ancestor
6058575|NCT00628758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6058576|NCT00628758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058577|NCT00628758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6058578|NCT00628758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6058579|NCT00628758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6058580|NCT00628758|Adrenergic Agents|adrenergic agents|mesh-ancestor
6058581|NCT00628758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6058582|NCT00628758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6058583|NCT00628862|Formoterol Fumarate|formoterol fumarate|mesh-list
6058584|NCT00628862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6058585|NCT00628862|Autonomic Agents|autonomic agents|mesh-ancestor
6058586|NCT00628862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6058587|NCT00628862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058588|NCT00628862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6058589|NCT00628862|Respiratory System Agents|respiratory system agents|mesh-ancestor
6058590|NCT00628862|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6058591|NCT00628862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6058592|NCT00628862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6058593|NCT00628862|Adrenergic Agents|adrenergic agents|mesh-ancestor
6058594|NCT00628862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6058595|NCT00628862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6058596|NCT00629122|Clotrimazole|clotrimazole|mesh-list
6058597|NCT00629122|Miconazole|miconazole|mesh-list
6058598|NCT00629122|Nystatin|nystatin|mesh-list
6058599|NCT00629122|Tacrolimus|tacrolimus|mesh-list
6058600|NCT00629122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6058601|NCT00629122|Immunologic Factors|immunologic factors|mesh-ancestor
6058602|NCT00629122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058603|NCT00629122|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6058604|NCT00629122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6058605|NCT00629122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6058606|NCT00629122|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6058607|NCT00629122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6058608|NCT00629122|Antifungal Agents|antifungal agents|mesh-ancestor
6058609|NCT00629122|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6058610|NCT00629122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6058611|NCT00629122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6058612|NCT00629122|Hormone Antagonists|hormone antagonists|mesh-ancestor
6058613|NCT00629122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6058614|NCT00629122|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6058615|NCT00629122|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6058616|NCT00629122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6058617|NCT00629122|Ionophores|ionophores|mesh-ancestor
6058618|NCT00629122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6058619|NCT00629499|Paclitaxel|paclitaxel|mesh-list
6058620|NCT00629499|Cyclophosphamide|cyclophosphamide|mesh-list
6665198|NCT01516216|Micronutrients|micronutrients|mesh-ancestor
6665199|NCT01516216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6665200|NCT01516216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6665201|NCT01516216|Antimetabolites|antimetabolites|mesh-ancestor
6665202|NCT01516216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665203|NCT01516216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6665204|NCT01516216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6665205|NCT01516216|Immunologic Factors|immunologic factors|mesh-ancestor
6665206|NCT01516216|Antidotes|antidotes|mesh-ancestor
6665207|NCT01516216|Protective Agents|protective agents|mesh-ancestor
6665208|NCT01516216|Vitamin B Complex|vitamin b complex|mesh-ancestor
6665209|NCT01516255|Liraglutide|liraglutide|mesh-list
6665210|NCT01516255|Moxifloxacin|moxifloxacin|mesh-list
6665211|NCT01516255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6665212|NCT01516255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6665213|NCT01516255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6665214|NCT01516255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6058621|NCT00629499|Trastuzumab|trastuzumab|mesh-list
6058622|NCT00629499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6058623|NCT00629499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6058624|NCT00629499|Tubulin Modulators|tubulin modulators|mesh-ancestor
6058625|NCT00629499|Antimitotic Agents|antimitotic agents|mesh-ancestor
6058626|NCT00629499|Mitosis Modulators|mitosis modulators|mesh-ancestor
6058627|NCT00629499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6058628|NCT00629499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6058629|NCT00629499|Immunologic Factors|immunologic factors|mesh-ancestor
6058630|NCT00629499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058631|NCT00629499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6058632|NCT00629499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6058633|NCT00629499|Alkylating Agents|alkylating agents|mesh-ancestor
6058634|NCT00629499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6058635|NCT00629499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6058636|NCT00629525|Everolimus|everolimus|mesh-list
6058637|NCT00629525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6058638|NCT00629525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6058639|NCT00629525|Immunologic Factors|immunologic factors|mesh-ancestor
6058640|NCT00629525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058641|NCT00629772|Infliximab|infliximab|mesh-list
6058642|NCT00629772|Dermatologic Agents|dermatologic agents|mesh-ancestor
6058643|NCT00629772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6058644|NCT00629772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5505159|NCT04443387|Vitamins|vitamins|mesh-ancestor
5505160|NCT04443387|Micronutrients|micronutrients|mesh-ancestor
5505161|NCT04443387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505162|NCT04443387|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5505163|NCT04443543|Fluorouracil|fluorouracil|mesh-list
5505164|NCT04443543|Capecitabine|capecitabine|mesh-list
5505165|NCT04443543|Oxaliplatin|oxaliplatin|mesh-list
5505166|NCT04443543|Irinotecan|irinotecan|mesh-list
5505167|NCT04443543|Antimetabolites|antimetabolites|mesh-ancestor
5505168|NCT04443543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505169|NCT04443543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5505170|NCT04443543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5505171|NCT04443543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5505172|NCT04443543|Immunologic Factors|immunologic factors|mesh-ancestor
5505173|NCT04443543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058645|NCT00630032|Cyclophosphamide|cyclophosphamide|mesh-list
6058646|NCT00630032|Docetaxel|docetaxel|mesh-list
6058647|NCT00630032|Fluorouracil|fluorouracil|mesh-list
6058648|NCT00630032|Epirubicin|epirubicin|mesh-list
6058649|NCT00630032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6058650|NCT00630032|Immunologic Factors|immunologic factors|mesh-ancestor
6058651|NCT00630032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058652|NCT00630032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6058653|NCT00630032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6058654|NCT00630032|Alkylating Agents|alkylating agents|mesh-ancestor
6058655|NCT00630032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6058656|NCT00630032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6058657|NCT00630032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6058658|NCT00630032|Tubulin Modulators|tubulin modulators|mesh-ancestor
6058659|NCT00630032|Antimitotic Agents|antimitotic agents|mesh-ancestor
6058660|NCT00630032|Mitosis Modulators|mitosis modulators|mesh-ancestor
6058661|NCT00630032|Antimetabolites|antimetabolites|mesh-ancestor
6058662|NCT00630032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6058663|NCT00630032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6058664|NCT00630032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6058665|NCT00630032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6058666|NCT00630032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6058667|NCT00630058|Interferon-alpha|interferon-alpha|mesh-list
6058668|NCT00630058|Interferon alpha-2|interferon alpha-2|mesh-list
6058669|NCT00630058|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
6058670|NCT00630058|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6058671|NCT00630058|Antiviral Agents|antiviral agents|mesh-ancestor
6058672|NCT00630058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6058673|NCT00630058|Immunologic Factors|immunologic factors|mesh-ancestor
6058674|NCT00630058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058675|NCT00630058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6058676|NCT00630253|Cyclosporine|cyclosporine|mesh-list
6058677|NCT00630253|Mycophenolic Acid|mycophenolic acid|mesh-list
6058678|NCT00630253|Methylprednisolone|methylprednisolone|mesh-list
6058679|NCT00630253|Cyclophosphamide|cyclophosphamide|mesh-list
6058680|NCT00630253|Fludarabine|fludarabine|mesh-list
6058681|NCT00630253|Cyclosporins|cyclosporins|mesh-list
5505174|NCT04443543|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6058682|NCT00630253|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6058683|NCT00630253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6058684|NCT00630253|Immunologic Factors|immunologic factors|mesh-ancestor
6058685|NCT00630253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058686|NCT00630253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6058687|NCT00630253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6058688|NCT00630253|Alkylating Agents|alkylating agents|mesh-ancestor
5505175|NCT04443543|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5505176|NCT04443543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5505177|NCT04443270|Chloroquine|chloroquine|mesh-list
5505178|NCT04443270|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
5505179|NCT04443270|Amebicides|amebicides|mesh-ancestor
6058689|NCT00630253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6058690|NCT00630253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6058691|NCT00630253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6058692|NCT00630253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6058693|NCT00630253|Antifungal Agents|antifungal agents|mesh-ancestor
6058694|NCT00630253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6058695|NCT00630253|Dermatologic Agents|dermatologic agents|mesh-ancestor
6058696|NCT00630253|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6058697|NCT00630253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6058698|NCT00630253|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6058699|NCT00630253|Antitubercular Agents|antitubercular agents|mesh-ancestor
6058700|NCT00630253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6058701|NCT00630253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6058702|NCT00630253|Antiemetics|antiemetics|mesh-ancestor
6058703|NCT00630253|Autonomic Agents|autonomic agents|mesh-ancestor
6058704|NCT00630253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6058705|NCT00630253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6058706|NCT00630253|Glucocorticoids|glucocorticoids|mesh-ancestor
6058707|NCT00630253|Hormones|hormones|mesh-ancestor
6058708|NCT00630253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6058709|NCT00630253|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6058710|NCT00630253|Protective Agents|protective agents|mesh-ancestor
6058711|NCT00630331|Vaccines|vaccines|mesh-list
6058712|NCT00630331|Immunologic Factors|immunologic factors|mesh-ancestor
6058713|NCT00630331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058714|NCT00630344|Everolimus|everolimus|mesh-list
6058715|NCT00630344|Bicalutamide|bicalutamide|mesh-list
6058716|NCT00630344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6058717|NCT00630344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5505180|NCT04443270|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5505181|NCT04443270|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5505182|NCT04443270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5505183|NCT04443270|Antimalarials|antimalarials|mesh-ancestor
5505184|NCT04443270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5505185|NCT04443270|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5505186|NCT04443270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5505187|NCT04443270|Analgesics|analgesics|mesh-ancestor
5505188|NCT04443270|Sensory System Agents|sensory system agents|mesh-ancestor
5505189|NCT04443270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5505190|NCT04443270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505191|NCT04443270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5505192|NCT04443270|Filaricides|filaricides|mesh-ancestor
5505193|NCT04443270|Antinematodal Agents|antinematodal agents|mesh-ancestor
5505194|NCT04443270|Anthelmintics|anthelmintics|mesh-ancestor
5505195|NCT04443322|Durvalumab|durvalumab|mesh-list
5505196|NCT04443322|Lenvatinib|lenvatinib|mesh-list
5505197|NCT04443322|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6058718|NCT00630344|Immunologic Factors|immunologic factors|mesh-ancestor
6058719|NCT00630344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058720|NCT00630344|Androgen Antagonists|androgen antagonists|mesh-ancestor
6058721|NCT00630344|Hormone Antagonists|hormone antagonists|mesh-ancestor
6058722|NCT00630344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6058723|NCT00630396|Minocycline|minocycline|mesh-list
5505198|NCT04443322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6058724|NCT00630396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6058725|NCT00630396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6058726|NCT00630409|Gemcitabine|gemcitabine|mesh-list
6058727|NCT00630409|Doxorubicin|doxorubicin|mesh-list
6058728|NCT00630409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6058729|NCT00630409|Antimetabolites|antimetabolites|mesh-ancestor
6058730|NCT00630409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6058731|NCT00630409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6058732|NCT00630409|Antiviral Agents|antiviral agents|mesh-ancestor
6058733|NCT00630409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6058734|NCT00630409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6058735|NCT00630409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6058736|NCT00630409|Immunologic Factors|immunologic factors|mesh-ancestor
6058737|NCT00630409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058738|NCT00630409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6058739|NCT00630409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6058740|NCT00630409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6058741|NCT00630539|Tamoxifen|tamoxifen|mesh-list
6058742|NCT00630539|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6058743|NCT00630539|Hormone Antagonists|hormone antagonists|mesh-ancestor
6058744|NCT00630539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6058745|NCT00630539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058746|NCT00630539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6058747|NCT00630539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6058748|NCT00630539|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6058749|NCT00630539|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6058750|NCT00630539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6058751|NCT00630734|Ritonavir|ritonavir|mesh-list
6058752|NCT00630734|Darunavir|darunavir|mesh-list
6058753|NCT00630734|Pravastatin|pravastatin|mesh-list
6058754|NCT00630734|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6058755|NCT00630734|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6058756|NCT00630734|Protease Inhibitors|protease inhibitors|mesh-ancestor
6058757|NCT00630734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6058758|NCT00630734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6058759|NCT00630734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6058760|NCT00630734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6058761|NCT00630734|Antiviral Agents|antiviral agents|mesh-ancestor
6058762|NCT00630734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6058763|NCT00630734|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6058764|NCT00630734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6058765|NCT00630734|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6058766|NCT00630734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6058767|NCT00630734|Antimetabolites|antimetabolites|mesh-ancestor
6058768|NCT00630734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6058769|NCT00630734|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6058770|NCT00630786|Panitumumab|panitumumab|mesh-list
6058771|NCT00630786|Conatumumab|conatumumab|mesh-list
6058772|NCT00630786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6058773|NCT00630786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6058774|NCT00630812|Mannitol|mannitol|mesh-list
6058775|NCT00630812|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6058776|NCT00630812|Diuretics|diuretics|mesh-ancestor
6058777|NCT00630812|Natriuretic Agents|natriuretic agents|mesh-ancestor
6058778|NCT00630812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058779|NCT00630825|Dulaglutide|dulaglutide|mesh-list
6058780|NCT00630825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6058781|NCT00630825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058782|NCT00630877|Aspirin|aspirin|mesh-list
6058783|NCT00630877|Niacin|niacin|mesh-list
6058784|NCT00630877|Niacinamide|niacinamide|mesh-list
6058785|NCT00630877|Nicotinic Acids|nicotinic acids|mesh-list
6058786|NCT00630877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6058787|NCT00630877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6058788|NCT00630877|Analgesics|analgesics|mesh-ancestor
6058789|NCT00630877|Sensory System Agents|sensory system agents|mesh-ancestor
6058790|NCT00630877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6058791|NCT00630877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058792|NCT00630877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6058793|NCT00630877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6058794|NCT00630877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6058795|NCT00630877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6058796|NCT00630877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6058797|NCT00630877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6058798|NCT00630877|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6058799|NCT00630877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6058800|NCT00630877|Antipyretics|antipyretics|mesh-ancestor
6058801|NCT00630877|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6058802|NCT00630877|Antimetabolites|antimetabolites|mesh-ancestor
6058803|NCT00630877|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6058804|NCT00630877|Vasodilator Agents|vasodilator agents|mesh-ancestor
6058805|NCT00630877|Vitamin B Complex|vitamin b complex|mesh-ancestor
6058806|NCT00630877|Vitamins|vitamins|mesh-ancestor
6058807|NCT00630877|Micronutrients|micronutrients|mesh-ancestor
6058808|NCT00630955|Memantine|memantine|mesh-list
6058809|NCT00630955|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6058810|NCT00630955|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6058811|NCT00630955|Dopamine Agents|dopamine agents|mesh-ancestor
6058812|NCT00630955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5505199|NCT04443322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5505200|NCT04443322|Immunologic Factors|immunologic factors|mesh-ancestor
5505201|NCT04443322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505202|NCT04443322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5505203|NCT04443322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5505204|NCT04443322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505205|NCT04443010|Temozolomide|temozolomide|mesh-list
5505206|NCT04443010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5505207|NCT04443010|Alkylating Agents|alkylating agents|mesh-ancestor
5505208|NCT04443010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505209|NCT04443010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5505210|NCT04443036|Paclitaxel|paclitaxel|mesh-list
5505211|NCT04443036|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5505212|NCT04443036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5505213|NCT04443036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5505214|NCT04443036|Tubulin Modulators|tubulin modulators|mesh-ancestor
5505215|NCT04443036|Antimitotic Agents|antimitotic agents|mesh-ancestor
5505216|NCT04443036|Mitosis Modulators|mitosis modulators|mesh-ancestor
5505217|NCT04443036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505218|NCT04443049|Mebendazole|mebendazole|mesh-list
5505219|NCT04443049|Piperazine|piperazine|mesh-list
5505220|NCT04443049|Piperazine citrate|piperazine citrate|mesh-list
5505221|NCT04443049|Lenvatinib|lenvatinib|mesh-list
5505222|NCT04443049|DMP 777|dmp 777|mesh-list
6058813|NCT00630955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6058814|NCT00630955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058815|NCT00630955|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6058816|NCT00630955|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6058817|NCT00630994|Decitabine|decitabine|mesh-list
5505223|NCT04443049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5505224|NCT04443049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5505225|NCT04443049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5505226|NCT04443049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6058818|NCT00630994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6058819|NCT00630994|Antimetabolites|antimetabolites|mesh-ancestor
6058820|NCT00630994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6058821|NCT00630994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6058822|NCT00630994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6058823|NCT00631007|Pioglitazone|pioglitazone|mesh-list
6058824|NCT00631007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6058825|NCT00631007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058826|NCT00631163|Deferasirox|deferasirox|mesh-list
6058827|NCT00631163|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6058828|NCT00631163|Chelating Agents|chelating agents|mesh-ancestor
6058829|NCT00631163|Sequestering Agents|sequestering agents|mesh-ancestor
6058830|NCT00631163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6058831|NCT00631189|Atorvastatin|atorvastatin|mesh-list
6058832|NCT00631189|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6058833|NCT00631189|Pravastatin|pravastatin|mesh-list
6058834|NCT00631189|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6058835|NCT00631189|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5505227|NCT04443049|Antinematodal Agents|antinematodal agents|mesh-ancestor
5505228|NCT04443049|Anthelmintics|anthelmintics|mesh-ancestor
5505229|NCT04443049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5505230|NCT04443049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5505231|NCT04443049|Tubulin Modulators|tubulin modulators|mesh-ancestor
5505232|NCT04443049|Antimitotic Agents|antimitotic agents|mesh-ancestor
5505233|NCT04443049|Mitosis Modulators|mitosis modulators|mesh-ancestor
5505234|NCT04443166|Hyaluronic Acid|hyaluronic acid|mesh-list
5505235|NCT04443166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5505236|NCT04443166|Immunologic Factors|immunologic factors|mesh-ancestor
5505237|NCT04443166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058836|NCT00631189|Antimetabolites|antimetabolites|mesh-ancestor
6058837|NCT00631189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6058838|NCT00631189|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6058839|NCT00631189|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6058840|NCT00631189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6058841|NCT00631319|Hydromorphone|hydromorphone|mesh-list
6058842|NCT00631319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6058843|NCT00631319|Narcotics|narcotics|mesh-ancestor
6058844|NCT00631319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6058845|NCT00631319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058846|NCT00631319|Analgesics|analgesics|mesh-ancestor
6058847|NCT00631319|Sensory System Agents|sensory system agents|mesh-ancestor
5505238|NCT04443166|Viscosupplements|viscosupplements|mesh-ancestor
6058848|NCT00631319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6058849|NCT00631358|Dexamethasone|dexamethasone|mesh-list
6058850|NCT00631358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6058851|NCT00631358|Antiemetics|antiemetics|mesh-ancestor
6058852|NCT00631358|Autonomic Agents|autonomic agents|mesh-ancestor
6058853|NCT00631358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6058854|NCT00631358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058855|NCT00631358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6058856|NCT00631358|Glucocorticoids|glucocorticoids|mesh-ancestor
6058857|NCT00631358|Hormones|hormones|mesh-ancestor
6058858|NCT00631358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6058859|NCT00631358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6058860|NCT00631358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6058861|NCT00631371|Interferons|interferons|mesh-list
6058862|NCT00631371|Interferon-alpha|interferon-alpha|mesh-list
5505239|NCT04443166|Protective Agents|protective agents|mesh-ancestor
5505240|NCT04442919|Morphine|morphine|mesh-list
5505241|NCT04442919|Methoxyflurane|methoxyflurane|mesh-list
5505242|NCT04442919|Ticagrelor|ticagrelor|mesh-list
5505243|NCT04442919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5505244|NCT04442919|Narcotics|narcotics|mesh-ancestor
5505245|NCT04442919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5505246|NCT04442919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505247|NCT04442919|Analgesics|analgesics|mesh-ancestor
5505248|NCT04442919|Sensory System Agents|sensory system agents|mesh-ancestor
5505249|NCT04442919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5505250|NCT04442919|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5505251|NCT04442919|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5505252|NCT04442919|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5505253|NCT04442919|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5505254|NCT04442919|Purinergic Agents|purinergic agents|mesh-ancestor
5505255|NCT04442919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5505256|NCT04442919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505257|NCT04442919|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5505258|NCT04442919|Anesthetics, General|anesthetics, general|mesh-ancestor
5505259|NCT04442919|Anesthetics|anesthetics|mesh-ancestor
5505260|NCT04442750|Bupivacaine|bupivacaine|mesh-list
5505261|NCT04442750|Anesthetics, Local|anesthetics, local|mesh-ancestor
5505262|NCT04442750|Anesthetics|anesthetics|mesh-ancestor
5505263|NCT04442750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5505264|NCT04442750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505265|NCT04442750|Sensory System Agents|sensory system agents|mesh-ancestor
5505266|NCT04442750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5505267|NCT04442984|Leucovorin|leucovorin|mesh-list
5505268|NCT04442984|Oxaliplatin|oxaliplatin|mesh-list
5505269|NCT04442984|Irinotecan|irinotecan|mesh-list
6058863|NCT00631371|Sirolimus|sirolimus|mesh-list
6058864|NCT00631371|Bevacizumab|bevacizumab|mesh-list
6058865|NCT00631371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6058866|NCT00631371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6058867|NCT00631371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6058868|NCT00631371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6058869|NCT00631371|Growth Substances|growth substances|mesh-ancestor
6058870|NCT00631371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058871|NCT00631371|Growth Inhibitors|growth inhibitors|mesh-ancestor
6058872|NCT00631371|Antiviral Agents|antiviral agents|mesh-ancestor
6058873|NCT00631371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6058874|NCT00631371|Immunologic Factors|immunologic factors|mesh-ancestor
6058875|NCT00631371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6058876|NCT00631371|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6058877|NCT00631371|Antifungal Agents|antifungal agents|mesh-ancestor
6058878|NCT00631371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6058879|NCT00631410|Sunitinib|sunitinib|mesh-list
6058880|NCT00631410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6058881|NCT00631410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6058882|NCT00631410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6058883|NCT00631410|Growth Substances|growth substances|mesh-ancestor
6058884|NCT00631410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058885|NCT00631410|Growth Inhibitors|growth inhibitors|mesh-ancestor
6058886|NCT00631410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6058887|NCT00631410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5505270|NCT04442984|Fluorouracil|fluorouracil|mesh-list
5505271|NCT04442984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5505272|NCT04442984|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5505273|NCT04442984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5505274|NCT04442984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6058888|NCT00631410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6058889|NCT00631449|Raltegravir Potassium|raltegravir potassium|mesh-list
6058890|NCT00631449|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6058891|NCT00631449|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6058892|NCT00631449|Antiviral Agents|antiviral agents|mesh-ancestor
6058893|NCT00631449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6058894|NCT00631449|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6058895|NCT00631449|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6058896|NCT00631449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6058897|NCT00631449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665215|NCT01516255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6665216|NCT01516255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665217|NCT01516255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5505275|NCT04442984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6058898|NCT00631475|Bosentan|bosentan|mesh-list
6058899|NCT00631475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6058900|NCT00631475|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6058901|NCT00631475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6058902|NCT00631488|Metformin|metformin|mesh-list
6058903|NCT00631488|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6058904|NCT00631488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6058905|NCT00631488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058906|NCT00631488|Incretins|incretins|mesh-ancestor
6058907|NCT00631488|Hormones|hormones|mesh-ancestor
6058908|NCT00631488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6058909|NCT00631488|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6058910|NCT00631488|Protease Inhibitors|protease inhibitors|mesh-ancestor
6058911|NCT00631488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6058912|NCT00631488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6058913|NCT00631566|Mupirocin|mupirocin|mesh-list
6058914|NCT00631566|Triclosan|triclosan|mesh-list
6058915|NCT00631566|Hexachlorophene|hexachlorophene|mesh-list
6058916|NCT00631566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6058917|NCT00631566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6058918|NCT00631566|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6058919|NCT00631566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5505276|NCT04442984|Antidotes|antidotes|mesh-ancestor
5505277|NCT04442984|Protective Agents|protective agents|mesh-ancestor
5505278|NCT04442984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505279|NCT04442984|Vitamin B Complex|vitamin b complex|mesh-ancestor
5505280|NCT04442984|Vitamins|vitamins|mesh-ancestor
5505281|NCT04442984|Micronutrients|micronutrients|mesh-ancestor
5505282|NCT04442984|Antimetabolites|antimetabolites|mesh-ancestor
5505283|NCT04442984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5505284|NCT04442984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5505285|NCT04442984|Immunologic Factors|immunologic factors|mesh-ancestor
5600073|NCT03714867|Sensory System Agents|sensory system agents|mesh-ancestor
5600074|NCT03714867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5600075|NCT03714867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600076|NCT03714867|Anticonvulsants|anticonvulsants|mesh-ancestor
6058920|NCT00631566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6058921|NCT00631566|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6058922|NCT00631566|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6058923|NCT00631566|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6058924|NCT00631566|Antimetabolites|antimetabolites|mesh-ancestor
6058925|NCT00631566|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6058926|NCT00631657|Mirtazapine|mirtazapine|mesh-list
6058927|NCT00631657|Antidepressive Agents|antidepressive agents|mesh-ancestor
6058928|NCT00631657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6058929|NCT00631657|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6058930|NCT00631657|Histamine Antagonists|histamine antagonists|mesh-ancestor
6058931|NCT00631657|Histamine Agents|histamine agents|mesh-ancestor
6058932|NCT00631657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6058933|NCT00631657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6058934|NCT00631657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058935|NCT00631657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6058936|NCT00631657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6058937|NCT00631657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6058938|NCT00631657|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6058939|NCT00631657|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6058940|NCT00631657|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6058941|NCT00631657|Adrenergic Agents|adrenergic agents|mesh-ancestor
6665218|NCT01516255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600077|NCT03714867|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5600078|NCT03714867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6058942|NCT00631657|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5505286|NCT04442906|Fentanyl|fentanyl|mesh-list
5505287|NCT04442906|Dexmedetomidine|dexmedetomidine|mesh-list
5505288|NCT04442906|Bupivacaine|bupivacaine|mesh-list
5505289|NCT04442906|Anesthetics, Local|anesthetics, local|mesh-ancestor
5505290|NCT04442906|Anesthetics|anesthetics|mesh-ancestor
5505291|NCT04442906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5505292|NCT04442906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505293|NCT04442906|Sensory System Agents|sensory system agents|mesh-ancestor
5505294|NCT04442906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5505295|NCT04442906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5505296|NCT04442906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6058943|NCT00631657|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6058944|NCT00631657|Serotonin Agents|serotonin agents|mesh-ancestor
6058945|NCT00631657|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6058946|NCT00631696|Pregabalin|pregabalin|mesh-list
6058947|NCT00631696|Analgesics|analgesics|mesh-ancestor
6058948|NCT00631696|Sensory System Agents|sensory system agents|mesh-ancestor
6058949|NCT00631696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6058950|NCT00631696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058951|NCT00631696|Anticonvulsants|anticonvulsants|mesh-ancestor
6058952|NCT00631696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6058953|NCT00631696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6058954|NCT00631696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6058955|NCT00631696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6058956|NCT00631696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6058957|NCT00631696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6058958|NCT00631696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6058959|NCT00631696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6058960|NCT00631748|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6058961|NCT00631748|Antidepressive Agents|antidepressive agents|mesh-ancestor
6058962|NCT00631748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6058963|NCT00631748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6058964|NCT00631748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6058965|NCT00631748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6058966|NCT00631748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058967|NCT00631917|Ramipril|ramipril|mesh-list
6462510|NCT00459992|Betahistine|betahistine|mesh-list
6462511|NCT00459992|Vasodilator Agents|vasodilator agents|mesh-ancestor
6462512|NCT00459992|Histamine Agonists|histamine agonists|mesh-ancestor
6462513|NCT00459992|Histamine Agents|histamine agents|mesh-ancestor
6462514|NCT00459992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6462515|NCT00459992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462516|NCT00459992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462517|NCT00460057|Alendronate|alendronate|mesh-list
6462518|NCT00460057|Diphosphonates|diphosphonates|mesh-list
6058968|NCT00631917|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6058969|NCT00631917|Protease Inhibitors|protease inhibitors|mesh-ancestor
6058970|NCT00631917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6058971|NCT00631917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6058972|NCT00631917|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6058973|NCT00631969|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6058974|NCT00631969|Vasodilator Agents|vasodilator agents|mesh-ancestor
6058975|NCT00631969|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6058976|NCT00631969|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6058977|NCT00631969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5505297|NCT04442906|Analgesics|analgesics|mesh-ancestor
6488399|NCT00583986|Albuterol|albuterol|mesh-list
6058978|NCT00631969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6058979|NCT00631969|Urological Agents|urological agents|mesh-ancestor
6058980|NCT00632099|Progesterone|progesterone|mesh-list
6058981|NCT00632099|Progestins|progestins|mesh-ancestor
6058982|NCT00632099|Hormones|hormones|mesh-ancestor
6058983|NCT00632099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6058984|NCT00632099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058985|NCT00632125|Epoetin Alfa|epoetin alfa|mesh-list
5505298|NCT04442906|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5505299|NCT04442906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5505300|NCT04442906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6058986|NCT00632125|Hematinics|hematinics|mesh-ancestor
6058987|NCT00632203|Temozolomide|temozolomide|mesh-list
6058988|NCT00632203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6058989|NCT00632203|Alkylating Agents|alkylating agents|mesh-ancestor
6058990|NCT00632203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505301|NCT04442906|Adrenergic Agents|adrenergic agents|mesh-ancestor
5505302|NCT04442906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5505303|NCT04442906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505304|NCT04442906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5505305|NCT04442906|Narcotics|narcotics|mesh-ancestor
5505306|NCT04442906|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5505307|NCT04442906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5505308|NCT04442906|Anesthetics, General|anesthetics, general|mesh-ancestor
5505309|NCT04443309|Lenvatinib|lenvatinib|mesh-list
5505310|NCT04443309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5505311|NCT04443309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5505312|NCT04443309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5505313|NCT04443309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505314|NCT04442412|Vitamin D|vitamin d|mesh-list
5505315|NCT04442412|Cholecalciferol|cholecalciferol|mesh-list
5505316|NCT04442412|Vitamins|vitamins|mesh-ancestor
5505317|NCT04442412|Micronutrients|micronutrients|mesh-ancestor
5505318|NCT04442412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505319|NCT04442412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5505320|NCT04442412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5505321|NCT04442633|Miconazole|miconazole|mesh-list
5505322|NCT04442633|Antifungal Agents|antifungal agents|mesh-ancestor
5505323|NCT04442633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5505324|NCT04442633|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6058991|NCT00632203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6058992|NCT00632229|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6058993|NCT00632229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6058994|NCT00632229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6058995|NCT00632229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6058996|NCT00632229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6058997|NCT00632229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6058998|NCT00632229|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6058999|NCT00632229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6059000|NCT00632229|Serotonin Agents|serotonin agents|mesh-ancestor
6059001|NCT00632229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6059002|NCT00632229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059003|NCT00632229|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6059004|NCT00632229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6059005|NCT00632229|Dopamine Agents|dopamine agents|mesh-ancestor
6059006|NCT00632359|Lenalidomide|lenalidomide|mesh-list
6059007|NCT00632359|Immunologic Factors|immunologic factors|mesh-ancestor
6059008|NCT00632359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059009|NCT00632359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6059010|NCT00632359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6059011|NCT00632359|Growth Substances|growth substances|mesh-ancestor
6059012|NCT00632359|Growth Inhibitors|growth inhibitors|mesh-ancestor
6059013|NCT00632359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6059014|NCT00632411|Nicotine|nicotine|mesh-list
6059015|NCT00632411|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6059016|NCT00632411|Autonomic Agents|autonomic agents|mesh-ancestor
6059017|NCT00632411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6059018|NCT00632411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059019|NCT00632411|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6059020|NCT00632411|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6059021|NCT00632411|Cholinergic Agents|cholinergic agents|mesh-ancestor
6059022|NCT00632411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6202044|NCT02034916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5505325|NCT04442633|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5505326|NCT04442633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5505327|NCT04442633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505328|NCT04442633|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5505329|NCT04442633|Hormone Antagonists|hormone antagonists|mesh-ancestor
5505330|NCT04442633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5505331|NCT04442633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505332|NCT04442633|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5505333|NCT04442633|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5505334|NCT04441918|Antibodies|antibodies|mesh-list
5505335|NCT04441918|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5505336|NCT04441918|Immunologic Factors|immunologic factors|mesh-ancestor
5505337|NCT04441918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505338|NCT04441385|Maraviroc|maraviroc|mesh-list
5505339|NCT04441385|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6059023|NCT00632411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059024|NCT00632489|Capecitabine|capecitabine|mesh-list
6059025|NCT00632489|Lapatinib|lapatinib|mesh-list
6059026|NCT00632489|Panobinostat|panobinostat|mesh-list
6059027|NCT00632489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6059028|NCT00632489|Antimetabolites|antimetabolites|mesh-ancestor
6059029|NCT00632489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059030|NCT00632489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6059031|NCT00632489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6059032|NCT00632489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6059033|NCT00632489|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5505340|NCT04441385|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5505341|NCT04441385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505342|NCT04441385|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5505343|NCT04441385|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5505344|NCT04441385|Antiviral Agents|antiviral agents|mesh-ancestor
5505345|NCT04441385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5505346|NCT04441385|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
5505347|NCT04441424|Azithromycin|azithromycin|mesh-list
5505348|NCT04441424|Hydroxychloroquine|hydroxychloroquine|mesh-list
5505349|NCT04441424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5505350|NCT04441424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5505351|NCT04441424|Antimalarials|antimalarials|mesh-ancestor
5505352|NCT04441424|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5505353|NCT04441424|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5505354|NCT04441424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5505355|NCT04441424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505356|NCT04441424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5505357|NCT04441398|Nitazoxanide|nitazoxanide|mesh-list
5505358|NCT04441398|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5505359|NCT04441398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5505360|NCT04441528|Hyaluronic Acid|hyaluronic acid|mesh-list
5505361|NCT04441528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5505362|NCT04441528|Immunologic Factors|immunologic factors|mesh-ancestor
5505363|NCT04441528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505364|NCT04441528|Viscosupplements|viscosupplements|mesh-ancestor
5505365|NCT04441528|Protective Agents|protective agents|mesh-ancestor
5505366|NCT04441112|Triamcinolone|triamcinolone|mesh-list
6059034|NCT00632541|Bevacizumab|bevacizumab|mesh-list
6059035|NCT00632541|Sorafenib|sorafenib|mesh-list
6059036|NCT00632541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6059037|NCT00632541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6059038|NCT00632541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6059039|NCT00632541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6059040|NCT00632541|Growth Substances|growth substances|mesh-ancestor
6059041|NCT00632541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059042|NCT00632541|Growth Inhibitors|growth inhibitors|mesh-ancestor
6059043|NCT00632541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6059044|NCT00632541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6059045|NCT00632541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059046|NCT00632619|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
6059047|NCT00632619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059048|NCT00632632|Cycloserine|cycloserine|mesh-list
6059049|NCT00632632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6059050|NCT00632632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6059051|NCT00632632|Renal Agents|renal agents|mesh-ancestor
6059052|NCT00632632|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6059053|NCT00632632|Antitubercular Agents|antitubercular agents|mesh-ancestor
6059054|NCT00632632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6059055|NCT00632632|Antimetabolites|antimetabolites|mesh-ancestor
5505367|NCT04441112|Ketorolac|ketorolac|mesh-list
6665219|NCT01516255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6059056|NCT00632632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059057|NCT00632736|Ropinirole|ropinirole|mesh-list
6059058|NCT00632736|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6059059|NCT00632736|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6059060|NCT00632736|Dopamine Agonists|dopamine agonists|mesh-ancestor
6059061|NCT00632736|Dopamine Agents|dopamine agents|mesh-ancestor
6059062|NCT00632736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5505368|NCT04441112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5505369|NCT04441112|Glucocorticoids|glucocorticoids|mesh-ancestor
5505370|NCT04441112|Hormones|hormones|mesh-ancestor
5505371|NCT04441112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5505372|NCT04441112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505373|NCT04441112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5505374|NCT04441112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505375|NCT04441112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5505376|NCT04441112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5505377|NCT04441112|Analgesics|analgesics|mesh-ancestor
6059063|NCT00632736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059064|NCT00632736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059065|NCT00632749|Cytarabine|cytarabine|mesh-list
6059066|NCT00632749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6059067|NCT00632749|Antimetabolites|antimetabolites|mesh-ancestor
6059068|NCT00632749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059069|NCT00632749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6059070|NCT00632749|Antiviral Agents|antiviral agents|mesh-ancestor
6059071|NCT00632749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6059072|NCT00632749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6059073|NCT00632749|Immunologic Factors|immunologic factors|mesh-ancestor
6059074|NCT00632749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059075|NCT00632814|Factor VIII|factor viii|mesh-list
6059076|NCT00632814|Coagulants|coagulants|mesh-ancestor
6059077|NCT00632827|Leucovorin|leucovorin|mesh-list
6059078|NCT00632827|Gemcitabine|gemcitabine|mesh-list
5505378|NCT04441112|Sensory System Agents|sensory system agents|mesh-ancestor
5505379|NCT04441112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5505380|NCT04441112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5505381|NCT04441112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5600079|NCT03714867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600080|NCT03714867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5600081|NCT03714867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5600082|NCT03714867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5600083|NCT03714867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5600084|NCT03714867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5600085|NCT03714789|Dialysis Solutions|dialysis solutions|mesh-list
5600086|NCT03714789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5600087|NCT03714737|Vaccines|vaccines|mesh-list
5600088|NCT03714737|Immunologic Factors|immunologic factors|mesh-ancestor
5600089|NCT03714737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059079|NCT00632827|Cytarabine|cytarabine|mesh-list
6059080|NCT00632827|Cyclophosphamide|cyclophosphamide|mesh-list
6059081|NCT00632827|Carmustine|carmustine|mesh-list
6059082|NCT00632827|Doxorubicin|doxorubicin|mesh-list
6059083|NCT00632827|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6059084|NCT00632827|Methotrexate|methotrexate|mesh-list
6059085|NCT00632827|Etoposide|etoposide|mesh-list
6059086|NCT00632827|Vincristine|vincristine|mesh-list
6059087|NCT00632827|Vinorelbine|vinorelbine|mesh-list
6059088|NCT00632827|Denileukin diftitox|denileukin diftitox|mesh-list
6059089|NCT00632827|Lenograstim|lenograstim|mesh-list
5600090|NCT03714685|Firibastat|firibastat|mesh-list
5600091|NCT03714685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5600092|NCT03714620|Ketamine|ketamine|mesh-list
5600093|NCT03714620|Analgesics|analgesics|mesh-ancestor
5600094|NCT03714620|Sensory System Agents|sensory system agents|mesh-ancestor
5600095|NCT03714620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5600096|NCT03714620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600097|NCT03714620|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5600098|NCT03714620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5600099|NCT03714620|Anesthetics, General|anesthetics, general|mesh-ancestor
5600100|NCT03714620|Anesthetics|anesthetics|mesh-ancestor
5600101|NCT03714620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6059090|NCT00632827|Sargramostim|sargramostim|mesh-list
5600102|NCT03714620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6059091|NCT00632827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6059092|NCT00632827|Immunologic Factors|immunologic factors|mesh-ancestor
6059093|NCT00632827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059094|NCT00632827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5505382|NCT04441034|Anticonvulsants|anticonvulsants|mesh-list
5505383|NCT04441034|Convulsants|convulsants|mesh-list
5505384|NCT04441034|Antidepressive Agents|antidepressive agents|mesh-list
5505385|NCT04441034|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5505386|NCT04441034|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5505387|NCT04441034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059095|NCT00632827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6059096|NCT00632827|Alkylating Agents|alkylating agents|mesh-ancestor
6462519|NCT00460057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6462520|NCT00460057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462521|NCT00460083|Pimecrolimus|pimecrolimus|mesh-list
6462522|NCT00460083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6462523|NCT00460083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6462524|NCT00460083|Analgesics|analgesics|mesh-ancestor
6462525|NCT00460083|Sensory System Agents|sensory system agents|mesh-ancestor
6462526|NCT00460083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6462527|NCT00460083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462528|NCT00460083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6462529|NCT00460083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6462530|NCT00460083|Dermatologic Agents|dermatologic agents|mesh-ancestor
6462531|NCT00460083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6462532|NCT00460083|Immunologic Factors|immunologic factors|mesh-ancestor
5505388|NCT04440917|Apatinib|apatinib|mesh-list
6059097|NCT00632827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059098|NCT00632827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6059099|NCT00632827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6059100|NCT00632827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6059101|NCT00632827|Antimetabolites|antimetabolites|mesh-ancestor
6059102|NCT00632827|Antiviral Agents|antiviral agents|mesh-ancestor
6059103|NCT00632827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6059104|NCT00632827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6059105|NCT00632827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6059106|NCT00632827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6059107|NCT00632827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6059108|NCT00632827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6059109|NCT00632827|Abortifacient Agents|abortifacient agents|mesh-ancestor
6059110|NCT00632827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6059111|NCT00632827|Dermatologic Agents|dermatologic agents|mesh-ancestor
6059112|NCT00632827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6059113|NCT00632827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6059114|NCT00632827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6059115|NCT00632827|Antidotes|antidotes|mesh-ancestor
6059116|NCT00632827|Protective Agents|protective agents|mesh-ancestor
6059117|NCT00632827|Vitamin B Complex|vitamin b complex|mesh-ancestor
6059118|NCT00632827|Vitamins|vitamins|mesh-ancestor
6059119|NCT00632827|Micronutrients|micronutrients|mesh-ancestor
6059120|NCT00632827|Tubulin Modulators|tubulin modulators|mesh-ancestor
6059121|NCT00632827|Antimitotic Agents|antimitotic agents|mesh-ancestor
6059122|NCT00632827|Mitosis Modulators|mitosis modulators|mesh-ancestor
6059123|NCT00632827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6059124|NCT00632931|Vorinostat|vorinostat|mesh-list
6059125|NCT00632931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6059126|NCT00632931|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6059127|NCT00632931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6059128|NCT00632931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059129|NCT00632970|Ritonavir|ritonavir|mesh-list
6059130|NCT00632970|Lopinavir|lopinavir|mesh-list
6059131|NCT00632970|Tenofovir|tenofovir|mesh-list
6059132|NCT00632970|Emtricitabine|emtricitabine|mesh-list
6059133|NCT00632970|Raltegravir Potassium|raltegravir potassium|mesh-list
6059134|NCT00632970|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6059135|NCT00632970|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5505389|NCT04440917|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5505390|NCT04440917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5505391|NCT04440917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5505392|NCT04440917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5505393|NCT04440917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505394|NCT04441138|Durvalumab|durvalumab|mesh-list
6059136|NCT00632970|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6059137|NCT00632970|Protease Inhibitors|protease inhibitors|mesh-ancestor
6059138|NCT00632970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6059139|NCT00632970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059140|NCT00632970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6059141|NCT00632970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6059142|NCT00632970|Antiviral Agents|antiviral agents|mesh-ancestor
5505395|NCT04441138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5505396|NCT04441138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6059143|NCT00632970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6059144|NCT00632970|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6059145|NCT00632970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6059146|NCT00632970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6059147|NCT00632970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6059148|NCT00632970|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6059149|NCT00632970|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6059150|NCT00633074|Vaccines|vaccines|mesh-list
6059151|NCT00633074|Immunologic Factors|immunologic factors|mesh-ancestor
6059152|NCT00633074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202045|NCT02034916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202046|NCT02034916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6202047|NCT02035267|Deoxycholic Acid|deoxycholic acid|mesh-list
6202048|NCT02035267|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6202049|NCT02035267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6202050|NCT02035345|Carboplatin|carboplatin|mesh-list
6202051|NCT02035345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6202052|NCT02035553|Pimavanserin|pimavanserin|mesh-list
6202053|NCT02035553|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6202054|NCT02035553|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6202055|NCT02035553|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6202056|NCT02035553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6202057|NCT02035553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6202058|NCT02035553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202059|NCT02035553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6202060|NCT02035553|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6202061|NCT02035553|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6202062|NCT02035553|Serotonin Agents|serotonin agents|mesh-ancestor
6202063|NCT02035553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6202064|NCT02035553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202065|NCT02035696|Vaccines|vaccines|mesh-list
6202066|NCT02035696|Immunologic Factors|immunologic factors|mesh-ancestor
6202067|NCT02035696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202068|NCT02036424|Dexamethasone|dexamethasone|mesh-list
6202069|NCT02036424|Bevacizumab|bevacizumab|mesh-list
6202070|NCT02036424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6202071|NCT02036424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6202072|NCT02036424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6202073|NCT02036424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6202074|NCT02036424|Growth Substances|growth substances|mesh-ancestor
6202075|NCT02036424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202076|NCT02036424|Growth Inhibitors|growth inhibitors|mesh-ancestor
6202077|NCT02036424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6202078|NCT02036424|Antiemetics|antiemetics|mesh-ancestor
6202079|NCT02036424|Autonomic Agents|autonomic agents|mesh-ancestor
6202080|NCT02036424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6202081|NCT02036424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6202082|NCT02036424|Glucocorticoids|glucocorticoids|mesh-ancestor
6202083|NCT02036424|Hormones|hormones|mesh-ancestor
6202084|NCT02036424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6202085|NCT02036424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6202086|NCT02036502|Dexamethasone|dexamethasone|mesh-list
6202087|NCT02036502|Pembrolizumab|pembrolizumab|mesh-list
6202088|NCT02036502|Lenalidomide|lenalidomide|mesh-list
6202089|NCT02036502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6202090|NCT02036502|Antiemetics|antiemetics|mesh-ancestor
6202091|NCT02036502|Autonomic Agents|autonomic agents|mesh-ancestor
6202092|NCT02036502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6202093|NCT02036502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202094|NCT02036502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6202095|NCT02036502|Glucocorticoids|glucocorticoids|mesh-ancestor
6202096|NCT02036502|Hormones|hormones|mesh-ancestor
6202097|NCT02036502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6202098|NCT02036502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6202099|NCT02036502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6202100|NCT02036502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6202101|NCT02036502|Immunologic Factors|immunologic factors|mesh-ancestor
6202102|NCT02036502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6202103|NCT02036502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6202104|NCT02036502|Growth Substances|growth substances|mesh-ancestor
5505397|NCT04441021|Penicillins|penicillins|mesh-list
6202105|NCT02036502|Growth Inhibitors|growth inhibitors|mesh-ancestor
6202106|NCT02036515|Metformin|metformin|mesh-list
6059153|NCT00633126|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
5505398|NCT04441021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5505399|NCT04441021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5505400|NCT04440735|Atezolizumab|atezolizumab|mesh-list
5505401|NCT04440735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5505402|NCT04440371|Betamethasone|betamethasone|mesh-list
5505403|NCT04440371|Calcipotriene|calcipotriene|mesh-list
5505404|NCT04440371|Tacrolimus|tacrolimus|mesh-list
5505405|NCT04440371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5505406|NCT04440371|Immunologic Factors|immunologic factors|mesh-ancestor
5505407|NCT04440371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505408|NCT04440371|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5505409|NCT04440371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5505410|NCT04440371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059154|NCT00633126|Cephalosporins|cephalosporins|mesh-list
6059155|NCT00633126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6059156|NCT00633126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6059157|NCT00633152|Linezolid|linezolid|mesh-list
6059158|NCT00633152|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
6059159|NCT00633152|Cephalosporins|cephalosporins|mesh-list
6059160|NCT00633152|Aztreonam|aztreonam|mesh-list
6059161|NCT00633152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6059162|NCT00633152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6059163|NCT00633152|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6059164|NCT00633152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6059165|NCT00633152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059166|NCT00633217|Fluticasone|fluticasone|mesh-list
6059167|NCT00633217|Xhance|xhance|mesh-list
6059168|NCT00633217|Norflurane|norflurane|mesh-list
6059169|NCT00633217|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6059170|NCT00633217|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6059171|NCT00633217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6059172|NCT00633217|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6059173|NCT00633217|Autonomic Agents|autonomic agents|mesh-ancestor
6059174|NCT00633217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6059175|NCT00633217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059176|NCT00633217|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6059177|NCT00633217|Respiratory System Agents|respiratory system agents|mesh-ancestor
6059178|NCT00633217|Dermatologic Agents|dermatologic agents|mesh-ancestor
6059179|NCT00633217|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6059180|NCT00633217|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6059181|NCT00633217|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6059182|NCT00633217|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6059183|NCT00633217|Adrenergic Agents|adrenergic agents|mesh-ancestor
6059184|NCT00633217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6059185|NCT00633217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059186|NCT00633217|Glucocorticoids|glucocorticoids|mesh-ancestor
6059187|NCT00633217|Hormones|hormones|mesh-ancestor
6059188|NCT00633217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6059189|NCT00633217|Sympathomimetics|sympathomimetics|mesh-ancestor
6059190|NCT00633217|Anesthetics|anesthetics|mesh-ancestor
6059191|NCT00633217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6059192|NCT00633256|Isoniazid|isoniazid|mesh-list
6059193|NCT00633256|Cycloserine|cycloserine|mesh-list
6059194|NCT00633256|Antitubercular Agents|antitubercular agents|mesh-ancestor
6059195|NCT00633256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6059196|NCT00633256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6059197|NCT00633256|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6059198|NCT00633256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6059199|NCT00633256|Antimetabolites|antimetabolites|mesh-ancestor
6059200|NCT00633256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059201|NCT00633256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6059202|NCT00633256|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6059203|NCT00633256|Renal Agents|renal agents|mesh-ancestor
6059204|NCT00633256|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6059205|NCT00633360|Drospirenone|drospirenone|mesh-list
6059206|NCT00633360|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6059207|NCT00633360|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
6059208|NCT00633360|Estradiol|estradiol|mesh-list
6059209|NCT00633360|Estrogens|estrogens|mesh-ancestor
6059210|NCT00633360|Hormones|hormones|mesh-ancestor
6059211|NCT00633360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6059212|NCT00633360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059213|NCT00633360|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6059214|NCT00633360|Contraceptive Agents|contraceptive agents|mesh-ancestor
5505411|NCT04440371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6202107|NCT02036515|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6059215|NCT00633360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6059216|NCT00633360|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5505412|NCT04440371|Glucocorticoids|glucocorticoids|mesh-ancestor
5505413|NCT04440371|Hormones|hormones|mesh-ancestor
5505414|NCT04440371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5505415|NCT04440371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5505416|NCT04440371|Respiratory System Agents|respiratory system agents|mesh-ancestor
5505417|NCT04440371|Dermatologic Agents|dermatologic agents|mesh-ancestor
5505418|NCT04440488|Protease Inhibitors|protease inhibitors|mesh-list
5505419|NCT04440488|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
5505420|NCT04440488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5505421|NCT04440488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505422|NCT04440488|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5505423|NCT04440488|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6059217|NCT00633360|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6059218|NCT00633360|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6059219|NCT00633360|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6059220|NCT00633360|Hormone Antagonists|hormone antagonists|mesh-ancestor
6059221|NCT00633360|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6059222|NCT00633360|Diuretics|diuretics|mesh-ancestor
6059223|NCT00633360|Natriuretic Agents|natriuretic agents|mesh-ancestor
6059224|NCT00633399|Ziprasidone|ziprasidone|mesh-list
6059225|NCT00633399|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6059226|NCT00633399|Serotonin Agents|serotonin agents|mesh-ancestor
6059227|NCT00633399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6059228|NCT00633399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059229|NCT00633399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059230|NCT00633399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6059231|NCT00633399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6059232|NCT00633399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6059233|NCT00633399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6059234|NCT00633399|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6059235|NCT00633399|Dopamine Agents|dopamine agents|mesh-ancestor
6059236|NCT00633464|Cetuximab|cetuximab|mesh-list
6059237|NCT00633464|Epothilones|epothilones|mesh-list
6059238|NCT00633464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6059239|NCT00633464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6059240|NCT00633464|Tubulin Modulators|tubulin modulators|mesh-ancestor
6059241|NCT00633464|Antimitotic Agents|antimitotic agents|mesh-ancestor
6059242|NCT00633464|Mitosis Modulators|mitosis modulators|mesh-ancestor
6059243|NCT00633464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059244|NCT00633594|Rituximab|rituximab|mesh-list
6059245|NCT00633594|Lenalidomide|lenalidomide|mesh-list
6059246|NCT00633594|Bortezomib|bortezomib|mesh-list
6059247|NCT00633594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6059248|NCT00633594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6059249|NCT00633594|Immunologic Factors|immunologic factors|mesh-ancestor
6059250|NCT00633594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059251|NCT00633594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6059252|NCT00633594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6059253|NCT00633594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6059254|NCT00633594|Growth Substances|growth substances|mesh-ancestor
6059255|NCT00633594|Growth Inhibitors|growth inhibitors|mesh-ancestor
6059256|NCT00633750|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6059257|NCT00633750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6059258|NCT00633750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6059259|NCT00633750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6059260|NCT00633750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059261|NCT00633880|Droxidopa|droxidopa|mesh-list
6059262|NCT00633880|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6059263|NCT00633880|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6059264|NCT00633893|Apixaban|apixaban|mesh-list
6059265|NCT00633893|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6059266|NCT00633893|Antithrombins|antithrombins|mesh-ancestor
6059267|NCT00633893|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6059268|NCT00633893|Protease Inhibitors|protease inhibitors|mesh-ancestor
6059269|NCT00633893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6059270|NCT00633893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059271|NCT00633893|Anticoagulants|anticoagulants|mesh-ancestor
5505424|NCT04440696|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
5505425|NCT04440696|Chelating Agents|chelating agents|mesh-ancestor
5505426|NCT04440696|Sequestering Agents|sequestering agents|mesh-ancestor
5505427|NCT04440696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505428|NCT04440280|Acetylcysteine|acetylcysteine|mesh-list
5505429|NCT04440280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6059272|NCT00633919|Prednisone|prednisone|mesh-list
6059273|NCT00633919|Budesonide|budesonide|mesh-list
6059274|NCT00633919|Albuterol|albuterol|mesh-list
6059275|NCT00633919|Formoterol Fumarate|formoterol fumarate|mesh-list
6059276|NCT00633919|Desloratadine|desloratadine|mesh-list
6059277|NCT00633919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6059278|NCT00633919|Glucocorticoids|glucocorticoids|mesh-ancestor
6059279|NCT00633919|Hormones|hormones|mesh-ancestor
6059280|NCT00633919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6059281|NCT00633919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059282|NCT00633919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6059283|NCT00633919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6059284|NCT00633919|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6059285|NCT00633919|Autonomic Agents|autonomic agents|mesh-ancestor
6059286|NCT00633919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6059287|NCT00633919|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6059288|NCT00633919|Respiratory System Agents|respiratory system agents|mesh-ancestor
6059289|NCT00633919|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6059290|NCT00633919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6059291|NCT00633919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5505430|NCT04440280|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5505431|NCT04440280|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5505432|NCT04440280|Antiviral Agents|antiviral agents|mesh-ancestor
5505433|NCT04440280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5505434|NCT04440280|Expectorants|expectorants|mesh-ancestor
5505435|NCT04440280|Respiratory System Agents|respiratory system agents|mesh-ancestor
5505436|NCT04440280|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5505437|NCT04440280|Antioxidants|antioxidants|mesh-ancestor
5505438|NCT04440280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505439|NCT04440280|Protective Agents|protective agents|mesh-ancestor
5505440|NCT04440280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505441|NCT04440280|Antidotes|antidotes|mesh-ancestor
6059292|NCT00633919|Adrenergic Agents|adrenergic agents|mesh-ancestor
6059293|NCT00633919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6059294|NCT00633919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059295|NCT00633919|Tocolytic Agents|tocolytic agents|mesh-ancestor
6059296|NCT00633919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6059297|NCT00633919|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5505442|NCT04440267|Dexamethasone|dexamethasone|mesh-list
5505443|NCT04440267|Prednisone|prednisone|mesh-list
5505444|NCT04440267|Cyclophosphamide|cyclophosphamide|mesh-list
5505445|NCT04440267|Methotrexate|methotrexate|mesh-list
5505446|NCT04440267|Vincristine|vincristine|mesh-list
5505447|NCT04440267|Daunorubicin|daunorubicin|mesh-list
6059298|NCT00633919|Cholinergic Agents|cholinergic agents|mesh-ancestor
6059299|NCT00633919|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6059300|NCT00633919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6059301|NCT00633919|Histamine Antagonists|histamine antagonists|mesh-ancestor
6059302|NCT00633919|Histamine Agents|histamine agents|mesh-ancestor
6059303|NCT00633932|Esomeprazole|esomeprazole|mesh-list
6059304|NCT00633932|Omeprazole|omeprazole|mesh-list
6059305|NCT00633932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6059306|NCT00633932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6059307|NCT00633932|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6059308|NCT00633932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6059309|NCT00633932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505448|NCT04440267|Asparaginase|asparaginase|mesh-list
6059310|NCT00633945|Lenalidomide|lenalidomide|mesh-list
6059311|NCT00633945|Immunologic Factors|immunologic factors|mesh-ancestor
5505449|NCT04440267|Mercaptopurine|mercaptopurine|mesh-list
6059312|NCT00633945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059313|NCT00633945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6059314|NCT00633945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6059315|NCT00633945|Growth Substances|growth substances|mesh-ancestor
6059316|NCT00633945|Growth Inhibitors|growth inhibitors|mesh-ancestor
6059317|NCT00633945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6059318|NCT00633984|Cycloserine|cycloserine|mesh-list
6059319|NCT00633984|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5505450|NCT04440267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5505451|NCT04440267|Immunologic Factors|immunologic factors|mesh-ancestor
5505452|NCT04440267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059320|NCT00633984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6059321|NCT00633984|Renal Agents|renal agents|mesh-ancestor
6059322|NCT00633984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6059323|NCT00633984|Antitubercular Agents|antitubercular agents|mesh-ancestor
6059324|NCT00633984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6059325|NCT00633984|Antimetabolites|antimetabolites|mesh-ancestor
6059326|NCT00633984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059327|NCT00634036|Pioglitazone|pioglitazone|mesh-list
6059328|NCT00634036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6059329|NCT00634036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059330|NCT00634049|Isavuconazole|isavuconazole|mesh-list
6059331|NCT00634049|Antifungal Agents|antifungal agents|mesh-ancestor
6059332|NCT00634049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6059333|NCT00634088|Capecitabine|capecitabine|mesh-list
6059334|NCT00634088|Lapatinib|lapatinib|mesh-list
6059335|NCT00634088|Epothilones|epothilones|mesh-list
6059336|NCT00634088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6059337|NCT00634088|Antimetabolites|antimetabolites|mesh-ancestor
6059338|NCT00634088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059339|NCT00634088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6059340|NCT00634088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6059341|NCT00634088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6059342|NCT00634088|Tubulin Modulators|tubulin modulators|mesh-ancestor
6059343|NCT00634088|Antimitotic Agents|antimitotic agents|mesh-ancestor
6059344|NCT00634088|Mitosis Modulators|mitosis modulators|mesh-ancestor
6059345|NCT00634114|Esomeprazole|esomeprazole|mesh-list
6059346|NCT00634114|Omeprazole|omeprazole|mesh-list
6059347|NCT00634114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6059348|NCT00634114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6059349|NCT00634114|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6059350|NCT00634114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6059351|NCT00634114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059352|NCT00634166|Vancomycin|vancomycin|mesh-list
6059353|NCT00634166|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5505453|NCT04440267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5505454|NCT04440267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5505455|NCT04440267|Alkylating Agents|alkylating agents|mesh-ancestor
5505456|NCT04440267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505457|NCT04440267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5505458|NCT04440267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5505459|NCT04440267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5505460|NCT04440267|Antiemetics|antiemetics|mesh-ancestor
5505461|NCT04440267|Autonomic Agents|autonomic agents|mesh-ancestor
5505462|NCT04440267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6059354|NCT00634166|Cefazolin|cefazolin|mesh-list
6059355|NCT00634166|Tazobactam|tazobactam|mesh-list
6059356|NCT00634166|Piperacillin|piperacillin|mesh-list
6059357|NCT00634166|Amphotericin B|amphotericin b|mesh-list
6059358|NCT00634166|Nystatin|nystatin|mesh-list
6059359|NCT00634166|Bacitracin|bacitracin|mesh-list
6059360|NCT00634166|Sulfadiazine|sulfadiazine|mesh-list
5505463|NCT04440267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6059361|NCT00634166|Mafenide|mafenide|mesh-list
6059362|NCT00634166|Fluconazole|fluconazole|mesh-list
6059363|NCT00634166|Anti-Infective Agents|anti-infective agents|mesh-list
6059364|NCT00634166|Clotrimazole|clotrimazole|mesh-list
6059365|NCT00634166|Miconazole|miconazole|mesh-list
6059366|NCT00634166|Silver Sulfadiazine|silver sulfadiazine|mesh-list
6059367|NCT00634166|Antifungal Agents|antifungal agents|mesh-list
5505464|NCT04440267|Glucocorticoids|glucocorticoids|mesh-ancestor
5505465|NCT04440267|Hormones|hormones|mesh-ancestor
5505466|NCT04440267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5505467|NCT04440267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5505468|NCT04440267|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5505469|NCT04440267|Abortifacient Agents|abortifacient agents|mesh-ancestor
5505470|NCT04440267|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5505471|NCT04440267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5505472|NCT04440267|Antimetabolites|antimetabolites|mesh-ancestor
5505473|NCT04440267|Dermatologic Agents|dermatologic agents|mesh-ancestor
5505474|NCT04440267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5505475|NCT04440267|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6059368|NCT00634166|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6059369|NCT00634166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6059370|NCT00634166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6059371|NCT00634166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059372|NCT00634166|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6059373|NCT00634166|Hormone Antagonists|hormone antagonists|mesh-ancestor
6059374|NCT00634166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6059375|NCT00634166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505476|NCT04440267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5505477|NCT04440267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5505478|NCT04440267|Tubulin Modulators|tubulin modulators|mesh-ancestor
5505479|NCT04440267|Antimitotic Agents|antimitotic agents|mesh-ancestor
5505480|NCT04440267|Mitosis Modulators|mitosis modulators|mesh-ancestor
5505481|NCT04440267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5505482|NCT04440267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5505483|NCT04440267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5505484|NCT04440436|Cyclophosphamide|cyclophosphamide|mesh-list
5505485|NCT04440436|Fludarabine|fludarabine|mesh-list
5505486|NCT04440436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5505487|NCT04440436|Immunologic Factors|immunologic factors|mesh-ancestor
5505488|NCT04440436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505489|NCT04440436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5505490|NCT04440436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5505491|NCT04440436|Alkylating Agents|alkylating agents|mesh-ancestor
5505492|NCT04440436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505493|NCT04440436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6059376|NCT00634166|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6059377|NCT00634166|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6059378|NCT00634166|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6059379|NCT00634166|Amebicides|amebicides|mesh-ancestor
6059380|NCT00634166|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6059381|NCT00634166|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6059382|NCT00634166|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6059383|NCT00634166|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6059384|NCT00634166|Ionophores|ionophores|mesh-ancestor
6059385|NCT00634166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6059386|NCT00634166|Coccidiostats|coccidiostats|mesh-ancestor
6059387|NCT00634166|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6059388|NCT00634179|Prednisone|prednisone|mesh-list
6059389|NCT00634179|Cyclophosphamide|cyclophosphamide|mesh-list
6059390|NCT00634179|Rituximab|rituximab|mesh-list
6059391|NCT00634179|Doxorubicin|doxorubicin|mesh-list
6059392|NCT00634179|Vincristine|vincristine|mesh-list
6059393|NCT00634179|Bortezomib|bortezomib|mesh-list
6059394|NCT00634179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6059395|NCT00634179|Immunologic Factors|immunologic factors|mesh-ancestor
6059396|NCT00634179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059397|NCT00634179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6059398|NCT00634179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6059399|NCT00634179|Alkylating Agents|alkylating agents|mesh-ancestor
6059400|NCT00634179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059401|NCT00634179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6059402|NCT00634179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6059403|NCT00634179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6059404|NCT00634179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6059405|NCT00634179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6059406|NCT00634179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6059407|NCT00634179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5505494|NCT04440436|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5505495|NCT04440085|Midodrine|midodrine|mesh-list
5505496|NCT04440085|Sympathomimetics|sympathomimetics|mesh-ancestor
5505497|NCT04440085|Autonomic Agents|autonomic agents|mesh-ancestor
5505498|NCT04440085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5505499|NCT04440085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505500|NCT04440085|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5505501|NCT04440085|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5505502|NCT04440085|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5505503|NCT04440085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5505504|NCT04440085|Adrenergic Agents|adrenergic agents|mesh-ancestor
5505505|NCT04440085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5505506|NCT04440085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505507|NCT04439929|Adalimumab|adalimumab|mesh-list
5505508|NCT04439929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5505509|NCT04439929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5505510|NCT04439890|Carboplatin|carboplatin|mesh-list
5505511|NCT04439890|Pemetrexed|pemetrexed|mesh-list
5505512|NCT04439890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5505513|NCT04439890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5505514|NCT04439890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059408|NCT00634179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6059409|NCT00634179|Glucocorticoids|glucocorticoids|mesh-ancestor
6059410|NCT00634179|Hormones|hormones|mesh-ancestor
6059411|NCT00634179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6059412|NCT00634179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6059413|NCT00634179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6059414|NCT00634179|Tubulin Modulators|tubulin modulators|mesh-ancestor
6059415|NCT00634179|Antimitotic Agents|antimitotic agents|mesh-ancestor
6059416|NCT00634179|Mitosis Modulators|mitosis modulators|mesh-ancestor
6059417|NCT00634244|Cytarabine|cytarabine|mesh-list
6059418|NCT00634244|Sirolimus|sirolimus|mesh-list
6059419|NCT00634244|Carboplatin|carboplatin|mesh-list
6059420|NCT00634244|Etoposide|etoposide|mesh-list
6059421|NCT00634244|Etoposide phosphate|etoposide phosphate|mesh-list
6059422|NCT00634244|Topotecan|topotecan|mesh-list
6059423|NCT00634244|Mitoxantrone|mitoxantrone|mesh-list
6059424|NCT00634244|Alvocidib|alvocidib|mesh-list
6059425|NCT00634244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6059426|NCT00634244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6059427|NCT00634244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6059428|NCT00634244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6059429|NCT00634244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6059430|NCT00634244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059431|NCT00634244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6059432|NCT00634244|Antimetabolites|antimetabolites|mesh-ancestor
6059433|NCT00634244|Antiviral Agents|antiviral agents|mesh-ancestor
6059434|NCT00634244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6059435|NCT00634244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6059436|NCT00634244|Immunologic Factors|immunologic factors|mesh-ancestor
6059437|NCT00634244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059438|NCT00634244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6059439|NCT00634244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6059440|NCT00634244|Antifungal Agents|antifungal agents|mesh-ancestor
6059441|NCT00634244|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6462533|NCT00460083|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5505515|NCT04439890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6059442|NCT00634244|Analgesics|analgesics|mesh-ancestor
6059443|NCT00634244|Sensory System Agents|sensory system agents|mesh-ancestor
6059444|NCT00634244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6059445|NCT00634244|Growth Inhibitors|growth inhibitors|mesh-ancestor
6059446|NCT00634244|Growth Substances|growth substances|mesh-ancestor
6059447|NCT00634244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6059448|NCT00634270|Sirolimus|sirolimus|mesh-list
6059449|NCT00634270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6059450|NCT00634270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6059451|NCT00634270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6059452|NCT00634270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6059453|NCT00634270|Antifungal Agents|antifungal agents|mesh-ancestor
6059454|NCT00634270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6059455|NCT00634270|Immunologic Factors|immunologic factors|mesh-ancestor
6059456|NCT00634270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059457|NCT00634283|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6059458|NCT00634283|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6059459|NCT00634283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6059460|NCT00634283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5505516|NCT04439890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5505517|NCT04439786|Lidocaine|lidocaine|mesh-list
5505518|NCT04439786|Anesthetics, Local|anesthetics, local|mesh-ancestor
5505519|NCT04439786|Anesthetics|anesthetics|mesh-ancestor
5505520|NCT04439786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5505521|NCT04439786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505522|NCT04439786|Sensory System Agents|sensory system agents|mesh-ancestor
5505523|NCT04439786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5505524|NCT04439786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5505525|NCT04439786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5505526|NCT04439786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5505527|NCT04439786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5505528|NCT04439786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505529|NCT04439799|Methyltestosterone|methyltestosterone|mesh-list
5505530|NCT04439799|Testosterone|testosterone|mesh-list
5505531|NCT04439799|Testosterone undecanoate|testosterone undecanoate|mesh-list
5505532|NCT04439799|Testosterone enanthate|testosterone enanthate|mesh-list
5505533|NCT04439799|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5505534|NCT04439799|Androgens|androgens|mesh-ancestor
5505535|NCT04439799|Hormones|hormones|mesh-ancestor
5505536|NCT04439799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5505537|NCT04439799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505538|NCT04439799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5505539|NCT04439799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5505540|NCT04439799|Anabolic Agents|anabolic agents|mesh-ancestor
6059461|NCT00634283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059462|NCT00634283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6059463|NCT00634283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059464|NCT00634283|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6059465|NCT00634283|Antidepressive Agents|antidepressive agents|mesh-ancestor
6059466|NCT00634283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6059467|NCT00634504|Leucovorin|leucovorin|mesh-list
6059468|NCT00634504|Methotrexate|methotrexate|mesh-list
6059469|NCT00634504|Levoleucovorin|levoleucovorin|mesh-list
6059470|NCT00634504|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6059471|NCT00634504|Abortifacient Agents|abortifacient agents|mesh-ancestor
6059472|NCT00634504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6059473|NCT00634504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059474|NCT00634504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6059475|NCT00634504|Antimetabolites|antimetabolites|mesh-ancestor
5505541|NCT04439825|Botulinum Toxins|botulinum toxins|mesh-list
5505542|NCT04439825|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5505543|NCT04439825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5505544|NCT04439825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059476|NCT00634504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059477|NCT00634504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6059478|NCT00634504|Dermatologic Agents|dermatologic agents|mesh-ancestor
6059479|NCT00634504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6059480|NCT00634504|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6059481|NCT00634504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6059482|NCT00634504|Immunologic Factors|immunologic factors|mesh-ancestor
6059483|NCT00634504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6059484|NCT00634504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6059485|NCT00634504|Antidotes|antidotes|mesh-ancestor
6059486|NCT00634504|Protective Agents|protective agents|mesh-ancestor
6059487|NCT00634504|Vitamin B Complex|vitamin b complex|mesh-ancestor
6059488|NCT00634504|Vitamins|vitamins|mesh-ancestor
6059489|NCT00634504|Micronutrients|micronutrients|mesh-ancestor
6059490|NCT00634543|Acetaminophen|acetaminophen|mesh-list
6059491|NCT00634543|Gabapentin|gabapentin|mesh-list
6059492|NCT00634543|Tramadol|tramadol|mesh-list
6059493|NCT00634543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6059494|NCT00634543|Analgesics|analgesics|mesh-ancestor
6059495|NCT00634543|Sensory System Agents|sensory system agents|mesh-ancestor
6059496|NCT00634543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6059497|NCT00634543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059498|NCT00634543|Antipyretics|antipyretics|mesh-ancestor
6059499|NCT00634543|Anticonvulsants|anticonvulsants|mesh-ancestor
6059500|NCT00634543|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6059501|NCT00634543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6059502|NCT00634543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6059503|NCT00634543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6059504|NCT00634543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6059505|NCT00634543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6059506|NCT00634543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6059507|NCT00634543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059508|NCT00634543|Antimanic Agents|antimanic agents|mesh-ancestor
6059509|NCT00634543|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6059510|NCT00634543|Narcotics|narcotics|mesh-ancestor
6059511|NCT00634569|gamma-Globulins|gamma-globulins|mesh-list
6059512|NCT00634569|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6059513|NCT00634569|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6059514|NCT00634569|Immunologic Factors|immunologic factors|mesh-ancestor
6059515|NCT00634569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059516|NCT00634647|Prednisone|prednisone|mesh-list
6059517|NCT00634647|Satraplatin|satraplatin|mesh-list
6059518|NCT00634647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6059519|NCT00634647|Glucocorticoids|glucocorticoids|mesh-ancestor
6059520|NCT00634647|Hormones|hormones|mesh-ancestor
6059521|NCT00634647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6059522|NCT00634647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059523|NCT00634647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6059524|NCT00634647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6059525|NCT00634751|Capecitabine|capecitabine|mesh-list
6059526|NCT00634751|Oxaliplatin|oxaliplatin|mesh-list
6059527|NCT00634751|Sorafenib|sorafenib|mesh-list
6059528|NCT00634751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5505545|NCT04439825|Cholinergic Agents|cholinergic agents|mesh-ancestor
6059529|NCT00634751|Antimetabolites|antimetabolites|mesh-ancestor
6059530|NCT00634751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059531|NCT00634751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6059532|NCT00634751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6059533|NCT00634751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6059534|NCT00634803|Buprenorphine|buprenorphine|mesh-list
6059535|NCT00634803|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6059536|NCT00634803|Narcotics|narcotics|mesh-ancestor
6059537|NCT00634803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6059538|NCT00634803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059539|NCT00634803|Analgesics|analgesics|mesh-ancestor
6059540|NCT00634803|Sensory System Agents|sensory system agents|mesh-ancestor
6462534|NCT00460083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6462535|NCT00460083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462536|NCT00460148|Ropinirole|ropinirole|mesh-list
6462537|NCT00460148|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6462538|NCT00460148|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6462539|NCT00460148|Dopamine Agonists|dopamine agonists|mesh-ancestor
6059541|NCT00634803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6059542|NCT00634803|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6059543|NCT00634842|Insulin|insulin|mesh-list
6059544|NCT00634842|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6059545|NCT00634842|Insulin Detemir|insulin detemir|mesh-list
6059546|NCT00634842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6059547|NCT00634842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059548|NCT00634907|Warfarin|warfarin|mesh-list
6059549|NCT00634907|Anticoagulants|anticoagulants|mesh-ancestor
6059550|NCT00634920|Cyclosporine|cyclosporine|mesh-list
6059551|NCT00634920|Mycophenolic Acid|mycophenolic acid|mesh-list
6462540|NCT00460148|Dopamine Agents|dopamine agents|mesh-ancestor
6059552|NCT00634920|Prednisolone|prednisolone|mesh-list
6059553|NCT00634920|Everolimus|everolimus|mesh-list
6059554|NCT00634920|Cyclosporins|cyclosporins|mesh-list
6059555|NCT00634920|Basiliximab|basiliximab|mesh-list
6059556|NCT00634920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6059557|NCT00634920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059558|NCT00634920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6059559|NCT00634920|Immunologic Factors|immunologic factors|mesh-ancestor
6059560|NCT00634920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059561|NCT00634920|Antifungal Agents|antifungal agents|mesh-ancestor
6059562|NCT00634920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6059563|NCT00634920|Dermatologic Agents|dermatologic agents|mesh-ancestor
6059564|NCT00634920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6059565|NCT00634920|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6059566|NCT00634920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6059567|NCT00634920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6059568|NCT00634920|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6059569|NCT00634920|Antitubercular Agents|antitubercular agents|mesh-ancestor
6059570|NCT00634920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6059571|NCT00634920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6059572|NCT00634920|Glucocorticoids|glucocorticoids|mesh-ancestor
6059573|NCT00634920|Hormones|hormones|mesh-ancestor
6059574|NCT00634920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6059575|NCT00634920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6059576|NCT00634933|Prednisone|prednisone|mesh-list
6059577|NCT00634933|Methylprednisolone|methylprednisolone|mesh-list
6059578|NCT00634933|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6059579|NCT00634933|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6462541|NCT00460148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6462542|NCT00460148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462543|NCT00460148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462544|NCT00460174|Gemcitabine|gemcitabine|mesh-list
6462545|NCT00460174|Bevacizumab|bevacizumab|mesh-list
5505546|NCT04439825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6462546|NCT00460174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6462547|NCT00460174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6462548|NCT00460174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6462549|NCT00460174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6462550|NCT00460174|Growth Substances|growth substances|mesh-ancestor
5505547|NCT04439825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505548|NCT04439773|Lidocaine|lidocaine|mesh-list
5505549|NCT04439773|Anesthetics, Local|anesthetics, local|mesh-ancestor
5505550|NCT04439773|Anesthetics|anesthetics|mesh-ancestor
5505551|NCT04439773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5505552|NCT04439773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505553|NCT04439773|Sensory System Agents|sensory system agents|mesh-ancestor
5505554|NCT04439773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5505555|NCT04439773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5505556|NCT04439773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5505557|NCT04439773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5505558|NCT04439773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6059580|NCT00634933|Prednisolone|prednisolone|mesh-list
6059581|NCT00634933|Prednisolone acetate|prednisolone acetate|mesh-list
6059582|NCT00634933|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6059583|NCT00634933|Prednisolone phosphate|prednisolone phosphate|mesh-list
6059584|NCT00634933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6059585|NCT00634933|Glucocorticoids|glucocorticoids|mesh-ancestor
6059586|NCT00634933|Hormones|hormones|mesh-ancestor
6202108|NCT02036515|Glimepiride|glimepiride|mesh-list
5505559|NCT04439773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505560|NCT04439474|Vitamin D|vitamin d|mesh-list
5505561|NCT04439474|Cholecalciferol|cholecalciferol|mesh-list
5505562|NCT04439474|Vitamins|vitamins|mesh-ancestor
5505563|NCT04439474|Micronutrients|micronutrients|mesh-ancestor
5505564|NCT04439474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505565|NCT04439474|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5505566|NCT04439474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5505567|NCT04439305|Dasatinib|dasatinib|mesh-list
5505568|NCT04439305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5505569|NCT04439305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5505570|NCT04439305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6462551|NCT00460174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462552|NCT00460174|Growth Inhibitors|growth inhibitors|mesh-ancestor
6462553|NCT00460174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6462554|NCT00460174|Antimetabolites|antimetabolites|mesh-ancestor
6462555|NCT00460174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462556|NCT00460174|Antiviral Agents|antiviral agents|mesh-ancestor
6462557|NCT00460174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6462558|NCT00460174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6462559|NCT00460174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6462560|NCT00460174|Immunologic Factors|immunologic factors|mesh-ancestor
6462561|NCT00460213|Valsartan|valsartan|mesh-list
5505571|NCT04439305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059587|NCT00634933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6462562|NCT00460213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6462563|NCT00460213|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6462564|NCT00460213|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6462565|NCT00460213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462566|NCT00460226|Lamotrigine|lamotrigine|mesh-list
6462567|NCT00460226|Anticonvulsants|anticonvulsants|mesh-ancestor
6462568|NCT00460226|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6462569|NCT00460226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6462570|NCT00460226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462571|NCT00460226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6462572|NCT00460226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462573|NCT00460226|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6462574|NCT00460226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6462575|NCT00460226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6059588|NCT00634933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059589|NCT00634933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6059590|NCT00634933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6059591|NCT00634933|Antiemetics|antiemetics|mesh-ancestor
6059592|NCT00634933|Autonomic Agents|autonomic agents|mesh-ancestor
6059593|NCT00634933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6059594|NCT00634933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6059595|NCT00634933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6059596|NCT00634933|Protective Agents|protective agents|mesh-ancestor
6059597|NCT00635024|Melphalan|melphalan|mesh-list
6059598|NCT00635024|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6059599|NCT00635024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6059600|NCT00635024|Alkylating Agents|alkylating agents|mesh-ancestor
6202109|NCT02036515|Ertugliflozin|ertugliflozin|mesh-list
6462576|NCT00460226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6462577|NCT00460226|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6059601|NCT00635024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059602|NCT00635024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6059603|NCT00635024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6059604|NCT00635024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6059605|NCT00635024|Immunologic Factors|immunologic factors|mesh-ancestor
6059606|NCT00635024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059607|NCT00635050|Paclitaxel|paclitaxel|mesh-list
6059608|NCT00635050|Cyclophosphamide|cyclophosphamide|mesh-list
6059609|NCT00635050|Bevacizumab|bevacizumab|mesh-list
6059610|NCT00635050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6059611|NCT00635050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6059612|NCT00635050|Tubulin Modulators|tubulin modulators|mesh-ancestor
6059613|NCT00635050|Antimitotic Agents|antimitotic agents|mesh-ancestor
6059614|NCT00635050|Mitosis Modulators|mitosis modulators|mesh-ancestor
6059615|NCT00635050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059616|NCT00635050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6059617|NCT00635050|Immunologic Factors|immunologic factors|mesh-ancestor
6059618|NCT00635050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059619|NCT00635050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6059620|NCT00635050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6059621|NCT00635050|Alkylating Agents|alkylating agents|mesh-ancestor
6665220|NCT01516255|Incretins|incretins|mesh-ancestor
6665221|NCT01516255|Hormones|hormones|mesh-ancestor
6665222|NCT01516255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6665223|NCT01516346|Hydralazine|hydralazine|mesh-list
6665224|NCT01516346|Isosorbide|isosorbide|mesh-list
6665225|NCT01516346|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
6665226|NCT01516346|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
6665227|NCT01516346|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6665228|NCT01516346|Diuretics|diuretics|mesh-ancestor
6665229|NCT01516346|Natriuretic Agents|natriuretic agents|mesh-ancestor
6059622|NCT00635050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6059623|NCT00635050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6059624|NCT00635050|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6059625|NCT00635050|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6059626|NCT00635050|Growth Substances|growth substances|mesh-ancestor
6059627|NCT00635050|Growth Inhibitors|growth inhibitors|mesh-ancestor
5505572|NCT04439487|Anesthetics|anesthetics|mesh-list
5505573|NCT04439487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5505574|NCT04439487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505575|NCT04439396|Ketorolac|ketorolac|mesh-list
5505576|NCT04439396|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
5505577|NCT04439396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5505578|NCT04439396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5505579|NCT04439396|Analgesics|analgesics|mesh-ancestor
5505580|NCT04439396|Sensory System Agents|sensory system agents|mesh-ancestor
5505581|NCT04439396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5505582|NCT04439396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505583|NCT04439396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5505584|NCT04439396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5505585|NCT04439396|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5505586|NCT04439396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5505587|NCT04439396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505588|NCT04439357|Trametinib|trametinib|mesh-list
5505589|NCT04439357|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
5505590|NCT04439357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5505591|NCT04439357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5505592|NCT04439357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5505593|NCT04439357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505594|NCT04439357|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
5505595|NCT04439357|Protective Agents|protective agents|mesh-ancestor
5505596|NCT04439357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505597|NCT04439357|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5505598|NCT04439357|Antioxidants|antioxidants|mesh-ancestor
5600103|NCT03714620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5600104|NCT03714620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5600105|NCT03714620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600106|NCT03714594|Dapagliflozin|dapagliflozin|mesh-list
5600107|NCT03714594|Saxagliptin|saxagliptin|mesh-list
5600108|NCT03714594|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5600109|NCT03714594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059628|NCT00635089|Reslizumab|reslizumab|mesh-list
6059629|NCT00635089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6665230|NCT01516346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059630|NCT00635089|Respiratory System Agents|respiratory system agents|mesh-ancestor
6059631|NCT00635102|Cycloserine|cycloserine|mesh-list
6059632|NCT00635102|Glycine|glycine|mesh-list
6059633|NCT00635102|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6059634|NCT00635102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6059635|NCT00635102|Renal Agents|renal agents|mesh-ancestor
6059636|NCT00635102|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6059637|NCT00635102|Antitubercular Agents|antitubercular agents|mesh-ancestor
6059638|NCT00635102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6059639|NCT00635102|Antimetabolites|antimetabolites|mesh-ancestor
6059640|NCT00635102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059641|NCT00635102|Glycine Agents|glycine agents|mesh-ancestor
6059642|NCT00635102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6059643|NCT00635102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059644|NCT00635154|Dexamethasone|dexamethasone|mesh-list
6059645|NCT00635154|Dexamethasone acetate|dexamethasone acetate|mesh-list
6059646|NCT00635154|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6059647|NCT00635154|BB 1101|bb 1101|mesh-list
6059648|NCT00635154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6059649|NCT00635154|Antiemetics|antiemetics|mesh-ancestor
6059650|NCT00635154|Autonomic Agents|autonomic agents|mesh-ancestor
6059651|NCT00635154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6059652|NCT00635154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059653|NCT00635154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6059654|NCT00635154|Glucocorticoids|glucocorticoids|mesh-ancestor
6059655|NCT00635154|Hormones|hormones|mesh-ancestor
6059656|NCT00635154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6059657|NCT00635154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6059658|NCT00635154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6059659|NCT00635154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5505599|NCT04438980|Methylprednisolone|methylprednisolone|mesh-list
5505600|NCT04438980|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5505601|NCT04438980|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5505602|NCT04438980|Prednisolone|prednisolone|mesh-list
5505603|NCT04438980|Prednisolone acetate|prednisolone acetate|mesh-list
6059660|NCT00635154|Protease Inhibitors|protease inhibitors|mesh-ancestor
6059661|NCT00635154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6059662|NCT00635154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059663|NCT00635219|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6059664|NCT00635219|Vortioxetine|vortioxetine|mesh-list
6059665|NCT00635219|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6059666|NCT00635219|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6059667|NCT00635219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6059668|NCT00635219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059669|NCT00635219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6059670|NCT00635219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059671|NCT00635219|Analgesics|analgesics|mesh-ancestor
6059672|NCT00635219|Sensory System Agents|sensory system agents|mesh-ancestor
6059673|NCT00635219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6059674|NCT00635219|Antidepressive Agents|antidepressive agents|mesh-ancestor
6059675|NCT00635219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6059676|NCT00635219|Dopamine Agents|dopamine agents|mesh-ancestor
6059677|NCT00635219|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6059678|NCT00635219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6059679|NCT00635219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6059680|NCT00635219|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6059681|NCT00635219|Serotonin Agents|serotonin agents|mesh-ancestor
6059682|NCT00635219|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6059683|NCT00635219|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6059684|NCT00635219|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6059685|NCT00635219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6059686|NCT00635232|Irbesartan|irbesartan|mesh-list
6059687|NCT00635232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6059688|NCT00635232|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6059689|NCT00635232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6059690|NCT00635232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059691|NCT00635349|Acetaminophen|acetaminophen|mesh-list
6059692|NCT00635349|Meloxicam|meloxicam|mesh-list
6059693|NCT00635349|Aceclofenac|aceclofenac|mesh-list
6059694|NCT00635349|Tramadol|tramadol|mesh-list
6059695|NCT00635349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6059696|NCT00635349|Analgesics|analgesics|mesh-ancestor
6059697|NCT00635349|Sensory System Agents|sensory system agents|mesh-ancestor
6202110|NCT02036515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5505604|NCT04438980|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6059698|NCT00635349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6059699|NCT00635349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059700|NCT00635349|Antipyretics|antipyretics|mesh-ancestor
6059701|NCT00635349|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6059702|NCT00635349|Narcotics|narcotics|mesh-ancestor
6059703|NCT00635349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6059704|NCT00635349|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6059705|NCT00635349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6059706|NCT00635349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6059707|NCT00635349|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6059708|NCT00635349|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6059709|NCT00635349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6059710|NCT00635349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059711|NCT00635362|Levonorgestrel|levonorgestrel|mesh-list
6059712|NCT00635362|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6059713|NCT00635362|Contraceptive Agents|contraceptive agents|mesh-ancestor
6059714|NCT00635362|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6059715|NCT00635362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059716|NCT00635362|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6059717|NCT00635362|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6059718|NCT00635362|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6059719|NCT00635492|Insulin|insulin|mesh-list
6059720|NCT00635492|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6059721|NCT00635492|Exenatide|exenatide|mesh-list
6059722|NCT00635492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6059723|NCT00635492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059724|NCT00635492|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6059725|NCT00635492|Incretins|incretins|mesh-ancestor
6059726|NCT00635492|Hormones|hormones|mesh-ancestor
5505605|NCT04438980|Prednisolone phosphate|prednisolone phosphate|mesh-list
5505606|NCT04438980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5505607|NCT04438980|Antiemetics|antiemetics|mesh-ancestor
5505608|NCT04438980|Autonomic Agents|autonomic agents|mesh-ancestor
5505609|NCT04438980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5505610|NCT04438980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505611|NCT04438980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5505612|NCT04438980|Glucocorticoids|glucocorticoids|mesh-ancestor
5505613|NCT04438980|Hormones|hormones|mesh-ancestor
5505614|NCT04438980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5505615|NCT04438980|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5505616|NCT04438980|Protective Agents|protective agents|mesh-ancestor
5505617|NCT04438980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5505618|NCT04438980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6059727|NCT00635492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6059728|NCT00635570|Moxifloxacin|moxifloxacin|mesh-list
6059729|NCT00635570|NuvaRing|nuvaring|mesh-list
6059730|NCT00635570|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6059731|NCT00635570|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6059732|NCT00635570|Contraceptive Agents|contraceptive agents|mesh-ancestor
6059733|NCT00635570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6059734|NCT00635570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059735|NCT00635570|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6059736|NCT00635570|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6059737|NCT00635570|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6059738|NCT00635570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6059739|NCT00635570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6059740|NCT00635570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6059741|NCT00635570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6059742|NCT00635570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6059743|NCT00635570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059744|NCT00635570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6059745|NCT00635609|Doxycycline|doxycycline|mesh-list
6059746|NCT00635609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6059747|NCT00635609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6059748|NCT00635609|Antimalarials|antimalarials|mesh-ancestor
5505619|NCT04438655|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5505620|NCT04438655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5505621|NCT04438837|Hydroxychloroquine|hydroxychloroquine|mesh-list
6059749|NCT00635609|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6059750|NCT00635609|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6059751|NCT00635648|Caspofungin|caspofungin|mesh-list
6059752|NCT00635648|Antifungal Agents|antifungal agents|mesh-ancestor
6059753|NCT00635648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6059754|NCT00635648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6462578|NCT00460252|Insulin|insulin|mesh-list
5505622|NCT04438837|Antimalarials|antimalarials|mesh-ancestor
5505623|NCT04438837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5505624|NCT04438837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6059755|NCT00635648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059756|NCT00635700|Ziprasidone|ziprasidone|mesh-list
6059757|NCT00635700|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6059758|NCT00635700|Serotonin Agents|serotonin agents|mesh-ancestor
6059759|NCT00635700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6059760|NCT00635700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059761|NCT00635700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059762|NCT00635700|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6059763|NCT00635700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6059764|NCT00635700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6059765|NCT00635700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6059766|NCT00635700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6059767|NCT00635700|Dopamine Agents|dopamine agents|mesh-ancestor
6059768|NCT00635817|Leuprolide|leuprolide|mesh-list
6059769|NCT00635817|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6059770|NCT00635817|Fertility Agents|fertility agents|mesh-ancestor
6462579|NCT00460252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6462580|NCT00460252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462581|NCT00460304|Pramlintide|pramlintide|mesh-list
6462582|NCT00460304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6462583|NCT00460304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059771|NCT00635817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6059772|NCT00635817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059773|NCT00635817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6059774|NCT00635817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6059775|NCT00636155|Cyclophosphamide|cyclophosphamide|mesh-list
6059776|NCT00636155|Rituximab|rituximab|mesh-list
6059777|NCT00636155|Fludarabine|fludarabine|mesh-list
6059778|NCT00636155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6059779|NCT00636155|Immunologic Factors|immunologic factors|mesh-ancestor
6059780|NCT00636155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059781|NCT00636155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6059782|NCT00636155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6059783|NCT00636155|Alkylating Agents|alkylating agents|mesh-ancestor
6059784|NCT00636155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059785|NCT00636155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6059786|NCT00636155|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6059787|NCT00636155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6059788|NCT00636168|Ipilimumab|ipilimumab|mesh-list
6059789|NCT00636168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6059790|NCT00636168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6059791|NCT00636168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6059792|NCT00636168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059793|NCT00636194|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6059794|NCT00636207|Montelukast|montelukast|mesh-list
6059795|NCT00636207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6059796|NCT00636207|Respiratory System Agents|respiratory system agents|mesh-ancestor
6059797|NCT00636207|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6059798|NCT00636207|Hormone Antagonists|hormone antagonists|mesh-ancestor
6059799|NCT00636207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6059800|NCT00636207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059801|NCT00636207|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6059802|NCT00636207|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6059803|NCT00636207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059804|NCT00636363|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6059805|NCT00636441|Cyclophosphamide|cyclophosphamide|mesh-list
6059806|NCT00636441|Docetaxel|docetaxel|mesh-list
6059807|NCT00636441|Doxorubicin|doxorubicin|mesh-list
6059808|NCT00636441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6059809|NCT00636441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6059810|NCT00636441|Immunologic Factors|immunologic factors|mesh-ancestor
6059811|NCT00636441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059812|NCT00636441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6059813|NCT00636441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6059814|NCT00636441|Alkylating Agents|alkylating agents|mesh-ancestor
6059815|NCT00636441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059816|NCT00636441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6059817|NCT00636441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6059818|NCT00636441|Tubulin Modulators|tubulin modulators|mesh-ancestor
6462584|NCT00460369|Artesunate|artesunate|mesh-list
5505625|NCT04438837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6059819|NCT00636441|Antimitotic Agents|antimitotic agents|mesh-ancestor
6059820|NCT00636441|Mitosis Modulators|mitosis modulators|mesh-ancestor
6059821|NCT00636441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6059822|NCT00636441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6059823|NCT00636441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6059824|NCT00636441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6059825|NCT00636610|Bevacizumab|bevacizumab|mesh-list
6059826|NCT00636610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6059827|NCT00636610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6059828|NCT00636610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6059829|NCT00636610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6059830|NCT00636610|Growth Substances|growth substances|mesh-ancestor
6059831|NCT00636610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059832|NCT00636610|Growth Inhibitors|growth inhibitors|mesh-ancestor
6059833|NCT00636636|Gabapentin|gabapentin|mesh-list
5505626|NCT04438837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5505627|NCT04438837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505628|NCT04438837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5505629|NCT04438902|Osimertinib|osimertinib|mesh-list
5505630|NCT04438902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5505631|NCT04438902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5505632|NCT04438902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5505633|NCT04438902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505634|NCT04438733|Anastrozole|anastrozole|mesh-list
5505635|NCT04438733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5505636|NCT04438733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5505637|NCT04438733|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5505638|NCT04438733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5505639|NCT04438733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5505640|NCT04438733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505641|NCT04438733|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5505642|NCT04438733|Hormone Antagonists|hormone antagonists|mesh-ancestor
5505643|NCT04438733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5505644|NCT04438733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505645|NCT04438811|Anesthetics|anesthetics|mesh-list
5505646|NCT04438811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5505647|NCT04438811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505648|NCT04438850|Ivermectin|ivermectin|mesh-list
5505649|NCT04438850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5505650|NCT04438850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5505651|NCT04438928|Micronutrients|micronutrients|mesh-list
5505652|NCT04438928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505653|NCT04438720|Nifedipine|nifedipine|mesh-list
5505654|NCT04438720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5505655|NCT04438720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5505656|NCT04438720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505657|NCT04438720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5505658|NCT04438720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505659|NCT04438720|Vasodilator Agents|vasodilator agents|mesh-ancestor
5505660|NCT04438720|Tocolytic Agents|tocolytic agents|mesh-ancestor
5505661|NCT04438720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5505662|NCT04438772|Anesthetics|anesthetics|mesh-list
5505663|NCT04438772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5505664|NCT04438772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505665|NCT04438330|Nickel|nickel|mesh-list
5505666|NCT04438330|Trace Elements|trace elements|mesh-ancestor
5505667|NCT04438330|Micronutrients|micronutrients|mesh-ancestor
5505668|NCT04438330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059834|NCT00636636|Analgesics|analgesics|mesh-ancestor
6059835|NCT00636636|Sensory System Agents|sensory system agents|mesh-ancestor
6059836|NCT00636636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6059837|NCT00636636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059838|NCT00636636|Anticonvulsants|anticonvulsants|mesh-ancestor
6059839|NCT00636636|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6059840|NCT00636636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6059841|NCT00636636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6059842|NCT00636636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6059843|NCT00636636|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6059844|NCT00636636|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6059845|NCT00636636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6059846|NCT00636636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059847|NCT00636636|Antimanic Agents|antimanic agents|mesh-ancestor
5505669|NCT04438213|Ertugliflozin|ertugliflozin|mesh-list
5505670|NCT04438213|Metolazone|metolazone|mesh-list
6059848|NCT00636649|Citalopram|citalopram|mesh-list
6059849|NCT00636649|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6059850|NCT00636649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6059851|NCT00636649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6059852|NCT00636649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059853|NCT00636649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6059854|NCT00636649|Serotonin Agents|serotonin agents|mesh-ancestor
6059855|NCT00636649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059856|NCT00636649|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6059857|NCT00636649|Antidepressive Agents|antidepressive agents|mesh-ancestor
5505671|NCT04438213|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5505672|NCT04438213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505673|NCT04438213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5505674|NCT04438213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505675|NCT04438213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5505676|NCT04438213|Diuretics|diuretics|mesh-ancestor
5505677|NCT04438213|Natriuretic Agents|natriuretic agents|mesh-ancestor
5505678|NCT04438213|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5505679|NCT04438213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5505680|NCT04438265|Levobupivacaine|levobupivacaine|mesh-list
5505681|NCT04438265|Anesthetics, Local|anesthetics, local|mesh-ancestor
5505682|NCT04438265|Anesthetics|anesthetics|mesh-ancestor
6059858|NCT00636649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6059859|NCT00636792|Rituximab|rituximab|mesh-list
6059860|NCT00636792|Bortezomib|bortezomib|mesh-list
6059861|NCT00636792|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6059862|NCT00636792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6059863|NCT00636792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6059864|NCT00636792|Immunologic Factors|immunologic factors|mesh-ancestor
6059865|NCT00636792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059866|NCT00636792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6059867|NCT00636792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6059868|NCT00636792|Alkylating Agents|alkylating agents|mesh-ancestor
6059869|NCT00636792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059870|NCT00636805|Dexamethasone|dexamethasone|mesh-list
6059871|NCT00636805|Palonosetron|palonosetron|mesh-list
6059872|NCT00636805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6059873|NCT00636805|Antiemetics|antiemetics|mesh-ancestor
6059874|NCT00636805|Autonomic Agents|autonomic agents|mesh-ancestor
6059875|NCT00636805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6059876|NCT00636805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059877|NCT00636805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6059878|NCT00636805|Glucocorticoids|glucocorticoids|mesh-ancestor
6059879|NCT00636805|Hormones|hormones|mesh-ancestor
6059880|NCT00636805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6059881|NCT00636805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6059882|NCT00636805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6059883|NCT00636805|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6059884|NCT00636805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6059885|NCT00636805|Serotonin Agents|serotonin agents|mesh-ancestor
6059886|NCT00636805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6059887|NCT00636805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059888|NCT00636818|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6059889|NCT00636818|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6059890|NCT00636818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6059891|NCT00636818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6059892|NCT00636818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505683|NCT04438265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6059893|NCT00636818|Adrenergic Agents|adrenergic agents|mesh-ancestor
6059894|NCT00636818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6059895|NCT00636818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059896|NCT00637000|Buprenorphine|buprenorphine|mesh-list
6059897|NCT00637000|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6059898|NCT00637000|Naloxone|naloxone|mesh-list
6059899|NCT00637000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6059900|NCT00637000|Narcotics|narcotics|mesh-ancestor
6059901|NCT00637000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6059902|NCT00637000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059903|NCT00637000|Analgesics|analgesics|mesh-ancestor
6059904|NCT00637000|Sensory System Agents|sensory system agents|mesh-ancestor
6059905|NCT00637000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6059906|NCT00637000|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6059907|NCT00637195|Vaccines|vaccines|mesh-list
6059908|NCT00637195|Immunologic Factors|immunologic factors|mesh-ancestor
6059909|NCT00637195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059910|NCT00637247|Gemcitabine|gemcitabine|mesh-list
6059911|NCT00637247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6059912|NCT00637247|Antimetabolites|antimetabolites|mesh-ancestor
6059913|NCT00637247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059914|NCT00637247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6059915|NCT00637247|Antiviral Agents|antiviral agents|mesh-ancestor
6059916|NCT00637247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6059917|NCT00637247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6059918|NCT00637247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6059919|NCT00637247|Immunologic Factors|immunologic factors|mesh-ancestor
6059920|NCT00637247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059921|NCT00637273|Pioglitazone|pioglitazone|mesh-list
6462585|NCT00460369|Lumefantrine|lumefantrine|mesh-list
6462586|NCT00460369|Artemether|artemether|mesh-list
6462587|NCT00460369|Pyrimethamine|pyrimethamine|mesh-list
6462588|NCT00460369|Sulfadoxine|sulfadoxine|mesh-list
6462589|NCT00460369|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6462590|NCT00460369|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6462591|NCT00460369|Amodiaquine|amodiaquine|mesh-list
6462592|NCT00460369|Antimalarials|antimalarials|mesh-ancestor
6462593|NCT00460369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6462594|NCT00460369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6462595|NCT00460369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6462596|NCT00460369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6462597|NCT00460369|Antiviral Agents|antiviral agents|mesh-ancestor
6462598|NCT00460369|Schistosomicides|schistosomicides|mesh-ancestor
6462599|NCT00460369|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6462600|NCT00460369|Anthelmintics|anthelmintics|mesh-ancestor
6059922|NCT00637273|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6059923|NCT00637273|Exenatide|exenatide|mesh-list
6059924|NCT00637273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6059925|NCT00637273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059926|NCT00637273|Incretins|incretins|mesh-ancestor
6059927|NCT00637273|Hormones|hormones|mesh-ancestor
6059928|NCT00637273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6059929|NCT00637273|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6059930|NCT00637273|Protease Inhibitors|protease inhibitors|mesh-ancestor
6059931|NCT00637273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6059932|NCT00637273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059933|NCT00637273|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6059934|NCT00637377|Ranibizumab|ranibizumab|mesh-list
6059935|NCT00637377|Aflibercept|aflibercept|mesh-list
5505684|NCT04438265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505685|NCT04438265|Sensory System Agents|sensory system agents|mesh-ancestor
5600110|NCT03714594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6059936|NCT00637377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6059937|NCT00637377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6059938|NCT00637377|Growth Substances|growth substances|mesh-ancestor
6059939|NCT00637377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059940|NCT00637377|Growth Inhibitors|growth inhibitors|mesh-ancestor
6059941|NCT00637377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6059942|NCT00637494|Mifepristone|mifepristone|mesh-list
6059943|NCT00637494|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6059944|NCT00637494|Abortifacient Agents|abortifacient agents|mesh-ancestor
6059945|NCT00637494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6059946|NCT00637494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059947|NCT00637494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6059948|NCT00637494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6059949|NCT00637494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6059950|NCT00637494|Contraceptive Agents|contraceptive agents|mesh-ancestor
6059951|NCT00637494|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6059952|NCT00637494|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6059953|NCT00637494|Hormone Antagonists|hormone antagonists|mesh-ancestor
6462601|NCT00460369|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6462602|NCT00460369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6665231|NCT01516346|Vasodilator Agents|vasodilator agents|mesh-ancestor
6059954|NCT00637494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6059955|NCT00637494|Luteolytic Agents|luteolytic agents|mesh-ancestor
6059956|NCT00637494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6059957|NCT00637494|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6059958|NCT00637572|Megestrol|megestrol|mesh-list
6462603|NCT00460369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462604|NCT00460369|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6462605|NCT00460369|Renal Agents|renal agents|mesh-ancestor
6462606|NCT00460382|Ritonavir|ritonavir|mesh-list
6462607|NCT00460382|Darunavir|darunavir|mesh-list
6462608|NCT00460382|Raltegravir Potassium|raltegravir potassium|mesh-list
6462609|NCT00460382|Enfuvirtide|enfuvirtide|mesh-list
6462610|NCT00460382|Etravirine|etravirine|mesh-list
6462611|NCT00460382|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6462612|NCT00460382|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6059959|NCT00637572|Megestrol Acetate|megestrol acetate|mesh-list
6059960|NCT00637572|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6059961|NCT00637572|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6059962|NCT00637572|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6059963|NCT00637572|Contraceptive Agents|contraceptive agents|mesh-ancestor
6059964|NCT00637572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6059965|NCT00637572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059966|NCT00637572|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6059967|NCT00637572|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6059968|NCT00637572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6059969|NCT00637572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6059970|NCT00637572|Appetite Stimulants|appetite stimulants|mesh-ancestor
6059971|NCT00637572|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6059972|NCT00637780|Sulfasalazine|sulfasalazine|mesh-list
5505686|NCT04438265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5505687|NCT04438421|Chlorhexidine|chlorhexidine|mesh-list
5505688|NCT04438421|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5505689|NCT04438421|Hydrogen Peroxide|hydrogen peroxide|mesh-list
5505690|NCT04438421|Hyaluronic Acid|hyaluronic acid|mesh-list
5505691|NCT04438421|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5505692|NCT04438421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5505693|NCT04438421|Disinfectants|disinfectants|mesh-ancestor
5505694|NCT04438421|Dermatologic Agents|dermatologic agents|mesh-ancestor
6059973|NCT00637780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6059974|NCT00637780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6059975|NCT00637780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6059976|NCT00637780|Analgesics|analgesics|mesh-ancestor
6059977|NCT00637780|Sensory System Agents|sensory system agents|mesh-ancestor
6059978|NCT00637780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6059979|NCT00637780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059980|NCT00637780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6059981|NCT00637780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6059982|NCT00637780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6059983|NCT00637923|Ribavirin|ribavirin|mesh-list
6059984|NCT00637923|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6059985|NCT00637923|Nitazoxanide|nitazoxanide|mesh-list
6059986|NCT00637923|Antimetabolites|antimetabolites|mesh-ancestor
6462613|NCT00460382|Protease Inhibitors|protease inhibitors|mesh-ancestor
6462614|NCT00460382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6462615|NCT00460382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462616|NCT00460382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6462617|NCT00460382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6462618|NCT00460382|Antiviral Agents|antiviral agents|mesh-ancestor
6462619|NCT00460382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6462620|NCT00460382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6462621|NCT00460382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6462622|NCT00460382|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6462623|NCT00460382|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6462624|NCT00460382|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6462625|NCT00460382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6462626|NCT00460382|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6462627|NCT00460382|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6462628|NCT00460447|Gemtuzumab|gemtuzumab|mesh-list
6462629|NCT00460447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6462630|NCT00460447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6462631|NCT00460473|Dexmedetomidine|dexmedetomidine|mesh-list
6462632|NCT00460473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6462633|NCT00460473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5505695|NCT04438421|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5505696|NCT04438421|Immunologic Factors|immunologic factors|mesh-ancestor
6462634|NCT00460473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462635|NCT00460473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6462636|NCT00460473|Analgesics|analgesics|mesh-ancestor
6462637|NCT00460473|Sensory System Agents|sensory system agents|mesh-ancestor
6462638|NCT00460473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6462639|NCT00460473|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6462640|NCT00460473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6462641|NCT00460473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6462642|NCT00460473|Adrenergic Agents|adrenergic agents|mesh-ancestor
6462643|NCT00460473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6462644|NCT00460473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505697|NCT04438421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505698|NCT04438421|Viscosupplements|viscosupplements|mesh-ancestor
5505699|NCT04438421|Protective Agents|protective agents|mesh-ancestor
5505700|NCT04438577|Lidocaine|lidocaine|mesh-list
5505701|NCT04438577|Anesthetics, Local|anesthetics, local|mesh-ancestor
5505702|NCT04438577|Anesthetics|anesthetics|mesh-ancestor
5505703|NCT04438577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5505704|NCT04438577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505705|NCT04438577|Sensory System Agents|sensory system agents|mesh-ancestor
5505706|NCT04438577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5505707|NCT04438577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5505708|NCT04438577|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5505709|NCT04438577|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6462645|NCT00460486|Formaldehyde|formaldehyde|mesh-list
6462646|NCT00460486|Disinfectants|disinfectants|mesh-ancestor
6462647|NCT00460486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6462648|NCT00460499|Insulin|insulin|mesh-list
6462649|NCT00460499|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6462650|NCT00460499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059987|NCT00637923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059988|NCT00637923|Antiviral Agents|antiviral agents|mesh-ancestor
6059989|NCT00637923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6059990|NCT00637923|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6059991|NCT00638027|Memantine|memantine|mesh-list
6059992|NCT00638027|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6059993|NCT00638027|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6059994|NCT00638027|Dopamine Agents|dopamine agents|mesh-ancestor
6059995|NCT00638027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6059996|NCT00638027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6059997|NCT00638027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6059998|NCT00638027|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6059999|NCT00638027|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6060000|NCT00638157|Gentamicins|gentamicins|mesh-list
6060001|NCT00638157|Daptomycin|daptomycin|mesh-list
6060002|NCT00638157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5505710|NCT04438577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5505711|NCT04438577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505712|NCT04438187|Anti-Infective Agents|anti-infective agents|mesh-list
5505713|NCT04438187|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5505714|NCT04438434|Chlorhexidine|chlorhexidine|mesh-list
5505715|NCT04438434|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5505716|NCT04438434|Hydrogen Peroxide|hydrogen peroxide|mesh-list
5505717|NCT04438434|Hyaluronic Acid|hyaluronic acid|mesh-list
5505718|NCT04438434|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5505719|NCT04438434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5505720|NCT04438434|Disinfectants|disinfectants|mesh-ancestor
5505721|NCT04438434|Dermatologic Agents|dermatologic agents|mesh-ancestor
5505722|NCT04438434|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5505723|NCT04438434|Immunologic Factors|immunologic factors|mesh-ancestor
5505724|NCT04438434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505725|NCT04438434|Viscosupplements|viscosupplements|mesh-ancestor
5505726|NCT04438434|Protective Agents|protective agents|mesh-ancestor
6060003|NCT00638157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6060004|NCT00638157|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6060005|NCT00638157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6060006|NCT00638157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202111|NCT02036515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202112|NCT02036515|Incretins|incretins|mesh-ancestor
6202113|NCT02036515|Hormones|hormones|mesh-ancestor
6202114|NCT02036515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6202115|NCT02036515|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6462651|NCT00460512|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6462652|NCT00460512|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5505727|NCT04437836|Rifampin|rifampin|mesh-list
6060007|NCT00638443|Diphenhydramine|diphenhydramine|mesh-list
6060008|NCT00638443|Promethazine|promethazine|mesh-list
6060009|NCT00638443|Pregabalin|pregabalin|mesh-list
6060010|NCT00638443|Analgesics|analgesics|mesh-ancestor
6060011|NCT00638443|Sensory System Agents|sensory system agents|mesh-ancestor
6060012|NCT00638443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6060013|NCT00638443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060014|NCT00638443|Anticonvulsants|anticonvulsants|mesh-ancestor
6060015|NCT00638443|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6060016|NCT00638443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6060017|NCT00638443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060018|NCT00638443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6060019|NCT00638443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5505728|NCT04437836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5505729|NCT04437836|Antitubercular Agents|antitubercular agents|mesh-ancestor
5505730|NCT04437836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5505731|NCT04437836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5505732|NCT04437836|Leprostatic Agents|leprostatic agents|mesh-ancestor
5505733|NCT04437836|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5505734|NCT04437836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5505735|NCT04437836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505736|NCT04437836|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5505737|NCT04437836|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5505738|NCT04437836|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5505739|NCT04437836|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5505740|NCT04437836|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5505741|NCT04437836|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5505742|NCT04437758|Ascorbic Acid|ascorbic acid|mesh-list
5505743|NCT04437758|Vitamins|vitamins|mesh-ancestor
5505744|NCT04437758|Micronutrients|micronutrients|mesh-ancestor
5505745|NCT04437758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505746|NCT04437758|Antioxidants|antioxidants|mesh-ancestor
5505747|NCT04437758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505748|NCT04437758|Protective Agents|protective agents|mesh-ancestor
5505749|NCT04437693|Hydroxychloroquine|hydroxychloroquine|mesh-list
5505750|NCT04437693|Antimalarials|antimalarials|mesh-ancestor
5505751|NCT04437693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6060020|NCT00638443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6060021|NCT00638443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6060022|NCT00638443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6060023|NCT00638443|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6060024|NCT00638443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6060025|NCT00638443|Anesthetics, Local|anesthetics, local|mesh-ancestor
6060026|NCT00638443|Anesthetics|anesthetics|mesh-ancestor
6060027|NCT00638443|Antiemetics|antiemetics|mesh-ancestor
6060028|NCT00638443|Autonomic Agents|autonomic agents|mesh-ancestor
6060029|NCT00638443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6060030|NCT00638443|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6060031|NCT00638443|Histamine Antagonists|histamine antagonists|mesh-ancestor
6060032|NCT00638443|Histamine Agents|histamine agents|mesh-ancestor
6060033|NCT00638443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6060034|NCT00638443|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6060035|NCT00638443|Antipruritics|antipruritics|mesh-ancestor
5505752|NCT04437693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5505753|NCT04437693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5505754|NCT04437693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5505755|NCT04437693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505756|NCT04437693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5505757|NCT04437654|Apixaban|apixaban|mesh-list
5505758|NCT04437654|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6060036|NCT00638443|Dermatologic Agents|dermatologic agents|mesh-ancestor
6060037|NCT00638456|Budesonide|budesonide|mesh-list
6060038|NCT00638456|Lansoprazole|lansoprazole|mesh-list
6060039|NCT00638456|Dexlansoprazole|dexlansoprazole|mesh-list
6060040|NCT00638456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6060041|NCT00638456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6060042|NCT00638456|Autonomic Agents|autonomic agents|mesh-ancestor
6060043|NCT00638456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6060044|NCT00638456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060045|NCT00638456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6060046|NCT00638456|Respiratory System Agents|respiratory system agents|mesh-ancestor
6060047|NCT00638456|Glucocorticoids|glucocorticoids|mesh-ancestor
6060048|NCT00638456|Hormones|hormones|mesh-ancestor
6060049|NCT00638456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6060050|NCT00638456|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6060051|NCT00638456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5505759|NCT04437654|Antithrombins|antithrombins|mesh-ancestor
5505760|NCT04437654|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5505761|NCT04437654|Protease Inhibitors|protease inhibitors|mesh-ancestor
5505762|NCT04437654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5505763|NCT04437654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505764|NCT04437654|Anticoagulants|anticoagulants|mesh-ancestor
5505765|NCT04437329|Cisplatin|cisplatin|mesh-list
5505766|NCT04437329|Docetaxel|docetaxel|mesh-list
5505767|NCT04437329|Fluorouracil|fluorouracil|mesh-list
5505768|NCT04437329|Nedaplatin|nedaplatin|mesh-list
5505769|NCT04437329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5505770|NCT04437329|Tubulin Modulators|tubulin modulators|mesh-ancestor
5505771|NCT04437329|Antimitotic Agents|antimitotic agents|mesh-ancestor
5505772|NCT04437329|Mitosis Modulators|mitosis modulators|mesh-ancestor
5505773|NCT04437329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505774|NCT04437329|Antimetabolites|antimetabolites|mesh-ancestor
5505775|NCT04437329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5505776|NCT04437329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5505777|NCT04437329|Immunologic Factors|immunologic factors|mesh-ancestor
5505778|NCT04437329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505779|NCT04437004|Fenfluramine|fenfluramine|mesh-list
5505780|NCT04437004|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5505781|NCT04437004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5505782|NCT04437004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5505783|NCT04437004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505784|NCT04437004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5505785|NCT04437004|Serotonin Agents|serotonin agents|mesh-ancestor
5505786|NCT04437004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505787|NCT04437225|Glycolic acid|glycolic acid|mesh-list
5505788|NCT04437225|Keratolytic Agents|keratolytic agents|mesh-ancestor
5505789|NCT04437225|Dermatologic Agents|dermatologic agents|mesh-ancestor
6060052|NCT00638456|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6060053|NCT00638456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6060054|NCT00638456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060055|NCT00638508|Ketorolac|ketorolac|mesh-list
6060056|NCT00638508|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6060057|NCT00638508|Ropivacaine|ropivacaine|mesh-list
6060058|NCT00638508|Anesthetics, Local|anesthetics, local|mesh-ancestor
6060059|NCT00638508|Anesthetics|anesthetics|mesh-ancestor
6060060|NCT00638508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6060061|NCT00638508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060062|NCT00638508|Sensory System Agents|sensory system agents|mesh-ancestor
6060063|NCT00638508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6060064|NCT00638508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6060065|NCT00638508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6060066|NCT00638508|Analgesics|analgesics|mesh-ancestor
6060067|NCT00638508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6060068|NCT00638508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6060069|NCT00638508|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6060070|NCT00638508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6060071|NCT00638508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060072|NCT00638651|Imiquimod|imiquimod|mesh-list
5600111|NCT03714594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600112|NCT03714594|Incretins|incretins|mesh-ancestor
5600113|NCT03714594|Hormones|hormones|mesh-ancestor
5600114|NCT03714594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5600115|NCT03714594|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5600116|NCT03714594|Protease Inhibitors|protease inhibitors|mesh-ancestor
5600117|NCT03714594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5600118|NCT03714555|Copper|copper|mesh-list
5600119|NCT03714555|Gemcitabine|gemcitabine|mesh-list
5600120|NCT03714555|Paclitaxel|paclitaxel|mesh-list
5600121|NCT03714555|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5600122|NCT03714555|Folfirinox|folfirinox|mesh-list
5600123|NCT03714555|Disulfiram|disulfiram|mesh-list
5600124|NCT03714555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5600125|NCT03714555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5600126|NCT03714555|Tubulin Modulators|tubulin modulators|mesh-ancestor
5600127|NCT03714555|Antimitotic Agents|antimitotic agents|mesh-ancestor
5600128|NCT03714555|Mitosis Modulators|mitosis modulators|mesh-ancestor
5600129|NCT03714555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600130|NCT03714555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5600131|NCT03714555|Antimetabolites|antimetabolites|mesh-ancestor
5600132|NCT03714555|Antiviral Agents|antiviral agents|mesh-ancestor
5600133|NCT03714555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5600134|NCT03714555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6060073|NCT00638651|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6060074|NCT00638651|Immunologic Factors|immunologic factors|mesh-ancestor
6060075|NCT00638651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060076|NCT00638651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6060077|NCT00638651|Interferon Inducers|interferon inducers|mesh-ancestor
6060078|NCT00638690|Prednisone|prednisone|mesh-list
6060079|NCT00638690|Prednisolone|prednisolone|mesh-list
6060080|NCT00638690|Abiraterone Acetate|abiraterone acetate|mesh-list
6060081|NCT00638690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6060082|NCT00638690|Glucocorticoids|glucocorticoids|mesh-ancestor
6060083|NCT00638690|Hormones|hormones|mesh-ancestor
6060084|NCT00638690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6060085|NCT00638690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060086|NCT00638690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6462653|NCT00460512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6462654|NCT00460512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6462655|NCT00460512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462656|NCT00460512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6462657|NCT00460512|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6462658|NCT00460512|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6462659|NCT00460512|Serotonin Agents|serotonin agents|mesh-ancestor
6462660|NCT00460512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6462661|NCT00460512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462662|NCT00460512|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6462663|NCT00460512|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6462664|NCT00460512|Dopamine Agents|dopamine agents|mesh-ancestor
6462665|NCT00460616|Cabergoline|cabergoline|mesh-list
6462666|NCT00460616|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6462667|NCT00460616|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6462668|NCT00460616|Dopamine Agonists|dopamine agonists|mesh-ancestor
6462669|NCT00460616|Dopamine Agents|dopamine agents|mesh-ancestor
6462670|NCT00460616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6060087|NCT00638690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6060088|NCT00638690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6060089|NCT00638690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6060090|NCT00638690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060091|NCT00638690|Hormone Antagonists|hormone antagonists|mesh-ancestor
6060092|NCT00638690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6060093|NCT00638820|Busulfan|busulfan|mesh-list
6060094|NCT00638820|Alemtuzumab|alemtuzumab|mesh-list
6060095|NCT00638820|Clofarabine|clofarabine|mesh-list
6060096|NCT00638820|Alkylating Agents|alkylating agents|mesh-ancestor
6060097|NCT00638820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060098|NCT00638820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6060099|NCT00638820|Immunologic Factors|immunologic factors|mesh-ancestor
5505790|NCT04437017|Dexamethasone|dexamethasone|mesh-list
5505791|NCT04437017|Fluprednisolone|fluprednisolone|mesh-list
5505792|NCT04437017|Olanzapine|olanzapine|mesh-list
5505793|NCT04437017|Serotonin|serotonin|mesh-list
5505794|NCT04437017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6060100|NCT00638820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060101|NCT00638820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6060102|NCT00638820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5505795|NCT04437017|Antiemetics|antiemetics|mesh-ancestor
5505796|NCT04437017|Autonomic Agents|autonomic agents|mesh-ancestor
5505797|NCT04437017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5505798|NCT04437017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462671|NCT00460616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505799|NCT04437017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6060103|NCT00638820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5505800|NCT04437017|Glucocorticoids|glucocorticoids|mesh-ancestor
5505801|NCT04437017|Hormones|hormones|mesh-ancestor
5505802|NCT04437017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5505803|NCT04437017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5505804|NCT04437017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5505805|NCT04437017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5505806|NCT04437017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5505807|NCT04437017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5505808|NCT04437017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5505809|NCT04437017|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5505810|NCT04437017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5505811|NCT04437017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5505812|NCT04437017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505813|NCT04437017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6060104|NCT00638820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6060105|NCT00638820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6060106|NCT00638820|Antimetabolites|antimetabolites|mesh-ancestor
6060107|NCT00638937|Saracatinib|saracatinib|mesh-list
6060108|NCT00638937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6060109|NCT00638937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6060110|NCT00638937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060111|NCT00638963|Temozolomide|temozolomide|mesh-list
6060112|NCT00638963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6060113|NCT00638963|Alkylating Agents|alkylating agents|mesh-ancestor
6060114|NCT00638963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060115|NCT00638963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6060116|NCT00638989|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6060117|NCT00638989|Immunologic Factors|immunologic factors|mesh-ancestor
6060118|NCT00638989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060119|NCT00639002|Dexamethasone|dexamethasone|mesh-list
6060120|NCT00639002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6060121|NCT00639002|Antiemetics|antiemetics|mesh-ancestor
6060122|NCT00639002|Autonomic Agents|autonomic agents|mesh-ancestor
6060123|NCT00639002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6060124|NCT00639002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060125|NCT00639002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6060126|NCT00639002|Glucocorticoids|glucocorticoids|mesh-ancestor
6060127|NCT00639002|Hormones|hormones|mesh-ancestor
6060128|NCT00639002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6060129|NCT00639002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6060130|NCT00639002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6060131|NCT00639158|Choline|choline|mesh-list
6060132|NCT00639158|Atorvastatin|atorvastatin|mesh-list
6060133|NCT00639158|Ezetimibe|ezetimibe|mesh-list
6060134|NCT00639158|Fenofibric acid|fenofibric acid|mesh-list
6060135|NCT00639158|Fenofibrate|fenofibrate|mesh-list
6060136|NCT00639158|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6060137|NCT00639158|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6060138|NCT00639158|Antimetabolites|antimetabolites|mesh-ancestor
6060139|NCT00639158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060140|NCT00639158|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6060141|NCT00639158|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6060142|NCT00639158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6060143|NCT00639158|Lipotropic Agents|lipotropic agents|mesh-ancestor
6060144|NCT00639158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6060145|NCT00639158|Nootropic Agents|nootropic agents|mesh-ancestor
6060146|NCT00639223|Pravastatin|pravastatin|mesh-list
6060147|NCT00639223|Red yeast rice|red yeast rice|mesh-list
6060148|NCT00639223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6060149|NCT00639223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6060150|NCT00639223|Antimetabolites|antimetabolites|mesh-ancestor
6060151|NCT00639223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060152|NCT00639223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6060153|NCT00639223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6060154|NCT00639223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6060155|NCT00639418|Vaccines|vaccines|mesh-list
6060156|NCT00639418|Immunologic Factors|immunologic factors|mesh-ancestor
6060157|NCT00639418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060158|NCT00639457|Pioglitazone|pioglitazone|mesh-list
6060159|NCT00639457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6060160|NCT00639457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060161|NCT00639509|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6060162|NCT00639509|Immunologic Factors|immunologic factors|mesh-ancestor
6060163|NCT00639509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060164|NCT00639678|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6060165|NCT00639678|Immunologic Factors|immunologic factors|mesh-ancestor
6060166|NCT00639678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060167|NCT00639717|Etanercept|etanercept|mesh-list
6060168|NCT00639717|Methoxsalen|methoxsalen|mesh-list
6060169|NCT00639717|Tacrolimus|tacrolimus|mesh-list
6060170|NCT00639717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6060171|NCT00639717|Immunologic Factors|immunologic factors|mesh-ancestor
6060172|NCT00639717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060173|NCT00639717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6060174|NCT00639717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6060175|NCT00639717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060176|NCT00639717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6060177|NCT00639717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6060178|NCT00639717|Analgesics|analgesics|mesh-ancestor
6060179|NCT00639717|Sensory System Agents|sensory system agents|mesh-ancestor
6060180|NCT00639717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6060181|NCT00639717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6060182|NCT00639717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6060183|NCT00639717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6060184|NCT00639717|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6060185|NCT00639717|Dermatologic Agents|dermatologic agents|mesh-ancestor
6060186|NCT00639769|Cisplatin|cisplatin|mesh-list
6060187|NCT00639769|Irinotecan|irinotecan|mesh-list
6060188|NCT00639769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6060189|NCT00639769|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6060190|NCT00639769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6060191|NCT00639769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6060192|NCT00639769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060193|NCT00640016|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6060194|NCT00640016|Immunologic Factors|immunologic factors|mesh-ancestor
6060195|NCT00640016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060196|NCT00640042|Morphine|morphine|mesh-list
6060197|NCT00640042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6060198|NCT00640042|Narcotics|narcotics|mesh-ancestor
6060199|NCT00640042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6060200|NCT00640042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060201|NCT00640042|Analgesics|analgesics|mesh-ancestor
6060202|NCT00640042|Sensory System Agents|sensory system agents|mesh-ancestor
6060203|NCT00640042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6060204|NCT00640146|Bromides|bromides|mesh-list
6060205|NCT00640146|Methylnaltrexone|methylnaltrexone|mesh-list
6060206|NCT00640146|Anticonvulsants|anticonvulsants|mesh-ancestor
6060207|NCT00640146|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5505814|NCT04437017|Serotonin Agents|serotonin agents|mesh-ancestor
5505815|NCT04437017|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5505816|NCT04437160|Cyclophosphamide|cyclophosphamide|mesh-list
5505817|NCT04437160|Epirubicin|epirubicin|mesh-list
5505818|NCT04437160|Pirarubicin|pirarubicin|mesh-list
5505819|NCT04437160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5505820|NCT04437160|Immunologic Factors|immunologic factors|mesh-ancestor
5505821|NCT04437160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505822|NCT04437160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5505823|NCT04437160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5505824|NCT04437160|Alkylating Agents|alkylating agents|mesh-ancestor
5505825|NCT04437160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505826|NCT04437160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5505827|NCT04437160|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5505828|NCT04437160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5505829|NCT04437160|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5505830|NCT04437160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6060208|NCT00640146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060209|NCT00640146|Sensory System Agents|sensory system agents|mesh-ancestor
6060210|NCT00640146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6060211|NCT00640224|Rosiglitazone|rosiglitazone|mesh-list
6060212|NCT00640224|Drospirenone|drospirenone|mesh-list
6060213|NCT00640224|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6060214|NCT00640224|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
6060215|NCT00640224|Estradiol|estradiol|mesh-list
6060216|NCT00640224|Estrogens|estrogens|mesh-ancestor
6060217|NCT00640224|Hormones|hormones|mesh-ancestor
6060218|NCT00640224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6060219|NCT00640224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060220|NCT00640224|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6060221|NCT00640224|Contraceptive Agents|contraceptive agents|mesh-ancestor
6060222|NCT00640224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5505831|NCT04437160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5505832|NCT04436796|Pancrelipase|pancrelipase|mesh-list
5505833|NCT04436796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5505834|NCT04436926|Analgesics, Opioid|analgesics, opioid|mesh-list
5505835|NCT04436926|Narcotics|narcotics|mesh-ancestor
5505836|NCT04436926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5505837|NCT04436926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505838|NCT04436926|Analgesics|analgesics|mesh-ancestor
5505839|NCT04436926|Sensory System Agents|sensory system agents|mesh-ancestor
5505840|NCT04436926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5505841|NCT04436601|Lactulose|lactulose|mesh-list
5505842|NCT04436601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5505843|NCT04436419|Thioctic Acid|thioctic acid|mesh-list
5505844|NCT04436419|Antioxidants|antioxidants|mesh-ancestor
5505845|NCT04436419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505846|NCT04436419|Protective Agents|protective agents|mesh-ancestor
5505847|NCT04436419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060223|NCT00640224|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6060224|NCT00640224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6060225|NCT00640224|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6060226|NCT00640224|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6060227|NCT00640224|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6060228|NCT00640224|Hormone Antagonists|hormone antagonists|mesh-ancestor
6060229|NCT00640224|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6060230|NCT00640224|Diuretics|diuretics|mesh-ancestor
6060231|NCT00640224|Natriuretic Agents|natriuretic agents|mesh-ancestor
6060232|NCT00640289|Fibrinolysin|fibrinolysin|mesh-list
6060233|NCT00640289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6060234|NCT00640289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6060235|NCT00640289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060236|NCT00640315|Riociguat|riociguat|mesh-list
6060237|NCT00640315|Enzyme Activators|enzyme activators|mesh-ancestor
6060238|NCT00640315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060239|NCT00640328|Ofatumumab|ofatumumab|mesh-list
6060240|NCT00640328|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6060241|NCT00640328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6060242|NCT00640328|Immunologic Factors|immunologic factors|mesh-ancestor
6060243|NCT00640328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060244|NCT00640393|Etanercept|etanercept|mesh-list
6060245|NCT00640393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6060246|NCT00640393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6060247|NCT00640393|Analgesics|analgesics|mesh-ancestor
6060248|NCT00640393|Sensory System Agents|sensory system agents|mesh-ancestor
6060249|NCT00640393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6060250|NCT00640393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060251|NCT00640393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6060252|NCT00640393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6060253|NCT00640393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6060254|NCT00640393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6060255|NCT00640393|Immunologic Factors|immunologic factors|mesh-ancestor
6060256|NCT00640510|Olanzapine|olanzapine|mesh-list
6060257|NCT00640510|Antiemetics|antiemetics|mesh-ancestor
6060258|NCT00640510|Autonomic Agents|autonomic agents|mesh-ancestor
6060259|NCT00640510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6060260|NCT00640510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060261|NCT00640510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6060262|NCT00640510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5505848|NCT04436419|Vitamin B Complex|vitamin b complex|mesh-ancestor
5505849|NCT04436419|Vitamins|vitamins|mesh-ancestor
6060263|NCT00640510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6060264|NCT00640510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6060265|NCT00640510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6060266|NCT00640510|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6060267|NCT00640510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6060268|NCT00640510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5505850|NCT04436419|Micronutrients|micronutrients|mesh-ancestor
5505851|NCT04436536|Methamphetamine|methamphetamine|mesh-list
5505852|NCT04436536|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5505853|NCT04436536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505854|NCT04436536|Sympathomimetics|sympathomimetics|mesh-ancestor
5505855|NCT04436536|Autonomic Agents|autonomic agents|mesh-ancestor
5505856|NCT04436536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6202116|NCT02036515|Protease Inhibitors|protease inhibitors|mesh-ancestor
5505857|NCT04436536|Dopamine Agents|dopamine agents|mesh-ancestor
5505858|NCT04436536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5505859|NCT04436536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060269|NCT00640510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060270|NCT00640510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6060271|NCT00640510|Serotonin Agents|serotonin agents|mesh-ancestor
6060272|NCT00640562|Risperidone|risperidone|mesh-list
6060273|NCT00640562|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6060274|NCT00640562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6060275|NCT00640562|Serotonin Agents|serotonin agents|mesh-ancestor
6060276|NCT00640562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6060277|NCT00640562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060278|NCT00640562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060279|NCT00640562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6060280|NCT00640562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6060281|NCT00640562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6060282|NCT00640562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6060283|NCT00640562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6060284|NCT00640562|Dopamine Agents|dopamine agents|mesh-ancestor
6060285|NCT00640562|Antidepressive Agents|antidepressive agents|mesh-ancestor
6060286|NCT00640601|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6060287|NCT00640601|Antidepressive Agents|antidepressive agents|mesh-ancestor
6060288|NCT00640601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6060289|NCT00640601|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6060290|NCT00640601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6060291|NCT00640601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6060292|NCT00640601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060293|NCT00640822|Calcitriol|calcitriol|mesh-list
6060294|NCT00640822|Hydrocortisone|hydrocortisone|mesh-list
6060295|NCT00640822|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6060296|NCT00640822|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6060297|NCT00640822|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6060298|NCT00640822|1 alpha,24-dihydroxyvitamin D3|1 alpha,24-dihydroxyvitamin d3|mesh-list
6060299|NCT00640822|Calcipotriene|calcipotriene|mesh-list
5505860|NCT04436536|Adrenergic Agents|adrenergic agents|mesh-ancestor
5505861|NCT04436536|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5505862|NCT04436536|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5505863|NCT04436536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5505864|NCT04436536|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5505865|NCT04436172|Anesthetics|anesthetics|mesh-list
5505866|NCT04436172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5505867|NCT04436172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505868|NCT04436328|Anti-Infective Agents|anti-infective agents|mesh-list
5505869|NCT04436328|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5505870|NCT04436250|Ketamine|ketamine|mesh-list
5505871|NCT04436250|Esketamine|esketamine|mesh-list
5505872|NCT04436250|Analgesics|analgesics|mesh-ancestor
5505873|NCT04436250|Sensory System Agents|sensory system agents|mesh-ancestor
5505874|NCT04436250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5505875|NCT04436250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505876|NCT04436250|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5505877|NCT04436250|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5505878|NCT04436250|Anesthetics, General|anesthetics, general|mesh-ancestor
5505879|NCT04436250|Anesthetics|anesthetics|mesh-ancestor
5505880|NCT04436250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5505881|NCT04436250|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5505882|NCT04436250|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5505883|NCT04436250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5505884|NCT04436250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505885|NCT04436250|Antidepressive Agents|antidepressive agents|mesh-ancestor
6060300|NCT00640822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6060301|NCT00640822|Dermatologic Agents|dermatologic agents|mesh-ancestor
6060302|NCT00640822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6462672|NCT00460616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462673|NCT00460642|Cetrorelix|cetrorelix|mesh-list
6462674|NCT00460642|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6462675|NCT00460642|Fertility Agents|fertility agents|mesh-ancestor
6060303|NCT00640822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060304|NCT00640822|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
5505886|NCT04436250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5505887|NCT04436107|Lenalidomide|lenalidomide|mesh-list
5505888|NCT04436107|Zanubrutinib|zanubrutinib|mesh-list
5505889|NCT04436107|Immunologic Factors|immunologic factors|mesh-ancestor
5505890|NCT04436107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505891|NCT04436107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5505892|NCT04436107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5505893|NCT04436107|Growth Substances|growth substances|mesh-ancestor
5505894|NCT04436107|Growth Inhibitors|growth inhibitors|mesh-ancestor
6060305|NCT00640822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6060306|NCT00640822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060307|NCT00640822|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6060308|NCT00640822|Vitamins|vitamins|mesh-ancestor
6060309|NCT00640822|Micronutrients|micronutrients|mesh-ancestor
6060310|NCT00640822|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6060311|NCT00640835|Buprenorphine|buprenorphine|mesh-list
6060312|NCT00640835|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6060313|NCT00640835|Naloxone|naloxone|mesh-list
6060314|NCT00640835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6060315|NCT00640835|Narcotics|narcotics|mesh-ancestor
6060316|NCT00640835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6060317|NCT00640835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060318|NCT00640835|Analgesics|analgesics|mesh-ancestor
6060319|NCT00640835|Sensory System Agents|sensory system agents|mesh-ancestor
6060320|NCT00640835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6060321|NCT00640835|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6060322|NCT00640926|Radezolid|radezolid|mesh-list
6060323|NCT00640926|Oxazolidinones|oxazolidinones|mesh-list
6060324|NCT00640926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6060325|NCT00640926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6060326|NCT00640926|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6060327|NCT00640926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6060328|NCT00640926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060329|NCT00640978|Everolimus|everolimus|mesh-list
6060330|NCT00640978|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6060331|NCT00640978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6060332|NCT00640978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6060333|NCT00640978|Immunologic Factors|immunologic factors|mesh-ancestor
6060334|NCT00640978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060335|NCT00640978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6060336|NCT00640978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6060337|NCT00640978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505895|NCT04436107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5505896|NCT04436107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5505897|NCT04436107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5505898|NCT04436107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505899|NCT04435912|Hydrocortisone|hydrocortisone|mesh-list
6060338|NCT00641043|Pioglitazone|pioglitazone|mesh-list
6060339|NCT00641043|Linagliptin|linagliptin|mesh-list
6060340|NCT00641043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6060341|NCT00641043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505900|NCT04435912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5505901|NCT04435925|Fentanyl|fentanyl|mesh-list
5505902|NCT04435925|Remifentanil|remifentanil|mesh-list
6060342|NCT00641043|Incretins|incretins|mesh-ancestor
6060343|NCT00641043|Hormones|hormones|mesh-ancestor
6060344|NCT00641043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6060345|NCT00641043|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6060346|NCT00641043|Protease Inhibitors|protease inhibitors|mesh-ancestor
6060347|NCT00641043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6060348|NCT00641043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060349|NCT00641056|Insulin Glargine|insulin glargine|mesh-list
6060350|NCT00641056|Exenatide|exenatide|mesh-list
6060351|NCT00641056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6060352|NCT00641056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060353|NCT00641056|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6060354|NCT00641056|Incretins|incretins|mesh-ancestor
6060355|NCT00641056|Hormones|hormones|mesh-ancestor
6060356|NCT00641056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6060357|NCT00641147|Curcumin|curcumin|mesh-list
6060358|NCT00641147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6060359|NCT00641147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6060360|NCT00641147|Analgesics|analgesics|mesh-ancestor
6060361|NCT00641147|Sensory System Agents|sensory system agents|mesh-ancestor
6060362|NCT00641147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6060363|NCT00641147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060364|NCT00641147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6060365|NCT00641147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6060366|NCT00641147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5505903|NCT04435925|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6060367|NCT00641147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6060368|NCT00641147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060369|NCT00641563|Midazolam|midazolam|mesh-list
6060370|NCT00641563|Dexmedetomidine|dexmedetomidine|mesh-list
5505904|NCT04435925|Narcotics|narcotics|mesh-ancestor
6060371|NCT00641563|Remifentanil|remifentanil|mesh-list
6462676|NCT00460642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6462677|NCT00460642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462678|NCT00460642|Hormone Antagonists|hormone antagonists|mesh-ancestor
6462679|NCT00460642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6462680|NCT00460681|Thymopentin|thymopentin|mesh-list
6462681|NCT00460681|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6462682|NCT00460681|Immunologic Factors|immunologic factors|mesh-ancestor
6462683|NCT00460681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505905|NCT04435925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6060372|NCT00641563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6060373|NCT00641563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6060374|NCT00641563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060375|NCT00641563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6060376|NCT00641563|Analgesics|analgesics|mesh-ancestor
6060377|NCT00641563|Sensory System Agents|sensory system agents|mesh-ancestor
6060378|NCT00641563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6060379|NCT00641563|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6060380|NCT00641563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6060381|NCT00641563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6060382|NCT00641563|Adrenergic Agents|adrenergic agents|mesh-ancestor
6060383|NCT00641563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6060384|NCT00641563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060385|NCT00641563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6060386|NCT00641563|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6060387|NCT00641563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6060388|NCT00641563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6060389|NCT00641563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6060390|NCT00641563|Anesthetics, General|anesthetics, general|mesh-ancestor
6060391|NCT00641563|Anesthetics|anesthetics|mesh-ancestor
6060392|NCT00641563|GABA Modulators|gaba modulators|mesh-ancestor
6060393|NCT00641563|GABA Agents|gaba agents|mesh-ancestor
6060394|NCT00641563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6060395|NCT00641563|Narcotics|narcotics|mesh-ancestor
6060396|NCT00641641|Tenofovir|tenofovir|mesh-list
6060397|NCT00641641|Emtricitabine|emtricitabine|mesh-list
6060398|NCT00641641|Raltegravir Potassium|raltegravir potassium|mesh-list
6060399|NCT00641641|Antiviral Agents|antiviral agents|mesh-ancestor
6060400|NCT00641641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6060401|NCT00641641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6060402|NCT00641641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6060403|NCT00641641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6060404|NCT00641641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060405|NCT00641641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6060406|NCT00641641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6060407|NCT00641641|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6060408|NCT00641641|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6060409|NCT00641667|Fentanyl|fentanyl|mesh-list
6060410|NCT00641667|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6060411|NCT00641667|Narcotics|narcotics|mesh-ancestor
6060412|NCT00641667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6060413|NCT00641667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060414|NCT00641667|Analgesics|analgesics|mesh-ancestor
6060415|NCT00641667|Sensory System Agents|sensory system agents|mesh-ancestor
6060416|NCT00641667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6060417|NCT00641667|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6060418|NCT00641667|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6060419|NCT00641667|Anesthetics, General|anesthetics, general|mesh-ancestor
6060420|NCT00641667|Anesthetics|anesthetics|mesh-ancestor
6060421|NCT00641706|Bortezomib|bortezomib|mesh-list
6060422|NCT00641706|Vorinostat|vorinostat|mesh-list
6060423|NCT00641706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6060424|NCT00641706|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6060425|NCT00641706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6060426|NCT00641706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060427|NCT00641719|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6060428|NCT00641719|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6060429|NCT00641719|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6060430|NCT00641719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6060431|NCT00641719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060432|NCT00641719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6060433|NCT00641719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060434|NCT00641719|Analgesics|analgesics|mesh-ancestor
6060435|NCT00641719|Sensory System Agents|sensory system agents|mesh-ancestor
6462684|NCT00460707|Ketoconazole|ketoconazole|mesh-list
6665232|NCT01516346|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6665233|NCT01516346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060436|NCT00641719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6060437|NCT00641719|Antidepressive Agents|antidepressive agents|mesh-ancestor
6060438|NCT00641719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6060439|NCT00641719|Dopamine Agents|dopamine agents|mesh-ancestor
6060440|NCT00641745|Risperidone|risperidone|mesh-list
6060441|NCT00641745|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
6060442|NCT00641745|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6060443|NCT00641745|Serotonin Agents|serotonin agents|mesh-ancestor
6060444|NCT00641745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6060445|NCT00641745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060446|NCT00641745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060447|NCT00641745|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6060448|NCT00641745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6060449|NCT00641745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6060450|NCT00641745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6060451|NCT00641745|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6060452|NCT00641745|Dopamine Agents|dopamine agents|mesh-ancestor
6060453|NCT00641745|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6060454|NCT00641745|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6060455|NCT00641745|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6060456|NCT00641745|Adrenergic Agents|adrenergic agents|mesh-ancestor
6060457|NCT00641745|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6060458|NCT00641745|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6060459|NCT00641797|Diphenhydramine|diphenhydramine|mesh-list
6060460|NCT00641797|Promethazine|promethazine|mesh-list
6060461|NCT00641797|Meclizine|meclizine|mesh-list
6060462|NCT00641797|Lorazepam|lorazepam|mesh-list
6060463|NCT00641797|Ondansetron|ondansetron|mesh-list
6060464|NCT00641797|Antiemetics|antiemetics|mesh-ancestor
6060465|NCT00641797|Autonomic Agents|autonomic agents|mesh-ancestor
6060466|NCT00641797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6060467|NCT00641797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060468|NCT00641797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6060469|NCT00641797|Antipruritics|antipruritics|mesh-ancestor
6060470|NCT00641797|Dermatologic Agents|dermatologic agents|mesh-ancestor
6060471|NCT00641797|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6060472|NCT00641797|Serotonin Agents|serotonin agents|mesh-ancestor
6060473|NCT00641797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6060474|NCT00641797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060475|NCT00641797|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6060476|NCT00641797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6060477|NCT00641797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6060478|NCT00641797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6060479|NCT00641797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6060480|NCT00641797|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6060481|NCT00641797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6060482|NCT00641797|Anesthetics, Local|anesthetics, local|mesh-ancestor
6060483|NCT00641797|Anesthetics|anesthetics|mesh-ancestor
6060484|NCT00641797|Sensory System Agents|sensory system agents|mesh-ancestor
6060485|NCT00641797|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6060486|NCT00641797|Histamine Antagonists|histamine antagonists|mesh-ancestor
6060487|NCT00641797|Histamine Agents|histamine agents|mesh-ancestor
6060488|NCT00641797|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6060489|NCT00641797|Anticonvulsants|anticonvulsants|mesh-ancestor
6060490|NCT00641797|GABA Modulators|gaba modulators|mesh-ancestor
6060491|NCT00641797|GABA Agents|gaba agents|mesh-ancestor
6060492|NCT00641862|Vitamin B 12|vitamin b 12|mesh-list
6060493|NCT00641862|Hydroxocobalamin|hydroxocobalamin|mesh-list
6060494|NCT00641862|Vitamins|vitamins|mesh-ancestor
6060495|NCT00641862|Micronutrients|micronutrients|mesh-ancestor
6060496|NCT00641862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060497|NCT00641862|Vitamin B Complex|vitamin b complex|mesh-ancestor
6060498|NCT00641862|Hematinics|hematinics|mesh-ancestor
6060499|NCT00642018|Prednisone|prednisone|mesh-list
6060500|NCT00642018|Docetaxel|docetaxel|mesh-list
6060501|NCT00642018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6060502|NCT00642018|Tubulin Modulators|tubulin modulators|mesh-ancestor
6060503|NCT00642018|Antimitotic Agents|antimitotic agents|mesh-ancestor
6060504|NCT00642018|Mitosis Modulators|mitosis modulators|mesh-ancestor
6060505|NCT00642018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060506|NCT00642018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6060507|NCT00642018|Glucocorticoids|glucocorticoids|mesh-ancestor
6060508|NCT00642018|Hormones|hormones|mesh-ancestor
6060509|NCT00642018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6060510|NCT00642018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060511|NCT00642018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6060512|NCT00642174|Clopidogrel|clopidogrel|mesh-list
6060513|NCT00642174|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6060514|NCT00642174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6060515|NCT00642174|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6060516|NCT00642174|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6060517|NCT00642174|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6060518|NCT00642174|Purinergic Agents|purinergic agents|mesh-ancestor
6060519|NCT00642174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6060520|NCT00642174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505906|NCT04435925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505907|NCT04435925|Analgesics|analgesics|mesh-ancestor
5505908|NCT04435925|Sensory System Agents|sensory system agents|mesh-ancestor
5505909|NCT04435925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5505910|NCT04435925|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5505911|NCT04435925|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5505912|NCT04435925|Anesthetics, General|anesthetics, general|mesh-ancestor
5505913|NCT04435925|Anesthetics|anesthetics|mesh-ancestor
5505914|NCT04435795|Ciclesonide|ciclesonide|mesh-list
5505915|NCT04435795|Glucocorticoids|glucocorticoids|mesh-ancestor
5505916|NCT04435795|Hormones|hormones|mesh-ancestor
5505917|NCT04435795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5505918|NCT04435795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505919|NCT04435795|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5505920|NCT04435743|Lenalidomide|lenalidomide|mesh-list
5505921|NCT04435743|Immunologic Factors|immunologic factors|mesh-ancestor
5505922|NCT04435743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505923|NCT04435743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5505924|NCT04435743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6060521|NCT00642174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060522|NCT00642278|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6060523|NCT00642278|Canagliflozin|canagliflozin|mesh-list
6060524|NCT00642278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6060525|NCT00642278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060526|NCT00642278|Incretins|incretins|mesh-ancestor
6060527|NCT00642278|Hormones|hormones|mesh-ancestor
6060528|NCT00642278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6060529|NCT00642278|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6060530|NCT00642278|Protease Inhibitors|protease inhibitors|mesh-ancestor
6060531|NCT00642278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6060532|NCT00642278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060533|NCT00642278|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6060534|NCT00642304|Epoetin Alfa|epoetin alfa|mesh-list
6060535|NCT00642304|Hematinics|hematinics|mesh-ancestor
6060536|NCT00642356|Levodopa|levodopa|mesh-list
6060537|NCT00642356|Carbidopa|carbidopa|mesh-list
6060538|NCT00642356|Entacapone|entacapone|mesh-list
6060539|NCT00642356|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
6060540|NCT00642356|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6060541|NCT00642356|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6060542|NCT00642356|Dopamine Agents|dopamine agents|mesh-ancestor
6060543|NCT00642356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6060544|NCT00642356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060545|NCT00642356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060546|NCT00642356|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6060547|NCT00642356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5505925|NCT04435743|Growth Substances|growth substances|mesh-ancestor
5505926|NCT04435743|Growth Inhibitors|growth inhibitors|mesh-ancestor
5505927|NCT04435743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5505928|NCT04435704|Oxytocin|oxytocin|mesh-list
5505929|NCT04435704|Oxytocics|oxytocics|mesh-ancestor
5505930|NCT04435704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5505931|NCT04435704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505932|NCT04435717|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5505933|NCT04435587|Ritonavir|ritonavir|mesh-list
5505934|NCT04435587|Darunavir|darunavir|mesh-list
5505935|NCT04435587|Hydroxychloroquine|hydroxychloroquine|mesh-list
5505936|NCT04435587|Ivermectin|ivermectin|mesh-list
5505937|NCT04435587|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5505938|NCT04435587|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5505939|NCT04435587|Protease Inhibitors|protease inhibitors|mesh-ancestor
5505940|NCT04435587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5505941|NCT04435587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505942|NCT04435587|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5505943|NCT04435587|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5505944|NCT04435587|Antiviral Agents|antiviral agents|mesh-ancestor
5505945|NCT04435587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5505946|NCT04435587|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5505947|NCT04435587|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5505948|NCT04435587|Antimalarials|antimalarials|mesh-ancestor
5505949|NCT04435587|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5505950|NCT04435587|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5505951|NCT04435587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5505952|NCT04435652|Paclitaxel|paclitaxel|mesh-list
5505953|NCT04435652|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5505954|NCT04435652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5505955|NCT04435652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5505956|NCT04435652|Tubulin Modulators|tubulin modulators|mesh-ancestor
5505957|NCT04435652|Antimitotic Agents|antimitotic agents|mesh-ancestor
5505958|NCT04435652|Mitosis Modulators|mitosis modulators|mesh-ancestor
5505959|NCT04435652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505960|NCT04435483|Acalabrutinib|acalabrutinib|mesh-list
5505961|NCT04435483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5505962|NCT04435522|Maraviroc|maraviroc|mesh-list
5505963|NCT04435522|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5505964|NCT04435522|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5505965|NCT04435522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505966|NCT04435522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5505967|NCT04435522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6060548|NCT00642356|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6060549|NCT00642356|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6060550|NCT00642356|Immunologic Factors|immunologic factors|mesh-ancestor
6060551|NCT00642356|Dopamine Agonists|dopamine agonists|mesh-ancestor
6060552|NCT00642369|Haloperidol|haloperidol|mesh-list
6060553|NCT00642369|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6060554|NCT00642369|Haloperidol decanoate|haloperidol decanoate|mesh-list
6060555|NCT00642369|Antidepressive Agents|antidepressive agents|mesh-ancestor
6060556|NCT00642369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6060557|NCT00642369|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6060558|NCT00642369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6060559|NCT00642369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6060560|NCT00642369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060561|NCT00642369|Antiemetics|antiemetics|mesh-ancestor
6060562|NCT00642369|Autonomic Agents|autonomic agents|mesh-ancestor
6060563|NCT00642369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6060564|NCT00642369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6060565|NCT00642369|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6060566|NCT00642369|Dopamine Agents|dopamine agents|mesh-ancestor
6060567|NCT00642369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6060568|NCT00642369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060569|NCT00642369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6060570|NCT00642460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
6060571|NCT00642460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
6060572|NCT00642460|Methotrexate|methotrexate|mesh-list
6060573|NCT00642460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5505968|NCT04435522|Antiviral Agents|antiviral agents|mesh-ancestor
5505969|NCT04435522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5505970|NCT04435522|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
5505971|NCT04435574|Lactoferrin|lactoferrin|mesh-list
5505972|NCT04435574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5600135|NCT03714555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5600136|NCT03714555|Immunologic Factors|immunologic factors|mesh-ancestor
5600137|NCT03714555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600138|NCT03714555|Trace Elements|trace elements|mesh-ancestor
5600139|NCT03714555|Micronutrients|micronutrients|mesh-ancestor
5600140|NCT03714555|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5600141|NCT03714555|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
6060574|NCT00642460|Abortifacient Agents|abortifacient agents|mesh-ancestor
6060575|NCT00642460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6060576|NCT00642460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5505973|NCT04435314|Nitazoxanide|nitazoxanide|mesh-list
5505974|NCT04435314|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5505975|NCT04435314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5505976|NCT04435418|Apixaban|apixaban|mesh-list
5505977|NCT04435418|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5505978|NCT04435418|Antithrombins|antithrombins|mesh-ancestor
5505979|NCT04435418|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5505980|NCT04435418|Protease Inhibitors|protease inhibitors|mesh-ancestor
5505981|NCT04435418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5505982|NCT04435418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5505983|NCT04435418|Anticoagulants|anticoagulants|mesh-ancestor
5505984|NCT04435197|Pembrolizumab|pembrolizumab|mesh-list
5505985|NCT04435197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5505986|NCT04435197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5505987|NCT04435015|Camostat|camostat|mesh-list
5505988|NCT04435015|Protease Inhibitors|protease inhibitors|mesh-ancestor
5505989|NCT04435015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5505990|NCT04435015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060577|NCT00642460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6060578|NCT00642460|Antimetabolites|antimetabolites|mesh-ancestor
6060579|NCT00642460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060580|NCT00642460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6060581|NCT00642460|Dermatologic Agents|dermatologic agents|mesh-ancestor
6060582|NCT00642460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6060583|NCT00642460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6060584|NCT00642460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6060585|NCT00642460|Immunologic Factors|immunologic factors|mesh-ancestor
6060586|NCT00642460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6060587|NCT00642460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6060588|NCT00642460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5505991|NCT04435015|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5505992|NCT04435015|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5505993|NCT04435028|Ketotifen|ketotifen|mesh-list
5505994|NCT04435028|Antipruritics|antipruritics|mesh-ancestor
5505995|NCT04435028|Dermatologic Agents|dermatologic agents|mesh-ancestor
5505996|NCT04435028|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5505997|NCT04435028|Histamine Antagonists|histamine antagonists|mesh-ancestor
5505998|NCT04435028|Histamine Agents|histamine agents|mesh-ancestor
5505999|NCT04435028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5506000|NCT04435028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506001|NCT04435028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506002|NCT04435028|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5506003|NCT04435210|Hydralazine|hydralazine|mesh-list
5506004|NCT04435210|Nifedipine|nifedipine|mesh-list
5506005|NCT04435210|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5506006|NCT04435210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5506007|NCT04435210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506008|NCT04435210|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5506009|NCT04435210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506010|NCT04435210|Vasodilator Agents|vasodilator agents|mesh-ancestor
5506011|NCT04435210|Tocolytic Agents|tocolytic agents|mesh-ancestor
5506012|NCT04435210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5506013|NCT04435210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6060589|NCT00642460|Analgesics|analgesics|mesh-ancestor
6060590|NCT00642460|Sensory System Agents|sensory system agents|mesh-ancestor
6060591|NCT00642460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6060592|NCT00642473|Metronidazole|metronidazole|mesh-list
6060593|NCT00642473|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6060594|NCT00642473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6060595|NCT00642473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6060596|NCT00642473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6060597|NCT00642473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060598|NCT00642473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6060599|NCT00642473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6060600|NCT00642473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6060601|NCT00642473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6060602|NCT00642616|Insulin|insulin|mesh-list
5506014|NCT04434482|Temozolomide|temozolomide|mesh-list
5506015|NCT04434482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5506016|NCT04434482|Alkylating Agents|alkylating agents|mesh-ancestor
5506017|NCT04434482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506018|NCT04434482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6060603|NCT00642616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5506019|NCT04434560|Nivolumab|nivolumab|mesh-list
5506020|NCT04434560|Ipilimumab|ipilimumab|mesh-list
5506021|NCT04434560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5506022|NCT04434560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5506023|NCT04434560|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5506024|NCT04434560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506025|NCT04434378|Tamsulosin|tamsulosin|mesh-list
5506026|NCT04434378|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6060604|NCT00642616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060605|NCT00642668|Epoetin Alfa|epoetin alfa|mesh-list
6060606|NCT00642668|Hematinics|hematinics|mesh-ancestor
6060607|NCT00642694|Dexetimide|dexetimide|mesh-list
6060608|NCT00642694|Citalopram|citalopram|mesh-list
6060609|NCT00642694|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6060610|NCT00642694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6060611|NCT00642694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6060612|NCT00642694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060613|NCT00642694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6060614|NCT00642694|Serotonin Agents|serotonin agents|mesh-ancestor
6060615|NCT00642694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060616|NCT00642694|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6060617|NCT00642694|Antidepressive Agents|antidepressive agents|mesh-ancestor
6060618|NCT00642694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6060619|NCT00642694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6060620|NCT00642694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6060621|NCT00642694|Parasympatholytics|parasympatholytics|mesh-ancestor
6060622|NCT00642694|Autonomic Agents|autonomic agents|mesh-ancestor
6060623|NCT00642694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6060624|NCT00642694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6060625|NCT00642694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6060626|NCT00642694|Cholinergic Agents|cholinergic agents|mesh-ancestor
6060627|NCT00642707|Leronlimab|leronlimab|mesh-list
6060628|NCT00642707|Antibodies|antibodies|mesh-list
6060629|NCT00642707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6060630|NCT00642707|Immunologic Factors|immunologic factors|mesh-ancestor
6060631|NCT00642707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060632|NCT00642707|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6060633|NCT00642707|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6060634|NCT00642707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060635|NCT00642707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6060636|NCT00642707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6060637|NCT00642707|Antiviral Agents|antiviral agents|mesh-ancestor
6060638|NCT00642707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6060639|NCT00642746|Leucovorin|leucovorin|mesh-list
6060640|NCT00642746|Fluorouracil|fluorouracil|mesh-list
6060641|NCT00642746|Oxaliplatin|oxaliplatin|mesh-list
6060642|NCT00642746|Irinotecan|irinotecan|mesh-list
6060643|NCT00642746|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6060644|NCT00642746|Antimetabolites|antimetabolites|mesh-ancestor
6060645|NCT00642746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060646|NCT00642746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6060647|NCT00642746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6060648|NCT00642746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6060649|NCT00642746|Immunologic Factors|immunologic factors|mesh-ancestor
6462685|NCT00460707|Casopitant|casopitant|mesh-list
6462686|NCT00460707|Antifungal Agents|antifungal agents|mesh-ancestor
6462687|NCT00460707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6060650|NCT00642746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060651|NCT00642746|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6060652|NCT00642746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6060653|NCT00642746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6060654|NCT00642746|Antidotes|antidotes|mesh-ancestor
6060655|NCT00642746|Protective Agents|protective agents|mesh-ancestor
6060656|NCT00642746|Vitamin B Complex|vitamin b complex|mesh-ancestor
6060657|NCT00642746|Vitamins|vitamins|mesh-ancestor
6060658|NCT00642746|Micronutrients|micronutrients|mesh-ancestor
6060659|NCT00642746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6060660|NCT00642759|Paclitaxel|paclitaxel|mesh-list
6060661|NCT00642759|Bevacizumab|bevacizumab|mesh-list
6060662|NCT00642759|Carboplatin|carboplatin|mesh-list
6060663|NCT00642759|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6060664|NCT00642759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6060665|NCT00642759|Tubulin Modulators|tubulin modulators|mesh-ancestor
6060666|NCT00642759|Antimitotic Agents|antimitotic agents|mesh-ancestor
6060667|NCT00642759|Mitosis Modulators|mitosis modulators|mesh-ancestor
6060668|NCT00642759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202117|NCT02036515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6060669|NCT00642759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6060670|NCT00642759|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6060671|NCT00642759|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6060672|NCT00642759|Growth Substances|growth substances|mesh-ancestor
6060673|NCT00642759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060674|NCT00642759|Growth Inhibitors|growth inhibitors|mesh-ancestor
6060675|NCT00642811|Aspirin|aspirin|mesh-list
5506027|NCT04434378|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5506028|NCT04434378|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5506029|NCT04434378|Adrenergic Agents|adrenergic agents|mesh-ancestor
5506030|NCT04434378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5506031|NCT04434378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506032|NCT04434378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506033|NCT04434378|Urological Agents|urological agents|mesh-ancestor
5506034|NCT04434664|Metoprolol|metoprolol|mesh-list
5506035|NCT04434664|Amlodipine|amlodipine|mesh-list
5506036|NCT04434664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5506037|NCT04434664|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6060676|NCT00642811|Clopidogrel|clopidogrel|mesh-list
6060677|NCT00642811|Ticagrelor|ticagrelor|mesh-list
6060678|NCT00642811|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6060679|NCT00642811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6060680|NCT00642811|Analgesics|analgesics|mesh-ancestor
6060681|NCT00642811|Sensory System Agents|sensory system agents|mesh-ancestor
6060682|NCT00642811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6060683|NCT00642811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060684|NCT00642811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6060685|NCT00642811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6462688|NCT00460707|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6462689|NCT00460707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6462690|NCT00460707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6462691|NCT00460707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462692|NCT00460707|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6462693|NCT00460707|Hormone Antagonists|hormone antagonists|mesh-ancestor
6462694|NCT00460707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5506038|NCT04434664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6060686|NCT00642811|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6060687|NCT00642811|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6060688|NCT00642811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060689|NCT00642811|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6060690|NCT00642811|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6060691|NCT00642811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6060692|NCT00642811|Antipyretics|antipyretics|mesh-ancestor
6060693|NCT00642811|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6060694|NCT00642811|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6060695|NCT00642811|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6060696|NCT00642811|Purinergic Agents|purinergic agents|mesh-ancestor
6060697|NCT00642811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6060698|NCT00642850|Epoetin Alfa|epoetin alfa|mesh-list
6060699|NCT00642850|Hematinics|hematinics|mesh-ancestor
6060700|NCT00642954|Dexamethasone|dexamethasone|mesh-list
6060701|NCT00642954|Lenalidomide|lenalidomide|mesh-list
6060702|NCT00642954|Vorinostat|vorinostat|mesh-list
6060703|NCT00642954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6060704|NCT00642954|Antiemetics|antiemetics|mesh-ancestor
5506039|NCT04434664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506040|NCT04434664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5506041|NCT04434664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506042|NCT04434664|Vasodilator Agents|vasodilator agents|mesh-ancestor
5506043|NCT04434664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5506044|NCT04434664|Sympatholytics|sympatholytics|mesh-ancestor
5506045|NCT04434664|Autonomic Agents|autonomic agents|mesh-ancestor
5506046|NCT04434664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5506047|NCT04434664|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5506048|NCT04434664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5506049|NCT04434664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5506050|NCT04434664|Adrenergic Agents|adrenergic agents|mesh-ancestor
5506051|NCT04434664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5506052|NCT04434404|Silymarin|silymarin|mesh-list
5506053|NCT04434404|Antioxidants|antioxidants|mesh-ancestor
6060705|NCT00642954|Autonomic Agents|autonomic agents|mesh-ancestor
6060706|NCT00642954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6060707|NCT00642954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060708|NCT00642954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6060709|NCT00642954|Glucocorticoids|glucocorticoids|mesh-ancestor
6060710|NCT00642954|Hormones|hormones|mesh-ancestor
6060711|NCT00642954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6060712|NCT00642954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6060713|NCT00642954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6060714|NCT00642954|Immunologic Factors|immunologic factors|mesh-ancestor
6060715|NCT00642954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6060716|NCT00642954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6060717|NCT00642954|Growth Substances|growth substances|mesh-ancestor
6060718|NCT00642954|Growth Inhibitors|growth inhibitors|mesh-ancestor
6060719|NCT00642954|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6060720|NCT00642954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6060721|NCT00642954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060722|NCT00643097|Temozolomide|temozolomide|mesh-list
6060723|NCT00643097|Sargramostim|sargramostim|mesh-list
6060724|NCT00643097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6060725|NCT00643097|Alkylating Agents|alkylating agents|mesh-ancestor
6060726|NCT00643097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060727|NCT00643097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6060728|NCT00643097|Immunologic Factors|immunologic factors|mesh-ancestor
6060729|NCT00643097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060730|NCT00643123|Allopurinol|allopurinol|mesh-list
6060731|NCT00643123|Antimetabolites|antimetabolites|mesh-ancestor
6060732|NCT00643123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060733|NCT00643123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6060734|NCT00643123|Gout Suppressants|gout suppressants|mesh-ancestor
6060735|NCT00643123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6060736|NCT00643123|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6060737|NCT00643123|Antioxidants|antioxidants|mesh-ancestor
6060738|NCT00643123|Protective Agents|protective agents|mesh-ancestor
6060739|NCT00643123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060740|NCT00643162|Citalopram|citalopram|mesh-list
6060741|NCT00643162|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6060742|NCT00643162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6060743|NCT00643162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6060744|NCT00643162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060745|NCT00643162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6060746|NCT00643162|Serotonin Agents|serotonin agents|mesh-ancestor
6060747|NCT00643162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060748|NCT00643162|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6060749|NCT00643162|Antidepressive Agents|antidepressive agents|mesh-ancestor
6060750|NCT00643162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6060751|NCT00643201|Enoxaparin|enoxaparin|mesh-list
6060752|NCT00643201|Warfarin|warfarin|mesh-list
6060753|NCT00643201|Enoxaparin sodium|enoxaparin sodium|mesh-list
6060754|NCT00643201|Apixaban|apixaban|mesh-list
6060755|NCT00643201|Anticoagulants|anticoagulants|mesh-ancestor
6060756|NCT00643201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6060757|NCT00643201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6060758|NCT00643201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060759|NCT00643201|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6060760|NCT00643201|Antithrombins|antithrombins|mesh-ancestor
6060761|NCT00643201|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6060762|NCT00643201|Protease Inhibitors|protease inhibitors|mesh-ancestor
6060763|NCT00643201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6060764|NCT00643565|Bevacizumab|bevacizumab|mesh-list
6060765|NCT00643565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6060766|NCT00643565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6060767|NCT00643565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6060768|NCT00643565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6060769|NCT00643565|Growth Substances|growth substances|mesh-ancestor
6060770|NCT00643565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060771|NCT00643565|Growth Inhibitors|growth inhibitors|mesh-ancestor
6060772|NCT00643578|Formoterol Fumarate|formoterol fumarate|mesh-list
6060773|NCT00643578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6060774|NCT00643578|Autonomic Agents|autonomic agents|mesh-ancestor
6060775|NCT00643578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6060776|NCT00643578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060777|NCT00643578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6060778|NCT00643578|Respiratory System Agents|respiratory system agents|mesh-ancestor
6060779|NCT00643578|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6060780|NCT00643578|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6060781|NCT00643578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6060782|NCT00643578|Adrenergic Agents|adrenergic agents|mesh-ancestor
6060783|NCT00643578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6060784|NCT00643578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060785|NCT00643604|Treprostinil|treprostinil|mesh-list
6060786|NCT00643604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6060787|NCT00643760|Pregabalin|pregabalin|mesh-list
6060788|NCT00643760|Gabapentin|gabapentin|mesh-list
6060789|NCT00643760|Analgesics|analgesics|mesh-ancestor
6060790|NCT00643760|Sensory System Agents|sensory system agents|mesh-ancestor
6060791|NCT00643760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6060792|NCT00643760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060793|NCT00643760|Anticonvulsants|anticonvulsants|mesh-ancestor
6060794|NCT00643760|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6060795|NCT00643760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6060796|NCT00643760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060797|NCT00643760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6462695|NCT00460707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462696|NCT00460707|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6462697|NCT00460707|Antiemetics|antiemetics|mesh-ancestor
6462698|NCT00460707|Autonomic Agents|autonomic agents|mesh-ancestor
6462699|NCT00460707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6462700|NCT00460707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6060798|NCT00643760|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6060799|NCT00643760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6060800|NCT00643760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6060801|NCT00643760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6060802|NCT00643760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6060803|NCT00643760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6060804|NCT00643760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6060805|NCT00643760|Antimanic Agents|antimanic agents|mesh-ancestor
6060806|NCT00643851|Metformin|metformin|mesh-list
6060807|NCT00643851|Dapagliflozin|dapagliflozin|mesh-list
6060808|NCT00643851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6060809|NCT00643851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060810|NCT00643851|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6060811|NCT00643851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202118|NCT02036515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202119|NCT02036515|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6202120|NCT02036515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6202121|NCT02036515|Immunologic Factors|immunologic factors|mesh-ancestor
6202122|NCT02036515|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6202123|NCT02036580|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6202124|NCT02036580|Immunologic Factors|immunologic factors|mesh-ancestor
6202125|NCT02036580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202126|NCT02036775|Ambroxol|ambroxol|mesh-list
6202127|NCT02036775|Expectorants|expectorants|mesh-ancestor
6202128|NCT02036775|Respiratory System Agents|respiratory system agents|mesh-ancestor
6202129|NCT02036840|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6202130|NCT02036840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6202131|NCT02037061|Bupivacaine|bupivacaine|mesh-list
6202132|NCT02037061|Anesthetics, Local|anesthetics, local|mesh-ancestor
6202133|NCT02037061|Anesthetics|anesthetics|mesh-ancestor
6202134|NCT02037061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6202135|NCT02037061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202136|NCT02037061|Sensory System Agents|sensory system agents|mesh-ancestor
6202137|NCT02037061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6202138|NCT02037165|Celecoxib|celecoxib|mesh-list
6202139|NCT02037165|Pregabalin|pregabalin|mesh-list
6202140|NCT02037165|Analgesics|analgesics|mesh-ancestor
6202141|NCT02037165|Sensory System Agents|sensory system agents|mesh-ancestor
6202142|NCT02037165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6202143|NCT02037165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202144|NCT02037165|Anticonvulsants|anticonvulsants|mesh-ancestor
6202145|NCT02037165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6202146|NCT02037165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6202147|NCT02037165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202148|NCT02037165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6202149|NCT02037165|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6202150|NCT02037165|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6202151|NCT02037165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6202152|NCT02037165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6060812|NCT00644059|Vaccines|vaccines|mesh-list
6060813|NCT00644059|Immunologic Factors|immunologic factors|mesh-ancestor
6060814|NCT00644059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060815|NCT00644189|Clofarabine|clofarabine|mesh-list
6060816|NCT00644189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6060817|NCT00644189|Antimetabolites|antimetabolites|mesh-ancestor
6060818|NCT00644189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060819|NCT00644189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6060820|NCT00644228|Dexamethasone|dexamethasone|mesh-list
6060821|NCT00644228|Dexamethasone acetate|dexamethasone acetate|mesh-list
6060822|NCT00644228|Lenalidomide|lenalidomide|mesh-list
6060823|NCT00644228|Bortezomib|bortezomib|mesh-list
6060824|NCT00644228|Ichthammol|ichthammol|mesh-list
6060825|NCT00644228|BB 1101|bb 1101|mesh-list
6060826|NCT00644228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6060827|NCT00644228|Antiemetics|antiemetics|mesh-ancestor
6060828|NCT00644228|Autonomic Agents|autonomic agents|mesh-ancestor
6060829|NCT00644228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6060830|NCT00644228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060831|NCT00644228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6060832|NCT00644228|Glucocorticoids|glucocorticoids|mesh-ancestor
6060833|NCT00644228|Hormones|hormones|mesh-ancestor
6060834|NCT00644228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6060835|NCT00644228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6060836|NCT00644228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6060837|NCT00644228|Protease Inhibitors|protease inhibitors|mesh-ancestor
6060838|NCT00644228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6060839|NCT00644228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060840|NCT00644228|Immunologic Factors|immunologic factors|mesh-ancestor
6060841|NCT00644228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6060842|NCT00644228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5506054|NCT04434404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506055|NCT04434404|Protective Agents|protective agents|mesh-ancestor
5506056|NCT04434404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506057|NCT04434430|Gabapentin|gabapentin|mesh-list
5506058|NCT04434430|Analgesics|analgesics|mesh-ancestor
5506059|NCT04434430|Sensory System Agents|sensory system agents|mesh-ancestor
5506060|NCT04434430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5506061|NCT04434430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506062|NCT04434430|Anticonvulsants|anticonvulsants|mesh-ancestor
5506063|NCT04434430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5506064|NCT04434430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5506065|NCT04434430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5506066|NCT04434430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5506067|NCT04434430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5506068|NCT04434430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5506069|NCT04434430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5506070|NCT04434430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506071|NCT04434430|Antimanic Agents|antimanic agents|mesh-ancestor
5506072|NCT04434365|Aspirin|aspirin|mesh-list
6060843|NCT00644228|Growth Substances|growth substances|mesh-ancestor
6060844|NCT00644228|Growth Inhibitors|growth inhibitors|mesh-ancestor
6060845|NCT00644228|Dermatologic Agents|dermatologic agents|mesh-ancestor
6060846|NCT00644280|Ranibizumab|ranibizumab|mesh-list
6060847|NCT00644280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6060848|NCT00644280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6060849|NCT00644280|Growth Substances|growth substances|mesh-ancestor
6060850|NCT00644280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060851|NCT00644280|Growth Inhibitors|growth inhibitors|mesh-ancestor
6060852|NCT00644280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6060853|NCT00644332|Ranolazine|ranolazine|mesh-list
6060854|NCT00644332|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6060855|NCT00644332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6060856|NCT00644332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060857|NCT00644358|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
6060858|NCT00644358|Antidepressive Agents|antidepressive agents|mesh-ancestor
6060859|NCT00644358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6060860|NCT00644358|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6060861|NCT00644358|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6060862|NCT00644358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6060863|NCT00644358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060864|NCT00644358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6060865|NCT00644358|Serotonin Agents|serotonin agents|mesh-ancestor
6060866|NCT00644358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060867|NCT00644358|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6060868|NCT00644358|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6060869|NCT00644592|Fenofibrate|fenofibrate|mesh-list
6060870|NCT00644592|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6060871|NCT00644592|Antimetabolites|antimetabolites|mesh-ancestor
6060872|NCT00644592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060873|NCT00644592|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6060874|NCT00644657|Clopidogrel|clopidogrel|mesh-list
6060875|NCT00644657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6060876|NCT00644657|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6060877|NCT00644657|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5506073|NCT04434365|Clopidogrel|clopidogrel|mesh-list
5506074|NCT04434365|Atorvastatin|atorvastatin|mesh-list
5506075|NCT04434365|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5506076|NCT04434365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5506077|NCT04434365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6060878|NCT00644657|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6060879|NCT00644657|Purinergic Agents|purinergic agents|mesh-ancestor
6060880|NCT00644657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6060881|NCT00644657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060882|NCT00644657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060883|NCT00644787|Fentanyl|fentanyl|mesh-list
6060884|NCT00644787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6060885|NCT00644787|Narcotics|narcotics|mesh-ancestor
6060886|NCT00644787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6060887|NCT00644787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060888|NCT00644787|Analgesics|analgesics|mesh-ancestor
6060889|NCT00644787|Sensory System Agents|sensory system agents|mesh-ancestor
6060890|NCT00644787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6060891|NCT00644787|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6060892|NCT00644787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6060893|NCT00644787|Anesthetics, General|anesthetics, general|mesh-ancestor
6060894|NCT00644787|Anesthetics|anesthetics|mesh-ancestor
6060895|NCT00644969|Varenicline|varenicline|mesh-list
6060896|NCT00644969|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6060897|NCT00644969|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6060898|NCT00644969|Cholinergic Agents|cholinergic agents|mesh-ancestor
6060899|NCT00644969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6060900|NCT00644969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060901|NCT00644969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060902|NCT00645099|Olanzapine|olanzapine|mesh-list
6060903|NCT00645099|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6060904|NCT00645099|Antiemetics|antiemetics|mesh-ancestor
6060905|NCT00645099|Autonomic Agents|autonomic agents|mesh-ancestor
6060906|NCT00645099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6060907|NCT00645099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060908|NCT00645099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5506078|NCT04434365|Analgesics|analgesics|mesh-ancestor
6060909|NCT00645099|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6060910|NCT00645099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6060911|NCT00645099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5506079|NCT04434365|Sensory System Agents|sensory system agents|mesh-ancestor
5506080|NCT04434365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5506081|NCT04434365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506082|NCT04434365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5506083|NCT04434365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5506084|NCT04434365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5506085|NCT04434365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5506086|NCT04434365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506087|NCT04434365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5506088|NCT04434365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6060912|NCT00645099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6060913|NCT00645099|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6060914|NCT00645099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6060915|NCT00645099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6060916|NCT00645099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506089|NCT04434365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5506090|NCT04434365|Antipyretics|antipyretics|mesh-ancestor
5506091|NCT04434365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5506092|NCT04434365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5506093|NCT04434365|Antimetabolites|antimetabolites|mesh-ancestor
5506094|NCT04434365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5506095|NCT04434365|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5506096|NCT04434365|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5506097|NCT04434365|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6060917|NCT00645099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6060918|NCT00645099|Serotonin Agents|serotonin agents|mesh-ancestor
6060919|NCT00645099|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6060920|NCT00645099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6060921|NCT00645099|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6060922|NCT00645099|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6060923|NCT00645099|Dopamine Agents|dopamine agents|mesh-ancestor
6060924|NCT00645333|Docetaxel|docetaxel|mesh-list
6060925|NCT00645333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6060926|NCT00645333|Tubulin Modulators|tubulin modulators|mesh-ancestor
6060927|NCT00645333|Antimitotic Agents|antimitotic agents|mesh-ancestor
6060928|NCT00645333|Mitosis Modulators|mitosis modulators|mesh-ancestor
6060929|NCT00645333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060930|NCT00645411|Vaccines|vaccines|mesh-list
6060931|NCT00645411|Immunologic Factors|immunologic factors|mesh-ancestor
6060932|NCT00645411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060933|NCT00645450|Propranolol|propranolol|mesh-list
6060934|NCT00645450|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6060935|NCT00645450|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6060936|NCT00645450|Adrenergic Agents|adrenergic agents|mesh-ancestor
6060937|NCT00645450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6060938|NCT00645450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060939|NCT00645450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060940|NCT00645450|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6060941|NCT00645450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6060942|NCT00645450|Vasodilator Agents|vasodilator agents|mesh-ancestor
6060943|NCT00645528|Insulin|insulin|mesh-list
5506098|NCT04434365|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5506099|NCT04434365|Purinergic Agents|purinergic agents|mesh-ancestor
5506100|NCT04434365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5506101|NCT04434248|Ritonavir|ritonavir|mesh-list
5506102|NCT04434248|Lopinavir|lopinavir|mesh-list
5506103|NCT04434248|Hydroxychloroquine|hydroxychloroquine|mesh-list
5506104|NCT04434248|Chloroquine|chloroquine|mesh-list
5506105|NCT04434248|Favipiravir|favipiravir|mesh-list
5506106|NCT04434248|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6060944|NCT00645528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6060945|NCT00645528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060946|NCT00645593|Gemcitabine|gemcitabine|mesh-list
6060947|NCT00645593|Cetuximab|cetuximab|mesh-list
6060948|NCT00645593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6060949|NCT00645593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6060950|NCT00645593|Antimetabolites|antimetabolites|mesh-ancestor
6060951|NCT00645593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060952|NCT00645593|Antiviral Agents|antiviral agents|mesh-ancestor
5506107|NCT04434248|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5506108|NCT04434248|Protease Inhibitors|protease inhibitors|mesh-ancestor
5506109|NCT04434248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6060953|NCT00645593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6060954|NCT00645593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6060955|NCT00645593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5506110|NCT04434248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506111|NCT04434248|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5506112|NCT04434248|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5506113|NCT04434248|Antiviral Agents|antiviral agents|mesh-ancestor
5506114|NCT04434248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5506115|NCT04434248|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5506116|NCT04434248|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5506117|NCT04434248|Antimalarials|antimalarials|mesh-ancestor
5506118|NCT04434248|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5506119|NCT04434248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5506120|NCT04434248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5506121|NCT04434248|Amebicides|amebicides|mesh-ancestor
5506122|NCT04434105|Triamcinolone|triamcinolone|mesh-list
5506123|NCT04434105|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5506124|NCT04434105|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5506125|NCT04434105|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5506126|NCT04434105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5506127|NCT04434105|Glucocorticoids|glucocorticoids|mesh-ancestor
5506128|NCT04434105|Hormones|hormones|mesh-ancestor
5506129|NCT04434105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5506130|NCT04434105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506131|NCT04434105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5506132|NCT04434105|Immunologic Factors|immunologic factors|mesh-ancestor
5506133|NCT04434105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5506134|NCT04434105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506135|NCT04434118|Antirheumatic Agents|antirheumatic agents|mesh-list
5506136|NCT04434144|Azithromycin|azithromycin|mesh-list
5506137|NCT04434144|Doxycycline|doxycycline|mesh-list
5506138|NCT04434144|Hydroxychloroquine|hydroxychloroquine|mesh-list
5506139|NCT04434144|Ivermectin|ivermectin|mesh-list
5506140|NCT04434144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5506141|NCT04434144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5506142|NCT04434144|Antimalarials|antimalarials|mesh-ancestor
5506143|NCT04434144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5506144|NCT04434144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5506145|NCT04434144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5506146|NCT04434144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506147|NCT04434144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5506148|NCT04434170|Valsartan|valsartan|mesh-list
5506149|NCT04434170|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5506150|NCT04434170|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5506151|NCT04434170|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5506152|NCT04434170|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5506153|NCT04434170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506154|NCT04433533|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5506155|NCT04433533|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5506156|NCT04433533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5506157|NCT04433533|Antimetabolites|antimetabolites|mesh-ancestor
6060956|NCT00645593|Immunologic Factors|immunologic factors|mesh-ancestor
6060957|NCT00645593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060958|NCT00645593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6060959|NCT00645671|Loteprednol Etabonate|loteprednol etabonate|mesh-list
6060960|NCT00645671|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6060961|NCT00645710|Gemcitabine|gemcitabine|mesh-list
6060962|NCT00645710|Floxuridine|floxuridine|mesh-list
6060963|NCT00645710|Antibodies|antibodies|mesh-list
6060964|NCT00645710|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6060965|NCT00645710|Immunologic Factors|immunologic factors|mesh-ancestor
6060966|NCT00645710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060967|NCT00645710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6060968|NCT00645710|Antimetabolites|antimetabolites|mesh-ancestor
6462701|NCT00460707|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6060969|NCT00645710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060970|NCT00645710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6060971|NCT00645710|Antiviral Agents|antiviral agents|mesh-ancestor
6060972|NCT00645710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6060973|NCT00645710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6060974|NCT00645710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6060975|NCT00645788|Ciprofloxacin|ciprofloxacin|mesh-list
6060976|NCT00645788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6060977|NCT00645788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6060978|NCT00645788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5506158|NCT04433533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506159|NCT04433533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5506160|NCT04433533|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5506161|NCT04433533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5506162|NCT04433780|Tenofovir|tenofovir|mesh-list
5506163|NCT04433780|Lamivudine|lamivudine|mesh-list
5506164|NCT04433780|Antiviral Agents|antiviral agents|mesh-ancestor
5506165|NCT04433780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5506166|NCT04433780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5506167|NCT04433780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5506168|NCT04433780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5506169|NCT04433780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506170|NCT04433780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6060979|NCT00645788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6060980|NCT00645788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6060981|NCT00645788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6060982|NCT00645788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6060983|NCT00645788|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6060984|NCT00645788|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5506171|NCT04433780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5600142|NCT03714490|Capecitabine|capecitabine|mesh-list
5600143|NCT03714490|Oxaliplatin|oxaliplatin|mesh-list
5600144|NCT03714490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5600145|NCT03714490|Antimetabolites|antimetabolites|mesh-ancestor
5600146|NCT03714490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600147|NCT03714490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5600148|NCT03714360|Tranexamic Acid|tranexamic acid|mesh-list
5600149|NCT03714360|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5600150|NCT03714360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5600151|NCT03714360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600152|NCT03714360|Hemostatics|hemostatics|mesh-ancestor
5600153|NCT03714360|Coagulants|coagulants|mesh-ancestor
5600154|NCT03714165|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5600155|NCT03714165|Defensins|defensins|mesh-list
5600156|NCT03714165|alpha-Defensins|alpha-defensins|mesh-list
5600157|NCT03714165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5600158|NCT03714113|Antibodies|antibodies|mesh-list
5600159|NCT03714113|Immunologic Factors|immunologic factors|mesh-ancestor
5600160|NCT03714113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600161|NCT03713918|Lithium Carbonate|lithium carbonate|mesh-list
6060985|NCT00645840|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6060986|NCT00645840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6060987|NCT00645853|Warfarin|warfarin|mesh-list
6060988|NCT00645853|Anticoagulants|anticoagulants|mesh-ancestor
6060989|NCT00645944|Eszopiclone|eszopiclone|mesh-list
5600162|NCT03713918|Antidepressive Agents|antidepressive agents|mesh-ancestor
5600163|NCT03713918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5600164|NCT03713918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5600165|NCT03713918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600166|NCT03713918|Antimanic Agents|antimanic agents|mesh-ancestor
5600167|NCT03713918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5600168|NCT03713918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5600169|NCT03713918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600170|NCT03713892|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
5600171|NCT03713892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5600172|NCT03713892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600173|NCT03713879|Indomethacin|indomethacin|mesh-list
5600174|NCT03713879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5600175|NCT03713879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5600176|NCT03713879|Analgesics|analgesics|mesh-ancestor
5600177|NCT03713879|Sensory System Agents|sensory system agents|mesh-ancestor
5600178|NCT03713879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5600179|NCT03713879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600180|NCT03713879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5600181|NCT03713879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5600182|NCT03713879|Gout Suppressants|gout suppressants|mesh-ancestor
6060990|NCT00645944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6060991|NCT00645944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6060992|NCT00645944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060993|NCT00646451|Pregabalin|pregabalin|mesh-list
6060994|NCT00646451|Analgesics|analgesics|mesh-ancestor
6060995|NCT00646451|Sensory System Agents|sensory system agents|mesh-ancestor
6060996|NCT00646451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5600183|NCT03713879|Tocolytic Agents|tocolytic agents|mesh-ancestor
6060997|NCT00646451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6060998|NCT00646451|Anticonvulsants|anticonvulsants|mesh-ancestor
6060999|NCT00646451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6061000|NCT00646451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6061001|NCT00646451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061002|NCT00646451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6061003|NCT00646451|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6061004|NCT00646451|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6061005|NCT00646451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6061006|NCT00646451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6061007|NCT00646581|Insulin|insulin|mesh-list
6061008|NCT00646581|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6061009|NCT00646581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6061010|NCT00646581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061011|NCT00646646|Midazolam|midazolam|mesh-list
6061012|NCT00646646|Dexmedetomidine|dexmedetomidine|mesh-list
6061013|NCT00646646|Propofol|propofol|mesh-list
6061014|NCT00646646|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6061015|NCT00646646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6061016|NCT00646646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061017|NCT00646646|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6061018|NCT00646646|Anesthetics, General|anesthetics, general|mesh-ancestor
6061019|NCT00646646|Anesthetics|anesthetics|mesh-ancestor
6061020|NCT00646646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6061021|NCT00646646|Analgesics|analgesics|mesh-ancestor
6061022|NCT00646646|Sensory System Agents|sensory system agents|mesh-ancestor
6061023|NCT00646646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6061024|NCT00646646|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6061025|NCT00646646|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6061026|NCT00646646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6061027|NCT00646646|Adrenergic Agents|adrenergic agents|mesh-ancestor
6061028|NCT00646646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6061029|NCT00646646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061030|NCT00646646|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6061031|NCT00646646|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6061032|NCT00646646|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6061033|NCT00646646|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6061034|NCT00646646|GABA Modulators|gaba modulators|mesh-ancestor
6061035|NCT00646646|GABA Agents|gaba agents|mesh-ancestor
6061036|NCT00646763|Lenograstim|lenograstim|mesh-list
6061037|NCT00646763|Sargramostim|sargramostim|mesh-list
6061038|NCT00646763|Mitogens|mitogens|mesh-list
6061039|NCT00646763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6061040|NCT00646763|Immunologic Factors|immunologic factors|mesh-ancestor
6061041|NCT00646763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061042|NCT00646763|Mitosis Modulators|mitosis modulators|mesh-ancestor
6061043|NCT00646763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061044|NCT00646776|Ritonavir|ritonavir|mesh-list
6061045|NCT00646776|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6061046|NCT00646776|Rifabutin|rifabutin|mesh-list
6061047|NCT00646776|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6061048|NCT00646776|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6061049|NCT00646776|Protease Inhibitors|protease inhibitors|mesh-ancestor
6061050|NCT00646776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6061051|NCT00646776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061052|NCT00646776|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6061053|NCT00646776|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6061054|NCT00646776|Antiviral Agents|antiviral agents|mesh-ancestor
6061055|NCT00646776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6061056|NCT00646776|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6061057|NCT00646776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6061058|NCT00646776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6061059|NCT00646776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6061060|NCT00646776|Antitubercular Agents|antitubercular agents|mesh-ancestor
6061061|NCT00646906|Aspirin|aspirin|mesh-list
6061062|NCT00646906|Acetaminophen|acetaminophen|mesh-list
6061063|NCT00646906|Ibuprofen|ibuprofen|mesh-list
6061064|NCT00646906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6061065|NCT00646906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6061066|NCT00646906|Analgesics|analgesics|mesh-ancestor
6061067|NCT00646906|Sensory System Agents|sensory system agents|mesh-ancestor
6061068|NCT00646906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6061069|NCT00646906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061070|NCT00646906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6061071|NCT00646906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6061072|NCT00646906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6061073|NCT00646906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6061074|NCT00646906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061075|NCT00646906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6061076|NCT00646906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6061077|NCT00646906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6061078|NCT00646906|Antipyretics|antipyretics|mesh-ancestor
6061079|NCT00646958|Linezolid|linezolid|mesh-list
6061080|NCT00646958|Radezolid|radezolid|mesh-list
6061081|NCT00646958|Oxazolidinones|oxazolidinones|mesh-list
6061082|NCT00646958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6061083|NCT00646958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6061084|NCT00646958|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6061085|NCT00646958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6061086|NCT00646958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061087|NCT00647270|Adalimumab|adalimumab|mesh-list
6061088|NCT00647270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6061089|NCT00647270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6061090|NCT00647296|Pramipexole|pramipexole|mesh-list
6061091|NCT00647296|Antioxidants|antioxidants|mesh-ancestor
6061092|NCT00647296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061093|NCT00647296|Protective Agents|protective agents|mesh-ancestor
6061094|NCT00647296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061095|NCT00647296|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6061096|NCT00647296|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6061097|NCT00647296|Dopamine Agonists|dopamine agonists|mesh-ancestor
6061098|NCT00647296|Dopamine Agents|dopamine agents|mesh-ancestor
6061099|NCT00647296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6061100|NCT00647348|Simvastatin|simvastatin|mesh-list
6061101|NCT00647348|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6061102|NCT00647348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6061103|NCT00647348|Antimetabolites|antimetabolites|mesh-ancestor
6061104|NCT00647348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061105|NCT00647348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6061106|NCT00647348|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6061107|NCT00647348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6061108|NCT00647400|Adalimumab|adalimumab|mesh-list
6061109|NCT00647400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6061110|NCT00647400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6061111|NCT00647556|Adapalene|adapalene|mesh-list
6061112|NCT00647556|Tretinoin|tretinoin|mesh-list
6061113|NCT00647556|Emollients|emollients|mesh-list
6061114|NCT00647556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6061115|NCT00647556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6061116|NCT00647556|Analgesics|analgesics|mesh-ancestor
6061117|NCT00647556|Sensory System Agents|sensory system agents|mesh-ancestor
6061118|NCT00647556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6061119|NCT00647556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061120|NCT00647556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6061121|NCT00647556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6061122|NCT00647556|Dermatologic Agents|dermatologic agents|mesh-ancestor
6061123|NCT00647556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6061124|NCT00647556|Keratolytic Agents|keratolytic agents|mesh-ancestor
6061125|NCT00647699|Riboflavin|riboflavin|mesh-list
6061126|NCT00647699|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6061127|NCT00647699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6061128|NCT00647699|Vitamin B Complex|vitamin b complex|mesh-ancestor
6061129|NCT00647699|Vitamins|vitamins|mesh-ancestor
6061130|NCT00647699|Micronutrients|micronutrients|mesh-ancestor
6061131|NCT00647699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061132|NCT00647699|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6061133|NCT00647699|Dermatologic Agents|dermatologic agents|mesh-ancestor
6061134|NCT00647998|Darbepoetin alfa|darbepoetin alfa|mesh-list
6061135|NCT00647998|Hematinics|hematinics|mesh-ancestor
6061136|NCT00648037|Rituximab|rituximab|mesh-list
6061137|NCT00648037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6061138|NCT00648037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6061139|NCT00648037|Immunologic Factors|immunologic factors|mesh-ancestor
6061140|NCT00648037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061141|NCT00648037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6061142|NCT00648375|Propranolol|propranolol|mesh-list
6061143|NCT00648375|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6061144|NCT00648375|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6061145|NCT00648375|Adrenergic Agents|adrenergic agents|mesh-ancestor
6061146|NCT00648375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6061147|NCT00648375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061148|NCT00648375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061149|NCT00648375|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6061150|NCT00648375|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6061151|NCT00648375|Vasodilator Agents|vasodilator agents|mesh-ancestor
6061152|NCT00648648|Gemcitabine|gemcitabine|mesh-list
6061153|NCT00648648|Carboplatin|carboplatin|mesh-list
6061154|NCT00648648|Adavosertib|adavosertib|mesh-list
6061155|NCT00648648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6061156|NCT00648648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6061157|NCT00648648|Antimetabolites|antimetabolites|mesh-ancestor
6061158|NCT00648648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061159|NCT00648648|Antiviral Agents|antiviral agents|mesh-ancestor
5506172|NCT04433611|Lidocaine|lidocaine|mesh-list
5506173|NCT04433611|Anesthetics, Local|anesthetics, local|mesh-ancestor
5506174|NCT04433611|Anesthetics|anesthetics|mesh-ancestor
5506175|NCT04433611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5506176|NCT04433611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506177|NCT04433611|Sensory System Agents|sensory system agents|mesh-ancestor
5506178|NCT04433611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5506179|NCT04433611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5506180|NCT04433611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5506181|NCT04433611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5506182|NCT04433611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5506183|NCT04433611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061160|NCT00648648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6061161|NCT00648648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6061162|NCT00648648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6061163|NCT00648648|Immunologic Factors|immunologic factors|mesh-ancestor
6061164|NCT00648648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061165|NCT00648908|4-Aminopyridine|4-aminopyridine|mesh-list
6061166|NCT00648908|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6061167|NCT00648908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6061168|NCT00648908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061169|NCT00649220|Memantine|memantine|mesh-list
6061170|NCT00649220|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6061171|NCT00649220|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6061172|NCT00649220|Dopamine Agents|dopamine agents|mesh-ancestor
6061173|NCT00649220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6061174|NCT00649220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061175|NCT00649220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061176|NCT00649220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6061177|NCT00649220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6061178|NCT00649389|Amlodipine|amlodipine|mesh-list
6061179|NCT00649389|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6061180|NCT00649389|Olmesartan|olmesartan|mesh-list
6061181|NCT00649389|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6061182|NCT00649389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6061183|NCT00649389|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6061184|NCT00649389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6061185|NCT00649389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061186|NCT00649389|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6061187|NCT00649389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061188|NCT00649389|Vasodilator Agents|vasodilator agents|mesh-ancestor
6061189|NCT00649389|Diuretics|diuretics|mesh-ancestor
6061190|NCT00649389|Natriuretic Agents|natriuretic agents|mesh-ancestor
6061191|NCT00649389|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6061192|NCT00649389|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5506184|NCT04433481|Dabigatran|dabigatran|mesh-list
5506185|NCT04433481|Antithrombins|antithrombins|mesh-ancestor
5506186|NCT04433481|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5506187|NCT04433481|Protease Inhibitors|protease inhibitors|mesh-ancestor
5506188|NCT04433481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5506189|NCT04433481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506190|NCT04433481|Anticoagulants|anticoagulants|mesh-ancestor
5506191|NCT04433494|Tamoxifen|tamoxifen|mesh-list
5506192|NCT04433494|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5506193|NCT04433494|Hormone Antagonists|hormone antagonists|mesh-ancestor
5506194|NCT04433494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5506195|NCT04433494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506196|NCT04433494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5506197|NCT04433494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5506198|NCT04433494|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5506199|NCT04433494|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5506200|NCT04433494|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6061193|NCT00649389|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6061194|NCT00649792|4-Aminopyridine|4-aminopyridine|mesh-list
6061195|NCT00649792|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6061196|NCT00649792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6061197|NCT00649792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061198|NCT00649961|Melatonin|melatonin|mesh-list
6061199|NCT00649961|Antioxidants|antioxidants|mesh-ancestor
6061200|NCT00649961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061201|NCT00649961|Protective Agents|protective agents|mesh-ancestor
6061202|NCT00649961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061203|NCT00649961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6061204|NCT00650078|Prednisone|prednisone|mesh-list
6061205|NCT00650078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6061206|NCT00650078|Glucocorticoids|glucocorticoids|mesh-ancestor
6061207|NCT00650078|Hormones|hormones|mesh-ancestor
6061208|NCT00650078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6061209|NCT00650078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061210|NCT00650078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6061211|NCT00650078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6061212|NCT00650091|Acetylcysteine|acetylcysteine|mesh-list
6061213|NCT00650091|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6061214|NCT00650091|Antiviral Agents|antiviral agents|mesh-ancestor
6061215|NCT00650091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6061216|NCT00650091|Expectorants|expectorants|mesh-ancestor
5506201|NCT04433741|Oxytocin|oxytocin|mesh-list
6061217|NCT00650091|Respiratory System Agents|respiratory system agents|mesh-ancestor
6061218|NCT00650091|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6061219|NCT00650091|Antioxidants|antioxidants|mesh-ancestor
6061220|NCT00650091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061221|NCT00650091|Protective Agents|protective agents|mesh-ancestor
6061222|NCT00650091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061223|NCT00650091|Antidotes|antidotes|mesh-ancestor
6061224|NCT00650104|Ropinirole|ropinirole|mesh-list
6061225|NCT00650104|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6061226|NCT00650104|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6061227|NCT00650104|Dopamine Agonists|dopamine agonists|mesh-ancestor
6061228|NCT00650104|Dopamine Agents|dopamine agents|mesh-ancestor
6061229|NCT00650104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6061230|NCT00650104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061231|NCT00650104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061232|NCT00650546|Exenatide|exenatide|mesh-list
6061233|NCT00650546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6061234|NCT00650546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061235|NCT00650546|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6061236|NCT00650546|Incretins|incretins|mesh-ancestor
6061237|NCT00650546|Hormones|hormones|mesh-ancestor
6061238|NCT00650546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6061239|NCT00650806|Canagliflozin|canagliflozin|mesh-list
6061240|NCT00650806|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6061241|NCT00650806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061242|NCT00650806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6061243|NCT00650806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061244|NCT00650845|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
6061245|NCT00650845|Chelating Agents|chelating agents|mesh-ancestor
6061246|NCT00650845|Sequestering Agents|sequestering agents|mesh-ancestor
6061247|NCT00650845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061248|NCT00650858|Plasminogen|plasminogen|mesh-list
6061249|NCT00650858|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6061250|NCT00650858|Fibrinolytic Agents|fibrinolytic agents|mesh-list
6061251|NCT00650858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6061252|NCT00650858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061253|NCT00651040|Prednisone|prednisone|mesh-list
6061254|NCT00651040|Prednisolone|prednisolone|mesh-list
6061255|NCT00651040|Methotrexate|methotrexate|mesh-list
6061256|NCT00651040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6061257|NCT00651040|Glucocorticoids|glucocorticoids|mesh-ancestor
6061258|NCT00651040|Hormones|hormones|mesh-ancestor
6061259|NCT00651040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6061260|NCT00651040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061261|NCT00651040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6061262|NCT00651040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6061263|NCT00651040|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6061264|NCT00651040|Abortifacient Agents|abortifacient agents|mesh-ancestor
6061265|NCT00651040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6061266|NCT00651040|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6061267|NCT00651040|Antimetabolites|antimetabolites|mesh-ancestor
6061268|NCT00651040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061269|NCT00651040|Dermatologic Agents|dermatologic agents|mesh-ancestor
6061270|NCT00651040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6061271|NCT00651040|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6061272|NCT00651040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6061273|NCT00651040|Immunologic Factors|immunologic factors|mesh-ancestor
6061274|NCT00651040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6061275|NCT00651040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6061276|NCT00651118|Fluticasone|fluticasone|mesh-list
6061277|NCT00651118|Xhance|xhance|mesh-list
6061278|NCT00651118|Azelastine|azelastine|mesh-list
6061279|NCT00651118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6061280|NCT00651118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6061281|NCT00651118|Autonomic Agents|autonomic agents|mesh-ancestor
6061282|NCT00651118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6061283|NCT00651118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061284|NCT00651118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6061285|NCT00651118|Respiratory System Agents|respiratory system agents|mesh-ancestor
6061286|NCT00651118|Dermatologic Agents|dermatologic agents|mesh-ancestor
6462702|NCT00460707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6462703|NCT00460733|Vitamin D|vitamin d|mesh-list
6462704|NCT00460733|Cholecalciferol|cholecalciferol|mesh-list
6462705|NCT00460733|Risedronic Acid|risedronic acid|mesh-list
6462706|NCT00460733|Calcium|calcium|mesh-list
6462707|NCT00460733|Vitamins|vitamins|mesh-ancestor
6462708|NCT00460733|Micronutrients|micronutrients|mesh-ancestor
6462709|NCT00460733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462710|NCT00460733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6462711|NCT00460733|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6462712|NCT00460733|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6462713|NCT00460733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6462714|NCT00460733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462715|NCT00460759|Moxifloxacin|moxifloxacin|mesh-list
6462716|NCT00460759|Rifapentine|rifapentine|mesh-list
6462717|NCT00460759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6462718|NCT00460759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6462719|NCT00460759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5506202|NCT04433741|Oxytocics|oxytocics|mesh-ancestor
6061287|NCT00651118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6061288|NCT00651118|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6061289|NCT00651118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6061290|NCT00651118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061291|NCT00651118|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6061292|NCT00651118|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6061293|NCT00651118|Histamine Antagonists|histamine antagonists|mesh-ancestor
6061294|NCT00651118|Histamine Agents|histamine agents|mesh-ancestor
6061295|NCT00651118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6061296|NCT00651183|Pramipexole|pramipexole|mesh-list
6061297|NCT00651183|Antioxidants|antioxidants|mesh-ancestor
6061298|NCT00651183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061299|NCT00651183|Protective Agents|protective agents|mesh-ancestor
6061300|NCT00651183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061301|NCT00651183|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6061302|NCT00651183|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6061303|NCT00651183|Dopamine Agonists|dopamine agonists|mesh-ancestor
6061304|NCT00651183|Dopamine Agents|dopamine agents|mesh-ancestor
6061305|NCT00651183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6061306|NCT00651261|Cytarabine|cytarabine|mesh-list
6061307|NCT00651261|Dexamethasone|dexamethasone|mesh-list
6061308|NCT00651261|Dexamethasone acetate|dexamethasone acetate|mesh-list
6061309|NCT00651261|Daunorubicin|daunorubicin|mesh-list
6061310|NCT00651261|Midostaurin|midostaurin|mesh-list
6061311|NCT00651261|BB 1101|bb 1101|mesh-list
6061312|NCT00651261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6462720|NCT00460759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6061313|NCT00651261|Antiemetics|antiemetics|mesh-ancestor
6061314|NCT00651261|Autonomic Agents|autonomic agents|mesh-ancestor
6061315|NCT00651261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6061316|NCT00651261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061317|NCT00651261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6061318|NCT00651261|Glucocorticoids|glucocorticoids|mesh-ancestor
5506203|NCT04433741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5506204|NCT04433741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506205|NCT04433572|Sirolimus|sirolimus|mesh-list
5506206|NCT04433572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5506207|NCT04433572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5506208|NCT04433572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5506209|NCT04433572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5506210|NCT04433572|Antifungal Agents|antifungal agents|mesh-ancestor
5506211|NCT04433572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5506212|NCT04433572|Immunologic Factors|immunologic factors|mesh-ancestor
5506213|NCT04433572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506214|NCT04433546|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
5506215|NCT04433546|Vasodilator Agents|vasodilator agents|mesh-ancestor
5506216|NCT04433559|Tadalafil|tadalafil|mesh-list
5506217|NCT04433559|Vasodilator Agents|vasodilator agents|mesh-ancestor
5506218|NCT04433559|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5506219|NCT04433559|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5506220|NCT04433559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5506221|NCT04433559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506222|NCT04433559|Urological Agents|urological agents|mesh-ancestor
5506223|NCT04433390|Naloxegol|naloxegol|mesh-list
5506224|NCT04433390|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5506225|NCT04433390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061319|NCT00651261|Hormones|hormones|mesh-ancestor
6061320|NCT00651261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6061321|NCT00651261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6061322|NCT00651261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6061323|NCT00651261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6061324|NCT00651261|Antimetabolites|antimetabolites|mesh-ancestor
6061325|NCT00651261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061326|NCT00651261|Antiviral Agents|antiviral agents|mesh-ancestor
6061327|NCT00651261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6061328|NCT00651261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6061329|NCT00651261|Immunologic Factors|immunologic factors|mesh-ancestor
5506226|NCT04433390|Sensory System Agents|sensory system agents|mesh-ancestor
5506227|NCT04433390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5506228|NCT04433169|Tretinoin|tretinoin|mesh-list
5506229|NCT04433169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5506230|NCT04433169|Keratolytic Agents|keratolytic agents|mesh-ancestor
5506231|NCT04433169|Dermatologic Agents|dermatologic agents|mesh-ancestor
5506232|NCT04433156|Prednisone|prednisone|mesh-list
5506233|NCT04433156|Cyclophosphamide|cyclophosphamide|mesh-list
5506234|NCT04433156|Rituximab|rituximab|mesh-list
5506235|NCT04433156|Bortezomib|bortezomib|mesh-list
5506236|NCT04433156|Epirubicin|epirubicin|mesh-list
5506237|NCT04433156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6061330|NCT00651261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6061331|NCT00651261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6061332|NCT00651261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6061333|NCT00651261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6061334|NCT00651261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6061335|NCT00651261|Protease Inhibitors|protease inhibitors|mesh-ancestor
6061336|NCT00651313|Lidocaine|lidocaine|mesh-list
6061337|NCT00651313|Anesthetics, Local|anesthetics, local|mesh-ancestor
6061338|NCT00651313|Anesthetics|anesthetics|mesh-ancestor
5506238|NCT04433156|Immunologic Factors|immunologic factors|mesh-ancestor
5506239|NCT04433156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506240|NCT04433156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5506241|NCT04433156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5506242|NCT04433156|Alkylating Agents|alkylating agents|mesh-ancestor
5506243|NCT04433156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506244|NCT04433156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5506245|NCT04433156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6061339|NCT00651313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6061340|NCT00651313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061341|NCT00651313|Sensory System Agents|sensory system agents|mesh-ancestor
6061342|NCT00651313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6061343|NCT00651313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5506246|NCT04433156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6462721|NCT00460759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6061344|NCT00651313|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6061345|NCT00651313|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6061346|NCT00651313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6061347|NCT00651313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061348|NCT00651482|Bevacizumab|bevacizumab|mesh-list
6061349|NCT00651482|Everolimus|everolimus|mesh-list
6061350|NCT00651482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6061351|NCT00651482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6061352|NCT00651482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6061353|NCT00651482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6061354|NCT00651482|Growth Substances|growth substances|mesh-ancestor
6061355|NCT00651482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506247|NCT04433156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5506248|NCT04433156|Glucocorticoids|glucocorticoids|mesh-ancestor
5506249|NCT04433156|Hormones|hormones|mesh-ancestor
5506250|NCT04433156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5506251|NCT04433156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6061356|NCT00651482|Growth Inhibitors|growth inhibitors|mesh-ancestor
6061357|NCT00651482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6061358|NCT00651482|Immunologic Factors|immunologic factors|mesh-ancestor
6061359|NCT00651755|Prednisone|prednisone|mesh-list
6665234|NCT01516346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6665235|NCT01516372|Moxifloxacin|moxifloxacin|mesh-list
6665236|NCT01516372|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6665237|NCT01516372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6665238|NCT01516372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6665239|NCT01516372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6665240|NCT01516372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6665241|NCT01516372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6665242|NCT01516372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665243|NCT01516372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6665244|NCT01516372|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6665245|NCT01516372|Contraceptive Agents|contraceptive agents|mesh-ancestor
6665246|NCT01516372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6665247|NCT01516372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665248|NCT01516372|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5506252|NCT04433156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5506253|NCT04433156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5506254|NCT04433156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5506255|NCT04433156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5506256|NCT04433143|Minocycline|minocycline|mesh-list
5506257|NCT04433143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5506258|NCT04433143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5506259|NCT04433078|Doxycycline|doxycycline|mesh-list
5506260|NCT04433078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5506261|NCT04433078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5506262|NCT04433078|Antimalarials|antimalarials|mesh-ancestor
5506263|NCT04433078|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5506264|NCT04433078|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5506265|NCT04432714|Prednisone|prednisone|mesh-list
5506266|NCT04432714|Cyclophosphamide|cyclophosphamide|mesh-list
5506267|NCT04432714|Rituximab|rituximab|mesh-list
5506268|NCT04432714|Doxorubicin|doxorubicin|mesh-list
5506269|NCT04432714|Etoposide|etoposide|mesh-list
6061360|NCT00651755|Cyclophosphamide|cyclophosphamide|mesh-list
6665249|NCT01516372|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6665250|NCT01516372|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6665251|NCT01516450|Belimumab|belimumab|mesh-list
6665252|NCT01516450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6665253|NCT01516450|Immunologic Factors|immunologic factors|mesh-ancestor
6665254|NCT01516450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665255|NCT01516463|Bacitracin|bacitracin|mesh-list
6061361|NCT00651755|Rituximab|rituximab|mesh-list
6061362|NCT00651755|Doxorubicin|doxorubicin|mesh-list
6061363|NCT00651755|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6061364|NCT00651755|Vincristine|vincristine|mesh-list
6061365|NCT00651755|Ondansetron|ondansetron|mesh-list
6061366|NCT00651755|Aprepitant|aprepitant|mesh-list
6061367|NCT00651755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6061368|NCT00651755|Immunologic Factors|immunologic factors|mesh-ancestor
6061369|NCT00651755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061370|NCT00651755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6061371|NCT00651755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6061372|NCT00651755|Alkylating Agents|alkylating agents|mesh-ancestor
6207710|NCT02119468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5506270|NCT04432714|Vincristine|vincristine|mesh-list
5506271|NCT04432714|Lenalidomide|lenalidomide|mesh-list
6061373|NCT00651755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061374|NCT00651755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6061375|NCT00651755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6462722|NCT00460759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462723|NCT00460759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6061376|NCT00651755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6061377|NCT00651755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6061378|NCT00651755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6061379|NCT00651755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6061380|NCT00651755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6061381|NCT00651755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6061382|NCT00651755|Glucocorticoids|glucocorticoids|mesh-ancestor
6061383|NCT00651755|Hormones|hormones|mesh-ancestor
6061384|NCT00651755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6061385|NCT00651755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5506272|NCT04432714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5506273|NCT04432714|Immunologic Factors|immunologic factors|mesh-ancestor
6061386|NCT00651755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6061387|NCT00651755|Tubulin Modulators|tubulin modulators|mesh-ancestor
6061388|NCT00651755|Antimitotic Agents|antimitotic agents|mesh-ancestor
6061389|NCT00651755|Mitosis Modulators|mitosis modulators|mesh-ancestor
6061390|NCT00651755|Antiemetics|antiemetics|mesh-ancestor
6061391|NCT00651755|Autonomic Agents|autonomic agents|mesh-ancestor
6061392|NCT00651755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6061393|NCT00651755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6061394|NCT00651755|Antipruritics|antipruritics|mesh-ancestor
6061395|NCT00651755|Dermatologic Agents|dermatologic agents|mesh-ancestor
6061396|NCT00651755|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6061397|NCT00651755|Serotonin Agents|serotonin agents|mesh-ancestor
6061398|NCT00651755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6061399|NCT00651755|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6061400|NCT00651755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6061401|NCT00651755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6061402|NCT00651755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6061403|NCT00651755|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6061404|NCT00651755|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6061405|NCT00651937|Melphalan|melphalan|mesh-list
6061406|NCT00651937|Sargramostim|sargramostim|mesh-list
6061407|NCT00651937|Lenograstim|lenograstim|mesh-list
6061408|NCT00651937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6061409|NCT00651937|Alkylating Agents|alkylating agents|mesh-ancestor
6061410|NCT00651937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061411|NCT00651937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6061412|NCT00651937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6061413|NCT00651937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6061414|NCT00651937|Immunologic Factors|immunologic factors|mesh-ancestor
6061415|NCT00651937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061416|NCT00651937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6061417|NCT00652028|Fentanyl|fentanyl|mesh-list
6061418|NCT00652028|Midazolam|midazolam|mesh-list
6061419|NCT00652028|Dexmedetomidine|dexmedetomidine|mesh-list
6061420|NCT00652028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6061421|NCT00652028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6061422|NCT00652028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061423|NCT00652028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6061424|NCT00652028|Analgesics|analgesics|mesh-ancestor
6061425|NCT00652028|Sensory System Agents|sensory system agents|mesh-ancestor
6061426|NCT00652028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6061427|NCT00652028|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6061428|NCT00652028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6061429|NCT00652028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6061430|NCT00652028|Adrenergic Agents|adrenergic agents|mesh-ancestor
6061431|NCT00652028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6061432|NCT00652028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061433|NCT00652028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6061434|NCT00652028|Narcotics|narcotics|mesh-ancestor
6061435|NCT00652028|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6061436|NCT00652028|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6061437|NCT00652028|Anesthetics, General|anesthetics, general|mesh-ancestor
6061438|NCT00652028|Anesthetics|anesthetics|mesh-ancestor
6061439|NCT00652028|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6061440|NCT00652028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6061441|NCT00652028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6061442|NCT00652028|GABA Modulators|gaba modulators|mesh-ancestor
5506274|NCT04432714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061443|NCT00652028|GABA Agents|gaba agents|mesh-ancestor
6061444|NCT00652093|Acetaminophen|acetaminophen|mesh-list
6061445|NCT00652093|Oxymorphone|oxymorphone|mesh-list
6061446|NCT00652093|Acetaminophen, dextropropoxyphene, drug combination|acetaminophen, dextropropoxyphene, drug combination|mesh-list
6061447|NCT00652093|Dextropropoxyphene|dextropropoxyphene|mesh-list
6061448|NCT00652093|Levopropoxyphene|levopropoxyphene|mesh-list
6061449|NCT00652093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6061450|NCT00652093|Analgesics|analgesics|mesh-ancestor
6061451|NCT00652093|Sensory System Agents|sensory system agents|mesh-ancestor
6061452|NCT00652093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6061453|NCT00652093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061454|NCT00652093|Antipyretics|antipyretics|mesh-ancestor
6061455|NCT00652093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6061456|NCT00652093|Narcotics|narcotics|mesh-ancestor
6061457|NCT00652093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6061458|NCT00652093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6061459|NCT00652093|Antitussive Agents|antitussive agents|mesh-ancestor
6061460|NCT00652093|Respiratory System Agents|respiratory system agents|mesh-ancestor
6061461|NCT00652145|Mesalamine|mesalamine|mesh-list
6061462|NCT00652145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6061463|NCT00652145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6061464|NCT00652145|Analgesics|analgesics|mesh-ancestor
6061465|NCT00652145|Sensory System Agents|sensory system agents|mesh-ancestor
6061466|NCT00652145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6061467|NCT00652145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061468|NCT00652145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6061469|NCT00652145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6061470|NCT00652314|Thrombin|thrombin|mesh-list
6061471|NCT00652314|Hemostatics|hemostatics|mesh-ancestor
6061472|NCT00652314|Coagulants|coagulants|mesh-ancestor
6061473|NCT00652340|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6061474|NCT00652340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6061475|NCT00652340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6061476|NCT00652340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6061477|NCT00652340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061478|NCT00652366|Gemcitabine|gemcitabine|mesh-list
6061479|NCT00652366|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6061480|NCT00652366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6061481|NCT00652366|Antimetabolites|antimetabolites|mesh-ancestor
6061482|NCT00652366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061483|NCT00652366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6061484|NCT00652366|Antiviral Agents|antiviral agents|mesh-ancestor
6061485|NCT00652366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6061486|NCT00652366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6061487|NCT00652366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6061488|NCT00652366|Immunologic Factors|immunologic factors|mesh-ancestor
6061489|NCT00652366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061490|NCT00652366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6061491|NCT00652626|Azacitidine|azacitidine|mesh-list
6061492|NCT00652626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6061493|NCT00652626|Antimetabolites|antimetabolites|mesh-ancestor
6061494|NCT00652626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061495|NCT00652626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6061496|NCT00652626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6061497|NCT00652834|Mycophenolic Acid|mycophenolic acid|mesh-list
6061498|NCT00652834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6061499|NCT00652834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6061500|NCT00652834|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6061501|NCT00652834|Antitubercular Agents|antitubercular agents|mesh-ancestor
6061502|NCT00652834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6061503|NCT00652834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6061504|NCT00652834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6061505|NCT00652834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061506|NCT00652899|Vidarabine|vidarabine|mesh-list
6061507|NCT00652899|Aldesleukin|aldesleukin|mesh-list
6061508|NCT00652899|Cyclophosphamide|cyclophosphamide|mesh-list
6061509|NCT00652899|Fludarabine|fludarabine|mesh-list
6061510|NCT00652899|Fludarabine phosphate|fludarabine phosphate|mesh-list
6061511|NCT00652899|Interleukin-2|interleukin-2|mesh-list
6061512|NCT00652899|Allopurinol|allopurinol|mesh-list
6061513|NCT00652899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6061514|NCT00652899|Immunologic Factors|immunologic factors|mesh-ancestor
6061515|NCT00652899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061516|NCT00652899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6061517|NCT00652899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6061518|NCT00652899|Alkylating Agents|alkylating agents|mesh-ancestor
6207711|NCT02119468|Glucocorticoids|glucocorticoids|mesh-ancestor
6061519|NCT00652899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061520|NCT00652899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6061521|NCT00652899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6061522|NCT00652899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6061523|NCT00652899|Antimetabolites|antimetabolites|mesh-ancestor
6061524|NCT00652899|Antiviral Agents|antiviral agents|mesh-ancestor
6061525|NCT00652899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6061526|NCT00652899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6061527|NCT00652899|Analgesics|analgesics|mesh-ancestor
6061528|NCT00652899|Sensory System Agents|sensory system agents|mesh-ancestor
6061529|NCT00652899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6061530|NCT00652899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6061531|NCT00652899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6061532|NCT00652899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6061533|NCT00652899|Gout Suppressants|gout suppressants|mesh-ancestor
6061534|NCT00652899|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6061535|NCT00652899|Antioxidants|antioxidants|mesh-ancestor
6061536|NCT00652899|Protective Agents|protective agents|mesh-ancestor
5506275|NCT04432714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5506276|NCT04432714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5506277|NCT04432714|Alkylating Agents|alkylating agents|mesh-ancestor
5506278|NCT04432714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506279|NCT04432714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5506280|NCT04432714|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5506281|NCT04432714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5506282|NCT04432714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5506283|NCT04432714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6061537|NCT00652951|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6061538|NCT00652951|Immunologic Factors|immunologic factors|mesh-ancestor
6061539|NCT00652951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061540|NCT00653068|Calcium, Dietary|calcium, dietary|mesh-list
6061541|NCT00653068|Leucovorin|leucovorin|mesh-list
6061542|NCT00653068|Folic Acid|folic acid|mesh-list
6061543|NCT00653068|Cyclophosphamide|cyclophosphamide|mesh-list
6061544|NCT00653068|Thiotepa|thiotepa|mesh-list
6061545|NCT00653068|Cisplatin|cisplatin|mesh-list
6061546|NCT00653068|Carboplatin|carboplatin|mesh-list
6061547|NCT00653068|Methotrexate|methotrexate|mesh-list
6061548|NCT00653068|Etoposide|etoposide|mesh-list
6061549|NCT00653068|Vincristine|vincristine|mesh-list
6061550|NCT00653068|Etoposide phosphate|etoposide phosphate|mesh-list
6061551|NCT00653068|Podophyllotoxin|podophyllotoxin|mesh-list
6061552|NCT00653068|Lenograstim|lenograstim|mesh-list
6061553|NCT00653068|Calcium|calcium|mesh-list
6061554|NCT00653068|Levoleucovorin|levoleucovorin|mesh-list
6061555|NCT00653068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6061556|NCT00653068|Immunologic Factors|immunologic factors|mesh-ancestor
6061557|NCT00653068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061558|NCT00653068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6061559|NCT00653068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6061560|NCT00653068|Alkylating Agents|alkylating agents|mesh-ancestor
6061561|NCT00653068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061562|NCT00653068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6061563|NCT00653068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6061564|NCT00653068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6061565|NCT00653068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6061566|NCT00653068|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6061567|NCT00653068|Abortifacient Agents|abortifacient agents|mesh-ancestor
6061568|NCT00653068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6061569|NCT00653068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6061570|NCT00653068|Antimetabolites|antimetabolites|mesh-ancestor
6061571|NCT00653068|Dermatologic Agents|dermatologic agents|mesh-ancestor
6061572|NCT00653068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6061573|NCT00653068|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6061574|NCT00653068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6061575|NCT00653068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6061576|NCT00653068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6061577|NCT00653068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5506284|NCT04432714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5506285|NCT04432714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5506286|NCT04432714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6061578|NCT00653068|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6061579|NCT00653068|Antidotes|antidotes|mesh-ancestor
6061580|NCT00653068|Protective Agents|protective agents|mesh-ancestor
6061581|NCT00653068|Vitamin B Complex|vitamin b complex|mesh-ancestor
6061582|NCT00653068|Vitamins|vitamins|mesh-ancestor
6061583|NCT00653068|Micronutrients|micronutrients|mesh-ancestor
6061584|NCT00653068|Tubulin Modulators|tubulin modulators|mesh-ancestor
6061585|NCT00653068|Antimitotic Agents|antimitotic agents|mesh-ancestor
6061586|NCT00653068|Mitosis Modulators|mitosis modulators|mesh-ancestor
6061587|NCT00653068|Hematinics|hematinics|mesh-ancestor
6061588|NCT00653068|Keratolytic Agents|keratolytic agents|mesh-ancestor
6202153|NCT02037165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6202154|NCT02037165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6202155|NCT02037165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6202156|NCT02037165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6202157|NCT02037165|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6202158|NCT02037165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6202159|NCT02037165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6202160|NCT02037230|Gemcitabine|gemcitabine|mesh-list
6202161|NCT02037230|Adavosertib|adavosertib|mesh-list
6202162|NCT02037230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6202163|NCT02037230|Antimetabolites|antimetabolites|mesh-ancestor
6202164|NCT02037230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202165|NCT02037230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6202166|NCT02037230|Antiviral Agents|antiviral agents|mesh-ancestor
6202167|NCT02037230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6202168|NCT02037230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6202169|NCT02037230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6202170|NCT02037230|Immunologic Factors|immunologic factors|mesh-ancestor
6202171|NCT02037230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202172|NCT02037256|Bortezomib|bortezomib|mesh-list
6202173|NCT02037256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6202174|NCT02037295|Vancomycin|vancomycin|mesh-list
6202175|NCT02037295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6202176|NCT02037295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6202177|NCT02037425|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6202178|NCT02037425|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6202179|NCT02037425|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6202180|NCT02037425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6202181|NCT02037425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202182|NCT02037425|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6202183|NCT02037425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6202184|NCT02037425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202185|NCT02037425|Cholinergic Agents|cholinergic agents|mesh-ancestor
6202186|NCT02037425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6202187|NCT02037477|Esomeprazole|esomeprazole|mesh-list
6202188|NCT02037477|Rabeprazole|rabeprazole|mesh-list
6202189|NCT02037477|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6202190|NCT02037477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6202191|NCT02037477|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6202192|NCT02037477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6202193|NCT02037477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202194|NCT02037555|Antithrombins|antithrombins|mesh-list
6202195|NCT02037555|Antithrombin III|antithrombin iii|mesh-list
6202196|NCT02037555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6462724|NCT00460759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6462725|NCT00460759|Antitubercular Agents|antitubercular agents|mesh-ancestor
6462726|NCT00460759|Leprostatic Agents|leprostatic agents|mesh-ancestor
6462727|NCT00460785|Analgesics, Opioid|analgesics, opioid|mesh-list
6462728|NCT00460785|Narcotics|narcotics|mesh-ancestor
6462729|NCT00460785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6202197|NCT02037555|Protease Inhibitors|protease inhibitors|mesh-ancestor
6202198|NCT02037555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6202199|NCT02037555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202200|NCT02037555|Anticoagulants|anticoagulants|mesh-ancestor
6202201|NCT02037893|Antipyrine|antipyrine|mesh-list
6202202|NCT02037893|Benzocaine|benzocaine|mesh-list
6202203|NCT02037893|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6202204|NCT02037893|Anesthetics, Local|anesthetics, local|mesh-ancestor
6202205|NCT02037893|Anesthetics|anesthetics|mesh-ancestor
6202206|NCT02037893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6202207|NCT02037893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202208|NCT02037893|Sensory System Agents|sensory system agents|mesh-ancestor
6202209|NCT02037893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6202210|NCT02037893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6202211|NCT02037893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6202212|NCT02037893|Analgesics|analgesics|mesh-ancestor
6202213|NCT02037893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6202214|NCT02037893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6202215|NCT02037984|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6462730|NCT00460785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462731|NCT00460785|Analgesics|analgesics|mesh-ancestor
5506287|NCT04432714|Glucocorticoids|glucocorticoids|mesh-ancestor
5506288|NCT04432714|Hormones|hormones|mesh-ancestor
5506289|NCT04432714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5506290|NCT04432714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5506291|NCT04432714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5506292|NCT04432714|Tubulin Modulators|tubulin modulators|mesh-ancestor
5506293|NCT04432714|Antimitotic Agents|antimitotic agents|mesh-ancestor
5506294|NCT04432714|Mitosis Modulators|mitosis modulators|mesh-ancestor
5506295|NCT04432714|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6061589|NCT00653159|Copper|copper|mesh-list
6061590|NCT00653159|Levonorgestrel|levonorgestrel|mesh-list
6061591|NCT00653159|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6061592|NCT00653159|Contraceptive Agents|contraceptive agents|mesh-ancestor
6061593|NCT00653159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6061594|NCT00653159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061595|NCT00653159|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6061596|NCT00653159|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6061597|NCT00653159|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6061598|NCT00653159|Trace Elements|trace elements|mesh-ancestor
6061599|NCT00653159|Micronutrients|micronutrients|mesh-ancestor
6061600|NCT00653224|Levocetirizine|levocetirizine|mesh-list
6061601|NCT00653224|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6061602|NCT00653224|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6061603|NCT00653224|Histamine Antagonists|histamine antagonists|mesh-ancestor
6061604|NCT00653224|Histamine Agents|histamine agents|mesh-ancestor
6061605|NCT00653224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6061606|NCT00653224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061607|NCT00653224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061608|NCT00653328|Doxorubicin|doxorubicin|mesh-list
6061609|NCT00653328|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6061610|NCT00653328|Atrasentan|atrasentan|mesh-list
6061611|NCT00653328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6061612|NCT00653328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6462732|NCT00460785|Sensory System Agents|sensory system agents|mesh-ancestor
6462733|NCT00460785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5506296|NCT04432714|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6061613|NCT00653328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6061614|NCT00653328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6061615|NCT00653328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6061616|NCT00653328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506297|NCT04432714|Growth Substances|growth substances|mesh-ancestor
5506298|NCT04432714|Growth Inhibitors|growth inhibitors|mesh-ancestor
5506299|NCT04432974|Anesthetics|anesthetics|mesh-list
5506300|NCT04432974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5506301|NCT04432974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506302|NCT04432688|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
5506303|NCT04432688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5506304|NCT04432688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5506305|NCT04432688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5506306|NCT04432688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506307|NCT04432688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5506308|NCT04432688|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5506309|NCT04432688|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5506310|NCT04432688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5506311|NCT04432688|Adrenergic Agents|adrenergic agents|mesh-ancestor
5506312|NCT04432688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6061617|NCT00653328|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
6061618|NCT00653328|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6061619|NCT00653432|Hyaluronic Acid|hyaluronic acid|mesh-list
6061620|NCT00653432|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6061621|NCT00653432|Immunologic Factors|immunologic factors|mesh-ancestor
6061622|NCT00653432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061623|NCT00653432|Viscosupplements|viscosupplements|mesh-ancestor
6061624|NCT00653432|Protective Agents|protective agents|mesh-ancestor
6061625|NCT00653861|Lidocaine|lidocaine|mesh-list
6061626|NCT00653861|Anesthetics, Local|anesthetics, local|mesh-ancestor
6061627|NCT00653861|Anesthetics|anesthetics|mesh-ancestor
6061628|NCT00653861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6061629|NCT00653861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061630|NCT00653861|Sensory System Agents|sensory system agents|mesh-ancestor
6061631|NCT00653861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6061632|NCT00653861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6061633|NCT00653861|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6061634|NCT00653861|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6061635|NCT00653861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6061636|NCT00653861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061637|NCT00653939|Paclitaxel|paclitaxel|mesh-list
6061638|NCT00653939|Fosbretabulin|fosbretabulin|mesh-list
6061639|NCT00653939|Combretastatin|combretastatin|mesh-list
6061640|NCT00653939|Bevacizumab|bevacizumab|mesh-list
6061641|NCT00653939|Carboplatin|carboplatin|mesh-list
6061642|NCT00653939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6061643|NCT00653939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6061644|NCT00653939|Tubulin Modulators|tubulin modulators|mesh-ancestor
5506313|NCT04432688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506314|NCT04432688|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5506315|NCT04432688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5506316|NCT04432688|Serotonin Agents|serotonin agents|mesh-ancestor
5506317|NCT04432688|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5506318|NCT04432688|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5506319|NCT04432688|Dopamine Agents|dopamine agents|mesh-ancestor
5506320|NCT04432935|Lactoferrin|lactoferrin|mesh-list
5506321|NCT04432935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5506322|NCT04432662|Epoetin Alfa|epoetin alfa|mesh-list
5506323|NCT04432662|Darbepoetin alfa|darbepoetin alfa|mesh-list
6061645|NCT00653939|Antimitotic Agents|antimitotic agents|mesh-ancestor
6061646|NCT00653939|Mitosis Modulators|mitosis modulators|mesh-ancestor
6061647|NCT00653939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061648|NCT00653939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6061649|NCT00653939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6061650|NCT00653939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6061651|NCT00653939|Growth Substances|growth substances|mesh-ancestor
6061652|NCT00653939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061653|NCT00653939|Growth Inhibitors|growth inhibitors|mesh-ancestor
6061654|NCT00654030|Vaccines|vaccines|mesh-list
6061655|NCT00654030|Immunologic Factors|immunologic factors|mesh-ancestor
6061656|NCT00654030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061657|NCT00654069|Niacin|niacin|mesh-list
6061658|NCT00654069|Niacinamide|niacinamide|mesh-list
6061659|NCT00654069|Nicotinic Acids|nicotinic acids|mesh-list
6061660|NCT00654069|Oxycodone|oxycodone|mesh-list
6061661|NCT00654069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6061662|NCT00654069|Narcotics|narcotics|mesh-ancestor
6061663|NCT00654069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6061664|NCT00654069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506324|NCT04432662|Hematinics|hematinics|mesh-ancestor
5506325|NCT04432506|Cyclophosphamide|cyclophosphamide|mesh-list
5506326|NCT04432506|Fludarabine|fludarabine|mesh-list
5506327|NCT04432506|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5506328|NCT04432506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5506329|NCT04432506|Immunologic Factors|immunologic factors|mesh-ancestor
5506330|NCT04432506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506331|NCT04432506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5506332|NCT04432506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5506333|NCT04432506|Alkylating Agents|alkylating agents|mesh-ancestor
5506334|NCT04432506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506335|NCT04432506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5506336|NCT04432506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5506337|NCT04432376|Miconazole|miconazole|mesh-list
5506338|NCT04432376|Antifungal Agents|antifungal agents|mesh-ancestor
5506339|NCT04432376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5506340|NCT04432376|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5506341|NCT04432376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5506342|NCT04432376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5506343|NCT04432376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506344|NCT04432376|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5506345|NCT04432376|Hormone Antagonists|hormone antagonists|mesh-ancestor
5506346|NCT04432376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5506347|NCT04432376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506348|NCT04432376|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5506349|NCT04432376|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5506350|NCT04432610|Nebivolol|nebivolol|mesh-list
5506351|NCT04432610|Bisoprolol|bisoprolol|mesh-list
5506352|NCT04432610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5506353|NCT04432610|Vasodilator Agents|vasodilator agents|mesh-ancestor
5506354|NCT04432610|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6061665|NCT00654069|Analgesics|analgesics|mesh-ancestor
6061666|NCT00654069|Sensory System Agents|sensory system agents|mesh-ancestor
6061667|NCT00654069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6061668|NCT00654069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6061669|NCT00654069|Antimetabolites|antimetabolites|mesh-ancestor
6061670|NCT00654069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061671|NCT00654069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6061672|NCT00654069|Vasodilator Agents|vasodilator agents|mesh-ancestor
6061673|NCT00654069|Vitamin B Complex|vitamin b complex|mesh-ancestor
6061674|NCT00654069|Vitamins|vitamins|mesh-ancestor
6061675|NCT00654069|Micronutrients|micronutrients|mesh-ancestor
6061676|NCT00654147|Ritonavir|ritonavir|mesh-list
6061677|NCT00654147|Lopinavir|lopinavir|mesh-list
6061678|NCT00654147|Tenofovir|tenofovir|mesh-list
6061679|NCT00654147|Emtricitabine|emtricitabine|mesh-list
6061680|NCT00654147|Raltegravir Potassium|raltegravir potassium|mesh-list
5506355|NCT04432610|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5506356|NCT04432610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5506357|NCT04432610|Adrenergic Agents|adrenergic agents|mesh-ancestor
5506358|NCT04432610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5506359|NCT04432610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506360|NCT04432610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506361|NCT04432610|Sympatholytics|sympatholytics|mesh-ancestor
5506362|NCT04432610|Autonomic Agents|autonomic agents|mesh-ancestor
5506363|NCT04432610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5506364|NCT04432610|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5506365|NCT04432610|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5506366|NCT04432610|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6061681|NCT00654147|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6061682|NCT00654147|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6061683|NCT00654147|Protease Inhibitors|protease inhibitors|mesh-ancestor
6061684|NCT00654147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6061685|NCT00654147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061686|NCT00654147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5506367|NCT04432415|Fluorides|fluorides|mesh-list
5506368|NCT04432415|Fluorides, Topical|fluorides, topical|mesh-list
5506369|NCT04432415|Cariostatic Agents|cariostatic agents|mesh-ancestor
5506370|NCT04432415|Protective Agents|protective agents|mesh-ancestor
5506371|NCT04432415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506372|NCT04432558|Acetaminophen|acetaminophen|mesh-list
5506373|NCT04432558|Diclofenac|diclofenac|mesh-list
5506374|NCT04432558|Tramadol|tramadol|mesh-list
5506375|NCT04432558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5506376|NCT04432558|Analgesics|analgesics|mesh-ancestor
6061687|NCT00654147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6061688|NCT00654147|Antiviral Agents|antiviral agents|mesh-ancestor
6061689|NCT00654147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6061690|NCT00654147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6061691|NCT00654147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6061692|NCT00654147|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6061693|NCT00654147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6061694|NCT00654147|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6061695|NCT00654147|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6061696|NCT00654186|Lenalidomide|lenalidomide|mesh-list
6061697|NCT00654186|Immunologic Factors|immunologic factors|mesh-ancestor
6061698|NCT00654186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061699|NCT00654186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6061700|NCT00654186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6061701|NCT00654186|Growth Substances|growth substances|mesh-ancestor
6061702|NCT00654186|Growth Inhibitors|growth inhibitors|mesh-ancestor
6061703|NCT00654186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6061704|NCT00654238|Sorafenib|sorafenib|mesh-list
6061705|NCT00654238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6061706|NCT00654238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6061707|NCT00654238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6061708|NCT00654238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061709|NCT00654329|Fentanyl|fentanyl|mesh-list
6061710|NCT00654329|Dexmedetomidine|dexmedetomidine|mesh-list
6061711|NCT00654329|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6061712|NCT00654329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6061713|NCT00654329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061714|NCT00654329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6061715|NCT00654329|Analgesics|analgesics|mesh-ancestor
6061716|NCT00654329|Sensory System Agents|sensory system agents|mesh-ancestor
6061717|NCT00654329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6061718|NCT00654329|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6061719|NCT00654329|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5506377|NCT04432558|Sensory System Agents|sensory system agents|mesh-ancestor
5506378|NCT04432558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6061720|NCT00654329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6061721|NCT00654329|Adrenergic Agents|adrenergic agents|mesh-ancestor
6061722|NCT00654329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6061723|NCT00654329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061724|NCT00654329|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6061725|NCT00654329|Narcotics|narcotics|mesh-ancestor
6061726|NCT00654329|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6061727|NCT00654329|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6061728|NCT00654329|Anesthetics, General|anesthetics, general|mesh-ancestor
6061729|NCT00654329|Anesthetics|anesthetics|mesh-ancestor
6061730|NCT00654355|Tacrolimus|tacrolimus|mesh-list
6061731|NCT00654355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6061732|NCT00654355|Immunologic Factors|immunologic factors|mesh-ancestor
6061733|NCT00654355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061734|NCT00654355|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6061735|NCT00654355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6061736|NCT00654355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061737|NCT00654368|Etanercept|etanercept|mesh-list
6061738|NCT00654368|Methotrexate|methotrexate|mesh-list
6061739|NCT00654368|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6061740|NCT00654368|Abortifacient Agents|abortifacient agents|mesh-ancestor
6061741|NCT00654368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6061742|NCT00654368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061743|NCT00654368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6061744|NCT00654368|Antimetabolites|antimetabolites|mesh-ancestor
6061745|NCT00654368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506379|NCT04432558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506380|NCT04432558|Antipyretics|antipyretics|mesh-ancestor
6061746|NCT00654368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6061747|NCT00654368|Dermatologic Agents|dermatologic agents|mesh-ancestor
6061748|NCT00654368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6061749|NCT00654368|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6061750|NCT00654368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6061751|NCT00654368|Immunologic Factors|immunologic factors|mesh-ancestor
6061752|NCT00654368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6061753|NCT00654368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6061754|NCT00654368|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6061755|NCT00654368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6061756|NCT00654368|Analgesics|analgesics|mesh-ancestor
6061757|NCT00654368|Sensory System Agents|sensory system agents|mesh-ancestor
6061758|NCT00654368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6061759|NCT00654368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6061760|NCT00654368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6061761|NCT00654381|Inositol|inositol|mesh-list
5506381|NCT04432558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5506382|NCT04432558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5506383|NCT04432558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5506384|NCT04432558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5506385|NCT04432558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5600184|NCT03713879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6061762|NCT00654381|Linagliptin|linagliptin|mesh-list
6061763|NCT00654381|Voglibose|voglibose|mesh-list
6061764|NCT00654381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6061765|NCT00654381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061766|NCT00654381|Incretins|incretins|mesh-ancestor
6061767|NCT00654381|Hormones|hormones|mesh-ancestor
6061768|NCT00654381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6061769|NCT00654381|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6061770|NCT00654381|Protease Inhibitors|protease inhibitors|mesh-ancestor
6061771|NCT00654381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6061772|NCT00654381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061773|NCT00654381|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6061774|NCT00654381|Vitamin B Complex|vitamin b complex|mesh-ancestor
6061775|NCT00654381|Vitamins|vitamins|mesh-ancestor
6061776|NCT00654381|Micronutrients|micronutrients|mesh-ancestor
6061777|NCT00654420|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6061778|NCT00654420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6061779|NCT00654420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6061780|NCT00654420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6061781|NCT00654420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061782|NCT00654498|Pramipexole|pramipexole|mesh-list
6061783|NCT00654498|Antioxidants|antioxidants|mesh-ancestor
6061784|NCT00654498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061785|NCT00654498|Protective Agents|protective agents|mesh-ancestor
6202216|NCT02037984|Immunologic Factors|immunologic factors|mesh-ancestor
5506386|NCT04432558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506387|NCT04432558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5506388|NCT04432558|Narcotics|narcotics|mesh-ancestor
5506389|NCT04432558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5506390|NCT04432402|Gemcitabine|gemcitabine|mesh-list
5506391|NCT04432402|Oxaliplatin|oxaliplatin|mesh-list
5506392|NCT04432402|Lenalidomide|lenalidomide|mesh-list
5506393|NCT04432402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5506394|NCT04432402|Immunologic Factors|immunologic factors|mesh-ancestor
5506395|NCT04432402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506396|NCT04432402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5506397|NCT04432402|Antimetabolites|antimetabolites|mesh-ancestor
5506398|NCT04432402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061786|NCT00654498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061787|NCT00654498|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6061788|NCT00654498|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6061789|NCT00654498|Dopamine Agonists|dopamine agonists|mesh-ancestor
6061790|NCT00654498|Dopamine Agents|dopamine agents|mesh-ancestor
6061791|NCT00654498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6061792|NCT00654511|Fentanyl|fentanyl|mesh-list
6061793|NCT00654511|Dexmedetomidine|dexmedetomidine|mesh-list
6061794|NCT00654511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6061795|NCT00654511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6061796|NCT00654511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061797|NCT00654511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6061798|NCT00654511|Analgesics|analgesics|mesh-ancestor
6061799|NCT00654511|Sensory System Agents|sensory system agents|mesh-ancestor
6061800|NCT00654511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6061801|NCT00654511|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6061802|NCT00654511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6061803|NCT00654511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6061804|NCT00654511|Adrenergic Agents|adrenergic agents|mesh-ancestor
6061805|NCT00654511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6061806|NCT00654511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061807|NCT00654511|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6061808|NCT00654511|Narcotics|narcotics|mesh-ancestor
6061809|NCT00654511|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5506399|NCT04432402|Antiviral Agents|antiviral agents|mesh-ancestor
5506400|NCT04432402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5506401|NCT04432402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5506402|NCT04432402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5506403|NCT04432402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5506404|NCT04432402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5506405|NCT04432402|Growth Substances|growth substances|mesh-ancestor
5506406|NCT04432402|Growth Inhibitors|growth inhibitors|mesh-ancestor
5506407|NCT04432428|Sufentanil|sufentanil|mesh-list
5506408|NCT04432428|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5506409|NCT04432428|Narcotics|narcotics|mesh-ancestor
5506410|NCT04432428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6061810|NCT00654511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6061811|NCT00654511|Anesthetics, General|anesthetics, general|mesh-ancestor
6061812|NCT00654511|Anesthetics|anesthetics|mesh-ancestor
6061813|NCT00654732|Rituximab|rituximab|mesh-list
6061814|NCT00654732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6061815|NCT00654732|Doxorubicin|doxorubicin|mesh-list
6061816|NCT00654732|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6061817|NCT00654732|Dacarbazine|dacarbazine|mesh-list
6061818|NCT00654732|Bleomycin|bleomycin|mesh-list
6061819|NCT00654732|Vinblastine|vinblastine|mesh-list
6061820|NCT00654732|Antibodies|antibodies|mesh-list
6061821|NCT00654732|Immunoglobulins|immunoglobulins|mesh-list
6061822|NCT00654732|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6061823|NCT00654732|Imidazole|imidazole|mesh-list
6061824|NCT00654732|Immunologic Factors|immunologic factors|mesh-ancestor
6061825|NCT00654732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061826|NCT00654732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6061827|NCT00654732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6061828|NCT00654732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6061829|NCT00654732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6061830|NCT00654732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6061831|NCT00654732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6061832|NCT00654732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061833|NCT00654732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6061834|NCT00654732|Alkylating Agents|alkylating agents|mesh-ancestor
6061835|NCT00654732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6061836|NCT00654732|Tubulin Modulators|tubulin modulators|mesh-ancestor
6061837|NCT00654732|Antimitotic Agents|antimitotic agents|mesh-ancestor
6061838|NCT00654732|Mitosis Modulators|mitosis modulators|mesh-ancestor
6061839|NCT00654745|Amlodipine|amlodipine|mesh-list
6061840|NCT00654745|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6061841|NCT00654745|Olmesartan|olmesartan|mesh-list
6061842|NCT00654745|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6061843|NCT00654745|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6061844|NCT00654745|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6061845|NCT00654745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6061846|NCT00654745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061847|NCT00654745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6061848|NCT00654745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061849|NCT00654745|Vasodilator Agents|vasodilator agents|mesh-ancestor
6061850|NCT00654745|Diuretics|diuretics|mesh-ancestor
6061851|NCT00654745|Natriuretic Agents|natriuretic agents|mesh-ancestor
6061852|NCT00654745|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6061853|NCT00654745|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6061854|NCT00654745|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6061855|NCT00654784|Idebenone|idebenone|mesh-list
6061856|NCT00654784|Antioxidants|antioxidants|mesh-ancestor
6061857|NCT00654784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061858|NCT00654784|Protective Agents|protective agents|mesh-ancestor
6061859|NCT00654784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061860|NCT00654836|Bevacizumab|bevacizumab|mesh-list
6061861|NCT00654836|Carboplatin|carboplatin|mesh-list
6061862|NCT00654836|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6061863|NCT00654836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6061864|NCT00654836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6061865|NCT00654836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6061866|NCT00654836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6061867|NCT00654836|Growth Substances|growth substances|mesh-ancestor
6061868|NCT00654836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061869|NCT00654836|Growth Inhibitors|growth inhibitors|mesh-ancestor
6061870|NCT00654901|Vaccines|vaccines|mesh-list
6061871|NCT00654901|Immunologic Factors|immunologic factors|mesh-ancestor
6061872|NCT00654901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061873|NCT00654927|4-Aminopyridine|4-aminopyridine|mesh-list
6061874|NCT00654927|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6061875|NCT00654927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6061876|NCT00654927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061877|NCT00654940|Pregabalin|pregabalin|mesh-list
6061878|NCT00654940|Analgesics|analgesics|mesh-ancestor
6061879|NCT00654940|Sensory System Agents|sensory system agents|mesh-ancestor
6061880|NCT00654940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6061881|NCT00654940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061882|NCT00654940|Anticonvulsants|anticonvulsants|mesh-ancestor
6061883|NCT00654940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6061884|NCT00654940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6061885|NCT00654940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061886|NCT00654940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6061887|NCT00654940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6061888|NCT00654940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6061889|NCT00654940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6061890|NCT00654940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6061891|NCT00654953|Gabapentin|gabapentin|mesh-list
6061892|NCT00654953|Sertraline|sertraline|mesh-list
6061893|NCT00654953|Analgesics|analgesics|mesh-ancestor
6061894|NCT00654953|Sensory System Agents|sensory system agents|mesh-ancestor
6061895|NCT00654953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6061896|NCT00654953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061897|NCT00654953|Anticonvulsants|anticonvulsants|mesh-ancestor
6061898|NCT00654953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6061899|NCT00654953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6061900|NCT00654953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6061901|NCT00654953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6061902|NCT00654953|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6061903|NCT00654953|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6061904|NCT00654953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6061905|NCT00654953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061906|NCT00654953|Antimanic Agents|antimanic agents|mesh-ancestor
6061907|NCT00654953|Antidepressive Agents|antidepressive agents|mesh-ancestor
6061908|NCT00654953|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6061909|NCT00654953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6061910|NCT00654953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6061911|NCT00654953|Serotonin Agents|serotonin agents|mesh-ancestor
6061912|NCT00655083|MEN 11420|men 11420|mesh-list
6061913|NCT00655083|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6061914|NCT00655083|Autonomic Agents|autonomic agents|mesh-ancestor
6061915|NCT00655083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6061916|NCT00655083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061917|NCT00655083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6061918|NCT00655083|Respiratory System Agents|respiratory system agents|mesh-ancestor
6061919|NCT00655473|Dalcetrapib|dalcetrapib|mesh-list
6061920|NCT00655473|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6061921|NCT00655473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6061922|NCT00655473|Antimetabolites|antimetabolites|mesh-ancestor
6061923|NCT00655473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061924|NCT00655473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6061925|NCT00655486|Lacosamide|lacosamide|mesh-list
6061926|NCT00655486|Anticonvulsants|anticonvulsants|mesh-ancestor
6061927|NCT00655486|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6061928|NCT00655486|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6061929|NCT00655486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6061930|NCT00655486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061931|NCT00655499|Irinotecan|irinotecan|mesh-list
6061932|NCT00655499|Panitumumab|panitumumab|mesh-list
6061933|NCT00655499|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6061934|NCT00655499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6061935|NCT00655499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6061936|NCT00655499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061937|NCT00655499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6061938|NCT00655499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6061939|NCT00655538|Dalcetrapib|dalcetrapib|mesh-list
6061940|NCT00655538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6061941|NCT00655538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6061942|NCT00655538|Antimetabolites|antimetabolites|mesh-ancestor
6061943|NCT00655538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061944|NCT00655538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6061945|NCT00655551|Lacosamide|lacosamide|mesh-list
6061946|NCT00655551|Anticonvulsants|anticonvulsants|mesh-ancestor
6061947|NCT00655551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6061948|NCT00655551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6061949|NCT00655551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6462734|NCT00460837|Picosulfate sodium|picosulfate sodium|mesh-list
6462735|NCT00460837|Cathartics|cathartics|mesh-ancestor
6462736|NCT00460837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6462737|NCT00460850|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6462738|NCT00460850|Antiviral Agents|antiviral agents|mesh-ancestor
6061950|NCT00655551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061951|NCT00655564|Alefacept|alefacept|mesh-list
6061952|NCT00655564|Dermatologic Agents|dermatologic agents|mesh-ancestor
6061953|NCT00655564|Immunologic Factors|immunologic factors|mesh-ancestor
6061954|NCT00655564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061955|NCT00655629|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6061956|NCT00655629|Vasodilator Agents|vasodilator agents|mesh-ancestor
6061957|NCT00655629|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6061958|NCT00655629|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6061959|NCT00655629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6061960|NCT00655629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061961|NCT00655629|Urological Agents|urological agents|mesh-ancestor
6061962|NCT00655642|Promethazine|promethazine|mesh-list
6061963|NCT00655642|Diphenhydramine|diphenhydramine|mesh-list
6061964|NCT00655642|Ondansetron|ondansetron|mesh-list
6061965|NCT00655642|Metoclopramide|metoclopramide|mesh-list
6061966|NCT00655642|Antiemetics|antiemetics|mesh-ancestor
6061967|NCT00655642|Autonomic Agents|autonomic agents|mesh-ancestor
6061968|NCT00655642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6061969|NCT00655642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506411|NCT04432428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061970|NCT00655642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6462739|NCT00460850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5506412|NCT04432428|Analgesics|analgesics|mesh-ancestor
5506413|NCT04432428|Sensory System Agents|sensory system agents|mesh-ancestor
5506414|NCT04432428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5506415|NCT04432428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5506416|NCT04432428|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6061971|NCT00655642|Antipruritics|antipruritics|mesh-ancestor
6061972|NCT00655642|Dermatologic Agents|dermatologic agents|mesh-ancestor
6061973|NCT00655642|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6061974|NCT00655642|Serotonin Agents|serotonin agents|mesh-ancestor
6061975|NCT00655642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6061976|NCT00655642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6061977|NCT00655642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6061978|NCT00655642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6061979|NCT00655642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6061980|NCT00655642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6061981|NCT00655642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6061982|NCT00655642|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6061983|NCT00655642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6061984|NCT00655642|Dopamine Agents|dopamine agents|mesh-ancestor
6061985|NCT00655642|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6061986|NCT00655642|Histamine Antagonists|histamine antagonists|mesh-ancestor
6061987|NCT00655642|Histamine Agents|histamine agents|mesh-ancestor
6061988|NCT00655642|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6061989|NCT00655642|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6061990|NCT00655642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6061991|NCT00655642|Anesthetics, Local|anesthetics, local|mesh-ancestor
6061992|NCT00655642|Anesthetics|anesthetics|mesh-ancestor
6061993|NCT00655642|Sensory System Agents|sensory system agents|mesh-ancestor
6061994|NCT00655668|Lenalidomide|lenalidomide|mesh-list
6061995|NCT00655668|Immunologic Factors|immunologic factors|mesh-ancestor
6061996|NCT00655668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6061997|NCT00655668|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6061998|NCT00655668|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6061999|NCT00655668|Growth Substances|growth substances|mesh-ancestor
6062000|NCT00655668|Growth Inhibitors|growth inhibitors|mesh-ancestor
5506417|NCT04432428|Anesthetics, General|anesthetics, general|mesh-ancestor
5506418|NCT04432428|Anesthetics|anesthetics|mesh-ancestor
5506419|NCT04432324|Immunoglobulins|immunoglobulins|mesh-list
5506420|NCT04432324|Antibodies|antibodies|mesh-list
5506421|NCT04432324|gamma-Globulins|gamma-globulins|mesh-list
5506422|NCT04432324|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5506423|NCT04432324|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5506424|NCT04432324|Immunologic Factors|immunologic factors|mesh-ancestor
5506425|NCT04432324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506426|NCT04432220|Apixaban|apixaban|mesh-list
5506427|NCT04432220|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5506428|NCT04432220|Antithrombins|antithrombins|mesh-ancestor
5506429|NCT04432220|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5506430|NCT04432220|Protease Inhibitors|protease inhibitors|mesh-ancestor
5506431|NCT04432220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5506432|NCT04432220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506433|NCT04432220|Anticoagulants|anticoagulants|mesh-ancestor
5506434|NCT04432285|Botulinum Toxins|botulinum toxins|mesh-list
5506435|NCT04432285|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5506436|NCT04432285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5506437|NCT04432285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506438|NCT04432285|Cholinergic Agents|cholinergic agents|mesh-ancestor
5506439|NCT04432285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5506440|NCT04432285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506441|NCT04432259|Dexamethasone|dexamethasone|mesh-list
5506442|NCT04432259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5506443|NCT04432259|Antiemetics|antiemetics|mesh-ancestor
5506444|NCT04432259|Autonomic Agents|autonomic agents|mesh-ancestor
6462740|NCT00460863|Dialysis Solutions|dialysis solutions|mesh-list
6462741|NCT00460863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6462742|NCT00460876|Topotecan|topotecan|mesh-list
6462743|NCT00460876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6462744|NCT00460876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6462745|NCT00460876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6462746|NCT00460876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462747|NCT00460876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6062001|NCT00655668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6062002|NCT00655746|Dasatinib|dasatinib|mesh-list
6062003|NCT00655746|Omeprazole|omeprazole|mesh-list
6062004|NCT00655746|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5506445|NCT04432259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6462748|NCT00460915|Amlodipine|amlodipine|mesh-list
6062005|NCT00655746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6062006|NCT00655746|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6062007|NCT00655746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6062008|NCT00655746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062009|NCT00655746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6062010|NCT00655746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6062011|NCT00655811|Capsaicin|capsaicin|mesh-list
6062012|NCT00655811|Antipruritics|antipruritics|mesh-ancestor
6062013|NCT00655811|Dermatologic Agents|dermatologic agents|mesh-ancestor
6062014|NCT00655811|Sensory System Agents|sensory system agents|mesh-ancestor
6062015|NCT00655811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6062016|NCT00655811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062017|NCT00655850|Gemcitabine|gemcitabine|mesh-list
6062018|NCT00655850|Paclitaxel|paclitaxel|mesh-list
6062019|NCT00655850|Bevacizumab|bevacizumab|mesh-list
6062020|NCT00655850|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6062021|NCT00655850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6062022|NCT00655850|Tubulin Modulators|tubulin modulators|mesh-ancestor
6062023|NCT00655850|Antimitotic Agents|antimitotic agents|mesh-ancestor
6062024|NCT00655850|Mitosis Modulators|mitosis modulators|mesh-ancestor
6062025|NCT00655850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062026|NCT00655850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6062027|NCT00655850|Antimetabolites|antimetabolites|mesh-ancestor
6062028|NCT00655850|Antiviral Agents|antiviral agents|mesh-ancestor
6062029|NCT00655850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6062030|NCT00655850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6062031|NCT00655850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6062032|NCT00655850|Immunologic Factors|immunologic factors|mesh-ancestor
6062033|NCT00655850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062034|NCT00655850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6062035|NCT00655850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6062036|NCT00655850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6062037|NCT00655850|Growth Substances|growth substances|mesh-ancestor
6062038|NCT00655850|Growth Inhibitors|growth inhibitors|mesh-ancestor
5506446|NCT04432259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506447|NCT04432259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5506448|NCT04432259|Glucocorticoids|glucocorticoids|mesh-ancestor
5506449|NCT04432259|Hormones|hormones|mesh-ancestor
5506450|NCT04432259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5506451|NCT04432259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5506452|NCT04432259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5506453|NCT04432233|Metronidazole|metronidazole|mesh-list
6062039|NCT00655863|Pioglitazone|pioglitazone|mesh-list
6062040|NCT00655863|Alogliptin|alogliptin|mesh-list
6062041|NCT00655863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6062042|NCT00655863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062043|NCT00655863|Incretins|incretins|mesh-ancestor
6062044|NCT00655863|Hormones|hormones|mesh-ancestor
6062045|NCT00655863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6062046|NCT00655863|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6062047|NCT00655863|Protease Inhibitors|protease inhibitors|mesh-ancestor
6062048|NCT00655863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6062049|NCT00655863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062050|NCT00655876|Paclitaxel|paclitaxel|mesh-list
6062051|NCT00655876|Cetuximab|cetuximab|mesh-list
6062052|NCT00655876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6062053|NCT00655876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6062054|NCT00655876|Tubulin Modulators|tubulin modulators|mesh-ancestor
6062055|NCT00655876|Antimitotic Agents|antimitotic agents|mesh-ancestor
6462749|NCT00460915|Lacidipine|lacidipine|mesh-list
6462750|NCT00460915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6462751|NCT00460915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5506454|NCT04432233|Levofloxacin|levofloxacin|mesh-list
5506455|NCT04432233|Ofloxacin|ofloxacin|mesh-list
5506456|NCT04432233|Esomeprazole|esomeprazole|mesh-list
5506457|NCT04432233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5506458|NCT04432233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5506459|NCT04432233|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5506460|NCT04432233|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5506461|NCT04432233|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5506462|NCT04432233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5506463|NCT04432233|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5506464|NCT04432233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5506465|NCT04432233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506466|NCT04432233|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6462752|NCT00460915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6488400|NCT00583986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5506467|NCT04432233|Renal Agents|renal agents|mesh-ancestor
6462753|NCT00460915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462754|NCT00460915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6462755|NCT00460915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462756|NCT00460915|Vasodilator Agents|vasodilator agents|mesh-ancestor
6062056|NCT00655876|Mitosis Modulators|mitosis modulators|mesh-ancestor
6062057|NCT00655876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062058|NCT00655876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6062059|NCT00655928|Acetylcysteine|acetylcysteine|mesh-list
6062060|NCT00655928|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6062061|NCT00655928|Antiviral Agents|antiviral agents|mesh-ancestor
6062062|NCT00655928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6062063|NCT00655928|Expectorants|expectorants|mesh-ancestor
6062064|NCT00655928|Respiratory System Agents|respiratory system agents|mesh-ancestor
6062065|NCT00655928|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6062066|NCT00655928|Antioxidants|antioxidants|mesh-ancestor
6062067|NCT00655928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062068|NCT00655928|Protective Agents|protective agents|mesh-ancestor
6062069|NCT00655928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062070|NCT00655928|Antidotes|antidotes|mesh-ancestor
6062071|NCT00655980|Folic Acid|folic acid|mesh-list
6062072|NCT00655980|Vitamin B 12|vitamin b 12|mesh-list
6062073|NCT00655980|Hydroxocobalamin|hydroxocobalamin|mesh-list
6062074|NCT00655980|Nitrous Oxide|nitrous oxide|mesh-list
6462757|NCT00460928|Immunoglobulins|immunoglobulins|mesh-list
6462758|NCT00460928|Antibodies|antibodies|mesh-list
6665256|NCT01516463|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5506468|NCT04432233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5506469|NCT04432233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6062075|NCT00655980|Vitamins|vitamins|mesh-ancestor
6062076|NCT00655980|Micronutrients|micronutrients|mesh-ancestor
6062077|NCT00655980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062078|NCT00655980|Hematinics|hematinics|mesh-ancestor
6062079|NCT00655980|Vitamin B Complex|vitamin b complex|mesh-ancestor
5506470|NCT04432233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5506471|NCT04432233|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5506472|NCT04432233|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5506473|NCT04432155|Xenon|xenon|mesh-list
5506474|NCT04432155|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5506475|NCT04432155|Anesthetics, General|anesthetics, general|mesh-ancestor
5506476|NCT04432155|Anesthetics|anesthetics|mesh-ancestor
5506477|NCT04432155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5506478|NCT04432155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506479|NCT04432012|Dexamethasone|dexamethasone|mesh-list
5506480|NCT04432012|Dexamethasone acetate|dexamethasone acetate|mesh-list
5506481|NCT04432012|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
5506482|NCT04432012|BB 1101|bb 1101|mesh-list
5506483|NCT04432012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5506484|NCT04432012|Antiemetics|antiemetics|mesh-ancestor
5506485|NCT04432012|Autonomic Agents|autonomic agents|mesh-ancestor
6062080|NCT00655980|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6062081|NCT00655980|Anesthetics, General|anesthetics, general|mesh-ancestor
6062082|NCT00655980|Anesthetics|anesthetics|mesh-ancestor
5506486|NCT04432012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5506487|NCT04432012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506488|NCT04432012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5506489|NCT04432012|Glucocorticoids|glucocorticoids|mesh-ancestor
5506490|NCT04432012|Hormones|hormones|mesh-ancestor
5506491|NCT04432012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5506492|NCT04432012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5506493|NCT04432012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5506494|NCT04432012|Protease Inhibitors|protease inhibitors|mesh-ancestor
5506495|NCT04432012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5506496|NCT04432012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506497|NCT04431895|Tofacitinib|tofacitinib|mesh-list
6062083|NCT00655980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6062084|NCT00655980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6062085|NCT00655980|Analgesics|analgesics|mesh-ancestor
6062086|NCT00655980|Sensory System Agents|sensory system agents|mesh-ancestor
6062087|NCT00655980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6062088|NCT00656019|Vitamin D|vitamin d|mesh-list
6062089|NCT00656019|Calcipotriene|calcipotriene|mesh-list
5506498|NCT04431895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6062090|NCT00656019|Vitamins|vitamins|mesh-ancestor
6062091|NCT00656019|Micronutrients|micronutrients|mesh-ancestor
6062092|NCT00656019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062093|NCT00656019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6062094|NCT00656019|Dermatologic Agents|dermatologic agents|mesh-ancestor
6062095|NCT00656058|Montelukast|montelukast|mesh-list
6062096|NCT00656058|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6062097|NCT00656058|Respiratory System Agents|respiratory system agents|mesh-ancestor
6062098|NCT00656058|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6062099|NCT00656058|Hormone Antagonists|hormone antagonists|mesh-ancestor
6062100|NCT00656058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6062101|NCT00656058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062102|NCT00656058|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6062103|NCT00656058|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6062104|NCT00656058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062105|NCT00656084|Gemcitabine|gemcitabine|mesh-list
6062106|NCT00656084|Rituximab|rituximab|mesh-list
6062107|NCT00656084|Mitoxantrone|mitoxantrone|mesh-list
6062108|NCT00656084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6062109|NCT00656084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6062110|NCT00656084|Immunologic Factors|immunologic factors|mesh-ancestor
6062111|NCT00656084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062112|NCT00656084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6062113|NCT00656084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6062114|NCT00656084|Antimetabolites|antimetabolites|mesh-ancestor
6062115|NCT00656084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062116|NCT00656084|Antiviral Agents|antiviral agents|mesh-ancestor
6062117|NCT00656084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6062118|NCT00656084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6062119|NCT00656084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6062120|NCT00656084|Analgesics|analgesics|mesh-ancestor
6062121|NCT00656084|Sensory System Agents|sensory system agents|mesh-ancestor
6062122|NCT00656084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6062123|NCT00656084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6062124|NCT00656084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5506499|NCT04431895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5506500|NCT04431895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600185|NCT03713879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6062125|NCT00656136|Afatinib|afatinib|mesh-list
6062126|NCT00656136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6062127|NCT00656136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6062128|NCT00656136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6062129|NCT00656136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062130|NCT00656175|Raltegravir Potassium|raltegravir potassium|mesh-list
6062131|NCT00656175|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6062132|NCT00656175|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6062133|NCT00656175|Antiviral Agents|antiviral agents|mesh-ancestor
6062134|NCT00656175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6062135|NCT00656175|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6062136|NCT00656175|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5600186|NCT03713879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5600187|NCT03713879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600188|NCT03713762|Lidocaine|lidocaine|mesh-list
6062137|NCT00656175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6062138|NCT00656175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062139|NCT00656201|Progesterone|progesterone|mesh-list
6062140|NCT00656201|Progestins|progestins|mesh-ancestor
6062141|NCT00656201|Hormones|hormones|mesh-ancestor
6062142|NCT00656201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6062143|NCT00656201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062144|NCT00656292|Simvastatin|simvastatin|mesh-list
6062145|NCT00656292|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6062146|NCT00656292|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6062147|NCT00656292|Antimetabolites|antimetabolites|mesh-ancestor
6062148|NCT00656292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062149|NCT00656292|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6062150|NCT00656292|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6062151|NCT00656292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6062152|NCT00656448|Epoetin Alfa|epoetin alfa|mesh-list
6062153|NCT00656448|Hematinics|hematinics|mesh-ancestor
6062154|NCT00656487|Rimonabant|rimonabant|mesh-list
6062155|NCT00656487|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6062156|NCT00656487|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
6062157|NCT00656487|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6062158|NCT00656487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6062159|NCT00656487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462759|NCT00460928|gamma-Globulins|gamma-globulins|mesh-list
6062160|NCT00656487|Hormones|hormones|mesh-ancestor
6062161|NCT00656487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6062162|NCT00656487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062163|NCT00656513|Pilocarpine|pilocarpine|mesh-list
6062164|NCT00656513|Miotics|miotics|mesh-ancestor
6062165|NCT00656513|Autonomic Agents|autonomic agents|mesh-ancestor
6062166|NCT00656513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6062167|NCT00656513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062168|NCT00656513|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6062169|NCT00656513|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6062170|NCT00656513|Cholinergic Agents|cholinergic agents|mesh-ancestor
6062171|NCT00656513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6062172|NCT00656513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062173|NCT00656617|Cytarabine|cytarabine|mesh-list
6062174|NCT00656617|Vorinostat|vorinostat|mesh-list
6062175|NCT00656617|Idarubicin|idarubicin|mesh-list
6062176|NCT00656617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6062177|NCT00656617|Antimetabolites|antimetabolites|mesh-ancestor
6062178|NCT00656617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062179|NCT00656617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6062180|NCT00656617|Antiviral Agents|antiviral agents|mesh-ancestor
6062181|NCT00656617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6062182|NCT00656617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6062183|NCT00656617|Immunologic Factors|immunologic factors|mesh-ancestor
6062184|NCT00656617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062185|NCT00656617|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6062186|NCT00656617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6062187|NCT00656617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6062188|NCT00656617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6062189|NCT00656617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6062190|NCT00656630|Naltrexone|naltrexone|mesh-list
6062191|NCT00656630|Acamprosate|acamprosate|mesh-list
6062192|NCT00656630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6062193|NCT00656630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6062194|NCT00656630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062195|NCT00656630|Sensory System Agents|sensory system agents|mesh-ancestor
6062196|NCT00656630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6062197|NCT00656656|Dexamethasone|dexamethasone|mesh-list
6062198|NCT00656656|Rituximab|rituximab|mesh-list
6062199|NCT00656656|Azathioprine|azathioprine|mesh-list
6062200|NCT00656656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6062201|NCT00656656|Antiemetics|antiemetics|mesh-ancestor
6062202|NCT00656656|Autonomic Agents|autonomic agents|mesh-ancestor
6062203|NCT00656656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6062204|NCT00656656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062205|NCT00656656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6062206|NCT00656656|Glucocorticoids|glucocorticoids|mesh-ancestor
6062207|NCT00656656|Hormones|hormones|mesh-ancestor
6062208|NCT00656656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6062209|NCT00656656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6062210|NCT00656656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6062211|NCT00656656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6062212|NCT00656656|Immunologic Factors|immunologic factors|mesh-ancestor
6062213|NCT00656656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6062214|NCT00656656|Antimetabolites|antimetabolites|mesh-ancestor
6462760|NCT00460928|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6462761|NCT00460928|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6462762|NCT00460928|Immunologic Factors|immunologic factors|mesh-ancestor
6062215|NCT00656656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062216|NCT00656656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6062217|NCT00656656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6062218|NCT00656669|Paclitaxel|paclitaxel|mesh-list
6062219|NCT00656669|Cyclophosphamide|cyclophosphamide|mesh-list
6062220|NCT00656669|Doxorubicin|doxorubicin|mesh-list
6062221|NCT00656669|Sunitinib|sunitinib|mesh-list
6062222|NCT00656669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6062223|NCT00656669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6062224|NCT00656669|Tubulin Modulators|tubulin modulators|mesh-ancestor
6062225|NCT00656669|Antimitotic Agents|antimitotic agents|mesh-ancestor
6062226|NCT00656669|Mitosis Modulators|mitosis modulators|mesh-ancestor
6062227|NCT00656669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062228|NCT00656669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6062229|NCT00656669|Immunologic Factors|immunologic factors|mesh-ancestor
6062230|NCT00656669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062231|NCT00656669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6062232|NCT00656669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6062233|NCT00656669|Alkylating Agents|alkylating agents|mesh-ancestor
6462763|NCT00460928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506501|NCT04431713|Exenatide|exenatide|mesh-list
5506502|NCT04431713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5506503|NCT04431713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506504|NCT04431713|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5506505|NCT04431713|Incretins|incretins|mesh-ancestor
5506506|NCT04431713|Hormones|hormones|mesh-ancestor
5506507|NCT04431713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6062234|NCT00656669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6062235|NCT00656669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6062236|NCT00656669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6062237|NCT00656669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6062238|NCT00656669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6062239|NCT00656669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6062240|NCT00656669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6062241|NCT00656669|Growth Substances|growth substances|mesh-ancestor
6062242|NCT00656669|Growth Inhibitors|growth inhibitors|mesh-ancestor
6062243|NCT00656669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6062244|NCT00656799|Bromides|bromides|mesh-list
6062245|NCT00656799|Rocuronium|rocuronium|mesh-list
6062246|NCT00656799|Anticonvulsants|anticonvulsants|mesh-ancestor
6062247|NCT00656799|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6062248|NCT00656799|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6062249|NCT00656799|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6062250|NCT00656799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6062251|NCT00656799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062252|NCT00656851|Pioglitazone|pioglitazone|mesh-list
6062253|NCT00656851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6062254|NCT00656851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062255|NCT00656968|Esomeprazole|esomeprazole|mesh-list
6062256|NCT00656968|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6062257|NCT00656968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6062258|NCT00656968|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6062259|NCT00656968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6062260|NCT00656968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062261|NCT00657020|Nicotine|nicotine|mesh-list
6062262|NCT00657020|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6062263|NCT00657020|Autonomic Agents|autonomic agents|mesh-ancestor
6062264|NCT00657020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6062265|NCT00657020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062266|NCT00657020|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6062267|NCT00657020|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6062268|NCT00657020|Cholinergic Agents|cholinergic agents|mesh-ancestor
6062269|NCT00657020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6062270|NCT00657020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062271|NCT00657046|Droxidopa|droxidopa|mesh-list
6062272|NCT00657046|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6062273|NCT00657046|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6062274|NCT00657150|Enoxaparin|enoxaparin|mesh-list
6062275|NCT00657150|Dabigatran|dabigatran|mesh-list
6062276|NCT00657150|Anticoagulants|anticoagulants|mesh-ancestor
6062277|NCT00657150|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6062278|NCT00657150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6062279|NCT00657150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062280|NCT00657150|Antithrombins|antithrombins|mesh-ancestor
6062281|NCT00657150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6062282|NCT00657150|Protease Inhibitors|protease inhibitors|mesh-ancestor
6062283|NCT00657150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6062284|NCT00657267|Temozolomide|temozolomide|mesh-list
6062285|NCT00657267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6062286|NCT00657267|Alkylating Agents|alkylating agents|mesh-ancestor
6062287|NCT00657267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506508|NCT04431349|Clopidogrel|clopidogrel|mesh-list
6062288|NCT00657267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5506509|NCT04431349|Ticagrelor|ticagrelor|mesh-list
6062289|NCT00657280|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6062290|NCT00657280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6062291|NCT00657280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062292|NCT00657280|Incretins|incretins|mesh-ancestor
6062293|NCT00657280|Hormones|hormones|mesh-ancestor
6062294|NCT00657280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6062295|NCT00657280|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6062296|NCT00657280|Protease Inhibitors|protease inhibitors|mesh-ancestor
6062297|NCT00657280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6062298|NCT00657280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062299|NCT00657358|Lidocaine|lidocaine|mesh-list
6062300|NCT00657358|Anesthetics, Local|anesthetics, local|mesh-ancestor
6062301|NCT00657358|Anesthetics|anesthetics|mesh-ancestor
6062302|NCT00657358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6062303|NCT00657358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062304|NCT00657358|Sensory System Agents|sensory system agents|mesh-ancestor
6062305|NCT00657358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6062306|NCT00657358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6062307|NCT00657358|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6062308|NCT00657358|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6062309|NCT00657358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6062310|NCT00657358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062311|NCT00657618|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
6062312|NCT00657618|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6062313|NCT00657618|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6062314|NCT00657618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6062315|NCT00657618|Schistosomicides|schistosomicides|mesh-ancestor
5506510|NCT04431349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5506511|NCT04431349|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5506512|NCT04431349|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5506513|NCT04431349|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5506514|NCT04431349|Purinergic Agents|purinergic agents|mesh-ancestor
5506515|NCT04431349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5506516|NCT04431349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506517|NCT04431349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506518|NCT04431388|Levobupivacaine|levobupivacaine|mesh-list
5506519|NCT04431388|Anesthetics, Local|anesthetics, local|mesh-ancestor
6062316|NCT00657618|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6062317|NCT00657618|Anthelmintics|anthelmintics|mesh-ancestor
6062318|NCT00657709|Vaccines|vaccines|mesh-list
6062319|NCT00657709|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6062320|NCT00657709|Immunologic Factors|immunologic factors|mesh-ancestor
6062321|NCT00657709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062322|NCT00657917|Gentamicins|gentamicins|mesh-list
6062323|NCT00657917|Paromomycin|paromomycin|mesh-list
6062324|NCT00657917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6062325|NCT00657917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6062326|NCT00657917|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6062327|NCT00657917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6062328|NCT00657917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062329|NCT00657917|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6062330|NCT00657917|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6062331|NCT00658021|Exenatide|exenatide|mesh-list
6062332|NCT00658021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6062333|NCT00658021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062334|NCT00658021|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6062335|NCT00658021|Incretins|incretins|mesh-ancestor
6062336|NCT00658021|Hormones|hormones|mesh-ancestor
6062337|NCT00658021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6062338|NCT00658112|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6062339|NCT00658112|Dermatologic Agents|dermatologic agents|mesh-ancestor
6062340|NCT00658320|Cyclosporine|cyclosporine|mesh-list
6062341|NCT00658320|Mycophenolic Acid|mycophenolic acid|mesh-list
6062342|NCT00658320|Everolimus|everolimus|mesh-list
6062343|NCT00658320|Cyclosporins|cyclosporins|mesh-list
6062344|NCT00658320|Basiliximab|basiliximab|mesh-list
6062345|NCT00658320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6062346|NCT00658320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062347|NCT00658320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6062348|NCT00658320|Immunologic Factors|immunologic factors|mesh-ancestor
6062349|NCT00658320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062350|NCT00658320|Antifungal Agents|antifungal agents|mesh-ancestor
6062351|NCT00658320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6062352|NCT00658320|Dermatologic Agents|dermatologic agents|mesh-ancestor
6062353|NCT00658320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6062354|NCT00658320|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5506520|NCT04431388|Anesthetics|anesthetics|mesh-ancestor
5506521|NCT04431388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5506522|NCT04431388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062355|NCT00658320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6062356|NCT00658320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6062357|NCT00658320|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6062358|NCT00658320|Antitubercular Agents|antitubercular agents|mesh-ancestor
6062359|NCT00658320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6062360|NCT00658333|Mycophenolic Acid|mycophenolic acid|mesh-list
6062361|NCT00658333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6062362|NCT00658333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6062363|NCT00658333|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5506523|NCT04431388|Sensory System Agents|sensory system agents|mesh-ancestor
5506524|NCT04431388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5506525|NCT04431193|Oxytocin|oxytocin|mesh-list
5506526|NCT04431193|Oxytocics|oxytocics|mesh-ancestor
5506527|NCT04431193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5506528|NCT04431193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506529|NCT04431245|Entecavir|entecavir|mesh-list
5506530|NCT04431245|Antiviral Agents|antiviral agents|mesh-ancestor
5506531|NCT04431245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5506534|NCT04431206|Oxytocin|oxytocin|mesh-list
6062364|NCT00658333|Antitubercular Agents|antitubercular agents|mesh-ancestor
6062365|NCT00658333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6062366|NCT00658333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6062367|NCT00658333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6062368|NCT00658333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062369|NCT00658359|Cyclosporine|cyclosporine|mesh-list
6062370|NCT00658359|Cyclosporins|cyclosporins|mesh-list
6062371|NCT00658359|Tofacitinib|tofacitinib|mesh-list
6062372|NCT00658359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6062373|NCT00658359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062374|NCT00658359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6062375|NCT00658359|Immunologic Factors|immunologic factors|mesh-ancestor
6062376|NCT00658359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062377|NCT00658359|Antifungal Agents|antifungal agents|mesh-ancestor
6062378|NCT00658359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6062379|NCT00658359|Dermatologic Agents|dermatologic agents|mesh-ancestor
6062380|NCT00658359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6062381|NCT00658359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6062382|NCT00658359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6062383|NCT00658411|Deferoxamine|deferoxamine|mesh-list
6062384|NCT00658411|Siderophores|siderophores|mesh-ancestor
6062385|NCT00658411|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6062386|NCT00658411|Chelating Agents|chelating agents|mesh-ancestor
6062387|NCT00658411|Sequestering Agents|sequestering agents|mesh-ancestor
6062388|NCT00658411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506535|NCT04431206|Oxytocics|oxytocics|mesh-ancestor
5506536|NCT04431206|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5506537|NCT04431206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506538|NCT04430790|Doxapram|doxapram|mesh-list
5506539|NCT04430790|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5506540|NCT04430790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506541|NCT04430790|Respiratory System Agents|respiratory system agents|mesh-ancestor
5506542|NCT04430777|Tranexamic Acid|tranexamic acid|mesh-list
5506543|NCT04430777|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5506544|NCT04430777|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5506545|NCT04430777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506546|NCT04430777|Hemostatics|hemostatics|mesh-ancestor
5506547|NCT04430777|Coagulants|coagulants|mesh-ancestor
5506548|NCT04430894|Dexamethasone|dexamethasone|mesh-list
5506549|NCT04430894|Lenalidomide|lenalidomide|mesh-list
5506550|NCT04430894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5506551|NCT04430894|Antiemetics|antiemetics|mesh-ancestor
5506552|NCT04430894|Autonomic Agents|autonomic agents|mesh-ancestor
5506553|NCT04430894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5506554|NCT04430894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506555|NCT04430894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5506556|NCT04430894|Glucocorticoids|glucocorticoids|mesh-ancestor
5506557|NCT04430894|Hormones|hormones|mesh-ancestor
5506558|NCT04430894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5506559|NCT04430894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5506560|NCT04430894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6062389|NCT00658515|Dalcetrapib|dalcetrapib|mesh-list
6062390|NCT00658515|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6062391|NCT00658515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6062392|NCT00658515|Antimetabolites|antimetabolites|mesh-ancestor
6062393|NCT00658515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062394|NCT00658515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6062395|NCT00658528|Esomeprazole|esomeprazole|mesh-list
6062396|NCT00658528|Rabeprazole|rabeprazole|mesh-list
6062397|NCT00658528|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6062398|NCT00658528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6062399|NCT00658528|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5506561|NCT04430894|Immunologic Factors|immunologic factors|mesh-ancestor
5506562|NCT04430894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5506563|NCT04430894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5506564|NCT04430894|Growth Substances|growth substances|mesh-ancestor
5506565|NCT04430894|Growth Inhibitors|growth inhibitors|mesh-ancestor
5506566|NCT04430933|Paclitaxel|paclitaxel|mesh-list
5506567|NCT04430933|Docetaxel|docetaxel|mesh-list
5506568|NCT04430933|Carboplatin|carboplatin|mesh-list
5506569|NCT04430933|Pemetrexed|pemetrexed|mesh-list
5506570|NCT04430933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5506571|NCT04430933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5506572|NCT04430933|Tubulin Modulators|tubulin modulators|mesh-ancestor
5506573|NCT04430933|Antimitotic Agents|antimitotic agents|mesh-ancestor
6062400|NCT00658528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6062401|NCT00658528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062402|NCT00658541|Zolpidem|zolpidem|mesh-list
5506574|NCT04430933|Mitosis Modulators|mitosis modulators|mesh-ancestor
5506575|NCT04430933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506576|NCT04430933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5506577|NCT04430933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5506578|NCT04430933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5506579|NCT04430959|Candesartan|candesartan|mesh-list
6062403|NCT00658541|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6062404|NCT00658541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6062405|NCT00658541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6062406|NCT00658541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062407|NCT00658541|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6062408|NCT00658541|GABA Agonists|gaba agonists|mesh-ancestor
6062409|NCT00658541|GABA Agents|gaba agents|mesh-ancestor
6062410|NCT00658541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6062411|NCT00658541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062412|NCT00658567|Pimavanserin|pimavanserin|mesh-list
6062413|NCT00658567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6062414|NCT00658567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6062415|NCT00658567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6062416|NCT00658567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6062417|NCT00658567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6062418|NCT00658567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062419|NCT00658567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6062420|NCT00658567|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6062421|NCT00658567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6062422|NCT00658567|Serotonin Agents|serotonin agents|mesh-ancestor
6062423|NCT00658567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6062424|NCT00658567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202217|NCT02037984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202218|NCT02038010|Trastuzumab|trastuzumab|mesh-list
6202219|NCT02038010|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
6202220|NCT02038010|Maytansine|maytansine|mesh-list
6202221|NCT02038010|Immunoconjugates|immunoconjugates|mesh-list
6202222|NCT02038010|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
6202223|NCT02038010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6202224|NCT02038010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5506580|NCT04430959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6202225|NCT02038010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5600189|NCT03713762|Fentanyl|fentanyl|mesh-list
6062425|NCT00658606|Alefacept|alefacept|mesh-list
6062426|NCT00658606|Dermatologic Agents|dermatologic agents|mesh-ancestor
6062427|NCT00658606|Immunologic Factors|immunologic factors|mesh-ancestor
6062428|NCT00658606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062429|NCT00658619|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6062430|NCT00658619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6062431|NCT00658619|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6062432|NCT00658619|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6062433|NCT00658619|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6062434|NCT00658619|Adrenergic Agents|adrenergic agents|mesh-ancestor
6062435|NCT00658619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6062436|NCT00658619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062437|NCT00658619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062438|NCT00658632|Esomeprazole|esomeprazole|mesh-list
6062439|NCT00658632|Rabeprazole|rabeprazole|mesh-list
6062440|NCT00658632|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6062441|NCT00658632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6062442|NCT00658632|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6062443|NCT00658632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6062444|NCT00658632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062445|NCT00658658|Panitumumab|panitumumab|mesh-list
6062446|NCT00658658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6062447|NCT00658658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6062448|NCT00658684|Fesoterodine|fesoterodine|mesh-list
6062449|NCT00658684|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6062450|NCT00658684|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6062451|NCT00658684|Cholinergic Agents|cholinergic agents|mesh-ancestor
6062452|NCT00658684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6062453|NCT00658684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062454|NCT00658684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062455|NCT00658684|Urological Agents|urological agents|mesh-ancestor
6062456|NCT00658697|Bevacizumab|bevacizumab|mesh-list
6062457|NCT00658697|Docetaxel|docetaxel|mesh-list
6062458|NCT00658697|Bicalutamide|bicalutamide|mesh-list
5506581|NCT04430959|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5506582|NCT04430959|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5506583|NCT04430959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506584|NCT04430998|Chlorhexidine|chlorhexidine|mesh-list
5506585|NCT04430998|Polaprezinc|polaprezinc|mesh-list
5506586|NCT04430998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5506587|NCT04430998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5506588|NCT04430998|Disinfectants|disinfectants|mesh-ancestor
5506589|NCT04430998|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5506590|NCT04430998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5506591|NCT04430699|Cisplatin|cisplatin|mesh-list
5506592|NCT04430699|Pembrolizumab|pembrolizumab|mesh-list
5506593|NCT04430699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5506594|NCT04430699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5506595|NCT04430621|Hormones|hormones|mesh-list
5506596|NCT04430621|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5506597|NCT04430621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5506598|NCT04430621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506599|NCT04430556|Sertraline|sertraline|mesh-list
5506600|NCT04430556|Antidepressive Agents|antidepressive agents|mesh-ancestor
6062459|NCT00658697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6062460|NCT00658697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6062461|NCT00658697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6062462|NCT00658697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6062463|NCT00658697|Growth Substances|growth substances|mesh-ancestor
6062464|NCT00658697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062465|NCT00658697|Growth Inhibitors|growth inhibitors|mesh-ancestor
6062466|NCT00658697|Tubulin Modulators|tubulin modulators|mesh-ancestor
6062467|NCT00658697|Antimitotic Agents|antimitotic agents|mesh-ancestor
6062468|NCT00658697|Mitosis Modulators|mitosis modulators|mesh-ancestor
6062469|NCT00658697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062470|NCT00658697|Androgen Antagonists|androgen antagonists|mesh-ancestor
6062471|NCT00658697|Hormone Antagonists|hormone antagonists|mesh-ancestor
6062472|NCT00658697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6062473|NCT00658736|Triamcinolone|triamcinolone|mesh-list
5506601|NCT04430556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5506602|NCT04430556|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5506603|NCT04430556|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5506604|NCT04430556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6062474|NCT00658736|Bupivacaine|bupivacaine|mesh-list
5506605|NCT04430556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506606|NCT04430556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5506607|NCT04430556|Serotonin Agents|serotonin agents|mesh-ancestor
5506608|NCT04430556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506609|NCT04430361|Dexamethasone|dexamethasone|mesh-list
5506610|NCT04430361|Megestrol|megestrol|mesh-list
5506611|NCT04430361|Megestrol Acetate|megestrol acetate|mesh-list
6062475|NCT00658736|Anesthetics, Local|anesthetics, local|mesh-ancestor
6062476|NCT00658736|Anesthetics|anesthetics|mesh-ancestor
6062477|NCT00658736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6062478|NCT00658736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062479|NCT00658736|Sensory System Agents|sensory system agents|mesh-ancestor
6062480|NCT00658736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6062481|NCT00658736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6062482|NCT00658736|Glucocorticoids|glucocorticoids|mesh-ancestor
6062483|NCT00658736|Hormones|hormones|mesh-ancestor
6062484|NCT00658736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6062485|NCT00658775|Esomeprazole|esomeprazole|mesh-list
6062486|NCT00658775|Rabeprazole|rabeprazole|mesh-list
6062487|NCT00658775|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6062488|NCT00658775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6062489|NCT00658775|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6062490|NCT00658775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6062491|NCT00658775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062492|NCT00658788|Calcitriol|calcitriol|mesh-list
6062493|NCT00658788|Clobetasol|clobetasol|mesh-list
6062494|NCT00658788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6062495|NCT00658788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062496|NCT00658788|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6062497|NCT00658788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6062498|NCT00658788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062499|NCT00658788|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6062500|NCT00658788|Vitamins|vitamins|mesh-ancestor
6062501|NCT00658788|Micronutrients|micronutrients|mesh-ancestor
6062502|NCT00658788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6062503|NCT00658788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6062504|NCT00658788|Glucocorticoids|glucocorticoids|mesh-ancestor
5506612|NCT04430361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5506613|NCT04430361|Antiemetics|antiemetics|mesh-ancestor
5506614|NCT04430361|Autonomic Agents|autonomic agents|mesh-ancestor
5506615|NCT04430361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5506616|NCT04430361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506617|NCT04430361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5506618|NCT04430361|Glucocorticoids|glucocorticoids|mesh-ancestor
5506619|NCT04430361|Hormones|hormones|mesh-ancestor
5506620|NCT04430361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5506621|NCT04430361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5506622|NCT04430361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5506623|NCT04430361|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5506624|NCT04430361|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5506625|NCT04430361|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5506626|NCT04430361|Contraceptive Agents|contraceptive agents|mesh-ancestor
5506627|NCT04430361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5506628|NCT04430361|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5506629|NCT04430361|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5506630|NCT04430361|Appetite Stimulants|appetite stimulants|mesh-ancestor
5506631|NCT04430361|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5506632|NCT04430166|Antibodies|antibodies|mesh-list
5506633|NCT04430166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6062505|NCT00658788|Hormones|hormones|mesh-ancestor
6062506|NCT00658788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6062507|NCT00658814|Azacitidine|azacitidine|mesh-list
6062508|NCT00658814|Gemtuzumab|gemtuzumab|mesh-list
6062509|NCT00658814|Calicheamicins|calicheamicins|mesh-list
6062510|NCT00658814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6062511|NCT00658814|Antimetabolites|antimetabolites|mesh-ancestor
6062512|NCT00658814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062513|NCT00658814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6062514|NCT00658814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6062515|NCT00658814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6062516|NCT00658814|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6062517|NCT00659165|Insulin|insulin|mesh-list
6062518|NCT00659165|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5506634|NCT04430166|Immunologic Factors|immunologic factors|mesh-ancestor
6062519|NCT00659165|Insulin Glargine|insulin glargine|mesh-list
6062520|NCT00659165|Insulin Detemir|insulin detemir|mesh-list
6062521|NCT00659165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6062522|NCT00659165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062523|NCT00659230|Dopamine|dopamine|mesh-list
6062524|NCT00659230|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6062525|NCT00659230|Sympathomimetics|sympathomimetics|mesh-ancestor
6062526|NCT00659230|Autonomic Agents|autonomic agents|mesh-ancestor
6062527|NCT00659230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6062528|NCT00659230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062529|NCT00659230|Dopamine Agents|dopamine agents|mesh-ancestor
6062530|NCT00659230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6062531|NCT00659230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062532|NCT00659230|Protective Agents|protective agents|mesh-ancestor
6062533|NCT00659269|Vitamins|vitamins|mesh-list
6062534|NCT00659269|Vitamin B 12|vitamin b 12|mesh-list
6062535|NCT00659269|Hydroxocobalamin|hydroxocobalamin|mesh-list
6062536|NCT00659269|Vitamin B 6|vitamin b 6|mesh-list
6062537|NCT00659269|Pyridoxal|pyridoxal|mesh-list
6062538|NCT00659269|Pyridoxine|pyridoxine|mesh-list
6062539|NCT00659269|Vitamin B Complex|vitamin b complex|mesh-list
6062540|NCT00659269|Paclitaxel|paclitaxel|mesh-list
6062541|NCT00659269|Vincristine|vincristine|mesh-list
6062542|NCT00659269|Vinorelbine|vinorelbine|mesh-list
6062543|NCT00659269|Docetaxel|docetaxel|mesh-list
6062544|NCT00659269|Cisplatin|cisplatin|mesh-list
6062545|NCT00659269|Oxaliplatin|oxaliplatin|mesh-list
6062546|NCT00659269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6062547|NCT00659269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6062548|NCT00659269|Tubulin Modulators|tubulin modulators|mesh-ancestor
6062549|NCT00659269|Antimitotic Agents|antimitotic agents|mesh-ancestor
6062550|NCT00659269|Mitosis Modulators|mitosis modulators|mesh-ancestor
6062551|NCT00659269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062552|NCT00659269|Micronutrients|micronutrients|mesh-ancestor
6062553|NCT00659269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062554|NCT00659269|Hematinics|hematinics|mesh-ancestor
6062555|NCT00659295|Insulin Detemir|insulin detemir|mesh-list
6062556|NCT00659295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6062557|NCT00659295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062558|NCT00659360|Saracatinib|saracatinib|mesh-list
6062559|NCT00659360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6062560|NCT00659360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6062561|NCT00659360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062562|NCT00659373|Tamoxifen|tamoxifen|mesh-list
6062563|NCT00659373|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6062564|NCT00659373|Exemestane|exemestane|mesh-list
6062565|NCT00659373|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6062566|NCT00659373|Hormone Antagonists|hormone antagonists|mesh-ancestor
6062567|NCT00659373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6062568|NCT00659373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062569|NCT00659373|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6062570|NCT00659373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6062571|NCT00659373|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6062572|NCT00659373|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6062573|NCT00659373|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6062574|NCT00659373|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6062575|NCT00659373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6062576|NCT00659373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6062577|NCT00659373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062578|NCT00659373|Luteolytic Agents|luteolytic agents|mesh-ancestor
6062579|NCT00659373|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6062580|NCT00659373|Contraceptive Agents|contraceptive agents|mesh-ancestor
6062581|NCT00659373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6062582|NCT00659373|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6062583|NCT00659425|Immunotoxin HA22|immunotoxin ha22|mesh-list
6062584|NCT00659425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6462764|NCT00460954|Levodopa|levodopa|mesh-list
6462765|NCT00460954|Carbidopa|carbidopa|mesh-list
6062585|NCT00659438|Bicalutamide|bicalutamide|mesh-list
6062586|NCT00659438|Androgen Antagonists|androgen antagonists|mesh-ancestor
6062587|NCT00659438|Hormone Antagonists|hormone antagonists|mesh-ancestor
6062588|NCT00659438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6462766|NCT00460954|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
6462767|NCT00460954|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6462768|NCT00460954|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6462769|NCT00460954|Dopamine Agents|dopamine agents|mesh-ancestor
6462770|NCT00460954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6062589|NCT00659438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062590|NCT00659438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6062591|NCT00659490|Naproxen|naproxen|mesh-list
6062592|NCT00659490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6062593|NCT00659490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6062594|NCT00659490|Analgesics|analgesics|mesh-ancestor
6062595|NCT00659490|Sensory System Agents|sensory system agents|mesh-ancestor
6062596|NCT00659490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6062597|NCT00659490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062598|NCT00659490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6062599|NCT00659490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6062600|NCT00659490|Gout Suppressants|gout suppressants|mesh-ancestor
6062601|NCT00659490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6062602|NCT00659490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6062603|NCT00659490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062604|NCT00659529|Sildenafil Citrate|sildenafil citrate|mesh-list
6062605|NCT00659529|Vasodilator Agents|vasodilator agents|mesh-ancestor
6062606|NCT00659529|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6062607|NCT00659529|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6062608|NCT00659529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6062609|NCT00659529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062610|NCT00659529|Urological Agents|urological agents|mesh-ancestor
6062611|NCT00659581|Telmisartan|telmisartan|mesh-list
5506635|NCT04430166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600190|NCT03713762|Bupivacaine|bupivacaine|mesh-list
5600191|NCT03713762|Anesthetics, Local|anesthetics, local|mesh-ancestor
5600192|NCT03713762|Anesthetics|anesthetics|mesh-ancestor
6062612|NCT00659581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6062613|NCT00659581|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6062614|NCT00659581|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6062615|NCT00659581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062616|NCT00659633|Lidocaine|lidocaine|mesh-list
6062617|NCT00659633|Anesthetics, Local|anesthetics, local|mesh-ancestor
6062618|NCT00659633|Anesthetics|anesthetics|mesh-ancestor
6062619|NCT00659633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6062620|NCT00659633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062621|NCT00659633|Sensory System Agents|sensory system agents|mesh-ancestor
6062622|NCT00659633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5600193|NCT03713762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5600194|NCT03713762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600195|NCT03713762|Sensory System Agents|sensory system agents|mesh-ancestor
5600196|NCT03713762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5600197|NCT03713762|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5600198|NCT03713762|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5600199|NCT03713762|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5600200|NCT03713762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6062623|NCT00659633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6062624|NCT00659633|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6062625|NCT00659633|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6062626|NCT00659633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6062627|NCT00659633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062628|NCT00659737|Scopolamine|scopolamine|mesh-list
6062629|NCT00659737|Aprepitant|aprepitant|mesh-list
6062630|NCT00659737|Fosaprepitant|fosaprepitant|mesh-list
6062631|NCT00659737|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
6062632|NCT00659737|Antiemetics|antiemetics|mesh-ancestor
6062633|NCT00659737|Autonomic Agents|autonomic agents|mesh-ancestor
6062634|NCT00659737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6062635|NCT00659737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062636|NCT00659737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6062637|NCT00659737|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6062638|NCT00659737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6062639|NCT00659737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062640|NCT00659737|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6062641|NCT00659737|Mydriatics|mydriatics|mesh-ancestor
6062642|NCT00659737|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6062643|NCT00659737|Cholinergic Agents|cholinergic agents|mesh-ancestor
6062644|NCT00659737|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6062645|NCT00659737|Parasympatholytics|parasympatholytics|mesh-ancestor
6062646|NCT00659815|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6062647|NCT00659945|Ondansetron|ondansetron|mesh-list
6062648|NCT00659945|Aprepitant|aprepitant|mesh-list
6062649|NCT00659945|Antiemetics|antiemetics|mesh-ancestor
6062650|NCT00659945|Autonomic Agents|autonomic agents|mesh-ancestor
6062651|NCT00659945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6062652|NCT00659945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062653|NCT00659945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6062654|NCT00659945|Antipruritics|antipruritics|mesh-ancestor
6062655|NCT00659945|Dermatologic Agents|dermatologic agents|mesh-ancestor
6062656|NCT00659945|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6062657|NCT00659945|Serotonin Agents|serotonin agents|mesh-ancestor
6062658|NCT00659945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6062659|NCT00659945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062660|NCT00659945|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6062661|NCT00659945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6062662|NCT00659945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6062663|NCT00659945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6062664|NCT00659945|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6462771|NCT00460954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462772|NCT00460954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462773|NCT00460954|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6462774|NCT00460954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6462775|NCT00460954|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6462776|NCT00460954|Immunologic Factors|immunologic factors|mesh-ancestor
5506636|NCT04430062|Anesthetics|anesthetics|mesh-list
6062665|NCT00659945|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6062666|NCT00659984|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
6062667|NCT00659984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6062668|NCT00659984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6062669|NCT00659984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062670|NCT00659984|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6062671|NCT00660010|Leuprolide|leuprolide|mesh-list
6062672|NCT00660010|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5506637|NCT04430062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5506638|NCT04430062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506639|NCT04429867|Hydroxychloroquine|hydroxychloroquine|mesh-list
6062673|NCT00660010|Fertility Agents|fertility agents|mesh-ancestor
6062674|NCT00660010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6062675|NCT00660010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062676|NCT00660010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6062677|NCT00660010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6062678|NCT00660023|Epoetin Alfa|epoetin alfa|mesh-list
6062679|NCT00660023|Hematinics|hematinics|mesh-ancestor
6062680|NCT00660075|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6062681|NCT00660075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6062682|NCT00660075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062683|NCT00660075|Incretins|incretins|mesh-ancestor
6062684|NCT00660075|Hormones|hormones|mesh-ancestor
6062685|NCT00660075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5506640|NCT04429867|Antimalarials|antimalarials|mesh-ancestor
5506641|NCT04429867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5506642|NCT04429867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5506643|NCT04429867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5506644|NCT04429867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5506645|NCT04429867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506646|NCT04429867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5506647|NCT04429893|Magnesium Sulfate|magnesium sulfate|mesh-list
5506648|NCT04429893|Bupivacaine|bupivacaine|mesh-list
6062686|NCT00660075|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6062687|NCT00660075|Protease Inhibitors|protease inhibitors|mesh-ancestor
6062688|NCT00660075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6062689|NCT00660075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062690|NCT00660179|Macitentan|macitentan|mesh-list
6062691|NCT00660179|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
6062692|NCT00660179|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6062693|NCT00660179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062694|NCT00660179|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
6062695|NCT00660309|Irbesartan|irbesartan|mesh-list
6062696|NCT00660309|Captopril|captopril|mesh-list
6062697|NCT00660309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6062698|NCT00660309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6062699|NCT00660309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6062700|NCT00660309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062701|NCT00660309|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6062702|NCT00660309|Protease Inhibitors|protease inhibitors|mesh-ancestor
6062703|NCT00660309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6062704|NCT00660387|Levodopa|levodopa|mesh-list
6062705|NCT00660387|Carbidopa|carbidopa|mesh-list
6062706|NCT00660387|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
6062707|NCT00660387|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6062708|NCT00660387|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6062709|NCT00660387|Dopamine Agents|dopamine agents|mesh-ancestor
6062710|NCT00660387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6062711|NCT00660387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062712|NCT00660387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062713|NCT00660387|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6062714|NCT00660387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6062715|NCT00660387|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6062716|NCT00660387|Immunologic Factors|immunologic factors|mesh-ancestor
6062717|NCT00660387|Dopamine Agonists|dopamine agonists|mesh-ancestor
6062718|NCT00660400|Azacitidine|azacitidine|mesh-list
6062719|NCT00660400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6062720|NCT00660400|Antimetabolites|antimetabolites|mesh-ancestor
6062721|NCT00660400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062722|NCT00660400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6062723|NCT00660400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6062724|NCT00660504|Etoposide|etoposide|mesh-list
6062725|NCT00660504|Amrubicin|amrubicin|mesh-list
6062726|NCT00660504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6062727|NCT00660504|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6062728|NCT00660504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6062729|NCT00660504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5506649|NCT04429893|Anesthetics, Local|anesthetics, local|mesh-ancestor
5506650|NCT04429893|Anesthetics|anesthetics|mesh-ancestor
5506651|NCT04429893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5506652|NCT04429893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506653|NCT04429893|Sensory System Agents|sensory system agents|mesh-ancestor
6062730|NCT00660504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5506654|NCT04429893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6062731|NCT00660504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062732|NCT00660517|Fluticasone|fluticasone|mesh-list
6062733|NCT00660517|Xhance|xhance|mesh-list
6062734|NCT00660517|Azelastine|azelastine|mesh-list
6062735|NCT00660517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6062736|NCT00660517|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6062737|NCT00660517|Autonomic Agents|autonomic agents|mesh-ancestor
6062738|NCT00660517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6062739|NCT00660517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062740|NCT00660517|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6062741|NCT00660517|Respiratory System Agents|respiratory system agents|mesh-ancestor
6062742|NCT00660517|Dermatologic Agents|dermatologic agents|mesh-ancestor
6062743|NCT00660517|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6062744|NCT00660517|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6062745|NCT00660517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6062746|NCT00660517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062747|NCT00660517|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6062748|NCT00660517|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6062749|NCT00660517|Histamine Antagonists|histamine antagonists|mesh-ancestor
6062750|NCT00660517|Histamine Agents|histamine agents|mesh-ancestor
6062751|NCT00660517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6062752|NCT00660543|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
6062753|NCT00660543|Hematinics|hematinics|mesh-ancestor
6062754|NCT00660543|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6062755|NCT00660543|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6062756|NCT00660660|Esomeprazole|esomeprazole|mesh-list
6062757|NCT00660660|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6062758|NCT00660660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6062759|NCT00660660|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6062760|NCT00660660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6062761|NCT00660660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062762|NCT00660699|Gemcitabine|gemcitabine|mesh-list
6062763|NCT00660699|Docetaxel|docetaxel|mesh-list
6062764|NCT00660699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6062765|NCT00660699|Antimetabolites|antimetabolites|mesh-ancestor
6062766|NCT00660699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062767|NCT00660699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6062768|NCT00660699|Antiviral Agents|antiviral agents|mesh-ancestor
6062769|NCT00660699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6062770|NCT00660699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6062771|NCT00660699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6062772|NCT00660699|Immunologic Factors|immunologic factors|mesh-ancestor
6062773|NCT00660699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062774|NCT00660699|Tubulin Modulators|tubulin modulators|mesh-ancestor
6062775|NCT00660699|Antimitotic Agents|antimitotic agents|mesh-ancestor
6062776|NCT00660699|Mitosis Modulators|mitosis modulators|mesh-ancestor
6062777|NCT00660816|Docetaxel|docetaxel|mesh-list
6062778|NCT00660816|Pemetrexed|pemetrexed|mesh-list
6062779|NCT00660816|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6062780|NCT00660816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6062781|NCT00660816|Tubulin Modulators|tubulin modulators|mesh-ancestor
6062782|NCT00660816|Antimitotic Agents|antimitotic agents|mesh-ancestor
6062783|NCT00660816|Mitosis Modulators|mitosis modulators|mesh-ancestor
6062784|NCT00660816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062785|NCT00660816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6062786|NCT00660816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6062787|NCT00660816|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6062788|NCT00660816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6062789|NCT00660829|Azelastine|azelastine|mesh-list
6062790|NCT00660829|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6062791|NCT00660829|Autonomic Agents|autonomic agents|mesh-ancestor
6062792|NCT00660829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6062793|NCT00660829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062794|NCT00660829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6062795|NCT00660829|Respiratory System Agents|respiratory system agents|mesh-ancestor
6062796|NCT00660829|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6062797|NCT00660829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6062798|NCT00660829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062799|NCT00660829|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6062800|NCT00660829|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6062801|NCT00660829|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6062802|NCT00660829|Histamine Antagonists|histamine antagonists|mesh-ancestor
6062803|NCT00660829|Histamine Agents|histamine agents|mesh-ancestor
5506655|NCT04429893|Analgesics|analgesics|mesh-ancestor
5506656|NCT04429893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5506657|NCT04429893|Anticonvulsants|anticonvulsants|mesh-ancestor
5506658|NCT04429893|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5506659|NCT04429893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5506660|NCT04429893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506661|NCT04429893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5506662|NCT04429893|Tocolytic Agents|tocolytic agents|mesh-ancestor
5506663|NCT04429893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5506664|NCT04430192|177Lu-PSMA-617|177lu-psma-617|mesh-list
5506665|NCT04430192|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5506666|NCT04430192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506667|NCT04430179|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5506668|NCT04430179|Immunologic Factors|immunologic factors|mesh-ancestor
5506669|NCT04430179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506670|NCT04429711|Ivermectin|ivermectin|mesh-list
5506671|NCT04429711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5506672|NCT04429711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5506673|NCT04429633|Candesartan|candesartan|mesh-list
5506674|NCT04429633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5506675|NCT04429633|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5506676|NCT04429633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5506677|NCT04429633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506678|NCT04429516|Morphine|morphine|mesh-list
5506679|NCT04429516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5506680|NCT04429516|Narcotics|narcotics|mesh-ancestor
6062804|NCT00660829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6062805|NCT00660907|Metformin|metformin|mesh-list
6062806|NCT00660907|Dapagliflozin|dapagliflozin|mesh-list
6062807|NCT00660907|Glipizide|glipizide|mesh-list
6062808|NCT00660907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6062809|NCT00660907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062810|NCT00660907|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6062811|NCT00660907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062812|NCT00660985|Adapalene|adapalene|mesh-list
6062813|NCT00660985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6062814|NCT00660985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6062815|NCT00660985|Analgesics|analgesics|mesh-ancestor
6062816|NCT00660985|Sensory System Agents|sensory system agents|mesh-ancestor
6062817|NCT00660985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6062818|NCT00660985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062819|NCT00660985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6062820|NCT00660985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6062821|NCT00660985|Dermatologic Agents|dermatologic agents|mesh-ancestor
6062822|NCT00661089|Botulinum Toxins|botulinum toxins|mesh-list
6062823|NCT00661089|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6062824|NCT00661089|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6062825|NCT00661089|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6062826|NCT00661089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6062827|NCT00661089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062828|NCT00661089|Cholinergic Agents|cholinergic agents|mesh-ancestor
6062829|NCT00661089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6062830|NCT00661089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062831|NCT00661089|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6062832|NCT00661089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6062833|NCT00661141|Ethanol|ethanol|mesh-list
6062834|NCT00661141|Fomepizole|fomepizole|mesh-list
6062835|NCT00661141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6062836|NCT00661141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6062837|NCT00661141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6062838|NCT00661141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062839|NCT00661141|Antidotes|antidotes|mesh-ancestor
6062840|NCT00661141|Protective Agents|protective agents|mesh-ancestor
6062841|NCT00661141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6062842|NCT00661141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062843|NCT00661193|Paclitaxel|paclitaxel|mesh-list
6062844|NCT00661193|Carboplatin|carboplatin|mesh-list
6062845|NCT00661193|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6062846|NCT00661193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6062847|NCT00661193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6062848|NCT00661193|Tubulin Modulators|tubulin modulators|mesh-ancestor
6062849|NCT00661193|Antimitotic Agents|antimitotic agents|mesh-ancestor
6062850|NCT00661193|Mitosis Modulators|mitosis modulators|mesh-ancestor
6062851|NCT00661193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062852|NCT00661193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6062853|NCT00661193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6062854|NCT00661362|Metformin|metformin|mesh-list
6062855|NCT00661362|Saxagliptin|saxagliptin|mesh-list
6062856|NCT00661362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6062857|NCT00661362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062858|NCT00661362|Incretins|incretins|mesh-ancestor
6062859|NCT00661362|Hormones|hormones|mesh-ancestor
6062860|NCT00661362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6062861|NCT00661362|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6062862|NCT00661362|Protease Inhibitors|protease inhibitors|mesh-ancestor
6062863|NCT00661362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6062864|NCT00661362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062865|NCT00661388|Epoetin Alfa|epoetin alfa|mesh-list
6062866|NCT00661388|Hematinics|hematinics|mesh-ancestor
6062867|NCT00661427|Cetuximab|cetuximab|mesh-list
6062868|NCT00661427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6062869|NCT00661427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6062870|NCT00661453|Valproic Acid|valproic acid|mesh-list
6062871|NCT00661453|Anticonvulsants|anticonvulsants|mesh-ancestor
6062872|NCT00661453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6062873|NCT00661453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062874|NCT00661453|GABA Agents|gaba agents|mesh-ancestor
6062875|NCT00661453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6062876|NCT00661453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062877|NCT00661453|Antimanic Agents|antimanic agents|mesh-ancestor
6062878|NCT00661453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6062879|NCT00661453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6062880|NCT00661453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6062881|NCT00661479|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6062882|NCT00661479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6062883|NCT00661479|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6062884|NCT00661479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6062885|NCT00661479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6062886|NCT00661479|Adrenergic Agents|adrenergic agents|mesh-ancestor
6062887|NCT00661479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6062888|NCT00661479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062889|NCT00661479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062890|NCT00661492|Cetuximab|cetuximab|mesh-list
6062891|NCT00661492|Mitoxantrone|mitoxantrone|mesh-list
6062892|NCT00661492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6062893|NCT00661492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6062894|NCT00661492|Analgesics|analgesics|mesh-ancestor
6062895|NCT00661492|Sensory System Agents|sensory system agents|mesh-ancestor
6062896|NCT00661492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6062897|NCT00661492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062898|NCT00661492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6062899|NCT00661492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6062900|NCT00661492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6062901|NCT00661492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062902|NCT00661505|Epoetin Alfa|epoetin alfa|mesh-list
6062903|NCT00661505|Hematinics|hematinics|mesh-ancestor
6062904|NCT00661531|Anastrozole|anastrozole|mesh-list
6062905|NCT00661531|Estradiol|estradiol|mesh-list
6062906|NCT00661531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6062907|NCT00661531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6062908|NCT00661531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6062909|NCT00661531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6062910|NCT00661531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6062911|NCT00661531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062912|NCT00661531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6062913|NCT00661531|Hormone Antagonists|hormone antagonists|mesh-ancestor
6062914|NCT00661531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6062915|NCT00661531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062916|NCT00661531|Estrogens|estrogens|mesh-ancestor
6062917|NCT00661531|Hormones|hormones|mesh-ancestor
6062918|NCT00661544|Ascorbic Acid|ascorbic acid|mesh-list
6062919|NCT00661544|Melphalan|melphalan|mesh-list
6062920|NCT00661544|Arsenic Trioxide|arsenic trioxide|mesh-list
6062921|NCT00661544|Vitamins|vitamins|mesh-ancestor
6062922|NCT00661544|Micronutrients|micronutrients|mesh-ancestor
6062923|NCT00661544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062924|NCT00661544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6062925|NCT00661544|Alkylating Agents|alkylating agents|mesh-ancestor
6062926|NCT00661544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062927|NCT00661544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6062928|NCT00661544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6062929|NCT00661544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5506681|NCT04429516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5506682|NCT04429516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506683|NCT04429516|Analgesics|analgesics|mesh-ancestor
5506684|NCT04429516|Sensory System Agents|sensory system agents|mesh-ancestor
5506685|NCT04429516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5506686|NCT04429503|Aflibercept|aflibercept|mesh-list
5506687|NCT04429503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5506688|NCT04429503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5506689|NCT04429503|Growth Substances|growth substances|mesh-ancestor
5506690|NCT04429503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506691|NCT04429503|Growth Inhibitors|growth inhibitors|mesh-ancestor
5506692|NCT04429503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5506693|NCT04429425|Anesthetics|anesthetics|mesh-list
5506694|NCT04429425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5506695|NCT04429425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506696|NCT04429282|Ibuprofen|ibuprofen|mesh-list
5506697|NCT04429282|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6062930|NCT00661544|Immunologic Factors|immunologic factors|mesh-ancestor
5506698|NCT04429282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5506699|NCT04429282|Analgesics|analgesics|mesh-ancestor
5506700|NCT04429282|Sensory System Agents|sensory system agents|mesh-ancestor
5506701|NCT04429282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5506702|NCT04429282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506703|NCT04429282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5506704|NCT04429282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5506705|NCT04429282|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5506706|NCT04429282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5506707|NCT04429282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506708|NCT04429555|Ibudilast|ibudilast|mesh-list
5506709|NCT04429555|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5506710|NCT04429555|Autonomic Agents|autonomic agents|mesh-ancestor
5506711|NCT04429555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5506712|NCT04429555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506713|NCT04429555|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5506714|NCT04429555|Respiratory System Agents|respiratory system agents|mesh-ancestor
6062931|NCT00661544|Antioxidants|antioxidants|mesh-ancestor
6062932|NCT00661544|Protective Agents|protective agents|mesh-ancestor
6062933|NCT00661583|Ranibizumab|ranibizumab|mesh-list
6062934|NCT00661583|Mitomycins|mitomycins|mesh-list
6062935|NCT00661583|Mitomycin|mitomycin|mesh-list
6062936|NCT00661583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6062937|NCT00661583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6062938|NCT00661583|Growth Substances|growth substances|mesh-ancestor
6062939|NCT00661583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062940|NCT00661583|Growth Inhibitors|growth inhibitors|mesh-ancestor
6062941|NCT00661583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6062942|NCT00661583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6062943|NCT00661583|Alkylating Agents|alkylating agents|mesh-ancestor
6062944|NCT00661583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062945|NCT00661583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6062946|NCT00661583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6062947|NCT00661622|Molgramostim|molgramostim|mesh-list
6062948|NCT00661622|Sargramostim|sargramostim|mesh-list
6062949|NCT00661622|Immunologic Factors|immunologic factors|mesh-ancestor
6062950|NCT00661622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062951|NCT00661622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6062952|NCT00661661|Tofacitinib|tofacitinib|mesh-list
6062953|NCT00661661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6062954|NCT00661661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6062955|NCT00661661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062956|NCT00661674|Palonosetron|palonosetron|mesh-list
6062957|NCT00661674|Hydroxyzine|hydroxyzine|mesh-list
6062958|NCT00661674|Antiemetics|antiemetics|mesh-ancestor
6062959|NCT00661674|Autonomic Agents|autonomic agents|mesh-ancestor
6062960|NCT00661674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6062961|NCT00661674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062962|NCT00661674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6062963|NCT00661674|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6062964|NCT00661674|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6062965|NCT00661674|Serotonin Agents|serotonin agents|mesh-ancestor
6062966|NCT00661674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6062967|NCT00661674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062968|NCT00661674|Antipruritics|antipruritics|mesh-ancestor
6062969|NCT00661674|Dermatologic Agents|dermatologic agents|mesh-ancestor
6062970|NCT00661674|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6062971|NCT00661674|Histamine Antagonists|histamine antagonists|mesh-ancestor
6062972|NCT00661674|Histamine Agents|histamine agents|mesh-ancestor
6062973|NCT00661713|Vaccines|vaccines|mesh-list
6062974|NCT00661713|Immunologic Factors|immunologic factors|mesh-ancestor
6062975|NCT00661713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062976|NCT00661726|Decitabine|decitabine|mesh-list
6062977|NCT00661726|Azacitidine|azacitidine|mesh-list
6062978|NCT00661726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6062979|NCT00661726|Antimetabolites|antimetabolites|mesh-ancestor
6062980|NCT00661726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062981|NCT00661726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6062982|NCT00661726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6062983|NCT00661778|Bevacizumab|bevacizumab|mesh-list
6062984|NCT00661778|Docetaxel|docetaxel|mesh-list
6062985|NCT00661778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6062986|NCT00661778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5506715|NCT04429555|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6062987|NCT00661778|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6062988|NCT00661778|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6062989|NCT00661778|Growth Substances|growth substances|mesh-ancestor
6062990|NCT00661778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6062991|NCT00661778|Growth Inhibitors|growth inhibitors|mesh-ancestor
6062992|NCT00661778|Tubulin Modulators|tubulin modulators|mesh-ancestor
6062993|NCT00661778|Antimitotic Agents|antimitotic agents|mesh-ancestor
6062994|NCT00661778|Mitosis Modulators|mitosis modulators|mesh-ancestor
6062995|NCT00661778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6062996|NCT00661830|Gemcitabine|gemcitabine|mesh-list
6062997|NCT00661830|Sorafenib|sorafenib|mesh-list
6062998|NCT00661830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6062999|NCT00661830|Antimetabolites|antimetabolites|mesh-ancestor
6063000|NCT00661830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063001|NCT00661830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6063002|NCT00661830|Antiviral Agents|antiviral agents|mesh-ancestor
5506716|NCT04429555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5506717|NCT04429555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506718|NCT04429555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5506719|NCT04429555|Vasodilator Agents|vasodilator agents|mesh-ancestor
5506720|NCT04429295|Vaccines|vaccines|mesh-list
5506721|NCT04429295|Immunologic Factors|immunologic factors|mesh-ancestor
5506722|NCT04429295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506723|NCT04429321|Nivolumab|nivolumab|mesh-list
5506724|NCT04429321|Ipilimumab|ipilimumab|mesh-list
5506725|NCT04429321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5506726|NCT04429321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6063003|NCT00661830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6063004|NCT00661830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6063005|NCT00661830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6063006|NCT00661830|Immunologic Factors|immunologic factors|mesh-ancestor
6063007|NCT00661830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063008|NCT00661830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6063009|NCT00661895|Metoprolol|metoprolol|mesh-list
6063010|NCT00661895|Atenolol|atenolol|mesh-list
6063011|NCT00661895|Amlodipine|amlodipine|mesh-list
6063012|NCT00661895|Valsartan|valsartan|mesh-list
6063013|NCT00661895|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6063014|NCT00661895|Clonidine|clonidine|mesh-list
6063015|NCT00661895|Lisinopril|lisinopril|mesh-list
6063016|NCT00661895|Doxazosin|doxazosin|mesh-list
6063017|NCT00661895|Hydralazine|hydralazine|mesh-list
6063018|NCT00661895|Nifedipine|nifedipine|mesh-list
6063019|NCT00661895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6063020|NCT00661895|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6063021|NCT00661895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6063022|NCT00661895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063023|NCT00661895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6063024|NCT00661895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063025|NCT00661895|Vasodilator Agents|vasodilator agents|mesh-ancestor
6063026|NCT00661895|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6063027|NCT00661895|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6063028|NCT00661895|Diuretics|diuretics|mesh-ancestor
6063029|NCT00661895|Natriuretic Agents|natriuretic agents|mesh-ancestor
6063030|NCT00661895|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6063031|NCT00661895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6063032|NCT00661895|Sympatholytics|sympatholytics|mesh-ancestor
6063033|NCT00661895|Autonomic Agents|autonomic agents|mesh-ancestor
6063034|NCT00661895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5506727|NCT04429321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5506728|NCT04429321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506729|NCT04429347|Gabapentin|gabapentin|mesh-list
6063035|NCT00661895|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6063036|NCT00661895|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6462777|NCT00460954|Dopamine Agonists|dopamine agonists|mesh-ancestor
6462778|NCT00461084|Clarithromycin|clarithromycin|mesh-list
5506730|NCT04429347|Tizanidine|tizanidine|mesh-list
5506731|NCT04429347|Analgesics|analgesics|mesh-ancestor
5506732|NCT04429347|Sensory System Agents|sensory system agents|mesh-ancestor
5506733|NCT04429347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5506734|NCT04429347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506735|NCT04429347|Anticonvulsants|anticonvulsants|mesh-ancestor
5506736|NCT04429347|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5506737|NCT04429347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5506738|NCT04429347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5506739|NCT04429347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6063037|NCT00661895|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6063038|NCT00661895|Adrenergic Agents|adrenergic agents|mesh-ancestor
6462779|NCT00461084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6462780|NCT00461084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6462781|NCT00461084|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6462782|NCT00461084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6063039|NCT00661895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6063040|NCT00661895|Analgesics|analgesics|mesh-ancestor
6063041|NCT00661895|Sensory System Agents|sensory system agents|mesh-ancestor
6063042|NCT00661895|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6063043|NCT00661895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6063044|NCT00661895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5506740|NCT04429347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5506741|NCT04429347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5506742|NCT04429347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5506743|NCT04429347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506744|NCT04429347|Antimanic Agents|antimanic agents|mesh-ancestor
5506745|NCT04429347|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5506746|NCT04429347|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5506747|NCT04429347|Parasympatholytics|parasympatholytics|mesh-ancestor
5506748|NCT04429347|Autonomic Agents|autonomic agents|mesh-ancestor
5506749|NCT04429347|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5506750|NCT04429347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5506751|NCT04429347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5506752|NCT04429347|Adrenergic Agents|adrenergic agents|mesh-ancestor
5506753|NCT04429334|Nangibotide|nangibotide|mesh-list
5506754|NCT04429334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5506755|NCT04429191|Antibodies|antibodies|mesh-list
5506756|NCT04429191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5506757|NCT04429191|Immunologic Factors|immunologic factors|mesh-ancestor
5506758|NCT04429191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506759|NCT04429152|Tenofovir|tenofovir|mesh-list
5506760|NCT04429152|Lamivudine|lamivudine|mesh-list
5506761|NCT04429152|Antiviral Agents|antiviral agents|mesh-ancestor
5506762|NCT04429152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5506763|NCT04429152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6063045|NCT00661895|Tocolytic Agents|tocolytic agents|mesh-ancestor
6063046|NCT00661895|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6063047|NCT00661895|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6063048|NCT00661895|Protease Inhibitors|protease inhibitors|mesh-ancestor
6063049|NCT00661895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6063050|NCT00661895|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6063051|NCT00661895|Protective Agents|protective agents|mesh-ancestor
6063052|NCT00661895|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6063053|NCT00661895|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6063054|NCT00661960|Efavirenz|efavirenz|mesh-list
6063055|NCT00661960|Raltegravir Potassium|raltegravir potassium|mesh-list
6063056|NCT00661960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6063057|NCT00661960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6063058|NCT00661960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6063059|NCT00661960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063060|NCT00661960|Antiviral Agents|antiviral agents|mesh-ancestor
6063061|NCT00661960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6063062|NCT00661960|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6063063|NCT00661960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6063064|NCT00661960|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6063065|NCT00661960|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6063066|NCT00661960|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6063067|NCT00661960|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6063068|NCT00661960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6063069|NCT00661960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6063070|NCT00661960|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6063071|NCT00661960|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6063072|NCT00661999|Darbepoetin alfa|darbepoetin alfa|mesh-list
6063073|NCT00661999|Ferric gluconate|ferric gluconate|mesh-list
6063074|NCT00661999|Hematinics|hematinics|mesh-ancestor
6063075|NCT00662012|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
6063076|NCT00662012|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6063077|NCT00662012|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6063078|NCT00662012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6063079|NCT00662012|Schistosomicides|schistosomicides|mesh-ancestor
6063080|NCT00662012|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6063081|NCT00662012|Anthelmintics|anthelmintics|mesh-ancestor
6063082|NCT00662025|Capecitabine|capecitabine|mesh-list
6063083|NCT00662025|Sunitinib|sunitinib|mesh-list
6063084|NCT00662025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6063085|NCT00662025|Antimetabolites|antimetabolites|mesh-ancestor
6488401|NCT00583986|Autonomic Agents|autonomic agents|mesh-ancestor
5506764|NCT04429152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5506765|NCT04429152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5506766|NCT04429152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506767|NCT04429152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5506768|NCT04429152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5506769|NCT04429035|Vitamin K|vitamin k|mesh-list
5506770|NCT04429035|Vitamin K 2|vitamin k 2|mesh-list
5506771|NCT04429035|Vitamins|vitamins|mesh-ancestor
5506772|NCT04429035|Micronutrients|micronutrients|mesh-ancestor
5506773|NCT04429035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506774|NCT04429035|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5506775|NCT04429035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5506776|NCT04429035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506777|NCT04429035|Hemostatics|hemostatics|mesh-ancestor
5506778|NCT04429035|Coagulants|coagulants|mesh-ancestor
5506779|NCT04429022|Acetaminophen|acetaminophen|mesh-list
5506780|NCT04429022|Celecoxib|celecoxib|mesh-list
5506781|NCT04429022|Ketorolac|ketorolac|mesh-list
5506782|NCT04429022|Oxycodone|oxycodone|mesh-list
5506783|NCT04429022|Gabapentin|gabapentin|mesh-list
5506784|NCT04429022|Hydromorphone|hydromorphone|mesh-list
5506785|NCT04429022|Ropivacaine|ropivacaine|mesh-list
5506786|NCT04429022|Anesthetics, Local|anesthetics, local|mesh-list
5506787|NCT04429022|Anesthetics|anesthetics|mesh-list
5506788|NCT04429022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5506789|NCT04429022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506790|NCT04429022|Sensory System Agents|sensory system agents|mesh-ancestor
5506791|NCT04429022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5506792|NCT04429022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5506793|NCT04429022|Analgesics|analgesics|mesh-ancestor
5506794|NCT04429022|Antipyretics|antipyretics|mesh-ancestor
5506795|NCT04429022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5506796|NCT04429022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5506797|NCT04429022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5506798|NCT04429022|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5506799|NCT04429022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5506800|NCT04429022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5506801|NCT04429022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506802|NCT04429022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5506803|NCT04429022|Narcotics|narcotics|mesh-ancestor
5506804|NCT04429022|Anticonvulsants|anticonvulsants|mesh-ancestor
5506805|NCT04429022|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5506806|NCT04429022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5506807|NCT04429022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5506808|NCT04429022|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5506809|NCT04429022|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5506810|NCT04429022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5506811|NCT04429022|Antimanic Agents|antimanic agents|mesh-ancestor
5506812|NCT04428879|Topotecan|topotecan|mesh-list
5506813|NCT04428879|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6063086|NCT00662025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063087|NCT00662025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6063088|NCT00662025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6063089|NCT00662025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6063090|NCT00662025|Growth Substances|growth substances|mesh-ancestor
6063091|NCT00662025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063092|NCT00662025|Growth Inhibitors|growth inhibitors|mesh-ancestor
6063093|NCT00662025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6063094|NCT00662025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6063095|NCT00662038|Pirfenidone|pirfenidone|mesh-list
6063096|NCT00662038|Analgesics|analgesics|mesh-ancestor
6063097|NCT00662038|Sensory System Agents|sensory system agents|mesh-ancestor
6063098|NCT00662038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6063099|NCT00662038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063100|NCT00662038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6063101|NCT00662038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6063102|NCT00662038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6063103|NCT00662038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6063104|NCT00662038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6063105|NCT00662129|Gemcitabine|gemcitabine|mesh-list
6063106|NCT00662129|Paclitaxel|paclitaxel|mesh-list
6063107|NCT00662129|Bevacizumab|bevacizumab|mesh-list
6063108|NCT00662129|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6063109|NCT00662129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5506814|NCT04428879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5506815|NCT04428879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5506816|NCT04428879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506817|NCT04428879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5506818|NCT04428814|Ustekinumab|ustekinumab|mesh-list
6063110|NCT00662129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6063111|NCT00662129|Tubulin Modulators|tubulin modulators|mesh-ancestor
6063112|NCT00662129|Antimitotic Agents|antimitotic agents|mesh-ancestor
6063113|NCT00662129|Mitosis Modulators|mitosis modulators|mesh-ancestor
6063114|NCT00662129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063115|NCT00662129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6063116|NCT00662129|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6063117|NCT00662129|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6063118|NCT00662129|Growth Substances|growth substances|mesh-ancestor
6063119|NCT00662129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063120|NCT00662129|Growth Inhibitors|growth inhibitors|mesh-ancestor
6063121|NCT00662129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6063122|NCT00662129|Antimetabolites|antimetabolites|mesh-ancestor
6063123|NCT00662129|Antiviral Agents|antiviral agents|mesh-ancestor
6063124|NCT00662129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6063125|NCT00662129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6063126|NCT00662129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6063127|NCT00662129|Immunologic Factors|immunologic factors|mesh-ancestor
6063128|NCT00662155|Zolpidem|zolpidem|mesh-list
6063129|NCT00662155|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6063130|NCT00662155|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6063131|NCT00662155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6063132|NCT00662155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063133|NCT00662155|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6063134|NCT00662155|GABA Agonists|gaba agonists|mesh-ancestor
6063135|NCT00662155|GABA Agents|gaba agents|mesh-ancestor
6063136|NCT00662155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6063137|NCT00662155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063138|NCT00662259|Alprazolam|alprazolam|mesh-list
6063139|NCT00662259|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6063140|NCT00662259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6063141|NCT00662259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063142|NCT00662259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6063143|NCT00662259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6063144|NCT00662259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6063145|NCT00662259|GABA Modulators|gaba modulators|mesh-ancestor
6063146|NCT00662259|GABA Agents|gaba agents|mesh-ancestor
6063147|NCT00662259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6063148|NCT00662259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063149|NCT00662298|Prednisolone|prednisolone|mesh-list
6063150|NCT00662298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6063151|NCT00662298|Glucocorticoids|glucocorticoids|mesh-ancestor
6063152|NCT00662298|Hormones|hormones|mesh-ancestor
6063153|NCT00662298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6063154|NCT00662298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063155|NCT00662298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5506819|NCT04428814|Dermatologic Agents|dermatologic agents|mesh-ancestor
5506820|NCT04428437|Lenvatinib|lenvatinib|mesh-list
5506821|NCT04428437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5506822|NCT04428437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5506823|NCT04428437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5506824|NCT04428437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506825|NCT04428671|Cemiplimab|cemiplimab|mesh-list
5506826|NCT04428671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5506827|NCT04428671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5506828|NCT04428684|Goserelin|goserelin|mesh-list
5506829|NCT04428684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5506830|NCT04428684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5506831|NCT04428372|Mannitol|mannitol|mesh-list
5506832|NCT04428372|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5506833|NCT04428372|Diuretics|diuretics|mesh-ancestor
5506834|NCT04428372|Natriuretic Agents|natriuretic agents|mesh-ancestor
5506835|NCT04428372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506836|NCT04428268|Chloroquine|chloroquine|mesh-list
5506837|NCT04428268|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
5506838|NCT04428268|Losartan|losartan|mesh-list
5506839|NCT04428268|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5506840|NCT04428268|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5506841|NCT04428268|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5506842|NCT04428268|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5506843|NCT04428268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506844|NCT04428268|Amebicides|amebicides|mesh-ancestor
5506845|NCT04428268|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6063156|NCT00662298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6063157|NCT00662311|Paclitaxel|paclitaxel|mesh-list
6063158|NCT00662311|Vorinostat|vorinostat|mesh-list
6063159|NCT00662311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6063160|NCT00662311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6063161|NCT00662311|Tubulin Modulators|tubulin modulators|mesh-ancestor
6063162|NCT00662311|Antimitotic Agents|antimitotic agents|mesh-ancestor
6063163|NCT00662311|Mitosis Modulators|mitosis modulators|mesh-ancestor
6063164|NCT00662311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063165|NCT00662311|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6063166|NCT00662311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6063167|NCT00662363|Lubiprostone|lubiprostone|mesh-list
6063168|NCT00662363|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6063169|NCT00662363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6063170|NCT00662363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063171|NCT00662532|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6063172|NCT00662532|Minocycline|minocycline|mesh-list
6063173|NCT00662532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6063174|NCT00662545|Tenofovir|tenofovir|mesh-list
6063175|NCT00662545|Lamivudine|lamivudine|mesh-list
6063176|NCT00662545|Emtricitabine|emtricitabine|mesh-list
6063177|NCT00662545|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6063178|NCT00662545|Entecavir|entecavir|mesh-list
6063179|NCT00662545|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6063180|NCT00662545|Antiviral Agents|antiviral agents|mesh-ancestor
6063181|NCT00662545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6063182|NCT00662545|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6063183|NCT00662545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6063184|NCT00662545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6063185|NCT00662545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063186|NCT00662545|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6063187|NCT00662558|Celecoxib|celecoxib|mesh-list
6063188|NCT00662558|Tramadol|tramadol|mesh-list
6063189|NCT00662558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6063190|NCT00662558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6063191|NCT00662558|Analgesics|analgesics|mesh-ancestor
6063192|NCT00662558|Sensory System Agents|sensory system agents|mesh-ancestor
6063193|NCT00662558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6462783|NCT00461084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462784|NCT00461084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6462785|NCT00461084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6462786|NCT00461149|Octreotide|octreotide|mesh-list
6462787|NCT00461149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5506846|NCT04428268|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5506847|NCT04428268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5506848|NCT04428268|Antimalarials|antimalarials|mesh-ancestor
5506849|NCT04428268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5506850|NCT04428268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5506851|NCT04428268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5506852|NCT04428268|Analgesics|analgesics|mesh-ancestor
5506853|NCT04428268|Sensory System Agents|sensory system agents|mesh-ancestor
5506854|NCT04428268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5506855|NCT04428268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506856|NCT04428268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5506857|NCT04428268|Filaricides|filaricides|mesh-ancestor
5506858|NCT04428268|Antinematodal Agents|antinematodal agents|mesh-ancestor
5506859|NCT04428268|Anthelmintics|anthelmintics|mesh-ancestor
5600201|NCT03713762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600202|NCT03713762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5600203|NCT03713762|Narcotics|narcotics|mesh-ancestor
5600204|NCT03713762|Analgesics|analgesics|mesh-ancestor
5600205|NCT03713762|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5600206|NCT03713762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5600207|NCT03713762|Anesthetics, General|anesthetics, general|mesh-ancestor
5600208|NCT03713658|Risperidone|risperidone|mesh-list
5600209|NCT03713658|Paliperidone Palmitate|paliperidone palmitate|mesh-list
5600210|NCT03713658|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5600211|NCT03713658|Serotonin Agents|serotonin agents|mesh-ancestor
5600212|NCT03713658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5600213|NCT03713658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600214|NCT03713658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600215|NCT03713658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5600216|NCT03713658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5600217|NCT03713658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5600218|NCT03713658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5600219|NCT03713658|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5600220|NCT03713658|Dopamine Agents|dopamine agents|mesh-ancestor
6202226|NCT02038010|Tubulin Modulators|tubulin modulators|mesh-ancestor
5506860|NCT04428086|Metformin|metformin|mesh-list
5506861|NCT04428086|Apatinib|apatinib|mesh-list
5506862|NCT04428086|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5506863|NCT04428086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5506864|NCT04428086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506865|NCT04428086|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5506866|NCT04428086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5506867|NCT04428086|Antimetabolites|antimetabolites|mesh-ancestor
5506868|NCT04428086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506869|NCT04428086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5506870|NCT04428086|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5506871|NCT04428086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5506872|NCT04428086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5506873|NCT04428086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5506874|NCT04428632|Berotralstat|berotralstat|mesh-list
5506875|NCT04428632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5506876|NCT04428632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063194|NCT00662558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063195|NCT00662558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6063196|NCT00662558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6063197|NCT00662558|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6063198|NCT00662558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6063199|NCT00662558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6063200|NCT00662558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063201|NCT00662558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6063202|NCT00662558|Narcotics|narcotics|mesh-ancestor
6063203|NCT00662558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6063204|NCT00662649|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6063205|NCT00662649|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6063206|NCT00662649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063207|NCT00662649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6063208|NCT00662649|Immunologic Factors|immunologic factors|mesh-ancestor
6063209|NCT00662649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202227|NCT02038010|Antimitotic Agents|antimitotic agents|mesh-ancestor
6202228|NCT02038010|Mitosis Modulators|mitosis modulators|mesh-ancestor
6202229|NCT02038010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202230|NCT02038010|Immunologic Factors|immunologic factors|mesh-ancestor
6202231|NCT02038010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202232|NCT02038010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6202233|NCT02038023|Iron|iron|mesh-list
6202234|NCT02038023|Dextrans|dextrans|mesh-list
6202235|NCT02038023|Iron-Dextran Complex|iron-dextran complex|mesh-list
6202236|NCT02038023|Trace Elements|trace elements|mesh-ancestor
6202237|NCT02038023|Micronutrients|micronutrients|mesh-ancestor
6202238|NCT02038023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202239|NCT02038023|Anticoagulants|anticoagulants|mesh-ancestor
6202240|NCT02038023|Plasma Substitutes|plasma substitutes|mesh-ancestor
6202241|NCT02038023|Blood Substitutes|blood substitutes|mesh-ancestor
6202242|NCT02038023|Hematinics|hematinics|mesh-ancestor
6202243|NCT02038179|Allopurinol|allopurinol|mesh-list
6202244|NCT02038179|Antimetabolites|antimetabolites|mesh-ancestor
6202245|NCT02038179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202246|NCT02038179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6202247|NCT02038179|Gout Suppressants|gout suppressants|mesh-ancestor
6202248|NCT02038179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6202249|NCT02038179|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6202250|NCT02038179|Antioxidants|antioxidants|mesh-ancestor
6202251|NCT02038179|Protective Agents|protective agents|mesh-ancestor
6202252|NCT02038179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207712|NCT02119468|Hormones|hormones|mesh-ancestor
6207713|NCT02119468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6207714|NCT02119468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6207715|NCT02119468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6207716|NCT02119468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207717|NCT02119468|Immunologic Factors|immunologic factors|mesh-ancestor
6207718|NCT02119468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6207719|NCT02119468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6207720|NCT02119468|Growth Substances|growth substances|mesh-ancestor
6207721|NCT02119468|Growth Inhibitors|growth inhibitors|mesh-ancestor
6207722|NCT02119468|Protease Inhibitors|protease inhibitors|mesh-ancestor
6207723|NCT02119468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6207724|NCT02119468|Glycine Agents|glycine agents|mesh-ancestor
6207725|NCT02119468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6207726|NCT02119650|Pemetrexed|pemetrexed|mesh-list
5506877|NCT04428866|Hypoglycemic Agents|hypoglycemic agents|mesh-list
5506878|NCT04428866|Glucagon|glucagon|mesh-list
5506879|NCT04428866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5506880|NCT04428866|Hormones|hormones|mesh-ancestor
5506881|NCT04428866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5506882|NCT04428866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506883|NCT04427709|Oxytocin|oxytocin|mesh-list
5506884|NCT04427709|Oxytocics|oxytocics|mesh-ancestor
5506885|NCT04427709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5506886|NCT04427709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506887|NCT04427826|Morphine|morphine|mesh-list
5506888|NCT04427826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5506889|NCT04427826|Narcotics|narcotics|mesh-ancestor
5506890|NCT04427826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5506891|NCT04427826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506892|NCT04427826|Analgesics|analgesics|mesh-ancestor
5506893|NCT04427826|Sensory System Agents|sensory system agents|mesh-ancestor
5506894|NCT04427826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5506895|NCT04427865|Lactoferrin|lactoferrin|mesh-list
5506896|NCT04427865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5506897|NCT04428008|Thymalfasin|thymalfasin|mesh-list
5506898|NCT04428008|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5506899|NCT04428008|Immunologic Factors|immunologic factors|mesh-ancestor
5506900|NCT04428008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506901|NCT04427787|Lanreotide|lanreotide|mesh-list
5506902|NCT04427787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5506903|NCT04427618|Tranexamic Acid|tranexamic acid|mesh-list
5506904|NCT04427618|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5506905|NCT04427618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5506906|NCT04427618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506907|NCT04427618|Hemostatics|hemostatics|mesh-ancestor
5506908|NCT04427618|Coagulants|coagulants|mesh-ancestor
5506909|NCT04427293|Pembrolizumab|pembrolizumab|mesh-list
5506910|NCT04427293|Lenvatinib|lenvatinib|mesh-list
5506911|NCT04427293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5506912|NCT04427293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5506913|NCT04427293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5506914|NCT04427293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5506915|NCT04427293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506916|NCT04427241|Amantadine|amantadine|mesh-list
5506917|NCT04427241|Cerebrolysin|cerebrolysin|mesh-list
5506918|NCT04427241|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5506919|NCT04427241|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5506920|NCT04427241|Antiviral Agents|antiviral agents|mesh-ancestor
5506921|NCT04427241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5506922|NCT04427241|Dopamine Agents|dopamine agents|mesh-ancestor
5506923|NCT04427241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5506924|NCT04427241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506925|NCT04427241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506926|NCT04427241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5506927|NCT04427241|Analgesics|analgesics|mesh-ancestor
5506928|NCT04427241|Sensory System Agents|sensory system agents|mesh-ancestor
5506929|NCT04427241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5506930|NCT04427241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6063210|NCT00662675|Pancrelipase|pancrelipase|mesh-list
6063211|NCT00662675|Pancreatin|pancreatin|mesh-list
6063212|NCT00662675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6063213|NCT00662818|Acetaminophen|acetaminophen|mesh-list
6063214|NCT00662818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6063215|NCT00662818|Analgesics|analgesics|mesh-ancestor
6063216|NCT00662818|Sensory System Agents|sensory system agents|mesh-ancestor
6063217|NCT00662818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6063218|NCT00662818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063219|NCT00662818|Antipyretics|antipyretics|mesh-ancestor
6063220|NCT00662831|Dalteparin|dalteparin|mesh-list
6063221|NCT00662831|Tinzaparin|tinzaparin|mesh-list
6063222|NCT00662831|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6063223|NCT00662831|Anticoagulants|anticoagulants|mesh-ancestor
6063224|NCT00662831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6063225|NCT00662831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6063226|NCT00662831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063227|NCT00662857|Insulin|insulin|mesh-list
6063228|NCT00662857|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6063229|NCT00662857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6063230|NCT00662857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506931|NCT04427241|Protective Agents|protective agents|mesh-ancestor
5506932|NCT04427241|Nootropic Agents|nootropic agents|mesh-ancestor
5506933|NCT04427540|Oxytocin|oxytocin|mesh-list
6063231|NCT00662909|Mirabegron|mirabegron|mesh-list
6063232|NCT00662909|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6063233|NCT00662909|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6063234|NCT00662909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6063235|NCT00662909|Adrenergic Agents|adrenergic agents|mesh-ancestor
6063236|NCT00662909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6063237|NCT00662909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063238|NCT00662909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063239|NCT00662909|Urological Agents|urological agents|mesh-ancestor
6063240|NCT00663039|Oxytocin|oxytocin|mesh-list
6063241|NCT00663039|Oxytocics|oxytocics|mesh-ancestor
6063242|NCT00663039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6063243|NCT00663039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063244|NCT00663117|Naltrexone|naltrexone|mesh-list
6063245|NCT00663117|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6063246|NCT00663117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6063247|NCT00663117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063248|NCT00663117|Sensory System Agents|sensory system agents|mesh-ancestor
6063249|NCT00663117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6063250|NCT00663169|Dexamethasone|dexamethasone|mesh-list
6063251|NCT00663169|Dexamethasone acetate|dexamethasone acetate|mesh-list
5506934|NCT04427540|Oxytocics|oxytocics|mesh-ancestor
5506935|NCT04427540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5506936|NCT04427540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506937|NCT04426890|Omalizumab|omalizumab|mesh-list
5506938|NCT04426890|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5506939|NCT04426890|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5506940|NCT04426890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5506941|NCT04426890|Respiratory System Agents|respiratory system agents|mesh-ancestor
5506942|NCT04426890|Immunologic Factors|immunologic factors|mesh-ancestor
5506943|NCT04426890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506944|NCT04427020|Caseins|caseins|mesh-list
6063252|NCT00663169|BB 1101|bb 1101|mesh-list
6063253|NCT00663169|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6063254|NCT00663169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6063255|NCT00663169|Antiemetics|antiemetics|mesh-ancestor
6063256|NCT00663169|Autonomic Agents|autonomic agents|mesh-ancestor
6063257|NCT00663169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5506945|NCT04427020|Chelating Agents|chelating agents|mesh-ancestor
5506946|NCT04427020|Sequestering Agents|sequestering agents|mesh-ancestor
5506947|NCT04427020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506948|NCT04426994|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
5506949|NCT04426994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5506950|NCT04426994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506951|NCT04427098|Enoxaparin|enoxaparin|mesh-list
6063258|NCT00663169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063259|NCT00663169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6063260|NCT00663169|Glucocorticoids|glucocorticoids|mesh-ancestor
5506952|NCT04427098|Enoxaparin sodium|enoxaparin sodium|mesh-list
5506953|NCT04427098|Anticoagulants|anticoagulants|mesh-ancestor
5506954|NCT04427098|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5506955|NCT04427098|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5506956|NCT04427098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506957|NCT04426734|Dexamethasone|dexamethasone|mesh-list
5506958|NCT04426734|Prednisolone|prednisolone|mesh-list
5506959|NCT04426734|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5506960|NCT04426734|Methylprednisolone|methylprednisolone|mesh-list
5506961|NCT04426734|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5506962|NCT04426734|Prednisolone acetate|prednisolone acetate|mesh-list
5506963|NCT04426734|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5506964|NCT04426734|Prednisolone phosphate|prednisolone phosphate|mesh-list
5506965|NCT04426734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6063261|NCT00663169|Hormones|hormones|mesh-ancestor
6063262|NCT00663169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6063263|NCT00663169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6063264|NCT00663169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6063265|NCT00663169|Protease Inhibitors|protease inhibitors|mesh-ancestor
6063266|NCT00663169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6063267|NCT00663169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063268|NCT00663169|Immunologic Factors|immunologic factors|mesh-ancestor
6063269|NCT00663234|Atorvastatin|atorvastatin|mesh-list
6063270|NCT00663234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6063271|NCT00663234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6063272|NCT00663234|Antimetabolites|antimetabolites|mesh-ancestor
6063273|NCT00663234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063274|NCT00663234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6202253|NCT02038647|Paclitaxel|paclitaxel|mesh-list
5506966|NCT04426734|Antiemetics|antiemetics|mesh-ancestor
5506967|NCT04426734|Autonomic Agents|autonomic agents|mesh-ancestor
5506968|NCT04426734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5506969|NCT04426734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063275|NCT00663234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6063276|NCT00663234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6063277|NCT00663260|Dapagliflozin|dapagliflozin|mesh-list
6063278|NCT00663260|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6665257|NCT01516463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6665258|NCT01516463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6665259|NCT01516554|Methyltestosterone|methyltestosterone|mesh-list
6665260|NCT01516554|Testosterone|testosterone|mesh-list
6665261|NCT01516554|Testosterone undecanoate|testosterone undecanoate|mesh-list
6665262|NCT01516554|Testosterone enanthate|testosterone enanthate|mesh-list
5506970|NCT04426734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5506971|NCT04426734|Glucocorticoids|glucocorticoids|mesh-ancestor
5506972|NCT04426734|Hormones|hormones|mesh-ancestor
5506973|NCT04426734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6063279|NCT00663260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063280|NCT00663260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6063281|NCT00663260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063282|NCT00663403|Daptomycin|daptomycin|mesh-list
6063283|NCT00663403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6063284|NCT00663403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6063285|NCT00663702|Abatacept|abatacept|mesh-list
6063286|NCT00663702|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6063287|NCT00663702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063288|NCT00663702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6063289|NCT00663702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6665263|NCT01516554|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6063290|NCT00663702|Immunologic Factors|immunologic factors|mesh-ancestor
6063291|NCT00663702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063292|NCT00663702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6063293|NCT00663793|Methyltestosterone|methyltestosterone|mesh-list
6063294|NCT00663793|Finasteride|finasteride|mesh-list
6063295|NCT00663793|Testosterone|testosterone|mesh-list
6063296|NCT00663793|Testosterone undecanoate|testosterone undecanoate|mesh-list
6063297|NCT00663793|Testosterone enanthate|testosterone enanthate|mesh-list
6063298|NCT00663793|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6063299|NCT00663793|Acyline|acyline|mesh-list
6063300|NCT00663793|Androgens|androgens|mesh-ancestor
6063301|NCT00663793|Hormones|hormones|mesh-ancestor
6063302|NCT00663793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6063303|NCT00663793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063304|NCT00663793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6063305|NCT00663793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6063306|NCT00663793|Anabolic Agents|anabolic agents|mesh-ancestor
6063307|NCT00663793|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6063308|NCT00663793|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6063309|NCT00663793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6063310|NCT00663793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063311|NCT00663793|Hormone Antagonists|hormone antagonists|mesh-ancestor
6063312|NCT00663793|Urological Agents|urological agents|mesh-ancestor
6063313|NCT00663858|Cetrorelix|cetrorelix|mesh-list
6063314|NCT00663858|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6462788|NCT00461149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6462789|NCT00461149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6462790|NCT00461266|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6462791|NCT00461266|Enfuvirtide|enfuvirtide|mesh-list
6462792|NCT00461266|Antiviral Agents|antiviral agents|mesh-ancestor
6462793|NCT00461266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6462794|NCT00461266|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6462795|NCT00461266|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6665264|NCT01516554|Androgens|androgens|mesh-ancestor
5506974|NCT04426734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6063315|NCT00663858|Fertility Agents|fertility agents|mesh-ancestor
6063316|NCT00663858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6063317|NCT00663858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506975|NCT04426734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5506976|NCT04426734|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5506977|NCT04426734|Protective Agents|protective agents|mesh-ancestor
5506978|NCT04426721|Hyaluronic Acid|hyaluronic acid|mesh-list
5506979|NCT04426721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5506980|NCT04426721|Immunologic Factors|immunologic factors|mesh-ancestor
5506981|NCT04426721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5506982|NCT04426721|Viscosupplements|viscosupplements|mesh-ancestor
6063318|NCT00663858|Hormone Antagonists|hormone antagonists|mesh-ancestor
6063319|NCT00663858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6063320|NCT00663962|Pregabalin|pregabalin|mesh-list
6063321|NCT00663962|Analgesics|analgesics|mesh-ancestor
6063322|NCT00663962|Sensory System Agents|sensory system agents|mesh-ancestor
6063323|NCT00663962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6063324|NCT00663962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063325|NCT00663962|Anticonvulsants|anticonvulsants|mesh-ancestor
6063326|NCT00663962|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6063327|NCT00663962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6063328|NCT00663962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506983|NCT04426721|Protective Agents|protective agents|mesh-ancestor
5506984|NCT04426552|Dexmedetomidine|dexmedetomidine|mesh-list
5506985|NCT04426552|Sevoflurane|sevoflurane|mesh-list
5506986|NCT04426552|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5506987|NCT04426552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5506988|NCT04426552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063329|NCT00663962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6063330|NCT00663962|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6063331|NCT00663962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6063332|NCT00663962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6063333|NCT00663962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6063334|NCT00664105|Carboplatin|carboplatin|mesh-list
6063335|NCT00664105|Docetaxel|docetaxel|mesh-list
6063336|NCT00664105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6063337|NCT00664105|Tubulin Modulators|tubulin modulators|mesh-ancestor
6063338|NCT00664105|Antimitotic Agents|antimitotic agents|mesh-ancestor
6063339|NCT00664105|Mitosis Modulators|mitosis modulators|mesh-ancestor
6063340|NCT00664105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063341|NCT00664209|Amoxicillin|amoxicillin|mesh-list
6063342|NCT00664209|Omeprazole|omeprazole|mesh-list
6462796|NCT00461266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462797|NCT00461266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6462798|NCT00461344|Docetaxel|docetaxel|mesh-list
6462799|NCT00461344|Doxorubicin|doxorubicin|mesh-list
6462800|NCT00461344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6462801|NCT00461344|Tubulin Modulators|tubulin modulators|mesh-ancestor
6063343|NCT00664209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6063344|NCT00664209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6063345|NCT00664209|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6063346|NCT00664209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6063347|NCT00664209|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6063348|NCT00664209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6063349|NCT00664209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063350|NCT00664430|Calcitriol|calcitriol|mesh-list
6063351|NCT00664430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6063352|NCT00664430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063353|NCT00664430|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6063354|NCT00664430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6063355|NCT00664430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063356|NCT00664430|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6063357|NCT00664430|Vitamins|vitamins|mesh-ancestor
6063358|NCT00664430|Micronutrients|micronutrients|mesh-ancestor
6063359|NCT00664430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6063360|NCT00664521|Rituximab|rituximab|mesh-list
6063361|NCT00664521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6063362|NCT00664521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6063363|NCT00664521|Immunologic Factors|immunologic factors|mesh-ancestor
6063364|NCT00664521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063365|NCT00664521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6063366|NCT00664534|Insulin|insulin|mesh-list
6063367|NCT00664534|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6462802|NCT00461344|Antimitotic Agents|antimitotic agents|mesh-ancestor
6063368|NCT00664534|Insulin Glargine|insulin glargine|mesh-list
6063369|NCT00664534|Insulin Lispro|insulin lispro|mesh-list
6063370|NCT00664534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6063371|NCT00664534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063372|NCT00664560|Celecoxib|celecoxib|mesh-list
5506989|NCT04426552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5506990|NCT04426552|Analgesics|analgesics|mesh-ancestor
5506991|NCT04426552|Sensory System Agents|sensory system agents|mesh-ancestor
5506992|NCT04426552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5506993|NCT04426552|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5506994|NCT04426552|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5506995|NCT04426552|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5506996|NCT04426552|Adrenergic Agents|adrenergic agents|mesh-ancestor
5506997|NCT04426552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5506998|NCT04426552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5506999|NCT04426552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5507000|NCT04426552|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5507001|NCT04426552|Anesthetics, General|anesthetics, general|mesh-ancestor
5507002|NCT04426552|Anesthetics|anesthetics|mesh-ancestor
5507003|NCT04426578|Perhexiline|perhexiline|mesh-list
5507004|NCT04426578|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5507005|NCT04426578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5507006|NCT04426578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507007|NCT04426578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5507008|NCT04426578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507009|NCT04426578|Vasodilator Agents|vasodilator agents|mesh-ancestor
5507010|NCT04426669|Aldesleukin|aldesleukin|mesh-list
5507011|NCT04426669|Cyclophosphamide|cyclophosphamide|mesh-list
5507012|NCT04426669|Fludarabine|fludarabine|mesh-list
5507013|NCT04426669|Interleukin-2|interleukin-2|mesh-list
5507014|NCT04426669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5507015|NCT04426669|Immunologic Factors|immunologic factors|mesh-ancestor
5507016|NCT04426669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507017|NCT04426669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5507018|NCT04426669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5507019|NCT04426669|Alkylating Agents|alkylating agents|mesh-ancestor
5507020|NCT04426669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507021|NCT04426669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5507022|NCT04426669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5507023|NCT04426669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5507024|NCT04426669|Analgesics|analgesics|mesh-ancestor
5507025|NCT04426669|Sensory System Agents|sensory system agents|mesh-ancestor
5507026|NCT04426669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5507027|NCT04426669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5507028|NCT04426669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5507029|NCT04426669|Antiviral Agents|antiviral agents|mesh-ancestor
5507030|NCT04426669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6063373|NCT00664560|Antacids|antacids|mesh-list
6063374|NCT00664560|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6063375|NCT00664560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6063376|NCT00664560|Analgesics|analgesics|mesh-ancestor
6063377|NCT00664560|Sensory System Agents|sensory system agents|mesh-ancestor
6063378|NCT00664560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6063379|NCT00664560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063380|NCT00664560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6063381|NCT00664560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6063382|NCT00664560|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6063383|NCT00664560|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6063384|NCT00664560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6063385|NCT00664560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063386|NCT00664560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6063387|NCT00664755|Nicotine|nicotine|mesh-list
6063388|NCT00664755|Varenicline|varenicline|mesh-list
6063389|NCT00664755|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6063390|NCT00664755|Autonomic Agents|autonomic agents|mesh-ancestor
6063391|NCT00664755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6063392|NCT00664755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063393|NCT00664755|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6063394|NCT00664755|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6063395|NCT00664755|Cholinergic Agents|cholinergic agents|mesh-ancestor
6063396|NCT00664755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6063397|NCT00664755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600221|NCT03713658|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5600222|NCT03713658|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6063398|NCT00664859|Atorvastatin|atorvastatin|mesh-list
6063399|NCT00664859|Fenofibrate|fenofibrate|mesh-list
6063400|NCT00664859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6063401|NCT00664859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6063402|NCT00664859|Antimetabolites|antimetabolites|mesh-ancestor
6063403|NCT00664859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063404|NCT00664859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6063405|NCT00664859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6063406|NCT00664859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6063407|NCT00665002|Sargramostim|sargramostim|mesh-list
6063408|NCT00665002|Immunologic Factors|immunologic factors|mesh-ancestor
6063409|NCT00665002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063410|NCT00665353|Pioglitazone|pioglitazone|mesh-list
6063411|NCT00665353|Ribavirin|ribavirin|mesh-list
6063412|NCT00665353|Antimetabolites|antimetabolites|mesh-ancestor
6063413|NCT00665353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063414|NCT00665353|Antiviral Agents|antiviral agents|mesh-ancestor
5507031|NCT04426422|Metformin|metformin|mesh-list
5507032|NCT04426422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5507033|NCT04426422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507034|NCT04426500|Bupivacaine|bupivacaine|mesh-list
5507035|NCT04426500|Anesthetics, Local|anesthetics, local|mesh-ancestor
5507036|NCT04426500|Anesthetics|anesthetics|mesh-ancestor
6063415|NCT00665353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6063416|NCT00665353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6063417|NCT00665353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063418|NCT00665366|Valproic Acid|valproic acid|mesh-list
6063419|NCT00665366|Aripiprazole|aripiprazole|mesh-list
6063420|NCT00665366|Antidepressive Agents|antidepressive agents|mesh-ancestor
6063421|NCT00665366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6063422|NCT00665366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6063423|NCT00665366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6063424|NCT00665366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6063425|NCT00665366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063426|NCT00665366|Dopamine Agonists|dopamine agonists|mesh-ancestor
6063427|NCT00665366|Dopamine Agents|dopamine agents|mesh-ancestor
6063428|NCT00665366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6063429|NCT00665366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063430|NCT00665366|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6063431|NCT00665366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6063432|NCT00665366|Serotonin Agents|serotonin agents|mesh-ancestor
6063433|NCT00665366|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6063434|NCT00665366|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6063435|NCT00665366|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6063436|NCT00665366|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6063437|NCT00665366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6063438|NCT00665366|Antimanic Agents|antimanic agents|mesh-ancestor
6063439|NCT00665366|Anticonvulsants|anticonvulsants|mesh-ancestor
6063440|NCT00665366|GABA Agents|gaba agents|mesh-ancestor
6063441|NCT00665392|Docetaxel|docetaxel|mesh-list
6063442|NCT00665392|Fluorouracil|fluorouracil|mesh-list
6063443|NCT00665392|Cetuximab|cetuximab|mesh-list
6063444|NCT00665392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6063445|NCT00665392|Tubulin Modulators|tubulin modulators|mesh-ancestor
6063446|NCT00665392|Antimitotic Agents|antimitotic agents|mesh-ancestor
6063447|NCT00665392|Mitosis Modulators|mitosis modulators|mesh-ancestor
6063448|NCT00665392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063449|NCT00665392|Antimetabolites|antimetabolites|mesh-ancestor
6063450|NCT00665392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6063451|NCT00665392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6063452|NCT00665392|Immunologic Factors|immunologic factors|mesh-ancestor
6063453|NCT00665392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063454|NCT00665392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6063455|NCT00665431|Celecoxib|celecoxib|mesh-list
6063456|NCT00665431|Antacids|antacids|mesh-list
6063457|NCT00665431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6063458|NCT00665431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6063459|NCT00665431|Analgesics|analgesics|mesh-ancestor
6063460|NCT00665431|Sensory System Agents|sensory system agents|mesh-ancestor
6063461|NCT00665431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6063462|NCT00665431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063463|NCT00665431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6063464|NCT00665431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6063465|NCT00665431|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5600223|NCT03713528|Vancomycin|vancomycin|mesh-list
6063466|NCT00665431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6063467|NCT00665431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6063468|NCT00665431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063469|NCT00665431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5507037|NCT04426500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5507038|NCT04426500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507039|NCT04426500|Sensory System Agents|sensory system agents|mesh-ancestor
5507040|NCT04426500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5507041|NCT04426409|Ofloxacin|ofloxacin|mesh-list
5507042|NCT04426409|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5507043|NCT04426409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5507044|NCT04426409|Renal Agents|renal agents|mesh-ancestor
5507045|NCT04426409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6063470|NCT00665457|Celecoxib|celecoxib|mesh-list
6063471|NCT00665457|Cyclophosphamide|cyclophosphamide|mesh-list
6063472|NCT00665457|Docetaxel|docetaxel|mesh-list
6063473|NCT00665457|Doxorubicin|doxorubicin|mesh-list
6063474|NCT00665457|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6063475|NCT00665457|Capecitabine|capecitabine|mesh-list
6063476|NCT00665457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6063477|NCT00665457|Immunologic Factors|immunologic factors|mesh-ancestor
6063478|NCT00665457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063479|NCT00665457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6063480|NCT00665457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6063481|NCT00665457|Alkylating Agents|alkylating agents|mesh-ancestor
6063482|NCT00665457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063483|NCT00665457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6063484|NCT00665457|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6063485|NCT00665457|Tubulin Modulators|tubulin modulators|mesh-ancestor
6063486|NCT00665457|Antimitotic Agents|antimitotic agents|mesh-ancestor
6063487|NCT00665457|Mitosis Modulators|mitosis modulators|mesh-ancestor
6063488|NCT00665457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6063489|NCT00665457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6063490|NCT00665457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6063491|NCT00665457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6063492|NCT00665457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6063493|NCT00665457|Antimetabolites|antimetabolites|mesh-ancestor
6063494|NCT00665457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6063495|NCT00665457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6063496|NCT00665457|Analgesics|analgesics|mesh-ancestor
6063497|NCT00665457|Sensory System Agents|sensory system agents|mesh-ancestor
6063498|NCT00665457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6063499|NCT00665457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6063500|NCT00665457|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6063501|NCT00665457|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6063502|NCT00665470|Aldesleukin|aldesleukin|mesh-list
6063503|NCT00665470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6063504|NCT00665470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6063505|NCT00665470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6063506|NCT00665470|Antiviral Agents|antiviral agents|mesh-ancestor
6063507|NCT00665470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6063508|NCT00665561|Maraviroc|maraviroc|mesh-list
6063509|NCT00665561|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6063510|NCT00665561|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6063511|NCT00665561|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6063512|NCT00665561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063513|NCT00665561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6063514|NCT00665561|Antiviral Agents|antiviral agents|mesh-ancestor
6063515|NCT00665561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6063516|NCT00665561|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6063517|NCT00665652|Lenalidomide|lenalidomide|mesh-list
6063518|NCT00665652|Immunologic Factors|immunologic factors|mesh-ancestor
6063519|NCT00665652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063520|NCT00665652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6063521|NCT00665652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5507046|NCT04426409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5507047|NCT04426409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5507048|NCT04426409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5507049|NCT04426409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507050|NCT04426409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5507051|NCT04426409|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5507052|NCT04426409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5507053|NCT04426487|Progesterone|progesterone|mesh-list
5507054|NCT04426487|Progestins|progestins|mesh-ancestor
5507055|NCT04426487|Hormones|hormones|mesh-ancestor
5600224|NCT03713528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6462803|NCT00461344|Mitosis Modulators|mitosis modulators|mesh-ancestor
6063522|NCT00665652|Growth Substances|growth substances|mesh-ancestor
6063523|NCT00665652|Growth Inhibitors|growth inhibitors|mesh-ancestor
6063524|NCT00665652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5507056|NCT04426487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5507057|NCT04426487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507058|NCT04426097|Iodine|iodine|mesh-list
5507059|NCT04426097|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5507060|NCT04426097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5507061|NCT04426097|Trace Elements|trace elements|mesh-ancestor
5507062|NCT04426097|Micronutrients|micronutrients|mesh-ancestor
5507063|NCT04426097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507064|NCT04425993|Indomethacin|indomethacin|mesh-list
5507065|NCT04425993|Isosorbide|isosorbide|mesh-list
5507066|NCT04425993|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
5507067|NCT04425993|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
5507068|NCT04425993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5507069|NCT04425993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5507070|NCT04425993|Analgesics|analgesics|mesh-ancestor
5507071|NCT04425993|Sensory System Agents|sensory system agents|mesh-ancestor
5507072|NCT04425993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5507073|NCT04425993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507074|NCT04425993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5507075|NCT04425993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5507076|NCT04425993|Gout Suppressants|gout suppressants|mesh-ancestor
5507077|NCT04425993|Tocolytic Agents|tocolytic agents|mesh-ancestor
5507078|NCT04425993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5507079|NCT04425993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5507080|NCT04425993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5507081|NCT04425993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507082|NCT04425993|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5507083|NCT04425993|Diuretics|diuretics|mesh-ancestor
5507084|NCT04425993|Natriuretic Agents|natriuretic agents|mesh-ancestor
6063525|NCT00665847|Etravirine|etravirine|mesh-list
6063526|NCT00665847|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6063527|NCT00665847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6063528|NCT00665847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6063529|NCT00665847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063530|NCT00665847|Antiviral Agents|antiviral agents|mesh-ancestor
6063531|NCT00665847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6063532|NCT00666029|Atorvastatin|atorvastatin|mesh-list
6063533|NCT00666029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6063534|NCT00666029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6063535|NCT00666029|Antimetabolites|antimetabolites|mesh-ancestor
6063536|NCT00666029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063537|NCT00666029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6063538|NCT00666029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6063539|NCT00666029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6063540|NCT00666198|Sildenafil Citrate|sildenafil citrate|mesh-list
6063541|NCT00666198|Vasodilator Agents|vasodilator agents|mesh-ancestor
6063542|NCT00666198|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6063543|NCT00666198|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6063544|NCT00666198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6063545|NCT00666198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507085|NCT04425993|Vasodilator Agents|vasodilator agents|mesh-ancestor
5507086|NCT04425993|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5507087|NCT04426955|Paclitaxel|paclitaxel|mesh-list
5507088|NCT04426955|Cisplatin|cisplatin|mesh-list
5507089|NCT04426955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5507090|NCT04426955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5507091|NCT04426955|Tubulin Modulators|tubulin modulators|mesh-ancestor
5507092|NCT04426955|Antimitotic Agents|antimitotic agents|mesh-ancestor
5507093|NCT04426955|Mitosis Modulators|mitosis modulators|mesh-ancestor
5507094|NCT04426955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507095|NCT04425902|Flurbiprofen|flurbiprofen|mesh-list
6063546|NCT00666198|Urological Agents|urological agents|mesh-ancestor
6063547|NCT00666224|Glatiramer Acetate|glatiramer acetate|mesh-list
6063548|NCT00666224|(T,G)-A-L|(t,g)-a-l|mesh-list
6063549|NCT00666224|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6063550|NCT00666224|Immunologic Factors|immunologic factors|mesh-ancestor
6063551|NCT00666224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063552|NCT00666224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6063553|NCT00666224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6063554|NCT00666263|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6063555|NCT00666263|Immunoglobulins|immunoglobulins|mesh-list
6063556|NCT00666263|Antibodies|antibodies|mesh-list
6063557|NCT00666263|gamma-Globulins|gamma-globulins|mesh-list
5507096|NCT04425902|Metoprolol|metoprolol|mesh-list
5507097|NCT04425902|Digoxin|digoxin|mesh-list
5507098|NCT04425902|Midazolam|midazolam|mesh-list
5507099|NCT04425902|Caffeine|caffeine|mesh-list
5507100|NCT04425902|Omeprazole|omeprazole|mesh-list
5507101|NCT04425902|Pravastatin|pravastatin|mesh-list
6063558|NCT00666263|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6063559|NCT00666263|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6063560|NCT00666263|Immunologic Factors|immunologic factors|mesh-ancestor
6063561|NCT00666263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063562|NCT00666276|Linezolid|linezolid|mesh-list
6063563|NCT00666276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6063564|NCT00666276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6063565|NCT00666276|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6063566|NCT00666276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6063567|NCT00666276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063568|NCT00666328|Clevidipine|clevidipine|mesh-list
6063569|NCT00666328|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6063570|NCT00666328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6063571|NCT00666328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063572|NCT00666328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6063573|NCT00666328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063574|NCT00666406|Factor VIII|factor viii|mesh-list
6063575|NCT00666406|Coagulants|coagulants|mesh-ancestor
6063576|NCT00666458|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6063577|NCT00666458|Saxagliptin|saxagliptin|mesh-list
6063578|NCT00666458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6063579|NCT00666458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063580|NCT00666458|Incretins|incretins|mesh-ancestor
6063581|NCT00666458|Hormones|hormones|mesh-ancestor
6063582|NCT00666458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6063583|NCT00666458|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6063584|NCT00666458|Protease Inhibitors|protease inhibitors|mesh-ancestor
6063585|NCT00666458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6063586|NCT00666458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063587|NCT00666536|Amlodipine|amlodipine|mesh-list
6063588|NCT00666536|Valsartan|valsartan|mesh-list
6063589|NCT00666536|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
6063590|NCT00666536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6063591|NCT00666536|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6063592|NCT00666536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5507102|NCT04425902|Montelukast|montelukast|mesh-list
5507103|NCT04425902|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5507104|NCT04425902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5507105|NCT04425902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5507106|NCT04425902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507107|NCT04425902|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5507108|NCT04425902|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6063593|NCT00666536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063594|NCT00666536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6063595|NCT00666536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063596|NCT00666536|Vasodilator Agents|vasodilator agents|mesh-ancestor
6063597|NCT00666536|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6063598|NCT00666536|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6063599|NCT00666562|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
6063600|NCT00666562|Antioxidants|antioxidants|mesh-ancestor
6063601|NCT00666562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063602|NCT00666562|Protective Agents|protective agents|mesh-ancestor
6063603|NCT00666562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063604|NCT00666562|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
6063605|NCT00666562|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6063606|NCT00666562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6063607|NCT00666562|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6063608|NCT00666588|Cytarabine|cytarabine|mesh-list
6063609|NCT00666588|Etoposide|etoposide|mesh-list
6063610|NCT00666588|Idarubicin|idarubicin|mesh-list
6063611|NCT00666588|Bortezomib|bortezomib|mesh-list
6063612|NCT00666588|Etoposide phosphate|etoposide phosphate|mesh-list
6063613|NCT00666588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6063614|NCT00666588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6063615|NCT00666588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6063616|NCT00666588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6063617|NCT00666588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6063618|NCT00666588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063619|NCT00666588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6063620|NCT00666588|Antimetabolites|antimetabolites|mesh-ancestor
5507109|NCT04425902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6063621|NCT00666588|Antiviral Agents|antiviral agents|mesh-ancestor
6063622|NCT00666588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6063623|NCT00666588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6063624|NCT00666588|Immunologic Factors|immunologic factors|mesh-ancestor
6063625|NCT00666588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063626|NCT00666588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5507110|NCT04425902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5507111|NCT04425902|Anesthetics, General|anesthetics, general|mesh-ancestor
5507112|NCT04425902|Anesthetics|anesthetics|mesh-ancestor
5507113|NCT04425902|GABA Modulators|gaba modulators|mesh-ancestor
5507114|NCT04425902|GABA Agents|gaba agents|mesh-ancestor
5507115|NCT04425902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5507116|NCT04425902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507117|NCT04425902|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5507118|NCT04425902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5507119|NCT04425902|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6063627|NCT00666666|Acetic Acid|acetic acid|mesh-list
6063628|NCT00666666|Bicalutamide|bicalutamide|mesh-list
6063629|NCT00666666|Gossypol acetic acid|gossypol acetic acid|mesh-list
6063630|NCT00666666|Gossypol|gossypol|mesh-list
6063631|NCT00666666|Hormones|hormones|mesh-list
6063632|NCT00666666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6063633|NCT00666666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063634|NCT00666666|Androgen Antagonists|androgen antagonists|mesh-ancestor
6063635|NCT00666666|Hormone Antagonists|hormone antagonists|mesh-ancestor
6063636|NCT00666666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6063637|NCT00666666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6063638|NCT00666666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6063639|NCT00666666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6063640|NCT00666666|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6063641|NCT00666666|Contraceptive Agents|contraceptive agents|mesh-ancestor
6063642|NCT00666666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6063643|NCT00666666|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
6063644|NCT00666666|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
6063645|NCT00666666|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6063646|NCT00666679|Mometasone Furoate|mometasone furoate|mesh-list
6063647|NCT00666679|Montelukast|montelukast|mesh-list
6063648|NCT00666679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6063649|NCT00666679|Respiratory System Agents|respiratory system agents|mesh-ancestor
6063650|NCT00666679|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6063651|NCT00666679|Hormone Antagonists|hormone antagonists|mesh-ancestor
6063652|NCT00666679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6063653|NCT00666679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063654|NCT00666679|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6063655|NCT00666679|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6063656|NCT00666679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063657|NCT00666679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6063658|NCT00666679|Dermatologic Agents|dermatologic agents|mesh-ancestor
6063659|NCT00666679|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6063660|NCT00666705|Raltegravir Potassium|raltegravir potassium|mesh-list
6063661|NCT00666705|Maraviroc|maraviroc|mesh-list
6063662|NCT00666705|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6063663|NCT00666705|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6063664|NCT00666705|Antiviral Agents|antiviral agents|mesh-ancestor
6063665|NCT00666705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6063666|NCT00666705|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6063667|NCT00666705|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6063668|NCT00666705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6063669|NCT00666705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063670|NCT00666705|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6063671|NCT00666705|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6063672|NCT00666705|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6063673|NCT00666718|Insulin|insulin|mesh-list
6063674|NCT00666718|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6063675|NCT00666718|Insulin Glargine|insulin glargine|mesh-list
6063676|NCT00666718|Insulin Lispro|insulin lispro|mesh-list
6063677|NCT00666718|Protamines|protamines|mesh-list
6063678|NCT00666718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6063679|NCT00666718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063680|NCT00666718|Heparin Antagonists|heparin antagonists|mesh-ancestor
6462804|NCT00461344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462805|NCT00461344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6063681|NCT00666718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063682|NCT00666718|Coagulants|coagulants|mesh-ancestor
5507120|NCT04425902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6063683|NCT00666757|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6063684|NCT00666757|Sertraline|sertraline|mesh-list
6063685|NCT00666757|Fluoxetine|fluoxetine|mesh-list
6063686|NCT00666757|Paroxetine|paroxetine|mesh-list
6063687|NCT00666757|Citalopram|citalopram|mesh-list
5507121|NCT04425902|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5507122|NCT04425902|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5507123|NCT04425902|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5507124|NCT04425902|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5507125|NCT04425902|Purinergic Agents|purinergic agents|mesh-ancestor
6063688|NCT00666757|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6063689|NCT00666757|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6063690|NCT00666757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6063691|NCT00666757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063692|NCT00666757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6063693|NCT00666757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063694|NCT00666757|Analgesics|analgesics|mesh-ancestor
6063695|NCT00666757|Sensory System Agents|sensory system agents|mesh-ancestor
6063696|NCT00666757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6063697|NCT00666757|Antidepressive Agents|antidepressive agents|mesh-ancestor
6063698|NCT00666757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6063699|NCT00666757|Dopamine Agents|dopamine agents|mesh-ancestor
6063700|NCT00666757|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6063701|NCT00666757|Serotonin Agents|serotonin agents|mesh-ancestor
6063702|NCT00666757|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6063703|NCT00666757|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6063704|NCT00666757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6063705|NCT00666757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6063706|NCT00666835|Epoetin Alfa|epoetin alfa|mesh-list
6063707|NCT00666835|Hematinics|hematinics|mesh-ancestor
6063708|NCT00666848|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6063709|NCT00666848|Enalapril|enalapril|mesh-list
6063710|NCT00666848|Enalaprilat|enalaprilat|mesh-list
6063711|NCT00666848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6063712|NCT00666848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063713|NCT00666848|Incretins|incretins|mesh-ancestor
6063714|NCT00666848|Hormones|hormones|mesh-ancestor
6063715|NCT00666848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6063716|NCT00666848|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6063717|NCT00666848|Protease Inhibitors|protease inhibitors|mesh-ancestor
6063718|NCT00666848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6063719|NCT00666848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063720|NCT00666848|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6063721|NCT00666848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6063722|NCT00666965|Rotigotine|rotigotine|mesh-list
6063723|NCT00666965|Dopamine Agonists|dopamine agonists|mesh-ancestor
6063724|NCT00666965|Dopamine Agents|dopamine agents|mesh-ancestor
6063725|NCT00666965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6063726|NCT00666965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063727|NCT00666965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063728|NCT00666978|Bupropion|bupropion|mesh-list
6063729|NCT00666978|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6063730|NCT00666978|Antidepressive Agents|antidepressive agents|mesh-ancestor
6063731|NCT00666978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6063732|NCT00666978|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6063733|NCT00666978|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6063734|NCT00666978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6063735|NCT00666978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063736|NCT00666978|Dopamine Agents|dopamine agents|mesh-ancestor
6063737|NCT00666978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6063738|NCT00666978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063739|NCT00666978|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5507126|NCT04425902|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5507127|NCT04425902|Respiratory System Agents|respiratory system agents|mesh-ancestor
5507128|NCT04425902|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5507129|NCT04425902|Hormone Antagonists|hormone antagonists|mesh-ancestor
5507130|NCT04425902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5507131|NCT04425902|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5507132|NCT04425902|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6063740|NCT00666978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6063741|NCT00666978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6063742|NCT00667004|Ecabet|ecabet|mesh-list
6063743|NCT00667004|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6063744|NCT00667004|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6063745|NCT00667004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6063746|NCT00667004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6063747|NCT00667004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6063748|NCT00667004|Protease Inhibitors|protease inhibitors|mesh-ancestor
6063749|NCT00667004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6063750|NCT00667004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063751|NCT00667004|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6063752|NCT00667004|Protective Agents|protective agents|mesh-ancestor
6063753|NCT00667004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063754|NCT00667004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6063755|NCT00667095|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6063756|NCT00667095|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
6063757|NCT00667095|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6063758|NCT00667095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6063759|NCT00667095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063760|NCT00667095|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6063761|NCT00667095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6063762|NCT00667095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063763|NCT00667095|Cholinergic Agents|cholinergic agents|mesh-ancestor
6063764|NCT00667095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6063765|NCT00667095|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6063766|NCT00667095|Protective Agents|protective agents|mesh-ancestor
6063767|NCT00667095|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6063768|NCT00667095|Antioxidants|antioxidants|mesh-ancestor
6063769|NCT00667225|Cantharidin|cantharidin|mesh-list
6063770|NCT00667225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6063771|NCT00667225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063772|NCT00667251|Paclitaxel|paclitaxel|mesh-list
6063773|NCT00667251|Docetaxel|docetaxel|mesh-list
6063774|NCT00667251|Trastuzumab|trastuzumab|mesh-list
6063775|NCT00667251|Lapatinib|lapatinib|mesh-list
6063776|NCT00667251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5507133|NCT04425902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5507134|NCT04425902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5507135|NCT04425902|Sympatholytics|sympatholytics|mesh-ancestor
5507136|NCT04425902|Autonomic Agents|autonomic agents|mesh-ancestor
5507137|NCT04425902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5507138|NCT04425902|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5507139|NCT04425902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5507140|NCT04425902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5507141|NCT04425902|Adrenergic Agents|adrenergic agents|mesh-ancestor
5507142|NCT04425902|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5507143|NCT04425902|Protective Agents|protective agents|mesh-ancestor
5507144|NCT04425902|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5507145|NCT04425902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5507146|NCT04425902|Antimetabolites|antimetabolites|mesh-ancestor
5507147|NCT04425902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5507148|NCT04425902|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5507149|NCT04425902|Analgesics|analgesics|mesh-ancestor
5507150|NCT04425902|Sensory System Agents|sensory system agents|mesh-ancestor
5507151|NCT04425902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5507152|NCT04425902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5507153|NCT04425902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5507154|NCT04425902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5507155|NCT04425902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5507156|NCT04426240|Cyclosporine|cyclosporine|mesh-list
5507157|NCT04426240|Cyclosporins|cyclosporins|mesh-list
5507158|NCT04426240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5507159|NCT04426240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507160|NCT04426240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6063777|NCT00667251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6063778|NCT00667251|Tubulin Modulators|tubulin modulators|mesh-ancestor
6063779|NCT00667251|Antimitotic Agents|antimitotic agents|mesh-ancestor
6063780|NCT00667251|Mitosis Modulators|mitosis modulators|mesh-ancestor
6063781|NCT00667251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063782|NCT00667251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6063783|NCT00667251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6063784|NCT00667251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6063785|NCT00667277|Bevacizumab|bevacizumab|mesh-list
6063786|NCT00667277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6063787|NCT00667277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6063788|NCT00667277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6063789|NCT00667277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6063790|NCT00667277|Growth Substances|growth substances|mesh-ancestor
6063791|NCT00667277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063792|NCT00667277|Growth Inhibitors|growth inhibitors|mesh-ancestor
6063793|NCT00667342|Bevacizumab|bevacizumab|mesh-list
6063794|NCT00667342|Doxorubicin|doxorubicin|mesh-list
6063795|NCT00667342|Methotrexate|methotrexate|mesh-list
6462806|NCT00461344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6462807|NCT00461344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6462808|NCT00461344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6462809|NCT00461396|Interferons|interferons|mesh-list
6462810|NCT00461396|Interferon beta-1b|interferon beta-1b|mesh-list
6462811|NCT00461396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6462812|NCT00461396|Antiviral Agents|antiviral agents|mesh-ancestor
6462813|NCT00461396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6462814|NCT00461396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6063796|NCT00667342|Etoposide|etoposide|mesh-list
6063797|NCT00667342|Ifosfamide|ifosfamide|mesh-list
6063798|NCT00667342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6063799|NCT00667342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6063800|NCT00667342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6063801|NCT00667342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6063802|NCT00667342|Growth Substances|growth substances|mesh-ancestor
6063803|NCT00667342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063804|NCT00667342|Growth Inhibitors|growth inhibitors|mesh-ancestor
6063805|NCT00667342|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6063806|NCT00667342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6063807|NCT00667342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6063808|NCT00667342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6063809|NCT00667342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063810|NCT00667342|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6063811|NCT00667342|Abortifacient Agents|abortifacient agents|mesh-ancestor
6063812|NCT00667342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6063813|NCT00667342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6063814|NCT00667342|Antimetabolites|antimetabolites|mesh-ancestor
6063815|NCT00667342|Dermatologic Agents|dermatologic agents|mesh-ancestor
6063816|NCT00667342|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6063817|NCT00667342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6063818|NCT00667342|Immunologic Factors|immunologic factors|mesh-ancestor
6063819|NCT00667342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6063820|NCT00667342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6063821|NCT00667342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6063822|NCT00667342|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6063823|NCT00667342|Alkylating Agents|alkylating agents|mesh-ancestor
6063824|NCT00667355|Adalimumab|adalimumab|mesh-list
6063825|NCT00667355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6063826|NCT00667355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6063827|NCT00667368|Metronidazole|metronidazole|mesh-list
6063828|NCT00667368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6063829|NCT00667368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6063830|NCT00667368|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6063831|NCT00667368|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6063832|NCT00667394|Bevacizumab|bevacizumab|mesh-list
6063833|NCT00667394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6063834|NCT00667394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6063835|NCT00667394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6063836|NCT00667394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6063837|NCT00667394|Growth Substances|growth substances|mesh-ancestor
6063838|NCT00667394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063839|NCT00667394|Growth Inhibitors|growth inhibitors|mesh-ancestor
6063840|NCT00667420|Oxaliplatin|oxaliplatin|mesh-list
6063841|NCT00667420|Epirubicin|epirubicin|mesh-list
6063842|NCT00667420|Panitumumab|panitumumab|mesh-list
6063843|NCT00667420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6462815|NCT00461396|Immunologic Factors|immunologic factors|mesh-ancestor
6462816|NCT00461396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063844|NCT00667420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063845|NCT00667420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6063846|NCT00667420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6063847|NCT00667420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6063848|NCT00667420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6063849|NCT00667420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6063850|NCT00667446|Leuprolide|leuprolide|mesh-list
6063851|NCT00667446|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6063852|NCT00667446|Fertility Agents|fertility agents|mesh-ancestor
6063853|NCT00667446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6063854|NCT00667446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063855|NCT00667446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6063856|NCT00667446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5507161|NCT04426240|Immunologic Factors|immunologic factors|mesh-ancestor
5507162|NCT04426240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507163|NCT04426240|Antifungal Agents|antifungal agents|mesh-ancestor
5507164|NCT04426240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5507165|NCT04426240|Dermatologic Agents|dermatologic agents|mesh-ancestor
5507166|NCT04426240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5507167|NCT04426240|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5507168|NCT04426123|Botulinum Toxins|botulinum toxins|mesh-list
6063857|NCT00667576|Maxacalcitol|maxacalcitol|mesh-list
6063858|NCT00667576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6063859|NCT00667576|Dermatologic Agents|dermatologic agents|mesh-ancestor
6063860|NCT00667576|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6063861|NCT00667576|Protective Agents|protective agents|mesh-ancestor
6063862|NCT00667576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063863|NCT00667589|Fluocinonide|fluocinonide|mesh-list
6063864|NCT00667589|Tazarotene|tazarotene|mesh-list
6063865|NCT00667589|Emollients|emollients|mesh-list
6063866|NCT00667589|Dermatologic Agents|dermatologic agents|mesh-ancestor
5507169|NCT04426123|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5507170|NCT04426123|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5507171|NCT04426123|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5507172|NCT04426123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6063867|NCT00667589|Keratolytic Agents|keratolytic agents|mesh-ancestor
6063868|NCT00667589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6063869|NCT00667589|Glucocorticoids|glucocorticoids|mesh-ancestor
6063870|NCT00667589|Hormones|hormones|mesh-ancestor
6063871|NCT00667589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6063872|NCT00667589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063873|NCT00667589|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6063874|NCT00667615|Prednisone|prednisone|mesh-list
6063875|NCT00667615|Cyclophosphamide|cyclophosphamide|mesh-list
6063876|NCT00667615|Rituximab|rituximab|mesh-list
6063877|NCT00667615|Etoposide|etoposide|mesh-list
6063878|NCT00667615|Vorinostat|vorinostat|mesh-list
6063879|NCT00667615|Lenograstim|lenograstim|mesh-list
6063880|NCT00667615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6063881|NCT00667615|Immunologic Factors|immunologic factors|mesh-ancestor
6063882|NCT00667615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063883|NCT00667615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6063884|NCT00667615|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6063885|NCT00667615|Alkylating Agents|alkylating agents|mesh-ancestor
6063886|NCT00667615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063887|NCT00667615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6063888|NCT00667615|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6063889|NCT00667615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6063890|NCT00667615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6063891|NCT00667615|Glucocorticoids|glucocorticoids|mesh-ancestor
6063892|NCT00667615|Hormones|hormones|mesh-ancestor
6063893|NCT00667615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6063894|NCT00667615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6063895|NCT00667615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6063896|NCT00667615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6063897|NCT00667615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6063898|NCT00667615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6063899|NCT00667615|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6063900|NCT00667615|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6063901|NCT00667719|Amlodipine|amlodipine|mesh-list
6063902|NCT00667719|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6063903|NCT00667719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6063904|NCT00667719|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6063905|NCT00667719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6063906|NCT00667719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462817|NCT00461422|Ganirelix|ganirelix|mesh-list
5507173|NCT04426123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507174|NCT04426123|Cholinergic Agents|cholinergic agents|mesh-ancestor
5507175|NCT04426123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5507176|NCT04426123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507177|NCT04426123|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5507178|NCT04426123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5507179|NCT04425564|Capecitabine|capecitabine|mesh-list
5507180|NCT04425564|Oxaliplatin|oxaliplatin|mesh-list
5507181|NCT04425564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5507182|NCT04425564|Antimetabolites|antimetabolites|mesh-ancestor
5507183|NCT04425564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507184|NCT04425564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5507185|NCT04425590|Aspirin|aspirin|mesh-list
5507186|NCT04425590|Atorvastatin|atorvastatin|mesh-list
5507187|NCT04425590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5507188|NCT04425590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5507189|NCT04425590|Analgesics|analgesics|mesh-ancestor
5507190|NCT04425590|Sensory System Agents|sensory system agents|mesh-ancestor
6063907|NCT00667719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6063908|NCT00667719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063909|NCT00667719|Vasodilator Agents|vasodilator agents|mesh-ancestor
6063910|NCT00667719|Diuretics|diuretics|mesh-ancestor
6063911|NCT00667719|Natriuretic Agents|natriuretic agents|mesh-ancestor
6063912|NCT00667719|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6063913|NCT00667732|Exenatide|exenatide|mesh-list
6063914|NCT00667732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6063915|NCT00667732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063916|NCT00667732|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6063917|NCT00667732|Incretins|incretins|mesh-ancestor
6063918|NCT00667732|Hormones|hormones|mesh-ancestor
6063919|NCT00667732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5507191|NCT04425590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5507192|NCT04425590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507193|NCT04425590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5507194|NCT04425590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5507195|NCT04425590|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5507196|NCT04425590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5507197|NCT04425590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507198|NCT04425590|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5507199|NCT04425590|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5507200|NCT04425590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5507201|NCT04425590|Antipyretics|antipyretics|mesh-ancestor
5507202|NCT04425590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5507203|NCT04425590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5507204|NCT04425590|Antimetabolites|antimetabolites|mesh-ancestor
6063920|NCT00667745|Lithium Carbonate|lithium carbonate|mesh-list
6063921|NCT00667745|Antidepressive Agents|antidepressive agents|mesh-ancestor
6063922|NCT00667745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6063923|NCT00667745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6063924|NCT00667745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063925|NCT00667745|Antimanic Agents|antimanic agents|mesh-ancestor
6063926|NCT00667745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6063927|NCT00667745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6063928|NCT00667745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063929|NCT00667862|Panobinostat|panobinostat|mesh-list
6063930|NCT00667862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6063931|NCT00667862|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6063932|NCT00667862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6063933|NCT00667862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462818|NCT00461422|Hormone Antagonists|hormone antagonists|mesh-ancestor
6462819|NCT00461422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6462820|NCT00461422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462821|NCT00461565|Sildenafil Citrate|sildenafil citrate|mesh-list
6462822|NCT00461565|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
5507205|NCT04425590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5507206|NCT04425590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5507207|NCT04425655|Fludarabine|fludarabine|mesh-list
5507208|NCT04425655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5507209|NCT04425460|Favipiravir|favipiravir|mesh-list
5507210|NCT04425460|Antiviral Agents|antiviral agents|mesh-ancestor
5507211|NCT04425460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6462823|NCT00461565|Vasodilator Agents|vasodilator agents|mesh-ancestor
5507212|NCT04425642|Methamphetamine|methamphetamine|mesh-list
6462824|NCT00461565|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6462825|NCT00461565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6063934|NCT00667875|Naltrexone|naltrexone|mesh-list
6063935|NCT00667875|Aripiprazole|aripiprazole|mesh-list
6063936|NCT00667875|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6063937|NCT00667875|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6063938|NCT00667875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063939|NCT00667875|Sensory System Agents|sensory system agents|mesh-ancestor
6063940|NCT00667875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6063941|NCT00667875|Antidepressive Agents|antidepressive agents|mesh-ancestor
6063942|NCT00667875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6063943|NCT00667875|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6063944|NCT00667875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6063945|NCT00667875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6063946|NCT00667875|Dopamine Agonists|dopamine agonists|mesh-ancestor
6063947|NCT00667875|Dopamine Agents|dopamine agents|mesh-ancestor
6063948|NCT00667875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6063949|NCT00667875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063950|NCT00667875|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6063951|NCT00667875|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6063952|NCT00667875|Serotonin Agents|serotonin agents|mesh-ancestor
6063953|NCT00667875|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6462826|NCT00461565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6462827|NCT00461565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462828|NCT00461565|Urological Agents|urological agents|mesh-ancestor
6462829|NCT00461578|Artesunate|artesunate|mesh-list
6462830|NCT00461578|Dapsone|dapsone|mesh-list
6462831|NCT00461578|Chlorproguanil|chlorproguanil|mesh-list
6462832|NCT00461578|Antimalarials|antimalarials|mesh-ancestor
6462833|NCT00461578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6462834|NCT00461578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6462835|NCT00461578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6462836|NCT00461578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6462837|NCT00461578|Antiviral Agents|antiviral agents|mesh-ancestor
6462838|NCT00461578|Schistosomicides|schistosomicides|mesh-ancestor
6462839|NCT00461578|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5507213|NCT04425642|SMOFlipid|smoflipid|mesh-list
5507214|NCT04425642|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5507215|NCT04425642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507216|NCT04425642|Sympathomimetics|sympathomimetics|mesh-ancestor
5507217|NCT04425642|Autonomic Agents|autonomic agents|mesh-ancestor
5507218|NCT04425642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5507219|NCT04425642|Dopamine Agents|dopamine agents|mesh-ancestor
5507220|NCT04425642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5507221|NCT04425642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507222|NCT04425642|Adrenergic Agents|adrenergic agents|mesh-ancestor
6462840|NCT00461578|Anthelmintics|anthelmintics|mesh-ancestor
6462841|NCT00461578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6462842|NCT00461578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6462843|NCT00461578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462844|NCT00461578|Leprostatic Agents|leprostatic agents|mesh-ancestor
6462845|NCT00461578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6462846|NCT00461617|Mitiglinide|mitiglinide|mesh-list
6462847|NCT00461617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5507223|NCT04425642|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5507224|NCT04425642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5507225|NCT04425642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5507226|NCT04425642|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5507227|NCT04425642|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
5507228|NCT04425642|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5507229|NCT04425642|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5507230|NCT04425681|Bevacizumab|bevacizumab|mesh-list
5507231|NCT04425681|Osimertinib|osimertinib|mesh-list
5507232|NCT04425681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6462848|NCT00461617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462849|NCT00461643|Metformin|metformin|mesh-list
6462850|NCT00461643|Citric Acid|citric acid|mesh-list
6462851|NCT00461643|Sodium Citrate|sodium citrate|mesh-list
6462852|NCT00461643|Clomiphene|clomiphene|mesh-list
6462853|NCT00461643|Enclomiphene|enclomiphene|mesh-list
6462854|NCT00461643|Zuclomiphene|zuclomiphene|mesh-list
6462855|NCT00461643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6462856|NCT00461643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462857|NCT00461643|Anticoagulants|anticoagulants|mesh-ancestor
6462858|NCT00461643|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6462859|NCT00461643|Chelating Agents|chelating agents|mesh-ancestor
6462860|NCT00461643|Sequestering Agents|sequestering agents|mesh-ancestor
6462861|NCT00461643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665265|NCT01516554|Hormones|hormones|mesh-ancestor
6063954|NCT00667875|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6063955|NCT00667875|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6063956|NCT00667875|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6063957|NCT00667992|Budesonide|budesonide|mesh-list
6063958|NCT00667992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6063959|NCT00667992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6063960|NCT00667992|Autonomic Agents|autonomic agents|mesh-ancestor
6063961|NCT00667992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6063962|NCT00667992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063963|NCT00667992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6063964|NCT00667992|Respiratory System Agents|respiratory system agents|mesh-ancestor
6063965|NCT00667992|Glucocorticoids|glucocorticoids|mesh-ancestor
6063966|NCT00667992|Hormones|hormones|mesh-ancestor
6063967|NCT00667992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6063968|NCT00668148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6063969|NCT00668148|Immunologic Factors|immunologic factors|mesh-ancestor
6063970|NCT00668148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063971|NCT00668200|Vitamin D|vitamin d|mesh-list
6063972|NCT00668200|Zoledronic Acid|zoledronic acid|mesh-list
6063973|NCT00668200|Calcium|calcium|mesh-list
6063974|NCT00668200|Vitamins|vitamins|mesh-ancestor
6063975|NCT00668200|Micronutrients|micronutrients|mesh-ancestor
6063976|NCT00668200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6063977|NCT00668200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6063978|NCT00668200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6063979|NCT00668317|Omeprazole|omeprazole|mesh-list
6063980|NCT00668317|Ranitidine|ranitidine|mesh-list
6063981|NCT00668317|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
6063982|NCT00668317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6063983|NCT00668317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6063984|NCT00668317|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6063985|NCT00668317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6063986|NCT00668317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063987|NCT00668317|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6063988|NCT00668317|Histamine Antagonists|histamine antagonists|mesh-ancestor
6063989|NCT00668317|Histamine Agents|histamine agents|mesh-ancestor
6063990|NCT00668317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6063991|NCT00668317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202254|NCT02038647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6202255|NCT02038647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6202256|NCT02038647|Tubulin Modulators|tubulin modulators|mesh-ancestor
6202257|NCT02038647|Antimitotic Agents|antimitotic agents|mesh-ancestor
6202258|NCT02038647|Mitosis Modulators|mitosis modulators|mesh-ancestor
6202259|NCT02038647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202260|NCT02038790|Buprenorphine|buprenorphine|mesh-list
6202261|NCT02038790|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6202262|NCT02038790|Naloxone|naloxone|mesh-list
6202263|NCT02038790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6202264|NCT02038790|Narcotics|narcotics|mesh-ancestor
5507233|NCT04425681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5507234|NCT04425681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5507235|NCT04425681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5507236|NCT04425681|Growth Substances|growth substances|mesh-ancestor
5507237|NCT04425681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507238|NCT04425681|Growth Inhibitors|growth inhibitors|mesh-ancestor
5507239|NCT04425681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5507240|NCT04425681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5507241|NCT04425681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507242|NCT04425707|Hydroxychloroquine|hydroxychloroquine|mesh-list
5507243|NCT04425707|Ivermectin|ivermectin|mesh-list
5507244|NCT04425707|Antimalarials|antimalarials|mesh-ancestor
5507245|NCT04425707|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5507246|NCT04425707|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5507247|NCT04425707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5507248|NCT04425707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5507249|NCT04425707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507250|NCT04425707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6202265|NCT02038790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6202266|NCT02038790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202267|NCT02038790|Analgesics|analgesics|mesh-ancestor
6202268|NCT02038790|Sensory System Agents|sensory system agents|mesh-ancestor
6202269|NCT02038790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6202270|NCT02038790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6202271|NCT02038881|Vaccines|vaccines|mesh-list
5507251|NCT04425824|Rituximab|rituximab|mesh-list
6063992|NCT00668395|Efavirenz|efavirenz|mesh-list
6063993|NCT00668395|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6063994|NCT00668395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6063995|NCT00668395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6063996|NCT00668395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6063997|NCT00668395|Antiviral Agents|antiviral agents|mesh-ancestor
6063998|NCT00668395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6063999|NCT00668395|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6064000|NCT00668395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6462862|NCT00461643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6462863|NCT00461643|Hormone Antagonists|hormone antagonists|mesh-ancestor
6462864|NCT00461643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6462865|NCT00461643|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6462866|NCT00461643|Fertility Agents|fertility agents|mesh-ancestor
6064001|NCT00668395|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6064002|NCT00668395|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6064003|NCT00668395|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6064004|NCT00668395|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6064005|NCT00668434|Prednisone|prednisone|mesh-list
6064006|NCT00668434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6064007|NCT00668434|Glucocorticoids|glucocorticoids|mesh-ancestor
6064008|NCT00668434|Hormones|hormones|mesh-ancestor
6064009|NCT00668434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6064010|NCT00668434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064011|NCT00668434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6064012|NCT00668434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6064013|NCT00668525|Dexetimide|dexetimide|mesh-list
6064014|NCT00668525|Citalopram|citalopram|mesh-list
6064015|NCT00668525|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6064016|NCT00668525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6064017|NCT00668525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6064018|NCT00668525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6064019|NCT00668525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6064020|NCT00668525|Serotonin Agents|serotonin agents|mesh-ancestor
6064021|NCT00668525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064022|NCT00668525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5507252|NCT04425824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5507253|NCT04425824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5507254|NCT04425824|Immunologic Factors|immunologic factors|mesh-ancestor
5507255|NCT04425824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507256|NCT04425824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5507257|NCT04425187|Bevacizumab|bevacizumab|mesh-list
5507258|NCT04425187|Gefitinib|gefitinib|mesh-list
5507259|NCT04425187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5507260|NCT04425187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5507261|NCT04425187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5507262|NCT04425187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5507263|NCT04425187|Growth Substances|growth substances|mesh-ancestor
5507264|NCT04425187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507265|NCT04425187|Growth Inhibitors|growth inhibitors|mesh-ancestor
5507266|NCT04425187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5507267|NCT04425187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5507268|NCT04425187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507269|NCT04425473|Esketamine|esketamine|mesh-list
6064023|NCT00668525|Antidepressive Agents|antidepressive agents|mesh-ancestor
6064024|NCT00668525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6064025|NCT00668525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6064026|NCT00668525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6064027|NCT00668525|Parasympatholytics|parasympatholytics|mesh-ancestor
6064028|NCT00668525|Autonomic Agents|autonomic agents|mesh-ancestor
6064029|NCT00668525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6064030|NCT00668525|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6064031|NCT00668525|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6064032|NCT00668525|Cholinergic Agents|cholinergic agents|mesh-ancestor
6064033|NCT00668564|Cyclophosphamide|cyclophosphamide|mesh-list
6064034|NCT00668564|Busulfan|busulfan|mesh-list
6064035|NCT00668564|Alemtuzumab|alemtuzumab|mesh-list
6064036|NCT00668564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6064037|NCT00668564|Immunologic Factors|immunologic factors|mesh-ancestor
6064038|NCT00668564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064039|NCT00668564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6064040|NCT00668564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6064041|NCT00668564|Alkylating Agents|alkylating agents|mesh-ancestor
5507270|NCT04425473|Antidepressive Agents|antidepressive agents|mesh-ancestor
5507271|NCT04425473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5507272|NCT04425382|Ritonavir|ritonavir|mesh-list
5507273|NCT04425382|Lopinavir|lopinavir|mesh-list
5507274|NCT04425382|Darunavir|darunavir|mesh-list
5507275|NCT04425382|Cobicistat|cobicistat|mesh-list
5507276|NCT04425382|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5507277|NCT04425382|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5507278|NCT04425382|Protease Inhibitors|protease inhibitors|mesh-ancestor
5507279|NCT04425382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5507280|NCT04425382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507281|NCT04425382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5507282|NCT04425382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5507283|NCT04425382|Antiviral Agents|antiviral agents|mesh-ancestor
5507284|NCT04425382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5507285|NCT04425382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5507286|NCT04425382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6064042|NCT00668564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6064043|NCT00668564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6064044|NCT00668564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6064045|NCT00668564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6064046|NCT00668707|Melatonin|melatonin|mesh-list
6064047|NCT00668707|Antioxidants|antioxidants|mesh-ancestor
6064048|NCT00668707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6064049|NCT00668707|Protective Agents|protective agents|mesh-ancestor
6064050|NCT00668707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064051|NCT00668707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6064052|NCT00668746|Minocycline|minocycline|mesh-list
6064053|NCT00668746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6064054|NCT00668746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6064055|NCT00668811|Sunitinib|sunitinib|mesh-list
6064056|NCT00668811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6064057|NCT00668811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6064058|NCT00668811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6064059|NCT00668811|Growth Substances|growth substances|mesh-ancestor
6064060|NCT00668811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064061|NCT00668811|Growth Inhibitors|growth inhibitors|mesh-ancestor
6064062|NCT00668811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6064063|NCT00668811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6064064|NCT00668811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6064065|NCT00668863|Leucovorin|leucovorin|mesh-list
6064066|NCT00668863|Fluorouracil|fluorouracil|mesh-list
6064067|NCT00668863|Irinotecan|irinotecan|mesh-list
6064068|NCT00668863|Sunitinib|sunitinib|mesh-list
6064069|NCT00668863|Levoleucovorin|levoleucovorin|mesh-list
6064070|NCT00668863|Antimetabolites|antimetabolites|mesh-ancestor
6064071|NCT00668863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6064072|NCT00668863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5507290|NCT04425135|Carboplatin|carboplatin|mesh-list
5507291|NCT04425135|Apatinib|apatinib|mesh-list
5507292|NCT04425135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6064073|NCT00668863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6064074|NCT00668863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6064075|NCT00668863|Immunologic Factors|immunologic factors|mesh-ancestor
6064076|NCT00668863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064077|NCT00668863|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6064078|NCT00668863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6064079|NCT00668863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6064080|NCT00668863|Antidotes|antidotes|mesh-ancestor
6064081|NCT00668863|Protective Agents|protective agents|mesh-ancestor
6064082|NCT00668863|Vitamin B Complex|vitamin b complex|mesh-ancestor
6064083|NCT00668863|Vitamins|vitamins|mesh-ancestor
6064084|NCT00668863|Micronutrients|micronutrients|mesh-ancestor
6064085|NCT00668863|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5507293|NCT04425135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6064086|NCT00668863|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5507294|NCT04425135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6064087|NCT00668863|Growth Substances|growth substances|mesh-ancestor
6064088|NCT00668863|Growth Inhibitors|growth inhibitors|mesh-ancestor
6064089|NCT00668863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6064090|NCT00668902|Pantoprazole|pantoprazole|mesh-list
6064091|NCT00668902|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6064092|NCT00668902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6064093|NCT00668902|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6064094|NCT00668902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5507295|NCT04425135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507296|NCT04424966|Infigratinib|infigratinib|mesh-list
5507297|NCT04424966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6064095|NCT00668902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6064096|NCT00669019|Saracatinib|saracatinib|mesh-list
6064097|NCT00669019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6064098|NCT00669019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6064099|NCT00669019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6064100|NCT00669032|Hyaluronic Acid|hyaluronic acid|mesh-list
6064101|NCT00669032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6064102|NCT00669032|Immunologic Factors|immunologic factors|mesh-ancestor
6064103|NCT00669032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064104|NCT00669032|Viscosupplements|viscosupplements|mesh-ancestor
6064105|NCT00669032|Protective Agents|protective agents|mesh-ancestor
6064106|NCT00669071|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
6064107|NCT00669071|Tretinoin|tretinoin|mesh-list
6064108|NCT00669071|Hydroquinone|hydroquinone|mesh-list
6064109|NCT00669071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6064110|NCT00669071|Keratolytic Agents|keratolytic agents|mesh-ancestor
6064111|NCT00669071|Dermatologic Agents|dermatologic agents|mesh-ancestor
6064112|NCT00669071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6064113|NCT00669071|Glucocorticoids|glucocorticoids|mesh-ancestor
6064114|NCT00669071|Hormones|hormones|mesh-ancestor
6064115|NCT00669071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6064116|NCT00669071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064117|NCT00669071|Antioxidants|antioxidants|mesh-ancestor
6064118|NCT00669071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6064119|NCT00669071|Protective Agents|protective agents|mesh-ancestor
6064120|NCT00669071|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6064121|NCT00669110|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6064122|NCT00669110|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5507298|NCT04425239|Leucovorin|leucovorin|mesh-list
5507299|NCT04425239|Folic Acid|folic acid|mesh-list
5507300|NCT04425239|Fluorouracil|fluorouracil|mesh-list
6064123|NCT00669110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6064124|NCT00669110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6064125|NCT00669110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6064126|NCT00669110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6064127|NCT00669110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064128|NCT00669110|Antidepressive Agents|antidepressive agents|mesh-ancestor
6064129|NCT00669110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6064130|NCT00669162|Docetaxel|docetaxel|mesh-list
6064131|NCT00669162|Leuprolide|leuprolide|mesh-list
5507301|NCT04425239|Irinotecan|irinotecan|mesh-list
5507302|NCT04425239|Panitumumab|panitumumab|mesh-list
5507303|NCT04425239|Levoleucovorin|levoleucovorin|mesh-list
5507304|NCT04425239|Antimetabolites|antimetabolites|mesh-ancestor
5507305|NCT04425239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507306|NCT04425239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5507307|NCT04425239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5507308|NCT04425239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5507309|NCT04425239|Immunologic Factors|immunologic factors|mesh-ancestor
5507310|NCT04425239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507311|NCT04425239|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5507312|NCT04425239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5507313|NCT04425239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5507314|NCT04425239|Antidotes|antidotes|mesh-ancestor
5507315|NCT04425239|Protective Agents|protective agents|mesh-ancestor
5507316|NCT04425239|Vitamin B Complex|vitamin b complex|mesh-ancestor
5507317|NCT04425239|Vitamins|vitamins|mesh-ancestor
5507318|NCT04425239|Micronutrients|micronutrients|mesh-ancestor
6064132|NCT00669162|Goserelin|goserelin|mesh-list
6064133|NCT00669162|Bicalutamide|bicalutamide|mesh-list
6064134|NCT00669162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6064135|NCT00669162|Tubulin Modulators|tubulin modulators|mesh-ancestor
6064136|NCT00669162|Antimitotic Agents|antimitotic agents|mesh-ancestor
5507319|NCT04425239|Hematinics|hematinics|mesh-ancestor
5507320|NCT04425239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6064137|NCT00669162|Mitosis Modulators|mitosis modulators|mesh-ancestor
5507321|NCT04425070|Gemcitabine|gemcitabine|mesh-list
5507322|NCT04425070|Carboplatin|carboplatin|mesh-list
6064138|NCT00669162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6064139|NCT00669162|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6064140|NCT00669162|Fertility Agents|fertility agents|mesh-ancestor
6064141|NCT00669162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6064142|NCT00669162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064143|NCT00669162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6064144|NCT00669162|Androgen Antagonists|androgen antagonists|mesh-ancestor
6064145|NCT00669162|Hormone Antagonists|hormone antagonists|mesh-ancestor
6064146|NCT00669162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6064147|NCT00669240|Varenicline|varenicline|mesh-list
6064148|NCT00669240|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6462867|NCT00461643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6462868|NCT00461643|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6462869|NCT00461643|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6462870|NCT00461695|Vaccines|vaccines|mesh-list
6462871|NCT00461695|Immunologic Factors|immunologic factors|mesh-ancestor
6462872|NCT00461695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462873|NCT00461747|Thalidomide|thalidomide|mesh-list
6462874|NCT00461747|Dexamethasone|dexamethasone|mesh-list
6064149|NCT00669240|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6064150|NCT00669240|Cholinergic Agents|cholinergic agents|mesh-ancestor
6064151|NCT00669240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6064152|NCT00669240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6064153|NCT00669240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064154|NCT00669279|Atenolol|atenolol|mesh-list
6064155|NCT00669279|Carvedilol|carvedilol|mesh-list
6064156|NCT00669279|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6064157|NCT00669279|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6064158|NCT00669279|Adrenergic Agents|adrenergic agents|mesh-ancestor
6064159|NCT00669279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6064160|NCT00669279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6064161|NCT00669279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064162|NCT00669279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6064163|NCT00669279|Antioxidants|antioxidants|mesh-ancestor
6064164|NCT00669279|Protective Agents|protective agents|mesh-ancestor
6064165|NCT00669279|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6064166|NCT00669279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6064167|NCT00669279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6064168|NCT00669279|Vasodilator Agents|vasodilator agents|mesh-ancestor
6064169|NCT00669279|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6064170|NCT00669279|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6064171|NCT00669279|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6064172|NCT00669279|Sympatholytics|sympatholytics|mesh-ancestor
6064173|NCT00669279|Autonomic Agents|autonomic agents|mesh-ancestor
6064174|NCT00669279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6064175|NCT00669279|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6064176|NCT00669318|Rituximab|rituximab|mesh-list
6462875|NCT00461747|Dexamethasone acetate|dexamethasone acetate|mesh-list
6462876|NCT00461747|Bortezomib|bortezomib|mesh-list
6462877|NCT00461747|BB 1101|bb 1101|mesh-list
6462878|NCT00461747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6462879|NCT00461747|Antiemetics|antiemetics|mesh-ancestor
6462880|NCT00461747|Autonomic Agents|autonomic agents|mesh-ancestor
6462881|NCT00461747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6462882|NCT00461747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064177|NCT00669318|Alemtuzumab|alemtuzumab|mesh-list
6064178|NCT00669318|Pentostatin|pentostatin|mesh-list
6064179|NCT00669318|Sargramostim|sargramostim|mesh-list
6064180|NCT00669318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6064181|NCT00669318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6064182|NCT00669318|Immunologic Factors|immunologic factors|mesh-ancestor
6064183|NCT00669318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462883|NCT00461747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5507323|NCT04425070|Oxaliplatin|oxaliplatin|mesh-list
5507324|NCT04425070|Etoposide|etoposide|mesh-list
5507325|NCT04425070|Ifosfamide|ifosfamide|mesh-list
5507326|NCT04425070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5507327|NCT04425070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5507328|NCT04425070|Antimetabolites|antimetabolites|mesh-ancestor
5507329|NCT04425070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507330|NCT04425070|Antiviral Agents|antiviral agents|mesh-ancestor
6672409|NCT01555879|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5507331|NCT04425070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5507332|NCT04425070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6064184|NCT00669318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6064185|NCT00669318|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
6064186|NCT00669318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6064187|NCT00669318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6064188|NCT00669331|Mannitol|mannitol|mesh-list
6064189|NCT00669331|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5507333|NCT04425070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5507334|NCT04425070|Immunologic Factors|immunologic factors|mesh-ancestor
5507335|NCT04425070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064190|NCT00669331|Diuretics|diuretics|mesh-ancestor
6064191|NCT00669331|Natriuretic Agents|natriuretic agents|mesh-ancestor
6064192|NCT00669331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064193|NCT00669383|Betamethasone|betamethasone|mesh-list
6064194|NCT00669383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6064195|NCT00669383|Glucocorticoids|glucocorticoids|mesh-ancestor
6064196|NCT00669383|Hormones|hormones|mesh-ancestor
6064197|NCT00669383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6064198|NCT00669383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064199|NCT00669383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6064200|NCT00669383|Respiratory System Agents|respiratory system agents|mesh-ancestor
6064201|NCT00669396|Copper|copper|mesh-list
6064202|NCT00669396|Levonorgestrel|levonorgestrel|mesh-list
6064203|NCT00669396|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6064204|NCT00669396|Contraceptive Agents|contraceptive agents|mesh-ancestor
6064205|NCT00669396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6064206|NCT00669396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064207|NCT00669396|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6064208|NCT00669396|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6064209|NCT00669396|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6064210|NCT00669396|Trace Elements|trace elements|mesh-ancestor
6064211|NCT00669396|Micronutrients|micronutrients|mesh-ancestor
6064212|NCT00669409|Tanezumab|tanezumab|mesh-list
6064213|NCT00669409|Analgesics|analgesics|mesh-ancestor
6064214|NCT00669409|Sensory System Agents|sensory system agents|mesh-ancestor
6064215|NCT00669409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6064216|NCT00669409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507336|NCT04425070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5507337|NCT04425070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5507338|NCT04425070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5507339|NCT04425070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5507340|NCT04425070|Alkylating Agents|alkylating agents|mesh-ancestor
5507341|NCT04425226|Pembrolizumab|pembrolizumab|mesh-list
5507342|NCT04425226|Lenvatinib|lenvatinib|mesh-list
5507343|NCT04425226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5507344|NCT04425226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5507345|NCT04425226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6064217|NCT00669578|Pomalidomide|pomalidomide|mesh-list
6064218|NCT00669578|Immunologic Factors|immunologic factors|mesh-ancestor
6064219|NCT00669578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064220|NCT00669578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6064221|NCT00669578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6064222|NCT00669578|Growth Substances|growth substances|mesh-ancestor
6064223|NCT00669578|Growth Inhibitors|growth inhibitors|mesh-ancestor
6064224|NCT00669578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6064225|NCT00669617|Fluticasone|fluticasone|mesh-list
5507346|NCT04425226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5507347|NCT04425226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507348|NCT04424901|Dipyridamole|dipyridamole|mesh-list
5507349|NCT04424901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5507350|NCT04424901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6064226|NCT00669617|Xhance|xhance|mesh-list
6064227|NCT00669617|Albuterol|albuterol|mesh-list
6064228|NCT00669617|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6064229|NCT00669617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6064230|NCT00669617|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6064231|NCT00669617|Autonomic Agents|autonomic agents|mesh-ancestor
6064232|NCT00669617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6064233|NCT00669617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064234|NCT00669617|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6064235|NCT00669617|Respiratory System Agents|respiratory system agents|mesh-ancestor
6064236|NCT00669617|Dermatologic Agents|dermatologic agents|mesh-ancestor
6064237|NCT00669617|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6064238|NCT00669617|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6064239|NCT00669617|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6064240|NCT00669617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6064241|NCT00669617|Adrenergic Agents|adrenergic agents|mesh-ancestor
6064242|NCT00669617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6064243|NCT00669617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6064244|NCT00669617|Tocolytic Agents|tocolytic agents|mesh-ancestor
6064245|NCT00669617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6064246|NCT00669669|Plerixafor|plerixafor|mesh-list
6064247|NCT00669669|Temozolomide|temozolomide|mesh-list
6064248|NCT00669669|Carmustine|carmustine|mesh-list
6064249|NCT00669669|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
6064250|NCT00669669|Lenograstim|lenograstim|mesh-list
6064251|NCT00669669|Sargramostim|sargramostim|mesh-list
6064252|NCT00669669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6064253|NCT00669669|Immunologic Factors|immunologic factors|mesh-ancestor
6064254|NCT00669669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064255|NCT00669669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6064256|NCT00669669|Alkylating Agents|alkylating agents|mesh-ancestor
6064257|NCT00669669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6064258|NCT00669669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6064259|NCT00669669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6064260|NCT00669669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6064261|NCT00669669|Antiviral Agents|antiviral agents|mesh-ancestor
6064262|NCT00669669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6064263|NCT00669669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6064264|NCT00669864|Metformin|metformin|mesh-list
6064265|NCT00669864|Insulin Aspart|insulin aspart|mesh-list
6064266|NCT00669864|Biphasic Insulins|biphasic insulins|mesh-list
6064267|NCT00669864|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6064268|NCT00669864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6064269|NCT00669864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064270|NCT00669877|Cytarabine|cytarabine|mesh-list
6064271|NCT00669877|Dexamethasone|dexamethasone|mesh-list
6064272|NCT00669877|Cyclophosphamide|cyclophosphamide|mesh-list
6064273|NCT00669877|Rituximab|rituximab|mesh-list
6064274|NCT00669877|Doxorubicin|doxorubicin|mesh-list
6064275|NCT00669877|Methotrexate|methotrexate|mesh-list
6064276|NCT00669877|Vincristine|vincristine|mesh-list
6064277|NCT00669877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6064278|NCT00669877|Immunologic Factors|immunologic factors|mesh-ancestor
5507351|NCT04424901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507352|NCT04424901|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5507353|NCT04424901|Vasodilator Agents|vasodilator agents|mesh-ancestor
5600225|NCT03713528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5600226|NCT03713437|Insulin|insulin|mesh-list
6064279|NCT00669877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064280|NCT00669877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6064281|NCT00669877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6064282|NCT00669877|Alkylating Agents|alkylating agents|mesh-ancestor
6064283|NCT00669877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6064284|NCT00669877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6064285|NCT00669877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6064286|NCT00669877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6064287|NCT00669877|Antiemetics|antiemetics|mesh-ancestor
6064288|NCT00669877|Autonomic Agents|autonomic agents|mesh-ancestor
6064289|NCT00669877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6064290|NCT00669877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6064291|NCT00669877|Glucocorticoids|glucocorticoids|mesh-ancestor
6064292|NCT00669877|Hormones|hormones|mesh-ancestor
6064293|NCT00669877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6064294|NCT00669877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6064295|NCT00669877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6064296|NCT00669877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5600227|NCT03713437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6064297|NCT00669877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6064298|NCT00669877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6665266|NCT01516554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5507354|NCT04424875|Melatonin|melatonin|mesh-list
5507355|NCT04424875|Antioxidants|antioxidants|mesh-ancestor
5507356|NCT04424875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507357|NCT04424875|Protective Agents|protective agents|mesh-ancestor
5507358|NCT04424875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507359|NCT04424875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5507360|NCT04424420|Acetaminophen|acetaminophen|mesh-list
5507361|NCT04424420|Ibuprofen|ibuprofen|mesh-list
5507362|NCT04424420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5507363|NCT04424420|Analgesics|analgesics|mesh-ancestor
5507364|NCT04424420|Sensory System Agents|sensory system agents|mesh-ancestor
5507365|NCT04424420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5507366|NCT04424420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507367|NCT04424420|Antipyretics|antipyretics|mesh-ancestor
5507368|NCT04424420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5507369|NCT04424420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5507370|NCT04424420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5507371|NCT04424420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5507372|NCT04424420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5507373|NCT04424420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507374|NCT04424654|Methyltestosterone|methyltestosterone|mesh-list
5507375|NCT04424654|Testosterone|testosterone|mesh-list
5507376|NCT04424654|Testosterone undecanoate|testosterone undecanoate|mesh-list
5507377|NCT04424654|Testosterone enanthate|testosterone enanthate|mesh-list
6665267|NCT01516554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665268|NCT01516554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6665269|NCT01516554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6665270|NCT01516554|Anabolic Agents|anabolic agents|mesh-ancestor
6064299|NCT00669877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6064300|NCT00669877|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6064301|NCT00669877|Abortifacient Agents|abortifacient agents|mesh-ancestor
6064302|NCT00669877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6064303|NCT00669877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6064304|NCT00669877|Antimetabolites|antimetabolites|mesh-ancestor
6064305|NCT00669877|Dermatologic Agents|dermatologic agents|mesh-ancestor
6064306|NCT00669877|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6064307|NCT00669877|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6064308|NCT00669877|Antiviral Agents|antiviral agents|mesh-ancestor
6064309|NCT00669877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6064310|NCT00669877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6064311|NCT00669877|Tubulin Modulators|tubulin modulators|mesh-ancestor
6064312|NCT00669877|Antimitotic Agents|antimitotic agents|mesh-ancestor
6064313|NCT00669877|Mitosis Modulators|mitosis modulators|mesh-ancestor
6064314|NCT00669955|Amoxicillin|amoxicillin|mesh-list
6064315|NCT00669955|Metronidazole|metronidazole|mesh-list
6064316|NCT00669955|Clarithromycin|clarithromycin|mesh-list
6064317|NCT00669955|Tetracycline|tetracycline|mesh-list
6064318|NCT00669955|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
6064319|NCT00669955|Omeprazole|omeprazole|mesh-list
6064320|NCT00669955|Bismuth|bismuth|mesh-list
6064321|NCT00669955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6064322|NCT00669955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6064323|NCT00669955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6064324|NCT00669955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6064325|NCT00669955|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6064326|NCT00669955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6064327|NCT00669955|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6064328|NCT00669955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6064329|NCT00669955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6064330|NCT00669955|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6064331|NCT00669955|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6202272|NCT02038881|Immunologic Factors|immunologic factors|mesh-ancestor
6064332|NCT00669955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6064333|NCT00669955|Antacids|antacids|mesh-ancestor
6064334|NCT00670007|Protease Inhibitors|protease inhibitors|mesh-list
6064335|NCT00670007|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
6064336|NCT00670007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6064337|NCT00670007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6064338|NCT00670007|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6064339|NCT00670007|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6064340|NCT00670046|Valproic Acid|valproic acid|mesh-list
5507378|NCT04424654|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5507379|NCT04424654|Androgens|androgens|mesh-ancestor
5507380|NCT04424654|Hormones|hormones|mesh-ancestor
5507381|NCT04424654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5507382|NCT04424654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507383|NCT04424654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5507384|NCT04424654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5507385|NCT04424654|Anabolic Agents|anabolic agents|mesh-ancestor
5507386|NCT04424511|Azithromycin|azithromycin|mesh-list
5507387|NCT04424511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5507388|NCT04424511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5507389|NCT04424563|Aminocaproic Acid|aminocaproic acid|mesh-list
5507390|NCT04424563|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5507391|NCT04424563|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5507392|NCT04424563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507393|NCT04424563|Hemostatics|hemostatics|mesh-ancestor
6064341|NCT00670046|Anticonvulsants|anticonvulsants|mesh-ancestor
6064342|NCT00670046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6064343|NCT00670046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6064344|NCT00670046|GABA Agents|gaba agents|mesh-ancestor
6064345|NCT00670046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6064346|NCT00670046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064347|NCT00670046|Antimanic Agents|antimanic agents|mesh-ancestor
6064348|NCT00670046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6064349|NCT00670046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6064350|NCT00670046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6064351|NCT00670202|Fasudil|fasudil|mesh-list
6064352|NCT00670202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6064353|NCT00670202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6064354|NCT00670202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6064355|NCT00670202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6064356|NCT00670202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064357|NCT00670202|Vasodilator Agents|vasodilator agents|mesh-ancestor
6064358|NCT00670202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6064359|NCT00670202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6665271|NCT01516567|Cyclophosphamide|cyclophosphamide|mesh-list
6665272|NCT01516567|Rituximab|rituximab|mesh-list
6665273|NCT01516567|Doxorubicin|doxorubicin|mesh-list
6665274|NCT01516567|Etoposide|etoposide|mesh-list
6665275|NCT01516567|Vincristine|vincristine|mesh-list
6665276|NCT01516567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6665277|NCT01516567|Immunologic Factors|immunologic factors|mesh-ancestor
6665278|NCT01516567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507394|NCT04424563|Coagulants|coagulants|mesh-ancestor
5507395|NCT04424485|Parathyroid Hormone|parathyroid hormone|mesh-list
5507396|NCT04424485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5507397|NCT04424485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507398|NCT04424459|Analgesics, Opioid|analgesics, opioid|mesh-list
5507399|NCT04424459|Narcotics|narcotics|mesh-ancestor
5507400|NCT04424459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6064360|NCT00670228|Insulin|insulin|mesh-list
6665279|NCT01516567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6665280|NCT01516567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6665281|NCT01516567|Alkylating Agents|alkylating agents|mesh-ancestor
6665282|NCT01516567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665283|NCT01516567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6665284|NCT01516567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6665285|NCT01516567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6064361|NCT00670228|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6064362|NCT00670228|Insulin Glargine|insulin glargine|mesh-list
6064363|NCT00670228|Insulin glulisine|insulin glulisine|mesh-list
6064364|NCT00670228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5507401|NCT04424459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507402|NCT04424459|Analgesics|analgesics|mesh-ancestor
6064365|NCT00670228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064366|NCT00670241|Betamethasone|betamethasone|mesh-list
6064367|NCT00670241|1 alpha,24-dihydroxyvitamin D3|1 alpha,24-dihydroxyvitamin d3|mesh-list
6064368|NCT00670241|Calcipotriene|calcipotriene|mesh-list
6064369|NCT00670241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6064370|NCT00670241|Glucocorticoids|glucocorticoids|mesh-ancestor
6064371|NCT00670241|Hormones|hormones|mesh-ancestor
6064372|NCT00670241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6064373|NCT00670241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064374|NCT00670241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6064375|NCT00670241|Respiratory System Agents|respiratory system agents|mesh-ancestor
6064376|NCT00670241|Dermatologic Agents|dermatologic agents|mesh-ancestor
6064377|NCT00670267|Nadolol|nadolol|mesh-list
6064378|NCT00670267|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6064379|NCT00670267|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6064380|NCT00670267|Adrenergic Agents|adrenergic agents|mesh-ancestor
6064381|NCT00670267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6064382|NCT00670267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6064383|NCT00670267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064384|NCT00670267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6064385|NCT00670267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6064386|NCT00670267|Sympatholytics|sympatholytics|mesh-ancestor
6064387|NCT00670267|Autonomic Agents|autonomic agents|mesh-ancestor
6064388|NCT00670267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6064389|NCT00670306|Cetrorelix|cetrorelix|mesh-list
6064390|NCT00670306|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6064391|NCT00670306|Fertility Agents|fertility agents|mesh-ancestor
6064392|NCT00670306|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6064393|NCT00670306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064394|NCT00670306|Hormone Antagonists|hormone antagonists|mesh-ancestor
6064395|NCT00670306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6064396|NCT00670449|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6064397|NCT00670449|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6064398|NCT00670449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6064399|NCT00670449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6064400|NCT00670449|Immunologic Factors|immunologic factors|mesh-ancestor
6064401|NCT00670449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064402|NCT00670748|Aldesleukin|aldesleukin|mesh-list
6064403|NCT00670748|Cyclophosphamide|cyclophosphamide|mesh-list
6064404|NCT00670748|Fludarabine|fludarabine|mesh-list
6064405|NCT00670748|Fludarabine phosphate|fludarabine phosphate|mesh-list
6064406|NCT00670748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6064407|NCT00670748|Immunologic Factors|immunologic factors|mesh-ancestor
6064408|NCT00670748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064409|NCT00670748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6064410|NCT00670748|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5507403|NCT04424459|Sensory System Agents|sensory system agents|mesh-ancestor
5507404|NCT04424459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5507405|NCT04424381|Rivaroxaban|rivaroxaban|mesh-list
5507406|NCT04424381|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5507407|NCT04424381|Antithrombins|antithrombins|mesh-ancestor
5507408|NCT04424381|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5507409|NCT04424381|Protease Inhibitors|protease inhibitors|mesh-ancestor
5507410|NCT04424381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5507411|NCT04424381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507412|NCT04424381|Anticoagulants|anticoagulants|mesh-ancestor
5507413|NCT04424264|Tenofovir|tenofovir|mesh-list
5507414|NCT04424264|Lamivudine|lamivudine|mesh-list
5507415|NCT04424264|Emtricitabine|emtricitabine|mesh-list
5507416|NCT04424264|Efavirenz|efavirenz|mesh-list
5600228|NCT03713437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064411|NCT00670748|Alkylating Agents|alkylating agents|mesh-ancestor
6064412|NCT00670748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6064413|NCT00670748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6064414|NCT00670748|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6064415|NCT00670748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6064416|NCT00670748|Antimetabolites|antimetabolites|mesh-ancestor
6064417|NCT00670748|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6064418|NCT00670748|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6064419|NCT00670748|Antiviral Agents|antiviral agents|mesh-ancestor
5507417|NCT04424264|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5507418|NCT04424264|Rifampin|rifampin|mesh-list
5507419|NCT04424264|Isoniazid|isoniazid|mesh-list
6064420|NCT00670748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6064421|NCT00670774|Eculizumab|eculizumab|mesh-list
6064422|NCT00670774|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6064423|NCT00670774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6064424|NCT00670774|Immunologic Factors|immunologic factors|mesh-ancestor
6064425|NCT00670774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064426|NCT00670800|Metformin|metformin|mesh-list
6064427|NCT00670800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6064428|NCT00670800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064429|NCT00670930|Omalizumab|omalizumab|mesh-list
6064430|NCT00670930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6064431|NCT00670930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6064432|NCT00670930|Respiratory System Agents|respiratory system agents|mesh-ancestor
6064433|NCT00670956|Betamethasone|betamethasone|mesh-list
6064434|NCT00670956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6064435|NCT00670956|Glucocorticoids|glucocorticoids|mesh-ancestor
6064436|NCT00670956|Hormones|hormones|mesh-ancestor
6064437|NCT00670956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6064438|NCT00670956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064439|NCT00670956|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6064440|NCT00670956|Respiratory System Agents|respiratory system agents|mesh-ancestor
6064441|NCT00670982|Bevacizumab|bevacizumab|mesh-list
6064442|NCT00670982|Trastuzumab|trastuzumab|mesh-list
6064443|NCT00670982|Vinorelbine|vinorelbine|mesh-list
6064444|NCT00670982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6064445|NCT00670982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6064446|NCT00670982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6064447|NCT00670982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6064448|NCT00670982|Growth Substances|growth substances|mesh-ancestor
6064449|NCT00670982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064450|NCT00670982|Growth Inhibitors|growth inhibitors|mesh-ancestor
6064451|NCT00670982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6064452|NCT00670982|Tubulin Modulators|tubulin modulators|mesh-ancestor
6064453|NCT00670982|Antimitotic Agents|antimitotic agents|mesh-ancestor
6064454|NCT00670982|Mitosis Modulators|mitosis modulators|mesh-ancestor
6064455|NCT00670982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6064456|NCT00671034|Cytarabine|cytarabine|mesh-list
6064457|NCT00671034|Dexamethasone|dexamethasone|mesh-list
6064458|NCT00671034|Dexamethasone acetate|dexamethasone acetate|mesh-list
6064459|NCT00671034|Prednisone|prednisone|mesh-list
6064460|NCT00671034|Cortisone|cortisone|mesh-list
6064461|NCT00671034|Cyclophosphamide|cyclophosphamide|mesh-list
6064462|NCT00671034|Doxorubicin|doxorubicin|mesh-list
6064463|NCT00671034|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6064464|NCT00671034|Methotrexate|methotrexate|mesh-list
6064465|NCT00671034|Vincristine|vincristine|mesh-list
6064466|NCT00671034|Daunorubicin|daunorubicin|mesh-list
6064467|NCT00671034|Asparaginase|asparaginase|mesh-list
6064468|NCT00671034|Mercaptopurine|mercaptopurine|mesh-list
6064469|NCT00671034|Pegaspargase|pegaspargase|mesh-list
6064470|NCT00671034|Thioguanine|thioguanine|mesh-list
6064471|NCT00671034|BB 1101|bb 1101|mesh-list
5507420|NCT04424264|Antiviral Agents|antiviral agents|mesh-ancestor
5507421|NCT04424264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5507422|NCT04424264|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5507423|NCT04424264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5507424|NCT04424264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6064472|NCT00671034|2-Aminopurine|2-aminopurine|mesh-list
6064473|NCT00671034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6064474|NCT00671034|Immunologic Factors|immunologic factors|mesh-ancestor
6064475|NCT00671034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064476|NCT00671034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6064477|NCT00671034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6064478|NCT00671034|Alkylating Agents|alkylating agents|mesh-ancestor
6064479|NCT00671034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6064480|NCT00671034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6064481|NCT00671034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6064482|NCT00671034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6064483|NCT00671034|Antiemetics|antiemetics|mesh-ancestor
6064484|NCT00671034|Autonomic Agents|autonomic agents|mesh-ancestor
6064485|NCT00671034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6064486|NCT00671034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6064487|NCT00671034|Glucocorticoids|glucocorticoids|mesh-ancestor
6064488|NCT00671034|Hormones|hormones|mesh-ancestor
6064489|NCT00671034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5507425|NCT04424264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507426|NCT04424264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5507427|NCT04424264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5507428|NCT04424264|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5507429|NCT04424264|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5507430|NCT04424264|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5507431|NCT04424264|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5507432|NCT04424264|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5507433|NCT04424264|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5507434|NCT04424264|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5507435|NCT04424264|Antitubercular Agents|antitubercular agents|mesh-ancestor
5507436|NCT04424264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5507437|NCT04424264|Leprostatic Agents|leprostatic agents|mesh-ancestor
6064490|NCT00671034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6064491|NCT00671034|Protease Inhibitors|protease inhibitors|mesh-ancestor
6064492|NCT00671034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6064493|NCT00671034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6064494|NCT00671034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6064495|NCT00671034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6064496|NCT00671034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6064497|NCT00671034|Abortifacient Agents|abortifacient agents|mesh-ancestor
6064498|NCT00671034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6064499|NCT00671034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6064500|NCT00671034|Antimetabolites|antimetabolites|mesh-ancestor
6064501|NCT00671034|Dermatologic Agents|dermatologic agents|mesh-ancestor
6064502|NCT00671034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6064503|NCT00671034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6064504|NCT00671034|Antiviral Agents|antiviral agents|mesh-ancestor
5507438|NCT04424264|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5507439|NCT04424264|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5507440|NCT04424264|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6064505|NCT00671034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6064506|NCT00671034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6064507|NCT00671034|Tubulin Modulators|tubulin modulators|mesh-ancestor
5507441|NCT04424264|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5507442|NCT04424264|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5507443|NCT04424264|Antimetabolites|antimetabolites|mesh-ancestor
5507444|NCT04424264|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5507445|NCT04424303|Tofacitinib|tofacitinib|mesh-list
5507446|NCT04424303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5507447|NCT04424303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5507448|NCT04424303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507449|NCT04423926|Prednisolone|prednisolone|mesh-list
5507450|NCT04423926|Cyclophosphamide|cyclophosphamide|mesh-list
5507451|NCT04423926|Doxorubicin|doxorubicin|mesh-list
5507452|NCT04423926|Vincristine|vincristine|mesh-list
5507453|NCT04423926|Lenalidomide|lenalidomide|mesh-list
5507454|NCT04423926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6064508|NCT00671034|Antimitotic Agents|antimitotic agents|mesh-ancestor
6064509|NCT00671034|Mitosis Modulators|mitosis modulators|mesh-ancestor
6064510|NCT00671060|Misoprostol|misoprostol|mesh-list
6064511|NCT00671060|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6064512|NCT00671060|Abortifacient Agents|abortifacient agents|mesh-ancestor
6064513|NCT00671060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6064514|NCT00671060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064515|NCT00671060|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6064516|NCT00671060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5507455|NCT04423926|Immunologic Factors|immunologic factors|mesh-ancestor
5507456|NCT04423926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507457|NCT04423926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5507458|NCT04423926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5507459|NCT04423926|Alkylating Agents|alkylating agents|mesh-ancestor
5507460|NCT04423926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507461|NCT04423926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5507462|NCT04423926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5507463|NCT04423926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6064517|NCT00671060|Oxytocics|oxytocics|mesh-ancestor
6064518|NCT00671437|Cetuximab|cetuximab|mesh-list
6064519|NCT00671437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6064520|NCT00671437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6064521|NCT00671502|Carisoprodol|carisoprodol|mesh-list
6064522|NCT00671502|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6064523|NCT00671502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064524|NCT00671502|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6064525|NCT00671502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6064526|NCT00671515|Pioglitazone|pioglitazone|mesh-list
6064527|NCT00671515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6064528|NCT00671515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064529|NCT00671658|Cytarabine|cytarabine|mesh-list
6064530|NCT00671658|Dexamethasone|dexamethasone|mesh-list
6064531|NCT00671658|Methylprednisolone|methylprednisolone|mesh-list
6064532|NCT00671658|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5507464|NCT04423926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5507465|NCT04423926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5507466|NCT04423926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5507467|NCT04423926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5507468|NCT04423926|Tubulin Modulators|tubulin modulators|mesh-ancestor
5507469|NCT04423926|Antimitotic Agents|antimitotic agents|mesh-ancestor
5507470|NCT04423926|Mitosis Modulators|mitosis modulators|mesh-ancestor
5507471|NCT04423926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5507472|NCT04423926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5507473|NCT04423926|Growth Substances|growth substances|mesh-ancestor
5507474|NCT04423926|Growth Inhibitors|growth inhibitors|mesh-ancestor
5507475|NCT04423926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5507476|NCT04423926|Glucocorticoids|glucocorticoids|mesh-ancestor
5507477|NCT04423926|Hormones|hormones|mesh-ancestor
6064533|NCT00671658|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6064534|NCT00671658|Prednisolone|prednisolone|mesh-list
6064535|NCT00671658|Prednisolone acetate|prednisolone acetate|mesh-list
6064536|NCT00671658|Cyclophosphamide|cyclophosphamide|mesh-list
6064537|NCT00671658|Rituximab|rituximab|mesh-list
6064538|NCT00671658|Doxorubicin|doxorubicin|mesh-list
6064539|NCT00671658|Methotrexate|methotrexate|mesh-list
6064540|NCT00671658|Vincristine|vincristine|mesh-list
6064541|NCT00671658|Asparaginase|asparaginase|mesh-list
6665286|NCT01516567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6665287|NCT01516567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6665288|NCT01516567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6665289|NCT01516567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6665290|NCT01516567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6665291|NCT01516567|Tubulin Modulators|tubulin modulators|mesh-ancestor
6665292|NCT01516567|Antimitotic Agents|antimitotic agents|mesh-ancestor
6665293|NCT01516567|Mitosis Modulators|mitosis modulators|mesh-ancestor
6665294|NCT01516580|Cytarabine|cytarabine|mesh-list
6064542|NCT00671658|Pegaspargase|pegaspargase|mesh-list
6064543|NCT00671658|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5507478|NCT04423926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5507479|NCT04423926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5507480|NCT04424056|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5507481|NCT04424056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5507482|NCT04424017|Antibodies|antibodies|mesh-list
5507483|NCT04424017|Immunologic Factors|immunologic factors|mesh-ancestor
5507484|NCT04424017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507485|NCT04424134|Spironolactone|spironolactone|mesh-list
5507486|NCT04424134|Bromhexine|bromhexine|mesh-list
6064544|NCT00671658|Prednisolone phosphate|prednisolone phosphate|mesh-list
6064545|NCT00671658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6064546|NCT00671658|Immunologic Factors|immunologic factors|mesh-ancestor
6064547|NCT00671658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665295|NCT01516580|Cyclophosphamide|cyclophosphamide|mesh-list
6064548|NCT00671658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6064549|NCT00671658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6064550|NCT00671658|Alkylating Agents|alkylating agents|mesh-ancestor
6665296|NCT01516580|Rituximab|rituximab|mesh-list
6665297|NCT01516580|Doxorubicin|doxorubicin|mesh-list
6064551|NCT00671658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6064552|NCT00671658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6064553|NCT00671658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6064554|NCT00671658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6064555|NCT00671658|Antiemetics|antiemetics|mesh-ancestor
6064556|NCT00671658|Autonomic Agents|autonomic agents|mesh-ancestor
6064557|NCT00671658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6064558|NCT00671658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6064559|NCT00671658|Glucocorticoids|glucocorticoids|mesh-ancestor
6064560|NCT00671658|Hormones|hormones|mesh-ancestor
6064561|NCT00671658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6064562|NCT00671658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6064563|NCT00671658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6064564|NCT00671658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6064565|NCT00671658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6064566|NCT00671658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6064567|NCT00671658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6064568|NCT00671658|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6064569|NCT00671658|Abortifacient Agents|abortifacient agents|mesh-ancestor
6064570|NCT00671658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6064571|NCT00671658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5507487|NCT04424134|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5507488|NCT04424134|Hormone Antagonists|hormone antagonists|mesh-ancestor
5507489|NCT04424134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5507490|NCT04424134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507491|NCT04424134|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5507492|NCT04424134|Diuretics|diuretics|mesh-ancestor
5507493|NCT04424134|Natriuretic Agents|natriuretic agents|mesh-ancestor
5507494|NCT04424134|Expectorants|expectorants|mesh-ancestor
5507495|NCT04424134|Respiratory System Agents|respiratory system agents|mesh-ancestor
5507496|NCT04423627|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5507497|NCT04423627|Clonidine|clonidine|mesh-list
5507498|NCT04423627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5507499|NCT04423627|Diuretics|diuretics|mesh-ancestor
6064572|NCT00671658|Antimetabolites|antimetabolites|mesh-ancestor
6064573|NCT00671658|Dermatologic Agents|dermatologic agents|mesh-ancestor
6064574|NCT00671658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6064575|NCT00671658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6064576|NCT00671658|Antiviral Agents|antiviral agents|mesh-ancestor
6064577|NCT00671658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6064578|NCT00671658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6064579|NCT00671658|Tubulin Modulators|tubulin modulators|mesh-ancestor
6064580|NCT00671658|Antimitotic Agents|antimitotic agents|mesh-ancestor
6064581|NCT00671658|Mitosis Modulators|mitosis modulators|mesh-ancestor
6064582|NCT00671658|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6064583|NCT00671658|Protective Agents|protective agents|mesh-ancestor
6064584|NCT00671749|Clindamycin|clindamycin|mesh-list
6064585|NCT00671749|Clindamycin palmitate|clindamycin palmitate|mesh-list
6064586|NCT00671749|Clindamycin phosphate|clindamycin phosphate|mesh-list
6064587|NCT00671749|Adapalene|adapalene|mesh-list
6064588|NCT00671749|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6064589|NCT00671749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6064590|NCT00671749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6064591|NCT00671749|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6064592|NCT00671749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6064593|NCT00671749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6064594|NCT00671749|Dermatologic Agents|dermatologic agents|mesh-ancestor
6064595|NCT00671749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6064596|NCT00671749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6064597|NCT00671749|Analgesics|analgesics|mesh-ancestor
6064598|NCT00671749|Sensory System Agents|sensory system agents|mesh-ancestor
6064599|NCT00671749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6064600|NCT00671749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064601|NCT00671749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6064602|NCT00671749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6064603|NCT00671788|Dasatinib|dasatinib|mesh-list
6064604|NCT00671788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6064605|NCT00671788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6064606|NCT00671788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6064607|NCT00671788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6064608|NCT00671853|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6064609|NCT00671853|Antidepressive Agents|antidepressive agents|mesh-ancestor
6064610|NCT00671853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5507500|NCT04423627|Natriuretic Agents|natriuretic agents|mesh-ancestor
5507501|NCT04423627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507502|NCT04423627|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5507503|NCT04423627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5507504|NCT04423627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507505|NCT04423627|Analgesics|analgesics|mesh-ancestor
5507506|NCT04423627|Sensory System Agents|sensory system agents|mesh-ancestor
5507507|NCT04423627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5507508|NCT04423627|Sympatholytics|sympatholytics|mesh-ancestor
5507509|NCT04423627|Autonomic Agents|autonomic agents|mesh-ancestor
6064611|NCT00671853|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6064612|NCT00671853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6064613|NCT00671853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6064614|NCT00671853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064615|NCT00671879|Carisoprodol|carisoprodol|mesh-list
6064616|NCT00671879|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6064617|NCT00671879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064618|NCT00671879|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6064619|NCT00671879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6064620|NCT00671931|Dexmedetomidine|dexmedetomidine|mesh-list
6064621|NCT00671931|Propofol|propofol|mesh-list
6064622|NCT00671931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6064623|NCT00671931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6064624|NCT00671931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064625|NCT00671931|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6064626|NCT00671931|Anesthetics, General|anesthetics, general|mesh-ancestor
6064627|NCT00671931|Anesthetics|anesthetics|mesh-ancestor
6064628|NCT00671931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6064629|NCT00671931|Analgesics|analgesics|mesh-ancestor
6064630|NCT00671931|Sensory System Agents|sensory system agents|mesh-ancestor
6064631|NCT00671931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6064632|NCT00671931|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5507510|NCT04423627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5507511|NCT04423627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5507512|NCT04423627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5507513|NCT04423627|Adrenergic Agents|adrenergic agents|mesh-ancestor
5507514|NCT04423627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6064633|NCT00671931|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6064634|NCT00671931|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6064635|NCT00671931|Adrenergic Agents|adrenergic agents|mesh-ancestor
6064636|NCT00671931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6064637|NCT00671931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6064638|NCT00671970|Bevacizumab|bevacizumab|mesh-list
6064639|NCT00671970|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6064640|NCT00671970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6064641|NCT00671970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6064642|NCT00671970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6064643|NCT00671970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6064644|NCT00671970|Growth Substances|growth substances|mesh-ancestor
6064645|NCT00671970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064646|NCT00671970|Growth Inhibitors|growth inhibitors|mesh-ancestor
6064647|NCT00671970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6064648|NCT00671970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6064649|NCT00671970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6064650|NCT00672100|Ropivacaine|ropivacaine|mesh-list
6064651|NCT00672100|Anesthetics, Local|anesthetics, local|mesh-ancestor
6064652|NCT00672100|Anesthetics|anesthetics|mesh-ancestor
6064653|NCT00672100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6064654|NCT00672100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462884|NCT00461747|Glucocorticoids|glucocorticoids|mesh-ancestor
5507515|NCT04423861|Nitazoxanide|nitazoxanide|mesh-list
5507516|NCT04423861|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5507517|NCT04423861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5507518|NCT04423731|Leucovorin|leucovorin|mesh-list
5507519|NCT04423731|Gemcitabine|gemcitabine|mesh-list
5507520|NCT04423731|Paclitaxel|paclitaxel|mesh-list
6064655|NCT00672100|Sensory System Agents|sensory system agents|mesh-ancestor
6064656|NCT00672100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6064657|NCT00672139|Bromides|bromides|mesh-list
6064658|NCT00672139|Methylnaltrexone|methylnaltrexone|mesh-list
6064659|NCT00672139|Anticonvulsants|anticonvulsants|mesh-ancestor
6064660|NCT00672139|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6064661|NCT00672139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064662|NCT00672139|Sensory System Agents|sensory system agents|mesh-ancestor
6064663|NCT00672139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6064664|NCT00672204|Sirolimus|sirolimus|mesh-list
6064665|NCT00672204|Thymoglobulin|thymoglobulin|mesh-list
6064666|NCT00672204|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6064667|NCT00672204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6064668|NCT00672204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6064669|NCT00672204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6064670|NCT00672204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6064671|NCT00672204|Antifungal Agents|antifungal agents|mesh-ancestor
6064672|NCT00672204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6064673|NCT00672204|Immunologic Factors|immunologic factors|mesh-ancestor
6064674|NCT00672204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064675|NCT00672243|Sirolimus|sirolimus|mesh-list
6064676|NCT00672243|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6064677|NCT00672243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6064678|NCT00672243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6064679|NCT00672243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6064680|NCT00672243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6064681|NCT00672243|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6064682|NCT00672243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6064683|NCT00672243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6064684|NCT00672243|Antifungal Agents|antifungal agents|mesh-ancestor
6064685|NCT00672243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6064686|NCT00672243|Immunologic Factors|immunologic factors|mesh-ancestor
6064687|NCT00672243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064688|NCT00672438|Alfentanil|alfentanil|mesh-list
6064689|NCT00672438|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6064690|NCT00672438|Narcotics|narcotics|mesh-ancestor
6064691|NCT00672438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6064692|NCT00672438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064693|NCT00672438|Analgesics|analgesics|mesh-ancestor
6064694|NCT00672438|Sensory System Agents|sensory system agents|mesh-ancestor
6064695|NCT00672438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6064696|NCT00672438|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6064697|NCT00672438|Anesthetics, General|anesthetics, general|mesh-ancestor
6064698|NCT00672438|Anesthetics|anesthetics|mesh-ancestor
6064699|NCT00672477|Methylnaltrexone|methylnaltrexone|mesh-list
6064700|NCT00672477|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6064701|NCT00672477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064702|NCT00672477|Sensory System Agents|sensory system agents|mesh-ancestor
6064703|NCT00672477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6064704|NCT00672490|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6462885|NCT00461747|Hormones|hormones|mesh-ancestor
6462886|NCT00461747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6462887|NCT00461747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6462888|NCT00461747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6462889|NCT00461747|Protease Inhibitors|protease inhibitors|mesh-ancestor
6462890|NCT00461747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6462891|NCT00461747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665298|NCT01516580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5507521|NCT04423731|Fluorouracil|fluorouracil|mesh-list
6064705|NCT00672490|Antidepressive Agents|antidepressive agents|mesh-ancestor
6064706|NCT00672490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6064707|NCT00672490|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6064708|NCT00672490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6064709|NCT00672490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6064710|NCT00672490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064711|NCT00672594|Sunitinib|sunitinib|mesh-list
6064712|NCT00672594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6064713|NCT00672594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6064714|NCT00672594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6064715|NCT00672594|Growth Substances|growth substances|mesh-ancestor
5507522|NCT04423731|Folfirinox|folfirinox|mesh-list
6064716|NCT00672594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064717|NCT00672594|Growth Inhibitors|growth inhibitors|mesh-ancestor
6064718|NCT00672594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6064719|NCT00672594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6064720|NCT00672594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462892|NCT00461747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6462893|NCT00461747|Immunologic Factors|immunologic factors|mesh-ancestor
6462894|NCT00461747|Leprostatic Agents|leprostatic agents|mesh-ancestor
6462895|NCT00461747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6064721|NCT00672620|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6064722|NCT00672620|Vortioxetine|vortioxetine|mesh-list
6064723|NCT00672620|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6064724|NCT00672620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6064725|NCT00672620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6064726|NCT00672620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6064727|NCT00672620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6064728|NCT00672620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064729|NCT00672620|Analgesics|analgesics|mesh-ancestor
6064730|NCT00672620|Sensory System Agents|sensory system agents|mesh-ancestor
6064731|NCT00672620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6064732|NCT00672620|Antidepressive Agents|antidepressive agents|mesh-ancestor
6064733|NCT00672620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6064734|NCT00672620|Dopamine Agents|dopamine agents|mesh-ancestor
6064735|NCT00672620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5507523|NCT04423731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5507524|NCT04423731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5507525|NCT04423731|Tubulin Modulators|tubulin modulators|mesh-ancestor
5507526|NCT04423731|Antimitotic Agents|antimitotic agents|mesh-ancestor
5507527|NCT04423731|Mitosis Modulators|mitosis modulators|mesh-ancestor
6064736|NCT00672620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6064737|NCT00672620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6064738|NCT00672620|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6064739|NCT00672620|Serotonin Agents|serotonin agents|mesh-ancestor
5507528|NCT04423731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507529|NCT04423731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5507530|NCT04423731|Antimetabolites|antimetabolites|mesh-ancestor
5507531|NCT04423731|Antiviral Agents|antiviral agents|mesh-ancestor
5507532|NCT04423731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5507533|NCT04423731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5507534|NCT04423731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5507535|NCT04423731|Immunologic Factors|immunologic factors|mesh-ancestor
5507536|NCT04423731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507537|NCT04423731|Antidotes|antidotes|mesh-ancestor
5507538|NCT04423731|Protective Agents|protective agents|mesh-ancestor
5507539|NCT04423731|Vitamin B Complex|vitamin b complex|mesh-ancestor
6064740|NCT00672620|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6064741|NCT00672620|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6064742|NCT00672620|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6064743|NCT00672620|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6064744|NCT00672646|Naproxen|naproxen|mesh-list
6064745|NCT00672646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6064746|NCT00672646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6064747|NCT00672646|Analgesics|analgesics|mesh-ancestor
6064748|NCT00672646|Sensory System Agents|sensory system agents|mesh-ancestor
6064749|NCT00672646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6064750|NCT00672646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064751|NCT00672646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6064752|NCT00672646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6064753|NCT00672646|Gout Suppressants|gout suppressants|mesh-ancestor
6064754|NCT00672646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6064755|NCT00672646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5507540|NCT04423731|Vitamins|vitamins|mesh-ancestor
5507541|NCT04423731|Micronutrients|micronutrients|mesh-ancestor
5507542|NCT04423510|Phenol|phenol|mesh-list
5507543|NCT04423510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5507544|NCT04423510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5507545|NCT04423510|Disinfectants|disinfectants|mesh-ancestor
5507546|NCT04423510|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
5507547|NCT04423510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5507548|NCT04423107|Acetaminophen|acetaminophen|mesh-list
5507549|NCT04423107|Ibuprofen|ibuprofen|mesh-list
5507550|NCT04423107|Oxycodone|oxycodone|mesh-list
5507551|NCT04423107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5507552|NCT04423107|Analgesics|analgesics|mesh-ancestor
5507553|NCT04423107|Sensory System Agents|sensory system agents|mesh-ancestor
5507554|NCT04423107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5507555|NCT04423107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507556|NCT04423107|Antipyretics|antipyretics|mesh-ancestor
5507557|NCT04423107|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5507558|NCT04423107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5507559|NCT04423107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5507560|NCT04423107|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5507561|NCT04423107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5507562|NCT04423107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507563|NCT04423107|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5507564|NCT04423107|Narcotics|narcotics|mesh-ancestor
5507565|NCT04423107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5507566|NCT04423276|Donepezil|donepezil|mesh-list
5507567|NCT04423276|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5507568|NCT04423276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5507569|NCT04423276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507570|NCT04423276|Cholinergic Agents|cholinergic agents|mesh-ancestor
5507571|NCT04423276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5507572|NCT04423276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064756|NCT00672646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6064757|NCT00672737|Remifentanil|remifentanil|mesh-list
6064758|NCT00672737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6064759|NCT00672737|Narcotics|narcotics|mesh-ancestor
6064760|NCT00672737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6064761|NCT00672737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064762|NCT00672737|Analgesics|analgesics|mesh-ancestor
6064763|NCT00672737|Sensory System Agents|sensory system agents|mesh-ancestor
6064764|NCT00672737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6064765|NCT00672841|Antifungal Agents|antifungal agents|mesh-list
6064766|NCT00672841|Clotrimazole|clotrimazole|mesh-list
6064767|NCT00672841|Miconazole|miconazole|mesh-list
6064768|NCT00672841|Anidulafungin|anidulafungin|mesh-list
6064769|NCT00672841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6064770|NCT00672841|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6064771|NCT00672841|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6064772|NCT00672841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6064773|NCT00672841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6064774|NCT00672841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6064775|NCT00672841|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6064776|NCT00672841|Hormone Antagonists|hormone antagonists|mesh-ancestor
6064777|NCT00672841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6064778|NCT00672841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064779|NCT00672841|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6064780|NCT00672841|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5507573|NCT04423276|Nootropic Agents|nootropic agents|mesh-ancestor
5507574|NCT04423185|Atezolizumab|atezolizumab|mesh-list
5507575|NCT04423185|Imatinib Mesylate|imatinib mesylate|mesh-list
5507576|NCT04423185|Palbociclib|palbociclib|mesh-list
5507577|NCT04423185|Niraparib|niraparib|mesh-list
5507578|NCT04423185|Vemurafenib|vemurafenib|mesh-list
6064781|NCT00672854|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6064782|NCT00672854|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6064783|NCT00672854|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6064784|NCT00672854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6064785|NCT00672932|Raltegravir Potassium|raltegravir potassium|mesh-list
6064786|NCT00672932|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6064787|NCT00672932|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6064788|NCT00672932|Antiviral Agents|antiviral agents|mesh-ancestor
6064789|NCT00672932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6064790|NCT00672932|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6064791|NCT00672932|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6064792|NCT00672932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5507579|NCT04423185|Crizotinib|crizotinib|mesh-list
5507580|NCT04423185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5507581|NCT04423185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5507582|NCT04423185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5507583|NCT04423185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507584|NCT04423185|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5507585|NCT04423367|Dexamethasone|dexamethasone|mesh-list
5507586|NCT04423367|Bortezomib|bortezomib|mesh-list
6064793|NCT00672932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6064794|NCT00672958|Vortioxetine|vortioxetine|mesh-list
6064795|NCT00672958|Antidepressive Agents|antidepressive agents|mesh-ancestor
6064796|NCT00672958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6064797|NCT00672958|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6064798|NCT00672958|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5507587|NCT04423367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5507588|NCT04423367|Antiemetics|antiemetics|mesh-ancestor
5507589|NCT04423367|Autonomic Agents|autonomic agents|mesh-ancestor
5507590|NCT04423367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5507591|NCT04423367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507592|NCT04423367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5507593|NCT04423367|Glucocorticoids|glucocorticoids|mesh-ancestor
5507594|NCT04423367|Hormones|hormones|mesh-ancestor
5507595|NCT04423367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5507596|NCT04423367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5507597|NCT04423367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6064799|NCT00672958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6064800|NCT00672958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064801|NCT00672958|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6064802|NCT00672958|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6064803|NCT00672958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6064804|NCT00672958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6064805|NCT00672958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6064806|NCT00672958|Serotonin Agents|serotonin agents|mesh-ancestor
6064807|NCT00672958|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6064808|NCT00672958|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6064809|NCT00672958|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6064810|NCT00672958|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6064811|NCT00672984|Moxifloxacin|moxifloxacin|mesh-list
6064812|NCT00672984|Guanfacine|guanfacine|mesh-list
6064813|NCT00672984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6064814|NCT00672984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6064815|NCT00672984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6064816|NCT00672984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6064817|NCT00672984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6064818|NCT00672984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6064819|NCT00672984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6064820|NCT00672984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064821|NCT00672984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6064822|NCT00672984|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6064823|NCT00672984|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6064824|NCT00672984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6064825|NCT00672984|Adrenergic Agents|adrenergic agents|mesh-ancestor
6064826|NCT00672984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6064827|NCT00673049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6064828|NCT00673049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6665299|NCT01516580|Methotrexate|methotrexate|mesh-list
5507604|NCT04422678|Imatinib Mesylate|imatinib mesylate|mesh-list
5507605|NCT04422678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6064829|NCT00673049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6064830|NCT00673049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6064831|NCT00673049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6064832|NCT00673075|Carvedilol|carvedilol|mesh-list
6064833|NCT00673075|Nebivolol|nebivolol|mesh-list
6064834|NCT00673075|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6064835|NCT00673075|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6064836|NCT00673075|Adrenergic Agents|adrenergic agents|mesh-ancestor
6064837|NCT00673075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6064838|NCT00673075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6064839|NCT00673075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064840|NCT00673075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6064841|NCT00673075|Antioxidants|antioxidants|mesh-ancestor
6064842|NCT00673075|Protective Agents|protective agents|mesh-ancestor
6064843|NCT00673075|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6064844|NCT00673075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6064845|NCT00673075|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6064846|NCT00673075|Vasodilator Agents|vasodilator agents|mesh-ancestor
6064847|NCT00673075|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6064848|NCT00673075|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6064849|NCT00673075|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6064850|NCT00673075|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6064851|NCT00673075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6064852|NCT00673127|Ketoconazole|ketoconazole|mesh-list
6064853|NCT00673127|Hydrocortisone|hydrocortisone|mesh-list
6064854|NCT00673127|Dutasteride|dutasteride|mesh-list
6064855|NCT00673127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6064856|NCT00673127|Antifungal Agents|antifungal agents|mesh-ancestor
5507606|NCT04422678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5507607|NCT04422678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5507608|NCT04422678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600229|NCT03713424|Clavulanic Acids|clavulanic acids|mesh-list
5600230|NCT03713424|Clavulanic Acid|clavulanic acid|mesh-list
5600231|NCT03713424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5600232|NCT03713424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6064857|NCT00673127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6064858|NCT00673127|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6064859|NCT00673127|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6064860|NCT00673127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6064861|NCT00673127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6064862|NCT00673127|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6064863|NCT00673127|Hormone Antagonists|hormone antagonists|mesh-ancestor
6064864|NCT00673127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6064865|NCT00673127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064866|NCT00673127|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6064867|NCT00673127|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6064868|NCT00673153|Vorinostat|vorinostat|mesh-list
6064869|NCT00673153|Gemtuzumab|gemtuzumab|mesh-list
6064870|NCT00673153|Calicheamicins|calicheamicins|mesh-list
6064871|NCT00673153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6064872|NCT00673153|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6064873|NCT00673153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6064874|NCT00673153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6064875|NCT00673153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6064876|NCT00673153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6064877|NCT00673231|Dapagliflozin|dapagliflozin|mesh-list
6064878|NCT00673231|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5600233|NCT03713424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5600234|NCT03713424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600235|NCT03713424|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6064879|NCT00673231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6064880|NCT00673231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6462896|NCT00461747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5606679|NCT03927274|Topotecan|topotecan|mesh-list
6462897|NCT00461747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6462898|NCT00461747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6462899|NCT00461747|Growth Substances|growth substances|mesh-ancestor
6462900|NCT00461747|Growth Inhibitors|growth inhibitors|mesh-ancestor
6462901|NCT00461799|Orlistat|orlistat|mesh-list
6462902|NCT00461799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6462903|NCT00461799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462904|NCT00461799|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6462905|NCT00461799|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6462906|NCT00461825|Cyclosporine|cyclosporine|mesh-list
6462907|NCT00461825|Mycophenolic Acid|mycophenolic acid|mesh-list
6462908|NCT00461825|Azathioprine|azathioprine|mesh-list
6462909|NCT00461825|Cyclosporins|cyclosporins|mesh-list
6462910|NCT00461825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6462911|NCT00461825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462912|NCT00461825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6462913|NCT00461825|Immunologic Factors|immunologic factors|mesh-ancestor
6462914|NCT00461825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462915|NCT00461825|Antifungal Agents|antifungal agents|mesh-ancestor
6462916|NCT00461825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6462917|NCT00461825|Dermatologic Agents|dermatologic agents|mesh-ancestor
6462918|NCT00461825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6462919|NCT00461825|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6462920|NCT00461825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6462921|NCT00461825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6462922|NCT00461825|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6462923|NCT00461825|Antitubercular Agents|antitubercular agents|mesh-ancestor
6064881|NCT00673231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064882|NCT00673244|Furosemide|furosemide|mesh-list
6064883|NCT00673244|Diuretics|diuretics|mesh-ancestor
6064884|NCT00673244|Natriuretic Agents|natriuretic agents|mesh-ancestor
6064885|NCT00673244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064886|NCT00673244|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6064887|NCT00673244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6064888|NCT00673244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6064889|NCT00673387|Pramlintide|pramlintide|mesh-list
6064890|NCT00673387|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
6064891|NCT00673387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6064892|NCT00673387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064893|NCT00673387|Appetite Depressants|appetite depressants|mesh-ancestor
6064894|NCT00673387|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6064895|NCT00673387|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
6064896|NCT00673387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202273|NCT02038881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202274|NCT02038894|Propofol|propofol|mesh-list
6202275|NCT02038894|Sevoflurane|sevoflurane|mesh-list
6202276|NCT02038894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6202277|NCT02038894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6202278|NCT02038894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202279|NCT02038894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6202280|NCT02038894|Anesthetics, General|anesthetics, general|mesh-ancestor
6202281|NCT02038894|Anesthetics|anesthetics|mesh-ancestor
6202282|NCT02038894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6202283|NCT02038894|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6202284|NCT02038907|Vaccines|vaccines|mesh-list
6202285|NCT02038907|Immunologic Factors|immunologic factors|mesh-ancestor
6202286|NCT02038907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202287|NCT02038920|Vedolizumab|vedolizumab|mesh-list
6202288|NCT02038920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6202289|NCT02038933|Nivolumab|nivolumab|mesh-list
6202290|NCT02038933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6202291|NCT02038933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6202292|NCT02038933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6202293|NCT02038933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202294|NCT02039115|Prednisone|prednisone|mesh-list
6202295|NCT02039115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6202296|NCT02039115|Glucocorticoids|glucocorticoids|mesh-ancestor
6202297|NCT02039115|Hormones|hormones|mesh-ancestor
6202298|NCT02039115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6202299|NCT02039115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202300|NCT02039115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6202301|NCT02039115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5507609|NCT04422652|Bupropion|bupropion|mesh-list
5507610|NCT04422652|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5507611|NCT04422652|Antidepressive Agents|antidepressive agents|mesh-ancestor
5507612|NCT04422652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5507613|NCT04422652|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5507614|NCT04422652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5507615|NCT04422652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5507616|NCT04422652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202302|NCT02039427|Dexamethasone|dexamethasone|mesh-list
6462924|NCT00461825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6064897|NCT00673439|PENTA|penta|mesh-list
6064898|NCT00673439|Warfarin|warfarin|mesh-list
6064899|NCT00673439|Fondaparinux|fondaparinux|mesh-list
6064900|NCT00673439|Anticoagulants|anticoagulants|mesh-ancestor
6064901|NCT00673439|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6064902|NCT00673439|Antithrombins|antithrombins|mesh-ancestor
6064903|NCT00673439|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6064904|NCT00673439|Protease Inhibitors|protease inhibitors|mesh-ancestor
6064905|NCT00673439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6064906|NCT00673439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6064907|NCT00673439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6064908|NCT00673439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6064909|NCT00673452|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6064910|NCT00673452|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6064911|NCT00673452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6064912|NCT00673452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6064913|NCT00673452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6064914|NCT00673452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6064915|NCT00673452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064916|NCT00673452|Analgesics|analgesics|mesh-ancestor
6064917|NCT00673452|Sensory System Agents|sensory system agents|mesh-ancestor
6064918|NCT00673452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6064919|NCT00673452|Antidepressive Agents|antidepressive agents|mesh-ancestor
6064920|NCT00673452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6064921|NCT00673452|Dopamine Agents|dopamine agents|mesh-ancestor
6064922|NCT00673465|Metformin|metformin|mesh-list
6064923|NCT00673465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6064924|NCT00673465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064925|NCT00673673|Bevacizumab|bevacizumab|mesh-list
6064926|NCT00673673|Fluorouracil|fluorouracil|mesh-list
6064927|NCT00673673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6064928|NCT00673673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6064929|NCT00673673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6064930|NCT00673673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6064931|NCT00673673|Growth Substances|growth substances|mesh-ancestor
6064932|NCT00673673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064933|NCT00673673|Growth Inhibitors|growth inhibitors|mesh-ancestor
6064934|NCT00673673|Antimetabolites|antimetabolites|mesh-ancestor
6064935|NCT00673673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507617|NCT04422652|Dopamine Agents|dopamine agents|mesh-ancestor
5507618|NCT04422652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5507619|NCT04422652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507620|NCT04422652|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5507621|NCT04422652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5507622|NCT04422652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5507623|NCT04422795|Ethyl Chloride|ethyl chloride|mesh-list
5507624|NCT04422795|Anesthetics, Local|anesthetics, local|mesh-ancestor
5507625|NCT04422795|Anesthetics|anesthetics|mesh-ancestor
5507626|NCT04422795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5507627|NCT04422795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507628|NCT04422795|Sensory System Agents|sensory system agents|mesh-ancestor
5507629|NCT04422795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5507630|NCT04422275|Budesonide|budesonide|mesh-list
5507631|NCT04422275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5507632|NCT04422275|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5507633|NCT04422275|Autonomic Agents|autonomic agents|mesh-ancestor
5507634|NCT04422275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5507635|NCT04422275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507636|NCT04422275|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5507637|NCT04422275|Respiratory System Agents|respiratory system agents|mesh-ancestor
5507638|NCT04422275|Glucocorticoids|glucocorticoids|mesh-ancestor
5507639|NCT04422275|Hormones|hormones|mesh-ancestor
5507640|NCT04422275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5507641|NCT04422431|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
5507642|NCT04422431|Choline|choline|mesh-list
5507643|NCT04422431|Lipotropic Agents|lipotropic agents|mesh-ancestor
5507644|NCT04422431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5507645|NCT04422431|Antimetabolites|antimetabolites|mesh-ancestor
5507646|NCT04422431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507647|NCT04422431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5507648|NCT04422431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6064936|NCT00673673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6064937|NCT00673673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6064938|NCT00673673|Immunologic Factors|immunologic factors|mesh-ancestor
6064939|NCT00673712|Analgesics, Opioid|analgesics, opioid|mesh-list
6064940|NCT00673712|Narcotics|narcotics|mesh-ancestor
6064941|NCT00673712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6064942|NCT00673712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064943|NCT00673712|Analgesics|analgesics|mesh-ancestor
6064944|NCT00673712|Sensory System Agents|sensory system agents|mesh-ancestor
6064945|NCT00673712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6064946|NCT00673738|Docetaxel|docetaxel|mesh-list
6064947|NCT00673738|Cetuximab|cetuximab|mesh-list
6064948|NCT00673738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6064949|NCT00673738|Tubulin Modulators|tubulin modulators|mesh-ancestor
6064950|NCT00673738|Antimitotic Agents|antimitotic agents|mesh-ancestor
6064951|NCT00673738|Mitosis Modulators|mitosis modulators|mesh-ancestor
6064952|NCT00673738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6064953|NCT00673738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6064954|NCT00673764|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6064955|NCT00673764|Lubricant Eye Drops|lubricant eye drops|mesh-list
6064956|NCT00673764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6064957|NCT00673790|Losartan|losartan|mesh-list
6064958|NCT00673790|Lisinopril|lisinopril|mesh-list
6064959|NCT00673790|Nebivolol|nebivolol|mesh-list
6064960|NCT00673790|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5507649|NCT04422431|Nootropic Agents|nootropic agents|mesh-ancestor
5507650|NCT04422431|Chelating Agents|chelating agents|mesh-ancestor
5507651|NCT04422431|Sequestering Agents|sequestering agents|mesh-ancestor
5507652|NCT04422431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6064961|NCT00673790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6064962|NCT00673790|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6064963|NCT00673790|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6064964|NCT00673790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6064965|NCT00673790|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6064966|NCT00673790|Protease Inhibitors|protease inhibitors|mesh-ancestor
6064967|NCT00673790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6064968|NCT00673790|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6064969|NCT00673790|Protective Agents|protective agents|mesh-ancestor
6064970|NCT00673790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064971|NCT00673790|Vasodilator Agents|vasodilator agents|mesh-ancestor
6064972|NCT00673790|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6064973|NCT00673790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6064974|NCT00673790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6064975|NCT00673790|Adrenergic Agents|adrenergic agents|mesh-ancestor
6064976|NCT00673790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6064977|NCT00673816|Sunitinib|sunitinib|mesh-list
6064978|NCT00673816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6064979|NCT00673816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6064980|NCT00673816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6064981|NCT00673816|Growth Substances|growth substances|mesh-ancestor
6064982|NCT00673816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6064983|NCT00673816|Growth Inhibitors|growth inhibitors|mesh-ancestor
6064984|NCT00673816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6064985|NCT00673816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6064986|NCT00673816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6064987|NCT00673855|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6064988|NCT00673855|Lubricant Eye Drops|lubricant eye drops|mesh-list
6064989|NCT00673855|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6064990|NCT00673881|Choline|choline|mesh-list
6064991|NCT00673881|Fenofibrate|fenofibrate|mesh-list
6064992|NCT00673881|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6064993|NCT00673881|Antimetabolites|antimetabolites|mesh-ancestor
5507653|NCT04422431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5507654|NCT04422431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5507655|NCT04422431|Growth Substances|growth substances|mesh-ancestor
5507656|NCT04422431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507657|NCT04422431|Growth Inhibitors|growth inhibitors|mesh-ancestor
5507658|NCT04422431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5507659|NCT04422197|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5507660|NCT04422197|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5507661|NCT04422197|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5507662|NCT04422197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5507663|NCT04422197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507664|NCT04422197|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6064994|NCT00673881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462925|NCT00461825|Antimetabolites|antimetabolites|mesh-ancestor
6462926|NCT00461825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6488402|NCT00583986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6488403|NCT00583986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507665|NCT04422197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5507666|NCT04422197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507667|NCT04422197|Cholinergic Agents|cholinergic agents|mesh-ancestor
5507668|NCT04422197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5507669|NCT04422392|Paclitaxel|paclitaxel|mesh-list
5507670|NCT04422392|Carboplatin|carboplatin|mesh-list
5507671|NCT04422392|Pemetrexed|pemetrexed|mesh-list
5507672|NCT04422392|Antibodies|antibodies|mesh-list
5507673|NCT04422392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5507674|NCT04422392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5507675|NCT04422392|Tubulin Modulators|tubulin modulators|mesh-ancestor
5507676|NCT04422392|Antimitotic Agents|antimitotic agents|mesh-ancestor
5507677|NCT04422392|Mitosis Modulators|mitosis modulators|mesh-ancestor
5507678|NCT04422392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507679|NCT04422392|Immunologic Factors|immunologic factors|mesh-ancestor
5507680|NCT04422392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507681|NCT04422392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5507682|NCT04422392|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5507683|NCT04422392|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5507684|NCT04422028|Desogestrel|desogestrel|mesh-list
6462927|NCT00461890|Naltrexone|naltrexone|mesh-list
6462928|NCT00461890|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6462929|NCT00461890|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6462930|NCT00461890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462931|NCT00461890|Sensory System Agents|sensory system agents|mesh-ancestor
6462932|NCT00461890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6462933|NCT00461903|Perindopril|perindopril|mesh-list
6462934|NCT00461903|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6064995|NCT00673881|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6064996|NCT00673881|Lipotropic Agents|lipotropic agents|mesh-ancestor
6064997|NCT00673881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6064998|NCT00673881|Nootropic Agents|nootropic agents|mesh-ancestor
6064999|NCT00673894|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6065000|NCT00673894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6065001|NCT00673894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507685|NCT04422028|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5507686|NCT04422028|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5507687|NCT04422028|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5507688|NCT04422028|Contraceptive Agents|contraceptive agents|mesh-ancestor
5507689|NCT04422028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6065002|NCT00673894|Incretins|incretins|mesh-ancestor
6065003|NCT00673894|Hormones|hormones|mesh-ancestor
6065004|NCT00673894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6065005|NCT00673894|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6065006|NCT00673894|Protease Inhibitors|protease inhibitors|mesh-ancestor
6065007|NCT00673894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6065008|NCT00673894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065009|NCT00673920|Methotrexate|methotrexate|mesh-list
6065010|NCT00673920|Ocrelizumab|ocrelizumab|mesh-list
6065011|NCT00673920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6065012|NCT00673920|Abortifacient Agents|abortifacient agents|mesh-ancestor
6065013|NCT00673920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6065014|NCT00673920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065015|NCT00673920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6065016|NCT00673920|Antimetabolites|antimetabolites|mesh-ancestor
6065017|NCT00673920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065018|NCT00673920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6065019|NCT00673920|Dermatologic Agents|dermatologic agents|mesh-ancestor
6065020|NCT00673920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6065021|NCT00673920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6065022|NCT00673920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6065023|NCT00673920|Immunologic Factors|immunologic factors|mesh-ancestor
6065024|NCT00673920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6065025|NCT00673920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6065026|NCT00673933|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6065027|NCT00673933|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
6065028|NCT00673933|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6065029|NCT00673933|Dermatologic Agents|dermatologic agents|mesh-ancestor
6065030|NCT00673959|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6065031|NCT00673959|Lubricant Eye Drops|lubricant eye drops|mesh-list
6065032|NCT00673959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6065033|NCT00674115|Omeprazole|omeprazole|mesh-list
6462935|NCT00461903|Protease Inhibitors|protease inhibitors|mesh-ancestor
5507690|NCT04422028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507691|NCT04422028|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6065034|NCT00674115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6065035|NCT00674115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6065036|NCT00674115|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6065037|NCT00674115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6462936|NCT00461903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6462937|NCT00461903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462938|NCT00461903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6462939|NCT00461916|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6462940|NCT00461916|Buserelin|buserelin|mesh-list
6065038|NCT00674115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065039|NCT00674154|Vitamin D|vitamin d|mesh-list
6065040|NCT00674154|Cholecalciferol|cholecalciferol|mesh-list
6065041|NCT00674154|Vitamins|vitamins|mesh-ancestor
6065042|NCT00674154|Micronutrients|micronutrients|mesh-ancestor
6065043|NCT00674154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065044|NCT00674154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6065045|NCT00674154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6065046|NCT00674206|Gemcitabine|gemcitabine|mesh-list
6065047|NCT00674206|Oxaliplatin|oxaliplatin|mesh-list
6065048|NCT00674206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6065049|NCT00674206|Antimetabolites|antimetabolites|mesh-ancestor
6065050|NCT00674206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065051|NCT00674206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6065052|NCT00674206|Antiviral Agents|antiviral agents|mesh-ancestor
6065053|NCT00674206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6065054|NCT00674206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6065055|NCT00674206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6065056|NCT00674206|Immunologic Factors|immunologic factors|mesh-ancestor
5507692|NCT04422028|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5507693|NCT04422028|Progestins|progestins|mesh-ancestor
5507694|NCT04422028|Hormones|hormones|mesh-ancestor
5600236|NCT03713372|Cetuximab|cetuximab|mesh-list
6665300|NCT01516580|Vincristine|vincristine|mesh-list
6665301|NCT01516580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6665302|NCT01516580|Immunologic Factors|immunologic factors|mesh-ancestor
6665303|NCT01516580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665304|NCT01516580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6665305|NCT01516580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6665306|NCT01516580|Alkylating Agents|alkylating agents|mesh-ancestor
6065057|NCT00674206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065058|NCT00674219|Memantine|memantine|mesh-list
6065059|NCT00674219|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6065060|NCT00674219|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6065061|NCT00674219|Dopamine Agents|dopamine agents|mesh-ancestor
6065062|NCT00674219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6065063|NCT00674219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065064|NCT00674219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065065|NCT00674219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6065066|NCT00674219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6065067|NCT00674323|Ranibizumab|ranibizumab|mesh-list
6065068|NCT00674323|Verteporfin|verteporfin|mesh-list
6065069|NCT00674323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6065070|NCT00674323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6065071|NCT00674323|Growth Substances|growth substances|mesh-ancestor
6065072|NCT00674323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065073|NCT00674323|Growth Inhibitors|growth inhibitors|mesh-ancestor
6065074|NCT00674323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6065075|NCT00674323|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6065076|NCT00674323|Dermatologic Agents|dermatologic agents|mesh-ancestor
6065077|NCT00674362|Certolizumab Pegol|certolizumab pegol|mesh-list
6065078|NCT00674362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6065079|NCT00674362|Immunologic Factors|immunologic factors|mesh-ancestor
6065080|NCT00674362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065081|NCT00674362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6065082|NCT00674570|Cycloserine|cycloserine|mesh-list
6065083|NCT00674570|Hydrocortisone|hydrocortisone|mesh-list
6065084|NCT00674570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6065085|NCT00674570|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6065086|NCT00674570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6462941|NCT00461916|Luteolytic Agents|luteolytic agents|mesh-ancestor
6462942|NCT00461916|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6462943|NCT00461916|Contraceptive Agents|contraceptive agents|mesh-ancestor
6462944|NCT00461916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6462945|NCT00461916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462946|NCT00461916|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6672633|NCT01557335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6065087|NCT00674570|Renal Agents|renal agents|mesh-ancestor
6065088|NCT00674570|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6065089|NCT00674570|Antitubercular Agents|antitubercular agents|mesh-ancestor
6065090|NCT00674570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6065091|NCT00674570|Antimetabolites|antimetabolites|mesh-ancestor
6065092|NCT00674570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065093|NCT00674583|Vaccines|vaccines|mesh-list
6065094|NCT00674583|Immunologic Factors|immunologic factors|mesh-ancestor
6065095|NCT00674583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065096|NCT00674609|Nabiximols|nabiximols|mesh-list
6065097|NCT00674609|Analgesics|analgesics|mesh-ancestor
6065098|NCT00674609|Sensory System Agents|sensory system agents|mesh-ancestor
6065099|NCT00674609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6065100|NCT00674609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065101|NCT00674661|Riboflavin|riboflavin|mesh-list
6065102|NCT00674661|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6065103|NCT00674661|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6065104|NCT00674661|Vitamin B Complex|vitamin b complex|mesh-ancestor
6065105|NCT00674661|Vitamins|vitamins|mesh-ancestor
6065106|NCT00674661|Micronutrients|micronutrients|mesh-ancestor
6065107|NCT00674661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065108|NCT00674661|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6065109|NCT00674661|Dermatologic Agents|dermatologic agents|mesh-ancestor
6065110|NCT00674700|Immunologic Factors|immunologic factors|mesh-list
6065111|NCT00674700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065112|NCT00674739|Imiquimod|imiquimod|mesh-list
6065113|NCT00674739|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6065114|NCT00674739|Immunologic Factors|immunologic factors|mesh-ancestor
6065115|NCT00674739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065116|NCT00674739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6065117|NCT00674739|Interferon Inducers|interferon inducers|mesh-ancestor
6065118|NCT00674765|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6065119|NCT00674765|Antidepressive Agents|antidepressive agents|mesh-ancestor
6065120|NCT00674765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6065121|NCT00674765|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6065122|NCT00674765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6065123|NCT00674765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6065124|NCT00674765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065125|NCT00674973|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6065126|NCT00674973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6065127|NCT00674973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6065128|NCT00674973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6065129|NCT00674973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065130|NCT00675025|Donepezil|donepezil|mesh-list
6065131|NCT00675025|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6462947|NCT00461916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6462948|NCT00461916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6462949|NCT00461916|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6462950|NCT00461916|Fertility Agents|fertility agents|mesh-ancestor
6462951|NCT00461968|Simvastatin|simvastatin|mesh-list
6462952|NCT00461968|Ezetimibe|ezetimibe|mesh-list
6462953|NCT00461968|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6665307|NCT01516580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665308|NCT01516580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6665309|NCT01516580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6665310|NCT01516580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6665311|NCT01516580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6665312|NCT01516580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6665313|NCT01516580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6665314|NCT01516580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6665315|NCT01516580|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6665316|NCT01516580|Abortifacient Agents|abortifacient agents|mesh-ancestor
6665317|NCT01516580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6665318|NCT01516580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6665319|NCT01516580|Antimetabolites|antimetabolites|mesh-ancestor
6665320|NCT01516580|Dermatologic Agents|dermatologic agents|mesh-ancestor
6665321|NCT01516580|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6665322|NCT01516580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5507695|NCT04422028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5507696|NCT04422184|Potassium Citrate|potassium citrate|mesh-list
5507697|NCT04422184|Diuretics|diuretics|mesh-ancestor
5507698|NCT04422184|Natriuretic Agents|natriuretic agents|mesh-ancestor
5600237|NCT03713372|Antibodies|antibodies|mesh-list
6462954|NCT00461968|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6462955|NCT00461968|Antimetabolites|antimetabolites|mesh-ancestor
6665323|NCT01516580|Antiviral Agents|antiviral agents|mesh-ancestor
6462956|NCT00461968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462957|NCT00461968|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6462958|NCT00461968|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6462959|NCT00461968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6462960|NCT00462111|Indomethacin|indomethacin|mesh-list
6462961|NCT00462111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6462962|NCT00462111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6462963|NCT00462111|Analgesics|analgesics|mesh-ancestor
6665324|NCT01516580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6065132|NCT00675025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6065133|NCT00675025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065134|NCT00675025|Cholinergic Agents|cholinergic agents|mesh-ancestor
6065135|NCT00675025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6065136|NCT00675025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065137|NCT00675025|Nootropic Agents|nootropic agents|mesh-ancestor
6065138|NCT00675259|Paclitaxel|paclitaxel|mesh-list
6065139|NCT00675259|Bevacizumab|bevacizumab|mesh-list
6065140|NCT00675259|Carboplatin|carboplatin|mesh-list
6065141|NCT00675259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6065142|NCT00675259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6065143|NCT00675259|Tubulin Modulators|tubulin modulators|mesh-ancestor
5507699|NCT04422184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507700|NCT04422184|Expectorants|expectorants|mesh-ancestor
5507701|NCT04422184|Respiratory System Agents|respiratory system agents|mesh-ancestor
5507702|NCT04421664|Hydroxychloroquine|hydroxychloroquine|mesh-list
5507703|NCT04421664|Antimalarials|antimalarials|mesh-ancestor
5507704|NCT04421664|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5507705|NCT04421664|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5507706|NCT04421664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5507707|NCT04421664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5507708|NCT04421664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507709|NCT04421664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5507710|NCT04421560|Rituximab|rituximab|mesh-list
6065144|NCT00675259|Antimitotic Agents|antimitotic agents|mesh-ancestor
6065145|NCT00675259|Mitosis Modulators|mitosis modulators|mesh-ancestor
6065146|NCT00675259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065147|NCT00675259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6065148|NCT00675259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6065149|NCT00675259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6065150|NCT00675259|Growth Substances|growth substances|mesh-ancestor
6065151|NCT00675259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065152|NCT00675259|Growth Inhibitors|growth inhibitors|mesh-ancestor
6065153|NCT00675428|Natalizumab|natalizumab|mesh-list
6065154|NCT00675428|Immunologic Factors|immunologic factors|mesh-ancestor
6065155|NCT00675428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065156|NCT00675441|Lenalidomide|lenalidomide|mesh-list
6065157|NCT00675441|Immunologic Factors|immunologic factors|mesh-ancestor
6065158|NCT00675441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665325|NCT01516580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6665326|NCT01516580|Tubulin Modulators|tubulin modulators|mesh-ancestor
6665327|NCT01516580|Antimitotic Agents|antimitotic agents|mesh-ancestor
6665328|NCT01516580|Mitosis Modulators|mitosis modulators|mesh-ancestor
6665329|NCT01516593|Cytarabine|cytarabine|mesh-list
6665330|NCT01516593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6665331|NCT01516593|Antimetabolites|antimetabolites|mesh-ancestor
6665332|NCT01516593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665333|NCT01516593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6665334|NCT01516593|Antiviral Agents|antiviral agents|mesh-ancestor
6065159|NCT00675441|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5507711|NCT04421560|Pembrolizumab|pembrolizumab|mesh-list
5507712|NCT04421560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5507713|NCT04421560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5507714|NCT04421560|Immunologic Factors|immunologic factors|mesh-ancestor
5507715|NCT04421560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507716|NCT04421560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5507717|NCT04421872|Anesthetics|anesthetics|mesh-list
6202303|NCT02039427|Ketorolac|ketorolac|mesh-list
6065160|NCT00675441|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6065161|NCT00675441|Growth Substances|growth substances|mesh-ancestor
6065162|NCT00675441|Growth Inhibitors|growth inhibitors|mesh-ancestor
6065163|NCT00675441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6065164|NCT00675506|Hormones|hormones|mesh-list
6065165|NCT00675506|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
6065166|NCT00675506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6065167|NCT00675506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065168|NCT00675584|Budesonide|budesonide|mesh-list
6065169|NCT00675584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6065170|NCT00675584|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6065171|NCT00675584|Autonomic Agents|autonomic agents|mesh-ancestor
6065172|NCT00675584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6065173|NCT00675584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065174|NCT00675584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6065175|NCT00675584|Respiratory System Agents|respiratory system agents|mesh-ancestor
6065176|NCT00675584|Glucocorticoids|glucocorticoids|mesh-ancestor
6065177|NCT00675584|Hormones|hormones|mesh-ancestor
6065178|NCT00675584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6065179|NCT00675597|Bevacizumab|bevacizumab|mesh-list
6065180|NCT00675597|Docetaxel|docetaxel|mesh-list
6065181|NCT00675597|Vinorelbine|vinorelbine|mesh-list
6065182|NCT00675597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6462964|NCT00462111|Sensory System Agents|sensory system agents|mesh-ancestor
6462965|NCT00462111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6462966|NCT00462111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462967|NCT00462111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6462968|NCT00462111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6462969|NCT00462111|Gout Suppressants|gout suppressants|mesh-ancestor
6462970|NCT00462111|Tocolytic Agents|tocolytic agents|mesh-ancestor
6462971|NCT00462111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6462972|NCT00462111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6462973|NCT00462111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6462974|NCT00462111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462975|NCT00462189|Immunotoxin HA22|immunotoxin ha22|mesh-list
6462976|NCT00462189|Immunotoxins|immunotoxins|mesh-list
6462977|NCT00462189|Immunologic Factors|immunologic factors|mesh-ancestor
6462978|NCT00462189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462979|NCT00462189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6462980|NCT00462215|Vaccines|vaccines|mesh-list
6462981|NCT00462215|Immunologic Factors|immunologic factors|mesh-ancestor
6462982|NCT00462215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462983|NCT00462358|Filanesib|filanesib|mesh-list
5507718|NCT04421872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5507719|NCT04421872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507720|NCT04421716|Ursolic acid|ursolic acid|mesh-list
5507721|NCT04421716|Curcumin|curcumin|mesh-list
5507722|NCT04421716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5507723|NCT04421716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5507724|NCT04421716|Analgesics|analgesics|mesh-ancestor
5507725|NCT04421716|Sensory System Agents|sensory system agents|mesh-ancestor
5507726|NCT04421716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5507727|NCT04421716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507728|NCT04421716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6065183|NCT00675597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6065184|NCT00675597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6065185|NCT00675597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6065186|NCT00675597|Growth Substances|growth substances|mesh-ancestor
6065187|NCT00675597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065188|NCT00675597|Growth Inhibitors|growth inhibitors|mesh-ancestor
6065189|NCT00675597|Tubulin Modulators|tubulin modulators|mesh-ancestor
6065190|NCT00675597|Antimitotic Agents|antimitotic agents|mesh-ancestor
6065191|NCT00675597|Mitosis Modulators|mitosis modulators|mesh-ancestor
6065192|NCT00675597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065193|NCT00675597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6065194|NCT00675792|Bromides|bromides|mesh-list
6065195|NCT00675792|Rocuronium|rocuronium|mesh-list
6065196|NCT00675792|Neostigmine|neostigmine|mesh-list
6065197|NCT00675792|Anticonvulsants|anticonvulsants|mesh-ancestor
6065198|NCT00675792|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6065199|NCT00675792|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6065200|NCT00675792|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6065201|NCT00675792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6065202|NCT00675792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462984|NCT00462358|Lenograstim|lenograstim|mesh-list
6065203|NCT00675792|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6065204|NCT00675792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6065205|NCT00675792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065206|NCT00675792|Cholinergic Agents|cholinergic agents|mesh-ancestor
6065207|NCT00675792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6065208|NCT00675792|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6065209|NCT00675792|Autonomic Agents|autonomic agents|mesh-ancestor
6065210|NCT00675909|Midazolam|midazolam|mesh-list
6065211|NCT00675909|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6065212|NCT00675909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6065213|NCT00675909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5507729|NCT04421716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5507730|NCT04421716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5507731|NCT04421716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5507732|NCT04421716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507733|NCT04421716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5507734|NCT04421716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5507735|NCT04421716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5507736|NCT04421911|Diclofenac|diclofenac|mesh-list
6065214|NCT00675909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065215|NCT00675909|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6065216|NCT00675909|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6065217|NCT00675909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6065218|NCT00675909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6065219|NCT00675909|Anesthetics, General|anesthetics, general|mesh-ancestor
6065220|NCT00675909|Anesthetics|anesthetics|mesh-ancestor
6065221|NCT00675909|GABA Modulators|gaba modulators|mesh-ancestor
6065222|NCT00675909|GABA Agents|gaba agents|mesh-ancestor
6065223|NCT00675909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6065224|NCT00675909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065225|NCT00675922|Silver Nitrate|silver nitrate|mesh-list
6065226|NCT00675922|Mafenide|mafenide|mesh-list
6065227|NCT00675922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6065228|NCT00675922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6065229|NCT00675922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6065230|NCT00675922|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6065231|NCT00675922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6065232|NCT00675922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065233|NCT00675948|Nabiximols|nabiximols|mesh-list
6065234|NCT00675948|Analgesics|analgesics|mesh-ancestor
6065235|NCT00675948|Sensory System Agents|sensory system agents|mesh-ancestor
6065236|NCT00675948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6065237|NCT00675948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065238|NCT00675987|Losartan|losartan|mesh-list
6065239|NCT00675987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6065240|NCT00675987|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6065241|NCT00675987|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6065242|NCT00675987|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6065243|NCT00675987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065244|NCT00676091|Vaccines|vaccines|mesh-list
6065245|NCT00676091|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6065246|NCT00676091|Immunologic Factors|immunologic factors|mesh-ancestor
6065247|NCT00676091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065248|NCT00676130|Trimethoprim|trimethoprim|mesh-list
6065249|NCT00676130|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6065250|NCT00676130|Sulfamethoxazole|sulfamethoxazole|mesh-list
6065251|NCT00676130|Cephalexin|cephalexin|mesh-list
6065252|NCT00676130|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6462985|NCT00462358|Sargramostim|sargramostim|mesh-list
6462986|NCT00462358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6462987|NCT00462358|Immunologic Factors|immunologic factors|mesh-ancestor
6462988|NCT00462358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462989|NCT00462358|Antimitotic Agents|antimitotic agents|mesh-ancestor
6462990|NCT00462358|Mitosis Modulators|mitosis modulators|mesh-ancestor
6462991|NCT00462358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6462992|NCT00462358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5507737|NCT04421911|Ketoprofen|ketoprofen|mesh-list
5507738|NCT04421911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5507739|NCT04421911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5507740|NCT04421911|Analgesics|analgesics|mesh-ancestor
5507741|NCT04421911|Sensory System Agents|sensory system agents|mesh-ancestor
5507742|NCT04421911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5507743|NCT04421911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507744|NCT04421911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6462993|NCT00462371|Insulin|insulin|mesh-list
6462994|NCT00462371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6462995|NCT00462371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6462996|NCT00462397|Paclitaxel|paclitaxel|mesh-list
6462997|NCT00462397|Carboplatin|carboplatin|mesh-list
6462998|NCT00462397|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6462999|NCT00462397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6463000|NCT00462397|Tubulin Modulators|tubulin modulators|mesh-ancestor
6463001|NCT00462397|Antimitotic Agents|antimitotic agents|mesh-ancestor
6463002|NCT00462397|Mitosis Modulators|mitosis modulators|mesh-ancestor
6463003|NCT00462397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463004|NCT00462475|Hormones|hormones|mesh-list
6463005|NCT00462475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6463006|NCT00462475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463007|NCT00462540|Bromides|bromides|mesh-list
6463008|NCT00462540|Albuterol|albuterol|mesh-list
6463009|NCT00462540|Formoterol Fumarate|formoterol fumarate|mesh-list
6463010|NCT00462540|Ipratropium|ipratropium|mesh-list
6065253|NCT00676130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6065254|NCT00676130|Renal Agents|renal agents|mesh-ancestor
6065255|NCT00676130|Antimalarials|antimalarials|mesh-ancestor
6065256|NCT00676130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6065257|NCT00676130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6065258|NCT00676130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6065259|NCT00676130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6065260|NCT00676130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065261|NCT00676130|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6065262|NCT00676130|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6065263|NCT00676130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6065264|NCT00676130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6065265|NCT00676195|Acetylcysteine|acetylcysteine|mesh-list
6065266|NCT00676195|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6065267|NCT00676195|Antiviral Agents|antiviral agents|mesh-ancestor
6065268|NCT00676195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6065269|NCT00676195|Expectorants|expectorants|mesh-ancestor
6065270|NCT00676195|Respiratory System Agents|respiratory system agents|mesh-ancestor
6065271|NCT00676195|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6065272|NCT00676195|Antioxidants|antioxidants|mesh-ancestor
6065273|NCT00676195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065274|NCT00676195|Protective Agents|protective agents|mesh-ancestor
6065275|NCT00676195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065276|NCT00676195|Antidotes|antidotes|mesh-ancestor
6065277|NCT00676338|Metformin|metformin|mesh-list
6065278|NCT00676338|Pioglitazone|pioglitazone|mesh-list
6065279|NCT00676338|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6065280|NCT00676338|Exenatide|exenatide|mesh-list
6065281|NCT00676338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6065282|NCT00676338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065283|NCT00676338|Incretins|incretins|mesh-ancestor
6065284|NCT00676338|Hormones|hormones|mesh-ancestor
6065285|NCT00676338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6065286|NCT00676338|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6065287|NCT00676338|Protease Inhibitors|protease inhibitors|mesh-ancestor
6065288|NCT00676338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6065289|NCT00676338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065290|NCT00676338|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6065291|NCT00676364|Lidocaine|lidocaine|mesh-list
6065292|NCT00676364|Anesthetics, Local|anesthetics, local|mesh-list
6065293|NCT00676364|Anesthetics|anesthetics|mesh-list
6065294|NCT00676364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6065295|NCT00676364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065296|NCT00676364|Sensory System Agents|sensory system agents|mesh-ancestor
6065297|NCT00676364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6065298|NCT00676364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6065299|NCT00676364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6065300|NCT00676364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6065301|NCT00676364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6065302|NCT00676364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065303|NCT00676403|Pregabalin|pregabalin|mesh-list
6065304|NCT00676403|Analgesics|analgesics|mesh-ancestor
6065305|NCT00676403|Sensory System Agents|sensory system agents|mesh-ancestor
6065306|NCT00676403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6065307|NCT00676403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065308|NCT00676403|Anticonvulsants|anticonvulsants|mesh-ancestor
6065309|NCT00676403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6463011|NCT00462540|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6463012|NCT00462540|Autonomic Agents|autonomic agents|mesh-ancestor
6463013|NCT00462540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6463014|NCT00462540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463015|NCT00462540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5507745|NCT04421911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6463016|NCT00462540|Respiratory System Agents|respiratory system agents|mesh-ancestor
6463017|NCT00462540|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6463018|NCT00462540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6463019|NCT00462540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6463020|NCT00462540|Adrenergic Agents|adrenergic agents|mesh-ancestor
6463021|NCT00462540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6463022|NCT00462540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463023|NCT00462540|Anticonvulsants|anticonvulsants|mesh-ancestor
6065310|NCT00676403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6065311|NCT00676403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065312|NCT00676403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6065313|NCT00676403|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6065314|NCT00676403|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6065315|NCT00676403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6065316|NCT00676403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6065317|NCT00676520|Everolimus|everolimus|mesh-list
6065318|NCT00676520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6065319|NCT00676520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6065320|NCT00676520|Immunologic Factors|immunologic factors|mesh-ancestor
6065321|NCT00676520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065322|NCT00676585|Hydrocortisone|hydrocortisone|mesh-list
6065323|NCT00676585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6065324|NCT00676650|Prednisone|prednisone|mesh-list
6065325|NCT00676650|Sunitinib|sunitinib|mesh-list
6065326|NCT00676650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6065327|NCT00676650|Glucocorticoids|glucocorticoids|mesh-ancestor
6065328|NCT00676650|Hormones|hormones|mesh-ancestor
6065329|NCT00676650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6065330|NCT00676650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065331|NCT00676650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6065332|NCT00676650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6065333|NCT00676650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6065334|NCT00676650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6065335|NCT00676650|Growth Substances|growth substances|mesh-ancestor
6065336|NCT00676650|Growth Inhibitors|growth inhibitors|mesh-ancestor
6065337|NCT00676650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6065338|NCT00676650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6065339|NCT00676650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065340|NCT00676663|Exemestane|exemestane|mesh-list
6065341|NCT00676663|Entinostat|entinostat|mesh-list
6065342|NCT00676663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6065343|NCT00676663|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6065344|NCT00676663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6065345|NCT00676663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6065346|NCT00676663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065347|NCT00676663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6065348|NCT00676663|Hormone Antagonists|hormone antagonists|mesh-ancestor
6065349|NCT00676663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6065350|NCT00676663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065351|NCT00676663|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6065352|NCT00676676|Testosterone|testosterone|mesh-list
6065353|NCT00676676|Androgens|androgens|mesh-ancestor
6065354|NCT00676676|Hormones|hormones|mesh-ancestor
6065355|NCT00676676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6065356|NCT00676676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065357|NCT00676806|Cyclophosphamide|cyclophosphamide|mesh-list
6065358|NCT00676806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6065359|NCT00676806|Immunologic Factors|immunologic factors|mesh-ancestor
6065360|NCT00676806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065361|NCT00676806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6065362|NCT00676806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6065363|NCT00676806|Alkylating Agents|alkylating agents|mesh-ancestor
6065364|NCT00676806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463024|NCT00462540|Tocolytic Agents|tocolytic agents|mesh-ancestor
6065365|NCT00676806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6065366|NCT00676806|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6065367|NCT00676897|Simvastatin|simvastatin|mesh-list
6065368|NCT00676897|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6065369|NCT00676897|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6065370|NCT00676897|Antimetabolites|antimetabolites|mesh-ancestor
6065371|NCT00676897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507746|NCT04421911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5507747|NCT04421911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5507748|NCT04421911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507749|NCT04421742|Beclomethasone|beclomethasone|mesh-list
5507750|NCT04421742|Formoterol Fumarate|formoterol fumarate|mesh-list
5507751|NCT04421742|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5507752|NCT04421742|Autonomic Agents|autonomic agents|mesh-ancestor
5507753|NCT04421742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6065372|NCT00676897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6065373|NCT00676897|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5507754|NCT04421742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507755|NCT04421742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5507756|NCT04421742|Respiratory System Agents|respiratory system agents|mesh-ancestor
5507757|NCT04421742|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5507758|NCT04421742|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5507759|NCT04421742|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5507760|NCT04421742|Adrenergic Agents|adrenergic agents|mesh-ancestor
5507761|NCT04421742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5507762|NCT04421742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507763|NCT04421742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5507764|NCT04421742|Glucocorticoids|glucocorticoids|mesh-ancestor
5507765|NCT04421742|Hormones|hormones|mesh-ancestor
5507766|NCT04421742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5507767|NCT04421677|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
5507768|NCT04421677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5507769|NCT04421547|Letrozole|letrozole|mesh-list
5507770|NCT04421547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5507771|NCT04421547|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5507772|NCT04421547|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5507773|NCT04421547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5507774|NCT04421547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507775|NCT04421547|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5507776|NCT04421547|Hormone Antagonists|hormone antagonists|mesh-ancestor
5507777|NCT04421547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5507778|NCT04421547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507779|NCT04421339|Melatonin|melatonin|mesh-list
5507780|NCT04421339|Antioxidants|antioxidants|mesh-ancestor
5507781|NCT04421339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065374|NCT00676897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6065375|NCT00677092|Imatinib Mesylate|imatinib mesylate|mesh-list
6065376|NCT00677092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5507782|NCT04421339|Protective Agents|protective agents|mesh-ancestor
5507783|NCT04421339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507784|NCT04421339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5507785|NCT04421534|Lactoferrin|lactoferrin|mesh-list
6065377|NCT00677092|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6065378|NCT00677092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6065379|NCT00677092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065380|NCT00677352|Sertraline|sertraline|mesh-list
6065381|NCT00677352|Paroxetine|paroxetine|mesh-list
6065382|NCT00677352|Antidepressive Agents|antidepressive agents|mesh-ancestor
6065383|NCT00677352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6065384|NCT00677352|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6065385|NCT00677352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6065386|NCT00677352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6065387|NCT00677352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065388|NCT00677352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6065389|NCT00677352|Serotonin Agents|serotonin agents|mesh-ancestor
6065390|NCT00677352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065391|NCT00677352|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6065392|NCT00677352|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6065393|NCT00677352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6065394|NCT00677352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6065395|NCT00677365|Levofloxacin|levofloxacin|mesh-list
6065396|NCT00677365|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6065397|NCT00677365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6065398|NCT00677365|Renal Agents|renal agents|mesh-ancestor
6065399|NCT00677365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6065400|NCT00677365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6065401|NCT00677365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6065402|NCT00677365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6065403|NCT00677365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065404|NCT00677365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6065405|NCT00677365|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6065406|NCT00677365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6065407|NCT00677534|Vitamin D|vitamin d|mesh-list
6065408|NCT00677534|Cholecalciferol|cholecalciferol|mesh-list
6065409|NCT00677534|Ergocalciferols|ergocalciferols|mesh-list
6065410|NCT00677534|Vitamins|vitamins|mesh-ancestor
5507786|NCT04421534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5507787|NCT04421300|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5507788|NCT04421300|Hyaluronic Acid|hyaluronic acid|mesh-list
5507789|NCT04421300|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5507790|NCT04421300|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5507791|NCT04421300|Immunologic Factors|immunologic factors|mesh-ancestor
5507792|NCT04421300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507793|NCT04421300|Viscosupplements|viscosupplements|mesh-ancestor
5507794|NCT04421300|Protective Agents|protective agents|mesh-ancestor
5507795|NCT04421209|Propranolol|propranolol|mesh-list
6065411|NCT00677534|Micronutrients|micronutrients|mesh-ancestor
6065412|NCT00677534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065413|NCT00677534|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6065414|NCT00677534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6065415|NCT00677833|Azithromycin|azithromycin|mesh-list
6065416|NCT00677833|Chloroquine|chloroquine|mesh-list
6065417|NCT00677833|Lumefantrine|lumefantrine|mesh-list
6065418|NCT00677833|Artemether|artemether|mesh-list
6065419|NCT00677833|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6065420|NCT00677833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6065421|NCT00677833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6065422|NCT00677833|Amebicides|amebicides|mesh-ancestor
6065423|NCT00677833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6065424|NCT00677833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6065425|NCT00677833|Antimalarials|antimalarials|mesh-ancestor
6065426|NCT00677833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6065427|NCT00677924|Zalutumumab|zalutumumab|mesh-list
6065428|NCT00677924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6065429|NCT00677924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6065430|NCT00678015|Masoprocol|masoprocol|mesh-list
6065431|NCT00678015|Antioxidants|antioxidants|mesh-ancestor
6065432|NCT00678015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065433|NCT00678015|Protective Agents|protective agents|mesh-ancestor
6065434|NCT00678015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065435|NCT00678015|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6065436|NCT00678015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6065437|NCT00678015|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6065438|NCT00678015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6065439|NCT00678015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6065440|NCT00678015|Analgesics|analgesics|mesh-ancestor
6065441|NCT00678015|Sensory System Agents|sensory system agents|mesh-ancestor
6065442|NCT00678015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6065443|NCT00678015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6065444|NCT00678015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6065445|NCT00678080|Metformin|metformin|mesh-list
6065446|NCT00678080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6065447|NCT00678080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065448|NCT00678210|Tofacitinib|tofacitinib|mesh-list
5507796|NCT04421209|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5507797|NCT04421209|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5507798|NCT04421209|Adrenergic Agents|adrenergic agents|mesh-ancestor
5507799|NCT04421209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6065449|NCT00678210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6065450|NCT00678210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5507800|NCT04421209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507801|NCT04421209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507802|NCT04421209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5507803|NCT04421209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5507804|NCT04421209|Vasodilator Agents|vasodilator agents|mesh-ancestor
5507805|NCT04421079|Resveratrol|resveratrol|mesh-list
5507806|NCT04421079|Antioxidants|antioxidants|mesh-ancestor
5507807|NCT04421079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507808|NCT04421079|Protective Agents|protective agents|mesh-ancestor
5507809|NCT04421079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507810|NCT04421079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5507811|NCT04421079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5600238|NCT03713372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5600239|NCT03713372|Immunologic Factors|immunologic factors|mesh-ancestor
5600240|NCT03713372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600241|NCT03713372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6065451|NCT00678210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065452|NCT00678301|Vaccines|vaccines|mesh-list
6065453|NCT00678301|Immunologic Factors|immunologic factors|mesh-ancestor
6065454|NCT00678301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065455|NCT00678379|Lidocaine|lidocaine|mesh-list
6065456|NCT00678379|Clonidine|clonidine|mesh-list
6065457|NCT00678379|Bupivacaine|bupivacaine|mesh-list
6065458|NCT00678379|Anesthetics, Local|anesthetics, local|mesh-ancestor
6065459|NCT00678379|Anesthetics|anesthetics|mesh-ancestor
6065460|NCT00678379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6065461|NCT00678379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065462|NCT00678379|Sensory System Agents|sensory system agents|mesh-ancestor
6065463|NCT00678379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6065464|NCT00678379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6065465|NCT00678379|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6065466|NCT00678379|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6065467|NCT00678379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6065468|NCT00678379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065469|NCT00678379|Analgesics|analgesics|mesh-ancestor
6065470|NCT00678379|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6065471|NCT00678379|Sympatholytics|sympatholytics|mesh-ancestor
6065472|NCT00678379|Autonomic Agents|autonomic agents|mesh-ancestor
6065473|NCT00678379|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6065474|NCT00678379|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6065475|NCT00678379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6065476|NCT00678379|Adrenergic Agents|adrenergic agents|mesh-ancestor
6065477|NCT00678379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6065478|NCT00678392|Sorafenib|sorafenib|mesh-list
6065479|NCT00678392|Axitinib|axitinib|mesh-list
6065480|NCT00678392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6065481|NCT00678392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6065482|NCT00678392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6065483|NCT00678392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065484|NCT00678418|Naltrexone|naltrexone|mesh-list
6065485|NCT00678418|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6065486|NCT00678418|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6065487|NCT00678418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065488|NCT00678418|Sensory System Agents|sensory system agents|mesh-ancestor
6065489|NCT00678418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6202304|NCT02039427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6202305|NCT02039427|Antiemetics|antiemetics|mesh-ancestor
6202306|NCT02039427|Autonomic Agents|autonomic agents|mesh-ancestor
6202307|NCT02039427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6202308|NCT02039427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202309|NCT02039427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6202310|NCT02039427|Glucocorticoids|glucocorticoids|mesh-ancestor
6202311|NCT02039427|Hormones|hormones|mesh-ancestor
6202312|NCT02039427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6202313|NCT02039427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6202314|NCT02039427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6202315|NCT02039427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6202316|NCT02039427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6202317|NCT02039427|Analgesics|analgesics|mesh-ancestor
6202318|NCT02039427|Sensory System Agents|sensory system agents|mesh-ancestor
6202319|NCT02039427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6202320|NCT02039427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6202321|NCT02039427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6202322|NCT02039427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065490|NCT00678470|Alefacept|alefacept|mesh-list
6065491|NCT00678470|Dermatologic Agents|dermatologic agents|mesh-ancestor
6065492|NCT00678470|Immunologic Factors|immunologic factors|mesh-ancestor
6065493|NCT00678470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065494|NCT00678535|Capecitabine|capecitabine|mesh-list
6065495|NCT00678535|Cetuximab|cetuximab|mesh-list
6065496|NCT00678535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6065497|NCT00678535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6065498|NCT00678535|Antimetabolites|antimetabolites|mesh-ancestor
5507812|NCT04421105|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
5507813|NCT04421105|Hallucinogens|hallucinogens|mesh-ancestor
5507814|NCT04421105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507815|NCT04421105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5507816|NCT04421105|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5507817|NCT04421105|Serotonin Agents|serotonin agents|mesh-ancestor
5507818|NCT04421105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5507819|NCT04421105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507820|NCT04421105|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5507821|NCT04420884|Pembrolizumab|pembrolizumab|mesh-list
5507822|NCT04420884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5507823|NCT04420884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6065499|NCT00678535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065500|NCT00678535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6065501|NCT00678561|Tofacitinib|tofacitinib|mesh-list
6065502|NCT00678561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6065503|NCT00678561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6065504|NCT00678561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065505|NCT00678652|Vaccines|vaccines|mesh-list
6065506|NCT00678652|Immunologic Factors|immunologic factors|mesh-ancestor
6065507|NCT00678652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065508|NCT00678691|Modafinil|modafinil|mesh-list
6065509|NCT00678691|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6065510|NCT00678691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065511|NCT00678691|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6065512|NCT00678691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6065513|NCT00678691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5507824|NCT04420975|Nivolumab|nivolumab|mesh-list
5507825|NCT04420975|Immunologic Factors|immunologic factors|mesh-list
5507826|NCT04420975|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
5507827|NCT04420975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5507828|NCT04420975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5507829|NCT04420975|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5507830|NCT04420975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507831|NCT04420975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507832|NCT04420598|Trastuzumab|trastuzumab|mesh-list
5507833|NCT04420598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5507834|NCT04420598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5507835|NCT04420936|Benzocaine|benzocaine|mesh-list
5507836|NCT04420936|Anesthetics, Local|anesthetics, local|mesh-ancestor
5507837|NCT04420936|Anesthetics|anesthetics|mesh-ancestor
5507838|NCT04420936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5507839|NCT04420936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507840|NCT04420936|Sensory System Agents|sensory system agents|mesh-ancestor
5507841|NCT04420936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5507842|NCT04420871|Capecitabine|capecitabine|mesh-list
5507843|NCT04420871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5507844|NCT04420871|Antimetabolites|antimetabolites|mesh-ancestor
6065514|NCT00678691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065515|NCT00678795|Nabiximols|nabiximols|mesh-list
6065516|NCT00678795|Analgesics|analgesics|mesh-ancestor
6065517|NCT00678795|Sensory System Agents|sensory system agents|mesh-ancestor
6065518|NCT00678795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6065519|NCT00678795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065520|NCT00678834|Tocopherols|tocopherols|mesh-list
6065521|NCT00678834|Vitamin E|vitamin e|mesh-list
6065522|NCT00678834|Tocotrienols|tocotrienols|mesh-list
6065523|NCT00678834|alpha-Tocopherol|alpha-tocopherol|mesh-list
6065524|NCT00678834|Antioxidants|antioxidants|mesh-ancestor
6065525|NCT00678834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065526|NCT00678834|Protective Agents|protective agents|mesh-ancestor
6065527|NCT00678834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065528|NCT00678834|Vitamins|vitamins|mesh-ancestor
6065529|NCT00678834|Micronutrients|micronutrients|mesh-ancestor
6065530|NCT00678886|Muromonab-CD3|muromonab-cd3|mesh-list
5507845|NCT04420871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507846|NCT04420871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5507847|NCT04420585|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
5507848|NCT04420585|Hemostatics|hemostatics|mesh-ancestor
5507849|NCT04420585|Coagulants|coagulants|mesh-ancestor
5507850|NCT04420585|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5507851|NCT04420585|Natriuretic Agents|natriuretic agents|mesh-ancestor
5507852|NCT04420585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507853|NCT04420260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
5507854|NCT04420260|Immunologic Factors|immunologic factors|mesh-ancestor
5507855|NCT04420260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507856|NCT04420533|Mirabegron|mirabegron|mesh-list
5507857|NCT04420533|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6065531|NCT00678886|Immunologic Factors|immunologic factors|mesh-ancestor
6065532|NCT00678886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065533|NCT00678886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6065534|NCT00679029|Gemcitabine|gemcitabine|mesh-list
6065535|NCT00679029|Cyclophosphamide|cyclophosphamide|mesh-list
6065536|NCT00679029|Bevacizumab|bevacizumab|mesh-list
6065537|NCT00679029|Doxorubicin|doxorubicin|mesh-list
6065538|NCT00679029|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6065539|NCT00679029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6065540|NCT00679029|Antibodies|antibodies|mesh-list
6065541|NCT00679029|Immunoglobulins|immunoglobulins|mesh-list
6065542|NCT00679029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6065543|NCT00679029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6065544|NCT00679029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065545|NCT00679029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6065546|NCT00679029|Immunologic Factors|immunologic factors|mesh-ancestor
6065547|NCT00679029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065548|NCT00679029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6065549|NCT00679029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6065550|NCT00679029|Alkylating Agents|alkylating agents|mesh-ancestor
6065551|NCT00679029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6065552|NCT00679029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6065553|NCT00679029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6065554|NCT00679029|Growth Substances|growth substances|mesh-ancestor
6065555|NCT00679029|Growth Inhibitors|growth inhibitors|mesh-ancestor
6065556|NCT00679029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6065557|NCT00679029|Antimetabolites|antimetabolites|mesh-ancestor
6065558|NCT00679029|Antiviral Agents|antiviral agents|mesh-ancestor
6065559|NCT00679029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6065560|NCT00679029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6065561|NCT00679029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6065562|NCT00679029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6065563|NCT00679029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6065564|NCT00679042|Exenatide|exenatide|mesh-list
6065565|NCT00679042|Sirolimus|sirolimus|mesh-list
6065566|NCT00679042|Etanercept|etanercept|mesh-list
6065567|NCT00679042|Tacrolimus|tacrolimus|mesh-list
6065568|NCT00679042|Basiliximab|basiliximab|mesh-list
6065569|NCT00679042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6065570|NCT00679042|Immunologic Factors|immunologic factors|mesh-ancestor
6065571|NCT00679042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065572|NCT00679042|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6065573|NCT00679042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6065574|NCT00679042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065575|NCT00679042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6065576|NCT00679042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6065577|NCT00679042|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6065578|NCT00679042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6065579|NCT00679042|Antifungal Agents|antifungal agents|mesh-ancestor
6065580|NCT00679042|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6065581|NCT00679042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6065582|NCT00679042|Analgesics|analgesics|mesh-ancestor
6065583|NCT00679042|Sensory System Agents|sensory system agents|mesh-ancestor
6065584|NCT00679042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6065585|NCT00679042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6065586|NCT00679042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6065587|NCT00679042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6065588|NCT00679042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6065589|NCT00679042|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6065590|NCT00679042|Incretins|incretins|mesh-ancestor
5507858|NCT04420533|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6065591|NCT00679042|Hormones|hormones|mesh-ancestor
6065592|NCT00679042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6065593|NCT00679211|Trastuzumab|trastuzumab|mesh-list
6065594|NCT00679211|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
6065595|NCT00679211|Maytansine|maytansine|mesh-list
6065596|NCT00679211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6065597|NCT00679211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6065598|NCT00679211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6065599|NCT00679211|Tubulin Modulators|tubulin modulators|mesh-ancestor
6065600|NCT00679211|Antimitotic Agents|antimitotic agents|mesh-ancestor
6065601|NCT00679211|Mitosis Modulators|mitosis modulators|mesh-ancestor
6065602|NCT00679211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065603|NCT00679289|Interferons|interferons|mesh-list
6065604|NCT00679289|Ecromeximab|ecromeximab|mesh-list
6065605|NCT00679289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6065606|NCT00679289|Antiviral Agents|antiviral agents|mesh-ancestor
6065607|NCT00679289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6065608|NCT00679289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6065609|NCT00679302|Trimethoprim|trimethoprim|mesh-list
6065610|NCT00679302|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6065611|NCT00679302|Sulfamethoxazole|sulfamethoxazole|mesh-list
6065612|NCT00679302|Simethicone|simethicone|mesh-list
6065613|NCT00679302|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6065614|NCT00679302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6065615|NCT00679302|Renal Agents|renal agents|mesh-ancestor
6065616|NCT00679302|Antimalarials|antimalarials|mesh-ancestor
6065617|NCT00679302|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6065618|NCT00679302|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6065619|NCT00679302|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6065620|NCT00679302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6065621|NCT00679302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065622|NCT00679302|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6065623|NCT00679302|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6065624|NCT00679302|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6065625|NCT00679302|Antifoaming Agents|antifoaming agents|mesh-ancestor
6065626|NCT00679302|Emollients|emollients|mesh-ancestor
6065627|NCT00679302|Dermatologic Agents|dermatologic agents|mesh-ancestor
6065628|NCT00679302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6065629|NCT00679341|Docetaxel|docetaxel|mesh-list
6065630|NCT00679341|Trastuzumab|trastuzumab|mesh-list
6065631|NCT00679341|Maytansine|maytansine|mesh-list
6065632|NCT00679341|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
6065633|NCT00679341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6065634|NCT00679341|Tubulin Modulators|tubulin modulators|mesh-ancestor
6065635|NCT00679341|Antimitotic Agents|antimitotic agents|mesh-ancestor
6065636|NCT00679341|Mitosis Modulators|mitosis modulators|mesh-ancestor
6065637|NCT00679341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065638|NCT00679341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6065639|NCT00679341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6065640|NCT00679367|Dexamethasone|dexamethasone|mesh-list
6065641|NCT00679367|Lenalidomide|lenalidomide|mesh-list
6065642|NCT00679367|Melphalan|melphalan|mesh-list
6065643|NCT00679367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6065644|NCT00679367|Antiemetics|antiemetics|mesh-ancestor
6065645|NCT00679367|Autonomic Agents|autonomic agents|mesh-ancestor
6065646|NCT00679367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6065647|NCT00679367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065648|NCT00679367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6065649|NCT00679367|Glucocorticoids|glucocorticoids|mesh-ancestor
6065650|NCT00679367|Hormones|hormones|mesh-ancestor
6065651|NCT00679367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6065652|NCT00679367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6065653|NCT00679367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6065654|NCT00679367|Immunologic Factors|immunologic factors|mesh-ancestor
6065655|NCT00679367|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6065656|NCT00679367|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6065657|NCT00679367|Growth Substances|growth substances|mesh-ancestor
6065658|NCT00679367|Growth Inhibitors|growth inhibitors|mesh-ancestor
6065659|NCT00679367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6065660|NCT00679367|Alkylating Agents|alkylating agents|mesh-ancestor
6065661|NCT00679367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065662|NCT00679367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6065663|NCT00679367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6065664|NCT00679380|Budesonide|budesonide|mesh-list
6065665|NCT00679380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6065666|NCT00679380|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6065667|NCT00679380|Autonomic Agents|autonomic agents|mesh-ancestor
6065668|NCT00679380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6065669|NCT00679380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507859|NCT04420533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6065670|NCT00679380|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6065671|NCT00679380|Respiratory System Agents|respiratory system agents|mesh-ancestor
6065672|NCT00679380|Glucocorticoids|glucocorticoids|mesh-ancestor
6065673|NCT00679380|Hormones|hormones|mesh-ancestor
6065674|NCT00679380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6065675|NCT00679432|Budesonide|budesonide|mesh-list
6065676|NCT00679432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6065677|NCT00679432|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6463025|NCT00462540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5507860|NCT04420533|Adrenergic Agents|adrenergic agents|mesh-ancestor
6065678|NCT00679432|Autonomic Agents|autonomic agents|mesh-ancestor
6065679|NCT00679432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6065680|NCT00679432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065681|NCT00679432|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6065682|NCT00679432|Respiratory System Agents|respiratory system agents|mesh-ancestor
6065683|NCT00679432|Glucocorticoids|glucocorticoids|mesh-ancestor
5507861|NCT04420533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5507862|NCT04420533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507863|NCT04420533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507864|NCT04420533|Urological Agents|urological agents|mesh-ancestor
5507865|NCT04419948|Ibuprofen|ibuprofen|mesh-list
5507866|NCT04419948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5507867|NCT04419948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5507868|NCT04419948|Analgesics|analgesics|mesh-ancestor
5507869|NCT04419948|Sensory System Agents|sensory system agents|mesh-ancestor
5507870|NCT04419948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6065684|NCT00679432|Hormones|hormones|mesh-ancestor
6065685|NCT00679432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6065686|NCT00679627|Galantamine|galantamine|mesh-list
6065687|NCT00679627|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6065688|NCT00679627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6065689|NCT00679627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065690|NCT00679627|Cholinergic Agents|cholinergic agents|mesh-ancestor
6065691|NCT00679627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6065692|NCT00679627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065693|NCT00679627|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6065694|NCT00679627|Autonomic Agents|autonomic agents|mesh-ancestor
5507871|NCT04419948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507872|NCT04419948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5507873|NCT04419948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5507874|NCT04419948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5507875|NCT04419948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5507876|NCT04419948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507877|NCT04420299|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5507878|NCT04420299|Bemiparin|bemiparin|mesh-list
5507879|NCT04420299|Anticoagulants|anticoagulants|mesh-ancestor
5507880|NCT04420299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5507881|NCT04420299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5507882|NCT04420299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507883|NCT04420195|Tacrolimus|tacrolimus|mesh-list
5507884|NCT04420195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5507885|NCT04420195|Immunologic Factors|immunologic factors|mesh-ancestor
5507886|NCT04420195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507887|NCT04420195|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5507888|NCT04420195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5507889|NCT04420195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507890|NCT04420351|Aspirin|aspirin|mesh-list
5507891|NCT04420351|Clopidogrel|clopidogrel|mesh-list
5507892|NCT04420351|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5507893|NCT04420351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5507894|NCT04420351|Analgesics|analgesics|mesh-ancestor
5507895|NCT04420351|Sensory System Agents|sensory system agents|mesh-ancestor
5507896|NCT04420351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6065695|NCT00679627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6065696|NCT00679627|Nootropic Agents|nootropic agents|mesh-ancestor
6065697|NCT00679783|Olaparib|olaparib|mesh-list
6065698|NCT00679783|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6065699|NCT00679783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6065700|NCT00679783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065701|NCT00679783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6065702|NCT00679939|Metformin|metformin|mesh-list
6065703|NCT00679939|Rosiglitazone|rosiglitazone|mesh-list
6065704|NCT00679939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6463026|NCT00462540|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6065705|NCT00679939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065706|NCT00680017|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6065707|NCT00680017|Fenofibric acid|fenofibric acid|mesh-list
6065708|NCT00680017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6065709|NCT00680017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6065710|NCT00680017|Antimetabolites|antimetabolites|mesh-ancestor
6065711|NCT00680017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065712|NCT00680017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6065713|NCT00680017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6065714|NCT00680017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6065715|NCT00680043|Epoetin Alfa|epoetin alfa|mesh-list
6065716|NCT00680043|Hematinics|hematinics|mesh-ancestor
6065717|NCT00680056|Formoterol Fumarate|formoterol fumarate|mesh-list
6065718|NCT00680056|Tiotropium Bromide|tiotropium bromide|mesh-list
6065719|NCT00680056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6065720|NCT00680056|Autonomic Agents|autonomic agents|mesh-ancestor
6065721|NCT00680056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6065722|NCT00680056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065723|NCT00680056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6065724|NCT00680056|Respiratory System Agents|respiratory system agents|mesh-ancestor
6065725|NCT00680056|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6065726|NCT00680056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6065727|NCT00680056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6065728|NCT00680056|Adrenergic Agents|adrenergic agents|mesh-ancestor
6065729|NCT00680056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6065730|NCT00680056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065731|NCT00680056|Parasympatholytics|parasympatholytics|mesh-ancestor
6065732|NCT00680056|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6065733|NCT00680056|Cholinergic Agents|cholinergic agents|mesh-ancestor
6065734|NCT00680121|Benphothiamine|benphothiamine|mesh-list
6065735|NCT00680121|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6065736|NCT00680121|Immunologic Factors|immunologic factors|mesh-ancestor
6065737|NCT00680121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065738|NCT00680121|Chelating Agents|chelating agents|mesh-ancestor
6065739|NCT00680121|Sequestering Agents|sequestering agents|mesh-ancestor
6065740|NCT00680121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065741|NCT00680186|Warfarin|warfarin|mesh-list
6065742|NCT00680186|Dabigatran|dabigatran|mesh-list
6065743|NCT00680186|Anticoagulants|anticoagulants|mesh-ancestor
6065744|NCT00680186|Antithrombins|antithrombins|mesh-ancestor
6065745|NCT00680186|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6065746|NCT00680186|Protease Inhibitors|protease inhibitors|mesh-ancestor
6065747|NCT00680186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6065748|NCT00680186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065749|NCT00680225|Ranibizumab|ranibizumab|mesh-list
6065750|NCT00680225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6065751|NCT00680225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6065752|NCT00680225|Growth Substances|growth substances|mesh-ancestor
6065753|NCT00680225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065754|NCT00680225|Growth Inhibitors|growth inhibitors|mesh-ancestor
6065755|NCT00680225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6065756|NCT00680407|Silymarin|silymarin|mesh-list
6065757|NCT00680407|Antioxidants|antioxidants|mesh-ancestor
6065758|NCT00680407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065759|NCT00680407|Protective Agents|protective agents|mesh-ancestor
6065760|NCT00680407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065761|NCT00680459|Ethanol|ethanol|mesh-list
6065762|NCT00680459|Heparin|heparin|mesh-list
6065763|NCT00680459|Anticoagulants|anticoagulants|mesh-list
6065764|NCT00680459|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6065765|NCT00680459|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6065766|NCT00680459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065767|NCT00680459|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6065768|NCT00680459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6065769|NCT00680459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6065770|NCT00680459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065771|NCT00680628|Enoxaparin|enoxaparin|mesh-list
6065772|NCT00680628|Tenecteplase|tenecteplase|mesh-list
6065773|NCT00680628|Enoxaparin sodium|enoxaparin sodium|mesh-list
5507897|NCT04420351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507898|NCT04420351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5507899|NCT04420351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5507900|NCT04420351|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5507901|NCT04420351|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5507902|NCT04420351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065774|NCT00680628|Anticoagulants|anticoagulants|mesh-ancestor
6065775|NCT00680628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6065776|NCT00680628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6065777|NCT00680628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065778|NCT00680706|Thiamine|thiamine|mesh-list
6065779|NCT00680706|Vitamins|vitamins|mesh-ancestor
6065780|NCT00680706|Micronutrients|micronutrients|mesh-ancestor
6065781|NCT00680706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507903|NCT04420351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5507904|NCT04420351|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5507905|NCT04420351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5507906|NCT04420351|Antipyretics|antipyretics|mesh-ancestor
5507907|NCT04420351|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5507908|NCT04420351|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5507909|NCT04420351|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5507910|NCT04420351|Purinergic Agents|purinergic agents|mesh-ancestor
5507911|NCT04420351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5507912|NCT04420247|Hydroxychloroquine|hydroxychloroquine|mesh-list
5507913|NCT04420247|Chloroquine|chloroquine|mesh-list
5507914|NCT04420247|Antimalarials|antimalarials|mesh-ancestor
5507915|NCT04420247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5507916|NCT04420247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5507917|NCT04420247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5507918|NCT04420247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6065782|NCT00680706|Vitamin B Complex|vitamin b complex|mesh-ancestor
6065783|NCT00680745|Metformin|metformin|mesh-list
6065784|NCT00680745|Pioglitazone|pioglitazone|mesh-list
6065785|NCT00680745|Dapagliflozin|dapagliflozin|mesh-list
6065786|NCT00680745|Glimepiride|glimepiride|mesh-list
6065787|NCT00680745|Rosiglitazone|rosiglitazone|mesh-list
6065788|NCT00680745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6065789|NCT00680745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065790|NCT00680745|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6065791|NCT00680745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065792|NCT00680745|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6065793|NCT00680745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6065794|NCT00680745|Immunologic Factors|immunologic factors|mesh-ancestor
6065795|NCT00680797|Testosterone|testosterone|mesh-list
6065796|NCT00680797|Estrogens|estrogens|mesh-list
6065797|NCT00680797|Androgens|androgens|mesh-ancestor
6065798|NCT00680797|Hormones|hormones|mesh-ancestor
6065799|NCT00680797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6065800|NCT00680797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065801|NCT00680823|Ropivacaine|ropivacaine|mesh-list
6065802|NCT00680823|Anesthetics, Local|anesthetics, local|mesh-ancestor
6065803|NCT00680823|Anesthetics|anesthetics|mesh-ancestor
6065804|NCT00680823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6065805|NCT00680823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065806|NCT00680823|Sensory System Agents|sensory system agents|mesh-ancestor
6065807|NCT00680823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6065808|NCT00680836|Rifaximin|rifaximin|mesh-list
6065809|NCT00680836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6065810|NCT00680836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6065811|NCT00680836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6065812|NCT00680901|Capecitabine|capecitabine|mesh-list
6065813|NCT00680901|Oxaliplatin|oxaliplatin|mesh-list
6065814|NCT00680901|Lapatinib|lapatinib|mesh-list
6065815|NCT00680901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6065816|NCT00680901|Antimetabolites|antimetabolites|mesh-ancestor
6065817|NCT00680901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065818|NCT00680901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6065819|NCT00680901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6065820|NCT00680901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6065821|NCT00680914|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6065822|NCT00680914|Immunologic Factors|immunologic factors|mesh-ancestor
6065823|NCT00680914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065824|NCT00680953|Denosumab|denosumab|mesh-list
6065825|NCT00680953|Alendronate|alendronate|mesh-list
6065826|NCT00680953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6065827|NCT00680953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065828|NCT00680992|Denosumab|denosumab|mesh-list
6065829|NCT00680992|Immunoglobulins|immunoglobulins|mesh-list
6065830|NCT00680992|Immunoglobulin G|immunoglobulin g|mesh-list
6065831|NCT00680992|Immunologic Factors|immunologic factors|mesh-ancestor
6065832|NCT00680992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065833|NCT00680992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6065834|NCT00681109|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5507919|NCT04420247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507920|NCT04420247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5507921|NCT04420247|Amebicides|amebicides|mesh-ancestor
5507922|NCT04419662|Phenylephrine|phenylephrine|mesh-list
5507923|NCT04419662|Oxymetazoline|oxymetazoline|mesh-list
6065835|NCT00681109|Lubricant Eye Drops|lubricant eye drops|mesh-list
6065836|NCT00681109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6065837|NCT00681109|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6065838|NCT00681109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6065839|NCT00681187|Lanreotide|lanreotide|mesh-list
6065840|NCT00681187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6065841|NCT00681265|Glycerol|glycerol|mesh-list
6065842|NCT00681265|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6065843|NCT00681265|Protective Agents|protective agents|mesh-ancestor
6065844|NCT00681265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065845|NCT00681538|Nabiximols|nabiximols|mesh-list
6065846|NCT00681538|Analgesics|analgesics|mesh-ancestor
6065847|NCT00681538|Sensory System Agents|sensory system agents|mesh-ancestor
6065848|NCT00681538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6065849|NCT00681538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065850|NCT00681590|Vitamin D|vitamin d|mesh-list
6065851|NCT00681590|Ergocalciferols|ergocalciferols|mesh-list
6065852|NCT00681590|Cholecalciferol|cholecalciferol|mesh-list
6065853|NCT00681590|Vitamins|vitamins|mesh-list
6065854|NCT00681590|Micronutrients|micronutrients|mesh-ancestor
6065855|NCT00681590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065856|NCT00681590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6065857|NCT00681590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6065858|NCT00681668|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6065859|NCT00681668|Antidepressive Agents|antidepressive agents|mesh-ancestor
6065860|NCT00681668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6065861|NCT00681668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6065862|NCT00681668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6065863|NCT00681668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6065864|NCT00681668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065865|NCT00681824|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6065866|NCT00681824|Thrombin|thrombin|mesh-list
6065867|NCT00681824|Aprotinin|aprotinin|mesh-list
6065868|NCT00681824|Hemostatics|hemostatics|mesh-ancestor
6065869|NCT00681824|Coagulants|coagulants|mesh-ancestor
6065870|NCT00681824|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6065871|NCT00681824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6065872|NCT00681824|Protease Inhibitors|protease inhibitors|mesh-ancestor
6065873|NCT00681824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6065874|NCT00681824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065875|NCT00681863|Pramipexole|pramipexole|mesh-list
6065876|NCT00681863|Antioxidants|antioxidants|mesh-ancestor
6065877|NCT00681863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065878|NCT00681863|Protective Agents|protective agents|mesh-ancestor
6065879|NCT00681863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065880|NCT00681863|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6065881|NCT00681863|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6065882|NCT00681863|Dopamine Agonists|dopamine agonists|mesh-ancestor
6065883|NCT00681863|Dopamine Agents|dopamine agents|mesh-ancestor
6065884|NCT00681863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6065885|NCT00681889|Ranibizumab|ranibizumab|mesh-list
6065886|NCT00681889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6065887|NCT00681889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6065888|NCT00681889|Growth Substances|growth substances|mesh-ancestor
6065889|NCT00681889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065890|NCT00681889|Growth Inhibitors|growth inhibitors|mesh-ancestor
6065891|NCT00681889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6065892|NCT00682357|Methylprednisolone|methylprednisolone|mesh-list
6065893|NCT00682357|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6065894|NCT00682357|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6065895|NCT00682357|Prednisolone|prednisolone|mesh-list
6065896|NCT00682357|Prednisolone acetate|prednisolone acetate|mesh-list
6065897|NCT00682357|Lidocaine|lidocaine|mesh-list
6065898|NCT00682357|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6065899|NCT00682357|Prednisolone phosphate|prednisolone phosphate|mesh-list
6065900|NCT00682357|Anesthetics, Local|anesthetics, local|mesh-ancestor
5507924|NCT04419662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6065901|NCT00682357|Anesthetics|anesthetics|mesh-ancestor
6065902|NCT00682357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6065903|NCT00682357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065904|NCT00682357|Sensory System Agents|sensory system agents|mesh-ancestor
6065905|NCT00682357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6065906|NCT00682357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6065907|NCT00682357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6065908|NCT00682357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6065909|NCT00682357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6065910|NCT00682357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065911|NCT00682357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6065912|NCT00682357|Antiemetics|antiemetics|mesh-ancestor
6065913|NCT00682357|Autonomic Agents|autonomic agents|mesh-ancestor
6065914|NCT00682357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6065915|NCT00682357|Glucocorticoids|glucocorticoids|mesh-ancestor
6065916|NCT00682357|Hormones|hormones|mesh-ancestor
6065917|NCT00682357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6065918|NCT00682357|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6065919|NCT00682357|Protective Agents|protective agents|mesh-ancestor
6065920|NCT00682357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6065921|NCT00682357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6065922|NCT00682435|Hydromorphone|hydromorphone|mesh-list
6065923|NCT00682435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6065924|NCT00682435|Narcotics|narcotics|mesh-ancestor
6065925|NCT00682435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6065926|NCT00682435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065927|NCT00682435|Analgesics|analgesics|mesh-ancestor
6065928|NCT00682435|Sensory System Agents|sensory system agents|mesh-ancestor
6065929|NCT00682435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6065930|NCT00682448|Metformin|metformin|mesh-list
6065931|NCT00682448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6065932|NCT00682448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065933|NCT00682461|Nicotine|nicotine|mesh-list
6065934|NCT00682461|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6065935|NCT00682461|Autonomic Agents|autonomic agents|mesh-ancestor
6065936|NCT00682461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6065937|NCT00682461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065938|NCT00682461|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6065939|NCT00682461|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6065940|NCT00682461|Cholinergic Agents|cholinergic agents|mesh-ancestor
6065941|NCT00682461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5507925|NCT04419662|Mydriatics|mydriatics|mesh-ancestor
5507926|NCT04419662|Autonomic Agents|autonomic agents|mesh-ancestor
5507927|NCT04419662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6065942|NCT00682461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065943|NCT00682539|Triamcinolone|triamcinolone|mesh-list
5507928|NCT04419662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507929|NCT04419662|Sympathomimetics|sympathomimetics|mesh-ancestor
6065944|NCT00682539|Bevacizumab|bevacizumab|mesh-list
6065945|NCT00682539|Ranibizumab|ranibizumab|mesh-list
6065946|NCT00682539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6065947|NCT00682539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6065948|NCT00682539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6065949|NCT00682539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6065950|NCT00682539|Growth Substances|growth substances|mesh-ancestor
6065951|NCT00682539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065952|NCT00682539|Growth Inhibitors|growth inhibitors|mesh-ancestor
6065953|NCT00682539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6065954|NCT00682539|Glucocorticoids|glucocorticoids|mesh-ancestor
6065955|NCT00682539|Hormones|hormones|mesh-ancestor
6065956|NCT00682539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6065957|NCT00682643|Fluticasone|fluticasone|mesh-list
6065958|NCT00682643|Xhance|xhance|mesh-list
6065959|NCT00682643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6065960|NCT00682643|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6065961|NCT00682643|Autonomic Agents|autonomic agents|mesh-ancestor
6065962|NCT00682643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6065963|NCT00682643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065964|NCT00682643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6065965|NCT00682643|Respiratory System Agents|respiratory system agents|mesh-ancestor
6065966|NCT00682643|Dermatologic Agents|dermatologic agents|mesh-ancestor
6065967|NCT00682643|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6065968|NCT00682734|Diphenhydramine|diphenhydramine|mesh-list
6065969|NCT00682734|Promethazine|promethazine|mesh-list
6065970|NCT00682734|Metoclopramide|metoclopramide|mesh-list
6065971|NCT00682734|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6065972|NCT00682734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6065973|NCT00682734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6065974|NCT00682734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6065975|NCT00682734|Anesthetics, Local|anesthetics, local|mesh-ancestor
6065976|NCT00682734|Anesthetics|anesthetics|mesh-ancestor
6065977|NCT00682734|Sensory System Agents|sensory system agents|mesh-ancestor
5507930|NCT04419662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5507931|NCT04419662|Nasal Decongestants|nasal decongestants|mesh-ancestor
5507932|NCT04419662|Respiratory System Agents|respiratory system agents|mesh-ancestor
5507933|NCT04419662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5507934|NCT04419662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5507935|NCT04419662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5507936|NCT04419662|Adrenergic Agents|adrenergic agents|mesh-ancestor
5507937|NCT04419662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5507938|NCT04419662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507939|NCT04419662|Protective Agents|protective agents|mesh-ancestor
5507940|NCT04419493|Heparin|heparin|mesh-list
5507941|NCT04419493|Calcium heparin|calcium heparin|mesh-list
5507942|NCT04419493|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5507943|NCT04419493|Anticoagulants|anticoagulants|mesh-ancestor
5507944|NCT04419493|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5507945|NCT04419493|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5507946|NCT04419493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463027|NCT00462540|Cholinergic Agents|cholinergic agents|mesh-ancestor
6463028|NCT00462553|Gemcitabine|gemcitabine|mesh-list
6463029|NCT00462553|Sunitinib|sunitinib|mesh-list
6463030|NCT00462553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6463031|NCT00462553|Antimetabolites|antimetabolites|mesh-ancestor
6463032|NCT00462553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463033|NCT00462553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6463034|NCT00462553|Antiviral Agents|antiviral agents|mesh-ancestor
6463035|NCT00462553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6463036|NCT00462553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6463037|NCT00462553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6463038|NCT00462553|Immunologic Factors|immunologic factors|mesh-ancestor
6463039|NCT00462553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463040|NCT00462553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6463041|NCT00462553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6463042|NCT00462553|Growth Substances|growth substances|mesh-ancestor
6463043|NCT00462553|Growth Inhibitors|growth inhibitors|mesh-ancestor
6463044|NCT00462553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6463045|NCT00462592|Budesonide|budesonide|mesh-list
6463046|NCT00462592|Montelukast|montelukast|mesh-list
6463047|NCT00462592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6463048|NCT00462592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6463049|NCT00462592|Autonomic Agents|autonomic agents|mesh-ancestor
5507947|NCT04419441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5507948|NCT04419441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507949|NCT04419441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5507950|NCT04419181|Carboplatin|carboplatin|mesh-list
5507951|NCT04419181|Docetaxel|docetaxel|mesh-list
5507952|NCT04419181|Trastuzumab|trastuzumab|mesh-list
6463050|NCT00462592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6463051|NCT00462592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463052|NCT00462592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6463053|NCT00462592|Respiratory System Agents|respiratory system agents|mesh-ancestor
6463054|NCT00462592|Glucocorticoids|glucocorticoids|mesh-ancestor
6463055|NCT00462592|Hormones|hormones|mesh-ancestor
6463056|NCT00462592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5507953|NCT04419181|Pertuzumab|pertuzumab|mesh-list
6463057|NCT00462592|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5507954|NCT04419181|Maytansine|maytansine|mesh-list
6463058|NCT00462592|Hormone Antagonists|hormone antagonists|mesh-ancestor
6463059|NCT00462592|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6463060|NCT00462592|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6065978|NCT00682734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6065979|NCT00682734|Antiemetics|antiemetics|mesh-ancestor
6065980|NCT00682734|Autonomic Agents|autonomic agents|mesh-ancestor
6065981|NCT00682734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6065982|NCT00682734|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6065983|NCT00682734|Histamine Antagonists|histamine antagonists|mesh-ancestor
5507955|NCT04419181|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
5507956|NCT04419181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5507957|NCT04419181|Tubulin Modulators|tubulin modulators|mesh-ancestor
5507958|NCT04419181|Antimitotic Agents|antimitotic agents|mesh-ancestor
5507959|NCT04419181|Mitosis Modulators|mitosis modulators|mesh-ancestor
5507960|NCT04419181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507961|NCT04419181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6065984|NCT00682734|Histamine Agents|histamine agents|mesh-ancestor
6065985|NCT00682734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6065986|NCT00682734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065987|NCT00682734|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6065988|NCT00682734|Antipruritics|antipruritics|mesh-ancestor
6065989|NCT00682734|Dermatologic Agents|dermatologic agents|mesh-ancestor
6065990|NCT00682734|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6065991|NCT00682734|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6065992|NCT00682734|Dopamine Agents|dopamine agents|mesh-ancestor
6065993|NCT00682786|Fluorouracil|fluorouracil|mesh-list
6065994|NCT00682786|Irinotecan|irinotecan|mesh-list
6065995|NCT00682786|Antimetabolites|antimetabolites|mesh-ancestor
6065996|NCT00682786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6065997|NCT00682786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5507962|NCT04419181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5507963|NCT04419259|Erenumab|erenumab|mesh-list
5507964|NCT04419259|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
5507965|NCT04419259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507966|NCT04419259|Analgesics|analgesics|mesh-ancestor
5507967|NCT04419259|Sensory System Agents|sensory system agents|mesh-ancestor
5507968|NCT04419259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5507969|NCT04419259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507970|NCT04419389|Rituximab|rituximab|mesh-list
5507971|NCT04419389|Venetoclax|venetoclax|mesh-list
5507972|NCT04419389|Acalabrutinib|acalabrutinib|mesh-list
5507973|NCT04419389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5507974|NCT04419389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5507975|NCT04419389|Immunologic Factors|immunologic factors|mesh-ancestor
6065998|NCT00682786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6065999|NCT00682786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6066000|NCT00682786|Immunologic Factors|immunologic factors|mesh-ancestor
6066001|NCT00682786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066002|NCT00682786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6066003|NCT00682786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6066004|NCT00682786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6066005|NCT00682890|Metformin|metformin|mesh-list
6066006|NCT00682890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6066007|NCT00682890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066008|NCT00682929|Dronabinol|dronabinol|mesh-list
6463061|NCT00462592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463062|NCT00462618|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6463063|NCT00462618|Antidepressive Agents|antidepressive agents|mesh-ancestor
6463064|NCT00462618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6463065|NCT00462618|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6463066|NCT00462618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5507976|NCT04419389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507977|NCT04419389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5600242|NCT03713372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5600243|NCT03713346|Caseins|caseins|mesh-list
5600244|NCT03713346|Chelating Agents|chelating agents|mesh-ancestor
5600245|NCT03713346|Sequestering Agents|sequestering agents|mesh-ancestor
5600246|NCT03713346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600247|NCT03713320|Vorinostat|vorinostat|mesh-list
5600248|NCT03713320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5600249|NCT03713320|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5600250|NCT03713320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5600251|NCT03713320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600252|NCT03713216|Morphine|morphine|mesh-list
6066009|NCT00682929|Hallucinogens|hallucinogens|mesh-ancestor
6463067|NCT00462618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6463068|NCT00462618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463069|NCT00462631|Paclitaxel|paclitaxel|mesh-list
6463070|NCT00462631|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6463071|NCT00462631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6463072|NCT00462631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6463073|NCT00462631|Tubulin Modulators|tubulin modulators|mesh-ancestor
6463074|NCT00462631|Antimitotic Agents|antimitotic agents|mesh-ancestor
6463075|NCT00462631|Mitosis Modulators|mitosis modulators|mesh-ancestor
6066010|NCT00682929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066011|NCT00682929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6066012|NCT00682929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6066013|NCT00682929|Analgesics|analgesics|mesh-ancestor
5507978|NCT04419246|Tranexamic Acid|tranexamic acid|mesh-list
5507979|NCT04419246|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5507980|NCT04419246|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5507981|NCT04419246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507982|NCT04419246|Hemostatics|hemostatics|mesh-ancestor
5507983|NCT04419246|Coagulants|coagulants|mesh-ancestor
5507984|NCT04419272|Methylphenidate|methylphenidate|mesh-list
5507985|NCT04419272|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6066014|NCT00682929|Sensory System Agents|sensory system agents|mesh-ancestor
6066015|NCT00682929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6066016|NCT00682929|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5507986|NCT04419272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5507987|NCT04419272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5507988|NCT04419272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5507989|NCT04419272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5507990|NCT04419272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507991|NCT04419272|Dopamine Agents|dopamine agents|mesh-ancestor
5507992|NCT04419272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5507993|NCT04419038|Mitomycins|mitomycins|mesh-list
5507994|NCT04419038|Mitomycin|mitomycin|mesh-list
5507995|NCT04419038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5507996|NCT04419038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5507997|NCT04419038|Alkylating Agents|alkylating agents|mesh-ancestor
5507998|NCT04419038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5507999|NCT04419038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5508000|NCT04419038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5508001|NCT04418999|Loteprednol Etabonate|loteprednol etabonate|mesh-list
5508002|NCT04418999|Dexamethasone|dexamethasone|mesh-list
5508003|NCT04418999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5508004|NCT04418999|Antiemetics|antiemetics|mesh-ancestor
5508005|NCT04418999|Autonomic Agents|autonomic agents|mesh-ancestor
5508006|NCT04418999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5508007|NCT04418999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508008|NCT04418999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5508009|NCT04418999|Glucocorticoids|glucocorticoids|mesh-ancestor
5508010|NCT04418999|Hormones|hormones|mesh-ancestor
5508011|NCT04418999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5508012|NCT04418999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5508013|NCT04418999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5508014|NCT04418999|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5508015|NCT04419025|Acetylcysteine|acetylcysteine|mesh-list
5508016|NCT04419025|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5508017|NCT04419025|Antiviral Agents|antiviral agents|mesh-ancestor
5508018|NCT04419025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5508019|NCT04419025|Expectorants|expectorants|mesh-ancestor
5508020|NCT04419025|Respiratory System Agents|respiratory system agents|mesh-ancestor
5508021|NCT04419025|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5508022|NCT04419025|Antioxidants|antioxidants|mesh-ancestor
5508023|NCT04419025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508024|NCT04419025|Protective Agents|protective agents|mesh-ancestor
6066017|NCT00682929|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6066018|NCT00682929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6066019|NCT00682929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066020|NCT00682929|Hormones|hormones|mesh-ancestor
6066021|NCT00682929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6463076|NCT00462631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508025|NCT04419025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508026|NCT04419025|Antidotes|antidotes|mesh-ancestor
5508027|NCT04418908|Cetrorelix|cetrorelix|mesh-list
5508028|NCT04418908|Estradiol|estradiol|mesh-list
5508029|NCT04418908|Estrogens|estrogens|mesh-ancestor
6066022|NCT00683046|Fludarabine|fludarabine|mesh-list
6066023|NCT00683046|Melphalan|melphalan|mesh-list
6066024|NCT00683046|Alemtuzumab|alemtuzumab|mesh-list
6066025|NCT00683046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6066026|NCT00683046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066027|NCT00683046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6066028|NCT00683046|Immunologic Factors|immunologic factors|mesh-ancestor
6066029|NCT00683046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066030|NCT00683046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6066031|NCT00683046|Alkylating Agents|alkylating agents|mesh-ancestor
6066032|NCT00683046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6066033|NCT00683046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6066034|NCT00683085|Vaccines|vaccines|mesh-list
6066035|NCT00683085|Immunologic Factors|immunologic factors|mesh-ancestor
6066036|NCT00683085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066037|NCT00683163|Ibandronic Acid|ibandronic acid|mesh-list
6066038|NCT00683163|Parathyroid Hormone|parathyroid hormone|mesh-list
6066039|NCT00683163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6066040|NCT00683163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066041|NCT00683163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6066042|NCT00683332|Tigecycline|tigecycline|mesh-list
6066043|NCT00683332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6066044|NCT00683332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6066045|NCT00683332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6066046|NCT00683332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5508030|NCT04418908|Hormones|hormones|mesh-ancestor
5508031|NCT04418908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6066047|NCT00683332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066048|NCT00683384|Etanercept|etanercept|mesh-list
6066049|NCT00683384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6066050|NCT00683384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6066051|NCT00683384|Analgesics|analgesics|mesh-ancestor
6066052|NCT00683384|Sensory System Agents|sensory system agents|mesh-ancestor
6066053|NCT00683384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6066054|NCT00683384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066055|NCT00683384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6066056|NCT00683384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6066057|NCT00683384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5508032|NCT04418908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508033|NCT04418908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5508034|NCT04418908|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5508035|NCT04418908|Fertility Agents|fertility agents|mesh-ancestor
5508036|NCT04418908|Hormone Antagonists|hormone antagonists|mesh-ancestor
5508037|NCT04418856|Methamphetamine|methamphetamine|mesh-list
5508038|NCT04418856|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5508039|NCT04418856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508040|NCT04418856|Sympathomimetics|sympathomimetics|mesh-ancestor
6066058|NCT00683384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6066059|NCT00683384|Immunologic Factors|immunologic factors|mesh-ancestor
6066060|NCT00683410|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6066061|NCT00683410|Immunologic Factors|immunologic factors|mesh-ancestor
6066062|NCT00683410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066063|NCT00683475|Prednisone|prednisone|mesh-list
6066064|NCT00683475|Mitoxantrone|mitoxantrone|mesh-list
6066065|NCT00683475|Ramucirumab|ramucirumab|mesh-list
6066066|NCT00683475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6066067|NCT00683475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6066068|NCT00683475|Glucocorticoids|glucocorticoids|mesh-ancestor
6066069|NCT00683475|Hormones|hormones|mesh-ancestor
5508041|NCT04418856|Autonomic Agents|autonomic agents|mesh-ancestor
5508042|NCT04418856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5508043|NCT04418856|Dopamine Agents|dopamine agents|mesh-ancestor
5508044|NCT04418856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5508045|NCT04418856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508046|NCT04418856|Adrenergic Agents|adrenergic agents|mesh-ancestor
5508047|NCT04418856|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5508048|NCT04418856|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5508049|NCT04418856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5508050|NCT04418856|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5508051|NCT04418557|Antibodies|antibodies|mesh-list
5508052|NCT04418557|Immunologic Factors|immunologic factors|mesh-ancestor
5508053|NCT04418557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508054|NCT04418674|Fentanyl|fentanyl|mesh-list
5508055|NCT04418674|Ketamine|ketamine|mesh-list
6066070|NCT00683475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6066071|NCT00683475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066072|NCT00683475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6066073|NCT00683475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6066074|NCT00683475|Analgesics|analgesics|mesh-ancestor
6066075|NCT00683475|Sensory System Agents|sensory system agents|mesh-ancestor
6066076|NCT00683475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6066077|NCT00683475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6066078|NCT00683475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6066079|NCT00683475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6066080|NCT00683475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066081|NCT00683475|Immunologic Factors|immunologic factors|mesh-ancestor
6066082|NCT00683592|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
6066083|NCT00683592|Antidepressive Agents|antidepressive agents|mesh-ancestor
6066084|NCT00683592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6066085|NCT00683592|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5508056|NCT04418674|Analgesics|analgesics|mesh-ancestor
5508057|NCT04418674|Sensory System Agents|sensory system agents|mesh-ancestor
5508058|NCT04418674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5508059|NCT04418674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508060|NCT04418674|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5508061|NCT04418674|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5508062|NCT04418674|Anesthetics, General|anesthetics, general|mesh-ancestor
5508063|NCT04418674|Anesthetics|anesthetics|mesh-ancestor
5508064|NCT04418674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5508065|NCT04418674|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5508066|NCT04418674|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5508067|NCT04418674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5508068|NCT04418674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508069|NCT04418674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5508070|NCT04418674|Narcotics|narcotics|mesh-ancestor
5508071|NCT04418674|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5508072|NCT04418531|Antibodies|antibodies|mesh-list
5508073|NCT04418531|Immunoglobulins|immunoglobulins|mesh-list
5508074|NCT04418531|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5508075|NCT04418531|Immunologic Factors|immunologic factors|mesh-ancestor
6066086|NCT00683592|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6066087|NCT00683592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6066088|NCT00683592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066089|NCT00683592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6066090|NCT00683592|Serotonin Agents|serotonin agents|mesh-ancestor
6066091|NCT00683592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066092|NCT00683592|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6066093|NCT00683592|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6066094|NCT00683618|Atorvastatin|atorvastatin|mesh-list
6066095|NCT00683618|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6066096|NCT00683618|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6066097|NCT00683618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6066098|NCT00683618|Antimetabolites|antimetabolites|mesh-ancestor
6066099|NCT00683618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066100|NCT00683618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6066101|NCT00683618|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6066102|NCT00683618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6066103|NCT00683644|Zinc|zinc|mesh-list
6066104|NCT00683644|Zinc Sulfate|zinc sulfate|mesh-list
6066105|NCT00683644|Trace Elements|trace elements|mesh-ancestor
6066106|NCT00683644|Micronutrients|micronutrients|mesh-ancestor
6066107|NCT00683644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066108|NCT00683644|Astringents|astringents|mesh-ancestor
6066109|NCT00683644|Dermatologic Agents|dermatologic agents|mesh-ancestor
6066110|NCT00683657|Saxagliptin|saxagliptin|mesh-list
6066111|NCT00683657|Incretins|incretins|mesh-ancestor
6066112|NCT00683657|Hormones|hormones|mesh-ancestor
5508076|NCT04418531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508077|NCT04418154|Paclitaxel|paclitaxel|mesh-list
5508078|NCT04418154|Cyclophosphamide|cyclophosphamide|mesh-list
6066113|NCT00683657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6066114|NCT00683657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066115|NCT00683657|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6066116|NCT00683657|Protease Inhibitors|protease inhibitors|mesh-ancestor
6066117|NCT00683657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6066118|NCT00683657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066119|NCT00683657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6066120|NCT00683774|Diazoxide|diazoxide|mesh-list
5508079|NCT04418154|Epirubicin|epirubicin|mesh-list
6066121|NCT00683774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6066122|NCT00683774|Vasodilator Agents|vasodilator agents|mesh-ancestor
6066123|NCT00683800|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6066124|NCT00683800|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6066125|NCT00683800|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6066126|NCT00683800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6066127|NCT00683800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066128|NCT00683800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6066129|NCT00683800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066130|NCT00683800|Antidepressive Agents|antidepressive agents|mesh-ancestor
6066131|NCT00683800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6202323|NCT02039505|Vedolizumab|vedolizumab|mesh-list
6202324|NCT02039505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6202325|NCT02039674|Paclitaxel|paclitaxel|mesh-list
6202326|NCT02039674|Bevacizumab|bevacizumab|mesh-list
6202327|NCT02039674|Carboplatin|carboplatin|mesh-list
6202328|NCT02039674|Pembrolizumab|pembrolizumab|mesh-list
6202329|NCT02039674|Pemetrexed|pemetrexed|mesh-list
6202330|NCT02039674|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5508080|NCT04418154|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5508081|NCT04418154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5508082|NCT04418154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6202331|NCT02039674|Ipilimumab|ipilimumab|mesh-list
6202332|NCT02039674|Gefitinib|gefitinib|mesh-list
6202333|NCT02039674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6202334|NCT02039674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6202335|NCT02039674|Tubulin Modulators|tubulin modulators|mesh-ancestor
6202336|NCT02039674|Antimitotic Agents|antimitotic agents|mesh-ancestor
6202337|NCT02039674|Mitosis Modulators|mitosis modulators|mesh-ancestor
6202338|NCT02039674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202339|NCT02039674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6202340|NCT02039674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6202341|NCT02039674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6202342|NCT02039674|Growth Substances|growth substances|mesh-ancestor
5508083|NCT04418154|Tubulin Modulators|tubulin modulators|mesh-ancestor
5508084|NCT04418154|Antimitotic Agents|antimitotic agents|mesh-ancestor
5508085|NCT04418154|Mitosis Modulators|mitosis modulators|mesh-ancestor
5508086|NCT04418154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508087|NCT04418154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5508088|NCT04418154|Immunologic Factors|immunologic factors|mesh-ancestor
5508089|NCT04418154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508090|NCT04418154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5508091|NCT04418154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5508092|NCT04418154|Alkylating Agents|alkylating agents|mesh-ancestor
5508093|NCT04418154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5508094|NCT04418154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6202343|NCT02039674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202344|NCT02039674|Growth Inhibitors|growth inhibitors|mesh-ancestor
6202345|NCT02039674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6202346|NCT02039674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6202347|NCT02039674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6202348|NCT02039674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6202349|NCT02039674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6202350|NCT02039778|Temozolomide|temozolomide|mesh-list
6202351|NCT02039778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6202352|NCT02039778|Alkylating Agents|alkylating agents|mesh-ancestor
6202353|NCT02039778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202354|NCT02039778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6202355|NCT02039908|Methylphenidate|methylphenidate|mesh-list
6202356|NCT02039908|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6202357|NCT02039908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202358|NCT02039908|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6202359|NCT02039908|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6202360|NCT02039908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6202361|NCT02039908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202362|NCT02039908|Dopamine Agents|dopamine agents|mesh-ancestor
6202363|NCT02039908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6202364|NCT02039947|Trametinib|trametinib|mesh-list
6202365|NCT02039947|Dabrafenib|dabrafenib|mesh-list
6202366|NCT02039947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6202367|NCT02039947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6202368|NCT02039947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6202369|NCT02039947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066132|NCT00683852|Aripiprazole|aripiprazole|mesh-list
6066133|NCT00683852|Antidepressive Agents|antidepressive agents|mesh-ancestor
6066134|NCT00683852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6066135|NCT00683852|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6066136|NCT00683852|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5508095|NCT04418154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5508096|NCT04418154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5508097|NCT04418154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5508098|NCT04418180|Fenofibrate|fenofibrate|mesh-list
5508099|NCT04418180|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5508100|NCT04418180|Antimetabolites|antimetabolites|mesh-ancestor
5508101|NCT04418180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508102|NCT04418180|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5508103|NCT04418219|Interferons|interferons|mesh-list
5508104|NCT04418219|Interferon-alpha|interferon-alpha|mesh-list
5508105|NCT04418219|Interferon alpha-2|interferon alpha-2|mesh-list
5508106|NCT04418219|Cyclophosphamide|cyclophosphamide|mesh-list
5508107|NCT04418219|Pembrolizumab|pembrolizumab|mesh-list
5508108|NCT04418219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5508109|NCT04418219|Immunologic Factors|immunologic factors|mesh-ancestor
5508110|NCT04418219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508111|NCT04418219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5508112|NCT04418219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5508113|NCT04418219|Alkylating Agents|alkylating agents|mesh-ancestor
5508114|NCT04418219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508115|NCT04418219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5508116|NCT04418219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5508117|NCT04418219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5508118|NCT04418219|Antiviral Agents|antiviral agents|mesh-ancestor
5508119|NCT04418219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5508120|NCT04418128|Nafamostat|nafamostat|mesh-list
5508121|NCT04418128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5508122|NCT04418128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5508123|NCT04418128|Analgesics|analgesics|mesh-ancestor
5508124|NCT04418128|Sensory System Agents|sensory system agents|mesh-ancestor
5508125|NCT04418128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5508126|NCT04418128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508127|NCT04418128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5508128|NCT04418128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5508129|NCT04418128|Anticoagulants|anticoagulants|mesh-ancestor
5508130|NCT04418128|Protease Inhibitors|protease inhibitors|mesh-ancestor
5508131|NCT04418128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5508132|NCT04418128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508133|NCT04418128|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5508134|NCT04418128|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5508135|NCT04418128|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5508136|NCT04418128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5508137|NCT04418128|Immunologic Factors|immunologic factors|mesh-ancestor
6066137|NCT00683852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6066138|NCT00683852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066139|NCT00683852|Dopamine Agonists|dopamine agonists|mesh-ancestor
6066140|NCT00683852|Dopamine Agents|dopamine agents|mesh-ancestor
6066141|NCT00683852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6066142|NCT00683852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066143|NCT00683852|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6066144|NCT00683852|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6066145|NCT00683852|Serotonin Agents|serotonin agents|mesh-ancestor
6066146|NCT00683852|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6066147|NCT00683852|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6066148|NCT00683852|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6066149|NCT00683852|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6066150|NCT00683878|Pioglitazone|pioglitazone|mesh-list
6066151|NCT00683878|Dapagliflozin|dapagliflozin|mesh-list
6066152|NCT00683878|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
6066153|NCT00683878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6066154|NCT00683878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066155|NCT00683878|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6066156|NCT00683878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066157|NCT00683904|Carboplatin|carboplatin|mesh-list
6066158|NCT00683904|Epothilones|epothilones|mesh-list
6066159|NCT00683904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6066160|NCT00683904|Tubulin Modulators|tubulin modulators|mesh-ancestor
6066161|NCT00683904|Antimitotic Agents|antimitotic agents|mesh-ancestor
5508138|NCT04417920|Mitomycins|mitomycins|mesh-list
6066162|NCT00683904|Mitosis Modulators|mitosis modulators|mesh-ancestor
6066163|NCT00683904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066164|NCT00683930|Mycophenolic Acid|mycophenolic acid|mesh-list
6066165|NCT00683930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6066166|NCT00683930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6066167|NCT00683930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6066168|NCT00683930|Antitubercular Agents|antitubercular agents|mesh-ancestor
6066169|NCT00683930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6066170|NCT00683930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6066171|NCT00683930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6066172|NCT00683930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066173|NCT00684073|Buprenorphine|buprenorphine|mesh-list
6066174|NCT00684073|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6066175|NCT00684073|Naloxone|naloxone|mesh-list
6066176|NCT00684073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6066177|NCT00684073|Narcotics|narcotics|mesh-ancestor
6066178|NCT00684073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6066179|NCT00684073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066180|NCT00684073|Analgesics|analgesics|mesh-ancestor
6066181|NCT00684073|Sensory System Agents|sensory system agents|mesh-ancestor
6066182|NCT00684073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6066183|NCT00684073|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6066184|NCT00684177|Retapamulin|retapamulin|mesh-list
6066185|NCT00684177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6066186|NCT00684177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6066187|NCT00684203|Aspirin|aspirin|mesh-list
6066188|NCT00684203|Clopidogrel|clopidogrel|mesh-list
6066189|NCT00684203|Vorapaxar|vorapaxar|mesh-list
6066190|NCT00684203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6066191|NCT00684203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6066192|NCT00684203|Analgesics|analgesics|mesh-ancestor
6066193|NCT00684203|Sensory System Agents|sensory system agents|mesh-ancestor
6066194|NCT00684203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6066195|NCT00684203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066196|NCT00684203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6066197|NCT00684203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6066198|NCT00684203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6066199|NCT00684203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6066200|NCT00684203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066201|NCT00684203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6066202|NCT00684203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6066203|NCT00684203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6066204|NCT00684203|Antipyretics|antipyretics|mesh-ancestor
6066205|NCT00684203|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6066206|NCT00684203|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6066207|NCT00684203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6066208|NCT00684203|Purinergic Agents|purinergic agents|mesh-ancestor
6066209|NCT00684203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6066210|NCT00684242|Lenalidomide|lenalidomide|mesh-list
6066211|NCT00684242|Immunologic Factors|immunologic factors|mesh-ancestor
6066212|NCT00684242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066213|NCT00684242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6066214|NCT00684242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6066215|NCT00684242|Growth Substances|growth substances|mesh-ancestor
6066216|NCT00684242|Growth Inhibitors|growth inhibitors|mesh-ancestor
6066217|NCT00684242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6066218|NCT00684307|Vitamin K|vitamin k|mesh-list
6066219|NCT00684307|Warfarin|warfarin|mesh-list
6066220|NCT00684307|Vitamins|vitamins|mesh-ancestor
6066221|NCT00684307|Micronutrients|micronutrients|mesh-ancestor
6066222|NCT00684307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066223|NCT00684307|Anticoagulants|anticoagulants|mesh-ancestor
6066224|NCT00684307|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6066225|NCT00684307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6066226|NCT00684307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066227|NCT00684307|Hemostatics|hemostatics|mesh-ancestor
6066228|NCT00684307|Coagulants|coagulants|mesh-ancestor
6066229|NCT00684411|Imatinib Mesylate|imatinib mesylate|mesh-list
5508139|NCT04417920|Mitomycin|mitomycin|mesh-list
5508140|NCT04417920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5508141|NCT04417920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5508142|NCT04417920|Alkylating Agents|alkylating agents|mesh-ancestor
5508143|NCT04417920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066230|NCT00684411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6066231|NCT00684411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6066232|NCT00684411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6202370|NCT02040116|Rituximab|rituximab|mesh-list
6066233|NCT00684411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066234|NCT00684515|Aspirin|aspirin|mesh-list
6066235|NCT00684515|Vorapaxar|vorapaxar|mesh-list
6066236|NCT00684515|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6066237|NCT00684515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6066238|NCT00684515|Analgesics|analgesics|mesh-ancestor
6066239|NCT00684515|Sensory System Agents|sensory system agents|mesh-ancestor
6066240|NCT00684515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6066241|NCT00684515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066242|NCT00684515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5508144|NCT04417920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5508145|NCT04417920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5508146|NCT04417998|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5508147|NCT04417998|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5508148|NCT04417998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508149|NCT04418102|Palmitic Acid|palmitic acid|mesh-list
5508150|NCT04418102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5508151|NCT04418102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508152|NCT04417699|Oxaliplatin|oxaliplatin|mesh-list
5508153|NCT04417699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5508154|NCT04417985|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5508155|NCT04417985|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5508156|NCT04417985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508157|NCT04418089|Simvastatin|simvastatin|mesh-list
5508158|NCT04418089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5508159|NCT04418089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6066243|NCT00684515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6066244|NCT00684515|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6066245|NCT00684515|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6066246|NCT00684515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066247|NCT00684515|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5508160|NCT04418089|Antimetabolites|antimetabolites|mesh-ancestor
5508161|NCT04418089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508162|NCT04418089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5508163|NCT04418089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5508164|NCT04418089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5508165|NCT04417582|Liraglutide|liraglutide|mesh-list
5508166|NCT04417582|Orlistat|orlistat|mesh-list
5508167|NCT04417582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5508168|NCT04417582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508169|NCT04417582|Incretins|incretins|mesh-ancestor
5508170|NCT04417582|Hormones|hormones|mesh-ancestor
5508171|NCT04417582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5508172|NCT04417582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5508173|NCT04417582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508174|NCT04417582|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5508175|NCT04417582|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5508176|NCT04417452|Adrenergic Agents|adrenergic agents|mesh-list
5508177|NCT04417452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5508178|NCT04417452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508179|NCT04417452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508180|NCT04417335|BCG Vaccine|bcg vaccine|mesh-list
5600253|NCT03713216|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6066248|NCT00684515|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6066249|NCT00684515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6066250|NCT00684515|Antipyretics|antipyretics|mesh-ancestor
6066251|NCT00684554|Buprenorphine|buprenorphine|mesh-list
6066252|NCT00684554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6066253|NCT00684554|Narcotics|narcotics|mesh-ancestor
6066254|NCT00684554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6066255|NCT00684554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066256|NCT00684554|Analgesics|analgesics|mesh-ancestor
6066257|NCT00684554|Sensory System Agents|sensory system agents|mesh-ancestor
6066258|NCT00684554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6066259|NCT00684554|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6066260|NCT00684567|Temozolomide|temozolomide|mesh-list
6066261|NCT00684567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6066262|NCT00684567|Alkylating Agents|alkylating agents|mesh-ancestor
6066263|NCT00684567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066264|NCT00684567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6066265|NCT00684645|Sunitinib|sunitinib|mesh-list
6066266|NCT00684645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6066267|NCT00684645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6463077|NCT00462696|Docetaxel|docetaxel|mesh-list
6066268|NCT00684645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6066269|NCT00684645|Growth Substances|growth substances|mesh-ancestor
6066270|NCT00684645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066271|NCT00684645|Growth Inhibitors|growth inhibitors|mesh-ancestor
6066272|NCT00684645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6066273|NCT00684645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6463078|NCT00462696|Epirubicin|epirubicin|mesh-list
6463079|NCT00462696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6463080|NCT00462696|Tubulin Modulators|tubulin modulators|mesh-ancestor
6463081|NCT00462696|Antimitotic Agents|antimitotic agents|mesh-ancestor
6463082|NCT00462696|Mitosis Modulators|mitosis modulators|mesh-ancestor
6463083|NCT00462696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463084|NCT00462696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6463085|NCT00462696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6463086|NCT00462696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6463087|NCT00462696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6463088|NCT00462787|Dexamethasone|dexamethasone|mesh-list
6463089|NCT00462787|Topotecan|topotecan|mesh-list
6463090|NCT00462787|Vinorelbine|vinorelbine|mesh-list
6463091|NCT00462787|Thiotepa|thiotepa|mesh-list
6463092|NCT00462787|Clofarabine|clofarabine|mesh-list
6463093|NCT00462787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6463094|NCT00462787|Antiemetics|antiemetics|mesh-ancestor
6463095|NCT00462787|Autonomic Agents|autonomic agents|mesh-ancestor
6463096|NCT00462787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6066274|NCT00684645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066275|NCT00684723|Lovastatin|lovastatin|mesh-list
6066276|NCT00684723|L 647318|l 647318|mesh-list
6066277|NCT00684723|Dihydromevinolin|dihydromevinolin|mesh-list
6066278|NCT00684723|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6066279|NCT00684723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6066280|NCT00684723|Antimetabolites|antimetabolites|mesh-ancestor
6066281|NCT00684723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066282|NCT00684723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6066283|NCT00684723|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6066284|NCT00684723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6066285|NCT00684762|Cilostazol|cilostazol|mesh-list
6066286|NCT00684762|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6066287|NCT00684762|Autonomic Agents|autonomic agents|mesh-ancestor
6066288|NCT00684762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6066289|NCT00684762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066290|NCT00684762|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6066291|NCT00684762|Respiratory System Agents|respiratory system agents|mesh-ancestor
6066292|NCT00684762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6066293|NCT00684762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6066294|NCT00684762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066295|NCT00684762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6066296|NCT00684762|Vasodilator Agents|vasodilator agents|mesh-ancestor
6066297|NCT00684762|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6066298|NCT00684762|Protective Agents|protective agents|mesh-ancestor
6066299|NCT00684762|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6066300|NCT00684762|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6066301|NCT00684762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6066302|NCT00684775|Naltrexone|naltrexone|mesh-list
6066303|NCT00684775|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6066304|NCT00684775|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6066305|NCT00684775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066306|NCT00684775|Sensory System Agents|sensory system agents|mesh-ancestor
6066307|NCT00684775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6066308|NCT00684814|Zolpidem|zolpidem|mesh-list
6066309|NCT00684814|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5508181|NCT04417335|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5508182|NCT04417335|Immunologic Factors|immunologic factors|mesh-ancestor
5508183|NCT04417335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508184|NCT04417361|Erenumab|erenumab|mesh-list
5508185|NCT04417361|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
5508186|NCT04417361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508187|NCT04417361|Analgesics|analgesics|mesh-ancestor
5508188|NCT04417361|Sensory System Agents|sensory system agents|mesh-ancestor
5508189|NCT04417361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6066310|NCT00684814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6463097|NCT00462787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463098|NCT00462787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5508190|NCT04417361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508191|NCT04417192|Pembrolizumab|pembrolizumab|mesh-list
5508192|NCT04417192|Olaparib|olaparib|mesh-list
5508193|NCT04417192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5508194|NCT04417192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5508195|NCT04417192|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5508196|NCT04417192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5508197|NCT04417192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600254|NCT03713216|Narcotics|narcotics|mesh-ancestor
5600255|NCT03713216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5600256|NCT03713216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600257|NCT03713216|Analgesics|analgesics|mesh-ancestor
5600258|NCT03713216|Sensory System Agents|sensory system agents|mesh-ancestor
5600259|NCT03713216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5600260|NCT03713190|Empagliflozin|empagliflozin|mesh-list
5600261|NCT03713190|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5600262|NCT03713190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600263|NCT03713190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5600264|NCT03713190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600265|NCT03712956|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6066311|NCT00684814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6066312|NCT00684814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066313|NCT00684814|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6066314|NCT00684814|GABA Agonists|gaba agonists|mesh-ancestor
6066315|NCT00684814|GABA Agents|gaba agents|mesh-ancestor
6066316|NCT00684814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6066317|NCT00684814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066318|NCT00684983|Capecitabine|capecitabine|mesh-list
6066319|NCT00684983|Lapatinib|lapatinib|mesh-list
6066320|NCT00684983|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6066321|NCT00684983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6066322|NCT00684983|Antimetabolites|antimetabolites|mesh-ancestor
5600266|NCT03712956|Doxorubicin|doxorubicin|mesh-list
5600267|NCT03712956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5600268|NCT03712956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5600269|NCT03712956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5600270|NCT03712956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5600271|NCT03712956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5600272|NCT03712956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600273|NCT03712904|Aflibercept|aflibercept|mesh-list
5600274|NCT03712904|Endothelial Growth Factors|endothelial growth factors|mesh-list
5600275|NCT03712904|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5600276|NCT03712904|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5600277|NCT03712904|Growth Substances|growth substances|mesh-ancestor
5600278|NCT03712904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600279|NCT03712904|Growth Inhibitors|growth inhibitors|mesh-ancestor
5600280|NCT03712904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5600281|NCT03712878|Mycophenolic Acid|mycophenolic acid|mesh-list
5600282|NCT03712878|Cyclophosphamide|cyclophosphamide|mesh-list
6066323|NCT00684983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066324|NCT00684983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6066325|NCT00684983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6066326|NCT00684983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6066327|NCT00684983|Immunologic Factors|immunologic factors|mesh-ancestor
6066328|NCT00684983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600283|NCT03712878|Tacrolimus|tacrolimus|mesh-list
5600284|NCT03712878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5600285|NCT03712878|Immunologic Factors|immunologic factors|mesh-ancestor
5600286|NCT03712878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600287|NCT03712878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5600288|NCT03712878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5600289|NCT03712878|Alkylating Agents|alkylating agents|mesh-ancestor
5600290|NCT03712878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600291|NCT03712878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5600292|NCT03712878|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6066329|NCT00684996|Bevacizumab|bevacizumab|mesh-list
6463099|NCT00462787|Glucocorticoids|glucocorticoids|mesh-ancestor
6066330|NCT00684996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6066331|NCT00684996|Antibodies|antibodies|mesh-list
6066332|NCT00684996|Immunoglobulins|immunoglobulins|mesh-list
6066333|NCT00684996|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6066334|NCT00684996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6066335|NCT00684996|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6066336|NCT00684996|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5508198|NCT04417179|Bupivacaine|bupivacaine|mesh-list
5508199|NCT04417179|Anesthetics, Local|anesthetics, local|mesh-ancestor
5508200|NCT04417179|Anesthetics|anesthetics|mesh-ancestor
5508201|NCT04417179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5508202|NCT04417179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508203|NCT04417179|Sensory System Agents|sensory system agents|mesh-ancestor
5508204|NCT04417179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5508205|NCT04417114|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5508206|NCT04417114|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5508207|NCT04417114|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5508208|NCT04417114|Antimetabolites|antimetabolites|mesh-ancestor
5508209|NCT04417114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066337|NCT00684996|Growth Substances|growth substances|mesh-ancestor
6066338|NCT00684996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066339|NCT00684996|Growth Inhibitors|growth inhibitors|mesh-ancestor
6066340|NCT00684996|Immunologic Factors|immunologic factors|mesh-ancestor
6066341|NCT00685139|Zonisamide|zonisamide|mesh-list
6066342|NCT00685139|Anticonvulsants|anticonvulsants|mesh-ancestor
6066343|NCT00685139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6066344|NCT00685139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6066345|NCT00685139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066346|NCT00685139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6066347|NCT00685139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066348|NCT00685165|Primidone|primidone|mesh-list
6066349|NCT00685165|Anticonvulsants|anticonvulsants|mesh-ancestor
6066350|NCT00685165|GABA Modulators|gaba modulators|mesh-ancestor
6066351|NCT00685165|GABA Agents|gaba agents|mesh-ancestor
6066352|NCT00685165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6066353|NCT00685165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066354|NCT00685165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066355|NCT00685178|Topiramate|topiramate|mesh-list
6066356|NCT00685178|Anticonvulsants|anticonvulsants|mesh-ancestor
6066357|NCT00685178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6066358|NCT00685178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066359|NCT00685295|Fentanyl|fentanyl|mesh-list
6066360|NCT00685295|Oxycodone|oxycodone|mesh-list
6066361|NCT00685295|Lansoprazole|lansoprazole|mesh-list
6066362|NCT00685295|Dexlansoprazole|dexlansoprazole|mesh-list
6066363|NCT00685295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6066364|NCT00685295|Narcotics|narcotics|mesh-ancestor
6066365|NCT00685295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6066366|NCT00685295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066367|NCT00685295|Analgesics|analgesics|mesh-ancestor
6066368|NCT00685295|Sensory System Agents|sensory system agents|mesh-ancestor
5508210|NCT04417114|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5508211|NCT04417114|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5508212|NCT04417114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5508213|NCT04417517|Azacitidine|azacitidine|mesh-list
5508214|NCT04417517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5508215|NCT04417517|Antimetabolites|antimetabolites|mesh-ancestor
5508216|NCT04417517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508217|NCT04417517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5508218|NCT04417517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5508219|NCT04417049|Pentoxifylline|pentoxifylline|mesh-list
5508220|NCT04417049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5508221|NCT04417049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5508222|NCT04417049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508223|NCT04417049|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5508224|NCT04417049|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5508225|NCT04417049|Protective Agents|protective agents|mesh-ancestor
5508226|NCT04417049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508227|NCT04417049|Vasodilator Agents|vasodilator agents|mesh-ancestor
6066369|NCT00685295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6066370|NCT00685295|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6066371|NCT00685295|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6066372|NCT00685295|Anesthetics, General|anesthetics, general|mesh-ancestor
6066373|NCT00685295|Anesthetics|anesthetics|mesh-ancestor
6066374|NCT00685295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6066375|NCT00685295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6066376|NCT00685295|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6066377|NCT00685295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6066378|NCT00685295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066379|NCT00685334|Olanzapine|olanzapine|mesh-list
6066380|NCT00685334|Aripiprazole|aripiprazole|mesh-list
6066381|NCT00685334|Antiemetics|antiemetics|mesh-ancestor
6066382|NCT00685334|Autonomic Agents|autonomic agents|mesh-ancestor
6066383|NCT00685334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6066384|NCT00685334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066385|NCT00685334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6066386|NCT00685334|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6066387|NCT00685334|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6066388|NCT00685334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6066389|NCT00685334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6066390|NCT00685334|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6066391|NCT00685334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6066392|NCT00685334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6066393|NCT00685334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066394|NCT00685334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6066395|NCT00685334|Serotonin Agents|serotonin agents|mesh-ancestor
6066396|NCT00685334|Antidepressive Agents|antidepressive agents|mesh-ancestor
6066397|NCT00685334|Dopamine Agonists|dopamine agonists|mesh-ancestor
6066398|NCT00685334|Dopamine Agents|dopamine agents|mesh-ancestor
6066399|NCT00685334|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6066400|NCT00685334|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6066401|NCT00685334|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5508228|NCT04417049|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5508229|NCT04417049|Antioxidants|antioxidants|mesh-ancestor
5508230|NCT04417348|Tretinoin|tretinoin|mesh-list
5508231|NCT04417348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5508232|NCT04417348|Keratolytic Agents|keratolytic agents|mesh-ancestor
5508233|NCT04417348|Dermatologic Agents|dermatologic agents|mesh-ancestor
5508234|NCT04417543|Memantine|memantine|mesh-list
5508235|NCT04417543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5508236|NCT04417543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5508237|NCT04417543|Dopamine Agents|dopamine agents|mesh-ancestor
5508238|NCT04417543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5508239|NCT04417543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066402|NCT00685334|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6066403|NCT00685334|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6066404|NCT00685334|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6066405|NCT00685399|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6066406|NCT00685399|Immunologic Factors|immunologic factors|mesh-ancestor
6066407|NCT00685399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066408|NCT00685685|Lovastatin|lovastatin|mesh-list
6066409|NCT00685685|L 647318|l 647318|mesh-list
6066410|NCT00685685|Dihydromevinolin|dihydromevinolin|mesh-list
6066411|NCT00685685|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6066412|NCT00685685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6066413|NCT00685685|Antimetabolites|antimetabolites|mesh-ancestor
6066414|NCT00685685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066415|NCT00685685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6066416|NCT00685685|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6066417|NCT00685685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6066418|NCT00685763|Gemcitabine|gemcitabine|mesh-list
6066419|NCT00685763|Capecitabine|capecitabine|mesh-list
6066420|NCT00685763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6066421|NCT00685763|Antimetabolites|antimetabolites|mesh-ancestor
6066422|NCT00685763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508240|NCT04417543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508241|NCT04417543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5508242|NCT04417543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6066423|NCT00685763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6066424|NCT00685763|Antiviral Agents|antiviral agents|mesh-ancestor
6066425|NCT00685763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6066426|NCT00685763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6066427|NCT00685763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6066428|NCT00685763|Immunologic Factors|immunologic factors|mesh-ancestor
6066429|NCT00685763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066430|NCT00685802|Cilostazol|cilostazol|mesh-list
6066431|NCT00685802|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6066432|NCT00685802|Autonomic Agents|autonomic agents|mesh-ancestor
6066433|NCT00685802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6066434|NCT00685802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508243|NCT04416750|Imatinib Mesylate|imatinib mesylate|mesh-list
6066435|NCT00685802|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6066436|NCT00685802|Respiratory System Agents|respiratory system agents|mesh-ancestor
6066437|NCT00685802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6066438|NCT00685802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6066439|NCT00685802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066440|NCT00685802|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6066441|NCT00685802|Vasodilator Agents|vasodilator agents|mesh-ancestor
6066442|NCT00685802|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6066443|NCT00685802|Protective Agents|protective agents|mesh-ancestor
6066444|NCT00685802|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6066445|NCT00685802|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5508244|NCT04416750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5508245|NCT04416750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5508246|NCT04416750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5508247|NCT04416750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508248|NCT04416568|Nivolumab|nivolumab|mesh-list
5508249|NCT04416568|Ipilimumab|ipilimumab|mesh-list
5508250|NCT04416568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5508251|NCT04416568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5508252|NCT04416568|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5508253|NCT04416568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066446|NCT00685802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6066447|NCT00685945|Isosorbide|isosorbide|mesh-list
6066448|NCT00685945|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
6066449|NCT00685945|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
6066450|NCT00685945|Sildenafil Citrate|sildenafil citrate|mesh-list
6066451|NCT00685945|Bradykinin|bradykinin|mesh-list
6066452|NCT00685945|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
6066453|NCT00685945|Kininogens|kininogens|mesh-list
6066454|NCT00685945|Vasodilator Agents|vasodilator agents|mesh-ancestor
6066455|NCT00685945|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6066456|NCT00685945|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6066457|NCT00685945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6066458|NCT00685945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066459|NCT00685945|Urological Agents|urological agents|mesh-ancestor
6066460|NCT00685945|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6066461|NCT00685945|Diuretics|diuretics|mesh-ancestor
6066462|NCT00685945|Natriuretic Agents|natriuretic agents|mesh-ancestor
6066463|NCT00685945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066464|NCT00685945|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6066465|NCT00685945|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
6066466|NCT00685945|Protease Inhibitors|protease inhibitors|mesh-ancestor
6066467|NCT00686127|Lidocaine|lidocaine|mesh-list
6066468|NCT00686127|Anesthetics, Local|anesthetics, local|mesh-ancestor
6066469|NCT00686127|Anesthetics|anesthetics|mesh-ancestor
6066470|NCT00686127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6066471|NCT00686127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066472|NCT00686127|Sensory System Agents|sensory system agents|mesh-ancestor
5508254|NCT04416334|Acetaminophen|acetaminophen|mesh-list
5508255|NCT04416334|Colchicine|colchicine|mesh-list
5508256|NCT04416334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5508257|NCT04416334|Analgesics|analgesics|mesh-ancestor
5508258|NCT04416334|Sensory System Agents|sensory system agents|mesh-ancestor
5508259|NCT04416334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5508260|NCT04416334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508261|NCT04416334|Antipyretics|antipyretics|mesh-ancestor
5508262|NCT04416334|Gout Suppressants|gout suppressants|mesh-ancestor
5508263|NCT04416334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5508264|NCT04416334|Tubulin Modulators|tubulin modulators|mesh-ancestor
5508265|NCT04416334|Antimitotic Agents|antimitotic agents|mesh-ancestor
5508266|NCT04416334|Mitosis Modulators|mitosis modulators|mesh-ancestor
5508267|NCT04416334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508268|NCT04416334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5508269|NCT04416399|Budesonide|budesonide|mesh-list
5508270|NCT04416399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5508271|NCT04416399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5508272|NCT04416399|Autonomic Agents|autonomic agents|mesh-ancestor
5508273|NCT04416399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5508274|NCT04416399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508275|NCT04416399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6066473|NCT00686127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6066474|NCT00686127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6066475|NCT00686127|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5508276|NCT04416399|Respiratory System Agents|respiratory system agents|mesh-ancestor
5508277|NCT04416399|Glucocorticoids|glucocorticoids|mesh-ancestor
5508278|NCT04416399|Hormones|hormones|mesh-ancestor
5508279|NCT04416399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5508280|NCT04416607|Menotropins|menotropins|mesh-list
6463100|NCT00462787|Hormones|hormones|mesh-ancestor
6463101|NCT00462787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6066476|NCT00686127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6066477|NCT00686127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6066478|NCT00686127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066479|NCT00686166|Capecitabine|capecitabine|mesh-list
6066480|NCT00686166|Oxaliplatin|oxaliplatin|mesh-list
6066481|NCT00686166|Cetuximab|cetuximab|mesh-list
6066482|NCT00686166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6066483|NCT00686166|Antimetabolites|antimetabolites|mesh-ancestor
6066484|NCT00686166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066485|NCT00686166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6066486|NCT00686166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6066487|NCT00686231|Lidocaine|lidocaine|mesh-list
6066488|NCT00686231|Nitroglycerin|nitroglycerin|mesh-list
6066489|NCT00686231|Anesthetics, Local|anesthetics, local|mesh-ancestor
6066490|NCT00686231|Anesthetics|anesthetics|mesh-ancestor
6066491|NCT00686231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6066492|NCT00686231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066493|NCT00686231|Sensory System Agents|sensory system agents|mesh-ancestor
6066494|NCT00686231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6066495|NCT00686231|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6066496|NCT00686231|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6066497|NCT00686231|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6066498|NCT00686231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6066499|NCT00686231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066500|NCT00686231|Vasodilator Agents|vasodilator agents|mesh-ancestor
6066501|NCT00686335|Prednisone|prednisone|mesh-list
6066502|NCT00686335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6066503|NCT00686335|Glucocorticoids|glucocorticoids|mesh-ancestor
6066504|NCT00686335|Hormones|hormones|mesh-ancestor
6066505|NCT00686335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6066506|NCT00686335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066507|NCT00686335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6066508|NCT00686335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6066509|NCT00686517|Interferons|interferons|mesh-list
6066510|NCT00686517|Ribavirin|ribavirin|mesh-list
6066511|NCT00686517|Interferon-alpha|interferon-alpha|mesh-list
6066512|NCT00686517|Interferon alpha-2|interferon alpha-2|mesh-list
6066513|NCT00686517|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6066514|NCT00686517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6066515|NCT00686517|Antiviral Agents|antiviral agents|mesh-ancestor
6066516|NCT00686517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6066517|NCT00686517|Antimetabolites|antimetabolites|mesh-ancestor
6066518|NCT00686517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463102|NCT00462787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6463103|NCT00462787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6463104|NCT00462787|Immunologic Factors|immunologic factors|mesh-ancestor
6463105|NCT00462787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6463106|NCT00462787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6066519|NCT00686517|Immunologic Factors|immunologic factors|mesh-ancestor
6066520|NCT00686517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066521|NCT00686543|Posaconazole|posaconazole|mesh-list
6066522|NCT00686543|Antifungal Agents|antifungal agents|mesh-ancestor
6066523|NCT00686543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6066524|NCT00686543|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6066525|NCT00686543|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6066526|NCT00686543|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6066527|NCT00686543|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6066528|NCT00686543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6066529|NCT00686543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6066530|NCT00686543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066531|NCT00686543|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6066532|NCT00686543|Hormone Antagonists|hormone antagonists|mesh-ancestor
6066533|NCT00686543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5508281|NCT04416607|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5508282|NCT04416607|Fertility Agents|fertility agents|mesh-ancestor
5508283|NCT04416607|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5508284|NCT04416607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508285|NCT04416269|Insulin|insulin|mesh-list
5508286|NCT04416269|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5508287|NCT04416269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6066534|NCT00686543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066535|NCT00686595|Infliximab|infliximab|mesh-list
6066536|NCT00686595|Dermatologic Agents|dermatologic agents|mesh-ancestor
6066537|NCT00686595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6066538|NCT00686595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6066539|NCT00686634|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6066540|NCT00686634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6066541|NCT00686634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066542|NCT00686634|Incretins|incretins|mesh-ancestor
6066543|NCT00686634|Hormones|hormones|mesh-ancestor
6066544|NCT00686634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6066545|NCT00686634|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6066546|NCT00686634|Protease Inhibitors|protease inhibitors|mesh-ancestor
6066547|NCT00686634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6066548|NCT00686634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066549|NCT00686686|Infliximab|infliximab|mesh-list
6066550|NCT00686686|Dermatologic Agents|dermatologic agents|mesh-ancestor
6066551|NCT00686686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6066552|NCT00686686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6066553|NCT00686712|Insulin|insulin|mesh-list
6066554|NCT00686712|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6066555|NCT00686712|Insulin Glargine|insulin glargine|mesh-list
6066556|NCT00686712|Insulin, Isophane|insulin, isophane|mesh-list
6066557|NCT00686712|Isophane Insulin, Human|isophane insulin, human|mesh-list
6066558|NCT00686712|Isophane insulin, beef|isophane insulin, beef|mesh-list
6066559|NCT00686712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6066560|NCT00686712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066561|NCT00686725|Temozolomide|temozolomide|mesh-list
6066562|NCT00686725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6066563|NCT00686725|Alkylating Agents|alkylating agents|mesh-ancestor
6066564|NCT00686725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066565|NCT00686725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6066566|NCT00686777|Interferons|interferons|mesh-list
6066567|NCT00686777|Ribavirin|ribavirin|mesh-list
6066568|NCT00686777|Interferon-alpha|interferon-alpha|mesh-list
6066569|NCT00686777|Interferon alpha-2|interferon alpha-2|mesh-list
6066570|NCT00686777|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6066571|NCT00686777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6066572|NCT00686777|Antiviral Agents|antiviral agents|mesh-ancestor
6066573|NCT00686777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6066574|NCT00686777|Antimetabolites|antimetabolites|mesh-ancestor
6066575|NCT00686777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066576|NCT00686777|Immunologic Factors|immunologic factors|mesh-ancestor
6066577|NCT00686777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066578|NCT00686790|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6066579|NCT00686790|Interferon-alpha|interferon-alpha|mesh-list
6066580|NCT00686790|Antiviral Agents|antiviral agents|mesh-ancestor
6066581|NCT00686790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6066582|NCT00686790|Immunologic Factors|immunologic factors|mesh-ancestor
6066583|NCT00686790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066584|NCT00686829|Maleic acid|maleic acid|mesh-list
6066585|NCT00686829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6066586|NCT00686829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066587|NCT00686855|Dexamethasone|dexamethasone|mesh-list
6066588|NCT00686855|Tacrolimus|tacrolimus|mesh-list
6066589|NCT00686855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6066590|NCT00686855|Antiemetics|antiemetics|mesh-ancestor
6066591|NCT00686855|Autonomic Agents|autonomic agents|mesh-ancestor
6066592|NCT00686855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6066593|NCT00686855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066594|NCT00686855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6066595|NCT00686855|Glucocorticoids|glucocorticoids|mesh-ancestor
6066596|NCT00686855|Hormones|hormones|mesh-ancestor
6066597|NCT00686855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6066598|NCT00686855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6066599|NCT00686855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6066600|NCT00686855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6066601|NCT00686855|Immunologic Factors|immunologic factors|mesh-ancestor
6066602|NCT00686855|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6066603|NCT00686855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6066604|NCT00686855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066605|NCT00686881|Interferons|interferons|mesh-list
6463107|NCT00462787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6066606|NCT00686881|Interferon-alpha|interferon-alpha|mesh-list
6066607|NCT00686881|Interferon alpha-2|interferon alpha-2|mesh-list
6066608|NCT00686881|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6066609|NCT00686881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6066610|NCT00686881|Antiviral Agents|antiviral agents|mesh-ancestor
6066611|NCT00686881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6066612|NCT00686881|Immunologic Factors|immunologic factors|mesh-ancestor
6066613|NCT00686881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066614|NCT00686894|Infliximab|infliximab|mesh-list
6066615|NCT00686894|Dermatologic Agents|dermatologic agents|mesh-ancestor
6463108|NCT00462787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463109|NCT00462787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6463110|NCT00462787|Tubulin Modulators|tubulin modulators|mesh-ancestor
6463111|NCT00462787|Antimitotic Agents|antimitotic agents|mesh-ancestor
6463112|NCT00462787|Mitosis Modulators|mitosis modulators|mesh-ancestor
6463113|NCT00462787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6463114|NCT00462787|Alkylating Agents|alkylating agents|mesh-ancestor
6066616|NCT00686894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6066617|NCT00686894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6066618|NCT00686920|Rifaximin|rifaximin|mesh-list
6066619|NCT00686920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6066620|NCT00686920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6066621|NCT00686920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6066622|NCT00686959|Paclitaxel|paclitaxel|mesh-list
6066623|NCT00686959|Etoposide|etoposide|mesh-list
6066624|NCT00686959|Vinorelbine|vinorelbine|mesh-list
6066625|NCT00686959|Carboplatin|carboplatin|mesh-list
6066626|NCT00686959|Pemetrexed|pemetrexed|mesh-list
6066627|NCT00686959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6066628|NCT00686959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6066629|NCT00686959|Tubulin Modulators|tubulin modulators|mesh-ancestor
6066630|NCT00686959|Antimitotic Agents|antimitotic agents|mesh-ancestor
6066631|NCT00686959|Mitosis Modulators|mitosis modulators|mesh-ancestor
6066632|NCT00686959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066633|NCT00686959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6066634|NCT00686959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6066635|NCT00686959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6066636|NCT00686959|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6066637|NCT00686959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5508288|NCT04416269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508289|NCT04416165|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5508290|NCT04416165|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5508291|NCT04416165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508292|NCT04415944|Carboplatin|carboplatin|mesh-list
5508293|NCT04415944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5508294|NCT04415840|Acetic Acid|acetic acid|mesh-list
5508295|NCT04415840|Retinol acetate|retinol acetate|mesh-list
6066638|NCT00686998|Olanzapine|olanzapine|mesh-list
6066639|NCT00686998|Antiemetics|antiemetics|mesh-ancestor
6066640|NCT00686998|Autonomic Agents|autonomic agents|mesh-ancestor
6066641|NCT00686998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6066642|NCT00686998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066643|NCT00686998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5508296|NCT04415840|Lugol's solution|lugol's solution|mesh-list
5508297|NCT04415840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5508298|NCT04415840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6066644|NCT00686998|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6066645|NCT00686998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6066646|NCT00686998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6066647|NCT00686998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6066648|NCT00686998|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6066649|NCT00686998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6066650|NCT00686998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6066651|NCT00686998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066652|NCT00686998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6066653|NCT00686998|Serotonin Agents|serotonin agents|mesh-ancestor
6066654|NCT00687076|Aspirin|aspirin|mesh-list
6066655|NCT00687076|Niacin|niacin|mesh-list
6066656|NCT00687076|Nicotinic Acids|nicotinic acids|mesh-list
6066657|NCT00687076|Clopidogrel|clopidogrel|mesh-list
6066658|NCT00687076|Ezetimibe|ezetimibe|mesh-list
6066659|NCT00687076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6066660|NCT00687076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6066661|NCT00687076|Analgesics|analgesics|mesh-ancestor
6066662|NCT00687076|Sensory System Agents|sensory system agents|mesh-ancestor
6066663|NCT00687076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5508299|NCT04415840|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6066664|NCT00687076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066665|NCT00687076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5508300|NCT04415840|Immunologic Factors|immunologic factors|mesh-ancestor
5508301|NCT04415840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508302|NCT04415840|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5508303|NCT04415840|Protective Agents|protective agents|mesh-ancestor
5508304|NCT04415840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5508305|NCT04415840|Hemostatics|hemostatics|mesh-ancestor
5508306|NCT04415840|Coagulants|coagulants|mesh-ancestor
5508307|NCT04415892|Cinnamaldehyde|cinnamaldehyde|mesh-list
5508308|NCT04415892|Capsaicin|capsaicin|mesh-list
5508309|NCT04415892|Antipruritics|antipruritics|mesh-ancestor
5508310|NCT04415892|Dermatologic Agents|dermatologic agents|mesh-ancestor
5508311|NCT04415892|Sensory System Agents|sensory system agents|mesh-ancestor
5508312|NCT04415892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5508313|NCT04415892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508314|NCT04415892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5508315|NCT04415892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5508316|NCT04415892|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
5508317|NCT04415892|Protective Agents|protective agents|mesh-ancestor
5508318|NCT04415905|Propofol|propofol|mesh-list
5508319|NCT04415905|Sevoflurane|sevoflurane|mesh-list
5508320|NCT04415905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5508321|NCT04415905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5508322|NCT04415905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508323|NCT04415905|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5508324|NCT04415905|Anesthetics, General|anesthetics, general|mesh-ancestor
5508325|NCT04415905|Anesthetics|anesthetics|mesh-ancestor
5508326|NCT04415905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5508327|NCT04415905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5508328|NCT04416035|Paclitaxel|paclitaxel|mesh-list
5508329|NCT04416035|Bevacizumab|bevacizumab|mesh-list
5508330|NCT04416035|Carboplatin|carboplatin|mesh-list
5508331|NCT04416035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5508332|NCT04416035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5508333|NCT04416035|Tubulin Modulators|tubulin modulators|mesh-ancestor
5508334|NCT04416035|Antimitotic Agents|antimitotic agents|mesh-ancestor
5508335|NCT04416035|Mitosis Modulators|mitosis modulators|mesh-ancestor
5508336|NCT04416035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508337|NCT04416035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5508338|NCT04416035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5508339|NCT04416035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5508340|NCT04416035|Growth Substances|growth substances|mesh-ancestor
6066666|NCT00687076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6066667|NCT00687076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6066668|NCT00687076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6066669|NCT00687076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066670|NCT00687076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6066671|NCT00687076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6066672|NCT00687076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6066673|NCT00687076|Antipyretics|antipyretics|mesh-ancestor
6066674|NCT00687076|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6066675|NCT00687076|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6066676|NCT00687076|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6066677|NCT00687076|Purinergic Agents|purinergic agents|mesh-ancestor
6066678|NCT00687076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6066679|NCT00687076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6066680|NCT00687076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6066681|NCT00687076|Antimetabolites|antimetabolites|mesh-ancestor
6066682|NCT00687076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6066683|NCT00687076|Vasodilator Agents|vasodilator agents|mesh-ancestor
6066684|NCT00687076|Vitamin B Complex|vitamin b complex|mesh-ancestor
6066685|NCT00687076|Vitamins|vitamins|mesh-ancestor
6066686|NCT00687076|Micronutrients|micronutrients|mesh-ancestor
6066687|NCT00687102|Tamoxifen|tamoxifen|mesh-list
6066688|NCT00687102|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
6066689|NCT00687102|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5508341|NCT04416035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508342|NCT04416035|Growth Inhibitors|growth inhibitors|mesh-ancestor
6066690|NCT00687102|Hormone Antagonists|hormone antagonists|mesh-ancestor
6066691|NCT00687102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6066692|NCT00687102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066693|NCT00687102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6066694|NCT00687102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6066695|NCT00687102|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5508343|NCT04415983|Metronidazole|metronidazole|mesh-list
5508344|NCT04415983|Clarithromycin|clarithromycin|mesh-list
5508345|NCT04415983|Nitazoxanide|nitazoxanide|mesh-list
6066696|NCT00687102|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5508346|NCT04415983|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
5508347|NCT04415983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5508348|NCT04415983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5508349|NCT04415983|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5508350|NCT04415983|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5508351|NCT04415983|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5508352|NCT04415983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5508353|NCT04415983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508354|NCT04415983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5508355|NCT04415983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5508356|NCT04415853|Irinotecan|irinotecan|mesh-list
5508357|NCT04415853|Tegafur|tegafur|mesh-list
5508358|NCT04415853|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5508359|NCT04415853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5508360|NCT04415853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5508361|NCT04415853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508362|NCT04415853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5508363|NCT04415853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5508364|NCT04415853|Antimetabolites|antimetabolites|mesh-ancestor
5508365|NCT04415567|Lenvatinib|lenvatinib|mesh-list
5508366|NCT04415567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5508367|NCT04415567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5508368|NCT04415567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5508369|NCT04415567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600293|NCT03712878|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5600294|NCT03712878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6066697|NCT00687102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6066698|NCT00687167|Zonisamide|zonisamide|mesh-list
6066699|NCT00687167|Anticonvulsants|anticonvulsants|mesh-ancestor
6066700|NCT00687167|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6066701|NCT00687167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6066702|NCT00687167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066703|NCT00687167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6066704|NCT00687167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066705|NCT00687193|Tofacitinib|tofacitinib|mesh-list
6066706|NCT00687193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6066707|NCT00687193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6066708|NCT00687193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066709|NCT00687219|Ribavirin|ribavirin|mesh-list
6066710|NCT00687219|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6066711|NCT00687219|Antimetabolites|antimetabolites|mesh-ancestor
6066712|NCT00687219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066713|NCT00687219|Antiviral Agents|antiviral agents|mesh-ancestor
6066714|NCT00687219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6066715|NCT00687271|Atorvastatin|atorvastatin|mesh-list
6066716|NCT00687271|Calcium|calcium|mesh-list
6066717|NCT00687271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6066718|NCT00687271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066719|NCT00687271|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6066720|NCT00687271|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6066721|NCT00687271|Antimetabolites|antimetabolites|mesh-ancestor
6066722|NCT00687271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066723|NCT00687271|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6066724|NCT00687271|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6066725|NCT00687271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6066726|NCT00687297|Carboplatin|carboplatin|mesh-list
6066727|NCT00687297|Docetaxel|docetaxel|mesh-list
6066728|NCT00687297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6066729|NCT00687297|Tubulin Modulators|tubulin modulators|mesh-ancestor
6066730|NCT00687297|Antimitotic Agents|antimitotic agents|mesh-ancestor
6066731|NCT00687297|Mitosis Modulators|mitosis modulators|mesh-ancestor
5600295|NCT03712878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5600296|NCT03712878|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5600297|NCT03712878|Antitubercular Agents|antitubercular agents|mesh-ancestor
5600298|NCT03712878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5600299|NCT03712878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5600300|NCT03712826|Ustekinumab|ustekinumab|mesh-list
5600301|NCT03712826|Dermatologic Agents|dermatologic agents|mesh-ancestor
5600302|NCT03712735|Fentanyl|fentanyl|mesh-list
5600303|NCT03712735|Bupivacaine|bupivacaine|mesh-list
5600304|NCT03712735|Anesthetics, Local|anesthetics, local|mesh-ancestor
5600305|NCT03712735|Anesthetics|anesthetics|mesh-ancestor
5600306|NCT03712735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6066732|NCT00687297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066733|NCT00687323|Temozolomide|temozolomide|mesh-list
6066734|NCT00687323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6066735|NCT00687323|Alkylating Agents|alkylating agents|mesh-ancestor
6066736|NCT00687323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066737|NCT00687323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6066738|NCT00687362|Infliximab|infliximab|mesh-list
6066739|NCT00687362|Dermatologic Agents|dermatologic agents|mesh-ancestor
6066740|NCT00687362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6066741|NCT00687362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6066742|NCT00687401|Infliximab|infliximab|mesh-list
6066743|NCT00687401|Dermatologic Agents|dermatologic agents|mesh-ancestor
6066744|NCT00687401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6066745|NCT00687401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6066746|NCT00687440|Docetaxel|docetaxel|mesh-list
6066747|NCT00687440|Doxorubicin|doxorubicin|mesh-list
6066748|NCT00687440|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6066749|NCT00687440|Trastuzumab|trastuzumab|mesh-list
6066750|NCT00687440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6066751|NCT00687440|Tubulin Modulators|tubulin modulators|mesh-ancestor
6066752|NCT00687440|Antimitotic Agents|antimitotic agents|mesh-ancestor
6066753|NCT00687440|Mitosis Modulators|mitosis modulators|mesh-ancestor
6066754|NCT00687440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066755|NCT00687440|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6066756|NCT00687440|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5508370|NCT04415320|Ensartinib|ensartinib|mesh-list
5508371|NCT04415320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5508372|NCT04415320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5508373|NCT04415320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5508374|NCT04415320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508375|NCT04415333|Butyric Acid|butyric acid|mesh-list
5508376|NCT04415333|Histamine Antagonists|histamine antagonists|mesh-ancestor
5508377|NCT04415333|Histamine Agents|histamine agents|mesh-ancestor
5508378|NCT04415333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5508379|NCT04415333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508380|NCT04415333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508381|NCT04415385|Apatinib|apatinib|mesh-list
5508382|NCT04415385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5508383|NCT04415385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5508384|NCT04415385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5508385|NCT04415385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508386|NCT04415476|Mycophenolic Acid|mycophenolic acid|mesh-list
5508387|NCT04415476|Sirolimus|sirolimus|mesh-list
5508388|NCT04415476|Prednisone|prednisone|mesh-list
5508389|NCT04415476|Tacrolimus|tacrolimus|mesh-list
6066757|NCT00687440|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6066758|NCT00687440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6066759|NCT00687440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6066760|NCT00687453|Insulin Glargine|insulin glargine|mesh-list
6066761|NCT00687453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6066762|NCT00687453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066763|NCT00687544|Ribavirin|ribavirin|mesh-list
6066764|NCT00687544|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6066765|NCT00687544|Antimetabolites|antimetabolites|mesh-ancestor
6066766|NCT00687544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066767|NCT00687544|Antiviral Agents|antiviral agents|mesh-ancestor
6066768|NCT00687544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6066769|NCT00687609|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6066770|NCT00687609|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6066771|NCT00687609|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6066772|NCT00687609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6066773|NCT00687609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066774|NCT00687609|Adrenergic Agents|adrenergic agents|mesh-ancestor
6066775|NCT00687609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6066776|NCT00687609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066777|NCT00687674|Dexamethasone|dexamethasone|mesh-list
6066778|NCT00687674|Lenalidomide|lenalidomide|mesh-list
6066779|NCT00687674|Sorafenib|sorafenib|mesh-list
6066780|NCT00687674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6066781|NCT00687674|Antiemetics|antiemetics|mesh-ancestor
6066782|NCT00687674|Autonomic Agents|autonomic agents|mesh-ancestor
6066783|NCT00687674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6066784|NCT00687674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066785|NCT00687674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5508390|NCT04415476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5508391|NCT04415476|Glucocorticoids|glucocorticoids|mesh-ancestor
5508392|NCT04415476|Hormones|hormones|mesh-ancestor
6665335|NCT01516593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6665336|NCT01516593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6665337|NCT01516593|Immunologic Factors|immunologic factors|mesh-ancestor
6665338|NCT01516593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665339|NCT01516606|Clarithromycin|clarithromycin|mesh-list
6463115|NCT00462787|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6463116|NCT00462787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6463117|NCT00462787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6463118|NCT00462787|Antimetabolites|antimetabolites|mesh-ancestor
6463119|NCT00462813|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
6463120|NCT00462813|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6463121|NCT00462813|Protective Agents|protective agents|mesh-ancestor
6463122|NCT00462813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463123|NCT00462813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6066786|NCT00687674|Glucocorticoids|glucocorticoids|mesh-ancestor
6066787|NCT00687674|Hormones|hormones|mesh-ancestor
6066788|NCT00687674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6066789|NCT00687674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6066790|NCT00687674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6066791|NCT00687674|Immunologic Factors|immunologic factors|mesh-ancestor
6066792|NCT00687674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6066793|NCT00687674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6066794|NCT00687674|Growth Substances|growth substances|mesh-ancestor
6066795|NCT00687674|Growth Inhibitors|growth inhibitors|mesh-ancestor
6066796|NCT00687674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5508393|NCT04415476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5508394|NCT04415476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508395|NCT04415476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5508396|NCT04415476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5508397|NCT04415476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5508398|NCT04415476|Immunologic Factors|immunologic factors|mesh-ancestor
5508399|NCT04415476|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6066797|NCT00687674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6066798|NCT00687674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066799|NCT00687713|Bupropion|bupropion|mesh-list
6066800|NCT00687713|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6066801|NCT00687713|Antidepressive Agents|antidepressive agents|mesh-ancestor
6066802|NCT00687713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6066803|NCT00687713|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6066804|NCT00687713|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6066805|NCT00687713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6066806|NCT00687713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066807|NCT00687713|Dopamine Agents|dopamine agents|mesh-ancestor
6066808|NCT00687713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6066809|NCT00687713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665340|NCT01516606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6665341|NCT01516606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6665342|NCT01516606|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5508400|NCT04415476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6665343|NCT01516606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6665344|NCT01516606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665345|NCT01516606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6665346|NCT01516606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6665347|NCT01516710|Liver Extracts|liver extracts|mesh-list
6665348|NCT01516710|Hematinics|hematinics|mesh-ancestor
6665349|NCT01516723|Sirolimus|sirolimus|mesh-list
6665350|NCT01516723|Everolimus|everolimus|mesh-list
6665351|NCT01516723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6665352|NCT01516723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6066810|NCT00687713|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6066811|NCT00687713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6066812|NCT00687713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6066813|NCT00687739|Leuprolide|leuprolide|mesh-list
6066814|NCT00687739|Estradiol|estradiol|mesh-list
6066815|NCT00687739|Estrogens|estrogens|mesh-ancestor
6066816|NCT00687739|Hormones|hormones|mesh-ancestor
6066817|NCT00687739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6066818|NCT00687739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066819|NCT00687739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6066820|NCT00687739|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6066821|NCT00687739|Fertility Agents|fertility agents|mesh-ancestor
6066822|NCT00687739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6665353|NCT01516723|Immunologic Factors|immunologic factors|mesh-ancestor
6066823|NCT00687739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6066824|NCT00687804|Ranibizumab|ranibizumab|mesh-list
6066825|NCT00687804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6066826|NCT00687804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6066827|NCT00687804|Growth Substances|growth substances|mesh-ancestor
6066828|NCT00687804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066829|NCT00687804|Growth Inhibitors|growth inhibitors|mesh-ancestor
6066830|NCT00687804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6066831|NCT00687908|Adapalene|adapalene|mesh-list
6066832|NCT00687908|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6066833|NCT00687908|Dermatologic Agents|dermatologic agents|mesh-ancestor
6066834|NCT00687908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6066835|NCT00687908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6463124|NCT00462852|Gemcitabine|gemcitabine|mesh-list
5508401|NCT04415476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508402|NCT04415476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5508403|NCT04415476|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5508404|NCT04415476|Antitubercular Agents|antitubercular agents|mesh-ancestor
5508405|NCT04415476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5508406|NCT04415476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5508407|NCT04415476|Antifungal Agents|antifungal agents|mesh-ancestor
6463125|NCT00462852|Dalteparin|dalteparin|mesh-list
6463126|NCT00462852|Tinzaparin|tinzaparin|mesh-list
6463127|NCT00462852|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6463128|NCT00462852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6463129|NCT00462852|Antimetabolites|antimetabolites|mesh-ancestor
6463130|NCT00462852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463131|NCT00462852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6066836|NCT00687908|Analgesics|analgesics|mesh-ancestor
6066837|NCT00687908|Sensory System Agents|sensory system agents|mesh-ancestor
6066838|NCT00687908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6066839|NCT00687908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066840|NCT00687908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6066841|NCT00687908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6066842|NCT00687973|Atenolol|atenolol|mesh-list
6066843|NCT00687973|Amlodipine|amlodipine|mesh-list
6066844|NCT00687973|Valsartan|valsartan|mesh-list
6066845|NCT00687973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6066846|NCT00687973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6066847|NCT00687973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6066848|NCT00687973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066849|NCT00687973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6066850|NCT00687973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066851|NCT00687973|Vasodilator Agents|vasodilator agents|mesh-ancestor
6066852|NCT00687973|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6066853|NCT00687973|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6066854|NCT00687973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6066855|NCT00687973|Sympatholytics|sympatholytics|mesh-ancestor
6066856|NCT00687973|Autonomic Agents|autonomic agents|mesh-ancestor
6066857|NCT00687973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6066858|NCT00687973|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6066859|NCT00687973|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6066860|NCT00687973|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6066861|NCT00687973|Adrenergic Agents|adrenergic agents|mesh-ancestor
6066862|NCT00687973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6202371|NCT02040116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6202372|NCT02040116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6202373|NCT02040116|Immunologic Factors|immunologic factors|mesh-ancestor
6202374|NCT02040116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202375|NCT02040116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6202376|NCT02040298|Clemastine|clemastine|mesh-list
6202377|NCT02040298|Antipruritics|antipruritics|mesh-ancestor
6202378|NCT02040298|Dermatologic Agents|dermatologic agents|mesh-ancestor
6202379|NCT02040298|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6202380|NCT02040298|Histamine Antagonists|histamine antagonists|mesh-ancestor
6202381|NCT02040298|Histamine Agents|histamine agents|mesh-ancestor
6202382|NCT02040298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6202383|NCT02040298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202384|NCT02040298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202385|NCT02040298|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6202386|NCT02040428|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6202387|NCT02040428|Hemostatics|hemostatics|mesh-ancestor
6202388|NCT02040428|Coagulants|coagulants|mesh-ancestor
6202389|NCT02040532|Gabapentin|gabapentin|mesh-list
6463132|NCT00462852|Antiviral Agents|antiviral agents|mesh-ancestor
6066863|NCT00688064|Doxycycline|doxycycline|mesh-list
6066864|NCT00688064|Adapalene|adapalene|mesh-list
6066865|NCT00688064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5508408|NCT04414748|Cetrorelix|cetrorelix|mesh-list
5508409|NCT04414748|Dydrogesterone|dydrogesterone|mesh-list
6066866|NCT00688064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6066867|NCT00688064|Antimalarials|antimalarials|mesh-ancestor
6066868|NCT00688064|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6066869|NCT00688064|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6066870|NCT00688064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6066871|NCT00688064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6066872|NCT00688064|Analgesics|analgesics|mesh-ancestor
6066873|NCT00688064|Sensory System Agents|sensory system agents|mesh-ancestor
6066874|NCT00688064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6066875|NCT00688064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066876|NCT00688064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6066877|NCT00688064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6066878|NCT00688064|Dermatologic Agents|dermatologic agents|mesh-ancestor
6066879|NCT00688103|Etanercept|etanercept|mesh-list
6066880|NCT00688103|Methotrexate|methotrexate|mesh-list
6066881|NCT00688103|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6066882|NCT00688103|Abortifacient Agents|abortifacient agents|mesh-ancestor
6066883|NCT00688103|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6066884|NCT00688103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066885|NCT00688103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6066886|NCT00688103|Antimetabolites|antimetabolites|mesh-ancestor
6066887|NCT00688103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066888|NCT00688103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6066889|NCT00688103|Dermatologic Agents|dermatologic agents|mesh-ancestor
6066890|NCT00688103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6066891|NCT00688103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6066892|NCT00688103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6066893|NCT00688103|Immunologic Factors|immunologic factors|mesh-ancestor
6066894|NCT00688103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6066895|NCT00688103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6066896|NCT00688103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6066897|NCT00688103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6066898|NCT00688103|Analgesics|analgesics|mesh-ancestor
6066899|NCT00688103|Sensory System Agents|sensory system agents|mesh-ancestor
6066900|NCT00688103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6066901|NCT00688103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6066902|NCT00688103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6463133|NCT00462852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6463134|NCT00462852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6463135|NCT00462852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6463136|NCT00462852|Immunologic Factors|immunologic factors|mesh-ancestor
6463137|NCT00462852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463138|NCT00462852|Anticoagulants|anticoagulants|mesh-ancestor
6463139|NCT00462852|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6066903|NCT00688324|Acamprosate|acamprosate|mesh-list
6066904|NCT00688324|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6463140|NCT00462852|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6665354|NCT01516723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665355|NCT01516723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6665356|NCT01516723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6665357|NCT01516723|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6665358|NCT01516723|Antifungal Agents|antifungal agents|mesh-ancestor
6665359|NCT01516762|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
6066905|NCT00688545|Celecoxib|celecoxib|mesh-list
6066906|NCT00688545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6066907|NCT00688545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6066908|NCT00688545|Analgesics|analgesics|mesh-ancestor
6066909|NCT00688545|Sensory System Agents|sensory system agents|mesh-ancestor
6066910|NCT00688545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6066911|NCT00688545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066912|NCT00688545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6066913|NCT00688545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6066914|NCT00688545|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6066915|NCT00688545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6066916|NCT00688545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6066917|NCT00688545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066918|NCT00688597|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
6066919|NCT00688597|Antiviral Agents|antiviral agents|mesh-ancestor
6066920|NCT00688597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6066921|NCT00688597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6066922|NCT00688597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066923|NCT00688623|Everolimus|everolimus|mesh-list
6066924|NCT00688623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6066925|NCT00688623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6066926|NCT00688623|Immunologic Factors|immunologic factors|mesh-ancestor
6066927|NCT00688623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066928|NCT00688636|Infliximab|infliximab|mesh-list
6066929|NCT00688636|Dermatologic Agents|dermatologic agents|mesh-ancestor
6066930|NCT00688636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6066931|NCT00688636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6066932|NCT00688688|Mirabegron|mirabegron|mesh-list
6066933|NCT00688688|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6066934|NCT00688688|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6066935|NCT00688688|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6066936|NCT00688688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6066937|NCT00688688|Adrenergic Agents|adrenergic agents|mesh-ancestor
6066938|NCT00688688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6066939|NCT00688688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066940|NCT00688688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066941|NCT00688688|Urological Agents|urological agents|mesh-ancestor
6066942|NCT00688688|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6066943|NCT00688688|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6066944|NCT00688688|Cholinergic Agents|cholinergic agents|mesh-ancestor
6066945|NCT00688701|Lixisenatide|lixisenatide|mesh-list
6066946|NCT00688701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6066947|NCT00688701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066948|NCT00688740|Cyclophosphamide|cyclophosphamide|mesh-list
6066949|NCT00688740|Docetaxel|docetaxel|mesh-list
6066950|NCT00688740|Doxorubicin|doxorubicin|mesh-list
6066951|NCT00688740|Fluorouracil|fluorouracil|mesh-list
6066952|NCT00688740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6066953|NCT00688740|Immunologic Factors|immunologic factors|mesh-ancestor
6066954|NCT00688740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066955|NCT00688740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6066956|NCT00688740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6066957|NCT00688740|Alkylating Agents|alkylating agents|mesh-ancestor
6066958|NCT00688740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066959|NCT00688740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6066960|NCT00688740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6066961|NCT00688740|Tubulin Modulators|tubulin modulators|mesh-ancestor
6066962|NCT00688740|Antimitotic Agents|antimitotic agents|mesh-ancestor
6066963|NCT00688740|Mitosis Modulators|mitosis modulators|mesh-ancestor
6066964|NCT00688740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6066965|NCT00688740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6066966|NCT00688740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6066967|NCT00688740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6066968|NCT00688740|Antimetabolites|antimetabolites|mesh-ancestor
6066969|NCT00688740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6066970|NCT00688753|Everolimus|everolimus|mesh-list
6066971|NCT00688753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6066972|NCT00688753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6066973|NCT00688753|Immunologic Factors|immunologic factors|mesh-ancestor
6066974|NCT00688753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066975|NCT00688870|Vaccines|vaccines|mesh-list
6066976|NCT00688870|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6066977|NCT00688870|Immunologic Factors|immunologic factors|mesh-ancestor
6066978|NCT00688870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066979|NCT00688909|Letrozole|letrozole|mesh-list
6066980|NCT00688909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6066981|NCT00688909|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6066982|NCT00688909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6066983|NCT00688909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6066984|NCT00688909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066985|NCT00688909|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6066986|NCT00688909|Hormone Antagonists|hormone antagonists|mesh-ancestor
6066987|NCT00688909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6066988|NCT00688909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6066989|NCT00689026|Lubiprostone|lubiprostone|mesh-list
6066990|NCT00689026|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6066991|NCT00689026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6066992|NCT00689026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6066993|NCT00689078|Loteprednol Etabonate|loteprednol etabonate|mesh-list
6066994|NCT00689078|Prednisolone|prednisolone|mesh-list
6463141|NCT00462878|Vancomycin|vancomycin|mesh-list
6463142|NCT00462878|Meropenem|meropenem|mesh-list
6463143|NCT00462878|Teicoplanin|teicoplanin|mesh-list
6463144|NCT00462878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6463145|NCT00462878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6066995|NCT00689078|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6066996|NCT00689078|Methylprednisolone|methylprednisolone|mesh-list
6066997|NCT00689078|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6066998|NCT00689078|Prednisolone acetate|prednisolone acetate|mesh-list
6066999|NCT00689078|Lubricant Eye Drops|lubricant eye drops|mesh-list
6067000|NCT00689078|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6067001|NCT00689078|Prednisolone phosphate|prednisolone phosphate|mesh-list
6067002|NCT00689078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6067003|NCT00689078|Glucocorticoids|glucocorticoids|mesh-ancestor
6067004|NCT00689078|Hormones|hormones|mesh-ancestor
6067005|NCT00689078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6067006|NCT00689078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067007|NCT00689078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6067008|NCT00689078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6067009|NCT00689078|Antiemetics|antiemetics|mesh-ancestor
6067010|NCT00689078|Autonomic Agents|autonomic agents|mesh-ancestor
6067011|NCT00689078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6067012|NCT00689078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6067013|NCT00689078|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6067014|NCT00689078|Protective Agents|protective agents|mesh-ancestor
6067015|NCT00689078|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6067016|NCT00689078|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6067017|NCT00689078|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6067018|NCT00689104|Mirabegron|mirabegron|mesh-list
6067019|NCT00689104|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6067020|NCT00689104|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6067021|NCT00689104|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6067022|NCT00689104|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6067023|NCT00689104|Adrenergic Agents|adrenergic agents|mesh-ancestor
6067024|NCT00689104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6067025|NCT00689104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067026|NCT00689104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067027|NCT00689104|Urological Agents|urological agents|mesh-ancestor
6067028|NCT00689104|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6067029|NCT00689104|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6067030|NCT00689104|Cholinergic Agents|cholinergic agents|mesh-ancestor
6067031|NCT00689117|Clindamycin|clindamycin|mesh-list
6067032|NCT00689117|Clindamycin palmitate|clindamycin palmitate|mesh-list
6067033|NCT00689117|Clindamycin phosphate|clindamycin phosphate|mesh-list
6067034|NCT00689117|Tretinoin|tretinoin|mesh-list
6067035|NCT00689117|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6067036|NCT00689117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6067037|NCT00689117|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6067038|NCT00689117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6067039|NCT00689117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067040|NCT00689117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6067041|NCT00689117|Keratolytic Agents|keratolytic agents|mesh-ancestor
6067042|NCT00689117|Dermatologic Agents|dermatologic agents|mesh-ancestor
6067043|NCT00689221|Temozolomide|temozolomide|mesh-list
6067044|NCT00689221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6067045|NCT00689221|Alkylating Agents|alkylating agents|mesh-ancestor
6067046|NCT00689221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067047|NCT00689221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6067048|NCT00689338|Fluconazole|fluconazole|mesh-list
6067049|NCT00689338|Voriconazole|voriconazole|mesh-list
6463146|NCT00462956|Lapatinib|lapatinib|mesh-list
6463147|NCT00462956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6067050|NCT00689338|Anidulafungin|anidulafungin|mesh-list
6067051|NCT00689338|Antifungal Agents|antifungal agents|mesh-ancestor
5508410|NCT04414748|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5508411|NCT04414748|Fertility Agents|fertility agents|mesh-ancestor
5508412|NCT04414748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5508413|NCT04414748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508414|NCT04414748|Hormone Antagonists|hormone antagonists|mesh-ancestor
5508415|NCT04414748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5508416|NCT04414748|Progestins|progestins|mesh-ancestor
6067052|NCT00689338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6067053|NCT00689338|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6067054|NCT00689338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6067055|NCT00689338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6067056|NCT00689338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067057|NCT00689338|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6067058|NCT00689338|Hormone Antagonists|hormone antagonists|mesh-ancestor
6067059|NCT00689338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5508417|NCT04414748|Hormones|hormones|mesh-ancestor
5508418|NCT04414995|Acetaminophen|acetaminophen|mesh-list
5508419|NCT04414995|Ibuprofen|ibuprofen|mesh-list
5508420|NCT04414995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5508421|NCT04414995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5508422|NCT04414995|Analgesics|analgesics|mesh-ancestor
5508423|NCT04414995|Sensory System Agents|sensory system agents|mesh-ancestor
6067060|NCT00689338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067061|NCT00689338|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6067062|NCT00689338|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6067063|NCT00689338|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6067064|NCT00689351|Vaccines|vaccines|mesh-list
6067065|NCT00689351|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6067066|NCT00689351|Immunologic Factors|immunologic factors|mesh-ancestor
6067067|NCT00689351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067068|NCT00689390|Ribavirin|ribavirin|mesh-list
6067069|NCT00689390|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6067070|NCT00689390|Antimetabolites|antimetabolites|mesh-ancestor
6067071|NCT00689390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067072|NCT00689390|Antiviral Agents|antiviral agents|mesh-ancestor
6067073|NCT00689390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6067074|NCT00689572|Ondansetron|ondansetron|mesh-list
6067075|NCT00689572|Antiemetics|antiemetics|mesh-ancestor
6067076|NCT00689572|Autonomic Agents|autonomic agents|mesh-ancestor
6067077|NCT00689572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6463148|NCT00462956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6463149|NCT00462956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6463150|NCT00462956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508424|NCT04414995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5508425|NCT04414995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508426|NCT04414995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5508427|NCT04414995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5508428|NCT04414995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5508429|NCT04414995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5508430|NCT04414995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508431|NCT04414995|Antipyretics|antipyretics|mesh-ancestor
5508432|NCT04414852|Apatinib|apatinib|mesh-list
6067078|NCT00689572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067079|NCT00689572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6067080|NCT00689572|Antipruritics|antipruritics|mesh-ancestor
6067081|NCT00689572|Dermatologic Agents|dermatologic agents|mesh-ancestor
6067082|NCT00689572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6067083|NCT00689572|Serotonin Agents|serotonin agents|mesh-ancestor
6067084|NCT00689572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6067085|NCT00689572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067086|NCT00689572|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6067087|NCT00689572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6067088|NCT00689572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6067089|NCT00689572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6067090|NCT00689572|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6067091|NCT00689611|Bupropion|bupropion|mesh-list
6067092|NCT00689611|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6067093|NCT00689611|Antidepressive Agents|antidepressive agents|mesh-ancestor
6067094|NCT00689611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6067095|NCT00689611|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5508433|NCT04414852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6067096|NCT00689611|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6067097|NCT00689611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6067098|NCT00689611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067099|NCT00689611|Dopamine Agents|dopamine agents|mesh-ancestor
6067100|NCT00689611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6067101|NCT00689611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067102|NCT00689611|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6067103|NCT00689611|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6067104|NCT00689611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6067105|NCT00689793|Iron|iron|mesh-list
6067106|NCT00689793|Trace Elements|trace elements|mesh-ancestor
6067107|NCT00689793|Micronutrients|micronutrients|mesh-ancestor
6067108|NCT00689793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067109|NCT00689936|Thalidomide|thalidomide|mesh-list
6067110|NCT00689936|Dexamethasone|dexamethasone|mesh-list
6067111|NCT00689936|Dexamethasone acetate|dexamethasone acetate|mesh-list
6067112|NCT00689936|Prednisone|prednisone|mesh-list
6067113|NCT00689936|Lenalidomide|lenalidomide|mesh-list
6067114|NCT00689936|Melphalan|melphalan|mesh-list
6067115|NCT00689936|BB 1101|bb 1101|mesh-list
6067116|NCT00689936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6067117|NCT00689936|Antiemetics|antiemetics|mesh-ancestor
6067118|NCT00689936|Autonomic Agents|autonomic agents|mesh-ancestor
6067119|NCT00689936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6067120|NCT00689936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067121|NCT00689936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5508434|NCT04414852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5508435|NCT04414852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5508436|NCT04414852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508437|NCT04415008|Cytarabine|cytarabine|mesh-list
5508438|NCT04415008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5508439|NCT04415008|Antimetabolites|antimetabolites|mesh-ancestor
5508440|NCT04415008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508441|NCT04415008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5508442|NCT04415008|Antiviral Agents|antiviral agents|mesh-ancestor
5508443|NCT04415008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5508444|NCT04415008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5508445|NCT04415008|Immunologic Factors|immunologic factors|mesh-ancestor
5508446|NCT04415008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508447|NCT04414969|Asparaginase|asparaginase|mesh-list
5508448|NCT04414969|Pegaspargase|pegaspargase|mesh-list
5508449|NCT04414969|Antibodies|antibodies|mesh-list
5508450|NCT04414969|Immunoglobulins|immunoglobulins|mesh-list
5508451|NCT04414969|Immunologic Factors|immunologic factors|mesh-ancestor
5508452|NCT04414969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508453|NCT04414969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5508454|NCT04415060|Sevoflurane|sevoflurane|mesh-list
6067122|NCT00689936|Glucocorticoids|glucocorticoids|mesh-ancestor
6067123|NCT00689936|Hormones|hormones|mesh-ancestor
6067124|NCT00689936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6067125|NCT00689936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6067126|NCT00689936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6067127|NCT00689936|Protease Inhibitors|protease inhibitors|mesh-ancestor
6067128|NCT00689936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6067129|NCT00689936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067130|NCT00689936|Immunologic Factors|immunologic factors|mesh-ancestor
6067131|NCT00689936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6067132|NCT00689936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6067133|NCT00689936|Growth Substances|growth substances|mesh-ancestor
6067134|NCT00689936|Growth Inhibitors|growth inhibitors|mesh-ancestor
6067135|NCT00689936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6067136|NCT00689936|Alkylating Agents|alkylating agents|mesh-ancestor
6067137|NCT00689936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6067138|NCT00689936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6067139|NCT00689936|Leprostatic Agents|leprostatic agents|mesh-ancestor
6067140|NCT00689936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6067141|NCT00689936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6067142|NCT00690235|Pramlintide|pramlintide|mesh-list
6067143|NCT00690235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5508455|NCT04415060|Isoflurane|isoflurane|mesh-list
5508456|NCT04415060|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5508457|NCT04415060|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5508458|NCT04415060|Anesthetics, General|anesthetics, general|mesh-ancestor
5508459|NCT04415060|Anesthetics|anesthetics|mesh-ancestor
6067144|NCT00690235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067145|NCT00690378|Imipenem|imipenem|mesh-list
6067146|NCT00690378|Ceftazidime|ceftazidime|mesh-list
5508460|NCT04415060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5508461|NCT04415060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508462|NCT04414956|Vitamin K|vitamin k|mesh-list
5508463|NCT04414956|Agglutinins|agglutinins|mesh-list
5508464|NCT04414956|Vitamins|vitamins|mesh-ancestor
5508465|NCT04414956|Micronutrients|micronutrients|mesh-ancestor
6067147|NCT00690378|Avibactam|avibactam|mesh-list
6067148|NCT00690378|Cilastatin|cilastatin|mesh-list
6067149|NCT00690378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6067150|NCT00690378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6067151|NCT00690378|Protease Inhibitors|protease inhibitors|mesh-ancestor
6067152|NCT00690378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6067153|NCT00690378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067154|NCT00690378|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6067155|NCT00690430|Octreotide|octreotide|mesh-list
6067156|NCT00690430|Pasireotide|pasireotide|mesh-list
6067157|NCT00690430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6067158|NCT00690430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6067159|NCT00690430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6067160|NCT00690430|Hormones|hormones|mesh-ancestor
6067161|NCT00690430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5508466|NCT04414956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508467|NCT04414956|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5508468|NCT04414956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5508469|NCT04414956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508470|NCT04414956|Hemostatics|hemostatics|mesh-ancestor
5508471|NCT04414956|Coagulants|coagulants|mesh-ancestor
5508472|NCT04414956|Immunologic Factors|immunologic factors|mesh-ancestor
5508473|NCT04414800|Fentanyl|fentanyl|mesh-list
5508474|NCT04414800|Ketamine|ketamine|mesh-list
5508475|NCT04414800|Analgesics|analgesics|mesh-ancestor
5508476|NCT04414800|Sensory System Agents|sensory system agents|mesh-ancestor
5508477|NCT04414800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6067162|NCT00690430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067163|NCT00690443|Atorvastatin|atorvastatin|mesh-list
6067164|NCT00690443|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6067165|NCT00690443|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6067166|NCT00690443|Antimetabolites|antimetabolites|mesh-ancestor
6067167|NCT00690443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067168|NCT00690443|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6067169|NCT00690443|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6067170|NCT00690443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6067171|NCT00690495|Propofol|propofol|mesh-list
6067172|NCT00690495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6067173|NCT00690495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6067174|NCT00690495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067175|NCT00690495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6067176|NCT00690495|Anesthetics, General|anesthetics, general|mesh-ancestor
6067177|NCT00690495|Anesthetics|anesthetics|mesh-ancestor
6067178|NCT00690573|Adalimumab|adalimumab|mesh-list
6067179|NCT00690573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6067180|NCT00690573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6067181|NCT00690612|Candesartan|candesartan|mesh-list
6067182|NCT00690612|Candesartan cilexetil|candesartan cilexetil|mesh-list
6067183|NCT00690612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6067184|NCT00690612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6067185|NCT00690612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6067186|NCT00690612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067187|NCT00690794|Travoprost|travoprost|mesh-list
5508478|NCT04414800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067188|NCT00690794|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6067189|NCT00690794|Latanoprost|latanoprost|mesh-list
6067190|NCT00690794|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6067191|NCT00690794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6067192|NCT00690820|Pancrelipase|pancrelipase|mesh-list
6067193|NCT00690820|Pancreatin|pancreatin|mesh-list
6067194|NCT00690820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6067195|NCT00690833|Desonide|desonide|mesh-list
6067196|NCT00690833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6067197|NCT00690898|Lanreotide|lanreotide|mesh-list
6067198|NCT00690898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6067199|NCT00690924|Calcitriol|calcitriol|mesh-list
6067200|NCT00690924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6067201|NCT00690924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067202|NCT00690924|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
5508479|NCT04414800|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6067203|NCT00690924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6067204|NCT00690924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067205|NCT00690924|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6067206|NCT00690924|Vitamins|vitamins|mesh-ancestor
6067207|NCT00690924|Micronutrients|micronutrients|mesh-ancestor
6067208|NCT00690924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6067209|NCT00691002|Calcitriol|calcitriol|mesh-list
6067210|NCT00691002|Hydrocortisone|hydrocortisone|mesh-list
6067211|NCT00691002|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6067212|NCT00691002|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6067213|NCT00691002|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6067214|NCT00691002|Calcipotriene|calcipotriene|mesh-list
6067215|NCT00691002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6067216|NCT00691002|Dermatologic Agents|dermatologic agents|mesh-ancestor
6067217|NCT00691002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6067218|NCT00691002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067219|NCT00691002|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6067220|NCT00691002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6067221|NCT00691002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067222|NCT00691002|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6067223|NCT00691002|Vitamins|vitamins|mesh-ancestor
6067224|NCT00691002|Micronutrients|micronutrients|mesh-ancestor
5508480|NCT04414800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5508481|NCT04414800|Anesthetics, General|anesthetics, general|mesh-ancestor
5508482|NCT04414800|Anesthetics|anesthetics|mesh-ancestor
5508483|NCT04414800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5508484|NCT04414800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6067225|NCT00691002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6067226|NCT00691015|Cytarabine|cytarabine|mesh-list
6067227|NCT00691015|Cyclophosphamide|cyclophosphamide|mesh-list
6067228|NCT00691015|Melphalan|melphalan|mesh-list
6067229|NCT00691015|Busulfan|busulfan|mesh-list
6067230|NCT00691015|Carmustine|carmustine|mesh-list
6067231|NCT00691015|Rituximab|rituximab|mesh-list
6067232|NCT00691015|Fludarabine|fludarabine|mesh-list
5508485|NCT04414800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5508486|NCT04414800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5508487|NCT04414800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508488|NCT04414800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5508489|NCT04414800|Narcotics|narcotics|mesh-ancestor
6067233|NCT00691015|Fludarabine phosphate|fludarabine phosphate|mesh-list
6067234|NCT00691015|Etoposide|etoposide|mesh-list
6067235|NCT00691015|Thymoglobulin|thymoglobulin|mesh-list
6067236|NCT00691015|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6067237|NCT00691015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6067238|NCT00691015|Immunologic Factors|immunologic factors|mesh-ancestor
6067239|NCT00691015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067240|NCT00691015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6067241|NCT00691015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6067242|NCT00691015|Alkylating Agents|alkylating agents|mesh-ancestor
6067243|NCT00691015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067244|NCT00691015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6067245|NCT00691015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6067246|NCT00691015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6067247|NCT00691015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6067248|NCT00691015|Antimetabolites|antimetabolites|mesh-ancestor
6067249|NCT00691015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6067250|NCT00691015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6067251|NCT00691015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6067252|NCT00691015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6067253|NCT00691015|Antiviral Agents|antiviral agents|mesh-ancestor
6067254|NCT00691015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6067255|NCT00691028|Infliximab|infliximab|mesh-list
6067256|NCT00691028|Dermatologic Agents|dermatologic agents|mesh-ancestor
6067257|NCT00691028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6067258|NCT00691028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6067259|NCT00691054|Paclitaxel|paclitaxel|mesh-list
6067260|NCT00691054|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5508490|NCT04414800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5508491|NCT04414761|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
5508492|NCT04414761|Medroxyprogesterone|medroxyprogesterone|mesh-list
6067261|NCT00691054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6067262|NCT00691054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6067263|NCT00691054|Tubulin Modulators|tubulin modulators|mesh-ancestor
6067264|NCT00691054|Antimitotic Agents|antimitotic agents|mesh-ancestor
6067265|NCT00691054|Mitosis Modulators|mitosis modulators|mesh-ancestor
6067266|NCT00691054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067267|NCT00691093|Fesoterodine|fesoterodine|mesh-list
6067268|NCT00691093|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6067269|NCT00691093|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6067270|NCT00691093|Cholinergic Agents|cholinergic agents|mesh-ancestor
6067271|NCT00691093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6067272|NCT00691093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067273|NCT00691093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067274|NCT00691093|Urological Agents|urological agents|mesh-ancestor
6067275|NCT00691132|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
6067276|NCT00691132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6067277|NCT00691132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067278|NCT00691132|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5508493|NCT04414761|Cetrorelix|cetrorelix|mesh-list
5508494|NCT04414761|Progesterone|progesterone|mesh-list
5508495|NCT04414761|Dydrogesterone|dydrogesterone|mesh-list
5508496|NCT04414761|Ganirelix|ganirelix|mesh-list
5508497|NCT04414761|Progestins|progestins|mesh-ancestor
5508498|NCT04414761|Hormones|hormones|mesh-ancestor
5508499|NCT04414761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5508500|NCT04414761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508501|NCT04414761|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5508502|NCT04414761|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5508503|NCT04414761|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5508504|NCT04414761|Contraceptive Agents|contraceptive agents|mesh-ancestor
5508505|NCT04414761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5508506|NCT04414761|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5508507|NCT04414761|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5508508|NCT04414761|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6067279|NCT00691132|Protective Agents|protective agents|mesh-ancestor
6067280|NCT00691132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067281|NCT00691132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6067282|NCT00691197|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6067283|NCT00691197|Glycerol|glycerol|mesh-list
6067284|NCT00691197|Laxatives|laxatives|mesh-ancestor
6067285|NCT00691197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6067286|NCT00691197|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6067287|NCT00691197|Protective Agents|protective agents|mesh-ancestor
6067288|NCT00691197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067289|NCT00691210|Niacinamide|niacinamide|mesh-list
6067290|NCT00691210|Niacin|niacin|mesh-list
6067291|NCT00691210|Nicotinic Acids|nicotinic acids|mesh-list
6067292|NCT00691210|Etoposide|etoposide|mesh-list
6463151|NCT00462995|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5508509|NCT04414761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5508510|NCT04414761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6463152|NCT00462995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6463153|NCT00462995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6463154|NCT00462995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6463155|NCT00462995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463156|NCT00463008|Methotrexate|methotrexate|mesh-list
6463157|NCT00463008|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6067293|NCT00691210|Vorinostat|vorinostat|mesh-list
6067294|NCT00691210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6067295|NCT00691210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6463158|NCT00463008|Abortifacient Agents|abortifacient agents|mesh-ancestor
6463159|NCT00463008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5508511|NCT04414761|Hormone Antagonists|hormone antagonists|mesh-ancestor
6067296|NCT00691210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6463160|NCT00463008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067297|NCT00691210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6067298|NCT00691210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6067299|NCT00691210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067300|NCT00691210|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6067301|NCT00691210|Vitamin B Complex|vitamin b complex|mesh-ancestor
6067302|NCT00691210|Vitamins|vitamins|mesh-ancestor
6067303|NCT00691210|Micronutrients|micronutrients|mesh-ancestor
6067304|NCT00691210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067305|NCT00691210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6067306|NCT00691210|Antimetabolites|antimetabolites|mesh-ancestor
6067307|NCT00691210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6067308|NCT00691210|Vasodilator Agents|vasodilator agents|mesh-ancestor
6067309|NCT00691301|Pemetrexed|pemetrexed|mesh-list
6067310|NCT00691301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6067311|NCT00691301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6067312|NCT00691301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067313|NCT00691301|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6067314|NCT00691301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6067315|NCT00691483|Varenicline|varenicline|mesh-list
6067316|NCT00691483|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6067317|NCT00691483|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6067318|NCT00691483|Cholinergic Agents|cholinergic agents|mesh-ancestor
6067319|NCT00691483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6067320|NCT00691483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067321|NCT00691483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067322|NCT00691600|Trimethoprim|trimethoprim|mesh-list
6067323|NCT00691600|Sulfamethoxazole|sulfamethoxazole|mesh-list
6067324|NCT00691600|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6067325|NCT00691600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6067326|NCT00691600|Renal Agents|renal agents|mesh-ancestor
6067327|NCT00691600|Antimalarials|antimalarials|mesh-ancestor
6067328|NCT00691600|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6067329|NCT00691600|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6067330|NCT00691600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6067331|NCT00691600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6067332|NCT00691600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067333|NCT00691600|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6067334|NCT00691600|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6067335|NCT00691600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6067336|NCT00691665|Fluticasone|fluticasone|mesh-list
6067337|NCT00691665|Xhance|xhance|mesh-list
6067338|NCT00691665|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
6067339|NCT00691665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6067340|NCT00691665|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6067341|NCT00691665|Autonomic Agents|autonomic agents|mesh-ancestor
6067342|NCT00691665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6067343|NCT00691665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067344|NCT00691665|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6067345|NCT00691665|Respiratory System Agents|respiratory system agents|mesh-ancestor
6067346|NCT00691665|Dermatologic Agents|dermatologic agents|mesh-ancestor
6067347|NCT00691665|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6067348|NCT00691665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6067349|NCT00691665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6067350|NCT00691665|Analgesics|analgesics|mesh-ancestor
6067351|NCT00691665|Sensory System Agents|sensory system agents|mesh-ancestor
6067352|NCT00691665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6067353|NCT00691665|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6067354|NCT00691665|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6067355|NCT00691665|Histamine Antagonists|histamine antagonists|mesh-ancestor
6067356|NCT00691665|Histamine Agents|histamine agents|mesh-ancestor
6067357|NCT00691665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6067358|NCT00691665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067359|NCT00691704|Aspirin|aspirin|mesh-list
6067360|NCT00691704|Prednisone|prednisone|mesh-list
6067361|NCT00691704|Lenalidomide|lenalidomide|mesh-list
6067362|NCT00691704|Bortezomib|bortezomib|mesh-list
6067363|NCT00691704|Melphalan|melphalan|mesh-list
6463161|NCT00463008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6463162|NCT00463008|Antimetabolites|antimetabolites|mesh-ancestor
6463163|NCT00463008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463164|NCT00463008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6463165|NCT00463008|Dermatologic Agents|dermatologic agents|mesh-ancestor
6067364|NCT00691704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6067365|NCT00691704|Glucocorticoids|glucocorticoids|mesh-ancestor
6067366|NCT00691704|Hormones|hormones|mesh-ancestor
6067367|NCT00691704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6067368|NCT00691704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067369|NCT00691704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6067370|NCT00691704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6067371|NCT00691704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6067372|NCT00691704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6067373|NCT00691704|Analgesics|analgesics|mesh-ancestor
6067374|NCT00691704|Sensory System Agents|sensory system agents|mesh-ancestor
6067375|NCT00691704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6067376|NCT00691704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6067377|NCT00691704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6067378|NCT00691704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6067379|NCT00691704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067380|NCT00691704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6067381|NCT00691704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6067382|NCT00691704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6067383|NCT00691704|Antipyretics|antipyretics|mesh-ancestor
6067384|NCT00691704|Immunologic Factors|immunologic factors|mesh-ancestor
6067385|NCT00691704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6067386|NCT00691704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6067387|NCT00691704|Growth Substances|growth substances|mesh-ancestor
6067388|NCT00691704|Growth Inhibitors|growth inhibitors|mesh-ancestor
6067389|NCT00691704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6067390|NCT00691704|Alkylating Agents|alkylating agents|mesh-ancestor
6067391|NCT00691704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6067392|NCT00691704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6067393|NCT00691938|Decitabine|decitabine|mesh-list
6067394|NCT00691938|Panobinostat|panobinostat|mesh-list
6067395|NCT00691938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6067396|NCT00691938|Antimetabolites|antimetabolites|mesh-ancestor
6067397|NCT00691938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067398|NCT00691938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6067399|NCT00691938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6067400|NCT00691938|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6067401|NCT00692185|Olanzapine|olanzapine|mesh-list
6067402|NCT00692185|Antiemetics|antiemetics|mesh-ancestor
6067403|NCT00692185|Autonomic Agents|autonomic agents|mesh-ancestor
6067404|NCT00692185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6067405|NCT00692185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067406|NCT00692185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6067407|NCT00692185|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6067408|NCT00692185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6067409|NCT00692185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6067410|NCT00692185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6067411|NCT00692185|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6067412|NCT00692185|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6067413|NCT00692185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6067414|NCT00692185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067415|NCT00692185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6067416|NCT00692185|Serotonin Agents|serotonin agents|mesh-ancestor
6067417|NCT00692237|Sildenafil Citrate|sildenafil citrate|mesh-list
6067418|NCT00692237|Vasodilator Agents|vasodilator agents|mesh-ancestor
6067419|NCT00692237|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6067420|NCT00692237|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6067421|NCT00692237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6067422|NCT00692237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067423|NCT00692237|Urological Agents|urological agents|mesh-ancestor
6067424|NCT00692341|Axitinib|axitinib|mesh-list
6067425|NCT00692341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6067426|NCT00692341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6067427|NCT00692341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6067428|NCT00692341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067429|NCT00692770|Sorafenib|sorafenib|mesh-list
6067430|NCT00692770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6067431|NCT00692770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6067432|NCT00692770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6202390|NCT02040532|Analgesics|analgesics|mesh-ancestor
5508512|NCT04414761|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5508513|NCT04414761|Fertility Agents|fertility agents|mesh-ancestor
5508514|NCT04414943|Ketamine|ketamine|mesh-list
5508515|NCT04414943|Esketamine|esketamine|mesh-list
5508516|NCT04414943|Analgesics|analgesics|mesh-ancestor
5508517|NCT04414943|Sensory System Agents|sensory system agents|mesh-ancestor
5508518|NCT04414943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5508519|NCT04414943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508520|NCT04414943|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5508521|NCT04414943|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5508522|NCT04414943|Anesthetics, General|anesthetics, general|mesh-ancestor
5508523|NCT04414943|Anesthetics|anesthetics|mesh-ancestor
5508524|NCT04414943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5508525|NCT04414943|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5508526|NCT04414943|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5508527|NCT04414943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5508528|NCT04414943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508529|NCT04414943|Antidepressive Agents|antidepressive agents|mesh-ancestor
5508530|NCT04414943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5508531|NCT04414540|Metformin|metformin|mesh-list
5508532|NCT04414540|Pembrolizumab|pembrolizumab|mesh-list
5508533|NCT04414540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5508534|NCT04414540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508535|NCT04414540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5508536|NCT04414540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5508537|NCT04414605|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5508538|NCT04414605|Immunologic Factors|immunologic factors|mesh-ancestor
5508539|NCT04414605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508540|NCT04414566|Gemcitabine|gemcitabine|mesh-list
5508541|NCT04414566|Cisplatin|cisplatin|mesh-list
5508542|NCT04414566|Docetaxel|docetaxel|mesh-list
6067433|NCT00692770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067434|NCT00692978|Fluticasone|fluticasone|mesh-list
6067435|NCT00692978|Xhance|xhance|mesh-list
6067436|NCT00692978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6067437|NCT00692978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6067438|NCT00692978|Autonomic Agents|autonomic agents|mesh-ancestor
6067439|NCT00692978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6067440|NCT00692978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508543|NCT04414566|Fluorouracil|fluorouracil|mesh-list
5508544|NCT04414566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5508545|NCT04414566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6067441|NCT00692978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6067442|NCT00692978|Respiratory System Agents|respiratory system agents|mesh-ancestor
6067443|NCT00692978|Dermatologic Agents|dermatologic agents|mesh-ancestor
6067444|NCT00692978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6067445|NCT00693160|Ketorolac|ketorolac|mesh-list
6067446|NCT00693160|Remifentanil|remifentanil|mesh-list
6067447|NCT00693160|Capsaicin|capsaicin|mesh-list
6067448|NCT00693160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6067449|NCT00693160|Narcotics|narcotics|mesh-ancestor
6067450|NCT00693160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6067451|NCT00693160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067452|NCT00693160|Analgesics|analgesics|mesh-ancestor
6067453|NCT00693160|Sensory System Agents|sensory system agents|mesh-ancestor
6067454|NCT00693160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6067455|NCT00693160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6067456|NCT00693160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6067457|NCT00693160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6067458|NCT00693160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6067459|NCT00693160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6067460|NCT00693160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6067461|NCT00693160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463166|NCT00463008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6463167|NCT00463008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6463168|NCT00463008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6067462|NCT00693160|Antipruritics|antipruritics|mesh-ancestor
6067463|NCT00693160|Dermatologic Agents|dermatologic agents|mesh-ancestor
6067464|NCT00693225|Omeprazole|omeprazole|mesh-list
6067465|NCT00693225|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6067466|NCT00693225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6067467|NCT00693225|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6067468|NCT00693225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6067469|NCT00693225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067470|NCT00693420|Bimatoprost|bimatoprost|mesh-list
6067471|NCT00693420|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6067472|NCT00693420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6463169|NCT00463008|Immunologic Factors|immunologic factors|mesh-ancestor
6463170|NCT00463008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6067473|NCT00693472|Propranolol|propranolol|mesh-list
6067474|NCT00693472|Haloperidol|haloperidol|mesh-list
6067475|NCT00693472|Haloperidol decanoate|haloperidol decanoate|mesh-list
6067476|NCT00693472|Cholinergic Antagonists|cholinergic antagonists|mesh-list
6067477|NCT00693472|Antiemetics|antiemetics|mesh-ancestor
6067478|NCT00693472|Autonomic Agents|autonomic agents|mesh-ancestor
6067479|NCT00693472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6067480|NCT00693472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067481|NCT00693472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6067482|NCT00693472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6067483|NCT00693472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6067484|NCT00693472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6067485|NCT00693472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6067486|NCT00693472|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6067487|NCT00693472|Dopamine Agents|dopamine agents|mesh-ancestor
6067488|NCT00693472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6067489|NCT00693472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067490|NCT00693472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6067491|NCT00693472|Cholinergic Agents|cholinergic agents|mesh-ancestor
6067492|NCT00693472|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6067493|NCT00693472|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6067494|NCT00693472|Adrenergic Agents|adrenergic agents|mesh-ancestor
6067495|NCT00693472|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6067496|NCT00693472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6067497|NCT00693472|Vasodilator Agents|vasodilator agents|mesh-ancestor
6067498|NCT00693485|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6067499|NCT00693485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6067500|NCT00693485|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6067501|NCT00693485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6067502|NCT00693485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6067503|NCT00693485|Adrenergic Agents|adrenergic agents|mesh-ancestor
6067504|NCT00693485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6067505|NCT00693485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067506|NCT00693485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067507|NCT00693693|Hydrocortisone|hydrocortisone|mesh-list
6067508|NCT00693693|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6067509|NCT00693693|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6067510|NCT00693693|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6067511|NCT00693693|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
6067512|NCT00693693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6067513|NCT00693693|Dermatologic Agents|dermatologic agents|mesh-ancestor
6067514|NCT00693719|Irinotecan|irinotecan|mesh-list
6067515|NCT00693719|Etoposide|etoposide|mesh-list
6067516|NCT00693719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6067517|NCT00693719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6067518|NCT00693719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6067519|NCT00693719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067520|NCT00693719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6067521|NCT00693719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6067522|NCT00693719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6067523|NCT00693992|Sunitinib|sunitinib|mesh-list
6067524|NCT00693992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6067525|NCT00693992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6067526|NCT00693992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6067527|NCT00693992|Growth Substances|growth substances|mesh-ancestor
6067528|NCT00693992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067529|NCT00693992|Growth Inhibitors|growth inhibitors|mesh-ancestor
6067530|NCT00693992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6067531|NCT00693992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6067532|NCT00693992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067533|NCT00694096|Sunitinib|sunitinib|mesh-list
6067534|NCT00694096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6067535|NCT00694096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6067536|NCT00694096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6067537|NCT00694096|Growth Substances|growth substances|mesh-ancestor
6067538|NCT00694096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067539|NCT00694096|Growth Inhibitors|growth inhibitors|mesh-ancestor
6067540|NCT00694096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6067541|NCT00694096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6067542|NCT00694096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067543|NCT00694109|Mipomersen|mipomersen|mesh-list
6067544|NCT00694109|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6067545|NCT00694109|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6067546|NCT00694109|Antimetabolites|antimetabolites|mesh-ancestor
6067547|NCT00694109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067548|NCT00694109|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6067549|NCT00694122|Insulin Glargine|insulin glargine|mesh-list
6067550|NCT00694122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6067551|NCT00694122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067552|NCT00694304|Vortioxetine|vortioxetine|mesh-list
6067553|NCT00694304|Antidepressive Agents|antidepressive agents|mesh-ancestor
6067554|NCT00694304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6067555|NCT00694304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6067556|NCT00694304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6067557|NCT00694304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6067558|NCT00694304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067559|NCT00694304|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6067560|NCT00694304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6067561|NCT00694304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6067562|NCT00694304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067563|NCT00694304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6067564|NCT00694304|Serotonin Agents|serotonin agents|mesh-ancestor
6067565|NCT00694304|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6067566|NCT00694304|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6067567|NCT00694304|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6067568|NCT00694304|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6067569|NCT00694551|Poly I-C|poly i-c|mesh-list
6067570|NCT00694551|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6067571|NCT00694551|Vaccines|vaccines|mesh-list
6067572|NCT00694551|Poly ICLC|poly iclc|mesh-list
6067573|NCT00694551|Immunologic Factors|immunologic factors|mesh-ancestor
6067574|NCT00694551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463171|NCT00463008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6463172|NCT00463021|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
6463173|NCT00463021|Vitamins|vitamins|mesh-ancestor
6463174|NCT00463021|Micronutrients|micronutrients|mesh-ancestor
6463175|NCT00463021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463176|NCT00463021|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6463177|NCT00463073|Bevacizumab|bevacizumab|mesh-list
6463178|NCT00463073|Cetuximab|cetuximab|mesh-list
6463179|NCT00463073|Irinotecan|irinotecan|mesh-list
6463180|NCT00463073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6463181|NCT00463073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6463182|NCT00463073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6463183|NCT00463073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6463184|NCT00463073|Growth Substances|growth substances|mesh-ancestor
6067575|NCT00694551|Interferon Inducers|interferon inducers|mesh-ancestor
6067576|NCT00694551|Laxatives|laxatives|mesh-ancestor
6067577|NCT00694551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6067578|NCT00694551|Antiviral Agents|antiviral agents|mesh-ancestor
6067579|NCT00694551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6067580|NCT00694603|Cetuximab|cetuximab|mesh-list
6067581|NCT00694603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5508546|NCT04414566|Antimetabolites|antimetabolites|mesh-ancestor
5508547|NCT04414566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508548|NCT04414566|Antiviral Agents|antiviral agents|mesh-ancestor
5508549|NCT04414566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5508550|NCT04414566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5508551|NCT04414566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6067582|NCT00694603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6067583|NCT00694707|Risperidone|risperidone|mesh-list
6067584|NCT00694707|Cariprazine|cariprazine|mesh-list
6067585|NCT00694707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6067586|NCT00694707|Serotonin Agents|serotonin agents|mesh-ancestor
6067587|NCT00694707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6067588|NCT00694707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067589|NCT00694707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067590|NCT00694707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6067591|NCT00694707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6067592|NCT00694707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6067593|NCT00694707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6067594|NCT00694707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5508552|NCT04414566|Immunologic Factors|immunologic factors|mesh-ancestor
5508553|NCT04414566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508554|NCT04414566|Tubulin Modulators|tubulin modulators|mesh-ancestor
5508555|NCT04414566|Antimitotic Agents|antimitotic agents|mesh-ancestor
5508556|NCT04414566|Mitosis Modulators|mitosis modulators|mesh-ancestor
5508557|NCT04414579|Insulin|insulin|mesh-list
5508558|NCT04414579|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5508559|NCT04414579|Insulin Aspart|insulin aspart|mesh-list
6067595|NCT00694707|Dopamine Agents|dopamine agents|mesh-ancestor
6067596|NCT00695019|Interferons|interferons|mesh-list
6067597|NCT00695019|Interferon-alpha|interferon-alpha|mesh-list
6067598|NCT00695019|Interferon alpha-2|interferon alpha-2|mesh-list
6067599|NCT00695019|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
6067600|NCT00695019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6067601|NCT00695019|Antiviral Agents|antiviral agents|mesh-ancestor
6067602|NCT00695019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6067603|NCT00695019|Immunologic Factors|immunologic factors|mesh-ancestor
6067604|NCT00695019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067605|NCT00695097|Rituximab|rituximab|mesh-list
6067606|NCT00695097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6067607|NCT00695097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6067608|NCT00695097|Immunologic Factors|immunologic factors|mesh-ancestor
6067609|NCT00695097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067610|NCT00695097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6067611|NCT00695110|Methyltestosterone|methyltestosterone|mesh-list
6067612|NCT00695110|Testosterone|testosterone|mesh-list
6067613|NCT00695110|Testosterone undecanoate|testosterone undecanoate|mesh-list
6067614|NCT00695110|Testosterone enanthate|testosterone enanthate|mesh-list
6067615|NCT00695110|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5508560|NCT04414579|Insulin, Long-Acting|insulin, long-acting|mesh-list
5508561|NCT04414579|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
5508562|NCT04414579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5508563|NCT04414579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508564|NCT04414228|Anesthetics|anesthetics|mesh-list
5508565|NCT04414228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5508566|NCT04414228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508567|NCT04414254|Cefprozil|cefprozil|mesh-list
5508568|NCT04414254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5508569|NCT04414254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6067616|NCT00695110|Androgens|androgens|mesh-ancestor
6067617|NCT00695110|Hormones|hormones|mesh-ancestor
6067618|NCT00695110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6067619|NCT00695110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067620|NCT00695110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6067621|NCT00695110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6067622|NCT00695110|Anabolic Agents|anabolic agents|mesh-ancestor
6067623|NCT00695136|Donepezil|donepezil|mesh-list
6067624|NCT00695136|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6067625|NCT00695136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6067626|NCT00695136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067627|NCT00695136|Cholinergic Agents|cholinergic agents|mesh-ancestor
6067628|NCT00695136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6067629|NCT00695136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067630|NCT00695136|Nootropic Agents|nootropic agents|mesh-ancestor
6067631|NCT00695188|Methotrexate|methotrexate|mesh-list
6067632|NCT00695188|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6067633|NCT00695188|Abortifacient Agents|abortifacient agents|mesh-ancestor
6067634|NCT00695188|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6067635|NCT00695188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067636|NCT00695188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6067637|NCT00695188|Antimetabolites|antimetabolites|mesh-ancestor
6067638|NCT00695188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067639|NCT00695188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6067640|NCT00695188|Dermatologic Agents|dermatologic agents|mesh-ancestor
6067641|NCT00695188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6067642|NCT00695188|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6067643|NCT00695188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6067644|NCT00695188|Immunologic Factors|immunologic factors|mesh-ancestor
6067645|NCT00695188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6067646|NCT00695188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6067647|NCT00695292|Carboplatin|carboplatin|mesh-list
6067648|NCT00695292|Irinotecan|irinotecan|mesh-list
6067649|NCT00695292|Sunitinib|sunitinib|mesh-list
6067650|NCT00695292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6067651|NCT00695292|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5508570|NCT04414267|Vaccines|vaccines|mesh-list
5508571|NCT04414267|BCG Vaccine|bcg vaccine|mesh-list
6067652|NCT00695292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6067653|NCT00695292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6067654|NCT00695292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067655|NCT00695292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6067656|NCT00695292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6067657|NCT00695292|Growth Substances|growth substances|mesh-ancestor
6067658|NCT00695292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067659|NCT00695292|Growth Inhibitors|growth inhibitors|mesh-ancestor
6067660|NCT00695292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6067661|NCT00695318|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
6067662|NCT00695318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6067663|NCT00695318|Glucocorticoids|glucocorticoids|mesh-ancestor
6067664|NCT00695318|Hormones|hormones|mesh-ancestor
6067665|NCT00695318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6067666|NCT00695318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067667|NCT00695396|Epoetin Alfa|epoetin alfa|mesh-list
6067668|NCT00695396|Hematinics|hematinics|mesh-ancestor
6067669|NCT00695409|Cytarabine|cytarabine|mesh-list
6067670|NCT00695409|Rituximab|rituximab|mesh-list
6067671|NCT00695409|Etoposide|etoposide|mesh-list
6067672|NCT00695409|Etoposide phosphate|etoposide phosphate|mesh-list
6067673|NCT00695409|Melphalan|melphalan|mesh-list
6067674|NCT00695409|Carmustine|carmustine|mesh-list
6067675|NCT00695409|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6067676|NCT00695409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6067677|NCT00695409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6067678|NCT00695409|Immunologic Factors|immunologic factors|mesh-ancestor
6067679|NCT00695409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067680|NCT00695409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6067681|NCT00695409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6067682|NCT00695409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6067683|NCT00695409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6067684|NCT00695409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6067685|NCT00695409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067686|NCT00695409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6067687|NCT00695409|Antimetabolites|antimetabolites|mesh-ancestor
6067688|NCT00695409|Antiviral Agents|antiviral agents|mesh-ancestor
6067689|NCT00695409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6067690|NCT00695409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6067691|NCT00695409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6067692|NCT00695409|Alkylating Agents|alkylating agents|mesh-ancestor
6067693|NCT00695409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6067694|NCT00695435|Tobramycin|tobramycin|mesh-list
6067695|NCT00695435|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
5508572|NCT04414267|Immunologic Factors|immunologic factors|mesh-ancestor
5508573|NCT04414267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508574|NCT04414267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5508575|NCT04413734|Gemcitabine|gemcitabine|mesh-list
5508576|NCT04413734|Cisplatin|cisplatin|mesh-list
5508577|NCT04413734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6067696|NCT00695435|Dexamethasone|dexamethasone|mesh-list
6067697|NCT00695435|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6067698|NCT00695435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6067699|NCT00695435|Antiemetics|antiemetics|mesh-ancestor
6067700|NCT00695435|Autonomic Agents|autonomic agents|mesh-ancestor
6067701|NCT00695435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6067702|NCT00695435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067703|NCT00695435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6067704|NCT00695435|Glucocorticoids|glucocorticoids|mesh-ancestor
5508578|NCT04413734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6067705|NCT00695435|Hormones|hormones|mesh-ancestor
6067706|NCT00695435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6067707|NCT00695435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6067708|NCT00695435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6067709|NCT00695435|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6067710|NCT00695435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6067711|NCT00695435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6067712|NCT00695500|Varenicline|varenicline|mesh-list
6067713|NCT00695500|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6067714|NCT00695500|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6067715|NCT00695500|Cholinergic Agents|cholinergic agents|mesh-ancestor
6067716|NCT00695500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6067717|NCT00695500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665360|NCT01516762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6665361|NCT01516814|Heparin|heparin|mesh-list
6665362|NCT01516814|Calcium heparin|calcium heparin|mesh-list
6665363|NCT01516814|Warfarin|warfarin|mesh-list
6665364|NCT01516814|Rivaroxaban|rivaroxaban|mesh-list
6665365|NCT01516814|Anticoagulants|anticoagulants|mesh-ancestor
6665366|NCT01516814|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6665367|NCT01516814|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6665368|NCT01516814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508579|NCT04413734|Antimetabolites|antimetabolites|mesh-ancestor
5508580|NCT04413734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067718|NCT00695500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067719|NCT00695565|Clonidine|clonidine|mesh-list
6067720|NCT00695565|Analgesics|analgesics|mesh-ancestor
6067721|NCT00695565|Sensory System Agents|sensory system agents|mesh-ancestor
6067722|NCT00695565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6067723|NCT00695565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067724|NCT00695565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5508581|NCT04413734|Antiviral Agents|antiviral agents|mesh-ancestor
5508582|NCT04413734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5508583|NCT04413734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5508584|NCT04413734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5508585|NCT04413734|Immunologic Factors|immunologic factors|mesh-ancestor
5508586|NCT04413734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508587|NCT04413799|Lidocaine|lidocaine|mesh-list
5508588|NCT04413799|Ketamine|ketamine|mesh-list
5508589|NCT04413799|Anesthetics, Local|anesthetics, local|mesh-ancestor
5508590|NCT04413799|Anesthetics|anesthetics|mesh-ancestor
5508591|NCT04413799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5508592|NCT04413799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508593|NCT04413799|Sensory System Agents|sensory system agents|mesh-ancestor
5508594|NCT04413799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5508595|NCT04413799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5508596|NCT04413799|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5508597|NCT04413799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5508598|NCT04413799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5508599|NCT04413799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067725|NCT00695565|Sympatholytics|sympatholytics|mesh-ancestor
5508600|NCT04413799|Analgesics|analgesics|mesh-ancestor
5508601|NCT04413799|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5508602|NCT04413799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5508603|NCT04413799|Anesthetics, General|anesthetics, general|mesh-ancestor
5508604|NCT04413799|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5508605|NCT04413799|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5508606|NCT04413799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5508607|NCT04413838|Nivolumab|nivolumab|mesh-list
5508608|NCT04413838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5508609|NCT04413838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5508610|NCT04413838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5508611|NCT04413838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508612|NCT04413864|Dexmedetomidine|dexmedetomidine|mesh-list
5508613|NCT04413864|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5508614|NCT04413864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5508615|NCT04413864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508616|NCT04413864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5508617|NCT04413864|Analgesics|analgesics|mesh-ancestor
5508618|NCT04413864|Sensory System Agents|sensory system agents|mesh-ancestor
5508619|NCT04413864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5508620|NCT04413864|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5508621|NCT04413864|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6067726|NCT00695565|Autonomic Agents|autonomic agents|mesh-ancestor
6665369|NCT01516814|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6665370|NCT01516814|Antithrombins|antithrombins|mesh-ancestor
6665371|NCT01516814|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5508622|NCT04413864|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5508623|NCT04413864|Adrenergic Agents|adrenergic agents|mesh-ancestor
5508624|NCT04413864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5508625|NCT04413864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067727|NCT00695565|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6067728|NCT00695565|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6067729|NCT00695565|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6067730|NCT00695565|Adrenergic Agents|adrenergic agents|mesh-ancestor
6067731|NCT00695565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6067732|NCT00695565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067733|NCT00695578|Bacitracin|bacitracin|mesh-list
6067734|NCT00695578|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6067735|NCT00695578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6067736|NCT00695578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6067737|NCT00695786|Rituximab|rituximab|mesh-list
6067738|NCT00695786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6067739|NCT00695786|Lenalidomide|lenalidomide|mesh-list
6067740|NCT00695786|Antibodies|antibodies|mesh-list
6067741|NCT00695786|Immunoglobulins|immunoglobulins|mesh-list
6067742|NCT00695786|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5508626|NCT04414020|Progesterone|progesterone|mesh-list
5508627|NCT04414020|Progestins|progestins|mesh-ancestor
5508628|NCT04414020|Hormones|hormones|mesh-ancestor
5508629|NCT04414020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6067743|NCT00695786|Immunologic Factors|immunologic factors|mesh-ancestor
6067744|NCT00695786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067745|NCT00695786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6067746|NCT00695786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6067747|NCT00695786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6067748|NCT00695786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6067749|NCT00695786|Growth Substances|growth substances|mesh-ancestor
6067750|NCT00695786|Growth Inhibitors|growth inhibitors|mesh-ancestor
6067751|NCT00695864|Ondansetron|ondansetron|mesh-list
6067752|NCT00695864|Antiemetics|antiemetics|mesh-ancestor
6067753|NCT00695864|Autonomic Agents|autonomic agents|mesh-ancestor
6067754|NCT00695864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6067755|NCT00695864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067756|NCT00695864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6067757|NCT00695864|Antipruritics|antipruritics|mesh-ancestor
6067758|NCT00695864|Dermatologic Agents|dermatologic agents|mesh-ancestor
6067759|NCT00695864|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6067760|NCT00695864|Serotonin Agents|serotonin agents|mesh-ancestor
6067761|NCT00695864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6067762|NCT00695864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067763|NCT00695864|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6067764|NCT00695864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6067765|NCT00695864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6067766|NCT00695864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6067767|NCT00695864|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6067768|NCT00695903|Vancomycin|vancomycin|mesh-list
6067769|NCT00695903|Daptomycin|daptomycin|mesh-list
6067770|NCT00695903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6067771|NCT00695903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6067772|NCT00695955|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6067773|NCT00695955|Chlorthalidone|chlorthalidone|mesh-list
6067774|NCT00695955|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
6067775|NCT00695955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6067776|NCT00695955|Diuretics|diuretics|mesh-ancestor
6067777|NCT00695955|Natriuretic Agents|natriuretic agents|mesh-ancestor
6067778|NCT00695955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067779|NCT00695955|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6067780|NCT00695955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6067781|NCT00695955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067782|NCT00695955|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6067783|NCT00695955|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6067784|NCT00696020|Bromides|bromides|mesh-list
6067785|NCT00696020|Tiotropium Bromide|tiotropium bromide|mesh-list
5508630|NCT04414020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067786|NCT00696020|Olodaterol|olodaterol|mesh-list
6067787|NCT00696020|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5508631|NCT04414137|Daptomycin|daptomycin|mesh-list
5508632|NCT04414137|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5508633|NCT04414137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5508634|NCT04413890|Dinoprostone|dinoprostone|mesh-list
5508635|NCT04413890|Oxytocics|oxytocics|mesh-ancestor
5508636|NCT04413890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5508637|NCT04413890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067788|NCT00696020|Autonomic Agents|autonomic agents|mesh-ancestor
6067789|NCT00696020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6067790|NCT00696020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067791|NCT00696020|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6067792|NCT00696020|Respiratory System Agents|respiratory system agents|mesh-ancestor
6067793|NCT00696020|Parasympatholytics|parasympatholytics|mesh-ancestor
6067794|NCT00696020|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6067795|NCT00696020|Cholinergic Agents|cholinergic agents|mesh-ancestor
6067796|NCT00696020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6067797|NCT00696020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067798|NCT00696020|Anticonvulsants|anticonvulsants|mesh-ancestor
6067799|NCT00696072|Letrozole|letrozole|mesh-list
6067800|NCT00696072|Dasatinib|dasatinib|mesh-list
6067801|NCT00696072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6067802|NCT00696072|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6067803|NCT00696072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6067804|NCT00696072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5508638|NCT04413396|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5508639|NCT04413396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5508640|NCT04413422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
5508641|NCT04413422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5508642|NCT04413422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508643|NCT04413253|Dexamethasone|dexamethasone|mesh-list
5508644|NCT04413253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5508645|NCT04413253|Lifitegrast|lifitegrast|mesh-list
5508646|NCT04413253|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5508647|NCT04413253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6463185|NCT00463073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463186|NCT00463073|Growth Inhibitors|growth inhibitors|mesh-ancestor
6463187|NCT00463073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6463188|NCT00463073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6463189|NCT00463073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6463190|NCT00463073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463191|NCT00463086|Isoniazid|isoniazid|mesh-list
6463192|NCT00463086|Antitubercular Agents|antitubercular agents|mesh-ancestor
6463193|NCT00463086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6463194|NCT00463086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6463195|NCT00463086|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6463196|NCT00463086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6463197|NCT00463086|Antimetabolites|antimetabolites|mesh-ancestor
5508648|NCT04413253|Antiemetics|antiemetics|mesh-ancestor
5508649|NCT04413253|Autonomic Agents|autonomic agents|mesh-ancestor
5508650|NCT04413253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5508651|NCT04413253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508652|NCT04413253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5508653|NCT04413253|Glucocorticoids|glucocorticoids|mesh-ancestor
6463198|NCT00463086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463199|NCT00463086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6463200|NCT00463112|Sibutramine|sibutramine|mesh-list
6463201|NCT00463112|Antidepressive Agents|antidepressive agents|mesh-ancestor
6463202|NCT00463112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6067805|NCT00696072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508654|NCT04413253|Hormones|hormones|mesh-ancestor
5600307|NCT03712735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463203|NCT00463112|Appetite Depressants|appetite depressants|mesh-ancestor
5508655|NCT04413253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5508656|NCT04413253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5508657|NCT04413253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5508658|NCT04413292|BIRC5 protein, human|birc5 protein, human|mesh-list
5508659|NCT04413292|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
5508660|NCT04413292|Protease Inhibitors|protease inhibitors|mesh-ancestor
5508661|NCT04413292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5508662|NCT04413292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508663|NCT04413227|Docetaxel|docetaxel|mesh-list
5508664|NCT04413227|Endostatins|endostatins|mesh-list
5508665|NCT04413227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6067806|NCT00696072|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6067807|NCT00696072|Hormone Antagonists|hormone antagonists|mesh-ancestor
6067808|NCT00696072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6067809|NCT00696072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067810|NCT00696072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6067811|NCT00696137|Fentanyl|fentanyl|mesh-list
6067812|NCT00696137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6067813|NCT00696137|Narcotics|narcotics|mesh-ancestor
6067814|NCT00696137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6067815|NCT00696137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067816|NCT00696137|Analgesics|analgesics|mesh-ancestor
6067817|NCT00696137|Sensory System Agents|sensory system agents|mesh-ancestor
6067818|NCT00696137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6067819|NCT00696137|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6067820|NCT00696137|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6067821|NCT00696137|Anesthetics, General|anesthetics, general|mesh-ancestor
6067822|NCT00696137|Anesthetics|anesthetics|mesh-ancestor
6067823|NCT00696241|Olmesartan|olmesartan|mesh-list
6067824|NCT00696241|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6067825|NCT00696241|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
6067826|NCT00696241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6067827|NCT00696241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6067828|NCT00696241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6067829|NCT00696241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067830|NCT00696293|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6067831|NCT00696293|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6067832|NCT00696293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6067833|NCT00696293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6067834|NCT00696293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067835|NCT00696293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6067836|NCT00696293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067837|NCT00696293|Analgesics|analgesics|mesh-ancestor
6067838|NCT00696293|Sensory System Agents|sensory system agents|mesh-ancestor
6067839|NCT00696293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6067840|NCT00696293|Antidepressive Agents|antidepressive agents|mesh-ancestor
6067841|NCT00696293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6067842|NCT00696293|Dopamine Agents|dopamine agents|mesh-ancestor
6067843|NCT00696384|Chlorthalidone|chlorthalidone|mesh-list
6067844|NCT00696384|Antihypertensive Agents|antihypertensive agents|mesh-list
6067845|NCT00696384|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
6067846|NCT00696384|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6067847|NCT00696384|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6067848|NCT00696384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067849|NCT00696384|Diuretics|diuretics|mesh-ancestor
6067850|NCT00696384|Natriuretic Agents|natriuretic agents|mesh-ancestor
6067851|NCT00696384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067852|NCT00696384|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6067853|NCT00696384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6067854|NCT00696410|Zinc|zinc|mesh-list
6067855|NCT00696410|Trace Elements|trace elements|mesh-ancestor
6067856|NCT00696410|Micronutrients|micronutrients|mesh-ancestor
6067857|NCT00696410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067858|NCT00696436|Valsartan|valsartan|mesh-list
6067859|NCT00696436|Olmesartan|olmesartan|mesh-list
6067860|NCT00696436|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
6067861|NCT00696436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6067862|NCT00696436|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6067863|NCT00696436|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6067864|NCT00696436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067865|NCT00696449|Adapalene|adapalene|mesh-list
6067866|NCT00696449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5508666|NCT04413227|Tubulin Modulators|tubulin modulators|mesh-ancestor
5508667|NCT04413227|Antimitotic Agents|antimitotic agents|mesh-ancestor
5508668|NCT04413227|Mitosis Modulators|mitosis modulators|mesh-ancestor
5508669|NCT04413227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508670|NCT04413227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5508671|NCT04413227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5508672|NCT04413227|Growth Substances|growth substances|mesh-ancestor
5508673|NCT04413227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508674|NCT04413227|Growth Inhibitors|growth inhibitors|mesh-ancestor
5508675|NCT04413279|Dexamethasone|dexamethasone|mesh-list
5508676|NCT04413279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5508677|NCT04413279|Antiemetics|antiemetics|mesh-ancestor
5508678|NCT04413279|Autonomic Agents|autonomic agents|mesh-ancestor
5508679|NCT04413279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5508680|NCT04413279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508681|NCT04413279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5508682|NCT04413279|Glucocorticoids|glucocorticoids|mesh-ancestor
5508683|NCT04413279|Hormones|hormones|mesh-ancestor
5508684|NCT04413279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5508685|NCT04413279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5508686|NCT04413279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6067867|NCT00696449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6067868|NCT00696449|Analgesics|analgesics|mesh-ancestor
6067869|NCT00696449|Sensory System Agents|sensory system agents|mesh-ancestor
6067870|NCT00696449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6067871|NCT00696449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067872|NCT00696449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6067873|NCT00696449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6067874|NCT00696449|Dermatologic Agents|dermatologic agents|mesh-ancestor
6067875|NCT00696488|Fluorouracil|fluorouracil|mesh-list
6067876|NCT00696488|Antimetabolites|antimetabolites|mesh-ancestor
6067877|NCT00696488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067878|NCT00696488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6067879|NCT00696488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6067880|NCT00696488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6067881|NCT00696488|Immunologic Factors|immunologic factors|mesh-ancestor
6067882|NCT00696488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067883|NCT00696618|Plasma-lyte 148|plasma-lyte 148|mesh-list
5508687|NCT04413344|Bromocriptine|bromocriptine|mesh-list
5508688|NCT04413344|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5508689|NCT04413344|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5508690|NCT04413344|Hormone Antagonists|hormone antagonists|mesh-ancestor
5508691|NCT04413344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5508692|NCT04413344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508693|NCT04413344|Dopamine Agonists|dopamine agonists|mesh-ancestor
5508694|NCT04413344|Dopamine Agents|dopamine agents|mesh-ancestor
5508695|NCT04413344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5508696|NCT04413344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508697|NCT04412876|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5508698|NCT04412876|Imipramine|imipramine|mesh-list
6067884|NCT00696618|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6067885|NCT00696618|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6067886|NCT00696657|Liraglutide|liraglutide|mesh-list
6067887|NCT00696657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6067888|NCT00696657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067889|NCT00696657|Incretins|incretins|mesh-ancestor
6067890|NCT00696657|Hormones|hormones|mesh-ancestor
6463204|NCT00463112|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6463205|NCT00463203|Bevacizumab|bevacizumab|mesh-list
5508699|NCT04412876|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5508700|NCT04412876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5508701|NCT04412876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5508702|NCT04412876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508703|NCT04412876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5508704|NCT04412876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508705|NCT04412876|Analgesics|analgesics|mesh-ancestor
5508706|NCT04412876|Sensory System Agents|sensory system agents|mesh-ancestor
5508707|NCT04412876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5508708|NCT04412876|Antidepressive Agents|antidepressive agents|mesh-ancestor
5508709|NCT04412876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5508710|NCT04412876|Dopamine Agents|dopamine agents|mesh-ancestor
5508711|NCT04412876|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5508712|NCT04412876|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5508713|NCT04412876|Adrenergic Agents|adrenergic agents|mesh-ancestor
5508714|NCT04412850|Magnesium Sulfate|magnesium sulfate|mesh-list
5508715|NCT04412850|Analgesics|analgesics|mesh-ancestor
6067891|NCT00696657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6067892|NCT00696696|Gemcitabine|gemcitabine|mesh-list
6067893|NCT00696696|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6067894|NCT00696696|Sorafenib|sorafenib|mesh-list
6067895|NCT00696696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6463206|NCT00463203|Irinotecan|irinotecan|mesh-list
6463207|NCT00463203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6463208|NCT00463203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6067896|NCT00696696|Antimetabolites|antimetabolites|mesh-ancestor
6067897|NCT00696696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067898|NCT00696696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6067899|NCT00696696|Antiviral Agents|antiviral agents|mesh-ancestor
6067900|NCT00696696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6067901|NCT00696696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6067902|NCT00696696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6067903|NCT00696696|Immunologic Factors|immunologic factors|mesh-ancestor
6067904|NCT00696696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067905|NCT00696696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6067906|NCT00696761|Alfuzosin|alfuzosin|mesh-list
6067907|NCT00696761|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6067908|NCT00696761|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6067909|NCT00696761|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6067910|NCT00696761|Adrenergic Agents|adrenergic agents|mesh-ancestor
6067911|NCT00696761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6067912|NCT00696761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067913|NCT00696761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067914|NCT00696761|Urological Agents|urological agents|mesh-ancestor
6067915|NCT00696774|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6067916|NCT00696774|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6067917|NCT00696774|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6067918|NCT00696774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6067919|NCT00696774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067920|NCT00696774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6067921|NCT00696774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067922|NCT00696774|Analgesics|analgesics|mesh-ancestor
6067923|NCT00696774|Sensory System Agents|sensory system agents|mesh-ancestor
6067924|NCT00696774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6067925|NCT00696774|Antidepressive Agents|antidepressive agents|mesh-ancestor
6067926|NCT00696774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6067927|NCT00696774|Dopamine Agents|dopamine agents|mesh-ancestor
6067928|NCT00696787|Pregabalin|pregabalin|mesh-list
6067929|NCT00696787|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6067930|NCT00696787|Analgesics|analgesics|mesh-ancestor
6067931|NCT00696787|Sensory System Agents|sensory system agents|mesh-ancestor
6067932|NCT00696787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6067933|NCT00696787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067934|NCT00696787|Anticonvulsants|anticonvulsants|mesh-ancestor
6067935|NCT00696787|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6067936|NCT00696787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6067937|NCT00696787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067938|NCT00696787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6067939|NCT00696787|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6067940|NCT00696787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6463209|NCT00463203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5508716|NCT04412850|Sensory System Agents|sensory system agents|mesh-ancestor
6463210|NCT00463203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6463211|NCT00463203|Growth Substances|growth substances|mesh-ancestor
6463212|NCT00463203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508717|NCT04412850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5508718|NCT04412850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508719|NCT04412850|Anesthetics|anesthetics|mesh-ancestor
5508720|NCT04412850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5508721|NCT04412850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5508722|NCT04412850|Anticonvulsants|anticonvulsants|mesh-ancestor
5508723|NCT04412850|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6463213|NCT00463203|Growth Inhibitors|growth inhibitors|mesh-ancestor
6463214|NCT00463203|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6463215|NCT00463203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6463216|NCT00463203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6463217|NCT00463203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463218|NCT00463268|Vitamin D|vitamin d|mesh-list
6067941|NCT00696787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6067942|NCT00696787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6067943|NCT00696787|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6067944|NCT00696787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6067945|NCT00696787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6067946|NCT00696787|Antidepressive Agents|antidepressive agents|mesh-ancestor
6067947|NCT00697073|Idebenone|idebenone|mesh-list
5508724|NCT04412850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5508725|NCT04412850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508726|NCT04412850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5508727|NCT04412850|Tocolytic Agents|tocolytic agents|mesh-ancestor
5508728|NCT04412850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5508729|NCT04412538|Vaccines|vaccines|mesh-list
5508730|NCT04412538|Immunologic Factors|immunologic factors|mesh-ancestor
5508731|NCT04412538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508732|NCT04412642|Methoxyflurane|methoxyflurane|mesh-list
6067948|NCT00697073|Antioxidants|antioxidants|mesh-ancestor
6067949|NCT00697073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067950|NCT00697073|Protective Agents|protective agents|mesh-ancestor
6067951|NCT00697073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067952|NCT00697112|Sirolimus|sirolimus|mesh-list
6463219|NCT00463268|Alendronate|alendronate|mesh-list
6463220|NCT00463268|Calcium|calcium|mesh-list
6463221|NCT00463268|Vitamins|vitamins|mesh-ancestor
6463222|NCT00463268|Micronutrients|micronutrients|mesh-ancestor
6463223|NCT00463268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463224|NCT00463268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6463225|NCT00463268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6463226|NCT00463320|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6463227|NCT00463320|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6463228|NCT00463359|Imiquimod|imiquimod|mesh-list
6463229|NCT00463359|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6463230|NCT00463359|Immunologic Factors|immunologic factors|mesh-ancestor
6463231|NCT00463359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463232|NCT00463359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6067953|NCT00697112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6067954|NCT00697112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6067955|NCT00697112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6067956|NCT00697112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6067957|NCT00697112|Antifungal Agents|antifungal agents|mesh-ancestor
6067958|NCT00697112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6067959|NCT00697112|Immunologic Factors|immunologic factors|mesh-ancestor
6067960|NCT00697112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067961|NCT00697203|Pravastatin|pravastatin|mesh-list
6067962|NCT00697203|Dalcetrapib|dalcetrapib|mesh-list
6067963|NCT00697203|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6067964|NCT00697203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6067965|NCT00697203|Antimetabolites|antimetabolites|mesh-ancestor
6067966|NCT00697203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067967|NCT00697203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6067968|NCT00697203|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6067969|NCT00697203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5508733|NCT04412642|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5508734|NCT04412642|Anesthetics, General|anesthetics, general|mesh-ancestor
5508735|NCT04412642|Anesthetics|anesthetics|mesh-ancestor
6067970|NCT00697463|Teriparatide|teriparatide|mesh-list
6067971|NCT00697463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6067972|NCT00697463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067973|NCT00697463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6067974|NCT00697541|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6067975|NCT00697541|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6067976|NCT00697541|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6067977|NCT00697541|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6067978|NCT00697541|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6067979|NCT00697541|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6067980|NCT00697541|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6067981|NCT00697541|Adrenergic Agents|adrenergic agents|mesh-ancestor
6067982|NCT00697541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6067983|NCT00697541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6067984|NCT00697541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067985|NCT00697593|Antibodies|antibodies|mesh-list
6067986|NCT00697593|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6067987|NCT00697593|Immunologic Factors|immunologic factors|mesh-ancestor
5508736|NCT04412642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6067988|NCT00697593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067989|NCT00697619|Zoledronic Acid|zoledronic acid|mesh-list
6067990|NCT00697619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6067991|NCT00697619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067992|NCT00697788|Dexmedetomidine|dexmedetomidine|mesh-list
6067993|NCT00697788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6067994|NCT00697788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6067995|NCT00697788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6067996|NCT00697788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6067997|NCT00697788|Analgesics|analgesics|mesh-ancestor
6067998|NCT00697788|Sensory System Agents|sensory system agents|mesh-ancestor
6067999|NCT00697788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6068000|NCT00697788|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6068001|NCT00697788|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6068002|NCT00697788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6068003|NCT00697788|Adrenergic Agents|adrenergic agents|mesh-ancestor
6068004|NCT00697788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6068005|NCT00697788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068006|NCT00698035|Methyltestosterone|methyltestosterone|mesh-list
6068007|NCT00698035|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6068008|NCT00698035|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6068009|NCT00698035|Testosterone|testosterone|mesh-list
6068010|NCT00698035|Testosterone undecanoate|testosterone undecanoate|mesh-list
6068011|NCT00698035|Testosterone enanthate|testosterone enanthate|mesh-list
6068012|NCT00698035|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6068013|NCT00698035|Estradiol|estradiol|mesh-list
6068014|NCT00698035|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6068015|NCT00698035|Androgens|androgens|mesh-ancestor
6068016|NCT00698035|Hormones|hormones|mesh-ancestor
6068017|NCT00698035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6068018|NCT00698035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068019|NCT00698035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6068020|NCT00698035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6068021|NCT00698035|Anabolic Agents|anabolic agents|mesh-ancestor
6068022|NCT00698035|Estrogens|estrogens|mesh-ancestor
6068023|NCT00698035|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6068024|NCT00698035|Contraceptive Agents|contraceptive agents|mesh-ancestor
6068025|NCT00698035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6463233|NCT00463359|Interferon Inducers|interferon inducers|mesh-ancestor
6463234|NCT00463502|Metformin|metformin|mesh-list
6463235|NCT00463502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6463236|NCT00463502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463237|NCT00463515|Gemcitabine|gemcitabine|mesh-list
6463238|NCT00463515|Carboplatin|carboplatin|mesh-list
6463239|NCT00463515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6463240|NCT00463515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6463241|NCT00463515|Antimetabolites|antimetabolites|mesh-ancestor
6463242|NCT00463515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463243|NCT00463515|Antiviral Agents|antiviral agents|mesh-ancestor
6463244|NCT00463515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6463245|NCT00463515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6463246|NCT00463515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6463247|NCT00463515|Immunologic Factors|immunologic factors|mesh-ancestor
6463248|NCT00463515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463249|NCT00463541|Solifenacin Succinate|solifenacin succinate|mesh-list
6068026|NCT00698035|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6068027|NCT00698204|Celecoxib|celecoxib|mesh-list
6068028|NCT00698204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6665372|NCT01516814|Protease Inhibitors|protease inhibitors|mesh-ancestor
5508737|NCT04412642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508738|NCT04412421|Vitamins|vitamins|mesh-list
5508739|NCT04412421|Micronutrients|micronutrients|mesh-ancestor
6068029|NCT00698204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6068030|NCT00698204|Analgesics|analgesics|mesh-ancestor
6068031|NCT00698204|Sensory System Agents|sensory system agents|mesh-ancestor
6068032|NCT00698204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6068033|NCT00698204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068034|NCT00698204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6068035|NCT00698204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6068036|NCT00698204|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6068037|NCT00698204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6068038|NCT00698204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5508740|NCT04412421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508741|NCT04412304|Dalteparin|dalteparin|mesh-list
5508742|NCT04412304|Tinzaparin|tinzaparin|mesh-list
5508743|NCT04412304|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5508744|NCT04412304|Anticoagulants|anticoagulants|mesh-ancestor
6068039|NCT00698204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068040|NCT00698451|Bevacizumab|bevacizumab|mesh-list
6068041|NCT00698451|Carboplatin|carboplatin|mesh-list
6068042|NCT00698451|Doxorubicin|doxorubicin|mesh-list
6068043|NCT00698451|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6068044|NCT00698451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6068045|NCT00698451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6068046|NCT00698451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6068047|NCT00698451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6068048|NCT00698451|Growth Substances|growth substances|mesh-ancestor
6068049|NCT00698451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068050|NCT00698451|Growth Inhibitors|growth inhibitors|mesh-ancestor
6068051|NCT00698451|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6068052|NCT00698451|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6068053|NCT00698451|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6068054|NCT00698451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6068055|NCT00698451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068056|NCT00698516|Bevacizumab|bevacizumab|mesh-list
6068057|NCT00698516|Topotecan|topotecan|mesh-list
6068058|NCT00698516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6068059|NCT00698516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6068060|NCT00698516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6068061|NCT00698516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6068062|NCT00698516|Growth Substances|growth substances|mesh-ancestor
6068063|NCT00698516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068064|NCT00698516|Growth Inhibitors|growth inhibitors|mesh-ancestor
6068065|NCT00698516|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6068066|NCT00698516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6068067|NCT00698516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6068068|NCT00698516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068069|NCT00698581|Brivaracetam|brivaracetam|mesh-list
6068070|NCT00698581|Anticonvulsants|anticonvulsants|mesh-ancestor
6068071|NCT00698646|Valsartan|valsartan|mesh-list
6068072|NCT00698646|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6068073|NCT00698646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6068074|NCT00698646|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6068075|NCT00698646|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6068076|NCT00698646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068077|NCT00698646|Diuretics|diuretics|mesh-ancestor
6068078|NCT00698646|Natriuretic Agents|natriuretic agents|mesh-ancestor
6068079|NCT00698646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068080|NCT00698646|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6068081|NCT00698646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6068082|NCT00698685|Alemtuzumab|alemtuzumab|mesh-list
6068083|NCT00698685|Pentostatin|pentostatin|mesh-list
6068084|NCT00698685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6068085|NCT00698685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5508745|NCT04412304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5508746|NCT04412304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5508747|NCT04412304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508748|NCT04412291|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5508749|NCT04412291|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6068086|NCT00698685|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
5508750|NCT04412291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6068087|NCT00698685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6068088|NCT00698685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068089|NCT00698841|Cetuximab|cetuximab|mesh-list
6068090|NCT00698841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6068091|NCT00698841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6068092|NCT00698932|Saxagliptin|saxagliptin|mesh-list
6068093|NCT00698932|Incretins|incretins|mesh-ancestor
6068094|NCT00698932|Hormones|hormones|mesh-ancestor
6068095|NCT00698932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6068096|NCT00698932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068097|NCT00698932|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6068098|NCT00698932|Protease Inhibitors|protease inhibitors|mesh-ancestor
6068099|NCT00698932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6068100|NCT00698932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068101|NCT00698932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6068102|NCT00699010|Oxycodone|oxycodone|mesh-list
6068103|NCT00699010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6068104|NCT00699010|Narcotics|narcotics|mesh-ancestor
6068105|NCT00699010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6068106|NCT00699010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068107|NCT00699010|Analgesics|analgesics|mesh-ancestor
6068108|NCT00699010|Sensory System Agents|sensory system agents|mesh-ancestor
6068109|NCT00699010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6068110|NCT00699153|Loteprednol Etabonate|loteprednol etabonate|mesh-list
6068111|NCT00699153|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6068112|NCT00699192|Amlodipine|amlodipine|mesh-list
6068113|NCT00699192|Valsartan|valsartan|mesh-list
6068114|NCT00699192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6068115|NCT00699192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6068116|NCT00699192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6068117|NCT00699192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068118|NCT00699192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6068119|NCT00699192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068120|NCT00699192|Vasodilator Agents|vasodilator agents|mesh-ancestor
6068121|NCT00699192|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6068122|NCT00699192|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6068123|NCT00699283|Brivaracetam|brivaracetam|mesh-list
6463250|NCT00463541|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6068124|NCT00699283|Anticonvulsants|anticonvulsants|mesh-ancestor
6068125|NCT00699335|Fentanyl|fentanyl|mesh-list
6068126|NCT00699335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6068127|NCT00699335|Narcotics|narcotics|mesh-ancestor
6068128|NCT00699335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6068129|NCT00699335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068130|NCT00699335|Analgesics|analgesics|mesh-ancestor
6068131|NCT00699335|Sensory System Agents|sensory system agents|mesh-ancestor
6068132|NCT00699335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6068133|NCT00699335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6068134|NCT00699335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6068135|NCT00699335|Anesthetics, General|anesthetics, general|mesh-ancestor
6068136|NCT00699335|Anesthetics|anesthetics|mesh-ancestor
6068137|NCT00699348|Epoetin Alfa|epoetin alfa|mesh-list
6068138|NCT00699348|Hematinics|hematinics|mesh-ancestor
6068139|NCT00699374|Sorafenib|sorafenib|mesh-list
6068140|NCT00699374|Sunitinib|sunitinib|mesh-list
6068141|NCT00699374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6068142|NCT00699374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6068143|NCT00699374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6068144|NCT00699374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068145|NCT00699374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6665373|NCT01516814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6068146|NCT00699374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6068147|NCT00699374|Growth Substances|growth substances|mesh-ancestor
6068148|NCT00699374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068149|NCT00699374|Growth Inhibitors|growth inhibitors|mesh-ancestor
6068150|NCT00699491|Sirolimus|sirolimus|mesh-list
6068151|NCT00699491|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6068152|NCT00699491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6068153|NCT00699491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6068154|NCT00699491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6068155|NCT00699491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6068156|NCT00699491|Antifungal Agents|antifungal agents|mesh-ancestor
6068157|NCT00699491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6068158|NCT00699491|Immunologic Factors|immunologic factors|mesh-ancestor
6068159|NCT00699491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068160|NCT00699556|Nicotine|nicotine|mesh-list
6068161|NCT00699556|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6068162|NCT00699556|Autonomic Agents|autonomic agents|mesh-ancestor
6068163|NCT00699556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6068164|NCT00699556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068165|NCT00699556|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6068166|NCT00699556|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6068167|NCT00699556|Cholinergic Agents|cholinergic agents|mesh-ancestor
6068168|NCT00699556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6068169|NCT00699556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068170|NCT00699608|Zopiclone|zopiclone|mesh-list
6068171|NCT00699608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6068172|NCT00699608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5508751|NCT04412291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5508752|NCT04412148|Triamcinolone|triamcinolone|mesh-list
5508753|NCT04412148|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5508754|NCT04412148|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5508755|NCT04412148|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5508756|NCT04412148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5508757|NCT04412148|Glucocorticoids|glucocorticoids|mesh-ancestor
5508758|NCT04412148|Hormones|hormones|mesh-ancestor
5508759|NCT04412148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5508760|NCT04412148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068173|NCT00699608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068174|NCT00699751|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
6068175|NCT00699751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6068176|NCT00699803|Prednisone|prednisone|mesh-list
6068177|NCT00699803|Prednisolone acetate|prednisolone acetate|mesh-list
6068178|NCT00699803|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6068179|NCT00699803|Methylprednisolone|methylprednisolone|mesh-list
6068180|NCT00699803|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6068181|NCT00699803|Prednisolone|prednisolone|mesh-list
6068182|NCT00699803|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6068183|NCT00699803|Prednisolone phosphate|prednisolone phosphate|mesh-list
6068184|NCT00699803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6068185|NCT00699803|Glucocorticoids|glucocorticoids|mesh-ancestor
6068186|NCT00699803|Hormones|hormones|mesh-ancestor
6068187|NCT00699803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6068188|NCT00699803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068189|NCT00699803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6068190|NCT00699803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6068191|NCT00699803|Antiemetics|antiemetics|mesh-ancestor
6068192|NCT00699803|Autonomic Agents|autonomic agents|mesh-ancestor
6068193|NCT00699803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6068194|NCT00699803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6068195|NCT00699803|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6068196|NCT00699803|Protective Agents|protective agents|mesh-ancestor
6068197|NCT00699907|Flutamide|flutamide|mesh-list
6068198|NCT00699907|Androgen Antagonists|androgen antagonists|mesh-ancestor
6068199|NCT00699907|Hormone Antagonists|hormone antagonists|mesh-ancestor
6068200|NCT00699907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6068201|NCT00699907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068202|NCT00699907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6068203|NCT00699907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6068204|NCT00699998|Aspirin|aspirin|mesh-list
6068205|NCT00699998|Clopidogrel|clopidogrel|mesh-list
6068206|NCT00699998|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6068207|NCT00699998|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6068208|NCT00699998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6068209|NCT00699998|Analgesics|analgesics|mesh-ancestor
6068210|NCT00699998|Sensory System Agents|sensory system agents|mesh-ancestor
5508761|NCT04412148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6068211|NCT00699998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6068212|NCT00699998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068213|NCT00699998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6068214|NCT00699998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6068215|NCT00699998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6068216|NCT00699998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6068217|NCT00699998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068218|NCT00699998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6068219|NCT00699998|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6068220|NCT00699998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6068221|NCT00699998|Antipyretics|antipyretics|mesh-ancestor
6068222|NCT00699998|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6068223|NCT00699998|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6068224|NCT00699998|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6068225|NCT00699998|Purinergic Agents|purinergic agents|mesh-ancestor
6068226|NCT00699998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6068227|NCT00700011|Clofarabine|clofarabine|mesh-list
6068228|NCT00700011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6068229|NCT00700011|Antimetabolites|antimetabolites|mesh-ancestor
6068230|NCT00700011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068231|NCT00700011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6068232|NCT00700102|Bevacizumab|bevacizumab|mesh-list
6068233|NCT00700102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6068234|NCT00700102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6068235|NCT00700102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6068236|NCT00700102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6068237|NCT00700102|Growth Substances|growth substances|mesh-ancestor
6068238|NCT00700102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068239|NCT00700102|Growth Inhibitors|growth inhibitors|mesh-ancestor
6068240|NCT00700115|Ritonavir|ritonavir|mesh-list
6068241|NCT00700115|Lopinavir|lopinavir|mesh-list
6068242|NCT00700115|Raltegravir Potassium|raltegravir potassium|mesh-list
6068243|NCT00700115|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6068244|NCT00700115|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6068245|NCT00700115|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6068246|NCT00700115|Protease Inhibitors|protease inhibitors|mesh-ancestor
6068247|NCT00700115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6068248|NCT00700115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068249|NCT00700115|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5508762|NCT04412148|Immunologic Factors|immunologic factors|mesh-ancestor
5508763|NCT04412148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5508764|NCT04412148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508765|NCT04411953|Haloperidol|haloperidol|mesh-list
5508766|NCT04411953|Benztropine|benztropine|mesh-list
5508767|NCT04411953|Haloperidol decanoate|haloperidol decanoate|mesh-list
5508768|NCT04411953|Antiemetics|antiemetics|mesh-ancestor
5508769|NCT04411953|Autonomic Agents|autonomic agents|mesh-ancestor
5508770|NCT04411953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5508771|NCT04411953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508772|NCT04411953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5508773|NCT04411953|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5508774|NCT04411953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5508775|NCT04411953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5508776|NCT04411953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5508777|NCT04411953|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5508778|NCT04411953|Dopamine Agents|dopamine agents|mesh-ancestor
5508779|NCT04411953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5508780|NCT04411953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508781|NCT04411953|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5508782|NCT04411953|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5508783|NCT04411953|Parasympatholytics|parasympatholytics|mesh-ancestor
5508784|NCT04411953|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5508785|NCT04411953|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6068250|NCT00700115|Antiviral Agents|antiviral agents|mesh-ancestor
5508786|NCT04411953|Cholinergic Agents|cholinergic agents|mesh-ancestor
5508787|NCT04411953|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5508788|NCT04411953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5508789|NCT04411953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5508790|NCT04412096|Timolol|timolol|mesh-list
5508791|NCT04412096|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5508792|NCT04412096|Latanoprost|latanoprost|mesh-list
5508793|NCT04412096|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5508794|NCT04412096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6068251|NCT00700115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6068252|NCT00700115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6068253|NCT00700115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6068254|NCT00700115|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6068255|NCT00700115|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6202391|NCT02040532|Sensory System Agents|sensory system agents|mesh-ancestor
6202392|NCT02040532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6202393|NCT02040532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202394|NCT02040532|Anticonvulsants|anticonvulsants|mesh-ancestor
6202395|NCT02040532|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6202396|NCT02040532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6202397|NCT02040532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6202398|NCT02040532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6202399|NCT02040532|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6202400|NCT02040532|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6202401|NCT02040532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6202402|NCT02040532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202403|NCT02040532|Antimanic Agents|antimanic agents|mesh-ancestor
6202404|NCT02040623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6202405|NCT02040623|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6202406|NCT02040766|Beclomethasone|beclomethasone|mesh-list
6202407|NCT02040766|Albuterol|albuterol|mesh-list
6202408|NCT02040766|Bronchodilator Agents|bronchodilator agents|mesh-list
6202409|NCT02040766|Autonomic Agents|autonomic agents|mesh-ancestor
6202410|NCT02040766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6202411|NCT02040766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202412|NCT02040766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6202413|NCT02040766|Respiratory System Agents|respiratory system agents|mesh-ancestor
6202414|NCT02040766|Tocolytic Agents|tocolytic agents|mesh-ancestor
6202415|NCT02040766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6202416|NCT02040766|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6202417|NCT02040766|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6202418|NCT02040766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6202419|NCT02040766|Adrenergic Agents|adrenergic agents|mesh-ancestor
6202420|NCT02040766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6202421|NCT02040766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202422|NCT02040766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6202423|NCT02040766|Glucocorticoids|glucocorticoids|mesh-ancestor
6202424|NCT02040766|Hormones|hormones|mesh-ancestor
6202425|NCT02040766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6202426|NCT02040779|Beclomethasone|beclomethasone|mesh-list
6202427|NCT02040779|Albuterol|albuterol|mesh-list
6202428|NCT02040779|Bronchodilator Agents|bronchodilator agents|mesh-list
6202429|NCT02040779|Autonomic Agents|autonomic agents|mesh-ancestor
6202430|NCT02040779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6202431|NCT02040779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202432|NCT02040779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6202433|NCT02040779|Respiratory System Agents|respiratory system agents|mesh-ancestor
6202434|NCT02040779|Tocolytic Agents|tocolytic agents|mesh-ancestor
6202435|NCT02040779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6202436|NCT02040779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6202437|NCT02040779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6202438|NCT02040779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6202439|NCT02040779|Adrenergic Agents|adrenergic agents|mesh-ancestor
6202440|NCT02040779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6202441|NCT02040779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202442|NCT02040779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6202443|NCT02040779|Glucocorticoids|glucocorticoids|mesh-ancestor
6202444|NCT02040779|Hormones|hormones|mesh-ancestor
6202445|NCT02040779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6202446|NCT02040857|Tamoxifen|tamoxifen|mesh-list
6202447|NCT02040857|Letrozole|letrozole|mesh-list
6202448|NCT02040857|Palbociclib|palbociclib|mesh-list
6202449|NCT02040857|Anastrozole|anastrozole|mesh-list
5508795|NCT04412096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5508796|NCT04412096|Adrenergic Agents|adrenergic agents|mesh-ancestor
5508797|NCT04412096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5508798|NCT04412096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508799|NCT04412096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068256|NCT00700180|Bevacizumab|bevacizumab|mesh-list
6068257|NCT00700180|Carboplatin|carboplatin|mesh-list
6068258|NCT00700180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5508800|NCT04412096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5508801|NCT04412096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6068259|NCT00700180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6068260|NCT00700180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6463251|NCT00463541|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6463252|NCT00463541|Cholinergic Agents|cholinergic agents|mesh-ancestor
6463253|NCT00463541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6463254|NCT00463541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463255|NCT00463541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463256|NCT00463541|Urological Agents|urological agents|mesh-ancestor
6463257|NCT00463671|Acetylcysteine|acetylcysteine|mesh-list
6463258|NCT00463671|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6463259|NCT00463671|Antiviral Agents|antiviral agents|mesh-ancestor
6463260|NCT00463671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6068261|NCT00700180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6068262|NCT00700180|Growth Substances|growth substances|mesh-ancestor
6068263|NCT00700180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068264|NCT00700180|Growth Inhibitors|growth inhibitors|mesh-ancestor
6068265|NCT00700271|Amlodipine|amlodipine|mesh-list
6068266|NCT00700271|Valsartan|valsartan|mesh-list
6068267|NCT00700271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6068268|NCT00700271|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6068269|NCT00700271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6068270|NCT00700271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068271|NCT00700271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6068272|NCT00700271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068273|NCT00700271|Vasodilator Agents|vasodilator agents|mesh-ancestor
6068274|NCT00700271|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6068275|NCT00700271|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6068276|NCT00700336|Cisplatin|cisplatin|mesh-list
6068277|NCT00700336|Pemetrexed|pemetrexed|mesh-list
5508802|NCT04411940|Haloperidol|haloperidol|mesh-list
5508803|NCT04411940|Benztropine|benztropine|mesh-list
5508804|NCT04411940|Haloperidol decanoate|haloperidol decanoate|mesh-list
5508805|NCT04411940|Antiemetics|antiemetics|mesh-ancestor
5508806|NCT04411940|Autonomic Agents|autonomic agents|mesh-ancestor
5508807|NCT04411940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5508808|NCT04411940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508809|NCT04411940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5508810|NCT04411940|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5508811|NCT04411940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5508812|NCT04411940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5508813|NCT04411940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5508814|NCT04411940|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6068278|NCT00700336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6068279|NCT00700336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6068280|NCT00700336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068281|NCT00700336|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6068282|NCT00700336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6068283|NCT00700401|Ribavirin|ribavirin|mesh-list
6068284|NCT00700401|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6068285|NCT00700401|Antimetabolites|antimetabolites|mesh-ancestor
6068286|NCT00700401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068287|NCT00700401|Antiviral Agents|antiviral agents|mesh-ancestor
6068288|NCT00700401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6068289|NCT00700427|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6068290|NCT00700427|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6068291|NCT00700427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6068292|NCT00700427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6068293|NCT00700427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068294|NCT00700427|Adrenergic Agents|adrenergic agents|mesh-ancestor
6068295|NCT00700427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6068296|NCT00700427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068297|NCT00700440|Cetuximab|cetuximab|mesh-list
6068298|NCT00700440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6463261|NCT00463671|Expectorants|expectorants|mesh-ancestor
5508815|NCT04411940|Dopamine Agents|dopamine agents|mesh-ancestor
6068299|NCT00700440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6068300|NCT00700570|Bevacizumab|bevacizumab|mesh-list
6068301|NCT00700570|Capecitabine|capecitabine|mesh-list
6068302|NCT00700570|Oxaliplatin|oxaliplatin|mesh-list
6068303|NCT00700570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6068304|NCT00700570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6068305|NCT00700570|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6068306|NCT00700570|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6068307|NCT00700570|Growth Substances|growth substances|mesh-ancestor
6068308|NCT00700570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508816|NCT04411940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5508817|NCT04411940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508818|NCT04411940|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5508819|NCT04411940|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5508820|NCT04411940|Parasympatholytics|parasympatholytics|mesh-ancestor
5508821|NCT04411940|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5508822|NCT04411940|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5508823|NCT04411940|Cholinergic Agents|cholinergic agents|mesh-ancestor
5508824|NCT04411940|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5508825|NCT04411940|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5508826|NCT04411940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5508827|NCT04412252|Tofacitinib|tofacitinib|mesh-list
5508828|NCT04412252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5508829|NCT04412252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5508830|NCT04412252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508831|NCT04411875|Amlodipine|amlodipine|mesh-list
5508832|NCT04411875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5508833|NCT04411875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5508834|NCT04411875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5508835|NCT04411875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508836|NCT04411875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5508837|NCT04411875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508838|NCT04411875|Vasodilator Agents|vasodilator agents|mesh-ancestor
5600308|NCT03712735|Sensory System Agents|sensory system agents|mesh-ancestor
5600309|NCT03712735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5600310|NCT03712735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6068309|NCT00700570|Growth Inhibitors|growth inhibitors|mesh-ancestor
6068310|NCT00700570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6068311|NCT00700570|Antimetabolites|antimetabolites|mesh-ancestor
6068312|NCT00700570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068313|NCT00700622|Insulin|insulin|mesh-list
6068314|NCT00700622|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6068315|NCT00700622|Insulin Glargine|insulin glargine|mesh-list
6068316|NCT00700622|Insulin Lispro|insulin lispro|mesh-list
6068317|NCT00700622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6068318|NCT00700622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068319|NCT00700817|Metformin|metformin|mesh-list
6068320|NCT00700817|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6068321|NCT00700817|Liraglutide|liraglutide|mesh-list
6068322|NCT00700817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6068323|NCT00700817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068324|NCT00700817|Incretins|incretins|mesh-ancestor
6068325|NCT00700817|Hormones|hormones|mesh-ancestor
6068326|NCT00700817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6068327|NCT00700817|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6068328|NCT00700817|Protease Inhibitors|protease inhibitors|mesh-ancestor
6068329|NCT00700817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6068330|NCT00700817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068331|NCT00700882|Dasatinib|dasatinib|mesh-list
6068332|NCT00700882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6068333|NCT00700882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6068334|NCT00700882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6068335|NCT00700882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068336|NCT00700999|Paroxetine|paroxetine|mesh-list
6068337|NCT00700999|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6068338|NCT00700999|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6068339|NCT00700999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6068340|NCT00700999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068341|NCT00700999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6068342|NCT00700999|Serotonin Agents|serotonin agents|mesh-ancestor
6068343|NCT00700999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068344|NCT00700999|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6068345|NCT00700999|Antidepressive Agents|antidepressive agents|mesh-ancestor
6068346|NCT00700999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6068347|NCT00700999|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6068348|NCT00700999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6068349|NCT00700999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6068350|NCT00701090|Metformin|metformin|mesh-list
6068351|NCT00701090|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6068352|NCT00701090|Glimepiride|glimepiride|mesh-list
6068353|NCT00701090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6068354|NCT00701090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068355|NCT00701090|Incretins|incretins|mesh-ancestor
6068356|NCT00701090|Hormones|hormones|mesh-ancestor
6068357|NCT00701090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6068358|NCT00701090|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6068359|NCT00701090|Protease Inhibitors|protease inhibitors|mesh-ancestor
6068360|NCT00701090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6068361|NCT00701090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068362|NCT00701090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6068363|NCT00701090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6068364|NCT00701090|Immunologic Factors|immunologic factors|mesh-ancestor
6068365|NCT00701129|Rituximab|rituximab|mesh-list
6068366|NCT00701129|Methotrexate|methotrexate|mesh-list
6068367|NCT00701129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6068368|NCT00701129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6068369|NCT00701129|Immunologic Factors|immunologic factors|mesh-ancestor
6068370|NCT00701129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068371|NCT00701129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6068372|NCT00701129|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6068373|NCT00701129|Abortifacient Agents|abortifacient agents|mesh-ancestor
6068374|NCT00701129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6068375|NCT00701129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6068376|NCT00701129|Antimetabolites|antimetabolites|mesh-ancestor
6068377|NCT00701129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068378|NCT00701129|Dermatologic Agents|dermatologic agents|mesh-ancestor
6068379|NCT00701129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5508839|NCT04411836|Primaquine|primaquine|mesh-list
5508840|NCT04411836|Tafenoquine|tafenoquine|mesh-list
5508841|NCT04411836|Antimalarials|antimalarials|mesh-ancestor
5508842|NCT04411836|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5508843|NCT04411836|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5508844|NCT04411836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5508845|NCT04411654|Sirolimus|sirolimus|mesh-list
5508846|NCT04411654|Prednisone|prednisone|mesh-list
5508847|NCT04411654|Methylprednisolone|methylprednisolone|mesh-list
5508848|NCT04411654|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5508849|NCT04411654|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5508850|NCT04411654|Prednisolone|prednisolone|mesh-list
5508851|NCT04411654|Prednisolone acetate|prednisolone acetate|mesh-list
6068380|NCT00701129|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6068381|NCT00701129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6068382|NCT00701129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6068383|NCT00701311|Apremilast|apremilast|mesh-list
6463262|NCT00463671|Respiratory System Agents|respiratory system agents|mesh-ancestor
6463263|NCT00463671|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6463264|NCT00463671|Antioxidants|antioxidants|mesh-ancestor
6463265|NCT00463671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463266|NCT00463671|Protective Agents|protective agents|mesh-ancestor
6068384|NCT00701311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6068385|NCT00701311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6068386|NCT00701311|Analgesics|analgesics|mesh-ancestor
6068387|NCT00701311|Sensory System Agents|sensory system agents|mesh-ancestor
6068388|NCT00701311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6068389|NCT00701311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068390|NCT00701311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6068391|NCT00701311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6068392|NCT00701311|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6068393|NCT00701311|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6068394|NCT00701311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6068395|NCT00701311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068396|NCT00701363|Lanreotide|lanreotide|mesh-list
6068397|NCT00701363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6068398|NCT00701376|Liver Extracts|liver extracts|mesh-list
6068399|NCT00701376|Hematinics|hematinics|mesh-ancestor
6068400|NCT00701389|Sumatriptan|sumatriptan|mesh-list
6068401|NCT00701389|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6463267|NCT00463671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508852|NCT04411654|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6068402|NCT00701389|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6068403|NCT00701389|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6068404|NCT00701389|Serotonin Agents|serotonin agents|mesh-ancestor
6068405|NCT00701389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5508853|NCT04411654|Prednisolone phosphate|prednisolone phosphate|mesh-list
5508854|NCT04411654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5508855|NCT04411654|Glucocorticoids|glucocorticoids|mesh-ancestor
5508856|NCT04411654|Hormones|hormones|mesh-ancestor
5508857|NCT04411654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6068406|NCT00701389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068407|NCT00701389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068408|NCT00701558|Gemcitabine|gemcitabine|mesh-list
6068409|NCT00701558|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6068410|NCT00701558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6068411|NCT00701558|Antimetabolites|antimetabolites|mesh-ancestor
6068412|NCT00701558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068413|NCT00701558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6068414|NCT00701558|Antiviral Agents|antiviral agents|mesh-ancestor
6068415|NCT00701558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6068416|NCT00701558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6068417|NCT00701558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6068418|NCT00701558|Immunologic Factors|immunologic factors|mesh-ancestor
6068419|NCT00701558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463268|NCT00463671|Antidotes|antidotes|mesh-ancestor
6463269|NCT00463710|Interferon beta-1a|interferon beta-1a|mesh-list
6463270|NCT00463710|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6463271|NCT00463710|Immunologic Factors|immunologic factors|mesh-ancestor
6463272|NCT00463710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463273|NCT00463710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6463274|NCT00463710|Antiviral Agents|antiviral agents|mesh-ancestor
6463275|NCT00463710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6463276|NCT00463723|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6463277|NCT00463723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6463278|NCT00463736|Magnesium Sulfate|magnesium sulfate|mesh-list
6463279|NCT00463736|Analgesics|analgesics|mesh-ancestor
6463280|NCT00463736|Sensory System Agents|sensory system agents|mesh-ancestor
6068420|NCT00701558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6068421|NCT00701636|Daptomycin|daptomycin|mesh-list
6068422|NCT00701636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6068423|NCT00701636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6068424|NCT00701662|Immunoglobulins|immunoglobulins|mesh-list
6068425|NCT00701662|Immunologic Factors|immunologic factors|mesh-ancestor
6068426|NCT00701662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068427|NCT00701675|Sertraline|sertraline|mesh-list
6068428|NCT00701675|Antidepressive Agents|antidepressive agents|mesh-ancestor
6068429|NCT00701675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6068430|NCT00701675|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6068431|NCT00701675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6068432|NCT00701675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6068433|NCT00701675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508858|NCT04411654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068434|NCT00701675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6068435|NCT00701675|Serotonin Agents|serotonin agents|mesh-ancestor
6068436|NCT00701675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068437|NCT00701714|Epoetin Alfa|epoetin alfa|mesh-list
6068438|NCT00701714|Hematinics|hematinics|mesh-ancestor
6068439|NCT00701727|Ezetimibe|ezetimibe|mesh-list
6068440|NCT00701727|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6068441|NCT00701727|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6068442|NCT00701727|Antimetabolites|antimetabolites|mesh-ancestor
6463281|NCT00463736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6463282|NCT00463736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068443|NCT00701727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068444|NCT00701727|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6068445|NCT00701779|Tamsulosin|tamsulosin|mesh-list
6068446|NCT00701779|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6068447|NCT00701779|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6068448|NCT00701779|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6068449|NCT00701779|Adrenergic Agents|adrenergic agents|mesh-ancestor
5508859|NCT04411654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5508860|NCT04411654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5508861|NCT04411654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6068450|NCT00701779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6068451|NCT00701779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068452|NCT00701779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068453|NCT00701779|Urological Agents|urological agents|mesh-ancestor
6068454|NCT00701896|Nicotine|nicotine|mesh-list
6068455|NCT00701896|Varenicline|varenicline|mesh-list
6068456|NCT00701896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6068457|NCT00701896|Autonomic Agents|autonomic agents|mesh-ancestor
6068458|NCT00701896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6068459|NCT00701896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068460|NCT00701896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6068461|NCT00701896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6068462|NCT00701896|Cholinergic Agents|cholinergic agents|mesh-ancestor
6068463|NCT00701896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6068464|NCT00701896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068465|NCT00701935|Exenatide|exenatide|mesh-list
6068466|NCT00701935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6068467|NCT00701935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068468|NCT00701935|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5508862|NCT04411654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5508863|NCT04411654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5508864|NCT04411654|Antifungal Agents|antifungal agents|mesh-ancestor
5508865|NCT04411654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5508866|NCT04411654|Immunologic Factors|immunologic factors|mesh-ancestor
5508867|NCT04411654|Antiemetics|antiemetics|mesh-ancestor
5508868|NCT04411654|Autonomic Agents|autonomic agents|mesh-ancestor
5508869|NCT04411654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5508870|NCT04411654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5508871|NCT04411654|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5508872|NCT04411654|Protective Agents|protective agents|mesh-ancestor
5508873|NCT04411693|Dexamethasone|dexamethasone|mesh-list
5508874|NCT04411693|Aflibercept|aflibercept|mesh-list
5508875|NCT04411693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5508876|NCT04411693|Antiemetics|antiemetics|mesh-ancestor
5508877|NCT04411693|Autonomic Agents|autonomic agents|mesh-ancestor
5508878|NCT04411693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5508879|NCT04411693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508880|NCT04411693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5508881|NCT04411693|Glucocorticoids|glucocorticoids|mesh-ancestor
5508882|NCT04411693|Hormones|hormones|mesh-ancestor
5508883|NCT04411693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5508884|NCT04411693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6068469|NCT00701935|Incretins|incretins|mesh-ancestor
6068470|NCT00701935|Hormones|hormones|mesh-ancestor
6068471|NCT00701935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5508885|NCT04411693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5508886|NCT04411693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5508887|NCT04411693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5508888|NCT04411693|Growth Substances|growth substances|mesh-ancestor
5508889|NCT04411693|Growth Inhibitors|growth inhibitors|mesh-ancestor
5508890|NCT04411706|Capecitabine|capecitabine|mesh-list
5508891|NCT04411706|Apatinib|apatinib|mesh-list
5508892|NCT04411706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5508893|NCT04411706|Antimetabolites|antimetabolites|mesh-ancestor
6068472|NCT00702052|Everolimus|everolimus|mesh-list
6068473|NCT00702052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6068474|NCT00702052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6068475|NCT00702052|Immunologic Factors|immunologic factors|mesh-ancestor
6068476|NCT00702052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068477|NCT00702221|Vaccines|vaccines|mesh-list
6068478|NCT00702221|Immunologic Factors|immunologic factors|mesh-ancestor
6068479|NCT00702221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068480|NCT00702299|Paclitaxel|paclitaxel|mesh-list
6068481|NCT00702299|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5508894|NCT04411706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508895|NCT04411706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6068482|NCT00702299|Cisplatin|cisplatin|mesh-list
6068483|NCT00702299|Pemetrexed|pemetrexed|mesh-list
6068484|NCT00702299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6068485|NCT00702299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6068486|NCT00702299|Tubulin Modulators|tubulin modulators|mesh-ancestor
6068487|NCT00702299|Antimitotic Agents|antimitotic agents|mesh-ancestor
6068488|NCT00702299|Mitosis Modulators|mitosis modulators|mesh-ancestor
6068489|NCT00702299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068490|NCT00702299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6665374|NCT01516840|Heparin|heparin|mesh-list
6665375|NCT01516840|Calcium heparin|calcium heparin|mesh-list
6665376|NCT01516840|Warfarin|warfarin|mesh-list
6665377|NCT01516840|Rivaroxaban|rivaroxaban|mesh-list
6665378|NCT01516840|Anticoagulants|anticoagulants|mesh-ancestor
6665379|NCT01516840|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6665380|NCT01516840|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6665381|NCT01516840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665382|NCT01516840|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6665383|NCT01516840|Antithrombins|antithrombins|mesh-ancestor
6068491|NCT00702299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6068492|NCT00702299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6068493|NCT00702325|Budesonide|budesonide|mesh-list
6068494|NCT00702325|Formoterol Fumarate|formoterol fumarate|mesh-list
6068495|NCT00702325|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6068496|NCT00702325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6068497|NCT00702325|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6068498|NCT00702325|Autonomic Agents|autonomic agents|mesh-ancestor
6068499|NCT00702325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6068500|NCT00702325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068501|NCT00702325|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6068502|NCT00702325|Respiratory System Agents|respiratory system agents|mesh-ancestor
6068503|NCT00702325|Glucocorticoids|glucocorticoids|mesh-ancestor
6068504|NCT00702325|Hormones|hormones|mesh-ancestor
6068505|NCT00702325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6068506|NCT00702325|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6068507|NCT00702325|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6068508|NCT00702325|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6068509|NCT00702325|Adrenergic Agents|adrenergic agents|mesh-ancestor
6068510|NCT00702325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6068511|NCT00702325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068512|NCT00702364|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6068513|NCT00702364|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6068514|NCT00702364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6068515|NCT00702364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6068516|NCT00702364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068517|NCT00702364|Adrenergic Agents|adrenergic agents|mesh-ancestor
6068518|NCT00702364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6068519|NCT00702364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068520|NCT00702403|Imatinib Mesylate|imatinib mesylate|mesh-list
6068521|NCT00702403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6068522|NCT00702403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6068523|NCT00702403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6068524|NCT00702403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068525|NCT00702468|Nabiximols|nabiximols|mesh-list
6068526|NCT00702468|Analgesics|analgesics|mesh-ancestor
6068527|NCT00702468|Sensory System Agents|sensory system agents|mesh-ancestor
6068528|NCT00702468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6068529|NCT00702468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068530|NCT00702507|Miconazole|miconazole|mesh-list
6068531|NCT00702507|Clotrimazole|clotrimazole|mesh-list
6068532|NCT00702507|Antifungal Agents|antifungal agents|mesh-ancestor
6068533|NCT00702507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6068534|NCT00702507|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5508896|NCT04411706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6202450|NCT02040857|Exemestane|exemestane|mesh-list
6665384|NCT01516840|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5508897|NCT04411706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6068535|NCT00702507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6068536|NCT00702507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6068537|NCT00702507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068538|NCT00702507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6068539|NCT00702507|Hormone Antagonists|hormone antagonists|mesh-ancestor
6068540|NCT00702507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6068541|NCT00702507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068542|NCT00702507|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6068543|NCT00702507|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6068544|NCT00702507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6463283|NCT00463736|Anesthetics|anesthetics|mesh-ancestor
6463284|NCT00463736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6463285|NCT00463736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6463286|NCT00463736|Anticonvulsants|anticonvulsants|mesh-ancestor
6463287|NCT00463736|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6463288|NCT00463736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6463289|NCT00463736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463290|NCT00463736|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6463291|NCT00463736|Tocolytic Agents|tocolytic agents|mesh-ancestor
6463292|NCT00463736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6463293|NCT00463762|Sulbactam|sulbactam|mesh-list
6463294|NCT00463762|Cefoperazone|cefoperazone|mesh-list
6463295|NCT00463762|Sulperazone|sulperazone|mesh-list
6463296|NCT00463762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6463297|NCT00463762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5508898|NCT04411524|Capecitabine|capecitabine|mesh-list
6068545|NCT00702650|Testosterone|testosterone|mesh-list
6068546|NCT00702650|Androgens|androgens|mesh-ancestor
6068547|NCT00702650|Hormones|hormones|mesh-ancestor
6068548|NCT00702650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6068549|NCT00702650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068550|NCT00702689|Imatinib Mesylate|imatinib mesylate|mesh-list
6068551|NCT00702689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6068552|NCT00702689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6068553|NCT00702689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6068554|NCT00702689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068555|NCT00702754|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
6068556|NCT00702754|Botulinum Toxins|botulinum toxins|mesh-list
6068557|NCT00702754|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6068558|NCT00702754|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6068559|NCT00702754|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6068560|NCT00702754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6068561|NCT00702754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068562|NCT00702754|Cholinergic Agents|cholinergic agents|mesh-ancestor
6068563|NCT00702754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6068564|NCT00702754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508899|NCT04411524|Irinotecan|irinotecan|mesh-list
5508900|NCT04411524|Antibodies|antibodies|mesh-list
6068565|NCT00702754|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6068566|NCT00702754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6068567|NCT00702754|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6068568|NCT00702780|Citalopram|citalopram|mesh-list
6068569|NCT00702780|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6068570|NCT00702780|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6068571|NCT00702780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6068572|NCT00702780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068573|NCT00702780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6068574|NCT00702780|Serotonin Agents|serotonin agents|mesh-ancestor
6068575|NCT00702780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068576|NCT00702780|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6068577|NCT00702780|Antidepressive Agents|antidepressive agents|mesh-ancestor
6068578|NCT00702780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6068579|NCT00702884|Sunitinib|sunitinib|mesh-list
6068580|NCT00702884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6068581|NCT00702884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6068582|NCT00702884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6068583|NCT00702884|Growth Substances|growth substances|mesh-ancestor
6068584|NCT00702884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068585|NCT00702884|Growth Inhibitors|growth inhibitors|mesh-ancestor
6068586|NCT00702884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6463298|NCT00463762|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5508901|NCT04411524|Immunologic Factors|immunologic factors|mesh-ancestor
6068587|NCT00702884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6068588|NCT00702884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068589|NCT00702923|Tremelimumab|tremelimumab|mesh-list
6068590|NCT00702923|Bicalutamide|bicalutamide|mesh-list
6068591|NCT00702923|Ipilimumab|ipilimumab|mesh-list
6068592|NCT00702923|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5508902|NCT04411524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508903|NCT04411524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5508904|NCT04411524|Antimetabolites|antimetabolites|mesh-ancestor
5508905|NCT04411524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508906|NCT04411524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5508907|NCT04411524|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5508908|NCT04411524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5508909|NCT04411524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5508910|NCT04411550|Pertuzumab|pertuzumab|mesh-list
5508911|NCT04411550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5508912|NCT04411550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5508913|NCT04411862|Choline|choline|mesh-list
5508914|NCT04411862|Lipotropic Agents|lipotropic agents|mesh-ancestor
6068593|NCT00702923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6068594|NCT00702923|Immunologic Factors|immunologic factors|mesh-ancestor
6068595|NCT00702923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068596|NCT00702923|Androgen Antagonists|androgen antagonists|mesh-ancestor
6068597|NCT00702923|Hormone Antagonists|hormone antagonists|mesh-ancestor
6068598|NCT00702923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6068599|NCT00702923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6068600|NCT00702923|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6068601|NCT00702923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068602|NCT00702949|Pregabalin|pregabalin|mesh-list
6068603|NCT00702949|Analgesics|analgesics|mesh-ancestor
6068604|NCT00702949|Sensory System Agents|sensory system agents|mesh-ancestor
6068605|NCT00702949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6068606|NCT00702949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068607|NCT00702949|Anticonvulsants|anticonvulsants|mesh-ancestor
6463299|NCT00463762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6463300|NCT00463762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463301|NCT00463762|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6068608|NCT00702949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6068609|NCT00702949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6068610|NCT00702949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068611|NCT00702949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6068612|NCT00702949|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6068613|NCT00702949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6068614|NCT00702949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6068615|NCT00702949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6068616|NCT00703118|Ribavirin|ribavirin|mesh-list
6068617|NCT00703118|Interferon alpha-2|interferon alpha-2|mesh-list
6068618|NCT00703118|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6068619|NCT00703118|Antimetabolites|antimetabolites|mesh-ancestor
6068620|NCT00703118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068621|NCT00703118|Antiviral Agents|antiviral agents|mesh-ancestor
6068622|NCT00703118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6068623|NCT00703118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6068624|NCT00703261|Atorvastatin|atorvastatin|mesh-list
6068625|NCT00703261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6068626|NCT00703261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6068627|NCT00703261|Antimetabolites|antimetabolites|mesh-ancestor
6068628|NCT00703261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068629|NCT00703261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6068630|NCT00703261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6068631|NCT00703261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6068632|NCT00703508|Metformin|metformin|mesh-list
6068633|NCT00703508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6068634|NCT00703508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068635|NCT00703664|Bortezomib|bortezomib|mesh-list
6068636|NCT00703664|Vorinostat|vorinostat|mesh-list
6068637|NCT00703664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6068638|NCT00703664|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6068639|NCT00703664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6068640|NCT00703664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068641|NCT00703677|Lithium Carbonate|lithium carbonate|mesh-list
6068642|NCT00703677|Antidepressive Agents|antidepressive agents|mesh-ancestor
6068643|NCT00703677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6463302|NCT00463762|Renal Agents|renal agents|mesh-ancestor
5508915|NCT04411862|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5508916|NCT04411862|Antimetabolites|antimetabolites|mesh-ancestor
5508917|NCT04411862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508918|NCT04411862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5508919|NCT04411862|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5508920|NCT04411862|Nootropic Agents|nootropic agents|mesh-ancestor
6068644|NCT00703677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6068645|NCT00703677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068646|NCT00703677|Antimanic Agents|antimanic agents|mesh-ancestor
6068647|NCT00703677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6068648|NCT00703677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6068649|NCT00703677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068650|NCT00703781|Bromfenac|bromfenac|mesh-list
6068651|NCT00703781|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6068652|NCT00703781|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6068653|NCT00703781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6068654|NCT00703781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6068655|NCT00703781|Analgesics|analgesics|mesh-ancestor
6068656|NCT00703781|Sensory System Agents|sensory system agents|mesh-ancestor
6068657|NCT00703781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6068658|NCT00703781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068659|NCT00703781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6068660|NCT00703781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6068661|NCT00703820|Cytarabine|cytarabine|mesh-list
6068662|NCT00703820|Etoposide|etoposide|mesh-list
6068663|NCT00703820|Daunorubicin|daunorubicin|mesh-list
6068664|NCT00703820|Clofarabine|clofarabine|mesh-list
6068665|NCT00703820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6068666|NCT00703820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6068667|NCT00703820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6068668|NCT00703820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6068669|NCT00703820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6068670|NCT00703820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068671|NCT00703820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6068672|NCT00703820|Antimetabolites|antimetabolites|mesh-ancestor
6068673|NCT00703820|Antiviral Agents|antiviral agents|mesh-ancestor
6068674|NCT00703820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6463303|NCT00463775|Topiramate|topiramate|mesh-list
6463304|NCT00463775|Anticonvulsants|anticonvulsants|mesh-ancestor
6463305|NCT00463775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6463306|NCT00463775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463307|NCT00463827|Atorvastatin|atorvastatin|mesh-list
6068675|NCT00703820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6068676|NCT00703820|Immunologic Factors|immunologic factors|mesh-ancestor
6068677|NCT00703820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068678|NCT00703820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6068679|NCT00703846|Ketoconazole|ketoconazole|mesh-list
6068680|NCT00703846|Antifungal Agents|antifungal agents|mesh-ancestor
6068681|NCT00703846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6068682|NCT00703846|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6068683|NCT00703846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6068684|NCT00703846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6068685|NCT00703846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068686|NCT00703846|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6068687|NCT00703846|Hormone Antagonists|hormone antagonists|mesh-ancestor
6068688|NCT00703846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6068689|NCT00703846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068690|NCT00703846|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6068691|NCT00703924|Paromomycin|paromomycin|mesh-list
6068692|NCT00703924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6068693|NCT00703924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6068694|NCT00703924|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6068695|NCT00703924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6068696|NCT00703976|Bevacizumab|bevacizumab|mesh-list
6068697|NCT00703976|Cetuximab|cetuximab|mesh-list
6068698|NCT00703976|Pemetrexed|pemetrexed|mesh-list
6068699|NCT00703976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5508921|NCT04411758|Propolis|propolis|mesh-list
5508922|NCT04411758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5508923|NCT04411537|Capecitabine|capecitabine|mesh-list
6068700|NCT00703976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5508924|NCT04411537|Irinotecan|irinotecan|mesh-list
5508925|NCT04411537|Antibodies|antibodies|mesh-list
5508926|NCT04411537|Immunologic Factors|immunologic factors|mesh-ancestor
5508927|NCT04411537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508928|NCT04411537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6068701|NCT00703976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6068702|NCT00703976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6068703|NCT00703976|Growth Substances|growth substances|mesh-ancestor
6068704|NCT00703976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068705|NCT00703976|Growth Inhibitors|growth inhibitors|mesh-ancestor
6068706|NCT00703976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6068707|NCT00703976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508929|NCT04411537|Antimetabolites|antimetabolites|mesh-ancestor
5508930|NCT04411537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508931|NCT04411537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5508932|NCT04411537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5508933|NCT04411537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5508934|NCT04411537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5508935|NCT04411901|Cholecalciferol|cholecalciferol|mesh-list
5508936|NCT04411901|Vitamin D|vitamin d|mesh-list
5508937|NCT04411901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5508938|NCT04411901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508939|NCT04411901|Vitamins|vitamins|mesh-ancestor
5508940|NCT04411901|Micronutrients|micronutrients|mesh-ancestor
5508941|NCT04411901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5508942|NCT04411433|Azithromycin|azithromycin|mesh-list
5508943|NCT04411433|Hydroxychloroquine|hydroxychloroquine|mesh-list
5508944|NCT04411433|Favipiravir|favipiravir|mesh-list
5508945|NCT04411433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5508946|NCT04411433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5508947|NCT04411433|Antimalarials|antimalarials|mesh-ancestor
5508948|NCT04411433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5508949|NCT04411433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5508950|NCT04411433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5508951|NCT04411433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508952|NCT04411433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5508953|NCT04411433|Antiviral Agents|antiviral agents|mesh-ancestor
5508954|NCT04411446|Vitamin D|vitamin d|mesh-list
5508955|NCT04411446|Cholecalciferol|cholecalciferol|mesh-list
5508956|NCT04411446|Vitamins|vitamins|mesh-ancestor
5508957|NCT04411446|Micronutrients|micronutrients|mesh-ancestor
5508958|NCT04411446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508959|NCT04411446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5508960|NCT04411446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5508961|NCT04411329|Dexamethasone|dexamethasone|mesh-list
5508962|NCT04411329|Dexmedetomidine|dexmedetomidine|mesh-list
6068708|NCT00703976|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6068709|NCT00703976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6068710|NCT00704028|Dextrans|dextrans|mesh-list
6068711|NCT00704028|Iron-Dextran Complex|iron-dextran complex|mesh-list
6068712|NCT00704028|Anticoagulants|anticoagulants|mesh-ancestor
6068713|NCT00704028|Plasma Substitutes|plasma substitutes|mesh-ancestor
6068714|NCT00704028|Blood Substitutes|blood substitutes|mesh-ancestor
6068715|NCT00704028|Hematinics|hematinics|mesh-ancestor
6068716|NCT00704132|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6068717|NCT00704132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6068718|NCT00704132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068719|NCT00704132|Incretins|incretins|mesh-ancestor
6068720|NCT00704132|Hormones|hormones|mesh-ancestor
6068721|NCT00704132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6068722|NCT00704132|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6068723|NCT00704132|Protease Inhibitors|protease inhibitors|mesh-ancestor
6068724|NCT00704132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6068725|NCT00704132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068726|NCT00704184|Interferons|interferons|mesh-list
6068727|NCT00704184|Ribavirin|ribavirin|mesh-list
6068728|NCT00704184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5508963|NCT04411329|Bupivacaine|bupivacaine|mesh-list
5508964|NCT04411329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5508965|NCT04411329|Antiemetics|antiemetics|mesh-ancestor
6068729|NCT00704184|Antiviral Agents|antiviral agents|mesh-ancestor
6068730|NCT00704184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6068731|NCT00704184|Antimetabolites|antimetabolites|mesh-ancestor
6068732|NCT00704184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068733|NCT00704262|Hydrocortisone|hydrocortisone|mesh-list
6068734|NCT00704262|Calcipotriene|calcipotriene|mesh-list
6068735|NCT00704262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6068736|NCT00704262|Dermatologic Agents|dermatologic agents|mesh-ancestor
6068737|NCT00704353|Ferric gluconate|ferric gluconate|mesh-list
6068738|NCT00704353|Iron-Dextran Complex|iron-dextran complex|mesh-list
6068739|NCT00704353|Hematinics|hematinics|mesh-ancestor
6068740|NCT00704379|Sertraline|sertraline|mesh-list
6068741|NCT00704379|Antidepressive Agents|antidepressive agents|mesh-ancestor
6068742|NCT00704379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6068743|NCT00704379|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6068744|NCT00704379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6068745|NCT00704379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6068746|NCT00704379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068747|NCT00704379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6068748|NCT00704379|Serotonin Agents|serotonin agents|mesh-ancestor
6068749|NCT00704379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068750|NCT00704405|Interferons|interferons|mesh-list
6068751|NCT00704405|Ribavirin|ribavirin|mesh-list
6068752|NCT00704405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6068753|NCT00704405|Antiviral Agents|antiviral agents|mesh-ancestor
6068754|NCT00704405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6068755|NCT00704405|Antimetabolites|antimetabolites|mesh-ancestor
5508966|NCT04411329|Autonomic Agents|autonomic agents|mesh-ancestor
5508967|NCT04411329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5508968|NCT04411329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508969|NCT04411329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5508970|NCT04411329|Glucocorticoids|glucocorticoids|mesh-ancestor
5508971|NCT04411329|Hormones|hormones|mesh-ancestor
5508972|NCT04411329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5508973|NCT04411329|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5508974|NCT04411329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5508975|NCT04411329|Anesthetics, Local|anesthetics, local|mesh-ancestor
5508976|NCT04411329|Anesthetics|anesthetics|mesh-ancestor
5508977|NCT04411329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5508978|NCT04411329|Sensory System Agents|sensory system agents|mesh-ancestor
5508979|NCT04411329|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5508980|NCT04411329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6068756|NCT00704405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068757|NCT00704418|Bromfenac|bromfenac|mesh-list
6068758|NCT00704418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6068759|NCT00704418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6068760|NCT00704418|Analgesics|analgesics|mesh-ancestor
6068761|NCT00704418|Sensory System Agents|sensory system agents|mesh-ancestor
6068762|NCT00704418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6068763|NCT00704418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068764|NCT00704418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6068765|NCT00704418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6068766|NCT00704522|Ribavirin|ribavirin|mesh-list
6068767|NCT00704522|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6068768|NCT00704522|Antimetabolites|antimetabolites|mesh-ancestor
6068769|NCT00704522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068770|NCT00704522|Antiviral Agents|antiviral agents|mesh-ancestor
6068771|NCT00704522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6068772|NCT00704717|Ribavirin|ribavirin|mesh-list
5508981|NCT04411329|Analgesics|analgesics|mesh-ancestor
5508982|NCT04411329|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5600311|NCT03712735|Narcotics|narcotics|mesh-ancestor
6068773|NCT00704717|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6068774|NCT00704717|Interferon-alpha|interferon-alpha|mesh-list
6068775|NCT00704717|Antimetabolites|antimetabolites|mesh-ancestor
6068776|NCT00704717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068777|NCT00704717|Antiviral Agents|antiviral agents|mesh-ancestor
6068778|NCT00704717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6463308|NCT00463827|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6463309|NCT00463827|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6463310|NCT00463827|Antimetabolites|antimetabolites|mesh-ancestor
6463311|NCT00463827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463312|NCT00463827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6463313|NCT00463827|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6068779|NCT00704717|Immunologic Factors|immunologic factors|mesh-ancestor
6068780|NCT00704717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202451|NCT02040857|Aromatase Inhibitors|aromatase inhibitors|mesh-list
6202452|NCT02040857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6202453|NCT02040857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6202454|NCT02040857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6202455|NCT02040857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202456|NCT02040857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6202457|NCT02040857|Hormone Antagonists|hormone antagonists|mesh-ancestor
6202458|NCT02040857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6202459|NCT02040857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202460|NCT02040857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6202461|NCT02040857|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6202462|NCT02040857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5508983|NCT04411329|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5508984|NCT04411329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5508985|NCT04411329|Adrenergic Agents|adrenergic agents|mesh-ancestor
6202463|NCT02040857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6202464|NCT02040857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6202465|NCT02040870|Ceritinib|ceritinib|mesh-list
6202466|NCT02040870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6202467|NCT02040870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6202468|NCT02040870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6202469|NCT02040870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202470|NCT02041091|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6202471|NCT02041091|Immunologic Factors|immunologic factors|mesh-ancestor
6202472|NCT02041091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202473|NCT02041299|Deferiprone|deferiprone|mesh-list
6202474|NCT02041299|Deferoxamine|deferoxamine|mesh-list
6202475|NCT02041299|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6202476|NCT02041299|Chelating Agents|chelating agents|mesh-ancestor
6202477|NCT02041299|Sequestering Agents|sequestering agents|mesh-ancestor
6202478|NCT02041299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202479|NCT02041299|Siderophores|siderophores|mesh-ancestor
6202480|NCT02041325|Lenalidomide|lenalidomide|mesh-list
6202481|NCT02041325|Immunologic Factors|immunologic factors|mesh-ancestor
6202482|NCT02041325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202483|NCT02041325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6202484|NCT02041325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6202485|NCT02041325|Growth Substances|growth substances|mesh-ancestor
6202486|NCT02041325|Growth Inhibitors|growth inhibitors|mesh-ancestor
6202487|NCT02041325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6202488|NCT02041429|Paclitaxel|paclitaxel|mesh-list
6202489|NCT02041429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6202490|NCT02041429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6202491|NCT02041429|Tubulin Modulators|tubulin modulators|mesh-ancestor
6202492|NCT02041429|Antimitotic Agents|antimitotic agents|mesh-ancestor
6202493|NCT02041429|Mitosis Modulators|mitosis modulators|mesh-ancestor
6202494|NCT02041429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202495|NCT02041533|Gemcitabine|gemcitabine|mesh-list
6202496|NCT02041533|Paclitaxel|paclitaxel|mesh-list
6202497|NCT02041533|Carboplatin|carboplatin|mesh-list
6202498|NCT02041533|Nivolumab|nivolumab|mesh-list
6202499|NCT02041533|Pemetrexed|pemetrexed|mesh-list
6202500|NCT02041533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6202501|NCT02041533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6202502|NCT02041533|Tubulin Modulators|tubulin modulators|mesh-ancestor
6202503|NCT02041533|Antimitotic Agents|antimitotic agents|mesh-ancestor
6202504|NCT02041533|Mitosis Modulators|mitosis modulators|mesh-ancestor
6202505|NCT02041533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202506|NCT02041533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6202507|NCT02041533|Antimetabolites|antimetabolites|mesh-ancestor
6202508|NCT02041533|Antiviral Agents|antiviral agents|mesh-ancestor
6202509|NCT02041533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5508986|NCT04411329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5508987|NCT04411329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202510|NCT02041533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6202511|NCT02041533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6202512|NCT02041533|Immunologic Factors|immunologic factors|mesh-ancestor
6202513|NCT02041533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202514|NCT02041533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6202515|NCT02041533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6202516|NCT02041533|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5508988|NCT04411225|Cannabidiol|cannabidiol|mesh-list
6202517|NCT02041533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6068781|NCT00704808|Temozolomide|temozolomide|mesh-list
6068782|NCT00704808|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6068783|NCT00704808|Alkylating Agents|alkylating agents|mesh-ancestor
6068784|NCT00704808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068785|NCT00704808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6068786|NCT00704847|Calcitonin|calcitonin|mesh-list
6068787|NCT00704847|Salmon calcitonin|salmon calcitonin|mesh-list
6068788|NCT00704847|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
6068789|NCT00704847|Katacalcin|katacalcin|mesh-list
6068790|NCT00704847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6068791|NCT00704847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068792|NCT00704847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6068793|NCT00704847|Vasodilator Agents|vasodilator agents|mesh-ancestor
6068794|NCT00704912|Orlistat|orlistat|mesh-list
6068795|NCT00704912|Contraceptive Agents|contraceptive agents|mesh-list
6068796|NCT00704912|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
6068797|NCT00704912|Contraceptives, Oral|contraceptives, oral|mesh-list
6068798|NCT00704912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6068799|NCT00704912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068800|NCT00704912|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6068801|NCT00704912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6068802|NCT00704912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068803|NCT00704912|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6068804|NCT00704912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6068805|NCT00704912|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6068806|NCT00704912|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6068807|NCT00704912|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6068808|NCT00704912|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
6068809|NCT00704912|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6068810|NCT00704938|Aldesleukin|aldesleukin|mesh-list
5508989|NCT04411225|Anticonvulsants|anticonvulsants|mesh-ancestor
5508990|NCT04411160|Ascorbic Acid|ascorbic acid|mesh-list
5508991|NCT04411160|Nitric Oxide|nitric oxide|mesh-list
5508992|NCT04411160|Vitamins|vitamins|mesh-ancestor
5508993|NCT04411160|Micronutrients|micronutrients|mesh-ancestor
6068811|NCT00704938|Cyclophosphamide|cyclophosphamide|mesh-list
6068812|NCT00704938|Fludarabine|fludarabine|mesh-list
6068813|NCT00704938|Fludarabine phosphate|fludarabine phosphate|mesh-list
6068814|NCT00704938|Sargramostim|sargramostim|mesh-list
6068815|NCT00704938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6068816|NCT00704938|Immunologic Factors|immunologic factors|mesh-ancestor
6068817|NCT00704938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068818|NCT00704938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6068819|NCT00704938|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6068820|NCT00704938|Alkylating Agents|alkylating agents|mesh-ancestor
6068821|NCT00704938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068822|NCT00704938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6068823|NCT00704938|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6068824|NCT00704938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6068825|NCT00704938|Antimetabolites|antimetabolites|mesh-ancestor
6068826|NCT00704938|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6068827|NCT00704938|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6068828|NCT00704938|Antiviral Agents|antiviral agents|mesh-ancestor
6068829|NCT00704938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6068830|NCT00704964|Ribavirin|ribavirin|mesh-list
6068831|NCT00704964|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6068832|NCT00704964|Interferon-alpha|interferon-alpha|mesh-list
6068833|NCT00704964|Antimetabolites|antimetabolites|mesh-ancestor
6068834|NCT00704964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068835|NCT00704964|Antiviral Agents|antiviral agents|mesh-ancestor
6068836|NCT00704964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5508994|NCT04411160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5508995|NCT04411160|Antioxidants|antioxidants|mesh-ancestor
6068837|NCT00704964|Immunologic Factors|immunologic factors|mesh-ancestor
6068838|NCT00704964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068839|NCT00705003|Melatonin|melatonin|mesh-list
6068840|NCT00705003|Buspirone|buspirone|mesh-list
6068841|NCT00705003|Antioxidants|antioxidants|mesh-ancestor
6068842|NCT00705003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068843|NCT00705003|Protective Agents|protective agents|mesh-ancestor
6068844|NCT00705003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068845|NCT00705003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6068846|NCT00705003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5508996|NCT04411160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5508997|NCT04411160|Protective Agents|protective agents|mesh-ancestor
5508998|NCT04411160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5508999|NCT04411160|Autonomic Agents|autonomic agents|mesh-ancestor
5509000|NCT04411160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5509001|NCT04411160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6068847|NCT00705003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6068848|NCT00705003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6068849|NCT00705003|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6068850|NCT00705003|Serotonin Agents|serotonin agents|mesh-ancestor
6068851|NCT00705003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6068852|NCT00705016|Fluorouracil|fluorouracil|mesh-list
6068853|NCT00705016|Cetuximab|cetuximab|mesh-list
5509002|NCT04411160|Respiratory System Agents|respiratory system agents|mesh-ancestor
5509003|NCT04411160|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5509004|NCT04411160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5509005|NCT04411160|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5509006|NCT04411160|Vasodilator Agents|vasodilator agents|mesh-ancestor
5509007|NCT04411160|Gasotransmitters|gasotransmitters|mesh-ancestor
5509008|NCT04411212|Sargramostim|sargramostim|mesh-list
5509009|NCT04411212|Lenograstim|lenograstim|mesh-list
5509010|NCT04411212|Immunologic Factors|immunologic factors|mesh-ancestor
5509011|NCT04411212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509012|NCT04411212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5509013|NCT04411069|Droperidol|droperidol|mesh-list
5509014|NCT04411069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5509015|NCT04411069|Antiemetics|antiemetics|mesh-ancestor
5509016|NCT04411069|Autonomic Agents|autonomic agents|mesh-ancestor
5509017|NCT04411069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5509018|NCT04411069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509019|NCT04411069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5509020|NCT04411069|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5509021|NCT04411069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5509022|NCT04411069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5509023|NCT04411069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5509024|NCT04411069|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5509025|NCT04411069|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5509026|NCT04411069|Dopamine Agents|dopamine agents|mesh-ancestor
5509027|NCT04411069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5509028|NCT04411069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5509029|NCT04410874|Vaccines|vaccines|mesh-list
5509030|NCT04410874|Immunologic Factors|immunologic factors|mesh-ancestor
5509031|NCT04410874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068854|NCT00705016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6068855|NCT00705016|Antimetabolites|antimetabolites|mesh-ancestor
5509032|NCT04410887|Olaparib|olaparib|mesh-list
5509033|NCT04410887|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5509034|NCT04410887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5509035|NCT04410887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5509036|NCT04410887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5509037|NCT04410965|Teriflunomide|teriflunomide|mesh-list
5509038|NCT04410965|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5509039|NCT04410965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5509040|NCT04410965|Analgesics|analgesics|mesh-ancestor
5509041|NCT04410965|Sensory System Agents|sensory system agents|mesh-ancestor
5509042|NCT04410965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5509043|NCT04410965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509044|NCT04410965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5509045|NCT04410965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5509046|NCT04410965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5509047|NCT04410965|Immunologic Factors|immunologic factors|mesh-ancestor
5509048|NCT04411030|Itraconazole|itraconazole|mesh-list
5509049|NCT04411030|Midazolam|midazolam|mesh-list
5509050|NCT04411030|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5509051|NCT04411030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6068856|NCT00705016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068857|NCT00705016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6068858|NCT00705016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6068859|NCT00705016|Immunologic Factors|immunologic factors|mesh-ancestor
6068860|NCT00705016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068861|NCT00705016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6068862|NCT00705107|Ribavirin|ribavirin|mesh-list
6068863|NCT00705107|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6068864|NCT00705107|Interferon-alpha|interferon-alpha|mesh-list
6068865|NCT00705107|Antimetabolites|antimetabolites|mesh-ancestor
6068866|NCT00705107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068867|NCT00705107|Antiviral Agents|antiviral agents|mesh-ancestor
6068868|NCT00705107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6068869|NCT00705107|Immunologic Factors|immunologic factors|mesh-ancestor
6068870|NCT00705107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068871|NCT00705133|Treprostinil|treprostinil|mesh-list
5509052|NCT04411030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5509053|NCT04411030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509054|NCT04411030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5509055|NCT04411030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5509056|NCT04411030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5509057|NCT04411030|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5509058|NCT04411030|Anesthetics, General|anesthetics, general|mesh-ancestor
5509059|NCT04411030|Anesthetics|anesthetics|mesh-ancestor
5509060|NCT04411030|GABA Modulators|gaba modulators|mesh-ancestor
5509061|NCT04411030|GABA Agents|gaba agents|mesh-ancestor
5509062|NCT04411030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5509063|NCT04411030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5509064|NCT04411030|Antifungal Agents|antifungal agents|mesh-ancestor
5509065|NCT04411030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5509066|NCT04411030|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5509067|NCT04411030|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5509068|NCT04411030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5509069|NCT04411030|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5509070|NCT04411030|Hormone Antagonists|hormone antagonists|mesh-ancestor
5509071|NCT04411030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5509072|NCT04411030|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5509073|NCT04410588|Fentanyl|fentanyl|mesh-list
5509074|NCT04410588|Levobupivacaine|levobupivacaine|mesh-list
5509075|NCT04410588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5509076|NCT04410588|Narcotics|narcotics|mesh-ancestor
5509077|NCT04410588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5509078|NCT04410588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509079|NCT04410588|Analgesics|analgesics|mesh-ancestor
5509080|NCT04410588|Sensory System Agents|sensory system agents|mesh-ancestor
5509081|NCT04410588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5509082|NCT04410588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5509083|NCT04410588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5509084|NCT04410588|Anesthetics, General|anesthetics, general|mesh-ancestor
5509085|NCT04410588|Anesthetics|anesthetics|mesh-ancestor
5509086|NCT04410588|Anesthetics, Local|anesthetics, local|mesh-ancestor
5509087|NCT04410354|Remdesivir|remdesivir|mesh-list
5509088|NCT04410354|Antimetabolites|antimetabolites|mesh-ancestor
5509089|NCT04410354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5509090|NCT04410354|Antiviral Agents|antiviral agents|mesh-ancestor
5509091|NCT04410354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6068872|NCT00705133|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6202518|NCT02042183|Lubiprostone|lubiprostone|mesh-list
6202519|NCT02042183|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6202520|NCT02042183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6202521|NCT02042183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202522|NCT02042443|Calcium, Dietary|calcium, dietary|mesh-list
6202523|NCT02042443|Leucovorin|leucovorin|mesh-list
6202524|NCT02042443|Folic Acid|folic acid|mesh-list
6202525|NCT02042443|Fluorouracil|fluorouracil|mesh-list
6202526|NCT02042443|Capecitabine|capecitabine|mesh-list
6202527|NCT02042443|Trametinib|trametinib|mesh-list
6202528|NCT02042443|Calcium|calcium|mesh-list
6202529|NCT02042443|Levoleucovorin|levoleucovorin|mesh-list
6202530|NCT02042443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5509092|NCT04409860|Paclitaxel|paclitaxel|mesh-list
5509093|NCT04409860|Cisplatin|cisplatin|mesh-list
5509094|NCT04409860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5509095|NCT04409860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5509096|NCT04409860|Tubulin Modulators|tubulin modulators|mesh-ancestor
5509097|NCT04409860|Antimitotic Agents|antimitotic agents|mesh-ancestor
5509098|NCT04409860|Mitosis Modulators|mitosis modulators|mesh-ancestor
5509099|NCT04409860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5509100|NCT04409912|Sirolimus|sirolimus|mesh-list
5509101|NCT04409912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6202531|NCT02042443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202532|NCT02042443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6202533|NCT02042443|Antimetabolites|antimetabolites|mesh-ancestor
6202534|NCT02042443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202535|NCT02042443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6202536|NCT02042443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6202537|NCT02042443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6202538|NCT02042443|Immunologic Factors|immunologic factors|mesh-ancestor
6202539|NCT02042443|Antidotes|antidotes|mesh-ancestor
6202540|NCT02042443|Protective Agents|protective agents|mesh-ancestor
6202541|NCT02042443|Vitamin B Complex|vitamin b complex|mesh-ancestor
6202542|NCT02042443|Vitamins|vitamins|mesh-ancestor
6202543|NCT02042443|Micronutrients|micronutrients|mesh-ancestor
6202544|NCT02042443|Hematinics|hematinics|mesh-ancestor
6202545|NCT02042443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6202546|NCT02042443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6202547|NCT02042534|Warfarin|warfarin|mesh-list
6202548|NCT02042534|Rivaroxaban|rivaroxaban|mesh-list
6202549|NCT02042534|Anticoagulants|anticoagulants|mesh-ancestor
6202550|NCT02042534|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6202551|NCT02042534|Antithrombins|antithrombins|mesh-ancestor
6202552|NCT02042534|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6202553|NCT02042534|Protease Inhibitors|protease inhibitors|mesh-ancestor
6202554|NCT02042534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6202555|NCT02042534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463314|NCT00463827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6463315|NCT00463879|Galantamine|galantamine|mesh-list
6463316|NCT00463879|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6202556|NCT02042872|Zoledronic Acid|zoledronic acid|mesh-list
6202557|NCT02042872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6202558|NCT02042872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202559|NCT02043132|Tranexamic Acid|tranexamic acid|mesh-list
6202560|NCT02043132|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
6202561|NCT02043132|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6202562|NCT02043132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202563|NCT02043132|Hemostatics|hemostatics|mesh-ancestor
5509102|NCT04409912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6202564|NCT02043132|Coagulants|coagulants|mesh-ancestor
6202565|NCT02043145|Botulinum Toxins|botulinum toxins|mesh-list
6202566|NCT02043145|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5509103|NCT04409912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5509104|NCT04409912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5509105|NCT04409912|Antifungal Agents|antifungal agents|mesh-ancestor
5509106|NCT04409912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5509107|NCT04409912|Immunologic Factors|immunologic factors|mesh-ancestor
5509108|NCT04409912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509109|NCT04409873|Hydrogen Peroxide|hydrogen peroxide|mesh-list
5509110|NCT04409873|Listerine|listerine|mesh-list
5509111|NCT04409873|Cetylpyridinium|cetylpyridinium|mesh-list
5509112|NCT04409873|Chlorine dioxide|chlorine dioxide|mesh-list
5509113|NCT04409873|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5509114|NCT04409873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6068873|NCT00705159|Loteprednol Etabonate|loteprednol etabonate|mesh-list
6068874|NCT00705159|Tobramycin|tobramycin|mesh-list
6068875|NCT00705159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6068876|NCT00705159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6068877|NCT00705159|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6068878|NCT00705224|Interferons|interferons|mesh-list
6068879|NCT00705224|Ribavirin|ribavirin|mesh-list
6068880|NCT00705224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6068881|NCT00705224|Antiviral Agents|antiviral agents|mesh-ancestor
6068882|NCT00705224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6068883|NCT00705224|Antimetabolites|antimetabolites|mesh-ancestor
6068884|NCT00705224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068885|NCT00705250|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6068886|NCT00705250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6068887|NCT00705250|Alkylating Agents|alkylating agents|mesh-ancestor
5509115|NCT04409873|Dental Disinfectants|dental disinfectants|mesh-ancestor
5509116|NCT04409873|Disinfectants|disinfectants|mesh-ancestor
5509117|NCT04410081|Lazertinib|lazertinib|mesh-list
6068888|NCT00705250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068889|NCT00705250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6068890|NCT00705263|Ribavirin|ribavirin|mesh-list
6068891|NCT00705263|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6068892|NCT00705263|Antimetabolites|antimetabolites|mesh-ancestor
6068893|NCT00705263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068894|NCT00705263|Antiviral Agents|antiviral agents|mesh-ancestor
6068895|NCT00705263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6068896|NCT00705289|Infliximab|infliximab|mesh-list
6068897|NCT00705289|Dermatologic Agents|dermatologic agents|mesh-ancestor
6068898|NCT00705289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6068899|NCT00705289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6068900|NCT00705341|Fluticasone|fluticasone|mesh-list
6068901|NCT00705341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6068902|NCT00705341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6068903|NCT00705341|Autonomic Agents|autonomic agents|mesh-ancestor
6068904|NCT00705341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6068905|NCT00705341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068906|NCT00705341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6068907|NCT00705341|Respiratory System Agents|respiratory system agents|mesh-ancestor
6068908|NCT00705341|Dermatologic Agents|dermatologic agents|mesh-ancestor
6068909|NCT00705341|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6068910|NCT00705367|Abatacept|abatacept|mesh-list
6068911|NCT00705367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6068912|NCT00705367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068913|NCT00705367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6068914|NCT00705367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6068915|NCT00705367|Immunologic Factors|immunologic factors|mesh-ancestor
6068916|NCT00705367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068917|NCT00705367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6068918|NCT00705406|Peramivir|peramivir|mesh-list
6068919|NCT00705406|Antiviral Agents|antiviral agents|mesh-ancestor
6068920|NCT00705406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6068921|NCT00705406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6068922|NCT00705406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068923|NCT00705432|Ribavirin|ribavirin|mesh-list
6068924|NCT00705432|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6068925|NCT00705432|Antimetabolites|antimetabolites|mesh-ancestor
6068926|NCT00705432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068927|NCT00705432|Antiviral Agents|antiviral agents|mesh-ancestor
6068928|NCT00705432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6068929|NCT00705484|Infliximab|infliximab|mesh-list
5509118|NCT04410081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5509119|NCT04410081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6068930|NCT00705484|Dermatologic Agents|dermatologic agents|mesh-ancestor
6068931|NCT00705484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6068932|NCT00705484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6068933|NCT00705523|Varenicline|varenicline|mesh-list
6068934|NCT00705523|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6068935|NCT00705523|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6068936|NCT00705523|Cholinergic Agents|cholinergic agents|mesh-ancestor
6068937|NCT00705523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6068938|NCT00705523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068939|NCT00705523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068940|NCT00705536|Insulin|insulin|mesh-list
6068941|NCT00705536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6068942|NCT00705536|Insulin Lispro|insulin lispro|mesh-list
6068943|NCT00705536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6068944|NCT00705536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068945|NCT00705575|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6068946|NCT00705575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6068947|NCT00705575|Diuretics|diuretics|mesh-ancestor
6068948|NCT00705575|Natriuretic Agents|natriuretic agents|mesh-ancestor
6068949|NCT00705575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068950|NCT00705575|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6068951|NCT00705575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6068952|NCT00705575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068953|NCT00705614|Infliximab|infliximab|mesh-list
6068954|NCT00705614|Dermatologic Agents|dermatologic agents|mesh-ancestor
6068955|NCT00705614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6068956|NCT00705614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6068957|NCT00705666|Ribavirin|ribavirin|mesh-list
6068958|NCT00705666|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6068959|NCT00705666|Antimetabolites|antimetabolites|mesh-ancestor
6068960|NCT00705666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068961|NCT00705666|Antiviral Agents|antiviral agents|mesh-ancestor
6068962|NCT00705666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6068963|NCT00705679|Tenofovir|tenofovir|mesh-list
6068964|NCT00705679|Emtricitabine|emtricitabine|mesh-list
6068965|NCT00705679|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6068966|NCT00705679|Antiviral Agents|antiviral agents|mesh-ancestor
6068967|NCT00705679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6068968|NCT00705679|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6068969|NCT00705679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6068970|NCT00705679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6068971|NCT00705679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068972|NCT00705679|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6068973|NCT00705679|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6068974|NCT00705757|Bimatoprost|bimatoprost|mesh-list
6068975|NCT00705757|Travoprost|travoprost|mesh-list
6068976|NCT00705757|Latanoprost|latanoprost|mesh-list
6068977|NCT00705757|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6068978|NCT00705757|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6068979|NCT00705757|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6068980|NCT00705783|Aripiprazole|aripiprazole|mesh-list
6068981|NCT00705783|Antidepressive Agents|antidepressive agents|mesh-ancestor
6068982|NCT00705783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6068983|NCT00705783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6068984|NCT00705783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6068985|NCT00705783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6068986|NCT00705783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6068987|NCT00705783|Dopamine Agonists|dopamine agonists|mesh-ancestor
6068988|NCT00705783|Dopamine Agents|dopamine agents|mesh-ancestor
5509120|NCT04410081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5509121|NCT04410094|Itraconazole|itraconazole|mesh-list
5509122|NCT04410094|Rifampin|rifampin|mesh-list
5509123|NCT04410094|Lazertinib|lazertinib|mesh-list
6068989|NCT00705783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6068990|NCT00705783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6068991|NCT00705783|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6068992|NCT00705783|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6068993|NCT00705783|Serotonin Agents|serotonin agents|mesh-ancestor
6068994|NCT00705783|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6068995|NCT00705783|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6068996|NCT00705783|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5509124|NCT04410094|Antifungal Agents|antifungal agents|mesh-ancestor
5509125|NCT04410094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5509126|NCT04410094|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5509127|NCT04410094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5509128|NCT04410094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5509129|NCT04410094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5509130|NCT04410094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6068997|NCT00705783|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6068998|NCT00705874|Leucovorin|leucovorin|mesh-list
6068999|NCT00705874|Gemcitabine|gemcitabine|mesh-list
6069000|NCT00705874|Bevacizumab|bevacizumab|mesh-list
6069001|NCT00705874|Sunitinib|sunitinib|mesh-list
6069002|NCT00705874|Docetaxel|docetaxel|mesh-list
6069003|NCT00705874|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6069004|NCT00705874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6069005|NCT00705874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6069006|NCT00705874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6069007|NCT00705874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6069008|NCT00705874|Growth Substances|growth substances|mesh-ancestor
6069009|NCT00705874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069010|NCT00705874|Growth Inhibitors|growth inhibitors|mesh-ancestor
6069011|NCT00705874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6069012|NCT00705874|Antimetabolites|antimetabolites|mesh-ancestor
5509131|NCT04410094|Hormone Antagonists|hormone antagonists|mesh-ancestor
5509132|NCT04410094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5509133|NCT04410094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509134|NCT04410094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5509135|NCT04410094|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5509136|NCT04410094|Antitubercular Agents|antitubercular agents|mesh-ancestor
5509137|NCT04410094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5509138|NCT04410094|Leprostatic Agents|leprostatic agents|mesh-ancestor
5509139|NCT04410094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5509140|NCT04410094|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5509141|NCT04410094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5509142|NCT04410094|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5509143|NCT04410094|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5509144|NCT04410094|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6069013|NCT00705874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069014|NCT00705874|Antiviral Agents|antiviral agents|mesh-ancestor
6069015|NCT00705874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6069016|NCT00705874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6069017|NCT00705874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6069018|NCT00705874|Immunologic Factors|immunologic factors|mesh-ancestor
6069019|NCT00705874|Tubulin Modulators|tubulin modulators|mesh-ancestor
6069020|NCT00705874|Antimitotic Agents|antimitotic agents|mesh-ancestor
6069021|NCT00705874|Mitosis Modulators|mitosis modulators|mesh-ancestor
6069022|NCT00705874|Antidotes|antidotes|mesh-ancestor
6069023|NCT00705874|Protective Agents|protective agents|mesh-ancestor
6069024|NCT00705874|Vitamin B Complex|vitamin b complex|mesh-ancestor
6069025|NCT00705874|Vitamins|vitamins|mesh-ancestor
6069026|NCT00705874|Micronutrients|micronutrients|mesh-ancestor
6069027|NCT00705874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6069028|NCT00706004|Lubiprostone|lubiprostone|mesh-list
6069029|NCT00706004|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6069030|NCT00706004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6069031|NCT00706004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069032|NCT00706030|Vinorelbine|vinorelbine|mesh-list
6069033|NCT00706030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6069034|NCT00706030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6069035|NCT00706030|Tubulin Modulators|tubulin modulators|mesh-ancestor
6069036|NCT00706030|Antimitotic Agents|antimitotic agents|mesh-ancestor
6069037|NCT00706030|Mitosis Modulators|mitosis modulators|mesh-ancestor
6069038|NCT00706030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069039|NCT00706121|Vitamins|vitamins|mesh-list
6069040|NCT00706121|Vitamin E|vitamin e|mesh-list
6069041|NCT00706121|Tocopherols|tocopherols|mesh-list
6069042|NCT00706121|Tocotrienols|tocotrienols|mesh-list
6069043|NCT00706121|alpha-Tocopherol|alpha-tocopherol|mesh-list
6069044|NCT00706121|Selenium|selenium|mesh-list
6069045|NCT00706121|Micronutrients|micronutrients|mesh-ancestor
6069046|NCT00706121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069047|NCT00706121|Antioxidants|antioxidants|mesh-ancestor
6069048|NCT00706121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069049|NCT00706121|Protective Agents|protective agents|mesh-ancestor
6069050|NCT00706121|Trace Elements|trace elements|mesh-ancestor
6069051|NCT00706264|Silicon|silicon|mesh-list
6069052|NCT00706264|Trace Elements|trace elements|mesh-ancestor
6069053|NCT00706264|Micronutrients|micronutrients|mesh-ancestor
6069054|NCT00706264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069055|NCT00706381|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
6069056|NCT00706381|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6069057|NCT00706381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6069058|NCT00706433|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6069059|NCT00706433|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6069060|NCT00706433|Dermatologic Agents|dermatologic agents|mesh-ancestor
6069061|NCT00706446|Fluticasone|fluticasone|mesh-list
6069062|NCT00706446|Xhance|xhance|mesh-list
6069063|NCT00706446|Budesonide|budesonide|mesh-list
6069064|NCT00706446|Bromides|bromides|mesh-list
5509145|NCT04410094|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5509146|NCT04410094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5509147|NCT04410211|Midazolam|midazolam|mesh-list
5509148|NCT04410211|Sevoflurane|sevoflurane|mesh-list
5509149|NCT04410211|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5509150|NCT04410211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5509151|NCT04410211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5509152|NCT04410211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509153|NCT04410211|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5509154|NCT04410211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5509155|NCT04410211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5509156|NCT04410211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5509157|NCT04410211|Anesthetics, General|anesthetics, general|mesh-ancestor
5509158|NCT04410211|Anesthetics|anesthetics|mesh-ancestor
5509159|NCT04410211|GABA Modulators|gaba modulators|mesh-ancestor
5509160|NCT04410211|GABA Agents|gaba agents|mesh-ancestor
5509161|NCT04410211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5509162|NCT04410211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5509163|NCT04410211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5509164|NCT04410211|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5509165|NCT04409522|Melatonin|melatonin|mesh-list
5509166|NCT04409522|Antioxidants|antioxidants|mesh-ancestor
5509167|NCT04409522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5509168|NCT04409522|Protective Agents|protective agents|mesh-ancestor
5509169|NCT04409522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509170|NCT04409522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5509171|NCT04409431|Epinephrine|epinephrine|mesh-list
5509172|NCT04409431|Racepinephrine|racepinephrine|mesh-list
5509173|NCT04409431|Epinephryl borate|epinephryl borate|mesh-list
5509174|NCT04409431|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5509175|NCT04409431|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5509176|NCT04409431|Adrenergic Agents|adrenergic agents|mesh-ancestor
5509177|NCT04409431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5509178|NCT04409431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5509179|NCT04409431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509180|NCT04409431|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5509181|NCT04409431|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6069065|NCT00706446|Formoterol Fumarate|formoterol fumarate|mesh-list
6069066|NCT00706446|Tiotropium Bromide|tiotropium bromide|mesh-list
6069067|NCT00706446|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6069068|NCT00706446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6069069|NCT00706446|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6069070|NCT00706446|Autonomic Agents|autonomic agents|mesh-ancestor
6069071|NCT00706446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6069072|NCT00706446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069073|NCT00706446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6069074|NCT00706446|Respiratory System Agents|respiratory system agents|mesh-ancestor
6069075|NCT00706446|Dermatologic Agents|dermatologic agents|mesh-ancestor
6069076|NCT00706446|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6069077|NCT00706446|Glucocorticoids|glucocorticoids|mesh-ancestor
6069078|NCT00706446|Hormones|hormones|mesh-ancestor
6069079|NCT00706446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6069080|NCT00706446|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6069081|NCT00706446|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6069082|NCT00706446|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6069083|NCT00706446|Adrenergic Agents|adrenergic agents|mesh-ancestor
6069084|NCT00706446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6069085|NCT00706446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069086|NCT00706446|Parasympatholytics|parasympatholytics|mesh-ancestor
6069087|NCT00706446|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6069088|NCT00706446|Cholinergic Agents|cholinergic agents|mesh-ancestor
6069089|NCT00706446|Anticonvulsants|anticonvulsants|mesh-ancestor
6069090|NCT00706550|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5509182|NCT04409431|Autonomic Agents|autonomic agents|mesh-ancestor
5509183|NCT04409431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5509184|NCT04409431|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5509185|NCT04409431|Respiratory System Agents|respiratory system agents|mesh-ancestor
5509186|NCT04409431|Mydriatics|mydriatics|mesh-ancestor
5509187|NCT04409431|Sympathomimetics|sympathomimetics|mesh-ancestor
6069091|NCT00706550|Immunologic Factors|immunologic factors|mesh-ancestor
6069092|NCT00706550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069093|NCT00706589|Aripiprazole|aripiprazole|mesh-list
5509188|NCT04409431|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5509189|NCT04409691|Sirolimus|sirolimus|mesh-list
5509190|NCT04409691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5509191|NCT04409691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5509192|NCT04409691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5509193|NCT04409691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5509194|NCT04409691|Antifungal Agents|antifungal agents|mesh-ancestor
5509195|NCT04409691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5509196|NCT04409691|Immunologic Factors|immunologic factors|mesh-ancestor
5509197|NCT04409691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509198|NCT04409600|Botulinum Toxins|botulinum toxins|mesh-list
5509199|NCT04409600|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5509200|NCT04409600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5509201|NCT04409600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5509202|NCT04409600|Cholinergic Agents|cholinergic agents|mesh-ancestor
5509203|NCT04409600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5509204|NCT04409600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509205|NCT04409769|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
5509206|NCT04409769|Ceftobiprole|ceftobiprole|mesh-list
5509207|NCT04409769|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
5509208|NCT04409769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5509209|NCT04409769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5509210|NCT04409223|Sunitinib|sunitinib|mesh-list
5509211|NCT04409223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5509212|NCT04409223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5509213|NCT04409223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5509214|NCT04409223|Growth Substances|growth substances|mesh-ancestor
5509215|NCT04409223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509216|NCT04409223|Growth Inhibitors|growth inhibitors|mesh-ancestor
5509217|NCT04409223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6069094|NCT00706589|Antidepressive Agents|antidepressive agents|mesh-ancestor
6069095|NCT00706589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6069096|NCT00706589|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6069097|NCT00706589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6069098|NCT00706589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6069099|NCT00706589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069100|NCT00706589|Dopamine Agonists|dopamine agonists|mesh-ancestor
6069101|NCT00706589|Dopamine Agents|dopamine agents|mesh-ancestor
6069102|NCT00706589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6069103|NCT00706589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069104|NCT00706589|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6069105|NCT00706589|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6069106|NCT00706589|Serotonin Agents|serotonin agents|mesh-ancestor
6069107|NCT00706589|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6069108|NCT00706589|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6069109|NCT00706589|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6069110|NCT00706589|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6069111|NCT00706628|Nintedanib|nintedanib|mesh-list
6069112|NCT00706628|Afatinib|afatinib|mesh-list
6069113|NCT00706628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6069114|NCT00706628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6069115|NCT00706628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6069116|NCT00706628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069117|NCT00706641|Dasatinib|dasatinib|mesh-list
6069118|NCT00706641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6069119|NCT00706641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6069120|NCT00706641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6069121|NCT00706641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069122|NCT00706654|Aripiprazole|aripiprazole|mesh-list
6069123|NCT00706654|Antidepressive Agents|antidepressive agents|mesh-ancestor
6069124|NCT00706654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6069125|NCT00706654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6069126|NCT00706654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6069127|NCT00706654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6069128|NCT00706654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069129|NCT00706654|Dopamine Agonists|dopamine agonists|mesh-ancestor
6069130|NCT00706654|Dopamine Agents|dopamine agents|mesh-ancestor
6069131|NCT00706654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6069132|NCT00706654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069133|NCT00706654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6069134|NCT00706654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6069135|NCT00706654|Serotonin Agents|serotonin agents|mesh-ancestor
6069136|NCT00706654|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6069137|NCT00706654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6069138|NCT00706654|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6069139|NCT00706654|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6069140|NCT00706706|Sunitinib|sunitinib|mesh-list
6069141|NCT00706706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6069142|NCT00706706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6069143|NCT00706706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5509218|NCT04409223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5509219|NCT04409223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5509220|NCT04409483|Ritonavir|ritonavir|mesh-list
5509221|NCT04409483|Lopinavir|lopinavir|mesh-list
5509222|NCT04409483|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5509223|NCT04409483|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5509224|NCT04409483|Protease Inhibitors|protease inhibitors|mesh-ancestor
6069144|NCT00706706|Growth Substances|growth substances|mesh-ancestor
6069145|NCT00706706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069146|NCT00706706|Growth Inhibitors|growth inhibitors|mesh-ancestor
6069147|NCT00706706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6069148|NCT00706706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6069149|NCT00706706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069150|NCT00706719|Enclomiphene|enclomiphene|mesh-list
6069151|NCT00706719|Clomiphene|clomiphene|mesh-list
6069152|NCT00706719|Zuclomiphene|zuclomiphene|mesh-list
6069153|NCT00706719|Testosterone|testosterone|mesh-list
6069154|NCT00706719|Androgens|androgens|mesh-ancestor
6069155|NCT00706719|Hormones|hormones|mesh-ancestor
6069156|NCT00706719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6069157|NCT00706719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069158|NCT00706719|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6069159|NCT00706719|Hormone Antagonists|hormone antagonists|mesh-ancestor
6069160|NCT00706719|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6069161|NCT00706719|Fertility Agents|fertility agents|mesh-ancestor
6069162|NCT00706719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6069163|NCT00706719|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6069164|NCT00706719|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6069165|NCT00706810|Hydroxyurea|hydroxyurea|mesh-list
6069166|NCT00706810|Verapamil|verapamil|mesh-list
6069167|NCT00706810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5509225|NCT04409483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5509226|NCT04409483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5509227|NCT04409483|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5509228|NCT04409483|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5509229|NCT04409483|Antiviral Agents|antiviral agents|mesh-ancestor
5509230|NCT04409483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5509231|NCT04409483|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5509232|NCT04409483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5509233|NCT04409327|Dactolisib|dactolisib|mesh-list
5509234|NCT04409327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5509235|NCT04408586|Topiramate|topiramate|mesh-list
5509236|NCT04408586|Phentermine|phentermine|mesh-list
5509237|NCT04408586|Anticonvulsants|anticonvulsants|mesh-ancestor
5509238|NCT04408586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6069168|NCT00706810|Antisickling Agents|antisickling agents|mesh-ancestor
6069169|NCT00706810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6069170|NCT00706810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069171|NCT00706810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6069172|NCT00706810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6069173|NCT00706810|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6069174|NCT00706810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6069175|NCT00706810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6069176|NCT00706810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069177|NCT00706810|Vasodilator Agents|vasodilator agents|mesh-ancestor
6069178|NCT00706836|Pregabalin|pregabalin|mesh-list
6069179|NCT00706836|Analgesics|analgesics|mesh-ancestor
5509239|NCT04408586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509240|NCT04408586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6069180|NCT00706836|Sensory System Agents|sensory system agents|mesh-ancestor
6069181|NCT00706836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6069182|NCT00706836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069183|NCT00706836|Anticonvulsants|anticonvulsants|mesh-ancestor
6069184|NCT00706836|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6069185|NCT00706836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6069186|NCT00706836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069187|NCT00706836|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6069188|NCT00706836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6069189|NCT00706836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6069190|NCT00706836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6069191|NCT00706836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6069192|NCT00706849|Mipomersen|mipomersen|mesh-list
6069193|NCT00706849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6069194|NCT00706849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6069195|NCT00706849|Antimetabolites|antimetabolites|mesh-ancestor
6069196|NCT00706849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463317|NCT00463879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6463318|NCT00463879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463319|NCT00463879|Cholinergic Agents|cholinergic agents|mesh-ancestor
6463320|NCT00463879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5509241|NCT04408586|Appetite Depressants|appetite depressants|mesh-ancestor
5509242|NCT04408586|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5509243|NCT04408586|Sympathomimetics|sympathomimetics|mesh-ancestor
5509244|NCT04408586|Autonomic Agents|autonomic agents|mesh-ancestor
5509245|NCT04408586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5509246|NCT04408586|Adrenergic Agents|adrenergic agents|mesh-ancestor
5509247|NCT04408586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5509248|NCT04408586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5509249|NCT04408560|Acetaminophen|acetaminophen|mesh-list
5509250|NCT04408560|Analgesics|analgesics|mesh-list
5509251|NCT04408560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5509252|NCT04408560|Sensory System Agents|sensory system agents|mesh-ancestor
5509253|NCT04408560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5509254|NCT04408560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509255|NCT04408560|Antipyretics|antipyretics|mesh-ancestor
5509256|NCT04408989|Bevacizumab|bevacizumab|mesh-list
5509257|NCT04408989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6463321|NCT00463879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463322|NCT00463879|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6463323|NCT00463879|Autonomic Agents|autonomic agents|mesh-ancestor
6463324|NCT00463879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6463325|NCT00463879|Nootropic Agents|nootropic agents|mesh-ancestor
6488404|NCT00583986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6488405|NCT00583986|Respiratory System Agents|respiratory system agents|mesh-ancestor
6488406|NCT00583986|Tocolytic Agents|tocolytic agents|mesh-ancestor
6488407|NCT00583986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5509258|NCT04408989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5509259|NCT04408989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5509260|NCT04408989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5509261|NCT04408989|Growth Substances|growth substances|mesh-ancestor
5509262|NCT04408989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069197|NCT00706849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6069198|NCT00706914|Formoterol Fumarate|formoterol fumarate|mesh-list
6069199|NCT00706914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6069200|NCT00706914|Autonomic Agents|autonomic agents|mesh-ancestor
6069201|NCT00706914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6069202|NCT00706914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069203|NCT00706914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6069204|NCT00706914|Respiratory System Agents|respiratory system agents|mesh-ancestor
6069205|NCT00706914|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6069206|NCT00706914|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6069207|NCT00706914|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6069208|NCT00706914|Adrenergic Agents|adrenergic agents|mesh-ancestor
6069209|NCT00706914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6069210|NCT00706914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069211|NCT00706966|Dutasteride|dutasteride|mesh-list
6069212|NCT00706966|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6069213|NCT00706966|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6069214|NCT00706966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6069215|NCT00706966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069216|NCT00706966|Hormone Antagonists|hormone antagonists|mesh-ancestor
6202567|NCT02043145|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5509263|NCT04408989|Growth Inhibitors|growth inhibitors|mesh-ancestor
5509264|NCT04408911|Midazolam|midazolam|mesh-list
5509265|NCT04408911|Lormetazepam|lormetazepam|mesh-list
5509266|NCT04408911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5509267|NCT04408911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5509268|NCT04408911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5509269|NCT04408911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509270|NCT04408911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5509271|NCT04408911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5509272|NCT04408911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5509273|NCT04408911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5509274|NCT04408911|Anesthetics, General|anesthetics, general|mesh-ancestor
5509275|NCT04408911|Anesthetics|anesthetics|mesh-ancestor
5509276|NCT04408911|GABA Modulators|gaba modulators|mesh-ancestor
5509277|NCT04408911|GABA Agents|gaba agents|mesh-ancestor
5509278|NCT04408911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5509279|NCT04408911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5509280|NCT04408625|Sirolimus|sirolimus|mesh-list
5509281|NCT04408625|Prednisone|prednisone|mesh-list
5509282|NCT04408625|Methylprednisolone|methylprednisolone|mesh-list
6069217|NCT00706966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6069218|NCT00706966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069219|NCT00706979|Nicotine|nicotine|mesh-list
6069220|NCT00706979|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6069221|NCT00706979|Autonomic Agents|autonomic agents|mesh-ancestor
6069222|NCT00706979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6069223|NCT00706979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069224|NCT00706979|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6069225|NCT00706979|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6069226|NCT00706979|Cholinergic Agents|cholinergic agents|mesh-ancestor
6069227|NCT00706979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6069228|NCT00706979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069229|NCT00706992|Aldesleukin|aldesleukin|mesh-list
6069230|NCT00706992|Vaccines|vaccines|mesh-list
6069231|NCT00706992|Freund's Adjuvant|freund's adjuvant|mesh-list
6069232|NCT00706992|Immunologic Factors|immunologic factors|mesh-ancestor
6069233|NCT00706992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069234|NCT00706992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6069235|NCT00706992|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6069236|NCT00706992|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6069237|NCT00706992|Antiviral Agents|antiviral agents|mesh-ancestor
6069238|NCT00706992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6069239|NCT00706992|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6069240|NCT00707031|Metformin|metformin|mesh-list
6069241|NCT00707031|Exenatide|exenatide|mesh-list
6069242|NCT00707031|Lixisenatide|lixisenatide|mesh-list
6069243|NCT00707031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6069244|NCT00707031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069245|NCT00707031|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6069246|NCT00707031|Incretins|incretins|mesh-ancestor
6069247|NCT00707031|Hormones|hormones|mesh-ancestor
6069248|NCT00707031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6069249|NCT00707057|Ibuprofen|ibuprofen|mesh-list
6069250|NCT00707057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6069251|NCT00707057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6069252|NCT00707057|Analgesics|analgesics|mesh-ancestor
6069253|NCT00707057|Sensory System Agents|sensory system agents|mesh-ancestor
6069254|NCT00707057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6069255|NCT00707057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069256|NCT00707057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6069257|NCT00707057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6069258|NCT00707057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6069259|NCT00707057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6069260|NCT00707057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069261|NCT00707174|Imiquimod|imiquimod|mesh-list
6069262|NCT00707174|Tazarotene|tazarotene|mesh-list
6069263|NCT00707174|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6069264|NCT00707174|Immunologic Factors|immunologic factors|mesh-ancestor
6069265|NCT00707174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069266|NCT00707174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6069267|NCT00707174|Interferon Inducers|interferon inducers|mesh-ancestor
6069268|NCT00707174|Dermatologic Agents|dermatologic agents|mesh-ancestor
6069269|NCT00707174|Keratolytic Agents|keratolytic agents|mesh-ancestor
6069270|NCT00707239|Imipenem|imipenem|mesh-list
6069271|NCT00707239|Tigecycline|tigecycline|mesh-list
5509283|NCT04408625|Rituximab|rituximab|mesh-list
5509284|NCT04408625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6069272|NCT00707239|Cilastatin|cilastatin|mesh-list
6069273|NCT00707239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6069274|NCT00707239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6069275|NCT00707239|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6069276|NCT00707239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6069277|NCT00707239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069278|NCT00707239|Protease Inhibitors|protease inhibitors|mesh-ancestor
5509285|NCT04408625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5509286|NCT04408625|Immunologic Factors|immunologic factors|mesh-ancestor
5509287|NCT04408625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509288|NCT04408625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5509289|NCT04408625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5509290|NCT04408625|Glucocorticoids|glucocorticoids|mesh-ancestor
5509291|NCT04408625|Hormones|hormones|mesh-ancestor
5509292|NCT04408625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5509293|NCT04408625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5509294|NCT04408625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6069279|NCT00707486|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
6069280|NCT00707486|Hemostatics|hemostatics|mesh-ancestor
6069281|NCT00707486|Coagulants|coagulants|mesh-ancestor
6069282|NCT00707655|Zalutumumab|zalutumumab|mesh-list
6069283|NCT00707655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6069284|NCT00707655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6069285|NCT00707746|Mipomersen|mipomersen|mesh-list
6069286|NCT00707746|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6069287|NCT00707746|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6069288|NCT00707746|Antimetabolites|antimetabolites|mesh-ancestor
6069289|NCT00707746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069290|NCT00707746|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6069291|NCT00707759|Mycophenolic Acid|mycophenolic acid|mesh-list
6069292|NCT00707759|Prednisone|prednisone|mesh-list
6069293|NCT00707759|Prednisolone|prednisolone|mesh-list
6069294|NCT00707759|Tacrolimus|tacrolimus|mesh-list
6069295|NCT00707759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6069296|NCT00707759|Glucocorticoids|glucocorticoids|mesh-ancestor
6069297|NCT00707759|Hormones|hormones|mesh-ancestor
6069298|NCT00707759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6069299|NCT00707759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069300|NCT00707759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5600312|NCT03712735|Analgesics|analgesics|mesh-ancestor
6069301|NCT00707759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6069302|NCT00707759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6069303|NCT00707759|Immunologic Factors|immunologic factors|mesh-ancestor
6069304|NCT00707759|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6069305|NCT00707759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6069306|NCT00707759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069307|NCT00707759|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6069308|NCT00707759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6069309|NCT00707759|Antitubercular Agents|antitubercular agents|mesh-ancestor
6069310|NCT00707759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6069311|NCT00707759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6069312|NCT00707863|Citalopram|citalopram|mesh-list
6069313|NCT00707863|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6069314|NCT00707863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6069315|NCT00707863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6069316|NCT00707863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069317|NCT00707863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6069318|NCT00707863|Serotonin Agents|serotonin agents|mesh-ancestor
6069319|NCT00707863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069320|NCT00707863|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6069321|NCT00707863|Antidepressive Agents|antidepressive agents|mesh-ancestor
6069322|NCT00707863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6069323|NCT00707967|Vaccines|vaccines|mesh-list
6069324|NCT00707967|Immunologic Factors|immunologic factors|mesh-ancestor
6069325|NCT00707967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069326|NCT00707980|Vortioxetine|vortioxetine|mesh-list
6069327|NCT00707980|Antidepressive Agents|antidepressive agents|mesh-ancestor
6069328|NCT00707980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6069329|NCT00707980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6069330|NCT00707980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6069331|NCT00707980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6069332|NCT00707980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069333|NCT00707980|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6069334|NCT00707980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6069335|NCT00707980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6069336|NCT00707980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069337|NCT00707980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6069338|NCT00707980|Serotonin Agents|serotonin agents|mesh-ancestor
6069339|NCT00707980|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6069340|NCT00707980|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6069341|NCT00707980|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6069342|NCT00707980|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6069343|NCT00707993|Alogliptin|alogliptin|mesh-list
6069344|NCT00707993|Glipizide|glipizide|mesh-list
6069345|NCT00707993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6069346|NCT00707993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069347|NCT00707993|Incretins|incretins|mesh-ancestor
6069348|NCT00707993|Hormones|hormones|mesh-ancestor
6069349|NCT00707993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6069350|NCT00707993|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6069351|NCT00707993|Protease Inhibitors|protease inhibitors|mesh-ancestor
6069352|NCT00707993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6069353|NCT00707993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069354|NCT00708071|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6069355|NCT00708071|Thrombin|thrombin|mesh-list
6463326|NCT00463918|Varenicline|varenicline|mesh-list
5509295|NCT04408625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5509296|NCT04408625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5509297|NCT04408625|Antifungal Agents|antifungal agents|mesh-ancestor
5509298|NCT04408625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5509299|NCT04408625|Antiemetics|antiemetics|mesh-ancestor
5509300|NCT04408625|Autonomic Agents|autonomic agents|mesh-ancestor
5509301|NCT04408625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5509302|NCT04408625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5509303|NCT04408625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5509304|NCT04408625|Protective Agents|protective agents|mesh-ancestor
5509305|NCT04408313|Naltrexone|naltrexone|mesh-list
5509306|NCT04408313|Buprenorphine|buprenorphine|mesh-list
5509307|NCT04408313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5509308|NCT04408313|Narcotics|narcotics|mesh-ancestor
5509309|NCT04408313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5509310|NCT04408313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509311|NCT04408313|Analgesics|analgesics|mesh-ancestor
5509312|NCT04408313|Sensory System Agents|sensory system agents|mesh-ancestor
5509313|NCT04408313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5509314|NCT04408313|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5509315|NCT04408313|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5509316|NCT04408326|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5509317|NCT04408326|Angiotensin II|angiotensin ii|mesh-list
5509318|NCT04408326|Giapreza|giapreza|mesh-list
5509319|NCT04408326|Angiotensinogen|angiotensinogen|mesh-list
5509320|NCT04408326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5509321|NCT04408326|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5509322|NCT04408326|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5509323|NCT04408326|Protease Inhibitors|protease inhibitors|mesh-ancestor
5509324|NCT04408326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5509325|NCT04408326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600313|NCT03712735|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5600314|NCT03712735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6463327|NCT00463918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6463328|NCT00463918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6463329|NCT00463918|Cholinergic Agents|cholinergic agents|mesh-ancestor
6069356|NCT00708071|Aprotinin|aprotinin|mesh-list
6069357|NCT00708071|Hemostatics|hemostatics|mesh-ancestor
6069358|NCT00708071|Coagulants|coagulants|mesh-ancestor
6069359|NCT00708071|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6069360|NCT00708071|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6069361|NCT00708071|Protease Inhibitors|protease inhibitors|mesh-ancestor
6069362|NCT00708071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6069363|NCT00708071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069364|NCT00708097|Fluorides|fluorides|mesh-list
6069365|NCT00708097|Cariostatic Agents|cariostatic agents|mesh-ancestor
6069366|NCT00708097|Protective Agents|protective agents|mesh-ancestor
6069367|NCT00708097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069368|NCT00708110|Dolutegravir|dolutegravir|mesh-list
6069369|NCT00708110|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6069370|NCT00708110|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6069371|NCT00708110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6069372|NCT00708110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069373|NCT00708110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6069374|NCT00708110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6069375|NCT00708110|Antiviral Agents|antiviral agents|mesh-ancestor
6069376|NCT00708110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6069377|NCT00708123|Listerine|listerine|mesh-list
6069378|NCT00708123|Fluorides|fluorides|mesh-list
6069379|NCT00708123|Sodium Fluoride|sodium fluoride|mesh-list
6069380|NCT00708123|Cariostatic Agents|cariostatic agents|mesh-ancestor
6069381|NCT00708123|Protective Agents|protective agents|mesh-ancestor
6069382|NCT00708123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069383|NCT00708123|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6069384|NCT00708123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6069385|NCT00708162|Raltegravir Potassium|raltegravir potassium|mesh-list
6069386|NCT00708162|Elvitegravir|elvitegravir|mesh-list
6069387|NCT00708162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6069388|NCT00708162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6069389|NCT00708162|Antiviral Agents|antiviral agents|mesh-ancestor
6069390|NCT00708162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6069391|NCT00708162|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6069392|NCT00708162|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6069393|NCT00708162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6069394|NCT00708162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069395|NCT00708175|Pioglitazone|pioglitazone|mesh-list
6069396|NCT00708175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6069397|NCT00708175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069398|NCT00708201|Alvimopan|alvimopan|mesh-list
6069399|NCT00708201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6069400|NCT00708214|Letrozole|letrozole|mesh-list
6069401|NCT00708214|Afatinib|afatinib|mesh-list
6069402|NCT00708214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6069403|NCT00708214|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6069404|NCT00708214|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6069405|NCT00708214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6069406|NCT00708214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069407|NCT00708214|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6069408|NCT00708214|Hormone Antagonists|hormone antagonists|mesh-ancestor
6069409|NCT00708214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6069410|NCT00708214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069411|NCT00708214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6069412|NCT00708305|Listerine|listerine|mesh-list
6069413|NCT00708305|Fluorides|fluorides|mesh-list
6069414|NCT00708305|Sodium Fluoride|sodium fluoride|mesh-list
6069415|NCT00708305|Cariostatic Agents|cariostatic agents|mesh-ancestor
6069416|NCT00708305|Protective Agents|protective agents|mesh-ancestor
6069417|NCT00708305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069418|NCT00708305|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6069419|NCT00708305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6069420|NCT00708422|Travoprost|travoprost|mesh-list
6069421|NCT00708422|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6069422|NCT00708422|Latanoprost|latanoprost|mesh-list
6069423|NCT00708422|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6069424|NCT00708422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6069425|NCT00708435|Protein C|protein c|mesh-list
6069426|NCT00708435|Protein S|protein s|mesh-list
6069427|NCT00708435|Anticoagulants|anticoagulants|mesh-ancestor
6069428|NCT00708435|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6069429|NCT00708435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6069430|NCT00708435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069431|NCT00708500|Interferons|interferons|mesh-list
6069432|NCT00708500|Ribavirin|ribavirin|mesh-list
6069433|NCT00708500|Interferon-alpha|interferon-alpha|mesh-list
6069434|NCT00708500|Interferon alpha-2|interferon alpha-2|mesh-list
6069435|NCT00708500|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
5509326|NCT04408144|Dydrogesterone|dydrogesterone|mesh-list
5509327|NCT04408144|Progestins|progestins|mesh-ancestor
5509328|NCT04408144|Hormones|hormones|mesh-ancestor
5509329|NCT04408144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5509330|NCT04408144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509331|NCT04408443|Vitamin D|vitamin d|mesh-list
5509332|NCT04408443|Cholecalciferol|cholecalciferol|mesh-list
5509333|NCT04408443|Vitamins|vitamins|mesh-ancestor
5509334|NCT04408443|Micronutrients|micronutrients|mesh-ancestor
5509335|NCT04408443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509336|NCT04408443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5509337|NCT04408443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5509338|NCT04408235|Enoxaparin|enoxaparin|mesh-list
5509339|NCT04408235|Anticoagulants|anticoagulants|mesh-ancestor
5509340|NCT04408235|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5509341|NCT04408235|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5509342|NCT04408235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5509343|NCT04407975|Betamethasone|betamethasone|mesh-list
5509344|NCT04407975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5509345|NCT04407975|Glucocorticoids|glucocorticoids|mesh-ancestor
5509346|NCT04407975|Hormones|hormones|mesh-ancestor
5509347|NCT04407975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5509348|NCT04407975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509349|NCT04407975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5509350|NCT04407975|Respiratory System Agents|respiratory system agents|mesh-ancestor
5509351|NCT04407754|Inositol|inositol|mesh-list
5509352|NCT04407754|Vitamin B Complex|vitamin b complex|mesh-ancestor
5509353|NCT04407754|Vitamins|vitamins|mesh-ancestor
6069436|NCT00708500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6069437|NCT00708500|Antiviral Agents|antiviral agents|mesh-ancestor
6069438|NCT00708500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6069439|NCT00708500|Antimetabolites|antimetabolites|mesh-ancestor
6069440|NCT00708500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069441|NCT00708500|Immunologic Factors|immunologic factors|mesh-ancestor
6069442|NCT00708500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069443|NCT00708526|Anesthetics|anesthetics|mesh-list
6069444|NCT00708526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6069445|NCT00708526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069446|NCT00708552|Donepezil|donepezil|mesh-list
6069447|NCT00708552|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6069448|NCT00708552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6069449|NCT00708552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069450|NCT00708552|Cholinergic Agents|cholinergic agents|mesh-ancestor
6069451|NCT00708552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6069452|NCT00708552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069453|NCT00708552|Nootropic Agents|nootropic agents|mesh-ancestor
6069454|NCT00708682|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6069455|NCT00708682|Immunologic Factors|immunologic factors|mesh-ancestor
6069456|NCT00708682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069457|NCT00708708|Etanercept|etanercept|mesh-list
6665385|NCT01516840|Protease Inhibitors|protease inhibitors|mesh-ancestor
5509354|NCT04407754|Micronutrients|micronutrients|mesh-ancestor
5509355|NCT04407754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509356|NCT04407650|Metformin|metformin|mesh-list
5509357|NCT04407650|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
5509358|NCT04407650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5509359|NCT04407650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600315|NCT03712735|Anesthetics, General|anesthetics, general|mesh-ancestor
6069458|NCT00708708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6069459|NCT00708708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6069460|NCT00708708|Analgesics|analgesics|mesh-ancestor
6069461|NCT00708708|Sensory System Agents|sensory system agents|mesh-ancestor
6069462|NCT00708708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6069463|NCT00708708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069464|NCT00708708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6069465|NCT00708708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6069466|NCT00708708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6069467|NCT00708708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6069468|NCT00708708|Immunologic Factors|immunologic factors|mesh-ancestor
6069469|NCT00708721|Clofarabine|clofarabine|mesh-list
6069470|NCT00708721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6069471|NCT00708721|Antimetabolites|antimetabolites|mesh-ancestor
6069472|NCT00708721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069473|NCT00708721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6069474|NCT00708942|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6069475|NCT00708942|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6069476|NCT00708942|Dermatologic Agents|dermatologic agents|mesh-ancestor
6069477|NCT00709059|Ribavirin|ribavirin|mesh-list
6069478|NCT00709059|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6069479|NCT00709059|Interferon-alpha|interferon-alpha|mesh-list
6069480|NCT00709059|Antimetabolites|antimetabolites|mesh-ancestor
6069481|NCT00709059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069482|NCT00709059|Antiviral Agents|antiviral agents|mesh-ancestor
6069483|NCT00709059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6069484|NCT00709059|Immunologic Factors|immunologic factors|mesh-ancestor
6069485|NCT00709059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202568|NCT02043145|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5509360|NCT04407650|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5509361|NCT04407650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5509362|NCT04408118|Paclitaxel|paclitaxel|mesh-list
5509363|NCT04408118|Bevacizumab|bevacizumab|mesh-list
5509364|NCT04408118|Atezolizumab|atezolizumab|mesh-list
6202569|NCT02043145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6202570|NCT02043145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202571|NCT02043145|Cholinergic Agents|cholinergic agents|mesh-ancestor
6202572|NCT02043145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6202573|NCT02043145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202574|NCT02043145|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6202575|NCT02043145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6202576|NCT02043301|Bococizumab|bococizumab|mesh-list
6202577|NCT02043301|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6202578|NCT02043301|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6202579|NCT02043301|Antimetabolites|antimetabolites|mesh-ancestor
6202580|NCT02043301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202581|NCT02043301|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6202582|NCT02043366|Flurbiprofen|flurbiprofen|mesh-list
6202583|NCT02043366|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
6202584|NCT02043366|Sufentanil|sufentanil|mesh-list
6202585|NCT02043366|Remifentanil|remifentanil|mesh-list
6463330|NCT00463918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6463331|NCT00463918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463332|NCT00463918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463333|NCT00463957|Sildenafil Citrate|sildenafil citrate|mesh-list
6463334|NCT00463957|Tadalafil|tadalafil|mesh-list
6463335|NCT00463957|Vasodilator Agents|vasodilator agents|mesh-ancestor
6463336|NCT00463957|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6463337|NCT00463957|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6202586|NCT02043366|Butorphanol|butorphanol|mesh-list
6202587|NCT02043366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6202588|NCT02043366|Narcotics|narcotics|mesh-ancestor
6202589|NCT02043366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6202590|NCT02043366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509365|NCT04408118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6069486|NCT00709098|Iloprost|iloprost|mesh-list
6069487|NCT00709098|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6069488|NCT00709098|Vasodilator Agents|vasodilator agents|mesh-ancestor
6069489|NCT00709111|Maraviroc|maraviroc|mesh-list
6069490|NCT00709111|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6069491|NCT00709111|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6069492|NCT00709111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069493|NCT00709111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6069494|NCT00709111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6069495|NCT00709111|Antiviral Agents|antiviral agents|mesh-ancestor
6069496|NCT00709111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6069497|NCT00709111|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6069498|NCT00709202|Betahistine|betahistine|mesh-list
6069499|NCT00709202|Vasodilator Agents|vasodilator agents|mesh-ancestor
6463338|NCT00463957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6463339|NCT00463957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5509366|NCT04408118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5509367|NCT04408118|Tubulin Modulators|tubulin modulators|mesh-ancestor
5509368|NCT04408118|Antimitotic Agents|antimitotic agents|mesh-ancestor
5509369|NCT04408118|Mitosis Modulators|mitosis modulators|mesh-ancestor
5509370|NCT04408118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5509371|NCT04408118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5509372|NCT04408118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5509373|NCT04408118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5509374|NCT04408118|Growth Substances|growth substances|mesh-ancestor
5509375|NCT04408118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509376|NCT04408118|Growth Inhibitors|growth inhibitors|mesh-ancestor
5509377|NCT04407715|Anesthetics|anesthetics|mesh-list
5509378|NCT04407715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5509379|NCT04407715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509380|NCT04407442|Dexamethasone|dexamethasone|mesh-list
5509381|NCT04407442|Dexamethasone acetate|dexamethasone acetate|mesh-list
5509382|NCT04407442|Azacitidine|azacitidine|mesh-list
5509383|NCT04407442|Daratumumab|daratumumab|mesh-list
5509384|NCT04407442|Ichthammol|ichthammol|mesh-list
5509385|NCT04407442|BB 1101|bb 1101|mesh-list
5509386|NCT04407442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5509387|NCT04407442|Antiemetics|antiemetics|mesh-ancestor
5509388|NCT04407442|Autonomic Agents|autonomic agents|mesh-ancestor
5509389|NCT04407442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5509390|NCT04407442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509391|NCT04407442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5509392|NCT04407442|Glucocorticoids|glucocorticoids|mesh-ancestor
5509393|NCT04407442|Hormones|hormones|mesh-ancestor
5509394|NCT04407442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5509395|NCT04407442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5509396|NCT04407442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5509397|NCT04407442|Protease Inhibitors|protease inhibitors|mesh-ancestor
6463340|NCT00463957|Urological Agents|urological agents|mesh-ancestor
6463341|NCT00463983|Octreotide|octreotide|mesh-list
5509398|NCT04407442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6069500|NCT00709202|Histamine Agonists|histamine agonists|mesh-ancestor
6069501|NCT00709202|Histamine Agents|histamine agents|mesh-ancestor
6069502|NCT00709202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6069503|NCT00709202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069504|NCT00709202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069505|NCT00709228|Ribavirin|ribavirin|mesh-list
6069506|NCT00709228|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6069507|NCT00709228|Antimetabolites|antimetabolites|mesh-ancestor
6069508|NCT00709228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069509|NCT00709228|Antiviral Agents|antiviral agents|mesh-ancestor
6069510|NCT00709228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6069511|NCT00709592|Mycophenolic Acid|mycophenolic acid|mesh-list
5509399|NCT04407442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5509400|NCT04407442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5509401|NCT04407442|Antimetabolites|antimetabolites|mesh-ancestor
5509402|NCT04407442|Dermatologic Agents|dermatologic agents|mesh-ancestor
5509403|NCT04407312|Aspirin|aspirin|mesh-list
6069512|NCT00709592|Tacrolimus|tacrolimus|mesh-list
6069513|NCT00709592|Thymoglobulin|thymoglobulin|mesh-list
6069514|NCT00709592|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6069515|NCT00709592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6069516|NCT00709592|Immunologic Factors|immunologic factors|mesh-ancestor
5509404|NCT04407312|Cilostazol|cilostazol|mesh-list
5509405|NCT04407312|Clopidogrel|clopidogrel|mesh-list
6069517|NCT00709592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069518|NCT00709592|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6069519|NCT00709592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6069520|NCT00709592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069521|NCT00709592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6069522|NCT00709592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6069523|NCT00709592|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6069524|NCT00709592|Antitubercular Agents|antitubercular agents|mesh-ancestor
6069525|NCT00709592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6069526|NCT00709592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6069527|NCT00709618|Vinorelbine|vinorelbine|mesh-list
6069528|NCT00709618|Lapatinib|lapatinib|mesh-list
6069529|NCT00709618|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6069530|NCT00709618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6069531|NCT00709618|Tubulin Modulators|tubulin modulators|mesh-ancestor
6069532|NCT00709618|Antimitotic Agents|antimitotic agents|mesh-ancestor
6069533|NCT00709618|Mitosis Modulators|mitosis modulators|mesh-ancestor
6069534|NCT00709618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069535|NCT00709618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6069536|NCT00709618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6069537|NCT00709696|Varenicline|varenicline|mesh-list
6069538|NCT00709696|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6069539|NCT00709696|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6069540|NCT00709696|Cholinergic Agents|cholinergic agents|mesh-ancestor
6069541|NCT00709696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6069542|NCT00709696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069543|NCT00709696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069544|NCT00709722|Gusperimus|gusperimus|mesh-list
5509406|NCT04407312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6069545|NCT00709722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6069546|NCT00709722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6069547|NCT00709722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6069548|NCT00709722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069549|NCT00709722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6069550|NCT00709722|Immunologic Factors|immunologic factors|mesh-ancestor
6069551|NCT00709722|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6069552|NCT00709722|Protective Agents|protective agents|mesh-ancestor
6069553|NCT00709735|Propranolol|propranolol|mesh-list
6069554|NCT00709735|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6069555|NCT00709735|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6069556|NCT00709735|Adrenergic Agents|adrenergic agents|mesh-ancestor
6069557|NCT00709735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6069558|NCT00709735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069559|NCT00709735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069560|NCT00709735|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6069561|NCT00709735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6069562|NCT00709735|Vasodilator Agents|vasodilator agents|mesh-ancestor
6069563|NCT00709761|Paclitaxel|paclitaxel|mesh-list
6069564|NCT00709761|Lapatinib|lapatinib|mesh-list
6069565|NCT00709761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6069566|NCT00709761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6069567|NCT00709761|Tubulin Modulators|tubulin modulators|mesh-ancestor
6069568|NCT00709761|Antimitotic Agents|antimitotic agents|mesh-ancestor
6069569|NCT00709761|Mitosis Modulators|mitosis modulators|mesh-ancestor
6069570|NCT00709761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069571|NCT00709761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6069572|NCT00709761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6069573|NCT00709826|Gemcitabine|gemcitabine|mesh-list
6069574|NCT00709826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6069575|NCT00709826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6069576|NCT00709826|Antimetabolites|antimetabolites|mesh-ancestor
6069577|NCT00709826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069578|NCT00709826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6069579|NCT00709826|Antiviral Agents|antiviral agents|mesh-ancestor
6069580|NCT00709826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6069581|NCT00709826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6069582|NCT00709826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6069583|NCT00709826|Immunologic Factors|immunologic factors|mesh-ancestor
5600316|NCT03712670|Pyranoprofen|pyranoprofen|mesh-list
6069584|NCT00709826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069585|NCT00709826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6069586|NCT00709956|Iloprost|iloprost|mesh-list
6069587|NCT00709956|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6069588|NCT00709956|Vasodilator Agents|vasodilator agents|mesh-ancestor
6069589|NCT00709995|Sunitinib|sunitinib|mesh-list
6069590|NCT00709995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6069591|NCT00709995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6069592|NCT00709995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6069593|NCT00709995|Growth Substances|growth substances|mesh-ancestor
6069594|NCT00709995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069595|NCT00709995|Growth Inhibitors|growth inhibitors|mesh-ancestor
6069596|NCT00709995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6069597|NCT00709995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6069598|NCT00709995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069599|NCT00710021|Vitamin D|vitamin d|mesh-list
6069600|NCT00710021|Ergocalciferols|ergocalciferols|mesh-list
6069601|NCT00710021|Cholecalciferol|cholecalciferol|mesh-list
6069602|NCT00710021|Vitamins|vitamins|mesh-list
6069603|NCT00710021|Micronutrients|micronutrients|mesh-ancestor
6069604|NCT00710021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069605|NCT00710021|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6069606|NCT00710021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6069607|NCT00710034|Nicotine|nicotine|mesh-list
6069608|NCT00710034|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6069609|NCT00710034|Autonomic Agents|autonomic agents|mesh-ancestor
6069610|NCT00710034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6069611|NCT00710034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069612|NCT00710034|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6069613|NCT00710034|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6069614|NCT00710034|Cholinergic Agents|cholinergic agents|mesh-ancestor
6069615|NCT00710034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6069616|NCT00710034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069617|NCT00710385|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6069618|NCT00710385|Buprenorphine|buprenorphine|mesh-list
6069619|NCT00710385|Heroin|heroin|mesh-list
6069620|NCT00710385|Naloxone|naloxone|mesh-list
6069621|NCT00710385|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6069622|NCT00710385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069623|NCT00710385|Sensory System Agents|sensory system agents|mesh-ancestor
6069624|NCT00710385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6069625|NCT00710385|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6069626|NCT00710385|Narcotics|narcotics|mesh-ancestor
5509407|NCT04407312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5509408|NCT04407312|Analgesics|analgesics|mesh-ancestor
5509409|NCT04407312|Sensory System Agents|sensory system agents|mesh-ancestor
5509410|NCT04407312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5509411|NCT04407312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509412|NCT04407312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5509413|NCT04407312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5509414|NCT04407312|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5509415|NCT04407312|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5509416|NCT04407312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069627|NCT00710385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6069628|NCT00710385|Analgesics|analgesics|mesh-ancestor
6069629|NCT00710424|Nabiximols|nabiximols|mesh-list
6069630|NCT00710424|Analgesics|analgesics|mesh-ancestor
6069631|NCT00710424|Sensory System Agents|sensory system agents|mesh-ancestor
6069632|NCT00710424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6069633|NCT00710424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069634|NCT00710554|Nabiximols|nabiximols|mesh-list
6069635|NCT00710554|Analgesics|analgesics|mesh-ancestor
6069636|NCT00710554|Sensory System Agents|sensory system agents|mesh-ancestor
6069637|NCT00710554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6069638|NCT00710554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069639|NCT00710606|NuvaRing|nuvaring|mesh-list
5509417|NCT04407312|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5509418|NCT04407312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5509419|NCT04407312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5509420|NCT04407312|Antipyretics|antipyretics|mesh-ancestor
6069640|NCT00710606|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6069641|NCT00710606|Desogestrel|desogestrel|mesh-list
6069642|NCT00710606|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6069643|NCT00710606|Contraceptive Agents|contraceptive agents|mesh-ancestor
6069644|NCT00710606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6069645|NCT00710606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509421|NCT04407312|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5509422|NCT04407312|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5509423|NCT04407312|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5509424|NCT04407312|Purinergic Agents|purinergic agents|mesh-ancestor
5509425|NCT04407312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5509426|NCT04407312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5509427|NCT04407312|Autonomic Agents|autonomic agents|mesh-ancestor
5509428|NCT04407312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6069646|NCT00710606|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6069647|NCT00710606|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6069648|NCT00710606|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6069649|NCT00710606|Estrogens|estrogens|mesh-ancestor
6069650|NCT00710606|Hormones|hormones|mesh-ancestor
6069651|NCT00710606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6069652|NCT00710606|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6069653|NCT00710606|Progestins|progestins|mesh-ancestor
6069654|NCT00710684|Donepezil|donepezil|mesh-list
6069655|NCT00710684|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6069656|NCT00710684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6069657|NCT00710684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069658|NCT00710684|Cholinergic Agents|cholinergic agents|mesh-ancestor
6069659|NCT00710684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6069660|NCT00710684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069661|NCT00710684|Nootropic Agents|nootropic agents|mesh-ancestor
6069662|NCT00710762|Nintedanib|nintedanib|mesh-list
6069663|NCT00710762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6069664|NCT00710762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6069665|NCT00710762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6069666|NCT00710762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069667|NCT00711009|Ritonavir|ritonavir|mesh-list
6069668|NCT00711009|Lopinavir|lopinavir|mesh-list
6069669|NCT00711009|Tenofovir|tenofovir|mesh-list
6069670|NCT00711009|Emtricitabine|emtricitabine|mesh-list
6069671|NCT00711009|Raltegravir Potassium|raltegravir potassium|mesh-list
5509429|NCT04407312|Respiratory System Agents|respiratory system agents|mesh-ancestor
5509430|NCT04407312|Vasodilator Agents|vasodilator agents|mesh-ancestor
5509431|NCT04407312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5509432|NCT04407312|Protective Agents|protective agents|mesh-ancestor
5509433|NCT04407312|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5509434|NCT04407312|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5509435|NCT04407247|Infliximab|infliximab|mesh-list
6069672|NCT00711009|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6069673|NCT00711009|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6069674|NCT00711009|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6069675|NCT00711009|Protease Inhibitors|protease inhibitors|mesh-ancestor
6069676|NCT00711009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6069677|NCT00711009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069678|NCT00711009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6069679|NCT00711009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6069680|NCT00711009|Antiviral Agents|antiviral agents|mesh-ancestor
6069681|NCT00711009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6069682|NCT00711009|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6069683|NCT00711009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6069684|NCT00711009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6069685|NCT00711009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5509436|NCT04407247|Vedolizumab|vedolizumab|mesh-list
5509437|NCT04407247|Immunoglobulins|immunoglobulins|mesh-list
5509438|NCT04407247|Immunoglobulin G|immunoglobulin g|mesh-list
5509439|NCT04407247|Immunologic Factors|immunologic factors|mesh-ancestor
6069686|NCT00711009|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6069687|NCT00711009|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6069688|NCT00711191|Antibodies|antibodies|mesh-list
6069689|NCT00711191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6069690|NCT00711191|Immunologic Factors|immunologic factors|mesh-ancestor
6069691|NCT00711191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069692|NCT00711243|Docetaxel|docetaxel|mesh-list
6069693|NCT00711243|Fluorouracil|fluorouracil|mesh-list
6069694|NCT00711243|Oxaliplatin|oxaliplatin|mesh-list
6069695|NCT00711243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6069696|NCT00711243|Tubulin Modulators|tubulin modulators|mesh-ancestor
6069697|NCT00711243|Antimitotic Agents|antimitotic agents|mesh-ancestor
6069698|NCT00711243|Mitosis Modulators|mitosis modulators|mesh-ancestor
5509440|NCT04407247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509441|NCT04407247|Dermatologic Agents|dermatologic agents|mesh-ancestor
5509442|NCT04407247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6069699|NCT00711243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069700|NCT00711243|Antimetabolites|antimetabolites|mesh-ancestor
6069701|NCT00711243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6069702|NCT00711243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6069703|NCT00711243|Immunologic Factors|immunologic factors|mesh-ancestor
6069704|NCT00711243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069705|NCT00711269|Risperidone|risperidone|mesh-list
6069706|NCT00711269|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
6069707|NCT00711269|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6069708|NCT00711269|Serotonin Agents|serotonin agents|mesh-ancestor
6069709|NCT00711269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6069710|NCT00711269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069711|NCT00711269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069712|NCT00711269|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6069713|NCT00711269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6069714|NCT00711269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6069715|NCT00711269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6069716|NCT00711269|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6069717|NCT00711269|Dopamine Agents|dopamine agents|mesh-ancestor
6069718|NCT00711269|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6069719|NCT00711269|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6463342|NCT00463983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6463343|NCT00463983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6463344|NCT00463983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6463345|NCT00464035|Calcium|calcium|mesh-list
6463346|NCT00464035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6463347|NCT00464035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463348|NCT00464165|Rimonabant|rimonabant|mesh-list
6463349|NCT00464165|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6463350|NCT00464165|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
5509443|NCT04407247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5509444|NCT04407234|Acetaminophen|acetaminophen|mesh-list
5509445|NCT04407234|Tirzepatide|tirzepatide|mesh-list
5509446|NCT04407234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5509447|NCT04407234|Analgesics|analgesics|mesh-ancestor
5509448|NCT04407234|Sensory System Agents|sensory system agents|mesh-ancestor
5509449|NCT04407234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5509450|NCT04407234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509451|NCT04407234|Antipyretics|antipyretics|mesh-ancestor
5509452|NCT04407234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5509453|NCT04407234|Incretins|incretins|mesh-ancestor
5509454|NCT04407234|Hormones|hormones|mesh-ancestor
5509455|NCT04407234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6463351|NCT00464165|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6463352|NCT00464165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6463353|NCT00464165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463354|NCT00464165|Hormones|hormones|mesh-ancestor
6463355|NCT00464165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6463356|NCT00464165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463357|NCT00464191|Citalopram|citalopram|mesh-list
6463358|NCT00464191|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6463359|NCT00464191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6069720|NCT00711269|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6069721|NCT00711269|Adrenergic Agents|adrenergic agents|mesh-ancestor
6069722|NCT00711269|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6069723|NCT00711269|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6069724|NCT00711347|Hyaluronic Acid|hyaluronic acid|mesh-list
6069725|NCT00711347|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6069726|NCT00711347|Immunologic Factors|immunologic factors|mesh-ancestor
6069727|NCT00711347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069728|NCT00711347|Viscosupplements|viscosupplements|mesh-ancestor
6069729|NCT00711347|Protective Agents|protective agents|mesh-ancestor
6069730|NCT00711412|Capecitabine|capecitabine|mesh-list
6069731|NCT00711412|Oxaliplatin|oxaliplatin|mesh-list
6069732|NCT00711412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6069733|NCT00711412|Antimetabolites|antimetabolites|mesh-ancestor
6463360|NCT00464191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6463361|NCT00464191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463362|NCT00464191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6463363|NCT00464191|Serotonin Agents|serotonin agents|mesh-ancestor
6069734|NCT00711412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069735|NCT00711412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6069736|NCT00711464|Modafinil|modafinil|mesh-list
6069737|NCT00711464|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6069738|NCT00711464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069739|NCT00711464|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6069740|NCT00711464|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6069741|NCT00711464|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6069742|NCT00711464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069743|NCT00711477|Naltrexone|naltrexone|mesh-list
6069744|NCT00711477|Bupropion|bupropion|mesh-list
6069745|NCT00711477|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6069746|NCT00711477|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6069747|NCT00711477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069748|NCT00711477|Sensory System Agents|sensory system agents|mesh-ancestor
6069749|NCT00711477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6069750|NCT00711477|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6069751|NCT00711477|Antidepressive Agents|antidepressive agents|mesh-ancestor
6069752|NCT00711477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6069753|NCT00711477|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6069754|NCT00711477|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6069755|NCT00711477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6069756|NCT00711477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069757|NCT00711477|Dopamine Agents|dopamine agents|mesh-ancestor
6069758|NCT00711477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6069759|NCT00711477|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6069760|NCT00711477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6069761|NCT00711477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6069762|NCT00711490|Sirolimus|sirolimus|mesh-list
6069763|NCT00711490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6069764|NCT00711490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6069765|NCT00711490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6069766|NCT00711490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6069767|NCT00711490|Antifungal Agents|antifungal agents|mesh-ancestor
5509456|NCT04407130|Doxycycline|doxycycline|mesh-list
5509457|NCT04407130|Ivermectin|ivermectin|mesh-list
5509458|NCT04407130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5509459|NCT04407130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5509460|NCT04407130|Antimalarials|antimalarials|mesh-ancestor
5509461|NCT04407130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5509462|NCT04407130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5509463|NCT04407078|Neostigmine|neostigmine|mesh-list
5509464|NCT04407078|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5509465|NCT04407078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5509466|NCT04407078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5509467|NCT04407078|Cholinergic Agents|cholinergic agents|mesh-ancestor
5509468|NCT04407078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5509469|NCT04407078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509470|NCT04407078|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5509471|NCT04407078|Autonomic Agents|autonomic agents|mesh-ancestor
5509472|NCT04407078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5509473|NCT04407390|Niacinamide|niacinamide|mesh-list
5509474|NCT04407390|Niacin|niacin|mesh-list
5509475|NCT04407390|Nicotinic Acids|nicotinic acids|mesh-list
6069768|NCT00711490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6069769|NCT00711490|Immunologic Factors|immunologic factors|mesh-ancestor
6463364|NCT00464191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665386|NCT01516840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6069770|NCT00711490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069771|NCT00711516|Modafinil|modafinil|mesh-list
6069772|NCT00711516|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6069773|NCT00711516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069774|NCT00711516|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6069775|NCT00711516|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6069776|NCT00711516|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6069777|NCT00711516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069778|NCT00711529|Gabapentin|gabapentin|mesh-list
6069779|NCT00711529|Analgesics|analgesics|mesh-ancestor
6069780|NCT00711529|Sensory System Agents|sensory system agents|mesh-ancestor
6069781|NCT00711529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6069782|NCT00711529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069783|NCT00711529|Anticonvulsants|anticonvulsants|mesh-ancestor
6069784|NCT00711529|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6069785|NCT00711529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6069786|NCT00711529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6069787|NCT00711529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6069788|NCT00711529|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5509476|NCT04407390|Vitamin B Complex|vitamin b complex|mesh-ancestor
5509477|NCT04407390|Vitamins|vitamins|mesh-ancestor
5509478|NCT04407390|Micronutrients|micronutrients|mesh-ancestor
6069789|NCT00711529|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6069790|NCT00711529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6069791|NCT00711529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069792|NCT00711529|Antimanic Agents|antimanic agents|mesh-ancestor
6069793|NCT00711594|Afatinib|afatinib|mesh-list
6069794|NCT00711594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6069795|NCT00711594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6069796|NCT00711594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6069797|NCT00711594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069798|NCT00711646|Nabiximols|nabiximols|mesh-list
6069799|NCT00711646|Analgesics|analgesics|mesh-ancestor
6069800|NCT00711646|Sensory System Agents|sensory system agents|mesh-ancestor
6069801|NCT00711646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6069802|NCT00711646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069803|NCT00711802|Daptomycin|daptomycin|mesh-list
6069804|NCT00711802|Cloxacillin|cloxacillin|mesh-list
6069805|NCT00711802|Oxacillin|oxacillin|mesh-list
6069806|NCT00711802|Nafcillin|nafcillin|mesh-list
6069807|NCT00711802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6069808|NCT00711802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6069809|NCT00711828|Dexamethasone|dexamethasone|mesh-list
6069810|NCT00711828|Cyclophosphamide|cyclophosphamide|mesh-list
6069811|NCT00711828|Rituximab|rituximab|mesh-list
6069812|NCT00711828|Bortezomib|bortezomib|mesh-list
6069813|NCT00711828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6069814|NCT00711828|Immunologic Factors|immunologic factors|mesh-ancestor
6069815|NCT00711828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069816|NCT00711828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6069817|NCT00711828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6069818|NCT00711828|Alkylating Agents|alkylating agents|mesh-ancestor
6069819|NCT00711828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069820|NCT00711828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6069821|NCT00711828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6069822|NCT00711828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6069823|NCT00711828|Antiemetics|antiemetics|mesh-ancestor
6463365|NCT00464191|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6463366|NCT00464191|Antidepressive Agents|antidepressive agents|mesh-ancestor
6463367|NCT00464191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5509479|NCT04407390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509480|NCT04407390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5509481|NCT04407390|Antimetabolites|antimetabolites|mesh-ancestor
5509482|NCT04407390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5509483|NCT04407390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6463368|NCT00464217|Idarubicin|idarubicin|mesh-list
6463369|NCT00464217|Molgramostim|molgramostim|mesh-list
6463370|NCT00464217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6463371|NCT00464217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6463372|NCT00464217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6463373|NCT00464217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6463374|NCT00464217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6069824|NCT00711828|Autonomic Agents|autonomic agents|mesh-ancestor
6069825|NCT00711828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6463375|NCT00464217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463376|NCT00464256|Rimonabant|rimonabant|mesh-list
6463377|NCT00464256|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6463378|NCT00464256|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
6463379|NCT00464256|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6463380|NCT00464256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6463381|NCT00464256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5509484|NCT04407390|Vasodilator Agents|vasodilator agents|mesh-ancestor
5509485|NCT04406779|Hormones|hormones|mesh-list
5509486|NCT04406779|Autoantibodies|autoantibodies|mesh-list
6463382|NCT00464256|Hormones|hormones|mesh-ancestor
6463383|NCT00464256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6463384|NCT00464256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463385|NCT00464295|Capecitabine|capecitabine|mesh-list
6463386|NCT00464295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6463387|NCT00464295|Antimetabolites|antimetabolites|mesh-ancestor
6069826|NCT00711828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6069827|NCT00711828|Glucocorticoids|glucocorticoids|mesh-ancestor
6069828|NCT00711828|Hormones|hormones|mesh-ancestor
6069829|NCT00711828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6069830|NCT00711828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6069831|NCT00711828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6069832|NCT00711880|Nabiximols|nabiximols|mesh-list
6069833|NCT00711880|Analgesics|analgesics|mesh-ancestor
6069834|NCT00711880|Sensory System Agents|sensory system agents|mesh-ancestor
6069835|NCT00711880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5509487|NCT04406779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5509488|NCT04406779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509489|NCT04406779|Immunologic Factors|immunologic factors|mesh-ancestor
6069836|NCT00711880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069837|NCT00711958|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6069838|NCT00712010|Caseins|caseins|mesh-list
6069839|NCT00712010|Chelating Agents|chelating agents|mesh-ancestor
6069840|NCT00712010|Sequestering Agents|sequestering agents|mesh-ancestor
6069841|NCT00712010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069842|NCT00712244|Hyaluronic Acid|hyaluronic acid|mesh-list
6069843|NCT00712244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6069844|NCT00712244|Immunologic Factors|immunologic factors|mesh-ancestor
6069845|NCT00712244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069846|NCT00712244|Viscosupplements|viscosupplements|mesh-ancestor
6069847|NCT00712244|Protective Agents|protective agents|mesh-ancestor
6069848|NCT00712270|Risperidone|risperidone|mesh-list
6069849|NCT00712270|Aripiprazole|aripiprazole|mesh-list
6069850|NCT00712270|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6069851|NCT00712270|Serotonin Agents|serotonin agents|mesh-ancestor
6069852|NCT00712270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6069853|NCT00712270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069854|NCT00712270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069855|NCT00712270|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6069856|NCT00712270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6069857|NCT00712270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6069858|NCT00712270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6069859|NCT00712270|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6069860|NCT00712270|Dopamine Agents|dopamine agents|mesh-ancestor
6069861|NCT00712270|Antidepressive Agents|antidepressive agents|mesh-ancestor
6069862|NCT00712270|Dopamine Agonists|dopamine agonists|mesh-ancestor
6069863|NCT00712270|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6069864|NCT00712270|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6069865|NCT00712270|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6069866|NCT00712270|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6069867|NCT00712335|Fluticasone|fluticasone|mesh-list
6069868|NCT00712335|Xhance|xhance|mesh-list
6069869|NCT00712335|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6069870|NCT00712335|Montelukast|montelukast|mesh-list
6069871|NCT00712335|Leukotriene Antagonists|leukotriene antagonists|mesh-list
6069872|NCT00712335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5509490|NCT04406870|Sirolimus|sirolimus|mesh-list
5509491|NCT04406870|Propranolol|propranolol|mesh-list
5509492|NCT04406870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5509493|NCT04406870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5509494|NCT04406870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5509495|NCT04406870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5509496|NCT04406870|Antifungal Agents|antifungal agents|mesh-ancestor
5509497|NCT04406870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6069873|NCT00712335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5509498|NCT04406870|Immunologic Factors|immunologic factors|mesh-ancestor
5509499|NCT04406870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509500|NCT04406870|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5509501|NCT04406870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5509502|NCT04406870|Adrenergic Agents|adrenergic agents|mesh-ancestor
5509503|NCT04406870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6069874|NCT00712335|Autonomic Agents|autonomic agents|mesh-ancestor
6069875|NCT00712335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6069876|NCT00712335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069877|NCT00712335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5509504|NCT04406870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5509505|NCT04406870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5509506|NCT04406870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6069878|NCT00712335|Respiratory System Agents|respiratory system agents|mesh-ancestor
6069879|NCT00712335|Dermatologic Agents|dermatologic agents|mesh-ancestor
6069880|NCT00712335|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6069881|NCT00712335|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6069882|NCT00712335|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6069883|NCT00712335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6069884|NCT00712335|Adrenergic Agents|adrenergic agents|mesh-ancestor
6069885|NCT00712335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5509507|NCT04406870|Vasodilator Agents|vasodilator agents|mesh-ancestor
5509508|NCT04406727|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
5509509|NCT04406727|UB-421|ub-421|mesh-list
5509510|NCT04406727|Antiviral Agents|antiviral agents|mesh-ancestor
5509511|NCT04406727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5509512|NCT04406805|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
5509513|NCT04406805|Natriuretic Agents|natriuretic agents|mesh-ancestor
5509514|NCT04406805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509515|NCT04407000|Favipiravir|favipiravir|mesh-list
5509516|NCT04407000|Antiviral Agents|antiviral agents|mesh-ancestor
5509517|NCT04407000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5509518|NCT04406883|Simvastatin|simvastatin|mesh-list
5509519|NCT04406883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6069886|NCT00712335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069887|NCT00712335|Hormone Antagonists|hormone antagonists|mesh-ancestor
6069888|NCT00712335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6069889|NCT00712335|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6069890|NCT00712335|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6069891|NCT00712530|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6069892|NCT00712530|Antiviral Agents|antiviral agents|mesh-ancestor
6069893|NCT00712530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6069894|NCT00712543|Lactulose|lactulose|mesh-list
6069895|NCT00712543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6069896|NCT00712673|Metformin|metformin|mesh-list
6069897|NCT00712673|Lixisenatide|lixisenatide|mesh-list
6069898|NCT00712673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6069899|NCT00712673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069900|NCT00712712|Acetaminophen|acetaminophen|mesh-list
6069901|NCT00712712|Morphine|morphine|mesh-list
6069902|NCT00712712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6069903|NCT00712712|Narcotics|narcotics|mesh-ancestor
6069904|NCT00712712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6069905|NCT00712712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069906|NCT00712712|Analgesics|analgesics|mesh-ancestor
6069907|NCT00712712|Sensory System Agents|sensory system agents|mesh-ancestor
6069908|NCT00712712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6069909|NCT00712712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6069910|NCT00712712|Antipyretics|antipyretics|mesh-ancestor
6069911|NCT00712920|Azelastine|azelastine|mesh-list
6069912|NCT00712920|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6069913|NCT00712920|Autonomic Agents|autonomic agents|mesh-ancestor
5509520|NCT04406883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5509521|NCT04406883|Antimetabolites|antimetabolites|mesh-ancestor
5509522|NCT04406883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5509523|NCT04406883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6069914|NCT00712920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5509524|NCT04406883|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5509525|NCT04406883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5600317|NCT03712670|Aflibercept|aflibercept|mesh-list
5600318|NCT03712670|Carotenoids|carotenoids|mesh-list
5600319|NCT03712670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5600320|NCT03712670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5600321|NCT03712670|Growth Substances|growth substances|mesh-ancestor
5600322|NCT03712670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600323|NCT03712670|Growth Inhibitors|growth inhibitors|mesh-ancestor
5600324|NCT03712670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5600325|NCT03712670|Antioxidants|antioxidants|mesh-ancestor
5600326|NCT03712670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600327|NCT03712670|Protective Agents|protective agents|mesh-ancestor
5600328|NCT03712670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5600329|NCT03712670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5600330|NCT03712670|Analgesics|analgesics|mesh-ancestor
6069915|NCT00712920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069916|NCT00712920|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6069917|NCT00712920|Respiratory System Agents|respiratory system agents|mesh-ancestor
6069918|NCT00712920|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6069919|NCT00712920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6069920|NCT00712920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069921|NCT00712920|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6069922|NCT00712920|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6069923|NCT00712920|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6069924|NCT00712920|Histamine Antagonists|histamine antagonists|mesh-ancestor
6069925|NCT00712920|Histamine Agents|histamine agents|mesh-ancestor
6069926|NCT00712920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6069927|NCT00712985|Zoledronic Acid|zoledronic acid|mesh-list
6069928|NCT00712985|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6069929|NCT00712985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069930|NCT00713219|Docetaxel|docetaxel|mesh-list
6069931|NCT00713219|Cetuximab|cetuximab|mesh-list
6069932|NCT00713219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6069933|NCT00713219|Tubulin Modulators|tubulin modulators|mesh-ancestor
6069934|NCT00713219|Antimitotic Agents|antimitotic agents|mesh-ancestor
6069935|NCT00713219|Mitosis Modulators|mitosis modulators|mesh-ancestor
6069936|NCT00713219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069937|NCT00713219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6069938|NCT00713284|Sirolimus|sirolimus|mesh-list
6069939|NCT00713284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6069940|NCT00713284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6069941|NCT00713284|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6069942|NCT00713284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6069943|NCT00713284|Antifungal Agents|antifungal agents|mesh-ancestor
6069944|NCT00713284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6069945|NCT00713284|Immunologic Factors|immunologic factors|mesh-ancestor
6069946|NCT00713284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069947|NCT00713310|Mesalamine|mesalamine|mesh-list
6069948|NCT00713310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6069949|NCT00713310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6069950|NCT00713310|Analgesics|analgesics|mesh-ancestor
6069951|NCT00713310|Sensory System Agents|sensory system agents|mesh-ancestor
6069952|NCT00713310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6069953|NCT00713310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069954|NCT00713310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6069955|NCT00713310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6069956|NCT00713323|Nabiximols|nabiximols|mesh-list
6069957|NCT00713323|Analgesics|analgesics|mesh-ancestor
6069958|NCT00713323|Sensory System Agents|sensory system agents|mesh-ancestor
6069959|NCT00713323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6069960|NCT00713323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069961|NCT00713479|Varenicline|varenicline|mesh-list
6069962|NCT00713479|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6069963|NCT00713479|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6069964|NCT00713479|Cholinergic Agents|cholinergic agents|mesh-ancestor
6069965|NCT00713479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6069966|NCT00713479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069967|NCT00713479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069968|NCT00713544|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
6069969|NCT00713544|Etanercept|etanercept|mesh-list
6202591|NCT02043366|Analgesics|analgesics|mesh-ancestor
5600331|NCT03712670|Sensory System Agents|sensory system agents|mesh-ancestor
6069970|NCT00713544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6069971|NCT00713544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6069972|NCT00713544|Analgesics|analgesics|mesh-ancestor
6069973|NCT00713544|Sensory System Agents|sensory system agents|mesh-ancestor
6069974|NCT00713544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6069975|NCT00713544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069976|NCT00713544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6069977|NCT00713544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6069978|NCT00713544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6069979|NCT00713544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6069980|NCT00713544|Immunologic Factors|immunologic factors|mesh-ancestor
6069981|NCT00713544|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6069982|NCT00713544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069983|NCT00713544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6069984|NCT00713544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6069985|NCT00713544|Antiviral Agents|antiviral agents|mesh-ancestor
6069986|NCT00713544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6069987|NCT00713583|Levodopa|levodopa|mesh-list
6069988|NCT00713583|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6069989|NCT00713583|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6463388|NCT00464295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463389|NCT00464295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6463390|NCT00464321|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6069990|NCT00713583|Dopamine Agents|dopamine agents|mesh-ancestor
6069991|NCT00713583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6069992|NCT00713583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6069993|NCT00713583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6069994|NCT00713609|Clindamycin|clindamycin|mesh-list
6069995|NCT00713609|Clindamycin palmitate|clindamycin palmitate|mesh-list
6069996|NCT00713609|Clindamycin phosphate|clindamycin phosphate|mesh-list
6069997|NCT00713609|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6069998|NCT00713609|Tazarotene|tazarotene|mesh-list
6069999|NCT00713609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6070000|NCT00713609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6070001|NCT00713609|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6070002|NCT00713609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6070003|NCT00713609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070004|NCT00713609|Dermatologic Agents|dermatologic agents|mesh-ancestor
6070005|NCT00713609|Keratolytic Agents|keratolytic agents|mesh-ancestor
6070006|NCT00713817|Nabiximols|nabiximols|mesh-list
6070007|NCT00713817|Analgesics|analgesics|mesh-ancestor
6070008|NCT00713817|Sensory System Agents|sensory system agents|mesh-ancestor
6070009|NCT00713817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6070010|NCT00713817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070011|NCT00713830|Metformin|metformin|mesh-list
6070012|NCT00713830|Lixisenatide|lixisenatide|mesh-list
6070013|NCT00713830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6070014|NCT00713830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070015|NCT00714233|Metformin|metformin|mesh-list
6070016|NCT00714233|Contraceptive Agents|contraceptive agents|mesh-list
6070017|NCT00714233|Contraceptives, Oral|contraceptives, oral|mesh-list
6070018|NCT00714233|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
6070019|NCT00714233|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
6070020|NCT00714233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6070021|NCT00714233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070022|NCT00714233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6070023|NCT00714233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6070024|NCT00714259|Fludarabine|fludarabine|mesh-list
6070025|NCT00714259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6202592|NCT02043366|Sensory System Agents|sensory system agents|mesh-ancestor
6202593|NCT02043366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6202594|NCT02043366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6202595|NCT02043366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5509526|NCT04406272|Bevacizumab|bevacizumab|mesh-list
5509527|NCT04406272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5509528|NCT04406272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5509529|NCT04406272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6202596|NCT02043366|Anesthetics, General|anesthetics, general|mesh-ancestor
6202597|NCT02043366|Anesthetics|anesthetics|mesh-ancestor
6202598|NCT02043366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6202599|NCT02043366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6202600|NCT02043366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6202601|NCT02043366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6202602|NCT02043366|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6202603|NCT02043366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6070026|NCT00714285|Vaccines|vaccines|mesh-list
6070027|NCT00714285|Immunologic Factors|immunologic factors|mesh-ancestor
6070028|NCT00714285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070029|NCT00714493|Infliximab|infliximab|mesh-list
6070030|NCT00714493|Dermatologic Agents|dermatologic agents|mesh-ancestor
6070031|NCT00714493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6665387|NCT01516866|Listerine|listerine|mesh-list
6665388|NCT01516866|Fluorides|fluorides|mesh-list
6665389|NCT01516866|Sodium Fluoride|sodium fluoride|mesh-list
6665390|NCT01516866|Cariostatic Agents|cariostatic agents|mesh-ancestor
6665391|NCT01516866|Protective Agents|protective agents|mesh-ancestor
6665392|NCT01516866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665393|NCT01516866|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6665394|NCT01516866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6665395|NCT01516944|Capecitabine|capecitabine|mesh-list
6665396|NCT01516944|Tegafur|tegafur|mesh-list
6665397|NCT01516944|Oxaliplatin|oxaliplatin|mesh-list
6665398|NCT01516944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6070032|NCT00714493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6070033|NCT00714688|Methylphenidate|methylphenidate|mesh-list
6070034|NCT00714688|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6070035|NCT00714688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070036|NCT00714688|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6070037|NCT00714688|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6070038|NCT00714688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6070039|NCT00714688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070040|NCT00714688|Dopamine Agents|dopamine agents|mesh-ancestor
6070041|NCT00714688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6070042|NCT00714714|Adapalene|adapalene|mesh-list
6070043|NCT00714714|Tretinoin|tretinoin|mesh-list
6070044|NCT00714714|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6070045|NCT00714714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6070046|NCT00714714|Analgesics|analgesics|mesh-ancestor
6070047|NCT00714714|Sensory System Agents|sensory system agents|mesh-ancestor
6070048|NCT00714714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6070049|NCT00714714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070050|NCT00714714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6070051|NCT00714714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6070052|NCT00714714|Dermatologic Agents|dermatologic agents|mesh-ancestor
6070053|NCT00714714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6070054|NCT00714714|Keratolytic Agents|keratolytic agents|mesh-ancestor
6070055|NCT00715117|Naltrexone|naltrexone|mesh-list
6070056|NCT00715117|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6070057|NCT00715117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6070058|NCT00715117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070059|NCT00715117|Sensory System Agents|sensory system agents|mesh-ancestor
6070060|NCT00715117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6070061|NCT00715208|Prednisone|prednisone|mesh-list
6070062|NCT00715208|Cyclophosphamide|cyclophosphamide|mesh-list
6070063|NCT00715208|Rituximab|rituximab|mesh-list
6070064|NCT00715208|Doxorubicin|doxorubicin|mesh-list
6070065|NCT00715208|Bortezomib|bortezomib|mesh-list
6070066|NCT00715208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6070067|NCT00715208|Immunologic Factors|immunologic factors|mesh-ancestor
6070068|NCT00715208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070069|NCT00715208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6070070|NCT00715208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6070071|NCT00715208|Alkylating Agents|alkylating agents|mesh-ancestor
6070072|NCT00715208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070073|NCT00715208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6463391|NCT00464321|Immunologic Factors|immunologic factors|mesh-ancestor
6463392|NCT00464321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463393|NCT00464347|Triamcinolone|triamcinolone|mesh-list
6463394|NCT00464347|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6463395|NCT00464347|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6463396|NCT00464347|Bevacizumab|bevacizumab|mesh-list
6463397|NCT00464347|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6463398|NCT00464347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6070074|NCT00715208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6070075|NCT00715208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6070076|NCT00715208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6070077|NCT00715208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5509530|NCT04406272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5509531|NCT04406272|Growth Substances|growth substances|mesh-ancestor
5509532|NCT04406272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509533|NCT04406272|Growth Inhibitors|growth inhibitors|mesh-ancestor
5509534|NCT04406389|Heparin|heparin|mesh-list
5509535|NCT04406389|Calcium heparin|calcium heparin|mesh-list
5509536|NCT04406389|Enoxaparin|enoxaparin|mesh-list
5509537|NCT04406389|Enoxaparin sodium|enoxaparin sodium|mesh-list
5509538|NCT04406389|Argatroban|argatroban|mesh-list
6070078|NCT00715208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6070079|NCT00715208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6070080|NCT00715208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6070081|NCT00715208|Glucocorticoids|glucocorticoids|mesh-ancestor
6070082|NCT00715208|Hormones|hormones|mesh-ancestor
6070083|NCT00715208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6070084|NCT00715208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6070085|NCT00715403|Nintedanib|nintedanib|mesh-list
6070086|NCT00715403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6070087|NCT00715403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6070088|NCT00715403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6070089|NCT00715403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5509539|NCT04406389|Anticoagulants|anticoagulants|mesh-ancestor
5509540|NCT04406389|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5509541|NCT04406389|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5509542|NCT04406389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5509543|NCT04406389|Antithrombins|antithrombins|mesh-ancestor
5509544|NCT04406389|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5509545|NCT04406389|Protease Inhibitors|protease inhibitors|mesh-ancestor
5509546|NCT04406389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5509547|NCT04406389|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5509548|NCT04406376|Prednisone|prednisone|mesh-list
6070090|NCT00715429|Vitamin D|vitamin d|mesh-list
6070091|NCT00715429|Ergocalciferols|ergocalciferols|mesh-list
6070092|NCT00715429|Vitamins|vitamins|mesh-ancestor
6070093|NCT00715429|Micronutrients|micronutrients|mesh-ancestor
6070094|NCT00715429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070095|NCT00715429|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6070096|NCT00715429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6070097|NCT00715520|Levodopa|levodopa|mesh-list
6070098|NCT00715520|Carbidopa|carbidopa|mesh-list
6070099|NCT00715520|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
6070100|NCT00715520|Methylphenidate|methylphenidate|mesh-list
6070101|NCT00715520|Amphetamine|amphetamine|mesh-list
6070102|NCT00715520|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6070103|NCT00715520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070104|NCT00715520|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6070105|NCT00715520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6070106|NCT00715520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6070107|NCT00715520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070108|NCT00715520|Dopamine Agents|dopamine agents|mesh-ancestor
6070109|NCT00715520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6070110|NCT00715520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6070111|NCT00715520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6070112|NCT00715520|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6070113|NCT00715520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6070114|NCT00715520|Sympathomimetics|sympathomimetics|mesh-ancestor
5509549|NCT04406376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5509550|NCT04406376|Glucocorticoids|glucocorticoids|mesh-ancestor
5509551|NCT04406376|Hormones|hormones|mesh-ancestor
5509552|NCT04406376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5509553|NCT04406376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509554|NCT04406376|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5509555|NCT04406376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5509556|NCT04406246|Nitazoxanide|nitazoxanide|mesh-list
5509557|NCT04406246|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5509558|NCT04406246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5509559|NCT04406506|Erythromycin|erythromycin|mesh-list
6070115|NCT00715520|Autonomic Agents|autonomic agents|mesh-ancestor
6070116|NCT00715520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6070117|NCT00715520|Adrenergic Agents|adrenergic agents|mesh-ancestor
5509560|NCT04406506|Erythromycin Estolate|erythromycin estolate|mesh-list
5509561|NCT04406506|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
6070118|NCT00715520|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6070119|NCT00715520|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6070120|NCT00715520|Immunologic Factors|immunologic factors|mesh-ancestor
6070121|NCT00715520|Dopamine Agonists|dopamine agonists|mesh-ancestor
6070122|NCT00715559|Cysteamine|cysteamine|mesh-list
6070123|NCT00715559|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
6070124|NCT00715559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070125|NCT00715624|Metformin|metformin|mesh-list
6070126|NCT00715624|Lixisenatide|lixisenatide|mesh-list
6070127|NCT00715624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6070128|NCT00715624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070129|NCT00715676|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
6070130|NCT00715676|Vitamins|vitamins|mesh-ancestor
6070131|NCT00715676|Micronutrients|micronutrients|mesh-ancestor
6070132|NCT00715676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509562|NCT04406506|Erythromycin stearate|erythromycin stearate|mesh-list
5509563|NCT04406506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5509564|NCT04406506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5509565|NCT04406506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5509566|NCT04406506|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5509567|NCT04406506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5509568|NCT04406506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5509569|NCT04406259|Verapamil|verapamil|mesh-list
5509570|NCT04406259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5509571|NCT04406259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5509572|NCT04406259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5509573|NCT04406259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5509574|NCT04406259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5509575|NCT04406259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509576|NCT04406259|Vasodilator Agents|vasodilator agents|mesh-ancestor
5509577|NCT04405999|Bromhexine|bromhexine|mesh-list
5509578|NCT04405999|Expectorants|expectorants|mesh-ancestor
5509579|NCT04405999|Respiratory System Agents|respiratory system agents|mesh-ancestor
5509580|NCT04406025|Anesthetics|anesthetics|mesh-list
5509581|NCT04406025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5509582|NCT04406025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509583|NCT04406051|Norepinephrine|norepinephrine|mesh-list
5509584|NCT04406051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5509585|NCT04406051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5509586|NCT04406051|Adrenergic Agents|adrenergic agents|mesh-ancestor
5509587|NCT04406051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5509588|NCT04406051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5509589|NCT04406051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509590|NCT04406051|Sympathomimetics|sympathomimetics|mesh-ancestor
5509591|NCT04406051|Autonomic Agents|autonomic agents|mesh-ancestor
5509592|NCT04406051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5509593|NCT04406051|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5509594|NCT04405960|Alfacalcidol|alfacalcidol|mesh-list
5509595|NCT04405960|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
5509596|NCT04405960|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5509597|NCT04405960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509598|NCT04405960|Vitamins|vitamins|mesh-ancestor
5509599|NCT04405960|Micronutrients|micronutrients|mesh-ancestor
5509600|NCT04405843|Ivermectin|ivermectin|mesh-list
5509601|NCT04405843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5509602|NCT04405843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5509603|NCT04405921|Azithromycin|azithromycin|mesh-list
5509604|NCT04405921|Hydroxychloroquine|hydroxychloroquine|mesh-list
5509605|NCT04405921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6070133|NCT00715676|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6070134|NCT00715793|Temozolomide|temozolomide|mesh-list
6070135|NCT00715793|Decitabine|decitabine|mesh-list
6070136|NCT00715793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6070137|NCT00715793|Alkylating Agents|alkylating agents|mesh-ancestor
6070138|NCT00715793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070139|NCT00715793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6070140|NCT00715793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6070141|NCT00715793|Antimetabolites|antimetabolites|mesh-ancestor
6070142|NCT00715793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6070143|NCT00715884|Sirolimus|sirolimus|mesh-list
6070144|NCT00715884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6070145|NCT00715884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6070146|NCT00715884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6070147|NCT00715884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6070148|NCT00715884|Antifungal Agents|antifungal agents|mesh-ancestor
6070149|NCT00715884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6070150|NCT00715884|Immunologic Factors|immunologic factors|mesh-ancestor
6070151|NCT00715884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070152|NCT00715910|Vaccines|vaccines|mesh-list
6070153|NCT00715910|Immunologic Factors|immunologic factors|mesh-ancestor
6070154|NCT00715910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070155|NCT00716079|Metoprolol|metoprolol|mesh-list
6070156|NCT00716079|Clonidine|clonidine|mesh-list
6070157|NCT00716079|Hydralazine|hydralazine|mesh-list
6070158|NCT00716079|Labetalol|labetalol|mesh-list
6070159|NCT00716079|Nicardipine|nicardipine|mesh-list
6070160|NCT00716079|Phentolamine|phentolamine|mesh-list
6070161|NCT00716079|Urapidil|urapidil|mesh-list
6070162|NCT00716079|Enalaprilat|enalaprilat|mesh-list
6070163|NCT00716079|Esmolol|esmolol|mesh-list
6070164|NCT00716079|Glycerol|glycerol|mesh-list
6070165|NCT00716079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6070166|NCT00716079|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6070167|NCT00716079|Sympatholytics|sympatholytics|mesh-ancestor
6070168|NCT00716079|Autonomic Agents|autonomic agents|mesh-ancestor
6070169|NCT00716079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6070170|NCT00716079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070171|NCT00716079|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6070172|NCT00716079|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6070173|NCT00716079|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6070174|NCT00716079|Adrenergic Agents|adrenergic agents|mesh-ancestor
6070175|NCT00716079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6070176|NCT00716079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070177|NCT00716079|Analgesics|analgesics|mesh-ancestor
6070178|NCT00716079|Sensory System Agents|sensory system agents|mesh-ancestor
6070179|NCT00716079|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5509606|NCT04405921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5509607|NCT04405921|Antimalarials|antimalarials|mesh-ancestor
5509608|NCT04405921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5509609|NCT04405921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5509610|NCT04405921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5509611|NCT04405921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5509612|NCT04405921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5509613|NCT04405596|Ambroxol|ambroxol|mesh-list
5509614|NCT04405596|Expectorants|expectorants|mesh-ancestor
5509615|NCT04405596|Respiratory System Agents|respiratory system agents|mesh-ancestor
5509616|NCT04405622|Gemcitabine|gemcitabine|mesh-list
5509617|NCT04405622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6070180|NCT00716079|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6070181|NCT00716079|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6070182|NCT00716079|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6070183|NCT00716079|Protective Agents|protective agents|mesh-ancestor
6070184|NCT00716079|Vasodilator Agents|vasodilator agents|mesh-ancestor
6070185|NCT00716079|Sympathomimetics|sympathomimetics|mesh-ancestor
6070186|NCT00716079|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6070187|NCT00716079|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6070188|NCT00716079|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6070189|NCT00716079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6070190|NCT00716079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6070191|NCT00716079|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6070192|NCT00716079|Serotonin Agents|serotonin agents|mesh-ancestor
6070193|NCT00716079|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6070194|NCT00716079|Protease Inhibitors|protease inhibitors|mesh-ancestor
6070195|NCT00716079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6070196|NCT00716092|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6070197|NCT00716092|Linagliptin|linagliptin|mesh-list
6070198|NCT00716092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6070199|NCT00716092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070200|NCT00716092|Incretins|incretins|mesh-ancestor
6070201|NCT00716092|Hormones|hormones|mesh-ancestor
6070202|NCT00716092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6070203|NCT00716092|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6070204|NCT00716092|Protease Inhibitors|protease inhibitors|mesh-ancestor
6070205|NCT00716092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5509618|NCT04405622|Antimetabolites|antimetabolites|mesh-ancestor
5509619|NCT04405622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070206|NCT00716092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070207|NCT00716144|R 115866|r 115866|mesh-list
6070208|NCT00716144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6070209|NCT00716144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6665399|NCT01516944|Antimetabolites|antimetabolites|mesh-ancestor
5509620|NCT04405622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5509621|NCT04405622|Antiviral Agents|antiviral agents|mesh-ancestor
5725054|NCT03182894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5725055|NCT03182894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6070210|NCT00716144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070211|NCT00716274|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6070212|NCT00716274|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6070213|NCT00716274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6070214|NCT00716274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6070215|NCT00716274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070216|NCT00716274|Adrenergic Agents|adrenergic agents|mesh-ancestor
6070217|NCT00716274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6070218|NCT00716274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070219|NCT00716417|Afatinib|afatinib|mesh-list
6070220|NCT00716417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6070221|NCT00716417|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6070222|NCT00716417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6070223|NCT00716417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070224|NCT00716443|Lidocaine|lidocaine|mesh-list
6070225|NCT00716443|Tetracaine|tetracaine|mesh-list
6070226|NCT00716443|Benzocaine|benzocaine|mesh-list
6070227|NCT00716443|Anesthetics, Local|anesthetics, local|mesh-ancestor
6070228|NCT00716443|Anesthetics|anesthetics|mesh-ancestor
6070229|NCT00716443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6070230|NCT00716443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070231|NCT00716443|Sensory System Agents|sensory system agents|mesh-ancestor
6070232|NCT00716443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6070233|NCT00716443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6070234|NCT00716443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6070235|NCT00716443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6070236|NCT00716443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6070237|NCT00716443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070238|NCT00716456|Cetuximab|cetuximab|mesh-list
6070239|NCT00716456|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6070240|NCT00716456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6070241|NCT00716456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6070242|NCT00716456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6070243|NCT00716456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5509622|NCT04405622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5509623|NCT04405622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5509624|NCT04405622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5509625|NCT04405622|Immunologic Factors|immunologic factors|mesh-ancestor
5509626|NCT04405622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509627|NCT04405505|Paclitaxel|paclitaxel|mesh-list
5509628|NCT04405505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5509629|NCT04405505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6070244|NCT00716456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070245|NCT00716586|Dorzolamide|dorzolamide|mesh-list
6070246|NCT00716586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6070247|NCT00716586|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6070248|NCT00716586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6070249|NCT00716586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070250|NCT00716625|Sunitinib|sunitinib|mesh-list
6070251|NCT00716625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6070252|NCT00716625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6070253|NCT00716625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6070254|NCT00716625|Growth Substances|growth substances|mesh-ancestor
6070255|NCT00716625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070256|NCT00716625|Growth Inhibitors|growth inhibitors|mesh-ancestor
5509630|NCT04405505|Tubulin Modulators|tubulin modulators|mesh-ancestor
5509631|NCT04405505|Antimitotic Agents|antimitotic agents|mesh-ancestor
6070257|NCT00716625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6070258|NCT00716625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6070259|NCT00716625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070260|NCT00716742|Bimatoprost|bimatoprost|mesh-list
6070261|NCT00716742|Travoprost|travoprost|mesh-list
6070262|NCT00716742|Latanoprost|latanoprost|mesh-list
6070263|NCT00716742|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6070264|NCT00716742|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6070265|NCT00716742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6070266|NCT00716820|Sunitinib|sunitinib|mesh-list
6070267|NCT00716820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6070268|NCT00716820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6070269|NCT00716820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6070270|NCT00716820|Growth Substances|growth substances|mesh-ancestor
5509632|NCT04405505|Mitosis Modulators|mitosis modulators|mesh-ancestor
5509633|NCT04405505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5509634|NCT04405375|Dexamethasone|dexamethasone|mesh-list
5509635|NCT04405375|Etoposide|etoposide|mesh-list
5509636|NCT04405375|Pegaspargase|pegaspargase|mesh-list
5509637|NCT04405375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5509638|NCT04405375|Antiemetics|antiemetics|mesh-ancestor
5509639|NCT04405375|Autonomic Agents|autonomic agents|mesh-ancestor
5509640|NCT04405375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5509641|NCT04405375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509642|NCT04405375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5509643|NCT04405375|Glucocorticoids|glucocorticoids|mesh-ancestor
6070271|NCT00716820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070272|NCT00716820|Growth Inhibitors|growth inhibitors|mesh-ancestor
6070273|NCT00716820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6070274|NCT00716820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6070275|NCT00716820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070276|NCT00716859|Timolol|timolol|mesh-list
6070277|NCT00716859|Latanoprost|latanoprost|mesh-list
6070278|NCT00716859|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6070279|NCT00716859|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6070280|NCT00716859|Adrenergic Agents|adrenergic agents|mesh-ancestor
6070281|NCT00716859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6070282|NCT00716859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070283|NCT00716859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070284|NCT00716859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6070285|NCT00716859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6070286|NCT00716859|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6070287|NCT00716859|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6070288|NCT00716963|Fluticasone|fluticasone|mesh-list
6070289|NCT00716963|Xhance|xhance|mesh-list
6070290|NCT00716963|Budesonide|budesonide|mesh-list
6070291|NCT00716963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6070292|NCT00716963|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6070293|NCT00716963|Autonomic Agents|autonomic agents|mesh-ancestor
6070294|NCT00716963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6070295|NCT00716963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070296|NCT00716963|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6070297|NCT00716963|Respiratory System Agents|respiratory system agents|mesh-ancestor
6070298|NCT00716963|Dermatologic Agents|dermatologic agents|mesh-ancestor
6070299|NCT00716963|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6070300|NCT00716963|Glucocorticoids|glucocorticoids|mesh-ancestor
6070301|NCT00716963|Hormones|hormones|mesh-ancestor
6070302|NCT00716963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6070303|NCT00716976|Sodium thiosulfate|sodium thiosulfate|mesh-list
6070304|NCT00716976|Antidotes|antidotes|mesh-ancestor
6070305|NCT00716976|Protective Agents|protective agents|mesh-ancestor
6070306|NCT00716976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070307|NCT00716976|Antioxidants|antioxidants|mesh-ancestor
6070308|NCT00716976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070309|NCT00716976|Antitubercular Agents|antitubercular agents|mesh-ancestor
6070310|NCT00716976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6070311|NCT00716976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6070312|NCT00716976|Chelating Agents|chelating agents|mesh-ancestor
6070313|NCT00716976|Sequestering Agents|sequestering agents|mesh-ancestor
6070314|NCT00717054|Scopolamine|scopolamine|mesh-list
6070315|NCT00717054|Aprepitant|aprepitant|mesh-list
6070316|NCT00717054|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
6070317|NCT00717054|Antiemetics|antiemetics|mesh-ancestor
6070318|NCT00717054|Autonomic Agents|autonomic agents|mesh-ancestor
6070319|NCT00717054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6070320|NCT00717054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070321|NCT00717054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5509644|NCT04405375|Hormones|hormones|mesh-ancestor
5509645|NCT04405375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5509646|NCT04405375|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5509647|NCT04405375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5509648|NCT04405375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6070322|NCT00717054|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6070323|NCT00717054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6070324|NCT00717054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070325|NCT00717054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6070326|NCT00717054|Mydriatics|mydriatics|mesh-ancestor
6070327|NCT00717054|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6070328|NCT00717054|Cholinergic Agents|cholinergic agents|mesh-ancestor
6070329|NCT00717054|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6070330|NCT00717054|Parasympatholytics|parasympatholytics|mesh-ancestor
6070331|NCT00717067|Ritonavir|ritonavir|mesh-list
6070332|NCT00717067|Saquinavir|saquinavir|mesh-list
6070333|NCT00717067|Maraviroc|maraviroc|mesh-list
6070334|NCT00717067|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6070335|NCT00717067|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6070336|NCT00717067|Protease Inhibitors|protease inhibitors|mesh-ancestor
6070337|NCT00717067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6070338|NCT00717067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070339|NCT00717067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6070340|NCT00717067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6070341|NCT00717067|Antiviral Agents|antiviral agents|mesh-ancestor
6070342|NCT00717067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6070343|NCT00717067|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6070344|NCT00717067|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6070345|NCT00717067|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6070346|NCT00717067|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6070347|NCT00717067|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6070348|NCT00717093|Varenicline|varenicline|mesh-list
6070349|NCT00717093|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6070350|NCT00717093|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6070351|NCT00717093|Cholinergic Agents|cholinergic agents|mesh-ancestor
6070352|NCT00717093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6070353|NCT00717093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070354|NCT00717093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070355|NCT00717197|Capecitabine|capecitabine|mesh-list
6070356|NCT00717197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6070357|NCT00717197|Antimetabolites|antimetabolites|mesh-ancestor
6070358|NCT00717197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070359|NCT00717197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6070360|NCT00717236|Certolizumab Pegol|certolizumab pegol|mesh-list
6070361|NCT00717236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5509649|NCT04405375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5509650|NCT04405375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5509651|NCT04405375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5509652|NCT04405375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5509653|NCT04405206|Capecitabine|capecitabine|mesh-list
5509654|NCT04405206|Oxaliplatin|oxaliplatin|mesh-list
5509655|NCT04405206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5509656|NCT04405206|Antimetabolites|antimetabolites|mesh-ancestor
5509657|NCT04405206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5509658|NCT04405206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5509659|NCT04405193|Acetylcysteine|acetylcysteine|mesh-list
5509660|NCT04405193|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5509661|NCT04405193|Antiviral Agents|antiviral agents|mesh-ancestor
5509662|NCT04405193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5509663|NCT04405193|Expectorants|expectorants|mesh-ancestor
5509664|NCT04405193|Respiratory System Agents|respiratory system agents|mesh-ancestor
5509665|NCT04405193|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5509666|NCT04405193|Antioxidants|antioxidants|mesh-ancestor
5509667|NCT04405193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070362|NCT00717236|Immunologic Factors|immunologic factors|mesh-ancestor
6070363|NCT00717236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070364|NCT00717236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6070365|NCT00717288|Insulin Detemir|insulin detemir|mesh-list
6070366|NCT00717288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6070367|NCT00717288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070368|NCT00717314|Mycophenolic Acid|mycophenolic acid|mesh-list
6070369|NCT00717314|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6070370|NCT00717314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6070371|NCT00717314|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6070372|NCT00717314|Antitubercular Agents|antitubercular agents|mesh-ancestor
6070373|NCT00717314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6070374|NCT00717314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6070375|NCT00717314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6070376|NCT00717314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070377|NCT00717366|Epoetin Alfa|epoetin alfa|mesh-list
6070378|NCT00717366|Hematinics|hematinics|mesh-ancestor
6070379|NCT00717405|Bevacizumab|bevacizumab|mesh-list
6070380|NCT00717405|Trastuzumab|trastuzumab|mesh-list
6070381|NCT00717405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6070382|NCT00717405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6070383|NCT00717405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6070384|NCT00717405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6070385|NCT00717405|Growth Substances|growth substances|mesh-ancestor
6070386|NCT00717405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070387|NCT00717405|Growth Inhibitors|growth inhibitors|mesh-ancestor
6070388|NCT00717418|Cyclosporine|cyclosporine|mesh-list
6070389|NCT00717418|Lubricant Eye Drops|lubricant eye drops|mesh-list
6463399|NCT00464347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6463400|NCT00464347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6463401|NCT00464347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6463402|NCT00464347|Growth Substances|growth substances|mesh-ancestor
6070390|NCT00717418|Cyclosporins|cyclosporins|mesh-list
6070391|NCT00717418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6070392|NCT00717418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070393|NCT00717418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6070394|NCT00717418|Immunologic Factors|immunologic factors|mesh-ancestor
6070395|NCT00717418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070396|NCT00717418|Antifungal Agents|antifungal agents|mesh-ancestor
6070397|NCT00717418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6070398|NCT00717418|Dermatologic Agents|dermatologic agents|mesh-ancestor
6070399|NCT00717418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6070400|NCT00717418|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6070401|NCT00717418|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6070402|NCT00717418|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6070403|NCT00717522|Pomalidomide|pomalidomide|mesh-list
5509668|NCT04405193|Protective Agents|protective agents|mesh-ancestor
5509669|NCT04405193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509670|NCT04405193|Antidotes|antidotes|mesh-ancestor
6070404|NCT00717522|Immunologic Factors|immunologic factors|mesh-ancestor
6070405|NCT00717522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070406|NCT00717522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6070407|NCT00717522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6070408|NCT00717522|Growth Substances|growth substances|mesh-ancestor
6070409|NCT00717522|Growth Inhibitors|growth inhibitors|mesh-ancestor
6070410|NCT00717522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6070411|NCT00717574|Nitrous Oxide|nitrous oxide|mesh-list
6070412|NCT00717574|Propofol|propofol|mesh-list
6070413|NCT00717574|Sevoflurane|sevoflurane|mesh-list
6070414|NCT00717574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6070415|NCT00717574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6070416|NCT00717574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070417|NCT00717574|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6070418|NCT00717574|Anesthetics, General|anesthetics, general|mesh-ancestor
6463403|NCT00464347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463404|NCT00464347|Growth Inhibitors|growth inhibitors|mesh-ancestor
6463405|NCT00464347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6463406|NCT00464347|Glucocorticoids|glucocorticoids|mesh-ancestor
6463407|NCT00464347|Hormones|hormones|mesh-ancestor
6463408|NCT00464347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6463409|NCT00464347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6463410|NCT00464347|Immunologic Factors|immunologic factors|mesh-ancestor
6070419|NCT00717574|Anesthetics|anesthetics|mesh-ancestor
6070420|NCT00717574|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6070421|NCT00717574|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6070422|NCT00717574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6070423|NCT00717574|Analgesics|analgesics|mesh-ancestor
6070424|NCT00717574|Sensory System Agents|sensory system agents|mesh-ancestor
6070425|NCT00717574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6070426|NCT00717626|Factor VIII|factor viii|mesh-list
6070427|NCT00717626|Coagulants|coagulants|mesh-ancestor
6070428|NCT00717756|Lenalidomide|lenalidomide|mesh-list
6070429|NCT00717756|Immunologic Factors|immunologic factors|mesh-ancestor
6070430|NCT00717756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463411|NCT00464347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6070431|NCT00717756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6070432|NCT00717756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6070433|NCT00717756|Growth Substances|growth substances|mesh-ancestor
5509671|NCT04405271|Tenofovir|tenofovir|mesh-list
5509672|NCT04405271|Emtricitabine|emtricitabine|mesh-list
5509673|NCT04405271|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
5509674|NCT04405271|Antiviral Agents|antiviral agents|mesh-ancestor
5509675|NCT04405271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5509676|NCT04405271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5509677|NCT04405271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6463412|NCT00464347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463413|NCT00464373|Botulinum Toxins|botulinum toxins|mesh-list
6463414|NCT00464373|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6463415|NCT00464373|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6463416|NCT00464373|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6070434|NCT00717756|Growth Inhibitors|growth inhibitors|mesh-ancestor
6070435|NCT00717756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6070436|NCT00717860|Caspofungin|caspofungin|mesh-list
6070437|NCT00717860|Micafungin|micafungin|mesh-list
6070438|NCT00717860|Antifungal Agents|antifungal agents|mesh-ancestor
6070439|NCT00717860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6070440|NCT00717860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6070441|NCT00717860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070442|NCT00718081|Sufentanil|sufentanil|mesh-list
6070443|NCT00718081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6070444|NCT00718081|Narcotics|narcotics|mesh-ancestor
6070445|NCT00718081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6070446|NCT00718081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070447|NCT00718081|Analgesics|analgesics|mesh-ancestor
6070448|NCT00718081|Sensory System Agents|sensory system agents|mesh-ancestor
6070449|NCT00718081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6070450|NCT00718081|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6070451|NCT00718081|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6070452|NCT00718081|Anesthetics, General|anesthetics, general|mesh-ancestor
6070453|NCT00718081|Anesthetics|anesthetics|mesh-ancestor
6070454|NCT00718315|Erythromycin|erythromycin|mesh-list
6463417|NCT00464373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5509678|NCT04405271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5509679|NCT04405271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5509680|NCT04405271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5509681|NCT04405271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5509682|NCT04405154|Cisplatin|cisplatin|mesh-list
5509683|NCT04405154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5509684|NCT04405245|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6070455|NCT00718315|Erythromycin Estolate|erythromycin estolate|mesh-list
6070456|NCT00718315|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
6070457|NCT00718315|Erythromycin stearate|erythromycin stearate|mesh-list
6070458|NCT00718315|Fusidic Acid|fusidic acid|mesh-list
6070459|NCT00718315|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6070460|NCT00718315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6070461|NCT00718315|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6070462|NCT00718315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6070463|NCT00718315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070464|NCT00718315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6070465|NCT00718315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6070466|NCT00718315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5509685|NCT04405245|Latanoprost|latanoprost|mesh-list
5509686|NCT04405245|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5509687|NCT04405037|Alvimopan|alvimopan|mesh-list
5509688|NCT04405037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5509689|NCT04405011|Entecavir|entecavir|mesh-list
5509690|NCT04405011|Antiviral Agents|antiviral agents|mesh-ancestor
5509691|NCT04405011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5509692|NCT04405323|Itraconazole|itraconazole|mesh-list
5509693|NCT04405323|Antifungal Agents|antifungal agents|mesh-ancestor
5509694|NCT04405323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5509695|NCT04405323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5509696|NCT04405323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5509697|NCT04405323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5509698|NCT04405323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5509699|NCT04405323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5509700|NCT04405323|Hormone Antagonists|hormone antagonists|mesh-ancestor
5509701|NCT04405323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5509702|NCT04405323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070467|NCT00718315|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6070468|NCT00718328|Simvastatin|simvastatin|mesh-list
6070469|NCT00718328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6070470|NCT00718328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6070471|NCT00718328|Antimetabolites|antimetabolites|mesh-ancestor
6463418|NCT00464373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463419|NCT00464373|Cholinergic Agents|cholinergic agents|mesh-ancestor
5509703|NCT04405323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5509704|NCT04404946|Phenylephrine|phenylephrine|mesh-list
5509705|NCT04404946|Oxymetazoline|oxymetazoline|mesh-list
5509706|NCT04404946|Norepinephrine|norepinephrine|mesh-list
5509707|NCT04404946|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5509708|NCT04404946|Mydriatics|mydriatics|mesh-ancestor
5509709|NCT04404946|Autonomic Agents|autonomic agents|mesh-ancestor
5509710|NCT04404946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5509711|NCT04404946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509712|NCT04404946|Sympathomimetics|sympathomimetics|mesh-ancestor
5509713|NCT04404946|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5509714|NCT04404946|Nasal Decongestants|nasal decongestants|mesh-ancestor
5509715|NCT04404946|Respiratory System Agents|respiratory system agents|mesh-ancestor
5509716|NCT04404946|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5509717|NCT04404946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5509718|NCT04404946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5509719|NCT04404946|Adrenergic Agents|adrenergic agents|mesh-ancestor
5509720|NCT04404946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5509721|NCT04404946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5509722|NCT04404946|Protective Agents|protective agents|mesh-ancestor
5509723|NCT04404881|Bevacizumab|bevacizumab|mesh-list
5509724|NCT04404881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5509725|NCT04404881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5509726|NCT04404881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5509727|NCT04404881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6463420|NCT00464373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6463421|NCT00464373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463422|NCT00464373|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6463423|NCT00464373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6463424|NCT00464399|Everolimus|everolimus|mesh-list
6463425|NCT00464399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6463426|NCT00464399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6463427|NCT00464399|Immunologic Factors|immunologic factors|mesh-ancestor
6463428|NCT00464399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463429|NCT00464451|Dexmedetomidine|dexmedetomidine|mesh-list
6463430|NCT00464451|Chloral Hydrate|chloral hydrate|mesh-list
6463431|NCT00464451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6463432|NCT00464451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6463433|NCT00464451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463434|NCT00464451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6463435|NCT00464451|Analgesics|analgesics|mesh-ancestor
6463436|NCT00464451|Sensory System Agents|sensory system agents|mesh-ancestor
6463437|NCT00464451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6463438|NCT00464451|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6463439|NCT00464451|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6463440|NCT00464451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6463441|NCT00464451|Adrenergic Agents|adrenergic agents|mesh-ancestor
5509728|NCT04404881|Growth Substances|growth substances|mesh-ancestor
5509729|NCT04404881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463442|NCT00464451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6463443|NCT00464451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463444|NCT00464503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6463445|NCT00464503|Pravastatin|pravastatin|mesh-list
6463446|NCT00464503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5509730|NCT04404881|Growth Inhibitors|growth inhibitors|mesh-ancestor
5600332|NCT03712670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5600333|NCT03712670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5600334|NCT03712670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5600335|NCT03712670|Gout Suppressants|gout suppressants|mesh-ancestor
5600336|NCT03712540|Rifampin|rifampin|mesh-list
6070472|NCT00718328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070473|NCT00718328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6070474|NCT00718328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6070475|NCT00718328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6070476|NCT00718523|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6070477|NCT00718523|Immunologic Factors|immunologic factors|mesh-ancestor
6070478|NCT00718523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070479|NCT00718549|Cyclophosphamide|cyclophosphamide|mesh-list
6070480|NCT00718549|Rituximab|rituximab|mesh-list
6070481|NCT00718549|Cladribine|cladribine|mesh-list
6070482|NCT00718549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6070483|NCT00718549|Immunologic Factors|immunologic factors|mesh-ancestor
5509731|NCT04404855|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5509732|NCT04404855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5509733|NCT04404959|Ropivacaine|ropivacaine|mesh-list
5509734|NCT04404959|Anesthetics|anesthetics|mesh-list
6070484|NCT00718549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070485|NCT00718549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6070486|NCT00718549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6070487|NCT00718549|Alkylating Agents|alkylating agents|mesh-ancestor
6070488|NCT00718549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070489|NCT00718549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6070490|NCT00718549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6070491|NCT00718549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6070492|NCT00718718|Methotrexate|methotrexate|mesh-list
6070493|NCT00718718|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5509735|NCT04404959|Anesthetics, Local|anesthetics, local|mesh-ancestor
5509736|NCT04404959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6070494|NCT00718718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6070495|NCT00718718|Abortifacient Agents|abortifacient agents|mesh-ancestor
6070496|NCT00718718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6070497|NCT00718718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070498|NCT00718718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6070499|NCT00718718|Antimetabolites|antimetabolites|mesh-ancestor
6070500|NCT00718718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070501|NCT00718718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6070502|NCT00718718|Dermatologic Agents|dermatologic agents|mesh-ancestor
6070503|NCT00718718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6070504|NCT00718718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6070505|NCT00718718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6070506|NCT00718718|Immunologic Factors|immunologic factors|mesh-ancestor
6070507|NCT00718718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6070508|NCT00718718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6070509|NCT00718770|Bexarotene|bexarotene|mesh-list
6070510|NCT00718770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6070511|NCT00718809|Saracatinib|saracatinib|mesh-list
6070512|NCT00718809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6070513|NCT00718809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6070514|NCT00718809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070515|NCT00718861|Zoledronic Acid|zoledronic acid|mesh-list
6070516|NCT00718861|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6070517|NCT00718861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070518|NCT00718887|Entecavir|entecavir|mesh-list
6070519|NCT00718887|Adefovir|adefovir|mesh-list
6070520|NCT00718887|Antiviral Agents|antiviral agents|mesh-ancestor
6070521|NCT00718887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6070522|NCT00718887|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6070523|NCT00718887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6070524|NCT00718887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6070525|NCT00718887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070526|NCT00719043|Vaccines|vaccines|mesh-list
6070527|NCT00719043|Immunologic Factors|immunologic factors|mesh-ancestor
6070528|NCT00719043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070529|NCT00719134|Rizatriptan|rizatriptan|mesh-list
6070530|NCT00719134|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6070531|NCT00719134|Serotonin Agents|serotonin agents|mesh-ancestor
6070532|NCT00719134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6070533|NCT00719134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070534|NCT00719134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070535|NCT00719160|Esomeprazole|esomeprazole|mesh-list
6070536|NCT00719160|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6070537|NCT00719160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6070538|NCT00719160|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6070539|NCT00719160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6070540|NCT00719160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070541|NCT00719186|Letrozole|letrozole|mesh-list
6070542|NCT00719186|Clomiphene|clomiphene|mesh-list
6070543|NCT00719186|Enclomiphene|enclomiphene|mesh-list
6070544|NCT00719186|Zuclomiphene|zuclomiphene|mesh-list
6070545|NCT00719186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070546|NCT00719186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6070547|NCT00719186|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6070548|NCT00719186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6070549|NCT00719186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6070550|NCT00719186|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6070551|NCT00719186|Hormone Antagonists|hormone antagonists|mesh-ancestor
6207727|NCT02119650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6070552|NCT00719186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6070553|NCT00719186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070554|NCT00719186|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6070555|NCT00719186|Fertility Agents|fertility agents|mesh-ancestor
6070556|NCT00719186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6070557|NCT00719186|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6070558|NCT00719186|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6070559|NCT00719264|Interferons|interferons|mesh-list
6070560|NCT00719264|Interferon-alpha|interferon-alpha|mesh-list
6070561|NCT00719264|Interferon alpha-2|interferon alpha-2|mesh-list
6070562|NCT00719264|Bevacizumab|bevacizumab|mesh-list
5509737|NCT04404959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509738|NCT04404959|Sensory System Agents|sensory system agents|mesh-ancestor
5509739|NCT04404959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6070563|NCT00719264|Everolimus|everolimus|mesh-list
6070564|NCT00719264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6070565|NCT00719264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6070566|NCT00719264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6070567|NCT00719264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6070568|NCT00719264|Growth Substances|growth substances|mesh-ancestor
6070569|NCT00719264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070570|NCT00719264|Growth Inhibitors|growth inhibitors|mesh-ancestor
6070571|NCT00719264|Antiviral Agents|antiviral agents|mesh-ancestor
6070572|NCT00719264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6070573|NCT00719264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6070574|NCT00719264|Immunologic Factors|immunologic factors|mesh-ancestor
6070575|NCT00719329|Chlorhexidine|chlorhexidine|mesh-list
6070576|NCT00719329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6070577|NCT00719329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5509740|NCT04404751|Folic Acid|folic acid|mesh-list
5509741|NCT04404751|Vitamin B 12|vitamin b 12|mesh-list
5509742|NCT04404751|Hydroxocobalamin|hydroxocobalamin|mesh-list
5509743|NCT04404751|Iron|iron|mesh-list
5509744|NCT04404751|Vitamins|vitamins|mesh-ancestor
5509745|NCT04404751|Micronutrients|micronutrients|mesh-ancestor
5509746|NCT04404751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509747|NCT04404751|Trace Elements|trace elements|mesh-ancestor
5509748|NCT04404751|Hematinics|hematinics|mesh-ancestor
5509749|NCT04404751|Vitamin B Complex|vitamin b complex|mesh-ancestor
5509750|NCT04404686|Indomethacin|indomethacin|mesh-list
5509751|NCT04404686|Nifedipine|nifedipine|mesh-list
5509752|NCT04404686|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5509753|NCT04404686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5509754|NCT04404686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5509755|NCT04404686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5509756|NCT04404686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509757|NCT04404686|Vasodilator Agents|vasodilator agents|mesh-ancestor
5509758|NCT04404686|Tocolytic Agents|tocolytic agents|mesh-ancestor
5509759|NCT04404686|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5509760|NCT04404686|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5509761|NCT04404686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5509762|NCT04404686|Analgesics|analgesics|mesh-ancestor
5509763|NCT04404686|Sensory System Agents|sensory system agents|mesh-ancestor
5509764|NCT04404686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5509765|NCT04404686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5509766|NCT04404686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5509767|NCT04404686|Gout Suppressants|gout suppressants|mesh-ancestor
5509768|NCT04404686|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5509769|NCT04404686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5509770|NCT04404517|Adalimumab|adalimumab|mesh-list
5509771|NCT04404517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5509772|NCT04404517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6070578|NCT00719329|Disinfectants|disinfectants|mesh-ancestor
6070579|NCT00719472|Antipyretics|antipyretics|mesh-list
6070580|NCT00719472|Prednisone|prednisone|mesh-list
6070581|NCT00719472|Cyclophosphamide|cyclophosphamide|mesh-list
6070582|NCT00719472|Rituximab|rituximab|mesh-list
6070583|NCT00719472|Doxorubicin|doxorubicin|mesh-list
6070584|NCT00719472|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6070585|NCT00719472|Vincristine|vincristine|mesh-list
6070586|NCT00719472|Analgesics|analgesics|mesh-list
6070587|NCT00719472|Histamine Antagonists|histamine antagonists|mesh-list
6070588|NCT00719472|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
6070589|NCT00719472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6070590|NCT00719472|Immunologic Factors|immunologic factors|mesh-ancestor
5509773|NCT04404491|Capecitabine|capecitabine|mesh-list
5509774|NCT04404491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6070591|NCT00719472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070592|NCT00719472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6070593|NCT00719472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6070594|NCT00719472|Alkylating Agents|alkylating agents|mesh-ancestor
6070595|NCT00719472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070596|NCT00719472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6070597|NCT00719472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6070598|NCT00719472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6070599|NCT00719472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6070600|NCT00719472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6070601|NCT00719472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6070602|NCT00719472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6070603|NCT00719472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6070604|NCT00719472|Glucocorticoids|glucocorticoids|mesh-ancestor
6070605|NCT00719472|Hormones|hormones|mesh-ancestor
6070606|NCT00719472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6070607|NCT00719472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6070608|NCT00719472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6070609|NCT00719472|Tubulin Modulators|tubulin modulators|mesh-ancestor
6070610|NCT00719472|Antimitotic Agents|antimitotic agents|mesh-ancestor
6070611|NCT00719472|Mitosis Modulators|mitosis modulators|mesh-ancestor
6070612|NCT00719472|Sensory System Agents|sensory system agents|mesh-ancestor
6070613|NCT00719472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6070614|NCT00719472|Histamine Agents|histamine agents|mesh-ancestor
6070615|NCT00719472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6070616|NCT00719537|Aspirin|aspirin|mesh-list
6070617|NCT00719537|Progesterone|progesterone|mesh-list
6070618|NCT00719537|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6070619|NCT00719537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6070620|NCT00719537|Analgesics|analgesics|mesh-ancestor
6070621|NCT00719537|Sensory System Agents|sensory system agents|mesh-ancestor
6070622|NCT00719537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6070623|NCT00719537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070624|NCT00719537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6070625|NCT00719537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6070626|NCT00719537|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6070627|NCT00719537|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6070628|NCT00719537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070629|NCT00719537|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6070630|NCT00719537|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6070631|NCT00719537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6070632|NCT00719537|Antipyretics|antipyretics|mesh-ancestor
6070633|NCT00719537|Progestins|progestins|mesh-ancestor
6070634|NCT00719537|Hormones|hormones|mesh-ancestor
6070635|NCT00719537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6202604|NCT02043366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202605|NCT02043366|Antitussive Agents|antitussive agents|mesh-ancestor
6202606|NCT02043366|Respiratory System Agents|respiratory system agents|mesh-ancestor
6202607|NCT02043366|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6202608|NCT02043379|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6202609|NCT02043379|Immunologic Factors|immunologic factors|mesh-ancestor
6202610|NCT02043379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202611|NCT02043652|Chloroquine|chloroquine|mesh-list
6202612|NCT02043652|Primaquine|primaquine|mesh-list
6202613|NCT02043652|Amebicides|amebicides|mesh-ancestor
6202614|NCT02043652|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6202615|NCT02043652|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6202616|NCT02043652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6202617|NCT02043652|Antimalarials|antimalarials|mesh-ancestor
6202618|NCT02043652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6202619|NCT02043704|Acetaminophen|acetaminophen|mesh-list
6202620|NCT02043704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6202621|NCT02043704|Analgesics|analgesics|mesh-ancestor
6202622|NCT02043704|Sensory System Agents|sensory system agents|mesh-ancestor
6202623|NCT02043704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6202624|NCT02043704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202625|NCT02043704|Antipyretics|antipyretics|mesh-ancestor
6202626|NCT02043899|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
6202627|NCT02043899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6202628|NCT02043899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6202629|NCT02043899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202630|NCT02043899|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6202631|NCT02044094|Buprenorphine|buprenorphine|mesh-list
6202632|NCT02044094|Hydromorphone|hydromorphone|mesh-list
6070636|NCT00719706|Acetylcarnitine|acetylcarnitine|mesh-list
6070637|NCT00719706|Vitamin B Complex|vitamin b complex|mesh-ancestor
6070638|NCT00719706|Vitamins|vitamins|mesh-ancestor
6070639|NCT00719706|Micronutrients|micronutrients|mesh-ancestor
6070640|NCT00719706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070641|NCT00719706|Nootropic Agents|nootropic agents|mesh-ancestor
6070642|NCT00719810|Tigecycline|tigecycline|mesh-list
6070643|NCT00719810|Fluoroquinolones|fluoroquinolones|mesh-list
6070644|NCT00719810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6070645|NCT00719810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6070646|NCT00719810|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6070647|NCT00719810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6070648|NCT00719810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070649|NCT00719810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6070650|NCT00719849|Cyclosporine|cyclosporine|mesh-list
6070651|NCT00719849|Mycophenolic Acid|mycophenolic acid|mesh-list
6070652|NCT00719849|Cyclophosphamide|cyclophosphamide|mesh-list
6070653|NCT00719849|Fludarabine|fludarabine|mesh-list
6070654|NCT00719849|Fludarabine phosphate|fludarabine phosphate|mesh-list
6070655|NCT00719849|Cyclosporins|cyclosporins|mesh-list
6070656|NCT00719849|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6070657|NCT00719849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6070658|NCT00719849|Immunologic Factors|immunologic factors|mesh-ancestor
6070659|NCT00719849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070660|NCT00719849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6070661|NCT00719849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6070662|NCT00719849|Alkylating Agents|alkylating agents|mesh-ancestor
6070663|NCT00719849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5509775|NCT04404491|Antimetabolites|antimetabolites|mesh-ancestor
5509776|NCT04404491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5509777|NCT04404491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5509778|NCT04404439|Topiramate|topiramate|mesh-list
5509779|NCT04404439|Verapamil|verapamil|mesh-list
6070664|NCT00719849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6070665|NCT00719849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6070666|NCT00719849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6070667|NCT00719849|Antimetabolites|antimetabolites|mesh-ancestor
6070668|NCT00719849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6070669|NCT00719849|Antifungal Agents|antifungal agents|mesh-ancestor
6070670|NCT00719849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6070671|NCT00719849|Dermatologic Agents|dermatologic agents|mesh-ancestor
6070672|NCT00719849|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6070673|NCT00719849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6070674|NCT00719849|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6070675|NCT00719849|Antitubercular Agents|antitubercular agents|mesh-ancestor
6070676|NCT00719849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6070677|NCT00719862|Azelastine|azelastine|mesh-list
6070678|NCT00719862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6070679|NCT00719862|Autonomic Agents|autonomic agents|mesh-ancestor
6070680|NCT00719862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6070681|NCT00719862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070682|NCT00719862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6070683|NCT00719862|Respiratory System Agents|respiratory system agents|mesh-ancestor
6070684|NCT00719862|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6070685|NCT00719862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6070686|NCT00719862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5509780|NCT04404439|Paroxetine|paroxetine|mesh-list
6070687|NCT00719862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6070688|NCT00719862|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6070689|NCT00719862|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6463447|NCT00464503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6463448|NCT00464503|Antimetabolites|antimetabolites|mesh-ancestor
6463449|NCT00464503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463450|NCT00464503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6463451|NCT00464503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6463452|NCT00464503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6070690|NCT00719862|Histamine Antagonists|histamine antagonists|mesh-ancestor
6070691|NCT00719862|Histamine Agents|histamine agents|mesh-ancestor
6070692|NCT00719862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5509781|NCT04404439|Nortriptyline|nortriptyline|mesh-list
5509782|NCT04404439|Anticonvulsants|anticonvulsants|mesh-ancestor
5509783|NCT04404439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6070693|NCT00719901|Bortezomib|bortezomib|mesh-list
6070694|NCT00719901|Obatoclax|obatoclax|mesh-list
6070695|NCT00719901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6070696|NCT00719901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6070697|NCT00719901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070698|NCT00720057|Naproxen|naproxen|mesh-list
6070699|NCT00720057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6070700|NCT00720057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6070701|NCT00720057|Analgesics|analgesics|mesh-ancestor
6070702|NCT00720057|Sensory System Agents|sensory system agents|mesh-ancestor
6070703|NCT00720057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5509784|NCT04404439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509785|NCT04404439|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5509786|NCT04404439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5509787|NCT04404439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5509788|NCT04404439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070704|NCT00720057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070705|NCT00720057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6070706|NCT00720057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6070707|NCT00720057|Gout Suppressants|gout suppressants|mesh-ancestor
6070708|NCT00720057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6070709|NCT00720057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6070710|NCT00720057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070711|NCT00720096|Doxorubicin|doxorubicin|mesh-list
6070712|NCT00720096|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6070713|NCT00720096|Topotecan|topotecan|mesh-list
6070714|NCT00720096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6070715|NCT00720096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6070716|NCT00720096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6070717|NCT00720096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6070718|NCT00720096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6070719|NCT00720096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070720|NCT00720096|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6070721|NCT00720109|Calcium, Dietary|calcium, dietary|mesh-list
6070722|NCT00720109|Leucovorin|leucovorin|mesh-list
6070723|NCT00720109|Folic Acid|folic acid|mesh-list
6070724|NCT00720109|Cytarabine|cytarabine|mesh-list
6070725|NCT00720109|Dexamethasone|dexamethasone|mesh-list
6070726|NCT00720109|Dexamethasone acetate|dexamethasone acetate|mesh-list
6070727|NCT00720109|Prednisone|prednisone|mesh-list
6070728|NCT00720109|Methylprednisolone|methylprednisolone|mesh-list
6070729|NCT00720109|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6070730|NCT00720109|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6070731|NCT00720109|Prednisolone|prednisolone|mesh-list
6070732|NCT00720109|Prednisolone acetate|prednisolone acetate|mesh-list
6070733|NCT00720109|Hydrocortisone|hydrocortisone|mesh-list
6070734|NCT00720109|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6070735|NCT00720109|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
5509789|NCT04404439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5509790|NCT04404439|Serotonin Agents|serotonin agents|mesh-ancestor
5509791|NCT04404439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5509792|NCT04404439|Antidepressive Agents|antidepressive agents|mesh-ancestor
5509793|NCT04404439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5509794|NCT04404439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5509795|NCT04404439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5509796|NCT04404439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5509797|NCT04404439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6070736|NCT00720109|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6070737|NCT00720109|Cortisone|cortisone|mesh-list
6070738|NCT00720109|Cyclophosphamide|cyclophosphamide|mesh-list
6070739|NCT00720109|Ifosfamide|ifosfamide|mesh-list
6070740|NCT00720109|Isophosphamide mustard|isophosphamide mustard|mesh-list
6070741|NCT00720109|Methotrexate|methotrexate|mesh-list
6070742|NCT00720109|Etoposide|etoposide|mesh-list
6070743|NCT00720109|Vincristine|vincristine|mesh-list
6070744|NCT00720109|Etoposide phosphate|etoposide phosphate|mesh-list
6070745|NCT00720109|Daunorubicin|daunorubicin|mesh-list
6070746|NCT00720109|Asparaginase|asparaginase|mesh-list
6070747|NCT00720109|Dasatinib|dasatinib|mesh-list
6070748|NCT00720109|Mercaptopurine|mercaptopurine|mesh-list
6070749|NCT00720109|Podophyllotoxin|podophyllotoxin|mesh-list
6070750|NCT00720109|Pegaspargase|pegaspargase|mesh-list
6070751|NCT00720109|Lenograstim|lenograstim|mesh-list
6070752|NCT00720109|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5509798|NCT04404439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5509799|NCT04404439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5509800|NCT04404439|Vasodilator Agents|vasodilator agents|mesh-ancestor
5509801|NCT04404439|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5509802|NCT04404439|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5509803|NCT04404439|Adrenergic Agents|adrenergic agents|mesh-ancestor
5509804|NCT04404361|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
5509805|NCT04404361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5509806|NCT04404361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5509807|NCT04404361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5509808|NCT04404387|Ascorbic Acid|ascorbic acid|mesh-list
5509809|NCT04404387|Vitamins|vitamins|mesh-ancestor
5509810|NCT04404387|Micronutrients|micronutrients|mesh-ancestor
6070753|NCT00720109|Prednisolone phosphate|prednisolone phosphate|mesh-list
6070754|NCT00720109|BB 1101|bb 1101|mesh-list
6070755|NCT00720109|Calcium|calcium|mesh-list
6070756|NCT00720109|Levoleucovorin|levoleucovorin|mesh-list
6070757|NCT00720109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6070758|NCT00720109|Immunologic Factors|immunologic factors|mesh-ancestor
6070759|NCT00720109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070760|NCT00720109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6070761|NCT00720109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6070762|NCT00720109|Alkylating Agents|alkylating agents|mesh-ancestor
6070763|NCT00720109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070764|NCT00720109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6070765|NCT00720109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6070766|NCT00720109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6070767|NCT00720109|Antiemetics|antiemetics|mesh-ancestor
6070768|NCT00720109|Autonomic Agents|autonomic agents|mesh-ancestor
6070769|NCT00720109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6070770|NCT00720109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6070771|NCT00720109|Glucocorticoids|glucocorticoids|mesh-ancestor
6070772|NCT00720109|Hormones|hormones|mesh-ancestor
6070773|NCT00720109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6070774|NCT00720109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6070775|NCT00720109|Protease Inhibitors|protease inhibitors|mesh-ancestor
6070776|NCT00720109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6070777|NCT00720109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6070778|NCT00720109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6070779|NCT00720109|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6070780|NCT00720109|Abortifacient Agents|abortifacient agents|mesh-ancestor
6070781|NCT00720109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6070782|NCT00720109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6070783|NCT00720109|Antimetabolites|antimetabolites|mesh-ancestor
5509811|NCT04404387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509812|NCT04404387|Antioxidants|antioxidants|mesh-ancestor
5509813|NCT04404387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5509814|NCT04404387|Protective Agents|protective agents|mesh-ancestor
5509815|NCT04404062|Antibodies|antibodies|mesh-list
6070784|NCT00720109|Dermatologic Agents|dermatologic agents|mesh-ancestor
5509816|NCT04404062|Immunoglobulins|immunoglobulins|mesh-list
6070785|NCT00720109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5509817|NCT04404062|Immunologic Factors|immunologic factors|mesh-ancestor
5509818|NCT04404062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509819|NCT04404049|UB-421|ub-421|mesh-list
5509820|NCT04404049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5509821|NCT04404049|Antiviral Agents|antiviral agents|mesh-ancestor
6070786|NCT00720109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6070787|NCT00720109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6070788|NCT00720109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6070789|NCT00720109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6070790|NCT00720109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6070791|NCT00720109|Antiviral Agents|antiviral agents|mesh-ancestor
6070792|NCT00720109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6070793|NCT00720109|Antidotes|antidotes|mesh-ancestor
6070794|NCT00720109|Protective Agents|protective agents|mesh-ancestor
6070795|NCT00720109|Vitamin B Complex|vitamin b complex|mesh-ancestor
6070796|NCT00720109|Vitamins|vitamins|mesh-ancestor
6070797|NCT00720109|Micronutrients|micronutrients|mesh-ancestor
6070798|NCT00720109|Tubulin Modulators|tubulin modulators|mesh-ancestor
6070799|NCT00720109|Antimitotic Agents|antimitotic agents|mesh-ancestor
6070800|NCT00720109|Mitosis Modulators|mitosis modulators|mesh-ancestor
6070801|NCT00720109|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6070802|NCT00720109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6070803|NCT00720109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6070804|NCT00720109|Hematinics|hematinics|mesh-ancestor
6070805|NCT00720109|Keratolytic Agents|keratolytic agents|mesh-ancestor
6070806|NCT00720122|Insulin|insulin|mesh-list
6070807|NCT00720122|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6070808|NCT00720122|Mitogens|mitogens|mesh-list
6070809|NCT00720122|Mecasermin|mecasermin|mesh-list
6070810|NCT00720122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6070811|NCT00720122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070812|NCT00720122|Mitosis Modulators|mitosis modulators|mesh-ancestor
6070813|NCT00720122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070814|NCT00720122|Growth Substances|growth substances|mesh-ancestor
6070815|NCT00720226|Losartan|losartan|mesh-list
6070816|NCT00720226|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6070817|NCT00720226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6070818|NCT00720226|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6070819|NCT00720226|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6070820|NCT00720226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070821|NCT00720278|Azelastine|azelastine|mesh-list
5509822|NCT04404049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5509823|NCT04404127|Basiliximab|basiliximab|mesh-list
5509824|NCT04404127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5509825|NCT04404127|Immunologic Factors|immunologic factors|mesh-ancestor
5509826|NCT04404127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509827|NCT04403776|Tofacitinib|tofacitinib|mesh-list
5509828|NCT04403776|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5509829|NCT04403776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5509830|NCT04403776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5509831|NCT04403503|Thrombin|thrombin|mesh-list
6070822|NCT00720278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6070823|NCT00720278|Autonomic Agents|autonomic agents|mesh-ancestor
6070824|NCT00720278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6070825|NCT00720278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070826|NCT00720278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6070827|NCT00720278|Respiratory System Agents|respiratory system agents|mesh-ancestor
6070828|NCT00720278|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6070829|NCT00720278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6070830|NCT00720278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070831|NCT00720278|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6070832|NCT00720278|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6070833|NCT00720278|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6070834|NCT00720278|Histamine Antagonists|histamine antagonists|mesh-ancestor
6070835|NCT00720278|Histamine Agents|histamine agents|mesh-ancestor
6070836|NCT00720278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6070837|NCT00720330|Lidocaine|lidocaine|mesh-list
6070838|NCT00720330|Ketamine|ketamine|mesh-list
6070839|NCT00720330|Ropivacaine|ropivacaine|mesh-list
6070840|NCT00720330|Anesthetics, Local|anesthetics, local|mesh-ancestor
6070841|NCT00720330|Anesthetics|anesthetics|mesh-ancestor
6070842|NCT00720330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6070843|NCT00720330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070844|NCT00720330|Sensory System Agents|sensory system agents|mesh-ancestor
6070845|NCT00720330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6070846|NCT00720330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6070847|NCT00720330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6070848|NCT00720330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6070849|NCT00720330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6070850|NCT00720330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070851|NCT00720330|Analgesics|analgesics|mesh-ancestor
6070852|NCT00720330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6070853|NCT00720330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6070854|NCT00720330|Anesthetics, General|anesthetics, general|mesh-ancestor
6070855|NCT00720330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6070856|NCT00720330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6070857|NCT00720330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6070858|NCT00720356|Bevacizumab|bevacizumab|mesh-list
6070859|NCT00720356|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6070860|NCT00720356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6070861|NCT00720356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6070862|NCT00720356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6070863|NCT00720356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6070864|NCT00720356|Growth Substances|growth substances|mesh-ancestor
6070865|NCT00720356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070866|NCT00720356|Growth Inhibitors|growth inhibitors|mesh-ancestor
6070867|NCT00720356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6070868|NCT00720356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6070869|NCT00720356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070870|NCT00720369|Ubiquinone|ubiquinone|mesh-list
6070871|NCT00720369|Coenzyme Q10|coenzyme q10|mesh-list
5509832|NCT04403503|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
5509833|NCT04403503|Hemostatics|hemostatics|mesh-ancestor
5509834|NCT04403503|Coagulants|coagulants|mesh-ancestor
5509835|NCT04403724|Fentanyl|fentanyl|mesh-list
5509836|NCT04403724|Morphine|morphine|mesh-list
5509837|NCT04403724|Bupivacaine|bupivacaine|mesh-list
5509838|NCT04403724|Anesthetics, Local|anesthetics, local|mesh-ancestor
5509839|NCT04403724|Anesthetics|anesthetics|mesh-ancestor
5509840|NCT04403724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5509841|NCT04403724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509842|NCT04403724|Sensory System Agents|sensory system agents|mesh-ancestor
6070872|NCT00720369|Micronutrients|micronutrients|mesh-ancestor
6070873|NCT00720369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070874|NCT00720369|Vitamins|vitamins|mesh-ancestor
6070875|NCT00720382|Mometasone Furoate|mometasone furoate|mesh-list
6070876|NCT00720382|Azelastine|azelastine|mesh-list
6070877|NCT00720382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6070878|NCT00720382|Dermatologic Agents|dermatologic agents|mesh-ancestor
6070879|NCT00720382|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6070880|NCT00720382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6070881|NCT00720382|Autonomic Agents|autonomic agents|mesh-ancestor
6070882|NCT00720382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6070883|NCT00720382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070884|NCT00720382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6070885|NCT00720382|Respiratory System Agents|respiratory system agents|mesh-ancestor
6070886|NCT00720382|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6070887|NCT00720382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6070888|NCT00720382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070889|NCT00720382|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6070890|NCT00720382|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6070891|NCT00720382|Histamine Antagonists|histamine antagonists|mesh-ancestor
6463453|NCT00464594|Metformin|metformin|mesh-list
5509843|NCT04403724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5509844|NCT04403724|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5509845|NCT04403724|Narcotics|narcotics|mesh-ancestor
5509846|NCT04403724|Analgesics|analgesics|mesh-ancestor
5509847|NCT04403724|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6463454|NCT00464594|Acarbose|acarbose|mesh-list
6463455|NCT00464594|Gliclazide|gliclazide|mesh-list
6070892|NCT00720382|Histamine Agents|histamine agents|mesh-ancestor
6070893|NCT00720382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6070894|NCT00720473|Lamotrigine|lamotrigine|mesh-list
6070895|NCT00720473|Anticonvulsants|anticonvulsants|mesh-ancestor
6070896|NCT00720473|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5509848|NCT04403724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5509849|NCT04403724|Anesthetics, General|anesthetics, general|mesh-ancestor
5509850|NCT04403516|Dexamethasone|dexamethasone|mesh-list
5509851|NCT04403516|Prednisolone|prednisolone|mesh-list
5509852|NCT04403516|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5509853|NCT04403516|Methylprednisolone|methylprednisolone|mesh-list
5509854|NCT04403516|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5509855|NCT04403516|Prednisolone acetate|prednisolone acetate|mesh-list
5509856|NCT04403516|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6463456|NCT00464594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6070897|NCT00720473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6070898|NCT00720473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070899|NCT00720473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6070900|NCT00720473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070901|NCT00720473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5509857|NCT04403516|Prednisolone phosphate|prednisolone phosphate|mesh-list
5509858|NCT04403516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5509859|NCT04403516|Antiemetics|antiemetics|mesh-ancestor
5509860|NCT04403516|Autonomic Agents|autonomic agents|mesh-ancestor
5509861|NCT04403516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5509862|NCT04403516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509863|NCT04403516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5509864|NCT04403516|Glucocorticoids|glucocorticoids|mesh-ancestor
5509865|NCT04403516|Hormones|hormones|mesh-ancestor
5509866|NCT04403516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5509867|NCT04403516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5509868|NCT04403516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5509869|NCT04403516|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5509870|NCT04403516|Protective Agents|protective agents|mesh-ancestor
5509871|NCT04403698|Alendronate|alendronate|mesh-list
6070902|NCT00720473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6070903|NCT00720473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6070904|NCT00720473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6070905|NCT00720473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6070906|NCT00720499|Bromides|bromides|mesh-list
6070907|NCT00720499|Tiotropium Bromide|tiotropium bromide|mesh-list
6070908|NCT00720499|Olodaterol|olodaterol|mesh-list
6070909|NCT00720499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6070910|NCT00720499|Autonomic Agents|autonomic agents|mesh-ancestor
6070911|NCT00720499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6070912|NCT00720499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070913|NCT00720499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6070914|NCT00720499|Respiratory System Agents|respiratory system agents|mesh-ancestor
6070915|NCT00720499|Parasympatholytics|parasympatholytics|mesh-ancestor
6070916|NCT00720499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6070917|NCT00720499|Cholinergic Agents|cholinergic agents|mesh-ancestor
6070918|NCT00720499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6070919|NCT00720499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070920|NCT00720499|Anticonvulsants|anticonvulsants|mesh-ancestor
6070921|NCT00720629|Methotrexate|methotrexate|mesh-list
6070922|NCT00720629|Tacrolimus|tacrolimus|mesh-list
6070923|NCT00720629|Thymoglobulin|thymoglobulin|mesh-list
6070924|NCT00720629|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6070925|NCT00720629|Visilizumab|visilizumab|mesh-list
6070926|NCT00720629|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6070927|NCT00720629|Abortifacient Agents|abortifacient agents|mesh-ancestor
6070928|NCT00720629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6070929|NCT00720629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070930|NCT00720629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6070931|NCT00720629|Antimetabolites|antimetabolites|mesh-ancestor
6070932|NCT00720629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070933|NCT00720629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6070934|NCT00720629|Dermatologic Agents|dermatologic agents|mesh-ancestor
6070935|NCT00720629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6070936|NCT00720629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6070937|NCT00720629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6070938|NCT00720629|Immunologic Factors|immunologic factors|mesh-ancestor
6070939|NCT00720629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6070940|NCT00720629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6070941|NCT00720629|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6070942|NCT00720759|Cycloserine|cycloserine|mesh-list
5509872|NCT04403698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5509873|NCT04403698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509874|NCT04403568|Ursolic acid|ursolic acid|mesh-list
5509875|NCT04403568|Curcumin|curcumin|mesh-list
5509876|NCT04403568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5509877|NCT04403568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5509878|NCT04403568|Analgesics|analgesics|mesh-ancestor
5509879|NCT04403568|Sensory System Agents|sensory system agents|mesh-ancestor
5509880|NCT04403568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5509881|NCT04403568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509882|NCT04403568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5509883|NCT04403568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5509884|NCT04403568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6070943|NCT00720759|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5509885|NCT04403568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5509886|NCT04403568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5509887|NCT04403568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5509888|NCT04403568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5509889|NCT04403568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5509890|NCT04403555|Ivermectin|ivermectin|mesh-list
5509891|NCT04403555|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5509892|NCT04403555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5509893|NCT04403711|Dexmedetomidine|dexmedetomidine|mesh-list
5509894|NCT04403711|Anesthetics|anesthetics|mesh-list
5509895|NCT04403711|Anesthetics, Local|anesthetics, local|mesh-list
5509896|NCT04403711|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5509897|NCT04403711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5509898|NCT04403711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509899|NCT04403711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5509900|NCT04403711|Analgesics|analgesics|mesh-ancestor
5509901|NCT04403711|Sensory System Agents|sensory system agents|mesh-ancestor
5509902|NCT04403711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5509903|NCT04403711|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5509904|NCT04403711|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5509905|NCT04403711|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6070944|NCT00720759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6070945|NCT00720759|Renal Agents|renal agents|mesh-ancestor
6070946|NCT00720759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6070947|NCT00720759|Antitubercular Agents|antitubercular agents|mesh-ancestor
6070948|NCT00720759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6070949|NCT00720759|Antimetabolites|antimetabolites|mesh-ancestor
6070950|NCT00720759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070951|NCT00720798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
6070952|NCT00720798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
6463457|NCT00464594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463458|NCT00464594|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6463459|NCT00464594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6463460|NCT00464594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463461|NCT00464763|Dexmedetomidine|dexmedetomidine|mesh-list
6463462|NCT00464763|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6463463|NCT00464763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6463464|NCT00464763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463465|NCT00464763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6463466|NCT00464763|Analgesics|analgesics|mesh-ancestor
6463467|NCT00464763|Sensory System Agents|sensory system agents|mesh-ancestor
6463468|NCT00464763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6463469|NCT00464763|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6463470|NCT00464763|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6463471|NCT00464763|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6070953|NCT00720798|Antirheumatic Agents|antirheumatic agents|mesh-list
6070954|NCT00720798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6070955|NCT00720798|Analgesics|analgesics|mesh-ancestor
6070956|NCT00720798|Sensory System Agents|sensory system agents|mesh-ancestor
6070957|NCT00720798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6070958|NCT00720798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070959|NCT00720876|Rituximab|rituximab|mesh-list
6070960|NCT00720876|Vorinostat|vorinostat|mesh-list
6070961|NCT00720876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6070962|NCT00720876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6070963|NCT00720876|Immunologic Factors|immunologic factors|mesh-ancestor
6070964|NCT00720876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070965|NCT00720876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6070966|NCT00720876|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6070967|NCT00720876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6070968|NCT00720876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070969|NCT00720941|Sunitinib|sunitinib|mesh-list
6070970|NCT00720941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6070971|NCT00720941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6070972|NCT00720941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6070973|NCT00720941|Growth Substances|growth substances|mesh-ancestor
6070974|NCT00720941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070975|NCT00720941|Growth Inhibitors|growth inhibitors|mesh-ancestor
6070976|NCT00720941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6070977|NCT00720941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6070978|NCT00720941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070979|NCT00721110|Lidocaine|lidocaine|mesh-list
6070980|NCT00721110|Ketamine|ketamine|mesh-list
6070981|NCT00721110|Anesthetics, Local|anesthetics, local|mesh-ancestor
6070982|NCT00721110|Anesthetics|anesthetics|mesh-ancestor
6070983|NCT00721110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6070984|NCT00721110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6070985|NCT00721110|Sensory System Agents|sensory system agents|mesh-ancestor
6070986|NCT00721110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6070987|NCT00721110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6070988|NCT00721110|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6070989|NCT00721110|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6070990|NCT00721110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6070991|NCT00721110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6070992|NCT00721110|Analgesics|analgesics|mesh-ancestor
6070993|NCT00721110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6070994|NCT00721110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6070995|NCT00721110|Anesthetics, General|anesthetics, general|mesh-ancestor
6070996|NCT00721110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6070997|NCT00721110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6070998|NCT00721110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6070999|NCT00721136|Heparin|heparin|mesh-list
6071000|NCT00721136|Warfarin|warfarin|mesh-list
6071001|NCT00721136|Anticoagulants|anticoagulants|mesh-ancestor
6071002|NCT00721136|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6071003|NCT00721136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5509906|NCT04403711|Adrenergic Agents|adrenergic agents|mesh-ancestor
5509907|NCT04403711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5509908|NCT04403711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5509909|NCT04403347|Losartan|losartan|mesh-list
5509910|NCT04403347|Antihypertensive Agents|antihypertensive agents|mesh-list
5509911|NCT04403347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5509912|NCT04403347|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5509913|NCT04403347|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5509914|NCT04403347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5509915|NCT04403087|Trimebutine|trimebutine|mesh-list
5509916|NCT04403087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5509917|NCT04403087|Parasympatholytics|parasympatholytics|mesh-ancestor
5509918|NCT04403087|Autonomic Agents|autonomic agents|mesh-ancestor
5509919|NCT04403087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5509920|NCT04403087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509921|NCT04403334|Moxifloxacin|moxifloxacin|mesh-list
5509922|NCT04403334|Levofloxacin|levofloxacin|mesh-list
5509923|NCT04403334|Ofloxacin|ofloxacin|mesh-list
5509924|NCT04403334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5509925|NCT04403334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6071004|NCT00721136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071005|NCT00721162|Ramucirumab|ramucirumab|mesh-list
6071006|NCT00721162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6071007|NCT00721188|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6071008|NCT00721188|Hematinics|hematinics|mesh-ancestor
6071009|NCT00721214|Azacitidine|azacitidine|mesh-list
6071010|NCT00721214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6071011|NCT00721214|Antimetabolites|antimetabolites|mesh-ancestor
6071012|NCT00721214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071013|NCT00721214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6071014|NCT00721214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6071015|NCT00721279|Pramipexole|pramipexole|mesh-list
6071016|NCT00721279|Antioxidants|antioxidants|mesh-ancestor
6071017|NCT00721279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071018|NCT00721279|Protective Agents|protective agents|mesh-ancestor
6071019|NCT00721279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071020|NCT00721279|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6071021|NCT00721279|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6071022|NCT00721279|Dopamine Agonists|dopamine agonists|mesh-ancestor
6071023|NCT00721279|Dopamine Agents|dopamine agents|mesh-ancestor
6071024|NCT00721279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6071025|NCT00721396|Vaccines|vaccines|mesh-list
6071026|NCT00721396|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6071027|NCT00721396|Immunologic Factors|immunologic factors|mesh-ancestor
6071028|NCT00721396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071029|NCT00721409|Letrozole|letrozole|mesh-list
6071030|NCT00721409|Palbociclib|palbociclib|mesh-list
6071031|NCT00721409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6071032|NCT00721409|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6071033|NCT00721409|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6071034|NCT00721409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6071035|NCT00721409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071036|NCT00721409|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6071037|NCT00721409|Hormone Antagonists|hormone antagonists|mesh-ancestor
6071038|NCT00721409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6071039|NCT00721409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071040|NCT00721409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6071041|NCT00721513|Docetaxel|docetaxel|mesh-list
6071042|NCT00721513|Fluorouracil|fluorouracil|mesh-list
6071043|NCT00721513|Cetuximab|cetuximab|mesh-list
5509926|NCT04403334|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5509927|NCT04403334|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5509928|NCT04403334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5509929|NCT04403334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5509930|NCT04403334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6071044|NCT00721513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6071045|NCT00721513|Tubulin Modulators|tubulin modulators|mesh-ancestor
6071046|NCT00721513|Antimitotic Agents|antimitotic agents|mesh-ancestor
6071047|NCT00721513|Mitosis Modulators|mitosis modulators|mesh-ancestor
6071048|NCT00721513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071049|NCT00721513|Antimetabolites|antimetabolites|mesh-ancestor
6071050|NCT00721513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6071051|NCT00721513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6071052|NCT00721513|Immunologic Factors|immunologic factors|mesh-ancestor
6071053|NCT00721513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071054|NCT00721513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6071055|NCT00721578|Voriconazole|voriconazole|mesh-list
6071056|NCT00721578|Antifungal Agents|antifungal agents|mesh-ancestor
6071057|NCT00721578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6071058|NCT00721578|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6071059|NCT00721578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6071060|NCT00721578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6071061|NCT00721578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071062|NCT00721578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6071063|NCT00721578|Hormone Antagonists|hormone antagonists|mesh-ancestor
6071064|NCT00721578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6071065|NCT00721578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071066|NCT00721578|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6071067|NCT00721617|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6071068|NCT00721617|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6071069|NCT00721617|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6071070|NCT00721617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6071071|NCT00721630|Capecitabine|capecitabine|mesh-list
6071072|NCT00721630|Lapatinib|lapatinib|mesh-list
6071073|NCT00721630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5509931|NCT04403334|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5509932|NCT04403334|Renal Agents|renal agents|mesh-ancestor
5509933|NCT04403334|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5509934|NCT04403334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5509935|NCT04403100|Ritonavir|ritonavir|mesh-list
5509936|NCT04403100|Lopinavir|lopinavir|mesh-list
5509937|NCT04403100|Hydroxychloroquine|hydroxychloroquine|mesh-list
5509938|NCT04403100|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5509939|NCT04403100|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5509940|NCT04403100|Protease Inhibitors|protease inhibitors|mesh-ancestor
6071074|NCT00721630|Antimetabolites|antimetabolites|mesh-ancestor
6071075|NCT00721630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071076|NCT00721630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6071077|NCT00721630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6071078|NCT00721630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6071079|NCT00721955|Loxapine|loxapine|mesh-list
6071080|NCT00721955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6071081|NCT00721955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6071082|NCT00721955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6071083|NCT00721955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071084|NCT00721955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6071085|NCT00721955|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6071086|NCT00721955|Dopamine Agents|dopamine agents|mesh-ancestor
6071087|NCT00721955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6071088|NCT00721955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071089|NCT00722072|Sorafenib|sorafenib|mesh-list
6071090|NCT00722072|Fulvestrant|fulvestrant|mesh-list
6071091|NCT00722072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6071092|NCT00722072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6071093|NCT00722072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6071094|NCT00722072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071095|NCT00722072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6071096|NCT00722072|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6071097|NCT00722072|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6071098|NCT00722072|Hormone Antagonists|hormone antagonists|mesh-ancestor
5509941|NCT04403100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5509942|NCT04403100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5509943|NCT04403100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5509944|NCT04403100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5509945|NCT04403100|Antiviral Agents|antiviral agents|mesh-ancestor
5509946|NCT04403100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5509947|NCT04403100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5509948|NCT04403100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5509949|NCT04403100|Antimalarials|antimalarials|mesh-ancestor
6071099|NCT00722072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6071100|NCT00722072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071101|NCT00722137|Prednisone|prednisone|mesh-list
6071102|NCT00722137|Cyclophosphamide|cyclophosphamide|mesh-list
6071103|NCT00722137|Rituximab|rituximab|mesh-list
6071104|NCT00722137|Doxorubicin|doxorubicin|mesh-list
6071105|NCT00722137|Vincristine|vincristine|mesh-list
6071106|NCT00722137|Bortezomib|bortezomib|mesh-list
6071107|NCT00722137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6071108|NCT00722137|Immunologic Factors|immunologic factors|mesh-ancestor
6071109|NCT00722137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071110|NCT00722137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6071111|NCT00722137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6071112|NCT00722137|Alkylating Agents|alkylating agents|mesh-ancestor
6071113|NCT00722137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071114|NCT00722137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6071115|NCT00722137|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6071116|NCT00722137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6071117|NCT00722137|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6071118|NCT00722137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6071119|NCT00722137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6071120|NCT00722137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6071121|NCT00722137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6071122|NCT00722137|Glucocorticoids|glucocorticoids|mesh-ancestor
6071123|NCT00722137|Hormones|hormones|mesh-ancestor
6071124|NCT00722137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6071125|NCT00722137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6071126|NCT00722137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5509950|NCT04403100|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6071127|NCT00722137|Tubulin Modulators|tubulin modulators|mesh-ancestor
6071128|NCT00722137|Antimitotic Agents|antimitotic agents|mesh-ancestor
6071129|NCT00722137|Mitosis Modulators|mitosis modulators|mesh-ancestor
6071130|NCT00722371|Metformin|metformin|mesh-list
6071131|NCT00722371|Pioglitazone|pioglitazone|mesh-list
6071132|NCT00722371|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5509951|NCT04403100|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5509952|NCT04403100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5509953|NCT04403243|Colchicine|colchicine|mesh-list
5509954|NCT04403243|Gout Suppressants|gout suppressants|mesh-ancestor
5509955|NCT04403243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5509956|NCT04403243|Tubulin Modulators|tubulin modulators|mesh-ancestor
5509957|NCT04403243|Antimitotic Agents|antimitotic agents|mesh-ancestor
5509958|NCT04403243|Mitosis Modulators|mitosis modulators|mesh-ancestor
5509959|NCT04403243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5509960|NCT04403243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5509961|NCT04403165|Norepinephrine|norepinephrine|mesh-list
5509962|NCT04403165|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5509963|NCT04403165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6071133|NCT00722371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6071134|NCT00722371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071135|NCT00722371|Incretins|incretins|mesh-ancestor
6071136|NCT00722371|Hormones|hormones|mesh-ancestor
6071137|NCT00722371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6071138|NCT00722371|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6071139|NCT00722371|Protease Inhibitors|protease inhibitors|mesh-ancestor
6071140|NCT00722371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6071141|NCT00722371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5509964|NCT04403165|Adrenergic Agents|adrenergic agents|mesh-ancestor
5509965|NCT04403165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5509966|NCT04403165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5509967|NCT04403165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509968|NCT04403165|Sympathomimetics|sympathomimetics|mesh-ancestor
5509969|NCT04403165|Autonomic Agents|autonomic agents|mesh-ancestor
6071142|NCT00722436|Tranexamic Acid|tranexamic acid|mesh-list
6071143|NCT00722436|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6071144|NCT00722436|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6071145|NCT00722436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071146|NCT00722436|Hemostatics|hemostatics|mesh-ancestor
6071147|NCT00722436|Coagulants|coagulants|mesh-ancestor
6071148|NCT00722553|Vitamins|vitamins|mesh-list
6071149|NCT00722553|Folic Acid|folic acid|mesh-list
6071150|NCT00722553|Vitamin B 12|vitamin b 12|mesh-list
5509970|NCT04403165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5509971|NCT04403165|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5509972|NCT04403282|Eflornithine|eflornithine|mesh-list
5509973|NCT04403282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5509974|NCT04403282|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5509975|NCT04403282|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5509976|NCT04403282|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5509977|NCT04403282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5509978|NCT04403282|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
5509979|NCT04403282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5509980|NCT04403282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5509981|NCT04403191|Ondansetron|ondansetron|mesh-list
5509982|NCT04403191|Antiemetics|antiemetics|mesh-ancestor
5509983|NCT04403191|Autonomic Agents|autonomic agents|mesh-ancestor
5509984|NCT04403191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5509985|NCT04403191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5509986|NCT04403191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5509987|NCT04403191|Antipruritics|antipruritics|mesh-ancestor
5509988|NCT04403191|Dermatologic Agents|dermatologic agents|mesh-ancestor
5509989|NCT04403191|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5509990|NCT04403191|Serotonin Agents|serotonin agents|mesh-ancestor
5509991|NCT04403191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5509992|NCT04403191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071151|NCT00722553|Hydroxocobalamin|hydroxocobalamin|mesh-list
6071152|NCT00722553|Vitamin B Complex|vitamin b complex|mesh-list
6071153|NCT00722553|10-deazaaminopterin|10-deazaaminopterin|mesh-list
6071154|NCT00722553|Aminopterin|aminopterin|mesh-list
6071155|NCT00722553|Micronutrients|micronutrients|mesh-ancestor
6071156|NCT00722553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071157|NCT00722553|Hematinics|hematinics|mesh-ancestor
6071158|NCT00722553|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6071159|NCT00722553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6071160|NCT00722553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071161|NCT00722553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6071162|NCT00722566|Bortezomib|bortezomib|mesh-list
6071163|NCT00722566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6071164|NCT00722722|Bortezomib|bortezomib|mesh-list
6071165|NCT00722722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6071166|NCT00722761|Drospirenone|drospirenone|mesh-list
6071167|NCT00722761|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6071168|NCT00722761|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
6071169|NCT00722761|Estradiol|estradiol|mesh-list
6071170|NCT00722761|Estrogens|estrogens|mesh-ancestor
6071171|NCT00722761|Hormones|hormones|mesh-ancestor
6071172|NCT00722761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6071173|NCT00722761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071174|NCT00722761|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6071175|NCT00722761|Contraceptive Agents|contraceptive agents|mesh-ancestor
6071176|NCT00722761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6071177|NCT00722761|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6071178|NCT00722761|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6071179|NCT00722761|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6071180|NCT00722761|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6071181|NCT00722761|Hormone Antagonists|hormone antagonists|mesh-ancestor
6071182|NCT00722761|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6071183|NCT00722761|Diuretics|diuretics|mesh-ancestor
6071184|NCT00722761|Natriuretic Agents|natriuretic agents|mesh-ancestor
6071185|NCT00722800|Drospirenone|drospirenone|mesh-list
6071186|NCT00722800|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6071187|NCT00722800|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
6071188|NCT00722800|Estradiol|estradiol|mesh-list
6071189|NCT00722800|Estrogens|estrogens|mesh-ancestor
6071190|NCT00722800|Hormones|hormones|mesh-ancestor
6071191|NCT00722800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6071192|NCT00722800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071193|NCT00722800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6071194|NCT00722800|Contraceptive Agents|contraceptive agents|mesh-ancestor
6071195|NCT00722800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6071196|NCT00722800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6071197|NCT00722800|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6071198|NCT00722800|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6071199|NCT00722800|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6071200|NCT00722800|Hormone Antagonists|hormone antagonists|mesh-ancestor
6071201|NCT00722800|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6071202|NCT00722800|Diuretics|diuretics|mesh-ancestor
6071203|NCT00722800|Natriuretic Agents|natriuretic agents|mesh-ancestor
6071204|NCT00722865|Bevacizumab|bevacizumab|mesh-list
6071205|NCT00722865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6071206|NCT00722865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6071207|NCT00722865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6071208|NCT00722865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6071209|NCT00722865|Growth Substances|growth substances|mesh-ancestor
6071210|NCT00722865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071211|NCT00722865|Growth Inhibitors|growth inhibitors|mesh-ancestor
6071212|NCT00723021|Zileuton|zileuton|mesh-list
6071213|NCT00723021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6071214|NCT00723021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6071215|NCT00723021|Analgesics|analgesics|mesh-ancestor
6071216|NCT00723021|Sensory System Agents|sensory system agents|mesh-ancestor
6071217|NCT00723021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6071218|NCT00723021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071219|NCT00723021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5509993|NCT04403191|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5509994|NCT04403191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5509995|NCT04403191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5509996|NCT04403191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5509997|NCT04403191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6071220|NCT00723021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6071221|NCT00723021|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6071222|NCT00723021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6071223|NCT00723021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071224|NCT00723021|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6071225|NCT00723021|Hormone Antagonists|hormone antagonists|mesh-ancestor
6071226|NCT00723021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6071227|NCT00723099|Cyclosporine|cyclosporine|mesh-list
6071228|NCT00723099|Mycophenolic Acid|mycophenolic acid|mesh-list
6071229|NCT00723099|Cyclophosphamide|cyclophosphamide|mesh-list
6071230|NCT00723099|Fludarabine|fludarabine|mesh-list
6071231|NCT00723099|Fludarabine phosphate|fludarabine phosphate|mesh-list
6071232|NCT00723099|Cyclosporins|cyclosporins|mesh-list
6071233|NCT00723099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6071234|NCT00723099|Immunologic Factors|immunologic factors|mesh-ancestor
6071235|NCT00723099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071236|NCT00723099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6071237|NCT00723099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6071238|NCT00723099|Alkylating Agents|alkylating agents|mesh-ancestor
6071239|NCT00723099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071240|NCT00723099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6071241|NCT00723099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6071242|NCT00723099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6071243|NCT00723099|Antimetabolites|antimetabolites|mesh-ancestor
6071244|NCT00723099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6071245|NCT00723099|Antifungal Agents|antifungal agents|mesh-ancestor
6071246|NCT00723099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6071247|NCT00723099|Dermatologic Agents|dermatologic agents|mesh-ancestor
6071248|NCT00723099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6071249|NCT00723099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6071250|NCT00723099|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6071251|NCT00723099|Antitubercular Agents|antitubercular agents|mesh-ancestor
6071252|NCT00723099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6071253|NCT00723125|Paclitaxel|paclitaxel|mesh-list
6071254|NCT00723125|Bevacizumab|bevacizumab|mesh-list
6071255|NCT00723125|Carboplatin|carboplatin|mesh-list
6071256|NCT00723125|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6071257|NCT00723125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6071258|NCT00723125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6071259|NCT00723125|Tubulin Modulators|tubulin modulators|mesh-ancestor
6071260|NCT00723125|Antimitotic Agents|antimitotic agents|mesh-ancestor
6071261|NCT00723125|Mitosis Modulators|mitosis modulators|mesh-ancestor
6071262|NCT00723125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071263|NCT00723125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6071264|NCT00723125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6071265|NCT00723125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6071266|NCT00723125|Growth Substances|growth substances|mesh-ancestor
6071267|NCT00723125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071268|NCT00723125|Growth Inhibitors|growth inhibitors|mesh-ancestor
6071269|NCT00723177|Ibudilast|ibudilast|mesh-list
6071270|NCT00723177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6071271|NCT00723177|Autonomic Agents|autonomic agents|mesh-ancestor
6071272|NCT00723177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6071273|NCT00723177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071274|NCT00723177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6071275|NCT00723177|Respiratory System Agents|respiratory system agents|mesh-ancestor
6071276|NCT00723177|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6071277|NCT00723177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6071278|NCT00723177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071279|NCT00723177|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6071280|NCT00723177|Vasodilator Agents|vasodilator agents|mesh-ancestor
6071281|NCT00723190|Clonidine|clonidine|mesh-list
6071282|NCT00723190|Analgesics|analgesics|mesh-ancestor
6071283|NCT00723190|Sensory System Agents|sensory system agents|mesh-ancestor
6071284|NCT00723190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6071285|NCT00723190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071286|NCT00723190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6071287|NCT00723190|Sympatholytics|sympatholytics|mesh-ancestor
6071288|NCT00723190|Autonomic Agents|autonomic agents|mesh-ancestor
6071289|NCT00723190|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6071290|NCT00723190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6071291|NCT00723190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6071292|NCT00723190|Adrenergic Agents|adrenergic agents|mesh-ancestor
6071293|NCT00723190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6071294|NCT00723190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071295|NCT00723203|Panobinostat|panobinostat|mesh-list
6071296|NCT00723203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6071297|NCT00723203|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6071298|NCT00723203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6071299|NCT00723203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071300|NCT00723229|Acyclovir|acyclovir|mesh-list
6071301|NCT00723229|Antiviral Agents|antiviral agents|mesh-ancestor
6071302|NCT00723229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6071303|NCT00723255|Sirolimus|sirolimus|mesh-list
6071304|NCT00723255|Bevacizumab|bevacizumab|mesh-list
6071305|NCT00723255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6071306|NCT00723255|Antibodies|antibodies|mesh-list
6071307|NCT00723255|Immunoglobulins|immunoglobulins|mesh-list
6071308|NCT00723255|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6071309|NCT00723255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6071310|NCT00723255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6071311|NCT00723255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6071312|NCT00723255|Growth Substances|growth substances|mesh-ancestor
6071313|NCT00723255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071314|NCT00723255|Growth Inhibitors|growth inhibitors|mesh-ancestor
6071315|NCT00723255|Immunologic Factors|immunologic factors|mesh-ancestor
6071316|NCT00723255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5509998|NCT04403321|Cyclosporine|cyclosporine|mesh-list
6071317|NCT00723255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6071318|NCT00723255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6071319|NCT00723255|Antifungal Agents|antifungal agents|mesh-ancestor
5509999|NCT04403321|Tacrolimus|tacrolimus|mesh-list
5510000|NCT04403321|Cyclosporins|cyclosporins|mesh-list
5510001|NCT04403321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5510002|NCT04403321|Immunologic Factors|immunologic factors|mesh-ancestor
5510003|NCT04403321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510004|NCT04403321|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5510005|NCT04403321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5510006|NCT04403321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510007|NCT04403321|Antifungal Agents|antifungal agents|mesh-ancestor
5510008|NCT04403321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5510009|NCT04403321|Dermatologic Agents|dermatologic agents|mesh-ancestor
5510010|NCT04403321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5510011|NCT04402892|Lithium Carbonate|lithium carbonate|mesh-list
5510012|NCT04402892|Antidepressive Agents|antidepressive agents|mesh-ancestor
5510013|NCT04402892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5510014|NCT04402892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5510015|NCT04402892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510016|NCT04402892|Antimanic Agents|antimanic agents|mesh-ancestor
5510017|NCT04402892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5510018|NCT04402892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5510019|NCT04402892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510020|NCT04402762|Enoxaparin|enoxaparin|mesh-list
5510021|NCT04402762|Enoxaparin sodium|enoxaparin sodium|mesh-list
6071320|NCT00723255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6071321|NCT00723398|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
6071322|NCT00723398|Pitavastatin|pitavastatin|mesh-list
6071323|NCT00723398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6071324|NCT00723398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6071325|NCT00723398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6071326|NCT00723398|Antimetabolites|antimetabolites|mesh-ancestor
6071327|NCT00723398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071328|NCT00723398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6071329|NCT00723398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6071330|NCT00723398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6071331|NCT00723398|Hormone Antagonists|hormone antagonists|mesh-ancestor
6071332|NCT00723398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6071333|NCT00723398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071334|NCT00723398|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6071335|NCT00723398|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6071336|NCT00723398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6071337|NCT00723450|Lamotrigine|lamotrigine|mesh-list
6071338|NCT00723450|Anticonvulsants|anticonvulsants|mesh-ancestor
6071339|NCT00723450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6071340|NCT00723450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6071341|NCT00723450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071342|NCT00723450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6071343|NCT00723450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071344|NCT00723450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6071345|NCT00723450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5510022|NCT04402762|Anticoagulants|anticoagulants|mesh-ancestor
6071346|NCT00723450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6071347|NCT00723450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6071348|NCT00723450|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6071349|NCT00723528|Ustekinumab|ustekinumab|mesh-list
6071350|NCT00723528|Dermatologic Agents|dermatologic agents|mesh-ancestor
6071351|NCT00723554|Iloprost|iloprost|mesh-list
6071352|NCT00723554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6071353|NCT00723554|Vasodilator Agents|vasodilator agents|mesh-ancestor
6071354|NCT00723580|Risperidone|risperidone|mesh-list
6071355|NCT00723580|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6071356|NCT00723580|Serotonin Agents|serotonin agents|mesh-ancestor
6071357|NCT00723580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6071358|NCT00723580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071359|NCT00723580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071360|NCT00723580|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6071361|NCT00723580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6071362|NCT00723580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6071363|NCT00723580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6071364|NCT00723580|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6071365|NCT00723580|Dopamine Agents|dopamine agents|mesh-ancestor
6071366|NCT00723606|Haloperidol|haloperidol|mesh-list
6071367|NCT00723606|Haloperidol decanoate|haloperidol decanoate|mesh-list
6071368|NCT00723606|Ziprasidone|ziprasidone|mesh-list
6071369|NCT00723606|Antiemetics|antiemetics|mesh-ancestor
6071370|NCT00723606|Autonomic Agents|autonomic agents|mesh-ancestor
6071371|NCT00723606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6071372|NCT00723606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510023|NCT04402762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5510024|NCT04402762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5510025|NCT04402762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510026|NCT04402658|Albuterol|albuterol|mesh-list
5510027|NCT04402658|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5510028|NCT04402658|Autonomic Agents|autonomic agents|mesh-ancestor
5510029|NCT04402658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6071373|NCT00723606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6071374|NCT00723606|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6071375|NCT00723606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6071376|NCT00723606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6071377|NCT00723606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6071378|NCT00723606|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6071379|NCT00723606|Dopamine Agents|dopamine agents|mesh-ancestor
6071380|NCT00723606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6071381|NCT00723606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071382|NCT00723606|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6071383|NCT00723606|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6071384|NCT00723606|Serotonin Agents|serotonin agents|mesh-ancestor
6071385|NCT00723632|Ribavirin|ribavirin|mesh-list
6071386|NCT00723632|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6071387|NCT00723632|Antimetabolites|antimetabolites|mesh-ancestor
6071388|NCT00723632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510030|NCT04402658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510031|NCT04402658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5510032|NCT04402658|Respiratory System Agents|respiratory system agents|mesh-ancestor
5510033|NCT04402658|Tocolytic Agents|tocolytic agents|mesh-ancestor
5510034|NCT04402658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5510035|NCT04402658|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5510036|NCT04402658|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6071389|NCT00723632|Antiviral Agents|antiviral agents|mesh-ancestor
6071390|NCT00723632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6071391|NCT00723697|Buprenorphine|buprenorphine|mesh-list
6071392|NCT00723697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6071393|NCT00723697|Narcotics|narcotics|mesh-ancestor
6071394|NCT00723697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6071395|NCT00723697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071396|NCT00723697|Analgesics|analgesics|mesh-ancestor
6071397|NCT00723697|Sensory System Agents|sensory system agents|mesh-ancestor
6071398|NCT00723697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6071399|NCT00723697|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6071400|NCT00723710|Interferons|interferons|mesh-list
5510037|NCT04402658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5510038|NCT04402658|Adrenergic Agents|adrenergic agents|mesh-ancestor
5510039|NCT04402658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5510040|NCT04402658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071401|NCT00723710|Interferon-alpha|interferon-alpha|mesh-list
5510041|NCT04402580|Mycophenolic Acid|mycophenolic acid|mesh-list
6071402|NCT00723710|Interferon alpha-2|interferon alpha-2|mesh-list
6071403|NCT00723710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6071404|NCT00723710|Antiviral Agents|antiviral agents|mesh-ancestor
6071405|NCT00723710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6071406|NCT00723710|Immunologic Factors|immunologic factors|mesh-ancestor
6071407|NCT00723710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071408|NCT00723749|Buprenorphine|buprenorphine|mesh-list
6071409|NCT00723749|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6071410|NCT00723749|Naloxone|naloxone|mesh-list
5510042|NCT04402580|Rituximab|rituximab|mesh-list
5510043|NCT04402580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5510044|NCT04402580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5510045|NCT04402580|Immunologic Factors|immunologic factors|mesh-ancestor
5510046|NCT04402580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510047|NCT04402580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5510048|NCT04402580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6071411|NCT00723749|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6071412|NCT00723749|Narcotics|narcotics|mesh-ancestor
6071413|NCT00723749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6071414|NCT00723749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071415|NCT00723749|Analgesics|analgesics|mesh-ancestor
6071416|NCT00723749|Sensory System Agents|sensory system agents|mesh-ancestor
6071417|NCT00723749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6071418|NCT00723749|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6071419|NCT00723801|Losartan|losartan|mesh-list
6071420|NCT00723801|Atenolol|atenolol|mesh-list
6071421|NCT00723801|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6071422|NCT00723801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6071423|NCT00723801|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6071424|NCT00723801|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6071425|NCT00723801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071426|NCT00723801|Sympatholytics|sympatholytics|mesh-ancestor
6071427|NCT00723801|Autonomic Agents|autonomic agents|mesh-ancestor
6071428|NCT00723801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6071429|NCT00723801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071430|NCT00723801|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6071431|NCT00723801|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6071432|NCT00723801|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6071433|NCT00723801|Adrenergic Agents|adrenergic agents|mesh-ancestor
6071434|NCT00723801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6071435|NCT00723827|Temozolomide|temozolomide|mesh-list
6071436|NCT00723827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5510049|NCT04402580|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5510050|NCT04402580|Antitubercular Agents|antitubercular agents|mesh-ancestor
5510051|NCT04402580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5510052|NCT04402580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5510053|NCT04402580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5510054|NCT04402580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071437|NCT00723827|Alkylating Agents|alkylating agents|mesh-ancestor
6071438|NCT00723827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071439|NCT00723827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6071440|NCT00723892|Ribavirin|ribavirin|mesh-list
6071441|NCT00723892|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6071442|NCT00723892|Interferon-alpha|interferon-alpha|mesh-list
6071443|NCT00723892|Antimetabolites|antimetabolites|mesh-ancestor
6071444|NCT00723892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071445|NCT00723892|Antiviral Agents|antiviral agents|mesh-ancestor
6071446|NCT00723892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6071447|NCT00723892|Immunologic Factors|immunologic factors|mesh-ancestor
6071448|NCT00723892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071449|NCT00723931|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6071450|NCT00723931|Antiviral Agents|antiviral agents|mesh-ancestor
6071451|NCT00723931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6071452|NCT00723944|Ethanol|ethanol|mesh-list
6071453|NCT00723944|Povidone-Iodine|povidone-iodine|mesh-list
6071454|NCT00723944|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6071455|NCT00723944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5510055|NCT04402671|Glutaral|glutaral|mesh-list
5510056|NCT04402671|Disinfectants|disinfectants|mesh-ancestor
5510057|NCT04402671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5510058|NCT04402723|Cytarabine|cytarabine|mesh-list
5510059|NCT04402723|Daunorubicin|daunorubicin|mesh-list
5510060|NCT04402723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5510061|NCT04402723|Antimetabolites|antimetabolites|mesh-ancestor
5510062|NCT04402723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510063|NCT04402723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6202633|NCT02044094|Naloxone|naloxone|mesh-list
6071456|NCT00723944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6071457|NCT00723944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071458|NCT00723957|Paclitaxel|paclitaxel|mesh-list
6071459|NCT00723957|Carboplatin|carboplatin|mesh-list
6071460|NCT00723957|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6071461|NCT00723957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5510064|NCT04402723|Antiviral Agents|antiviral agents|mesh-ancestor
5510065|NCT04402723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5510066|NCT04402723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5510067|NCT04402723|Immunologic Factors|immunologic factors|mesh-ancestor
5510068|NCT04402723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510069|NCT04402723|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5510070|NCT04402723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5510071|NCT04402723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5510072|NCT04402723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5510073|NCT04402320|Midazolam|midazolam|mesh-list
5510074|NCT04402320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5510075|NCT04402320|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5510076|NCT04402320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5510077|NCT04402320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510078|NCT04402320|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5510079|NCT04402320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5510080|NCT04402320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5510081|NCT04402320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5510082|NCT04402320|Anesthetics, General|anesthetics, general|mesh-ancestor
5510083|NCT04402320|Anesthetics|anesthetics|mesh-ancestor
5510084|NCT04402320|GABA Modulators|gaba modulators|mesh-ancestor
5510085|NCT04402320|GABA Agents|gaba agents|mesh-ancestor
5510086|NCT04402320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5510087|NCT04402320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510088|NCT04402359|Meropenem|meropenem|mesh-list
5510089|NCT04402359|Ceftazidime|ceftazidime|mesh-list
5510090|NCT04402359|Avibactam|avibactam|mesh-list
5510091|NCT04402359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5510092|NCT04402359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5510093|NCT04402359|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5510094|NCT04402359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5510095|NCT04402359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510096|NCT04402411|Analgesics, Opioid|analgesics, opioid|mesh-list
5510097|NCT04402411|Narcotics|narcotics|mesh-ancestor
5510098|NCT04402411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5510099|NCT04402411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510100|NCT04402411|Analgesics|analgesics|mesh-ancestor
5510101|NCT04402411|Sensory System Agents|sensory system agents|mesh-ancestor
5510102|NCT04402411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5510103|NCT04402346|Pancrelipase|pancrelipase|mesh-list
5510104|NCT04402346|Pancreatin|pancreatin|mesh-list
5510105|NCT04402346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5510106|NCT04402203|Favipiravir|favipiravir|mesh-list
5510107|NCT04402203|Antiviral Agents|antiviral agents|mesh-ancestor
5510108|NCT04402203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5510109|NCT04402047|Diclofenac|diclofenac|mesh-list
5510110|NCT04402047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5510111|NCT04402047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5510112|NCT04402047|Analgesics|analgesics|mesh-ancestor
5510113|NCT04402047|Sensory System Agents|sensory system agents|mesh-ancestor
5510114|NCT04402047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5510115|NCT04402047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071462|NCT00723957|Tubulin Modulators|tubulin modulators|mesh-ancestor
5510116|NCT04402047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5510117|NCT04402047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5510118|NCT04402047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5510119|NCT04402047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6071463|NCT00723957|Antimitotic Agents|antimitotic agents|mesh-ancestor
6071464|NCT00723957|Mitosis Modulators|mitosis modulators|mesh-ancestor
6071465|NCT00723957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202634|NCT02044094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6202635|NCT02044094|Narcotics|narcotics|mesh-ancestor
6202636|NCT02044094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6202637|NCT02044094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202638|NCT02044094|Analgesics|analgesics|mesh-ancestor
6202639|NCT02044094|Sensory System Agents|sensory system agents|mesh-ancestor
6202640|NCT02044094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6202641|NCT02044094|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5510120|NCT04402047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510121|NCT04402112|Pitavastatin|pitavastatin|mesh-list
6202642|NCT02044159|Hydrocortisone|hydrocortisone|mesh-list
6071466|NCT00724009|Clofarabine|clofarabine|mesh-list
6071467|NCT00724009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6071468|NCT00724009|Antimetabolites|antimetabolites|mesh-ancestor
6071469|NCT00724009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071470|NCT00724009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6071471|NCT00724061|Interferons|interferons|mesh-list
5510122|NCT04402112|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5510123|NCT04402112|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5510124|NCT04402112|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5510125|NCT04402112|Antimetabolites|antimetabolites|mesh-ancestor
5510126|NCT04402112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510127|NCT04402112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5510128|NCT04402112|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5510129|NCT04402138|Acalabrutinib|acalabrutinib|mesh-list
5510130|NCT04402138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5510131|NCT04401878|Lidocaine|lidocaine|mesh-list
5510132|NCT04401878|Anesthetics, Local|anesthetics, local|mesh-ancestor
5510133|NCT04401878|Anesthetics|anesthetics|mesh-ancestor
5510134|NCT04401878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5510135|NCT04401878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510136|NCT04401878|Sensory System Agents|sensory system agents|mesh-ancestor
6071472|NCT00724061|Interferon-alpha|interferon-alpha|mesh-list
6071473|NCT00724061|Interferon alpha-2|interferon alpha-2|mesh-list
6071474|NCT00724061|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6071475|NCT00724061|Furocoumarins|furocoumarins|mesh-list
6071476|NCT00724061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6071477|NCT00724061|Antiviral Agents|antiviral agents|mesh-ancestor
6071478|NCT00724061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6071479|NCT00724061|Immunologic Factors|immunologic factors|mesh-ancestor
6071480|NCT00724061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071481|NCT00724061|Dermatologic Agents|dermatologic agents|mesh-ancestor
6071482|NCT00724061|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6071483|NCT00724126|Rifaximin|rifaximin|mesh-list
6071484|NCT00724126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6071485|NCT00724126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6071486|NCT00724126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6071487|NCT00724243|Infliximab|infliximab|mesh-list
6071488|NCT00724243|Dermatologic Agents|dermatologic agents|mesh-ancestor
6071489|NCT00724243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6071490|NCT00724243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6071491|NCT00724373|Ribavirin|ribavirin|mesh-list
6071492|NCT00724373|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6071493|NCT00724373|Antimetabolites|antimetabolites|mesh-ancestor
6071494|NCT00724373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071495|NCT00724373|Antiviral Agents|antiviral agents|mesh-ancestor
6071496|NCT00724373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6071497|NCT00724451|Ribavirin|ribavirin|mesh-list
6071498|NCT00724451|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6071499|NCT00724451|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6071500|NCT00724451|Antimetabolites|antimetabolites|mesh-ancestor
6071501|NCT00724451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071502|NCT00724451|Antiviral Agents|antiviral agents|mesh-ancestor
6071503|NCT00724451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5510137|NCT04401878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5510138|NCT04401878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5510139|NCT04401878|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5510140|NCT04401878|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5510141|NCT04401878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5510142|NCT04401878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510143|NCT04401982|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6071504|NCT00724464|Interferons|interferons|mesh-list
6071505|NCT00724464|Ribavirin|ribavirin|mesh-list
6071506|NCT00724464|Interferon-alpha|interferon-alpha|mesh-list
6071507|NCT00724464|Interferon alpha-2|interferon alpha-2|mesh-list
6071508|NCT00724464|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6071509|NCT00724464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6071510|NCT00724464|Antiviral Agents|antiviral agents|mesh-ancestor
6071511|NCT00724464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6071512|NCT00724464|Antimetabolites|antimetabolites|mesh-ancestor
6071513|NCT00724464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071514|NCT00724464|Immunologic Factors|immunologic factors|mesh-ancestor
6071515|NCT00724464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071516|NCT00724568|Dexamethasone|dexamethasone|mesh-list
6071517|NCT00724568|Lenalidomide|lenalidomide|mesh-list
6071518|NCT00724568|Bortezomib|bortezomib|mesh-list
6071519|NCT00724568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6071520|NCT00724568|Antiemetics|antiemetics|mesh-ancestor
6071521|NCT00724568|Autonomic Agents|autonomic agents|mesh-ancestor
6071522|NCT00724568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6071523|NCT00724568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071524|NCT00724568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6071525|NCT00724568|Glucocorticoids|glucocorticoids|mesh-ancestor
6071526|NCT00724568|Hormones|hormones|mesh-ancestor
6071527|NCT00724568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6071528|NCT00724568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6071529|NCT00724568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6071530|NCT00724568|Immunologic Factors|immunologic factors|mesh-ancestor
6071531|NCT00724568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6071532|NCT00724568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6071533|NCT00724568|Growth Substances|growth substances|mesh-ancestor
6071534|NCT00724568|Growth Inhibitors|growth inhibitors|mesh-ancestor
6071535|NCT00724594|Acetylcysteine|acetylcysteine|mesh-list
5510144|NCT04401982|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5510145|NCT04402073|Vincristine|vincristine|mesh-list
5510146|NCT04402073|Lomustine|lomustine|mesh-list
5510147|NCT04402073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6071536|NCT00724594|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6071537|NCT00724594|Antiviral Agents|antiviral agents|mesh-ancestor
6071538|NCT00724594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6071539|NCT00724594|Expectorants|expectorants|mesh-ancestor
6071540|NCT00724594|Respiratory System Agents|respiratory system agents|mesh-ancestor
6071541|NCT00724594|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6071542|NCT00724594|Antioxidants|antioxidants|mesh-ancestor
6071543|NCT00724594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071544|NCT00724594|Protective Agents|protective agents|mesh-ancestor
6071545|NCT00724594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071546|NCT00724594|Antidotes|antidotes|mesh-ancestor
6071547|NCT00724711|Tenofovir|tenofovir|mesh-list
6071548|NCT00724711|Lamivudine|lamivudine|mesh-list
6071549|NCT00724711|Emtricitabine|emtricitabine|mesh-list
6071550|NCT00724711|Abacavir|abacavir|mesh-list
6071551|NCT00724711|Antiviral Agents|antiviral agents|mesh-ancestor
6071552|NCT00724711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6071553|NCT00724711|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6071554|NCT00724711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6071555|NCT00724711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6071556|NCT00724711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071557|NCT00724711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6071558|NCT00724711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6071559|NCT00724815|Sumatriptan|sumatriptan|mesh-list
6071560|NCT00724815|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6071561|NCT00724815|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5510148|NCT04402073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6071562|NCT00724815|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6071563|NCT00724815|Serotonin Agents|serotonin agents|mesh-ancestor
6071564|NCT00724815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6071565|NCT00724815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071566|NCT00724815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510149|NCT04402073|Tubulin Modulators|tubulin modulators|mesh-ancestor
5510150|NCT04402073|Antimitotic Agents|antimitotic agents|mesh-ancestor
5510151|NCT04402073|Mitosis Modulators|mitosis modulators|mesh-ancestor
5510152|NCT04402073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510153|NCT04402073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5510154|NCT04402073|Alkylating Agents|alkylating agents|mesh-ancestor
5510155|NCT04401852|Magnesium Sulfate|magnesium sulfate|mesh-list
6071567|NCT00724854|Ribavirin|ribavirin|mesh-list
6071568|NCT00724854|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6071569|NCT00724854|Interferon-alpha|interferon-alpha|mesh-list
6071570|NCT00724854|Antimetabolites|antimetabolites|mesh-ancestor
6071571|NCT00724854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071572|NCT00724854|Antiviral Agents|antiviral agents|mesh-ancestor
6071573|NCT00724854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6071574|NCT00724854|Immunologic Factors|immunologic factors|mesh-ancestor
5510156|NCT04401852|Analgesics|analgesics|mesh-ancestor
5510157|NCT04401852|Sensory System Agents|sensory system agents|mesh-ancestor
5510158|NCT04401852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5510159|NCT04401852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510160|NCT04401852|Anesthetics|anesthetics|mesh-ancestor
5510161|NCT04401852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5510162|NCT04401852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5510163|NCT04401852|Anticonvulsants|anticonvulsants|mesh-ancestor
5510164|NCT04401852|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6071575|NCT00724854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071576|NCT00724867|Belimumab|belimumab|mesh-list
6071577|NCT00724867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6071578|NCT00724867|Immunologic Factors|immunologic factors|mesh-ancestor
6071579|NCT00724867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071580|NCT00724893|Interferons|interferons|mesh-list
6071581|NCT00724893|Ribavirin|ribavirin|mesh-list
6071582|NCT00724893|Interferon-alpha|interferon-alpha|mesh-list
6071583|NCT00724893|Interferon alpha-2|interferon alpha-2|mesh-list
6071584|NCT00724893|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6071585|NCT00724893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6071586|NCT00724893|Antiviral Agents|antiviral agents|mesh-ancestor
6071587|NCT00724893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6071588|NCT00724893|Antimetabolites|antimetabolites|mesh-ancestor
6071589|NCT00724893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463472|NCT00464763|Adrenergic Agents|adrenergic agents|mesh-ancestor
6463473|NCT00464763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6463474|NCT00464763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510165|NCT04401852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5510166|NCT04401852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510167|NCT04401852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5510168|NCT04401852|Tocolytic Agents|tocolytic agents|mesh-ancestor
5510169|NCT04401852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5510170|NCT04401839|Oxytocin|oxytocin|mesh-list
5510171|NCT04401839|Oxytocics|oxytocics|mesh-ancestor
5510172|NCT04401839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5510173|NCT04401839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510174|NCT04401709|Gemcitabine|gemcitabine|mesh-list
5510175|NCT04401709|Capecitabine|capecitabine|mesh-list
5510176|NCT04401709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5510177|NCT04401709|Antimetabolites|antimetabolites|mesh-ancestor
6463475|NCT00464789|Bazedoxifene|bazedoxifene|mesh-list
6463476|NCT00464789|Estrogens|estrogens|mesh-list
6463477|NCT00464789|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6463478|NCT00464789|Hormones|hormones|mesh-ancestor
6463479|NCT00464789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6071590|NCT00724893|Immunologic Factors|immunologic factors|mesh-ancestor
5510178|NCT04401709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510179|NCT04401709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6071591|NCT00724893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071592|NCT00724932|Atropine|atropine|mesh-list
6071593|NCT00724932|Bromides|bromides|mesh-list
6071594|NCT00724932|Rocuronium|rocuronium|mesh-list
6071595|NCT00724932|Neostigmine|neostigmine|mesh-list
6071596|NCT00724932|Anticonvulsants|anticonvulsants|mesh-ancestor
6071597|NCT00724932|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6071598|NCT00724932|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6071599|NCT00724932|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6071600|NCT00724932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6071601|NCT00724932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071602|NCT00724932|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6071603|NCT00724932|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5510180|NCT04401709|Antiviral Agents|antiviral agents|mesh-ancestor
5510181|NCT04401709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5510182|NCT04401709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5510183|NCT04401709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5510184|NCT04401709|Immunologic Factors|immunologic factors|mesh-ancestor
5510185|NCT04401709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510186|NCT04401774|Nivolumab|nivolumab|mesh-list
5510187|NCT04401774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5510188|NCT04401774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5510189|NCT04401774|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5510190|NCT04401774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510191|NCT04401488|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5510192|NCT04401488|Immunologic Factors|immunologic factors|mesh-ancestor
5510193|NCT04401488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510194|NCT04401657|Adenosine|adenosine|mesh-list
5510195|NCT04401657|Analgesics|analgesics|mesh-ancestor
5510196|NCT04401657|Sensory System Agents|sensory system agents|mesh-ancestor
5510197|NCT04401657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5510198|NCT04401657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510199|NCT04401657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5510200|NCT04401657|Vasodilator Agents|vasodilator agents|mesh-ancestor
5510201|NCT04401657|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5510202|NCT04401657|Purinergic Agonists|purinergic agonists|mesh-ancestor
6071604|NCT00724932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6071605|NCT00724932|Autonomic Agents|autonomic agents|mesh-ancestor
6071606|NCT00724932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6071607|NCT00724932|Respiratory System Agents|respiratory system agents|mesh-ancestor
6071608|NCT00724932|Mydriatics|mydriatics|mesh-ancestor
6071609|NCT00724932|Parasympatholytics|parasympatholytics|mesh-ancestor
6071610|NCT00724932|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5510203|NCT04401657|Purinergic Agents|purinergic agents|mesh-ancestor
5510204|NCT04401657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5510205|NCT04401657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510206|NCT04401137|Topiramate|topiramate|mesh-list
5510207|NCT04401137|Anticonvulsants|anticonvulsants|mesh-ancestor
5510208|NCT04401137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5510209|NCT04401137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510210|NCT04401176|Lidocaine|lidocaine|mesh-list
5510211|NCT04401176|Heparin|heparin|mesh-list
5510212|NCT04401176|Anesthetics, Local|anesthetics, local|mesh-ancestor
5510213|NCT04401176|Anesthetics|anesthetics|mesh-ancestor
5510214|NCT04401176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5510215|NCT04401176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510216|NCT04401176|Sensory System Agents|sensory system agents|mesh-ancestor
5510217|NCT04401176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5510218|NCT04401176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5510219|NCT04401176|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5510220|NCT04401176|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5510221|NCT04401176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5510222|NCT04401176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510223|NCT04401176|Anticoagulants|anticoagulants|mesh-ancestor
6071611|NCT00724932|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6071612|NCT00724932|Cholinergic Agents|cholinergic agents|mesh-ancestor
6071613|NCT00724932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6071614|NCT00724932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071615|NCT00724932|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6071616|NCT00724932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6071617|NCT00724932|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6071618|NCT00724958|Infliximab|infliximab|mesh-list
6071619|NCT00724958|Dermatologic Agents|dermatologic agents|mesh-ancestor
5510224|NCT04401176|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5510225|NCT04401176|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5510226|NCT04401345|Glycopyrrolate|glycopyrrolate|mesh-list
5510227|NCT04401345|Bromides|bromides|mesh-list
5510228|NCT04401345|Anticonvulsants|anticonvulsants|mesh-ancestor
5510229|NCT04401345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5510230|NCT04401345|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5510231|NCT04401345|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5510232|NCT04401345|Cholinergic Agents|cholinergic agents|mesh-ancestor
6071620|NCT00724958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6071621|NCT00724958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6071622|NCT00724971|Rituximab|rituximab|mesh-list
5510233|NCT04401345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6071623|NCT00724971|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
6071624|NCT00724971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6071625|NCT00724971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6071626|NCT00724971|Immunologic Factors|immunologic factors|mesh-ancestor
6071627|NCT00724971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071628|NCT00724971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6071629|NCT00724971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6071630|NCT00724984|Abexinostat|abexinostat|mesh-list
6071631|NCT00724984|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6071632|NCT00724984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6071633|NCT00724984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071634|NCT00725010|Temozolomide|temozolomide|mesh-list
6071635|NCT00725010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6071636|NCT00725010|Alkylating Agents|alkylating agents|mesh-ancestor
6071637|NCT00725010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071638|NCT00725010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6071639|NCT00725205|Ribavirin|ribavirin|mesh-list
6071640|NCT00725205|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6071641|NCT00725205|Interferon-alpha|interferon-alpha|mesh-list
6463480|NCT00464789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463481|NCT00464789|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6463482|NCT00464789|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6463483|NCT00464789|Hormone Antagonists|hormone antagonists|mesh-ancestor
6071642|NCT00725205|Antimetabolites|antimetabolites|mesh-ancestor
6071643|NCT00725205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071644|NCT00725205|Antiviral Agents|antiviral agents|mesh-ancestor
6071645|NCT00725205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5510234|NCT04401345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510235|NCT04401345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510236|NCT04401085|Antibodies|antibodies|mesh-list
5510237|NCT04401085|Immunologic Factors|immunologic factors|mesh-ancestor
5510238|NCT04401085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510239|NCT04401423|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
5510240|NCT04401423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5510241|NCT04401423|Vasodilator Agents|vasodilator agents|mesh-ancestor
5600337|NCT03712540|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6071646|NCT00725205|Immunologic Factors|immunologic factors|mesh-ancestor
6071647|NCT00725205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071648|NCT00725270|Mifepristone|mifepristone|mesh-list
6071649|NCT00725270|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6071650|NCT00725270|Abortifacient Agents|abortifacient agents|mesh-ancestor
6071651|NCT00725270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6071652|NCT00725270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071653|NCT00725270|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6071654|NCT00725270|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6071655|NCT00725270|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6071656|NCT00725270|Contraceptive Agents|contraceptive agents|mesh-ancestor
6071657|NCT00725270|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6071658|NCT00725270|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6071659|NCT00725270|Hormone Antagonists|hormone antagonists|mesh-ancestor
6071660|NCT00725270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6071661|NCT00725270|Luteolytic Agents|luteolytic agents|mesh-ancestor
6071662|NCT00725270|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6071663|NCT00725270|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6071664|NCT00725296|Infliximab|infliximab|mesh-list
6071665|NCT00725296|Dermatologic Agents|dermatologic agents|mesh-ancestor
6071666|NCT00725296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6071667|NCT00725296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6071668|NCT00725322|Botulinum Toxins|botulinum toxins|mesh-list
6071669|NCT00725322|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6071670|NCT00725322|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5600338|NCT03712540|Antitubercular Agents|antitubercular agents|mesh-ancestor
5600339|NCT03712540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5600340|NCT03712540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5600341|NCT03712540|Leprostatic Agents|leprostatic agents|mesh-ancestor
6071671|NCT00725322|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6071672|NCT00725322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6071673|NCT00725322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071674|NCT00725322|Cholinergic Agents|cholinergic agents|mesh-ancestor
6071675|NCT00725322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6071676|NCT00725322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071677|NCT00725322|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5510242|NCT04401007|Lidocaine|lidocaine|mesh-list
5510243|NCT04401007|Anesthetics, Local|anesthetics, local|mesh-ancestor
5510244|NCT04401007|Anesthetics|anesthetics|mesh-ancestor
5510245|NCT04401007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5510246|NCT04401007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510247|NCT04401007|Sensory System Agents|sensory system agents|mesh-ancestor
5510248|NCT04401007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5510249|NCT04401007|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5510250|NCT04401007|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5510251|NCT04401007|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5510252|NCT04401007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5510253|NCT04401007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510254|NCT04400747|Vitamin D|vitamin d|mesh-list
5510255|NCT04400747|Cholecalciferol|cholecalciferol|mesh-list
5510256|NCT04400747|Vitamins|vitamins|mesh-ancestor
5510257|NCT04400747|Micronutrients|micronutrients|mesh-ancestor
5510258|NCT04400747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510259|NCT04400747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5510260|NCT04400747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5510261|NCT04400721|Ropivacaine|ropivacaine|mesh-list
6071678|NCT00725322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6071679|NCT00725361|Ambrisentan|ambrisentan|mesh-list
6071680|NCT00725361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6071681|NCT00725452|Infliximab|infliximab|mesh-list
6071682|NCT00725452|Dermatologic Agents|dermatologic agents|mesh-ancestor
6071683|NCT00725452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6071684|NCT00725452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6071685|NCT00725504|Lidocaine|lidocaine|mesh-list
6071686|NCT00725504|Anesthetics, Local|anesthetics, local|mesh-ancestor
6071687|NCT00725504|Anesthetics|anesthetics|mesh-ancestor
6071688|NCT00725504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6071689|NCT00725504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071690|NCT00725504|Sensory System Agents|sensory system agents|mesh-ancestor
6071691|NCT00725504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6071692|NCT00725504|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6071693|NCT00725504|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6071694|NCT00725504|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6071695|NCT00725504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6071696|NCT00725504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071697|NCT00725543|Infliximab|infliximab|mesh-list
6071698|NCT00725543|Dermatologic Agents|dermatologic agents|mesh-ancestor
6071699|NCT00725543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6071700|NCT00725543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6071701|NCT00725608|Buprenorphine|buprenorphine|mesh-list
6071702|NCT00725608|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6071703|NCT00725608|Naloxone|naloxone|mesh-list
6071704|NCT00725608|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6071705|NCT00725608|Narcotics|narcotics|mesh-ancestor
6071706|NCT00725608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6071707|NCT00725608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071708|NCT00725608|Analgesics|analgesics|mesh-ancestor
6071709|NCT00725608|Sensory System Agents|sensory system agents|mesh-ancestor
6071710|NCT00725608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6071711|NCT00725608|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6071712|NCT00725621|Infliximab|infliximab|mesh-list
6071713|NCT00725621|Dermatologic Agents|dermatologic agents|mesh-ancestor
6071714|NCT00725621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6071715|NCT00725621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6071716|NCT00725751|Interferons|interferons|mesh-list
6071717|NCT00725751|Ribavirin|ribavirin|mesh-list
6071718|NCT00725751|Interferon-alpha|interferon-alpha|mesh-list
6071719|NCT00725751|Interferon alpha-2|interferon alpha-2|mesh-list
6071720|NCT00725751|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6071721|NCT00725751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6071722|NCT00725751|Antiviral Agents|antiviral agents|mesh-ancestor
6071723|NCT00725751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6071724|NCT00725751|Antimetabolites|antimetabolites|mesh-ancestor
6071725|NCT00725751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071726|NCT00725751|Immunologic Factors|immunologic factors|mesh-ancestor
6071727|NCT00725751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071728|NCT00725842|Ribavirin|ribavirin|mesh-list
6071729|NCT00725842|Interferon alpha-2|interferon alpha-2|mesh-list
6071730|NCT00725842|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6071731|NCT00725842|Antimetabolites|antimetabolites|mesh-ancestor
6071732|NCT00725842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071733|NCT00725842|Antiviral Agents|antiviral agents|mesh-ancestor
6071734|NCT00725842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6071735|NCT00725842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6071736|NCT00725920|Topiramate|topiramate|mesh-list
6071737|NCT00725920|Anticonvulsants|anticonvulsants|mesh-ancestor
6071738|NCT00725920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6071739|NCT00725920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071740|NCT00726375|Etanercept|etanercept|mesh-list
6071741|NCT00726375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6071742|NCT00726375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6071743|NCT00726375|Analgesics|analgesics|mesh-ancestor
6071744|NCT00726375|Sensory System Agents|sensory system agents|mesh-ancestor
6071745|NCT00726375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6071746|NCT00726375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071747|NCT00726375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6071748|NCT00726375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6071749|NCT00726375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6071750|NCT00726375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6071751|NCT00726375|Immunologic Factors|immunologic factors|mesh-ancestor
6071752|NCT00726388|Diclofenac|diclofenac|mesh-list
6071753|NCT00726388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6071754|NCT00726388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6071755|NCT00726388|Analgesics|analgesics|mesh-ancestor
6071756|NCT00726388|Sensory System Agents|sensory system agents|mesh-ancestor
6071757|NCT00726388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6071758|NCT00726388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071759|NCT00726388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6071760|NCT00726388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6071761|NCT00726388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6071762|NCT00726388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6071763|NCT00726388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071764|NCT00726414|Quinine|quinine|mesh-list
6071765|NCT00726414|Antimalarials|antimalarials|mesh-ancestor
6071766|NCT00726414|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6071767|NCT00726414|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6071768|NCT00726414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6071769|NCT00726414|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6071770|NCT00726414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510262|NCT04400721|Anesthetics, Local|anesthetics, local|mesh-ancestor
5510263|NCT04400721|Anesthetics|anesthetics|mesh-ancestor
5510264|NCT04400721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5510265|NCT04400721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510266|NCT04400721|Sensory System Agents|sensory system agents|mesh-ancestor
5510267|NCT04400721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5510268|NCT04400994|Rituximab|rituximab|mesh-list
5510269|NCT04400994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5510270|NCT04400994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5510271|NCT04400994|Immunologic Factors|immunologic factors|mesh-ancestor
5510272|NCT04400994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510273|NCT04400994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5510274|NCT04400916|Tranexamic Acid|tranexamic acid|mesh-list
5510275|NCT04400916|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6071771|NCT00726414|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6071772|NCT00726414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6071773|NCT00726414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6071774|NCT00726414|Analgesics|analgesics|mesh-ancestor
6071775|NCT00726414|Sensory System Agents|sensory system agents|mesh-ancestor
6071776|NCT00726557|Interferons|interferons|mesh-list
6071777|NCT00726557|Ribavirin|ribavirin|mesh-list
6071778|NCT00726557|Interferon-alpha|interferon-alpha|mesh-list
5510276|NCT04400916|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6071779|NCT00726557|Interferon alpha-2|interferon alpha-2|mesh-list
6071780|NCT00726557|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6071781|NCT00726557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6071782|NCT00726557|Antiviral Agents|antiviral agents|mesh-ancestor
6071783|NCT00726557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6071784|NCT00726557|Antimetabolites|antimetabolites|mesh-ancestor
6071785|NCT00726557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071786|NCT00726557|Immunologic Factors|immunologic factors|mesh-ancestor
6071787|NCT00726557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071788|NCT00726609|Posaconazole|posaconazole|mesh-list
6071789|NCT00726609|Antifungal Agents|antifungal agents|mesh-ancestor
6071790|NCT00726609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6071791|NCT00726609|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6071792|NCT00726609|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6071793|NCT00726609|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6071794|NCT00726609|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6071795|NCT00726609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6071796|NCT00726609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6071797|NCT00726609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071798|NCT00726609|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6071799|NCT00726609|Hormone Antagonists|hormone antagonists|mesh-ancestor
6071800|NCT00726609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5510277|NCT04400916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510278|NCT04400916|Hemostatics|hemostatics|mesh-ancestor
5510279|NCT04400916|Coagulants|coagulants|mesh-ancestor
5510280|NCT04400929|Molgramostim|molgramostim|mesh-list
5510281|NCT04400929|Sargramostim|sargramostim|mesh-list
5510282|NCT04400929|Immunologic Factors|immunologic factors|mesh-ancestor
5510283|NCT04400929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510284|NCT04400929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5510285|NCT04400890|Vitamin D|vitamin d|mesh-list
5510286|NCT04400890|Cholecalciferol|cholecalciferol|mesh-list
5510287|NCT04400890|Resveratrol|resveratrol|mesh-list
5510288|NCT04400890|Vitamins|vitamins|mesh-ancestor
5510289|NCT04400890|Micronutrients|micronutrients|mesh-ancestor
5510290|NCT04400890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510291|NCT04400890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5510292|NCT04400890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5510293|NCT04400890|Antioxidants|antioxidants|mesh-ancestor
5510294|NCT04400890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071801|NCT00726609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071802|NCT00726713|Vitamin B 12|vitamin b 12|mesh-list
6071803|NCT00726713|Vitamin B Complex|vitamin b complex|mesh-ancestor
6071804|NCT00726713|Vitamins|vitamins|mesh-ancestor
6071805|NCT00726713|Micronutrients|micronutrients|mesh-ancestor
6071806|NCT00726713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071807|NCT00726739|Aldesleukin|aldesleukin|mesh-list
6071808|NCT00726739|Interleukin-2|interleukin-2|mesh-list
6071809|NCT00726739|Vaccines|vaccines|mesh-list
6071810|NCT00726739|Immunologic Factors|immunologic factors|mesh-ancestor
6071811|NCT00726739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071812|NCT00726739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6071813|NCT00726739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6071814|NCT00726739|Analgesics|analgesics|mesh-ancestor
6071815|NCT00726739|Sensory System Agents|sensory system agents|mesh-ancestor
6071816|NCT00726739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6071817|NCT00726739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6071818|NCT00726739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6071819|NCT00726739|Antiviral Agents|antiviral agents|mesh-ancestor
6071820|NCT00726739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6071821|NCT00726752|Axitinib|axitinib|mesh-list
6071822|NCT00726752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6071823|NCT00726752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6071824|NCT00726752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6071825|NCT00726752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071826|NCT00726895|Quinine|quinine|mesh-list
6071827|NCT00726895|Antimalarials|antimalarials|mesh-ancestor
6071828|NCT00726895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6071829|NCT00726895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6071830|NCT00726895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6071831|NCT00726895|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6071832|NCT00726895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071833|NCT00726895|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6071834|NCT00726895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6071835|NCT00726895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6071836|NCT00726895|Analgesics|analgesics|mesh-ancestor
6071837|NCT00726895|Sensory System Agents|sensory system agents|mesh-ancestor
6071838|NCT00726986|Etoposide|etoposide|mesh-list
6071839|NCT00726986|Sorafenib|sorafenib|mesh-list
5510295|NCT04400890|Protective Agents|protective agents|mesh-ancestor
6071840|NCT00726986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6071841|NCT00726986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6071842|NCT00726986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6071843|NCT00726986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6071844|NCT00726986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6071845|NCT00726986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071846|NCT00726986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6071847|NCT00726999|Morphine|morphine|mesh-list
6071848|NCT00726999|Gabapentin|gabapentin|mesh-list
6071849|NCT00726999|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6071850|NCT00726999|Narcotics|narcotics|mesh-ancestor
6071851|NCT00726999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6071852|NCT00726999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071853|NCT00726999|Analgesics|analgesics|mesh-ancestor
6071854|NCT00726999|Sensory System Agents|sensory system agents|mesh-ancestor
6071855|NCT00726999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6071856|NCT00726999|Anticonvulsants|anticonvulsants|mesh-ancestor
6071857|NCT00726999|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6071858|NCT00726999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6071859|NCT00726999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6071860|NCT00726999|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6071861|NCT00726999|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6071862|NCT00726999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6071863|NCT00726999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071864|NCT00726999|Antimanic Agents|antimanic agents|mesh-ancestor
6071865|NCT00727064|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6071866|NCT00727064|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6071867|NCT00727064|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6071868|NCT00727064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6071869|NCT00727064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6071870|NCT00727064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071871|NCT00727064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6071872|NCT00727064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071873|NCT00727064|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6071874|NCT00727064|Antidepressive Agents|antidepressive agents|mesh-ancestor
6071875|NCT00727064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6071876|NCT00727090|Conivaptan|conivaptan|mesh-list
6071877|NCT00727090|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6071878|NCT00727090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071879|NCT00727090|Natriuretic Agents|natriuretic agents|mesh-ancestor
6071880|NCT00727090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071881|NCT00727194|Eculizumab|eculizumab|mesh-list
6071882|NCT00727194|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6071883|NCT00727194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6071884|NCT00727194|Immunologic Factors|immunologic factors|mesh-ancestor
6071885|NCT00727194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071886|NCT00727246|Choline|choline|mesh-list
6071887|NCT00727246|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
6071888|NCT00727246|Lipotropic Agents|lipotropic agents|mesh-ancestor
6071889|NCT00727246|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6071890|NCT00727246|Antimetabolites|antimetabolites|mesh-ancestor
6071891|NCT00727246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071892|NCT00727246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6071893|NCT00727246|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6071894|NCT00727246|Nootropic Agents|nootropic agents|mesh-ancestor
6071895|NCT00727259|Ribavirin|ribavirin|mesh-list
6071896|NCT00727259|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6071897|NCT00727259|Antimetabolites|antimetabolites|mesh-ancestor
6071898|NCT00727259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510296|NCT04400890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5510297|NCT04400890|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5510298|NCT04400539|Nivolumab|nivolumab|mesh-list
5510299|NCT04400539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5510300|NCT04400539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5510301|NCT04400539|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5510302|NCT04400539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071899|NCT00727259|Antiviral Agents|antiviral agents|mesh-ancestor
6071900|NCT00727259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6071901|NCT00727272|Quinine|quinine|mesh-list
6071902|NCT00727272|Antimalarials|antimalarials|mesh-ancestor
6071903|NCT00727272|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6071904|NCT00727272|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6071905|NCT00727272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6071906|NCT00727272|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6071907|NCT00727272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071908|NCT00727272|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6071909|NCT00727272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6463484|NCT00464789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6463485|NCT00464854|Insulin Aspart|insulin aspart|mesh-list
6463486|NCT00464854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6463487|NCT00464854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463488|NCT00464893|Catumaxomab|catumaxomab|mesh-list
6463489|NCT00464893|Antibodies, Bispecific|antibodies, bispecific|mesh-list
6463490|NCT00464893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5510303|NCT04400201|Propofol|propofol|mesh-list
5510304|NCT04400201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5510305|NCT04400201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5510306|NCT04400201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510307|NCT04400201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5510308|NCT04400201|Anesthetics, General|anesthetics, general|mesh-ancestor
5510309|NCT04400201|Anesthetics|anesthetics|mesh-ancestor
5510310|NCT04400175|Silicon|silicon|mesh-list
5510311|NCT04400175|Trace Elements|trace elements|mesh-ancestor
5510312|NCT04400175|Micronutrients|micronutrients|mesh-ancestor
5510313|NCT04400175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463491|NCT00464893|Immunologic Factors|immunologic factors|mesh-ancestor
6463492|NCT00464893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463493|NCT00464919|Sorafenib|sorafenib|mesh-list
6463494|NCT00464919|Tegafur|tegafur|mesh-list
6463495|NCT00464919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6463496|NCT00464919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6463497|NCT00464919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6463498|NCT00464919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463499|NCT00464919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6463500|NCT00464919|Antimetabolites|antimetabolites|mesh-ancestor
6071910|NCT00727272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6071911|NCT00727272|Analgesics|analgesics|mesh-ancestor
6071912|NCT00727272|Sensory System Agents|sensory system agents|mesh-ancestor
6071913|NCT00727298|Infliximab|infliximab|mesh-list
6071914|NCT00727298|Dermatologic Agents|dermatologic agents|mesh-ancestor
6071915|NCT00727298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6071916|NCT00727298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5510314|NCT04400188|Temozolomide|temozolomide|mesh-list
6071917|NCT00727311|Ribavirin|ribavirin|mesh-list
6071918|NCT00727311|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6071919|NCT00727311|Interferon-alpha|interferon-alpha|mesh-list
6071920|NCT00727311|Antimetabolites|antimetabolites|mesh-ancestor
6071921|NCT00727311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071922|NCT00727311|Antiviral Agents|antiviral agents|mesh-ancestor
6071923|NCT00727311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6071924|NCT00727311|Immunologic Factors|immunologic factors|mesh-ancestor
6071925|NCT00727311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071926|NCT00727415|Cyclophosphamide|cyclophosphamide|mesh-list
6071927|NCT00727415|Fludarabine|fludarabine|mesh-list
6071928|NCT00727415|Fludarabine phosphate|fludarabine phosphate|mesh-list
6071929|NCT00727415|Lenalidomide|lenalidomide|mesh-list
6071930|NCT00727415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6071931|NCT00727415|Immunologic Factors|immunologic factors|mesh-ancestor
6071932|NCT00727415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071933|NCT00727415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6071934|NCT00727415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6071935|NCT00727415|Alkylating Agents|alkylating agents|mesh-ancestor
6071936|NCT00727415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071937|NCT00727415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6071938|NCT00727415|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6071939|NCT00727415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6071940|NCT00727415|Antimetabolites|antimetabolites|mesh-ancestor
6071941|NCT00727415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6071942|NCT00727415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6071943|NCT00727415|Growth Substances|growth substances|mesh-ancestor
6071944|NCT00727415|Growth Inhibitors|growth inhibitors|mesh-ancestor
6071945|NCT00727441|Cyclophosphamide|cyclophosphamide|mesh-list
6071946|NCT00727441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6071947|NCT00727441|Immunologic Factors|immunologic factors|mesh-ancestor
6071948|NCT00727441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071949|NCT00727441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6071950|NCT00727441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6463501|NCT00464932|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
5510315|NCT04400188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5510316|NCT04400188|Alkylating Agents|alkylating agents|mesh-ancestor
6071951|NCT00727441|Alkylating Agents|alkylating agents|mesh-ancestor
6071952|NCT00727441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071953|NCT00727441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6071954|NCT00727441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6071955|NCT00727506|Afatinib|afatinib|mesh-list
6071956|NCT00727506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6071957|NCT00727506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6071958|NCT00727506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6071959|NCT00727506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071960|NCT00727532|Sorafenib|sorafenib|mesh-list
6071961|NCT00727532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6071962|NCT00727532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6071963|NCT00727532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6071964|NCT00727532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071965|NCT00727597|Efavirenz|efavirenz|mesh-list
6071966|NCT00727597|Fosamprenavir|fosamprenavir|mesh-list
6071967|NCT00727597|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6071968|NCT00727597|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6463502|NCT00464932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6463503|NCT00464932|Vasodilator Agents|vasodilator agents|mesh-ancestor
6463504|NCT00464932|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6463505|NCT00464932|Protective Agents|protective agents|mesh-ancestor
6463506|NCT00464932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463507|NCT00464958|Tizanidine|tizanidine|mesh-list
6463508|NCT00464958|Analgesics|analgesics|mesh-ancestor
6463509|NCT00464958|Sensory System Agents|sensory system agents|mesh-ancestor
6463510|NCT00464958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6071969|NCT00727597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6071970|NCT00727597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6071971|NCT00727597|Antiviral Agents|antiviral agents|mesh-ancestor
6071972|NCT00727597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6071973|NCT00727597|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6071974|NCT00727597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6071975|NCT00727597|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6071976|NCT00727597|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6071977|NCT00727597|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6071978|NCT00727597|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6071979|NCT00727597|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6071980|NCT00727597|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6071981|NCT00727597|Protease Inhibitors|protease inhibitors|mesh-ancestor
6071982|NCT00727597|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6071983|NCT00727597|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6071984|NCT00727636|Vaccines|vaccines|mesh-list
6071985|NCT00727636|Immunologic Factors|immunologic factors|mesh-ancestor
6071986|NCT00727636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071987|NCT00727649|Loperamide|loperamide|mesh-list
6071988|NCT00727649|Antidiarrheals|antidiarrheals|mesh-list
6071989|NCT00727649|Psyllium|psyllium|mesh-list
6071990|NCT00727649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6071991|NCT00727649|Cathartics|cathartics|mesh-ancestor
6071992|NCT00727740|Indomethacin|indomethacin|mesh-list
6071993|NCT00727740|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6071994|NCT00727740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6071995|NCT00727740|Analgesics|analgesics|mesh-ancestor
6071996|NCT00727740|Sensory System Agents|sensory system agents|mesh-ancestor
6071997|NCT00727740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6071998|NCT00727740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6071999|NCT00727740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6072000|NCT00727740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6072001|NCT00727740|Gout Suppressants|gout suppressants|mesh-ancestor
6072002|NCT00727740|Tocolytic Agents|tocolytic agents|mesh-ancestor
6072003|NCT00727740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6072004|NCT00727740|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6072005|NCT00727740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6072006|NCT00727740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072007|NCT00727844|Linezolid|linezolid|mesh-list
6072008|NCT00727844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6072009|NCT00727844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6072010|NCT00727844|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6072011|NCT00727844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6072012|NCT00727844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072013|NCT00727857|Metformin|metformin|mesh-list
6072014|NCT00727857|Pioglitazone|pioglitazone|mesh-list
6072015|NCT00727857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6072016|NCT00727857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072017|NCT00727961|Doxorubicin|doxorubicin|mesh-list
6072018|NCT00727961|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6072019|NCT00727961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6072020|NCT00727961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6072021|NCT00727961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6072022|NCT00727961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6072023|NCT00727961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6072024|NCT00727961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072025|NCT00728481|Budesonide|budesonide|mesh-list
6072026|NCT00728481|Esomeprazole|esomeprazole|mesh-list
6072027|NCT00728481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6072028|NCT00728481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6072029|NCT00728481|Autonomic Agents|autonomic agents|mesh-ancestor
6072030|NCT00728481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6072031|NCT00728481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072032|NCT00728481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6072033|NCT00728481|Respiratory System Agents|respiratory system agents|mesh-ancestor
6072034|NCT00728481|Glucocorticoids|glucocorticoids|mesh-ancestor
6072035|NCT00728481|Hormones|hormones|mesh-ancestor
6072036|NCT00728481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6072037|NCT00728481|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6072038|NCT00728481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6072039|NCT00728481|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6072040|NCT00728481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6072041|NCT00728481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072042|NCT00728494|Ribavirin|ribavirin|mesh-list
6072043|NCT00728494|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6072044|NCT00728494|Interferon-alpha|interferon-alpha|mesh-list
6072045|NCT00728494|Antimetabolites|antimetabolites|mesh-ancestor
6072046|NCT00728494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072047|NCT00728494|Antiviral Agents|antiviral agents|mesh-ancestor
6072048|NCT00728494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6072049|NCT00728494|Immunologic Factors|immunologic factors|mesh-ancestor
6072050|NCT00728494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072051|NCT00728507|Moxifloxacin|moxifloxacin|mesh-list
6072052|NCT00728507|Rifampin|rifampin|mesh-list
6072053|NCT00728507|Isoniazid|isoniazid|mesh-list
6072054|NCT00728507|Pyrazinamide|pyrazinamide|mesh-list
6072055|NCT00728507|Ethambutol|ethambutol|mesh-list
6072056|NCT00728507|Rifapentine|rifapentine|mesh-list
6072057|NCT00728507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6072058|NCT00728507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6072059|NCT00728507|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6072060|NCT00728507|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6072061|NCT00728507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6072062|NCT00728507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072063|NCT00728507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6072064|NCT00728507|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6072065|NCT00728507|Antitubercular Agents|antitubercular agents|mesh-ancestor
6072066|NCT00728507|Leprostatic Agents|leprostatic agents|mesh-ancestor
6072067|NCT00728507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6072068|NCT00728507|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6072069|NCT00728507|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6072070|NCT00728507|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6072071|NCT00728507|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6072072|NCT00728507|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6072073|NCT00728507|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6072074|NCT00728507|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6072075|NCT00728507|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6072076|NCT00728507|Antimetabolites|antimetabolites|mesh-ancestor
6072077|NCT00728507|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6202643|NCT02044159|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6202644|NCT02044159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6202645|NCT02044367|Dabigatran|dabigatran|mesh-list
6202646|NCT02044367|Antithrombins|antithrombins|mesh-ancestor
6202647|NCT02044367|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6202648|NCT02044367|Protease Inhibitors|protease inhibitors|mesh-ancestor
6202649|NCT02044367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6202650|NCT02044367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202651|NCT02044367|Anticoagulants|anticoagulants|mesh-ancestor
6202652|NCT02044380|Afatinib|afatinib|mesh-list
6202653|NCT02044380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6202654|NCT02044380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6202655|NCT02044380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6202656|NCT02044380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072078|NCT00728754|Ethanol|ethanol|mesh-list
6072079|NCT00728754|Povidone-Iodine|povidone-iodine|mesh-list
6072080|NCT00728754|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6072081|NCT00728754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6072082|NCT00728754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6072083|NCT00728754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072084|NCT00728910|Niacin|niacin|mesh-list
6072085|NCT00728910|Atorvastatin|atorvastatin|mesh-list
6072086|NCT00728910|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6072087|NCT00728910|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6072088|NCT00728910|Antimetabolites|antimetabolites|mesh-ancestor
6072089|NCT00728910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072090|NCT00728910|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6072091|NCT00728910|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6072092|NCT00728910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6072093|NCT00728910|Vasodilator Agents|vasodilator agents|mesh-ancestor
6072094|NCT00728910|Vitamin B Complex|vitamin b complex|mesh-ancestor
6072095|NCT00728910|Vitamins|vitamins|mesh-ancestor
6072096|NCT00728910|Micronutrients|micronutrients|mesh-ancestor
6072097|NCT00728910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072098|NCT00728949|Tamoxifen|tamoxifen|mesh-list
6072099|NCT00728949|Letrozole|letrozole|mesh-list
6072100|NCT00728949|Fulvestrant|fulvestrant|mesh-list
6072101|NCT00728949|Anastrozole|anastrozole|mesh-list
6072102|NCT00728949|Exemestane|exemestane|mesh-list
6072103|NCT00728949|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6072104|NCT00728949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6072105|NCT00728949|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6072106|NCT00728949|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6072107|NCT00728949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6072108|NCT00728949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072109|NCT00728949|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6072110|NCT00728949|Hormone Antagonists|hormone antagonists|mesh-ancestor
6072111|NCT00728949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6072112|NCT00728949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072113|NCT00728949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6072114|NCT00728949|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6072115|NCT00728949|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6072116|NCT00728949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6072117|NCT00728949|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6072118|NCT00728949|Immunologic Factors|immunologic factors|mesh-ancestor
6072119|NCT00728988|Atorvastatin|atorvastatin|mesh-list
6072120|NCT00728988|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6072121|NCT00728988|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6463511|NCT00464958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463512|NCT00464958|Anticonvulsants|anticonvulsants|mesh-ancestor
6463513|NCT00464958|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6463514|NCT00464958|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6463515|NCT00464958|Parasympatholytics|parasympatholytics|mesh-ancestor
6072122|NCT00728988|Antimetabolites|antimetabolites|mesh-ancestor
6072123|NCT00728988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072124|NCT00728988|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6072125|NCT00728988|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6072126|NCT00728988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6072127|NCT00729157|Deoxyglucose|deoxyglucose|mesh-list
6072128|NCT00729157|Aflibercept|aflibercept|mesh-list
6072129|NCT00729157|Endothelial Growth Factors|endothelial growth factors|mesh-list
6072130|NCT00729157|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6072131|NCT00729157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6072132|NCT00729157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6072133|NCT00729157|Growth Substances|growth substances|mesh-ancestor
6072134|NCT00729157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072135|NCT00729157|Growth Inhibitors|growth inhibitors|mesh-ancestor
6072136|NCT00729157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6072137|NCT00729157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072138|NCT00729157|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6072139|NCT00729157|Antimetabolites|antimetabolites|mesh-ancestor
6072140|NCT00729157|Antiviral Agents|antiviral agents|mesh-ancestor
6072141|NCT00729157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6072142|NCT00729183|Calcium, Dietary|calcium, dietary|mesh-list
6072143|NCT00729183|Vitamin D|vitamin d|mesh-list
6072144|NCT00729183|Cholecalciferol|cholecalciferol|mesh-list
6072145|NCT00729183|Calcium Carbonate|calcium carbonate|mesh-list
6072146|NCT00729183|Calcium|calcium|mesh-list
6072147|NCT00729183|Vitamins|vitamins|mesh-ancestor
6072148|NCT00729183|Micronutrients|micronutrients|mesh-ancestor
6463516|NCT00464958|Autonomic Agents|autonomic agents|mesh-ancestor
6072149|NCT00729183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072150|NCT00729183|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6072151|NCT00729183|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6072152|NCT00729183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072153|NCT00729183|Antacids|antacids|mesh-ancestor
6072154|NCT00729183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6072155|NCT00729326|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6072156|NCT00729326|Exenatide|exenatide|mesh-list
6072157|NCT00729326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6072158|NCT00729326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072159|NCT00729326|Incretins|incretins|mesh-ancestor
6072160|NCT00729326|Hormones|hormones|mesh-ancestor
6072161|NCT00729326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5510317|NCT04400188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510318|NCT04400188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5510319|NCT04400045|Treosulfan|treosulfan|mesh-list
6072162|NCT00729326|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6072163|NCT00729326|Protease Inhibitors|protease inhibitors|mesh-ancestor
6072164|NCT00729326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6072165|NCT00729326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072166|NCT00729326|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6072167|NCT00729482|Everolimus|everolimus|mesh-list
6072168|NCT00729482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6072169|NCT00729482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6072170|NCT00729482|Immunologic Factors|immunologic factors|mesh-ancestor
6072171|NCT00729482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072172|NCT00729586|Tamoxifen|tamoxifen|mesh-list
6072173|NCT00729586|Sirolimus|sirolimus|mesh-list
6072174|NCT00729586|Megestrol|megestrol|mesh-list
6072175|NCT00729586|Megestrol Acetate|megestrol acetate|mesh-list
6072176|NCT00729586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6072177|NCT00729586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6072178|NCT00729586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6072179|NCT00729586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6072180|NCT00729586|Antifungal Agents|antifungal agents|mesh-ancestor
6072181|NCT00729586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6072182|NCT00729586|Immunologic Factors|immunologic factors|mesh-ancestor
6072183|NCT00729586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072184|NCT00729586|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6072185|NCT00729586|Hormone Antagonists|hormone antagonists|mesh-ancestor
6072186|NCT00729586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6072187|NCT00729586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6072188|NCT00729586|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6072189|NCT00729586|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6072190|NCT00729586|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6072191|NCT00729586|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6072192|NCT00729586|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6072193|NCT00729586|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6072194|NCT00729586|Contraceptive Agents|contraceptive agents|mesh-ancestor
6072195|NCT00729586|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6072196|NCT00729586|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6072197|NCT00729586|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6072198|NCT00729586|Appetite Stimulants|appetite stimulants|mesh-ancestor
6072199|NCT00729586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6072200|NCT00729612|Paclitaxel|paclitaxel|mesh-list
6072201|NCT00729612|Carboplatin|carboplatin|mesh-list
6072202|NCT00729612|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6072203|NCT00729612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6072204|NCT00729612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6072205|NCT00729612|Tubulin Modulators|tubulin modulators|mesh-ancestor
6072206|NCT00729612|Antimitotic Agents|antimitotic agents|mesh-ancestor
6072207|NCT00729612|Mitosis Modulators|mitosis modulators|mesh-ancestor
6072208|NCT00729612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072209|NCT00729690|Pregabalin|pregabalin|mesh-list
6072210|NCT00729690|Analgesics|analgesics|mesh-ancestor
6072211|NCT00729690|Sensory System Agents|sensory system agents|mesh-ancestor
6072212|NCT00729690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6072213|NCT00729690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072214|NCT00729690|Anticonvulsants|anticonvulsants|mesh-ancestor
6072215|NCT00729690|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6072216|NCT00729690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6072217|NCT00729690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072218|NCT00729690|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6072219|NCT00729690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6072220|NCT00729690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6072221|NCT00729690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6072222|NCT00729690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6072223|NCT00729807|Pentamidine|pentamidine|mesh-list
6072224|NCT00729807|Antifungal Agents|antifungal agents|mesh-ancestor
6072225|NCT00729807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6072226|NCT00729807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6072227|NCT00729807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6072228|NCT00729807|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6072229|NCT00729833|Sunitinib|sunitinib|mesh-list
6072230|NCT00729833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6072231|NCT00729833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6072232|NCT00729833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6072233|NCT00729833|Growth Substances|growth substances|mesh-ancestor
6072234|NCT00729833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072235|NCT00729833|Growth Inhibitors|growth inhibitors|mesh-ancestor
6072236|NCT00729833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6072237|NCT00729833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6072238|NCT00729833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072239|NCT00729846|Bevacizumab|bevacizumab|mesh-list
6072240|NCT00729846|Verteporfin|verteporfin|mesh-list
6072241|NCT00729846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6072242|NCT00729846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6072243|NCT00729846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6072244|NCT00729846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6072245|NCT00729846|Growth Substances|growth substances|mesh-ancestor
6072246|NCT00729846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072247|NCT00729846|Growth Inhibitors|growth inhibitors|mesh-ancestor
6072248|NCT00729846|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6072249|NCT00729846|Dermatologic Agents|dermatologic agents|mesh-ancestor
6072250|NCT00729859|Methyltestosterone|methyltestosterone|mesh-list
6072251|NCT00729859|Anastrozole|anastrozole|mesh-list
6072252|NCT00729859|Testosterone|testosterone|mesh-list
6072253|NCT00729859|Testosterone undecanoate|testosterone undecanoate|mesh-list
6072254|NCT00729859|Testosterone enanthate|testosterone enanthate|mesh-list
6072255|NCT00729859|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5510320|NCT04400045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5510321|NCT04400045|Alkylating Agents|alkylating agents|mesh-ancestor
5510322|NCT04400045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510323|NCT04400045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5510324|NCT04399746|Cholecalciferol|cholecalciferol|mesh-list
5510325|NCT04399746|Azithromycin|azithromycin|mesh-list
5510326|NCT04399746|Ivermectin|ivermectin|mesh-list
5510327|NCT04399746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5510328|NCT04399746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510329|NCT04399746|Vitamins|vitamins|mesh-ancestor
5510330|NCT04399746|Micronutrients|micronutrients|mesh-ancestor
6072256|NCT00729859|Acyline|acyline|mesh-list
6072257|NCT00729859|Androgens|androgens|mesh-ancestor
6072258|NCT00729859|Hormones|hormones|mesh-ancestor
6072259|NCT00729859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6072260|NCT00729859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072261|NCT00729859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6072262|NCT00729859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6072263|NCT00729859|Anabolic Agents|anabolic agents|mesh-ancestor
6072264|NCT00729859|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6072265|NCT00729859|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6072266|NCT00729859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6072267|NCT00729859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072268|NCT00729859|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6072269|NCT00729859|Hormone Antagonists|hormone antagonists|mesh-ancestor
6072270|NCT00729924|Raltegravir Potassium|raltegravir potassium|mesh-list
6072271|NCT00729924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6072272|NCT00729924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6072273|NCT00729924|Antiviral Agents|antiviral agents|mesh-ancestor
6072274|NCT00729924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5510331|NCT04399746|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5510332|NCT04399746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6072275|NCT00729924|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6072276|NCT00729924|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6072277|NCT00729924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6072278|NCT00729924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072279|NCT00729937|Clindamycin|clindamycin|mesh-list
6072280|NCT00729937|Clindamycin palmitate|clindamycin palmitate|mesh-list
6072281|NCT00729937|Clindamycin phosphate|clindamycin phosphate|mesh-list
6072282|NCT00729937|Cephalexin|cephalexin|mesh-list
6072283|NCT00729937|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6072284|NCT00729937|Trimethoprim|trimethoprim|mesh-list
6072285|NCT00729937|Sulfamethoxazole|sulfamethoxazole|mesh-list
6072286|NCT00729937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6072287|NCT00729937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6072288|NCT00729937|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6072289|NCT00729937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6072290|NCT00729937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072291|NCT00729937|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6072292|NCT00729937|Renal Agents|renal agents|mesh-ancestor
6072293|NCT00729937|Antimalarials|antimalarials|mesh-ancestor
6072294|NCT00729937|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6072295|NCT00729937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6072296|NCT00729937|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6072297|NCT00729937|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6072298|NCT00729937|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6072299|NCT00729937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6072300|NCT00730015|Linaclotide|linaclotide|mesh-list
6072301|NCT00730015|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
6072302|NCT00730015|Enzyme Activators|enzyme activators|mesh-ancestor
6072303|NCT00730015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510333|NCT04399746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5510334|NCT04399746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5510335|NCT04400019|Hydroxychloroquine|hydroxychloroquine|mesh-list
6072304|NCT00730015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6072305|NCT00730028|Clindamycin|clindamycin|mesh-list
6072306|NCT00730028|Clindamycin palmitate|clindamycin palmitate|mesh-list
6072307|NCT00730028|Clindamycin phosphate|clindamycin phosphate|mesh-list
6072308|NCT00730028|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6072309|NCT00730028|Trimethoprim|trimethoprim|mesh-list
6072310|NCT00730028|Sulfamethoxazole|sulfamethoxazole|mesh-list
6072311|NCT00730028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6072312|NCT00730028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6072313|NCT00730028|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6072314|NCT00730028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6072315|NCT00730028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072316|NCT00730028|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6072317|NCT00730028|Renal Agents|renal agents|mesh-ancestor
6072318|NCT00730028|Antimalarials|antimalarials|mesh-ancestor
6072319|NCT00730028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6072320|NCT00730028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6072321|NCT00730028|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6072322|NCT00730028|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6072323|NCT00730028|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6072324|NCT00730028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6072325|NCT00730158|Irinotecan|irinotecan|mesh-list
6072326|NCT00730158|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6072327|NCT00730158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6072328|NCT00730158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6072329|NCT00730158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072330|NCT00730158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6072331|NCT00730171|Linaclotide|linaclotide|mesh-list
6072332|NCT00730171|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
6072333|NCT00730171|Enzyme Activators|enzyme activators|mesh-ancestor
6072334|NCT00730171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072335|NCT00730171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6072336|NCT00730275|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6072337|NCT00730275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6072338|NCT00730275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072339|NCT00730275|Incretins|incretins|mesh-ancestor
6072340|NCT00730275|Hormones|hormones|mesh-ancestor
6072341|NCT00730275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6072342|NCT00730275|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6072343|NCT00730275|Protease Inhibitors|protease inhibitors|mesh-ancestor
6072344|NCT00730275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6072345|NCT00730275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072346|NCT00730353|Paclitaxel|paclitaxel|mesh-list
5510336|NCT04400019|Antimalarials|antimalarials|mesh-ancestor
5510337|NCT04400019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6072347|NCT00730353|Sunitinib|sunitinib|mesh-list
6072348|NCT00730353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6072349|NCT00730353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6072350|NCT00730353|Tubulin Modulators|tubulin modulators|mesh-ancestor
5510338|NCT04400019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5510339|NCT04400019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5510340|NCT04400019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5510341|NCT04400019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510342|NCT04400019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5510343|NCT04400136|Lansoprazole|lansoprazole|mesh-list
6072351|NCT00730353|Antimitotic Agents|antimitotic agents|mesh-ancestor
6072352|NCT00730353|Mitosis Modulators|mitosis modulators|mesh-ancestor
6072353|NCT00730353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072354|NCT00730353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6072355|NCT00730353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6072356|NCT00730353|Growth Substances|growth substances|mesh-ancestor
6072357|NCT00730353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072358|NCT00730353|Growth Inhibitors|growth inhibitors|mesh-ancestor
6072359|NCT00730353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6072360|NCT00730353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6072361|NCT00730405|Albaconazole|albaconazole|mesh-list
6072362|NCT00730405|Antifungal Agents|antifungal agents|mesh-ancestor
6072363|NCT00730405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6072364|NCT00730483|Doxorubicin|doxorubicin|mesh-list
6072365|NCT00730483|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6072366|NCT00730483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6072367|NCT00730483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6072368|NCT00730483|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6072369|NCT00730483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6072370|NCT00730483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6072371|NCT00730483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072372|NCT00730522|Vigabatrin|vigabatrin|mesh-list
6072373|NCT00730522|Anticonvulsants|anticonvulsants|mesh-ancestor
6072374|NCT00730522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6072375|NCT00730522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072376|NCT00730522|GABA Agents|gaba agents|mesh-ancestor
6072377|NCT00730522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6072378|NCT00730522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510344|NCT04400136|Dexlansoprazole|dexlansoprazole|mesh-list
5510345|NCT04400136|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5510346|NCT04400136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5510347|NCT04400136|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5510348|NCT04400136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5510349|NCT04400136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510350|NCT04399187|Sodium Hypochlorite|sodium hypochlorite|mesh-list
5510351|NCT04399187|Eusol|eusol|mesh-list
5510352|NCT04399187|Disinfectants|disinfectants|mesh-ancestor
5510353|NCT04399187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6072379|NCT00730691|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6072380|NCT00730691|Vortioxetine|vortioxetine|mesh-list
6072381|NCT00730691|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6072382|NCT00730691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6072383|NCT00730691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6072384|NCT00730691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072385|NCT00730691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6072386|NCT00730691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072387|NCT00730691|Analgesics|analgesics|mesh-ancestor
6072388|NCT00730691|Sensory System Agents|sensory system agents|mesh-ancestor
6072389|NCT00730691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6072390|NCT00730691|Antidepressive Agents|antidepressive agents|mesh-ancestor
6072391|NCT00730691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6072392|NCT00730691|Dopamine Agents|dopamine agents|mesh-ancestor
6072393|NCT00730691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6072394|NCT00730691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6072395|NCT00730691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6072396|NCT00730691|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6072397|NCT00730691|Serotonin Agents|serotonin agents|mesh-ancestor
6072398|NCT00730691|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6072399|NCT00730691|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6072400|NCT00730691|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6072401|NCT00730691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6072402|NCT00730756|Fluticasone|fluticasone|mesh-list
6072403|NCT00730756|Xhance|xhance|mesh-list
6072404|NCT00730756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6072405|NCT00730756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6072406|NCT00730756|Autonomic Agents|autonomic agents|mesh-ancestor
6072407|NCT00730756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6072408|NCT00730756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510354|NCT04399213|Histamine|histamine|mesh-list
5510355|NCT04399213|Histamine phosphate|histamine phosphate|mesh-list
5510356|NCT04399213|Histamine Agonists|histamine agonists|mesh-ancestor
5510357|NCT04399213|Histamine Agents|histamine agents|mesh-ancestor
5510358|NCT04399213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5510359|NCT04399213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510360|NCT04399213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510361|NCT04399226|Dexmedetomidine|dexmedetomidine|mesh-list
6072409|NCT00730756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6072410|NCT00730756|Respiratory System Agents|respiratory system agents|mesh-ancestor
6072411|NCT00730756|Dermatologic Agents|dermatologic agents|mesh-ancestor
6072412|NCT00730756|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6072413|NCT00730847|Vaccines|vaccines|mesh-list
6072414|NCT00730847|Immunologic Factors|immunologic factors|mesh-ancestor
6072415|NCT00730847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072416|NCT00730912|Loratadine|loratadine|mesh-list
6072417|NCT00730912|Antipruritics|antipruritics|mesh-ancestor
6072418|NCT00730912|Dermatologic Agents|dermatologic agents|mesh-ancestor
6072419|NCT00730912|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6072420|NCT00730912|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6072421|NCT00730912|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6072422|NCT00730912|Histamine Antagonists|histamine antagonists|mesh-ancestor
6072423|NCT00730912|Histamine Agents|histamine agents|mesh-ancestor
6072424|NCT00730912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6072425|NCT00730912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072426|NCT00730912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072427|NCT00730925|Paclitaxel|paclitaxel|mesh-list
6072428|NCT00730925|Afatinib|afatinib|mesh-list
6072429|NCT00730925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6072430|NCT00730925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6072431|NCT00730925|Tubulin Modulators|tubulin modulators|mesh-ancestor
6072432|NCT00730925|Antimitotic Agents|antimitotic agents|mesh-ancestor
6072433|NCT00730925|Mitosis Modulators|mitosis modulators|mesh-ancestor
6072434|NCT00730925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072435|NCT00730925|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6072436|NCT00730925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6072437|NCT00731042|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6072438|NCT00731042|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6072439|NCT00731042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6072440|NCT00731042|Dermatologic Agents|dermatologic agents|mesh-ancestor
6072441|NCT00731055|Varenicline|varenicline|mesh-list
6072442|NCT00731055|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6072443|NCT00731055|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6072444|NCT00731055|Cholinergic Agents|cholinergic agents|mesh-ancestor
6072445|NCT00731055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6072446|NCT00731055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072447|NCT00731055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072448|NCT00731120|Vortioxetine|vortioxetine|mesh-list
6072449|NCT00731120|Antidepressive Agents|antidepressive agents|mesh-ancestor
6072450|NCT00731120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6072451|NCT00731120|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6072452|NCT00731120|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6072453|NCT00731120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6072454|NCT00731120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072455|NCT00731120|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6072456|NCT00731120|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6072457|NCT00731120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6202657|NCT02044393|Itraconazole|itraconazole|mesh-list
5510362|NCT04399226|Ketamine|ketamine|mesh-list
5510363|NCT04399226|Propofol|propofol|mesh-list
5510364|NCT04399226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5510365|NCT04399226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5510366|NCT04399226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510367|NCT04399226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5510368|NCT04399226|Anesthetics, General|anesthetics, general|mesh-ancestor
5510369|NCT04399226|Anesthetics|anesthetics|mesh-ancestor
5510370|NCT04399226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5510371|NCT04399226|Analgesics|analgesics|mesh-ancestor
5510372|NCT04399226|Sensory System Agents|sensory system agents|mesh-ancestor
5510373|NCT04399226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5510374|NCT04399226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5510375|NCT04399226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5510376|NCT04399226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5510377|NCT04399226|Adrenergic Agents|adrenergic agents|mesh-ancestor
5510378|NCT04399226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5510379|NCT04399226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510380|NCT04399226|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5510381|NCT04399226|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5510382|NCT04399226|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5510383|NCT04399395|Naltrexone|naltrexone|mesh-list
5510384|NCT04399395|Bupropion|bupropion|mesh-list
5510385|NCT04399395|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5510386|NCT04399395|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5510387|NCT04399395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510388|NCT04399395|Sensory System Agents|sensory system agents|mesh-ancestor
5510389|NCT04399395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5510390|NCT04399395|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5510391|NCT04399395|Antidepressive Agents|antidepressive agents|mesh-ancestor
5510392|NCT04399395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5510393|NCT04399395|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5510394|NCT04399395|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5510395|NCT04399395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5510396|NCT04399395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510397|NCT04399395|Dopamine Agents|dopamine agents|mesh-ancestor
5510398|NCT04399395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5510399|NCT04399395|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5510400|NCT04399395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5510401|NCT04399395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5510402|NCT04399434|Insulin|insulin|mesh-list
5510403|NCT04399434|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5510404|NCT04399434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510405|NCT04399525|Cetirizine|cetirizine|mesh-list
5510406|NCT04399525|Loratadine|loratadine|mesh-list
5510407|NCT04399525|Levocetirizine|levocetirizine|mesh-list
5510408|NCT04399525|Desloratadine|desloratadine|mesh-list
5510409|NCT04399525|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5510410|NCT04399525|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5510411|NCT04399525|Histamine Antagonists|histamine antagonists|mesh-ancestor
5510412|NCT04399525|Histamine Agents|histamine agents|mesh-ancestor
5510413|NCT04399525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6072458|NCT00731120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072459|NCT00731120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6072460|NCT00731120|Serotonin Agents|serotonin agents|mesh-ancestor
6072461|NCT00731120|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5510414|NCT04399525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510415|NCT04399525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510416|NCT04399525|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5510417|NCT04399525|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5510418|NCT04399525|Cholinergic Agents|cholinergic agents|mesh-ancestor
5510419|NCT04399525|Antipruritics|antipruritics|mesh-ancestor
5510420|NCT04399525|Dermatologic Agents|dermatologic agents|mesh-ancestor
5600342|NCT03712540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5600343|NCT03712540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5600344|NCT03712540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600345|NCT03712540|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5600346|NCT03712540|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5600347|NCT03712540|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5600348|NCT03712540|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5600349|NCT03712540|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5600350|NCT03712540|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6072462|NCT00731120|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6072463|NCT00731120|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6072464|NCT00731120|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6072465|NCT00731133|Disulfiram|disulfiram|mesh-list
6072466|NCT00731133|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6072467|NCT00731133|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
6072468|NCT00731133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6072469|NCT00731133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072470|NCT00731198|Drotaverin|drotaverin|mesh-list
6072471|NCT00731198|Scopolamine|scopolamine|mesh-list
6072472|NCT00731198|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
6072473|NCT00731198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6072474|NCT00731198|Antiemetics|antiemetics|mesh-ancestor
6072475|NCT00731198|Autonomic Agents|autonomic agents|mesh-ancestor
6072476|NCT00731198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6072477|NCT00731198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072478|NCT00731198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6072479|NCT00731198|Mydriatics|mydriatics|mesh-ancestor
5600351|NCT03712475|Pregabalin|pregabalin|mesh-list
6072480|NCT00731198|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6072481|NCT00731198|Cholinergic Agents|cholinergic agents|mesh-ancestor
5510421|NCT04399343|Dexmedetomidine|dexmedetomidine|mesh-list
5510422|NCT04399343|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5510423|NCT04399343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5510424|NCT04399343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510425|NCT04399343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6072482|NCT00731198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6072483|NCT00731198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072484|NCT00731198|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6072485|NCT00731198|Parasympatholytics|parasympatholytics|mesh-ancestor
6072486|NCT00731198|Analgesics|analgesics|mesh-ancestor
6072487|NCT00731198|Sensory System Agents|sensory system agents|mesh-ancestor
6072488|NCT00731198|Vasodilator Agents|vasodilator agents|mesh-ancestor
6072489|NCT00731549|Aripiprazole|aripiprazole|mesh-list
5510426|NCT04399343|Analgesics|analgesics|mesh-ancestor
5510427|NCT04399343|Sensory System Agents|sensory system agents|mesh-ancestor
5510428|NCT04399343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5510429|NCT04399343|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5510430|NCT04399343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6072490|NCT00731549|Antidepressive Agents|antidepressive agents|mesh-ancestor
6072491|NCT00731549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6072492|NCT00731549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6072493|NCT00731549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6072494|NCT00731549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6072495|NCT00731549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072496|NCT00731549|Dopamine Agonists|dopamine agonists|mesh-ancestor
6072497|NCT00731549|Dopamine Agents|dopamine agents|mesh-ancestor
6072498|NCT00731549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5510431|NCT04399343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5510432|NCT04399343|Adrenergic Agents|adrenergic agents|mesh-ancestor
5510433|NCT04399343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5510434|NCT04399343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510435|NCT04399148|Ketotifen|ketotifen|mesh-list
5510436|NCT04399148|Aprepitant|aprepitant|mesh-list
5510437|NCT04399148|Desloratadine|desloratadine|mesh-list
5510438|NCT04399148|Antiemetics|antiemetics|mesh-ancestor
5510439|NCT04399148|Autonomic Agents|autonomic agents|mesh-ancestor
5510440|NCT04399148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5510441|NCT04399148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510442|NCT04399148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6072499|NCT00731549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072500|NCT00731549|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6072501|NCT00731549|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6072502|NCT00731549|Serotonin Agents|serotonin agents|mesh-ancestor
6072503|NCT00731549|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6072504|NCT00731549|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6072505|NCT00731549|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6072506|NCT00731549|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6072507|NCT00731588|Biotin|biotin|mesh-list
6072508|NCT00731588|Vitamin B Complex|vitamin b complex|mesh-ancestor
6072509|NCT00731588|Vitamins|vitamins|mesh-ancestor
6072510|NCT00731588|Micronutrients|micronutrients|mesh-ancestor
6072511|NCT00731588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072512|NCT00731679|Rifaximin|rifaximin|mesh-list
6072513|NCT00731679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6072514|NCT00731679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6072515|NCT00731679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6072516|NCT00731692|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6072517|NCT00731692|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6072518|NCT00731692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072519|NCT00731692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6072520|NCT00731692|Immunologic Factors|immunologic factors|mesh-ancestor
6072521|NCT00731692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072522|NCT00731783|Chlorhexidine|chlorhexidine|mesh-list
6072523|NCT00731783|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6072524|NCT00731783|Mupirocin|mupirocin|mesh-list
6072525|NCT00731783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6072526|NCT00731783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5510443|NCT04399148|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5510444|NCT04399148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5510445|NCT04399148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510446|NCT04399148|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5510447|NCT04399148|Cholinergic Agents|cholinergic agents|mesh-ancestor
5510448|NCT04399148|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6072527|NCT00731783|Disinfectants|disinfectants|mesh-ancestor
6072528|NCT00731783|Dermatologic Agents|dermatologic agents|mesh-ancestor
6072529|NCT00731783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6072530|NCT00731783|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6072531|NCT00731783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6072532|NCT00731783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072533|NCT00731874|Tacrolimus|tacrolimus|mesh-list
6072534|NCT00731874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6072535|NCT00731874|Immunologic Factors|immunologic factors|mesh-ancestor
6072536|NCT00731874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072537|NCT00731874|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5510449|NCT04399148|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5510450|NCT04399148|Histamine Antagonists|histamine antagonists|mesh-ancestor
5510451|NCT04399148|Histamine Agents|histamine agents|mesh-ancestor
5510452|NCT04399148|Antipruritics|antipruritics|mesh-ancestor
5510453|NCT04399148|Dermatologic Agents|dermatologic agents|mesh-ancestor
5510454|NCT04399148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5510455|NCT04398823|Polidocanol|polidocanol|mesh-list
5510456|NCT04398823|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
5510457|NCT04398823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5510458|NCT04399070|Ketamine|ketamine|mesh-list
5510459|NCT04399070|Esketamine|esketamine|mesh-list
5510460|NCT04399070|Analgesics|analgesics|mesh-ancestor
5510461|NCT04399070|Sensory System Agents|sensory system agents|mesh-ancestor
5510462|NCT04399070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5510463|NCT04399070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510464|NCT04399070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5510465|NCT04399070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5510466|NCT04399070|Anesthetics, General|anesthetics, general|mesh-ancestor
5510467|NCT04399070|Anesthetics|anesthetics|mesh-ancestor
5510468|NCT04399070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5510469|NCT04399070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5510470|NCT04399070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5510471|NCT04399070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5510472|NCT04399070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072538|NCT00731874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6072539|NCT00731874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072540|NCT00732069|Valsartan|valsartan|mesh-list
6072541|NCT00732069|Ramipril|ramipril|mesh-list
6072542|NCT00732069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6072543|NCT00732069|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6072544|NCT00732069|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6072545|NCT00732069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072546|NCT00732069|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6072547|NCT00732069|Protease Inhibitors|protease inhibitors|mesh-ancestor
6072548|NCT00732069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6072549|NCT00732212|Hemostatics|hemostatics|mesh-list
6072550|NCT00732212|Coagulants|coagulants|mesh-ancestor
6072551|NCT00732225|Hyaluronic Acid|hyaluronic acid|mesh-list
6072552|NCT00732225|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6072553|NCT00732225|Immunologic Factors|immunologic factors|mesh-ancestor
6072554|NCT00732225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072555|NCT00732225|Viscosupplements|viscosupplements|mesh-ancestor
6072556|NCT00732225|Protective Agents|protective agents|mesh-ancestor
6072557|NCT00732238|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6072558|NCT00732238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6072559|NCT00732251|Allopurinol|allopurinol|mesh-list
6072560|NCT00732251|Antimetabolites|antimetabolites|mesh-ancestor
6072561|NCT00732251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072562|NCT00732251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6072563|NCT00732251|Gout Suppressants|gout suppressants|mesh-ancestor
6072564|NCT00732251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6072565|NCT00732251|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6072566|NCT00732251|Antioxidants|antioxidants|mesh-ancestor
6072567|NCT00732251|Protective Agents|protective agents|mesh-ancestor
6072568|NCT00732251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072569|NCT00732303|Pemetrexed|pemetrexed|mesh-list
6072570|NCT00732303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6072571|NCT00732303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6072572|NCT00732303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072573|NCT00732303|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6072574|NCT00732303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6072575|NCT00732498|Cytarabine|cytarabine|mesh-list
6072576|NCT00732498|Methylprednisolone|methylprednisolone|mesh-list
6072577|NCT00732498|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6072578|NCT00732498|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5510473|NCT04399070|Antidepressive Agents|antidepressive agents|mesh-ancestor
5510474|NCT04399070|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5510475|NCT04398914|Paclitaxel|paclitaxel|mesh-list
5510476|NCT04398914|Trastuzumab|trastuzumab|mesh-list
5510477|NCT04398914|Pertuzumab|pertuzumab|mesh-list
5510478|NCT04398914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5510479|NCT04398914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5510480|NCT04398914|Tubulin Modulators|tubulin modulators|mesh-ancestor
5510481|NCT04398914|Antimitotic Agents|antimitotic agents|mesh-ancestor
5510482|NCT04398914|Mitosis Modulators|mitosis modulators|mesh-ancestor
5510483|NCT04398914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510484|NCT04398914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5510485|NCT04398927|Folfirinox|folfirinox|mesh-list
5510486|NCT04398927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5510487|NCT04399083|Caffeine|caffeine|mesh-list
5510488|NCT04399083|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5510489|NCT04399083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510490|NCT04399083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6072579|NCT00732498|Prednisolone|prednisolone|mesh-list
6072580|NCT00732498|Prednisolone acetate|prednisolone acetate|mesh-list
6072581|NCT00732498|Rituximab|rituximab|mesh-list
6072582|NCT00732498|Etoposide|etoposide|mesh-list
6072583|NCT00732498|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6072584|NCT00732498|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6072585|NCT00732498|Prednisolone phosphate|prednisolone phosphate|mesh-list
6072586|NCT00732498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6072587|NCT00732498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6072588|NCT00732498|Immunologic Factors|immunologic factors|mesh-ancestor
6072589|NCT00732498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072590|NCT00732498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6072591|NCT00732498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6072592|NCT00732498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6072593|NCT00732498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6072594|NCT00732498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6072595|NCT00732498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072596|NCT00732498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6072597|NCT00732498|Antimetabolites|antimetabolites|mesh-ancestor
6072598|NCT00732498|Antiviral Agents|antiviral agents|mesh-ancestor
6072599|NCT00732498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6072600|NCT00732498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6072601|NCT00732498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6072602|NCT00732498|Antiemetics|antiemetics|mesh-ancestor
6072603|NCT00732498|Autonomic Agents|autonomic agents|mesh-ancestor
6072604|NCT00732498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6072605|NCT00732498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6072606|NCT00732498|Glucocorticoids|glucocorticoids|mesh-ancestor
6072607|NCT00732498|Hormones|hormones|mesh-ancestor
6072608|NCT00732498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6072609|NCT00732498|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6072610|NCT00732498|Protective Agents|protective agents|mesh-ancestor
6072611|NCT00732498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5510491|NCT04399083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5510492|NCT04399083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600352|NCT03712475|Analgesics|analgesics|mesh-ancestor
5510493|NCT04399083|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5510494|NCT04399083|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5510495|NCT04399083|Purinergic Agents|purinergic agents|mesh-ancestor
5510496|NCT04399083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5510497|NCT04398537|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
5510498|NCT04398537|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
5510499|NCT04398537|beta-Endorphin|beta-endorphin|mesh-list
5510500|NCT04398537|Hormones|hormones|mesh-ancestor
5510501|NCT04398537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5510502|NCT04398537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510503|NCT04398537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5510504|NCT04398537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510505|NCT04398719|Capsaicin|capsaicin|mesh-list
5510506|NCT04398719|Antipruritics|antipruritics|mesh-ancestor
5510507|NCT04398719|Dermatologic Agents|dermatologic agents|mesh-ancestor
5510508|NCT04398719|Sensory System Agents|sensory system agents|mesh-ancestor
5510509|NCT04398719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5510510|NCT04398719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510511|NCT04398771|Valsartan|valsartan|mesh-list
6072612|NCT00732654|Immunologic Factors|immunologic factors|mesh-list
6072613|NCT00732654|Caseins|caseins|mesh-list
6072614|NCT00732654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072615|NCT00732654|Chelating Agents|chelating agents|mesh-ancestor
6072616|NCT00732654|Sequestering Agents|sequestering agents|mesh-ancestor
6072617|NCT00732654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072618|NCT00732758|Vitamin D|vitamin d|mesh-list
5510512|NCT04398771|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5510513|NCT04398771|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5510514|NCT04398771|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5510515|NCT04398771|Antimetabolites|antimetabolites|mesh-ancestor
5510516|NCT04398771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510517|NCT04398771|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5510518|NCT04398771|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5510519|NCT04398771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5510520|NCT04398771|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5510521|NCT04398771|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5510522|NCT04398771|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5510523|NCT04398589|Dexmedetomidine|dexmedetomidine|mesh-list
5510524|NCT04398589|Ropivacaine|ropivacaine|mesh-list
5510525|NCT04398589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5510526|NCT04398589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5510527|NCT04398589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510528|NCT04398589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5510529|NCT04398589|Analgesics|analgesics|mesh-ancestor
5510530|NCT04398589|Sensory System Agents|sensory system agents|mesh-ancestor
5510531|NCT04398589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5510532|NCT04398589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5510533|NCT04398589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5510534|NCT04398589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5510535|NCT04398589|Adrenergic Agents|adrenergic agents|mesh-ancestor
6072619|NCT00732758|Cholecalciferol|cholecalciferol|mesh-list
6072620|NCT00732758|Vitamins|vitamins|mesh-ancestor
6072621|NCT00732758|Micronutrients|micronutrients|mesh-ancestor
6072622|NCT00732758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072623|NCT00732758|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6072624|NCT00732758|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6072625|NCT00732875|Methotrexate|methotrexate|mesh-list
6072626|NCT00732875|Infliximab|infliximab|mesh-list
6072627|NCT00732875|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6072628|NCT00732875|Abortifacient Agents|abortifacient agents|mesh-ancestor
6072629|NCT00732875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6072630|NCT00732875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072631|NCT00732875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6072632|NCT00732875|Antimetabolites|antimetabolites|mesh-ancestor
5510536|NCT04398589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5510537|NCT04398589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510538|NCT04398589|Anesthetics, Local|anesthetics, local|mesh-ancestor
5510539|NCT04398589|Anesthetics|anesthetics|mesh-ancestor
5510540|NCT04398251|Febuxostat|febuxostat|mesh-list
5510541|NCT04398251|Gout Suppressants|gout suppressants|mesh-ancestor
5510542|NCT04398251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5510543|NCT04398108|Margetuximab|margetuximab|mesh-list
6072633|NCT00732875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072634|NCT00732875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6072635|NCT00732875|Dermatologic Agents|dermatologic agents|mesh-ancestor
6072636|NCT00732875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6072637|NCT00732875|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6072638|NCT00732875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6072639|NCT00732875|Immunologic Factors|immunologic factors|mesh-ancestor
6072640|NCT00732875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6072641|NCT00732875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6072642|NCT00732875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6072643|NCT00732901|Citalopram|citalopram|mesh-list
6072644|NCT00732901|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6072645|NCT00732901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6072646|NCT00732901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6072647|NCT00732901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072648|NCT00732901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6072649|NCT00732901|Serotonin Agents|serotonin agents|mesh-ancestor
6072650|NCT00732901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072651|NCT00732901|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6072652|NCT00732901|Antidepressive Agents|antidepressive agents|mesh-ancestor
6072653|NCT00732901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6072654|NCT00732940|Belimumab|belimumab|mesh-list
6072655|NCT00732940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6072656|NCT00732940|Immunologic Factors|immunologic factors|mesh-ancestor
6072657|NCT00732940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072658|NCT00732992|Pemetrexed|pemetrexed|mesh-list
6072659|NCT00732992|Sunitinib|sunitinib|mesh-list
6072660|NCT00732992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6072661|NCT00732992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6072662|NCT00732992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072663|NCT00732992|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6072664|NCT00732992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6072665|NCT00732992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6072666|NCT00732992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6072667|NCT00732992|Growth Substances|growth substances|mesh-ancestor
6072668|NCT00732992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072669|NCT00732992|Growth Inhibitors|growth inhibitors|mesh-ancestor
6072670|NCT00732992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6072671|NCT00733096|Methylprednisolone|methylprednisolone|mesh-list
6072672|NCT00733096|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6072673|NCT00733096|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6072674|NCT00733096|Prednisolone|prednisolone|mesh-list
6072675|NCT00733096|Prednisolone acetate|prednisolone acetate|mesh-list
6072676|NCT00733096|Etanercept|etanercept|mesh-list
6072677|NCT00733096|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6072678|NCT00733096|Prednisolone phosphate|prednisolone phosphate|mesh-list
6072679|NCT00733096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6072680|NCT00733096|Antiemetics|antiemetics|mesh-ancestor
6072681|NCT00733096|Autonomic Agents|autonomic agents|mesh-ancestor
6072682|NCT00733096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6072683|NCT00733096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072684|NCT00733096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6072685|NCT00733096|Glucocorticoids|glucocorticoids|mesh-ancestor
6072686|NCT00733096|Hormones|hormones|mesh-ancestor
6072687|NCT00733096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6072688|NCT00733096|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6072689|NCT00733096|Protective Agents|protective agents|mesh-ancestor
6072690|NCT00733096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6072691|NCT00733096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6072692|NCT00733096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5510544|NCT04398108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5510545|NCT04398290|Nitric Oxide|nitric oxide|mesh-list
5510546|NCT04398290|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6072693|NCT00733096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6072694|NCT00733096|Analgesics|analgesics|mesh-ancestor
6072695|NCT00733096|Sensory System Agents|sensory system agents|mesh-ancestor
6072696|NCT00733096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6072697|NCT00733096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6072698|NCT00733096|Immunologic Factors|immunologic factors|mesh-ancestor
6072699|NCT00733226|Broncho-Vaxom|broncho-vaxom|mesh-list
5510547|NCT04398290|Autonomic Agents|autonomic agents|mesh-ancestor
5510548|NCT04398290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5510549|NCT04398290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510550|NCT04398290|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5510551|NCT04398290|Respiratory System Agents|respiratory system agents|mesh-ancestor
5510552|NCT04398290|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6072700|NCT00733226|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6072701|NCT00733226|Immunologic Factors|immunologic factors|mesh-ancestor
6072702|NCT00733226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072703|NCT00733278|Copper|copper|mesh-list
6072704|NCT00733278|Contraceptive Agents|contraceptive agents|mesh-list
6072705|NCT00733278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6072706|NCT00733278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072707|NCT00733278|Trace Elements|trace elements|mesh-ancestor
6072708|NCT00733278|Micronutrients|micronutrients|mesh-ancestor
6072709|NCT00733291|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6072710|NCT00733356|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6072711|NCT00733356|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6072712|NCT00733356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072713|NCT00733356|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6072714|NCT00733356|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6072715|NCT00733356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6072716|NCT00733356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072717|NCT00733356|Dopamine Agents|dopamine agents|mesh-ancestor
6072718|NCT00733356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6202658|NCT02044393|Antifungal Agents|antifungal agents|mesh-ancestor
6202659|NCT02044393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6202660|NCT02044393|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6202661|NCT02044393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6202662|NCT02044393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6202663|NCT02044393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202664|NCT02044393|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6202665|NCT02044393|Hormone Antagonists|hormone antagonists|mesh-ancestor
5510553|NCT04398290|Antioxidants|antioxidants|mesh-ancestor
6072719|NCT00733408|Paclitaxel|paclitaxel|mesh-list
6072720|NCT00733408|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6072721|NCT00733408|Bevacizumab|bevacizumab|mesh-list
6072722|NCT00733408|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6072723|NCT00733408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6072724|NCT00733408|Antibodies|antibodies|mesh-list
6072725|NCT00733408|Immunoglobulins|immunoglobulins|mesh-list
6072726|NCT00733408|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6072727|NCT00733408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6072728|NCT00733408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6072729|NCT00733408|Tubulin Modulators|tubulin modulators|mesh-ancestor
5725056|NCT03182894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5725057|NCT03182894|Antimetabolites|antimetabolites|mesh-ancestor
5725058|NCT03182894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725059|NCT03182894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5725060|NCT03182803|Antibodies|antibodies|mesh-list
5725061|NCT03182803|Immunologic Factors|immunologic factors|mesh-ancestor
5725062|NCT03182803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725063|NCT03183024|Benralizumab|benralizumab|mesh-list
5725064|NCT03183024|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5725065|NCT03183024|Respiratory System Agents|respiratory system agents|mesh-ancestor
5725066|NCT03182673|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
5725067|NCT03182673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5725068|NCT03182673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725069|NCT03182673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5725070|NCT03182855|Ticagrelor|ticagrelor|mesh-list
5725071|NCT03182855|Cangrelor|cangrelor|mesh-list
6072730|NCT00733408|Antimitotic Agents|antimitotic agents|mesh-ancestor
6072731|NCT00733408|Mitosis Modulators|mitosis modulators|mesh-ancestor
6072732|NCT00733408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072733|NCT00733408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6072734|NCT00733408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6072735|NCT00733408|Growth Substances|growth substances|mesh-ancestor
6072736|NCT00733408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072737|NCT00733408|Growth Inhibitors|growth inhibitors|mesh-ancestor
6072738|NCT00733408|Immunologic Factors|immunologic factors|mesh-ancestor
6072739|NCT00733408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6072740|NCT00733408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6072741|NCT00733421|Etoricoxib|etoricoxib|mesh-list
6072742|NCT00733421|Tramadol|tramadol|mesh-list
6072743|NCT00733421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6072744|NCT00733421|Narcotics|narcotics|mesh-ancestor
6072745|NCT00733421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5510554|NCT04398290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510555|NCT04398290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5510556|NCT04398290|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5510557|NCT04398290|Vasodilator Agents|vasodilator agents|mesh-ancestor
5510558|NCT04398290|Gasotransmitters|gasotransmitters|mesh-ancestor
5510559|NCT04398290|Protective Agents|protective agents|mesh-ancestor
5510560|NCT04398316|Lidocaine|lidocaine|mesh-list
5510561|NCT04398316|Hydromorphone|hydromorphone|mesh-list
5510562|NCT04398316|Anesthetics, Local|anesthetics, local|mesh-ancestor
5510563|NCT04398316|Anesthetics|anesthetics|mesh-ancestor
5510564|NCT04398316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5510565|NCT04398316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510566|NCT04398316|Sensory System Agents|sensory system agents|mesh-ancestor
5510567|NCT04398316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5510568|NCT04398316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5510569|NCT04398316|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5510570|NCT04398316|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5510571|NCT04398316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5510572|NCT04398316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072746|NCT00733421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072747|NCT00733421|Analgesics|analgesics|mesh-ancestor
6072748|NCT00733421|Sensory System Agents|sensory system agents|mesh-ancestor
6072749|NCT00733421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6072750|NCT00733421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6072751|NCT00733421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6072752|NCT00733421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6072753|NCT00733421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6072754|NCT00733421|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5510573|NCT04398316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6072755|NCT00733421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6072756|NCT00733421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6207728|NCT02119650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6072757|NCT00733421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072758|NCT00733746|Gemcitabine|gemcitabine|mesh-list
6072759|NCT00733746|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6072760|NCT00733746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6072761|NCT00733746|Antimetabolites|antimetabolites|mesh-ancestor
6072762|NCT00733746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072763|NCT00733746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6072764|NCT00733746|Antiviral Agents|antiviral agents|mesh-ancestor
6072765|NCT00733746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6072766|NCT00733746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6072767|NCT00733746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6072768|NCT00733746|Immunologic Factors|immunologic factors|mesh-ancestor
6072769|NCT00733746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072770|NCT00733746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6463517|NCT00464958|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6463518|NCT00464958|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6463519|NCT00464958|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6072771|NCT00733824|Plerixafor|plerixafor|mesh-list
6072772|NCT00733824|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6072773|NCT00733824|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6072774|NCT00733824|Antiviral Agents|antiviral agents|mesh-ancestor
6072775|NCT00733824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6072776|NCT00733902|Tanezumab|tanezumab|mesh-list
6072777|NCT00733902|Analgesics|analgesics|mesh-ancestor
6072778|NCT00733902|Sensory System Agents|sensory system agents|mesh-ancestor
6072779|NCT00733902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6072780|NCT00733902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072781|NCT00733954|Clobetasol|clobetasol|mesh-list
6072782|NCT00733954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6072783|NCT00733954|Glucocorticoids|glucocorticoids|mesh-ancestor
6072784|NCT00733954|Hormones|hormones|mesh-ancestor
6072785|NCT00733954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6072786|NCT00733954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072787|NCT00733993|Caffeine|caffeine|mesh-list
6072788|NCT00733993|Amphetamine|amphetamine|mesh-list
6072789|NCT00733993|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6072790|NCT00733993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072791|NCT00733993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6072792|NCT00733993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6072793|NCT00733993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072794|NCT00733993|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6072795|NCT00733993|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6072796|NCT00733993|Purinergic Agents|purinergic agents|mesh-ancestor
6072797|NCT00733993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6072798|NCT00733993|Sympathomimetics|sympathomimetics|mesh-ancestor
6072799|NCT00733993|Autonomic Agents|autonomic agents|mesh-ancestor
6072800|NCT00733993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6072801|NCT00733993|Dopamine Agents|dopamine agents|mesh-ancestor
6072802|NCT00733993|Adrenergic Agents|adrenergic agents|mesh-ancestor
6072803|NCT00733993|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6072804|NCT00733993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6072805|NCT00733993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6072806|NCT00733993|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6072807|NCT00734032|Darapladib|darapladib|mesh-list
5510574|NCT04398316|Narcotics|narcotics|mesh-ancestor
5510575|NCT04398316|Analgesics|analgesics|mesh-ancestor
5510576|NCT04398004|Clarithromycin|clarithromycin|mesh-list
6072808|NCT00734032|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
6072809|NCT00734032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6072810|NCT00734032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072811|NCT00734071|Vortioxetine|vortioxetine|mesh-list
6072812|NCT00734071|Antidepressive Agents|antidepressive agents|mesh-ancestor
6072813|NCT00734071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6072814|NCT00734071|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6072815|NCT00734071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6072816|NCT00734071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6072817|NCT00734071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072818|NCT00734071|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6072819|NCT00734071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6072820|NCT00734071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6072821|NCT00734071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072822|NCT00734071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6072823|NCT00734071|Serotonin Agents|serotonin agents|mesh-ancestor
6072824|NCT00734071|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6072825|NCT00734071|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6072826|NCT00734071|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6072827|NCT00734071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6072828|NCT00734097|Esomeprazole|esomeprazole|mesh-list
6072829|NCT00734097|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6072830|NCT00734097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6072831|NCT00734097|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6072832|NCT00734097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6072833|NCT00734097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072834|NCT00734149|Prednisone|prednisone|mesh-list
6072835|NCT00734149|Bortezomib|bortezomib|mesh-list
6072836|NCT00734149|Melphalan|melphalan|mesh-list
6072837|NCT00734149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6072838|NCT00734149|Glucocorticoids|glucocorticoids|mesh-ancestor
6072839|NCT00734149|Hormones|hormones|mesh-ancestor
6072840|NCT00734149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6072841|NCT00734149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072842|NCT00734149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6072843|NCT00734149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6072844|NCT00734149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6072845|NCT00734149|Alkylating Agents|alkylating agents|mesh-ancestor
6072846|NCT00734149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072847|NCT00734149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5510577|NCT04398004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5510578|NCT04398004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5510579|NCT04398004|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5510580|NCT04398004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5510581|NCT04398004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510582|NCT04398004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5510583|NCT04398004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5510584|NCT04397770|Temozolomide|temozolomide|mesh-list
5510585|NCT04397770|Apatinib|apatinib|mesh-list
5510586|NCT04397770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5510587|NCT04397770|Alkylating Agents|alkylating agents|mesh-ancestor
5510588|NCT04397770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510589|NCT04397770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5510590|NCT04397770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5510591|NCT04397770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5510592|NCT04397601|Bevacizumab|bevacizumab|mesh-list
5510593|NCT04397601|Aflibercept|aflibercept|mesh-list
5510594|NCT04397601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5510595|NCT04397601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5510596|NCT04397601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5510597|NCT04397601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5510598|NCT04397601|Growth Substances|growth substances|mesh-ancestor
5510599|NCT04397601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510600|NCT04397601|Growth Inhibitors|growth inhibitors|mesh-ancestor
6072848|NCT00734149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6072849|NCT00734149|Immunologic Factors|immunologic factors|mesh-ancestor
6072850|NCT00734162|Tenofovir|tenofovir|mesh-list
6072851|NCT00734162|Antiviral Agents|antiviral agents|mesh-ancestor
6463520|NCT00464958|Adrenergic Agents|adrenergic agents|mesh-ancestor
5510601|NCT04397991|Furosemide|furosemide|mesh-list
5510602|NCT04397991|Diuretics|diuretics|mesh-ancestor
5510603|NCT04397991|Natriuretic Agents|natriuretic agents|mesh-ancestor
5510604|NCT04397991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072852|NCT00734162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6072853|NCT00734162|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6072854|NCT00734162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6072855|NCT00734162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6072856|NCT00734162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072857|NCT00734162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6072858|NCT00734162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5510605|NCT04397991|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5510606|NCT04397991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5510607|NCT04397991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510608|NCT04397653|Ezetimibe|ezetimibe|mesh-list
5510609|NCT04397653|Evolocumab|evolocumab|mesh-list
6072859|NCT00734344|Tenofovir|tenofovir|mesh-list
6072860|NCT00734344|Efavirenz|efavirenz|mesh-list
6072861|NCT00734344|Raltegravir Potassium|raltegravir potassium|mesh-list
6072862|NCT00734344|Antiviral Agents|antiviral agents|mesh-ancestor
6072863|NCT00734344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6072864|NCT00734344|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6072865|NCT00734344|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6072866|NCT00734344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6072867|NCT00734344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072868|NCT00734344|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6072869|NCT00734344|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6072870|NCT00734344|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6463521|NCT00464958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6463522|NCT00464958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463523|NCT00464971|Estradiol|estradiol|mesh-list
6463524|NCT00464971|Estrogens|estrogens|mesh-ancestor
5510610|NCT04397653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5510611|NCT04397653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5510612|NCT04397653|Antimetabolites|antimetabolites|mesh-ancestor
5510613|NCT04397653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510614|NCT04397653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5510615|NCT04397679|Chloroquine|chloroquine|mesh-list
5510616|NCT04397679|Temozolomide|temozolomide|mesh-list
5510617|NCT04397679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5510618|NCT04397679|Alkylating Agents|alkylating agents|mesh-ancestor
5510619|NCT04397679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510620|NCT04397679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5510621|NCT04397679|Amebicides|amebicides|mesh-ancestor
5510622|NCT04397679|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5510623|NCT04397679|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5510624|NCT04397679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5510625|NCT04397679|Antimalarials|antimalarials|mesh-ancestor
5510626|NCT04397679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5510627|NCT04397692|Nitric Oxide|nitric oxide|mesh-list
5510628|NCT04397692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5510629|NCT04397692|Autonomic Agents|autonomic agents|mesh-ancestor
5510630|NCT04397692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5510631|NCT04397692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510632|NCT04397692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5510633|NCT04397692|Respiratory System Agents|respiratory system agents|mesh-ancestor
5510634|NCT04397692|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5510635|NCT04397692|Antioxidants|antioxidants|mesh-ancestor
5510636|NCT04397692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510637|NCT04397692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5510638|NCT04397692|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5510639|NCT04397692|Vasodilator Agents|vasodilator agents|mesh-ancestor
5510640|NCT04397692|Gasotransmitters|gasotransmitters|mesh-ancestor
5510641|NCT04397692|Protective Agents|protective agents|mesh-ancestor
5510642|NCT04397913|Acetaminophen|acetaminophen|mesh-list
5510643|NCT04397913|Ibuprofen|ibuprofen|mesh-list
5510644|NCT04397913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5510645|NCT04397913|Analgesics|analgesics|mesh-ancestor
5510646|NCT04397913|Sensory System Agents|sensory system agents|mesh-ancestor
6463525|NCT00464971|Hormones|hormones|mesh-ancestor
6463526|NCT00464971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6072871|NCT00734344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6072872|NCT00734344|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6072873|NCT00734344|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5510647|NCT04397913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6072874|NCT00734344|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6072875|NCT00734344|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6072876|NCT00734344|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6072877|NCT00734344|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6072878|NCT00734474|Metformin|metformin|mesh-list
6072879|NCT00734474|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6072880|NCT00734474|Dulaglutide|dulaglutide|mesh-list
6072881|NCT00734474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6072882|NCT00734474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072883|NCT00734474|Incretins|incretins|mesh-ancestor
6072884|NCT00734474|Hormones|hormones|mesh-ancestor
6072885|NCT00734474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6072886|NCT00734474|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6072887|NCT00734474|Protease Inhibitors|protease inhibitors|mesh-ancestor
6072888|NCT00734474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6072889|NCT00734474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072890|NCT00734500|Anidulafungin|anidulafungin|mesh-list
6072891|NCT00734500|Antifungal Agents|antifungal agents|mesh-ancestor
6072892|NCT00734500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6072893|NCT00734539|Fluconazole|fluconazole|mesh-list
6072894|NCT00734539|Antifungal Agents|antifungal agents|mesh-ancestor
6072895|NCT00734539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6072896|NCT00734539|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6072897|NCT00734539|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6072898|NCT00734539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6072899|NCT00734539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072900|NCT00734539|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6072901|NCT00734539|Hormone Antagonists|hormone antagonists|mesh-ancestor
6072902|NCT00734539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6072903|NCT00734539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072904|NCT00734539|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6072905|NCT00734539|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5510648|NCT04397913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510649|NCT04397913|Antipyretics|antipyretics|mesh-ancestor
5510650|NCT04397913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5510651|NCT04397913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5510652|NCT04397913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5510653|NCT04397913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5510654|NCT04397913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5510655|NCT04397913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510656|NCT04397497|Mavrilimumab|mavrilimumab|mesh-list
5510657|NCT04397497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5510658|NCT04397341|Docetaxel|docetaxel|mesh-list
5510659|NCT04397341|Fluorouracil|fluorouracil|mesh-list
5510660|NCT04397341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5510661|NCT04397341|Tubulin Modulators|tubulin modulators|mesh-ancestor
5510662|NCT04397341|Antimitotic Agents|antimitotic agents|mesh-ancestor
5510663|NCT04397341|Mitosis Modulators|mitosis modulators|mesh-ancestor
5510664|NCT04397341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510665|NCT04397341|Antimetabolites|antimetabolites|mesh-ancestor
5510666|NCT04397341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5510667|NCT04397341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5510668|NCT04397341|Immunologic Factors|immunologic factors|mesh-ancestor
5510669|NCT04397341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510670|NCT04397458|Dexamethasone|dexamethasone|mesh-list
5510671|NCT04397458|Bupivacaine|bupivacaine|mesh-list
6072906|NCT00734578|Guanfacine|guanfacine|mesh-list
6072907|NCT00734578|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6072908|NCT00734578|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6072909|NCT00734578|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6072910|NCT00734578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6072911|NCT00734578|Adrenergic Agents|adrenergic agents|mesh-ancestor
6072912|NCT00734578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6072913|NCT00734578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072914|NCT00734578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072915|NCT00734604|Sildenafil Citrate|sildenafil citrate|mesh-list
6072916|NCT00734604|Tadalafil|tadalafil|mesh-list
6072917|NCT00734604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072918|NCT00734604|Vasodilator Agents|vasodilator agents|mesh-ancestor
6072919|NCT00734604|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6072920|NCT00734604|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5510672|NCT04397458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6072921|NCT00734604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6072922|NCT00734604|Urological Agents|urological agents|mesh-ancestor
6072923|NCT00734617|Nicotine|nicotine|mesh-list
5510673|NCT04397458|Antiemetics|antiemetics|mesh-ancestor
5510674|NCT04397458|Autonomic Agents|autonomic agents|mesh-ancestor
5510675|NCT04397458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5510676|NCT04397458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510677|NCT04397458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6072924|NCT00734617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6072925|NCT00734617|Autonomic Agents|autonomic agents|mesh-ancestor
6072926|NCT00734617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6072927|NCT00734617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072928|NCT00734617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6072929|NCT00734617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6072930|NCT00734617|Cholinergic Agents|cholinergic agents|mesh-ancestor
6072931|NCT00734617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6072932|NCT00734617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072933|NCT00734630|Losartan|losartan|mesh-list
6072934|NCT00734630|Lisinopril|lisinopril|mesh-list
6072935|NCT00734630|Nebivolol|nebivolol|mesh-list
6072936|NCT00734630|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6072937|NCT00734630|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6072938|NCT00734630|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6072939|NCT00734630|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6072940|NCT00734630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072941|NCT00734630|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6072942|NCT00734630|Protease Inhibitors|protease inhibitors|mesh-ancestor
6072943|NCT00734630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5510678|NCT04397458|Glucocorticoids|glucocorticoids|mesh-ancestor
5510679|NCT04397458|Hormones|hormones|mesh-ancestor
5510680|NCT04397458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5510681|NCT04397458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5510682|NCT04397458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5510683|NCT04397458|Anesthetics, Local|anesthetics, local|mesh-ancestor
5510684|NCT04397458|Anesthetics|anesthetics|mesh-ancestor
5510685|NCT04397458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5510686|NCT04397458|Sensory System Agents|sensory system agents|mesh-ancestor
5510687|NCT04397510|Heparin|heparin|mesh-list
5510688|NCT04397510|Anticoagulants|anticoagulants|mesh-ancestor
5510689|NCT04397510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5510690|NCT04397510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5510691|NCT04397510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072944|NCT00734630|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6072945|NCT00734630|Protective Agents|protective agents|mesh-ancestor
6072946|NCT00734630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072947|NCT00734630|Vasodilator Agents|vasodilator agents|mesh-ancestor
6072948|NCT00734630|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6072949|NCT00734630|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6072950|NCT00734630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6072951|NCT00734630|Adrenergic Agents|adrenergic agents|mesh-ancestor
6072952|NCT00734630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6072953|NCT00734656|Ethanol|ethanol|mesh-list
6072954|NCT00734656|Dutasteride|dutasteride|mesh-list
6072955|NCT00734656|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6072956|NCT00734656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6072957|NCT00734656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6072958|NCT00734656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072959|NCT00734656|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6072960|NCT00734656|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6072961|NCT00734656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6072962|NCT00734656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072963|NCT00734656|Hormone Antagonists|hormone antagonists|mesh-ancestor
6072964|NCT00734656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6072965|NCT00734851|Docetaxel|docetaxel|mesh-list
6072966|NCT00734851|Sunitinib|sunitinib|mesh-list
6072967|NCT00734851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6072968|NCT00734851|Tubulin Modulators|tubulin modulators|mesh-ancestor
6072969|NCT00734851|Antimitotic Agents|antimitotic agents|mesh-ancestor
6463527|NCT00464971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463528|NCT00465036|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
6463529|NCT00465036|Cathartics|cathartics|mesh-ancestor
6463530|NCT00465036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6463531|NCT00465075|Bazedoxifene|bazedoxifene|mesh-list
5510692|NCT04397393|Midazolam|midazolam|mesh-list
5510693|NCT04397393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6072970|NCT00734851|Mitosis Modulators|mitosis modulators|mesh-ancestor
6463532|NCT00465075|Estrogens|estrogens|mesh-list
6072971|NCT00734851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072972|NCT00734851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6463533|NCT00465075|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6463534|NCT00465075|Hormones|hormones|mesh-ancestor
6463535|NCT00465075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6463536|NCT00465075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463537|NCT00465075|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6463538|NCT00465075|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6463539|NCT00465075|Hormone Antagonists|hormone antagonists|mesh-ancestor
6463540|NCT00465075|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6463541|NCT00465192|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6463542|NCT00465192|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6463543|NCT00465192|Estradiol|estradiol|mesh-list
6665400|NCT01516944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665401|NCT01516944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6665402|NCT01516996|Docetaxel|docetaxel|mesh-list
6665403|NCT01516996|Nimotuzumab|nimotuzumab|mesh-list
6072973|NCT00734851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6072974|NCT00734851|Growth Substances|growth substances|mesh-ancestor
6072975|NCT00734851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072976|NCT00734851|Growth Inhibitors|growth inhibitors|mesh-ancestor
6072977|NCT00734851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6072978|NCT00734851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6072979|NCT00734929|Dexamethasone|dexamethasone|mesh-list
6072980|NCT00734929|Dexamethasone acetate|dexamethasone acetate|mesh-list
6072981|NCT00734929|Ondansetron|ondansetron|mesh-list
6072982|NCT00734929|Aprepitant|aprepitant|mesh-list
6072983|NCT00734929|BB 1101|bb 1101|mesh-list
6072984|NCT00734929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6072985|NCT00734929|Antiemetics|antiemetics|mesh-ancestor
6072986|NCT00734929|Autonomic Agents|autonomic agents|mesh-ancestor
6072987|NCT00734929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6072988|NCT00734929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6072989|NCT00734929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6072990|NCT00734929|Glucocorticoids|glucocorticoids|mesh-ancestor
6072991|NCT00734929|Hormones|hormones|mesh-ancestor
6072992|NCT00734929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6072993|NCT00734929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6072994|NCT00734929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6072995|NCT00734929|Protease Inhibitors|protease inhibitors|mesh-ancestor
6072996|NCT00734929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6072997|NCT00734929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6072998|NCT00734929|Antipruritics|antipruritics|mesh-ancestor
6072999|NCT00734929|Dermatologic Agents|dermatologic agents|mesh-ancestor
6073000|NCT00734929|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6073001|NCT00734929|Serotonin Agents|serotonin agents|mesh-ancestor
6073002|NCT00734929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6073003|NCT00734929|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6073004|NCT00734929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6073005|NCT00734929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6073006|NCT00734929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6073007|NCT00734929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6073008|NCT00734929|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6073009|NCT00734968|Nitrofurantoin|nitrofurantoin|mesh-list
6073010|NCT00734968|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6073011|NCT00734968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6073012|NCT00734968|Renal Agents|renal agents|mesh-ancestor
6073013|NCT00734968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6073014|NCT00734994|Mitomycins|mitomycins|mesh-list
6073015|NCT00734994|Mitomycin|mitomycin|mesh-list
6073016|NCT00734994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6073017|NCT00734994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6073018|NCT00734994|Alkylating Agents|alkylating agents|mesh-ancestor
6073019|NCT00734994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073020|NCT00734994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6073021|NCT00734994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6073022|NCT00735072|Maraviroc|maraviroc|mesh-list
6073023|NCT00735072|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6073024|NCT00735072|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6073025|NCT00735072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073026|NCT00735072|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6073027|NCT00735072|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6073028|NCT00735072|Antiviral Agents|antiviral agents|mesh-ancestor
6463544|NCT00465192|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6665404|NCT01516996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6073029|NCT00735072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6073030|NCT00735072|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6073031|NCT00735306|Bevacizumab|bevacizumab|mesh-list
6073032|NCT00735306|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6073033|NCT00735306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6073034|NCT00735306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6073035|NCT00735306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6073036|NCT00735306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6073037|NCT00735306|Growth Substances|growth substances|mesh-ancestor
6073038|NCT00735306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073039|NCT00735306|Growth Inhibitors|growth inhibitors|mesh-ancestor
6073040|NCT00735306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6073041|NCT00735306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6073042|NCT00735306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073043|NCT00735371|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6073044|NCT00735371|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6073045|NCT00735371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073046|NCT00735371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6073047|NCT00735371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6073048|NCT00735371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6073049|NCT00735371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073050|NCT00735371|Dopamine Agents|dopamine agents|mesh-ancestor
6073051|NCT00735371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6073052|NCT00735436|Bevacizumab|bevacizumab|mesh-list
6073053|NCT00735436|Irinotecan|irinotecan|mesh-list
6073054|NCT00735436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6073055|NCT00735436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6073056|NCT00735436|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6073057|NCT00735436|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6073058|NCT00735436|Growth Substances|growth substances|mesh-ancestor
6073059|NCT00735436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073060|NCT00735436|Growth Inhibitors|growth inhibitors|mesh-ancestor
6073061|NCT00735436|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6073062|NCT00735436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6073063|NCT00735436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6073064|NCT00735436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073065|NCT00735449|Timolol|timolol|mesh-list
6073066|NCT00735449|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6073067|NCT00735449|Latanoprost|latanoprost|mesh-list
6073068|NCT00735449|Maleic acid|maleic acid|mesh-list
6073069|NCT00735449|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6073070|NCT00735449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6073071|NCT00735449|Adrenergic Agents|adrenergic agents|mesh-ancestor
6073072|NCT00735449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6073073|NCT00735449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073074|NCT00735449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073075|NCT00735449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6073076|NCT00735449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6073077|NCT00735449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6073078|NCT00735449|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6073079|NCT00735449|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6463545|NCT00465192|Estrogens|estrogens|mesh-ancestor
6463546|NCT00465192|Hormones|hormones|mesh-ancestor
5510694|NCT04397393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5510695|NCT04397393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5510696|NCT04397393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510697|NCT04397393|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5510698|NCT04397393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5510699|NCT04397393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5510700|NCT04397393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5510701|NCT04397393|Anesthetics, General|anesthetics, general|mesh-ancestor
6073080|NCT00735449|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6073081|NCT00735449|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6073082|NCT00735449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6073083|NCT00735462|Imiquimod|imiquimod|mesh-list
6073084|NCT00735462|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6073085|NCT00735462|Immunologic Factors|immunologic factors|mesh-ancestor
6073086|NCT00735462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073087|NCT00735462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5510702|NCT04397393|Anesthetics|anesthetics|mesh-ancestor
5510703|NCT04397393|GABA Modulators|gaba modulators|mesh-ancestor
6073088|NCT00735462|Interferon Inducers|interferon inducers|mesh-ancestor
6073089|NCT00735475|Vaccines|vaccines|mesh-list
6073090|NCT00735475|Immunologic Factors|immunologic factors|mesh-ancestor
6073091|NCT00735475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073092|NCT00735644|Vaccines|vaccines|mesh-list
6073093|NCT00735644|Immunologic Factors|immunologic factors|mesh-ancestor
6073094|NCT00735644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073095|NCT00735670|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6073096|NCT00735670|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6073097|NCT00735670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6073098|NCT00735670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6073099|NCT00735670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073100|NCT00735670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6073101|NCT00735670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073102|NCT00735670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6073103|NCT00735670|Antidepressive Agents|antidepressive agents|mesh-ancestor
5510704|NCT04397393|GABA Agents|gaba agents|mesh-ancestor
5510705|NCT04397393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5510706|NCT04397393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600353|NCT03712475|Sensory System Agents|sensory system agents|mesh-ancestor
5600354|NCT03712475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5600355|NCT03712475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073104|NCT00735670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6073105|NCT00735696|Paclitaxel|paclitaxel|mesh-list
6073106|NCT00735696|Carboplatin|carboplatin|mesh-list
6073107|NCT00735696|Ramucirumab|ramucirumab|mesh-list
6073108|NCT00735696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6073109|NCT00735696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6073110|NCT00735696|Tubulin Modulators|tubulin modulators|mesh-ancestor
6073111|NCT00735696|Antimitotic Agents|antimitotic agents|mesh-ancestor
6073112|NCT00735696|Mitosis Modulators|mitosis modulators|mesh-ancestor
6073113|NCT00735696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073114|NCT00735709|Vortioxetine|vortioxetine|mesh-list
6073115|NCT00735709|Antidepressive Agents|antidepressive agents|mesh-ancestor
6073116|NCT00735709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6073117|NCT00735709|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6073118|NCT00735709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6073119|NCT00735709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6073120|NCT00735709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073121|NCT00735709|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6073122|NCT00735709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6073123|NCT00735709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5600356|NCT03712475|Anticonvulsants|anticonvulsants|mesh-ancestor
5600357|NCT03712475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5600358|NCT03712475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5600359|NCT03712475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600360|NCT03712475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5600361|NCT03712475|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5600362|NCT03712475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6073124|NCT00735709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073125|NCT00735709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6073126|NCT00735709|Serotonin Agents|serotonin agents|mesh-ancestor
6073127|NCT00735709|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6073128|NCT00735709|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6073129|NCT00735709|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6073130|NCT00735709|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6073131|NCT00735787|Adalimumab|adalimumab|mesh-list
6073132|NCT00735787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6073133|NCT00735787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6073134|NCT00735826|Vorinostat|vorinostat|mesh-list
6073135|NCT00735826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6073136|NCT00735826|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6073137|NCT00735826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6073138|NCT00735826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073139|NCT00735878|Carboplatin|carboplatin|mesh-list
6073140|NCT00735878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6073141|NCT00735904|Gemcitabine|gemcitabine|mesh-list
6073142|NCT00735904|Axitinib|axitinib|mesh-list
6073143|NCT00735904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6073144|NCT00735904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6073145|NCT00735904|Antimetabolites|antimetabolites|mesh-ancestor
6073146|NCT00735904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073147|NCT00735904|Antiviral Agents|antiviral agents|mesh-ancestor
6073148|NCT00735904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6073149|NCT00735904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6463547|NCT00465192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6463548|NCT00465192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463549|NCT00465192|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6073150|NCT00735904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6073151|NCT00735904|Immunologic Factors|immunologic factors|mesh-ancestor
6073152|NCT00735904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073153|NCT00735904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6073154|NCT00735917|Saracatinib|saracatinib|mesh-list
6073155|NCT00735917|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6073156|NCT00735917|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6073157|NCT00735917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073158|NCT00735917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6073159|NCT00735917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6073160|NCT00735969|Ribavirin|ribavirin|mesh-list
6073161|NCT00735969|Antimetabolites|antimetabolites|mesh-ancestor
6073162|NCT00735969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073163|NCT00735969|Antiviral Agents|antiviral agents|mesh-ancestor
6073164|NCT00735969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6073165|NCT00736073|Aprepitant|aprepitant|mesh-list
6073166|NCT00736073|Antiemetics|antiemetics|mesh-ancestor
6073167|NCT00736073|Autonomic Agents|autonomic agents|mesh-ancestor
6073168|NCT00736073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6073169|NCT00736073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073170|NCT00736073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6073171|NCT00736073|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6073172|NCT00736073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6073173|NCT00736073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073174|NCT00736099|Pioglitazone|pioglitazone|mesh-list
6073175|NCT00736099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6073176|NCT00736099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073177|NCT00736190|Tenofovir|tenofovir|mesh-list
6073178|NCT00736190|Antiviral Agents|antiviral agents|mesh-ancestor
6073179|NCT00736190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6073180|NCT00736190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6073181|NCT00736190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6073182|NCT00736190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6073183|NCT00736190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073184|NCT00736190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6073185|NCT00736190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6073186|NCT00736229|Exenatide|exenatide|mesh-list
6073187|NCT00736229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6073188|NCT00736229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073189|NCT00736229|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6073190|NCT00736229|Incretins|incretins|mesh-ancestor
6073191|NCT00736229|Hormones|hormones|mesh-ancestor
6073192|NCT00736229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6073193|NCT00736242|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6073194|NCT00736242|Interferon alpha-2|interferon alpha-2|mesh-list
6073195|NCT00736242|Antiviral Agents|antiviral agents|mesh-ancestor
6073196|NCT00736242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6073197|NCT00736242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6073198|NCT00736255|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6073199|NCT00736255|Dextroamphetamine|dextroamphetamine|mesh-list
6073200|NCT00736255|Nicotine|nicotine|mesh-list
6073201|NCT00736255|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6463550|NCT00465192|Contraceptive Agents|contraceptive agents|mesh-ancestor
6463551|NCT00465192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6463552|NCT00465192|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6463553|NCT00465205|Valacyclovir|valacyclovir|mesh-list
6463554|NCT00465205|Antiviral Agents|antiviral agents|mesh-ancestor
6463555|NCT00465205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6463556|NCT00465231|Fentanyl|fentanyl|mesh-list
6463557|NCT00465231|Bupivacaine|bupivacaine|mesh-list
6463558|NCT00465231|Anesthetics, Local|anesthetics, local|mesh-ancestor
6073202|NCT00736255|Autonomic Agents|autonomic agents|mesh-ancestor
6073203|NCT00736255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6073204|NCT00736255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073205|NCT00736255|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6073206|NCT00736255|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6073207|NCT00736255|Cholinergic Agents|cholinergic agents|mesh-ancestor
6073208|NCT00736255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6073209|NCT00736255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073210|NCT00736255|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5510707|NCT04397289|Heparin|heparin|mesh-list
5510708|NCT04397289|Rivaroxaban|rivaroxaban|mesh-list
5510709|NCT04397289|Anticoagulants|anticoagulants|mesh-ancestor
5510710|NCT04397289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5510711|NCT04397289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5510712|NCT04397289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510713|NCT04397289|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5510714|NCT04397289|Antithrombins|antithrombins|mesh-ancestor
6073211|NCT00736255|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6073212|NCT00736255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6073213|NCT00736255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6073214|NCT00736255|Dopamine Agents|dopamine agents|mesh-ancestor
6073215|NCT00736333|Doxorubicin|doxorubicin|mesh-list
6073216|NCT00736333|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6073217|NCT00736333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5510715|NCT04397289|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5510716|NCT04397289|Protease Inhibitors|protease inhibitors|mesh-ancestor
5510717|NCT04397289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5510718|NCT04397549|Morphine|morphine|mesh-list
5510719|NCT04397549|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5510720|NCT04397549|Narcotics|narcotics|mesh-ancestor
5510721|NCT04397549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5510722|NCT04397549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510723|NCT04397549|Analgesics|analgesics|mesh-ancestor
5510724|NCT04397549|Sensory System Agents|sensory system agents|mesh-ancestor
5510725|NCT04397549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5510726|NCT04397484|Lidocaine|lidocaine|mesh-list
5510727|NCT04397484|Epinephrine|epinephrine|mesh-list
5510728|NCT04397484|Racepinephrine|racepinephrine|mesh-list
5510729|NCT04397484|Levobupivacaine|levobupivacaine|mesh-list
6073218|NCT00736333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6073219|NCT00736333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6073220|NCT00736333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6073221|NCT00736333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6073222|NCT00736333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073223|NCT00736450|Prednisone|prednisone|mesh-list
6073224|NCT00736450|Cyclophosphamide|cyclophosphamide|mesh-list
6073225|NCT00736450|Rituximab|rituximab|mesh-list
6073226|NCT00736450|Doxorubicin|doxorubicin|mesh-list
6073227|NCT00736450|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6073228|NCT00736450|Vincristine|vincristine|mesh-list
6073229|NCT00736450|Oblimersen|oblimersen|mesh-list
6073230|NCT00736450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6073231|NCT00736450|Immunologic Factors|immunologic factors|mesh-ancestor
6073232|NCT00736450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073233|NCT00736450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6073234|NCT00736450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6073235|NCT00736450|Alkylating Agents|alkylating agents|mesh-ancestor
6073236|NCT00736450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073237|NCT00736450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6073238|NCT00736450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5510730|NCT04397484|Epinephryl borate|epinephryl borate|mesh-list
5510731|NCT04397484|Anesthetics, Local|anesthetics, local|mesh-ancestor
6073239|NCT00736450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6073240|NCT00736450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6073241|NCT00736450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6073242|NCT00736450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6073243|NCT00736450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6073244|NCT00736450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6073245|NCT00736450|Glucocorticoids|glucocorticoids|mesh-ancestor
6073246|NCT00736450|Hormones|hormones|mesh-ancestor
6073247|NCT00736450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6073248|NCT00736450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6073249|NCT00736450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6073250|NCT00736450|Tubulin Modulators|tubulin modulators|mesh-ancestor
5510732|NCT04397484|Anesthetics|anesthetics|mesh-ancestor
5510733|NCT04397484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5510734|NCT04397484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510735|NCT04397484|Sensory System Agents|sensory system agents|mesh-ancestor
5510736|NCT04397484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5510737|NCT04397484|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5510738|NCT04397484|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5510739|NCT04397484|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5510740|NCT04397484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5510741|NCT04397484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510742|NCT04397484|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5510743|NCT04397484|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5510744|NCT04397484|Adrenergic Agents|adrenergic agents|mesh-ancestor
5510745|NCT04397484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6073251|NCT00736450|Antimitotic Agents|antimitotic agents|mesh-ancestor
6073252|NCT00736450|Mitosis Modulators|mitosis modulators|mesh-ancestor
6073253|NCT00736476|Vaccines|vaccines|mesh-list
6073254|NCT00736476|Immunologic Factors|immunologic factors|mesh-ancestor
5510746|NCT04397484|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5510747|NCT04397484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5510748|NCT04397484|Autonomic Agents|autonomic agents|mesh-ancestor
6073255|NCT00736476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073256|NCT00736489|Formoterol Fumarate|formoterol fumarate|mesh-list
6073257|NCT00736489|AZD-3199|azd-3199|mesh-list
6073258|NCT00736489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6073259|NCT00736489|Autonomic Agents|autonomic agents|mesh-ancestor
6073260|NCT00736489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6073261|NCT00736489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073262|NCT00736489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6073263|NCT00736489|Respiratory System Agents|respiratory system agents|mesh-ancestor
6073264|NCT00736489|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6073265|NCT00736489|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6073266|NCT00736489|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6073267|NCT00736489|Adrenergic Agents|adrenergic agents|mesh-ancestor
6073268|NCT00736489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6073269|NCT00736489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073270|NCT00736632|Vitamin D|vitamin d|mesh-list
6073271|NCT00736632|Ergocalciferols|ergocalciferols|mesh-list
6073272|NCT00736632|Cholecalciferol|cholecalciferol|mesh-list
6073273|NCT00736632|Vitamins|vitamins|mesh-list
6073274|NCT00736632|Micronutrients|micronutrients|mesh-ancestor
6073275|NCT00736632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510749|NCT04397484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5510750|NCT04397484|Respiratory System Agents|respiratory system agents|mesh-ancestor
5510751|NCT04397484|Mydriatics|mydriatics|mesh-ancestor
5510752|NCT04397484|Sympathomimetics|sympathomimetics|mesh-ancestor
5510753|NCT04397484|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5510754|NCT04397328|Hydroxychloroquine|hydroxychloroquine|mesh-list
5510755|NCT04397328|Antimalarials|antimalarials|mesh-ancestor
5510756|NCT04397328|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5510757|NCT04397328|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5510758|NCT04397328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5510759|NCT04397328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5510760|NCT04397328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510761|NCT04397328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5510762|NCT04397406|Fentanyl|fentanyl|mesh-list
5510763|NCT04397406|Dexmedetomidine|dexmedetomidine|mesh-list
5510764|NCT04397406|Levobupivacaine|levobupivacaine|mesh-list
5510765|NCT04397406|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5510766|NCT04397406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5510767|NCT04397406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510768|NCT04397406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5510769|NCT04397406|Analgesics|analgesics|mesh-ancestor
5510770|NCT04397406|Sensory System Agents|sensory system agents|mesh-ancestor
5510771|NCT04397406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6073276|NCT00736632|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6073277|NCT00736632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5510772|NCT04397406|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6073278|NCT00736645|Selenium|selenium|mesh-list
6073279|NCT00736645|Finasteride|finasteride|mesh-list
6073280|NCT00736645|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6073281|NCT00736645|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6073282|NCT00736645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6073283|NCT00736645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073284|NCT00736645|Hormone Antagonists|hormone antagonists|mesh-ancestor
6073285|NCT00736645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6073286|NCT00736645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073287|NCT00736645|Urological Agents|urological agents|mesh-ancestor
6073288|NCT00736645|Antioxidants|antioxidants|mesh-ancestor
5510773|NCT04397406|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5510774|NCT04397406|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5510775|NCT04397406|Adrenergic Agents|adrenergic agents|mesh-ancestor
5510776|NCT04397406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5510777|NCT04397406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510778|NCT04397406|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5510779|NCT04397406|Narcotics|narcotics|mesh-ancestor
5510780|NCT04397406|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5510781|NCT04397406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5510782|NCT04397406|Anesthetics, General|anesthetics, general|mesh-ancestor
5510783|NCT04397406|Anesthetics|anesthetics|mesh-ancestor
5510784|NCT04397406|Anesthetics, Local|anesthetics, local|mesh-ancestor
5510785|NCT04396990|Prednisolone|prednisolone|mesh-list
5510786|NCT04396990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6073289|NCT00736645|Protective Agents|protective agents|mesh-ancestor
6073290|NCT00736645|Trace Elements|trace elements|mesh-ancestor
6073291|NCT00736645|Micronutrients|micronutrients|mesh-ancestor
6073292|NCT00736853|Acetaminophen|acetaminophen|mesh-list
6073293|NCT00736853|Tramadol|tramadol|mesh-list
6073294|NCT00736853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6073295|NCT00736853|Analgesics|analgesics|mesh-ancestor
6073296|NCT00736853|Sensory System Agents|sensory system agents|mesh-ancestor
6073297|NCT00736853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6073298|NCT00736853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073299|NCT00736853|Antipyretics|antipyretics|mesh-ancestor
6073300|NCT00736853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6073301|NCT00736853|Narcotics|narcotics|mesh-ancestor
6073302|NCT00736853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6073303|NCT00736879|Dapagliflozin|dapagliflozin|mesh-list
6073304|NCT00736879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6073305|NCT00736879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073306|NCT00736879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6073307|NCT00736879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073308|NCT00736944|Cisplatin|cisplatin|mesh-list
6073309|NCT00736944|Cetuximab|cetuximab|mesh-list
6073310|NCT00736944|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6073311|NCT00736944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6073312|NCT00736944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6073313|NCT00736957|Acetaminophen|acetaminophen|mesh-list
6073314|NCT00736957|Tramadol|tramadol|mesh-list
6073315|NCT00736957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6073316|NCT00736957|Analgesics|analgesics|mesh-ancestor
6073317|NCT00736957|Sensory System Agents|sensory system agents|mesh-ancestor
6073318|NCT00736957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6073319|NCT00736957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073320|NCT00736957|Antipyretics|antipyretics|mesh-ancestor
6073321|NCT00736957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6073322|NCT00736957|Narcotics|narcotics|mesh-ancestor
6073323|NCT00736957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6073324|NCT00736996|Pioglitazone|pioglitazone|mesh-list
6073325|NCT00736996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6073326|NCT00736996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073327|NCT00737048|Acetaminophen|acetaminophen|mesh-list
6073328|NCT00737048|Tramadol|tramadol|mesh-list
6073329|NCT00737048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6073330|NCT00737048|Analgesics|analgesics|mesh-ancestor
6073331|NCT00737048|Sensory System Agents|sensory system agents|mesh-ancestor
6073332|NCT00737048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6073333|NCT00737048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073334|NCT00737048|Antipyretics|antipyretics|mesh-ancestor
6073335|NCT00737048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6073336|NCT00737048|Narcotics|narcotics|mesh-ancestor
6073337|NCT00737048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6073338|NCT00737100|Bromides|bromides|mesh-list
6073339|NCT00737100|Tiotropium Bromide|tiotropium bromide|mesh-list
6073340|NCT00737100|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6073341|NCT00737100|Autonomic Agents|autonomic agents|mesh-ancestor
6073342|NCT00737100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6073343|NCT00737100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073344|NCT00737100|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6073345|NCT00737100|Respiratory System Agents|respiratory system agents|mesh-ancestor
6073346|NCT00737100|Parasympatholytics|parasympatholytics|mesh-ancestor
6073347|NCT00737100|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6073348|NCT00737100|Cholinergic Agents|cholinergic agents|mesh-ancestor
6073349|NCT00737100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6073350|NCT00737100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073351|NCT00737100|Anticonvulsants|anticonvulsants|mesh-ancestor
6073352|NCT00737178|Copper|copper|mesh-list
6073353|NCT00737178|Trace Elements|trace elements|mesh-ancestor
6073354|NCT00737178|Micronutrients|micronutrients|mesh-ancestor
6073355|NCT00737178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073356|NCT00737204|Modafinil|modafinil|mesh-list
6073357|NCT00737204|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6073358|NCT00737204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073359|NCT00737204|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6073360|NCT00737204|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6073361|NCT00737204|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6073362|NCT00737204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073363|NCT00737243|Paclitaxel|paclitaxel|mesh-list
6073364|NCT00737243|Bevacizumab|bevacizumab|mesh-list
6073365|NCT00737243|Carboplatin|carboplatin|mesh-list
6073366|NCT00737243|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6073367|NCT00737243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6073368|NCT00737243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6073369|NCT00737243|Tubulin Modulators|tubulin modulators|mesh-ancestor
6073370|NCT00737243|Antimitotic Agents|antimitotic agents|mesh-ancestor
6073371|NCT00737243|Mitosis Modulators|mitosis modulators|mesh-ancestor
6073372|NCT00737243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073373|NCT00737243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6073374|NCT00737243|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6073375|NCT00737243|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6073376|NCT00737243|Growth Substances|growth substances|mesh-ancestor
6073377|NCT00737243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073378|NCT00737243|Growth Inhibitors|growth inhibitors|mesh-ancestor
6073379|NCT00737243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6073380|NCT00737243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6073381|NCT00737438|Bevacizumab|bevacizumab|mesh-list
6073382|NCT00737438|Docetaxel|docetaxel|mesh-list
5510787|NCT04396990|Glucocorticoids|glucocorticoids|mesh-ancestor
5510788|NCT04396990|Hormones|hormones|mesh-ancestor
5510789|NCT04396990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6073383|NCT00737438|Capecitabine|capecitabine|mesh-list
6073384|NCT00737438|Irinotecan|irinotecan|mesh-list
6073385|NCT00737438|Epirubicin|epirubicin|mesh-list
6073386|NCT00737438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6073387|NCT00737438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6073388|NCT00737438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6073389|NCT00737438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6073390|NCT00737438|Growth Substances|growth substances|mesh-ancestor
6073391|NCT00737438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073392|NCT00737438|Growth Inhibitors|growth inhibitors|mesh-ancestor
6073393|NCT00737438|Tubulin Modulators|tubulin modulators|mesh-ancestor
6073394|NCT00737438|Antimitotic Agents|antimitotic agents|mesh-ancestor
6073395|NCT00737438|Mitosis Modulators|mitosis modulators|mesh-ancestor
6207998|NCT02122770|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5510790|NCT04396990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510791|NCT04396990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5510792|NCT04396990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5510793|NCT04397003|Durvalumab|durvalumab|mesh-list
5510794|NCT04397003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5510795|NCT04397003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5510796|NCT04396938|Lamotrigine|lamotrigine|mesh-list
5510797|NCT04396938|Anticonvulsants|anticonvulsants|mesh-ancestor
5510798|NCT04396938|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5510799|NCT04396938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5510800|NCT04396938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510801|NCT04396938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5510802|NCT04396938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510803|NCT04396938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5510804|NCT04396938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5510805|NCT04396938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5510806|NCT04396938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5510807|NCT04396938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5510808|NCT04396730|Cannabidiol|cannabidiol|mesh-list
5510809|NCT04396730|Contraceptive Agents|contraceptive agents|mesh-list
5510810|NCT04396730|Contraceptives, Oral|contraceptives, oral|mesh-list
5510811|NCT04396730|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
5510812|NCT04396730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5510813|NCT04396730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510814|NCT04396730|Anticonvulsants|anticonvulsants|mesh-ancestor
5510815|NCT04396730|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5510816|NCT04396743|Clotrimazole|clotrimazole|mesh-list
6073396|NCT00737438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073397|NCT00737438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6073398|NCT00737438|Antimetabolites|antimetabolites|mesh-ancestor
6073399|NCT00737438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6073400|NCT00737438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6073401|NCT00737438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6073402|NCT00737438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6073403|NCT00737438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6073404|NCT00737464|Epoetin Alfa|epoetin alfa|mesh-list
6073405|NCT00737464|Hematinics|hematinics|mesh-ancestor
6073406|NCT00737477|Epoetin Alfa|epoetin alfa|mesh-list
6073407|NCT00737477|Hematinics|hematinics|mesh-ancestor
6073408|NCT00737529|Lenalidomide|lenalidomide|mesh-list
6073409|NCT00737529|Immunologic Factors|immunologic factors|mesh-ancestor
6073410|NCT00737529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073411|NCT00737529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6073412|NCT00737529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6073413|NCT00737529|Growth Substances|growth substances|mesh-ancestor
6073414|NCT00737529|Growth Inhibitors|growth inhibitors|mesh-ancestor
6073415|NCT00737529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5510817|NCT04396743|Miconazole|miconazole|mesh-list
5510818|NCT04396743|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5510819|NCT04396743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5510820|NCT04396743|Antifungal Agents|antifungal agents|mesh-ancestor
5510821|NCT04396743|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5510822|NCT04396743|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5510823|NCT04396743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5510824|NCT04396743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510825|NCT04396743|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5510826|NCT04396743|Hormone Antagonists|hormone antagonists|mesh-ancestor
5510827|NCT04396743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5510828|NCT04396743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510829|NCT04396743|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5510830|NCT04396743|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5510831|NCT04396977|Histamine|histamine|mesh-list
5510832|NCT04396977|Histamine Agonists|histamine agonists|mesh-ancestor
5510833|NCT04396977|Histamine Agents|histamine agents|mesh-ancestor
5510834|NCT04396977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5510835|NCT04396977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510836|NCT04396977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073416|NCT00737568|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6073417|NCT00737568|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6073418|NCT00737568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6073419|NCT00737568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6073420|NCT00737568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073421|NCT00737568|Antiviral Agents|antiviral agents|mesh-ancestor
6073422|NCT00737568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6073423|NCT00737568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6073424|NCT00737568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6073425|NCT00737711|Epoetin Alfa|epoetin alfa|mesh-list
6073426|NCT00737711|Hematinics|hematinics|mesh-ancestor
6073427|NCT00737737|Morphine|morphine|mesh-list
6073428|NCT00737737|Oxycodone|oxycodone|mesh-list
5510837|NCT04396457|Pembrolizumab|pembrolizumab|mesh-list
6073429|NCT00737737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6073430|NCT00737737|Narcotics|narcotics|mesh-ancestor
6073431|NCT00737737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6073432|NCT00737737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073433|NCT00737737|Analgesics|analgesics|mesh-ancestor
6073434|NCT00737737|Sensory System Agents|sensory system agents|mesh-ancestor
6073435|NCT00737737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6073436|NCT00737893|Epoetin Alfa|epoetin alfa|mesh-list
6073437|NCT00737893|Hematinics|hematinics|mesh-ancestor
6202666|NCT02044393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6202667|NCT02044393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202668|NCT02044393|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6202669|NCT02044510|Mirabegron|mirabegron|mesh-list
6202670|NCT02044510|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6202671|NCT02044510|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6202672|NCT02044510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6202673|NCT02044510|Adrenergic Agents|adrenergic agents|mesh-ancestor
6202674|NCT02044510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6202675|NCT02044510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202676|NCT02044510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202677|NCT02044510|Urological Agents|urological agents|mesh-ancestor
6202678|NCT02044796|Cytarabine|cytarabine|mesh-list
6202679|NCT02044796|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
6202680|NCT02044796|Mitoxantrone|mitoxantrone|mesh-list
6202681|NCT02044796|Cladribine|cladribine|mesh-list
6202682|NCT02044796|Lenograstim|lenograstim|mesh-list
6202683|NCT02044796|Sargramostim|sargramostim|mesh-list
6202684|NCT02044796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6202685|NCT02044796|Immunologic Factors|immunologic factors|mesh-ancestor
6202686|NCT02044796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202687|NCT02044796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6202688|NCT02044796|Antimetabolites|antimetabolites|mesh-ancestor
6202689|NCT02044796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202690|NCT02044796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6202691|NCT02044796|Antiviral Agents|antiviral agents|mesh-ancestor
6202692|NCT02044796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6202693|NCT02044796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6202694|NCT02044796|Analgesics|analgesics|mesh-ancestor
6202695|NCT02044796|Sensory System Agents|sensory system agents|mesh-ancestor
6202696|NCT02044796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5510838|NCT04396457|Pemetrexed|pemetrexed|mesh-list
5510839|NCT04396457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6202697|NCT02044796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6202698|NCT02044796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6202699|NCT02044796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6202700|NCT02045264|Icatibant|icatibant|mesh-list
6202701|NCT02045264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6202702|NCT02045264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6202703|NCT02045264|Analgesics|analgesics|mesh-ancestor
6202704|NCT02045264|Sensory System Agents|sensory system agents|mesh-ancestor
6202705|NCT02045264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6202706|NCT02045264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202707|NCT02045264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6202708|NCT02045264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6202709|NCT02045264|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
6202710|NCT02045264|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
6202711|NCT02045264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202712|NCT02045264|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6202713|NCT02045264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6202714|NCT02045264|Immunologic Factors|immunologic factors|mesh-ancestor
6202715|NCT02045836|Vaccines|vaccines|mesh-list
6202716|NCT02045836|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6202717|NCT02045836|Immunologic Factors|immunologic factors|mesh-ancestor
6202718|NCT02045836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207729|NCT02119650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207730|NCT02119650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6207731|NCT02119650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6207732|NCT02119663|Capecitabine|capecitabine|mesh-list
6207733|NCT02119663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6207734|NCT02119663|Antimetabolites|antimetabolites|mesh-ancestor
6207735|NCT02119663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207736|NCT02119663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6207737|NCT02119819|Metformin|metformin|mesh-list
6073438|NCT00738023|Rosiglitazone|rosiglitazone|mesh-list
6073439|NCT00738023|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6073440|NCT00738023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6073441|NCT00738023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073442|NCT00738023|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6073443|NCT00738023|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6073444|NCT00738023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6073445|NCT00738049|Darusentan|darusentan|mesh-list
6073446|NCT00738049|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6073447|NCT00738049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073448|NCT00738062|Droxidopa|droxidopa|mesh-list
6073449|NCT00738062|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6073450|NCT00738062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6073451|NCT00738361|Paclitaxel|paclitaxel|mesh-list
6073452|NCT00738361|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6073453|NCT00738361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6073454|NCT00738361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6073455|NCT00738361|Tubulin Modulators|tubulin modulators|mesh-ancestor
6073456|NCT00738361|Antimitotic Agents|antimitotic agents|mesh-ancestor
6073457|NCT00738361|Mitosis Modulators|mitosis modulators|mesh-ancestor
6073458|NCT00738361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073459|NCT00738374|Rituximab|rituximab|mesh-list
6073460|NCT00738374|Chlorambucil|chlorambucil|mesh-list
6073461|NCT00738374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6073462|NCT00738374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6073463|NCT00738374|Immunologic Factors|immunologic factors|mesh-ancestor
6073464|NCT00738374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073465|NCT00738374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6073466|NCT00738374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6073467|NCT00738374|Alkylating Agents|alkylating agents|mesh-ancestor
6073468|NCT00738374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073469|NCT00738400|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6073470|NCT00738400|Vasodilator Agents|vasodilator agents|mesh-ancestor
6073471|NCT00738400|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6073472|NCT00738400|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6073473|NCT00738400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6073474|NCT00738400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073475|NCT00738400|Urological Agents|urological agents|mesh-ancestor
6073476|NCT00738530|Interferons|interferons|mesh-list
6073477|NCT00738530|Interferon-alpha|interferon-alpha|mesh-list
6073478|NCT00738530|Interferon alpha-2|interferon alpha-2|mesh-list
6073479|NCT00738530|Bevacizumab|bevacizumab|mesh-list
6073480|NCT00738530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6073481|NCT00738530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6073482|NCT00738530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6073483|NCT00738530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6073484|NCT00738530|Growth Substances|growth substances|mesh-ancestor
6073485|NCT00738530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073486|NCT00738530|Growth Inhibitors|growth inhibitors|mesh-ancestor
6073487|NCT00738530|Antiviral Agents|antiviral agents|mesh-ancestor
5510840|NCT04396457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5510841|NCT04396457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6073488|NCT00738530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6073489|NCT00738530|Immunologic Factors|immunologic factors|mesh-ancestor
6073490|NCT00738543|Povidone-Iodine|povidone-iodine|mesh-list
6463559|NCT00465231|Anesthetics|anesthetics|mesh-ancestor
6463560|NCT00465231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6463561|NCT00465231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463562|NCT00465231|Sensory System Agents|sensory system agents|mesh-ancestor
6463563|NCT00465231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6463564|NCT00465231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6463565|NCT00465231|Narcotics|narcotics|mesh-ancestor
6463566|NCT00465231|Analgesics|analgesics|mesh-ancestor
6463567|NCT00465231|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6463568|NCT00465231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6463569|NCT00465231|Anesthetics, General|anesthetics, general|mesh-ancestor
6463570|NCT00465244|Levetiracetam|levetiracetam|mesh-list
6073491|NCT00738543|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6073492|NCT00738543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6073493|NCT00738699|Paclitaxel|paclitaxel|mesh-list
6073494|NCT00738699|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6073495|NCT00738699|Farletuzumab|farletuzumab|mesh-list
6463571|NCT00465244|Lorazepam|lorazepam|mesh-list
6463572|NCT00465244|Anticonvulsants|anticonvulsants|mesh-ancestor
6463573|NCT00465244|Nootropic Agents|nootropic agents|mesh-ancestor
6463574|NCT00465244|Antiemetics|antiemetics|mesh-ancestor
6463575|NCT00465244|Autonomic Agents|autonomic agents|mesh-ancestor
6463576|NCT00465244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6463577|NCT00465244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463578|NCT00465244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5510842|NCT04396457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510843|NCT04396457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5510844|NCT04396457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5510845|NCT04396496|Daratumumab|daratumumab|mesh-list
5510846|NCT04396496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5510847|NCT04396548|Midodrine|midodrine|mesh-list
5510848|NCT04396548|Anesthetics|anesthetics|mesh-list
5510849|NCT04396548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6463579|NCT00465244|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6463580|NCT00465244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6463581|NCT00465244|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6463582|NCT00465244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6463583|NCT00465244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6463584|NCT00465244|GABA Modulators|gaba modulators|mesh-ancestor
6463585|NCT00465244|GABA Agents|gaba agents|mesh-ancestor
6463586|NCT00465244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6463587|NCT00465244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463588|NCT00465257|Artesunate|artesunate|mesh-list
6073496|NCT00738699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6073497|NCT00738699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6073498|NCT00738699|Tubulin Modulators|tubulin modulators|mesh-ancestor
6073499|NCT00738699|Antimitotic Agents|antimitotic agents|mesh-ancestor
6073500|NCT00738699|Mitosis Modulators|mitosis modulators|mesh-ancestor
6073501|NCT00738699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073502|NCT00738881|Pemetrexed|pemetrexed|mesh-list
6073503|NCT00738881|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6073504|NCT00738881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6073505|NCT00738881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6073506|NCT00738881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073507|NCT00738881|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6073508|NCT00738881|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6073509|NCT00738881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6073510|NCT00738894|Aspirin|aspirin|mesh-list
6073511|NCT00738894|Dipyridamole|dipyridamole|mesh-list
6073512|NCT00738894|Clopidogrel|clopidogrel|mesh-list
6073513|NCT00738894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6073514|NCT00738894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6073515|NCT00738894|Analgesics|analgesics|mesh-ancestor
6463589|NCT00465257|Amodiaquine|amodiaquine|mesh-list
6463590|NCT00465257|Antimalarials|antimalarials|mesh-ancestor
6463591|NCT00465257|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6463592|NCT00465257|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6463593|NCT00465257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6463594|NCT00465257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6463595|NCT00465257|Antiviral Agents|antiviral agents|mesh-ancestor
6463596|NCT00465257|Schistosomicides|schistosomicides|mesh-ancestor
5510850|NCT04396548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510851|NCT04396548|Sympathomimetics|sympathomimetics|mesh-ancestor
5510852|NCT04396548|Autonomic Agents|autonomic agents|mesh-ancestor
5510853|NCT04396548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5510854|NCT04396548|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5510855|NCT04396548|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5510856|NCT04396548|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5510857|NCT04396548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5510858|NCT04396548|Adrenergic Agents|adrenergic agents|mesh-ancestor
5510859|NCT04396548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5510860|NCT04396548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510861|NCT04396223|Methotrexate|methotrexate|mesh-list
5510862|NCT04396223|Avelumab|avelumab|mesh-list
5510863|NCT04396223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5510864|NCT04396223|Abortifacient Agents|abortifacient agents|mesh-ancestor
5510865|NCT04396223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5510866|NCT04396223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510867|NCT04396223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5510868|NCT04396223|Antimetabolites|antimetabolites|mesh-ancestor
5510869|NCT04396223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510870|NCT04396223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5510871|NCT04396223|Dermatologic Agents|dermatologic agents|mesh-ancestor
5510872|NCT04396223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5510873|NCT04396223|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5510874|NCT04396223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6463597|NCT00465257|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6463598|NCT00465257|Anthelmintics|anthelmintics|mesh-ancestor
6463599|NCT00465283|Donepezil|donepezil|mesh-list
6463600|NCT00465283|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6463601|NCT00465283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6463602|NCT00465283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463603|NCT00465283|Cholinergic Agents|cholinergic agents|mesh-ancestor
6463604|NCT00465283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6463605|NCT00465283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463606|NCT00465283|Nootropic Agents|nootropic agents|mesh-ancestor
6463607|NCT00465296|Rosiglitazone|rosiglitazone|mesh-list
6463608|NCT00465296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6463609|NCT00465296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463610|NCT00465439|Lidocaine|lidocaine|mesh-list
6073516|NCT00738894|Sensory System Agents|sensory system agents|mesh-ancestor
6073517|NCT00738894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6073518|NCT00738894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073519|NCT00738894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6073520|NCT00738894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6073521|NCT00738894|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6073522|NCT00738894|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6073523|NCT00738894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073524|NCT00738894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6073525|NCT00738894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6073526|NCT00738894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6073527|NCT00738894|Antipyretics|antipyretics|mesh-ancestor
6073528|NCT00738894|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6073529|NCT00738894|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6073530|NCT00738894|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6073531|NCT00738894|Purinergic Agents|purinergic agents|mesh-ancestor
6073532|NCT00738894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6073533|NCT00738894|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6073534|NCT00738894|Vasodilator Agents|vasodilator agents|mesh-ancestor
6073535|NCT00739297|Montelukast|montelukast|mesh-list
6073536|NCT00739297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6073537|NCT00739297|Respiratory System Agents|respiratory system agents|mesh-ancestor
6073538|NCT00739297|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6073539|NCT00739297|Hormone Antagonists|hormone antagonists|mesh-ancestor
6073540|NCT00739297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6073541|NCT00739297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073542|NCT00739297|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6073543|NCT00739297|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6073544|NCT00739297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073545|NCT00739596|Amlodipine|amlodipine|mesh-list
6073546|NCT00739596|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6073547|NCT00739596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6073548|NCT00739596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6073549|NCT00739596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6073550|NCT00739596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073551|NCT00739596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6073552|NCT00739596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073553|NCT00739596|Vasodilator Agents|vasodilator agents|mesh-ancestor
6073554|NCT00739596|Diuretics|diuretics|mesh-ancestor
6073555|NCT00739596|Natriuretic Agents|natriuretic agents|mesh-ancestor
6073556|NCT00739596|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6073557|NCT00739648|Levofloxacin|levofloxacin|mesh-list
6073558|NCT00739648|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6073559|NCT00739648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6073560|NCT00739648|Renal Agents|renal agents|mesh-ancestor
5510875|NCT04396223|Immunologic Factors|immunologic factors|mesh-ancestor
5510876|NCT04396223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6073561|NCT00739648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6073562|NCT00739648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6073563|NCT00739648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6073564|NCT00739648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6073565|NCT00739648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073566|NCT00739648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6073567|NCT00739648|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6073568|NCT00739648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6073569|NCT00739934|Voriconazole|voriconazole|mesh-list
6073570|NCT00739934|Antifungal Agents|antifungal agents|mesh-ancestor
6073571|NCT00739934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6463611|NCT00465439|Epinephrine|epinephrine|mesh-list
6463612|NCT00465439|Racepinephrine|racepinephrine|mesh-list
6073572|NCT00739934|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6073573|NCT00739934|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6073574|NCT00739934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6073575|NCT00739934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073576|NCT00739934|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6073577|NCT00739934|Hormone Antagonists|hormone antagonists|mesh-ancestor
6073578|NCT00739934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6073579|NCT00739934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073580|NCT00739934|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6073581|NCT00739960|Abatacept|abatacept|mesh-list
6073582|NCT00739960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6073583|NCT00739960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073584|NCT00739960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6073585|NCT00739960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6073586|NCT00739960|Immunologic Factors|immunologic factors|mesh-ancestor
6073587|NCT00739960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073588|NCT00739960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6073589|NCT00739973|Amlodipine|amlodipine|mesh-list
6073590|NCT00739973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6073591|NCT00739973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6073592|NCT00739973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6073593|NCT00739973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073594|NCT00739973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6073595|NCT00739973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073596|NCT00739973|Vasodilator Agents|vasodilator agents|mesh-ancestor
5510877|NCT04396223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5510878|NCT04396223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5510879|NCT04396067|Tretinoin|tretinoin|mesh-list
5510880|NCT04396067|Isotretinoin|isotretinoin|mesh-list
5510881|NCT04396067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5510882|NCT04396067|Keratolytic Agents|keratolytic agents|mesh-ancestor
5510883|NCT04396067|Dermatologic Agents|dermatologic agents|mesh-ancestor
6073597|NCT00739999|Atorvastatin|atorvastatin|mesh-list
6073598|NCT00739999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6073599|NCT00739999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6073600|NCT00739999|Antimetabolites|antimetabolites|mesh-ancestor
6073601|NCT00739999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073602|NCT00739999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6073603|NCT00739999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6073604|NCT00739999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6073605|NCT00740051|Glimepiride|glimepiride|mesh-list
6073606|NCT00740051|Linagliptin|linagliptin|mesh-list
6073607|NCT00740051|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6073608|NCT00740051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6073609|NCT00740051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073610|NCT00740051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6073611|NCT00740051|Immunologic Factors|immunologic factors|mesh-ancestor
6073612|NCT00740051|Incretins|incretins|mesh-ancestor
6073613|NCT00740051|Hormones|hormones|mesh-ancestor
6073614|NCT00740051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6073615|NCT00740051|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5510884|NCT04396184|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5510885|NCT04396184|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5510886|NCT04396184|Dermatologic Agents|dermatologic agents|mesh-ancestor
5510887|NCT04395768|Vitamin D|vitamin d|mesh-list
5510888|NCT04395768|Cholecalciferol|cholecalciferol|mesh-list
5510889|NCT04395768|Vitamins|vitamins|mesh-list
5510890|NCT04395768|Ascorbic Acid|ascorbic acid|mesh-list
5510891|NCT04395768|Vitamin B 12|vitamin b 12|mesh-list
5510892|NCT04395768|Hydroxocobalamin|hydroxocobalamin|mesh-list
5510893|NCT04395768|Azithromycin|azithromycin|mesh-list
5510894|NCT04395768|Hydroxychloroquine|hydroxychloroquine|mesh-list
5510895|NCT04395768|Micronutrients|micronutrients|mesh-ancestor
5510896|NCT04395768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510897|NCT04395768|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5510898|NCT04395768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510899|NCT04395768|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5510900|NCT04395768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5510901|NCT04395768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5510902|NCT04395768|Antimalarials|antimalarials|mesh-ancestor
5510903|NCT04395768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5510904|NCT04395768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5510905|NCT04395768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5510906|NCT04395768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6073616|NCT00740051|Protease Inhibitors|protease inhibitors|mesh-ancestor
6073617|NCT00740051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6073618|NCT00740051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073619|NCT00740129|Zoledronic Acid|zoledronic acid|mesh-list
6073620|NCT00740129|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6073621|NCT00740129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073622|NCT00740636|Temozolomide|temozolomide|mesh-list
5510907|NCT04395768|Antioxidants|antioxidants|mesh-ancestor
5510908|NCT04395768|Protective Agents|protective agents|mesh-ancestor
5510909|NCT04395768|Vitamin B Complex|vitamin b complex|mesh-ancestor
5510910|NCT04395768|Hematinics|hematinics|mesh-ancestor
5510911|NCT04395989|Paclitaxel|paclitaxel|mesh-list
5510912|NCT04395989|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5510913|NCT04395989|Capecitabine|capecitabine|mesh-list
6073623|NCT00740636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6073624|NCT00740636|Alkylating Agents|alkylating agents|mesh-ancestor
6073625|NCT00740636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073626|NCT00740636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6073627|NCT00740714|Vitamins|vitamins|mesh-list
6073628|NCT00740714|Vitamin E|vitamin e|mesh-list
6073629|NCT00740714|Tocopherols|tocopherols|mesh-list
6665405|NCT01516996|Tubulin Modulators|tubulin modulators|mesh-ancestor
6665406|NCT01516996|Antimitotic Agents|antimitotic agents|mesh-ancestor
6665407|NCT01516996|Mitosis Modulators|mitosis modulators|mesh-ancestor
6665408|NCT01516996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510914|NCT04395989|Everolimus|everolimus|mesh-list
5510915|NCT04395989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5510916|NCT04395989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6665409|NCT01516996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6665410|NCT01517009|Docetaxel|docetaxel|mesh-list
6665411|NCT01517009|Capecitabine|capecitabine|mesh-list
6665412|NCT01517009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6665413|NCT01517009|Tubulin Modulators|tubulin modulators|mesh-ancestor
6665414|NCT01517009|Antimitotic Agents|antimitotic agents|mesh-ancestor
6073630|NCT00740714|Tocotrienols|tocotrienols|mesh-list
6073631|NCT00740714|alpha-Tocopherol|alpha-tocopherol|mesh-list
6073632|NCT00740714|Coenzyme Q10|coenzyme q10|mesh-list
6073633|NCT00740714|Ubiquinone|ubiquinone|mesh-list
6073634|NCT00740714|Micronutrients|micronutrients|mesh-ancestor
6073635|NCT00740714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073636|NCT00740714|Antioxidants|antioxidants|mesh-ancestor
6073637|NCT00740714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073638|NCT00740714|Protective Agents|protective agents|mesh-ancestor
6073639|NCT00740779|Silodosin|silodosin|mesh-list
6073640|NCT00740779|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6073641|NCT00740779|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6073642|NCT00740779|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6073643|NCT00740779|Adrenergic Agents|adrenergic agents|mesh-ancestor
6073644|NCT00740779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6073645|NCT00740779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073646|NCT00740779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073647|NCT00740779|Urological Agents|urological agents|mesh-ancestor
6073648|NCT00740792|Fluticasone|fluticasone|mesh-list
5510917|NCT04395989|Tubulin Modulators|tubulin modulators|mesh-ancestor
5510918|NCT04395989|Antimitotic Agents|antimitotic agents|mesh-ancestor
5510919|NCT04395989|Mitosis Modulators|mitosis modulators|mesh-ancestor
5510920|NCT04395989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510921|NCT04395989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6073649|NCT00740792|Xhance|xhance|mesh-list
6073650|NCT00740792|Azelastine|azelastine|mesh-list
6073651|NCT00740792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6073652|NCT00740792|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5510922|NCT04395989|Antimetabolites|antimetabolites|mesh-ancestor
6073653|NCT00740792|Autonomic Agents|autonomic agents|mesh-ancestor
6073654|NCT00740792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6073655|NCT00740792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073656|NCT00740792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6073657|NCT00740792|Respiratory System Agents|respiratory system agents|mesh-ancestor
6073658|NCT00740792|Dermatologic Agents|dermatologic agents|mesh-ancestor
6073659|NCT00740792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6073660|NCT00740792|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6073661|NCT00740792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5510923|NCT04395989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5510924|NCT04395989|Immunologic Factors|immunologic factors|mesh-ancestor
5510925|NCT04395989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600363|NCT03712475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5600364|NCT03712475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5600365|NCT03712423|Docetaxel|docetaxel|mesh-list
5600366|NCT03712423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5600367|NCT03712423|Tubulin Modulators|tubulin modulators|mesh-ancestor
5600368|NCT03712423|Antimitotic Agents|antimitotic agents|mesh-ancestor
5600369|NCT03712423|Mitosis Modulators|mitosis modulators|mesh-ancestor
6073662|NCT00740792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073663|NCT00740792|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6073664|NCT00740792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6073665|NCT00740792|Histamine Antagonists|histamine antagonists|mesh-ancestor
6073666|NCT00740792|Histamine Agents|histamine agents|mesh-ancestor
6073667|NCT00740792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6073668|NCT00740831|Leuprolide|leuprolide|mesh-list
6073669|NCT00740831|Ulipristal acetate|ulipristal acetate|mesh-list
6073670|NCT00740831|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6073671|NCT00740831|Fertility Agents|fertility agents|mesh-ancestor
6073672|NCT00740831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6073673|NCT00740831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073674|NCT00740831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6073675|NCT00740831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6073676|NCT00740831|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6073677|NCT00740831|Contraceptive Agents|contraceptive agents|mesh-ancestor
6073678|NCT00740831|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6073679|NCT00740857|Ibuprofen|ibuprofen|mesh-list
5600370|NCT03712423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600371|NCT03712397|Irinotecan|irinotecan|mesh-list
5600372|NCT03712397|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5600373|NCT03712397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5600374|NCT03712397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5600375|NCT03712397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600376|NCT03712397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5600377|NCT03712345|Vilobelimab|vilobelimab|mesh-list
5600378|NCT03712345|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5600379|NCT03712345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5600380|NCT03712345|Immunologic Factors|immunologic factors|mesh-ancestor
5600381|NCT03712345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600382|NCT03712254|Fosphenytoin|fosphenytoin|mesh-list
5600383|NCT03712254|Anticonvulsants|anticonvulsants|mesh-ancestor
5600384|NCT03712254|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5600385|NCT03712254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5600386|NCT03712254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073680|NCT00740857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6073681|NCT00740857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6073682|NCT00740857|Analgesics|analgesics|mesh-ancestor
6073683|NCT00740857|Sensory System Agents|sensory system agents|mesh-ancestor
6073684|NCT00740857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6073685|NCT00740857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073686|NCT00740857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6073687|NCT00740857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6073688|NCT00740857|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6073689|NCT00740857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6073690|NCT00740857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073691|NCT00741013|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
6073692|NCT00741013|Protein C|protein c|mesh-list
6073693|NCT00741013|Lovastatin|lovastatin|mesh-list
6073694|NCT00741013|L 647318|l 647318|mesh-list
6073695|NCT00741013|Dihydromevinolin|dihydromevinolin|mesh-list
6073696|NCT00741013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6073697|NCT00741013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6073698|NCT00741013|Antimetabolites|antimetabolites|mesh-ancestor
6073699|NCT00741013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073700|NCT00741013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6073701|NCT00741013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6073702|NCT00741013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6073703|NCT00741013|Anticoagulants|anticoagulants|mesh-ancestor
6073704|NCT00741013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6073705|NCT00741013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6073706|NCT00741013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6073707|NCT00741026|Olanzapine|olanzapine|mesh-list
6073708|NCT00741026|Antiemetics|antiemetics|mesh-ancestor
6073709|NCT00741026|Autonomic Agents|autonomic agents|mesh-ancestor
6073710|NCT00741026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6073711|NCT00741026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073712|NCT00741026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6073713|NCT00741026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6073714|NCT00741026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6073715|NCT00741026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6073716|NCT00741026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6073717|NCT00741026|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6073718|NCT00741026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6073719|NCT00741026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6073720|NCT00741026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073721|NCT00741026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6073722|NCT00741026|Serotonin Agents|serotonin agents|mesh-ancestor
6073723|NCT00741039|Vaccines|vaccines|mesh-list
6073724|NCT00741039|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6073725|NCT00741039|Immunologic Factors|immunologic factors|mesh-ancestor
6073726|NCT00741039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073727|NCT00741104|Infliximab|infliximab|mesh-list
6073728|NCT00741104|Dermatologic Agents|dermatologic agents|mesh-ancestor
6073729|NCT00741104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6073730|NCT00741104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6073731|NCT00741156|Enalaprilat|enalaprilat|mesh-list
6073732|NCT00741156|Enalapril|enalapril|mesh-list
6073733|NCT00741156|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6073734|NCT00741156|Protease Inhibitors|protease inhibitors|mesh-ancestor
6073735|NCT00741156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6073736|NCT00741156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073737|NCT00741156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6073738|NCT00741260|Capecitabine|capecitabine|mesh-list
6073739|NCT00741260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6073740|NCT00741260|Antimetabolites|antimetabolites|mesh-ancestor
6073741|NCT00741260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073742|NCT00741260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6073743|NCT00741286|Aspirin|aspirin|mesh-list
6073744|NCT00741286|Cilostazol|cilostazol|mesh-list
6073745|NCT00741286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5510926|NCT04395612|Niraparib|niraparib|mesh-list
6073746|NCT00741286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6073747|NCT00741286|Analgesics|analgesics|mesh-ancestor
6073748|NCT00741286|Sensory System Agents|sensory system agents|mesh-ancestor
6073749|NCT00741286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6073750|NCT00741286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073751|NCT00741286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6073752|NCT00741286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6073753|NCT00741286|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6073754|NCT00741286|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6073755|NCT00741286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073756|NCT00741286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6073757|NCT00741286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6073758|NCT00741286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6073759|NCT00741286|Antipyretics|antipyretics|mesh-ancestor
6073760|NCT00741286|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6073761|NCT00741286|Autonomic Agents|autonomic agents|mesh-ancestor
6073762|NCT00741286|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6073763|NCT00741286|Respiratory System Agents|respiratory system agents|mesh-ancestor
6073764|NCT00741286|Vasodilator Agents|vasodilator agents|mesh-ancestor
6073765|NCT00741286|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6073766|NCT00741286|Protective Agents|protective agents|mesh-ancestor
6073767|NCT00741286|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6073768|NCT00741286|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6073769|NCT00741338|Cyclosporine|cyclosporine|mesh-list
6073770|NCT00741338|Azathioprine|azathioprine|mesh-list
6073771|NCT00741338|Cyclosporins|cyclosporins|mesh-list
6073772|NCT00741338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6073773|NCT00741338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073774|NCT00741338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6073775|NCT00741338|Immunologic Factors|immunologic factors|mesh-ancestor
6073776|NCT00741338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073777|NCT00741338|Antifungal Agents|antifungal agents|mesh-ancestor
6073778|NCT00741338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6073779|NCT00741338|Dermatologic Agents|dermatologic agents|mesh-ancestor
6073780|NCT00741338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6073781|NCT00741338|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6073782|NCT00741338|Antimetabolites|antimetabolites|mesh-ancestor
6073783|NCT00741338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6073784|NCT00741338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6073785|NCT00741455|Cyclosporine|cyclosporine|mesh-list
6073786|NCT00741455|Cyclophosphamide|cyclophosphamide|mesh-list
6073787|NCT00741455|Methotrexate|methotrexate|mesh-list
6073788|NCT00741455|Fludarabine|fludarabine|mesh-list
6073789|NCT00741455|Cyclosporins|cyclosporins|mesh-list
6073790|NCT00741455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6073791|NCT00741455|Immunologic Factors|immunologic factors|mesh-ancestor
6073792|NCT00741455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073793|NCT00741455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6073794|NCT00741455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6073795|NCT00741455|Alkylating Agents|alkylating agents|mesh-ancestor
6073796|NCT00741455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073797|NCT00741455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6073798|NCT00741455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6073799|NCT00741455|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6073800|NCT00741455|Abortifacient Agents|abortifacient agents|mesh-ancestor
6073801|NCT00741455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6073802|NCT00741455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6073803|NCT00741455|Antimetabolites|antimetabolites|mesh-ancestor
6073804|NCT00741455|Dermatologic Agents|dermatologic agents|mesh-ancestor
6073805|NCT00741455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6073806|NCT00741455|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6073807|NCT00741455|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6073808|NCT00741455|Antifungal Agents|antifungal agents|mesh-ancestor
6073809|NCT00741455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6073810|NCT00741455|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6073811|NCT00741468|Tolbutamide|tolbutamide|mesh-list
6073812|NCT00741468|Midazolam|midazolam|mesh-list
6073813|NCT00741468|Dextromethorphan|dextromethorphan|mesh-list
6073814|NCT00741468|Caffeine|caffeine|mesh-list
6073815|NCT00741468|Omeprazole|omeprazole|mesh-list
6073816|NCT00741468|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6073817|NCT00741468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6073818|NCT00741468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6073819|NCT00741468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073820|NCT00741468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6073821|NCT00741468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6073822|NCT00741468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6073823|NCT00741468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6073824|NCT00741468|Anesthetics, General|anesthetics, general|mesh-ancestor
6073825|NCT00741468|Anesthetics|anesthetics|mesh-ancestor
6073826|NCT00741468|GABA Modulators|gaba modulators|mesh-ancestor
6073827|NCT00741468|GABA Agents|gaba agents|mesh-ancestor
6073828|NCT00741468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6073829|NCT00741468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073830|NCT00741468|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6073831|NCT00741468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6073832|NCT00741468|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6073833|NCT00741468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6073834|NCT00741468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6073835|NCT00741468|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6073836|NCT00741468|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6073837|NCT00741468|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6073838|NCT00741468|Purinergic Agents|purinergic agents|mesh-ancestor
5510927|NCT04395612|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5510928|NCT04395612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6073839|NCT00741468|Antitussive Agents|antitussive agents|mesh-ancestor
6073840|NCT00741468|Respiratory System Agents|respiratory system agents|mesh-ancestor
6073841|NCT00741468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6073842|NCT00741468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6073843|NCT00741468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6073844|NCT00741598|Galantamine|galantamine|mesh-list
6073845|NCT00741598|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6073846|NCT00741598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6073847|NCT00741598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073848|NCT00741598|Cholinergic Agents|cholinergic agents|mesh-ancestor
6073849|NCT00741598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6073850|NCT00741598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073851|NCT00741598|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6073852|NCT00741598|Autonomic Agents|autonomic agents|mesh-ancestor
6073853|NCT00741598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6073854|NCT00741598|Nootropic Agents|nootropic agents|mesh-ancestor
6073855|NCT00741611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
6073856|NCT00741819|Treprostinil|treprostinil|mesh-list
6073857|NCT00741819|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6073858|NCT00741858|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6073859|NCT00741858|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6073860|NCT00741858|Estradiol|estradiol|mesh-list
6073861|NCT00741858|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6073862|NCT00741858|Estrogens|estrogens|mesh-ancestor
6073863|NCT00741858|Hormones|hormones|mesh-ancestor
6073864|NCT00741858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6073865|NCT00741858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073866|NCT00741858|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6073867|NCT00741858|Contraceptive Agents|contraceptive agents|mesh-ancestor
6073868|NCT00741858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6073869|NCT00741858|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6073870|NCT00742027|Panobinostat|panobinostat|mesh-list
6073871|NCT00742027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6073872|NCT00742027|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5510929|NCT04395612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510930|NCT04395612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5510931|NCT04395638|Vitamin D|vitamin d|mesh-list
5510932|NCT04395638|Ergocalciferols|ergocalciferols|mesh-list
5510933|NCT04395638|Cholecalciferol|cholecalciferol|mesh-list
5510934|NCT04395638|Vitamins|vitamins|mesh-list
5510935|NCT04395638|Micronutrients|micronutrients|mesh-ancestor
5510936|NCT04395638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510937|NCT04395638|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5510938|NCT04395638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5510939|NCT04395417|Hyaluronic Acid|hyaluronic acid|mesh-list
5510940|NCT04395417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5510941|NCT04395417|Immunologic Factors|immunologic factors|mesh-ancestor
5510942|NCT04395417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510943|NCT04395417|Viscosupplements|viscosupplements|mesh-ancestor
5510944|NCT04395417|Protective Agents|protective agents|mesh-ancestor
5510945|NCT04395365|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
5510946|NCT04395365|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5510947|NCT04395365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6073873|NCT00742027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6073874|NCT00742027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073875|NCT00742079|Cycloserine|cycloserine|mesh-list
6073876|NCT00742079|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6073877|NCT00742079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6073878|NCT00742079|Renal Agents|renal agents|mesh-ancestor
6073879|NCT00742079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6073880|NCT00742079|Antitubercular Agents|antitubercular agents|mesh-ancestor
6073881|NCT00742079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6073882|NCT00742079|Antimetabolites|antimetabolites|mesh-ancestor
6073883|NCT00742079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073884|NCT00742183|Silver Sulfadiazine|silver sulfadiazine|mesh-list
6073885|NCT00742183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6073886|NCT00742183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6073887|NCT00742235|Vitamin D|vitamin d|mesh-list
6073888|NCT00742235|Ergocalciferols|ergocalciferols|mesh-list
6073889|NCT00742235|Vitamins|vitamins|mesh-ancestor
5510948|NCT04395365|Renal Agents|renal agents|mesh-ancestor
5600387|NCT03712241|Indomethacin|indomethacin|mesh-list
6073890|NCT00742235|Micronutrients|micronutrients|mesh-ancestor
5510949|NCT04395365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5510950|NCT04395365|Antimalarials|antimalarials|mesh-ancestor
5510951|NCT04395365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5510952|NCT04395365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5510953|NCT04395183|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
5510954|NCT04395183|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5510955|NCT04395183|Antidepressive Agents|antidepressive agents|mesh-ancestor
5510956|NCT04395183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5510957|NCT04395105|Dexamethasone|dexamethasone|mesh-list
5510958|NCT04395105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6073891|NCT00742235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665415|NCT01517009|Mitosis Modulators|mitosis modulators|mesh-ancestor
6665416|NCT01517009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073892|NCT00742235|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6073893|NCT00742235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6073894|NCT00742313|Hemostatics|hemostatics|mesh-list
6073895|NCT00742313|Coagulants|coagulants|mesh-ancestor
6073896|NCT00742326|Pioglitazone|pioglitazone|mesh-list
6073897|NCT00742326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6073898|NCT00742326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073899|NCT00742469|Rifaximin|rifaximin|mesh-list
6073900|NCT00742469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6073901|NCT00742469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6073902|NCT00742469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6073903|NCT00742508|Carvedilol|carvedilol|mesh-list
6073904|NCT00742508|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6073905|NCT00742508|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6073906|NCT00742508|Adrenergic Agents|adrenergic agents|mesh-ancestor
6073907|NCT00742508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6073908|NCT00742508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073909|NCT00742508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073910|NCT00742508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6073911|NCT00742508|Antioxidants|antioxidants|mesh-ancestor
6073912|NCT00742508|Protective Agents|protective agents|mesh-ancestor
6073913|NCT00742508|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6073914|NCT00742508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6073915|NCT00742508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6073916|NCT00742508|Vasodilator Agents|vasodilator agents|mesh-ancestor
6073917|NCT00742508|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6073918|NCT00742508|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6073919|NCT00742560|Dexamethasone|dexamethasone|mesh-list
6073920|NCT00742560|Dexamethasone acetate|dexamethasone acetate|mesh-list
6073921|NCT00742560|Lenalidomide|lenalidomide|mesh-list
6073922|NCT00742560|Elotuzumab|elotuzumab|mesh-list
6073923|NCT00742560|BB 1101|bb 1101|mesh-list
5510959|NCT04395105|Antiemetics|antiemetics|mesh-ancestor
5510960|NCT04395105|Autonomic Agents|autonomic agents|mesh-ancestor
5510961|NCT04395105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6073924|NCT00742560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6073925|NCT00742560|Antiemetics|antiemetics|mesh-ancestor
6073926|NCT00742560|Autonomic Agents|autonomic agents|mesh-ancestor
6073927|NCT00742560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6073928|NCT00742560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073929|NCT00742560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6073930|NCT00742560|Glucocorticoids|glucocorticoids|mesh-ancestor
6073931|NCT00742560|Hormones|hormones|mesh-ancestor
6073932|NCT00742560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6073933|NCT00742560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6073934|NCT00742560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6073935|NCT00742560|Protease Inhibitors|protease inhibitors|mesh-ancestor
6073936|NCT00742560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6073937|NCT00742560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073938|NCT00742560|Immunologic Factors|immunologic factors|mesh-ancestor
6463613|NCT00465439|Epinephryl borate|epinephryl borate|mesh-list
5510962|NCT04395105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073939|NCT00742560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6073940|NCT00742560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6073941|NCT00742560|Growth Substances|growth substances|mesh-ancestor
6073942|NCT00742560|Growth Inhibitors|growth inhibitors|mesh-ancestor
6073943|NCT00742573|Bupropion|bupropion|mesh-list
6073944|NCT00742573|Antidepressive Agents|antidepressive agents|mesh-list
6073945|NCT00742573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6073946|NCT00742573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6073947|NCT00742573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073948|NCT00742573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6073949|NCT00742573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073950|NCT00742573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6073951|NCT00742573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6073952|NCT00742573|Dopamine Agents|dopamine agents|mesh-ancestor
6073953|NCT00742573|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5510963|NCT04395105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5510964|NCT04395105|Glucocorticoids|glucocorticoids|mesh-ancestor
5510965|NCT04395105|Hormones|hormones|mesh-ancestor
5510966|NCT04395105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6073954|NCT00742573|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6073955|NCT00742573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6073956|NCT00742573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6073957|NCT00742625|Cytarabine|cytarabine|mesh-list
6073958|NCT00742625|Bortezomib|bortezomib|mesh-list
6073959|NCT00742625|Daunorubicin|daunorubicin|mesh-list
6073960|NCT00742625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6073961|NCT00742625|Antimetabolites|antimetabolites|mesh-ancestor
6073962|NCT00742625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073963|NCT00742625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6073964|NCT00742625|Antiviral Agents|antiviral agents|mesh-ancestor
6073965|NCT00742625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6073966|NCT00742625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6073967|NCT00742625|Immunologic Factors|immunologic factors|mesh-ancestor
6073968|NCT00742625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073969|NCT00742625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6073970|NCT00742625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6073971|NCT00742625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6073972|NCT00742625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5510967|NCT04395105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5510968|NCT04395105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5510969|NCT04395248|Anesthetics|anesthetics|mesh-list
5510970|NCT04395248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5510971|NCT04395248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510972|NCT04395196|Choline|choline|mesh-list
5510973|NCT04395196|Lipotropic Agents|lipotropic agents|mesh-ancestor
5510974|NCT04395196|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5510975|NCT04395196|Antimetabolites|antimetabolites|mesh-ancestor
6073973|NCT00742781|Vitamin D|vitamin d|mesh-list
6073974|NCT00742781|Cholecalciferol|cholecalciferol|mesh-list
6073975|NCT00742781|Vitamins|vitamins|mesh-ancestor
6073976|NCT00742781|Micronutrients|micronutrients|mesh-ancestor
5510976|NCT04395196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5510977|NCT04395196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5510978|NCT04395196|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5510979|NCT04395196|Nootropic Agents|nootropic agents|mesh-ancestor
5510980|NCT04394975|Sunitinib|sunitinib|mesh-list
5510981|NCT04394975|Axitinib|axitinib|mesh-list
5510982|NCT04394975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6073977|NCT00742781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073978|NCT00742781|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6073979|NCT00742781|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6073980|NCT00742859|Warfarin|warfarin|mesh-list
6073981|NCT00742859|Acenocoumarol|acenocoumarol|mesh-list
6073982|NCT00742859|Betrixaban|betrixaban|mesh-list
6073983|NCT00742859|Anticoagulants|anticoagulants|mesh-ancestor
6073984|NCT00742859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6073985|NCT00742859|Antithrombins|antithrombins|mesh-ancestor
6073986|NCT00742859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6073987|NCT00742859|Protease Inhibitors|protease inhibitors|mesh-ancestor
6073988|NCT00742859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6073989|NCT00742859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073990|NCT00742872|Mosapride|mosapride|mesh-list
5510983|NCT04394975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5510984|NCT04394975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6073991|NCT00742872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073992|NCT00742872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5510985|NCT04394975|Growth Substances|growth substances|mesh-ancestor
5510986|NCT04394975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510987|NCT04394975|Growth Inhibitors|growth inhibitors|mesh-ancestor
5510988|NCT04394975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5510989|NCT04394975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5510990|NCT04394975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6073993|NCT00742872|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6073994|NCT00742872|Serotonin Agents|serotonin agents|mesh-ancestor
6073995|NCT00742872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6073996|NCT00742872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6073997|NCT00742924|Zoledronic Acid|zoledronic acid|mesh-list
6073998|NCT00742924|Leucovorin|leucovorin|mesh-list
5510991|NCT04395170|Immunoglobulins|immunoglobulins|mesh-list
5510992|NCT04395170|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5510993|NCT04395170|Antibodies|antibodies|mesh-list
5510994|NCT04395170|Immunologic Factors|immunologic factors|mesh-ancestor
5510995|NCT04395170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5510996|NCT04395079|Durvalumab|durvalumab|mesh-list
5510997|NCT04395079|Ipilimumab|ipilimumab|mesh-list
5510998|NCT04395079|Tremelimumab|tremelimumab|mesh-list
5510999|NCT04395079|Immunoglobulins|immunoglobulins|mesh-list
5511000|NCT04395079|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5511001|NCT04395079|Immunoglobulin G|immunoglobulin g|mesh-list
5511002|NCT04395079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6073999|NCT00742924|Cisplatin|cisplatin|mesh-list
6074000|NCT00742924|Doxorubicin|doxorubicin|mesh-list
6074001|NCT00742924|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6074002|NCT00742924|Methotrexate|methotrexate|mesh-list
6074003|NCT00742924|Etoposide|etoposide|mesh-list
6074004|NCT00742924|Ifosfamide|ifosfamide|mesh-list
6074005|NCT00742924|Isophosphamide mustard|isophosphamide mustard|mesh-list
6074006|NCT00742924|Dexrazoxane|dexrazoxane|mesh-list
6074007|NCT00742924|Razoxane|razoxane|mesh-list
6074008|NCT00742924|Imidazole|imidazole|mesh-list
6074009|NCT00742924|Lenograstim|lenograstim|mesh-list
6074010|NCT00742924|Levoleucovorin|levoleucovorin|mesh-list
6074011|NCT00742924|Mesna|mesna|mesh-list
6074012|NCT00742924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6074013|NCT00742924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6074014|NCT00742924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6074015|NCT00742924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6074016|NCT00742924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6074017|NCT00742924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074018|NCT00742924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074019|NCT00742924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5511003|NCT04395079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5511004|NCT04395079|Immunologic Factors|immunologic factors|mesh-ancestor
5511005|NCT04395079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511006|NCT04395079|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5511007|NCT04395079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074020|NCT00742924|Abortifacient Agents|abortifacient agents|mesh-ancestor
6074021|NCT00742924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6074022|NCT00742924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6074023|NCT00742924|Antimetabolites|antimetabolites|mesh-ancestor
6074024|NCT00742924|Dermatologic Agents|dermatologic agents|mesh-ancestor
6074025|NCT00742924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6074026|NCT00742924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6074027|NCT00742924|Immunologic Factors|immunologic factors|mesh-ancestor
6074028|NCT00742924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6074029|NCT00742924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6074030|NCT00742924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5511008|NCT04395001|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6074031|NCT00742924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6074032|NCT00742924|Antidotes|antidotes|mesh-ancestor
6074033|NCT00742924|Protective Agents|protective agents|mesh-ancestor
6074034|NCT00742924|Vitamin B Complex|vitamin b complex|mesh-ancestor
6074035|NCT00742924|Vitamins|vitamins|mesh-ancestor
6074036|NCT00742924|Micronutrients|micronutrients|mesh-ancestor
6074037|NCT00742924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6074038|NCT00742924|Alkylating Agents|alkylating agents|mesh-ancestor
6074039|NCT00742924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6074040|NCT00742924|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6074041|NCT00742924|Antimitotic Agents|antimitotic agents|mesh-ancestor
5511009|NCT04395001|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5511010|NCT04395001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5511011|NCT04395001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5511012|NCT04395001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511013|NCT04395001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5511014|NCT04395001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511015|NCT04395001|Analgesics|analgesics|mesh-ancestor
5511016|NCT04395001|Sensory System Agents|sensory system agents|mesh-ancestor
5511017|NCT04395001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5511018|NCT04395001|Antidepressive Agents|antidepressive agents|mesh-ancestor
5511019|NCT04395001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5511020|NCT04395001|Dopamine Agents|dopamine agents|mesh-ancestor
6074042|NCT00742924|Mitosis Modulators|mitosis modulators|mesh-ancestor
6074043|NCT00743093|Acetaminophen|acetaminophen|mesh-list
6074044|NCT00743093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6074045|NCT00743093|Analgesics|analgesics|mesh-ancestor
6074046|NCT00743093|Sensory System Agents|sensory system agents|mesh-ancestor
6074047|NCT00743093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6074048|NCT00743093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074049|NCT00743093|Antipyretics|antipyretics|mesh-ancestor
6074050|NCT00743106|Fenoldopam|fenoldopam|mesh-list
6074051|NCT00743106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6074052|NCT00743106|Vasodilator Agents|vasodilator agents|mesh-ancestor
6074053|NCT00743106|Dopamine Agonists|dopamine agonists|mesh-ancestor
6074054|NCT00743106|Dopamine Agents|dopamine agents|mesh-ancestor
6074055|NCT00743106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6074056|NCT00743106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074057|NCT00743106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074058|NCT00743119|Dronabinol|dronabinol|mesh-list
6074059|NCT00743119|Hallucinogens|hallucinogens|mesh-ancestor
6074060|NCT00743119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074061|NCT00743119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6074062|NCT00743119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6074063|NCT00743119|Analgesics|analgesics|mesh-ancestor
6074064|NCT00743119|Sensory System Agents|sensory system agents|mesh-ancestor
6074065|NCT00743119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6074066|NCT00743119|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6074067|NCT00743119|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6074068|NCT00743119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6074069|NCT00743119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074070|NCT00743119|Hormones|hormones|mesh-ancestor
6074071|NCT00743119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6074072|NCT00743145|Naltrexone|naltrexone|mesh-list
6074073|NCT00743145|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6074074|NCT00743145|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6074075|NCT00743145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074076|NCT00743145|Sensory System Agents|sensory system agents|mesh-ancestor
6074077|NCT00743145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6074078|NCT00743288|Melphalan|melphalan|mesh-list
6074079|NCT00743288|Panobinostat|panobinostat|mesh-list
6074080|NCT00743288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6074081|NCT00743288|Alkylating Agents|alkylating agents|mesh-ancestor
6074082|NCT00743288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074083|NCT00743288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6074084|NCT00743288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6074085|NCT00743288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6074086|NCT00743288|Immunologic Factors|immunologic factors|mesh-ancestor
6074087|NCT00743288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074088|NCT00743288|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6074089|NCT00743288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6074090|NCT00743340|Emtricitabine|emtricitabine|mesh-list
6074091|NCT00743340|Antiviral Agents|antiviral agents|mesh-ancestor
6074092|NCT00743340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6074093|NCT00743340|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6074094|NCT00743340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6074095|NCT00743340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6074096|NCT00743340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074097|NCT00743340|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6074098|NCT00743340|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6074099|NCT00743366|Riboflavin|riboflavin|mesh-list
6074100|NCT00743366|Quetiapine Fumarate|quetiapine fumarate|mesh-list
5511021|NCT04394897|Remifentanil|remifentanil|mesh-list
5511022|NCT04394897|Propofol|propofol|mesh-list
5511023|NCT04394897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5511024|NCT04394897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5511025|NCT04394897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511026|NCT04394897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5511027|NCT04394897|Anesthetics, General|anesthetics, general|mesh-ancestor
6074101|NCT00743366|Antidepressive Agents|antidepressive agents|mesh-ancestor
6074102|NCT00743366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6074103|NCT00743366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6074104|NCT00743366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6074105|NCT00743366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6074106|NCT00743366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074107|NCT00743366|Vitamin B Complex|vitamin b complex|mesh-ancestor
6074108|NCT00743366|Vitamins|vitamins|mesh-ancestor
6074109|NCT00743366|Micronutrients|micronutrients|mesh-ancestor
6074110|NCT00743366|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6074111|NCT00743366|Dermatologic Agents|dermatologic agents|mesh-ancestor
6074112|NCT00743431|Doxorubicin|doxorubicin|mesh-list
6074113|NCT00743431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6074114|NCT00743431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6074115|NCT00743431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6074116|NCT00743431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6074117|NCT00743431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6074118|NCT00743431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074119|NCT00743444|Lesogaberan|lesogaberan|mesh-list
6074120|NCT00743444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6074121|NCT00743444|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6074122|NCT00743444|GABA Agonists|gaba agonists|mesh-ancestor
6074123|NCT00743444|GABA Agents|gaba agents|mesh-ancestor
6074124|NCT00743444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6074125|NCT00743444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511028|NCT04394897|Anesthetics|anesthetics|mesh-ancestor
5511029|NCT04394897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5511030|NCT04394897|Narcotics|narcotics|mesh-ancestor
5511031|NCT04394897|Analgesics|analgesics|mesh-ancestor
5511032|NCT04394897|Sensory System Agents|sensory system agents|mesh-ancestor
5511033|NCT04394897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6074126|NCT00743444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074127|NCT00743509|Sirolimus|sirolimus|mesh-list
6074128|NCT00743509|Cyclophosphamide|cyclophosphamide|mesh-list
6074129|NCT00743509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6074130|NCT00743509|Immunologic Factors|immunologic factors|mesh-ancestor
6074131|NCT00743509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074132|NCT00743509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6074133|NCT00743509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6074134|NCT00743509|Alkylating Agents|alkylating agents|mesh-ancestor
6074135|NCT00743509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074136|NCT00743509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6074137|NCT00743509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6074138|NCT00743509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6074139|NCT00743509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6074140|NCT00743509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6074141|NCT00743509|Antifungal Agents|antifungal agents|mesh-ancestor
6074142|NCT00743574|Vitamin D|vitamin d|mesh-list
6074143|NCT00743574|Ergocalciferols|ergocalciferols|mesh-list
6074144|NCT00743574|Cholecalciferol|cholecalciferol|mesh-list
6074145|NCT00743574|Vitamins|vitamins|mesh-list
6074146|NCT00743574|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
5511034|NCT04394728|Trabectedin|trabectedin|mesh-list
6074147|NCT00743574|Medroxyprogesterone|medroxyprogesterone|mesh-list
6074148|NCT00743574|Calcium|calcium|mesh-list
6074149|NCT00743574|Micronutrients|micronutrients|mesh-ancestor
6074150|NCT00743574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074151|NCT00743574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6074152|NCT00743574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6074153|NCT00743574|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6074154|NCT00743574|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6074155|NCT00743574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6074156|NCT00743574|Contraceptive Agents|contraceptive agents|mesh-ancestor
6074157|NCT00743574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6074158|NCT00743574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6074159|NCT00743574|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6074160|NCT00743574|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6074161|NCT00743574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6074162|NCT00743574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6202719|NCT02045862|Solifenacin Succinate|solifenacin succinate|mesh-list
6202720|NCT02045862|Mirabegron|mirabegron|mesh-list
6202721|NCT02045862|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6202722|NCT02045862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6202723|NCT02045862|Cholinergic Agents|cholinergic agents|mesh-ancestor
6202724|NCT02045862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6202725|NCT02045862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511035|NCT04394728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5511036|NCT04394728|Alkylating Agents|alkylating agents|mesh-ancestor
5511037|NCT04394728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511038|NCT04394728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5511039|NCT04394598|Capecitabine|capecitabine|mesh-list
5511040|NCT04394598|Irinotecan|irinotecan|mesh-list
5511041|NCT04394598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5511042|NCT04394598|Antimetabolites|antimetabolites|mesh-ancestor
5511043|NCT04394598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511044|NCT04394598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5511045|NCT04394598|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5511046|NCT04394598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5511047|NCT04394598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5511048|NCT04394663|Omeprazole|omeprazole|mesh-list
5511049|NCT04394663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5511050|NCT04394663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5511051|NCT04394663|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5511052|NCT04394663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6202726|NCT02045862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202727|NCT02045862|Urological Agents|urological agents|mesh-ancestor
6202728|NCT02045862|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6202729|NCT02045862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6202730|NCT02045862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6202731|NCT02045862|Adrenergic Agents|adrenergic agents|mesh-ancestor
6202732|NCT02045875|Mometasone Furoate|mometasone furoate|mesh-list
6202733|NCT02045875|Formoterol Fumarate|formoterol fumarate|mesh-list
6202734|NCT02045875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6202735|NCT02045875|Autonomic Agents|autonomic agents|mesh-ancestor
6202736|NCT02045875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6202737|NCT02045875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202738|NCT02045875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6202739|NCT02045875|Respiratory System Agents|respiratory system agents|mesh-ancestor
6202740|NCT02045875|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5511053|NCT04394663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511054|NCT04394533|Bupivacaine|bupivacaine|mesh-list
5511055|NCT04394533|Prilocaine|prilocaine|mesh-list
5511056|NCT04394533|Anesthetics, Local|anesthetics, local|mesh-ancestor
5511057|NCT04394533|Anesthetics|anesthetics|mesh-ancestor
5511058|NCT04394533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5511059|NCT04394533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511060|NCT04394533|Sensory System Agents|sensory system agents|mesh-ancestor
6202741|NCT02045875|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6074163|NCT00743652|Vaccines|vaccines|mesh-list
6074164|NCT00743652|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5511061|NCT04394533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5511062|NCT04394234|Warfarin|warfarin|mesh-list
5511063|NCT04394234|Anticoagulants|anticoagulants|mesh-list
5511064|NCT04394182|Ritonavir|ritonavir|mesh-list
5511065|NCT04394182|Lopinavir|lopinavir|mesh-list
5511066|NCT04394182|Azithromycin|azithromycin|mesh-list
5511067|NCT04394182|Hydroxychloroquine|hydroxychloroquine|mesh-list
5511068|NCT04394182|Tazobactam|tazobactam|mesh-list
5511069|NCT04394182|Piperacillin|piperacillin|mesh-list
5511070|NCT04394182|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
5511071|NCT04394182|Heparin|heparin|mesh-list
5511072|NCT04394182|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5511073|NCT04394182|Tinzaparin|tinzaparin|mesh-list
5511074|NCT04394182|Dalteparin|dalteparin|mesh-list
5511075|NCT04394182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5511076|NCT04394182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5511077|NCT04394182|Protease Inhibitors|protease inhibitors|mesh-ancestor
6074165|NCT00743652|Immunologic Factors|immunologic factors|mesh-ancestor
6074166|NCT00743652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074167|NCT00743717|Cobalt|cobalt|mesh-list
6074168|NCT00743717|Trace Elements|trace elements|mesh-ancestor
6074169|NCT00743717|Micronutrients|micronutrients|mesh-ancestor
6074170|NCT00743717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074171|NCT00743730|Morphine|morphine|mesh-list
6074172|NCT00743730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6074173|NCT00743730|Narcotics|narcotics|mesh-ancestor
6074174|NCT00743730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6074175|NCT00743730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074176|NCT00743730|Analgesics|analgesics|mesh-ancestor
6074177|NCT00743730|Sensory System Agents|sensory system agents|mesh-ancestor
6074178|NCT00743730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6074179|NCT00744042|Immunoglobulin G|immunoglobulin g|mesh-list
6074180|NCT00744042|Immunologic Factors|immunologic factors|mesh-ancestor
6074181|NCT00744042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074182|NCT00744055|Prazosin|prazosin|mesh-list
6074183|NCT00744055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6074184|NCT00744055|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6074185|NCT00744055|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6074186|NCT00744055|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6074187|NCT00744055|Adrenergic Agents|adrenergic agents|mesh-ancestor
6074188|NCT00744055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6074189|NCT00744055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074190|NCT00744055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074191|NCT00744211|Sitaxsentan|sitaxsentan|mesh-list
6074192|NCT00744211|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6074193|NCT00744211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074194|NCT00744237|Metoprolol|metoprolol|mesh-list
6074195|NCT00744237|Nebivolol|nebivolol|mesh-list
6074196|NCT00744237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6074197|NCT00744237|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6074198|NCT00744237|Sympatholytics|sympatholytics|mesh-ancestor
6074199|NCT00744237|Autonomic Agents|autonomic agents|mesh-ancestor
6074200|NCT00744237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6074201|NCT00744237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074202|NCT00744237|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6074203|NCT00744237|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6074204|NCT00744237|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6074205|NCT00744237|Adrenergic Agents|adrenergic agents|mesh-ancestor
6074206|NCT00744237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6074207|NCT00744237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074208|NCT00744237|Vasodilator Agents|vasodilator agents|mesh-ancestor
6074209|NCT00744237|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5511078|NCT04394182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5511079|NCT04394182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074210|NCT00744237|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6074211|NCT00744237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5511080|NCT04394182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5511081|NCT04394182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5511082|NCT04394182|Antiviral Agents|antiviral agents|mesh-ancestor
5511083|NCT04394182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5511084|NCT04394182|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5511085|NCT04394182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5511086|NCT04394182|Anticoagulants|anticoagulants|mesh-ancestor
5511087|NCT04394182|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5511088|NCT04394182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5511089|NCT04394182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5511090|NCT04394182|Antimalarials|antimalarials|mesh-ancestor
5511091|NCT04394182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5511092|NCT04394182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5511093|NCT04394182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5511094|NCT04394182|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5511095|NCT04394130|Ropivacaine|ropivacaine|mesh-list
5511096|NCT04394130|Anesthetics, Local|anesthetics, local|mesh-ancestor
5511097|NCT04394130|Anesthetics|anesthetics|mesh-ancestor
6074212|NCT00744263|Vaccines|vaccines|mesh-list
6074213|NCT00744263|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6074214|NCT00744263|Immunologic Factors|immunologic factors|mesh-ancestor
6074215|NCT00744263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074216|NCT00744328|Sertraline|sertraline|mesh-list
6074217|NCT00744328|Estradiol|estradiol|mesh-list
6074218|NCT00744328|Estrogens|estrogens|mesh-ancestor
5511098|NCT04394130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5511099|NCT04394130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511100|NCT04394130|Sensory System Agents|sensory system agents|mesh-ancestor
5511101|NCT04394130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5511102|NCT04394208|Silymarin|silymarin|mesh-list
5511103|NCT04394208|Antioxidants|antioxidants|mesh-ancestor
5511104|NCT04394208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511105|NCT04394208|Protective Agents|protective agents|mesh-ancestor
5511106|NCT04394208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511107|NCT04394442|Hydroxychloroquine|hydroxychloroquine|mesh-list
5511108|NCT04394442|Antimalarials|antimalarials|mesh-ancestor
5511109|NCT04394442|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5511110|NCT04394442|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6074219|NCT00744328|Hormones|hormones|mesh-ancestor
6074220|NCT00744328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6074221|NCT00744328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074222|NCT00744328|Antidepressive Agents|antidepressive agents|mesh-ancestor
6074223|NCT00744328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6074224|NCT00744328|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6074225|NCT00744328|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6074226|NCT00744328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6074227|NCT00744328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074228|NCT00744328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6074229|NCT00744328|Serotonin Agents|serotonin agents|mesh-ancestor
6074230|NCT00744380|Midazolam|midazolam|mesh-list
5511111|NCT04394442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5511112|NCT04394442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5511113|NCT04394442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511114|NCT04394442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5511115|NCT04394390|Vitamin D|vitamin d|mesh-list
5511116|NCT04394390|Ergocalciferols|ergocalciferols|mesh-list
5511117|NCT04394390|Vitamins|vitamins|mesh-list
5511118|NCT04394390|Micronutrients|micronutrients|mesh-ancestor
5511119|NCT04394390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511120|NCT04394390|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5511121|NCT04394390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5511122|NCT04394416|Imatinib Mesylate|imatinib mesylate|mesh-list
5511123|NCT04394416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6074231|NCT00744380|Dexmedetomidine|dexmedetomidine|mesh-list
6074232|NCT00744380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5511124|NCT04394416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6202742|NCT02045875|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6074233|NCT00744380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6074234|NCT00744380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074235|NCT00744380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6074236|NCT00744380|Analgesics|analgesics|mesh-ancestor
6074237|NCT00744380|Sensory System Agents|sensory system agents|mesh-ancestor
5511125|NCT04394416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5511126|NCT04394416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511127|NCT04394377|Heparin|heparin|mesh-list
5511128|NCT04394377|Enoxaparin|enoxaparin|mesh-list
5511129|NCT04394377|Calcium heparin|calcium heparin|mesh-list
6074238|NCT00744380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6074239|NCT00744380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6074240|NCT00744380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6074241|NCT00744380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6074242|NCT00744380|Adrenergic Agents|adrenergic agents|mesh-ancestor
6074243|NCT00744380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6074244|NCT00744380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074245|NCT00744380|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5511130|NCT04394377|Rivaroxaban|rivaroxaban|mesh-list
5511131|NCT04394377|Enoxaparin sodium|enoxaparin sodium|mesh-list
5511132|NCT04394377|Anticoagulants|anticoagulants|mesh-ancestor
5511133|NCT04394377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5511134|NCT04394377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5511135|NCT04394377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511136|NCT04394377|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6074246|NCT00744380|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6074247|NCT00744380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6074248|NCT00744380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5511137|NCT04394377|Antithrombins|antithrombins|mesh-ancestor
5511138|NCT04394377|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5511139|NCT04394377|Protease Inhibitors|protease inhibitors|mesh-ancestor
5511140|NCT04394377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5511141|NCT04394143|Mannitol|mannitol|mesh-list
5511142|NCT04394143|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5511143|NCT04394143|Diuretics|diuretics|mesh-ancestor
5511144|NCT04394143|Natriuretic Agents|natriuretic agents|mesh-ancestor
5511145|NCT04394143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074249|NCT00744380|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6074250|NCT00744380|Anesthetics, General|anesthetics, general|mesh-ancestor
6074251|NCT00744380|Anesthetics|anesthetics|mesh-ancestor
6074252|NCT00744380|GABA Modulators|gaba modulators|mesh-ancestor
6074253|NCT00744380|GABA Agents|gaba agents|mesh-ancestor
6074254|NCT00744471|Tanezumab|tanezumab|mesh-list
6074255|NCT00744471|Analgesics|analgesics|mesh-ancestor
6074256|NCT00744471|Sensory System Agents|sensory system agents|mesh-ancestor
6074257|NCT00744471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6074258|NCT00744471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074259|NCT00744497|Prednisone|prednisone|mesh-list
6074260|NCT00744497|Docetaxel|docetaxel|mesh-list
6074261|NCT00744497|Dasatinib|dasatinib|mesh-list
6074262|NCT00744497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6074263|NCT00744497|Tubulin Modulators|tubulin modulators|mesh-ancestor
6074264|NCT00744497|Antimitotic Agents|antimitotic agents|mesh-ancestor
6074265|NCT00744497|Mitosis Modulators|mitosis modulators|mesh-ancestor
6074266|NCT00744497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074267|NCT00744497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6074268|NCT00744497|Glucocorticoids|glucocorticoids|mesh-ancestor
6074269|NCT00744497|Hormones|hormones|mesh-ancestor
6074270|NCT00744497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6074271|NCT00744497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074272|NCT00744497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6074273|NCT00744497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6074274|NCT00744497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6074275|NCT00744627|Vortioxetine|vortioxetine|mesh-list
6074276|NCT00744627|Antidepressive Agents|antidepressive agents|mesh-ancestor
6074277|NCT00744627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6074278|NCT00744627|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6074279|NCT00744627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6074280|NCT00744627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6074281|NCT00744627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074282|NCT00744627|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6074283|NCT00744627|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6074284|NCT00744627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6074285|NCT00744627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074286|NCT00744627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6074287|NCT00744627|Serotonin Agents|serotonin agents|mesh-ancestor
6074288|NCT00744627|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6074289|NCT00744627|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6074290|NCT00744627|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6074291|NCT00744627|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6074292|NCT00744653|Bleomycin|bleomycin|mesh-list
6074293|NCT00744653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6074294|NCT00744653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6074295|NCT00744692|Fludarabine|fludarabine|mesh-list
6074296|NCT00744692|Melphalan|melphalan|mesh-list
6074297|NCT00744692|Thiotepa|thiotepa|mesh-list
6074298|NCT00744692|Hydroxyurea|hydroxyurea|mesh-list
6074299|NCT00744692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6074300|NCT00744692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074301|NCT00744692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6074302|NCT00744692|Immunologic Factors|immunologic factors|mesh-ancestor
6074303|NCT00744692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074304|NCT00744692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6074305|NCT00744692|Alkylating Agents|alkylating agents|mesh-ancestor
6074306|NCT00744692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6074307|NCT00744692|Antisickling Agents|antisickling agents|mesh-ancestor
6074308|NCT00744692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6074309|NCT00744692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6074310|NCT00744757|Decitabine|decitabine|mesh-list
6074311|NCT00744757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6074312|NCT00744757|Antimetabolites|antimetabolites|mesh-ancestor
6074313|NCT00744757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074314|NCT00744757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6074315|NCT00744757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6074316|NCT00744848|Epinephrine|epinephrine|mesh-list
6074317|NCT00744848|Bupivacaine|bupivacaine|mesh-list
6074318|NCT00744848|Anesthetics, Local|anesthetics, local|mesh-ancestor
6074319|NCT00744848|Anesthetics|anesthetics|mesh-ancestor
6074320|NCT00744848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6074321|NCT00744848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074322|NCT00744848|Sensory System Agents|sensory system agents|mesh-ancestor
6074323|NCT00744848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6074324|NCT00744848|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6074325|NCT00744848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6074326|NCT00744848|Adrenergic Agents|adrenergic agents|mesh-ancestor
6074327|NCT00744848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6074328|NCT00744848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074329|NCT00744848|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6074330|NCT00744848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6074331|NCT00744848|Autonomic Agents|autonomic agents|mesh-ancestor
6074332|NCT00744848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6074333|NCT00744848|Respiratory System Agents|respiratory system agents|mesh-ancestor
6074334|NCT00744848|Mydriatics|mydriatics|mesh-ancestor
6074335|NCT00744848|Sympathomimetics|sympathomimetics|mesh-ancestor
6074336|NCT00744848|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5511146|NCT04393883|Pembrolizumab|pembrolizumab|mesh-list
5511147|NCT04393883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5511148|NCT04393883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5511149|NCT04393805|Heparin|heparin|mesh-list
5511150|NCT04393805|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5511151|NCT04393805|Tinzaparin|tinzaparin|mesh-list
5511152|NCT04393805|Dalteparin|dalteparin|mesh-list
6074337|NCT00744965|Glyburide|glyburide|mesh-list
6074338|NCT00744965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6074339|NCT00744965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074340|NCT00744978|Varenicline|varenicline|mesh-list
6074341|NCT00744978|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6074342|NCT00744978|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6074343|NCT00744978|Cholinergic Agents|cholinergic agents|mesh-ancestor
6074344|NCT00744978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6074345|NCT00744978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074346|NCT00744978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074347|NCT00745095|Neostigmine|neostigmine|mesh-list
6074348|NCT00745095|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6074349|NCT00745095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6074350|NCT00745095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463614|NCT00465439|Anesthetics, Local|anesthetics, local|mesh-ancestor
6463615|NCT00465439|Anesthetics|anesthetics|mesh-ancestor
6463616|NCT00465439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6463617|NCT00465439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074351|NCT00745095|Cholinergic Agents|cholinergic agents|mesh-ancestor
6074352|NCT00745095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6074353|NCT00745095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074354|NCT00745095|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6074355|NCT00745095|Autonomic Agents|autonomic agents|mesh-ancestor
6074356|NCT00745095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6074357|NCT00745290|Bupivacaine|bupivacaine|mesh-list
6074358|NCT00745290|Anesthetics, Local|anesthetics, local|mesh-ancestor
6074359|NCT00745290|Anesthetics|anesthetics|mesh-ancestor
6074360|NCT00745290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6074361|NCT00745290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074362|NCT00745290|Sensory System Agents|sensory system agents|mesh-ancestor
6074363|NCT00745290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6074364|NCT00745368|Raltegravir Potassium|raltegravir potassium|mesh-list
6074365|NCT00745368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6074366|NCT00745368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6074367|NCT00745368|Antiviral Agents|antiviral agents|mesh-ancestor
6074368|NCT00745368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6074369|NCT00745368|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6074370|NCT00745368|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5511153|NCT04393805|Anticoagulants|anticoagulants|mesh-ancestor
5511154|NCT04393805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5511155|NCT04393805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5511156|NCT04393805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511157|NCT04393792|Povidone-Iodine|povidone-iodine|mesh-list
5511158|NCT04393792|Povidone|povidone|mesh-list
5511159|NCT04393792|Plasma Substitutes|plasma substitutes|mesh-ancestor
5511160|NCT04393792|Blood Substitutes|blood substitutes|mesh-ancestor
5511161|NCT04393792|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5511162|NCT04393792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5600388|NCT03712241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5600389|NCT03712241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5600390|NCT03712241|Analgesics|analgesics|mesh-ancestor
6074371|NCT00745368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6074372|NCT00745368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074373|NCT00745498|Bevacizumab|bevacizumab|mesh-list
6074374|NCT00745498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6074375|NCT00745498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6074376|NCT00745498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6074377|NCT00745498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6074378|NCT00745498|Growth Substances|growth substances|mesh-ancestor
6074379|NCT00745498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074380|NCT00745498|Growth Inhibitors|growth inhibitors|mesh-ancestor
5600391|NCT03712241|Sensory System Agents|sensory system agents|mesh-ancestor
5600392|NCT03712241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5600393|NCT03712241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600394|NCT03712241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5600395|NCT03712241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5600396|NCT03712241|Gout Suppressants|gout suppressants|mesh-ancestor
5600397|NCT03712241|Tocolytic Agents|tocolytic agents|mesh-ancestor
5600398|NCT03712241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5600399|NCT03712241|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5600400|NCT03712241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6074381|NCT00745823|Raltegravir Potassium|raltegravir potassium|mesh-list
6074382|NCT00745823|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5606680|NCT03927274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6074383|NCT00745823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6074384|NCT00745823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6074385|NCT00745823|Antiviral Agents|antiviral agents|mesh-ancestor
6074386|NCT00745823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6074387|NCT00745823|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6074388|NCT00745823|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6074389|NCT00745823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6074390|NCT00745823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074391|NCT00745823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6074392|NCT00745823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6074393|NCT00745849|Esomeprazole|esomeprazole|mesh-list
6074394|NCT00745849|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6074395|NCT00745849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6074396|NCT00745849|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6074397|NCT00745849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6074398|NCT00745849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074399|NCT00745875|Pemetrexed|pemetrexed|mesh-list
6074400|NCT00745875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6074401|NCT00745875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6074402|NCT00745875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074403|NCT00745875|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6074404|NCT00745875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6074405|NCT00745901|Drospirenone|drospirenone|mesh-list
6074406|NCT00745901|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6074407|NCT00745901|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6074408|NCT00745901|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6074409|NCT00745901|Norgestimate|norgestimate|mesh-list
6074410|NCT00745901|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
6074411|NCT00745901|Estradiol|estradiol|mesh-list
6074412|NCT00745901|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6074413|NCT00745901|Estrogens|estrogens|mesh-ancestor
6074414|NCT00745901|Hormones|hormones|mesh-ancestor
6074415|NCT00745901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6074416|NCT00745901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074417|NCT00745901|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6074418|NCT00745901|Contraceptive Agents|contraceptive agents|mesh-ancestor
6074419|NCT00745901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5511163|NCT04393610|Lidocaine|lidocaine|mesh-list
5511164|NCT04393610|Magnesium Sulfate|magnesium sulfate|mesh-list
5511165|NCT04393610|Fentanyl|fentanyl|mesh-list
5511166|NCT04393610|Anesthetics, Local|anesthetics, local|mesh-ancestor
5511167|NCT04393610|Anesthetics|anesthetics|mesh-ancestor
5511168|NCT04393610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5511169|NCT04393610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511170|NCT04393610|Sensory System Agents|sensory system agents|mesh-ancestor
5511171|NCT04393610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5511172|NCT04393610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5511173|NCT04393610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6074420|NCT00745901|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6074421|NCT00745901|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6074422|NCT00745901|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6074423|NCT00745901|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6074424|NCT00745901|Hormone Antagonists|hormone antagonists|mesh-ancestor
6074425|NCT00745901|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6074426|NCT00745901|Diuretics|diuretics|mesh-ancestor
6074427|NCT00745901|Natriuretic Agents|natriuretic agents|mesh-ancestor
6074428|NCT00745901|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6074429|NCT00746252|Risperidone|risperidone|mesh-list
6074430|NCT00746252|Aripiprazole|aripiprazole|mesh-list
6074431|NCT00746252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6074432|NCT00746252|Serotonin Agents|serotonin agents|mesh-ancestor
6074433|NCT00746252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6074434|NCT00746252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074435|NCT00746252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074436|NCT00746252|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6074437|NCT00746252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6074438|NCT00746252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6074439|NCT00746252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6074440|NCT00746252|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6074441|NCT00746252|Dopamine Agents|dopamine agents|mesh-ancestor
6074442|NCT00746252|Antidepressive Agents|antidepressive agents|mesh-ancestor
6074443|NCT00746252|Dopamine Agonists|dopamine agonists|mesh-ancestor
6074444|NCT00746252|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6074445|NCT00746252|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5511174|NCT04393610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5511175|NCT04393610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5511176|NCT04393610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511177|NCT04393610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5511178|NCT04393610|Narcotics|narcotics|mesh-ancestor
5511179|NCT04393610|Analgesics|analgesics|mesh-ancestor
5511180|NCT04393610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5511181|NCT04393610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5511182|NCT04393610|Anesthetics, General|anesthetics, general|mesh-ancestor
6074446|NCT00746252|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6074447|NCT00746252|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6074448|NCT00746330|Mometasone Furoate|mometasone furoate|mesh-list
6074449|NCT00746330|Formoterol Fumarate|formoterol fumarate|mesh-list
6074450|NCT00746330|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6074451|NCT00746330|Autonomic Agents|autonomic agents|mesh-ancestor
5511183|NCT04393610|Anticonvulsants|anticonvulsants|mesh-ancestor
5511184|NCT04393610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5511185|NCT04393610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5511186|NCT04393610|Tocolytic Agents|tocolytic agents|mesh-ancestor
5511187|NCT04393610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5511188|NCT04393389|Paclitaxel|paclitaxel|mesh-list
5511189|NCT04393389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5511190|NCT04393389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5511191|NCT04393389|Tubulin Modulators|tubulin modulators|mesh-ancestor
5511192|NCT04393389|Antimitotic Agents|antimitotic agents|mesh-ancestor
5511193|NCT04393389|Mitosis Modulators|mitosis modulators|mesh-ancestor
5511194|NCT04393389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511195|NCT04393506|Apatinib|apatinib|mesh-list
5511196|NCT04393506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5511197|NCT04393506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5511198|NCT04393506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6074452|NCT00746330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6074453|NCT00746330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074454|NCT00746330|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6074455|NCT00746330|Respiratory System Agents|respiratory system agents|mesh-ancestor
6074456|NCT00746330|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6074457|NCT00746330|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6074458|NCT00746330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6074459|NCT00746330|Adrenergic Agents|adrenergic agents|mesh-ancestor
6074460|NCT00746330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6074461|NCT00746330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074462|NCT00746330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6074463|NCT00746330|Dermatologic Agents|dermatologic agents|mesh-ancestor
6074464|NCT00746330|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6074465|NCT00746395|Lubiprostone|lubiprostone|mesh-list
6074466|NCT00746395|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6074467|NCT00746395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6074468|NCT00746395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074469|NCT00746421|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6074470|NCT00746421|Antidepressive Agents|antidepressive agents|mesh-ancestor
6074471|NCT00746421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6074472|NCT00746421|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6074473|NCT00746421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6074474|NCT00746421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6074475|NCT00746421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511199|NCT04393506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5511200|NCT04393506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511201|NCT04393454|Sirolimus|sirolimus|mesh-list
6074476|NCT00746512|Prednisone|prednisone|mesh-list
6074477|NCT00746512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6074478|NCT00746512|Glucocorticoids|glucocorticoids|mesh-ancestor
6074479|NCT00746512|Hormones|hormones|mesh-ancestor
6074480|NCT00746512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6074481|NCT00746512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074482|NCT00746512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6074483|NCT00746512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6074484|NCT00746551|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6074485|NCT00746551|Hematinics|hematinics|mesh-ancestor
6074486|NCT00746733|Amphetamine|amphetamine|mesh-list
6074487|NCT00746733|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6074488|NCT00746733|Adderall|adderall|mesh-list
6074489|NCT00746733|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6074490|NCT00746733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511202|NCT04393454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6074491|NCT00746733|Sympathomimetics|sympathomimetics|mesh-ancestor
6074492|NCT00746733|Autonomic Agents|autonomic agents|mesh-ancestor
6074493|NCT00746733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6463618|NCT00465439|Sensory System Agents|sensory system agents|mesh-ancestor
6463619|NCT00465439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6463620|NCT00465439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6463621|NCT00465439|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5511203|NCT04393454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5511204|NCT04393454|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5511205|NCT04393454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5511206|NCT04393454|Antifungal Agents|antifungal agents|mesh-ancestor
5511207|NCT04393454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5511208|NCT04393454|Immunologic Factors|immunologic factors|mesh-ancestor
5511209|NCT04393454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511210|NCT04393584|Leucovorin|leucovorin|mesh-list
6463622|NCT00465439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6463623|NCT00465439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6488408|NCT00583986|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6074494|NCT00746733|Dopamine Agents|dopamine agents|mesh-ancestor
6074495|NCT00746733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6074496|NCT00746733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074497|NCT00746733|Adrenergic Agents|adrenergic agents|mesh-ancestor
6074498|NCT00746733|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6074499|NCT00746733|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6074500|NCT00746733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6074501|NCT00746733|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5511211|NCT04393584|Docetaxel|docetaxel|mesh-list
5511212|NCT04393584|Oxaliplatin|oxaliplatin|mesh-list
5511213|NCT04393584|Irinotecan|irinotecan|mesh-list
5511214|NCT04393584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5511215|NCT04393584|Tubulin Modulators|tubulin modulators|mesh-ancestor
5511216|NCT04393584|Antimitotic Agents|antimitotic agents|mesh-ancestor
5511217|NCT04393584|Mitosis Modulators|mitosis modulators|mesh-ancestor
5511218|NCT04393584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511219|NCT04393584|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5511220|NCT04393584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5511221|NCT04393584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5511222|NCT04393584|Antidotes|antidotes|mesh-ancestor
5511223|NCT04393584|Protective Agents|protective agents|mesh-ancestor
5511224|NCT04393584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511225|NCT04393584|Vitamin B Complex|vitamin b complex|mesh-ancestor
5511226|NCT04393584|Vitamins|vitamins|mesh-ancestor
5511227|NCT04393584|Micronutrients|micronutrients|mesh-ancestor
5511228|NCT04393441|Lubricant Eye Drops|lubricant eye drops|mesh-list
5511229|NCT04393441|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5511230|NCT04393441|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5511231|NCT04393220|Bevacizumab|bevacizumab|mesh-list
5511232|NCT04393220|Nivolumab|nivolumab|mesh-list
5511233|NCT04393220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5511234|NCT04393220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5511235|NCT04393220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5511236|NCT04393220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5511237|NCT04393220|Growth Substances|growth substances|mesh-ancestor
5511238|NCT04393220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511239|NCT04393220|Growth Inhibitors|growth inhibitors|mesh-ancestor
5511240|NCT04393220|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5511241|NCT04393220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511242|NCT04393246|Dapagliflozin|dapagliflozin|mesh-list
5511243|NCT04393246|Ambrisentan|ambrisentan|mesh-list
5511244|NCT04393246|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5511245|NCT04393246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511246|NCT04393246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6074502|NCT00746785|Olanzapine|olanzapine|mesh-list
6074503|NCT00746785|Antiemetics|antiemetics|mesh-ancestor
6074504|NCT00746785|Autonomic Agents|autonomic agents|mesh-ancestor
6074505|NCT00746785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6074506|NCT00746785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074507|NCT00746785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6074508|NCT00746785|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6074509|NCT00746785|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5511247|NCT04393246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511248|NCT04393246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5511249|NCT04393207|Bupivacaine|bupivacaine|mesh-list
5511250|NCT04393207|Anesthetics, Local|anesthetics, local|mesh-ancestor
5511251|NCT04393207|Anesthetics|anesthetics|mesh-ancestor
5511252|NCT04393207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5511253|NCT04393207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511254|NCT04393207|Sensory System Agents|sensory system agents|mesh-ancestor
5511255|NCT04393207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5511256|NCT04392921|Amiodarone|amiodarone|mesh-list
5511257|NCT04392921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5511258|NCT04392921|Vasodilator Agents|vasodilator agents|mesh-ancestor
5511259|NCT04392921|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5511260|NCT04392921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5511261|NCT04392921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511262|NCT04392921|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5511263|NCT04392921|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5511264|NCT04392921|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5511265|NCT04392921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6074510|NCT00746785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6074511|NCT00746785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6074512|NCT00746785|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6074513|NCT00746785|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6074514|NCT00746785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6074515|NCT00746785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074516|NCT00746785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6074517|NCT00746785|Serotonin Agents|serotonin agents|mesh-ancestor
6074518|NCT00746798|Vaccines|vaccines|mesh-list
6074519|NCT00746798|Immunologic Factors|immunologic factors|mesh-ancestor
6074520|NCT00746798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074521|NCT00746863|Bupivacaine|bupivacaine|mesh-list
5511266|NCT04392921|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5511267|NCT04392921|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5511268|NCT04392921|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5511269|NCT04393025|Aspirin|aspirin|mesh-list
5511270|NCT04393025|Clopidogrel|clopidogrel|mesh-list
5511271|NCT04393025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5511272|NCT04393025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5511273|NCT04393025|Analgesics|analgesics|mesh-ancestor
5511274|NCT04393025|Sensory System Agents|sensory system agents|mesh-ancestor
5511275|NCT04393025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6074522|NCT00746863|Anesthetics, Local|anesthetics, local|mesh-ancestor
6074523|NCT00746863|Anesthetics|anesthetics|mesh-ancestor
6074524|NCT00746863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6074525|NCT00746863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074526|NCT00746863|Sensory System Agents|sensory system agents|mesh-ancestor
6074527|NCT00746863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6074528|NCT00746889|Triamcinolone|triamcinolone|mesh-list
5511276|NCT04393025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511277|NCT04393025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5511278|NCT04393025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5511279|NCT04393025|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5511280|NCT04393025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5511281|NCT04393025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511282|NCT04393025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5511283|NCT04393025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5511284|NCT04393025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5511285|NCT04393025|Antipyretics|antipyretics|mesh-ancestor
5511286|NCT04393025|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5511287|NCT04393025|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5511288|NCT04393025|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5511289|NCT04393025|Purinergic Agents|purinergic agents|mesh-ancestor
5511290|NCT04393025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5511291|NCT04392973|Hydroxychloroquine|hydroxychloroquine|mesh-list
5511292|NCT04392973|Favipiravir|favipiravir|mesh-list
6074529|NCT00746889|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6074530|NCT00746889|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6074531|NCT00746889|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6074532|NCT00746889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6074533|NCT00746889|Glucocorticoids|glucocorticoids|mesh-ancestor
6074534|NCT00746889|Hormones|hormones|mesh-ancestor
6074535|NCT00746889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6074536|NCT00746889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511293|NCT04392973|Antimalarials|antimalarials|mesh-ancestor
5511294|NCT04392973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5511295|NCT04392973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5511296|NCT04392973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5511297|NCT04392973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6074537|NCT00746889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6074538|NCT00746889|Immunologic Factors|immunologic factors|mesh-ancestor
6074539|NCT00746889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6074540|NCT00746889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074541|NCT00746941|Mefloquine|mefloquine|mesh-list
6074542|NCT00746941|Antimalarials|antimalarials|mesh-ancestor
6074543|NCT00746941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6074544|NCT00746941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6074545|NCT00746941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6074546|NCT00746954|Acetazolamide|acetazolamide|mesh-list
6074547|NCT00746954|Buspirone|buspirone|mesh-list
6074548|NCT00746954|Anticonvulsants|anticonvulsants|mesh-ancestor
6074549|NCT00746954|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6074550|NCT00746954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6074551|NCT00746954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074552|NCT00746954|Diuretics|diuretics|mesh-ancestor
6074553|NCT00746954|Natriuretic Agents|natriuretic agents|mesh-ancestor
6074554|NCT00746954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074555|NCT00746954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6074556|NCT00746954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6074557|NCT00746954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6074558|NCT00746954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6074559|NCT00746954|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6074560|NCT00746954|Serotonin Agents|serotonin agents|mesh-ancestor
6074561|NCT00746954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6074562|NCT00747006|Insulin Lispro|insulin lispro|mesh-list
5511298|NCT04392973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511299|NCT04392973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5511300|NCT04392973|Antiviral Agents|antiviral agents|mesh-ancestor
5511301|NCT04392427|Ribavirin|ribavirin|mesh-list
5511302|NCT04392427|Ivermectin|ivermectin|mesh-list
5511303|NCT04392427|Nitazoxanide|nitazoxanide|mesh-list
6074563|NCT00747006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6074564|NCT00747006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074565|NCT00747149|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6074566|NCT00747149|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5511304|NCT04392427|Antimetabolites|antimetabolites|mesh-ancestor
5511305|NCT04392427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511306|NCT04392427|Antiviral Agents|antiviral agents|mesh-ancestor
5511307|NCT04392427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5511308|NCT04392427|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5511309|NCT04392622|Cisplatin|cisplatin|mesh-list
5511310|NCT04392622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5511311|NCT04392700|Tenofovir|tenofovir|mesh-list
5511312|NCT04392700|Entecavir|entecavir|mesh-list
6074567|NCT00747149|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6074568|NCT00747149|Antimetabolites|antimetabolites|mesh-ancestor
6074569|NCT00747149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074570|NCT00747149|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6074571|NCT00747149|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6074572|NCT00747149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6074573|NCT00747214|Prednisolone|prednisolone|mesh-list
6074574|NCT00747214|Antirheumatic Agents|antirheumatic agents|mesh-list
6074575|NCT00747214|Dipyridamole|dipyridamole|mesh-list
6074576|NCT00747214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6074577|NCT00747214|Glucocorticoids|glucocorticoids|mesh-ancestor
6074578|NCT00747214|Hormones|hormones|mesh-ancestor
6074579|NCT00747214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6074580|NCT00747214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074581|NCT00747214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6074582|NCT00747214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6074583|NCT00747214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6074584|NCT00747214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6074585|NCT00747214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074586|NCT00747214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6074587|NCT00747214|Vasodilator Agents|vasodilator agents|mesh-ancestor
5511313|NCT04392700|Antiviral Agents|antiviral agents|mesh-ancestor
6074588|NCT00747344|Ustekinumab|ustekinumab|mesh-list
6074589|NCT00747344|Dermatologic Agents|dermatologic agents|mesh-ancestor
5511314|NCT04392700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5511315|NCT04392700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5511316|NCT04392700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5511317|NCT04392700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5511318|NCT04392700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074590|NCT00747617|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6074591|NCT00747617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6074592|NCT00747617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074593|NCT00747643|Varenicline|varenicline|mesh-list
5511319|NCT04392700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5511320|NCT04392700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5511321|NCT04392648|Dexamethasone|dexamethasone|mesh-list
5511322|NCT04392648|Cyclophosphamide|cyclophosphamide|mesh-list
5511323|NCT04392648|Bortezomib|bortezomib|mesh-list
5511324|NCT04392648|Pomalidomide|pomalidomide|mesh-list
5511325|NCT04392648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5511326|NCT04392648|Immunologic Factors|immunologic factors|mesh-ancestor
5511327|NCT04392648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511328|NCT04392648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6074594|NCT00747643|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6074595|NCT00747643|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6074596|NCT00747643|Cholinergic Agents|cholinergic agents|mesh-ancestor
6074597|NCT00747643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6074598|NCT00747643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074599|NCT00747643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074600|NCT00748072|Vasopressins|vasopressins|mesh-list
6074601|NCT00748072|Hemostatics|hemostatics|mesh-ancestor
6074602|NCT00748072|Coagulants|coagulants|mesh-ancestor
6074603|NCT00748072|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6074604|NCT00748072|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6074605|NCT00748072|Natriuretic Agents|natriuretic agents|mesh-ancestor
6074606|NCT00748072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074607|NCT00748098|Gabapentin|gabapentin|mesh-list
6074608|NCT00748098|Analgesics|analgesics|mesh-ancestor
6074609|NCT00748098|Sensory System Agents|sensory system agents|mesh-ancestor
6074610|NCT00748098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6074611|NCT00748098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074612|NCT00748098|Anticonvulsants|anticonvulsants|mesh-ancestor
6074613|NCT00748098|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5511329|NCT04392648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5511330|NCT04392648|Alkylating Agents|alkylating agents|mesh-ancestor
5511331|NCT04392648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511332|NCT04392648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5511333|NCT04392648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5511334|NCT04392648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5511335|NCT04392648|Antiemetics|antiemetics|mesh-ancestor
5511336|NCT04392648|Autonomic Agents|autonomic agents|mesh-ancestor
5511337|NCT04392648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6074614|NCT00748098|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6074615|NCT00748098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6074616|NCT00748098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6074617|NCT00748098|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6074618|NCT00748098|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6074619|NCT00748098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6074620|NCT00748098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074621|NCT00748098|Antimanic Agents|antimanic agents|mesh-ancestor
6074622|NCT00748189|Ofatumumab|ofatumumab|mesh-list
6074623|NCT00748189|Chlorambucil|chlorambucil|mesh-list
6074624|NCT00748189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6074625|NCT00748189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6074626|NCT00748189|Alkylating Agents|alkylating agents|mesh-ancestor
6074627|NCT00748189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074628|NCT00748215|Antidiarrheals|antidiarrheals|mesh-list
6074629|NCT00748215|Loperamide|loperamide|mesh-list
6074630|NCT00748215|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
6074631|NCT00748215|Calcium|calcium|mesh-list
6074632|NCT00748215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6074633|NCT00748215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074634|NCT00748215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6074635|NCT00748553|Paclitaxel|paclitaxel|mesh-list
6074636|NCT00748553|Azacitidine|azacitidine|mesh-list
6074637|NCT00748553|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6074638|NCT00748553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5511338|NCT04392648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5511339|NCT04392648|Glucocorticoids|glucocorticoids|mesh-ancestor
5511340|NCT04392648|Hormones|hormones|mesh-ancestor
5511341|NCT04392648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5511342|NCT04392648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5511343|NCT04392648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5511344|NCT04392648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5511345|NCT04392648|Growth Substances|growth substances|mesh-ancestor
5511346|NCT04392648|Growth Inhibitors|growth inhibitors|mesh-ancestor
5511347|NCT04392479|Aflibercept|aflibercept|mesh-list
5511348|NCT04392479|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5511349|NCT04392479|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5511350|NCT04392479|Growth Substances|growth substances|mesh-ancestor
5511351|NCT04392479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511352|NCT04392479|Growth Inhibitors|growth inhibitors|mesh-ancestor
5511353|NCT04392479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5511354|NCT04392557|Metformin|metformin|mesh-list
5511355|NCT04392557|Pioglitazone|pioglitazone|mesh-list
5511356|NCT04392557|Alogliptin|alogliptin|mesh-list
5511357|NCT04392557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5511358|NCT04392557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511359|NCT04392557|Incretins|incretins|mesh-ancestor
5511360|NCT04392557|Hormones|hormones|mesh-ancestor
5511361|NCT04392557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5511362|NCT04392557|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5511363|NCT04392557|Protease Inhibitors|protease inhibitors|mesh-ancestor
5511364|NCT04392557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5511365|NCT04392557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511366|NCT04392713|Ivermectin|ivermectin|mesh-list
5511367|NCT04392713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5511368|NCT04392713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5511369|NCT04392375|Nifedipine|nifedipine|mesh-list
5511370|NCT04392375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5511371|NCT04392375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5511372|NCT04392375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511373|NCT04392375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5511374|NCT04392375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511375|NCT04392375|Vasodilator Agents|vasodilator agents|mesh-ancestor
5511376|NCT04392375|Tocolytic Agents|tocolytic agents|mesh-ancestor
5511377|NCT04392375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5511378|NCT04392531|Cyclosporine|cyclosporine|mesh-list
5511379|NCT04392531|Cyclosporins|cyclosporins|mesh-list
5511380|NCT04392531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5511381|NCT04392531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511382|NCT04392531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5511383|NCT04392531|Immunologic Factors|immunologic factors|mesh-ancestor
5511384|NCT04392531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511385|NCT04392531|Antifungal Agents|antifungal agents|mesh-ancestor
5511386|NCT04392531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5511387|NCT04392531|Dermatologic Agents|dermatologic agents|mesh-ancestor
5511388|NCT04392531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5511389|NCT04392531|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5511390|NCT04391985|Sofosbuvir|sofosbuvir|mesh-list
5511391|NCT04391985|Antiviral Agents|antiviral agents|mesh-ancestor
5511392|NCT04391985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5511393|NCT04392102|Niraparib|niraparib|mesh-list
5511394|NCT04392102|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5511395|NCT04392102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5511396|NCT04392102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511397|NCT04392102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6074639|NCT00748553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6074640|NCT00748553|Tubulin Modulators|tubulin modulators|mesh-ancestor
6074641|NCT00748553|Antimitotic Agents|antimitotic agents|mesh-ancestor
6074642|NCT00748553|Mitosis Modulators|mitosis modulators|mesh-ancestor
6074643|NCT00748553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074644|NCT00748553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6074645|NCT00748553|Antimetabolites|antimetabolites|mesh-ancestor
6074646|NCT00748553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5511398|NCT04392063|Melatonin|melatonin|mesh-list
5511399|NCT04392063|Antioxidants|antioxidants|mesh-ancestor
5511400|NCT04392063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511401|NCT04392063|Protective Agents|protective agents|mesh-ancestor
5511402|NCT04392063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511403|NCT04392063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5600401|NCT03712241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074647|NCT00748566|Ziprasidone|ziprasidone|mesh-list
6074648|NCT00748566|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6074649|NCT00748566|Serotonin Agents|serotonin agents|mesh-ancestor
6074650|NCT00748566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6074651|NCT00748566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074652|NCT00748566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074653|NCT00748566|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6074654|NCT00748566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6074655|NCT00748566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6074656|NCT00748566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6074657|NCT00748566|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6074658|NCT00748566|Dopamine Agents|dopamine agents|mesh-ancestor
6074659|NCT00748657|Bevacizumab|bevacizumab|mesh-list
6074660|NCT00748657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6074661|NCT00748657|Endothelial Growth Factors|endothelial growth factors|mesh-list
6074662|NCT00748657|Antibodies|antibodies|mesh-list
6074663|NCT00748657|Immunoglobulins|immunoglobulins|mesh-list
6074664|NCT00748657|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6074665|NCT00748657|Immunoglobulin G|immunoglobulin g|mesh-list
6074666|NCT00748657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6074667|NCT00748657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6074668|NCT00748657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6074669|NCT00748657|Growth Substances|growth substances|mesh-ancestor
6074670|NCT00748657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074671|NCT00748657|Growth Inhibitors|growth inhibitors|mesh-ancestor
6074672|NCT00748657|Immunologic Factors|immunologic factors|mesh-ancestor
6074673|NCT00748709|Afatinib|afatinib|mesh-list
6074674|NCT00748709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6074675|NCT00748709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6074676|NCT00748709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6074677|NCT00748709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074678|NCT00748826|Infliximab|infliximab|mesh-list
6074679|NCT00748826|Dermatologic Agents|dermatologic agents|mesh-ancestor
6074680|NCT00748826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6074681|NCT00748826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6074682|NCT00748865|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6074683|NCT00748865|Lubricant Eye Drops|lubricant eye drops|mesh-list
6074684|NCT00748865|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5511404|NCT04392128|Azithromycin|azithromycin|mesh-list
5511405|NCT04392128|Hydroxychloroquine|hydroxychloroquine|mesh-list
5511406|NCT04392128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5511407|NCT04392128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5511408|NCT04392128|Antimalarials|antimalarials|mesh-ancestor
5511409|NCT04392128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5511410|NCT04392128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5511411|NCT04392128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5511412|NCT04392128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511413|NCT04392128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5511414|NCT04392297|Antibodies|antibodies|mesh-list
6074685|NCT00749125|Citalopram|citalopram|mesh-list
6074686|NCT00749125|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6074687|NCT00749125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6074688|NCT00749125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6074689|NCT00749125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074690|NCT00749125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6074691|NCT00749125|Serotonin Agents|serotonin agents|mesh-ancestor
6074692|NCT00749125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074693|NCT00749125|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6074694|NCT00749125|Antidepressive Agents|antidepressive agents|mesh-ancestor
6074695|NCT00749125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6074696|NCT00749190|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6074697|NCT00749190|Empagliflozin|empagliflozin|mesh-list
6074698|NCT00749190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6074699|NCT00749190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074700|NCT00749190|Incretins|incretins|mesh-ancestor
6074701|NCT00749190|Hormones|hormones|mesh-ancestor
6074702|NCT00749190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6074703|NCT00749190|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6074704|NCT00749190|Protease Inhibitors|protease inhibitors|mesh-ancestor
6074705|NCT00749190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6074706|NCT00749190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074707|NCT00749190|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6074708|NCT00749203|Midazolam|midazolam|mesh-list
6074709|NCT00749203|Ketamine|ketamine|mesh-list
5511415|NCT04392297|Immunoglobulin G|immunoglobulin g|mesh-list
5511416|NCT04392297|Immunologic Factors|immunologic factors|mesh-ancestor
5511417|NCT04392297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511418|NCT04392037|Dexamethasone|dexamethasone|mesh-list
5511419|NCT04392037|Cyclophosphamide|cyclophosphamide|mesh-list
5511420|NCT04392037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5511421|NCT04392037|Immunologic Factors|immunologic factors|mesh-ancestor
5511422|NCT04392037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511423|NCT04392037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5511424|NCT04392037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5511425|NCT04392037|Alkylating Agents|alkylating agents|mesh-ancestor
5511426|NCT04392037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511427|NCT04392037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5511428|NCT04392037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5511429|NCT04392037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5511430|NCT04392037|Antiemetics|antiemetics|mesh-ancestor
5511431|NCT04392037|Autonomic Agents|autonomic agents|mesh-ancestor
6074710|NCT00749203|Analgesics|analgesics|mesh-ancestor
6074711|NCT00749203|Sensory System Agents|sensory system agents|mesh-ancestor
6074712|NCT00749203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6074713|NCT00749203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074714|NCT00749203|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6074715|NCT00749203|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6074716|NCT00749203|Anesthetics, General|anesthetics, general|mesh-ancestor
6074717|NCT00749203|Anesthetics|anesthetics|mesh-ancestor
6074718|NCT00749203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6074719|NCT00749203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6074720|NCT00749203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6074721|NCT00749203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5511432|NCT04392037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5511433|NCT04392037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6074722|NCT00749203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074723|NCT00749203|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6074724|NCT00749203|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6074725|NCT00749203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6074726|NCT00749203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6074727|NCT00749203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6074728|NCT00749203|GABA Modulators|gaba modulators|mesh-ancestor
6074729|NCT00749203|GABA Agents|gaba agents|mesh-ancestor
6074730|NCT00749398|Infliximab|infliximab|mesh-list
6074731|NCT00749398|Dermatologic Agents|dermatologic agents|mesh-ancestor
6074732|NCT00749398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6074733|NCT00749398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6074734|NCT00749463|Nicotine|nicotine|mesh-list
6074735|NCT00749463|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6074736|NCT00749463|Autonomic Agents|autonomic agents|mesh-ancestor
6074737|NCT00749463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6074738|NCT00749463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074739|NCT00749463|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6074740|NCT00749463|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6074741|NCT00749463|Cholinergic Agents|cholinergic agents|mesh-ancestor
6074742|NCT00749463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6074743|NCT00749463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074744|NCT00749515|Deferasirox|deferasirox|mesh-list
6074745|NCT00749515|Deferoxamine|deferoxamine|mesh-list
6074746|NCT00749515|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6074747|NCT00749515|Chelating Agents|chelating agents|mesh-ancestor
6074748|NCT00749515|Sequestering Agents|sequestering agents|mesh-ancestor
6074749|NCT00749515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074750|NCT00749515|Siderophores|siderophores|mesh-ancestor
5511434|NCT04392037|Glucocorticoids|glucocorticoids|mesh-ancestor
5511435|NCT04392037|Hormones|hormones|mesh-ancestor
5511436|NCT04392037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5511437|NCT04392037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5511438|NCT04392011|Midazolam|midazolam|mesh-list
5511439|NCT04392011|Dextromethorphan|dextromethorphan|mesh-list
5511440|NCT04392011|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5511441|NCT04392011|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5511442|NCT04392011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5511443|NCT04392011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511444|NCT04392011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5511445|NCT04392011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5511446|NCT04392011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5511447|NCT04392011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5511448|NCT04392011|Anesthetics, General|anesthetics, general|mesh-ancestor
5511449|NCT04392011|Anesthetics|anesthetics|mesh-ancestor
5511450|NCT04392011|GABA Modulators|gaba modulators|mesh-ancestor
5511451|NCT04392011|GABA Agents|gaba agents|mesh-ancestor
6074751|NCT00749580|Raltegravir Potassium|raltegravir potassium|mesh-list
6074752|NCT00749580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5511452|NCT04392011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5511453|NCT04392011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511454|NCT04392011|Antitussive Agents|antitussive agents|mesh-ancestor
5511455|NCT04392011|Respiratory System Agents|respiratory system agents|mesh-ancestor
5511456|NCT04392011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5511457|NCT04392011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5511458|NCT04391998|Metronidazole|metronidazole|mesh-list
5511459|NCT04391998|Albendazole|albendazole|mesh-list
5511460|NCT04391998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5511461|NCT04391998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5511462|NCT04391998|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5511463|NCT04391998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5511464|NCT04391998|Anthelmintics|anthelmintics|mesh-ancestor
5511465|NCT04391998|Anticestodal Agents|anticestodal agents|mesh-ancestor
5511466|NCT04391998|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5511467|NCT04391998|Tubulin Modulators|tubulin modulators|mesh-ancestor
6074753|NCT00749580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6074754|NCT00749580|Antiviral Agents|antiviral agents|mesh-ancestor
6074755|NCT00749580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6074756|NCT00749580|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5511468|NCT04391998|Antimitotic Agents|antimitotic agents|mesh-ancestor
5511469|NCT04391998|Mitosis Modulators|mitosis modulators|mesh-ancestor
5511470|NCT04391998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511471|NCT04391998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5511472|NCT04391868|Sildenafil Citrate|sildenafil citrate|mesh-list
5511473|NCT04391868|Citric Acid|citric acid|mesh-list
5511474|NCT04391868|Sodium Citrate|sodium citrate|mesh-list
5511475|NCT04391868|Anticoagulants|anticoagulants|mesh-ancestor
5511476|NCT04391868|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5511477|NCT04391868|Chelating Agents|chelating agents|mesh-ancestor
5511478|NCT04391868|Sequestering Agents|sequestering agents|mesh-ancestor
5511479|NCT04391868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511480|NCT04391868|Vasodilator Agents|vasodilator agents|mesh-ancestor
5511481|NCT04391868|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5511482|NCT04391868|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5511483|NCT04391868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6074757|NCT00749580|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6074758|NCT00749580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6074759|NCT00749580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202743|NCT02045875|Adrenergic Agents|adrenergic agents|mesh-ancestor
6202744|NCT02045875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6202745|NCT02045875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202746|NCT02045875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6202747|NCT02045875|Dermatologic Agents|dermatologic agents|mesh-ancestor
6202748|NCT02045875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6202749|NCT02045979|Adalimumab|adalimumab|mesh-list
6202750|NCT02045979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6202751|NCT02045979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6202752|NCT02046070|Dexamethasone|dexamethasone|mesh-list
6202753|NCT02046070|Cyclophosphamide|cyclophosphamide|mesh-list
6202754|NCT02046070|Ixazomib|ixazomib|mesh-list
6202755|NCT02046070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6202756|NCT02046070|Immunologic Factors|immunologic factors|mesh-ancestor
6202757|NCT02046070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202758|NCT02046070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5511484|NCT04391868|Urological Agents|urological agents|mesh-ancestor
5511485|NCT04391582|Sulfadiazine|sulfadiazine|mesh-list
5511486|NCT04391582|Silver Sulfadiazine|silver sulfadiazine|mesh-list
5511487|NCT04391582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5511488|NCT04391582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5511489|NCT04391582|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5511490|NCT04391582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5511491|NCT04391582|Coccidiostats|coccidiostats|mesh-ancestor
5511492|NCT04391582|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5511493|NCT04391621|Triamcinolone|triamcinolone|mesh-list
5511494|NCT04391621|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6202759|NCT02046070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6202760|NCT02046070|Alkylating Agents|alkylating agents|mesh-ancestor
6202761|NCT02046070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202762|NCT02046070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6202763|NCT02046070|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6202764|NCT02046070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6202765|NCT02046070|Antiemetics|antiemetics|mesh-ancestor
6202766|NCT02046070|Autonomic Agents|autonomic agents|mesh-ancestor
5600402|NCT03712163|Ketotifen|ketotifen|mesh-list
5511495|NCT04391621|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5511496|NCT04391621|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5511497|NCT04391621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5511498|NCT04391621|Glucocorticoids|glucocorticoids|mesh-ancestor
5511499|NCT04391621|Hormones|hormones|mesh-ancestor
5511500|NCT04391621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5511501|NCT04391621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511502|NCT04391621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5511503|NCT04391621|Immunologic Factors|immunologic factors|mesh-ancestor
5511504|NCT04391621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5511505|NCT04391621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511506|NCT04391660|Ethanol|ethanol|mesh-list
5511507|NCT04391660|Sodium Hypochlorite|sodium hypochlorite|mesh-list
5511508|NCT04391660|Eusol|eusol|mesh-list
5511509|NCT04391660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6074760|NCT00749684|Interferons|interferons|mesh-list
6074761|NCT00749684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6074762|NCT00749684|Antiviral Agents|antiviral agents|mesh-ancestor
6074763|NCT00749684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6074764|NCT00749749|Bupivacaine|bupivacaine|mesh-list
6074765|NCT00749749|Anesthetics, Local|anesthetics, local|mesh-ancestor
6074766|NCT00749749|Anesthetics|anesthetics|mesh-ancestor
6074767|NCT00749749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6074768|NCT00749749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074769|NCT00749749|Sensory System Agents|sensory system agents|mesh-ancestor
6074770|NCT00749749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6074771|NCT00749892|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6074772|NCT00749892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6074773|NCT00749892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6074774|NCT00749892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6074775|NCT00749892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074776|NCT00749944|Varenicline|varenicline|mesh-list
6074777|NCT00749944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6074778|NCT00749944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6074779|NCT00749944|Cholinergic Agents|cholinergic agents|mesh-ancestor
6074780|NCT00749944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6074781|NCT00749944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074782|NCT00749944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074783|NCT00750061|Lithium Carbonate|lithium carbonate|mesh-list
6074784|NCT00750061|Antidepressive Agents|antidepressive agents|mesh-ancestor
6074785|NCT00750061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6074786|NCT00750061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6074787|NCT00750061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074788|NCT00750061|Antimanic Agents|antimanic agents|mesh-ancestor
6074789|NCT00750061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6074790|NCT00750061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6074791|NCT00750061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074792|NCT00750308|Ramipril|ramipril|mesh-list
6074793|NCT00750308|Tadalafil|tadalafil|mesh-list
6074794|NCT00750308|Vasodilator Agents|vasodilator agents|mesh-ancestor
6074795|NCT00750308|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6074796|NCT00750308|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6074797|NCT00750308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6074798|NCT00750308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074799|NCT00750308|Urological Agents|urological agents|mesh-ancestor
6074800|NCT00750308|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6074801|NCT00750308|Protease Inhibitors|protease inhibitors|mesh-ancestor
6074802|NCT00750308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6074803|NCT00750737|Amphotericin B|amphotericin b|mesh-list
6074804|NCT00750737|Posaconazole|posaconazole|mesh-list
6074805|NCT00750737|Amebicides|amebicides|mesh-ancestor
6074806|NCT00750737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6074807|NCT00750737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6074808|NCT00750737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6074809|NCT00750737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6074810|NCT00750737|Antifungal Agents|antifungal agents|mesh-ancestor
6074811|NCT00750737|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6074812|NCT00750737|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5511510|NCT04391660|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5511511|NCT04391660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5511512|NCT04391660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5511513|NCT04391660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074813|NCT00750737|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6074814|NCT00750737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6202767|NCT02046070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6074815|NCT00750737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463624|NCT00465439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463625|NCT00465439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5511514|NCT04391660|Disinfectants|disinfectants|mesh-ancestor
5511515|NCT04391608|Tenofovir|tenofovir|mesh-list
5511516|NCT04391608|Antiviral Agents|antiviral agents|mesh-ancestor
5511517|NCT04391608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5511518|NCT04391608|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6463626|NCT00465439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5511519|NCT04391608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6074816|NCT00750737|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6074817|NCT00750737|Hormone Antagonists|hormone antagonists|mesh-ancestor
6074818|NCT00750737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6074819|NCT00750737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074820|NCT00750815|Dexamethasone|dexamethasone|mesh-list
6074821|NCT00750815|Cyclophosphamide|cyclophosphamide|mesh-list
6074822|NCT00750815|Doxorubicin|doxorubicin|mesh-list
6074823|NCT00750815|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6074824|NCT00750815|Bortezomib|bortezomib|mesh-list
6074825|NCT00750815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6074826|NCT00750815|Immunologic Factors|immunologic factors|mesh-ancestor
6074827|NCT00750815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074828|NCT00750815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6074829|NCT00750815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6074830|NCT00750815|Alkylating Agents|alkylating agents|mesh-ancestor
6074831|NCT00750815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074832|NCT00750815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6074833|NCT00750815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6074834|NCT00750815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6074835|NCT00750815|Antiemetics|antiemetics|mesh-ancestor
6074836|NCT00750815|Autonomic Agents|autonomic agents|mesh-ancestor
6074837|NCT00750815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6074838|NCT00750815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6074839|NCT00750815|Glucocorticoids|glucocorticoids|mesh-ancestor
6074840|NCT00750815|Hormones|hormones|mesh-ancestor
6074841|NCT00750815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6074842|NCT00750815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6074843|NCT00750815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6074844|NCT00750815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6074845|NCT00750815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6074846|NCT00750815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6074847|NCT00750867|Immunoglobulins|immunoglobulins|mesh-list
6074848|NCT00750867|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6074849|NCT00750867|Antibodies|antibodies|mesh-list
6074850|NCT00750867|gamma-Globulins|gamma-globulins|mesh-list
6074851|NCT00750867|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6074852|NCT00750867|Immunologic Factors|immunologic factors|mesh-ancestor
6074853|NCT00750867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074854|NCT00750919|Mirtazapine|mirtazapine|mesh-list
6074855|NCT00750919|Antidepressive Agents|antidepressive agents|mesh-ancestor
6074856|NCT00750919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6074857|NCT00750919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6074858|NCT00750919|Histamine Antagonists|histamine antagonists|mesh-ancestor
6074859|NCT00750919|Histamine Agents|histamine agents|mesh-ancestor
6074860|NCT00750919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6074861|NCT00750919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074862|NCT00750919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074863|NCT00750919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6074864|NCT00750919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6074865|NCT00750919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6074866|NCT00750919|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6074867|NCT00750919|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5511520|NCT04391608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5511521|NCT04391608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074868|NCT00750919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6074869|NCT00750919|Adrenergic Agents|adrenergic agents|mesh-ancestor
6074870|NCT00750919|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6665417|NCT01517009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5511522|NCT04391608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5511523|NCT04391608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5511524|NCT04391764|Naltrexone|naltrexone|mesh-list
5511525|NCT04391764|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5511526|NCT04391764|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6074871|NCT00750919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6074872|NCT00750919|Serotonin Agents|serotonin agents|mesh-ancestor
6074873|NCT00750919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6074874|NCT00751023|Modafinil|modafinil|mesh-list
6074875|NCT00751023|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6074876|NCT00751023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074877|NCT00751023|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6074878|NCT00751023|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6074879|NCT00751023|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6074880|NCT00751023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074881|NCT00751036|Imatinib Mesylate|imatinib mesylate|mesh-list
6074882|NCT00751036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6074883|NCT00751036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6074884|NCT00751036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6074885|NCT00751036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074886|NCT00751101|Nicotine|nicotine|mesh-list
6074887|NCT00751101|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6074888|NCT00751101|Autonomic Agents|autonomic agents|mesh-ancestor
6074889|NCT00751101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6074890|NCT00751101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074891|NCT00751101|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6074892|NCT00751101|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6074893|NCT00751101|Cholinergic Agents|cholinergic agents|mesh-ancestor
6074894|NCT00751101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6074895|NCT00751101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074896|NCT00751114|Metformin|metformin|mesh-list
6074897|NCT00751114|Insulin Glargine|insulin glargine|mesh-list
6074898|NCT00751114|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6074899|NCT00751114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6074900|NCT00751114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074901|NCT00751114|Incretins|incretins|mesh-ancestor
6074902|NCT00751114|Hormones|hormones|mesh-ancestor
6074903|NCT00751114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6074904|NCT00751114|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5511527|NCT04391764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511528|NCT04391764|Sensory System Agents|sensory system agents|mesh-ancestor
5511529|NCT04391764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5511530|NCT04391569|Ganaxolone|ganaxolone|mesh-list
5511531|NCT04391569|Neurosteroids|neurosteroids|mesh-ancestor
5511532|NCT04391569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5511533|NCT04391569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074905|NCT00751114|Protease Inhibitors|protease inhibitors|mesh-ancestor
6074906|NCT00751114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6074907|NCT00751114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074908|NCT00751179|Bromides|bromides|mesh-list
6074909|NCT00751179|Rocuronium|rocuronium|mesh-list
6074910|NCT00751179|Succinylcholine|succinylcholine|mesh-list
6074911|NCT00751179|Anticonvulsants|anticonvulsants|mesh-ancestor
5511534|NCT04391569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511535|NCT04391569|GABA Modulators|gaba modulators|mesh-ancestor
5511536|NCT04391569|GABA Agents|gaba agents|mesh-ancestor
5511537|NCT04391478|Milrinone|milrinone|mesh-list
5511538|NCT04391478|Sildenafil Citrate|sildenafil citrate|mesh-list
5511539|NCT04391478|Vasodilator Agents|vasodilator agents|mesh-ancestor
5511540|NCT04391478|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5511541|NCT04391478|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5511542|NCT04391478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5511543|NCT04391478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511544|NCT04391478|Urological Agents|urological agents|mesh-ancestor
5511545|NCT04391478|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5511546|NCT04391478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5511547|NCT04391478|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5511548|NCT04391478|Protective Agents|protective agents|mesh-ancestor
5511549|NCT04391478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511550|NCT04391361|Atropine|atropine|mesh-list
5511551|NCT04391361|Scopolamine|scopolamine|mesh-list
5511552|NCT04391361|Dexmedetomidine|dexmedetomidine|mesh-list
5511553|NCT04391361|Edaravone|edaravone|mesh-list
5511554|NCT04391361|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
5511555|NCT04391361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5511556|NCT04391361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5511557|NCT04391361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511558|NCT04391361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5511559|NCT04391361|Analgesics|analgesics|mesh-ancestor
5511560|NCT04391361|Sensory System Agents|sensory system agents|mesh-ancestor
5511561|NCT04391361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6074912|NCT00751179|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6074913|NCT00751179|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6074914|NCT00751179|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6074915|NCT00751179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6074916|NCT00751179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074917|NCT00751179|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
6074918|NCT00751296|Lenalidomide|lenalidomide|mesh-list
6074919|NCT00751296|Immunologic Factors|immunologic factors|mesh-ancestor
6074920|NCT00751296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074921|NCT00751296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6074922|NCT00751296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6074923|NCT00751296|Growth Substances|growth substances|mesh-ancestor
6074924|NCT00751296|Growth Inhibitors|growth inhibitors|mesh-ancestor
6074925|NCT00751296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6074926|NCT00751400|Naproxen|naproxen|mesh-list
6074927|NCT00751400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6074928|NCT00751400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6074929|NCT00751400|Analgesics|analgesics|mesh-ancestor
6074930|NCT00751400|Sensory System Agents|sensory system agents|mesh-ancestor
6074931|NCT00751400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6074932|NCT00751400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074933|NCT00751400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6074934|NCT00751400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6074935|NCT00751400|Gout Suppressants|gout suppressants|mesh-ancestor
6074936|NCT00751400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6074937|NCT00751400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6074938|NCT00751400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074939|NCT00751530|Raltegravir Potassium|raltegravir potassium|mesh-list
6074940|NCT00751530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6074941|NCT00751530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6074942|NCT00751530|Antiviral Agents|antiviral agents|mesh-ancestor
6074943|NCT00751530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6074944|NCT00751530|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6074945|NCT00751530|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6074946|NCT00751530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6074947|NCT00751530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074948|NCT00751777|Vaccines|vaccines|mesh-list
6074949|NCT00751777|Immunologic Factors|immunologic factors|mesh-ancestor
6074950|NCT00751777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074951|NCT00751790|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6074952|NCT00751790|Luteolytic Agents|luteolytic agents|mesh-ancestor
6074953|NCT00751790|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6074954|NCT00751790|Contraceptive Agents|contraceptive agents|mesh-ancestor
6074955|NCT00751790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6074956|NCT00751790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074957|NCT00751790|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6074958|NCT00751790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6074959|NCT00751790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6074960|NCT00751881|Teriflunomide|teriflunomide|mesh-list
6074961|NCT00751881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6074962|NCT00751881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5511562|NCT04391361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5511563|NCT04391361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5511564|NCT04391361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5511565|NCT04391361|Adrenergic Agents|adrenergic agents|mesh-ancestor
5511566|NCT04391361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5511567|NCT04391361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511568|NCT04391361|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5511569|NCT04391361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5511570|NCT04391361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5511571|NCT04391361|Autonomic Agents|autonomic agents|mesh-ancestor
5511572|NCT04391361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5511573|NCT04391361|Respiratory System Agents|respiratory system agents|mesh-ancestor
5511574|NCT04391361|Mydriatics|mydriatics|mesh-ancestor
6074963|NCT00751881|Analgesics|analgesics|mesh-ancestor
6074964|NCT00751881|Sensory System Agents|sensory system agents|mesh-ancestor
6463627|NCT00465439|Adrenergic Agents|adrenergic agents|mesh-ancestor
6463628|NCT00465439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6463629|NCT00465439|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6463630|NCT00465439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6463631|NCT00465439|Autonomic Agents|autonomic agents|mesh-ancestor
6463632|NCT00465439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6463633|NCT00465439|Respiratory System Agents|respiratory system agents|mesh-ancestor
6463634|NCT00465439|Mydriatics|mydriatics|mesh-ancestor
6463635|NCT00465439|Sympathomimetics|sympathomimetics|mesh-ancestor
6463636|NCT00465439|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6463637|NCT00465452|Dopamine|dopamine|mesh-list
6463638|NCT00465452|Dopamine Agonists|dopamine agonists|mesh-list
6463639|NCT00465452|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6074965|NCT00751881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6074966|NCT00751881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074967|NCT00751881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6074968|NCT00751881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5511575|NCT04391361|Parasympatholytics|parasympatholytics|mesh-ancestor
5511576|NCT04391361|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5511577|NCT04391361|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5511578|NCT04391361|Cholinergic Agents|cholinergic agents|mesh-ancestor
5511579|NCT04391361|Antiemetics|antiemetics|mesh-ancestor
5511580|NCT04391361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5511581|NCT04391361|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5511582|NCT04391361|Antioxidants|antioxidants|mesh-ancestor
5511583|NCT04391361|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5511584|NCT04391361|Protective Agents|protective agents|mesh-ancestor
5511585|NCT04391348|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5511586|NCT04391348|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5511587|NCT04391348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511588|NCT04391231|Pentoxifylline|pentoxifylline|mesh-list
5511589|NCT04391231|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5511590|NCT04391231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5511591|NCT04391231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511592|NCT04391231|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5511593|NCT04391231|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5511594|NCT04391231|Protective Agents|protective agents|mesh-ancestor
5511595|NCT04391231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511596|NCT04391231|Vasodilator Agents|vasodilator agents|mesh-ancestor
5511597|NCT04391231|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5511598|NCT04391231|Antioxidants|antioxidants|mesh-ancestor
5511599|NCT04391309|Remdesivir|remdesivir|mesh-list
5511600|NCT04391309|Antimetabolites|antimetabolites|mesh-ancestor
5511601|NCT04391309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511602|NCT04391309|Antiviral Agents|antiviral agents|mesh-ancestor
5511603|NCT04391309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5511604|NCT04391283|Osimertinib|osimertinib|mesh-list
5511605|NCT04391283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5511606|NCT04391283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5511607|NCT04391283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5511608|NCT04391283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074969|NCT00751881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6074970|NCT00751881|Immunologic Factors|immunologic factors|mesh-ancestor
6074971|NCT00752102|Calcitriol|calcitriol|mesh-list
6074972|NCT00752102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6074973|NCT00752102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074974|NCT00752102|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6074975|NCT00752102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6074976|NCT00752102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074977|NCT00752102|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6074978|NCT00752102|Vitamins|vitamins|mesh-ancestor
6074979|NCT00752102|Micronutrients|micronutrients|mesh-ancestor
6074980|NCT00752102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6074981|NCT00752206|Saracatinib|saracatinib|mesh-list
6074982|NCT00752206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6074983|NCT00752206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6074984|NCT00752206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074985|NCT00752219|Metronidazole|metronidazole|mesh-list
6074986|NCT00752219|Meropenem|meropenem|mesh-list
6074987|NCT00752219|Ceftazidime|ceftazidime|mesh-list
6074988|NCT00752219|Avibactam|avibactam|mesh-list
5511609|NCT04391127|Hydroxychloroquine|hydroxychloroquine|mesh-list
5511610|NCT04391127|Ivermectin|ivermectin|mesh-list
5511611|NCT04391127|Antimalarials|antimalarials|mesh-ancestor
5511612|NCT04391127|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5511613|NCT04391127|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5511614|NCT04391127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5511615|NCT04391127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5511616|NCT04391127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511617|NCT04391127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6074989|NCT00752219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5511618|NCT04390789|Calcium|calcium|mesh-list
6074990|NCT00752219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6463640|NCT00465452|Sympathomimetics|sympathomimetics|mesh-ancestor
6463641|NCT00465452|Autonomic Agents|autonomic agents|mesh-ancestor
6463642|NCT00465452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6463643|NCT00465452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6074991|NCT00752219|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6074992|NCT00752219|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6074993|NCT00752219|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6074994|NCT00752219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6074995|NCT00752219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6074996|NCT00752232|Saponin QA-21V1|saponin qa-21v1|mesh-list
6074997|NCT00752232|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5511619|NCT04390789|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5511620|NCT04390789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511621|NCT04391179|Dipyridamole|dipyridamole|mesh-list
5511622|NCT04391179|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5511623|NCT04391179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5511624|NCT04391179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511625|NCT04391179|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5511626|NCT04391179|Vasodilator Agents|vasodilator agents|mesh-ancestor
5511627|NCT04390984|Apatinib|apatinib|mesh-list
5511628|NCT04390984|Gefitinib|gefitinib|mesh-list
5511629|NCT04390984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5511630|NCT04390984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5511631|NCT04390984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5511632|NCT04390984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511633|NCT04390698|Analgesics, Opioid|analgesics, opioid|mesh-list
5511634|NCT04390698|Anesthetics|anesthetics|mesh-list
6074998|NCT00752232|Immunologic Factors|immunologic factors|mesh-ancestor
6074999|NCT00752232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075000|NCT00752557|Calcium, Dietary|calcium, dietary|mesh-list
6075001|NCT00752557|Vitamin D|vitamin d|mesh-list
6075002|NCT00752557|Ergocalciferols|ergocalciferols|mesh-list
6075003|NCT00752557|Diphosphonates|diphosphonates|mesh-list
6075004|NCT00752557|Vitamins|vitamins|mesh-list
6075005|NCT00752557|Calcium|calcium|mesh-list
6075006|NCT00752557|Micronutrients|micronutrients|mesh-ancestor
6075007|NCT00752557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075008|NCT00752557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6075009|NCT00752557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6075010|NCT00752622|Infliximab|infliximab|mesh-list
6075011|NCT00752622|Dermatologic Agents|dermatologic agents|mesh-ancestor
6075012|NCT00752622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6075013|NCT00752622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6075014|NCT00752726|Orlistat|orlistat|mesh-list
6075015|NCT00752726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6075016|NCT00752726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075017|NCT00752726|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6075018|NCT00752726|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6075019|NCT00752856|Ritonavir|ritonavir|mesh-list
6075020|NCT00752856|Lopinavir|lopinavir|mesh-list
6075021|NCT00752856|Tenofovir|tenofovir|mesh-list
6075022|NCT00752856|Emtricitabine|emtricitabine|mesh-list
6075023|NCT00752856|Raltegravir Potassium|raltegravir potassium|mesh-list
6075024|NCT00752856|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6075025|NCT00752856|Efavirenz|efavirenz|mesh-list
6075026|NCT00752856|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6075027|NCT00752856|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6075028|NCT00752856|Protease Inhibitors|protease inhibitors|mesh-ancestor
6075029|NCT00752856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6075030|NCT00752856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075031|NCT00752856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6075032|NCT00752856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6075033|NCT00752856|Antiviral Agents|antiviral agents|mesh-ancestor
6075034|NCT00752856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6075035|NCT00752856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6075036|NCT00752856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6075037|NCT00752856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5511635|NCT04390698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5511636|NCT04390698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511637|NCT04390698|Narcotics|narcotics|mesh-ancestor
5511638|NCT04390698|Analgesics|analgesics|mesh-ancestor
5511639|NCT04390698|Sensory System Agents|sensory system agents|mesh-ancestor
5511640|NCT04390698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5511641|NCT04390854|Clotrimazole|clotrimazole|mesh-list
6075038|NCT00752856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6075039|NCT00752856|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6075040|NCT00752856|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6075041|NCT00752856|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6075042|NCT00752856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6075043|NCT00752856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6075044|NCT00752856|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6075045|NCT00752856|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6075046|NCT00752973|Malathion|malathion|mesh-list
5511642|NCT04390854|Miconazole|miconazole|mesh-list
5511643|NCT04390854|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5511644|NCT04390854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5511645|NCT04390854|Antifungal Agents|antifungal agents|mesh-ancestor
5511646|NCT04390854|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5511647|NCT04390854|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5511648|NCT04390854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5511649|NCT04390854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511650|NCT04390854|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5511651|NCT04390854|Hormone Antagonists|hormone antagonists|mesh-ancestor
5511652|NCT04390854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5511653|NCT04390854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511654|NCT04390854|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5511655|NCT04390854|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5511656|NCT04390815|Insulin|insulin|mesh-list
5511657|NCT04390815|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5511658|NCT04390815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5511659|NCT04390815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511660|NCT04390958|Paclitaxel|paclitaxel|mesh-list
5511661|NCT04390958|Capecitabine|capecitabine|mesh-list
5511662|NCT04390958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5511663|NCT04390958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5511664|NCT04390958|Tubulin Modulators|tubulin modulators|mesh-ancestor
6075047|NCT00752973|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6075048|NCT00752973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6075049|NCT00752973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075050|NCT00752973|Cholinergic Agents|cholinergic agents|mesh-ancestor
6075051|NCT00752973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6075052|NCT00752973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075053|NCT00753012|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6075054|NCT00753012|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6075055|NCT00753012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075056|NCT00753012|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6075057|NCT00753012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6075058|NCT00753012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6075059|NCT00753012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075060|NCT00753012|Dopamine Agents|dopamine agents|mesh-ancestor
6075061|NCT00753012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6075062|NCT00753142|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6075063|NCT00753142|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6075064|NCT00753142|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6075065|NCT00753142|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6075066|NCT00753220|Cyclophosphamide|cyclophosphamide|mesh-list
6075067|NCT00753220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6075068|NCT00753220|Immunologic Factors|immunologic factors|mesh-ancestor
6075069|NCT00753220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075070|NCT00753220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6075071|NCT00753220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6075072|NCT00753220|Alkylating Agents|alkylating agents|mesh-ancestor
6075073|NCT00753220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075074|NCT00753220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6075075|NCT00753220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6075076|NCT00753337|Cobalt|cobalt|mesh-list
6075077|NCT00753337|Trace Elements|trace elements|mesh-ancestor
6075078|NCT00753337|Micronutrients|micronutrients|mesh-ancestor
5511665|NCT04390958|Antimitotic Agents|antimitotic agents|mesh-ancestor
5511666|NCT04390958|Mitosis Modulators|mitosis modulators|mesh-ancestor
5511667|NCT04390958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511668|NCT04390958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5511669|NCT04390958|Antimetabolites|antimetabolites|mesh-ancestor
5511670|NCT04390464|Ravulizumab|ravulizumab|mesh-list
5511671|NCT04390464|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5511672|NCT04390464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5511673|NCT04390464|Immunologic Factors|immunologic factors|mesh-ancestor
5511674|NCT04390464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511675|NCT04390685|Tacrolimus|tacrolimus|mesh-list
5511676|NCT04390685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5511677|NCT04390685|Immunologic Factors|immunologic factors|mesh-ancestor
5511678|NCT04390685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511679|NCT04390685|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5511680|NCT04390685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5511681|NCT04390685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511686|NCT04391439|Methylprednisolone|methylprednisolone|mesh-list
6075079|NCT00753337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075080|NCT00753454|Certolizumab Pegol|certolizumab pegol|mesh-list
6075081|NCT00753454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6075082|NCT00753454|Immunologic Factors|immunologic factors|mesh-ancestor
6075083|NCT00753454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075084|NCT00753454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6075085|NCT00753506|Artemisinins|artemisinins|mesh-list
6075086|NCT00753506|Artemisinin|artemisinin|mesh-list
6075087|NCT00753506|Antimalarials|antimalarials|mesh-ancestor
6463644|NCT00465452|Dopamine Agents|dopamine agents|mesh-ancestor
6463645|NCT00465452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5511687|NCT04391439|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6075088|NCT00753506|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6075089|NCT00753506|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6075090|NCT00753506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6075091|NCT00753545|Olaparib|olaparib|mesh-list
6075092|NCT00753545|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6075093|NCT00753545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6075094|NCT00753545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075095|NCT00753545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6075096|NCT00753636|Isradipine|isradipine|mesh-list
6075097|NCT00753636|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6075098|NCT00753636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6075099|NCT00753636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6075100|NCT00753636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075101|NCT00753636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6075102|NCT00753636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075103|NCT00753636|Vasodilator Agents|vasodilator agents|mesh-ancestor
6075104|NCT00753675|Gemcitabine|gemcitabine|mesh-list
6075105|NCT00753675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6075106|NCT00753675|Antimetabolites|antimetabolites|mesh-ancestor
6075107|NCT00753675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075108|NCT00753675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6075109|NCT00753675|Antiviral Agents|antiviral agents|mesh-ancestor
6075110|NCT00753675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6075111|NCT00753675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6075112|NCT00753675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6075113|NCT00753675|Immunologic Factors|immunologic factors|mesh-ancestor
5511688|NCT04391439|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5511689|NCT04391439|Prednisolone|prednisolone|mesh-list
5511690|NCT04391439|Prednisolone acetate|prednisolone acetate|mesh-list
5511691|NCT04391439|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5511692|NCT04391439|Prednisolone phosphate|prednisolone phosphate|mesh-list
6075114|NCT00753675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075115|NCT00753714|Gemcitabine|gemcitabine|mesh-list
6075116|NCT00753714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6075117|NCT00753714|Antimetabolites|antimetabolites|mesh-ancestor
6075118|NCT00753714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075119|NCT00753714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6075120|NCT00753714|Antiviral Agents|antiviral agents|mesh-ancestor
6075121|NCT00753714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6075122|NCT00753714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6488409|NCT00583986|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5511693|NCT04391439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5511694|NCT04391439|Antiemetics|antiemetics|mesh-ancestor
5511695|NCT04391439|Autonomic Agents|autonomic agents|mesh-ancestor
5511696|NCT04391439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5511697|NCT04391439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511698|NCT04391439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5511699|NCT04391439|Glucocorticoids|glucocorticoids|mesh-ancestor
5511700|NCT04391439|Hormones|hormones|mesh-ancestor
5511701|NCT04391439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5511702|NCT04391439|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5511703|NCT04391439|Protective Agents|protective agents|mesh-ancestor
6075123|NCT00753714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6075124|NCT00753714|Immunologic Factors|immunologic factors|mesh-ancestor
6075125|NCT00753714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075126|NCT00753896|Exenatide|exenatide|mesh-list
6075127|NCT00753896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6075128|NCT00753896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075129|NCT00753896|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6075130|NCT00753896|Incretins|incretins|mesh-ancestor
6075131|NCT00753896|Hormones|hormones|mesh-ancestor
6075132|NCT00753896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6075133|NCT00753935|Aspirin|aspirin|mesh-list
6075134|NCT00753935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6075135|NCT00753935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6075136|NCT00753935|Analgesics|analgesics|mesh-ancestor
6075137|NCT00753935|Sensory System Agents|sensory system agents|mesh-ancestor
6075138|NCT00753935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6075139|NCT00753935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075140|NCT00753935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6075141|NCT00753935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6075142|NCT00753935|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6075143|NCT00753935|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6075144|NCT00753935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075145|NCT00753935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6075146|NCT00753935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6075147|NCT00753935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6075148|NCT00753935|Antipyretics|antipyretics|mesh-ancestor
6075149|NCT00754065|Moxifloxacin|moxifloxacin|mesh-list
6075150|NCT00754065|Dienogest|dienogest|mesh-list
6075151|NCT00754065|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6075152|NCT00754065|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6075153|NCT00754065|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6075154|NCT00754065|Estradiol|estradiol|mesh-list
6075155|NCT00754065|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6075156|NCT00754065|Estrogens|estrogens|mesh-ancestor
6075157|NCT00754065|Hormones|hormones|mesh-ancestor
6075158|NCT00754065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6075159|NCT00754065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511704|NCT04391439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5511705|NCT04391439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5600403|NCT03712163|Antipruritics|antipruritics|mesh-ancestor
5600404|NCT03712163|Dermatologic Agents|dermatologic agents|mesh-ancestor
5600405|NCT03712163|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5600406|NCT03712163|Histamine Antagonists|histamine antagonists|mesh-ancestor
5600407|NCT03712163|Histamine Agents|histamine agents|mesh-ancestor
5600408|NCT03712163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5600409|NCT03712163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600410|NCT03712163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600411|NCT03712163|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5600412|NCT03712111|Norepinephrine|norepinephrine|mesh-list
5600413|NCT03712111|Bupivacaine|bupivacaine|mesh-list
5600414|NCT03712111|Anesthetics, Local|anesthetics, local|mesh-ancestor
6075160|NCT00754065|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6075161|NCT00754065|Contraceptive Agents|contraceptive agents|mesh-ancestor
6075162|NCT00754065|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6075163|NCT00754065|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6075164|NCT00754065|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6075165|NCT00754065|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5600415|NCT03712111|Anesthetics|anesthetics|mesh-ancestor
5600416|NCT03712111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5600417|NCT03712111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600418|NCT03712111|Sensory System Agents|sensory system agents|mesh-ancestor
5600419|NCT03712111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5600420|NCT03712111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5600421|NCT03712111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6075166|NCT00754065|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6075167|NCT00754065|Hormone Antagonists|hormone antagonists|mesh-ancestor
6075168|NCT00754065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6075169|NCT00754065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6075170|NCT00754065|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6075171|NCT00754065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6075172|NCT00754065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6075173|NCT00754065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6075174|NCT00754065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6075175|NCT00754065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6075176|NCT00754065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075177|NCT00754208|Methylphenidate|methylphenidate|mesh-list
6075178|NCT00754208|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6075179|NCT00754208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075180|NCT00754208|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6075181|NCT00754208|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6075182|NCT00754208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6075183|NCT00754208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075184|NCT00754208|Dopamine Agents|dopamine agents|mesh-ancestor
6075185|NCT00754208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6075186|NCT00754247|Vitamin E|vitamin e|mesh-list
6075187|NCT00754247|Hydrocortisone|hydrocortisone|mesh-list
6075188|NCT00754247|Vitamins|vitamins|mesh-ancestor
6075189|NCT00754247|Micronutrients|micronutrients|mesh-ancestor
6075190|NCT00754247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075191|NCT00754247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6075192|NCT00754247|Antioxidants|antioxidants|mesh-ancestor
6075193|NCT00754247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075194|NCT00754247|Protective Agents|protective agents|mesh-ancestor
6075195|NCT00754325|Dasatinib|dasatinib|mesh-list
6075196|NCT00754325|Fulvestrant|fulvestrant|mesh-list
6075197|NCT00754325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6075198|NCT00754325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6075199|NCT00754325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6075200|NCT00754325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075201|NCT00754325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6075202|NCT00754325|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6075203|NCT00754325|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6075204|NCT00754325|Hormone Antagonists|hormone antagonists|mesh-ancestor
6075205|NCT00754325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6075206|NCT00754325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075207|NCT00754338|Dipivefrin|dipivefrin|mesh-list
6075208|NCT00754338|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6075209|NCT00754338|Adrenergic Agents|adrenergic agents|mesh-ancestor
6075210|NCT00754338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6075211|NCT00754338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075212|NCT00754338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511706|NCT04390334|Efavirenz|efavirenz|mesh-list
5511707|NCT04390334|Famotidine|famotidine|mesh-list
5511708|NCT04390334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5511709|NCT04390334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5511710|NCT04390334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5511711|NCT04390334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511712|NCT04390334|Antiviral Agents|antiviral agents|mesh-ancestor
5511713|NCT04390334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5511714|NCT04390334|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5511715|NCT04390334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5511716|NCT04390334|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5600422|NCT03712111|Adrenergic Agents|adrenergic agents|mesh-ancestor
6075213|NCT00754390|Calcium, Dietary|calcium, dietary|mesh-list
6075214|NCT00754390|Calcium|calcium|mesh-list
6075215|NCT00754390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6075216|NCT00754390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075217|NCT00754390|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6075218|NCT00754442|Teriparatide|teriparatide|mesh-list
6075219|NCT00754442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6075220|NCT00754442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075221|NCT00754442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6075222|NCT00754494|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6075223|NCT00754494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6075224|NCT00754494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6075225|NCT00754494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6075226|NCT00754494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075227|NCT00754546|Formoterol Fumarate|formoterol fumarate|mesh-list
6075228|NCT00754546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6075229|NCT00754546|Autonomic Agents|autonomic agents|mesh-ancestor
6075230|NCT00754546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6075231|NCT00754546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075232|NCT00754546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6075233|NCT00754546|Respiratory System Agents|respiratory system agents|mesh-ancestor
6075234|NCT00754546|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6075235|NCT00754546|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6075236|NCT00754546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6075237|NCT00754546|Adrenergic Agents|adrenergic agents|mesh-ancestor
6075238|NCT00754546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6075239|NCT00754546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075240|NCT00754572|Methotrexate|methotrexate|mesh-list
6075241|NCT00754572|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6075242|NCT00754572|Abortifacient Agents|abortifacient agents|mesh-ancestor
6075243|NCT00754572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6075244|NCT00754572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075245|NCT00754572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6075246|NCT00754572|Antimetabolites|antimetabolites|mesh-ancestor
6075247|NCT00754572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075248|NCT00754572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6075249|NCT00754572|Dermatologic Agents|dermatologic agents|mesh-ancestor
6075250|NCT00754572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6075251|NCT00754572|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6075252|NCT00754572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6075253|NCT00754572|Immunologic Factors|immunologic factors|mesh-ancestor
6075254|NCT00754572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6075255|NCT00754572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6075256|NCT00754624|Insulin|insulin|mesh-list
6075257|NCT00754624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6075258|NCT00754624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075259|NCT00754650|Bevacizumab|bevacizumab|mesh-list
6075260|NCT00754650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6075261|NCT00754650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6075262|NCT00754650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6075263|NCT00754650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6075264|NCT00754650|Growth Substances|growth substances|mesh-ancestor
6075265|NCT00754650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075266|NCT00754650|Growth Inhibitors|growth inhibitors|mesh-ancestor
6202768|NCT02046070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6202769|NCT02046070|Glucocorticoids|glucocorticoids|mesh-ancestor
6202770|NCT02046070|Hormones|hormones|mesh-ancestor
6202771|NCT02046070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6202772|NCT02046070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6202773|NCT02046070|Protease Inhibitors|protease inhibitors|mesh-ancestor
6202774|NCT02046070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6202775|NCT02046122|Cytarabine|cytarabine|mesh-list
6202776|NCT02046122|Idarubicin|idarubicin|mesh-list
6202777|NCT02046122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6202778|NCT02046122|Antimetabolites|antimetabolites|mesh-ancestor
6202779|NCT02046122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202780|NCT02046122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6202781|NCT02046122|Antiviral Agents|antiviral agents|mesh-ancestor
6202782|NCT02046122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6202783|NCT02046122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6202784|NCT02046122|Immunologic Factors|immunologic factors|mesh-ancestor
6202785|NCT02046122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202786|NCT02046122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6202787|NCT02046122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6202788|NCT02046122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6202789|NCT02046122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6202790|NCT02046200|Ethanol|ethanol|mesh-list
6202791|NCT02046200|Ivermectin|ivermectin|mesh-list
6202792|NCT02046200|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6202793|NCT02046200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6202794|NCT02046200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5511717|NCT04390334|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5511718|NCT04390334|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5511719|NCT04390334|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5511720|NCT04390334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5511721|NCT04390334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6075267|NCT00754845|Letrozole|letrozole|mesh-list
6075268|NCT00754845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6075269|NCT00754845|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6075270|NCT00754845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6075271|NCT00754845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6075272|NCT00754845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075273|NCT00754845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6075274|NCT00754845|Hormone Antagonists|hormone antagonists|mesh-ancestor
6075275|NCT00754845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6075276|NCT00754845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075277|NCT00754923|Sorafenib|sorafenib|mesh-list
6075278|NCT00754923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6075279|NCT00754923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6075280|NCT00754923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6075281|NCT00754923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075282|NCT00754936|Citalopram|citalopram|mesh-list
6075283|NCT00754936|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6075284|NCT00754936|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6075285|NCT00754936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6075286|NCT00754936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075287|NCT00754936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6075288|NCT00754936|Serotonin Agents|serotonin agents|mesh-ancestor
6075289|NCT00754936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075290|NCT00754936|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6075291|NCT00754936|Antidepressive Agents|antidepressive agents|mesh-ancestor
6075292|NCT00754936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6075293|NCT00755040|Cyclosporine|cyclosporine|mesh-list
6075294|NCT00755040|Cyclosporins|cyclosporins|mesh-list
6075295|NCT00755040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6075296|NCT00755040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075297|NCT00755040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6075298|NCT00755040|Immunologic Factors|immunologic factors|mesh-ancestor
6075299|NCT00755040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075300|NCT00755040|Antifungal Agents|antifungal agents|mesh-ancestor
6075301|NCT00755040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6075302|NCT00755040|Dermatologic Agents|dermatologic agents|mesh-ancestor
6075303|NCT00755040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5511722|NCT04390334|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5511723|NCT04390334|Histamine Antagonists|histamine antagonists|mesh-ancestor
5511724|NCT04390334|Histamine Agents|histamine agents|mesh-ancestor
5511725|NCT04390334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5511726|NCT04390334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511727|NCT04390594|Nafamostat|nafamostat|mesh-list
5511728|NCT04390594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5511729|NCT04390594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5511730|NCT04390594|Analgesics|analgesics|mesh-ancestor
5511731|NCT04390594|Sensory System Agents|sensory system agents|mesh-ancestor
5511732|NCT04390594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5511733|NCT04390594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511734|NCT04390594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5511735|NCT04390594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5511736|NCT04390594|Anticoagulants|anticoagulants|mesh-ancestor
5511737|NCT04390594|Protease Inhibitors|protease inhibitors|mesh-ancestor
5511738|NCT04390594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5511739|NCT04390594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511740|NCT04390594|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5511741|NCT04390594|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5511742|NCT04390594|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5511743|NCT04390594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5511744|NCT04390594|Immunologic Factors|immunologic factors|mesh-ancestor
5511745|NCT04390295|Metformin|metformin|mesh-list
5511746|NCT04390295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5511747|NCT04390295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511748|NCT04390009|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
5511749|NCT04390009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511750|NCT04390217|Tranexamic Acid|tranexamic acid|mesh-list
5511751|NCT04390217|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6075304|NCT00755040|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6075305|NCT00755079|Adrenergic Agents|adrenergic agents|mesh-list
6075306|NCT00755079|Adrenergic Agonists|adrenergic agonists|mesh-list
6075307|NCT00755079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6075308|NCT00755079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511752|NCT04390217|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6075309|NCT00755079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075310|NCT00755183|Methyltestosterone|methyltestosterone|mesh-list
6075311|NCT00755183|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6075312|NCT00755183|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6075313|NCT00755183|Testosterone|testosterone|mesh-list
6075314|NCT00755183|Testosterone undecanoate|testosterone undecanoate|mesh-list
6075315|NCT00755183|Testosterone enanthate|testosterone enanthate|mesh-list
6075316|NCT00755183|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6075317|NCT00755183|Androgens|androgens|mesh-ancestor
6075318|NCT00755183|Hormones|hormones|mesh-ancestor
6075319|NCT00755183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6075320|NCT00755183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075321|NCT00755183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6075322|NCT00755183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6075323|NCT00755183|Anabolic Agents|anabolic agents|mesh-ancestor
6075324|NCT00755274|Vaccines|vaccines|mesh-list
6075325|NCT00755274|Immunologic Factors|immunologic factors|mesh-ancestor
6075326|NCT00755274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075327|NCT00755417|Gabapentin|gabapentin|mesh-list
6075328|NCT00755417|Analgesics|analgesics|mesh-ancestor
6075329|NCT00755417|Sensory System Agents|sensory system agents|mesh-ancestor
6075330|NCT00755417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6075331|NCT00755417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075332|NCT00755417|Anticonvulsants|anticonvulsants|mesh-ancestor
6075333|NCT00755417|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6075334|NCT00755417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6075335|NCT00755417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6075336|NCT00755417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6075337|NCT00755417|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6075338|NCT00755417|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6075339|NCT00755417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6075340|NCT00755417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075341|NCT00755417|Antimanic Agents|antimanic agents|mesh-ancestor
6075342|NCT00755716|Topiramate|topiramate|mesh-list
6075343|NCT00755716|Nicotine|nicotine|mesh-list
6075344|NCT00755716|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6075345|NCT00755716|Autonomic Agents|autonomic agents|mesh-ancestor
6075346|NCT00755716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6075347|NCT00755716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075348|NCT00755716|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6075349|NCT00755716|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6075350|NCT00755716|Cholinergic Agents|cholinergic agents|mesh-ancestor
6075351|NCT00755716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6075352|NCT00755716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075353|NCT00755716|Anticonvulsants|anticonvulsants|mesh-ancestor
6075354|NCT00755716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6075355|NCT00755755|Iron|iron|mesh-list
6075356|NCT00755755|Ulipristal acetate|ulipristal acetate|mesh-list
6075357|NCT00755755|Trace Elements|trace elements|mesh-ancestor
6075358|NCT00755755|Micronutrients|micronutrients|mesh-ancestor
6075359|NCT00755755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075360|NCT00755755|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6075361|NCT00755755|Contraceptive Agents|contraceptive agents|mesh-ancestor
6075362|NCT00755755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6075363|NCT00755755|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6075364|NCT00755807|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6075365|NCT00755807|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6075366|NCT00755807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6075367|NCT00755807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6075368|NCT00755807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075369|NCT00755807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6075370|NCT00755807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075371|NCT00755807|Analgesics|analgesics|mesh-ancestor
6075372|NCT00755807|Sensory System Agents|sensory system agents|mesh-ancestor
6075373|NCT00755807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6075374|NCT00755807|Antidepressive Agents|antidepressive agents|mesh-ancestor
6075375|NCT00755807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6075376|NCT00755807|Dopamine Agents|dopamine agents|mesh-ancestor
6075377|NCT00755846|Alogliptin|alogliptin|mesh-list
6075378|NCT00755846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6075379|NCT00755846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075380|NCT00755846|Incretins|incretins|mesh-ancestor
5511753|NCT04390217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511754|NCT04390217|Hemostatics|hemostatics|mesh-ancestor
5511755|NCT04390217|Coagulants|coagulants|mesh-ancestor
6075381|NCT00755846|Hormones|hormones|mesh-ancestor
5511756|NCT04390061|Hydroxychloroquine|hydroxychloroquine|mesh-list
5511757|NCT04390061|Tofacitinib|tofacitinib|mesh-list
5511758|NCT04390061|Antimalarials|antimalarials|mesh-ancestor
5511759|NCT04390061|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5511760|NCT04390061|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5511761|NCT04390061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5511762|NCT04390061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5511763|NCT04390061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511764|NCT04390061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5511765|NCT04390061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5511766|NCT04389866|Hyaluronic Acid|hyaluronic acid|mesh-list
5511767|NCT04389866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5511768|NCT04389866|Immunologic Factors|immunologic factors|mesh-ancestor
5511769|NCT04389866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511770|NCT04389866|Viscosupplements|viscosupplements|mesh-ancestor
6075382|NCT00755846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6075383|NCT00755846|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6075384|NCT00755846|Protease Inhibitors|protease inhibitors|mesh-ancestor
6075385|NCT00755846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6075386|NCT00755846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075387|NCT00755911|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
6075388|NCT00755911|Hemostatics|hemostatics|mesh-ancestor
6075389|NCT00755911|Coagulants|coagulants|mesh-ancestor
5511771|NCT04389866|Protective Agents|protective agents|mesh-ancestor
5511772|NCT04390152|Ritonavir|ritonavir|mesh-list
5511773|NCT04390152|Lopinavir|lopinavir|mesh-list
5511774|NCT04390152|Azithromycin|azithromycin|mesh-list
5511775|NCT04390152|Hydroxychloroquine|hydroxychloroquine|mesh-list
5511776|NCT04390152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6075390|NCT00756093|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6075391|NCT00756093|Lubricant Eye Drops|lubricant eye drops|mesh-list
6075392|NCT00756093|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6075393|NCT00756106|Temozolomide|temozolomide|mesh-list
6075394|NCT00756106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6075395|NCT00756106|Alkylating Agents|alkylating agents|mesh-ancestor
6075396|NCT00756106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075397|NCT00756106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6075398|NCT00756236|Metoprolol|metoprolol|mesh-list
6075399|NCT00756236|Esmolol|esmolol|mesh-list
6075400|NCT00756236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6075401|NCT00756236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6075402|NCT00756236|Sympatholytics|sympatholytics|mesh-ancestor
5511777|NCT04390152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5511778|NCT04390152|Protease Inhibitors|protease inhibitors|mesh-ancestor
5511779|NCT04390152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5511780|NCT04390152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511781|NCT04390152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5511782|NCT04390152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5511783|NCT04390152|Antiviral Agents|antiviral agents|mesh-ancestor
5511784|NCT04390152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5511785|NCT04390152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6075403|NCT00756236|Autonomic Agents|autonomic agents|mesh-ancestor
6075404|NCT00756236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6075405|NCT00756236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075406|NCT00756236|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6075407|NCT00756236|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6075408|NCT00756236|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6075409|NCT00756236|Adrenergic Agents|adrenergic agents|mesh-ancestor
6075410|NCT00756236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6075411|NCT00756236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075412|NCT00756275|Nicotine|nicotine|mesh-list
6075413|NCT00756275|Varenicline|varenicline|mesh-list
6075414|NCT00756275|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6075415|NCT00756275|Autonomic Agents|autonomic agents|mesh-ancestor
6075416|NCT00756275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6075417|NCT00756275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075418|NCT00756275|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6075419|NCT00756275|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6075420|NCT00756275|Cholinergic Agents|cholinergic agents|mesh-ancestor
6075421|NCT00756275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6075422|NCT00756275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075423|NCT00756314|Contraceptive Agents|contraceptive agents|mesh-list
6075424|NCT00756314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6075425|NCT00756314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075426|NCT00756444|Panitumumab|panitumumab|mesh-list
6075427|NCT00756444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6075428|NCT00756444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6075429|NCT00756470|Paclitaxel|paclitaxel|mesh-list
6075430|NCT00756470|Cyclophosphamide|cyclophosphamide|mesh-list
6075431|NCT00756470|Fluorouracil|fluorouracil|mesh-list
6075432|NCT00756470|Epirubicin|epirubicin|mesh-list
6075433|NCT00756470|Lapatinib|lapatinib|mesh-list
6075434|NCT00756470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6075435|NCT00756470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6075436|NCT00756470|Tubulin Modulators|tubulin modulators|mesh-ancestor
6075437|NCT00756470|Antimitotic Agents|antimitotic agents|mesh-ancestor
6075438|NCT00756470|Mitosis Modulators|mitosis modulators|mesh-ancestor
6075439|NCT00756470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075440|NCT00756470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6075441|NCT00756470|Immunologic Factors|immunologic factors|mesh-ancestor
6075442|NCT00756470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511786|NCT04390152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5511787|NCT04390152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5511788|NCT04390152|Antimalarials|antimalarials|mesh-ancestor
5511789|NCT04390152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5511790|NCT04390152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5511791|NCT04390152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5511792|NCT04390100|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
5511793|NCT04390100|Hyaluronic Acid|hyaluronic acid|mesh-list
5511794|NCT04390100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5511795|NCT04390100|Immunologic Factors|immunologic factors|mesh-ancestor
5511796|NCT04390100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511797|NCT04390100|Viscosupplements|viscosupplements|mesh-ancestor
5511798|NCT04390100|Protective Agents|protective agents|mesh-ancestor
5511799|NCT04390100|Hemostatics|hemostatics|mesh-ancestor
5511800|NCT04390100|Coagulants|coagulants|mesh-ancestor
5511801|NCT04389840|Heparin|heparin|mesh-list
5511802|NCT04389840|Anticoagulants|anticoagulants|mesh-ancestor
5511803|NCT04389840|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5511804|NCT04389840|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5511805|NCT04389840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511806|NCT04389554|Fibrin fragment D|fibrin fragment d|mesh-list
5511807|NCT04389554|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5511808|NCT04389554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6075443|NCT00756470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6075444|NCT00756470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6075445|NCT00756470|Alkylating Agents|alkylating agents|mesh-ancestor
6075446|NCT00756470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6075447|NCT00756470|Antimetabolites|antimetabolites|mesh-ancestor
6075448|NCT00756470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6075449|NCT00756470|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6075450|NCT00756470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6075451|NCT00756470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6075452|NCT00756470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6075453|NCT00756470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6075454|NCT00756548|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
6075455|NCT00756548|Laxatives|laxatives|mesh-ancestor
6075456|NCT00756548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6075457|NCT00756600|Anesthetics|anesthetics|mesh-list
6075458|NCT00756600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6075459|NCT00756600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075460|NCT00756678|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6075461|NCT00756678|Lubricant Eye Drops|lubricant eye drops|mesh-list
5511809|NCT04389554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075462|NCT00756678|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6075463|NCT00756730|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6075464|NCT00756730|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6075465|NCT00756730|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6075466|NCT00756730|Protease Inhibitors|protease inhibitors|mesh-ancestor
6075467|NCT00756730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6075468|NCT00756730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075469|NCT00756730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6075470|NCT00756730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6075471|NCT00756730|Antiviral Agents|antiviral agents|mesh-ancestor
6075472|NCT00756730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6075473|NCT00756886|Atorvastatin|atorvastatin|mesh-list
6075474|NCT00756886|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6075475|NCT00756886|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6075476|NCT00756886|Antimetabolites|antimetabolites|mesh-ancestor
6075477|NCT00756886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075478|NCT00756886|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6075479|NCT00756886|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5511810|NCT04389554|Hemostatics|hemostatics|mesh-ancestor
5511811|NCT04389554|Coagulants|coagulants|mesh-ancestor
5511812|NCT04389567|Famotidine|famotidine|mesh-list
5511813|NCT04389567|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5511814|NCT04389567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5511815|NCT04389567|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5511816|NCT04389567|Histamine Antagonists|histamine antagonists|mesh-ancestor
5511817|NCT04389567|Histamine Agents|histamine agents|mesh-ancestor
5511818|NCT04389567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5511819|NCT04389567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511820|NCT04389567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511821|NCT04389801|Deferoxamine|deferoxamine|mesh-list
5511822|NCT04389801|Siderophores|siderophores|mesh-ancestor
5511823|NCT04389801|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5511824|NCT04389801|Chelating Agents|chelating agents|mesh-ancestor
5511825|NCT04389801|Sequestering Agents|sequestering agents|mesh-ancestor
5511826|NCT04389801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511827|NCT04389580|Tamoxifen|tamoxifen|mesh-list
5511828|NCT04389580|Isotretinoin|isotretinoin|mesh-list
6075480|NCT00756886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6075481|NCT00756964|Rasburicase|rasburicase|mesh-list
6075482|NCT00756964|Gout Suppressants|gout suppressants|mesh-ancestor
6075483|NCT00756964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6075484|NCT00756977|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
6075485|NCT00756977|Laxatives|laxatives|mesh-ancestor
6075486|NCT00756977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6075487|NCT00757172|Docetaxel|docetaxel|mesh-list
6075488|NCT00757172|Panitumumab|panitumumab|mesh-list
6075489|NCT00757172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6075490|NCT00757172|Tubulin Modulators|tubulin modulators|mesh-ancestor
6075491|NCT00757172|Antimitotic Agents|antimitotic agents|mesh-ancestor
6075492|NCT00757172|Mitosis Modulators|mitosis modulators|mesh-ancestor
6075493|NCT00757172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075494|NCT00757172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6075495|NCT00757237|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6075496|NCT00757237|Tobramycin|tobramycin|mesh-list
6075497|NCT00757237|Aztreonam|aztreonam|mesh-list
6075498|NCT00757237|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6075499|NCT00757237|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6075500|NCT00757237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6075501|NCT00757237|Antitubercular Agents|antitubercular agents|mesh-ancestor
6075502|NCT00757588|Insulin|insulin|mesh-list
6075503|NCT00757588|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6075504|NCT00757588|Saxagliptin|saxagliptin|mesh-list
6075505|NCT00757588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6075506|NCT00757588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511829|NCT04389580|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5511830|NCT04389580|Hormone Antagonists|hormone antagonists|mesh-ancestor
6075507|NCT00757588|Incretins|incretins|mesh-ancestor
6075508|NCT00757588|Hormones|hormones|mesh-ancestor
6075509|NCT00757588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6075510|NCT00757588|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6075511|NCT00757588|Protease Inhibitors|protease inhibitors|mesh-ancestor
6075512|NCT00757588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5511831|NCT04389580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5511832|NCT04389580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511833|NCT04389580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5511834|NCT04389580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6075513|NCT00757588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511835|NCT04389580|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5511836|NCT04389580|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5511837|NCT04389580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5511838|NCT04389580|Dermatologic Agents|dermatologic agents|mesh-ancestor
5511839|NCT04389424|Tamoxifen|tamoxifen|mesh-list
5511840|NCT04389424|Anastrozole|anastrozole|mesh-list
5511841|NCT04389424|Exemestane|exemestane|mesh-list
5511842|NCT04389424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5511843|NCT04389424|Hormone Antagonists|hormone antagonists|mesh-ancestor
5511844|NCT04389424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6075514|NCT00757705|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6075515|NCT00757705|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6075516|NCT00757705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6075517|NCT00757705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6075518|NCT00757705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075519|NCT00757705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6075520|NCT00757705|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6075521|NCT00757705|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6075522|NCT00757705|Serotonin Agents|serotonin agents|mesh-ancestor
6075523|NCT00757705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6075524|NCT00757705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075525|NCT00757705|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6075526|NCT00757705|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6075527|NCT00757705|Dopamine Agents|dopamine agents|mesh-ancestor
6075528|NCT00757783|Ritonavir|ritonavir|mesh-list
6075529|NCT00757783|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6075530|NCT00757783|Darunavir|darunavir|mesh-list
6075531|NCT00757783|Tenofovir|tenofovir|mesh-list
6075532|NCT00757783|Emtricitabine|emtricitabine|mesh-list
6075533|NCT00757783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6075534|NCT00757783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6075535|NCT00757783|Protease Inhibitors|protease inhibitors|mesh-ancestor
6075536|NCT00757783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6075537|NCT00757783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075538|NCT00757783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6075539|NCT00757783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6075540|NCT00757783|Antiviral Agents|antiviral agents|mesh-ancestor
6075541|NCT00757783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6075542|NCT00757783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6075543|NCT00757783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6075544|NCT00757783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6075545|NCT00757783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6075546|NCT00757822|Dronabinol|dronabinol|mesh-list
6075547|NCT00757822|Ondansetron|ondansetron|mesh-list
6075548|NCT00757822|Antiemetics|antiemetics|mesh-ancestor
6075549|NCT00757822|Autonomic Agents|autonomic agents|mesh-ancestor
6075550|NCT00757822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5511845|NCT04389424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511846|NCT04389424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5511847|NCT04389424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5511848|NCT04389424|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5511849|NCT04389424|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5511850|NCT04389424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5511851|NCT04389424|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5511852|NCT04389424|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5511853|NCT04389424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5511854|NCT04389424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511855|NCT04389359|Hydroxychloroquine|hydroxychloroquine|mesh-list
5511856|NCT04389359|Antimalarials|antimalarials|mesh-ancestor
5511857|NCT04389359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6075551|NCT00757822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511858|NCT04389359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6075552|NCT00757822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5511859|NCT04389359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5511860|NCT04389359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5511861|NCT04389359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075553|NCT00757822|Antipruritics|antipruritics|mesh-ancestor
6075554|NCT00757822|Dermatologic Agents|dermatologic agents|mesh-ancestor
6075555|NCT00757822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6075556|NCT00757822|Serotonin Agents|serotonin agents|mesh-ancestor
6075557|NCT00757822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6075558|NCT00757822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075559|NCT00757822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6075560|NCT00757822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6075561|NCT00757822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6075562|NCT00757822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6075563|NCT00757822|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6075564|NCT00757822|Hallucinogens|hallucinogens|mesh-ancestor
6075565|NCT00757822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6075566|NCT00757822|Analgesics|analgesics|mesh-ancestor
6075567|NCT00757822|Sensory System Agents|sensory system agents|mesh-ancestor
6075568|NCT00757822|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6075569|NCT00757822|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6075570|NCT00757822|Hormones|hormones|mesh-ancestor
6075571|NCT00757822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6075572|NCT00758043|Ribavirin|ribavirin|mesh-list
6075573|NCT00758043|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6075574|NCT00758043|Antimetabolites|antimetabolites|mesh-ancestor
6075575|NCT00758043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075576|NCT00758043|Antiviral Agents|antiviral agents|mesh-ancestor
6075577|NCT00758043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6075578|NCT00758069|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6075579|NCT00758069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6075580|NCT00758069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511862|NCT04389359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5511863|NCT04389411|Montelukast|montelukast|mesh-list
5511864|NCT04389411|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5511865|NCT04389411|Respiratory System Agents|respiratory system agents|mesh-ancestor
5511866|NCT04389411|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5511867|NCT04389411|Hormone Antagonists|hormone antagonists|mesh-ancestor
5511868|NCT04389411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5511869|NCT04389411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511870|NCT04389411|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5511871|NCT04389411|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5511872|NCT04389411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511873|NCT04389320|Hydroxychloroquine|hydroxychloroquine|mesh-list
5511874|NCT04389320|Antimalarials|antimalarials|mesh-ancestor
5511875|NCT04389320|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5511876|NCT04389320|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6075581|NCT00758069|Incretins|incretins|mesh-ancestor
6075582|NCT00758069|Hormones|hormones|mesh-ancestor
6075583|NCT00758069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6075584|NCT00758069|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6075585|NCT00758069|Protease Inhibitors|protease inhibitors|mesh-ancestor
6075586|NCT00758069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6075587|NCT00758069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075588|NCT00758160|Methylphenidate|methylphenidate|mesh-list
6075589|NCT00758160|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6075590|NCT00758160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075591|NCT00758160|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6075592|NCT00758160|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6075593|NCT00758160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6075594|NCT00758160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075595|NCT00758160|Dopamine Agents|dopamine agents|mesh-ancestor
6075596|NCT00758160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6075597|NCT00758264|Vaccines|vaccines|mesh-list
6075598|NCT00758264|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6075599|NCT00758264|Immunologic Factors|immunologic factors|mesh-ancestor
6075600|NCT00758264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075601|NCT00758342|Travoprost|travoprost|mesh-list
6075602|NCT00758342|Brinzolamide|brinzolamide|mesh-list
6075603|NCT00758342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6075604|NCT00758342|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6075605|NCT00758342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6075606|NCT00758342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075607|NCT00758394|Listerine|listerine|mesh-list
5511877|NCT04389320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5511878|NCT04389320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5511879|NCT04389320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511880|NCT04389320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6075608|NCT00758394|Triclosan|triclosan|mesh-list
6075609|NCT00758394|Fluorides|fluorides|mesh-list
6075610|NCT00758394|Sodium Fluoride|sodium fluoride|mesh-list
6075611|NCT00758394|Fluorophosphate|fluorophosphate|mesh-list
6075612|NCT00758394|Cariostatic Agents|cariostatic agents|mesh-ancestor
6075613|NCT00758394|Protective Agents|protective agents|mesh-ancestor
6075614|NCT00758394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075615|NCT00758394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6075616|NCT00758394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6075617|NCT00758394|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6075618|NCT00758394|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6075619|NCT00758394|Antimetabolites|antimetabolites|mesh-ancestor
6075620|NCT00758394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075621|NCT00758394|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6075622|NCT00758420|Polidocanol|polidocanol|mesh-list
6075623|NCT00758420|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
6075624|NCT00758420|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6075625|NCT00758498|Modafinil|modafinil|mesh-list
6075626|NCT00758498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6075627|NCT00758498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075628|NCT00758498|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6075629|NCT00758498|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6075630|NCT00758498|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6075631|NCT00758498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075632|NCT00758524|Eplerenone|eplerenone|mesh-list
6075633|NCT00758524|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6075634|NCT00758524|Hormone Antagonists|hormone antagonists|mesh-ancestor
6075635|NCT00758524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6075636|NCT00758524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075637|NCT00758524|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6075638|NCT00758524|Diuretics|diuretics|mesh-ancestor
6075639|NCT00758524|Natriuretic Agents|natriuretic agents|mesh-ancestor
6075640|NCT00758524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6075641|NCT00758602|Mycophenolic Acid|mycophenolic acid|mesh-list
6075642|NCT00758602|Tacrolimus|tacrolimus|mesh-list
6075643|NCT00758602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6075644|NCT00758602|Immunologic Factors|immunologic factors|mesh-ancestor
6075645|NCT00758602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075646|NCT00758602|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6075647|NCT00758602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6075648|NCT00758602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075649|NCT00758602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6075650|NCT00758602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6075651|NCT00758602|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6075652|NCT00758602|Antitubercular Agents|antitubercular agents|mesh-ancestor
6075653|NCT00758602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6075654|NCT00758602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6075655|NCT00758667|Mesna|mesna|mesh-list
6075656|NCT00758667|Protective Agents|protective agents|mesh-ancestor
6075657|NCT00758667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075658|NCT00758784|Bromfenac|bromfenac|mesh-list
6075659|NCT00758784|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6075660|NCT00758784|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6075661|NCT00758784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6075662|NCT00758784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6075663|NCT00758784|Analgesics|analgesics|mesh-ancestor
6075664|NCT00758784|Sensory System Agents|sensory system agents|mesh-ancestor
6075665|NCT00758784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6075666|NCT00758784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075667|NCT00758784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6075668|NCT00758784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6075669|NCT00758836|Acetaminophen|acetaminophen|mesh-list
6075670|NCT00758836|Ibuprofen|ibuprofen|mesh-list
6075671|NCT00758836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6075672|NCT00758836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6075673|NCT00758836|Analgesics|analgesics|mesh-ancestor
6075674|NCT00758836|Sensory System Agents|sensory system agents|mesh-ancestor
6075675|NCT00758836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6075676|NCT00758836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075677|NCT00758836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6075678|NCT00758836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6075679|NCT00758836|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6075680|NCT00758836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6075681|NCT00758836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075682|NCT00758836|Antipyretics|antipyretics|mesh-ancestor
6075683|NCT00759031|Listerine|listerine|mesh-list
6075684|NCT00759031|Triclosan|triclosan|mesh-list
6075685|NCT00759031|Fluorides|fluorides|mesh-list
6075686|NCT00759031|Sodium Fluoride|sodium fluoride|mesh-list
6075687|NCT00759031|Fluorophosphate|fluorophosphate|mesh-list
6075688|NCT00759031|Cariostatic Agents|cariostatic agents|mesh-ancestor
6075689|NCT00759031|Protective Agents|protective agents|mesh-ancestor
6075690|NCT00759031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075691|NCT00759031|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6075692|NCT00759031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6075693|NCT00759031|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6075694|NCT00759031|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6075695|NCT00759031|Antimetabolites|antimetabolites|mesh-ancestor
6075696|NCT00759031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075697|NCT00759031|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6075698|NCT00759109|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6075699|NCT00759109|Antiviral Agents|antiviral agents|mesh-ancestor
6075700|NCT00759109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6075701|NCT00759148|Moxifloxacin|moxifloxacin|mesh-list
6075702|NCT00759148|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6075703|NCT00759148|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6075704|NCT00759148|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6075705|NCT00759148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6075706|NCT00759148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6075707|NCT00759148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6075708|NCT00759148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6075709|NCT00759148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6075710|NCT00759148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075711|NCT00759148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6075712|NCT00759148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6075713|NCT00759148|Contraceptive Agents|contraceptive agents|mesh-ancestor
6075714|NCT00759148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6075715|NCT00759148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075716|NCT00759148|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6075717|NCT00759148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6075718|NCT00759148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6075719|NCT00759187|Chlorhexidine|chlorhexidine|mesh-list
6075720|NCT00759187|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6075721|NCT00759187|Triclosan|triclosan|mesh-list
6075722|NCT00759187|Fluorides|fluorides|mesh-list
6075723|NCT00759187|Sodium Fluoride|sodium fluoride|mesh-list
6075724|NCT00759187|Fluorophosphate|fluorophosphate|mesh-list
6075725|NCT00759187|Cariostatic Agents|cariostatic agents|mesh-ancestor
6075726|NCT00759187|Protective Agents|protective agents|mesh-ancestor
6075727|NCT00759187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075728|NCT00759187|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6075729|NCT00759187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6075730|NCT00759187|Disinfectants|disinfectants|mesh-ancestor
6075731|NCT00759187|Dermatologic Agents|dermatologic agents|mesh-ancestor
6075732|NCT00759187|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6075733|NCT00759187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6075734|NCT00759187|Antimetabolites|antimetabolites|mesh-ancestor
6075735|NCT00759187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075736|NCT00759187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6075737|NCT00759330|Flurbiprofen|flurbiprofen|mesh-list
6075738|NCT00759330|Analgesics|analgesics|mesh-ancestor
6075739|NCT00759330|Sensory System Agents|sensory system agents|mesh-ancestor
6075740|NCT00759330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6075741|NCT00759330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075742|NCT00759330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6075743|NCT00759330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6075744|NCT00759330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6075745|NCT00759330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6075746|NCT00759330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6075747|NCT00759330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6075748|NCT00759330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075749|NCT00759356|Morphine|morphine|mesh-list
6075750|NCT00759356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6075751|NCT00759356|Narcotics|narcotics|mesh-ancestor
6075752|NCT00759356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6075753|NCT00759356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075754|NCT00759356|Analgesics|analgesics|mesh-ancestor
6075755|NCT00759356|Sensory System Agents|sensory system agents|mesh-ancestor
6075756|NCT00759356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5511905|NCT04389060|Grape Seed Extract|grape seed extract|mesh-list
5511906|NCT04389060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5511907|NCT04389060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5511908|NCT04389060|Antioxidants|antioxidants|mesh-ancestor
5511909|NCT04389060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511910|NCT04389060|Protective Agents|protective agents|mesh-ancestor
5511911|NCT04389060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511912|NCT04389229|Aldesleukin|aldesleukin|mesh-list
5511913|NCT04389229|Cyclophosphamide|cyclophosphamide|mesh-list
5511914|NCT04389229|Fludarabine|fludarabine|mesh-list
5511915|NCT04389229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6075757|NCT00759408|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
6075758|NCT00759408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6075759|NCT00759408|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6075760|NCT00759408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075761|NCT00759473|Cycloserine|cycloserine|mesh-list
6075762|NCT00759473|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6075763|NCT00759473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6075764|NCT00759473|Renal Agents|renal agents|mesh-ancestor
6075765|NCT00759473|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6075766|NCT00759473|Antitubercular Agents|antitubercular agents|mesh-ancestor
6075767|NCT00759473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6075768|NCT00759473|Antimetabolites|antimetabolites|mesh-ancestor
6075769|NCT00759473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075770|NCT00759525|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
6075771|NCT00759525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6075772|NCT00759564|Lactams|lactams|mesh-list
6075773|NCT00759564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6075774|NCT00759564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6075775|NCT00759603|Rituximab|rituximab|mesh-list
6075776|NCT00759603|Lenalidomide|lenalidomide|mesh-list
6075777|NCT00759603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6075778|NCT00759603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6075779|NCT00759603|Immunologic Factors|immunologic factors|mesh-ancestor
6075780|NCT00759603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075781|NCT00759603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6075782|NCT00759603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6075783|NCT00759603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6075784|NCT00759603|Growth Substances|growth substances|mesh-ancestor
6075785|NCT00759603|Growth Inhibitors|growth inhibitors|mesh-ancestor
6075786|NCT00759642|Lapatinib|lapatinib|mesh-list
6075787|NCT00759642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6075788|NCT00759642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6075789|NCT00759642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6075790|NCT00759642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075791|NCT00759655|Factor VIII|factor viii|mesh-list
6075792|NCT00759655|Coagulants|coagulants|mesh-ancestor
6075793|NCT00759681|Thrombin|thrombin|mesh-list
6075794|NCT00759681|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
6075795|NCT00759681|Hemostatics|hemostatics|mesh-ancestor
6075796|NCT00759681|Coagulants|coagulants|mesh-ancestor
6075797|NCT00759707|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
6075798|NCT00759707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6075799|NCT00759707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075800|NCT00759759|Morphine|morphine|mesh-list
6075801|NCT00759759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6075802|NCT00759759|Narcotics|narcotics|mesh-ancestor
6075803|NCT00759759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6075804|NCT00759759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075805|NCT00759759|Analgesics|analgesics|mesh-ancestor
6075806|NCT00759759|Sensory System Agents|sensory system agents|mesh-ancestor
6075807|NCT00759759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6075808|NCT00759772|Teriparatide|teriparatide|mesh-list
6075809|NCT00759772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6075810|NCT00759772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075811|NCT00759772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6075812|NCT00759785|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6075813|NCT00759785|Immunologic Factors|immunologic factors|mesh-ancestor
6075814|NCT00759785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202795|NCT02046200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202796|NCT02046200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6202797|NCT02046369|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
5511916|NCT04389229|Immunologic Factors|immunologic factors|mesh-ancestor
6202798|NCT02046369|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6075815|NCT00759798|Cyclophosphamide|cyclophosphamide|mesh-list
6075816|NCT00759798|Rituximab|rituximab|mesh-list
6075817|NCT00759798|Fludarabine|fludarabine|mesh-list
6075818|NCT00759798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6075819|NCT00759798|Immunologic Factors|immunologic factors|mesh-ancestor
6075820|NCT00759798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075821|NCT00759798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6075822|NCT00759798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6075823|NCT00759798|Alkylating Agents|alkylating agents|mesh-ancestor
6075824|NCT00759798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075825|NCT00759798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6075826|NCT00759798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6075827|NCT00759798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6075828|NCT00759811|Methotrexate|methotrexate|mesh-list
6075829|NCT00759811|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6075830|NCT00759811|Abortifacient Agents|abortifacient agents|mesh-ancestor
6075831|NCT00759811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6075832|NCT00759811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075833|NCT00759811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6075834|NCT00759811|Antimetabolites|antimetabolites|mesh-ancestor
6075835|NCT00759811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075836|NCT00759811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6075837|NCT00759811|Dermatologic Agents|dermatologic agents|mesh-ancestor
6075838|NCT00759811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6075839|NCT00759811|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6075840|NCT00759811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6075841|NCT00759811|Immunologic Factors|immunologic factors|mesh-ancestor
6075842|NCT00759811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6075843|NCT00759811|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6075844|NCT00759902|Morphine|morphine|mesh-list
6075845|NCT00759902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6075846|NCT00759902|Narcotics|narcotics|mesh-ancestor
6075847|NCT00759902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6075848|NCT00759902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075849|NCT00759902|Analgesics|analgesics|mesh-ancestor
6075850|NCT00759902|Sensory System Agents|sensory system agents|mesh-ancestor
6075851|NCT00759902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6075852|NCT00759915|Morphine|morphine|mesh-list
6075853|NCT00759915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6075854|NCT00759915|Narcotics|narcotics|mesh-ancestor
6075855|NCT00759915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6075856|NCT00759915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075857|NCT00759915|Analgesics|analgesics|mesh-ancestor
6075858|NCT00759915|Sensory System Agents|sensory system agents|mesh-ancestor
5511917|NCT04389229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511918|NCT04389229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5511919|NCT04389229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5511920|NCT04389229|Alkylating Agents|alkylating agents|mesh-ancestor
5511921|NCT04389229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511922|NCT04389229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5511923|NCT04389229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5511924|NCT04389229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5511925|NCT04389229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5511926|NCT04389229|Antiviral Agents|antiviral agents|mesh-ancestor
6075859|NCT00759915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6075860|NCT00759941|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6075861|NCT00759941|Latanoprost|latanoprost|mesh-list
6075862|NCT00759941|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6075863|NCT00759941|Brinzolamide|brinzolamide|mesh-list
6075864|NCT00759941|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6075865|NCT00759941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6075866|NCT00759941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075867|NCT00759954|Morphine|morphine|mesh-list
6075868|NCT00759954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6075869|NCT00759954|Narcotics|narcotics|mesh-ancestor
6075870|NCT00759954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5511927|NCT04389229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5511928|NCT04389177|Paclitaxel|paclitaxel|mesh-list
5511929|NCT04389177|Cisplatin|cisplatin|mesh-list
5511930|NCT04389177|Pembrolizumab|pembrolizumab|mesh-list
5511931|NCT04389177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5511932|NCT04389177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5511933|NCT04389177|Tubulin Modulators|tubulin modulators|mesh-ancestor
6075871|NCT00759954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075872|NCT00759954|Analgesics|analgesics|mesh-ancestor
5511934|NCT04389177|Antimitotic Agents|antimitotic agents|mesh-ancestor
6075873|NCT00759954|Sensory System Agents|sensory system agents|mesh-ancestor
6075874|NCT00759954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6075875|NCT00760006|Ampicillin|ampicillin|mesh-list
6075876|NCT00760006|Sulbactam|sulbactam|mesh-list
6075877|NCT00760006|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6075878|NCT00760006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6075879|NCT00760006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6075880|NCT00760006|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6075881|NCT00760006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6075882|NCT00760006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075883|NCT00760019|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
6075884|NCT00760019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6075885|NCT00760019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6075886|NCT00760019|Analgesics|analgesics|mesh-ancestor
6075887|NCT00760019|Sensory System Agents|sensory system agents|mesh-ancestor
5511935|NCT04389177|Mitosis Modulators|mitosis modulators|mesh-ancestor
5511936|NCT04389177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511937|NCT04389177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5511938|NCT04388774|Ketamine|ketamine|mesh-list
5511939|NCT04388774|Analgesics|analgesics|mesh-ancestor
5511940|NCT04388774|Sensory System Agents|sensory system agents|mesh-ancestor
5511941|NCT04388774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5511942|NCT04388774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511943|NCT04388774|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5511944|NCT04388774|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5511945|NCT04388774|Anesthetics, General|anesthetics, general|mesh-ancestor
5511946|NCT04388774|Anesthetics|anesthetics|mesh-ancestor
5511947|NCT04388774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5511948|NCT04388774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5511949|NCT04388774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5511950|NCT04388774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6075888|NCT00760019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6075889|NCT00760019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075890|NCT00760019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6075891|NCT00760019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6075892|NCT00760084|Decitabine|decitabine|mesh-list
6075893|NCT00760084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6075894|NCT00760084|Antimetabolites|antimetabolites|mesh-ancestor
6075895|NCT00760084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075896|NCT00760084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6075897|NCT00760084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6075898|NCT00760214|Ramipril|ramipril|mesh-list
6075899|NCT00760214|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
6075900|NCT00760214|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6075901|NCT00760214|Protease Inhibitors|protease inhibitors|mesh-ancestor
6075902|NCT00760214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6075903|NCT00760214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075904|NCT00760214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6075905|NCT00760214|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6075906|NCT00760214|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6075907|NCT00760266|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6075908|NCT00760266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6075909|NCT00760266|Diuretics|diuretics|mesh-ancestor
6075910|NCT00760266|Natriuretic Agents|natriuretic agents|mesh-ancestor
6075911|NCT00760266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075912|NCT00760266|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6075913|NCT00760266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6075914|NCT00760266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075915|NCT00760435|Infliximab|infliximab|mesh-list
6075916|NCT00760435|Dermatologic Agents|dermatologic agents|mesh-ancestor
6075917|NCT00760435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6075918|NCT00760435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6075919|NCT00760474|Pregabalin|pregabalin|mesh-list
6075920|NCT00760474|Analgesics|analgesics|mesh-ancestor
6075921|NCT00760474|Sensory System Agents|sensory system agents|mesh-ancestor
6075922|NCT00760474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6075923|NCT00760474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075924|NCT00760474|Anticonvulsants|anticonvulsants|mesh-ancestor
6075925|NCT00760474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6075926|NCT00760474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6075927|NCT00760474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075928|NCT00760474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6075929|NCT00760474|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6075930|NCT00760474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6075931|NCT00760474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6075932|NCT00760474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6075933|NCT00760578|Pioglitazone|pioglitazone|mesh-list
6075934|NCT00760578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6075935|NCT00760578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075936|NCT00760669|Methotrexate|methotrexate|mesh-list
6075937|NCT00760669|Infliximab|infliximab|mesh-list
5511951|NCT04388774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600423|NCT03712111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5600424|NCT03712111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600425|NCT03712111|Sympathomimetics|sympathomimetics|mesh-ancestor
5600426|NCT03712111|Autonomic Agents|autonomic agents|mesh-ancestor
5600427|NCT03712111|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5600428|NCT03712046|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6075938|NCT00760669|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6075939|NCT00760669|Abortifacient Agents|abortifacient agents|mesh-ancestor
6075940|NCT00760669|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6075941|NCT00760669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075942|NCT00760669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6075943|NCT00760669|Antimetabolites|antimetabolites|mesh-ancestor
6075944|NCT00760669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075945|NCT00760669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6075946|NCT00760669|Dermatologic Agents|dermatologic agents|mesh-ancestor
5600429|NCT03712046|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5600430|NCT03712046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600431|NCT03711708|Sertraline|sertraline|mesh-list
5600432|NCT03711708|Antidepressive Agents|antidepressive agents|mesh-ancestor
5600433|NCT03711708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5600434|NCT03711708|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5600435|NCT03711708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5600436|NCT03711708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5600437|NCT03711708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600438|NCT03711708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5600439|NCT03711708|Serotonin Agents|serotonin agents|mesh-ancestor
5600440|NCT03711708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606681|NCT03927274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5606682|NCT03927274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5606683|NCT03927274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606684|NCT03927274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5606685|NCT03907826|Antibodies|antibodies|mesh-list
5606686|NCT03907826|Antibodies, Blocking|antibodies, blocking|mesh-list
5606687|NCT03907826|Immunologic Factors|immunologic factors|mesh-ancestor
5606688|NCT03907826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606689|NCT03905889|Sunitinib|sunitinib|mesh-list
5606690|NCT03905889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6075947|NCT00760669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6075948|NCT00760669|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6075949|NCT00760669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6075950|NCT00760669|Immunologic Factors|immunologic factors|mesh-ancestor
6075951|NCT00760669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6075952|NCT00760669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6075953|NCT00760669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6075954|NCT00760747|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6075955|NCT00760747|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6075956|NCT00760747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6075957|NCT00760747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6075958|NCT00760747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606691|NCT03905889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5606692|NCT03905889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5606693|NCT03905889|Growth Substances|growth substances|mesh-ancestor
5606694|NCT03905889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606695|NCT03905889|Growth Inhibitors|growth inhibitors|mesh-ancestor
5606696|NCT03905889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5606697|NCT03905889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5606698|NCT03905889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606699|NCT03896503|Topotecan|topotecan|mesh-list
5606700|NCT03896503|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5606701|NCT03896503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6075959|NCT00760747|Adrenergic Agents|adrenergic agents|mesh-ancestor
6075960|NCT00760747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6075961|NCT00760747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075962|NCT00760838|Azithromycin|azithromycin|mesh-list
5511952|NCT04388683|Nitric Oxide|nitric oxide|mesh-list
5511953|NCT04388683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5511954|NCT04388683|Autonomic Agents|autonomic agents|mesh-ancestor
5511955|NCT04388683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5511956|NCT04388683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5511957|NCT04388683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5511958|NCT04388683|Respiratory System Agents|respiratory system agents|mesh-ancestor
5511959|NCT04388683|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5511960|NCT04388683|Antioxidants|antioxidants|mesh-ancestor
5511961|NCT04388683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511962|NCT04388683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5511963|NCT04388683|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6075963|NCT00760838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6075964|NCT00760838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6075965|NCT00760877|Imatinib Mesylate|imatinib mesylate|mesh-list
6075966|NCT00760877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6075967|NCT00760877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6075968|NCT00760877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6075969|NCT00760877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075970|NCT00760929|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6075971|NCT00760929|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6075972|NCT00760929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6075973|NCT00760929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6075974|NCT00760929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6075975|NCT00760929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075976|NCT00760929|Immunologic Factors|immunologic factors|mesh-ancestor
6075977|NCT00760929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075978|NCT00761085|Morphine|morphine|mesh-list
6075979|NCT00761085|Methadone|methadone|mesh-list
6075980|NCT00761085|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6075981|NCT00761085|Narcotics|narcotics|mesh-ancestor
6075982|NCT00761085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6075983|NCT00761085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075984|NCT00761085|Analgesics|analgesics|mesh-ancestor
6075985|NCT00761085|Sensory System Agents|sensory system agents|mesh-ancestor
5511964|NCT04388683|Vasodilator Agents|vasodilator agents|mesh-ancestor
5511965|NCT04388683|Gasotransmitters|gasotransmitters|mesh-ancestor
5511966|NCT04388683|Protective Agents|protective agents|mesh-ancestor
5511967|NCT04388709|Interferons|interferons|mesh-list
5511968|NCT04388709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5511969|NCT04388709|Antiviral Agents|antiviral agents|mesh-ancestor
5511970|NCT04388709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5511971|NCT04388176|Compound 21|compound 21|mesh-list
5511972|NCT04388176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5511973|NCT04388904|Tenofovir|tenofovir|mesh-list
5511974|NCT04388904|Emtricitabine|emtricitabine|mesh-list
5511975|NCT04388904|Darunavir|darunavir|mesh-list
5511976|NCT04388904|Cobicistat|cobicistat|mesh-list
5511977|NCT04388904|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
5511978|NCT04388904|Antiviral Agents|antiviral agents|mesh-ancestor
5511979|NCT04388904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5511980|NCT04388904|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5511981|NCT04388904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5511982|NCT04388904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5511983|NCT04388904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511984|NCT04388904|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5511985|NCT04388904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5511986|NCT04388904|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5511987|NCT04388904|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6075986|NCT00761085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6075987|NCT00761085|Antitussive Agents|antitussive agents|mesh-ancestor
5511988|NCT04388904|Protease Inhibitors|protease inhibitors|mesh-ancestor
5600441|NCT03711474|Dexamethasone|dexamethasone|mesh-list
5511989|NCT04388904|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5511990|NCT04388904|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5511991|NCT04388202|Citalopram|citalopram|mesh-list
5511992|NCT04388202|Sertraline|sertraline|mesh-list
5511993|NCT04388202|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5511994|NCT04388202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5511995|NCT04388202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5511996|NCT04388202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5511997|NCT04388202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5511998|NCT04388202|Serotonin Agents|serotonin agents|mesh-ancestor
5511999|NCT04388202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512000|NCT04388202|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5512001|NCT04388202|Antidepressive Agents|antidepressive agents|mesh-ancestor
5512002|NCT04388202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5512003|NCT04388124|Bosentan|bosentan|mesh-list
6075988|NCT00761085|Respiratory System Agents|respiratory system agents|mesh-ancestor
6075989|NCT00761137|Tropicamide|tropicamide|mesh-list
6075990|NCT00761137|Mydriatics|mydriatics|mesh-ancestor
6075991|NCT00761137|Autonomic Agents|autonomic agents|mesh-ancestor
6075992|NCT00761137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6075993|NCT00761137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6075994|NCT00761137|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6075995|NCT00761137|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6075996|NCT00761137|Cholinergic Agents|cholinergic agents|mesh-ancestor
6075997|NCT00761137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6075998|NCT00761137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6075999|NCT00761150|Acetaminophen|acetaminophen|mesh-list
6076000|NCT00761150|Hydrocodone|hydrocodone|mesh-list
6076001|NCT00761150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6076002|NCT00761150|Analgesics|analgesics|mesh-ancestor
6076003|NCT00761150|Sensory System Agents|sensory system agents|mesh-ancestor
6076004|NCT00761150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6076005|NCT00761150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076006|NCT00761150|Antipyretics|antipyretics|mesh-ancestor
6076007|NCT00761150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6076008|NCT00761150|Narcotics|narcotics|mesh-ancestor
6076009|NCT00761150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6076010|NCT00761150|Antitussive Agents|antitussive agents|mesh-ancestor
6076011|NCT00761150|Respiratory System Agents|respiratory system agents|mesh-ancestor
6076012|NCT00761189|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6076013|NCT00761189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6076014|NCT00761189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6076015|NCT00761189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6076016|NCT00761189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076017|NCT00761189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6076018|NCT00761189|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6076019|NCT00761189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6076020|NCT00761189|Serotonin Agents|serotonin agents|mesh-ancestor
6076021|NCT00761189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6076022|NCT00761189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512004|NCT04388124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5512005|NCT04388124|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5512006|NCT04388124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512007|NCT04388189|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5512008|NCT04388189|Bupropion|bupropion|mesh-list
5512009|NCT04388189|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5512010|NCT04388189|Antidepressive Agents|antidepressive agents|mesh-ancestor
5512011|NCT04388189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5512012|NCT04388189|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5512013|NCT04388189|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5512014|NCT04388189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5512015|NCT04388189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512016|NCT04388189|Dopamine Agents|dopamine agents|mesh-ancestor
5512017|NCT04388189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5512018|NCT04388189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512019|NCT04388189|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5512020|NCT04388189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5512021|NCT04388189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5606702|NCT03896503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6076023|NCT00761189|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6076024|NCT00761189|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6076025|NCT00761189|Dopamine Agents|dopamine agents|mesh-ancestor
6463646|NCT00465452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463647|NCT00465452|Protective Agents|protective agents|mesh-ancestor
6463648|NCT00465543|Rosmarinic acid|rosmarinic acid|mesh-list
6463649|NCT00465543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6463650|NCT00465543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6463651|NCT00465543|Analgesics|analgesics|mesh-ancestor
6463652|NCT00465543|Sensory System Agents|sensory system agents|mesh-ancestor
6463653|NCT00465543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6463654|NCT00465543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463655|NCT00465543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6463656|NCT00465543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6463657|NCT00465543|Antioxidants|antioxidants|mesh-ancestor
6463658|NCT00465543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463659|NCT00465543|Protective Agents|protective agents|mesh-ancestor
5512022|NCT04388189|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5512023|NCT04388189|Analgesics|analgesics|mesh-ancestor
5512024|NCT04388189|Sensory System Agents|sensory system agents|mesh-ancestor
5512025|NCT04388189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5512026|NCT04388111|Morphine|morphine|mesh-list
5512027|NCT04388111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5512028|NCT04388111|Narcotics|narcotics|mesh-ancestor
5512029|NCT04388111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5512030|NCT04388111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463660|NCT00465543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6463661|NCT00465543|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6076026|NCT00761202|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6076027|NCT00761202|Hyaluronic Acid|hyaluronic acid|mesh-list
6076028|NCT00761202|Glycerol|glycerol|mesh-list
6076029|NCT00761202|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6076030|NCT00761202|Immunologic Factors|immunologic factors|mesh-ancestor
6076031|NCT00761202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076032|NCT00761202|Viscosupplements|viscosupplements|mesh-ancestor
6076033|NCT00761202|Protective Agents|protective agents|mesh-ancestor
6076034|NCT00761202|Laxatives|laxatives|mesh-ancestor
6076035|NCT00761202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6076036|NCT00761202|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6076037|NCT00761215|Tedizolid phosphate|tedizolid phosphate|mesh-list
6076038|NCT00761215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6076039|NCT00761215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5512031|NCT04388111|Analgesics|analgesics|mesh-ancestor
5512032|NCT04388111|Sensory System Agents|sensory system agents|mesh-ancestor
5512033|NCT04388111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5512034|NCT04388319|Zonisamide|zonisamide|mesh-list
5512035|NCT04388319|Bupropion|bupropion|mesh-list
5512036|NCT04388319|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6076040|NCT00761267|Fluconazole|fluconazole|mesh-list
6076041|NCT00761267|Anidulafungin|anidulafungin|mesh-list
6076042|NCT00761267|Antifungal Agents|antifungal agents|mesh-ancestor
6076043|NCT00761267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6076044|NCT00761267|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6076045|NCT00761267|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6076046|NCT00761267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6076047|NCT00761267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076048|NCT00761267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6076049|NCT00761267|Hormone Antagonists|hormone antagonists|mesh-ancestor
6076050|NCT00761267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6076051|NCT00761267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076052|NCT00761267|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6076053|NCT00761267|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6076054|NCT00761280|Temozolomide|temozolomide|mesh-list
6076055|NCT00761280|Carmustine|carmustine|mesh-list
6076056|NCT00761280|Lomustine|lomustine|mesh-list
5512037|NCT04388319|Antidepressive Agents|antidepressive agents|mesh-ancestor
6076057|NCT00761280|Trabedersen|trabedersen|mesh-list
6076058|NCT00761280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6076059|NCT00761280|Alkylating Agents|alkylating agents|mesh-ancestor
6076060|NCT00761280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076061|NCT00761280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6076062|NCT00761306|Vortioxetine|vortioxetine|mesh-list
6076063|NCT00761306|Antidepressive Agents|antidepressive agents|mesh-ancestor
6076064|NCT00761306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6076065|NCT00761306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5512038|NCT04388319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5512039|NCT04388319|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5512040|NCT04388319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5512041|NCT04388319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5512042|NCT04388319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512043|NCT04388319|Dopamine Agents|dopamine agents|mesh-ancestor
5512044|NCT04388319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5512045|NCT04388319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512046|NCT04388319|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5512047|NCT04388319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5512048|NCT04388319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5512049|NCT04388319|Anticonvulsants|anticonvulsants|mesh-ancestor
5512050|NCT04388319|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5512051|NCT04388319|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6076066|NCT00761306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6076067|NCT00761306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6076068|NCT00761306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076069|NCT00761306|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6076070|NCT00761306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6076071|NCT00761306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6076072|NCT00761306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076073|NCT00761306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6076074|NCT00761306|Serotonin Agents|serotonin agents|mesh-ancestor
6076075|NCT00761306|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6076076|NCT00761306|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6076077|NCT00761306|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6076078|NCT00761306|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6076079|NCT00761319|Travoprost|travoprost|mesh-list
6076080|NCT00761319|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6076081|NCT00761319|Latanoprost|latanoprost|mesh-list
6076082|NCT00761319|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6076083|NCT00761319|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6076084|NCT00761345|Gemcitabine|gemcitabine|mesh-list
6076085|NCT00761345|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6076086|NCT00761345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6076087|NCT00761345|Antimetabolites|antimetabolites|mesh-ancestor
6076088|NCT00761345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076089|NCT00761345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6076090|NCT00761345|Antiviral Agents|antiviral agents|mesh-ancestor
6076091|NCT00761345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6076092|NCT00761345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6076093|NCT00761345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6076094|NCT00761345|Immunologic Factors|immunologic factors|mesh-ancestor
6076095|NCT00761345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076096|NCT00761345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6076097|NCT00761462|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6076098|NCT00761462|Ciprofloxacin|ciprofloxacin|mesh-list
5512052|NCT04387786|Albuterol|albuterol|mesh-list
5512053|NCT04387786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5512054|NCT04387786|Autonomic Agents|autonomic agents|mesh-ancestor
5512055|NCT04387786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5512056|NCT04387786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512057|NCT04387786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5512058|NCT04387786|Respiratory System Agents|respiratory system agents|mesh-ancestor
5512059|NCT04387786|Tocolytic Agents|tocolytic agents|mesh-ancestor
5512060|NCT04387786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6076099|NCT00761462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6076100|NCT00761462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6076101|NCT00761462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6076102|NCT00761462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6202799|NCT02046369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5512061|NCT04387786|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5512062|NCT04387786|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5512063|NCT04387786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6076103|NCT00761462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076104|NCT00761462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6076105|NCT00761462|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6076106|NCT00761462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6076107|NCT00761514|Adalimumab|adalimumab|mesh-list
6076108|NCT00761514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6076109|NCT00761514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6076110|NCT00761579|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6076111|NCT00761579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6076112|NCT00761579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6076113|NCT00761579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6076114|NCT00761579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076115|NCT00761579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6076116|NCT00761579|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6076117|NCT00761579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6076118|NCT00761579|Serotonin Agents|serotonin agents|mesh-ancestor
6076119|NCT00761579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6076120|NCT00761579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076121|NCT00761579|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6076122|NCT00761579|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6076123|NCT00761579|Dopamine Agents|dopamine agents|mesh-ancestor
6076124|NCT00761592|Botulinum Toxins|botulinum toxins|mesh-list
6076125|NCT00761592|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6076126|NCT00761592|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6076127|NCT00761592|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6076128|NCT00761592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6076129|NCT00761592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076130|NCT00761592|Cholinergic Agents|cholinergic agents|mesh-ancestor
6076131|NCT00761592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6076132|NCT00761592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076133|NCT00761592|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6076134|NCT00761592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6076135|NCT00761605|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6076136|NCT00761605|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6076137|NCT00761605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6076138|NCT00761605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6076139|NCT00761605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076140|NCT00761605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6076141|NCT00761605|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6076142|NCT00761605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6076143|NCT00761605|Serotonin Agents|serotonin agents|mesh-ancestor
6076144|NCT00761605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6076145|NCT00761605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076146|NCT00761605|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6076147|NCT00761605|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6076148|NCT00761605|Dopamine Agents|dopamine agents|mesh-ancestor
6076149|NCT00761631|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6076150|NCT00761631|Immunologic Factors|immunologic factors|mesh-ancestor
6076151|NCT00761631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076152|NCT00761735|Ribavirin|ribavirin|mesh-list
6076153|NCT00761735|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6076154|NCT00761735|Antimetabolites|antimetabolites|mesh-ancestor
6076155|NCT00761735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076156|NCT00761735|Antiviral Agents|antiviral agents|mesh-ancestor
6076157|NCT00761735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6076158|NCT00761774|Brivaracetam|brivaracetam|mesh-list
6076159|NCT00761774|Anticonvulsants|anticonvulsants|mesh-ancestor
6076160|NCT00761891|Aspirin|aspirin|mesh-list
6076161|NCT00761891|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6076162|NCT00761891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6076163|NCT00761891|Analgesics|analgesics|mesh-ancestor
6076164|NCT00761891|Sensory System Agents|sensory system agents|mesh-ancestor
6076165|NCT00761891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6076166|NCT00761891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076167|NCT00761891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6076168|NCT00761891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6076169|NCT00761891|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6076170|NCT00761891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6076171|NCT00761891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076172|NCT00761891|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6076173|NCT00761891|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6076174|NCT00761891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6076175|NCT00761891|Antipyretics|antipyretics|mesh-ancestor
5512064|NCT04387786|Adrenergic Agents|adrenergic agents|mesh-ancestor
5512065|NCT04387786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5512066|NCT04387786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512067|NCT04387929|Antibodies|antibodies|mesh-list
5512068|NCT04387929|Immunologic Factors|immunologic factors|mesh-ancestor
6076176|NCT00761930|Listerine|listerine|mesh-list
6076177|NCT00761930|Triclosan|triclosan|mesh-list
6076178|NCT00761930|Fluorides|fluorides|mesh-list
6076179|NCT00761930|Sodium Fluoride|sodium fluoride|mesh-list
6076180|NCT00761930|Cariostatic Agents|cariostatic agents|mesh-ancestor
6076181|NCT00761930|Protective Agents|protective agents|mesh-ancestor
6076182|NCT00761930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076183|NCT00761930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6076184|NCT00761930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6076185|NCT00761930|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6076186|NCT00761930|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6076187|NCT00761930|Antimetabolites|antimetabolites|mesh-ancestor
6076188|NCT00761930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512069|NCT04387929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512070|NCT04387695|Sorafenib|sorafenib|mesh-list
5512071|NCT04387695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5512072|NCT04387695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5512073|NCT04387695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5512074|NCT04387695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076189|NCT00761930|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6076190|NCT00762034|Paclitaxel|paclitaxel|mesh-list
6076191|NCT00762034|Bevacizumab|bevacizumab|mesh-list
6076192|NCT00762034|Carboplatin|carboplatin|mesh-list
6076193|NCT00762034|Pemetrexed|pemetrexed|mesh-list
6076194|NCT00762034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6076195|NCT00762034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6076196|NCT00762034|Tubulin Modulators|tubulin modulators|mesh-ancestor
6076197|NCT00762034|Antimitotic Agents|antimitotic agents|mesh-ancestor
5512075|NCT04387734|Ocrelizumab|ocrelizumab|mesh-list
5512076|NCT04387734|Immunologic Factors|immunologic factors|mesh-ancestor
5512077|NCT04387734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512078|NCT04388033|Temozolomide|temozolomide|mesh-list
5512079|NCT04388033|Interleukin-12|interleukin-12|mesh-list
5512080|NCT04388033|Vaccines|vaccines|mesh-list
5512081|NCT04388033|Immunologic Factors|immunologic factors|mesh-ancestor
5512082|NCT04388033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512083|NCT04388033|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5512084|NCT04388033|Alkylating Agents|alkylating agents|mesh-ancestor
5512085|NCT04388033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512086|NCT04388033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5512087|NCT04388033|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5512088|NCT04388033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5512089|NCT04388033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5512090|NCT04388033|Growth Substances|growth substances|mesh-ancestor
5512091|NCT04388033|Growth Inhibitors|growth inhibitors|mesh-ancestor
5512092|NCT04387617|Cannabidiol|cannabidiol|mesh-list
5512093|NCT04387617|Anticonvulsants|anticonvulsants|mesh-ancestor
6076198|NCT00762034|Mitosis Modulators|mitosis modulators|mesh-ancestor
6076199|NCT00762034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076200|NCT00762034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6076201|NCT00762034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6076202|NCT00762034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6076203|NCT00762034|Growth Substances|growth substances|mesh-ancestor
6076204|NCT00762034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076205|NCT00762034|Growth Inhibitors|growth inhibitors|mesh-ancestor
6076206|NCT00762034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6076207|NCT00762034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6076208|NCT00762034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5512094|NCT04387604|Ranibizumab|ranibizumab|mesh-list
6076209|NCT00762073|Budesonide|budesonide|mesh-list
6076210|NCT00762073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5512095|NCT04387604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5512096|NCT04387604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6076211|NCT00762073|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5512097|NCT04387604|Growth Substances|growth substances|mesh-ancestor
6076212|NCT00762073|Autonomic Agents|autonomic agents|mesh-ancestor
6076213|NCT00762073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6076214|NCT00762073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076215|NCT00762073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6076216|NCT00762073|Respiratory System Agents|respiratory system agents|mesh-ancestor
6076217|NCT00762073|Glucocorticoids|glucocorticoids|mesh-ancestor
6076218|NCT00762073|Hormones|hormones|mesh-ancestor
6076219|NCT00762073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6076220|NCT00762164|Simvastatin|simvastatin|mesh-list
6076221|NCT00762164|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
6076222|NCT00762164|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6076223|NCT00762164|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6076224|NCT00762164|Antimetabolites|antimetabolites|mesh-ancestor
6076225|NCT00762164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076226|NCT00762164|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6207738|NCT02119819|Exenatide|exenatide|mesh-list
6076227|NCT00762164|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6076228|NCT00762164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6076229|NCT00762177|Triclosan|triclosan|mesh-list
6076230|NCT00762177|Fluorides|fluorides|mesh-list
6076231|NCT00762177|Tin Fluorides|tin fluorides|mesh-list
6076232|NCT00762177|Cariostatic Agents|cariostatic agents|mesh-ancestor
6076233|NCT00762177|Protective Agents|protective agents|mesh-ancestor
6076234|NCT00762177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076235|NCT00762177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6076236|NCT00762177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6076237|NCT00762177|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5512098|NCT04387604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512099|NCT04387604|Growth Inhibitors|growth inhibitors|mesh-ancestor
6076238|NCT00762177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6076239|NCT00762177|Antimetabolites|antimetabolites|mesh-ancestor
6076240|NCT00762177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076241|NCT00762177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6076242|NCT00762229|Ezetimibe|ezetimibe|mesh-list
6076243|NCT00762229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6076244|NCT00762229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6076245|NCT00762229|Antimetabolites|antimetabolites|mesh-ancestor
6076246|NCT00762229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076247|NCT00762229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6076248|NCT00762320|Ritonavir|ritonavir|mesh-list
6076249|NCT00762320|Lopinavir|lopinavir|mesh-list
6076250|NCT00762320|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6076251|NCT00762320|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6076252|NCT00762320|Protease Inhibitors|protease inhibitors|mesh-ancestor
6076253|NCT00762320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6076254|NCT00762320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076255|NCT00762320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6076256|NCT00762320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6076257|NCT00762320|Antiviral Agents|antiviral agents|mesh-ancestor
6076258|NCT00762320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6076259|NCT00762320|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6076260|NCT00762320|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6076261|NCT00762359|Lansoprazole|lansoprazole|mesh-list
6076262|NCT00762359|Dexlansoprazole|dexlansoprazole|mesh-list
6076263|NCT00762359|Gefarnate|gefarnate|mesh-list
6076264|NCT00762359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6076265|NCT00762359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6076266|NCT00762359|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6076267|NCT00762359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6076268|NCT00762359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076269|NCT00762372|Nitrous Oxide|nitrous oxide|mesh-list
6076270|NCT00762372|Sevoflurane|sevoflurane|mesh-list
6076271|NCT00762372|Desflurane|desflurane|mesh-list
6076272|NCT00762372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6076273|NCT00762372|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6076274|NCT00762372|Anesthetics, General|anesthetics, general|mesh-ancestor
6076275|NCT00762372|Anesthetics|anesthetics|mesh-ancestor
6076276|NCT00762372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6076277|NCT00762372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076278|NCT00762372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6076279|NCT00762372|Analgesics|analgesics|mesh-ancestor
6076280|NCT00762372|Sensory System Agents|sensory system agents|mesh-ancestor
6076281|NCT00762372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6076282|NCT00762450|Triclosan|triclosan|mesh-list
6076283|NCT00762450|Fluorides|fluorides|mesh-list
6076284|NCT00762450|Cariostatic Agents|cariostatic agents|mesh-ancestor
6076285|NCT00762450|Protective Agents|protective agents|mesh-ancestor
6076286|NCT00762450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076287|NCT00762450|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6076288|NCT00762450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6076289|NCT00762450|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6076290|NCT00762450|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6076291|NCT00762450|Antimetabolites|antimetabolites|mesh-ancestor
6076292|NCT00762450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076293|NCT00762450|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6076294|NCT00762463|Celecoxib|celecoxib|mesh-list
6076295|NCT00762463|Diclofenac|diclofenac|mesh-list
6076296|NCT00762463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6076297|NCT00762463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6076298|NCT00762463|Analgesics|analgesics|mesh-ancestor
6076299|NCT00762463|Sensory System Agents|sensory system agents|mesh-ancestor
6076300|NCT00762463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6076301|NCT00762463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512100|NCT04387604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5512101|NCT04387305|Tranexamic Acid|tranexamic acid|mesh-list
5512102|NCT04387305|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5512103|NCT04387305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5512104|NCT04387305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076302|NCT00762463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6076303|NCT00762463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6076304|NCT00762463|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6076305|NCT00762463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6076306|NCT00762463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6076307|NCT00762463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076308|NCT00762515|Triclosan|triclosan|mesh-list
6076309|NCT00762515|Fluorides|fluorides|mesh-list
6076310|NCT00762515|Cariostatic Agents|cariostatic agents|mesh-ancestor
5512105|NCT04387305|Hemostatics|hemostatics|mesh-ancestor
5512106|NCT04387305|Coagulants|coagulants|mesh-ancestor
6076311|NCT00762515|Protective Agents|protective agents|mesh-ancestor
6076312|NCT00762515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076313|NCT00762515|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5512107|NCT04387539|Sofosbuvir|sofosbuvir|mesh-list
5512108|NCT04387539|Simeprevir|simeprevir|mesh-list
5512109|NCT04387539|Antiviral Agents|antiviral agents|mesh-ancestor
5512110|NCT04387539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5512111|NCT04387539|Protease Inhibitors|protease inhibitors|mesh-ancestor
5512112|NCT04387539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5512113|NCT04387539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512114|NCT04387565|Vanadium|vanadium|mesh-list
5512115|NCT04387565|Trace Elements|trace elements|mesh-ancestor
5512116|NCT04387565|Micronutrients|micronutrients|mesh-ancestor
5512117|NCT04387565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512118|NCT04387526|Sofosbuvir|sofosbuvir|mesh-list
5512119|NCT04387526|Antiviral Agents|antiviral agents|mesh-ancestor
5512120|NCT04387526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6076314|NCT00762515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6076315|NCT00762515|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6076316|NCT00762515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6076317|NCT00762515|Antimetabolites|antimetabolites|mesh-ancestor
6076318|NCT00762515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076319|NCT00762515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6076320|NCT00762528|Triclosan|triclosan|mesh-list
6076321|NCT00762528|Fluorides|fluorides|mesh-list
6076322|NCT00762528|Fluorophosphate|fluorophosphate|mesh-list
6076323|NCT00762528|Cariostatic Agents|cariostatic agents|mesh-ancestor
6076324|NCT00762528|Protective Agents|protective agents|mesh-ancestor
6076325|NCT00762528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076326|NCT00762528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6076327|NCT00762528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6076328|NCT00762528|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5512121|NCT04387500|Axitinib|axitinib|mesh-list
5512122|NCT04387500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5512123|NCT04387500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5512124|NCT04387500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5512125|NCT04387500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512126|NCT04387630|Metformin|metformin|mesh-list
5512127|NCT04387630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5512128|NCT04387630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512129|NCT04387110|Ocrelizumab|ocrelizumab|mesh-list
5512130|NCT04387110|Immunologic Factors|immunologic factors|mesh-ancestor
5512131|NCT04387110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512132|NCT04387240|Artesunate|artesunate|mesh-list
5512133|NCT04387240|Artemisinins|artemisinins|mesh-list
5512134|NCT04387240|Artemisinin|artemisinin|mesh-list
5512135|NCT04387240|Antimalarials|antimalarials|mesh-ancestor
5512136|NCT04387240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5512137|NCT04387240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5512138|NCT04387240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5512139|NCT04387240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5512140|NCT04387240|Antiviral Agents|antiviral agents|mesh-ancestor
5512141|NCT04387240|Schistosomicides|schistosomicides|mesh-ancestor
6076329|NCT00762528|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6076330|NCT00762528|Antimetabolites|antimetabolites|mesh-ancestor
5512142|NCT04387240|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5512143|NCT04387240|Anthelmintics|anthelmintics|mesh-ancestor
5512144|NCT04387227|Carboplatin|carboplatin|mesh-list
5512145|NCT04387227|Pembrolizumab|pembrolizumab|mesh-list
5512146|NCT04387227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5512147|NCT04387227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5512148|NCT04387201|Vitamin B 12|vitamin b 12|mesh-list
5512149|NCT04387201|Hydroxocobalamin|hydroxocobalamin|mesh-list
5512150|NCT04387201|Dulaglutide|dulaglutide|mesh-list
5512151|NCT04387201|Vitamins|vitamins|mesh-ancestor
5512152|NCT04387201|Micronutrients|micronutrients|mesh-ancestor
5512153|NCT04387201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512154|NCT04387201|Vitamin B Complex|vitamin b complex|mesh-ancestor
5512155|NCT04387201|Hematinics|hematinics|mesh-ancestor
5512156|NCT04387201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5512157|NCT04386967|Pembrolizumab|pembrolizumab|mesh-list
5512158|NCT04386967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5512159|NCT04386967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5512160|NCT04387136|Sufentanil|sufentanil|mesh-list
5512161|NCT04387136|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5512162|NCT04387136|Narcotics|narcotics|mesh-ancestor
5512163|NCT04387136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5512164|NCT04387136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512165|NCT04387136|Analgesics|analgesics|mesh-ancestor
5512166|NCT04387136|Sensory System Agents|sensory system agents|mesh-ancestor
5512167|NCT04387136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5512168|NCT04387136|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6076331|NCT00762528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076332|NCT00762528|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6076333|NCT00762619|Triclosan|triclosan|mesh-list
6076334|NCT00762619|Fluorides|fluorides|mesh-list
6076335|NCT00762619|Cariostatic Agents|cariostatic agents|mesh-ancestor
6076336|NCT00762619|Protective Agents|protective agents|mesh-ancestor
6076337|NCT00762619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076338|NCT00762619|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6076339|NCT00762619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6076340|NCT00762619|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6076341|NCT00762619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6076342|NCT00762619|Antimetabolites|antimetabolites|mesh-ancestor
6076343|NCT00762619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076344|NCT00762619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6076345|NCT00762645|Travoprost|travoprost|mesh-list
6076346|NCT00762645|Pilocarpine|pilocarpine|mesh-list
6076347|NCT00762645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6076348|NCT00762645|Miotics|miotics|mesh-ancestor
6076349|NCT00762645|Autonomic Agents|autonomic agents|mesh-ancestor
6076350|NCT00762645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6076351|NCT00762645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076352|NCT00762645|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6076353|NCT00762645|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6076354|NCT00762645|Cholinergic Agents|cholinergic agents|mesh-ancestor
6076355|NCT00762645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6076356|NCT00762645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076357|NCT00762710|Prazosin|prazosin|mesh-list
6076358|NCT00762710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6076359|NCT00762710|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6076360|NCT00762710|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6076361|NCT00762710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6076362|NCT00762710|Adrenergic Agents|adrenergic agents|mesh-ancestor
6076363|NCT00762710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6076364|NCT00762710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076365|NCT00762710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076366|NCT00762762|Triclosan|triclosan|mesh-list
6076367|NCT00762762|Fluorides|fluorides|mesh-list
6076368|NCT00762762|Cariostatic Agents|cariostatic agents|mesh-ancestor
6076369|NCT00762762|Protective Agents|protective agents|mesh-ancestor
6076370|NCT00762762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076371|NCT00762762|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6076372|NCT00762762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6076373|NCT00762762|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6076374|NCT00762762|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6076375|NCT00762762|Antimetabolites|antimetabolites|mesh-ancestor
6076376|NCT00762762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076377|NCT00762762|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5512169|NCT04387136|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5512170|NCT04387136|Anesthetics, General|anesthetics, general|mesh-ancestor
5512171|NCT04387136|Anesthetics|anesthetics|mesh-ancestor
5512172|NCT04386876|Ritonavir|ritonavir|mesh-list
5512173|NCT04386876|Lopinavir|lopinavir|mesh-list
5512174|NCT04386876|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5512175|NCT04386876|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5512176|NCT04386876|Protease Inhibitors|protease inhibitors|mesh-ancestor
5512177|NCT04386876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5512178|NCT04386876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512179|NCT04386876|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5512180|NCT04386876|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5512181|NCT04386876|Antiviral Agents|antiviral agents|mesh-ancestor
6076378|NCT00762853|Triclosan|triclosan|mesh-list
6076379|NCT00762853|Fluorides|fluorides|mesh-list
6076380|NCT00762853|Cariostatic Agents|cariostatic agents|mesh-ancestor
6076381|NCT00762853|Protective Agents|protective agents|mesh-ancestor
6076382|NCT00762853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076383|NCT00762853|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6076384|NCT00762853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6076385|NCT00762853|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6076386|NCT00762853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6076387|NCT00762853|Antimetabolites|antimetabolites|mesh-ancestor
6076388|NCT00762853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076389|NCT00762853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6076390|NCT00762892|Tenofovir|tenofovir|mesh-list
6076391|NCT00762892|Emtricitabine|emtricitabine|mesh-list
6076392|NCT00762892|Raltegravir Potassium|raltegravir potassium|mesh-list
6076393|NCT00762892|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6076394|NCT00762892|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6076395|NCT00762892|Antiviral Agents|antiviral agents|mesh-ancestor
6076396|NCT00762892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6076397|NCT00762892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6076398|NCT00762892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6076399|NCT00762892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6076400|NCT00762892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076401|NCT00762892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6076402|NCT00762892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6076403|NCT00762892|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6076404|NCT00762892|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6076405|NCT00762892|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6076406|NCT00762892|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6076407|NCT00762892|Protease Inhibitors|protease inhibitors|mesh-ancestor
6076408|NCT00763035|Dobutamine|dobutamine|mesh-list
6076409|NCT00763035|Regadenoson|regadenoson|mesh-list
6076410|NCT00763035|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6076411|NCT00763035|Sympathomimetics|sympathomimetics|mesh-ancestor
6076412|NCT00763035|Autonomic Agents|autonomic agents|mesh-ancestor
6076413|NCT00763035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6076414|NCT00763035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076415|NCT00763035|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6076416|NCT00763035|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6076417|NCT00763035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6076418|NCT00763035|Adrenergic Agents|adrenergic agents|mesh-ancestor
6076419|NCT00763035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6076420|NCT00763035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076421|NCT00763035|Protective Agents|protective agents|mesh-ancestor
6076422|NCT00763035|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
6076423|NCT00763035|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5512182|NCT04386876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5512183|NCT04386876|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5512184|NCT04386876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5512185|NCT04387084|Pembrolizumab|pembrolizumab|mesh-list
5512186|NCT04387084|Nivolumab|nivolumab|mesh-list
5512187|NCT04387084|Durvalumab|durvalumab|mesh-list
5512188|NCT04387084|Avelumab|avelumab|mesh-list
5512189|NCT04387084|Cemiplimab|cemiplimab|mesh-list
5512190|NCT04387084|Atezolizumab|atezolizumab|mesh-list
5512191|NCT04387084|Immunoglobulins|immunoglobulins|mesh-list
5512192|NCT04387084|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5512193|NCT04387084|Immunoglobulin G|immunoglobulin g|mesh-list
5512194|NCT04387084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5512195|NCT04387084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5512196|NCT04387084|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5512197|NCT04387084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512198|NCT04387084|Immunologic Factors|immunologic factors|mesh-ancestor
5512199|NCT04387084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512200|NCT04386850|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
5512201|NCT04386850|Calcifediol|calcifediol|mesh-list
5512202|NCT04386850|Vitamins|vitamins|mesh-ancestor
5512203|NCT04386850|Micronutrients|micronutrients|mesh-ancestor
5512204|NCT04386850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512205|NCT04386850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5512206|NCT04386746|Gemcitabine|gemcitabine|mesh-list
5512207|NCT04386746|Docetaxel|docetaxel|mesh-list
5512208|NCT04386746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5512209|NCT04386746|Antimetabolites|antimetabolites|mesh-ancestor
5512210|NCT04386746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512211|NCT04386746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5512212|NCT04386746|Antiviral Agents|antiviral agents|mesh-ancestor
6076424|NCT00763035|Purinergic Agonists|purinergic agonists|mesh-ancestor
6076425|NCT00763035|Purinergic Agents|purinergic agents|mesh-ancestor
6076426|NCT00763048|Triclosan|triclosan|mesh-list
6076427|NCT00763048|Fluorides|fluorides|mesh-list
6076428|NCT00763048|Cariostatic Agents|cariostatic agents|mesh-ancestor
6076429|NCT00763048|Protective Agents|protective agents|mesh-ancestor
6665418|NCT01517009|Antimetabolites|antimetabolites|mesh-ancestor
6665419|NCT01517022|Nicotine|nicotine|mesh-list
6665420|NCT01517022|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6076430|NCT00763048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076431|NCT00763048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6076432|NCT00763048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6076433|NCT00763048|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6076434|NCT00763048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5512213|NCT04386746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5512214|NCT04386746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5512215|NCT04386746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5512216|NCT04386746|Immunologic Factors|immunologic factors|mesh-ancestor
5512217|NCT04386746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512218|NCT04386746|Tubulin Modulators|tubulin modulators|mesh-ancestor
5512219|NCT04386746|Antimitotic Agents|antimitotic agents|mesh-ancestor
5512220|NCT04386746|Mitosis Modulators|mitosis modulators|mesh-ancestor
5512221|NCT04387097|Remifentanil|remifentanil|mesh-list
6076435|NCT00763048|Antimetabolites|antimetabolites|mesh-ancestor
6076436|NCT00763048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076437|NCT00763048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6076438|NCT00763061|Timolol|timolol|mesh-list
6076439|NCT00763061|Travoprost|travoprost|mesh-list
6076440|NCT00763061|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6076441|NCT00763061|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6076442|NCT00763061|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6076443|NCT00763061|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6076444|NCT00763061|Adrenergic Agents|adrenergic agents|mesh-ancestor
6076445|NCT00763061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5512222|NCT04387097|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5512223|NCT04387097|Narcotics|narcotics|mesh-ancestor
5512224|NCT04387097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5512225|NCT04387097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512226|NCT04387097|Analgesics|analgesics|mesh-ancestor
6076446|NCT00763061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076447|NCT00763061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076448|NCT00763061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6076449|NCT00763061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6076450|NCT00763139|Pioglitazone|pioglitazone|mesh-list
6076451|NCT00763139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6076452|NCT00763139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076453|NCT00763256|Triclosan|triclosan|mesh-list
6076454|NCT00763256|Fluorides|fluorides|mesh-list
6076455|NCT00763256|Cariostatic Agents|cariostatic agents|mesh-ancestor
6076456|NCT00763256|Protective Agents|protective agents|mesh-ancestor
6076457|NCT00763256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076458|NCT00763256|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6076459|NCT00763256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6076460|NCT00763256|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6076461|NCT00763256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6076462|NCT00763256|Antimetabolites|antimetabolites|mesh-ancestor
6076463|NCT00763256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512227|NCT04387097|Sensory System Agents|sensory system agents|mesh-ancestor
5512228|NCT04387097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5512229|NCT04386499|Folic Acid|folic acid|mesh-list
6076464|NCT00763256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6076465|NCT00763269|Silicon|silicon|mesh-list
6076466|NCT00763269|Triclosan|triclosan|mesh-list
6076467|NCT00763269|Fluorides|fluorides|mesh-list
6076468|NCT00763269|Cariostatic Agents|cariostatic agents|mesh-ancestor
5512230|NCT04386499|Resveratrol|resveratrol|mesh-list
5512231|NCT04386499|Hematinics|hematinics|mesh-ancestor
6076469|NCT00763269|Protective Agents|protective agents|mesh-ancestor
6665421|NCT01517022|Autonomic Agents|autonomic agents|mesh-ancestor
5512232|NCT04386499|Vitamin B Complex|vitamin b complex|mesh-ancestor
5512233|NCT04386499|Vitamins|vitamins|mesh-ancestor
5512234|NCT04386499|Micronutrients|micronutrients|mesh-ancestor
6076470|NCT00763269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076471|NCT00763269|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6076472|NCT00763269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6076473|NCT00763269|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6076474|NCT00763269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6076475|NCT00763269|Antimetabolites|antimetabolites|mesh-ancestor
6076476|NCT00763269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076477|NCT00763269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6076478|NCT00763269|Trace Elements|trace elements|mesh-ancestor
6076479|NCT00763269|Micronutrients|micronutrients|mesh-ancestor
6076480|NCT00763321|Acetaminophen|acetaminophen|mesh-list
6076481|NCT00763321|Hydrocodone|hydrocodone|mesh-list
6076482|NCT00763321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6076483|NCT00763321|Analgesics|analgesics|mesh-ancestor
6076484|NCT00763321|Sensory System Agents|sensory system agents|mesh-ancestor
6076485|NCT00763321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6076486|NCT00763321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076487|NCT00763321|Antipyretics|antipyretics|mesh-ancestor
6076488|NCT00763321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6076489|NCT00763321|Narcotics|narcotics|mesh-ancestor
6076490|NCT00763321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6076491|NCT00763321|Antitussive Agents|antitussive agents|mesh-ancestor
6076492|NCT00763321|Respiratory System Agents|respiratory system agents|mesh-ancestor
6202800|NCT02046369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6202801|NCT02046369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202802|NCT02046369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6202803|NCT02046369|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6202804|NCT02046369|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6202805|NCT02046369|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6202806|NCT02046369|Adrenergic Agents|adrenergic agents|mesh-ancestor
6202807|NCT02046369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6202808|NCT02046369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202809|NCT02046369|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6202810|NCT02046369|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6202811|NCT02046369|Serotonin Agents|serotonin agents|mesh-ancestor
6202812|NCT02046369|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6202813|NCT02046369|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6202814|NCT02046369|Dopamine Agents|dopamine agents|mesh-ancestor
6202815|NCT02046382|Acetaminophen|acetaminophen|mesh-list
5512235|NCT04386499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512236|NCT04386499|Antioxidants|antioxidants|mesh-ancestor
5512237|NCT04386499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512238|NCT04386499|Protective Agents|protective agents|mesh-ancestor
5512239|NCT04386499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5512240|NCT04386499|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5512241|NCT04386642|Tranexamic Acid|tranexamic acid|mesh-list
5512242|NCT04386642|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5512243|NCT04386642|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5512244|NCT04386642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512245|NCT04386642|Hemostatics|hemostatics|mesh-ancestor
6202816|NCT02046382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6202817|NCT02046382|Analgesics|analgesics|mesh-ancestor
6202818|NCT02046382|Sensory System Agents|sensory system agents|mesh-ancestor
6202819|NCT02046382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6202820|NCT02046382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202821|NCT02046382|Antipyretics|antipyretics|mesh-ancestor
6202822|NCT02046603|Methotrexate|methotrexate|mesh-list
6202823|NCT02046603|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5512246|NCT04386642|Coagulants|coagulants|mesh-ancestor
5512247|NCT04386577|Vitamin D|vitamin d|mesh-list
5512248|NCT04386577|Cholecalciferol|cholecalciferol|mesh-list
5512249|NCT04386577|Vitamins|vitamins|mesh-ancestor
5512250|NCT04386577|Micronutrients|micronutrients|mesh-ancestor
5512251|NCT04386577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512252|NCT04386577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5512253|NCT04386577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5512254|NCT04386122|Loxoprofen|loxoprofen|mesh-list
5512255|NCT04386122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5512256|NCT04386122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5512257|NCT04386122|Analgesics|analgesics|mesh-ancestor
6202824|NCT02046603|Abortifacient Agents|abortifacient agents|mesh-ancestor
6202825|NCT02046603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6207739|NCT02119819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5512258|NCT04386122|Sensory System Agents|sensory system agents|mesh-ancestor
5512259|NCT04386122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5512260|NCT04386122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512261|NCT04386122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5512262|NCT04386122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5512263|NCT04386447|Oxytocin|oxytocin|mesh-list
5512264|NCT04386447|Oxytocics|oxytocics|mesh-ancestor
5512265|NCT04386447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5512266|NCT04386447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512267|NCT04385940|Vitamin D|vitamin d|mesh-list
5512268|NCT04385940|Cholecalciferol|cholecalciferol|mesh-list
5512269|NCT04385940|Vitamins|vitamins|mesh-ancestor
6076493|NCT00763360|Hyaluronic Acid|hyaluronic acid|mesh-list
6076494|NCT00763360|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6076495|NCT00763360|Immunologic Factors|immunologic factors|mesh-ancestor
6076496|NCT00763360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076497|NCT00763360|Viscosupplements|viscosupplements|mesh-ancestor
6076498|NCT00763360|Protective Agents|protective agents|mesh-ancestor
6076499|NCT00763412|Repaglinide|repaglinide|mesh-list
6076500|NCT00763412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6076501|NCT00763412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076502|NCT00763451|Metformin|metformin|mesh-list
6076503|NCT00763451|Lixisenatide|lixisenatide|mesh-list
6076504|NCT00763451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6076505|NCT00763451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076506|NCT00763490|Mycophenolic Acid|mycophenolic acid|mesh-list
6076507|NCT00763490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6076508|NCT00763490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6076509|NCT00763490|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6076510|NCT00763490|Antitubercular Agents|antitubercular agents|mesh-ancestor
6076511|NCT00763490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6076512|NCT00763490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6076513|NCT00763490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6076514|NCT00763490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076515|NCT00763815|Metformin|metformin|mesh-list
6076516|NCT00763815|Pioglitazone|pioglitazone|mesh-list
6076517|NCT00763815|Lixisenatide|lixisenatide|mesh-list
6076518|NCT00763815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6463662|NCT00465543|Protease Inhibitors|protease inhibitors|mesh-ancestor
6463663|NCT00465543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6463664|NCT00465608|Propranolol|propranolol|mesh-list
6463665|NCT00465608|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6463666|NCT00465608|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6463667|NCT00465608|Adrenergic Agents|adrenergic agents|mesh-ancestor
6463668|NCT00465608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6076519|NCT00763815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076520|NCT00763867|Sildenafil Citrate|sildenafil citrate|mesh-list
6076521|NCT00763867|Vasodilator Agents|vasodilator agents|mesh-ancestor
6076522|NCT00763867|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5512270|NCT04385940|Micronutrients|micronutrients|mesh-ancestor
5512271|NCT04385940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076523|NCT00763867|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6076524|NCT00763867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5512272|NCT04385940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6076525|NCT00763867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076526|NCT00763867|Urological Agents|urological agents|mesh-ancestor
6488410|NCT00583986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6076527|NCT00763958|Buprenorphine|buprenorphine|mesh-list
6076528|NCT00763958|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6076529|NCT00763958|Narcotics|narcotics|mesh-ancestor
5512273|NCT04385940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5512274|NCT04385719|Remdesivir|remdesivir|mesh-list
5512275|NCT04385719|Antimetabolites|antimetabolites|mesh-ancestor
5512276|NCT04385719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512277|NCT04385719|Antiviral Agents|antiviral agents|mesh-ancestor
6076530|NCT00763958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6076531|NCT00763958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076532|NCT00763958|Analgesics|analgesics|mesh-ancestor
6076533|NCT00763958|Sensory System Agents|sensory system agents|mesh-ancestor
6076534|NCT00763958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6076535|NCT00763958|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6076536|NCT00763971|Methylphenidate|methylphenidate|mesh-list
6076537|NCT00763971|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6076538|NCT00763971|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6076539|NCT00763971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512278|NCT04385719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5512279|NCT04385992|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
5512280|NCT04385992|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5512281|NCT04385992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512282|NCT04385667|Levonorgestrel|levonorgestrel|mesh-list
5512283|NCT04385667|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5512284|NCT04385667|Contraceptive Agents|contraceptive agents|mesh-ancestor
5512285|NCT04385667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5512286|NCT04385667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512287|NCT04385667|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5512288|NCT04385667|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5512289|NCT04385667|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5512290|NCT04385966|Levobupivacaine|levobupivacaine|mesh-list
5512291|NCT04385966|Anesthetics, Local|anesthetics, local|mesh-ancestor
5512292|NCT04385966|Anesthetics|anesthetics|mesh-ancestor
5512293|NCT04385966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5512294|NCT04385966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512295|NCT04385966|Sensory System Agents|sensory system agents|mesh-ancestor
5512296|NCT04385966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5512297|NCT04385602|Dexmedetomidine|dexmedetomidine|mesh-list
5512298|NCT04385602|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5512299|NCT04385602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5512300|NCT04385602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512301|NCT04385602|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5512302|NCT04385602|Analgesics|analgesics|mesh-ancestor
5512303|NCT04385602|Sensory System Agents|sensory system agents|mesh-ancestor
5512304|NCT04385602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5512305|NCT04385602|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5512306|NCT04385602|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5512307|NCT04385602|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5512308|NCT04385602|Adrenergic Agents|adrenergic agents|mesh-ancestor
5512309|NCT04385602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5512310|NCT04385602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512311|NCT04385680|Chlorhexidine|chlorhexidine|mesh-list
6076540|NCT00763971|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6076541|NCT00763971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6076542|NCT00763971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6076543|NCT00763971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076544|NCT00763971|Dopamine Agents|dopamine agents|mesh-ancestor
6076545|NCT00763971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6076546|NCT00764309|Dasatinib|dasatinib|mesh-list
6076547|NCT00764309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6076548|NCT00764309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6076549|NCT00764309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6076550|NCT00764309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076551|NCT00764322|Tamoxifen|tamoxifen|mesh-list
6076552|NCT00764322|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6076553|NCT00764322|Hormone Antagonists|hormone antagonists|mesh-ancestor
6076554|NCT00764322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6076555|NCT00764322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076556|NCT00764322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6076557|NCT00764322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6076558|NCT00764322|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5512312|NCT04385680|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6076559|NCT00764322|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6076560|NCT00764322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6076561|NCT00764361|Doxycycline|doxycycline|mesh-list
6076562|NCT00764361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6076563|NCT00764361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6076564|NCT00764361|Antimalarials|antimalarials|mesh-ancestor
6076565|NCT00764361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6076566|NCT00764361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6076567|NCT00764465|Ritonavir|ritonavir|mesh-list
6076568|NCT00764465|Fosamprenavir|fosamprenavir|mesh-list
6076569|NCT00764465|Maraviroc|maraviroc|mesh-list
6076570|NCT00764465|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6076571|NCT00764465|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6076572|NCT00764465|Protease Inhibitors|protease inhibitors|mesh-ancestor
6076573|NCT00764465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6076574|NCT00764465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076575|NCT00764465|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6076576|NCT00764465|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6076577|NCT00764465|Antiviral Agents|antiviral agents|mesh-ancestor
6076578|NCT00764465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6076579|NCT00764465|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6076580|NCT00764465|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6076581|NCT00764465|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6076582|NCT00764465|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6076583|NCT00764465|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6076584|NCT00764517|Rituximab|rituximab|mesh-list
6076585|NCT00764517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6076586|NCT00764517|Vorinostat|vorinostat|mesh-list
6076587|NCT00764517|Cladribine|cladribine|mesh-list
5512313|NCT04385680|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5512314|NCT04385680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5512315|NCT04385680|Disinfectants|disinfectants|mesh-ancestor
5512316|NCT04385680|Dermatologic Agents|dermatologic agents|mesh-ancestor
5512317|NCT04385836|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
5512318|NCT04385836|Protein C Inhibitor|protein c inhibitor|mesh-list
6076588|NCT00764517|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
6076589|NCT00764517|Antibodies|antibodies|mesh-list
6076590|NCT00764517|Immunoglobulins|immunoglobulins|mesh-list
6076591|NCT00764517|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6076592|NCT00764517|Immunologic Factors|immunologic factors|mesh-ancestor
6076593|NCT00764517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076594|NCT00764517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6076595|NCT00764517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6076596|NCT00764517|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6076597|NCT00764517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6076598|NCT00764517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076599|NCT00764517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6076600|NCT00764517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6076601|NCT00764517|Antimetabolites|antimetabolites|mesh-ancestor
6076602|NCT00764738|Ranibizumab|ranibizumab|mesh-list
6076603|NCT00764738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6076604|NCT00764738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6076605|NCT00764738|Growth Substances|growth substances|mesh-ancestor
6076606|NCT00764738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076607|NCT00764738|Growth Inhibitors|growth inhibitors|mesh-ancestor
6076608|NCT00764738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6076609|NCT00764751|Calcipotriene|calcipotriene|mesh-list
6076610|NCT00764751|Dermatologic Agents|dermatologic agents|mesh-ancestor
6076611|NCT00764868|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6076612|NCT00764868|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6076613|NCT00764868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076614|NCT00764868|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6076615|NCT00764868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6076616|NCT00764868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6076617|NCT00764868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076618|NCT00764868|Dopamine Agents|dopamine agents|mesh-ancestor
6076619|NCT00764868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6076620|NCT00764881|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
6076621|NCT00764881|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
6076622|NCT00764881|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6076623|NCT00764881|Contraceptive Agents|contraceptive agents|mesh-ancestor
6076624|NCT00764881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6076625|NCT00764881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076626|NCT00764881|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6076627|NCT00764881|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6076628|NCT00764881|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6076629|NCT00764881|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6076630|NCT00764881|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6076631|NCT00764881|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
6076632|NCT00764881|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6076633|NCT00764881|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6076634|NCT00764946|Raltegravir Potassium|raltegravir potassium|mesh-list
6076635|NCT00764946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6076636|NCT00764946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6076637|NCT00764946|Antiviral Agents|antiviral agents|mesh-ancestor
6076638|NCT00764946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6076639|NCT00764946|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6076640|NCT00764946|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6076641|NCT00764946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6076642|NCT00764946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076643|NCT00765063|Dalteparin|dalteparin|mesh-list
6076644|NCT00765063|Anticoagulants|anticoagulants|mesh-ancestor
6076645|NCT00765063|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6076646|NCT00765063|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6076647|NCT00765063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076648|NCT00765102|Bortezomib|bortezomib|mesh-list
6076649|NCT00765102|Romidepsin|romidepsin|mesh-list
6076650|NCT00765102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6076651|NCT00765102|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6076652|NCT00765128|Ketorolac|ketorolac|mesh-list
6076653|NCT00765128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6076654|NCT00765128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6076655|NCT00765128|Analgesics|analgesics|mesh-ancestor
6076656|NCT00765128|Sensory System Agents|sensory system agents|mesh-ancestor
6076657|NCT00765128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6076658|NCT00765128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076659|NCT00765128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6076660|NCT00765128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6076661|NCT00765128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6076662|NCT00765128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6076663|NCT00765128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076664|NCT00765206|Omeprazole|omeprazole|mesh-list
6076665|NCT00765206|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6076666|NCT00765206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6076667|NCT00765206|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6076668|NCT00765206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6076669|NCT00765206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076670|NCT00765232|Ketorolac|ketorolac|mesh-list
6076671|NCT00765232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6076672|NCT00765232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6076673|NCT00765232|Analgesics|analgesics|mesh-ancestor
6076674|NCT00765232|Sensory System Agents|sensory system agents|mesh-ancestor
6076675|NCT00765232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6076676|NCT00765232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076677|NCT00765232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6076678|NCT00765232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5512319|NCT04385836|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5512320|NCT04385836|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5512321|NCT04385836|Protease Inhibitors|protease inhibitors|mesh-ancestor
5512322|NCT04385836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5512323|NCT04385836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512324|NCT04385654|Axitinib|axitinib|mesh-list
5512325|NCT04385654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5512326|NCT04385654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5512327|NCT04385654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5512328|NCT04385654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512329|NCT04385563|Docetaxel|docetaxel|mesh-list
5512330|NCT04385563|Trastuzumab|trastuzumab|mesh-list
5512331|NCT04385563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6076679|NCT00765232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6076680|NCT00765232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6076681|NCT00765232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076682|NCT00765245|Rituximab|rituximab|mesh-list
6076683|NCT00765245|Lenalidomide|lenalidomide|mesh-list
6076684|NCT00765245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6076685|NCT00765245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6076686|NCT00765245|Immunologic Factors|immunologic factors|mesh-ancestor
6076687|NCT00765245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076688|NCT00765245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6076689|NCT00765245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6076690|NCT00765245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6076691|NCT00765245|Growth Substances|growth substances|mesh-ancestor
6076692|NCT00765245|Growth Inhibitors|growth inhibitors|mesh-ancestor
6076693|NCT00765336|Minocycline|minocycline|mesh-list
6076694|NCT00765336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6076695|NCT00765336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6076696|NCT00765375|Botulinum Toxins|botulinum toxins|mesh-list
6076697|NCT00765375|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6076698|NCT00765375|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6076699|NCT00765375|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6076700|NCT00765375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6076701|NCT00765375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076702|NCT00765375|Cholinergic Agents|cholinergic agents|mesh-ancestor
6076703|NCT00765375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6076704|NCT00765375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076705|NCT00765375|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6076706|NCT00765375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6076707|NCT00765648|Labetalol|labetalol|mesh-list
6076708|NCT00765648|Nicardipine|nicardipine|mesh-list
6076709|NCT00765648|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6076710|NCT00765648|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6076711|NCT00765648|Adrenergic Agents|adrenergic agents|mesh-ancestor
6076712|NCT00765648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6076713|NCT00765648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076714|NCT00765648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076715|NCT00765648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6076716|NCT00765648|Sympathomimetics|sympathomimetics|mesh-ancestor
6076717|NCT00765648|Autonomic Agents|autonomic agents|mesh-ancestor
6076718|NCT00765648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6076719|NCT00765648|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6076720|NCT00765648|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6076721|NCT00765648|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5512332|NCT04385563|Tubulin Modulators|tubulin modulators|mesh-ancestor
5512333|NCT04385563|Antimitotic Agents|antimitotic agents|mesh-ancestor
5512334|NCT04385563|Mitosis Modulators|mitosis modulators|mesh-ancestor
5512335|NCT04385563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512336|NCT04385563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5512337|NCT04385550|Paclitaxel|paclitaxel|mesh-list
5512338|NCT04385550|Docetaxel|docetaxel|mesh-list
5512339|NCT04385550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5512340|NCT04385550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6076722|NCT00765648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6076723|NCT00765648|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6076724|NCT00765648|Vasodilator Agents|vasodilator agents|mesh-ancestor
6076725|NCT00765661|Tacrolimus|tacrolimus|mesh-list
6076726|NCT00765661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6076727|NCT00765661|Immunologic Factors|immunologic factors|mesh-ancestor
5512341|NCT04385550|Tubulin Modulators|tubulin modulators|mesh-ancestor
5512342|NCT04385550|Antimitotic Agents|antimitotic agents|mesh-ancestor
5512343|NCT04385550|Mitosis Modulators|mitosis modulators|mesh-ancestor
5512344|NCT04385550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076728|NCT00765661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076729|NCT00765661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6076730|NCT00765661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6076731|NCT00765661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076732|NCT00765674|Amlodipine|amlodipine|mesh-list
6076733|NCT00765674|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6076734|NCT00765674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6076735|NCT00765674|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6076736|NCT00765674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6076737|NCT00765674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076738|NCT00765674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6076739|NCT00765674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076740|NCT00765674|Vasodilator Agents|vasodilator agents|mesh-ancestor
6076741|NCT00765674|Diuretics|diuretics|mesh-ancestor
6076742|NCT00765674|Natriuretic Agents|natriuretic agents|mesh-ancestor
6076743|NCT00765674|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6076744|NCT00765726|Factor VIII|factor viii|mesh-list
6076745|NCT00765726|Coagulants|coagulants|mesh-ancestor
6076746|NCT00765817|Exenatide|exenatide|mesh-list
6076747|NCT00765817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6076748|NCT00765817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512345|NCT04385290|Cytarabine|cytarabine|mesh-list
5512346|NCT04385290|Daunorubicin|daunorubicin|mesh-list
5512347|NCT04385290|Gemtuzumab|gemtuzumab|mesh-list
5512348|NCT04385290|Midostaurin|midostaurin|mesh-list
5512349|NCT04385290|Staurosporine|staurosporine|mesh-list
6076749|NCT00765817|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6076750|NCT00765817|Incretins|incretins|mesh-ancestor
6076751|NCT00765817|Hormones|hormones|mesh-ancestor
6076752|NCT00765817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6076753|NCT00765856|Oxymorphone|oxymorphone|mesh-list
6076754|NCT00765856|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6076755|NCT00765856|Narcotics|narcotics|mesh-ancestor
6076756|NCT00765856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6076757|NCT00765856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076758|NCT00765856|Analgesics|analgesics|mesh-ancestor
6076759|NCT00765856|Sensory System Agents|sensory system agents|mesh-ancestor
6076760|NCT00765856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6076761|NCT00765856|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6076762|NCT00765882|Linaclotide|linaclotide|mesh-list
6076763|NCT00765882|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
6076764|NCT00765882|Enzyme Activators|enzyme activators|mesh-ancestor
6076765|NCT00765882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076766|NCT00765882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6076767|NCT00765895|Nortriptyline|nortriptyline|mesh-list
6076768|NCT00765895|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6076769|NCT00765895|Antidepressive Agents|antidepressive agents|mesh-ancestor
6076770|NCT00765895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6076771|NCT00765895|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6076772|NCT00765895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6076773|NCT00765895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6076774|NCT00765895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076775|NCT00765895|Adrenergic Agents|adrenergic agents|mesh-ancestor
6076776|NCT00765895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6076777|NCT00765895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076778|NCT00765947|Amlodipine|amlodipine|mesh-list
6076779|NCT00765947|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6076780|NCT00765947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6076781|NCT00765947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6076782|NCT00765947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6076783|NCT00765947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076784|NCT00765947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6076785|NCT00765947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076786|NCT00765947|Vasodilator Agents|vasodilator agents|mesh-ancestor
6076787|NCT00765947|Diuretics|diuretics|mesh-ancestor
6076788|NCT00765947|Natriuretic Agents|natriuretic agents|mesh-ancestor
6076789|NCT00765947|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6076790|NCT00765999|Linaclotide|linaclotide|mesh-list
6076791|NCT00765999|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
5512350|NCT04385290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5512351|NCT04385290|Antimetabolites|antimetabolites|mesh-ancestor
5512352|NCT04385290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512353|NCT04385290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5512354|NCT04385290|Antiviral Agents|antiviral agents|mesh-ancestor
5512355|NCT04385290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5512356|NCT04385290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5512357|NCT04385290|Immunologic Factors|immunologic factors|mesh-ancestor
5512358|NCT04385290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512359|NCT04385290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5512360|NCT04385290|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5512361|NCT04385290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6076792|NCT00765999|Enzyme Activators|enzyme activators|mesh-ancestor
6076793|NCT00765999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076794|NCT00765999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6076795|NCT00766038|Hormones|hormones|mesh-list
6076796|NCT00766038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6076797|NCT00766038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076798|NCT00766116|Azacitidine|azacitidine|mesh-list
6076799|NCT00766116|Gemtuzumab|gemtuzumab|mesh-list
6076800|NCT00766116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6076801|NCT00766116|Antimetabolites|antimetabolites|mesh-ancestor
6076802|NCT00766116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076803|NCT00766116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6076804|NCT00766116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6076805|NCT00766116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6076806|NCT00766142|Leucovorin|leucovorin|mesh-list
6076807|NCT00766142|Fluorouracil|fluorouracil|mesh-list
6076808|NCT00766142|Oxaliplatin|oxaliplatin|mesh-list
6076809|NCT00766142|Cetuximab|cetuximab|mesh-list
6076810|NCT00766142|Calcium|calcium|mesh-list
6076811|NCT00766142|Levoleucovorin|levoleucovorin|mesh-list
6076812|NCT00766142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6076813|NCT00766142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076814|NCT00766142|Antimetabolites|antimetabolites|mesh-ancestor
6076815|NCT00766142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076816|NCT00766142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6076817|NCT00766142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6076818|NCT00766142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6076819|NCT00766142|Immunologic Factors|immunologic factors|mesh-ancestor
6076820|NCT00766142|Antidotes|antidotes|mesh-ancestor
6076821|NCT00766142|Protective Agents|protective agents|mesh-ancestor
6076822|NCT00766142|Vitamin B Complex|vitamin b complex|mesh-ancestor
6076823|NCT00766142|Vitamins|vitamins|mesh-ancestor
6076824|NCT00766142|Micronutrients|micronutrients|mesh-ancestor
6076825|NCT00766142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6076826|NCT00766363|Rivastigmine|rivastigmine|mesh-list
6076827|NCT00766363|Donepezil|donepezil|mesh-list
6076828|NCT00766363|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6076829|NCT00766363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6076830|NCT00766363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463669|NCT00465608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463670|NCT00465608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463671|NCT00465608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6463672|NCT00465608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6463673|NCT00465608|Vasodilator Agents|vasodilator agents|mesh-ancestor
6463674|NCT00465621|Latanoprost|latanoprost|mesh-list
6463675|NCT00465621|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6463676|NCT00465621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6488411|NCT00583986|Adrenergic Agents|adrenergic agents|mesh-ancestor
6488412|NCT00583986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6076831|NCT00766363|Cholinergic Agents|cholinergic agents|mesh-ancestor
6076832|NCT00766363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6076833|NCT00766363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076834|NCT00766363|Nootropic Agents|nootropic agents|mesh-ancestor
6076835|NCT00766363|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6076836|NCT00766363|Protective Agents|protective agents|mesh-ancestor
6076837|NCT00766467|Modafinil|modafinil|mesh-list
6076838|NCT00766467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6076839|NCT00766467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076840|NCT00766467|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6076841|NCT00766467|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6076842|NCT00766467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6076843|NCT00766467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076844|NCT00766506|Fentanyl|fentanyl|mesh-list
6076845|NCT00766506|Morphine|morphine|mesh-list
6076846|NCT00766506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6076847|NCT00766506|Narcotics|narcotics|mesh-ancestor
6076848|NCT00766506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6076849|NCT00766506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076850|NCT00766506|Analgesics|analgesics|mesh-ancestor
6076851|NCT00766506|Sensory System Agents|sensory system agents|mesh-ancestor
6076852|NCT00766506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6076853|NCT00766506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6076854|NCT00766506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6076855|NCT00766506|Anesthetics, General|anesthetics, general|mesh-ancestor
6076856|NCT00766506|Anesthetics|anesthetics|mesh-ancestor
6076857|NCT00766532|Aromatase Inhibitors|aromatase inhibitors|mesh-list
6076858|NCT00766532|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6076859|NCT00766532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6076860|NCT00766532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076861|NCT00766532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6076862|NCT00766532|Hormone Antagonists|hormone antagonists|mesh-ancestor
6076863|NCT00766532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6076864|NCT00766532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076865|NCT00766649|Sirolimus|sirolimus|mesh-list
6076866|NCT00766649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6076867|NCT00766649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6076868|NCT00766649|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6076869|NCT00766649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6076870|NCT00766649|Antifungal Agents|antifungal agents|mesh-ancestor
6076871|NCT00766649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6076872|NCT00766649|Immunologic Factors|immunologic factors|mesh-ancestor
6076873|NCT00766649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076874|NCT00766675|Acetaminophen|acetaminophen|mesh-list
6076875|NCT00766675|Tramadol|tramadol|mesh-list
6076876|NCT00766675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6076877|NCT00766675|Analgesics|analgesics|mesh-ancestor
6076878|NCT00766675|Sensory System Agents|sensory system agents|mesh-ancestor
6076879|NCT00766675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6076880|NCT00766675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076881|NCT00766675|Antipyretics|antipyretics|mesh-ancestor
6076882|NCT00766675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6076883|NCT00766675|Narcotics|narcotics|mesh-ancestor
6076884|NCT00766675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6076885|NCT00766753|Vaccines|vaccines|mesh-list
6076886|NCT00766753|Immunologic Factors|immunologic factors|mesh-ancestor
6076887|NCT00766753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076888|NCT00766831|Hydromorphone|hydromorphone|mesh-list
6076889|NCT00766831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6076890|NCT00766831|Narcotics|narcotics|mesh-ancestor
6076891|NCT00766831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6076892|NCT00766831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076893|NCT00766831|Analgesics|analgesics|mesh-ancestor
6076894|NCT00766831|Sensory System Agents|sensory system agents|mesh-ancestor
6076895|NCT00766831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6076896|NCT00767000|Metformin|metformin|mesh-list
6076897|NCT00767000|Insulin Glargine|insulin glargine|mesh-list
6076898|NCT00767000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6076899|NCT00767000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076900|NCT00767039|Poractant alfa|poractant alfa|mesh-list
6076901|NCT00767039|Beractant|beractant|mesh-list
6076902|NCT00767039|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
6076903|NCT00767039|Respiratory System Agents|respiratory system agents|mesh-ancestor
6076904|NCT00767325|Methotrexate|methotrexate|mesh-list
6076905|NCT00767325|Abatacept|abatacept|mesh-list
6076906|NCT00767325|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6076907|NCT00767325|Abortifacient Agents|abortifacient agents|mesh-ancestor
6076908|NCT00767325|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6076909|NCT00767325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076910|NCT00767325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6076911|NCT00767325|Antimetabolites|antimetabolites|mesh-ancestor
6076912|NCT00767325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076913|NCT00767325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6076914|NCT00767325|Dermatologic Agents|dermatologic agents|mesh-ancestor
6076915|NCT00767325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6076916|NCT00767325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6076917|NCT00767325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6076918|NCT00767325|Immunologic Factors|immunologic factors|mesh-ancestor
6076919|NCT00767325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6076920|NCT00767325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6076921|NCT00767325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6076922|NCT00767364|Vaccines|vaccines|mesh-list
6076923|NCT00767364|Immunologic Factors|immunologic factors|mesh-ancestor
6076924|NCT00767364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076925|NCT00767507|Cangrelor|cangrelor|mesh-list
6076926|NCT00767507|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6076927|NCT00767507|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6076928|NCT00767507|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6076929|NCT00767507|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6076930|NCT00767507|Purinergic Agents|purinergic agents|mesh-ancestor
6076931|NCT00767507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6076932|NCT00767507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076933|NCT00767507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076934|NCT00767520|Dasatinib|dasatinib|mesh-list
6076935|NCT00767520|Exemestane|exemestane|mesh-list
6076936|NCT00767520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6076937|NCT00767520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6076938|NCT00767520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5512362|NCT04385290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5512363|NCT04385290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5512364|NCT04385290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5512365|NCT04385173|Temozolomide|temozolomide|mesh-list
5512366|NCT04385173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5512367|NCT04385173|Alkylating Agents|alkylating agents|mesh-ancestor
5512368|NCT04385173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076939|NCT00767520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076940|NCT00767520|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6076941|NCT00767520|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6076942|NCT00767520|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6076943|NCT00767520|Hormone Antagonists|hormone antagonists|mesh-ancestor
6076944|NCT00767520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6076945|NCT00767520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076946|NCT00767572|Atorvastatin|atorvastatin|mesh-list
6076947|NCT00767572|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6076948|NCT00767572|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6076949|NCT00767572|Antimetabolites|antimetabolites|mesh-ancestor
6076950|NCT00767572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512369|NCT04385173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5512370|NCT04385264|Hydroxychloroquine|hydroxychloroquine|mesh-list
5512371|NCT04385264|Mannitol|mannitol|mesh-list
5512372|NCT04385264|Antimalarials|antimalarials|mesh-ancestor
5512373|NCT04385264|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5512374|NCT04385264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5512375|NCT04385264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5512376|NCT04385264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5512377|NCT04385264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512378|NCT04385264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5512379|NCT04385264|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5512380|NCT04385264|Diuretics|diuretics|mesh-ancestor
6076951|NCT00767572|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6076952|NCT00767572|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6076953|NCT00767572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6076954|NCT00767624|Antidepressive Agents|antidepressive agents|mesh-list
6076955|NCT00767624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6076956|NCT00767767|Thiopental|thiopental|mesh-list
6076957|NCT00767767|Propofol|propofol|mesh-list
6076958|NCT00767767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6076959|NCT00767767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6076960|NCT00767767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076961|NCT00767767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6463677|NCT00465673|Doxorubicin|doxorubicin|mesh-list
6463678|NCT00465673|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6463679|NCT00465673|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6463680|NCT00465673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6463681|NCT00465673|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6463682|NCT00465673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6463683|NCT00465673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6463684|NCT00465673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463685|NCT00465751|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
5512381|NCT04385264|Natriuretic Agents|natriuretic agents|mesh-ancestor
5512382|NCT04385264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600442|NCT03711474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5600443|NCT03711474|Antiemetics|antiemetics|mesh-ancestor
5600444|NCT03711474|Autonomic Agents|autonomic agents|mesh-ancestor
6463686|NCT00465751|Cathartics|cathartics|mesh-ancestor
6463687|NCT00465751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6076962|NCT00767767|Anesthetics, General|anesthetics, general|mesh-ancestor
6076963|NCT00767767|Anesthetics|anesthetics|mesh-ancestor
6076964|NCT00767767|Anticonvulsants|anticonvulsants|mesh-ancestor
6076965|NCT00767767|GABA Modulators|gaba modulators|mesh-ancestor
6076966|NCT00767767|GABA Agents|gaba agents|mesh-ancestor
6076967|NCT00767767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6076968|NCT00767767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076969|NCT00767806|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6076970|NCT00767806|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6076971|NCT00767806|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6076972|NCT00767806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6076973|NCT00767806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6076974|NCT00767806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6076975|NCT00767806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076976|NCT00767806|Analgesics|analgesics|mesh-ancestor
6076977|NCT00767806|Sensory System Agents|sensory system agents|mesh-ancestor
6076978|NCT00767806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6076979|NCT00767806|Antidepressive Agents|antidepressive agents|mesh-ancestor
6076980|NCT00767806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6076981|NCT00767806|Dopamine Agents|dopamine agents|mesh-ancestor
6463688|NCT00465907|Paclitaxel|paclitaxel|mesh-list
6463689|NCT00465907|Carboplatin|carboplatin|mesh-list
6463690|NCT00465907|Irinotecan|irinotecan|mesh-list
6463691|NCT00465907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6463692|NCT00465907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6463693|NCT00465907|Tubulin Modulators|tubulin modulators|mesh-ancestor
6463694|NCT00465907|Antimitotic Agents|antimitotic agents|mesh-ancestor
6463695|NCT00465907|Mitosis Modulators|mitosis modulators|mesh-ancestor
6463696|NCT00465907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512383|NCT04385407|Ribavirin|ribavirin|mesh-list
5512384|NCT04385407|Sofosbuvir|sofosbuvir|mesh-list
5512385|NCT04385407|Simeprevir|simeprevir|mesh-list
5512386|NCT04385407|Antimetabolites|antimetabolites|mesh-ancestor
5512387|NCT04385407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512388|NCT04385407|Antiviral Agents|antiviral agents|mesh-ancestor
5512389|NCT04385407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5512390|NCT04385407|Protease Inhibitors|protease inhibitors|mesh-ancestor
5512391|NCT04385407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6463697|NCT00465907|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6463698|NCT00465907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6463699|NCT00465907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6463700|NCT00466063|Deferasirox|deferasirox|mesh-list
6076982|NCT00767819|Everolimus|everolimus|mesh-list
6076983|NCT00767819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6076984|NCT00767819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6076985|NCT00767819|Immunologic Factors|immunologic factors|mesh-ancestor
6076986|NCT00767819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076987|NCT00768053|Etanercept|etanercept|mesh-list
6076988|NCT00768053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6463701|NCT00466063|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6665422|NCT01517022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5512392|NCT04384744|Hormones|hormones|mesh-list
5512393|NCT04384744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5512394|NCT04384744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512395|NCT04384783|Hormones|hormones|mesh-list
5512396|NCT04384783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5512397|NCT04384783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512398|NCT04384991|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5512399|NCT04384991|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5512400|NCT04384666|Rotigotine|rotigotine|mesh-list
5512401|NCT04384666|Dopamine Agonists|dopamine agonists|mesh-ancestor
5512402|NCT04384666|Dopamine Agents|dopamine agents|mesh-ancestor
5512403|NCT04384666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5512404|NCT04384666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512405|NCT04384666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512406|NCT04384562|Methylphenidate|methylphenidate|mesh-list
5512407|NCT04384562|Reboxetine|reboxetine|mesh-list
5512408|NCT04384562|Nicotine|nicotine|mesh-list
5512409|NCT04384562|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5512410|NCT04384562|Autonomic Agents|autonomic agents|mesh-ancestor
5512411|NCT04384562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5512412|NCT04384562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512413|NCT04384562|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5512414|NCT04384562|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5512415|NCT04384562|Cholinergic Agents|cholinergic agents|mesh-ancestor
5512416|NCT04384562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6076989|NCT00768053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6076990|NCT00768053|Analgesics|analgesics|mesh-ancestor
6076991|NCT00768053|Sensory System Agents|sensory system agents|mesh-ancestor
6076992|NCT00768053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6076993|NCT00768053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6076994|NCT00768053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6076995|NCT00768053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6076996|NCT00768053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6076997|NCT00768053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6076998|NCT00768053|Immunologic Factors|immunologic factors|mesh-ancestor
6076999|NCT00768079|Benralizumab|benralizumab|mesh-list
6077000|NCT00768079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6077001|NCT00768079|Respiratory System Agents|respiratory system agents|mesh-ancestor
6077002|NCT00768118|Curcumin|curcumin|mesh-list
6077003|NCT00768118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6077004|NCT00768118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6077005|NCT00768118|Analgesics|analgesics|mesh-ancestor
6077006|NCT00768118|Sensory System Agents|sensory system agents|mesh-ancestor
6077007|NCT00768118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6077008|NCT00768118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077009|NCT00768118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6077010|NCT00768118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6077011|NCT00768118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6077012|NCT00768118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6077013|NCT00768118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077014|NCT00768144|Sunitinib|sunitinib|mesh-list
6077015|NCT00768144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6077016|NCT00768144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6077017|NCT00768144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6077018|NCT00768144|Growth Substances|growth substances|mesh-ancestor
6077019|NCT00768144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512417|NCT04384562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512418|NCT04384562|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5512419|NCT04384562|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5512420|NCT04384562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5512421|NCT04384562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5512422|NCT04384562|Dopamine Agents|dopamine agents|mesh-ancestor
5512423|NCT04384562|Antidepressive Agents|antidepressive agents|mesh-ancestor
6077020|NCT00768144|Growth Inhibitors|growth inhibitors|mesh-ancestor
6077021|NCT00768144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6077022|NCT00768144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6077023|NCT00768144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077024|NCT00768222|Triclosan|triclosan|mesh-list
6077025|NCT00768222|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6077026|NCT00768222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6077027|NCT00768222|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6077028|NCT00768222|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6077029|NCT00768222|Antimetabolites|antimetabolites|mesh-ancestor
6077030|NCT00768222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077031|NCT00768222|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6077032|NCT00768261|Memantine|memantine|mesh-list
6077033|NCT00768261|Donepezil|donepezil|mesh-list
6077034|NCT00768261|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6077035|NCT00768261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6077036|NCT00768261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077037|NCT00768261|Cholinergic Agents|cholinergic agents|mesh-ancestor
6077038|NCT00768261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5512424|NCT04384562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5512425|NCT04384562|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5512426|NCT04384562|Adrenergic Agents|adrenergic agents|mesh-ancestor
5512427|NCT04384380|Hydroxychloroquine|hydroxychloroquine|mesh-list
5512428|NCT04384380|Antimalarials|antimalarials|mesh-ancestor
5512429|NCT04384380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5512430|NCT04384380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5512431|NCT04384380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5512432|NCT04384380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5512433|NCT04384380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512434|NCT04384380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5512435|NCT04384653|Furosemide|furosemide|mesh-list
5512436|NCT04384653|Diuretics|diuretics|mesh-ancestor
5512437|NCT04384653|Natriuretic Agents|natriuretic agents|mesh-ancestor
5512438|NCT04384653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512439|NCT04384653|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5512440|NCT04384653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5512441|NCT04384653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512442|NCT04384367|Naproxen|naproxen|mesh-list
5512443|NCT04384367|Rizatriptan|rizatriptan|mesh-list
5512444|NCT04384367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5512445|NCT04384367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5512446|NCT04384367|Analgesics|analgesics|mesh-ancestor
5512447|NCT04384367|Sensory System Agents|sensory system agents|mesh-ancestor
5512448|NCT04384367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5512449|NCT04384367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512450|NCT04384367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6077039|NCT00768261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077040|NCT00768261|Nootropic Agents|nootropic agents|mesh-ancestor
6077041|NCT00768261|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6077042|NCT00768261|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6077043|NCT00768261|Dopamine Agents|dopamine agents|mesh-ancestor
6077044|NCT00768261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6077045|NCT00768261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6077046|NCT00768300|Ambrisentan|ambrisentan|mesh-list
6077047|NCT00768300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6077048|NCT00768430|Midazolam|midazolam|mesh-list
6077049|NCT00768430|Ketamine|ketamine|mesh-list
6077050|NCT00768430|Analgesics|analgesics|mesh-ancestor
6077051|NCT00768430|Sensory System Agents|sensory system agents|mesh-ancestor
6077052|NCT00768430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6077053|NCT00768430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077054|NCT00768430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6077055|NCT00768430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6077056|NCT00768430|Anesthetics, General|anesthetics, general|mesh-ancestor
6077057|NCT00768430|Anesthetics|anesthetics|mesh-ancestor
6077058|NCT00768430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6077059|NCT00768430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6077060|NCT00768430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6077061|NCT00768430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6077062|NCT00768430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077063|NCT00768430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6077064|NCT00768430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6077065|NCT00768430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6077066|NCT00768430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6077067|NCT00768430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6077068|NCT00768430|GABA Modulators|gaba modulators|mesh-ancestor
6077069|NCT00768430|GABA Agents|gaba agents|mesh-ancestor
6077070|NCT00768469|Paclitaxel|paclitaxel|mesh-list
6077071|NCT00768469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6077072|NCT00768469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6077073|NCT00768469|Tubulin Modulators|tubulin modulators|mesh-ancestor
6077074|NCT00768469|Antimitotic Agents|antimitotic agents|mesh-ancestor
6077075|NCT00768469|Mitosis Modulators|mitosis modulators|mesh-ancestor
6077076|NCT00768469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077077|NCT00768521|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6077078|NCT00768521|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6077079|NCT00768521|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5512451|NCT04384367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5512452|NCT04384367|Gout Suppressants|gout suppressants|mesh-ancestor
5512453|NCT04384367|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5512454|NCT04384367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5512455|NCT04384367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077080|NCT00768521|Cholinergic Agents|cholinergic agents|mesh-ancestor
6077081|NCT00768521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5512456|NCT04384367|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5512457|NCT04384367|Serotonin Agents|serotonin agents|mesh-ancestor
5512458|NCT04384367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5512459|NCT04384731|Poractant alfa|poractant alfa|mesh-list
5512460|NCT04384731|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
5512461|NCT04384731|Respiratory System Agents|respiratory system agents|mesh-ancestor
5512462|NCT04384458|Hydroxychloroquine|hydroxychloroquine|mesh-list
5512463|NCT04384458|Ivermectin|ivermectin|mesh-list
5512464|NCT04384458|Antimalarials|antimalarials|mesh-ancestor
5512465|NCT04384458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5512466|NCT04384458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5512467|NCT04384458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5512468|NCT04384458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6077082|NCT00768521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077083|NCT00768521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077084|NCT00768521|Urological Agents|urological agents|mesh-ancestor
6077085|NCT00768560|Nifedipine|nifedipine|mesh-list
6077086|NCT00768560|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6077087|NCT00768560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6077088|NCT00768560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077089|NCT00768560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6077090|NCT00768560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077091|NCT00768560|Vasodilator Agents|vasodilator agents|mesh-ancestor
6077092|NCT00768560|Tocolytic Agents|tocolytic agents|mesh-ancestor
6077093|NCT00768560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6077094|NCT00768599|Econazole|econazole|mesh-list
6077095|NCT00768599|Antifungal Agents|antifungal agents|mesh-ancestor
6077096|NCT00768599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6077097|NCT00768599|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6077098|NCT00768599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6077099|NCT00768599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6077100|NCT00768599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077101|NCT00768599|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6077102|NCT00768599|Hormone Antagonists|hormone antagonists|mesh-ancestor
6077103|NCT00768599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6077104|NCT00768599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077105|NCT00768651|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6077106|NCT00768651|Pantoprazole|pantoprazole|mesh-list
6077107|NCT00768651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6077108|NCT00768651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077109|NCT00768651|Incretins|incretins|mesh-ancestor
6077110|NCT00768651|Hormones|hormones|mesh-ancestor
6077111|NCT00768651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6077112|NCT00768651|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6077113|NCT00768651|Protease Inhibitors|protease inhibitors|mesh-ancestor
6077114|NCT00768651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6077115|NCT00768651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077116|NCT00768651|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6077117|NCT00768651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6077118|NCT00768651|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6202826|NCT02046603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202827|NCT02046603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6202828|NCT02046603|Antimetabolites|antimetabolites|mesh-ancestor
5512469|NCT04384458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077119|NCT00768716|Acetaminophen|acetaminophen|mesh-list
6077120|NCT00768716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6077121|NCT00768716|Analgesics|analgesics|mesh-ancestor
6077122|NCT00768716|Sensory System Agents|sensory system agents|mesh-ancestor
6077123|NCT00768716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6077124|NCT00768716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077125|NCT00768716|Antipyretics|antipyretics|mesh-ancestor
6077126|NCT00768755|Pemetrexed|pemetrexed|mesh-list
6077127|NCT00768755|Axitinib|axitinib|mesh-list
6077128|NCT00768755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6077129|NCT00768755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5512470|NCT04384458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5512471|NCT04384133|Nitric Oxide|nitric oxide|mesh-list
5512472|NCT04384133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6077130|NCT00768755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077131|NCT00768755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6077132|NCT00768755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6077133|NCT00768755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6077134|NCT00768989|Ritonavir|ritonavir|mesh-list
6077135|NCT00768989|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6077136|NCT00768989|Tenofovir|tenofovir|mesh-list
6077137|NCT00768989|Emtricitabine|emtricitabine|mesh-list
6077138|NCT00768989|Raltegravir Potassium|raltegravir potassium|mesh-list
6077139|NCT00768989|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6077140|NCT00768989|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6077141|NCT00768989|Protease Inhibitors|protease inhibitors|mesh-ancestor
6665423|NCT01517022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665424|NCT01517022|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6665425|NCT01517022|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6665426|NCT01517022|Cholinergic Agents|cholinergic agents|mesh-ancestor
6665427|NCT01517022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5512473|NCT04384133|Autonomic Agents|autonomic agents|mesh-ancestor
6077142|NCT00768989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6077143|NCT00768989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077144|NCT00768989|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6077145|NCT00768989|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6077146|NCT00768989|Antiviral Agents|antiviral agents|mesh-ancestor
6077147|NCT00768989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5512474|NCT04384133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5512475|NCT04384133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512476|NCT04384133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5512477|NCT04384133|Respiratory System Agents|respiratory system agents|mesh-ancestor
5512478|NCT04384133|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5512479|NCT04384133|Antioxidants|antioxidants|mesh-ancestor
5512480|NCT04384133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512481|NCT04384133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5512482|NCT04384133|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5512483|NCT04384133|Vasodilator Agents|vasodilator agents|mesh-ancestor
5512484|NCT04384133|Gasotransmitters|gasotransmitters|mesh-ancestor
6077148|NCT00768989|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6077149|NCT00768989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6077150|NCT00768989|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6077151|NCT00768989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6077152|NCT00768989|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6077153|NCT00768989|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6077154|NCT00769067|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6077155|NCT00769067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6077156|NCT00769067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6077157|NCT00769067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6077158|NCT00769067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077159|NCT00769132|Niacin|niacin|mesh-list
6077160|NCT00769132|Niacinamide|niacinamide|mesh-list
6077161|NCT00769132|Nicotinic Acids|nicotinic acids|mesh-list
6077162|NCT00769132|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6077163|NCT00769132|Antimetabolites|antimetabolites|mesh-ancestor
6077164|NCT00769132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077165|NCT00769132|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6077166|NCT00769132|Vasodilator Agents|vasodilator agents|mesh-ancestor
6077167|NCT00769132|Vitamin B Complex|vitamin b complex|mesh-ancestor
6077168|NCT00769132|Vitamins|vitamins|mesh-ancestor
6077169|NCT00769132|Micronutrients|micronutrients|mesh-ancestor
6077170|NCT00769132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077171|NCT00769184|Clobetasol|clobetasol|mesh-list
6077172|NCT00769184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6077173|NCT00769184|Glucocorticoids|glucocorticoids|mesh-ancestor
6077174|NCT00769184|Hormones|hormones|mesh-ancestor
6077175|NCT00769184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6077176|NCT00769184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077177|NCT00769314|Acyclovir|acyclovir|mesh-list
6077178|NCT00769314|Antiviral Agents|antiviral agents|mesh-ancestor
6077179|NCT00769314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6077180|NCT00769392|Lidocaine|lidocaine|mesh-list
6077181|NCT00769392|Tetracaine|tetracaine|mesh-list
6077182|NCT00769392|Proxymetacaine|proxymetacaine|mesh-list
6077183|NCT00769392|Anesthetics, Local|anesthetics, local|mesh-ancestor
6077184|NCT00769392|Anesthetics|anesthetics|mesh-ancestor
6077185|NCT00769392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6077186|NCT00769392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077187|NCT00769392|Sensory System Agents|sensory system agents|mesh-ancestor
6077188|NCT00769392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6077189|NCT00769392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6077190|NCT00769392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6077191|NCT00769392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6077192|NCT00769392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6077193|NCT00769392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077194|NCT00769483|Gemcitabine|gemcitabine|mesh-list
6077195|NCT00769483|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6077196|NCT00769483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6077197|NCT00769483|Antimetabolites|antimetabolites|mesh-ancestor
6077198|NCT00769483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077199|NCT00769483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6077200|NCT00769483|Antiviral Agents|antiviral agents|mesh-ancestor
6077201|NCT00769483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6077202|NCT00769483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6077203|NCT00769483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6077204|NCT00769483|Immunologic Factors|immunologic factors|mesh-ancestor
6077205|NCT00769483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077206|NCT00769483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6077207|NCT00769561|Salicylic Acid|salicylic acid|mesh-list
6077208|NCT00769561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6077209|NCT00769561|Antifungal Agents|antifungal agents|mesh-ancestor
6077210|NCT00769561|Keratolytic Agents|keratolytic agents|mesh-ancestor
6077211|NCT00769561|Dermatologic Agents|dermatologic agents|mesh-ancestor
6077212|NCT00769600|Itraconazole|itraconazole|mesh-list
5512485|NCT04384133|Protective Agents|protective agents|mesh-ancestor
5512486|NCT04383990|Insulin|insulin|mesh-list
5512487|NCT04383990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5512488|NCT04383990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512489|NCT04383977|Etoposide|etoposide|mesh-list
5512490|NCT04383977|Apatinib|apatinib|mesh-list
5512491|NCT04383977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5512492|NCT04383977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5512493|NCT04383977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5512494|NCT04383977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5512495|NCT04383977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5512496|NCT04383977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512497|NCT04383977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6077213|NCT00769600|Pemetrexed|pemetrexed|mesh-list
5512498|NCT04383795|Antithyroid Agents|antithyroid agents|mesh-list
5512499|NCT04383795|Hormone Antagonists|hormone antagonists|mesh-ancestor
5512500|NCT04383795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5512501|NCT04383795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512502|NCT04383691|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
5512503|NCT04383691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5512504|NCT04383691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5512505|NCT04383691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5512506|NCT04383691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512507|NCT04383691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5512508|NCT04383691|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5512509|NCT04383691|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5512510|NCT04383691|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5512511|NCT04383691|Adrenergic Agents|adrenergic agents|mesh-ancestor
6077214|NCT00769600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6077215|NCT00769600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6077216|NCT00769600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077217|NCT00769600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6077218|NCT00769600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5512512|NCT04383691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5512513|NCT04383691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077219|NCT00769600|Antifungal Agents|antifungal agents|mesh-ancestor
5512514|NCT04383691|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5512515|NCT04383691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5512516|NCT04383691|Serotonin Agents|serotonin agents|mesh-ancestor
5512517|NCT04383691|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5512518|NCT04383691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5512519|NCT04383691|Dopamine Agents|dopamine agents|mesh-ancestor
5512520|NCT04383639|Locust bean gum|locust bean gum|mesh-list
5512521|NCT04383639|Antidiarrheals|antidiarrheals|mesh-ancestor
5512522|NCT04383639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5512523|NCT04383717|Azithromycin|azithromycin|mesh-list
5512524|NCT04383717|Hydroxychloroquine|hydroxychloroquine|mesh-list
5512525|NCT04383717|Levamisole|levamisole|mesh-list
5512526|NCT04383717|Inosine Pranobex|inosine pranobex|mesh-list
6077220|NCT00769600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6077221|NCT00769600|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6077222|NCT00769600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6077223|NCT00769600|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6077224|NCT00769600|Hormone Antagonists|hormone antagonists|mesh-ancestor
6077225|NCT00769600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6077226|NCT00769600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077227|NCT00769600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6077228|NCT00769704|Molgramostim|molgramostim|mesh-list
6077229|NCT00769704|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
6077230|NCT00769704|Sargramostim|sargramostim|mesh-list
6077231|NCT00769704|Immunologic Factors|immunologic factors|mesh-ancestor
6077232|NCT00769704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077233|NCT00769704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6077234|NCT00769704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6077235|NCT00769886|Ketotifen|ketotifen|mesh-list
6077236|NCT00769886|Naphazoline|naphazoline|mesh-list
6077237|NCT00769886|Antipruritics|antipruritics|mesh-ancestor
6077238|NCT00769886|Dermatologic Agents|dermatologic agents|mesh-ancestor
6077239|NCT00769886|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6077240|NCT00769886|Histamine Antagonists|histamine antagonists|mesh-ancestor
6077241|NCT00769886|Histamine Agents|histamine agents|mesh-ancestor
6077242|NCT00769886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6077243|NCT00769886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077244|NCT00769886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512527|NCT04383717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5512528|NCT04383717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5512529|NCT04383717|Antimalarials|antimalarials|mesh-ancestor
5512530|NCT04383717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5512531|NCT04383717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5512532|NCT04383717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5512533|NCT04383717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512534|NCT04383717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6077245|NCT00769886|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6077246|NCT00769886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6077247|NCT00769886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6077248|NCT00769886|Adrenergic Agents|adrenergic agents|mesh-ancestor
6077249|NCT00769886|Nasal Decongestants|nasal decongestants|mesh-ancestor
6077250|NCT00769886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6077251|NCT00769886|Respiratory System Agents|respiratory system agents|mesh-ancestor
6077252|NCT00770029|Botulinum Toxins|botulinum toxins|mesh-list
6077253|NCT00770029|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6077254|NCT00770029|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6077255|NCT00770029|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
6077256|NCT00770029|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6077257|NCT00770029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6077258|NCT00770029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077259|NCT00770029|Cholinergic Agents|cholinergic agents|mesh-ancestor
6077260|NCT00770029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6077261|NCT00770029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077262|NCT00770029|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6077263|NCT00770029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6077264|NCT00770120|Everolimus|everolimus|mesh-list
6077265|NCT00770120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6077266|NCT00770120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6077267|NCT00770120|Immunologic Factors|immunologic factors|mesh-ancestor
6077268|NCT00770120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077269|NCT00770133|Ketotifen|ketotifen|mesh-list
6077270|NCT00770133|Naphazoline|naphazoline|mesh-list
5512535|NCT04383717|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5512536|NCT04383717|Immunologic Factors|immunologic factors|mesh-ancestor
6077271|NCT00770133|Antipruritics|antipruritics|mesh-ancestor
6077272|NCT00770133|Dermatologic Agents|dermatologic agents|mesh-ancestor
6077273|NCT00770133|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6077274|NCT00770133|Histamine Antagonists|histamine antagonists|mesh-ancestor
6077275|NCT00770133|Histamine Agents|histamine agents|mesh-ancestor
6077276|NCT00770133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6077277|NCT00770133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077278|NCT00770133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077279|NCT00770133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6077280|NCT00770133|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6077281|NCT00770133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6077282|NCT00770133|Adrenergic Agents|adrenergic agents|mesh-ancestor
6077283|NCT00770133|Nasal Decongestants|nasal decongestants|mesh-ancestor
6077284|NCT00770133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6077285|NCT00770133|Respiratory System Agents|respiratory system agents|mesh-ancestor
6077286|NCT00770146|Mipomersen|mipomersen|mesh-list
6077287|NCT00770146|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6077288|NCT00770146|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6077289|NCT00770146|Antimetabolites|antimetabolites|mesh-ancestor
6077290|NCT00770146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077291|NCT00770146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6077292|NCT00770211|Botulinum Toxins|botulinum toxins|mesh-list
6077293|NCT00770211|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6077294|NCT00770211|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6077295|NCT00770211|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
6077296|NCT00770211|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6077297|NCT00770211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5512537|NCT04383717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512538|NCT04383717|Antinematodal Agents|antinematodal agents|mesh-ancestor
5512539|NCT04383717|Anthelmintics|anthelmintics|mesh-ancestor
5512540|NCT04383717|Antiviral Agents|antiviral agents|mesh-ancestor
5512541|NCT04383574|Vaccines|vaccines|mesh-list
6077298|NCT00770211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077299|NCT00770211|Cholinergic Agents|cholinergic agents|mesh-ancestor
6077300|NCT00770211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6077301|NCT00770211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077302|NCT00770211|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6077303|NCT00770211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6077304|NCT00770224|Prednisone|prednisone|mesh-list
6077305|NCT00770224|Cyclophosphamide|cyclophosphamide|mesh-list
6077306|NCT00770224|Rituximab|rituximab|mesh-list
6077307|NCT00770224|Doxorubicin|doxorubicin|mesh-list
6077308|NCT00770224|Vincristine|vincristine|mesh-list
6077309|NCT00770224|Tositumomab I-131|tositumomab i-131|mesh-list
6077310|NCT00770224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6077311|NCT00770224|Immunologic Factors|immunologic factors|mesh-ancestor
5512542|NCT04383574|Immunologic Factors|immunologic factors|mesh-ancestor
5512543|NCT04383574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600445|NCT03711474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5600446|NCT03711474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600447|NCT03711474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5600448|NCT03711474|Glucocorticoids|glucocorticoids|mesh-ancestor
5600449|NCT03711474|Hormones|hormones|mesh-ancestor
5600450|NCT03711474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6077312|NCT00770224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077313|NCT00770224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5600451|NCT03711474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6077314|NCT00770224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5512544|NCT04383418|Dexmedetomidine|dexmedetomidine|mesh-list
5512545|NCT04383418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5512546|NCT04383418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5512547|NCT04383418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512548|NCT04383418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5512549|NCT04383418|Analgesics|analgesics|mesh-ancestor
5512550|NCT04383418|Sensory System Agents|sensory system agents|mesh-ancestor
5512551|NCT04383418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5512552|NCT04383418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5512553|NCT04383418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5512554|NCT04383418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6077315|NCT00770224|Alkylating Agents|alkylating agents|mesh-ancestor
6077316|NCT00770224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077317|NCT00770224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6077318|NCT00770224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6077319|NCT00770224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6077320|NCT00770224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6077321|NCT00770224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6077322|NCT00770224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6077323|NCT00770224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6077324|NCT00770224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6077325|NCT00770224|Glucocorticoids|glucocorticoids|mesh-ancestor
6077326|NCT00770224|Hormones|hormones|mesh-ancestor
6077327|NCT00770224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6077328|NCT00770224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6077329|NCT00770224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6077330|NCT00770224|Tubulin Modulators|tubulin modulators|mesh-ancestor
6077331|NCT00770224|Antimitotic Agents|antimitotic agents|mesh-ancestor
6077332|NCT00770224|Mitosis Modulators|mitosis modulators|mesh-ancestor
6077333|NCT00770328|Pentoxifylline|pentoxifylline|mesh-list
6077334|NCT00770328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6077335|NCT00770328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6077336|NCT00770328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077337|NCT00770328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6077338|NCT00770328|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6077339|NCT00770328|Protective Agents|protective agents|mesh-ancestor
6077340|NCT00770328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077341|NCT00770328|Vasodilator Agents|vasodilator agents|mesh-ancestor
6077342|NCT00770328|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6077343|NCT00770328|Antioxidants|antioxidants|mesh-ancestor
6077344|NCT00770341|Vancomycin|vancomycin|mesh-list
6077345|NCT00770341|Daptomycin|daptomycin|mesh-list
6077346|NCT00770341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6077347|NCT00770341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6077348|NCT00770367|Pioglitazone|pioglitazone|mesh-list
6077349|NCT00770367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6077350|NCT00770367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077351|NCT00770432|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
6077352|NCT00770432|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6077353|NCT00770432|Laxatives|laxatives|mesh-ancestor
6077354|NCT00770432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6077355|NCT00770484|Propranolol|propranolol|mesh-list
6077356|NCT00770484|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6077357|NCT00770484|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6077358|NCT00770484|Adrenergic Agents|adrenergic agents|mesh-ancestor
6077359|NCT00770484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6077360|NCT00770484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077361|NCT00770484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077362|NCT00770484|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6077363|NCT00770484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6077364|NCT00770484|Vasodilator Agents|vasodilator agents|mesh-ancestor
6077365|NCT00770510|Zolpidem|zolpidem|mesh-list
6077366|NCT00770510|Eszopiclone|eszopiclone|mesh-list
5512555|NCT04383418|Adrenergic Agents|adrenergic agents|mesh-ancestor
5512556|NCT04383418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5512557|NCT04383418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512558|NCT04383548|Immunoglobulins|immunoglobulins|mesh-list
5512559|NCT04383548|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5512560|NCT04383548|Antibodies|antibodies|mesh-list
5512561|NCT04383548|Immunologic Factors|immunologic factors|mesh-ancestor
5512562|NCT04383548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512563|NCT04383093|Tadalafil|tadalafil|mesh-list
5512564|NCT04383093|Tamsulosin|tamsulosin|mesh-list
5512565|NCT04383093|Vasodilator Agents|vasodilator agents|mesh-ancestor
5512566|NCT04383093|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5512567|NCT04383093|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5512568|NCT04383093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5512569|NCT04383093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512570|NCT04383093|Urological Agents|urological agents|mesh-ancestor
5512571|NCT04383093|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5512572|NCT04383093|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5512573|NCT04383093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5512574|NCT04383093|Adrenergic Agents|adrenergic agents|mesh-ancestor
5512575|NCT04383093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5512576|NCT04383093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512577|NCT04382781|Immunosuppressive Agents|immunosuppressive agents|mesh-list
5512578|NCT04382781|Immunologic Factors|immunologic factors|mesh-ancestor
5512579|NCT04382781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512580|NCT04382768|Ibuprofen|ibuprofen|mesh-list
5512581|NCT04382768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5512582|NCT04382768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5512583|NCT04382768|Analgesics|analgesics|mesh-ancestor
5512584|NCT04382768|Sensory System Agents|sensory system agents|mesh-ancestor
5512585|NCT04382768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5512586|NCT04382768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512587|NCT04382768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5512588|NCT04382768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5512589|NCT04382768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5512590|NCT04382768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5512591|NCT04382768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512592|NCT04383002|Nitric Oxide|nitric oxide|mesh-list
5512593|NCT04383002|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5512594|NCT04383002|Autonomic Agents|autonomic agents|mesh-ancestor
6077367|NCT00770510|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6077368|NCT00770510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6077369|NCT00770510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6077370|NCT00770510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077371|NCT00770510|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6077372|NCT00770510|GABA Agonists|gaba agonists|mesh-ancestor
6077373|NCT00770510|GABA Agents|gaba agents|mesh-ancestor
6077374|NCT00770510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6077375|NCT00770510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077376|NCT00770562|Dexamethasone|dexamethasone|mesh-list
6077377|NCT00770562|Rituximab|rituximab|mesh-list
6077378|NCT00770562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5512595|NCT04383002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5512596|NCT04383002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512597|NCT04383002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5512598|NCT04383002|Respiratory System Agents|respiratory system agents|mesh-ancestor
5512599|NCT04383002|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5512600|NCT04383002|Antioxidants|antioxidants|mesh-ancestor
5512601|NCT04383002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512602|NCT04383002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5512603|NCT04383002|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5512604|NCT04383002|Vasodilator Agents|vasodilator agents|mesh-ancestor
5512605|NCT04383002|Gasotransmitters|gasotransmitters|mesh-ancestor
5512606|NCT04383002|Protective Agents|protective agents|mesh-ancestor
5512607|NCT04383275|Capecitabine|capecitabine|mesh-list
5512608|NCT04383275|Trastuzumab|trastuzumab|mesh-list
5512609|NCT04383275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5512610|NCT04383275|Antimetabolites|antimetabolites|mesh-ancestor
5512611|NCT04383275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512612|NCT04383275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5512613|NCT04383275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5512614|NCT04382846|Nitazoxanide|nitazoxanide|mesh-list
5512615|NCT04382846|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6077379|NCT00770562|Antiemetics|antiemetics|mesh-ancestor
6077380|NCT00770562|Autonomic Agents|autonomic agents|mesh-ancestor
6077381|NCT00770562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6077382|NCT00770562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077383|NCT00770562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6077384|NCT00770562|Glucocorticoids|glucocorticoids|mesh-ancestor
6077385|NCT00770562|Hormones|hormones|mesh-ancestor
5512616|NCT04382846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5512617|NCT04383067|Aldesleukin|aldesleukin|mesh-list
5512618|NCT04383067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5512619|NCT04383067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5512620|NCT04383067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5512621|NCT04383067|Antiviral Agents|antiviral agents|mesh-ancestor
5512622|NCT04383067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5512623|NCT04382950|Tretinoin|tretinoin|mesh-list
5512624|NCT04382950|Isotretinoin|isotretinoin|mesh-list
5512625|NCT04382950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5512626|NCT04382950|Keratolytic Agents|keratolytic agents|mesh-ancestor
5512627|NCT04382950|Dermatologic Agents|dermatologic agents|mesh-ancestor
6077386|NCT00770562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6077387|NCT00770562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6077388|NCT00770562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5512628|NCT04382859|Bupivacaine|bupivacaine|mesh-list
5512629|NCT04382859|Anesthetics, Local|anesthetics, local|mesh-ancestor
5512630|NCT04382859|Anesthetics|anesthetics|mesh-ancestor
6077389|NCT00770562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6077390|NCT00770562|Immunologic Factors|immunologic factors|mesh-ancestor
6077391|NCT00770562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6077392|NCT00770588|Gefitinib|gefitinib|mesh-list
6077393|NCT00770588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6077394|NCT00770588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6077395|NCT00770588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6077396|NCT00770588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077397|NCT00770653|Metformin|metformin|mesh-list
6077398|NCT00770653|Pioglitazone|pioglitazone|mesh-list
5512631|NCT04382859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5512632|NCT04382859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512633|NCT04382859|Sensory System Agents|sensory system agents|mesh-ancestor
5512634|NCT04382859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5512635|NCT04382404|Sofosbuvir|sofosbuvir|mesh-list
5512636|NCT04382404|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
5512637|NCT04382404|Velpatasvir|velpatasvir|mesh-list
5512638|NCT04382404|Antiviral Agents|antiviral agents|mesh-ancestor
5512639|NCT04382404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5512640|NCT04382625|Hydroxychloroquine|hydroxychloroquine|mesh-list
5512641|NCT04382625|Antimalarials|antimalarials|mesh-ancestor
5512642|NCT04382625|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5512643|NCT04382625|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5512644|NCT04382625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5512645|NCT04382625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5512646|NCT04382625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512647|NCT04382625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5512648|NCT04382443|Colchicine|colchicine|mesh-list
5512649|NCT04382443|Gout Suppressants|gout suppressants|mesh-ancestor
5512650|NCT04382443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5512651|NCT04382443|Tubulin Modulators|tubulin modulators|mesh-ancestor
5512652|NCT04382443|Antimitotic Agents|antimitotic agents|mesh-ancestor
5512653|NCT04382443|Mitosis Modulators|mitosis modulators|mesh-ancestor
5512654|NCT04382443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512655|NCT04382443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5512656|NCT04382170|Dexmedetomidine|dexmedetomidine|mesh-list
5512657|NCT04382170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5512658|NCT04382170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6077399|NCT00770653|Glimepiride|glimepiride|mesh-list
6077400|NCT00770653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6077401|NCT00770653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077402|NCT00770653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6077403|NCT00770653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6077404|NCT00770653|Immunologic Factors|immunologic factors|mesh-ancestor
6077405|NCT00770679|Atorvastatin|atorvastatin|mesh-list
6077406|NCT00770679|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6077407|NCT00770679|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6077408|NCT00770679|Antimetabolites|antimetabolites|mesh-ancestor
6077409|NCT00770679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077410|NCT00770679|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5512659|NCT04382170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512660|NCT04382170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6207740|NCT02119819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463702|NCT00466063|Chelating Agents|chelating agents|mesh-ancestor
6463703|NCT00466063|Sequestering Agents|sequestering agents|mesh-ancestor
5512661|NCT04382170|Analgesics|analgesics|mesh-ancestor
6077411|NCT00770679|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5512662|NCT04382170|Sensory System Agents|sensory system agents|mesh-ancestor
5512663|NCT04382170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5512664|NCT04382170|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5512665|NCT04382170|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5512666|NCT04382170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5512667|NCT04382170|Adrenergic Agents|adrenergic agents|mesh-ancestor
5512668|NCT04382170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5512669|NCT04382170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512670|NCT04382586|Zanubrutinib|zanubrutinib|mesh-list
5512671|NCT04382586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5512672|NCT04382586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5512673|NCT04382586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6077412|NCT00770679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6077413|NCT00770692|Eszopiclone|eszopiclone|mesh-list
6077414|NCT00770692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6077415|NCT00770692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6077416|NCT00770692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077417|NCT00770757|Pomalidomide|pomalidomide|mesh-list
6077418|NCT00770757|Immunologic Factors|immunologic factors|mesh-ancestor
6077419|NCT00770757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077420|NCT00770757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6077421|NCT00770757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6077422|NCT00770757|Growth Substances|growth substances|mesh-ancestor
6077423|NCT00770757|Growth Inhibitors|growth inhibitors|mesh-ancestor
6077424|NCT00770757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6077425|NCT00770770|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
6077426|NCT00770770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6077427|NCT00770770|Glucocorticoids|glucocorticoids|mesh-ancestor
6077428|NCT00770770|Hormones|hormones|mesh-ancestor
6077429|NCT00770770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6077430|NCT00770770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077431|NCT00770809|Paclitaxel|paclitaxel|mesh-list
6077432|NCT00770809|Trastuzumab|trastuzumab|mesh-list
6077433|NCT00770809|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6077434|NCT00770809|Lapatinib|lapatinib|mesh-list
6077435|NCT00770809|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
6077436|NCT00770809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6077437|NCT00770809|Antibodies|antibodies|mesh-list
6077438|NCT00770809|Immunoglobulins|immunoglobulins|mesh-list
6077439|NCT00770809|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6077440|NCT00770809|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6077441|NCT00770809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6077442|NCT00770809|Tubulin Modulators|tubulin modulators|mesh-ancestor
6077443|NCT00770809|Antimitotic Agents|antimitotic agents|mesh-ancestor
6077444|NCT00770809|Mitosis Modulators|mitosis modulators|mesh-ancestor
6077445|NCT00770809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077446|NCT00770809|Immunologic Factors|immunologic factors|mesh-ancestor
6077447|NCT00770809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077448|NCT00770809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6077449|NCT00770809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6077450|NCT00770861|Nebivolol|nebivolol|mesh-list
6077451|NCT00770861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6077452|NCT00770861|Vasodilator Agents|vasodilator agents|mesh-ancestor
6077453|NCT00770861|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6077454|NCT00770861|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6077455|NCT00770861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6077456|NCT00770861|Adrenergic Agents|adrenergic agents|mesh-ancestor
5512674|NCT04382586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512675|NCT04382079|Propolis|propolis|mesh-list
5512676|NCT04382079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5512677|NCT04382352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5512678|NCT04382352|Trastuzumab|trastuzumab|mesh-list
5512679|NCT04382352|Antibodies|antibodies|mesh-list
5512680|NCT04382352|Immunoglobulins|immunoglobulins|mesh-list
5512681|NCT04382352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5512682|NCT04382352|Immunologic Factors|immunologic factors|mesh-ancestor
5512683|NCT04382352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512684|NCT04382352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5512685|NCT04382209|Meperidine|meperidine|mesh-list
5512686|NCT04382209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6077457|NCT00770861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6207741|NCT02119819|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5512687|NCT04382209|Narcotics|narcotics|mesh-ancestor
5512688|NCT04382209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5512689|NCT04382209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512690|NCT04382209|Analgesics|analgesics|mesh-ancestor
5512691|NCT04382209|Sensory System Agents|sensory system agents|mesh-ancestor
5512692|NCT04382209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5512693|NCT04382209|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5512694|NCT04382300|Thalidomide|thalidomide|mesh-list
5512695|NCT04382300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5512696|NCT04382300|Immunologic Factors|immunologic factors|mesh-ancestor
5512697|NCT04382300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512698|NCT04382300|Leprostatic Agents|leprostatic agents|mesh-ancestor
5512699|NCT04382300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6077458|NCT00770861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077459|NCT00770861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077460|NCT00770874|Cisplatin|cisplatin|mesh-list
5512700|NCT04382300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5512701|NCT04382300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5512702|NCT04382300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5512703|NCT04382300|Growth Substances|growth substances|mesh-ancestor
5512704|NCT04382300|Growth Inhibitors|growth inhibitors|mesh-ancestor
5512705|NCT04382300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5512706|NCT04382027|Vitamins|vitamins|mesh-list
5512707|NCT04382027|Vitamin K|vitamin k|mesh-list
5512708|NCT04382027|Vitamin K 2|vitamin k 2|mesh-list
5512709|NCT04382027|Micronutrients|micronutrients|mesh-ancestor
5512710|NCT04382027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512711|NCT04382027|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5512712|NCT04382027|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6077461|NCT00770874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6077462|NCT00770913|Rabeprazole|rabeprazole|mesh-list
6077463|NCT00770913|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6077464|NCT00770913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6077465|NCT00770913|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6077466|NCT00770913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6077467|NCT00770913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077468|NCT00771030|Brodalumab|brodalumab|mesh-list
6077469|NCT00771030|Dermatologic Agents|dermatologic agents|mesh-ancestor
5512713|NCT04382027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512714|NCT04382027|Hemostatics|hemostatics|mesh-ancestor
5512715|NCT04382027|Coagulants|coagulants|mesh-ancestor
5512716|NCT04381884|Ivermectin|ivermectin|mesh-list
5512717|NCT04381884|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5512718|NCT04381884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5512719|NCT04381962|Azithromycin|azithromycin|mesh-list
5512720|NCT04381962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5512721|NCT04381962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5512722|NCT04381910|Irinotecan|irinotecan|mesh-list
5512723|NCT04381910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5512724|NCT04381910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6077470|NCT00771056|Hydroxychloroquine|hydroxychloroquine|mesh-list
6077471|NCT00771056|Antimalarials|antimalarials|mesh-ancestor
6077472|NCT00771056|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6077473|NCT00771056|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6077474|NCT00771056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6077475|NCT00771056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6077476|NCT00771056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077477|NCT00771056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6077478|NCT00771472|Vorinostat|vorinostat|mesh-list
6077479|NCT00771472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6077480|NCT00771472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6077481|NCT00771472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6077482|NCT00771472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077483|NCT00771667|Ustekinumab|ustekinumab|mesh-list
6077484|NCT00771667|Dermatologic Agents|dermatologic agents|mesh-ancestor
6077485|NCT00771745|Thymoglobulin|thymoglobulin|mesh-list
6077486|NCT00771745|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6077487|NCT00771745|Immunologic Factors|immunologic factors|mesh-ancestor
6077488|NCT00771745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077489|NCT00771745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6077490|NCT00771758|Oxycodone|oxycodone|mesh-list
6077491|NCT00771758|Tapentadol|tapentadol|mesh-list
6077492|NCT00771758|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6077493|NCT00771758|Narcotics|narcotics|mesh-ancestor
5512725|NCT04381910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5512726|NCT04381910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077494|NCT00771758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6077495|NCT00771758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077496|NCT00771758|Analgesics|analgesics|mesh-ancestor
6077497|NCT00771758|Sensory System Agents|sensory system agents|mesh-ancestor
6077498|NCT00771758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6077499|NCT00771758|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6077500|NCT00771758|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6077501|NCT00771758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6077502|NCT00771758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077503|NCT00771758|Adrenergic Agents|adrenergic agents|mesh-ancestor
6077504|NCT00771758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6077505|NCT00771810|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
6077506|NCT00771810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6077507|NCT00771810|Vasodilator Agents|vasodilator agents|mesh-ancestor
6077508|NCT00771875|Acetaminophen|acetaminophen|mesh-list
6077509|NCT00771875|Diphenhydramine|diphenhydramine|mesh-list
6077510|NCT00771875|Methylprednisolone|methylprednisolone|mesh-list
6077511|NCT00771875|Rituximab|rituximab|mesh-list
6077512|NCT00771875|Bortezomib|bortezomib|mesh-list
6077513|NCT00771875|Thymoglobulin|thymoglobulin|mesh-list
6077514|NCT00771875|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6077515|NCT00771875|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
6077516|NCT00771875|Histamine Antagonists|histamine antagonists|mesh-list
6077517|NCT00771875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6077518|NCT00771875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6077519|NCT00771875|Immunologic Factors|immunologic factors|mesh-ancestor
6077520|NCT00771875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077521|NCT00771875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6077522|NCT00771875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6077523|NCT00771875|Analgesics|analgesics|mesh-ancestor
6077524|NCT00771875|Sensory System Agents|sensory system agents|mesh-ancestor
6077525|NCT00771875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6077526|NCT00771875|Antipyretics|antipyretics|mesh-ancestor
6077527|NCT00771875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6077528|NCT00771875|Antiemetics|antiemetics|mesh-ancestor
5512727|NCT04381910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5512728|NCT04381741|Antibodies|antibodies|mesh-list
5512729|NCT04381741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5512730|NCT04381741|Immunologic Factors|immunologic factors|mesh-ancestor
5512731|NCT04381741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077529|NCT00771875|Autonomic Agents|autonomic agents|mesh-ancestor
6077530|NCT00771875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6077531|NCT00771875|Glucocorticoids|glucocorticoids|mesh-ancestor
6077532|NCT00771875|Hormones|hormones|mesh-ancestor
6077533|NCT00771875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6077534|NCT00771875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6077535|NCT00771875|Protective Agents|protective agents|mesh-ancestor
6077536|NCT00771875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6077537|NCT00771875|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6077538|NCT00771875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6077539|NCT00771875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6077540|NCT00771875|Anesthetics, Local|anesthetics, local|mesh-ancestor
6077541|NCT00771875|Anesthetics|anesthetics|mesh-ancestor
6077542|NCT00771875|Histamine Agents|histamine agents|mesh-ancestor
6077543|NCT00771875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6077544|NCT00771875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077545|NCT00771875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6077546|NCT00771901|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
6077547|NCT00771901|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
6077548|NCT00771901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6077549|NCT00771901|Antiviral Agents|antiviral agents|mesh-ancestor
6077550|NCT00771901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6077551|NCT00771901|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6077552|NCT00771901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6077553|NCT00771914|Aspirin|aspirin|mesh-list
6077554|NCT00771914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6077555|NCT00771914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6077556|NCT00771914|Analgesics|analgesics|mesh-ancestor
6077557|NCT00771914|Sensory System Agents|sensory system agents|mesh-ancestor
6077558|NCT00771914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6077559|NCT00771914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077560|NCT00771914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6077561|NCT00771914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6077562|NCT00771914|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6077563|NCT00771914|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6077564|NCT00771914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512732|NCT04381520|Antihypertensive Agents|antihypertensive agents|mesh-list
6077565|NCT00771914|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6463704|NCT00466063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463705|NCT00466076|Glatiramer Acetate|glatiramer acetate|mesh-list
6463706|NCT00466076|(T,G)-A-L|(t,g)-a-l|mesh-list
6463707|NCT00466076|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6463708|NCT00466076|Immunologic Factors|immunologic factors|mesh-ancestor
6463709|NCT00466076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463710|NCT00466076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6463711|NCT00466076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5512733|NCT04381845|Vaccines|vaccines|mesh-list
5512734|NCT04381845|Immunologic Factors|immunologic factors|mesh-ancestor
5512735|NCT04381845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512736|NCT04382144|Bupivacaine|bupivacaine|mesh-list
5512737|NCT04382144|Anesthetics, Local|anesthetics, local|mesh-ancestor
5512738|NCT04382144|Anesthetics|anesthetics|mesh-ancestor
5512739|NCT04382144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5512740|NCT04382144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512741|NCT04382144|Sensory System Agents|sensory system agents|mesh-ancestor
5512742|NCT04382144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5600452|NCT03711474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5600453|NCT03711448|Prednisone|prednisone|mesh-list
6463712|NCT00466089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6463713|NCT00466089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6463714|NCT00466089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6463715|NCT00466089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5600454|NCT03711448|Ustekinumab|ustekinumab|mesh-list
5600455|NCT03711448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5600456|NCT03711448|Glucocorticoids|glucocorticoids|mesh-ancestor
6077566|NCT00771914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6077567|NCT00771914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6077568|NCT00771914|Antipyretics|antipyretics|mesh-ancestor
6077569|NCT00771927|Lacosamide|lacosamide|mesh-list
6077570|NCT00771927|Anticonvulsants|anticonvulsants|mesh-ancestor
6077571|NCT00771927|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5600457|NCT03711448|Hormones|hormones|mesh-ancestor
5600458|NCT03711448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5600459|NCT03711448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600460|NCT03711448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5600461|NCT03711448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5600462|NCT03711448|Dermatologic Agents|dermatologic agents|mesh-ancestor
5600463|NCT03711422|Afatinib|afatinib|mesh-list
5600464|NCT03711422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5600465|NCT03711422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5600466|NCT03711422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6077572|NCT00771927|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6077573|NCT00771927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6077574|NCT00771927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077575|NCT00771953|Docetaxel|docetaxel|mesh-list
6077576|NCT00771953|Pemetrexed|pemetrexed|mesh-list
6077577|NCT00771953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6077578|NCT00771953|Tubulin Modulators|tubulin modulators|mesh-ancestor
6077579|NCT00771953|Antimitotic Agents|antimitotic agents|mesh-ancestor
6077580|NCT00771953|Mitosis Modulators|mitosis modulators|mesh-ancestor
6077581|NCT00771953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077582|NCT00771953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6077583|NCT00771953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6077584|NCT00771953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6077585|NCT00772005|Modafinil|modafinil|mesh-list
6077586|NCT00772005|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6077587|NCT00772005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077588|NCT00772005|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6077589|NCT00772005|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6077590|NCT00772005|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6077591|NCT00772005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077592|NCT00772031|Topiramate|topiramate|mesh-list
6077593|NCT00772031|Propranolol|propranolol|mesh-list
6077594|NCT00772031|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6077595|NCT00772031|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6077596|NCT00772031|Adrenergic Agents|adrenergic agents|mesh-ancestor
6077597|NCT00772031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6077598|NCT00772031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077599|NCT00772031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077600|NCT00772031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6077601|NCT00772031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6077602|NCT00772031|Vasodilator Agents|vasodilator agents|mesh-ancestor
5512743|NCT04382014|Curcumin|curcumin|mesh-list
5512744|NCT04382014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5512745|NCT04382014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5512746|NCT04382014|Analgesics|analgesics|mesh-ancestor
5512747|NCT04382014|Sensory System Agents|sensory system agents|mesh-ancestor
5512748|NCT04382014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5512749|NCT04382014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512750|NCT04382014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5512751|NCT04382014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5512752|NCT04382014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5512753|NCT04382014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5512754|NCT04382014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512755|NCT04381858|Immunoglobulins|immunoglobulins|mesh-list
5512756|NCT04381858|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5512757|NCT04381858|Antibodies|antibodies|mesh-list
5512758|NCT04381858|Immunologic Factors|immunologic factors|mesh-ancestor
5512759|NCT04381858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512760|NCT04381377|Bromides|bromides|mesh-list
5512761|NCT04381377|Anticonvulsants|anticonvulsants|mesh-ancestor
5512762|NCT04381429|Insulin Aspart|insulin aspart|mesh-list
5512763|NCT04381429|Insulin, Long-Acting|insulin, long-acting|mesh-list
5512764|NCT04381429|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
5512765|NCT04381429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5512766|NCT04381429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512767|NCT04381234|Citric Acid|citric acid|mesh-list
5512768|NCT04381234|Sodium Citrate|sodium citrate|mesh-list
5512769|NCT04381234|Dialysis Solutions|dialysis solutions|mesh-list
5512770|NCT04381234|Anticoagulants|anticoagulants|mesh-ancestor
5512771|NCT04381234|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5512772|NCT04381234|Chelating Agents|chelating agents|mesh-ancestor
5512773|NCT04381234|Sequestering Agents|sequestering agents|mesh-ancestor
5512774|NCT04381234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512775|NCT04381234|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5512776|NCT04380974|Bevacizumab|bevacizumab|mesh-list
5512777|NCT04380974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5512778|NCT04380974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5512779|NCT04380974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5512780|NCT04380974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5512781|NCT04380974|Growth Substances|growth substances|mesh-ancestor
5512782|NCT04380974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512783|NCT04380974|Growth Inhibitors|growth inhibitors|mesh-ancestor
5512784|NCT04381104|Acetaminophen|acetaminophen|mesh-list
5512785|NCT04381104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5512786|NCT04381104|Analgesics|analgesics|mesh-ancestor
5512787|NCT04381104|Sensory System Agents|sensory system agents|mesh-ancestor
5512788|NCT04381104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5512789|NCT04381104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512790|NCT04381104|Antipyretics|antipyretics|mesh-ancestor
5512791|NCT04380597|Betamethasone|betamethasone|mesh-list
5512792|NCT04380597|Betamethasone Valerate|betamethasone valerate|mesh-list
5512793|NCT04380597|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5512794|NCT04380597|Betamethasone benzoate|betamethasone benzoate|mesh-list
5512795|NCT04380597|Calcipotriene|calcipotriene|mesh-list
5512796|NCT04380597|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
6077603|NCT00772031|Anticonvulsants|anticonvulsants|mesh-ancestor
6077604|NCT00772031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6077605|NCT00772070|Vaccines|vaccines|mesh-list
6077606|NCT00772070|Immunologic Factors|immunologic factors|mesh-ancestor
6077607|NCT00772070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077608|NCT00772109|Vaccines|vaccines|mesh-list
6077609|NCT00772109|Immunologic Factors|immunologic factors|mesh-ancestor
6077610|NCT00772109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077611|NCT00772148|Tacrolimus|tacrolimus|mesh-list
6077612|NCT00772148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6077613|NCT00772148|Immunologic Factors|immunologic factors|mesh-ancestor
6077614|NCT00772148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077615|NCT00772148|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6077616|NCT00772148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6077617|NCT00772148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077618|NCT00772304|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
6077619|NCT00772304|Azelastine|azelastine|mesh-list
6077620|NCT00772304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6077621|NCT00772304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6077622|NCT00772304|Analgesics|analgesics|mesh-ancestor
6077623|NCT00772304|Sensory System Agents|sensory system agents|mesh-ancestor
6207742|NCT02119819|Incretins|incretins|mesh-ancestor
6077624|NCT00772304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6077625|NCT00772304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077626|NCT00772304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6077627|NCT00772304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6077628|NCT00772304|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6077629|NCT00772304|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6077630|NCT00772304|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6077631|NCT00772304|Histamine Antagonists|histamine antagonists|mesh-ancestor
6077632|NCT00772304|Histamine Agents|histamine agents|mesh-ancestor
6077633|NCT00772304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6077634|NCT00772304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077635|NCT00772304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6077636|NCT00772304|Autonomic Agents|autonomic agents|mesh-ancestor
6077637|NCT00772304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6077638|NCT00772304|Respiratory System Agents|respiratory system agents|mesh-ancestor
6077639|NCT00772304|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6077640|NCT00772304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6077641|NCT00772447|Vancomycin|vancomycin|mesh-list
6077642|NCT00772447|Daptomycin|daptomycin|mesh-list
6077643|NCT00772447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6077644|NCT00772447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6077645|NCT00772538|Tiotropium Bromide|tiotropium bromide|mesh-list
6077646|NCT00772538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6077647|NCT00772538|Autonomic Agents|autonomic agents|mesh-ancestor
6077648|NCT00772538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6077649|NCT00772538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077650|NCT00772538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6077651|NCT00772538|Respiratory System Agents|respiratory system agents|mesh-ancestor
6077652|NCT00772538|Parasympatholytics|parasympatholytics|mesh-ancestor
6077653|NCT00772538|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6077654|NCT00772538|Cholinergic Agents|cholinergic agents|mesh-ancestor
6077655|NCT00772538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6077656|NCT00772538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077657|NCT00772577|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6077658|NCT00772577|Ramipril|ramipril|mesh-list
6077659|NCT00772577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6077660|NCT00772577|Diuretics|diuretics|mesh-ancestor
6077661|NCT00772577|Natriuretic Agents|natriuretic agents|mesh-ancestor
6077662|NCT00772577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077663|NCT00772577|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6077664|NCT00772577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6077665|NCT00772577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077666|NCT00772577|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5512797|NCT04380597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5512798|NCT04380597|Glucocorticoids|glucocorticoids|mesh-ancestor
5512799|NCT04380597|Hormones|hormones|mesh-ancestor
5512800|NCT04380597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5512801|NCT04380597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512802|NCT04380597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5512803|NCT04380597|Respiratory System Agents|respiratory system agents|mesh-ancestor
5512804|NCT04380597|Dermatologic Agents|dermatologic agents|mesh-ancestor
6077667|NCT00772577|Protease Inhibitors|protease inhibitors|mesh-ancestor
6077668|NCT00772577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6077669|NCT00772590|Raltegravir Potassium|raltegravir potassium|mesh-list
6077670|NCT00772590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6077671|NCT00772590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6077672|NCT00772590|Antiviral Agents|antiviral agents|mesh-ancestor
6077673|NCT00772590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6077674|NCT00772590|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6077675|NCT00772590|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6077676|NCT00772590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6077677|NCT00772590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077678|NCT00772603|Oxcarbazepine|oxcarbazepine|mesh-list
6077679|NCT00772603|Anticonvulsants|anticonvulsants|mesh-ancestor
6077680|NCT00772603|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6077681|NCT00772603|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6077682|NCT00772603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6077683|NCT00772603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077684|NCT00772603|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6077685|NCT00772603|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6077686|NCT00772668|Prednisone|prednisone|mesh-list
6077687|NCT00772668|Cyclophosphamide|cyclophosphamide|mesh-list
6077688|NCT00772668|Rituximab|rituximab|mesh-list
6077689|NCT00772668|Bortezomib|bortezomib|mesh-list
6077690|NCT00772668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6077691|NCT00772668|Immunologic Factors|immunologic factors|mesh-ancestor
6077692|NCT00772668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077693|NCT00772668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6077694|NCT00772668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6077695|NCT00772668|Alkylating Agents|alkylating agents|mesh-ancestor
6077696|NCT00772668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077697|NCT00772668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6077698|NCT00772668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6077699|NCT00772668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6077700|NCT00772668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6077701|NCT00772668|Glucocorticoids|glucocorticoids|mesh-ancestor
6077702|NCT00772668|Hormones|hormones|mesh-ancestor
6077703|NCT00772668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6077704|NCT00772668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6077705|NCT00772772|Vitamin D|vitamin d|mesh-list
6077706|NCT00772772|Ergocalciferols|ergocalciferols|mesh-list
6077707|NCT00772772|Cholecalciferol|cholecalciferol|mesh-list
6077708|NCT00772772|Vitamins|vitamins|mesh-list
6077709|NCT00772772|Micronutrients|micronutrients|mesh-ancestor
6077710|NCT00772772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077711|NCT00772772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6077712|NCT00772772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6077713|NCT00772915|Dexamethasone|dexamethasone|mesh-list
6077714|NCT00772915|Lenalidomide|lenalidomide|mesh-list
6077715|NCT00772915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6077716|NCT00772915|Antiemetics|antiemetics|mesh-ancestor
6077717|NCT00772915|Autonomic Agents|autonomic agents|mesh-ancestor
6077718|NCT00772915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6077719|NCT00772915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077720|NCT00772915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6077721|NCT00772915|Glucocorticoids|glucocorticoids|mesh-ancestor
6077722|NCT00772915|Hormones|hormones|mesh-ancestor
6077723|NCT00772915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6077724|NCT00772915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6077725|NCT00772915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6077726|NCT00772915|Immunologic Factors|immunologic factors|mesh-ancestor
6077727|NCT00772915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5512805|NCT04380818|Ritonavir|ritonavir|mesh-list
5512806|NCT04380818|Lopinavir|lopinavir|mesh-list
5512807|NCT04380818|Azithromycin|azithromycin|mesh-list
5512808|NCT04380818|Hydroxychloroquine|hydroxychloroquine|mesh-list
5512809|NCT04380818|Heparin|heparin|mesh-list
5512810|NCT04380818|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6077728|NCT00772915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5512811|NCT04380818|Tinzaparin|tinzaparin|mesh-list
6077729|NCT00772915|Growth Substances|growth substances|mesh-ancestor
6077730|NCT00772915|Growth Inhibitors|growth inhibitors|mesh-ancestor
6077731|NCT00772928|Vaccines|vaccines|mesh-list
6077732|NCT00772928|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6077733|NCT00772928|Immunologic Factors|immunologic factors|mesh-ancestor
6077734|NCT00772928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077735|NCT00772941|Varenicline|varenicline|mesh-list
6077736|NCT00772941|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6077737|NCT00772941|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6077738|NCT00772941|Cholinergic Agents|cholinergic agents|mesh-ancestor
6077739|NCT00772941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6077740|NCT00772941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077741|NCT00772941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077742|NCT00772954|Vaccines|vaccines|mesh-list
6077743|NCT00772954|Immunologic Factors|immunologic factors|mesh-ancestor
6077744|NCT00772954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463716|NCT00466089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463717|NCT00466102|Everolimus|everolimus|mesh-list
6463718|NCT00466102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6077745|NCT00772967|Naproxen|naproxen|mesh-list
5512812|NCT04380818|Dalteparin|dalteparin|mesh-list
5512813|NCT04380818|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5512814|NCT04380818|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5512815|NCT04380818|Protease Inhibitors|protease inhibitors|mesh-ancestor
5512816|NCT04380818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6077746|NCT00772967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6077747|NCT00772967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6077748|NCT00772967|Analgesics|analgesics|mesh-ancestor
6077749|NCT00772967|Sensory System Agents|sensory system agents|mesh-ancestor
6077750|NCT00772967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6077751|NCT00772967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077752|NCT00772967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6077753|NCT00772967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6077754|NCT00772967|Gout Suppressants|gout suppressants|mesh-ancestor
6077755|NCT00772967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6077756|NCT00772967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6077757|NCT00772967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077758|NCT00773097|Poly ICLC|poly iclc|mesh-list
6077759|NCT00773097|Interferon Inducers|interferon inducers|mesh-ancestor
6077760|NCT00773097|Immunologic Factors|immunologic factors|mesh-ancestor
6077761|NCT00773097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077762|NCT00773136|Bimatoprost|bimatoprost|mesh-list
6077763|NCT00773136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6077764|NCT00773253|Botulinum Toxins|botulinum toxins|mesh-list
6077765|NCT00773253|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6077766|NCT00773253|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6077767|NCT00773253|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6077768|NCT00773253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6077769|NCT00773253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077770|NCT00773253|Cholinergic Agents|cholinergic agents|mesh-ancestor
6077771|NCT00773253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6077772|NCT00773253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077773|NCT00773253|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6077774|NCT00773253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6077775|NCT00773292|Cyclosporine|cyclosporine|mesh-list
6077776|NCT00773292|Cyclosporins|cyclosporins|mesh-list
6077777|NCT00773292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6077778|NCT00773292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077779|NCT00773292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5512817|NCT04380818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512818|NCT04380818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5512819|NCT04380818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5512820|NCT04380818|Antiviral Agents|antiviral agents|mesh-ancestor
5512821|NCT04380818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5512822|NCT04380818|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5512823|NCT04380818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5512824|NCT04380818|Anticoagulants|anticoagulants|mesh-ancestor
5512825|NCT04380818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5512826|NCT04380818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5512827|NCT04380818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5512828|NCT04380818|Antimalarials|antimalarials|mesh-ancestor
6077780|NCT00773292|Immunologic Factors|immunologic factors|mesh-ancestor
5512829|NCT04380818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5512830|NCT04380818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6077781|NCT00773292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077782|NCT00773292|Antifungal Agents|antifungal agents|mesh-ancestor
6077783|NCT00773292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5512831|NCT04380818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5512832|NCT04380857|Dexamethasone|dexamethasone|mesh-list
5512833|NCT04380857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5512834|NCT04380857|Antiemetics|antiemetics|mesh-ancestor
5512835|NCT04380857|Autonomic Agents|autonomic agents|mesh-ancestor
5512836|NCT04380857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5512837|NCT04380857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077784|NCT00773292|Dermatologic Agents|dermatologic agents|mesh-ancestor
6077785|NCT00773292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6077786|NCT00773292|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6077787|NCT00773383|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6077788|NCT00773383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6077789|NCT00773383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6077790|NCT00773383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6077791|NCT00773383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077792|NCT00773422|Naltrexone|naltrexone|mesh-list
6077793|NCT00773422|Varenicline|varenicline|mesh-list
6077794|NCT00773422|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6077795|NCT00773422|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6077796|NCT00773422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077797|NCT00773422|Sensory System Agents|sensory system agents|mesh-ancestor
6077798|NCT00773422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6077799|NCT00773422|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6077800|NCT00773422|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6077801|NCT00773422|Cholinergic Agents|cholinergic agents|mesh-ancestor
6077802|NCT00773422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6077803|NCT00773422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202829|NCT02046603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202830|NCT02046603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6202831|NCT02046603|Dermatologic Agents|dermatologic agents|mesh-ancestor
6202832|NCT02046603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6202833|NCT02046603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6202834|NCT02046603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6202835|NCT02046603|Immunologic Factors|immunologic factors|mesh-ancestor
6202836|NCT02046603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6202837|NCT02046603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6202838|NCT02046616|Methotrexate|methotrexate|mesh-list
6202839|NCT02046616|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6202840|NCT02046616|Abortifacient Agents|abortifacient agents|mesh-ancestor
6202841|NCT02046616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6202842|NCT02046616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077804|NCT00773474|Lonafarnib|lonafarnib|mesh-list
6077805|NCT00773474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6077806|NCT00773474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512838|NCT04380857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5512839|NCT04380857|Glucocorticoids|glucocorticoids|mesh-ancestor
5512840|NCT04380857|Hormones|hormones|mesh-ancestor
6077807|NCT00773513|Epoetin Alfa|epoetin alfa|mesh-list
6077808|NCT00773513|Darbepoetin alfa|darbepoetin alfa|mesh-list
6077809|NCT00773513|Hematinics|hematinics|mesh-ancestor
6077810|NCT00773734|Thalidomide|thalidomide|mesh-list
6077811|NCT00773734|Apremilast|apremilast|mesh-list
6077812|NCT00773734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6077813|NCT00773734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6077814|NCT00773734|Analgesics|analgesics|mesh-ancestor
6077815|NCT00773734|Sensory System Agents|sensory system agents|mesh-ancestor
6077816|NCT00773734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6077817|NCT00773734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077818|NCT00773734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6077819|NCT00773734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6077820|NCT00773734|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6077821|NCT00773734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6077822|NCT00773734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6077823|NCT00773734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077824|NCT00773734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6077825|NCT00773734|Immunologic Factors|immunologic factors|mesh-ancestor
6077826|NCT00773734|Leprostatic Agents|leprostatic agents|mesh-ancestor
6077827|NCT00773734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6077828|NCT00773734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6077829|NCT00773734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6077830|NCT00773734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6077831|NCT00773734|Growth Substances|growth substances|mesh-ancestor
6077832|NCT00773734|Growth Inhibitors|growth inhibitors|mesh-ancestor
6077833|NCT00773734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6077834|NCT00773747|Bortezomib|bortezomib|mesh-list
6077835|NCT00773747|Vorinostat|vorinostat|mesh-list
6077836|NCT00773747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6077837|NCT00773747|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6077838|NCT00773747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6077839|NCT00773747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077840|NCT00773786|Formoterol Fumarate|formoterol fumarate|mesh-list
6077841|NCT00773786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6077842|NCT00773786|Autonomic Agents|autonomic agents|mesh-ancestor
6077843|NCT00773786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6077844|NCT00773786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077845|NCT00773786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6077846|NCT00773786|Respiratory System Agents|respiratory system agents|mesh-ancestor
6077847|NCT00773786|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6077848|NCT00773786|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6077849|NCT00773786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6077850|NCT00773786|Adrenergic Agents|adrenergic agents|mesh-ancestor
6077851|NCT00773786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6077852|NCT00773786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077853|NCT00773838|Dexamethasone|dexamethasone|mesh-list
6077854|NCT00773838|Bortezomib|bortezomib|mesh-list
6077855|NCT00773838|Vorinostat|vorinostat|mesh-list
6077856|NCT00773838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6077857|NCT00773838|Antiemetics|antiemetics|mesh-ancestor
6077858|NCT00773838|Autonomic Agents|autonomic agents|mesh-ancestor
6077859|NCT00773838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6077860|NCT00773838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077861|NCT00773838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6077862|NCT00773838|Glucocorticoids|glucocorticoids|mesh-ancestor
6077863|NCT00773838|Hormones|hormones|mesh-ancestor
6077864|NCT00773838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6077865|NCT00773838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6077866|NCT00773838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6077867|NCT00773838|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6077868|NCT00773838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6077869|NCT00773838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077870|NCT00773955|Acetic Acid|acetic acid|mesh-list
6077871|NCT00773955|Retinol acetate|retinol acetate|mesh-list
6077872|NCT00773955|Gossypol acetic acid|gossypol acetic acid|mesh-list
6077873|NCT00773955|Gossypol|gossypol|mesh-list
6077874|NCT00773955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6077875|NCT00773955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6077876|NCT00773955|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6077877|NCT00773955|Immunologic Factors|immunologic factors|mesh-ancestor
6077878|NCT00773955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077879|NCT00773955|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6077880|NCT00773955|Protective Agents|protective agents|mesh-ancestor
6077881|NCT00773955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6077882|NCT00773955|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6077883|NCT00773955|Contraceptive Agents|contraceptive agents|mesh-ancestor
6077884|NCT00773955|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6077885|NCT00773955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6077886|NCT00773955|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6077887|NCT00773955|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
6077888|NCT00773955|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
6077889|NCT00773968|Epoetin Alfa|epoetin alfa|mesh-list
6077890|NCT00773968|Hematinics|hematinics|mesh-ancestor
6077891|NCT00774046|Cytarabine|cytarabine|mesh-list
6077892|NCT00774046|Etoposide|etoposide|mesh-list
6077893|NCT00774046|Mitoxantrone|mitoxantrone|mesh-list
6077894|NCT00774046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6077895|NCT00774046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6077896|NCT00774046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6077897|NCT00774046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6077898|NCT00774046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6077899|NCT00774046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077900|NCT00774046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6077901|NCT00774046|Antimetabolites|antimetabolites|mesh-ancestor
6077902|NCT00774046|Antiviral Agents|antiviral agents|mesh-ancestor
6077903|NCT00774046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6077904|NCT00774046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6077905|NCT00774046|Immunologic Factors|immunologic factors|mesh-ancestor
6077906|NCT00774046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077907|NCT00774046|Analgesics|analgesics|mesh-ancestor
6077908|NCT00774046|Sensory System Agents|sensory system agents|mesh-ancestor
6077909|NCT00774046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6077910|NCT00774202|Prednisone|prednisone|mesh-list
6077911|NCT00774202|Cyclophosphamide|cyclophosphamide|mesh-list
6077912|NCT00774202|Rituximab|rituximab|mesh-list
6077913|NCT00774202|Vincristine|vincristine|mesh-list
6077914|NCT00774202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6077915|NCT00774202|Immunologic Factors|immunologic factors|mesh-ancestor
6077916|NCT00774202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077917|NCT00774202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6077918|NCT00774202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5512841|NCT04380857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5512842|NCT04380857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5512843|NCT04380857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5512844|NCT04380402|Atorvastatin|atorvastatin|mesh-list
5512845|NCT04380402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5512846|NCT04380402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5512847|NCT04380402|Antimetabolites|antimetabolites|mesh-ancestor
5512848|NCT04380402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077919|NCT00774202|Alkylating Agents|alkylating agents|mesh-ancestor
6077920|NCT00774202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077921|NCT00774202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6077922|NCT00774202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6077923|NCT00774202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6077924|NCT00774202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6077925|NCT00774202|Glucocorticoids|glucocorticoids|mesh-ancestor
6077926|NCT00774202|Hormones|hormones|mesh-ancestor
6077927|NCT00774202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6077928|NCT00774202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6077929|NCT00774202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6077930|NCT00774202|Tubulin Modulators|tubulin modulators|mesh-ancestor
6077931|NCT00774202|Antimitotic Agents|antimitotic agents|mesh-ancestor
6077932|NCT00774202|Mitosis Modulators|mitosis modulators|mesh-ancestor
6077933|NCT00774267|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
6077934|NCT00774267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6077935|NCT00774267|Hormone Antagonists|hormone antagonists|mesh-ancestor
6463719|NCT00466102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6463720|NCT00466102|Immunologic Factors|immunologic factors|mesh-ancestor
6463721|NCT00466102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463722|NCT00466128|Indomethacin|indomethacin|mesh-list
6463723|NCT00466128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6463724|NCT00466128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6463725|NCT00466128|Analgesics|analgesics|mesh-ancestor
5512849|NCT04380402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6077936|NCT00774267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6077937|NCT00774267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077938|NCT00774267|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6077939|NCT00774267|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6077940|NCT00774267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6077941|NCT00774787|Imiquimod|imiquimod|mesh-list
6077942|NCT00774787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6077943|NCT00774787|Immunologic Factors|immunologic factors|mesh-ancestor
6077944|NCT00774787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077945|NCT00774787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6077946|NCT00774787|Interferon Inducers|interferon inducers|mesh-ancestor
5512850|NCT04380402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5512851|NCT04380402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5512852|NCT04380467|Vitamin D|vitamin d|mesh-list
5512853|NCT04380467|Cholecalciferol|cholecalciferol|mesh-list
5512854|NCT04380467|Vitamins|vitamins|mesh-ancestor
5512855|NCT04380467|Micronutrients|micronutrients|mesh-ancestor
5512856|NCT04380467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512857|NCT04380467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5512858|NCT04380467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6077947|NCT00774800|Insulin|insulin|mesh-list
6077948|NCT00774800|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6077949|NCT00774800|Insulin Lispro|insulin lispro|mesh-list
6077950|NCT00774800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6077951|NCT00774800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077952|NCT00774852|Prednisone|prednisone|mesh-list
6077953|NCT00774852|Cyclophosphamide|cyclophosphamide|mesh-list
6077954|NCT00774852|Abatacept|abatacept|mesh-list
6077955|NCT00774852|Azathioprine|azathioprine|mesh-list
6077956|NCT00774852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6077957|NCT00774852|Immunologic Factors|immunologic factors|mesh-ancestor
6077958|NCT00774852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077959|NCT00774852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6077960|NCT00774852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6077961|NCT00774852|Alkylating Agents|alkylating agents|mesh-ancestor
6077962|NCT00774852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077963|NCT00774852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6077964|NCT00774852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6077965|NCT00774852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6077966|NCT00774852|Glucocorticoids|glucocorticoids|mesh-ancestor
6077967|NCT00774852|Hormones|hormones|mesh-ancestor
6077968|NCT00774852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6077969|NCT00774852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6077970|NCT00774852|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6077971|NCT00774852|Antimetabolites|antimetabolites|mesh-ancestor
6077972|NCT00774852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6077973|NCT00774930|Lanreotide|lanreotide|mesh-list
6077974|NCT00774930|Somatostatin|somatostatin|mesh-list
6077975|NCT00774930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5512859|NCT04380220|Protein C|protein c|mesh-list
6077976|NCT00774930|Hormones|hormones|mesh-ancestor
6077977|NCT00774930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6077978|NCT00774930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077979|NCT00775138|Amikacin|amikacin|mesh-list
6077980|NCT00775138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6077981|NCT00775138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6077982|NCT00775203|Trazodone|trazodone|mesh-list
6077983|NCT00775203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6077984|NCT00775203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6077985|NCT00775203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6077986|NCT00775203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6077987|NCT00775203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5512860|NCT04380220|Antithrombins|antithrombins|mesh-list
5512861|NCT04380220|Protein S|protein s|mesh-list
5512862|NCT04380220|Factor VIII|factor viii|mesh-list
5512863|NCT04380220|Complement C3|complement c3|mesh-list
5512864|NCT04380220|Coagulants|coagulants|mesh-ancestor
5512865|NCT04380220|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5512866|NCT04380220|Protease Inhibitors|protease inhibitors|mesh-ancestor
5512867|NCT04380220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5512868|NCT04380220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512869|NCT04380220|Anticoagulants|anticoagulants|mesh-ancestor
5512870|NCT04380220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5512871|NCT04380220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5512872|NCT04380220|Immunologic Factors|immunologic factors|mesh-ancestor
5512873|NCT04380220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512874|NCT04380376|Melphalan|melphalan|mesh-list
5512875|NCT04380376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6077988|NCT00775203|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6077989|NCT00775203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6077990|NCT00775203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6077991|NCT00775203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6077992|NCT00775203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6077993|NCT00775203|Serotonin Agents|serotonin agents|mesh-ancestor
6077994|NCT00775203|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6077995|NCT00775203|Antidepressive Agents|antidepressive agents|mesh-ancestor
6077996|NCT00775229|Naltrexone|naltrexone|mesh-list
6077997|NCT00775229|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6077998|NCT00775229|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6077999|NCT00775229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078000|NCT00775229|Sensory System Agents|sensory system agents|mesh-ancestor
6078001|NCT00775229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6078002|NCT00775268|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6078003|NCT00775268|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6078004|NCT00775268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078005|NCT00775411|Dexamethasone|dexamethasone|mesh-list
6078006|NCT00775411|Ranibizumab|ranibizumab|mesh-list
6078007|NCT00775411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5512876|NCT04380376|Alkylating Agents|alkylating agents|mesh-ancestor
5512877|NCT04380376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512878|NCT04380376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5512879|NCT04380376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5512880|NCT04380376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5512881|NCT04380376|Immunologic Factors|immunologic factors|mesh-ancestor
5512882|NCT04380376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512883|NCT04380181|Milrinone|milrinone|mesh-list
5512884|NCT04380181|Epinephrine|epinephrine|mesh-list
5512885|NCT04380181|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5512886|NCT04380181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5512887|NCT04380181|Adrenergic Agents|adrenergic agents|mesh-ancestor
5512888|NCT04380181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5512889|NCT04380181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512890|NCT04380181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512891|NCT04380181|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5512892|NCT04380181|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5512893|NCT04380181|Autonomic Agents|autonomic agents|mesh-ancestor
5512894|NCT04380181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6463726|NCT00466128|Sensory System Agents|sensory system agents|mesh-ancestor
6463727|NCT00466128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6463728|NCT00466128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463729|NCT00466128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6463730|NCT00466128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6463731|NCT00466128|Gout Suppressants|gout suppressants|mesh-ancestor
6463732|NCT00466128|Tocolytic Agents|tocolytic agents|mesh-ancestor
6078008|NCT00775411|Antiemetics|antiemetics|mesh-ancestor
5512895|NCT04380181|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5512896|NCT04380181|Respiratory System Agents|respiratory system agents|mesh-ancestor
5512897|NCT04380181|Mydriatics|mydriatics|mesh-ancestor
5512898|NCT04380181|Sympathomimetics|sympathomimetics|mesh-ancestor
5512899|NCT04380181|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5512900|NCT04380181|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5512901|NCT04380181|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6078009|NCT00775411|Autonomic Agents|autonomic agents|mesh-ancestor
6078010|NCT00775411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6078011|NCT00775411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512902|NCT04380181|Vasodilator Agents|vasodilator agents|mesh-ancestor
5512903|NCT04380181|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5512904|NCT04380181|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5512905|NCT04380181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5512906|NCT04380181|Protective Agents|protective agents|mesh-ancestor
6078012|NCT00775411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6078013|NCT00775411|Glucocorticoids|glucocorticoids|mesh-ancestor
6078014|NCT00775411|Hormones|hormones|mesh-ancestor
6078015|NCT00775411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6078016|NCT00775411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6078017|NCT00775411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6078018|NCT00775411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6078019|NCT00775411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6078020|NCT00775411|Growth Substances|growth substances|mesh-ancestor
6078021|NCT00775411|Growth Inhibitors|growth inhibitors|mesh-ancestor
6078022|NCT00775437|Adalimumab|adalimumab|mesh-list
6078023|NCT00775437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6078024|NCT00775437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6078025|NCT00775450|Vaccines|vaccines|mesh-list
6078026|NCT00775450|Immunologic Factors|immunologic factors|mesh-ancestor
6078027|NCT00775450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078028|NCT00775463|Treprostinil|treprostinil|mesh-list
6078029|NCT00775463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6078030|NCT00775528|Pancrelipase|pancrelipase|mesh-list
6078031|NCT00775528|Pancreatin|pancreatin|mesh-list
6078032|NCT00775528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6078033|NCT00775593|Sirolimus|sirolimus|mesh-list
6078034|NCT00775593|Clofarabine|clofarabine|mesh-list
6078035|NCT00775593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6078036|NCT00775593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6078037|NCT00775593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5512907|NCT04380311|Tacrolimus|tacrolimus|mesh-list
6078038|NCT00775593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6078039|NCT00775593|Antifungal Agents|antifungal agents|mesh-ancestor
6078040|NCT00775593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6078041|NCT00775593|Immunologic Factors|immunologic factors|mesh-ancestor
6078042|NCT00775593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078043|NCT00775593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6078044|NCT00775593|Antimetabolites|antimetabolites|mesh-ancestor
6078045|NCT00775593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078046|NCT00775606|Ritonavir|ritonavir|mesh-list
6078047|NCT00775606|Lopinavir|lopinavir|mesh-list
6078048|NCT00775606|Efavirenz|efavirenz|mesh-list
6078049|NCT00775606|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6078050|NCT00775606|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6078051|NCT00775606|Protease Inhibitors|protease inhibitors|mesh-ancestor
6078052|NCT00775606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6078053|NCT00775606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078054|NCT00775606|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6078055|NCT00775606|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6078056|NCT00775606|Antiviral Agents|antiviral agents|mesh-ancestor
6078057|NCT00775606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6078058|NCT00775606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6078059|NCT00775606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6078060|NCT00775606|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6078061|NCT00775606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6078062|NCT00775606|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6078063|NCT00775606|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6078064|NCT00775606|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6078065|NCT00775606|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6078066|NCT00775606|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6078067|NCT00775645|Acetylcarnitine|acetylcarnitine|mesh-list
6078068|NCT00775645|Vitamin B Complex|vitamin b complex|mesh-ancestor
6078069|NCT00775645|Vitamins|vitamins|mesh-ancestor
6078070|NCT00775645|Micronutrients|micronutrients|mesh-ancestor
6078071|NCT00775645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078072|NCT00775645|Nootropic Agents|nootropic agents|mesh-ancestor
6078073|NCT00775658|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
6078074|NCT00775658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6078075|NCT00775658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6078076|NCT00775658|Analgesics|analgesics|mesh-ancestor
6078077|NCT00775658|Sensory System Agents|sensory system agents|mesh-ancestor
6078078|NCT00775658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6078079|NCT00775658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078080|NCT00775658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6078081|NCT00775658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6078082|NCT00775658|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6078083|NCT00775658|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6078084|NCT00775658|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6078085|NCT00775658|Histamine Antagonists|histamine antagonists|mesh-ancestor
6078086|NCT00775658|Histamine Agents|histamine agents|mesh-ancestor
6078087|NCT00775658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6078088|NCT00775658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078089|NCT00775671|Metoprolol|metoprolol|mesh-list
6078090|NCT00775671|Nebivolol|nebivolol|mesh-list
6078091|NCT00775671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6078092|NCT00775671|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6078093|NCT00775671|Sympatholytics|sympatholytics|mesh-ancestor
6078094|NCT00775671|Autonomic Agents|autonomic agents|mesh-ancestor
6078095|NCT00775671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5512908|NCT04380311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5512909|NCT04380311|Immunologic Factors|immunologic factors|mesh-ancestor
5512910|NCT04380311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512911|NCT04380311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5512912|NCT04380311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5512913|NCT04380311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512914|NCT04380298|Ketorolac|ketorolac|mesh-list
5512915|NCT04380298|Epinephrine|epinephrine|mesh-list
5512916|NCT04380298|Ropivacaine|ropivacaine|mesh-list
5512917|NCT04380298|Anesthetics, Local|anesthetics, local|mesh-ancestor
5512918|NCT04380298|Anesthetics|anesthetics|mesh-ancestor
5512919|NCT04380298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5512920|NCT04380298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512921|NCT04380298|Sensory System Agents|sensory system agents|mesh-ancestor
5512922|NCT04380298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5512923|NCT04380298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5512924|NCT04380298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6078096|NCT00775671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512925|NCT04380298|Adrenergic Agents|adrenergic agents|mesh-ancestor
5512926|NCT04380298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5512927|NCT04380298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512928|NCT04380298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5512929|NCT04380298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5512930|NCT04380298|Autonomic Agents|autonomic agents|mesh-ancestor
5512931|NCT04380298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5512932|NCT04380298|Respiratory System Agents|respiratory system agents|mesh-ancestor
5512933|NCT04380298|Mydriatics|mydriatics|mesh-ancestor
5512934|NCT04380298|Sympathomimetics|sympathomimetics|mesh-ancestor
5512935|NCT04380298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5512936|NCT04380298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5512937|NCT04380298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5512938|NCT04380298|Analgesics|analgesics|mesh-ancestor
5512939|NCT04380298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5512940|NCT04380298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5512941|NCT04380298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5512942|NCT04380298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5512943|NCT04380103|Bevacizumab|bevacizumab|mesh-list
5512944|NCT04380103|Capecitabine|capecitabine|mesh-list
5512945|NCT04380103|Oxaliplatin|oxaliplatin|mesh-list
5512946|NCT04380103|Irinotecan|irinotecan|mesh-list
5512947|NCT04380103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5512948|NCT04380103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5512949|NCT04380103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5512950|NCT04380103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5512951|NCT04380103|Growth Substances|growth substances|mesh-ancestor
5512952|NCT04380103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512953|NCT04380103|Growth Inhibitors|growth inhibitors|mesh-ancestor
5512954|NCT04380103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5512955|NCT04380103|Antimetabolites|antimetabolites|mesh-ancestor
5512956|NCT04380103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512957|NCT04380103|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5512958|NCT04380103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5512959|NCT04380103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5512960|NCT04379973|Ethiodized Oil|ethiodized oil|mesh-list
5512961|NCT04379973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5512962|NCT04380012|Trastuzumab|trastuzumab|mesh-list
5512963|NCT04380012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5512964|NCT04380012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5512965|NCT04379999|Aspirin|aspirin|mesh-list
5512966|NCT04379999|Atorvastatin|atorvastatin|mesh-list
5512967|NCT04379999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5512968|NCT04379999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5512969|NCT04379999|Analgesics|analgesics|mesh-ancestor
5512970|NCT04379999|Sensory System Agents|sensory system agents|mesh-ancestor
5512971|NCT04379999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6078097|NCT00775671|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6078098|NCT00775671|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6078099|NCT00775671|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6078100|NCT00775671|Adrenergic Agents|adrenergic agents|mesh-ancestor
6078101|NCT00775671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6078102|NCT00775671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078103|NCT00775671|Vasodilator Agents|vasodilator agents|mesh-ancestor
6078104|NCT00775671|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6078105|NCT00775671|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5512972|NCT04379999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512973|NCT04379999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5512974|NCT04379999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5512975|NCT04379999|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5512976|NCT04379999|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5512977|NCT04379999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512978|NCT04379999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5512979|NCT04379999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5512980|NCT04379999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5512981|NCT04379999|Antipyretics|antipyretics|mesh-ancestor
5512982|NCT04379999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5512983|NCT04379999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5512984|NCT04379999|Antimetabolites|antimetabolites|mesh-ancestor
5512985|NCT04379999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5512986|NCT04379999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5600467|NCT03711422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600468|NCT03711305|Carboplatin|carboplatin|mesh-list
5600469|NCT03711305|Etoposide|etoposide|mesh-list
5600470|NCT03711305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5512987|NCT04380025|Pycnogenols|pycnogenols|mesh-list
5512988|NCT04380025|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5512989|NCT04380025|Immunologic Factors|immunologic factors|mesh-ancestor
5512990|NCT04380025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5512991|NCT04380025|Antioxidants|antioxidants|mesh-ancestor
5512992|NCT04380025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5512993|NCT04380025|Protective Agents|protective agents|mesh-ancestor
5512994|NCT04380025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5512995|NCT04379739|Apatinib|apatinib|mesh-list
5512996|NCT04379739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5512997|NCT04379739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5512998|NCT04379739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5512999|NCT04379739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513000|NCT04379492|Hydroxychloroquine|hydroxychloroquine|mesh-list
5513001|NCT04379492|Antimalarials|antimalarials|mesh-ancestor
6078106|NCT00775671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6078107|NCT00775684|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6078108|NCT00775684|Exenatide|exenatide|mesh-list
6078109|NCT00775684|Glimepiride|glimepiride|mesh-list
6078110|NCT00775684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6078111|NCT00775684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078112|NCT00775684|Incretins|incretins|mesh-ancestor
6078113|NCT00775684|Hormones|hormones|mesh-ancestor
6078114|NCT00775684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6078115|NCT00775684|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6078116|NCT00775684|Protease Inhibitors|protease inhibitors|mesh-ancestor
6078117|NCT00775684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6078118|NCT00775684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078119|NCT00775684|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6078120|NCT00775684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6078121|NCT00775684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6078122|NCT00775684|Immunologic Factors|immunologic factors|mesh-ancestor
6078123|NCT00775931|Cyclophosphamide|cyclophosphamide|mesh-list
6078124|NCT00775931|Busulfan|busulfan|mesh-list
6078125|NCT00775931|Fludarabine|fludarabine|mesh-list
6078126|NCT00775931|Fludarabine phosphate|fludarabine phosphate|mesh-list
6078127|NCT00775931|Alemtuzumab|alemtuzumab|mesh-list
6078128|NCT00775931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6078129|NCT00775931|Immunologic Factors|immunologic factors|mesh-ancestor
6078130|NCT00775931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078131|NCT00775931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6078132|NCT00775931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6078133|NCT00775931|Alkylating Agents|alkylating agents|mesh-ancestor
6078134|NCT00775931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078135|NCT00775931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6078136|NCT00775931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6078137|NCT00775931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6078138|NCT00775931|Antimetabolites|antimetabolites|mesh-ancestor
6078139|NCT00775931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6078140|NCT00775944|Nicotine|nicotine|mesh-list
6078141|NCT00775944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5513002|NCT04379492|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5513003|NCT04379492|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5513004|NCT04379492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5513005|NCT04379492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5513006|NCT04379492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513007|NCT04379492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5513008|NCT04379180|Bosentan|bosentan|mesh-list
5513009|NCT04379180|Sildenafil Citrate|sildenafil citrate|mesh-list
5513010|NCT04379180|Tadalafil|tadalafil|mesh-list
5513011|NCT04379180|Vasodilator Agents|vasodilator agents|mesh-ancestor
5513012|NCT04379180|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5513013|NCT04379180|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5513014|NCT04379180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5513015|NCT04379180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078142|NCT00775944|Autonomic Agents|autonomic agents|mesh-ancestor
6078143|NCT00775944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6078144|NCT00775944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078145|NCT00775944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6078146|NCT00775944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6078147|NCT00775944|Cholinergic Agents|cholinergic agents|mesh-ancestor
6078148|NCT00775944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6078149|NCT00775944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078150|NCT00776009|Methylphenidate|methylphenidate|mesh-list
6078151|NCT00776009|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
6078152|NCT00776009|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6078153|NCT00776009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078154|NCT00776009|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6078155|NCT00776009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6078156|NCT00776009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5513016|NCT04379180|Urological Agents|urological agents|mesh-ancestor
5513017|NCT04379180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5513018|NCT04379180|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5513019|NCT04379271|Calcium|calcium|mesh-list
5513020|NCT04379271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5513021|NCT04379271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078157|NCT00776009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078158|NCT00776009|Dopamine Agents|dopamine agents|mesh-ancestor
6078159|NCT00776009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6078160|NCT00776230|Vaccines|vaccines|mesh-list
6078161|NCT00776230|Immunologic Factors|immunologic factors|mesh-ancestor
6078162|NCT00776230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078163|NCT00776594|Bevacizumab|bevacizumab|mesh-list
6078164|NCT00776594|Bicalutamide|bicalutamide|mesh-list
6078165|NCT00776594|Androgens|androgens|mesh-list
6078166|NCT00776594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6078167|NCT00776594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6078168|NCT00776594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6078169|NCT00776594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6078170|NCT00776594|Growth Substances|growth substances|mesh-ancestor
6078171|NCT00776594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078172|NCT00776594|Growth Inhibitors|growth inhibitors|mesh-ancestor
6078173|NCT00776594|Androgen Antagonists|androgen antagonists|mesh-ancestor
6078174|NCT00776594|Hormone Antagonists|hormone antagonists|mesh-ancestor
6078175|NCT00776594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6078176|NCT00776594|Hormones|hormones|mesh-ancestor
6078177|NCT00776659|Exemestane|exemestane|mesh-list
6078178|NCT00776659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6078179|NCT00776659|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6078180|NCT00776659|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6078181|NCT00776659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6078182|NCT00776659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078183|NCT00776659|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6078184|NCT00776659|Hormone Antagonists|hormone antagonists|mesh-ancestor
6078185|NCT00776659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6078186|NCT00776659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078187|NCT00776919|Clindamycin|clindamycin|mesh-list
6078188|NCT00776919|Clindamycin palmitate|clindamycin palmitate|mesh-list
6078189|NCT00776919|Clindamycin phosphate|clindamycin phosphate|mesh-list
6078190|NCT00776919|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6078191|NCT00776919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6078192|NCT00776919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6078193|NCT00776919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6078194|NCT00776919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6078195|NCT00776919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078196|NCT00776919|Dermatologic Agents|dermatologic agents|mesh-ancestor
6078197|NCT00776984|Tiotropium Bromide|tiotropium bromide|mesh-list
6078198|NCT00776984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6078199|NCT00776984|Autonomic Agents|autonomic agents|mesh-ancestor
6078200|NCT00776984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6078201|NCT00776984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513022|NCT04379219|Methotrexate|methotrexate|mesh-list
5513023|NCT04379219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5513024|NCT04379219|Abortifacient Agents|abortifacient agents|mesh-ancestor
5513025|NCT04379219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5513026|NCT04379219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513027|NCT04379219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5513028|NCT04379219|Antimetabolites|antimetabolites|mesh-ancestor
5600471|NCT03711305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6078202|NCT00776984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6078203|NCT00776984|Respiratory System Agents|respiratory system agents|mesh-ancestor
6078204|NCT00776984|Parasympatholytics|parasympatholytics|mesh-ancestor
6078205|NCT00776984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6078206|NCT00776984|Cholinergic Agents|cholinergic agents|mesh-ancestor
6078207|NCT00776984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6078208|NCT00776984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078209|NCT00777023|Gabapentin|gabapentin|mesh-list
6078210|NCT00777023|Analgesics|analgesics|mesh-ancestor
6078211|NCT00777023|Sensory System Agents|sensory system agents|mesh-ancestor
6078212|NCT00777023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6078213|NCT00777023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078214|NCT00777023|Anticonvulsants|anticonvulsants|mesh-ancestor
6078215|NCT00777023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6078216|NCT00777023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6078217|NCT00777023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6078218|NCT00777023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6078219|NCT00777023|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6078220|NCT00777023|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6078221|NCT00777023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6078222|NCT00777023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078223|NCT00777023|Antimanic Agents|antimanic agents|mesh-ancestor
6078224|NCT00777049|Panobinostat|panobinostat|mesh-list
6078225|NCT00777049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6078226|NCT00777049|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6078227|NCT00777049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5513029|NCT04379219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513030|NCT04379219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5513031|NCT04379219|Dermatologic Agents|dermatologic agents|mesh-ancestor
5513032|NCT04379219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5513033|NCT04379219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5513034|NCT04379219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5513035|NCT04379219|Immunologic Factors|immunologic factors|mesh-ancestor
5513036|NCT04379219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5513037|NCT04379219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6078228|NCT00777049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078229|NCT00777062|Naltrexone|naltrexone|mesh-list
6078230|NCT00777062|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6078231|NCT00777062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6078232|NCT00777062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078233|NCT00777062|Sensory System Agents|sensory system agents|mesh-ancestor
6078234|NCT00777062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6078235|NCT00777101|Capecitabine|capecitabine|mesh-list
6078236|NCT00777101|Lapatinib|lapatinib|mesh-list
6078237|NCT00777101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6078238|NCT00777101|Antimetabolites|antimetabolites|mesh-ancestor
6078239|NCT00777101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078240|NCT00777101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6078241|NCT00777101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6078242|NCT00777101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6078243|NCT00777153|Cediranib|cediranib|mesh-list
6078244|NCT00777153|Lomustine|lomustine|mesh-list
6078245|NCT00777153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6078246|NCT00777153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6078247|NCT00777153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5513038|NCT04379310|Calcium Channel Blockers|calcium channel blockers|mesh-list
5513039|NCT04379310|Calcium|calcium|mesh-list
5513040|NCT04379310|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
5513041|NCT04379310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5513042|NCT04379310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513043|NCT04379310|Protease Inhibitors|protease inhibitors|mesh-ancestor
5513044|NCT04379310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5513045|NCT04379310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513046|NCT04379310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5513047|NCT04378972|Vitamin D|vitamin d|mesh-list
5513048|NCT04378972|Cholecalciferol|cholecalciferol|mesh-list
5513049|NCT04378972|Curcumin|curcumin|mesh-list
5513050|NCT04378972|Tramiprosate|tramiprosate|mesh-list
5513051|NCT04378972|Vitamins|vitamins|mesh-ancestor
5513052|NCT04378972|Micronutrients|micronutrients|mesh-ancestor
5513053|NCT04378972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513054|NCT04378972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5513055|NCT04378972|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5513056|NCT04378972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5513057|NCT04378972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6078248|NCT00777153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078249|NCT00777153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6078250|NCT00777153|Alkylating Agents|alkylating agents|mesh-ancestor
6078251|NCT00777296|Amikacin|amikacin|mesh-list
6078252|NCT00777296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6078253|NCT00777296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6078254|NCT00777335|Panobinostat|panobinostat|mesh-list
6078255|NCT00777335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6078256|NCT00777335|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6078257|NCT00777335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6078258|NCT00777335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078259|NCT00777491|Gemcitabine|gemcitabine|mesh-list
6078260|NCT00777491|Cisplatin|cisplatin|mesh-list
6078261|NCT00777491|Fluorouracil|fluorouracil|mesh-list
6078262|NCT00777491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6078263|NCT00777491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6078264|NCT00777491|Antimetabolites|antimetabolites|mesh-ancestor
6078265|NCT00777491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078266|NCT00777491|Antiviral Agents|antiviral agents|mesh-ancestor
6078267|NCT00777491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6078268|NCT00777491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6078269|NCT00777491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6078270|NCT00777491|Immunologic Factors|immunologic factors|mesh-ancestor
6078271|NCT00777491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078272|NCT00777556|Levonorgestrel|levonorgestrel|mesh-list
6078273|NCT00777556|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6078274|NCT00777556|Contraceptive Agents|contraceptive agents|mesh-ancestor
6078275|NCT00777556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6078276|NCT00777556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078277|NCT00777556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6078278|NCT00777556|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6078279|NCT00777556|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6078280|NCT00777608|Donepezil|donepezil|mesh-list
6078281|NCT00777608|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5513058|NCT04378972|Analgesics|analgesics|mesh-ancestor
5513059|NCT04378972|Sensory System Agents|sensory system agents|mesh-ancestor
5513060|NCT04378972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5513061|NCT04378972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5513062|NCT04378972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5513063|NCT04378972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5513064|NCT04378972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5513065|NCT04378972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513066|NCT04378972|Anticonvulsants|anticonvulsants|mesh-ancestor
5513067|NCT04378972|GABA Agonists|gaba agonists|mesh-ancestor
5513068|NCT04378972|GABA Agents|gaba agents|mesh-ancestor
5513069|NCT04378972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5513072|NCT04379102|Anesthetics|anesthetics|mesh-list
5513073|NCT04379102|Anesthetics, Local|anesthetics, local|mesh-list
5513074|NCT04379102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5513075|NCT04379102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513076|NCT04379102|Sensory System Agents|sensory system agents|mesh-ancestor
6078282|NCT00777608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6078283|NCT00777608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078284|NCT00777608|Cholinergic Agents|cholinergic agents|mesh-ancestor
6078285|NCT00777608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6078286|NCT00777608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078287|NCT00777608|Nootropic Agents|nootropic agents|mesh-ancestor
6078288|NCT00777803|Botulinum Toxins|botulinum toxins|mesh-list
6078289|NCT00777803|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6078290|NCT00777803|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6078291|NCT00777803|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
6078292|NCT00777803|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6078293|NCT00777803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6078294|NCT00777803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078295|NCT00777803|Cholinergic Agents|cholinergic agents|mesh-ancestor
5513077|NCT04379102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5513078|NCT04378868|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5513079|NCT04378868|Metronidazole|metronidazole|mesh-list
5513080|NCT04378868|Cefuroxime|cefuroxime|mesh-list
5513081|NCT04378868|Cefuroxime axetil|cefuroxime axetil|mesh-list
5513082|NCT04378868|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5513083|NCT04378868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6078296|NCT00777803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6078297|NCT00777803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078298|NCT00777803|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6078299|NCT00777803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6078300|NCT00777829|Zolpidem|zolpidem|mesh-list
6078301|NCT00777829|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5513084|NCT04378868|Antitubercular Agents|antitubercular agents|mesh-ancestor
5513085|NCT04378868|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5513086|NCT04378868|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5513087|NCT04378608|Ribavirin|ribavirin|mesh-list
5513088|NCT04378608|Antimetabolites|antimetabolites|mesh-ancestor
5600472|NCT03711305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6665428|NCT01517022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665429|NCT01517165|Pioglitazone|pioglitazone|mesh-list
6665430|NCT01517165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6665431|NCT01517165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665432|NCT01517308|Interferons|interferons|mesh-list
6665433|NCT01517308|Ribavirin|ribavirin|mesh-list
6078302|NCT00777829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6078303|NCT00777829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6078304|NCT00777829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078305|NCT00777829|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6078306|NCT00777829|GABA Agonists|gaba agonists|mesh-ancestor
6078307|NCT00777829|GABA Agents|gaba agents|mesh-ancestor
6078308|NCT00777829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6078309|NCT00777829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078310|NCT00777855|Rifampin|rifampin|mesh-list
6078311|NCT00777855|Warfarin|warfarin|mesh-list
6078312|NCT00777855|Anticoagulants|anticoagulants|mesh-ancestor
6078313|NCT00777855|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6078314|NCT00777855|Antitubercular Agents|antitubercular agents|mesh-ancestor
6078315|NCT00777855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6078316|NCT00777855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6078317|NCT00777855|Leprostatic Agents|leprostatic agents|mesh-ancestor
6078318|NCT00777855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6078319|NCT00777855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6078320|NCT00777855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078321|NCT00777855|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6078322|NCT00777855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6078323|NCT00777855|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6078324|NCT00777855|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6078325|NCT00777855|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6078326|NCT00777855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6078327|NCT00777920|Ambrisentan|ambrisentan|mesh-list
6078328|NCT00777920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6078329|NCT00777946|Amlodipine|amlodipine|mesh-list
6078330|NCT00777946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6078331|NCT00777946|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6665434|NCT01517308|Interferon-alpha|interferon-alpha|mesh-list
6665435|NCT01517308|Interferon alpha-2|interferon alpha-2|mesh-list
6665436|NCT01517308|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6665437|NCT01517308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6665438|NCT01517308|Antiviral Agents|antiviral agents|mesh-ancestor
6665439|NCT01517308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6665440|NCT01517308|Antimetabolites|antimetabolites|mesh-ancestor
6078332|NCT00777946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6078333|NCT00777946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078334|NCT00777946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6078335|NCT00777946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078336|NCT00777946|Vasodilator Agents|vasodilator agents|mesh-ancestor
6078337|NCT00778102|Leucovorin|leucovorin|mesh-list
6078338|NCT00778102|Bevacizumab|bevacizumab|mesh-list
6078339|NCT00778102|Oxaliplatin|oxaliplatin|mesh-list
6078340|NCT00778102|Irinotecan|irinotecan|mesh-list
6078341|NCT00778102|Fluorouracil|fluorouracil|mesh-list
6078342|NCT00778102|Levoleucovorin|levoleucovorin|mesh-list
6078343|NCT00778102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6078344|NCT00778102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6078345|NCT00778102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6078346|NCT00778102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6078347|NCT00778102|Growth Substances|growth substances|mesh-ancestor
6078348|NCT00778102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078349|NCT00778102|Growth Inhibitors|growth inhibitors|mesh-ancestor
6078350|NCT00778102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6078351|NCT00778102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6078352|NCT00778102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5513089|NCT04378608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513090|NCT04378608|Antiviral Agents|antiviral agents|mesh-ancestor
5513091|NCT04378608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5513092|NCT04378621|Adalimumab|adalimumab|mesh-list
6078353|NCT00778102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078354|NCT00778102|Antidotes|antidotes|mesh-ancestor
6078355|NCT00778102|Protective Agents|protective agents|mesh-ancestor
6078356|NCT00778102|Vitamin B Complex|vitamin b complex|mesh-ancestor
6078357|NCT00778102|Vitamins|vitamins|mesh-ancestor
6078358|NCT00778102|Micronutrients|micronutrients|mesh-ancestor
6078359|NCT00778102|Antimetabolites|antimetabolites|mesh-ancestor
6078360|NCT00778102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6078361|NCT00778102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6078362|NCT00778102|Immunologic Factors|immunologic factors|mesh-ancestor
6078363|NCT00778167|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6078364|NCT00778167|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6078365|NCT00778167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6078366|NCT00778167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6078367|NCT00778167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6078368|NCT00778167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078369|NCT00778167|Immunologic Factors|immunologic factors|mesh-ancestor
6078370|NCT00778167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078371|NCT00778310|Methylphenidate|methylphenidate|mesh-list
6078372|NCT00778310|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6078373|NCT00778310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078374|NCT00778310|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6078375|NCT00778310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6078376|NCT00778310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6078377|NCT00778310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078378|NCT00778310|Dopamine Agents|dopamine agents|mesh-ancestor
6078379|NCT00778310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6078380|NCT00778375|Cytarabine|cytarabine|mesh-list
6078381|NCT00778375|Decitabine|decitabine|mesh-list
6078382|NCT00778375|Clofarabine|clofarabine|mesh-list
6078383|NCT00778375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6078384|NCT00778375|Antimetabolites|antimetabolites|mesh-ancestor
6078385|NCT00778375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078386|NCT00778375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5513093|NCT04378621|Etanercept|etanercept|mesh-list
5513094|NCT04378621|Golimumab|golimumab|mesh-list
5513095|NCT04378621|Infliximab|infliximab|mesh-list
5513096|NCT04378621|Certolizumab Pegol|certolizumab pegol|mesh-list
5513097|NCT04378621|Tofacitinib|tofacitinib|mesh-list
5513098|NCT04378621|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
5513099|NCT04378621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5513100|NCT04378621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5513101|NCT04378621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5513102|NCT04378621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5513103|NCT04378621|Analgesics|analgesics|mesh-ancestor
5513104|NCT04378621|Sensory System Agents|sensory system agents|mesh-ancestor
5513105|NCT04378621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5513106|NCT04378621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513107|NCT04378621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5513108|NCT04378621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5513109|NCT04378621|Immunologic Factors|immunologic factors|mesh-ancestor
5513110|NCT04378621|Dermatologic Agents|dermatologic agents|mesh-ancestor
5513111|NCT04378621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5513112|NCT04378621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5513113|NCT04378621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513114|NCT04378621|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
5513115|NCT04378647|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5513116|NCT04378647|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5513117|NCT04378647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5513118|NCT04378647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5513119|NCT04378647|Immunologic Factors|immunologic factors|mesh-ancestor
5513120|NCT04378647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513121|NCT04378231|Amoxicillin|amoxicillin|mesh-list
5513122|NCT04378231|Clavulanic Acid|clavulanic acid|mesh-list
6078387|NCT00778375|Antiviral Agents|antiviral agents|mesh-ancestor
6078388|NCT00778375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6078389|NCT00778375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6078390|NCT00778375|Immunologic Factors|immunologic factors|mesh-ancestor
6078391|NCT00778375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665441|NCT01517308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513123|NCT04378231|Clavulanic Acids|clavulanic acids|mesh-list
6078392|NCT00778375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6078393|NCT00778622|Metformin|metformin|mesh-list
6078394|NCT00778622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6078395|NCT00778622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078396|NCT00778817|Mitotane|mitotane|mesh-list
5513124|NCT04378231|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5513125|NCT04378231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5513126|NCT04378231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5513127|NCT04378231|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5513128|NCT04378231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5513129|NCT04378231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513130|NCT04378283|Lidocaine|lidocaine|mesh-list
5513131|NCT04378283|Epinephrine|epinephrine|mesh-list
5513132|NCT04378283|Tetracaine|tetracaine|mesh-list
5513133|NCT04378283|Anesthetics|anesthetics|mesh-list
5513134|NCT04378283|Anesthetics, Local|anesthetics, local|mesh-ancestor
5513135|NCT04378283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5513136|NCT04378283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513137|NCT04378283|Sensory System Agents|sensory system agents|mesh-ancestor
5513138|NCT04378283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5513139|NCT04378283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5513140|NCT04378283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5513141|NCT04378283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5513142|NCT04378283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5513143|NCT04378283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078397|NCT00778817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6078398|NCT00778817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6078399|NCT00778830|Cetuximab|cetuximab|mesh-list
6078400|NCT00778830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6078401|NCT00778830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6078402|NCT00778869|Infliximab|infliximab|mesh-list
6078403|NCT00778869|Dermatologic Agents|dermatologic agents|mesh-ancestor
6078404|NCT00778869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6078405|NCT00778869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6078406|NCT00778921|Amlodipine|amlodipine|mesh-list
6078407|NCT00778921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6078408|NCT00778921|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6078409|NCT00778921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6078410|NCT00778921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078411|NCT00778921|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6078412|NCT00778921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078413|NCT00778921|Vasodilator Agents|vasodilator agents|mesh-ancestor
6078414|NCT00779142|Methotrexate|methotrexate|mesh-list
6078415|NCT00779142|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6078416|NCT00779142|Abortifacient Agents|abortifacient agents|mesh-ancestor
6078417|NCT00779142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6078418|NCT00779142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078419|NCT00779142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6078420|NCT00779142|Antimetabolites|antimetabolites|mesh-ancestor
6078421|NCT00779142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078422|NCT00779142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6078423|NCT00779142|Dermatologic Agents|dermatologic agents|mesh-ancestor
6078424|NCT00779142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6078425|NCT00779142|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6078426|NCT00779142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6078427|NCT00779142|Immunologic Factors|immunologic factors|mesh-ancestor
6078428|NCT00779142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6078429|NCT00779142|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6665442|NCT01517308|Immunologic Factors|immunologic factors|mesh-ancestor
6078430|NCT00779246|Chlorhexidine|chlorhexidine|mesh-list
6078431|NCT00779246|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6078432|NCT00779246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6078433|NCT00779246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6078434|NCT00779246|Disinfectants|disinfectants|mesh-ancestor
6078435|NCT00779246|Dermatologic Agents|dermatologic agents|mesh-ancestor
6078436|NCT00779259|Quinine|quinine|mesh-list
6078437|NCT00779259|Theophylline|theophylline|mesh-list
6078438|NCT00779259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6078439|NCT00779259|Autonomic Agents|autonomic agents|mesh-ancestor
6078440|NCT00779259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6078441|NCT00779259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078442|NCT00779259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6078443|NCT00779259|Respiratory System Agents|respiratory system agents|mesh-ancestor
6078444|NCT00779259|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6078445|NCT00779259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6078446|NCT00779259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078447|NCT00779259|Vasodilator Agents|vasodilator agents|mesh-ancestor
6078448|NCT00779259|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6078449|NCT00779259|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6078450|NCT00779259|Purinergic Agents|purinergic agents|mesh-ancestor
6078451|NCT00779259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6078452|NCT00779259|Antimalarials|antimalarials|mesh-ancestor
6078453|NCT00779259|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6078454|NCT00779259|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6078455|NCT00779259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6078456|NCT00779259|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6078457|NCT00779259|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6078458|NCT00779259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6078459|NCT00779259|Analgesics|analgesics|mesh-ancestor
6078460|NCT00779259|Sensory System Agents|sensory system agents|mesh-ancestor
6078461|NCT00779285|Doxorubicin|doxorubicin|mesh-list
6078462|NCT00779285|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6078463|NCT00779285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6078464|NCT00779285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6078465|NCT00779285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6078466|NCT00779285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6078467|NCT00779285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6078468|NCT00779285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078469|NCT00779311|Bevacizumab|bevacizumab|mesh-list
6078470|NCT00779311|Sorafenib|sorafenib|mesh-list
6078471|NCT00779311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6078472|NCT00779311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6078473|NCT00779311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6078474|NCT00779311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6078475|NCT00779311|Growth Substances|growth substances|mesh-ancestor
6078476|NCT00779311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078477|NCT00779311|Growth Inhibitors|growth inhibitors|mesh-ancestor
6078478|NCT00779311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6078479|NCT00779311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6078480|NCT00779311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078481|NCT00779324|Amantadine|amantadine|mesh-list
6078482|NCT00779324|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6078483|NCT00779324|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6078484|NCT00779324|Antiviral Agents|antiviral agents|mesh-ancestor
6078485|NCT00779324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6078486|NCT00779324|Dopamine Agents|dopamine agents|mesh-ancestor
6078487|NCT00779324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6078488|NCT00779324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078489|NCT00779324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078490|NCT00779324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6078491|NCT00779324|Analgesics|analgesics|mesh-ancestor
6463733|NCT00466128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6463734|NCT00466128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6463735|NCT00466128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6463736|NCT00466128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463737|NCT00466154|Aspirin|aspirin|mesh-list
5513144|NCT04378283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5513145|NCT04378283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5513146|NCT04378283|Adrenergic Agents|adrenergic agents|mesh-ancestor
5513147|NCT04378283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5513148|NCT04378283|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5513149|NCT04378283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5513150|NCT04378283|Autonomic Agents|autonomic agents|mesh-ancestor
5513151|NCT04378283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5513152|NCT04378283|Respiratory System Agents|respiratory system agents|mesh-ancestor
5513153|NCT04378283|Mydriatics|mydriatics|mesh-ancestor
5513154|NCT04378283|Sympathomimetics|sympathomimetics|mesh-ancestor
5513155|NCT04378283|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5513156|NCT04377867|Abatacept|abatacept|mesh-list
5513157|NCT04377867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6078492|NCT00779324|Sensory System Agents|sensory system agents|mesh-ancestor
6078493|NCT00779324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6078494|NCT00779467|Fentanyl|fentanyl|mesh-list
6078495|NCT00779467|Bupivacaine|bupivacaine|mesh-list
6078496|NCT00779467|Neostigmine|neostigmine|mesh-list
6078497|NCT00779467|Anesthetics, Local|anesthetics, local|mesh-ancestor
6078498|NCT00779467|Anesthetics|anesthetics|mesh-ancestor
6078499|NCT00779467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6078500|NCT00779467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078501|NCT00779467|Sensory System Agents|sensory system agents|mesh-ancestor
6078502|NCT00779467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6078503|NCT00779467|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6078504|NCT00779467|Narcotics|narcotics|mesh-ancestor
6078505|NCT00779467|Analgesics|analgesics|mesh-ancestor
6078506|NCT00779467|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6078507|NCT00779467|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6078508|NCT00779467|Anesthetics, General|anesthetics, general|mesh-ancestor
6078509|NCT00779467|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5513158|NCT04377867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513159|NCT04377867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5513160|NCT04377867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5513161|NCT04377867|Immunologic Factors|immunologic factors|mesh-ancestor
5513162|NCT04377867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513163|NCT04377867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5513164|NCT04377789|Quercetin|quercetin|mesh-list
5513165|NCT04377789|Antioxidants|antioxidants|mesh-ancestor
5513166|NCT04377789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513167|NCT04377789|Protective Agents|protective agents|mesh-ancestor
5513168|NCT04377789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600473|NCT03711305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5600474|NCT03711305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5600475|NCT03711305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600476|NCT03711292|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5600477|NCT03711292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5600478|NCT03711279|Apatinib|apatinib|mesh-list
5600479|NCT03711279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5600480|NCT03711279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5600481|NCT03711279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5600482|NCT03711279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078510|NCT00779467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6078511|NCT00779467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078512|NCT00779467|Cholinergic Agents|cholinergic agents|mesh-ancestor
6078513|NCT00779467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6078514|NCT00779467|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5600483|NCT03711253|Tenofovir|tenofovir|mesh-list
5600484|NCT03711253|Emtricitabine|emtricitabine|mesh-list
5600485|NCT03711253|Antiviral Agents|antiviral agents|mesh-ancestor
5513169|NCT04377503|Methylprednisolone|methylprednisolone|mesh-list
5513170|NCT04377503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5513171|NCT04377503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5513172|NCT04377503|Prednisolone|prednisolone|mesh-list
5513173|NCT04377503|Prednisolone acetate|prednisolone acetate|mesh-list
5513174|NCT04377503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5513175|NCT04377503|Prednisolone phosphate|prednisolone phosphate|mesh-list
5513176|NCT04377503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5513177|NCT04377503|Antiemetics|antiemetics|mesh-ancestor
5513178|NCT04377503|Autonomic Agents|autonomic agents|mesh-ancestor
5513179|NCT04377503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5513180|NCT04377503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078515|NCT00779467|Autonomic Agents|autonomic agents|mesh-ancestor
6078516|NCT00779506|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6078517|NCT00779506|Antidepressive Agents|antidepressive agents|mesh-ancestor
6078518|NCT00779506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6078519|NCT00779506|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6078520|NCT00779506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6078521|NCT00779506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6078522|NCT00779506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078523|NCT00779558|Heparin|heparin|mesh-list
6078524|NCT00779558|Calcium heparin|calcium heparin|mesh-list
6078525|NCT00779558|Anticoagulants|anticoagulants|mesh-ancestor
6078526|NCT00779558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6078527|NCT00779558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6078528|NCT00779558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463738|NCT00466154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6463739|NCT00466154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5513181|NCT04377503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5513182|NCT04377503|Glucocorticoids|glucocorticoids|mesh-ancestor
5513183|NCT04377503|Hormones|hormones|mesh-ancestor
5513184|NCT04377503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5513185|NCT04377503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5513186|NCT04377503|Protective Agents|protective agents|mesh-ancestor
5513187|NCT04377503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5513188|NCT04377503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5513189|NCT04377646|Zinc|zinc|mesh-list
5513190|NCT04377646|Hydroxychloroquine|hydroxychloroquine|mesh-list
5513191|NCT04377646|Antimalarials|antimalarials|mesh-ancestor
5513192|NCT04377646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5513193|NCT04377646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5513194|NCT04377646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5513195|NCT04377646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5513196|NCT04377646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513197|NCT04377646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5513198|NCT04377646|Trace Elements|trace elements|mesh-ancestor
5513199|NCT04377646|Micronutrients|micronutrients|mesh-ancestor
5513200|NCT04377646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513201|NCT04377555|Ocrelizumab|ocrelizumab|mesh-list
5513202|NCT04377555|Immunologic Factors|immunologic factors|mesh-ancestor
5513203|NCT04377555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513204|NCT04377386|Vitamin D|vitamin d|mesh-list
5513205|NCT04377386|Ergocalciferols|ergocalciferols|mesh-list
5513206|NCT04377386|Vitamins|vitamins|mesh-list
5513207|NCT04377386|Micronutrients|micronutrients|mesh-ancestor
5513208|NCT04377386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513209|NCT04377386|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5513210|NCT04377386|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6463740|NCT00466154|Analgesics|analgesics|mesh-ancestor
6463741|NCT00466154|Sensory System Agents|sensory system agents|mesh-ancestor
6463742|NCT00466154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6463743|NCT00466154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078529|NCT00779584|Gemcitabine|gemcitabine|mesh-list
6078530|NCT00779584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6078531|NCT00779584|Antimetabolites|antimetabolites|mesh-ancestor
6078532|NCT00779584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078533|NCT00779584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6078534|NCT00779584|Antiviral Agents|antiviral agents|mesh-ancestor
6078535|NCT00779584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6078536|NCT00779584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6078537|NCT00779584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6078538|NCT00779584|Immunologic Factors|immunologic factors|mesh-ancestor
6078539|NCT00779584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513211|NCT04377399|Vitamin D|vitamin d|mesh-list
5513212|NCT04377399|Vitamins|vitamins|mesh-ancestor
5513213|NCT04377399|Micronutrients|micronutrients|mesh-ancestor
6202843|NCT02046616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6078540|NCT00779675|Infliximab|infliximab|mesh-list
6078541|NCT00779675|Dermatologic Agents|dermatologic agents|mesh-ancestor
6078542|NCT00779675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6078543|NCT00779675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6078544|NCT00779701|Insulin|insulin|mesh-list
6078545|NCT00779701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6078546|NCT00779701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078547|NCT00779909|Vitamin D|vitamin d|mesh-list
6078548|NCT00779909|Cholecalciferol|cholecalciferol|mesh-list
6078549|NCT00779909|Vitamins|vitamins|mesh-ancestor
6078550|NCT00779909|Micronutrients|micronutrients|mesh-ancestor
6078551|NCT00779909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078552|NCT00779909|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6078553|NCT00779909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6078554|NCT00780026|Insulin|insulin|mesh-list
6078555|NCT00780026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6078556|NCT00780026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078557|NCT00780143|Cytarabine|cytarabine|mesh-list
6078558|NCT00780143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6078559|NCT00780143|Antimetabolites|antimetabolites|mesh-ancestor
6078560|NCT00780143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078561|NCT00780143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6078562|NCT00780143|Antiviral Agents|antiviral agents|mesh-ancestor
6078563|NCT00780143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6078564|NCT00780143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6078565|NCT00780143|Immunologic Factors|immunologic factors|mesh-ancestor
6078566|NCT00780143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078567|NCT00780208|Methylphenidate|methylphenidate|mesh-list
6078568|NCT00780208|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6078569|NCT00780208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078570|NCT00780208|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6078571|NCT00780208|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6078572|NCT00780208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6078573|NCT00780208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078574|NCT00780208|Dopamine Agents|dopamine agents|mesh-ancestor
6078575|NCT00780208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6078576|NCT00780234|Pioglitazone|pioglitazone|mesh-list
6078577|NCT00780234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6078578|NCT00780234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078579|NCT00780273|Cimetidine|cimetidine|mesh-list
6078580|NCT00780273|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6078581|NCT00780273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6078582|NCT00780273|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6078583|NCT00780273|Histamine Antagonists|histamine antagonists|mesh-ancestor
6078584|NCT00780273|Histamine Agents|histamine agents|mesh-ancestor
6078585|NCT00780273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6078586|NCT00780273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078587|NCT00780273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078588|NCT00780273|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6078589|NCT00780273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6078590|NCT00780273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6078591|NCT00780416|Ribavirin|ribavirin|mesh-list
6078592|NCT00780416|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6078593|NCT00780416|Interferon-alpha|interferon-alpha|mesh-list
6078594|NCT00780416|Antimetabolites|antimetabolites|mesh-ancestor
6078595|NCT00780416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078596|NCT00780416|Antiviral Agents|antiviral agents|mesh-ancestor
6078597|NCT00780416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6078598|NCT00780416|Immunologic Factors|immunologic factors|mesh-ancestor
6078599|NCT00780416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078600|NCT00780442|Cycloserine|cycloserine|mesh-list
6078601|NCT00780442|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6078602|NCT00780442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6078603|NCT00780442|Renal Agents|renal agents|mesh-ancestor
6078604|NCT00780442|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6078605|NCT00780442|Antitubercular Agents|antitubercular agents|mesh-ancestor
6078606|NCT00780442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6078607|NCT00780442|Antimetabolites|antimetabolites|mesh-ancestor
6078608|NCT00780442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078609|NCT00780494|Bevacizumab|bevacizumab|mesh-list
6078610|NCT00780494|Carboplatin|carboplatin|mesh-list
6078611|NCT00780494|Capecitabine|capecitabine|mesh-list
6078612|NCT00780494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6078613|NCT00780494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6078614|NCT00780494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6078615|NCT00780494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6078616|NCT00780494|Growth Substances|growth substances|mesh-ancestor
6078617|NCT00780494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078618|NCT00780494|Growth Inhibitors|growth inhibitors|mesh-ancestor
6078619|NCT00780494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6078620|NCT00780494|Antimetabolites|antimetabolites|mesh-ancestor
6078621|NCT00780494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078622|NCT00780676|Dasatinib|dasatinib|mesh-list
6078623|NCT00780676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6078624|NCT00780676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6078625|NCT00780676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6078626|NCT00780676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078627|NCT00780715|Metformin|metformin|mesh-list
6078628|NCT00780715|Pioglitazone|pioglitazone|mesh-list
6078629|NCT00780715|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6078630|NCT00780715|Gliclazide|gliclazide|mesh-list
6078631|NCT00780715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6078632|NCT00780715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078633|NCT00780715|Incretins|incretins|mesh-ancestor
6078634|NCT00780715|Hormones|hormones|mesh-ancestor
6078635|NCT00780715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6078636|NCT00780715|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6078637|NCT00780715|Protease Inhibitors|protease inhibitors|mesh-ancestor
6078638|NCT00780715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6078639|NCT00780715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078640|NCT00780910|Ribavirin|ribavirin|mesh-list
6078641|NCT00780910|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6078642|NCT00780910|Antimetabolites|antimetabolites|mesh-ancestor
6078643|NCT00780910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078644|NCT00780910|Antiviral Agents|antiviral agents|mesh-ancestor
6078645|NCT00780910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6078646|NCT00780962|Acetylcysteine|acetylcysteine|mesh-list
6078647|NCT00780962|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6078648|NCT00780962|Antiviral Agents|antiviral agents|mesh-ancestor
6078649|NCT00780962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6078650|NCT00780962|Expectorants|expectorants|mesh-ancestor
6078651|NCT00780962|Respiratory System Agents|respiratory system agents|mesh-ancestor
6078652|NCT00780962|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6078653|NCT00780962|Antioxidants|antioxidants|mesh-ancestor
6078654|NCT00780962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078655|NCT00780962|Protective Agents|protective agents|mesh-ancestor
6078656|NCT00780962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078657|NCT00780962|Antidotes|antidotes|mesh-ancestor
6078658|NCT00781274|Ribavirin|ribavirin|mesh-list
6078659|NCT00781274|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6463744|NCT00466154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6463745|NCT00466154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6463746|NCT00466154|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6078660|NCT00781274|Antimetabolites|antimetabolites|mesh-ancestor
6078661|NCT00781274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078662|NCT00781274|Antiviral Agents|antiviral agents|mesh-ancestor
6078663|NCT00781274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6078664|NCT00781326|Nimodipine|nimodipine|mesh-list
6078665|NCT00781326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6078666|NCT00781326|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6078667|NCT00781326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6078668|NCT00781326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078669|NCT00781326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6078670|NCT00781326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078671|NCT00781326|Vasodilator Agents|vasodilator agents|mesh-ancestor
6078672|NCT00781391|Warfarin|warfarin|mesh-list
6078673|NCT00781391|Edoxaban|edoxaban|mesh-list
6078674|NCT00781391|Anticoagulants|anticoagulants|mesh-ancestor
6078675|NCT00781391|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6078676|NCT00781391|Antithrombins|antithrombins|mesh-ancestor
6078677|NCT00781391|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6078678|NCT00781391|Protease Inhibitors|protease inhibitors|mesh-ancestor
6078679|NCT00781391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6078680|NCT00781391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078681|NCT00781456|Contraceptive Agents|contraceptive agents|mesh-list
6078682|NCT00781456|Levonorgestrel|levonorgestrel|mesh-list
6078683|NCT00781456|Contraceptives, Oral|contraceptives, oral|mesh-list
6078684|NCT00781456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6078685|NCT00781456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078686|NCT00781456|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6078687|NCT00781456|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6463747|NCT00466154|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5513214|NCT04377399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078688|NCT00781456|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6078689|NCT00781508|Sildenafil Citrate|sildenafil citrate|mesh-list
6078690|NCT00781508|Vasodilator Agents|vasodilator agents|mesh-ancestor
6078691|NCT00781508|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6078692|NCT00781508|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6078693|NCT00781508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6078694|NCT00781508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078695|NCT00781508|Urological Agents|urological agents|mesh-ancestor
6078696|NCT00781599|Varenicline|varenicline|mesh-list
6078697|NCT00781599|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6078698|NCT00781599|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6078699|NCT00781599|Cholinergic Agents|cholinergic agents|mesh-ancestor
5513215|NCT04377399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5513216|NCT04377321|Colchicine|colchicine|mesh-list
5513217|NCT04377321|Gout Suppressants|gout suppressants|mesh-ancestor
5513218|NCT04377321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6078700|NCT00781599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6078701|NCT00781599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078702|NCT00781599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078703|NCT00781768|Ondansetron|ondansetron|mesh-list
6078704|NCT00781768|Aprepitant|aprepitant|mesh-list
6078705|NCT00781768|Antiemetics|antiemetics|mesh-ancestor
6078706|NCT00781768|Autonomic Agents|autonomic agents|mesh-ancestor
6078707|NCT00781768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6078708|NCT00781768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078709|NCT00781768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6078710|NCT00781768|Antipruritics|antipruritics|mesh-ancestor
5513219|NCT04377321|Tubulin Modulators|tubulin modulators|mesh-ancestor
5513220|NCT04377321|Antimitotic Agents|antimitotic agents|mesh-ancestor
5513221|NCT04377321|Mitosis Modulators|mitosis modulators|mesh-ancestor
5513222|NCT04377321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513223|NCT04377321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5513224|NCT04377087|Olaparib|olaparib|mesh-list
5513225|NCT04377087|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5513226|NCT04377087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5513227|NCT04377087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513228|NCT04377087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5513229|NCT04377204|Lidocaine|lidocaine|mesh-list
5513230|NCT04377204|Bupivacaine|bupivacaine|mesh-list
5513231|NCT04377204|Anesthetics, Local|anesthetics, local|mesh-ancestor
5513232|NCT04377204|Anesthetics|anesthetics|mesh-ancestor
5513233|NCT04377204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5513234|NCT04377204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513235|NCT04377204|Sensory System Agents|sensory system agents|mesh-ancestor
5513236|NCT04377204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6078711|NCT00781768|Dermatologic Agents|dermatologic agents|mesh-ancestor
6078712|NCT00781768|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6078713|NCT00781768|Serotonin Agents|serotonin agents|mesh-ancestor
6078714|NCT00781768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6078715|NCT00781768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078716|NCT00781768|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6078717|NCT00781768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6078718|NCT00781768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6078719|NCT00781768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6078720|NCT00781768|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6078721|NCT00781768|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6078722|NCT00781859|Plasminogen|plasminogen|mesh-list
6078723|NCT00781859|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6078724|NCT00781859|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5513237|NCT04377204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5513238|NCT04377204|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5513239|NCT04377204|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5513240|NCT04377204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5513241|NCT04377204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513242|NCT04377308|Fluoxetine|fluoxetine|mesh-list
5513243|NCT04377308|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5513244|NCT04377308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5513245|NCT04377308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6078725|NCT00781859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078726|NCT00781885|Beraprost|beraprost|mesh-list
6665443|NCT01517308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665444|NCT01517321|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6078727|NCT00781885|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5513246|NCT04377308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513247|NCT04377308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5513248|NCT04377308|Serotonin Agents|serotonin agents|mesh-ancestor
5513249|NCT04377308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513250|NCT04377308|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5513251|NCT04377308|Antidepressive Agents|antidepressive agents|mesh-ancestor
5513252|NCT04377308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5513253|NCT04377308|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5513254|NCT04377308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5513255|NCT04377308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5513256|NCT04376970|Fluorometholone|fluorometholone|mesh-list
5513257|NCT04376970|Cyclosporine|cyclosporine|mesh-list
5513258|NCT04376970|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6078728|NCT00781885|Vasodilator Agents|vasodilator agents|mesh-ancestor
6078729|NCT00781898|Naltrexone|naltrexone|mesh-list
6078730|NCT00781898|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5513259|NCT04376970|Cyclosporins|cyclosporins|mesh-list
5513260|NCT04376970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5513261|NCT04376970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513262|NCT04376970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5513263|NCT04376970|Immunologic Factors|immunologic factors|mesh-ancestor
5513264|NCT04376970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513265|NCT04376970|Antifungal Agents|antifungal agents|mesh-ancestor
5513266|NCT04376970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5513267|NCT04376970|Dermatologic Agents|dermatologic agents|mesh-ancestor
5513268|NCT04376970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5513269|NCT04376970|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5513270|NCT04376970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6078731|NCT00781898|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6078732|NCT00781898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078733|NCT00781898|Sensory System Agents|sensory system agents|mesh-ancestor
6078734|NCT00781898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6078735|NCT00781911|Octreotide|octreotide|mesh-list
6078736|NCT00781911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6078737|NCT00781911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6078738|NCT00781911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6078739|NCT00781937|Liraglutide|liraglutide|mesh-list
6078740|NCT00781937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6078741|NCT00781937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078742|NCT00781937|Incretins|incretins|mesh-ancestor
6078743|NCT00781937|Hormones|hormones|mesh-ancestor
6078744|NCT00781937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6078745|NCT00782067|Midostaurin|midostaurin|mesh-list
6078746|NCT00782067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6078747|NCT00782067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5513271|NCT04376970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6078748|NCT00782067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6078749|NCT00782067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078750|NCT00782210|Olodaterol|olodaterol|mesh-list
6078751|NCT00782210|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6078752|NCT00782210|Autonomic Agents|autonomic agents|mesh-ancestor
6078753|NCT00782210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6078754|NCT00782210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078755|NCT00782210|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6078756|NCT00782210|Respiratory System Agents|respiratory system agents|mesh-ancestor
6078757|NCT00782275|Sirolimus|sirolimus|mesh-list
6078758|NCT00782275|Bevacizumab|bevacizumab|mesh-list
6078759|NCT00782275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6078760|NCT00782275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6078761|NCT00782275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6078762|NCT00782275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6078763|NCT00782275|Growth Substances|growth substances|mesh-ancestor
6078764|NCT00782275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078765|NCT00782275|Growth Inhibitors|growth inhibitors|mesh-ancestor
6078766|NCT00782275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6078767|NCT00782275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6078768|NCT00782275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6078769|NCT00782275|Antifungal Agents|antifungal agents|mesh-ancestor
6078770|NCT00782275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6078771|NCT00782275|Immunologic Factors|immunologic factors|mesh-ancestor
6078772|NCT00782288|Digitoxin|digitoxin|mesh-list
6078773|NCT00782288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6078774|NCT00782288|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6078775|NCT00782288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6078776|NCT00782288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513272|NCT04376970|Glucocorticoids|glucocorticoids|mesh-ancestor
5513273|NCT04376970|Hormones|hormones|mesh-ancestor
5513274|NCT04376970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5513275|NCT04376970|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5513276|NCT04377048|Gemcitabine|gemcitabine|mesh-list
5513277|NCT04377048|Tegafur|tegafur|mesh-list
5513278|NCT04377048|Nivolumab|nivolumab|mesh-list
5513279|NCT04377048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5513280|NCT04377048|Antimetabolites|antimetabolites|mesh-ancestor
5513281|NCT04377048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513282|NCT04377048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5513283|NCT04377048|Antiviral Agents|antiviral agents|mesh-ancestor
5513284|NCT04377048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5513285|NCT04377048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5513286|NCT04377048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5513287|NCT04377048|Immunologic Factors|immunologic factors|mesh-ancestor
5513288|NCT04377048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513289|NCT04377048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5513290|NCT04377048|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5513291|NCT04376788|Methylene Blue|methylene blue|mesh-list
6078777|NCT00782288|Protective Agents|protective agents|mesh-ancestor
6078778|NCT00782288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078779|NCT00782340|Droxidopa|droxidopa|mesh-list
6078780|NCT00782340|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6078781|NCT00782340|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6078782|NCT00782379|Mycophenolic Acid|mycophenolic acid|mesh-list
6078783|NCT00782379|Cyclophosphamide|cyclophosphamide|mesh-list
6078784|NCT00782379|Busulfan|busulfan|mesh-list
6078785|NCT00782379|Fludarabine|fludarabine|mesh-list
6078786|NCT00782379|Fludarabine phosphate|fludarabine phosphate|mesh-list
6078787|NCT00782379|Tacrolimus|tacrolimus|mesh-list
5513292|NCT04376788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5513293|NCT04376788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513294|NCT04376528|Cyclosporine|cyclosporine|mesh-list
5513295|NCT04376528|Mycophenolic Acid|mycophenolic acid|mesh-list
5513296|NCT04376528|Cyclosporins|cyclosporins|mesh-list
5513297|NCT04376528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5513298|NCT04376528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513299|NCT04376528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6078788|NCT00782379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5513300|NCT04376528|Immunologic Factors|immunologic factors|mesh-ancestor
5513301|NCT04376528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078789|NCT00782379|Immunologic Factors|immunologic factors|mesh-ancestor
6078790|NCT00782379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078791|NCT00782379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6078792|NCT00782379|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6078793|NCT00782379|Alkylating Agents|alkylating agents|mesh-ancestor
6078794|NCT00782379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078795|NCT00782379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6078796|NCT00782379|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6078797|NCT00782379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6078798|NCT00782379|Antimetabolites|antimetabolites|mesh-ancestor
6078799|NCT00782379|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6078800|NCT00782379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6078801|NCT00782379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6078802|NCT00782379|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6078803|NCT00782379|Antitubercular Agents|antitubercular agents|mesh-ancestor
6078804|NCT00782379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6078805|NCT00782379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6078806|NCT00782418|Exenatide|exenatide|mesh-list
6078807|NCT00782418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6078808|NCT00782418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078809|NCT00782418|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5513302|NCT04376528|Antifungal Agents|antifungal agents|mesh-ancestor
5513303|NCT04376528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5513304|NCT04376528|Dermatologic Agents|dermatologic agents|mesh-ancestor
5513305|NCT04376528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5513306|NCT04376528|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5513307|NCT04376528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5513308|NCT04376528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5513309|NCT04376528|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6078810|NCT00782418|Incretins|incretins|mesh-ancestor
6078811|NCT00782418|Hormones|hormones|mesh-ancestor
6078812|NCT00782418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5513310|NCT04376528|Antitubercular Agents|antitubercular agents|mesh-ancestor
5513311|NCT04376528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5513312|NCT04376814|Ritonavir|ritonavir|mesh-list
5513313|NCT04376814|Lopinavir|lopinavir|mesh-list
5513314|NCT04376814|Hydroxychloroquine|hydroxychloroquine|mesh-list
5513315|NCT04376814|Favipiravir|favipiravir|mesh-list
5513316|NCT04376814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5513317|NCT04376814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5513318|NCT04376814|Protease Inhibitors|protease inhibitors|mesh-ancestor
5513319|NCT04376814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5513320|NCT04376814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513321|NCT04376814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5513322|NCT04376814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5513323|NCT04376814|Antiviral Agents|antiviral agents|mesh-ancestor
5513324|NCT04376814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5513325|NCT04376814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5513326|NCT04376814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5513327|NCT04376814|Antimalarials|antimalarials|mesh-ancestor
5513328|NCT04376814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5513329|NCT04376814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5513330|NCT04376814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5513331|NCT04376554|Amoxicillin|amoxicillin|mesh-list
5513332|NCT04376554|Clavulanic Acid|clavulanic acid|mesh-list
5513333|NCT04376554|Clavulanic Acids|clavulanic acids|mesh-list
5513334|NCT04376554|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5513335|NCT04376554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5513336|NCT04376554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5513337|NCT04376554|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5513338|NCT04376554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5513339|NCT04376554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513340|NCT04376541|Fentanyl|fentanyl|mesh-list
5513341|NCT04376541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5513342|NCT04376541|Narcotics|narcotics|mesh-ancestor
5513343|NCT04376541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5513344|NCT04376541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513345|NCT04376541|Analgesics|analgesics|mesh-ancestor
5513346|NCT04376541|Sensory System Agents|sensory system agents|mesh-ancestor
5513347|NCT04376541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5513348|NCT04376541|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5513349|NCT04376541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6078813|NCT00782509|Olodaterol|olodaterol|mesh-list
6078814|NCT00782509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6078815|NCT00782509|Autonomic Agents|autonomic agents|mesh-ancestor
6078816|NCT00782509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6078817|NCT00782509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078818|NCT00782509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6078819|NCT00782509|Respiratory System Agents|respiratory system agents|mesh-ancestor
6078820|NCT00782626|Everolimus|everolimus|mesh-list
6078821|NCT00782626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6078822|NCT00782626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6078823|NCT00782626|Immunologic Factors|immunologic factors|mesh-ancestor
6078824|NCT00782626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078825|NCT00782717|Prednisolone|prednisolone|mesh-list
5513350|NCT04376541|Anesthetics, General|anesthetics, general|mesh-ancestor
5513351|NCT04376541|Anesthetics|anesthetics|mesh-ancestor
5513352|NCT04376307|Anesthetics|anesthetics|mesh-list
5513353|NCT04376307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5513354|NCT04376307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513355|NCT04376073|Niraparib|niraparib|mesh-list
5513356|NCT04376073|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5513357|NCT04376073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5513358|NCT04376073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513359|NCT04376073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5600486|NCT03711253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6078826|NCT00782717|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6078827|NCT00782717|Methylprednisolone|methylprednisolone|mesh-list
6078828|NCT00782717|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6078829|NCT00782717|Prednisolone acetate|prednisolone acetate|mesh-list
6078830|NCT00782717|Nepafenac|nepafenac|mesh-list
6078831|NCT00782717|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6078832|NCT00782717|Prednisolone phosphate|prednisolone phosphate|mesh-list
6078833|NCT00782717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6078834|NCT00782717|Glucocorticoids|glucocorticoids|mesh-ancestor
6078835|NCT00782717|Hormones|hormones|mesh-ancestor
6078836|NCT00782717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6078837|NCT00782717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600487|NCT03711253|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5600488|NCT03711253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5600489|NCT03711253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5600490|NCT03711253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600491|NCT03711253|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5600492|NCT03711253|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5600493|NCT03711240|Leucovorin|leucovorin|mesh-list
5600494|NCT03711240|Bevacizumab|bevacizumab|mesh-list
6078838|NCT00782717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6078839|NCT00782717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6078840|NCT00782717|Antiemetics|antiemetics|mesh-ancestor
6078841|NCT00782717|Autonomic Agents|autonomic agents|mesh-ancestor
6463748|NCT00466154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463749|NCT00466154|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6463750|NCT00466154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6463751|NCT00466154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6463752|NCT00466154|Antipyretics|antipyretics|mesh-ancestor
6463753|NCT00466180|Nevirapine|nevirapine|mesh-list
6463754|NCT00466180|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6463755|NCT00466180|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6463756|NCT00466180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6463757|NCT00466180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463758|NCT00466180|Antiviral Agents|antiviral agents|mesh-ancestor
6078842|NCT00782717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6078843|NCT00782717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6078844|NCT00782717|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6078845|NCT00782717|Protective Agents|protective agents|mesh-ancestor
6078846|NCT00782717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6078847|NCT00782717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6078848|NCT00782717|Analgesics|analgesics|mesh-ancestor
6078849|NCT00782717|Sensory System Agents|sensory system agents|mesh-ancestor
6078850|NCT00782717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6078851|NCT00782756|Bevacizumab|bevacizumab|mesh-list
6078852|NCT00782756|Temozolomide|temozolomide|mesh-list
6078853|NCT00782756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6078854|NCT00782756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6078855|NCT00782756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6078856|NCT00782756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6078857|NCT00782756|Growth Substances|growth substances|mesh-ancestor
6078858|NCT00782756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078859|NCT00782756|Growth Inhibitors|growth inhibitors|mesh-ancestor
6078860|NCT00782756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6078861|NCT00782756|Alkylating Agents|alkylating agents|mesh-ancestor
6078862|NCT00782756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078863|NCT00782795|Pioglitazone|pioglitazone|mesh-list
6078864|NCT00782795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6078865|NCT00782795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078866|NCT00782821|Rituximab|rituximab|mesh-list
6078867|NCT00782821|Bortezomib|bortezomib|mesh-list
6078868|NCT00782821|Thymoglobulin|thymoglobulin|mesh-list
6078869|NCT00782821|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6078870|NCT00782821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6078871|NCT00782821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6078872|NCT00782821|Immunologic Factors|immunologic factors|mesh-ancestor
6078873|NCT00782821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078874|NCT00782821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6078875|NCT00782821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6078876|NCT00783094|Tadalafil|tadalafil|mesh-list
6078877|NCT00783094|Vasodilator Agents|vasodilator agents|mesh-ancestor
6078878|NCT00783094|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6078879|NCT00783094|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6078880|NCT00783094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6078881|NCT00783094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078882|NCT00783094|Urological Agents|urological agents|mesh-ancestor
6078883|NCT00783289|Benralizumab|benralizumab|mesh-list
6078884|NCT00783289|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6078885|NCT00783289|Respiratory System Agents|respiratory system agents|mesh-ancestor
6078886|NCT00783367|Dexamethasone|dexamethasone|mesh-list
6078887|NCT00783367|Dexamethasone acetate|dexamethasone acetate|mesh-list
6078888|NCT00783367|Rituximab|rituximab|mesh-list
6078889|NCT00783367|Lenalidomide|lenalidomide|mesh-list
6078890|NCT00783367|BB 1101|bb 1101|mesh-list
6078891|NCT00783367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5513360|NCT04376086|Anesthetics|anesthetics|mesh-list
5513361|NCT04376086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5513362|NCT04376086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513363|NCT04376216|Prednisone|prednisone|mesh-list
5513364|NCT04376216|Prednisolone|prednisolone|mesh-list
5513365|NCT04376216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5513366|NCT04376216|Glucocorticoids|glucocorticoids|mesh-ancestor
5513367|NCT04376216|Hormones|hormones|mesh-ancestor
5513368|NCT04376216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5513369|NCT04376216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513370|NCT04376216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5513371|NCT04376216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6078892|NCT00783367|Antiemetics|antiemetics|mesh-ancestor
6078893|NCT00783367|Autonomic Agents|autonomic agents|mesh-ancestor
6078894|NCT00783367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6078895|NCT00783367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078896|NCT00783367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6078897|NCT00783367|Glucocorticoids|glucocorticoids|mesh-ancestor
6078898|NCT00783367|Hormones|hormones|mesh-ancestor
6078899|NCT00783367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6078900|NCT00783367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6078901|NCT00783367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6078902|NCT00783367|Protease Inhibitors|protease inhibitors|mesh-ancestor
5513372|NCT04375995|Nitric Oxide|nitric oxide|mesh-list
5513373|NCT04375995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5513374|NCT04375995|Autonomic Agents|autonomic agents|mesh-ancestor
5513375|NCT04375995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5513376|NCT04375995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513377|NCT04375995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5513378|NCT04375995|Respiratory System Agents|respiratory system agents|mesh-ancestor
5513379|NCT04375995|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5513380|NCT04375995|Antioxidants|antioxidants|mesh-ancestor
5513381|NCT04375995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513382|NCT04375995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5513383|NCT04375995|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5513384|NCT04375995|Vasodilator Agents|vasodilator agents|mesh-ancestor
5513385|NCT04375995|Gasotransmitters|gasotransmitters|mesh-ancestor
5513386|NCT04375995|Protective Agents|protective agents|mesh-ancestor
5513387|NCT04375943|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
5513388|NCT04375943|Hypoglycemic Agents|hypoglycemic agents|mesh-list
5513389|NCT04375943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600495|NCT03711240|Oxaliplatin|oxaliplatin|mesh-list
6078903|NCT00783367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6202844|NCT02046616|Antimetabolites|antimetabolites|mesh-ancestor
5513390|NCT04375943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513391|NCT04375852|Autoantibodies|autoantibodies|mesh-list
5513392|NCT04375852|Immunologic Factors|immunologic factors|mesh-ancestor
5513393|NCT04375852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513394|NCT04375683|HH-GV-678|hh-gv-678|mesh-list
5513395|NCT04375683|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5513396|NCT04375683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5513397|NCT04375683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513398|NCT04375527|Nivolumab|nivolumab|mesh-list
5513399|NCT04375527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5513400|NCT04375527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5513401|NCT04375527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5513402|NCT04375527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513403|NCT04375605|Leucovorin|leucovorin|mesh-list
5513404|NCT04375605|Docetaxel|docetaxel|mesh-list
5513405|NCT04375605|Fluorouracil|fluorouracil|mesh-list
5513406|NCT04375605|Oxaliplatin|oxaliplatin|mesh-list
5513407|NCT04375605|Calcium|calcium|mesh-list
5513408|NCT04375605|Levoleucovorin|levoleucovorin|mesh-list
5513409|NCT04375605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5513410|NCT04375605|Tubulin Modulators|tubulin modulators|mesh-ancestor
5513411|NCT04375605|Antimitotic Agents|antimitotic agents|mesh-ancestor
5513412|NCT04375605|Mitosis Modulators|mitosis modulators|mesh-ancestor
5513413|NCT04375605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513414|NCT04375605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5513415|NCT04375605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513416|NCT04375605|Antimetabolites|antimetabolites|mesh-ancestor
5513417|NCT04375605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5513418|NCT04375605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5513419|NCT04375605|Immunologic Factors|immunologic factors|mesh-ancestor
5513420|NCT04375605|Antidotes|antidotes|mesh-ancestor
5513421|NCT04375605|Protective Agents|protective agents|mesh-ancestor
5513422|NCT04375605|Vitamin B Complex|vitamin b complex|mesh-ancestor
5513423|NCT04375605|Vitamins|vitamins|mesh-ancestor
6078904|NCT00783367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078905|NCT00783367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6078906|NCT00783367|Immunologic Factors|immunologic factors|mesh-ancestor
6078907|NCT00783367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6078908|NCT00783367|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6078909|NCT00783367|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6078910|NCT00783367|Growth Substances|growth substances|mesh-ancestor
6078911|NCT00783367|Growth Inhibitors|growth inhibitors|mesh-ancestor
6078912|NCT00783432|Azelastine|azelastine|mesh-list
6078913|NCT00783432|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6078914|NCT00783432|Autonomic Agents|autonomic agents|mesh-ancestor
6078915|NCT00783432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6078916|NCT00783432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078917|NCT00783432|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6078918|NCT00783432|Respiratory System Agents|respiratory system agents|mesh-ancestor
6078919|NCT00783432|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6078920|NCT00783432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6078921|NCT00783432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078922|NCT00783432|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6078923|NCT00783432|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6078924|NCT00783432|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6078925|NCT00783432|Histamine Antagonists|histamine antagonists|mesh-ancestor
6078926|NCT00783432|Histamine Agents|histamine agents|mesh-ancestor
6078927|NCT00783432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6078928|NCT00783614|Aspirin|aspirin|mesh-list
6078929|NCT00783614|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6078930|NCT00783614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6078931|NCT00783614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6078932|NCT00783614|Analgesics|analgesics|mesh-ancestor
6078933|NCT00783614|Sensory System Agents|sensory system agents|mesh-ancestor
6078934|NCT00783614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6078935|NCT00783614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078936|NCT00783614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6078937|NCT00783614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6078938|NCT00783614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6078939|NCT00783614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6078940|NCT00783614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078941|NCT00783614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6078942|NCT00783614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5513424|NCT04375605|Micronutrients|micronutrients|mesh-ancestor
5513425|NCT04374981|Celecoxib|celecoxib|mesh-list
6078943|NCT00783614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6078944|NCT00783614|Antipyretics|antipyretics|mesh-ancestor
6078945|NCT00783614|Antiviral Agents|antiviral agents|mesh-ancestor
6078946|NCT00783614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6078947|NCT00783692|Vedolizumab|vedolizumab|mesh-list
6463759|NCT00466180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6463760|NCT00466180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6463761|NCT00466180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5513426|NCT04374981|Montelukast|montelukast|mesh-list
5513427|NCT04374981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5513428|NCT04374981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5513429|NCT04374981|Analgesics|analgesics|mesh-ancestor
5513430|NCT04374981|Sensory System Agents|sensory system agents|mesh-ancestor
5513431|NCT04374981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5513432|NCT04374981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513433|NCT04374981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5513434|NCT04374981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5513435|NCT04374981|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5513436|NCT04374981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5513437|NCT04374981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5513438|NCT04374981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513439|NCT04374981|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5513440|NCT04374981|Respiratory System Agents|respiratory system agents|mesh-ancestor
5513441|NCT04374981|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5513442|NCT04374981|Hormone Antagonists|hormone antagonists|mesh-ancestor
5513443|NCT04374981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5513444|NCT04374981|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5513445|NCT04374981|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5513446|NCT04375228|Rituximab|rituximab|mesh-list
5513447|NCT04375228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5513448|NCT04375228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5513449|NCT04375228|Immunologic Factors|immunologic factors|mesh-ancestor
5513450|NCT04375228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513451|NCT04375228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5513452|NCT04375267|Olaparib|olaparib|mesh-list
5513453|NCT04375267|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
5600496|NCT03711240|Irinotecan|irinotecan|mesh-list
6078948|NCT00783692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6078949|NCT00783705|Inositol|inositol|mesh-list
6463762|NCT00466180|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6463763|NCT00466180|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6463764|NCT00466219|Interferons|interferons|mesh-list
6463765|NCT00466219|Ribavirin|ribavirin|mesh-list
6463766|NCT00466219|Interferon-alpha|interferon-alpha|mesh-list
6463767|NCT00466219|Interferon alpha-2|interferon alpha-2|mesh-list
6078950|NCT00783705|Vitamin B Complex|vitamin b complex|mesh-ancestor
6078951|NCT00783705|Vitamins|vitamins|mesh-ancestor
6078952|NCT00783705|Micronutrients|micronutrients|mesh-ancestor
6078953|NCT00783705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078954|NCT00783718|Vedolizumab|vedolizumab|mesh-list
6078955|NCT00783718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6078956|NCT00783796|Everolimus|everolimus|mesh-list
6078957|NCT00783796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6078958|NCT00783796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6078959|NCT00783796|Immunologic Factors|immunologic factors|mesh-ancestor
6078960|NCT00783796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078961|NCT00783835|Methylphenidate|methylphenidate|mesh-list
6078962|NCT00783835|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6078963|NCT00783835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078964|NCT00783835|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6078965|NCT00783835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6078966|NCT00783835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6078967|NCT00783835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463768|NCT00466219|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6463769|NCT00466219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6463770|NCT00466219|Antiviral Agents|antiviral agents|mesh-ancestor
6078968|NCT00783835|Dopamine Agents|dopamine agents|mesh-ancestor
6078969|NCT00783835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6078970|NCT00783965|Tazarotene|tazarotene|mesh-list
5513454|NCT04375267|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5513455|NCT04375267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5513456|NCT04375267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513457|NCT04375267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5513458|NCT04375267|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5513459|NCT04375202|Colchicine|colchicine|mesh-list
5513460|NCT04375202|Gout Suppressants|gout suppressants|mesh-ancestor
5513461|NCT04375202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5513462|NCT04375202|Tubulin Modulators|tubulin modulators|mesh-ancestor
5513463|NCT04375202|Antimitotic Agents|antimitotic agents|mesh-ancestor
5513464|NCT04375202|Mitosis Modulators|mitosis modulators|mesh-ancestor
5513465|NCT04375202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513466|NCT04375202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6078971|NCT00783965|Dermatologic Agents|dermatologic agents|mesh-ancestor
6078972|NCT00783965|Keratolytic Agents|keratolytic agents|mesh-ancestor
6078973|NCT00784134|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6078974|NCT00784134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6078975|NCT00784134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6078976|NCT00784134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078977|NCT00784147|Ibalizumab|ibalizumab|mesh-list
5513467|NCT04374929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
5513468|NCT04374929|Glucocorticoids|glucocorticoids|mesh-list
5513469|NCT04374929|Hormones|hormones|mesh-ancestor
5513470|NCT04374929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5513471|NCT04374929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513472|NCT04374942|Hydroxychloroquine|hydroxychloroquine|mesh-list
6078978|NCT00784147|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6078979|NCT00784147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6078980|NCT00784147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6078981|NCT00784147|Antiviral Agents|antiviral agents|mesh-ancestor
6078982|NCT00784147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6078983|NCT00784147|Immunologic Factors|immunologic factors|mesh-ancestor
6078984|NCT00784147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078985|NCT00784225|Vitamins|vitamins|mesh-list
6463771|NCT00466219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6463772|NCT00466219|Antimetabolites|antimetabolites|mesh-ancestor
6463773|NCT00466219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463774|NCT00466219|Immunologic Factors|immunologic factors|mesh-ancestor
6463775|NCT00466219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6078986|NCT00784225|Vitamin E|vitamin e|mesh-list
6078987|NCT00784225|Tocopherols|tocopherols|mesh-list
6078988|NCT00784225|Tocotrienols|tocotrienols|mesh-list
6078989|NCT00784225|alpha-Tocopherol|alpha-tocopherol|mesh-list
6078990|NCT00784225|Selenium|selenium|mesh-list
6078991|NCT00784225|Micronutrients|micronutrients|mesh-ancestor
6078992|NCT00784225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513473|NCT04374942|Antimalarials|antimalarials|mesh-ancestor
5513474|NCT04374942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5513475|NCT04374942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5513476|NCT04374942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5513477|NCT04374942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5513478|NCT04374942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078993|NCT00784225|Antioxidants|antioxidants|mesh-ancestor
6078994|NCT00784225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6078995|NCT00784225|Protective Agents|protective agents|mesh-ancestor
6078996|NCT00784225|Trace Elements|trace elements|mesh-ancestor
6078997|NCT00784238|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6078998|NCT00784238|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6078999|NCT00784238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6079000|NCT00784238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6079001|NCT00784238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463776|NCT00466232|Sorafenib|sorafenib|mesh-list
6079002|NCT00784238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6079003|NCT00784238|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6079004|NCT00784238|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6079005|NCT00784238|Serotonin Agents|serotonin agents|mesh-ancestor
6079006|NCT00784238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6079007|NCT00784238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079008|NCT00784238|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6079009|NCT00784238|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6079010|NCT00784238|Dopamine Agents|dopamine agents|mesh-ancestor
6079011|NCT00784277|Oxycodone|oxycodone|mesh-list
6079012|NCT00784277|Tapentadol|tapentadol|mesh-list
6079013|NCT00784277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6079014|NCT00784277|Narcotics|narcotics|mesh-ancestor
6079015|NCT00784277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6079016|NCT00784277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079017|NCT00784277|Analgesics|analgesics|mesh-ancestor
6079018|NCT00784277|Sensory System Agents|sensory system agents|mesh-ancestor
6079019|NCT00784277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6079020|NCT00784277|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6079021|NCT00784277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6079022|NCT00784277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6079023|NCT00784277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079024|NCT00784277|Adrenergic Agents|adrenergic agents|mesh-ancestor
6079025|NCT00784277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6079026|NCT00784303|Lenvatinib|lenvatinib|mesh-list
6079027|NCT00784303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6079028|NCT00784303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6079029|NCT00784303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6079030|NCT00784303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079031|NCT00784368|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6079032|NCT00784459|Abatacept|abatacept|mesh-list
6079033|NCT00784459|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6079034|NCT00784459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079035|NCT00784459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5513479|NCT04374942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5513480|NCT04374604|Mitogens|mitogens|mesh-list
5513481|NCT04374604|Mitosis Modulators|mitosis modulators|mesh-ancestor
5513482|NCT04374604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513483|NCT04374318|Dexmedetomidine|dexmedetomidine|mesh-list
5513484|NCT04374318|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5513485|NCT04374318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6079036|NCT00784459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6079037|NCT00784459|Immunologic Factors|immunologic factors|mesh-ancestor
6079038|NCT00784459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079039|NCT00784459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6079040|NCT00784524|Aldesleukin|aldesleukin|mesh-list
6079041|NCT00784524|Interleukin-2|interleukin-2|mesh-list
6079042|NCT00784524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6079043|NCT00784524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6079044|NCT00784524|Analgesics|analgesics|mesh-ancestor
6079045|NCT00784524|Sensory System Agents|sensory system agents|mesh-ancestor
6079046|NCT00784524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6079047|NCT00784524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079048|NCT00784524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6079049|NCT00784524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5513486|NCT04374318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513487|NCT04374318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5513488|NCT04374318|Analgesics|analgesics|mesh-ancestor
5513489|NCT04374318|Sensory System Agents|sensory system agents|mesh-ancestor
5513490|NCT04374318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5513491|NCT04374318|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5513492|NCT04374318|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5513493|NCT04374318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5513494|NCT04374318|Adrenergic Agents|adrenergic agents|mesh-ancestor
5513495|NCT04374318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6079050|NCT00784524|Antiviral Agents|antiviral agents|mesh-ancestor
6079051|NCT00784524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6079052|NCT00784550|Fluticasone|fluticasone|mesh-list
6079053|NCT00784550|Xhance|xhance|mesh-list
6079054|NCT00784550|Bromides|bromides|mesh-list
6079055|NCT00784550|Tiotropium Bromide|tiotropium bromide|mesh-list
6079056|NCT00784550|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6079057|NCT00784550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6079058|NCT00784550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6079059|NCT00784550|Autonomic Agents|autonomic agents|mesh-ancestor
6079060|NCT00784550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6463777|NCT00466232|Topotecan|topotecan|mesh-list
6079061|NCT00784550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079062|NCT00784550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6079063|NCT00784550|Respiratory System Agents|respiratory system agents|mesh-ancestor
6079064|NCT00784550|Dermatologic Agents|dermatologic agents|mesh-ancestor
5513496|NCT04374318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513497|NCT04374474|Budesonide|budesonide|mesh-list
5513498|NCT04374474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5513499|NCT04374474|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5513500|NCT04374474|Autonomic Agents|autonomic agents|mesh-ancestor
5513501|NCT04374474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5513502|NCT04374474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513503|NCT04374474|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5513504|NCT04374474|Respiratory System Agents|respiratory system agents|mesh-ancestor
6079065|NCT00784550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6079066|NCT00784550|Parasympatholytics|parasympatholytics|mesh-ancestor
6079067|NCT00784550|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6079068|NCT00784550|Cholinergic Agents|cholinergic agents|mesh-ancestor
6079069|NCT00784550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6079070|NCT00784550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079071|NCT00784550|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6079072|NCT00784550|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6079073|NCT00784550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6079074|NCT00784550|Adrenergic Agents|adrenergic agents|mesh-ancestor
6079075|NCT00784550|Anticonvulsants|anticonvulsants|mesh-ancestor
6079076|NCT00784654|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
5513505|NCT04374474|Glucocorticoids|glucocorticoids|mesh-ancestor
5513506|NCT04374474|Hormones|hormones|mesh-ancestor
5513507|NCT04374474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5513508|NCT04374578|Dulaglutide|dulaglutide|mesh-list
5513509|NCT04374578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5513510|NCT04374578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513511|NCT04374773|Dronabinol|dronabinol|mesh-list
5513512|NCT04374773|Hallucinogens|hallucinogens|mesh-ancestor
5513513|NCT04374773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513514|NCT04374773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5513515|NCT04374773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6079077|NCT00784654|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6079078|NCT00784654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079079|NCT00784654|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6079080|NCT00784654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6079081|NCT00784654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6079082|NCT00784654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079083|NCT00784654|Dopamine Agents|dopamine agents|mesh-ancestor
6079084|NCT00784654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6079085|NCT00784693|Tanezumab|tanezumab|mesh-list
6079086|NCT00784693|Analgesics|analgesics|mesh-ancestor
6079087|NCT00784693|Sensory System Agents|sensory system agents|mesh-ancestor
6079088|NCT00784693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6079089|NCT00784693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079090|NCT00784719|Cyclosporine|cyclosporine|mesh-list
6079091|NCT00784719|Cyclosporins|cyclosporins|mesh-list
6079092|NCT00784719|Tofacitinib|tofacitinib|mesh-list
6079093|NCT00784719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6079094|NCT00784719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079095|NCT00784719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6079096|NCT00784719|Immunologic Factors|immunologic factors|mesh-ancestor
6079097|NCT00784719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079098|NCT00784719|Antifungal Agents|antifungal agents|mesh-ancestor
6079099|NCT00784719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6079100|NCT00784719|Dermatologic Agents|dermatologic agents|mesh-ancestor
6079101|NCT00784719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6079102|NCT00784719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5513516|NCT04374773|Analgesics|analgesics|mesh-ancestor
5513517|NCT04374773|Sensory System Agents|sensory system agents|mesh-ancestor
5513518|NCT04374773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5513519|NCT04374773|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5513520|NCT04374773|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5513521|NCT04374773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5513522|NCT04374773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513523|NCT04374773|Hormones|hormones|mesh-ancestor
5513524|NCT04374773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5600497|NCT03711240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6079103|NCT00784719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6079104|NCT00784784|Zanamivir|zanamivir|mesh-list
6079105|NCT00784784|Antiviral Agents|antiviral agents|mesh-ancestor
6079106|NCT00784784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6079107|NCT00784784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6079108|NCT00784784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079109|NCT00784810|Acetaminophen|acetaminophen|mesh-list
6079110|NCT00784810|Oxycodone|oxycodone|mesh-list
6079111|NCT00784810|Codeine|codeine|mesh-list
6079112|NCT00784810|Naloxone|naloxone|mesh-list
6079113|NCT00784810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6079114|NCT00784810|Analgesics|analgesics|mesh-ancestor
6079115|NCT00784810|Sensory System Agents|sensory system agents|mesh-ancestor
6079116|NCT00784810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6079117|NCT00784810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079118|NCT00784810|Antipyretics|antipyretics|mesh-ancestor
6079119|NCT00784810|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6079120|NCT00784810|Narcotics|narcotics|mesh-ancestor
6079121|NCT00784810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6079122|NCT00784810|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6079123|NCT00784810|Antitussive Agents|antitussive agents|mesh-ancestor
6079124|NCT00784810|Respiratory System Agents|respiratory system agents|mesh-ancestor
6079125|NCT00784836|Interferons|interferons|mesh-list
6079126|NCT00784836|Interferon-beta|interferon-beta|mesh-list
6079127|NCT00784836|Interferon beta-1a|interferon beta-1a|mesh-list
6079128|NCT00784836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6079129|NCT00784836|Antiviral Agents|antiviral agents|mesh-ancestor
6079130|NCT00784836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6079131|NCT00784836|Immunologic Factors|immunologic factors|mesh-ancestor
6079132|NCT00784836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079133|NCT00784836|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6079134|NCT00784849|Methylene Blue|methylene blue|mesh-list
6079135|NCT00784849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6079136|NCT00784849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079137|NCT00784875|Zolpidem|zolpidem|mesh-list
6079138|NCT00784875|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6079139|NCT00784875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6079140|NCT00784875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6079141|NCT00784875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079142|NCT00784875|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6079143|NCT00784875|GABA Agonists|gaba agonists|mesh-ancestor
6079144|NCT00784875|GABA Agents|gaba agents|mesh-ancestor
6079145|NCT00784875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6079146|NCT00784875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079147|NCT00784927|Dexamethasone|dexamethasone|mesh-list
6079148|NCT00784927|Cyclophosphamide|cyclophosphamide|mesh-list
6079149|NCT00784927|Rituximab|rituximab|mesh-list
6665445|NCT01517321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5600498|NCT03711240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5600499|NCT03711240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5600500|NCT03711240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5600501|NCT03711240|Growth Substances|growth substances|mesh-ancestor
5600502|NCT03711240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079150|NCT00784927|Lenalidomide|lenalidomide|mesh-list
6079151|NCT00784927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6079152|NCT00784927|Immunologic Factors|immunologic factors|mesh-ancestor
5513525|NCT04374461|Acetylcysteine|acetylcysteine|mesh-list
5513526|NCT04374461|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5513527|NCT04374461|Antiviral Agents|antiviral agents|mesh-ancestor
5513528|NCT04374461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5513529|NCT04374461|Expectorants|expectorants|mesh-ancestor
5513530|NCT04374461|Respiratory System Agents|respiratory system agents|mesh-ancestor
5513531|NCT04374461|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6079153|NCT00784927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079154|NCT00784927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6079155|NCT00784927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6079156|NCT00784927|Alkylating Agents|alkylating agents|mesh-ancestor
6079157|NCT00784927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079158|NCT00784927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6079159|NCT00784927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6079160|NCT00784927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6079161|NCT00784927|Antiemetics|antiemetics|mesh-ancestor
6079162|NCT00784927|Autonomic Agents|autonomic agents|mesh-ancestor
6079163|NCT00784927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6079164|NCT00784927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6079165|NCT00784927|Glucocorticoids|glucocorticoids|mesh-ancestor
6079166|NCT00784927|Hormones|hormones|mesh-ancestor
6079167|NCT00784927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6079168|NCT00784927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6079169|NCT00784927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5513532|NCT04374461|Antioxidants|antioxidants|mesh-ancestor
5513533|NCT04374461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079170|NCT00784927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6079171|NCT00784927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6079172|NCT00784927|Growth Substances|growth substances|mesh-ancestor
6079173|NCT00784927|Growth Inhibitors|growth inhibitors|mesh-ancestor
6079174|NCT00784979|Immunoglobulins|immunoglobulins|mesh-list
6079175|NCT00784979|Immunologic Factors|immunologic factors|mesh-ancestor
6079176|NCT00784979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079177|NCT00785213|Rosiglitazone|rosiglitazone|mesh-list
6079178|NCT00785213|Quinine|quinine|mesh-list
6079179|NCT00785213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6079180|NCT00785213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079181|NCT00785213|Antimalarials|antimalarials|mesh-ancestor
6079182|NCT00785213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6079183|NCT00785213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5513534|NCT04374461|Protective Agents|protective agents|mesh-ancestor
5513535|NCT04374461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513536|NCT04374461|Antidotes|antidotes|mesh-ancestor
5513537|NCT04374799|Heparin|heparin|mesh-list
5513538|NCT04374799|Anticoagulants|anticoagulants|mesh-ancestor
6079184|NCT00785213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6079185|NCT00785213|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6079186|NCT00785213|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6079187|NCT00785213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6079188|NCT00785213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6079189|NCT00785213|Analgesics|analgesics|mesh-ancestor
6079190|NCT00785213|Sensory System Agents|sensory system agents|mesh-ancestor
6079191|NCT00785486|Quinine|quinine|mesh-list
6079192|NCT00785486|Midazolam|midazolam|mesh-list
6079193|NCT00785486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6079194|NCT00785486|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6079195|NCT00785486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6079196|NCT00785486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079197|NCT00785486|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6079198|NCT00785486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6079199|NCT00785486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6079200|NCT00785486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6079201|NCT00785486|Anesthetics, General|anesthetics, general|mesh-ancestor
6079202|NCT00785486|Anesthetics|anesthetics|mesh-ancestor
6079203|NCT00785486|GABA Modulators|gaba modulators|mesh-ancestor
6079204|NCT00785486|GABA Agents|gaba agents|mesh-ancestor
6079205|NCT00785486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5513539|NCT04374799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5513540|NCT04374799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5513541|NCT04374799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513542|NCT04374279|Bicalutamide|bicalutamide|mesh-list
5513543|NCT04374279|Androgen Antagonists|androgen antagonists|mesh-ancestor
5513544|NCT04374279|Hormone Antagonists|hormone antagonists|mesh-ancestor
5513545|NCT04374279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5513546|NCT04374279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513547|NCT04374279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5513548|NCT04374552|Azithromycin|azithromycin|mesh-list
5513549|NCT04374552|Hydroxychloroquine|hydroxychloroquine|mesh-list
5513550|NCT04374552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5513551|NCT04374552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5513552|NCT04374552|Antimalarials|antimalarials|mesh-ancestor
5513553|NCT04374552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5513554|NCT04374552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5513555|NCT04374552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5513556|NCT04374552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513557|NCT04374552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5513558|NCT04374071|Methylprednisolone|methylprednisolone|mesh-list
5513559|NCT04374071|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5513560|NCT04374071|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5513561|NCT04374071|Prednisolone|prednisolone|mesh-list
5513562|NCT04374071|Prednisolone acetate|prednisolone acetate|mesh-list
5513563|NCT04374071|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5513564|NCT04374071|Prednisolone phosphate|prednisolone phosphate|mesh-list
5513565|NCT04374071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5513566|NCT04374071|Antiemetics|antiemetics|mesh-ancestor
6079206|NCT00785486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079207|NCT00785486|Antimalarials|antimalarials|mesh-ancestor
6079208|NCT00785486|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6079209|NCT00785486|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6079210|NCT00785486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6079211|NCT00785486|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6079212|NCT00785486|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6079213|NCT00785486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6079214|NCT00785486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6079215|NCT00785486|Analgesics|analgesics|mesh-ancestor
6079216|NCT00785486|Sensory System Agents|sensory system agents|mesh-ancestor
6079217|NCT00785512|Nebivolol|nebivolol|mesh-list
6079218|NCT00785512|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6079219|NCT00785512|Vasodilator Agents|vasodilator agents|mesh-ancestor
6079220|NCT00785512|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6079221|NCT00785512|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6079222|NCT00785512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6079223|NCT00785512|Adrenergic Agents|adrenergic agents|mesh-ancestor
6079224|NCT00785512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6079225|NCT00785512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079226|NCT00785512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202845|NCT02046616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202846|NCT02046616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6202847|NCT02046616|Dermatologic Agents|dermatologic agents|mesh-ancestor
5513567|NCT04374071|Autonomic Agents|autonomic agents|mesh-ancestor
5513568|NCT04374071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5513569|NCT04374071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513570|NCT04374071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5513571|NCT04374071|Glucocorticoids|glucocorticoids|mesh-ancestor
5513572|NCT04374071|Hormones|hormones|mesh-ancestor
5513573|NCT04374071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5513574|NCT04374071|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5513575|NCT04374071|Protective Agents|protective agents|mesh-ancestor
5513576|NCT04374071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5513577|NCT04374071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5513578|NCT04373824|Ivermectin|ivermectin|mesh-list
5513579|NCT04373824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5513580|NCT04373824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5513581|NCT04374006|Propolis|propolis|mesh-list
5513582|NCT04374006|Dienogest|dienogest|mesh-list
5513583|NCT04374006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5513584|NCT04374006|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5513585|NCT04374006|Contraceptive Agents|contraceptive agents|mesh-ancestor
5513586|NCT04374006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5513587|NCT04374006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202848|NCT02046616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6202849|NCT02046616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6202850|NCT02046616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5513588|NCT04374006|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6079227|NCT00785538|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6079228|NCT00785538|Immunologic Factors|immunologic factors|mesh-ancestor
6079229|NCT00785538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079230|NCT00785577|Pregabalin|pregabalin|mesh-list
6079231|NCT00785577|Analgesics|analgesics|mesh-ancestor
6079232|NCT00785577|Sensory System Agents|sensory system agents|mesh-ancestor
6079233|NCT00785577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6079234|NCT00785577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079235|NCT00785577|Anticonvulsants|anticonvulsants|mesh-ancestor
6079236|NCT00785577|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6079237|NCT00785577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6079238|NCT00785577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079239|NCT00785577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6079240|NCT00785577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6079241|NCT00785577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6079242|NCT00785577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6079243|NCT00785577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6079244|NCT00785629|Calcium|calcium|mesh-list
6079245|NCT00785629|Sevelamer|sevelamer|mesh-list
6079246|NCT00785629|Calcium acetate|calcium acetate|mesh-list
6079247|NCT00785629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5513589|NCT04374006|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5513590|NCT04374006|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5513591|NCT04374006|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5513592|NCT04374006|Hormone Antagonists|hormone antagonists|mesh-ancestor
5513593|NCT04374006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5513594|NCT04374006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5513595|NCT04374006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5513596|NCT04374188|Ciprofloxacin|ciprofloxacin|mesh-list
5513597|NCT04374188|Levofloxacin|levofloxacin|mesh-list
5513598|NCT04374188|Ofloxacin|ofloxacin|mesh-list
5513599|NCT04374188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5513600|NCT04374188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5513601|NCT04374188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5513602|NCT04374188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5513603|NCT04374188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5513604|NCT04374188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079248|NCT00785629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079249|NCT00785629|Chelating Agents|chelating agents|mesh-ancestor
6079250|NCT00785629|Sequestering Agents|sequestering agents|mesh-ancestor
6079251|NCT00785629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079252|NCT00785772|Gabapentin|gabapentin|mesh-list
6079253|NCT00785772|Analgesics|analgesics|mesh-ancestor
6079254|NCT00785772|Sensory System Agents|sensory system agents|mesh-ancestor
6079255|NCT00785772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6079256|NCT00785772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079257|NCT00785772|Anticonvulsants|anticonvulsants|mesh-ancestor
6079258|NCT00785772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6079259|NCT00785772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6079260|NCT00785772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6079261|NCT00785772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6079262|NCT00785772|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5513605|NCT04374188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5513606|NCT04374188|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5513607|NCT04374188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5513608|NCT04374188|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5513609|NCT04374188|Renal Agents|renal agents|mesh-ancestor
5513610|NCT04373785|Temozolomide|temozolomide|mesh-list
5513611|NCT04373785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5513612|NCT04373785|Alkylating Agents|alkylating agents|mesh-ancestor
6463778|NCT00466232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6463779|NCT00466232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5513613|NCT04373785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513614|NCT04373785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5513615|NCT04373967|Metformin|metformin|mesh-list
5513616|NCT04373967|Liraglutide|liraglutide|mesh-list
5513617|NCT04373967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5513618|NCT04373967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513619|NCT04373967|Incretins|incretins|mesh-ancestor
5513620|NCT04373967|Hormones|hormones|mesh-ancestor
5513621|NCT04373967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5513622|NCT04373941|Lenograstim|lenograstim|mesh-list
5513623|NCT04373941|Sargramostim|sargramostim|mesh-list
5513624|NCT04373941|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6463780|NCT00466232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6463781|NCT00466232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463782|NCT00466232|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6463783|NCT00466232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6463784|NCT00466258|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6463785|NCT00466258|Antiviral Agents|antiviral agents|mesh-ancestor
6463786|NCT00466258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6463787|NCT00466284|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6463788|NCT00466284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6079263|NCT00785772|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6079264|NCT00785772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6079265|NCT00785772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079266|NCT00785772|Antimanic Agents|antimanic agents|mesh-ancestor
6079267|NCT00785785|Imatinib Mesylate|imatinib mesylate|mesh-list
6079268|NCT00785785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6079269|NCT00785785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6079270|NCT00785785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6079271|NCT00785785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079272|NCT00785798|Doxorubicin|doxorubicin|mesh-list
6079273|NCT00785798|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6079274|NCT00785798|Vorinostat|vorinostat|mesh-list
6079275|NCT00785798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6079276|NCT00785798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6079277|NCT00785798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6079278|NCT00785798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6079279|NCT00785798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6079280|NCT00785798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079281|NCT00785798|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6079282|NCT00785980|Ciprofloxacin|ciprofloxacin|mesh-list
6079283|NCT00785980|Quinine|quinine|mesh-list
6079284|NCT00785980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6079285|NCT00785980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6079286|NCT00785980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6079287|NCT00785980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6079288|NCT00785980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6079289|NCT00785980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079290|NCT00785980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6079291|NCT00785980|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6079292|NCT00785980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6079293|NCT00785980|Antimalarials|antimalarials|mesh-ancestor
6079294|NCT00785980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6079295|NCT00785980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6079296|NCT00785980|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6079297|NCT00785980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079298|NCT00785980|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6079299|NCT00785980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6079300|NCT00785980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6463789|NCT00466284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6463790|NCT00466284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6463791|NCT00466284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513625|NCT04373941|Immunologic Factors|immunologic factors|mesh-ancestor
6079301|NCT00785980|Analgesics|analgesics|mesh-ancestor
6079302|NCT00785980|Sensory System Agents|sensory system agents|mesh-ancestor
6079303|NCT00786019|Vitamins|vitamins|mesh-list
6079304|NCT00786019|Ascorbic Acid|ascorbic acid|mesh-list
6079305|NCT00786019|Micronutrients|micronutrients|mesh-ancestor
6079306|NCT00786019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079307|NCT00786019|Antioxidants|antioxidants|mesh-ancestor
6079308|NCT00786019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079309|NCT00786019|Protective Agents|protective agents|mesh-ancestor
5513626|NCT04373941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513627|NCT04373668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
5513628|NCT04373668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5513629|NCT04373668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079310|NCT00786188|Paroxetine|paroxetine|mesh-list
6079311|NCT00786188|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6079312|NCT00786188|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5513633|NCT04373356|Listerine|listerine|mesh-list
5513634|NCT04373356|Fluorides|fluorides|mesh-list
5513635|NCT04373356|Sodium Fluoride|sodium fluoride|mesh-list
5513636|NCT04373356|Fluorides, Topical|fluorides, topical|mesh-list
5513637|NCT04373356|Cariostatic Agents|cariostatic agents|mesh-ancestor
6079313|NCT00786188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6463792|NCT00466388|Cevimeline|cevimeline|mesh-list
6463793|NCT00466388|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6079314|NCT00786188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513638|NCT04373356|Protective Agents|protective agents|mesh-ancestor
5513639|NCT04373356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513640|NCT04373356|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5513641|NCT04373356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5513642|NCT04372706|Pembrolizumab|pembrolizumab|mesh-list
5513643|NCT04372706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5513644|NCT04372706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5513645|NCT04373083|Cemiplimab|cemiplimab|mesh-list
5513646|NCT04373083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5513647|NCT04373083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5513648|NCT04372849|Insulin|insulin|mesh-list
5513649|NCT04372849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5513650|NCT04372849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079315|NCT00786188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6079316|NCT00786188|Serotonin Agents|serotonin agents|mesh-ancestor
6079317|NCT00786188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079318|NCT00786188|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6079319|NCT00786188|Antidepressive Agents|antidepressive agents|mesh-ancestor
6079320|NCT00786188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6079321|NCT00786188|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6079322|NCT00786188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6079323|NCT00786188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6079324|NCT00786422|Rivaroxaban|rivaroxaban|mesh-list
6079325|NCT00786422|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6079326|NCT00786422|Antithrombins|antithrombins|mesh-ancestor
6079327|NCT00786422|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6079328|NCT00786422|Protease Inhibitors|protease inhibitors|mesh-ancestor
6079329|NCT00786422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6079330|NCT00786422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079331|NCT00786422|Anticoagulants|anticoagulants|mesh-ancestor
6079332|NCT00786474|Dalteparin|dalteparin|mesh-list
6079333|NCT00786474|Tinzaparin|tinzaparin|mesh-list
6079334|NCT00786474|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6079335|NCT00786474|Anticoagulants|anticoagulants|mesh-ancestor
6079336|NCT00786474|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6079337|NCT00786474|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6079338|NCT00786474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079339|NCT00786487|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6079340|NCT00786487|Glycerol|glycerol|mesh-list
6079341|NCT00786487|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6079342|NCT00786487|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6079343|NCT00786487|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6079344|NCT00786487|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6079345|NCT00786487|Protective Agents|protective agents|mesh-ancestor
6079346|NCT00786487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079347|NCT00786643|Leucovorin|leucovorin|mesh-list
6079348|NCT00786643|Interferons|interferons|mesh-list
6079349|NCT00786643|Interferon-gamma|interferon-gamma|mesh-list
6079350|NCT00786643|Bevacizumab|bevacizumab|mesh-list
6079351|NCT00786643|Fluorouracil|fluorouracil|mesh-list
6079352|NCT00786643|Levoleucovorin|levoleucovorin|mesh-list
6079353|NCT00786643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6079354|NCT00786643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6079355|NCT00786643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6079356|NCT00786643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6079357|NCT00786643|Growth Substances|growth substances|mesh-ancestor
6079358|NCT00786643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079359|NCT00786643|Growth Inhibitors|growth inhibitors|mesh-ancestor
6079360|NCT00786643|Antimetabolites|antimetabolites|mesh-ancestor
6079361|NCT00786643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079362|NCT00786643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6079363|NCT00786643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6079364|NCT00786643|Immunologic Factors|immunologic factors|mesh-ancestor
6079365|NCT00786643|Antiviral Agents|antiviral agents|mesh-ancestor
6079366|NCT00786643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6079367|NCT00786643|Antidotes|antidotes|mesh-ancestor
6079368|NCT00786643|Protective Agents|protective agents|mesh-ancestor
6079369|NCT00786643|Vitamin B Complex|vitamin b complex|mesh-ancestor
6079370|NCT00786643|Vitamins|vitamins|mesh-ancestor
6079371|NCT00786643|Micronutrients|micronutrients|mesh-ancestor
6079372|NCT00786825|Somatostatin|somatostatin|mesh-list
6079373|NCT00786825|Hormones|hormones|mesh-ancestor
6079374|NCT00786825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5513651|NCT04372836|Vasopressins|vasopressins|mesh-list
6079375|NCT00786825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513652|NCT04372836|Arginine Vasopressin|arginine vasopressin|mesh-list
5513653|NCT04372836|Hemostatics|hemostatics|mesh-ancestor
5513654|NCT04372836|Coagulants|coagulants|mesh-ancestor
5513655|NCT04372836|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5513656|NCT04372836|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5513657|NCT04372836|Natriuretic Agents|natriuretic agents|mesh-ancestor
5513658|NCT04372836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513659|NCT04373044|Hydroxychloroquine|hydroxychloroquine|mesh-list
5513660|NCT04373044|Antimalarials|antimalarials|mesh-ancestor
5513661|NCT04373044|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5513662|NCT04373044|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5513663|NCT04373044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6079376|NCT00786838|Trabectedin|trabectedin|mesh-list
6079377|NCT00786838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6079378|NCT00786838|Alkylating Agents|alkylating agents|mesh-ancestor
6079379|NCT00786838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079380|NCT00786838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6079381|NCT00786916|Lidocaine|lidocaine|mesh-list
6079382|NCT00786916|Anesthetics, Local|anesthetics, local|mesh-ancestor
6079383|NCT00786916|Anesthetics|anesthetics|mesh-ancestor
6079384|NCT00786916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6079385|NCT00786916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079386|NCT00786916|Sensory System Agents|sensory system agents|mesh-ancestor
6079387|NCT00786916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6079388|NCT00786916|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6079389|NCT00786916|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6079390|NCT00786916|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6079391|NCT00786916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6079392|NCT00786916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079393|NCT00786994|Petrolatum|petrolatum|mesh-list
6079394|NCT00786994|Emollients|emollients|mesh-ancestor
6079395|NCT00786994|Dermatologic Agents|dermatologic agents|mesh-ancestor
6079396|NCT00787150|Warfarin|warfarin|mesh-list
6079397|NCT00787150|Apixaban|apixaban|mesh-list
5513664|NCT04373044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5513665|NCT04373044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513666|NCT04373044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5513667|NCT04373018|Chlorhexidine|chlorhexidine|mesh-list
5513668|NCT04373018|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5513669|NCT04373018|Hydrogen Peroxide|hydrogen peroxide|mesh-list
5513670|NCT04373018|Sodium Hypochlorite|sodium hypochlorite|mesh-list
5513671|NCT04373018|Eusol|eusol|mesh-list
5513672|NCT04373018|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5513673|NCT04373018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5513674|NCT04373018|Disinfectants|disinfectants|mesh-ancestor
5513675|NCT04373018|Dermatologic Agents|dermatologic agents|mesh-ancestor
5513676|NCT04372732|Autoantibodies|autoantibodies|mesh-list
5513677|NCT04372732|Immunologic Factors|immunologic factors|mesh-ancestor
6079398|NCT00787150|Anticoagulants|anticoagulants|mesh-ancestor
6079399|NCT00787150|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6079400|NCT00787150|Antithrombins|antithrombins|mesh-ancestor
6079401|NCT00787150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6079402|NCT00787150|Protease Inhibitors|protease inhibitors|mesh-ancestor
6079403|NCT00787150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6079404|NCT00787150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079405|NCT00787254|Lansoprazole|lansoprazole|mesh-list
6079406|NCT00787254|Dexlansoprazole|dexlansoprazole|mesh-list
6079407|NCT00787254|Gefarnate|gefarnate|mesh-list
6079408|NCT00787254|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6079409|NCT00787254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6079410|NCT00787254|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6079411|NCT00787254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6079412|NCT00787254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079413|NCT00787267|Dasatinib|dasatinib|mesh-list
6079414|NCT00787267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6079415|NCT00787267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6079416|NCT00787267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6079417|NCT00787267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079418|NCT00787332|Desirudin|desirudin|mesh-list
6079419|NCT00787332|Argatroban|argatroban|mesh-list
6079420|NCT00787332|Antithrombins|antithrombins|mesh-ancestor
6079421|NCT00787332|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5513678|NCT04372732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513679|NCT04372589|Heparin|heparin|mesh-list
6079422|NCT00787332|Protease Inhibitors|protease inhibitors|mesh-ancestor
6079423|NCT00787332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5513680|NCT04372589|Anticoagulants|anticoagulants|mesh-ancestor
6079424|NCT00787332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079425|NCT00787332|Anticoagulants|anticoagulants|mesh-ancestor
6079426|NCT00787332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6079427|NCT00787332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6079428|NCT00787332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6079429|NCT00787527|Prednisone|prednisone|mesh-list
6079430|NCT00787527|Cyclophosphamide|cyclophosphamide|mesh-list
6079431|NCT00787527|Doxorubicin|doxorubicin|mesh-list
6079432|NCT00787527|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6079433|NCT00787527|Vincristine|vincristine|mesh-list
6079434|NCT00787527|Vorinostat|vorinostat|mesh-list
6079435|NCT00787527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6079436|NCT00787527|Immunologic Factors|immunologic factors|mesh-ancestor
6079437|NCT00787527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079438|NCT00787527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6079439|NCT00787527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6079440|NCT00787527|Alkylating Agents|alkylating agents|mesh-ancestor
6079441|NCT00787527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079442|NCT00787527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6079443|NCT00787527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6079444|NCT00787527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6079445|NCT00787527|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6079446|NCT00787527|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6079447|NCT00787527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6079448|NCT00787527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6079449|NCT00787527|Glucocorticoids|glucocorticoids|mesh-ancestor
6079450|NCT00787527|Hormones|hormones|mesh-ancestor
6079451|NCT00787527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6079452|NCT00787527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6079453|NCT00787527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6463794|NCT00466388|Autonomic Agents|autonomic agents|mesh-ancestor
6463795|NCT00466388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6463796|NCT00466388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463797|NCT00466388|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6463798|NCT00466388|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6463799|NCT00466388|Cholinergic Agents|cholinergic agents|mesh-ancestor
6463800|NCT00466388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6463801|NCT00466388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513681|NCT04372589|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5513682|NCT04372589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5513683|NCT04372589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513684|NCT04372342|Remifentanil|remifentanil|mesh-list
5513685|NCT04372342|Nalbuphine|nalbuphine|mesh-list
5513686|NCT04372342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5513687|NCT04372342|Narcotics|narcotics|mesh-ancestor
5513688|NCT04372342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5513689|NCT04372342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513690|NCT04372342|Analgesics|analgesics|mesh-ancestor
5513691|NCT04372342|Sensory System Agents|sensory system agents|mesh-ancestor
5513692|NCT04372342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5513693|NCT04372264|Acetaminophen|acetaminophen|mesh-list
5513694|NCT04372264|Ibuprofen|ibuprofen|mesh-list
5513695|NCT04372264|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
5513696|NCT04372264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5513697|NCT04372264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5513698|NCT04372264|Analgesics|analgesics|mesh-ancestor
5513699|NCT04372264|Sensory System Agents|sensory system agents|mesh-ancestor
6463802|NCT00466401|Simvastatin|simvastatin|mesh-list
6079454|NCT00787527|Tubulin Modulators|tubulin modulators|mesh-ancestor
6079455|NCT00787527|Antimitotic Agents|antimitotic agents|mesh-ancestor
6079456|NCT00787527|Mitosis Modulators|mitosis modulators|mesh-ancestor
6079457|NCT00787527|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6079458|NCT00787566|Granisetron|granisetron|mesh-list
6079459|NCT00787566|Antiemetics|antiemetics|mesh-ancestor
5600503|NCT03711240|Growth Inhibitors|growth inhibitors|mesh-ancestor
6079460|NCT00787566|Autonomic Agents|autonomic agents|mesh-ancestor
6079461|NCT00787566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6079462|NCT00787566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079463|NCT00787566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6079464|NCT00787566|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6079465|NCT00787566|Serotonin Agents|serotonin agents|mesh-ancestor
6079466|NCT00787566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6079467|NCT00787566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079468|NCT00787605|Amlodipine|amlodipine|mesh-list
6079469|NCT00787605|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6079470|NCT00787605|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6079471|NCT00787605|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6079472|NCT00787605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6079473|NCT00787605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079474|NCT00787605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6079475|NCT00787605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079476|NCT00787605|Vasodilator Agents|vasodilator agents|mesh-ancestor
6079477|NCT00787605|Diuretics|diuretics|mesh-ancestor
6079478|NCT00787605|Natriuretic Agents|natriuretic agents|mesh-ancestor
6079479|NCT00787605|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6079480|NCT00787644|Pioglitazone|pioglitazone|mesh-list
6079481|NCT00787644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6079482|NCT00787644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079483|NCT00787722|Methylprednisolone|methylprednisolone|mesh-list
6079484|NCT00787722|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6079485|NCT00787722|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6079486|NCT00787722|Prednisolone|prednisolone|mesh-list
6079487|NCT00787722|Prednisolone acetate|prednisolone acetate|mesh-list
6079488|NCT00787722|Cyclophosphamide|cyclophosphamide|mesh-list
6079489|NCT00787722|Rituximab|rituximab|mesh-list
6079490|NCT00787722|Thymoglobulin|thymoglobulin|mesh-list
6079491|NCT00787722|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6079492|NCT00787722|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6079493|NCT00787722|Prednisolone phosphate|prednisolone phosphate|mesh-list
6079494|NCT00787722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6079495|NCT00787722|Immunologic Factors|immunologic factors|mesh-ancestor
6079496|NCT00787722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079497|NCT00787722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6079498|NCT00787722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6079499|NCT00787722|Alkylating Agents|alkylating agents|mesh-ancestor
6079500|NCT00787722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079501|NCT00787722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6079502|NCT00787722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6079503|NCT00787722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6079504|NCT00787722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6079505|NCT00787722|Antiemetics|antiemetics|mesh-ancestor
6079506|NCT00787722|Autonomic Agents|autonomic agents|mesh-ancestor
6079507|NCT00787722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6079508|NCT00787722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6079509|NCT00787722|Glucocorticoids|glucocorticoids|mesh-ancestor
6079510|NCT00787722|Hormones|hormones|mesh-ancestor
6079511|NCT00787722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6079512|NCT00787722|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6079513|NCT00787722|Protective Agents|protective agents|mesh-ancestor
6079514|NCT00787722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6079515|NCT00787761|Cyclophosphamide|cyclophosphamide|mesh-list
6079516|NCT00787761|Busulfan|busulfan|mesh-list
6079517|NCT00787761|Methotrexate|methotrexate|mesh-list
6079518|NCT00787761|Fludarabine|fludarabine|mesh-list
6079519|NCT00787761|Fludarabine phosphate|fludarabine phosphate|mesh-list
6079520|NCT00787761|Tacrolimus|tacrolimus|mesh-list
6079521|NCT00787761|Thymoglobulin|thymoglobulin|mesh-list
6079522|NCT00787761|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6079523|NCT00787761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6079524|NCT00787761|Immunologic Factors|immunologic factors|mesh-ancestor
6079525|NCT00787761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079526|NCT00787761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6079527|NCT00787761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6079528|NCT00787761|Alkylating Agents|alkylating agents|mesh-ancestor
6079529|NCT00787761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079530|NCT00787761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6079531|NCT00787761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6079532|NCT00787761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6079533|NCT00787761|Abortifacient Agents|abortifacient agents|mesh-ancestor
6079534|NCT00787761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5513700|NCT04372264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5513701|NCT04372264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513702|NCT04372264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5513703|NCT04372264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5513704|NCT04372264|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5513705|NCT04372264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5513706|NCT04372264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513707|NCT04372264|Antipyretics|antipyretics|mesh-ancestor
5600504|NCT03711240|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6079535|NCT00787761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6079536|NCT00787761|Antimetabolites|antimetabolites|mesh-ancestor
6079537|NCT00787761|Dermatologic Agents|dermatologic agents|mesh-ancestor
6079538|NCT00787761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6079539|NCT00787761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6079540|NCT00787761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6079541|NCT00787761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6079542|NCT00787787|Capecitabine|capecitabine|mesh-list
6079543|NCT00787787|Sunitinib|sunitinib|mesh-list
6079544|NCT00787787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5600505|NCT03711240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5600506|NCT03711240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5600507|NCT03711240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600508|NCT03711240|Antidotes|antidotes|mesh-ancestor
5600509|NCT03711240|Protective Agents|protective agents|mesh-ancestor
6079545|NCT00787787|Antimetabolites|antimetabolites|mesh-ancestor
6079546|NCT00787787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079547|NCT00787787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6079548|NCT00787787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6079549|NCT00787787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6079550|NCT00787787|Growth Substances|growth substances|mesh-ancestor
6079551|NCT00787787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079552|NCT00787787|Growth Inhibitors|growth inhibitors|mesh-ancestor
6079553|NCT00787787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6079554|NCT00787787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6079555|NCT00787852|Paclitaxel|paclitaxel|mesh-list
6079556|NCT00787852|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6079557|NCT00787852|Dasatinib|dasatinib|mesh-list
6079558|NCT00787852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6079559|NCT00787852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6079560|NCT00787852|Tubulin Modulators|tubulin modulators|mesh-ancestor
6079561|NCT00787852|Antimitotic Agents|antimitotic agents|mesh-ancestor
6079562|NCT00787852|Mitosis Modulators|mitosis modulators|mesh-ancestor
6079563|NCT00787852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079564|NCT00787852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6079565|NCT00787852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6079566|NCT00787891|Rabeprazole|rabeprazole|mesh-list
6079567|NCT00787891|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6079568|NCT00787891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6079569|NCT00787891|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6079570|NCT00787891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6079571|NCT00787891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600510|NCT03711240|Vitamin B Complex|vitamin b complex|mesh-ancestor
5600511|NCT03711240|Vitamins|vitamins|mesh-ancestor
5600512|NCT03711240|Micronutrients|micronutrients|mesh-ancestor
5600513|NCT03711188|Nivolumab|nivolumab|mesh-list
5600514|NCT03711188|Ipilimumab|ipilimumab|mesh-list
5600515|NCT03711188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5600516|NCT03711188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5600517|NCT03711188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5600518|NCT03711188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600519|NCT03710902|Antihypertensive Agents|antihypertensive agents|mesh-list
5600520|NCT03710863|Vorolanib|vorolanib|mesh-list
5600521|NCT03710863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5600522|NCT03710863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5600523|NCT03710863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600524|NCT03710811|Insulin|insulin|mesh-list
5600525|NCT03710811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5600526|NCT03710811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600527|NCT03710772|Cytarabine|cytarabine|mesh-list
5600528|NCT03710772|Dexamethasone|dexamethasone|mesh-list
5600529|NCT03710772|Dexamethasone acetate|dexamethasone acetate|mesh-list
5600530|NCT03710772|Cyclophosphamide|cyclophosphamide|mesh-list
6079572|NCT00787930|Valproic Acid|valproic acid|mesh-list
5600531|NCT03710772|Rituximab|rituximab|mesh-list
5600532|NCT03710772|Doxorubicin|doxorubicin|mesh-list
6079573|NCT00787930|Anticonvulsants|anticonvulsants|mesh-ancestor
6079574|NCT00787930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5513708|NCT04372316|Vitamin B 12|vitamin b 12|mesh-list
5513709|NCT04372316|Vitamin B Complex|vitamin b complex|mesh-ancestor
5513710|NCT04372316|Vitamins|vitamins|mesh-ancestor
5513711|NCT04372316|Micronutrients|micronutrients|mesh-ancestor
5513712|NCT04372316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513713|NCT04372407|Itraconazole|itraconazole|mesh-list
5513714|NCT04372407|Antifungal Agents|antifungal agents|mesh-ancestor
5513715|NCT04372407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5513716|NCT04372407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6463803|NCT00466401|Ezetimibe|ezetimibe|mesh-list
6463804|NCT00466401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6463805|NCT00466401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6463806|NCT00466401|Antimetabolites|antimetabolites|mesh-ancestor
6463807|NCT00466401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463808|NCT00466401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6463809|NCT00466401|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6463810|NCT00466401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6463811|NCT00466466|Everolimus|everolimus|mesh-list
6463812|NCT00466466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6463813|NCT00466466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6463814|NCT00466466|Immunologic Factors|immunologic factors|mesh-ancestor
5513717|NCT04372407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5513718|NCT04372407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5513719|NCT04372407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513720|NCT04372407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5513721|NCT04372407|Hormone Antagonists|hormone antagonists|mesh-ancestor
5513722|NCT04372407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5513723|NCT04372407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463815|NCT00466466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463816|NCT00466479|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6463817|NCT00466479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6463818|NCT00466479|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6463819|NCT00466479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6463820|NCT00466479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6463821|NCT00466479|Adrenergic Agents|adrenergic agents|mesh-ancestor
6463822|NCT00466479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6463823|NCT00466479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513724|NCT04372407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5513725|NCT04371952|Doxycycline|doxycycline|mesh-list
5513726|NCT04371952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5513727|NCT04371952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5513728|NCT04371952|Antimalarials|antimalarials|mesh-ancestor
5513729|NCT04371952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5513730|NCT04371952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5513731|NCT04371874|Aspirin|aspirin|mesh-list
5513732|NCT04371874|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5513733|NCT04371874|Captopril|captopril|mesh-list
5513734|NCT04371874|Nitrendipine|nitrendipine|mesh-list
5513735|NCT04371874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5513736|NCT04371874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5513737|NCT04371874|Analgesics|analgesics|mesh-ancestor
5513738|NCT04371874|Sensory System Agents|sensory system agents|mesh-ancestor
5513739|NCT04371874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5513740|NCT04371874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513741|NCT04371874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5513742|NCT04371874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5513743|NCT04371874|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5513744|NCT04371874|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5513745|NCT04371874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079575|NCT00787930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079576|NCT00787930|GABA Agents|gaba agents|mesh-ancestor
6079577|NCT00787930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6079578|NCT00787930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079579|NCT00787930|Antimanic Agents|antimanic agents|mesh-ancestor
6079580|NCT00787930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6079581|NCT00787930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6079582|NCT00787930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6079583|NCT00787943|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6079584|NCT00787943|Dermatologic Agents|dermatologic agents|mesh-ancestor
6079585|NCT00788008|Propofol|propofol|mesh-list
6079586|NCT00788008|Isoflurane|isoflurane|mesh-list
6079587|NCT00788008|Anesthetics|anesthetics|mesh-ancestor
6079588|NCT00788008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6079589|NCT00788008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513746|NCT04371874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5513747|NCT04371874|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5513748|NCT04371874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5513749|NCT04371874|Antipyretics|antipyretics|mesh-ancestor
5513750|NCT04371874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5513751|NCT04371874|Diuretics|diuretics|mesh-ancestor
5513752|NCT04371874|Natriuretic Agents|natriuretic agents|mesh-ancestor
5513753|NCT04371874|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5513754|NCT04371874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5513755|NCT04371874|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5513756|NCT04371874|Protease Inhibitors|protease inhibitors|mesh-ancestor
5513757|NCT04371874|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6079590|NCT00788008|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6079591|NCT00788008|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6079592|NCT00788008|Anesthetics, General|anesthetics, general|mesh-ancestor
6079593|NCT00788008|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6079594|NCT00788151|Vaccines|vaccines|mesh-list
6079595|NCT00788151|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6079596|NCT00788151|Immunologic Factors|immunologic factors|mesh-ancestor
6079597|NCT00788151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513758|NCT04371874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5513759|NCT04371874|Vasodilator Agents|vasodilator agents|mesh-ancestor
5513760|NCT04371965|Povidone-Iodine|povidone-iodine|mesh-list
5513761|NCT04371965|Povidone|povidone|mesh-list
5513762|NCT04371965|Plasma Substitutes|plasma substitutes|mesh-ancestor
5513763|NCT04371965|Blood Substitutes|blood substitutes|mesh-ancestor
6079598|NCT00788255|Oxytocin|oxytocin|mesh-list
6079599|NCT00788255|Oxytocics|oxytocics|mesh-ancestor
6079600|NCT00788255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6079601|NCT00788255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079602|NCT00788372|Fentanyl|fentanyl|mesh-list
6079603|NCT00788372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6079604|NCT00788372|Narcotics|narcotics|mesh-ancestor
6079605|NCT00788372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6079606|NCT00788372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079607|NCT00788372|Analgesics|analgesics|mesh-ancestor
6079608|NCT00788372|Sensory System Agents|sensory system agents|mesh-ancestor
6079609|NCT00788372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6079610|NCT00788372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6079611|NCT00788372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6079612|NCT00788372|Anesthetics, General|anesthetics, general|mesh-ancestor
6079613|NCT00788372|Anesthetics|anesthetics|mesh-ancestor
6079614|NCT00788593|Pancreatin|pancreatin|mesh-list
6079615|NCT00788593|Pancrelipase|pancrelipase|mesh-list
6079616|NCT00788593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5513764|NCT04371965|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5513765|NCT04371965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5513766|NCT04372082|Hydroxychloroquine|hydroxychloroquine|mesh-list
5513767|NCT04372082|Niclosamide|niclosamide|mesh-list
5513768|NCT04372082|Diltiazem|diltiazem|mesh-list
5513769|NCT04372082|Antimalarials|antimalarials|mesh-ancestor
6079617|NCT00788892|Cytarabine|cytarabine|mesh-list
6079618|NCT00788892|Daunorubicin|daunorubicin|mesh-list
6079619|NCT00788892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6079620|NCT00788892|Antimetabolites|antimetabolites|mesh-ancestor
6079621|NCT00788892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079622|NCT00788892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6079623|NCT00788892|Antiviral Agents|antiviral agents|mesh-ancestor
5513770|NCT04372082|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5513771|NCT04372082|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6079624|NCT00788892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6079625|NCT00788892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6079626|NCT00788892|Immunologic Factors|immunologic factors|mesh-ancestor
6079627|NCT00788892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079628|NCT00788892|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6079629|NCT00788892|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6079630|NCT00788892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6079631|NCT00788892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6079632|NCT00788957|Panitumumab|panitumumab|mesh-list
6079633|NCT00788957|Rilotumumab|rilotumumab|mesh-list
6079634|NCT00788957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6079635|NCT00788957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6079636|NCT00789035|Metformin|metformin|mesh-list
6079637|NCT00789035|Empagliflozin|empagliflozin|mesh-list
6079638|NCT00789035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6079639|NCT00789035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079640|NCT00789035|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6079641|NCT00789035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079642|NCT00789074|Varenicline|varenicline|mesh-list
6079643|NCT00789074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6079644|NCT00789074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6079645|NCT00789074|Cholinergic Agents|cholinergic agents|mesh-ancestor
6079646|NCT00789074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6079647|NCT00789074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079648|NCT00789074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079649|NCT00789113|Lamotrigine|lamotrigine|mesh-list
6079650|NCT00789113|Anticonvulsants|anticonvulsants|mesh-ancestor
6079651|NCT00789113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6079652|NCT00789113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6079653|NCT00789113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079654|NCT00789113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6079655|NCT00789113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079656|NCT00789113|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6079657|NCT00789113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6079658|NCT00789113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6079659|NCT00789113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6079660|NCT00789113|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6079661|NCT00789191|Metformin|metformin|mesh-list
6079662|NCT00789191|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6079663|NCT00789191|Insulin Detemir|insulin detemir|mesh-list
6079664|NCT00789191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6079665|NCT00789191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079666|NCT00789191|Incretins|incretins|mesh-ancestor
6079667|NCT00789191|Hormones|hormones|mesh-ancestor
6079668|NCT00789191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6079669|NCT00789191|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6079670|NCT00789191|Protease Inhibitors|protease inhibitors|mesh-ancestor
6079671|NCT00789191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6079672|NCT00789191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079673|NCT00789256|Bortezomib|bortezomib|mesh-list
6079674|NCT00789256|Melphalan|melphalan|mesh-list
6079675|NCT00789256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6079676|NCT00789256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6079677|NCT00789256|Alkylating Agents|alkylating agents|mesh-ancestor
6079678|NCT00789256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079679|NCT00789256|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6079680|NCT00789256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6079681|NCT00789256|Immunologic Factors|immunologic factors|mesh-ancestor
6079682|NCT00789256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079683|NCT00789321|Amlodipine|amlodipine|mesh-list
6079684|NCT00789321|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6079685|NCT00789321|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6079686|NCT00789321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6079687|NCT00789321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079688|NCT00789321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6079689|NCT00789321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079690|NCT00789321|Vasodilator Agents|vasodilator agents|mesh-ancestor
6079691|NCT00789360|Loxapine|loxapine|mesh-list
6079692|NCT00789360|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6463824|NCT00466479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463825|NCT00466518|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6463826|NCT00466518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6079693|NCT00789360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6079694|NCT00789360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6079695|NCT00789360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079696|NCT00789360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6079697|NCT00789360|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6079698|NCT00789360|Dopamine Agents|dopamine agents|mesh-ancestor
6079699|NCT00789360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5513772|NCT04372082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5513773|NCT04372082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5513774|NCT04372082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513775|NCT04372082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5513776|NCT04372082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5513777|NCT04372082|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5513778|NCT04372082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5513779|NCT04372082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5513780|NCT04372082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513781|NCT04372082|Vasodilator Agents|vasodilator agents|mesh-ancestor
5513782|NCT04372082|Anticestodal Agents|anticestodal agents|mesh-ancestor
5513783|NCT04372082|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5513784|NCT04372082|Anthelmintics|anthelmintics|mesh-ancestor
5513785|NCT04372082|Antinematodal Agents|antinematodal agents|mesh-ancestor
5513786|NCT04371978|Linagliptin|linagliptin|mesh-list
5513787|NCT04371978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5513788|NCT04371978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513789|NCT04371978|Incretins|incretins|mesh-ancestor
5513790|NCT04371978|Hormones|hormones|mesh-ancestor
5513791|NCT04371978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6079700|NCT00789360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079701|NCT00789373|Pemetrexed|pemetrexed|mesh-list
6079702|NCT00789373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6079703|NCT00789373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6079704|NCT00789373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079705|NCT00789373|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6079706|NCT00789373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6079707|NCT00789477|Aflibercept|aflibercept|mesh-list
6079708|NCT00789477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6079709|NCT00789477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6079710|NCT00789477|Growth Substances|growth substances|mesh-ancestor
6079711|NCT00789477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079712|NCT00789477|Growth Inhibitors|growth inhibitors|mesh-ancestor
6079713|NCT00789477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5513792|NCT04371978|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5513793|NCT04371978|Protease Inhibitors|protease inhibitors|mesh-ancestor
5513794|NCT04371978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5513795|NCT04371978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513796|NCT04371926|Hydroxychloroquine|hydroxychloroquine|mesh-list
6463827|NCT00466518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513797|NCT04371926|Antimalarials|antimalarials|mesh-ancestor
6079714|NCT00789555|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
6079715|NCT00789555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6079716|NCT00789555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6079717|NCT00789555|Analgesics|analgesics|mesh-ancestor
5513798|NCT04371926|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5513799|NCT04371926|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5513800|NCT04371926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5513801|NCT04371926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5513802|NCT04371926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513803|NCT04371926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5513804|NCT04371757|Doxazosin|doxazosin|mesh-list
5513805|NCT04371757|Adrenergic Agents|adrenergic agents|mesh-list
5513806|NCT04371757|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5513807|NCT04371757|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5513808|NCT04371757|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5513809|NCT04371757|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5513810|NCT04371757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5513811|NCT04371757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513812|NCT04371757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513813|NCT04371601|Oseltamivir|oseltamivir|mesh-list
5513814|NCT04371601|Hormones|hormones|mesh-list
5513815|NCT04371601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5513816|NCT04371601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513817|NCT04371601|Antiviral Agents|antiviral agents|mesh-ancestor
5513818|NCT04371601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5513819|NCT04371601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5513820|NCT04371601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079718|NCT00789555|Sensory System Agents|sensory system agents|mesh-ancestor
6079719|NCT00789555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6079720|NCT00789555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079721|NCT00789555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6079722|NCT00789555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6079723|NCT00789555|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6079724|NCT00789555|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6079725|NCT00789555|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6079726|NCT00789555|Histamine Antagonists|histamine antagonists|mesh-ancestor
6079727|NCT00789555|Histamine Agents|histamine agents|mesh-ancestor
6079728|NCT00789555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6079729|NCT00789555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079730|NCT00789581|Paclitaxel|paclitaxel|mesh-list
6079731|NCT00789581|Cyclophosphamide|cyclophosphamide|mesh-list
6463828|NCT00466518|Incretins|incretins|mesh-ancestor
6463829|NCT00466518|Hormones|hormones|mesh-ancestor
6463830|NCT00466518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6463831|NCT00466518|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6079732|NCT00789581|Doxorubicin|doxorubicin|mesh-list
6079733|NCT00789581|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6079734|NCT00789581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6079735|NCT00789581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6079736|NCT00789581|Tubulin Modulators|tubulin modulators|mesh-ancestor
6079737|NCT00789581|Antimitotic Agents|antimitotic agents|mesh-ancestor
6079738|NCT00789581|Mitosis Modulators|mitosis modulators|mesh-ancestor
6079739|NCT00789581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079740|NCT00789581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6079741|NCT00789581|Immunologic Factors|immunologic factors|mesh-ancestor
6079742|NCT00789581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079743|NCT00789581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6079744|NCT00789581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6079745|NCT00789581|Alkylating Agents|alkylating agents|mesh-ancestor
6079746|NCT00789581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6079747|NCT00789581|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6079748|NCT00789581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6079749|NCT00789581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6079750|NCT00789581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5513842|NCT04371523|Hydroxychloroquine|hydroxychloroquine|mesh-list
5513843|NCT04371523|Antimalarials|antimalarials|mesh-ancestor
6079751|NCT00789672|Levodopa|levodopa|mesh-list
6079752|NCT00789672|Carbidopa|carbidopa|mesh-list
6079753|NCT00789672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6079754|NCT00789672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6079755|NCT00789672|Dopamine Agents|dopamine agents|mesh-ancestor
6079756|NCT00789672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6202851|NCT02046616|Immunologic Factors|immunologic factors|mesh-ancestor
5513844|NCT04371523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6079757|NCT00789672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079758|NCT00789672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079759|NCT00789672|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6079760|NCT00789672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6079761|NCT00789685|Interferons|interferons|mesh-list
6079762|NCT00789685|Interferon-beta|interferon-beta|mesh-list
6079763|NCT00789685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6079764|NCT00789685|Antiviral Agents|antiviral agents|mesh-ancestor
6079765|NCT00789685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6079766|NCT00789685|Immunologic Factors|immunologic factors|mesh-ancestor
6079767|NCT00789685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079768|NCT00789698|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6079769|NCT00789698|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
6079770|NCT00789698|Antidepressive Agents|antidepressive agents|mesh-ancestor
6079771|NCT00789698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5513845|NCT04371523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5513846|NCT04371523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5513847|NCT04371523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5513848|NCT04371523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513849|NCT04371523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5513850|NCT04371822|Protoporphyrin IX|protoporphyrin ix|mesh-list
6079772|NCT00789698|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6079773|NCT00789698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6079774|NCT00789698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6079775|NCT00789698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079776|NCT00789698|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6079777|NCT00789698|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6079778|NCT00789698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6079779|NCT00789698|Adrenergic Agents|adrenergic agents|mesh-ancestor
6079780|NCT00789698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6079781|NCT00789698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079782|NCT00789698|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6079783|NCT00789698|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6079784|NCT00789698|Serotonin Agents|serotonin agents|mesh-ancestor
6079785|NCT00789698|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6079786|NCT00789698|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6079787|NCT00789698|Dopamine Agents|dopamine agents|mesh-ancestor
6079788|NCT00789724|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6079789|NCT00789724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6079790|NCT00789737|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
6079791|NCT00789737|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6079792|NCT00789737|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6079793|NCT00789737|Antimetabolites|antimetabolites|mesh-ancestor
6079794|NCT00789737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079795|NCT00789737|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6079796|NCT00789750|Pioglitazone|pioglitazone|mesh-list
6079797|NCT00789750|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
6079798|NCT00789750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6079799|NCT00789750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079800|NCT00789750|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6079801|NCT00789750|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6079802|NCT00789750|Antimetabolites|antimetabolites|mesh-ancestor
6079803|NCT00789750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079804|NCT00789750|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6079805|NCT00789776|Mycophenolic Acid|mycophenolic acid|mesh-list
6079806|NCT00789776|Cyclophosphamide|cyclophosphamide|mesh-list
6079807|NCT00789776|Fludarabine|fludarabine|mesh-list
6079808|NCT00789776|Fludarabine phosphate|fludarabine phosphate|mesh-list
6079809|NCT00789776|Tacrolimus|tacrolimus|mesh-list
6079810|NCT00789776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6079811|NCT00789776|Immunologic Factors|immunologic factors|mesh-ancestor
6079812|NCT00789776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079813|NCT00789776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6079814|NCT00789776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6079815|NCT00789776|Alkylating Agents|alkylating agents|mesh-ancestor
6079816|NCT00789776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079817|NCT00789776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6079818|NCT00789776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6079819|NCT00789776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6079820|NCT00789776|Antimetabolites|antimetabolites|mesh-ancestor
6079821|NCT00789776|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5513851|NCT04371822|Tin protoporphyrin IX|tin protoporphyrin ix|mesh-list
6079822|NCT00789776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5513852|NCT04371822|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5513853|NCT04371822|Dermatologic Agents|dermatologic agents|mesh-ancestor
5513854|NCT04371822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5513855|NCT04371822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513856|NCT04371393|Remestemcel-l|remestemcel-l|mesh-list
5513857|NCT04371393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5513858|NCT04371393|Antiviral Agents|antiviral agents|mesh-ancestor
5513859|NCT04371393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5513860|NCT04371224|Leucovorin|leucovorin|mesh-list
5513861|NCT04371224|Fluorouracil|fluorouracil|mesh-list
5513862|NCT04371224|Capecitabine|capecitabine|mesh-list
5513863|NCT04371224|Irinotecan|irinotecan|mesh-list
5513864|NCT04371224|Antimetabolites|antimetabolites|mesh-ancestor
5513865|NCT04371224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513866|NCT04371224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5513867|NCT04371224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6079823|NCT00789776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6079824|NCT00789776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6079825|NCT00789776|Antitubercular Agents|antitubercular agents|mesh-ancestor
6079826|NCT00789776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6079827|NCT00789776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6079828|NCT00789802|Naproxen|naproxen|mesh-list
5513868|NCT04371224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5513869|NCT04371224|Immunologic Factors|immunologic factors|mesh-ancestor
5513870|NCT04371224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513871|NCT04371224|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5513872|NCT04371224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5513873|NCT04371224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5513874|NCT04371224|Antidotes|antidotes|mesh-ancestor
5513875|NCT04371224|Protective Agents|protective agents|mesh-ancestor
5513876|NCT04371224|Vitamin B Complex|vitamin b complex|mesh-ancestor
6079829|NCT00789802|Estradiol|estradiol|mesh-list
6079830|NCT00789802|Estrogens|estrogens|mesh-ancestor
6079831|NCT00789802|Hormones|hormones|mesh-ancestor
6079832|NCT00789802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6079833|NCT00789802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079834|NCT00789802|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6079835|NCT00789802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6079836|NCT00789802|Analgesics|analgesics|mesh-ancestor
6079837|NCT00789802|Sensory System Agents|sensory system agents|mesh-ancestor
6079838|NCT00789802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6079839|NCT00789802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6079840|NCT00789802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6079841|NCT00789802|Gout Suppressants|gout suppressants|mesh-ancestor
6079842|NCT00789802|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6079843|NCT00789802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6079844|NCT00789802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079845|NCT00789815|Midazolam|midazolam|mesh-list
6079846|NCT00789815|Propofol|propofol|mesh-list
6079847|NCT00789815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6079848|NCT00789815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6079849|NCT00789815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079850|NCT00789815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6079851|NCT00789815|Anesthetics, General|anesthetics, general|mesh-ancestor
6079852|NCT00789815|Anesthetics|anesthetics|mesh-ancestor
6079853|NCT00789815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5513877|NCT04371224|Vitamins|vitamins|mesh-ancestor
5513878|NCT04371224|Micronutrients|micronutrients|mesh-ancestor
5513879|NCT04371575|Carbamazepine|carbamazepine|mesh-list
5513880|NCT04371575|Oxcarbazepine|oxcarbazepine|mesh-list
5513881|NCT04371575|Anticonvulsants|anticonvulsants|mesh-ancestor
5513882|NCT04371575|Antimanic Agents|antimanic agents|mesh-ancestor
5513883|NCT04371575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5513884|NCT04371575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5513885|NCT04371575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513886|NCT04371575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5513887|NCT04371575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5513888|NCT04371575|Analgesics|analgesics|mesh-ancestor
6079854|NCT00789815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6079855|NCT00789815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6079856|NCT00789815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6079857|NCT00789815|GABA Modulators|gaba modulators|mesh-ancestor
6079858|NCT00789815|GABA Agents|gaba agents|mesh-ancestor
6079859|NCT00789815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6079860|NCT00789815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079861|NCT00789828|Everolimus|everolimus|mesh-list
6079862|NCT00789828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6079863|NCT00789828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6079864|NCT00789828|Immunologic Factors|immunologic factors|mesh-ancestor
6079865|NCT00789828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079866|NCT00789854|Quetiapine Fumarate|quetiapine fumarate|mesh-list
5513889|NCT04371575|Sensory System Agents|sensory system agents|mesh-ancestor
5513890|NCT04371575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5513891|NCT04371575|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5513892|NCT04371575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5513893|NCT04371575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513894|NCT04371575|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5513895|NCT04371575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5513896|NCT04371575|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5513897|NCT04371341|Bupivacaine|bupivacaine|mesh-list
5513898|NCT04371341|Anesthetics, Local|anesthetics, local|mesh-ancestor
5513899|NCT04371341|Anesthetics|anesthetics|mesh-ancestor
5513900|NCT04371341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5513901|NCT04371341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513902|NCT04371341|Sensory System Agents|sensory system agents|mesh-ancestor
6079867|NCT00789854|Lithium Carbonate|lithium carbonate|mesh-list
6079868|NCT00789854|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6079869|NCT00789854|Antidepressive Agents|antidepressive agents|mesh-ancestor
6079870|NCT00789854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6079871|NCT00789854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6079872|NCT00789854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6079873|NCT00789854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6079874|NCT00789854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079875|NCT00789854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6079876|NCT00789854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079877|NCT00789854|Antimanic Agents|antimanic agents|mesh-ancestor
6079878|NCT00789854|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6079879|NCT00789854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6079880|NCT00789854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6079881|NCT00789854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6079882|NCT00789854|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6079883|NCT00789880|Vitamin D|vitamin d|mesh-list
6079884|NCT00789880|Ergocalciferols|ergocalciferols|mesh-list
6079885|NCT00789880|Cholecalciferol|cholecalciferol|mesh-list
6079886|NCT00789880|Vitamins|vitamins|mesh-list
6079887|NCT00789880|Micronutrients|micronutrients|mesh-ancestor
6463832|NCT00466518|Protease Inhibitors|protease inhibitors|mesh-ancestor
6463833|NCT00466518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6463834|NCT00466518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463835|NCT00466570|Moxifloxacin|moxifloxacin|mesh-list
6463836|NCT00466570|Gatifloxacin|gatifloxacin|mesh-list
6463837|NCT00466570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6463838|NCT00466570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6463839|NCT00466570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6463840|NCT00466570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6463841|NCT00466570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6463842|NCT00466570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513903|NCT04371341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6079888|NCT00789880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079889|NCT00789880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6079890|NCT00789880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5513904|NCT04371367|Avdoralimab|avdoralimab|mesh-list
5513905|NCT04371367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5513906|NCT04371367|Antiviral Agents|antiviral agents|mesh-ancestor
5513907|NCT04371367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5513908|NCT04371406|Azithromycin|azithromycin|mesh-list
5513909|NCT04371406|Hydroxychloroquine|hydroxychloroquine|mesh-list
5513910|NCT04371406|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5513911|NCT04371406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5513912|NCT04371406|Antimalarials|antimalarials|mesh-ancestor
5513913|NCT04371406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5513914|NCT04371406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5513915|NCT04371406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5513916|NCT04371406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513917|NCT04371406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5513918|NCT04371185|Ustekinumab|ustekinumab|mesh-list
5513919|NCT04371185|Dermatologic Agents|dermatologic agents|mesh-ancestor
5513920|NCT04371146|Methylphenidate|methylphenidate|mesh-list
5513921|NCT04371146|Reboxetine|reboxetine|mesh-list
5513922|NCT04371146|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5513923|NCT04371146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513924|NCT04371146|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6463843|NCT00466570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6079891|NCT00789958|Gemcitabine|gemcitabine|mesh-list
6079892|NCT00789958|Capecitabine|capecitabine|mesh-list
6079893|NCT00789958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6079894|NCT00789958|Antimetabolites|antimetabolites|mesh-ancestor
6079895|NCT00789958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079896|NCT00789958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6079897|NCT00789958|Antiviral Agents|antiviral agents|mesh-ancestor
6079898|NCT00789958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6079899|NCT00789958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6079900|NCT00789958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6079901|NCT00789958|Immunologic Factors|immunologic factors|mesh-ancestor
6079902|NCT00789958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513925|NCT04371146|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5513926|NCT04371146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5513927|NCT04371146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079903|NCT00789997|Levofloxacin|levofloxacin|mesh-list
6079904|NCT00789997|Ofloxacin|ofloxacin|mesh-list
6079905|NCT00789997|Prednisone|prednisone|mesh-list
6079906|NCT00789997|Etanercept|etanercept|mesh-list
6079907|NCT00789997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6079908|NCT00789997|Glucocorticoids|glucocorticoids|mesh-ancestor
6079909|NCT00789997|Hormones|hormones|mesh-ancestor
6079910|NCT00789997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6079911|NCT00789997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079912|NCT00789997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6079913|NCT00789997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6079914|NCT00789997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6079915|NCT00789997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6079916|NCT00789997|Analgesics|analgesics|mesh-ancestor
6079917|NCT00789997|Sensory System Agents|sensory system agents|mesh-ancestor
6079918|NCT00789997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6079919|NCT00789997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6079920|NCT00789997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6079921|NCT00789997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6079922|NCT00789997|Immunologic Factors|immunologic factors|mesh-ancestor
6079923|NCT00789997|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6079924|NCT00789997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6079925|NCT00789997|Renal Agents|renal agents|mesh-ancestor
6079926|NCT00789997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6079927|NCT00789997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6079928|NCT00789997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6079929|NCT00789997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6079930|NCT00789997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079931|NCT00789997|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6079932|NCT00789997|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6079933|NCT00790023|Ciclesonide|ciclesonide|mesh-list
6079934|NCT00790023|Glucocorticoids|glucocorticoids|mesh-ancestor
6079935|NCT00790023|Hormones|hormones|mesh-ancestor
6079936|NCT00790023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6079937|NCT00790023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079938|NCT00790023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6079939|NCT00790036|Everolimus|everolimus|mesh-list
6079940|NCT00790036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6079941|NCT00790036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6079942|NCT00790036|Immunologic Factors|immunologic factors|mesh-ancestor
6079943|NCT00790036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079944|NCT00790062|Oxytocin|oxytocin|mesh-list
6079945|NCT00790062|Oxytocics|oxytocics|mesh-ancestor
6079946|NCT00790062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6079947|NCT00790062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079948|NCT00790192|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6079949|NCT00790192|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
6079950|NCT00790192|Antidepressive Agents|antidepressive agents|mesh-ancestor
6079951|NCT00790192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6079952|NCT00790192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6079953|NCT00790192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6079954|NCT00790192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6079955|NCT00790192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079956|NCT00790192|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6079957|NCT00790192|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6079958|NCT00790192|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6079959|NCT00790192|Adrenergic Agents|adrenergic agents|mesh-ancestor
6079960|NCT00790192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6079961|NCT00790192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079962|NCT00790192|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6079963|NCT00790192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6079964|NCT00790192|Serotonin Agents|serotonin agents|mesh-ancestor
6079965|NCT00790192|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6079966|NCT00790192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6079967|NCT00790192|Dopamine Agents|dopamine agents|mesh-ancestor
6079968|NCT00790205|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6079969|NCT00790205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6079970|NCT00790205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079971|NCT00790205|Incretins|incretins|mesh-ancestor
6079972|NCT00790205|Hormones|hormones|mesh-ancestor
6079973|NCT00790205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6079974|NCT00790205|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6079975|NCT00790205|Protease Inhibitors|protease inhibitors|mesh-ancestor
6079976|NCT00790205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6079977|NCT00790205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079978|NCT00790218|Adenosine|adenosine|mesh-list
6079979|NCT00790218|Analgesics|analgesics|mesh-ancestor
6079980|NCT00790218|Sensory System Agents|sensory system agents|mesh-ancestor
6079981|NCT00790218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6079982|NCT00790218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079983|NCT00790218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6079984|NCT00790218|Vasodilator Agents|vasodilator agents|mesh-ancestor
6079985|NCT00790218|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6079986|NCT00790218|Purinergic Agonists|purinergic agonists|mesh-ancestor
6079987|NCT00790218|Purinergic Agents|purinergic agents|mesh-ancestor
6079988|NCT00790218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6079989|NCT00790218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6079990|NCT00790270|Ibuprofen|ibuprofen|mesh-list
6079991|NCT00790270|Amitriptyline|amitriptyline|mesh-list
6079992|NCT00790270|Cyclobenzaprine|cyclobenzaprine|mesh-list
6079993|NCT00790270|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6079994|NCT00790270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6079995|NCT00790270|Analgesics|analgesics|mesh-ancestor
6079996|NCT00790270|Sensory System Agents|sensory system agents|mesh-ancestor
6079997|NCT00790270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6079998|NCT00790270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6079999|NCT00790270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6080000|NCT00790270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6080001|NCT00790270|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6080002|NCT00790270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6080003|NCT00790270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080004|NCT00790270|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6080005|NCT00790270|Antidepressive Agents|antidepressive agents|mesh-ancestor
6080006|NCT00790270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6080007|NCT00790270|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6080008|NCT00790270|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5513928|NCT04371146|Dopamine Agents|dopamine agents|mesh-ancestor
5513929|NCT04371146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6080009|NCT00790270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6080010|NCT00790270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6080011|NCT00790270|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6080012|NCT00790270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6080013|NCT00790270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6080014|NCT00790270|Adrenergic Agents|adrenergic agents|mesh-ancestor
6080015|NCT00790270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6080016|NCT00790296|Hormones|hormones|mesh-list
6080017|NCT00790296|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
6080018|NCT00790296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6080019|NCT00790296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080020|NCT00790335|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6080021|NCT00790335|Plasminogen|plasminogen|mesh-list
6080022|NCT00790335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6080023|NCT00790335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6080024|NCT00790335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080025|NCT00790400|Everolimus|everolimus|mesh-list
6080026|NCT00790400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6080027|NCT00790400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6080028|NCT00790400|Immunologic Factors|immunologic factors|mesh-ancestor
6080029|NCT00790400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080030|NCT00790569|Nicotine|nicotine|mesh-list
6080031|NCT00790569|Varenicline|varenicline|mesh-list
6080032|NCT00790569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6080033|NCT00790569|Autonomic Agents|autonomic agents|mesh-ancestor
6080034|NCT00790569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6080035|NCT00790569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080036|NCT00790569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6080037|NCT00790569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6080038|NCT00790569|Cholinergic Agents|cholinergic agents|mesh-ancestor
6080039|NCT00790569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5513930|NCT04371146|Antidepressive Agents|antidepressive agents|mesh-ancestor
5513931|NCT04371146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5513932|NCT04371146|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5513933|NCT04371146|Adrenergic Agents|adrenergic agents|mesh-ancestor
5513934|NCT04370977|Artesunate|artesunate|mesh-list
5513935|NCT04370977|Lumefantrine|lumefantrine|mesh-list
5513936|NCT04370977|Artemether|artemether|mesh-list
5513937|NCT04370977|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
5513938|NCT04370977|Amodiaquine|amodiaquine|mesh-list
5513939|NCT04370977|Antimalarials|antimalarials|mesh-ancestor
5513940|NCT04370977|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5513941|NCT04370977|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5513942|NCT04370977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5513943|NCT04370977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5513944|NCT04370977|Antiviral Agents|antiviral agents|mesh-ancestor
5513945|NCT04370977|Schistosomicides|schistosomicides|mesh-ancestor
5513946|NCT04370977|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5513947|NCT04370977|Anthelmintics|anthelmintics|mesh-ancestor
5513948|NCT04370782|Azithromycin|azithromycin|mesh-list
5513949|NCT04370782|Doxycycline|doxycycline|mesh-list
5513950|NCT04370782|Hydroxychloroquine|hydroxychloroquine|mesh-list
5513951|NCT04370782|Zinc Sulfate|zinc sulfate|mesh-list
5513952|NCT04370782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5513953|NCT04370782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6080040|NCT00790569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202852|NCT02046616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6202853|NCT02046616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6202854|NCT02046772|Morphine|morphine|mesh-list
6202855|NCT02046772|Bupivacaine|bupivacaine|mesh-list
6202856|NCT02046772|Anesthetics, Local|anesthetics, local|mesh-ancestor
6202857|NCT02046772|Anesthetics|anesthetics|mesh-ancestor
6202858|NCT02046772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5513954|NCT04370782|Antimalarials|antimalarials|mesh-ancestor
5513955|NCT04370782|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5513956|NCT04370782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5513957|NCT04370782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5513958|NCT04370782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513959|NCT04370782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5513960|NCT04370782|Astringents|astringents|mesh-ancestor
5513961|NCT04370782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513962|NCT04370782|Dermatologic Agents|dermatologic agents|mesh-ancestor
5513963|NCT04371107|Azithromycin|azithromycin|mesh-list
5513964|NCT04371107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5513965|NCT04371107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5513966|NCT04370483|Leflunomide|leflunomide|mesh-list
5513967|NCT04370483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5513968|NCT04370483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513969|NCT04370483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5513970|NCT04370483|Immunologic Factors|immunologic factors|mesh-ancestor
5513971|NCT04370483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600533|NCT03710772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5600534|NCT03710772|Methotrexate|methotrexate|mesh-list
5600535|NCT03710772|Vincristine|vincristine|mesh-list
5600536|NCT03710772|Venetoclax|venetoclax|mesh-list
5600537|NCT03710772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5600538|NCT03710772|Antibodies|antibodies|mesh-list
5600539|NCT03710772|Immunoglobulins|immunoglobulins|mesh-list
6202859|NCT02046772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202860|NCT02046772|Sensory System Agents|sensory system agents|mesh-ancestor
6202861|NCT02046772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6202862|NCT02046772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6202863|NCT02046772|Narcotics|narcotics|mesh-ancestor
6202864|NCT02046772|Analgesics|analgesics|mesh-ancestor
6202865|NCT02047032|Solifenacin Succinate|solifenacin succinate|mesh-list
6202866|NCT02047032|Cholinergic Antagonists|cholinergic antagonists|mesh-list
6202867|NCT02047032|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6202868|NCT02047032|Cholinergic Agents|cholinergic agents|mesh-ancestor
5600540|NCT03710772|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5600541|NCT03710772|BB 1101|bb 1101|mesh-list
5600542|NCT03710772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5600543|NCT03710772|Immunologic Factors|immunologic factors|mesh-ancestor
5600544|NCT03710772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600545|NCT03710772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6080041|NCT00790582|Lithium Carbonate|lithium carbonate|mesh-list
6080042|NCT00790582|Antidepressive Agents|antidepressive agents|mesh-ancestor
6080043|NCT00790582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6080044|NCT00790582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6080045|NCT00790582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080046|NCT00790582|Antimanic Agents|antimanic agents|mesh-ancestor
6080047|NCT00790582|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6080048|NCT00790582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6080049|NCT00790582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080050|NCT00790647|Bortezomib|bortezomib|mesh-list
6080051|NCT00790647|Melphalan|melphalan|mesh-list
5513980|NCT04370431|Edaravone|edaravone|mesh-list
5513981|NCT04370431|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5513982|NCT04370431|Antioxidants|antioxidants|mesh-ancestor
5513983|NCT04370431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513984|NCT04370431|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5513985|NCT04370431|Protective Agents|protective agents|mesh-ancestor
6080052|NCT00790647|Sargramostim|sargramostim|mesh-list
6080053|NCT00790647|Immunologic Factors|immunologic factors|mesh-ancestor
6080054|NCT00790647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080055|NCT00790647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6080056|NCT00790647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6080057|NCT00790647|Alkylating Agents|alkylating agents|mesh-ancestor
6080058|NCT00790647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080059|NCT00790647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6080060|NCT00790647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6080061|NCT00790842|Aspirin|aspirin|mesh-list
6080062|NCT00790842|Dexamethasone|dexamethasone|mesh-list
6080063|NCT00790842|Lenalidomide|lenalidomide|mesh-list
6080064|NCT00790842|Heparin|heparin|mesh-list
6080065|NCT00790842|Calcium heparin|calcium heparin|mesh-list
6080066|NCT00790842|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5513986|NCT04370431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513987|NCT04370587|Pembrolizumab|pembrolizumab|mesh-list
5513988|NCT04370587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5513989|NCT04370587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5513990|NCT04370262|Famotidine|famotidine|mesh-list
5513991|NCT04370262|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5513992|NCT04370262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5513993|NCT04370262|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5513994|NCT04370262|Histamine Antagonists|histamine antagonists|mesh-ancestor
5513995|NCT04370262|Histamine Agents|histamine agents|mesh-ancestor
5513996|NCT04370262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5513997|NCT04370262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5513998|NCT04370262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5513999|NCT04370093|Pioglitazone|pioglitazone|mesh-list
5514000|NCT04370093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5514001|NCT04370093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514002|NCT04370145|Meropenem|meropenem|mesh-list
5514003|NCT04370145|Tinidazole|tinidazole|mesh-list
5514004|NCT04370145|Teicoplanin|teicoplanin|mesh-list
5514005|NCT04370145|Sulperazone|sulperazone|mesh-list
5514006|NCT04370145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5514007|NCT04370145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5514008|NCT04370145|Alkylating Agents|alkylating agents|mesh-ancestor
5514009|NCT04370145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514010|NCT04370145|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
5514011|NCT04370145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6080067|NCT00790842|Tinzaparin|tinzaparin|mesh-list
6080068|NCT00790842|Dalteparin|dalteparin|mesh-list
6080069|NCT00790842|Anticoagulants|anticoagulants|mesh-list
6080070|NCT00790842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6080071|NCT00790842|Antiemetics|antiemetics|mesh-ancestor
6080072|NCT00790842|Autonomic Agents|autonomic agents|mesh-ancestor
5514012|NCT04370145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5514013|NCT04370145|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5514014|NCT04370145|Renal Agents|renal agents|mesh-ancestor
6080073|NCT00790842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6080074|NCT00790842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080075|NCT00790842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5514015|NCT04370015|Hydroxychloroquine|hydroxychloroquine|mesh-list
5514016|NCT04370015|Antimalarials|antimalarials|mesh-ancestor
5514017|NCT04370015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5514018|NCT04370015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6080076|NCT00790842|Glucocorticoids|glucocorticoids|mesh-ancestor
6080077|NCT00790842|Hormones|hormones|mesh-ancestor
6080078|NCT00790842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6080079|NCT00790842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6080080|NCT00790842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6080081|NCT00790842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6080082|NCT00790842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6080083|NCT00790842|Analgesics|analgesics|mesh-ancestor
6080084|NCT00790842|Sensory System Agents|sensory system agents|mesh-ancestor
6080085|NCT00790842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6080086|NCT00790842|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6080087|NCT00790842|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6080088|NCT00790842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080089|NCT00790842|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6080090|NCT00790842|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5514019|NCT04370015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5514020|NCT04370015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5514021|NCT04370015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514022|NCT04370015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5514023|NCT04370288|Ascorbic Acid|ascorbic acid|mesh-list
5514024|NCT04370288|Acetylcysteine|acetylcysteine|mesh-list
5514025|NCT04370288|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5514026|NCT04370288|Methylene Blue|methylene blue|mesh-list
5514027|NCT04370288|Vitamins|vitamins|mesh-ancestor
5514028|NCT04370288|Micronutrients|micronutrients|mesh-ancestor
5514029|NCT04370288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514030|NCT04370288|Antioxidants|antioxidants|mesh-ancestor
5514031|NCT04370288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514032|NCT04370288|Protective Agents|protective agents|mesh-ancestor
5514033|NCT04370288|Antiviral Agents|antiviral agents|mesh-ancestor
5514034|NCT04370288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5514035|NCT04370288|Expectorants|expectorants|mesh-ancestor
5514036|NCT04370288|Respiratory System Agents|respiratory system agents|mesh-ancestor
5514037|NCT04370288|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5514038|NCT04370288|Antidotes|antidotes|mesh-ancestor
5514039|NCT04370288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5514040|NCT04369794|BCG Vaccine|bcg vaccine|mesh-list
5514041|NCT04369794|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5514042|NCT04369794|Immunologic Factors|immunologic factors|mesh-ancestor
5514043|NCT04369794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080091|NCT00790842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6080092|NCT00790842|Antipyretics|antipyretics|mesh-ancestor
6080093|NCT00790842|Immunologic Factors|immunologic factors|mesh-ancestor
6080094|NCT00790842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6080095|NCT00790842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6080096|NCT00790842|Growth Substances|growth substances|mesh-ancestor
6080097|NCT00790842|Growth Inhibitors|growth inhibitors|mesh-ancestor
6080098|NCT00790855|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6080099|NCT00790855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6080100|NCT00790855|Alkylating Agents|alkylating agents|mesh-ancestor
6080101|NCT00790855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080102|NCT00790855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6080103|NCT00790868|Cycloserine|cycloserine|mesh-list
6080104|NCT00790868|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6080105|NCT00790868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6080106|NCT00790868|Renal Agents|renal agents|mesh-ancestor
6080107|NCT00790868|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6080108|NCT00790868|Antitubercular Agents|antitubercular agents|mesh-ancestor
6080109|NCT00790868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6080110|NCT00790868|Antimetabolites|antimetabolites|mesh-ancestor
6080111|NCT00790868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080112|NCT00790907|Heparin|heparin|mesh-list
6080113|NCT00790907|PENTA|penta|mesh-list
6080114|NCT00790907|Fondaparinux|fondaparinux|mesh-list
6080115|NCT00790907|Anticoagulants|anticoagulants|mesh-ancestor
6080116|NCT00790907|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6080117|NCT00790907|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6080118|NCT00790907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080119|NCT00790907|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6080120|NCT00790907|Antithrombins|antithrombins|mesh-ancestor
5514044|NCT04369937|Pembrolizumab|pembrolizumab|mesh-list
5514045|NCT04369937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5514046|NCT04369937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6080121|NCT00790907|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6080122|NCT00790907|Protease Inhibitors|protease inhibitors|mesh-ancestor
6080123|NCT00790907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6080124|NCT00790933|Vedolizumab|vedolizumab|mesh-list
6080125|NCT00790933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6080126|NCT00791037|Cyclophosphamide|cyclophosphamide|mesh-list
6080127|NCT00791037|Sargramostim|sargramostim|mesh-list
6080128|NCT00791037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6080129|NCT00791037|Immunologic Factors|immunologic factors|mesh-ancestor
6080130|NCT00791037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080131|NCT00791037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6080132|NCT00791037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6080133|NCT00791037|Alkylating Agents|alkylating agents|mesh-ancestor
6080134|NCT00791037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080135|NCT00791037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5514047|NCT04369950|Lidocaine|lidocaine|mesh-list
5514048|NCT04369950|Epinephrine|epinephrine|mesh-list
5514049|NCT04369950|Morphine|morphine|mesh-list
5514050|NCT04369950|Chloroprocaine|chloroprocaine|mesh-list
5514051|NCT04369950|Anesthetics, Local|anesthetics, local|mesh-ancestor
5514052|NCT04369950|Anesthetics|anesthetics|mesh-ancestor
5514053|NCT04369950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5514054|NCT04369950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080136|NCT00791037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6080137|NCT00791219|Itraconazole|itraconazole|mesh-list
6080138|NCT00791219|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
6080139|NCT00791219|Antifungal Agents|antifungal agents|mesh-ancestor
6080140|NCT00791219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6080141|NCT00791219|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6463844|NCT00466570|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6463845|NCT00466570|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6463846|NCT00466596|Vitamins|vitamins|mesh-list
6080142|NCT00791219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6080143|NCT00791219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6080144|NCT00791219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080145|NCT00791219|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6080146|NCT00791219|Hormone Antagonists|hormone antagonists|mesh-ancestor
6080147|NCT00791219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6080148|NCT00791219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080149|NCT00791219|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6080150|NCT00791258|Amlodipine|amlodipine|mesh-list
6080151|NCT00791258|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6080152|NCT00791258|Olmesartan|olmesartan|mesh-list
6080153|NCT00791258|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6080154|NCT00791258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6080155|NCT00791258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6080156|NCT00791258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6080157|NCT00791258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080158|NCT00791258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6080159|NCT00791258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080160|NCT00791258|Vasodilator Agents|vasodilator agents|mesh-ancestor
6080161|NCT00791258|Diuretics|diuretics|mesh-ancestor
6080162|NCT00791258|Natriuretic Agents|natriuretic agents|mesh-ancestor
6080163|NCT00791258|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6080164|NCT00791258|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6080165|NCT00791258|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6080166|NCT00791323|Ketorolac|ketorolac|mesh-list
6080167|NCT00791323|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6080168|NCT00791323|Lubricant Eye Drops|lubricant eye drops|mesh-list
6080169|NCT00791323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6080170|NCT00791323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6080171|NCT00791323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6080172|NCT00791323|Analgesics|analgesics|mesh-ancestor
6080173|NCT00791323|Sensory System Agents|sensory system agents|mesh-ancestor
6080174|NCT00791323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6080175|NCT00791323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080176|NCT00791323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6080177|NCT00791323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6080178|NCT00791323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6080179|NCT00791323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6080180|NCT00791323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080181|NCT00791479|Dulaglutide|dulaglutide|mesh-list
6080182|NCT00791479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6463847|NCT00466596|Vitamin E|vitamin e|mesh-list
5514055|NCT04369950|Sensory System Agents|sensory system agents|mesh-ancestor
6080183|NCT00791479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514056|NCT04369950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5514057|NCT04369950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5514058|NCT04369950|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5514059|NCT04369950|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5514060|NCT04369950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5514061|NCT04369950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514062|NCT04369950|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5514063|NCT04369950|Narcotics|narcotics|mesh-ancestor
5514064|NCT04369950|Analgesics|analgesics|mesh-ancestor
5514065|NCT04369950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5514066|NCT04369950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5514067|NCT04369950|Adrenergic Agents|adrenergic agents|mesh-ancestor
5514068|NCT04369950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5514069|NCT04369950|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5514070|NCT04369950|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5514071|NCT04369950|Autonomic Agents|autonomic agents|mesh-ancestor
5514072|NCT04369950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6080184|NCT00791557|Infliximab|infliximab|mesh-list
6080185|NCT00791557|Dermatologic Agents|dermatologic agents|mesh-ancestor
6080186|NCT00791557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6080187|NCT00791557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6080188|NCT00791648|Atorvastatin|atorvastatin|mesh-list
6080189|NCT00791648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6080190|NCT00791648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6080191|NCT00791648|Antimetabolites|antimetabolites|mesh-ancestor
6080192|NCT00791648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080193|NCT00791648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6080194|NCT00791648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6080195|NCT00791648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6080196|NCT00791700|Maraviroc|maraviroc|mesh-list
6080197|NCT00791700|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6080198|NCT00791700|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6080199|NCT00791700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080200|NCT00791700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6080201|NCT00791700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6080202|NCT00791700|Antiviral Agents|antiviral agents|mesh-ancestor
6080203|NCT00791700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6080204|NCT00791700|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6080205|NCT00791765|Etanercept|etanercept|mesh-list
6080206|NCT00791765|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6080207|NCT00791765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6080208|NCT00791765|Analgesics|analgesics|mesh-ancestor
6080209|NCT00791765|Sensory System Agents|sensory system agents|mesh-ancestor
6080210|NCT00791765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6080211|NCT00791765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080212|NCT00791765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6080213|NCT00791765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6080214|NCT00791765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6080215|NCT00791765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6080216|NCT00791765|Immunologic Factors|immunologic factors|mesh-ancestor
6080217|NCT00791778|Sorafenib|sorafenib|mesh-list
6080218|NCT00791778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6080219|NCT00791778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6080220|NCT00791778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6080221|NCT00791778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080222|NCT00791921|Certolizumab Pegol|certolizumab pegol|mesh-list
6080223|NCT00791921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5514073|NCT04369950|Respiratory System Agents|respiratory system agents|mesh-ancestor
5514074|NCT04369950|Mydriatics|mydriatics|mesh-ancestor
5514075|NCT04369950|Sympathomimetics|sympathomimetics|mesh-ancestor
5514076|NCT04369950|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5514077|NCT04369742|Hydroxychloroquine|hydroxychloroquine|mesh-list
5514078|NCT04369742|Calcium|calcium|mesh-list
5514079|NCT04369742|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5514080|NCT04369742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514081|NCT04369742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514082|NCT04369742|Antimalarials|antimalarials|mesh-ancestor
5514083|NCT04369742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5514084|NCT04369742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5514085|NCT04369742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5514086|NCT04369742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5514087|NCT04369742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5514088|NCT04369534|Clopidogrel|clopidogrel|mesh-list
6463848|NCT00466596|Tocopherols|tocopherols|mesh-list
5514089|NCT04369534|Ticagrelor|ticagrelor|mesh-list
6080224|NCT00791921|Immunologic Factors|immunologic factors|mesh-ancestor
6080225|NCT00791921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080226|NCT00791921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6080227|NCT00791973|Fluticasone|fluticasone|mesh-list
6080228|NCT00791973|Xhance|xhance|mesh-list
6080229|NCT00791973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5514090|NCT04369534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5514091|NCT04369534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5514092|NCT04369534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5514093|NCT04369534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5514094|NCT04369534|Purinergic Agents|purinergic agents|mesh-ancestor
6080230|NCT00791973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6080231|NCT00791973|Autonomic Agents|autonomic agents|mesh-ancestor
6080232|NCT00791973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6080233|NCT00791973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080234|NCT00791973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6080235|NCT00791973|Respiratory System Agents|respiratory system agents|mesh-ancestor
6080236|NCT00791973|Dermatologic Agents|dermatologic agents|mesh-ancestor
6080237|NCT00791973|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6080238|NCT00791999|Certolizumab Pegol|certolizumab pegol|mesh-list
6080239|NCT00791999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6080240|NCT00791999|Immunologic Factors|immunologic factors|mesh-ancestor
6080241|NCT00791999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080242|NCT00791999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6080243|NCT00792077|Lenalidomide|lenalidomide|mesh-list
6080244|NCT00792077|Immunologic Factors|immunologic factors|mesh-ancestor
6080245|NCT00792077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080246|NCT00792077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6080247|NCT00792077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6080248|NCT00792077|Growth Substances|growth substances|mesh-ancestor
6080249|NCT00792077|Growth Inhibitors|growth inhibitors|mesh-ancestor
6080250|NCT00792077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6080251|NCT00792142|Thalidomide|thalidomide|mesh-list
6080252|NCT00792142|Dexamethasone|dexamethasone|mesh-list
6080253|NCT00792142|Bortezomib|bortezomib|mesh-list
6080254|NCT00792142|Melphalan|melphalan|mesh-list
6080255|NCT00792142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6080256|NCT00792142|Antiemetics|antiemetics|mesh-ancestor
6080257|NCT00792142|Autonomic Agents|autonomic agents|mesh-ancestor
6080258|NCT00792142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6080259|NCT00792142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080260|NCT00792142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6080261|NCT00792142|Glucocorticoids|glucocorticoids|mesh-ancestor
6080262|NCT00792142|Hormones|hormones|mesh-ancestor
6080263|NCT00792142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6080264|NCT00792142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6080265|NCT00792142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6080266|NCT00792142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6080267|NCT00792142|Alkylating Agents|alkylating agents|mesh-ancestor
5514095|NCT04369534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5514096|NCT04369534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514097|NCT04369534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514098|NCT04369469|Ravulizumab|ravulizumab|mesh-list
5514099|NCT04369469|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5514100|NCT04369469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5514101|NCT04369469|Immunologic Factors|immunologic factors|mesh-ancestor
5514102|NCT04369469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514103|NCT04370080|Fluorides|fluorides|mesh-list
5514104|NCT04370080|Cariostatic Agents|cariostatic agents|mesh-ancestor
6080268|NCT00792142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080269|NCT00792142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6080270|NCT00792142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6080271|NCT00792142|Immunologic Factors|immunologic factors|mesh-ancestor
6080272|NCT00792142|Leprostatic Agents|leprostatic agents|mesh-ancestor
6080273|NCT00792142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6080274|NCT00792142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6080275|NCT00792142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6080276|NCT00792142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6080277|NCT00792142|Growth Substances|growth substances|mesh-ancestor
6080278|NCT00792142|Growth Inhibitors|growth inhibitors|mesh-ancestor
6080279|NCT00792298|Suvorexant|suvorexant|mesh-list
6080280|NCT00792298|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6080281|NCT00792298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6080282|NCT00792298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6080283|NCT00792298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080284|NCT00792298|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
6080285|NCT00792298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6080286|NCT00792298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080287|NCT00792467|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
6080288|NCT00792467|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
6080289|NCT00792467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6080290|NCT00792467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080291|NCT00792571|Epoprostenol|epoprostenol|mesh-list
6080292|NCT00792571|Beraprost|beraprost|mesh-list
6080293|NCT00792571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6080294|NCT00792571|Vasodilator Agents|vasodilator agents|mesh-ancestor
6080295|NCT00792571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6080296|NCT00792636|Naproxen|naproxen|mesh-list
6080297|NCT00792636|Sumatriptan|sumatriptan|mesh-list
6080298|NCT00792636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6080299|NCT00792636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6080300|NCT00792636|Analgesics|analgesics|mesh-ancestor
6080301|NCT00792636|Sensory System Agents|sensory system agents|mesh-ancestor
6080302|NCT00792636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6080303|NCT00792636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080304|NCT00792636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6080305|NCT00792636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6080306|NCT00792636|Gout Suppressants|gout suppressants|mesh-ancestor
6080307|NCT00792636|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6080308|NCT00792636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6080309|NCT00792636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080310|NCT00792636|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6080311|NCT00792636|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6080312|NCT00792636|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6080313|NCT00792636|Serotonin Agents|serotonin agents|mesh-ancestor
6080314|NCT00792636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6080315|NCT00792701|Gemcitabine|gemcitabine|mesh-list
6080316|NCT00792701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6080317|NCT00792701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6080318|NCT00792701|Antimetabolites|antimetabolites|mesh-ancestor
6080319|NCT00792701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080320|NCT00792701|Antiviral Agents|antiviral agents|mesh-ancestor
6080321|NCT00792701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6080322|NCT00792701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6080323|NCT00792701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6080324|NCT00792701|Immunologic Factors|immunologic factors|mesh-ancestor
6080325|NCT00792701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080326|NCT00792909|Vaccines|vaccines|mesh-list
6080327|NCT00792909|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6080328|NCT00792909|Immunologic Factors|immunologic factors|mesh-ancestor
6080329|NCT00792909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080330|NCT00792922|Azithromycin|azithromycin|mesh-list
6080331|NCT00792922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6080332|NCT00792922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6080333|NCT00792935|Metformin|metformin|mesh-list
6080334|NCT00792935|Glimepiride|glimepiride|mesh-list
6080335|NCT00792935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6080336|NCT00792935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080337|NCT00792935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6080338|NCT00792935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6080339|NCT00792935|Immunologic Factors|immunologic factors|mesh-ancestor
6080340|NCT00793546|Exemestane|exemestane|mesh-list
6080341|NCT00793546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6080342|NCT00793546|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6080343|NCT00793546|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6080344|NCT00793546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6463849|NCT00466596|Tocotrienols|tocotrienols|mesh-list
6202869|NCT02047032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6463850|NCT00466596|alpha-Tocopherol|alpha-tocopherol|mesh-list
5514105|NCT04370080|Protective Agents|protective agents|mesh-ancestor
5514106|NCT04370080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514107|NCT04370392|Anesthetics|anesthetics|mesh-list
5514108|NCT04370392|Anesthetics, Local|anesthetics, local|mesh-list
5514109|NCT04370392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5514110|NCT04370392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514111|NCT04370392|Sensory System Agents|sensory system agents|mesh-ancestor
5514112|NCT04370392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5514113|NCT04369391|Moxifloxacin|moxifloxacin|mesh-list
5514114|NCT04369391|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5514115|NCT04369391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5514116|NCT04369391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5514117|NCT04369391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5514118|NCT04369391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5514119|NCT04369391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514120|NCT04369391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5514121|NCT04369365|Azithromycin|azithromycin|mesh-list
6080345|NCT00793546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080346|NCT00793546|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6080347|NCT00793546|Hormone Antagonists|hormone antagonists|mesh-ancestor
6080348|NCT00793546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6080349|NCT00793546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080350|NCT00793572|Cyclosporine|cyclosporine|mesh-list
6080351|NCT00793572|Mycophenolic Acid|mycophenolic acid|mesh-list
6080352|NCT00793572|Fludarabine|fludarabine|mesh-list
6080353|NCT00793572|Fludarabine phosphate|fludarabine phosphate|mesh-list
6080354|NCT00793572|Bortezomib|bortezomib|mesh-list
5514122|NCT04369365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6080355|NCT00793572|Melphalan|melphalan|mesh-list
6080356|NCT00793572|Mechlorethamine|mechlorethamine|mesh-list
6080357|NCT00793572|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
6080358|NCT00793572|Cyclosporins|cyclosporins|mesh-list
6080359|NCT00793572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6080360|NCT00793572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6080361|NCT00793572|Antimetabolites|antimetabolites|mesh-ancestor
6080362|NCT00793572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080363|NCT00793572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6080364|NCT00793572|Immunologic Factors|immunologic factors|mesh-ancestor
6080365|NCT00793572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080366|NCT00793572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6080367|NCT00793572|Antifungal Agents|antifungal agents|mesh-ancestor
6080368|NCT00793572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6080369|NCT00793572|Dermatologic Agents|dermatologic agents|mesh-ancestor
6080370|NCT00793572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6080371|NCT00793572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6080372|NCT00793572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6080373|NCT00793572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6080374|NCT00793572|Antitubercular Agents|antitubercular agents|mesh-ancestor
6080375|NCT00793572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6463851|NCT00466596|gamma-Tocopherol|gamma-tocopherol|mesh-list
6463852|NCT00466596|Micronutrients|micronutrients|mesh-ancestor
6463853|NCT00466596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463854|NCT00466596|Antioxidants|antioxidants|mesh-ancestor
6463855|NCT00466596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463856|NCT00466596|Protective Agents|protective agents|mesh-ancestor
6463857|NCT00466609|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6463858|NCT00466609|Fluoxetine|fluoxetine|mesh-list
6080376|NCT00793572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6080377|NCT00793572|Alkylating Agents|alkylating agents|mesh-ancestor
6080378|NCT00793572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6080379|NCT00793585|Allopurinol|allopurinol|mesh-list
6080380|NCT00793585|Antimetabolites|antimetabolites|mesh-ancestor
6080381|NCT00793585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080382|NCT00793585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6080383|NCT00793585|Gout Suppressants|gout suppressants|mesh-ancestor
6080384|NCT00793585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6080385|NCT00793585|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6080386|NCT00793585|Antioxidants|antioxidants|mesh-ancestor
6080387|NCT00793585|Protective Agents|protective agents|mesh-ancestor
6080388|NCT00793585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080389|NCT00793598|Brincidofovir|brincidofovir|mesh-list
6080390|NCT00793598|Antiviral Agents|antiviral agents|mesh-ancestor
6080391|NCT00793598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6080392|NCT00793624|Formoterol Fumarate|formoterol fumarate|mesh-list
6080393|NCT00793624|Olodaterol|olodaterol|mesh-list
6080394|NCT00793624|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6080395|NCT00793624|Autonomic Agents|autonomic agents|mesh-ancestor
6080396|NCT00793624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6080397|NCT00793624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080398|NCT00793624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6080399|NCT00793624|Respiratory System Agents|respiratory system agents|mesh-ancestor
6080400|NCT00793624|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6080401|NCT00793624|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6080402|NCT00793624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6080403|NCT00793624|Adrenergic Agents|adrenergic agents|mesh-ancestor
6080404|NCT00793624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6080405|NCT00793624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080406|NCT00793650|Bortezomib|bortezomib|mesh-list
6080407|NCT00793650|Melphalan|melphalan|mesh-list
6080408|NCT00793650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5514123|NCT04369365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5514124|NCT04369222|Acetaminophen|acetaminophen|mesh-list
5514125|NCT04369222|Aspirin|aspirin|mesh-list
5514126|NCT04369222|Salicylic Acid|salicylic acid|mesh-list
5514127|NCT04369222|Salicylates|salicylates|mesh-list
5514128|NCT04369222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
5514129|NCT04369222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
6080409|NCT00793650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6080410|NCT00793650|Alkylating Agents|alkylating agents|mesh-ancestor
6080411|NCT00793650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080412|NCT00793650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6080413|NCT00793650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6080414|NCT00793650|Immunologic Factors|immunologic factors|mesh-ancestor
5514130|NCT04369222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5514131|NCT04369222|Analgesics|analgesics|mesh-ancestor
5514132|NCT04369222|Sensory System Agents|sensory system agents|mesh-ancestor
5514133|NCT04369222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5514134|NCT04369222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514135|NCT04369222|Antipyretics|antipyretics|mesh-ancestor
6080415|NCT00793650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080416|NCT00793780|Naltrexone|naltrexone|mesh-list
6080417|NCT00793780|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5514136|NCT04369222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5514137|NCT04369222|Antifungal Agents|antifungal agents|mesh-ancestor
5514138|NCT04369222|Keratolytic Agents|keratolytic agents|mesh-ancestor
5514139|NCT04369222|Dermatologic Agents|dermatologic agents|mesh-ancestor
5514140|NCT04369222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5514141|NCT04369222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5514142|NCT04369222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5514143|NCT04369222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514144|NCT04369222|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5514145|NCT04369222|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5514146|NCT04369222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5514147|NCT04368819|Allopurinol|allopurinol|mesh-list
5514148|NCT04368819|Antimetabolites|antimetabolites|mesh-ancestor
5514149|NCT04368819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514150|NCT04368819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5514151|NCT04368819|Gout Suppressants|gout suppressants|mesh-ancestor
5514152|NCT04368819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5514153|NCT04368819|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5514154|NCT04368819|Antioxidants|antioxidants|mesh-ancestor
5514155|NCT04368819|Protective Agents|protective agents|mesh-ancestor
5514156|NCT04368819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514157|NCT04368585|Simethicone|simethicone|mesh-list
5514158|NCT04368585|Omeprazole|omeprazole|mesh-list
5514159|NCT04368585|Aluminum Hydroxide|aluminum hydroxide|mesh-list
5514160|NCT04368585|Magnesium Hydroxide|magnesium hydroxide|mesh-list
5514161|NCT04368585|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
5514162|NCT04368585|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
6080418|NCT00793780|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6080419|NCT00793780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514163|NCT04368585|TEMPO|tempo|mesh-list
5514164|NCT04368585|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6080420|NCT00793780|Sensory System Agents|sensory system agents|mesh-ancestor
6080421|NCT00793780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6080422|NCT00793819|Silodosin|silodosin|mesh-list
6080423|NCT00793819|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5514165|NCT04368585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5514166|NCT04368585|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5514167|NCT04368585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5514168|NCT04368585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514169|NCT04368585|Antifoaming Agents|antifoaming agents|mesh-ancestor
6080424|NCT00793819|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6080425|NCT00793819|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6080426|NCT00793819|Adrenergic Agents|adrenergic agents|mesh-ancestor
6080427|NCT00793819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6080428|NCT00793819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080429|NCT00793819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463859|NCT00466609|Clomipramine|clomipramine|mesh-list
5514170|NCT04368585|Emollients|emollients|mesh-ancestor
5514171|NCT04368585|Dermatologic Agents|dermatologic agents|mesh-ancestor
6463860|NCT00466609|Antidepressive Agents|antidepressive agents|mesh-ancestor
6463861|NCT00466609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5514172|NCT04368585|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5514173|NCT04368585|Immunologic Factors|immunologic factors|mesh-ancestor
5514174|NCT04368585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514175|NCT04368585|Antacids|antacids|mesh-ancestor
5514176|NCT04368585|Antioxidants|antioxidants|mesh-ancestor
5514177|NCT04368585|Protective Agents|protective agents|mesh-ancestor
5600546|NCT03710772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5600547|NCT03710772|Alkylating Agents|alkylating agents|mesh-ancestor
5600548|NCT03710772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600549|NCT03710772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5600550|NCT03710772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5600551|NCT03710772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5600552|NCT03710772|Antiemetics|antiemetics|mesh-ancestor
5600553|NCT03710772|Autonomic Agents|autonomic agents|mesh-ancestor
5600554|NCT03710772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5600555|NCT03710772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5600556|NCT03710772|Glucocorticoids|glucocorticoids|mesh-ancestor
5600557|NCT03710772|Hormones|hormones|mesh-ancestor
5600558|NCT03710772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5600559|NCT03710772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5600560|NCT03710772|Protease Inhibitors|protease inhibitors|mesh-ancestor
6463862|NCT00466609|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6463863|NCT00466609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6463864|NCT00466609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6463865|NCT00466609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463866|NCT00466609|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6463867|NCT00466609|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6463868|NCT00466609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6463869|NCT00466609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600561|NCT03710772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5600562|NCT03710772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5600563|NCT03710772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5600564|NCT03710772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5600565|NCT03710772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5600566|NCT03710772|Abortifacient Agents|abortifacient agents|mesh-ancestor
5600567|NCT03710772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5600568|NCT03710772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5600569|NCT03710772|Antimetabolites|antimetabolites|mesh-ancestor
5600570|NCT03710772|Dermatologic Agents|dermatologic agents|mesh-ancestor
5600571|NCT03710772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5600572|NCT03710772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6080430|NCT00793819|Urological Agents|urological agents|mesh-ancestor
6463870|NCT00466609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6463871|NCT00466609|Serotonin Agents|serotonin agents|mesh-ancestor
6463872|NCT00466609|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6463873|NCT00466609|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6463874|NCT00466609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6463875|NCT00466609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6463876|NCT00466609|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6463877|NCT00466622|Metformin|metformin|mesh-list
6463878|NCT00466622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6080431|NCT00793871|Sunitinib|sunitinib|mesh-list
6080432|NCT00793871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6080433|NCT00793871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6080434|NCT00793871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6080435|NCT00793871|Growth Substances|growth substances|mesh-ancestor
6080436|NCT00793871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080437|NCT00793871|Growth Inhibitors|growth inhibitors|mesh-ancestor
6080438|NCT00793871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6080439|NCT00793871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6080440|NCT00793871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080441|NCT00793910|Gabapentin|gabapentin|mesh-list
5514178|NCT04368546|Sunitinib|sunitinib|mesh-list
5514179|NCT04368546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5514180|NCT04368546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5514181|NCT04368546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5514182|NCT04368546|Growth Substances|growth substances|mesh-ancestor
5514183|NCT04368546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514184|NCT04368546|Growth Inhibitors|growth inhibitors|mesh-ancestor
6080442|NCT00793910|Analgesics|analgesics|mesh-ancestor
6080443|NCT00793910|Sensory System Agents|sensory system agents|mesh-ancestor
6080444|NCT00793910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6080445|NCT00793910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080446|NCT00793910|Anticonvulsants|anticonvulsants|mesh-ancestor
6080447|NCT00793910|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6080448|NCT00793910|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6080449|NCT00793910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6080450|NCT00793910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6080451|NCT00793910|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6080452|NCT00793910|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6080453|NCT00793910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6080454|NCT00793910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080455|NCT00793910|Antimanic Agents|antimanic agents|mesh-ancestor
6080456|NCT00794040|Methylphenidate|methylphenidate|mesh-list
6080457|NCT00794040|Citalopram|citalopram|mesh-list
6080458|NCT00794040|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6080459|NCT00794040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080460|NCT00794040|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6080461|NCT00794040|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6080462|NCT00794040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6080463|NCT00794040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665446|NCT01517321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665447|NCT01517321|Incretins|incretins|mesh-ancestor
5514185|NCT04368546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5514186|NCT04368546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5514187|NCT04368546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514188|NCT04368598|Acetylcysteine|acetylcysteine|mesh-list
6080464|NCT00794040|Dopamine Agents|dopamine agents|mesh-ancestor
6665448|NCT01517321|Hormones|hormones|mesh-ancestor
6665449|NCT01517321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6080465|NCT00794040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6080466|NCT00794040|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6080467|NCT00794040|Serotonin Agents|serotonin agents|mesh-ancestor
6080468|NCT00794040|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6080469|NCT00794040|Antidepressive Agents|antidepressive agents|mesh-ancestor
6080470|NCT00794040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6080471|NCT00794144|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
6080472|NCT00794144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6080473|NCT00794144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6080474|NCT00794144|Analgesics|analgesics|mesh-ancestor
6080475|NCT00794144|Sensory System Agents|sensory system agents|mesh-ancestor
6080476|NCT00794144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6080477|NCT00794144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080478|NCT00794144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6080479|NCT00794144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6080480|NCT00794144|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6080481|NCT00794144|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6080482|NCT00794144|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6080483|NCT00794144|Histamine Antagonists|histamine antagonists|mesh-ancestor
6080484|NCT00794144|Histamine Agents|histamine agents|mesh-ancestor
6080485|NCT00794144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6080486|NCT00794144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080487|NCT00794196|Antidepressive Agents|antidepressive agents|mesh-list
6080488|NCT00794196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6080489|NCT00794313|Topiramate|topiramate|mesh-list
6080490|NCT00794313|Amantadine|amantadine|mesh-list
6665450|NCT01517321|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6080491|NCT00794313|Anticonvulsants|anticonvulsants|mesh-ancestor
6080492|NCT00794313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6080493|NCT00794313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080494|NCT00794313|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6080495|NCT00794313|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6080496|NCT00794313|Antiviral Agents|antiviral agents|mesh-ancestor
6080497|NCT00794313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6080498|NCT00794313|Dopamine Agents|dopamine agents|mesh-ancestor
6080499|NCT00794313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6080500|NCT00794313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080501|NCT00794313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6080502|NCT00794313|Analgesics|analgesics|mesh-ancestor
6080503|NCT00794313|Sensory System Agents|sensory system agents|mesh-ancestor
6080504|NCT00794313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6080505|NCT00794339|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6080506|NCT00794339|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6080507|NCT00794339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080508|NCT00794365|Varenicline|varenicline|mesh-list
6080509|NCT00794365|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6080510|NCT00794365|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6080511|NCT00794365|Cholinergic Agents|cholinergic agents|mesh-ancestor
5514189|NCT04368598|Dexamethasone|dexamethasone|mesh-list
5514190|NCT04368598|Dexamethasone acetate|dexamethasone acetate|mesh-list
5514191|NCT04368598|BB 1101|bb 1101|mesh-list
5514192|NCT04368598|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5514193|NCT04368598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5514194|NCT04368598|Antiemetics|antiemetics|mesh-ancestor
5514195|NCT04368598|Autonomic Agents|autonomic agents|mesh-ancestor
5514196|NCT04368598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5514197|NCT04368598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514198|NCT04368598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5514199|NCT04368598|Glucocorticoids|glucocorticoids|mesh-ancestor
6080512|NCT00794365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6080513|NCT00794365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080514|NCT00794365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080515|NCT00794417|Pemetrexed|pemetrexed|mesh-list
6080516|NCT00794417|Aflibercept|aflibercept|mesh-list
6080517|NCT00794417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6080518|NCT00794417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6080519|NCT00794417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080520|NCT00794417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6080521|NCT00794417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6080522|NCT00794417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6080523|NCT00794417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6080524|NCT00794417|Growth Substances|growth substances|mesh-ancestor
6080525|NCT00794417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080526|NCT00794417|Growth Inhibitors|growth inhibitors|mesh-ancestor
6080527|NCT00794547|Calcitriol|calcitriol|mesh-list
6080528|NCT00794547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5514200|NCT04368598|Hormones|hormones|mesh-ancestor
5514201|NCT04368598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5514202|NCT04368598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5514203|NCT04368598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5514204|NCT04368598|Protease Inhibitors|protease inhibitors|mesh-ancestor
5514205|NCT04368598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5514206|NCT04368598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514207|NCT04368598|Antiviral Agents|antiviral agents|mesh-ancestor
5514208|NCT04368598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5514209|NCT04368598|Expectorants|expectorants|mesh-ancestor
5514210|NCT04368598|Respiratory System Agents|respiratory system agents|mesh-ancestor
5514211|NCT04368598|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5514212|NCT04368598|Antioxidants|antioxidants|mesh-ancestor
5514213|NCT04368598|Protective Agents|protective agents|mesh-ancestor
6080529|NCT00794547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080530|NCT00794547|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6080531|NCT00794547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6080532|NCT00794547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080533|NCT00794547|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6080534|NCT00794547|Vitamins|vitamins|mesh-ancestor
6080535|NCT00794547|Micronutrients|micronutrients|mesh-ancestor
6080536|NCT00794547|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6080537|NCT00794573|Varenicline|varenicline|mesh-list
6080538|NCT00794573|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6080539|NCT00794573|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5514214|NCT04368598|Antidotes|antidotes|mesh-ancestor
5514215|NCT04368520|Vitamin D|vitamin d|mesh-list
6080540|NCT00794573|Cholinergic Agents|cholinergic agents|mesh-ancestor
6080541|NCT00794573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5514216|NCT04368520|Ergocalciferols|ergocalciferols|mesh-list
5514217|NCT04368520|Cholecalciferol|cholecalciferol|mesh-list
5514218|NCT04368520|Vitamins|vitamins|mesh-list
5514219|NCT04368520|Micronutrients|micronutrients|mesh-ancestor
5514220|NCT04368520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514221|NCT04368520|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5514222|NCT04368520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5514223|NCT04368533|Fluorides|fluorides|mesh-list
5514224|NCT04368533|Cariostatic Agents|cariostatic agents|mesh-ancestor
5514225|NCT04368533|Protective Agents|protective agents|mesh-ancestor
5514226|NCT04368533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514227|NCT04368377|Aspirin|aspirin|mesh-list
5514228|NCT04368377|PENTA|penta|mesh-list
5514229|NCT04368377|Tirofiban|tirofiban|mesh-list
5514230|NCT04368377|Fondaparinux|fondaparinux|mesh-list
5514231|NCT04368377|Clopidogrel|clopidogrel|mesh-list
5514232|NCT04368377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5514233|NCT04368377|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5514234|NCT04368377|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5514235|NCT04368377|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5514236|NCT04368377|Purinergic Agents|purinergic agents|mesh-ancestor
5514237|NCT04368377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5514238|NCT04368377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514239|NCT04368377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514240|NCT04368377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5514241|NCT04368377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5514242|NCT04368377|Analgesics|analgesics|mesh-ancestor
5514243|NCT04368377|Sensory System Agents|sensory system agents|mesh-ancestor
5514244|NCT04368377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5514245|NCT04368377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5514246|NCT04368377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5514247|NCT04368377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5514248|NCT04368377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5514249|NCT04368377|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5514250|NCT04368377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5514251|NCT04368377|Antipyretics|antipyretics|mesh-ancestor
5514252|NCT04368377|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6080542|NCT00794573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080543|NCT00794573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080544|NCT00794664|Mipomersen|mipomersen|mesh-list
6080545|NCT00794664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6080546|NCT00794664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6080547|NCT00794664|Antimetabolites|antimetabolites|mesh-ancestor
6080548|NCT00794664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080549|NCT00794664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6080550|NCT00794820|Vidarabine|vidarabine|mesh-list
6080551|NCT00794820|Cyclophosphamide|cyclophosphamide|mesh-list
6080552|NCT00794820|Rituximab|rituximab|mesh-list
6080553|NCT00794820|Fludarabine|fludarabine|mesh-list
6080554|NCT00794820|Fludarabine phosphate|fludarabine phosphate|mesh-list
6080555|NCT00794820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6080556|NCT00794820|Immunologic Factors|immunologic factors|mesh-ancestor
6080557|NCT00794820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080558|NCT00794820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6080559|NCT00794820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5514253|NCT04368377|Antithrombins|antithrombins|mesh-ancestor
5514254|NCT04368377|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5514255|NCT04368377|Protease Inhibitors|protease inhibitors|mesh-ancestor
6080560|NCT00794820|Alkylating Agents|alkylating agents|mesh-ancestor
6080561|NCT00794820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080562|NCT00794820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6080563|NCT00794820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6080564|NCT00794820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6080565|NCT00794820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6080566|NCT00794820|Antimetabolites|antimetabolites|mesh-ancestor
6080567|NCT00794820|Antiviral Agents|antiviral agents|mesh-ancestor
6080568|NCT00794820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6080569|NCT00794950|Sunitinib|sunitinib|mesh-list
6080570|NCT00794950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6080571|NCT00794950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6080572|NCT00794950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5514256|NCT04368377|Anticoagulants|anticoagulants|mesh-ancestor
5514257|NCT04368403|Brodalumab|brodalumab|mesh-list
5514258|NCT04368403|Dermatologic Agents|dermatologic agents|mesh-ancestor
6080573|NCT00794950|Growth Substances|growth substances|mesh-ancestor
6080574|NCT00794950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080575|NCT00794950|Growth Inhibitors|growth inhibitors|mesh-ancestor
6080576|NCT00794950|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6080577|NCT00794950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6080578|NCT00794950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080579|NCT00794963|Metformin|metformin|mesh-list
6080580|NCT00794963|Orlistat|orlistat|mesh-list
6080581|NCT00794963|Irbesartan|irbesartan|mesh-list
6080582|NCT00794963|Fenofibrate|fenofibrate|mesh-list
6080583|NCT00794963|Pravastatin|pravastatin|mesh-list
6080584|NCT00794963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6080585|NCT00794963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080586|NCT00794963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6080587|NCT00794963|Antimetabolites|antimetabolites|mesh-ancestor
6080588|NCT00794963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080589|NCT00794963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6080590|NCT00794963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6080591|NCT00794963|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6080592|NCT00794963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6080593|NCT00794963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6080594|NCT00794963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6080595|NCT00794963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6080596|NCT00794963|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6080597|NCT00795002|Cytarabine|cytarabine|mesh-list
6080598|NCT00795002|Mitoxantrone|mitoxantrone|mesh-list
6080599|NCT00795002|Alvocidib|alvocidib|mesh-list
6080600|NCT00795002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6080601|NCT00795002|Antimetabolites|antimetabolites|mesh-ancestor
6080602|NCT00795002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080603|NCT00795002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6080604|NCT00795002|Antiviral Agents|antiviral agents|mesh-ancestor
6080605|NCT00795002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6080606|NCT00795002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6080607|NCT00795002|Immunologic Factors|immunologic factors|mesh-ancestor
6080608|NCT00795002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080609|NCT00795002|Analgesics|analgesics|mesh-ancestor
6080610|NCT00795002|Sensory System Agents|sensory system agents|mesh-ancestor
6080611|NCT00795002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6080612|NCT00795002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6080613|NCT00795002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6080614|NCT00795002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6080615|NCT00795002|Growth Inhibitors|growth inhibitors|mesh-ancestor
6080616|NCT00795002|Growth Substances|growth substances|mesh-ancestor
6080617|NCT00795002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6080618|NCT00795132|Cyclosporine|cyclosporine|mesh-list
6080619|NCT00795132|Mycophenolic Acid|mycophenolic acid|mesh-list
6080620|NCT00795132|Fludarabine|fludarabine|mesh-list
6080621|NCT00795132|Busulfan|busulfan|mesh-list
6080622|NCT00795132|Cyclosporins|cyclosporins|mesh-list
6080623|NCT00795132|Thymoglobulin|thymoglobulin|mesh-list
6080624|NCT00795132|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6080625|NCT00795132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6080626|NCT00795132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080627|NCT00795132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6080628|NCT00795132|Immunologic Factors|immunologic factors|mesh-ancestor
6080629|NCT00795132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080630|NCT00795132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6080631|NCT00795132|Antifungal Agents|antifungal agents|mesh-ancestor
6080632|NCT00795132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6080633|NCT00795132|Dermatologic Agents|dermatologic agents|mesh-ancestor
6080634|NCT00795132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6080635|NCT00795132|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5514259|NCT04368273|Antibodies|antibodies|mesh-list
5514260|NCT04368273|Immunologic Factors|immunologic factors|mesh-ancestor
5514261|NCT04368273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514262|NCT04368078|Lenvatinib|lenvatinib|mesh-list
5514263|NCT04368078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5514264|NCT04368078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5514265|NCT04368078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5514266|NCT04368078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514267|NCT04367948|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5514268|NCT04367948|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5600573|NCT03710772|Antiviral Agents|antiviral agents|mesh-ancestor
6080636|NCT00795132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6080637|NCT00795132|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6080638|NCT00795132|Antitubercular Agents|antitubercular agents|mesh-ancestor
6080639|NCT00795132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6080640|NCT00795132|Alkylating Agents|alkylating agents|mesh-ancestor
6080641|NCT00795132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6080642|NCT00795132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6080643|NCT00795145|Moxifloxacin|moxifloxacin|mesh-list
6080644|NCT00795145|Linezolid|linezolid|mesh-list
6080645|NCT00795145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6080646|NCT00795145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6080647|NCT00795145|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6080648|NCT00795145|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6080649|NCT00795145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6080650|NCT00795145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514269|NCT04367948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514270|NCT04368091|Sirolimus|sirolimus|mesh-list
5514271|NCT04368091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5514272|NCT04368091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5514273|NCT04368091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5514274|NCT04368091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6080651|NCT00795145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6080652|NCT00795145|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6080653|NCT00795210|Hormones|hormones|mesh-list
6080654|NCT00795210|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
6080655|NCT00795210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6080656|NCT00795210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080657|NCT00795275|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6080658|NCT00795275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6080659|NCT00795275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080660|NCT00795275|Incretins|incretins|mesh-ancestor
6080661|NCT00795275|Hormones|hormones|mesh-ancestor
6080662|NCT00795275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6080663|NCT00795275|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6080664|NCT00795275|Protease Inhibitors|protease inhibitors|mesh-ancestor
6080665|NCT00795275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6080666|NCT00795275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080667|NCT00795288|Simvastatin|simvastatin|mesh-list
6080668|NCT00795288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6080669|NCT00795288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6080670|NCT00795288|Antimetabolites|antimetabolites|mesh-ancestor
5514275|NCT04368091|Antifungal Agents|antifungal agents|mesh-ancestor
5514276|NCT04368091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5514277|NCT04368091|Immunologic Factors|immunologic factors|mesh-ancestor
5514278|NCT04368091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514279|NCT04368351|Azithromycin|azithromycin|mesh-list
5514280|NCT04368351|Hydroxychloroquine|hydroxychloroquine|mesh-list
5514281|NCT04368351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5514282|NCT04368351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5514283|NCT04368351|Antimalarials|antimalarials|mesh-ancestor
5514284|NCT04368351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5514285|NCT04368351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5514286|NCT04368351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6080671|NCT00795288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080672|NCT00795288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6080673|NCT00795288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6080674|NCT00795288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6080675|NCT00795340|Paclitaxel|paclitaxel|mesh-list
5514287|NCT04368351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514288|NCT04368351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5514289|NCT04367935|Pentoxifylline|pentoxifylline|mesh-list
5514290|NCT04367935|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5514291|NCT04367935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5514292|NCT04367935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514293|NCT04367935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5514294|NCT04367935|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5514295|NCT04367935|Protective Agents|protective agents|mesh-ancestor
5514296|NCT04367935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080676|NCT00795340|Carboplatin|carboplatin|mesh-list
6080677|NCT00795340|Cediranib|cediranib|mesh-list
6080678|NCT00795340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6080679|NCT00795340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6080680|NCT00795340|Tubulin Modulators|tubulin modulators|mesh-ancestor
6080681|NCT00795340|Antimitotic Agents|antimitotic agents|mesh-ancestor
6080682|NCT00795340|Mitosis Modulators|mitosis modulators|mesh-ancestor
6080683|NCT00795340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080684|NCT00795340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6080685|NCT00795340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6080686|NCT00795366|Vasopressins|vasopressins|mesh-list
6080687|NCT00795366|Arginine Vasopressin|arginine vasopressin|mesh-list
6080688|NCT00795366|Hemostatics|hemostatics|mesh-ancestor
6080689|NCT00795366|Coagulants|coagulants|mesh-ancestor
6080690|NCT00795366|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6080691|NCT00795366|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6080692|NCT00795366|Natriuretic Agents|natriuretic agents|mesh-ancestor
6080693|NCT00795366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080694|NCT00795509|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6080695|NCT00795509|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6080696|NCT00795509|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6080697|NCT00795509|Cholinergic Agents|cholinergic agents|mesh-ancestor
6080698|NCT00795509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6080699|NCT00795509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080700|NCT00795509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665451|NCT01517321|Protease Inhibitors|protease inhibitors|mesh-ancestor
6665452|NCT01517321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6665453|NCT01517321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665454|NCT01517334|Minocycline|minocycline|mesh-list
6665455|NCT01517334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6665456|NCT01517334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6665457|NCT01517347|Interleukin-2|interleukin-2|mesh-list
6665458|NCT01517347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6665459|NCT01517347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6665460|NCT01517347|Analgesics|analgesics|mesh-ancestor
6080701|NCT00795509|Urological Agents|urological agents|mesh-ancestor
5514297|NCT04367935|Vasodilator Agents|vasodilator agents|mesh-ancestor
6080702|NCT00795600|Insulin|insulin|mesh-list
6080703|NCT00795600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6080704|NCT00795600|Insulin Detemir|insulin detemir|mesh-list
6080705|NCT00795600|Isophane Insulin, Human|isophane insulin, human|mesh-list
6080706|NCT00795600|Insulin, Isophane|insulin, isophane|mesh-list
6080707|NCT00795600|Isophane insulin, beef|isophane insulin, beef|mesh-list
6080708|NCT00795600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6080709|NCT00795600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202870|NCT02047032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202871|NCT02047032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202872|NCT02047032|Urological Agents|urological agents|mesh-ancestor
6202873|NCT02047045|Prucalopride|prucalopride|mesh-list
6202874|NCT02047045|Serotonin|serotonin|mesh-list
6202875|NCT02047045|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6202876|NCT02047045|Serotonin Agents|serotonin agents|mesh-ancestor
6202877|NCT02047045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6202878|NCT02047045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202879|NCT02047045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202880|NCT02047045|Laxatives|laxatives|mesh-ancestor
6202881|NCT02047045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6202882|NCT02047045|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
6202883|NCT02047110|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6202884|NCT02047110|Immunologic Factors|immunologic factors|mesh-ancestor
6202885|NCT02047110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202886|NCT02047227|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6202887|NCT02047227|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6202888|NCT02047227|Hormones|hormones|mesh-ancestor
6202889|NCT02047227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6202890|NCT02047227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202891|NCT02047227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6202892|NCT02047253|Acyclovir|acyclovir|mesh-list
6202893|NCT02047253|Dexamethasone|dexamethasone|mesh-list
6202894|NCT02047253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6202895|NCT02047253|Antiemetics|antiemetics|mesh-ancestor
6202896|NCT02047253|Autonomic Agents|autonomic agents|mesh-ancestor
6202897|NCT02047253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6202898|NCT02047253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665461|NCT01517347|Sensory System Agents|sensory system agents|mesh-ancestor
6080710|NCT00795639|Sitaxsentan|sitaxsentan|mesh-list
6080711|NCT00795639|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6080712|NCT00795639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080713|NCT00795769|Ondansetron|ondansetron|mesh-list
6080714|NCT00795769|Antiemetics|antiemetics|mesh-ancestor
5514298|NCT04367935|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5514299|NCT04367935|Antioxidants|antioxidants|mesh-ancestor
5514300|NCT04368364|Morphine|morphine|mesh-list
5514301|NCT04368364|Bupivacaine|bupivacaine|mesh-list
5514302|NCT04368364|Ropivacaine|ropivacaine|mesh-list
5514303|NCT04368364|Anesthetics, Local|anesthetics, local|mesh-ancestor
5514304|NCT04368364|Anesthetics|anesthetics|mesh-ancestor
5514305|NCT04368364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5514306|NCT04368364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514307|NCT04368364|Sensory System Agents|sensory system agents|mesh-ancestor
5514308|NCT04368364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5514309|NCT04368364|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5514310|NCT04368364|Narcotics|narcotics|mesh-ancestor
5514311|NCT04368364|Analgesics|analgesics|mesh-ancestor
6080715|NCT00795769|Autonomic Agents|autonomic agents|mesh-ancestor
6080716|NCT00795769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6080717|NCT00795769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080718|NCT00795769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6080719|NCT00795769|Antipruritics|antipruritics|mesh-ancestor
6080720|NCT00795769|Dermatologic Agents|dermatologic agents|mesh-ancestor
6080721|NCT00795769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5514312|NCT04367883|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
5514313|NCT04367883|Protease Inhibitors|protease inhibitors|mesh-ancestor
5514314|NCT04367883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5514315|NCT04367883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514316|NCT04367831|Heparin|heparin|mesh-list
5514317|NCT04367831|Calcium heparin|calcium heparin|mesh-list
5514318|NCT04367831|Enoxaparin|enoxaparin|mesh-list
5514319|NCT04367831|Enoxaparin sodium|enoxaparin sodium|mesh-list
5514320|NCT04367831|Anticoagulants|anticoagulants|mesh-ancestor
5514321|NCT04367831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5514322|NCT04367831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5514323|NCT04367831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514324|NCT04367818|Anesthetics|anesthetics|mesh-list
5514325|NCT04367818|Anesthetics, Local|anesthetics, local|mesh-list
5514326|NCT04367818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5514327|NCT04367818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514328|NCT04367818|Sensory System Agents|sensory system agents|mesh-ancestor
5514329|NCT04367818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5514330|NCT04367155|Tranexamic Acid|tranexamic acid|mesh-list
5514331|NCT04367155|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5514332|NCT04367155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6080722|NCT00795769|Serotonin Agents|serotonin agents|mesh-ancestor
6080723|NCT00795769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6080724|NCT00795769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080725|NCT00795769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6080726|NCT00795769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6080727|NCT00795769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6080728|NCT00795769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6080729|NCT00795769|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6080730|NCT00795886|Sirolimus|sirolimus|mesh-list
6080731|NCT00795886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6080732|NCT00795886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6080733|NCT00795886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6080734|NCT00795886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6080735|NCT00795886|Antifungal Agents|antifungal agents|mesh-ancestor
6080736|NCT00795886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6080737|NCT00795886|Immunologic Factors|immunologic factors|mesh-ancestor
6080738|NCT00795886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080739|NCT00796003|Decitabine|decitabine|mesh-list
6080740|NCT00796003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6080741|NCT00796003|Antimetabolites|antimetabolites|mesh-ancestor
6080742|NCT00796003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080743|NCT00796003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6080744|NCT00796003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6080745|NCT00796120|Doxorubicin|doxorubicin|mesh-list
6080746|NCT00796120|Ifosfamide|ifosfamide|mesh-list
5514333|NCT04367155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514334|NCT04367155|Hemostatics|hemostatics|mesh-ancestor
5514335|NCT04367155|Coagulants|coagulants|mesh-ancestor
5514336|NCT04367103|Phenylephrine|phenylephrine|mesh-list
5514337|NCT04367103|Oxymetazoline|oxymetazoline|mesh-list
6080747|NCT00796120|Trabectedin|trabectedin|mesh-list
6080748|NCT00796120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6080749|NCT00796120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6080750|NCT00796120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6080751|NCT00796120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6080752|NCT00796120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6080753|NCT00796120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080754|NCT00796120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6080755|NCT00796120|Alkylating Agents|alkylating agents|mesh-ancestor
6080756|NCT00796224|Azithromycin|azithromycin|mesh-list
6080757|NCT00796224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6080758|NCT00796224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6080759|NCT00796302|Risperidone|risperidone|mesh-list
6665462|NCT01517347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6665463|NCT01517347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665464|NCT01517360|Oxytocin|oxytocin|mesh-list
5514338|NCT04367103|Norepinephrine|norepinephrine|mesh-list
5514339|NCT04367103|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5514340|NCT04367103|Mydriatics|mydriatics|mesh-ancestor
5514341|NCT04367103|Autonomic Agents|autonomic agents|mesh-ancestor
6665465|NCT01517360|Oxytocics|oxytocics|mesh-ancestor
6665466|NCT01517360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6665467|NCT01517360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665468|NCT01517399|Vitamin K|vitamin k|mesh-list
6080760|NCT00796302|Methylphenidate|methylphenidate|mesh-list
6080761|NCT00796302|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6080762|NCT00796302|Serotonin Agents|serotonin agents|mesh-ancestor
6080763|NCT00796302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6080764|NCT00796302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080765|NCT00796302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080766|NCT00796302|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6080767|NCT00796302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6080768|NCT00796302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6080769|NCT00796302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6080770|NCT00796302|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6080771|NCT00796302|Dopamine Agents|dopamine agents|mesh-ancestor
6080772|NCT00796302|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6080773|NCT00796302|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6080774|NCT00796302|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6080775|NCT00796302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6080776|NCT00796315|Doxylamine|doxylamine|mesh-list
6080777|NCT00796315|Doxylamine succinate|doxylamine succinate|mesh-list
6080778|NCT00796315|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6080779|NCT00796315|Histamine Antagonists|histamine antagonists|mesh-ancestor
6080780|NCT00796315|Histamine Agents|histamine agents|mesh-ancestor
6080781|NCT00796315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6080782|NCT00796315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080783|NCT00796315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080784|NCT00796315|Antiemetics|antiemetics|mesh-ancestor
6080785|NCT00796315|Autonomic Agents|autonomic agents|mesh-ancestor
6080786|NCT00796315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6080787|NCT00796315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6080788|NCT00796328|Phenylephrine|phenylephrine|mesh-list
6080789|NCT00796328|Oxymetazoline|oxymetazoline|mesh-list
6080790|NCT00796328|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6080791|NCT00796328|Mydriatics|mydriatics|mesh-ancestor
6080792|NCT00796328|Autonomic Agents|autonomic agents|mesh-ancestor
6080793|NCT00796328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6080794|NCT00796328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080795|NCT00796328|Sympathomimetics|sympathomimetics|mesh-ancestor
6080796|NCT00796328|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6080797|NCT00796328|Nasal Decongestants|nasal decongestants|mesh-ancestor
6080798|NCT00796328|Respiratory System Agents|respiratory system agents|mesh-ancestor
6080799|NCT00796328|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6080800|NCT00796328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6080801|NCT00796328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6080802|NCT00796328|Adrenergic Agents|adrenergic agents|mesh-ancestor
6080803|NCT00796328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6080804|NCT00796328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080805|NCT00796328|Protective Agents|protective agents|mesh-ancestor
6080806|NCT00796419|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
6080807|NCT00796419|Plasma Substitutes|plasma substitutes|mesh-ancestor
6080808|NCT00796419|Blood Substitutes|blood substitutes|mesh-ancestor
6080809|NCT00796549|Afatinib|afatinib|mesh-list
6080810|NCT00796549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5514342|NCT04367103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6080811|NCT00796549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5514343|NCT04367103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080812|NCT00796549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6080813|NCT00796549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080814|NCT00796562|Cyclophosphamide|cyclophosphamide|mesh-list
6080815|NCT00796562|Busulfan|busulfan|mesh-list
6080816|NCT00796562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6080817|NCT00796562|Immunologic Factors|immunologic factors|mesh-ancestor
6080818|NCT00796562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080819|NCT00796562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6080820|NCT00796562|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6080821|NCT00796562|Alkylating Agents|alkylating agents|mesh-ancestor
6080822|NCT00796562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080823|NCT00796562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6080824|NCT00796562|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6080825|NCT00796614|Tamsulosin|tamsulosin|mesh-list
6080826|NCT00796614|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6080827|NCT00796614|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6080828|NCT00796614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6080829|NCT00796614|Adrenergic Agents|adrenergic agents|mesh-ancestor
6080830|NCT00796614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6080831|NCT00796614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080832|NCT00796614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080833|NCT00796614|Urological Agents|urological agents|mesh-ancestor
6080834|NCT00796653|Formoterol Fumarate|formoterol fumarate|mesh-list
6080835|NCT00796653|Olodaterol|olodaterol|mesh-list
6080836|NCT00796653|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6080837|NCT00796653|Autonomic Agents|autonomic agents|mesh-ancestor
6080838|NCT00796653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6463879|NCT00466622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463880|NCT00466713|Rosiglitazone|rosiglitazone|mesh-list
6080839|NCT00796653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080840|NCT00796653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6080841|NCT00796653|Respiratory System Agents|respiratory system agents|mesh-ancestor
6080842|NCT00796653|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6080843|NCT00796653|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6080844|NCT00796653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6080845|NCT00796653|Adrenergic Agents|adrenergic agents|mesh-ancestor
6080846|NCT00796653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6080847|NCT00796653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080848|NCT00796666|Sildenafil Citrate|sildenafil citrate|mesh-list
6080849|NCT00796666|Sitaxsentan|sitaxsentan|mesh-list
6080850|NCT00796666|Vasodilator Agents|vasodilator agents|mesh-ancestor
6080851|NCT00796666|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6080852|NCT00796666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6080853|NCT00796666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6080854|NCT00796666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080855|NCT00796666|Urological Agents|urological agents|mesh-ancestor
6080856|NCT00796666|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6080857|NCT00796705|Adalimumab|adalimumab|mesh-list
6080858|NCT00796705|Etanercept|etanercept|mesh-list
6080859|NCT00796705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6080860|NCT00796705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6080861|NCT00796705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6080862|NCT00796705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6080863|NCT00796705|Analgesics|analgesics|mesh-ancestor
6080864|NCT00796705|Sensory System Agents|sensory system agents|mesh-ancestor
6080865|NCT00796705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6080866|NCT00796705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080867|NCT00796705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6080868|NCT00796705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6080869|NCT00796705|Immunologic Factors|immunologic factors|mesh-ancestor
6080870|NCT00796718|Capecitabine|capecitabine|mesh-list
6463881|NCT00466713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6463882|NCT00466713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463883|NCT00466791|Methylphenidate|methylphenidate|mesh-list
6665469|NCT01517399|Digoxin|digoxin|mesh-list
5514344|NCT04367103|Sympathomimetics|sympathomimetics|mesh-ancestor
5514345|NCT04367103|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5514346|NCT04367103|Nasal Decongestants|nasal decongestants|mesh-ancestor
5514347|NCT04367103|Respiratory System Agents|respiratory system agents|mesh-ancestor
5514348|NCT04367103|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5514349|NCT04367103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5514350|NCT04367103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5514351|NCT04367103|Adrenergic Agents|adrenergic agents|mesh-ancestor
5514352|NCT04367103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6080871|NCT00796718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6080872|NCT00796718|Antimetabolites|antimetabolites|mesh-ancestor
6080873|NCT00796718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080874|NCT00796718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6080875|NCT00796744|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
6080876|NCT00796744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6080877|NCT00796744|Vasodilator Agents|vasodilator agents|mesh-ancestor
6080878|NCT00796757|Interferons|interferons|mesh-list
6080879|NCT00796757|Interferon-alpha|interferon-alpha|mesh-list
6080880|NCT00796757|Interferon alpha-2|interferon alpha-2|mesh-list
6080881|NCT00796757|Bevacizumab|bevacizumab|mesh-list
6080882|NCT00796757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6080883|NCT00796757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6080884|NCT00796757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6080885|NCT00796757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6080886|NCT00796757|Growth Substances|growth substances|mesh-ancestor
6080887|NCT00796757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080888|NCT00796757|Growth Inhibitors|growth inhibitors|mesh-ancestor
6080889|NCT00796757|Antiviral Agents|antiviral agents|mesh-ancestor
6080890|NCT00796757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6080891|NCT00796757|Immunologic Factors|immunologic factors|mesh-ancestor
6080892|NCT00796822|Pentoxifylline|pentoxifylline|mesh-list
6080893|NCT00796822|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6080894|NCT00796822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6080895|NCT00796822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080896|NCT00796822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6080897|NCT00796822|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6080898|NCT00796822|Protective Agents|protective agents|mesh-ancestor
6080899|NCT00796822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080900|NCT00796822|Vasodilator Agents|vasodilator agents|mesh-ancestor
6080901|NCT00796822|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6080902|NCT00796822|Antioxidants|antioxidants|mesh-ancestor
5514353|NCT04367103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514354|NCT04367103|Protective Agents|protective agents|mesh-ancestor
5514355|NCT04367051|Spironolactone|spironolactone|mesh-list
5514356|NCT04367051|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5514357|NCT04367051|Hormone Antagonists|hormone antagonists|mesh-ancestor
5514358|NCT04367051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5514359|NCT04367051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514360|NCT04367051|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5514361|NCT04367051|Diuretics|diuretics|mesh-ancestor
5514362|NCT04367051|Natriuretic Agents|natriuretic agents|mesh-ancestor
5514363|NCT04367025|Oxaliplatin|oxaliplatin|mesh-list
5514364|NCT04367025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5514365|NCT04367168|Colchicine|colchicine|mesh-list
5514366|NCT04367168|Gout Suppressants|gout suppressants|mesh-ancestor
5514367|NCT04367168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5514368|NCT04367168|Tubulin Modulators|tubulin modulators|mesh-ancestor
5514369|NCT04367168|Antimitotic Agents|antimitotic agents|mesh-ancestor
5514370|NCT04367168|Mitosis Modulators|mitosis modulators|mesh-ancestor
5514371|NCT04367168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514372|NCT04367168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5600574|NCT03710772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5600575|NCT03710772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5600576|NCT03710772|Tubulin Modulators|tubulin modulators|mesh-ancestor
5600577|NCT03710772|Antimitotic Agents|antimitotic agents|mesh-ancestor
5600578|NCT03710772|Mitosis Modulators|mitosis modulators|mesh-ancestor
5600579|NCT03710655|Histamine|histamine|mesh-list
5600580|NCT03710655|Histamine Agonists|histamine agonists|mesh-ancestor
5600581|NCT03710655|Histamine Agents|histamine agents|mesh-ancestor
5600582|NCT03710655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5600583|NCT03710655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600584|NCT03710655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600585|NCT03710603|Dexamethasone|dexamethasone|mesh-list
5600586|NCT03710603|Dexamethasone acetate|dexamethasone acetate|mesh-list
5600587|NCT03710603|Lenalidomide|lenalidomide|mesh-list
6080903|NCT00796926|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6080904|NCT00796926|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6080905|NCT00796978|Trastuzumab|trastuzumab|mesh-list
6080906|NCT00796978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6080907|NCT00796978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6080908|NCT00796991|Paclitaxel|paclitaxel|mesh-list
6080909|NCT00796991|Carboplatin|carboplatin|mesh-list
6080910|NCT00796991|Ipilimumab|ipilimumab|mesh-list
6080911|NCT00796991|Dacarbazine|dacarbazine|mesh-list
6080912|NCT00796991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6080913|NCT00796991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5514373|NCT04366609|Methylphenidate|methylphenidate|mesh-list
5514374|NCT04366609|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5514375|NCT04366609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514376|NCT04366609|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5514377|NCT04366609|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5514378|NCT04366609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5514379|NCT04366609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514380|NCT04366609|Dopamine Agents|dopamine agents|mesh-ancestor
6080914|NCT00796991|Tubulin Modulators|tubulin modulators|mesh-ancestor
6080915|NCT00796991|Antimitotic Agents|antimitotic agents|mesh-ancestor
6080916|NCT00796991|Mitosis Modulators|mitosis modulators|mesh-ancestor
6080917|NCT00796991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080918|NCT00796991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6080919|NCT00796991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6080920|NCT00796991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6080921|NCT00796991|Alkylating Agents|alkylating agents|mesh-ancestor
6080922|NCT00797108|Amoxicillin|amoxicillin|mesh-list
6080923|NCT00797108|Ceftriaxone|ceftriaxone|mesh-list
6080924|NCT00797108|Clavulanic Acid|clavulanic acid|mesh-list
5514381|NCT04366609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5514382|NCT04366622|Riociguat|riociguat|mesh-list
5514383|NCT04366622|Enzyme Activators|enzyme activators|mesh-ancestor
5514384|NCT04366622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514385|NCT04366596|Paclitaxel|paclitaxel|mesh-list
5514386|NCT04366596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5514387|NCT04366596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5514388|NCT04366596|Tubulin Modulators|tubulin modulators|mesh-ancestor
5514389|NCT04366596|Antimitotic Agents|antimitotic agents|mesh-ancestor
5514390|NCT04366596|Mitosis Modulators|mitosis modulators|mesh-ancestor
5514391|NCT04366596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514392|NCT04366739|Chlorpromazine|chlorpromazine|mesh-list
5514393|NCT04366739|Antiemetics|antiemetics|mesh-ancestor
5514394|NCT04366739|Autonomic Agents|autonomic agents|mesh-ancestor
5514395|NCT04366739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5514396|NCT04366739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514397|NCT04366739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5514398|NCT04366739|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5514399|NCT04366739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5514400|NCT04366739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5514401|NCT04366739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5514402|NCT04366739|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5514403|NCT04366739|Dopamine Agents|dopamine agents|mesh-ancestor
5514404|NCT04366739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5514405|NCT04366739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514406|NCT04366869|Salicylic Acid|salicylic acid|mesh-list
5514407|NCT04366869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5514408|NCT04366869|Antifungal Agents|antifungal agents|mesh-ancestor
5514409|NCT04366869|Keratolytic Agents|keratolytic agents|mesh-ancestor
5514410|NCT04366869|Dermatologic Agents|dermatologic agents|mesh-ancestor
5514411|NCT04366726|Abaloparatide|abaloparatide|mesh-list
5514412|NCT04366726|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5514413|NCT04366726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514414|NCT04366960|Enoxaparin|enoxaparin|mesh-list
6080925|NCT00797108|Clavulanic Acids|clavulanic acids|mesh-list
6080926|NCT00797108|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6080927|NCT00797108|Lactams|lactams|mesh-list
6080928|NCT00797108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6080929|NCT00797108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6080930|NCT00797108|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6080931|NCT00797108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6080932|NCT00797108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080933|NCT00797225|Leuprolide|leuprolide|mesh-list
6080934|NCT00797225|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6080935|NCT00797225|Fertility Agents|fertility agents|mesh-ancestor
5514415|NCT04366960|Anticoagulants|anticoagulants|mesh-ancestor
5514416|NCT04366960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5514417|NCT04366960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5514418|NCT04366960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080936|NCT00797225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6080937|NCT00797225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080938|NCT00797225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6080939|NCT00797225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6080940|NCT00797277|Lorazepam|lorazepam|mesh-list
6080941|NCT00797277|Haloperidol|haloperidol|mesh-list
6080942|NCT00797277|Olanzapine|olanzapine|mesh-list
6080943|NCT00797277|Haloperidol decanoate|haloperidol decanoate|mesh-list
6080944|NCT00797277|Antiemetics|antiemetics|mesh-ancestor
6080945|NCT00797277|Autonomic Agents|autonomic agents|mesh-ancestor
6080946|NCT00797277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6080947|NCT00797277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080948|NCT00797277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6080949|NCT00797277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6080950|NCT00797277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6080951|NCT00797277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6080952|NCT00797277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6080953|NCT00797277|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5514419|NCT04366908|Calcifediol|calcifediol|mesh-list
5514420|NCT04366908|Vitamins|vitamins|mesh-ancestor
5514421|NCT04366908|Micronutrients|micronutrients|mesh-ancestor
5514422|NCT04366908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514423|NCT04366908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5514424|NCT04366232|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5514425|NCT04366232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5514426|NCT04366089|Azithromycin|azithromycin|mesh-list
5514427|NCT04366089|Hydroxychloroquine|hydroxychloroquine|mesh-list
5514428|NCT04366089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5514429|NCT04366089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5514430|NCT04366089|Antimalarials|antimalarials|mesh-ancestor
5514431|NCT04366089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5514432|NCT04366089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5514433|NCT04366089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5514434|NCT04366089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514435|NCT04366089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6665470|NCT01517399|Midazolam|midazolam|mesh-list
6665471|NCT01517399|Caffeine|caffeine|mesh-list
6665472|NCT01517399|Omeprazole|omeprazole|mesh-list
6080954|NCT00797277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6080955|NCT00797277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6080956|NCT00797277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080957|NCT00797277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6080958|NCT00797277|Serotonin Agents|serotonin agents|mesh-ancestor
6080959|NCT00797277|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6080960|NCT00797277|Dopamine Agents|dopamine agents|mesh-ancestor
6080961|NCT00797277|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6080962|NCT00797277|Anticonvulsants|anticonvulsants|mesh-ancestor
6080963|NCT00797277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6080964|NCT00797277|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6080965|NCT00797277|GABA Modulators|gaba modulators|mesh-ancestor
6080966|NCT00797277|GABA Agents|gaba agents|mesh-ancestor
6080967|NCT00797316|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6080968|NCT00797316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6080969|NCT00797316|Diuretics|diuretics|mesh-ancestor
6080970|NCT00797316|Natriuretic Agents|natriuretic agents|mesh-ancestor
6080971|NCT00797316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080972|NCT00797316|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6080973|NCT00797316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6080974|NCT00797316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6080975|NCT00797459|Hyaluronic Acid|hyaluronic acid|mesh-list
6080976|NCT00797459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6080977|NCT00797459|Immunologic Factors|immunologic factors|mesh-ancestor
6080978|NCT00797459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080979|NCT00797459|Viscosupplements|viscosupplements|mesh-ancestor
6080980|NCT00797459|Protective Agents|protective agents|mesh-ancestor
6080981|NCT00797797|Milnacipran|milnacipran|mesh-list
6080982|NCT00797797|Levomilnacipran|levomilnacipran|mesh-list
6080983|NCT00797797|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6080984|NCT00797797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6080985|NCT00797797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6080986|NCT00797797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665473|NCT01517399|Warfarin|warfarin|mesh-list
6665474|NCT01517399|Vitamins|vitamins|mesh-ancestor
6080987|NCT00797797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6080988|NCT00797797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6080989|NCT00797797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6080990|NCT00797797|Analgesics|analgesics|mesh-ancestor
6080991|NCT00797797|Sensory System Agents|sensory system agents|mesh-ancestor
6080992|NCT00797797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6080993|NCT00797797|Antidepressive Agents|antidepressive agents|mesh-ancestor
6080994|NCT00797797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6463884|NCT00466791|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6463885|NCT00466791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463886|NCT00466791|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6665475|NCT01517399|Micronutrients|micronutrients|mesh-ancestor
6665476|NCT01517399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665477|NCT01517399|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6080995|NCT00797823|Insulin|insulin|mesh-list
6080996|NCT00797823|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6080997|NCT00797823|Glucagon|glucagon|mesh-list
6080998|NCT00797823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6080999|NCT00797823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081000|NCT00797823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6081001|NCT00797823|Hormones|hormones|mesh-ancestor
6081002|NCT00797823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6081003|NCT00797862|Amlodipine|amlodipine|mesh-list
6081004|NCT00797862|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6081005|NCT00797862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6081006|NCT00797862|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6081007|NCT00797862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6081008|NCT00797862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081009|NCT00797862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6081010|NCT00797862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463887|NCT00466791|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6463888|NCT00466791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6463889|NCT00466791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463890|NCT00466791|Dopamine Agents|dopamine agents|mesh-ancestor
6463891|NCT00466791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6463892|NCT00466843|Prednisone|prednisone|mesh-list
6463893|NCT00466843|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6463894|NCT00466843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6665478|NCT01517399|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6665479|NCT01517399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6665480|NCT01517399|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6665481|NCT01517399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6665482|NCT01517399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6665483|NCT01517399|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6665484|NCT01517399|Anesthetics, General|anesthetics, general|mesh-ancestor
6665485|NCT01517399|Anesthetics|anesthetics|mesh-ancestor
6665486|NCT01517399|GABA Modulators|gaba modulators|mesh-ancestor
6665487|NCT01517399|GABA Agents|gaba agents|mesh-ancestor
6665488|NCT01517399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6665489|NCT01517399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665490|NCT01517399|Anticoagulants|anticoagulants|mesh-ancestor
6665491|NCT01517399|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6665492|NCT01517399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6665493|NCT01517399|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6665494|NCT01517399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5514436|NCT04366050|Ramipril|ramipril|mesh-list
5514437|NCT04366050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5514438|NCT04366050|Protease Inhibitors|protease inhibitors|mesh-ancestor
5514439|NCT04366050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5514440|NCT04366050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514441|NCT04366050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5514442|NCT04365933|Interferons|interferons|mesh-list
5514443|NCT04365933|Interferon-alpha|interferon-alpha|mesh-list
5514444|NCT04365933|Interferon alpha-2|interferon alpha-2|mesh-list
5514445|NCT04365933|Entecavir|entecavir|mesh-list
5514446|NCT04365933|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5514447|NCT04365933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5514448|NCT04365933|Antiviral Agents|antiviral agents|mesh-ancestor
5514449|NCT04365933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5514450|NCT04365933|Immunologic Factors|immunologic factors|mesh-ancestor
5514451|NCT04365933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514452|NCT04365686|Propofol|propofol|mesh-list
5514453|NCT04365686|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5514454|NCT04365686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5514455|NCT04365686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514456|NCT04365686|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5514457|NCT04365686|Anesthetics, General|anesthetics, general|mesh-ancestor
5514458|NCT04365686|Anesthetics|anesthetics|mesh-ancestor
5514459|NCT04365517|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5514460|NCT04365517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5514461|NCT04365517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514462|NCT04365517|Incretins|incretins|mesh-ancestor
5514463|NCT04365517|Hormones|hormones|mesh-ancestor
5514464|NCT04365517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5514465|NCT04365517|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6081011|NCT00797862|Vasodilator Agents|vasodilator agents|mesh-ancestor
6081012|NCT00797862|Diuretics|diuretics|mesh-ancestor
6081013|NCT00797862|Natriuretic Agents|natriuretic agents|mesh-ancestor
6081014|NCT00797862|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6081015|NCT00797966|Citalopram|citalopram|mesh-list
6081016|NCT00797966|Fluoxetine|fluoxetine|mesh-list
6081017|NCT00797966|Paroxetine|paroxetine|mesh-list
6081018|NCT00797966|Sertraline|sertraline|mesh-list
6081019|NCT00797966|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6081020|NCT00797966|Brexpiprazole|brexpiprazole|mesh-list
6081021|NCT00797966|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6081022|NCT00797966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6081023|NCT00797966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6081024|NCT00797966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081025|NCT00797966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6081026|NCT00797966|Serotonin Agents|serotonin agents|mesh-ancestor
6081027|NCT00797966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081028|NCT00797966|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6081029|NCT00797966|Antidepressive Agents|antidepressive agents|mesh-ancestor
6081030|NCT00797966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6081031|NCT00797966|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5514466|NCT04365517|Protease Inhibitors|protease inhibitors|mesh-ancestor
6081032|NCT00797966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6081033|NCT00797966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6081034|NCT00797966|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6081035|NCT00797966|Dopamine Agonists|dopamine agonists|mesh-ancestor
6081036|NCT00797966|Dopamine Agents|dopamine agents|mesh-ancestor
6081037|NCT00798018|Lidocaine|lidocaine|mesh-list
6081038|NCT00798018|Tetracaine|tetracaine|mesh-list
6081039|NCT00798018|Anesthetics, Local|anesthetics, local|mesh-ancestor
6081040|NCT00798018|Anesthetics|anesthetics|mesh-ancestor
6081041|NCT00798018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6081042|NCT00798018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081043|NCT00798018|Sensory System Agents|sensory system agents|mesh-ancestor
6081044|NCT00798018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6081045|NCT00798018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6081046|NCT00798018|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6081047|NCT00798018|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6081048|NCT00798018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5514467|NCT04365517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5514468|NCT04365517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514469|NCT04365582|Ritonavir|ritonavir|mesh-list
5514470|NCT04365582|Lopinavir|lopinavir|mesh-list
5514471|NCT04365582|Azithromycin|azithromycin|mesh-list
5514472|NCT04365582|Hydroxychloroquine|hydroxychloroquine|mesh-list
5514473|NCT04365582|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5514474|NCT04365582|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5514475|NCT04365582|Protease Inhibitors|protease inhibitors|mesh-ancestor
5514476|NCT04365582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5514477|NCT04365582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514478|NCT04365582|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5514479|NCT04365582|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5514480|NCT04365582|Antiviral Agents|antiviral agents|mesh-ancestor
5514481|NCT04365582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5514482|NCT04365582|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5514483|NCT04365582|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5514484|NCT04365582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5514485|NCT04365582|Antimalarials|antimalarials|mesh-ancestor
6081049|NCT00798018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081050|NCT00798135|Itraconazole|itraconazole|mesh-list
6081051|NCT00798135|Antifungal Agents|antifungal agents|mesh-ancestor
6081052|NCT00798135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6081053|NCT00798135|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5514486|NCT04365582|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5514487|NCT04365582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5514488|NCT04365582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5514489|NCT04365270|Chlorhexidine|chlorhexidine|mesh-list
5514490|NCT04365270|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5514491|NCT04365270|Titanium dioxide|titanium dioxide|mesh-list
5514492|NCT04365270|Chitosan|chitosan|mesh-list
5514493|NCT04365270|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5514494|NCT04365270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6081054|NCT00798135|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6081055|NCT00798135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6081056|NCT00798135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081057|NCT00798135|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6081058|NCT00798135|Hormone Antagonists|hormone antagonists|mesh-ancestor
6081059|NCT00798135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6081060|NCT00798135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514495|NCT04365270|Disinfectants|disinfectants|mesh-ancestor
5514496|NCT04365270|Dermatologic Agents|dermatologic agents|mesh-ancestor
5514497|NCT04365270|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5514498|NCT04365270|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5514499|NCT04365270|Antimetabolites|antimetabolites|mesh-ancestor
5514500|NCT04365270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514501|NCT04365270|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5514502|NCT04365270|Chelating Agents|chelating agents|mesh-ancestor
5514503|NCT04365270|Sequestering Agents|sequestering agents|mesh-ancestor
5514504|NCT04365270|Hemostatics|hemostatics|mesh-ancestor
5514505|NCT04365270|Coagulants|coagulants|mesh-ancestor
5514506|NCT04365270|Sunscreening Agents|sunscreening agents|mesh-ancestor
5514507|NCT04365270|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5514508|NCT04365270|Protective Agents|protective agents|mesh-ancestor
5514509|NCT04365270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514510|NCT04365270|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5600588|NCT03710603|Bortezomib|bortezomib|mesh-list
5600589|NCT03710603|Daratumumab|daratumumab|mesh-list
5600590|NCT03710603|BB 1101|bb 1101|mesh-list
5600591|NCT03710603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5600592|NCT03710603|Antiemetics|antiemetics|mesh-ancestor
5600593|NCT03710603|Autonomic Agents|autonomic agents|mesh-ancestor
5600594|NCT03710603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6081061|NCT00798135|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6081062|NCT00798161|Metformin|metformin|mesh-list
6081063|NCT00798161|Linagliptin|linagliptin|mesh-list
6081064|NCT00798161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6081065|NCT00798161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600595|NCT03710603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600596|NCT03710603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5600597|NCT03710603|Glucocorticoids|glucocorticoids|mesh-ancestor
5600598|NCT03710603|Hormones|hormones|mesh-ancestor
5600599|NCT03710603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5600600|NCT03710603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5600601|NCT03710603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5600602|NCT03710603|Protease Inhibitors|protease inhibitors|mesh-ancestor
6081066|NCT00798161|Incretins|incretins|mesh-ancestor
6081067|NCT00798161|Hormones|hormones|mesh-ancestor
6081068|NCT00798161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6081069|NCT00798161|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6081070|NCT00798161|Protease Inhibitors|protease inhibitors|mesh-ancestor
6081071|NCT00798161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6081072|NCT00798161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514511|NCT04365127|Progesterone|progesterone|mesh-list
5514512|NCT04365127|Progestins|progestins|mesh-ancestor
5514513|NCT04365127|Hormones|hormones|mesh-ancestor
5514514|NCT04365127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5514515|NCT04365127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514516|NCT04365309|Aspirin|aspirin|mesh-list
5514517|NCT04365309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5514518|NCT04365309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5514519|NCT04365309|Analgesics|analgesics|mesh-ancestor
5514520|NCT04365309|Sensory System Agents|sensory system agents|mesh-ancestor
5514521|NCT04365309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5514522|NCT04365309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514523|NCT04365309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5514524|NCT04365309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5514525|NCT04365309|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5514526|NCT04365309|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5514527|NCT04365309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514528|NCT04365309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5514529|NCT04365309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5514530|NCT04365309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5514531|NCT04365309|Antipyretics|antipyretics|mesh-ancestor
5514532|NCT04365231|Azithromycin|azithromycin|mesh-list
5514533|NCT04365231|Hydroxychloroquine|hydroxychloroquine|mesh-list
6081073|NCT00798304|Vaccines|vaccines|mesh-list
6081074|NCT00798304|Immunologic Factors|immunologic factors|mesh-ancestor
6081075|NCT00798304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081076|NCT00798317|Plasminogen|plasminogen|mesh-list
6081077|NCT00798317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6081078|NCT00798317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6081079|NCT00798317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081080|NCT00798369|Triamcinolone|triamcinolone|mesh-list
6081081|NCT00798369|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6081082|NCT00798369|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6081083|NCT00798369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6081084|NCT00798369|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6081085|NCT00798369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6081086|NCT00798369|Glucocorticoids|glucocorticoids|mesh-ancestor
6081087|NCT00798369|Hormones|hormones|mesh-ancestor
6081088|NCT00798369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6081089|NCT00798369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081090|NCT00798369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6081091|NCT00798369|Immunologic Factors|immunologic factors|mesh-ancestor
6081092|NCT00798369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6081093|NCT00798369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081094|NCT00798434|Fesoterodine|fesoterodine|mesh-list
6081095|NCT00798434|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6081096|NCT00798434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6081097|NCT00798434|Cholinergic Agents|cholinergic agents|mesh-ancestor
6081098|NCT00798434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6081099|NCT00798434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081100|NCT00798434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081101|NCT00798434|Urological Agents|urological agents|mesh-ancestor
6081102|NCT00798577|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6081103|NCT00798577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6081104|NCT00798603|Bevacizumab|bevacizumab|mesh-list
6081105|NCT00798603|Carboplatin|carboplatin|mesh-list
6081106|NCT00798603|Pemetrexed|pemetrexed|mesh-list
6081107|NCT00798603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6081108|NCT00798603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6081109|NCT00798603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6081110|NCT00798603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6081111|NCT00798603|Growth Substances|growth substances|mesh-ancestor
6081112|NCT00798603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081113|NCT00798603|Growth Inhibitors|growth inhibitors|mesh-ancestor
6081114|NCT00798603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6081115|NCT00798603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514534|NCT04365231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6081116|NCT00798603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6081117|NCT00798603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5514535|NCT04365231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5514536|NCT04365231|Antimalarials|antimalarials|mesh-ancestor
5514537|NCT04365231|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5514538|NCT04365231|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5514539|NCT04365231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5514540|NCT04365231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514541|NCT04365231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5514542|NCT04365426|Contraceptive Agents|contraceptive agents|mesh-list
6081118|NCT00798655|Cisplatin|cisplatin|mesh-list
6081119|NCT00798655|Panitumumab|panitumumab|mesh-list
6081120|NCT00798655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6081121|NCT00798655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6081122|NCT00798694|Travoprost|travoprost|mesh-list
6081123|NCT00798694|Latanoprost|latanoprost|mesh-list
6081124|NCT00798694|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6081125|NCT00798694|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5514543|NCT04365426|Contraceptives, Oral|contraceptives, oral|mesh-list
5514544|NCT04365426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5514545|NCT04365426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514546|NCT04365426|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5514547|NCT04364893|Enzyme Inhibitors|enzyme inhibitors|mesh-list
5514548|NCT04364893|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
5514549|NCT04364893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
5514550|NCT04364893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514551|NCT04364893|Protease Inhibitors|protease inhibitors|mesh-ancestor
5514552|NCT04364906|Anesthetics|anesthetics|mesh-list
5514553|NCT04364906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5514554|NCT04364906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514555|NCT04364815|Hydroxychloroquine|hydroxychloroquine|mesh-list
5514556|NCT04364815|Antimalarials|antimalarials|mesh-ancestor
6081126|NCT00798694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6081127|NCT00798707|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6081128|NCT00798707|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6081129|NCT00798707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6081130|NCT00798707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6081131|NCT00798707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081132|NCT00798707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6081133|NCT00798707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081134|NCT00798707|Antidepressive Agents|antidepressive agents|mesh-ancestor
6081135|NCT00798707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6081136|NCT00798720|Bortezomib|bortezomib|mesh-list
5514557|NCT04364815|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5514558|NCT04364815|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5514559|NCT04364815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5514560|NCT04364815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5514561|NCT04364815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081137|NCT00798720|Vorinostat|vorinostat|mesh-list
6081138|NCT00798720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6081139|NCT00798720|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6081140|NCT00798720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6081141|NCT00798720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081142|NCT00798759|Travoprost|travoprost|mesh-list
6081143|NCT00798759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6081144|NCT00798759|Latanoprost|latanoprost|mesh-list
6081145|NCT00798759|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6081146|NCT00798759|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6081147|NCT00798889|Sunitinib|sunitinib|mesh-list
5514562|NCT04364815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5514563|NCT04365049|Gemcitabine|gemcitabine|mesh-list
5514564|NCT04365049|Apatinib|apatinib|mesh-list
5514565|NCT04365049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5514566|NCT04365049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5514567|NCT04365049|Antimetabolites|antimetabolites|mesh-ancestor
6081148|NCT00798889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6081149|NCT00798889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6081150|NCT00798889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6081151|NCT00798889|Growth Substances|growth substances|mesh-ancestor
6081152|NCT00798889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081153|NCT00798889|Growth Inhibitors|growth inhibitors|mesh-ancestor
6081154|NCT00798889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6081155|NCT00798889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6202899|NCT02047253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5600603|NCT03710603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5514568|NCT04365049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514569|NCT04365049|Antiviral Agents|antiviral agents|mesh-ancestor
5514570|NCT04365049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5514571|NCT04365049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5514572|NCT04365049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5514573|NCT04365049|Immunologic Factors|immunologic factors|mesh-ancestor
5514574|NCT04365049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514575|NCT04365049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5514576|NCT04364945|Dexmedetomidine|dexmedetomidine|mesh-list
5514577|NCT04364945|Remifentanil|remifentanil|mesh-list
5514578|NCT04364945|Sevoflurane|sevoflurane|mesh-list
6081156|NCT00798889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081157|NCT00798967|Teduglutide|teduglutide|mesh-list
6081158|NCT00798967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6081159|NCT00798967|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6081160|NCT00798967|Protective Agents|protective agents|mesh-ancestor
6081161|NCT00798967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081162|NCT00799227|Dexamethasone|dexamethasone|mesh-list
6081163|NCT00799227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6081164|NCT00799227|Antiemetics|antiemetics|mesh-ancestor
6081165|NCT00799227|Autonomic Agents|autonomic agents|mesh-ancestor
6665495|NCT01517399|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6665496|NCT01517399|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6665497|NCT01517399|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5514579|NCT04364945|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6081166|NCT00799227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6081167|NCT00799227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081168|NCT00799227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6081169|NCT00799227|Glucocorticoids|glucocorticoids|mesh-ancestor
6081170|NCT00799227|Hormones|hormones|mesh-ancestor
6081171|NCT00799227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6081172|NCT00799227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6081173|NCT00799227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6081174|NCT00799383|Vitamin D|vitamin d|mesh-list
6081175|NCT00799383|Calcium|calcium|mesh-list
6081176|NCT00799383|Vitamins|vitamins|mesh-ancestor
6081177|NCT00799383|Micronutrients|micronutrients|mesh-ancestor
6081178|NCT00799383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081179|NCT00799383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6081180|NCT00799383|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6081181|NCT00799409|Methylphenidate|methylphenidate|mesh-list
6081182|NCT00799409|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6081183|NCT00799409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081184|NCT00799409|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6081185|NCT00799409|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6081186|NCT00799409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6081187|NCT00799409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081188|NCT00799409|Dopamine Agents|dopamine agents|mesh-ancestor
6081189|NCT00799409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6081190|NCT00799435|Exenatide|exenatide|mesh-list
6081191|NCT00799435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6081192|NCT00799435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081193|NCT00799435|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6081194|NCT00799435|Incretins|incretins|mesh-ancestor
6081195|NCT00799435|Hormones|hormones|mesh-ancestor
6081196|NCT00799435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6081197|NCT00799487|Methylphenidate|methylphenidate|mesh-list
6081198|NCT00799487|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6081199|NCT00799487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081200|NCT00799487|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6081201|NCT00799487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6081202|NCT00799487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6081203|NCT00799487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081204|NCT00799487|Dopamine Agents|dopamine agents|mesh-ancestor
6081205|NCT00799487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6081206|NCT00799578|Cysteamine|cysteamine|mesh-list
6081207|NCT00799578|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
6081208|NCT00799578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081209|NCT00799604|Clevidipine|clevidipine|mesh-list
6081210|NCT00799604|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6081211|NCT00799604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6081212|NCT00799604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202900|NCT02047253|Glucocorticoids|glucocorticoids|mesh-ancestor
5514580|NCT04364945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5514581|NCT04364945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514582|NCT04364945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5514583|NCT04364945|Analgesics|analgesics|mesh-ancestor
5514584|NCT04364945|Sensory System Agents|sensory system agents|mesh-ancestor
5514585|NCT04364945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6081213|NCT00799604|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6081214|NCT00799604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081215|NCT00799617|Methyltestosterone|methyltestosterone|mesh-list
6081216|NCT00799617|Testosterone|testosterone|mesh-list
6081217|NCT00799617|Testosterone undecanoate|testosterone undecanoate|mesh-list
6081218|NCT00799617|Testosterone enanthate|testosterone enanthate|mesh-list
6081219|NCT00799617|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6081220|NCT00799617|Androgens|androgens|mesh-ancestor
6081221|NCT00799617|Hormones|hormones|mesh-ancestor
6081222|NCT00799617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5514586|NCT04364945|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5514587|NCT04364945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5514588|NCT04364945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5514589|NCT04364945|Adrenergic Agents|adrenergic agents|mesh-ancestor
6081223|NCT00799617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081224|NCT00799617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6081225|NCT00799617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6081226|NCT00799617|Anabolic Agents|anabolic agents|mesh-ancestor
6081227|NCT00799643|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
6081228|NCT00799643|Sodium Salicylate|sodium salicylate|mesh-list
6081229|NCT00799643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6081230|NCT00799643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6081231|NCT00799643|Analgesics|analgesics|mesh-ancestor
6081232|NCT00799643|Sensory System Agents|sensory system agents|mesh-ancestor
6081233|NCT00799643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6081234|NCT00799643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514590|NCT04364945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5514591|NCT04364945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514592|NCT04364945|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5514593|NCT04364945|Narcotics|narcotics|mesh-ancestor
5514594|NCT04364945|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5514595|NCT04364945|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5514596|NCT04364945|Anesthetics, General|anesthetics, general|mesh-ancestor
5514597|NCT04364945|Anesthetics|anesthetics|mesh-ancestor
6081235|NCT00799643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6081236|NCT00799643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6081237|NCT00799643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6081238|NCT00799643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6081239|NCT00799643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081240|NCT00799708|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6081241|NCT00799708|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6081242|NCT00799708|Estradiol|estradiol|mesh-list
6081243|NCT00799708|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6081244|NCT00799708|Estrogens|estrogens|mesh-ancestor
6081245|NCT00799708|Hormones|hormones|mesh-ancestor
6081246|NCT00799708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6463895|NCT00466843|Glucocorticoids|glucocorticoids|mesh-ancestor
6463896|NCT00466843|Hormones|hormones|mesh-ancestor
6463897|NCT00466843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6463898|NCT00466843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463899|NCT00466843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6463900|NCT00466843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6463901|NCT00466843|Immunologic Factors|immunologic factors|mesh-ancestor
6463902|NCT00466843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6463903|NCT00466856|Octreotide|octreotide|mesh-list
6463904|NCT00466856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6463905|NCT00466856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6463906|NCT00466856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6665498|NCT01517399|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5514598|NCT04364802|Iodine|iodine|mesh-list
5514599|NCT04364802|Cadexomer iodine|cadexomer iodine|mesh-list
5514600|NCT04364802|Povidone-Iodine|povidone-iodine|mesh-list
5514601|NCT04364802|Povidone|povidone|mesh-list
5514602|NCT04364802|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5514603|NCT04364802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5514604|NCT04364802|Trace Elements|trace elements|mesh-ancestor
5514605|NCT04364802|Micronutrients|micronutrients|mesh-ancestor
5514606|NCT04364802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514607|NCT04364802|Plasma Substitutes|plasma substitutes|mesh-ancestor
5514608|NCT04364802|Blood Substitutes|blood substitutes|mesh-ancestor
5514609|NCT04364620|Docetaxel|docetaxel|mesh-list
5514610|NCT04364620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5514611|NCT04364620|Tubulin Modulators|tubulin modulators|mesh-ancestor
5514612|NCT04364620|Antimitotic Agents|antimitotic agents|mesh-ancestor
5514613|NCT04364620|Mitosis Modulators|mitosis modulators|mesh-ancestor
5514614|NCT04364620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514615|NCT04365036|Gemcitabine|gemcitabine|mesh-list
5514616|NCT04365036|Oxaliplatin|oxaliplatin|mesh-list
5514617|NCT04365036|Pegaspargase|pegaspargase|mesh-list
5514618|NCT04365036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5514619|NCT04365036|Antimetabolites|antimetabolites|mesh-ancestor
5514620|NCT04365036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514621|NCT04365036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5514622|NCT04365036|Antiviral Agents|antiviral agents|mesh-ancestor
5514623|NCT04365036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5514624|NCT04365036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5514625|NCT04365036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5514626|NCT04365036|Immunologic Factors|immunologic factors|mesh-ancestor
6463907|NCT00466869|Betahistine|betahistine|mesh-list
6463908|NCT00466869|Vasodilator Agents|vasodilator agents|mesh-ancestor
6463909|NCT00466869|Histamine Agonists|histamine agonists|mesh-ancestor
6463910|NCT00466869|Histamine Agents|histamine agents|mesh-ancestor
6463911|NCT00466869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6463912|NCT00466869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463913|NCT00466869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463914|NCT00466895|Lenalidomide|lenalidomide|mesh-list
6463915|NCT00466895|Immunologic Factors|immunologic factors|mesh-ancestor
6463916|NCT00466895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463917|NCT00466895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6463918|NCT00466895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6463919|NCT00466895|Growth Substances|growth substances|mesh-ancestor
6081247|NCT00799708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514627|NCT04365036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514628|NCT04364516|Vitamin K|vitamin k|mesh-list
5514629|NCT04364516|Anticoagulants|anticoagulants|mesh-list
5514630|NCT04364516|Vitamins|vitamins|mesh-ancestor
5514631|NCT04364516|Micronutrients|micronutrients|mesh-ancestor
5514632|NCT04364516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514633|NCT04364516|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5514634|NCT04364516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5514635|NCT04364516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514636|NCT04364516|Hemostatics|hemostatics|mesh-ancestor
5514637|NCT04364516|Coagulants|coagulants|mesh-ancestor
5514638|NCT04364607|Neostigmine|neostigmine|mesh-list
5514639|NCT04364607|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5514640|NCT04364607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5514641|NCT04364607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514642|NCT04364607|Cholinergic Agents|cholinergic agents|mesh-ancestor
5514643|NCT04364607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5514644|NCT04364607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514645|NCT04364607|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5514646|NCT04364607|Autonomic Agents|autonomic agents|mesh-ancestor
5514647|NCT04364607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5514648|NCT04364399|Vaccines|vaccines|mesh-list
5514649|NCT04364399|Immunologic Factors|immunologic factors|mesh-ancestor
5514650|NCT04364399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514651|NCT04364477|Anesthetics|anesthetics|mesh-list
6081248|NCT00799708|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6081249|NCT00799708|Contraceptive Agents|contraceptive agents|mesh-ancestor
6081250|NCT00799708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6081251|NCT00799708|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6081252|NCT00799812|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6081253|NCT00799812|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6081254|NCT00799812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6081255|NCT00799812|Dermatologic Agents|dermatologic agents|mesh-ancestor
6081256|NCT00799903|Darapladib|darapladib|mesh-list
6081257|NCT00799903|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
5514652|NCT04364477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5514653|NCT04364477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514654|NCT04364360|Sulforaphane|sulforaphane|mesh-list
5514655|NCT04364360|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5514656|NCT04364360|Protective Agents|protective agents|mesh-ancestor
5514657|NCT04364360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514658|NCT04364360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6081258|NCT00799903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6081259|NCT00799903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081260|NCT00800202|Paclitaxel|paclitaxel|mesh-list
6081261|NCT00800202|Bevacizumab|bevacizumab|mesh-list
6081262|NCT00800202|Carboplatin|carboplatin|mesh-list
6081263|NCT00800202|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6081264|NCT00800202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6081265|NCT00800202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6081266|NCT00800202|Tubulin Modulators|tubulin modulators|mesh-ancestor
6081267|NCT00800202|Antimitotic Agents|antimitotic agents|mesh-ancestor
6081268|NCT00800202|Mitosis Modulators|mitosis modulators|mesh-ancestor
6081269|NCT00800202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081270|NCT00800202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6081271|NCT00800202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6081272|NCT00800202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6081273|NCT00800202|Growth Substances|growth substances|mesh-ancestor
6081274|NCT00800202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081275|NCT00800202|Growth Inhibitors|growth inhibitors|mesh-ancestor
6081276|NCT00800202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6081277|NCT00800202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6081278|NCT00800345|Topotecan|topotecan|mesh-list
6081279|NCT00800345|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6081280|NCT00800345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6081281|NCT00800345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6081282|NCT00800345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081283|NCT00800345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6081284|NCT00800436|Trastuzumab|trastuzumab|mesh-list
6081285|NCT00800436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6081286|NCT00800436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6081287|NCT00800540|Timolol|timolol|mesh-list
6081288|NCT00800540|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6081289|NCT00800540|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6081290|NCT00800540|Brinzolamide|brinzolamide|mesh-list
6081291|NCT00800540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6081292|NCT00800540|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6081293|NCT00800540|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6081294|NCT00800540|Adrenergic Agents|adrenergic agents|mesh-ancestor
6081295|NCT00800540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6081296|NCT00800540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081297|NCT00800540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081298|NCT00800540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6081299|NCT00800540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6081300|NCT00800540|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6081301|NCT00800540|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6081302|NCT00800540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6081303|NCT00800540|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6081304|NCT00800540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6081305|NCT00800683|Linagliptin|linagliptin|mesh-list
6081306|NCT00800683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6081307|NCT00800683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081308|NCT00800683|Incretins|incretins|mesh-ancestor
6081309|NCT00800683|Hormones|hormones|mesh-ancestor
6081310|NCT00800683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6081311|NCT00800683|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6081312|NCT00800683|Protease Inhibitors|protease inhibitors|mesh-ancestor
6081313|NCT00800683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6081314|NCT00800683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081315|NCT00800735|Interferons|interferons|mesh-list
6081316|NCT00800735|Ribavirin|ribavirin|mesh-list
6081317|NCT00800735|Interferon-alpha|interferon-alpha|mesh-list
6081318|NCT00800735|Interferon alpha-2|interferon alpha-2|mesh-list
6081319|NCT00800735|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6081320|NCT00800735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5514659|NCT04364555|Clobetasol|clobetasol|mesh-list
5514660|NCT04364555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6081321|NCT00800735|Antiviral Agents|antiviral agents|mesh-ancestor
6081322|NCT00800735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6081323|NCT00800735|Antimetabolites|antimetabolites|mesh-ancestor
6081324|NCT00800735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081325|NCT00800735|Immunologic Factors|immunologic factors|mesh-ancestor
6081326|NCT00800735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081327|NCT00800839|Vidarabine|vidarabine|mesh-list
6081328|NCT00800839|Cyclophosphamide|cyclophosphamide|mesh-list
6081329|NCT00800839|Busulfan|busulfan|mesh-list
6081330|NCT00800839|Fludarabine|fludarabine|mesh-list
6665499|NCT01517399|Purinergic Agents|purinergic agents|mesh-ancestor
6081331|NCT00800839|Fludarabine phosphate|fludarabine phosphate|mesh-list
6081332|NCT00800839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5514661|NCT04364555|Glucocorticoids|glucocorticoids|mesh-ancestor
5514662|NCT04364555|Hormones|hormones|mesh-ancestor
5514663|NCT04364555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5514664|NCT04364555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514665|NCT04364451|Asparaginase|asparaginase|mesh-list
6081333|NCT00800839|Immunologic Factors|immunologic factors|mesh-ancestor
6081334|NCT00800839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081335|NCT00800839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6081336|NCT00800839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6081337|NCT00800839|Alkylating Agents|alkylating agents|mesh-ancestor
6081338|NCT00800839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081339|NCT00800839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6081340|NCT00800839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6081341|NCT00800839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6081342|NCT00800839|Antimetabolites|antimetabolites|mesh-ancestor
6081343|NCT00800839|Antiviral Agents|antiviral agents|mesh-ancestor
6081344|NCT00800839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6081345|NCT00800982|Etanercept|etanercept|mesh-list
5514666|NCT04364451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5514667|NCT04364464|Riociguat|riociguat|mesh-list
5514668|NCT04364464|Enzyme Activators|enzyme activators|mesh-ancestor
5514669|NCT04364464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514670|NCT04364425|Triamcinolone|triamcinolone|mesh-list
5514671|NCT04364425|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5514672|NCT04364425|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5514673|NCT04364425|Lidocaine|lidocaine|mesh-list
5514674|NCT04364425|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5514675|NCT04364425|Anesthetics, Local|anesthetics, local|mesh-ancestor
5514676|NCT04364425|Anesthetics|anesthetics|mesh-ancestor
5514677|NCT04364425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5514678|NCT04364425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514679|NCT04364425|Sensory System Agents|sensory system agents|mesh-ancestor
5514680|NCT04364425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5514681|NCT04364425|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5514682|NCT04364425|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5514683|NCT04364425|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5514684|NCT04364425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5514685|NCT04364425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514686|NCT04364425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5514687|NCT04364425|Glucocorticoids|glucocorticoids|mesh-ancestor
5514688|NCT04364425|Hormones|hormones|mesh-ancestor
5514689|NCT04364425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5514690|NCT04364425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5514691|NCT04364425|Immunologic Factors|immunologic factors|mesh-ancestor
5514692|NCT04364425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5514693|NCT04364321|Diazepam|diazepam|mesh-list
5514694|NCT04364321|Clonazepam|clonazepam|mesh-list
5514695|NCT04364321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5514696|NCT04364321|Anticonvulsants|anticonvulsants|mesh-ancestor
5514697|NCT04364321|Antiemetics|antiemetics|mesh-ancestor
5514698|NCT04364321|Autonomic Agents|autonomic agents|mesh-ancestor
5514699|NCT04364321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5514700|NCT04364321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514701|NCT04364321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5514702|NCT04364321|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5514703|NCT04364321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5514704|NCT04364321|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5514705|NCT04364321|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5514706|NCT04364321|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5514707|NCT04364321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5514708|NCT04364321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5514709|NCT04364321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5514710|NCT04364321|Anesthetics, General|anesthetics, general|mesh-ancestor
6081346|NCT00800982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6081347|NCT00800982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6081348|NCT00800982|Analgesics|analgesics|mesh-ancestor
6081349|NCT00800982|Sensory System Agents|sensory system agents|mesh-ancestor
6081350|NCT00800982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6081351|NCT00800982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081352|NCT00800982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6081353|NCT00800982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6081354|NCT00800982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6081355|NCT00800982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6081356|NCT00800982|Immunologic Factors|immunologic factors|mesh-ancestor
6081357|NCT00801099|Amoxicillin|amoxicillin|mesh-list
6081358|NCT00801099|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6081359|NCT00801099|Clavulanic Acids|clavulanic acids|mesh-list
6081360|NCT00801099|Clavulanic Acid|clavulanic acid|mesh-list
6081361|NCT00801099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6081362|NCT00801099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6081363|NCT00801099|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6081364|NCT00801099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6081365|NCT00801099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081366|NCT00801138|Dexamethasone|dexamethasone|mesh-list
6081367|NCT00801138|Bupivacaine|bupivacaine|mesh-list
6081368|NCT00801138|Ropivacaine|ropivacaine|mesh-list
6081369|NCT00801138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6081370|NCT00801138|Antiemetics|antiemetics|mesh-ancestor
6081371|NCT00801138|Autonomic Agents|autonomic agents|mesh-ancestor
6081372|NCT00801138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6081373|NCT00801138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081374|NCT00801138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6081375|NCT00801138|Glucocorticoids|glucocorticoids|mesh-ancestor
6081376|NCT00801138|Hormones|hormones|mesh-ancestor
6081377|NCT00801138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6081378|NCT00801138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6081379|NCT00801138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6081380|NCT00801138|Anesthetics, Local|anesthetics, local|mesh-ancestor
6081381|NCT00801138|Anesthetics|anesthetics|mesh-ancestor
6081382|NCT00801138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6081383|NCT00801138|Sensory System Agents|sensory system agents|mesh-ancestor
6081384|NCT00801229|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6081385|NCT00801229|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5514711|NCT04364321|Anesthetics|anesthetics|mesh-ancestor
5514712|NCT04364321|GABA Modulators|gaba modulators|mesh-ancestor
5514713|NCT04364321|GABA Agents|gaba agents|mesh-ancestor
5514714|NCT04364321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5514715|NCT04364321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514716|NCT04364139|Metoprolol|metoprolol|mesh-list
5514717|NCT04364139|Amlodipine|amlodipine|mesh-list
5514718|NCT04364139|Ramipril|ramipril|mesh-list
5514719|NCT04364139|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5514720|NCT04364139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5514721|NCT04364139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5514722|NCT04364139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514723|NCT04364139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5514724|NCT04364139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514725|NCT04364139|Vasodilator Agents|vasodilator agents|mesh-ancestor
5514726|NCT04364139|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5514727|NCT04364139|Sympatholytics|sympatholytics|mesh-ancestor
5514728|NCT04364139|Autonomic Agents|autonomic agents|mesh-ancestor
5514729|NCT04364139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5514730|NCT04364139|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5514731|NCT04364139|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5514732|NCT04364139|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5514733|NCT04364139|Adrenergic Agents|adrenergic agents|mesh-ancestor
5514734|NCT04364139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5514735|NCT04364139|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5514736|NCT04364139|Protease Inhibitors|protease inhibitors|mesh-ancestor
5514737|NCT04364139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5514738|NCT04364581|Letrozole|letrozole|mesh-list
5514739|NCT04364581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5514740|NCT04364581|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5514741|NCT04364581|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5514742|NCT04364581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5514743|NCT04364581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514744|NCT04364581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5514745|NCT04364581|Hormone Antagonists|hormone antagonists|mesh-ancestor
5514746|NCT04364581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5514747|NCT04364581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514748|NCT04364009|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5514749|NCT04364009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5514750|NCT04363827|Hydroxychloroquine|hydroxychloroquine|mesh-list
5514751|NCT04363827|Antimalarials|antimalarials|mesh-ancestor
5514752|NCT04363827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5514753|NCT04363827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5514754|NCT04363827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6081386|NCT00801229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081387|NCT00801229|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6081388|NCT00801229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6081389|NCT00801229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6081390|NCT00801229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081391|NCT00801229|Dopamine Agents|dopamine agents|mesh-ancestor
6081392|NCT00801229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6081393|NCT00801398|Oxymorphone|oxymorphone|mesh-list
6081394|NCT00801398|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6081395|NCT00801398|Narcotics|narcotics|mesh-ancestor
6081396|NCT00801398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6081397|NCT00801398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081398|NCT00801398|Analgesics|analgesics|mesh-ancestor
6081399|NCT00801398|Sensory System Agents|sensory system agents|mesh-ancestor
6081400|NCT00801398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6081401|NCT00801398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6081402|NCT00801632|Prednisone|prednisone|mesh-list
6081403|NCT00801632|Methylprednisolone|methylprednisolone|mesh-list
6081404|NCT00801632|Cyclophosphamide|cyclophosphamide|mesh-list
6081405|NCT00801632|Rituximab|rituximab|mesh-list
6081406|NCT00801632|Tacrolimus|tacrolimus|mesh-list
6081407|NCT00801632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6081408|NCT00801632|Immunologic Factors|immunologic factors|mesh-ancestor
6081409|NCT00801632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081410|NCT00801632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6081411|NCT00801632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6081412|NCT00801632|Alkylating Agents|alkylating agents|mesh-ancestor
6081413|NCT00801632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081414|NCT00801632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6081415|NCT00801632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6081416|NCT00801632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6081417|NCT00801632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6081418|NCT00801632|Glucocorticoids|glucocorticoids|mesh-ancestor
6081419|NCT00801632|Hormones|hormones|mesh-ancestor
6081420|NCT00801632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6081421|NCT00801632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6081422|NCT00801632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6081423|NCT00801632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6081424|NCT00801632|Antiemetics|antiemetics|mesh-ancestor
6081425|NCT00801632|Autonomic Agents|autonomic agents|mesh-ancestor
5514755|NCT04363827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5514756|NCT04363827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081426|NCT00801632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6081427|NCT00801632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6081428|NCT00801632|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6081429|NCT00801632|Protective Agents|protective agents|mesh-ancestor
6081430|NCT00801684|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6081431|NCT00801684|Formoterol Fumarate|formoterol fumarate|mesh-list
5514757|NCT04363827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5514758|NCT04364113|Benzocaine|benzocaine|mesh-list
5514759|NCT04364113|Anesthetics, Local|anesthetics, local|mesh-ancestor
5514760|NCT04364113|Anesthetics|anesthetics|mesh-ancestor
5514761|NCT04364113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5514762|NCT04364113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514763|NCT04364113|Sensory System Agents|sensory system agents|mesh-ancestor
5514764|NCT04364113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5514765|NCT04364022|Ritonavir|ritonavir|mesh-list
6081432|NCT00801684|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5514766|NCT04364022|Lopinavir|lopinavir|mesh-list
5514767|NCT04364022|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6463920|NCT00466895|Growth Inhibitors|growth inhibitors|mesh-ancestor
6081433|NCT00801684|Autonomic Agents|autonomic agents|mesh-ancestor
6081434|NCT00801684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6081435|NCT00801684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081436|NCT00801684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6081437|NCT00801684|Respiratory System Agents|respiratory system agents|mesh-ancestor
6081438|NCT00801684|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6081439|NCT00801684|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6081440|NCT00801684|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6081441|NCT00801684|Adrenergic Agents|adrenergic agents|mesh-ancestor
6081442|NCT00801684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6081443|NCT00801684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081444|NCT00801684|Luteolytic Agents|luteolytic agents|mesh-ancestor
6081445|NCT00801684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6081446|NCT00801684|Contraceptive Agents|contraceptive agents|mesh-ancestor
6081447|NCT00801684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6081448|NCT00801684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6081449|NCT00801684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6081450|NCT00801684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6081451|NCT00801723|Budesonide|budesonide|mesh-list
6081452|NCT00801723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6081453|NCT00801723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6081454|NCT00801723|Autonomic Agents|autonomic agents|mesh-ancestor
6081455|NCT00801723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6081456|NCT00801723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081457|NCT00801723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6081458|NCT00801723|Respiratory System Agents|respiratory system agents|mesh-ancestor
6081459|NCT00801723|Glucocorticoids|glucocorticoids|mesh-ancestor
6081460|NCT00801723|Hormones|hormones|mesh-ancestor
6081461|NCT00801723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6202901|NCT02047253|Hormones|hormones|mesh-ancestor
5514768|NCT04364022|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5514769|NCT04364022|Protease Inhibitors|protease inhibitors|mesh-ancestor
5514770|NCT04364022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5514771|NCT04364022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514772|NCT04364022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5514773|NCT04364022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5514774|NCT04364022|Antiviral Agents|antiviral agents|mesh-ancestor
5514775|NCT04364022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5514776|NCT04364022|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5514777|NCT04364022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5514778|NCT04364035|Vesatolimod|vesatolimod|mesh-list
5514779|NCT04364035|Antiviral Agents|antiviral agents|mesh-ancestor
5514780|NCT04364035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6202902|NCT02047253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6202903|NCT02047253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6202904|NCT02047253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6202905|NCT02047253|Antiviral Agents|antiviral agents|mesh-ancestor
6202906|NCT02047253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6202907|NCT02047500|Gemcitabine|gemcitabine|mesh-list
6202908|NCT02047500|Paclitaxel|paclitaxel|mesh-list
6202909|NCT02047500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6202910|NCT02047500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6202911|NCT02047500|Tubulin Modulators|tubulin modulators|mesh-ancestor
6202912|NCT02047500|Antimitotic Agents|antimitotic agents|mesh-ancestor
6202913|NCT02047500|Mitosis Modulators|mitosis modulators|mesh-ancestor
6202914|NCT02047500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463921|NCT00466895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6081462|NCT00801801|Docetaxel|docetaxel|mesh-list
6081463|NCT00801801|Sorafenib|sorafenib|mesh-list
6081464|NCT00801801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6081465|NCT00801801|Tubulin Modulators|tubulin modulators|mesh-ancestor
6081466|NCT00801801|Antimitotic Agents|antimitotic agents|mesh-ancestor
6081467|NCT00801801|Mitosis Modulators|mitosis modulators|mesh-ancestor
6081468|NCT00801801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081469|NCT00801801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6081470|NCT00801801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6081471|NCT00801827|Fallypride|fallypride|mesh-list
6081472|NCT00801827|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6081473|NCT00801827|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6081474|NCT00801827|Dopamine Agents|dopamine agents|mesh-ancestor
6081475|NCT00801827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6081476|NCT00801827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081477|NCT00801827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081478|NCT00802074|Ritonavir|ritonavir|mesh-list
6081479|NCT00802074|Fosamprenavir|fosamprenavir|mesh-list
6081480|NCT00802074|Raltegravir Potassium|raltegravir potassium|mesh-list
6081481|NCT00802074|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6081482|NCT00802074|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6081483|NCT00802074|Protease Inhibitors|protease inhibitors|mesh-ancestor
6081484|NCT00802074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5514781|NCT04363866|Hydroxychloroquine|hydroxychloroquine|mesh-list
5514782|NCT04363866|Antimalarials|antimalarials|mesh-ancestor
5514783|NCT04363866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5514784|NCT04363866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5514785|NCT04363866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5514786|NCT04363866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5514787|NCT04363866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514788|NCT04363866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5600604|NCT03710603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600605|NCT03710603|Immunologic Factors|immunologic factors|mesh-ancestor
5600606|NCT03710603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5600607|NCT03710603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5600608|NCT03710603|Growth Substances|growth substances|mesh-ancestor
5600609|NCT03710603|Growth Inhibitors|growth inhibitors|mesh-ancestor
5600610|NCT03710460|Metformin|metformin|mesh-list
5600611|NCT03710460|Dapagliflozin|dapagliflozin|mesh-list
6081485|NCT00802074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081486|NCT00802074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6081487|NCT00802074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6081488|NCT00802074|Antiviral Agents|antiviral agents|mesh-ancestor
6081489|NCT00802074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6081490|NCT00802074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6081491|NCT00802074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6081492|NCT00802074|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6081493|NCT00802074|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6081494|NCT00802100|Metformin|metformin|mesh-list
6081495|NCT00802100|Benztropine|benztropine|mesh-list
6081496|NCT00802100|Olanzapine|olanzapine|mesh-list
6081497|NCT00802100|Aripiprazole|aripiprazole|mesh-list
6081498|NCT00802100|Perphenazine|perphenazine|mesh-list
6081499|NCT00802100|Simvastatin|simvastatin|mesh-list
6081500|NCT00802100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6081501|NCT00802100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081502|NCT00802100|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6081503|NCT00802100|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6081504|NCT00802100|Antimetabolites|antimetabolites|mesh-ancestor
6081505|NCT00802100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081506|NCT00802100|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6081507|NCT00802100|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6081508|NCT00802100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6081509|NCT00802100|Antiemetics|antiemetics|mesh-ancestor
6081510|NCT00802100|Autonomic Agents|autonomic agents|mesh-ancestor
6081511|NCT00802100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6081512|NCT00802100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6081513|NCT00802100|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6081514|NCT00802100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6081515|NCT00802100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6081516|NCT00802100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6081517|NCT00802100|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6081518|NCT00802100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6081519|NCT00802100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6081520|NCT00802100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6081521|NCT00802100|Serotonin Agents|serotonin agents|mesh-ancestor
6207743|NCT02119819|Hormones|hormones|mesh-ancestor
5514789|NCT04363762|Salicylic Acid|salicylic acid|mesh-list
6081522|NCT00802100|Antidepressive Agents|antidepressive agents|mesh-ancestor
6081523|NCT00802100|Dopamine Agonists|dopamine agonists|mesh-ancestor
6081524|NCT00802100|Dopamine Agents|dopamine agents|mesh-ancestor
6081525|NCT00802100|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6081526|NCT00802100|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6081527|NCT00802100|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6081528|NCT00802100|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6081529|NCT00802100|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6081530|NCT00802100|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6081531|NCT00802100|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5514790|NCT04363762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5514791|NCT04363762|Antifungal Agents|antifungal agents|mesh-ancestor
5514792|NCT04363762|Keratolytic Agents|keratolytic agents|mesh-ancestor
5514793|NCT04363762|Dermatologic Agents|dermatologic agents|mesh-ancestor
5514794|NCT04363801|Capecitabine|capecitabine|mesh-list
5514795|NCT04363801|Oxaliplatin|oxaliplatin|mesh-list
5514796|NCT04363801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5514797|NCT04363801|Antimetabolites|antimetabolites|mesh-ancestor
5514798|NCT04363801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514799|NCT04363801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5514800|NCT04363450|Hydroxychloroquine|hydroxychloroquine|mesh-list
5514801|NCT04363450|Antimalarials|antimalarials|mesh-ancestor
5514802|NCT04363450|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6081532|NCT00802100|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6081533|NCT00802100|Parasympatholytics|parasympatholytics|mesh-ancestor
6081534|NCT00802100|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6081535|NCT00802100|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6081536|NCT00802100|Cholinergic Agents|cholinergic agents|mesh-ancestor
6081537|NCT00802100|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6081538|NCT00802113|Fludarabine|fludarabine|mesh-list
6081539|NCT00802113|Busulfan|busulfan|mesh-list
6081540|NCT00802113|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6081541|NCT00802113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6081542|NCT00802113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081543|NCT00802113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6081544|NCT00802113|Immunologic Factors|immunologic factors|mesh-ancestor
6081545|NCT00802113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081546|NCT00802113|Alkylating Agents|alkylating agents|mesh-ancestor
6081547|NCT00802113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6081548|NCT00802113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6081549|NCT00802360|Menotropins|menotropins|mesh-list
6081550|NCT00802360|Progesterone|progesterone|mesh-list
6081551|NCT00802360|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6081552|NCT00802360|Ganirelix|ganirelix|mesh-list
6081553|NCT00802360|Progestins|progestins|mesh-ancestor
6081554|NCT00802360|Hormones|hormones|mesh-ancestor
6081555|NCT00802360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6081556|NCT00802360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081557|NCT00802360|Hormone Antagonists|hormone antagonists|mesh-ancestor
6081558|NCT00802360|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6081559|NCT00802360|Fertility Agents|fertility agents|mesh-ancestor
6081560|NCT00802360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6081561|NCT00802412|Topiramate|topiramate|mesh-list
6081562|NCT00802412|Anticonvulsants|anticonvulsants|mesh-ancestor
6081563|NCT00802412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6081564|NCT00802412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081565|NCT00802529|Gentamicins|gentamicins|mesh-list
6081566|NCT00802529|Methylprednisolone|methylprednisolone|mesh-list
6081567|NCT00802529|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6081568|NCT00802529|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5514803|NCT04363450|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5514804|NCT04363450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5514805|NCT04363450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5514806|NCT04363450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514807|NCT04363450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5514808|NCT04363203|Azithromycin|azithromycin|mesh-list
5514809|NCT04363203|Hydroxychloroquine|hydroxychloroquine|mesh-list
5514810|NCT04363203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6081569|NCT00802529|Prednisolone|prednisolone|mesh-list
6081570|NCT00802529|Prednisolone acetate|prednisolone acetate|mesh-list
6081571|NCT00802529|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6081572|NCT00802529|Prednisolone phosphate|prednisolone phosphate|mesh-list
6081573|NCT00802529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6081574|NCT00802529|Antiemetics|antiemetics|mesh-ancestor
6081575|NCT00802529|Autonomic Agents|autonomic agents|mesh-ancestor
6081576|NCT00802529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6081577|NCT00802529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081578|NCT00802529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6081579|NCT00802529|Glucocorticoids|glucocorticoids|mesh-ancestor
6081580|NCT00802529|Hormones|hormones|mesh-ancestor
6081581|NCT00802529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6081582|NCT00802529|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6081583|NCT00802529|Protective Agents|protective agents|mesh-ancestor
6081584|NCT00802529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6081585|NCT00802529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6081586|NCT00802529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6081587|NCT00802529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6081588|NCT00802529|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6081589|NCT00802529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6081590|NCT00802529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081591|NCT00802672|Ciclopirox|ciclopirox|mesh-list
6081592|NCT00802672|Antifungal Agents|antifungal agents|mesh-ancestor
6081593|NCT00802672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6081594|NCT00802685|Ibuprofen|ibuprofen|mesh-list
6081595|NCT00802685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6081596|NCT00802685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6081597|NCT00802685|Analgesics|analgesics|mesh-ancestor
6081598|NCT00802685|Sensory System Agents|sensory system agents|mesh-ancestor
6081599|NCT00802685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6081600|NCT00802685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081601|NCT00802685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6081602|NCT00802685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6081603|NCT00802685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6081604|NCT00802685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6081605|NCT00802685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081606|NCT00802737|Ofatumumab|ofatumumab|mesh-list
6081607|NCT00802737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6081608|NCT00802841|Imatinib Mesylate|imatinib mesylate|mesh-list
6081609|NCT00802841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6081610|NCT00802841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6081611|NCT00802841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6081612|NCT00802841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081613|NCT00802880|Dacarbazine|dacarbazine|mesh-list
6081614|NCT00802880|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6081615|NCT00802880|Alkylating Agents|alkylating agents|mesh-ancestor
6081616|NCT00802880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081617|NCT00802880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6081618|NCT00802919|Varenicline|varenicline|mesh-list
6081619|NCT00802919|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6081620|NCT00802919|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6081621|NCT00802919|Cholinergic Agents|cholinergic agents|mesh-ancestor
6081622|NCT00802919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6081623|NCT00802919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081624|NCT00802919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081625|NCT00802945|Etirinotecan pegol|etirinotecan pegol|mesh-list
6081626|NCT00802945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6081627|NCT00802945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6081628|NCT00802945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6081629|NCT00802945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6081630|NCT00802945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514811|NCT04363203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5514812|NCT04363203|Antimalarials|antimalarials|mesh-ancestor
5514813|NCT04363203|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5514814|NCT04363203|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5514815|NCT04363203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6081631|NCT00803010|Sirolimus|sirolimus|mesh-list
6081632|NCT00803010|Methotrexate|methotrexate|mesh-list
6081633|NCT00803010|Tacrolimus|tacrolimus|mesh-list
6081634|NCT00803010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6081635|NCT00803010|Abortifacient Agents|abortifacient agents|mesh-ancestor
6081636|NCT00803010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5514816|NCT04363203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514817|NCT04363203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5514818|NCT04363255|Cisplatin|cisplatin|mesh-list
5514819|NCT04363255|Carboplatin|carboplatin|mesh-list
5514820|NCT04363255|Etoposide|etoposide|mesh-list
5514821|NCT04363255|Etoposide phosphate|etoposide phosphate|mesh-list
5514822|NCT04363255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5514823|NCT04363255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5514824|NCT04363255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5514825|NCT04363255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5514826|NCT04363255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5514827|NCT04363255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514828|NCT04363359|Vaccines|vaccines|mesh-list
5514829|NCT04363359|Immunologic Factors|immunologic factors|mesh-ancestor
6081637|NCT00803010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081638|NCT00803010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6081639|NCT00803010|Antimetabolites|antimetabolites|mesh-ancestor
6081640|NCT00803010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081641|NCT00803010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6081642|NCT00803010|Dermatologic Agents|dermatologic agents|mesh-ancestor
6081643|NCT00803010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6081644|NCT00803010|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6081645|NCT00803010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6081646|NCT00803010|Immunologic Factors|immunologic factors|mesh-ancestor
6081647|NCT00803010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6081648|NCT00803010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6081649|NCT00803010|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6081650|NCT00803010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6081651|NCT00803010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6081652|NCT00803010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5514830|NCT04363359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514831|NCT04363216|Ascorbic Acid|ascorbic acid|mesh-list
5514832|NCT04363216|Vitamins|vitamins|mesh-ancestor
5514833|NCT04363216|Micronutrients|micronutrients|mesh-ancestor
5514834|NCT04363216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514835|NCT04363216|Antioxidants|antioxidants|mesh-ancestor
5514836|NCT04363216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514837|NCT04363216|Protective Agents|protective agents|mesh-ancestor
5514838|NCT04363060|Amoxicillin|amoxicillin|mesh-list
5514839|NCT04363060|Azithromycin|azithromycin|mesh-list
5514840|NCT04363060|Clavulanic Acid|clavulanic acid|mesh-list
5514841|NCT04363060|Clavulanic Acids|clavulanic acids|mesh-list
6081653|NCT00803010|Antifungal Agents|antifungal agents|mesh-ancestor
6081654|NCT00803023|Sodium Oxybate|sodium oxybate|mesh-list
6081655|NCT00803023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6081656|NCT00803023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6081657|NCT00803023|Anesthetics, General|anesthetics, general|mesh-ancestor
6081658|NCT00803023|Anesthetics|anesthetics|mesh-ancestor
6081659|NCT00803023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6081660|NCT00803023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081661|NCT00803049|Teriflunomide|teriflunomide|mesh-list
6081662|NCT00803049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6081663|NCT00803049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6081664|NCT00803049|Analgesics|analgesics|mesh-ancestor
6081665|NCT00803049|Sensory System Agents|sensory system agents|mesh-ancestor
6081666|NCT00803049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6081667|NCT00803049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081668|NCT00803049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6081669|NCT00803049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6081670|NCT00803049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6081671|NCT00803049|Immunologic Factors|immunologic factors|mesh-ancestor
6081672|NCT00803062|Paclitaxel|paclitaxel|mesh-list
6081673|NCT00803062|Bevacizumab|bevacizumab|mesh-list
6081674|NCT00803062|Cisplatin|cisplatin|mesh-list
6081675|NCT00803062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6081676|NCT00803062|Topotecan|topotecan|mesh-list
6081677|NCT00803062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6081678|NCT00803062|Endothelial Growth Factors|endothelial growth factors|mesh-list
6081679|NCT00803062|Antibodies|antibodies|mesh-list
6081680|NCT00803062|Immunoglobulins|immunoglobulins|mesh-list
6081681|NCT00803062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6081682|NCT00803062|Immunoglobulin G|immunoglobulin g|mesh-list
6081683|NCT00803062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6081684|NCT00803062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6081685|NCT00803062|Tubulin Modulators|tubulin modulators|mesh-ancestor
6081686|NCT00803062|Antimitotic Agents|antimitotic agents|mesh-ancestor
6081687|NCT00803062|Mitosis Modulators|mitosis modulators|mesh-ancestor
6081688|NCT00803062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081689|NCT00803062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6081690|NCT00803062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5514842|NCT04363060|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6081691|NCT00803062|Growth Substances|growth substances|mesh-ancestor
5514843|NCT04363060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6081692|NCT00803062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081693|NCT00803062|Growth Inhibitors|growth inhibitors|mesh-ancestor
6081694|NCT00803062|Immunologic Factors|immunologic factors|mesh-ancestor
6081695|NCT00803062|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6081696|NCT00803062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6081697|NCT00803062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6081698|NCT00803101|Protein C|protein c|mesh-list
6081699|NCT00803101|Protein S|protein s|mesh-list
6081700|NCT00803101|Anticoagulants|anticoagulants|mesh-ancestor
6081701|NCT00803101|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6081702|NCT00803101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6081703|NCT00803101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081704|NCT00803361|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6665500|NCT01517399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6665501|NCT01517399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6665502|NCT01517399|Protective Agents|protective agents|mesh-ancestor
5514844|NCT04363060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5514845|NCT04363060|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5514846|NCT04363060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5514847|NCT04363060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665503|NCT01517399|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6665504|NCT01517399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6665505|NCT01517399|Hemostatics|hemostatics|mesh-ancestor
6665506|NCT01517399|Coagulants|coagulants|mesh-ancestor
6665507|NCT01517451|Androgens|androgens|mesh-list
6665508|NCT01517451|Hormones|hormones|mesh-ancestor
6665509|NCT01517451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6665510|NCT01517451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081705|NCT00803361|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6081706|NCT00803361|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6081707|NCT00803361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6081708|NCT00803361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081709|NCT00803361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6081710|NCT00803361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514848|NCT04362943|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5514849|NCT04362943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5514850|NCT04362735|Vedolizumab|vedolizumab|mesh-list
5514851|NCT04362735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5514852|NCT04362527|Milrinone|milrinone|mesh-list
5514853|NCT04362527|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5514854|NCT04362527|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5514855|NCT04362527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5514856|NCT04362527|Vasodilator Agents|vasodilator agents|mesh-ancestor
5514857|NCT04362527|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5514858|NCT04362527|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5514859|NCT04362527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5514860|NCT04362527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514861|NCT04362527|Protective Agents|protective agents|mesh-ancestor
5514862|NCT04362527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514863|NCT04362488|Benzoyl Peroxide|benzoyl peroxide|mesh-list
5514864|NCT04362488|Dermatologic Agents|dermatologic agents|mesh-ancestor
5514865|NCT04362384|Vitamin E|vitamin e|mesh-list
5514866|NCT04362384|Prednisolone|prednisolone|mesh-list
5514867|NCT04362384|Vitamins|vitamins|mesh-ancestor
5514868|NCT04362384|Micronutrients|micronutrients|mesh-ancestor
5514869|NCT04362384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514870|NCT04362384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5514871|NCT04362384|Glucocorticoids|glucocorticoids|mesh-ancestor
5514872|NCT04362384|Hormones|hormones|mesh-ancestor
6081711|NCT00803361|Analgesics|analgesics|mesh-ancestor
6081712|NCT00803361|Sensory System Agents|sensory system agents|mesh-ancestor
6081713|NCT00803361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6081714|NCT00803361|Antidepressive Agents|antidepressive agents|mesh-ancestor
6081715|NCT00803361|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6081716|NCT00803361|Dopamine Agents|dopamine agents|mesh-ancestor
6081717|NCT00803400|Alprazolam|alprazolam|mesh-list
6081718|NCT00803400|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6081719|NCT00803400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6081720|NCT00803400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081721|NCT00803400|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6081722|NCT00803400|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6081723|NCT00803400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6081724|NCT00803400|GABA Modulators|gaba modulators|mesh-ancestor
6081725|NCT00803400|GABA Agents|gaba agents|mesh-ancestor
5514873|NCT04362384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5514874|NCT04362384|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5514875|NCT04362384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6081726|NCT00803400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6081727|NCT00803400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081728|NCT00803452|Azithromycin|azithromycin|mesh-list
6081729|NCT00803452|Doxycycline|doxycycline|mesh-list
6081730|NCT00803452|Minocycline|minocycline|mesh-list
6081731|NCT00803452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6081732|NCT00803452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6081733|NCT00803452|Antimalarials|antimalarials|mesh-ancestor
6081734|NCT00803452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6081735|NCT00803452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6081736|NCT00803543|Valacyclovir|valacyclovir|mesh-list
6081737|NCT00803543|Antiviral Agents|antiviral agents|mesh-ancestor
6081738|NCT00803543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6081739|NCT00803569|Sargramostim|sargramostim|mesh-list
6081740|NCT00803569|Immunologic Factors|immunologic factors|mesh-ancestor
6463922|NCT00466986|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6463923|NCT00466986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6463924|NCT00466999|Misoprostol|misoprostol|mesh-list
6463925|NCT00466999|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6463926|NCT00466999|Abortifacient Agents|abortifacient agents|mesh-ancestor
6081741|NCT00803569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081742|NCT00803595|Oseltamivir|oseltamivir|mesh-list
6081743|NCT00803595|Antiviral Agents|antiviral agents|mesh-ancestor
6081744|NCT00803595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6081745|NCT00803595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6081746|NCT00803595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081747|NCT00803634|Antihypertensive Agents|antihypertensive agents|mesh-list
6081748|NCT00803634|Diltiazem|diltiazem|mesh-list
6081749|NCT00803634|Nitroprusside|nitroprusside|mesh-list
6081750|NCT00803634|Nicardipine|nicardipine|mesh-list
6081751|NCT00803634|Clevidipine|clevidipine|mesh-list
6081752|NCT00803634|Isosorbide|isosorbide|mesh-list
6081753|NCT00803634|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
6081754|NCT00803634|Nitroglycerin|nitroglycerin|mesh-list
6081755|NCT00803634|Vasodilator Agents|vasodilator agents|mesh-ancestor
6081756|NCT00803634|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6081757|NCT00803634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6081758|NCT00803634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081759|NCT00803634|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6081760|NCT00803634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081761|NCT00803634|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6081762|NCT00803634|Diuretics|diuretics|mesh-ancestor
6081763|NCT00803634|Natriuretic Agents|natriuretic agents|mesh-ancestor
6081764|NCT00803634|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6081765|NCT00803647|Leucovorin|leucovorin|mesh-list
6081766|NCT00803647|Fluorouracil|fluorouracil|mesh-list
6081767|NCT00803647|Oxaliplatin|oxaliplatin|mesh-list
6081768|NCT00803647|Cetuximab|cetuximab|mesh-list
6081769|NCT00803647|Antimetabolites|antimetabolites|mesh-ancestor
6081770|NCT00803647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081771|NCT00803647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6081772|NCT00803647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6081773|NCT00803647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6081774|NCT00803647|Immunologic Factors|immunologic factors|mesh-ancestor
6081775|NCT00803647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081776|NCT00803647|Antidotes|antidotes|mesh-ancestor
6081777|NCT00803647|Protective Agents|protective agents|mesh-ancestor
6081778|NCT00803647|Vitamin B Complex|vitamin b complex|mesh-ancestor
6081779|NCT00803647|Vitamins|vitamins|mesh-ancestor
6081780|NCT00803647|Micronutrients|micronutrients|mesh-ancestor
6081781|NCT00803647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6081782|NCT00803686|Salmon calcitonin|salmon calcitonin|mesh-list
6081783|NCT00803686|Calcitonin|calcitonin|mesh-list
6081784|NCT00803686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6081785|NCT00803686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081786|NCT00803686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6081787|NCT00803712|Vitamin D|vitamin d|mesh-list
6081788|NCT00803712|Ergocalciferols|ergocalciferols|mesh-list
6081789|NCT00803712|Vitamins|vitamins|mesh-list
6081790|NCT00803712|Cinacalcet|cinacalcet|mesh-list
6081791|NCT00803712|Micronutrients|micronutrients|mesh-ancestor
6081792|NCT00803712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081793|NCT00803712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6081794|NCT00803712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6081795|NCT00803712|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6081796|NCT00803712|Hormone Antagonists|hormone antagonists|mesh-ancestor
6081797|NCT00803712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6081798|NCT00803738|Terconazole|terconazole|mesh-list
6463927|NCT00466999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5514876|NCT04362384|Protective Agents|protective agents|mesh-ancestor
5514877|NCT04362384|Antioxidants|antioxidants|mesh-ancestor
5514878|NCT04362384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514879|NCT04362241|Prednisolone|prednisolone|mesh-list
5514880|NCT04362241|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5514881|NCT04362241|Methylprednisolone|methylprednisolone|mesh-list
5514882|NCT04362241|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5514883|NCT04362241|Prednisolone acetate|prednisolone acetate|mesh-list
5514884|NCT04362241|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5514885|NCT04362241|Prednisolone phosphate|prednisolone phosphate|mesh-list
5514886|NCT04362241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5514887|NCT04362241|Glucocorticoids|glucocorticoids|mesh-ancestor
5514888|NCT04362241|Hormones|hormones|mesh-ancestor
5514889|NCT04362241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5514890|NCT04362241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514891|NCT04362241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5514892|NCT04362241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5514893|NCT04362241|Antiemetics|antiemetics|mesh-ancestor
5514894|NCT04362241|Autonomic Agents|autonomic agents|mesh-ancestor
5514895|NCT04362241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5514896|NCT04362241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5514897|NCT04362241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6081799|NCT00803738|Antifungal Agents|antifungal agents|mesh-ancestor
6081800|NCT00803738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6081801|NCT00804141|Bromides|bromides|mesh-list
6081802|NCT00804141|Methylnaltrexone|methylnaltrexone|mesh-list
6081803|NCT00804141|Anticonvulsants|anticonvulsants|mesh-ancestor
6081804|NCT00804141|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6081805|NCT00804141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081806|NCT00804141|Sensory System Agents|sensory system agents|mesh-ancestor
6081807|NCT00804141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5514898|NCT04362241|Protective Agents|protective agents|mesh-ancestor
5514899|NCT04362293|Sirolimus|sirolimus|mesh-list
5514900|NCT04362293|Plerixafor|plerixafor|mesh-list
5514901|NCT04362293|Cyclophosphamide|cyclophosphamide|mesh-list
5514902|NCT04362293|Thiotepa|thiotepa|mesh-list
5514903|NCT04362293|Alemtuzumab|alemtuzumab|mesh-list
5514904|NCT04362293|Hydroxyurea|hydroxyurea|mesh-list
5514905|NCT04362293|Azathioprine|azathioprine|mesh-list
5514906|NCT04362293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5514907|NCT04362293|Immunologic Factors|immunologic factors|mesh-ancestor
6081808|NCT00804193|Ciclopirox|ciclopirox|mesh-list
6081809|NCT00804193|Antifungal Agents|antifungal agents|mesh-ancestor
6081810|NCT00804193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6081811|NCT00804609|Lidocaine|lidocaine|mesh-list
6081812|NCT00804609|Morphine|morphine|mesh-list
6081813|NCT00804609|Anesthetics|anesthetics|mesh-list
6081814|NCT00804609|Anesthetics, Local|anesthetics, local|mesh-ancestor
6081815|NCT00804609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6081816|NCT00804609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081817|NCT00804609|Sensory System Agents|sensory system agents|mesh-ancestor
6081818|NCT00804609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6081819|NCT00804609|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6081820|NCT00804609|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6081821|NCT00804609|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6081822|NCT00804609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6081823|NCT00804609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081824|NCT00804609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6081825|NCT00804609|Narcotics|narcotics|mesh-ancestor
6081826|NCT00804609|Analgesics|analgesics|mesh-ancestor
6463928|NCT00466999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514908|NCT04362293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514909|NCT04362293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5514910|NCT04362293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6463929|NCT00466999|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6463930|NCT00466999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6463931|NCT00466999|Oxytocics|oxytocics|mesh-ancestor
6463932|NCT00467012|Paclitaxel|paclitaxel|mesh-list
6463933|NCT00467012|Bevacizumab|bevacizumab|mesh-list
6463934|NCT00467012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6463935|NCT00467012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6081827|NCT00804648|Timolol|timolol|mesh-list
6081828|NCT00804648|Maleic acid|maleic acid|mesh-list
6081829|NCT00804648|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6081830|NCT00804648|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5514911|NCT04362293|Alkylating Agents|alkylating agents|mesh-ancestor
5600612|NCT03710460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6081831|NCT00804648|Adrenergic Agents|adrenergic agents|mesh-ancestor
6463936|NCT00467012|Tubulin Modulators|tubulin modulators|mesh-ancestor
6463937|NCT00467012|Antimitotic Agents|antimitotic agents|mesh-ancestor
6463938|NCT00467012|Mitosis Modulators|mitosis modulators|mesh-ancestor
6463939|NCT00467012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081832|NCT00804648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6081833|NCT00804648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081834|NCT00804648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081835|NCT00804648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6081836|NCT00804648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6081837|NCT00804648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6081838|NCT00804687|Pseudoephedrine|pseudoephedrine|mesh-list
6081839|NCT00804687|Ephedrine|ephedrine|mesh-list
6081840|NCT00804687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6081841|NCT00804687|Autonomic Agents|autonomic agents|mesh-ancestor
6081842|NCT00804687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6081843|NCT00804687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081844|NCT00804687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6081845|NCT00804687|Respiratory System Agents|respiratory system agents|mesh-ancestor
6081846|NCT00804687|Nasal Decongestants|nasal decongestants|mesh-ancestor
6081847|NCT00804687|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6081848|NCT00804687|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6081849|NCT00804687|Sympathomimetics|sympathomimetics|mesh-ancestor
6081850|NCT00804687|Adrenergic Agents|adrenergic agents|mesh-ancestor
6081851|NCT00804687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6081852|NCT00804687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081853|NCT00804843|Niacin|niacin|mesh-list
6081854|NCT00804843|Atorvastatin|atorvastatin|mesh-list
5514912|NCT04362293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514913|NCT04362293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5514914|NCT04362293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5514915|NCT04362293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5514916|NCT04362293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5514917|NCT04362293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5514918|NCT04362293|Antifungal Agents|antifungal agents|mesh-ancestor
5514919|NCT04362293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5514920|NCT04362293|Antisickling Agents|antisickling agents|mesh-ancestor
5514921|NCT04362293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6081855|NCT00804843|Simvastatin|simvastatin|mesh-list
6081856|NCT00804843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6081857|NCT00804843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6081858|NCT00804843|Antimetabolites|antimetabolites|mesh-ancestor
6081859|NCT00804843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081860|NCT00804843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6081861|NCT00804843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6081862|NCT00804843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6081863|NCT00804843|Vasodilator Agents|vasodilator agents|mesh-ancestor
6081864|NCT00804843|Vitamin B Complex|vitamin b complex|mesh-ancestor
6081865|NCT00804843|Vitamins|vitamins|mesh-ancestor
6081866|NCT00804843|Micronutrients|micronutrients|mesh-ancestor
6081867|NCT00804843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081868|NCT00804908|Temozolomide|temozolomide|mesh-list
6081869|NCT00804908|Veliparib|veliparib|mesh-list
6081870|NCT00804908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6081871|NCT00804908|Alkylating Agents|alkylating agents|mesh-ancestor
6081872|NCT00804908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081873|NCT00804908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6081874|NCT00804908|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6081875|NCT00804908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6081876|NCT00804973|Sumatriptan|sumatriptan|mesh-list
6463940|NCT00467012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6463941|NCT00467012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6463942|NCT00467012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6463943|NCT00467012|Growth Substances|growth substances|mesh-ancestor
6463944|NCT00467012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081877|NCT00804973|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6081878|NCT00804973|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6081879|NCT00804973|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6463945|NCT00467012|Growth Inhibitors|growth inhibitors|mesh-ancestor
6463946|NCT00467116|Gemcitabine|gemcitabine|mesh-list
6463947|NCT00467116|Cetuximab|cetuximab|mesh-list
6081880|NCT00804973|Serotonin Agents|serotonin agents|mesh-ancestor
6081881|NCT00804973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6081882|NCT00804973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081883|NCT00804973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665511|NCT01517490|Insulin|insulin|mesh-list
6665512|NCT01517490|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6665513|NCT01517490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6665514|NCT01517490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665515|NCT01517555|Acetaminophen|acetaminophen|mesh-list
6081884|NCT00804999|Hydrogen Peroxide|hydrogen peroxide|mesh-list
6081885|NCT00804999|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6081886|NCT00804999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6081887|NCT00805142|Tapentadol|tapentadol|mesh-list
6081888|NCT00805142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6081889|NCT00805142|Narcotics|narcotics|mesh-ancestor
6081890|NCT00805142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6081891|NCT00805142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081892|NCT00805142|Analgesics|analgesics|mesh-ancestor
6081893|NCT00805142|Sensory System Agents|sensory system agents|mesh-ancestor
6081894|NCT00805142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6081895|NCT00805142|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6081896|NCT00805142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6081897|NCT00805142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6081898|NCT00805142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081899|NCT00805142|Adrenergic Agents|adrenergic agents|mesh-ancestor
6081900|NCT00805142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6081901|NCT00805194|Docetaxel|docetaxel|mesh-list
6081902|NCT00805194|Nintedanib|nintedanib|mesh-list
6081903|NCT00805194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6081904|NCT00805194|Tubulin Modulators|tubulin modulators|mesh-ancestor
6081905|NCT00805194|Antimitotic Agents|antimitotic agents|mesh-ancestor
6081906|NCT00805194|Mitosis Modulators|mitosis modulators|mesh-ancestor
6081907|NCT00805194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081908|NCT00805194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6081909|NCT00805194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6081910|NCT00805207|Estradiol|estradiol|mesh-list
6081911|NCT00805207|Estrogens|estrogens|mesh-list
6081912|NCT00805207|Testosterone|testosterone|mesh-list
6081913|NCT00805207|Progesterone|progesterone|mesh-list
6081914|NCT00805207|Glucocorticoids|glucocorticoids|mesh-list
6081915|NCT00805207|Hormones|hormones|mesh-ancestor
6081916|NCT00805207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6081917|NCT00805207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081918|NCT00805207|Androgens|androgens|mesh-ancestor
6081919|NCT00805207|Progestins|progestins|mesh-ancestor
6081920|NCT00805285|Budesonide|budesonide|mesh-list
6081921|NCT00805285|Hydrocortisone|hydrocortisone|mesh-list
6081922|NCT00805285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6081923|NCT00805285|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6081924|NCT00805285|Autonomic Agents|autonomic agents|mesh-ancestor
6665516|NCT01517555|Liraglutide|liraglutide|mesh-list
6665517|NCT01517555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6081925|NCT00805285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5514922|NCT04362293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5514923|NCT04362293|Antimetabolites|antimetabolites|mesh-ancestor
5514924|NCT04362293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5514925|NCT04362293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5514926|NCT04362293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6081926|NCT00805285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081927|NCT00805285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6081928|NCT00805285|Respiratory System Agents|respiratory system agents|mesh-ancestor
6081929|NCT00805285|Glucocorticoids|glucocorticoids|mesh-ancestor
6081930|NCT00805285|Hormones|hormones|mesh-ancestor
6081931|NCT00805285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6081932|NCT00805493|Riluzole|riluzole|mesh-list
6081933|NCT00805493|Anticonvulsants|anticonvulsants|mesh-ancestor
6081934|NCT00805493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6081935|NCT00805493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6081936|NCT00805493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6081937|NCT00805493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081938|NCT00805493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081939|NCT00805493|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6081940|NCT00805493|Protective Agents|protective agents|mesh-ancestor
6463948|NCT00467116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6463949|NCT00467116|Antimetabolites|antimetabolites|mesh-ancestor
6489049|NCT00589082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6081941|NCT00805545|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5514927|NCT04362293|Antiviral Agents|antiviral agents|mesh-ancestor
5514928|NCT04362111|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5514929|NCT04362111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5514930|NCT04362332|Hydroxychloroquine|hydroxychloroquine|mesh-list
5514931|NCT04362332|Chloroquine|chloroquine|mesh-list
5514932|NCT04362332|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
5514933|NCT04362332|Antimalarials|antimalarials|mesh-ancestor
5514934|NCT04362332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5514935|NCT04362332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5514936|NCT04362332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6081942|NCT00805545|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6081943|NCT00805545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6081944|NCT00805545|Antitubercular Agents|antitubercular agents|mesh-ancestor
6081945|NCT00805675|Tenofovir|tenofovir|mesh-list
6081946|NCT00805675|Telbivudine|telbivudine|mesh-list
6081947|NCT00805675|Antiviral Agents|antiviral agents|mesh-ancestor
6081948|NCT00805675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6081949|NCT00805675|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6081950|NCT00805675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6081951|NCT00805675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5514937|NCT04362332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5514938|NCT04362332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514939|NCT04362332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5514940|NCT04362332|Amebicides|amebicides|mesh-ancestor
5514941|NCT04362332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5514942|NCT04362332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5514943|NCT04362332|Analgesics|analgesics|mesh-ancestor
5514944|NCT04362332|Sensory System Agents|sensory system agents|mesh-ancestor
5514945|NCT04362332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5514946|NCT04362332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514947|NCT04362332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6081952|NCT00805675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514948|NCT04362332|Filaricides|filaricides|mesh-ancestor
6081953|NCT00805675|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6081954|NCT00805675|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6081955|NCT00805740|Caspofungin|caspofungin|mesh-list
6081956|NCT00805740|Anidulafungin|anidulafungin|mesh-list
6081957|NCT00805740|Antifungal Agents|antifungal agents|mesh-ancestor
6081958|NCT00805740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6081959|NCT00805740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6081960|NCT00805740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081961|NCT00805766|Infliximab|infliximab|mesh-list
5514949|NCT04362332|Antinematodal Agents|antinematodal agents|mesh-ancestor
5514950|NCT04362332|Anthelmintics|anthelmintics|mesh-ancestor
5514951|NCT04362124|BCG Vaccine|bcg vaccine|mesh-list
5514952|NCT04362124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5514953|NCT04362124|Immunologic Factors|immunologic factors|mesh-ancestor
5514954|NCT04362124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514955|NCT04362410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5514956|NCT04362410|Immunologic Factors|immunologic factors|mesh-ancestor
5514957|NCT04362410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514958|NCT04361825|Durvalumab|durvalumab|mesh-list
5514959|NCT04361825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5514960|NCT04361825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5514961|NCT04361734|Nitroglycerin|nitroglycerin|mesh-list
5514962|NCT04361734|Vasodilator Agents|vasodilator agents|mesh-ancestor
5600613|NCT03710460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600614|NCT03710460|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5600615|NCT03710460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600616|NCT03710434|Lansoprazole|lansoprazole|mesh-list
6081962|NCT00805766|Dermatologic Agents|dermatologic agents|mesh-ancestor
6081963|NCT00805766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6081964|NCT00805766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6081965|NCT00805792|Donepezil|donepezil|mesh-list
6081966|NCT00805792|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6081967|NCT00805792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6081968|NCT00805792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081969|NCT00805792|Cholinergic Agents|cholinergic agents|mesh-ancestor
6081970|NCT00805792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6081971|NCT00805792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081972|NCT00805792|Nootropic Agents|nootropic agents|mesh-ancestor
6081973|NCT00805935|Leuprolide|leuprolide|mesh-list
6081974|NCT00805935|Menotropins|menotropins|mesh-list
6081975|NCT00805935|Progesterone|progesterone|mesh-list
6081976|NCT00805935|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6081977|NCT00805935|Progestins|progestins|mesh-ancestor
6081978|NCT00805935|Hormones|hormones|mesh-ancestor
6081979|NCT00805935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6081980|NCT00805935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081981|NCT00805935|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6081982|NCT00805935|Fertility Agents|fertility agents|mesh-ancestor
6081983|NCT00805935|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6081984|NCT00805935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6081985|NCT00805935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6081986|NCT00806026|Pregabalin|pregabalin|mesh-list
6081987|NCT00806026|Pramipexole|pramipexole|mesh-list
6081988|NCT00806026|Analgesics|analgesics|mesh-ancestor
6081989|NCT00806026|Sensory System Agents|sensory system agents|mesh-ancestor
6081990|NCT00806026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6081991|NCT00806026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6081992|NCT00806026|Anticonvulsants|anticonvulsants|mesh-ancestor
6081993|NCT00806026|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6081994|NCT00806026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6081995|NCT00806026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6081996|NCT00806026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6081997|NCT00806026|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6081998|NCT00806026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6081999|NCT00806026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6082000|NCT00806026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6082001|NCT00806026|Antioxidants|antioxidants|mesh-ancestor
6082002|NCT00806026|Protective Agents|protective agents|mesh-ancestor
6082003|NCT00806026|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6082004|NCT00806026|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6082005|NCT00806026|Dopamine Agonists|dopamine agonists|mesh-ancestor
6082006|NCT00806026|Dopamine Agents|dopamine agents|mesh-ancestor
6082007|NCT00806026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6082008|NCT00806078|Quinine|quinine|mesh-list
6082009|NCT00806078|Antimalarials|antimalarials|mesh-ancestor
6082010|NCT00806078|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6082011|NCT00806078|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6082012|NCT00806078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6082013|NCT00806078|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6082014|NCT00806078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082015|NCT00806078|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6082016|NCT00806078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6082017|NCT00806078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6082018|NCT00806078|Analgesics|analgesics|mesh-ancestor
6082019|NCT00806078|Sensory System Agents|sensory system agents|mesh-ancestor
6082020|NCT00806156|Etirinotecan pegol|etirinotecan pegol|mesh-list
6082021|NCT00806156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6082022|NCT00806156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6082023|NCT00806156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6082024|NCT00806156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6082025|NCT00806156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6082026|NCT00806195|Vaccines|vaccines|mesh-list
6082027|NCT00806195|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6082028|NCT00806195|Immunologic Factors|immunologic factors|mesh-ancestor
6082029|NCT00806195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463950|NCT00467116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463951|NCT00467116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6463952|NCT00467116|Antiviral Agents|antiviral agents|mesh-ancestor
6463953|NCT00467116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6463954|NCT00467116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6463955|NCT00467116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5514963|NCT04361708|Leucovorin|leucovorin|mesh-list
5514964|NCT04361708|Docetaxel|docetaxel|mesh-list
5514965|NCT04361708|Fluorouracil|fluorouracil|mesh-list
6082030|NCT00806221|Emollients|emollients|mesh-list
6463956|NCT00467116|Immunologic Factors|immunologic factors|mesh-ancestor
6463957|NCT00467116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463958|NCT00467116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6463959|NCT00467142|Leucovorin|leucovorin|mesh-list
6082031|NCT00806221|Dermatologic Agents|dermatologic agents|mesh-ancestor
6082032|NCT00806234|Metformin|metformin|mesh-list
6082033|NCT00806234|Olanzapine|olanzapine|mesh-list
6082034|NCT00806234|Risperidone|risperidone|mesh-list
6082035|NCT00806234|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6082036|NCT00806234|Aripiprazole|aripiprazole|mesh-list
6082037|NCT00806234|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6082038|NCT00806234|Ziprasidone|ziprasidone|mesh-list
6082039|NCT00806234|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
6082040|NCT00806234|Asenapine|asenapine|mesh-list
6082041|NCT00806234|Iloperidone|iloperidone|mesh-list
6082042|NCT00806234|Perphenazine|perphenazine|mesh-list
6082043|NCT00806234|Fluoxetine|fluoxetine|mesh-list
6082044|NCT00806234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6082045|NCT00806234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082046|NCT00806234|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6082047|NCT00806234|Serotonin Agents|serotonin agents|mesh-ancestor
6082048|NCT00806234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6082049|NCT00806234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6082050|NCT00806234|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6082051|NCT00806234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6082052|NCT00806234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6082053|NCT00806234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5514966|NCT04361708|Oxaliplatin|oxaliplatin|mesh-list
5514967|NCT04361708|Irinotecan|irinotecan|mesh-list
6082054|NCT00806234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6463960|NCT00467142|Bevacizumab|bevacizumab|mesh-list
6463961|NCT00467142|Fluorouracil|fluorouracil|mesh-list
6082055|NCT00806234|Dopamine Agents|dopamine agents|mesh-ancestor
6082056|NCT00806234|Antiemetics|antiemetics|mesh-ancestor
6082057|NCT00806234|Autonomic Agents|autonomic agents|mesh-ancestor
6082058|NCT00806234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6082059|NCT00806234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6082060|NCT00806234|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6082061|NCT00806234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6082062|NCT00806234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6082063|NCT00806234|Antidepressive Agents|antidepressive agents|mesh-ancestor
6082064|NCT00806234|Dopamine Agonists|dopamine agonists|mesh-ancestor
6082065|NCT00806234|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6082066|NCT00806234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6082067|NCT00806234|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6082068|NCT00806234|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6082069|NCT00806234|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6082070|NCT00806234|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6082071|NCT00806234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6082072|NCT00806234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6082073|NCT00806234|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6082074|NCT00806234|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6082075|NCT00806234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5514968|NCT04361708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5514969|NCT04361708|Tubulin Modulators|tubulin modulators|mesh-ancestor
5514970|NCT04361708|Antimitotic Agents|antimitotic agents|mesh-ancestor
6082076|NCT00806234|Adrenergic Agents|adrenergic agents|mesh-ancestor
6082077|NCT00806260|Ethanol|ethanol|mesh-list
6082078|NCT00806260|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6082079|NCT00806260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6082080|NCT00806260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6082081|NCT00806260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082082|NCT00806286|Paclitaxel|paclitaxel|mesh-list
6082083|NCT00806286|Carboplatin|carboplatin|mesh-list
6082084|NCT00806286|Efatutazone|efatutazone|mesh-list
6082085|NCT00806286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6082086|NCT00806286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6082087|NCT00806286|Tubulin Modulators|tubulin modulators|mesh-ancestor
6082088|NCT00806286|Antimitotic Agents|antimitotic agents|mesh-ancestor
6082089|NCT00806286|Mitosis Modulators|mitosis modulators|mesh-ancestor
6082090|NCT00806286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514971|NCT04361708|Mitosis Modulators|mitosis modulators|mesh-ancestor
5514972|NCT04361708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514973|NCT04361708|Antimetabolites|antimetabolites|mesh-ancestor
5514974|NCT04361708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5514975|NCT04361708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5514976|NCT04361708|Immunologic Factors|immunologic factors|mesh-ancestor
5514977|NCT04361708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514978|NCT04361708|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5514979|NCT04361708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5514980|NCT04361708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5514981|NCT04361708|Antidotes|antidotes|mesh-ancestor
5514982|NCT04361708|Protective Agents|protective agents|mesh-ancestor
5514983|NCT04361708|Vitamin B Complex|vitamin b complex|mesh-ancestor
5514984|NCT04361708|Vitamins|vitamins|mesh-ancestor
5514985|NCT04361708|Micronutrients|micronutrients|mesh-ancestor
5514986|NCT04361552|Immunoglobulins|immunoglobulins|mesh-list
5514987|NCT04361552|Immunoglobulin G|immunoglobulin g|mesh-list
5514988|NCT04361552|Immunologic Factors|immunologic factors|mesh-ancestor
5514989|NCT04361552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514990|NCT04361721|Erenumab|erenumab|mesh-list
5514991|NCT04361721|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
6082091|NCT00806351|Caspofungin|caspofungin|mesh-list
6082092|NCT00806351|Anidulafungin|anidulafungin|mesh-list
6082093|NCT00806351|Antifungal Agents|antifungal agents|mesh-ancestor
6082094|NCT00806351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6082095|NCT00806351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5514992|NCT04361721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5514993|NCT04361721|Analgesics|analgesics|mesh-ancestor
5514994|NCT04361721|Sensory System Agents|sensory system agents|mesh-ancestor
5514995|NCT04361721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6082096|NCT00806351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6082097|NCT00806442|Borage oil|borage oil|mesh-list
5514996|NCT04361721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5514997|NCT04361812|Omalizumab|omalizumab|mesh-list
5514998|NCT04361812|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5514999|NCT04361812|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5515000|NCT04361812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5515001|NCT04361812|Respiratory System Agents|respiratory system agents|mesh-ancestor
5515002|NCT04361812|Immunologic Factors|immunologic factors|mesh-ancestor
5515003|NCT04361812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082098|NCT00806442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6082099|NCT00806494|Fesoterodine|fesoterodine|mesh-list
6082100|NCT00806494|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6082101|NCT00806494|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6082102|NCT00806494|Cholinergic Agents|cholinergic agents|mesh-ancestor
6082103|NCT00806494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6082104|NCT00806494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6082105|NCT00806494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082106|NCT00806494|Urological Agents|urological agents|mesh-ancestor
6463962|NCT00467142|Irinotecan|irinotecan|mesh-list
6463963|NCT00467142|Calcium|calcium|mesh-list
6463964|NCT00467142|Levoleucovorin|levoleucovorin|mesh-list
5515004|NCT04361656|Lubiprostone|lubiprostone|mesh-list
6082107|NCT00806598|Cyclosporine|cyclosporine|mesh-list
6082108|NCT00806598|Methylprednisolone|methylprednisolone|mesh-list
6082109|NCT00806598|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6082110|NCT00806598|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6082111|NCT00806598|Prednisolone|prednisolone|mesh-list
6082112|NCT00806598|Prednisolone acetate|prednisolone acetate|mesh-list
6082113|NCT00806598|Cyclosporins|cyclosporins|mesh-list
6082114|NCT00806598|Thymoglobulin|thymoglobulin|mesh-list
6082115|NCT00806598|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6082116|NCT00806598|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6082117|NCT00806598|Prednisolone phosphate|prednisolone phosphate|mesh-list
6082118|NCT00806598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6082119|NCT00806598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6082120|NCT00806598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6082121|NCT00806598|Immunologic Factors|immunologic factors|mesh-ancestor
6082122|NCT00806598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082123|NCT00806598|Antifungal Agents|antifungal agents|mesh-ancestor
6082124|NCT00806598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6082125|NCT00806598|Dermatologic Agents|dermatologic agents|mesh-ancestor
6082126|NCT00806598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5515005|NCT04361656|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
5515006|NCT04361656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5515007|NCT04361656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515008|NCT04361643|Lenalidomide|lenalidomide|mesh-list
5515009|NCT04361643|Immunologic Factors|immunologic factors|mesh-ancestor
5515010|NCT04361643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5515011|NCT04361643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5600617|NCT03710434|Dexlansoprazole|dexlansoprazole|mesh-list
6082127|NCT00806598|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6082128|NCT00806598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6082129|NCT00806598|Antiemetics|antiemetics|mesh-ancestor
6082130|NCT00806598|Autonomic Agents|autonomic agents|mesh-ancestor
6082131|NCT00806598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6082132|NCT00806598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6082133|NCT00806598|Glucocorticoids|glucocorticoids|mesh-ancestor
6082134|NCT00806598|Hormones|hormones|mesh-ancestor
6082135|NCT00806598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6082136|NCT00806598|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6082137|NCT00806598|Protective Agents|protective agents|mesh-ancestor
6082138|NCT00806598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6082139|NCT00806598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6082140|NCT00806624|Warfarin|warfarin|mesh-list
6082141|NCT00806624|Edoxaban|edoxaban|mesh-list
6082142|NCT00806624|Anticoagulants|anticoagulants|mesh-ancestor
6082143|NCT00806624|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6082144|NCT00806624|Antithrombins|antithrombins|mesh-ancestor
6082145|NCT00806624|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6082146|NCT00806624|Protease Inhibitors|protease inhibitors|mesh-ancestor
6082147|NCT00806624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6082148|NCT00806624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6082149|NCT00806676|Vaccines|vaccines|mesh-list
6463965|NCT00467142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6082150|NCT00806676|Immunologic Factors|immunologic factors|mesh-ancestor
6082151|NCT00806676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082152|NCT00806819|Folic Acid|folic acid|mesh-list
6082153|NCT00806819|Vitamin B Complex|vitamin b complex|mesh-list
6082154|NCT00806819|Hydroxocobalamin|hydroxocobalamin|mesh-list
6082155|NCT00806819|Vitamin B 12|vitamin b 12|mesh-list
6082156|NCT00806819|Dexamethasone|dexamethasone|mesh-list
6463966|NCT00467142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6463967|NCT00467142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6463968|NCT00467142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6463969|NCT00467142|Growth Substances|growth substances|mesh-ancestor
6463970|NCT00467142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463971|NCT00467142|Growth Inhibitors|growth inhibitors|mesh-ancestor
6082157|NCT00806819|Dexamethasone acetate|dexamethasone acetate|mesh-list
6082158|NCT00806819|Pemetrexed|pemetrexed|mesh-list
6082159|NCT00806819|Nintedanib|nintedanib|mesh-list
6082160|NCT00806819|BB 1101|bb 1101|mesh-list
6082161|NCT00806819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6082162|NCT00806819|Antiemetics|antiemetics|mesh-ancestor
6082163|NCT00806819|Autonomic Agents|autonomic agents|mesh-ancestor
6082164|NCT00806819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6082165|NCT00806819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082166|NCT00806819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6082167|NCT00806819|Glucocorticoids|glucocorticoids|mesh-ancestor
6082168|NCT00806819|Hormones|hormones|mesh-ancestor
6082169|NCT00806819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6082170|NCT00806819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6082171|NCT00806819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6082172|NCT00806819|Protease Inhibitors|protease inhibitors|mesh-ancestor
6082173|NCT00806819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6082174|NCT00806819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6082175|NCT00806819|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6082176|NCT00806819|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6082177|NCT00806819|Hematinics|hematinics|mesh-ancestor
6082178|NCT00806819|Vitamins|vitamins|mesh-ancestor
6082179|NCT00806819|Micronutrients|micronutrients|mesh-ancestor
6082180|NCT00806819|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6082181|NCT00807014|Adapalene|adapalene|mesh-list
6082182|NCT00807014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6082183|NCT00807014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6082184|NCT00807014|Analgesics|analgesics|mesh-ancestor
6082185|NCT00807014|Sensory System Agents|sensory system agents|mesh-ancestor
6082186|NCT00807014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6082187|NCT00807014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082188|NCT00807014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6082189|NCT00807014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6082190|NCT00807014|Dermatologic Agents|dermatologic agents|mesh-ancestor
6202915|NCT02047500|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6202916|NCT02047500|Antimetabolites|antimetabolites|mesh-ancestor
6202917|NCT02047500|Antiviral Agents|antiviral agents|mesh-ancestor
6202918|NCT02047500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6202919|NCT02047500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6202920|NCT02047500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6202921|NCT02047500|Immunologic Factors|immunologic factors|mesh-ancestor
6202922|NCT02047500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202923|NCT02047734|Interferons|interferons|mesh-list
6202924|NCT02047734|Interferon-beta|interferon-beta|mesh-list
6202925|NCT02047734|Interferon beta-1a|interferon beta-1a|mesh-list
6202926|NCT02047734|Ozanimod|ozanimod|mesh-list
6202927|NCT02047734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6202928|NCT02047734|Antiviral Agents|antiviral agents|mesh-ancestor
6202929|NCT02047734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6202930|NCT02047734|Immunologic Factors|immunologic factors|mesh-ancestor
6202931|NCT02047734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202932|NCT02047734|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6202933|NCT02047734|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6202934|NCT02047734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202935|NCT02047734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6202936|NCT02047903|Afatinib|afatinib|mesh-list
6202937|NCT02047903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6202938|NCT02047903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6489050|NCT00589082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6202939|NCT02047903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6082191|NCT00807092|Insulin|insulin|mesh-list
6082192|NCT00807092|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6082193|NCT00807092|Metformin|metformin|mesh-list
6082194|NCT00807092|Insulin Aspart|insulin aspart|mesh-list
6082195|NCT00807092|Biphasic Insulins|biphasic insulins|mesh-list
6082196|NCT00807092|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6082197|NCT00807092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6082198|NCT00807092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082199|NCT00807144|Tacrolimus|tacrolimus|mesh-list
6082200|NCT00807144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6082201|NCT00807144|Immunologic Factors|immunologic factors|mesh-ancestor
6082202|NCT00807144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082203|NCT00807144|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6082204|NCT00807144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6082205|NCT00807144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6082206|NCT00807209|Fentanyl|fentanyl|mesh-list
6082207|NCT00807209|Bupivacaine|bupivacaine|mesh-list
6082208|NCT00807209|Anesthetics, Local|anesthetics, local|mesh-ancestor
6082209|NCT00807209|Anesthetics|anesthetics|mesh-ancestor
6082210|NCT00807209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6082211|NCT00807209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082212|NCT00807209|Sensory System Agents|sensory system agents|mesh-ancestor
6082213|NCT00807209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6082214|NCT00807209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6082215|NCT00807209|Narcotics|narcotics|mesh-ancestor
6082216|NCT00807209|Analgesics|analgesics|mesh-ancestor
6082217|NCT00807209|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6082218|NCT00807209|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6082219|NCT00807209|Anesthetics, General|anesthetics, general|mesh-ancestor
6082220|NCT00807235|Pulmonary Surfactants|pulmonary surfactants|mesh-list
6082221|NCT00807235|Respiratory System Agents|respiratory system agents|mesh-ancestor
6082222|NCT00807248|Gaboxadol|gaboxadol|mesh-list
6082223|NCT00807248|Dexetimide|dexetimide|mesh-list
6082224|NCT00807248|Citalopram|citalopram|mesh-list
6082225|NCT00807248|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6082226|NCT00807248|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6082227|NCT00807248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6082228|NCT00807248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6082229|NCT00807248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6082230|NCT00807248|Serotonin Agents|serotonin agents|mesh-ancestor
6082231|NCT00807248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082232|NCT00807248|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5515012|NCT04361643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5515013|NCT04361643|Growth Substances|growth substances|mesh-ancestor
5515014|NCT04361643|Growth Inhibitors|growth inhibitors|mesh-ancestor
5515015|NCT04361643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5515016|NCT04361513|Triamcinolone|triamcinolone|mesh-list
5515017|NCT04361513|Bupivacaine|bupivacaine|mesh-list
5515018|NCT04361513|Anesthetics, Local|anesthetics, local|mesh-ancestor
5515019|NCT04361513|Anesthetics|anesthetics|mesh-ancestor
5515020|NCT04361513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5515021|NCT04361513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5515022|NCT04361513|Sensory System Agents|sensory system agents|mesh-ancestor
5515023|NCT04361513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5515024|NCT04361513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5515025|NCT04361513|Glucocorticoids|glucocorticoids|mesh-ancestor
5515026|NCT04361513|Hormones|hormones|mesh-ancestor
5515027|NCT04361513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5515028|NCT04361175|Letrozole|letrozole|mesh-list
5515029|NCT04361175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515030|NCT04361175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5515031|NCT04361175|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5515032|NCT04361175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6082233|NCT00807248|Antidepressive Agents|antidepressive agents|mesh-ancestor
6082234|NCT00807248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6082235|NCT00807248|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6082236|NCT00807248|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6082237|NCT00807248|Parasympatholytics|parasympatholytics|mesh-ancestor
6082238|NCT00807248|Autonomic Agents|autonomic agents|mesh-ancestor
6082239|NCT00807248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6082240|NCT00807248|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6082241|NCT00807248|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6082242|NCT00807248|Cholinergic Agents|cholinergic agents|mesh-ancestor
6082243|NCT00807248|Analgesics|analgesics|mesh-ancestor
6082244|NCT00807248|Sensory System Agents|sensory system agents|mesh-ancestor
6082245|NCT00807248|Anticonvulsants|anticonvulsants|mesh-ancestor
6082246|NCT00807248|GABA Agonists|gaba agonists|mesh-ancestor
5515033|NCT04361175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5515034|NCT04361175|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5515035|NCT04361175|Hormone Antagonists|hormone antagonists|mesh-ancestor
5515036|NCT04361175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5515037|NCT04361175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5515038|NCT04361461|Azithromycin|azithromycin|mesh-list
5515039|NCT04361461|Hydroxychloroquine|hydroxychloroquine|mesh-list
5515040|NCT04361461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5515041|NCT04361461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5515042|NCT04361461|Antimalarials|antimalarials|mesh-ancestor
5515043|NCT04361461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5515044|NCT04361461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5515045|NCT04361461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5515046|NCT04361461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515047|NCT04361461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5515048|NCT04361279|Rituximab|rituximab|mesh-list
5515049|NCT04361279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5515050|NCT04361279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5515051|NCT04361279|Immunologic Factors|immunologic factors|mesh-ancestor
5515052|NCT04361279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5515053|NCT04361279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5515054|NCT04361188|Anesthetics|anesthetics|mesh-list
5515055|NCT04361188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5515056|NCT04361188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5515057|NCT04361422|Isotretinoin|isotretinoin|mesh-list
5515058|NCT04361422|Dermatologic Agents|dermatologic agents|mesh-ancestor
5515059|NCT04361331|Lenvatinib|lenvatinib|mesh-list
5515060|NCT04361331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5515061|NCT04361331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5515062|NCT04361331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5515063|NCT04361331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515064|NCT04361214|Leflunomide|leflunomide|mesh-list
5515065|NCT04361214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5515066|NCT04361214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515067|NCT04361214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5515068|NCT04361214|Immunologic Factors|immunologic factors|mesh-ancestor
5515069|NCT04361214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5515070|NCT04361305|Tadalafil|tadalafil|mesh-list
5515071|NCT04361305|Vasodilator Agents|vasodilator agents|mesh-ancestor
5515072|NCT04361305|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5515073|NCT04361305|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5515074|NCT04361305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5515075|NCT04361305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515076|NCT04361305|Urological Agents|urological agents|mesh-ancestor
6082247|NCT00807248|GABA Agents|gaba agents|mesh-ancestor
6082248|NCT00807573|Paclitaxel|paclitaxel|mesh-list
6082249|NCT00807573|Bevacizumab|bevacizumab|mesh-list
6082250|NCT00807573|Pemetrexed|pemetrexed|mesh-list
6082251|NCT00807573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6082252|NCT00807573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6082253|NCT00807573|Tubulin Modulators|tubulin modulators|mesh-ancestor
6082254|NCT00807573|Antimitotic Agents|antimitotic agents|mesh-ancestor
6082255|NCT00807573|Mitosis Modulators|mitosis modulators|mesh-ancestor
6082256|NCT00807573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6082257|NCT00807573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6082258|NCT00807573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6082259|NCT00807573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6082260|NCT00807573|Growth Substances|growth substances|mesh-ancestor
6082261|NCT00807573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082262|NCT00807573|Growth Inhibitors|growth inhibitors|mesh-ancestor
6082263|NCT00807573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6082264|NCT00807573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6082265|NCT00807573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6082266|NCT00807586|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6082267|NCT00807586|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6082268|NCT00807586|Methylprednisolone|methylprednisolone|mesh-list
6082269|NCT00807586|Prednisolone|prednisolone|mesh-list
6665518|NCT01517555|Analgesics|analgesics|mesh-ancestor
6665519|NCT01517555|Sensory System Agents|sensory system agents|mesh-ancestor
6665520|NCT01517555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5515077|NCT04361370|Bevacizumab|bevacizumab|mesh-list
5515078|NCT04361370|Pembrolizumab|pembrolizumab|mesh-list
5515079|NCT04361370|Olaparib|olaparib|mesh-list
5515080|NCT04361370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5515081|NCT04361370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5515082|NCT04361370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5515083|NCT04361370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6665521|NCT01517555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665522|NCT01517555|Antipyretics|antipyretics|mesh-ancestor
6665523|NCT01517555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6665524|NCT01517555|Incretins|incretins|mesh-ancestor
6665525|NCT01517555|Hormones|hormones|mesh-ancestor
6665526|NCT01517555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6665527|NCT01517568|Liraglutide|liraglutide|mesh-list
6082270|NCT00807586|Prednisolone acetate|prednisolone acetate|mesh-list
6082271|NCT00807586|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6082272|NCT00807586|Prednisolone phosphate|prednisolone phosphate|mesh-list
6082273|NCT00807586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6082274|NCT00807586|Glucocorticoids|glucocorticoids|mesh-ancestor
6082275|NCT00807586|Hormones|hormones|mesh-ancestor
6082276|NCT00807586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6082277|NCT00807586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082278|NCT00807586|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6082279|NCT00807586|Protective Agents|protective agents|mesh-ancestor
6082280|NCT00807586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6082281|NCT00807586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6082282|NCT00807586|Antiemetics|antiemetics|mesh-ancestor
6082283|NCT00807586|Autonomic Agents|autonomic agents|mesh-ancestor
6082284|NCT00807586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6082285|NCT00807586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6082286|NCT00807599|Dexamethasone|dexamethasone|mesh-list
5515084|NCT04361370|Growth Substances|growth substances|mesh-ancestor
5515085|NCT04361370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5515086|NCT04361370|Growth Inhibitors|growth inhibitors|mesh-ancestor
5515087|NCT04361370|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5515088|NCT04361370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5515089|NCT04361370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515090|NCT04361318|Hydroxychloroquine|hydroxychloroquine|mesh-list
5515091|NCT04361318|Nitazoxanide|nitazoxanide|mesh-list
5515092|NCT04361318|Antimalarials|antimalarials|mesh-ancestor
6082287|NCT00807599|Dexamethasone acetate|dexamethasone acetate|mesh-list
6082288|NCT00807599|Lenalidomide|lenalidomide|mesh-list
6082289|NCT00807599|Melphalan|melphalan|mesh-list
6082290|NCT00807599|BB 1101|bb 1101|mesh-list
6082291|NCT00807599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6082292|NCT00807599|Antiemetics|antiemetics|mesh-ancestor
6082293|NCT00807599|Autonomic Agents|autonomic agents|mesh-ancestor
6082294|NCT00807599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6082295|NCT00807599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082296|NCT00807599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6082297|NCT00807599|Glucocorticoids|glucocorticoids|mesh-ancestor
6082298|NCT00807599|Hormones|hormones|mesh-ancestor
6082299|NCT00807599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6082300|NCT00807599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6082301|NCT00807599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6082302|NCT00807599|Protease Inhibitors|protease inhibitors|mesh-ancestor
6082303|NCT00807599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6082304|NCT00807599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6082305|NCT00807599|Immunologic Factors|immunologic factors|mesh-ancestor
6082306|NCT00807599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6082307|NCT00807599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6082308|NCT00807599|Growth Substances|growth substances|mesh-ancestor
6082309|NCT00807599|Growth Inhibitors|growth inhibitors|mesh-ancestor
6082310|NCT00807599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6082311|NCT00807599|Alkylating Agents|alkylating agents|mesh-ancestor
6082312|NCT00807599|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6082313|NCT00807599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6082314|NCT00807742|Nicotine|nicotine|mesh-list
6082315|NCT00807742|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6082316|NCT00807742|Autonomic Agents|autonomic agents|mesh-ancestor
6082317|NCT00807742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6082318|NCT00807742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665528|NCT01517568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5515093|NCT04361318|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5515094|NCT04361318|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5515095|NCT04361318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5515096|NCT04361318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5515097|NCT04361318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515098|NCT04361318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5515099|NCT04361149|Capsaicin|capsaicin|mesh-list
6082319|NCT00807742|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6082320|NCT00807742|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6463972|NCT00467142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6463973|NCT00467142|Antimetabolites|antimetabolites|mesh-ancestor
6463974|NCT00467142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463975|NCT00467142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6082321|NCT00807742|Cholinergic Agents|cholinergic agents|mesh-ancestor
6082322|NCT00807742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6082323|NCT00807742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6082324|NCT00807768|Paclitaxel|paclitaxel|mesh-list
6082325|NCT00807768|Carboplatin|carboplatin|mesh-list
6082326|NCT00807768|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6082327|NCT00807768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6082328|NCT00807768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6082329|NCT00807768|Tubulin Modulators|tubulin modulators|mesh-ancestor
6082330|NCT00807768|Antimitotic Agents|antimitotic agents|mesh-ancestor
6082331|NCT00807768|Mitosis Modulators|mitosis modulators|mesh-ancestor
6082332|NCT00807768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6082333|NCT00807846|Celecoxib|celecoxib|mesh-list
6082334|NCT00807846|Naproxen|naproxen|mesh-list
6082335|NCT00807846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6082336|NCT00807846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6082337|NCT00807846|Analgesics|analgesics|mesh-ancestor
6082338|NCT00807846|Sensory System Agents|sensory system agents|mesh-ancestor
6082339|NCT00807846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6082340|NCT00807846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082341|NCT00807846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6082342|NCT00807846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6082343|NCT00807846|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6082344|NCT00807846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6082345|NCT00807846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6082346|NCT00807846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6082347|NCT00807846|Gout Suppressants|gout suppressants|mesh-ancestor
6082348|NCT00807937|Lorazepam|lorazepam|mesh-list
6082349|NCT00807937|Anticonvulsants|anticonvulsants|mesh-ancestor
6082350|NCT00807937|Antiemetics|antiemetics|mesh-ancestor
5515100|NCT04361149|Antipruritics|antipruritics|mesh-ancestor
5515101|NCT04361149|Dermatologic Agents|dermatologic agents|mesh-ancestor
5515102|NCT04361149|Sensory System Agents|sensory system agents|mesh-ancestor
5515103|NCT04361149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5515104|NCT04361149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5515105|NCT04361474|Budesonide|budesonide|mesh-list
5515106|NCT04361474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5515107|NCT04361474|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5515108|NCT04361474|Autonomic Agents|autonomic agents|mesh-ancestor
5515109|NCT04361474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6082351|NCT00807937|Autonomic Agents|autonomic agents|mesh-ancestor
6082352|NCT00807937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6082353|NCT00807937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082354|NCT00807937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6082355|NCT00807937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6082356|NCT00807937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6082357|NCT00807937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5515110|NCT04361474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5515111|NCT04361474|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5515112|NCT04361474|Respiratory System Agents|respiratory system agents|mesh-ancestor
5515113|NCT04361474|Glucocorticoids|glucocorticoids|mesh-ancestor
5515114|NCT04361474|Hormones|hormones|mesh-ancestor
5515115|NCT04361474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5515116|NCT04361058|Nivolumab|nivolumab|mesh-list
5515117|NCT04361058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6082358|NCT00807937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6082359|NCT00807937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5515118|NCT04361058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6082360|NCT00807937|GABA Modulators|gaba modulators|mesh-ancestor
6082361|NCT00807937|GABA Agents|gaba agents|mesh-ancestor
6082362|NCT00807937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6082363|NCT00807937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6082364|NCT00807989|Lamotrigine|lamotrigine|mesh-list
6082365|NCT00807989|Carbamazepine|carbamazepine|mesh-list
6082366|NCT00807989|Valproic Acid|valproic acid|mesh-list
6082367|NCT00807989|Anticonvulsants|anticonvulsants|mesh-ancestor
6082368|NCT00807989|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6082369|NCT00807989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6082370|NCT00807989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6082371|NCT00807989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6082372|NCT00807989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082373|NCT00807989|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6082374|NCT00807989|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6082375|NCT00807989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6082376|NCT00807989|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6082377|NCT00807989|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6082378|NCT00807989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6082379|NCT00807989|GABA Agents|gaba agents|mesh-ancestor
5515119|NCT04361058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5600618|NCT03710434|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6082380|NCT00807989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6082381|NCT00807989|Antimanic Agents|antimanic agents|mesh-ancestor
6082382|NCT00807989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6082383|NCT00807989|Analgesics|analgesics|mesh-ancestor
6082384|NCT00807989|Sensory System Agents|sensory system agents|mesh-ancestor
6082385|NCT00807989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6082386|NCT00807989|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6082387|NCT00807989|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6082388|NCT00808015|Varenicline|varenicline|mesh-list
6082389|NCT00808015|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6082390|NCT00808015|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6082391|NCT00808015|Cholinergic Agents|cholinergic agents|mesh-ancestor
6082392|NCT00808015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6082393|NCT00808015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6082394|NCT00808015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082395|NCT00808028|Vaccines|vaccines|mesh-list
6082396|NCT00808028|Immunologic Factors|immunologic factors|mesh-ancestor
6082397|NCT00808028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082398|NCT00808067|Dabigatran|dabigatran|mesh-list
6082399|NCT00808067|Antithrombins|antithrombins|mesh-ancestor
6082400|NCT00808067|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6082401|NCT00808067|Protease Inhibitors|protease inhibitors|mesh-ancestor
6082402|NCT00808067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6082403|NCT00808067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6082404|NCT00808067|Anticoagulants|anticoagulants|mesh-ancestor
6082405|NCT00808132|Bazedoxifene|bazedoxifene|mesh-list
6082406|NCT00808132|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6082407|NCT00808132|Medroxyprogesterone|medroxyprogesterone|mesh-list
6082408|NCT00808132|Estrogens|estrogens|mesh-list
6082409|NCT00808132|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6082410|NCT00808132|Hormones|hormones|mesh-ancestor
6082411|NCT00808132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6082412|NCT00808132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082413|NCT00808132|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6082414|NCT00808132|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6082415|NCT00808132|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6082416|NCT00808132|Contraceptive Agents|contraceptive agents|mesh-ancestor
6082417|NCT00808132|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6082418|NCT00808132|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6082419|NCT00808132|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6082420|NCT00808132|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6082421|NCT00808132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6082422|NCT00808132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6082423|NCT00808132|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6082424|NCT00808132|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6082425|NCT00808132|Hormone Antagonists|hormone antagonists|mesh-ancestor
6082426|NCT00808132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6082427|NCT00808210|Methylprednisolone|methylprednisolone|mesh-list
6082428|NCT00808210|Methotrexate|methotrexate|mesh-list
6082429|NCT00808210|Infliximab|infliximab|mesh-list
6082430|NCT00808210|Ocrelizumab|ocrelizumab|mesh-list
6082431|NCT00808210|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6082432|NCT00808210|Abortifacient Agents|abortifacient agents|mesh-ancestor
6082433|NCT00808210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5515120|NCT04361058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515121|NCT04360681|Lofexidine|lofexidine|mesh-list
5515122|NCT04360681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5515123|NCT04360681|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5515124|NCT04360681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5515125|NCT04360681|Sensory System Agents|sensory system agents|mesh-ancestor
6082434|NCT00808210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082435|NCT00808210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6082436|NCT00808210|Antimetabolites|antimetabolites|mesh-ancestor
6082437|NCT00808210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6082438|NCT00808210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6082439|NCT00808210|Dermatologic Agents|dermatologic agents|mesh-ancestor
6082440|NCT00808210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6082441|NCT00808210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6082442|NCT00808210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6082443|NCT00808210|Immunologic Factors|immunologic factors|mesh-ancestor
6082444|NCT00808210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6082445|NCT00808210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6082446|NCT00808210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6082447|NCT00808210|Antiemetics|antiemetics|mesh-ancestor
6082448|NCT00808210|Autonomic Agents|autonomic agents|mesh-ancestor
6082449|NCT00808210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6082450|NCT00808210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6082451|NCT00808210|Glucocorticoids|glucocorticoids|mesh-ancestor
6082452|NCT00808210|Hormones|hormones|mesh-ancestor
6082453|NCT00808210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6082454|NCT00808210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6082455|NCT00808210|Protective Agents|protective agents|mesh-ancestor
6082456|NCT00808405|Acyclovir|acyclovir|mesh-list
6082457|NCT00808405|Antiviral Agents|antiviral agents|mesh-ancestor
6082458|NCT00808405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6082459|NCT00808444|Vaccines|vaccines|mesh-list
6082460|NCT00808444|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6082461|NCT00808444|Immunologic Factors|immunologic factors|mesh-ancestor
5515126|NCT04360681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5515127|NCT04360681|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5515128|NCT04360681|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5515129|NCT04360681|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5515130|NCT04360681|Adrenergic Agents|adrenergic agents|mesh-ancestor
5515131|NCT04360681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5515132|NCT04360681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515133|NCT04361409|Gemcitabine|gemcitabine|mesh-list
5515134|NCT04361409|Rituximab|rituximab|mesh-list
5515135|NCT04361409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6082462|NCT00808444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082463|NCT00808470|Ascorbic Acid|ascorbic acid|mesh-list
6082464|NCT00808470|Beta Carotene|beta carotene|mesh-list
6082465|NCT00808470|Carotenoids|carotenoids|mesh-list
6082466|NCT00808470|Vitamins|vitamins|mesh-ancestor
6082467|NCT00808470|Micronutrients|micronutrients|mesh-ancestor
5515136|NCT04361409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5515137|NCT04361409|Immunologic Factors|immunologic factors|mesh-ancestor
5515138|NCT04361409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5515139|NCT04361409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5515140|NCT04361409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5515141|NCT04361409|Antimetabolites|antimetabolites|mesh-ancestor
5515142|NCT04361409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515143|NCT04361409|Antiviral Agents|antiviral agents|mesh-ancestor
5515144|NCT04361409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5515145|NCT04361409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6082468|NCT00808470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082469|NCT00808470|Antioxidants|antioxidants|mesh-ancestor
6082470|NCT00808470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6082471|NCT00808470|Protective Agents|protective agents|mesh-ancestor
6082472|NCT00808470|Provitamins|provitamins|mesh-ancestor
6082473|NCT00808509|Adalimumab|adalimumab|mesh-list
6082474|NCT00808509|Methotrexate|methotrexate|mesh-list
6082475|NCT00808509|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6082476|NCT00808509|Abortifacient Agents|abortifacient agents|mesh-ancestor
6082477|NCT00808509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6082478|NCT00808509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082479|NCT00808509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6082480|NCT00808509|Antimetabolites|antimetabolites|mesh-ancestor
6082481|NCT00808509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6082482|NCT00808509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6082483|NCT00808509|Dermatologic Agents|dermatologic agents|mesh-ancestor
6082484|NCT00808509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6082485|NCT00808509|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6082486|NCT00808509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6082487|NCT00808509|Immunologic Factors|immunologic factors|mesh-ancestor
6082488|NCT00808509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6082489|NCT00808509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6082490|NCT00808509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6082491|NCT00808639|Doxorubicin|doxorubicin|mesh-list
6082492|NCT00808639|Methotrexate|methotrexate|mesh-list
6082493|NCT00808639|Vinblastine|vinblastine|mesh-list
6082494|NCT00808639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6082495|NCT00808639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6082496|NCT00808639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6082497|NCT00808639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6082498|NCT00808639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6082499|NCT00808639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6082500|NCT00808639|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6082501|NCT00808639|Abortifacient Agents|abortifacient agents|mesh-ancestor
6082502|NCT00808639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6082503|NCT00808639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082504|NCT00808639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6082505|NCT00808639|Antimetabolites|antimetabolites|mesh-ancestor
6082506|NCT00808639|Dermatologic Agents|dermatologic agents|mesh-ancestor
6082507|NCT00808639|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6082508|NCT00808639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6082509|NCT00808639|Immunologic Factors|immunologic factors|mesh-ancestor
6082510|NCT00808639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6082511|NCT00808639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6082512|NCT00808639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6082513|NCT00808639|Tubulin Modulators|tubulin modulators|mesh-ancestor
6082514|NCT00808639|Antimitotic Agents|antimitotic agents|mesh-ancestor
6082515|NCT00808639|Mitosis Modulators|mitosis modulators|mesh-ancestor
6082516|NCT00808665|Dexmedetomidine|dexmedetomidine|mesh-list
6082517|NCT00808665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6082518|NCT00808665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6082519|NCT00808665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082520|NCT00808665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6082521|NCT00808665|Analgesics|analgesics|mesh-ancestor
6082522|NCT00808665|Sensory System Agents|sensory system agents|mesh-ancestor
6082523|NCT00808665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6082524|NCT00808665|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6082525|NCT00808665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6082526|NCT00808665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6082527|NCT00808665|Adrenergic Agents|adrenergic agents|mesh-ancestor
6082528|NCT00808665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6082529|NCT00808665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6082530|NCT00809055|Caffeine|caffeine|mesh-list
6082531|NCT00809055|Caffeine citrate|caffeine citrate|mesh-list
6082532|NCT00809055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515146|NCT04361409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5515147|NCT04361162|Nivolumab|nivolumab|mesh-list
5515148|NCT04361162|Ipilimumab|ipilimumab|mesh-list
5515149|NCT04361162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5515150|NCT04361162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5515151|NCT04361162|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5515152|NCT04361162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515153|NCT04360759|Hydroxychloroquine|hydroxychloroquine|mesh-list
5515154|NCT04360759|Chloroquine|chloroquine|mesh-list
5515155|NCT04360759|Antimalarials|antimalarials|mesh-ancestor
5515156|NCT04360759|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5515157|NCT04360759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5515158|NCT04360759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5515159|NCT04360759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5515160|NCT04360759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6082533|NCT00809055|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6082534|NCT00809055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082535|NCT00809055|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6082536|NCT00809055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6082537|NCT00809055|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6082538|NCT00809055|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5515161|NCT04360759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5515162|NCT04360759|Amebicides|amebicides|mesh-ancestor
5515163|NCT04361032|Deferoxamine|deferoxamine|mesh-list
5515164|NCT04361032|Siderophores|siderophores|mesh-ancestor
5515165|NCT04361032|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5515166|NCT04361032|Chelating Agents|chelating agents|mesh-ancestor
6082539|NCT00809055|Purinergic Agents|purinergic agents|mesh-ancestor
6082540|NCT00809055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6082541|NCT00809094|Acetylcysteine|acetylcysteine|mesh-list
6082542|NCT00809094|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6082543|NCT00809094|Antiviral Agents|antiviral agents|mesh-ancestor
6082544|NCT00809094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6082545|NCT00809094|Expectorants|expectorants|mesh-ancestor
6082546|NCT00809094|Respiratory System Agents|respiratory system agents|mesh-ancestor
6082547|NCT00809094|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6082548|NCT00809094|Antioxidants|antioxidants|mesh-ancestor
6082549|NCT00809094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6082550|NCT00809094|Protective Agents|protective agents|mesh-ancestor
6082551|NCT00809094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082552|NCT00809094|Antidotes|antidotes|mesh-ancestor
6082553|NCT00809133|Paclitaxel|paclitaxel|mesh-list
6082554|NCT00809133|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6082555|NCT00809133|Bevacizumab|bevacizumab|mesh-list
6082556|NCT00809133|Carboplatin|carboplatin|mesh-list
6082557|NCT00809133|Afatinib|afatinib|mesh-list
6082558|NCT00809133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6082559|NCT00809133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6082560|NCT00809133|Tubulin Modulators|tubulin modulators|mesh-ancestor
6082561|NCT00809133|Antimitotic Agents|antimitotic agents|mesh-ancestor
6082562|NCT00809133|Mitosis Modulators|mitosis modulators|mesh-ancestor
6082563|NCT00809133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6082564|NCT00809133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6082565|NCT00809133|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6082566|NCT00809133|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6082567|NCT00809133|Growth Substances|growth substances|mesh-ancestor
6082568|NCT00809133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082569|NCT00809133|Growth Inhibitors|growth inhibitors|mesh-ancestor
6082570|NCT00809133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6082571|NCT00809133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6082572|NCT00809185|Everolimus|everolimus|mesh-list
5515167|NCT04361032|Sequestering Agents|sequestering agents|mesh-ancestor
5515168|NCT04361032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515169|NCT04360941|Palbociclib|palbociclib|mesh-list
5515170|NCT04360941|Avelumab|avelumab|mesh-list
5515171|NCT04360941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5515172|NCT04360941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5515173|NCT04360941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5515174|NCT04360941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515175|NCT04360941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5515176|NCT04360824|Enoxaparin|enoxaparin|mesh-list
5515177|NCT04360824|Anticoagulants|anticoagulants|mesh-ancestor
5515178|NCT04360824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5515179|NCT04360824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5515180|NCT04360824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6082573|NCT00809185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6082574|NCT00809185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6082575|NCT00809185|Immunologic Factors|immunologic factors|mesh-ancestor
6082576|NCT00809185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082577|NCT00809276|Cyclophosphamide|cyclophosphamide|mesh-list
6082578|NCT00809276|Busulfan|busulfan|mesh-list
6082579|NCT00809276|Fludarabine|fludarabine|mesh-list
6082580|NCT00809276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6082581|NCT00809276|Immunologic Factors|immunologic factors|mesh-ancestor
6082582|NCT00809276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082583|NCT00809276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6082584|NCT00809276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6082585|NCT00809276|Alkylating Agents|alkylating agents|mesh-ancestor
6082586|NCT00809276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515181|NCT04360889|Tocopherols|tocopherols|mesh-list
6082587|NCT00809276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5515182|NCT04360889|Vitamin E|vitamin e|mesh-list
6082588|NCT00809276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6082589|NCT00809328|Azithromycin|azithromycin|mesh-list
6082590|NCT00809328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6082591|NCT00809328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6082592|NCT00809354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
6082593|NCT00809354|Tanezumab|tanezumab|mesh-list
6082594|NCT00809354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6082595|NCT00809354|Analgesics|analgesics|mesh-ancestor
6082596|NCT00809354|Sensory System Agents|sensory system agents|mesh-ancestor
6082597|NCT00809354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6082598|NCT00809354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082599|NCT00809354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6082600|NCT00809354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6082601|NCT00809757|Albuterol|albuterol|mesh-list
6082602|NCT00809757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6082603|NCT00809757|Autonomic Agents|autonomic agents|mesh-ancestor
6082604|NCT00809757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6082605|NCT00809757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082606|NCT00809757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6082607|NCT00809757|Respiratory System Agents|respiratory system agents|mesh-ancestor
6082608|NCT00809757|Tocolytic Agents|tocolytic agents|mesh-ancestor
6082609|NCT00809757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6082610|NCT00809757|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6082611|NCT00809757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6082612|NCT00809757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6082613|NCT00809757|Adrenergic Agents|adrenergic agents|mesh-ancestor
6082614|NCT00809757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6082615|NCT00809757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6082616|NCT00809783|Tanezumab|tanezumab|mesh-list
6082617|NCT00809783|Analgesics|analgesics|mesh-ancestor
6082618|NCT00809783|Sensory System Agents|sensory system agents|mesh-ancestor
6082619|NCT00809783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6082620|NCT00809783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082621|NCT00809809|Zinc|zinc|mesh-list
6082622|NCT00809809|Trace Elements|trace elements|mesh-ancestor
6082623|NCT00809809|Micronutrients|micronutrients|mesh-ancestor
6082624|NCT00809809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082625|NCT00809835|Galantamine|galantamine|mesh-list
6082626|NCT00809835|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6082627|NCT00809835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6082628|NCT00809835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6082629|NCT00809835|Cholinergic Agents|cholinergic agents|mesh-ancestor
6082630|NCT00809835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6082631|NCT00809835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082632|NCT00809835|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6082633|NCT00809835|Autonomic Agents|autonomic agents|mesh-ancestor
6082634|NCT00809835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6082635|NCT00809835|Nootropic Agents|nootropic agents|mesh-ancestor
6082636|NCT00809848|Bimatoprost|bimatoprost|mesh-list
6082637|NCT00809848|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6082638|NCT00809848|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6082639|NCT00809848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6082640|NCT00809926|Valsartan|valsartan|mesh-list
6082641|NCT00809926|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6082642|NCT00809926|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6082643|NCT00809926|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6082644|NCT00809926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6082645|NCT00809965|Rivaroxaban|rivaroxaban|mesh-list
6082646|NCT00809965|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6082647|NCT00809965|Antithrombins|antithrombins|mesh-ancestor
6082648|NCT00809965|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6082649|NCT00809965|Protease Inhibitors|protease inhibitors|mesh-ancestor
5515183|NCT04360889|Tocotrienols|tocotrienols|mesh-list
5515184|NCT04360889|alpha-Tocopherol|alpha-tocopherol|mesh-list
5515185|NCT04360889|Antioxidants|antioxidants|mesh-ancestor
5515186|NCT04360889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515187|NCT04360889|Protective Agents|protective agents|mesh-ancestor
5515188|NCT04360889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5515189|NCT04360889|Vitamins|vitamins|mesh-ancestor
5515190|NCT04360889|Micronutrients|micronutrients|mesh-ancestor
5515191|NCT04360785|Methotrexate|methotrexate|mesh-list
5515192|NCT04360785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6082650|NCT00809965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6082651|NCT00809965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6082652|NCT00809965|Anticoagulants|anticoagulants|mesh-ancestor
6082653|NCT00810069|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5515193|NCT04360785|Abortifacient Agents|abortifacient agents|mesh-ancestor
5515194|NCT04360785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5515195|NCT04360785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5515196|NCT04360785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5515197|NCT04360785|Antimetabolites|antimetabolites|mesh-ancestor
5515198|NCT04360785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515199|NCT04360785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5515200|NCT04360785|Dermatologic Agents|dermatologic agents|mesh-ancestor
5515201|NCT04360785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5515202|NCT04360785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5515203|NCT04360785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5515204|NCT04360785|Immunologic Factors|immunologic factors|mesh-ancestor
5515205|NCT04360785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5515206|NCT04360785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5515207|NCT04360655|Antibodies|antibodies|mesh-list
5515208|NCT04360655|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5515209|NCT04360655|Immunologic Factors|immunologic factors|mesh-ancestor
5515210|NCT04360655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5515211|NCT04360317|Docetaxel|docetaxel|mesh-list
5515212|NCT04360317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5515213|NCT04360317|Tubulin Modulators|tubulin modulators|mesh-ancestor
5515214|NCT04360317|Antimitotic Agents|antimitotic agents|mesh-ancestor
5515215|NCT04360317|Mitosis Modulators|mitosis modulators|mesh-ancestor
5515216|NCT04360317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515217|NCT04360551|Telmisartan|telmisartan|mesh-list
5515218|NCT04360551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6082654|NCT00810069|Citalopram|citalopram|mesh-list
6082655|NCT00810069|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6082656|NCT00810069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6082657|NCT00810069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6082658|NCT00810069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6082659|NCT00810069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6082660|NCT00810069|Serotonin Agents|serotonin agents|mesh-ancestor
6082661|NCT00810069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082662|NCT00810069|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6082663|NCT00810069|Antidepressive Agents|antidepressive agents|mesh-ancestor
6082664|NCT00810069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6082665|NCT00810069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6082666|NCT00810069|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6082667|NCT00810069|Analgesics|analgesics|mesh-ancestor
6082668|NCT00810069|Sensory System Agents|sensory system agents|mesh-ancestor
6082669|NCT00810069|Dopamine Agents|dopamine agents|mesh-ancestor
6082670|NCT00810108|Ritonavir|ritonavir|mesh-list
6082671|NCT00810108|Lopinavir|lopinavir|mesh-list
6082672|NCT00810108|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6082673|NCT00810108|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6082674|NCT00810108|Protease Inhibitors|protease inhibitors|mesh-ancestor
6082675|NCT00810108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6082676|NCT00810108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6082677|NCT00810108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6082678|NCT00810108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6082679|NCT00810108|Antiviral Agents|antiviral agents|mesh-ancestor
6082680|NCT00810108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6082681|NCT00810108|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6082682|NCT00810108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6082683|NCT00810199|Methotrexate|methotrexate|mesh-list
6082684|NCT00810199|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6082685|NCT00810199|Abortifacient Agents|abortifacient agents|mesh-ancestor
6082686|NCT00810199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5515219|NCT04360551|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5515220|NCT04360551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5515221|NCT04360551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515222|NCT04360421|Bupivacaine|bupivacaine|mesh-list
5515223|NCT04360421|Anesthetics, Local|anesthetics, local|mesh-ancestor
5515224|NCT04360421|Anesthetics|anesthetics|mesh-ancestor
5515225|NCT04360421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5515226|NCT04360421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5515227|NCT04360421|Sensory System Agents|sensory system agents|mesh-ancestor
5515228|NCT04360421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5515229|NCT04360473|Magnesium Sulfate|magnesium sulfate|mesh-list
5515230|NCT04360473|Ketamine|ketamine|mesh-list
5515231|NCT04360473|Anesthetics|anesthetics|mesh-list
5515232|NCT04360473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5515233|NCT04360473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5515234|NCT04360473|Analgesics|analgesics|mesh-ancestor
5515235|NCT04360473|Sensory System Agents|sensory system agents|mesh-ancestor
5515236|NCT04360473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5515237|NCT04360473|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5515238|NCT04360473|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5515239|NCT04360473|Anesthetics, General|anesthetics, general|mesh-ancestor
5515240|NCT04360473|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5515241|NCT04360473|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5515242|NCT04360473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5515243|NCT04360473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515244|NCT04360473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5515245|NCT04360473|Anticonvulsants|anticonvulsants|mesh-ancestor
5515246|NCT04360473|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5515247|NCT04360473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5515248|NCT04360473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5515249|NCT04360473|Tocolytic Agents|tocolytic agents|mesh-ancestor
5515250|NCT04360473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5515251|NCT04359979|Tamsulosin|tamsulosin|mesh-list
6082687|NCT00810199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082688|NCT00810199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6082689|NCT00810199|Antimetabolites|antimetabolites|mesh-ancestor
6082690|NCT00810199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6082691|NCT00810199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6082692|NCT00810199|Dermatologic Agents|dermatologic agents|mesh-ancestor
6082693|NCT00810199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6082694|NCT00810199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6082695|NCT00810199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6082696|NCT00810199|Immunologic Factors|immunologic factors|mesh-ancestor
5515252|NCT04359979|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5515253|NCT04359979|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5515254|NCT04359979|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5515255|NCT04359979|Adrenergic Agents|adrenergic agents|mesh-ancestor
5515256|NCT04359979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5515257|NCT04359979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515258|NCT04359979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5515259|NCT04359979|Urological Agents|urological agents|mesh-ancestor
5600619|NCT03710434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5600620|NCT03710434|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5600621|NCT03710434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6082697|NCT00810199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6082698|NCT00810199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6082699|NCT00810303|Efavirenz|efavirenz|mesh-list
6082700|NCT00810303|Ezetimibe|ezetimibe|mesh-list
6082701|NCT00810303|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6082702|NCT00810303|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6082703|NCT00810303|Antimetabolites|antimetabolites|mesh-ancestor
6082704|NCT00810303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6082705|NCT00810303|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6082706|NCT00810303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6082707|NCT00810303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6082708|NCT00810303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6082709|NCT00810303|Antiviral Agents|antiviral agents|mesh-ancestor
6082710|NCT00810303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6082711|NCT00810303|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6082712|NCT00810303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6082713|NCT00810303|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6082714|NCT00810303|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6082715|NCT00810303|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6082716|NCT00810303|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6082717|NCT00810394|Sorafenib|sorafenib|mesh-list
6082718|NCT00810394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6082719|NCT00810394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6082720|NCT00810394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6082721|NCT00810394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6082722|NCT00810407|Rifabutin|rifabutin|mesh-list
6082723|NCT00810407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6082724|NCT00810407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6082725|NCT00810407|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6082726|NCT00810407|Antitubercular Agents|antitubercular agents|mesh-ancestor
6082727|NCT00810576|Bortezomib|bortezomib|mesh-list
6082728|NCT00810576|Vorinostat|vorinostat|mesh-list
6082729|NCT00810576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6082730|NCT00810576|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5515260|NCT04360070|Ketamine|ketamine|mesh-list
5515261|NCT04360070|Analgesics|analgesics|mesh-ancestor
5515262|NCT04360070|Sensory System Agents|sensory system agents|mesh-ancestor
5515263|NCT04360070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5515264|NCT04360070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5515265|NCT04360070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5515266|NCT04360070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5515267|NCT04360070|Anesthetics, General|anesthetics, general|mesh-ancestor
5515268|NCT04360070|Anesthetics|anesthetics|mesh-ancestor
5515269|NCT04360070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5515270|NCT04360070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5515271|NCT04360070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6082731|NCT00810576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6082732|NCT00810576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6082733|NCT00810602|Vorinostat|vorinostat|mesh-list
6082734|NCT00810602|Tacrolimus|tacrolimus|mesh-list
6082735|NCT00810602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6082736|NCT00810602|Immunologic Factors|immunologic factors|mesh-ancestor
6082737|NCT00810602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082738|NCT00810602|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6082739|NCT00810602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6082740|NCT00810602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6082741|NCT00810602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6082742|NCT00810602|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6463976|NCT00467142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6463977|NCT00467142|Immunologic Factors|immunologic factors|mesh-ancestor
6463978|NCT00467142|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6463979|NCT00467142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6463980|NCT00467142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6463981|NCT00467142|Antidotes|antidotes|mesh-ancestor
6463982|NCT00467142|Protective Agents|protective agents|mesh-ancestor
6082743|NCT00810693|Riociguat|riociguat|mesh-list
6082744|NCT00810693|Enzyme Activators|enzyme activators|mesh-ancestor
6082745|NCT00810693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6082746|NCT00810719|Gemcitabine|gemcitabine|mesh-list
6082747|NCT00810719|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6082748|NCT00810719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6082749|NCT00810719|Antimetabolites|antimetabolites|mesh-ancestor
6082750|NCT00810719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6082751|NCT00810719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6082752|NCT00810719|Antiviral Agents|antiviral agents|mesh-ancestor
6082753|NCT00810719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6082754|NCT00810719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6082755|NCT00810719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6082756|NCT00810719|Immunologic Factors|immunologic factors|mesh-ancestor
6082757|NCT00810719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082758|NCT00810719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6082759|NCT00810797|Exemestane|exemestane|mesh-list
6082760|NCT00810797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6082761|NCT00810797|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6082762|NCT00810797|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6082763|NCT00810797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6082764|NCT00810797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6082765|NCT00810797|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6082766|NCT00810797|Hormone Antagonists|hormone antagonists|mesh-ancestor
6082767|NCT00810797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6082768|NCT00810797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082769|NCT00811018|Sitaxsentan|sitaxsentan|mesh-list
6082770|NCT00811018|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6082771|NCT00811018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6082772|NCT00811057|Indomethacin|indomethacin|mesh-list
6082773|NCT00811057|Magnesium Sulfate|magnesium sulfate|mesh-list
6463983|NCT00467142|Vitamin B Complex|vitamin b complex|mesh-ancestor
5515272|NCT04360070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5515273|NCT04360070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515274|NCT04359953|Azithromycin|azithromycin|mesh-list
5515275|NCT04359953|Hydroxychloroquine|hydroxychloroquine|mesh-list
5515276|NCT04359953|Telmisartan|telmisartan|mesh-list
5515277|NCT04359953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5515278|NCT04359953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5515279|NCT04359953|Antimalarials|antimalarials|mesh-ancestor
5515280|NCT04359953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5515281|NCT04359953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5515282|NCT04359953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5607014|NCT03032510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6082774|NCT00811057|Nifedipine|nifedipine|mesh-list
6082775|NCT00811057|Analgesics|analgesics|mesh-ancestor
6082776|NCT00811057|Sensory System Agents|sensory system agents|mesh-ancestor
6082777|NCT00811057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6082778|NCT00811057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5515283|NCT04359953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515284|NCT04359953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5515285|NCT04359953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6082779|NCT00811057|Anesthetics|anesthetics|mesh-ancestor
6082780|NCT00811057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6082781|NCT00811057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6082782|NCT00811057|Anticonvulsants|anticonvulsants|mesh-ancestor
6082783|NCT00811057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6082784|NCT00811057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6082785|NCT00811057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6082786|NCT00811057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6082787|NCT00811057|Tocolytic Agents|tocolytic agents|mesh-ancestor
6082788|NCT00811057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6082789|NCT00811057|Vasodilator Agents|vasodilator agents|mesh-ancestor
6082790|NCT00811057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6082791|NCT00811057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6082792|NCT00811057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6082793|NCT00811057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6082794|NCT00811057|Gout Suppressants|gout suppressants|mesh-ancestor
6082795|NCT00811057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6082796|NCT00811057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6082797|NCT00811135|Bevacizumab|bevacizumab|mesh-list
6082798|NCT00811135|Trastuzumab|trastuzumab|mesh-list
6082799|NCT00811135|Capecitabine|capecitabine|mesh-list
6082800|NCT00811135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6082801|NCT00811135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6082802|NCT00811135|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6082803|NCT00811135|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6082804|NCT00811135|Growth Substances|growth substances|mesh-ancestor
6082805|NCT00811135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082806|NCT00811135|Growth Inhibitors|growth inhibitors|mesh-ancestor
6082807|NCT00811135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6082808|NCT00811135|Antimetabolites|antimetabolites|mesh-ancestor
6082809|NCT00811135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6082810|NCT00811174|gamma-Globulins|gamma-globulins|mesh-list
6082811|NCT00811174|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5515286|NCT04359953|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5515287|NCT04359953|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5515288|NCT04359966|Amoxicillin|amoxicillin|mesh-list
5515289|NCT04359966|Metronidazole|metronidazole|mesh-list
5515290|NCT04359966|Clarithromycin|clarithromycin|mesh-list
5515291|NCT04359966|Levofloxacin|levofloxacin|mesh-list
5515292|NCT04359966|Ofloxacin|ofloxacin|mesh-list
5515293|NCT04359966|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
5515294|NCT04359966|Esomeprazole|esomeprazole|mesh-list
5515295|NCT04359966|Bismuth|bismuth|mesh-list
5515296|NCT04359966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5515297|NCT04359966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5515298|NCT04359966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6082812|NCT00811174|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6082813|NCT00811174|Immunologic Factors|immunologic factors|mesh-ancestor
6082814|NCT00811174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082815|NCT00811187|Lidocaine|lidocaine|mesh-list
6082816|NCT00811187|Anesthetics, Local|anesthetics, local|mesh-ancestor
6082817|NCT00811187|Anesthetics|anesthetics|mesh-ancestor
6082818|NCT00811187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6082819|NCT00811187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082820|NCT00811187|Sensory System Agents|sensory system agents|mesh-ancestor
6082821|NCT00811187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6082822|NCT00811187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6082823|NCT00811187|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6082824|NCT00811187|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6082825|NCT00811187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6082826|NCT00811187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6082827|NCT00811252|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6082828|NCT00811252|Vortioxetine|vortioxetine|mesh-list
5515299|NCT04359966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5515300|NCT04359966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6082829|NCT00811252|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6463984|NCT00467142|Vitamins|vitamins|mesh-ancestor
6082830|NCT00811252|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6082831|NCT00811252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6082832|NCT00811252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6082833|NCT00811252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6082834|NCT00811252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082835|NCT00811252|Analgesics|analgesics|mesh-ancestor
6082836|NCT00811252|Sensory System Agents|sensory system agents|mesh-ancestor
6082837|NCT00811252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6082838|NCT00811252|Antidepressive Agents|antidepressive agents|mesh-ancestor
6082839|NCT00811252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6082840|NCT00811252|Dopamine Agents|dopamine agents|mesh-ancestor
6082841|NCT00811252|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6082842|NCT00811252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6082843|NCT00811252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6082844|NCT00811252|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6082845|NCT00811252|Serotonin Agents|serotonin agents|mesh-ancestor
6082846|NCT00811252|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6082847|NCT00811252|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6082848|NCT00811252|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6082849|NCT00811252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6082850|NCT00811395|Interferons|interferons|mesh-list
6082851|NCT00811395|Interferon-beta|interferon-beta|mesh-list
6082852|NCT00811395|Teriflunomide|teriflunomide|mesh-list
6082853|NCT00811395|Glatiramer Acetate|glatiramer acetate|mesh-list
6082854|NCT00811395|Interferon beta-1b|interferon beta-1b|mesh-list
6082855|NCT00811395|(T,G)-A-L|(t,g)-a-l|mesh-list
6082856|NCT00811395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6082857|NCT00811395|Antiviral Agents|antiviral agents|mesh-ancestor
5515301|NCT04359966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5515302|NCT04359966|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5515303|NCT04359966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5515304|NCT04359966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515305|NCT04359966|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5515306|NCT04359966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5515307|NCT04359966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5515308|NCT04359966|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5515309|NCT04359966|Renal Agents|renal agents|mesh-ancestor
5515310|NCT04359966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5515311|NCT04359966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5515312|NCT04359966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5515313|NCT04359966|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5515314|NCT04359966|Antacids|antacids|mesh-ancestor
5515315|NCT04359862|Propofol|propofol|mesh-list
6082858|NCT00811395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6082859|NCT00811395|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6082860|NCT00811395|Immunologic Factors|immunologic factors|mesh-ancestor
6082861|NCT00811395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082862|NCT00811395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5515316|NCT04359862|Sevoflurane|sevoflurane|mesh-list
5515317|NCT04359862|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5515318|NCT04359862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5515319|NCT04359862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5515320|NCT04359862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5515321|NCT04359862|Anesthetics, General|anesthetics, general|mesh-ancestor
5515322|NCT04359862|Anesthetics|anesthetics|mesh-ancestor
5515323|NCT04359862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6082863|NCT00811395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6463985|NCT00467142|Micronutrients|micronutrients|mesh-ancestor
6463986|NCT00467181|Fenoldopam|fenoldopam|mesh-list
6463987|NCT00467181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6463988|NCT00467181|Vasodilator Agents|vasodilator agents|mesh-ancestor
6463989|NCT00467181|Dopamine Agonists|dopamine agonists|mesh-ancestor
6463990|NCT00467181|Dopamine Agents|dopamine agents|mesh-ancestor
5515324|NCT04359862|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5515325|NCT04360031|Mycophenolic Acid|mycophenolic acid|mesh-list
5515326|NCT04360031|Tacrolimus|tacrolimus|mesh-list
5515327|NCT04360031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5515328|NCT04360031|Immunologic Factors|immunologic factors|mesh-ancestor
5515329|NCT04360031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5515330|NCT04360031|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5515331|NCT04360031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5515332|NCT04360031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515333|NCT04360031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5515334|NCT04360031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5515335|NCT04360031|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5515336|NCT04360031|Antitubercular Agents|antitubercular agents|mesh-ancestor
5515337|NCT04360031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5515338|NCT04360031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5515339|NCT04360122|Levamisole|levamisole|mesh-list
5515340|NCT04360122|Inosine Pranobex|inosine pranobex|mesh-list
5515341|NCT04360122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6463991|NCT00467181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6463992|NCT00467181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6463993|NCT00467181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463994|NCT00467194|Sirolimus|sirolimus|mesh-list
6463995|NCT00467194|Bevacizumab|bevacizumab|mesh-list
5515342|NCT04360122|Immunologic Factors|immunologic factors|mesh-ancestor
6082864|NCT00811395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6082865|NCT00811395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6082866|NCT00811395|Analgesics|analgesics|mesh-ancestor
6082867|NCT00811395|Sensory System Agents|sensory system agents|mesh-ancestor
6082868|NCT00811395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6082869|NCT00811395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6082870|NCT00811434|Lactulose|lactulose|mesh-list
6082871|NCT00811434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6082872|NCT00811473|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6082873|NCT00811473|Antidepressive Agents|antidepressive agents|mesh-ancestor
6082874|NCT00811473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6082875|NCT00811473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6082876|NCT00811473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6082877|NCT00811473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6082878|NCT00811473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082879|NCT00811564|Timolol|timolol|mesh-list
6082880|NCT00811564|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6082881|NCT00811564|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6082882|NCT00811564|Latanoprost|latanoprost|mesh-list
5515343|NCT04360122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5515344|NCT04360122|Antinematodal Agents|antinematodal agents|mesh-ancestor
5515345|NCT04360122|Anthelmintics|anthelmintics|mesh-ancestor
5515346|NCT04360122|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5515347|NCT04360122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5515348|NCT04360122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5515349|NCT04360122|Antiviral Agents|antiviral agents|mesh-ancestor
5515350|NCT04360044|Dronabinol|dronabinol|mesh-list
5515351|NCT04360044|Cannabidiol|cannabidiol|mesh-list
5515352|NCT04360044|Anticonvulsants|anticonvulsants|mesh-ancestor
5515353|NCT04360044|Hallucinogens|hallucinogens|mesh-ancestor
6082883|NCT00811564|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6082884|NCT00811564|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6082885|NCT00811564|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6082886|NCT00811564|Adrenergic Agents|adrenergic agents|mesh-ancestor
6082887|NCT00811564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6082888|NCT00811564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6082889|NCT00811564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082890|NCT00811564|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6082891|NCT00811564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6082892|NCT00811564|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6082893|NCT00811564|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6082894|NCT00811564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6082895|NCT00811642|Posaconazole|posaconazole|mesh-list
6082896|NCT00811642|Antifungal Agents|antifungal agents|mesh-ancestor
6082897|NCT00811642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6082898|NCT00811642|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6082899|NCT00811642|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6082900|NCT00811642|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6082901|NCT00811642|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6082902|NCT00811642|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5515354|NCT04360044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5515355|NCT04360044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6082903|NCT00811642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6082904|NCT00811642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6082905|NCT00811642|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6082906|NCT00811642|Hormone Antagonists|hormone antagonists|mesh-ancestor
6082907|NCT00811642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6082908|NCT00811642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202940|NCT02047903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202941|NCT02047981|Azithromycin|azithromycin|mesh-list
6202942|NCT02047981|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6202943|NCT02047981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6202944|NCT02048072|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6202945|NCT02048072|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6202946|NCT02048072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202947|NCT02048072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6202948|NCT02048072|Immunologic Factors|immunologic factors|mesh-ancestor
6202949|NCT02048072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202950|NCT02048241|Guanfacine|guanfacine|mesh-list
6202951|NCT02048241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6202952|NCT02048241|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6202953|NCT02048241|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6202954|NCT02048241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6202955|NCT02048241|Adrenergic Agents|adrenergic agents|mesh-ancestor
6202956|NCT02048241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6202957|NCT02048241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202958|NCT02048241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202959|NCT02048891|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6202960|NCT02048891|Progesterone|progesterone|mesh-list
6202961|NCT02048891|Progestins|progestins|mesh-ancestor
6202962|NCT02048891|Hormones|hormones|mesh-ancestor
6202963|NCT02048891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6202964|NCT02048891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202965|NCT02048891|Luteolytic Agents|luteolytic agents|mesh-ancestor
6202966|NCT02048891|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6202967|NCT02048891|Contraceptive Agents|contraceptive agents|mesh-ancestor
6202968|NCT02048891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6202969|NCT02048891|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6202970|NCT02048891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6202971|NCT02048891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6202972|NCT02049151|Cyclophosphamide|cyclophosphamide|mesh-list
6202973|NCT02049151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6202974|NCT02049151|Immunologic Factors|immunologic factors|mesh-ancestor
6202975|NCT02049151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202976|NCT02049151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6202977|NCT02049151|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6202978|NCT02049151|Alkylating Agents|alkylating agents|mesh-ancestor
6202979|NCT02049151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202980|NCT02049151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5515356|NCT04360044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5515357|NCT04360044|Analgesics|analgesics|mesh-ancestor
5515358|NCT04360044|Sensory System Agents|sensory system agents|mesh-ancestor
5515359|NCT04360044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5515360|NCT04360044|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5515361|NCT04360044|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5515362|NCT04360044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5515363|NCT04360044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515364|NCT04360044|Hormones|hormones|mesh-ancestor
5515365|NCT04360044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5515366|NCT04360135|Acetaminophen|acetaminophen|mesh-list
5515367|NCT04360135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5515368|NCT04360135|Analgesics|analgesics|mesh-ancestor
5515369|NCT04360135|Sensory System Agents|sensory system agents|mesh-ancestor
5515370|NCT04360135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5515371|NCT04360135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5515372|NCT04360135|Antipyretics|antipyretics|mesh-ancestor
5515373|NCT04360356|Ivermectin|ivermectin|mesh-list
5515374|NCT04360356|Nitazoxanide|nitazoxanide|mesh-list
5515375|NCT04360356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5515376|NCT04360356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5515377|NCT04360876|Dexamethasone|dexamethasone|mesh-list
5515378|NCT04360876|Dexamethasone acetate|dexamethasone acetate|mesh-list
5515379|NCT04360876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5515380|NCT04360876|Antiemetics|antiemetics|mesh-ancestor
6082909|NCT00811720|Nalmefene|nalmefene|mesh-list
6082910|NCT00811720|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6082911|NCT00811720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082912|NCT00811720|Sensory System Agents|sensory system agents|mesh-ancestor
6082913|NCT00811720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6082914|NCT00811733|Ofatumumab|ofatumumab|mesh-list
6082915|NCT00811733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6082916|NCT00811850|Timolol|timolol|mesh-list
6082917|NCT00811850|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6082918|NCT00811850|Dorzolamide|dorzolamide|mesh-list
6082919|NCT00811850|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6082920|NCT00811850|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6082921|NCT00811850|Maleic acid|maleic acid|mesh-list
6082922|NCT00811850|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6082923|NCT00811850|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6082924|NCT00811850|Adrenergic Agents|adrenergic agents|mesh-ancestor
6082925|NCT00811850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6082926|NCT00811850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6082927|NCT00811850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082928|NCT00811850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6082929|NCT00811850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6082930|NCT00811850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6082931|NCT00811850|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6082932|NCT00811850|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6082933|NCT00811850|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6082934|NCT00811850|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6082935|NCT00811928|Fluconazole|fluconazole|mesh-list
6082936|NCT00811928|Posaconazole|posaconazole|mesh-list
6082937|NCT00811928|Antifungal Agents|antifungal agents|mesh-ancestor
6082938|NCT00811928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6082939|NCT00811928|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6082940|NCT00811928|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6082941|NCT00811928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6082942|NCT00811928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6082943|NCT00811928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6082944|NCT00811928|Hormone Antagonists|hormone antagonists|mesh-ancestor
6082945|NCT00811928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6082946|NCT00811928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082947|NCT00811928|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6082948|NCT00811928|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6082949|NCT00811928|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6082950|NCT00811928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6082951|NCT00811928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6082952|NCT00811941|Nalmefene|nalmefene|mesh-list
6082953|NCT00811941|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6082954|NCT00811941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082955|NCT00811941|Sensory System Agents|sensory system agents|mesh-ancestor
6082956|NCT00811941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6082957|NCT00811954|Ritonavir|ritonavir|mesh-list
6082958|NCT00811954|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6082959|NCT00811954|Darunavir|darunavir|mesh-list
6082960|NCT00811954|Tenofovir|tenofovir|mesh-list
6082961|NCT00811954|Emtricitabine|emtricitabine|mesh-list
6082962|NCT00811954|Raltegravir Potassium|raltegravir potassium|mesh-list
6082963|NCT00811954|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6082964|NCT00811954|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6082965|NCT00811954|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6082966|NCT00811954|Protease Inhibitors|protease inhibitors|mesh-ancestor
6082967|NCT00811954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6082968|NCT00811954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6082969|NCT00811954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6082970|NCT00811954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6082971|NCT00811954|Antiviral Agents|antiviral agents|mesh-ancestor
6082972|NCT00811954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6082973|NCT00811954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6082974|NCT00811954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6082975|NCT00811954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6082976|NCT00811954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6082977|NCT00811954|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6082978|NCT00811954|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6082979|NCT00812253|Insulin|insulin|mesh-list
6082980|NCT00812253|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6082981|NCT00812253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6082982|NCT00812253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082983|NCT00812331|Simeprevir|simeprevir|mesh-list
5515381|NCT04360876|Autonomic Agents|autonomic agents|mesh-ancestor
5515382|NCT04360876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5515383|NCT04360876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5515384|NCT04360876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5515385|NCT04360876|Glucocorticoids|glucocorticoids|mesh-ancestor
5515386|NCT04360876|Hormones|hormones|mesh-ancestor
5515387|NCT04360876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5515388|NCT04360876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5515389|NCT04360876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5515390|NCT04359680|Nitazoxanide|nitazoxanide|mesh-list
6082984|NCT00812331|Antiviral Agents|antiviral agents|mesh-ancestor
6082985|NCT00812331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6082986|NCT00812331|Protease Inhibitors|protease inhibitors|mesh-ancestor
6082987|NCT00812331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6082988|NCT00812331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6082989|NCT00812461|Nalmefene|nalmefene|mesh-list
6082990|NCT00812461|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6082991|NCT00812461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082992|NCT00812461|Sensory System Agents|sensory system agents|mesh-ancestor
6082993|NCT00812461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6082994|NCT00812487|Insulin|insulin|mesh-list
6082995|NCT00812487|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6082996|NCT00812487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6082997|NCT00812487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6082998|NCT00812565|gamma-Globulins|gamma-globulins|mesh-list
6082999|NCT00812565|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6083000|NCT00812565|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6083001|NCT00812565|Immunologic Factors|immunologic factors|mesh-ancestor
6083002|NCT00812565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083003|NCT00812604|Analgesics|analgesics|mesh-list
6083004|NCT00812604|Petrolatum|petrolatum|mesh-list
6083005|NCT00812604|Sensory System Agents|sensory system agents|mesh-ancestor
6083006|NCT00812604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6083007|NCT00812604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5515391|NCT04359680|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5515392|NCT04359680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5515393|NCT04359615|Hydroxychloroquine|hydroxychloroquine|mesh-list
5515394|NCT04359615|Favipiravir|favipiravir|mesh-list
5515395|NCT04359615|Antimalarials|antimalarials|mesh-ancestor
5515396|NCT04359615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5515397|NCT04359615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5515398|NCT04359615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5515399|NCT04359615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5515400|NCT04359615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515401|NCT04359615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5515402|NCT04359615|Antiviral Agents|antiviral agents|mesh-ancestor
5515403|NCT04359823|Lovastatin|lovastatin|mesh-list
5515404|NCT04359823|L 647318|l 647318|mesh-list
5515405|NCT04359823|Dihydromevinolin|dihydromevinolin|mesh-list
5515406|NCT04359823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5515407|NCT04359823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5515408|NCT04359823|Antimetabolites|antimetabolites|mesh-ancestor
5515409|NCT04359823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515410|NCT04359823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5515411|NCT04359823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5515412|NCT04359823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5515413|NCT04359576|Hemostatics|hemostatics|mesh-list
5515414|NCT04359576|Coagulants|coagulants|mesh-ancestor
5515415|NCT04359537|Hydroxychloroquine|hydroxychloroquine|mesh-list
5515416|NCT04359537|Antimalarials|antimalarials|mesh-ancestor
5515417|NCT04359537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5515418|NCT04359537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5515419|NCT04359537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5515420|NCT04359537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5515421|NCT04359537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515422|NCT04359537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5515423|NCT04359485|Glycolic acid|glycolic acid|mesh-list
5515424|NCT04359485|Keratolytic Agents|keratolytic agents|mesh-ancestor
5515425|NCT04359485|Dermatologic Agents|dermatologic agents|mesh-ancestor
5515426|NCT04359511|Prednisone|prednisone|mesh-list
5515427|NCT04359511|Hydrocortisone|hydrocortisone|mesh-list
5515428|NCT04359511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5515429|NCT04359511|Glucocorticoids|glucocorticoids|mesh-ancestor
5515430|NCT04359511|Hormones|hormones|mesh-ancestor
6083008|NCT00812604|Emollients|emollients|mesh-ancestor
5515431|NCT04359511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5515432|NCT04359511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607015|NCT03032510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6083009|NCT00812604|Dermatologic Agents|dermatologic agents|mesh-ancestor
6083010|NCT00812812|Paroxetine|paroxetine|mesh-list
6083011|NCT00812812|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6083012|NCT00812812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6083013|NCT00812812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6083014|NCT00812812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083015|NCT00812812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6083016|NCT00812812|Serotonin Agents|serotonin agents|mesh-ancestor
6083017|NCT00812812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083018|NCT00812812|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5515433|NCT04359511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5515434|NCT04359511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5515435|NCT04359550|Antibodies|antibodies|mesh-list
5515436|NCT04359550|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5515437|NCT04359550|Immunologic Factors|immunologic factors|mesh-ancestor
5515438|NCT04359550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5515439|NCT04359524|Vitamin D|vitamin d|mesh-list
5515440|NCT04359524|Cholecalciferol|cholecalciferol|mesh-list
5515441|NCT04359524|Vitamins|vitamins|mesh-ancestor
5515442|NCT04359524|Micronutrients|micronutrients|mesh-ancestor
5515443|NCT04359524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5515444|NCT04359524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5515445|NCT04359524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5515446|NCT04359199|Cisplatin|cisplatin|mesh-list
5515447|NCT04359199|Pembrolizumab|pembrolizumab|mesh-list
5515448|NCT04359199|Nivolumab|nivolumab|mesh-list
5515449|NCT04359199|Cetuximab|cetuximab|mesh-list
6083019|NCT00812812|Antidepressive Agents|antidepressive agents|mesh-ancestor
6083020|NCT00812812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6083021|NCT00812812|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6083022|NCT00812812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6083023|NCT00812812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6083024|NCT00812838|Botulinum Toxins|botulinum toxins|mesh-list
6083025|NCT00812838|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5515450|NCT04359199|Durvalumab|durvalumab|mesh-list
5515451|NCT04359199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5515452|NCT04359199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6083026|NCT00812838|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6083027|NCT00812838|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6083028|NCT00812838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6083029|NCT00812838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083030|NCT00812838|Cholinergic Agents|cholinergic agents|mesh-ancestor
6083031|NCT00812838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6083032|NCT00812838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083033|NCT00812838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6083034|NCT00812838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6083035|NCT00812877|Calcium|calcium|mesh-list
6083036|NCT00812877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6083037|NCT00812877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083038|NCT00812955|Simvastatin|simvastatin|mesh-list
6083039|NCT00812955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6083040|NCT00812955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6083041|NCT00812955|Antimetabolites|antimetabolites|mesh-ancestor
6083042|NCT00812955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083043|NCT00812955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5515453|NCT04359199|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5515454|NCT04359199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515455|NCT04359095|Tenofovir|tenofovir|mesh-list
5515456|NCT04359095|Emtricitabine|emtricitabine|mesh-list
6083044|NCT00812955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6083045|NCT00812955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6083046|NCT00812968|Lenalidomide|lenalidomide|mesh-list
6083047|NCT00812968|Immunologic Factors|immunologic factors|mesh-ancestor
6083048|NCT00812968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083049|NCT00812968|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6083050|NCT00812968|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6083051|NCT00812968|Growth Substances|growth substances|mesh-ancestor
6083052|NCT00812968|Growth Inhibitors|growth inhibitors|mesh-ancestor
6083053|NCT00812968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6083054|NCT00813111|Epinephrine|epinephrine|mesh-list
6083055|NCT00813111|Bupivacaine|bupivacaine|mesh-list
6083056|NCT00813111|Anesthetics, Local|anesthetics, local|mesh-ancestor
5515457|NCT04359095|Colchicine|colchicine|mesh-list
5515458|NCT04359095|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5515459|NCT04359095|Antiviral Agents|antiviral agents|mesh-ancestor
5515460|NCT04359095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6083057|NCT00813111|Anesthetics|anesthetics|mesh-ancestor
6083058|NCT00813111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6083059|NCT00813111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083060|NCT00813111|Sensory System Agents|sensory system agents|mesh-ancestor
6083061|NCT00813111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6083062|NCT00813111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6083063|NCT00813111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6083064|NCT00813111|Adrenergic Agents|adrenergic agents|mesh-ancestor
6083065|NCT00813111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6083066|NCT00813111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083067|NCT00813111|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6083068|NCT00813111|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6083069|NCT00813111|Autonomic Agents|autonomic agents|mesh-ancestor
6083070|NCT00813111|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6083071|NCT00813111|Respiratory System Agents|respiratory system agents|mesh-ancestor
6083072|NCT00813111|Mydriatics|mydriatics|mesh-ancestor
6083073|NCT00813111|Sympathomimetics|sympathomimetics|mesh-ancestor
6083074|NCT00813111|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6083075|NCT00813124|Vidarabine|vidarabine|mesh-list
6083076|NCT00813124|Fludarabine|fludarabine|mesh-list
6083077|NCT00813124|Fludarabine phosphate|fludarabine phosphate|mesh-list
6083078|NCT00813124|Azacitidine|azacitidine|mesh-list
6083079|NCT00813124|Busulfan|busulfan|mesh-list
6083080|NCT00813124|Thymoglobulin|thymoglobulin|mesh-list
6083081|NCT00813124|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6083082|NCT00813124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6083083|NCT00813124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6083084|NCT00813124|Antimetabolites|antimetabolites|mesh-ancestor
6083085|NCT00813124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083086|NCT00813124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5515461|NCT04359095|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5515462|NCT04359095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5515463|NCT04359095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5515464|NCT04359095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515465|NCT04359095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5515466|NCT04359095|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5515467|NCT04359095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5515468|NCT04359095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5515469|NCT04359095|Antimetabolites|antimetabolites|mesh-ancestor
5515470|NCT04359095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5515471|NCT04359095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5515472|NCT04359095|Gout Suppressants|gout suppressants|mesh-ancestor
5515473|NCT04359095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5515474|NCT04359095|Tubulin Modulators|tubulin modulators|mesh-ancestor
5515475|NCT04359095|Antimitotic Agents|antimitotic agents|mesh-ancestor
6083087|NCT00813124|Immunologic Factors|immunologic factors|mesh-ancestor
6083088|NCT00813124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083089|NCT00813124|Antiviral Agents|antiviral agents|mesh-ancestor
6083090|NCT00813124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6083091|NCT00813124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6083092|NCT00813124|Alkylating Agents|alkylating agents|mesh-ancestor
6083093|NCT00813124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6083094|NCT00813124|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6083095|NCT00813150|Dexamethasone|dexamethasone|mesh-list
6083096|NCT00813150|Cyclophosphamide|cyclophosphamide|mesh-list
6083097|NCT00813150|Bortezomib|bortezomib|mesh-list
6083098|NCT00813150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6083099|NCT00813150|Immunologic Factors|immunologic factors|mesh-ancestor
6083100|NCT00813150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083101|NCT00813150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6083102|NCT00813150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6083103|NCT00813150|Alkylating Agents|alkylating agents|mesh-ancestor
6083104|NCT00813150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083105|NCT00813150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6083106|NCT00813150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6083107|NCT00813150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6083108|NCT00813150|Antiemetics|antiemetics|mesh-ancestor
6083109|NCT00813150|Autonomic Agents|autonomic agents|mesh-ancestor
6083110|NCT00813150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6083111|NCT00813150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6083112|NCT00813150|Glucocorticoids|glucocorticoids|mesh-ancestor
6083113|NCT00813150|Hormones|hormones|mesh-ancestor
6083114|NCT00813150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6083115|NCT00813150|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6083116|NCT00813293|Sorafenib|sorafenib|mesh-list
6083117|NCT00813293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6083118|NCT00813293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6083119|NCT00813293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6083120|NCT00813293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083121|NCT00813488|Fentanyl|fentanyl|mesh-list
6083122|NCT00813488|Oxycodone|oxycodone|mesh-list
6083123|NCT00813488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6083124|NCT00813488|Narcotics|narcotics|mesh-ancestor
6083125|NCT00813488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6083126|NCT00813488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083127|NCT00813488|Analgesics|analgesics|mesh-ancestor
6083128|NCT00813488|Sensory System Agents|sensory system agents|mesh-ancestor
6083129|NCT00813488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6083130|NCT00813488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6083131|NCT00813488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6083132|NCT00813488|Anesthetics, General|anesthetics, general|mesh-ancestor
6083133|NCT00813488|Anesthetics|anesthetics|mesh-ancestor
6083134|NCT00813592|Pasireotide|pasireotide|mesh-list
6083135|NCT00813592|Hormones|hormones|mesh-ancestor
6083136|NCT00813592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6083137|NCT00813592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083138|NCT00813709|Interferon beta-1a|interferon beta-1a|mesh-list
6083139|NCT00813709|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6083140|NCT00813709|Immunologic Factors|immunologic factors|mesh-ancestor
6083141|NCT00813709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083142|NCT00813709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6083143|NCT00813709|Antiviral Agents|antiviral agents|mesh-ancestor
6083144|NCT00813709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6083145|NCT00813748|Omalizumab|omalizumab|mesh-list
5515476|NCT04359095|Mitosis Modulators|mitosis modulators|mesh-ancestor
5515477|NCT04359095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5515478|NCT04359147|Hydrocortisone|hydrocortisone|mesh-list
5515479|NCT04359147|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
5515480|NCT04359147|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
5515481|NCT04359147|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
5515482|NCT04359147|Yohimbine|yohimbine|mesh-list
6083146|NCT00813748|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6083147|NCT00813748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6083148|NCT00813748|Respiratory System Agents|respiratory system agents|mesh-ancestor
6083149|NCT00813761|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6083150|NCT00813800|Varenicline|varenicline|mesh-list
6083151|NCT00813800|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6083152|NCT00813800|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6083153|NCT00813800|Cholinergic Agents|cholinergic agents|mesh-ancestor
6083154|NCT00813800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6083155|NCT00813800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083156|NCT00813800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083157|NCT00813917|Varenicline|varenicline|mesh-list
6083158|NCT00813917|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5515483|NCT04359147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5515484|NCT04359147|Mydriatics|mydriatics|mesh-ancestor
5515485|NCT04359147|Autonomic Agents|autonomic agents|mesh-ancestor
5515486|NCT04359147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5515487|NCT04359147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5515488|NCT04359147|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5515489|NCT04359147|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5515490|NCT04359147|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5515491|NCT04359147|Adrenergic Agents|adrenergic agents|mesh-ancestor
5515492|NCT04359147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5515493|NCT04359147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515494|NCT04359147|Urological Agents|urological agents|mesh-ancestor
5515495|NCT04359212|Heparin|heparin|mesh-list
5515496|NCT04359212|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5515497|NCT04359212|Tinzaparin|tinzaparin|mesh-list
6083159|NCT00813917|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6083160|NCT00813917|Cholinergic Agents|cholinergic agents|mesh-ancestor
6083161|NCT00813917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6083162|NCT00813917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083163|NCT00813917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083164|NCT00813943|Temozolomide|temozolomide|mesh-list
6083165|NCT00813943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6083166|NCT00813943|Alkylating Agents|alkylating agents|mesh-ancestor
6083167|NCT00813943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515498|NCT04359212|Dalteparin|dalteparin|mesh-list
5515499|NCT04359212|PENTA|penta|mesh-list
5515500|NCT04359212|Fondaparinux|fondaparinux|mesh-list
6083168|NCT00813943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6083169|NCT00813995|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6083170|NCT00813995|Metformin|metformin|mesh-list
6083171|NCT00813995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6083172|NCT00813995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6463996|NCT00467194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6463997|NCT00467194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6463998|NCT00467194|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6463999|NCT00467194|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6464000|NCT00467194|Growth Substances|growth substances|mesh-ancestor
6464001|NCT00467194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464002|NCT00467194|Growth Inhibitors|growth inhibitors|mesh-ancestor
6464003|NCT00467194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6464004|NCT00467194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5515501|NCT04359212|Anticoagulants|anticoagulants|mesh-ancestor
5515502|NCT04359212|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5515503|NCT04359212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5515504|NCT04359212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515505|NCT04359212|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5515506|NCT04359212|Antithrombins|antithrombins|mesh-ancestor
5515507|NCT04359212|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6083173|NCT00813995|Incretins|incretins|mesh-ancestor
6083174|NCT00813995|Hormones|hormones|mesh-ancestor
6083175|NCT00813995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6083176|NCT00813995|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6083177|NCT00813995|Protease Inhibitors|protease inhibitors|mesh-ancestor
6083178|NCT00813995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6083179|NCT00813995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083180|NCT00814138|Methotrexate|methotrexate|mesh-list
6083181|NCT00814138|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6083182|NCT00814138|Abortifacient Agents|abortifacient agents|mesh-ancestor
6083183|NCT00814138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6083184|NCT00814138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083185|NCT00814138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6083186|NCT00814138|Antimetabolites|antimetabolites|mesh-ancestor
6083187|NCT00814138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083188|NCT00814138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6083189|NCT00814138|Dermatologic Agents|dermatologic agents|mesh-ancestor
6083190|NCT00814138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6083191|NCT00814138|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6083192|NCT00814138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6083193|NCT00814138|Immunologic Factors|immunologic factors|mesh-ancestor
6083194|NCT00814138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6083195|NCT00814138|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6083196|NCT00814164|Daunorubicin|daunorubicin|mesh-list
6083197|NCT00814164|Clofarabine|clofarabine|mesh-list
6083198|NCT00814164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6083199|NCT00814164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6083200|NCT00814164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6083201|NCT00814164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6083202|NCT00814164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6083203|NCT00814164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083204|NCT00814164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6083205|NCT00814164|Antimetabolites|antimetabolites|mesh-ancestor
6083206|NCT00814177|Warfarin|warfarin|mesh-list
6083207|NCT00814177|Anticoagulants|anticoagulants|mesh-ancestor
6083208|NCT00814255|Adalimumab|adalimumab|mesh-list
6083209|NCT00814255|Losartan|losartan|mesh-list
6083210|NCT00814255|Lisinopril|lisinopril|mesh-list
6083211|NCT00814255|Atorvastatin|atorvastatin|mesh-list
6083212|NCT00814255|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6083213|NCT00814255|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6083214|NCT00814255|Antimetabolites|antimetabolites|mesh-ancestor
6083215|NCT00814255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083216|NCT00814255|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6083217|NCT00814255|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6083218|NCT00814255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6083219|NCT00814255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6083220|NCT00814255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6083221|NCT00814255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6083222|NCT00814255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6083223|NCT00814255|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6083224|NCT00814255|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6083225|NCT00814255|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6083226|NCT00814255|Protease Inhibitors|protease inhibitors|mesh-ancestor
6083227|NCT00814255|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6083228|NCT00814255|Protective Agents|protective agents|mesh-ancestor
6083229|NCT00814255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083230|NCT00814307|Tofacitinib|tofacitinib|mesh-list
6083231|NCT00814307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6083232|NCT00814307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6083233|NCT00814307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083234|NCT00814320|Immunoglobulins|immunoglobulins|mesh-list
6083235|NCT00814320|Antibodies|antibodies|mesh-list
6083236|NCT00814320|gamma-Globulins|gamma-globulins|mesh-list
6083237|NCT00814320|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6083238|NCT00814320|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6083239|NCT00814320|Immunoglobulin G|immunoglobulin g|mesh-list
6083240|NCT00814320|Immunologic Factors|immunologic factors|mesh-ancestor
6083241|NCT00814320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083242|NCT00814502|Zolpidem|zolpidem|mesh-list
6083243|NCT00814502|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6083244|NCT00814502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6083245|NCT00814502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6083246|NCT00814502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083247|NCT00814502|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6083248|NCT00814502|GABA Agonists|gaba agonists|mesh-ancestor
6083249|NCT00814502|GABA Agents|gaba agents|mesh-ancestor
6083250|NCT00814502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6083251|NCT00814502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083252|NCT00814580|Oxycodone|oxycodone|mesh-list
6083253|NCT00814580|Tapentadol|tapentadol|mesh-list
6083254|NCT00814580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6083255|NCT00814580|Narcotics|narcotics|mesh-ancestor
5515508|NCT04359212|Protease Inhibitors|protease inhibitors|mesh-ancestor
5515509|NCT04359212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5515510|NCT04359316|Azithromycin|azithromycin|mesh-list
5515511|NCT04359316|Hydroxychloroquine|hydroxychloroquine|mesh-list
5515512|NCT04359316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5515513|NCT04359316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5515514|NCT04359316|Antimalarials|antimalarials|mesh-ancestor
5515515|NCT04359316|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5515516|NCT04359316|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5515517|NCT04359316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5515518|NCT04359316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515519|NCT04359316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5515520|NCT04358965|Misoprostol|misoprostol|mesh-list
5515521|NCT04358965|Tranexamic Acid|tranexamic acid|mesh-list
5515522|NCT04358965|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5515523|NCT04358965|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5515524|NCT04358965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515525|NCT04358965|Hemostatics|hemostatics|mesh-ancestor
5515526|NCT04358965|Coagulants|coagulants|mesh-ancestor
5515527|NCT04358965|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6083256|NCT00814580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6083257|NCT00814580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083258|NCT00814580|Analgesics|analgesics|mesh-ancestor
6083259|NCT00814580|Sensory System Agents|sensory system agents|mesh-ancestor
6083260|NCT00814580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6083261|NCT00814580|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6083262|NCT00814580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6083263|NCT00814580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6083264|NCT00814580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083265|NCT00814580|Adrenergic Agents|adrenergic agents|mesh-ancestor
6083266|NCT00814580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6083267|NCT00814632|Apremilast|apremilast|mesh-list
6083268|NCT00814632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6083269|NCT00814632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6083270|NCT00814632|Analgesics|analgesics|mesh-ancestor
6083271|NCT00814632|Sensory System Agents|sensory system agents|mesh-ancestor
6083272|NCT00814632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6083273|NCT00814632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083274|NCT00814632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6083275|NCT00814632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6083276|NCT00814632|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6083277|NCT00814632|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6083278|NCT00814632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6083279|NCT00814632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515528|NCT04358965|Abortifacient Agents|abortifacient agents|mesh-ancestor
5515529|NCT04358965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5515530|NCT04358965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5515531|NCT04358965|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5515532|NCT04358965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5515533|NCT04358965|Oxytocics|oxytocics|mesh-ancestor
5515534|NCT04358614|Ritonavir|ritonavir|mesh-list
5515535|NCT04358614|Lopinavir|lopinavir|mesh-list
5515536|NCT04358614|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5515537|NCT04358614|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5515538|NCT04358614|Protease Inhibitors|protease inhibitors|mesh-ancestor
6083280|NCT00814658|Nimodipine|nimodipine|mesh-list
6083281|NCT00814658|Galantamine|galantamine|mesh-list
6083282|NCT00814658|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6083283|NCT00814658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6083284|NCT00814658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083285|NCT00814658|Cholinergic Agents|cholinergic agents|mesh-ancestor
6083286|NCT00814658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6083287|NCT00814658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083288|NCT00814658|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6464005|NCT00467194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6464006|NCT00467194|Antifungal Agents|antifungal agents|mesh-ancestor
6464007|NCT00467194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6083289|NCT00814658|Autonomic Agents|autonomic agents|mesh-ancestor
6083290|NCT00814658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6083291|NCT00814658|Nootropic Agents|nootropic agents|mesh-ancestor
6083292|NCT00814658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6083293|NCT00814658|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6083294|NCT00814658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6083295|NCT00814658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6083296|NCT00814658|Vasodilator Agents|vasodilator agents|mesh-ancestor
6083297|NCT00814671|Rifampin|rifampin|mesh-list
6083298|NCT00814671|Rifapentine|rifapentine|mesh-list
6083299|NCT00814671|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6083300|NCT00814671|Antitubercular Agents|antitubercular agents|mesh-ancestor
6083301|NCT00814671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6083302|NCT00814671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6083303|NCT00814671|Leprostatic Agents|leprostatic agents|mesh-ancestor
6083304|NCT00814671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6083305|NCT00814671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6083306|NCT00814671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083307|NCT00814671|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6083308|NCT00814671|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6083309|NCT00814671|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6083310|NCT00814671|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6083311|NCT00814671|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6083312|NCT00814671|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6083313|NCT00814710|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6083314|NCT00814710|Immunologic Factors|immunologic factors|mesh-ancestor
6083315|NCT00814710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083316|NCT00814788|Everolimus|everolimus|mesh-list
6083317|NCT00814788|Bicalutamide|bicalutamide|mesh-list
6083318|NCT00814788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6083319|NCT00814788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6083320|NCT00814788|Immunologic Factors|immunologic factors|mesh-ancestor
6083321|NCT00814788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083322|NCT00814788|Androgen Antagonists|androgen antagonists|mesh-ancestor
6083323|NCT00814788|Hormone Antagonists|hormone antagonists|mesh-ancestor
6083324|NCT00814788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6083325|NCT00814801|Galantamine|galantamine|mesh-list
6083326|NCT00814801|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6083327|NCT00814801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6083328|NCT00814801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083329|NCT00814801|Cholinergic Agents|cholinergic agents|mesh-ancestor
6083330|NCT00814801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6083331|NCT00814801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083332|NCT00814801|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6083333|NCT00814801|Autonomic Agents|autonomic agents|mesh-ancestor
6083334|NCT00814801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6083335|NCT00814801|Nootropic Agents|nootropic agents|mesh-ancestor
6083336|NCT00814879|Raltegravir Potassium|raltegravir potassium|mesh-list
6083337|NCT00814879|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6083338|NCT00814879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6083339|NCT00814879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5515539|NCT04358614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5607024|NCT03031730|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
5515540|NCT04358614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515541|NCT04358614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6083340|NCT00814879|Antiviral Agents|antiviral agents|mesh-ancestor
6083341|NCT00814879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6083342|NCT00814879|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6083343|NCT00814879|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6083344|NCT00814879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6083345|NCT00814879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083346|NCT00814879|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6083347|NCT00814879|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6083348|NCT00814879|Protease Inhibitors|protease inhibitors|mesh-ancestor
6083349|NCT00815295|Cetuximab|cetuximab|mesh-list
6083350|NCT00815295|Sorafenib|sorafenib|mesh-list
6083351|NCT00815295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5515542|NCT04358614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5515543|NCT04358614|Antiviral Agents|antiviral agents|mesh-ancestor
5515544|NCT04358614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5515545|NCT04358614|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5515546|NCT04358614|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5515547|NCT04358796|Perflubron|perflubron|mesh-list
5515548|NCT04358796|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5515549|NCT04358627|Dexmedetomidine|dexmedetomidine|mesh-list
5515550|NCT04358627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5515551|NCT04358627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5515552|NCT04358627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083352|NCT00815295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6083353|NCT00815295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6083354|NCT00815295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5515553|NCT04358627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5515554|NCT04358627|Analgesics|analgesics|mesh-ancestor
5515555|NCT04358627|Sensory System Agents|sensory system agents|mesh-ancestor
5515556|NCT04358627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5515557|NCT04358627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5515558|NCT04358627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5515559|NCT04358627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5515560|NCT04358627|Adrenergic Agents|adrenergic agents|mesh-ancestor
5515561|NCT04358627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5515562|NCT04358627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515563|NCT04358718|Anesthetics|anesthetics|mesh-list
5515564|NCT04358718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5515565|NCT04358718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5515566|NCT04358770|Clocortolone|clocortolone|mesh-list
5515567|NCT04358770|Fluocortolone|fluocortolone|mesh-list
5515568|NCT04358770|Clocortolone pivalate|clocortolone pivalate|mesh-list
5515569|NCT04358770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5515570|NCT04358770|Glucocorticoids|glucocorticoids|mesh-ancestor
5515571|NCT04358770|Hormones|hormones|mesh-ancestor
5515572|NCT04358770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5515573|NCT04358770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5515574|NCT04358562|Gefitinib|gefitinib|mesh-list
5515575|NCT04358562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5515576|NCT04358562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5515577|NCT04358562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5515578|NCT04358562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515579|NCT04358237|Pembrolizumab|pembrolizumab|mesh-list
5515580|NCT04358237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5515581|NCT04358237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5515582|NCT04358146|Locust bean gum|locust bean gum|mesh-list
6083355|NCT00815295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083356|NCT00815308|Paclitaxel|paclitaxel|mesh-list
6083357|NCT00815308|Cetuximab|cetuximab|mesh-list
6083358|NCT00815308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6083359|NCT00815308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6083360|NCT00815308|Tubulin Modulators|tubulin modulators|mesh-ancestor
6083361|NCT00815308|Antimitotic Agents|antimitotic agents|mesh-ancestor
6083362|NCT00815308|Mitosis Modulators|mitosis modulators|mesh-ancestor
6083363|NCT00815308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083364|NCT00815308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6083365|NCT00815347|Bosentan|bosentan|mesh-list
6083366|NCT00815347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6083367|NCT00815347|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6083368|NCT00815347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515583|NCT04358146|Antidiarrheals|antidiarrheals|mesh-ancestor
5515584|NCT04358146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5515585|NCT04358367|Dexmedetomidine|dexmedetomidine|mesh-list
5515586|NCT04358367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5515587|NCT04358367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5515588|NCT04358367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5515589|NCT04358367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5515590|NCT04358367|Analgesics|analgesics|mesh-ancestor
5515591|NCT04358367|Sensory System Agents|sensory system agents|mesh-ancestor
5515592|NCT04358367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6083369|NCT00815360|Triamcinolone|triamcinolone|mesh-list
6083370|NCT00815360|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6083371|NCT00815360|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6083372|NCT00815360|Ranibizumab|ranibizumab|mesh-list
6083373|NCT00815360|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6083374|NCT00815360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6083375|NCT00815360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6083376|NCT00815360|Growth Substances|growth substances|mesh-ancestor
6083377|NCT00815360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083378|NCT00815360|Growth Inhibitors|growth inhibitors|mesh-ancestor
6083379|NCT00815360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6083380|NCT00815360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6083381|NCT00815360|Glucocorticoids|glucocorticoids|mesh-ancestor
6083382|NCT00815360|Hormones|hormones|mesh-ancestor
6083383|NCT00815360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6083384|NCT00815360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6083385|NCT00815360|Immunologic Factors|immunologic factors|mesh-ancestor
6083386|NCT00815360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6083387|NCT00815360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083388|NCT00815516|Amphotericin B|amphotericin b|mesh-list
6083389|NCT00815516|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6083390|NCT00815516|Micafungin|micafungin|mesh-list
6083391|NCT00815516|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
6083392|NCT00815516|Deoxycholic Acid|deoxycholic acid|mesh-list
6083393|NCT00815516|Amebicides|amebicides|mesh-ancestor
5515593|NCT04358367|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5515594|NCT04358367|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5515595|NCT04358367|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5515596|NCT04358367|Adrenergic Agents|adrenergic agents|mesh-ancestor
5515597|NCT04358367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5515598|NCT04358367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515599|NCT04358341|Doxorubicin|doxorubicin|mesh-list
5515600|NCT04358341|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5515601|NCT04358341|Fluorouracil|fluorouracil|mesh-list
5515602|NCT04358341|Irinotecan|irinotecan|mesh-list
5515603|NCT04358341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5515604|NCT04358341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5515605|NCT04358341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5515606|NCT04358341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5515607|NCT04358341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5515608|NCT04358341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515609|NCT04358341|Antimetabolites|antimetabolites|mesh-ancestor
5515610|NCT04358341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5515611|NCT04358341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5515612|NCT04358341|Immunologic Factors|immunologic factors|mesh-ancestor
6083394|NCT00815516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6083395|NCT00815516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6083396|NCT00815516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5515613|NCT04358341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5515614|NCT04358341|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5515615|NCT04358432|Ezetimibe|ezetimibe|mesh-list
5515616|NCT04358432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5515617|NCT04358432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6083397|NCT00815516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6083398|NCT00815516|Antifungal Agents|antifungal agents|mesh-ancestor
6083399|NCT00815516|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6083400|NCT00815516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6083401|NCT00815659|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6083402|NCT00815659|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6083403|NCT00815659|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6083404|NCT00815659|Antimetabolites|antimetabolites|mesh-ancestor
6083405|NCT00815659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083406|NCT00815659|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5515618|NCT04358432|Antimetabolites|antimetabolites|mesh-ancestor
5515619|NCT04358432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515620|NCT04358432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6202981|NCT02049151|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5515621|NCT04358354|Fluorouracil|fluorouracil|mesh-list
5515622|NCT04358354|Oxaliplatin|oxaliplatin|mesh-list
5515623|NCT04358354|Irinotecan|irinotecan|mesh-list
5515624|NCT04358354|Antimetabolites|antimetabolites|mesh-ancestor
5515625|NCT04358354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515626|NCT04358354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5515627|NCT04358354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5515628|NCT04358354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5515629|NCT04358354|Immunologic Factors|immunologic factors|mesh-ancestor
5515630|NCT04358354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5515631|NCT04358354|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5515632|NCT04358354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5515633|NCT04358354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5515634|NCT04358523|Sofosbuvir|sofosbuvir|mesh-list
5515635|NCT04358523|Antiviral Agents|antiviral agents|mesh-ancestor
6083407|NCT00815659|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6083408|NCT00815659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6083409|NCT00815919|Prednisone|prednisone|mesh-list
6083410|NCT00815919|Bortezomib|bortezomib|mesh-list
6083411|NCT00815919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6083412|NCT00815919|Glucocorticoids|glucocorticoids|mesh-ancestor
6083413|NCT00815919|Hormones|hormones|mesh-ancestor
6083414|NCT00815919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6083415|NCT00815919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083416|NCT00815919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6083417|NCT00815919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6083418|NCT00816023|Ecallantide|ecallantide|mesh-list
6083419|NCT00816023|Analgesics|analgesics|mesh-ancestor
6083420|NCT00816023|Sensory System Agents|sensory system agents|mesh-ancestor
6083421|NCT00816023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6083422|NCT00816023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083423|NCT00816023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6083424|NCT00816023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6083425|NCT00816023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6083426|NCT00816023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6083427|NCT00816101|Anti-Infective Agents|anti-infective agents|mesh-list
6464008|NCT00467194|Immunologic Factors|immunologic factors|mesh-ancestor
6464009|NCT00467207|Botulinum Toxins|botulinum toxins|mesh-list
6464010|NCT00467207|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6083428|NCT00816101|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6083429|NCT00816166|Aspirin|aspirin|mesh-list
6083430|NCT00816166|Clopidogrel|clopidogrel|mesh-list
6083431|NCT00816166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6083432|NCT00816166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6083433|NCT00816166|Analgesics|analgesics|mesh-ancestor
5515636|NCT04358523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5515637|NCT04358289|Anti-Infective Agents|anti-infective agents|mesh-list
5515638|NCT04358289|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5515639|NCT04358003|Coal Tar|coal tar|mesh-list
5515640|NCT04358003|Keratolytic Agents|keratolytic agents|mesh-ancestor
5515641|NCT04358003|Dermatologic Agents|dermatologic agents|mesh-ancestor
5515642|NCT04358497|Ibuprofen|ibuprofen|mesh-list
5515643|NCT04358497|Polidocanol|polidocanol|mesh-list
6083434|NCT00816166|Sensory System Agents|sensory system agents|mesh-ancestor
6083435|NCT00816166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6083436|NCT00816166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083437|NCT00816166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6083438|NCT00816166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6083439|NCT00816166|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6083440|NCT00816166|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6083441|NCT00816166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083442|NCT00816166|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6083443|NCT00816166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6083444|NCT00816166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6083445|NCT00816166|Antipyretics|antipyretics|mesh-ancestor
6083446|NCT00816166|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6083447|NCT00816166|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6083448|NCT00816166|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6083449|NCT00816166|Purinergic Agents|purinergic agents|mesh-ancestor
6083450|NCT00816166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6083451|NCT00816556|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6083452|NCT00816556|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5515644|NCT04358497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5515645|NCT04358497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5515646|NCT04358497|Analgesics|analgesics|mesh-ancestor
6464011|NCT00467207|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5515647|NCT04358497|Sensory System Agents|sensory system agents|mesh-ancestor
5515648|NCT04358497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6083453|NCT00816556|Estradiol|estradiol|mesh-list
6083454|NCT00816556|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6083455|NCT00816556|Estrogens|estrogens|mesh-ancestor
6083456|NCT00816556|Hormones|hormones|mesh-ancestor
6083457|NCT00816556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6083458|NCT00816556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083459|NCT00816556|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6083460|NCT00816556|Contraceptive Agents|contraceptive agents|mesh-ancestor
6083461|NCT00816556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5515649|NCT04358497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5515650|NCT04358497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5515651|NCT04358497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5515652|NCT04358497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5515653|NCT04358497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5515654|NCT04358497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515655|NCT04358497|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
5515656|NCT04358497|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5515657|NCT04358120|Hyaluronic Acid|hyaluronic acid|mesh-list
5515658|NCT04358120|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5515659|NCT04358120|Immunologic Factors|immunologic factors|mesh-ancestor
5515660|NCT04358120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083462|NCT00816556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6083463|NCT00816595|Cyclophosphamide|cyclophosphamide|mesh-list
6083464|NCT00816595|Bevacizumab|bevacizumab|mesh-list
6083465|NCT00816595|Rituximab|rituximab|mesh-list
6083466|NCT00816595|Pentostatin|pentostatin|mesh-list
6083467|NCT00816595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6083468|NCT00816595|Immunologic Factors|immunologic factors|mesh-ancestor
6083469|NCT00816595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083470|NCT00816595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6083471|NCT00816595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6083472|NCT00816595|Alkylating Agents|alkylating agents|mesh-ancestor
6083473|NCT00816595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083474|NCT00816595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6083475|NCT00816595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6083476|NCT00816595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6083477|NCT00816595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6083478|NCT00816595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6083479|NCT00816595|Growth Substances|growth substances|mesh-ancestor
6083480|NCT00816595|Growth Inhibitors|growth inhibitors|mesh-ancestor
6083481|NCT00816595|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
6083482|NCT00816595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6083483|NCT00816751|Lidocaine|lidocaine|mesh-list
6083484|NCT00816751|Vasopressins|vasopressins|mesh-list
6083485|NCT00816751|Arginine Vasopressin|arginine vasopressin|mesh-list
6083486|NCT00816751|Anesthetics, Local|anesthetics, local|mesh-ancestor
6083487|NCT00816751|Anesthetics|anesthetics|mesh-ancestor
6083488|NCT00816751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6083489|NCT00816751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083490|NCT00816751|Sensory System Agents|sensory system agents|mesh-ancestor
6083491|NCT00816751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6083492|NCT00816751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6083493|NCT00816751|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6083494|NCT00816751|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6083495|NCT00816751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6083496|NCT00816751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083497|NCT00816751|Hemostatics|hemostatics|mesh-ancestor
6083498|NCT00816751|Coagulants|coagulants|mesh-ancestor
6083499|NCT00816751|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6083500|NCT00816751|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6083501|NCT00816751|Natriuretic Agents|natriuretic agents|mesh-ancestor
6083502|NCT00816829|Fenofibrate|fenofibrate|mesh-list
6083503|NCT00816829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6083504|NCT00816829|Antimetabolites|antimetabolites|mesh-ancestor
6083505|NCT00816829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083506|NCT00816829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6083507|NCT00816907|Metformin|metformin|mesh-list
6083508|NCT00816907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5515661|NCT04358120|Viscosupplements|viscosupplements|mesh-ancestor
5515662|NCT04358120|Protective Agents|protective agents|mesh-ancestor
5515663|NCT04358055|Hyaluronic Acid|hyaluronic acid|mesh-list
5515664|NCT04358055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6083509|NCT00816907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083510|NCT00817063|Alitretinoin|alitretinoin|mesh-list
5515665|NCT04358055|Immunologic Factors|immunologic factors|mesh-ancestor
5515666|NCT04358055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5515667|NCT04358055|Viscosupplements|viscosupplements|mesh-ancestor
6083511|NCT00817063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6083512|NCT00817063|Dermatologic Agents|dermatologic agents|mesh-ancestor
6083513|NCT00817089|Naltrexone|naltrexone|mesh-list
6083514|NCT00817089|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6083515|NCT00817089|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6083516|NCT00817089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083517|NCT00817089|Sensory System Agents|sensory system agents|mesh-ancestor
6083518|NCT00817089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6083519|NCT00817206|Tacrolimus|tacrolimus|mesh-list
6083520|NCT00817206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6083521|NCT00817206|Immunologic Factors|immunologic factors|mesh-ancestor
6083522|NCT00817206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083523|NCT00817206|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6083524|NCT00817206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6083525|NCT00817206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083526|NCT00817219|Betamethasone|betamethasone|mesh-list
6083527|NCT00817219|Betamethasone Valerate|betamethasone valerate|mesh-list
6083528|NCT00817219|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
6083529|NCT00817219|Betamethasone benzoate|betamethasone benzoate|mesh-list
6083530|NCT00817219|Calcipotriene|calcipotriene|mesh-list
6083531|NCT00817219|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
6083532|NCT00817219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6083533|NCT00817219|Glucocorticoids|glucocorticoids|mesh-ancestor
6083534|NCT00817219|Hormones|hormones|mesh-ancestor
6083535|NCT00817219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6083536|NCT00817219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083537|NCT00817219|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6083538|NCT00817219|Respiratory System Agents|respiratory system agents|mesh-ancestor
6083539|NCT00817219|Dermatologic Agents|dermatologic agents|mesh-ancestor
6083540|NCT00817479|Dexamethasone|dexamethasone|mesh-list
6083541|NCT00817479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6083542|NCT00817479|Antiemetics|antiemetics|mesh-ancestor
6083543|NCT00817479|Autonomic Agents|autonomic agents|mesh-ancestor
6083544|NCT00817479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6083545|NCT00817479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083546|NCT00817479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6083547|NCT00817479|Glucocorticoids|glucocorticoids|mesh-ancestor
6083548|NCT00817479|Hormones|hormones|mesh-ancestor
6083549|NCT00817479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6083550|NCT00817479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6083551|NCT00817479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6202982|NCT02049307|Losartan|losartan|mesh-list
6202983|NCT02049307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6202984|NCT02049307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6202985|NCT02049307|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6202986|NCT02049307|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5515668|NCT04358055|Protective Agents|protective agents|mesh-ancestor
5515669|NCT04357899|Hypolipidemic Agents|hypolipidemic agents|mesh-list
5515670|NCT04357899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515671|NCT04357899|Antimetabolites|antimetabolites|mesh-ancestor
5515672|NCT04357899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5515673|NCT04357860|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5515674|NCT04358016|Terlipressin|terlipressin|mesh-list
5515675|NCT04358016|Somatostatin|somatostatin|mesh-list
5515676|NCT04358016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5515677|NCT04358016|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5515678|NCT04358016|Hormones|hormones|mesh-ancestor
5515679|NCT04358016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5515680|NCT04358016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5515681|NCT04357873|Pembrolizumab|pembrolizumab|mesh-list
5515682|NCT04357873|Vorinostat|vorinostat|mesh-list
5515683|NCT04357873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6207999|NCT02122770|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6083552|NCT00817531|Dasatinib|dasatinib|mesh-list
6083553|NCT00817531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6083554|NCT00817531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6083555|NCT00817531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6083556|NCT00817531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083557|NCT00817635|Eplerenone|eplerenone|mesh-list
6083558|NCT00817635|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6083559|NCT00817635|Hormone Antagonists|hormone antagonists|mesh-ancestor
6083560|NCT00817635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6083561|NCT00817635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083562|NCT00817635|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6083563|NCT00817635|Diuretics|diuretics|mesh-ancestor
5515684|NCT04357873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5515685|NCT04357873|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5515686|NCT04357873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5515687|NCT04357873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515688|NCT04357522|Vaccines|vaccines|mesh-list
5515689|NCT04357522|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5515690|NCT04357522|Immunologic Factors|immunologic factors|mesh-ancestor
5515691|NCT04357522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083564|NCT00817635|Natriuretic Agents|natriuretic agents|mesh-ancestor
6083565|NCT00817635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6083566|NCT00817843|Simvastatin|simvastatin|mesh-list
6083567|NCT00817843|Ezetimibe|ezetimibe|mesh-list
6083568|NCT00817843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6083569|NCT00817843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6083570|NCT00817843|Antimetabolites|antimetabolites|mesh-ancestor
5515699|NCT04357535|Angiotensin II|angiotensin ii|mesh-list
5515700|NCT04357535|Giapreza|giapreza|mesh-list
5515701|NCT04357535|Enzyme Inhibitors|enzyme inhibitors|mesh-list
5515702|NCT04357535|Angiotensinogen|angiotensinogen|mesh-list
5515703|NCT04357535|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
5515704|NCT04357535|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
5515705|NCT04357535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515706|NCT04357535|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5515707|NCT04357535|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5515708|NCT04357535|Protease Inhibitors|protease inhibitors|mesh-ancestor
5515709|NCT04357483|Thrombin|thrombin|mesh-list
5515710|NCT04357483|Hemostatics|hemostatics|mesh-ancestor
6083571|NCT00817843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083572|NCT00817843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6083573|NCT00817843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6083574|NCT00817843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6083575|NCT00817999|Clopidogrel|clopidogrel|mesh-list
6083576|NCT00817999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6083577|NCT00817999|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6083578|NCT00817999|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6083579|NCT00817999|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6083580|NCT00817999|Purinergic Agents|purinergic agents|mesh-ancestor
6083581|NCT00817999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6083582|NCT00817999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083583|NCT00817999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083584|NCT00818168|Infliximab|infliximab|mesh-list
6083585|NCT00818168|Dermatologic Agents|dermatologic agents|mesh-ancestor
6083586|NCT00818168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6083587|NCT00818168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6083588|NCT00818259|Dexamethasone|dexamethasone|mesh-list
6083589|NCT00818259|Ondansetron|ondansetron|mesh-list
6083590|NCT00818259|Aprepitant|aprepitant|mesh-list
6083591|NCT00818259|Fosaprepitant|fosaprepitant|mesh-list
6083592|NCT00818259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6083593|NCT00818259|Antiemetics|antiemetics|mesh-ancestor
6083594|NCT00818259|Autonomic Agents|autonomic agents|mesh-ancestor
6083595|NCT00818259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6083596|NCT00818259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083597|NCT00818259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6083598|NCT00818259|Glucocorticoids|glucocorticoids|mesh-ancestor
6083599|NCT00818259|Hormones|hormones|mesh-ancestor
6083600|NCT00818259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6083601|NCT00818259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6083602|NCT00818259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6083603|NCT00818259|Antipruritics|antipruritics|mesh-ancestor
5515711|NCT04357483|Coagulants|coagulants|mesh-ancestor
5607025|NCT03031730|BB 1101|bb 1101|mesh-list
6083604|NCT00818259|Dermatologic Agents|dermatologic agents|mesh-ancestor
6083605|NCT00818259|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6083606|NCT00818259|Serotonin Agents|serotonin agents|mesh-ancestor
6083607|NCT00818259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6083608|NCT00818259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083609|NCT00818259|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6083610|NCT00818259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6083611|NCT00818259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6083612|NCT00818259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6083613|NCT00818259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6083614|NCT00818259|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6083615|NCT00818272|Infliximab|infliximab|mesh-list
6083616|NCT00818272|Dermatologic Agents|dermatologic agents|mesh-ancestor
6083617|NCT00818272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6083618|NCT00818272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6083619|NCT00818324|Rebamipide|rebamipide|mesh-list
6083620|NCT00818324|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6083621|NCT00818324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6083622|NCT00818324|Antioxidants|antioxidants|mesh-ancestor
6083623|NCT00818324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083624|NCT00818324|Protective Agents|protective agents|mesh-ancestor
6083625|NCT00818324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083626|NCT00818324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6083627|NCT00818337|Aspirin|aspirin|mesh-list
6083628|NCT00818337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6083629|NCT00818337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6083630|NCT00818337|Analgesics|analgesics|mesh-ancestor
6083631|NCT00818337|Sensory System Agents|sensory system agents|mesh-ancestor
6083632|NCT00818337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6083633|NCT00818337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083634|NCT00818337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6083635|NCT00818337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6083636|NCT00818337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6083637|NCT00818337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6083638|NCT00818337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083639|NCT00818337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6083640|NCT00818337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6083641|NCT00818337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6083642|NCT00818337|Antipyretics|antipyretics|mesh-ancestor
6083643|NCT00818363|Bupivacaine|bupivacaine|mesh-list
6083644|NCT00818363|Anesthetics, Local|anesthetics, local|mesh-ancestor
6083645|NCT00818363|Anesthetics|anesthetics|mesh-ancestor
6083646|NCT00818363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6083647|NCT00818363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083648|NCT00818363|Sensory System Agents|sensory system agents|mesh-ancestor
6083649|NCT00818363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5515712|NCT04357366|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5515713|NCT04357366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5515714|NCT04357392|Hypoglycemic Agents|hypoglycemic agents|mesh-list
5515715|NCT04357392|Prednisone|prednisone|mesh-list
5515716|NCT04357392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5515717|NCT04357392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5515718|NCT04357392|Glucocorticoids|glucocorticoids|mesh-ancestor
5515719|NCT04357392|Hormones|hormones|mesh-ancestor
5515720|NCT04357392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5515721|NCT04357392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5515722|NCT04357392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6083650|NCT00818389|Riluzole|riluzole|mesh-list
6083651|NCT00818389|Lithium Carbonate|lithium carbonate|mesh-list
6083652|NCT00818389|Antidepressive Agents|antidepressive agents|mesh-ancestor
6083653|NCT00818389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6083654|NCT00818389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6083655|NCT00818389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083656|NCT00818389|Antimanic Agents|antimanic agents|mesh-ancestor
6083657|NCT00818389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6083658|NCT00818389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6083659|NCT00818389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083660|NCT00818389|Anticonvulsants|anticonvulsants|mesh-ancestor
6083661|NCT00818389|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6083662|NCT00818389|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6083663|NCT00818389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6083664|NCT00818389|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6083665|NCT00818389|Protective Agents|protective agents|mesh-ancestor
6083666|NCT00818454|Albuterol|albuterol|mesh-list
6083667|NCT00818454|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5515723|NCT04357093|Listerine|listerine|mesh-list
6083668|NCT00818454|Autonomic Agents|autonomic agents|mesh-ancestor
6083669|NCT00818454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6083670|NCT00818454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083671|NCT00818454|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6083672|NCT00818454|Respiratory System Agents|respiratory system agents|mesh-ancestor
6083673|NCT00818454|Tocolytic Agents|tocolytic agents|mesh-ancestor
6083674|NCT00818454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6083675|NCT00818454|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5515724|NCT04357093|Grape Seed Extract|grape seed extract|mesh-list
5515725|NCT04357093|Fluorides|fluorides|mesh-list
5515726|NCT04357093|Sodium Fluoride|sodium fluoride|mesh-list
5515727|NCT04357093|Cariostatic Agents|cariostatic agents|mesh-ancestor
5515728|NCT04357093|Protective Agents|protective agents|mesh-ancestor
5515729|NCT04357093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5515730|NCT04357093|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5515731|NCT04357093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5515732|NCT04357093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6083676|NCT00818454|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6083677|NCT00818454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6083678|NCT00818454|Adrenergic Agents|adrenergic agents|mesh-ancestor
6083679|NCT00818454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6083680|NCT00818454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083681|NCT00818519|Drospirenone|drospirenone|mesh-list
6083682|NCT00818519|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6083683|NCT00818519|Hormone Antagonists|hormone antagonists|mesh-ancestor
6083684|NCT00818519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6083685|NCT00818519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083686|NCT00818519|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6083687|NCT00818519|Diuretics|diuretics|mesh-ancestor
6083688|NCT00818519|Natriuretic Agents|natriuretic agents|mesh-ancestor
6083689|NCT00818649|Bortezomib|bortezomib|mesh-list
6083690|NCT00818649|Vorinostat|vorinostat|mesh-list
6083691|NCT00818649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6083692|NCT00818649|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6083693|NCT00818649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6083694|NCT00818649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083695|NCT00818662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6083696|NCT00818662|Immunoglobulins|immunoglobulins|mesh-list
6083697|NCT00818662|Antibodies|antibodies|mesh-list
6083698|NCT00818662|gamma-Globulins|gamma-globulins|mesh-list
6083699|NCT00818662|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6083700|NCT00818662|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6083701|NCT00818662|Immunoglobulin G|immunoglobulin g|mesh-list
6083702|NCT00818662|Immunologic Factors|immunologic factors|mesh-ancestor
6083703|NCT00818662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083704|NCT00818753|Heparin|heparin|mesh-list
6083705|NCT00818753|Calcium heparin|calcium heparin|mesh-list
6083706|NCT00818753|Dabigatran|dabigatran|mesh-list
6083707|NCT00818753|Anticoagulants|anticoagulants|mesh-ancestor
6083708|NCT00818753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6083709|NCT00818753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6083710|NCT00818753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083711|NCT00818753|Antithrombins|antithrombins|mesh-ancestor
6083712|NCT00818753|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6083713|NCT00818753|Protease Inhibitors|protease inhibitors|mesh-ancestor
6083714|NCT00818753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6083715|NCT00818766|Vancomycin|vancomycin|mesh-list
6083716|NCT00818766|Cefazolin|cefazolin|mesh-list
6083717|NCT00818766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6083718|NCT00818766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6083719|NCT00818779|Amlodipine|amlodipine|mesh-list
6083720|NCT00818779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6083721|NCT00818779|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6083722|NCT00818779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6208000|NCT02123017|Lactulose|lactulose|mesh-list
6083723|NCT00818779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083724|NCT00818779|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6083725|NCT00818779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083726|NCT00818779|Vasodilator Agents|vasodilator agents|mesh-ancestor
6083727|NCT00818805|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
6083728|NCT00818805|Tranilast|tranilast|mesh-list
6083729|NCT00818805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6083730|NCT00818805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6083731|NCT00818805|Analgesics|analgesics|mesh-ancestor
6083732|NCT00818805|Sensory System Agents|sensory system agents|mesh-ancestor
6083733|NCT00818805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6083734|NCT00818805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083735|NCT00818805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6083736|NCT00818805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6083737|NCT00818805|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6083738|NCT00818805|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6083739|NCT00818805|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6083740|NCT00818805|Histamine Antagonists|histamine antagonists|mesh-ancestor
5515733|NCT04357093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5515734|NCT04357093|Antioxidants|antioxidants|mesh-ancestor
5515735|NCT04357093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515736|NCT04357002|Tranexamic Acid|tranexamic acid|mesh-list
5515737|NCT04357002|Dinoprostone|dinoprostone|mesh-list
5515738|NCT04357002|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5515739|NCT04357002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5515740|NCT04357002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515741|NCT04357002|Hemostatics|hemostatics|mesh-ancestor
5515742|NCT04357002|Coagulants|coagulants|mesh-ancestor
5515743|NCT04357002|Oxytocics|oxytocics|mesh-ancestor
5515744|NCT04357002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5515745|NCT04357002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5515746|NCT04357301|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
5515747|NCT04357015|Tranexamic Acid|tranexamic acid|mesh-list
5515748|NCT04357015|Carbetocin|carbetocin|mesh-list
5515749|NCT04357015|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5515750|NCT04357015|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5515751|NCT04357015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515752|NCT04357015|Hemostatics|hemostatics|mesh-ancestor
5515753|NCT04357015|Coagulants|coagulants|mesh-ancestor
5515754|NCT04357015|Oxytocics|oxytocics|mesh-ancestor
5515755|NCT04357015|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6083741|NCT00818805|Histamine Agents|histamine agents|mesh-ancestor
6083742|NCT00818805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6083743|NCT00818805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6464012|NCT00467207|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6464013|NCT00467207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6464014|NCT00467207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6464015|NCT00467207|Cholinergic Agents|cholinergic agents|mesh-ancestor
6464016|NCT00467207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6083744|NCT00818805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6083745|NCT00818805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6083746|NCT00818805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6083747|NCT00818805|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6083748|NCT00818883|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6083749|NCT00818883|Chlorthalidone|chlorthalidone|mesh-list
6083750|NCT00818883|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
6083751|NCT00818883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6083752|NCT00818883|Diuretics|diuretics|mesh-ancestor
6083753|NCT00818883|Natriuretic Agents|natriuretic agents|mesh-ancestor
6083754|NCT00818883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083755|NCT00818883|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6083756|NCT00818883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6083757|NCT00818883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083758|NCT00818883|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6083759|NCT00818883|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6083760|NCT00818961|Cyclophosphamide|cyclophosphamide|mesh-list
6083761|NCT00818961|Busulfan|busulfan|mesh-list
6083762|NCT00818961|Rituximab|rituximab|mesh-list
6083763|NCT00818961|Methotrexate|methotrexate|mesh-list
6083764|NCT00818961|Fludarabine|fludarabine|mesh-list
6083765|NCT00818961|Fludarabine phosphate|fludarabine phosphate|mesh-list
5515756|NCT04357015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5515757|NCT04356872|Doxorubicin|doxorubicin|mesh-list
5515758|NCT04356872|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5515759|NCT04356872|Ifosfamide|ifosfamide|mesh-list
5515760|NCT04356872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5515761|NCT04356872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5515762|NCT04356872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5515763|NCT04356872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5515764|NCT04356872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5515765|NCT04356872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515766|NCT04356872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5515767|NCT04356872|Alkylating Agents|alkylating agents|mesh-ancestor
5515768|NCT04356716|Sildenafil Citrate|sildenafil citrate|mesh-list
5515769|NCT04356716|Vasodilator Agents|vasodilator agents|mesh-ancestor
5515770|NCT04356716|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5515771|NCT04356716|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5515772|NCT04356716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5515773|NCT04356716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515774|NCT04356716|Urological Agents|urological agents|mesh-ancestor
5515775|NCT04356729|Bevacizumab|bevacizumab|mesh-list
6083766|NCT00818961|Alemtuzumab|alemtuzumab|mesh-list
6083767|NCT00818961|Tacrolimus|tacrolimus|mesh-list
6083768|NCT00818961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6083769|NCT00818961|Immunologic Factors|immunologic factors|mesh-ancestor
6083770|NCT00818961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083771|NCT00818961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6083772|NCT00818961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6083773|NCT00818961|Alkylating Agents|alkylating agents|mesh-ancestor
6083774|NCT00818961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083775|NCT00818961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6083776|NCT00818961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6083777|NCT00818961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6083778|NCT00818961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6083779|NCT00818961|Abortifacient Agents|abortifacient agents|mesh-ancestor
6083780|NCT00818961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6083781|NCT00818961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6083782|NCT00818961|Antimetabolites|antimetabolites|mesh-ancestor
6083783|NCT00818961|Dermatologic Agents|dermatologic agents|mesh-ancestor
6083784|NCT00818961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6083785|NCT00818961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6083786|NCT00818961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6083787|NCT00818961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6083788|NCT00819013|Vaccines|vaccines|mesh-list
6083789|NCT00819013|Immunologic Factors|immunologic factors|mesh-ancestor
6083790|NCT00819013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083791|NCT00819039|Ondansetron|ondansetron|mesh-list
5515776|NCT04356729|Atezolizumab|atezolizumab|mesh-list
5515777|NCT04356729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5515778|NCT04356729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5515779|NCT04356729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5515780|NCT04356729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5515781|NCT04356729|Growth Substances|growth substances|mesh-ancestor
5515782|NCT04356729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5515783|NCT04356729|Growth Inhibitors|growth inhibitors|mesh-ancestor
6083792|NCT00819039|Aprepitant|aprepitant|mesh-list
6083793|NCT00819039|Antiemetics|antiemetics|mesh-ancestor
6083794|NCT00819039|Autonomic Agents|autonomic agents|mesh-ancestor
6083795|NCT00819039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6083796|NCT00819039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083797|NCT00819039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6083798|NCT00819039|Antipruritics|antipruritics|mesh-ancestor
6083799|NCT00819039|Dermatologic Agents|dermatologic agents|mesh-ancestor
6083800|NCT00819039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6083801|NCT00819039|Serotonin Agents|serotonin agents|mesh-ancestor
6083802|NCT00819039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6083803|NCT00819039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083804|NCT00819039|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6083805|NCT00819039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6083806|NCT00819039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6083807|NCT00819039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6083808|NCT00819039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6083809|NCT00819039|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6083810|NCT00819052|Nevirapine|nevirapine|mesh-list
6083811|NCT00819052|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6083812|NCT00819052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6083813|NCT00819052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6083814|NCT00819052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083815|NCT00819052|Antiviral Agents|antiviral agents|mesh-ancestor
6083816|NCT00819052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6083817|NCT00819052|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6083818|NCT00819052|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6083819|NCT00819052|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6083820|NCT00819052|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6083821|NCT00819091|Linagliptin|linagliptin|mesh-list
6083822|NCT00819091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6083823|NCT00819091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083824|NCT00819091|Incretins|incretins|mesh-ancestor
6083825|NCT00819091|Hormones|hormones|mesh-ancestor
6083826|NCT00819091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6083827|NCT00819091|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6083828|NCT00819091|Protease Inhibitors|protease inhibitors|mesh-ancestor
6083829|NCT00819091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6083830|NCT00819091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083831|NCT00819234|Pramlintide|pramlintide|mesh-list
6083832|NCT00819234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6083833|NCT00819234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083834|NCT00819390|Chloroquine|chloroquine|mesh-list
6083835|NCT00819390|Amebicides|amebicides|mesh-ancestor
6083836|NCT00819390|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6083837|NCT00819390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6083838|NCT00819390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6083839|NCT00819390|Antimalarials|antimalarials|mesh-ancestor
6083840|NCT00819390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6083841|NCT00819403|Simvastatin|simvastatin|mesh-list
6083842|NCT00819403|Ezetimibe|ezetimibe|mesh-list
6083843|NCT00819403|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
6083844|NCT00819403|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6083845|NCT00819403|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6083846|NCT00819403|Antimetabolites|antimetabolites|mesh-ancestor
6083847|NCT00819403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083848|NCT00819403|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6083849|NCT00819403|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6083850|NCT00819403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6083851|NCT00819507|Fluocinonide|fluocinonide|mesh-list
6083852|NCT00819507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6083853|NCT00819507|Glucocorticoids|glucocorticoids|mesh-ancestor
6083854|NCT00819507|Hormones|hormones|mesh-ancestor
6083855|NCT00819507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6083856|NCT00819507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083857|NCT00819507|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6083858|NCT00819585|Colchicine|colchicine|mesh-list
6083859|NCT00819585|Allopurinol|allopurinol|mesh-list
6083860|NCT00819585|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6083861|NCT00819585|Gout Suppressants|gout suppressants|mesh-ancestor
6083862|NCT00819585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6083863|NCT00819585|Tubulin Modulators|tubulin modulators|mesh-ancestor
6083864|NCT00819585|Antimitotic Agents|antimitotic agents|mesh-ancestor
6083865|NCT00819585|Mitosis Modulators|mitosis modulators|mesh-ancestor
6083866|NCT00819585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083867|NCT00819585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6083868|NCT00819585|Antimetabolites|antimetabolites|mesh-ancestor
6083869|NCT00819585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6083870|NCT00819585|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6083871|NCT00819585|Antioxidants|antioxidants|mesh-ancestor
6083872|NCT00819585|Protective Agents|protective agents|mesh-ancestor
6083873|NCT00819585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083874|NCT00819585|Immunologic Factors|immunologic factors|mesh-ancestor
6083875|NCT00819637|Albuterol|albuterol|mesh-list
6083876|NCT00819637|Formoterol Fumarate|formoterol fumarate|mesh-list
6083877|NCT00819637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6083878|NCT00819637|Autonomic Agents|autonomic agents|mesh-ancestor
6083879|NCT00819637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6083880|NCT00819637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083881|NCT00819637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6083882|NCT00819637|Respiratory System Agents|respiratory system agents|mesh-ancestor
6083883|NCT00819637|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6083884|NCT00819637|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6083885|NCT00819637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6083886|NCT00819637|Adrenergic Agents|adrenergic agents|mesh-ancestor
6083887|NCT00819637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6083888|NCT00819637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083889|NCT00819637|Tocolytic Agents|tocolytic agents|mesh-ancestor
6083890|NCT00819637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6083891|NCT00819741|Metformin|metformin|mesh-list
6083892|NCT00819741|Repaglinide|repaglinide|mesh-list
6083893|NCT00819741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6083894|NCT00819741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083895|NCT00819767|Valsartan|valsartan|mesh-list
6083896|NCT00819767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6083897|NCT00819767|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5600622|NCT03710434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600623|NCT03710395|Nifedipine|nifedipine|mesh-list
5600624|NCT03710395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5600625|NCT03710395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5600626|NCT03710395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083898|NCT00819767|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6083899|NCT00819767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083900|NCT00819780|Bevacizumab|bevacizumab|mesh-list
6083901|NCT00819780|Panitumumab|panitumumab|mesh-list
6083902|NCT00819780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6083903|NCT00819780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6083904|NCT00819780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6083905|NCT00819780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6083906|NCT00819780|Growth Substances|growth substances|mesh-ancestor
6083907|NCT00819780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600627|NCT03710395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5600628|NCT03710395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600629|NCT03710395|Vasodilator Agents|vasodilator agents|mesh-ancestor
5600630|NCT03710395|Tocolytic Agents|tocolytic agents|mesh-ancestor
5600631|NCT03710395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5600632|NCT03710369|Sildenafil Citrate|sildenafil citrate|mesh-list
5600633|NCT03710369|Vasodilator Agents|vasodilator agents|mesh-ancestor
5600634|NCT03710369|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5600635|NCT03710369|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5600636|NCT03710369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5600637|NCT03710369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600638|NCT03710369|Urological Agents|urological agents|mesh-ancestor
5600639|NCT03710356|Danazol|danazol|mesh-list
5600640|NCT03710356|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5600641|NCT03710356|Hormone Antagonists|hormone antagonists|mesh-ancestor
5600642|NCT03710356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5600643|NCT03710356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600644|NCT03710343|Metformin|metformin|mesh-list
5600645|NCT03710343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5600646|NCT03710343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600647|NCT03710330|Tranexamic Acid|tranexamic acid|mesh-list
5515808|NCT04356742|Metformin|metformin|mesh-list
5515809|NCT04356742|Dapagliflozin|dapagliflozin|mesh-list
5515810|NCT04356742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5515811|NCT04356742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5515812|NCT04356742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5515813|NCT04356742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515814|NCT04356508|Nivolumab|nivolumab|mesh-list
5515815|NCT04356508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5515816|NCT04356508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5515817|NCT04356508|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5515818|NCT04356508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515819|NCT04356677|Ribavirin|ribavirin|mesh-list
6083908|NCT00819780|Growth Inhibitors|growth inhibitors|mesh-ancestor
6083909|NCT00819910|Rosiglitazone|rosiglitazone|mesh-list
6083910|NCT00819910|Fenofibrate|fenofibrate|mesh-list
6083911|NCT00819910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6083912|NCT00819910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083913|NCT00819910|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6083914|NCT00819910|Antimetabolites|antimetabolites|mesh-ancestor
6083915|NCT00819910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083916|NCT00819910|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6083917|NCT00820170|Paclitaxel|paclitaxel|mesh-list
6083918|NCT00820170|Dasatinib|dasatinib|mesh-list
6083919|NCT00820170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6083920|NCT00820170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6083921|NCT00820170|Tubulin Modulators|tubulin modulators|mesh-ancestor
6083922|NCT00820170|Antimitotic Agents|antimitotic agents|mesh-ancestor
6083923|NCT00820170|Mitosis Modulators|mitosis modulators|mesh-ancestor
6083924|NCT00820170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083925|NCT00820170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6083926|NCT00820170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6083927|NCT00820222|Capecitabine|capecitabine|mesh-list
6083928|NCT00820222|Trastuzumab|trastuzumab|mesh-list
6083929|NCT00820222|Lapatinib|lapatinib|mesh-list
6083930|NCT00820222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6083931|NCT00820222|Antimetabolites|antimetabolites|mesh-ancestor
6083932|NCT00820222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083933|NCT00820222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6083934|NCT00820222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6083935|NCT00820222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6083936|NCT00820222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6083937|NCT00820248|Panitumumab|panitumumab|mesh-list
6083938|NCT00820248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6083939|NCT00820248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6083940|NCT00820534|Penciclovir|penciclovir|mesh-list
6083941|NCT00820534|Antiviral Agents|antiviral agents|mesh-ancestor
6083942|NCT00820534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6083943|NCT00820573|Metformin|metformin|mesh-list
6083944|NCT00820573|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6083945|NCT00820573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6083946|NCT00820573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083947|NCT00820573|Incretins|incretins|mesh-ancestor
6083948|NCT00820573|Hormones|hormones|mesh-ancestor
6083949|NCT00820573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6665529|NCT01517568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665530|NCT01517568|Incretins|incretins|mesh-ancestor
6083950|NCT00820573|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6083951|NCT00820573|Protease Inhibitors|protease inhibitors|mesh-ancestor
6083952|NCT00820573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6083953|NCT00820573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083954|NCT00820612|Indomethacin|indomethacin|mesh-list
6665531|NCT01517568|Hormones|hormones|mesh-ancestor
5515820|NCT04356677|Antimetabolites|antimetabolites|mesh-ancestor
5515821|NCT04356677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515822|NCT04356677|Antiviral Agents|antiviral agents|mesh-ancestor
5515823|NCT04356677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5515824|NCT04356664|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6083955|NCT00820612|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6083956|NCT00820612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6083957|NCT00820612|Analgesics|analgesics|mesh-ancestor
6083958|NCT00820612|Sensory System Agents|sensory system agents|mesh-ancestor
6083959|NCT00820612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6083960|NCT00820612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083961|NCT00820612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5515825|NCT04356664|Luteolytic Agents|luteolytic agents|mesh-ancestor
5515826|NCT04356664|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5515827|NCT04356664|Contraceptive Agents|contraceptive agents|mesh-ancestor
5515828|NCT04356664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5515829|NCT04356664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5515830|NCT04356664|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5515831|NCT04356664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5515832|NCT04356664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5515833|NCT04356833|Plasminogen|plasminogen|mesh-list
6083962|NCT00820612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6083963|NCT00820612|Gout Suppressants|gout suppressants|mesh-ancestor
6083964|NCT00820612|Tocolytic Agents|tocolytic agents|mesh-ancestor
6083965|NCT00820612|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6083966|NCT00820612|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6083967|NCT00820612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5515834|NCT04356833|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5515835|NCT04356833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6083968|NCT00820612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083969|NCT00820664|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6083970|NCT00820664|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6083971|NCT00820664|Estradiol|estradiol|mesh-list
6083972|NCT00820664|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6083973|NCT00820664|Estrogens|estrogens|mesh-ancestor
6083974|NCT00820664|Hormones|hormones|mesh-ancestor
6083975|NCT00820664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6083976|NCT00820664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6083977|NCT00820664|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6083978|NCT00820664|Contraceptive Agents|contraceptive agents|mesh-ancestor
6083979|NCT00820664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6083980|NCT00820664|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6083981|NCT00820755|Cetuximab|cetuximab|mesh-list
6083982|NCT00820755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6083983|NCT00820755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6083984|NCT00820872|Carboplatin|carboplatin|mesh-list
6083985|NCT00820872|Docetaxel|docetaxel|mesh-list
6083986|NCT00820872|Trastuzumab|trastuzumab|mesh-list
6083987|NCT00820872|Lapatinib|lapatinib|mesh-list
6083988|NCT00820872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6083989|NCT00820872|Tubulin Modulators|tubulin modulators|mesh-ancestor
6083990|NCT00820872|Antimitotic Agents|antimitotic agents|mesh-ancestor
6083991|NCT00820872|Mitosis Modulators|mitosis modulators|mesh-ancestor
6083992|NCT00820872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6083993|NCT00820872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6083994|NCT00820872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6083995|NCT00820872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6083996|NCT00820898|Gemcitabine|gemcitabine|mesh-list
6083997|NCT00820898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6083998|NCT00820898|Antimetabolites|antimetabolites|mesh-ancestor
6083999|NCT00820898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084000|NCT00820898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6084001|NCT00820898|Antiviral Agents|antiviral agents|mesh-ancestor
6084002|NCT00820898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6084003|NCT00820898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6084004|NCT00820898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6084005|NCT00820898|Immunologic Factors|immunologic factors|mesh-ancestor
6084006|NCT00820898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084007|NCT00821093|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6084008|NCT00821093|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6084009|NCT00821093|Autonomic Agents|autonomic agents|mesh-ancestor
6084010|NCT00821093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6084011|NCT00821093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084012|NCT00821093|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6084013|NCT00821093|Respiratory System Agents|respiratory system agents|mesh-ancestor
6084014|NCT00821093|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6084015|NCT00821093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6084016|NCT00821093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6084017|NCT00821093|Adrenergic Agents|adrenergic agents|mesh-ancestor
6084018|NCT00821093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6084019|NCT00821093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084020|NCT00821184|Solifenacin Succinate|solifenacin succinate|mesh-list
6084021|NCT00821184|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6084022|NCT00821184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6084023|NCT00821184|Cholinergic Agents|cholinergic agents|mesh-ancestor
6084024|NCT00821184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6084025|NCT00821184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084026|NCT00821184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084027|NCT00821184|Urological Agents|urological agents|mesh-ancestor
6084028|NCT05237141|Etonogestrel|etonogestrel|mesh-list
6084029|NCT05237141|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6084030|NCT05237141|Contraceptive Agents|contraceptive agents|mesh-ancestor
6084031|NCT05237141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6084032|NCT05237141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084033|NCT05237141|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6084034|NCT05237115|Amoxicillin|amoxicillin|mesh-list
6084035|NCT05237115|Clarithromycin|clarithromycin|mesh-list
6084036|NCT05237115|Esomeprazole|esomeprazole|mesh-list
6084037|NCT05237115|Bismuth|bismuth|mesh-list
6464017|NCT00467207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464018|NCT00467207|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6464019|NCT00467207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6464020|NCT00467246|Insulin Detemir|insulin detemir|mesh-list
6464021|NCT00467246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6464022|NCT00467246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464023|NCT00467376|Insulin|insulin|mesh-list
6464024|NCT00467376|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6464025|NCT00467376|Insulin Glargine|insulin glargine|mesh-list
6464026|NCT00467376|Insulin glulisine|insulin glulisine|mesh-list
6464027|NCT00467376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6464028|NCT00467376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464029|NCT00467454|Naltrexone|naltrexone|mesh-list
6464030|NCT00467454|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6464031|NCT00467454|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6464032|NCT00467454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464033|NCT00467454|Sensory System Agents|sensory system agents|mesh-ancestor
6464034|NCT00467454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6084038|NCT05237115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6084039|NCT05237115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6084040|NCT05237115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6084041|NCT05237115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6084042|NCT05237115|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6084043|NCT05237115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6084044|NCT05237115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084045|NCT05237115|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6084046|NCT05237115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6084047|NCT05237115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6084048|NCT05237115|Antacids|antacids|mesh-ancestor
6084049|NCT05236998|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6084050|NCT05236998|Dapagliflozin|dapagliflozin|mesh-list
6084051|NCT05236998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6084052|NCT05236998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084053|NCT05236998|Incretins|incretins|mesh-ancestor
6084054|NCT05236998|Hormones|hormones|mesh-ancestor
6084055|NCT05236998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6084056|NCT05236998|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6084057|NCT05236998|Protease Inhibitors|protease inhibitors|mesh-ancestor
6084058|NCT05236998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6084059|NCT05236998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084060|NCT05236998|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6084061|NCT05236985|Oxytocin|oxytocin|mesh-list
6084062|NCT05236985|Oxytocics|oxytocics|mesh-ancestor
6464035|NCT00467467|Alfuzosin|alfuzosin|mesh-list
6084063|NCT05236985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6084064|NCT05236985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084065|NCT05236972|Capecitabine|capecitabine|mesh-list
6084066|NCT05236972|Oxaliplatin|oxaliplatin|mesh-list
6084067|NCT05236972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6084068|NCT05236972|Antimetabolites|antimetabolites|mesh-ancestor
6084069|NCT05236972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084070|NCT05236972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6084071|NCT05236907|Midazolam|midazolam|mesh-list
6084072|NCT05236907|Melatonin|melatonin|mesh-list
6084073|NCT05236907|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6084074|NCT05236907|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6084075|NCT05236907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6084076|NCT05236907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084077|NCT05236907|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6084078|NCT05236907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6084079|NCT05236907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6084080|NCT05236907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6084081|NCT05236907|Anesthetics, General|anesthetics, general|mesh-ancestor
6084082|NCT05236907|Anesthetics|anesthetics|mesh-ancestor
5515836|NCT04356833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5515837|NCT04356833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515838|NCT04356326|Aspirin|aspirin|mesh-list
6084083|NCT05236907|GABA Modulators|gaba modulators|mesh-ancestor
6084084|NCT05236907|GABA Agents|gaba agents|mesh-ancestor
6084085|NCT05236907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6084086|NCT05236907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084087|NCT05236907|Antioxidants|antioxidants|mesh-ancestor
6084088|NCT05236907|Protective Agents|protective agents|mesh-ancestor
6084089|NCT05236894|Nicotine|nicotine|mesh-list
6084090|NCT05236894|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6084091|NCT05236894|Autonomic Agents|autonomic agents|mesh-ancestor
6084092|NCT05236894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6084093|NCT05236894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084094|NCT05236894|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6084095|NCT05236894|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6084096|NCT05236894|Cholinergic Agents|cholinergic agents|mesh-ancestor
6084097|NCT05236894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6084098|NCT05236894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084099|NCT05236842|Sulthiame|sulthiame|mesh-list
6084100|NCT05236842|Anticonvulsants|anticonvulsants|mesh-ancestor
6084101|NCT05236777|Natalizumab|natalizumab|mesh-list
6084102|NCT05236777|Immunologic Factors|immunologic factors|mesh-ancestor
6084103|NCT05236777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202987|NCT02049307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6202988|NCT02049385|Diazoxide|diazoxide|mesh-list
6202989|NCT02049385|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6202990|NCT02049385|Vasodilator Agents|vasodilator agents|mesh-ancestor
6207744|NCT02119819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6207745|NCT02120157|Mycophenolic Acid|mycophenolic acid|mesh-list
6207746|NCT02120157|Cyclophosphamide|cyclophosphamide|mesh-list
6207747|NCT02120157|Busulfan|busulfan|mesh-list
6207748|NCT02120157|Tacrolimus|tacrolimus|mesh-list
6207749|NCT02120157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6207750|NCT02120157|Immunologic Factors|immunologic factors|mesh-ancestor
6207751|NCT02120157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207752|NCT02120157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5515839|NCT04356326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5515840|NCT04356326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5515841|NCT04356326|Analgesics|analgesics|mesh-ancestor
5515842|NCT04356326|Sensory System Agents|sensory system agents|mesh-ancestor
5515843|NCT04356326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6207753|NCT02120157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6207754|NCT02120157|Alkylating Agents|alkylating agents|mesh-ancestor
6208001|NCT02123017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6084104|NCT05236738|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6084105|NCT05236738|Cobicistat|cobicistat|mesh-list
6084106|NCT05236738|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6084107|NCT05236738|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6084108|NCT05236738|Protease Inhibitors|protease inhibitors|mesh-ancestor
6084109|NCT05236738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6084110|NCT05236738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084111|NCT05236738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6084112|NCT05236738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6084113|NCT05236738|Antiviral Agents|antiviral agents|mesh-ancestor
6084114|NCT05236738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6084115|NCT05236738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6084116|NCT05236738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6084117|NCT05236673|Empagliflozin|empagliflozin|mesh-list
6084118|NCT05236673|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6084119|NCT05236673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084120|NCT05236673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6084121|NCT05236673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084122|NCT05236647|Morphine|morphine|mesh-list
6084123|NCT05236647|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6084124|NCT05236647|Narcotics|narcotics|mesh-ancestor
6084125|NCT05236647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6084126|NCT05236647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084127|NCT05236647|Analgesics|analgesics|mesh-ancestor
6084128|NCT05236647|Sensory System Agents|sensory system agents|mesh-ancestor
6084129|NCT05236647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6084130|NCT05236634|Tadalafil|tadalafil|mesh-list
6084131|NCT05236634|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
6084132|NCT05236634|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
6084133|NCT05236634|Vasodilator Agents|vasodilator agents|mesh-ancestor
6084134|NCT05236634|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6084135|NCT05236634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6084136|NCT05236634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084137|NCT05236634|Urological Agents|urological agents|mesh-ancestor
6084138|NCT05236634|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6084139|NCT05236634|Adrenergic Agents|adrenergic agents|mesh-ancestor
6084140|NCT05236634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6084141|NCT05236634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084142|NCT05236621|Dexamethasone|dexamethasone|mesh-list
6084143|NCT05236621|Pomalidomide|pomalidomide|mesh-list
6084144|NCT05236621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6084145|NCT05236621|Antiemetics|antiemetics|mesh-ancestor
6084146|NCT05236621|Autonomic Agents|autonomic agents|mesh-ancestor
6084147|NCT05236621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6084148|NCT05236621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084149|NCT05236621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6084150|NCT05236621|Glucocorticoids|glucocorticoids|mesh-ancestor
6084151|NCT05236621|Hormones|hormones|mesh-ancestor
6084152|NCT05236621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6084153|NCT05236621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6084154|NCT05236621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6084155|NCT05236621|Immunologic Factors|immunologic factors|mesh-ancestor
6084156|NCT05236621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6084157|NCT05236621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6084158|NCT05236621|Growth Substances|growth substances|mesh-ancestor
6084159|NCT05236621|Growth Inhibitors|growth inhibitors|mesh-ancestor
6084160|NCT05236569|Tranexamic Acid|tranexamic acid|mesh-list
6084161|NCT05236569|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6084162|NCT05236569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6084163|NCT05236569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084164|NCT05236569|Hemostatics|hemostatics|mesh-ancestor
6084165|NCT05236569|Coagulants|coagulants|mesh-ancestor
6084166|NCT05236543|Itraconazole|itraconazole|mesh-list
6084167|NCT05236543|Antifungal Agents|antifungal agents|mesh-ancestor
6084168|NCT05236543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6084169|NCT05236543|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6084170|NCT05236543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6084171|NCT05236543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6084172|NCT05236543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084173|NCT05236543|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6084174|NCT05236543|Hormone Antagonists|hormone antagonists|mesh-ancestor
6084175|NCT05236543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6084176|NCT05236543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202991|NCT02049476|Dexamethasone|dexamethasone|mesh-list
6084177|NCT05236543|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6084178|NCT05236530|Metformin|metformin|mesh-list
6084179|NCT05236530|Repaglinide|repaglinide|mesh-list
6084180|NCT05236530|Lumefantrine|lumefantrine|mesh-list
6084181|NCT05236530|Dolutegravir|dolutegravir|mesh-list
6084182|NCT05236530|Midazolam|midazolam|mesh-list
6084183|NCT05236530|Dextromethorphan|dextromethorphan|mesh-list
6084184|NCT05236530|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6084185|NCT05236530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6084186|NCT05236530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084187|NCT05236530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6084188|NCT05236530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6084189|NCT05236530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6084190|NCT05236530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6084191|NCT05236530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6084192|NCT05236530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6084193|NCT05236530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6084194|NCT05236530|Anesthetics, General|anesthetics, general|mesh-ancestor
6084195|NCT05236530|Anesthetics|anesthetics|mesh-ancestor
6084196|NCT05236530|GABA Modulators|gaba modulators|mesh-ancestor
6084197|NCT05236530|GABA Agents|gaba agents|mesh-ancestor
6084198|NCT05236530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6084199|NCT05236530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084200|NCT05236530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6084201|NCT05236530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6084202|NCT05236530|Antimetabolites|antimetabolites|mesh-ancestor
6084203|NCT05236530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6084204|NCT05236530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6084205|NCT05236530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6084206|NCT05236530|Antimalarials|antimalarials|mesh-ancestor
6084207|NCT05236530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6084208|NCT05236530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6084209|NCT05236530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6084210|NCT05236530|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6084211|NCT05236530|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6084212|NCT05236530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6084213|NCT05236530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6084214|NCT05236530|Antiviral Agents|antiviral agents|mesh-ancestor
6084215|NCT05236530|Antitussive Agents|antitussive agents|mesh-ancestor
6084216|NCT05236530|Respiratory System Agents|respiratory system agents|mesh-ancestor
6084217|NCT05236530|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6084218|NCT05236530|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6084219|NCT05236504|Melatonin|melatonin|mesh-list
6084220|NCT05236504|Antioxidants|antioxidants|mesh-ancestor
6084221|NCT05236504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6464036|NCT00467467|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6084222|NCT05236504|Protective Agents|protective agents|mesh-ancestor
6084223|NCT05236504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084224|NCT05236504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6084225|NCT05236270|Vaccines|vaccines|mesh-list
6084226|NCT05236270|Immunologic Factors|immunologic factors|mesh-ancestor
6084227|NCT05236270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084228|NCT05236231|Tadalafil|tadalafil|mesh-list
6084229|NCT05236231|Macitentan|macitentan|mesh-list
6084230|NCT05236231|Vasodilator Agents|vasodilator agents|mesh-ancestor
6084231|NCT05236231|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6084232|NCT05236231|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6084233|NCT05236231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6084234|NCT05236231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084235|NCT05236231|Urological Agents|urological agents|mesh-ancestor
6084236|NCT05236231|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
6084237|NCT05236231|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6084238|NCT05236231|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
6084239|NCT05236166|Anticonvulsants|anticonvulsants|mesh-list
6084240|NCT05236036|Mycophenolic Acid|mycophenolic acid|mesh-list
6084241|NCT05236036|Temozolomide|temozolomide|mesh-list
6084242|NCT05236036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6084243|NCT05236036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6084244|NCT05236036|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6084245|NCT05236036|Antitubercular Agents|antitubercular agents|mesh-ancestor
6084246|NCT05236036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6084247|NCT05236036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6084248|NCT05236036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6084249|NCT05236036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084250|NCT05236036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6084251|NCT05236036|Alkylating Agents|alkylating agents|mesh-ancestor
6084252|NCT05235737|Pembrolizumab|pembrolizumab|mesh-list
6084253|NCT05235737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6084254|NCT05235737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6084255|NCT05235542|Paclitaxel|paclitaxel|mesh-list
6084256|NCT05235542|Docetaxel|docetaxel|mesh-list
6084257|NCT05235542|Capecitabine|capecitabine|mesh-list
6084258|NCT05235542|Oxaliplatin|oxaliplatin|mesh-list
6084259|NCT05235542|Irinotecan|irinotecan|mesh-list
6084260|NCT05235542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6084261|NCT05235542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6084262|NCT05235542|Tubulin Modulators|tubulin modulators|mesh-ancestor
6084263|NCT05235542|Antimitotic Agents|antimitotic agents|mesh-ancestor
6084264|NCT05235542|Mitosis Modulators|mitosis modulators|mesh-ancestor
6084265|NCT05235542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084266|NCT05235542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6084267|NCT05235542|Antimetabolites|antimetabolites|mesh-ancestor
6084268|NCT05235542|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6084269|NCT05235542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6084270|NCT05235542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6084271|NCT05235516|Cisplatin|cisplatin|mesh-list
6084272|NCT05235516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6202992|NCT02049476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6202993|NCT02049476|Antiemetics|antiemetics|mesh-ancestor
6202994|NCT02049476|Autonomic Agents|autonomic agents|mesh-ancestor
6202995|NCT02049476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6202996|NCT02049476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6202997|NCT02049476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6202998|NCT02049476|Glucocorticoids|glucocorticoids|mesh-ancestor
6202999|NCT02049476|Hormones|hormones|mesh-ancestor
6203000|NCT02049476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6203001|NCT02049476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6203002|NCT02049476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6203003|NCT02049814|Metformin|metformin|mesh-list
6203004|NCT02049814|Acarbose|acarbose|mesh-list
6203005|NCT02049814|Voglibose|voglibose|mesh-list
6203006|NCT02049814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6203007|NCT02049814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203008|NCT02049814|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6203009|NCT02049814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6203010|NCT02049814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203011|NCT02049866|Denosumab|denosumab|mesh-list
6203012|NCT02049866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6203013|NCT02049866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203014|NCT02049944|Cefazolin|cefazolin|mesh-list
6203015|NCT02049944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6203016|NCT02049944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6203017|NCT02049957|Fulvestrant|fulvestrant|mesh-list
6203018|NCT02049957|Exemestane|exemestane|mesh-list
6203019|NCT02049957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6203020|NCT02049957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6203021|NCT02049957|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6203022|NCT02049957|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5515844|NCT04356326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5515845|NCT04356326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5515846|NCT04356326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5515847|NCT04356326|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5515848|NCT04356326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5515849|NCT04356326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203023|NCT02049957|Hormone Antagonists|hormone antagonists|mesh-ancestor
6203024|NCT02049957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6203025|NCT02049957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203026|NCT02049957|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5515850|NCT04356326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5515851|NCT04356326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5515852|NCT04356326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5515853|NCT04356326|Antipyretics|antipyretics|mesh-ancestor
5515854|NCT04356352|Lidocaine|lidocaine|mesh-list
5515855|NCT04356352|Esmolol|esmolol|mesh-list
5515856|NCT04356352|Anesthetics, Local|anesthetics, local|mesh-ancestor
5515857|NCT04356352|Anesthetics|anesthetics|mesh-ancestor
5515858|NCT04356352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5515859|NCT04356352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5515860|NCT04356352|Sensory System Agents|sensory system agents|mesh-ancestor
5515861|NCT04356352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5515862|NCT04356352|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6203027|NCT02049957|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6464037|NCT00467467|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6464038|NCT00467467|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6464039|NCT00467467|Adrenergic Agents|adrenergic agents|mesh-ancestor
6464040|NCT00467467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6084273|NCT05235256|Dexamethasone|dexamethasone|mesh-list
6084274|NCT05235256|Lidocaine|lidocaine|mesh-list
6084275|NCT05235256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6084276|NCT05235256|Antiemetics|antiemetics|mesh-ancestor
6084277|NCT05235256|Autonomic Agents|autonomic agents|mesh-ancestor
6084278|NCT05235256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6084279|NCT05235256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084280|NCT05235256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6084281|NCT05235256|Glucocorticoids|glucocorticoids|mesh-ancestor
6084282|NCT05235256|Hormones|hormones|mesh-ancestor
6084283|NCT05235256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6084284|NCT05235256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6084285|NCT05235256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6084286|NCT05235256|Anesthetics, Local|anesthetics, local|mesh-ancestor
6084287|NCT05235256|Anesthetics|anesthetics|mesh-ancestor
6084288|NCT05235256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6084289|NCT05235256|Sensory System Agents|sensory system agents|mesh-ancestor
6084290|NCT05235256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6084291|NCT05235256|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6084292|NCT05235256|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6084293|NCT05235256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6084294|NCT05235256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084295|NCT05235191|Methadone|methadone|mesh-list
6084296|NCT05235191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6084297|NCT05235191|Narcotics|narcotics|mesh-ancestor
6084298|NCT05235191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6084299|NCT05235191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084300|NCT05235191|Analgesics|analgesics|mesh-ancestor
6084301|NCT05235191|Sensory System Agents|sensory system agents|mesh-ancestor
6084302|NCT05235191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6084303|NCT05235191|Antitussive Agents|antitussive agents|mesh-ancestor
6084304|NCT05235191|Respiratory System Agents|respiratory system agents|mesh-ancestor
6084305|NCT05222555|Lenalidomide|lenalidomide|mesh-list
6084306|NCT05222555|Immunologic Factors|immunologic factors|mesh-ancestor
6084307|NCT05222555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084308|NCT05222555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6084309|NCT05222555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6084310|NCT05222555|Growth Substances|growth substances|mesh-ancestor
6084311|NCT05222555|Growth Inhibitors|growth inhibitors|mesh-ancestor
6084312|NCT05222555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6084313|NCT05216614|Fluvoxamine|fluvoxamine|mesh-list
6084314|NCT05216614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6084315|NCT05216614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6084316|NCT05216614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6084317|NCT05216614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084318|NCT05216614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6084319|NCT05216614|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6084320|NCT05216614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6084321|NCT05216614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6084322|NCT05216614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084323|NCT05216614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6084324|NCT05216614|Serotonin Agents|serotonin agents|mesh-ancestor
6084325|NCT05216614|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6084326|NCT05216614|Antidepressive Agents|antidepressive agents|mesh-ancestor
6084327|NCT05216614|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6084328|NCT05216614|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6084329|NCT05216614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6084330|NCT05216614|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6084331|NCT05215158|Dexmedetomidine|dexmedetomidine|mesh-list
6084332|NCT05215158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6084333|NCT05215158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6084334|NCT05215158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084335|NCT05215158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6084336|NCT05215158|Analgesics|analgesics|mesh-ancestor
6084337|NCT05215158|Sensory System Agents|sensory system agents|mesh-ancestor
6084338|NCT05215158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6084339|NCT05215158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6084340|NCT05215158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6464041|NCT00467467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515863|NCT04356352|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5515864|NCT04356352|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6084341|NCT05215158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6084342|NCT05215158|Adrenergic Agents|adrenergic agents|mesh-ancestor
6084343|NCT05215158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6084344|NCT05215158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084345|NCT05214196|Povidone-Iodine|povidone-iodine|mesh-list
6084346|NCT05214196|Povidone|povidone|mesh-list
6084347|NCT05214196|Plasma Substitutes|plasma substitutes|mesh-ancestor
6084348|NCT05214196|Blood Substitutes|blood substitutes|mesh-ancestor
6084349|NCT05214196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6084350|NCT05214196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6084351|NCT05210621|Ocrelizumab|ocrelizumab|mesh-list
6084352|NCT05210621|Immunologic Factors|immunologic factors|mesh-ancestor
6084353|NCT05210621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084354|NCT05209711|Lidocaine|lidocaine|mesh-list
6464042|NCT00467467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464043|NCT00467467|Urological Agents|urological agents|mesh-ancestor
6464044|NCT00467493|Anastrozole|anastrozole|mesh-list
6464045|NCT00467493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6464046|NCT00467493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5515865|NCT04356352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5515866|NCT04356352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515867|NCT04356352|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5515868|NCT04356352|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5515869|NCT04356352|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5515870|NCT04356352|Adrenergic Agents|adrenergic agents|mesh-ancestor
5515871|NCT04356352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5515872|NCT04356417|Antimalarials|antimalarials|mesh-list
5515873|NCT04356417|Enzyme Inhibitors|enzyme inhibitors|mesh-list
5515874|NCT04356417|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
5515875|NCT04356417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515876|NCT04356417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5515877|NCT04356417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5515878|NCT04356417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5515879|NCT04356222|Methotrexate|methotrexate|mesh-list
5515880|NCT04356222|Durvalumab|durvalumab|mesh-list
5515881|NCT04356222|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5515882|NCT04356222|Abortifacient Agents|abortifacient agents|mesh-ancestor
5515883|NCT04356222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5515884|NCT04356222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5515885|NCT04356222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5515886|NCT04356222|Antimetabolites|antimetabolites|mesh-ancestor
5515887|NCT04356222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515888|NCT04356222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5515889|NCT04356222|Dermatologic Agents|dermatologic agents|mesh-ancestor
5515890|NCT04356222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5515891|NCT04356222|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5515892|NCT04356222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5515893|NCT04356222|Immunologic Factors|immunologic factors|mesh-ancestor
5515894|NCT04356222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5515895|NCT04356222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6464047|NCT00467493|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6464048|NCT00467493|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6464049|NCT00467493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6464050|NCT00467493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515896|NCT04356222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5515897|NCT04356144|Thrombin|thrombin|mesh-list
5515898|NCT04356144|Hemostatics|hemostatics|mesh-ancestor
6464051|NCT00467493|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6464052|NCT00467493|Hormone Antagonists|hormone antagonists|mesh-ancestor
6464053|NCT00467493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6084355|NCT05209711|Anesthetics, Local|anesthetics, local|mesh-ancestor
6084356|NCT05209711|Anesthetics|anesthetics|mesh-ancestor
6084357|NCT05209711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6084358|NCT05209711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084359|NCT05209711|Sensory System Agents|sensory system agents|mesh-ancestor
6084360|NCT05209711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6084361|NCT05209711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6084362|NCT05209711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6084363|NCT05209711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6084364|NCT05209711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6203028|NCT02049957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6084365|NCT05209711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084366|NCT05209620|Pemetrexed|pemetrexed|mesh-list
6084367|NCT05209620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6084368|NCT05209620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6084369|NCT05209620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084370|NCT05209620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6084371|NCT05209620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6084372|NCT05209308|Rituximab|rituximab|mesh-list
6084373|NCT05209308|Venetoclax|venetoclax|mesh-list
6084374|NCT05209308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6084375|NCT05209308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6084376|NCT05209308|Immunologic Factors|immunologic factors|mesh-ancestor
6084377|NCT05209308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084378|NCT05209308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6084379|NCT05206812|Durvalumab|durvalumab|mesh-list
6084380|NCT05206812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6084381|NCT05206812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6084382|NCT05201144|Sildenafil Citrate|sildenafil citrate|mesh-list
6084383|NCT05201144|Vasodilator Agents|vasodilator agents|mesh-ancestor
6084384|NCT05201144|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6084385|NCT05201144|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6084386|NCT05201144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6084387|NCT05201144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084388|NCT05201144|Urological Agents|urological agents|mesh-ancestor
6084389|NCT05198791|Eplerenone|eplerenone|mesh-list
6084390|NCT05198791|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6084391|NCT05198791|Hormone Antagonists|hormone antagonists|mesh-ancestor
6084392|NCT05198791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6084393|NCT05198791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084394|NCT05198791|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6084395|NCT05198791|Diuretics|diuretics|mesh-ancestor
6084396|NCT05198791|Natriuretic Agents|natriuretic agents|mesh-ancestor
6084397|NCT05198791|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6084398|NCT05198232|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
6084399|NCT05198232|TEMPO|tempo|mesh-list
6084400|NCT05198232|Antioxidants|antioxidants|mesh-ancestor
6084401|NCT05198232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084402|NCT05198232|Protective Agents|protective agents|mesh-ancestor
6084403|NCT05198232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084404|NCT05198232|Antacids|antacids|mesh-ancestor
6084405|NCT05198232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6084406|NCT05178628|Gemcitabine|gemcitabine|mesh-list
6084407|NCT05178628|Paclitaxel|paclitaxel|mesh-list
6084408|NCT05178628|Tinzaparin|tinzaparin|mesh-list
6084409|NCT05178628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6084410|NCT05178628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6084411|NCT05178628|Tubulin Modulators|tubulin modulators|mesh-ancestor
6084412|NCT05178628|Antimitotic Agents|antimitotic agents|mesh-ancestor
6084413|NCT05178628|Mitosis Modulators|mitosis modulators|mesh-ancestor
6084414|NCT05178628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084415|NCT05178628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6084416|NCT05178628|Antimetabolites|antimetabolites|mesh-ancestor
5515899|NCT04356144|Coagulants|coagulants|mesh-ancestor
5515900|NCT04356118|Methotrexate|methotrexate|mesh-list
5515901|NCT04356118|Endostatins|endostatins|mesh-list
5515902|NCT04356118|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5515903|NCT04356118|Abortifacient Agents|abortifacient agents|mesh-ancestor
5515904|NCT04356118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5515905|NCT04356118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5515906|NCT04356118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5515907|NCT04356118|Antimetabolites|antimetabolites|mesh-ancestor
5515908|NCT04356118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515909|NCT04356118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5515910|NCT04356118|Dermatologic Agents|dermatologic agents|mesh-ancestor
5515911|NCT04356118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5515912|NCT04356118|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6084417|NCT05178628|Antiviral Agents|antiviral agents|mesh-ancestor
6084418|NCT05178628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6084419|NCT05178628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5515913|NCT04356118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5515914|NCT04356118|Immunologic Factors|immunologic factors|mesh-ancestor
5515915|NCT04356118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5515916|NCT04356118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5515917|NCT04356118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6464054|NCT00467493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488413|NCT00583986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488414|NCT00584090|Solifenacin Succinate|solifenacin succinate|mesh-list
6488415|NCT00584090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6488416|NCT00584090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5515918|NCT04356118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6084420|NCT05178628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6084421|NCT05178628|Immunologic Factors|immunologic factors|mesh-ancestor
6084422|NCT05178628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084423|NCT05178628|Anticoagulants|anticoagulants|mesh-ancestor
6084424|NCT05178628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6084425|NCT05178628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6084426|NCT05177848|Nicotine|nicotine|mesh-list
6084427|NCT05177848|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6084428|NCT05177848|Autonomic Agents|autonomic agents|mesh-ancestor
6084429|NCT05177848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6084430|NCT05177848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084431|NCT05177848|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6084432|NCT05177848|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6084433|NCT05177848|Cholinergic Agents|cholinergic agents|mesh-ancestor
6084434|NCT05177848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6084435|NCT05177848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084436|NCT05177198|Clindamycin|clindamycin|mesh-list
6084437|NCT05177198|Clindamycin palmitate|clindamycin palmitate|mesh-list
6084438|NCT05177198|Clindamycin phosphate|clindamycin phosphate|mesh-list
6084439|NCT05177198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6084440|NCT05177198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6084441|NCT05177198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6084442|NCT05177198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6084443|NCT05177198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084444|NCT05170841|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
6084445|NCT05170841|Tramadol|tramadol|mesh-list
6084446|NCT05170841|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6084447|NCT05170841|Narcotics|narcotics|mesh-ancestor
6084448|NCT05170841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6084449|NCT05170841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084450|NCT05170841|Analgesics|analgesics|mesh-ancestor
6084451|NCT05170841|Sensory System Agents|sensory system agents|mesh-ancestor
6084452|NCT05170841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6084453|NCT05170841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6084454|NCT05170841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6084455|NCT05170841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6084456|NCT05170841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6084457|NCT05161806|Aflibercept|aflibercept|mesh-list
6084458|NCT05161806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6084459|NCT05161806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5515919|NCT04356118|Growth Substances|growth substances|mesh-ancestor
6084460|NCT05161806|Growth Substances|growth substances|mesh-ancestor
6084461|NCT05161806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084462|NCT05161806|Growth Inhibitors|growth inhibitors|mesh-ancestor
6084463|NCT05161806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6084464|NCT05157685|Azithromycin|azithromycin|mesh-list
6084465|NCT05157685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6084466|NCT05157685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6084467|NCT05153408|Carboplatin|carboplatin|mesh-list
6084468|NCT05153408|Pemetrexed|pemetrexed|mesh-list
6084469|NCT05153408|Osimertinib|osimertinib|mesh-list
6084470|NCT05153408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6084471|NCT05153408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6084472|NCT05153408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084473|NCT05153408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6084474|NCT05153408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6084475|NCT05153408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6084476|NCT05137717|Maribavir|maribavir|mesh-list
6084477|NCT05137717|Antiviral Agents|antiviral agents|mesh-ancestor
6084478|NCT05137717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6084479|NCT05131152|Cyclosporine|cyclosporine|mesh-list
6084480|NCT05131152|Cyclosporins|cyclosporins|mesh-list
6084481|NCT05131152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6084482|NCT05131152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084483|NCT05131152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6084484|NCT05131152|Immunologic Factors|immunologic factors|mesh-ancestor
6084485|NCT05131152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084486|NCT05131152|Antifungal Agents|antifungal agents|mesh-ancestor
6084487|NCT05131152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6488417|NCT00584090|Cholinergic Agents|cholinergic agents|mesh-ancestor
6084488|NCT05131152|Dermatologic Agents|dermatologic agents|mesh-ancestor
6084489|NCT05131152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6084490|NCT05131152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6084491|NCT05126784|Denosumab|denosumab|mesh-list
6084492|NCT05126784|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6084493|NCT05126784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203029|NCT02049957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515920|NCT04356118|Growth Inhibitors|growth inhibitors|mesh-ancestor
5515921|NCT04356170|Docetaxel|docetaxel|mesh-list
5515922|NCT04356170|Fluorouracil|fluorouracil|mesh-list
5515923|NCT04356170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5515924|NCT04356170|Tubulin Modulators|tubulin modulators|mesh-ancestor
5515925|NCT04356170|Antimitotic Agents|antimitotic agents|mesh-ancestor
5515926|NCT04356170|Mitosis Modulators|mitosis modulators|mesh-ancestor
5515927|NCT04356170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515928|NCT04356170|Antimetabolites|antimetabolites|mesh-ancestor
5515929|NCT04356170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5515930|NCT04356170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5515931|NCT04356170|Immunologic Factors|immunologic factors|mesh-ancestor
5515932|NCT04356170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5515933|NCT04355832|Glucagon|glucagon|mesh-list
5515934|NCT04355832|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5515935|NCT04355832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5515936|NCT04355832|Hormones|hormones|mesh-ancestor
6203030|NCT02050321|Vemurafenib|vemurafenib|mesh-list
6203031|NCT02050321|Acitretin|acitretin|mesh-list
6203032|NCT02050321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6203033|NCT02050321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6203034|NCT02050321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5515937|NCT04355832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5515938|NCT04355832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5515939|NCT04355832|Incretins|incretins|mesh-ancestor
5515940|NCT04355845|Sumatriptan|sumatriptan|mesh-list
5515941|NCT04355845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5515942|NCT04355845|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5515943|NCT04355845|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6203035|NCT02050321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203036|NCT02050321|Keratolytic Agents|keratolytic agents|mesh-ancestor
6203037|NCT02050321|Dermatologic Agents|dermatologic agents|mesh-ancestor
6203038|NCT02050334|Caffeic acid|caffeic acid|mesh-list
6203039|NCT02050334|Antioxidants|antioxidants|mesh-ancestor
6203040|NCT02050334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203041|NCT02050334|Protective Agents|protective agents|mesh-ancestor
6203042|NCT02050334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203043|NCT02050919|Sorafenib|sorafenib|mesh-list
6203044|NCT02050919|Epirubicin|epirubicin|mesh-list
6203045|NCT02050919|Ifosfamide|ifosfamide|mesh-list
6203046|NCT02050919|Isophosphamide mustard|isophosphamide mustard|mesh-list
6203047|NCT02050919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6203048|NCT02050919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6203049|NCT02050919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6203050|NCT02050919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203051|NCT02050919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6203052|NCT02050919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6203053|NCT02050919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6203054|NCT02050919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6203055|NCT02050919|Alkylating Agents|alkylating agents|mesh-ancestor
5515944|NCT04355845|Serotonin Agents|serotonin agents|mesh-ancestor
5515945|NCT04355845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5515946|NCT04355845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515947|NCT04355845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5515948|NCT04355962|Sevoflurane|sevoflurane|mesh-list
5515949|NCT04355962|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5515950|NCT04355962|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5515951|NCT04355962|Anesthetics, General|anesthetics, general|mesh-ancestor
5515952|NCT04355962|Anesthetics|anesthetics|mesh-ancestor
5515953|NCT04355962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5515954|NCT04355962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5515955|NCT04355949|Vitamin D|vitamin d|mesh-list
5515956|NCT04355949|Ergocalciferols|ergocalciferols|mesh-list
5515957|NCT04355949|Vitamins|vitamins|mesh-list
5515958|NCT04355949|Folic Acid|folic acid|mesh-list
5515959|NCT04355949|Vitamin B 12|vitamin b 12|mesh-list
5515960|NCT04355949|Hydroxocobalamin|hydroxocobalamin|mesh-list
5515961|NCT04355949|Vitamin B Complex|vitamin b complex|mesh-list
5515962|NCT04355949|Micronutrients|micronutrients|mesh-ancestor
5515963|NCT04355949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084494|NCT05125029|Botulinum Toxins|botulinum toxins|mesh-list
6084495|NCT05125029|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6084496|NCT05125029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6084497|NCT05125029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084498|NCT05125029|Cholinergic Agents|cholinergic agents|mesh-ancestor
6084499|NCT05125029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6084500|NCT05125029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084501|NCT05124704|Ropivacaine|ropivacaine|mesh-list
5515964|NCT04355949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5515965|NCT04355949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5515966|NCT04355949|Hematinics|hematinics|mesh-ancestor
5515967|NCT04355936|Telmisartan|telmisartan|mesh-list
5515968|NCT04355936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5515969|NCT04355936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5515970|NCT04355936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5515971|NCT04355936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084502|NCT05124704|Anesthetics, Local|anesthetics, local|mesh-ancestor
6084503|NCT05124704|Anesthetics|anesthetics|mesh-ancestor
6084504|NCT05124704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6084505|NCT05124704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084506|NCT05124704|Sensory System Agents|sensory system agents|mesh-ancestor
6084507|NCT05124704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6084508|NCT05120505|Metformin|metformin|mesh-list
5515972|NCT04355806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6084509|NCT05120505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6084510|NCT05120505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084511|NCT05112601|Nivolumab|nivolumab|mesh-list
6084512|NCT05112601|Ipilimumab|ipilimumab|mesh-list
5515973|NCT04355806|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5515974|NCT04355806|Vaccines|vaccines|mesh-list
5515975|NCT04355806|Antibodies|antibodies|mesh-list
5515976|NCT04355806|Immunoglobulins|immunoglobulins|mesh-list
5515977|NCT04355806|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5515978|NCT04355806|Immunologic Factors|immunologic factors|mesh-ancestor
5515979|NCT04355806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5515980|NCT04355806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5515981|NCT04355806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515982|NCT04355585|Colchicine|colchicine|mesh-list
5515983|NCT04355585|Gout Suppressants|gout suppressants|mesh-ancestor
5515984|NCT04355585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5515985|NCT04355585|Tubulin Modulators|tubulin modulators|mesh-ancestor
5515986|NCT04355585|Antimitotic Agents|antimitotic agents|mesh-ancestor
5515987|NCT04355585|Mitosis Modulators|mitosis modulators|mesh-ancestor
6084513|NCT05112601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6084514|NCT05112601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6084515|NCT05112601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6084516|NCT05112601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084517|NCT05101070|Pembrolizumab|pembrolizumab|mesh-list
6084518|NCT05101070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6084519|NCT05101070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6084520|NCT05091567|Carboplatin|carboplatin|mesh-list
6084521|NCT05091567|Etoposide|etoposide|mesh-list
6084522|NCT05091567|Atezolizumab|atezolizumab|mesh-list
6084523|NCT05091567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6084524|NCT05091567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6084525|NCT05091567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6084526|NCT05091567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6084527|NCT05091567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6084528|NCT05091567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084529|NCT05085002|Letrozole|letrozole|mesh-list
6084530|NCT05085002|Fulvestrant|fulvestrant|mesh-list
6084531|NCT05085002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6084532|NCT05085002|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6084533|NCT05085002|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6084534|NCT05085002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6084535|NCT05085002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515988|NCT04355585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5515989|NCT04355585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5515990|NCT04355598|Lidocaine|lidocaine|mesh-list
5515991|NCT04355598|Nitroglycerin|nitroglycerin|mesh-list
5515992|NCT04355598|Prilocaine|prilocaine|mesh-list
5515993|NCT04355598|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
5515994|NCT04355598|Anesthetics, Local|anesthetics, local|mesh-ancestor
5515995|NCT04355598|Anesthetics|anesthetics|mesh-ancestor
5515996|NCT04355598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5515997|NCT04355598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5515998|NCT04355598|Sensory System Agents|sensory system agents|mesh-ancestor
6084536|NCT05085002|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6084537|NCT05085002|Hormone Antagonists|hormone antagonists|mesh-ancestor
6084538|NCT05085002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6084539|NCT05085002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084540|NCT05085002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6084541|NCT05085002|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6084542|NCT05084053|Immunoglobulins|immunoglobulins|mesh-list
6084543|NCT05084053|Immunologic Factors|immunologic factors|mesh-ancestor
6084544|NCT05084053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084545|NCT05076110|Acetaminophen|acetaminophen|mesh-list
6084546|NCT05076110|Ibuprofen|ibuprofen|mesh-list
6084547|NCT05076110|Oxycodone|oxycodone|mesh-list
6084548|NCT05076110|Gabapentin|gabapentin|mesh-list
6084549|NCT05076110|Methocarbamol|methocarbamol|mesh-list
6084550|NCT05076110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6084551|NCT05076110|Analgesics|analgesics|mesh-ancestor
6084552|NCT05076110|Sensory System Agents|sensory system agents|mesh-ancestor
6084553|NCT05076110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6084554|NCT05076110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084555|NCT05076110|Antipyretics|antipyretics|mesh-ancestor
6084556|NCT05076110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5515999|NCT04355598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5516000|NCT04355598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5516001|NCT04355598|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5516002|NCT04355598|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5516003|NCT04355598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5516004|NCT04355598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516005|NCT04355598|Vasodilator Agents|vasodilator agents|mesh-ancestor
6084557|NCT05076110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6084558|NCT05076110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6084559|NCT05076110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6084560|NCT05076110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6084561|NCT05076110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084562|NCT05076110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6084563|NCT05076110|Narcotics|narcotics|mesh-ancestor
6084564|NCT05076110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6084565|NCT05076110|Anticonvulsants|anticonvulsants|mesh-ancestor
6084566|NCT05076110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6084567|NCT05076110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6084568|NCT05076110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6084569|NCT05076110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6084570|NCT05076110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6464055|NCT00467506|Antibodies|antibodies|mesh-list
6464056|NCT00467506|Antibodies, Bispecific|antibodies, bispecific|mesh-list
6464057|NCT00467506|Immunologic Factors|immunologic factors|mesh-ancestor
6464058|NCT00467506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464059|NCT00467545|Telbivudine|telbivudine|mesh-list
6464060|NCT00467545|Antiviral Agents|antiviral agents|mesh-ancestor
6464061|NCT00467545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6084571|NCT05076110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5516006|NCT04355598|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
5516007|NCT04355637|Budesonide|budesonide|mesh-list
5516008|NCT04355637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5516009|NCT04355637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5516010|NCT04355637|Autonomic Agents|autonomic agents|mesh-ancestor
5516011|NCT04355637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5516012|NCT04355637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5516013|NCT04355637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5516014|NCT04355637|Respiratory System Agents|respiratory system agents|mesh-ancestor
5516015|NCT04355637|Glucocorticoids|glucocorticoids|mesh-ancestor
5516016|NCT04355637|Hormones|hormones|mesh-ancestor
5516017|NCT04355637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5516018|NCT04355468|Analgesics, Opioid|analgesics, opioid|mesh-list
5516019|NCT04355468|Anesthetics|anesthetics|mesh-list
5516020|NCT04355468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5516021|NCT04355468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5516022|NCT04355468|Narcotics|narcotics|mesh-ancestor
5516023|NCT04355468|Analgesics|analgesics|mesh-ancestor
5516024|NCT04355468|Sensory System Agents|sensory system agents|mesh-ancestor
5516025|NCT04355468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5516026|NCT04355416|Curcumin|curcumin|mesh-list
5516027|NCT04355416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5516028|NCT04355416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5516029|NCT04355416|Analgesics|analgesics|mesh-ancestor
5516030|NCT04355416|Sensory System Agents|sensory system agents|mesh-ancestor
5516031|NCT04355416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5516032|NCT04355416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5516033|NCT04355416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5516034|NCT04355416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5516035|NCT04355416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5516036|NCT04355416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5516037|NCT04355416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516038|NCT04355494|Eculizumab|eculizumab|mesh-list
5516039|NCT04355494|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6084572|NCT05076110|Antimanic Agents|antimanic agents|mesh-ancestor
6084573|NCT05076110|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6084574|NCT05076110|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6084575|NCT05070247|Pembrolizumab|pembrolizumab|mesh-list
6084576|NCT05070247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6084577|NCT05070247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6084578|NCT05063201|Cariprazine|cariprazine|mesh-list
6084579|NCT05063201|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6084580|NCT05063201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6084581|NCT05063201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6084582|NCT05063201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084583|NCT05063201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6084584|NCT05057858|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6084585|NCT05057858|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6084586|NCT05057858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6084587|NCT05057858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6084588|NCT05057858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084589|NCT05057858|Antiviral Agents|antiviral agents|mesh-ancestor
6084590|NCT05057858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6084591|NCT05057858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6084592|NCT05057858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6084593|NCT05039736|Nivolumab|nivolumab|mesh-list
6084594|NCT05039736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6084595|NCT05039736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6084596|NCT05039736|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6084597|NCT05039736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084598|NCT05038839|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
6084599|NCT05038839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5516040|NCT04355494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5516041|NCT04355494|Immunologic Factors|immunologic factors|mesh-ancestor
5516042|NCT04355494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5516043|NCT04355520|Fulvestrant|fulvestrant|mesh-list
6084600|NCT05038839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084601|NCT05038839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6084602|NCT05036226|Metformin|metformin|mesh-list
6084603|NCT05036226|Sirolimus|sirolimus|mesh-list
6084604|NCT05036226|Hydroxychloroquine|hydroxychloroquine|mesh-list
6084605|NCT05036226|Nelfinavir|nelfinavir|mesh-list
6084606|NCT05036226|Dasatinib|dasatinib|mesh-list
6084607|NCT05036226|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6203056|NCT02051296|Minocycline|minocycline|mesh-list
5516044|NCT04355520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5516045|NCT04355520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5516046|NCT04355520|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5516047|NCT04355520|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5516048|NCT04355520|Hormone Antagonists|hormone antagonists|mesh-ancestor
5516049|NCT04355520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5516050|NCT04355520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5516051|NCT04355273|Heparin|heparin|mesh-list
5516052|NCT04355273|Calcium heparin|calcium heparin|mesh-list
5516053|NCT04355273|Anticoagulants|anticoagulants|mesh-ancestor
6084608|NCT05036226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084609|NCT05036226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6084610|NCT05036226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6084611|NCT05036226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6084612|NCT05036226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6084613|NCT05036226|Antifungal Agents|antifungal agents|mesh-ancestor
6084614|NCT05036226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6084615|NCT05036226|Immunologic Factors|immunologic factors|mesh-ancestor
6084616|NCT05036226|Antimalarials|antimalarials|mesh-ancestor
6084617|NCT05036226|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6084618|NCT05036226|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6084619|NCT05036226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5516054|NCT04355273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5516055|NCT04355273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5516056|NCT04355273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516057|NCT04355429|Captopril|captopril|mesh-list
5516058|NCT04355429|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5516059|NCT04355429|Protease Inhibitors|protease inhibitors|mesh-ancestor
5516060|NCT04355429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5516061|NCT04355429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516062|NCT04355429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5516063|NCT04355247|Methylprednisolone|methylprednisolone|mesh-list
5516064|NCT04355247|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5516065|NCT04355247|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5516066|NCT04355247|Prednisolone|prednisolone|mesh-list
6084620|NCT05036226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084621|NCT05036226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6084622|NCT05036226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6084623|NCT05036226|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6084624|NCT05036226|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6084625|NCT05036226|Protease Inhibitors|protease inhibitors|mesh-ancestor
6084626|NCT05036226|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6084627|NCT05036226|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6084628|NCT05036226|Antiviral Agents|antiviral agents|mesh-ancestor
6084629|NCT05028075|Cobalt|cobalt|mesh-list
6084630|NCT05028075|Trace Elements|trace elements|mesh-ancestor
6084631|NCT05028075|Micronutrients|micronutrients|mesh-ancestor
6084632|NCT05028075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084633|NCT05025423|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6084634|NCT05025423|Venetoclax|venetoclax|mesh-list
6084635|NCT05025423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6084636|NCT05025423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6084637|NCT05025423|Alkylating Agents|alkylating agents|mesh-ancestor
6084638|NCT05025423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084639|NCT05022758|Warfarin|warfarin|mesh-list
6084640|NCT05022758|Rivaroxaban|rivaroxaban|mesh-list
6084641|NCT05022758|Anticoagulants|anticoagulants|mesh-ancestor
6084642|NCT05022758|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6084643|NCT05022758|Antithrombins|antithrombins|mesh-ancestor
6084644|NCT05022758|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6084645|NCT05022758|Protease Inhibitors|protease inhibitors|mesh-ancestor
6084646|NCT05022758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6084647|NCT05022758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084648|NCT05003089|Prednisolone|prednisolone|mesh-list
6084649|NCT05003089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6084650|NCT05003089|Glucocorticoids|glucocorticoids|mesh-ancestor
6084651|NCT05003089|Hormones|hormones|mesh-ancestor
6084652|NCT05003089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6084653|NCT05003089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084654|NCT05003089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6084655|NCT05003089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6084656|NCT05000450|Cyclophosphamide|cyclophosphamide|mesh-list
6084657|NCT05000450|Fludarabine|fludarabine|mesh-list
6084658|NCT05000450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6084659|NCT05000450|Immunologic Factors|immunologic factors|mesh-ancestor
6208002|NCT02123134|Deoxycholic Acid|deoxycholic acid|mesh-list
5516067|NCT04355247|Prednisolone acetate|prednisolone acetate|mesh-list
6084660|NCT05000450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084661|NCT05000450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6084662|NCT05000450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6084663|NCT05000450|Alkylating Agents|alkylating agents|mesh-ancestor
6084664|NCT05000450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084665|NCT05000450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6084666|NCT05000450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6084667|NCT04999202|Pembrolizumab|pembrolizumab|mesh-list
6084668|NCT04999202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6084669|NCT04999202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6084670|NCT04994431|Tamsulosin|tamsulosin|mesh-list
6084671|NCT04994431|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6084672|NCT04994431|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6084673|NCT04994431|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6084674|NCT04994431|Adrenergic Agents|adrenergic agents|mesh-ancestor
6084675|NCT04994431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6084676|NCT04994431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084677|NCT04994431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084678|NCT04994431|Urological Agents|urological agents|mesh-ancestor
6084679|NCT04991493|Tramadol|tramadol|mesh-list
6084680|NCT04991493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6464062|NCT00467545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6464063|NCT00467545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6464064|NCT00467545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6464065|NCT00467571|Amoxicillin|amoxicillin|mesh-list
6464066|NCT00467571|Clarithromycin|clarithromycin|mesh-list
6464067|NCT00467571|Lansoprazole|lansoprazole|mesh-list
6464068|NCT00467571|Dexlansoprazole|dexlansoprazole|mesh-list
6464069|NCT00467571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6464070|NCT00467571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5516068|NCT04355247|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6084681|NCT04991493|Narcotics|narcotics|mesh-ancestor
6084682|NCT04991493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6084683|NCT04991493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084684|NCT04991493|Analgesics|analgesics|mesh-ancestor
6084685|NCT04991493|Sensory System Agents|sensory system agents|mesh-ancestor
6084686|NCT04991493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6084687|NCT04964947|Tobramycin|tobramycin|mesh-list
6084688|NCT04964947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6084689|NCT04964947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6084690|NCT04959266|Itraconazole|itraconazole|mesh-list
6084691|NCT04959266|Rifampin|rifampin|mesh-list
6084692|NCT04959266|Omeprazole|omeprazole|mesh-list
6084693|NCT04959266|Adavosertib|adavosertib|mesh-list
6084694|NCT04959266|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6084695|NCT04959266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6084696|NCT04959266|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6084697|NCT04959266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6084698|NCT04959266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084699|NCT04959266|Antifungal Agents|antifungal agents|mesh-ancestor
6084700|NCT04959266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6084701|NCT04959266|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6084702|NCT04959266|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6084703|NCT04959266|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6084704|NCT04959266|Hormone Antagonists|hormone antagonists|mesh-ancestor
6084705|NCT04959266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6084706|NCT04959266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084707|NCT04959266|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6084708|NCT04959266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5516069|NCT04355247|Prednisolone phosphate|prednisolone phosphate|mesh-list
5516070|NCT04355247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5516071|NCT04355247|Antiemetics|antiemetics|mesh-ancestor
5516072|NCT04355247|Autonomic Agents|autonomic agents|mesh-ancestor
5516073|NCT04355247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5516074|NCT04355247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5516075|NCT04355247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6084709|NCT04959266|Antitubercular Agents|antitubercular agents|mesh-ancestor
6084710|NCT04959266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6084711|NCT04959266|Leprostatic Agents|leprostatic agents|mesh-ancestor
6084712|NCT04959266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6084713|NCT04959266|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5516076|NCT04355247|Glucocorticoids|glucocorticoids|mesh-ancestor
6464071|NCT00467571|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6084714|NCT04959266|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6084715|NCT04959266|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6084716|NCT04959266|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6084717|NCT04959266|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5516077|NCT04355247|Hormones|hormones|mesh-ancestor
5516078|NCT04355247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5516079|NCT04355247|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5516080|NCT04355247|Protective Agents|protective agents|mesh-ancestor
5516081|NCT04355247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5516082|NCT04355247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5516083|NCT04355455|Citalopram|citalopram|mesh-list
5516084|NCT04355455|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5516085|NCT04355455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5516086|NCT04355455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5516087|NCT04355455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516088|NCT04355455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5516089|NCT04355455|Serotonin Agents|serotonin agents|mesh-ancestor
5516090|NCT04355455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5516091|NCT04355455|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5516092|NCT04355455|Antidepressive Agents|antidepressive agents|mesh-ancestor
5516093|NCT04355455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5516094|NCT04355026|Hydroxychloroquine|hydroxychloroquine|mesh-list
5516095|NCT04355026|Bromhexine|bromhexine|mesh-list
5516096|NCT04355026|Antimalarials|antimalarials|mesh-ancestor
5516097|NCT04355026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5516098|NCT04355026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5516099|NCT04355026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5516100|NCT04355026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5516101|NCT04355026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084718|NCT04959266|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6084719|NCT04956640|Cetuximab|cetuximab|mesh-list
6084720|NCT04956640|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6084721|NCT04956640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5516102|NCT04355026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5516103|NCT04355026|Expectorants|expectorants|mesh-ancestor
5516104|NCT04355026|Respiratory System Agents|respiratory system agents|mesh-ancestor
5516105|NCT04355052|Azithromycin|azithromycin|mesh-list
5516106|NCT04355052|Hydroxychloroquine|hydroxychloroquine|mesh-list
5516107|NCT04355052|Camostat|camostat|mesh-list
5516108|NCT04355052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5516109|NCT04355052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5516110|NCT04355052|Antimalarials|antimalarials|mesh-ancestor
5516111|NCT04355052|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5516112|NCT04355052|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5516113|NCT04355052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5516114|NCT04355052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084722|NCT04956640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6084723|NCT04956640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6084724|NCT04956640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6084725|NCT04956640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203057|NCT02051296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6203058|NCT02051296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6203059|NCT02051335|Scopolamine|scopolamine|mesh-list
6203060|NCT02051335|Donepezil|donepezil|mesh-list
6203061|NCT02051335|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
6203062|NCT02051335|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6203063|NCT02051335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6203064|NCT02051335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203065|NCT02051335|Cholinergic Agents|cholinergic agents|mesh-ancestor
6203066|NCT02051335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6203067|NCT02051335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203068|NCT02051335|Nootropic Agents|nootropic agents|mesh-ancestor
6203069|NCT02051335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6203070|NCT02051335|Antiemetics|antiemetics|mesh-ancestor
6203071|NCT02051335|Autonomic Agents|autonomic agents|mesh-ancestor
6203072|NCT02051335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6203073|NCT02051335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6203074|NCT02051335|Mydriatics|mydriatics|mesh-ancestor
6203075|NCT02051335|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6203076|NCT02051335|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6203077|NCT02051335|Parasympatholytics|parasympatholytics|mesh-ancestor
6203078|NCT02051452|Methylphenidate|methylphenidate|mesh-list
6203079|NCT02051452|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6203080|NCT02051452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5516115|NCT04355052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5516116|NCT04355052|Protease Inhibitors|protease inhibitors|mesh-ancestor
5516117|NCT04355052|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5516118|NCT04355052|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5600648|NCT03710330|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5600649|NCT03710330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5600650|NCT03710330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600651|NCT03710330|Hemostatics|hemostatics|mesh-ancestor
5600652|NCT03710330|Coagulants|coagulants|mesh-ancestor
5600653|NCT03710317|Misoprostol|misoprostol|mesh-list
5600654|NCT03710317|Tranexamic Acid|tranexamic acid|mesh-list
6084726|NCT04926324|Niraparib|niraparib|mesh-list
6084727|NCT04926324|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6084728|NCT04926324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6084729|NCT04926324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084730|NCT04926324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6084731|NCT04918407|Empagliflozin|empagliflozin|mesh-list
6084732|NCT04918407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6084733|NCT04918407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084734|NCT04918407|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6084735|NCT04918407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084736|NCT04903509|Acetaminophen|acetaminophen|mesh-list
6084737|NCT04903509|Liraglutide|liraglutide|mesh-list
6084738|NCT04903509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6084739|NCT04903509|Analgesics|analgesics|mesh-ancestor
6084740|NCT04903509|Sensory System Agents|sensory system agents|mesh-ancestor
5600655|NCT03710317|Carbetocin|carbetocin|mesh-list
5600656|NCT03710317|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5600657|NCT03710317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5600658|NCT03710317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600659|NCT03710317|Hemostatics|hemostatics|mesh-ancestor
5600660|NCT03710317|Coagulants|coagulants|mesh-ancestor
5600661|NCT03710317|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5600662|NCT03710317|Abortifacient Agents|abortifacient agents|mesh-ancestor
5600663|NCT03710317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5600664|NCT03710317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600665|NCT03710317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6084741|NCT04903509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6084742|NCT04903509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084743|NCT04903509|Antipyretics|antipyretics|mesh-ancestor
6084744|NCT04903509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6084745|NCT04903509|Incretins|incretins|mesh-ancestor
6084746|NCT04903509|Hormones|hormones|mesh-ancestor
6084747|NCT04903509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6084748|NCT04900116|Bupivacaine|bupivacaine|mesh-list
6084749|NCT04900116|Anesthetics, Local|anesthetics, local|mesh-ancestor
6084750|NCT04900116|Anesthetics|anesthetics|mesh-ancestor
6084751|NCT04900116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6084752|NCT04900116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084753|NCT04900116|Sensory System Agents|sensory system agents|mesh-ancestor
6084754|NCT04900116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5600666|NCT03710317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5600667|NCT03710317|Oxytocics|oxytocics|mesh-ancestor
5600668|NCT03710304|Misoprostol|misoprostol|mesh-list
5600669|NCT03710304|Tranexamic Acid|tranexamic acid|mesh-list
5600670|NCT03710304|Oxytocin|oxytocin|mesh-list
5600671|NCT03710304|Oxytocics|oxytocics|mesh-ancestor
5600672|NCT03710304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5600673|NCT03710304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600674|NCT03710304|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5600675|NCT03710304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5600676|NCT03710304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600677|NCT03710304|Hemostatics|hemostatics|mesh-ancestor
6084755|NCT04894123|Trifluridine|trifluridine|mesh-list
6084756|NCT04894123|Oxaliplatin|oxaliplatin|mesh-list
6084757|NCT04894123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6084758|NCT04894123|Antimetabolites|antimetabolites|mesh-ancestor
6084759|NCT04894123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084760|NCT04894123|Antiviral Agents|antiviral agents|mesh-ancestor
6084761|NCT04894123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6084762|NCT04875195|Pembrolizumab|pembrolizumab|mesh-list
6084763|NCT04875195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6084764|NCT04875195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6084765|NCT04869449|Ketoconazole|ketoconazole|mesh-list
6084766|NCT04869449|Antifungal Agents|antifungal agents|mesh-ancestor
5600678|NCT03710304|Coagulants|coagulants|mesh-ancestor
5600679|NCT03710304|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6084767|NCT04869449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6084768|NCT04869449|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6084769|NCT04869449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6084770|NCT04869449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6084771|NCT04869449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084772|NCT04869449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6084773|NCT04869449|Hormone Antagonists|hormone antagonists|mesh-ancestor
6084774|NCT04869449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6084775|NCT04869449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084776|NCT04869449|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6084777|NCT04857684|Bevacizumab|bevacizumab|mesh-list
6084778|NCT04857684|Atezolizumab|atezolizumab|mesh-list
6084779|NCT04857684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6084780|NCT04857684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6084781|NCT04857684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5516119|NCT04354961|Paclitaxel|paclitaxel|mesh-list
5516120|NCT04354961|Carboplatin|carboplatin|mesh-list
5516121|NCT04354961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5516122|NCT04354961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5516123|NCT04354961|Tubulin Modulators|tubulin modulators|mesh-ancestor
5516124|NCT04354961|Antimitotic Agents|antimitotic agents|mesh-ancestor
5516125|NCT04354961|Mitosis Modulators|mitosis modulators|mesh-ancestor
6084782|NCT04857684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6084783|NCT04857684|Growth Substances|growth substances|mesh-ancestor
5516126|NCT04354961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516127|NCT04355039|Dexamethasone|dexamethasone|mesh-list
5516128|NCT04355039|Pomalidomide|pomalidomide|mesh-list
5516129|NCT04355039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5516130|NCT04355039|Antiemetics|antiemetics|mesh-ancestor
5516131|NCT04355039|Autonomic Agents|autonomic agents|mesh-ancestor
5516132|NCT04355039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5516133|NCT04355039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5516134|NCT04355039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5516135|NCT04355039|Glucocorticoids|glucocorticoids|mesh-ancestor
5516136|NCT04355039|Hormones|hormones|mesh-ancestor
5516137|NCT04355039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5516138|NCT04355039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5516139|NCT04355039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5516140|NCT04355039|Immunologic Factors|immunologic factors|mesh-ancestor
5516141|NCT04355039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5516142|NCT04355039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5516143|NCT04355039|Growth Substances|growth substances|mesh-ancestor
5516144|NCT04355039|Growth Inhibitors|growth inhibitors|mesh-ancestor
5516145|NCT04354805|Chlorpromazine|chlorpromazine|mesh-list
5516146|NCT04354805|Antiemetics|antiemetics|mesh-ancestor
5516147|NCT04354805|Autonomic Agents|autonomic agents|mesh-ancestor
5516148|NCT04354805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5516149|NCT04354805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5516150|NCT04354805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5516151|NCT04354805|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5516152|NCT04354805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5516153|NCT04354805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5516154|NCT04354805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5516155|NCT04354805|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5516156|NCT04354805|Dopamine Agents|dopamine agents|mesh-ancestor
6084784|NCT04857684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084785|NCT04857684|Growth Inhibitors|growth inhibitors|mesh-ancestor
6084786|NCT04833855|Omalizumab|omalizumab|mesh-list
6084787|NCT04833855|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6084788|NCT04833855|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6084789|NCT04833855|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6084790|NCT04833855|Respiratory System Agents|respiratory system agents|mesh-ancestor
5516157|NCT04354805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5600680|NCT03710304|Abortifacient Agents|abortifacient agents|mesh-ancestor
5516158|NCT04354805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516159|NCT04355156|Axitinib|axitinib|mesh-list
5516160|NCT04355156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5516161|NCT04355156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5516162|NCT04355156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5516163|NCT04355156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516164|NCT04354662|Leucovorin|leucovorin|mesh-list
5516165|NCT04354662|Docetaxel|docetaxel|mesh-list
5516166|NCT04354662|Fluorouracil|fluorouracil|mesh-list
5516167|NCT04354662|Oxaliplatin|oxaliplatin|mesh-list
5516168|NCT04354662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5516169|NCT04354662|Tubulin Modulators|tubulin modulators|mesh-ancestor
5516170|NCT04354662|Antimitotic Agents|antimitotic agents|mesh-ancestor
5516171|NCT04354662|Mitosis Modulators|mitosis modulators|mesh-ancestor
5516172|NCT04354662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516173|NCT04354662|Antimetabolites|antimetabolites|mesh-ancestor
5516174|NCT04354662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5516175|NCT04354662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5516176|NCT04354662|Immunologic Factors|immunologic factors|mesh-ancestor
5516177|NCT04354662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5516178|NCT04354662|Antidotes|antidotes|mesh-ancestor
5516179|NCT04354662|Protective Agents|protective agents|mesh-ancestor
6084791|NCT04833855|Immunologic Factors|immunologic factors|mesh-ancestor
6084792|NCT04833855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084793|NCT04825275|Posaconazole|posaconazole|mesh-list
6084794|NCT04825275|Antifungal Agents|antifungal agents|mesh-ancestor
6084795|NCT04825275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6084796|NCT04825275|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6084797|NCT04825275|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6084798|NCT04825275|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6084799|NCT04825275|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6084800|NCT04825275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6084801|NCT04825275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6084802|NCT04825275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084803|NCT04825275|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6084804|NCT04825275|Hormone Antagonists|hormone antagonists|mesh-ancestor
6084805|NCT04825275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6084806|NCT04825275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084807|NCT04821622|Talazoparib|talazoparib|mesh-list
6084808|NCT04821622|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6084809|NCT04821622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6084810|NCT04821622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084811|NCT04821622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6084815|NCT04787744|Prednisone|prednisone|mesh-list
6084816|NCT04787744|Methylprednisolone|methylprednisolone|mesh-list
6084817|NCT04787744|Docetaxel|docetaxel|mesh-list
6084818|NCT04787744|Leuprolide|leuprolide|mesh-list
6084819|NCT04787744|Goserelin|goserelin|mesh-list
6084820|NCT04787744|Bicalutamide|bicalutamide|mesh-list
6084821|NCT04787744|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6084822|NCT04787744|Flutamide|flutamide|mesh-list
6084823|NCT04787744|Nilutamide|nilutamide|mesh-list
6084824|NCT04787744|Relugolix|relugolix|mesh-list
6084825|NCT04787744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6084826|NCT04787744|Tubulin Modulators|tubulin modulators|mesh-ancestor
6084827|NCT04787744|Antimitotic Agents|antimitotic agents|mesh-ancestor
6084828|NCT04787744|Mitosis Modulators|mitosis modulators|mesh-ancestor
6084829|NCT04787744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084830|NCT04787744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6084831|NCT04787744|Glucocorticoids|glucocorticoids|mesh-ancestor
6084832|NCT04787744|Hormones|hormones|mesh-ancestor
6084833|NCT04787744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6084834|NCT04787744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084835|NCT04787744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6084836|NCT04787744|Antiemetics|antiemetics|mesh-ancestor
6084837|NCT04787744|Autonomic Agents|autonomic agents|mesh-ancestor
6084838|NCT04787744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6084839|NCT04787744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6084840|NCT04787744|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6084841|NCT04787744|Protective Agents|protective agents|mesh-ancestor
6084842|NCT04787744|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6084843|NCT04787744|Fertility Agents|fertility agents|mesh-ancestor
6084844|NCT04787744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6084845|NCT04787744|Androgen Antagonists|androgen antagonists|mesh-ancestor
6084846|NCT04787744|Hormone Antagonists|hormone antagonists|mesh-ancestor
6084847|NCT04787744|Luteolytic Agents|luteolytic agents|mesh-ancestor
6084848|NCT04787744|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6084849|NCT04787744|Contraceptive Agents|contraceptive agents|mesh-ancestor
6084850|NCT04787744|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6084851|NCT04774094|Ceftazidime|ceftazidime|mesh-list
6084852|NCT04774094|Avibactam|avibactam|mesh-list
6084853|NCT04774094|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
6084854|NCT04774094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6084855|NCT04774094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6084856|NCT04774094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6084857|NCT04774094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6084858|NCT04774094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084859|NCT04767984|Calcium, Dietary|calcium, dietary|mesh-list
6084860|NCT04767984|Atorvastatin|atorvastatin|mesh-list
6084861|NCT04767984|Calcium|calcium|mesh-list
6084862|NCT04767984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6084863|NCT04767984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084864|NCT04767984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6084865|NCT04767984|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6084866|NCT04767984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6084867|NCT04767984|Antimetabolites|antimetabolites|mesh-ancestor
5516180|NCT04354662|Vitamin B Complex|vitamin b complex|mesh-ancestor
5516181|NCT04354662|Vitamins|vitamins|mesh-ancestor
5516182|NCT04354662|Micronutrients|micronutrients|mesh-ancestor
5516183|NCT04354441|Hydroxychloroquine|hydroxychloroquine|mesh-list
5516184|NCT04354441|Antimalarials|antimalarials|mesh-ancestor
5516185|NCT04354441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5516186|NCT04354441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5516187|NCT04354441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5516188|NCT04354441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5516189|NCT04354441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516190|NCT04354441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5516191|NCT04354545|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5516192|NCT04354545|Lifitegrast|lifitegrast|mesh-list
5516193|NCT04354545|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5516194|NCT04354350|Telmisartan|telmisartan|mesh-list
6084868|NCT04767984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084869|NCT04767984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6084870|NCT04767984|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5516195|NCT04354350|Ramipril|ramipril|mesh-list
5516196|NCT04354350|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5516197|NCT04354350|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5516198|NCT04354350|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5516199|NCT04354350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516200|NCT04354350|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6084871|NCT04767984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6084872|NCT04760275|Fluoxetine|fluoxetine|mesh-list
6084873|NCT04760275|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6084874|NCT04760275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6464072|NCT00467571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5516201|NCT04354350|Protease Inhibitors|protease inhibitors|mesh-ancestor
5516202|NCT04354350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5516203|NCT04354428|Folic Acid|folic acid|mesh-list
5516204|NCT04354428|Ascorbic Acid|ascorbic acid|mesh-list
5516205|NCT04354428|Ritonavir|ritonavir|mesh-list
5516206|NCT04354428|Lopinavir|lopinavir|mesh-list
5516207|NCT04354428|Azithromycin|azithromycin|mesh-list
5516208|NCT04354428|Hydroxychloroquine|hydroxychloroquine|mesh-list
5600681|NCT03710304|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5725072|NCT03182855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5725073|NCT03182855|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5725074|NCT03182855|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5725075|NCT03182855|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5725076|NCT03182855|Purinergic Agents|purinergic agents|mesh-ancestor
5725077|NCT03182855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5725078|NCT03182855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725079|NCT03182855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725080|NCT03182634|Olaparib|olaparib|mesh-list
5725081|NCT03182634|Fulvestrant|fulvestrant|mesh-list
5725082|NCT03182634|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5725083|NCT03182634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5725084|NCT03182634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725085|NCT03182634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5516209|NCT04354428|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5516210|NCT04354428|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5516211|NCT04354428|Protease Inhibitors|protease inhibitors|mesh-ancestor
5516212|NCT04354428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5516213|NCT04354428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516214|NCT04354428|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5516215|NCT04354428|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5516216|NCT04354428|Antiviral Agents|antiviral agents|mesh-ancestor
5516217|NCT04354428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5516218|NCT04354428|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5516219|NCT04354428|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5516220|NCT04354428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5516221|NCT04354428|Antimalarials|antimalarials|mesh-ancestor
5516222|NCT04354428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5516223|NCT04354428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5516224|NCT04354428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5516225|NCT04354428|Hematinics|hematinics|mesh-ancestor
5516226|NCT04354428|Vitamin B Complex|vitamin b complex|mesh-ancestor
5516227|NCT04354428|Vitamins|vitamins|mesh-ancestor
5516228|NCT04354428|Micronutrients|micronutrients|mesh-ancestor
5516229|NCT04354428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5516230|NCT04354428|Antioxidants|antioxidants|mesh-ancestor
5516231|NCT04354428|Protective Agents|protective agents|mesh-ancestor
5516232|NCT04354376|Telmisartan|telmisartan|mesh-list
5516233|NCT04354376|1,4-dihydropyridine|1,4-dihydropyridine|mesh-list
5516234|NCT04354376|Diuretics|diuretics|mesh-list
5516235|NCT04354376|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
5516236|NCT04354376|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
5516237|NCT04354376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5516238|NCT04354376|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5516239|NCT04354376|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5516240|NCT04354376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516241|NCT04354376|Natriuretic Agents|natriuretic agents|mesh-ancestor
5516242|NCT04354376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5516243|NCT04354376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5516244|NCT04354376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5516245|NCT04354376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5516246|NCT04354155|Enoxaparin|enoxaparin|mesh-list
5516247|NCT04354155|Anticoagulants|anticoagulants|mesh-ancestor
5516248|NCT04354155|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5516249|NCT04354155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5516250|NCT04354155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516251|NCT04354129|Immunoglobulins|immunoglobulins|mesh-list
5516252|NCT04354129|Immunologic Factors|immunologic factors|mesh-ancestor
5516253|NCT04354129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5516254|NCT04353986|Sofosbuvir|sofosbuvir|mesh-list
5516255|NCT04353986|Ledipasvir|ledipasvir|mesh-list
5516256|NCT04353986|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
5516257|NCT04353986|Antiviral Agents|antiviral agents|mesh-ancestor
5516258|NCT04353986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5516259|NCT04353778|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
5516260|NCT04353778|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5516261|NCT04353778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5516262|NCT04353778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516263|NCT04353778|Cholinergic Agents|cholinergic agents|mesh-ancestor
5516264|NCT04353778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5516265|NCT04353778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5516266|NCT04353817|Ivacaftor|ivacaftor|mesh-list
5516267|NCT04353817|Elexacaftor|elexacaftor|mesh-list
5516268|NCT04353817|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
5516269|NCT04353817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5516270|NCT04353817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516271|NCT04353505|Dexamethasone|dexamethasone|mesh-list
5516272|NCT04353505|Ketorolac|ketorolac|mesh-list
5516273|NCT04353505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5516274|NCT04353505|Antiemetics|antiemetics|mesh-ancestor
6084875|NCT04760275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6084876|NCT04760275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084877|NCT04760275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6084878|NCT04760275|Serotonin Agents|serotonin agents|mesh-ancestor
6084879|NCT04760275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084880|NCT04760275|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6084881|NCT04760275|Antidepressive Agents|antidepressive agents|mesh-ancestor
5516275|NCT04353505|Autonomic Agents|autonomic agents|mesh-ancestor
5516276|NCT04353505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5516277|NCT04353505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5516278|NCT04353505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5516279|NCT04353505|Glucocorticoids|glucocorticoids|mesh-ancestor
5516280|NCT04353505|Hormones|hormones|mesh-ancestor
6084882|NCT04760275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6084883|NCT04760275|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6084884|NCT04760275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6084885|NCT04760275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6084886|NCT04744363|Ustekinumab|ustekinumab|mesh-list
6084887|NCT04744363|Dermatologic Agents|dermatologic agents|mesh-ancestor
6084888|NCT04743804|Ravulizumab|ravulizumab|mesh-list
6084889|NCT04743804|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6084890|NCT04743804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6084891|NCT04743804|Immunologic Factors|immunologic factors|mesh-ancestor
6084892|NCT04743804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084893|NCT04742283|Timolol|timolol|mesh-list
5516281|NCT04353505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5516282|NCT04353505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5516283|NCT04353505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5516284|NCT04353505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5516285|NCT04353505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5516286|NCT04353505|Analgesics|analgesics|mesh-ancestor
5516287|NCT04353505|Sensory System Agents|sensory system agents|mesh-ancestor
5516288|NCT04353505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5516289|NCT04353505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5516290|NCT04353505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5516291|NCT04353505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516292|NCT04353479|Decitabine|decitabine|mesh-list
5516293|NCT04353479|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5516294|NCT04353479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5516295|NCT04353479|Antimetabolites|antimetabolites|mesh-ancestor
5516296|NCT04353479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516297|NCT04353479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5516298|NCT04353479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5516299|NCT04353596|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
5516300|NCT04353596|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
5516301|NCT04353596|Protease Inhibitors|protease inhibitors|mesh-ancestor
5516302|NCT04353596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5516303|NCT04353596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516304|NCT04353362|Amoxicillin|amoxicillin|mesh-list
5516305|NCT04353362|Metronidazole|metronidazole|mesh-list
5516306|NCT04353362|Ofloxacin|ofloxacin|mesh-list
5516307|NCT04353362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5516308|NCT04353362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5516309|NCT04353362|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5516310|NCT04353362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5516311|NCT04353362|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5516312|NCT04353362|Renal Agents|renal agents|mesh-ancestor
5516313|NCT04353362|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5516314|NCT04353362|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5516315|NCT04353362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5516316|NCT04353362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516317|NCT04353362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5516318|NCT04353362|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5516319|NCT04353362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5516320|NCT04353713|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
5516321|NCT04353713|Laxatives|laxatives|mesh-ancestor
5516322|NCT04353713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5516323|NCT04353336|Hydroxychloroquine|hydroxychloroquine|mesh-list
5516324|NCT04353336|Chloroquine|chloroquine|mesh-list
5516325|NCT04353336|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
5516326|NCT04353336|Antimalarials|antimalarials|mesh-ancestor
5516327|NCT04353336|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5516328|NCT04353336|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5516329|NCT04353336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5516330|NCT04353336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5516331|NCT04353336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516332|NCT04353336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5516333|NCT04353336|Amebicides|amebicides|mesh-ancestor
5516334|NCT04353336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5516335|NCT04353336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5516336|NCT04353336|Analgesics|analgesics|mesh-ancestor
6084894|NCT04742283|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6084895|NCT04742283|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6084896|NCT04742283|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6084897|NCT04742283|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6084898|NCT04742283|Adrenergic Agents|adrenergic agents|mesh-ancestor
5516337|NCT04353336|Sensory System Agents|sensory system agents|mesh-ancestor
5516338|NCT04353336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5516339|NCT04353336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5516340|NCT04353336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5516341|NCT04353336|Filaricides|filaricides|mesh-ancestor
6084899|NCT04742283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6084900|NCT04742283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084901|NCT04742283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084902|NCT04742283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6084903|NCT04742283|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6084904|NCT04740580|Acetylcysteine|acetylcysteine|mesh-list
6084905|NCT04740580|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6084906|NCT04740580|Glycine|glycine|mesh-list
5516342|NCT04353336|Antinematodal Agents|antinematodal agents|mesh-ancestor
5516343|NCT04353336|Anthelmintics|anthelmintics|mesh-ancestor
5516344|NCT04353414|Bupivacaine|bupivacaine|mesh-list
5516345|NCT04353414|Anesthetics, Local|anesthetics, local|mesh-ancestor
5516346|NCT04353414|Anesthetics|anesthetics|mesh-ancestor
5516347|NCT04353414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5516348|NCT04353414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5516349|NCT04353414|Sensory System Agents|sensory system agents|mesh-ancestor
5516350|NCT04353414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5516351|NCT04353284|Gabexate|gabexate|mesh-list
5516352|NCT04353284|Camostat|camostat|mesh-list
6084907|NCT04740580|Antiviral Agents|antiviral agents|mesh-ancestor
6084908|NCT04740580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6084909|NCT04740580|Expectorants|expectorants|mesh-ancestor
6084910|NCT04740580|Respiratory System Agents|respiratory system agents|mesh-ancestor
6084911|NCT04740580|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6084912|NCT04740580|Antioxidants|antioxidants|mesh-ancestor
6084913|NCT04740580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084914|NCT04740580|Protective Agents|protective agents|mesh-ancestor
6084915|NCT04740580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084916|NCT04740580|Antidotes|antidotes|mesh-ancestor
6084917|NCT04740580|Glycine Agents|glycine agents|mesh-ancestor
6084918|NCT04740580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6084919|NCT04738942|Vedolizumab|vedolizumab|mesh-list
6084920|NCT04738942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6084921|NCT04729725|Cemiplimab|cemiplimab|mesh-list
6084922|NCT04729725|Antibodies|antibodies|mesh-list
6084923|NCT04729725|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6084924|NCT04729725|Immunologic Factors|immunologic factors|mesh-ancestor
6084925|NCT04729725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084926|NCT04729725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6084927|NCT04729725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6084928|NCT04729608|Paclitaxel|paclitaxel|mesh-list
6084929|NCT04729608|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6084930|NCT04729608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6084931|NCT04729608|Tubulin Modulators|tubulin modulators|mesh-ancestor
6084932|NCT04729608|Antimitotic Agents|antimitotic agents|mesh-ancestor
6084933|NCT04729608|Mitosis Modulators|mitosis modulators|mesh-ancestor
6084934|NCT04729608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084935|NCT04708470|Entinostat|entinostat|mesh-list
6084936|NCT04708470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6084937|NCT04708470|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6084938|NCT04708470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6084939|NCT04708470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084940|NCT04703335|Anti-Infective Agents|anti-infective agents|mesh-list
6084941|NCT04703335|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6084942|NCT04696731|Cyclophosphamide|cyclophosphamide|mesh-list
6084943|NCT04696731|Fludarabine|fludarabine|mesh-list
6084944|NCT04696731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6084945|NCT04696731|Immunologic Factors|immunologic factors|mesh-ancestor
6084946|NCT04696731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084947|NCT04696731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6084948|NCT04696731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6084949|NCT04696731|Alkylating Agents|alkylating agents|mesh-ancestor
6084950|NCT04696731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516353|NCT04353284|Protease Inhibitors|protease inhibitors|mesh-ancestor
5516354|NCT04353284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6084951|NCT04696731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6084952|NCT04696731|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6084953|NCT04694976|Vitamin D|vitamin d|mesh-list
6084954|NCT04694976|Vitamins|vitamins|mesh-ancestor
6084955|NCT04694976|Micronutrients|micronutrients|mesh-ancestor
6084956|NCT04694976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084957|NCT04694976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6084958|NCT04669665|Ketamine|ketamine|mesh-list
6084959|NCT04669665|Analgesics|analgesics|mesh-ancestor
6084960|NCT04669665|Sensory System Agents|sensory system agents|mesh-ancestor
6084961|NCT04669665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6084962|NCT04669665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084963|NCT04669665|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6084964|NCT04669665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6084965|NCT04669665|Anesthetics, General|anesthetics, general|mesh-ancestor
6084966|NCT04669665|Anesthetics|anesthetics|mesh-ancestor
6084967|NCT04669665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6084968|NCT04669665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6084969|NCT04669665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6084970|NCT04669665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6084971|NCT04669665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084972|NCT04667312|Durvalumab|durvalumab|mesh-list
6084973|NCT04667312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6084974|NCT04667312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6084975|NCT04666740|Pembrolizumab|pembrolizumab|mesh-list
6084976|NCT04666740|Olaparib|olaparib|mesh-list
6084977|NCT04666740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6084978|NCT04666740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6084979|NCT04666740|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5516355|NCT04353284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516356|NCT04353284|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5516357|NCT04353284|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5516358|NCT04353284|Anticoagulants|anticoagulants|mesh-ancestor
5600682|NCT03710304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5600683|NCT03710252|Ritonavir|ritonavir|mesh-list
5600684|NCT03710252|Ribavirin|ribavirin|mesh-list
5600685|NCT03710252|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5600686|NCT03710252|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5600687|NCT03710252|Protease Inhibitors|protease inhibitors|mesh-ancestor
5600688|NCT03710252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5600689|NCT03710252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600690|NCT03710252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5600691|NCT03710252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5600692|NCT03710252|Antiviral Agents|antiviral agents|mesh-ancestor
5600693|NCT03710252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5600694|NCT03710252|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5600695|NCT03710252|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5600696|NCT03710252|Antimetabolites|antimetabolites|mesh-ancestor
5600697|NCT03710174|Salicylic Acid|salicylic acid|mesh-list
5600698|NCT03710174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5600699|NCT03710174|Antifungal Agents|antifungal agents|mesh-ancestor
5600700|NCT03710174|Keratolytic Agents|keratolytic agents|mesh-ancestor
5600701|NCT03710174|Dermatologic Agents|dermatologic agents|mesh-ancestor
5600702|NCT03710122|Vancomycin|vancomycin|mesh-list
5600703|NCT03710122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5600704|NCT03710122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5600705|NCT03710044|Cyclosporine|cyclosporine|mesh-list
5600706|NCT03710044|Cyclosporins|cyclosporins|mesh-list
5600707|NCT03710044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5600708|NCT03710044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600709|NCT03710044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5600710|NCT03710044|Immunologic Factors|immunologic factors|mesh-ancestor
5600711|NCT03710044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600712|NCT03710044|Antifungal Agents|antifungal agents|mesh-ancestor
5600713|NCT03710044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5600714|NCT03710044|Dermatologic Agents|dermatologic agents|mesh-ancestor
5600715|NCT03710044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6084980|NCT04666740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6084981|NCT04666740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084982|NCT04661280|Donepezil|donepezil|mesh-list
6084983|NCT04661280|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6084984|NCT04661280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6084985|NCT04661280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6084986|NCT04661280|Cholinergic Agents|cholinergic agents|mesh-ancestor
6084987|NCT04661280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6084988|NCT04661280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084989|NCT04661280|Nootropic Agents|nootropic agents|mesh-ancestor
5600716|NCT03710044|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6464073|NCT00467571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516359|NCT04352959|Betadex|betadex|mesh-list
5516360|NCT04352959|Sequestering Agents|sequestering agents|mesh-ancestor
5516361|NCT04352959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516362|NCT04353180|Tretinoin|tretinoin|mesh-list
5516363|NCT04353180|Isotretinoin|isotretinoin|mesh-list
5516364|NCT04353180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6084990|NCT04650854|Rozanolixizumab|rozanolixizumab|mesh-list
6084991|NCT04650854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6084992|NCT04650854|Immunologic Factors|immunologic factors|mesh-ancestor
6084993|NCT04650854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6084994|NCT04645550|Aspirin|aspirin|mesh-list
6084995|NCT04645550|Heparin|heparin|mesh-list
6084996|NCT04645550|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6084997|NCT04645550|Tinzaparin|tinzaparin|mesh-list
6084998|NCT04645550|Dalteparin|dalteparin|mesh-list
6084999|NCT04645550|Dipyridamole|dipyridamole|mesh-list
6085000|NCT04645550|Warfarin|warfarin|mesh-list
6085001|NCT04645550|Apixaban|apixaban|mesh-list
6085002|NCT04645550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6085003|NCT04645550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6085004|NCT04645550|Analgesics|analgesics|mesh-ancestor
5516365|NCT04353180|Keratolytic Agents|keratolytic agents|mesh-ancestor
5516366|NCT04353180|Dermatologic Agents|dermatologic agents|mesh-ancestor
5516367|NCT04353024|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
5516368|NCT04353024|Hallucinogens|hallucinogens|mesh-ancestor
5516369|NCT04353024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5516370|NCT04353024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5516371|NCT04353024|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5516372|NCT04353024|Serotonin Agents|serotonin agents|mesh-ancestor
5516373|NCT04353024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5516374|NCT04353024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516375|NCT04353024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5516376|NCT04353193|Octreotide|octreotide|mesh-list
6085005|NCT04645550|Sensory System Agents|sensory system agents|mesh-ancestor
6085006|NCT04645550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6085007|NCT04645550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085008|NCT04645550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6085009|NCT04645550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6085010|NCT04645550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6085011|NCT04645550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6085012|NCT04645550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085013|NCT04645550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6085014|NCT04645550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6085015|NCT04645550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6085016|NCT04645550|Antipyretics|antipyretics|mesh-ancestor
6085017|NCT04645550|Anticoagulants|anticoagulants|mesh-ancestor
6085018|NCT04645550|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6085019|NCT04645550|Antithrombins|antithrombins|mesh-ancestor
6085020|NCT04645550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6085021|NCT04645550|Protease Inhibitors|protease inhibitors|mesh-ancestor
6085022|NCT04645550|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6085023|NCT04645550|Vasodilator Agents|vasodilator agents|mesh-ancestor
6085024|NCT04634071|Bupropion|bupropion|mesh-list
6085025|NCT04634071|Nicotine|nicotine|mesh-list
6085026|NCT04634071|Varenicline|varenicline|mesh-list
6085027|NCT04634071|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6085028|NCT04634071|Autonomic Agents|autonomic agents|mesh-ancestor
6085029|NCT04634071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6085030|NCT04634071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085031|NCT04634071|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6085032|NCT04634071|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6085033|NCT04634071|Cholinergic Agents|cholinergic agents|mesh-ancestor
6085034|NCT04634071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6085035|NCT04634071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085036|NCT04634071|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6085037|NCT04634071|Antidepressive Agents|antidepressive agents|mesh-ancestor
6085038|NCT04634071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6085039|NCT04634071|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6085040|NCT04634071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6085041|NCT04634071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6085042|NCT04634071|Dopamine Agents|dopamine agents|mesh-ancestor
6085043|NCT04634071|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6085044|NCT04634071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6085045|NCT04634071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5516377|NCT04353193|Terlipressin|terlipressin|mesh-list
6085046|NCT04613492|Durvalumab|durvalumab|mesh-list
6085047|NCT04613492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6085048|NCT04613492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6085049|NCT04609514|Nicotine|nicotine|mesh-list
6085050|NCT04609514|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6085051|NCT04609514|Autonomic Agents|autonomic agents|mesh-ancestor
6085052|NCT04609514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6085053|NCT04609514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085054|NCT04609514|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6085055|NCT04609514|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6085056|NCT04609514|Cholinergic Agents|cholinergic agents|mesh-ancestor
5516378|NCT04353193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5516379|NCT04353193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5516380|NCT04353193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5516381|NCT04353193|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5516382|NCT04353193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5516383|NCT04352946|Hydroxychloroquine|hydroxychloroquine|mesh-list
5516384|NCT04352946|Antimalarials|antimalarials|mesh-ancestor
5516385|NCT04352946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5516386|NCT04352946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5516387|NCT04352946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5516388|NCT04352946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5516389|NCT04352946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516390|NCT04352946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5516391|NCT04352933|Hydroxychloroquine|hydroxychloroquine|mesh-list
5516392|NCT04352933|Antimalarials|antimalarials|mesh-ancestor
6085057|NCT04609514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6085058|NCT04609514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085059|NCT04608201|Nicotine|nicotine|mesh-list
6085060|NCT04608201|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6085061|NCT04608201|Autonomic Agents|autonomic agents|mesh-ancestor
6085062|NCT04608201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6085063|NCT04608201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085064|NCT04608201|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6085065|NCT04608201|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6085066|NCT04608201|Cholinergic Agents|cholinergic agents|mesh-ancestor
6464074|NCT00467571|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6464075|NCT00467571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6464076|NCT00467571|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6085067|NCT04608201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6085068|NCT04608201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085069|NCT04603248|Nivolumab|nivolumab|mesh-list
6085070|NCT04603248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6085071|NCT04603248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6085072|NCT04603248|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6085073|NCT04603248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085074|NCT04592913|Durvalumab|durvalumab|mesh-list
6085075|NCT04592913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6085076|NCT04592913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6085077|NCT04591925|Insulin|insulin|mesh-list
6085078|NCT04591925|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6085079|NCT04591925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6085080|NCT04591925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085081|NCT04576104|Metformin|metformin|mesh-list
5516393|NCT04352933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6085082|NCT04576104|Megestrol|megestrol|mesh-list
6085083|NCT04576104|Megestrol Acetate|megestrol acetate|mesh-list
6085084|NCT04576104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6085085|NCT04576104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5516394|NCT04352933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5516395|NCT04352933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5516396|NCT04352933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5516397|NCT04352933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516398|NCT04352933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5516399|NCT04352855|Tazobactam|tazobactam|mesh-list
5516400|NCT04352855|Ceftolozane|ceftolozane|mesh-list
5516401|NCT04352855|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
5516402|NCT04352855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5516403|NCT04352855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5516404|NCT04352855|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5516405|NCT04352855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5516406|NCT04352855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516407|NCT04352855|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5516408|NCT04352855|Renal Agents|renal agents|mesh-ancestor
5516409|NCT04352777|Fulvestrant|fulvestrant|mesh-list
5516410|NCT04352777|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5516411|NCT04352777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5516412|NCT04352777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6085086|NCT04576104|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6085087|NCT04576104|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6085088|NCT04576104|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6085089|NCT04576104|Contraceptive Agents|contraceptive agents|mesh-ancestor
6085090|NCT04576104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6085091|NCT04576104|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6085092|NCT04576104|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6085093|NCT04576104|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6085094|NCT04576104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6085095|NCT04576104|Appetite Stimulants|appetite stimulants|mesh-ancestor
6085096|NCT04576104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6085097|NCT04572256|Montelukast|montelukast|mesh-list
6085098|NCT04572256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6085099|NCT04572256|Respiratory System Agents|respiratory system agents|mesh-ancestor
6085100|NCT04572256|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6085101|NCT04572256|Hormone Antagonists|hormone antagonists|mesh-ancestor
6085102|NCT04572256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6085103|NCT04572256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085104|NCT04572256|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6085105|NCT04572256|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6085106|NCT04572256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085107|NCT04565730|Anesthetics|anesthetics|mesh-list
6085108|NCT04565730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6085109|NCT04565730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085110|NCT04562467|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
6085111|NCT04562467|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6085112|NCT04562467|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6085113|NCT04550481|Lisinopril|lisinopril|mesh-list
6085114|NCT04550481|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6085115|NCT04550481|Protease Inhibitors|protease inhibitors|mesh-ancestor
6085116|NCT04550481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6085117|NCT04550481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085118|NCT04550481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6085119|NCT04550481|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6085120|NCT04550481|Protective Agents|protective agents|mesh-ancestor
6085121|NCT04550481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085122|NCT04538742|Paclitaxel|paclitaxel|mesh-list
6085123|NCT04538742|Trastuzumab|trastuzumab|mesh-list
6085124|NCT04538742|Durvalumab|durvalumab|mesh-list
6085125|NCT04538742|Pertuzumab|pertuzumab|mesh-list
6085126|NCT04538742|Tucatinib|tucatinib|mesh-list
6085127|NCT04538742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6085128|NCT04538742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6085129|NCT04538742|Tubulin Modulators|tubulin modulators|mesh-ancestor
6085130|NCT04538742|Antimitotic Agents|antimitotic agents|mesh-ancestor
6085131|NCT04538742|Mitosis Modulators|mitosis modulators|mesh-ancestor
6085132|NCT04538742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085133|NCT04538742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5516413|NCT04352777|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5516414|NCT04352777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6085134|NCT04538742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6085135|NCT04538742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6085136|NCT04537156|Vaccines|vaccines|mesh-list
6085137|NCT04537156|Immunologic Factors|immunologic factors|mesh-ancestor
6085138|NCT04537156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085139|NCT04530565|Cytarabine|cytarabine|mesh-list
6085140|NCT04530565|Dexamethasone|dexamethasone|mesh-list
6085141|NCT04530565|Dexamethasone acetate|dexamethasone acetate|mesh-list
6085142|NCT04530565|Prednisone|prednisone|mesh-list
6085143|NCT04530565|Cortisone|cortisone|mesh-list
6085144|NCT04530565|Cyclophosphamide|cyclophosphamide|mesh-list
6085145|NCT04530565|Doxorubicin|doxorubicin|mesh-list
6085146|NCT04530565|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6464077|NCT00467571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6085147|NCT04530565|Methotrexate|methotrexate|mesh-list
6085148|NCT04530565|Vincristine|vincristine|mesh-list
6085149|NCT04530565|Dasatinib|dasatinib|mesh-list
6085150|NCT04530565|Blinatumomab|blinatumomab|mesh-list
6085151|NCT04530565|Ponatinib|ponatinib|mesh-list
5516415|NCT04352777|Hormone Antagonists|hormone antagonists|mesh-ancestor
5516416|NCT04352777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5516417|NCT04352777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5516418|NCT04352777|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5516419|NCT04352777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5516420|NCT04352777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516421|NCT04352686|Buspirone|buspirone|mesh-list
5516422|NCT04352686|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5516423|NCT04352686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5516424|NCT04352686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5516425|NCT04352686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5516426|NCT04352686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6085152|NCT04530565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6085153|NCT04530565|Muromonab-CD3|muromonab-cd3|mesh-list
6085154|NCT04530565|Antibodies|antibodies|mesh-list
6085155|NCT04530565|Immunoglobulins|immunoglobulins|mesh-list
6085156|NCT04530565|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6085157|NCT04530565|Antibodies, Bispecific|antibodies, bispecific|mesh-list
6085158|NCT04530565|BB 1101|bb 1101|mesh-list
6085159|NCT04530565|Mesna|mesna|mesh-list
6085160|NCT04530565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6085161|NCT04530565|Immunologic Factors|immunologic factors|mesh-ancestor
6085162|NCT04530565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085163|NCT04530565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6085164|NCT04530565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6085165|NCT04530565|Alkylating Agents|alkylating agents|mesh-ancestor
6085166|NCT04530565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085167|NCT04530565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6085168|NCT04530565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6085169|NCT04530565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6085170|NCT04530565|Antiemetics|antiemetics|mesh-ancestor
6085171|NCT04530565|Autonomic Agents|autonomic agents|mesh-ancestor
6085172|NCT04530565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6085173|NCT04530565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6085174|NCT04530565|Glucocorticoids|glucocorticoids|mesh-ancestor
6085175|NCT04530565|Hormones|hormones|mesh-ancestor
6085176|NCT04530565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6085177|NCT04530565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6085178|NCT04530565|Protease Inhibitors|protease inhibitors|mesh-ancestor
6085179|NCT04530565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6085180|NCT04530565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6085181|NCT04530565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6085182|NCT04530565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6085183|NCT04530565|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6085184|NCT04530565|Abortifacient Agents|abortifacient agents|mesh-ancestor
6085185|NCT04530565|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6085186|NCT04530565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6085187|NCT04530565|Antimetabolites|antimetabolites|mesh-ancestor
6085188|NCT04530565|Dermatologic Agents|dermatologic agents|mesh-ancestor
6085189|NCT04530565|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6085190|NCT04530565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6085191|NCT04530565|Antiviral Agents|antiviral agents|mesh-ancestor
6085192|NCT04530565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6085193|NCT04530565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6085194|NCT04530565|Tubulin Modulators|tubulin modulators|mesh-ancestor
6085195|NCT04530565|Antimitotic Agents|antimitotic agents|mesh-ancestor
6085196|NCT04530565|Mitosis Modulators|mitosis modulators|mesh-ancestor
6085197|NCT04530565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6085198|NCT04530565|Protective Agents|protective agents|mesh-ancestor
6085199|NCT04526691|Carboplatin|carboplatin|mesh-list
6085200|NCT04526691|Pembrolizumab|pembrolizumab|mesh-list
6085201|NCT04526691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6085202|NCT04526691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6085203|NCT04524689|Carboplatin|carboplatin|mesh-list
6085204|NCT04524689|Pembrolizumab|pembrolizumab|mesh-list
6085205|NCT04524689|Pemetrexed|pemetrexed|mesh-list
6085206|NCT04524689|Maytansine|maytansine|mesh-list
6085207|NCT04524689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6085208|NCT04524689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6085209|NCT04524689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6085210|NCT04524689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085211|NCT04524689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6085212|NCT04524689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6085213|NCT04524689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6085214|NCT04524689|Tubulin Modulators|tubulin modulators|mesh-ancestor
6085215|NCT04524689|Antimitotic Agents|antimitotic agents|mesh-ancestor
6085216|NCT04524689|Mitosis Modulators|mitosis modulators|mesh-ancestor
6085217|NCT04509674|Empagliflozin|empagliflozin|mesh-list
5516427|NCT04352686|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5516428|NCT04352686|Serotonin Agents|serotonin agents|mesh-ancestor
5516429|NCT04352686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5516430|NCT04352686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516431|NCT04352621|Ketamine|ketamine|mesh-list
5516432|NCT04352621|Analgesics|analgesics|mesh-ancestor
5516433|NCT04352621|Sensory System Agents|sensory system agents|mesh-ancestor
5516434|NCT04352621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5516435|NCT04352621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085218|NCT04509674|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6085219|NCT04509674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085220|NCT04509674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6085221|NCT04509674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085222|NCT04501718|Etoposide|etoposide|mesh-list
6085223|NCT04501718|Temozolomide|temozolomide|mesh-list
6085224|NCT04501718|Apatinib|apatinib|mesh-list
6085225|NCT04501718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6085226|NCT04501718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6085227|NCT04501718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6085228|NCT04501718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6085229|NCT04501718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6085230|NCT04501718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085231|NCT04501718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6085232|NCT04501718|Alkylating Agents|alkylating agents|mesh-ancestor
6085233|NCT04501718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6085234|NCT04501705|Apatinib|apatinib|mesh-list
6085235|NCT04501705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6085236|NCT04501705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6085237|NCT04501705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6085238|NCT04501705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085239|NCT04490018|Vaccines|vaccines|mesh-list
6085240|NCT04490018|Immunologic Factors|immunologic factors|mesh-ancestor
6085241|NCT04490018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085242|NCT04489888|Paclitaxel|paclitaxel|mesh-list
6085243|NCT04489888|Carboplatin|carboplatin|mesh-list
6085244|NCT04489888|Pembrolizumab|pembrolizumab|mesh-list
6085245|NCT04489888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6085246|NCT04489888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6085247|NCT04489888|Tubulin Modulators|tubulin modulators|mesh-ancestor
6085248|NCT04489888|Antimitotic Agents|antimitotic agents|mesh-ancestor
6085249|NCT04489888|Mitosis Modulators|mitosis modulators|mesh-ancestor
6085250|NCT04489888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085251|NCT04489888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6085252|NCT04445662|Varenicline|varenicline|mesh-list
5516436|NCT04352621|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6085253|NCT04445662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6085254|NCT04445662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6085255|NCT04445662|Cholinergic Agents|cholinergic agents|mesh-ancestor
6085256|NCT04445662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6085257|NCT04445662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085258|NCT04445662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085259|NCT04430855|Upadacitinib|upadacitinib|mesh-list
6085260|NCT04430855|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
6085261|NCT04430855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6085262|NCT04430855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6085263|NCT04430855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085264|NCT04430855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6085265|NCT04411914|Clavulanic Acids|clavulanic acids|mesh-list
5516437|NCT04352621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5516438|NCT04352621|Anesthetics, General|anesthetics, general|mesh-ancestor
5516439|NCT04352621|Anesthetics|anesthetics|mesh-ancestor
5516440|NCT04352621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5516441|NCT04352621|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5516442|NCT04352621|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5516443|NCT04352621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6085266|NCT04411914|Clavulanic Acid|clavulanic acid|mesh-list
6085267|NCT04411914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6085268|NCT04411914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6085269|NCT04411914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6085270|NCT04411914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085271|NCT04411914|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6085272|NCT04410991|Teriflunomide|teriflunomide|mesh-list
6085273|NCT04410991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6085274|NCT04410991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6085275|NCT04410991|Analgesics|analgesics|mesh-ancestor
6085276|NCT04410991|Sensory System Agents|sensory system agents|mesh-ancestor
6085277|NCT04410991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6085278|NCT04410991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085279|NCT04410991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6085280|NCT04410991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6085281|NCT04410991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6085282|NCT04410991|Immunologic Factors|immunologic factors|mesh-ancestor
6085283|NCT04410978|Teriflunomide|teriflunomide|mesh-list
6085284|NCT04410978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6085285|NCT04410978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6085286|NCT04410978|Analgesics|analgesics|mesh-ancestor
6085287|NCT04410978|Sensory System Agents|sensory system agents|mesh-ancestor
6085288|NCT04410978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6085289|NCT04410978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085290|NCT04410978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6085291|NCT04410978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6085292|NCT04410978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6085293|NCT04410978|Immunologic Factors|immunologic factors|mesh-ancestor
6085294|NCT04410406|Ivermectin|ivermectin|mesh-list
6085295|NCT04410406|Albendazole|albendazole|mesh-list
6085296|NCT04410406|Moxidectin|moxidectin|mesh-list
6085297|NCT04410406|Diethylcarbamazine|diethylcarbamazine|mesh-list
6085298|NCT04410406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085299|NCT04410406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6085300|NCT04410406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6085301|NCT04410406|Anthelmintics|anthelmintics|mesh-ancestor
6085302|NCT04410406|Anticestodal Agents|anticestodal agents|mesh-ancestor
6085303|NCT04410406|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6085304|NCT04410406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6085305|NCT04410406|Tubulin Modulators|tubulin modulators|mesh-ancestor
6085306|NCT04410406|Antimitotic Agents|antimitotic agents|mesh-ancestor
6085307|NCT04410406|Mitosis Modulators|mitosis modulators|mesh-ancestor
6085308|NCT04410406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6085309|NCT04410406|Antinematodal Agents|antinematodal agents|mesh-ancestor
6085310|NCT04410406|Filaricides|filaricides|mesh-ancestor
5516444|NCT04352621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516445|NCT04352400|Nafamostat|nafamostat|mesh-list
5516446|NCT04352400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5516447|NCT04352400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5516448|NCT04352400|Analgesics|analgesics|mesh-ancestor
5516449|NCT04352400|Sensory System Agents|sensory system agents|mesh-ancestor
5516450|NCT04352400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5516451|NCT04352400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5516452|NCT04352400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5516453|NCT04352400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6085311|NCT04410406|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6085312|NCT04410406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6085313|NCT04387461|Pembrolizumab|pembrolizumab|mesh-list
6085314|NCT04387461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6085315|NCT04387461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6085316|NCT04374253|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6085317|NCT04374253|Immunologic Factors|immunologic factors|mesh-ancestor
6085318|NCT04374253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665532|NCT01517568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6665533|NCT01517607|Mesalamine|mesalamine|mesh-list
6665534|NCT01517607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6665535|NCT01517607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6665536|NCT01517607|Analgesics|analgesics|mesh-ancestor
6665537|NCT01517607|Sensory System Agents|sensory system agents|mesh-ancestor
6665538|NCT01517607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6665539|NCT01517607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665540|NCT01517607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6665541|NCT01517607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6665542|NCT01517711|Tramadol|tramadol|mesh-list
6665543|NCT01517711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6665544|NCT01517711|Narcotics|narcotics|mesh-ancestor
6665545|NCT01517711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6665546|NCT01517711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665547|NCT01517711|Analgesics|analgesics|mesh-ancestor
6665548|NCT01517711|Sensory System Agents|sensory system agents|mesh-ancestor
6665549|NCT01517711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6665550|NCT01517724|Bortezomib|bortezomib|mesh-list
6665551|NCT01517724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6665552|NCT01517802|Prednisone|prednisone|mesh-list
5516454|NCT04352400|Anticoagulants|anticoagulants|mesh-ancestor
5516455|NCT04352400|Protease Inhibitors|protease inhibitors|mesh-ancestor
5516456|NCT04352400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5516457|NCT04352400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516458|NCT04352400|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5516459|NCT04352400|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5516460|NCT04352400|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5516461|NCT04352400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5516462|NCT04352400|Immunologic Factors|immunologic factors|mesh-ancestor
6085323|NCT04342975|Niacinamide|niacinamide|mesh-list
6665553|NCT01517802|Abiraterone Acetate|abiraterone acetate|mesh-list
6665554|NCT01517802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6665555|NCT01517802|Glucocorticoids|glucocorticoids|mesh-ancestor
6665556|NCT01517802|Hormones|hormones|mesh-ancestor
6665557|NCT01517802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6665558|NCT01517802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665559|NCT01517802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6665560|NCT01517802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6665561|NCT01517802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6665562|NCT01517802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6665563|NCT01517802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665564|NCT01517802|Hormone Antagonists|hormone antagonists|mesh-ancestor
6665565|NCT01517802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6665566|NCT01517815|Tazobactam|tazobactam|mesh-list
6665567|NCT01517815|Piperacillin|piperacillin|mesh-list
6665568|NCT01517815|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
6665569|NCT01517815|Doripenem|doripenem|mesh-list
6665570|NCT01517815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6665571|NCT01517815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6665572|NCT01517815|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6085324|NCT04342975|Niacin|niacin|mesh-list
6085325|NCT04342975|Nicotinic Acids|nicotinic acids|mesh-list
6085326|NCT04342975|Vitamin B Complex|vitamin b complex|mesh-ancestor
5516466|NCT04352153|Febuxostat|febuxostat|mesh-list
5516467|NCT04352153|Citric Acid|citric acid|mesh-list
5516468|NCT04352153|Anticoagulants|anticoagulants|mesh-ancestor
5516469|NCT04352153|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5516470|NCT04352153|Chelating Agents|chelating agents|mesh-ancestor
5516471|NCT04352153|Sequestering Agents|sequestering agents|mesh-ancestor
5516472|NCT04352153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516473|NCT04352153|Gout Suppressants|gout suppressants|mesh-ancestor
5516474|NCT04352153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5516475|NCT04352205|Thalidomide|thalidomide|mesh-list
5516476|NCT04352205|Dexamethasone|dexamethasone|mesh-list
5516477|NCT04352205|Dexamethasone acetate|dexamethasone acetate|mesh-list
6085327|NCT04342975|Vitamins|vitamins|mesh-ancestor
6085328|NCT04342975|Micronutrients|micronutrients|mesh-ancestor
6085329|NCT04342975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085330|NCT04342975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6085331|NCT04342975|Antimetabolites|antimetabolites|mesh-ancestor
6085332|NCT04342975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085333|NCT04342975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6085334|NCT04342975|Vasodilator Agents|vasodilator agents|mesh-ancestor
6085335|NCT04329494|Leucovorin|leucovorin|mesh-list
6085336|NCT04329494|Cisplatin|cisplatin|mesh-list
6085337|NCT04329494|Doxorubicin|doxorubicin|mesh-list
6085338|NCT04329494|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6085339|NCT04329494|Fluorouracil|fluorouracil|mesh-list
6085340|NCT04329494|Oxaliplatin|oxaliplatin|mesh-list
6085341|NCT04329494|Irinotecan|irinotecan|mesh-list
6085342|NCT04329494|Daunorubicin|daunorubicin|mesh-list
6085343|NCT04329494|Mitomycins|mitomycins|mesh-list
6085344|NCT04329494|Mitomycin|mitomycin|mesh-list
6085345|NCT04329494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6085346|NCT04329494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5516478|NCT04352205|Lenalidomide|lenalidomide|mesh-list
6085347|NCT04329494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6085348|NCT04329494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6085349|NCT04329494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6085350|NCT04329494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085351|NCT04329494|Antimetabolites|antimetabolites|mesh-ancestor
6085352|NCT04329494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6085353|NCT04329494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6085354|NCT04329494|Immunologic Factors|immunologic factors|mesh-ancestor
6085355|NCT04329494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085356|NCT04329494|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6085357|NCT04329494|Antidotes|antidotes|mesh-ancestor
6085358|NCT04329494|Protective Agents|protective agents|mesh-ancestor
6085359|NCT04329494|Vitamin B Complex|vitamin b complex|mesh-ancestor
6085360|NCT04329494|Vitamins|vitamins|mesh-ancestor
6085361|NCT04329494|Micronutrients|micronutrients|mesh-ancestor
6085362|NCT04329494|Alkylating Agents|alkylating agents|mesh-ancestor
6085363|NCT04329494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6085364|NCT04294654|Vortioxetine|vortioxetine|mesh-list
6464078|NCT00467571|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6464079|NCT00467636|Insulin glulisine|insulin glulisine|mesh-list
6464080|NCT00467636|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6464081|NCT00467636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464082|NCT00467662|Acyclovir|acyclovir|mesh-list
6464083|NCT00467662|Docosanol|docosanol|mesh-list
6464084|NCT00467662|Antiviral Agents|antiviral agents|mesh-ancestor
6464085|NCT00467662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5516479|NCT04352205|Bortezomib|bortezomib|mesh-list
5516480|NCT04352205|Daratumumab|daratumumab|mesh-list
5516481|NCT04352205|Ichthammol|ichthammol|mesh-list
5516482|NCT04352205|BB 1101|bb 1101|mesh-list
5516483|NCT04352205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5516484|NCT04352205|Antiemetics|antiemetics|mesh-ancestor
5516485|NCT04352205|Autonomic Agents|autonomic agents|mesh-ancestor
5516486|NCT04352205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5516487|NCT04352205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5516488|NCT04352205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5516489|NCT04352205|Glucocorticoids|glucocorticoids|mesh-ancestor
5516490|NCT04352205|Hormones|hormones|mesh-ancestor
6464086|NCT00467766|Donepezil|donepezil|mesh-list
6464087|NCT00467766|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5516491|NCT04352205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5516492|NCT04352205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5516493|NCT04352205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6085365|NCT04294654|Antidepressive Agents|antidepressive agents|mesh-ancestor
6085366|NCT04294654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6085367|NCT04294654|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6464088|NCT00467766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6665573|NCT01517815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6464089|NCT00467766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516494|NCT04352205|Protease Inhibitors|protease inhibitors|mesh-ancestor
6085368|NCT04294654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5516495|NCT04352205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5516496|NCT04352205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085369|NCT04294654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6085370|NCT04294654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085371|NCT04294654|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6085372|NCT04294654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6085373|NCT04294654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6085374|NCT04294654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085375|NCT04294654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6085376|NCT04294654|Serotonin Agents|serotonin agents|mesh-ancestor
6085377|NCT04294654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6085378|NCT04294654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6085379|NCT04294654|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6085380|NCT04294654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6085381|NCT04294069|Azithromycin|azithromycin|mesh-list
6085382|NCT04294069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6085383|NCT04294069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6203081|NCT02051452|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6203082|NCT02051452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6203083|NCT02051452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6203084|NCT02051452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203085|NCT02051452|Dopamine Agents|dopamine agents|mesh-ancestor
6203086|NCT02051452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6203087|NCT02051595|Vancomycin|vancomycin|mesh-list
6203088|NCT02051595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6203089|NCT02051595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6203090|NCT02051686|Tranexamic Acid|tranexamic acid|mesh-list
6203091|NCT02051686|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6203092|NCT02051686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6203093|NCT02051686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203094|NCT02051686|Hemostatics|hemostatics|mesh-ancestor
6203095|NCT02051686|Coagulants|coagulants|mesh-ancestor
6203096|NCT02052011|Ranolazine|ranolazine|mesh-list
6203097|NCT02052011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6203098|NCT02052011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6203099|NCT02052011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203100|NCT02052141|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
6203101|NCT02052141|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6203102|NCT02052141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6203103|NCT02052141|Immunologic Factors|immunologic factors|mesh-ancestor
6203104|NCT02052141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203105|NCT02052310|Epoetin Alfa|epoetin alfa|mesh-list
6203106|NCT02052310|Hematinics|hematinics|mesh-ancestor
6203107|NCT02052414|Gabapentin|gabapentin|mesh-list
6203108|NCT02052414|Analgesics|analgesics|mesh-ancestor
6203109|NCT02052414|Sensory System Agents|sensory system agents|mesh-ancestor
6203110|NCT02052414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5516497|NCT04352205|Immunologic Factors|immunologic factors|mesh-ancestor
5516498|NCT04352205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5516499|NCT04352205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6203111|NCT02052414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203112|NCT02052414|Anticonvulsants|anticonvulsants|mesh-ancestor
6203113|NCT02052414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6203114|NCT02052414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6203115|NCT02052414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6203116|NCT02052414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6203117|NCT02052414|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6203118|NCT02052414|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6203119|NCT02052414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6203120|NCT02052414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203121|NCT02052414|Antimanic Agents|antimanic agents|mesh-ancestor
6203122|NCT02052440|Baclofen|baclofen|mesh-list
6203123|NCT02052440|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6203124|NCT02052440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203125|NCT02052440|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6203126|NCT02052440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6203127|NCT02052440|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6203128|NCT02052440|GABA Agonists|gaba agonists|mesh-ancestor
6203129|NCT02052440|GABA Agents|gaba agents|mesh-ancestor
6464090|NCT00467766|Cholinergic Agents|cholinergic agents|mesh-ancestor
5516500|NCT04352205|Growth Substances|growth substances|mesh-ancestor
5516501|NCT04352205|Growth Inhibitors|growth inhibitors|mesh-ancestor
5516502|NCT04352205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5516503|NCT04352205|Leprostatic Agents|leprostatic agents|mesh-ancestor
5516504|NCT04352205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5516505|NCT04352205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5516506|NCT04352205|Dermatologic Agents|dermatologic agents|mesh-ancestor
5516507|NCT04352166|Buprenorphine|buprenorphine|mesh-list
5516508|NCT04352166|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5516509|NCT04352166|Narcotics|narcotics|mesh-ancestor
5516510|NCT04352166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6085384|NCT04290689|Botulinum Toxins|botulinum toxins|mesh-list
6085385|NCT04290689|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6085386|NCT04290689|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6085387|NCT04290689|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6085388|NCT04290689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6085389|NCT04290689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085390|NCT04290689|Cholinergic Agents|cholinergic agents|mesh-ancestor
6085391|NCT04290689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6085392|NCT04290689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085393|NCT04290689|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6085394|NCT04290689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6085395|NCT04285567|Cyclophosphamide|cyclophosphamide|mesh-list
6085396|NCT04285567|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6085397|NCT04285567|Rituximab|rituximab|mesh-list
6085398|NCT04285567|Fludarabine|fludarabine|mesh-list
6085399|NCT04285567|Venetoclax|venetoclax|mesh-list
6085400|NCT04285567|Obinutuzumab|obinutuzumab|mesh-list
6085401|NCT04285567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6085402|NCT04285567|Immunologic Factors|immunologic factors|mesh-ancestor
6085403|NCT04285567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085404|NCT04285567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6085405|NCT04285567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6085406|NCT04285567|Alkylating Agents|alkylating agents|mesh-ancestor
6085407|NCT04285567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085408|NCT04285567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6085409|NCT04285567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6085410|NCT04285567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6085411|NCT04271904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
6085412|NCT04270747|Aflibercept|aflibercept|mesh-list
6085413|NCT04270747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6085414|NCT04270747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6085415|NCT04270747|Growth Substances|growth substances|mesh-ancestor
6085416|NCT04270747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085417|NCT04270747|Growth Inhibitors|growth inhibitors|mesh-ancestor
6085418|NCT04270747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6085419|NCT04270409|Dexamethasone|dexamethasone|mesh-list
6085420|NCT04270409|Lenalidomide|lenalidomide|mesh-list
6085421|NCT04270409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6085422|NCT04270409|Antiemetics|antiemetics|mesh-ancestor
6085423|NCT04270409|Autonomic Agents|autonomic agents|mesh-ancestor
6085424|NCT04270409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6085425|NCT04270409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085426|NCT04270409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5516511|NCT04352166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5516512|NCT04352166|Analgesics|analgesics|mesh-ancestor
5516513|NCT04352166|Sensory System Agents|sensory system agents|mesh-ancestor
5516514|NCT04352166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5516515|NCT04352166|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5516516|NCT04352465|Methotrexate|methotrexate|mesh-list
5516517|NCT04352465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6085427|NCT04270409|Glucocorticoids|glucocorticoids|mesh-ancestor
6085428|NCT04270409|Hormones|hormones|mesh-ancestor
6085429|NCT04270409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6085430|NCT04270409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6085431|NCT04270409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6085432|NCT04270409|Immunologic Factors|immunologic factors|mesh-ancestor
6085433|NCT04270409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6085434|NCT04270409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6085435|NCT04270409|Growth Substances|growth substances|mesh-ancestor
5516518|NCT04352465|Abortifacient Agents|abortifacient agents|mesh-ancestor
5516519|NCT04352465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5516520|NCT04352465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5516521|NCT04352465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5516522|NCT04352465|Antimetabolites|antimetabolites|mesh-ancestor
6085436|NCT04270409|Growth Inhibitors|growth inhibitors|mesh-ancestor
6085437|NCT04267978|Irinotecan|irinotecan|mesh-list
6085438|NCT04267978|Temozolomide|temozolomide|mesh-list
6085439|NCT04267978|Endostatins|endostatins|mesh-list
6085440|NCT04267978|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6085441|NCT04267978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6085442|NCT04267978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6085443|NCT04267978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085444|NCT04267978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6085445|NCT04267978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6085446|NCT04267978|Alkylating Agents|alkylating agents|mesh-ancestor
6085447|NCT04267978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6085448|NCT04267978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6085449|NCT04267978|Growth Substances|growth substances|mesh-ancestor
6085450|NCT04267978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085451|NCT04267978|Growth Inhibitors|growth inhibitors|mesh-ancestor
6085452|NCT04263038|Rivaroxaban|rivaroxaban|mesh-list
6085453|NCT04263038|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6085454|NCT04263038|Antithrombins|antithrombins|mesh-ancestor
6085455|NCT04263038|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6085456|NCT04263038|Protease Inhibitors|protease inhibitors|mesh-ancestor
6085457|NCT04263038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6085458|NCT04263038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085459|NCT04263038|Anticoagulants|anticoagulants|mesh-ancestor
6085460|NCT04261075|Durvalumab|durvalumab|mesh-list
6085461|NCT04261075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6085462|NCT04261075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6085463|NCT04260022|Blinatumomab|blinatumomab|mesh-list
6085464|NCT04260022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6085465|NCT04259138|Vedolizumab|vedolizumab|mesh-list
6085466|NCT04259138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6085467|NCT04234568|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
6085468|NCT04234568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085469|NCT04234568|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6085470|NCT04225715|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6085471|NCT04225715|Antiviral Agents|antiviral agents|mesh-ancestor
6085472|NCT04225715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6085487|NCT04203901|Nivolumab|nivolumab|mesh-list
6085488|NCT04203901|Ipilimumab|ipilimumab|mesh-list
6085489|NCT04203901|Everolimus|everolimus|mesh-list
6085490|NCT04203901|Lenvatinib|lenvatinib|mesh-list
6085491|NCT04203901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6085492|NCT04203901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6085493|NCT04203901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6085494|NCT04203901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085495|NCT04203901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6085496|NCT04203901|Immunologic Factors|immunologic factors|mesh-ancestor
6085497|NCT04203901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085498|NCT04203901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6085499|NCT04203901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6085500|NCT04200456|Rozanolixizumab|rozanolixizumab|mesh-list
6085501|NCT04200456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6085502|NCT04200456|Immunologic Factors|immunologic factors|mesh-ancestor
6085503|NCT04200456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085504|NCT04178005|Cladribine|cladribine|mesh-list
6085505|NCT04178005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6085506|NCT04178005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6085507|NCT04178005|Immunologic Factors|immunologic factors|mesh-ancestor
6085508|NCT04178005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085509|NCT04173494|Danazol|danazol|mesh-list
6085510|NCT04173494|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
6085511|NCT04173494|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5600717|NCT03709992|Tamsulosin|tamsulosin|mesh-list
6085512|NCT04173494|Hormone Antagonists|hormone antagonists|mesh-ancestor
6085513|NCT04173494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6085514|NCT04173494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085515|NCT04173494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6085516|NCT04173494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6085517|NCT04173494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085518|NCT04170153|Niraparib|niraparib|mesh-list
6085519|NCT04170153|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6085520|NCT04170153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6085521|NCT04170153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085522|NCT04170153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6085523|NCT04155164|Metformin|metformin|mesh-list
6085524|NCT04155164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6085525|NCT04155164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085526|NCT04138316|Candesartan|candesartan|mesh-list
6085527|NCT04138316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6085528|NCT04138316|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6085529|NCT04138316|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6085530|NCT04138316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085531|NCT04134663|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
6085532|NCT04134663|Oxytocin|oxytocin|mesh-list
6085533|NCT04134663|Oxytocics|oxytocics|mesh-ancestor
6085534|NCT04134663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6085535|NCT04134663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085536|NCT04131504|Adalimumab|adalimumab|mesh-list
6085537|NCT04131504|Infliximab|infliximab|mesh-list
6085538|NCT04131504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6085539|NCT04131504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6085540|NCT04131504|Dermatologic Agents|dermatologic agents|mesh-ancestor
6085541|NCT04131504|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6085542|NCT04126031|Ceftazidime|ceftazidime|mesh-list
6085543|NCT04126031|Avibactam|avibactam|mesh-list
6085544|NCT04126031|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
6085545|NCT04126031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6085546|NCT04126031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6085547|NCT04126031|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6085548|NCT04126031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6085549|NCT04126031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085550|NCT04095221|Irinotecan|irinotecan|mesh-list
6085551|NCT04095221|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6085552|NCT04095221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6085553|NCT04095221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6085554|NCT04095221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085555|NCT04095221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6085556|NCT04088188|Gemcitabine|gemcitabine|mesh-list
6085557|NCT04088188|Cisplatin|cisplatin|mesh-list
6085558|NCT04088188|Ivosidenib|ivosidenib|mesh-list
6085559|NCT04088188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6085560|NCT04088188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6085561|NCT04088188|Antimetabolites|antimetabolites|mesh-ancestor
6085562|NCT04088188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085563|NCT04088188|Antiviral Agents|antiviral agents|mesh-ancestor
6085564|NCT04088188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6085565|NCT04088188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6085566|NCT04088188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6085567|NCT04088188|Immunologic Factors|immunologic factors|mesh-ancestor
6085568|NCT04088188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085569|NCT04072952|Palbociclib|palbociclib|mesh-list
6085570|NCT04072952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6085571|NCT04072952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6085572|NCT04072952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6085573|NCT04072952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085576|NCT04037683|Misoprostol|misoprostol|mesh-list
6085577|NCT04037683|Oxytocin|oxytocin|mesh-list
6085578|NCT04037683|Oxytocics|oxytocics|mesh-ancestor
6085579|NCT04037683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6085580|NCT04037683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085581|NCT04037683|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6085582|NCT04037683|Abortifacient Agents|abortifacient agents|mesh-ancestor
6085583|NCT04037683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6085584|NCT04037683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6085585|NCT04016818|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6085586|NCT04016818|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6085587|NCT04016818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085588|NCT03972488|Octreotide|octreotide|mesh-list
6085589|NCT03972488|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
6085590|NCT03972488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6085591|NCT03972488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6085592|NCT03972488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6085593|NCT03972488|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6085594|NCT03972488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085595|NCT03969004|Cemiplimab|cemiplimab|mesh-list
6085596|NCT03969004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6085597|NCT03969004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6085598|NCT03965728|Methotrexate|methotrexate|mesh-list
5516523|NCT04352465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516524|NCT04352465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5516525|NCT04352465|Dermatologic Agents|dermatologic agents|mesh-ancestor
5516526|NCT04352465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5516527|NCT04352465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5516528|NCT04352465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5516529|NCT04352465|Immunologic Factors|immunologic factors|mesh-ancestor
5516530|NCT04352465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5516531|NCT04352465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5516532|NCT04351724|Ritonavir|ritonavir|mesh-list
5516533|NCT04351724|Lopinavir|lopinavir|mesh-list
5516534|NCT04351724|Hydroxychloroquine|hydroxychloroquine|mesh-list
5516535|NCT04351724|Chloroquine|chloroquine|mesh-list
5516536|NCT04351724|Remdesivir|remdesivir|mesh-list
5516537|NCT04351724|Candesartan|candesartan|mesh-list
5516538|NCT04351724|Antihypertensive Agents|antihypertensive agents|mesh-list
5516539|NCT04351724|Rivaroxaban|rivaroxaban|mesh-list
5516540|NCT04351724|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5516541|NCT04351724|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5516542|NCT04351724|Protease Inhibitors|protease inhibitors|mesh-ancestor
5516543|NCT04351724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5516544|NCT04351724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516545|NCT04351724|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5516546|NCT04351724|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5516547|NCT04351724|Antiviral Agents|antiviral agents|mesh-ancestor
5516548|NCT04351724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5516549|NCT04351724|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5516550|NCT04351724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5516551|NCT04351724|Antimalarials|antimalarials|mesh-ancestor
5516552|NCT04351724|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5516553|NCT04351724|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5516554|NCT04351724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5516555|NCT04351724|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5516556|NCT04351724|Antithrombins|antithrombins|mesh-ancestor
5516557|NCT04351724|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5516558|NCT04351724|Anticoagulants|anticoagulants|mesh-ancestor
5516559|NCT04351724|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5516560|NCT04351724|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5516561|NCT04351724|Amebicides|amebicides|mesh-ancestor
5516562|NCT04351724|Antimetabolites|antimetabolites|mesh-ancestor
5516563|NCT04351763|Amiodarone|amiodarone|mesh-list
5516564|NCT04351763|Verapamil|verapamil|mesh-list
5516565|NCT04351763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5516566|NCT04351763|Vasodilator Agents|vasodilator agents|mesh-ancestor
5516567|NCT04351763|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5516568|NCT04351763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6085599|NCT03965728|Midazolam|midazolam|mesh-list
6085600|NCT03965728|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6085601|NCT03965728|Abortifacient Agents|abortifacient agents|mesh-ancestor
6085602|NCT03965728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6085603|NCT03965728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085604|NCT03965728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6085605|NCT03965728|Antimetabolites|antimetabolites|mesh-ancestor
6085606|NCT03965728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085607|NCT03965728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6085608|NCT03965728|Dermatologic Agents|dermatologic agents|mesh-ancestor
6085609|NCT03965728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6085610|NCT03965728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6085611|NCT03965728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5516569|NCT04351763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516570|NCT04351763|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5516571|NCT04351763|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5516572|NCT04351763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6085612|NCT03965728|Immunologic Factors|immunologic factors|mesh-ancestor
6085613|NCT03965728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6085614|NCT03965728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6085615|NCT03965728|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5516573|NCT04351763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5516574|NCT04351763|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5516575|NCT04351763|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5516576|NCT04351763|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5516577|NCT04351763|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5516578|NCT04351763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5516579|NCT04351763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5516580|NCT04352062|Amoxicillin|amoxicillin|mesh-list
5516581|NCT04352062|Levofloxacin|levofloxacin|mesh-list
5516582|NCT04352062|Ofloxacin|ofloxacin|mesh-list
5516583|NCT04352062|Melatonin|melatonin|mesh-list
5516584|NCT04352062|Pantoprazole|pantoprazole|mesh-list
5516585|NCT04352062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5516586|NCT04352062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5516587|NCT04352062|Antioxidants|antioxidants|mesh-ancestor
5516588|NCT04352062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516589|NCT04352062|Protective Agents|protective agents|mesh-ancestor
5516590|NCT04352062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085616|NCT03965728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6085617|NCT03965728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6085618|NCT03965728|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6085619|NCT03965728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5516591|NCT04352062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5516592|NCT04352062|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6085620|NCT03965728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6085621|NCT03965728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6085622|NCT03965728|Anesthetics, General|anesthetics, general|mesh-ancestor
6085623|NCT03965728|Anesthetics|anesthetics|mesh-ancestor
6085624|NCT03965728|GABA Modulators|gaba modulators|mesh-ancestor
6464091|NCT00467766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6464092|NCT00467766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464093|NCT00467766|Nootropic Agents|nootropic agents|mesh-ancestor
6464094|NCT00467883|Amphotericin B|amphotericin b|mesh-list
6464095|NCT00467883|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6464096|NCT00467883|Amebicides|amebicides|mesh-ancestor
6464097|NCT00467883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6464098|NCT00467883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5516593|NCT04352062|Renal Agents|renal agents|mesh-ancestor
5516594|NCT04352062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5516595|NCT04352062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5516596|NCT04352062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5516597|NCT04352062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5516598|NCT04352062|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5516599|NCT04352062|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5516600|NCT04352062|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5516601|NCT04352062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5516602|NCT04352062|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5516603|NCT04351919|Azithromycin|azithromycin|mesh-list
6085625|NCT03965728|GABA Agents|gaba agents|mesh-ancestor
6085626|NCT03965728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6085627|NCT03958474|Remifentanil|remifentanil|mesh-list
6085628|NCT03958474|Oxycodone|oxycodone|mesh-list
6085629|NCT03958474|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6085630|NCT03958474|Narcotics|narcotics|mesh-ancestor
6085631|NCT03958474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6085632|NCT03958474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085633|NCT03958474|Analgesics|analgesics|mesh-ancestor
6085634|NCT03958474|Sensory System Agents|sensory system agents|mesh-ancestor
6464099|NCT00467883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6085635|NCT03958474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6085636|NCT03946800|Durvalumab|durvalumab|mesh-list
6085637|NCT03946800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6085638|NCT03946800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6085639|NCT03936270|Letrozole|letrozole|mesh-list
6085640|NCT03936270|Palbociclib|palbociclib|mesh-list
6085641|NCT03936270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6085642|NCT03936270|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6085643|NCT03936270|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6085644|NCT03936270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6085645|NCT03936270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085646|NCT03936270|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6085647|NCT03936270|Hormone Antagonists|hormone antagonists|mesh-ancestor
6085648|NCT03936270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6085649|NCT03936270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085650|NCT03936270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6085651|NCT03934905|Sulforaphane|sulforaphane|mesh-list
6085652|NCT03934905|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6085653|NCT03934905|Protective Agents|protective agents|mesh-ancestor
6085654|NCT03934905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085655|NCT03934905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6085656|NCT03932201|Factor VIII|factor viii|mesh-list
6085657|NCT03932201|Coagulants|coagulants|mesh-ancestor
6085658|NCT03924635|Budesonide|budesonide|mesh-list
6085659|NCT03924635|Albuterol|albuterol|mesh-list
6085660|NCT03924635|Formoterol Fumarate|formoterol fumarate|mesh-list
6085661|NCT03924635|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6085662|NCT03924635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6085663|NCT03924635|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6085664|NCT03924635|Autonomic Agents|autonomic agents|mesh-ancestor
6085665|NCT03924635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6085666|NCT03924635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085667|NCT03924635|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6085668|NCT03924635|Respiratory System Agents|respiratory system agents|mesh-ancestor
6085669|NCT03924635|Glucocorticoids|glucocorticoids|mesh-ancestor
6085670|NCT03924635|Hormones|hormones|mesh-ancestor
6085671|NCT03924635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6085672|NCT03924635|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6085673|NCT03924635|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6085674|NCT03924635|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6085675|NCT03924635|Adrenergic Agents|adrenergic agents|mesh-ancestor
6085676|NCT03924635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6085677|NCT03924635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085678|NCT03924635|Tocolytic Agents|tocolytic agents|mesh-ancestor
6085679|NCT03924635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6203130|NCT02052440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6203131|NCT02052440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203132|NCT02052557|Bupivacaine|bupivacaine|mesh-list
6203133|NCT02052557|Anesthetics, Local|anesthetics, local|mesh-ancestor
5516604|NCT04351919|Hydroxychloroquine|hydroxychloroquine|mesh-list
5516605|NCT04351919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5516606|NCT04351919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5516607|NCT04351919|Antimalarials|antimalarials|mesh-ancestor
5516608|NCT04351919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6203134|NCT02052557|Anesthetics|anesthetics|mesh-ancestor
6203135|NCT02052557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6203136|NCT02052557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203137|NCT02052557|Sensory System Agents|sensory system agents|mesh-ancestor
6203138|NCT02052557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6203139|NCT02052635|Clopidogrel|clopidogrel|mesh-list
6203140|NCT02052635|Ticagrelor|ticagrelor|mesh-list
6203141|NCT02052635|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6203142|NCT02052635|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6203143|NCT02052635|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5516609|NCT04351919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5516610|NCT04351919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5516611|NCT04351919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516612|NCT04351919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5516613|NCT04351867|Docetaxel|docetaxel|mesh-list
5516614|NCT04351867|Capecitabine|capecitabine|mesh-list
5516615|NCT04351867|Oxaliplatin|oxaliplatin|mesh-list
5516616|NCT04351867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5516617|NCT04351867|Tubulin Modulators|tubulin modulators|mesh-ancestor
5516618|NCT04351867|Antimitotic Agents|antimitotic agents|mesh-ancestor
5516619|NCT04351867|Mitosis Modulators|mitosis modulators|mesh-ancestor
5516620|NCT04351867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085680|NCT03918850|Buprenorphine|buprenorphine|mesh-list
6085681|NCT03918850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6085682|NCT03918850|Narcotics|narcotics|mesh-ancestor
6085683|NCT03918850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6085684|NCT03918850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085685|NCT03918850|Analgesics|analgesics|mesh-ancestor
6085686|NCT03918850|Sensory System Agents|sensory system agents|mesh-ancestor
6085687|NCT03918850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6085688|NCT03918850|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6085689|NCT03911739|Buprenorphine|buprenorphine|mesh-list
6085690|NCT03911739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6085691|NCT03911739|Narcotics|narcotics|mesh-ancestor
6085692|NCT03911739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5516621|NCT04351867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5516622|NCT04351867|Antimetabolites|antimetabolites|mesh-ancestor
5516623|NCT04351737|Dexamethasone|dexamethasone|mesh-list
5516624|NCT04351737|Prednisolone|prednisolone|mesh-list
5516625|NCT04351737|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6085693|NCT03911739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085694|NCT03911739|Analgesics|analgesics|mesh-ancestor
6085695|NCT03911739|Sensory System Agents|sensory system agents|mesh-ancestor
6085696|NCT03911739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6085697|NCT03911739|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6085698|NCT03911466|Buprenorphine|buprenorphine|mesh-list
6085699|NCT03911466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6085700|NCT03911466|Narcotics|narcotics|mesh-ancestor
5516626|NCT04351737|Methylprednisolone|methylprednisolone|mesh-list
5516627|NCT04351737|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5516628|NCT04351737|Prednisolone acetate|prednisolone acetate|mesh-list
6085701|NCT03911466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6085702|NCT03911466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085703|NCT03911466|Analgesics|analgesics|mesh-ancestor
6085704|NCT03911466|Sensory System Agents|sensory system agents|mesh-ancestor
6085705|NCT03911466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6085706|NCT03911466|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6085707|NCT03897127|Cytarabine|cytarabine|mesh-list
6085708|NCT03897127|Daunorubicin|daunorubicin|mesh-list
6085709|NCT03897127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6085710|NCT03897127|Antimetabolites|antimetabolites|mesh-ancestor
6085711|NCT03897127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085712|NCT03897127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6085713|NCT03897127|Antiviral Agents|antiviral agents|mesh-ancestor
6085714|NCT03897127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6085715|NCT03897127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6085716|NCT03897127|Immunologic Factors|immunologic factors|mesh-ancestor
6085717|NCT03897127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085718|NCT03897127|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6085719|NCT03897127|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6085720|NCT03897127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6085721|NCT03897127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6085722|NCT03879135|Factor VIII|factor viii|mesh-list
6085723|NCT03879135|Coagulants|coagulants|mesh-ancestor
6085724|NCT03872180|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6085725|NCT03872180|Venetoclax|venetoclax|mesh-list
6085726|NCT03872180|Obinutuzumab|obinutuzumab|mesh-list
6085727|NCT03872180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6085728|NCT03872180|Alkylating Agents|alkylating agents|mesh-ancestor
6085729|NCT03872180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085730|NCT03872180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6085731|NCT03872180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6085732|NCT03869190|Gemcitabine|gemcitabine|mesh-list
6085733|NCT03869190|Atezolizumab|atezolizumab|mesh-list
6085734|NCT03869190|Niraparib|niraparib|mesh-list
5516629|NCT04351737|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5516630|NCT04351737|Prednisolone phosphate|prednisolone phosphate|mesh-list
6085735|NCT03869190|Magrolimab|magrolimab|mesh-list
6085736|NCT03869190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6085737|NCT03869190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6085738|NCT03869190|Antimetabolites|antimetabolites|mesh-ancestor
6464100|NCT00467883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5516631|NCT04351737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5516632|NCT04351737|Antiemetics|antiemetics|mesh-ancestor
5516633|NCT04351737|Autonomic Agents|autonomic agents|mesh-ancestor
5516634|NCT04351737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5516635|NCT04351737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085739|NCT03869190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085740|NCT03869190|Antiviral Agents|antiviral agents|mesh-ancestor
6085741|NCT03869190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6085742|NCT03869190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6085743|NCT03869190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6085744|NCT03869190|Immunologic Factors|immunologic factors|mesh-ancestor
5516636|NCT04351737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5516637|NCT04351737|Glucocorticoids|glucocorticoids|mesh-ancestor
5516638|NCT04351737|Hormones|hormones|mesh-ancestor
5516639|NCT04351737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5516640|NCT04351737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5516641|NCT04351737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5516642|NCT04351737|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6085745|NCT03869190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085746|NCT03869190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6085747|NCT03869190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6085748|NCT03859427|Dexamethasone|dexamethasone|mesh-list
6085749|NCT03859427|Lenalidomide|lenalidomide|mesh-list
6085750|NCT03859427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6085751|NCT03859427|Antiemetics|antiemetics|mesh-ancestor
6085752|NCT03859427|Autonomic Agents|autonomic agents|mesh-ancestor
6085753|NCT03859427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6085754|NCT03859427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085755|NCT03859427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6085756|NCT03859427|Glucocorticoids|glucocorticoids|mesh-ancestor
6085757|NCT03859427|Hormones|hormones|mesh-ancestor
6085758|NCT03859427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6085759|NCT03859427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6085760|NCT03859427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6085761|NCT03859427|Immunologic Factors|immunologic factors|mesh-ancestor
6085762|NCT03859427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6085763|NCT03859427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6085764|NCT03859427|Growth Substances|growth substances|mesh-ancestor
6085765|NCT03859427|Growth Inhibitors|growth inhibitors|mesh-ancestor
6085766|NCT03857321|Insulin|insulin|mesh-list
6085767|NCT03857321|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6085768|NCT03857321|Insulin, Isophane|insulin, isophane|mesh-list
6085769|NCT03857321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5516643|NCT04351737|Protective Agents|protective agents|mesh-ancestor
5516644|NCT04351620|Hydroxychloroquine|hydroxychloroquine|mesh-list
5516645|NCT04351620|Antimalarials|antimalarials|mesh-ancestor
5516646|NCT04351620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5516647|NCT04351620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6085770|NCT03857321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085771|NCT03846219|Calcium, Dietary|calcium, dietary|mesh-list
6085772|NCT03846219|Calcium|calcium|mesh-list
6085773|NCT03846219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6085774|NCT03846219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085775|NCT03846219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6085776|NCT03839446|Etoposide|etoposide|mesh-list
6085777|NCT03839446|Mitoxantrone|mitoxantrone|mesh-list
6085778|NCT03839446|Gemtuzumab|gemtuzumab|mesh-list
6085779|NCT03839446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6085780|NCT03839446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6085781|NCT03839446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6085782|NCT03839446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6085783|NCT03839446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6085784|NCT03839446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085785|NCT03839446|Analgesics|analgesics|mesh-ancestor
5516648|NCT04351620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5516649|NCT04351620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6464101|NCT00467883|Antifungal Agents|antifungal agents|mesh-ancestor
6464102|NCT00467909|Micronutrients|micronutrients|mesh-list
6464103|NCT00467909|Trace Elements|trace elements|mesh-list
6464104|NCT00467909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5516650|NCT04351620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516651|NCT04351620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5516652|NCT04351412|Fluorides|fluorides|mesh-list
5516653|NCT04351412|Fluorides, Topical|fluorides, topical|mesh-list
5516654|NCT04351412|Cariostatic Agents|cariostatic agents|mesh-ancestor
5516655|NCT04351412|Protective Agents|protective agents|mesh-ancestor
5516656|NCT04351412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5516657|NCT04351594|Menthol|menthol|mesh-list
5516658|NCT04351594|Antipruritics|antipruritics|mesh-ancestor
5516659|NCT04351594|Dermatologic Agents|dermatologic agents|mesh-ancestor
5600718|NCT03709992|Trospium chloride|trospium chloride|mesh-list
6085786|NCT03839446|Sensory System Agents|sensory system agents|mesh-ancestor
6464105|NCT00467935|Ranibizumab|ranibizumab|mesh-list
6464106|NCT00467935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6464107|NCT00467935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6464108|NCT00467935|Growth Substances|growth substances|mesh-ancestor
6085787|NCT03839446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6085788|NCT03839446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085789|NCT03839446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6085790|NCT03822013|Miglustat|miglustat|mesh-list
6085791|NCT03822013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6085792|NCT03822013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085793|NCT03822013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6085794|NCT03822013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6085795|NCT03822013|Antiviral Agents|antiviral agents|mesh-ancestor
6085796|NCT03822013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6085797|NCT03822013|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6085798|NCT03822013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6085799|NCT03822013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085800|NCT03806452|Hydroxyurea|hydroxyurea|mesh-list
6085801|NCT03806452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6085802|NCT03806452|Antisickling Agents|antisickling agents|mesh-ancestor
6085803|NCT03806452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6085804|NCT03806452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085805|NCT03806452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6085806|NCT03794999|Benralizumab|benralizumab|mesh-list
6085807|NCT03794999|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6085808|NCT03794999|Respiratory System Agents|respiratory system agents|mesh-ancestor
6085809|NCT03781986|Carboplatin|carboplatin|mesh-list
6085810|NCT03781986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6085811|NCT03781934|Pembrolizumab|pembrolizumab|mesh-list
6085812|NCT03781934|Lenvatinib|lenvatinib|mesh-list
6085813|NCT03781934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6085814|NCT03781934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6085815|NCT03781934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6085816|NCT03781934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6085817|NCT03781934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085818|NCT03763656|Hydroxyurea|hydroxyurea|mesh-list
6085819|NCT03763656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6085820|NCT03763656|Antisickling Agents|antisickling agents|mesh-ancestor
6085821|NCT03763656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6085822|NCT03763656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085823|NCT03763656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6085824|NCT03713645|Tacrolimus|tacrolimus|mesh-list
6085825|NCT03713645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6085826|NCT03713645|Immunologic Factors|immunologic factors|mesh-ancestor
6085827|NCT03713645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085828|NCT03713645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6085829|NCT03713645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6085830|NCT03713645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085831|NCT03690869|Cemiplimab|cemiplimab|mesh-list
6085832|NCT03690869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6085833|NCT03690869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6085834|NCT03641001|Micronutrients|micronutrients|mesh-list
6085835|NCT03641001|Trace Elements|trace elements|mesh-list
6085836|NCT03641001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085837|NCT03620981|Brexpiprazole|brexpiprazole|mesh-list
6085838|NCT03620981|Serotonin Agents|serotonin agents|mesh-ancestor
6085839|NCT03620981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6085840|NCT03620981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085841|NCT03620981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085842|NCT03620981|Dopamine Agonists|dopamine agonists|mesh-ancestor
5516660|NCT04351347|Ivermectin|ivermectin|mesh-list
5516661|NCT04351347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5516662|NCT04351347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5516663|NCT04351308|Apatinib|apatinib|mesh-list
5516664|NCT04351308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5516665|NCT04351308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5516666|NCT04351308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5516667|NCT04351308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516668|NCT04351516|Hydroxychloroquine|hydroxychloroquine|mesh-list
5516669|NCT04351516|Antimalarials|antimalarials|mesh-ancestor
6085843|NCT03620981|Dopamine Agents|dopamine agents|mesh-ancestor
6085844|NCT03611881|Nicotine|nicotine|mesh-list
6085845|NCT03611881|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6085846|NCT03611881|Autonomic Agents|autonomic agents|mesh-ancestor
6085847|NCT03611881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6085848|NCT03611881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085849|NCT03611881|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6085850|NCT03611881|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6085851|NCT03611881|Cholinergic Agents|cholinergic agents|mesh-ancestor
6085852|NCT03611881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6085853|NCT03611881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085854|NCT03608696|Buprenorphine|buprenorphine|mesh-list
6085855|NCT03608696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6085856|NCT03608696|Narcotics|narcotics|mesh-ancestor
6085857|NCT03608696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6085858|NCT03608696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085859|NCT03608696|Analgesics|analgesics|mesh-ancestor
6085860|NCT03608696|Sensory System Agents|sensory system agents|mesh-ancestor
6085861|NCT03608696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6085862|NCT03608696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6085863|NCT03587636|Bupivacaine|bupivacaine|mesh-list
6085864|NCT03587636|Anesthetics, Local|anesthetics, local|mesh-ancestor
6085865|NCT03587636|Anesthetics|anesthetics|mesh-ancestor
6085866|NCT03587636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6085867|NCT03587636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085868|NCT03587636|Sensory System Agents|sensory system agents|mesh-ancestor
6085869|NCT03587636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6085870|NCT03541486|Gemcitabine|gemcitabine|mesh-list
5516670|NCT04351516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5516671|NCT04351516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5516672|NCT04351516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5516673|NCT04351516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5516674|NCT04351516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516675|NCT04351516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5516676|NCT04351256|Durvalumab|durvalumab|mesh-list
5516677|NCT04351256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5516678|NCT04351256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5516679|NCT04351490|Cholecalciferol|cholecalciferol|mesh-list
5516680|NCT04351490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5516681|NCT04351490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5516682|NCT04351490|Vitamins|vitamins|mesh-ancestor
5516683|NCT04351490|Micronutrients|micronutrients|mesh-ancestor
5516684|NCT04351490|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5516685|NCT04351230|Trastuzumab|trastuzumab|mesh-list
5516686|NCT04351230|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
5516687|NCT04351230|Maytansine|maytansine|mesh-list
6085871|NCT03541486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085872|NCT03541486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5516688|NCT04351230|Immunoconjugates|immunoconjugates|mesh-list
5516689|NCT04351230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5516690|NCT04351230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5516691|NCT04351230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5516692|NCT04351230|Tubulin Modulators|tubulin modulators|mesh-ancestor
5516693|NCT04351230|Antimitotic Agents|antimitotic agents|mesh-ancestor
6085873|NCT03541486|Antimetabolites|antimetabolites|mesh-ancestor
6085874|NCT03541486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085875|NCT03541486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6085876|NCT03541486|Antiviral Agents|antiviral agents|mesh-ancestor
6085877|NCT03541486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6085878|NCT03541486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5516694|NCT04351230|Mitosis Modulators|mitosis modulators|mesh-ancestor
5516695|NCT04351230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516696|NCT04351230|Immunologic Factors|immunologic factors|mesh-ancestor
5516697|NCT04351230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5516698|NCT04351191|Hydroxychloroquine|hydroxychloroquine|mesh-list
6085879|NCT03541486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6085880|NCT03541486|Immunologic Factors|immunologic factors|mesh-ancestor
6085881|NCT03508570|Nivolumab|nivolumab|mesh-list
6085882|NCT03508570|Ipilimumab|ipilimumab|mesh-list
6085883|NCT03508570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6085884|NCT03508570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6085885|NCT03508570|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6085886|NCT03508570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085887|NCT03500731|Rituximab|rituximab|mesh-list
6085888|NCT03500731|Alemtuzumab|alemtuzumab|mesh-list
6085889|NCT03500731|Fludarabine|fludarabine|mesh-list
6085890|NCT03500731|Thiotepa|thiotepa|mesh-list
6085891|NCT03500731|Hydroxyurea|hydroxyurea|mesh-list
6085892|NCT03500731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6085893|NCT03500731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6085894|NCT03500731|Immunologic Factors|immunologic factors|mesh-ancestor
6085895|NCT03500731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085896|NCT03500731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6085897|NCT03500731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516699|NCT04351191|Chloroquine|chloroquine|mesh-list
5516700|NCT04351191|Antimalarials|antimalarials|mesh-ancestor
5516701|NCT04351191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5516702|NCT04351191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5516703|NCT04351191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5516704|NCT04351191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5516705|NCT04351191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516706|NCT04351191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5516707|NCT04351191|Amebicides|amebicides|mesh-ancestor
6085898|NCT03500731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6085899|NCT03500731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6085900|NCT03500731|Alkylating Agents|alkylating agents|mesh-ancestor
6085901|NCT03500731|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6085902|NCT03500731|Antisickling Agents|antisickling agents|mesh-ancestor
6085903|NCT03500731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6085904|NCT03500731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6085905|NCT03493178|Acetylcysteine|acetylcysteine|mesh-list
6085906|NCT03493178|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6085907|NCT03493178|Glycine|glycine|mesh-list
5516708|NCT04351581|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
5516709|NCT04351581|Protease Inhibitors|protease inhibitors|mesh-ancestor
5516710|NCT04351581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5516711|NCT04351581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516712|NCT04350931|BCG Vaccine|bcg vaccine|mesh-list
6085908|NCT03493178|Antiviral Agents|antiviral agents|mesh-ancestor
6085909|NCT03493178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6085910|NCT03493178|Expectorants|expectorants|mesh-ancestor
6085911|NCT03493178|Respiratory System Agents|respiratory system agents|mesh-ancestor
6085912|NCT03493178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6085913|NCT03493178|Antioxidants|antioxidants|mesh-ancestor
6085914|NCT03493178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085915|NCT03493178|Protective Agents|protective agents|mesh-ancestor
6464109|NCT00467935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085916|NCT03493178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085917|NCT03493178|Antidotes|antidotes|mesh-ancestor
6085918|NCT03493178|Glycine Agents|glycine agents|mesh-ancestor
6085919|NCT03493178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6085920|NCT03417193|Analgesics, Opioid|analgesics, opioid|mesh-list
6085921|NCT03417193|Anesthetics|anesthetics|mesh-list
6085922|NCT03417193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6085923|NCT03417193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085924|NCT03417193|Narcotics|narcotics|mesh-ancestor
6085925|NCT03417193|Analgesics|analgesics|mesh-ancestor
6085926|NCT03417193|Sensory System Agents|sensory system agents|mesh-ancestor
6085927|NCT03417193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6085928|NCT03414112|Oxytocin|oxytocin|mesh-list
6085929|NCT03414112|Oxytocics|oxytocics|mesh-ancestor
6085930|NCT03414112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6085931|NCT03414112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085932|NCT03410030|Ascorbic Acid|ascorbic acid|mesh-list
6085933|NCT03410030|Gemcitabine|gemcitabine|mesh-list
6464110|NCT00467935|Growth Inhibitors|growth inhibitors|mesh-ancestor
6464111|NCT00467935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6464112|NCT00467948|Cefazolin|cefazolin|mesh-list
6464113|NCT00467948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6464114|NCT00467948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5516713|NCT04350931|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6085934|NCT03410030|Paclitaxel|paclitaxel|mesh-list
6085935|NCT03410030|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6085936|NCT03410030|Cisplatin|cisplatin|mesh-list
6085937|NCT03410030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6085938|NCT03410030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6085939|NCT03410030|Tubulin Modulators|tubulin modulators|mesh-ancestor
6085940|NCT03410030|Antimitotic Agents|antimitotic agents|mesh-ancestor
6085941|NCT03410030|Mitosis Modulators|mitosis modulators|mesh-ancestor
6085942|NCT03410030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085943|NCT03410030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5516714|NCT04350931|Immunologic Factors|immunologic factors|mesh-ancestor
5516715|NCT04350931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5516716|NCT04351126|Fludrocortisone|fludrocortisone|mesh-list
5516717|NCT04351126|Bromocriptine|bromocriptine|mesh-list
5516718|NCT04351126|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5516719|NCT04351126|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5516720|NCT04351126|Hormone Antagonists|hormone antagonists|mesh-ancestor
5516721|NCT04351126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5516722|NCT04351126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5516723|NCT04351126|Dopamine Agonists|dopamine agonists|mesh-ancestor
5516724|NCT04351126|Dopamine Agents|dopamine agents|mesh-ancestor
5516725|NCT04351126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5516726|NCT04351126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516727|NCT04351126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5516728|NCT04351100|Diacetylrhein|diacetylrhein|mesh-list
5516729|NCT04351100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5516730|NCT04350645|Tranexamic Acid|tranexamic acid|mesh-list
5516731|NCT04350645|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5516732|NCT04350645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5516733|NCT04350645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516734|NCT04350645|Hemostatics|hemostatics|mesh-ancestor
5516735|NCT04350645|Coagulants|coagulants|mesh-ancestor
5516736|NCT04350320|Colchicine|colchicine|mesh-list
5516737|NCT04350320|Gout Suppressants|gout suppressants|mesh-ancestor
5516738|NCT04350320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5516739|NCT04350320|Tubulin Modulators|tubulin modulators|mesh-ancestor
6085944|NCT03410030|Antimetabolites|antimetabolites|mesh-ancestor
6464115|NCT00467987|Testosterone|testosterone|mesh-list
6464116|NCT00467987|Androgens|androgens|mesh-ancestor
6464117|NCT00467987|Hormones|hormones|mesh-ancestor
6464118|NCT00467987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6464119|NCT00467987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464120|NCT00468091|Atropine|atropine|mesh-list
6085945|NCT03410030|Antiviral Agents|antiviral agents|mesh-ancestor
6085946|NCT03410030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6085947|NCT03410030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6085948|NCT03410030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6085949|NCT03410030|Immunologic Factors|immunologic factors|mesh-ancestor
6085950|NCT03410030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085951|NCT03410030|Antioxidants|antioxidants|mesh-ancestor
6085952|NCT03410030|Protective Agents|protective agents|mesh-ancestor
6085953|NCT03410030|Vitamins|vitamins|mesh-ancestor
5516740|NCT04350320|Antimitotic Agents|antimitotic agents|mesh-ancestor
5516741|NCT04350320|Mitosis Modulators|mitosis modulators|mesh-ancestor
5516742|NCT04350320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516743|NCT04350320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5516744|NCT04350528|Pentobarbital|pentobarbital|mesh-list
5516745|NCT04350528|Chlorpromazine|chlorpromazine|mesh-list
5516746|NCT04350528|Antiemetics|antiemetics|mesh-ancestor
5516747|NCT04350528|Autonomic Agents|autonomic agents|mesh-ancestor
5516748|NCT04350528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5516749|NCT04350528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085954|NCT03410030|Micronutrients|micronutrients|mesh-ancestor
6085955|NCT03399539|Dexamethasone|dexamethasone|mesh-list
6085956|NCT03399539|Dexamethasone acetate|dexamethasone acetate|mesh-list
6085957|NCT03399539|Venetoclax|venetoclax|mesh-list
6085958|NCT03399539|Ixazomib|ixazomib|mesh-list
6085959|NCT03399539|Ichthammol|ichthammol|mesh-list
6085960|NCT03399539|BB 1101|bb 1101|mesh-list
5516750|NCT04350528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6085961|NCT03399539|Glycine|glycine|mesh-list
6085962|NCT03399539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6085963|NCT03399539|Antiemetics|antiemetics|mesh-ancestor
6085964|NCT03399539|Autonomic Agents|autonomic agents|mesh-ancestor
6085965|NCT03399539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6085966|NCT03399539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085967|NCT03399539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6085968|NCT03399539|Glucocorticoids|glucocorticoids|mesh-ancestor
6085969|NCT03399539|Hormones|hormones|mesh-ancestor
6085970|NCT03399539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6085971|NCT03399539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6085972|NCT03399539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6085973|NCT03399539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085974|NCT03399539|Protease Inhibitors|protease inhibitors|mesh-ancestor
6085975|NCT03399539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6085976|NCT03399539|Dermatologic Agents|dermatologic agents|mesh-ancestor
6085977|NCT03399539|Glycine Agents|glycine agents|mesh-ancestor
6085978|NCT03399539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6085979|NCT03386240|Triclosan|triclosan|mesh-list
6085980|NCT03386240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6085981|NCT03386240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5516751|NCT04350528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5516752|NCT04350528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5516753|NCT04350528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5516754|NCT04350528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5516755|NCT04350528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5516756|NCT04350528|Dopamine Agents|dopamine agents|mesh-ancestor
5516757|NCT04350528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5516758|NCT04350528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516759|NCT04350528|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5516760|NCT04350528|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5516761|NCT04350528|GABA Modulators|gaba modulators|mesh-ancestor
5516762|NCT04350528|GABA Agents|gaba agents|mesh-ancestor
5516763|NCT04350580|Immunoglobulins|immunoglobulins|mesh-list
5516764|NCT04350580|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6085982|NCT03386240|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6085983|NCT03386240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6085984|NCT03386240|Antimetabolites|antimetabolites|mesh-ancestor
6085985|NCT03386240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085986|NCT03386240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6085987|NCT03343197|Ivosidenib|ivosidenib|mesh-list
6085988|NCT03343197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6085989|NCT03343197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5516765|NCT04350580|Antibodies|antibodies|mesh-list
5516766|NCT04350580|Immunologic Factors|immunologic factors|mesh-ancestor
5516767|NCT04350580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5516768|NCT04350593|Dapagliflozin|dapagliflozin|mesh-list
5516769|NCT04350593|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5516770|NCT04350593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516771|NCT04350593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5516772|NCT04350593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5516773|NCT04350502|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5516774|NCT04350502|Amoxicillin|amoxicillin|mesh-list
6085990|NCT03343197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6085991|NCT03334305|Vaccines|vaccines|mesh-list
6085992|NCT03334305|Immunologic Factors|immunologic factors|mesh-ancestor
6085993|NCT03334305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085994|NCT03298802|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6085995|NCT03298802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6085996|NCT03298802|Diuretics|diuretics|mesh-ancestor
6085997|NCT03298802|Natriuretic Agents|natriuretic agents|mesh-ancestor
6085998|NCT03298802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6085999|NCT03298802|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6086000|NCT03298802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6086001|NCT03298802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086002|NCT03287908|Dexamethasone|dexamethasone|mesh-list
6086003|NCT03287908|Pomalidomide|pomalidomide|mesh-list
6665574|NCT01517815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665575|NCT01517828|Midazolam|midazolam|mesh-list
6665576|NCT01517828|Ketamine|ketamine|mesh-list
6665577|NCT01517828|Analgesics|analgesics|mesh-ancestor
6665578|NCT01517828|Sensory System Agents|sensory system agents|mesh-ancestor
6665579|NCT01517828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6665580|NCT01517828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665581|NCT01517828|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6665582|NCT01517828|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5516775|NCT04350502|Clavulanic Acids|clavulanic acids|mesh-list
5516776|NCT04350502|Clavulanic Acid|clavulanic acid|mesh-list
6665583|NCT01517828|Anesthetics, General|anesthetics, general|mesh-ancestor
6086004|NCT03287908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6086005|NCT03287908|Antiemetics|antiemetics|mesh-ancestor
6086006|NCT03287908|Autonomic Agents|autonomic agents|mesh-ancestor
6086007|NCT03287908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6086008|NCT03287908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086009|NCT03287908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6086010|NCT03287908|Glucocorticoids|glucocorticoids|mesh-ancestor
6086011|NCT03287908|Hormones|hormones|mesh-ancestor
6086012|NCT03287908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6086013|NCT03287908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6086014|NCT03287908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6086015|NCT03287908|Immunologic Factors|immunologic factors|mesh-ancestor
6086016|NCT03287908|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6086017|NCT03287908|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6086018|NCT03287908|Growth Substances|growth substances|mesh-ancestor
6086019|NCT03287908|Growth Inhibitors|growth inhibitors|mesh-ancestor
6086020|NCT03259503|Gemcitabine|gemcitabine|mesh-list
6086021|NCT03259503|Rituximab|rituximab|mesh-list
6086022|NCT03259503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6086023|NCT03259503|Melphalan|melphalan|mesh-list
6086024|NCT03259503|Busulfan|busulfan|mesh-list
6086025|NCT03259503|Mechlorethamine|mechlorethamine|mesh-list
6086026|NCT03259503|Olaparib|olaparib|mesh-list
6086027|NCT03259503|Vorinostat|vorinostat|mesh-list
6086028|NCT03259503|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
6086029|NCT03259503|Antibodies|antibodies|mesh-list
6086030|NCT03259503|Immunoglobulins|immunoglobulins|mesh-list
6086031|NCT03259503|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6086032|NCT03259503|Immunologic Factors|immunologic factors|mesh-ancestor
6086033|NCT03259503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086034|NCT03259503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6086035|NCT03259503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6086036|NCT03259503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6086037|NCT03259503|Antimetabolites|antimetabolites|mesh-ancestor
6086038|NCT03259503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086039|NCT03259503|Antiviral Agents|antiviral agents|mesh-ancestor
6086040|NCT03259503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6086041|NCT03259503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6086042|NCT03259503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6086043|NCT03259503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6086044|NCT03259503|Alkylating Agents|alkylating agents|mesh-ancestor
6086045|NCT03259503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6086046|NCT03259503|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6086047|NCT03259503|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6086048|NCT03240861|Aldesleukin|aldesleukin|mesh-list
6086049|NCT03240861|Plerixafor|plerixafor|mesh-list
5516777|NCT04350502|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5516778|NCT04350502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5516779|NCT04350502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5516780|NCT04350502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516781|NCT04350502|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5516782|NCT04350684|Interferons|interferons|mesh-list
5516783|NCT04350684|Ritonavir|ritonavir|mesh-list
5516784|NCT04350684|Lopinavir|lopinavir|mesh-list
5516785|NCT04350684|Interferon-beta|interferon-beta|mesh-list
5516786|NCT04350684|Interferon beta-1a|interferon beta-1a|mesh-list
5516787|NCT04350684|Hydroxychloroquine|hydroxychloroquine|mesh-list
5516788|NCT04350684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5516789|NCT04350684|Antiviral Agents|antiviral agents|mesh-ancestor
5516790|NCT04350684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5516791|NCT04350684|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5516792|NCT04350684|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5516793|NCT04350684|Protease Inhibitors|protease inhibitors|mesh-ancestor
5516794|NCT04350684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5516795|NCT04350684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516796|NCT04350684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5516797|NCT04350684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5516798|NCT04350684|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5516799|NCT04350684|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5516800|NCT04350684|Antimalarials|antimalarials|mesh-ancestor
5516801|NCT04350684|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5516802|NCT04350684|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5516803|NCT04350684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6086050|NCT03240861|Fludarabine|fludarabine|mesh-list
5516804|NCT04350684|Immunologic Factors|immunologic factors|mesh-ancestor
6086051|NCT03240861|Busulfan|busulfan|mesh-list
6086052|NCT03240861|Interleukin-2|interleukin-2|mesh-list
6086053|NCT03240861|Lenograstim|lenograstim|mesh-list
6086054|NCT03240861|Sargramostim|sargramostim|mesh-list
6086055|NCT03240861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6086056|NCT03240861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086057|NCT03240861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6086058|NCT03240861|Immunologic Factors|immunologic factors|mesh-ancestor
6086059|NCT03240861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086060|NCT03240861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6086061|NCT03240861|Alkylating Agents|alkylating agents|mesh-ancestor
6086062|NCT03240861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6086063|NCT03240861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5516805|NCT04350684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5516806|NCT04350684|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5516807|NCT04350450|Hydroxychloroquine|hydroxychloroquine|mesh-list
5516808|NCT04350450|Antimalarials|antimalarials|mesh-ancestor
5516809|NCT04350450|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5516810|NCT04350450|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5516811|NCT04350450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6086064|NCT03240861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6086065|NCT03240861|Analgesics|analgesics|mesh-ancestor
6086066|NCT03240861|Sensory System Agents|sensory system agents|mesh-ancestor
6086067|NCT03240861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6086068|NCT03240861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6086069|NCT03240861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5516812|NCT04350450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5516813|NCT04350450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516814|NCT04350450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5516815|NCT04350671|Interferons|interferons|mesh-list
5516816|NCT04350671|Ritonavir|ritonavir|mesh-list
5516817|NCT04350671|Lopinavir|lopinavir|mesh-list
5516818|NCT04350671|Interferon-beta|interferon-beta|mesh-list
5516819|NCT04350671|Interferon beta-1a|interferon beta-1a|mesh-list
5516820|NCT04350671|Hydroxychloroquine|hydroxychloroquine|mesh-list
6086070|NCT03240861|Antiviral Agents|antiviral agents|mesh-ancestor
6086071|NCT03240861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6086072|NCT03233724|Pembrolizumab|pembrolizumab|mesh-list
6086073|NCT03233724|Decitabine|decitabine|mesh-list
6464121|NCT00468091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6464122|NCT00468091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6464123|NCT00468091|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6464124|NCT00468091|Autonomic Agents|autonomic agents|mesh-ancestor
6464125|NCT00468091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6086074|NCT03233724|Tetrahydrouridine|tetrahydrouridine|mesh-list
6086075|NCT03233724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6086076|NCT03233724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6086077|NCT03233724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6086078|NCT03233724|Antimetabolites|antimetabolites|mesh-ancestor
6086079|NCT03233724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086080|NCT03233724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6203144|NCT02052635|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6203145|NCT02052635|Purinergic Agents|purinergic agents|mesh-ancestor
6203146|NCT02052635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6203147|NCT02052635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203148|NCT02052635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203149|NCT02052752|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6203150|NCT02052752|Dermatologic Agents|dermatologic agents|mesh-ancestor
6203151|NCT02052960|Cisplatin|cisplatin|mesh-list
6203152|NCT02052960|Fluorouracil|fluorouracil|mesh-list
6203153|NCT02052960|Cetuximab|cetuximab|mesh-list
6203154|NCT02052960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6203155|NCT02052960|Antimetabolites|antimetabolites|mesh-ancestor
5516821|NCT04350671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5516822|NCT04350671|Antiviral Agents|antiviral agents|mesh-ancestor
6203156|NCT02052960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203157|NCT02052960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5516823|NCT04350671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5516824|NCT04350671|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5516825|NCT04350671|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5516826|NCT04350671|Protease Inhibitors|protease inhibitors|mesh-ancestor
5516827|NCT04350671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5516828|NCT04350671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516829|NCT04350671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5516830|NCT04350671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5516831|NCT04350671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5516832|NCT04350671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5516833|NCT04350671|Antimalarials|antimalarials|mesh-ancestor
5516834|NCT04350671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5516835|NCT04350671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5516836|NCT04350671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5516837|NCT04350671|Immunologic Factors|immunologic factors|mesh-ancestor
5516838|NCT04350671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5516839|NCT04350671|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5516840|NCT04350086|Dexmedetomidine|dexmedetomidine|mesh-list
5516841|NCT04350086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5516842|NCT04350086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5516843|NCT04350086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5516844|NCT04350086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5516845|NCT04350086|Analgesics|analgesics|mesh-ancestor
5516846|NCT04350086|Sensory System Agents|sensory system agents|mesh-ancestor
6086081|NCT03151057|Idelalisib|idelalisib|mesh-list
6086082|NCT03151057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6086083|NCT03151057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6086084|NCT03151057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086085|NCT03149770|Naloxone|naloxone|mesh-list
6086086|NCT03149770|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6086087|NCT03149770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086088|NCT03149770|Sensory System Agents|sensory system agents|mesh-ancestor
6086089|NCT03149770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5516847|NCT04350086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5516848|NCT04350086|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5516849|NCT04350086|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5516850|NCT04350086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5516851|NCT04350086|Adrenergic Agents|adrenergic agents|mesh-ancestor
5516852|NCT04350086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5516853|NCT04350086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516854|NCT04350190|Apatinib|apatinib|mesh-list
5516855|NCT04350190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5516856|NCT04350190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5516857|NCT04350190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5516858|NCT04350190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516859|NCT04350281|Interferons|interferons|mesh-list
5516860|NCT04350281|Interferon-beta|interferon-beta|mesh-list
5516861|NCT04350281|Hydroxychloroquine|hydroxychloroquine|mesh-list
5516862|NCT04350281|Interferon beta-1b|interferon beta-1b|mesh-list
5516863|NCT04350281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5516864|NCT04350281|Antiviral Agents|antiviral agents|mesh-ancestor
5516865|NCT04350281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6086090|NCT03088930|Crizotinib|crizotinib|mesh-list
6086091|NCT03088930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6086092|NCT03088930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6086093|NCT03088930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6086094|NCT03088930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086098|NCT03053440|Zanubrutinib|zanubrutinib|mesh-list
6086099|NCT03053440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6086100|NCT03053440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6086101|NCT03053440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6086102|NCT03053440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086103|NCT03032172|Risdiplam|risdiplam|mesh-list
6086104|NCT03032172|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6086105|NCT03032172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6086106|NCT03032172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086107|NCT02955511|Pyrithione zinc|pyrithione zinc|mesh-list
6086108|NCT02955511|Keratolytic Agents|keratolytic agents|mesh-ancestor
6086109|NCT02955511|Dermatologic Agents|dermatologic agents|mesh-ancestor
6086110|NCT02942095|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6086111|NCT02942095|Ixazomib|ixazomib|mesh-list
6086112|NCT02942095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6086113|NCT02942095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6086114|NCT02942095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6086115|NCT02942095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086116|NCT02942095|Protease Inhibitors|protease inhibitors|mesh-ancestor
6086117|NCT02941783|Factor VIII|factor viii|mesh-list
6086118|NCT02941783|Coagulants|coagulants|mesh-ancestor
6086119|NCT02907099|Pembrolizumab|pembrolizumab|mesh-list
6086120|NCT02907099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6086121|NCT02907099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6086122|NCT02858310|Aldesleukin|aldesleukin|mesh-list
6086123|NCT02858310|Cyclophosphamide|cyclophosphamide|mesh-list
6086124|NCT02858310|Fludarabine|fludarabine|mesh-list
6086125|NCT02858310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6086126|NCT02858310|Immunologic Factors|immunologic factors|mesh-ancestor
6086127|NCT02858310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5516866|NCT04350281|Antimalarials|antimalarials|mesh-ancestor
5516867|NCT04350281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5516868|NCT04350281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5516869|NCT04350281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5516870|NCT04350281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516871|NCT04350281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5516872|NCT04350281|Immunologic Factors|immunologic factors|mesh-ancestor
5516873|NCT04350281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5516874|NCT04350281|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5516875|NCT04349982|Fibrin fragment D|fibrin fragment d|mesh-list
5516876|NCT04349982|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5516877|NCT04349982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5516878|NCT04349982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516879|NCT04349982|Hemostatics|hemostatics|mesh-ancestor
5516880|NCT04349982|Coagulants|coagulants|mesh-ancestor
5516881|NCT04349930|Cannabidiol|cannabidiol|mesh-list
5516882|NCT04349930|Anticonvulsants|anticonvulsants|mesh-ancestor
5516883|NCT04349722|Scopolamine|scopolamine|mesh-list
5516884|NCT04349722|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
5516885|NCT04349722|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5516886|NCT04349722|Antiemetics|antiemetics|mesh-ancestor
5516887|NCT04349722|Autonomic Agents|autonomic agents|mesh-ancestor
5516888|NCT04349722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5516889|NCT04349722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5516890|NCT04349722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5516891|NCT04349722|Mydriatics|mydriatics|mesh-ancestor
5516892|NCT04349722|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5516893|NCT04349722|Cholinergic Agents|cholinergic agents|mesh-ancestor
5516894|NCT04349722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5516895|NCT04349722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516896|NCT04349722|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6086128|NCT02858310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6086129|NCT02858310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6086130|NCT02858310|Alkylating Agents|alkylating agents|mesh-ancestor
6086131|NCT02858310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086132|NCT02858310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6086133|NCT02858310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6086134|NCT02858310|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6086135|NCT02858310|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6086136|NCT02858310|Antiviral Agents|antiviral agents|mesh-ancestor
6086137|NCT02858310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6086138|NCT02845596|Cyclosporine|cyclosporine|mesh-list
6086139|NCT02845596|Cyclophosphamide|cyclophosphamide|mesh-list
6086140|NCT02845596|Methotrexate|methotrexate|mesh-list
6086141|NCT02845596|Fludarabine|fludarabine|mesh-list
6086142|NCT02845596|Cyclosporins|cyclosporins|mesh-list
6086143|NCT02845596|Thymoglobulin|thymoglobulin|mesh-list
6086144|NCT02845596|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6086145|NCT02845596|Immunosuppressive Agents|immunosuppressive agents|mesh-list
6086146|NCT02845596|Immunologic Factors|immunologic factors|mesh-ancestor
6086147|NCT02845596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5516897|NCT04349722|Parasympatholytics|parasympatholytics|mesh-ancestor
5516898|NCT04349592|Azithromycin|azithromycin|mesh-list
5516899|NCT04349592|Hydroxychloroquine|hydroxychloroquine|mesh-list
5516900|NCT04349592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5516901|NCT04349592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5516902|NCT04349592|Antimalarials|antimalarials|mesh-ancestor
5516903|NCT04349592|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5516904|NCT04349592|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5516905|NCT04349592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6086148|NCT02845596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6086149|NCT02845596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6086150|NCT02845596|Alkylating Agents|alkylating agents|mesh-ancestor
6086151|NCT02845596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086152|NCT02845596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6086153|NCT02845596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6086154|NCT02845596|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6086155|NCT02845596|Abortifacient Agents|abortifacient agents|mesh-ancestor
6086156|NCT02845596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6086157|NCT02845596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6086158|NCT02845596|Antimetabolites|antimetabolites|mesh-ancestor
6086159|NCT02845596|Dermatologic Agents|dermatologic agents|mesh-ancestor
6086160|NCT02845596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6086161|NCT02845596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6086162|NCT02845596|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6086163|NCT02845596|Antifungal Agents|antifungal agents|mesh-ancestor
6086164|NCT02845596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6086165|NCT02845596|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6086166|NCT02815995|Durvalumab|durvalumab|mesh-list
6086167|NCT02815995|Tremelimumab|tremelimumab|mesh-list
6086168|NCT02815995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6086169|NCT02815995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6086170|NCT02812615|Micronutrients|micronutrients|mesh-list
6086171|NCT02812615|Trace Elements|trace elements|mesh-list
6086172|NCT02812615|Albendazole|albendazole|mesh-list
6086173|NCT02812615|Pyrantel|pyrantel|mesh-list
6086174|NCT02812615|Pyrantel Pamoate|pyrantel pamoate|mesh-list
6086175|NCT02812615|Anthelmintics|anthelmintics|mesh-ancestor
6086176|NCT02812615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6086177|NCT02812615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6086178|NCT02812615|Anticestodal Agents|anticestodal agents|mesh-ancestor
6086179|NCT02812615|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6086180|NCT02812615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6086181|NCT02812615|Tubulin Modulators|tubulin modulators|mesh-ancestor
6086182|NCT02812615|Antimitotic Agents|antimitotic agents|mesh-ancestor
6086183|NCT02812615|Mitosis Modulators|mitosis modulators|mesh-ancestor
6086184|NCT02812615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086185|NCT02812615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6086186|NCT02812615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086187|NCT02812615|Antinematodal Agents|antinematodal agents|mesh-ancestor
6086188|NCT02812615|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
6086189|NCT02812615|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6086190|NCT02812615|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6086191|NCT02812615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6086192|NCT02807883|Blinatumomab|blinatumomab|mesh-list
6086193|NCT02807883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6086194|NCT02807363|Leuprolide|leuprolide|mesh-list
6086195|NCT02807363|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6086196|NCT02807363|Fertility Agents|fertility agents|mesh-ancestor
6086197|NCT02807363|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6086198|NCT02807363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086199|NCT02807363|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6086200|NCT02807363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6086201|NCT02784496|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
6086202|NCT02784496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6086203|NCT02784496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6086204|NCT02784496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086205|NCT02756403|Azithromycin|azithromycin|mesh-list
6086206|NCT02756403|Metronidazole|metronidazole|mesh-list
6086207|NCT02756403|Doxycycline|doxycycline|mesh-list
6086208|NCT02756403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6086209|NCT02756403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6086210|NCT02756403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6086211|NCT02756403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6086212|NCT02756403|Antimalarials|antimalarials|mesh-ancestor
6086213|NCT02752035|Azacitidine|azacitidine|mesh-list
6086214|NCT02752035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6086215|NCT02752035|Antimetabolites|antimetabolites|mesh-ancestor
6086216|NCT02752035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086217|NCT02752035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6086218|NCT02752035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6086219|NCT02739035|Dexamethasone|dexamethasone|mesh-list
6086220|NCT02739035|Celecoxib|celecoxib|mesh-list
6086221|NCT02739035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6086222|NCT02739035|Antiemetics|antiemetics|mesh-ancestor
6086223|NCT02739035|Autonomic Agents|autonomic agents|mesh-ancestor
6086224|NCT02739035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6086225|NCT02739035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665584|NCT01517828|Anesthetics|anesthetics|mesh-ancestor
6086226|NCT02739035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6086227|NCT02739035|Glucocorticoids|glucocorticoids|mesh-ancestor
6086228|NCT02739035|Hormones|hormones|mesh-ancestor
6086229|NCT02739035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6086230|NCT02739035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6086231|NCT02739035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6086232|NCT02739035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6086233|NCT02739035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6086234|NCT02739035|Analgesics|analgesics|mesh-ancestor
6086235|NCT02739035|Sensory System Agents|sensory system agents|mesh-ancestor
6086236|NCT02739035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6086237|NCT02739035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6086238|NCT02739035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6086239|NCT02739035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6086240|NCT02739035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086241|NCT02710851|Vaccines|vaccines|mesh-list
6086242|NCT02710851|Immunologic Factors|immunologic factors|mesh-ancestor
6086243|NCT02710851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086244|NCT02704858|Perillyl alcohol|perillyl alcohol|mesh-list
6086245|NCT02704858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6464126|NCT00468091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464127|NCT00468091|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6464128|NCT00468091|Respiratory System Agents|respiratory system agents|mesh-ancestor
6464129|NCT00468091|Mydriatics|mydriatics|mesh-ancestor
6464130|NCT00468091|Parasympatholytics|parasympatholytics|mesh-ancestor
6086246|NCT02704858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6086247|NCT02704858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086248|NCT02682888|Oxytocin|oxytocin|mesh-list
6086249|NCT02682888|Oxytocics|oxytocics|mesh-ancestor
6086250|NCT02682888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6464131|NCT00468091|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6464132|NCT00468091|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6464133|NCT00468091|Cholinergic Agents|cholinergic agents|mesh-ancestor
6464134|NCT00468091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6464135|NCT00468091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086251|NCT02682888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086252|NCT02675452|Itraconazole|itraconazole|mesh-list
6086253|NCT02675452|Azacitidine|azacitidine|mesh-list
6086254|NCT02675452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6086255|NCT02675452|Antimetabolites|antimetabolites|mesh-ancestor
6086256|NCT02675452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086257|NCT02675452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6086258|NCT02675452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6086259|NCT02675452|Antifungal Agents|antifungal agents|mesh-ancestor
6086260|NCT02675452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6086261|NCT02675452|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6086262|NCT02675452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6086263|NCT02675452|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6086264|NCT02675452|Hormone Antagonists|hormone antagonists|mesh-ancestor
6086265|NCT02675452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6086266|NCT02675452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086267|NCT02675452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6086268|NCT02669186|Fentanyl|fentanyl|mesh-list
6086269|NCT02669186|Bupivacaine|bupivacaine|mesh-list
6086270|NCT02669186|Anesthetics, Local|anesthetics, local|mesh-ancestor
6086271|NCT02669186|Anesthetics|anesthetics|mesh-ancestor
6086272|NCT02669186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6086273|NCT02669186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086274|NCT02669186|Sensory System Agents|sensory system agents|mesh-ancestor
6086275|NCT02669186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6086276|NCT02669186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6086277|NCT02669186|Narcotics|narcotics|mesh-ancestor
6086278|NCT02669186|Analgesics|analgesics|mesh-ancestor
6086279|NCT02669186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6086280|NCT02669186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6086281|NCT02669186|Anesthetics, General|anesthetics, general|mesh-ancestor
6086282|NCT02665117|Chlorthalidone|chlorthalidone|mesh-list
6086283|NCT02665117|Magnesium citrate|magnesium citrate|mesh-list
6086284|NCT02665117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086285|NCT02665117|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6086286|NCT02665117|Diuretics|diuretics|mesh-ancestor
6086287|NCT02665117|Natriuretic Agents|natriuretic agents|mesh-ancestor
6086288|NCT02665117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086289|NCT02665117|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6464136|NCT00468182|Interferons|interferons|mesh-list
5516906|NCT04349592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516907|NCT04349592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5600719|NCT03709992|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5600720|NCT03709992|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5600721|NCT03709992|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5600722|NCT03709992|Adrenergic Agents|adrenergic agents|mesh-ancestor
6086290|NCT02665117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6086291|NCT02665117|Cathartics|cathartics|mesh-ancestor
6086292|NCT02665117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6086293|NCT02646839|Biotin|biotin|mesh-list
6086294|NCT02646839|Vitamin B Complex|vitamin b complex|mesh-ancestor
6086295|NCT02646839|Vitamins|vitamins|mesh-ancestor
6086296|NCT02646839|Micronutrients|micronutrients|mesh-ancestor
6086297|NCT02646839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086298|NCT02641236|Vancomycin|vancomycin|mesh-list
6086299|NCT02641236|Polymyxins|polymyxins|mesh-list
6086300|NCT02641236|Polymyxin B|polymyxin b|mesh-list
6086301|NCT02641236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6086302|NCT02641236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6086303|NCT02595866|Pembrolizumab|pembrolizumab|mesh-list
6086304|NCT02595866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6464137|NCT00468182|Interferon-beta|interferon-beta|mesh-list
6464138|NCT00468182|Interferon beta-1b|interferon beta-1b|mesh-list
6464139|NCT00468182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6464140|NCT00468182|Antiviral Agents|antiviral agents|mesh-ancestor
6464141|NCT00468182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6086305|NCT02595866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6086306|NCT02487797|Oxytocin|oxytocin|mesh-list
6086307|NCT02487797|Oxytocics|oxytocics|mesh-ancestor
6086308|NCT02487797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6086309|NCT02487797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086310|NCT02476786|Tamoxifen|tamoxifen|mesh-list
6086311|NCT02476786|Fulvestrant|fulvestrant|mesh-list
6086312|NCT02476786|Anastrozole|anastrozole|mesh-list
6086313|NCT02476786|Goserelin|goserelin|mesh-list
6086314|NCT02476786|Exemestane|exemestane|mesh-list
6086315|NCT02476786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6086316|NCT02476786|Hormone Antagonists|hormone antagonists|mesh-ancestor
6086317|NCT02476786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6086318|NCT02476786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086319|NCT02476786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6086320|NCT02476786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5600723|NCT03709992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5600724|NCT03709992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600725|NCT03709992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600726|NCT03709992|Urological Agents|urological agents|mesh-ancestor
5600727|NCT03709992|Parasympatholytics|parasympatholytics|mesh-ancestor
5600728|NCT03709992|Autonomic Agents|autonomic agents|mesh-ancestor
5600729|NCT03709992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5600730|NCT03709992|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5600731|NCT03709992|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6086321|NCT02476786|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5600732|NCT03709992|Cholinergic Agents|cholinergic agents|mesh-ancestor
5600733|NCT03709953|Apatinib|apatinib|mesh-list
5600734|NCT03709953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5600735|NCT03709953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5600736|NCT03709953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5600737|NCT03709953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600738|NCT03709940|Methylphenidate|methylphenidate|mesh-list
5600739|NCT03709940|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5600740|NCT03709940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600741|NCT03709940|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5600742|NCT03709940|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5600743|NCT03709940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5600744|NCT03709940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600745|NCT03709940|Dopamine Agents|dopamine agents|mesh-ancestor
5600746|NCT03709940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5600747|NCT03709927|Moxifloxacin|moxifloxacin|mesh-list
5600748|NCT03709927|Fosfomycin|fosfomycin|mesh-list
5600749|NCT03709927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5600750|NCT03709927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5600751|NCT03709927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6086322|NCT02476786|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6086323|NCT02476786|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6086324|NCT02476786|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6086325|NCT02476786|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6086326|NCT02476786|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6086327|NCT02476786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6086328|NCT02476786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086329|NCT02405520|Vaccines|vaccines|mesh-list
6086330|NCT02405520|Immunologic Factors|immunologic factors|mesh-ancestor
6086331|NCT02405520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086332|NCT02403505|BCG Vaccine|bcg vaccine|mesh-list
6086333|NCT02403505|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6086334|NCT02403505|Immunologic Factors|immunologic factors|mesh-ancestor
6086335|NCT02403505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086336|NCT02348762|Acetylcysteine|acetylcysteine|mesh-list
6086337|NCT02348762|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6086338|NCT02348762|Glycine|glycine|mesh-list
6086339|NCT02348762|Antiviral Agents|antiviral agents|mesh-ancestor
6086340|NCT02348762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6086341|NCT02348762|Expectorants|expectorants|mesh-ancestor
6086342|NCT02348762|Respiratory System Agents|respiratory system agents|mesh-ancestor
6086343|NCT02348762|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6086344|NCT02348762|Antioxidants|antioxidants|mesh-ancestor
5516908|NCT04349696|Mitiglinide|mitiglinide|mesh-list
5516909|NCT04349696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5516910|NCT04349696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086345|NCT02348762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086346|NCT02348762|Protective Agents|protective agents|mesh-ancestor
6086347|NCT02348762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086348|NCT02348762|Antidotes|antidotes|mesh-ancestor
6086349|NCT02348762|Glycine Agents|glycine agents|mesh-ancestor
6086350|NCT02348762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6086351|NCT02348359|Bevacizumab|bevacizumab|mesh-list
6086352|NCT02348359|Ranibizumab|ranibizumab|mesh-list
6086353|NCT02348359|Aflibercept|aflibercept|mesh-list
6086354|NCT02348359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6086355|NCT02348359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6086356|NCT02348359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6086357|NCT02348359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6086358|NCT02348359|Growth Substances|growth substances|mesh-ancestor
6086359|NCT02348359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086360|NCT02348359|Growth Inhibitors|growth inhibitors|mesh-ancestor
6086361|NCT02285062|Prednisone|prednisone|mesh-list
6086362|NCT02285062|Cyclophosphamide|cyclophosphamide|mesh-list
6086363|NCT02285062|Rituximab|rituximab|mesh-list
6086364|NCT02285062|Doxorubicin|doxorubicin|mesh-list
5516911|NCT04349228|Hydroxychloroquine|hydroxychloroquine|mesh-list
5516912|NCT04349228|Antimalarials|antimalarials|mesh-ancestor
5516913|NCT04349228|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5516914|NCT04349228|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5516915|NCT04349228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5516916|NCT04349228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5516917|NCT04349228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516918|NCT04349228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5516919|NCT04349306|Rasburicase|rasburicase|mesh-list
5516920|NCT04349306|Gout Suppressants|gout suppressants|mesh-ancestor
5516921|NCT04349306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5516922|NCT04349410|Interferons|interferons|mesh-list
6086365|NCT02285062|Vincristine|vincristine|mesh-list
6086366|NCT02285062|Lenalidomide|lenalidomide|mesh-list
6086367|NCT02285062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6086368|NCT02285062|Immunologic Factors|immunologic factors|mesh-ancestor
6086369|NCT02285062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086370|NCT02285062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6086371|NCT02285062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6086372|NCT02285062|Alkylating Agents|alkylating agents|mesh-ancestor
6086373|NCT02285062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086374|NCT02285062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6086375|NCT02285062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6086376|NCT02285062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6086377|NCT02285062|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6086378|NCT02285062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6086379|NCT02285062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6086380|NCT02285062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6086381|NCT02285062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5516923|NCT04349410|Interferon-alpha|interferon-alpha|mesh-list
5516924|NCT04349410|Interferon alpha-2|interferon alpha-2|mesh-list
5516925|NCT04349410|Remdesivir|remdesivir|mesh-list
6086382|NCT02285062|Glucocorticoids|glucocorticoids|mesh-ancestor
6086383|NCT02285062|Hormones|hormones|mesh-ancestor
5516926|NCT04349410|Azithromycin|azithromycin|mesh-list
5516927|NCT04349410|Hydroxychloroquine|hydroxychloroquine|mesh-list
6086384|NCT02285062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6086385|NCT02285062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6086386|NCT02285062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5516928|NCT04349410|Doxycycline|doxycycline|mesh-list
5516929|NCT04349410|Clindamycin|clindamycin|mesh-list
5516930|NCT04349410|Clindamycin palmitate|clindamycin palmitate|mesh-list
5516931|NCT04349410|Clindamycin phosphate|clindamycin phosphate|mesh-list
5516932|NCT04349410|Primaquine|primaquine|mesh-list
5516933|NCT04349410|Methylprednisolone|methylprednisolone|mesh-list
6086387|NCT02285062|Tubulin Modulators|tubulin modulators|mesh-ancestor
6086388|NCT02285062|Antimitotic Agents|antimitotic agents|mesh-ancestor
6086389|NCT02285062|Mitosis Modulators|mitosis modulators|mesh-ancestor
6086390|NCT02285062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6086391|NCT02285062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6086392|NCT02285062|Growth Substances|growth substances|mesh-ancestor
6086393|NCT02285062|Growth Inhibitors|growth inhibitors|mesh-ancestor
6086394|NCT02252432|Ketamine|ketamine|mesh-list
6086395|NCT02252432|Methadone|methadone|mesh-list
6086396|NCT02252432|Analgesics|analgesics|mesh-ancestor
6086397|NCT02252432|Sensory System Agents|sensory system agents|mesh-ancestor
6086398|NCT02252432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6086399|NCT02252432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086400|NCT02252432|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6086401|NCT02252432|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6086402|NCT02252432|Anesthetics, General|anesthetics, general|mesh-ancestor
6086403|NCT02252432|Anesthetics|anesthetics|mesh-ancestor
6086404|NCT02252432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6086405|NCT02252432|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6086406|NCT02252432|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6086407|NCT02252432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6086408|NCT02252432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086409|NCT02252432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6086410|NCT02252432|Narcotics|narcotics|mesh-ancestor
6086411|NCT02252432|Antitussive Agents|antitussive agents|mesh-ancestor
6086412|NCT02252432|Respiratory System Agents|respiratory system agents|mesh-ancestor
6086413|NCT02230969|Interferons|interferons|mesh-list
6086414|NCT02230969|Interferon-beta|interferon-beta|mesh-list
6086415|NCT02230969|Interferon beta-1a|interferon beta-1a|mesh-list
6086416|NCT02230969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6086417|NCT02230969|Antiviral Agents|antiviral agents|mesh-ancestor
6086418|NCT02230969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6086419|NCT02230969|Immunologic Factors|immunologic factors|mesh-ancestor
6086420|NCT02230969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086421|NCT02230969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6086422|NCT02224872|Mycophenolic Acid|mycophenolic acid|mesh-list
6086423|NCT02224872|Cyclophosphamide|cyclophosphamide|mesh-list
6086424|NCT02224872|Fludarabine|fludarabine|mesh-list
6086425|NCT02224872|Tacrolimus|tacrolimus|mesh-list
6086426|NCT02224872|Thymoglobulin|thymoglobulin|mesh-list
6086427|NCT02224872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6086428|NCT02224872|Immunologic Factors|immunologic factors|mesh-ancestor
6086429|NCT02224872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086430|NCT02224872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6086431|NCT02224872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6086432|NCT02224872|Alkylating Agents|alkylating agents|mesh-ancestor
6086433|NCT02224872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086434|NCT02224872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6086435|NCT02224872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6086436|NCT02224872|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6086437|NCT02224872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6086438|NCT02224872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6086439|NCT02224872|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6086440|NCT02224872|Antitubercular Agents|antitubercular agents|mesh-ancestor
6086441|NCT02224872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6086442|NCT02224872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6086443|NCT02187224|Progesterone|progesterone|mesh-list
6086444|NCT02187224|Progestins|progestins|mesh-ancestor
6086445|NCT02187224|Hormones|hormones|mesh-ancestor
6086446|NCT02187224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6086447|NCT02187224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086448|NCT02059499|Fluorouracil|fluorouracil|mesh-list
6086449|NCT02059499|Imiquimod|imiquimod|mesh-list
6086450|NCT02059499|Antimetabolites|antimetabolites|mesh-ancestor
6086451|NCT02059499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086452|NCT02059499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5516934|NCT04349410|Losartan|losartan|mesh-list
6086453|NCT02059499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5516935|NCT04349410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6464142|NCT00468182|Immunologic Factors|immunologic factors|mesh-ancestor
5516936|NCT04349410|Antiviral Agents|antiviral agents|mesh-ancestor
5516937|NCT04349410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5516938|NCT04349410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5516939|NCT04349410|Antiemetics|antiemetics|mesh-ancestor
5516940|NCT04349410|Autonomic Agents|autonomic agents|mesh-ancestor
5516941|NCT04349410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5516942|NCT04349410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5516943|NCT04349410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5516944|NCT04349410|Glucocorticoids|glucocorticoids|mesh-ancestor
5516945|NCT04349410|Hormones|hormones|mesh-ancestor
5516946|NCT04349410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5516947|NCT04349410|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5516948|NCT04349410|Protective Agents|protective agents|mesh-ancestor
5516949|NCT04349410|Immunologic Factors|immunologic factors|mesh-ancestor
5516950|NCT04349410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5516951|NCT04349410|Antimalarials|antimalarials|mesh-ancestor
5516952|NCT04349410|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6086454|NCT02059499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6086455|NCT02059499|Immunologic Factors|immunologic factors|mesh-ancestor
6086456|NCT02059499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086457|NCT02059499|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6086458|NCT02059499|Interferon Inducers|interferon inducers|mesh-ancestor
6203158|NCT02052960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6203159|NCT02052960|Immunologic Factors|immunologic factors|mesh-ancestor
6203160|NCT02052960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203161|NCT02052960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6203162|NCT02053493|Isosorbide|isosorbide|mesh-list
6203163|NCT02053493|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
6464143|NCT00468182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464144|NCT00468182|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5516953|NCT04349410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5516954|NCT04349410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5516955|NCT04349410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516956|NCT04349410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5516957|NCT04349410|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5516958|NCT04349410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5516959|NCT04349410|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5516960|NCT04349410|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5516961|NCT04349410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5516962|NCT04349410|Antimetabolites|antimetabolites|mesh-ancestor
5516963|NCT04349241|Favipiravir|favipiravir|mesh-list
5516964|NCT04349241|Antiviral Agents|antiviral agents|mesh-ancestor
5516965|NCT04349241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5516966|NCT04349826|Azithromycin|azithromycin|mesh-list
5516967|NCT04349826|Cefixime|cefixime|mesh-list
5516968|NCT04349826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6464145|NCT00468234|Nicotine|nicotine|mesh-list
6464146|NCT00468234|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6464147|NCT00468234|Autonomic Agents|autonomic agents|mesh-ancestor
6464148|NCT00468234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6464149|NCT00468234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464150|NCT00468234|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6464151|NCT00468234|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6464152|NCT00468234|Cholinergic Agents|cholinergic agents|mesh-ancestor
5516969|NCT04349826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5516970|NCT04348786|Amoxicillin|amoxicillin|mesh-list
6203164|NCT02053493|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
6203165|NCT02053493|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5516971|NCT04348786|Doxycycline|doxycycline|mesh-list
5516972|NCT04348786|Levofloxacin|levofloxacin|mesh-list
5516973|NCT04348786|Ofloxacin|ofloxacin|mesh-list
5516974|NCT04348786|Esomeprazole|esomeprazole|mesh-list
5516975|NCT04348786|Bismuth|bismuth|mesh-list
5516976|NCT04348786|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
5516977|NCT04348786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5516978|NCT04348786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5516979|NCT04348786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5516980|NCT04348786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5516981|NCT04348786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5516982|NCT04348786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5516983|NCT04348786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5516984|NCT04348786|Antimalarials|antimalarials|mesh-ancestor
5516985|NCT04348786|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6203166|NCT02053493|Diuretics|diuretics|mesh-ancestor
6203167|NCT02053493|Natriuretic Agents|natriuretic agents|mesh-ancestor
5516986|NCT04348786|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5516987|NCT04348786|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6464153|NCT00468234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6086459|NCT01995669|Lenalidomide|lenalidomide|mesh-list
6086460|NCT01995669|Obinutuzumab|obinutuzumab|mesh-list
6086461|NCT01995669|Immunologic Factors|immunologic factors|mesh-ancestor
6086462|NCT01995669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086463|NCT01995669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6086464|NCT01995669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6086465|NCT01995669|Growth Substances|growth substances|mesh-ancestor
6086466|NCT01995669|Growth Inhibitors|growth inhibitors|mesh-ancestor
6086467|NCT01995669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6086468|NCT01995669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6086469|NCT01968109|Nivolumab|nivolumab|mesh-list
6086470|NCT01968109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6086471|NCT01968109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6086472|NCT01968109|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6086473|NCT01968109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086474|NCT01962415|Fludarabine|fludarabine|mesh-list
6086475|NCT01962415|Melphalan|melphalan|mesh-list
6086476|NCT01962415|Alemtuzumab|alemtuzumab|mesh-list
6086477|NCT01962415|Thiotepa|thiotepa|mesh-list
6086478|NCT01962415|Hydroxyurea|hydroxyurea|mesh-list
6086479|NCT01962415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6086480|NCT01962415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086481|NCT01962415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6086482|NCT01962415|Immunologic Factors|immunologic factors|mesh-ancestor
6086483|NCT01962415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086484|NCT01962415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5516988|NCT04348786|Renal Agents|renal agents|mesh-ancestor
5516989|NCT04348786|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5516990|NCT04348786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5516991|NCT04348786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5516992|NCT04348786|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5516993|NCT04348786|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5516994|NCT04348786|Antacids|antacids|mesh-ancestor
5516995|NCT04348786|Antidiarrheals|antidiarrheals|mesh-ancestor
5516996|NCT04348695|Simvastatin|simvastatin|mesh-list
5516997|NCT04348695|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5516998|NCT04348695|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5516999|NCT04348695|Antimetabolites|antimetabolites|mesh-ancestor
5517000|NCT04348695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086485|NCT01962415|Alkylating Agents|alkylating agents|mesh-ancestor
6086486|NCT01962415|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6086487|NCT01962415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6086488|NCT01962415|Antisickling Agents|antisickling agents|mesh-ancestor
6086489|NCT01962415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6086490|NCT01962415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6086491|NCT01935336|Ponatinib|ponatinib|mesh-list
6086492|NCT01935336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6086493|NCT01935336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6086494|NCT01935336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6086495|NCT01935336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086496|NCT01905436|Ivermectin|ivermectin|mesh-list
6086497|NCT01905436|Albendazole|albendazole|mesh-list
6086498|NCT01905436|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6086499|NCT01905436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6086500|NCT01905436|Anthelmintics|anthelmintics|mesh-ancestor
6086501|NCT01905436|Anticestodal Agents|anticestodal agents|mesh-ancestor
6086502|NCT01905436|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6086503|NCT01905436|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6086504|NCT01905436|Tubulin Modulators|tubulin modulators|mesh-ancestor
6086505|NCT01905436|Antimitotic Agents|antimitotic agents|mesh-ancestor
6086506|NCT01905436|Mitosis Modulators|mitosis modulators|mesh-ancestor
6086507|NCT01905436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086508|NCT01905436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6086509|NCT01885702|Vaccines|vaccines|mesh-list
6086510|NCT01885702|Immunologic Factors|immunologic factors|mesh-ancestor
6086511|NCT01885702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086512|NCT01797523|Metformin|metformin|mesh-list
6086513|NCT01797523|Everolimus|everolimus|mesh-list
6086514|NCT01797523|Letrozole|letrozole|mesh-list
6086515|NCT01797523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6086516|NCT01797523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517001|NCT04348695|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5517002|NCT04348695|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6086517|NCT01797523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6086518|NCT01797523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6086519|NCT01797523|Immunologic Factors|immunologic factors|mesh-ancestor
6086520|NCT01797523|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6086521|NCT01797523|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6086522|NCT01797523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6086523|NCT01797523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086524|NCT01797523|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6086525|NCT01797523|Hormone Antagonists|hormone antagonists|mesh-ancestor
6086526|NCT01797523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6086527|NCT01733693|Buprenorphine|buprenorphine|mesh-list
6086528|NCT01733693|Methadone|methadone|mesh-list
6086529|NCT01733693|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6086530|NCT01733693|Narcotics|narcotics|mesh-ancestor
6086531|NCT01733693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6086532|NCT01733693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086533|NCT01733693|Analgesics|analgesics|mesh-ancestor
6086534|NCT01733693|Sensory System Agents|sensory system agents|mesh-ancestor
6086535|NCT01733693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6086536|NCT01733693|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6086537|NCT01733693|Antitussive Agents|antitussive agents|mesh-ancestor
6086538|NCT01733693|Respiratory System Agents|respiratory system agents|mesh-ancestor
6086539|NCT01712490|Doxorubicin|doxorubicin|mesh-list
6086540|NCT01712490|Bleomycin|bleomycin|mesh-list
6086541|NCT01712490|Dacarbazine|dacarbazine|mesh-list
5517003|NCT04348695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5517004|NCT04348877|Antibodies|antibodies|mesh-list
5517005|NCT04348877|Immunologic Factors|immunologic factors|mesh-ancestor
5517006|NCT04348877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517007|NCT04348916|Pembrolizumab|pembrolizumab|mesh-list
5517008|NCT04348916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5517009|NCT04348916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5517010|NCT04348292|Sirolimus|sirolimus|mesh-list
5517011|NCT04348292|Durvalumab|durvalumab|mesh-list
5517012|NCT04348292|Immunoglobulins|immunoglobulins|mesh-list
5517013|NCT04348292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5517014|NCT04348292|Immunoglobulin G|immunoglobulin g|mesh-list
5517015|NCT04348292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5517016|NCT04348292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5517017|NCT04348292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5517018|NCT04348292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5517019|NCT04348292|Antifungal Agents|antifungal agents|mesh-ancestor
5517020|NCT04348292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5517021|NCT04348292|Immunologic Factors|immunologic factors|mesh-ancestor
5517022|NCT04348292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517023|NCT04348292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5517024|NCT04348305|Hydrocortisone|hydrocortisone|mesh-list
5517025|NCT04348305|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
5517026|NCT04348305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6086542|NCT01712490|Vinblastine|vinblastine|mesh-list
6086543|NCT01712490|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6086544|NCT01712490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6086545|NCT01712490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6086546|NCT01712490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6086547|NCT01712490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6086548|NCT01712490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6086549|NCT01712490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086550|NCT01712490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6086551|NCT01712490|Alkylating Agents|alkylating agents|mesh-ancestor
6086552|NCT01712490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6086553|NCT01712490|Tubulin Modulators|tubulin modulators|mesh-ancestor
6086554|NCT01712490|Antimitotic Agents|antimitotic agents|mesh-ancestor
6086555|NCT01712490|Mitosis Modulators|mitosis modulators|mesh-ancestor
5517027|NCT04348370|Vaccines|vaccines|mesh-list
5517028|NCT04348370|BCG Vaccine|bcg vaccine|mesh-list
5517029|NCT04348370|Immunologic Factors|immunologic factors|mesh-ancestor
5517030|NCT04348370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517031|NCT04348370|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5517032|NCT04348383|Defibrotide|defibrotide|mesh-list
5517033|NCT04348383|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5517034|NCT04348383|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5517035|NCT04348383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517036|NCT04348383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5517037|NCT04348474|Azithromycin|azithromycin|mesh-list
5517038|NCT04348474|Hydroxychloroquine|hydroxychloroquine|mesh-list
6086556|NCT01712490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6086557|NCT01499160|Everolimus|everolimus|mesh-list
5517039|NCT04348474|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5517040|NCT04348474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6086558|NCT01499160|Letrozole|letrozole|mesh-list
6086559|NCT01499160|Lapatinib|lapatinib|mesh-list
6086560|NCT01499160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5517041|NCT04348474|Antimalarials|antimalarials|mesh-ancestor
5517042|NCT04348474|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5517043|NCT04348474|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5517044|NCT04348474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6086561|NCT01499160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6086562|NCT01499160|Immunologic Factors|immunologic factors|mesh-ancestor
6086563|NCT01499160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086564|NCT01499160|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6086565|NCT01499160|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6086566|NCT01499160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6086567|NCT01499160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086568|NCT01499160|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6464154|NCT00468234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6464155|NCT00468260|Epothilone B|epothilone b|mesh-list
6464156|NCT00468260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6464157|NCT00468260|Tubulin Modulators|tubulin modulators|mesh-ancestor
6464158|NCT00468260|Antimitotic Agents|antimitotic agents|mesh-ancestor
6464159|NCT00468260|Mitosis Modulators|mitosis modulators|mesh-ancestor
6086569|NCT01499160|Hormone Antagonists|hormone antagonists|mesh-ancestor
6086570|NCT01499160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6086571|NCT01499160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6086572|NCT01256086|Formoterol Fumarate|formoterol fumarate|mesh-list
6086573|NCT01256086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6086574|NCT01256086|Autonomic Agents|autonomic agents|mesh-ancestor
6086575|NCT01256086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6086576|NCT01256086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517045|NCT04348474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517046|NCT04348474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5517047|NCT04348409|Nitazoxanide|nitazoxanide|mesh-list
5517048|NCT04348409|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5517049|NCT04348409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5517050|NCT04347915|Clevudine|clevudine|mesh-list
5517051|NCT04347915|Antiviral Agents|antiviral agents|mesh-ancestor
5517052|NCT04347915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5517053|NCT04348006|Dexamethasone|dexamethasone|mesh-list
6086577|NCT01256086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6086578|NCT01256086|Respiratory System Agents|respiratory system agents|mesh-ancestor
6086579|NCT01256086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6086580|NCT01256086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6086581|NCT01256086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6086582|NCT01256086|Adrenergic Agents|adrenergic agents|mesh-ancestor
6086583|NCT01256086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6086584|NCT01256086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086585|NCT01149850|Bevacizumab|bevacizumab|mesh-list
6086586|NCT01149850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5517054|NCT04348006|Cyclophosphamide|cyclophosphamide|mesh-list
5517055|NCT04348006|Lenalidomide|lenalidomide|mesh-list
5517056|NCT04348006|Bortezomib|bortezomib|mesh-list
5517057|NCT04348006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5517058|NCT04348006|Immunologic Factors|immunologic factors|mesh-ancestor
5517059|NCT04348006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725086|NCT03182634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5725087|NCT03182634|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5725088|NCT03182634|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5725089|NCT03182634|Hormone Antagonists|hormone antagonists|mesh-ancestor
5725090|NCT03182634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5517060|NCT04348006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5725091|NCT03182634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725092|NCT03182595|Acetaminophen|acetaminophen|mesh-list
5725093|NCT03182595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5725094|NCT03182595|Analgesics|analgesics|mesh-ancestor
5517061|NCT04348006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6086587|NCT01149850|Temozolomide|temozolomide|mesh-list
6086588|NCT01149850|Antibodies|antibodies|mesh-list
6086589|NCT01149850|Immunoglobulins|immunoglobulins|mesh-list
6086590|NCT01149850|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6086591|NCT01149850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6086592|NCT01149850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6086593|NCT01149850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6086594|NCT01149850|Growth Substances|growth substances|mesh-ancestor
6086595|NCT01149850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086596|NCT01149850|Growth Inhibitors|growth inhibitors|mesh-ancestor
6086597|NCT01149850|Immunologic Factors|immunologic factors|mesh-ancestor
6086598|NCT01149850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6086599|NCT01149850|Alkylating Agents|alkylating agents|mesh-ancestor
6086600|NCT01149850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086601|NCT01090089|Dexamethasone|dexamethasone|mesh-list
6086602|NCT01090089|Dexamethasone acetate|dexamethasone acetate|mesh-list
6086603|NCT01090089|Lenalidomide|lenalidomide|mesh-list
6086604|NCT01090089|BB 1101|bb 1101|mesh-list
6086605|NCT01090089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6086606|NCT01090089|Antiemetics|antiemetics|mesh-ancestor
6086607|NCT01090089|Autonomic Agents|autonomic agents|mesh-ancestor
6086608|NCT01090089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6086609|NCT01090089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086610|NCT01090089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6086611|NCT01090089|Glucocorticoids|glucocorticoids|mesh-ancestor
6086612|NCT01090089|Hormones|hormones|mesh-ancestor
6086613|NCT01090089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6086614|NCT01090089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6086615|NCT01090089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6086616|NCT01090089|Protease Inhibitors|protease inhibitors|mesh-ancestor
6086617|NCT01090089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6086618|NCT01090089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086619|NCT01090089|Immunologic Factors|immunologic factors|mesh-ancestor
6086620|NCT01090089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6086621|NCT01090089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6086622|NCT01090089|Growth Substances|growth substances|mesh-ancestor
6086623|NCT01090089|Growth Inhibitors|growth inhibitors|mesh-ancestor
6086624|NCT01061151|Ritonavir|ritonavir|mesh-list
6086625|NCT01061151|Lopinavir|lopinavir|mesh-list
6086626|NCT01061151|Tenofovir|tenofovir|mesh-list
6086627|NCT01061151|Lamivudine|lamivudine|mesh-list
6086628|NCT01061151|Zidovudine|zidovudine|mesh-list
6086629|NCT01061151|Emtricitabine|emtricitabine|mesh-list
6086630|NCT01061151|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6086631|NCT01061151|Nevirapine|nevirapine|mesh-list
6086632|NCT01061151|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6086633|NCT01061151|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6086634|NCT01061151|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6086635|NCT01061151|Protease Inhibitors|protease inhibitors|mesh-ancestor
6086636|NCT01061151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6086637|NCT01061151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086638|NCT01061151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6086639|NCT01061151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6086640|NCT01061151|Antiviral Agents|antiviral agents|mesh-ancestor
6086641|NCT01061151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6086642|NCT01061151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6086643|NCT01061151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6086644|NCT01061151|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6086645|NCT01061151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6086646|NCT01061151|Antimetabolites|antimetabolites|mesh-ancestor
6086647|NCT01061151|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6086648|NCT01061151|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6086649|NCT00981058|Gemcitabine|gemcitabine|mesh-list
6086650|NCT00981058|Necitumumab|necitumumab|mesh-list
6086651|NCT00981058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6086652|NCT00981058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6086653|NCT00981058|Antimetabolites|antimetabolites|mesh-ancestor
6086654|NCT00981058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086655|NCT00981058|Antiviral Agents|antiviral agents|mesh-ancestor
6086656|NCT00981058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6086657|NCT00981058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6086658|NCT00981058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6086659|NCT00981058|Immunologic Factors|immunologic factors|mesh-ancestor
5517062|NCT04348006|Alkylating Agents|alkylating agents|mesh-ancestor
6086660|NCT00981058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086661|NCT00981058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5517063|NCT04348006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086662|NCT00885495|Ritonavir|ritonavir|mesh-list
6086663|NCT00885495|Darunavir|darunavir|mesh-list
6086664|NCT00885495|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6086665|NCT00885495|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6086666|NCT00885495|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6086667|NCT00885495|Protease Inhibitors|protease inhibitors|mesh-ancestor
6086668|NCT00885495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6086669|NCT00885495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086670|NCT00885495|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6086671|NCT00885495|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6086672|NCT00885495|Antiviral Agents|antiviral agents|mesh-ancestor
6086673|NCT00885495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6086674|NCT00885495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6086675|NCT00885495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6086676|NCT00885495|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6086677|NCT00885495|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6086678|NCT00885495|Antimetabolites|antimetabolites|mesh-ancestor
5517064|NCT04348006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5517065|NCT04348006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5517066|NCT04348006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5517067|NCT04348006|Antiemetics|antiemetics|mesh-ancestor
5517068|NCT04348006|Autonomic Agents|autonomic agents|mesh-ancestor
6086679|NCT00885495|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6086680|NCT00885495|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6086681|NCT00692939|Cyclophosphamide|cyclophosphamide|mesh-list
6086682|NCT00692939|Melphalan|melphalan|mesh-list
6086683|NCT00692939|Thiotepa|thiotepa|mesh-list
6086684|NCT00692939|Rituximab|rituximab|mesh-list
6086685|NCT00692939|Alemtuzumab|alemtuzumab|mesh-list
6086686|NCT00692939|Thymoglobulin|thymoglobulin|mesh-list
6086687|NCT00692939|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6086688|NCT00692939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6086689|NCT00692939|Immunologic Factors|immunologic factors|mesh-ancestor
6464160|NCT00468260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6464161|NCT00468351|Triamcinolone|triamcinolone|mesh-list
6464162|NCT00468351|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6464163|NCT00468351|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6464164|NCT00468351|Bevacizumab|bevacizumab|mesh-list
6464165|NCT00468351|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6464166|NCT00468351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6464167|NCT00468351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6464168|NCT00468351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6464169|NCT00468351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6464170|NCT00468351|Growth Substances|growth substances|mesh-ancestor
6464171|NCT00468351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086690|NCT00692939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086691|NCT00692939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6086692|NCT00692939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6086693|NCT00692939|Alkylating Agents|alkylating agents|mesh-ancestor
6086694|NCT00692939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086695|NCT00692939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6086696|NCT00692939|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6086697|NCT00692939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6086698|NCT00388921|Vitamin A|vitamin a|mesh-list
6464172|NCT00468351|Growth Inhibitors|growth inhibitors|mesh-ancestor
6086699|NCT00388921|Vitamins|vitamins|mesh-ancestor
6086700|NCT00388921|Micronutrients|micronutrients|mesh-ancestor
6086701|NCT00388921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086702|NCT00142285|Zinc Sulfate|zinc sulfate|mesh-list
6086703|NCT00142285|Astringents|astringents|mesh-ancestor
6086704|NCT00142285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086705|NCT00142285|Dermatologic Agents|dermatologic agents|mesh-ancestor
6086706|NCT00142272|Ciprofloxacin|ciprofloxacin|mesh-list
6086707|NCT00142272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6086708|NCT00142272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6086709|NCT00142272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6086710|NCT00142272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6086711|NCT00142272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6086712|NCT00142272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086713|NCT00142272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6086714|NCT00142272|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6086715|NCT00142272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6086716|NCT00084799|Antibodies|antibodies|mesh-list
6086717|NCT00084799|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6086718|NCT00084799|Immunologic Factors|immunologic factors|mesh-ancestor
6086719|NCT00084799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086720|NCT00821327|Gemcitabine|gemcitabine|mesh-list
6086721|NCT00821327|Sunitinib|sunitinib|mesh-list
6086722|NCT00821327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6086723|NCT00821327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6086724|NCT00821327|Antimetabolites|antimetabolites|mesh-ancestor
6086725|NCT00821327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086726|NCT00821327|Antiviral Agents|antiviral agents|mesh-ancestor
6086727|NCT00821327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6086728|NCT00821327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6086729|NCT00821327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6086730|NCT00821327|Immunologic Factors|immunologic factors|mesh-ancestor
6086731|NCT00821327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086732|NCT00821327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6086733|NCT00821327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6086734|NCT00821327|Growth Substances|growth substances|mesh-ancestor
6086735|NCT00821327|Growth Inhibitors|growth inhibitors|mesh-ancestor
6086736|NCT00821327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6086737|NCT00821509|Disinfectants|disinfectants|mesh-list
6086738|NCT00821509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6086739|NCT00821795|Insulin|insulin|mesh-list
6086740|NCT00821795|Insulin Aspart|insulin aspart|mesh-list
6086741|NCT00821795|Protamines|protamines|mesh-list
6086742|NCT00821795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6086743|NCT00821795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086744|NCT00821795|Heparin Antagonists|heparin antagonists|mesh-ancestor
6086745|NCT00821795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086746|NCT00821795|Coagulants|coagulants|mesh-ancestor
6086747|NCT00821821|Edaravone|edaravone|mesh-list
6086748|NCT00821821|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5517069|NCT04348006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5517070|NCT04348006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5517071|NCT04348006|Glucocorticoids|glucocorticoids|mesh-ancestor
5517072|NCT04348006|Hormones|hormones|mesh-ancestor
5517073|NCT04348006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5517074|NCT04348006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5517075|NCT04348006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5517076|NCT04348006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6086749|NCT00821821|Antioxidants|antioxidants|mesh-ancestor
6086750|NCT00821821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086751|NCT00821821|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6086752|NCT00821821|Protective Agents|protective agents|mesh-ancestor
6086753|NCT00821821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086754|NCT00821886|Carboplatin|carboplatin|mesh-list
6086755|NCT00821886|Trastuzumab|trastuzumab|mesh-list
6086756|NCT00821886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6086757|NCT00821886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6086758|NCT00821951|Vorinostat|vorinostat|mesh-list
6086759|NCT00821951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6086760|NCT00821951|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6086761|NCT00821951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6086762|NCT00821951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086763|NCT00821964|Paclitaxel|paclitaxel|mesh-list
6086764|NCT00821964|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6086765|NCT00821964|Imiquimod|imiquimod|mesh-list
6086766|NCT00821964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5517077|NCT04348006|Growth Substances|growth substances|mesh-ancestor
5517078|NCT04348006|Growth Inhibitors|growth inhibitors|mesh-ancestor
6086767|NCT00821964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6086768|NCT00821964|Tubulin Modulators|tubulin modulators|mesh-ancestor
6086769|NCT00821964|Antimitotic Agents|antimitotic agents|mesh-ancestor
6086770|NCT00821964|Mitosis Modulators|mitosis modulators|mesh-ancestor
6086771|NCT00821964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086772|NCT00821964|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6086773|NCT00821964|Immunologic Factors|immunologic factors|mesh-ancestor
6086774|NCT00821964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086775|NCT00821964|Interferon Inducers|interferon inducers|mesh-ancestor
6086776|NCT00822107|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6086777|NCT00822107|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5517079|NCT04347733|Triamcinolone|triamcinolone|mesh-list
5517080|NCT04347733|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5517081|NCT04347733|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5517082|NCT04347733|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5517083|NCT04347733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5517084|NCT04347733|Glucocorticoids|glucocorticoids|mesh-ancestor
5517085|NCT04347733|Hormones|hormones|mesh-ancestor
5517086|NCT04347733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5517087|NCT04347733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517088|NCT04347733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5517089|NCT04347733|Immunologic Factors|immunologic factors|mesh-ancestor
5517090|NCT04347733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5517091|NCT04347733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600752|NCT03709927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5600753|NCT03709927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5607026|NCT03031730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6086778|NCT00822107|Diuretics|diuretics|mesh-ancestor
6086779|NCT00822107|Natriuretic Agents|natriuretic agents|mesh-ancestor
6086780|NCT00822107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086781|NCT00822107|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6086782|NCT00822107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6086783|NCT00822107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086784|NCT00822172|Cilostazol|cilostazol|mesh-list
6086785|NCT00822172|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6086786|NCT00822172|Autonomic Agents|autonomic agents|mesh-ancestor
6086787|NCT00822172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6086788|NCT00822172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086789|NCT00822172|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6086790|NCT00822172|Respiratory System Agents|respiratory system agents|mesh-ancestor
6086791|NCT00822172|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6086792|NCT00822172|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6086793|NCT00822172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086794|NCT00822172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6086795|NCT00822172|Vasodilator Agents|vasodilator agents|mesh-ancestor
6086796|NCT00822172|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6086797|NCT00822172|Protective Agents|protective agents|mesh-ancestor
6086798|NCT00822172|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6086799|NCT00822172|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6086800|NCT00822172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6086801|NCT00822237|Vaccines|vaccines|mesh-list
6086802|NCT00822237|Immunoglobulins|immunoglobulins|mesh-list
6086803|NCT00822237|Immunologic Factors|immunologic factors|mesh-ancestor
6086804|NCT00822237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086805|NCT00822354|Tadalafil|tadalafil|mesh-list
6086806|NCT00822354|Vasodilator Agents|vasodilator agents|mesh-ancestor
6086807|NCT00822354|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6086808|NCT00822354|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6086809|NCT00822354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6086810|NCT00822354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086811|NCT00822354|Urological Agents|urological agents|mesh-ancestor
6086812|NCT00822523|Botulinum Toxins|botulinum toxins|mesh-list
6086813|NCT00822523|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6086814|NCT00822523|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6086815|NCT00822523|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6086816|NCT00822523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6086817|NCT00822523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086818|NCT00822523|Cholinergic Agents|cholinergic agents|mesh-ancestor
6086819|NCT00822523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6086820|NCT00822523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086821|NCT00822523|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6086822|NCT00822523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6086823|NCT00822692|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6086824|NCT00822692|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6086825|NCT00822692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6086826|NCT00822692|Renal Agents|renal agents|mesh-ancestor
6086827|NCT00822692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6086828|NCT00822692|Antimalarials|antimalarials|mesh-ancestor
6086829|NCT00822692|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6086830|NCT00822692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6086831|NCT00822770|Vidarabine|vidarabine|mesh-list
6086832|NCT00822770|Plerixafor|plerixafor|mesh-list
6086833|NCT00822770|Fludarabine|fludarabine|mesh-list
6086834|NCT00822770|Fludarabine phosphate|fludarabine phosphate|mesh-list
6086835|NCT00822770|Busulfan|busulfan|mesh-list
6086836|NCT00822770|Thymoglobulin|thymoglobulin|mesh-list
6086837|NCT00822770|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6086838|NCT00822770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5517092|NCT04347902|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
5517093|NCT04347902|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5517094|NCT04347902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5517095|NCT04348045|Durvalumab|durvalumab|mesh-list
5517096|NCT04348045|Olaparib|olaparib|mesh-list
5517097|NCT04348045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5517098|NCT04348045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5517099|NCT04348045|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5517100|NCT04348045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5517101|NCT04348045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517102|NCT04347889|Ascorbic Acid|ascorbic acid|mesh-list
5517103|NCT04347889|Hydroxychloroquine|hydroxychloroquine|mesh-list
5517104|NCT04347889|Vitamins|vitamins|mesh-ancestor
5517105|NCT04347889|Micronutrients|micronutrients|mesh-ancestor
5517106|NCT04347889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517107|NCT04347889|Antimalarials|antimalarials|mesh-ancestor
5517108|NCT04347889|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5517109|NCT04347889|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6086839|NCT00822770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6086840|NCT00822770|Antimetabolites|antimetabolites|mesh-ancestor
6086841|NCT00822770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086842|NCT00822770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6086843|NCT00822770|Immunologic Factors|immunologic factors|mesh-ancestor
6086844|NCT00822770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086845|NCT00822770|Antiviral Agents|antiviral agents|mesh-ancestor
6086846|NCT00822770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6086847|NCT00822770|Alkylating Agents|alkylating agents|mesh-ancestor
6086848|NCT00822770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6086849|NCT00822770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6086850|NCT00822770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6086851|NCT00822770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6086852|NCT00822900|Progesterone|progesterone|mesh-list
6086853|NCT00822900|Progestins|progestins|mesh-ancestor
6086854|NCT00822900|Hormones|hormones|mesh-ancestor
6086855|NCT00822900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6086856|NCT00822900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086857|NCT00822926|Botulinum Toxins|botulinum toxins|mesh-list
6086858|NCT00822926|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6086859|NCT00822926|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6086860|NCT00822926|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6086861|NCT00822926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6086862|NCT00822926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086863|NCT00822926|Cholinergic Agents|cholinergic agents|mesh-ancestor
6086864|NCT00822926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6086865|NCT00822926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086866|NCT00822926|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6086867|NCT00822926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6086868|NCT00823043|Timolol|timolol|mesh-list
6086869|NCT00823043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5517110|NCT04347889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5517111|NCT04347889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5517112|NCT04347889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517113|NCT04347889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5517114|NCT04347889|Antioxidants|antioxidants|mesh-ancestor
5517115|NCT04347889|Protective Agents|protective agents|mesh-ancestor
5517116|NCT04347980|Hydroxychloroquine|hydroxychloroquine|mesh-list
5517117|NCT04347980|Dexamethasone|dexamethasone|mesh-list
5517118|NCT04347980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6086870|NCT00823043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6086871|NCT00823043|Adrenergic Agents|adrenergic agents|mesh-ancestor
6086872|NCT00823043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6086873|NCT00823043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086874|NCT00823043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086875|NCT00823043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6086876|NCT00823043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6086877|NCT00823082|Antithrombins|antithrombins|mesh-list
6086878|NCT00823082|Antithrombin III|antithrombin iii|mesh-list
6086879|NCT00823082|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6086880|NCT00823082|Protease Inhibitors|protease inhibitors|mesh-ancestor
6086881|NCT00823082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6086882|NCT00823082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086883|NCT00823082|Anticoagulants|anticoagulants|mesh-ancestor
6086884|NCT00823212|Aspirin|aspirin|mesh-list
6086885|NCT00823212|Ticlopidine|ticlopidine|mesh-list
6086886|NCT00823212|Clopidogrel|clopidogrel|mesh-list
6086887|NCT00823212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6086888|NCT00823212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6086889|NCT00823212|Analgesics|analgesics|mesh-ancestor
6086890|NCT00823212|Sensory System Agents|sensory system agents|mesh-ancestor
6086891|NCT00823212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6086892|NCT00823212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086893|NCT00823212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6086894|NCT00823212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6086895|NCT00823212|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6086896|NCT00823212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6086897|NCT00823212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086898|NCT00823212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6086899|NCT00823212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6086900|NCT00823212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6086901|NCT00823212|Antipyretics|antipyretics|mesh-ancestor
6086902|NCT00823212|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6086903|NCT00823212|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6086904|NCT00823212|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6086905|NCT00823212|Purinergic Agents|purinergic agents|mesh-ancestor
6086906|NCT00823212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6086907|NCT00823212|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6086908|NCT00823212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6086909|NCT00823264|Charcoal|charcoal|mesh-list
6086910|NCT00823264|Antidotes|antidotes|mesh-ancestor
6086911|NCT00823264|Protective Agents|protective agents|mesh-ancestor
6086912|NCT00823264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086913|NCT00823303|Calcitriol|calcitriol|mesh-list
6086914|NCT00823303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6086915|NCT00823303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086916|NCT00823303|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6086917|NCT00823303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6086918|NCT00823303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086919|NCT00823303|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6086920|NCT00823303|Vitamins|vitamins|mesh-ancestor
6086921|NCT00823303|Micronutrients|micronutrients|mesh-ancestor
6086922|NCT00823303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6086923|NCT00823459|Everolimus|everolimus|mesh-list
6086924|NCT00823459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6086925|NCT00823459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6086926|NCT00823459|Immunologic Factors|immunologic factors|mesh-ancestor
6086927|NCT00823459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086928|NCT00823472|Ganirelix|ganirelix|mesh-list
6086929|NCT00823472|Hormone Antagonists|hormone antagonists|mesh-ancestor
6086930|NCT00823472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6086931|NCT00823472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086932|NCT00823719|Ofatumumab|ofatumumab|mesh-list
6086933|NCT00823719|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6086934|NCT00823719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6086935|NCT00823719|Immunologic Factors|immunologic factors|mesh-ancestor
6086936|NCT00823719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517119|NCT04347980|Antiemetics|antiemetics|mesh-ancestor
5517120|NCT04347980|Autonomic Agents|autonomic agents|mesh-ancestor
5517121|NCT04347980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5517122|NCT04347980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517123|NCT04347980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5517124|NCT04347980|Glucocorticoids|glucocorticoids|mesh-ancestor
5517125|NCT04347980|Hormones|hormones|mesh-ancestor
5517126|NCT04347980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5517127|NCT04347980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5517128|NCT04347980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5517129|NCT04347980|Antimalarials|antimalarials|mesh-ancestor
5517130|NCT04347980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6086937|NCT00823797|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6086938|NCT00823797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6086939|NCT00823797|Alkylating Agents|alkylating agents|mesh-ancestor
6086940|NCT00823797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086941|NCT00823797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6086942|NCT00823823|Calpastatin|calpastatin|mesh-list
6086943|NCT00823823|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
6086944|NCT00823823|Protease Inhibitors|protease inhibitors|mesh-ancestor
6086945|NCT00823823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6086946|NCT00823823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086947|NCT00823836|Ropinirole|ropinirole|mesh-list
5517131|NCT04347980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5517132|NCT04347980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5517133|NCT04347980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5517134|NCT04347980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517135|NCT04347980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5517136|NCT04348032|Apatinib|apatinib|mesh-list
6086948|NCT00823836|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6086949|NCT00823836|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6086950|NCT00823836|Dopamine Agonists|dopamine agonists|mesh-ancestor
6086951|NCT00823836|Dopamine Agents|dopamine agents|mesh-ancestor
6086952|NCT00823836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6086953|NCT00823836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086954|NCT00823836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086955|NCT00823901|Clindamycin|clindamycin|mesh-list
6086956|NCT00823901|Clindamycin palmitate|clindamycin palmitate|mesh-list
6086957|NCT00823901|Clindamycin phosphate|clindamycin phosphate|mesh-list
6086958|NCT00823901|Tretinoin|tretinoin|mesh-list
6086959|NCT00823901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6086960|NCT00823901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6086961|NCT00823901|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6086962|NCT00823901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6086963|NCT00823901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086964|NCT00823901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6086965|NCT00823901|Keratolytic Agents|keratolytic agents|mesh-ancestor
5517137|NCT04348032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5517138|NCT04348032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5517139|NCT04348032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5517140|NCT04348032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517141|NCT04347798|Hydroxychloroquine|hydroxychloroquine|mesh-list
5517142|NCT04347798|Chloroquine|chloroquine|mesh-list
5517143|NCT04347798|Antimalarials|antimalarials|mesh-ancestor
5517144|NCT04347798|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5517145|NCT04347798|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6086966|NCT00823901|Dermatologic Agents|dermatologic agents|mesh-ancestor
6086967|NCT00823966|Delavirdine|delavirdine|mesh-list
6086968|NCT00823966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6086969|NCT00823966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6086970|NCT00823966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6086971|NCT00823966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086972|NCT00823966|Antiviral Agents|antiviral agents|mesh-ancestor
6086973|NCT00823966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6086974|NCT00823966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6086975|NCT00823966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6086976|NCT00823979|Etravirine|etravirine|mesh-list
6086977|NCT00823979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6086978|NCT00823979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6086979|NCT00823979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6086980|NCT00823979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086981|NCT00823979|Antiviral Agents|antiviral agents|mesh-ancestor
5517146|NCT04347798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5517147|NCT04347798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6086982|NCT00823979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6086983|NCT00824044|Citalopram|citalopram|mesh-list
6086984|NCT00824044|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6086985|NCT00824044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6086986|NCT00824044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5517148|NCT04347798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517149|NCT04347798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5517150|NCT04347798|Amebicides|amebicides|mesh-ancestor
5517151|NCT04347720|Acetaminophen|acetaminophen|mesh-list
5517152|NCT04347720|Ibuprofen|ibuprofen|mesh-list
5517153|NCT04347720|Indomethacin|indomethacin|mesh-list
5517154|NCT04347720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5517155|NCT04347720|Analgesics|analgesics|mesh-ancestor
5517156|NCT04347720|Sensory System Agents|sensory system agents|mesh-ancestor
5517157|NCT04347720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5517158|NCT04347720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517159|NCT04347720|Antipyretics|antipyretics|mesh-ancestor
5517160|NCT04347720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5517161|NCT04347720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5517162|NCT04347720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5517163|NCT04347720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5517164|NCT04347720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5517165|NCT04347720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517166|NCT04347720|Gout Suppressants|gout suppressants|mesh-ancestor
5517167|NCT04347720|Tocolytic Agents|tocolytic agents|mesh-ancestor
5517168|NCT04347720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5517169|NCT04347577|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5517170|NCT04347577|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5517171|NCT04347577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5517172|NCT04347577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5517173|NCT04347577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517174|NCT04347577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5517175|NCT04347577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517176|NCT04347577|Analgesics|analgesics|mesh-ancestor
5517177|NCT04347577|Sensory System Agents|sensory system agents|mesh-ancestor
5517178|NCT04347577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5517179|NCT04347577|Antidepressive Agents|antidepressive agents|mesh-ancestor
5517180|NCT04347577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5517181|NCT04347577|Dopamine Agents|dopamine agents|mesh-ancestor
5517182|NCT04347512|Azithromycin|azithromycin|mesh-list
5517183|NCT04347512|Hydroxychloroquine|hydroxychloroquine|mesh-list
5517184|NCT04347512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5517185|NCT04347512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6086987|NCT00824044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6086988|NCT00824044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6086989|NCT00824044|Serotonin Agents|serotonin agents|mesh-ancestor
6086990|NCT00824044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6086991|NCT00824044|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6086992|NCT00824044|Antidepressive Agents|antidepressive agents|mesh-ancestor
6086993|NCT00824044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6086994|NCT00824070|Moxifloxacin|moxifloxacin|mesh-list
6086995|NCT00824070|Gatifloxacin|gatifloxacin|mesh-list
6086996|NCT00824070|Besifloxacin|besifloxacin|mesh-list
6086997|NCT00824070|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6086998|NCT00824070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6086999|NCT00824070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6087000|NCT00824070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6087001|NCT00824070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6087002|NCT00824070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6087003|NCT00824070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087004|NCT00824070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6087005|NCT00824070|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6087006|NCT00824070|Contraceptive Agents|contraceptive agents|mesh-ancestor
6087007|NCT00824070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6087008|NCT00824070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087009|NCT00824070|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6087010|NCT00824070|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6087011|NCT00824070|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6087012|NCT00824070|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6087013|NCT00824070|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6203168|NCT02053493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203169|NCT02053493|Vasodilator Agents|vasodilator agents|mesh-ancestor
6203170|NCT02053493|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5517186|NCT04347512|Antimalarials|antimalarials|mesh-ancestor
6087014|NCT00824291|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6087015|NCT00824291|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6087016|NCT00824291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6087017|NCT00824291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6087018|NCT00824291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087019|NCT00824291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6087020|NCT00824291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087021|NCT00824291|Antidepressive Agents|antidepressive agents|mesh-ancestor
6087022|NCT00824291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6087023|NCT00824382|Olodaterol|olodaterol|mesh-list
6087024|NCT00824382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6087025|NCT00824382|Autonomic Agents|autonomic agents|mesh-ancestor
6087026|NCT00824382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6087027|NCT00824382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087028|NCT00824382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6087029|NCT00824382|Respiratory System Agents|respiratory system agents|mesh-ancestor
6087030|NCT00824408|Pemetrexed|pemetrexed|mesh-list
6087031|NCT00824408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6087032|NCT00824408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6087033|NCT00824408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087034|NCT00824408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6087035|NCT00824408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6087036|NCT00824460|Iron|iron|mesh-list
6087037|NCT00824460|Sevelamer|sevelamer|mesh-list
6087038|NCT00824460|Trace Elements|trace elements|mesh-ancestor
6087039|NCT00824460|Micronutrients|micronutrients|mesh-ancestor
6087040|NCT00824460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087041|NCT00824460|Chelating Agents|chelating agents|mesh-ancestor
6087042|NCT00824460|Sequestering Agents|sequestering agents|mesh-ancestor
6087043|NCT00824460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087044|NCT00824473|Azelastine|azelastine|mesh-list
5517187|NCT04347512|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6087045|NCT00824473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6087046|NCT00824473|Autonomic Agents|autonomic agents|mesh-ancestor
6087047|NCT00824473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6087048|NCT00824473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087049|NCT00824473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6087050|NCT00824473|Respiratory System Agents|respiratory system agents|mesh-ancestor
6087051|NCT00824473|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
5517188|NCT04347512|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5517189|NCT04347512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5517190|NCT04347512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087052|NCT00824473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5517191|NCT04347512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5517192|NCT04347434|Atorvastatin|atorvastatin|mesh-list
5517193|NCT04347434|Ezetimibe|ezetimibe|mesh-list
5517194|NCT04347434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5517195|NCT04347434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5517196|NCT04347434|Antimetabolites|antimetabolites|mesh-ancestor
5517197|NCT04347434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517198|NCT04347434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5517199|NCT04347434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5517200|NCT04347434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6087053|NCT00824473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087054|NCT00824473|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6087055|NCT00824473|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6087056|NCT00824473|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6087057|NCT00824473|Histamine Antagonists|histamine antagonists|mesh-ancestor
6087058|NCT00824473|Histamine Agents|histamine agents|mesh-ancestor
5517201|NCT04347252|Glucagon|glucagon|mesh-list
6087059|NCT00824473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6087060|NCT00824538|Sunitinib|sunitinib|mesh-list
6087061|NCT00824538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6087062|NCT00824538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6087063|NCT00824538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6087064|NCT00824538|Growth Substances|growth substances|mesh-ancestor
6087065|NCT00824538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087066|NCT00824538|Growth Inhibitors|growth inhibitors|mesh-ancestor
5517202|NCT04347252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5517203|NCT04347252|Hormones|hormones|mesh-ancestor
5517204|NCT04347252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6087067|NCT00824538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6087068|NCT00824538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6087069|NCT00824538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087070|NCT00824564|Tranexamic Acid|tranexamic acid|mesh-list
6087071|NCT00824564|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6087072|NCT00824564|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6087073|NCT00824564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087074|NCT00824564|Hemostatics|hemostatics|mesh-ancestor
5517205|NCT04347252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517206|NCT04346914|Carboplatin|carboplatin|mesh-list
5517207|NCT04346914|Etoposide|etoposide|mesh-list
5517208|NCT04346914|Antibodies|antibodies|mesh-list
5517209|NCT04346914|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5517210|NCT04346914|Immunologic Factors|immunologic factors|mesh-ancestor
6087075|NCT00824564|Coagulants|coagulants|mesh-ancestor
6087076|NCT00824616|Insulin|insulin|mesh-list
6087077|NCT00824616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6087078|NCT00824616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087079|NCT00824733|Trastuzumab|trastuzumab|mesh-list
6087080|NCT00824733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6087081|NCT00824733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6087082|NCT00824746|Gefitinib|gefitinib|mesh-list
6087083|NCT00824746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6087084|NCT00824746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6087085|NCT00824746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6087086|NCT00824746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087087|NCT00824824|Timolol|timolol|mesh-list
6087088|NCT00824824|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6087089|NCT00824824|Dorzolamide|dorzolamide|mesh-list
6087090|NCT00824824|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6087091|NCT00824824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6087092|NCT00824824|Adrenergic Agents|adrenergic agents|mesh-ancestor
6087093|NCT00824824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6087094|NCT00824824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087095|NCT00824824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087096|NCT00824824|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6087097|NCT00824824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6087098|NCT00824824|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6087099|NCT00824824|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6087100|NCT00824824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6087101|NCT00824824|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6087102|NCT00824824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6087103|NCT00824850|Vaccines|vaccines|mesh-list
6087104|NCT00824850|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6087105|NCT00824850|Immunologic Factors|immunologic factors|mesh-ancestor
6087106|NCT00824850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087107|NCT00824993|Ibandronic Acid|ibandronic acid|mesh-list
6087108|NCT00824993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517211|NCT04346914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087109|NCT00824993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6087110|NCT00825162|Vaccines|vaccines|mesh-list
6087111|NCT00825162|Immunologic Factors|immunologic factors|mesh-ancestor
6087112|NCT00825162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087113|NCT00825266|Pioglitazone|pioglitazone|mesh-list
6087114|NCT00825266|Bosentan|bosentan|mesh-list
6087115|NCT00825266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6087116|NCT00825266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087117|NCT00825266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6087118|NCT00825266|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6087119|NCT00825266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087120|NCT00825305|Vaccines|vaccines|mesh-list
6087121|NCT00825305|Immunologic Factors|immunologic factors|mesh-ancestor
6087122|NCT00825305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087123|NCT00825344|Etanercept|etanercept|mesh-list
6087124|NCT00825344|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6087125|NCT00825344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6087126|NCT00825344|Analgesics|analgesics|mesh-ancestor
5517212|NCT04346914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5517213|NCT04346914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5517214|NCT04346914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5517215|NCT04346914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5517216|NCT04346914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5517217|NCT04346914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517218|NCT04346901|Methimazole|methimazole|mesh-list
5517219|NCT04346901|Antithyroid Agents|antithyroid agents|mesh-ancestor
5517220|NCT04346901|Hormone Antagonists|hormone antagonists|mesh-ancestor
5517221|NCT04346901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5517222|NCT04346901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517223|NCT04347031|Azithromycin|azithromycin|mesh-list
5517224|NCT04347031|Hydroxychloroquine|hydroxychloroquine|mesh-list
5517225|NCT04347031|Mefloquine|mefloquine|mesh-list
5517226|NCT04347031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5517227|NCT04347031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5517228|NCT04347031|Antimalarials|antimalarials|mesh-ancestor
5517229|NCT04347031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5517230|NCT04347031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5517231|NCT04347031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6087127|NCT00825344|Sensory System Agents|sensory system agents|mesh-ancestor
6087128|NCT00825344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6087129|NCT00825344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087130|NCT00825344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6087131|NCT00825344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5517232|NCT04347031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517233|NCT04347031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5517234|NCT04347005|Allopurinol|allopurinol|mesh-list
5517235|NCT04347005|Febuxostat|febuxostat|mesh-list
5517236|NCT04347005|Antimetabolites|antimetabolites|mesh-ancestor
5517237|NCT04347005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517238|NCT04347005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5517239|NCT04347005|Gout Suppressants|gout suppressants|mesh-ancestor
5517240|NCT04347005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5517241|NCT04347005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5517242|NCT04347005|Antioxidants|antioxidants|mesh-ancestor
5517243|NCT04347005|Protective Agents|protective agents|mesh-ancestor
5517244|NCT04347005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517245|NCT04347200|Anticoagulants|anticoagulants|mesh-list
5517246|NCT04347200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
5517247|NCT04346862|Acetylcarnitine|acetylcarnitine|mesh-list
6087132|NCT00825344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6087133|NCT00825344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6087134|NCT00825344|Immunologic Factors|immunologic factors|mesh-ancestor
6087135|NCT00825370|Hydromorphone|hydromorphone|mesh-list
6087136|NCT00825370|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6087137|NCT00825370|Narcotics|narcotics|mesh-ancestor
5517248|NCT04346862|Vitamin B Complex|vitamin b complex|mesh-ancestor
5517249|NCT04346862|Vitamins|vitamins|mesh-ancestor
5517250|NCT04346862|Micronutrients|micronutrients|mesh-ancestor
5517251|NCT04346862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517252|NCT04346862|Nootropic Agents|nootropic agents|mesh-ancestor
5517253|NCT04347122|Tranexamic Acid|tranexamic acid|mesh-list
6087138|NCT00825370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6087139|NCT00825370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087140|NCT00825370|Analgesics|analgesics|mesh-ancestor
5517254|NCT04347122|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5517255|NCT04347122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6087141|NCT00825370|Sensory System Agents|sensory system agents|mesh-ancestor
5517256|NCT04347122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517257|NCT04347122|Hemostatics|hemostatics|mesh-ancestor
6087142|NCT00825370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6087143|NCT00825500|Loxapine|loxapine|mesh-list
6087144|NCT00825500|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6087145|NCT00825500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6087146|NCT00825500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6087147|NCT00825500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087148|NCT00825500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6087149|NCT00825500|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6087150|NCT00825500|Dopamine Agents|dopamine agents|mesh-ancestor
6087151|NCT00825500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6087152|NCT00825500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087153|NCT00825565|Allantoin|allantoin|mesh-list
5517258|NCT04347122|Coagulants|coagulants|mesh-ancestor
5517259|NCT04346823|Sevoflurane|sevoflurane|mesh-list
5517260|NCT04346823|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5517261|NCT04346823|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6087154|NCT00825565|Dermatologic Agents|dermatologic agents|mesh-ancestor
6087155|NCT00825630|Esomeprazole|esomeprazole|mesh-list
6087156|NCT00825630|Pantoprazole|pantoprazole|mesh-list
6087157|NCT00825630|Lansoprazole|lansoprazole|mesh-list
6087158|NCT00825630|Dexlansoprazole|dexlansoprazole|mesh-list
6087159|NCT00825630|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6087160|NCT00825630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6087161|NCT00825630|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6087162|NCT00825630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5725095|NCT03182595|Sensory System Agents|sensory system agents|mesh-ancestor
5517262|NCT04346823|Anesthetics, General|anesthetics, general|mesh-ancestor
5517263|NCT04346823|Anesthetics|anesthetics|mesh-ancestor
5517264|NCT04346823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5517265|NCT04346823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517266|NCT04347187|Anticoagulants|anticoagulants|mesh-list
5517267|NCT04346797|Eculizumab|eculizumab|mesh-list
5725096|NCT03182595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5725097|NCT03182595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725098|NCT03182595|Antipyretics|antipyretics|mesh-ancestor
5725099|NCT03182413|Modafinil|modafinil|mesh-list
5725100|NCT03182413|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5725101|NCT03182413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725102|NCT03182413|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
5517268|NCT04346797|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5517269|NCT04346797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5517270|NCT04346797|Immunologic Factors|immunologic factors|mesh-ancestor
5517271|NCT04346797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517272|NCT04346628|Favipiravir|favipiravir|mesh-list
5517273|NCT04346628|Antiviral Agents|antiviral agents|mesh-ancestor
5517274|NCT04346628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5517275|NCT04346667|Hydroxychloroquine|hydroxychloroquine|mesh-list
5517276|NCT04346667|Chloroquine|chloroquine|mesh-list
5517277|NCT04346667|Antimalarials|antimalarials|mesh-ancestor
5517278|NCT04346667|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6464173|NCT00468351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6464174|NCT00468351|Glucocorticoids|glucocorticoids|mesh-ancestor
6464175|NCT00468351|Hormones|hormones|mesh-ancestor
5517279|NCT04346667|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5517280|NCT04346667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5517281|NCT04346667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5517282|NCT04346667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517283|NCT04346667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5517284|NCT04346667|Amebicides|amebicides|mesh-ancestor
6087163|NCT00825630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087164|NCT00825734|Sorafenib|sorafenib|mesh-list
6087165|NCT00825734|Epothilones|epothilones|mesh-list
6087166|NCT00825734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6087167|NCT00825734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6087168|NCT00825734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6087169|NCT00825734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087170|NCT00825734|Tubulin Modulators|tubulin modulators|mesh-ancestor
6087171|NCT00825734|Antimitotic Agents|antimitotic agents|mesh-ancestor
6087172|NCT00825734|Mitosis Modulators|mitosis modulators|mesh-ancestor
6087173|NCT00825786|Ropivacaine|ropivacaine|mesh-list
6464176|NCT00468351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6464177|NCT00468351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6464178|NCT00468351|Immunologic Factors|immunologic factors|mesh-ancestor
6464179|NCT00468351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5517285|NCT04346407|Dronabinol|dronabinol|mesh-list
6087174|NCT00825786|Mepivacaine|mepivacaine|mesh-list
6665585|NCT01517828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6665586|NCT01517828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5517286|NCT04346407|Hallucinogens|hallucinogens|mesh-ancestor
5517287|NCT04346407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517288|NCT04346407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5517289|NCT04346407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5517290|NCT04346407|Analgesics|analgesics|mesh-ancestor
5517291|NCT04346407|Sensory System Agents|sensory system agents|mesh-ancestor
5517292|NCT04346407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5517293|NCT04346407|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5517294|NCT04346407|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5517295|NCT04346407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5517296|NCT04346407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517297|NCT04346407|Hormones|hormones|mesh-ancestor
6665587|NCT01517828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6665588|NCT01517828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5517298|NCT04346407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6087175|NCT00825786|Anesthetics, Local|anesthetics, local|mesh-ancestor
6087176|NCT00825786|Anesthetics|anesthetics|mesh-ancestor
6087177|NCT00825786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6087178|NCT00825786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087179|NCT00825786|Sensory System Agents|sensory system agents|mesh-ancestor
6087180|NCT00825786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6087181|NCT00825812|Atropine|atropine|mesh-list
6087182|NCT00825812|Neostigmine|neostigmine|mesh-list
6087183|NCT00825812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6087184|NCT00825812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6087185|NCT00825812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6087186|NCT00825812|Autonomic Agents|autonomic agents|mesh-ancestor
6087187|NCT00825812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6087188|NCT00825812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087189|NCT00825812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6087190|NCT00825812|Respiratory System Agents|respiratory system agents|mesh-ancestor
6087191|NCT00825812|Mydriatics|mydriatics|mesh-ancestor
6087192|NCT00825812|Parasympatholytics|parasympatholytics|mesh-ancestor
6087193|NCT00825812|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6087194|NCT00825812|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6087195|NCT00825812|Cholinergic Agents|cholinergic agents|mesh-ancestor
6087196|NCT00825812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5517299|NCT04346589|Antibodies|antibodies|mesh-list
5517300|NCT04346589|Immunoglobulins|immunoglobulins|mesh-list
5517301|NCT04346589|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5517302|NCT04346589|Immunologic Factors|immunologic factors|mesh-ancestor
5517303|NCT04346589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087197|NCT00825812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087198|NCT00825812|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6087199|NCT00825812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6087200|NCT00825812|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6087201|NCT00825825|Citalopram|citalopram|mesh-list
6087202|NCT00825825|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6087203|NCT00825825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6087204|NCT00825825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6087205|NCT00825825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087206|NCT00825825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6087207|NCT00825825|Serotonin Agents|serotonin agents|mesh-ancestor
6087208|NCT00825825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087209|NCT00825825|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6665589|NCT01517828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665590|NCT01517828|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6665591|NCT01517828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6665592|NCT01517828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6665593|NCT01517828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6665594|NCT01517828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6665595|NCT01517828|GABA Modulators|gaba modulators|mesh-ancestor
6665596|NCT01517828|GABA Agents|gaba agents|mesh-ancestor
6087210|NCT00825825|Antidepressive Agents|antidepressive agents|mesh-ancestor
6087211|NCT00825825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6087212|NCT00826111|Eszopiclone|eszopiclone|mesh-list
6087213|NCT00826111|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6087214|NCT00826111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6087215|NCT00826111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087216|NCT00826228|Teriparatide|teriparatide|mesh-list
6087217|NCT00826228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6087218|NCT00826228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087219|NCT00826228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6087220|NCT00826241|Temozolomide|temozolomide|mesh-list
6087221|NCT00826241|Lapatinib|lapatinib|mesh-list
6087222|NCT00826241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6087223|NCT00826241|Alkylating Agents|alkylating agents|mesh-ancestor
6087224|NCT00826241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087225|NCT00826241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6087226|NCT00826241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6087227|NCT00826241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6087228|NCT00826267|Trastuzumab|trastuzumab|mesh-list
6087229|NCT00826267|Lapatinib|lapatinib|mesh-list
6087230|NCT00826267|Afatinib|afatinib|mesh-list
6087231|NCT00826267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6087232|NCT00826267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6087233|NCT00826267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6087234|NCT00826267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6087235|NCT00826267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087236|NCT00826280|Caffeine|caffeine|mesh-list
6087237|NCT00826280|Regadenoson|regadenoson|mesh-list
6087238|NCT00826280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6087239|NCT00826280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087240|NCT00826280|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6087241|NCT00826280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6087242|NCT00826280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087243|NCT00826280|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6087244|NCT00826280|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6087245|NCT00826280|Purinergic Agents|purinergic agents|mesh-ancestor
6087246|NCT00826280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6087247|NCT00826280|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
6087248|NCT00826280|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6087249|NCT00826280|Purinergic Agonists|purinergic agonists|mesh-ancestor
6087250|NCT00826449|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6087251|NCT00826449|Dasatinib|dasatinib|mesh-list
6087252|NCT00826449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6087253|NCT00826449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5517304|NCT04346004|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
5517305|NCT04346004|Hematinics|hematinics|mesh-ancestor
5517306|NCT04346329|Hydroxychloroquine|hydroxychloroquine|mesh-list
5517307|NCT04346329|Antimalarials|antimalarials|mesh-ancestor
5517308|NCT04346329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5517309|NCT04346329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5517310|NCT04346329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5517311|NCT04346329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5517312|NCT04346329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517313|NCT04346329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5517314|NCT04346290|Dexmedetomidine|dexmedetomidine|mesh-list
5517315|NCT04346290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5517316|NCT04346290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5517317|NCT04346290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517318|NCT04346290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5517319|NCT04346290|Analgesics|analgesics|mesh-ancestor
5517320|NCT04346290|Sensory System Agents|sensory system agents|mesh-ancestor
5517321|NCT04346290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5517322|NCT04346290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6087254|NCT00826449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6087255|NCT00826449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087256|NCT00826514|Tanezumab|tanezumab|mesh-list
6087257|NCT00826514|Analgesics|analgesics|mesh-ancestor
5517323|NCT04346290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5517324|NCT04346290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5517325|NCT04346290|Adrenergic Agents|adrenergic agents|mesh-ancestor
5517326|NCT04346290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5517327|NCT04346290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517328|NCT04346277|Antibodies|antibodies|mesh-list
5517329|NCT04346277|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5517330|NCT04346277|Immunologic Factors|immunologic factors|mesh-ancestor
5517331|NCT04346277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517332|NCT04346186|Immunoglobulin G|immunoglobulin g|mesh-list
5517333|NCT04346186|Immunoglobulin M|immunoglobulin m|mesh-list
5517334|NCT04346186|Immunologic Factors|immunologic factors|mesh-ancestor
5517335|NCT04346186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517336|NCT04345926|Propofol|propofol|mesh-list
5517337|NCT04345926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5517338|NCT04345926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6087258|NCT00826514|Sensory System Agents|sensory system agents|mesh-ancestor
6087259|NCT00826514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6087260|NCT00826514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517339|NCT04345926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517340|NCT04345926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5517341|NCT04345926|Anesthetics, General|anesthetics, general|mesh-ancestor
5517342|NCT04345926|Anesthetics|anesthetics|mesh-ancestor
5517343|NCT04346030|Triamcinolone|triamcinolone|mesh-list
5517344|NCT04346030|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5517345|NCT04346030|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5517346|NCT04346030|Lidocaine|lidocaine|mesh-list
5517347|NCT04346030|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5517348|NCT04346030|Anesthetics, Local|anesthetics, local|mesh-ancestor
5517349|NCT04346030|Anesthetics|anesthetics|mesh-ancestor
5517350|NCT04346030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5517351|NCT04346030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517352|NCT04346030|Sensory System Agents|sensory system agents|mesh-ancestor
5517353|NCT04346030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5517354|NCT04346030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5517355|NCT04346030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5517356|NCT04346030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6087261|NCT00826540|Bevacizumab|bevacizumab|mesh-list
6087262|NCT00826540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6087263|NCT00826540|Sorafenib|sorafenib|mesh-list
6087264|NCT00826540|Antibodies|antibodies|mesh-list
6087265|NCT00826540|Immunoglobulins|immunoglobulins|mesh-list
6087266|NCT00826540|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6087267|NCT00826540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6087268|NCT00826540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6087269|NCT00826540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6087270|NCT00826540|Growth Substances|growth substances|mesh-ancestor
5517357|NCT04346030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5517358|NCT04346030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517359|NCT04346030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5517360|NCT04346030|Glucocorticoids|glucocorticoids|mesh-ancestor
5517361|NCT04346030|Hormones|hormones|mesh-ancestor
5517362|NCT04346030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5517363|NCT04346030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5517364|NCT04346030|Immunologic Factors|immunologic factors|mesh-ancestor
5517365|NCT04346030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6087271|NCT00826540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087272|NCT00826540|Growth Inhibitors|growth inhibitors|mesh-ancestor
6087273|NCT00826540|Immunologic Factors|immunologic factors|mesh-ancestor
6087274|NCT00826540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6087275|NCT00826540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6087276|NCT00826540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087277|NCT00826618|Ranibizumab|ranibizumab|mesh-list
6087278|NCT00826618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6087279|NCT00826618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6464180|NCT00468351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6464181|NCT00468364|Insulin|insulin|mesh-list
6464182|NCT00468364|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6464183|NCT00468364|Insulin Glargine|insulin glargine|mesh-list
6464184|NCT00468364|Insulin, Isophane|insulin, isophane|mesh-list
6464185|NCT00468364|Isophane Insulin, Human|isophane insulin, human|mesh-list
6464186|NCT00468364|Isophane insulin, beef|isophane insulin, beef|mesh-list
6087280|NCT00826618|Growth Substances|growth substances|mesh-ancestor
6087281|NCT00826618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087282|NCT00826618|Growth Inhibitors|growth inhibitors|mesh-ancestor
6087283|NCT00826618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6087284|NCT00826748|Beclomethasone|beclomethasone|mesh-list
6087285|NCT00826748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6087286|NCT00826748|Glucocorticoids|glucocorticoids|mesh-ancestor
6087287|NCT00826748|Hormones|hormones|mesh-ancestor
6087288|NCT00826748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6087289|NCT00826748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087290|NCT00826748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6087291|NCT00826748|Respiratory System Agents|respiratory system agents|mesh-ancestor
6087292|NCT00826800|Bevacizumab|bevacizumab|mesh-list
6087293|NCT00826800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6087294|NCT00826800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6087295|NCT00826800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6087296|NCT00826800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6464187|NCT00468364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6464188|NCT00468364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087297|NCT00826800|Growth Substances|growth substances|mesh-ancestor
6087298|NCT00826800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087299|NCT00826800|Growth Inhibitors|growth inhibitors|mesh-ancestor
6087300|NCT00826943|Cetirizine|cetirizine|mesh-list
6087301|NCT00826943|Levocetirizine|levocetirizine|mesh-list
5517374|NCT04346095|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
5517375|NCT04346095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5517376|NCT04346095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517377|NCT04346017|Complement System Proteins|complement system proteins|mesh-list
5517378|NCT04346017|Immunologic Factors|immunologic factors|mesh-ancestor
5517379|NCT04346017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517380|NCT04346147|Imatinib Mesylate|imatinib mesylate|mesh-list
5517381|NCT04346147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5517382|NCT04346147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5517383|NCT04346147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5517384|NCT04346147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517385|NCT04345848|Heparin|heparin|mesh-list
5517386|NCT04345848|Enoxaparin|enoxaparin|mesh-list
5517387|NCT04345848|Calcium heparin|calcium heparin|mesh-list
5517388|NCT04345848|Anticoagulants|anticoagulants|mesh-ancestor
5517389|NCT04345848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5517390|NCT04345848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5517391|NCT04345848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517392|NCT04345783|Apatinib|apatinib|mesh-list
5517393|NCT04345783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5517394|NCT04345783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5517395|NCT04345783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5517396|NCT04345783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517397|NCT04345432|Gabapentin|gabapentin|mesh-list
5517398|NCT04345432|Analgesics|analgesics|mesh-ancestor
5517399|NCT04345432|Sensory System Agents|sensory system agents|mesh-ancestor
5517400|NCT04345432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5517401|NCT04345432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517402|NCT04345432|Anticonvulsants|anticonvulsants|mesh-ancestor
6087302|NCT00826943|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6087303|NCT00826943|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6087304|NCT00826943|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6087305|NCT00826943|Histamine Antagonists|histamine antagonists|mesh-ancestor
6087306|NCT00826943|Histamine Agents|histamine agents|mesh-ancestor
6087307|NCT00826943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6087308|NCT00826943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087309|NCT00826943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087310|NCT00827073|Lidocaine|lidocaine|mesh-list
6087311|NCT00827073|Tetracaine|tetracaine|mesh-list
6087312|NCT00827073|Anesthetics, Local|anesthetics, local|mesh-ancestor
6087313|NCT00827073|Anesthetics|anesthetics|mesh-ancestor
6087314|NCT00827073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6087315|NCT00827073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087316|NCT00827073|Sensory System Agents|sensory system agents|mesh-ancestor
6087317|NCT00827073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6087318|NCT00827073|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6087319|NCT00827073|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6087320|NCT00827073|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6087321|NCT00827073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6087322|NCT00827073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087323|NCT00827099|Mycophenolic Acid|mycophenolic acid|mesh-list
6087324|NCT00827099|Fludarabine|fludarabine|mesh-list
6087325|NCT00827099|Fludarabine phosphate|fludarabine phosphate|mesh-list
6087326|NCT00827099|Melphalan|melphalan|mesh-list
6087327|NCT00827099|Tacrolimus|tacrolimus|mesh-list
6087328|NCT00827099|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6087329|NCT00827099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6087330|NCT00827099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6087331|NCT00827099|Antimetabolites|antimetabolites|mesh-ancestor
6087332|NCT00827099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087333|NCT00827099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6087334|NCT00827099|Immunologic Factors|immunologic factors|mesh-ancestor
6087335|NCT00827099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087336|NCT00827099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6087337|NCT00827099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6087338|NCT00827099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6087339|NCT00827099|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6087340|NCT00827099|Antitubercular Agents|antitubercular agents|mesh-ancestor
6087341|NCT00827099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5517403|NCT04345432|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5517404|NCT04345432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5517405|NCT04345432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5517406|NCT04345432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5517407|NCT04345432|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5517408|NCT04345432|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6087342|NCT00827099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6087343|NCT00827099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6087344|NCT00827099|Alkylating Agents|alkylating agents|mesh-ancestor
6087345|NCT00827099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6087346|NCT00827112|Ritonavir|ritonavir|mesh-list
6087347|NCT00827112|Lopinavir|lopinavir|mesh-list
6087348|NCT00827112|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6087349|NCT00827112|Darunavir|darunavir|mesh-list
6087350|NCT00827112|Tenofovir|tenofovir|mesh-list
6087351|NCT00827112|Emtricitabine|emtricitabine|mesh-list
6087352|NCT00827112|Maraviroc|maraviroc|mesh-list
6087353|NCT00827112|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6087354|NCT00827112|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6087355|NCT00827112|Protease Inhibitors|protease inhibitors|mesh-ancestor
6087356|NCT00827112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6087357|NCT00827112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517409|NCT04345432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5517410|NCT04345432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517411|NCT04345432|Antimanic Agents|antimanic agents|mesh-ancestor
6087358|NCT00827112|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6087359|NCT00827112|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6087360|NCT00827112|Antiviral Agents|antiviral agents|mesh-ancestor
6087361|NCT00827112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6087362|NCT00827112|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6087363|NCT00827112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6087364|NCT00827112|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6087365|NCT00827112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6087366|NCT00827112|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6087367|NCT00827112|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6087368|NCT00827112|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6087369|NCT00827242|Tadalafil|tadalafil|mesh-list
6087370|NCT00827242|Vasodilator Agents|vasodilator agents|mesh-ancestor
6087371|NCT00827242|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6087372|NCT00827242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6087373|NCT00827242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6087374|NCT00827242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087375|NCT00827242|Urological Agents|urological agents|mesh-ancestor
6087376|NCT00827255|Cyclosporine|cyclosporine|mesh-list
5517412|NCT04345692|Hydroxychloroquine|hydroxychloroquine|mesh-list
5517413|NCT04345692|Antimalarials|antimalarials|mesh-ancestor
5517414|NCT04345692|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5517415|NCT04345692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5517416|NCT04345692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5517417|NCT04345692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5517418|NCT04345692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517419|NCT04345692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5517420|NCT04345445|Methylprednisolone|methylprednisolone|mesh-list
5517421|NCT04345445|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5517422|NCT04345445|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5517423|NCT04345445|Prednisolone|prednisolone|mesh-list
5517424|NCT04345445|Prednisolone acetate|prednisolone acetate|mesh-list
5517425|NCT04345445|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5517426|NCT04345445|Prednisolone phosphate|prednisolone phosphate|mesh-list
5517427|NCT04345445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5517428|NCT04345445|Antiemetics|antiemetics|mesh-ancestor
6087377|NCT00827255|Cyclosporins|cyclosporins|mesh-list
6087378|NCT00827255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6087379|NCT00827255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087380|NCT00827255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6087381|NCT00827255|Immunologic Factors|immunologic factors|mesh-ancestor
6087382|NCT00827255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087383|NCT00827255|Antifungal Agents|antifungal agents|mesh-ancestor
6087384|NCT00827255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6087385|NCT00827255|Dermatologic Agents|dermatologic agents|mesh-ancestor
6087386|NCT00827255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6087387|NCT00827255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6087388|NCT00827359|Everolimus|everolimus|mesh-list
6087389|NCT00827359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6087390|NCT00827359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5517429|NCT04345445|Autonomic Agents|autonomic agents|mesh-ancestor
6087391|NCT00827359|Immunologic Factors|immunologic factors|mesh-ancestor
5517430|NCT04345445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5517431|NCT04345445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087392|NCT00827359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087393|NCT00827541|Tigecycline|tigecycline|mesh-list
6087394|NCT00827541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6087395|NCT00827541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6087396|NCT00827541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6087397|NCT00827541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6087398|NCT00827541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517432|NCT04345445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5517433|NCT04345445|Glucocorticoids|glucocorticoids|mesh-ancestor
5517434|NCT04345445|Hormones|hormones|mesh-ancestor
5517435|NCT04345445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5517436|NCT04345445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6087399|NCT00827606|Atorvastatin|atorvastatin|mesh-list
6087400|NCT00827606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6087401|NCT00827606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6087402|NCT00827606|Antimetabolites|antimetabolites|mesh-ancestor
6087403|NCT00827606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087404|NCT00827606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6087405|NCT00827606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6087406|NCT00827606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6087407|NCT00827775|Carvedilol|carvedilol|mesh-list
6087408|NCT00827775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6087409|NCT00827775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6087410|NCT00827775|Adrenergic Agents|adrenergic agents|mesh-ancestor
6087411|NCT00827775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6087412|NCT00827775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087413|NCT00827775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087414|NCT00827775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6087415|NCT00827775|Antioxidants|antioxidants|mesh-ancestor
6087416|NCT00827775|Protective Agents|protective agents|mesh-ancestor
6087417|NCT00827775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6087418|NCT00827775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6087419|NCT00827775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6087420|NCT00827775|Vasodilator Agents|vasodilator agents|mesh-ancestor
5517437|NCT04345445|Protective Agents|protective agents|mesh-ancestor
5517438|NCT04345445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5517439|NCT04345445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5517440|NCT04345588|Dexamethasone|dexamethasone|mesh-list
5517441|NCT04345588|Dexamethasone acetate|dexamethasone acetate|mesh-list
5517442|NCT04345588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5517443|NCT04345588|Antiemetics|antiemetics|mesh-ancestor
6087421|NCT00827775|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6087422|NCT00827775|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6087423|NCT00827918|Olanzapine|olanzapine|mesh-list
6087424|NCT00827918|Antiemetics|antiemetics|mesh-ancestor
6087425|NCT00827918|Autonomic Agents|autonomic agents|mesh-ancestor
6087426|NCT00827918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6087427|NCT00827918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087428|NCT00827918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6087429|NCT00827918|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6087430|NCT00827918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6087431|NCT00827918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6087432|NCT00827918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6087433|NCT00827918|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6087434|NCT00827918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6087435|NCT00827918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6087436|NCT00827918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087437|NCT00827918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6087438|NCT00827918|Serotonin Agents|serotonin agents|mesh-ancestor
6087439|NCT00827931|Tranexamic Acid|tranexamic acid|mesh-list
6087440|NCT00827931|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5517444|NCT04345588|Autonomic Agents|autonomic agents|mesh-ancestor
5517445|NCT04345588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5517446|NCT04345588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517447|NCT04345588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5517448|NCT04345588|Glucocorticoids|glucocorticoids|mesh-ancestor
5517449|NCT04345588|Hormones|hormones|mesh-ancestor
5517450|NCT04345588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5517451|NCT04345588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6087441|NCT00827931|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6087442|NCT00827931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087443|NCT00827931|Hemostatics|hemostatics|mesh-ancestor
6087444|NCT00827931|Coagulants|coagulants|mesh-ancestor
6087445|NCT00827983|Progesterone|progesterone|mesh-list
5517452|NCT04345588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5517453|NCT04345744|Chlorhexidine|chlorhexidine|mesh-list
5517454|NCT04345744|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5517455|NCT04345744|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5517456|NCT04345744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5517457|NCT04345744|Disinfectants|disinfectants|mesh-ancestor
5517458|NCT04345744|Dermatologic Agents|dermatologic agents|mesh-ancestor
5517459|NCT04345458|Etanercept|etanercept|mesh-list
5517460|NCT04345458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5517461|NCT04345458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5517462|NCT04345458|Analgesics|analgesics|mesh-ancestor
6087446|NCT00827983|Progestins|progestins|mesh-ancestor
6087447|NCT00827983|Hormones|hormones|mesh-ancestor
6087448|NCT00827983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6087449|NCT00827983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087450|NCT00828009|Paclitaxel|paclitaxel|mesh-list
6087451|NCT00828009|Cyclophosphamide|cyclophosphamide|mesh-list
6087452|NCT00828009|Bevacizumab|bevacizumab|mesh-list
6087453|NCT00828009|Carboplatin|carboplatin|mesh-list
6087454|NCT00828009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6087455|NCT00828009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6087456|NCT00828009|Tubulin Modulators|tubulin modulators|mesh-ancestor
6087457|NCT00828009|Antimitotic Agents|antimitotic agents|mesh-ancestor
6087458|NCT00828009|Mitosis Modulators|mitosis modulators|mesh-ancestor
6087459|NCT00828009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087460|NCT00828009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6087461|NCT00828009|Immunologic Factors|immunologic factors|mesh-ancestor
6087462|NCT00828009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087463|NCT00828009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6087464|NCT00828009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6087465|NCT00828009|Alkylating Agents|alkylating agents|mesh-ancestor
6087466|NCT00828009|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6087467|NCT00828009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6087468|NCT00828009|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6087469|NCT00828009|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6087470|NCT00828009|Growth Substances|growth substances|mesh-ancestor
6087471|NCT00828009|Growth Inhibitors|growth inhibitors|mesh-ancestor
6087472|NCT00828061|Prednisone|prednisone|mesh-list
6087473|NCT00828061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6087474|NCT00828061|Glucocorticoids|glucocorticoids|mesh-ancestor
6087475|NCT00828061|Hormones|hormones|mesh-ancestor
6087476|NCT00828061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6087477|NCT00828061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087478|NCT00828061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6087479|NCT00828061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6087480|NCT00828074|Sorafenib|sorafenib|mesh-list
6087481|NCT00828074|Vinorelbine|vinorelbine|mesh-list
6087482|NCT00828074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6087483|NCT00828074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6087484|NCT00828074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6087485|NCT00828074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517463|NCT04345458|Sensory System Agents|sensory system agents|mesh-ancestor
5517464|NCT04345458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5517465|NCT04345458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517466|NCT04345458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5517467|NCT04345458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5517468|NCT04345458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5517469|NCT04345458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5517470|NCT04345458|Immunologic Factors|immunologic factors|mesh-ancestor
5517471|NCT04345419|Remdesivir|remdesivir|mesh-list
5517472|NCT04345419|Antimetabolites|antimetabolites|mesh-ancestor
5607027|NCT03031730|Antiemetics|antiemetics|mesh-ancestor
6464189|NCT00468429|Bevacizumab|bevacizumab|mesh-list
6087486|NCT00828074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6087487|NCT00828074|Tubulin Modulators|tubulin modulators|mesh-ancestor
6087488|NCT00828074|Antimitotic Agents|antimitotic agents|mesh-ancestor
6087489|NCT00828074|Mitosis Modulators|mitosis modulators|mesh-ancestor
5517473|NCT04345419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517474|NCT04345419|Antiviral Agents|antiviral agents|mesh-ancestor
5517475|NCT04345419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5517476|NCT04345406|Chloroquine|chloroquine|mesh-list
5517477|NCT04345406|Enalapril|enalapril|mesh-list
5517478|NCT04345406|Captopril|captopril|mesh-list
5517479|NCT04345406|Amebicides|amebicides|mesh-ancestor
5517480|NCT04345406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5517481|NCT04345406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5517482|NCT04345406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5517483|NCT04345406|Antimalarials|antimalarials|mesh-ancestor
5517484|NCT04345406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5517485|NCT04345406|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5517486|NCT04345406|Protease Inhibitors|protease inhibitors|mesh-ancestor
5517487|NCT04345406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5517488|NCT04345406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517489|NCT04345406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5517490|NCT04345471|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
5517491|NCT04345471|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5517492|NCT04345471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5517493|NCT04345471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5517494|NCT04345471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517495|NCT04345471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5517496|NCT04345471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517497|NCT04345471|Antidepressive Agents|antidepressive agents|mesh-ancestor
5517498|NCT04345471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5517499|NCT04345666|Methyltestosterone|methyltestosterone|mesh-list
5517500|NCT04345666|Testosterone|testosterone|mesh-list
5517501|NCT04345666|Testosterone undecanoate|testosterone undecanoate|mesh-list
5517502|NCT04345666|Testosterone enanthate|testosterone enanthate|mesh-list
5517503|NCT04345666|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5517504|NCT04345666|Androgens|androgens|mesh-ancestor
5517505|NCT04345666|Hormones|hormones|mesh-ancestor
5517506|NCT04345666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5517507|NCT04345666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517508|NCT04345666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6087490|NCT00828113|Varenicline|varenicline|mesh-list
6087491|NCT00828113|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6087492|NCT00828113|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6087493|NCT00828113|Cholinergic Agents|cholinergic agents|mesh-ancestor
6087494|NCT00828113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6087495|NCT00828113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087496|NCT00828113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087497|NCT00828139|Aflibercept|aflibercept|mesh-list
6087498|NCT00828139|Topotecan|topotecan|mesh-list
6087499|NCT00828139|Endothelial Growth Factors|endothelial growth factors|mesh-list
6087500|NCT00828139|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6087501|NCT00828139|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6087502|NCT00828139|Growth Substances|growth substances|mesh-ancestor
6087503|NCT00828139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087504|NCT00828139|Growth Inhibitors|growth inhibitors|mesh-ancestor
5517509|NCT04345666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5517510|NCT04345666|Anabolic Agents|anabolic agents|mesh-ancestor
5517511|NCT04345718|Buprenorphine|buprenorphine|mesh-list
5517512|NCT04345718|Analgesics, Opioid|analgesics, opioid|mesh-list
5517513|NCT04345718|Narcotics|narcotics|mesh-ancestor
5517514|NCT04345718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5517515|NCT04345718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517516|NCT04345718|Analgesics|analgesics|mesh-ancestor
5517517|NCT04345718|Sensory System Agents|sensory system agents|mesh-ancestor
5517518|NCT04345718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5517519|NCT04345718|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5517520|NCT04344951|Chloroquine|chloroquine|mesh-list
5517521|NCT04344951|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
5517522|NCT04344951|Amebicides|amebicides|mesh-ancestor
5517523|NCT04344951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5517524|NCT04344951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5517525|NCT04344951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5517526|NCT04344951|Antimalarials|antimalarials|mesh-ancestor
5517527|NCT04344951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5517528|NCT04344951|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6087505|NCT00828139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5517529|NCT04344951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5517530|NCT04344951|Analgesics|analgesics|mesh-ancestor
6087506|NCT00828139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6087507|NCT00828139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6087508|NCT00828139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6087509|NCT00828139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087510|NCT00828191|Progesterone|progesterone|mesh-list
6087511|NCT00828191|Progestins|progestins|mesh-ancestor
6087512|NCT00828191|Hormones|hormones|mesh-ancestor
6087513|NCT00828191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6087514|NCT00828191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087515|NCT00828204|Interferons|interferons|mesh-list
6087516|NCT00828204|Interferon-beta|interferon-beta|mesh-list
6087517|NCT00828204|Interferon beta-1a|interferon beta-1a|mesh-list
6087518|NCT00828204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6087519|NCT00828204|Antiviral Agents|antiviral agents|mesh-ancestor
6087520|NCT00828204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6087521|NCT00828204|Immunologic Factors|immunologic factors|mesh-ancestor
6087522|NCT00828204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087523|NCT00828204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6087524|NCT00828295|Palonosetron|palonosetron|mesh-list
6087525|NCT00828295|Antiemetics|antiemetics|mesh-ancestor
6087526|NCT00828295|Autonomic Agents|autonomic agents|mesh-ancestor
6087527|NCT00828295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6087528|NCT00828295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087529|NCT00828295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5517531|NCT04344951|Sensory System Agents|sensory system agents|mesh-ancestor
5517532|NCT04344951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5517533|NCT04344951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517534|NCT04344951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5517535|NCT04344951|Filaricides|filaricides|mesh-ancestor
5517536|NCT04344951|Antinematodal Agents|antinematodal agents|mesh-ancestor
5517537|NCT04344951|Anthelmintics|anthelmintics|mesh-ancestor
5517538|NCT04345094|Hydroquinone|hydroquinone|mesh-list
5517539|NCT04345094|Antioxidants|antioxidants|mesh-ancestor
5517540|NCT04345094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517541|NCT04345094|Protective Agents|protective agents|mesh-ancestor
5517542|NCT04345094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517543|NCT04345094|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5517544|NCT04345146|Bevacizumab|bevacizumab|mesh-list
5517545|NCT04345146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5517546|NCT04345146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5517547|NCT04345146|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5517548|NCT04345146|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5517549|NCT04345146|Growth Substances|growth substances|mesh-ancestor
5517550|NCT04345146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517551|NCT04345146|Growth Inhibitors|growth inhibitors|mesh-ancestor
5517552|NCT04345276|Ritonavir|ritonavir|mesh-list
5517553|NCT04345276|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5517554|NCT04345276|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5517555|NCT04345276|Protease Inhibitors|protease inhibitors|mesh-ancestor
5517556|NCT04345276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5517557|NCT04345276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087530|NCT00828295|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6087531|NCT00828295|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6087532|NCT00828295|Serotonin Agents|serotonin agents|mesh-ancestor
6087533|NCT00828295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6087534|NCT00828295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087535|NCT00828347|Alfacalcidol|alfacalcidol|mesh-list
6087536|NCT00828347|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
6087537|NCT00828347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6087538|NCT00828347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087539|NCT00828347|Vitamins|vitamins|mesh-ancestor
6087540|NCT00828347|Micronutrients|micronutrients|mesh-ancestor
6087541|NCT00828412|Desonide|desonide|mesh-list
6087542|NCT00828412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6087543|NCT00828464|Clobetasol|clobetasol|mesh-list
6087544|NCT00828464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6087545|NCT00828464|Glucocorticoids|glucocorticoids|mesh-ancestor
6087546|NCT00828464|Hormones|hormones|mesh-ancestor
6087547|NCT00828464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6087548|NCT00828464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087549|NCT00828542|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6087550|NCT00828542|Medroxyprogesterone|medroxyprogesterone|mesh-list
6087551|NCT00828542|Desogestrel|desogestrel|mesh-list
6087552|NCT00828542|Etonogestrel|etonogestrel|mesh-list
6087553|NCT00828542|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6087554|NCT00828542|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6087555|NCT00828542|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6087556|NCT00828542|Contraceptive Agents|contraceptive agents|mesh-ancestor
6087557|NCT00828542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6087558|NCT00828542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087559|NCT00828542|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6087560|NCT00828542|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6087561|NCT00828542|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6087562|NCT00828542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5517558|NCT04345276|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5517559|NCT04345276|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6087563|NCT00828542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6464190|NCT00468429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6464191|NCT00468429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6464192|NCT00468429|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6464193|NCT00468429|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6464194|NCT00468429|Growth Substances|growth substances|mesh-ancestor
6464195|NCT00468429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665597|NCT01517854|Sildenafil Citrate|sildenafil citrate|mesh-list
6087564|NCT00828542|Progestins|progestins|mesh-ancestor
6087565|NCT00828542|Hormones|hormones|mesh-ancestor
6087566|NCT00828542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6087567|NCT00828568|Imiquimod|imiquimod|mesh-list
5517560|NCT04345276|Antiviral Agents|antiviral agents|mesh-ancestor
5517561|NCT04345276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5517562|NCT04345276|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5517563|NCT04345276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5517564|NCT04345198|Epinephrine|epinephrine|mesh-list
5517565|NCT04345198|Racepinephrine|racepinephrine|mesh-list
5517566|NCT04345198|Epinephryl borate|epinephryl borate|mesh-list
6087568|NCT00828568|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6087569|NCT00828568|Immunologic Factors|immunologic factors|mesh-ancestor
6087570|NCT00828568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087571|NCT00828568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6087572|NCT00828568|Interferon Inducers|interferon inducers|mesh-ancestor
6087573|NCT00828672|Bevacizumab|bevacizumab|mesh-list
6087574|NCT00828672|Capecitabine|capecitabine|mesh-list
6087575|NCT00828672|Oxaliplatin|oxaliplatin|mesh-list
6087576|NCT00828672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6087577|NCT00828672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5517567|NCT04345198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5517568|NCT04345198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5517569|NCT04345198|Adrenergic Agents|adrenergic agents|mesh-ancestor
6087578|NCT00828672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6087579|NCT00828672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6087580|NCT00828672|Growth Substances|growth substances|mesh-ancestor
6087581|NCT00828672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087582|NCT00828672|Growth Inhibitors|growth inhibitors|mesh-ancestor
6087583|NCT00828672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6087584|NCT00828672|Antimetabolites|antimetabolites|mesh-ancestor
6087585|NCT00828672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087586|NCT00828841|Gemcitabine|gemcitabine|mesh-list
6087587|NCT00828841|Paclitaxel|paclitaxel|mesh-list
6087588|NCT00828841|Carboplatin|carboplatin|mesh-list
6087589|NCT00828841|Cetuximab|cetuximab|mesh-list
6087590|NCT00828841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5517570|NCT04345198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5517571|NCT04345198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517572|NCT04345198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517573|NCT04345198|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5517574|NCT04345198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5517575|NCT04345198|Autonomic Agents|autonomic agents|mesh-ancestor
5517576|NCT04345198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5517577|NCT04345198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6087591|NCT00828841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6087592|NCT00828841|Tubulin Modulators|tubulin modulators|mesh-ancestor
6087593|NCT00828841|Antimitotic Agents|antimitotic agents|mesh-ancestor
6087594|NCT00828841|Mitosis Modulators|mitosis modulators|mesh-ancestor
6087595|NCT00828841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087596|NCT00828841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6087597|NCT00828841|Antimetabolites|antimetabolites|mesh-ancestor
6087598|NCT00828841|Antiviral Agents|antiviral agents|mesh-ancestor
6087599|NCT00828841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6087600|NCT00828841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6087601|NCT00828841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6087602|NCT00828841|Immunologic Factors|immunologic factors|mesh-ancestor
6087603|NCT00828841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087604|NCT00828841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6087605|NCT00828984|Laxatives|laxatives|mesh-list
6087606|NCT00828984|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
6087607|NCT00828984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5725103|NCT03182413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5725104|NCT03182413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5725105|NCT03182413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725106|NCT03182426|Liraglutide|liraglutide|mesh-list
5725107|NCT03182426|Plerixafor|plerixafor|mesh-list
5725108|NCT03182426|Etanercept|etanercept|mesh-list
5725109|NCT03182426|Alemtuzumab|alemtuzumab|mesh-list
6087608|NCT00829010|Vaccines|vaccines|mesh-list
6087609|NCT00829010|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6087610|NCT00829010|Immunologic Factors|immunologic factors|mesh-ancestor
6087611|NCT00829010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087612|NCT00829049|Adapalene|adapalene|mesh-list
5517578|NCT04345198|Respiratory System Agents|respiratory system agents|mesh-ancestor
5517579|NCT04345198|Mydriatics|mydriatics|mesh-ancestor
5517580|NCT04345198|Sympathomimetics|sympathomimetics|mesh-ancestor
6087613|NCT00829049|Tazarotene|tazarotene|mesh-list
6087614|NCT00829049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6087615|NCT00829049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6087616|NCT00829049|Analgesics|analgesics|mesh-ancestor
6087617|NCT00829049|Sensory System Agents|sensory system agents|mesh-ancestor
6087618|NCT00829049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6087619|NCT00829049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087620|NCT00829049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6087621|NCT00829049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6087622|NCT00829049|Dermatologic Agents|dermatologic agents|mesh-ancestor
6087623|NCT00829049|Keratolytic Agents|keratolytic agents|mesh-ancestor
6087624|NCT00829166|Capecitabine|capecitabine|mesh-list
6464196|NCT00468429|Growth Inhibitors|growth inhibitors|mesh-ancestor
6464197|NCT00468520|Oxytocin|oxytocin|mesh-list
6464198|NCT00468520|Oxytocics|oxytocics|mesh-ancestor
6464199|NCT00468520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6464200|NCT00468520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087625|NCT00829166|Trastuzumab|trastuzumab|mesh-list
5517581|NCT04345198|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5517582|NCT04344860|Tranexamic Acid|tranexamic acid|mesh-list
5517583|NCT04344860|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5517584|NCT04344860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6087626|NCT00829166|Lapatinib|lapatinib|mesh-list
6464201|NCT00468533|Aripiprazole|aripiprazole|mesh-list
6087627|NCT00829166|Maytansine|maytansine|mesh-list
6464202|NCT00468533|Antidepressive Agents|antidepressive agents|mesh-ancestor
6087628|NCT00829166|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
6087629|NCT00829166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6087630|NCT00829166|Antimetabolites|antimetabolites|mesh-ancestor
6087631|NCT00829166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087632|NCT00829166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6087633|NCT00829166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6087634|NCT00829166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6087635|NCT00829166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6087636|NCT00829166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6087637|NCT00829166|Tubulin Modulators|tubulin modulators|mesh-ancestor
6087638|NCT00829166|Antimitotic Agents|antimitotic agents|mesh-ancestor
6087639|NCT00829166|Mitosis Modulators|mitosis modulators|mesh-ancestor
6087640|NCT00829179|Omalizumab|omalizumab|mesh-list
6087641|NCT00829179|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6665598|NCT01517854|Vasodilator Agents|vasodilator agents|mesh-ancestor
6665599|NCT01517854|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6665600|NCT01517854|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6665601|NCT01517854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6665602|NCT01517854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665603|NCT01517854|Urological Agents|urological agents|mesh-ancestor
6087642|NCT00829179|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6087643|NCT00829179|Respiratory System Agents|respiratory system agents|mesh-ancestor
6203171|NCT02053493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203172|NCT02053610|Rituximab|rituximab|mesh-list
6203173|NCT02053610|Obinutuzumab|obinutuzumab|mesh-list
6203174|NCT02053610|Chlorambucil|chlorambucil|mesh-list
6203175|NCT02053610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6203176|NCT02053610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6203177|NCT02053610|Immunologic Factors|immunologic factors|mesh-ancestor
6203178|NCT02053610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203179|NCT02053610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6203180|NCT02053610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6203181|NCT02053610|Alkylating Agents|alkylating agents|mesh-ancestor
6203182|NCT02053610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203183|NCT02053753|Denosumab|denosumab|mesh-list
5517585|NCT04344860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517586|NCT04344860|Hemostatics|hemostatics|mesh-ancestor
6203184|NCT02053753|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6203185|NCT02053753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203186|NCT02054156|Azithromycin|azithromycin|mesh-list
6203187|NCT02054156|Tobramycin|tobramycin|mesh-list
6203188|NCT02054156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6203189|NCT02054156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6203190|NCT02054325|Polidocanol|polidocanol|mesh-list
6203191|NCT02054325|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
6203192|NCT02054325|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6203193|NCT02054338|Gemcitabine|gemcitabine|mesh-list
6203194|NCT02054338|Paclitaxel|paclitaxel|mesh-list
6203195|NCT02054338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5517587|NCT04344860|Coagulants|coagulants|mesh-ancestor
5517588|NCT04344821|Calcium|calcium|mesh-list
5517589|NCT04344821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5517590|NCT04344821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517591|NCT04344483|Lidocaine|lidocaine|mesh-list
5517592|NCT04344483|Epinephrine|epinephrine|mesh-list
5517593|NCT04344483|Racepinephrine|racepinephrine|mesh-list
5517594|NCT04344483|Epinephryl borate|epinephryl borate|mesh-list
5517595|NCT04344483|Anesthetics, Local|anesthetics, local|mesh-ancestor
5517596|NCT04344483|Anesthetics|anesthetics|mesh-ancestor
5517597|NCT04344483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5517598|NCT04344483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517599|NCT04344483|Sensory System Agents|sensory system agents|mesh-ancestor
6203196|NCT02054338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6665604|NCT01517932|Dexmedetomidine|dexmedetomidine|mesh-list
6665605|NCT01517932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6203197|NCT02054338|Tubulin Modulators|tubulin modulators|mesh-ancestor
6203198|NCT02054338|Antimitotic Agents|antimitotic agents|mesh-ancestor
5517600|NCT04344483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5517601|NCT04344483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5517602|NCT04344483|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5517603|NCT04344483|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5517604|NCT04344483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5607028|NCT03031730|Autonomic Agents|autonomic agents|mesh-ancestor
6203199|NCT02054338|Mitosis Modulators|mitosis modulators|mesh-ancestor
6203200|NCT02054338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517605|NCT04344483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517606|NCT04344483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6087644|NCT00829244|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6087645|NCT00829244|Hormones|hormones|mesh-ancestor
6087646|NCT00829244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6087647|NCT00829244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087648|NCT00829283|Orlistat|orlistat|mesh-list
6087649|NCT00829283|Sibutramine|sibutramine|mesh-list
6087650|NCT00829283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6087651|NCT00829283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087652|NCT00829283|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6087653|NCT00829283|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6087654|NCT00829283|Antidepressive Agents|antidepressive agents|mesh-ancestor
6087655|NCT00829283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6087656|NCT00829283|Appetite Depressants|appetite depressants|mesh-ancestor
6087657|NCT00829296|Metoprolol|metoprolol|mesh-list
6087658|NCT00829296|Nebivolol|nebivolol|mesh-list
6087659|NCT00829296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6087660|NCT00829296|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6087661|NCT00829296|Sympatholytics|sympatholytics|mesh-ancestor
6087662|NCT00829296|Autonomic Agents|autonomic agents|mesh-ancestor
6087663|NCT00829296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6087664|NCT00829296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087665|NCT00829296|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6087666|NCT00829296|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6087667|NCT00829296|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6087668|NCT00829296|Adrenergic Agents|adrenergic agents|mesh-ancestor
6087669|NCT00829296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6665606|NCT01517932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6665607|NCT01517932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665608|NCT01517932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6665609|NCT01517932|Analgesics|analgesics|mesh-ancestor
6665610|NCT01517932|Sensory System Agents|sensory system agents|mesh-ancestor
6665611|NCT01517932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6665612|NCT01517932|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6087670|NCT00829296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087671|NCT00829296|Vasodilator Agents|vasodilator agents|mesh-ancestor
6087672|NCT00829296|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6087673|NCT00829296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6087674|NCT00829296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5517607|NCT04344483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5517608|NCT04344483|Adrenergic Agents|adrenergic agents|mesh-ancestor
5517609|NCT04344483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5517610|NCT04344483|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5517611|NCT04344483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5517612|NCT04344483|Autonomic Agents|autonomic agents|mesh-ancestor
5517613|NCT04344483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5517614|NCT04344483|Respiratory System Agents|respiratory system agents|mesh-ancestor
5517615|NCT04344483|Mydriatics|mydriatics|mesh-ancestor
5517616|NCT04344483|Sympathomimetics|sympathomimetics|mesh-ancestor
5517617|NCT04344483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5517618|NCT04344457|Hydroxychloroquine|hydroxychloroquine|mesh-list
5517619|NCT04344457|Azithromycin|azithromycin|mesh-list
5517620|NCT04344457|Indomethacin|indomethacin|mesh-list
5517621|NCT04344457|Antimalarials|antimalarials|mesh-ancestor
5517622|NCT04344457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5517623|NCT04344457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5517624|NCT04344457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5517625|NCT04344457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5517626|NCT04344457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517627|NCT04344457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5517628|NCT04344457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5517629|NCT04344457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6087675|NCT00829439|Levodopa|levodopa|mesh-list
6087676|NCT00829439|Carbidopa|carbidopa|mesh-list
6087677|NCT00829439|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6087678|NCT00829439|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6087679|NCT00829439|Dopamine Agents|dopamine agents|mesh-ancestor
6087680|NCT00829439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6087681|NCT00829439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087682|NCT00829439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087683|NCT00829439|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6087684|NCT00829439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5517630|NCT04344457|Analgesics|analgesics|mesh-ancestor
5517631|NCT04344457|Sensory System Agents|sensory system agents|mesh-ancestor
6087685|NCT00829738|Pantoprazole|pantoprazole|mesh-list
6087686|NCT00829738|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6087687|NCT00829738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6087688|NCT00829738|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6087689|NCT00829738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6087690|NCT00829738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087691|NCT00829829|Rilonacept|rilonacept|mesh-list
6087692|NCT00829829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6087693|NCT00829933|Warfarin|warfarin|mesh-list
6087694|NCT00829933|Edoxaban|edoxaban|mesh-list
6087695|NCT00829933|Anticoagulants|anticoagulants|mesh-ancestor
6087696|NCT00829933|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6087697|NCT00829933|Antithrombins|antithrombins|mesh-ancestor
6087698|NCT00829933|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6087699|NCT00829933|Protease Inhibitors|protease inhibitors|mesh-ancestor
6087700|NCT00829933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6087701|NCT00829933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087702|NCT00830063|Naproxen|naproxen|mesh-list
6087703|NCT00830063|Tanezumab|tanezumab|mesh-list
6087704|NCT00830063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6087705|NCT00830063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6087706|NCT00830063|Analgesics|analgesics|mesh-ancestor
6087707|NCT00830063|Sensory System Agents|sensory system agents|mesh-ancestor
6087708|NCT00830063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6087709|NCT00830063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087710|NCT00830063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5517632|NCT04344457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5517633|NCT04344457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517634|NCT04344457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5517635|NCT04344457|Gout Suppressants|gout suppressants|mesh-ancestor
5517636|NCT04344457|Tocolytic Agents|tocolytic agents|mesh-ancestor
5517637|NCT04344457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6087711|NCT00830063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6087712|NCT00830063|Gout Suppressants|gout suppressants|mesh-ancestor
6087713|NCT00830063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6087714|NCT00830063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6087715|NCT00830063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087716|NCT00830076|Metformin|metformin|mesh-list
6087717|NCT00830076|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6087718|NCT00830076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6087719|NCT00830076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087720|NCT00830076|Incretins|incretins|mesh-ancestor
6087721|NCT00830076|Hormones|hormones|mesh-ancestor
6087722|NCT00830076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6087723|NCT00830076|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6087724|NCT00830076|Protease Inhibitors|protease inhibitors|mesh-ancestor
6087725|NCT00830076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6087726|NCT00830076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087727|NCT00830115|Pantoprazole|pantoprazole|mesh-list
6087728|NCT00830115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6087729|NCT00830115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6087730|NCT00830115|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6087731|NCT00830115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6087732|NCT00830115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087733|NCT00830128|Pregabalin|pregabalin|mesh-list
6087734|NCT00830128|Analgesics|analgesics|mesh-ancestor
6087735|NCT00830128|Sensory System Agents|sensory system agents|mesh-ancestor
6087736|NCT00830128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6087737|NCT00830128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087738|NCT00830128|Anticonvulsants|anticonvulsants|mesh-ancestor
6087739|NCT00830128|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6087740|NCT00830128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6087741|NCT00830128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087742|NCT00830128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6087743|NCT00830128|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6087744|NCT00830128|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6087745|NCT00830128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6087746|NCT00830128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6087747|NCT00830167|Pregabalin|pregabalin|mesh-list
6087748|NCT00830167|Analgesics|analgesics|mesh-ancestor
6087749|NCT00830167|Sensory System Agents|sensory system agents|mesh-ancestor
6087750|NCT00830167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6087751|NCT00830167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087752|NCT00830167|Anticonvulsants|anticonvulsants|mesh-ancestor
6087753|NCT00830167|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6087754|NCT00830167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6087755|NCT00830167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087756|NCT00830167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6087757|NCT00830167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6087758|NCT00830167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6087759|NCT00830167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6087760|NCT00830167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6665613|NCT01517932|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6665614|NCT01517932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6665615|NCT01517932|Adrenergic Agents|adrenergic agents|mesh-ancestor
6665616|NCT01517932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6665617|NCT01517932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087761|NCT00830362|Propranolol|propranolol|mesh-list
6087762|NCT00830362|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6087763|NCT00830362|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6087764|NCT00830362|Adrenergic Agents|adrenergic agents|mesh-ancestor
6087765|NCT00830362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6087766|NCT00830362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087767|NCT00830362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087768|NCT00830362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5517638|NCT04344457|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5517639|NCT04344457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5600754|NCT03709927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600755|NCT03709927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5600756|NCT03709914|Fosfomycin|fosfomycin|mesh-list
6087769|NCT00830362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6087770|NCT00830362|Vasodilator Agents|vasodilator agents|mesh-ancestor
6087771|NCT00830375|Memantine|memantine|mesh-list
6087772|NCT00830375|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6087773|NCT00830375|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6087774|NCT00830375|Dopamine Agents|dopamine agents|mesh-ancestor
6087775|NCT00830375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6087776|NCT00830375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087777|NCT00830375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087778|NCT00830375|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6087779|NCT00830375|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6087780|NCT00830388|Ketoconazole|ketoconazole|mesh-list
6087781|NCT00830388|Antifungal Agents|antifungal agents|mesh-ancestor
6087782|NCT00830388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6087783|NCT00830388|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6087784|NCT00830388|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6087785|NCT00830388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6087786|NCT00830388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087787|NCT00830388|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6087788|NCT00830388|Hormone Antagonists|hormone antagonists|mesh-ancestor
6087789|NCT00830388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6087790|NCT00830388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087791|NCT00830388|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6087792|NCT00830765|Progesterone|progesterone|mesh-list
6087793|NCT00830765|Progestins|progestins|mesh-ancestor
6087794|NCT00830765|Hormones|hormones|mesh-ancestor
6087795|NCT00830765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6087796|NCT00830765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087797|NCT00830804|Ritonavir|ritonavir|mesh-list
6087798|NCT00830804|Darunavir|darunavir|mesh-list
6087799|NCT00830804|Raltegravir Potassium|raltegravir potassium|mesh-list
6087800|NCT00830804|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6087801|NCT00830804|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6087802|NCT00830804|Protease Inhibitors|protease inhibitors|mesh-ancestor
6087803|NCT00830804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6087804|NCT00830804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087805|NCT00830804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6087806|NCT00830804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6087807|NCT00830804|Antiviral Agents|antiviral agents|mesh-ancestor
6087808|NCT00830804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6087809|NCT00830804|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5600757|NCT03709914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5600758|NCT03709914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5600759|NCT03709888|Pregabalin|pregabalin|mesh-list
6087810|NCT00830804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6087811|NCT00830804|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6087812|NCT00830804|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6665618|NCT01517997|Paclitaxel|paclitaxel|mesh-list
6665619|NCT01517997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6665620|NCT01517997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6665621|NCT01517997|Tubulin Modulators|tubulin modulators|mesh-ancestor
5517640|NCT04344717|Apixaban|apixaban|mesh-list
5517641|NCT04344717|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5517642|NCT04344717|Antithrombins|antithrombins|mesh-ancestor
5517643|NCT04344717|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5517644|NCT04344717|Protease Inhibitors|protease inhibitors|mesh-ancestor
5517645|NCT04344717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5517646|NCT04344717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517647|NCT04344717|Anticoagulants|anticoagulants|mesh-ancestor
5517648|NCT04344756|Heparin|heparin|mesh-list
5517649|NCT04344756|Calcium heparin|calcium heparin|mesh-list
5517650|NCT04344756|Tinzaparin|tinzaparin|mesh-list
5517651|NCT04344756|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5517652|NCT04344756|Dalteparin|dalteparin|mesh-list
5517653|NCT04344756|Anticoagulants|anticoagulants|mesh-ancestor
5517654|NCT04344756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6665622|NCT01517997|Antimitotic Agents|antimitotic agents|mesh-ancestor
6464203|NCT00468533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6464204|NCT00468533|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6464205|NCT00468533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6464206|NCT00468533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6464207|NCT00468533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464208|NCT00468533|Dopamine Agonists|dopamine agonists|mesh-ancestor
6087813|NCT00830869|Ixazomib|ixazomib|mesh-list
6087814|NCT00830869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6087815|NCT00830869|Protease Inhibitors|protease inhibitors|mesh-ancestor
6087816|NCT00830869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6087817|NCT00830869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087818|NCT00830960|Clopidogrel|clopidogrel|mesh-list
6087819|NCT00830960|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6665623|NCT01517997|Mitosis Modulators|mitosis modulators|mesh-ancestor
6665624|NCT01517997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665625|NCT01518062|Estrogens|estrogens|mesh-list
5517655|NCT04344756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5517656|NCT04344756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517657|NCT04344782|Bevacizumab|bevacizumab|mesh-list
5517658|NCT04344782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5517659|NCT04344782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6087820|NCT00830960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6087821|NCT00830960|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6087822|NCT00830960|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6087823|NCT00830960|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6087824|NCT00830960|Purinergic Agents|purinergic agents|mesh-ancestor
6087825|NCT00830960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6087826|NCT00830960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087827|NCT00830960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087828|NCT00831129|Rosiglitazone|rosiglitazone|mesh-list
6087829|NCT00831129|Simvastatin|simvastatin|mesh-list
6087830|NCT00831129|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6087831|NCT00831129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6087832|NCT00831129|Antimetabolites|antimetabolites|mesh-ancestor
6087833|NCT00831129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087834|NCT00831129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6087835|NCT00831129|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6087836|NCT00831129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6087837|NCT00831129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6087838|NCT00831129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087839|NCT00831181|Leucovorin|leucovorin|mesh-list
6087840|NCT00831181|Fluorouracil|fluorouracil|mesh-list
6087841|NCT00831181|Oxaliplatin|oxaliplatin|mesh-list
6087842|NCT00831181|Antimetabolites|antimetabolites|mesh-ancestor
6087843|NCT00831181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087844|NCT00831181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6087845|NCT00831181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6464209|NCT00468533|Dopamine Agents|dopamine agents|mesh-ancestor
5517660|NCT04344782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6464210|NCT00468533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6464211|NCT00468533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6464212|NCT00468533|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6464213|NCT00468533|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6464214|NCT00468533|Serotonin Agents|serotonin agents|mesh-ancestor
6665626|NCT01518062|Hormones|hormones|mesh-ancestor
6087846|NCT00831181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6087847|NCT00831181|Immunologic Factors|immunologic factors|mesh-ancestor
6087848|NCT00831181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087849|NCT00831181|Antidotes|antidotes|mesh-ancestor
6087850|NCT00831181|Protective Agents|protective agents|mesh-ancestor
6087851|NCT00831181|Vitamin B Complex|vitamin b complex|mesh-ancestor
6087852|NCT00831181|Vitamins|vitamins|mesh-ancestor
6087853|NCT00831181|Micronutrients|micronutrients|mesh-ancestor
6087854|NCT00831233|Goserelin|goserelin|mesh-list
6087855|NCT00831233|Bicalutamide|bicalutamide|mesh-list
6087856|NCT00831233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6087857|NCT00831233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6087858|NCT00831233|Androgen Antagonists|androgen antagonists|mesh-ancestor
6087859|NCT00831233|Hormone Antagonists|hormone antagonists|mesh-ancestor
6087860|NCT00831233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6087861|NCT00831233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087862|NCT00831272|Naltrexone|naltrexone|mesh-list
6087863|NCT00831272|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6087864|NCT00831272|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6087865|NCT00831272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087866|NCT00831272|Sensory System Agents|sensory system agents|mesh-ancestor
6087867|NCT00831272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6087868|NCT00831311|Vaccines|vaccines|mesh-list
6087869|NCT00831311|Immunologic Factors|immunologic factors|mesh-ancestor
6087870|NCT00831311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087871|NCT00831415|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6087872|NCT00831415|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6087873|NCT00831415|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6087874|NCT00831415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6087875|NCT00831415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087876|NCT00831415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6087877|NCT00831415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087878|NCT00831415|Antidepressive Agents|antidepressive agents|mesh-ancestor
6087879|NCT00831415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6087880|NCT00831441|Apixaban|apixaban|mesh-list
6087881|NCT00831441|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6087882|NCT00831441|Antithrombins|antithrombins|mesh-ancestor
6087883|NCT00831441|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6087884|NCT00831441|Protease Inhibitors|protease inhibitors|mesh-ancestor
6087885|NCT00831441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6087886|NCT00831441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087887|NCT00831441|Anticoagulants|anticoagulants|mesh-ancestor
5517661|NCT04344782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5517662|NCT04344782|Growth Substances|growth substances|mesh-ancestor
5517663|NCT04344782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517664|NCT04344782|Growth Inhibitors|growth inhibitors|mesh-ancestor
5517665|NCT04344730|Dexamethasone|dexamethasone|mesh-list
5517666|NCT04344730|Dexamethasone acetate|dexamethasone acetate|mesh-list
5517667|NCT04344730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5517668|NCT04344730|Antiemetics|antiemetics|mesh-ancestor
5517669|NCT04344730|Autonomic Agents|autonomic agents|mesh-ancestor
5517670|NCT04344730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5517671|NCT04344730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517672|NCT04344730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5517673|NCT04344730|Glucocorticoids|glucocorticoids|mesh-ancestor
5517674|NCT04344730|Hormones|hormones|mesh-ancestor
5517675|NCT04344730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5517676|NCT04344730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5517677|NCT04344730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5517678|NCT04344236|Chlorhexidine|chlorhexidine|mesh-list
5517679|NCT04344236|Povidone-Iodine|povidone-iodine|mesh-list
5517680|NCT04344236|Povidone|povidone|mesh-list
5517681|NCT04344236|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5517682|NCT04344236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5517683|NCT04344236|Disinfectants|disinfectants|mesh-ancestor
5517684|NCT04344236|Plasma Substitutes|plasma substitutes|mesh-ancestor
5517685|NCT04344236|Blood Substitutes|blood substitutes|mesh-ancestor
5517686|NCT04344288|Prednisone|prednisone|mesh-list
5517687|NCT04344288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5517688|NCT04344288|Glucocorticoids|glucocorticoids|mesh-ancestor
5517689|NCT04344288|Hormones|hormones|mesh-ancestor
5517690|NCT04344288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5517691|NCT04344288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087888|NCT00831480|Everolimus|everolimus|mesh-list
5517692|NCT04344288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5517693|NCT04344288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6087889|NCT00831480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6087890|NCT00831480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6087891|NCT00831480|Immunologic Factors|immunologic factors|mesh-ancestor
6087892|NCT00831480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087893|NCT00831493|Vorinostat|vorinostat|mesh-list
6087894|NCT00831493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6087895|NCT00831493|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6087896|NCT00831493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6087897|NCT00831493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087898|NCT00831675|Vaccines|vaccines|mesh-list
6087899|NCT00831675|Immunologic Factors|immunologic factors|mesh-ancestor
6087900|NCT00831675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087901|NCT00831701|Tamsulosin|tamsulosin|mesh-list
6087902|NCT00831701|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6087903|NCT00831701|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6087904|NCT00831701|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6087905|NCT00831701|Adrenergic Agents|adrenergic agents|mesh-ancestor
6087906|NCT00831701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6087907|NCT00831701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087908|NCT00831701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087909|NCT00831701|Urological Agents|urological agents|mesh-ancestor
6087910|NCT00831766|Cytarabine|cytarabine|mesh-list
6087911|NCT00831766|Lenalidomide|lenalidomide|mesh-list
6087912|NCT00831766|Idarubicin|idarubicin|mesh-list
6087913|NCT00831766|Antineoplastic Agents|antineoplastic agents|mesh-list
5517694|NCT04344262|Atracurium|atracurium|mesh-list
5517695|NCT04344262|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5517696|NCT04344262|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5517697|NCT04344262|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5517698|NCT04344262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5517699|NCT04344262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517700|NCT04344262|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
5517701|NCT04344262|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6087914|NCT00831766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6087915|NCT00831766|Antimetabolites|antimetabolites|mesh-ancestor
6087916|NCT00831766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087917|NCT00831766|Antiviral Agents|antiviral agents|mesh-ancestor
6087918|NCT00831766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6087919|NCT00831766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6087920|NCT00831766|Immunologic Factors|immunologic factors|mesh-ancestor
6087921|NCT00831766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087922|NCT00831766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6464215|NCT00468533|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6464216|NCT00468533|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6464217|NCT00468533|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6464218|NCT00468533|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6464219|NCT00468689|Ketoconazole|ketoconazole|mesh-list
6464220|NCT00468689|Antifungal Agents|antifungal agents|mesh-ancestor
6464221|NCT00468689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6087923|NCT00831766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6087924|NCT00831766|Growth Substances|growth substances|mesh-ancestor
6087925|NCT00831766|Growth Inhibitors|growth inhibitors|mesh-ancestor
6087926|NCT00831766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6087927|NCT00831766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6087928|NCT00831766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6087929|NCT00831766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6087930|NCT00831779|Dapagliflozin|dapagliflozin|mesh-list
6087931|NCT00831779|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6087932|NCT00831779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087933|NCT00831779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6087934|NCT00831779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087935|NCT00831844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6087936|NCT00831844|Immunologic Factors|immunologic factors|mesh-ancestor
6087937|NCT00831844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087938|NCT00831987|Vaccines|vaccines|mesh-list
6087939|NCT00831987|Immunologic Factors|immunologic factors|mesh-ancestor
6087940|NCT00831987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087941|NCT00832000|Mexiletine|mexiletine|mesh-list
6087942|NCT00832000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6087943|NCT00832000|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6087944|NCT00832000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6087945|NCT00832000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6464222|NCT00468689|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5517702|NCT04344262|Cholinergic Agents|cholinergic agents|mesh-ancestor
6087946|NCT00832000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087947|NCT00832117|Cisplatin|cisplatin|mesh-list
6087948|NCT00832117|Epothilones|epothilones|mesh-list
6087949|NCT00832117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6087950|NCT00832117|Tubulin Modulators|tubulin modulators|mesh-ancestor
6087951|NCT00832117|Antimitotic Agents|antimitotic agents|mesh-ancestor
6087952|NCT00832117|Mitosis Modulators|mitosis modulators|mesh-ancestor
6087953|NCT00832117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087954|NCT00832338|Dexamethasone|dexamethasone|mesh-list
6087955|NCT00832338|Docetaxel|docetaxel|mesh-list
6087956|NCT00832338|Cyclophosphamide|cyclophosphamide|mesh-list
6087957|NCT00832338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6087958|NCT00832338|Antiemetics|antiemetics|mesh-ancestor
6087959|NCT00832338|Autonomic Agents|autonomic agents|mesh-ancestor
6087960|NCT00832338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6087961|NCT00832338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087962|NCT00832338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6087963|NCT00832338|Glucocorticoids|glucocorticoids|mesh-ancestor
5517703|NCT04344262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5517704|NCT04344262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517705|NCT04344405|Vitamin D|vitamin d|mesh-list
5517706|NCT04344405|Vitamins|vitamins|mesh-ancestor
5517707|NCT04344405|Micronutrients|micronutrients|mesh-ancestor
5517708|NCT04344405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517709|NCT04344405|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5517710|NCT04344184|Ascorbic Acid|ascorbic acid|mesh-list
5517711|NCT04344184|Vitamins|vitamins|mesh-ancestor
5517712|NCT04344184|Micronutrients|micronutrients|mesh-ancestor
5517713|NCT04344184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517714|NCT04344184|Antioxidants|antioxidants|mesh-ancestor
5517715|NCT04344184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517716|NCT04344184|Protective Agents|protective agents|mesh-ancestor
6087964|NCT00832338|Hormones|hormones|mesh-ancestor
6087965|NCT00832338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5517717|NCT04344379|Azithromycin|azithromycin|mesh-list
5517718|NCT04344379|Hydroxychloroquine|hydroxychloroquine|mesh-list
5517719|NCT04344379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5517720|NCT04344379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5517721|NCT04344379|Antimalarials|antimalarials|mesh-ancestor
5517722|NCT04344379|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5517723|NCT04344379|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5517724|NCT04344379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5517725|NCT04344379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517726|NCT04344379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5517727|NCT04344041|Cholecalciferol|cholecalciferol|mesh-list
5517728|NCT04344041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6087966|NCT00832338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6087967|NCT00832338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6087968|NCT00832338|Tubulin Modulators|tubulin modulators|mesh-ancestor
6087969|NCT00832338|Antimitotic Agents|antimitotic agents|mesh-ancestor
6087970|NCT00832338|Mitosis Modulators|mitosis modulators|mesh-ancestor
6087971|NCT00832338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6087972|NCT00832338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6087973|NCT00832338|Immunologic Factors|immunologic factors|mesh-ancestor
6087974|NCT00832338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6087975|NCT00832338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6087976|NCT00832338|Alkylating Agents|alkylating agents|mesh-ancestor
6087977|NCT00832338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6087978|NCT00832377|Timolol|timolol|mesh-list
6087979|NCT00832377|Dorzolamide|dorzolamide|mesh-list
6087980|NCT00832377|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6087981|NCT00832377|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6087982|NCT00832377|Adrenergic Agents|adrenergic agents|mesh-ancestor
6087983|NCT00832377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6087984|NCT00832377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665627|NCT01518062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6665628|NCT01518062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665629|NCT01518101|Metformin|metformin|mesh-list
6087985|NCT00832377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087986|NCT00832377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6087987|NCT00832377|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6087988|NCT00832377|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6087989|NCT00832377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6087990|NCT00832390|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5517729|NCT04344041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087991|NCT00832390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6087992|NCT00832390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6087993|NCT00832390|Incretins|incretins|mesh-ancestor
6087994|NCT00832390|Hormones|hormones|mesh-ancestor
6087995|NCT00832390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6087996|NCT00832390|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6087997|NCT00832390|Protease Inhibitors|protease inhibitors|mesh-ancestor
6087998|NCT00832390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6087999|NCT00832390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088000|NCT00832416|Tramadol|tramadol|mesh-list
6088001|NCT00832416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6088002|NCT00832416|Narcotics|narcotics|mesh-ancestor
6088003|NCT00832416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6088004|NCT00832416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088005|NCT00832416|Analgesics|analgesics|mesh-ancestor
6088006|NCT00832416|Sensory System Agents|sensory system agents|mesh-ancestor
6088007|NCT00832416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6088008|NCT00832585|Alefacept|alefacept|mesh-list
6088009|NCT00832585|Dermatologic Agents|dermatologic agents|mesh-ancestor
6088010|NCT00832585|Immunologic Factors|immunologic factors|mesh-ancestor
6088011|NCT00832585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088012|NCT00832637|Gemcitabine|gemcitabine|mesh-list
6088013|NCT00832637|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6088014|NCT00832637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6088015|NCT00832637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6088016|NCT00832637|Antimetabolites|antimetabolites|mesh-ancestor
6088017|NCT00832637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088018|NCT00832637|Antiviral Agents|antiviral agents|mesh-ancestor
6088019|NCT00832637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6665630|NCT01518101|Liraglutide|liraglutide|mesh-list
6665631|NCT01518101|Vildagliptin|vildagliptin|mesh-list
6665632|NCT01518101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6665633|NCT01518101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665634|NCT01518101|Incretins|incretins|mesh-ancestor
6665635|NCT01518101|Hormones|hormones|mesh-ancestor
6665636|NCT01518101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6665637|NCT01518101|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6665638|NCT01518101|Protease Inhibitors|protease inhibitors|mesh-ancestor
6665639|NCT01518101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6665640|NCT01518101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665641|NCT01518166|Liraglutide|liraglutide|mesh-list
6665642|NCT01518166|Griseofulvin|griseofulvin|mesh-list
6665643|NCT01518166|Digoxin|digoxin|mesh-list
6088020|NCT00832637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6088021|NCT00832637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6088022|NCT00832637|Immunologic Factors|immunologic factors|mesh-ancestor
6088023|NCT00832637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088024|NCT00832637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6088025|NCT00832650|Solifenacin Succinate|solifenacin succinate|mesh-list
6088026|NCT00832650|Fesoterodine|fesoterodine|mesh-list
6088027|NCT00832650|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6088028|NCT00832650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6088029|NCT00832650|Cholinergic Agents|cholinergic agents|mesh-ancestor
6088030|NCT00832650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6088031|NCT00832650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088032|NCT00832650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088033|NCT00832650|Urological Agents|urological agents|mesh-ancestor
6088034|NCT00832819|Paclitaxel|paclitaxel|mesh-list
6088035|NCT00832819|Carboplatin|carboplatin|mesh-list
6088036|NCT00832819|Lenvatinib|lenvatinib|mesh-list
6088037|NCT00832819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6088038|NCT00832819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6088039|NCT00832819|Tubulin Modulators|tubulin modulators|mesh-ancestor
6088040|NCT00832819|Antimitotic Agents|antimitotic agents|mesh-ancestor
6088041|NCT00832819|Mitosis Modulators|mitosis modulators|mesh-ancestor
6088042|NCT00832819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088043|NCT00832819|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6088044|NCT00832819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6088045|NCT00832871|Mifepristone|mifepristone|mesh-list
6088046|NCT00832871|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6088047|NCT00832871|Abortifacient Agents|abortifacient agents|mesh-ancestor
6088048|NCT00832871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6088049|NCT00832871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088050|NCT00832871|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6088051|NCT00832871|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6665644|NCT01518166|Lisinopril|lisinopril|mesh-list
6088052|NCT00832871|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6088053|NCT00832871|Contraceptive Agents|contraceptive agents|mesh-ancestor
6088054|NCT00832871|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6088055|NCT00832871|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6088056|NCT00832871|Hormone Antagonists|hormone antagonists|mesh-ancestor
5517730|NCT04344041|Vitamins|vitamins|mesh-ancestor
5517731|NCT04344041|Micronutrients|micronutrients|mesh-ancestor
5517732|NCT04344041|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5517733|NCT04343976|Interferons|interferons|mesh-list
5517734|NCT04343976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5517735|NCT04343976|Antiviral Agents|antiviral agents|mesh-ancestor
5517736|NCT04343976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5517737|NCT04343885|Docetaxel|docetaxel|mesh-list
5517738|NCT04343885|177Lu-PSMA-617|177lu-psma-617|mesh-list
5517739|NCT04343885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5517740|NCT04343885|Tubulin Modulators|tubulin modulators|mesh-ancestor
5517741|NCT04343885|Antimitotic Agents|antimitotic agents|mesh-ancestor
5517742|NCT04343885|Mitosis Modulators|mitosis modulators|mesh-ancestor
5517743|NCT04343885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517744|NCT04343885|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5517745|NCT04344158|Sorafenib|sorafenib|mesh-list
5517746|NCT04344158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5517747|NCT04344158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5517748|NCT04344158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5517749|NCT04344158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517750|NCT04343872|Metformin|metformin|mesh-list
5517751|NCT04343872|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5517752|NCT04343872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517753|NCT04343742|Chlorine dioxide|chlorine dioxide|mesh-list
5517754|NCT04343742|Dental Disinfectants|dental disinfectants|mesh-ancestor
5517755|NCT04343742|Disinfectants|disinfectants|mesh-ancestor
5517756|NCT04343742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5517757|NCT04343768|Interferons|interferons|mesh-list
5517758|NCT04343768|Ritonavir|ritonavir|mesh-list
5517759|NCT04343768|Lopinavir|lopinavir|mesh-list
5517760|NCT04343768|Interferon-beta|interferon-beta|mesh-list
5517761|NCT04343768|Interferon beta-1a|interferon beta-1a|mesh-list
5517762|NCT04343768|Hydroxychloroquine|hydroxychloroquine|mesh-list
5517763|NCT04343768|Interferon beta-1b|interferon beta-1b|mesh-list
5517764|NCT04343768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5517765|NCT04343768|Antiviral Agents|antiviral agents|mesh-ancestor
5517766|NCT04343768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5517767|NCT04343768|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5517768|NCT04343768|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5517769|NCT04343768|Protease Inhibitors|protease inhibitors|mesh-ancestor
5517770|NCT04343768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6088057|NCT00832871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6088058|NCT00832871|Luteolytic Agents|luteolytic agents|mesh-ancestor
6088059|NCT00832871|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6088060|NCT00832871|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6088061|NCT00833027|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5517771|NCT04343768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517772|NCT04343768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5517773|NCT04343768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5517774|NCT04343768|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5517775|NCT04343768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5517776|NCT04343768|Antimalarials|antimalarials|mesh-ancestor
5517777|NCT04343768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6088062|NCT00833027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6088063|NCT00833027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088064|NCT00833027|Incretins|incretins|mesh-ancestor
6088065|NCT00833027|Hormones|hormones|mesh-ancestor
6088066|NCT00833027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6088067|NCT00833027|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6088068|NCT00833027|Protease Inhibitors|protease inhibitors|mesh-ancestor
5517778|NCT04343768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5517779|NCT04343768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5517780|NCT04343768|Immunologic Factors|immunologic factors|mesh-ancestor
5517781|NCT04343768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517782|NCT04343768|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5517783|NCT04343729|Methylprednisolone|methylprednisolone|mesh-list
5517784|NCT04343729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5517785|NCT04343729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5517786|NCT04343729|Prednisolone|prednisolone|mesh-list
5517787|NCT04343729|Prednisolone acetate|prednisolone acetate|mesh-list
5517788|NCT04343729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5517789|NCT04343729|Prednisolone phosphate|prednisolone phosphate|mesh-list
5517790|NCT04343729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5517791|NCT04343729|Antiemetics|antiemetics|mesh-ancestor
5517792|NCT04343729|Autonomic Agents|autonomic agents|mesh-ancestor
5517793|NCT04343729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5517794|NCT04343729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088069|NCT00833027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6088070|NCT00833027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088071|NCT00833040|Sufentanil|sufentanil|mesh-list
6088072|NCT00833040|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6088073|NCT00833040|Narcotics|narcotics|mesh-ancestor
5517795|NCT04343729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5517796|NCT04343729|Glucocorticoids|glucocorticoids|mesh-ancestor
5517797|NCT04343729|Hormones|hormones|mesh-ancestor
5517798|NCT04343729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5517799|NCT04343729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5517800|NCT04343729|Protective Agents|protective agents|mesh-ancestor
5517801|NCT04343729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5517802|NCT04343729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5517803|NCT04343963|Bromides|bromides|mesh-list
5517804|NCT04343963|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
6088074|NCT00833040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6088075|NCT00833040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088076|NCT00833040|Analgesics|analgesics|mesh-ancestor
6088077|NCT00833040|Sensory System Agents|sensory system agents|mesh-ancestor
6088078|NCT00833040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6088079|NCT00833040|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6088080|NCT00833040|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6088081|NCT00833040|Anesthetics, General|anesthetics, general|mesh-ancestor
6088082|NCT00833040|Anesthetics|anesthetics|mesh-ancestor
6088083|NCT00833053|Methotrexate|methotrexate|mesh-list
6088084|NCT00833053|Infliximab|infliximab|mesh-list
6088085|NCT00833053|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6088086|NCT00833053|Abortifacient Agents|abortifacient agents|mesh-ancestor
5517805|NCT04343963|Anticonvulsants|anticonvulsants|mesh-ancestor
5517806|NCT04343963|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5517807|NCT04343963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5517808|NCT04343963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517809|NCT04343963|Cholinergic Agents|cholinergic agents|mesh-ancestor
5517810|NCT04343963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5517811|NCT04343963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517812|NCT04343651|Leronlimab|leronlimab|mesh-list
6088087|NCT00833053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6088088|NCT00833053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088089|NCT00833053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6088090|NCT00833053|Antimetabolites|antimetabolites|mesh-ancestor
6088091|NCT00833053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088092|NCT00833053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6088093|NCT00833053|Dermatologic Agents|dermatologic agents|mesh-ancestor
6088094|NCT00833053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6088095|NCT00833053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6088096|NCT00833053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6088097|NCT00833053|Immunologic Factors|immunologic factors|mesh-ancestor
6088098|NCT00833053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6088099|NCT00833053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6088100|NCT00833053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6088101|NCT00833248|Goserelin|goserelin|mesh-list
6088102|NCT00833248|Bicalutamide|bicalutamide|mesh-list
6088103|NCT00833248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6088104|NCT00833248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6088105|NCT00833248|Androgen Antagonists|androgen antagonists|mesh-ancestor
6088106|NCT00833248|Hormone Antagonists|hormone antagonists|mesh-ancestor
6088107|NCT00833248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6088108|NCT00833248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088109|NCT00833261|Paclitaxel|paclitaxel|mesh-list
6088110|NCT00833261|Cetuximab|cetuximab|mesh-list
6088111|NCT00833261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6088112|NCT00833261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6088113|NCT00833261|Tubulin Modulators|tubulin modulators|mesh-ancestor
6088114|NCT00833261|Antimitotic Agents|antimitotic agents|mesh-ancestor
5517813|NCT04343651|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5517814|NCT04343651|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5517815|NCT04343651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088115|NCT00833261|Mitosis Modulators|mitosis modulators|mesh-ancestor
6088116|NCT00833261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665645|NCT01518166|Atorvastatin|atorvastatin|mesh-list
6088117|NCT00833261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6088118|NCT00833365|Ibuprofen|ibuprofen|mesh-list
6088119|NCT00833365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6088120|NCT00833365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6088121|NCT00833365|Analgesics|analgesics|mesh-ancestor
6088122|NCT00833365|Sensory System Agents|sensory system agents|mesh-ancestor
6088123|NCT00833365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6088124|NCT00833365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088125|NCT00833365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6088126|NCT00833365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6088127|NCT00833365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6088128|NCT00833365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6088129|NCT00833365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088130|NCT00833443|Bupropion|bupropion|mesh-list
6088131|NCT00833443|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6088132|NCT00833443|Antidepressive Agents|antidepressive agents|mesh-ancestor
6088133|NCT00833443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6088134|NCT00833443|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6088135|NCT00833443|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6088136|NCT00833443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6088137|NCT00833443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517816|NCT04343651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5517817|NCT04343651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5517818|NCT04343651|Antiviral Agents|antiviral agents|mesh-ancestor
5517819|NCT04343651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5517820|NCT04343326|Menthol|menthol|mesh-list
5517821|NCT04343326|Antipruritics|antipruritics|mesh-ancestor
6088138|NCT00833443|Dopamine Agents|dopamine agents|mesh-ancestor
6088139|NCT00833443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6088140|NCT00833443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088141|NCT00833443|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6088142|NCT00833443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6088143|NCT00833443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6088144|NCT00833469|Citalopram|citalopram|mesh-list
6088145|NCT00833469|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5725110|NCT03182426|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5725111|NCT03182426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5517822|NCT04343326|Dermatologic Agents|dermatologic agents|mesh-ancestor
5517823|NCT04343170|Folic Acid|folic acid|mesh-list
5517824|NCT04343170|Vitamin B 12|vitamin b 12|mesh-list
5517825|NCT04343170|Hydroxocobalamin|hydroxocobalamin|mesh-list
5517826|NCT04343170|Epoetin Alfa|epoetin alfa|mesh-list
5517827|NCT04343170|Vitamins|vitamins|mesh-ancestor
5517828|NCT04343170|Micronutrients|micronutrients|mesh-ancestor
5517829|NCT04343170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517830|NCT04343170|Hematinics|hematinics|mesh-ancestor
5517831|NCT04343170|Vitamin B Complex|vitamin b complex|mesh-ancestor
5517832|NCT04343248|Nitazoxanide|nitazoxanide|mesh-list
5517833|NCT04343248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5517834|NCT04343248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5517835|NCT04343001|Aspirin|aspirin|mesh-list
5725112|NCT03182426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725113|NCT03182426|Incretins|incretins|mesh-ancestor
5725114|NCT03182426|Hormones|hormones|mesh-ancestor
5725115|NCT03182426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6088146|NCT00833469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6088147|NCT00833469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6088148|NCT00833469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088149|NCT00833469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6088150|NCT00833469|Serotonin Agents|serotonin agents|mesh-ancestor
6665646|NCT01518166|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6665647|NCT01518166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6665648|NCT01518166|Antimetabolites|antimetabolites|mesh-ancestor
6665649|NCT01518166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665650|NCT01518166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6088151|NCT00833469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088152|NCT00833469|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6088153|NCT00833469|Antidepressive Agents|antidepressive agents|mesh-ancestor
6088154|NCT00833469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6088155|NCT00833482|Ritonavir|ritonavir|mesh-list
6665651|NCT01518166|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5517836|NCT04343001|Losartan|losartan|mesh-list
5517837|NCT04343001|Simvastatin|simvastatin|mesh-list
5517838|NCT04343001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5517839|NCT04343001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6088156|NCT00833482|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6088157|NCT00833482|Voriconazole|voriconazole|mesh-list
6088158|NCT00833482|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6088159|NCT00833482|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6088160|NCT00833482|Protease Inhibitors|protease inhibitors|mesh-ancestor
6088161|NCT00833482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6088162|NCT00833482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088163|NCT00833482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6088164|NCT00833482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6088165|NCT00833482|Antiviral Agents|antiviral agents|mesh-ancestor
5517840|NCT04343001|Analgesics|analgesics|mesh-ancestor
5517841|NCT04343001|Sensory System Agents|sensory system agents|mesh-ancestor
6088166|NCT00833482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6088167|NCT00833482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6088168|NCT00833482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6088169|NCT00833482|Antifungal Agents|antifungal agents|mesh-ancestor
6088170|NCT00833482|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6088171|NCT00833482|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6088172|NCT00833482|Hormone Antagonists|hormone antagonists|mesh-ancestor
6088173|NCT00833482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6088174|NCT00833482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088175|NCT00833547|Eszopiclone|eszopiclone|mesh-list
6088176|NCT00833547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6088177|NCT00833547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6088178|NCT00833547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464223|NCT00468689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6464224|NCT00468689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6464225|NCT00468689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088179|NCT00833560|Dexamethasone|dexamethasone|mesh-list
6088180|NCT00833560|Cyclophosphamide|cyclophosphamide|mesh-list
6088181|NCT00833560|Bortezomib|bortezomib|mesh-list
6088182|NCT00833560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6088183|NCT00833560|Immunologic Factors|immunologic factors|mesh-ancestor
6088184|NCT00833560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088185|NCT00833560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6088186|NCT00833560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6088187|NCT00833560|Alkylating Agents|alkylating agents|mesh-ancestor
6088188|NCT00833560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088189|NCT00833560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6088190|NCT00833560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6088191|NCT00833560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6088192|NCT00833560|Antiemetics|antiemetics|mesh-ancestor
6088193|NCT00833560|Autonomic Agents|autonomic agents|mesh-ancestor
6088194|NCT00833560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6088195|NCT00833560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6088196|NCT00833560|Glucocorticoids|glucocorticoids|mesh-ancestor
6088197|NCT00833560|Hormones|hormones|mesh-ancestor
6088198|NCT00833560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6088199|NCT00833560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6088200|NCT00833638|Tadalafil|tadalafil|mesh-list
6088201|NCT00833638|Vasodilator Agents|vasodilator agents|mesh-ancestor
6088202|NCT00833638|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6088203|NCT00833638|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6088204|NCT00833638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6088205|NCT00833638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088206|NCT00833638|Urological Agents|urological agents|mesh-ancestor
6088207|NCT00833703|Clopidogrel|clopidogrel|mesh-list
6088208|NCT00833703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6088209|NCT00833703|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6088210|NCT00833703|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6088211|NCT00833703|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6088212|NCT00833703|Purinergic Agents|purinergic agents|mesh-ancestor
6088213|NCT00833703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6088214|NCT00833703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088215|NCT00833703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088216|NCT00833755|Ketamine|ketamine|mesh-list
6088217|NCT00833755|Analgesics|analgesics|mesh-ancestor
6088218|NCT00833755|Sensory System Agents|sensory system agents|mesh-ancestor
6088219|NCT00833755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6088220|NCT00833755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088221|NCT00833755|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6088222|NCT00833755|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6088223|NCT00833755|Anesthetics, General|anesthetics, general|mesh-ancestor
5517842|NCT04343001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5517843|NCT04343001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517844|NCT04343001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5517845|NCT04343001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5517846|NCT04343001|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5517847|NCT04343001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5517848|NCT04343001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517849|NCT04343001|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5517850|NCT04343001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5517851|NCT04343001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5517852|NCT04343001|Antipyretics|antipyretics|mesh-ancestor
5517853|NCT04343001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5517854|NCT04343001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5517855|NCT04343001|Antimetabolites|antimetabolites|mesh-ancestor
5517856|NCT04343001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5517857|NCT04343001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6088224|NCT00833755|Anesthetics|anesthetics|mesh-ancestor
6088225|NCT00833755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6088226|NCT00833755|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6088227|NCT00833755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6088228|NCT00833755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6088229|NCT00833755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088230|NCT00833794|Tramadol|tramadol|mesh-list
6088231|NCT00833794|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6088232|NCT00833794|Narcotics|narcotics|mesh-ancestor
6088233|NCT00833794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6088234|NCT00833794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088235|NCT00833794|Analgesics|analgesics|mesh-ancestor
6088236|NCT00833794|Sensory System Agents|sensory system agents|mesh-ancestor
6088237|NCT00833794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6088238|NCT00833833|Aspirin|aspirin|mesh-list
6088239|NCT00833833|Dexamethasone|dexamethasone|mesh-list
6088240|NCT00833833|Dexamethasone acetate|dexamethasone acetate|mesh-list
6088241|NCT00833833|Pomalidomide|pomalidomide|mesh-list
6088242|NCT00833833|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
6088243|NCT00833833|BB 1101|bb 1101|mesh-list
5517858|NCT04343001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5517859|NCT04343001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5517860|NCT04343001|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5517861|NCT04343001|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5517862|NCT04343235|Labetalol|labetalol|mesh-list
5517863|NCT04343235|Furosemide|furosemide|mesh-list
5517864|NCT04343235|Diuretics|diuretics|mesh-ancestor
5517865|NCT04343235|Natriuretic Agents|natriuretic agents|mesh-ancestor
5517866|NCT04343235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517867|NCT04343235|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5517868|NCT04343235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5517869|NCT04343235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517870|NCT04343235|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5517871|NCT04343235|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5517872|NCT04343235|Adrenergic Agents|adrenergic agents|mesh-ancestor
5517873|NCT04343235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5517874|NCT04343235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5517875|NCT04343235|Sympathomimetics|sympathomimetics|mesh-ancestor
5517876|NCT04343235|Autonomic Agents|autonomic agents|mesh-ancestor
5517877|NCT04343235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5517878|NCT04343235|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5517879|NCT04343235|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5517880|NCT04343144|Nivolumab|nivolumab|mesh-list
5517881|NCT04343144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5600760|NCT03709888|Memantine|memantine|mesh-list
6088244|NCT00833833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6088245|NCT00833833|Antiemetics|antiemetics|mesh-ancestor
6088246|NCT00833833|Autonomic Agents|autonomic agents|mesh-ancestor
6088247|NCT00833833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6088248|NCT00833833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088249|NCT00833833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6088250|NCT00833833|Glucocorticoids|glucocorticoids|mesh-ancestor
6088251|NCT00833833|Hormones|hormones|mesh-ancestor
6088252|NCT00833833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6088253|NCT00833833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6088254|NCT00833833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6088255|NCT00833833|Protease Inhibitors|protease inhibitors|mesh-ancestor
6088256|NCT00833833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6088257|NCT00833833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088258|NCT00833833|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6665652|NCT01518166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6665653|NCT01518166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6665654|NCT01518166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665655|NCT01518166|Incretins|incretins|mesh-ancestor
6665656|NCT01518166|Hormones|hormones|mesh-ancestor
6665657|NCT01518166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6665658|NCT01518166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6665659|NCT01518166|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6665660|NCT01518166|Protective Agents|protective agents|mesh-ancestor
5517882|NCT04343144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5517883|NCT04343144|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5517884|NCT04343144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517885|NCT04342910|Paclitaxel|paclitaxel|mesh-list
5517886|NCT04342910|Irinotecan|irinotecan|mesh-list
6665661|NCT01518166|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6665662|NCT01518166|Protease Inhibitors|protease inhibitors|mesh-ancestor
6665663|NCT01518166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6665664|NCT01518166|Antifungal Agents|antifungal agents|mesh-ancestor
6665665|NCT01518166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6088259|NCT00833833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6088260|NCT00833833|Analgesics|analgesics|mesh-ancestor
6088261|NCT00833833|Sensory System Agents|sensory system agents|mesh-ancestor
6088262|NCT00833833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6088263|NCT00833833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6088264|NCT00833833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6088265|NCT00833833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6088266|NCT00833833|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6088267|NCT00833833|Antipyretics|antipyretics|mesh-ancestor
6088268|NCT00833833|Immunologic Factors|immunologic factors|mesh-ancestor
6088269|NCT00833833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6088270|NCT00833833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6088271|NCT00833833|Growth Substances|growth substances|mesh-ancestor
6088272|NCT00833833|Growth Inhibitors|growth inhibitors|mesh-ancestor
6088273|NCT00833911|Tramadol|tramadol|mesh-list
6088274|NCT00833911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6088275|NCT00833911|Narcotics|narcotics|mesh-ancestor
6088276|NCT00833911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6088277|NCT00833911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088278|NCT00833911|Analgesics|analgesics|mesh-ancestor
6088279|NCT00833911|Sensory System Agents|sensory system agents|mesh-ancestor
6088280|NCT00833911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6088281|NCT00834080|Naltrexone|naltrexone|mesh-list
6088282|NCT00834080|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6088283|NCT00834080|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6088284|NCT00834080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088285|NCT00834080|Sensory System Agents|sensory system agents|mesh-ancestor
6088286|NCT00834080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6088287|NCT00834171|Loteprednol Etabonate|loteprednol etabonate|mesh-list
6088288|NCT00834171|Tobramycin|tobramycin|mesh-list
6088289|NCT00834171|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6088290|NCT00834171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6088291|NCT00834171|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6203201|NCT02054338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6203202|NCT02054338|Antimetabolites|antimetabolites|mesh-ancestor
6203203|NCT02054338|Antiviral Agents|antiviral agents|mesh-ancestor
6203204|NCT02054338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6203205|NCT02054338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6203206|NCT02054338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6203207|NCT02054338|Immunologic Factors|immunologic factors|mesh-ancestor
6203208|NCT02054338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203209|NCT02054481|Ustekinumab|ustekinumab|mesh-list
6203210|NCT02054481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5517887|NCT04342910|Apatinib|apatinib|mesh-list
6203211|NCT02054481|Dermatologic Agents|dermatologic agents|mesh-ancestor
6088292|NCT00834210|Nicotinic Acids|nicotinic acids|mesh-list
6088293|NCT00834210|Dapsone|dapsone|mesh-list
6088294|NCT00834210|Tazarotene|tazarotene|mesh-list
6088295|NCT00834210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6088296|NCT00834210|Antimalarials|antimalarials|mesh-ancestor
6088297|NCT00834210|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6088298|NCT00834210|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6088299|NCT00834210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6088300|NCT00834210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6088301|NCT00834210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088302|NCT00834210|Leprostatic Agents|leprostatic agents|mesh-ancestor
6088303|NCT00834210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6088304|NCT00834210|Dermatologic Agents|dermatologic agents|mesh-ancestor
6088305|NCT00834210|Keratolytic Agents|keratolytic agents|mesh-ancestor
6088306|NCT00834210|Vitamin B Complex|vitamin b complex|mesh-ancestor
6088307|NCT00834210|Vitamins|vitamins|mesh-ancestor
6088308|NCT00834210|Micronutrients|micronutrients|mesh-ancestor
6464226|NCT00468689|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6464227|NCT00468689|Hormone Antagonists|hormone antagonists|mesh-ancestor
6464228|NCT00468689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6464229|NCT00468689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464230|NCT00468689|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6464231|NCT00468715|Bicalutamide|bicalutamide|mesh-list
6464232|NCT00468715|Androgen Antagonists|androgen antagonists|mesh-ancestor
6464233|NCT00468715|Hormone Antagonists|hormone antagonists|mesh-ancestor
6464234|NCT00468715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6464235|NCT00468715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517888|NCT04342910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6088309|NCT00834210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088310|NCT00834288|Tramadol|tramadol|mesh-list
6088311|NCT00834288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6088312|NCT00834288|Narcotics|narcotics|mesh-ancestor
6088313|NCT00834288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6088314|NCT00834288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088315|NCT00834288|Analgesics|analgesics|mesh-ancestor
6088316|NCT00834288|Sensory System Agents|sensory system agents|mesh-ancestor
6088317|NCT00834288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6088318|NCT00834366|Tramadol|tramadol|mesh-list
6088319|NCT00834366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6088320|NCT00834366|Narcotics|narcotics|mesh-ancestor
6088321|NCT00834366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6088322|NCT00834366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088323|NCT00834366|Analgesics|analgesics|mesh-ancestor
5517889|NCT04342910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5517890|NCT04342910|Tubulin Modulators|tubulin modulators|mesh-ancestor
5517891|NCT04342910|Antimitotic Agents|antimitotic agents|mesh-ancestor
5517892|NCT04342910|Mitosis Modulators|mitosis modulators|mesh-ancestor
5517893|NCT04342910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517894|NCT04342910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5517895|NCT04342910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5517896|NCT04342910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5517897|NCT04342910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5600761|NCT03709888|Analgesics|analgesics|mesh-ancestor
5600762|NCT03709888|Sensory System Agents|sensory system agents|mesh-ancestor
5600763|NCT03709888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5600764|NCT03709888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600765|NCT03709888|Anticonvulsants|anticonvulsants|mesh-ancestor
5600766|NCT03709888|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5600767|NCT03709888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5600768|NCT03709888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600769|NCT03709888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5600770|NCT03709888|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6088324|NCT00834366|Sensory System Agents|sensory system agents|mesh-ancestor
6088325|NCT00834366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6088326|NCT00834652|Metformin|metformin|mesh-list
6088327|NCT00834652|Sertraline|sertraline|mesh-list
6088328|NCT00834652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6088329|NCT00834652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088330|NCT00834652|Antidepressive Agents|antidepressive agents|mesh-ancestor
6088331|NCT00834652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6088332|NCT00834652|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6088333|NCT00834652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6088334|NCT00834652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6088335|NCT00834652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517898|NCT04342676|Panitumumab|panitumumab|mesh-list
5517899|NCT04342676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5517900|NCT04342676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5517901|NCT04342598|Vitamin D|vitamin d|mesh-list
5517902|NCT04342598|Vitamins|vitamins|mesh-ancestor
6088336|NCT00834652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6088337|NCT00834652|Serotonin Agents|serotonin agents|mesh-ancestor
6088338|NCT00834678|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6088339|NCT00834678|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6088340|NCT00834678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6088341|NCT00834678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6088342|NCT00834678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6088343|NCT00834678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088344|NCT00834678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6088345|NCT00834678|Alkylating Agents|alkylating agents|mesh-ancestor
6088346|NCT00834808|Tramadol|tramadol|mesh-list
6088347|NCT00834808|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6088348|NCT00834808|Narcotics|narcotics|mesh-ancestor
6088349|NCT00834808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6088350|NCT00834808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088351|NCT00834808|Analgesics|analgesics|mesh-ancestor
6088352|NCT00834808|Sensory System Agents|sensory system agents|mesh-ancestor
6088353|NCT00834808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6088354|NCT00834834|Fluoxetine|fluoxetine|mesh-list
6088355|NCT00834834|Citalopram|citalopram|mesh-list
6088356|NCT00834834|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6088357|NCT00834834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6088358|NCT00834834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6088359|NCT00834834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088360|NCT00834834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6088361|NCT00834834|Serotonin Agents|serotonin agents|mesh-ancestor
6088362|NCT00834834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088363|NCT00834834|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6088364|NCT00834834|Antidepressive Agents|antidepressive agents|mesh-ancestor
5517903|NCT04342598|Micronutrients|micronutrients|mesh-ancestor
5517904|NCT04342598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517905|NCT04342598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5517906|NCT04342585|Progesterone|progesterone|mesh-list
5517907|NCT04342585|Progestins|progestins|mesh-ancestor
5517908|NCT04342585|Hormones|hormones|mesh-ancestor
5517909|NCT04342585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6088365|NCT00834834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6088366|NCT00834834|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6088367|NCT00834834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6088368|NCT00834834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6088369|NCT00834886|Melatonin|melatonin|mesh-list
6088370|NCT00834886|Antioxidants|antioxidants|mesh-ancestor
6088371|NCT00834886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088372|NCT00834886|Protective Agents|protective agents|mesh-ancestor
6088373|NCT00834886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088374|NCT00834886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6088375|NCT00834899|Eptifibatide|eptifibatide|mesh-list
6088376|NCT00834899|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6088377|NCT00834912|Tramadol|tramadol|mesh-list
6088378|NCT00834912|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6088379|NCT00834912|Narcotics|narcotics|mesh-ancestor
6088380|NCT00834912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6088381|NCT00834912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088382|NCT00834912|Analgesics|analgesics|mesh-ancestor
6088383|NCT00834912|Sensory System Agents|sensory system agents|mesh-ancestor
6088384|NCT00834912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6088385|NCT00835120|Pioglitazone|pioglitazone|mesh-list
6088386|NCT00835120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6088387|NCT00835120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088388|NCT00835159|Rivastigmine|rivastigmine|mesh-list
6088389|NCT00835159|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6088390|NCT00835159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6088391|NCT00835159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088392|NCT00835159|Cholinergic Agents|cholinergic agents|mesh-ancestor
6088393|NCT00835159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6088394|NCT00835159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088395|NCT00835159|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6088396|NCT00835159|Protective Agents|protective agents|mesh-ancestor
6088397|NCT00835185|Leucovorin|leucovorin|mesh-list
5517910|NCT04342585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517911|NCT04342858|Listerine|listerine|mesh-list
6088398|NCT00835185|Folic Acid|folic acid|mesh-list
6088399|NCT00835185|Oxaliplatin|oxaliplatin|mesh-list
5517912|NCT04342858|Fluorides|fluorides|mesh-list
5517913|NCT04342858|Sodium Fluoride|sodium fluoride|mesh-list
5517914|NCT04342858|Fluorides, Topical|fluorides, topical|mesh-list
5517915|NCT04342858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517916|NCT04342858|Cariostatic Agents|cariostatic agents|mesh-ancestor
5517917|NCT04342858|Protective Agents|protective agents|mesh-ancestor
5517918|NCT04342858|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5517919|NCT04342858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5517920|NCT04342728|Vitamins|vitamins|mesh-list
5517921|NCT04342728|Ascorbic Acid|ascorbic acid|mesh-list
5517922|NCT04342728|Zinc|zinc|mesh-list
5517923|NCT04342728|Micronutrients|micronutrients|mesh-ancestor
5517924|NCT04342728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517925|NCT04342728|Trace Elements|trace elements|mesh-ancestor
5517926|NCT04342728|Antioxidants|antioxidants|mesh-ancestor
5517927|NCT04342728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517928|NCT04342728|Protective Agents|protective agents|mesh-ancestor
6088400|NCT00835185|Necitumumab|necitumumab|mesh-list
6088401|NCT00835185|Levoleucovorin|levoleucovorin|mesh-list
6088402|NCT00835185|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6088403|NCT00835185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6088404|NCT00835185|Antidotes|antidotes|mesh-ancestor
6088405|NCT00835185|Protective Agents|protective agents|mesh-ancestor
6088406|NCT00835185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088407|NCT00835185|Vitamin B Complex|vitamin b complex|mesh-ancestor
6088408|NCT00835185|Vitamins|vitamins|mesh-ancestor
6088409|NCT00835185|Micronutrients|micronutrients|mesh-ancestor
6088410|NCT00835185|Hematinics|hematinics|mesh-ancestor
6088411|NCT00835185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6088412|NCT00835185|Immunologic Factors|immunologic factors|mesh-ancestor
6088413|NCT00835198|Dapsone|dapsone|mesh-list
6088414|NCT00835198|Tretinoin|tretinoin|mesh-list
6088415|NCT00835198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6088416|NCT00835198|Keratolytic Agents|keratolytic agents|mesh-ancestor
6088417|NCT00835198|Dermatologic Agents|dermatologic agents|mesh-ancestor
6088418|NCT00835198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6088419|NCT00835198|Antimalarials|antimalarials|mesh-ancestor
5517929|NCT04342650|Chloroquine|chloroquine|mesh-list
5517930|NCT04342650|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
5517931|NCT04342650|Amebicides|amebicides|mesh-ancestor
5517932|NCT04342650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5517933|NCT04342650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6088420|NCT00835198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6088421|NCT00835198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6088422|NCT00835198|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6088423|NCT00835198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6088424|NCT00835198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517934|NCT04342650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5517935|NCT04342650|Antimalarials|antimalarials|mesh-ancestor
5517936|NCT04342650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5600771|NCT03709888|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6088425|NCT00835198|Leprostatic Agents|leprostatic agents|mesh-ancestor
6088426|NCT00835198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6088427|NCT00835224|Midodrine|midodrine|mesh-list
6088428|NCT00835224|Sympathomimetics|sympathomimetics|mesh-ancestor
6088429|NCT00835224|Autonomic Agents|autonomic agents|mesh-ancestor
6088430|NCT00835224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6088431|NCT00835224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517937|NCT04342650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5517938|NCT04342650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5517939|NCT04342650|Analgesics|analgesics|mesh-ancestor
5517940|NCT04342650|Sensory System Agents|sensory system agents|mesh-ancestor
5517941|NCT04342650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5517942|NCT04342650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517943|NCT04342650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5517944|NCT04342650|Filaricides|filaricides|mesh-ancestor
5517945|NCT04342650|Antinematodal Agents|antinematodal agents|mesh-ancestor
5517946|NCT04342650|Anthelmintics|anthelmintics|mesh-ancestor
5517947|NCT04342819|Empagliflozin|empagliflozin|mesh-list
5517948|NCT04342819|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
5517949|NCT04342819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517950|NCT04342819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5517951|NCT04342819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517952|NCT04342065|Celecoxib|celecoxib|mesh-list
5517953|NCT04342065|Pregabalin|pregabalin|mesh-list
5517954|NCT04342065|Analgesics|analgesics|mesh-ancestor
5517955|NCT04342065|Sensory System Agents|sensory system agents|mesh-ancestor
5517956|NCT04342065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5517957|NCT04342065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5517958|NCT04342065|Anticonvulsants|anticonvulsants|mesh-ancestor
5517959|NCT04342065|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5517960|NCT04342065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6088432|NCT00835224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6088433|NCT00835224|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6088434|NCT00835224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6088435|NCT00835224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6088436|NCT00835224|Adrenergic Agents|adrenergic agents|mesh-ancestor
6088437|NCT00835224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6088438|NCT00835224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088439|NCT00835510|Butenafine|butenafine|mesh-list
6088440|NCT00835510|Clotrimazole|clotrimazole|mesh-list
6088441|NCT00835510|Antifungal Agents|antifungal agents|mesh-ancestor
6088442|NCT00835510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6088443|NCT00835510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6088444|NCT00835510|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6088445|NCT00835510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6088446|NCT00835510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6088447|NCT00835510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088448|NCT00835510|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6088449|NCT00835510|Hormone Antagonists|hormone antagonists|mesh-ancestor
6088450|NCT00835510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6088451|NCT00835510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088452|NCT00835731|Vitamin B 12|vitamin b 12|mesh-list
6088453|NCT00835731|Hydroxocobalamin|hydroxocobalamin|mesh-list
6088454|NCT00835731|Misoprostol|misoprostol|mesh-list
6088455|NCT00835731|Vitamins|vitamins|mesh-ancestor
6088456|NCT00835731|Micronutrients|micronutrients|mesh-ancestor
6088457|NCT00835731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088458|NCT00835731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6088459|NCT00835731|Abortifacient Agents|abortifacient agents|mesh-ancestor
6088460|NCT00835731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6088461|NCT00835731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6088462|NCT00835731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6088463|NCT00835731|Oxytocics|oxytocics|mesh-ancestor
5517961|NCT04342065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517962|NCT04342065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5517963|NCT04342065|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5517964|NCT04342065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5517965|NCT04342065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5517966|NCT04342065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5517967|NCT04342065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5517968|NCT04342065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5517969|NCT04342065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5517970|NCT04342065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5517971|NCT04342065|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5517972|NCT04342065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5517973|NCT04342065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5517974|NCT04342156|Hydroxychloroquine|hydroxychloroquine|mesh-list
6088464|NCT00835731|Vitamin B Complex|vitamin b complex|mesh-ancestor
5517975|NCT04342156|Antimalarials|antimalarials|mesh-ancestor
5517976|NCT04342156|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5517977|NCT04342156|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5517978|NCT04342156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5517979|NCT04342156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5517980|NCT04342156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517981|NCT04342156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5517982|NCT04342221|Hydroxychloroquine|hydroxychloroquine|mesh-list
5517983|NCT04342221|Antimalarials|antimalarials|mesh-ancestor
5517984|NCT04342221|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6088465|NCT00835731|Hematinics|hematinics|mesh-ancestor
6088466|NCT00835770|Dimethyl Fumarate|dimethyl fumarate|mesh-list
6088467|NCT00835770|Dermatologic Agents|dermatologic agents|mesh-ancestor
6088468|NCT00835770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6088469|NCT00835770|Immunologic Factors|immunologic factors|mesh-ancestor
6088470|NCT00835770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088471|NCT00835861|Insulin|insulin|mesh-list
6088472|NCT00835861|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6088473|NCT00835861|Metformin|metformin|mesh-list
6088474|NCT00835861|Insulin, Isophane|insulin, isophane|mesh-list
6088475|NCT00835861|Isophane Insulin, Human|isophane insulin, human|mesh-list
6088476|NCT00835861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6088477|NCT00835861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088478|NCT00835900|Varenicline|varenicline|mesh-list
6088479|NCT00835900|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6088480|NCT00835900|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6088481|NCT00835900|Cholinergic Agents|cholinergic agents|mesh-ancestor
6088482|NCT00835900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6088483|NCT00835900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088484|NCT00835900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088485|NCT00835926|Vaccines|vaccines|mesh-list
6088486|NCT00835926|Immunologic Factors|immunologic factors|mesh-ancestor
5517985|NCT04342221|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6665666|NCT01518231|Aspirin|aspirin|mesh-list
6665667|NCT01518231|Edaravone|edaravone|mesh-list
6665668|NCT01518231|Warfarin|warfarin|mesh-list
6665669|NCT01518231|Atorvastatin|atorvastatin|mesh-list
6665670|NCT01518231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6665671|NCT01518231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6665672|NCT01518231|Analgesics|analgesics|mesh-ancestor
6665673|NCT01518231|Sensory System Agents|sensory system agents|mesh-ancestor
6665674|NCT01518231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6665675|NCT01518231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665676|NCT01518231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6665677|NCT01518231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6665678|NCT01518231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5517986|NCT04342221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5517987|NCT04342221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5517988|NCT04342221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5517989|NCT04342221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5517990|NCT04342247|Methyltestosterone|methyltestosterone|mesh-list
5517991|NCT04342247|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5517992|NCT04342247|Testosterone|testosterone|mesh-list
5517993|NCT04342247|Testosterone undecanoate|testosterone undecanoate|mesh-list
5517994|NCT04342247|Testosterone enanthate|testosterone enanthate|mesh-list
5517995|NCT04342247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5517996|NCT04342247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5517997|NCT04342247|Anabolic Agents|anabolic agents|mesh-ancestor
5517998|NCT04342247|Hormones|hormones|mesh-ancestor
5517999|NCT04342247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6088487|NCT00835926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088488|NCT00835978|Axitinib|axitinib|mesh-list
6088489|NCT00835978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6088490|NCT00835978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6088491|NCT00835978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6088492|NCT00835978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088493|NCT00836277|Irinotecan|irinotecan|mesh-list
6088494|NCT00836277|Panitumumab|panitumumab|mesh-list
6088495|NCT00836277|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6088496|NCT00836277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6088497|NCT00836277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6088498|NCT00836277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088499|NCT00836277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5518000|NCT04342247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088500|NCT00836277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6088501|NCT00836407|Ipilimumab|ipilimumab|mesh-list
6088502|NCT00836407|Vaccines|vaccines|mesh-list
6088503|NCT00836407|Immunologic Factors|immunologic factors|mesh-ancestor
6088504|NCT00836407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088505|NCT00836407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6088506|NCT00836407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6088507|NCT00836407|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6088508|NCT00836407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088509|NCT00836641|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5518001|NCT04342247|Androgens|androgens|mesh-ancestor
5518002|NCT04342351|Valsartan|valsartan|mesh-list
5518003|NCT04342351|Perindopril|perindopril|mesh-list
5518004|NCT04342351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5518005|NCT04342351|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5518006|NCT04342351|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5518007|NCT04342351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088510|NCT00836641|Immunologic Factors|immunologic factors|mesh-ancestor
6088511|NCT00836641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088512|NCT00836693|Tadalafil|tadalafil|mesh-list
6088513|NCT00836693|Vasodilator Agents|vasodilator agents|mesh-ancestor
6088514|NCT00836693|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6088515|NCT00836693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6088516|NCT00836693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6088517|NCT00836693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088518|NCT00836693|Urological Agents|urological agents|mesh-ancestor
6088519|NCT00836810|Prednisone|prednisone|mesh-list
6088520|NCT00836810|Prednisolone|prednisolone|mesh-list
5518008|NCT04342351|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5518009|NCT04342351|Protease Inhibitors|protease inhibitors|mesh-ancestor
5518010|NCT04342351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5518011|NCT04342169|Hydroxychloroquine|hydroxychloroquine|mesh-list
5518012|NCT04342169|Antimalarials|antimalarials|mesh-ancestor
5518013|NCT04342169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5518014|NCT04342169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5518015|NCT04342169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5518016|NCT04342169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5518017|NCT04342169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518018|NCT04342169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6088521|NCT00836810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6088522|NCT00836810|Glucocorticoids|glucocorticoids|mesh-ancestor
6088523|NCT00836810|Hormones|hormones|mesh-ancestor
6088524|NCT00836810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6088525|NCT00836810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088526|NCT00836810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6088527|NCT00836810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6088528|NCT00836875|Voriconazole|voriconazole|mesh-list
6088529|NCT00836875|Antifungal Agents|antifungal agents|mesh-ancestor
6088530|NCT00836875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6088531|NCT00836875|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5518019|NCT04342273|Moxifloxacin|moxifloxacin|mesh-list
5518020|NCT04342273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5518021|NCT04342273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5518022|NCT04342273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5518023|NCT04342273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5518024|NCT04342273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5518025|NCT04342273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518026|NCT04342273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5518027|NCT04342026|Endocrine Disruptors|endocrine disruptors|mesh-list
6088532|NCT00836875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6088533|NCT00836875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6088534|NCT00836875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088535|NCT00836875|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6088536|NCT00836875|Hormone Antagonists|hormone antagonists|mesh-ancestor
6088537|NCT00836875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6088538|NCT00836875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088539|NCT00836875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6088540|NCT00836888|Nivolumab|nivolumab|mesh-list
6088541|NCT00836888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6088542|NCT00836888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6203212|NCT02054481|Immunologic Factors|immunologic factors|mesh-ancestor
6464236|NCT00468715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6464237|NCT00468754|Insulin|insulin|mesh-list
6464238|NCT00468754|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6464239|NCT00468754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5518028|NCT04342026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5518029|NCT04341870|Azithromycin|azithromycin|mesh-list
5518030|NCT04341870|Hydroxychloroquine|hydroxychloroquine|mesh-list
5518031|NCT04341870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5518032|NCT04341870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5518033|NCT04341870|Antimalarials|antimalarials|mesh-ancestor
5518034|NCT04341870|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5518035|NCT04341870|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5518036|NCT04341870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5518037|NCT04341870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518038|NCT04341870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6464240|NCT00468871|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
6464241|NCT00468871|Immunosuppressive Agents|immunosuppressive agents|mesh-list
6464242|NCT00468871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6464243|NCT00468871|Glucocorticoids|glucocorticoids|mesh-ancestor
6464244|NCT00468871|Hormones|hormones|mesh-ancestor
6464245|NCT00468871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6464246|NCT00468871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464247|NCT00468871|Immunologic Factors|immunologic factors|mesh-ancestor
6464248|NCT00468923|Candesartan|candesartan|mesh-list
6464249|NCT00468923|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6088543|NCT00836888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6088544|NCT00836888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088545|NCT00836927|Sirolimus|sirolimus|mesh-list
6088546|NCT00836927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6088547|NCT00836927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6088548|NCT00836927|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6088549|NCT00836927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6088550|NCT00836927|Antifungal Agents|antifungal agents|mesh-ancestor
6088551|NCT00836927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6088552|NCT00836927|Immunologic Factors|immunologic factors|mesh-ancestor
6088553|NCT00836927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088554|NCT00837031|Gemcitabine|gemcitabine|mesh-list
6088555|NCT00837031|Lenalidomide|lenalidomide|mesh-list
6088556|NCT00837031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6088557|NCT00837031|Antimetabolites|antimetabolites|mesh-ancestor
6088558|NCT00837031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088559|NCT00837031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6088560|NCT00837031|Antiviral Agents|antiviral agents|mesh-ancestor
6088561|NCT00837031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6088562|NCT00837031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6088563|NCT00837031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6088564|NCT00837031|Immunologic Factors|immunologic factors|mesh-ancestor
6088565|NCT00837031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464250|NCT00468923|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5725116|NCT03182426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5725117|NCT03182426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5725118|NCT03182426|Analgesics|analgesics|mesh-ancestor
5725119|NCT03182426|Sensory System Agents|sensory system agents|mesh-ancestor
5725120|NCT03182426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5725121|NCT03182426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5725122|NCT03182426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5725123|NCT03182426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5725124|NCT03182426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5725125|NCT03182426|Immunologic Factors|immunologic factors|mesh-ancestor
5725126|NCT03182426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5725127|NCT03182426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5725128|NCT03182426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5725129|NCT03182426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5725130|NCT03182426|Antiviral Agents|antiviral agents|mesh-ancestor
5725131|NCT03182426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5725132|NCT03182504|Meropenem|meropenem|mesh-list
5725133|NCT03182504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5725134|NCT03182504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5725135|NCT03182491|Anaphylatoxins|anaphylatoxins|mesh-list
5725136|NCT03182491|Immunologic Factors|immunologic factors|mesh-ancestor
5725137|NCT03182491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725138|NCT03182218|Heparin|heparin|mesh-list
5725139|NCT03182218|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5725140|NCT03182218|Tinzaparin|tinzaparin|mesh-list
5725141|NCT03182218|Dalteparin|dalteparin|mesh-list
5725142|NCT03182218|Anticoagulants|anticoagulants|mesh-list
5725143|NCT03182218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5725144|NCT03182218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5725145|NCT03182218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088566|NCT00837031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6088567|NCT00837031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6088568|NCT00837031|Growth Substances|growth substances|mesh-ancestor
6088569|NCT00837031|Growth Inhibitors|growth inhibitors|mesh-ancestor
6088570|NCT00837148|Sorafenib|sorafenib|mesh-list
6088571|NCT00837148|Dacarbazine|dacarbazine|mesh-list
5518039|NCT04341935|Linagliptin|linagliptin|mesh-list
5518040|NCT04341935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5518041|NCT04341935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5518042|NCT04341935|Incretins|incretins|mesh-ancestor
5518043|NCT04341935|Hormones|hormones|mesh-ancestor
5518044|NCT04341935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5518045|NCT04341935|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5518046|NCT04341935|Protease Inhibitors|protease inhibitors|mesh-ancestor
5518047|NCT04341935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5518048|NCT04341935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088572|NCT00837148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6088573|NCT00837148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6088574|NCT00837148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6088575|NCT00837148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088576|NCT00837148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6088577|NCT00837148|Alkylating Agents|alkylating agents|mesh-ancestor
6088578|NCT00837200|Doxorubicin|doxorubicin|mesh-list
6088579|NCT00837200|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6088580|NCT00837200|Asparaginase|asparaginase|mesh-list
6088581|NCT00837200|Pegaspargase|pegaspargase|mesh-list
6088582|NCT00837200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6088583|NCT00837200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6088584|NCT00837200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6088585|NCT00837200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6088586|NCT00837200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6088587|NCT00837200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088588|NCT00837213|Doxycycline|doxycycline|mesh-list
6088589|NCT00837213|Clindamycin|clindamycin|mesh-list
6088590|NCT00837213|Clindamycin palmitate|clindamycin palmitate|mesh-list
6088591|NCT00837213|Clindamycin phosphate|clindamycin phosphate|mesh-list
6088592|NCT00837213|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6088593|NCT00837213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6088594|NCT00837213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6088595|NCT00837213|Antimalarials|antimalarials|mesh-ancestor
6088596|NCT00837213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6088597|NCT00837213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6088598|NCT00837213|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6088599|NCT00837213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6088600|NCT00837213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088601|NCT00837213|Dermatologic Agents|dermatologic agents|mesh-ancestor
6088602|NCT00837252|Finasteride|finasteride|mesh-list
6088603|NCT00837252|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6088604|NCT00837252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6088605|NCT00837252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6088606|NCT00837252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088607|NCT00837252|Hormone Antagonists|hormone antagonists|mesh-ancestor
5518049|NCT04341831|Teicoplanin|teicoplanin|mesh-list
5518050|NCT04341831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5518051|NCT04341831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5518052|NCT04341844|Methylene Blue|methylene blue|mesh-list
5518053|NCT04341844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5518054|NCT04341844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518055|NCT04341857|Antibodies|antibodies|mesh-list
5518056|NCT04341857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5518057|NCT04341857|Immunologic Factors|immunologic factors|mesh-ancestor
5518058|NCT04341857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5518059|NCT04341883|Paclitaxel|paclitaxel|mesh-list
5518060|NCT04341883|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5518061|NCT04341883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5518062|NCT04341883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5518063|NCT04341883|Tubulin Modulators|tubulin modulators|mesh-ancestor
5518064|NCT04341883|Antimitotic Agents|antimitotic agents|mesh-ancestor
5518065|NCT04341883|Mitosis Modulators|mitosis modulators|mesh-ancestor
5518066|NCT04341883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518067|NCT04341779|Tenofovir|tenofovir|mesh-list
5518068|NCT04341779|Antiviral Agents|antiviral agents|mesh-ancestor
6088608|NCT00837252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6088609|NCT00837252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725146|NCT03182296|Exenatide|exenatide|mesh-list
6088610|NCT00837252|Urological Agents|urological agents|mesh-ancestor
6088611|NCT00837330|Ranibizumab|ranibizumab|mesh-list
6088612|NCT00837330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6088613|NCT00837330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6088614|NCT00837330|Growth Substances|growth substances|mesh-ancestor
6088615|NCT00837330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088616|NCT00837330|Growth Inhibitors|growth inhibitors|mesh-ancestor
6088617|NCT00837330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6088618|NCT00837434|Adalimumab|adalimumab|mesh-list
6088619|NCT00837434|Etanercept|etanercept|mesh-list
6088620|NCT00837434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6088621|NCT00837434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5518069|NCT04341779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5518070|NCT04341779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5518071|NCT04341779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5518072|NCT04341779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5518073|NCT04341779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518074|NCT04341779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5518075|NCT04341779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6088622|NCT00837434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6088623|NCT00837434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6088624|NCT00837434|Analgesics|analgesics|mesh-ancestor
6088625|NCT00837434|Sensory System Agents|sensory system agents|mesh-ancestor
6088626|NCT00837434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6088627|NCT00837434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088628|NCT00837434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6088629|NCT00837434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6088630|NCT00837434|Immunologic Factors|immunologic factors|mesh-ancestor
6088631|NCT00837512|Insulin|insulin|mesh-list
6088632|NCT00837512|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5518076|NCT04341402|Antifungal Agents|antifungal agents|mesh-list
5518077|NCT04341402|Clotrimazole|clotrimazole|mesh-list
5518078|NCT04341402|Miconazole|miconazole|mesh-list
5518079|NCT04341402|Diclofenac|diclofenac|mesh-list
5518080|NCT04341402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5518081|NCT04341402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5518082|NCT04341402|Analgesics|analgesics|mesh-ancestor
5518083|NCT04341402|Sensory System Agents|sensory system agents|mesh-ancestor
5518084|NCT04341402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5518085|NCT04341402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5518086|NCT04341402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5518087|NCT04341402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5518088|NCT04341402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5518089|NCT04341402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5518090|NCT04341402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518091|NCT04341402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5518092|NCT04341402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5518093|NCT04341402|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6088633|NCT00837512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6088634|NCT00837512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088635|NCT00837577|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5518094|NCT04341402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5518095|NCT04341402|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6088636|NCT00837577|Voglibose|voglibose|mesh-list
6088637|NCT00837577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6088638|NCT00837577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088639|NCT00837577|Incretins|incretins|mesh-ancestor
6088640|NCT00837577|Hormones|hormones|mesh-ancestor
6088641|NCT00837577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6088642|NCT00837577|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6088643|NCT00837577|Protease Inhibitors|protease inhibitors|mesh-ancestor
6088644|NCT00837577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6088645|NCT00837577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665679|NCT01518231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6665680|NCT01518231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665681|NCT01518231|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6665682|NCT01518231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6665683|NCT01518231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6088646|NCT00837577|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6088647|NCT00837590|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
6088648|NCT00837590|Sodium Salicylate|sodium salicylate|mesh-list
6088649|NCT00837590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6088650|NCT00837590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6088651|NCT00837590|Analgesics|analgesics|mesh-ancestor
6088652|NCT00837590|Sensory System Agents|sensory system agents|mesh-ancestor
5518096|NCT04341402|Hormone Antagonists|hormone antagonists|mesh-ancestor
5518097|NCT04341402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5518098|NCT04341402|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6088653|NCT00837590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6088654|NCT00837590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088655|NCT00837590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6088656|NCT00837590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6088657|NCT00837590|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6088658|NCT00837590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6088659|NCT00837590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088660|NCT00837616|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6088661|NCT00837616|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6088662|NCT00837616|Estradiol|estradiol|mesh-list
6088663|NCT00837616|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6088664|NCT00837616|Estrogens|estrogens|mesh-ancestor
6088665|NCT00837616|Hormones|hormones|mesh-ancestor
6088666|NCT00837616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6088667|NCT00837616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088668|NCT00837616|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6088669|NCT00837616|Contraceptive Agents|contraceptive agents|mesh-ancestor
6088670|NCT00837616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6088671|NCT00837616|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6088672|NCT00837759|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6088673|NCT00837759|Lansoprazole|lansoprazole|mesh-list
6088674|NCT00837759|Dexlansoprazole|dexlansoprazole|mesh-list
6088675|NCT00837759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6088676|NCT00837759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088677|NCT00837759|Incretins|incretins|mesh-ancestor
6088678|NCT00837759|Hormones|hormones|mesh-ancestor
6088679|NCT00837759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6088680|NCT00837759|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6088681|NCT00837759|Protease Inhibitors|protease inhibitors|mesh-ancestor
6088682|NCT00837759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5518099|NCT04341402|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5518100|NCT04341584|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5518101|NCT04341584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5518102|NCT04341428|Lansoprazole|lansoprazole|mesh-list
5518103|NCT04341428|Dexlansoprazole|dexlansoprazole|mesh-list
5518104|NCT04341428|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6088683|NCT00837759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088684|NCT00837759|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6088685|NCT00837759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6088686|NCT00837759|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6088687|NCT00837876|Sorafenib|sorafenib|mesh-list
6088688|NCT00837876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6464251|NCT00468923|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6464252|NCT00468923|Antimetabolites|antimetabolites|mesh-ancestor
6464253|NCT00468923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6464254|NCT00468923|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6464255|NCT00468923|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6464256|NCT00468923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6464257|NCT00468923|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6464258|NCT00468923|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6464259|NCT00468923|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6464260|NCT00468936|Mycophenolic Acid|mycophenolic acid|mesh-list
6464261|NCT00468936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6464262|NCT00468936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6464263|NCT00468936|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6464264|NCT00468936|Antitubercular Agents|antitubercular agents|mesh-ancestor
6464265|NCT00468936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6464266|NCT00468936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6464267|NCT00468936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6464268|NCT00468936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6464269|NCT00468988|Travoprost|travoprost|mesh-list
6464270|NCT00468988|Latanoprost|latanoprost|mesh-list
6464271|NCT00468988|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6464272|NCT00468988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6464273|NCT00468988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6464274|NCT00469053|Buprenorphine|buprenorphine|mesh-list
6464275|NCT00469053|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6464276|NCT00469053|Narcotics|narcotics|mesh-ancestor
6464277|NCT00469053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6464278|NCT00469053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464279|NCT00469053|Analgesics|analgesics|mesh-ancestor
5518105|NCT04341428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5518106|NCT04341428|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5518107|NCT04341428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5518108|NCT04341428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518109|NCT04341571|Metformin|metformin|mesh-list
5518110|NCT04341571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5518111|NCT04341571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5518112|NCT04341493|Hydroxychloroquine|hydroxychloroquine|mesh-list
5518113|NCT04341493|Nitazoxanide|nitazoxanide|mesh-list
5518114|NCT04341493|Antimalarials|antimalarials|mesh-ancestor
5518115|NCT04341493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5725147|NCT03182296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5725148|NCT03182296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725149|NCT03182296|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5725150|NCT03182296|Incretins|incretins|mesh-ancestor
5725151|NCT03182296|Hormones|hormones|mesh-ancestor
5725152|NCT03182296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5725153|NCT03182257|ONO-7579|ono-7579|mesh-list
5725154|NCT03182257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5725155|NCT03182257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5725156|NCT03182257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725157|NCT03182374|Hylan|hylan|mesh-list
5725158|NCT03182374|Viscosupplements|viscosupplements|mesh-ancestor
5725159|NCT03182374|Protective Agents|protective agents|mesh-ancestor
5725160|NCT03182374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725161|NCT03182322|Insulin|insulin|mesh-list
5725162|NCT03182322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5725163|NCT03182322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725164|NCT03182231|Exenatide|exenatide|mesh-list
5725165|NCT03182231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5725166|NCT03182231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725167|NCT03182231|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5725168|NCT03182231|Incretins|incretins|mesh-ancestor
5725169|NCT03182231|Hormones|hormones|mesh-ancestor
5725170|NCT03182231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5518116|NCT04341493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5518117|NCT04341493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5518118|NCT04341493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5518119|NCT04341493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518120|NCT04341493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5518121|NCT04341675|Sirolimus|sirolimus|mesh-list
6088689|NCT00837876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6088690|NCT00837876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6088691|NCT00837876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088692|NCT00837902|Atenolol|atenolol|mesh-list
6088693|NCT00837902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6088694|NCT00837902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6088695|NCT00837902|Sympatholytics|sympatholytics|mesh-ancestor
6088696|NCT00837902|Autonomic Agents|autonomic agents|mesh-ancestor
6088697|NCT00837902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6088698|NCT00837902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088699|NCT00837902|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6088700|NCT00837902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6088701|NCT00837902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6088702|NCT00837902|Adrenergic Agents|adrenergic agents|mesh-ancestor
6088703|NCT00837902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6088704|NCT00837902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088705|NCT00837967|Terbutaline|terbutaline|mesh-list
6088706|NCT00837967|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6088707|NCT00837967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6088708|NCT00837967|Respiratory System Agents|respiratory system agents|mesh-ancestor
6088709|NCT00837967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6088710|NCT00837967|Autonomic Agents|autonomic agents|mesh-ancestor
6088711|NCT00837967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6088712|NCT00837967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5518122|NCT04341675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5518123|NCT04341675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5518124|NCT04341675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5518125|NCT04341675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5518126|NCT04341675|Antifungal Agents|antifungal agents|mesh-ancestor
5518127|NCT04341675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5518128|NCT04341675|Immunologic Factors|immunologic factors|mesh-ancestor
5518129|NCT04341675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5518130|NCT04341818|Vitamin D|vitamin d|mesh-list
6088713|NCT00837967|Sympathomimetics|sympathomimetics|mesh-ancestor
6088714|NCT00837967|Tocolytic Agents|tocolytic agents|mesh-ancestor
6088715|NCT00837967|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6088716|NCT00837967|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6088717|NCT00837967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6088718|NCT00837967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6088719|NCT00837967|Adrenergic Agents|adrenergic agents|mesh-ancestor
6088720|NCT00837967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6088721|NCT00837967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088722|NCT00838162|Ritonavir|ritonavir|mesh-list
6088723|NCT00838162|TMC-310911|tmc-310911|mesh-list
6088724|NCT00838162|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6088725|NCT00838162|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6088726|NCT00838162|Protease Inhibitors|protease inhibitors|mesh-ancestor
6088727|NCT00838162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6088728|NCT00838162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088729|NCT00838162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6088730|NCT00838162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6088731|NCT00838162|Antiviral Agents|antiviral agents|mesh-ancestor
6088732|NCT00838162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6088733|NCT00838162|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6088734|NCT00838162|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6088735|NCT00838201|Denosumab|denosumab|mesh-list
6088736|NCT00838201|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6088737|NCT00838201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088738|NCT00838435|Verapamil|verapamil|mesh-list
6088739|NCT00838435|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5518131|NCT04341818|Ergocalciferols|ergocalciferols|mesh-list
5518132|NCT04341818|Vitamins|vitamins|mesh-list
5518133|NCT04341818|Micronutrients|micronutrients|mesh-ancestor
5518134|NCT04341818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5518135|NCT04341818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5518136|NCT04341818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5518137|NCT04341727|Azithromycin|azithromycin|mesh-list
5518138|NCT04341727|Hydroxychloroquine|hydroxychloroquine|mesh-list
5518139|NCT04341727|Chloroquine|chloroquine|mesh-list
5518140|NCT04341727|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
5518141|NCT04341727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5518142|NCT04341727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6088740|NCT00838435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6088741|NCT00838435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6088742|NCT00838435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088743|NCT00838435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6088744|NCT00838435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088745|NCT00838435|Vasodilator Agents|vasodilator agents|mesh-ancestor
6088746|NCT00838513|Eculizumab|eculizumab|mesh-list
6088747|NCT00838513|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6088748|NCT00838513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6088749|NCT00838513|Immunologic Factors|immunologic factors|mesh-ancestor
5518143|NCT04341727|Antimalarials|antimalarials|mesh-ancestor
5518144|NCT04341727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5518145|NCT04341727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5518146|NCT04341727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5518147|NCT04341727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518148|NCT04341727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5518149|NCT04341727|Amebicides|amebicides|mesh-ancestor
5518150|NCT04341727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5518151|NCT04341727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6088750|NCT00838513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088751|NCT00838526|Rabeprazole|rabeprazole|mesh-list
6088752|NCT00838526|Ranitidine|ranitidine|mesh-list
6088753|NCT00838526|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
6088754|NCT00838526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6088755|NCT00838526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6088756|NCT00838526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6088757|NCT00838526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6088758|NCT00838526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088759|NCT00838526|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6088760|NCT00838526|Histamine Antagonists|histamine antagonists|mesh-ancestor
6088761|NCT00838526|Histamine Agents|histamine agents|mesh-ancestor
6088762|NCT00838526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6088763|NCT00838526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088764|NCT00838539|Sirolimus|sirolimus|mesh-list
6088765|NCT00838539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6088766|NCT00838539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6088767|NCT00838539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6088768|NCT00838539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6088769|NCT00838539|Antifungal Agents|antifungal agents|mesh-ancestor
6088770|NCT00838539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6088771|NCT00838539|Immunologic Factors|immunologic factors|mesh-ancestor
6088772|NCT00838539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088773|NCT00838578|Irinotecan|irinotecan|mesh-list
6088774|NCT00838578|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6088775|NCT00838578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6088776|NCT00838578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6088777|NCT00838578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088778|NCT00838578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6088779|NCT00838682|Omeprazole|omeprazole|mesh-list
6088780|NCT00838682|Rabeprazole|rabeprazole|mesh-list
6088781|NCT00838682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6088782|NCT00838682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6088783|NCT00838682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6088784|NCT00838682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6088785|NCT00838682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088786|NCT00838695|Phenylephrine|phenylephrine|mesh-list
6088787|NCT00838695|Oxymetazoline|oxymetazoline|mesh-list
6088788|NCT00838695|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5518152|NCT04341727|Analgesics|analgesics|mesh-ancestor
5518153|NCT04341727|Sensory System Agents|sensory system agents|mesh-ancestor
5518154|NCT04341727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5518155|NCT04341727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5518156|NCT04341727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5518157|NCT04341727|Filaricides|filaricides|mesh-ancestor
5518158|NCT04341727|Antinematodal Agents|antinematodal agents|mesh-ancestor
5518159|NCT04341727|Anthelmintics|anthelmintics|mesh-ancestor
5518160|NCT04341545|Letrozole|letrozole|mesh-list
5518161|NCT04341545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5518162|NCT04341545|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5518163|NCT04341545|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5518164|NCT04341545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6088789|NCT00838695|Mydriatics|mydriatics|mesh-ancestor
5518165|NCT04341545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088790|NCT00838695|Autonomic Agents|autonomic agents|mesh-ancestor
6088791|NCT00838695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6088792|NCT00838695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088793|NCT00838695|Sympathomimetics|sympathomimetics|mesh-ancestor
6088794|NCT00838695|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6088795|NCT00838695|Nasal Decongestants|nasal decongestants|mesh-ancestor
6088796|NCT00838695|Respiratory System Agents|respiratory system agents|mesh-ancestor
6088797|NCT00838695|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6088798|NCT00838695|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5518166|NCT04341545|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5518167|NCT04341545|Hormone Antagonists|hormone antagonists|mesh-ancestor
5518168|NCT04341545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5518169|NCT04341545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5518170|NCT04341350|Analgesics|analgesics|mesh-list
5518171|NCT04341350|Propofol|propofol|mesh-list
5518172|NCT04341350|Isoflurane|isoflurane|mesh-list
5518173|NCT04341350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5518174|NCT04341350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5518175|NCT04341350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5518176|NCT04341350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5518177|NCT04341350|Anesthetics, General|anesthetics, general|mesh-ancestor
5518178|NCT04341350|Anesthetics|anesthetics|mesh-ancestor
5518179|NCT04341350|Sensory System Agents|sensory system agents|mesh-ancestor
5518180|NCT04341350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5518181|NCT04341350|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5518182|NCT04341207|Azithromycin|azithromycin|mesh-list
5518183|NCT04341207|Hydroxychloroquine|hydroxychloroquine|mesh-list
5518184|NCT04341207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5518185|NCT04341207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5518186|NCT04341207|Antimalarials|antimalarials|mesh-ancestor
5518187|NCT04341207|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5518188|NCT04341207|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5518189|NCT04341207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5518190|NCT04341207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518191|NCT04341207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5518192|NCT04341311|Panobinostat|panobinostat|mesh-list
5518193|NCT04341311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5518194|NCT04341311|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6088799|NCT00838695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6088800|NCT00838695|Adrenergic Agents|adrenergic agents|mesh-ancestor
6088801|NCT00838695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6088802|NCT00838695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088803|NCT00838695|Protective Agents|protective agents|mesh-ancestor
6088804|NCT00838903|Metformin|metformin|mesh-list
5518195|NCT04341311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5518196|NCT04341311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518197|NCT04341181|Trastuzumab|trastuzumab|mesh-list
5518198|NCT04341181|Avelumab|avelumab|mesh-list
5518199|NCT04341181|Pertuzumab|pertuzumab|mesh-list
5518200|NCT04341181|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
5518201|NCT04341181|Atezolizumab|atezolizumab|mesh-list
5518202|NCT04341181|Axitinib|axitinib|mesh-list
5518203|NCT04341181|Niraparib|niraparib|mesh-list
5518204|NCT04341181|Vemurafenib|vemurafenib|mesh-list
5518205|NCT04341181|Maytansine|maytansine|mesh-list
5518206|NCT04341181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5518207|NCT04341181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5518208|NCT04341181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5518209|NCT04341181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5518210|NCT04341181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518211|NCT04341181|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5518212|NCT04341181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5518213|NCT04341181|Tubulin Modulators|tubulin modulators|mesh-ancestor
5518214|NCT04341181|Antimitotic Agents|antimitotic agents|mesh-ancestor
5518215|NCT04341181|Mitosis Modulators|mitosis modulators|mesh-ancestor
6088805|NCT00838903|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6088806|NCT00838903|Glimepiride|glimepiride|mesh-list
6088807|NCT00838903|rGLP-1 protein|rglp-1 protein|mesh-list
6088808|NCT00838903|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6088809|NCT00838903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5518216|NCT04341038|Methylprednisolone|methylprednisolone|mesh-list
5518217|NCT04341038|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5518218|NCT04341038|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5518219|NCT04341038|Prednisolone|prednisolone|mesh-list
5518220|NCT04341038|Prednisolone acetate|prednisolone acetate|mesh-list
5518221|NCT04341038|Tacrolimus|tacrolimus|mesh-list
5518222|NCT04341038|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5518223|NCT04341038|Prednisolone phosphate|prednisolone phosphate|mesh-list
5518224|NCT04341038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5518225|NCT04341038|Immunologic Factors|immunologic factors|mesh-ancestor
6088810|NCT00838903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088811|NCT00838903|Incretins|incretins|mesh-ancestor
6088812|NCT00838903|Hormones|hormones|mesh-ancestor
6088813|NCT00838903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6088814|NCT00838903|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6088815|NCT00838903|Protease Inhibitors|protease inhibitors|mesh-ancestor
6088816|NCT00838903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6088817|NCT00838903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088818|NCT00838903|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6088819|NCT00838903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6088820|NCT00838903|Immunologic Factors|immunologic factors|mesh-ancestor
6088821|NCT00838916|Insulin Glargine|insulin glargine|mesh-list
6088822|NCT00838916|rGLP-1 protein|rglp-1 protein|mesh-list
6088823|NCT00838916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6088824|NCT00838916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088825|NCT00838916|Incretins|incretins|mesh-ancestor
6088826|NCT00838916|Hormones|hormones|mesh-ancestor
6088827|NCT00838916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6088828|NCT00838929|Vorinostat|vorinostat|mesh-list
6088829|NCT00838929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6088830|NCT00838929|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6088831|NCT00838929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6088832|NCT00838929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088833|NCT00839072|Trazodone|trazodone|mesh-list
6088834|NCT00839072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6088835|NCT00839072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6088836|NCT00839072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6088837|NCT00839072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088838|NCT00839072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6088839|NCT00839072|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6088840|NCT00839072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6088841|NCT00839072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6088842|NCT00839072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088843|NCT00839072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6088844|NCT00839072|Serotonin Agents|serotonin agents|mesh-ancestor
6088845|NCT00839072|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6088846|NCT00839072|Antidepressive Agents|antidepressive agents|mesh-ancestor
6088847|NCT00839254|Vaccines|vaccines|mesh-list
6088848|NCT00839254|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6088849|NCT00839254|Immunologic Factors|immunologic factors|mesh-ancestor
6088850|NCT00839254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088851|NCT00839306|Rabeprazole|rabeprazole|mesh-list
6088852|NCT00839306|Ranitidine|ranitidine|mesh-list
6088853|NCT00839306|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
6088854|NCT00839306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6088855|NCT00839306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6088856|NCT00839306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6088857|NCT00839306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6088858|NCT00839306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088859|NCT00839306|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6088860|NCT00839306|Histamine Antagonists|histamine antagonists|mesh-ancestor
6088861|NCT00839306|Histamine Agents|histamine agents|mesh-ancestor
6088862|NCT00839306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6088863|NCT00839306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088864|NCT00839319|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6088865|NCT00839319|Testosterone|testosterone|mesh-list
6088866|NCT00839319|Acyline|acyline|mesh-list
6088867|NCT00839319|Androgens|androgens|mesh-ancestor
6088868|NCT00839319|Hormones|hormones|mesh-ancestor
6088869|NCT00839319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6088870|NCT00839319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088871|NCT00839319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6088872|NCT00839319|Hormone Antagonists|hormone antagonists|mesh-ancestor
6088873|NCT00839332|Gemcitabine|gemcitabine|mesh-list
6088874|NCT00839332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6088875|NCT00839332|Antimetabolites|antimetabolites|mesh-ancestor
6088876|NCT00839332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088877|NCT00839332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6088878|NCT00839332|Antiviral Agents|antiviral agents|mesh-ancestor
6088879|NCT00839332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6088880|NCT00839332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6088881|NCT00839332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6088882|NCT00839332|Immunologic Factors|immunologic factors|mesh-ancestor
6088883|NCT00839332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088884|NCT00839423|Vortioxetine|vortioxetine|mesh-list
6088885|NCT00839423|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6088886|NCT00839423|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6088887|NCT00839423|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6464280|NCT00469053|Sensory System Agents|sensory system agents|mesh-ancestor
6464281|NCT00469053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6088888|NCT00839423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6088889|NCT00839423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088890|NCT00839423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6088891|NCT00839423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088892|NCT00839423|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6088893|NCT00839423|Antidepressive Agents|antidepressive agents|mesh-ancestor
6088894|NCT00839423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6088895|NCT00839423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6088896|NCT00839423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6088897|NCT00839423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6088898|NCT00839423|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6088899|NCT00839423|Serotonin Agents|serotonin agents|mesh-ancestor
6088900|NCT00839423|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5518226|NCT04341038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5518227|NCT04341038|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5518228|NCT04341038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5518229|NCT04341038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518230|NCT04341038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5518231|NCT04341038|Antiemetics|antiemetics|mesh-ancestor
5518232|NCT04341038|Autonomic Agents|autonomic agents|mesh-ancestor
5518233|NCT04341038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6088901|NCT00839423|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6088902|NCT00839423|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6088903|NCT00839423|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6088904|NCT00839527|Metformin|metformin|mesh-list
6088905|NCT00839527|Pioglitazone|pioglitazone|mesh-list
6088906|NCT00839527|Glimepiride|glimepiride|mesh-list
6088907|NCT00839527|rGLP-1 protein|rglp-1 protein|mesh-list
6088908|NCT00839527|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6088909|NCT00839527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6088910|NCT00839527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088911|NCT00839527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6088912|NCT00839527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6088913|NCT00839527|Immunologic Factors|immunologic factors|mesh-ancestor
6088914|NCT00839527|Incretins|incretins|mesh-ancestor
6088915|NCT00839527|Hormones|hormones|mesh-ancestor
6088916|NCT00839527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6088917|NCT00839540|Caspofungin|caspofungin|mesh-list
6088918|NCT00839540|Micafungin|micafungin|mesh-list
6088919|NCT00839540|Antifungal Agents|antifungal agents|mesh-ancestor
6088920|NCT00839540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6088921|NCT00839540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6088922|NCT00839540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203213|NCT02054481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207755|NCT02120157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088923|NCT00839800|Terbutaline|terbutaline|mesh-list
6088924|NCT00839800|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6088925|NCT00839800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6088926|NCT00839800|Respiratory System Agents|respiratory system agents|mesh-ancestor
6088927|NCT00839800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6088928|NCT00839800|Autonomic Agents|autonomic agents|mesh-ancestor
6088929|NCT00839800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6088930|NCT00839800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088931|NCT00839800|Sympathomimetics|sympathomimetics|mesh-ancestor
6088932|NCT00839800|Tocolytic Agents|tocolytic agents|mesh-ancestor
6088933|NCT00839800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6088934|NCT00839800|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6088935|NCT00839800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6088936|NCT00839800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6088937|NCT00839800|Adrenergic Agents|adrenergic agents|mesh-ancestor
6088938|NCT00839800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6088939|NCT00839800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088940|NCT00839852|Cariprazine|cariprazine|mesh-list
6088941|NCT00839852|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6088942|NCT00839852|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6088943|NCT00839852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6088944|NCT00839852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088945|NCT00839852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6088946|NCT00839956|Bortezomib|bortezomib|mesh-list
6088947|NCT00839956|Vorinostat|vorinostat|mesh-list
6088948|NCT00839956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6088949|NCT00839956|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6088950|NCT00839956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6088951|NCT00839956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088952|NCT00839982|Cytarabine|cytarabine|mesh-list
6088953|NCT00839982|Clofarabine|clofarabine|mesh-list
6088954|NCT00839982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6088955|NCT00839982|Antimetabolites|antimetabolites|mesh-ancestor
6088956|NCT00839982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088957|NCT00839982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6088958|NCT00839982|Antiviral Agents|antiviral agents|mesh-ancestor
6088959|NCT00839982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6088960|NCT00839982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6088961|NCT00839982|Immunologic Factors|immunologic factors|mesh-ancestor
6088962|NCT00839982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5518234|NCT04341038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5518235|NCT04341038|Glucocorticoids|glucocorticoids|mesh-ancestor
5518236|NCT04341038|Hormones|hormones|mesh-ancestor
5518237|NCT04341038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5518238|NCT04341038|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5518239|NCT04341038|Protective Agents|protective agents|mesh-ancestor
5518240|NCT04341038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5518241|NCT04341038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5600772|NCT03709888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5600773|NCT03709888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5600774|NCT03709888|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5600775|NCT03709888|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6088963|NCT00840294|Ciprofloxacin|ciprofloxacin|mesh-list
6088964|NCT00840294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6088965|NCT00840294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6088966|NCT00840294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6088967|NCT00840294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6088968|NCT00840294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6088969|NCT00840294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088970|NCT00840294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6088971|NCT00840294|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6088972|NCT00840294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6088973|NCT00840450|Paclitaxel|paclitaxel|mesh-list
6088974|NCT00840450|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6088975|NCT00840450|Imatinib Mesylate|imatinib mesylate|mesh-list
6088976|NCT00840450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6088977|NCT00840450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5600776|NCT03709888|Dopamine Agents|dopamine agents|mesh-ancestor
5600777|NCT03709888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5600778|NCT03709888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5600779|NCT03709888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5600780|NCT03709849|Citric Acid|citric acid|mesh-list
5600781|NCT03709849|Sodium Citrate|sodium citrate|mesh-list
5600782|NCT03709849|Clomiphene|clomiphene|mesh-list
6088978|NCT00840450|Tubulin Modulators|tubulin modulators|mesh-ancestor
6088979|NCT00840450|Antimitotic Agents|antimitotic agents|mesh-ancestor
6088980|NCT00840450|Mitosis Modulators|mitosis modulators|mesh-ancestor
6088981|NCT00840450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088982|NCT00840450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6088983|NCT00840450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6088984|NCT00840463|Ambrisentan|ambrisentan|mesh-list
6088985|NCT00840463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6088986|NCT00840996|Lidocaine|lidocaine|mesh-list
6088987|NCT00840996|Anesthetics, Local|anesthetics, local|mesh-ancestor
6088988|NCT00840996|Anesthetics|anesthetics|mesh-ancestor
6088989|NCT00840996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6088990|NCT00840996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6088991|NCT00840996|Sensory System Agents|sensory system agents|mesh-ancestor
6088992|NCT00840996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5518242|NCT04341155|Dexamethasone|dexamethasone|mesh-list
5518243|NCT04341155|Dexamethasone acetate|dexamethasone acetate|mesh-list
5518244|NCT04341155|BB 1101|bb 1101|mesh-list
5518245|NCT04341155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5518246|NCT04341155|Antiemetics|antiemetics|mesh-ancestor
5518247|NCT04341155|Autonomic Agents|autonomic agents|mesh-ancestor
5518248|NCT04341155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5518249|NCT04341155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5518250|NCT04341155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5518251|NCT04341155|Glucocorticoids|glucocorticoids|mesh-ancestor
5518252|NCT04341155|Hormones|hormones|mesh-ancestor
5518253|NCT04341155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5518254|NCT04341155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5518255|NCT04341155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5518256|NCT04341155|Protease Inhibitors|protease inhibitors|mesh-ancestor
5518257|NCT04341155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5518258|NCT04341155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518259|NCT04340544|Hydroxychloroquine|hydroxychloroquine|mesh-list
6088993|NCT00840996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6088994|NCT00840996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6088995|NCT00840996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6088996|NCT00840996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6088997|NCT00840996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6088998|NCT00841087|Insulin|insulin|mesh-list
6088999|NCT00841087|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6089000|NCT00841087|Insulin Aspart|insulin aspart|mesh-list
6089001|NCT00841087|Insulin Detemir|insulin detemir|mesh-list
6089002|NCT00841087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6089003|NCT00841087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089004|NCT00841204|Sulindac|sulindac|mesh-list
6089005|NCT00841204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6089006|NCT00841204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6089007|NCT00841204|Analgesics|analgesics|mesh-ancestor
6089008|NCT00841204|Sensory System Agents|sensory system agents|mesh-ancestor
6089009|NCT00841204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6089010|NCT00841204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089011|NCT00841204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6089012|NCT00841204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6089013|NCT00841204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6089014|NCT00841204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6089015|NCT00841204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6089016|NCT00841204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089017|NCT00841555|Temozolomide|temozolomide|mesh-list
6089018|NCT00841555|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6089019|NCT00841555|Alkylating Agents|alkylating agents|mesh-ancestor
6089020|NCT00841555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665684|NCT01518231|Antipyretics|antipyretics|mesh-ancestor
5518260|NCT04340544|Antimalarials|antimalarials|mesh-ancestor
6089021|NCT00841555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6089022|NCT00841568|Tolvaptan|tolvaptan|mesh-list
6089023|NCT00841568|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6089024|NCT00841568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089025|NCT00841568|Natriuretic Agents|natriuretic agents|mesh-ancestor
6089026|NCT00841568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089027|NCT00841672|Amlodipine|amlodipine|mesh-list
6089028|NCT00841672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6089029|NCT00841672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6089030|NCT00841672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6089031|NCT00841672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089032|NCT00841672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6089033|NCT00841672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089034|NCT00841672|Vasodilator Agents|vasodilator agents|mesh-ancestor
6089035|NCT00841763|Vaccines|vaccines|mesh-list
6089036|NCT00841763|Immunologic Factors|immunologic factors|mesh-ancestor
6089037|NCT00841763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5518261|NCT04340544|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5518262|NCT04340544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5518263|NCT04340544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6089038|NCT00841828|Cyclophosphamide|cyclophosphamide|mesh-list
6089039|NCT00841828|Docetaxel|docetaxel|mesh-list
6089040|NCT00841828|Trastuzumab|trastuzumab|mesh-list
6464282|NCT00469053|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6464283|NCT00469131|Mycophenolic Acid|mycophenolic acid|mesh-list
6464284|NCT00469131|Tacrolimus|tacrolimus|mesh-list
6464285|NCT00469131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6464286|NCT00469131|Immunologic Factors|immunologic factors|mesh-ancestor
6464287|NCT00469131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5518264|NCT04340544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6089041|NCT00841828|Epirubicin|epirubicin|mesh-list
6089042|NCT00841828|Lapatinib|lapatinib|mesh-list
6089043|NCT00841828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6089044|NCT00841828|Immunologic Factors|immunologic factors|mesh-ancestor
5518265|NCT04340544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518266|NCT04340544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5518267|NCT04340882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5518268|NCT04340882|Pembrolizumab|pembrolizumab|mesh-list
5518269|NCT04340882|Docetaxel|docetaxel|mesh-list
6089045|NCT00841828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089046|NCT00841828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6089047|NCT00841828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6089048|NCT00841828|Alkylating Agents|alkylating agents|mesh-ancestor
6089049|NCT00841828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089050|NCT00841828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6089051|NCT00841828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6089052|NCT00841828|Tubulin Modulators|tubulin modulators|mesh-ancestor
6089053|NCT00841828|Antimitotic Agents|antimitotic agents|mesh-ancestor
6089054|NCT00841828|Mitosis Modulators|mitosis modulators|mesh-ancestor
6089055|NCT00841828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6089056|NCT00841828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6089057|NCT00841828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6089058|NCT00841828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6089059|NCT00841828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6089060|NCT00841828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6089061|NCT00841971|Fluconazole|fluconazole|mesh-list
6089062|NCT00841971|Anidulafungin|anidulafungin|mesh-list
6089063|NCT00841971|Antifungal Agents|antifungal agents|mesh-ancestor
6089064|NCT00841971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6089065|NCT00841971|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6089066|NCT00841971|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6089067|NCT00841971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6089068|NCT00841971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089069|NCT00841971|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6089070|NCT00841971|Hormone Antagonists|hormone antagonists|mesh-ancestor
6089071|NCT00841971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6089072|NCT00841971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089073|NCT00841971|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6089074|NCT00841971|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6089075|NCT00842023|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6089076|NCT00842023|Nitroglycerin|nitroglycerin|mesh-list
6089077|NCT00842023|Vasodilator Agents|vasodilator agents|mesh-ancestor
6464288|NCT00469131|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5518270|NCT04340882|Ramucirumab|ramucirumab|mesh-list
6089078|NCT00842023|Natriuretic Agents|natriuretic agents|mesh-ancestor
5518271|NCT04340882|Antibodies|antibodies|mesh-list
5518272|NCT04340882|Immunoglobulins|immunoglobulins|mesh-list
5518273|NCT04340882|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5518274|NCT04340882|Lexatumumab|lexatumumab|mesh-list
5518275|NCT04340882|Immunologic Factors|immunologic factors|mesh-ancestor
5518276|NCT04340882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5518277|NCT04340882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5518278|NCT04340882|Tubulin Modulators|tubulin modulators|mesh-ancestor
5518279|NCT04340882|Antimitotic Agents|antimitotic agents|mesh-ancestor
5518280|NCT04340882|Mitosis Modulators|mitosis modulators|mesh-ancestor
5518281|NCT04340882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518282|NCT04340869|Theobromine|theobromine|mesh-list
5518283|NCT04340869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5518284|NCT04340869|Autonomic Agents|autonomic agents|mesh-ancestor
5518285|NCT04340869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6089079|NCT00842023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089080|NCT00842075|Pramlintide|pramlintide|mesh-list
6089081|NCT00842075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6089082|NCT00842075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089083|NCT00842153|Clobetasol|clobetasol|mesh-list
6089084|NCT00842153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6089085|NCT00842153|Glucocorticoids|glucocorticoids|mesh-ancestor
6464289|NCT00469131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6464290|NCT00469131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6464291|NCT00469131|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6464292|NCT00469131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6464293|NCT00469131|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6089086|NCT00842153|Hormones|hormones|mesh-ancestor
6089087|NCT00842153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6089088|NCT00842153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089089|NCT00842244|Capecitabine|capecitabine|mesh-list
6089090|NCT00842244|Axitinib|axitinib|mesh-list
6089091|NCT00842244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6089092|NCT00842244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6089093|NCT00842244|Antimetabolites|antimetabolites|mesh-ancestor
6089094|NCT00842244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089095|NCT00842244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6089096|NCT00842244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6089097|NCT00842257|Panitumumab|panitumumab|mesh-list
6089098|NCT00842257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6089099|NCT00842257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5518286|NCT04340869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5518287|NCT04340869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5518288|NCT04340869|Respiratory System Agents|respiratory system agents|mesh-ancestor
5518289|NCT04340869|Vasodilator Agents|vasodilator agents|mesh-ancestor
5518290|NCT04340856|Bisacodyl|bisacodyl|mesh-list
5518291|NCT04340856|Laxatives|laxatives|mesh-list
5518292|NCT04340856|Cathartics|cathartics|mesh-ancestor
5518293|NCT04340856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5518294|NCT04340778|Lidocaine|lidocaine|mesh-list
5518295|NCT04340778|Prilocaine|prilocaine|mesh-list
5518296|NCT04340778|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
5518297|NCT04340778|Dinoprostone|dinoprostone|mesh-list
5518298|NCT04340778|Anesthetics, Local|anesthetics, local|mesh-ancestor
5518299|NCT04340778|Anesthetics|anesthetics|mesh-ancestor
5518300|NCT04340778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5518301|NCT04340778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5518302|NCT04340778|Sensory System Agents|sensory system agents|mesh-ancestor
5518303|NCT04340778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5518304|NCT04340778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5518305|NCT04340778|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5518306|NCT04340778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5518307|NCT04340778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5518308|NCT04340778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518309|NCT04340778|Oxytocics|oxytocics|mesh-ancestor
5518310|NCT04340778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5518311|NCT04340778|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
5518312|NCT04340505|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
5518313|NCT04340505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5518314|NCT04340505|Glucocorticoids|glucocorticoids|mesh-ancestor
5518315|NCT04340505|Hormones|hormones|mesh-ancestor
5518316|NCT04340505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5518317|NCT04340505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5518318|NCT04340908|Dapagliflozin|dapagliflozin|mesh-list
5518319|NCT04340908|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5518320|NCT04340908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518321|NCT04340908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5518322|NCT04340908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5518323|NCT04340258|Pembrolizumab|pembrolizumab|mesh-list
5518324|NCT04340258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5518325|NCT04340258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5518326|NCT04340401|Capecitabine|capecitabine|mesh-list
5518327|NCT04340401|Oxaliplatin|oxaliplatin|mesh-list
5518328|NCT04340401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5518329|NCT04340401|Antimetabolites|antimetabolites|mesh-ancestor
5518330|NCT04340401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518331|NCT04340401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5518332|NCT04340349|Hydroxychloroquine|hydroxychloroquine|mesh-list
5518333|NCT04340349|Bromhexine|bromhexine|mesh-list
5518334|NCT04340349|Antimalarials|antimalarials|mesh-ancestor
5518335|NCT04340349|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5518336|NCT04340349|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5518337|NCT04340349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5518338|NCT04340349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5518339|NCT04340349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518340|NCT04340349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5518341|NCT04340349|Expectorants|expectorants|mesh-ancestor
6089100|NCT00842309|Cycloserine|cycloserine|mesh-list
6089101|NCT00842309|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6089102|NCT00842309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6089103|NCT00842309|Renal Agents|renal agents|mesh-ancestor
6089104|NCT00842309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6089105|NCT00842309|Antitubercular Agents|antitubercular agents|mesh-ancestor
6089106|NCT00842309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6089107|NCT00842309|Antimetabolites|antimetabolites|mesh-ancestor
6089108|NCT00842309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089109|NCT00842348|Lanreotide|lanreotide|mesh-list
6089110|NCT00842348|Somatostatin|somatostatin|mesh-list
6089111|NCT00842348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6089112|NCT00842348|Hormones|hormones|mesh-ancestor
6089113|NCT00842348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6089114|NCT00842348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089115|NCT00842361|Insulin|insulin|mesh-list
6089116|NCT00842361|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6089117|NCT00842361|Insulin Aspart|insulin aspart|mesh-list
6089118|NCT00842361|Insulin, Long-Acting|insulin, long-acting|mesh-list
6089119|NCT00842361|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6089120|NCT00842361|Biphasic Insulins|biphasic insulins|mesh-list
6089121|NCT00842361|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6089122|NCT00842361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6089123|NCT00842361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089124|NCT00842530|Vaccines|vaccines|mesh-list
6089125|NCT00842530|Immunologic Factors|immunologic factors|mesh-ancestor
6089126|NCT00842530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089127|NCT00842608|Haloperidol|haloperidol|mesh-list
6089128|NCT00842608|Haloperidol decanoate|haloperidol decanoate|mesh-list
6089129|NCT00842608|Cholinergic Antagonists|cholinergic antagonists|mesh-list
6089130|NCT00842608|Antiemetics|antiemetics|mesh-ancestor
6089131|NCT00842608|Autonomic Agents|autonomic agents|mesh-ancestor
6089132|NCT00842608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6089133|NCT00842608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089134|NCT00842608|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6089135|NCT00842608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6089136|NCT00842608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6089137|NCT00842608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5518342|NCT04340349|Respiratory System Agents|respiratory system agents|mesh-ancestor
6089138|NCT00842608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5518343|NCT04340128|Meglumine Antimoniate|meglumine antimoniate|mesh-list
5518344|NCT04340128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5518345|NCT04340128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5518346|NCT04340128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5518347|NCT04340388|Tenofovir|tenofovir|mesh-list
6089139|NCT00842608|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6089140|NCT00842608|Dopamine Agents|dopamine agents|mesh-ancestor
6089141|NCT00842608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6089142|NCT00842608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089143|NCT00842608|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6089144|NCT00842608|Cholinergic Agents|cholinergic agents|mesh-ancestor
6089145|NCT00842712|Gemcitabine|gemcitabine|mesh-list
6089146|NCT00842712|Cisplatin|cisplatin|mesh-list
6089147|NCT00842712|Cetuximab|cetuximab|mesh-list
6089148|NCT00842712|Vinorelbine|vinorelbine|mesh-list
6089149|NCT00842712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6089150|NCT00842712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6089151|NCT00842712|Antimetabolites|antimetabolites|mesh-ancestor
6089152|NCT00842712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089153|NCT00842712|Antiviral Agents|antiviral agents|mesh-ancestor
6089154|NCT00842712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6089155|NCT00842712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6089156|NCT00842712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6089157|NCT00842712|Immunologic Factors|immunologic factors|mesh-ancestor
6089158|NCT00842712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089159|NCT00842712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6089160|NCT00842712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5518348|NCT04340388|Lamivudine|lamivudine|mesh-list
6089161|NCT00842712|Tubulin Modulators|tubulin modulators|mesh-ancestor
6089162|NCT00842712|Antimitotic Agents|antimitotic agents|mesh-ancestor
6089163|NCT00842712|Mitosis Modulators|mitosis modulators|mesh-ancestor
6089164|NCT00842751|Finasteride|finasteride|mesh-list
6089165|NCT00842751|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6089166|NCT00842751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6089167|NCT00842751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6089168|NCT00842751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089169|NCT00842751|Hormone Antagonists|hormone antagonists|mesh-ancestor
6089170|NCT00842751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6089171|NCT00842751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089172|NCT00842751|Urological Agents|urological agents|mesh-ancestor
6089173|NCT00842829|Fentanyl|fentanyl|mesh-list
6089174|NCT00842829|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6089175|NCT00842829|Narcotics|narcotics|mesh-ancestor
6089176|NCT00842829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6089177|NCT00842829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089178|NCT00842829|Analgesics|analgesics|mesh-ancestor
6089179|NCT00842829|Sensory System Agents|sensory system agents|mesh-ancestor
6089180|NCT00842829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6089181|NCT00842829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6089182|NCT00842829|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6089183|NCT00842829|Anesthetics, General|anesthetics, general|mesh-ancestor
6089184|NCT00842829|Anesthetics|anesthetics|mesh-ancestor
6089185|NCT00842985|Dronabinol|dronabinol|mesh-list
6089186|NCT00842985|Modafinil|modafinil|mesh-list
6089187|NCT00842985|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6089188|NCT00842985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089189|NCT00842985|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6089190|NCT00842985|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6089191|NCT00842985|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5518349|NCT04340388|Zidovudine|zidovudine|mesh-list
5518350|NCT04340388|Darunavir|darunavir|mesh-list
6089192|NCT00842985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089193|NCT00842985|Hallucinogens|hallucinogens|mesh-ancestor
6089194|NCT00842985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6089195|NCT00842985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5518351|NCT04340388|Abacavir|abacavir|mesh-list
5518352|NCT04340388|Dolutegravir|dolutegravir|mesh-list
5518353|NCT04340388|Cobicistat|cobicistat|mesh-list
5518354|NCT04340388|Rilpivirine|rilpivirine|mesh-list
5518355|NCT04340388|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
5518356|NCT04340388|Antiviral Agents|antiviral agents|mesh-ancestor
5518357|NCT04340388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5518358|NCT04340388|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5518359|NCT04340388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5518360|NCT04340388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5518361|NCT04340388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518362|NCT04340388|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5518363|NCT04340388|Antimetabolites|antimetabolites|mesh-ancestor
5518364|NCT04340388|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5518365|NCT04340388|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5518366|NCT04340388|Protease Inhibitors|protease inhibitors|mesh-ancestor
5518367|NCT04340388|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5518368|NCT04340388|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5518369|NCT04340388|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5518370|NCT04340388|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5518371|NCT04340141|Leucovorin|leucovorin|mesh-list
5518372|NCT04340141|Fluorouracil|fluorouracil|mesh-list
5518373|NCT04340141|Oxaliplatin|oxaliplatin|mesh-list
5518374|NCT04340141|Irinotecan|irinotecan|mesh-list
6089196|NCT00842985|Analgesics|analgesics|mesh-ancestor
6089197|NCT00842985|Sensory System Agents|sensory system agents|mesh-ancestor
6089198|NCT00842985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6089199|NCT00842985|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6089200|NCT00842985|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6089201|NCT00842985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6089202|NCT00842985|Hormones|hormones|mesh-ancestor
6089203|NCT00842985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6089204|NCT00843024|Naproxen|naproxen|mesh-list
6089205|NCT00843024|Sumatriptan|sumatriptan|mesh-list
6089206|NCT00843024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6089207|NCT00843024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6089208|NCT00843024|Analgesics|analgesics|mesh-ancestor
6089209|NCT00843024|Sensory System Agents|sensory system agents|mesh-ancestor
6089210|NCT00843024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6089211|NCT00843024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089212|NCT00843024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6089213|NCT00843024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6089214|NCT00843024|Gout Suppressants|gout suppressants|mesh-ancestor
6089215|NCT00843024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6089216|NCT00843024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5518375|NCT04340141|Calcium|calcium|mesh-list
5518376|NCT04340141|Levoleucovorin|levoleucovorin|mesh-list
5518377|NCT04340141|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5518378|NCT04340141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089217|NCT00843024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089218|NCT00843024|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6089219|NCT00843024|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6089220|NCT00843024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6089221|NCT00843024|Serotonin Agents|serotonin agents|mesh-ancestor
6089222|NCT00843024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6089223|NCT00843115|Donepezil|donepezil|mesh-list
6089224|NCT00843115|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6089225|NCT00843115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6089226|NCT00843115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089227|NCT00843115|Cholinergic Agents|cholinergic agents|mesh-ancestor
6089228|NCT00843115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6464294|NCT00469131|Antitubercular Agents|antitubercular agents|mesh-ancestor
5518379|NCT04340141|Antimetabolites|antimetabolites|mesh-ancestor
5600783|NCT03709849|Enclomiphene|enclomiphene|mesh-list
5518380|NCT04340141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518381|NCT04340141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5518382|NCT04340141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5518383|NCT04340141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6089229|NCT00843115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089230|NCT00843115|Nootropic Agents|nootropic agents|mesh-ancestor
6089231|NCT00843193|Fluticasone|fluticasone|mesh-list
6089232|NCT00843193|Xhance|xhance|mesh-list
6089233|NCT00843193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6089234|NCT00843193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5518384|NCT04340141|Immunologic Factors|immunologic factors|mesh-ancestor
5518385|NCT04340141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5518386|NCT04340141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5518387|NCT04340141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5518388|NCT04340141|Antidotes|antidotes|mesh-ancestor
6089235|NCT00843193|Autonomic Agents|autonomic agents|mesh-ancestor
6089236|NCT00843193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6089237|NCT00843193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089238|NCT00843193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6089239|NCT00843193|Respiratory System Agents|respiratory system agents|mesh-ancestor
6089240|NCT00843193|Dermatologic Agents|dermatologic agents|mesh-ancestor
6089241|NCT00843193|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6089242|NCT00843284|Pregabalin|pregabalin|mesh-list
6089243|NCT00843284|Analgesics|analgesics|mesh-ancestor
5518389|NCT04340141|Protective Agents|protective agents|mesh-ancestor
5518390|NCT04340141|Vitamin B Complex|vitamin b complex|mesh-ancestor
5518391|NCT04340141|Vitamins|vitamins|mesh-ancestor
5518392|NCT04340141|Micronutrients|micronutrients|mesh-ancestor
5518393|NCT04339816|Azithromycin|azithromycin|mesh-list
5518394|NCT04339816|Hydroxychloroquine|hydroxychloroquine|mesh-list
5518395|NCT04339816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5518396|NCT04339816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5518397|NCT04339816|Antimalarials|antimalarials|mesh-ancestor
5518398|NCT04339816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5518399|NCT04339816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5518400|NCT04339816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5518401|NCT04339816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089244|NCT00843284|Sensory System Agents|sensory system agents|mesh-ancestor
6089245|NCT00843284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6089246|NCT00843284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089247|NCT00843284|Anticonvulsants|anticonvulsants|mesh-ancestor
6089248|NCT00843284|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6089249|NCT00843284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6089250|NCT00843284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089251|NCT00843284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5518402|NCT04339816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5518403|NCT04339868|Terlipressin|terlipressin|mesh-list
5518404|NCT04339868|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5518405|NCT04339868|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5518406|NCT04339712|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5518407|NCT04339712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5518408|NCT04339426|Azithromycin|azithromycin|mesh-list
5518409|NCT04339426|Atovaquone|atovaquone|mesh-list
5518410|NCT04339426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5518411|NCT04339426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5518412|NCT04339426|Antimalarials|antimalarials|mesh-ancestor
5518413|NCT04339426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5518414|NCT04339426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5518415|NCT04339426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5518416|NCT04339426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518417|NCT04339361|Lidocaine|lidocaine|mesh-list
5518418|NCT04339361|Dinoprostone|dinoprostone|mesh-list
5518419|NCT04339361|Anesthetics, Local|anesthetics, local|mesh-ancestor
5518420|NCT04339361|Anesthetics|anesthetics|mesh-ancestor
6089252|NCT00843284|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6089253|NCT00843284|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6089254|NCT00843284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6089255|NCT00843284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6089256|NCT00843492|PENTA|penta|mesh-list
6089257|NCT00843492|Nadroparin|nadroparin|mesh-list
6089258|NCT00843492|Fondaparinux|fondaparinux|mesh-list
6089259|NCT00843492|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6089260|NCT00843492|Antithrombins|antithrombins|mesh-ancestor
6464295|NCT00469131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5518421|NCT04339361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5518422|NCT04339361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089261|NCT00843492|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6089262|NCT00843492|Protease Inhibitors|protease inhibitors|mesh-ancestor
6089263|NCT00843492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6089264|NCT00843492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089265|NCT00843492|Anticoagulants|anticoagulants|mesh-ancestor
6089266|NCT00843492|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6089267|NCT00843492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6089268|NCT00843531|Everolimus|everolimus|mesh-list
6089269|NCT00843531|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6089270|NCT00843531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6089271|NCT00843531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6089272|NCT00843531|Immunologic Factors|immunologic factors|mesh-ancestor
6089273|NCT00843531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089274|NCT00843531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6089275|NCT00843531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5518423|NCT04339361|Sensory System Agents|sensory system agents|mesh-ancestor
5518424|NCT04339361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5518425|NCT04339361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5518426|NCT04339361|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5518427|NCT04339361|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5518428|NCT04339361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5518429|NCT04339361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518430|NCT04339361|Oxytocics|oxytocics|mesh-ancestor
5518431|NCT04339361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5600784|NCT03709849|Zuclomiphene|zuclomiphene|mesh-list
5600785|NCT03709849|Anticoagulants|anticoagulants|mesh-ancestor
5600786|NCT03709849|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5600787|NCT03709849|Chelating Agents|chelating agents|mesh-ancestor
5600788|NCT03709849|Sequestering Agents|sequestering agents|mesh-ancestor
5600789|NCT03709849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089276|NCT00843531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089277|NCT00843635|Tadalafil|tadalafil|mesh-list
6089278|NCT00843635|Vasodilator Agents|vasodilator agents|mesh-ancestor
6089279|NCT00843635|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6089280|NCT00843635|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6089281|NCT00843635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6089282|NCT00843635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089283|NCT00843635|Urological Agents|urological agents|mesh-ancestor
6089284|NCT00843713|Raltegravir Potassium|raltegravir potassium|mesh-list
6089285|NCT00843713|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6089286|NCT00843713|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6089287|NCT00843713|Antiviral Agents|antiviral agents|mesh-ancestor
6089288|NCT00843713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6089289|NCT00843713|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6089290|NCT00843713|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6089291|NCT00843713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6089292|NCT00843713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089293|NCT00843778|Certolizumab Pegol|certolizumab pegol|mesh-list
6089294|NCT00843778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6089295|NCT00843778|Immunologic Factors|immunologic factors|mesh-ancestor
6089296|NCT00843778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089297|NCT00843778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6089298|NCT00843856|Mycophenolic Acid|mycophenolic acid|mesh-list
6089299|NCT00843856|Tacrolimus|tacrolimus|mesh-list
6089300|NCT00843856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6089301|NCT00843856|Immunologic Factors|immunologic factors|mesh-ancestor
6089302|NCT00843856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089303|NCT00843856|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5600790|NCT03709849|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5600791|NCT03709849|Hormone Antagonists|hormone antagonists|mesh-ancestor
5600792|NCT03709849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5600793|NCT03709849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600794|NCT03709849|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5600795|NCT03709849|Fertility Agents|fertility agents|mesh-ancestor
5600796|NCT03709849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5600797|NCT03709849|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5600798|NCT03709849|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5600799|NCT03709745|Ranibizumab|ranibizumab|mesh-list
5600800|NCT03709745|Aflibercept|aflibercept|mesh-list
5600801|NCT03709745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5600802|NCT03709745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5600803|NCT03709745|Growth Substances|growth substances|mesh-ancestor
5600804|NCT03709745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600805|NCT03709745|Growth Inhibitors|growth inhibitors|mesh-ancestor
5600806|NCT03709745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5600807|NCT03709719|Blinatumomab|blinatumomab|mesh-list
6089304|NCT00843856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6089305|NCT00843856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089306|NCT00843856|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6089307|NCT00843856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6089308|NCT00843856|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6089309|NCT00843856|Antitubercular Agents|antitubercular agents|mesh-ancestor
6089310|NCT00843856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6089311|NCT00843856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6089312|NCT00844051|Vaccines|vaccines|mesh-list
6089313|NCT00844051|Immunologic Factors|immunologic factors|mesh-ancestor
6089314|NCT00844051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089315|NCT00844090|Methylphenidate|methylphenidate|mesh-list
6089316|NCT00844090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6089317|NCT00844090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089318|NCT00844090|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6089319|NCT00844090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6089320|NCT00844090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6089321|NCT00844090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089322|NCT00844090|Dopamine Agents|dopamine agents|mesh-ancestor
6089323|NCT00844090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6089324|NCT00844194|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6089325|NCT00844194|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6089326|NCT00844194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6089327|NCT00844194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6089328|NCT00844194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089329|NCT00844194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6089330|NCT00844194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089331|NCT00844194|Analgesics|analgesics|mesh-ancestor
6089332|NCT00844194|Sensory System Agents|sensory system agents|mesh-ancestor
6089333|NCT00844194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6089334|NCT00844194|Antidepressive Agents|antidepressive agents|mesh-ancestor
6089335|NCT00844194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6089336|NCT00844194|Dopamine Agents|dopamine agents|mesh-ancestor
6089337|NCT00844298|Cytarabine|cytarabine|mesh-list
6089338|NCT00844298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6089339|NCT00844298|Antimetabolites|antimetabolites|mesh-ancestor
6089340|NCT00844298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089341|NCT00844298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6089342|NCT00844298|Antiviral Agents|antiviral agents|mesh-ancestor
6089343|NCT00844298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6089344|NCT00844298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6089345|NCT00844298|Immunologic Factors|immunologic factors|mesh-ancestor
6089346|NCT00844298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089347|NCT00844376|Atorvastatin|atorvastatin|mesh-list
6089348|NCT00844376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6089349|NCT00844376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6089350|NCT00844376|Antimetabolites|antimetabolites|mesh-ancestor
6089351|NCT00844376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089352|NCT00844376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6089353|NCT00844376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6089354|NCT00844376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6089355|NCT00844415|Dabigatran|dabigatran|mesh-list
5518432|NCT04339062|Sirolimus|sirolimus|mesh-list
5518433|NCT04339062|Prednisone|prednisone|mesh-list
5518434|NCT04339062|Everolimus|everolimus|mesh-list
5518435|NCT04339062|Cemiplimab|cemiplimab|mesh-list
6089356|NCT00844415|Antithrombins|antithrombins|mesh-ancestor
6089357|NCT00844415|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6089358|NCT00844415|Protease Inhibitors|protease inhibitors|mesh-ancestor
6089359|NCT00844415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5518436|NCT04339062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5518437|NCT04339062|Glucocorticoids|glucocorticoids|mesh-ancestor
5518438|NCT04339062|Hormones|hormones|mesh-ancestor
5518439|NCT04339062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5518440|NCT04339062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5518441|NCT04339062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5518442|NCT04339062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5518443|NCT04339062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5518444|NCT04339062|Immunologic Factors|immunologic factors|mesh-ancestor
5518445|NCT04339062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5518446|NCT04339062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5518447|NCT04339062|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5518448|NCT04339062|Antifungal Agents|antifungal agents|mesh-ancestor
5518449|NCT04339062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5518450|NCT04339348|Lidocaine|lidocaine|mesh-list
5518451|NCT04339348|Prilocaine|prilocaine|mesh-list
5518452|NCT04339348|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
5518453|NCT04339348|Misoprostol|misoprostol|mesh-list
5518454|NCT04339348|Anesthetics, Local|anesthetics, local|mesh-ancestor
5518455|NCT04339348|Anesthetics|anesthetics|mesh-ancestor
5518456|NCT04339348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5518457|NCT04339348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5518458|NCT04339348|Sensory System Agents|sensory system agents|mesh-ancestor
5518459|NCT04339348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5518460|NCT04339348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6089360|NCT00844415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089361|NCT00844415|Anticoagulants|anticoagulants|mesh-ancestor
6089362|NCT00844428|Eculizumab|eculizumab|mesh-list
6089363|NCT00844428|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6089364|NCT00844428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6089365|NCT00844428|Immunologic Factors|immunologic factors|mesh-ancestor
6089366|NCT00844428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089367|NCT00844519|Maraviroc|maraviroc|mesh-list
6089368|NCT00844519|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6089369|NCT00844519|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6089370|NCT00844519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089371|NCT00844519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6089372|NCT00844519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6089373|NCT00844519|Antiviral Agents|antiviral agents|mesh-ancestor
6089374|NCT00844519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6089375|NCT00844519|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6089376|NCT00844545|Eculizumab|eculizumab|mesh-list
6089377|NCT00844545|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6089378|NCT00844545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6089379|NCT00844545|Immunologic Factors|immunologic factors|mesh-ancestor
6089380|NCT00844545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089381|NCT00844649|Gemcitabine|gemcitabine|mesh-list
6089382|NCT00844649|Paclitaxel|paclitaxel|mesh-list
6089383|NCT00844649|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6089384|NCT00844649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6089385|NCT00844649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6089386|NCT00844649|Tubulin Modulators|tubulin modulators|mesh-ancestor
6089387|NCT00844649|Antimitotic Agents|antimitotic agents|mesh-ancestor
6089388|NCT00844649|Mitosis Modulators|mitosis modulators|mesh-ancestor
6665685|NCT01518231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6665686|NCT01518231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6665687|NCT01518231|Antimetabolites|antimetabolites|mesh-ancestor
5518461|NCT04339348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6089389|NCT00844649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089390|NCT00844649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6089391|NCT00844649|Antimetabolites|antimetabolites|mesh-ancestor
6089392|NCT00844649|Antiviral Agents|antiviral agents|mesh-ancestor
6089393|NCT00844649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6089394|NCT00844649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6089395|NCT00844649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6089396|NCT00844649|Immunologic Factors|immunologic factors|mesh-ancestor
6089397|NCT00844649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089398|NCT00844714|Rituximab|rituximab|mesh-list
6089399|NCT00844714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6089400|NCT00844714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6089401|NCT00844714|Immunologic Factors|immunologic factors|mesh-ancestor
6089402|NCT00844714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089403|NCT00844714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6089404|NCT00844753|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6089405|NCT00844753|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6089406|NCT00844753|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6089407|NCT00844753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5518462|NCT04339348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5518463|NCT04339348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5518464|NCT04339348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518465|NCT04339348|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5518466|NCT04339348|Abortifacient Agents|abortifacient agents|mesh-ancestor
5518467|NCT04339348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5518468|NCT04339348|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5518469|NCT04339348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5518470|NCT04339348|Oxytocics|oxytocics|mesh-ancestor
5518471|NCT04339348|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
5518472|NCT04338984|Fentanyl|fentanyl|mesh-list
5518473|NCT04338984|Anesthetics|anesthetics|mesh-list
5518474|NCT04338984|Ropivacaine|ropivacaine|mesh-list
5518475|NCT04338984|Anesthetics, General|anesthetics, general|mesh-list
5518476|NCT04338984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5518477|NCT04338984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5518478|NCT04338984|Anesthetics, Local|anesthetics, local|mesh-ancestor
5518479|NCT04338984|Sensory System Agents|sensory system agents|mesh-ancestor
5518480|NCT04338984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5518481|NCT04338984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5518482|NCT04338984|Narcotics|narcotics|mesh-ancestor
5518483|NCT04338984|Analgesics|analgesics|mesh-ancestor
5518484|NCT04338984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5518485|NCT04338984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5518486|NCT04338633|Calcium, Dietary|calcium, dietary|mesh-list
5518487|NCT04338633|Calcium|calcium|mesh-list
5518488|NCT04338633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5518489|NCT04338633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5518490|NCT04338633|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5518491|NCT04338711|Tofacitinib|tofacitinib|mesh-list
5518492|NCT04338711|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5518493|NCT04338711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5518494|NCT04338711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518495|NCT04338763|Gemcitabine|gemcitabine|mesh-list
5518496|NCT04338763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5518497|NCT04338763|Antimetabolites|antimetabolites|mesh-ancestor
5518498|NCT04338763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518499|NCT04338763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5518500|NCT04338763|Antiviral Agents|antiviral agents|mesh-ancestor
6089408|NCT00844753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089409|NCT00844753|Adrenergic Agents|adrenergic agents|mesh-ancestor
6089410|NCT00844753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6089411|NCT00844753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089412|NCT00844805|Naproxen|naproxen|mesh-list
6089413|NCT00844805|Infliximab|infliximab|mesh-list
6089414|NCT00844805|Dermatologic Agents|dermatologic agents|mesh-ancestor
6089415|NCT00844805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6089416|NCT00844805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6089417|NCT00844805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6089418|NCT00844805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6089419|NCT00844805|Analgesics|analgesics|mesh-ancestor
6089420|NCT00844805|Sensory System Agents|sensory system agents|mesh-ancestor
6089421|NCT00844805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6089422|NCT00844805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089423|NCT00844805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6089424|NCT00844805|Gout Suppressants|gout suppressants|mesh-ancestor
6089425|NCT00844805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6089426|NCT00844805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6203214|NCT02054520|Pembrolizumab|pembrolizumab|mesh-list
6464296|NCT00469131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5725171|NCT03181919|Letrozole|letrozole|mesh-list
6089427|NCT00844805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089428|NCT00844831|Lubiprostone|lubiprostone|mesh-list
6089429|NCT00844831|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6089430|NCT00844831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6089431|NCT00844831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089432|NCT00844844|Eculizumab|eculizumab|mesh-list
6089433|NCT00844844|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6089434|NCT00844844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6089435|NCT00844844|Immunologic Factors|immunologic factors|mesh-ancestor
6089436|NCT00844844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089437|NCT00844857|Olanzapine|olanzapine|mesh-list
6089438|NCT00844857|Fluoxetine|fluoxetine|mesh-list
6089439|NCT00844857|Antiemetics|antiemetics|mesh-ancestor
6089440|NCT00844857|Autonomic Agents|autonomic agents|mesh-ancestor
6089441|NCT00844857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6089442|NCT00844857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089443|NCT00844857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6089444|NCT00844857|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6089445|NCT00844857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6089446|NCT00844857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6089447|NCT00844857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6089448|NCT00844857|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6089449|NCT00844857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6089450|NCT00844857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6089451|NCT00844857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089452|NCT00844857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6089453|NCT00844857|Serotonin Agents|serotonin agents|mesh-ancestor
6089454|NCT00844857|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6089455|NCT00844857|Antidepressive Agents|antidepressive agents|mesh-ancestor
6089456|NCT00844857|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6089457|NCT00844857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6089458|NCT00844857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6089459|NCT00844883|Sorafenib|sorafenib|mesh-list
6089460|NCT00844883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6089461|NCT00844883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6089462|NCT00844883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6089463|NCT00844883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089464|NCT00844896|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
6089465|NCT00844896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6089466|NCT00844896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089467|NCT00845000|Levodopa|levodopa|mesh-list
6089468|NCT00845000|Carbidopa|carbidopa|mesh-list
6089469|NCT00845000|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6089470|NCT00845000|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6089471|NCT00845000|Dopamine Agents|dopamine agents|mesh-ancestor
6089472|NCT00845000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6089473|NCT00845000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089474|NCT00845000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089475|NCT00845000|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6089476|NCT00845000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6089477|NCT00845039|Irinotecan|irinotecan|mesh-list
6089478|NCT00845039|Cetuximab|cetuximab|mesh-list
6089479|NCT00845039|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6089480|NCT00845039|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6089481|NCT00845039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6089482|NCT00845039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6089483|NCT00845039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089484|NCT00845039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5518501|NCT04338763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5518502|NCT04338763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5518503|NCT04338763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5518504|NCT04338763|Immunologic Factors|immunologic factors|mesh-ancestor
5518505|NCT04338763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5518506|NCT04338906|Hydroxychloroquine|hydroxychloroquine|mesh-list
5518507|NCT04338906|Camostat|camostat|mesh-list
5518508|NCT04338906|Antimalarials|antimalarials|mesh-ancestor
5518509|NCT04338906|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5518510|NCT04338906|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5518511|NCT04338906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5518512|NCT04338906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5518513|NCT04338906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518514|NCT04338906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6203215|NCT02054520|Nivolumab|nivolumab|mesh-list
5518515|NCT04338906|Protease Inhibitors|protease inhibitors|mesh-ancestor
6089485|NCT00845039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6089486|NCT00845039|Immunologic Factors|immunologic factors|mesh-ancestor
6089487|NCT00845039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089488|NCT00845065|Ribavirin|ribavirin|mesh-list
5518516|NCT04338906|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5518517|NCT04338906|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5518518|NCT04338802|Nintedanib|nintedanib|mesh-list
6089489|NCT00845065|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6089490|NCT00845065|Antimetabolites|antimetabolites|mesh-ancestor
6089491|NCT00845065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089492|NCT00845065|Antiviral Agents|antiviral agents|mesh-ancestor
6089493|NCT00845065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6089494|NCT00845130|Vitamins|vitamins|mesh-list
5518519|NCT04338802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5518520|NCT04338802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5518521|NCT04338802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5518522|NCT04338802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518523|NCT04338919|Aspirin|aspirin|mesh-list
5518524|NCT04338919|Ticagrelor|ticagrelor|mesh-list
5518525|NCT04338919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5518526|NCT04338919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5518527|NCT04338919|Analgesics|analgesics|mesh-ancestor
5518528|NCT04338919|Sensory System Agents|sensory system agents|mesh-ancestor
5518529|NCT04338919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5518530|NCT04338919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5518531|NCT04338919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5518532|NCT04338919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5518533|NCT04338919|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5518534|NCT04338919|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5725172|NCT03181919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5725173|NCT03181919|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6089495|NCT00845130|Ascorbic Acid|ascorbic acid|mesh-list
6089496|NCT00845130|Micronutrients|micronutrients|mesh-ancestor
6089497|NCT00845130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089498|NCT00845130|Antioxidants|antioxidants|mesh-ancestor
6089499|NCT00845130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089500|NCT00845130|Protective Agents|protective agents|mesh-ancestor
6089501|NCT00845182|Pioglitazone|pioglitazone|mesh-list
6089502|NCT00845182|Exenatide|exenatide|mesh-list
6089503|NCT00845182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6089504|NCT00845182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725174|NCT03181919|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5725175|NCT03181919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5725176|NCT03181919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725177|NCT03181919|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5725178|NCT03181919|Hormone Antagonists|hormone antagonists|mesh-ancestor
5725179|NCT03181919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5725180|NCT03181919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089505|NCT00845182|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6089506|NCT00845182|Incretins|incretins|mesh-ancestor
6089507|NCT00845182|Hormones|hormones|mesh-ancestor
6089508|NCT00845182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6089509|NCT00845195|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
6089510|NCT00845195|Azelastine|azelastine|mesh-list
6089511|NCT00845195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6089512|NCT00845195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6089513|NCT00845195|Analgesics|analgesics|mesh-ancestor
6089514|NCT00845195|Sensory System Agents|sensory system agents|mesh-ancestor
6089515|NCT00845195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6089516|NCT00845195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089517|NCT00845195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6089518|NCT00845195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5725181|NCT03182088|Norepinephrine|norepinephrine|mesh-list
5725182|NCT03182088|Bupivacaine|bupivacaine|mesh-list
5725183|NCT03182088|Anesthetics, Local|anesthetics, local|mesh-ancestor
5725184|NCT03182088|Anesthetics|anesthetics|mesh-ancestor
5725185|NCT03182088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5518535|NCT04338919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518536|NCT04338919|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5518537|NCT04338919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5518538|NCT04338919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5518539|NCT04338919|Antipyretics|antipyretics|mesh-ancestor
5518540|NCT04338919|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5518541|NCT04338919|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5518542|NCT04338919|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5518543|NCT04338919|Purinergic Agents|purinergic agents|mesh-ancestor
5518544|NCT04338919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5518545|NCT04338620|Paclitaxel|paclitaxel|mesh-list
5518546|NCT04338620|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5518547|NCT04338620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5518548|NCT04338620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6089519|NCT00845195|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6089520|NCT00845195|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6089521|NCT00845195|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5518549|NCT04338620|Tubulin Modulators|tubulin modulators|mesh-ancestor
6089522|NCT00845195|Histamine Antagonists|histamine antagonists|mesh-ancestor
6089523|NCT00845195|Histamine Agents|histamine agents|mesh-ancestor
6089524|NCT00845195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6089525|NCT00845195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089526|NCT00845195|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6089527|NCT00845195|Autonomic Agents|autonomic agents|mesh-ancestor
5518550|NCT04338620|Antimitotic Agents|antimitotic agents|mesh-ancestor
5518551|NCT04338620|Mitosis Modulators|mitosis modulators|mesh-ancestor
5518552|NCT04338620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518553|NCT04338373|Atropine|atropine|mesh-list
5518554|NCT04338373|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5518555|NCT04338373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5518556|NCT04338373|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5518557|NCT04338373|Autonomic Agents|autonomic agents|mesh-ancestor
5518558|NCT04338373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5518559|NCT04338373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5518560|NCT04338373|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5518561|NCT04338373|Respiratory System Agents|respiratory system agents|mesh-ancestor
5518562|NCT04338373|Mydriatics|mydriatics|mesh-ancestor
5518563|NCT04338373|Parasympatholytics|parasympatholytics|mesh-ancestor
5518564|NCT04338373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5518565|NCT04338373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5518566|NCT04338373|Cholinergic Agents|cholinergic agents|mesh-ancestor
5518567|NCT04338373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5518568|NCT04338373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518569|NCT04338191|Leucovorin|leucovorin|mesh-list
5518570|NCT04338191|Fluorouracil|fluorouracil|mesh-list
5518571|NCT04338191|Oxaliplatin|oxaliplatin|mesh-list
5518572|NCT04338191|Irinotecan|irinotecan|mesh-list
5518573|NCT04338191|Levoleucovorin|levoleucovorin|mesh-list
5518574|NCT04338191|Antimetabolites|antimetabolites|mesh-ancestor
5518575|NCT04338191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518576|NCT04338191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5518577|NCT04338191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5518578|NCT04338191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5518579|NCT04338191|Immunologic Factors|immunologic factors|mesh-ancestor
5518580|NCT04338191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5518581|NCT04338191|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6089528|NCT00845195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6089529|NCT00845195|Respiratory System Agents|respiratory system agents|mesh-ancestor
6089530|NCT00845195|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6089531|NCT00845195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6089532|NCT00845429|Vaccines|vaccines|mesh-list
6089533|NCT00845429|Immunologic Factors|immunologic factors|mesh-ancestor
6089534|NCT00845429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089535|NCT00845481|Calcitriol|calcitriol|mesh-list
6089536|NCT00845481|Betamethasone|betamethasone|mesh-list
6089537|NCT00845481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6089538|NCT00845481|Glucocorticoids|glucocorticoids|mesh-ancestor
6089539|NCT00845481|Hormones|hormones|mesh-ancestor
6089540|NCT00845481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6089541|NCT00845481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089542|NCT00845481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6089543|NCT00845481|Respiratory System Agents|respiratory system agents|mesh-ancestor
6089544|NCT00845481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6089545|NCT00845481|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6089546|NCT00845481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6089547|NCT00845481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089548|NCT00845481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6089549|NCT00845481|Vitamins|vitamins|mesh-ancestor
6089550|NCT00845481|Micronutrients|micronutrients|mesh-ancestor
6089551|NCT00845481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6089552|NCT00845507|Exenatide|exenatide|mesh-list
6089553|NCT00845507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6089554|NCT00845507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089555|NCT00845507|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6089556|NCT00845507|Incretins|incretins|mesh-ancestor
6089557|NCT00845507|Hormones|hormones|mesh-ancestor
6089558|NCT00845507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6203216|NCT02054520|Ipilimumab|ipilimumab|mesh-list
6203217|NCT02054520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6203218|NCT02054520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6203219|NCT02054520|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6203220|NCT02054520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203221|NCT02054702|Aripiprazole|aripiprazole|mesh-list
6203222|NCT02054702|Brexpiprazole|brexpiprazole|mesh-list
6203223|NCT02054702|Antidepressive Agents|antidepressive agents|mesh-ancestor
6203224|NCT02054702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6203225|NCT02054702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6203226|NCT02054702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6203227|NCT02054702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6203228|NCT02054702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203229|NCT02054702|Dopamine Agonists|dopamine agonists|mesh-ancestor
6203230|NCT02054702|Dopamine Agents|dopamine agents|mesh-ancestor
6203231|NCT02054702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6203232|NCT02054702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203233|NCT02054702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6203234|NCT02054702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6203235|NCT02054702|Serotonin Agents|serotonin agents|mesh-ancestor
6203236|NCT02054702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6203237|NCT02054702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6203238|NCT02054702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6464297|NCT00469183|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
6464298|NCT00469183|Tretinoin|tretinoin|mesh-list
6464299|NCT00469183|Hydroquinone|hydroquinone|mesh-list
6464300|NCT00469183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6464301|NCT00469183|Keratolytic Agents|keratolytic agents|mesh-ancestor
5518582|NCT04338191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6203239|NCT02054702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6203240|NCT02054754|HU 211|hu 211|mesh-list
6203241|NCT02054754|Dronabinol|dronabinol|mesh-list
6203242|NCT02054754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6203243|NCT02054754|Antiemetics|antiemetics|mesh-ancestor
6203244|NCT02054754|Autonomic Agents|autonomic agents|mesh-ancestor
6203245|NCT02054754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6203246|NCT02054754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203247|NCT02054754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5518583|NCT04338191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5518584|NCT04338191|Antidotes|antidotes|mesh-ancestor
5518585|NCT04338191|Protective Agents|protective agents|mesh-ancestor
5518586|NCT04338191|Vitamin B Complex|vitamin b complex|mesh-ancestor
5518587|NCT04338191|Vitamins|vitamins|mesh-ancestor
6203248|NCT02054754|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6203249|NCT02054754|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6203250|NCT02054754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6464302|NCT00469183|Dermatologic Agents|dermatologic agents|mesh-ancestor
6089559|NCT00845650|Immunoglobulins|immunoglobulins|mesh-list
6089560|NCT00845650|gamma-Globulins|gamma-globulins|mesh-list
6089561|NCT00845650|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6089562|NCT00845650|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6089563|NCT00845650|Immunologic Factors|immunologic factors|mesh-ancestor
5518588|NCT04338191|Micronutrients|micronutrients|mesh-ancestor
5518589|NCT04338438|Apatinib|apatinib|mesh-list
5518590|NCT04338438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5518591|NCT04338438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5518592|NCT04338438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5518593|NCT04338438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518594|NCT04338165|Evolocumab|evolocumab|mesh-list
5518595|NCT04338165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5518596|NCT04338165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5518597|NCT04338165|Antimetabolites|antimetabolites|mesh-ancestor
5518598|NCT04338165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518599|NCT04338165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5518600|NCT04337970|Axitinib|axitinib|mesh-list
5518601|NCT04337970|Talazoparib|talazoparib|mesh-list
5518602|NCT04337970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5518603|NCT04337970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5518604|NCT04337970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5518605|NCT04337970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518606|NCT04337970|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5518607|NCT04338126|Tranexamic Acid|tranexamic acid|mesh-list
5518608|NCT04338126|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5518609|NCT04338126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5518610|NCT04338126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518611|NCT04338126|Hemostatics|hemostatics|mesh-ancestor
6089564|NCT00845650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089565|NCT00845663|Certolizumab Pegol|certolizumab pegol|mesh-list
6089566|NCT00845663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6089567|NCT00845663|Immunologic Factors|immunologic factors|mesh-ancestor
6089568|NCT00845663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089569|NCT00845663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6089570|NCT00845676|Interferons|interferons|mesh-list
6089571|NCT00845676|Ribavirin|ribavirin|mesh-list
6089572|NCT00845676|Interferon-alpha|interferon-alpha|mesh-list
6089573|NCT00845676|Interferon alpha-2|interferon alpha-2|mesh-list
6089574|NCT00845676|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6089575|NCT00845676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6089576|NCT00845676|Antiviral Agents|antiviral agents|mesh-ancestor
6089577|NCT00845676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5518612|NCT04338126|Coagulants|coagulants|mesh-ancestor
5518613|NCT04337879|Oxaliplatin|oxaliplatin|mesh-list
5518614|NCT04337879|Irinotecan|irinotecan|mesh-list
5518615|NCT04337879|Calcium|calcium|mesh-list
5518616|NCT04337879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5518617|NCT04337879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089578|NCT00845676|Antimetabolites|antimetabolites|mesh-ancestor
6089579|NCT00845676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089580|NCT00845676|Immunologic Factors|immunologic factors|mesh-ancestor
6089581|NCT00845676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089582|NCT00845728|Tiotropium Bromide|tiotropium bromide|mesh-list
6089583|NCT00845728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6089584|NCT00845728|Autonomic Agents|autonomic agents|mesh-ancestor
6089585|NCT00845728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6089586|NCT00845728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089587|NCT00845728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6089588|NCT00845728|Respiratory System Agents|respiratory system agents|mesh-ancestor
6089589|NCT00845728|Parasympatholytics|parasympatholytics|mesh-ancestor
6089590|NCT00845728|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6089591|NCT00845728|Cholinergic Agents|cholinergic agents|mesh-ancestor
6089592|NCT00845728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6089593|NCT00845728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089594|NCT00845832|Rituximab|rituximab|mesh-list
6089595|NCT00845832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6089596|NCT00845832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6089597|NCT00845832|Immunologic Factors|immunologic factors|mesh-ancestor
6089598|NCT00845832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089599|NCT00845832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6089600|NCT00845858|Metoclopramide|metoclopramide|mesh-list
6089601|NCT00845858|Antiemetics|antiemetics|mesh-ancestor
6089602|NCT00845858|Autonomic Agents|autonomic agents|mesh-ancestor
5518618|NCT04337879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5518619|NCT04337879|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6089603|NCT00845858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6089604|NCT00845858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089605|NCT00845858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6089606|NCT00845858|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6089607|NCT00845858|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6089608|NCT00845858|Dopamine Agents|dopamine agents|mesh-ancestor
6089609|NCT00845858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6089610|NCT00845858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089611|NCT00845871|Deferasirox|deferasirox|mesh-list
6089612|NCT00845871|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6089613|NCT00845871|Chelating Agents|chelating agents|mesh-ancestor
6089614|NCT00845871|Sequestering Agents|sequestering agents|mesh-ancestor
6089615|NCT00845871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665688|NCT01518231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6665689|NCT01518231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6665690|NCT01518231|Anticoagulants|anticoagulants|mesh-ancestor
6665691|NCT01518231|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6665692|NCT01518231|Antioxidants|antioxidants|mesh-ancestor
6665693|NCT01518231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5518620|NCT04337879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6089616|NCT00845897|Botulinum Toxins|botulinum toxins|mesh-list
6089617|NCT00845897|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6089618|NCT00845897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6089619|NCT00845897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089620|NCT00845897|Cholinergic Agents|cholinergic agents|mesh-ancestor
6089621|NCT00845897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6089622|NCT00845897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089623|NCT00846027|Gemcitabine|gemcitabine|mesh-list
6089624|NCT00846027|Paclitaxel|paclitaxel|mesh-list
6089625|NCT00846027|Bevacizumab|bevacizumab|mesh-list
6089626|NCT00846027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6089627|NCT00846027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6089628|NCT00846027|Tubulin Modulators|tubulin modulators|mesh-ancestor
6089629|NCT00846027|Antimitotic Agents|antimitotic agents|mesh-ancestor
6089630|NCT00846027|Mitosis Modulators|mitosis modulators|mesh-ancestor
6089631|NCT00846027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089632|NCT00846027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6089633|NCT00846027|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6089634|NCT00846027|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6089635|NCT00846027|Growth Substances|growth substances|mesh-ancestor
6089636|NCT00846027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089637|NCT00846027|Growth Inhibitors|growth inhibitors|mesh-ancestor
5518621|NCT04337879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5518622|NCT04337879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518623|NCT04337918|Nitric Oxide|nitric oxide|mesh-list
5518624|NCT04337918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5518625|NCT04337918|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5518626|NCT04337918|Autonomic Agents|autonomic agents|mesh-ancestor
5518627|NCT04337918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5518628|NCT04337918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5518629|NCT04337918|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5518630|NCT04337918|Respiratory System Agents|respiratory system agents|mesh-ancestor
5518631|NCT04337918|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5518632|NCT04337918|Antioxidants|antioxidants|mesh-ancestor
5518633|NCT04337918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518634|NCT04337918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5518635|NCT04337918|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5518636|NCT04337918|Vasodilator Agents|vasodilator agents|mesh-ancestor
5518637|NCT04337918|Gasotransmitters|gasotransmitters|mesh-ancestor
5518638|NCT04337918|Protective Agents|protective agents|mesh-ancestor
5518639|NCT04337814|Ibuprofen|ibuprofen|mesh-list
5518640|NCT04337814|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
5518641|NCT04337814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5518642|NCT04337814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6089638|NCT00846027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6089639|NCT00846027|Antimetabolites|antimetabolites|mesh-ancestor
6089640|NCT00846027|Antiviral Agents|antiviral agents|mesh-ancestor
6089641|NCT00846027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6089642|NCT00846027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6089643|NCT00846027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6089644|NCT00846027|Immunologic Factors|immunologic factors|mesh-ancestor
5518643|NCT04337814|Analgesics|analgesics|mesh-ancestor
5518644|NCT04337814|Sensory System Agents|sensory system agents|mesh-ancestor
5518645|NCT04337814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6089645|NCT00846040|Fallypride|fallypride|mesh-list
6089646|NCT00846040|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6089647|NCT00846040|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6089648|NCT00846040|Dopamine Agents|dopamine agents|mesh-ancestor
6089649|NCT00846040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6089650|NCT00846040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089651|NCT00846040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089652|NCT00846365|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6089653|NCT00846365|Olmesartan|olmesartan|mesh-list
6089654|NCT00846365|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6089655|NCT00846365|Chlorthalidone|chlorthalidone|mesh-list
6089656|NCT00846365|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
6089657|NCT00846365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6089658|NCT00846365|Diuretics|diuretics|mesh-ancestor
6089659|NCT00846365|Natriuretic Agents|natriuretic agents|mesh-ancestor
6089660|NCT00846365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089661|NCT00846365|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6089662|NCT00846365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6089663|NCT00846365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089664|NCT00846365|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6089665|NCT00846365|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6089666|NCT00846482|Oxaliplatin|oxaliplatin|mesh-list
5518646|NCT04337814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5518647|NCT04337814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5518648|NCT04337814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5518649|NCT04337814|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5518650|NCT04337814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5518651|NCT04337814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089667|NCT00846482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6089668|NCT00846495|Topiramate|topiramate|mesh-list
6089669|NCT00846495|Frovatriptan|frovatriptan|mesh-list
6089670|NCT00846495|Anticonvulsants|anticonvulsants|mesh-ancestor
6089671|NCT00846495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6089672|NCT00846495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089673|NCT00846495|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6089674|NCT00846495|Serotonin Agents|serotonin agents|mesh-ancestor
6089675|NCT00846495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6089676|NCT00846495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089677|NCT00846521|Acarbose|acarbose|mesh-list
6089678|NCT00846521|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6089679|NCT00846521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6089680|NCT00846521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089681|NCT00846521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6089682|NCT00846521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089683|NCT00846586|Tiotropium Bromide|tiotropium bromide|mesh-list
6089684|NCT00846586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6089685|NCT00846586|Autonomic Agents|autonomic agents|mesh-ancestor
6089686|NCT00846586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6089687|NCT00846586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089688|NCT00846586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6089689|NCT00846586|Respiratory System Agents|respiratory system agents|mesh-ancestor
6089690|NCT00846586|Parasympatholytics|parasympatholytics|mesh-ancestor
6089691|NCT00846586|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6089692|NCT00846586|Cholinergic Agents|cholinergic agents|mesh-ancestor
6089693|NCT00846586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5518652|NCT04337814|Anesthetics, Local|anesthetics, local|mesh-ancestor
5518653|NCT04337814|Anesthetics|anesthetics|mesh-ancestor
5518654|NCT04337814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5518655|NCT04337814|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
5518656|NCT04337593|Pegaspargase|pegaspargase|mesh-list
6089694|NCT00846586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089695|NCT00846651|Phenylephrine|phenylephrine|mesh-list
6089696|NCT00846651|Oxymetazoline|oxymetazoline|mesh-list
6089697|NCT00846651|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6089698|NCT00846651|Mydriatics|mydriatics|mesh-ancestor
6089699|NCT00846651|Autonomic Agents|autonomic agents|mesh-ancestor
6089700|NCT00846651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6089701|NCT00846651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089702|NCT00846651|Sympathomimetics|sympathomimetics|mesh-ancestor
6089703|NCT00846651|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6089704|NCT00846651|Nasal Decongestants|nasal decongestants|mesh-ancestor
6089705|NCT00846651|Respiratory System Agents|respiratory system agents|mesh-ancestor
5518657|NCT04337593|Basiliximab|basiliximab|mesh-list
6089706|NCT00846651|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6089707|NCT00846651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6089708|NCT00846651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6089709|NCT00846651|Adrenergic Agents|adrenergic agents|mesh-ancestor
6089710|NCT00846651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6089711|NCT00846651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089712|NCT00846651|Protective Agents|protective agents|mesh-ancestor
6089713|NCT00846768|Olodaterol|olodaterol|mesh-list
6089714|NCT00846768|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6089715|NCT00846768|Autonomic Agents|autonomic agents|mesh-ancestor
6089716|NCT00846768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6089717|NCT00846768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089718|NCT00846768|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6089719|NCT00846768|Respiratory System Agents|respiratory system agents|mesh-ancestor
6089720|NCT00847015|Gemcitabine|gemcitabine|mesh-list
6089721|NCT00847015|Sunitinib|sunitinib|mesh-list
6089722|NCT00847015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6089723|NCT00847015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6089724|NCT00847015|Antimetabolites|antimetabolites|mesh-ancestor
6089725|NCT00847015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089726|NCT00847015|Antiviral Agents|antiviral agents|mesh-ancestor
6089727|NCT00847015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6089728|NCT00847015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6089729|NCT00847015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6089730|NCT00847015|Immunologic Factors|immunologic factors|mesh-ancestor
6089731|NCT00847015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089732|NCT00847015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6089733|NCT00847015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6089734|NCT00847015|Growth Substances|growth substances|mesh-ancestor
6089735|NCT00847015|Growth Inhibitors|growth inhibitors|mesh-ancestor
6089736|NCT00847015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6089737|NCT00847145|Vaccines|vaccines|mesh-list
6089738|NCT00847145|Immunologic Factors|immunologic factors|mesh-ancestor
6089739|NCT00847145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464303|NCT00469183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6464304|NCT00469183|Glucocorticoids|glucocorticoids|mesh-ancestor
5518658|NCT04337593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6089740|NCT00847171|Cyclophosphamide|cyclophosphamide|mesh-list
6089741|NCT00847171|Trastuzumab|trastuzumab|mesh-list
6089742|NCT00847171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6089743|NCT00847171|Immunologic Factors|immunologic factors|mesh-ancestor
6089744|NCT00847171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089745|NCT00847171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6089746|NCT00847171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6089747|NCT00847171|Alkylating Agents|alkylating agents|mesh-ancestor
6089748|NCT00847171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089749|NCT00847171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6089750|NCT00847171|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6089751|NCT00847171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6089752|NCT00847210|Dexlansoprazole|dexlansoprazole|mesh-list
6089753|NCT00847210|Lansoprazole|lansoprazole|mesh-list
6089754|NCT00847210|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6089755|NCT00847210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6089756|NCT00847210|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6089757|NCT00847210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6089758|NCT00847210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089759|NCT00847587|Contraceptive Agents|contraceptive agents|mesh-list
6089760|NCT00847587|Etonogestrel|etonogestrel|mesh-list
6089761|NCT00847587|Desogestrel|desogestrel|mesh-list
6089762|NCT00847587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6089763|NCT00847587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5518659|NCT04337593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6089764|NCT00847587|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6089765|NCT00847587|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6089766|NCT00847587|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6089767|NCT00847587|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6089768|NCT00847587|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6089769|NCT00847587|Progestins|progestins|mesh-ancestor
6089770|NCT00847587|Hormones|hormones|mesh-ancestor
6089771|NCT00847587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6089772|NCT00847613|Tofacitinib|tofacitinib|mesh-list
6089773|NCT00847613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6089774|NCT00847613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6089775|NCT00847613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089776|NCT00847626|Chlorthalidone|chlorthalidone|mesh-list
6089777|NCT00847626|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
5518660|NCT04337593|Immunologic Factors|immunologic factors|mesh-ancestor
6089778|NCT00847626|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6089779|NCT00847626|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6089780|NCT00847626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089781|NCT00847626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6089782|NCT00847626|Diuretics|diuretics|mesh-ancestor
6089783|NCT00847626|Natriuretic Agents|natriuretic agents|mesh-ancestor
6089784|NCT00847626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089785|NCT00847626|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6089786|NCT00847626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6089787|NCT00847808|Dexlansoprazole|dexlansoprazole|mesh-list
6089788|NCT00847808|Lansoprazole|lansoprazole|mesh-list
6089789|NCT00847808|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6089790|NCT00847808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6089791|NCT00847808|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6089792|NCT00847808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6089793|NCT00847808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089794|NCT00847886|Methotrexate|methotrexate|mesh-list
6089795|NCT00847886|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5518661|NCT04337593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5518662|NCT04337632|Paclitaxel|paclitaxel|mesh-list
5518663|NCT04337632|Carboplatin|carboplatin|mesh-list
5518664|NCT04337632|Doxorubicin|doxorubicin|mesh-list
5518665|NCT04337632|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5518666|NCT04337632|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5518667|NCT04337632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6089796|NCT00847886|Abortifacient Agents|abortifacient agents|mesh-ancestor
6089797|NCT00847886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6089798|NCT00847886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089799|NCT00847886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6089800|NCT00847886|Antimetabolites|antimetabolites|mesh-ancestor
6089801|NCT00847886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089802|NCT00847886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6089803|NCT00847886|Dermatologic Agents|dermatologic agents|mesh-ancestor
6089804|NCT00847886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6089805|NCT00847886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6089806|NCT00847886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6089807|NCT00847886|Immunologic Factors|immunologic factors|mesh-ancestor
6089808|NCT00847886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6089809|NCT00847886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6089810|NCT00847912|Fluorouracil|fluorouracil|mesh-list
6089811|NCT00847912|Antimetabolites|antimetabolites|mesh-ancestor
6089812|NCT00847912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089813|NCT00847912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6089814|NCT00847912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6089815|NCT00847912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6089816|NCT00847912|Immunologic Factors|immunologic factors|mesh-ancestor
6089817|NCT00847912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089818|NCT00847938|Neostigmine|neostigmine|mesh-list
6089819|NCT00847938|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6089820|NCT00847938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6089821|NCT00847938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089822|NCT00847938|Cholinergic Agents|cholinergic agents|mesh-ancestor
6089823|NCT00847938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6089824|NCT00847938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089825|NCT00847938|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6089826|NCT00847938|Autonomic Agents|autonomic agents|mesh-ancestor
6089827|NCT00847938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6089828|NCT00848016|Acetic Acid|acetic acid|mesh-list
5518668|NCT04337632|Tubulin Modulators|tubulin modulators|mesh-ancestor
5518669|NCT04337632|Antimitotic Agents|antimitotic agents|mesh-ancestor
5518670|NCT04337632|Mitosis Modulators|mitosis modulators|mesh-ancestor
5518671|NCT04337632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518672|NCT04337632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5518673|NCT04337632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6089829|NCT00848016|Retinol acetate|retinol acetate|mesh-list
6089830|NCT00848016|Gossypol acetic acid|gossypol acetic acid|mesh-list
6089831|NCT00848016|Gossypol|gossypol|mesh-list
6089832|NCT00848016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6089833|NCT00848016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6089834|NCT00848016|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6089835|NCT00848016|Immunologic Factors|immunologic factors|mesh-ancestor
6089836|NCT00848016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089837|NCT00848016|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6089838|NCT00848016|Protective Agents|protective agents|mesh-ancestor
6089839|NCT00848016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6089840|NCT00848016|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6089841|NCT00848016|Contraceptive Agents|contraceptive agents|mesh-ancestor
6089842|NCT00848016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6089843|NCT00848016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6089844|NCT00848016|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6089845|NCT00848016|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
6089846|NCT00848016|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
6089847|NCT00848081|Tadalafil|tadalafil|mesh-list
6089848|NCT00848081|Vasodilator Agents|vasodilator agents|mesh-ancestor
6089849|NCT00848081|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6089850|NCT00848081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6089851|NCT00848081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6089852|NCT00848081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089853|NCT00848081|Urological Agents|urological agents|mesh-ancestor
6089854|NCT00848107|Treprostinil|treprostinil|mesh-list
6089855|NCT00848107|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6089856|NCT00848250|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6089857|NCT00848250|Enzyme Inhibitors|enzyme inhibitors|mesh-list
6089858|NCT00848250|Protease Inhibitors|protease inhibitors|mesh-ancestor
6089859|NCT00848250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089860|NCT00848354|Etanercept|etanercept|mesh-list
6089861|NCT00848354|Methotrexate|methotrexate|mesh-list
6089862|NCT00848354|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6089863|NCT00848354|Abortifacient Agents|abortifacient agents|mesh-ancestor
6089864|NCT00848354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6089865|NCT00848354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089866|NCT00848354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6089867|NCT00848354|Antimetabolites|antimetabolites|mesh-ancestor
6089868|NCT00848354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089869|NCT00848354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6089870|NCT00848354|Dermatologic Agents|dermatologic agents|mesh-ancestor
6089871|NCT00848354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6089872|NCT00848354|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6089873|NCT00848354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6089874|NCT00848354|Immunologic Factors|immunologic factors|mesh-ancestor
6089875|NCT00848354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6089876|NCT00848354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6089877|NCT00848354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6089878|NCT00848354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6089879|NCT00848354|Analgesics|analgesics|mesh-ancestor
6089880|NCT00848354|Sensory System Agents|sensory system agents|mesh-ancestor
6089881|NCT00848354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6089882|NCT00848354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6089883|NCT00848354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6089884|NCT00848393|Fentanyl|fentanyl|mesh-list
6089885|NCT00848393|Dexmedetomidine|dexmedetomidine|mesh-list
6089886|NCT00848393|Citric Acid|citric acid|mesh-list
6089887|NCT00848393|Sodium Citrate|sodium citrate|mesh-list
6089888|NCT00848393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6089889|NCT00848393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6089890|NCT00848393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089891|NCT00848393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6089892|NCT00848393|Analgesics|analgesics|mesh-ancestor
6089893|NCT00848393|Sensory System Agents|sensory system agents|mesh-ancestor
6089894|NCT00848393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5518674|NCT04337632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5518675|NCT04337632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5518676|NCT04337658|Capecitabine|capecitabine|mesh-list
5518677|NCT04337658|Trastuzumab|trastuzumab|mesh-list
5518678|NCT04337658|Fulvestrant|fulvestrant|mesh-list
5518679|NCT04337658|Pertuzumab|pertuzumab|mesh-list
5518680|NCT04337658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5518681|NCT04337658|Antimetabolites|antimetabolites|mesh-ancestor
5518682|NCT04337658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518683|NCT04337658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5518684|NCT04337658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5518685|NCT04337658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5518686|NCT04337658|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5518687|NCT04337658|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5518688|NCT04337658|Hormone Antagonists|hormone antagonists|mesh-ancestor
5518689|NCT04337658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5518690|NCT04337658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5518691|NCT04337450|Lamivudine|lamivudine|mesh-list
5518692|NCT04337450|Dolutegravir|dolutegravir|mesh-list
5518693|NCT04337450|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5518694|NCT04337450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5518695|NCT04337450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5518696|NCT04337450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518697|NCT04337450|Antiviral Agents|antiviral agents|mesh-ancestor
6089895|NCT00848393|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6089896|NCT00848393|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6089897|NCT00848393|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6089898|NCT00848393|Adrenergic Agents|adrenergic agents|mesh-ancestor
6089899|NCT00848393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6089900|NCT00848393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089901|NCT00848393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6089902|NCT00848393|Narcotics|narcotics|mesh-ancestor
6089903|NCT00848393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6089904|NCT00848393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6089905|NCT00848393|Anesthetics, General|anesthetics, general|mesh-ancestor
6089906|NCT00848393|Anesthetics|anesthetics|mesh-ancestor
6089907|NCT00848393|Anticoagulants|anticoagulants|mesh-ancestor
6089908|NCT00848393|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6089909|NCT00848393|Chelating Agents|chelating agents|mesh-ancestor
6089910|NCT00848393|Sequestering Agents|sequestering agents|mesh-ancestor
5518698|NCT04337450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6089911|NCT00848497|Methyltestosterone|methyltestosterone|mesh-list
6089912|NCT00848497|Sildenafil Citrate|sildenafil citrate|mesh-list
6089913|NCT00848497|Testosterone|testosterone|mesh-list
5518699|NCT04337450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6089914|NCT00848497|Testosterone undecanoate|testosterone undecanoate|mesh-list
6089915|NCT00848497|Testosterone enanthate|testosterone enanthate|mesh-list
6089916|NCT00848497|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6089917|NCT00848497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089918|NCT00848497|Androgens|androgens|mesh-ancestor
6089919|NCT00848497|Hormones|hormones|mesh-ancestor
6089920|NCT00848497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6089921|NCT00848497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089922|NCT00848497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6089923|NCT00848497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6089924|NCT00848497|Anabolic Agents|anabolic agents|mesh-ancestor
6089925|NCT00848497|Vasodilator Agents|vasodilator agents|mesh-ancestor
6089926|NCT00848497|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6089927|NCT00848497|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6089928|NCT00848497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6089929|NCT00848497|Urological Agents|urological agents|mesh-ancestor
6089930|NCT00848536|Travoprost|travoprost|mesh-list
6089931|NCT00848536|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6089932|NCT00848536|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6089933|NCT00848536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6089934|NCT00848549|Carbamazepine|carbamazepine|mesh-list
6089935|NCT00848549|Zonisamide|zonisamide|mesh-list
6089936|NCT00848549|Anticonvulsants|anticonvulsants|mesh-ancestor
6089937|NCT00848549|Antimanic Agents|antimanic agents|mesh-ancestor
6089938|NCT00848549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6089939|NCT00848549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6089940|NCT00848549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089941|NCT00848549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6089942|NCT00848549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6089943|NCT00848549|Analgesics|analgesics|mesh-ancestor
6089944|NCT00848549|Sensory System Agents|sensory system agents|mesh-ancestor
5518700|NCT04337450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5518701|NCT04337450|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5518702|NCT04337450|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5600808|NCT03709719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5600809|NCT03709550|Decitabine|decitabine|mesh-list
5600810|NCT03709550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5600811|NCT03709550|Antimetabolites|antimetabolites|mesh-ancestor
5600812|NCT03709550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600813|NCT03709550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5600814|NCT03709550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5600815|NCT03709459|Doxycycline|doxycycline|mesh-list
5600816|NCT03709459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5600817|NCT03709459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5600818|NCT03709459|Antimalarials|antimalarials|mesh-ancestor
5600819|NCT03709459|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5600820|NCT03709459|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5600821|NCT03709381|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
5600822|NCT03709381|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
5600823|NCT03709381|Cosyntropin|cosyntropin|mesh-list
5600824|NCT03709381|beta-Endorphin|beta-endorphin|mesh-list
5600825|NCT03709381|Hormones|hormones|mesh-ancestor
5600826|NCT03709381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5600827|NCT03709381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600828|NCT03709381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5600829|NCT03709381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600830|NCT03709160|Bumetanide|bumetanide|mesh-list
6089945|NCT00848549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6089946|NCT00848549|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5518709|NCT04337606|Decitabine|decitabine|mesh-list
5518710|NCT04337606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5518711|NCT04337606|Antimetabolites|antimetabolites|mesh-ancestor
5518712|NCT04337606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518713|NCT04337606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5518714|NCT04337606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5518715|NCT04337268|Glucagon|glucagon|mesh-list
5518716|NCT04337268|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5518717|NCT04337268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5518718|NCT04337268|Hormones|hormones|mesh-ancestor
5518719|NCT04337268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5518720|NCT04337268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5518721|NCT04337268|Incretins|incretins|mesh-ancestor
5518722|NCT04336891|Methyltestosterone|methyltestosterone|mesh-list
5518723|NCT04336891|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5518724|NCT04336891|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5518725|NCT04336891|Estradiol|estradiol|mesh-list
5518726|NCT04336891|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5518727|NCT04336891|Testosterone|testosterone|mesh-list
5518728|NCT04336891|Testosterone undecanoate|testosterone undecanoate|mesh-list
6089947|NCT00848549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6089948|NCT00848549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089949|NCT00848549|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6089950|NCT00848549|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6089951|NCT00848549|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6089952|NCT00848549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6089953|NCT00848718|Paclitaxel|paclitaxel|mesh-list
6089954|NCT00848718|Docetaxel|docetaxel|mesh-list
6089955|NCT00848718|Carboplatin|carboplatin|mesh-list
6089956|NCT00848718|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6089957|NCT00848718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6089958|NCT00848718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6089959|NCT00848718|Tubulin Modulators|tubulin modulators|mesh-ancestor
6089960|NCT00848718|Antimitotic Agents|antimitotic agents|mesh-ancestor
6089961|NCT00848718|Mitosis Modulators|mitosis modulators|mesh-ancestor
6089962|NCT00848718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089963|NCT00848718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6089964|NCT00848718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5518729|NCT04336891|Testosterone enanthate|testosterone enanthate|mesh-list
5518730|NCT04336891|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5518731|NCT04336891|Estrogens|estrogens|mesh-ancestor
5518732|NCT04336891|Hormones|hormones|mesh-ancestor
5518733|NCT04336891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5518734|NCT04336891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5518735|NCT04336891|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5518736|NCT04336891|Contraceptive Agents|contraceptive agents|mesh-ancestor
5518737|NCT04336891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5518738|NCT04336891|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5518739|NCT04336891|Androgens|androgens|mesh-ancestor
5518740|NCT04336891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5518741|NCT04336891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5518742|NCT04336891|Anabolic Agents|anabolic agents|mesh-ancestor
5518743|NCT04336904|Favipiravir|favipiravir|mesh-list
5518744|NCT04336904|Antiviral Agents|antiviral agents|mesh-ancestor
5518745|NCT04336904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5518746|NCT04336748|Hydroxychloroquine|hydroxychloroquine|mesh-list
5518747|NCT04336748|Antimalarials|antimalarials|mesh-ancestor
5518748|NCT04336748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5518749|NCT04336748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5518750|NCT04336748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5518751|NCT04336748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5518752|NCT04336748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518753|NCT04336748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6089965|NCT00848783|Capecitabine|capecitabine|mesh-list
6089966|NCT00848783|Irinotecan|irinotecan|mesh-list
6089967|NCT00848783|Floxuridine|floxuridine|mesh-list
6089968|NCT00848783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6089969|NCT00848783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6089970|NCT00848783|Antimetabolites|antimetabolites|mesh-ancestor
6464305|NCT00469183|Hormones|hormones|mesh-ancestor
5518761|NCT04336917|Lidocaine|lidocaine|mesh-list
5518762|NCT04336917|Bupivacaine|bupivacaine|mesh-list
5518763|NCT04336917|Anesthetics, Local|anesthetics, local|mesh-list
5518764|NCT04336917|Anesthetics|anesthetics|mesh-list
5518765|NCT04336917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5518766|NCT04336917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5518767|NCT04336917|Sensory System Agents|sensory system agents|mesh-ancestor
6089971|NCT00848783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6089972|NCT00848783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6089973|NCT00848783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6089974|NCT00848783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6089975|NCT00848926|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6089976|NCT00848926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6089977|NCT00848926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6089978|NCT00848965|Fluticasone|fluticasone|mesh-list
5518768|NCT04336917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5518769|NCT04336917|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5518770|NCT04336917|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5518771|NCT04336917|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5518772|NCT04336917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5518773|NCT04336917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518774|NCT04337099|Tempol|tempol|mesh-list
5518775|NCT04337099|TEMPO|tempo|mesh-list
5518776|NCT04337099|TEMPOL-H|tempol-h|mesh-list
5518777|NCT04337099|Antioxidants|antioxidants|mesh-ancestor
6089979|NCT00848965|Xhance|xhance|mesh-list
6089980|NCT00848965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6089981|NCT00848965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6089982|NCT00848965|Autonomic Agents|autonomic agents|mesh-ancestor
6089983|NCT00848965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6089984|NCT00848965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089985|NCT00848965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6089986|NCT00848965|Respiratory System Agents|respiratory system agents|mesh-ancestor
6089987|NCT00848965|Dermatologic Agents|dermatologic agents|mesh-ancestor
6089988|NCT00848965|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6089989|NCT00849017|rGLP-1 protein|rglp-1 protein|mesh-list
6089990|NCT00849017|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6089991|NCT00849017|Incretins|incretins|mesh-ancestor
6089992|NCT00849017|Hormones|hormones|mesh-ancestor
6089993|NCT00849017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6089994|NCT00849017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6089995|NCT00849056|rGLP-1 protein|rglp-1 protein|mesh-list
6089996|NCT00849056|Incretins|incretins|mesh-ancestor
6089997|NCT00849056|Hormones|hormones|mesh-ancestor
6089998|NCT00849056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6089999|NCT00849056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090000|NCT00849121|Vaccines|vaccines|mesh-list
6090001|NCT00849121|Immunologic Factors|immunologic factors|mesh-ancestor
6090002|NCT00849121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090003|NCT00849186|Sunitinib|sunitinib|mesh-list
6090004|NCT00849186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6090005|NCT00849186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6090006|NCT00849186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6090007|NCT00849186|Growth Substances|growth substances|mesh-ancestor
6090008|NCT00849186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090009|NCT00849186|Growth Inhibitors|growth inhibitors|mesh-ancestor
6090010|NCT00849186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6090011|NCT00849186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6090012|NCT00849186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090013|NCT00849251|Dexamethasone|dexamethasone|mesh-list
6090014|NCT00849251|Cyclophosphamide|cyclophosphamide|mesh-list
6090015|NCT00849251|Doxorubicin|doxorubicin|mesh-list
5518778|NCT04337099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518779|NCT04337099|Protective Agents|protective agents|mesh-ancestor
5518780|NCT04337099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5518781|NCT04337099|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5518782|NCT04337099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6090016|NCT00849251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6090017|NCT00849251|Bortezomib|bortezomib|mesh-list
6090018|NCT00849251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6090019|NCT00849251|Immunologic Factors|immunologic factors|mesh-ancestor
5518783|NCT04337099|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5518784|NCT04337099|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5518785|NCT04336566|Melatonin|melatonin|mesh-list
5518786|NCT04336566|Antioxidants|antioxidants|mesh-ancestor
5518787|NCT04336566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518788|NCT04336566|Protective Agents|protective agents|mesh-ancestor
5518789|NCT04336566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5518790|NCT04336566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5518791|NCT04336189|Pyrimethamine|pyrimethamine|mesh-list
6090020|NCT00849251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090021|NCT00849251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6090022|NCT00849251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6090023|NCT00849251|Alkylating Agents|alkylating agents|mesh-ancestor
6090024|NCT00849251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090025|NCT00849251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6090026|NCT00849251|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6090027|NCT00849251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6090028|NCT00849251|Antiemetics|antiemetics|mesh-ancestor
6090029|NCT00849251|Autonomic Agents|autonomic agents|mesh-ancestor
6090030|NCT00849251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6090031|NCT00849251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6090032|NCT00849251|Glucocorticoids|glucocorticoids|mesh-ancestor
6090033|NCT00849251|Hormones|hormones|mesh-ancestor
6090034|NCT00849251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6090035|NCT00849251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6090036|NCT00849251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6090037|NCT00849251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6090038|NCT00849251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6090039|NCT00849251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6090040|NCT00849472|Paclitaxel|paclitaxel|mesh-list
6090041|NCT00849472|Cyclophosphamide|cyclophosphamide|mesh-list
6090042|NCT00849472|Doxorubicin|doxorubicin|mesh-list
6090043|NCT00849472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6090044|NCT00849472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6090045|NCT00849472|Tubulin Modulators|tubulin modulators|mesh-ancestor
5518792|NCT04336189|Piperaquine|piperaquine|mesh-list
5518793|NCT04336189|Sulfadoxine|sulfadoxine|mesh-list
5518794|NCT04336189|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
5518795|NCT04336189|Artenimol|artenimol|mesh-list
5518796|NCT04336189|Antimalarials|antimalarials|mesh-ancestor
5518797|NCT04336189|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5518798|NCT04336189|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5518799|NCT04336189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5518800|NCT04336189|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5518801|NCT04336189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5518802|NCT04336189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090046|NCT00849472|Antimitotic Agents|antimitotic agents|mesh-ancestor
6090047|NCT00849472|Mitosis Modulators|mitosis modulators|mesh-ancestor
6090048|NCT00849472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090049|NCT00849472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6090050|NCT00849472|Immunologic Factors|immunologic factors|mesh-ancestor
6090051|NCT00849472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090052|NCT00849472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6090053|NCT00849472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6090054|NCT00849472|Alkylating Agents|alkylating agents|mesh-ancestor
6090055|NCT00849472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6090056|NCT00849472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6090057|NCT00849472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6090058|NCT00849472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6090059|NCT00849472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6090060|NCT00849680|Vaccines|vaccines|mesh-list
6090061|NCT00849680|Immunologic Factors|immunologic factors|mesh-ancestor
6090062|NCT00849680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090063|NCT00849693|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5518803|NCT04336189|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5518804|NCT04336189|Renal Agents|renal agents|mesh-ancestor
5518805|NCT04336332|Azithromycin|azithromycin|mesh-list
5518806|NCT04336332|Hydroxychloroquine|hydroxychloroquine|mesh-list
5518807|NCT04336332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5518808|NCT04336332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5518809|NCT04336332|Antimalarials|antimalarials|mesh-ancestor
5518810|NCT04336332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5518811|NCT04336332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5518812|NCT04336332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5518813|NCT04336332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518814|NCT04336332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5518815|NCT04336488|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5518816|NCT04336488|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-list
5518817|NCT04336488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5518818|NCT04336488|Glucocorticoids|glucocorticoids|mesh-ancestor
5518819|NCT04336488|Hormones|hormones|mesh-ancestor
5518820|NCT04336488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5518821|NCT04336488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5518822|NCT04336488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5518823|NCT04336488|Immunologic Factors|immunologic factors|mesh-ancestor
5518824|NCT04336488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5518825|NCT04336488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518826|NCT04336488|Protease Inhibitors|protease inhibitors|mesh-ancestor
5518827|NCT04336605|Analgesics|analgesics|mesh-list
5518828|NCT04336605|Sensory System Agents|sensory system agents|mesh-ancestor
5518829|NCT04336605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5518830|NCT04336605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5518831|NCT04336228|Dexetimide|dexetimide|mesh-list
5518832|NCT04336228|Citalopram|citalopram|mesh-list
5518833|NCT04336228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5518834|NCT04336228|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5518835|NCT04336228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5518836|NCT04336228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5518837|NCT04336228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518838|NCT04336228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5518839|NCT04336228|Serotonin Agents|serotonin agents|mesh-ancestor
5518840|NCT04336228|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5518841|NCT04336228|Antidepressive Agents|antidepressive agents|mesh-ancestor
5518842|NCT04336228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5518843|NCT04336228|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5518844|NCT04336228|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6665694|NCT01518231|Protective Agents|protective agents|mesh-ancestor
6665695|NCT01518413|Irinotecan|irinotecan|mesh-list
6665696|NCT01518413|Sorafenib|sorafenib|mesh-list
6665697|NCT01518413|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6665698|NCT01518413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6665699|NCT01518413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6665700|NCT01518413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518845|NCT04336228|Parasympatholytics|parasympatholytics|mesh-ancestor
5518846|NCT04336228|Autonomic Agents|autonomic agents|mesh-ancestor
5518847|NCT04336228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5518848|NCT04336228|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5518849|NCT04336228|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5518850|NCT04336228|Cholinergic Agents|cholinergic agents|mesh-ancestor
5518851|NCT04336046|Bupivacaine|bupivacaine|mesh-list
5518852|NCT04336046|Anesthetics, Local|anesthetics, local|mesh-ancestor
5518853|NCT04336046|Anesthetics|anesthetics|mesh-ancestor
5518854|NCT04336046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5518855|NCT04336046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5518856|NCT04336046|Sensory System Agents|sensory system agents|mesh-ancestor
6665701|NCT01518413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5600831|NCT03709160|Diuretics|diuretics|mesh-ancestor
6665702|NCT01518413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6665703|NCT01518465|Dexamethasone|dexamethasone|mesh-list
6665704|NCT01518465|Lenalidomide|lenalidomide|mesh-list
6665705|NCT01518465|Dalteparin|dalteparin|mesh-list
5518857|NCT04336046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5518858|NCT04336241|Nivolumab|nivolumab|mesh-list
5518859|NCT04336241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5518860|NCT04336241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5518861|NCT04336241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5518862|NCT04336241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665706|NCT01518465|Tinzaparin|tinzaparin|mesh-list
6665707|NCT01518465|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6665708|NCT01518465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6665709|NCT01518465|Antiemetics|antiemetics|mesh-ancestor
6665710|NCT01518465|Autonomic Agents|autonomic agents|mesh-ancestor
5518863|NCT04335968|Melatonin|melatonin|mesh-list
5518864|NCT04335968|Antioxidants|antioxidants|mesh-ancestor
5518865|NCT04335968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518866|NCT04335968|Protective Agents|protective agents|mesh-ancestor
5518867|NCT04335968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5518868|NCT04335968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5518869|NCT04335786|Valsartan|valsartan|mesh-list
5518870|NCT04335786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5518871|NCT04335786|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5518872|NCT04335786|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5518873|NCT04335786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518874|NCT04335890|Vaccines|vaccines|mesh-list
5518875|NCT04335890|Immunologic Factors|immunologic factors|mesh-ancestor
5518876|NCT04335890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5518877|NCT04335461|Anesthetics|anesthetics|mesh-list
5518878|NCT04335461|Anesthetics, Local|anesthetics, local|mesh-list
5518879|NCT04335461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5518880|NCT04335461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5518881|NCT04335461|Sensory System Agents|sensory system agents|mesh-ancestor
5518882|NCT04335461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5600832|NCT03709160|Natriuretic Agents|natriuretic agents|mesh-ancestor
5600833|NCT03709160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600834|NCT03709160|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5600835|NCT03709160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5600836|NCT03709160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600837|NCT03709147|Metformin|metformin|mesh-list
5600838|NCT03709147|Carboplatin|carboplatin|mesh-list
6090064|NCT00849693|Fluoxetine|fluoxetine|mesh-list
6090065|NCT00849693|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6090066|NCT00849693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6090067|NCT00849693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6090068|NCT00849693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090069|NCT00849693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6090070|NCT00849693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090071|NCT00849693|Analgesics|analgesics|mesh-ancestor
6090072|NCT00849693|Sensory System Agents|sensory system agents|mesh-ancestor
6090073|NCT00849693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6090074|NCT00849693|Antidepressive Agents|antidepressive agents|mesh-ancestor
6090075|NCT00849693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6090076|NCT00849693|Dopamine Agents|dopamine agents|mesh-ancestor
6090077|NCT00849693|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6090078|NCT00849693|Serotonin Agents|serotonin agents|mesh-ancestor
6090079|NCT00849693|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6090080|NCT00849693|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6090081|NCT00849693|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6090082|NCT00849693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6090083|NCT00849810|Metoprolol|metoprolol|mesh-list
6090084|NCT00849810|Nebivolol|nebivolol|mesh-list
6090085|NCT00849810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6665711|NCT01518465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6090086|NCT00849810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6090087|NCT00849810|Sympatholytics|sympatholytics|mesh-ancestor
5518883|NCT04335526|Cholestyramine Resin|cholestyramine resin|mesh-list
5518884|NCT04335526|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5518885|NCT04335526|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5518886|NCT04335526|Antimetabolites|antimetabolites|mesh-ancestor
5518887|NCT04335526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090088|NCT00849810|Autonomic Agents|autonomic agents|mesh-ancestor
6090089|NCT00849810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6090090|NCT00849810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090091|NCT00849810|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6090092|NCT00849810|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6090093|NCT00849810|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6090094|NCT00849810|Adrenergic Agents|adrenergic agents|mesh-ancestor
6090095|NCT00849810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6090096|NCT00849810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090097|NCT00849810|Vasodilator Agents|vasodilator agents|mesh-ancestor
6090098|NCT00849810|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6090099|NCT00849810|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6090100|NCT00849810|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6090101|NCT00849875|Dacarbazine|dacarbazine|mesh-list
6090102|NCT00849875|Imidazole|imidazole|mesh-list
6090103|NCT00849875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6090104|NCT00849875|Alkylating Agents|alkylating agents|mesh-ancestor
6090105|NCT00849875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518888|NCT04335526|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5518889|NCT04335292|Pemetrexed|pemetrexed|mesh-list
5518890|NCT04335292|Osimertinib|osimertinib|mesh-list
5518891|NCT04335292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5518892|NCT04335292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5518893|NCT04335292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518894|NCT04335292|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5518895|NCT04335292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5518896|NCT04335292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5518897|NCT04335383|Antibodies|antibodies|mesh-list
5518898|NCT04335383|Immunologic Factors|immunologic factors|mesh-ancestor
5518899|NCT04335383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5518900|NCT04335305|Pembrolizumab|pembrolizumab|mesh-list
5518901|NCT04335305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5518902|NCT04335305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5518903|NCT04335123|Losartan|losartan|mesh-list
5518904|NCT04335123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5518905|NCT04335123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5518906|NCT04335123|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5518907|NCT04335123|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5518908|NCT04335123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090106|NCT00849875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6090107|NCT00849875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6090108|NCT00849901|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6090109|NCT00849901|Fluoxetine|fluoxetine|mesh-list
6090110|NCT00849901|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6090111|NCT00849901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6090112|NCT00849901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6090113|NCT00849901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090114|NCT00849901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6090115|NCT00849901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090116|NCT00849901|Analgesics|analgesics|mesh-ancestor
6090117|NCT00849901|Sensory System Agents|sensory system agents|mesh-ancestor
5518909|NCT04335513|Insulin|insulin|mesh-list
5518910|NCT04335513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5518911|NCT04335513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090118|NCT00849901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6090119|NCT00849901|Antidepressive Agents|antidepressive agents|mesh-ancestor
6090120|NCT00849901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6090121|NCT00849901|Dopamine Agents|dopamine agents|mesh-ancestor
6090122|NCT00849901|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6090123|NCT00849901|Serotonin Agents|serotonin agents|mesh-ancestor
6090124|NCT00849901|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6090125|NCT00849901|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6090126|NCT00849901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6090127|NCT00849901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5518912|NCT04335006|Paclitaxel|paclitaxel|mesh-list
5518913|NCT04335006|Apatinib|apatinib|mesh-list
6090128|NCT00850096|Insulin|insulin|mesh-list
6090129|NCT00850096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6090130|NCT00850096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090131|NCT00850343|Certolizumab Pegol|certolizumab pegol|mesh-list
6090132|NCT00850343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6090133|NCT00850343|Immunologic Factors|immunologic factors|mesh-ancestor
6090134|NCT00850343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090135|NCT00850343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6090136|NCT00850395|Maraviroc|maraviroc|mesh-list
6090137|NCT00850395|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6090138|NCT00850395|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6090139|NCT00850395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090140|NCT00850395|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6090141|NCT00850395|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6090142|NCT00850395|Antiviral Agents|antiviral agents|mesh-ancestor
6090143|NCT00850395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6090144|NCT00850395|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6090145|NCT00850460|Atorvastatin|atorvastatin|mesh-list
6090146|NCT00850460|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6090147|NCT00850460|Simvastatin|simvastatin|mesh-list
6090148|NCT00850460|Pravastatin|pravastatin|mesh-list
6090149|NCT00850460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6090150|NCT00850460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6090151|NCT00850460|Antimetabolites|antimetabolites|mesh-ancestor
6090152|NCT00850460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090153|NCT00850460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6090154|NCT00850460|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6090155|NCT00850460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6090156|NCT00850499|Rituximab|rituximab|mesh-list
6090157|NCT00850499|Fludarabine|fludarabine|mesh-list
6090158|NCT00850499|Bortezomib|bortezomib|mesh-list
6090159|NCT00850499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6090160|NCT00850499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6090161|NCT00850499|Immunologic Factors|immunologic factors|mesh-ancestor
6090162|NCT00850499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090163|NCT00850499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6203251|NCT02054754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203252|NCT02054754|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6203253|NCT02054754|Protective Agents|protective agents|mesh-ancestor
6203254|NCT02054754|Hallucinogens|hallucinogens|mesh-ancestor
6203255|NCT02054754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6203256|NCT02054754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6203257|NCT02054754|Analgesics|analgesics|mesh-ancestor
6203258|NCT02054754|Sensory System Agents|sensory system agents|mesh-ancestor
6203259|NCT02054754|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6203260|NCT02054754|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6203261|NCT02054754|Hormones|hormones|mesh-ancestor
6203262|NCT02054754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6203263|NCT02055157|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
5518914|NCT04335006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5518915|NCT04335006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5518916|NCT04335006|Tubulin Modulators|tubulin modulators|mesh-ancestor
5518917|NCT04335006|Antimitotic Agents|antimitotic agents|mesh-ancestor
5518918|NCT04335006|Mitosis Modulators|mitosis modulators|mesh-ancestor
5518919|NCT04335006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518920|NCT04335006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5518921|NCT04335006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5518922|NCT04334993|Blinatumomab|blinatumomab|mesh-list
5518923|NCT04334993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5518924|NCT04334824|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5600839|NCT03709147|Pembrolizumab|pembrolizumab|mesh-list
6203264|NCT02055157|Natriuretic Agents|natriuretic agents|mesh-ancestor
6203265|NCT02055157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203266|NCT02055352|Fluticasone|fluticasone|mesh-list
6203267|NCT02055352|Budesonide|budesonide|mesh-list
6203268|NCT02055352|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6203269|NCT02055352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6203270|NCT02055352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6203271|NCT02055352|Autonomic Agents|autonomic agents|mesh-ancestor
6203272|NCT02055352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6203273|NCT02055352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203274|NCT02055352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6203275|NCT02055352|Respiratory System Agents|respiratory system agents|mesh-ancestor
6203276|NCT02055352|Dermatologic Agents|dermatologic agents|mesh-ancestor
6203277|NCT02055352|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6203278|NCT02055352|Glucocorticoids|glucocorticoids|mesh-ancestor
6203279|NCT02055352|Hormones|hormones|mesh-ancestor
6090164|NCT00850564|Hormones|hormones|mesh-list
6090165|NCT00850564|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
6090166|NCT00850564|Tesamorelin|tesamorelin|mesh-list
6090167|NCT00850564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6090168|NCT00850564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090169|NCT00850564|Growth Substances|growth substances|mesh-ancestor
6090170|NCT00850889|Lidocaine|lidocaine|mesh-list
6090171|NCT00850889|Hyaluronic Acid|hyaluronic acid|mesh-list
6090172|NCT00850889|Anesthetics, Local|anesthetics, local|mesh-ancestor
5518925|NCT04334824|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
5518926|NCT04334824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5518927|NCT04334824|Diuretics|diuretics|mesh-ancestor
5518928|NCT04334824|Natriuretic Agents|natriuretic agents|mesh-ancestor
5518929|NCT04334824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5518930|NCT04334824|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5518931|NCT04334824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5518932|NCT04334824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518933|NCT04334824|Protease Inhibitors|protease inhibitors|mesh-ancestor
5518934|NCT04334824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5518935|NCT04334967|Ascorbic Acid|ascorbic acid|mesh-list
6090173|NCT00850889|Anesthetics|anesthetics|mesh-ancestor
6090174|NCT00850889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6090175|NCT00850889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090176|NCT00850889|Sensory System Agents|sensory system agents|mesh-ancestor
6090177|NCT00850889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6090178|NCT00850889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6090179|NCT00850889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6090180|NCT00850889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6090181|NCT00850889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6090182|NCT00850889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090183|NCT00850889|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6090184|NCT00850889|Immunologic Factors|immunologic factors|mesh-ancestor
6090185|NCT00850889|Viscosupplements|viscosupplements|mesh-ancestor
6090186|NCT00850889|Protective Agents|protective agents|mesh-ancestor
6090187|NCT00850993|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
6090188|NCT00850993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5518936|NCT04334967|Hydroxychloroquine|hydroxychloroquine|mesh-list
5518937|NCT04334967|Vitamins|vitamins|mesh-ancestor
5518938|NCT04334967|Micronutrients|micronutrients|mesh-ancestor
5518939|NCT04334967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5518940|NCT04334967|Antimalarials|antimalarials|mesh-ancestor
5518941|NCT04334967|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5518942|NCT04334967|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5518943|NCT04334967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5518944|NCT04334967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5518945|NCT04334967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518946|NCT04334967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5518947|NCT04334967|Antioxidants|antioxidants|mesh-ancestor
6090189|NCT00850993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090190|NCT00851084|Leucovorin|leucovorin|mesh-list
6090191|NCT00851084|Folic Acid|folic acid|mesh-list
6090192|NCT00851084|Oxaliplatin|oxaliplatin|mesh-list
6090193|NCT00851084|Aflibercept|aflibercept|mesh-list
6090194|NCT00851084|Levoleucovorin|levoleucovorin|mesh-list
6090195|NCT00851084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6090196|NCT00851084|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6090197|NCT00851084|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6090198|NCT00851084|Growth Substances|growth substances|mesh-ancestor
6090199|NCT00851084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090200|NCT00851084|Growth Inhibitors|growth inhibitors|mesh-ancestor
6090201|NCT00851084|Antidotes|antidotes|mesh-ancestor
6090202|NCT00851084|Protective Agents|protective agents|mesh-ancestor
6090203|NCT00851084|Vitamin B Complex|vitamin b complex|mesh-ancestor
6090204|NCT00851084|Vitamins|vitamins|mesh-ancestor
6090205|NCT00851084|Micronutrients|micronutrients|mesh-ancestor
6090206|NCT00851084|Hematinics|hematinics|mesh-ancestor
6090207|NCT00851318|Methotrexate|methotrexate|mesh-list
6090208|NCT00851318|Certolizumab Pegol|certolizumab pegol|mesh-list
5518948|NCT04334967|Protective Agents|protective agents|mesh-ancestor
5518949|NCT04334928|Tenofovir|tenofovir|mesh-list
5518950|NCT04334928|Emtricitabine|emtricitabine|mesh-list
5518951|NCT04334928|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5518952|NCT04334928|Hydroxychloroquine|hydroxychloroquine|mesh-list
5518953|NCT04334928|Antiviral Agents|antiviral agents|mesh-ancestor
5518954|NCT04334928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6090209|NCT00851318|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5600840|NCT03709147|Pemetrexed|pemetrexed|mesh-list
5518955|NCT04334928|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5518956|NCT04334928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5518957|NCT04334928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5518958|NCT04334928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518959|NCT04334928|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5518960|NCT04334928|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5518961|NCT04334928|Antimalarials|antimalarials|mesh-ancestor
5518962|NCT04334928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5518963|NCT04334928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5518964|NCT04334928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5518965|NCT04334863|Tyrphostins|tyrphostins|mesh-list
5518966|NCT04334863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6090210|NCT00851318|Abortifacient Agents|abortifacient agents|mesh-ancestor
6090211|NCT00851318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6090212|NCT00851318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090213|NCT00851318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6090214|NCT00851318|Antimetabolites|antimetabolites|mesh-ancestor
6090215|NCT00851318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090216|NCT00851318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6090217|NCT00851318|Dermatologic Agents|dermatologic agents|mesh-ancestor
6090218|NCT00851318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6090219|NCT00851318|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6090220|NCT00851318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6090221|NCT00851318|Immunologic Factors|immunologic factors|mesh-ancestor
6090222|NCT00851318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6090223|NCT00851318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6090224|NCT00851357|Nicotine|nicotine|mesh-list
6090225|NCT00851357|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6090226|NCT00851357|Autonomic Agents|autonomic agents|mesh-ancestor
6090227|NCT00851357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6090228|NCT00851357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090229|NCT00851357|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6090230|NCT00851357|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6090231|NCT00851357|Cholinergic Agents|cholinergic agents|mesh-ancestor
6090232|NCT00851357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6090233|NCT00851357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090234|NCT00851409|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
6090235|NCT00851409|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6090236|NCT00851409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6090237|NCT00851409|Immunologic Factors|immunologic factors|mesh-ancestor
6090238|NCT00851409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090239|NCT00851630|Lamivudine|lamivudine|mesh-list
6090240|NCT00851630|Zidovudine|zidovudine|mesh-list
6090241|NCT00851630|Abacavir|abacavir|mesh-list
6090242|NCT00851630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6090243|NCT00851630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6090244|NCT00851630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6090245|NCT00851630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090246|NCT00851630|Antiviral Agents|antiviral agents|mesh-ancestor
6090247|NCT00851630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6090248|NCT00851630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6090249|NCT00851630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6090250|NCT00851630|Antimetabolites|antimetabolites|mesh-ancestor
6090251|NCT00851721|Factor VIII|factor viii|mesh-list
6090252|NCT00851721|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
6090253|NCT00851721|Coagulants|coagulants|mesh-ancestor
6090254|NCT00851799|Ritonavir|ritonavir|mesh-list
6090255|NCT00851799|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6090256|NCT00851799|Darunavir|darunavir|mesh-list
6090257|NCT00851799|Tenofovir|tenofovir|mesh-list
6090258|NCT00851799|Emtricitabine|emtricitabine|mesh-list
6090259|NCT00851799|Raltegravir Potassium|raltegravir potassium|mesh-list
6090260|NCT00851799|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5518967|NCT04334863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5518968|NCT04334863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518969|NCT04334915|Cenicriviroc|cenicriviroc|mesh-list
5518970|NCT04334915|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
5600841|NCT03709147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6090261|NCT00851799|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6090262|NCT00851799|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6090263|NCT00851799|Protease Inhibitors|protease inhibitors|mesh-ancestor
6090264|NCT00851799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6090265|NCT00851799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090266|NCT00851799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6090267|NCT00851799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6090268|NCT00851799|Antiviral Agents|antiviral agents|mesh-ancestor
6090269|NCT00851799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6090270|NCT00851799|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6090271|NCT00851799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6090272|NCT00851799|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6090273|NCT00851799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6090274|NCT00851799|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6090275|NCT00851799|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6090276|NCT00851877|Paclitaxel|paclitaxel|mesh-list
6090277|NCT00851877|Cetuximab|cetuximab|mesh-list
6090278|NCT00851877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6090279|NCT00851877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6090280|NCT00851877|Tubulin Modulators|tubulin modulators|mesh-ancestor
6090281|NCT00851877|Antimitotic Agents|antimitotic agents|mesh-ancestor
6090282|NCT00851877|Mitosis Modulators|mitosis modulators|mesh-ancestor
6090283|NCT00851877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090284|NCT00851877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6090285|NCT00851890|Interferons|interferons|mesh-list
6090286|NCT00851890|Ribavirin|ribavirin|mesh-list
6464306|NCT00469183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6464307|NCT00469183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090287|NCT00851890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6090288|NCT00851890|Antiviral Agents|antiviral agents|mesh-ancestor
6090289|NCT00851890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6090290|NCT00851890|Antimetabolites|antimetabolites|mesh-ancestor
6090291|NCT00851890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090292|NCT00851903|Metformin|metformin|mesh-list
6090293|NCT00851903|Insulin Glargine|insulin glargine|mesh-list
6090294|NCT00851903|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6090295|NCT00851903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6090296|NCT00851903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090297|NCT00851903|Incretins|incretins|mesh-ancestor
6090298|NCT00851903|Hormones|hormones|mesh-ancestor
6090299|NCT00851903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6090300|NCT00851903|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6090301|NCT00851903|Protease Inhibitors|protease inhibitors|mesh-ancestor
6090302|NCT00851903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6090303|NCT00851903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090304|NCT00852202|Cariprazine|cariprazine|mesh-list
6090305|NCT00852202|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6090306|NCT00852202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6090307|NCT00852202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6090308|NCT00852202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090309|NCT00852202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6090310|NCT00852397|Apixaban|apixaban|mesh-list
6090311|NCT00852397|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6090312|NCT00852397|Antithrombins|antithrombins|mesh-ancestor
6090313|NCT00852397|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6090314|NCT00852397|Protease Inhibitors|protease inhibitors|mesh-ancestor
6090315|NCT00852397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6090316|NCT00852397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090317|NCT00852397|Anticoagulants|anticoagulants|mesh-ancestor
6090318|NCT00852540|Linezolid|linezolid|mesh-list
6090319|NCT00852540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6090320|NCT00852540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6090321|NCT00852540|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6090322|NCT00852540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6090323|NCT00852540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090324|NCT00852631|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6090325|NCT00852631|Antidepressive Agents|antidepressive agents|mesh-ancestor
6090326|NCT00852631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6090327|NCT00852631|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6090328|NCT00852631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6090329|NCT00852631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6090330|NCT00852631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090331|NCT00852644|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6090332|NCT00852644|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6090333|NCT00852644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090334|NCT00852761|Clobetasol|clobetasol|mesh-list
6090335|NCT00852761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6090336|NCT00852761|Glucocorticoids|glucocorticoids|mesh-ancestor
6090337|NCT00852761|Hormones|hormones|mesh-ancestor
6090338|NCT00852761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6090339|NCT00852761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090340|NCT00852917|Tramadol|tramadol|mesh-list
6090341|NCT00852917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6090342|NCT00852917|Narcotics|narcotics|mesh-ancestor
6090343|NCT00852917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6090344|NCT00852917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090345|NCT00852917|Analgesics|analgesics|mesh-ancestor
6090346|NCT00852917|Sensory System Agents|sensory system agents|mesh-ancestor
6090347|NCT00852917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6090348|NCT00852969|Niacin|niacin|mesh-list
6090349|NCT00852969|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6090350|NCT00852969|Antimetabolites|antimetabolites|mesh-ancestor
6090351|NCT00852969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090352|NCT00852969|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6090353|NCT00852969|Vasodilator Agents|vasodilator agents|mesh-ancestor
6090354|NCT00852969|Vitamin B Complex|vitamin b complex|mesh-ancestor
6090355|NCT00852969|Vitamins|vitamins|mesh-ancestor
6090356|NCT00852969|Micronutrients|micronutrients|mesh-ancestor
6090357|NCT00852969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5518971|NCT04334915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518972|NCT04334915|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5518973|NCT04334915|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5518974|NCT04334915|Antiviral Agents|antiviral agents|mesh-ancestor
6090358|NCT00853021|Aldesleukin|aldesleukin|mesh-list
6090359|NCT00853021|Bevacizumab|bevacizumab|mesh-list
6090360|NCT00853021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6090361|NCT00853021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6090362|NCT00853021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6090363|NCT00853021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6090364|NCT00853021|Growth Substances|growth substances|mesh-ancestor
6090365|NCT00853021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090366|NCT00853021|Growth Inhibitors|growth inhibitors|mesh-ancestor
6090367|NCT00853021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5518975|NCT04334915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5518976|NCT04334629|Ibuprofen|ibuprofen|mesh-list
5518977|NCT04334629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5518978|NCT04334629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5518979|NCT04334629|Analgesics|analgesics|mesh-ancestor
5518980|NCT04334629|Sensory System Agents|sensory system agents|mesh-ancestor
5518981|NCT04334629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5518982|NCT04334629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5518983|NCT04334629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5518984|NCT04334629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5518985|NCT04334629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5518986|NCT04334629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5518987|NCT04334629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5518988|NCT04334850|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5518989|NCT04334850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5518990|NCT04334512|Vitamin D|vitamin d|mesh-list
5518991|NCT04334512|Vitamins|vitamins|mesh-list
5518992|NCT04334512|Ascorbic Acid|ascorbic acid|mesh-list
5518993|NCT04334512|Azithromycin|azithromycin|mesh-list
5518994|NCT04334512|Hydroxychloroquine|hydroxychloroquine|mesh-list
5518995|NCT04334512|Micronutrients|micronutrients|mesh-ancestor
6090368|NCT00853021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6090369|NCT00853021|Antiviral Agents|antiviral agents|mesh-ancestor
6090370|NCT00853021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5518996|NCT04334512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5518997|NCT04334512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5518998|NCT04334512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5518999|NCT04334512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5519000|NCT04334512|Antimalarials|antimalarials|mesh-ancestor
5519001|NCT04334512|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6090371|NCT00853047|Octreotide|octreotide|mesh-list
5519002|NCT04334512|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6090372|NCT00853047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5519003|NCT04334512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5519004|NCT04334512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519005|NCT04334512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5519006|NCT04334512|Antioxidants|antioxidants|mesh-ancestor
5519007|NCT04334512|Protective Agents|protective agents|mesh-ancestor
5519008|NCT04334330|Trastuzumab|trastuzumab|mesh-list
5519009|NCT04334330|Fulvestrant|fulvestrant|mesh-list
5519010|NCT04334330|Lapatinib|lapatinib|mesh-list
5519011|NCT04334330|Palbociclib|palbociclib|mesh-list
5519012|NCT04334330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5519013|NCT04334330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6090373|NCT00853047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6090374|NCT00853047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6090375|NCT00853073|Bevacizumab|bevacizumab|mesh-list
6090376|NCT00853073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6090377|NCT00853073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6090378|NCT00853073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6090379|NCT00853073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6090380|NCT00853073|Growth Substances|growth substances|mesh-ancestor
6090381|NCT00853073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090382|NCT00853073|Growth Inhibitors|growth inhibitors|mesh-ancestor
6090383|NCT00853099|Adalimumab|adalimumab|mesh-list
6090384|NCT00853099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6090385|NCT00853099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6090386|NCT00853112|Sildenafil Citrate|sildenafil citrate|mesh-list
6090387|NCT00853112|Vasodilator Agents|vasodilator agents|mesh-ancestor
6090388|NCT00853112|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6090389|NCT00853112|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6090390|NCT00853112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6090391|NCT00853112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090392|NCT00853112|Urological Agents|urological agents|mesh-ancestor
5519014|NCT04334330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6090393|NCT00853125|Sunitinib|sunitinib|mesh-list
6090394|NCT00853125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6090395|NCT00853125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6090396|NCT00853125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6090397|NCT00853125|Growth Substances|growth substances|mesh-ancestor
6090398|NCT00853125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090399|NCT00853125|Growth Inhibitors|growth inhibitors|mesh-ancestor
6090400|NCT00853125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6090401|NCT00853125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6090402|NCT00853125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090403|NCT00853242|Sevelamer|sevelamer|mesh-list
6090404|NCT00853242|Chelating Agents|chelating agents|mesh-ancestor
6090405|NCT00853242|Sequestering Agents|sequestering agents|mesh-ancestor
6090406|NCT00853242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090407|NCT00853333|Midazolam|midazolam|mesh-list
6090408|NCT00853333|Dexmedetomidine|dexmedetomidine|mesh-list
6090409|NCT00853333|Propofol|propofol|mesh-list
6090410|NCT00853333|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6090411|NCT00853333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6090412|NCT00853333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090413|NCT00853333|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6090414|NCT00853333|Anesthetics, General|anesthetics, general|mesh-ancestor
6090415|NCT00853333|Anesthetics|anesthetics|mesh-ancestor
6090416|NCT00853333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6090417|NCT00853333|Analgesics|analgesics|mesh-ancestor
6090418|NCT00853333|Sensory System Agents|sensory system agents|mesh-ancestor
6090419|NCT00853333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6464308|NCT00469183|Antioxidants|antioxidants|mesh-ancestor
5519015|NCT04334330|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6090420|NCT00853333|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6090421|NCT00853333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6090422|NCT00853333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6090423|NCT00853333|Adrenergic Agents|adrenergic agents|mesh-ancestor
6090424|NCT00853333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6090425|NCT00853333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090426|NCT00853333|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6090427|NCT00853333|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6090428|NCT00853333|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6090429|NCT00853333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6090430|NCT00853333|GABA Modulators|gaba modulators|mesh-ancestor
6090431|NCT00853333|GABA Agents|gaba agents|mesh-ancestor
6090432|NCT00853372|Sunitinib|sunitinib|mesh-list
6090433|NCT00853372|Trebananib|trebananib|mesh-list
6090434|NCT00853372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
6090435|NCT00853372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6090436|NCT00853372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6090437|NCT00853372|Growth Substances|growth substances|mesh-ancestor
6090438|NCT00853372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090439|NCT00853372|Growth Inhibitors|growth inhibitors|mesh-ancestor
6090440|NCT00853372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6090441|NCT00853372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6090442|NCT00853372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090443|NCT00853385|Adalimumab|adalimumab|mesh-list
6090444|NCT00853385|Tofacitinib|tofacitinib|mesh-list
5519016|NCT04334330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5519017|NCT04334330|Hormone Antagonists|hormone antagonists|mesh-ancestor
5519018|NCT04334330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5519019|NCT04334330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519020|NCT04334330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5519021|NCT04334330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6464309|NCT00469183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6464310|NCT00469183|Protective Agents|protective agents|mesh-ancestor
6464311|NCT00469183|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6464312|NCT00469261|Doxycycline|doxycycline|mesh-list
6464313|NCT00469261|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5519022|NCT04334330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519023|NCT04334382|Azithromycin|azithromycin|mesh-list
5519024|NCT04334382|Hydroxychloroquine|hydroxychloroquine|mesh-list
5519025|NCT04334382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5519026|NCT04334382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5519027|NCT04334382|Antimalarials|antimalarials|mesh-ancestor
5519028|NCT04334382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5519029|NCT04334382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5519030|NCT04334382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5519031|NCT04334382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519032|NCT04334382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5519033|NCT04334005|Vitamin D|vitamin d|mesh-list
6090445|NCT00853385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6464314|NCT00469261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6464315|NCT00469261|Antimalarials|antimalarials|mesh-ancestor
6464316|NCT00469261|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6464317|NCT00469261|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6464318|NCT00469300|Acyclovir|acyclovir|mesh-list
6090446|NCT00853385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6090447|NCT00853385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5519034|NCT04334005|Vitamins|vitamins|mesh-ancestor
5519035|NCT04334005|Micronutrients|micronutrients|mesh-ancestor
5519036|NCT04334005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519037|NCT04334005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6090448|NCT00853385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6090449|NCT00853385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090450|NCT00853580|Lovastatin|lovastatin|mesh-list
6090451|NCT00853580|L 647318|l 647318|mesh-list
6090452|NCT00853580|Dihydromevinolin|dihydromevinolin|mesh-list
6090453|NCT00853580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6090454|NCT00853580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6090455|NCT00853580|Antimetabolites|antimetabolites|mesh-ancestor
6090456|NCT00853580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090457|NCT00853580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6090458|NCT00853580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6090459|NCT00853580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6090460|NCT00853658|Enalapril|enalapril|mesh-list
6090461|NCT00853658|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6090462|NCT00853658|Protease Inhibitors|protease inhibitors|mesh-ancestor
6090463|NCT00853658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6090464|NCT00853658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090465|NCT00853658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6090466|NCT00853671|Adenosine|adenosine|mesh-list
6090467|NCT00853671|Analgesics|analgesics|mesh-ancestor
6090468|NCT00853671|Sensory System Agents|sensory system agents|mesh-ancestor
6090469|NCT00853671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6090470|NCT00853671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090471|NCT00853671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6090472|NCT00853671|Vasodilator Agents|vasodilator agents|mesh-ancestor
6090473|NCT00853671|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6090474|NCT00853671|Purinergic Agonists|purinergic agonists|mesh-ancestor
6090475|NCT00853671|Purinergic Agents|purinergic agents|mesh-ancestor
6090476|NCT00853671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6090477|NCT00853671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090478|NCT00853723|Teriparatide|teriparatide|mesh-list
6090479|NCT00853723|Hormones|hormones|mesh-list
6090480|NCT00853723|Parathyroid Hormone|parathyroid hormone|mesh-list
6090481|NCT00853723|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
6090482|NCT00853723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5519038|NCT04333823|Dapagliflozin|dapagliflozin|mesh-list
5519039|NCT04333823|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5519040|NCT04333823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519041|NCT04333823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5519042|NCT04333823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600842|NCT03709147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5600843|NCT03709147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600844|NCT03709147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5600845|NCT03709147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5600846|NCT03709147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600847|NCT03709147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5600848|NCT03709147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5600849|NCT03709082|Trastuzumab|trastuzumab|mesh-list
5600850|NCT03709082|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
5600851|NCT03709082|Letrozole|letrozole|mesh-list
6090483|NCT00853723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090484|NCT00853723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6090485|NCT00853723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6090486|NCT00853749|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6090487|NCT00853749|Immunologic Factors|immunologic factors|mesh-ancestor
6090488|NCT00853749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090489|NCT00853840|Maraviroc|maraviroc|mesh-list
6090490|NCT00853840|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6090491|NCT00853840|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6090492|NCT00853840|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6090493|NCT00853840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090494|NCT00853840|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6090495|NCT00853840|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6090496|NCT00853840|Antiviral Agents|antiviral agents|mesh-ancestor
6090497|NCT00853840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6090498|NCT00853840|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6090499|NCT00853840|Vasodilator Agents|vasodilator agents|mesh-ancestor
6090500|NCT00853840|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6090501|NCT00853840|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6090502|NCT00853840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6090503|NCT00853840|Urological Agents|urological agents|mesh-ancestor
6090504|NCT00853905|Triamcinolone|triamcinolone|mesh-list
6090505|NCT00853905|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6090506|NCT00853905|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6090507|NCT00853905|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6090508|NCT00853905|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6090509|NCT00853905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6090510|NCT00853905|Glucocorticoids|glucocorticoids|mesh-ancestor
6090511|NCT00853905|Hormones|hormones|mesh-ancestor
6090512|NCT00853905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6090513|NCT00853905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090514|NCT00853905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6090515|NCT00853905|Immunologic Factors|immunologic factors|mesh-ancestor
6090516|NCT00853905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6090517|NCT00853905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090518|NCT00853957|Amlodipine|amlodipine|mesh-list
6464319|NCT00469300|Antiviral Agents|antiviral agents|mesh-ancestor
6464320|NCT00469300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6464321|NCT00469326|Atorvastatin|atorvastatin|mesh-list
6464322|NCT00469326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6464323|NCT00469326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5519043|NCT04333992|Remifentanil|remifentanil|mesh-list
5519044|NCT04333992|Propofol|propofol|mesh-list
5519045|NCT04333992|Sevoflurane|sevoflurane|mesh-list
5519046|NCT04333992|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5519047|NCT04333992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5519048|NCT04333992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090519|NCT00853957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6090520|NCT00853957|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6090521|NCT00853957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6090522|NCT00853957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090523|NCT00853957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6090524|NCT00853957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090525|NCT00853957|Vasodilator Agents|vasodilator agents|mesh-ancestor
6090526|NCT00853970|Bromfenac|bromfenac|mesh-list
6090527|NCT00853970|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6090528|NCT00853970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6090529|NCT00853970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6090530|NCT00853970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6090531|NCT00853970|Analgesics|analgesics|mesh-ancestor
6090532|NCT00853970|Sensory System Agents|sensory system agents|mesh-ancestor
6090533|NCT00853970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6090534|NCT00853970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090535|NCT00853970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6090536|NCT00853970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6090537|NCT00854061|Prednisone|prednisone|mesh-list
6090538|NCT00854061|Prednisolone acetate|prednisolone acetate|mesh-list
5519049|NCT04333992|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6090539|NCT00854061|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6090540|NCT00854061|Methylprednisolone|methylprednisolone|mesh-list
6090541|NCT00854061|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6090542|NCT00854061|Prednisolone|prednisolone|mesh-list
6464324|NCT00469326|Antimetabolites|antimetabolites|mesh-ancestor
5519050|NCT04333992|Anesthetics, General|anesthetics, general|mesh-ancestor
5519051|NCT04333992|Anesthetics|anesthetics|mesh-ancestor
5519052|NCT04333992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5519053|NCT04333992|Narcotics|narcotics|mesh-ancestor
5519054|NCT04333992|Analgesics|analgesics|mesh-ancestor
5519055|NCT04333992|Sensory System Agents|sensory system agents|mesh-ancestor
5519056|NCT04333992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6090543|NCT00854061|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6090544|NCT00854061|Prednisolone phosphate|prednisolone phosphate|mesh-list
6090545|NCT00854061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6090546|NCT00854061|Glucocorticoids|glucocorticoids|mesh-ancestor
6090547|NCT00854061|Hormones|hormones|mesh-ancestor
6090548|NCT00854061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6090549|NCT00854061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090550|NCT00854061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6090551|NCT00854061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6090552|NCT00854061|Antiemetics|antiemetics|mesh-ancestor
6090553|NCT00854061|Autonomic Agents|autonomic agents|mesh-ancestor
6090554|NCT00854061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6090555|NCT00854061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6090556|NCT00854061|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6090557|NCT00854061|Protective Agents|protective agents|mesh-ancestor
6090558|NCT00854100|Cariprazine|cariprazine|mesh-list
6090559|NCT00854100|Antidepressive Agents|antidepressive agents|mesh-list
6090560|NCT00854100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6090561|NCT00854100|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6090562|NCT00854100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6090563|NCT00854100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6090564|NCT00854100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090565|NCT00854113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
6090566|NCT00854113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090567|NCT00854113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6090568|NCT00854113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090569|NCT00854308|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6090570|NCT00854308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6090571|NCT00854308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6090572|NCT00854308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6090573|NCT00854308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090574|NCT00854360|Beclomethasone|beclomethasone|mesh-list
6090575|NCT00854360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6090576|NCT00854360|Glucocorticoids|glucocorticoids|mesh-ancestor
6090577|NCT00854360|Hormones|hormones|mesh-ancestor
6090578|NCT00854360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5519057|NCT04333992|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5519058|NCT04333992|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5519059|NCT04333654|Hydroxychloroquine|hydroxychloroquine|mesh-list
5519060|NCT04333654|Antimalarials|antimalarials|mesh-ancestor
5519061|NCT04333654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5519062|NCT04333654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5519063|NCT04333654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5519064|NCT04333654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5519065|NCT04333654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519066|NCT04333654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5519067|NCT04333628|Chloroquine|chloroquine|mesh-list
5519068|NCT04333628|Amebicides|amebicides|mesh-ancestor
5519069|NCT04333628|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5519070|NCT04333628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5519071|NCT04333628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5519072|NCT04333628|Antimalarials|antimalarials|mesh-ancestor
5519073|NCT04333628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5519074|NCT04333550|Deferoxamine|deferoxamine|mesh-list
6090579|NCT00854360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090580|NCT00854360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6090581|NCT00854360|Respiratory System Agents|respiratory system agents|mesh-ancestor
6090582|NCT00854373|Hormones|hormones|mesh-list
6090583|NCT00854373|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6090584|NCT00854373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6090585|NCT00854373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090586|NCT00854581|Interferons|interferons|mesh-list
6090587|NCT00854581|Interferon-alpha|interferon-alpha|mesh-list
6090588|NCT00854581|Interferon alpha-2|interferon alpha-2|mesh-list
6090589|NCT00854581|Zidovudine|zidovudine|mesh-list
6090590|NCT00854581|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6090591|NCT00854581|Valproic Acid|valproic acid|mesh-list
5519075|NCT04333550|Siderophores|siderophores|mesh-ancestor
5519076|NCT04333550|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5519077|NCT04333550|Chelating Agents|chelating agents|mesh-ancestor
6090592|NCT00854581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6090593|NCT00854581|Antiviral Agents|antiviral agents|mesh-ancestor
5519078|NCT04333550|Sequestering Agents|sequestering agents|mesh-ancestor
5519079|NCT04333550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519080|NCT04333589|Favipiravir|favipiravir|mesh-list
5519081|NCT04333589|Antiviral Agents|antiviral agents|mesh-ancestor
6090594|NCT00854581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6090595|NCT00854581|Immunologic Factors|immunologic factors|mesh-ancestor
6090596|NCT00854581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090597|NCT00854581|Antimetabolites|antimetabolites|mesh-ancestor
6090598|NCT00854581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090599|NCT00854581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6090600|NCT00854581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6090601|NCT00854581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6090602|NCT00854581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6090603|NCT00854581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6090604|NCT00854581|Anticonvulsants|anticonvulsants|mesh-ancestor
6090605|NCT00854581|GABA Agents|gaba agents|mesh-ancestor
6090606|NCT00854581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6090607|NCT00854581|Antimanic Agents|antimanic agents|mesh-ancestor
6090608|NCT00854581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6090609|NCT00854581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6090610|NCT00854581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6090611|NCT00854620|Sorafenib|sorafenib|mesh-list
6090612|NCT00854620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6090613|NCT00854620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6090614|NCT00854620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6090615|NCT00854620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090616|NCT00854724|Puerarin|puerarin|mesh-list
6090617|NCT00854724|Vasodilator Agents|vasodilator agents|mesh-ancestor
6090618|NCT00855010|Pioglitazone|pioglitazone|mesh-list
6090619|NCT00855010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6090620|NCT00855010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090621|NCT00855062|Minocycline|minocycline|mesh-list
5519082|NCT04333589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5519083|NCT04333407|Aspirin|aspirin|mesh-list
5519084|NCT04333407|Omeprazole|omeprazole|mesh-list
5519085|NCT04333407|Rivaroxaban|rivaroxaban|mesh-list
5519086|NCT04333407|Clopidogrel|clopidogrel|mesh-list
5519087|NCT04333407|Atorvastatin|atorvastatin|mesh-list
5519088|NCT04333407|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5519089|NCT04333407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5519090|NCT04333407|Analgesics|analgesics|mesh-ancestor
5519091|NCT04333407|Sensory System Agents|sensory system agents|mesh-ancestor
5519092|NCT04333407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5519093|NCT04333407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519094|NCT04333407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5519095|NCT04333407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5519096|NCT04333407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5519097|NCT04333407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5519098|NCT04333407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519099|NCT04333407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5519100|NCT04333407|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5519101|NCT04333407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5519102|NCT04333407|Antipyretics|antipyretics|mesh-ancestor
5519103|NCT04333407|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5519104|NCT04333407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5519105|NCT04333407|Antimetabolites|antimetabolites|mesh-ancestor
5519106|NCT04333407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5519107|NCT04333407|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5519108|NCT04333407|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5519109|NCT04333407|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5519110|NCT04333407|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5519111|NCT04333407|Purinergic Agents|purinergic agents|mesh-ancestor
5519112|NCT04333407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6090622|NCT00855062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6090623|NCT00855062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6090624|NCT00855166|Metformin|metformin|mesh-list
6090625|NCT00855166|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6090626|NCT00855166|Dapagliflozin|dapagliflozin|mesh-list
6090627|NCT00855166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6090628|NCT00855166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090629|NCT00855166|Incretins|incretins|mesh-ancestor
6090630|NCT00855166|Hormones|hormones|mesh-ancestor
6090631|NCT00855166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6090632|NCT00855166|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6090633|NCT00855166|Protease Inhibitors|protease inhibitors|mesh-ancestor
6090634|NCT00855166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6090635|NCT00855166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090636|NCT00855166|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5519113|NCT04333407|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5519114|NCT04333407|Antithrombins|antithrombins|mesh-ancestor
5519115|NCT04333407|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5519116|NCT04333407|Protease Inhibitors|protease inhibitors|mesh-ancestor
5519117|NCT04333407|Anticoagulants|anticoagulants|mesh-ancestor
5519118|NCT04333407|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5519119|NCT04333407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5519120|NCT04333407|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5519121|NCT04332978|Fluticasone|fluticasone|mesh-list
5519122|NCT04332978|Xhance|xhance|mesh-list
6090637|NCT00855218|Sorafenib|sorafenib|mesh-list
6090638|NCT00855218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6090639|NCT00855218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6090640|NCT00855218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6090641|NCT00855218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090642|NCT00855309|Acyclovir|acyclovir|mesh-list
6090643|NCT00855309|Antiviral Agents|antiviral agents|mesh-ancestor
6090644|NCT00855309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6090645|NCT00855335|Ritonavir|ritonavir|mesh-list
6090646|NCT00855335|Darunavir|darunavir|mesh-list
6090647|NCT00855335|Cobicistat|cobicistat|mesh-list
6090648|NCT00855335|Rilpivirine|rilpivirine|mesh-list
6090649|NCT00855335|Etravirine|etravirine|mesh-list
6090650|NCT00855335|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6090651|NCT00855335|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6090652|NCT00855335|Protease Inhibitors|protease inhibitors|mesh-ancestor
6090653|NCT00855335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6090654|NCT00855335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090655|NCT00855335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6090656|NCT00855335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6090657|NCT00855335|Antiviral Agents|antiviral agents|mesh-ancestor
6090658|NCT00855335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6090659|NCT00855335|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6090660|NCT00855335|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6090661|NCT00855335|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6090662|NCT00855335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6090663|NCT00855413|Ritonavir|ritonavir|mesh-list
6090664|NCT00855413|Darunavir|darunavir|mesh-list
6090665|NCT00855413|Etravirine|etravirine|mesh-list
6090666|NCT00855413|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6090667|NCT00855413|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6090668|NCT00855413|Protease Inhibitors|protease inhibitors|mesh-ancestor
6090669|NCT00855413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6090670|NCT00855413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090671|NCT00855413|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6090672|NCT00855413|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6090673|NCT00855413|Antiviral Agents|antiviral agents|mesh-ancestor
6090674|NCT00855413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6090675|NCT00855413|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6090676|NCT00855413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6090677|NCT00855413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6090678|NCT00855413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6090679|NCT00855439|Exenatide|exenatide|mesh-list
6090680|NCT00855439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6090681|NCT00855439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090682|NCT00855439|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6090683|NCT00855439|Incretins|incretins|mesh-ancestor
6090684|NCT00855439|Hormones|hormones|mesh-ancestor
6090685|NCT00855439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6090686|NCT00855465|Riociguat|riociguat|mesh-list
6090687|NCT00855465|Enzyme Activators|enzyme activators|mesh-ancestor
6090688|NCT00855465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090689|NCT00855582|Tadalafil|tadalafil|mesh-list
6090690|NCT00855582|Vasodilator Agents|vasodilator agents|mesh-ancestor
5519123|NCT04332978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5519124|NCT04332978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5519125|NCT04332978|Autonomic Agents|autonomic agents|mesh-ancestor
5519126|NCT04332978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5519127|NCT04332978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519128|NCT04332978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5519129|NCT04332978|Respiratory System Agents|respiratory system agents|mesh-ancestor
6090691|NCT00855582|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6090692|NCT00855582|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6090693|NCT00855582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6090694|NCT00855582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090695|NCT00855582|Urological Agents|urological agents|mesh-ancestor
6090696|NCT00855595|Metronidazole|metronidazole|mesh-list
6090697|NCT00855595|Doxycycline|doxycycline|mesh-list
6090698|NCT00855595|Azelaic acid|azelaic acid|mesh-list
6090699|NCT00855595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6090700|NCT00855595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6090701|NCT00855595|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6090702|NCT00855595|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6090703|NCT00855595|Antimalarials|antimalarials|mesh-ancestor
6090704|NCT00855595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6090705|NCT00855595|Dermatologic Agents|dermatologic agents|mesh-ancestor
6090706|NCT00855738|Topiramate|topiramate|mesh-list
6090707|NCT00855738|Pregabalin|pregabalin|mesh-list
6090708|NCT00855738|Lamotrigine|lamotrigine|mesh-list
6090709|NCT00855738|Zonisamide|zonisamide|mesh-list
6090710|NCT00855738|Gabapentin|gabapentin|mesh-list
6090711|NCT00855738|Levetiracetam|levetiracetam|mesh-list
6090712|NCT00855738|Tiagabine|tiagabine|mesh-list
6090713|NCT00855738|Analgesics|analgesics|mesh-ancestor
6090714|NCT00855738|Sensory System Agents|sensory system agents|mesh-ancestor
6090715|NCT00855738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6090716|NCT00855738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090717|NCT00855738|Anticonvulsants|anticonvulsants|mesh-ancestor
6090718|NCT00855738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6090719|NCT00855738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6090720|NCT00855738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090721|NCT00855738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6090722|NCT00855738|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6090723|NCT00855738|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6090724|NCT00855738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6090725|NCT00855738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6090726|NCT00855738|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6090727|NCT00855738|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6090728|NCT00855738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6090729|NCT00855738|Antimanic Agents|antimanic agents|mesh-ancestor
6090730|NCT00855738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6090731|NCT00855738|Nootropic Agents|nootropic agents|mesh-ancestor
6090732|NCT00855738|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6090733|NCT00855738|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6090734|NCT00855738|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
6090735|NCT00855738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6090736|NCT00855738|GABA Agents|gaba agents|mesh-ancestor
6090737|NCT00855894|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6090738|NCT00855894|Pertuzumab|pertuzumab|mesh-list
6090739|NCT00855894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6090740|NCT00855894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6090741|NCT00855894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6090742|NCT00855894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090743|NCT00855894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6090744|NCT00855920|Indomethacin|indomethacin|mesh-list
6090745|NCT00855920|Rilonacept|rilonacept|mesh-list
6090746|NCT00855920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6090747|NCT00855920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6090748|NCT00855920|Analgesics|analgesics|mesh-ancestor
6090749|NCT00855920|Sensory System Agents|sensory system agents|mesh-ancestor
6090750|NCT00855920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6090751|NCT00855920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090752|NCT00855920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6090753|NCT00855920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6090754|NCT00855920|Gout Suppressants|gout suppressants|mesh-ancestor
6090755|NCT00855920|Tocolytic Agents|tocolytic agents|mesh-ancestor
6090756|NCT00855920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6090757|NCT00855920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5519130|NCT04332978|Dermatologic Agents|dermatologic agents|mesh-ancestor
6090758|NCT00855920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6090759|NCT00855920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519131|NCT04332978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5519132|NCT04332874|Dactinomycin|dactinomycin|mesh-list
5519133|NCT04332874|Pembrolizumab|pembrolizumab|mesh-list
5519134|NCT04332874|Melphalan|melphalan|mesh-list
5519135|NCT04332874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5519136|NCT04332874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5519137|NCT04332874|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5519138|NCT04332874|Alkylating Agents|alkylating agents|mesh-ancestor
6090760|NCT00855933|Cetylpyridinium|cetylpyridinium|mesh-list
6090761|NCT00855933|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6090762|NCT00855933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6090763|NCT00855959|Budesonide|budesonide|mesh-list
6090764|NCT00855959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6090765|NCT00855959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6090766|NCT00855959|Autonomic Agents|autonomic agents|mesh-ancestor
6090767|NCT00855959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6090768|NCT00855959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090769|NCT00855959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6090770|NCT00855959|Respiratory System Agents|respiratory system agents|mesh-ancestor
6090771|NCT00855959|Glucocorticoids|glucocorticoids|mesh-ancestor
6090772|NCT00855959|Hormones|hormones|mesh-ancestor
6090773|NCT00855959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6090774|NCT00856024|Ribavirin|ribavirin|mesh-list
6090775|NCT00856024|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6090776|NCT00856024|Antimetabolites|antimetabolites|mesh-ancestor
6090777|NCT00856024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090778|NCT00856024|Antiviral Agents|antiviral agents|mesh-ancestor
6090779|NCT00856024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6090780|NCT00856050|Letrozole|letrozole|mesh-list
6090781|NCT00856050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6090782|NCT00856050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6090783|NCT00856050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6090784|NCT00856050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6090785|NCT00856050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090786|NCT00856050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6090787|NCT00856050|Hormone Antagonists|hormone antagonists|mesh-ancestor
6090788|NCT00856050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6090789|NCT00856050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090790|NCT00856180|Cyclophosphamide|cyclophosphamide|mesh-list
5519139|NCT04332874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519140|NCT04332874|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5519141|NCT04332874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5519142|NCT04332874|Immunologic Factors|immunologic factors|mesh-ancestor
5519143|NCT04332874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519144|NCT04332874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5519145|NCT04332874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5519146|NCT04332874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5519147|NCT04332874|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5519148|NCT04332874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5519149|NCT04332874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5519150|NCT04333095|Bupivacaine|bupivacaine|mesh-list
5519151|NCT04333095|Anesthetics, Local|anesthetics, local|mesh-ancestor
5519152|NCT04333095|Anesthetics|anesthetics|mesh-ancestor
5519153|NCT04333095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5519154|NCT04333095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665712|NCT01518465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519155|NCT04333095|Sensory System Agents|sensory system agents|mesh-ancestor
6090791|NCT00856180|Bevacizumab|bevacizumab|mesh-list
6090792|NCT00856180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6090793|NCT00856180|Immunologic Factors|immunologic factors|mesh-ancestor
6090794|NCT00856180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090795|NCT00856180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6090796|NCT00856180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6090797|NCT00856180|Alkylating Agents|alkylating agents|mesh-ancestor
6090798|NCT00856180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090799|NCT00856180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6090800|NCT00856180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6090801|NCT00856180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6090802|NCT00856180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6090803|NCT00856180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6090804|NCT00856180|Growth Substances|growth substances|mesh-ancestor
6090805|NCT00856180|Growth Inhibitors|growth inhibitors|mesh-ancestor
6203280|NCT02055352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6203281|NCT02055352|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6203282|NCT02055352|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6203283|NCT02055352|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6203284|NCT02055352|Adrenergic Agents|adrenergic agents|mesh-ancestor
6203285|NCT02055352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6203286|NCT02055352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203287|NCT02055638|SRX246|srx246|mesh-list
6203288|NCT02055638|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6203289|NCT02055638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203290|NCT02055638|Natriuretic Agents|natriuretic agents|mesh-ancestor
6203291|NCT02055638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203292|NCT02055820|Prednisone|prednisone|mesh-list
6203293|NCT02055820|Cyclophosphamide|cyclophosphamide|mesh-list
6203294|NCT02055820|Rituximab|rituximab|mesh-list
6203295|NCT02055820|Doxorubicin|doxorubicin|mesh-list
6203296|NCT02055820|Vincristine|vincristine|mesh-list
6203297|NCT02055820|Venetoclax|venetoclax|mesh-list
6203298|NCT02055820|Obinutuzumab|obinutuzumab|mesh-list
6203299|NCT02055820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6203300|NCT02055820|Immunologic Factors|immunologic factors|mesh-ancestor
6203301|NCT02055820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203302|NCT02055820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6203303|NCT02055820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6203304|NCT02055820|Alkylating Agents|alkylating agents|mesh-ancestor
6203305|NCT02055820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203306|NCT02055820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6203307|NCT02055820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6464325|NCT00469326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6464326|NCT00469326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6203308|NCT02055820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6203309|NCT02055820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6203310|NCT02055820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6203311|NCT02055820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6203312|NCT02055820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6203313|NCT02055820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6203314|NCT02055820|Glucocorticoids|glucocorticoids|mesh-ancestor
6203315|NCT02055820|Hormones|hormones|mesh-ancestor
6203316|NCT02055820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6203317|NCT02055820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6203318|NCT02055820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6203319|NCT02055820|Tubulin Modulators|tubulin modulators|mesh-ancestor
6203320|NCT02055820|Antimitotic Agents|antimitotic agents|mesh-ancestor
6203321|NCT02055820|Mitosis Modulators|mitosis modulators|mesh-ancestor
6203322|NCT02055898|Sodium Oxybate|sodium oxybate|mesh-list
6203323|NCT02055898|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6203324|NCT02055898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6203325|NCT02055898|Anesthetics, General|anesthetics, general|mesh-ancestor
6203326|NCT02055898|Anesthetics|anesthetics|mesh-ancestor
6203327|NCT02055898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6203328|NCT02055898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203329|NCT02055976|Ezetimibe|ezetimibe|mesh-list
6203330|NCT02055976|Bococizumab|bococizumab|mesh-list
6203331|NCT02055976|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6203332|NCT02055976|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6203333|NCT02055976|Antimetabolites|antimetabolites|mesh-ancestor
6203334|NCT02055976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203335|NCT02055976|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6090806|NCT00856193|Glycopyrrolate|glycopyrrolate|mesh-list
6090807|NCT00856193|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6090808|NCT00856193|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6090809|NCT00856193|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6090810|NCT00856193|Cholinergic Agents|cholinergic agents|mesh-ancestor
6090811|NCT00856193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6090812|NCT00856193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090813|NCT00856193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090814|NCT00856206|Rilonacept|rilonacept|mesh-list
6090815|NCT00856206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6090816|NCT00856245|Rituximab|rituximab|mesh-list
6090817|NCT00856245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6090818|NCT00856245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6090819|NCT00856245|Immunologic Factors|immunologic factors|mesh-ancestor
6090820|NCT00856245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090821|NCT00856245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6090822|NCT00856284|Metformin|metformin|mesh-list
6090823|NCT00856284|Alogliptin|alogliptin|mesh-list
6090824|NCT00856284|Glipizide|glipizide|mesh-list
6090825|NCT00856284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6090826|NCT00856284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090827|NCT00856284|Incretins|incretins|mesh-ancestor
6090828|NCT00856284|Hormones|hormones|mesh-ancestor
6090829|NCT00856284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6090830|NCT00856284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6090831|NCT00856284|Protease Inhibitors|protease inhibitors|mesh-ancestor
6090832|NCT00856284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6090833|NCT00856284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090834|NCT00856297|Vaccines|vaccines|mesh-list
6090835|NCT00856297|Immunologic Factors|immunologic factors|mesh-ancestor
6090836|NCT00856297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090837|NCT00856323|Tenofovir|tenofovir|mesh-list
6090838|NCT00856323|Emtricitabine|emtricitabine|mesh-list
6090839|NCT00856323|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6090840|NCT00856323|Antiviral Agents|antiviral agents|mesh-ancestor
6090841|NCT00856323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6090842|NCT00856323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6090843|NCT00856323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6090844|NCT00856323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6090845|NCT00856323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090846|NCT00856323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6090847|NCT00856323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6090848|NCT00856375|Irinotecan|irinotecan|mesh-list
6090849|NCT00856375|Etirinotecan pegol|etirinotecan pegol|mesh-list
6090850|NCT00856375|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6090851|NCT00856375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6090852|NCT00856375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6090853|NCT00856375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090854|NCT00856375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6090855|NCT00856375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6090856|NCT00856388|Fludarabine|fludarabine|mesh-list
6090857|NCT00856388|Fludarabine phosphate|fludarabine phosphate|mesh-list
6090858|NCT00856388|Melphalan|melphalan|mesh-list
6090859|NCT00856388|Thymoglobulin|thymoglobulin|mesh-list
6090860|NCT00856388|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6090861|NCT00856388|Immunoglobulins|immunoglobulins|mesh-list
6090862|NCT00856388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6090863|NCT00856388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6090864|NCT00856388|Antimetabolites|antimetabolites|mesh-ancestor
6090865|NCT00856388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090866|NCT00856388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6090867|NCT00856388|Immunologic Factors|immunologic factors|mesh-ancestor
6090868|NCT00856388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090869|NCT00856388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6090870|NCT00856388|Alkylating Agents|alkylating agents|mesh-ancestor
6090871|NCT00856388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6090872|NCT00856414|Botulinum Toxins|botulinum toxins|mesh-list
6090873|NCT00856414|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6090874|NCT00856414|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6090875|NCT00856414|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6090876|NCT00856414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6090877|NCT00856414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090878|NCT00856414|Cholinergic Agents|cholinergic agents|mesh-ancestor
6090879|NCT00856414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6090880|NCT00856414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090881|NCT00856414|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6090882|NCT00856414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6090883|NCT00856492|Paclitaxel|paclitaxel|mesh-list
6090884|NCT00856492|Cyclophosphamide|cyclophosphamide|mesh-list
6090885|NCT00856492|Bevacizumab|bevacizumab|mesh-list
6090886|NCT00856492|Doxorubicin|doxorubicin|mesh-list
6090887|NCT00856492|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6090888|NCT00856492|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6090889|NCT00856492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6090890|NCT00856492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6090891|NCT00856492|Tubulin Modulators|tubulin modulators|mesh-ancestor
6090892|NCT00856492|Antimitotic Agents|antimitotic agents|mesh-ancestor
6090893|NCT00856492|Mitosis Modulators|mitosis modulators|mesh-ancestor
6090894|NCT00856492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090895|NCT00856492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6464327|NCT00469326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6464328|NCT00469326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6464329|NCT00469352|Ranibizumab|ranibizumab|mesh-list
6464330|NCT00469352|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6464331|NCT00469352|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6090896|NCT00856492|Immunologic Factors|immunologic factors|mesh-ancestor
6090897|NCT00856492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090898|NCT00856492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6090899|NCT00856492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6090900|NCT00856492|Alkylating Agents|alkylating agents|mesh-ancestor
6090901|NCT00856492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6090902|NCT00856492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6090903|NCT00856492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6090904|NCT00856492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6090905|NCT00856492|Growth Substances|growth substances|mesh-ancestor
6090906|NCT00856492|Growth Inhibitors|growth inhibitors|mesh-ancestor
6090907|NCT00856492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6090908|NCT00856492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6090909|NCT00856492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6090910|NCT00856492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6090911|NCT00856544|Tofacitinib|tofacitinib|mesh-list
6090912|NCT00856544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6090913|NCT00856544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6090914|NCT00856544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090915|NCT00856583|Risperidone|risperidone|mesh-list
6090916|NCT00856583|Sertindole|sertindole|mesh-list
6090917|NCT00856583|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6090918|NCT00856583|Serotonin Agents|serotonin agents|mesh-ancestor
6090919|NCT00856583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6090920|NCT00856583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090921|NCT00856583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090922|NCT00856583|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6090923|NCT00856583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5519156|NCT04333095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5519157|NCT04333004|Pembrolizumab|pembrolizumab|mesh-list
5519158|NCT04333004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5519159|NCT04333004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5519160|NCT04333160|Hylan|hylan|mesh-list
5519161|NCT04333160|Viscosupplements|viscosupplements|mesh-ancestor
5519162|NCT04333160|Protective Agents|protective agents|mesh-ancestor
5519163|NCT04333160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519164|NCT04332744|Talazoparib|talazoparib|mesh-list
5519165|NCT04332744|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5519166|NCT04332744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6090924|NCT00856583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6090925|NCT00856583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6090926|NCT00856583|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6090927|NCT00856583|Dopamine Agents|dopamine agents|mesh-ancestor
6090928|NCT00856609|Exenatide|exenatide|mesh-list
6090929|NCT00856609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6090930|NCT00856609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090931|NCT00856609|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6090932|NCT00856609|Incretins|incretins|mesh-ancestor
6090933|NCT00856609|Hormones|hormones|mesh-ancestor
5519167|NCT04332744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519168|NCT04332744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5519169|NCT04332627|Neostigmine|neostigmine|mesh-list
5519170|NCT04332627|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5519171|NCT04332627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5519172|NCT04332627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090934|NCT00856609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6090935|NCT00856635|Glatiramer Acetate|glatiramer acetate|mesh-list
6090936|NCT00856635|(T,G)-A-L|(t,g)-a-l|mesh-list
6090937|NCT00856635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6090938|NCT00856635|Immunologic Factors|immunologic factors|mesh-ancestor
6090939|NCT00856635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519173|NCT04332627|Cholinergic Agents|cholinergic agents|mesh-ancestor
5519174|NCT04332627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5519175|NCT04332627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519176|NCT04332627|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5519177|NCT04332627|Autonomic Agents|autonomic agents|mesh-ancestor
5519178|NCT04332627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6090940|NCT00856635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6090941|NCT00856635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6090942|NCT00856661|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
5519182|NCT04332666|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
5519183|NCT04332666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5519184|NCT04332666|Vasodilator Agents|vasodilator agents|mesh-ancestor
5519185|NCT04332536|Codeine|codeine|mesh-list
5519186|NCT04332536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5519187|NCT04332536|Narcotics|narcotics|mesh-ancestor
5519188|NCT04332536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5519189|NCT04332536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090943|NCT00856661|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6090944|NCT00856661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6090945|NCT00856661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090946|NCT00856726|Parathyroid Hormone|parathyroid hormone|mesh-list
6090947|NCT00856726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6090948|NCT00856726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090949|NCT00856791|ON 01910|on 01910|mesh-list
6090950|NCT00856791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6090951|NCT00856791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6090952|NCT00856791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6090953|NCT00856791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090954|NCT00856830|Carboplatin|carboplatin|mesh-list
6090955|NCT00856830|Irinotecan|irinotecan|mesh-list
6090956|NCT00856830|Etoposide|etoposide|mesh-list
6090957|NCT00856830|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6090958|NCT00856830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6090959|NCT00856830|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6090960|NCT00856830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6090961|NCT00856830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6090962|NCT00856830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090963|NCT00856830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6090964|NCT00856830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6090965|NCT00856830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6090966|NCT00856830|Alkylating Agents|alkylating agents|mesh-ancestor
6090967|NCT00856843|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
6090968|NCT00856843|Laxatives|laxatives|mesh-ancestor
6090969|NCT00856843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6090970|NCT00856856|Everolimus|everolimus|mesh-list
6090971|NCT00856856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6090972|NCT00856856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6090973|NCT00856856|Immunologic Factors|immunologic factors|mesh-ancestor
6090974|NCT00856856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090975|NCT00856973|Eszopiclone|eszopiclone|mesh-list
6090976|NCT00856973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6090977|NCT00856973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6090978|NCT00856973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090979|NCT00856986|Metformin|metformin|mesh-list
6090980|NCT00856986|Liraglutide|liraglutide|mesh-list
6090981|NCT00856986|Insulin Detemir|insulin detemir|mesh-list
6090982|NCT00856986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6090983|NCT00856986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090984|NCT00856986|Incretins|incretins|mesh-ancestor
6090985|NCT00856986|Hormones|hormones|mesh-ancestor
6090986|NCT00856986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6090987|NCT00857220|Eszopiclone|eszopiclone|mesh-list
6090988|NCT00857220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6464332|NCT00469352|Growth Substances|growth substances|mesh-ancestor
6464333|NCT00469352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464334|NCT00469352|Growth Inhibitors|growth inhibitors|mesh-ancestor
6464335|NCT00469352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6464336|NCT00469404|Buprenorphine|buprenorphine|mesh-list
5519190|NCT04332536|Analgesics|analgesics|mesh-ancestor
6464337|NCT00469404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6464338|NCT00469404|Narcotics|narcotics|mesh-ancestor
6464339|NCT00469404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6464340|NCT00469404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464341|NCT00469404|Analgesics|analgesics|mesh-ancestor
6464342|NCT00469404|Sensory System Agents|sensory system agents|mesh-ancestor
6464343|NCT00469404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6464344|NCT00469404|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5519191|NCT04332536|Sensory System Agents|sensory system agents|mesh-ancestor
6090989|NCT00857220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6090990|NCT00857220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090991|NCT00857233|Memantine|memantine|mesh-list
5519192|NCT04332536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5519193|NCT04332536|Antitussive Agents|antitussive agents|mesh-ancestor
5519194|NCT04332536|Respiratory System Agents|respiratory system agents|mesh-ancestor
5519195|NCT04332809|Gentamicins|gentamicins|mesh-list
5519196|NCT04332809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5519197|NCT04332809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5519198|NCT04332809|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5519199|NCT04332809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5519200|NCT04332809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519201|NCT04332367|Paclitaxel|paclitaxel|mesh-list
5519202|NCT04332367|Carboplatin|carboplatin|mesh-list
5519203|NCT04332367|Ramucirumab|ramucirumab|mesh-list
5519204|NCT04332367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6090992|NCT00857233|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6090993|NCT00857233|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6090994|NCT00857233|Dopamine Agents|dopamine agents|mesh-ancestor
6090995|NCT00857233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6090996|NCT00857233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6090997|NCT00857233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6090998|NCT00857233|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6090999|NCT00857233|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6091000|NCT00857246|Irinotecan|irinotecan|mesh-list
6091001|NCT00857246|Cetuximab|cetuximab|mesh-list
6091002|NCT00857246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6091003|NCT00857246|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6091004|NCT00857246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6091005|NCT00857246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6091006|NCT00857246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091007|NCT00857246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6091008|NCT00857259|Everolimus|everolimus|mesh-list
6091009|NCT00857259|Ranibizumab|ranibizumab|mesh-list
6091010|NCT00857259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6091011|NCT00857259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6091012|NCT00857259|Immunologic Factors|immunologic factors|mesh-ancestor
6091013|NCT00857259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091014|NCT00857259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6091015|NCT00857259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6091016|NCT00857259|Growth Substances|growth substances|mesh-ancestor
6091017|NCT00857259|Growth Inhibitors|growth inhibitors|mesh-ancestor
5519205|NCT04332367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5519206|NCT04332367|Tubulin Modulators|tubulin modulators|mesh-ancestor
5519207|NCT04332367|Antimitotic Agents|antimitotic agents|mesh-ancestor
5519208|NCT04332367|Mitosis Modulators|mitosis modulators|mesh-ancestor
5519209|NCT04332367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519210|NCT04332276|Dopamine|dopamine|mesh-list
5519211|NCT04332276|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5519212|NCT04332276|Sympathomimetics|sympathomimetics|mesh-ancestor
5519213|NCT04332276|Autonomic Agents|autonomic agents|mesh-ancestor
5519214|NCT04332276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6091018|NCT00857272|Bisacodyl|bisacodyl|mesh-list
6091019|NCT00857272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6091020|NCT00857272|Cathartics|cathartics|mesh-ancestor
6091021|NCT00857272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6091022|NCT00857272|Laxatives|laxatives|mesh-ancestor
6091023|NCT00857311|Vaccines|vaccines|mesh-list
6091024|NCT00857311|Immunologic Factors|immunologic factors|mesh-ancestor
6091025|NCT00857311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519215|NCT04332276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519216|NCT04332276|Dopamine Agents|dopamine agents|mesh-ancestor
5519217|NCT04332276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6091026|NCT00857389|Cyclophosphamide|cyclophosphamide|mesh-list
6464345|NCT00469417|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5519218|NCT04332276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091027|NCT00857389|Busulfan|busulfan|mesh-list
5519219|NCT04332276|Protective Agents|protective agents|mesh-ancestor
5519220|NCT04332289|Deuterium Oxide|deuterium oxide|mesh-list
5519221|NCT04332289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5519222|NCT04332289|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5519223|NCT04332289|Protective Agents|protective agents|mesh-ancestor
5519224|NCT04332289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519225|NCT04332497|Ibuprofen|ibuprofen|mesh-list
6091028|NCT00857389|Thiotepa|thiotepa|mesh-list
6091029|NCT00857389|Methotrexate|methotrexate|mesh-list
6091030|NCT00857389|Clofarabine|clofarabine|mesh-list
6091031|NCT00857389|Tacrolimus|tacrolimus|mesh-list
6091032|NCT00857389|Thymoglobulin|thymoglobulin|mesh-list
6091033|NCT00857389|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6091034|NCT00857389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6091035|NCT00857389|Immunologic Factors|immunologic factors|mesh-ancestor
6091036|NCT00857389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091037|NCT00857389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6091038|NCT00857389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6091039|NCT00857389|Alkylating Agents|alkylating agents|mesh-ancestor
6091040|NCT00857389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091041|NCT00857389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6091042|NCT00857389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6091043|NCT00857389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6091044|NCT00857389|Abortifacient Agents|abortifacient agents|mesh-ancestor
6665713|NCT01518465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6665714|NCT01518465|Glucocorticoids|glucocorticoids|mesh-ancestor
6665715|NCT01518465|Hormones|hormones|mesh-ancestor
6665716|NCT01518465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5519226|NCT04332497|Fentanyl|fentanyl|mesh-list
5519227|NCT04332497|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6665717|NCT01518465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6665718|NCT01518465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6665719|NCT01518465|Immunologic Factors|immunologic factors|mesh-ancestor
6665720|NCT01518465|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6665721|NCT01518465|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6665722|NCT01518465|Growth Substances|growth substances|mesh-ancestor
6665723|NCT01518465|Growth Inhibitors|growth inhibitors|mesh-ancestor
6665724|NCT01518465|Anticoagulants|anticoagulants|mesh-ancestor
5519228|NCT04332497|Narcotics|narcotics|mesh-ancestor
5519229|NCT04332497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5519230|NCT04332497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519231|NCT04332497|Analgesics|analgesics|mesh-ancestor
5519232|NCT04332497|Sensory System Agents|sensory system agents|mesh-ancestor
5519233|NCT04332497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5519234|NCT04332497|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5519235|NCT04332497|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5519236|NCT04332497|Anesthetics, General|anesthetics, general|mesh-ancestor
5519237|NCT04332497|Anesthetics|anesthetics|mesh-ancestor
5519238|NCT04332497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5725186|NCT03182088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725187|NCT03182088|Sensory System Agents|sensory system agents|mesh-ancestor
5725188|NCT03182088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5725189|NCT03182088|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5725190|NCT03182088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5725191|NCT03182088|Adrenergic Agents|adrenergic agents|mesh-ancestor
5725192|NCT03182088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5725193|NCT03182088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725194|NCT03182088|Sympathomimetics|sympathomimetics|mesh-ancestor
5725195|NCT03182088|Autonomic Agents|autonomic agents|mesh-ancestor
5725196|NCT03182088|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5725197|NCT03182140|Levonorgestrel|levonorgestrel|mesh-list
5725198|NCT03182140|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5725199|NCT03182140|Contraceptive Agents|contraceptive agents|mesh-ancestor
5725200|NCT03182140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5725201|NCT03182140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091045|NCT00857389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6091046|NCT00857389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6091047|NCT00857389|Antimetabolites|antimetabolites|mesh-ancestor
6091048|NCT00857389|Dermatologic Agents|dermatologic agents|mesh-ancestor
6091049|NCT00857389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6091050|NCT00857389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6091051|NCT00857389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6091052|NCT00857389|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6091053|NCT00857454|Testosterone|testosterone|mesh-list
6091054|NCT00857454|Androgens|androgens|mesh-ancestor
6091055|NCT00857454|Hormones|hormones|mesh-ancestor
6091056|NCT00857454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6091057|NCT00857454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091058|NCT00857545|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
6091059|NCT00857545|Immunologic Factors|immunologic factors|mesh-ancestor
6091060|NCT00857545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091061|NCT00857584|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6091062|NCT00857584|Sertraline|sertraline|mesh-list
6091063|NCT00857584|Antidepressive Agents|antidepressive agents|mesh-ancestor
6091064|NCT00857584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6091065|NCT00857584|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6091066|NCT00857584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6091067|NCT00857584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6091068|NCT00857584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091069|NCT00857584|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6091070|NCT00857584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6091071|NCT00857584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6091072|NCT00857584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091073|NCT00857584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6091074|NCT00857584|Serotonin Agents|serotonin agents|mesh-ancestor
6091075|NCT00857649|Memantine|memantine|mesh-list
6091076|NCT00857649|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6091077|NCT00857649|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6091078|NCT00857649|Dopamine Agents|dopamine agents|mesh-ancestor
5519239|NCT04332497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5519240|NCT04332497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5519241|NCT04332497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5519242|NCT04332497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5519243|NCT04332497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5519244|NCT04332497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519245|NCT04332341|Niacinamide|niacinamide|mesh-list
5519246|NCT04332341|Niacin|niacin|mesh-list
5519247|NCT04332341|Nicotinic Acids|nicotinic acids|mesh-list
5519248|NCT04332341|Vitamin B Complex|vitamin b complex|mesh-ancestor
5519249|NCT04332341|Vitamins|vitamins|mesh-ancestor
5519250|NCT04332341|Micronutrients|micronutrients|mesh-ancestor
5519251|NCT04332341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519252|NCT04332341|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5519253|NCT04332341|Antimetabolites|antimetabolites|mesh-ancestor
5519254|NCT04332341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519255|NCT04332341|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5519256|NCT04332341|Vasodilator Agents|vasodilator agents|mesh-ancestor
5519257|NCT04332042|Tofacitinib|tofacitinib|mesh-list
6091079|NCT00857649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6091080|NCT00857649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091081|NCT00857649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091082|NCT00857649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6091083|NCT00857649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6091084|NCT00857714|Lapatinib|lapatinib|mesh-list
6091085|NCT00857714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6091086|NCT00857714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6091087|NCT00857714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6091088|NCT00857714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091089|NCT00857727|Dexmedetomidine|dexmedetomidine|mesh-list
6091090|NCT00857727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6091091|NCT00857727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6091092|NCT00857727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091093|NCT00857727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6091094|NCT00857727|Analgesics|analgesics|mesh-ancestor
6091095|NCT00857727|Sensory System Agents|sensory system agents|mesh-ancestor
6091096|NCT00857727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6091097|NCT00857727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6091098|NCT00857727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6091099|NCT00857727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6091100|NCT00857727|Adrenergic Agents|adrenergic agents|mesh-ancestor
6091101|NCT00857727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6091102|NCT00857727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091103|NCT00857766|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6091104|NCT00857766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6091105|NCT00857766|Autonomic Agents|autonomic agents|mesh-ancestor
6091106|NCT00857766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6091107|NCT00857766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519258|NCT04332042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6091108|NCT00857766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6091109|NCT00857766|Respiratory System Agents|respiratory system agents|mesh-ancestor
6091110|NCT00857766|Glucocorticoids|glucocorticoids|mesh-ancestor
6091111|NCT00857766|Hormones|hormones|mesh-ancestor
6091112|NCT00857766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6091113|NCT00857766|Sympathomimetics|sympathomimetics|mesh-ancestor
5519259|NCT04332042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5519260|NCT04332042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519261|NCT04332393|Metformin|metformin|mesh-list
5519262|NCT04332393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6091114|NCT00857792|Regadenoson|regadenoson|mesh-list
6091115|NCT00857792|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
6464346|NCT00469417|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
6464347|NCT00469417|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6464348|NCT00469417|Dermatologic Agents|dermatologic agents|mesh-ancestor
6464349|NCT00469430|Metronidazole|metronidazole|mesh-list
6464350|NCT00469430|Cefotaxime|cefotaxime|mesh-list
6464351|NCT00469430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6464352|NCT00469430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6464353|NCT00469430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6464354|NCT00469430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6464355|NCT00469443|Leucovorin|leucovorin|mesh-list
6464356|NCT00469443|Bevacizumab|bevacizumab|mesh-list
6464357|NCT00469443|Fluorouracil|fluorouracil|mesh-list
6464358|NCT00469443|Capecitabine|capecitabine|mesh-list
6464359|NCT00469443|Irinotecan|irinotecan|mesh-list
6464360|NCT00469443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6464361|NCT00469443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6091116|NCT00857792|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6091117|NCT00857792|Purinergic Agonists|purinergic agonists|mesh-ancestor
6091118|NCT00857792|Purinergic Agents|purinergic agents|mesh-ancestor
6091119|NCT00857792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6091120|NCT00857792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091121|NCT00857792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091122|NCT00857818|Risperidone|risperidone|mesh-list
5519263|NCT04332393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519264|NCT04332094|Azithromycin|azithromycin|mesh-list
5519265|NCT04332094|Hydroxychloroquine|hydroxychloroquine|mesh-list
5519266|NCT04332094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5519267|NCT04332094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5519268|NCT04332094|Antimalarials|antimalarials|mesh-ancestor
5519269|NCT04332094|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5519270|NCT04332094|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5519271|NCT04332094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5519272|NCT04332094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519273|NCT04332094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5600852|NCT03709082|Palbociclib|palbociclib|mesh-list
5600853|NCT03709082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5600854|NCT03709082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5600855|NCT03709082|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5600856|NCT03709082|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5600857|NCT03709082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5600858|NCT03709082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600859|NCT03709082|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5600860|NCT03709082|Hormone Antagonists|hormone antagonists|mesh-ancestor
5600861|NCT03709082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6091123|NCT00857818|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6091124|NCT00857818|Aripiprazole|aripiprazole|mesh-list
6091125|NCT00857818|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6091126|NCT00857818|Serotonin Agents|serotonin agents|mesh-ancestor
5600862|NCT03709082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091127|NCT00857818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6203336|NCT02056171|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6464362|NCT00469443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5519274|NCT04331834|Hydroxychloroquine|hydroxychloroquine|mesh-list
5519275|NCT04331834|Antimalarials|antimalarials|mesh-ancestor
5519276|NCT04331834|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5519277|NCT04331834|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6091128|NCT00857818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091129|NCT00857818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091130|NCT00857818|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6091131|NCT00857818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5519278|NCT04331834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5519279|NCT04331834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5519280|NCT04331834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091132|NCT00857818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6091133|NCT00857818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6091134|NCT00857818|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6091135|NCT00857818|Dopamine Agents|dopamine agents|mesh-ancestor
6091136|NCT00857818|Antidepressive Agents|antidepressive agents|mesh-ancestor
6091137|NCT00857818|Dopamine Agonists|dopamine agonists|mesh-ancestor
6091138|NCT00857818|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6091139|NCT00857818|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6091140|NCT00857818|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6091141|NCT00857818|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6091142|NCT00857896|Fesoterodine|fesoterodine|mesh-list
6091143|NCT00857896|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6091144|NCT00857896|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6091145|NCT00857896|Cholinergic Agents|cholinergic agents|mesh-ancestor
6091146|NCT00857896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6091147|NCT00857896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091148|NCT00857896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091149|NCT00857896|Urological Agents|urological agents|mesh-ancestor
6091150|NCT00857948|Ivermectin|ivermectin|mesh-list
6091151|NCT00857948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6091152|NCT00857948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5519281|NCT04331834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5519282|NCT04331652|Anesthetics|anesthetics|mesh-list
5519283|NCT04331652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5519284|NCT04331652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519285|NCT04331743|Mitoxantrone|mitoxantrone|mesh-list
5519286|NCT04331743|Analgesics|analgesics|mesh-ancestor
5519287|NCT04331743|Sensory System Agents|sensory system agents|mesh-ancestor
5519288|NCT04331743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5519289|NCT04331743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519290|NCT04331743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5519291|NCT04331743|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5519292|NCT04331743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5519293|NCT04331743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5519294|NCT04331743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519295|NCT04331730|Aflibercept|aflibercept|mesh-list
5519296|NCT04331730|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5519297|NCT04331730|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5519298|NCT04331730|Growth Substances|growth substances|mesh-ancestor
5519299|NCT04331730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519300|NCT04331730|Growth Inhibitors|growth inhibitors|mesh-ancestor
5519301|NCT04331730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5519302|NCT04331626|Gemcitabine|gemcitabine|mesh-list
5519303|NCT04331626|Nivolumab|nivolumab|mesh-list
5519304|NCT04331626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5519305|NCT04331626|Antimetabolites|antimetabolites|mesh-ancestor
5519306|NCT04331626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519307|NCT04331626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5519308|NCT04331626|Antiviral Agents|antiviral agents|mesh-ancestor
5519309|NCT04331626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5519310|NCT04331626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6091153|NCT00857961|Testosterone|testosterone|mesh-list
6091154|NCT00857961|Androgens|androgens|mesh-ancestor
6091155|NCT00857961|Hormones|hormones|mesh-ancestor
6091156|NCT00857961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6091157|NCT00857961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091158|NCT00858013|Glimepiride|glimepiride|mesh-list
6091159|NCT00858013|Nateglinide|nateglinide|mesh-list
6091160|NCT00858013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6091161|NCT00858013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6091162|NCT00858013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091163|NCT00858013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6091164|NCT00858013|Immunologic Factors|immunologic factors|mesh-ancestor
6091165|NCT00858117|Rituximab|rituximab|mesh-list
6091166|NCT00858117|Alemtuzumab|alemtuzumab|mesh-list
6091167|NCT00858117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6091168|NCT00858117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6091169|NCT00858117|Immunologic Factors|immunologic factors|mesh-ancestor
6091170|NCT00858117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091171|NCT00858117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6091172|NCT00858234|Bortezomib|bortezomib|mesh-list
6091173|NCT00858234|Vorinostat|vorinostat|mesh-list
6091174|NCT00858234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6091175|NCT00858234|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6091176|NCT00858234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6091177|NCT00858234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091178|NCT00858247|Vitamin D|vitamin d|mesh-list
6091179|NCT00858247|Cholecalciferol|cholecalciferol|mesh-list
6091180|NCT00858247|Vitamins|vitamins|mesh-ancestor
6091181|NCT00858247|Micronutrients|micronutrients|mesh-ancestor
6091182|NCT00858247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091183|NCT00858247|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6091184|NCT00858247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6091185|NCT00858364|Darbepoetin alfa|darbepoetin alfa|mesh-list
6091186|NCT00858364|Hematinics|hematinics|mesh-ancestor
6091187|NCT00858403|Dasatinib|dasatinib|mesh-list
6091188|NCT00858403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5519311|NCT04331626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5519312|NCT04331626|Immunologic Factors|immunologic factors|mesh-ancestor
6091189|NCT00858403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6091190|NCT00858403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6091191|NCT00858403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091192|NCT00858468|Vaccines|vaccines|mesh-list
6091193|NCT00858468|Immunologic Factors|immunologic factors|mesh-ancestor
6091194|NCT00858468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091195|NCT00858637|Bile Acids and Salts|bile acids and salts|mesh-list
6091196|NCT00858637|Simvastatin|simvastatin|mesh-list
6091197|NCT00858637|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6091198|NCT00858637|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6091199|NCT00858637|Antimetabolites|antimetabolites|mesh-ancestor
6091200|NCT00858637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091201|NCT00858637|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6091202|NCT00858637|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6091203|NCT00858637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6091204|NCT00858637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6091205|NCT00858689|Minocycline|minocycline|mesh-list
6091206|NCT00858689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6091207|NCT00858689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6091208|NCT00858780|Etanercept|etanercept|mesh-list
6091209|NCT00858780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6091210|NCT00858780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6091211|NCT00858780|Analgesics|analgesics|mesh-ancestor
6091212|NCT00858780|Sensory System Agents|sensory system agents|mesh-ancestor
6091213|NCT00858780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5519313|NCT04331626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519314|NCT04331626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5519315|NCT04331626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5519316|NCT04331691|Amiloride|amiloride|mesh-list
5519317|NCT04331691|Spironolactone|spironolactone|mesh-list
5519318|NCT04331691|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5519319|NCT04331691|Hormone Antagonists|hormone antagonists|mesh-ancestor
5519320|NCT04331691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5519321|NCT04331691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519322|NCT04331691|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5519323|NCT04331691|Diuretics|diuretics|mesh-ancestor
5519324|NCT04331691|Natriuretic Agents|natriuretic agents|mesh-ancestor
5519325|NCT04331691|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
5519326|NCT04331691|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5519327|NCT04331691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5519328|NCT04331691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519329|NCT04331691|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
5519330|NCT04331600|Chloroquine|chloroquine|mesh-list
5519331|NCT04331600|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
5519332|NCT04331600|Amebicides|amebicides|mesh-ancestor
6091214|NCT00858780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091215|NCT00858780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6091216|NCT00858780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6091217|NCT00858780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6091218|NCT00858780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6464363|NCT00469443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6464364|NCT00469443|Growth Substances|growth substances|mesh-ancestor
6464365|NCT00469443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464366|NCT00469443|Growth Inhibitors|growth inhibitors|mesh-ancestor
6464367|NCT00469443|Antimetabolites|antimetabolites|mesh-ancestor
6464368|NCT00469443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6464369|NCT00469443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6464370|NCT00469443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6464371|NCT00469443|Immunologic Factors|immunologic factors|mesh-ancestor
6464372|NCT00469443|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6091219|NCT00858780|Immunologic Factors|immunologic factors|mesh-ancestor
6091220|NCT00858832|Methylergonovine|methylergonovine|mesh-list
6091221|NCT00858832|Oxytocics|oxytocics|mesh-ancestor
6091222|NCT00858832|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6091223|NCT00858832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091224|NCT00858845|Clonidine|clonidine|mesh-list
6091225|NCT00858845|Analgesics|analgesics|mesh-ancestor
6091226|NCT00858845|Sensory System Agents|sensory system agents|mesh-ancestor
6091227|NCT00858845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6091228|NCT00858845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091229|NCT00858845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6091230|NCT00858845|Sympatholytics|sympatholytics|mesh-ancestor
6091231|NCT00858845|Autonomic Agents|autonomic agents|mesh-ancestor
6091232|NCT00858845|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6091233|NCT00858845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6091234|NCT00858845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6091235|NCT00858845|Adrenergic Agents|adrenergic agents|mesh-ancestor
6091236|NCT00858845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6091237|NCT00858845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091238|NCT00858858|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
6091239|NCT00858858|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6091240|NCT00858858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6091241|NCT00858962|Raltegravir Potassium|raltegravir potassium|mesh-list
6091242|NCT00858962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6091243|NCT00858962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6091244|NCT00858962|Antiviral Agents|antiviral agents|mesh-ancestor
6091245|NCT00858962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6091246|NCT00858962|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6091247|NCT00858962|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6091248|NCT00858962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6091249|NCT00858962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091250|NCT00858988|Rifaximin|rifaximin|mesh-list
6091251|NCT00858988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6091252|NCT00858988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6091253|NCT00858988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6091254|NCT00859027|Risedronic Acid|risedronic acid|mesh-list
6091255|NCT00859027|Etidronic Acid|etidronic acid|mesh-list
6091256|NCT00859027|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6091257|NCT00859027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6091258|NCT00859027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091259|NCT00859027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6091260|NCT00859027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091261|NCT00859027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6091262|NCT00859040|Pasireotide|pasireotide|mesh-list
6091263|NCT00859040|Hormones|hormones|mesh-ancestor
6091264|NCT00859040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6091265|NCT00859040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091266|NCT00859131|Thymoglobulin|thymoglobulin|mesh-list
6091267|NCT00859131|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6091268|NCT00859131|Daclizumab|daclizumab|mesh-list
6091269|NCT00859131|Immunologic Factors|immunologic factors|mesh-ancestor
6091270|NCT00859131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091271|NCT00859131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6091272|NCT00859222|Bevacizumab|bevacizumab|mesh-list
6091273|NCT00859222|Panobinostat|panobinostat|mesh-list
6091274|NCT00859222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6091275|NCT00859222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6091276|NCT00859222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6091277|NCT00859222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6091278|NCT00859222|Growth Substances|growth substances|mesh-ancestor
6091279|NCT00859222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519333|NCT04331600|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6091280|NCT00859222|Growth Inhibitors|growth inhibitors|mesh-ancestor
6091281|NCT00859222|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5519334|NCT04331600|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5519335|NCT04331600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5519336|NCT04331600|Antimalarials|antimalarials|mesh-ancestor
5519337|NCT04331600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6091282|NCT00859222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6464373|NCT00469443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6464374|NCT00469443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6464375|NCT00469443|Antidotes|antidotes|mesh-ancestor
6464376|NCT00469443|Protective Agents|protective agents|mesh-ancestor
6091283|NCT00859222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091284|NCT00859313|Sufentanil|sufentanil|mesh-list
6091285|NCT00859313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6091286|NCT00859313|Narcotics|narcotics|mesh-ancestor
6091287|NCT00859313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6091288|NCT00859313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091289|NCT00859313|Analgesics|analgesics|mesh-ancestor
6091290|NCT00859313|Sensory System Agents|sensory system agents|mesh-ancestor
6091291|NCT00859313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6091292|NCT00859313|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6091293|NCT00859313|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6091294|NCT00859313|Anesthetics, General|anesthetics, general|mesh-ancestor
6091295|NCT00859313|Anesthetics|anesthetics|mesh-ancestor
6091296|NCT00859339|Gemcitabine|gemcitabine|mesh-list
6091297|NCT00859339|Sunitinib|sunitinib|mesh-list
6091298|NCT00859339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6091299|NCT00859339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6091300|NCT00859339|Antimetabolites|antimetabolites|mesh-ancestor
6091301|NCT00859339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519338|NCT04331600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5519339|NCT04331600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5519340|NCT04331600|Analgesics|analgesics|mesh-ancestor
5519341|NCT04331600|Sensory System Agents|sensory system agents|mesh-ancestor
5519342|NCT04331600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5519343|NCT04331600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091302|NCT00859339|Antiviral Agents|antiviral agents|mesh-ancestor
6091303|NCT00859339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6091304|NCT00859339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6091305|NCT00859339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6091306|NCT00859339|Immunologic Factors|immunologic factors|mesh-ancestor
6091307|NCT00859339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091308|NCT00859339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6091309|NCT00859339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6091310|NCT00859339|Growth Substances|growth substances|mesh-ancestor
6091311|NCT00859339|Growth Inhibitors|growth inhibitors|mesh-ancestor
6091312|NCT00859339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5519344|NCT04331600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5519345|NCT04331600|Filaricides|filaricides|mesh-ancestor
5519346|NCT04331600|Antinematodal Agents|antinematodal agents|mesh-ancestor
5519347|NCT04331600|Anthelmintics|anthelmintics|mesh-ancestor
5519348|NCT04331639|Vitamin D|vitamin d|mesh-list
5519349|NCT04331639|Cholecalciferol|cholecalciferol|mesh-list
5519350|NCT04331639|Vitamins|vitamins|mesh-ancestor
5519351|NCT04331639|Micronutrients|micronutrients|mesh-ancestor
5519352|NCT04331639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519353|NCT04331639|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5519354|NCT04331639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5519355|NCT04331418|Dexmedetomidine|dexmedetomidine|mesh-list
5519356|NCT04331418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5519357|NCT04331418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5519358|NCT04331418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519359|NCT04331418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5519360|NCT04331418|Analgesics|analgesics|mesh-ancestor
5519361|NCT04331418|Sensory System Agents|sensory system agents|mesh-ancestor
6464377|NCT00469443|Vitamin B Complex|vitamin b complex|mesh-ancestor
6091313|NCT00859456|Sunitinib|sunitinib|mesh-list
6091314|NCT00859456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6091315|NCT00859456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6091316|NCT00859456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6091317|NCT00859456|Growth Substances|growth substances|mesh-ancestor
6091318|NCT00859456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091319|NCT00859456|Growth Inhibitors|growth inhibitors|mesh-ancestor
6091320|NCT00859456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6091321|NCT00859456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6091322|NCT00859456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091323|NCT00859469|Gemcitabine|gemcitabine|mesh-list
6091324|NCT00859469|Oxaliplatin|oxaliplatin|mesh-list
6091325|NCT00859469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6091326|NCT00859469|Antimetabolites|antimetabolites|mesh-ancestor
6091327|NCT00859469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091328|NCT00859469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6091329|NCT00859469|Antiviral Agents|antiviral agents|mesh-ancestor
6091330|NCT00859469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6091331|NCT00859469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6091332|NCT00859469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6091333|NCT00859469|Immunologic Factors|immunologic factors|mesh-ancestor
6091334|NCT00859469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091335|NCT00859495|Doxorubicin|doxorubicin|mesh-list
6091336|NCT00859495|Pemetrexed|pemetrexed|mesh-list
6091337|NCT00859495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6091338|NCT00859495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6091339|NCT00859495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6091340|NCT00859495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6091341|NCT00859495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6091342|NCT00859495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091343|NCT00859495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6091344|NCT00859495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6091345|NCT00859508|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6091346|NCT00859508|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6091347|NCT00859508|Estradiol|estradiol|mesh-list
6091348|NCT00859508|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6091349|NCT00859508|Estrogens|estrogens|mesh-ancestor
6091350|NCT00859508|Hormones|hormones|mesh-ancestor
6091351|NCT00859508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6091352|NCT00859508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091353|NCT00859508|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6091354|NCT00859508|Contraceptive Agents|contraceptive agents|mesh-ancestor
6091355|NCT00859508|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6091356|NCT00859508|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6091357|NCT00859573|Modafinil|modafinil|mesh-list
6091358|NCT00859573|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6091359|NCT00859573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091360|NCT00859573|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6091361|NCT00859573|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6091362|NCT00859573|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6091363|NCT00859573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091364|NCT00859651|Vitamin D|vitamin d|mesh-list
6091365|NCT00859651|Cholecalciferol|cholecalciferol|mesh-list
6091366|NCT00859651|Vitamins|vitamins|mesh-ancestor
6091367|NCT00859651|Micronutrients|micronutrients|mesh-ancestor
6091368|NCT00859651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091369|NCT00859651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6091370|NCT00859651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6091371|NCT00859833|Adenosine|adenosine|mesh-list
6091372|NCT00859833|Regadenoson|regadenoson|mesh-list
6091373|NCT00859833|Analgesics|analgesics|mesh-ancestor
5519362|NCT04331418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5519363|NCT04331418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6091374|NCT00859833|Sensory System Agents|sensory system agents|mesh-ancestor
6091375|NCT00859833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6091376|NCT00859833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091377|NCT00859833|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5519364|NCT04331418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5519365|NCT04331418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5519366|NCT04331418|Adrenergic Agents|adrenergic agents|mesh-ancestor
5519367|NCT04331418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5519368|NCT04331418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519369|NCT04331470|Ritonavir|ritonavir|mesh-list
5519370|NCT04331470|Lopinavir|lopinavir|mesh-list
5519371|NCT04331470|Chloroquine|chloroquine|mesh-list
5519372|NCT04331470|Levamisole|levamisole|mesh-list
5519373|NCT04331470|Hydroxychloroquine|hydroxychloroquine|mesh-list
5519374|NCT04331470|Budesonide|budesonide|mesh-list
5519375|NCT04331470|Formoterol Fumarate|formoterol fumarate|mesh-list
6091378|NCT00859833|Vasodilator Agents|vasodilator agents|mesh-ancestor
6091379|NCT00859833|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6091380|NCT00859833|Purinergic Agonists|purinergic agonists|mesh-ancestor
6091381|NCT00859833|Purinergic Agents|purinergic agents|mesh-ancestor
6091382|NCT00859833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6091383|NCT00859833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091384|NCT00859833|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
6091385|NCT00859898|Metformin|metformin|mesh-list
6091386|NCT00859898|Dapagliflozin|dapagliflozin|mesh-list
6091387|NCT00859898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6091388|NCT00859898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091389|NCT00859898|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5519376|NCT04331470|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5519377|NCT04331470|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5519378|NCT04331470|Protease Inhibitors|protease inhibitors|mesh-ancestor
5519379|NCT04331470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5519380|NCT04331470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091390|NCT00859898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091391|NCT00859937|Dasatinib|dasatinib|mesh-list
6091392|NCT00859937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6091393|NCT00859937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6091394|NCT00859937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6091395|NCT00859937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203337|NCT02056171|Antidepressive Agents|antidepressive agents|mesh-ancestor
6203338|NCT02056171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6203339|NCT02056171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6203340|NCT02056171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6203341|NCT02056171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6203342|NCT02056171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203343|NCT02056288|Fentanyl|fentanyl|mesh-list
6203344|NCT02056288|Ropivacaine|ropivacaine|mesh-list
6203345|NCT02056288|Anesthetics, Local|anesthetics, local|mesh-ancestor
6203346|NCT02056288|Anesthetics|anesthetics|mesh-ancestor
6203347|NCT02056288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6203348|NCT02056288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203349|NCT02056288|Sensory System Agents|sensory system agents|mesh-ancestor
6203350|NCT02056288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6203351|NCT02056288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6203352|NCT02056288|Narcotics|narcotics|mesh-ancestor
6203353|NCT02056288|Analgesics|analgesics|mesh-ancestor
6203354|NCT02056288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6203355|NCT02056288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6203356|NCT02056288|Anesthetics, General|anesthetics, general|mesh-ancestor
6203357|NCT02056301|Morphine|morphine|mesh-list
6203358|NCT02056301|Hydromorphone|hydromorphone|mesh-list
6203359|NCT02056301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6203360|NCT02056301|Narcotics|narcotics|mesh-ancestor
6203361|NCT02056301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6203362|NCT02056301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203363|NCT02056301|Analgesics|analgesics|mesh-ancestor
6203364|NCT02056301|Sensory System Agents|sensory system agents|mesh-ancestor
6203365|NCT02056301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6203366|NCT02056340|Atorvastatin|atorvastatin|mesh-list
6203367|NCT02056340|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6203368|NCT02056340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6203369|NCT02056340|Antimetabolites|antimetabolites|mesh-ancestor
6203370|NCT02056340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203371|NCT02056340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6203372|NCT02056340|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6203373|NCT02056340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6203374|NCT02056392|Moxifloxacin|moxifloxacin|mesh-list
6203375|NCT02056392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6203376|NCT02056392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6203377|NCT02056392|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6203378|NCT02056392|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6203379|NCT02056392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6203380|NCT02056392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203381|NCT02056392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6203382|NCT02056626|Carvedilol|carvedilol|mesh-list
6203383|NCT02056626|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6203384|NCT02056626|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6203385|NCT02056626|Adrenergic Agents|adrenergic agents|mesh-ancestor
6203386|NCT02056626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6203387|NCT02056626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203388|NCT02056626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203389|NCT02056626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6203390|NCT02056626|Antioxidants|antioxidants|mesh-ancestor
6203391|NCT02056626|Protective Agents|protective agents|mesh-ancestor
6203392|NCT02056626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6203393|NCT02056626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6203394|NCT02056626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6203395|NCT02056626|Vasodilator Agents|vasodilator agents|mesh-ancestor
6203396|NCT02056626|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6203397|NCT02056626|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6203398|NCT02057198|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5519381|NCT04331470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5519382|NCT04331470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6091396|NCT00860015|Gemcitabine|gemcitabine|mesh-list
6091397|NCT00860015|Pemetrexed|pemetrexed|mesh-list
6091398|NCT00860015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6091399|NCT00860015|Antimetabolites|antimetabolites|mesh-ancestor
6091400|NCT00860015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091401|NCT00860015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6091402|NCT00860015|Antiviral Agents|antiviral agents|mesh-ancestor
6091403|NCT00860015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6091404|NCT00860015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6091405|NCT00860015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6091406|NCT00860015|Immunologic Factors|immunologic factors|mesh-ancestor
6091407|NCT00860015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091408|NCT00860015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6091409|NCT00860015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6091410|NCT00860028|Varenicline|varenicline|mesh-list
6091411|NCT00860028|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6091412|NCT00860028|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6091413|NCT00860028|Cholinergic Agents|cholinergic agents|mesh-ancestor
6091414|NCT00860028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6091415|NCT00860028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091416|NCT00860028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091417|NCT00860171|Iodine|iodine|mesh-list
6091418|NCT00860171|Cadexomer iodine|cadexomer iodine|mesh-list
6091419|NCT00860171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6091420|NCT00860171|Antibodies|antibodies|mesh-list
6091421|NCT00860171|Immunoglobulins|immunoglobulins|mesh-list
6091422|NCT00860171|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6091423|NCT00860171|Immunologic Factors|immunologic factors|mesh-ancestor
6091424|NCT00860171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091425|NCT00860171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6091426|NCT00860171|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6091427|NCT00860171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6091428|NCT00860171|Trace Elements|trace elements|mesh-ancestor
6091429|NCT00860171|Micronutrients|micronutrients|mesh-ancestor
6091430|NCT00860262|Amlodipine|amlodipine|mesh-list
6091431|NCT00860262|Telmisartan|telmisartan|mesh-list
6091432|NCT00860262|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
6091433|NCT00860262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6091434|NCT00860262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6091435|NCT00860262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6091436|NCT00860262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091437|NCT00860262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6091438|NCT00860262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091439|NCT00860262|Vasodilator Agents|vasodilator agents|mesh-ancestor
6091440|NCT00860262|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6091441|NCT00860262|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6091442|NCT00860379|Selenium|selenium|mesh-list
6091443|NCT00860379|Antioxidants|antioxidants|mesh-ancestor
6091444|NCT00860379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091445|NCT00860379|Protective Agents|protective agents|mesh-ancestor
6091446|NCT00860379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091447|NCT00860379|Trace Elements|trace elements|mesh-ancestor
6091448|NCT00860379|Micronutrients|micronutrients|mesh-ancestor
6091449|NCT00860405|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
6091450|NCT00860405|Plasma Substitutes|plasma substitutes|mesh-ancestor
6091451|NCT00860405|Blood Substitutes|blood substitutes|mesh-ancestor
6091452|NCT00860457|Rituximab|rituximab|mesh-list
6091453|NCT00860457|Fludarabine|fludarabine|mesh-list
6091454|NCT00860457|Lenalidomide|lenalidomide|mesh-list
6091455|NCT00860457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6091456|NCT00860457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6091457|NCT00860457|Immunologic Factors|immunologic factors|mesh-ancestor
6091458|NCT00860457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091459|NCT00860457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6091460|NCT00860457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6091461|NCT00860457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6091462|NCT00860457|Growth Substances|growth substances|mesh-ancestor
6091463|NCT00860457|Growth Inhibitors|growth inhibitors|mesh-ancestor
6091464|NCT00860470|Iron|iron|mesh-list
6091465|NCT00860470|Trace Elements|trace elements|mesh-list
6091466|NCT00860470|Folic Acid|folic acid|mesh-list
6091467|NCT00860470|Micronutrients|micronutrients|mesh-list
6091468|NCT00860470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091469|NCT00860470|Hematinics|hematinics|mesh-ancestor
6665725|NCT01518465|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6091470|NCT00860470|Vitamin B Complex|vitamin b complex|mesh-ancestor
6091471|NCT00860470|Vitamins|vitamins|mesh-ancestor
6091472|NCT00860574|Methotrexate|methotrexate|mesh-list
6091473|NCT00860574|Fludarabine phosphate|fludarabine phosphate|mesh-list
6091474|NCT00860574|Fludarabine|fludarabine|mesh-list
6091475|NCT00860574|Treosulfan|treosulfan|mesh-list
6091476|NCT00860574|Tacrolimus|tacrolimus|mesh-list
6091477|NCT00860574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6091478|NCT00860574|Abortifacient Agents|abortifacient agents|mesh-ancestor
6091479|NCT00860574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6091480|NCT00860574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091481|NCT00860574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6091482|NCT00860574|Antimetabolites|antimetabolites|mesh-ancestor
6464378|NCT00469443|Vitamins|vitamins|mesh-ancestor
6464379|NCT00469443|Micronutrients|micronutrients|mesh-ancestor
6464380|NCT00469469|Bevacizumab|bevacizumab|mesh-list
6464381|NCT00469469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6464382|NCT00469469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6464383|NCT00469469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6464384|NCT00469469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6464385|NCT00469469|Growth Substances|growth substances|mesh-ancestor
6464386|NCT00469469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464387|NCT00469469|Growth Inhibitors|growth inhibitors|mesh-ancestor
6464388|NCT00469495|Anthelmintics|anthelmintics|mesh-list
6464389|NCT00469495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6091483|NCT00860574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091484|NCT00860574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6091485|NCT00860574|Dermatologic Agents|dermatologic agents|mesh-ancestor
6464390|NCT00469495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6488418|NCT00584090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6091486|NCT00860574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6091487|NCT00860574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6091488|NCT00860574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6091489|NCT00860574|Immunologic Factors|immunologic factors|mesh-ancestor
6091490|NCT00860574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6091491|NCT00860574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6091492|NCT00860574|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6091493|NCT00860574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6091494|NCT00860574|Alkylating Agents|alkylating agents|mesh-ancestor
6091495|NCT00860743|Antioxidants|antioxidants|mesh-list
6091496|NCT00860743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091497|NCT00860743|Protective Agents|protective agents|mesh-ancestor
6091498|NCT00860743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091499|NCT00860847|Ubiquinone|ubiquinone|mesh-list
6091500|NCT00860847|Coenzyme Q10|coenzyme q10|mesh-list
6091501|NCT00860847|Micronutrients|micronutrients|mesh-ancestor
6091502|NCT00860847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091503|NCT00860847|Vitamins|vitamins|mesh-ancestor
5519383|NCT04331470|Antiviral Agents|antiviral agents|mesh-ancestor
5519384|NCT04331470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5519385|NCT04331470|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5519386|NCT04331470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5519387|NCT04331470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5519388|NCT04331470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5519389|NCT04331470|Autonomic Agents|autonomic agents|mesh-ancestor
5519390|NCT04331470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5519391|NCT04331470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519392|NCT04331470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5519393|NCT04331470|Respiratory System Agents|respiratory system agents|mesh-ancestor
5519394|NCT04331470|Glucocorticoids|glucocorticoids|mesh-ancestor
5519395|NCT04331470|Hormones|hormones|mesh-ancestor
5519396|NCT04331470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5519397|NCT04331470|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5519398|NCT04331470|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5519399|NCT04331470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5519400|NCT04331470|Adrenergic Agents|adrenergic agents|mesh-ancestor
5519401|NCT04331470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5519402|NCT04331470|Amebicides|amebicides|mesh-ancestor
5519403|NCT04331470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5519404|NCT04331470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5519405|NCT04331470|Antimalarials|antimalarials|mesh-ancestor
5519406|NCT04331470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5519407|NCT04331470|Antinematodal Agents|antinematodal agents|mesh-ancestor
5519408|NCT04331470|Anthelmintics|anthelmintics|mesh-ancestor
5519409|NCT04331470|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6091504|NCT00860938|Budesonide|budesonide|mesh-list
6091505|NCT00860938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6091506|NCT00860938|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6091507|NCT00860938|Autonomic Agents|autonomic agents|mesh-ancestor
6091508|NCT00860938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6091509|NCT00860938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091510|NCT00860938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6091511|NCT00860938|Respiratory System Agents|respiratory system agents|mesh-ancestor
6091512|NCT00860938|Glucocorticoids|glucocorticoids|mesh-ancestor
6665726|NCT01518465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5519410|NCT04331470|Immunologic Factors|immunologic factors|mesh-ancestor
5519411|NCT04331327|Mitogens|mitogens|mesh-list
6091513|NCT00860938|Hormones|hormones|mesh-ancestor
6203399|NCT02057198|Metronidazole|metronidazole|mesh-list
6091514|NCT00860938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6091515|NCT00861341|Aspirin|aspirin|mesh-list
6091516|NCT00861341|Pioglitazone|pioglitazone|mesh-list
6091517|NCT00861341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6091518|NCT00861341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6091519|NCT00861341|Analgesics|analgesics|mesh-ancestor
6091520|NCT00861341|Sensory System Agents|sensory system agents|mesh-ancestor
6091521|NCT00861341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6091522|NCT00861341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091523|NCT00861341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6091524|NCT00861341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6091525|NCT00861341|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5519412|NCT04331327|Mitosis Modulators|mitosis modulators|mesh-ancestor
5519413|NCT04331327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519414|NCT04331197|Letrozole|letrozole|mesh-list
5519415|NCT04331197|Clomiphene|clomiphene|mesh-list
5519416|NCT04331197|Enclomiphene|enclomiphene|mesh-list
5519417|NCT04331197|Zuclomiphene|zuclomiphene|mesh-list
6091526|NCT00861341|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6091527|NCT00861341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091528|NCT00861341|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6091529|NCT00861341|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6091530|NCT00861341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6091531|NCT00861341|Antipyretics|antipyretics|mesh-ancestor
6091532|NCT00861341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6091533|NCT00861380|Vaccines|vaccines|mesh-list
6091534|NCT00861380|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6091535|NCT00861380|Immunologic Factors|immunologic factors|mesh-ancestor
6091536|NCT00861380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091537|NCT00861471|Docetaxel|docetaxel|mesh-list
5519418|NCT04331197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519419|NCT04331197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5519420|NCT04331197|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5519421|NCT04331197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5519422|NCT04331197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5519423|NCT04331197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5519424|NCT04331197|Hormone Antagonists|hormone antagonists|mesh-ancestor
5519425|NCT04331197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5519426|NCT04331197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519427|NCT04331197|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6091538|NCT00861471|Imatinib Mesylate|imatinib mesylate|mesh-list
5519428|NCT04331197|Fertility Agents|fertility agents|mesh-ancestor
6091539|NCT00861471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6091540|NCT00861471|Tubulin Modulators|tubulin modulators|mesh-ancestor
6091541|NCT00861471|Antimitotic Agents|antimitotic agents|mesh-ancestor
6091542|NCT00861471|Mitosis Modulators|mitosis modulators|mesh-ancestor
6091543|NCT00861471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091544|NCT00861471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6091545|NCT00861471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6091546|NCT00861614|Ipilimumab|ipilimumab|mesh-list
6091547|NCT00861614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5519429|NCT04331197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5519430|NCT04331197|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5519431|NCT04331197|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5519432|NCT04331210|Diclofenac|diclofenac|mesh-list
5519433|NCT04331210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5519434|NCT04331210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5519435|NCT04331210|Analgesics|analgesics|mesh-ancestor
5519436|NCT04331210|Sensory System Agents|sensory system agents|mesh-ancestor
5519437|NCT04331210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6091548|NCT00861614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6091549|NCT00861614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6091550|NCT00861614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091551|NCT00861692|Argatroban|argatroban|mesh-list
6091552|NCT00861692|Antithrombins|antithrombins|mesh-ancestor
6091553|NCT00861692|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6091554|NCT00861692|Protease Inhibitors|protease inhibitors|mesh-ancestor
6091555|NCT00861692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6091556|NCT00861692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091557|NCT00861692|Anticoagulants|anticoagulants|mesh-ancestor
6091558|NCT00861692|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6091559|NCT00861744|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6091560|NCT00861744|Immunologic Factors|immunologic factors|mesh-ancestor
6091561|NCT00861744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519438|NCT04331210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519439|NCT04331210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5519440|NCT04331210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5519441|NCT04331210|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5519442|NCT04331210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5519443|NCT04331210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519444|NCT04331054|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
5519445|NCT04331054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5519446|NCT04331054|Respiratory System Agents|respiratory system agents|mesh-ancestor
5519447|NCT04331145|Ticagrelor|ticagrelor|mesh-list
5519448|NCT04331145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5519449|NCT04331145|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5519450|NCT04331145|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5519451|NCT04331145|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5519452|NCT04331145|Purinergic Agents|purinergic agents|mesh-ancestor
5519453|NCT04331145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5519454|NCT04331145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519455|NCT04331145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519456|NCT04331132|Tolvaptan|tolvaptan|mesh-list
5519457|NCT04331132|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
5519458|NCT04331132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519459|NCT04331132|Natriuretic Agents|natriuretic agents|mesh-ancestor
5519460|NCT04331132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519461|NCT04330872|Aspirin|aspirin|mesh-list
5519462|NCT04330872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6091562|NCT00861757|Tadalafil|tadalafil|mesh-list
6091563|NCT00861757|Tamsulosin|tamsulosin|mesh-list
6091564|NCT00861757|Vasodilator Agents|vasodilator agents|mesh-ancestor
6091565|NCT00861757|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6091566|NCT00861757|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6091567|NCT00861757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6091568|NCT00861757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091569|NCT00861757|Urological Agents|urological agents|mesh-ancestor
6091570|NCT00861757|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6091571|NCT00861757|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6091572|NCT00861757|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6091573|NCT00861757|Adrenergic Agents|adrenergic agents|mesh-ancestor
6091574|NCT00861757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6091575|NCT00861757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091576|NCT00862082|Sorafenib|sorafenib|mesh-list
6091577|NCT00862082|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
6091578|NCT00862082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6091579|NCT00862082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6091580|NCT00862082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6091581|NCT00862082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519463|NCT04330872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5519464|NCT04330872|Analgesics|analgesics|mesh-ancestor
5519465|NCT04330872|Sensory System Agents|sensory system agents|mesh-ancestor
5519466|NCT04330872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5519467|NCT04330872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519468|NCT04330872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5519469|NCT04330872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5519470|NCT04330872|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6091582|NCT00862082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6091583|NCT00862082|Alkylating Agents|alkylating agents|mesh-ancestor
6091584|NCT00862121|Mesalamine|mesalamine|mesh-list
6091585|NCT00862121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6091586|NCT00862121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6091587|NCT00862121|Analgesics|analgesics|mesh-ancestor
6091588|NCT00862121|Sensory System Agents|sensory system agents|mesh-ancestor
6091589|NCT00862121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6091590|NCT00862121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091591|NCT00862121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6091592|NCT00862121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6091593|NCT00862134|Docetaxel|docetaxel|mesh-list
6091594|NCT00862134|Sargramostim|sargramostim|mesh-list
6091595|NCT00862134|Lenograstim|lenograstim|mesh-list
6091596|NCT00862134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6091597|NCT00862134|Tubulin Modulators|tubulin modulators|mesh-ancestor
6091598|NCT00862134|Antimitotic Agents|antimitotic agents|mesh-ancestor
6091599|NCT00862134|Mitosis Modulators|mitosis modulators|mesh-ancestor
6091600|NCT00862134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091601|NCT00862134|Immunologic Factors|immunologic factors|mesh-ancestor
6091602|NCT00862134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091603|NCT00862134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6091604|NCT00862563|Topiramate|topiramate|mesh-list
6091605|NCT00862563|Zonisamide|zonisamide|mesh-list
6091606|NCT00862563|Levetiracetam|levetiracetam|mesh-list
6091607|NCT00862563|Anticonvulsants|anticonvulsants|mesh-ancestor
6091608|NCT00862563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6091609|NCT00862563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091610|NCT00862563|Nootropic Agents|nootropic agents|mesh-ancestor
6091611|NCT00862563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6091612|NCT00862563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6091613|NCT00862563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519471|NCT04330872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5519472|NCT04330872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519473|NCT04330872|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5519474|NCT04330872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5519475|NCT04330872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5519476|NCT04330872|Antipyretics|antipyretics|mesh-ancestor
5519477|NCT04330820|Venetoclax|venetoclax|mesh-list
5519478|NCT04330820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6091614|NCT00862563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6091615|NCT00862641|Regadenoson|regadenoson|mesh-list
6091616|NCT00862641|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
6091617|NCT00862641|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6091618|NCT00862641|Purinergic Agonists|purinergic agonists|mesh-ancestor
6091619|NCT00862641|Purinergic Agents|purinergic agents|mesh-ancestor
6091620|NCT00862641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6091621|NCT00862641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091622|NCT00862641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091623|NCT00862654|Ketoconazole|ketoconazole|mesh-list
6091624|NCT00862654|Clobetasol|clobetasol|mesh-list
6091625|NCT00862654|Antifungal Agents|antifungal agents|mesh-ancestor
6091626|NCT00862654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6091627|NCT00862654|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6091628|NCT00862654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6091629|NCT00862654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6091630|NCT00862654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091631|NCT00862654|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5519479|NCT04331093|Apatinib|apatinib|mesh-list
5519480|NCT04331093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5519481|NCT04331093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5519482|NCT04331093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5519483|NCT04331093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519484|NCT04330729|Aspirin|aspirin|mesh-list
5519485|NCT04330729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5519486|NCT04330729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5519487|NCT04330729|Analgesics|analgesics|mesh-ancestor
5519488|NCT04330729|Sensory System Agents|sensory system agents|mesh-ancestor
5519489|NCT04330729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5519490|NCT04330729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519491|NCT04330729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5519492|NCT04330729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5519493|NCT04330729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5519494|NCT04330729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5519495|NCT04330729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519496|NCT04330729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5519497|NCT04330729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5519498|NCT04330729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5519499|NCT04330729|Antipyretics|antipyretics|mesh-ancestor
5519500|NCT04330690|Interferons|interferons|mesh-list
6464391|NCT00469547|Ethanol|ethanol|mesh-list
6464392|NCT00469547|Anti-Infective Agents|anti-infective agents|mesh-list
6464393|NCT00469547|Emollients|emollients|mesh-list
6464394|NCT00469547|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6464395|NCT00469547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6091632|NCT00862654|Hormone Antagonists|hormone antagonists|mesh-ancestor
5519501|NCT04330690|Interferon-beta|interferon-beta|mesh-list
5519502|NCT04330690|Interferon beta-1a|interferon beta-1a|mesh-list
5519503|NCT04330690|Remdesivir|remdesivir|mesh-list
5519504|NCT04330690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5519505|NCT04330690|Antiviral Agents|antiviral agents|mesh-ancestor
5519506|NCT04330690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5519507|NCT04330690|Immunologic Factors|immunologic factors|mesh-ancestor
5519508|NCT04330690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519509|NCT04330690|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5519510|NCT04330690|Antimetabolites|antimetabolites|mesh-ancestor
6091633|NCT00862654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6091634|NCT00862654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091635|NCT00862654|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6091636|NCT00862654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6091637|NCT00862654|Glucocorticoids|glucocorticoids|mesh-ancestor
6091638|NCT00862654|Hormones|hormones|mesh-ancestor
6091639|NCT00862719|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6091640|NCT00862719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6091641|NCT00862719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091642|NCT00862719|Incretins|incretins|mesh-ancestor
6091643|NCT00862719|Hormones|hormones|mesh-ancestor
6091644|NCT00862719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6091645|NCT00862719|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6091646|NCT00862719|Protease Inhibitors|protease inhibitors|mesh-ancestor
6091647|NCT00862719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6091648|NCT00862719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091649|NCT00862745|Fesoterodine|fesoterodine|mesh-list
6091650|NCT00862745|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6091651|NCT00862745|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6091652|NCT00862745|Cholinergic Agents|cholinergic agents|mesh-ancestor
6091653|NCT00862745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6091654|NCT00862745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091655|NCT00862745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091656|NCT00862745|Urological Agents|urological agents|mesh-ancestor
6091657|NCT00862784|Leucovorin|leucovorin|mesh-list
6091658|NCT00862784|Folic Acid|folic acid|mesh-list
6091659|NCT00862784|Oxaliplatin|oxaliplatin|mesh-list
6091660|NCT00862784|Fluorouracil|fluorouracil|mesh-list
6091661|NCT00862784|Ramucirumab|ramucirumab|mesh-list
6091662|NCT00862784|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6091663|NCT00862784|Levoleucovorin|levoleucovorin|mesh-list
6091664|NCT00862784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6091665|NCT00862784|Antimetabolites|antimetabolites|mesh-ancestor
6091666|NCT00862784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091667|NCT00862784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6091668|NCT00862784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6091669|NCT00862784|Immunologic Factors|immunologic factors|mesh-ancestor
6091670|NCT00862784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091671|NCT00862784|Antidotes|antidotes|mesh-ancestor
6091672|NCT00862784|Protective Agents|protective agents|mesh-ancestor
5519511|NCT04330690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091673|NCT00862784|Vitamin B Complex|vitamin b complex|mesh-ancestor
6091674|NCT00862784|Vitamins|vitamins|mesh-ancestor
5519512|NCT04330755|Magnesium Sulfate|magnesium sulfate|mesh-list
5519513|NCT04330755|Simendan|simendan|mesh-list
5519514|NCT04330755|Analgesics|analgesics|mesh-ancestor
5519515|NCT04330755|Sensory System Agents|sensory system agents|mesh-ancestor
6091675|NCT00862784|Micronutrients|micronutrients|mesh-ancestor
6091676|NCT00862784|Hematinics|hematinics|mesh-ancestor
6091677|NCT00862810|Vaccines|vaccines|mesh-list
6091678|NCT00862810|Immunologic Factors|immunologic factors|mesh-ancestor
6091679|NCT00862810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091680|NCT00862823|Tenofovir|tenofovir|mesh-list
6091681|NCT00862823|Emtricitabine|emtricitabine|mesh-list
6091682|NCT00862823|Efavirenz|efavirenz|mesh-list
6091683|NCT00862823|Antiviral Agents|antiviral agents|mesh-ancestor
6091684|NCT00862823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6091685|NCT00862823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6091686|NCT00862823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6091687|NCT00862823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6091688|NCT00862823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091689|NCT00862823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6091690|NCT00862823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6091691|NCT00862823|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6091692|NCT00862823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6091693|NCT00862823|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6091694|NCT00862823|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5519516|NCT04330755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5519517|NCT04330755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091695|NCT00862823|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6091696|NCT00862823|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6091697|NCT00862849|Insulin|insulin|mesh-list
6091698|NCT00862849|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5519518|NCT04330755|Anesthetics|anesthetics|mesh-ancestor
5519519|NCT04330755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5519520|NCT04330755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5519521|NCT04330755|Anticonvulsants|anticonvulsants|mesh-ancestor
6091699|NCT00862849|Insulin Lispro|insulin lispro|mesh-list
6091700|NCT00862849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6091701|NCT00862849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519522|NCT04330755|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5519523|NCT04330755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5519524|NCT04330755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519525|NCT04330755|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5519526|NCT04330755|Tocolytic Agents|tocolytic agents|mesh-ancestor
5519527|NCT04330755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5519528|NCT04330755|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5519529|NCT04330755|Vasodilator Agents|vasodilator agents|mesh-ancestor
5519530|NCT04330755|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5519531|NCT04330755|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5519532|NCT04330755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5519533|NCT04330755|Protective Agents|protective agents|mesh-ancestor
5519534|NCT04330300|Losartan|losartan|mesh-list
6091702|NCT00862940|Memantine|memantine|mesh-list
6091703|NCT00862940|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6091704|NCT00862940|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6091705|NCT00862940|Dopamine Agents|dopamine agents|mesh-ancestor
6091706|NCT00862940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6091707|NCT00862940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091708|NCT00862940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091709|NCT00862940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6091710|NCT00862940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6091711|NCT00862979|Cyclosporine|cyclosporine|mesh-list
6091712|NCT00862979|Mycophenolic Acid|mycophenolic acid|mesh-list
6091713|NCT00862979|Everolimus|everolimus|mesh-list
5519535|NCT04330300|Verapamil|verapamil|mesh-list
6091714|NCT00862979|Tacrolimus|tacrolimus|mesh-list
6091715|NCT00862979|Cyclosporins|cyclosporins|mesh-list
6091716|NCT00862979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6091717|NCT00862979|Immunologic Factors|immunologic factors|mesh-ancestor
6091718|NCT00862979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091719|NCT00862979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6091720|NCT00862979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6091721|NCT00862979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091722|NCT00862979|Antifungal Agents|antifungal agents|mesh-ancestor
6091723|NCT00862979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6091724|NCT00862979|Dermatologic Agents|dermatologic agents|mesh-ancestor
6091725|NCT00862979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6091726|NCT00862979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6091727|NCT00862979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6091728|NCT00862979|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6091729|NCT00862979|Antitubercular Agents|antitubercular agents|mesh-ancestor
6091730|NCT00862979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6091731|NCT00862992|Cariprazine|cariprazine|mesh-list
6091732|NCT00862992|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6091733|NCT00862992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6091734|NCT00862992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6091735|NCT00862992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091736|NCT00862992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6091737|NCT00863057|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6091738|NCT00863057|Methadone|methadone|mesh-list
6091739|NCT00863057|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6091740|NCT00863057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6091741|NCT00863057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6091742|NCT00863057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091743|NCT00863057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6091744|NCT00863057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091745|NCT00863057|Analgesics|analgesics|mesh-ancestor
6091746|NCT00863057|Sensory System Agents|sensory system agents|mesh-ancestor
6091747|NCT00863057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6091748|NCT00863057|Antidepressive Agents|antidepressive agents|mesh-ancestor
6091749|NCT00863057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6091750|NCT00863057|Dopamine Agents|dopamine agents|mesh-ancestor
6091751|NCT00863057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6091752|NCT00863057|Narcotics|narcotics|mesh-ancestor
6091753|NCT00863057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6091754|NCT00863057|Antitussive Agents|antitussive agents|mesh-ancestor
6091755|NCT00863057|Respiratory System Agents|respiratory system agents|mesh-ancestor
6091756|NCT00863109|Ribavirin|ribavirin|mesh-list
6091757|NCT00863109|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6091758|NCT00863109|Antimetabolites|antimetabolites|mesh-ancestor
6091759|NCT00863109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091760|NCT00863109|Antiviral Agents|antiviral agents|mesh-ancestor
6091761|NCT00863109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6091762|NCT00863122|Lapatinib|lapatinib|mesh-list
6091763|NCT00863122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6091764|NCT00863122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6091765|NCT00863122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6091766|NCT00863122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091767|NCT00863265|Ezetimibe|ezetimibe|mesh-list
6091768|NCT00863265|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6091769|NCT00863265|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6091770|NCT00863265|Antimetabolites|antimetabolites|mesh-ancestor
6091771|NCT00863265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091772|NCT00863265|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6091773|NCT00863304|Naproxen|naproxen|mesh-list
6091774|NCT00863304|Tanezumab|tanezumab|mesh-list
6091775|NCT00863304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6091776|NCT00863304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6091777|NCT00863304|Analgesics|analgesics|mesh-ancestor
6091778|NCT00863304|Sensory System Agents|sensory system agents|mesh-ancestor
5519536|NCT04330300|Felodipine|felodipine|mesh-list
5519537|NCT04330300|Amlodipine|amlodipine|mesh-list
5519538|NCT04330300|Valsartan|valsartan|mesh-list
5519539|NCT04330300|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5519540|NCT04330300|Telmisartan|telmisartan|mesh-list
5519541|NCT04330300|Candesartan|candesartan|mesh-list
5519542|NCT04330300|Ramipril|ramipril|mesh-list
5519543|NCT04330300|Olmesartan|olmesartan|mesh-list
5519544|NCT04330300|Enalapril|enalapril|mesh-list
5519545|NCT04330300|Lisinopril|lisinopril|mesh-list
5519546|NCT04330300|Irbesartan|irbesartan|mesh-list
5519547|NCT04330300|Chlorthalidone|chlorthalidone|mesh-list
5519548|NCT04330300|Diltiazem|diltiazem|mesh-list
5519549|NCT04330300|Perindopril|perindopril|mesh-list
5519550|NCT04330300|Benazepril|benazepril|mesh-list
5519551|NCT04330300|Captopril|captopril|mesh-list
5519552|NCT04330300|Indapamide|indapamide|mesh-list
6091779|NCT00863304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6091780|NCT00863304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091781|NCT00863304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6091782|NCT00863304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6091783|NCT00863304|Gout Suppressants|gout suppressants|mesh-ancestor
6091784|NCT00863304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6091785|NCT00863304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6091786|NCT00863304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091787|NCT00863317|Montelukast|montelukast|mesh-list
6091788|NCT00863317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6091789|NCT00863317|Respiratory System Agents|respiratory system agents|mesh-ancestor
6091790|NCT00863317|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6091791|NCT00863317|Hormone Antagonists|hormone antagonists|mesh-ancestor
6091792|NCT00863317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6091793|NCT00863317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091794|NCT00863317|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6091795|NCT00863317|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6091796|NCT00863317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519553|NCT04330300|Nicardipine|nicardipine|mesh-list
5519554|NCT04330300|Nimodipine|nimodipine|mesh-list
5519555|NCT04330300|Quinapril|quinapril|mesh-list
5519556|NCT04330300|Trandolapril|trandolapril|mesh-list
5519557|NCT04330300|Metolazone|metolazone|mesh-list
5519558|NCT04330300|Fosinopril|fosinopril|mesh-list
5519559|NCT04330300|Eprosartan|eprosartan|mesh-list
5519560|NCT04330300|Nitrendipine|nitrendipine|mesh-list
5519561|NCT04330300|Bendroflumethiazide|bendroflumethiazide|mesh-list
5519562|NCT04330300|Chlorothiazide|chlorothiazide|mesh-list
5519563|NCT04330300|Nifedipine|nifedipine|mesh-list
6091797|NCT00863356|Hemostatics|hemostatics|mesh-list
6091798|NCT00863356|Chitosan|chitosan|mesh-list
6091799|NCT00863356|Coagulants|coagulants|mesh-ancestor
6091800|NCT00863356|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6091801|NCT00863356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6091802|NCT00863356|Antimetabolites|antimetabolites|mesh-ancestor
6091803|NCT00863356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091804|NCT00863356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6091805|NCT00863356|Chelating Agents|chelating agents|mesh-ancestor
6091806|NCT00863356|Sequestering Agents|sequestering agents|mesh-ancestor
5519564|NCT04330300|Calcium Channel Blockers|calcium channel blockers|mesh-list
5519565|NCT04330300|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
5519566|NCT04330300|Diuretics|diuretics|mesh-list
5519567|NCT04330300|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
5519568|NCT04330300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5519569|NCT04330300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519570|NCT04330300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6091807|NCT00863434|Cytarabine|cytarabine|mesh-list
6091808|NCT00863434|Clofarabine|clofarabine|mesh-list
6091809|NCT00863434|Immunologic Factors|immunologic factors|mesh-ancestor
6091810|NCT00863434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091811|NCT00863434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6091812|NCT00863434|Antimetabolites|antimetabolites|mesh-ancestor
6091813|NCT00863434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091814|NCT00863434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6091815|NCT00863434|Antiviral Agents|antiviral agents|mesh-ancestor
6091816|NCT00863434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6091817|NCT00863434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6091818|NCT00863551|Trospium chloride|trospium chloride|mesh-list
6091819|NCT00863551|Parasympatholytics|parasympatholytics|mesh-ancestor
6091820|NCT00863551|Autonomic Agents|autonomic agents|mesh-ancestor
6091821|NCT00863551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6091822|NCT00863551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091823|NCT00863551|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6091824|NCT00863551|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6091825|NCT00863551|Cholinergic Agents|cholinergic agents|mesh-ancestor
6091826|NCT00863551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6091827|NCT00863551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091828|NCT00863551|Urological Agents|urological agents|mesh-ancestor
6091829|NCT00863655|Everolimus|everolimus|mesh-list
6091830|NCT00863655|Exemestane|exemestane|mesh-list
6091831|NCT00863655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6091832|NCT00863655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6091833|NCT00863655|Immunologic Factors|immunologic factors|mesh-ancestor
5519571|NCT04330300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5519572|NCT04330300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519573|NCT04330300|Vasodilator Agents|vasodilator agents|mesh-ancestor
5519574|NCT04330300|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5519575|NCT04330300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5519576|NCT04330300|Natriuretic Agents|natriuretic agents|mesh-ancestor
5519577|NCT04330300|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5519578|NCT04330300|Protease Inhibitors|protease inhibitors|mesh-ancestor
5519579|NCT04330300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5519580|NCT04330300|Tocolytic Agents|tocolytic agents|mesh-ancestor
5519581|NCT04330300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5519582|NCT04330300|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5519583|NCT04330300|Protective Agents|protective agents|mesh-ancestor
5519584|NCT04330300|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
6091834|NCT00863655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091835|NCT00863655|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6091836|NCT00863655|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6091837|NCT00863655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6091838|NCT00863655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091839|NCT00863655|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6091840|NCT00863655|Hormone Antagonists|hormone antagonists|mesh-ancestor
6091841|NCT00863655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6091842|NCT00863681|Riociguat|riociguat|mesh-list
6091843|NCT00863681|Enzyme Activators|enzyme activators|mesh-ancestor
6091844|NCT00863681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091845|NCT00863707|Regadenoson|regadenoson|mesh-list
6091846|NCT00863707|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
6091847|NCT00863707|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6091848|NCT00863707|Purinergic Agonists|purinergic agonists|mesh-ancestor
6091849|NCT00863707|Purinergic Agents|purinergic agents|mesh-ancestor
6091850|NCT00863707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6091851|NCT00863707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091852|NCT00863707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091853|NCT00863746|Sorafenib|sorafenib|mesh-list
6091854|NCT00863746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6091855|NCT00863746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6091856|NCT00863746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6091857|NCT00863746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091858|NCT00863772|Tanezumab|tanezumab|mesh-list
6091859|NCT00863772|Analgesics|analgesics|mesh-ancestor
6091860|NCT00863772|Sensory System Agents|sensory system agents|mesh-ancestor
6464396|NCT00469547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464397|NCT00469547|Dermatologic Agents|dermatologic agents|mesh-ancestor
6464398|NCT00469560|Deferasirox|deferasirox|mesh-list
6464399|NCT00469560|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6464400|NCT00469560|Chelating Agents|chelating agents|mesh-ancestor
6464401|NCT00469560|Sequestering Agents|sequestering agents|mesh-ancestor
6464402|NCT00469560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6464403|NCT00469586|Insulin|insulin|mesh-list
6464404|NCT00469586|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6091861|NCT00863772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6091862|NCT00863772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091863|NCT00863798|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6091864|NCT00863798|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6091865|NCT00863798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6091866|NCT00863798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6091867|NCT00863798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091868|NCT00863798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6091869|NCT00863798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091870|NCT00863798|Antidepressive Agents|antidepressive agents|mesh-ancestor
6091871|NCT00863798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6091872|NCT00864032|Sorafenib|sorafenib|mesh-list
6091873|NCT00864032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6091874|NCT00864032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6091875|NCT00864032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6091876|NCT00864032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091877|NCT00864097|Diclofenac|diclofenac|mesh-list
6091878|NCT00864097|Tanezumab|tanezumab|mesh-list
6091879|NCT00864097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6091880|NCT00864097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6091881|NCT00864097|Analgesics|analgesics|mesh-ancestor
6091882|NCT00864097|Sensory System Agents|sensory system agents|mesh-ancestor
6091883|NCT00864097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6091884|NCT00864097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091885|NCT00864097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6091886|NCT00864097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6091887|NCT00864097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6091888|NCT00864097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6091889|NCT00864097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091890|NCT00864123|Cycloserine|cycloserine|mesh-list
6091891|NCT00864123|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6091892|NCT00864123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6091893|NCT00864123|Renal Agents|renal agents|mesh-ancestor
6091894|NCT00864123|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6091895|NCT00864123|Antitubercular Agents|antitubercular agents|mesh-ancestor
6091896|NCT00864123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6091897|NCT00864123|Antimetabolites|antimetabolites|mesh-ancestor
6091898|NCT00864123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091899|NCT00864253|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6091900|NCT00864253|Dacarbazine|dacarbazine|mesh-list
6091901|NCT00864253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6091902|NCT00864253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6091903|NCT00864253|Alkylating Agents|alkylating agents|mesh-ancestor
6091904|NCT00864253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091905|NCT00864383|Moxifloxacin|moxifloxacin|mesh-list
6464405|NCT00469586|Metformin|metformin|mesh-list
6464406|NCT00469586|Glimepiride|glimepiride|mesh-list
5519585|NCT04330547|Analgesics|analgesics|mesh-list
5519586|NCT04330547|Sensory System Agents|sensory system agents|mesh-ancestor
6091906|NCT00864383|Rifampin|rifampin|mesh-list
6091907|NCT00864383|Isoniazid|isoniazid|mesh-list
6091908|NCT00864383|Pyrazinamide|pyrazinamide|mesh-list
6091909|NCT00864383|Ethambutol|ethambutol|mesh-list
6091910|NCT00864383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6091911|NCT00864383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6091912|NCT00864383|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6091913|NCT00864383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5519587|NCT04330547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5519588|NCT04330547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519589|NCT04330586|Ciclesonide|ciclesonide|mesh-list
5519590|NCT04330586|Glucocorticoids|glucocorticoids|mesh-ancestor
5519591|NCT04330586|Hormones|hormones|mesh-ancestor
5600863|NCT03709082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6091914|NCT00864383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6091915|NCT00864383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091916|NCT00864383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6091917|NCT00864383|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6091918|NCT00864383|Antitubercular Agents|antitubercular agents|mesh-ancestor
6091919|NCT00864383|Leprostatic Agents|leprostatic agents|mesh-ancestor
6091920|NCT00864383|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6091921|NCT00864383|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5519592|NCT04330586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5519593|NCT04330586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519594|NCT04330586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5519595|NCT04330443|Pulmonary Surfactants|pulmonary surfactants|mesh-list
5519596|NCT04330443|Respiratory System Agents|respiratory system agents|mesh-ancestor
6091922|NCT00864383|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6091923|NCT00864383|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6203400|NCT02057198|Vancomycin|vancomycin|mesh-list
6464407|NCT00469586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6464408|NCT00469586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519597|NCT04330495|Hydroxychloroquine|hydroxychloroquine|mesh-list
6091924|NCT00864383|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6091925|NCT00864383|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6091926|NCT00864383|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6091927|NCT00864383|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6091928|NCT00864383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6091929|NCT00864383|Antimetabolites|antimetabolites|mesh-ancestor
6091930|NCT00864383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6091931|NCT00864513|Pemetrexed|pemetrexed|mesh-list
6091932|NCT00864513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6091933|NCT00864513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6091934|NCT00864513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091935|NCT00864513|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6091936|NCT00864513|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6091937|NCT00864539|Vitamin D|vitamin d|mesh-list
5519598|NCT04330495|Antimalarials|antimalarials|mesh-ancestor
5519599|NCT04330495|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5519600|NCT04330495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6091938|NCT00864539|Calcium|calcium|mesh-list
6091939|NCT00864539|Vitamins|vitamins|mesh-ancestor
6091940|NCT00864539|Micronutrients|micronutrients|mesh-ancestor
6091941|NCT00864539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091942|NCT00864539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6091943|NCT00864539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6091944|NCT00864682|Lidocaine|lidocaine|mesh-list
6091945|NCT00864682|Propofol|propofol|mesh-list
6091946|NCT00864682|Anesthetics, Local|anesthetics, local|mesh-ancestor
6091947|NCT00864682|Anesthetics|anesthetics|mesh-ancestor
6091948|NCT00864682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6091949|NCT00864682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091950|NCT00864682|Sensory System Agents|sensory system agents|mesh-ancestor
6091951|NCT00864682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6091952|NCT00864682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6091953|NCT00864682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6091954|NCT00864682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6091955|NCT00864682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6091956|NCT00864682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091957|NCT00864682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6464409|NCT00469586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6464410|NCT00469586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6464411|NCT00469586|Immunologic Factors|immunologic factors|mesh-ancestor
6464412|NCT00469599|Alfacalcidol|alfacalcidol|mesh-list
6464413|NCT00469599|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
5519601|NCT04330495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5519602|NCT04330495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5519603|NCT04330495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519604|NCT04330495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5519605|NCT04330677|Oxytocin|oxytocin|mesh-list
5519606|NCT04330677|Estrogens|estrogens|mesh-list
6464414|NCT00469599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6464415|NCT00469599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464416|NCT00469599|Vitamins|vitamins|mesh-ancestor
6464417|NCT00469599|Micronutrients|micronutrients|mesh-ancestor
6464418|NCT00469651|Vaccines|vaccines|mesh-list
6464419|NCT00469651|Immunologic Factors|immunologic factors|mesh-ancestor
6464420|NCT00469651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464421|NCT00469664|Guanfacine|guanfacine|mesh-list
6091958|NCT00864682|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6091959|NCT00864682|Anesthetics, General|anesthetics, general|mesh-ancestor
6091960|NCT00864721|Sunitinib|sunitinib|mesh-list
6091961|NCT00864721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6091962|NCT00864721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6091963|NCT00864721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6091964|NCT00864721|Growth Substances|growth substances|mesh-ancestor
6091965|NCT00864721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091966|NCT00864721|Growth Inhibitors|growth inhibitors|mesh-ancestor
6091967|NCT00864721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6091968|NCT00864721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6091969|NCT00864721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091970|NCT00864916|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6091971|NCT00864916|Pentoxifylline|pentoxifylline|mesh-list
6091972|NCT00864916|Antiviral Agents|antiviral agents|mesh-ancestor
6091973|NCT00864916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6091974|NCT00864916|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6091975|NCT00864916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5519607|NCT04330677|Oxytocics|oxytocics|mesh-ancestor
5519608|NCT04330677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5519609|NCT04330677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519610|NCT04330677|Hormones|hormones|mesh-ancestor
5519611|NCT04330677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5600864|NCT03709082|Tubulin Modulators|tubulin modulators|mesh-ancestor
5600865|NCT03709082|Antimitotic Agents|antimitotic agents|mesh-ancestor
5600866|NCT03709082|Mitosis Modulators|mitosis modulators|mesh-ancestor
5600867|NCT03709056|Propofol|propofol|mesh-list
5600868|NCT03709056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5600869|NCT03709056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5600870|NCT03709056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203401|NCT02057198|Fidaxomicin|fidaxomicin|mesh-list
5519612|NCT04330027|Mitogens|mitogens|mesh-list
5519613|NCT04330027|Mitosis Modulators|mitosis modulators|mesh-ancestor
5519614|NCT04330027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519615|NCT04330638|Siltuximab|siltuximab|mesh-list
5519616|NCT04330638|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5519617|NCT04330638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5519618|NCT04330638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5519619|NCT04330326|Sorbitol|sorbitol|mesh-list
5519620|NCT04330326|Cathartics|cathartics|mesh-ancestor
5519621|NCT04330326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5519622|NCT04330079|Dapagliflozin|dapagliflozin|mesh-list
5519623|NCT04330079|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5519624|NCT04330079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519625|NCT04330079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6091976|NCT00864916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091977|NCT00864916|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6091978|NCT00864916|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6091979|NCT00864916|Protective Agents|protective agents|mesh-ancestor
6091980|NCT00864916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091981|NCT00864916|Vasodilator Agents|vasodilator agents|mesh-ancestor
6091982|NCT00864916|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6091983|NCT00864916|Antioxidants|antioxidants|mesh-ancestor
6091984|NCT00865020|Telmisartan|telmisartan|mesh-list
6091985|NCT00865020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6091986|NCT00865020|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6091987|NCT00865020|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6091988|NCT00865020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6091989|NCT00865098|Cetuximab|cetuximab|mesh-list
6091990|NCT00865098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6091991|NCT00865098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6091992|NCT00865124|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6091993|NCT00865124|Spironolactone|spironolactone|mesh-list
6091994|NCT00865124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6091995|NCT00865124|Diuretics|diuretics|mesh-ancestor
6091996|NCT00865124|Natriuretic Agents|natriuretic agents|mesh-ancestor
6091997|NCT00865124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6091998|NCT00865124|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6091999|NCT00865124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6464422|NCT00469664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6464423|NCT00469664|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6464424|NCT00469664|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6464425|NCT00469664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6464426|NCT00469664|Adrenergic Agents|adrenergic agents|mesh-ancestor
6464427|NCT00469664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6464428|NCT00469664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6464429|NCT00469664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464430|NCT00469690|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6464431|NCT00469690|Bromfenac|bromfenac|mesh-list
6464432|NCT00469690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6464433|NCT00469690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6092000|NCT00865124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092001|NCT00865124|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6092002|NCT00865124|Hormone Antagonists|hormone antagonists|mesh-ancestor
6092003|NCT00865124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6092004|NCT00865124|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6092005|NCT00865189|Leucovorin|leucovorin|mesh-list
6092006|NCT00865189|Folic Acid|folic acid|mesh-list
6092007|NCT00865189|Bevacizumab|bevacizumab|mesh-list
6092008|NCT00865189|Fluorouracil|fluorouracil|mesh-list
6092009|NCT00865189|Oxaliplatin|oxaliplatin|mesh-list
6092010|NCT00865189|Levoleucovorin|levoleucovorin|mesh-list
6092011|NCT00865189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6464434|NCT00469690|Analgesics|analgesics|mesh-ancestor
6464435|NCT00469690|Sensory System Agents|sensory system agents|mesh-ancestor
6464436|NCT00469690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6464437|NCT00469690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464438|NCT00469690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5519626|NCT04330079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519627|NCT04329624|Simendan|simendan|mesh-list
6092012|NCT00865189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6092013|NCT00865189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6092014|NCT00865189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5519628|NCT04329624|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5519629|NCT04329624|Vasodilator Agents|vasodilator agents|mesh-ancestor
5519630|NCT04329624|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5519631|NCT04329624|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5519632|NCT04329624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5519633|NCT04329624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519634|NCT04329624|Protective Agents|protective agents|mesh-ancestor
5519635|NCT04329624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519636|NCT04329611|Hydroxychloroquine|hydroxychloroquine|mesh-list
5519637|NCT04329611|Antimalarials|antimalarials|mesh-ancestor
5519638|NCT04329611|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6092015|NCT00865189|Growth Substances|growth substances|mesh-ancestor
6092016|NCT00865189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092017|NCT00865189|Growth Inhibitors|growth inhibitors|mesh-ancestor
6464439|NCT00469690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6092018|NCT00865189|Antimetabolites|antimetabolites|mesh-ancestor
6092019|NCT00865189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092020|NCT00865189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6092021|NCT00865189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6092022|NCT00865189|Immunologic Factors|immunologic factors|mesh-ancestor
6092023|NCT00865189|Antidotes|antidotes|mesh-ancestor
6092024|NCT00865189|Protective Agents|protective agents|mesh-ancestor
6092025|NCT00865189|Vitamin B Complex|vitamin b complex|mesh-ancestor
6092026|NCT00865189|Vitamins|vitamins|mesh-ancestor
6092027|NCT00865189|Micronutrients|micronutrients|mesh-ancestor
6092028|NCT00865189|Hematinics|hematinics|mesh-ancestor
6092029|NCT00865202|Tryptophan|tryptophan|mesh-list
6092030|NCT00865202|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6092031|NCT00865202|Antidepressive Agents|antidepressive agents|mesh-ancestor
6092032|NCT00865202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6092033|NCT00865280|Moxifloxacin|moxifloxacin|mesh-list
6092034|NCT00865280|Linezolid|linezolid|mesh-list
6092035|NCT00865280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6092036|NCT00865280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5519639|NCT04329611|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5519640|NCT04329611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5519641|NCT04329611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5519642|NCT04329611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519643|NCT04329611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5519644|NCT04329650|Methylprednisolone|methylprednisolone|mesh-list
5519645|NCT04329650|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5519646|NCT04329650|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5519647|NCT04329650|Prednisolone|prednisolone|mesh-list
5519648|NCT04329650|Prednisolone acetate|prednisolone acetate|mesh-list
5519649|NCT04329650|Siltuximab|siltuximab|mesh-list
5519650|NCT04329650|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5519651|NCT04329650|Prednisolone phosphate|prednisolone phosphate|mesh-list
5519652|NCT04329650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5519653|NCT04329650|Antiemetics|antiemetics|mesh-ancestor
6092037|NCT00865280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6092038|NCT00865280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6092039|NCT00865280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6092040|NCT00865280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092041|NCT00865280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6092042|NCT00865280|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6092043|NCT00865566|Vaccines|vaccines|mesh-list
6092044|NCT00865566|Immunologic Factors|immunologic factors|mesh-ancestor
6092045|NCT00865566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092046|NCT00865709|Leucovorin|leucovorin|mesh-list
6092047|NCT00865709|Oxaliplatin|oxaliplatin|mesh-list
6092048|NCT00865709|Fluorouracil|fluorouracil|mesh-list
6092049|NCT00865709|Sorafenib|sorafenib|mesh-list
6092050|NCT00865709|Levoleucovorin|levoleucovorin|mesh-list
6092051|NCT00865709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6092052|NCT00865709|Antidotes|antidotes|mesh-ancestor
6092053|NCT00865709|Protective Agents|protective agents|mesh-ancestor
6092054|NCT00865709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092055|NCT00865709|Vitamin B Complex|vitamin b complex|mesh-ancestor
6092056|NCT00865709|Vitamins|vitamins|mesh-ancestor
6092057|NCT00865709|Micronutrients|micronutrients|mesh-ancestor
6092058|NCT00865709|Antimetabolites|antimetabolites|mesh-ancestor
6092059|NCT00865709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092060|NCT00865709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6092061|NCT00865709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6092062|NCT00865709|Immunologic Factors|immunologic factors|mesh-ancestor
6092063|NCT00865709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6092064|NCT00865709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6092065|NCT00865969|Belinostat|belinostat|mesh-list
6092066|NCT00865969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6092067|NCT00865969|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5519654|NCT04329650|Autonomic Agents|autonomic agents|mesh-ancestor
5519655|NCT04329650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5519656|NCT04329650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519657|NCT04329650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5519658|NCT04329650|Glucocorticoids|glucocorticoids|mesh-ancestor
5519659|NCT04329650|Hormones|hormones|mesh-ancestor
5519660|NCT04329650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5519661|NCT04329650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5519662|NCT04329650|Protective Agents|protective agents|mesh-ancestor
6092068|NCT00865969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6092069|NCT00865969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092070|NCT00866034|Cetrorelix|cetrorelix|mesh-list
6092071|NCT00866034|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5519663|NCT04329650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5519664|NCT04329650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5519665|NCT04329832|Azithromycin|azithromycin|mesh-list
6092072|NCT00866034|Fertility Agents|fertility agents|mesh-ancestor
6092073|NCT00866034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6092074|NCT00866034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092075|NCT00866034|Hormone Antagonists|hormone antagonists|mesh-ancestor
6092076|NCT00866034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6092077|NCT00866047|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6092078|NCT00866047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6092079|NCT00866047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6092080|NCT00866281|Midostaurin|midostaurin|mesh-list
6092081|NCT00866281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6092082|NCT00866281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6092083|NCT00866281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6092084|NCT00866281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092085|NCT00866294|Paroxetine|paroxetine|mesh-list
6092086|NCT00866294|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6092087|NCT00866294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6092088|NCT00866294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6092089|NCT00866294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092090|NCT00866294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6092091|NCT00866294|Serotonin Agents|serotonin agents|mesh-ancestor
6092092|NCT00866294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092093|NCT00866294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6092094|NCT00866294|Antidepressive Agents|antidepressive agents|mesh-ancestor
6092095|NCT00866294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6092096|NCT00866294|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6092097|NCT00866294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6092098|NCT00866294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6092099|NCT00866307|Cytarabine|cytarabine|mesh-list
6092100|NCT00866307|Dexamethasone|dexamethasone|mesh-list
6092101|NCT00866307|Dexamethasone acetate|dexamethasone acetate|mesh-list
6092102|NCT00866307|Prednisone|prednisone|mesh-list
6092103|NCT00866307|Cortisone|cortisone|mesh-list
6092104|NCT00866307|Cyclophosphamide|cyclophosphamide|mesh-list
6092105|NCT00866307|Doxorubicin|doxorubicin|mesh-list
6092106|NCT00866307|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6092107|NCT00866307|Methotrexate|methotrexate|mesh-list
6092108|NCT00866307|Vincristine|vincristine|mesh-list
6092109|NCT00866307|Daunorubicin|daunorubicin|mesh-list
6092110|NCT00866307|Asparaginase|asparaginase|mesh-list
6092111|NCT00866307|Mercaptopurine|mercaptopurine|mesh-list
6092112|NCT00866307|Pegaspargase|pegaspargase|mesh-list
6092113|NCT00866307|Thioguanine|thioguanine|mesh-list
6092114|NCT00866307|BB 1101|bb 1101|mesh-list
6092115|NCT00866307|2-Aminopurine|2-aminopurine|mesh-list
6092116|NCT00866307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6092117|NCT00866307|Immunologic Factors|immunologic factors|mesh-ancestor
6092118|NCT00866307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092119|NCT00866307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6092120|NCT00866307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6092121|NCT00866307|Alkylating Agents|alkylating agents|mesh-ancestor
6092122|NCT00866307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092123|NCT00866307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6092124|NCT00866307|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6092125|NCT00866307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6092126|NCT00866307|Antiemetics|antiemetics|mesh-ancestor
6092127|NCT00866307|Autonomic Agents|autonomic agents|mesh-ancestor
6092128|NCT00866307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6092129|NCT00866307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6092130|NCT00866307|Glucocorticoids|glucocorticoids|mesh-ancestor
6092131|NCT00866307|Hormones|hormones|mesh-ancestor
6464440|NCT00469690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6464441|NCT00469690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6464442|NCT00469690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6464443|NCT00469703|Thalidomide|thalidomide|mesh-list
6464444|NCT00469703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6464445|NCT00469703|Immunologic Factors|immunologic factors|mesh-ancestor
6464446|NCT00469703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092132|NCT00866307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6092133|NCT00866307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6092134|NCT00866307|Protease Inhibitors|protease inhibitors|mesh-ancestor
6092135|NCT00866307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6092136|NCT00866307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6092137|NCT00866307|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6092138|NCT00866307|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6092139|NCT00866307|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6092140|NCT00866307|Abortifacient Agents|abortifacient agents|mesh-ancestor
6092141|NCT00866307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6092142|NCT00866307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6092143|NCT00866307|Antimetabolites|antimetabolites|mesh-ancestor
6092144|NCT00866307|Dermatologic Agents|dermatologic agents|mesh-ancestor
6092145|NCT00866307|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6092146|NCT00866307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6092147|NCT00866307|Antiviral Agents|antiviral agents|mesh-ancestor
6092148|NCT00866307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6092149|NCT00866307|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6092150|NCT00866307|Tubulin Modulators|tubulin modulators|mesh-ancestor
6092151|NCT00866307|Antimitotic Agents|antimitotic agents|mesh-ancestor
6092152|NCT00866307|Mitosis Modulators|mitosis modulators|mesh-ancestor
6092153|NCT00866320|Sorafenib|sorafenib|mesh-list
6092154|NCT00866320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6092155|NCT00866320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6092156|NCT00866320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6092157|NCT00866320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203402|NCT02057198|Amebicides|amebicides|mesh-list
6203403|NCT02057198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5519666|NCT04329832|Hydroxychloroquine|hydroxychloroquine|mesh-list
5519667|NCT04329832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5519668|NCT04329832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5519669|NCT04329832|Antimalarials|antimalarials|mesh-ancestor
5519670|NCT04329832|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5519671|NCT04329832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5519672|NCT04329832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5519673|NCT04329832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519674|NCT04329832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5519675|NCT04329949|Paclitaxel|paclitaxel|mesh-list
5519676|NCT04329949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5519677|NCT04329949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5519678|NCT04329949|Tubulin Modulators|tubulin modulators|mesh-ancestor
6203404|NCT02057198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6203405|NCT02057198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6203406|NCT02057250|Hydroxychloroquine|hydroxychloroquine|mesh-list
6203407|NCT02057250|Sulfasalazine|sulfasalazine|mesh-list
6203408|NCT02057250|Methotrexate|methotrexate|mesh-list
6203409|NCT02057250|Leflunomide|leflunomide|mesh-list
6203410|NCT02057250|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6203411|NCT02057250|Abortifacient Agents|abortifacient agents|mesh-ancestor
6203412|NCT02057250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6203413|NCT02057250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203414|NCT02057250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6203415|NCT02057250|Antimetabolites|antimetabolites|mesh-ancestor
6203416|NCT02057250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203417|NCT02057250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6203418|NCT02057250|Dermatologic Agents|dermatologic agents|mesh-ancestor
6203419|NCT02057250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6203420|NCT02057250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6203421|NCT02057250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6203422|NCT02057250|Immunologic Factors|immunologic factors|mesh-ancestor
6203423|NCT02057250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6203424|NCT02057250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6203425|NCT02057250|Antimalarials|antimalarials|mesh-ancestor
6203426|NCT02057250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6203427|NCT02057250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5519679|NCT04329949|Antimitotic Agents|antimitotic agents|mesh-ancestor
5519680|NCT04329949|Mitosis Modulators|mitosis modulators|mesh-ancestor
6203428|NCT02057250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6092158|NCT00866333|Entinostat|entinostat|mesh-list
6092159|NCT00866333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5519681|NCT04329949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519682|NCT04329858|Methamphetamine|methamphetamine|mesh-list
5519683|NCT04329858|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5519684|NCT04329858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519685|NCT04329858|Sympathomimetics|sympathomimetics|mesh-ancestor
6092160|NCT00866333|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6092161|NCT00866333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6092162|NCT00866333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092163|NCT00866359|Apremilast|apremilast|mesh-list
6092164|NCT00866359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6092165|NCT00866359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6092166|NCT00866359|Analgesics|analgesics|mesh-ancestor
6092167|NCT00866359|Sensory System Agents|sensory system agents|mesh-ancestor
6092168|NCT00866359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6092169|NCT00866359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092170|NCT00866359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6092171|NCT00866359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6092172|NCT00866359|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5519686|NCT04329858|Autonomic Agents|autonomic agents|mesh-ancestor
5519687|NCT04329858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5519688|NCT04329858|Dopamine Agents|dopamine agents|mesh-ancestor
5519689|NCT04329858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5519690|NCT04329858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519691|NCT04329858|Adrenergic Agents|adrenergic agents|mesh-ancestor
5519692|NCT04329858|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6092173|NCT00866359|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6092174|NCT00866359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6092175|NCT00866359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092176|NCT00866619|Vaccines|vaccines|mesh-list
6092177|NCT00866619|Immunologic Factors|immunologic factors|mesh-ancestor
6092178|NCT00866619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092179|NCT00866658|Lixisenatide|lixisenatide|mesh-list
6092180|NCT00866658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6092181|NCT00866658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092182|NCT00866723|Bevacizumab|bevacizumab|mesh-list
6092183|NCT00866723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6092184|NCT00866723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6092185|NCT00866723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6092186|NCT00866723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6092187|NCT00866723|Growth Substances|growth substances|mesh-ancestor
6092188|NCT00866723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092189|NCT00866723|Growth Inhibitors|growth inhibitors|mesh-ancestor
6092190|NCT00866749|Cytarabine|cytarabine|mesh-list
6092191|NCT00866749|Cyclophosphamide|cyclophosphamide|mesh-list
6092192|NCT00866749|Doxorubicin|doxorubicin|mesh-list
6092193|NCT00866749|Methotrexate|methotrexate|mesh-list
6092194|NCT00866749|Vincristine|vincristine|mesh-list
6092195|NCT00866749|Daunorubicin|daunorubicin|mesh-list
6092196|NCT00866749|Asparaginase|asparaginase|mesh-list
6092197|NCT00866749|Mercaptopurine|mercaptopurine|mesh-list
6092198|NCT00866749|Thioguanine|thioguanine|mesh-list
6092199|NCT00866749|Pegaspargase|pegaspargase|mesh-list
6092200|NCT00866749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6092201|NCT00866749|Immunologic Factors|immunologic factors|mesh-ancestor
6092202|NCT00866749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092203|NCT00866749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6092204|NCT00866749|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6092205|NCT00866749|Alkylating Agents|alkylating agents|mesh-ancestor
6092206|NCT00866749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092207|NCT00866749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6092208|NCT00866749|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6092209|NCT00866749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6092210|NCT00866749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6092211|NCT00866749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6092212|NCT00866749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6092213|NCT00866749|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6092214|NCT00866749|Abortifacient Agents|abortifacient agents|mesh-ancestor
6092215|NCT00866749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6092216|NCT00866749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6092217|NCT00866749|Antimetabolites|antimetabolites|mesh-ancestor
6092218|NCT00866749|Dermatologic Agents|dermatologic agents|mesh-ancestor
6092219|NCT00866749|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6092220|NCT00866749|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6092221|NCT00866749|Antiviral Agents|antiviral agents|mesh-ancestor
6092222|NCT00866749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6092223|NCT00866749|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6092224|NCT00866749|Tubulin Modulators|tubulin modulators|mesh-ancestor
6092225|NCT00866749|Antimitotic Agents|antimitotic agents|mesh-ancestor
6092226|NCT00866749|Mitosis Modulators|mitosis modulators|mesh-ancestor
6092227|NCT00866775|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
6092228|NCT00866775|Anticonvulsants|anticonvulsants|mesh-ancestor
6092229|NCT00866775|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6092230|NCT00866775|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5519693|NCT04329858|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5519694|NCT04329858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5519695|NCT04329858|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5519696|NCT04329806|Amlodipine|amlodipine|mesh-list
5519697|NCT04329806|Moxonidine|moxonidine|mesh-list
5519698|NCT04329806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5519699|NCT04329806|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6092231|NCT00866775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6092232|NCT00866775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092233|NCT00866788|Omalizumab|omalizumab|mesh-list
6092234|NCT00866788|Diphenhydramine|diphenhydramine|mesh-list
6092235|NCT00866788|Promethazine|promethazine|mesh-list
6092236|NCT00866788|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
6092237|NCT00866788|Histamine Antagonists|histamine antagonists|mesh-list
6092238|NCT00866788|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6092239|NCT00866788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6092240|NCT00866788|Respiratory System Agents|respiratory system agents|mesh-ancestor
6092241|NCT00866788|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6092242|NCT00866788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6092243|NCT00866788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6092244|NCT00866788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092245|NCT00866788|Anesthetics, Local|anesthetics, local|mesh-ancestor
6092246|NCT00866788|Anesthetics|anesthetics|mesh-ancestor
6092247|NCT00866788|Sensory System Agents|sensory system agents|mesh-ancestor
6092248|NCT00866788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6092249|NCT00866788|Antiemetics|antiemetics|mesh-ancestor
6092250|NCT00866788|Autonomic Agents|autonomic agents|mesh-ancestor
6092251|NCT00866788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6092252|NCT00866788|Histamine Agents|histamine agents|mesh-ancestor
6092253|NCT00866788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6092254|NCT00866788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092255|NCT00866788|Antipruritics|antipruritics|mesh-ancestor
6092256|NCT00866788|Dermatologic Agents|dermatologic agents|mesh-ancestor
6092257|NCT00866879|Sirolimus|sirolimus|mesh-list
6092258|NCT00866879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6092259|NCT00866879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6092260|NCT00866879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6092261|NCT00866879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6092262|NCT00866879|Antifungal Agents|antifungal agents|mesh-ancestor
6092263|NCT00866879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6092264|NCT00866879|Immunologic Factors|immunologic factors|mesh-ancestor
6092265|NCT00866879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092266|NCT00866905|Cyclophosphamide|cyclophosphamide|mesh-list
6092267|NCT00866905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6092268|NCT00866905|Immunologic Factors|immunologic factors|mesh-ancestor
6092269|NCT00866905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092270|NCT00866905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6092271|NCT00866905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6092272|NCT00866905|Alkylating Agents|alkylating agents|mesh-ancestor
6092273|NCT00866905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092274|NCT00866905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6092275|NCT00866905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6092276|NCT00866918|Cytarabine|cytarabine|mesh-list
6092277|NCT00866918|Methotrexate|methotrexate|mesh-list
6092278|NCT00866918|Mercaptopurine|mercaptopurine|mesh-list
6092279|NCT00866918|Mitoxantrone|mitoxantrone|mesh-list
6092280|NCT00866918|Idarubicin|idarubicin|mesh-list
5519700|NCT04329806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6092281|NCT00866918|Arsenic Trioxide|arsenic trioxide|mesh-list
6092282|NCT00866918|Tretinoin|tretinoin|mesh-list
6092283|NCT00866918|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6092284|NCT00866918|Abortifacient Agents|abortifacient agents|mesh-ancestor
6092285|NCT00866918|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6092286|NCT00866918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092287|NCT00866918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6092288|NCT00866918|Antimetabolites|antimetabolites|mesh-ancestor
6092289|NCT00866918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092290|NCT00866918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6092291|NCT00866918|Dermatologic Agents|dermatologic agents|mesh-ancestor
6092292|NCT00866918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6092293|NCT00866918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6092294|NCT00866918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6092295|NCT00866918|Immunologic Factors|immunologic factors|mesh-ancestor
6092296|NCT00866918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6092297|NCT00866918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6092298|NCT00866918|Antiviral Agents|antiviral agents|mesh-ancestor
6092299|NCT00866918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6092300|NCT00866918|Analgesics|analgesics|mesh-ancestor
6092301|NCT00866918|Sensory System Agents|sensory system agents|mesh-ancestor
6092302|NCT00866918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6092303|NCT00866918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6092304|NCT00866918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5519701|NCT04329806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519702|NCT04329806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5519703|NCT04329806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519704|NCT04329806|Vasodilator Agents|vasodilator agents|mesh-ancestor
5519705|NCT04330144|Hydroxychloroquine|hydroxychloroquine|mesh-list
5519706|NCT04330144|Antimalarials|antimalarials|mesh-ancestor
5519707|NCT04330144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5519708|NCT04330144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6092305|NCT00866918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6092306|NCT00866918|Keratolytic Agents|keratolytic agents|mesh-ancestor
6092307|NCT00867009|Pemetrexed|pemetrexed|mesh-list
6092308|NCT00867009|Cetuximab|cetuximab|mesh-list
6092309|NCT00867009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6092310|NCT00867009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6092311|NCT00867009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092312|NCT00867009|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6092313|NCT00867009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6092314|NCT00867009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6092315|NCT00867035|Chlorhexidine|chlorhexidine|mesh-list
6092316|NCT00867035|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6092317|NCT00867035|Chlorine dioxide|chlorine dioxide|mesh-list
6092318|NCT00867035|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6092319|NCT00867035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6092320|NCT00867035|Disinfectants|disinfectants|mesh-ancestor
6092321|NCT00867035|Dermatologic Agents|dermatologic agents|mesh-ancestor
5519709|NCT04330144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5519710|NCT04330144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5519711|NCT04330144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519712|NCT04330144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5519713|NCT04329585|Flumazenil|flumazenil|mesh-list
5519714|NCT04329585|Antidotes|antidotes|mesh-ancestor
5519715|NCT04329585|Protective Agents|protective agents|mesh-ancestor
5519716|NCT04329585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519717|NCT04329585|GABA Modulators|gaba modulators|mesh-ancestor
5519718|NCT04329585|GABA Agents|gaba agents|mesh-ancestor
5519719|NCT04329585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5519720|NCT04329585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519721|NCT04329572|Azithromycin|azithromycin|mesh-list
5519722|NCT04329572|Hydroxychloroquine|hydroxychloroquine|mesh-list
5519723|NCT04329572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5519724|NCT04329572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5519725|NCT04329572|Antimalarials|antimalarials|mesh-ancestor
5519726|NCT04329572|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5519727|NCT04329572|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6092322|NCT00867035|Dental Disinfectants|dental disinfectants|mesh-ancestor
6092323|NCT00867087|Rituximab|rituximab|mesh-list
6092324|NCT00867087|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
6092325|NCT00867087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6092326|NCT00867087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6092327|NCT00867087|Immunologic Factors|immunologic factors|mesh-ancestor
6464447|NCT00469703|Leprostatic Agents|leprostatic agents|mesh-ancestor
5519728|NCT04329572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6092328|NCT00867087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092329|NCT00867087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6092330|NCT00867087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5519729|NCT04329572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519730|NCT04329572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5519731|NCT04329403|Adapalene|adapalene|mesh-list
5519732|NCT04329403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5519733|NCT04329403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5519734|NCT04329403|Analgesics|analgesics|mesh-ancestor
5519735|NCT04329403|Sensory System Agents|sensory system agents|mesh-ancestor
5519736|NCT04329403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5519737|NCT04329403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519738|NCT04329403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5519739|NCT04329403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5519740|NCT04329403|Dermatologic Agents|dermatologic agents|mesh-ancestor
5519741|NCT04329390|Anticoagulants|anticoagulants|mesh-list
5519742|NCT04329442|Tenofovir|tenofovir|mesh-list
5519743|NCT04329442|Emtricitabine|emtricitabine|mesh-list
5519744|NCT04329442|Antiviral Agents|antiviral agents|mesh-ancestor
5519745|NCT04329442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5519746|NCT04329442|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5519747|NCT04329442|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5519748|NCT04329442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5519749|NCT04329442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519750|NCT04329442|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5519751|NCT04329442|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5519752|NCT04329039|Somatostatin|somatostatin|mesh-list
5519753|NCT04329039|Hormones|hormones|mesh-ancestor
6092331|NCT00867113|Imatinib Mesylate|imatinib mesylate|mesh-list
6092332|NCT00867113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6092333|NCT00867113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6092334|NCT00867113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6092335|NCT00867113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092336|NCT00867139|Oseltamivir|oseltamivir|mesh-list
6092337|NCT00867139|Ribavirin|ribavirin|mesh-list
6092338|NCT00867139|Zanamivir|zanamivir|mesh-list
6092339|NCT00867139|Amantadine|amantadine|mesh-list
6092340|NCT00867139|Thiazole-4-carboxamide adenine dinucleotide|thiazole-4-carboxamide adenine dinucleotide|mesh-list
6092341|NCT00867139|Antiviral Agents|antiviral agents|mesh-ancestor
6092342|NCT00867139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6092343|NCT00867139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6092344|NCT00867139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092345|NCT00867139|Antimetabolites|antimetabolites|mesh-ancestor
6092346|NCT00867139|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6092347|NCT00867139|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6092348|NCT00867139|Dopamine Agents|dopamine agents|mesh-ancestor
6092349|NCT00867139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6092350|NCT00867139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092351|NCT00867139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6092352|NCT00867139|Analgesics|analgesics|mesh-ancestor
6092353|NCT00867139|Sensory System Agents|sensory system agents|mesh-ancestor
6092354|NCT00867139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5519754|NCT04329039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5519755|NCT04329039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519756|NCT04329130|Lenalidomide|lenalidomide|mesh-list
6092355|NCT00867217|Vitamin D|vitamin d|mesh-list
6092356|NCT00867217|Ergocalciferols|ergocalciferols|mesh-list
6092357|NCT00867217|Cholecalciferol|cholecalciferol|mesh-list
6092358|NCT00867217|Vitamins|vitamins|mesh-list
6092359|NCT00867217|Letrozole|letrozole|mesh-list
6092360|NCT00867217|Micronutrients|micronutrients|mesh-ancestor
6092361|NCT00867217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092362|NCT00867217|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6092363|NCT00867217|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6092364|NCT00867217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6092365|NCT00867217|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6092366|NCT00867217|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6092367|NCT00867217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6092368|NCT00867217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092369|NCT00867217|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6092370|NCT00867217|Hormone Antagonists|hormone antagonists|mesh-ancestor
6092371|NCT00867217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6092372|NCT00867308|Lenalidomide|lenalidomide|mesh-list
6092373|NCT00867308|Immunologic Factors|immunologic factors|mesh-ancestor
6092374|NCT00867308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092375|NCT00867308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6092376|NCT00867308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6092377|NCT00867308|Growth Substances|growth substances|mesh-ancestor
6092378|NCT00867308|Growth Inhibitors|growth inhibitors|mesh-ancestor
6092379|NCT00867308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6092380|NCT00867321|Bevacizumab|bevacizumab|mesh-list
6092381|NCT00867321|Sorafenib|sorafenib|mesh-list
6092382|NCT00867321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6092383|NCT00867321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6092384|NCT00867321|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6092385|NCT00867321|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6092386|NCT00867321|Growth Substances|growth substances|mesh-ancestor
6092387|NCT00867321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092388|NCT00867321|Growth Inhibitors|growth inhibitors|mesh-ancestor
6092389|NCT00867321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6092390|NCT00867321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6092391|NCT00867321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092392|NCT00867334|Imatinib Mesylate|imatinib mesylate|mesh-list
6092393|NCT00867334|Panitumumab|panitumumab|mesh-list
6092394|NCT00867334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6092395|NCT00867334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6092396|NCT00867334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6092397|NCT00867334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092398|NCT00867334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6092399|NCT00867360|Mifepristone|mifepristone|mesh-list
6092400|NCT00867360|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6092401|NCT00867360|Abortifacient Agents|abortifacient agents|mesh-ancestor
6092402|NCT00867360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6092403|NCT00867360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092404|NCT00867360|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6092405|NCT00867360|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6092406|NCT00867360|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6092407|NCT00867360|Contraceptive Agents|contraceptive agents|mesh-ancestor
5519757|NCT04329130|Immunologic Factors|immunologic factors|mesh-ancestor
5519758|NCT04329130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519759|NCT04329130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5519760|NCT04329130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5519761|NCT04329130|Growth Substances|growth substances|mesh-ancestor
5519762|NCT04329130|Growth Inhibitors|growth inhibitors|mesh-ancestor
5519763|NCT04329130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5519764|NCT04329429|Trastuzumab|trastuzumab|mesh-list
5519765|NCT04329429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5519766|NCT04329429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5519767|NCT04329221|Calcitriol|calcitriol|mesh-list
5519768|NCT04329221|Fluorouracil|fluorouracil|mesh-list
5519769|NCT04329221|Calcipotriene|calcipotriene|mesh-list
5519770|NCT04329221|Petrolatum|petrolatum|mesh-list
5519771|NCT04329221|Antimetabolites|antimetabolites|mesh-ancestor
5519772|NCT04329221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519773|NCT04329221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5519774|NCT04329221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5519775|NCT04329221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5519776|NCT04329221|Immunologic Factors|immunologic factors|mesh-ancestor
5519777|NCT04329221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519778|NCT04329221|Dermatologic Agents|dermatologic agents|mesh-ancestor
5519779|NCT04329221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5519780|NCT04329221|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
5519781|NCT04329221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5519782|NCT04329221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6092408|NCT00867360|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6092409|NCT00867360|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6092410|NCT00867360|Hormone Antagonists|hormone antagonists|mesh-ancestor
6092411|NCT00867360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6092412|NCT00867360|Luteolytic Agents|luteolytic agents|mesh-ancestor
6092413|NCT00867360|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6092414|NCT00867360|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6092415|NCT00867451|Melatonin|melatonin|mesh-list
6092416|NCT00867451|Antioxidants|antioxidants|mesh-ancestor
5519783|NCT04329221|Vitamins|vitamins|mesh-ancestor
5519784|NCT04329221|Micronutrients|micronutrients|mesh-ancestor
5519785|NCT04329221|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5519786|NCT04329221|Emollients|emollients|mesh-ancestor
5519787|NCT04329091|Dexmedetomidine|dexmedetomidine|mesh-list
5519788|NCT04329091|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5519789|NCT04329091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5519790|NCT04329091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519791|NCT04329091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5519792|NCT04329091|Analgesics|analgesics|mesh-ancestor
5519793|NCT04329091|Sensory System Agents|sensory system agents|mesh-ancestor
5519794|NCT04329091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5519795|NCT04329091|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5519796|NCT04329091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5519797|NCT04329091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5519798|NCT04329091|Adrenergic Agents|adrenergic agents|mesh-ancestor
5519799|NCT04329091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5519800|NCT04329091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519801|NCT04328870|Oxytocin|oxytocin|mesh-list
6092417|NCT00867451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092418|NCT00867451|Protective Agents|protective agents|mesh-ancestor
6092419|NCT00867451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092420|NCT00867451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6092421|NCT00867490|Amlodipine|amlodipine|mesh-list
6092422|NCT00867490|Candesartan|candesartan|mesh-list
6092423|NCT00867490|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6092424|NCT00867490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6092425|NCT00867490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6092426|NCT00867490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6092427|NCT00867490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092428|NCT00867490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6092429|NCT00867490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092430|NCT00867490|Vasodilator Agents|vasodilator agents|mesh-ancestor
6092431|NCT00867490|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6092432|NCT00867490|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6092433|NCT00867490|Diuretics|diuretics|mesh-ancestor
6092434|NCT00867490|Natriuretic Agents|natriuretic agents|mesh-ancestor
6092435|NCT00867490|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6092436|NCT00867503|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6092437|NCT00867503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6092438|NCT00867503|Alkylating Agents|alkylating agents|mesh-ancestor
6092439|NCT00867503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092440|NCT00867503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6092441|NCT00867529|Rituximab|rituximab|mesh-list
6092442|NCT00867529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6092443|NCT00867529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6464448|NCT00469703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6464449|NCT00469703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5519802|NCT04328870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519803|NCT04328870|Oxytocics|oxytocics|mesh-ancestor
5519804|NCT04328870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5519805|NCT04328805|Ibuprofen|ibuprofen|mesh-list
5519806|NCT04328805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5519807|NCT04328805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5519808|NCT04328805|Analgesics|analgesics|mesh-ancestor
5519809|NCT04328805|Sensory System Agents|sensory system agents|mesh-ancestor
5519810|NCT04328805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6464450|NCT00469703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6464451|NCT00469703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6464452|NCT00469703|Growth Substances|growth substances|mesh-ancestor
6464453|NCT00469703|Growth Inhibitors|growth inhibitors|mesh-ancestor
6464454|NCT00469703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6464455|NCT00469716|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
6464456|NCT00469716|Plasma Substitutes|plasma substitutes|mesh-ancestor
6092444|NCT00867529|Immunologic Factors|immunologic factors|mesh-ancestor
6092445|NCT00867529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092446|NCT00867529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6092447|NCT00867659|Cetrorelix|cetrorelix|mesh-list
6092448|NCT00867659|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6092449|NCT00867659|Fertility Agents|fertility agents|mesh-ancestor
6092450|NCT00867659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6092451|NCT00867659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092452|NCT00867659|Hormone Antagonists|hormone antagonists|mesh-ancestor
6092453|NCT00867659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6092454|NCT00867789|Trimethoprim|trimethoprim|mesh-list
6092455|NCT00867789|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6092456|NCT00867789|Sulfamethoxazole|sulfamethoxazole|mesh-list
6092457|NCT00867789|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6464457|NCT00469716|Blood Substitutes|blood substitutes|mesh-ancestor
6092458|NCT00867789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6092459|NCT00867789|Renal Agents|renal agents|mesh-ancestor
6092460|NCT00867789|Antimalarials|antimalarials|mesh-ancestor
6092461|NCT00867789|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6092462|NCT00867789|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6092463|NCT00867789|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6092464|NCT00867789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6092465|NCT00867789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092466|NCT00867789|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6092467|NCT00867789|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6092468|NCT00867789|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6092469|NCT00867789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6092470|NCT00867932|Eculizumab|eculizumab|mesh-list
6092471|NCT00867932|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6092472|NCT00867932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6092473|NCT00867932|Immunologic Factors|immunologic factors|mesh-ancestor
6092474|NCT00867932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092475|NCT00868140|Pioglitazone|pioglitazone|mesh-list
6092476|NCT00868140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6092477|NCT00868140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092478|NCT00868166|Riluzole|riluzole|mesh-list
6092479|NCT00868166|Anticonvulsants|anticonvulsants|mesh-ancestor
6092480|NCT00868166|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6092481|NCT00868166|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6092482|NCT00868166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6092483|NCT00868166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092484|NCT00868166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092485|NCT00868166|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6092486|NCT00868166|Protective Agents|protective agents|mesh-ancestor
6092487|NCT00868192|Bevacizumab|bevacizumab|mesh-list
6092488|NCT00868192|Pemetrexed|pemetrexed|mesh-list
6092489|NCT00868192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6092490|NCT00868192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6092491|NCT00868192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6092492|NCT00868192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6092493|NCT00868192|Growth Substances|growth substances|mesh-ancestor
6092494|NCT00868192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092495|NCT00868192|Growth Inhibitors|growth inhibitors|mesh-ancestor
6092496|NCT00868192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6092497|NCT00868192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092498|NCT00868192|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6092499|NCT00868192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6092500|NCT00868231|Bromides|bromides|mesh-list
6092501|NCT00868231|Tiotropium Bromide|tiotropium bromide|mesh-list
6092502|NCT00868231|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6092503|NCT00868231|Autonomic Agents|autonomic agents|mesh-ancestor
6092504|NCT00868231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6092505|NCT00868231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092506|NCT00868231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6092507|NCT00868231|Respiratory System Agents|respiratory system agents|mesh-ancestor
6092508|NCT00868231|Parasympatholytics|parasympatholytics|mesh-ancestor
6092509|NCT00868231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6092510|NCT00868231|Cholinergic Agents|cholinergic agents|mesh-ancestor
6092511|NCT00868231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6092512|NCT00868231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092513|NCT00868231|Anticonvulsants|anticonvulsants|mesh-ancestor
6092514|NCT00868296|Pantoprazole|pantoprazole|mesh-list
6092515|NCT00868296|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6092516|NCT00868296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6092517|NCT00868296|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6092518|NCT00868296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6092519|NCT00868296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092520|NCT00868309|Antivenins|antivenins|mesh-list
6092521|NCT00868309|Immunologic Factors|immunologic factors|mesh-ancestor
6092522|NCT00868309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092523|NCT00868348|Ketorolac|ketorolac|mesh-list
6092524|NCT00868348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6092525|NCT00868348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6092526|NCT00868348|Analgesics|analgesics|mesh-ancestor
6092527|NCT00868348|Sensory System Agents|sensory system agents|mesh-ancestor
6092528|NCT00868348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6092529|NCT00868348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092530|NCT00868348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6092531|NCT00868348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6092532|NCT00868348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6092533|NCT00868348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6092534|NCT00868348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092535|NCT00868374|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6092536|NCT00868374|Antidepressive Agents|antidepressive agents|mesh-ancestor
6092537|NCT00868374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6092538|NCT00868374|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6092539|NCT00868374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6092540|NCT00868374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6092541|NCT00868374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092542|NCT00868452|Valproic Acid|valproic acid|mesh-list
6092543|NCT00868452|Lithium Carbonate|lithium carbonate|mesh-list
6092544|NCT00868452|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
6092545|NCT00868452|Antidepressive Agents|antidepressive agents|mesh-ancestor
6092546|NCT00868452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6092547|NCT00868452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6092548|NCT00868452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092549|NCT00868452|Antimanic Agents|antimanic agents|mesh-ancestor
6092550|NCT00868452|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6092551|NCT00868452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6092552|NCT00868452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092553|NCT00868452|Anticonvulsants|anticonvulsants|mesh-ancestor
6092554|NCT00868452|GABA Agents|gaba agents|mesh-ancestor
6092555|NCT00868452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6092556|NCT00868452|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6092557|NCT00868452|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6092558|NCT00868452|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6092559|NCT00868452|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6092560|NCT00868452|Adrenergic Agents|adrenergic agents|mesh-ancestor
5519811|NCT04328805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519812|NCT04328805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5519813|NCT04328805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5519814|NCT04328805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5519815|NCT04328805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5519816|NCT04328805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519817|NCT04329000|Esomeprazole|esomeprazole|mesh-list
5519818|NCT04329000|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5519819|NCT04329000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5519820|NCT04329000|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5519821|NCT04329000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5519822|NCT04329000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519823|NCT04328883|Aspirin|aspirin|mesh-list
5519824|NCT04328883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5519825|NCT04328883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5519826|NCT04328883|Analgesics|analgesics|mesh-ancestor
5519827|NCT04328883|Sensory System Agents|sensory system agents|mesh-ancestor
5519828|NCT04328883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6092561|NCT00868452|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6092562|NCT00868452|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5519829|NCT04328883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519830|NCT04328883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5519831|NCT04328883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5519832|NCT04328883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5519833|NCT04328883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6092563|NCT00868452|Serotonin Agents|serotonin agents|mesh-ancestor
6092564|NCT00868452|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5519834|NCT04328883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519835|NCT04328883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5519836|NCT04328883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5519837|NCT04328883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5519838|NCT04328883|Antipyretics|antipyretics|mesh-ancestor
6092565|NCT00868452|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5519839|NCT04328636|Magnesium Sulfate|magnesium sulfate|mesh-list
6092566|NCT00868452|Dopamine Agents|dopamine agents|mesh-ancestor
6092567|NCT00868608|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
6092568|NCT00868608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6092569|NCT00868608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6092570|NCT00868608|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6092571|NCT00868699|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
6092572|NCT00868699|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6092573|NCT00868699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6092574|NCT00868699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6092575|NCT00868699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092576|NCT00868699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6092577|NCT00868699|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6092578|NCT00868699|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6092579|NCT00868699|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6092580|NCT00868699|Adrenergic Agents|adrenergic agents|mesh-ancestor
6092581|NCT00868699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6092582|NCT00868699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092583|NCT00868699|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6092584|NCT00868699|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6092585|NCT00868699|Serotonin Agents|serotonin agents|mesh-ancestor
6092586|NCT00868699|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6092587|NCT00868699|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6092588|NCT00868699|Dopamine Agents|dopamine agents|mesh-ancestor
6092589|NCT00868790|Metformin|metformin|mesh-list
6092590|NCT00868790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6092591|NCT00868790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092592|NCT00868959|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
6092593|NCT00868959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6092594|NCT00868959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6092595|NCT00868959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6092596|NCT00868959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092597|NCT00868959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6092598|NCT00868959|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6092599|NCT00868959|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6092600|NCT00868959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6092601|NCT00868959|Adrenergic Agents|adrenergic agents|mesh-ancestor
6092602|NCT00868959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6092603|NCT00868959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092604|NCT00868959|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6092605|NCT00868959|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6092606|NCT00868959|Serotonin Agents|serotonin agents|mesh-ancestor
6092607|NCT00868959|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6092608|NCT00868959|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6092609|NCT00868959|Dopamine Agents|dopamine agents|mesh-ancestor
5519840|NCT04328636|Analgesics|analgesics|mesh-ancestor
5519841|NCT04328636|Sensory System Agents|sensory system agents|mesh-ancestor
5519842|NCT04328636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5519843|NCT04328636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519844|NCT04328636|Anesthetics|anesthetics|mesh-ancestor
5519845|NCT04328636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5519846|NCT04328636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5519847|NCT04328636|Anticonvulsants|anticonvulsants|mesh-ancestor
5519848|NCT04328636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5519849|NCT04328636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5519850|NCT04328636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519851|NCT04328636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5519852|NCT04328636|Tocolytic Agents|tocolytic agents|mesh-ancestor
5519853|NCT04328636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5519854|NCT04328753|Chlorhexidine|chlorhexidine|mesh-list
5519855|NCT04328753|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5519856|NCT04328753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5519857|NCT04328753|Disinfectants|disinfectants|mesh-ancestor
5519858|NCT04328493|Chloroquine|chloroquine|mesh-list
5519859|NCT04328493|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
5519860|NCT04328493|Amebicides|amebicides|mesh-ancestor
5519861|NCT04328493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5519862|NCT04328493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5519863|NCT04328493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5519864|NCT04328493|Antimalarials|antimalarials|mesh-ancestor
5519865|NCT04328493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5519866|NCT04328493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5519867|NCT04328493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5519868|NCT04328493|Analgesics|analgesics|mesh-ancestor
5519869|NCT04328493|Sensory System Agents|sensory system agents|mesh-ancestor
5519870|NCT04328493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5519871|NCT04328493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519872|NCT04328493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6092610|NCT00869050|Capecitabine|capecitabine|mesh-list
6092611|NCT00869050|Temozolomide|temozolomide|mesh-list
6092612|NCT00869050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6092613|NCT00869050|Antimetabolites|antimetabolites|mesh-ancestor
6092614|NCT00869050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092615|NCT00869050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5519873|NCT04328493|Filaricides|filaricides|mesh-ancestor
5519874|NCT04328493|Antinematodal Agents|antinematodal agents|mesh-ancestor
5519875|NCT04328493|Anthelmintics|anthelmintics|mesh-ancestor
5600871|NCT03709056|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5600872|NCT03709056|Anesthetics, General|anesthetics, general|mesh-ancestor
5600873|NCT03709056|Anesthetics|anesthetics|mesh-ancestor
5600874|NCT03709017|Ponatinib|ponatinib|mesh-list
5600875|NCT03709017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5600876|NCT03709017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5600877|NCT03709017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5600878|NCT03709017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600879|NCT03708926|Abaloparatide|abaloparatide|mesh-list
5600880|NCT03708926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6092616|NCT00869050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6092617|NCT00869050|Alkylating Agents|alkylating agents|mesh-ancestor
6092618|NCT00869089|Apremilast|apremilast|mesh-list
6092619|NCT00869089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6092620|NCT00869089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6092621|NCT00869089|Analgesics|analgesics|mesh-ancestor
6092622|NCT00869089|Sensory System Agents|sensory system agents|mesh-ancestor
6092623|NCT00869089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6092624|NCT00869089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092625|NCT00869089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6092626|NCT00869089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6092627|NCT00869089|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6092628|NCT00869089|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6092629|NCT00869089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6092630|NCT00869089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092631|NCT00869141|Timolol|timolol|mesh-list
6092632|NCT00869141|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6092633|NCT00869141|Dorzolamide|dorzolamide|mesh-list
6092634|NCT00869141|Brinzolamide|brinzolamide|mesh-list
6092635|NCT00869141|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6092636|NCT00869141|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6092637|NCT00869141|Adrenergic Agents|adrenergic agents|mesh-ancestor
6092638|NCT00869141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6092639|NCT00869141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092640|NCT00869141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092641|NCT00869141|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6092642|NCT00869141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6092643|NCT00869141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6092644|NCT00869141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6092645|NCT00869141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6092646|NCT00869141|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6092647|NCT00869141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6092648|NCT00869206|Zoledronic Acid|zoledronic acid|mesh-list
6092649|NCT00869206|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6092650|NCT00869206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092651|NCT00869323|Rituximab|rituximab|mesh-list
6092652|NCT00869323|Bortezomib|bortezomib|mesh-list
5600881|NCT03708926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600882|NCT03708861|Ritonavir|ritonavir|mesh-list
5600883|NCT03708861|Atazanavir Sulfate|atazanavir sulfate|mesh-list
5600884|NCT03708861|Maraviroc|maraviroc|mesh-list
5600885|NCT03708861|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6092653|NCT00869323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6092654|NCT00869323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6092655|NCT00869323|Immunologic Factors|immunologic factors|mesh-ancestor
6092656|NCT00869323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092657|NCT00869323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6092658|NCT00869401|Temozolomide|temozolomide|mesh-list
6092659|NCT00869401|Dasatinib|dasatinib|mesh-list
6092660|NCT00869401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6092661|NCT00869401|Alkylating Agents|alkylating agents|mesh-ancestor
6464458|NCT00469755|Nicotinic Acids|nicotinic acids|mesh-list
5600886|NCT03708861|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5600887|NCT03708861|Protease Inhibitors|protease inhibitors|mesh-ancestor
6207756|NCT02120157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6092662|NCT00869401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092663|NCT00869401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6092664|NCT00869401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6092665|NCT00869401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6092666|NCT00869440|Midazolam|midazolam|mesh-list
6092667|NCT00869440|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6092668|NCT00869440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6092669|NCT00869440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6092670|NCT00869440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092671|NCT00869440|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6092672|NCT00869440|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6092673|NCT00869440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6092674|NCT00869440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5519876|NCT04328441|BCG Vaccine|bcg vaccine|mesh-list
5519877|NCT04328441|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5519878|NCT04328441|Immunologic Factors|immunologic factors|mesh-ancestor
5519879|NCT04328441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519880|NCT04328285|Ritonavir|ritonavir|mesh-list
5519881|NCT04328285|Lopinavir|lopinavir|mesh-list
5519882|NCT04328285|Hydroxychloroquine|hydroxychloroquine|mesh-list
5519883|NCT04328285|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5519884|NCT04328285|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5519885|NCT04328285|Protease Inhibitors|protease inhibitors|mesh-ancestor
5519886|NCT04328285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5519887|NCT04328285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519888|NCT04328285|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5519889|NCT04328285|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5519890|NCT04328285|Antiviral Agents|antiviral agents|mesh-ancestor
5519891|NCT04328285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5519892|NCT04328285|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5519893|NCT04328285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5519894|NCT04328285|Antimalarials|antimalarials|mesh-ancestor
5519895|NCT04328285|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5519896|NCT04328285|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5519897|NCT04328285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6092675|NCT00869440|Anesthetics, General|anesthetics, general|mesh-ancestor
6092676|NCT00869440|Anesthetics|anesthetics|mesh-ancestor
6092677|NCT00869440|GABA Modulators|gaba modulators|mesh-ancestor
6092678|NCT00869440|GABA Agents|gaba agents|mesh-ancestor
6092679|NCT00869440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6092680|NCT00869440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092681|NCT00869518|Trimethoprim|trimethoprim|mesh-list
6092682|NCT00869518|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6092683|NCT00869518|Sulfamethoxazole|sulfamethoxazole|mesh-list
6092684|NCT00869518|Rifabutin|rifabutin|mesh-list
6092685|NCT00869518|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6092686|NCT00869518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6092687|NCT00869518|Renal Agents|renal agents|mesh-ancestor
6092688|NCT00869518|Antimalarials|antimalarials|mesh-ancestor
6092689|NCT00869518|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6092690|NCT00869518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6092691|NCT00869518|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6092692|NCT00869518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6092693|NCT00869518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092694|NCT00869518|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6092695|NCT00869518|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6092696|NCT00869518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6092697|NCT00869518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6092698|NCT00869518|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6092699|NCT00869518|Antitubercular Agents|antitubercular agents|mesh-ancestor
6092700|NCT00869557|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6092701|NCT00869557|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6092702|NCT00869557|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6092703|NCT00869557|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6092704|NCT00869557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6092705|NCT00869557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092706|NCT00869557|Antiviral Agents|antiviral agents|mesh-ancestor
6092707|NCT00869557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6092708|NCT00869557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6092709|NCT00869557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6092710|NCT00869622|Vitamin D|vitamin d|mesh-list
6092711|NCT00869622|Risedronic Acid|risedronic acid|mesh-list
6092712|NCT00869622|Calcium|calcium|mesh-list
5519898|NCT04328480|Colchicine|colchicine|mesh-list
5519899|NCT04328480|Gout Suppressants|gout suppressants|mesh-ancestor
5519900|NCT04328480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5519901|NCT04328480|Tubulin Modulators|tubulin modulators|mesh-ancestor
5519902|NCT04328480|Antimitotic Agents|antimitotic agents|mesh-ancestor
5519903|NCT04328480|Mitosis Modulators|mitosis modulators|mesh-ancestor
5519904|NCT04328480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092713|NCT00869622|Vitamins|vitamins|mesh-ancestor
6092714|NCT00869622|Micronutrients|micronutrients|mesh-ancestor
6092715|NCT00869622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092716|NCT00869622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6092717|NCT00869622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6092718|NCT00869622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6092719|NCT00869622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6092720|NCT00869622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092721|NCT00869778|Vaccines|vaccines|mesh-list
6092722|NCT00869778|Immunologic Factors|immunologic factors|mesh-ancestor
6092723|NCT00869778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092724|NCT00869791|Levodopa|levodopa|mesh-list
6092725|NCT00869791|Carbidopa|carbidopa|mesh-list
6092726|NCT00869791|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
6092727|NCT00869791|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6092728|NCT00869791|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6092729|NCT00869791|Dopamine Agents|dopamine agents|mesh-ancestor
6092730|NCT00869791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6092731|NCT00869791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092732|NCT00869791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092733|NCT00869791|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6092734|NCT00869791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6092735|NCT00869791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6092736|NCT00869791|Immunologic Factors|immunologic factors|mesh-ancestor
6092737|NCT00869791|Dopamine Agonists|dopamine agonists|mesh-ancestor
6092738|NCT00869960|Ritonavir|ritonavir|mesh-list
6092739|NCT00869960|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6092740|NCT00869960|Tenofovir|tenofovir|mesh-list
6092741|NCT00869960|Emtricitabine|emtricitabine|mesh-list
6092742|NCT00869960|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6092743|NCT00869960|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6092744|NCT00869960|Protease Inhibitors|protease inhibitors|mesh-ancestor
6092745|NCT00869960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6092746|NCT00869960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092747|NCT00869960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6092748|NCT00869960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6092749|NCT00869960|Antiviral Agents|antiviral agents|mesh-ancestor
6092750|NCT00869960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6092751|NCT00869960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6092752|NCT00869960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6092753|NCT00869960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6092754|NCT00869960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6092755|NCT00869999|Rituximab|rituximab|mesh-list
6092756|NCT00869999|Everolimus|everolimus|mesh-list
6092757|NCT00869999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6092758|NCT00869999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6092759|NCT00869999|Immunologic Factors|immunologic factors|mesh-ancestor
6092760|NCT00869999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092761|NCT00869999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6092762|NCT00869999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6092763|NCT00870103|Moxifloxacin|moxifloxacin|mesh-list
6092764|NCT00870103|Dexamethasone|dexamethasone|mesh-list
6092765|NCT00870103|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6092766|NCT00870103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6092767|NCT00870103|Antiemetics|antiemetics|mesh-ancestor
6092768|NCT00870103|Autonomic Agents|autonomic agents|mesh-ancestor
6092769|NCT00870103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6092770|NCT00870103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092771|NCT00870103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6092772|NCT00870103|Glucocorticoids|glucocorticoids|mesh-ancestor
6092773|NCT00870103|Hormones|hormones|mesh-ancestor
6092774|NCT00870103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6092775|NCT00870103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6092776|NCT00870103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6092777|NCT00870103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6092778|NCT00870103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6092779|NCT00870103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6092780|NCT00870103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6092781|NCT00870103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5519905|NCT04328480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5519906|NCT04328337|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
5519907|NCT04328337|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
5519908|NCT04328337|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5519909|NCT04328337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5519910|NCT04328272|Azithromycin|azithromycin|mesh-list
5519911|NCT04328272|Hydroxychloroquine|hydroxychloroquine|mesh-list
5519912|NCT04328272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5519913|NCT04328272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5519914|NCT04328272|Antimalarials|antimalarials|mesh-ancestor
5519915|NCT04328272|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5519916|NCT04328272|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5519917|NCT04328272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6092782|NCT00870103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092783|NCT00870103|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6092784|NCT00870194|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6092785|NCT00870194|Exenatide|exenatide|mesh-list
6092786|NCT00870194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6092787|NCT00870194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092788|NCT00870194|Incretins|incretins|mesh-ancestor
6092789|NCT00870194|Hormones|hormones|mesh-ancestor
6092790|NCT00870194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6092791|NCT00870194|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6092792|NCT00870194|Protease Inhibitors|protease inhibitors|mesh-ancestor
6092793|NCT00870194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6092794|NCT00870194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092795|NCT00870194|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6092796|NCT00870363|Efavirenz|efavirenz|mesh-list
5519918|NCT04328272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519919|NCT04328272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5519920|NCT04328194|Thrombin|thrombin|mesh-list
5519921|NCT04328194|Hemostatics|hemostatics|mesh-ancestor
5519922|NCT04328194|Coagulants|coagulants|mesh-ancestor
5519923|NCT04328012|Losartan|losartan|mesh-list
5519924|NCT04328012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5519925|NCT04328012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5519926|NCT04328012|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5519927|NCT04328012|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5519928|NCT04328012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519929|NCT04327791|Baloxavir|baloxavir|mesh-list
5519930|NCT04327791|Antiviral Agents|antiviral agents|mesh-ancestor
5519931|NCT04327791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5519932|NCT04327791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5519933|NCT04327791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519934|NCT04327934|Methyltestosterone|methyltestosterone|mesh-list
5519935|NCT04327934|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
5519936|NCT04327934|Testosterone|testosterone|mesh-list
5519937|NCT04327934|Testosterone undecanoate|testosterone undecanoate|mesh-list
5519938|NCT04327934|Testosterone enanthate|testosterone enanthate|mesh-list
5519939|NCT04327934|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6092797|NCT00870363|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
6092798|NCT00870363|Raltegravir Potassium|raltegravir potassium|mesh-list
6092799|NCT00870363|Maraviroc|maraviroc|mesh-list
6092800|NCT00870363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5519940|NCT04327934|Hormones|hormones|mesh-ancestor
5519941|NCT04327934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5519942|NCT04327934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519943|NCT04327934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6092801|NCT00870363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6092802|NCT00870363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092803|NCT00870363|Antiviral Agents|antiviral agents|mesh-ancestor
6092804|NCT00870363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6092805|NCT00870363|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6092806|NCT00870363|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6092807|NCT00870363|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6092808|NCT00870363|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6092809|NCT00870363|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6092810|NCT00870363|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6092811|NCT00870363|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6092812|NCT00870363|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6092813|NCT00870363|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6092814|NCT00870363|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5519944|NCT04327934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6092815|NCT00870363|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6092816|NCT00870363|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6092817|NCT00870363|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6092818|NCT00870467|Adalimumab|adalimumab|mesh-list
6092819|NCT00870467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6092820|NCT00870467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6092821|NCT00870584|Omalizumab|omalizumab|mesh-list
6092822|NCT00870584|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6092823|NCT00870584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6092824|NCT00870584|Respiratory System Agents|respiratory system agents|mesh-ancestor
6092825|NCT00870727|Aripiprazole|aripiprazole|mesh-list
6092826|NCT00870727|Antidepressive Agents|antidepressive agents|mesh-ancestor
6092827|NCT00870727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6092828|NCT00870727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6092829|NCT00870727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6092830|NCT00870727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6092831|NCT00870727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092832|NCT00870727|Dopamine Agonists|dopamine agonists|mesh-ancestor
6092833|NCT00870727|Dopamine Agents|dopamine agents|mesh-ancestor
6092834|NCT00870727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6092835|NCT00870727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092836|NCT00870727|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6092837|NCT00870727|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6092838|NCT00870727|Serotonin Agents|serotonin agents|mesh-ancestor
6092839|NCT00870727|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6092840|NCT00870727|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6092841|NCT00870727|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6092842|NCT00870727|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6092843|NCT00870740|Daclizumab|daclizumab|mesh-list
6092844|NCT00870740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6092845|NCT00870740|Immunologic Factors|immunologic factors|mesh-ancestor
6092846|NCT00870740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092847|NCT00870870|Gemcitabine|gemcitabine|mesh-list
5519945|NCT04327934|Anabolic Agents|anabolic agents|mesh-ancestor
5519946|NCT04327934|Androgens|androgens|mesh-ancestor
5519947|NCT04327947|Hyaluronic Acid|hyaluronic acid|mesh-list
5519948|NCT04327947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5519949|NCT04327947|Immunologic Factors|immunologic factors|mesh-ancestor
5519950|NCT04327947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519951|NCT04327947|Viscosupplements|viscosupplements|mesh-ancestor
5519952|NCT04327947|Protective Agents|protective agents|mesh-ancestor
6092848|NCT00870870|Carboplatin|carboplatin|mesh-list
6092849|NCT00870870|Cetuximab|cetuximab|mesh-list
6092850|NCT00870870|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6092851|NCT00870870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6092852|NCT00870870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6092853|NCT00870870|Antimetabolites|antimetabolites|mesh-ancestor
6092854|NCT00870870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092855|NCT00870870|Antiviral Agents|antiviral agents|mesh-ancestor
6092856|NCT00870870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6092857|NCT00870870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6092858|NCT00870870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6092859|NCT00870870|Immunologic Factors|immunologic factors|mesh-ancestor
6092860|NCT00870870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092861|NCT00870870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6092862|NCT00870896|Tiotropium Bromide|tiotropium bromide|mesh-list
6092863|NCT00870896|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6092864|NCT00870896|Autonomic Agents|autonomic agents|mesh-ancestor
5519953|NCT04328090|Anti-Infective Agents|anti-infective agents|mesh-list
6092865|NCT00870896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6092866|NCT00870896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092867|NCT00870896|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6464459|NCT00469755|Adapalene|adapalene|mesh-list
6092868|NCT00870896|Respiratory System Agents|respiratory system agents|mesh-ancestor
6092869|NCT00870896|Parasympatholytics|parasympatholytics|mesh-ancestor
6092870|NCT00870896|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6092871|NCT00870896|Cholinergic Agents|cholinergic agents|mesh-ancestor
6092872|NCT00870896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6092873|NCT00870896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092874|NCT00871000|Pentetic Acid|pentetic acid|mesh-list
6092875|NCT00871000|Antidotes|antidotes|mesh-ancestor
6092876|NCT00871000|Protective Agents|protective agents|mesh-ancestor
6092877|NCT00871000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092878|NCT00871000|Chelating Agents|chelating agents|mesh-ancestor
6092879|NCT00871000|Sequestering Agents|sequestering agents|mesh-ancestor
6092880|NCT00871000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092881|NCT00871000|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6092882|NCT00871169|Oxaliplatin|oxaliplatin|mesh-list
6092883|NCT00871169|Irinotecan|irinotecan|mesh-list
6092884|NCT00871169|Cetuximab|cetuximab|mesh-list
6092885|NCT00871169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6092886|NCT00871169|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6092887|NCT00871169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6092888|NCT00871169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6092889|NCT00871169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092890|NCT00871169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6092891|NCT00871234|Etravirine|etravirine|mesh-list
6092892|NCT00871234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6092893|NCT00871234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6092894|NCT00871234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6092895|NCT00871234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092896|NCT00871234|Antiviral Agents|antiviral agents|mesh-ancestor
6092897|NCT00871234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6092898|NCT00871260|Regadenoson|regadenoson|mesh-list
6092899|NCT00871260|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
6092900|NCT00871260|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6092901|NCT00871260|Purinergic Agonists|purinergic agonists|mesh-ancestor
6092902|NCT00871260|Purinergic Agents|purinergic agents|mesh-ancestor
6092903|NCT00871260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6092904|NCT00871260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092905|NCT00871260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092906|NCT00871338|Vaccines|vaccines|mesh-list
6092907|NCT00871338|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6092908|NCT00871338|Immunologic Factors|immunologic factors|mesh-ancestor
6092909|NCT00871338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092910|NCT00871403|Pemetrexed|pemetrexed|mesh-list
6092911|NCT00871403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6092912|NCT00871403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6092913|NCT00871403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092914|NCT00871403|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6092915|NCT00871403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5519954|NCT04328090|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5519955|NCT04328064|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5519956|NCT04328064|Calcium|calcium|mesh-list
5519957|NCT04328064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5519958|NCT04328064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519959|NCT04328064|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5519960|NCT04328064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5519961|NCT04328064|Antimetabolites|antimetabolites|mesh-ancestor
5519962|NCT04328064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519963|NCT04328064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5519964|NCT04328064|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5519965|NCT04328064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5519966|NCT04327726|Dexmedetomidine|dexmedetomidine|mesh-list
5519967|NCT04327726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5519968|NCT04327726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5519969|NCT04327726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519970|NCT04327726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5519971|NCT04327726|Analgesics|analgesics|mesh-ancestor
5519972|NCT04327726|Sensory System Agents|sensory system agents|mesh-ancestor
5519973|NCT04327726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5519974|NCT04327726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5519975|NCT04327726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5519976|NCT04327726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6092916|NCT00871494|Azithromycin|azithromycin|mesh-list
6092917|NCT00871494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6092918|NCT00871494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6092919|NCT00871624|Dexmedetomidine|dexmedetomidine|mesh-list
5519977|NCT04327726|Adrenergic Agents|adrenergic agents|mesh-ancestor
5519978|NCT04327726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5519979|NCT04327726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519980|NCT04327245|Tagatose|tagatose|mesh-list
6092920|NCT00871624|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6092921|NCT00871624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6092922|NCT00871624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092923|NCT00871624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6092924|NCT00871624|Analgesics|analgesics|mesh-ancestor
6092925|NCT00871624|Sensory System Agents|sensory system agents|mesh-ancestor
6092926|NCT00871624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6092927|NCT00871624|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6092928|NCT00871624|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6092929|NCT00871624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6092930|NCT00871624|Adrenergic Agents|adrenergic agents|mesh-ancestor
6092931|NCT00871624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6092932|NCT00871624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203429|NCT02057250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6203430|NCT02057250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6203431|NCT02057250|Analgesics|analgesics|mesh-ancestor
6203432|NCT02057250|Sensory System Agents|sensory system agents|mesh-ancestor
6203433|NCT02057250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6203434|NCT02057250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6203435|NCT02057250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6203436|NCT02057393|Methylene Blue|methylene blue|mesh-list
6203437|NCT02057393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6203438|NCT02057393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203439|NCT02057458|Sildenafil Citrate|sildenafil citrate|mesh-list
6203440|NCT02057458|Vasodilator Agents|vasodilator agents|mesh-ancestor
6203441|NCT02057458|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6203442|NCT02057458|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6203443|NCT02057458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6203444|NCT02057458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203445|NCT02057458|Urological Agents|urological agents|mesh-ancestor
6203446|NCT02057523|Hormones|hormones|mesh-list
6203447|NCT02057523|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
5519981|NCT04327245|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5519982|NCT04327245|Chelating Agents|chelating agents|mesh-ancestor
5519983|NCT04327245|Sequestering Agents|sequestering agents|mesh-ancestor
5519984|NCT04327245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5519985|NCT04327401|Dexamethasone|dexamethasone|mesh-list
5519986|NCT04327401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5519987|NCT04327401|Antiemetics|antiemetics|mesh-ancestor
5519988|NCT04327401|Autonomic Agents|autonomic agents|mesh-ancestor
5519989|NCT04327401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5519990|NCT04327401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203448|NCT02057523|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
6203449|NCT02057523|beta-Endorphin|beta-endorphin|mesh-list
6203450|NCT02057523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6203451|NCT02057523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203452|NCT02057523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6203453|NCT02057523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203454|NCT02057549|Haloperidol|haloperidol|mesh-list
6203455|NCT02057549|Haloperidol decanoate|haloperidol decanoate|mesh-list
6203456|NCT02057549|Antiemetics|antiemetics|mesh-ancestor
6203457|NCT02057549|Autonomic Agents|autonomic agents|mesh-ancestor
6203458|NCT02057549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6203459|NCT02057549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5519991|NCT04327401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5519992|NCT04327401|Glucocorticoids|glucocorticoids|mesh-ancestor
5519993|NCT04327401|Hormones|hormones|mesh-ancestor
5519994|NCT04327401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5519995|NCT04327401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5519996|NCT04327401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5519997|NCT04327427|Aspirin|aspirin|mesh-list
5519998|NCT04327427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5519999|NCT04327427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5520000|NCT04327427|Analgesics|analgesics|mesh-ancestor
5520001|NCT04327427|Sensory System Agents|sensory system agents|mesh-ancestor
5520002|NCT04327427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5520003|NCT04327427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520004|NCT04327427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5520005|NCT04327427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5520006|NCT04327427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5520007|NCT04327427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5520008|NCT04327427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520009|NCT04327427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5520010|NCT04327427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5520011|NCT04327427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5520012|NCT04327427|Antipyretics|antipyretics|mesh-ancestor
5520013|NCT04327453|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5520014|NCT04327453|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5520015|NCT04327453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5520016|NCT04327453|Antitubercular Agents|antitubercular agents|mesh-ancestor
5520017|NCT04327232|Spironolactone|spironolactone|mesh-list
5520018|NCT04327232|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5520019|NCT04327232|Hormone Antagonists|hormone antagonists|mesh-ancestor
5520020|NCT04327232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5520021|NCT04327232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520022|NCT04327232|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5520023|NCT04327232|Diuretics|diuretics|mesh-ancestor
5520024|NCT04327232|Natriuretic Agents|natriuretic agents|mesh-ancestor
5520025|NCT04326920|Sargramostim|sargramostim|mesh-list
5520026|NCT04326920|Immunologic Factors|immunologic factors|mesh-ancestor
5520027|NCT04326920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520028|NCT04327011|Flucytosine|flucytosine|mesh-list
5520029|NCT04327011|Antifungal Agents|antifungal agents|mesh-ancestor
5520030|NCT04327011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5520031|NCT04327011|Antimetabolites|antimetabolites|mesh-ancestor
5520032|NCT04327011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520033|NCT04326959|Triamcinolone|triamcinolone|mesh-list
5520034|NCT04326959|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5520035|NCT04326959|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5520036|NCT04326959|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5520037|NCT04326959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5520038|NCT04326959|Glucocorticoids|glucocorticoids|mesh-ancestor
5520039|NCT04326959|Hormones|hormones|mesh-ancestor
5520040|NCT04326959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5520041|NCT04326959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520042|NCT04326959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5520043|NCT04326959|Immunologic Factors|immunologic factors|mesh-ancestor
5520044|NCT04326959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5520045|NCT04326959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520046|NCT04326985|Hyaluronic Acid|hyaluronic acid|mesh-list
5520047|NCT04326985|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5520048|NCT04326985|Immunologic Factors|immunologic factors|mesh-ancestor
5520049|NCT04326985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520050|NCT04326985|Viscosupplements|viscosupplements|mesh-ancestor
5520051|NCT04326985|Protective Agents|protective agents|mesh-ancestor
5520052|NCT04326894|Methotrexate|methotrexate|mesh-list
5520053|NCT04326894|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5520054|NCT04326894|Abortifacient Agents|abortifacient agents|mesh-ancestor
5520055|NCT04326894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5520056|NCT04326894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725202|NCT03182140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5725203|NCT03182140|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5725204|NCT03182140|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5725205|NCT03182192|Exenatide|exenatide|mesh-list
5725206|NCT03182192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5725207|NCT03182192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725208|NCT03182192|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5725209|NCT03182192|Incretins|incretins|mesh-ancestor
5725210|NCT03182192|Hormones|hormones|mesh-ancestor
5725721|NCT03178292|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6092933|NCT00871689|Vidarabine|vidarabine|mesh-list
6092934|NCT00871689|Aldesleukin|aldesleukin|mesh-list
6092935|NCT00871689|Cyclophosphamide|cyclophosphamide|mesh-list
6092936|NCT00871689|Fludarabine|fludarabine|mesh-list
6092937|NCT00871689|Fludarabine phosphate|fludarabine phosphate|mesh-list
6092938|NCT00871689|Interleukin-2|interleukin-2|mesh-list
6092939|NCT00871689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6092940|NCT00871689|Immunologic Factors|immunologic factors|mesh-ancestor
6092941|NCT00871689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092942|NCT00871689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6092943|NCT00871689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6092944|NCT00871689|Alkylating Agents|alkylating agents|mesh-ancestor
6092945|NCT00871689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092946|NCT00871689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6092947|NCT00871689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6092948|NCT00871689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6092949|NCT00871689|Antimetabolites|antimetabolites|mesh-ancestor
6092950|NCT00871689|Antiviral Agents|antiviral agents|mesh-ancestor
6092951|NCT00871689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6092952|NCT00871689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6092953|NCT00871689|Analgesics|analgesics|mesh-ancestor
6092954|NCT00871689|Sensory System Agents|sensory system agents|mesh-ancestor
5520057|NCT04326894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5520058|NCT04326894|Antimetabolites|antimetabolites|mesh-ancestor
5520059|NCT04326894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520060|NCT04326894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5520061|NCT04326894|Dermatologic Agents|dermatologic agents|mesh-ancestor
5520062|NCT04326894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5520063|NCT04326894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5520064|NCT04326894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5520065|NCT04326894|Immunologic Factors|immunologic factors|mesh-ancestor
5520066|NCT04326894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6092955|NCT00871689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6092956|NCT00871689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6092957|NCT00871689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6092958|NCT00871728|Itraconazole|itraconazole|mesh-list
6092959|NCT00871728|Antifungal Agents|antifungal agents|mesh-ancestor
6092960|NCT00871728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6092961|NCT00871728|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6092962|NCT00871728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6092963|NCT00871728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6092964|NCT00871728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092965|NCT00871728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6092966|NCT00871728|Hormone Antagonists|hormone antagonists|mesh-ancestor
5520067|NCT04326894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5520068|NCT04326868|Albendazole|albendazole|mesh-list
5520069|NCT04326868|Mebendazole|mebendazole|mesh-list
5520070|NCT04326868|Benzimidazole|benzimidazole|mesh-list
5520071|NCT04326868|Pyrantel|pyrantel|mesh-list
6092967|NCT00871728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6092968|NCT00871728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092969|NCT00871728|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6092970|NCT00871780|Natalizumab|natalizumab|mesh-list
6092971|NCT00871780|Immunologic Factors|immunologic factors|mesh-ancestor
6092972|NCT00871780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092973|NCT00871858|Fulvestrant|fulvestrant|mesh-list
6092974|NCT00871858|Anastrozole|anastrozole|mesh-list
6092975|NCT00871858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6092976|NCT00871858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6092977|NCT00871858|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6092978|NCT00871858|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6092979|NCT00871858|Hormone Antagonists|hormone antagonists|mesh-ancestor
6092980|NCT00871858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6092981|NCT00871858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092982|NCT00871858|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6092983|NCT00871858|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6092984|NCT00871858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6092985|NCT00871858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092986|NCT00871871|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6092987|NCT00871871|Isosorbide|isosorbide|mesh-list
6092988|NCT00871871|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
6092989|NCT00871871|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
5520072|NCT04326868|Anthelmintics|anthelmintics|mesh-list
5520073|NCT04326868|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6092990|NCT00871871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5520074|NCT04326868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5520075|NCT04326868|Anticestodal Agents|anticestodal agents|mesh-ancestor
5520076|NCT04326868|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5520077|NCT04326868|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5520078|NCT04326868|Tubulin Modulators|tubulin modulators|mesh-ancestor
5520079|NCT04326868|Antimitotic Agents|antimitotic agents|mesh-ancestor
5520080|NCT04326868|Mitosis Modulators|mitosis modulators|mesh-ancestor
5520081|NCT04326868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092991|NCT00871871|Diuretics|diuretics|mesh-ancestor
6092992|NCT00871871|Natriuretic Agents|natriuretic agents|mesh-ancestor
6092993|NCT00871871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6092994|NCT00871871|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6092995|NCT00871871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6092996|NCT00871871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6092997|NCT00871871|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6092998|NCT00871871|Vasodilator Agents|vasodilator agents|mesh-ancestor
6092999|NCT00871871|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6093000|NCT00871923|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6093001|NCT00871923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6093002|NCT00871923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6093003|NCT00871923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6093004|NCT00871923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093005|NCT00872027|Citalopram|citalopram|mesh-list
6093006|NCT00872027|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6464460|NCT00469755|Tazarotene|tazarotene|mesh-list
6464461|NCT00469755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6464462|NCT00469755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6464463|NCT00469755|Analgesics|analgesics|mesh-ancestor
6464464|NCT00469755|Sensory System Agents|sensory system agents|mesh-ancestor
6464465|NCT00469755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6464466|NCT00469755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464467|NCT00469755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6464468|NCT00469755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6464469|NCT00469755|Dermatologic Agents|dermatologic agents|mesh-ancestor
6464470|NCT00469755|Keratolytic Agents|keratolytic agents|mesh-ancestor
6093007|NCT00872027|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6093008|NCT00872027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6093009|NCT00872027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520082|NCT04326868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5520083|NCT04326868|Antinematodal Agents|antinematodal agents|mesh-ancestor
5520084|NCT04326868|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
5520085|NCT04326868|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5520086|NCT04326868|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6093010|NCT00872027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6093011|NCT00872027|Serotonin Agents|serotonin agents|mesh-ancestor
6093012|NCT00872027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093013|NCT00872027|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6093014|NCT00872027|Antidepressive Agents|antidepressive agents|mesh-ancestor
6093015|NCT00872027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6093016|NCT00872170|Sildenafil Citrate|sildenafil citrate|mesh-list
6093017|NCT00872170|Vasodilator Agents|vasodilator agents|mesh-ancestor
6093018|NCT00872170|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6093019|NCT00872170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6093020|NCT00872170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6093021|NCT00872170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093022|NCT00872170|Urological Agents|urological agents|mesh-ancestor
6093023|NCT00872534|Aspirin|aspirin|mesh-list
6093024|NCT00872534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6093025|NCT00872534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6093026|NCT00872534|Analgesics|analgesics|mesh-ancestor
6093027|NCT00872534|Sensory System Agents|sensory system agents|mesh-ancestor
6093028|NCT00872534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6093029|NCT00872534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093030|NCT00872534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6093031|NCT00872534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6093032|NCT00872534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6093033|NCT00872534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6093034|NCT00872534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6464471|NCT00469755|Vitamin B Complex|vitamin b complex|mesh-ancestor
6464472|NCT00469755|Vitamins|vitamins|mesh-ancestor
5520087|NCT04326868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5520088|NCT04326868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520089|NCT04326764|Panobinostat|panobinostat|mesh-list
5520090|NCT04326764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5520091|NCT04326764|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5520092|NCT04326764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5520093|NCT04326764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520094|NCT04326790|Colchicine|colchicine|mesh-list
5520095|NCT04326790|Gout Suppressants|gout suppressants|mesh-ancestor
5520096|NCT04326790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5520097|NCT04326790|Tubulin Modulators|tubulin modulators|mesh-ancestor
5520098|NCT04326790|Antimitotic Agents|antimitotic agents|mesh-ancestor
5520099|NCT04326790|Mitosis Modulators|mitosis modulators|mesh-ancestor
5520100|NCT04326790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520101|NCT04326790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5520102|NCT04326803|Vaccines|vaccines|mesh-list
5520103|NCT04326803|Immunologic Factors|immunologic factors|mesh-ancestor
5520104|NCT04326803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093035|NCT00872534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6093036|NCT00872534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6093037|NCT00872534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6093038|NCT00872534|Antipyretics|antipyretics|mesh-ancestor
6093039|NCT00872599|Fenofibrate|fenofibrate|mesh-list
6093040|NCT00872599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6093041|NCT00872599|Antimetabolites|antimetabolites|mesh-ancestor
6093042|NCT00872599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093043|NCT00872599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5520105|NCT04326673|Methyltestosterone|methyltestosterone|mesh-list
5520106|NCT04326673|Testosterone|testosterone|mesh-list
5520107|NCT04326673|Testosterone undecanoate|testosterone undecanoate|mesh-list
5520108|NCT04326673|Testosterone enanthate|testosterone enanthate|mesh-list
5520109|NCT04326673|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5520110|NCT04326673|Androgens|androgens|mesh-ancestor
5520111|NCT04326673|Hormones|hormones|mesh-ancestor
5520112|NCT04326673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5520113|NCT04326673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520114|NCT04326673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5520115|NCT04326673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5520116|NCT04326673|Anabolic Agents|anabolic agents|mesh-ancestor
5600888|NCT03708861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5600889|NCT03708861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600890|NCT03708861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5600891|NCT03708861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5600892|NCT03708861|Antiviral Agents|antiviral agents|mesh-ancestor
6093044|NCT00872729|Cysteamine|cysteamine|mesh-list
6093045|NCT00872729|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
6093046|NCT00872729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093047|NCT00872898|Memantine|memantine|mesh-list
6093048|NCT00872898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6093049|NCT00872898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6093050|NCT00872898|Dopamine Agents|dopamine agents|mesh-ancestor
6093051|NCT00872898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6093052|NCT00872898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093053|NCT00872898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093054|NCT00872898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6093055|NCT00872898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6093056|NCT00872989|Docetaxel|docetaxel|mesh-list
6093057|NCT00872989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6093058|NCT00872989|Tubulin Modulators|tubulin modulators|mesh-ancestor
6093059|NCT00872989|Antimitotic Agents|antimitotic agents|mesh-ancestor
6093060|NCT00872989|Mitosis Modulators|mitosis modulators|mesh-ancestor
6093061|NCT00872989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093062|NCT00873041|Deferasirox|deferasirox|mesh-list
6093063|NCT00873041|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5600893|NCT03708861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5600894|NCT03708861|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5600895|NCT03708861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5600896|NCT03708861|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6093064|NCT00873041|Chelating Agents|chelating agents|mesh-ancestor
6093065|NCT00873041|Sequestering Agents|sequestering agents|mesh-ancestor
6093066|NCT00873041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093067|NCT00873093|Leucovorin|leucovorin|mesh-list
6093068|NCT00873093|Cytarabine|cytarabine|mesh-list
6093069|NCT00873093|Prednisone|prednisone|mesh-list
6093070|NCT00873093|Hydrocortisone|hydrocortisone|mesh-list
6093071|NCT00873093|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6093072|NCT00873093|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6093073|NCT00873093|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
5520117|NCT04326725|Hydroxychloroquine|hydroxychloroquine|mesh-list
5520118|NCT04326725|Antimalarials|antimalarials|mesh-ancestor
5520119|NCT04326725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5520120|NCT04326725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5520121|NCT04326725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5520122|NCT04326725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5520123|NCT04326725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520124|NCT04326725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5520125|NCT04326296|Lenalidomide|lenalidomide|mesh-list
5520126|NCT04326296|Antibodies|antibodies|mesh-list
5520127|NCT04326296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5520128|NCT04326296|Immunologic Factors|immunologic factors|mesh-ancestor
6093074|NCT00873093|Cyclophosphamide|cyclophosphamide|mesh-list
6093075|NCT00873093|Doxorubicin|doxorubicin|mesh-list
6093076|NCT00873093|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6093077|NCT00873093|Methotrexate|methotrexate|mesh-list
6093078|NCT00873093|Etoposide|etoposide|mesh-list
6093079|NCT00873093|Vincristine|vincristine|mesh-list
6093080|NCT00873093|Bortezomib|bortezomib|mesh-list
6093081|NCT00873093|Asparaginase|asparaginase|mesh-list
6093082|NCT00873093|Pegaspargase|pegaspargase|mesh-list
6093083|NCT00873093|Etoposide phosphate|etoposide phosphate|mesh-list
6093084|NCT00873093|Levoleucovorin|levoleucovorin|mesh-list
6093085|NCT00873093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6093086|NCT00873093|Immunologic Factors|immunologic factors|mesh-ancestor
5520129|NCT04326296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520130|NCT04326296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5520131|NCT04326296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5520132|NCT04326296|Growth Substances|growth substances|mesh-ancestor
5520133|NCT04326296|Growth Inhibitors|growth inhibitors|mesh-ancestor
5520134|NCT04326296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5520135|NCT04326439|Cytarabine|cytarabine|mesh-list
5520136|NCT04326439|Etoposide|etoposide|mesh-list
5520137|NCT04326439|Daunorubicin|daunorubicin|mesh-list
5520138|NCT04326439|Sorafenib|sorafenib|mesh-list
5520139|NCT04326439|Asparaginase|asparaginase|mesh-list
5520140|NCT04326439|Gemtuzumab|gemtuzumab|mesh-list
5520141|NCT04326439|Calicheamicins|calicheamicins|mesh-list
5520142|NCT04326439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5520143|NCT04326439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5520144|NCT04326439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5520145|NCT04326439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5520146|NCT04326439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5520147|NCT04326439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520148|NCT04326439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5520149|NCT04326439|Antimetabolites|antimetabolites|mesh-ancestor
5520150|NCT04326439|Antiviral Agents|antiviral agents|mesh-ancestor
5520151|NCT04326439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6093087|NCT00873093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093088|NCT00873093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6093089|NCT00873093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6093090|NCT00873093|Alkylating Agents|alkylating agents|mesh-ancestor
6093091|NCT00873093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093092|NCT00873093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6093093|NCT00873093|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6093094|NCT00873093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6093095|NCT00873093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6093096|NCT00873093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6093097|NCT00873093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6093098|NCT00873093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6093099|NCT00873093|Glucocorticoids|glucocorticoids|mesh-ancestor
5520152|NCT04326439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5520153|NCT04326439|Immunologic Factors|immunologic factors|mesh-ancestor
5520154|NCT04326439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520155|NCT04326439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5520156|NCT04326439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5520157|NCT04326439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5520158|NCT04326257|Nivolumab|nivolumab|mesh-list
5520159|NCT04326257|Ipilimumab|ipilimumab|mesh-list
5520160|NCT04326257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5520161|NCT04326257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5520162|NCT04326257|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5520163|NCT04326257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520164|NCT04326478|Azithromycin|azithromycin|mesh-list
6093100|NCT00873093|Hormones|hormones|mesh-ancestor
6203460|NCT02057549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5520165|NCT04326478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5520166|NCT04326478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5520167|NCT04326166|Metformin|metformin|mesh-list
6093101|NCT00873093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6093102|NCT00873093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6093103|NCT00873093|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6093104|NCT00873093|Abortifacient Agents|abortifacient agents|mesh-ancestor
6093105|NCT00873093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6093106|NCT00873093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6093107|NCT00873093|Antimetabolites|antimetabolites|mesh-ancestor
6093108|NCT00873093|Dermatologic Agents|dermatologic agents|mesh-ancestor
6093109|NCT00873093|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6093110|NCT00873093|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6093111|NCT00873093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6093112|NCT00873093|Antiviral Agents|antiviral agents|mesh-ancestor
6093113|NCT00873093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6093114|NCT00873093|Antidotes|antidotes|mesh-ancestor
6093115|NCT00873093|Protective Agents|protective agents|mesh-ancestor
6093116|NCT00873093|Vitamin B Complex|vitamin b complex|mesh-ancestor
5520168|NCT04326166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5520169|NCT04326166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520170|NCT04325984|Dexamethasone|dexamethasone|mesh-list
5520171|NCT04325984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5520172|NCT04325984|Antiemetics|antiemetics|mesh-ancestor
5520173|NCT04325984|Autonomic Agents|autonomic agents|mesh-ancestor
5520174|NCT04325984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5520175|NCT04325984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520176|NCT04325984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5520177|NCT04325984|Glucocorticoids|glucocorticoids|mesh-ancestor
5520178|NCT04325984|Hormones|hormones|mesh-ancestor
5520179|NCT04325984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5520180|NCT04325984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5520181|NCT04325984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5520182|NCT04325932|Kallikreins|kallikreins|mesh-list
5520183|NCT04325932|Coagulants|coagulants|mesh-ancestor
5520184|NCT04325932|Fertility Agents, Male|fertility agents, male|mesh-ancestor
6093117|NCT00873093|Vitamins|vitamins|mesh-ancestor
6093118|NCT00873093|Micronutrients|micronutrients|mesh-ancestor
6093119|NCT00873093|Tubulin Modulators|tubulin modulators|mesh-ancestor
6093120|NCT00873093|Antimitotic Agents|antimitotic agents|mesh-ancestor
6093121|NCT00873093|Mitosis Modulators|mitosis modulators|mesh-ancestor
6093122|NCT00873119|Paclitaxel|paclitaxel|mesh-list
6093123|NCT00873119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6093124|NCT00873119|Carboplatin|carboplatin|mesh-list
6093125|NCT00873119|Belinostat|belinostat|mesh-list
6093126|NCT00873119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6093127|NCT00873119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6093128|NCT00873119|Tubulin Modulators|tubulin modulators|mesh-ancestor
6093129|NCT00873119|Antimitotic Agents|antimitotic agents|mesh-ancestor
6093130|NCT00873119|Mitosis Modulators|mitosis modulators|mesh-ancestor
6093131|NCT00873119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093132|NCT00873119|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6093133|NCT00873119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6093134|NCT00873327|Tazobactam|tazobactam|mesh-list
6093135|NCT00873327|Piperacillin|piperacillin|mesh-list
6093136|NCT00873327|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
6093137|NCT00873327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6093138|NCT00873327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6093139|NCT00873327|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6093140|NCT00873327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6093141|NCT00873327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093142|NCT00873730|Etanercept|etanercept|mesh-list
6093143|NCT00873730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6093144|NCT00873730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6093145|NCT00873730|Analgesics|analgesics|mesh-ancestor
6093146|NCT00873730|Sensory System Agents|sensory system agents|mesh-ancestor
6093147|NCT00873730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6093148|NCT00873730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093149|NCT00873730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6093150|NCT00873730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6093151|NCT00873730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6093152|NCT00873730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6093153|NCT00873730|Immunologic Factors|immunologic factors|mesh-ancestor
6093154|NCT00873860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6093155|NCT00873860|Immunologic Factors|immunologic factors|mesh-ancestor
6093156|NCT00873860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093157|NCT00874120|Phenylephrine|phenylephrine|mesh-list
6093158|NCT00874120|Oxymetazoline|oxymetazoline|mesh-list
5520185|NCT04325932|Fertility Agents|fertility agents|mesh-ancestor
6093159|NCT00874120|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6093160|NCT00874120|Mydriatics|mydriatics|mesh-ancestor
6093161|NCT00874120|Autonomic Agents|autonomic agents|mesh-ancestor
6093162|NCT00874120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6093163|NCT00874120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093164|NCT00874120|Sympathomimetics|sympathomimetics|mesh-ancestor
6093165|NCT00874120|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6093166|NCT00874120|Nasal Decongestants|nasal decongestants|mesh-ancestor
6093167|NCT00874120|Respiratory System Agents|respiratory system agents|mesh-ancestor
6093168|NCT00874120|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6093169|NCT00874120|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6093170|NCT00874120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6093171|NCT00874120|Adrenergic Agents|adrenergic agents|mesh-ancestor
6093172|NCT00874120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6093173|NCT00874120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093174|NCT00874120|Protective Agents|protective agents|mesh-ancestor
5520186|NCT04325932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5520187|NCT04325932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520188|NCT04325893|Hydroxychloroquine|hydroxychloroquine|mesh-list
5520189|NCT04325893|Antimalarials|antimalarials|mesh-ancestor
5520190|NCT04325893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5520191|NCT04325893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5520192|NCT04325893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6093175|NCT00874237|Moxifloxacin|moxifloxacin|mesh-list
6093176|NCT00874237|Loxapine|loxapine|mesh-list
6093177|NCT00874237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6093178|NCT00874237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6093179|NCT00874237|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6093180|NCT00874237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6093181|NCT00874237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5520193|NCT04325893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5520194|NCT04325893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520195|NCT04325893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5520196|NCT04325802|Naltrexone|naltrexone|mesh-list
5520197|NCT04325802|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5520198|NCT04325802|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5520199|NCT04325802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520200|NCT04325802|Sensory System Agents|sensory system agents|mesh-ancestor
6093182|NCT00874237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093183|NCT00874237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6093184|NCT00874237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093185|NCT00874237|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6093186|NCT00874237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6093187|NCT00874237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6093188|NCT00874237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6093189|NCT00874237|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5520201|NCT04325802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5520202|NCT04325633|Naproxen|naproxen|mesh-list
5520203|NCT04325633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5520204|NCT04325633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5520205|NCT04325633|Analgesics|analgesics|mesh-ancestor
5520206|NCT04325633|Sensory System Agents|sensory system agents|mesh-ancestor
5520207|NCT04325633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5520208|NCT04325633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520209|NCT04325633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5520210|NCT04325633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5520211|NCT04325633|Gout Suppressants|gout suppressants|mesh-ancestor
5520212|NCT04325633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5520213|NCT04325633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6093190|NCT00874237|Dopamine Agents|dopamine agents|mesh-ancestor
6093191|NCT00874237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6093192|NCT00874432|Lisinopril|lisinopril|mesh-list
6093193|NCT00874432|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6093194|NCT00874432|Enzyme Inhibitors|enzyme inhibitors|mesh-list
6093195|NCT00874432|Protease Inhibitors|protease inhibitors|mesh-ancestor
6093196|NCT00874432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093197|NCT00874432|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6093198|NCT00874432|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6093199|NCT00874432|Protective Agents|protective agents|mesh-ancestor
6093200|NCT00874432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093201|NCT00874614|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
6093202|NCT00874614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6093203|NCT00874614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6093204|NCT00874614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093205|NCT00874614|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6464473|NCT00469755|Micronutrients|micronutrients|mesh-ancestor
6464474|NCT00469768|Dapivirine|dapivirine|mesh-list
6464475|NCT00469768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6464476|NCT00469768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6093206|NCT00874731|Sirolimus|sirolimus|mesh-list
6093207|NCT00874731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6093208|NCT00874731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6093209|NCT00874731|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6093210|NCT00874731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6093211|NCT00874731|Antifungal Agents|antifungal agents|mesh-ancestor
6093212|NCT00874731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6093213|NCT00874731|Immunologic Factors|immunologic factors|mesh-ancestor
6093214|NCT00874731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093215|NCT00874770|Ribavirin|ribavirin|mesh-list
6093216|NCT00874770|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6093217|NCT00874770|Antimetabolites|antimetabolites|mesh-ancestor
6093218|NCT00874770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093219|NCT00874770|Antiviral Agents|antiviral agents|mesh-ancestor
6093220|NCT00874770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6093221|NCT00874848|Paclitaxel|paclitaxel|mesh-list
6093222|NCT00874848|Carboplatin|carboplatin|mesh-list
6093223|NCT00874848|Cetuximab|cetuximab|mesh-list
6093224|NCT00874848|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6093225|NCT00874848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6093226|NCT00874848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6093227|NCT00874848|Tubulin Modulators|tubulin modulators|mesh-ancestor
6093228|NCT00874848|Antimitotic Agents|antimitotic agents|mesh-ancestor
6093229|NCT00874848|Mitosis Modulators|mitosis modulators|mesh-ancestor
6093230|NCT00874848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093231|NCT00874848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6093232|NCT00874887|Moxifloxacin|moxifloxacin|mesh-list
6093233|NCT00874887|Gatifloxacin|gatifloxacin|mesh-list
6093234|NCT00874887|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6093235|NCT00874887|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6093236|NCT00874887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6093237|NCT00874887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6093238|NCT00874887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6093239|NCT00874887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6093240|NCT00874887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5520214|NCT04325633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520215|NCT04325685|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
5520216|NCT04325685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5520217|NCT04325724|Dermatologic Agents|dermatologic agents|mesh-list
5520218|NCT04325490|Hydrocortisone|hydrocortisone|mesh-list
5520219|NCT04325490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5520220|NCT04325503|Levodopa|levodopa|mesh-list
5520221|NCT04325503|Carbidopa|carbidopa|mesh-list
5520222|NCT04325503|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5520223|NCT04325503|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5520224|NCT04325503|Dopamine Agents|dopamine agents|mesh-ancestor
5520225|NCT04325503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5520226|NCT04325503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520227|NCT04325503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520228|NCT04325503|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5520229|NCT04325503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5520230|NCT04325698|Paclitaxel|paclitaxel|mesh-list
5520231|NCT04325698|Bevacizumab|bevacizumab|mesh-list
6093241|NCT00874887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093242|NCT00874887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6093243|NCT00875017|Sevelamer|sevelamer|mesh-list
6093244|NCT00875017|Chelating Agents|chelating agents|mesh-ancestor
6093245|NCT00875017|Sequestering Agents|sequestering agents|mesh-ancestor
6093246|NCT00875017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093247|NCT00875056|Vorinostat|vorinostat|mesh-list
6093248|NCT00875056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6093249|NCT00875056|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6093250|NCT00875056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6093251|NCT00875056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093252|NCT00875212|Calcium|calcium|mesh-list
6093253|NCT00875212|Fluorides|fluorides|mesh-list
6093254|NCT00875212|Sodium Fluoride|sodium fluoride|mesh-list
6093255|NCT00875212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6093256|NCT00875212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093257|NCT00875212|Cariostatic Agents|cariostatic agents|mesh-ancestor
6093258|NCT00875212|Protective Agents|protective agents|mesh-ancestor
6093259|NCT00875277|Betamethasone|betamethasone|mesh-list
6093260|NCT00875277|Betamethasone Valerate|betamethasone valerate|mesh-list
6093261|NCT00875277|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
6093262|NCT00875277|Betamethasone benzoate|betamethasone benzoate|mesh-list
6093263|NCT00875277|Calcipotriene|calcipotriene|mesh-list
6093264|NCT00875277|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
6093265|NCT00875277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6093266|NCT00875277|Glucocorticoids|glucocorticoids|mesh-ancestor
6093267|NCT00875277|Hormones|hormones|mesh-ancestor
6093268|NCT00875277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6093269|NCT00875277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093270|NCT00875277|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6093271|NCT00875277|Respiratory System Agents|respiratory system agents|mesh-ancestor
6093272|NCT00875277|Dermatologic Agents|dermatologic agents|mesh-ancestor
6093273|NCT00875433|Afatinib|afatinib|mesh-list
6093274|NCT00875433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6093275|NCT00875433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6093276|NCT00875433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6093277|NCT00875433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093278|NCT00875524|Vaccines|vaccines|mesh-list
5520232|NCT04325698|Carboplatin|carboplatin|mesh-list
5520233|NCT04325698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5520234|NCT04325698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5520235|NCT04325698|Tubulin Modulators|tubulin modulators|mesh-ancestor
5520236|NCT04325698|Antimitotic Agents|antimitotic agents|mesh-ancestor
5520237|NCT04325698|Mitosis Modulators|mitosis modulators|mesh-ancestor
5520238|NCT04325698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520239|NCT04325698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5520240|NCT04325698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5520241|NCT04325698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5520242|NCT04325698|Growth Substances|growth substances|mesh-ancestor
5520243|NCT04325698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520244|NCT04325698|Growth Inhibitors|growth inhibitors|mesh-ancestor
5520245|NCT04325581|Liraglutide|liraglutide|mesh-list
5520246|NCT04325581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5520247|NCT04325581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520248|NCT04325581|Incretins|incretins|mesh-ancestor
5520249|NCT04325581|Hormones|hormones|mesh-ancestor
5520250|NCT04325581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5520251|NCT04325776|Zoledronic Acid|zoledronic acid|mesh-list
5520252|NCT04325776|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5520253|NCT04325776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520254|NCT04325425|Carboplatin|carboplatin|mesh-list
5520255|NCT04325425|Etoposide|etoposide|mesh-list
5520256|NCT04325425|Folfirinox|folfirinox|mesh-list
5520257|NCT04325425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5520258|NCT04325425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6093279|NCT00875524|Immunologic Factors|immunologic factors|mesh-ancestor
6093280|NCT00875524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093281|NCT00875550|Fentanyl|fentanyl|mesh-list
6093282|NCT00875550|Midazolam|midazolam|mesh-list
6093283|NCT00875550|Dexmedetomidine|dexmedetomidine|mesh-list
6093284|NCT00875550|Morphine|morphine|mesh-list
6093285|NCT00875550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6093286|NCT00875550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6093287|NCT00875550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093288|NCT00875550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6093289|NCT00875550|Analgesics|analgesics|mesh-ancestor
5520259|NCT04325425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5520260|NCT04325425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5520261|NCT04325425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5520262|NCT04325425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520263|NCT04325113|Levobupivacaine|levobupivacaine|mesh-list
6093290|NCT00875550|Sensory System Agents|sensory system agents|mesh-ancestor
6093291|NCT00875550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6093292|NCT00875550|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6093293|NCT00875550|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6093294|NCT00875550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6093295|NCT00875550|Adrenergic Agents|adrenergic agents|mesh-ancestor
6093296|NCT00875550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6093297|NCT00875550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093298|NCT00875550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6093299|NCT00875550|Narcotics|narcotics|mesh-ancestor
5520264|NCT04325113|Anesthetics, Local|anesthetics, local|mesh-ancestor
5520265|NCT04325113|Anesthetics|anesthetics|mesh-ancestor
6093300|NCT00875550|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5520266|NCT04325113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6093301|NCT00875550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6093302|NCT00875550|Anesthetics, General|anesthetics, general|mesh-ancestor
6093303|NCT00875550|Anesthetics|anesthetics|mesh-ancestor
6093304|NCT00875550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6093305|NCT00875550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6093306|NCT00875550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6093307|NCT00875550|GABA Modulators|gaba modulators|mesh-ancestor
6093308|NCT00875550|GABA Agents|gaba agents|mesh-ancestor
6093309|NCT00875615|Carboplatin|carboplatin|mesh-list
6093310|NCT00875615|Sorafenib|sorafenib|mesh-list
6093311|NCT00875615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6093312|NCT00875615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6093313|NCT00875615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6093314|NCT00875615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093315|NCT00875667|Fludarabine|fludarabine|mesh-list
6093316|NCT00875667|Fludarabine phosphate|fludarabine phosphate|mesh-list
6093317|NCT00875667|Lenalidomide|lenalidomide|mesh-list
6093318|NCT00875667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6093319|NCT00875667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6093320|NCT00875667|Antimetabolites|antimetabolites|mesh-ancestor
6093321|NCT00875667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093322|NCT00875667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6093323|NCT00875667|Immunologic Factors|immunologic factors|mesh-ancestor
6093324|NCT00875667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093325|NCT00875667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6093326|NCT00875667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6093327|NCT00875667|Growth Substances|growth substances|mesh-ancestor
6093328|NCT00875667|Growth Inhibitors|growth inhibitors|mesh-ancestor
6093329|NCT00875836|Buspirone|buspirone|mesh-list
6093330|NCT00875836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6093331|NCT00875836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6093332|NCT00875836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6093333|NCT00875836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093334|NCT00875836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6093335|NCT00875836|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6093336|NCT00875836|Serotonin Agents|serotonin agents|mesh-ancestor
6093337|NCT00875836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6093338|NCT00875836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093339|NCT00875979|Trastuzumab|trastuzumab|mesh-list
6093340|NCT00875979|Pertuzumab|pertuzumab|mesh-list
6093341|NCT00875979|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
6093342|NCT00875979|Maytansine|maytansine|mesh-list
6093343|NCT00875979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6093344|NCT00875979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6093345|NCT00875979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6093346|NCT00875979|Tubulin Modulators|tubulin modulators|mesh-ancestor
6093347|NCT00875979|Antimitotic Agents|antimitotic agents|mesh-ancestor
6093348|NCT00875979|Mitosis Modulators|mitosis modulators|mesh-ancestor
6093349|NCT00875979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093350|NCT00876187|Naproxen|naproxen|mesh-list
6093351|NCT00876187|Tanezumab|tanezumab|mesh-list
6093352|NCT00876187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6093353|NCT00876187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6093354|NCT00876187|Analgesics|analgesics|mesh-ancestor
6093355|NCT00876187|Sensory System Agents|sensory system agents|mesh-ancestor
6093356|NCT00876187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6093357|NCT00876187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093358|NCT00876187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6093359|NCT00876187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6093360|NCT00876187|Gout Suppressants|gout suppressants|mesh-ancestor
6093361|NCT00876187|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6093362|NCT00876187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6093363|NCT00876187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093364|NCT00876200|Minoxidil|minoxidil|mesh-list
6093365|NCT00876200|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6093366|NCT00876200|Vasodilator Agents|vasodilator agents|mesh-ancestor
6093367|NCT00876343|Aripiprazole|aripiprazole|mesh-list
6093368|NCT00876343|Antidepressive Agents|antidepressive agents|mesh-ancestor
6093369|NCT00876343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6093370|NCT00876343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6093371|NCT00876343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6093372|NCT00876343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6093373|NCT00876343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093374|NCT00876343|Dopamine Agonists|dopamine agonists|mesh-ancestor
6093375|NCT00876343|Dopamine Agents|dopamine agents|mesh-ancestor
6093376|NCT00876343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6203461|NCT02057549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6093377|NCT00876343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093378|NCT00876343|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6093379|NCT00876343|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6093380|NCT00876343|Serotonin Agents|serotonin agents|mesh-ancestor
6093381|NCT00876343|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6464477|NCT00469768|Antiviral Agents|antiviral agents|mesh-ancestor
6464478|NCT00469768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6464479|NCT00469781|Bromfenac|bromfenac|mesh-list
6464480|NCT00469781|Prednisolone acetate|prednisolone acetate|mesh-list
6464481|NCT00469781|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6464482|NCT00469781|Methylprednisolone|methylprednisolone|mesh-list
6464483|NCT00469781|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6464484|NCT00469781|Prednisolone|prednisolone|mesh-list
5520267|NCT04325113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093382|NCT00876343|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6093383|NCT00876343|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6093384|NCT00876343|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6093385|NCT00876395|Paclitaxel|paclitaxel|mesh-list
6093386|NCT00876395|Trastuzumab|trastuzumab|mesh-list
6093387|NCT00876395|Everolimus|everolimus|mesh-list
6093388|NCT00876395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6093389|NCT00876395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6093390|NCT00876395|Tubulin Modulators|tubulin modulators|mesh-ancestor
6093391|NCT00876395|Antimitotic Agents|antimitotic agents|mesh-ancestor
6093392|NCT00876395|Mitosis Modulators|mitosis modulators|mesh-ancestor
6093393|NCT00876395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093394|NCT00876395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6093395|NCT00876395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6093396|NCT00876395|Immunologic Factors|immunologic factors|mesh-ancestor
6093397|NCT00876395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093398|NCT00876447|Botulinum Toxins|botulinum toxins|mesh-list
6093399|NCT00876447|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6093400|NCT00876447|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6093401|NCT00876447|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6093402|NCT00876447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6093403|NCT00876447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093404|NCT00876447|Cholinergic Agents|cholinergic agents|mesh-ancestor
6093405|NCT00876447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6093406|NCT00876447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093407|NCT00876447|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6093408|NCT00876447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6093409|NCT00876460|Docetaxel|docetaxel|mesh-list
5520268|NCT04325113|Sensory System Agents|sensory system agents|mesh-ancestor
5520269|NCT04325113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5520270|NCT04325191|Melatonin|melatonin|mesh-list
5520271|NCT04325191|Antioxidants|antioxidants|mesh-ancestor
5520272|NCT04325191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520273|NCT04325191|Protective Agents|protective agents|mesh-ancestor
5520274|NCT04325191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520275|NCT04325191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5600897|NCT03708861|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5600898|NCT03708861|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
5600899|NCT03708848|Metronidazole|metronidazole|mesh-list
5600900|NCT03708848|Clarithromycin|clarithromycin|mesh-list
5600901|NCT03708848|Levofloxacin|levofloxacin|mesh-list
5600902|NCT03708848|Ofloxacin|ofloxacin|mesh-list
5600903|NCT03708848|Tetracycline|tetracycline|mesh-list
5600904|NCT03708848|Potassium Citrate|potassium citrate|mesh-list
5600905|NCT03708848|Esomeprazole|esomeprazole|mesh-list
5600906|NCT03708848|Bismuth|bismuth|mesh-list
5600907|NCT03708848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600908|NCT03708848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5600909|NCT03708848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5600910|NCT03708848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5600911|NCT03708848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5600912|NCT03708848|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5600913|NCT03708848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5600914|NCT03708848|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5600915|NCT03708848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6093410|NCT00876460|Nintedanib|nintedanib|mesh-list
6093411|NCT00876460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6093412|NCT00876460|Tubulin Modulators|tubulin modulators|mesh-ancestor
6093413|NCT00876460|Antimitotic Agents|antimitotic agents|mesh-ancestor
6464485|NCT00469781|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5600916|NCT03708848|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5600917|NCT03708848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6093414|NCT00876460|Mitosis Modulators|mitosis modulators|mesh-ancestor
6093415|NCT00876460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093416|NCT00876460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6093417|NCT00876460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6093418|NCT00876694|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6093419|NCT00876694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6093420|NCT00876694|Autonomic Agents|autonomic agents|mesh-ancestor
6093421|NCT00876694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6093422|NCT00876694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093423|NCT00876694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6093424|NCT00876694|Respiratory System Agents|respiratory system agents|mesh-ancestor
6093425|NCT00876694|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6093426|NCT00876694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6093427|NCT00876694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6093428|NCT00876694|Adrenergic Agents|adrenergic agents|mesh-ancestor
5520276|NCT04325243|Sildenafil Citrate|sildenafil citrate|mesh-list
5520277|NCT04325243|Vasodilator Agents|vasodilator agents|mesh-ancestor
5520278|NCT04325243|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5520279|NCT04325243|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5520280|NCT04325243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5520281|NCT04325243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520282|NCT04325243|Urological Agents|urological agents|mesh-ancestor
5520283|NCT04325061|Dexamethasone|dexamethasone|mesh-list
5520284|NCT04325061|Dexamethasone acetate|dexamethasone acetate|mesh-list
5520285|NCT04325061|BB 1101|bb 1101|mesh-list
5520286|NCT04325061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6093429|NCT00876694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6093430|NCT00876694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093431|NCT00876915|Dalteparin|dalteparin|mesh-list
6093432|NCT00876915|Tinzaparin|tinzaparin|mesh-list
6093433|NCT00876915|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6093434|NCT00876915|Anticoagulants|anticoagulants|mesh-ancestor
6093435|NCT00876915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6093436|NCT00876915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6093437|NCT00876915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093438|NCT00876928|Vitamin D|vitamin d|mesh-list
6093439|NCT00876928|Vitamins|vitamins|mesh-ancestor
6093440|NCT00876928|Micronutrients|micronutrients|mesh-ancestor
6093441|NCT00876928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093442|NCT00876928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6093443|NCT00876993|Bevacizumab|bevacizumab|mesh-list
6093444|NCT00876993|Irinotecan|irinotecan|mesh-list
6093445|NCT00876993|Temozolomide|temozolomide|mesh-list
6093446|NCT00876993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6093447|NCT00876993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6093448|NCT00876993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6093449|NCT00876993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5520287|NCT04325061|Antiemetics|antiemetics|mesh-ancestor
5520288|NCT04325061|Autonomic Agents|autonomic agents|mesh-ancestor
5520289|NCT04325061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5520290|NCT04325061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520291|NCT04325061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5520292|NCT04325061|Glucocorticoids|glucocorticoids|mesh-ancestor
5520293|NCT04325061|Hormones|hormones|mesh-ancestor
5520294|NCT04325061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5520295|NCT04325061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5520296|NCT04325061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5520297|NCT04325061|Protease Inhibitors|protease inhibitors|mesh-ancestor
5520298|NCT04325061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5520299|NCT04325061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520300|NCT04325009|Atorvastatin|atorvastatin|mesh-list
5520301|NCT04325009|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5520302|NCT04325009|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5520303|NCT04325009|Antimetabolites|antimetabolites|mesh-ancestor
5520304|NCT04325009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520305|NCT04325009|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5520306|NCT04325009|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5520307|NCT04325009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5520308|NCT04324411|Sirolimus|sirolimus|mesh-list
5520309|NCT04324411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5520310|NCT04324411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5520311|NCT04324411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5520312|NCT04324411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5520313|NCT04324411|Antifungal Agents|antifungal agents|mesh-ancestor
5520314|NCT04324411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5520315|NCT04324411|Immunologic Factors|immunologic factors|mesh-ancestor
5520316|NCT04324411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093450|NCT00876993|Growth Substances|growth substances|mesh-ancestor
6093451|NCT00876993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093452|NCT00876993|Growth Inhibitors|growth inhibitors|mesh-ancestor
6093453|NCT00876993|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6093454|NCT00876993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6093455|NCT00876993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6093456|NCT00876993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093457|NCT00876993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6093458|NCT00876993|Alkylating Agents|alkylating agents|mesh-ancestor
6093459|NCT00877006|Prednisone|prednisone|mesh-list
6093460|NCT00877006|Cyclophosphamide|cyclophosphamide|mesh-list
6093461|NCT00877006|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6093462|NCT00877006|Rituximab|rituximab|mesh-list
6093463|NCT00877006|Doxorubicin|doxorubicin|mesh-list
5520317|NCT04324346|Paclitaxel|paclitaxel|mesh-list
5520318|NCT04324346|Docetaxel|docetaxel|mesh-list
5520319|NCT04324346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6093464|NCT00877006|Vincristine|vincristine|mesh-list
6093465|NCT00877006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6093466|NCT00877006|Immunologic Factors|immunologic factors|mesh-ancestor
6093467|NCT00877006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520320|NCT04324346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5520321|NCT04324346|Tubulin Modulators|tubulin modulators|mesh-ancestor
5520322|NCT04324346|Antimitotic Agents|antimitotic agents|mesh-ancestor
5520323|NCT04324346|Mitosis Modulators|mitosis modulators|mesh-ancestor
6093468|NCT00877006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6093469|NCT00877006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6093470|NCT00877006|Alkylating Agents|alkylating agents|mesh-ancestor
6093471|NCT00877006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093472|NCT00877006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6093473|NCT00877006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6093474|NCT00877006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6093475|NCT00877006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6093476|NCT00877006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6093477|NCT00877006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6093478|NCT00877006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6093479|NCT00877006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6093480|NCT00877006|Glucocorticoids|glucocorticoids|mesh-ancestor
6093481|NCT00877006|Hormones|hormones|mesh-ancestor
6093482|NCT00877006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6093483|NCT00877006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6093484|NCT00877006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6093485|NCT00877006|Tubulin Modulators|tubulin modulators|mesh-ancestor
6093486|NCT00877006|Antimitotic Agents|antimitotic agents|mesh-ancestor
6093487|NCT00877006|Mitosis Modulators|mitosis modulators|mesh-ancestor
6093488|NCT00877370|Ertapenem|ertapenem|mesh-list
6093489|NCT00877370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6093490|NCT00877370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5520324|NCT04324346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520325|NCT04324229|Liraglutide|liraglutide|mesh-list
5520326|NCT04324229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5520327|NCT04324229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520328|NCT04324229|Incretins|incretins|mesh-ancestor
5520329|NCT04324229|Hormones|hormones|mesh-ancestor
5520330|NCT04324229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5520331|NCT04324021|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5520332|NCT04324021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5520333|NCT04324307|Gemcitabine|gemcitabine|mesh-list
5520334|NCT04324307|Paclitaxel|paclitaxel|mesh-list
6093491|NCT00877383|Tiotropium Bromide|tiotropium bromide|mesh-list
6093492|NCT00877383|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6093493|NCT00877383|Autonomic Agents|autonomic agents|mesh-ancestor
6093494|NCT00877383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6093495|NCT00877383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093496|NCT00877383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6093497|NCT00877383|Respiratory System Agents|respiratory system agents|mesh-ancestor
6093498|NCT00877383|Parasympatholytics|parasympatholytics|mesh-ancestor
6093499|NCT00877383|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6093500|NCT00877383|Cholinergic Agents|cholinergic agents|mesh-ancestor
6093501|NCT00877383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6093502|NCT00877383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093503|NCT00877487|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6203462|NCT02057549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6093504|NCT00877487|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6093505|NCT00877487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520335|NCT04324307|Fluorouracil|fluorouracil|mesh-list
5520336|NCT04324307|Oxaliplatin|oxaliplatin|mesh-list
5520337|NCT04324307|Irinotecan|irinotecan|mesh-list
5520338|NCT04324307|Folfirinox|folfirinox|mesh-list
5520339|NCT04324307|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5520340|NCT04324307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5520341|NCT04324307|Tubulin Modulators|tubulin modulators|mesh-ancestor
5520342|NCT04324307|Antimitotic Agents|antimitotic agents|mesh-ancestor
5520343|NCT04324307|Mitosis Modulators|mitosis modulators|mesh-ancestor
5520344|NCT04324307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520345|NCT04324307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5520346|NCT04324307|Antimetabolites|antimetabolites|mesh-ancestor
5520347|NCT04324307|Antiviral Agents|antiviral agents|mesh-ancestor
5520348|NCT04324307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5520349|NCT04324307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5520350|NCT04324307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5520351|NCT04324307|Immunologic Factors|immunologic factors|mesh-ancestor
5520352|NCT04324307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520353|NCT04324307|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5520354|NCT04324307|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5520355|NCT04324476|Bevacizumab|bevacizumab|mesh-list
5520356|NCT04324476|Capecitabine|capecitabine|mesh-list
6093506|NCT00877487|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6093507|NCT00877487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6093508|NCT00877487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6093509|NCT00877487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093510|NCT00877487|Dopamine Agents|dopamine agents|mesh-ancestor
6093511|NCT00877487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6093512|NCT00877604|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
6093513|NCT00877604|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6093514|NCT00877604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6093515|NCT00877604|Antiviral Agents|antiviral agents|mesh-ancestor
6093516|NCT00877604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6093517|NCT00877773|Sirolimus|sirolimus|mesh-list
6093518|NCT00877773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6093519|NCT00877773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6093520|NCT00877773|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6093521|NCT00877773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6093522|NCT00877773|Antifungal Agents|antifungal agents|mesh-ancestor
6093523|NCT00877773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6093524|NCT00877773|Immunologic Factors|immunologic factors|mesh-ancestor
6093525|NCT00877773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093526|NCT00877890|Exenatide|exenatide|mesh-list
6093527|NCT00877890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6093528|NCT00877890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093529|NCT00877890|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6093530|NCT00877890|Incretins|incretins|mesh-ancestor
6093531|NCT00877890|Hormones|hormones|mesh-ancestor
6093532|NCT00877890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6093533|NCT00877929|Amlodipine|amlodipine|mesh-list
6093534|NCT00877929|Telmisartan|telmisartan|mesh-list
6093535|NCT00877929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6093536|NCT00877929|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6093537|NCT00877929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6093538|NCT00877929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520357|NCT04324476|Oxaliplatin|oxaliplatin|mesh-list
5520358|NCT04324476|Irinotecan|irinotecan|mesh-list
6093539|NCT00877929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6093540|NCT00877929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093541|NCT00877929|Vasodilator Agents|vasodilator agents|mesh-ancestor
6093542|NCT00877929|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6093543|NCT00877929|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6093544|NCT00878072|Famciclovir|famciclovir|mesh-list
6093545|NCT00878072|Antiviral Agents|antiviral agents|mesh-ancestor
6093546|NCT00878072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6093547|NCT00878072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6093548|NCT00878072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6093549|NCT00878072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203463|NCT02057549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6203464|NCT02057549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6203465|NCT02057549|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5520359|NCT04324476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5520360|NCT04324476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6093550|NCT00878215|Liver Extracts|liver extracts|mesh-list
6093551|NCT00878215|Hematinics|hematinics|mesh-ancestor
6093552|NCT00878228|Ondansetron|ondansetron|mesh-list
6093553|NCT00878228|Antiemetics|antiemetics|mesh-ancestor
6093554|NCT00878228|Autonomic Agents|autonomic agents|mesh-ancestor
6093555|NCT00878228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6093556|NCT00878228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520361|NCT04324476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5520362|NCT04324476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6093557|NCT00878228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6093558|NCT00878228|Antipruritics|antipruritics|mesh-ancestor
6093559|NCT00878228|Dermatologic Agents|dermatologic agents|mesh-ancestor
6093560|NCT00878228|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6093561|NCT00878228|Serotonin Agents|serotonin agents|mesh-ancestor
6093562|NCT00878228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6093563|NCT00878228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093564|NCT00878228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6093565|NCT00878228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6093566|NCT00878228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6093567|NCT00878228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6093568|NCT00878228|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6093569|NCT00878436|Bicalutamide|bicalutamide|mesh-list
6093570|NCT00878436|Panobinostat|panobinostat|mesh-list
6093571|NCT00878436|Androgen Antagonists|androgen antagonists|mesh-ancestor
6093572|NCT00878436|Hormone Antagonists|hormone antagonists|mesh-ancestor
6093573|NCT00878436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6093574|NCT00878436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093575|NCT00878436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6093576|NCT00878436|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6093577|NCT00878436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6093578|NCT00878436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093579|NCT00878553|Zaleplon|zaleplon|mesh-list
6093580|NCT00878553|Anticonvulsants|anticonvulsants|mesh-ancestor
6093581|NCT00878553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6093582|NCT00878553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6093583|NCT00878553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093584|NCT00878553|GABA Modulators|gaba modulators|mesh-ancestor
6093585|NCT00878553|GABA Agents|gaba agents|mesh-ancestor
6093586|NCT00878553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6093587|NCT00878553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093588|NCT00878722|Idarubicin|idarubicin|mesh-list
6093589|NCT00878722|Belinostat|belinostat|mesh-list
6093590|NCT00878722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6093591|NCT00878722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6093592|NCT00878722|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6093593|NCT00878722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5520363|NCT04324476|Growth Substances|growth substances|mesh-ancestor
5520364|NCT04324476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520365|NCT04324476|Growth Inhibitors|growth inhibitors|mesh-ancestor
5520366|NCT04324476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5520367|NCT04324476|Antimetabolites|antimetabolites|mesh-ancestor
5520368|NCT04324476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520369|NCT04324476|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6093594|NCT00878722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6093595|NCT00878722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093596|NCT00878722|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6093597|NCT00878800|Doxorubicin|doxorubicin|mesh-list
6093598|NCT00878800|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6093599|NCT00878800|Belinostat|belinostat|mesh-list
6093600|NCT00878800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6093601|NCT00878800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6093602|NCT00878800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6093603|NCT00878800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6093604|NCT00878800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6093605|NCT00878800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093606|NCT00878800|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6093607|NCT00878826|Enoxaparin|enoxaparin|mesh-list
6093608|NCT00878826|Anticoagulants|anticoagulants|mesh-ancestor
6093609|NCT00878826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6093610|NCT00878826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6093611|NCT00878826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093612|NCT00878995|Methyltestosterone|methyltestosterone|mesh-list
6093613|NCT00878995|Testosterone|testosterone|mesh-list
6093614|NCT00878995|Testosterone undecanoate|testosterone undecanoate|mesh-list
5520370|NCT04324476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6093615|NCT00878995|Testosterone enanthate|testosterone enanthate|mesh-list
6093616|NCT00878995|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6093617|NCT00878995|Androgens|androgens|mesh-ancestor
6093618|NCT00878995|Hormones|hormones|mesh-ancestor
6093619|NCT00878995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6093620|NCT00878995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093621|NCT00878995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6093622|NCT00878995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6093623|NCT00878995|Anabolic Agents|anabolic agents|mesh-ancestor
6093624|NCT00879034|Zoledronic Acid|zoledronic acid|mesh-list
6093625|NCT00879034|Pravastatin|pravastatin|mesh-list
6093626|NCT00879034|Lonafarnib|lonafarnib|mesh-list
6464486|NCT00469781|Prednisolone phosphate|prednisolone phosphate|mesh-list
5520371|NCT04324476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6093627|NCT00879034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6093628|NCT00879034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093629|NCT00879034|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6093630|NCT00879034|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6093631|NCT00879034|Antimetabolites|antimetabolites|mesh-ancestor
6093632|NCT00879034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093633|NCT00879034|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6093634|NCT00879034|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6093635|NCT00879034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6093636|NCT00879060|Spironolactone|spironolactone|mesh-list
6093637|NCT00879060|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6093638|NCT00879060|Hormone Antagonists|hormone antagonists|mesh-ancestor
6093639|NCT00879060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6093640|NCT00879060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093641|NCT00879060|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6093642|NCT00879060|Diuretics|diuretics|mesh-ancestor
6093643|NCT00879060|Natriuretic Agents|natriuretic agents|mesh-ancestor
6093644|NCT00879190|Gentamicins|gentamicins|mesh-list
6093645|NCT00879190|Ampicillin|ampicillin|mesh-list
6093646|NCT00879190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6093647|NCT00879190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6093648|NCT00879190|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6093649|NCT00879190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6093650|NCT00879190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093651|NCT00879229|Ambrisentan|ambrisentan|mesh-list
6093652|NCT00879229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6093653|NCT00879333|Everolimus|everolimus|mesh-list
6093654|NCT00879333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6093655|NCT00879333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6093656|NCT00879333|Immunologic Factors|immunologic factors|mesh-ancestor
6093657|NCT00879333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093658|NCT00879359|Paclitaxel|paclitaxel|mesh-list
6093659|NCT00879359|Bevacizumab|bevacizumab|mesh-list
6093660|NCT00879359|Carboplatin|carboplatin|mesh-list
6093661|NCT00879359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6093662|NCT00879359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6093663|NCT00879359|Tubulin Modulators|tubulin modulators|mesh-ancestor
6093664|NCT00879359|Antimitotic Agents|antimitotic agents|mesh-ancestor
6093665|NCT00879359|Mitosis Modulators|mitosis modulators|mesh-ancestor
6093666|NCT00879359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093667|NCT00879359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6093668|NCT00879359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6093669|NCT00879359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6093670|NCT00879359|Growth Substances|growth substances|mesh-ancestor
6093671|NCT00879359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093672|NCT00879359|Growth Inhibitors|growth inhibitors|mesh-ancestor
6093673|NCT00879398|Fesoterodine|fesoterodine|mesh-list
6093674|NCT00879398|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6093675|NCT00879398|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6093676|NCT00879398|Cholinergic Agents|cholinergic agents|mesh-ancestor
6093677|NCT00879398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6093678|NCT00879398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093679|NCT00879398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093680|NCT00879398|Urological Agents|urological agents|mesh-ancestor
5520372|NCT04324086|Calcium, Dietary|calcium, dietary|mesh-list
5520373|NCT04324086|Calcium|calcium|mesh-list
5520374|NCT04324086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5520375|NCT04324086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520376|NCT04324086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5520377|NCT04324060|Danazol|danazol|mesh-list
6093681|NCT00879411|Telmisartan|telmisartan|mesh-list
6093682|NCT00879411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6093683|NCT00879411|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6093684|NCT00879411|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6093685|NCT00879411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093686|NCT00879437|Bevacizumab|bevacizumab|mesh-list
6093687|NCT00879437|Valproic Acid|valproic acid|mesh-list
6093688|NCT00879437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6093689|NCT00879437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6093690|NCT00879437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6093691|NCT00879437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6093692|NCT00879437|Growth Substances|growth substances|mesh-ancestor
6093693|NCT00879437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093694|NCT00879437|Growth Inhibitors|growth inhibitors|mesh-ancestor
6093695|NCT00879437|Anticonvulsants|anticonvulsants|mesh-ancestor
6093696|NCT00879437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6093697|NCT00879437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093698|NCT00879437|GABA Agents|gaba agents|mesh-ancestor
6093699|NCT00879437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6093700|NCT00879437|Antimanic Agents|antimanic agents|mesh-ancestor
6093701|NCT00879437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6093702|NCT00879437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6093703|NCT00879437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6093704|NCT00879658|Siponimod|siponimod|mesh-list
6093705|NCT00879658|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6093706|NCT00879658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093707|NCT00879658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6093708|NCT00879658|Immunologic Factors|immunologic factors|mesh-ancestor
6093709|NCT00879658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093710|NCT00879710|Simvastatin|simvastatin|mesh-list
6093711|NCT00879710|Ezetimibe|ezetimibe|mesh-list
6093712|NCT00879710|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6093713|NCT00879710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6093714|NCT00879710|Antimetabolites|antimetabolites|mesh-ancestor
6093715|NCT00879710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093716|NCT00879710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6093717|NCT00879710|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6093718|NCT00879710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6093719|NCT00879775|Sodium Benzoate|sodium benzoate|mesh-list
6093720|NCT00879775|Caffeine|caffeine|mesh-list
6093721|NCT00879775|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6093722|NCT00879775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093723|NCT00879775|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6093724|NCT00879775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6093725|NCT00879775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093726|NCT00879775|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6093727|NCT00879775|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6093728|NCT00879775|Purinergic Agents|purinergic agents|mesh-ancestor
6093729|NCT00879775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6093730|NCT00879775|Antifungal Agents|antifungal agents|mesh-ancestor
6093731|NCT00879775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6093732|NCT00879814|Vaccines|vaccines|mesh-list
6093733|NCT00879814|Immunologic Factors|immunologic factors|mesh-ancestor
6093734|NCT00879814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093735|NCT00879879|Losartan|losartan|mesh-list
6093736|NCT00879879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6093737|NCT00879879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6093738|NCT00879879|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6093739|NCT00879879|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6093740|NCT00879879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093741|NCT00879970|Vitamin D|vitamin d|mesh-list
6093742|NCT00879970|Pioglitazone|pioglitazone|mesh-list
6093743|NCT00879970|Rosiglitazone|rosiglitazone|mesh-list
6093744|NCT00879970|Vitamins|vitamins|mesh-ancestor
6093745|NCT00879970|Micronutrients|micronutrients|mesh-ancestor
6093746|NCT00879970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093747|NCT00879970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6093748|NCT00879970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6093749|NCT00879996|Buprenorphine|buprenorphine|mesh-list
6093750|NCT00879996|Methadone|methadone|mesh-list
6093751|NCT00879996|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6093752|NCT00879996|Naloxone|naloxone|mesh-list
6093753|NCT00879996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6093754|NCT00879996|Narcotics|narcotics|mesh-ancestor
6093755|NCT00879996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6093756|NCT00879996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093757|NCT00879996|Analgesics|analgesics|mesh-ancestor
6093758|NCT00879996|Sensory System Agents|sensory system agents|mesh-ancestor
5520378|NCT04324060|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5520379|NCT04324060|Hormone Antagonists|hormone antagonists|mesh-ancestor
5520380|NCT04324060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5520381|NCT04324060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520382|NCT04324294|Pancrelipase|pancrelipase|mesh-list
5520383|NCT04324294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5520384|NCT04323748|Rituximab|rituximab|mesh-list
6093759|NCT00879996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6093760|NCT00879996|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6464487|NCT00469781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6464488|NCT00469781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6464489|NCT00469781|Analgesics|analgesics|mesh-ancestor
6464490|NCT00469781|Sensory System Agents|sensory system agents|mesh-ancestor
6464491|NCT00469781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6464492|NCT00469781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464493|NCT00469781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6464494|NCT00469781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6464495|NCT00469781|Antiemetics|antiemetics|mesh-ancestor
6464496|NCT00469781|Autonomic Agents|autonomic agents|mesh-ancestor
6464497|NCT00469781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6464498|NCT00469781|Glucocorticoids|glucocorticoids|mesh-ancestor
6464499|NCT00469781|Hormones|hormones|mesh-ancestor
6464500|NCT00469781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6093761|NCT00879996|Antitussive Agents|antitussive agents|mesh-ancestor
6093762|NCT00879996|Respiratory System Agents|respiratory system agents|mesh-ancestor
6093763|NCT00880009|Letrozole|letrozole|mesh-list
6093764|NCT00880009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6093765|NCT00880009|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6093766|NCT00880009|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6093767|NCT00880009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6093768|NCT00880009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093769|NCT00880009|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6093770|NCT00880009|Hormone Antagonists|hormone antagonists|mesh-ancestor
6093771|NCT00880009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6093772|NCT00880009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093773|NCT00880100|Pancrelipase|pancrelipase|mesh-list
6093774|NCT00880100|Pancreatin|pancreatin|mesh-list
6093775|NCT00880100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6093776|NCT00880191|Dexamethasone|dexamethasone|mesh-list
6093777|NCT00880191|Gabapentin|gabapentin|mesh-list
6093778|NCT00880191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6093779|NCT00880191|Antiemetics|antiemetics|mesh-ancestor
6093780|NCT00880191|Autonomic Agents|autonomic agents|mesh-ancestor
6093781|NCT00880191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6093782|NCT00880191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093783|NCT00880191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6093784|NCT00880191|Glucocorticoids|glucocorticoids|mesh-ancestor
6093785|NCT00880191|Hormones|hormones|mesh-ancestor
6093786|NCT00880191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6093787|NCT00880191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6093788|NCT00880191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6093789|NCT00880191|Analgesics|analgesics|mesh-ancestor
6093790|NCT00880191|Sensory System Agents|sensory system agents|mesh-ancestor
6093791|NCT00880191|Anticonvulsants|anticonvulsants|mesh-ancestor
6093792|NCT00880191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6093793|NCT00880191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6093794|NCT00880191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6093795|NCT00880191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6093796|NCT00880191|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6093797|NCT00880191|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6093798|NCT00880191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5520385|NCT04323748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5520386|NCT04323748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5520387|NCT04323748|Immunologic Factors|immunologic factors|mesh-ancestor
5520388|NCT04323748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520389|NCT04323748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5520390|NCT04323956|Prednisone|prednisone|mesh-list
5520391|NCT04323956|Cortisone|cortisone|mesh-list
6093799|NCT00880191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093800|NCT00880191|Antimanic Agents|antimanic agents|mesh-ancestor
6093801|NCT00880269|Panobinostat|panobinostat|mesh-list
6093802|NCT00880269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6093803|NCT00880269|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6093804|NCT00880269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6093805|NCT00880269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093806|NCT00880334|Docetaxel|docetaxel|mesh-list
6093807|NCT00880334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6093808|NCT00880334|Tubulin Modulators|tubulin modulators|mesh-ancestor
6093809|NCT00880334|Antimitotic Agents|antimitotic agents|mesh-ancestor
6093810|NCT00880334|Mitosis Modulators|mitosis modulators|mesh-ancestor
6093811|NCT00880334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093812|NCT00880360|Denileukin diftitox|denileukin diftitox|mesh-list
6093813|NCT00880360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6093814|NCT00880607|Morphine|morphine|mesh-list
5520392|NCT04323956|Cyclophosphamide|cyclophosphamide|mesh-list
5520393|NCT04323956|Rituximab|rituximab|mesh-list
5520394|NCT04323956|Doxorubicin|doxorubicin|mesh-list
5520395|NCT04323956|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6093815|NCT00880607|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6093816|NCT00880607|Narcotics|narcotics|mesh-ancestor
6093817|NCT00880607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6093818|NCT00880607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093819|NCT00880607|Analgesics|analgesics|mesh-ancestor
6093820|NCT00880607|Sensory System Agents|sensory system agents|mesh-ancestor
6093821|NCT00880607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6093822|NCT00880620|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
6093823|NCT00880620|Carbidopa|carbidopa|mesh-list
6093824|NCT00880620|Levodopa|levodopa|mesh-list
6093825|NCT00880620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6093826|NCT00880620|Immunologic Factors|immunologic factors|mesh-ancestor
6093827|NCT00880620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093828|NCT00880620|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6093829|NCT00880620|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6093830|NCT00880620|Dopamine Agonists|dopamine agonists|mesh-ancestor
6093831|NCT00880620|Dopamine Agents|dopamine agents|mesh-ancestor
6093832|NCT00880620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6093833|NCT00880620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093834|NCT00880620|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6093835|NCT00880620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6093836|NCT00880685|Memantine|memantine|mesh-list
6093837|NCT00880685|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6093838|NCT00880685|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6093839|NCT00880685|Dopamine Agents|dopamine agents|mesh-ancestor
6093840|NCT00880685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6093841|NCT00880685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093842|NCT00880685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093843|NCT00880685|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6093844|NCT00880685|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6093845|NCT00880763|Interferons|interferons|mesh-list
6093846|NCT00880763|Ribavirin|ribavirin|mesh-list
6093847|NCT00880763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6093848|NCT00880763|Antiviral Agents|antiviral agents|mesh-ancestor
6093849|NCT00880763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6093850|NCT00880763|Antimetabolites|antimetabolites|mesh-ancestor
6093851|NCT00880763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093852|NCT00880893|Vaccines|vaccines|mesh-list
6093853|NCT00880893|Immunologic Factors|immunologic factors|mesh-ancestor
6093854|NCT00880893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093855|NCT00880906|Fluticasone|fluticasone|mesh-list
6093856|NCT00880906|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
6093857|NCT00880906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6093858|NCT00880906|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6093859|NCT00880906|Autonomic Agents|autonomic agents|mesh-ancestor
6093860|NCT00880906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6093861|NCT00880906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093862|NCT00880906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6093863|NCT00880906|Respiratory System Agents|respiratory system agents|mesh-ancestor
6093864|NCT00880906|Dermatologic Agents|dermatologic agents|mesh-ancestor
6093865|NCT00880906|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6093866|NCT00880906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6093867|NCT00880906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093868|NCT00880919|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6093869|NCT00880919|Antidepressive Agents|antidepressive agents|mesh-ancestor
6093870|NCT00880919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6093871|NCT00880919|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6093872|NCT00880919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6093873|NCT00880919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6093874|NCT00880919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093875|NCT00880997|Doxazosin|doxazosin|mesh-list
6093876|NCT00880997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6093877|NCT00880997|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6093878|NCT00880997|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6093879|NCT00880997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6093880|NCT00880997|Adrenergic Agents|adrenergic agents|mesh-ancestor
6093881|NCT00880997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6093882|NCT00880997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093883|NCT00880997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093884|NCT00881504|Bevacizumab|bevacizumab|mesh-list
6093885|NCT00881504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6093886|NCT00881504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6093887|NCT00881504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6093888|NCT00881504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6093889|NCT00881504|Growth Substances|growth substances|mesh-ancestor
6093890|NCT00881504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093891|NCT00881504|Growth Inhibitors|growth inhibitors|mesh-ancestor
6093892|NCT00881530|Metformin|metformin|mesh-list
6093893|NCT00881530|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6093894|NCT00881530|Empagliflozin|empagliflozin|mesh-list
6093895|NCT00881530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6093896|NCT00881530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093897|NCT00881530|Incretins|incretins|mesh-ancestor
6093898|NCT00881530|Hormones|hormones|mesh-ancestor
6093899|NCT00881530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6093900|NCT00881530|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6093901|NCT00881530|Protease Inhibitors|protease inhibitors|mesh-ancestor
6093902|NCT00881530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6093903|NCT00881530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093904|NCT00881530|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6093905|NCT00881569|Efatutazone|efatutazone|mesh-list
6093906|NCT00881569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6093907|NCT00881621|Capecitabine|capecitabine|mesh-list
6093908|NCT00881621|Lapatinib|lapatinib|mesh-list
6093909|NCT00881621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6093910|NCT00881621|Antimetabolites|antimetabolites|mesh-ancestor
6093911|NCT00881621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093912|NCT00881621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6093913|NCT00881621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6093914|NCT00881621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6093915|NCT00881751|Bevacizumab|bevacizumab|mesh-list
6093916|NCT00881751|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6093917|NCT00881751|Sorafenib|sorafenib|mesh-list
6093918|NCT00881751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6093919|NCT00881751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6093920|NCT00881751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6093921|NCT00881751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6093922|NCT00881751|Growth Substances|growth substances|mesh-ancestor
6093923|NCT00881751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093924|NCT00881751|Growth Inhibitors|growth inhibitors|mesh-ancestor
6093925|NCT00881751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6093926|NCT00881751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6093927|NCT00881751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093928|NCT00881868|Clobetasol|clobetasol|mesh-list
6093929|NCT00881868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6093930|NCT00881868|Glucocorticoids|glucocorticoids|mesh-ancestor
6093931|NCT00881868|Hormones|hormones|mesh-ancestor
6093932|NCT00881868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6093933|NCT00881868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093934|NCT00881894|Rotigotine|rotigotine|mesh-list
6093935|NCT00881894|Dopamine Agonists|dopamine agonists|mesh-ancestor
6093936|NCT00881894|Dopamine Agents|dopamine agents|mesh-ancestor
6093937|NCT00881894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6093938|NCT00881894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093939|NCT00881894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093940|NCT00882102|Decitabine|decitabine|mesh-list
6093941|NCT00882102|Gemtuzumab|gemtuzumab|mesh-list
6093942|NCT00882102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6093943|NCT00882102|Antimetabolites|antimetabolites|mesh-ancestor
6093944|NCT00882102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093945|NCT00882102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6093946|NCT00882102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6093947|NCT00882102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6093948|NCT00882115|Sulforaphane|sulforaphane|mesh-list
6093949|NCT00882115|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6093950|NCT00882115|Protective Agents|protective agents|mesh-ancestor
6093951|NCT00882115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093952|NCT00882115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6093953|NCT00882206|Cytarabine|cytarabine|mesh-list
6093954|NCT00882206|Prednisone|prednisone|mesh-list
6093955|NCT00882206|Doxorubicin|doxorubicin|mesh-list
6093956|NCT00882206|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6093957|NCT00882206|Methotrexate|methotrexate|mesh-list
6093958|NCT00882206|Vincristine|vincristine|mesh-list
6093959|NCT00882206|Imatinib Mesylate|imatinib mesylate|mesh-list
6093960|NCT00882206|Decitabine|decitabine|mesh-list
6093961|NCT00882206|Asparaginase|asparaginase|mesh-list
6093962|NCT00882206|Vorinostat|vorinostat|mesh-list
6093963|NCT00882206|Pegaspargase|pegaspargase|mesh-list
6093964|NCT00882206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6093965|NCT00882206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6093966|NCT00882206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5520396|NCT04323956|Vincristine|vincristine|mesh-list
5520397|NCT04323956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5520398|NCT04323956|Antibodies|antibodies|mesh-list
5520399|NCT04323956|Immunoglobulins|immunoglobulins|mesh-list
5520400|NCT04323956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5520401|NCT04323956|Lenograstim|lenograstim|mesh-list
5520402|NCT04323956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5520403|NCT04323956|Immunologic Factors|immunologic factors|mesh-ancestor
5520404|NCT04323956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520405|NCT04323956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5520406|NCT04323956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5520407|NCT04323956|Alkylating Agents|alkylating agents|mesh-ancestor
6093967|NCT00882206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6093968|NCT00882206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6093969|NCT00882206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6093970|NCT00882206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6093971|NCT00882206|Glucocorticoids|glucocorticoids|mesh-ancestor
6093972|NCT00882206|Hormones|hormones|mesh-ancestor
6093973|NCT00882206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6093974|NCT00882206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6093975|NCT00882206|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6093976|NCT00882206|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6093977|NCT00882206|Abortifacient Agents|abortifacient agents|mesh-ancestor
5520408|NCT04323956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520409|NCT04323956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5520410|NCT04323956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5520411|NCT04323956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5520412|NCT04323956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5520413|NCT04323956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5520414|NCT04323956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5520415|NCT04323956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5520416|NCT04323956|Glucocorticoids|glucocorticoids|mesh-ancestor
5520417|NCT04323956|Hormones|hormones|mesh-ancestor
5520418|NCT04323956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5520419|NCT04323956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5520420|NCT04323956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5520421|NCT04323956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5520422|NCT04323956|Tubulin Modulators|tubulin modulators|mesh-ancestor
5520423|NCT04323956|Antimitotic Agents|antimitotic agents|mesh-ancestor
5520424|NCT04323956|Mitosis Modulators|mitosis modulators|mesh-ancestor
5520425|NCT04323566|Rituximab|rituximab|mesh-list
5520426|NCT04323566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5520427|NCT04323566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5520428|NCT04323566|Immunologic Factors|immunologic factors|mesh-ancestor
5520429|NCT04323566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520430|NCT04323566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6093978|NCT00882206|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5520431|NCT04323761|Remdesivir|remdesivir|mesh-list
5520432|NCT04323761|Antimetabolites|antimetabolites|mesh-ancestor
5520433|NCT04323761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520434|NCT04323761|Antiviral Agents|antiviral agents|mesh-ancestor
5520435|NCT04323761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5520436|NCT04323657|Cyclophosphamide|cyclophosphamide|mesh-list
5520437|NCT04323657|Fludarabine|fludarabine|mesh-list
5520438|NCT04323657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5520439|NCT04323657|Immunologic Factors|immunologic factors|mesh-ancestor
5520440|NCT04323657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520441|NCT04323657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6093979|NCT00882206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6093980|NCT00882206|Antimetabolites|antimetabolites|mesh-ancestor
6093981|NCT00882206|Dermatologic Agents|dermatologic agents|mesh-ancestor
6093982|NCT00882206|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6093983|NCT00882206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6093984|NCT00882206|Immunologic Factors|immunologic factors|mesh-ancestor
6093985|NCT00882206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6093986|NCT00882206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6093987|NCT00882206|Antiviral Agents|antiviral agents|mesh-ancestor
6093988|NCT00882206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6093989|NCT00882206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6093990|NCT00882206|Tubulin Modulators|tubulin modulators|mesh-ancestor
6093991|NCT00882206|Antimitotic Agents|antimitotic agents|mesh-ancestor
6093992|NCT00882206|Mitosis Modulators|mitosis modulators|mesh-ancestor
6093993|NCT00882206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6093994|NCT00882206|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6093995|NCT00882362|Aripiprazole|aripiprazole|mesh-list
6093996|NCT00882362|Antidepressive Agents|antidepressive agents|mesh-ancestor
6093997|NCT00882362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6093998|NCT00882362|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6093999|NCT00882362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6094000|NCT00882362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6094001|NCT00882362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094002|NCT00882362|Dopamine Agonists|dopamine agonists|mesh-ancestor
6094003|NCT00882362|Dopamine Agents|dopamine agents|mesh-ancestor
6094004|NCT00882362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6094005|NCT00882362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094006|NCT00882362|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6094007|NCT00882362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6094008|NCT00882362|Serotonin Agents|serotonin agents|mesh-ancestor
6094009|NCT00882362|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6094010|NCT00882362|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6094011|NCT00882362|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5520442|NCT04323657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5520443|NCT04323657|Alkylating Agents|alkylating agents|mesh-ancestor
5520444|NCT04323657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520445|NCT04323657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5520446|NCT04323657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5520447|NCT04323527|Chloroquine|chloroquine|mesh-list
5520448|NCT04323527|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
5520449|NCT04323527|Amebicides|amebicides|mesh-ancestor
5520450|NCT04323527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5520451|NCT04323527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5520452|NCT04323527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5520453|NCT04323527|Antimalarials|antimalarials|mesh-ancestor
5520454|NCT04323527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5520455|NCT04323527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5520456|NCT04323527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5520457|NCT04323527|Analgesics|analgesics|mesh-ancestor
6094012|NCT00882362|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6094013|NCT00882518|Chlorpromazine|chlorpromazine|mesh-list
6094014|NCT00882518|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6094015|NCT00882518|Antidepressive Agents|antidepressive agents|mesh-ancestor
6094016|NCT00882518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6094017|NCT00882518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6094018|NCT00882518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6094019|NCT00882518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6094020|NCT00882518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094021|NCT00882518|Antiemetics|antiemetics|mesh-ancestor
6094022|NCT00882518|Autonomic Agents|autonomic agents|mesh-ancestor
6094023|NCT00882518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6094024|NCT00882518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6094025|NCT00882518|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6094026|NCT00882518|Dopamine Agents|dopamine agents|mesh-ancestor
5520458|NCT04323527|Sensory System Agents|sensory system agents|mesh-ancestor
6094027|NCT00882518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6094028|NCT00882518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094029|NCT00882557|Daptomycin|daptomycin|mesh-list
6094030|NCT00882557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6094031|NCT00882557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6094032|NCT00882583|Cisplatin|cisplatin|mesh-list
6094033|NCT00882583|Cetuximab|cetuximab|mesh-list
6094034|NCT00882583|Dasatinib|dasatinib|mesh-list
6094035|NCT00882583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6094036|NCT00882583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6094037|NCT00882583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6094038|NCT00882583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6094039|NCT00882583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094040|NCT00882687|Lifitegrast|lifitegrast|mesh-list
6094041|NCT00882687|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6094042|NCT00882687|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6094043|NCT00882713|Epoetin Alfa|epoetin alfa|mesh-list
6094044|NCT00882713|Hematinics|hematinics|mesh-ancestor
6094045|NCT00882908|Ribavirin|ribavirin|mesh-list
6094046|NCT00882908|Simeprevir|simeprevir|mesh-list
6094047|NCT00882908|Antimetabolites|antimetabolites|mesh-ancestor
6094048|NCT00882908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094049|NCT00882908|Antiviral Agents|antiviral agents|mesh-ancestor
6094050|NCT00882908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6094051|NCT00882908|Protease Inhibitors|protease inhibitors|mesh-ancestor
6094052|NCT00882908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6094053|NCT00883051|Lasmiditan|lasmiditan|mesh-list
6094054|NCT00883051|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6094055|NCT00883051|Serotonin Agents|serotonin agents|mesh-ancestor
6094056|NCT00883051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6094057|NCT00883051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094058|NCT00883051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094059|NCT00883090|Fibrinolysin|fibrinolysin|mesh-list
6094060|NCT00883090|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6094061|NCT00883090|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6094062|NCT00883090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094063|NCT00883103|Lidocaine|lidocaine|mesh-list
6094064|NCT00883103|Anesthetics, Local|anesthetics, local|mesh-ancestor
6094065|NCT00883103|Anesthetics|anesthetics|mesh-ancestor
6094066|NCT00883103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6094067|NCT00883103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094068|NCT00883103|Sensory System Agents|sensory system agents|mesh-ancestor
6094069|NCT00883103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6094070|NCT00883103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6094071|NCT00883103|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6094072|NCT00883103|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6094073|NCT00883103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6094074|NCT00883103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094075|NCT00883116|Paclitaxel|paclitaxel|mesh-list
6094076|NCT00883116|Doxorubicin|doxorubicin|mesh-list
6094077|NCT00883116|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6094078|NCT00883116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6094079|NCT00883116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6094080|NCT00883116|Tubulin Modulators|tubulin modulators|mesh-ancestor
5520459|NCT04323527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5520460|NCT04323527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520461|NCT04323527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5520462|NCT04323527|Filaricides|filaricides|mesh-ancestor
5520463|NCT04323527|Antinematodal Agents|antinematodal agents|mesh-ancestor
5520464|NCT04323527|Anthelmintics|anthelmintics|mesh-ancestor
5520465|NCT04323514|Ascorbic Acid|ascorbic acid|mesh-list
5520466|NCT04323514|Vitamins|vitamins|mesh-ancestor
5520467|NCT04323514|Micronutrients|micronutrients|mesh-ancestor
5520468|NCT04323514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520469|NCT04323514|Antioxidants|antioxidants|mesh-ancestor
5520470|NCT04323514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520471|NCT04323514|Protective Agents|protective agents|mesh-ancestor
5600918|NCT03708848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5600919|NCT03708848|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5600920|NCT03708848|Renal Agents|renal agents|mesh-ancestor
5600921|NCT03708848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5600922|NCT03708848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5600923|NCT03708848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5600924|NCT03708848|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5600925|NCT03708848|Antacids|antacids|mesh-ancestor
5600926|NCT03708848|Diuretics|diuretics|mesh-ancestor
6094081|NCT00883116|Antimitotic Agents|antimitotic agents|mesh-ancestor
6094082|NCT00883116|Mitosis Modulators|mitosis modulators|mesh-ancestor
6094083|NCT00883116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094084|NCT00883116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6094085|NCT00883116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6094086|NCT00883116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6464501|NCT00469781|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6464502|NCT00469781|Protective Agents|protective agents|mesh-ancestor
5520472|NCT04323631|Hydroxychloroquine|hydroxychloroquine|mesh-list
5520473|NCT04323631|Antimalarials|antimalarials|mesh-ancestor
5520474|NCT04323631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5520475|NCT04323631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5520476|NCT04323631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5520477|NCT04323631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5520478|NCT04323631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6464503|NCT00469781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6464504|NCT00469781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6464505|NCT00469846|Ascorbic Acid|ascorbic acid|mesh-list
6464506|NCT00469846|Vitamins|vitamins|mesh-ancestor
6464507|NCT00469846|Micronutrients|micronutrients|mesh-ancestor
6464508|NCT00469846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520479|NCT04323631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5520480|NCT04322955|Nivolumab|nivolumab|mesh-list
5520481|NCT04322955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5520482|NCT04322955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5520483|NCT04322955|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5520484|NCT04322955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520485|NCT04323280|Dexamethasone|dexamethasone|mesh-list
5520486|NCT04323280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5520487|NCT04323280|Antiemetics|antiemetics|mesh-ancestor
5520488|NCT04323280|Autonomic Agents|autonomic agents|mesh-ancestor
5520489|NCT04323280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5520490|NCT04323280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520491|NCT04323280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6464509|NCT00469846|Antioxidants|antioxidants|mesh-ancestor
6464510|NCT00469846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094087|NCT00883116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6094088|NCT00883129|Mycophenolic Acid|mycophenolic acid|mesh-list
6094089|NCT00883129|Cyclophosphamide|cyclophosphamide|mesh-list
6094090|NCT00883129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5520492|NCT04323280|Glucocorticoids|glucocorticoids|mesh-ancestor
5520493|NCT04323280|Hormones|hormones|mesh-ancestor
5520494|NCT04323280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6094091|NCT00883129|Immunologic Factors|immunologic factors|mesh-ancestor
6094092|NCT00883129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094093|NCT00883129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6094094|NCT00883129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6094095|NCT00883129|Alkylating Agents|alkylating agents|mesh-ancestor
6094096|NCT00883129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094097|NCT00883129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6094098|NCT00883129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6094099|NCT00883129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6094100|NCT00883129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6094101|NCT00883129|Antitubercular Agents|antitubercular agents|mesh-ancestor
6094102|NCT00883129|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6094103|NCT00883129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6094104|NCT00883129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6094105|NCT00883168|Fluticasone|fluticasone|mesh-list
6094106|NCT00883168|Xhance|xhance|mesh-list
6094107|NCT00883168|Azelastine|azelastine|mesh-list
6094108|NCT00883168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6094109|NCT00883168|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6094110|NCT00883168|Autonomic Agents|autonomic agents|mesh-ancestor
6094111|NCT00883168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6094112|NCT00883168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094113|NCT00883168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5520495|NCT04323280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5520496|NCT04323280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5520497|NCT04323228|Antioxidants|antioxidants|mesh-list
6094114|NCT00883168|Respiratory System Agents|respiratory system agents|mesh-ancestor
6094115|NCT00883168|Dermatologic Agents|dermatologic agents|mesh-ancestor
6094116|NCT00883168|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6094117|NCT00883168|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6094118|NCT00883168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6094119|NCT00883168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094120|NCT00883168|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6094121|NCT00883168|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6094122|NCT00883168|Histamine Antagonists|histamine antagonists|mesh-ancestor
6094123|NCT00883168|Histamine Agents|histamine agents|mesh-ancestor
6094124|NCT00883168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6094125|NCT00883233|Adapalene|adapalene|mesh-list
6094126|NCT00883233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6094127|NCT00883233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6094128|NCT00883233|Analgesics|analgesics|mesh-ancestor
6094129|NCT00883233|Sensory System Agents|sensory system agents|mesh-ancestor
6094130|NCT00883233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6094131|NCT00883233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094132|NCT00883233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6094133|NCT00883233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6094134|NCT00883233|Dermatologic Agents|dermatologic agents|mesh-ancestor
6094135|NCT00883337|Interferons|interferons|mesh-list
6094136|NCT00883337|Interferon-beta|interferon-beta|mesh-list
6094137|NCT00883337|Interferon beta-1a|interferon beta-1a|mesh-list
6094138|NCT00883337|Teriflunomide|teriflunomide|mesh-list
6094139|NCT00883337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6094140|NCT00883337|Antiviral Agents|antiviral agents|mesh-ancestor
6094141|NCT00883337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5520498|NCT04323228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520499|NCT04323228|Protective Agents|protective agents|mesh-ancestor
5520500|NCT04323228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520501|NCT04323202|Pembrolizumab|pembrolizumab|mesh-list
5520502|NCT04323202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5520503|NCT04323202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5520504|NCT04322760|Lidocaine|lidocaine|mesh-list
5520505|NCT04322760|Dexmedetomidine|dexmedetomidine|mesh-list
6094142|NCT00883337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6094143|NCT00883337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6094144|NCT00883337|Analgesics|analgesics|mesh-ancestor
6094145|NCT00883337|Sensory System Agents|sensory system agents|mesh-ancestor
6094146|NCT00883337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6094147|NCT00883337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094148|NCT00883337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6094149|NCT00883337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6094150|NCT00883337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6094151|NCT00883337|Immunologic Factors|immunologic factors|mesh-ancestor
6094152|NCT00883337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6094153|NCT00883415|Darbepoetin alfa|darbepoetin alfa|mesh-list
5520506|NCT04322760|Bupivacaine|bupivacaine|mesh-list
5520507|NCT04322760|Anesthetics, Local|anesthetics, local|mesh-ancestor
5520508|NCT04322760|Anesthetics|anesthetics|mesh-ancestor
5520509|NCT04322760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5520510|NCT04322760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520511|NCT04322760|Sensory System Agents|sensory system agents|mesh-ancestor
5520512|NCT04322760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5520513|NCT04322760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5520514|NCT04322760|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5520515|NCT04322760|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5520516|NCT04322760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5520517|NCT04322760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520518|NCT04322760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5520519|NCT04322760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5520520|NCT04322760|Analgesics|analgesics|mesh-ancestor
5520521|NCT04322760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6094154|NCT00883415|Hematinics|hematinics|mesh-ancestor
6094155|NCT00883493|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6094156|NCT00883493|Lithium Carbonate|lithium carbonate|mesh-list
6094157|NCT00883493|Antidepressive Agents|antidepressive agents|mesh-ancestor
6094158|NCT00883493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6094159|NCT00883493|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6094160|NCT00883493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6094161|NCT00883493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5520522|NCT04322760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5520523|NCT04322760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5520524|NCT04322760|Adrenergic Agents|adrenergic agents|mesh-ancestor
5520525|NCT04322760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5520526|NCT04322565|Colchicine|colchicine|mesh-list
5520527|NCT04322565|Gout Suppressants|gout suppressants|mesh-ancestor
5520528|NCT04322565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5520529|NCT04322565|Tubulin Modulators|tubulin modulators|mesh-ancestor
5520530|NCT04322565|Antimitotic Agents|antimitotic agents|mesh-ancestor
6094162|NCT00883493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094163|NCT00883493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6094164|NCT00883493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094165|NCT00883493|Antimanic Agents|antimanic agents|mesh-ancestor
6203466|NCT02057549|Dopamine Agents|dopamine agents|mesh-ancestor
6203467|NCT02057549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6203468|NCT02057549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203469|NCT02057549|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6203470|NCT02057575|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6203471|NCT02057575|Latanoprost|latanoprost|mesh-list
6203472|NCT02057575|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6203473|NCT02057640|Dexamethasone|dexamethasone|mesh-list
6203474|NCT02057640|Ixazomib|ixazomib|mesh-list
6203475|NCT02057640|Panobinostat|panobinostat|mesh-list
6203476|NCT02057640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6203477|NCT02057640|Antiemetics|antiemetics|mesh-ancestor
6203478|NCT02057640|Autonomic Agents|autonomic agents|mesh-ancestor
6203479|NCT02057640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6203480|NCT02057640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203481|NCT02057640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6203482|NCT02057640|Glucocorticoids|glucocorticoids|mesh-ancestor
6203483|NCT02057640|Hormones|hormones|mesh-ancestor
6203484|NCT02057640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6203485|NCT02057640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6203486|NCT02057640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6203487|NCT02057640|Protease Inhibitors|protease inhibitors|mesh-ancestor
5520531|NCT04322565|Mitosis Modulators|mitosis modulators|mesh-ancestor
5520532|NCT04322565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520533|NCT04322565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6203488|NCT02057640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6203489|NCT02057640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203490|NCT02057640|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6203491|NCT02057757|Nitazoxanide|nitazoxanide|mesh-list
6203492|NCT02057757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5520534|NCT04322643|Pembrolizumab|pembrolizumab|mesh-list
5520535|NCT04322643|Nivolumab|nivolumab|mesh-list
5520536|NCT04322643|Durvalumab|durvalumab|mesh-list
5520537|NCT04322643|Avelumab|avelumab|mesh-list
5520538|NCT04322643|Atezolizumab|atezolizumab|mesh-list
5520539|NCT04322643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6203493|NCT02057757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6203494|NCT02057939|Leuprolide|leuprolide|mesh-list
6203495|NCT02057939|Androgens|androgens|mesh-list
6203496|NCT02057939|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6203497|NCT02057939|Fertility Agents|fertility agents|mesh-ancestor
6203498|NCT02057939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6203499|NCT02057939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203500|NCT02057939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6203501|NCT02057939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6203502|NCT02057939|Hormones|hormones|mesh-ancestor
6203503|NCT02057939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6203504|NCT02058095|Tadalafil|tadalafil|mesh-list
6203505|NCT02058095|Vasodilator Agents|vasodilator agents|mesh-ancestor
6203506|NCT02058095|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6203507|NCT02058095|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6203508|NCT02058095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6203509|NCT02058095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203510|NCT02058095|Urological Agents|urological agents|mesh-ancestor
6203511|NCT02058108|Telbivudine|telbivudine|mesh-list
6203512|NCT02058108|Antiviral Agents|antiviral agents|mesh-ancestor
6203513|NCT02058108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6203514|NCT02058108|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6203515|NCT02058108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6203516|NCT02058108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203517|NCT02058147|Insulin|insulin|mesh-list
5520540|NCT04322643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5520541|NCT04322643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5600927|NCT03708848|Natriuretic Agents|natriuretic agents|mesh-ancestor
6094166|NCT00883558|Insulin|insulin|mesh-list
6094167|NCT00883558|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6094168|NCT00883558|Insulin Glargine|insulin glargine|mesh-list
6094169|NCT00883558|Insulin Lispro|insulin lispro|mesh-list
6094170|NCT00883558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6094171|NCT00883558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094172|NCT00883675|Carboplatin|carboplatin|mesh-list
6094173|NCT00883675|Docetaxel|docetaxel|mesh-list
6094174|NCT00883675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6464511|NCT00469846|Protective Agents|protective agents|mesh-ancestor
6464512|NCT00469885|Nicotine|nicotine|mesh-list
6464513|NCT00469885|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6464514|NCT00469885|Autonomic Agents|autonomic agents|mesh-ancestor
6464515|NCT00469885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6464516|NCT00469885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464517|NCT00469885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6464518|NCT00469885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6464519|NCT00469885|Cholinergic Agents|cholinergic agents|mesh-ancestor
6094175|NCT00883675|Tubulin Modulators|tubulin modulators|mesh-ancestor
6094176|NCT00883675|Antimitotic Agents|antimitotic agents|mesh-ancestor
6094177|NCT00883675|Mitosis Modulators|mitosis modulators|mesh-ancestor
6094178|NCT00883675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094179|NCT00883688|Bevacizumab|bevacizumab|mesh-list
6094180|NCT00883688|Lapatinib|lapatinib|mesh-list
6094181|NCT00883688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6094182|NCT00883688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6094183|NCT00883688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6094184|NCT00883688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6094185|NCT00883688|Growth Substances|growth substances|mesh-ancestor
6094186|NCT00883688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094187|NCT00883688|Growth Inhibitors|growth inhibitors|mesh-ancestor
6094188|NCT00883688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6094189|NCT00883688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6094190|NCT00883688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094191|NCT00883740|Pregabalin|pregabalin|mesh-list
6094192|NCT00883740|Analgesics|analgesics|mesh-ancestor
6094193|NCT00883740|Sensory System Agents|sensory system agents|mesh-ancestor
6094194|NCT00883740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6094195|NCT00883740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094196|NCT00883740|Anticonvulsants|anticonvulsants|mesh-ancestor
6094197|NCT00883740|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6094198|NCT00883740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6094199|NCT00883740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094200|NCT00883740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6094201|NCT00883740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6094202|NCT00883740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6094203|NCT00883740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6094204|NCT00883740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6094205|NCT00883779|Gemcitabine|gemcitabine|mesh-list
6094206|NCT00883779|Carboplatin|carboplatin|mesh-list
6094207|NCT00883779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6094208|NCT00883779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6094209|NCT00883779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6094210|NCT00883779|Antimetabolites|antimetabolites|mesh-ancestor
6094211|NCT00883779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094212|NCT00883779|Antiviral Agents|antiviral agents|mesh-ancestor
6094213|NCT00883779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6094214|NCT00883779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6094215|NCT00883779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6094216|NCT00883779|Immunologic Factors|immunologic factors|mesh-ancestor
6094217|NCT00883779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094218|NCT00883779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6094219|NCT00884039|Hydrocortisone|hydrocortisone|mesh-list
6094220|NCT00884039|Anecortave|anecortave|mesh-list
6094221|NCT00884039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6094222|NCT00884039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6094223|NCT00884039|Growth Substances|growth substances|mesh-ancestor
6094224|NCT00884039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094225|NCT00884039|Growth Inhibitors|growth inhibitors|mesh-ancestor
6094226|NCT00884039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6094227|NCT00884039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6094228|NCT00884052|Levetiracetam|levetiracetam|mesh-list
6094229|NCT00884052|Anticonvulsants|anticonvulsants|mesh-ancestor
6094230|NCT00884052|Nootropic Agents|nootropic agents|mesh-ancestor
6094231|NCT00884117|Oseltamivir|oseltamivir|mesh-list
6094232|NCT00884117|Antiviral Agents|antiviral agents|mesh-ancestor
6094233|NCT00884117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6094234|NCT00884117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6094235|NCT00884117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094236|NCT00884221|Menotropins|menotropins|mesh-list
6094237|NCT00884221|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5520542|NCT04322643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520543|NCT04322552|Apatinib|apatinib|mesh-list
5520544|NCT04322552|Digoxin|digoxin|mesh-list
5520545|NCT04322552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5520546|NCT04322552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5520547|NCT04322552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5520548|NCT04322552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520549|NCT04322552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5520550|NCT04322552|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5520551|NCT04322552|Protective Agents|protective agents|mesh-ancestor
5520552|NCT04322552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520553|NCT04322786|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
5520554|NCT04322786|Protease Inhibitors|protease inhibitors|mesh-ancestor
5520555|NCT04322786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5520556|NCT04322786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520557|NCT04322422|Montelukast|montelukast|mesh-list
5520558|NCT04322422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5520559|NCT04322422|Respiratory System Agents|respiratory system agents|mesh-ancestor
5520560|NCT04322422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5520561|NCT04322422|Hormone Antagonists|hormone antagonists|mesh-ancestor
5520562|NCT04322422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5520563|NCT04322422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520564|NCT04322422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5520565|NCT04322422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5520566|NCT04322422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520567|NCT04322175|Meloxicam|meloxicam|mesh-list
5520568|NCT04322175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5520569|NCT04322175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5520570|NCT04322175|Analgesics|analgesics|mesh-ancestor
5520571|NCT04322175|Sensory System Agents|sensory system agents|mesh-ancestor
5520572|NCT04322175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5520573|NCT04322175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520574|NCT04322175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5520575|NCT04322175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5520576|NCT04322175|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5520577|NCT04322175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6094238|NCT00884221|Fertility Agents|fertility agents|mesh-ancestor
6094239|NCT00884221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6094240|NCT00884221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094241|NCT00884273|Goserelin|goserelin|mesh-list
6094242|NCT00884273|Bicalutamide|bicalutamide|mesh-list
6094243|NCT00884273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6094244|NCT00884273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6094245|NCT00884273|Androgen Antagonists|androgen antagonists|mesh-ancestor
6094246|NCT00884273|Hormone Antagonists|hormone antagonists|mesh-ancestor
6094247|NCT00884273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6094248|NCT00884273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094249|NCT00884325|Levocetirizine|levocetirizine|mesh-list
6094250|NCT00884325|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6094251|NCT00884325|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6094252|NCT00884325|Histamine Antagonists|histamine antagonists|mesh-ancestor
6094253|NCT00884325|Histamine Agents|histamine agents|mesh-ancestor
6094254|NCT00884325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6094255|NCT00884325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094256|NCT00884325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094257|NCT00884377|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
6094258|NCT00884377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6094259|NCT00884377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6094260|NCT00884377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6094261|NCT00884377|Schistosomicides|schistosomicides|mesh-ancestor
6094262|NCT00884377|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6094263|NCT00884377|Anthelmintics|anthelmintics|mesh-ancestor
6094264|NCT00884390|Factor VIII|factor viii|mesh-list
6094265|NCT00884390|Coagulants|coagulants|mesh-ancestor
6094266|NCT00884585|Cyclosporine|cyclosporine|mesh-list
6094267|NCT00884585|Cyclosporins|cyclosporins|mesh-list
6094268|NCT00884585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6094269|NCT00884585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094270|NCT00884585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5520578|NCT04322175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6094271|NCT00884585|Immunologic Factors|immunologic factors|mesh-ancestor
6094272|NCT00884585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094273|NCT00884585|Antifungal Agents|antifungal agents|mesh-ancestor
6094274|NCT00884585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6094275|NCT00884585|Dermatologic Agents|dermatologic agents|mesh-ancestor
6094276|NCT00884585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6094277|NCT00884585|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6094278|NCT00884650|Analgesics|analgesics|mesh-list
6094279|NCT00884650|Sensory System Agents|sensory system agents|mesh-ancestor
6094280|NCT00884650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6094281|NCT00884650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094282|NCT00884741|Bevacizumab|bevacizumab|mesh-list
5520579|NCT04322175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520580|NCT04322214|Cobicistat|cobicistat|mesh-list
5520581|NCT04322214|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5520582|NCT04322214|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5520583|NCT04322214|Antiviral Agents|antiviral agents|mesh-ancestor
6094283|NCT00884741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6094284|NCT00884741|Temozolomide|temozolomide|mesh-list
6094285|NCT00884741|Endothelial Growth Factors|endothelial growth factors|mesh-list
6094286|NCT00884741|Antibodies|antibodies|mesh-list
6094287|NCT00884741|Immunoglobulins|immunoglobulins|mesh-list
6094288|NCT00884741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6094289|NCT00884741|Immunoglobulin G|immunoglobulin g|mesh-list
6094290|NCT00884741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6094291|NCT00884741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6094292|NCT00884741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5520584|NCT04322214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5520585|NCT04322214|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5520586|NCT04322214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5520587|NCT04322214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5520588|NCT04322214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520589|NCT04322240|Thioctic Acid|thioctic acid|mesh-list
5520590|NCT04322240|Antioxidants|antioxidants|mesh-ancestor
6094293|NCT00884741|Growth Substances|growth substances|mesh-ancestor
6094294|NCT00884741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094295|NCT00884741|Growth Inhibitors|growth inhibitors|mesh-ancestor
6094296|NCT00884741|Immunologic Factors|immunologic factors|mesh-ancestor
6094297|NCT00884741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6094298|NCT00884741|Alkylating Agents|alkylating agents|mesh-ancestor
6094299|NCT00884741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094300|NCT00884793|Ritonavir|ritonavir|mesh-list
6094301|NCT00884793|Lopinavir|lopinavir|mesh-list
6094302|NCT00884793|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6094303|NCT00884793|Fosamprenavir|fosamprenavir|mesh-list
6094304|NCT00884793|Raltegravir Potassium|raltegravir potassium|mesh-list
5520591|NCT04322240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520592|NCT04322240|Protective Agents|protective agents|mesh-ancestor
5520593|NCT04322240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520594|NCT04322240|Vitamin B Complex|vitamin b complex|mesh-ancestor
5520595|NCT04322240|Vitamins|vitamins|mesh-ancestor
5520596|NCT04322240|Micronutrients|micronutrients|mesh-ancestor
5520597|NCT04322123|Azithromycin|azithromycin|mesh-list
5520598|NCT04322123|Hydroxychloroquine|hydroxychloroquine|mesh-list
5520599|NCT04322123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6094305|NCT00884793|Efavirenz|efavirenz|mesh-list
6094306|NCT00884793|Etravirine|etravirine|mesh-list
6094307|NCT00884793|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6094308|NCT00884793|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6094309|NCT00884793|Protease Inhibitors|protease inhibitors|mesh-ancestor
6094310|NCT00884793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6094311|NCT00884793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094312|NCT00884793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6094313|NCT00884793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6094314|NCT00884793|Antiviral Agents|antiviral agents|mesh-ancestor
6094315|NCT00884793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6094316|NCT00884793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6094317|NCT00884793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6094318|NCT00884793|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6094319|NCT00884793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6094320|NCT00884793|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6094321|NCT00884793|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6094322|NCT00884793|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6094323|NCT00884793|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5520600|NCT04322123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6094324|NCT00884793|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6094325|NCT00884793|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6094326|NCT00884793|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5520601|NCT04322123|Antimalarials|antimalarials|mesh-ancestor
5520602|NCT04322123|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5520603|NCT04322123|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5520604|NCT04322123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5520605|NCT04322123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520606|NCT04322123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5520607|NCT04322305|Pregabalin|pregabalin|mesh-list
5520608|NCT04322305|Analgesics|analgesics|mesh-ancestor
5520609|NCT04322305|Sensory System Agents|sensory system agents|mesh-ancestor
5520610|NCT04322305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6094327|NCT00884832|Clonidine|clonidine|mesh-list
6094328|NCT00884832|Analgesics|analgesics|mesh-ancestor
6094329|NCT00884832|Sensory System Agents|sensory system agents|mesh-ancestor
6094330|NCT00884832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6094331|NCT00884832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094332|NCT00884832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6094333|NCT00884832|Sympatholytics|sympatholytics|mesh-ancestor
6094334|NCT00884832|Autonomic Agents|autonomic agents|mesh-ancestor
6094335|NCT00884832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6094336|NCT00884832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6094337|NCT00884832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6094338|NCT00884832|Adrenergic Agents|adrenergic agents|mesh-ancestor
6094339|NCT00884832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6094340|NCT00884832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094341|NCT00884897|Oxytocin|oxytocin|mesh-list
6094342|NCT00884897|Oxytocics|oxytocics|mesh-ancestor
6094343|NCT00884897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6094344|NCT00884897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094345|NCT00885079|Rebamipide|rebamipide|mesh-list
6094346|NCT00885079|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6094347|NCT00885079|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6094348|NCT00885079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6094349|NCT00885079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6094350|NCT00885079|Antioxidants|antioxidants|mesh-ancestor
6094351|NCT00885079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094352|NCT00885079|Protective Agents|protective agents|mesh-ancestor
6094353|NCT00885079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094354|NCT00885079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6094355|NCT00885092|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5520611|NCT04322305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520612|NCT04322305|Anticonvulsants|anticonvulsants|mesh-ancestor
5520613|NCT04322305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5520614|NCT04322305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5520615|NCT04322305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520616|NCT04322305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5520617|NCT04322305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5520618|NCT04322305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5520619|NCT04322305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5520620|NCT04322305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5520621|NCT04321993|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
5520622|NCT04321993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5520623|NCT04321993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5520624|NCT04321993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520625|NCT04321967|Nitroglycerin|nitroglycerin|mesh-list
5520626|NCT04321967|Vasodilator Agents|vasodilator agents|mesh-ancestor
5520627|NCT04321785|Caffeine|caffeine|mesh-list
5520628|NCT04321785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5520629|NCT04321785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520630|NCT04321785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5520631|NCT04321785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5520632|NCT04321785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520633|NCT04321785|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5520634|NCT04321785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5520635|NCT04321785|Purinergic Agents|purinergic agents|mesh-ancestor
5520636|NCT04321785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5520637|NCT04321694|Mogamulizumab|mogamulizumab|mesh-list
5520638|NCT04321694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5520639|NCT04321655|Ibuprofen|ibuprofen|mesh-list
6094356|NCT00885105|Vaccines|vaccines|mesh-list
6094357|NCT00885105|Immunologic Factors|immunologic factors|mesh-ancestor
6094358|NCT00885105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464520|NCT00469885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6094359|NCT00885118|Empagliflozin|empagliflozin|mesh-list
6094360|NCT00885118|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6094361|NCT00885118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094362|NCT00885118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6094363|NCT00885118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094364|NCT00885170|Vitamin D|vitamin d|mesh-list
6094365|NCT00885170|Cholecalciferol|cholecalciferol|mesh-list
6094366|NCT00885170|Calcium|calcium|mesh-list
6094367|NCT00885170|Vitamins|vitamins|mesh-ancestor
6094368|NCT00885170|Micronutrients|micronutrients|mesh-ancestor
6094369|NCT00885170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094370|NCT00885170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6094371|NCT00885170|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6094372|NCT00885352|Metformin|metformin|mesh-list
6094373|NCT00885352|Pioglitazone|pioglitazone|mesh-list
6094374|NCT00885352|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5520640|NCT04321655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5520641|NCT04321655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5520642|NCT04321655|Analgesics|analgesics|mesh-ancestor
5520643|NCT04321655|Sensory System Agents|sensory system agents|mesh-ancestor
5520644|NCT04321655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6094375|NCT00885352|Glipizide|glipizide|mesh-list
6094376|NCT00885352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6094377|NCT00885352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094378|NCT00885352|Incretins|incretins|mesh-ancestor
6094379|NCT00885352|Hormones|hormones|mesh-ancestor
6094380|NCT00885352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6094381|NCT00885352|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6094382|NCT00885352|Protease Inhibitors|protease inhibitors|mesh-ancestor
6094383|NCT00885352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6094384|NCT00885352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094385|NCT00885365|Tobramycin|tobramycin|mesh-list
6094386|NCT00885365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6094387|NCT00885365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6094388|NCT00885378|Metformin|metformin|mesh-list
6094389|NCT00885378|Saxagliptin|saxagliptin|mesh-list
6094390|NCT00885378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6094391|NCT00885378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094392|NCT00885378|Incretins|incretins|mesh-ancestor
6094393|NCT00885378|Hormones|hormones|mesh-ancestor
6094394|NCT00885378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6094395|NCT00885378|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6094396|NCT00885378|Protease Inhibitors|protease inhibitors|mesh-ancestor
6094397|NCT00885378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6094398|NCT00885378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094399|NCT00885482|Ritonavir|ritonavir|mesh-list
6094400|NCT00885482|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6094401|NCT00885482|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6094402|NCT00885482|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6094403|NCT00885482|Protease Inhibitors|protease inhibitors|mesh-ancestor
6094404|NCT00885482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6094405|NCT00885482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094406|NCT00885482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6094407|NCT00885482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6094408|NCT00885482|Antiviral Agents|antiviral agents|mesh-ancestor
6094409|NCT00885482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5520645|NCT04321655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520646|NCT04321655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5520647|NCT04321655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5520648|NCT04321655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5520649|NCT04321655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5520650|NCT04321655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094410|NCT00885482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6464521|NCT00469885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6464522|NCT00469924|Caffeine|caffeine|mesh-list
6464523|NCT00469924|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6464524|NCT00469924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464525|NCT00469924|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6464526|NCT00469924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6464527|NCT00469924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6464528|NCT00469924|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6464529|NCT00469924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6094411|NCT00885482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6094412|NCT00885534|Temozolomide|temozolomide|mesh-list
6094413|NCT00885534|Vinblastine|vinblastine|mesh-list
6094414|NCT00885534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6094415|NCT00885534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6094416|NCT00885534|Alkylating Agents|alkylating agents|mesh-ancestor
6094417|NCT00885534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094418|NCT00885534|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6094419|NCT00885534|Tubulin Modulators|tubulin modulators|mesh-ancestor
6094420|NCT00885534|Antimitotic Agents|antimitotic agents|mesh-ancestor
6094421|NCT00885534|Mitosis Modulators|mitosis modulators|mesh-ancestor
6094422|NCT00885638|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6094423|NCT00885638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6094424|NCT00885638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094425|NCT00885638|Incretins|incretins|mesh-ancestor
6094426|NCT00885638|Hormones|hormones|mesh-ancestor
6094427|NCT00885638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6094428|NCT00885638|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6094429|NCT00885638|Protease Inhibitors|protease inhibitors|mesh-ancestor
6094430|NCT00885638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6094431|NCT00885638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094432|NCT00885703|Fluconazole|fluconazole|mesh-list
6094433|NCT00885703|Amphotericin B|amphotericin b|mesh-list
6094434|NCT00885703|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6094435|NCT00885703|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
6094436|NCT00885703|Deoxycholic Acid|deoxycholic acid|mesh-list
6094437|NCT00885703|Antifungal Agents|antifungal agents|mesh-ancestor
6094438|NCT00885703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6094439|NCT00885703|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6094440|NCT00885703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6094441|NCT00885703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6094442|NCT00885703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094443|NCT00885703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6094444|NCT00885703|Hormone Antagonists|hormone antagonists|mesh-ancestor
6094445|NCT00885703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6094446|NCT00885703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094447|NCT00885703|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6094448|NCT00885703|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6094449|NCT00885703|Amebicides|amebicides|mesh-ancestor
6094450|NCT00885703|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6094451|NCT00885703|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6094452|NCT00885703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6094453|NCT00885703|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6094454|NCT00885703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6094455|NCT00885742|Fibrinolysin|fibrinolysin|mesh-list
6094456|NCT00885742|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6094457|NCT00885742|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6094458|NCT00885742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094459|NCT00885755|Capecitabine|capecitabine|mesh-list
6094460|NCT00885755|Trastuzumab|trastuzumab|mesh-list
6094461|NCT00885755|Taxane|taxane|mesh-list
5520651|NCT04321642|Nitrous Oxide|nitrous oxide|mesh-list
5520652|NCT04321642|Entonox|entonox|mesh-list
5520653|NCT04321642|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
5520654|NCT04321642|Anesthetics|anesthetics|mesh-ancestor
5520655|NCT04321642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5520656|NCT04321642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520657|NCT04321642|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5520658|NCT04321642|Anesthetics, General|anesthetics, general|mesh-ancestor
5520659|NCT04321642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5520660|NCT04321642|Analgesics|analgesics|mesh-ancestor
5520661|NCT04321642|Sensory System Agents|sensory system agents|mesh-ancestor
5520662|NCT04321642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5520663|NCT04321850|Zinc|zinc|mesh-list
5520664|NCT04321850|Zinc Sulfate|zinc sulfate|mesh-list
5520665|NCT04321850|Trace Elements|trace elements|mesh-ancestor
6094462|NCT00885755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6464530|NCT00469924|Purinergic Agents|purinergic agents|mesh-ancestor
6464531|NCT00469924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6464532|NCT00469937|Lithium Carbonate|lithium carbonate|mesh-list
6464533|NCT00469937|Antidepressive Agents|antidepressive agents|mesh-ancestor
6464534|NCT00469937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6464535|NCT00469937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6094463|NCT00885755|Antimetabolites|antimetabolites|mesh-ancestor
6094464|NCT00885755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094465|NCT00885755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6094466|NCT00885755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6094467|NCT00886236|Gabapentin|gabapentin|mesh-list
6094468|NCT00886236|Analgesics|analgesics|mesh-ancestor
6094469|NCT00886236|Sensory System Agents|sensory system agents|mesh-ancestor
6094470|NCT00886236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6094471|NCT00886236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094472|NCT00886236|Anticonvulsants|anticonvulsants|mesh-ancestor
6094473|NCT00886236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6094474|NCT00886236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6094475|NCT00886236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6094476|NCT00886236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6094477|NCT00886236|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6094478|NCT00886236|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6094479|NCT00886236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6094480|NCT00886236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094481|NCT00886236|Antimanic Agents|antimanic agents|mesh-ancestor
6094482|NCT00886262|Vasopressins|vasopressins|mesh-list
6094483|NCT00886262|Arginine Vasopressin|arginine vasopressin|mesh-list
6094484|NCT00886262|Hemostatics|hemostatics|mesh-ancestor
6094485|NCT00886262|Coagulants|coagulants|mesh-ancestor
6094486|NCT00886262|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6094487|NCT00886262|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6094488|NCT00886262|Natriuretic Agents|natriuretic agents|mesh-ancestor
6094489|NCT00886262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094490|NCT00886379|Vitamin D|vitamin d|mesh-list
6094491|NCT00886379|Ergocalciferols|ergocalciferols|mesh-list
6094492|NCT00886379|Vitamins|vitamins|mesh-list
6094493|NCT00886379|Micronutrients|micronutrients|mesh-ancestor
6094494|NCT00886379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094495|NCT00886379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6094496|NCT00886379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6094497|NCT00886613|Vaccines|vaccines|mesh-list
6094498|NCT00886613|Immunologic Factors|immunologic factors|mesh-ancestor
6094499|NCT00886613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094500|NCT00886626|Exenatide|exenatide|mesh-list
6094501|NCT00886626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6094502|NCT00886626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094503|NCT00886626|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6094504|NCT00886626|Incretins|incretins|mesh-ancestor
6094505|NCT00886626|Hormones|hormones|mesh-ancestor
6094506|NCT00886626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6094507|NCT00886743|Oprelvekin|oprelvekin|mesh-list
6094508|NCT00886743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6094509|NCT00886795|Abatacept|abatacept|mesh-list
5520666|NCT04321850|Micronutrients|micronutrients|mesh-ancestor
5520667|NCT04321850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520668|NCT04321850|Astringents|astringents|mesh-ancestor
5520669|NCT04321850|Dermatologic Agents|dermatologic agents|mesh-ancestor
5520670|NCT04321616|Hydroxychloroquine|hydroxychloroquine|mesh-list
5520671|NCT04321616|Remdesivir|remdesivir|mesh-list
5520672|NCT04321616|Antimalarials|antimalarials|mesh-ancestor
5520673|NCT04321616|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6094510|NCT00886795|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6094511|NCT00886795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094512|NCT00886795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6094513|NCT00886795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6094514|NCT00886795|Immunologic Factors|immunologic factors|mesh-ancestor
6094515|NCT00886795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094516|NCT00886795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6094517|NCT00886834|Misoprostol|misoprostol|mesh-list
6094518|NCT00886834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6094519|NCT00886834|Abortifacient Agents|abortifacient agents|mesh-ancestor
6094520|NCT00886834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6094521|NCT00886834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520674|NCT04321616|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5520675|NCT04321616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6094522|NCT00886834|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6094523|NCT00886834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5520676|NCT04321616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5520677|NCT04321616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520678|NCT04321616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5520679|NCT04321616|Antimetabolites|antimetabolites|mesh-ancestor
5520680|NCT04321616|Antiviral Agents|antiviral agents|mesh-ancestor
5520681|NCT04321720|Mechlorethamine|mechlorethamine|mesh-list
5520682|NCT04321720|Alkylating Agents|alkylating agents|mesh-ancestor
5520683|NCT04321720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520684|NCT04321720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5520685|NCT04321720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5600928|NCT03708848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600929|NCT03708848|Expectorants|expectorants|mesh-ancestor
5600930|NCT03708848|Respiratory System Agents|respiratory system agents|mesh-ancestor
5600931|NCT03708822|Docetaxel|docetaxel|mesh-list
6094524|NCT00886834|Oxytocics|oxytocics|mesh-ancestor
6094525|NCT00887068|Azacitidine|azacitidine|mesh-list
6094526|NCT00887068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6094527|NCT00887068|Antimetabolites|antimetabolites|mesh-ancestor
6094528|NCT00887068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094529|NCT00887068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6094530|NCT00887068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6094531|NCT00887159|Cisplatin|cisplatin|mesh-list
6094532|NCT00887159|Etoposide|etoposide|mesh-list
6094533|NCT00887159|Etoposide phosphate|etoposide phosphate|mesh-list
6094534|NCT00887159|Podophyllotoxin|podophyllotoxin|mesh-list
6094535|NCT00887159|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6094536|NCT00887159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6094537|NCT00887159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6094538|NCT00887159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6094539|NCT00887159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6094540|NCT00887159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6094541|NCT00887159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094542|NCT00887159|Keratolytic Agents|keratolytic agents|mesh-ancestor
6094543|NCT00887159|Dermatologic Agents|dermatologic agents|mesh-ancestor
6094544|NCT00887159|Tubulin Modulators|tubulin modulators|mesh-ancestor
6094545|NCT00887159|Antimitotic Agents|antimitotic agents|mesh-ancestor
6094546|NCT00887159|Mitosis Modulators|mitosis modulators|mesh-ancestor
6094547|NCT00887159|Immunologic Factors|immunologic factors|mesh-ancestor
6094548|NCT00887159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094549|NCT00887198|Prednisone|prednisone|mesh-list
6094550|NCT00887198|Abiraterone Acetate|abiraterone acetate|mesh-list
6094551|NCT00887198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6094552|NCT00887198|Glucocorticoids|glucocorticoids|mesh-ancestor
6094553|NCT00887198|Hormones|hormones|mesh-ancestor
6094554|NCT00887198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6094555|NCT00887198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094556|NCT00887198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6094557|NCT00887198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5600932|NCT03708822|Nimotuzumab|nimotuzumab|mesh-list
5600933|NCT03708822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5600934|NCT03708822|Tubulin Modulators|tubulin modulators|mesh-ancestor
5600935|NCT03708822|Antimitotic Agents|antimitotic agents|mesh-ancestor
5725211|NCT03182192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6094558|NCT00887198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6094559|NCT00887198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6203518|NCT02058147|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5725212|NCT03181880|Bromides|bromides|mesh-list
5725213|NCT03181880|Formoterol Fumarate|formoterol fumarate|mesh-list
5725214|NCT03181880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5725215|NCT03181880|Autonomic Agents|autonomic agents|mesh-ancestor
5725216|NCT03181880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5725217|NCT03181880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725218|NCT03181880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5725219|NCT03181880|Respiratory System Agents|respiratory system agents|mesh-ancestor
5725220|NCT03181880|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5725221|NCT03181880|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5725222|NCT03181880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5725223|NCT03181880|Adrenergic Agents|adrenergic agents|mesh-ancestor
5725224|NCT03181880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5725225|NCT03181880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725226|NCT03181880|Anticonvulsants|anticonvulsants|mesh-ancestor
5725227|NCT03182114|Bupivacaine|bupivacaine|mesh-list
5725228|NCT03182114|Anesthetics, Local|anesthetics, local|mesh-ancestor
5725229|NCT03182114|Anesthetics|anesthetics|mesh-ancestor
5725230|NCT03182114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5520686|NCT04321837|Vitamin D|vitamin d|mesh-list
5520687|NCT04321837|Cholecalciferol|cholecalciferol|mesh-list
5520688|NCT04321837|Ibandronic Acid|ibandronic acid|mesh-list
5520689|NCT04321837|Vitamins|vitamins|mesh-ancestor
5520690|NCT04321837|Micronutrients|micronutrients|mesh-ancestor
5520691|NCT04321837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094560|NCT00887198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094561|NCT00887198|Hormone Antagonists|hormone antagonists|mesh-ancestor
6094562|NCT00887198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6094563|NCT00887224|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6094564|NCT00887224|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6094565|NCT00887224|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6094566|NCT00887224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6094567|NCT00887224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094568|NCT00887224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6094569|NCT00887224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094570|NCT00887224|Antidepressive Agents|antidepressive agents|mesh-ancestor
6094571|NCT00887224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6094572|NCT00887354|Vitamin D|vitamin d|mesh-list
6094573|NCT00887354|Teriparatide|teriparatide|mesh-list
6094574|NCT00887354|Risedronic Acid|risedronic acid|mesh-list
6094575|NCT00887354|Calcium|calcium|mesh-list
6094576|NCT00887354|Vitamins|vitamins|mesh-ancestor
6094577|NCT00887354|Micronutrients|micronutrients|mesh-ancestor
6094578|NCT00887354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094579|NCT00887354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6094580|NCT00887354|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5520692|NCT04321837|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5520693|NCT04321837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5520694|NCT04321668|Hylan|hylan|mesh-list
5520695|NCT04321668|Viscosupplements|viscosupplements|mesh-ancestor
5520696|NCT04321668|Protective Agents|protective agents|mesh-ancestor
5520697|NCT04321668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520698|NCT04321551|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5520699|NCT04321551|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5520700|NCT04321551|Hormones|hormones|mesh-list
5520701|NCT04321551|Estradiol|estradiol|mesh-list
5520702|NCT04321551|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5520703|NCT04321551|Progesterone|progesterone|mesh-list
5520704|NCT04321551|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5520705|NCT04321551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5520706|NCT04321551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520707|NCT04321551|Estrogens|estrogens|mesh-ancestor
5520708|NCT04321551|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5520709|NCT04321551|Contraceptive Agents|contraceptive agents|mesh-ancestor
5520710|NCT04321551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5520711|NCT04321551|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5520712|NCT04321551|Progestins|progestins|mesh-ancestor
5520713|NCT04321746|Ketamine|ketamine|mesh-list
5520714|NCT04321746|Analgesics|analgesics|mesh-ancestor
5520715|NCT04321746|Sensory System Agents|sensory system agents|mesh-ancestor
5520716|NCT04321746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5520717|NCT04321746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520718|NCT04321746|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5725231|NCT03182114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725232|NCT03182114|Sensory System Agents|sensory system agents|mesh-ancestor
5725233|NCT03182114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5725234|NCT03181763|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
5725235|NCT03181763|Hallucinogens|hallucinogens|mesh-ancestor
5725236|NCT03181763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725237|NCT03181763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5725238|NCT03181763|Serotonin Agents|serotonin agents|mesh-ancestor
5725239|NCT03181763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5725240|NCT03181763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094581|NCT00887354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6094582|NCT00887354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6094583|NCT00887354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094584|NCT00887432|Vitamin D|vitamin d|mesh-list
6094585|NCT00887432|Cholecalciferol|cholecalciferol|mesh-list
6094586|NCT00887432|Vitamins|vitamins|mesh-ancestor
6094587|NCT00887432|Micronutrients|micronutrients|mesh-ancestor
6094588|NCT00887432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094589|NCT00887432|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6094590|NCT00887432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6094591|NCT00887458|Itraconazole|itraconazole|mesh-list
6094592|NCT00887458|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
6094593|NCT00887458|Antifungal Agents|antifungal agents|mesh-ancestor
5520719|NCT04321746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5520720|NCT04321746|Anesthetics, General|anesthetics, general|mesh-ancestor
5520721|NCT04321746|Anesthetics|anesthetics|mesh-ancestor
5520722|NCT04321746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5520723|NCT04321746|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5520724|NCT04321746|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5520725|NCT04321746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5520726|NCT04321746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520727|NCT04321408|Ziconotide|ziconotide|mesh-list
5520728|NCT04321408|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5520729|NCT04321408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5520730|NCT04321408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520731|NCT04321408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5520732|NCT04321408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520733|NCT04321408|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5520734|NCT04321408|Protective Agents|protective agents|mesh-ancestor
5520735|NCT04321408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5520736|NCT04321408|Analgesics|analgesics|mesh-ancestor
5520737|NCT04321408|Sensory System Agents|sensory system agents|mesh-ancestor
5520738|NCT04321408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6094594|NCT00887458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6094595|NCT00887458|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6094596|NCT00887458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6094597|NCT00887458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6094598|NCT00887458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094599|NCT00887458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6094600|NCT00887458|Hormone Antagonists|hormone antagonists|mesh-ancestor
6094601|NCT00887458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6094602|NCT00887458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094603|NCT00887458|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6094604|NCT00887484|Clindamycin|clindamycin|mesh-list
6094605|NCT00887484|Clindamycin palmitate|clindamycin palmitate|mesh-list
6094606|NCT00887484|Clindamycin phosphate|clindamycin phosphate|mesh-list
6094607|NCT00887484|Adapalene|adapalene|mesh-list
6094608|NCT00887484|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6094609|NCT00887484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6094610|NCT00887484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6094611|NCT00887484|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6094612|NCT00887484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6094613|NCT00887484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094614|NCT00887484|Dermatologic Agents|dermatologic agents|mesh-ancestor
6094615|NCT00887484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6094616|NCT00887484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5520739|NCT04321395|Vigabatrin|vigabatrin|mesh-list
5520740|NCT04321395|Anticonvulsants|anticonvulsants|mesh-ancestor
5520741|NCT04321395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5520742|NCT04321395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520743|NCT04321395|GABA Agents|gaba agents|mesh-ancestor
5520744|NCT04321395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5520745|NCT04321395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520746|NCT04321278|Azithromycin|azithromycin|mesh-list
5520747|NCT04321278|Hydroxychloroquine|hydroxychloroquine|mesh-list
6094617|NCT00887484|Analgesics|analgesics|mesh-ancestor
6094618|NCT00887484|Sensory System Agents|sensory system agents|mesh-ancestor
6094619|NCT00887484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6094620|NCT00887484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094621|NCT00887484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6094622|NCT00887484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6094623|NCT00887510|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6094624|NCT00887510|Trandolapril|trandolapril|mesh-list
6094625|NCT00887510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6094626|NCT00887510|Diuretics|diuretics|mesh-ancestor
6094627|NCT00887510|Natriuretic Agents|natriuretic agents|mesh-ancestor
6094628|NCT00887510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094629|NCT00887510|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6094630|NCT00887510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6094631|NCT00887510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094632|NCT00887510|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6094633|NCT00887510|Protease Inhibitors|protease inhibitors|mesh-ancestor
6094634|NCT00887510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6094635|NCT00887549|Pemetrexed|pemetrexed|mesh-list
5520748|NCT04321278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5520749|NCT04321278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5520750|NCT04321278|Antimalarials|antimalarials|mesh-ancestor
5520751|NCT04321278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5520752|NCT04321278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5520753|NCT04321278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5520754|NCT04321278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520755|NCT04321278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5520756|NCT04321070|Clindamycin|clindamycin|mesh-list
5520757|NCT04321070|Clindamycin palmitate|clindamycin palmitate|mesh-list
5520758|NCT04321070|Clindamycin phosphate|clindamycin phosphate|mesh-list
5520759|NCT04321070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6094636|NCT00887549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6094637|NCT00887549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6094638|NCT00887549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094639|NCT00887549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6094640|NCT00887549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6094641|NCT00887562|Ubiquinone|ubiquinone|mesh-list
6094642|NCT00887562|Idebenone|idebenone|mesh-list
6094643|NCT00887562|Antioxidants|antioxidants|mesh-ancestor
6094644|NCT00887562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094645|NCT00887562|Protective Agents|protective agents|mesh-ancestor
6094646|NCT00887562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094647|NCT00887562|Micronutrients|micronutrients|mesh-ancestor
6094648|NCT00887575|Paclitaxel|paclitaxel|mesh-list
6094649|NCT00887575|Carboplatin|carboplatin|mesh-list
6094650|NCT00887575|Sunitinib|sunitinib|mesh-list
6094651|NCT00887575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6094652|NCT00887575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6094653|NCT00887575|Tubulin Modulators|tubulin modulators|mesh-ancestor
6094654|NCT00887575|Antimitotic Agents|antimitotic agents|mesh-ancestor
6094655|NCT00887575|Mitosis Modulators|mitosis modulators|mesh-ancestor
6094656|NCT00887575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094657|NCT00887575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6094658|NCT00887575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6094659|NCT00887575|Growth Substances|growth substances|mesh-ancestor
6094660|NCT00887575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094661|NCT00887575|Growth Inhibitors|growth inhibitors|mesh-ancestor
6094662|NCT00887575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6094663|NCT00887575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6094664|NCT00887588|Valsartan|valsartan|mesh-list
6094665|NCT00887588|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
6094666|NCT00887588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5520760|NCT04321070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5520761|NCT04321070|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5520762|NCT04321070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5520763|NCT04321070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520764|NCT04321096|Camostat|camostat|mesh-list
5520765|NCT04321096|Protease Inhibitors|protease inhibitors|mesh-ancestor
6094667|NCT00887588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6094668|NCT00887588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6094669|NCT00887588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094670|NCT00887640|Diphenhydramine|diphenhydramine|mesh-list
6094671|NCT00887640|Promethazine|promethazine|mesh-list
6094672|NCT00887640|Sirolimus|sirolimus|mesh-list
6094673|NCT00887640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6094674|NCT00887640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6094675|NCT00887640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6094676|NCT00887640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6094677|NCT00887640|Antifungal Agents|antifungal agents|mesh-ancestor
6094678|NCT00887640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5520766|NCT04321096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6094679|NCT00887640|Immunologic Factors|immunologic factors|mesh-ancestor
6203519|NCT02058147|Metformin|metformin|mesh-list
5520767|NCT04321096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520768|NCT04321096|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5520769|NCT04321096|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5520770|NCT04320914|Ibuprofen|ibuprofen|mesh-list
5520771|NCT04320914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5520772|NCT04320914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6094680|NCT00887640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094681|NCT00887640|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6094682|NCT00887640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6094683|NCT00887640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6094684|NCT00887640|Anesthetics, Local|anesthetics, local|mesh-ancestor
6094685|NCT00887640|Anesthetics|anesthetics|mesh-ancestor
6094686|NCT00887640|Sensory System Agents|sensory system agents|mesh-ancestor
6094687|NCT00887640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6094688|NCT00887640|Antiemetics|antiemetics|mesh-ancestor
6094689|NCT00887640|Autonomic Agents|autonomic agents|mesh-ancestor
6094690|NCT00887640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6094691|NCT00887640|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6094692|NCT00887640|Histamine Antagonists|histamine antagonists|mesh-ancestor
6094693|NCT00887640|Histamine Agents|histamine agents|mesh-ancestor
6094694|NCT00887640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6094695|NCT00887640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094696|NCT00887640|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6094697|NCT00887640|Antipruritics|antipruritics|mesh-ancestor
6094698|NCT00887640|Dermatologic Agents|dermatologic agents|mesh-ancestor
6094699|NCT00887653|Raltegravir Potassium|raltegravir potassium|mesh-list
6094700|NCT00887653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6094701|NCT00887653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6094702|NCT00887653|Antiviral Agents|antiviral agents|mesh-ancestor
6094703|NCT00887653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6094704|NCT00887653|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6094705|NCT00887653|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6094706|NCT00887653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6094707|NCT00887653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094708|NCT00887679|Citalopram|citalopram|mesh-list
6094709|NCT00887679|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6094710|NCT00887679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6094711|NCT00887679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6094712|NCT00887679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094713|NCT00887679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6094714|NCT00887679|Serotonin Agents|serotonin agents|mesh-ancestor
6094715|NCT00887679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094716|NCT00887679|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6094717|NCT00887679|Antidepressive Agents|antidepressive agents|mesh-ancestor
6094718|NCT00887679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6094719|NCT00887783|Vinorelbine|vinorelbine|mesh-list
6094720|NCT00887783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6094721|NCT00887783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6094722|NCT00887783|Tubulin Modulators|tubulin modulators|mesh-ancestor
6094723|NCT00887783|Antimitotic Agents|antimitotic agents|mesh-ancestor
6094724|NCT00887783|Mitosis Modulators|mitosis modulators|mesh-ancestor
6094725|NCT00887783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520773|NCT04320914|Analgesics|analgesics|mesh-ancestor
5520774|NCT04320914|Sensory System Agents|sensory system agents|mesh-ancestor
5520775|NCT04320914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5520776|NCT04320914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520777|NCT04320914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5520778|NCT04320914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5520779|NCT04320914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5520780|NCT04320914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5520781|NCT04320914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520782|NCT04320706|Oxytocin|oxytocin|mesh-list
5520783|NCT04320706|Oxytocics|oxytocics|mesh-ancestor
5520784|NCT04320706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5520785|NCT04320706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520786|NCT04320745|Testosterone|testosterone|mesh-list
5520787|NCT04320745|Androgens|androgens|mesh-ancestor
5520788|NCT04320745|Hormones|hormones|mesh-ancestor
5520789|NCT04320745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5520790|NCT04320745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520791|NCT04320602|Eculizumab|eculizumab|mesh-list
5520792|NCT04320602|Ravulizumab|ravulizumab|mesh-list
6094726|NCT00887809|Gemcitabine|gemcitabine|mesh-list
5520793|NCT04320602|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5520794|NCT04320602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5520795|NCT04320602|Immunologic Factors|immunologic factors|mesh-ancestor
6094727|NCT00887809|Bevacizumab|bevacizumab|mesh-list
6094728|NCT00887809|Docetaxel|docetaxel|mesh-list
6094729|NCT00887809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6094730|NCT00887809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6094731|NCT00887809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6094732|NCT00887809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6094733|NCT00887809|Growth Substances|growth substances|mesh-ancestor
6094734|NCT00887809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094735|NCT00887809|Growth Inhibitors|growth inhibitors|mesh-ancestor
6094736|NCT00887809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6094737|NCT00887809|Antimetabolites|antimetabolites|mesh-ancestor
6094738|NCT00887809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094739|NCT00887809|Antiviral Agents|antiviral agents|mesh-ancestor
6094740|NCT00887809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6094741|NCT00887809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6094742|NCT00887809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6094743|NCT00887809|Immunologic Factors|immunologic factors|mesh-ancestor
6094744|NCT00887809|Tubulin Modulators|tubulin modulators|mesh-ancestor
6464536|NCT00469937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094745|NCT00887809|Antimitotic Agents|antimitotic agents|mesh-ancestor
6094746|NCT00887809|Mitosis Modulators|mitosis modulators|mesh-ancestor
6094747|NCT00887822|Bevacizumab|bevacizumab|mesh-list
6094748|NCT00887822|Capecitabine|capecitabine|mesh-list
6094749|NCT00887822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6094750|NCT00887822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6094751|NCT00887822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6094752|NCT00887822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6094753|NCT00887822|Growth Substances|growth substances|mesh-ancestor
6094754|NCT00887822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094755|NCT00887822|Growth Inhibitors|growth inhibitors|mesh-ancestor
6094756|NCT00887822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6094757|NCT00887822|Antimetabolites|antimetabolites|mesh-ancestor
6094758|NCT00887822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094759|NCT00887965|Denosumab|denosumab|mesh-list
6094760|NCT00887965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6094761|NCT00887965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094762|NCT00887978|Treprostinil|treprostinil|mesh-list
6094763|NCT00887978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6094764|NCT00888238|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6094765|NCT00888238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5520796|NCT04320602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520797|NCT04320589|Dexmedetomidine|dexmedetomidine|mesh-list
5520798|NCT04320589|Anesthetics|anesthetics|mesh-list
5520799|NCT04320589|Anesthetics, General|anesthetics, general|mesh-list
5520800|NCT04320589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5520801|NCT04320589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5520802|NCT04320589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520803|NCT04320589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5520804|NCT04320589|Analgesics|analgesics|mesh-ancestor
6094766|NCT00888238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094767|NCT00888238|Incretins|incretins|mesh-ancestor
6094768|NCT00888238|Hormones|hormones|mesh-ancestor
6094769|NCT00888238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6094770|NCT00888238|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6094771|NCT00888238|Protease Inhibitors|protease inhibitors|mesh-ancestor
6094772|NCT00888238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6094773|NCT00888238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094774|NCT00888329|Aprepitant|aprepitant|mesh-list
6094775|NCT00888329|Antiemetics|antiemetics|mesh-ancestor
6094776|NCT00888329|Autonomic Agents|autonomic agents|mesh-ancestor
5520805|NCT04320589|Sensory System Agents|sensory system agents|mesh-ancestor
5520806|NCT04320589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5520807|NCT04320589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5520808|NCT04320589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5520809|NCT04320589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5520810|NCT04320589|Adrenergic Agents|adrenergic agents|mesh-ancestor
5520811|NCT04320589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5520812|NCT04320589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520813|NCT04320238|Interferons|interferons|mesh-list
5520814|NCT04320238|Interferon-alpha|interferon-alpha|mesh-list
5520815|NCT04320238|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
5520816|NCT04320238|Thymalfasin|thymalfasin|mesh-list
5520817|NCT04320238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5520818|NCT04320238|Antiviral Agents|antiviral agents|mesh-ancestor
5520819|NCT04320238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5520820|NCT04320238|Immunologic Factors|immunologic factors|mesh-ancestor
5520821|NCT04320238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094777|NCT00888329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6094778|NCT00888329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094779|NCT00888329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6094780|NCT00888329|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6094781|NCT00888329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6094782|NCT00888329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094783|NCT00888381|Vaccines|vaccines|mesh-list
6094784|NCT00888381|Immunologic Factors|immunologic factors|mesh-ancestor
6094785|NCT00888381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094786|NCT00888459|Nicotine|nicotine|mesh-list
6094787|NCT00888459|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6094788|NCT00888459|Autonomic Agents|autonomic agents|mesh-ancestor
6094789|NCT00888459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6094790|NCT00888459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094791|NCT00888459|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5520822|NCT04320238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5520823|NCT04320290|Antiviral Agents|antiviral agents|mesh-list
5520824|NCT04320290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5520825|NCT04320277|Ritonavir|ritonavir|mesh-list
5520826|NCT04320277|Lopinavir|lopinavir|mesh-list
5520827|NCT04320277|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5520828|NCT04320277|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5520829|NCT04320277|Protease Inhibitors|protease inhibitors|mesh-ancestor
5520830|NCT04320277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5520831|NCT04320277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520832|NCT04320277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5520833|NCT04320277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5520834|NCT04320277|Antiviral Agents|antiviral agents|mesh-ancestor
5520835|NCT04320277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5520836|NCT04320277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5520837|NCT04320277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5520838|NCT04320225|Dexamethasone|dexamethasone|mesh-list
5520839|NCT04320225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5520840|NCT04320225|Antiemetics|antiemetics|mesh-ancestor
5520841|NCT04320225|Autonomic Agents|autonomic agents|mesh-ancestor
6094792|NCT00888459|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6094793|NCT00888459|Cholinergic Agents|cholinergic agents|mesh-ancestor
6094794|NCT00888459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6094795|NCT00888459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203520|NCT02058147|Insulin Glargine|insulin glargine|mesh-list
6203521|NCT02058147|Lixisenatide|lixisenatide|mesh-list
6203522|NCT02058147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6203523|NCT02058147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203524|NCT02058160|Insulin|insulin|mesh-list
6203525|NCT02058160|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6203526|NCT02058160|Metformin|metformin|mesh-list
6203527|NCT02058160|Insulin Glargine|insulin glargine|mesh-list
6203528|NCT02058160|Lixisenatide|lixisenatide|mesh-list
6203529|NCT02058160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5520842|NCT04320225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5520843|NCT04320225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520844|NCT04320225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5520845|NCT04320225|Glucocorticoids|glucocorticoids|mesh-ancestor
6203530|NCT02058160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203531|NCT02058251|Oxytocin|oxytocin|mesh-list
6203532|NCT02058251|Oxytocics|oxytocics|mesh-ancestor
6203533|NCT02058251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6203534|NCT02058251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203535|NCT02058290|Morphine|morphine|mesh-list
6203536|NCT02058290|Bupivacaine|bupivacaine|mesh-list
5520846|NCT04320225|Hormones|hormones|mesh-ancestor
5520847|NCT04320225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5520848|NCT04320225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5520849|NCT04320225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5520850|NCT04319978|Dexamethasone|dexamethasone|mesh-list
5520851|NCT04319978|Dexamethasone acetate|dexamethasone acetate|mesh-list
5520852|NCT04319978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5520853|NCT04319978|Antiemetics|antiemetics|mesh-ancestor
5520854|NCT04319978|Autonomic Agents|autonomic agents|mesh-ancestor
5520855|NCT04319978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5520856|NCT04319978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520857|NCT04319978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5520858|NCT04319978|Glucocorticoids|glucocorticoids|mesh-ancestor
5520859|NCT04319978|Hormones|hormones|mesh-ancestor
5520860|NCT04319978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6094796|NCT00888511|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6094797|NCT00888511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6094798|NCT00888511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6094799|NCT00888511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6094800|NCT00888511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094801|NCT00888615|Paclitaxel|paclitaxel|mesh-list
6094802|NCT00888615|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5520861|NCT04319978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5520862|NCT04319978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5520863|NCT04320173|Lidocaine|lidocaine|mesh-list
5520864|NCT04320173|Anesthetics, Local|anesthetics, local|mesh-ancestor
5520865|NCT04320173|Anesthetics|anesthetics|mesh-ancestor
5520866|NCT04320173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5520867|NCT04320173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520868|NCT04320173|Sensory System Agents|sensory system agents|mesh-ancestor
5520869|NCT04320173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5520870|NCT04320173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5520871|NCT04320173|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5520872|NCT04320173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5520873|NCT04320173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5520874|NCT04320173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520875|NCT04319926|Lidocaine|lidocaine|mesh-list
5520876|NCT04319926|Anesthetics, Local|anesthetics, local|mesh-ancestor
5520877|NCT04319926|Anesthetics|anesthetics|mesh-ancestor
5520878|NCT04319926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6094803|NCT00888615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6094804|NCT00888615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6094805|NCT00888615|Tubulin Modulators|tubulin modulators|mesh-ancestor
6094806|NCT00888615|Antimitotic Agents|antimitotic agents|mesh-ancestor
6094807|NCT00888615|Mitosis Modulators|mitosis modulators|mesh-ancestor
6094808|NCT00888615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094809|NCT00888628|Etanercept|etanercept|mesh-list
6094810|NCT00888628|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6094811|NCT00888628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6094812|NCT00888628|Analgesics|analgesics|mesh-ancestor
6094813|NCT00888628|Sensory System Agents|sensory system agents|mesh-ancestor
6094814|NCT00888628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6094815|NCT00888628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094816|NCT00888628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6094817|NCT00888628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6094818|NCT00888628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6094819|NCT00888628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6094820|NCT00888628|Immunologic Factors|immunologic factors|mesh-ancestor
6094821|NCT00888654|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
6094822|NCT00888654|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6094823|NCT00888654|Protective Agents|protective agents|mesh-ancestor
6094824|NCT00888654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094825|NCT00888654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6094826|NCT00888927|Mogamulizumab|mogamulizumab|mesh-list
6094827|NCT00888927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6094828|NCT00888940|Ecallantide|ecallantide|mesh-list
6094829|NCT00888940|Tranexamic Acid|tranexamic acid|mesh-list
6094830|NCT00888940|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6094831|NCT00888940|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6094832|NCT00888940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094833|NCT00888940|Hemostatics|hemostatics|mesh-ancestor
6094834|NCT00888940|Coagulants|coagulants|mesh-ancestor
6094835|NCT00888940|Analgesics|analgesics|mesh-ancestor
5520879|NCT04319926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094836|NCT00888940|Sensory System Agents|sensory system agents|mesh-ancestor
6094837|NCT00888940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6094838|NCT00888940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094839|NCT00888940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6094840|NCT00888940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5520880|NCT04319926|Sensory System Agents|sensory system agents|mesh-ancestor
5520881|NCT04319926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6094841|NCT00888940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6094842|NCT00888940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6094843|NCT00888979|Nicotine|nicotine|mesh-list
6094844|NCT00888979|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6094845|NCT00888979|Autonomic Agents|autonomic agents|mesh-ancestor
6094846|NCT00888979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6464537|NCT00469937|Antimanic Agents|antimanic agents|mesh-ancestor
6464538|NCT00469937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6464539|NCT00469937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6464540|NCT00469937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464541|NCT00469976|Gemcitabine|gemcitabine|mesh-list
6464542|NCT00469976|Bevacizumab|bevacizumab|mesh-list
6464543|NCT00469976|Carboplatin|carboplatin|mesh-list
6464544|NCT00469976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6464545|NCT00469976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6464546|NCT00469976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6464547|NCT00469976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6094847|NCT00888979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094848|NCT00888979|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6094849|NCT00888979|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6094850|NCT00888979|Cholinergic Agents|cholinergic agents|mesh-ancestor
6094851|NCT00888979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6094852|NCT00888979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094853|NCT00889187|Capecitabine|capecitabine|mesh-list
6094854|NCT00889187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6094855|NCT00889187|Antimetabolites|antimetabolites|mesh-ancestor
6094856|NCT00889187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094857|NCT00889187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6094858|NCT00889200|Eszopiclone|eszopiclone|mesh-list
6094859|NCT00889200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6094860|NCT00889200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6094861|NCT00889200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094862|NCT00889226|Atorvastatin|atorvastatin|mesh-list
6094863|NCT00889226|Pitavastatin|pitavastatin|mesh-list
6094864|NCT00889226|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6094865|NCT00889226|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6094866|NCT00889226|Antimetabolites|antimetabolites|mesh-ancestor
6094867|NCT00889226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094868|NCT00889226|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6094869|NCT00889226|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6094870|NCT00889226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6094871|NCT00889252|Ketotifen|ketotifen|mesh-list
6094872|NCT00889252|Antipruritics|antipruritics|mesh-ancestor
6094873|NCT00889252|Dermatologic Agents|dermatologic agents|mesh-ancestor
6094874|NCT00889252|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6094875|NCT00889252|Histamine Antagonists|histamine antagonists|mesh-ancestor
6094876|NCT00889252|Histamine Agents|histamine agents|mesh-ancestor
6094877|NCT00889252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6094878|NCT00889252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094879|NCT00889252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094880|NCT00889252|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6094881|NCT00889330|Alcaftadine|alcaftadine|mesh-list
6094882|NCT00889330|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6094883|NCT00889330|Histamine Antagonists|histamine antagonists|mesh-ancestor
6094884|NCT00889330|Histamine Agents|histamine agents|mesh-ancestor
6094885|NCT00889330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6094886|NCT00889330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094887|NCT00889330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094888|NCT00889603|Donepezil|donepezil|mesh-list
6094889|NCT00889603|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6094890|NCT00889603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6094891|NCT00889603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094892|NCT00889603|Cholinergic Agents|cholinergic agents|mesh-ancestor
6094893|NCT00889603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6094894|NCT00889603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464548|NCT00469976|Growth Substances|growth substances|mesh-ancestor
6464549|NCT00469976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094895|NCT00889603|Nootropic Agents|nootropic agents|mesh-ancestor
6094896|NCT00889720|Varenicline|varenicline|mesh-list
6094897|NCT00889720|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6094898|NCT00889720|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6094899|NCT00889720|Cholinergic Agents|cholinergic agents|mesh-ancestor
6094900|NCT00889720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6094901|NCT00889720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094902|NCT00889720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094903|NCT00889915|Methylphenidate|methylphenidate|mesh-list
6094904|NCT00889915|Amphetamine|amphetamine|mesh-list
6094905|NCT00889915|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6094906|NCT00889915|Adderall|adderall|mesh-list
6094907|NCT00889915|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6094908|NCT00889915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665727|NCT01518465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665728|NCT01518556|Idarubicin|idarubicin|mesh-list
6665729|NCT01518556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6665730|NCT01518556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5520882|NCT04319926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5520883|NCT04319926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5520884|NCT04319926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5520885|NCT04319926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5520886|NCT04319926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600936|NCT03708822|Mitosis Modulators|mitosis modulators|mesh-ancestor
5600937|NCT03708822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600938|NCT03708822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5600939|NCT03708718|Prednisolone|prednisolone|mesh-list
6094909|NCT00889915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6094910|NCT00889915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6094911|NCT00889915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6094912|NCT00889915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094913|NCT00889915|Dopamine Agents|dopamine agents|mesh-ancestor
6094914|NCT00889915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6094915|NCT00889915|Sympathomimetics|sympathomimetics|mesh-ancestor
6094916|NCT00889915|Autonomic Agents|autonomic agents|mesh-ancestor
6094917|NCT00889915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6094918|NCT00889915|Adrenergic Agents|adrenergic agents|mesh-ancestor
6094919|NCT00889915|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6094920|NCT00890084|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6094921|NCT00890084|Telmisartan|telmisartan|mesh-list
6094922|NCT00890084|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
5600940|NCT03708718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5600941|NCT03708718|Glucocorticoids|glucocorticoids|mesh-ancestor
6094923|NCT00890084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6094924|NCT00890084|Diuretics|diuretics|mesh-ancestor
6094925|NCT00890084|Natriuretic Agents|natriuretic agents|mesh-ancestor
6094926|NCT00890084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094927|NCT00890084|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6094928|NCT00890084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6094929|NCT00890084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094930|NCT00890084|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6094931|NCT00890084|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6094932|NCT00890097|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6094933|NCT00890097|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6094934|NCT00890162|Omalizumab|omalizumab|mesh-list
6094935|NCT00890162|Epinephrine|epinephrine|mesh-list
6094936|NCT00890162|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6094937|NCT00890162|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6094938|NCT00890162|Adrenergic Agents|adrenergic agents|mesh-ancestor
6094939|NCT00890162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6094940|NCT00890162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094941|NCT00890162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094942|NCT00890162|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6464550|NCT00469976|Growth Inhibitors|growth inhibitors|mesh-ancestor
6464551|NCT00469976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6464552|NCT00469976|Antimetabolites|antimetabolites|mesh-ancestor
5600942|NCT03708718|Hormones|hormones|mesh-ancestor
6464553|NCT00469976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6464554|NCT00469976|Antiviral Agents|antiviral agents|mesh-ancestor
6464555|NCT00469976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6464556|NCT00469976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6464557|NCT00469976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6094943|NCT00890162|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6094944|NCT00890162|Autonomic Agents|autonomic agents|mesh-ancestor
6094945|NCT00890162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6094946|NCT00890162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6094947|NCT00890162|Respiratory System Agents|respiratory system agents|mesh-ancestor
6094948|NCT00890162|Mydriatics|mydriatics|mesh-ancestor
6094949|NCT00890162|Sympathomimetics|sympathomimetics|mesh-ancestor
6094950|NCT00890162|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6094951|NCT00890162|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6094952|NCT00890396|Hydroxyurea|hydroxyurea|mesh-list
6094953|NCT00890396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6094954|NCT00890396|Antisickling Agents|antisickling agents|mesh-ancestor
6094955|NCT00890396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6094956|NCT00890396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094957|NCT00890396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6094958|NCT00890552|Dexamethasone|dexamethasone|mesh-list
6094959|NCT00890552|Dexamethasone acetate|dexamethasone acetate|mesh-list
6094960|NCT00890552|Lenalidomide|lenalidomide|mesh-list
6094961|NCT00890552|Melphalan|melphalan|mesh-list
6094962|NCT00890552|BB 1101|bb 1101|mesh-list
6094963|NCT00890552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6094964|NCT00890552|Antiemetics|antiemetics|mesh-ancestor
6094965|NCT00890552|Autonomic Agents|autonomic agents|mesh-ancestor
6094966|NCT00890552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6094967|NCT00890552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094968|NCT00890552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6094969|NCT00890552|Glucocorticoids|glucocorticoids|mesh-ancestor
6094970|NCT00890552|Hormones|hormones|mesh-ancestor
6094971|NCT00890552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6094972|NCT00890552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6094973|NCT00890552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6094974|NCT00890552|Protease Inhibitors|protease inhibitors|mesh-ancestor
6094975|NCT00890552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6094976|NCT00890552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6094977|NCT00890552|Immunologic Factors|immunologic factors|mesh-ancestor
6094978|NCT00890552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6094979|NCT00890552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6094980|NCT00890552|Growth Substances|growth substances|mesh-ancestor
6094981|NCT00890552|Growth Inhibitors|growth inhibitors|mesh-ancestor
6094982|NCT00890552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6094983|NCT00890552|Alkylating Agents|alkylating agents|mesh-ancestor
6094984|NCT00890552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6094985|NCT00890552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6094986|NCT00890617|Prednisone|prednisone|mesh-list
6094987|NCT00890617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6094988|NCT00890617|Glucocorticoids|glucocorticoids|mesh-ancestor
6094989|NCT00890617|Hormones|hormones|mesh-ancestor
6094990|NCT00890617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6094991|NCT00890617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6094992|NCT00890617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6094993|NCT00890617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6094994|NCT00890656|Dexamethasone|dexamethasone|mesh-list
6094995|NCT00890656|Cyclophosphamide|cyclophosphamide|mesh-list
6094996|NCT00890656|Doxorubicin|doxorubicin|mesh-list
6094997|NCT00890656|Methotrexate|methotrexate|mesh-list
6094998|NCT00890656|Vincristine|vincristine|mesh-list
6094999|NCT00890656|Asparaginase|asparaginase|mesh-list
6095000|NCT00890656|Pegaspargase|pegaspargase|mesh-list
6095001|NCT00890656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6095002|NCT00890656|Immunologic Factors|immunologic factors|mesh-ancestor
6095003|NCT00890656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095004|NCT00890656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6095005|NCT00890656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5520887|NCT04319900|Chloroquine|chloroquine|mesh-list
5520888|NCT04319900|Favipiravir|favipiravir|mesh-list
5520889|NCT04319900|Amebicides|amebicides|mesh-ancestor
5520890|NCT04319900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6095006|NCT00890656|Alkylating Agents|alkylating agents|mesh-ancestor
6095007|NCT00890656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095008|NCT00890656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6095009|NCT00890656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6095010|NCT00890656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6095011|NCT00890656|Antiemetics|antiemetics|mesh-ancestor
5520891|NCT04319900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6095012|NCT00890656|Autonomic Agents|autonomic agents|mesh-ancestor
6095013|NCT00890656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6095014|NCT00890656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6095015|NCT00890656|Glucocorticoids|glucocorticoids|mesh-ancestor
5520892|NCT04319900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5520893|NCT04319900|Antimalarials|antimalarials|mesh-ancestor
5520894|NCT04319900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5520895|NCT04319900|Antiviral Agents|antiviral agents|mesh-ancestor
5520896|NCT04319757|Cyclophosphamide|cyclophosphamide|mesh-list
5520897|NCT04319757|Fludarabine|fludarabine|mesh-list
5520898|NCT04319757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6095016|NCT00890656|Hormones|hormones|mesh-ancestor
6095017|NCT00890656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6095018|NCT00890656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6095019|NCT00890656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6095020|NCT00890656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5520899|NCT04319757|Immunologic Factors|immunologic factors|mesh-ancestor
5520900|NCT04319757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520901|NCT04319757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5520902|NCT04319757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5520903|NCT04319757|Alkylating Agents|alkylating agents|mesh-ancestor
5520904|NCT04319757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520905|NCT04319757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5520906|NCT04319757|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5520907|NCT04319471|Capecitabine|capecitabine|mesh-list
5520908|NCT04319471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5520909|NCT04319471|Antimetabolites|antimetabolites|mesh-ancestor
5520910|NCT04319471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520911|NCT04319471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5520912|NCT04319588|Anesthetics|anesthetics|mesh-list
5520913|NCT04319588|Anesthetics, Local|anesthetics, local|mesh-list
5520914|NCT04319588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5520915|NCT04319588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520916|NCT04319588|Sensory System Agents|sensory system agents|mesh-ancestor
5520917|NCT04319588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5520918|NCT04319770|Hyaluronic Acid|hyaluronic acid|mesh-list
5520919|NCT04319770|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5520920|NCT04319770|Immunologic Factors|immunologic factors|mesh-ancestor
5520921|NCT04319770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520922|NCT04319770|Viscosupplements|viscosupplements|mesh-ancestor
5520923|NCT04319770|Protective Agents|protective agents|mesh-ancestor
5520924|NCT04319484|Lenvatinib|lenvatinib|mesh-list
6095021|NCT00890656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6095022|NCT00890656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6095023|NCT00890656|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6095024|NCT00890656|Abortifacient Agents|abortifacient agents|mesh-ancestor
6095025|NCT00890656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6095026|NCT00890656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6095027|NCT00890656|Antimetabolites|antimetabolites|mesh-ancestor
6095028|NCT00890656|Dermatologic Agents|dermatologic agents|mesh-ancestor
6095029|NCT00890656|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6095030|NCT00890656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6095031|NCT00890656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6095032|NCT00890656|Tubulin Modulators|tubulin modulators|mesh-ancestor
6095033|NCT00890656|Antimitotic Agents|antimitotic agents|mesh-ancestor
6095034|NCT00890656|Mitosis Modulators|mitosis modulators|mesh-ancestor
6095035|NCT00890825|Docetaxel|docetaxel|mesh-list
6095036|NCT00890825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6095037|NCT00890825|Tubulin Modulators|tubulin modulators|mesh-ancestor
6095038|NCT00890825|Antimitotic Agents|antimitotic agents|mesh-ancestor
6095039|NCT00890825|Mitosis Modulators|mitosis modulators|mesh-ancestor
6095040|NCT00890825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095041|NCT00890929|Lenalidomide|lenalidomide|mesh-list
6665731|NCT01518556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6665732|NCT01518556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6665733|NCT01518556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6095042|NCT00890929|Azacitidine|azacitidine|mesh-list
6095043|NCT00890929|Immunologic Factors|immunologic factors|mesh-ancestor
6095044|NCT00890929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095045|NCT00890929|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6095046|NCT00890929|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6095047|NCT00890929|Growth Substances|growth substances|mesh-ancestor
6095048|NCT00890929|Growth Inhibitors|growth inhibitors|mesh-ancestor
6095049|NCT00890929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6095050|NCT00890929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6095051|NCT00890929|Antimetabolites|antimetabolites|mesh-ancestor
5520925|NCT04319484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5520926|NCT04319484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5520927|NCT04319484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5520928|NCT04319484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520929|NCT04319601|Rituximab|rituximab|mesh-list
5520930|NCT04319601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5520931|NCT04319601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6095052|NCT00890929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095053|NCT00890929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6095054|NCT00890981|Denosumab|denosumab|mesh-list
6095055|NCT00890981|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6095056|NCT00890981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095057|NCT00891176|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6095058|NCT00891176|Immunologic Factors|immunologic factors|mesh-ancestor
6095059|NCT00891176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095060|NCT00891202|Eliglustat|eliglustat|mesh-list
6095061|NCT00891202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6095062|NCT00891202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095063|NCT00891228|ST 1435|st 1435|mesh-list
5520932|NCT04319601|Immunologic Factors|immunologic factors|mesh-ancestor
5520933|NCT04319601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520934|NCT04319601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5520935|NCT04319692|Acetic Acid|acetic acid|mesh-list
5520936|NCT04319692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5520937|NCT04319692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6095064|NCT00891228|Testosterone|testosterone|mesh-list
6095065|NCT00891228|Androgens|androgens|mesh-ancestor
6095066|NCT00891228|Hormones|hormones|mesh-ancestor
6095067|NCT00891228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6095068|NCT00891228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095069|NCT00891228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6095070|NCT00891228|Contraceptive Agents|contraceptive agents|mesh-ancestor
6095071|NCT00891228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6095072|NCT00891228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6095073|NCT00891293|Fenofibrate|fenofibrate|mesh-list
6095074|NCT00891293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6095075|NCT00891293|Antimetabolites|antimetabolites|mesh-ancestor
6095076|NCT00891293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095077|NCT00891293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6095078|NCT00891371|Lanreotide|lanreotide|mesh-list
5520938|NCT04319705|Azithromycin|azithromycin|mesh-list
5520939|NCT04319705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5520940|NCT04319705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5520941|NCT04319614|Tranexamic Acid|tranexamic acid|mesh-list
5520942|NCT04319614|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5520943|NCT04319614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5520944|NCT04319614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520945|NCT04319614|Hemostatics|hemostatics|mesh-ancestor
5520946|NCT04319614|Coagulants|coagulants|mesh-ancestor
5520947|NCT04319328|Ciprofloxacin|ciprofloxacin|mesh-list
5520948|NCT04319328|Cefazolin|cefazolin|mesh-list
6095079|NCT00891371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6095080|NCT00891436|Fluticasone|fluticasone|mesh-list
6095081|NCT00891436|Xhance|xhance|mesh-list
6095082|NCT00891436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6095083|NCT00891436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6095084|NCT00891436|Autonomic Agents|autonomic agents|mesh-ancestor
6095085|NCT00891436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6095086|NCT00891436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095087|NCT00891436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6095088|NCT00891436|Respiratory System Agents|respiratory system agents|mesh-ancestor
6095089|NCT00891436|Dermatologic Agents|dermatologic agents|mesh-ancestor
6095090|NCT00891436|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6095091|NCT00891462|Bromides|bromides|mesh-list
6095092|NCT00891462|Anticonvulsants|anticonvulsants|mesh-ancestor
6095093|NCT00891527|Bevacizumab|bevacizumab|mesh-list
6095094|NCT00891527|Imatinib Mesylate|imatinib mesylate|mesh-list
6095095|NCT00891527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6095096|NCT00891527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6095097|NCT00891527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6095098|NCT00891527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6095099|NCT00891527|Growth Substances|growth substances|mesh-ancestor
6095100|NCT00891527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095101|NCT00891527|Growth Inhibitors|growth inhibitors|mesh-ancestor
6095102|NCT00891527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6095103|NCT00891527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6095104|NCT00891527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6464558|NCT00469976|Immunologic Factors|immunologic factors|mesh-ancestor
6464559|NCT00470015|Aldesleukin|aldesleukin|mesh-list
5520949|NCT04319328|Ceftazidime|ceftazidime|mesh-list
6095105|NCT00891735|Ranibizumab|ranibizumab|mesh-list
6095106|NCT00891735|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6095107|NCT00891735|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6095108|NCT00891735|Growth Substances|growth substances|mesh-ancestor
6464560|NCT00470015|Interleukin-2|interleukin-2|mesh-list
6464561|NCT00470015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6464562|NCT00470015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6095109|NCT00891735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095110|NCT00891735|Growth Inhibitors|growth inhibitors|mesh-ancestor
6095111|NCT00891735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6095112|NCT00891813|Ergocalciferols|ergocalciferols|mesh-list
6095113|NCT00891813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6095114|NCT00891813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095115|NCT00891813|Vitamins|vitamins|mesh-ancestor
5520950|NCT04319328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6095116|NCT00891813|Micronutrients|micronutrients|mesh-ancestor
6095117|NCT00891813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6095118|NCT00891839|Rituximab|rituximab|mesh-list
6095119|NCT00891839|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6095120|NCT00891839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6095121|NCT00891839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6095122|NCT00891839|Immunologic Factors|immunologic factors|mesh-ancestor
6095123|NCT00891839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095124|NCT00891839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6095125|NCT00891839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6095126|NCT00891839|Alkylating Agents|alkylating agents|mesh-ancestor
6095127|NCT00891839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095128|NCT00891878|Capecitabine|capecitabine|mesh-list
6095129|NCT00891878|Sunitinib|sunitinib|mesh-list
6095130|NCT00891878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6095131|NCT00891878|Antimetabolites|antimetabolites|mesh-ancestor
6095132|NCT00891878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095133|NCT00891878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6095134|NCT00891878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6095135|NCT00891878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6095136|NCT00891878|Growth Substances|growth substances|mesh-ancestor
6095137|NCT00891878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095138|NCT00891878|Growth Inhibitors|growth inhibitors|mesh-ancestor
6095139|NCT00891878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6095140|NCT00891878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6095141|NCT00891930|Irinotecan|irinotecan|mesh-list
6095142|NCT00891930|Panitumumab|panitumumab|mesh-list
6095143|NCT00891930|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6095144|NCT00891930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6095145|NCT00891930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6095146|NCT00891930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095147|NCT00891930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6095148|NCT00891930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6095149|NCT00891982|Clindamycin, tretinoin drug combination|clindamycin, tretinoin drug combination|mesh-list
6095150|NCT00891982|Dermatologic Agents|dermatologic agents|mesh-ancestor
6095151|NCT00891995|Insulin|insulin|mesh-list
6095152|NCT00891995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6095153|NCT00891995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095154|NCT00892008|Pregabalin|pregabalin|mesh-list
6095155|NCT00892008|Analgesics|analgesics|mesh-ancestor
6095156|NCT00892008|Sensory System Agents|sensory system agents|mesh-ancestor
6095157|NCT00892008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6095158|NCT00892008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095159|NCT00892008|Anticonvulsants|anticonvulsants|mesh-ancestor
6095160|NCT00892008|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6095161|NCT00892008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6464563|NCT00470015|Analgesics|analgesics|mesh-ancestor
6095162|NCT00892008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095163|NCT00892008|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6095164|NCT00892008|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6095165|NCT00892008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6095166|NCT00892008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6095167|NCT00892008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6095168|NCT00892047|Aripiprazole|aripiprazole|mesh-list
6095169|NCT00892047|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6095170|NCT00892047|Antidepressive Agents|antidepressive agents|mesh-ancestor
6095171|NCT00892047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6095172|NCT00892047|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6095173|NCT00892047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6095174|NCT00892047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6095175|NCT00892047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095176|NCT00892047|Dopamine Agonists|dopamine agonists|mesh-ancestor
6095177|NCT00892047|Dopamine Agents|dopamine agents|mesh-ancestor
6095178|NCT00892047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6095179|NCT00892047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095180|NCT00892047|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6095181|NCT00892047|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6095182|NCT00892047|Serotonin Agents|serotonin agents|mesh-ancestor
6095183|NCT00892047|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6095184|NCT00892047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6095185|NCT00892047|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6095186|NCT00892047|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6095187|NCT00892047|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6095188|NCT00892047|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6095189|NCT00892047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5520951|NCT04319328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5520952|NCT04319328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5520953|NCT04319328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5520954|NCT04319328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5520955|NCT04319328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520956|NCT04319328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5520957|NCT04319328|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5520958|NCT04319328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5520959|NCT04319549|Sodium Hypochlorite|sodium hypochlorite|mesh-list
5520960|NCT04319549|Eusol|eusol|mesh-list
5520961|NCT04319549|Ketorolac|ketorolac|mesh-list
5520962|NCT04319549|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
5520963|NCT04319549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5520964|NCT04319549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5520965|NCT04319549|Analgesics|analgesics|mesh-ancestor
5520966|NCT04319549|Sensory System Agents|sensory system agents|mesh-ancestor
5520967|NCT04319549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5520968|NCT04319549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520969|NCT04319549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5520970|NCT04319549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5520971|NCT04319549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5520972|NCT04319549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5520973|NCT04319549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520974|NCT04319549|Disinfectants|disinfectants|mesh-ancestor
5520975|NCT04319549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5520976|NCT04319289|Vitamin D|vitamin d|mesh-list
5520977|NCT04319289|Ergocalciferols|ergocalciferols|mesh-list
5520978|NCT04319289|Vitamins|vitamins|mesh-list
5520979|NCT04319289|Micronutrients|micronutrients|mesh-ancestor
5520980|NCT04319289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520981|NCT04319289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5520982|NCT04319289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5520983|NCT04319224|Nivolumab|nivolumab|mesh-list
5520984|NCT04319224|Ipilimumab|ipilimumab|mesh-list
5520985|NCT04319224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5520986|NCT04319224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5520987|NCT04319224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5520988|NCT04319224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5520989|NCT04319419|Micronutrients|micronutrients|mesh-list
5520990|NCT04319419|Trace Elements|trace elements|mesh-list
5520991|NCT04319419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520992|NCT04318847|Ondansetron|ondansetron|mesh-list
5520993|NCT04318847|Antiemetics|antiemetics|mesh-ancestor
5520994|NCT04318847|Autonomic Agents|autonomic agents|mesh-ancestor
5520995|NCT04318847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6095190|NCT00892047|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6095191|NCT00892099|Vitamin D|vitamin d|mesh-list
6095192|NCT00892099|Ergocalciferols|ergocalciferols|mesh-list
6095193|NCT00892099|Vitamins|vitamins|mesh-list
5520996|NCT04318847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5520997|NCT04318847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5520998|NCT04318847|Antipruritics|antipruritics|mesh-ancestor
5520999|NCT04318847|Dermatologic Agents|dermatologic agents|mesh-ancestor
5521000|NCT04318847|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5521001|NCT04318847|Serotonin Agents|serotonin agents|mesh-ancestor
5521002|NCT04318847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5521003|NCT04318847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095194|NCT00892099|Micronutrients|micronutrients|mesh-ancestor
6095195|NCT00892099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095196|NCT00892099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6095197|NCT00892099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6095198|NCT00892177|Bevacizumab|bevacizumab|mesh-list
6095199|NCT00892177|Dasatinib|dasatinib|mesh-list
6095200|NCT00892177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6095201|NCT00892177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6095202|NCT00892177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6095203|NCT00892177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6095204|NCT00892177|Growth Substances|growth substances|mesh-ancestor
6095205|NCT00892177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095206|NCT00892177|Growth Inhibitors|growth inhibitors|mesh-ancestor
6095207|NCT00892177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6095208|NCT00892177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6095209|NCT00892177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095210|NCT00892281|Doxycycline|doxycycline|mesh-list
5521004|NCT04318847|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5521005|NCT04318847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5521006|NCT04318847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5521007|NCT04318847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5521008|NCT04318847|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5521009|NCT04318444|Hydroxychloroquine|hydroxychloroquine|mesh-list
5521010|NCT04318444|Antimalarials|antimalarials|mesh-ancestor
5521011|NCT04318444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5521012|NCT04318444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5521013|NCT04318444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5521014|NCT04318444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5521015|NCT04318444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521016|NCT04318444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5521017|NCT04318730|Apatinib|apatinib|mesh-list
5521018|NCT04318730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5521019|NCT04318730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5521020|NCT04318730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5521021|NCT04318730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521022|NCT04318678|Cyclophosphamide|cyclophosphamide|mesh-list
6095211|NCT00892281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6095212|NCT00892281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6095213|NCT00892281|Antimalarials|antimalarials|mesh-ancestor
6095214|NCT00892281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6095215|NCT00892281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6095216|NCT00892437|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6095217|NCT00892437|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6095218|NCT00892437|Cobicistat|cobicistat|mesh-list
6095219|NCT00892437|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6095220|NCT00892437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6095221|NCT00892437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6095222|NCT00892437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095223|NCT00892437|Antiviral Agents|antiviral agents|mesh-ancestor
6095224|NCT00892437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6095225|NCT00892437|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6095226|NCT00892437|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6095227|NCT00892437|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6095228|NCT00892437|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6095229|NCT00892437|Protease Inhibitors|protease inhibitors|mesh-ancestor
6095230|NCT00892437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6095231|NCT00892437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6095232|NCT00892606|Morphine|morphine|mesh-list
6095233|NCT00892606|Methadone|methadone|mesh-list
5521023|NCT04318678|Rituximab|rituximab|mesh-list
5521024|NCT04318678|Fludarabine|fludarabine|mesh-list
5521025|NCT04318678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5521026|NCT04318678|Immunologic Factors|immunologic factors|mesh-ancestor
6095234|NCT00892606|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6095235|NCT00892606|Narcotics|narcotics|mesh-ancestor
6095236|NCT00892606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6095237|NCT00892606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095238|NCT00892606|Analgesics|analgesics|mesh-ancestor
6095239|NCT00892606|Sensory System Agents|sensory system agents|mesh-ancestor
6095240|NCT00892606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6095241|NCT00892606|Antitussive Agents|antitussive agents|mesh-ancestor
6095242|NCT00892606|Respiratory System Agents|respiratory system agents|mesh-ancestor
6095243|NCT00892697|Ribavirin|ribavirin|mesh-list
6095244|NCT00892697|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6095245|NCT00892697|Antimetabolites|antimetabolites|mesh-ancestor
6095246|NCT00892697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095247|NCT00892697|Antiviral Agents|antiviral agents|mesh-ancestor
6095248|NCT00892697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6095249|NCT00892710|Bevacizumab|bevacizumab|mesh-list
6095250|NCT00892710|Carboplatin|carboplatin|mesh-list
5521027|NCT04318678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521028|NCT04318678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5521029|NCT04318678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5521030|NCT04318678|Alkylating Agents|alkylating agents|mesh-ancestor
5521031|NCT04318678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095251|NCT00892710|Pemetrexed|pemetrexed|mesh-list
6095252|NCT00892710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6095253|NCT00892710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6095254|NCT00892710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6095255|NCT00892710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6095256|NCT00892710|Growth Substances|growth substances|mesh-ancestor
6095257|NCT00892710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095258|NCT00892710|Growth Inhibitors|growth inhibitors|mesh-ancestor
6095259|NCT00892710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6095260|NCT00892710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095261|NCT00892710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6095262|NCT00892710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6095263|NCT00892957|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6095264|NCT00892957|Thrombin|thrombin|mesh-list
6095265|NCT00892957|Aprotinin|aprotinin|mesh-list
6095266|NCT00892957|Hemostatics|hemostatics|mesh-ancestor
6095267|NCT00892957|Coagulants|coagulants|mesh-ancestor
6095268|NCT00892957|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6095269|NCT00892957|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6095270|NCT00892957|Protease Inhibitors|protease inhibitors|mesh-ancestor
6095271|NCT00892957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6095272|NCT00892957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095273|NCT00893074|Dronabinol|dronabinol|mesh-list
6095274|NCT00893074|Hallucinogens|hallucinogens|mesh-ancestor
6095275|NCT00893074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095276|NCT00893074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6095277|NCT00893074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6095278|NCT00893074|Analgesics|analgesics|mesh-ancestor
6095279|NCT00893074|Sensory System Agents|sensory system agents|mesh-ancestor
6095280|NCT00893074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6095281|NCT00893074|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6095282|NCT00893074|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6095283|NCT00893074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6095284|NCT00893074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095285|NCT00893074|Hormones|hormones|mesh-ancestor
6095286|NCT00893074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6095287|NCT00893113|Alfuzosin|alfuzosin|mesh-list
6095288|NCT00893113|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6095289|NCT00893113|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6095290|NCT00893113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6095291|NCT00893113|Adrenergic Agents|adrenergic agents|mesh-ancestor
6095292|NCT00893113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6095293|NCT00893113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095294|NCT00893113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095295|NCT00893113|Urological Agents|urological agents|mesh-ancestor
6095296|NCT00893464|Ixazomib|ixazomib|mesh-list
6095297|NCT00893464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6095298|NCT00893464|Protease Inhibitors|protease inhibitors|mesh-ancestor
6095299|NCT00893464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6095300|NCT00893464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095301|NCT00893737|Naproxen|naproxen|mesh-list
6095302|NCT00893737|Sumatriptan|sumatriptan|mesh-list
6203537|NCT02058290|Anesthetics, Local|anesthetics, local|mesh-ancestor
6095303|NCT00893737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6095304|NCT00893737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6095305|NCT00893737|Analgesics|analgesics|mesh-ancestor
6095306|NCT00893737|Sensory System Agents|sensory system agents|mesh-ancestor
6095307|NCT00893737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6095308|NCT00893737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095309|NCT00893737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6095310|NCT00893737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5521032|NCT04318678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5521033|NCT04318678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5521034|NCT04318678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6095311|NCT00893737|Gout Suppressants|gout suppressants|mesh-ancestor
6095312|NCT00893737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6095313|NCT00893737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6095314|NCT00893737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095315|NCT00893737|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6095316|NCT00893737|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6095317|NCT00893737|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6095318|NCT00893737|Serotonin Agents|serotonin agents|mesh-ancestor
6095319|NCT00893737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6095320|NCT00893984|Nebivolol|nebivolol|mesh-list
6095321|NCT00893984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6095322|NCT00893984|Vasodilator Agents|vasodilator agents|mesh-ancestor
6095323|NCT00893984|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6095324|NCT00893984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6095325|NCT00893984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6665734|NCT01518556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665735|NCT01518569|Urinastatin|urinastatin|mesh-list
6665736|NCT01518569|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6665737|NCT01518569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6665738|NCT01518569|Protease Inhibitors|protease inhibitors|mesh-ancestor
6665739|NCT01518569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6665740|NCT01518569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665741|NCT01518595|Bosentan|bosentan|mesh-list
6665742|NCT01518595|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5521035|NCT04318652|Methylprednisolone|methylprednisolone|mesh-list
5521036|NCT04318652|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5521037|NCT04318652|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5521038|NCT04318652|Prednisolone|prednisolone|mesh-list
5521039|NCT04318652|Prednisolone acetate|prednisolone acetate|mesh-list
6665743|NCT01518595|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6665744|NCT01518595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665745|NCT01518608|Alfentanil|alfentanil|mesh-list
6665746|NCT01518608|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6095326|NCT00893984|Adrenergic Agents|adrenergic agents|mesh-ancestor
6095327|NCT00893984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6095328|NCT00893984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095329|NCT00893984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095330|NCT00893997|Vaccines|vaccines|mesh-list
6095331|NCT00893997|Immunologic Factors|immunologic factors|mesh-ancestor
6095332|NCT00893997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095333|NCT00894166|Bupropion|bupropion|mesh-list
6095334|NCT00894166|Nicotine|nicotine|mesh-list
6095335|NCT00894166|Varenicline|varenicline|mesh-list
6095336|NCT00894166|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6095337|NCT00894166|Autonomic Agents|autonomic agents|mesh-ancestor
6095338|NCT00894166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6095339|NCT00894166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095340|NCT00894166|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6095341|NCT00894166|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6095342|NCT00894166|Cholinergic Agents|cholinergic agents|mesh-ancestor
6095343|NCT00894166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6095344|NCT00894166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095345|NCT00894166|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6095346|NCT00894166|Antidepressive Agents|antidepressive agents|mesh-ancestor
6095347|NCT00894166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6095348|NCT00894166|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6095349|NCT00894166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6095350|NCT00894166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6095351|NCT00894166|Dopamine Agents|dopamine agents|mesh-ancestor
6095352|NCT00894166|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6203538|NCT02058290|Anesthetics|anesthetics|mesh-ancestor
6665747|NCT01518608|Narcotics|narcotics|mesh-ancestor
5521040|NCT04318652|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5521041|NCT04318652|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5521042|NCT04318652|Prednisolone phosphate|prednisolone phosphate|mesh-list
5521043|NCT04318652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5521044|NCT04318652|Antiemetics|antiemetics|mesh-ancestor
5521045|NCT04318652|Autonomic Agents|autonomic agents|mesh-ancestor
5521046|NCT04318652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5521047|NCT04318652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521048|NCT04318652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5521049|NCT04318652|Glucocorticoids|glucocorticoids|mesh-ancestor
5521050|NCT04318652|Hormones|hormones|mesh-ancestor
5521051|NCT04318652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5521052|NCT04318652|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5521053|NCT04318652|Protective Agents|protective agents|mesh-ancestor
5521054|NCT04318652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6095353|NCT00894166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6095354|NCT00894166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6095355|NCT00894322|Exenatide|exenatide|mesh-list
6095356|NCT00894322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6095357|NCT00894322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095358|NCT00894322|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6095359|NCT00894322|Incretins|incretins|mesh-ancestor
6095360|NCT00894322|Hormones|hormones|mesh-ancestor
6095361|NCT00894322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6095362|NCT00894413|Tadalafil|tadalafil|mesh-list
6095363|NCT00894413|Vasodilator Agents|vasodilator agents|mesh-ancestor
6665748|NCT01518608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6665749|NCT01518608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665750|NCT01518608|Analgesics|analgesics|mesh-ancestor
6095364|NCT00894413|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6095365|NCT00894413|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6095366|NCT00894413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6095367|NCT00894413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095368|NCT00894413|Urological Agents|urological agents|mesh-ancestor
6095369|NCT00894465|Midazolam|midazolam|mesh-list
6095370|NCT00894465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6095371|NCT00894465|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6095372|NCT00894465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6095373|NCT00894465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095374|NCT00894465|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6095375|NCT00894465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6095376|NCT00894465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6095377|NCT00894465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6095378|NCT00894465|Anesthetics, General|anesthetics, general|mesh-ancestor
6095379|NCT00894465|Anesthetics|anesthetics|mesh-ancestor
6095380|NCT00894465|GABA Modulators|gaba modulators|mesh-ancestor
6095381|NCT00894465|GABA Agents|gaba agents|mesh-ancestor
6095382|NCT00894465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6095383|NCT00894465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095384|NCT00894504|Gemcitabine|gemcitabine|mesh-list
6095385|NCT00894504|Carboplatin|carboplatin|mesh-list
6095386|NCT00894504|Panitumumab|panitumumab|mesh-list
6095387|NCT00894504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6095388|NCT00894504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6095389|NCT00894504|Antimetabolites|antimetabolites|mesh-ancestor
6095390|NCT00894504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095391|NCT00894504|Antiviral Agents|antiviral agents|mesh-ancestor
6095392|NCT00894504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6095393|NCT00894504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6095394|NCT00894504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6095395|NCT00894504|Immunologic Factors|immunologic factors|mesh-ancestor
6095396|NCT00894504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095397|NCT00894504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6095398|NCT00894517|Botulinum Toxins|botulinum toxins|mesh-list
6095399|NCT00894517|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6095400|NCT00894517|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6095401|NCT00894517|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6095402|NCT00894517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6095403|NCT00894517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095404|NCT00894517|Cholinergic Agents|cholinergic agents|mesh-ancestor
6095405|NCT00894517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6095406|NCT00894517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095407|NCT00894517|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6095408|NCT00894517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6095409|NCT00894543|Citalopram|citalopram|mesh-list
6095410|NCT00894543|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6095411|NCT00894543|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6095412|NCT00894543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6095413|NCT00894543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095414|NCT00894543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6095415|NCT00894543|Serotonin Agents|serotonin agents|mesh-ancestor
6095416|NCT00894543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095417|NCT00894543|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6095418|NCT00894543|Antidepressive Agents|antidepressive agents|mesh-ancestor
6095419|NCT00894543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6095420|NCT00894647|Imiquimod|imiquimod|mesh-list
6095421|NCT00894647|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6095422|NCT00894647|Immunologic Factors|immunologic factors|mesh-ancestor
6095423|NCT00894647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095424|NCT00894647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6095425|NCT00894647|Interferon Inducers|interferon inducers|mesh-ancestor
6095426|NCT00894699|Sufentanil|sufentanil|mesh-list
5521055|NCT04318652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5521056|NCT04318652|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5521057|NCT04318158|Fentanyl|fentanyl|mesh-list
5521058|NCT04318158|Dexmedetomidine|dexmedetomidine|mesh-list
5521059|NCT04318158|Bupivacaine|bupivacaine|mesh-list
5521060|NCT04318158|Anesthetics, Local|anesthetics, local|mesh-ancestor
5521061|NCT04318158|Anesthetics|anesthetics|mesh-ancestor
5521062|NCT04318158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5521063|NCT04318158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521064|NCT04318158|Sensory System Agents|sensory system agents|mesh-ancestor
5521065|NCT04318158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5521066|NCT04318158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5521067|NCT04318158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5521068|NCT04318158|Analgesics|analgesics|mesh-ancestor
5521069|NCT04318158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5521070|NCT04318158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5521071|NCT04318158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5521072|NCT04318158|Adrenergic Agents|adrenergic agents|mesh-ancestor
5521073|NCT04318158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5521074|NCT04318158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521075|NCT04318158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5521076|NCT04318158|Narcotics|narcotics|mesh-ancestor
5521077|NCT04318158|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5521078|NCT04318158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5521079|NCT04318158|Anesthetics, General|anesthetics, general|mesh-ancestor
5521080|NCT04318210|Tenofovir|tenofovir|mesh-list
6095427|NCT00894699|Triazolam|triazolam|mesh-list
6095428|NCT00894699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6095429|NCT00894699|Narcotics|narcotics|mesh-ancestor
6095430|NCT00894699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6095431|NCT00894699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095432|NCT00894699|Analgesics|analgesics|mesh-ancestor
6095433|NCT00894699|Sensory System Agents|sensory system agents|mesh-ancestor
6095434|NCT00894699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6095435|NCT00894699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6095436|NCT00894699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5521081|NCT04318210|Emtricitabine|emtricitabine|mesh-list
5521082|NCT04318210|Antiviral Agents|antiviral agents|mesh-ancestor
5521083|NCT04318210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5521084|NCT04318210|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5521085|NCT04318210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5521086|NCT04318210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5521087|NCT04318210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521088|NCT04318210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5521089|NCT04318210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5521090|NCT04318223|Palbociclib|palbociclib|mesh-list
5521091|NCT04318223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5521092|NCT04318223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5521093|NCT04318223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5521094|NCT04318223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095437|NCT00894699|Anesthetics, General|anesthetics, general|mesh-ancestor
6095438|NCT00894699|Anesthetics|anesthetics|mesh-ancestor
6095439|NCT00894699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6095440|NCT00894699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6095441|NCT00894699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6095442|NCT00894699|GABA Modulators|gaba modulators|mesh-ancestor
6095443|NCT00894699|GABA Agents|gaba agents|mesh-ancestor
6095444|NCT00894699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5607029|NCT03031730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6095445|NCT00894699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095446|NCT00894803|Eptifibatide|eptifibatide|mesh-list
6095447|NCT00894803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6203539|NCT02058290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6203540|NCT02058290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203541|NCT02058290|Sensory System Agents|sensory system agents|mesh-ancestor
6203542|NCT02058290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6464564|NCT00470015|Sensory System Agents|sensory system agents|mesh-ancestor
5521095|NCT04318262|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6203543|NCT02058290|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6203544|NCT02058290|Narcotics|narcotics|mesh-ancestor
6203545|NCT02058290|Analgesics|analgesics|mesh-ancestor
6203546|NCT02058368|Tamsulosin|tamsulosin|mesh-list
6203547|NCT02058368|Dutasteride|dutasteride|mesh-list
5521096|NCT04318262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5521097|NCT04318067|Melatonin|melatonin|mesh-list
5521098|NCT04318067|Antioxidants|antioxidants|mesh-ancestor
5521099|NCT04318067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203548|NCT02058368|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6203549|NCT02058368|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6203550|NCT02058368|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6203551|NCT02058368|Adrenergic Agents|adrenergic agents|mesh-ancestor
6203552|NCT02058368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6203553|NCT02058368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203554|NCT02058368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203555|NCT02058368|Urological Agents|urological agents|mesh-ancestor
6203556|NCT02058368|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6203557|NCT02058368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6203558|NCT02058368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6203559|NCT02058368|Hormone Antagonists|hormone antagonists|mesh-ancestor
6203560|NCT02058368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6203561|NCT02058511|Anesthetics|anesthetics|mesh-list
6203562|NCT02058511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6203563|NCT02058511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203564|NCT02058628|Clindamycin|clindamycin|mesh-list
6203565|NCT02058628|Clindamycin palmitate|clindamycin palmitate|mesh-list
6203566|NCT02058628|Clindamycin phosphate|clindamycin phosphate|mesh-list
6203567|NCT02058628|Azelaic acid|azelaic acid|mesh-list
6203568|NCT02058628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6203569|NCT02058628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6203570|NCT02058628|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6203571|NCT02058628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5521100|NCT04318067|Protective Agents|protective agents|mesh-ancestor
5521101|NCT04318067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521102|NCT04318067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5521103|NCT04317872|Dexamethasone|dexamethasone|mesh-list
5521104|NCT04317872|Dexamethasone acetate|dexamethasone acetate|mesh-list
5521105|NCT04317872|BB 1101|bb 1101|mesh-list
5521106|NCT04317872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5521107|NCT04317872|Antiemetics|antiemetics|mesh-ancestor
5521108|NCT04317872|Autonomic Agents|autonomic agents|mesh-ancestor
5521109|NCT04317872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5521110|NCT04317872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521111|NCT04317872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5521112|NCT04317872|Glucocorticoids|glucocorticoids|mesh-ancestor
5521113|NCT04317872|Hormones|hormones|mesh-ancestor
5521114|NCT04317872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5521115|NCT04317872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5521116|NCT04317872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5521117|NCT04317872|Protease Inhibitors|protease inhibitors|mesh-ancestor
5521118|NCT04317872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5521119|NCT04317872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521120|NCT04317703|Metformin|metformin|mesh-list
6203572|NCT02058628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203573|NCT02058628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6203574|NCT02058628|Dermatologic Agents|dermatologic agents|mesh-ancestor
5521121|NCT04317703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6095448|NCT00895037|Factor VIII|factor viii|mesh-list
6095449|NCT00895037|Coagulants|coagulants|mesh-ancestor
6095450|NCT00895180|Ramucirumab|ramucirumab|mesh-list
6095451|NCT00895180|Olaratumab|olaratumab|mesh-list
6095452|NCT00895180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6095453|NCT00895193|Aspirin|aspirin|mesh-list
6095454|NCT00895193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6095455|NCT00895193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6095456|NCT00895193|Analgesics|analgesics|mesh-ancestor
6095457|NCT00895193|Sensory System Agents|sensory system agents|mesh-ancestor
6095458|NCT00895193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6095459|NCT00895193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095460|NCT00895193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6095461|NCT00895193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6095462|NCT00895193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6464565|NCT00470015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6464566|NCT00470015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464567|NCT00470015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6464568|NCT00470015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6464569|NCT00470015|Antiviral Agents|antiviral agents|mesh-ancestor
5521122|NCT04317703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521123|NCT04317300|Varenicline|varenicline|mesh-list
5521124|NCT04317300|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5521125|NCT04317300|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5521126|NCT04317300|Cholinergic Agents|cholinergic agents|mesh-ancestor
5521127|NCT04317300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5521128|NCT04317300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521129|NCT04317300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521130|NCT04317508|Benzocaine|benzocaine|mesh-list
5521131|NCT04317508|Anesthetics, Local|anesthetics, local|mesh-ancestor
5521132|NCT04317508|Anesthetics|anesthetics|mesh-ancestor
5521133|NCT04317508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5521134|NCT04317508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095463|NCT00895193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6095464|NCT00895193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095465|NCT00895193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6095466|NCT00895193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6095467|NCT00895193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6464570|NCT00470015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6464571|NCT00470041|Lamivudine|lamivudine|mesh-list
6464572|NCT00470041|Zidovudine|zidovudine|mesh-list
6464573|NCT00470041|Antiviral Agents|antiviral agents|mesh-list
6464574|NCT00470041|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6464575|NCT00470041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6464576|NCT00470041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6095468|NCT00895193|Antipyretics|antipyretics|mesh-ancestor
6095469|NCT00895232|Iron|iron|mesh-list
6095470|NCT00895232|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6095471|NCT00895232|Trace Elements|trace elements|mesh-ancestor
6095472|NCT00895232|Micronutrients|micronutrients|mesh-ancestor
6095473|NCT00895232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095474|NCT00895232|Hematinics|hematinics|mesh-ancestor
6095475|NCT00895245|Dexamethasone|dexamethasone|mesh-list
6095476|NCT00895245|Palonosetron|palonosetron|mesh-list
6095477|NCT00895245|Fosaprepitant|fosaprepitant|mesh-list
6095478|NCT00895245|Aprepitant|aprepitant|mesh-list
6095479|NCT00895245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6095480|NCT00895245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6095481|NCT00895245|Antiemetics|antiemetics|mesh-ancestor
6095482|NCT00895245|Autonomic Agents|autonomic agents|mesh-ancestor
6095483|NCT00895245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6095484|NCT00895245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095485|NCT00895245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6095486|NCT00895245|Glucocorticoids|glucocorticoids|mesh-ancestor
6095487|NCT00895245|Hormones|hormones|mesh-ancestor
6095488|NCT00895245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6095489|NCT00895245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6095490|NCT00895245|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6665751|NCT01518608|Sensory System Agents|sensory system agents|mesh-ancestor
5521135|NCT04317508|Sensory System Agents|sensory system agents|mesh-ancestor
5521136|NCT04317508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5521137|NCT04317430|Niclosamide|niclosamide|mesh-list
5521138|NCT04317430|Anticestodal Agents|anticestodal agents|mesh-ancestor
5521139|NCT04317430|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5521140|NCT04317430|Anthelmintics|anthelmintics|mesh-ancestor
6095491|NCT00895245|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6095492|NCT00895245|Serotonin Agents|serotonin agents|mesh-ancestor
6095493|NCT00895245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6095494|NCT00895245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095495|NCT00895245|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6095496|NCT00895310|Ketoconazole|ketoconazole|mesh-list
6095497|NCT00895310|Hydrocortisone|hydrocortisone|mesh-list
5521141|NCT04317430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6095498|NCT00895310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6095499|NCT00895310|Antifungal Agents|antifungal agents|mesh-ancestor
6095500|NCT00895310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6095501|NCT00895310|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6095502|NCT00895310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6095503|NCT00895310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6095504|NCT00895310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095505|NCT00895310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6095506|NCT00895310|Hormone Antagonists|hormone antagonists|mesh-ancestor
6095507|NCT00895310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6095508|NCT00895310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095509|NCT00895310|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6095510|NCT00895414|Doxorubicin|doxorubicin|mesh-list
6095511|NCT00895414|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6095512|NCT00895414|Enalapril|enalapril|mesh-list
6095513|NCT00895414|Enalaprilat|enalaprilat|mesh-list
6095514|NCT00895414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6095515|NCT00895414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6095516|NCT00895414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6095517|NCT00895414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6095518|NCT00895414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6095519|NCT00895414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095520|NCT00895414|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6095521|NCT00895414|Protease Inhibitors|protease inhibitors|mesh-ancestor
6095522|NCT00895414|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6095523|NCT00895453|Iron|iron|mesh-list
6095524|NCT00895453|Itraconazole|itraconazole|mesh-list
6095525|NCT00895453|Antifungal Agents|antifungal agents|mesh-ancestor
6095526|NCT00895453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6095527|NCT00895453|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6095528|NCT00895453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6095529|NCT00895453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6095530|NCT00895453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095531|NCT00895453|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6095532|NCT00895453|Hormone Antagonists|hormone antagonists|mesh-ancestor
6095533|NCT00895453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6095534|NCT00895453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521142|NCT04317430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5521143|NCT04317430|Antinematodal Agents|antinematodal agents|mesh-ancestor
5521144|NCT04317235|Ropivacaine|ropivacaine|mesh-list
5521145|NCT04317235|Anesthetics, Local|anesthetics, local|mesh-ancestor
5521146|NCT04317235|Anesthetics|anesthetics|mesh-ancestor
5521147|NCT04317235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5521148|NCT04317235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521149|NCT04317235|Sensory System Agents|sensory system agents|mesh-ancestor
5521150|NCT04317235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5521151|NCT04317248|Cyclophosphamide|cyclophosphamide|mesh-list
5521152|NCT04317248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5521153|NCT04317248|Immunologic Factors|immunologic factors|mesh-ancestor
5521154|NCT04317248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095535|NCT00895453|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6095536|NCT00895453|Trace Elements|trace elements|mesh-ancestor
6095537|NCT00895453|Micronutrients|micronutrients|mesh-ancestor
6095538|NCT00895531|Morphine|morphine|mesh-list
6095539|NCT00895531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6095540|NCT00895531|Narcotics|narcotics|mesh-ancestor
6095541|NCT00895531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6095542|NCT00895531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095543|NCT00895531|Analgesics|analgesics|mesh-ancestor
6095544|NCT00895531|Sensory System Agents|sensory system agents|mesh-ancestor
6095545|NCT00895531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6095546|NCT00895583|Sirolimus|sirolimus|mesh-list
6095547|NCT00895583|Tacrolimus|tacrolimus|mesh-list
6095548|NCT00895583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6095549|NCT00895583|Immunologic Factors|immunologic factors|mesh-ancestor
6095550|NCT00895583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095551|NCT00895583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6095552|NCT00895583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6095553|NCT00895583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095554|NCT00895583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6095555|NCT00895583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5521155|NCT04317248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5521156|NCT04317248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5521157|NCT04317248|Alkylating Agents|alkylating agents|mesh-ancestor
5521158|NCT04317248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521159|NCT04317248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5521160|NCT04317248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5521161|NCT04316936|Dexamethasone|dexamethasone|mesh-list
5521162|NCT04316936|Prednisolone|prednisolone|mesh-list
5521163|NCT04316936|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5521164|NCT04316936|Methylprednisolone|methylprednisolone|mesh-list
6095556|NCT00895583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6095557|NCT00895583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6095558|NCT00895583|Antifungal Agents|antifungal agents|mesh-ancestor
6095559|NCT00895661|Rituximab|rituximab|mesh-list
6095560|NCT00895661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6095561|NCT00895661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6095562|NCT00895661|Immunologic Factors|immunologic factors|mesh-ancestor
6095563|NCT00895661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095564|NCT00895661|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5521165|NCT04316936|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5521166|NCT04316936|Prednisolone acetate|prednisolone acetate|mesh-list
5521167|NCT04316936|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5521168|NCT04316936|Prednisolone phosphate|prednisolone phosphate|mesh-list
5521169|NCT04316936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5521170|NCT04316936|Antiemetics|antiemetics|mesh-ancestor
5521171|NCT04316936|Autonomic Agents|autonomic agents|mesh-ancestor
5521172|NCT04316936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5521173|NCT04316936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521174|NCT04316936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5521175|NCT04316936|Glucocorticoids|glucocorticoids|mesh-ancestor
5521176|NCT04316936|Hormones|hormones|mesh-ancestor
5521177|NCT04316936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5521178|NCT04316936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5521179|NCT04316936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5521180|NCT04316936|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5521181|NCT04316936|Protective Agents|protective agents|mesh-ancestor
5521182|NCT04317157|Caffeine|caffeine|mesh-list
5521183|NCT04317157|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5521184|NCT04317157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521185|NCT04317157|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5521186|NCT04317157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5607030|NCT03031730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095565|NCT00895752|Riluzole|riluzole|mesh-list
6095566|NCT00895752|Anticonvulsants|anticonvulsants|mesh-ancestor
6095567|NCT00895752|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6095568|NCT00895752|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6095569|NCT00895752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6095570|NCT00895752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095571|NCT00895752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095572|NCT00895752|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6095573|NCT00895752|Protective Agents|protective agents|mesh-ancestor
6095574|NCT00895817|Fluticasone|fluticasone|mesh-list
6095575|NCT00895817|Esomeprazole|esomeprazole|mesh-list
6095576|NCT00895817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6095577|NCT00895817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6095578|NCT00895817|Autonomic Agents|autonomic agents|mesh-ancestor
6095579|NCT00895817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6095580|NCT00895817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095581|NCT00895817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6095582|NCT00895817|Respiratory System Agents|respiratory system agents|mesh-ancestor
6095583|NCT00895817|Dermatologic Agents|dermatologic agents|mesh-ancestor
6095584|NCT00895817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6095585|NCT00895817|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6095586|NCT00895817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6095587|NCT00895817|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6095588|NCT00895817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6095589|NCT00895817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095590|NCT00895843|Ibuprofen|ibuprofen|mesh-list
6095591|NCT00895843|Epinephrine|epinephrine|mesh-list
6095592|NCT00895843|Bupivacaine|bupivacaine|mesh-list
6095593|NCT00895843|Anesthetics, Local|anesthetics, local|mesh-ancestor
6095594|NCT00895843|Anesthetics|anesthetics|mesh-ancestor
6095595|NCT00895843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6095596|NCT00895843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095597|NCT00895843|Sensory System Agents|sensory system agents|mesh-ancestor
6095598|NCT00895843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6095599|NCT00895843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6095600|NCT00895843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6095601|NCT00895843|Analgesics|analgesics|mesh-ancestor
6095602|NCT00895843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6095603|NCT00895843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6095604|NCT00895843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6095605|NCT00895843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6095606|NCT00895843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095607|NCT00895843|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6095608|NCT00895843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6095609|NCT00895843|Adrenergic Agents|adrenergic agents|mesh-ancestor
6095610|NCT00895843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6095611|NCT00895843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6095612|NCT00895843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6095613|NCT00895843|Autonomic Agents|autonomic agents|mesh-ancestor
6095614|NCT00895843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6095615|NCT00895843|Respiratory System Agents|respiratory system agents|mesh-ancestor
6095616|NCT00895843|Mydriatics|mydriatics|mesh-ancestor
6095617|NCT00895843|Sympathomimetics|sympathomimetics|mesh-ancestor
6095618|NCT00895843|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6095619|NCT00895895|Donepezil|donepezil|mesh-list
6095620|NCT00895895|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6095621|NCT00895895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6095622|NCT00895895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095623|NCT00895895|Cholinergic Agents|cholinergic agents|mesh-ancestor
6095624|NCT00895895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6095625|NCT00895895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095626|NCT00895895|Nootropic Agents|nootropic agents|mesh-ancestor
6095627|NCT00895921|Olanzapine|olanzapine|mesh-list
6095628|NCT00895921|Aripiprazole|aripiprazole|mesh-list
5521187|NCT04317157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521188|NCT04317157|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5521189|NCT04317157|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5521190|NCT04317157|Purinergic Agents|purinergic agents|mesh-ancestor
5521191|NCT04317157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5521192|NCT04317079|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
5521193|NCT04317079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6095629|NCT00895921|Antiemetics|antiemetics|mesh-ancestor
6095630|NCT00895921|Autonomic Agents|autonomic agents|mesh-ancestor
6095631|NCT00895921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6095632|NCT00895921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095633|NCT00895921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6095634|NCT00895921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6095635|NCT00895921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6095636|NCT00895921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6095637|NCT00895921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6095638|NCT00895921|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6095639|NCT00895921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6095640|NCT00895921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5521194|NCT04317079|Antioxidants|antioxidants|mesh-ancestor
5521195|NCT04317079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203575|NCT02058836|Botulinum Toxins|botulinum toxins|mesh-list
6095641|NCT00895921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095642|NCT00895921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6095643|NCT00895921|Serotonin Agents|serotonin agents|mesh-ancestor
6095644|NCT00895921|Antidepressive Agents|antidepressive agents|mesh-ancestor
6095645|NCT00895921|Dopamine Agonists|dopamine agonists|mesh-ancestor
6095646|NCT00895921|Dopamine Agents|dopamine agents|mesh-ancestor
6095647|NCT00895921|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6095648|NCT00895921|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6095649|NCT00895921|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6095650|NCT00895921|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6095651|NCT00895921|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6095652|NCT00895921|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6095653|NCT00895934|Azacitidine|azacitidine|mesh-list
6095654|NCT00895934|Vorinostat|vorinostat|mesh-list
6095655|NCT00895934|Gemtuzumab|gemtuzumab|mesh-list
6095656|NCT00895934|Calicheamicins|calicheamicins|mesh-list
6095657|NCT00895934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6095658|NCT00895934|Antimetabolites|antimetabolites|mesh-ancestor
6095659|NCT00895934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095660|NCT00895934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6095661|NCT00895934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6095662|NCT00895934|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6095663|NCT00895934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6095664|NCT00895934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6095665|NCT00895947|Interferons|interferons|mesh-list
6095666|NCT00895947|Interferon-alpha|interferon-alpha|mesh-list
6095667|NCT00895947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6095668|NCT00895947|Antiviral Agents|antiviral agents|mesh-ancestor
6095669|NCT00895947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6095670|NCT00895947|Immunologic Factors|immunologic factors|mesh-ancestor
6095671|NCT00895947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095672|NCT00896012|Sirolimus|sirolimus|mesh-list
6095673|NCT00896012|Tacrolimus|tacrolimus|mesh-list
6095674|NCT00896012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6095675|NCT00896012|Immunologic Factors|immunologic factors|mesh-ancestor
6095676|NCT00896012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095677|NCT00896012|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6095678|NCT00896012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6095679|NCT00896012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095680|NCT00896012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6095681|NCT00896012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6095682|NCT00896012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6095683|NCT00896012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6095684|NCT00896012|Antifungal Agents|antifungal agents|mesh-ancestor
6095685|NCT00896038|Aprepitant|aprepitant|mesh-list
6095686|NCT00896038|Antiemetics|antiemetics|mesh-ancestor
6095687|NCT00896038|Autonomic Agents|autonomic agents|mesh-ancestor
6095688|NCT00896038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6095689|NCT00896038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095690|NCT00896038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6095691|NCT00896038|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6095692|NCT00896038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6095693|NCT00896038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095694|NCT00896051|Ritonavir|ritonavir|mesh-list
6095695|NCT00896051|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6095696|NCT00896051|Tenofovir|tenofovir|mesh-list
6095697|NCT00896051|Etravirine|etravirine|mesh-list
6095698|NCT00896051|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
6095699|NCT00896051|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6095700|NCT00896051|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6095701|NCT00896051|Protease Inhibitors|protease inhibitors|mesh-ancestor
6095702|NCT00896051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6095703|NCT00896051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095704|NCT00896051|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6095705|NCT00896051|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6665752|NCT01518608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5521196|NCT04317079|Protective Agents|protective agents|mesh-ancestor
6095706|NCT00896051|Antiviral Agents|antiviral agents|mesh-ancestor
6095707|NCT00896051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6095708|NCT00896051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6095709|NCT00896051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5521197|NCT04317079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095710|NCT00896051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6095711|NCT00896064|Vaccines|vaccines|mesh-list
6095712|NCT00896064|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6095713|NCT00896064|Immunologic Factors|immunologic factors|mesh-ancestor
6095714|NCT00896064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095715|NCT00896168|Methotrexate|methotrexate|mesh-list
6095716|NCT00896168|Infliximab|infliximab|mesh-list
6095717|NCT00896168|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5521198|NCT04317079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5521199|NCT04317183|Miconazole|miconazole|mesh-list
5521200|NCT04317183|Antifungal Agents|antifungal agents|mesh-ancestor
5521201|NCT04317183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5521202|NCT04317183|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5521203|NCT04317183|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5521204|NCT04317183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5521205|NCT04317183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521206|NCT04317183|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5521207|NCT04317183|Hormone Antagonists|hormone antagonists|mesh-ancestor
5521208|NCT04317183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5521209|NCT04317183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521210|NCT04317183|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5521211|NCT04317183|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5521212|NCT04317001|Modafinil|modafinil|mesh-list
5521213|NCT04317001|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5521214|NCT04317001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521215|NCT04317001|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
5521216|NCT04317001|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5521217|NCT04317001|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5521218|NCT04317001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095718|NCT00896168|Abortifacient Agents|abortifacient agents|mesh-ancestor
6095719|NCT00896168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6095720|NCT00896168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095721|NCT00896168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6095722|NCT00896168|Antimetabolites|antimetabolites|mesh-ancestor
6095723|NCT00896168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521219|NCT04316845|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
5521220|NCT04316845|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5521221|NCT04316845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095724|NCT00896168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6095725|NCT00896168|Dermatologic Agents|dermatologic agents|mesh-ancestor
6095726|NCT00896168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6095727|NCT00896168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6095728|NCT00896168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6095729|NCT00896168|Immunologic Factors|immunologic factors|mesh-ancestor
6095730|NCT00896168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6095731|NCT00896168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6095732|NCT00896168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6095733|NCT00896181|Carboplatin|carboplatin|mesh-list
6095734|NCT00896181|Docetaxel|docetaxel|mesh-list
6095735|NCT00896181|Fluorouracil|fluorouracil|mesh-list
6095736|NCT00896181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6095737|NCT00896181|Tubulin Modulators|tubulin modulators|mesh-ancestor
6095738|NCT00896181|Antimitotic Agents|antimitotic agents|mesh-ancestor
6464577|NCT00470041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6464578|NCT00470041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6464579|NCT00470041|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6464580|NCT00470041|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6464581|NCT00470041|Antimetabolites|antimetabolites|mesh-ancestor
6464582|NCT00470197|Cytarabine|cytarabine|mesh-list
6464583|NCT00470197|Mitoxantrone|mitoxantrone|mesh-list
6464584|NCT00470197|Alvocidib|alvocidib|mesh-list
6464585|NCT00470197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6464586|NCT00470197|Antimetabolites|antimetabolites|mesh-ancestor
6464587|NCT00470197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6464588|NCT00470197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6464589|NCT00470197|Antiviral Agents|antiviral agents|mesh-ancestor
6464590|NCT00470197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6464591|NCT00470197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6464592|NCT00470197|Immunologic Factors|immunologic factors|mesh-ancestor
6464593|NCT00470197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464594|NCT00470197|Analgesics|analgesics|mesh-ancestor
6464595|NCT00470197|Sensory System Agents|sensory system agents|mesh-ancestor
6464596|NCT00470197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6464597|NCT00470197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6464598|NCT00470197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6464599|NCT00470197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6464600|NCT00470197|Growth Inhibitors|growth inhibitors|mesh-ancestor
6464601|NCT00470197|Growth Substances|growth substances|mesh-ancestor
6464602|NCT00470197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6464603|NCT00470210|Ribavirin|ribavirin|mesh-list
6464604|NCT00470210|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6464605|NCT00470210|Antimetabolites|antimetabolites|mesh-ancestor
6464606|NCT00470210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6464607|NCT00470210|Antiviral Agents|antiviral agents|mesh-ancestor
6464608|NCT00470210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6464609|NCT00470223|Zoledronic Acid|zoledronic acid|mesh-list
6464610|NCT00470223|Doxorubicin|doxorubicin|mesh-list
6464611|NCT00470223|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6464612|NCT00470223|Methotrexate|methotrexate|mesh-list
6464613|NCT00470223|Etoposide|etoposide|mesh-list
6464614|NCT00470223|Ifosfamide|ifosfamide|mesh-list
6464615|NCT00470223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6464616|NCT00470223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6464617|NCT00470223|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6464618|NCT00470223|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6464619|NCT00470223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6464620|NCT00470223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095739|NCT00896181|Mitosis Modulators|mitosis modulators|mesh-ancestor
6095740|NCT00896181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095741|NCT00896181|Antimetabolites|antimetabolites|mesh-ancestor
6095742|NCT00896181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6095743|NCT00896181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6095744|NCT00896181|Immunologic Factors|immunologic factors|mesh-ancestor
6095745|NCT00896181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095746|NCT00896389|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6095747|NCT00896389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6095748|NCT00896389|Diuretics|diuretics|mesh-ancestor
6095749|NCT00896389|Natriuretic Agents|natriuretic agents|mesh-ancestor
6095750|NCT00896389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095751|NCT00896389|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6095752|NCT00896389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6095753|NCT00896389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095754|NCT00896441|Citalopram|citalopram|mesh-list
6095755|NCT00896441|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6095756|NCT00896441|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6095757|NCT00896441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6095758|NCT00896441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521226|NCT04316390|Vitamins|vitamins|mesh-list
5521227|NCT04316390|Ascorbic Acid|ascorbic acid|mesh-list
5521228|NCT04316390|Micronutrients|micronutrients|mesh-ancestor
5521229|NCT04316390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521230|NCT04316390|Antioxidants|antioxidants|mesh-ancestor
5521231|NCT04316390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521232|NCT04316390|Protective Agents|protective agents|mesh-ancestor
5521233|NCT04316676|Regadenoson|regadenoson|mesh-list
5521234|NCT04316676|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
5521235|NCT04316676|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5521236|NCT04316676|Purinergic Agonists|purinergic agonists|mesh-ancestor
5521237|NCT04316676|Purinergic Agents|purinergic agents|mesh-ancestor
5521238|NCT04316676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5521239|NCT04316676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521240|NCT04316676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521241|NCT04316377|Hydroxychloroquine|hydroxychloroquine|mesh-list
5521242|NCT04316377|Antimalarials|antimalarials|mesh-ancestor
5521243|NCT04316377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5521244|NCT04316377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5521245|NCT04316377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5521246|NCT04316377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5521247|NCT04316377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095759|NCT00896441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6095760|NCT00896441|Serotonin Agents|serotonin agents|mesh-ancestor
6095761|NCT00896441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095762|NCT00896441|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6095763|NCT00896441|Antidepressive Agents|antidepressive agents|mesh-ancestor
6095764|NCT00896441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6095765|NCT00896454|Denosumab|denosumab|mesh-list
6095766|NCT00896454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6464621|NCT00470223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5521248|NCT04316377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6095767|NCT00896454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095768|NCT00896532|Zoledronic Acid|zoledronic acid|mesh-list
6095769|NCT00896532|Denosumab|denosumab|mesh-list
6095770|NCT00896532|Alendronate|alendronate|mesh-list
6095771|NCT00896532|Teriparatide|teriparatide|mesh-list
6095772|NCT00896532|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6095773|NCT00896532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6095774|NCT00896532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095775|NCT00896532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6095776|NCT00896532|Immunologic Factors|immunologic factors|mesh-ancestor
6095777|NCT00896779|Ranibizumab|ranibizumab|mesh-list
6095778|NCT00896779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6095779|NCT00896779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6095780|NCT00896779|Growth Substances|growth substances|mesh-ancestor
6095781|NCT00896779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095782|NCT00896779|Growth Inhibitors|growth inhibitors|mesh-ancestor
6095783|NCT00896779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6095784|NCT00897390|Metformin|metformin|mesh-list
6095785|NCT00897390|Saxagliptin|saxagliptin|mesh-list
6095786|NCT00897390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6095787|NCT00897390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095788|NCT00897390|Incretins|incretins|mesh-ancestor
6095789|NCT00897390|Hormones|hormones|mesh-ancestor
6095790|NCT00897390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6095791|NCT00897390|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6095792|NCT00897390|Protease Inhibitors|protease inhibitors|mesh-ancestor
6095793|NCT00897390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6095794|NCT00897390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095795|NCT00897715|Rilonacept|rilonacept|mesh-list
6095796|NCT00897715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6095797|NCT00898222|Aspirin|aspirin|mesh-list
6095798|NCT00898222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6095799|NCT00898222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6095800|NCT00898222|Analgesics|analgesics|mesh-ancestor
6095801|NCT00898222|Sensory System Agents|sensory system agents|mesh-ancestor
6095802|NCT00898222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6095803|NCT00898222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095804|NCT00898222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6095805|NCT00898222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6095806|NCT00898222|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6095807|NCT00898222|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6095808|NCT00898222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095809|NCT00898222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6095810|NCT00898222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6095811|NCT00898222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6095812|NCT00898222|Antipyretics|antipyretics|mesh-ancestor
6095813|NCT00898443|Anesthetics|anesthetics|mesh-list
5521249|NCT04316702|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5521250|NCT04316702|Analgesics|analgesics|mesh-ancestor
5521251|NCT04316702|Sensory System Agents|sensory system agents|mesh-ancestor
5521252|NCT04316702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5521253|NCT04316702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521254|NCT04316702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5521255|NCT04316702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521256|NCT04316702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5521257|NCT04316702|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5521258|NCT04316702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5521259|NCT04316702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5521260|NCT04316702|Antidepressive Agents|antidepressive agents|mesh-ancestor
6464622|NCT00470223|Abortifacient Agents|abortifacient agents|mesh-ancestor
6464623|NCT00470223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6464624|NCT00470223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464625|NCT00470223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6464626|NCT00470223|Antimetabolites|antimetabolites|mesh-ancestor
6095814|NCT00898443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6095815|NCT00898443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095816|NCT00898560|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
6095817|NCT00898560|Anticonvulsants|anticonvulsants|mesh-ancestor
6095818|NCT00898560|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6095819|NCT00898560|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6095820|NCT00898560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6095821|NCT00898560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095822|NCT00898807|Citalopram|citalopram|mesh-list
6095823|NCT00898807|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6095824|NCT00898807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6095825|NCT00898807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6095826|NCT00898807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095827|NCT00898807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6095828|NCT00898807|Serotonin Agents|serotonin agents|mesh-ancestor
6095829|NCT00898807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095830|NCT00898807|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6095831|NCT00898807|Antidepressive Agents|antidepressive agents|mesh-ancestor
6095832|NCT00898807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6095833|NCT00899431|Vidarabine|vidarabine|mesh-list
6095834|NCT00899431|Rituximab|rituximab|mesh-list
6095835|NCT00899431|Fludarabine|fludarabine|mesh-list
6095836|NCT00899431|Fludarabine phosphate|fludarabine phosphate|mesh-list
6095837|NCT00899431|Lenalidomide|lenalidomide|mesh-list
6095838|NCT00899431|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6095839|NCT00899431|Allopurinol|allopurinol|mesh-list
6095840|NCT00899431|Thymoglobulin|thymoglobulin|mesh-list
6095841|NCT00899431|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6095842|NCT00899431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6095843|NCT00899431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6095844|NCT00899431|Immunologic Factors|immunologic factors|mesh-ancestor
6095845|NCT00899431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095846|NCT00899431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6095847|NCT00899431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6095848|NCT00899431|Antimetabolites|antimetabolites|mesh-ancestor
6095849|NCT00899431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095850|NCT00899431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6095851|NCT00899431|Antiviral Agents|antiviral agents|mesh-ancestor
6095852|NCT00899431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6095853|NCT00899431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6095854|NCT00899431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5521261|NCT04316702|Dopamine Agents|dopamine agents|mesh-ancestor
5521262|NCT04316351|Pemetrexed|pemetrexed|mesh-list
5521263|NCT04316351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6095855|NCT00899431|Growth Substances|growth substances|mesh-ancestor
6095856|NCT00899431|Growth Inhibitors|growth inhibitors|mesh-ancestor
6095857|NCT00899431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6095858|NCT00899431|Alkylating Agents|alkylating agents|mesh-ancestor
5521264|NCT04316351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5521265|NCT04316351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521266|NCT04316351|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6095859|NCT00899431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6095860|NCT00899431|Gout Suppressants|gout suppressants|mesh-ancestor
6095861|NCT00899431|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6095862|NCT00899431|Antioxidants|antioxidants|mesh-ancestor
6095863|NCT00899431|Protective Agents|protective agents|mesh-ancestor
6095864|NCT00899470|Metformin|metformin|mesh-list
6095865|NCT00899470|Saxagliptin|saxagliptin|mesh-list
6095866|NCT00899470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6095867|NCT00899470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095868|NCT00899470|Incretins|incretins|mesh-ancestor
5521267|NCT04316351|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5521268|NCT04316494|Hydroxychloroquine|hydroxychloroquine|mesh-list
5521269|NCT04316494|Antimalarials|antimalarials|mesh-ancestor
5521270|NCT04316494|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5521271|NCT04316494|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5521272|NCT04316494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5521273|NCT04316494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5521274|NCT04316494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521275|NCT04316494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5521276|NCT04316442|Immunoconjugates|immunoconjugates|mesh-list
5521277|NCT04316442|Immunologic Factors|immunologic factors|mesh-ancestor
5521278|NCT04316442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600943|NCT03708718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5600944|NCT03708718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095869|NCT00899470|Hormones|hormones|mesh-ancestor
6095870|NCT00899470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6095871|NCT00899470|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6095872|NCT00899470|Protease Inhibitors|protease inhibitors|mesh-ancestor
6095873|NCT00899470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6095874|NCT00899470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095875|NCT00899574|Imiquimod|imiquimod|mesh-list
5600945|NCT03708718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5600946|NCT03708718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5600947|NCT03708627|Bimatoprost|bimatoprost|mesh-list
6095876|NCT00899574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6095877|NCT00899574|Immunologic Factors|immunologic factors|mesh-ancestor
6095878|NCT00899574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095879|NCT00899574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6095880|NCT00899574|Interferon Inducers|interferon inducers|mesh-ancestor
6095881|NCT00899600|Ketamine|ketamine|mesh-list
6095882|NCT00899600|Analgesics|analgesics|mesh-ancestor
6095883|NCT00899600|Sensory System Agents|sensory system agents|mesh-ancestor
6095884|NCT00899600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6095885|NCT00899600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095886|NCT00899600|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6095887|NCT00899600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6095888|NCT00899600|Anesthetics, General|anesthetics, general|mesh-ancestor
6095889|NCT00899600|Anesthetics|anesthetics|mesh-ancestor
5600948|NCT03708627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6095890|NCT00899600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6095891|NCT00899600|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6095892|NCT00899600|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6095893|NCT00899600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6095894|NCT00899600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095895|NCT00899678|Certolizumab Pegol|certolizumab pegol|mesh-list
6095896|NCT00899678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6095897|NCT00899678|Immunologic Factors|immunologic factors|mesh-ancestor
6095898|NCT00899678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095899|NCT00899678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6095900|NCT00899717|Salicylic Acid|salicylic acid|mesh-list
6095901|NCT00899717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6095902|NCT00899717|Antifungal Agents|antifungal agents|mesh-ancestor
6095903|NCT00899717|Keratolytic Agents|keratolytic agents|mesh-ancestor
6095904|NCT00899717|Dermatologic Agents|dermatologic agents|mesh-ancestor
6095905|NCT00899847|Acetaminophen|acetaminophen|mesh-list
6095906|NCT00899847|Diphenhydramine|diphenhydramine|mesh-list
6095907|NCT00899847|Promethazine|promethazine|mesh-list
6095908|NCT00899847|Cyclosporine|cyclosporine|mesh-list
6095909|NCT00899847|Mycophenolic Acid|mycophenolic acid|mesh-list
6095910|NCT00899847|Hydrocortisone|hydrocortisone|mesh-list
6095911|NCT00899847|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6095912|NCT00899847|Cyclophosphamide|cyclophosphamide|mesh-list
6095913|NCT00899847|Melphalan|melphalan|mesh-list
6095914|NCT00899847|Mechlorethamine|mechlorethamine|mesh-list
5600949|NCT03708588|Ticagrelor|ticagrelor|mesh-list
6095915|NCT00899847|Cyclosporins|cyclosporins|mesh-list
6095916|NCT00899847|Thymoglobulin|thymoglobulin|mesh-list
6095917|NCT00899847|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6095918|NCT00899847|Lenograstim|lenograstim|mesh-list
6095919|NCT00899847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6095920|NCT00899847|Immunologic Factors|immunologic factors|mesh-ancestor
6095921|NCT00899847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095922|NCT00899847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6095923|NCT00899847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6095924|NCT00899847|Alkylating Agents|alkylating agents|mesh-ancestor
6095925|NCT00899847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095926|NCT00899847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5521279|NCT04315974|Rivaroxaban|rivaroxaban|mesh-list
5521280|NCT04315974|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5521281|NCT04315974|Antithrombins|antithrombins|mesh-ancestor
5521282|NCT04315974|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6095927|NCT00899847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6095928|NCT00899847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6095929|NCT00899847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6095930|NCT00899847|Antifungal Agents|antifungal agents|mesh-ancestor
6095931|NCT00899847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6095932|NCT00899847|Dermatologic Agents|dermatologic agents|mesh-ancestor
6095933|NCT00899847|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6095934|NCT00899847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6095935|NCT00899847|Analgesics|analgesics|mesh-ancestor
6095936|NCT00899847|Sensory System Agents|sensory system agents|mesh-ancestor
6095937|NCT00899847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6095938|NCT00899847|Antipyretics|antipyretics|mesh-ancestor
6095939|NCT00899847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6095940|NCT00899847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6095941|NCT00899847|Antitubercular Agents|antitubercular agents|mesh-ancestor
6095942|NCT00899847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6095943|NCT00899847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6095944|NCT00899847|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6095945|NCT00899847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6095946|NCT00899847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6095947|NCT00899847|Anesthetics, Local|anesthetics, local|mesh-ancestor
6095948|NCT00899847|Anesthetics|anesthetics|mesh-ancestor
6095949|NCT00899847|Antiemetics|antiemetics|mesh-ancestor
6095950|NCT00899847|Autonomic Agents|autonomic agents|mesh-ancestor
6095951|NCT00899847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6095952|NCT00899847|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6095953|NCT00899847|Histamine Antagonists|histamine antagonists|mesh-ancestor
6095954|NCT00899847|Histamine Agents|histamine agents|mesh-ancestor
6095955|NCT00899847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6095956|NCT00899847|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6095957|NCT00899847|Antipruritics|antipruritics|mesh-ancestor
6095958|NCT00899847|Glucocorticoids|glucocorticoids|mesh-ancestor
5521283|NCT04315974|Protease Inhibitors|protease inhibitors|mesh-ancestor
5521284|NCT04315974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6095959|NCT00899847|Hormones|hormones|mesh-ancestor
6095960|NCT00899847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6095961|NCT00899847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6095962|NCT00899847|Protective Agents|protective agents|mesh-ancestor
6095963|NCT00899847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6095964|NCT00900146|Metformin|metformin|mesh-list
6095965|NCT00900146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6095966|NCT00900146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095967|NCT00900159|Eszopiclone|eszopiclone|mesh-list
6095968|NCT00900159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6095969|NCT00900159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6095970|NCT00900159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095971|NCT00900237|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
6095972|NCT00900237|Oxcarbazepine|oxcarbazepine|mesh-list
6095973|NCT00900237|Anticonvulsants|anticonvulsants|mesh-ancestor
6095974|NCT00900237|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6095975|NCT00900237|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6095976|NCT00900237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6095977|NCT00900237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095978|NCT00900237|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6095979|NCT00900237|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6095980|NCT00900627|Paclitaxel|paclitaxel|mesh-list
6095981|NCT00900627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6095982|NCT00900627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6095983|NCT00900627|Tubulin Modulators|tubulin modulators|mesh-ancestor
6095984|NCT00900627|Antimitotic Agents|antimitotic agents|mesh-ancestor
6095985|NCT00900627|Mitosis Modulators|mitosis modulators|mesh-ancestor
6095986|NCT00900627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6464627|NCT00470223|Dermatologic Agents|dermatologic agents|mesh-ancestor
6095987|NCT00900666|Botulinum Toxins|botulinum toxins|mesh-list
6095988|NCT00900666|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6095989|NCT00900666|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6095990|NCT00900666|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6095991|NCT00900666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6095992|NCT00900666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6095993|NCT00900666|Cholinergic Agents|cholinergic agents|mesh-ancestor
6095994|NCT00900666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6095995|NCT00900666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6095996|NCT00900666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6095997|NCT00900666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6095998|NCT00900731|Tiotropium Bromide|tiotropium bromide|mesh-list
6095999|NCT00900731|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6096000|NCT00900731|Autonomic Agents|autonomic agents|mesh-ancestor
6096001|NCT00900731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6096002|NCT00900731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096003|NCT00900731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6096004|NCT00900731|Respiratory System Agents|respiratory system agents|mesh-ancestor
6096005|NCT00900731|Parasympatholytics|parasympatholytics|mesh-ancestor
5521285|NCT04315974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521286|NCT04315974|Anticoagulants|anticoagulants|mesh-ancestor
5521287|NCT04316013|Lidocaine|lidocaine|mesh-list
5521288|NCT04316013|Propofol|propofol|mesh-list
5521289|NCT04316013|Sevoflurane|sevoflurane|mesh-list
5521290|NCT04316013|Anesthetics, Local|anesthetics, local|mesh-ancestor
5521291|NCT04316013|Anesthetics|anesthetics|mesh-ancestor
5521292|NCT04316013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5521293|NCT04316013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521294|NCT04316013|Sensory System Agents|sensory system agents|mesh-ancestor
5521295|NCT04316013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5521296|NCT04316013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6096006|NCT00900731|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6096007|NCT00900731|Cholinergic Agents|cholinergic agents|mesh-ancestor
6096008|NCT00900731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5521297|NCT04316013|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5521298|NCT04316013|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5521299|NCT04316013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5521300|NCT04316013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521301|NCT04316013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6096009|NCT00900731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096010|NCT00900757|Palonosetron|palonosetron|mesh-list
6096011|NCT00900757|Antiemetics|antiemetics|mesh-ancestor
6096012|NCT00900757|Autonomic Agents|autonomic agents|mesh-ancestor
6096013|NCT00900757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6096014|NCT00900757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096015|NCT00900757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6096016|NCT00900757|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6096017|NCT00900757|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6096018|NCT00900757|Serotonin Agents|serotonin agents|mesh-ancestor
6096019|NCT00900757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6096020|NCT00900757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096021|NCT00901186|Ranibizumab|ranibizumab|mesh-list
6096022|NCT00901186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6096023|NCT00901186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6096024|NCT00901186|Growth Substances|growth substances|mesh-ancestor
6096025|NCT00901186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096026|NCT00901186|Growth Inhibitors|growth inhibitors|mesh-ancestor
6096027|NCT00901186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6096028|NCT00901199|Deferasirox|deferasirox|mesh-list
6096029|NCT00901199|Deferoxamine|deferoxamine|mesh-list
6096030|NCT00901199|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6096031|NCT00901199|Chelating Agents|chelating agents|mesh-ancestor
6096032|NCT00901199|Sequestering Agents|sequestering agents|mesh-ancestor
6096033|NCT00901199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096034|NCT00901199|Siderophores|siderophores|mesh-ancestor
5521302|NCT04316013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5521303|NCT04316013|Anesthetics, General|anesthetics, general|mesh-ancestor
5521304|NCT04316013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5521305|NCT04316013|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5521306|NCT04316039|Temozolomide|temozolomide|mesh-list
6096035|NCT00901225|Plerixafor|plerixafor|mesh-list
6096036|NCT00901225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6096037|NCT00901225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5521307|NCT04316039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6096038|NCT00901225|Antiviral Agents|antiviral agents|mesh-ancestor
6096039|NCT00901225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6096040|NCT00901394|Folic Acid|folic acid|mesh-list
6096041|NCT00901394|Nitrous Oxide|nitrous oxide|mesh-list
5521308|NCT04316039|Alkylating Agents|alkylating agents|mesh-ancestor
5521309|NCT04316039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521310|NCT04316039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5521311|NCT04315935|Fentanyl|fentanyl|mesh-list
5521312|NCT04315935|Butorphanol|butorphanol|mesh-list
5521313|NCT04315935|Propofol|propofol|mesh-list
5521314|NCT04315935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5521315|NCT04315935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5521316|NCT04315935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521317|NCT04315935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5521318|NCT04315935|Anesthetics, General|anesthetics, general|mesh-ancestor
5521319|NCT04315935|Anesthetics|anesthetics|mesh-ancestor
5521320|NCT04315935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5521321|NCT04315935|Narcotics|narcotics|mesh-ancestor
5521322|NCT04315935|Analgesics|analgesics|mesh-ancestor
5521323|NCT04315935|Sensory System Agents|sensory system agents|mesh-ancestor
5521324|NCT04315935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5521325|NCT04315935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5521326|NCT04315935|Antitussive Agents|antitussive agents|mesh-ancestor
6096042|NCT00901394|Hematinics|hematinics|mesh-ancestor
6096043|NCT00901394|Vitamin B Complex|vitamin b complex|mesh-ancestor
6096044|NCT00901394|Vitamins|vitamins|mesh-ancestor
6096045|NCT00901394|Micronutrients|micronutrients|mesh-ancestor
6096046|NCT00901394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096047|NCT00901394|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6096048|NCT00901394|Anesthetics, General|anesthetics, general|mesh-ancestor
6096049|NCT00901394|Anesthetics|anesthetics|mesh-ancestor
6096050|NCT00901394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6096051|NCT00901394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6096052|NCT00901394|Analgesics|analgesics|mesh-ancestor
6096053|NCT00901394|Sensory System Agents|sensory system agents|mesh-ancestor
6096054|NCT00901394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6096055|NCT00901576|Methylphenidate|methylphenidate|mesh-list
6096056|NCT00901576|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6096057|NCT00901576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096058|NCT00901576|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6096059|NCT00901576|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6096060|NCT00901576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6096061|NCT00901576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096062|NCT00901576|Dopamine Agents|dopamine agents|mesh-ancestor
6096063|NCT00901576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6096064|NCT00901628|Cefuroxime|cefuroxime|mesh-list
6096065|NCT00901628|Cefuroxime axetil|cefuroxime axetil|mesh-list
6096066|NCT00901628|Ketorolac|ketorolac|mesh-list
6096067|NCT00901628|Epinephrine|epinephrine|mesh-list
6096068|NCT00901628|Morphine|morphine|mesh-list
6096069|NCT00901628|Ropivacaine|ropivacaine|mesh-list
6096070|NCT00901628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6096071|NCT00901628|Narcotics|narcotics|mesh-ancestor
6096072|NCT00901628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6096073|NCT00901628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096074|NCT00901628|Analgesics|analgesics|mesh-ancestor
6096075|NCT00901628|Sensory System Agents|sensory system agents|mesh-ancestor
6096076|NCT00901628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6096077|NCT00901628|Anesthetics, Local|anesthetics, local|mesh-ancestor
6096078|NCT00901628|Anesthetics|anesthetics|mesh-ancestor
6096079|NCT00901628|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6096080|NCT00901628|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6096081|NCT00901628|Adrenergic Agents|adrenergic agents|mesh-ancestor
6096082|NCT00901628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6096083|NCT00901628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096084|NCT00901628|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6096085|NCT00901628|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6096086|NCT00901628|Autonomic Agents|autonomic agents|mesh-ancestor
5521327|NCT04315935|Respiratory System Agents|respiratory system agents|mesh-ancestor
5521328|NCT04315935|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5521329|NCT04315909|Vitamin E|vitamin e|mesh-list
6096087|NCT00901628|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6096088|NCT00901628|Respiratory System Agents|respiratory system agents|mesh-ancestor
5521330|NCT04315909|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
5521331|NCT04315909|Vitamins|vitamins|mesh-ancestor
6096089|NCT00901628|Mydriatics|mydriatics|mesh-ancestor
6096090|NCT00901628|Sympathomimetics|sympathomimetics|mesh-ancestor
6096091|NCT00901628|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6096092|NCT00901628|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6096093|NCT00901628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6096094|NCT00901628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6096095|NCT00901628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6096096|NCT00901628|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6096097|NCT00901628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6096098|NCT00901628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6096099|NCT00901628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6096100|NCT00901901|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6096101|NCT00901901|Sorafenib|sorafenib|mesh-list
6096102|NCT00901901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6096103|NCT00901901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6096104|NCT00901901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6096105|NCT00901901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096106|NCT00901927|Rituximab|rituximab|mesh-list
6096107|NCT00901927|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6096108|NCT00901927|Mitoxantrone|mitoxantrone|mesh-list
6096109|NCT00901927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6096110|NCT00901927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6096111|NCT00901927|Immunologic Factors|immunologic factors|mesh-ancestor
6096112|NCT00901927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096113|NCT00901927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6096114|NCT00901927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6096115|NCT00901927|Alkylating Agents|alkylating agents|mesh-ancestor
6096116|NCT00901927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096117|NCT00901927|Analgesics|analgesics|mesh-ancestor
6096118|NCT00901927|Sensory System Agents|sensory system agents|mesh-ancestor
6096119|NCT00901927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6096120|NCT00901927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6096121|NCT00901927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6096122|NCT00901927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6096123|NCT00902161|Propranolol|propranolol|mesh-list
6096124|NCT00902161|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6096125|NCT00902161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6096126|NCT00902161|Adrenergic Agents|adrenergic agents|mesh-ancestor
6096127|NCT00902161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6096128|NCT00902161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096129|NCT00902161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096130|NCT00902161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6096131|NCT00902161|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6096132|NCT00902161|Vasodilator Agents|vasodilator agents|mesh-ancestor
6096133|NCT00902174|Imatinib Mesylate|imatinib mesylate|mesh-list
6096134|NCT00902174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6096135|NCT00902174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6096136|NCT00902174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6096137|NCT00902174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096138|NCT00902226|Citalopram|citalopram|mesh-list
5521332|NCT04315909|Micronutrients|micronutrients|mesh-ancestor
5521333|NCT04315909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521334|NCT04315909|Antioxidants|antioxidants|mesh-ancestor
5521335|NCT04315909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521336|NCT04315909|Protective Agents|protective agents|mesh-ancestor
5521337|NCT04315909|Hemostatics|hemostatics|mesh-ancestor
5521338|NCT04315909|Coagulants|coagulants|mesh-ancestor
5521339|NCT04315584|Deoxyglucose|deoxyglucose|mesh-list
5521340|NCT04315584|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5521341|NCT04315584|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
5521342|NCT04315584|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5521343|NCT04315584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096139|NCT00902226|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6096140|NCT00902226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6096141|NCT00902226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5521344|NCT04315584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521345|NCT04315584|Antimetabolites|antimetabolites|mesh-ancestor
5521346|NCT04315584|Antiviral Agents|antiviral agents|mesh-ancestor
6096142|NCT00902226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096143|NCT00902226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6096144|NCT00902226|Serotonin Agents|serotonin agents|mesh-ancestor
6096145|NCT00902226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521347|NCT04315584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5521348|NCT04315584|Dopamine Agents|dopamine agents|mesh-ancestor
5521349|NCT04315584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5521350|NCT04315831|Buprenorphine|buprenorphine|mesh-list
5521351|NCT04315831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5521352|NCT04315831|Narcotics|narcotics|mesh-ancestor
6096146|NCT00902226|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6096147|NCT00902226|Antidepressive Agents|antidepressive agents|mesh-ancestor
6096148|NCT00902226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6096149|NCT00902265|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
6096150|NCT00902265|Hemostatics|hemostatics|mesh-ancestor
6096151|NCT00902265|Coagulants|coagulants|mesh-ancestor
6096152|NCT00902265|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6096153|NCT00902265|Natriuretic Agents|natriuretic agents|mesh-ancestor
5521353|NCT04315831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5521354|NCT04315831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521355|NCT04315831|Analgesics|analgesics|mesh-ancestor
5521356|NCT04315831|Sensory System Agents|sensory system agents|mesh-ancestor
5521357|NCT04315831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5521358|NCT04315831|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5521359|NCT04315558|Bromides|bromides|mesh-list
6096154|NCT00902265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096155|NCT00902304|Amlodipine|amlodipine|mesh-list
6096156|NCT00902304|Valsartan|valsartan|mesh-list
6096157|NCT00902304|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6096158|NCT00902304|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
6096159|NCT00902304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6096160|NCT00902304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6096161|NCT00902304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6096162|NCT00902304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096163|NCT00902304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6096164|NCT00902304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096165|NCT00902304|Vasodilator Agents|vasodilator agents|mesh-ancestor
6096166|NCT00902304|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6096167|NCT00902304|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6096168|NCT00902304|Diuretics|diuretics|mesh-ancestor
6096169|NCT00902304|Natriuretic Agents|natriuretic agents|mesh-ancestor
6096170|NCT00902304|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6096171|NCT00902538|Amlodipine|amlodipine|mesh-list
6096172|NCT00902538|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6096173|NCT00902538|Olmesartan|olmesartan|mesh-list
6096174|NCT00902538|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6096175|NCT00902538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6096176|NCT00902538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6096177|NCT00902538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5521360|NCT04315558|Ipratropium|ipratropium|mesh-list
5521361|NCT04315558|Anticonvulsants|anticonvulsants|mesh-ancestor
5521362|NCT04315558|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6096178|NCT00902538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096179|NCT00902538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6096180|NCT00902538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096181|NCT00902538|Vasodilator Agents|vasodilator agents|mesh-ancestor
6096182|NCT00902538|Diuretics|diuretics|mesh-ancestor
6096183|NCT00902538|Natriuretic Agents|natriuretic agents|mesh-ancestor
6096184|NCT00902538|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6096185|NCT00902538|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6096186|NCT00902538|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6096187|NCT00902564|Citalopram|citalopram|mesh-list
6096188|NCT00902564|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6096189|NCT00902564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6096190|NCT00902564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6096191|NCT00902564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096192|NCT00902564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6096193|NCT00902564|Serotonin Agents|serotonin agents|mesh-ancestor
6096194|NCT00902564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464628|NCT00470223|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6464629|NCT00470223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5521363|NCT04315558|Autonomic Agents|autonomic agents|mesh-ancestor
6096195|NCT00902564|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6096196|NCT00902564|Antidepressive Agents|antidepressive agents|mesh-ancestor
6096197|NCT00902564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6096198|NCT00902577|Misonidazole|misonidazole|mesh-list
6096199|NCT00902577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6096200|NCT00902577|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6096201|NCT00902577|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6096202|NCT00902577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6096203|NCT00903162|Zoledronic Acid|zoledronic acid|mesh-list
6096204|NCT00903162|Letrozole|letrozole|mesh-list
6096205|NCT00903162|Leuprolide|leuprolide|mesh-list
6096206|NCT00903162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6096207|NCT00903162|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6096208|NCT00903162|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6096209|NCT00903162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6096210|NCT00903162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096211|NCT00903162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6096212|NCT00903162|Hormone Antagonists|hormone antagonists|mesh-ancestor
5521364|NCT04315558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5521365|NCT04315558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521366|NCT04315558|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5521367|NCT04315558|Respiratory System Agents|respiratory system agents|mesh-ancestor
5521368|NCT04315558|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5521369|NCT04315558|Cholinergic Agents|cholinergic agents|mesh-ancestor
5521370|NCT04315558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5521371|NCT04315558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521372|NCT04315688|Insulin|insulin|mesh-list
5521373|NCT04315688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5521374|NCT04315688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521375|NCT04315454|Levobupivacaine|levobupivacaine|mesh-list
5521376|NCT04315454|Anesthetics, Local|anesthetics, local|mesh-ancestor
5521377|NCT04315454|Anesthetics|anesthetics|mesh-ancestor
5521378|NCT04315454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5521379|NCT04315454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521380|NCT04315454|Sensory System Agents|sensory system agents|mesh-ancestor
5521381|NCT04315454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5521382|NCT04315493|Maleic acid|maleic acid|mesh-list
5521383|NCT04315493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5521384|NCT04315493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521385|NCT04315194|Clarithromycin|clarithromycin|mesh-list
5521386|NCT04315194|Oseltamivir|oseltamivir|mesh-list
6096213|NCT00903162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6096214|NCT00903162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096215|NCT00903162|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6096216|NCT00903162|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6096217|NCT00903162|Fertility Agents|fertility agents|mesh-ancestor
6096218|NCT00903162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6096219|NCT00903162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6096220|NCT00903175|Everolimus|everolimus|mesh-list
6096221|NCT00903175|Sunitinib|sunitinib|mesh-list
6096222|NCT00903175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6096223|NCT00903175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6096224|NCT00903175|Immunologic Factors|immunologic factors|mesh-ancestor
6464630|NCT00470223|Immunologic Factors|immunologic factors|mesh-ancestor
5521387|NCT04315194|Naproxen|naproxen|mesh-list
5521388|NCT04315194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5521389|NCT04315194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5521390|NCT04315194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5521391|NCT04315194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5521392|NCT04315194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521393|NCT04315194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5521394|NCT04315194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5521395|NCT04315194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5521396|NCT04315194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6096225|NCT00903175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096226|NCT00903175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6096227|NCT00903175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5521397|NCT04315194|Analgesics|analgesics|mesh-ancestor
5521398|NCT04315194|Sensory System Agents|sensory system agents|mesh-ancestor
6096228|NCT00903175|Growth Substances|growth substances|mesh-ancestor
6096229|NCT00903175|Growth Inhibitors|growth inhibitors|mesh-ancestor
6096230|NCT00903175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6096231|NCT00903175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6096232|NCT00903175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203576|NCT02058836|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6203577|NCT02058836|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6203578|NCT02058836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6203579|NCT02058836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203580|NCT02058836|Cholinergic Agents|cholinergic agents|mesh-ancestor
5521399|NCT04315194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5521400|NCT04315194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521401|NCT04315194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5521402|NCT04315194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5521403|NCT04315194|Gout Suppressants|gout suppressants|mesh-ancestor
5521404|NCT04315194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6203581|NCT02058836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6203582|NCT02058836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203583|NCT02058836|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6203584|NCT02058836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6203585|NCT02058940|Exenatide|exenatide|mesh-list
6203586|NCT02058940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6203587|NCT02058940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203588|NCT02058940|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6203589|NCT02058940|Incretins|incretins|mesh-ancestor
6203590|NCT02058940|Hormones|hormones|mesh-ancestor
6203591|NCT02058940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6203592|NCT02058966|Entacapone|entacapone|mesh-list
6203593|NCT02058966|Methamphetamine|methamphetamine|mesh-list
6203594|NCT02058966|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6203595|NCT02058966|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6203596|NCT02058966|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6203597|NCT02058966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6203598|NCT02058966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203599|NCT02058966|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6203600|NCT02058966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203601|NCT02058966|Sympathomimetics|sympathomimetics|mesh-ancestor
6203602|NCT02058966|Autonomic Agents|autonomic agents|mesh-ancestor
6203603|NCT02058966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6203604|NCT02058966|Dopamine Agents|dopamine agents|mesh-ancestor
6203605|NCT02058966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6203606|NCT02058966|Adrenergic Agents|adrenergic agents|mesh-ancestor
6203607|NCT02058966|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5521405|NCT04315194|Antiviral Agents|antiviral agents|mesh-ancestor
5521406|NCT04315350|Prednisolone|prednisolone|mesh-list
5521407|NCT04315350|Curcumin|curcumin|mesh-list
6203608|NCT02058966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6203609|NCT02058966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6203610|NCT02058966|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6203611|NCT02059070|Bupivacaine|bupivacaine|mesh-list
6203612|NCT02059070|Ropivacaine|ropivacaine|mesh-list
6203613|NCT02059070|Anesthetics, Local|anesthetics, local|mesh-ancestor
6203614|NCT02059070|Anesthetics|anesthetics|mesh-ancestor
6203615|NCT02059070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6203616|NCT02059070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203617|NCT02059070|Sensory System Agents|sensory system agents|mesh-ancestor
6203618|NCT02059070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6203619|NCT02059135|Antithrombins|antithrombins|mesh-list
6096233|NCT00903331|Macitentan|macitentan|mesh-list
6096234|NCT00903331|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
6096235|NCT00903331|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6096236|NCT00903331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096237|NCT00903331|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
6096238|NCT00903344|Vitamin D|vitamin d|mesh-list
6096239|NCT00903344|Cholecalciferol|cholecalciferol|mesh-list
6096240|NCT00903344|Vitamins|vitamins|mesh-ancestor
6096241|NCT00903344|Micronutrients|micronutrients|mesh-ancestor
6096242|NCT00903344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096243|NCT00903344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6096244|NCT00903344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6096245|NCT00903357|Ascorbic Acid|ascorbic acid|mesh-list
6096246|NCT00903357|Montelukast|montelukast|mesh-list
6096247|NCT00903357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6096248|NCT00903357|Respiratory System Agents|respiratory system agents|mesh-ancestor
6096249|NCT00903357|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6096250|NCT00903357|Hormone Antagonists|hormone antagonists|mesh-ancestor
6096251|NCT00903357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6096252|NCT00903357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096253|NCT00903357|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6096254|NCT00903357|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6096255|NCT00903357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096256|NCT00903357|Antioxidants|antioxidants|mesh-ancestor
6096257|NCT00903357|Protective Agents|protective agents|mesh-ancestor
6096258|NCT00903357|Vitamins|vitamins|mesh-ancestor
6096259|NCT00903357|Micronutrients|micronutrients|mesh-ancestor
6096260|NCT00903409|Simvastatin|simvastatin|mesh-list
6096261|NCT00903409|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6096262|NCT00903409|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6096263|NCT00903409|Antimetabolites|antimetabolites|mesh-ancestor
6096264|NCT00903409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096265|NCT00903409|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6096266|NCT00903409|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6096267|NCT00903409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6096268|NCT00903448|Omeprazole|omeprazole|mesh-list
6096269|NCT00903448|Lansoprazole|lansoprazole|mesh-list
6096270|NCT00903448|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6096271|NCT00903448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6464631|NCT00470223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6464632|NCT00470223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6464633|NCT00470223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6464634|NCT00470223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6464635|NCT00470223|Alkylating Agents|alkylating agents|mesh-ancestor
6464636|NCT00470223|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6464637|NCT00470249|Gemcitabine|gemcitabine|mesh-list
6464638|NCT00470249|Carboplatin|carboplatin|mesh-list
6464639|NCT00470249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6464640|NCT00470249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6096272|NCT00903448|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6096273|NCT00903448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6096274|NCT00903448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096275|NCT00903617|Niacin|niacin|mesh-list
6096276|NCT00903617|Nicotinic Acids|nicotinic acids|mesh-list
6096277|NCT00903617|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6096278|NCT00903617|Antimetabolites|antimetabolites|mesh-ancestor
6096279|NCT00903617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096280|NCT00903617|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6096281|NCT00903617|Vasodilator Agents|vasodilator agents|mesh-ancestor
6096282|NCT00903617|Vitamin B Complex|vitamin b complex|mesh-ancestor
6096283|NCT00903617|Vitamins|vitamins|mesh-ancestor
6096284|NCT00903617|Micronutrients|micronutrients|mesh-ancestor
6096285|NCT00903617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096286|NCT00903630|Doxorubicin|doxorubicin|mesh-list
6096287|NCT00903630|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6096288|NCT00903630|Lenalidomide|lenalidomide|mesh-list
6096289|NCT00903630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6096290|NCT00903630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6096291|NCT00903630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6096292|NCT00903630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6096293|NCT00903630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6096294|NCT00903630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096295|NCT00903630|Immunologic Factors|immunologic factors|mesh-ancestor
6096296|NCT00903630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464641|NCT00470249|Antimetabolites|antimetabolites|mesh-ancestor
5521408|NCT04315350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5521409|NCT04315350|Glucocorticoids|glucocorticoids|mesh-ancestor
5521410|NCT04315350|Hormones|hormones|mesh-ancestor
5521411|NCT04315350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5521412|NCT04315350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521413|NCT04315350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5521414|NCT04315350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5521415|NCT04315350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5521416|NCT04315350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6096297|NCT00903630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6096298|NCT00903630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6096299|NCT00903630|Growth Substances|growth substances|mesh-ancestor
6096300|NCT00903630|Growth Inhibitors|growth inhibitors|mesh-ancestor
6096301|NCT00903682|Efavirenz|efavirenz|mesh-list
6096302|NCT00903682|Etravirine|etravirine|mesh-list
6096303|NCT00903682|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6096304|NCT00903682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6096305|NCT00903682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6096306|NCT00903682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096307|NCT00903682|Antiviral Agents|antiviral agents|mesh-ancestor
6096308|NCT00903682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6096309|NCT00903682|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6096310|NCT00903682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6096311|NCT00903682|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6096312|NCT00903682|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6096313|NCT00903682|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6096314|NCT00903682|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6096315|NCT00903760|Decitabine|decitabine|mesh-list
6096316|NCT00903760|Clofarabine|clofarabine|mesh-list
6096317|NCT00903760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6096318|NCT00903760|Antimetabolites|antimetabolites|mesh-ancestor
6096319|NCT00903760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096320|NCT00903760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6096321|NCT00903760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6096322|NCT00903968|Plerixafor|plerixafor|mesh-list
6096323|NCT00903968|Dexamethasone|dexamethasone|mesh-list
6096324|NCT00903968|Bortezomib|bortezomib|mesh-list
6464642|NCT00470249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6464643|NCT00470249|Antiviral Agents|antiviral agents|mesh-ancestor
6464644|NCT00470249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6464645|NCT00470249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6464646|NCT00470249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6096325|NCT00903968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6096326|NCT00903968|Antiemetics|antiemetics|mesh-ancestor
5521417|NCT04315350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5521418|NCT04315350|Analgesics|analgesics|mesh-ancestor
5521419|NCT04315350|Sensory System Agents|sensory system agents|mesh-ancestor
5521420|NCT04315350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5521421|NCT04315350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5521422|NCT04315350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521423|NCT04315155|Nivolumab|nivolumab|mesh-list
5521424|NCT04315155|Ipilimumab|ipilimumab|mesh-list
5521425|NCT04315155|Belinostat|belinostat|mesh-list
5521426|NCT04315155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5521427|NCT04315155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5521428|NCT04315155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5521429|NCT04315155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521430|NCT04315155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5521431|NCT04315155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5521432|NCT04315116|Loperamide|loperamide|mesh-list
5521433|NCT04315116|Antidiarrheals|antidiarrheals|mesh-list
6096327|NCT00903968|Autonomic Agents|autonomic agents|mesh-ancestor
6096328|NCT00903968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6096329|NCT00903968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096330|NCT00903968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6096331|NCT00903968|Glucocorticoids|glucocorticoids|mesh-ancestor
6096332|NCT00903968|Hormones|hormones|mesh-ancestor
6096333|NCT00903968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6096334|NCT00903968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6096335|NCT00903968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6096336|NCT00903968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6096337|NCT00903968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6096338|NCT00903968|Antiviral Agents|antiviral agents|mesh-ancestor
6096339|NCT00903968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6096340|NCT00904033|Calcitriol|calcitriol|mesh-list
6096341|NCT00904033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6096342|NCT00904033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096343|NCT00904033|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6096344|NCT00904033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6096345|NCT00904033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096346|NCT00904033|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6096347|NCT00904033|Vitamins|vitamins|mesh-ancestor
6096348|NCT00904033|Micronutrients|micronutrients|mesh-ancestor
6096349|NCT00904033|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6096350|NCT00904215|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6096351|NCT00904215|Telmisartan|telmisartan|mesh-list
6096352|NCT00904215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6096353|NCT00904215|Diuretics|diuretics|mesh-ancestor
6096354|NCT00904215|Natriuretic Agents|natriuretic agents|mesh-ancestor
6096355|NCT00904215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096356|NCT00904215|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6096357|NCT00904215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6096358|NCT00904215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096359|NCT00904215|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6096360|NCT00904215|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5521434|NCT04315116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5521435|NCT04314713|Scopolamine|scopolamine|mesh-list
5521436|NCT04314713|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
5521437|NCT04314713|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5521438|NCT04314713|Antiemetics|antiemetics|mesh-ancestor
5521439|NCT04314713|Autonomic Agents|autonomic agents|mesh-ancestor
5521440|NCT04314713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5521441|NCT04314713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521442|NCT04314713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5521443|NCT04314713|Mydriatics|mydriatics|mesh-ancestor
5521444|NCT04314713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5521445|NCT04314713|Cholinergic Agents|cholinergic agents|mesh-ancestor
5521446|NCT04314713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5521447|NCT04314713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521448|NCT04314713|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5521449|NCT04314713|Parasympatholytics|parasympatholytics|mesh-ancestor
6096361|NCT00904345|Cetuximab|cetuximab|mesh-list
6096362|NCT00904345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6096363|NCT00904345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6096364|NCT00904488|Metolazone|metolazone|mesh-list
6096365|NCT00904488|Furosemide|furosemide|mesh-list
6096366|NCT00904488|Diuretics|diuretics|mesh-ancestor
6096367|NCT00904488|Natriuretic Agents|natriuretic agents|mesh-ancestor
6096368|NCT00904488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096369|NCT00904488|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6096370|NCT00904488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6096371|NCT00904488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096372|NCT00904488|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6203620|NCT02059135|Antithrombin III|antithrombin iii|mesh-list
6096373|NCT00904488|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6096374|NCT00904618|Lidocaine|lidocaine|mesh-list
6096375|NCT00904618|Anesthetics, Local|anesthetics, local|mesh-ancestor
6096376|NCT00904618|Anesthetics|anesthetics|mesh-ancestor
6096377|NCT00904618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6096378|NCT00904618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096379|NCT00904618|Sensory System Agents|sensory system agents|mesh-ancestor
6096380|NCT00904618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6096381|NCT00904618|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6096382|NCT00904618|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6096383|NCT00904618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6096384|NCT00904618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6096385|NCT00904618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096386|NCT00904670|Methylphenidate|methylphenidate|mesh-list
6096387|NCT00904670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6096388|NCT00904670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096389|NCT00904670|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6096390|NCT00904670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6096391|NCT00904670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6096392|NCT00904670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096393|NCT00904670|Dopamine Agents|dopamine agents|mesh-ancestor
6096394|NCT00904670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6096395|NCT00904722|Rituximab|rituximab|mesh-list
6096396|NCT00904722|Pidilizumab|pidilizumab|mesh-list
6096397|NCT00904722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6096398|NCT00904722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6096399|NCT00904722|Immunologic Factors|immunologic factors|mesh-ancestor
6096400|NCT00904722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096401|NCT00904722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6096402|NCT00904748|Sildenafil Citrate|sildenafil citrate|mesh-list
6096403|NCT00904748|Citric Acid|citric acid|mesh-list
6096404|NCT00904748|Sodium Citrate|sodium citrate|mesh-list
6096405|NCT00904748|Anticoagulants|anticoagulants|mesh-ancestor
6096406|NCT00904748|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6096407|NCT00904748|Chelating Agents|chelating agents|mesh-ancestor
6096408|NCT00904748|Sequestering Agents|sequestering agents|mesh-ancestor
6096409|NCT00904748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096410|NCT00904748|Vasodilator Agents|vasodilator agents|mesh-ancestor
6096411|NCT00904748|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6096412|NCT00904748|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6096413|NCT00904748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6096414|NCT00904748|Urological Agents|urological agents|mesh-ancestor
6096415|NCT00904826|Eculizumab|eculizumab|mesh-list
6096416|NCT00904826|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6096417|NCT00904826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6096418|NCT00904826|Immunologic Factors|immunologic factors|mesh-ancestor
6096419|NCT00904826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096420|NCT00904839|Bevacizumab|bevacizumab|mesh-list
6096421|NCT00904839|Nintedanib|nintedanib|mesh-list
6096422|NCT00904839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6096423|NCT00904839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6096424|NCT00904839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6096425|NCT00904839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6096426|NCT00904839|Growth Substances|growth substances|mesh-ancestor
6096427|NCT00904839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096428|NCT00904839|Growth Inhibitors|growth inhibitors|mesh-ancestor
6096429|NCT00904839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6096430|NCT00904839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6096431|NCT00904839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096432|NCT00904995|Voriconazole|voriconazole|mesh-list
6096433|NCT00904995|Antifungal Agents|antifungal agents|mesh-ancestor
6096434|NCT00904995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6096435|NCT00904995|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6096436|NCT00904995|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6096437|NCT00904995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6096438|NCT00904995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096439|NCT00904995|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6096440|NCT00904995|Hormone Antagonists|hormone antagonists|mesh-ancestor
6096441|NCT00904995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6096442|NCT00904995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096443|NCT00904995|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6096444|NCT00905021|Sunitinib|sunitinib|mesh-list
6096445|NCT00905021|Exemestane|exemestane|mesh-list
6096446|NCT00905021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6096447|NCT00905021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6096448|NCT00905021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6096449|NCT00905021|Growth Substances|growth substances|mesh-ancestor
6096450|NCT00905021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096451|NCT00905021|Growth Inhibitors|growth inhibitors|mesh-ancestor
6096452|NCT00905021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6096453|NCT00905021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6096454|NCT00905021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096455|NCT00905021|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6096456|NCT00905021|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6096457|NCT00905021|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6096458|NCT00905021|Hormone Antagonists|hormone antagonists|mesh-ancestor
6096459|NCT00905021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6096460|NCT00905034|Dexamethasone|dexamethasone|mesh-list
6096461|NCT00905034|Rituximab|rituximab|mesh-list
6096462|NCT00905034|Methotrexate|methotrexate|mesh-list
6096463|NCT00905034|Vincristine|vincristine|mesh-list
6096464|NCT00905034|Asparaginase|asparaginase|mesh-list
6096465|NCT00905034|Pegaspargase|pegaspargase|mesh-list
6096466|NCT00905034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6096467|NCT00905034|Antiemetics|antiemetics|mesh-ancestor
6096468|NCT00905034|Autonomic Agents|autonomic agents|mesh-ancestor
6096469|NCT00905034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6096470|NCT00905034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096471|NCT00905034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6464647|NCT00470249|Immunologic Factors|immunologic factors|mesh-ancestor
6096472|NCT00905034|Glucocorticoids|glucocorticoids|mesh-ancestor
6096473|NCT00905034|Hormones|hormones|mesh-ancestor
6096474|NCT00905034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6096475|NCT00905034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6096476|NCT00905034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6096477|NCT00905034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6096478|NCT00905034|Immunologic Factors|immunologic factors|mesh-ancestor
6096479|NCT00905034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6096480|NCT00905034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6096481|NCT00905034|Abortifacient Agents|abortifacient agents|mesh-ancestor
6096482|NCT00905034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6096483|NCT00905034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6096484|NCT00905034|Antimetabolites|antimetabolites|mesh-ancestor
6096485|NCT00905034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096486|NCT00905034|Dermatologic Agents|dermatologic agents|mesh-ancestor
6096487|NCT00905034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6096488|NCT00905034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6096489|NCT00905034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6096490|NCT00905034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6096491|NCT00905034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6096492|NCT00905034|Tubulin Modulators|tubulin modulators|mesh-ancestor
6096493|NCT00905034|Antimitotic Agents|antimitotic agents|mesh-ancestor
6096494|NCT00905034|Mitosis Modulators|mitosis modulators|mesh-ancestor
6096495|NCT00905060|Temozolomide|temozolomide|mesh-list
6096496|NCT00905060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6096497|NCT00905060|Alkylating Agents|alkylating agents|mesh-ancestor
6096498|NCT00905060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096499|NCT00905060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6096500|NCT00905255|Lixisenatide|lixisenatide|mesh-list
6096501|NCT00905255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6096502|NCT00905255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096503|NCT00905268|Idebenone|idebenone|mesh-list
6096504|NCT00905268|Antioxidants|antioxidants|mesh-ancestor
6096505|NCT00905268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096506|NCT00905268|Protective Agents|protective agents|mesh-ancestor
6096507|NCT00905268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096508|NCT00905307|Aripiprazole|aripiprazole|mesh-list
6096509|NCT00905307|Antidepressive Agents|antidepressive agents|mesh-ancestor
6096510|NCT00905307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6096511|NCT00905307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6096512|NCT00905307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6096513|NCT00905307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6096514|NCT00905307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096515|NCT00905307|Dopamine Agonists|dopamine agonists|mesh-ancestor
6096516|NCT00905307|Dopamine Agents|dopamine agents|mesh-ancestor
6096517|NCT00905307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6464648|NCT00470249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096518|NCT00905307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096519|NCT00905307|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6096520|NCT00905307|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6096521|NCT00905307|Serotonin Agents|serotonin agents|mesh-ancestor
6096522|NCT00905307|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6096523|NCT00905307|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6096524|NCT00905307|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6096525|NCT00905307|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6096526|NCT00905424|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6096527|NCT00905424|Antidepressive Agents|antidepressive agents|mesh-list
6096528|NCT00905424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6096529|NCT00905424|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6096530|NCT00905424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096531|NCT00905424|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6096532|NCT00905424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6096533|NCT00905424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6096534|NCT00905424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096535|NCT00905424|Dopamine Agents|dopamine agents|mesh-ancestor
6096536|NCT00905424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6096537|NCT00905437|Pregabalin|pregabalin|mesh-list
6096538|NCT00905437|Analgesics|analgesics|mesh-ancestor
6096539|NCT00905437|Sensory System Agents|sensory system agents|mesh-ancestor
6096540|NCT00905437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6096541|NCT00905437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096542|NCT00905437|Anticonvulsants|anticonvulsants|mesh-ancestor
6096543|NCT00905437|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6096544|NCT00905437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6096545|NCT00905437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096546|NCT00905437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6096547|NCT00905437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6096548|NCT00905437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6096549|NCT00905437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6096550|NCT00905437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6096551|NCT00905489|Nevirapine|nevirapine|mesh-list
6096552|NCT00905489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6096553|NCT00905489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6096554|NCT00905489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5521450|NCT04314843|Cyclophosphamide|cyclophosphamide|mesh-list
5521451|NCT04314843|Fludarabine|fludarabine|mesh-list
5521452|NCT04314843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5521453|NCT04314843|Immunologic Factors|immunologic factors|mesh-ancestor
5521454|NCT04314843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521455|NCT04314843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5521456|NCT04314843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5521457|NCT04314843|Alkylating Agents|alkylating agents|mesh-ancestor
5600950|NCT03708588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6096555|NCT00905489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096556|NCT00905489|Antiviral Agents|antiviral agents|mesh-ancestor
6096557|NCT00905489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6096558|NCT00905489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6096559|NCT00905489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6096560|NCT00905489|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6096561|NCT00905489|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6096562|NCT00905515|Cyclosporine|cyclosporine|mesh-list
6096563|NCT00905515|Tacrolimus|tacrolimus|mesh-list
6096564|NCT00905515|Cyclosporins|cyclosporins|mesh-list
6096565|NCT00905515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6096566|NCT00905515|Immunologic Factors|immunologic factors|mesh-ancestor
6096567|NCT00905515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096568|NCT00905515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6096569|NCT00905515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6096570|NCT00905515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096571|NCT00905515|Antifungal Agents|antifungal agents|mesh-ancestor
6096572|NCT00905515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5521458|NCT04314843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521459|NCT04314843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5521460|NCT04314843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5521461|NCT04314739|Resveratrol|resveratrol|mesh-list
5521462|NCT04314739|Antioxidants|antioxidants|mesh-ancestor
5521463|NCT04314739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521464|NCT04314739|Protective Agents|protective agents|mesh-ancestor
5521465|NCT04314739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521466|NCT04314739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5521467|NCT04314739|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5521468|NCT04314570|Ropivacaine|ropivacaine|mesh-list
5521469|NCT04314570|Anesthetics, Local|anesthetics, local|mesh-ancestor
6096573|NCT00905515|Dermatologic Agents|dermatologic agents|mesh-ancestor
6096574|NCT00905515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6096575|NCT00905580|Pregabalin|pregabalin|mesh-list
6096576|NCT00905580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096577|NCT00905580|Analgesics|analgesics|mesh-ancestor
6096578|NCT00905580|Sensory System Agents|sensory system agents|mesh-ancestor
6096579|NCT00905580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6096580|NCT00905580|Anticonvulsants|anticonvulsants|mesh-ancestor
6096581|NCT00905580|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6096582|NCT00905580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6096583|NCT00905580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096584|NCT00905580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6096585|NCT00905580|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6096586|NCT00905580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6096587|NCT00905580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6096588|NCT00905580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6096589|NCT00906087|Timolol|timolol|mesh-list
6096590|NCT00906087|Dorzolamide|dorzolamide|mesh-list
6096591|NCT00906087|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6096592|NCT00906087|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6096593|NCT00906087|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6096594|NCT00906087|Adrenergic Agents|adrenergic agents|mesh-ancestor
6096595|NCT00906087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5521470|NCT04314570|Anesthetics|anesthetics|mesh-ancestor
5521471|NCT04314570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5521472|NCT04314570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521473|NCT04314570|Sensory System Agents|sensory system agents|mesh-ancestor
5521474|NCT04314570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5521475|NCT04314310|Tenoxicam|tenoxicam|mesh-list
5521476|NCT04314310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5521477|NCT04314310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5521478|NCT04314310|Analgesics|analgesics|mesh-ancestor
5521479|NCT04314310|Sensory System Agents|sensory system agents|mesh-ancestor
5521480|NCT04314310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5521481|NCT04314310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464649|NCT00470314|N-Methylaspartate|n-methylaspartate|mesh-list
6464650|NCT00470314|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
6464651|NCT00470314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6464652|NCT00470314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5521482|NCT04314310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5521483|NCT04314310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5521484|NCT04314310|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5521485|NCT04314310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5521486|NCT04314310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521487|NCT04314375|Budesonide|budesonide|mesh-list
5521488|NCT04314375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5521489|NCT04314375|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5521490|NCT04314375|Autonomic Agents|autonomic agents|mesh-ancestor
5521491|NCT04314375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5521492|NCT04314375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521493|NCT04314375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5521494|NCT04314375|Respiratory System Agents|respiratory system agents|mesh-ancestor
5521495|NCT04314375|Glucocorticoids|glucocorticoids|mesh-ancestor
5521496|NCT04314375|Hormones|hormones|mesh-ancestor
5521497|NCT04314375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5600951|NCT03708588|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5600952|NCT03708588|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5600953|NCT03708588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5600954|NCT03708588|Purinergic Agents|purinergic agents|mesh-ancestor
5600955|NCT03708588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6203621|NCT02059135|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6464653|NCT00470314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096596|NCT00906087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096597|NCT00906087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096598|NCT00906087|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6096599|NCT00906087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6096600|NCT00906087|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6096601|NCT00906087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6096602|NCT00906087|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6464654|NCT00470314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464655|NCT00470340|Gemcitabine|gemcitabine|mesh-list
6464656|NCT00470340|Oxaliplatin|oxaliplatin|mesh-list
6464657|NCT00470340|Ethiodized Oil|ethiodized oil|mesh-list
6464658|NCT00470340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6464659|NCT00470340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6464660|NCT00470340|Antimetabolites|antimetabolites|mesh-ancestor
6464661|NCT00470340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6464662|NCT00470340|Antiviral Agents|antiviral agents|mesh-ancestor
6464663|NCT00470340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6464664|NCT00470340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6464665|NCT00470340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6464666|NCT00470340|Immunologic Factors|immunologic factors|mesh-ancestor
6464667|NCT00470340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464668|NCT00470353|Cholecalciferol|cholecalciferol|mesh-list
6464669|NCT00470353|Calcium Carbonate|calcium carbonate|mesh-list
6464670|NCT00470353|Calcium|calcium|mesh-list
6464671|NCT00470353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6464672|NCT00470353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464673|NCT00470353|Vitamins|vitamins|mesh-ancestor
6464674|NCT00470353|Micronutrients|micronutrients|mesh-ancestor
6464675|NCT00470353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6464676|NCT00470353|Antacids|antacids|mesh-ancestor
6464677|NCT00470353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6464678|NCT00470353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6464679|NCT00470405|Oxaliplatin|oxaliplatin|mesh-list
6464680|NCT00470405|Pemetrexed|pemetrexed|mesh-list
6464681|NCT00470405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6464682|NCT00470405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6096603|NCT00906204|Thymoglobulin|thymoglobulin|mesh-list
6096604|NCT00906204|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6096605|NCT00906204|Immunologic Factors|immunologic factors|mesh-ancestor
6096606|NCT00906204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096607|NCT00906204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6096608|NCT00906282|Carboplatin|carboplatin|mesh-list
6096609|NCT00906282|Pemetrexed|pemetrexed|mesh-list
6096610|NCT00906282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6096611|NCT00906282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6096612|NCT00906282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096613|NCT00906282|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6096614|NCT00906282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6096615|NCT00906347|Misoprostol|misoprostol|mesh-list
6096616|NCT00906347|Oxytocin|oxytocin|mesh-list
6096617|NCT00906347|Oxytocics|oxytocics|mesh-ancestor
6096618|NCT00906347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6096619|NCT00906347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096620|NCT00906347|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6096621|NCT00906347|Abortifacient Agents|abortifacient agents|mesh-ancestor
6096622|NCT00906347|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6096623|NCT00906347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6096624|NCT00906373|Sorafenib|sorafenib|mesh-list
6096625|NCT00906373|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6096626|NCT00906373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6096627|NCT00906373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6096628|NCT00906373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6096629|NCT00906373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096630|NCT00906373|Immunologic Factors|immunologic factors|mesh-ancestor
6464683|NCT00470405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096631|NCT00906373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096632|NCT00906399|Interferons|interferons|mesh-list
6096633|NCT00906399|Interferon-beta|interferon-beta|mesh-list
6096634|NCT00906399|Interferon beta-1a|interferon beta-1a|mesh-list
6096635|NCT00906399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6096636|NCT00906399|Antiviral Agents|antiviral agents|mesh-ancestor
6096637|NCT00906399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6096638|NCT00906399|Immunologic Factors|immunologic factors|mesh-ancestor
6096639|NCT00906399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096640|NCT00906399|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6096641|NCT00906503|Dexamethasone|dexamethasone|mesh-list
6096642|NCT00906503|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6096643|NCT00906503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6096644|NCT00906503|Antiemetics|antiemetics|mesh-ancestor
6096645|NCT00906503|Autonomic Agents|autonomic agents|mesh-ancestor
6096646|NCT00906503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6096647|NCT00906503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096648|NCT00906503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6096649|NCT00906503|Glucocorticoids|glucocorticoids|mesh-ancestor
6096650|NCT00906503|Hormones|hormones|mesh-ancestor
6096651|NCT00906503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6096652|NCT00906503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6096653|NCT00906503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6096654|NCT00906503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6096655|NCT00906503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096656|NCT00906698|Vinorelbine|vinorelbine|mesh-list
5521498|NCT04314297|Durvalumab|durvalumab|mesh-list
5521499|NCT04314297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5521500|NCT04314297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5521501|NCT04314219|Cyclophosphamide|cyclophosphamide|mesh-list
5521502|NCT04314219|Methotrexate|methotrexate|mesh-list
5521503|NCT04314219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5521504|NCT04314219|Immunologic Factors|immunologic factors|mesh-ancestor
6096657|NCT00906698|Afatinib|afatinib|mesh-list
6096658|NCT00906698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6096659|NCT00906698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6096660|NCT00906698|Tubulin Modulators|tubulin modulators|mesh-ancestor
6096661|NCT00906698|Antimitotic Agents|antimitotic agents|mesh-ancestor
6096662|NCT00906698|Mitosis Modulators|mitosis modulators|mesh-ancestor
6096663|NCT00906698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096664|NCT00906698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6096665|NCT00906698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6096666|NCT00906945|Cytarabine|cytarabine|mesh-list
6096667|NCT00906945|Plerixafor|plerixafor|mesh-list
6096668|NCT00906945|Etoposide|etoposide|mesh-list
6096669|NCT00906945|Mitoxantrone|mitoxantrone|mesh-list
6096670|NCT00906945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5521505|NCT04314219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521506|NCT04314219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5521507|NCT04314219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5521508|NCT04314219|Alkylating Agents|alkylating agents|mesh-ancestor
5521509|NCT04314219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521510|NCT04314219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5521511|NCT04314219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5521512|NCT04314219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5521513|NCT04314219|Abortifacient Agents|abortifacient agents|mesh-ancestor
5521514|NCT04314219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5521515|NCT04314219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5521516|NCT04314219|Antimetabolites|antimetabolites|mesh-ancestor
5521517|NCT04314219|Dermatologic Agents|dermatologic agents|mesh-ancestor
5521518|NCT04314219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5521519|NCT04314219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5521520|NCT04314219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5521521|NCT04314674|Mannitol|mannitol|mesh-list
5521522|NCT04314674|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5521523|NCT04314674|Diuretics|diuretics|mesh-ancestor
5521524|NCT04314674|Natriuretic Agents|natriuretic agents|mesh-ancestor
5521525|NCT04314674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096671|NCT00906945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6096672|NCT00906945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6096673|NCT00906945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6096674|NCT00906945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6096675|NCT00906945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096676|NCT00906945|Immunologic Factors|immunologic factors|mesh-ancestor
5521526|NCT04314505|Analgesics, Opioid|analgesics, opioid|mesh-list
6096677|NCT00906945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521527|NCT04314505|Narcotics|narcotics|mesh-ancestor
5521528|NCT04314505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5521529|NCT04314505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521530|NCT04314505|Analgesics|analgesics|mesh-ancestor
5521531|NCT04314505|Sensory System Agents|sensory system agents|mesh-ancestor
5521532|NCT04314505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5521533|NCT04313985|Immunologic Factors|immunologic factors|mesh-list
5521534|NCT04313985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521535|NCT04313959|Dexamethasone|dexamethasone|mesh-list
5521536|NCT04313959|Ropivacaine|ropivacaine|mesh-list
5521537|NCT04313959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5521538|NCT04313959|Antiemetics|antiemetics|mesh-ancestor
5521539|NCT04313959|Autonomic Agents|autonomic agents|mesh-ancestor
5521540|NCT04313959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6096678|NCT00906945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6096679|NCT00906945|Antimetabolites|antimetabolites|mesh-ancestor
6096680|NCT00906945|Antiviral Agents|antiviral agents|mesh-ancestor
6096681|NCT00906945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6096682|NCT00906945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5521541|NCT04313959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521542|NCT04313959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5521543|NCT04313959|Glucocorticoids|glucocorticoids|mesh-ancestor
5521544|NCT04313959|Hormones|hormones|mesh-ancestor
5521545|NCT04313959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5521546|NCT04313959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5521547|NCT04313959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5521548|NCT04313959|Anesthetics, Local|anesthetics, local|mesh-ancestor
6096683|NCT00906945|Analgesics|analgesics|mesh-ancestor
6096684|NCT00906945|Sensory System Agents|sensory system agents|mesh-ancestor
6096685|NCT00906945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6096686|NCT00906945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6096687|NCT00906945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6096688|NCT00907101|Adapalene|adapalene|mesh-list
6096689|NCT00907101|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
6096690|NCT00907101|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6096691|NCT00907101|Dermatologic Agents|dermatologic agents|mesh-ancestor
6096692|NCT00907101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6096693|NCT00907101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6096694|NCT00907101|Analgesics|analgesics|mesh-ancestor
6096695|NCT00907101|Sensory System Agents|sensory system agents|mesh-ancestor
6096696|NCT00907101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6096697|NCT00907101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096698|NCT00907101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6096699|NCT00907101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6096700|NCT00907153|Vitamin D|vitamin d|mesh-list
6096701|NCT00907153|Vitamins|vitamins|mesh-ancestor
6096702|NCT00907153|Micronutrients|micronutrients|mesh-ancestor
6096703|NCT00907153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096704|NCT00907153|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6096705|NCT00907257|Tretinoin|tretinoin|mesh-list
6096706|NCT00907257|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6096707|NCT00907257|Dermatologic Agents|dermatologic agents|mesh-ancestor
6096708|NCT00907257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6096709|NCT00907257|Keratolytic Agents|keratolytic agents|mesh-ancestor
6096710|NCT00907335|Tretinoin|tretinoin|mesh-list
6096711|NCT00907335|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6096712|NCT00907335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6096713|NCT00907335|Keratolytic Agents|keratolytic agents|mesh-ancestor
6096714|NCT00907335|Dermatologic Agents|dermatologic agents|mesh-ancestor
6096715|NCT00907374|Benazepril|benazepril|mesh-list
6096716|NCT00907374|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6096717|NCT00907374|Protease Inhibitors|protease inhibitors|mesh-ancestor
6096718|NCT00907374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6096719|NCT00907374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096720|NCT00907374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6096721|NCT00907426|Bimatoprost|bimatoprost|mesh-list
6096722|NCT00907426|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6096723|NCT00907426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6096724|NCT00907517|Cytarabine|cytarabine|mesh-list
6096725|NCT00907517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6096726|NCT00907517|Antimetabolites|antimetabolites|mesh-ancestor
6096727|NCT00907517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096728|NCT00907517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6096729|NCT00907517|Antiviral Agents|antiviral agents|mesh-ancestor
6096730|NCT00907517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6096731|NCT00907517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6096732|NCT00907517|Immunologic Factors|immunologic factors|mesh-ancestor
6096733|NCT00907517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096734|NCT00907738|Vorinostat|vorinostat|mesh-list
6096735|NCT00907738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6464684|NCT00470405|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6464685|NCT00470405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6464686|NCT00470483|Paroxetine|paroxetine|mesh-list
5521549|NCT04313959|Anesthetics|anesthetics|mesh-ancestor
5521550|NCT04313959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6096736|NCT00907738|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6096737|NCT00907738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6096738|NCT00907738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096739|NCT00907777|Vaccines|vaccines|mesh-list
6096740|NCT00907777|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6096741|NCT00907777|Immunologic Factors|immunologic factors|mesh-ancestor
6096742|NCT00907777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464687|NCT00470483|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6464688|NCT00470483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6096743|NCT00908011|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6096744|NCT00908011|Ezetimibe|ezetimibe|mesh-list
6096745|NCT00908011|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6096746|NCT00908011|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6096747|NCT00908011|Antimetabolites|antimetabolites|mesh-ancestor
6096748|NCT00908011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096749|NCT00908011|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6096750|NCT00908011|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6096751|NCT00908011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6096752|NCT00908076|Lubiprostone|lubiprostone|mesh-list
6096753|NCT00908076|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6096754|NCT00908076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6096755|NCT00908076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096756|NCT00908141|Sargramostim|sargramostim|mesh-list
6096757|NCT00908141|Immunologic Factors|immunologic factors|mesh-ancestor
6096758|NCT00908141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096759|NCT00908232|Dexamethasone|dexamethasone|mesh-list
6096760|NCT00908232|Cyclophosphamide|cyclophosphamide|mesh-list
6096761|NCT00908232|Lenalidomide|lenalidomide|mesh-list
6096762|NCT00908232|Bortezomib|bortezomib|mesh-list
6096763|NCT00908232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6096764|NCT00908232|Immunologic Factors|immunologic factors|mesh-ancestor
6096765|NCT00908232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096766|NCT00908232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6096767|NCT00908232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6096768|NCT00908232|Alkylating Agents|alkylating agents|mesh-ancestor
6096769|NCT00908232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096770|NCT00908232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6096771|NCT00908232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6096772|NCT00908232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6096773|NCT00908232|Antiemetics|antiemetics|mesh-ancestor
6096774|NCT00908232|Autonomic Agents|autonomic agents|mesh-ancestor
6096775|NCT00908232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6096776|NCT00908232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6096777|NCT00908232|Glucocorticoids|glucocorticoids|mesh-ancestor
6096778|NCT00908232|Hormones|hormones|mesh-ancestor
6096779|NCT00908232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6096780|NCT00908232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6096781|NCT00908232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6096782|NCT00908232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6096783|NCT00908232|Growth Substances|growth substances|mesh-ancestor
6096784|NCT00908232|Growth Inhibitors|growth inhibitors|mesh-ancestor
6096785|NCT00908349|Oxcarbazepine|oxcarbazepine|mesh-list
6096786|NCT00908349|Anticonvulsants|anticonvulsants|mesh-ancestor
6096787|NCT00908349|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6096788|NCT00908349|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6096789|NCT00908349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6203622|NCT02059135|Protease Inhibitors|protease inhibitors|mesh-ancestor
6464689|NCT00470483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6096790|NCT00908349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096791|NCT00908349|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6096792|NCT00908349|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6096793|NCT00908375|Pregabalin|pregabalin|mesh-list
6096794|NCT00908375|Analgesics|analgesics|mesh-ancestor
6096795|NCT00908375|Sensory System Agents|sensory system agents|mesh-ancestor
6096796|NCT00908375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6096797|NCT00908375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096798|NCT00908375|Anticonvulsants|anticonvulsants|mesh-ancestor
6096799|NCT00908375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6096800|NCT00908375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6096801|NCT00908375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096802|NCT00908375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6096803|NCT00908375|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6096804|NCT00908375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6096805|NCT00908375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6096806|NCT00908375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6096807|NCT00908466|Sirolimus|sirolimus|mesh-list
6096808|NCT00908466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6096809|NCT00908466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6096810|NCT00908466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6096811|NCT00908466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6096812|NCT00908466|Antifungal Agents|antifungal agents|mesh-ancestor
6096813|NCT00908466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6096814|NCT00908466|Immunologic Factors|immunologic factors|mesh-ancestor
6096815|NCT00908466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096816|NCT00908583|Methylprednisolone|methylprednisolone|mesh-list
6096817|NCT00908583|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6096818|NCT00908583|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6096819|NCT00908583|Prednisolone|prednisolone|mesh-list
6096820|NCT00908583|Prednisolone acetate|prednisolone acetate|mesh-list
6096821|NCT00908583|Rituximab|rituximab|mesh-list
6096822|NCT00908583|Bortezomib|bortezomib|mesh-list
6096823|NCT00908583|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6096824|NCT00908583|Prednisolone phosphate|prednisolone phosphate|mesh-list
6096825|NCT00908583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6096826|NCT00908583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6096827|NCT00908583|Immunologic Factors|immunologic factors|mesh-ancestor
6096828|NCT00908583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096829|NCT00908583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6096830|NCT00908583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6096831|NCT00908583|Antiemetics|antiemetics|mesh-ancestor
6096832|NCT00908583|Autonomic Agents|autonomic agents|mesh-ancestor
6096833|NCT00908583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6096834|NCT00908583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6096835|NCT00908583|Glucocorticoids|glucocorticoids|mesh-ancestor
6096836|NCT00908583|Hormones|hormones|mesh-ancestor
6096837|NCT00908583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6096838|NCT00908583|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6096839|NCT00908583|Protective Agents|protective agents|mesh-ancestor
6096840|NCT00908583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5521551|NCT04313959|Sensory System Agents|sensory system agents|mesh-ancestor
5521552|NCT04314193|Prednisolone|prednisolone|mesh-list
5521553|NCT04314193|Methotrexate|methotrexate|mesh-list
5521554|NCT04314193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5521555|NCT04314193|Abortifacient Agents|abortifacient agents|mesh-ancestor
5521556|NCT04314193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5521557|NCT04314193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521558|NCT04314193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5521559|NCT04314193|Antimetabolites|antimetabolites|mesh-ancestor
5521560|NCT04314193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521561|NCT04314193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5521562|NCT04314193|Dermatologic Agents|dermatologic agents|mesh-ancestor
5521563|NCT04314193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5521564|NCT04314193|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6203623|NCT02059135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6203624|NCT02059135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203625|NCT02059135|Anticoagulants|anticoagulants|mesh-ancestor
6203626|NCT02059161|Insulin|insulin|mesh-list
6203627|NCT02059161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6203628|NCT02059161|Insulin Glargine|insulin glargine|mesh-list
6203629|NCT02059161|MK-1293|mk-1293|mesh-list
6203630|NCT02059161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6203631|NCT02059161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203632|NCT02059161|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6096841|NCT00908960|Enoxaparin|enoxaparin|mesh-list
6096842|NCT00908960|Anticoagulants|anticoagulants|mesh-ancestor
6096843|NCT00908960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6096844|NCT00908960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6096845|NCT00908960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096846|NCT00909064|PENTA|penta|mesh-list
6096847|NCT00909064|Fondaparinux|fondaparinux|mesh-list
6096848|NCT00909064|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6096849|NCT00909064|Antithrombins|antithrombins|mesh-ancestor
6096850|NCT00909064|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6096851|NCT00909064|Protease Inhibitors|protease inhibitors|mesh-ancestor
6096852|NCT00909064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6096853|NCT00909064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096854|NCT00909064|Anticoagulants|anticoagulants|mesh-ancestor
6096855|NCT00909064|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6096856|NCT00909064|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6096857|NCT00909155|Fluoxetine|fluoxetine|mesh-list
6096858|NCT00909155|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6096859|NCT00909155|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6096860|NCT00909155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6096861|NCT00909155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6096862|NCT00909155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096863|NCT00909155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6096864|NCT00909155|Serotonin Agents|serotonin agents|mesh-ancestor
6096865|NCT00909155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096866|NCT00909155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6096867|NCT00909155|Antidepressive Agents|antidepressive agents|mesh-ancestor
6096868|NCT00909155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6096869|NCT00909155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6096870|NCT00909155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6096871|NCT00909155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6096872|NCT00909155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5521565|NCT04314193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5521566|NCT04314193|Immunologic Factors|immunologic factors|mesh-ancestor
6096873|NCT00909181|Mandelic Acids|mandelic acids|mesh-list
6096874|NCT00909181|Oxybutynin|oxybutynin|mesh-list
6096875|NCT00909181|Parasympatholytics|parasympatholytics|mesh-ancestor
6096876|NCT00909181|Autonomic Agents|autonomic agents|mesh-ancestor
6096877|NCT00909181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6096878|NCT00909181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096879|NCT00909181|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6096880|NCT00909181|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6096881|NCT00909181|Cholinergic Agents|cholinergic agents|mesh-ancestor
6096882|NCT00909181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6096883|NCT00909181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521567|NCT04314193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5521568|NCT04314193|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5521569|NCT04314193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5521570|NCT04314193|Glucocorticoids|glucocorticoids|mesh-ancestor
5521571|NCT04314193|Hormones|hormones|mesh-ancestor
6096884|NCT00909181|Urological Agents|urological agents|mesh-ancestor
6096885|NCT00909181|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6096886|NCT00909181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6096887|NCT00909181|Renal Agents|renal agents|mesh-ancestor
6096888|NCT00909428|Solifenacin Succinate|solifenacin succinate|mesh-list
6096889|NCT00909428|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6096890|NCT00909428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6096891|NCT00909428|Cholinergic Agents|cholinergic agents|mesh-ancestor
6096892|NCT00909428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6096893|NCT00909428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096894|NCT00909428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096895|NCT00909428|Urological Agents|urological agents|mesh-ancestor
6096896|NCT00909480|Insulin|insulin|mesh-list
6096897|NCT00909480|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5521572|NCT04314193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5521573|NCT04314193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5521574|NCT04313972|Naltrexone|naltrexone|mesh-list
5521575|NCT04313972|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5521576|NCT04313972|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5521577|NCT04313972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521578|NCT04313972|Sensory System Agents|sensory system agents|mesh-ancestor
5521579|NCT04313972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6096898|NCT00909480|Insulin Glargine|insulin glargine|mesh-list
6096899|NCT00909480|Insulin Detemir|insulin detemir|mesh-list
5521580|NCT04313907|Clonazepam|clonazepam|mesh-list
6096900|NCT00909480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6096901|NCT00909480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096902|NCT00909532|Ivacaftor|ivacaftor|mesh-list
6096903|NCT00909532|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6096904|NCT00909532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5521581|NCT04313907|Anticonvulsants|anticonvulsants|mesh-ancestor
5521582|NCT04313907|GABA Modulators|gaba modulators|mesh-ancestor
5521583|NCT04313907|GABA Agents|gaba agents|mesh-ancestor
6096905|NCT00909532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096906|NCT00909545|Isradipine|isradipine|mesh-list
6096907|NCT00909545|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6096908|NCT00909545|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6096909|NCT00909545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6096910|NCT00909545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096911|NCT00909545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6096912|NCT00909545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096913|NCT00909545|Vasodilator Agents|vasodilator agents|mesh-ancestor
6096914|NCT00909727|Ivacaftor|ivacaftor|mesh-list
6096915|NCT00909727|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6096916|NCT00909727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6096917|NCT00909727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096918|NCT00909779|Formoterol Fumarate|formoterol fumarate|mesh-list
6096919|NCT00909779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6096920|NCT00909779|Autonomic Agents|autonomic agents|mesh-ancestor
6096921|NCT00909779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6096922|NCT00909779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096923|NCT00909779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6096924|NCT00909779|Respiratory System Agents|respiratory system agents|mesh-ancestor
6096925|NCT00909779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6096926|NCT00909779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6096927|NCT00909779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6096928|NCT00909779|Adrenergic Agents|adrenergic agents|mesh-ancestor
6096929|NCT00909779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6096930|NCT00909779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096931|NCT00909844|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6096932|NCT00909844|Luteolytic Agents|luteolytic agents|mesh-ancestor
6096933|NCT00909844|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6096934|NCT00909844|Contraceptive Agents|contraceptive agents|mesh-ancestor
6096935|NCT00909844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6096936|NCT00909844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096937|NCT00909844|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5521584|NCT04313907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5521585|NCT04313907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521586|NCT04313907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521587|NCT04313790|Heparin|heparin|mesh-list
6096938|NCT00909844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6096939|NCT00909844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6096940|NCT00909857|Dienogest|dienogest|mesh-list
6096941|NCT00909857|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6096942|NCT00909857|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6096943|NCT00909857|Levonorgestrel|levonorgestrel|mesh-list
6096944|NCT00909857|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6096945|NCT00909857|Estradiol|estradiol|mesh-list
6096946|NCT00909857|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6096947|NCT00909857|Estrogens|estrogens|mesh-ancestor
6096948|NCT00909857|Hormones|hormones|mesh-ancestor
6096949|NCT00909857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6096950|NCT00909857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096951|NCT00909857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6096952|NCT00909857|Contraceptive Agents|contraceptive agents|mesh-ancestor
6096953|NCT00909857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6096954|NCT00909857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6096955|NCT00909857|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6096956|NCT00909857|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6096957|NCT00909857|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6096958|NCT00909857|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6096959|NCT00909857|Hormone Antagonists|hormone antagonists|mesh-ancestor
6096960|NCT00909857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6096961|NCT00909857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6096962|NCT00910000|Gemcitabine|gemcitabine|mesh-list
6096963|NCT00910000|Carboplatin|carboplatin|mesh-list
6096964|NCT00910000|Vorinostat|vorinostat|mesh-list
5521588|NCT04313790|Calcium heparin|calcium heparin|mesh-list
5521589|NCT04313790|Anticoagulants|anticoagulants|mesh-ancestor
6096965|NCT00910000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6096966|NCT00910000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6096967|NCT00910000|Antimetabolites|antimetabolites|mesh-ancestor
6096968|NCT00910000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096969|NCT00910000|Antiviral Agents|antiviral agents|mesh-ancestor
6096970|NCT00910000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6096971|NCT00910000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6096972|NCT00910000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6096973|NCT00910000|Immunologic Factors|immunologic factors|mesh-ancestor
6096974|NCT00910000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096975|NCT00910000|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6096976|NCT00910039|Sunitinib|sunitinib|mesh-list
6096977|NCT00910039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6096978|NCT00910039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6096979|NCT00910039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6096980|NCT00910039|Growth Substances|growth substances|mesh-ancestor
6096981|NCT00910039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096982|NCT00910039|Growth Inhibitors|growth inhibitors|mesh-ancestor
6096983|NCT00910039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6096984|NCT00910039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6096985|NCT00910039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096986|NCT00910091|Megestrol|megestrol|mesh-list
6096987|NCT00910091|Megestrol Acetate|megestrol acetate|mesh-list
6096988|NCT00910091|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6096989|NCT00910091|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5521590|NCT04313790|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5521591|NCT04313790|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5521592|NCT04313790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6096990|NCT00910091|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6096991|NCT00910091|Contraceptive Agents|contraceptive agents|mesh-ancestor
6096992|NCT00910091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6096993|NCT00910091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6096994|NCT00910091|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6096995|NCT00910091|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6096996|NCT00910091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6096997|NCT00910091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6096998|NCT00910091|Appetite Stimulants|appetite stimulants|mesh-ancestor
6096999|NCT00910091|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6097000|NCT00910208|Morphine|morphine|mesh-list
6097001|NCT00910208|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6097002|NCT00910208|Narcotics|narcotics|mesh-ancestor
6097003|NCT00910208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6097004|NCT00910208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097005|NCT00910208|Analgesics|analgesics|mesh-ancestor
6097006|NCT00910208|Sensory System Agents|sensory system agents|mesh-ancestor
6097007|NCT00910208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6097008|NCT00910247|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
6097009|NCT00910247|Anticonvulsants|anticonvulsants|mesh-ancestor
6097010|NCT00910247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6097011|NCT00910247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6097012|NCT00910247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6097013|NCT00910247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097014|NCT00910273|Etanercept|etanercept|mesh-list
6097015|NCT00910273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6097016|NCT00910273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6097017|NCT00910273|Analgesics|analgesics|mesh-ancestor
6097018|NCT00910273|Sensory System Agents|sensory system agents|mesh-ancestor
6097019|NCT00910273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6097020|NCT00910273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097021|NCT00910273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6097022|NCT00910273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6097023|NCT00910273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6097024|NCT00910273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6097025|NCT00910273|Immunologic Factors|immunologic factors|mesh-ancestor
6097026|NCT00910299|Clopidogrel|clopidogrel|mesh-list
6097027|NCT00910299|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6097028|NCT00910299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6097029|NCT00910299|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6097030|NCT00910299|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6097031|NCT00910299|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6097032|NCT00910299|Purinergic Agents|purinergic agents|mesh-ancestor
6097033|NCT00910299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6097034|NCT00910299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097035|NCT00910299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097036|NCT00910429|Riociguat|riociguat|mesh-list
6097037|NCT00910429|Enzyme Activators|enzyme activators|mesh-ancestor
6097038|NCT00910429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097039|NCT00910520|Botulinum Toxins|botulinum toxins|mesh-list
6097040|NCT00910520|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6097041|NCT00910520|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6097042|NCT00910520|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6097043|NCT00910520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6097044|NCT00910520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097045|NCT00910520|Cholinergic Agents|cholinergic agents|mesh-ancestor
6097046|NCT00910520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6097047|NCT00910520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097048|NCT00910520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6097049|NCT00910520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6097050|NCT00910624|Ribavirin|ribavirin|mesh-list
6097051|NCT00910624|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6097052|NCT00910624|Antimetabolites|antimetabolites|mesh-ancestor
6097053|NCT00910624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097054|NCT00910624|Antiviral Agents|antiviral agents|mesh-ancestor
6097055|NCT00910624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6097056|NCT00910663|Mycophenolic Acid|mycophenolic acid|mesh-list
6097057|NCT00910663|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6097058|NCT00910663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6097059|NCT00910663|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6097060|NCT00910663|Antitubercular Agents|antitubercular agents|mesh-ancestor
6097061|NCT00910663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6097062|NCT00910663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6097063|NCT00910663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6097064|NCT00910663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097065|NCT00910689|Propranolol|propranolol|mesh-list
6097066|NCT00910689|Nadolol|nadolol|mesh-list
6097067|NCT00910689|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6097068|NCT00910689|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6097069|NCT00910689|Adrenergic Agents|adrenergic agents|mesh-ancestor
6097070|NCT00910689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6097071|NCT00910689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097072|NCT00910689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097073|NCT00910689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6097074|NCT00910689|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6097075|NCT00910689|Vasodilator Agents|vasodilator agents|mesh-ancestor
6097076|NCT00910689|Sympatholytics|sympatholytics|mesh-ancestor
6097077|NCT00910689|Autonomic Agents|autonomic agents|mesh-ancestor
6097078|NCT00910689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6097079|NCT00910715|Doxycycline|doxycycline|mesh-list
6097080|NCT00910715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6097081|NCT00910715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6097082|NCT00910715|Antimalarials|antimalarials|mesh-ancestor
5521593|NCT04313699|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
5521594|NCT04313699|Antiviral Agents|antiviral agents|mesh-ancestor
5521595|NCT04313699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5521596|NCT04313764|Bupivacaine|bupivacaine|mesh-list
5521597|NCT04313764|Anesthetics, Local|anesthetics, local|mesh-ancestor
5521598|NCT04313764|Anesthetics|anesthetics|mesh-ancestor
5521599|NCT04313764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5521600|NCT04313764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521601|NCT04313764|Sensory System Agents|sensory system agents|mesh-ancestor
5521602|NCT04313764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5521603|NCT04313504|Niraparib|niraparib|mesh-list
5521604|NCT04313504|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5521605|NCT04313504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5521606|NCT04313504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521607|NCT04313504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5521608|NCT04313452|Insulin|insulin|mesh-list
5521609|NCT04313452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6097083|NCT00910715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6097084|NCT00910715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6097085|NCT00910845|Botulinum Toxins|botulinum toxins|mesh-list
6097086|NCT00910845|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6097087|NCT00910845|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6097088|NCT00910845|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6097089|NCT00910845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6097090|NCT00910845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097091|NCT00910845|Cholinergic Agents|cholinergic agents|mesh-ancestor
6097092|NCT00910845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6097093|NCT00910845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097094|NCT00910845|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6097095|NCT00910845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6097096|NCT00910858|Lenalidomide|lenalidomide|mesh-list
6097097|NCT00910858|Epoetin Alfa|epoetin alfa|mesh-list
6097098|NCT00910858|Immunologic Factors|immunologic factors|mesh-ancestor
5521610|NCT04313452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521611|NCT04313634|Dasatinib|dasatinib|mesh-list
5521612|NCT04313634|Quercetin|quercetin|mesh-list
5521613|NCT04313634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5521614|NCT04313634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5521615|NCT04313634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6097099|NCT00910858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097100|NCT00910858|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6097101|NCT00910858|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6097102|NCT00910858|Growth Substances|growth substances|mesh-ancestor
6097103|NCT00910858|Growth Inhibitors|growth inhibitors|mesh-ancestor
6665753|NCT01518608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6665754|NCT01518608|Anesthetics, General|anesthetics, general|mesh-ancestor
6665755|NCT01518608|Anesthetics|anesthetics|mesh-ancestor
6665756|NCT01518621|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6665757|NCT01518621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6665758|NCT01518621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6665759|NCT01518621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6665760|NCT01518621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521616|NCT04313634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521617|NCT04313634|Antioxidants|antioxidants|mesh-ancestor
5521618|NCT04313634|Protective Agents|protective agents|mesh-ancestor
5521619|NCT04313634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521620|NCT04313270|Evolocumab|evolocumab|mesh-list
5521621|NCT04313270|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5521622|NCT04313270|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5521623|NCT04313270|Antimetabolites|antimetabolites|mesh-ancestor
5521624|NCT04313270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521625|NCT04313270|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5521626|NCT04313218|Misoprostol|misoprostol|mesh-list
5521627|NCT04313218|Carbetocin|carbetocin|mesh-list
5521628|NCT04313218|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5521629|NCT04313218|Abortifacient Agents|abortifacient agents|mesh-ancestor
6097104|NCT00910858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6097105|NCT00910858|Hematinics|hematinics|mesh-ancestor
5521630|NCT04313218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5521631|NCT04313218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521632|NCT04313218|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5521633|NCT04313218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5521634|NCT04313218|Oxytocics|oxytocics|mesh-ancestor
5521635|NCT04313374|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
5521636|NCT04313374|Morphine|morphine|mesh-list
5521637|NCT04313374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5521638|NCT04313374|Narcotics|narcotics|mesh-ancestor
6097106|NCT00910871|Bedaquiline|bedaquiline|mesh-list
6097107|NCT00910871|Antitubercular Agents|antitubercular agents|mesh-ancestor
6097108|NCT00910871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6097109|NCT00910871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6097110|NCT00910910|Lenalidomide|lenalidomide|mesh-list
6097111|NCT00910910|Chlorambucil|chlorambucil|mesh-list
6097112|NCT00910910|Immunologic Factors|immunologic factors|mesh-ancestor
6097113|NCT00910910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097114|NCT00910910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6097115|NCT00910910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6097116|NCT00910910|Growth Substances|growth substances|mesh-ancestor
6097117|NCT00910910|Growth Inhibitors|growth inhibitors|mesh-ancestor
6097118|NCT00910910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6097119|NCT00910910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6097120|NCT00910910|Alkylating Agents|alkylating agents|mesh-ancestor
6097121|NCT00910910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097122|NCT00910988|Olanzapine|olanzapine|mesh-list
6097123|NCT00910988|Ziprasidone|ziprasidone|mesh-list
6097124|NCT00910988|Antiemetics|antiemetics|mesh-ancestor
6097125|NCT00910988|Autonomic Agents|autonomic agents|mesh-ancestor
6097126|NCT00910988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6097127|NCT00910988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097128|NCT00910988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6097129|NCT00910988|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6097130|NCT00910988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6097131|NCT00910988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6097132|NCT00910988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6097133|NCT00910988|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6097134|NCT00910988|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6097135|NCT00910988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6097136|NCT00910988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097137|NCT00910988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6097138|NCT00910988|Serotonin Agents|serotonin agents|mesh-ancestor
6097139|NCT00910988|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6097140|NCT00910988|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6097141|NCT00910988|Dopamine Agents|dopamine agents|mesh-ancestor
6097142|NCT00911144|Vaccines|vaccines|mesh-list
6097143|NCT00911144|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6097144|NCT00911144|Immunologic Factors|immunologic factors|mesh-ancestor
6097145|NCT00911144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097146|NCT00911157|Heparin|heparin|mesh-list
6097147|NCT00911157|Calcium heparin|calcium heparin|mesh-list
6097148|NCT00911157|PENTA|penta|mesh-list
6097149|NCT00911157|Fondaparinux|fondaparinux|mesh-list
6097150|NCT00911157|Anticoagulants|anticoagulants|mesh-ancestor
6097151|NCT00911157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6097152|NCT00911157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6097153|NCT00911157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097154|NCT00911157|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6097155|NCT00911157|Antithrombins|antithrombins|mesh-ancestor
6097156|NCT00911157|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6097157|NCT00911157|Protease Inhibitors|protease inhibitors|mesh-ancestor
6097158|NCT00911157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6464690|NCT00470483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6464691|NCT00470483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6464692|NCT00470483|Serotonin Agents|serotonin agents|mesh-ancestor
6464693|NCT00470483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464694|NCT00470483|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6464695|NCT00470483|Antidepressive Agents|antidepressive agents|mesh-ancestor
6464696|NCT00470483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6464697|NCT00470483|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6464698|NCT00470483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6464699|NCT00470483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6464700|NCT00470509|Adalimumab|adalimumab|mesh-list
6464701|NCT00470509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6464702|NCT00470509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6464703|NCT00470522|Folic Acid|folic acid|mesh-list
6097159|NCT00911170|Bevacizumab|bevacizumab|mesh-list
6097160|NCT00911170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6097161|NCT00911170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6097162|NCT00911170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6097163|NCT00911170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6097164|NCT00911170|Growth Substances|growth substances|mesh-ancestor
6097165|NCT00911170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097166|NCT00911170|Growth Inhibitors|growth inhibitors|mesh-ancestor
6097167|NCT00911300|Vitamin K|vitamin k|mesh-list
6097168|NCT00911300|Heparin|heparin|mesh-list
6097169|NCT00911300|Calcium heparin|calcium heparin|mesh-list
6097170|NCT00911300|PENTA|penta|mesh-list
6097171|NCT00911300|Fondaparinux|fondaparinux|mesh-list
6097172|NCT00911300|Vitamins|vitamins|mesh-ancestor
6097173|NCT00911300|Micronutrients|micronutrients|mesh-ancestor
6097174|NCT00911300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097175|NCT00911300|Anticoagulants|anticoagulants|mesh-ancestor
6097176|NCT00911300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6097177|NCT00911300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6097178|NCT00911300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097179|NCT00911300|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6097180|NCT00911300|Hemostatics|hemostatics|mesh-ancestor
6097181|NCT00911300|Coagulants|coagulants|mesh-ancestor
6097182|NCT00911300|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6097183|NCT00911300|Antithrombins|antithrombins|mesh-ancestor
5521639|NCT04313374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5521640|NCT04313374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521641|NCT04313374|Analgesics|analgesics|mesh-ancestor
5521642|NCT04313374|Sensory System Agents|sensory system agents|mesh-ancestor
5521643|NCT04313374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5521644|NCT04313374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5521645|NCT04313374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5521646|NCT04313374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5521647|NCT04313374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5521648|NCT04313335|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5521649|NCT04313335|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5521650|NCT04313335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5521651|NCT04313335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5521652|NCT04313335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521653|NCT04313335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5521654|NCT04313335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521655|NCT04313335|Analgesics|analgesics|mesh-ancestor
5521656|NCT04313335|Sensory System Agents|sensory system agents|mesh-ancestor
5521657|NCT04313335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5521658|NCT04313335|Antidepressive Agents|antidepressive agents|mesh-ancestor
5521659|NCT04313335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5521660|NCT04313335|Dopamine Agents|dopamine agents|mesh-ancestor
5521661|NCT04312997|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
5521662|NCT04312997|Respiratory System Agents|respiratory system agents|mesh-ancestor
5521663|NCT04313023|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
5521664|NCT04313023|Respiratory System Agents|respiratory system agents|mesh-ancestor
6097184|NCT00911300|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6097185|NCT00911300|Protease Inhibitors|protease inhibitors|mesh-ancestor
6097186|NCT00911300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6097187|NCT00911326|Dextrans|dextrans|mesh-list
6097188|NCT00911326|Technetium Tc 99m Pentetate|technetium tc 99m pentetate|mesh-list
6097189|NCT00911326|Anticoagulants|anticoagulants|mesh-ancestor
6097190|NCT00911326|Plasma Substitutes|plasma substitutes|mesh-ancestor
6097191|NCT00911326|Blood Substitutes|blood substitutes|mesh-ancestor
6097192|NCT00911326|Chelating Agents|chelating agents|mesh-ancestor
6097193|NCT00911326|Sequestering Agents|sequestering agents|mesh-ancestor
6097194|NCT00911326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097195|NCT00911326|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6097196|NCT00911534|Rabeprazole|rabeprazole|mesh-list
6097197|NCT00911534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6097198|NCT00911534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6097199|NCT00911534|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6097200|NCT00911534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6097201|NCT00911534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097202|NCT00911586|Methyltestosterone|methyltestosterone|mesh-list
6097203|NCT00911586|Testosterone|testosterone|mesh-list
6097204|NCT00911586|Testosterone undecanoate|testosterone undecanoate|mesh-list
6097205|NCT00911586|Testosterone enanthate|testosterone enanthate|mesh-list
6097206|NCT00911586|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6097207|NCT00911586|Androgens|androgens|mesh-ancestor
6097208|NCT00911586|Hormones|hormones|mesh-ancestor
6203633|NCT02059161|Antimetabolites|antimetabolites|mesh-ancestor
6097209|NCT00911586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6097210|NCT00911586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097211|NCT00911586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6097212|NCT00911586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6097213|NCT00911586|Anabolic Agents|anabolic agents|mesh-ancestor
6097214|NCT00911612|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
6097215|NCT00911612|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6097216|NCT00911612|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6097217|NCT00911612|Antimetabolites|antimetabolites|mesh-ancestor
6097218|NCT00911612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097219|NCT00911612|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6097220|NCT00911625|Insulin|insulin|mesh-list
6097221|NCT00911625|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6097222|NCT00911625|Insulin Glargine|insulin glargine|mesh-list
6097223|NCT00911625|Insulin glulisine|insulin glulisine|mesh-list
6097224|NCT00911625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6097225|NCT00911625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097226|NCT00911742|Tramadol|tramadol|mesh-list
6097227|NCT00911742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6097228|NCT00911742|Narcotics|narcotics|mesh-ancestor
6097229|NCT00911742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6097230|NCT00911742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097231|NCT00911742|Analgesics|analgesics|mesh-ancestor
6097232|NCT00911742|Sensory System Agents|sensory system agents|mesh-ancestor
6097233|NCT00911742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6097234|NCT00911807|Cerebrolysin|cerebrolysin|mesh-list
6097235|NCT00911807|Donepezil|donepezil|mesh-list
6097236|NCT00911807|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6097237|NCT00911807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6097238|NCT00911807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097239|NCT00911807|Cholinergic Agents|cholinergic agents|mesh-ancestor
6097240|NCT00911807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6097241|NCT00911807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097242|NCT00911807|Nootropic Agents|nootropic agents|mesh-ancestor
6097243|NCT00911807|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6097244|NCT00911807|Protective Agents|protective agents|mesh-ancestor
6097245|NCT00911820|Bevacizumab|bevacizumab|mesh-list
6097246|NCT00911820|Cisplatin|cisplatin|mesh-list
6097247|NCT00911820|Docetaxel|docetaxel|mesh-list
6097248|NCT00911820|Irinotecan|irinotecan|mesh-list
6097249|NCT00911820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6097250|NCT00911820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6097251|NCT00911820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6097252|NCT00911820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6097253|NCT00911820|Growth Substances|growth substances|mesh-ancestor
6097254|NCT00911820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097255|NCT00911820|Growth Inhibitors|growth inhibitors|mesh-ancestor
6097256|NCT00911820|Tubulin Modulators|tubulin modulators|mesh-ancestor
6097257|NCT00911820|Antimitotic Agents|antimitotic agents|mesh-ancestor
6097258|NCT00911820|Mitosis Modulators|mitosis modulators|mesh-ancestor
6097259|NCT00911820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097260|NCT00911820|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6097261|NCT00911820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6097262|NCT00911820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6097263|NCT00911859|Prednisone|prednisone|mesh-list
6097264|NCT00911859|Bortezomib|bortezomib|mesh-list
6097265|NCT00911859|Melphalan|melphalan|mesh-list
6097266|NCT00911859|Siltuximab|siltuximab|mesh-list
6097267|NCT00911859|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6097268|NCT00911859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6097269|NCT00911859|Glucocorticoids|glucocorticoids|mesh-ancestor
6097270|NCT00911859|Hormones|hormones|mesh-ancestor
6097271|NCT00911859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6097272|NCT00911859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097273|NCT00911859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6097274|NCT00911859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6097275|NCT00911859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6097276|NCT00911859|Alkylating Agents|alkylating agents|mesh-ancestor
6097277|NCT00911859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097278|NCT00911859|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6097279|NCT00911859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6097280|NCT00911859|Immunologic Factors|immunologic factors|mesh-ancestor
6097281|NCT00911937|Fesoterodine|fesoterodine|mesh-list
6097282|NCT00911937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6097283|NCT00911937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6097284|NCT00911937|Cholinergic Agents|cholinergic agents|mesh-ancestor
5521665|NCT04312880|Tranexamic Acid|tranexamic acid|mesh-list
5521666|NCT04312880|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5521667|NCT04312880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5521668|NCT04312880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097285|NCT00911937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6097286|NCT00911937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097287|NCT00911937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097288|NCT00911937|Urological Agents|urological agents|mesh-ancestor
6097289|NCT00912015|Tramadol|tramadol|mesh-list
6097290|NCT00912015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5521669|NCT04312880|Hemostatics|hemostatics|mesh-ancestor
5521670|NCT04312880|Coagulants|coagulants|mesh-ancestor
5521671|NCT04313036|Defibrotide|defibrotide|mesh-list
5521672|NCT04313036|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5521673|NCT04313036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5521674|NCT04313036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521675|NCT04313036|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5521676|NCT04312841|Acetic Acid|acetic acid|mesh-list
5521677|NCT04312841|Letermovir|letermovir|mesh-list
5521678|NCT04312841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5521679|NCT04312841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5521680|NCT04312841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5521681|NCT04312841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521682|NCT04312841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5521683|NCT04312841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5521684|NCT04312841|Antiviral Agents|antiviral agents|mesh-ancestor
5600956|NCT03708588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600957|NCT03708588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600958|NCT03708536|Bevacizumab|bevacizumab|mesh-list
5600959|NCT03708536|Capecitabine|capecitabine|mesh-list
5600960|NCT03708536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5600961|NCT03708536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5600962|NCT03708536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5600963|NCT03708536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5600964|NCT03708536|Growth Substances|growth substances|mesh-ancestor
5600965|NCT03708536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600966|NCT03708536|Growth Inhibitors|growth inhibitors|mesh-ancestor
5600967|NCT03708536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5600968|NCT03708536|Antimetabolites|antimetabolites|mesh-ancestor
5600969|NCT03708536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600970|NCT03708497|Misoprostol|misoprostol|mesh-list
5600971|NCT03708497|Tranexamic Acid|tranexamic acid|mesh-list
5600972|NCT03708497|Carbetocin|carbetocin|mesh-list
5600973|NCT03708497|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5600974|NCT03708497|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5600975|NCT03708497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600976|NCT03708497|Hemostatics|hemostatics|mesh-ancestor
5600977|NCT03708497|Coagulants|coagulants|mesh-ancestor
5600978|NCT03708497|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5600979|NCT03708497|Abortifacient Agents|abortifacient agents|mesh-ancestor
5600980|NCT03708497|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5600981|NCT03708497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600982|NCT03708497|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5600983|NCT03708497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5600984|NCT03708497|Oxytocics|oxytocics|mesh-ancestor
5600985|NCT03708458|Acetylcysteine|acetylcysteine|mesh-list
5600986|NCT03708458|Indomethacin|indomethacin|mesh-list
5600987|NCT03708458|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5600988|NCT03708458|Antiviral Agents|antiviral agents|mesh-ancestor
5600989|NCT03708458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5600990|NCT03708458|Expectorants|expectorants|mesh-ancestor
6097291|NCT00912015|Narcotics|narcotics|mesh-ancestor
6097292|NCT00912015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6097293|NCT00912015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097294|NCT00912015|Analgesics|analgesics|mesh-ancestor
6097295|NCT00912015|Sensory System Agents|sensory system agents|mesh-ancestor
6097296|NCT00912015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6097297|NCT00912093|Icatibant|icatibant|mesh-list
6097298|NCT00912093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6097299|NCT00912093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6097300|NCT00912093|Analgesics|analgesics|mesh-ancestor
6097301|NCT00912093|Sensory System Agents|sensory system agents|mesh-ancestor
6097302|NCT00912093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6097303|NCT00912093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600991|NCT03708458|Respiratory System Agents|respiratory system agents|mesh-ancestor
5521685|NCT04312750|Lidocaine|lidocaine|mesh-list
5521686|NCT04312750|Anesthetics, Local|anesthetics, local|mesh-ancestor
5521687|NCT04312750|Anesthetics|anesthetics|mesh-ancestor
5521688|NCT04312750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6097304|NCT00912093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6097305|NCT00912093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6097306|NCT00912093|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
6097307|NCT00912093|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
6097308|NCT00912093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097309|NCT00912093|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6097310|NCT00912093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6097311|NCT00912093|Immunologic Factors|immunologic factors|mesh-ancestor
6097312|NCT00912301|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
6097313|NCT00912301|Cathartics|cathartics|mesh-ancestor
6097314|NCT00912301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6097315|NCT00912340|Trastuzumab|trastuzumab|mesh-list
6097316|NCT00912340|Everolimus|everolimus|mesh-list
6097317|NCT00912340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6097318|NCT00912340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6464704|NCT00470522|Methotrexate|methotrexate|mesh-list
6464705|NCT00470522|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6464706|NCT00470522|Abortifacient Agents|abortifacient agents|mesh-ancestor
6464707|NCT00470522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6464708|NCT00470522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464709|NCT00470522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6097319|NCT00912340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6097320|NCT00912340|Immunologic Factors|immunologic factors|mesh-ancestor
6097321|NCT00912340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097322|NCT00912509|Riboflavin|riboflavin|mesh-list
6097323|NCT00912509|Vitamin B Complex|vitamin b complex|mesh-ancestor
6097324|NCT00912509|Vitamins|vitamins|mesh-ancestor
6097325|NCT00912509|Micronutrients|micronutrients|mesh-ancestor
6097326|NCT00912509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097327|NCT00912509|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6097328|NCT00912509|Dermatologic Agents|dermatologic agents|mesh-ancestor
6097329|NCT00912743|Olaparib|olaparib|mesh-list
5521689|NCT04312750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521690|NCT04312750|Sensory System Agents|sensory system agents|mesh-ancestor
5521691|NCT04312750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5521692|NCT04312750|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5521693|NCT04312750|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5521694|NCT04312750|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5521695|NCT04312750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6097330|NCT00912743|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6097331|NCT00912743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6097332|NCT00912743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097333|NCT00912743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6097334|NCT00912782|Vitamin D|vitamin d|mesh-list
6097335|NCT00912782|Cholecalciferol|cholecalciferol|mesh-list
6097336|NCT00912782|Vitamins|vitamins|mesh-ancestor
6097337|NCT00912782|Micronutrients|micronutrients|mesh-ancestor
6097338|NCT00912782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097339|NCT00912782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6097340|NCT00912782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6097341|NCT00912808|Donepezil|donepezil|mesh-list
6097342|NCT00912808|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6097343|NCT00912808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6097344|NCT00912808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097345|NCT00912808|Cholinergic Agents|cholinergic agents|mesh-ancestor
6097346|NCT00912808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5521696|NCT04312750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521697|NCT04313088|Eluxadoline|eluxadoline|mesh-list
5521698|NCT04313088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5521699|NCT04312503|Olanzapine|olanzapine|mesh-list
5521700|NCT04312503|Risperidone|risperidone|mesh-list
5521701|NCT04312503|Quetiapine Fumarate|quetiapine fumarate|mesh-list
5521702|NCT04312503|Aripiprazole|aripiprazole|mesh-list
5521703|NCT04312503|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
5521704|NCT04312503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5521705|NCT04312503|Serotonin Agents|serotonin agents|mesh-ancestor
5521706|NCT04312503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5521707|NCT04312503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097347|NCT00912808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097348|NCT00912808|Nootropic Agents|nootropic agents|mesh-ancestor
6097349|NCT00912873|Ropivacaine|ropivacaine|mesh-list
5521708|NCT04312503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521709|NCT04312503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6097350|NCT00912873|Anesthetics, Local|anesthetics, local|mesh-ancestor
6097351|NCT00912873|Anesthetics|anesthetics|mesh-ancestor
6097352|NCT00912873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6097353|NCT00912873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097354|NCT00912873|Sensory System Agents|sensory system agents|mesh-ancestor
6097355|NCT00912873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6097356|NCT00912912|Sunitinib|sunitinib|mesh-list
6097357|NCT00912912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6097358|NCT00912912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6097359|NCT00912912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6097360|NCT00912912|Growth Substances|growth substances|mesh-ancestor
6097361|NCT00912912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097362|NCT00912912|Growth Inhibitors|growth inhibitors|mesh-ancestor
6097363|NCT00912912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6097364|NCT00912912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6097365|NCT00912912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097366|NCT00912964|Mirabegron|mirabegron|mesh-list
6097367|NCT00912964|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6097368|NCT00912964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6097369|NCT00912964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6097370|NCT00912964|Adrenergic Agents|adrenergic agents|mesh-ancestor
6097371|NCT00912964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6097372|NCT00912964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097373|NCT00912964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097374|NCT00912964|Urological Agents|urological agents|mesh-ancestor
6097375|NCT00912990|Cisatracurium|cisatracurium|mesh-list
6097376|NCT00912990|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6097377|NCT00912990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6097378|NCT00912990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6097379|NCT00912990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097380|NCT00913003|Lidocaine|lidocaine|mesh-list
6097381|NCT00913003|Anesthetics, Local|anesthetics, local|mesh-ancestor
6097382|NCT00913003|Anesthetics|anesthetics|mesh-ancestor
6097383|NCT00913003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6097384|NCT00913003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097385|NCT00913003|Sensory System Agents|sensory system agents|mesh-ancestor
6097386|NCT00913003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6097387|NCT00913003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6097388|NCT00913003|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6097389|NCT00913003|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6097390|NCT00913003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6097391|NCT00913003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097392|NCT00913068|Lidocaine|lidocaine|mesh-list
6097393|NCT00913068|Ropivacaine|ropivacaine|mesh-list
6097394|NCT00913068|Anesthetics, Local|anesthetics, local|mesh-ancestor
6097395|NCT00913068|Anesthetics|anesthetics|mesh-ancestor
6097396|NCT00913068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6097397|NCT00913068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097398|NCT00913068|Sensory System Agents|sensory system agents|mesh-ancestor
6097399|NCT00913068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6097400|NCT00913068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6097401|NCT00913068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6097402|NCT00913068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6097403|NCT00913068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6097404|NCT00913068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097405|NCT00913081|Quercetin|quercetin|mesh-list
6097406|NCT00913081|Antioxidants|antioxidants|mesh-ancestor
6097407|NCT00913081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097408|NCT00913081|Protective Agents|protective agents|mesh-ancestor
6097409|NCT00913081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097410|NCT00913133|Desirudin|desirudin|mesh-list
6097411|NCT00913133|Anticoagulants|anticoagulants|mesh-ancestor
6097412|NCT00913133|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6097413|NCT00913133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6097414|NCT00913133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097415|NCT00913263|Flutamide|flutamide|mesh-list
6097416|NCT00913263|Hydroxyflutamide|hydroxyflutamide|mesh-list
6097417|NCT00913263|Androgen Antagonists|androgen antagonists|mesh-ancestor
6097418|NCT00913263|Hormone Antagonists|hormone antagonists|mesh-ancestor
6097419|NCT00913263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5521710|NCT04312503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6097420|NCT00913263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097421|NCT00913263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6097422|NCT00913263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6097423|NCT00913458|Etanercept|etanercept|mesh-list
6097424|NCT00913458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6097425|NCT00913458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6097426|NCT00913458|Analgesics|analgesics|mesh-ancestor
6097427|NCT00913458|Sensory System Agents|sensory system agents|mesh-ancestor
6097428|NCT00913458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6097429|NCT00913458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097430|NCT00913458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6097431|NCT00913458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6097432|NCT00913458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6097433|NCT00913458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6097434|NCT00913458|Immunologic Factors|immunologic factors|mesh-ancestor
6097435|NCT00913510|Cholinergic Antagonists|cholinergic antagonists|mesh-list
6097436|NCT00913510|Cholinergic Agents|cholinergic agents|mesh-ancestor
6097437|NCT00913510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6097438|NCT00913510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097439|NCT00913510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097440|NCT00913627|Ibuprofen|ibuprofen|mesh-list
6097441|NCT00913627|Naproxen|naproxen|mesh-list
6097442|NCT00913627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6097443|NCT00913627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6097444|NCT00913627|Analgesics|analgesics|mesh-ancestor
6097445|NCT00913627|Sensory System Agents|sensory system agents|mesh-ancestor
6097446|NCT00913627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6097447|NCT00913627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097448|NCT00913627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6097449|NCT00913627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6097450|NCT00913627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6097451|NCT00913627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6097452|NCT00913627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097453|NCT00913627|Gout Suppressants|gout suppressants|mesh-ancestor
6097454|NCT00913770|Buprenorphine|buprenorphine|mesh-list
6097455|NCT00913770|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6097456|NCT00913770|Narcotics|narcotics|mesh-ancestor
6097457|NCT00913770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6097458|NCT00913770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097459|NCT00913770|Analgesics|analgesics|mesh-ancestor
6097460|NCT00913770|Sensory System Agents|sensory system agents|mesh-ancestor
6097461|NCT00913770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6097462|NCT00913770|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6097463|NCT00913835|Doxorubicin|doxorubicin|mesh-list
6097464|NCT00913835|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6097465|NCT00913835|Olaratumab|olaratumab|mesh-list
6097466|NCT00913835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6097467|NCT00913835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6097468|NCT00913835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6097469|NCT00913835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6097470|NCT00913835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6097471|NCT00913835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097472|NCT00913913|Bevacizumab|bevacizumab|mesh-list
6097473|NCT00913913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6097474|NCT00913913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6097475|NCT00913913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6097476|NCT00913913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6097477|NCT00913913|Growth Substances|growth substances|mesh-ancestor
6097478|NCT00913913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097479|NCT00913913|Growth Inhibitors|growth inhibitors|mesh-ancestor
5521711|NCT04312503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5521712|NCT04312503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5521713|NCT04312503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5521714|NCT04312503|Dopamine Agents|dopamine agents|mesh-ancestor
5521715|NCT04312503|Antiemetics|antiemetics|mesh-ancestor
5521716|NCT04312503|Autonomic Agents|autonomic agents|mesh-ancestor
5521717|NCT04312503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5521718|NCT04312503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5521719|NCT04312503|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5521720|NCT04312503|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5521721|NCT04312503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5521722|NCT04312503|Antidepressive Agents|antidepressive agents|mesh-ancestor
5521723|NCT04312503|Dopamine Agonists|dopamine agonists|mesh-ancestor
6203634|NCT02059161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521724|NCT04312503|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5521725|NCT04312503|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5521726|NCT04312503|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5521727|NCT04312503|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5521728|NCT04312503|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5521729|NCT04312503|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5521730|NCT04312503|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5521731|NCT04312503|Adrenergic Agents|adrenergic agents|mesh-ancestor
5521732|NCT04312698|Antihypertensive Agents|antihypertensive agents|mesh-list
5521733|NCT04312698|Hypolipidemic Agents|hypolipidemic agents|mesh-list
5521734|NCT04312698|Antimetabolites|antimetabolites|mesh-ancestor
6097480|NCT00914316|Ranolazine|ranolazine|mesh-list
6097481|NCT00914316|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6097482|NCT00914316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6097483|NCT00914316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097484|NCT00914459|Factor VIII|factor viii|mesh-list
6097485|NCT00914459|Coagulants|coagulants|mesh-ancestor
6097486|NCT00914732|Vaccines|vaccines|mesh-list
6097487|NCT00914732|Immunologic Factors|immunologic factors|mesh-ancestor
6097488|NCT00914732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097489|NCT00914810|Vitamin D|vitamin d|mesh-list
6097490|NCT00914810|Cholecalciferol|cholecalciferol|mesh-list
6097491|NCT00914810|Vitamins|vitamins|mesh-ancestor
6097492|NCT00914810|Micronutrients|micronutrients|mesh-ancestor
6097493|NCT00914810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097494|NCT00914810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6097495|NCT00914810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6097496|NCT00914849|Plerixafor|plerixafor|mesh-list
6097497|NCT00914849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6097498|NCT00914849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6097499|NCT00914849|Antiviral Agents|antiviral agents|mesh-ancestor
6097500|NCT00914849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6097501|NCT00914940|Fludarabine|fludarabine|mesh-list
6097502|NCT00914940|Fludarabine phosphate|fludarabine phosphate|mesh-list
6097503|NCT00914940|Thiotepa|thiotepa|mesh-list
6097504|NCT00914940|Tacrolimus|tacrolimus|mesh-list
6097505|NCT00914940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6097506|NCT00914940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6097507|NCT00914940|Antimetabolites|antimetabolites|mesh-ancestor
6097508|NCT00914940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097509|NCT00914940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6097510|NCT00914940|Immunologic Factors|immunologic factors|mesh-ancestor
6097511|NCT00914940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097512|NCT00914940|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6097513|NCT00914940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6097514|NCT00914940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6097515|NCT00914940|Alkylating Agents|alkylating agents|mesh-ancestor
6097516|NCT00914940|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6097517|NCT00914966|Complement C1s|complement c1s|mesh-list
6097518|NCT00914966|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
6097519|NCT00914966|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
6097520|NCT00914966|Immunologic Factors|immunologic factors|mesh-ancestor
6097521|NCT00914966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097522|NCT00914966|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6097523|NCT00914966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6097524|NCT00915005|Paclitaxel|paclitaxel|mesh-list
6097525|NCT00915005|Carboplatin|carboplatin|mesh-list
6097526|NCT00915005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6097527|NCT00915005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6097528|NCT00915005|Tubulin Modulators|tubulin modulators|mesh-ancestor
5521735|NCT04312698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521736|NCT04312698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5521737|NCT04312347|Tamoxifen|tamoxifen|mesh-list
5521738|NCT04312347|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5521739|NCT04312347|Hormone Antagonists|hormone antagonists|mesh-ancestor
5521740|NCT04312347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5521741|NCT04312347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521742|NCT04312347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5521743|NCT04312347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5521744|NCT04312347|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5521745|NCT04312347|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5521746|NCT04312347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5521747|NCT04312243|Nitric Oxide|nitric oxide|mesh-list
6097529|NCT00915005|Antimitotic Agents|antimitotic agents|mesh-ancestor
6097530|NCT00915005|Mitosis Modulators|mitosis modulators|mesh-ancestor
6097531|NCT00915005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097532|NCT00915018|Paclitaxel|paclitaxel|mesh-list
6097533|NCT00915018|Trastuzumab|trastuzumab|mesh-list
5521748|NCT04312243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5521749|NCT04312243|Autonomic Agents|autonomic agents|mesh-ancestor
5521750|NCT04312243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5521751|NCT04312243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521752|NCT04312243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5521753|NCT04312243|Respiratory System Agents|respiratory system agents|mesh-ancestor
5521754|NCT04312243|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5521755|NCT04312243|Antioxidants|antioxidants|mesh-ancestor
6097534|NCT00915018|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6097535|NCT00915018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6097536|NCT00915018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6097537|NCT00915018|Tubulin Modulators|tubulin modulators|mesh-ancestor
6097538|NCT00915018|Antimitotic Agents|antimitotic agents|mesh-ancestor
6097539|NCT00915018|Mitosis Modulators|mitosis modulators|mesh-ancestor
6097540|NCT00915018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097541|NCT00915018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6097542|NCT00915343|Hydrocortisone|hydrocortisone|mesh-list
6097543|NCT00915343|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6097544|NCT00915343|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6097545|NCT00915343|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6097546|NCT00915343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6097547|NCT00915473|Methylprednisolone|methylprednisolone|mesh-list
6097548|NCT00915473|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6097549|NCT00915473|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6097550|NCT00915473|Prednisolone|prednisolone|mesh-list
6097551|NCT00915473|Prednisolone acetate|prednisolone acetate|mesh-list
6097552|NCT00915473|Lidocaine|lidocaine|mesh-list
6097553|NCT00915473|Bupivacaine|bupivacaine|mesh-list
6097554|NCT00915473|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6097555|NCT00915473|Prednisolone phosphate|prednisolone phosphate|mesh-list
6097556|NCT00915473|Anesthetics, Local|anesthetics, local|mesh-ancestor
6097557|NCT00915473|Anesthetics|anesthetics|mesh-ancestor
6097558|NCT00915473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6097559|NCT00915473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097560|NCT00915473|Sensory System Agents|sensory system agents|mesh-ancestor
6097561|NCT00915473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6097562|NCT00915473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6097563|NCT00915473|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6097564|NCT00915473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6097565|NCT00915473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6097566|NCT00915473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097567|NCT00915473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6097568|NCT00915473|Antiemetics|antiemetics|mesh-ancestor
6097569|NCT00915473|Autonomic Agents|autonomic agents|mesh-ancestor
6097570|NCT00915473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6097571|NCT00915473|Glucocorticoids|glucocorticoids|mesh-ancestor
6097572|NCT00915473|Hormones|hormones|mesh-ancestor
6097573|NCT00915473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6097574|NCT00915473|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6097575|NCT00915473|Protective Agents|protective agents|mesh-ancestor
6097576|NCT00915473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6097577|NCT00915473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6097578|NCT00915525|Botulinum Toxins|botulinum toxins|mesh-list
6097579|NCT00915525|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6097580|NCT00915525|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6097581|NCT00915525|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6097582|NCT00915525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6097583|NCT00915525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097584|NCT00915525|Cholinergic Agents|cholinergic agents|mesh-ancestor
6097585|NCT00915525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6097586|NCT00915525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097587|NCT00915525|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6097588|NCT00915525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6097589|NCT00915538|Budesonide|budesonide|mesh-list
6097590|NCT00915538|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6097591|NCT00915538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6097592|NCT00915538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6097593|NCT00915538|Autonomic Agents|autonomic agents|mesh-ancestor
6097594|NCT00915538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6097595|NCT00915538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097596|NCT00915538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6097597|NCT00915538|Respiratory System Agents|respiratory system agents|mesh-ancestor
6097598|NCT00915538|Glucocorticoids|glucocorticoids|mesh-ancestor
6097599|NCT00915538|Hormones|hormones|mesh-ancestor
6097600|NCT00915538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6097601|NCT00915590|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6097602|NCT00915590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6097603|NCT00915603|Paclitaxel|paclitaxel|mesh-list
6097604|NCT00915603|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6097605|NCT00915603|Bevacizumab|bevacizumab|mesh-list
6097606|NCT00915603|Everolimus|everolimus|mesh-list
6097607|NCT00915603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6097608|NCT00915603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6097609|NCT00915603|Tubulin Modulators|tubulin modulators|mesh-ancestor
6097610|NCT00915603|Antimitotic Agents|antimitotic agents|mesh-ancestor
6097611|NCT00915603|Mitosis Modulators|mitosis modulators|mesh-ancestor
6097612|NCT00915603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097613|NCT00915603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6097614|NCT00915603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6097615|NCT00915603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6097616|NCT00915603|Growth Substances|growth substances|mesh-ancestor
6097617|NCT00915603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521756|NCT04312243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521757|NCT04312243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5521758|NCT04312243|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5521759|NCT04312243|Vasodilator Agents|vasodilator agents|mesh-ancestor
5521760|NCT04312243|Gasotransmitters|gasotransmitters|mesh-ancestor
5521761|NCT04312243|Protective Agents|protective agents|mesh-ancestor
5521762|NCT04312438|Caseins|caseins|mesh-list
5521763|NCT04312438|Chelating Agents|chelating agents|mesh-ancestor
5521764|NCT04312438|Sequestering Agents|sequestering agents|mesh-ancestor
5521765|NCT04312438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097618|NCT00915603|Growth Inhibitors|growth inhibitors|mesh-ancestor
6097619|NCT00915603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6097620|NCT00915603|Immunologic Factors|immunologic factors|mesh-ancestor
6097621|NCT00915655|Ritonavir|ritonavir|mesh-list
6097622|NCT00915655|Darunavir|darunavir|mesh-list
6097623|NCT00915655|Lamivudine|lamivudine|mesh-list
6097624|NCT00915655|Zidovudine|zidovudine|mesh-list
6097625|NCT00915655|Abacavir|abacavir|mesh-list
6097626|NCT00915655|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6097627|NCT00915655|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6097628|NCT00915655|Protease Inhibitors|protease inhibitors|mesh-ancestor
6097629|NCT00915655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6097630|NCT00915655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097631|NCT00915655|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6097632|NCT00915655|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6097633|NCT00915655|Antiviral Agents|antiviral agents|mesh-ancestor
6097634|NCT00915655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6097635|NCT00915655|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6097636|NCT00915655|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6097637|NCT00915655|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6097638|NCT00915655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6097639|NCT00915655|Antimetabolites|antimetabolites|mesh-ancestor
6097640|NCT00915772|Metformin|metformin|mesh-list
6097641|NCT00915772|Linagliptin|linagliptin|mesh-list
6097642|NCT00915772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6097643|NCT00915772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097644|NCT00915772|Incretins|incretins|mesh-ancestor
6097645|NCT00915772|Hormones|hormones|mesh-ancestor
6097646|NCT00915772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6097647|NCT00915772|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6097648|NCT00915772|Protease Inhibitors|protease inhibitors|mesh-ancestor
5521766|NCT04312360|Metronidazole|metronidazole|mesh-list
6097649|NCT00915772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6097650|NCT00915772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097651|NCT00915928|Perindopril|perindopril|mesh-list
6097652|NCT00915928|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6097653|NCT00915928|Protease Inhibitors|protease inhibitors|mesh-ancestor
6097654|NCT00915928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6097655|NCT00915928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097656|NCT00915928|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6097657|NCT00915967|Vancomycin|vancomycin|mesh-list
6097658|NCT00915967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6097659|NCT00915967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6097660|NCT00916032|Factor VIII|factor viii|mesh-list
6097661|NCT00916032|Coagulants|coagulants|mesh-ancestor
6097662|NCT00916058|Melphalan|melphalan|mesh-list
6097663|NCT00916058|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6097664|NCT00916058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6097665|NCT00916058|Alkylating Agents|alkylating agents|mesh-ancestor
6097666|NCT00916058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097667|NCT00916058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6097668|NCT00916058|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6097669|NCT00916058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6097670|NCT00916058|Immunologic Factors|immunologic factors|mesh-ancestor
6097671|NCT00916058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097672|NCT00916149|Lamotrigine|lamotrigine|mesh-list
6097673|NCT00916149|Levetiracetam|levetiracetam|mesh-list
6097674|NCT00916149|Anticonvulsants|anticonvulsants|mesh-ancestor
6097675|NCT00916149|Nootropic Agents|nootropic agents|mesh-ancestor
6097676|NCT00916149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6097677|NCT00916149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6097678|NCT00916149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097679|NCT00916149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6097680|NCT00916149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097681|NCT00916149|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6097682|NCT00916149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6097683|NCT00916149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6097684|NCT00916149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6097685|NCT00916149|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6097686|NCT00916279|Paclitaxel|paclitaxel|mesh-list
6097687|NCT00916279|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6097688|NCT00916279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6097689|NCT00916279|Tubulin Modulators|tubulin modulators|mesh-ancestor
6097690|NCT00916279|Antimitotic Agents|antimitotic agents|mesh-ancestor
6097691|NCT00916279|Mitosis Modulators|mitosis modulators|mesh-ancestor
6097692|NCT00916279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097693|NCT00916357|Insulin|insulin|mesh-list
6097694|NCT00916357|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6097695|NCT00916357|Insulin Lispro|insulin lispro|mesh-list
6097696|NCT00916357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6097697|NCT00916357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097698|NCT00916383|Donepezil|donepezil|mesh-list
6464710|NCT00470522|Antimetabolites|antimetabolites|mesh-ancestor
5521767|NCT04312360|Fosfomycin|fosfomycin|mesh-list
5521768|NCT04312360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5521769|NCT04312360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5521770|NCT04312360|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5521771|NCT04312360|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5521772|NCT04312204|Gemcitabine|gemcitabine|mesh-list
5521773|NCT04312204|Carboplatin|carboplatin|mesh-list
5521774|NCT04312204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5521775|NCT04312204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5521776|NCT04312204|Antimetabolites|antimetabolites|mesh-ancestor
5521777|NCT04312204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521778|NCT04312204|Antiviral Agents|antiviral agents|mesh-ancestor
5521779|NCT04312204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5521780|NCT04312204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5521781|NCT04312204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5521782|NCT04312204|Immunologic Factors|immunologic factors|mesh-ancestor
5521783|NCT04312204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521784|NCT04312282|Itraconazole|itraconazole|mesh-list
5521785|NCT04312282|Rifampin|rifampin|mesh-list
5521786|NCT04312282|Antifungal Agents|antifungal agents|mesh-ancestor
5521787|NCT04312282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5521788|NCT04312282|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5521789|NCT04312282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5521790|NCT04312282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5521791|NCT04312282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097699|NCT00916383|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6097700|NCT00916383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6097701|NCT00916383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097702|NCT00916383|Cholinergic Agents|cholinergic agents|mesh-ancestor
6097703|NCT00916383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5521792|NCT04312282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5521793|NCT04312282|Hormone Antagonists|hormone antagonists|mesh-ancestor
5521794|NCT04312282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5521795|NCT04312282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521796|NCT04312282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5521797|NCT04312282|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5521798|NCT04312282|Antitubercular Agents|antitubercular agents|mesh-ancestor
5521799|NCT04312282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6097704|NCT00916383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097705|NCT00916383|Nootropic Agents|nootropic agents|mesh-ancestor
6097706|NCT00916539|Calpastatin|calpastatin|mesh-list
6097707|NCT00916539|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
6097708|NCT00916539|Protease Inhibitors|protease inhibitors|mesh-ancestor
6097709|NCT00916539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6097710|NCT00916539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097711|NCT00916578|Capecitabine|capecitabine|mesh-list
6097712|NCT00916578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6097713|NCT00916578|Antimetabolites|antimetabolites|mesh-ancestor
6097714|NCT00916578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097715|NCT00916578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6097716|NCT00916721|Propranolol|propranolol|mesh-list
6097717|NCT00916721|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6097718|NCT00916721|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6097719|NCT00916721|Adrenergic Agents|adrenergic agents|mesh-ancestor
6097720|NCT00916721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6097721|NCT00916721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097722|NCT00916721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097723|NCT00916721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6097724|NCT00916721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6097725|NCT00916721|Vasodilator Agents|vasodilator agents|mesh-ancestor
6097726|NCT00917267|Exenatide|exenatide|mesh-list
6097727|NCT00917267|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6097728|NCT00917267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097729|NCT00917267|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6097730|NCT00917267|Incretins|incretins|mesh-ancestor
6097731|NCT00917267|Hormones|hormones|mesh-ancestor
6097732|NCT00917267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6097733|NCT00917384|Ramucirumab|ramucirumab|mesh-list
6097734|NCT00917384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6097735|NCT00917462|Sorafenib|sorafenib|mesh-list
6097736|NCT00917462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6097737|NCT00917462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6097738|NCT00917462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6097739|NCT00917462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097740|NCT00917553|Doxycycline|doxycycline|mesh-list
6097741|NCT00917553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6097742|NCT00917553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6097743|NCT00917553|Antimalarials|antimalarials|mesh-ancestor
6097744|NCT00917553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6097745|NCT00917553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6097746|NCT00917579|Atorvastatin|atorvastatin|mesh-list
5521800|NCT04312282|Leprostatic Agents|leprostatic agents|mesh-ancestor
5521801|NCT04312282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5521802|NCT04312282|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5521803|NCT04312282|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5521804|NCT04312282|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6097747|NCT00917579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6097748|NCT00917579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6097749|NCT00917579|Antimetabolites|antimetabolites|mesh-ancestor
6097750|NCT00917579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097751|NCT00917579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6097752|NCT00917579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6665761|NCT01518634|Imipramine|imipramine|mesh-list
5521805|NCT04312282|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5521806|NCT04312282|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5521807|NCT04312282|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5521808|NCT04312152|Vitamins|vitamins|mesh-list
5521809|NCT04312152|Vitamin E|vitamin e|mesh-list
6665762|NCT01518634|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6665763|NCT01518634|Antidepressive Agents|antidepressive agents|mesh-ancestor
6665764|NCT01518634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5521810|NCT04312152|Tocopherols|tocopherols|mesh-list
5521811|NCT04312152|Folic Acid|folic acid|mesh-list
5521812|NCT04312152|Vitamin B Complex|vitamin b complex|mesh-list
5521813|NCT04312152|Micronutrients|micronutrients|mesh-ancestor
5521814|NCT04312152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521815|NCT04312152|Antioxidants|antioxidants|mesh-ancestor
5521816|NCT04312152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521817|NCT04312152|Protective Agents|protective agents|mesh-ancestor
6665765|NCT01518634|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6665766|NCT01518634|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6665767|NCT01518634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6665768|NCT01518634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665769|NCT01518634|Adrenergic Agents|adrenergic agents|mesh-ancestor
6665770|NCT01518634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6665771|NCT01518634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665772|NCT01518712|Metformin|metformin|mesh-list
6665773|NCT01518712|Canagliflozin|canagliflozin|mesh-list
5521818|NCT04312152|Hematinics|hematinics|mesh-ancestor
5521819|NCT04311762|Cisplatin|cisplatin|mesh-list
5521820|NCT04311762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5521821|NCT04312009|Losartan|losartan|mesh-list
5521822|NCT04312009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6665774|NCT01518712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6665775|NCT01518712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665776|NCT01518712|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5521823|NCT04312009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6097753|NCT00917579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6097754|NCT00917644|Atorvastatin|atorvastatin|mesh-list
6097755|NCT00917644|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6097756|NCT00917644|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6097757|NCT00917644|Antimetabolites|antimetabolites|mesh-ancestor
6097758|NCT00917644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097759|NCT00917644|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6097760|NCT00917644|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6097761|NCT00917644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6097762|NCT00918138|Metformin|metformin|mesh-list
5521824|NCT04312009|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5521825|NCT04312009|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5521826|NCT04312009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521827|NCT04312139|Lincomycin|lincomycin|mesh-list
5521828|NCT04312139|Calcium|calcium|mesh-list
5521829|NCT04312139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5521830|NCT04312139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521831|NCT04312139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5521832|NCT04312139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5521833|NCT04312139|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5521834|NCT04312139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5521835|NCT04312139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521836|NCT04312048|Isosorbide|isosorbide|mesh-list
6097763|NCT00918138|Saxagliptin|saxagliptin|mesh-list
6097764|NCT00918138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6097765|NCT00918138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097766|NCT00918138|Incretins|incretins|mesh-ancestor
6097767|NCT00918138|Hormones|hormones|mesh-ancestor
6097768|NCT00918138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6097769|NCT00918138|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6097770|NCT00918138|Protease Inhibitors|protease inhibitors|mesh-ancestor
6097771|NCT00918138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6097772|NCT00918138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521837|NCT04312048|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
5521838|NCT04312048|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
5521839|NCT04312048|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5521840|NCT04312048|Diuretics|diuretics|mesh-ancestor
5521841|NCT04312048|Natriuretic Agents|natriuretic agents|mesh-ancestor
5521842|NCT04312048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521843|NCT04312048|Vasodilator Agents|vasodilator agents|mesh-ancestor
5521844|NCT04312048|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5521845|NCT04312048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521846|NCT04312061|Tramadol|tramadol|mesh-list
6097773|NCT00918203|Paclitaxel|paclitaxel|mesh-list
5521847|NCT04312061|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5521848|NCT04312061|Narcotics|narcotics|mesh-ancestor
6097774|NCT00918203|Carboplatin|carboplatin|mesh-list
6097775|NCT00918203|Olaratumab|olaratumab|mesh-list
6097776|NCT00918203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5521849|NCT04312061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5521850|NCT04312061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521851|NCT04312061|Analgesics|analgesics|mesh-ancestor
5521852|NCT04312061|Sensory System Agents|sensory system agents|mesh-ancestor
5521853|NCT04312061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5521854|NCT04311489|Ularitide|ularitide|mesh-list
5521855|NCT04311489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5521856|NCT04311489|Autonomic Agents|autonomic agents|mesh-ancestor
5521857|NCT04311489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5521858|NCT04311489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097777|NCT00918203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6097778|NCT00918203|Tubulin Modulators|tubulin modulators|mesh-ancestor
6097779|NCT00918203|Antimitotic Agents|antimitotic agents|mesh-ancestor
6097780|NCT00918203|Mitosis Modulators|mitosis modulators|mesh-ancestor
6097781|NCT00918203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097782|NCT00918255|Adalimumab|adalimumab|mesh-list
6097783|NCT00918255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6097784|NCT00918255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6097785|NCT00918333|Everolimus|everolimus|mesh-list
6097786|NCT00918333|Panobinostat|panobinostat|mesh-list
6097787|NCT00918333|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
6097788|NCT00918333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6097789|NCT00918333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6097790|NCT00918333|Immunologic Factors|immunologic factors|mesh-ancestor
6097791|NCT00918333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097792|NCT00918333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6097793|NCT00918333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097794|NCT00918385|Dasatinib|dasatinib|mesh-list
6097795|NCT00918385|Nilutamide|nilutamide|mesh-list
6097796|NCT00918385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6097797|NCT00918385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6097798|NCT00918385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6097799|NCT00918385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097800|NCT00918385|Androgen Antagonists|androgen antagonists|mesh-ancestor
6097801|NCT00918385|Hormone Antagonists|hormone antagonists|mesh-ancestor
6097802|NCT00918385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6097803|NCT00918385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521859|NCT04311489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5521860|NCT04311489|Respiratory System Agents|respiratory system agents|mesh-ancestor
5521861|NCT04311489|Diuretics|diuretics|mesh-ancestor
5521862|NCT04311489|Natriuretic Agents|natriuretic agents|mesh-ancestor
5521863|NCT04311515|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5521864|NCT04311515|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5521865|NCT04311515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521866|NCT04311567|Methotrexate|methotrexate|mesh-list
5521867|NCT04311567|Tofacitinib|tofacitinib|mesh-list
5521868|NCT04311567|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5521869|NCT04311567|Abortifacient Agents|abortifacient agents|mesh-ancestor
5521870|NCT04311567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5521871|NCT04311567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097804|NCT00918567|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6097805|NCT00918567|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6097806|NCT00918567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6097807|NCT00918567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5521872|NCT04311567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5521873|NCT04311567|Antimetabolites|antimetabolites|mesh-ancestor
5521874|NCT04311567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521875|NCT04311567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5521876|NCT04311567|Dermatologic Agents|dermatologic agents|mesh-ancestor
5521877|NCT04311567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5521878|NCT04311567|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5521879|NCT04311567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5521880|NCT04311567|Immunologic Factors|immunologic factors|mesh-ancestor
5521881|NCT04311567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5521882|NCT04311567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5521883|NCT04311567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5521884|NCT04311671|Ivermectin|ivermectin|mesh-list
5521885|NCT04311671|Moxidectin|moxidectin|mesh-list
5521886|NCT04311671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5521887|NCT04311671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5521888|NCT04311671|Anthelmintics|anthelmintics|mesh-ancestor
6097808|NCT00918567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097809|NCT00918567|Adrenergic Agents|adrenergic agents|mesh-ancestor
6097810|NCT00918567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6097811|NCT00918567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097812|NCT00918684|Citalopram|citalopram|mesh-list
6097813|NCT00918684|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6097814|NCT00918684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6097815|NCT00918684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6097816|NCT00918684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097817|NCT00918684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6097818|NCT00918684|Serotonin Agents|serotonin agents|mesh-ancestor
5521889|NCT04311671|Antinematodal Agents|antinematodal agents|mesh-ancestor
5521890|NCT04311697|Phentolamine|phentolamine|mesh-list
5521891|NCT04311697|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
5521892|NCT04311697|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5521893|NCT04311697|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5521894|NCT04311697|Adrenergic Agents|adrenergic agents|mesh-ancestor
5521895|NCT04311697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5521896|NCT04311697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521897|NCT04311697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521898|NCT04311697|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5521899|NCT04311697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5521900|NCT04311697|Vasodilator Agents|vasodilator agents|mesh-ancestor
5521901|NCT04311697|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6097819|NCT00918684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097820|NCT00918684|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6097821|NCT00918684|Antidepressive Agents|antidepressive agents|mesh-ancestor
6097822|NCT00918684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6097823|NCT00918723|Cyclophosphamide|cyclophosphamide|mesh-list
6097824|NCT00918723|Rituximab|rituximab|mesh-list
6097825|NCT00918723|Fludarabine|fludarabine|mesh-list
6097826|NCT00918723|Fludarabine phosphate|fludarabine phosphate|mesh-list
6097827|NCT00918723|Vorinostat|vorinostat|mesh-list
6097828|NCT00918723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6097829|NCT00918723|Immunologic Factors|immunologic factors|mesh-ancestor
6097830|NCT00918723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097831|NCT00918723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6097832|NCT00918723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6097833|NCT00918723|Alkylating Agents|alkylating agents|mesh-ancestor
6097834|NCT00918723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097835|NCT00918723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6097836|NCT00918723|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6097837|NCT00918723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6097838|NCT00918723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6097839|NCT00918723|Antimetabolites|antimetabolites|mesh-ancestor
6097840|NCT00918723|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6097841|NCT00918723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6097842|NCT00918736|Hyaluronic Acid|hyaluronic acid|mesh-list
6097843|NCT00918736|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6097844|NCT00918736|Immunologic Factors|immunologic factors|mesh-ancestor
6097845|NCT00918736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097846|NCT00918736|Viscosupplements|viscosupplements|mesh-ancestor
6097847|NCT00918736|Protective Agents|protective agents|mesh-ancestor
6097848|NCT00918879|Saxagliptin|saxagliptin|mesh-list
6097849|NCT00918879|Incretins|incretins|mesh-ancestor
6097850|NCT00918879|Hormones|hormones|mesh-ancestor
5521902|NCT04311697|Protective Agents|protective agents|mesh-ancestor
5521903|NCT04311580|Mitomycins|mitomycins|mesh-list
6097851|NCT00918879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6097852|NCT00918879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097853|NCT00918879|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6097854|NCT00918879|Protease Inhibitors|protease inhibitors|mesh-ancestor
6097855|NCT00918879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6097856|NCT00918879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097857|NCT00918879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6097858|NCT00918931|Obatoclax|obatoclax|mesh-list
6097859|NCT00918931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6097860|NCT00918931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097861|NCT00918957|Tobramycin|tobramycin|mesh-list
6097862|NCT00918957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6097863|NCT00918957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6097864|NCT00919035|Sirolimus|sirolimus|mesh-list
6097865|NCT00919035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6097866|NCT00919035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6097867|NCT00919035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6097868|NCT00919035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6097869|NCT00919035|Antifungal Agents|antifungal agents|mesh-ancestor
6097870|NCT00919035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6097871|NCT00919035|Immunologic Factors|immunologic factors|mesh-ancestor
6097872|NCT00919035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097873|NCT00919061|Gemcitabine|gemcitabine|mesh-list
6097874|NCT00919061|Sorafenib|sorafenib|mesh-list
6097875|NCT00919061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6097876|NCT00919061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6097877|NCT00919061|Antimetabolites|antimetabolites|mesh-ancestor
6097878|NCT00919061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097879|NCT00919061|Antiviral Agents|antiviral agents|mesh-ancestor
6097880|NCT00919061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6097881|NCT00919061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6097882|NCT00919061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6097883|NCT00919061|Immunologic Factors|immunologic factors|mesh-ancestor
5521904|NCT04311580|Mitomycin|mitomycin|mesh-list
5521905|NCT04311580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5521906|NCT04311580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6097884|NCT00919061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097885|NCT00919061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6097886|NCT00919126|Xenon|xenon|mesh-list
6097887|NCT00919126|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6097888|NCT00919126|Anesthetics, General|anesthetics, general|mesh-ancestor
6097889|NCT00919126|Anesthetics|anesthetics|mesh-ancestor
6097890|NCT00919126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6097891|NCT00919126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097892|NCT00919191|Adapalene|adapalene|mesh-list
5521907|NCT04311580|Alkylating Agents|alkylating agents|mesh-ancestor
5521908|NCT04311580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521909|NCT04311580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5521910|NCT04311580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5521911|NCT04311632|Mycophenolic Acid|mycophenolic acid|mesh-list
5521912|NCT04311632|Tacrolimus|tacrolimus|mesh-list
5521913|NCT04311632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5521914|NCT04311632|Immunologic Factors|immunologic factors|mesh-ancestor
5521915|NCT04311632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521916|NCT04311632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5521917|NCT04311632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5521918|NCT04311632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521919|NCT04311632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5521920|NCT04311632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5521921|NCT04311632|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5521922|NCT04311632|Antitubercular Agents|antitubercular agents|mesh-ancestor
5521923|NCT04311632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5521924|NCT04311632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5521925|NCT04311424|Tirzepatide|tirzepatide|mesh-list
5521926|NCT04311424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5521927|NCT04311424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521928|NCT04311424|Incretins|incretins|mesh-ancestor
6097893|NCT00919191|Tretinoin|tretinoin|mesh-list
6097894|NCT00919191|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6097895|NCT00919191|Dermatologic Agents|dermatologic agents|mesh-ancestor
6097896|NCT00919191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6097897|NCT00919191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6097898|NCT00919191|Analgesics|analgesics|mesh-ancestor
6097899|NCT00919191|Sensory System Agents|sensory system agents|mesh-ancestor
5521929|NCT04311424|Hormones|hormones|mesh-ancestor
6097900|NCT00919191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5521930|NCT04311424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6097901|NCT00919191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097902|NCT00919191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6097903|NCT00919191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6097904|NCT00919191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6097905|NCT00919191|Keratolytic Agents|keratolytic agents|mesh-ancestor
6097906|NCT00919503|Cyclosporine|cyclosporine|mesh-list
6097907|NCT00919503|Mycophenolic Acid|mycophenolic acid|mesh-list
6097908|NCT00919503|Methotrexate|methotrexate|mesh-list
6097909|NCT00919503|Fludarabine phosphate|fludarabine phosphate|mesh-list
6097910|NCT00919503|Fludarabine|fludarabine|mesh-list
6097911|NCT00919503|Treosulfan|treosulfan|mesh-list
6097912|NCT00919503|Busulfan|busulfan|mesh-list
6097913|NCT00919503|Tacrolimus|tacrolimus|mesh-list
6097914|NCT00919503|Cyclosporins|cyclosporins|mesh-list
6097915|NCT00919503|Thymoglobulin|thymoglobulin|mesh-list
6097916|NCT00919503|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6097917|NCT00919503|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6097918|NCT00919503|Abortifacient Agents|abortifacient agents|mesh-ancestor
6097919|NCT00919503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6097920|NCT00919503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097921|NCT00919503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6097922|NCT00919503|Antimetabolites|antimetabolites|mesh-ancestor
6097923|NCT00919503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097924|NCT00919503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6097925|NCT00919503|Dermatologic Agents|dermatologic agents|mesh-ancestor
6097926|NCT00919503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6097927|NCT00919503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6097928|NCT00919503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6097929|NCT00919503|Immunologic Factors|immunologic factors|mesh-ancestor
6097930|NCT00919503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6097931|NCT00919503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6097932|NCT00919503|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6097933|NCT00919503|Antifungal Agents|antifungal agents|mesh-ancestor
6097934|NCT00919503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5521931|NCT04311658|Isosorbide|isosorbide|mesh-list
5521932|NCT04311658|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
5521933|NCT04311658|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
5521934|NCT04311658|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5521935|NCT04311658|Diuretics|diuretics|mesh-ancestor
5521936|NCT04311658|Natriuretic Agents|natriuretic agents|mesh-ancestor
6097935|NCT00919503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6097936|NCT00919503|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6097937|NCT00919503|Antitubercular Agents|antitubercular agents|mesh-ancestor
6097938|NCT00919503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6097939|NCT00919503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6097940|NCT00919503|Alkylating Agents|alkylating agents|mesh-ancestor
6097941|NCT00919503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6097942|NCT00919633|Interferons|interferons|mesh-list
6097943|NCT00919633|Ribavirin|ribavirin|mesh-list
6097944|NCT00919633|Interferon-alpha|interferon-alpha|mesh-list
6097945|NCT00919633|Interferon alpha-2|interferon alpha-2|mesh-list
6097946|NCT00919633|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6097947|NCT00919633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097948|NCT00919633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6097949|NCT00919633|Antiviral Agents|antiviral agents|mesh-ancestor
6097950|NCT00919633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6097951|NCT00919633|Antimetabolites|antimetabolites|mesh-ancestor
6097952|NCT00919633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097953|NCT00919633|Immunologic Factors|immunologic factors|mesh-ancestor
6097954|NCT00919711|Denosumab|denosumab|mesh-list
6097955|NCT00919711|Risedronic Acid|risedronic acid|mesh-list
6097956|NCT00919711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6097957|NCT00919711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097958|NCT00919711|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6097959|NCT00919711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6097960|NCT00919711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097961|NCT00919711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6097962|NCT00919802|Oxytocin|oxytocin|mesh-list
6097963|NCT00919802|Oxytocics|oxytocics|mesh-ancestor
6097964|NCT00919802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6097965|NCT00919802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097966|NCT00919854|Ritonavir|ritonavir|mesh-list
6097967|NCT00919854|Darunavir|darunavir|mesh-list
6097968|NCT00919854|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6097969|NCT00919854|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6097970|NCT00919854|Protease Inhibitors|protease inhibitors|mesh-ancestor
6097971|NCT00919854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6097972|NCT00919854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097973|NCT00919854|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6097974|NCT00919854|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6097975|NCT00919854|Antiviral Agents|antiviral agents|mesh-ancestor
6097976|NCT00919854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6097977|NCT00919854|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5521937|NCT04311658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521938|NCT04311658|Vasodilator Agents|vasodilator agents|mesh-ancestor
5521939|NCT04311658|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5521940|NCT04311658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521941|NCT04311645|Charcoal|charcoal|mesh-list
5521942|NCT04311645|Antidotes|antidotes|mesh-ancestor
5521943|NCT04311645|Protective Agents|protective agents|mesh-ancestor
5521944|NCT04311645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097978|NCT00919854|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6097979|NCT00919867|Guanfacine|guanfacine|mesh-list
6097980|NCT00919867|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6097981|NCT00919867|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6097982|NCT00919867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097983|NCT00919867|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6097984|NCT00919867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6097985|NCT00919867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6097986|NCT00919867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6097987|NCT00919867|Dopamine Agents|dopamine agents|mesh-ancestor
6097988|NCT00919867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6097989|NCT00919867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5521952|NCT04311255|Anesthetics|anesthetics|mesh-list
5521953|NCT04311255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5521954|NCT04311255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521955|NCT04310995|Nicorandil|nicorandil|mesh-list
5521956|NCT04310995|Diltiazem|diltiazem|mesh-list
5521957|NCT04310995|Isosorbide|isosorbide|mesh-list
5521958|NCT04310995|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
5521959|NCT04310995|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
5521960|NCT04310995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5521961|NCT04310995|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5521962|NCT04310995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5521963|NCT04310995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521964|NCT04310995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5521965|NCT04310995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5521966|NCT04310995|Vasodilator Agents|vasodilator agents|mesh-ancestor
5521967|NCT04310995|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5521968|NCT04310995|Diuretics|diuretics|mesh-ancestor
5521969|NCT04310995|Natriuretic Agents|natriuretic agents|mesh-ancestor
5521970|NCT04310995|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5521971|NCT04310995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5521972|NCT04310995|Vitamin B Complex|vitamin b complex|mesh-ancestor
5521973|NCT04310995|Vitamins|vitamins|mesh-ancestor
5521974|NCT04310995|Micronutrients|micronutrients|mesh-ancestor
5600992|NCT03708458|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5600993|NCT03708458|Antioxidants|antioxidants|mesh-ancestor
5600994|NCT03708458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600995|NCT03708458|Protective Agents|protective agents|mesh-ancestor
5600996|NCT03708458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600997|NCT03708458|Antidotes|antidotes|mesh-ancestor
5600998|NCT03708458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5600999|NCT03708458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5601000|NCT03708458|Analgesics|analgesics|mesh-ancestor
5601001|NCT03708458|Sensory System Agents|sensory system agents|mesh-ancestor
5601002|NCT03708458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5601003|NCT03708458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5601004|NCT03708458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5601005|NCT03708458|Gout Suppressants|gout suppressants|mesh-ancestor
5601006|NCT03708458|Tocolytic Agents|tocolytic agents|mesh-ancestor
5601007|NCT03708458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5601008|NCT03708458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6097990|NCT00919867|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6097991|NCT00919867|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6097992|NCT00919867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6097993|NCT00919867|Adrenergic Agents|adrenergic agents|mesh-ancestor
6203635|NCT02059161|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6203636|NCT02059174|Insulin Aspart|insulin aspart|mesh-list
6203637|NCT02059174|MK-1293|mk-1293|mesh-list
6203638|NCT02059174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6203639|NCT02059174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203640|NCT02059174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6203641|NCT02059174|Antimetabolites|antimetabolites|mesh-ancestor
5521975|NCT04310930|Azithromycin|azithromycin|mesh-list
5521976|NCT04310930|Moxifloxacin|moxifloxacin|mesh-list
5521977|NCT04310930|Clarithromycin|clarithromycin|mesh-list
6203642|NCT02059174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203643|NCT02059174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6203644|NCT02059187|Insulin|insulin|mesh-list
6203645|NCT02059187|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6203646|NCT02059187|Insulin Glargine|insulin glargine|mesh-list
6203647|NCT02059187|MK-1293|mk-1293|mesh-list
6203648|NCT02059187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6203649|NCT02059187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203650|NCT02059187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6203651|NCT02059187|Antimetabolites|antimetabolites|mesh-ancestor
6203652|NCT02059187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203653|NCT02059187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6203654|NCT02059213|Palbociclib|palbociclib|mesh-list
5521978|NCT04310930|Doxycycline|doxycycline|mesh-list
5521979|NCT04310930|Linezolid|linezolid|mesh-list
5521980|NCT04310930|Imipenem|imipenem|mesh-list
5521981|NCT04310930|Amikacin|amikacin|mesh-list
6203655|NCT02059213|Leuprolide|leuprolide|mesh-list
6203656|NCT02059213|Goserelin|goserelin|mesh-list
6203657|NCT02059213|Bicalutamide|bicalutamide|mesh-list
6203658|NCT02059213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6203659|NCT02059213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6203660|NCT02059213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6203661|NCT02059213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203662|NCT02059213|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6203663|NCT02059213|Fertility Agents|fertility agents|mesh-ancestor
6203664|NCT02059213|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6203665|NCT02059213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203666|NCT02059213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6203667|NCT02059213|Androgen Antagonists|androgen antagonists|mesh-ancestor
6203668|NCT02059213|Hormone Antagonists|hormone antagonists|mesh-ancestor
6203669|NCT02059213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6203670|NCT02059239|Cytarabine|cytarabine|mesh-list
6203671|NCT02059239|Rituximab|rituximab|mesh-list
6203672|NCT02059239|Alemtuzumab|alemtuzumab|mesh-list
6203673|NCT02059239|Etoposide|etoposide|mesh-list
6203674|NCT02059239|Melphalan|melphalan|mesh-list
6203675|NCT02059239|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6203676|NCT02059239|Carmustine|carmustine|mesh-list
6203677|NCT02059239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6203678|NCT02059239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6203679|NCT02059239|Immunologic Factors|immunologic factors|mesh-ancestor
6203680|NCT02059239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203681|NCT02059239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6203682|NCT02059239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6203683|NCT02059239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6203684|NCT02059239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6203685|NCT02059239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6203686|NCT02059239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203687|NCT02059239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6203688|NCT02059239|Antimetabolites|antimetabolites|mesh-ancestor
6203689|NCT02059239|Antiviral Agents|antiviral agents|mesh-ancestor
6203690|NCT02059239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6203691|NCT02059239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6203692|NCT02059239|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6203693|NCT02059239|Alkylating Agents|alkylating agents|mesh-ancestor
5521982|NCT04310930|Ethambutol|ethambutol|mesh-list
5521983|NCT04310930|Rifabutin|rifabutin|mesh-list
5521984|NCT04310930|Tigecycline|tigecycline|mesh-list
6203694|NCT02059239|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5521985|NCT04310930|Bedaquiline|bedaquiline|mesh-list
6203695|NCT02059278|Latanoprost|latanoprost|mesh-list
6203696|NCT02059278|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5521986|NCT04310930|Clofazimine|clofazimine|mesh-list
5521987|NCT04310930|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
5521988|NCT04310930|Cefoxitin|cefoxitin|mesh-list
5521989|NCT04310930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5521990|NCT04310930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5521991|NCT04310930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5521992|NCT04310930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5521993|NCT04310930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5521994|NCT04310930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5521995|NCT04310930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5521996|NCT04310930|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5521997|NCT04310930|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5521998|NCT04310930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5521999|NCT04310930|Antimalarials|antimalarials|mesh-ancestor
5522000|NCT04310930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5522001|NCT04310930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5522002|NCT04310930|Antitubercular Agents|antitubercular agents|mesh-ancestor
5522003|NCT04310930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5522004|NCT04310930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5522005|NCT04310930|Leprostatic Agents|leprostatic agents|mesh-ancestor
5522006|NCT04310930|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5522007|NCT04310930|Renal Agents|renal agents|mesh-ancestor
6097994|NCT00920075|Alendronate|alendronate|mesh-list
6097995|NCT00920075|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6097996|NCT00920075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6097997|NCT00920140|Trametinib|trametinib|mesh-list
6097998|NCT00920140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6097999|NCT00920140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6098000|NCT00920140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6098001|NCT00920140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098002|NCT00920218|Vaccines|vaccines|mesh-list
6098003|NCT00920218|Immunologic Factors|immunologic factors|mesh-ancestor
6098004|NCT00920218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098005|NCT00920426|Cabotegravir|cabotegravir|mesh-list
6098006|NCT00920426|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6098007|NCT00920426|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6098008|NCT00920426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6098009|NCT00920426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098010|NCT00920426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6098011|NCT00920426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6098012|NCT00920426|Antiviral Agents|antiviral agents|mesh-ancestor
6098013|NCT00920426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6098014|NCT00920556|Bortezomib|bortezomib|mesh-list
6098015|NCT00920556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6098016|NCT00920621|Vitamin D|vitamin d|mesh-list
6098017|NCT00920621|Ergocalciferols|ergocalciferols|mesh-list
6098018|NCT00920621|Cholecalciferol|cholecalciferol|mesh-list
6098019|NCT00920621|Vitamins|vitamins|mesh-list
6098020|NCT00920621|Micronutrients|micronutrients|mesh-ancestor
6098021|NCT00920621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098022|NCT00920621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6098023|NCT00920621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6098024|NCT00920686|Sumatriptan|sumatriptan|mesh-list
6098025|NCT00920686|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6098026|NCT00920686|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6098027|NCT00920686|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6098028|NCT00920686|Serotonin Agents|serotonin agents|mesh-ancestor
6098029|NCT00920686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6098030|NCT00920686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098031|NCT00920686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098032|NCT00920699|Ubiquinone|ubiquinone|mesh-list
5522008|NCT04310943|Paclitaxel|paclitaxel|mesh-list
5522009|NCT04310943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5522010|NCT04310943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6098033|NCT00920699|Coenzyme Q10|coenzyme q10|mesh-list
5522011|NCT04310943|Tubulin Modulators|tubulin modulators|mesh-ancestor
6098034|NCT00920699|Micronutrients|micronutrients|mesh-ancestor
6098035|NCT00920699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098036|NCT00920699|Vitamins|vitamins|mesh-ancestor
6098037|NCT00920790|Mogamulizumab|mogamulizumab|mesh-list
6098038|NCT00920790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6098039|NCT00920816|Sorafenib|sorafenib|mesh-list
6098040|NCT00920816|Axitinib|axitinib|mesh-list
6098041|NCT00920816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6098042|NCT00920816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6098043|NCT00920816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6098044|NCT00920816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098045|NCT00920829|Naltrexone|naltrexone|mesh-list
6098046|NCT00920829|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6098047|NCT00920829|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6098048|NCT00920829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098049|NCT00920829|Sensory System Agents|sensory system agents|mesh-ancestor
6098050|NCT00920829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5522012|NCT04310943|Antimitotic Agents|antimitotic agents|mesh-ancestor
5522013|NCT04310943|Mitosis Modulators|mitosis modulators|mesh-ancestor
5522014|NCT04310943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098051|NCT00920855|Bortezomib|bortezomib|mesh-list
6098052|NCT00920855|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6098053|NCT00920855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6098054|NCT00920855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6098055|NCT00920855|Alkylating Agents|alkylating agents|mesh-ancestor
6098056|NCT00920855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098057|NCT00920907|Ipilimumab|ipilimumab|mesh-list
6098058|NCT00920907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6098059|NCT00920907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6098060|NCT00920907|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6098061|NCT00920907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098062|NCT00921024|Ceftazidime|ceftazidime|mesh-list
6098063|NCT00921024|Ceftolozane|ceftolozane|mesh-list
6098064|NCT00921024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6098065|NCT00921024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6098066|NCT00921115|Fulvestrant|fulvestrant|mesh-list
6098067|NCT00921115|Anastrozole|anastrozole|mesh-list
6098068|NCT00921115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6098069|NCT00921115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6098070|NCT00921115|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6098071|NCT00921115|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6098072|NCT00921115|Hormone Antagonists|hormone antagonists|mesh-ancestor
6098073|NCT00921115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6098074|NCT00921115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098075|NCT00921115|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5522015|NCT04311073|Tranexamic Acid|tranexamic acid|mesh-list
5522016|NCT04311073|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5522017|NCT04311073|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5522018|NCT04311073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522019|NCT04311073|Hemostatics|hemostatics|mesh-ancestor
5522020|NCT04311073|Coagulants|coagulants|mesh-ancestor
5522021|NCT04311099|Ropivacaine|ropivacaine|mesh-list
5522022|NCT04311099|Anesthetics, Local|anesthetics, local|mesh-ancestor
5522023|NCT04311099|Anesthetics|anesthetics|mesh-ancestor
6098076|NCT00921115|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6098077|NCT00921115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6098078|NCT00921115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098079|NCT00921310|Sirolimus|sirolimus|mesh-list
6098080|NCT00921310|Pemetrexed|pemetrexed|mesh-list
6098081|NCT00921310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6098082|NCT00921310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5522024|NCT04311099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5522025|NCT04311099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522026|NCT04311099|Sensory System Agents|sensory system agents|mesh-ancestor
5522027|NCT04311099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6098083|NCT00921310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098084|NCT00921310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6098085|NCT00921310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6098086|NCT00921310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6098087|NCT00921310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6098088|NCT00921310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6098089|NCT00921310|Antifungal Agents|antifungal agents|mesh-ancestor
6098090|NCT00921310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6098091|NCT00921310|Immunologic Factors|immunologic factors|mesh-ancestor
6098092|NCT00921310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098093|NCT00921557|Vitamin D|vitamin d|mesh-list
5522028|NCT04311177|Losartan|losartan|mesh-list
5522029|NCT04311177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5522030|NCT04311177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5522031|NCT04311177|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5522032|NCT04311177|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5522033|NCT04311177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522034|NCT04310683|Hormones|hormones|mesh-list
5522035|NCT04310683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5522036|NCT04310683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522037|NCT04310579|Midazolam|midazolam|mesh-list
5522038|NCT04310579|Oxycodone|oxycodone|mesh-list
5522039|NCT04310579|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6098094|NCT00921557|Alendronate|alendronate|mesh-list
6098095|NCT00921557|Calcium Carbonate|calcium carbonate|mesh-list
6098096|NCT00921557|Calcium|calcium|mesh-list
6098097|NCT00921557|Vitamins|vitamins|mesh-ancestor
6098098|NCT00921557|Micronutrients|micronutrients|mesh-ancestor
6098099|NCT00921557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098100|NCT00921557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6098101|NCT00921557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6098102|NCT00921557|Antacids|antacids|mesh-ancestor
6098103|NCT00921557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098104|NCT00921557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6098105|NCT00921843|Methadone|methadone|mesh-list
6098106|NCT00921843|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6098107|NCT00921843|Narcotics|narcotics|mesh-ancestor
5522040|NCT04310579|Paroxetine|paroxetine|mesh-list
5522041|NCT04310579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5522042|NCT04310579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5522043|NCT04310579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6098108|NCT00921843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6098109|NCT00921843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098110|NCT00921843|Analgesics|analgesics|mesh-ancestor
6098111|NCT00921843|Sensory System Agents|sensory system agents|mesh-ancestor
6098112|NCT00921843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6098113|NCT00921843|Antitussive Agents|antitussive agents|mesh-ancestor
6098114|NCT00921843|Respiratory System Agents|respiratory system agents|mesh-ancestor
6098115|NCT00922116|Epoetin Alfa|epoetin alfa|mesh-list
6098116|NCT00922116|Hematinics|hematinics|mesh-ancestor
6098117|NCT00922194|Metformin|metformin|mesh-list
6098118|NCT00922194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6098119|NCT00922194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098120|NCT00922207|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6464711|NCT00470522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6464712|NCT00470522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5522044|NCT04310579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522045|NCT04310579|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5522046|NCT04310579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5522047|NCT04310579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5522048|NCT04310579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5522049|NCT04310579|Anesthetics, General|anesthetics, general|mesh-ancestor
5522050|NCT04310579|Anesthetics|anesthetics|mesh-ancestor
5522051|NCT04310579|GABA Modulators|gaba modulators|mesh-ancestor
5522052|NCT04310579|GABA Agents|gaba agents|mesh-ancestor
5522053|NCT04310579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5522054|NCT04310579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522055|NCT04310579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5522056|NCT04310579|Narcotics|narcotics|mesh-ancestor
5522057|NCT04310579|Analgesics|analgesics|mesh-ancestor
5522058|NCT04310579|Sensory System Agents|sensory system agents|mesh-ancestor
5522059|NCT04310579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5522060|NCT04310579|Antidepressive Agents|antidepressive agents|mesh-ancestor
5522061|NCT04310579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6464713|NCT00470522|Dermatologic Agents|dermatologic agents|mesh-ancestor
5522062|NCT04310579|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6098121|NCT00922207|Entecavir|entecavir|mesh-list
6098122|NCT00922207|Adefovir|adefovir|mesh-list
6098123|NCT00922207|Antiviral Agents|antiviral agents|mesh-ancestor
6098124|NCT00922207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6464714|NCT00470522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6464715|NCT00470522|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6464716|NCT00470522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6464717|NCT00470522|Immunologic Factors|immunologic factors|mesh-ancestor
6464718|NCT00470522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6464719|NCT00470522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6464720|NCT00470522|Hematinics|hematinics|mesh-ancestor
6098125|NCT00922207|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6098126|NCT00922207|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6098127|NCT00922207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6098128|NCT00922207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098129|NCT00922233|Levonorgestrel|levonorgestrel|mesh-list
6098130|NCT00922233|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6098131|NCT00922233|Contraceptive Agents|contraceptive agents|mesh-ancestor
6098132|NCT00922233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6098133|NCT00922233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098134|NCT00922233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6098135|NCT00922233|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6098136|NCT00922233|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6098137|NCT00922272|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6098138|NCT00922272|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6098139|NCT00922272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098140|NCT00922272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6098141|NCT00922272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6098142|NCT00922272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6098143|NCT00922272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098144|NCT00922272|Dopamine Agents|dopamine agents|mesh-ancestor
6098145|NCT00922272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6098146|NCT00922441|Valsartan|valsartan|mesh-list
6098147|NCT00922441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6098148|NCT00922441|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6098149|NCT00922441|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6098150|NCT00922441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098151|NCT00922480|Losartan|losartan|mesh-list
6098152|NCT00922480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6098153|NCT00922480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6098154|NCT00922480|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6098155|NCT00922480|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6098156|NCT00922480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098157|NCT00922636|Methylphenidate|methylphenidate|mesh-list
6098158|NCT00922636|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6098159|NCT00922636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098160|NCT00922636|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6098161|NCT00922636|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6098162|NCT00922636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6098163|NCT00922636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098164|NCT00922636|Dopamine Agents|dopamine agents|mesh-ancestor
6098165|NCT00922636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6098166|NCT00922766|Dalteparin|dalteparin|mesh-list
6098167|NCT00922766|Tinzaparin|tinzaparin|mesh-list
5522063|NCT04310579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5522064|NCT04310579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5522065|NCT04310579|Serotonin Agents|serotonin agents|mesh-ancestor
5522066|NCT04310579|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5522067|NCT04310579|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5522068|NCT04310579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5522069|NCT04310579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5522070|NCT04310709|Nivolumab|nivolumab|mesh-list
6098168|NCT00922766|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6098169|NCT00922766|Anticoagulants|anticoagulants|mesh-ancestor
6098170|NCT00922766|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6098171|NCT00922766|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6098172|NCT00922766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098173|NCT00922779|Ribavirin|ribavirin|mesh-list
6098174|NCT00922779|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6098175|NCT00922779|Antimetabolites|antimetabolites|mesh-ancestor
6098176|NCT00922779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098177|NCT00922779|Antiviral Agents|antiviral agents|mesh-ancestor
6098178|NCT00922779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6098179|NCT00922987|Pregabalin|pregabalin|mesh-list
6098180|NCT00922987|Analgesics|analgesics|mesh-ancestor
6098181|NCT00922987|Sensory System Agents|sensory system agents|mesh-ancestor
6098182|NCT00922987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6098183|NCT00922987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098184|NCT00922987|Anticonvulsants|anticonvulsants|mesh-ancestor
6098185|NCT00922987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6098186|NCT00922987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6098187|NCT00922987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098188|NCT00922987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6098189|NCT00922987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5522071|NCT04310709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5522072|NCT04310709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5522073|NCT04310709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5522074|NCT04310709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522075|NCT04310774|Tegafur|tegafur|mesh-list
5522076|NCT04310774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5522077|NCT04310774|Antimetabolites|antimetabolites|mesh-ancestor
5522078|NCT04310774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522079|NCT04310774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5522080|NCT04310254|Edetic Acid|edetic acid|mesh-list
5522081|NCT04310254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5522082|NCT04310254|Pentetic Acid|pentetic acid|mesh-list
6098190|NCT00922987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6098191|NCT00922987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6098192|NCT00922987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6098193|NCT00923091|Amlodipine|amlodipine|mesh-list
6098194|NCT00923091|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6098195|NCT00923091|Olmesartan|olmesartan|mesh-list
6098196|NCT00923091|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6098197|NCT00923091|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
6098198|NCT00923091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6098199|NCT00923091|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6098200|NCT00923091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6098201|NCT00923091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098202|NCT00923091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6098203|NCT00923091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098204|NCT00923091|Vasodilator Agents|vasodilator agents|mesh-ancestor
6098205|NCT00923091|Diuretics|diuretics|mesh-ancestor
6098206|NCT00923091|Natriuretic Agents|natriuretic agents|mesh-ancestor
6098207|NCT00923091|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6098208|NCT00923091|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6098209|NCT00923091|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6098210|NCT00923117|Sunitinib|sunitinib|mesh-list
6098211|NCT00923117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6098212|NCT00923117|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6098213|NCT00923117|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6098214|NCT00923117|Growth Substances|growth substances|mesh-ancestor
6098215|NCT00923117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098216|NCT00923117|Growth Inhibitors|growth inhibitors|mesh-ancestor
6098217|NCT00923117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6098218|NCT00923117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6098219|NCT00923117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098220|NCT00923130|Bevacizumab|bevacizumab|mesh-list
6098221|NCT00923130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6098222|NCT00923130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6098223|NCT00923130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6098224|NCT00923130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6098225|NCT00923130|Growth Substances|growth substances|mesh-ancestor
6098226|NCT00923130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098227|NCT00923130|Growth Inhibitors|growth inhibitors|mesh-ancestor
6098228|NCT00923156|Ramipril|ramipril|mesh-list
6098229|NCT00923156|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6464721|NCT00470522|Vitamin B Complex|vitamin b complex|mesh-ancestor
6464722|NCT00470522|Vitamins|vitamins|mesh-ancestor
6464723|NCT00470522|Micronutrients|micronutrients|mesh-ancestor
6464724|NCT00470561|Aspirin|aspirin|mesh-list
6464725|NCT00470561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6464726|NCT00470561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6464727|NCT00470561|Analgesics|analgesics|mesh-ancestor
6464728|NCT00470561|Sensory System Agents|sensory system agents|mesh-ancestor
6464729|NCT00470561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6464730|NCT00470561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522083|NCT04310254|Anticoagulants|anticoagulants|mesh-ancestor
6464731|NCT00470561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6464732|NCT00470561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6464733|NCT00470561|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6464734|NCT00470561|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5522084|NCT04310254|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5522085|NCT04310254|Chelating Agents|chelating agents|mesh-ancestor
5522086|NCT04310254|Sequestering Agents|sequestering agents|mesh-ancestor
5522087|NCT04310254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522088|NCT04310254|Antidotes|antidotes|mesh-ancestor
5522089|NCT04310254|Protective Agents|protective agents|mesh-ancestor
5522090|NCT04310254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522091|NCT04310254|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5522092|NCT04310280|Insulin Glargine|insulin glargine|mesh-list
5522093|NCT04310280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5522094|NCT04310280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522095|NCT04310228|Favipiravir|favipiravir|mesh-list
5522096|NCT04310228|Antiviral Agents|antiviral agents|mesh-ancestor
5522097|NCT04310228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6464735|NCT00470561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6464736|NCT00470561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6464737|NCT00470561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6464738|NCT00470561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6464739|NCT00470561|Antipyretics|antipyretics|mesh-ancestor
6464740|NCT00470665|Sirolimus|sirolimus|mesh-list
6464741|NCT00470665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6665777|NCT01518712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665778|NCT01518725|Vitamin D|vitamin d|mesh-list
6098230|NCT00923156|Protease Inhibitors|protease inhibitors|mesh-ancestor
6098231|NCT00923156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6098232|NCT00923156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098233|NCT00923156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6098234|NCT00923195|Aldesleukin|aldesleukin|mesh-list
6098235|NCT00923195|Cyclophosphamide|cyclophosphamide|mesh-list
6098236|NCT00923195|Fludarabine|fludarabine|mesh-list
6098237|NCT00923195|Interleukin-2|interleukin-2|mesh-list
6098238|NCT00923195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6098239|NCT00923195|Immunologic Factors|immunologic factors|mesh-ancestor
6098240|NCT00923195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098241|NCT00923195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5522098|NCT04310176|Bevacizumab|bevacizumab|mesh-list
5522099|NCT04310176|Fluorouracil|fluorouracil|mesh-list
5522100|NCT04310176|Capecitabine|capecitabine|mesh-list
5522101|NCT04310176|Valproic Acid|valproic acid|mesh-list
5522102|NCT04310176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5522103|NCT04310176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6098242|NCT00923195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6098243|NCT00923195|Alkylating Agents|alkylating agents|mesh-ancestor
6098244|NCT00923195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098245|NCT00923195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6098246|NCT00923195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6098247|NCT00923195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6098248|NCT00923195|Analgesics|analgesics|mesh-ancestor
6665779|NCT01518725|Cholecalciferol|cholecalciferol|mesh-list
6665780|NCT01518725|Vitamins|vitamins|mesh-ancestor
5522104|NCT04310176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5522105|NCT04310176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5522106|NCT04310176|Growth Substances|growth substances|mesh-ancestor
5522107|NCT04310176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522108|NCT04310176|Growth Inhibitors|growth inhibitors|mesh-ancestor
6665781|NCT01518725|Micronutrients|micronutrients|mesh-ancestor
6665782|NCT01518725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665783|NCT01518725|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6665784|NCT01518725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6665785|NCT01518790|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
6665786|NCT01518790|Laxatives|laxatives|mesh-ancestor
6665787|NCT01518790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6665788|NCT01518855|Amlodipine|amlodipine|mesh-list
6665789|NCT01518855|Nifedipine|nifedipine|mesh-list
6665790|NCT01518855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6665791|NCT01518855|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5522109|NCT04310176|Antimetabolites|antimetabolites|mesh-ancestor
5522110|NCT04310176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522111|NCT04310176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6098249|NCT00923195|Sensory System Agents|sensory system agents|mesh-ancestor
6464742|NCT00470665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6464743|NCT00470665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5522112|NCT04310176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5522113|NCT04310176|Immunologic Factors|immunologic factors|mesh-ancestor
5522114|NCT04310176|Anticonvulsants|anticonvulsants|mesh-ancestor
5522115|NCT04310176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5522116|NCT04310176|GABA Agents|gaba agents|mesh-ancestor
5522117|NCT04310176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5522118|NCT04310176|Antimanic Agents|antimanic agents|mesh-ancestor
5522119|NCT04310176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5522120|NCT04310176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5522121|NCT04310176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5522122|NCT04310397|Trametinib|trametinib|mesh-list
5522123|NCT04310397|Dabrafenib|dabrafenib|mesh-list
5522124|NCT04310397|Spartalizumab|spartalizumab|mesh-list
5522125|NCT04310397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5522126|NCT04310397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5522127|NCT04310397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5522128|NCT04310397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522129|NCT04310397|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5522130|NCT04309838|Treprostinil|treprostinil|mesh-list
6098250|NCT00923195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6098251|NCT00923195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6098252|NCT00923195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6098253|NCT00923195|Antiviral Agents|antiviral agents|mesh-ancestor
6098254|NCT00923195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6098255|NCT00923273|Folic Acid|folic acid|mesh-list
6098256|NCT00923273|Vitamin B 12|vitamin b 12|mesh-list
6098257|NCT00923273|Hydroxocobalamin|hydroxocobalamin|mesh-list
6098258|NCT00923273|Sirolimus|sirolimus|mesh-list
6098259|NCT00923273|Dexamethasone|dexamethasone|mesh-list
6098260|NCT00923273|Pemetrexed|pemetrexed|mesh-list
6098261|NCT00923273|Vitamins|vitamins|mesh-ancestor
6098262|NCT00923273|Micronutrients|micronutrients|mesh-ancestor
5522131|NCT04309838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5522132|NCT04310150|Hemostatics|hemostatics|mesh-list
5522133|NCT04310150|Coagulants|coagulants|mesh-ancestor
5522134|NCT04310059|Folic Acid|folic acid|mesh-list
5522135|NCT04310059|Hematinics|hematinics|mesh-ancestor
5522136|NCT04310059|Vitamin B Complex|vitamin b complex|mesh-ancestor
5522137|NCT04310059|Vitamins|vitamins|mesh-ancestor
5522138|NCT04310059|Micronutrients|micronutrients|mesh-ancestor
5522139|NCT04310059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522140|NCT04310293|Hormones|hormones|mesh-list
5522141|NCT04310293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5522142|NCT04310293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522143|NCT04309929|Analgesics|analgesics|mesh-list
5522144|NCT04309929|Sensory System Agents|sensory system agents|mesh-ancestor
5522145|NCT04309929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5522146|NCT04309929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098263|NCT00923273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098264|NCT00923273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6098265|NCT00923273|Antiemetics|antiemetics|mesh-ancestor
6098266|NCT00923273|Autonomic Agents|autonomic agents|mesh-ancestor
6464744|NCT00470665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6464745|NCT00470665|Antifungal Agents|antifungal agents|mesh-ancestor
6464746|NCT00470665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6464747|NCT00470665|Immunologic Factors|immunologic factors|mesh-ancestor
6464748|NCT00470665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098267|NCT00923273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6098268|NCT00923273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6098269|NCT00923273|Glucocorticoids|glucocorticoids|mesh-ancestor
6098270|NCT00923273|Hormones|hormones|mesh-ancestor
6098271|NCT00923273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6098272|NCT00923273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6098273|NCT00923273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6098274|NCT00923273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6098275|NCT00923273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098276|NCT00923273|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6098277|NCT00923273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6464749|NCT00470678|Ranibizumab|ranibizumab|mesh-list
6464750|NCT00470678|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6464751|NCT00470678|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6464752|NCT00470678|Growth Substances|growth substances|mesh-ancestor
6464753|NCT00470678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464754|NCT00470678|Growth Inhibitors|growth inhibitors|mesh-ancestor
6464755|NCT00470678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5522147|NCT04309643|Levonorgestrel|levonorgestrel|mesh-list
5522148|NCT04309643|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5522149|NCT04309643|Contraceptive Agents|contraceptive agents|mesh-list
6098278|NCT00923273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5522150|NCT04309643|Contraceptives, Oral|contraceptives, oral|mesh-list
5522151|NCT04309643|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
5522152|NCT04309643|Estradiol|estradiol|mesh-list
5522153|NCT04309643|Estrogens|estrogens|mesh-ancestor
6464756|NCT00470704|Trastuzumab|trastuzumab|mesh-list
6098279|NCT00923273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6098280|NCT00923273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6098281|NCT00923273|Antifungal Agents|antifungal agents|mesh-ancestor
6098282|NCT00923273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6098283|NCT00923273|Immunologic Factors|immunologic factors|mesh-ancestor
5522154|NCT04309643|Hormones|hormones|mesh-ancestor
5522155|NCT04309643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5522156|NCT04309643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522157|NCT04309643|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5522158|NCT04309643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5522159|NCT04309643|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5522160|NCT04309643|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5522161|NCT04309643|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5601009|NCT03708458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5606703|NCT03896503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098284|NCT00923273|Hematinics|hematinics|mesh-ancestor
6098285|NCT00923273|Vitamin B Complex|vitamin b complex|mesh-ancestor
6098286|NCT00923351|Vaccines|vaccines|mesh-list
6098287|NCT00923351|Immunologic Factors|immunologic factors|mesh-ancestor
6098288|NCT00923351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098289|NCT00923364|Cyclophosphamide|cyclophosphamide|mesh-list
6098290|NCT00923364|Fludarabine|fludarabine|mesh-list
6098291|NCT00923364|Fludarabine phosphate|fludarabine phosphate|mesh-list
6098292|NCT00923364|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6098293|NCT00923364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6098294|NCT00923364|Immunologic Factors|immunologic factors|mesh-ancestor
6098295|NCT00923364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098296|NCT00923364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6098297|NCT00923364|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6098298|NCT00923364|Alkylating Agents|alkylating agents|mesh-ancestor
6098299|NCT00923364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098300|NCT00923364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6098301|NCT00923364|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6098302|NCT00923364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6098303|NCT00923364|Antimetabolites|antimetabolites|mesh-ancestor
6098304|NCT00923845|Sirolimus|sirolimus|mesh-list
6098305|NCT00923845|Cyclophosphamide|cyclophosphamide|mesh-list
6098306|NCT00923845|Pentostatin|pentostatin|mesh-list
6098307|NCT00923845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6098308|NCT00923845|Immunologic Factors|immunologic factors|mesh-ancestor
6098309|NCT00923845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098310|NCT00923845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6098311|NCT00923845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6098312|NCT00923845|Alkylating Agents|alkylating agents|mesh-ancestor
6098313|NCT00923845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098314|NCT00923845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5606704|NCT03896503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5606705|NCT03847311|Sulfasalazine|sulfasalazine|mesh-list
5606706|NCT03847311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6098315|NCT00923845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6098316|NCT00923845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6098317|NCT00923845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6098318|NCT00923845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6098319|NCT00923845|Antifungal Agents|antifungal agents|mesh-ancestor
6098320|NCT00923845|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
6098321|NCT00923845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6098322|NCT00923910|Acetaminophen|acetaminophen|mesh-list
6098323|NCT00923910|Diphenhydramine|diphenhydramine|mesh-list
6098324|NCT00923910|Promethazine|promethazine|mesh-list
6098325|NCT00923910|Interleukin-4|interleukin-4|mesh-list
6098326|NCT00923910|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
6098327|NCT00923910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6098328|NCT00923910|Analgesics|analgesics|mesh-ancestor
6098329|NCT00923910|Sensory System Agents|sensory system agents|mesh-ancestor
6098330|NCT00923910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6098331|NCT00923910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098332|NCT00923910|Antipyretics|antipyretics|mesh-ancestor
6098333|NCT00923910|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6098334|NCT00923910|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6098335|NCT00923910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6464757|NCT00470704|Lapatinib|lapatinib|mesh-list
5522162|NCT04309708|Nimodipine|nimodipine|mesh-list
5522163|NCT04309708|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5522164|NCT04309708|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5522165|NCT04309708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5522166|NCT04309708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522167|NCT04309708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5522168|NCT04309708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522169|NCT04309708|Vasodilator Agents|vasodilator agents|mesh-ancestor
5522170|NCT04309578|Capecitabine|capecitabine|mesh-list
5522171|NCT04309578|Trastuzumab|trastuzumab|mesh-list
5522172|NCT04309578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5522173|NCT04309578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5522174|NCT04309578|Antimetabolites|antimetabolites|mesh-ancestor
5522175|NCT04309578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098336|NCT00923910|Anesthetics, Local|anesthetics, local|mesh-ancestor
6098337|NCT00923910|Anesthetics|anesthetics|mesh-ancestor
6098338|NCT00923910|Antiemetics|antiemetics|mesh-ancestor
6098339|NCT00923910|Autonomic Agents|autonomic agents|mesh-ancestor
6098340|NCT00923910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6098341|NCT00923910|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6098342|NCT00923910|Histamine Antagonists|histamine antagonists|mesh-ancestor
6098343|NCT00923910|Histamine Agents|histamine agents|mesh-ancestor
6098344|NCT00923910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6098345|NCT00923910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098346|NCT00923910|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6098347|NCT00923910|Antipruritics|antipruritics|mesh-ancestor
6098348|NCT00923910|Dermatologic Agents|dermatologic agents|mesh-ancestor
6098349|NCT00923910|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6098350|NCT00923910|Immunologic Factors|immunologic factors|mesh-ancestor
6098351|NCT00923910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6098352|NCT00923910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6098353|NCT00923936|Bevacizumab|bevacizumab|mesh-list
6098354|NCT00923936|Doxorubicin|doxorubicin|mesh-list
6098355|NCT00923936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6098356|NCT00923936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6098357|NCT00923936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6098358|NCT00923936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6098359|NCT00923936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6098360|NCT00923936|Growth Substances|growth substances|mesh-ancestor
6098361|NCT00923936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098362|NCT00923936|Growth Inhibitors|growth inhibitors|mesh-ancestor
6098363|NCT00923936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6098364|NCT00923936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6098365|NCT00923936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6098366|NCT00923936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6098367|NCT00923936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098368|NCT00923949|Pioglitazone|pioglitazone|mesh-list
6098369|NCT00923949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6098370|NCT00923949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098371|NCT00924001|Aldesleukin|aldesleukin|mesh-list
6098372|NCT00924001|Cyclophosphamide|cyclophosphamide|mesh-list
6098373|NCT00924001|Fludarabine|fludarabine|mesh-list
6098374|NCT00924001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6098375|NCT00924001|Immunologic Factors|immunologic factors|mesh-ancestor
6098376|NCT00924001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098377|NCT00924001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6098378|NCT00924001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6098379|NCT00924001|Alkylating Agents|alkylating agents|mesh-ancestor
6098380|NCT00924001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522176|NCT04309578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5522177|NCT04309552|Alovudine|alovudine|mesh-list
5522178|NCT04309552|Antiviral Agents|antiviral agents|mesh-ancestor
5522179|NCT04309552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5522180|NCT04309357|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5522181|NCT04309357|Plasminogen|plasminogen|mesh-list
6098381|NCT00924001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6098382|NCT00924001|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6098383|NCT00924001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6098384|NCT00924001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6098385|NCT00924001|Antiviral Agents|antiviral agents|mesh-ancestor
5522182|NCT04309357|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5522183|NCT04309357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5522184|NCT04309357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098386|NCT00924001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5522185|NCT04309240|Rivaroxaban|rivaroxaban|mesh-list
6098387|NCT00924053|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
6098388|NCT00924053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098389|NCT00924053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6098390|NCT00924053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098391|NCT00924066|Epothilones|epothilones|mesh-list
6098392|NCT00924066|Tubulin Modulators|tubulin modulators|mesh-ancestor
6098393|NCT00924066|Antimitotic Agents|antimitotic agents|mesh-ancestor
6098394|NCT00924066|Mitosis Modulators|mitosis modulators|mesh-ancestor
6098395|NCT00924066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098396|NCT00924066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6098397|NCT00924209|Gemcitabine|gemcitabine|mesh-list
6098398|NCT00924209|Bevacizumab|bevacizumab|mesh-list
6098399|NCT00924209|Etoposide|etoposide|mesh-list
6098400|NCT00924209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6098401|NCT00924209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6098402|NCT00924209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6098403|NCT00924209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6098404|NCT00924209|Growth Substances|growth substances|mesh-ancestor
6098405|NCT00924209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098406|NCT00924209|Growth Inhibitors|growth inhibitors|mesh-ancestor
6098407|NCT00924209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6098408|NCT00924209|Antimetabolites|antimetabolites|mesh-ancestor
6098409|NCT00924209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098410|NCT00924209|Antiviral Agents|antiviral agents|mesh-ancestor
6098411|NCT00924209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5522186|NCT04309240|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5522187|NCT04309240|Antithrombins|antithrombins|mesh-ancestor
5522188|NCT04309240|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5522189|NCT04309240|Protease Inhibitors|protease inhibitors|mesh-ancestor
5522190|NCT04309240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5522191|NCT04309240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522192|NCT04309240|Anticoagulants|anticoagulants|mesh-ancestor
5522193|NCT04308954|Flumazenil|flumazenil|mesh-list
5522194|NCT04308954|Antidotes|antidotes|mesh-ancestor
5522195|NCT04308954|Protective Agents|protective agents|mesh-ancestor
5522196|NCT04308954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522197|NCT04308954|GABA Modulators|gaba modulators|mesh-ancestor
6098412|NCT00924209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6098413|NCT00924209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6098414|NCT00924209|Immunologic Factors|immunologic factors|mesh-ancestor
6098415|NCT00924209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6098416|NCT00924209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6098417|NCT00924209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6098418|NCT00924287|Aldesleukin|aldesleukin|mesh-list
6098419|NCT00924287|Cyclophosphamide|cyclophosphamide|mesh-list
6098420|NCT00924287|Fludarabine|fludarabine|mesh-list
6098421|NCT00924287|Interleukin-2|interleukin-2|mesh-list
6098422|NCT00924287|Mesna|mesna|mesh-list
6098423|NCT00924287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5522198|NCT04308954|GABA Agents|gaba agents|mesh-ancestor
5522199|NCT04308954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5522200|NCT04308954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098424|NCT00924287|Immunologic Factors|immunologic factors|mesh-ancestor
6098425|NCT00924287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098426|NCT00924287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6098427|NCT00924287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6098428|NCT00924287|Alkylating Agents|alkylating agents|mesh-ancestor
6098429|NCT00924287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098430|NCT00924287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6098431|NCT00924287|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6098432|NCT00924287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6098433|NCT00924287|Analgesics|analgesics|mesh-ancestor
6098434|NCT00924287|Sensory System Agents|sensory system agents|mesh-ancestor
6098435|NCT00924287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6464758|NCT00470704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5522201|NCT04309058|Vitamin D|vitamin d|mesh-list
5522202|NCT04309058|Vitamins|vitamins|mesh-ancestor
6098436|NCT00924287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5522203|NCT04309058|Micronutrients|micronutrients|mesh-ancestor
5522204|NCT04309058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522205|NCT04309058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5522206|NCT04308863|Chitosan|chitosan|mesh-list
5522207|NCT04308863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522208|NCT04308863|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5522209|NCT04308863|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5522210|NCT04308863|Antimetabolites|antimetabolites|mesh-ancestor
5522211|NCT04308863|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5522212|NCT04308863|Chelating Agents|chelating agents|mesh-ancestor
5522213|NCT04308863|Sequestering Agents|sequestering agents|mesh-ancestor
5522214|NCT04308863|Hemostatics|hemostatics|mesh-ancestor
6098437|NCT00924287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6098438|NCT00924287|Antiviral Agents|antiviral agents|mesh-ancestor
6098439|NCT00924287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6098440|NCT00924287|Protective Agents|protective agents|mesh-ancestor
6098441|NCT00924352|Dasatinib|dasatinib|mesh-list
6098442|NCT00924352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6098443|NCT00924352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6098444|NCT00924352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6098445|NCT00924352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522215|NCT04308863|Coagulants|coagulants|mesh-ancestor
5522216|NCT04308551|Aspirin|aspirin|mesh-list
5522217|NCT04308551|Indobufen|indobufen|mesh-list
5522218|NCT04308551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5522219|NCT04308551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5522220|NCT04308551|Analgesics|analgesics|mesh-ancestor
5522221|NCT04308551|Sensory System Agents|sensory system agents|mesh-ancestor
5522222|NCT04308551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5522223|NCT04308551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522224|NCT04308551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5522225|NCT04308551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5522226|NCT04308551|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5522227|NCT04308551|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5522228|NCT04308551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522229|NCT04308551|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5522230|NCT04308551|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5522231|NCT04308551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5522232|NCT04308551|Antipyretics|antipyretics|mesh-ancestor
5522233|NCT04308850|Vitamin D|vitamin d|mesh-list
5522234|NCT04308850|Vitamins|vitamins|mesh-ancestor
5522235|NCT04308850|Micronutrients|micronutrients|mesh-ancestor
5522236|NCT04308850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522237|NCT04308850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5522238|NCT04308525|Analgesics, Opioid|analgesics, opioid|mesh-list
5522239|NCT04308525|Narcotics|narcotics|mesh-ancestor
5522240|NCT04308525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5522241|NCT04308525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522242|NCT04308525|Analgesics|analgesics|mesh-ancestor
5522243|NCT04308525|Sensory System Agents|sensory system agents|mesh-ancestor
5522244|NCT04308525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5522245|NCT04308317|Tetrandrine|tetrandrine|mesh-list
5522246|NCT04308317|Antimalarials|antimalarials|mesh-ancestor
5522247|NCT04308317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5522248|NCT04308317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5522249|NCT04308317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5522250|NCT04308317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6098446|NCT00924443|Clofarabine|clofarabine|mesh-list
6098447|NCT00924443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6098448|NCT00924443|Antimetabolites|antimetabolites|mesh-ancestor
6098449|NCT00924443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098450|NCT00924443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6098451|NCT00924469|Prednisone|prednisone|mesh-list
6098452|NCT00924469|Leuprolide|leuprolide|mesh-list
6098453|NCT00924469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6098454|NCT00924469|Glucocorticoids|glucocorticoids|mesh-ancestor
6098455|NCT00924469|Hormones|hormones|mesh-ancestor
6098456|NCT00924469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6098457|NCT00924469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098458|NCT00924469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6098459|NCT00924469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6098460|NCT00924469|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6098461|NCT00924469|Fertility Agents|fertility agents|mesh-ancestor
6098462|NCT00924469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5522251|NCT04308317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5522252|NCT04308317|Antiviral Agents|antiviral agents|mesh-ancestor
5522253|NCT04308317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5522254|NCT04308317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5522255|NCT04308317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522256|NCT04308317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5522257|NCT04308317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522258|NCT04308317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6098463|NCT00924508|Triamcinolone|triamcinolone|mesh-list
6098464|NCT00924508|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6098465|NCT00924508|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6098466|NCT00924508|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6098467|NCT00924508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6098468|NCT00924508|Glucocorticoids|glucocorticoids|mesh-ancestor
6098469|NCT00924508|Hormones|hormones|mesh-ancestor
6098470|NCT00924508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6098471|NCT00924508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098472|NCT00924508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6098473|NCT00924508|Immunologic Factors|immunologic factors|mesh-ancestor
6098474|NCT00924508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6098475|NCT00924508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098476|NCT00924560|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6098477|NCT00924560|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6098478|NCT00924560|Levonorgestrel|levonorgestrel|mesh-list
6098479|NCT00924560|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6098480|NCT00924560|Contraceptive Agents|contraceptive agents|mesh-list
6098481|NCT00924560|Contraceptives, Oral|contraceptives, oral|mesh-list
6098482|NCT00924560|Estradiol|estradiol|mesh-list
6098483|NCT00924560|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6098484|NCT00924560|Estrogens|estrogens|mesh-ancestor
6098485|NCT00924560|Hormones|hormones|mesh-ancestor
6098486|NCT00924560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6098487|NCT00924560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098488|NCT00924560|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6098489|NCT00924560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6098490|NCT00924560|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6098491|NCT00924560|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6098492|NCT00924560|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6098493|NCT00924612|Methyltestosterone|methyltestosterone|mesh-list
6098494|NCT00924612|Testosterone|testosterone|mesh-list
6098495|NCT00924612|Testosterone undecanoate|testosterone undecanoate|mesh-list
6098496|NCT00924612|Testosterone enanthate|testosterone enanthate|mesh-list
6098497|NCT00924612|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6098498|NCT00924612|Androgens|androgens|mesh-ancestor
6098499|NCT00924612|Hormones|hormones|mesh-ancestor
6098500|NCT00924612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6098501|NCT00924612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098502|NCT00924612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5522259|NCT04308317|Immunologic Factors|immunologic factors|mesh-ancestor
5522260|NCT04308343|Methotrexate|methotrexate|mesh-list
5522261|NCT04308343|Letrozole|letrozole|mesh-list
5522262|NCT04308343|Cetrorelix|cetrorelix|mesh-list
5522263|NCT04308343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5522264|NCT04308343|Abortifacient Agents|abortifacient agents|mesh-ancestor
5522265|NCT04308343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5522266|NCT04308343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522267|NCT04308343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6098503|NCT00924612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6098504|NCT00924612|Anabolic Agents|anabolic agents|mesh-ancestor
6098505|NCT00924664|Tanezumab|tanezumab|mesh-list
6098506|NCT00924664|Analgesics|analgesics|mesh-ancestor
6098507|NCT00924664|Sensory System Agents|sensory system agents|mesh-ancestor
6098508|NCT00924664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6098509|NCT00924664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098510|NCT00924729|Moxifloxacin|moxifloxacin|mesh-list
6098511|NCT00924729|Besifloxacin|besifloxacin|mesh-list
6098512|NCT00924729|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6098513|NCT00924729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6098514|NCT00924729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6098515|NCT00924729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6098516|NCT00924729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6098517|NCT00924729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6098518|NCT00924729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6098519|NCT00924729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098520|NCT00924729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6098521|NCT00924781|Epoetin Alfa|epoetin alfa|mesh-list
6098522|NCT00924781|Hematinics|hematinics|mesh-ancestor
6098523|NCT00924820|Bevacizumab|bevacizumab|mesh-list
5522268|NCT04308343|Antimetabolites|antimetabolites|mesh-ancestor
5522269|NCT04308343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522270|NCT04308343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5522271|NCT04308343|Dermatologic Agents|dermatologic agents|mesh-ancestor
5522272|NCT04308343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5522273|NCT04308343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5522274|NCT04308343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5522275|NCT04308343|Immunologic Factors|immunologic factors|mesh-ancestor
5522276|NCT04308343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5522277|NCT04308343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5522278|NCT04308343|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5522279|NCT04308343|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5522280|NCT04308343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5522281|NCT04308343|Hormone Antagonists|hormone antagonists|mesh-ancestor
5522282|NCT04308343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5522283|NCT04308343|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5522284|NCT04308343|Fertility Agents|fertility agents|mesh-ancestor
5522285|NCT04308174|Durvalumab|durvalumab|mesh-list
5522286|NCT04308174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5522287|NCT04308174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5522288|NCT04308161|Vitamin D|vitamin d|mesh-list
5522289|NCT04308161|Miconazole|miconazole|mesh-list
5522290|NCT04308161|Vitamins|vitamins|mesh-ancestor
5522291|NCT04308161|Micronutrients|micronutrients|mesh-ancestor
5522292|NCT04308161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522293|NCT04308161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5522294|NCT04308161|Antifungal Agents|antifungal agents|mesh-ancestor
5522295|NCT04308161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5522296|NCT04308161|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5522297|NCT04308161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5522298|NCT04308161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5522299|NCT04308161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522300|NCT04308161|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5522301|NCT04308161|Hormone Antagonists|hormone antagonists|mesh-ancestor
6098524|NCT00924820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6098525|NCT00924820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6098526|NCT00924820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6098527|NCT00924820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6098528|NCT00924820|Growth Substances|growth substances|mesh-ancestor
6098529|NCT00924820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098530|NCT00924820|Growth Inhibitors|growth inhibitors|mesh-ancestor
5522302|NCT04308161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5522303|NCT04308161|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5522304|NCT04308161|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5522305|NCT04308031|Digoxin|digoxin|mesh-list
5522306|NCT04308031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5522307|NCT04308031|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5522308|NCT04308031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5522309|NCT04308031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522310|NCT04308031|Protective Agents|protective agents|mesh-ancestor
5522311|NCT04308031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098531|NCT00924898|Tenofovir|tenofovir|mesh-list
6098532|NCT00924898|Emtricitabine|emtricitabine|mesh-list
6098533|NCT00924898|Efavirenz|efavirenz|mesh-list
6098534|NCT00924898|Antiviral Agents|antiviral agents|mesh-ancestor
6098535|NCT00924898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6098536|NCT00924898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6098537|NCT00924898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6098538|NCT00924898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6098539|NCT00924898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098540|NCT00924898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6098541|NCT00924898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6098542|NCT00924898|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6098543|NCT00924898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6098544|NCT00924898|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6098545|NCT00924898|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6098546|NCT00924898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6098547|NCT00924898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6098548|NCT00924950|Calcitriol|calcitriol|mesh-list
6098549|NCT00924950|Betamethasone|betamethasone|mesh-list
6098550|NCT00924950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6098551|NCT00924950|Glucocorticoids|glucocorticoids|mesh-ancestor
6098552|NCT00924950|Hormones|hormones|mesh-ancestor
6098553|NCT00924950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6098554|NCT00924950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098555|NCT00924950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6098556|NCT00924950|Respiratory System Agents|respiratory system agents|mesh-ancestor
6098557|NCT00924950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6098558|NCT00924950|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6098559|NCT00924950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6098560|NCT00924950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098561|NCT00924950|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5522312|NCT04308070|Hemostatics|hemostatics|mesh-list
5522313|NCT04308070|Coagulants|coagulants|mesh-ancestor
5601010|NCT03708341|Melatonin|melatonin|mesh-list
5601011|NCT03708341|Antioxidants|antioxidants|mesh-ancestor
5601012|NCT03708341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601013|NCT03708341|Protective Agents|protective agents|mesh-ancestor
5601014|NCT03708341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601015|NCT03708341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5601016|NCT03708237|Gabapentin|gabapentin|mesh-list
5601017|NCT03708237|Ropinirole|ropinirole|mesh-list
5601018|NCT03708237|Analgesics|analgesics|mesh-ancestor
5601019|NCT03708237|Sensory System Agents|sensory system agents|mesh-ancestor
5601020|NCT03708237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5601021|NCT03708237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601022|NCT03708237|Anticonvulsants|anticonvulsants|mesh-ancestor
5601023|NCT03708237|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5601024|NCT03708237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5601025|NCT03708237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5601026|NCT03708237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5601027|NCT03708237|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5601028|NCT03708237|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5601029|NCT03708237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5601030|NCT03708237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601031|NCT03708237|Antimanic Agents|antimanic agents|mesh-ancestor
5601032|NCT03708237|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5601033|NCT03708237|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5601034|NCT03708237|Dopamine Agonists|dopamine agonists|mesh-ancestor
5601035|NCT03708237|Dopamine Agents|dopamine agents|mesh-ancestor
6098562|NCT00924950|Vitamins|vitamins|mesh-ancestor
6098563|NCT00924950|Micronutrients|micronutrients|mesh-ancestor
6098564|NCT00924950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6098565|NCT00925015|Irinotecan|irinotecan|mesh-list
6098566|NCT00925015|Cetuximab|cetuximab|mesh-list
6098567|NCT00925015|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6098568|NCT00925015|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6098569|NCT00925015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6098570|NCT00925015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5601036|NCT03708198|Bupivacaine|bupivacaine|mesh-list
5601037|NCT03708198|Anesthetics, Local|anesthetics, local|mesh-ancestor
5601038|NCT03708198|Anesthetics|anesthetics|mesh-ancestor
5601039|NCT03708198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5601040|NCT03708198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601041|NCT03708198|Sensory System Agents|sensory system agents|mesh-ancestor
5601042|NCT03708198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5601043|NCT03708146|Zamicastat|zamicastat|mesh-list
5601044|NCT03708146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5601045|NCT03708146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601046|NCT03708133|Nifurtimox|nifurtimox|mesh-list
5601047|NCT03708133|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5601048|NCT03708133|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5601049|NCT03708133|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5601050|NCT03708133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5601051|NCT03708120|Insect Repellents|insect repellents|mesh-list
5601052|NCT03708120|Protective Agents|protective agents|mesh-ancestor
5601053|NCT03708120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601054|NCT03707951|Acetylcysteine|acetylcysteine|mesh-list
6098571|NCT00925015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098572|NCT00925015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6098573|NCT00925015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6098574|NCT00925015|Immunologic Factors|immunologic factors|mesh-ancestor
6098575|NCT00925015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098576|NCT00925119|Atenolol|atenolol|mesh-list
6098577|NCT00925119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6098578|NCT00925119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6098579|NCT00925119|Sympatholytics|sympatholytics|mesh-ancestor
5601055|NCT03707951|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5601056|NCT03707951|Antiviral Agents|antiviral agents|mesh-ancestor
5522314|NCT04307693|Ritonavir|ritonavir|mesh-list
5522315|NCT04307693|Lopinavir|lopinavir|mesh-list
5522316|NCT04307693|Hydroxychloroquine|hydroxychloroquine|mesh-list
5522317|NCT04307693|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5522318|NCT04307693|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5522319|NCT04307693|Protease Inhibitors|protease inhibitors|mesh-ancestor
5522320|NCT04307693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5522321|NCT04307693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522322|NCT04307693|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5522323|NCT04307693|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5522324|NCT04307693|Antiviral Agents|antiviral agents|mesh-ancestor
5522325|NCT04307693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5522326|NCT04307693|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6098580|NCT00925119|Autonomic Agents|autonomic agents|mesh-ancestor
6098581|NCT00925119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6098582|NCT00925119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098583|NCT00925119|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6098584|NCT00925119|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6098585|NCT00925119|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6098586|NCT00925119|Adrenergic Agents|adrenergic agents|mesh-ancestor
6098587|NCT00925119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6098588|NCT00925119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098589|NCT00925132|Temozolomide|temozolomide|mesh-list
6098590|NCT00925132|Decitabine|decitabine|mesh-list
6098591|NCT00925132|Panobinostat|panobinostat|mesh-list
6098592|NCT00925132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5522327|NCT04307693|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5522328|NCT04307693|Antimalarials|antimalarials|mesh-ancestor
5522329|NCT04307693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5522330|NCT04307693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5522331|NCT04307693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5522332|NCT04307953|Saracatinib|saracatinib|mesh-list
5522333|NCT04307953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5522334|NCT04307953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5522335|NCT04307953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522336|NCT04307550|Ethanol|ethanol|mesh-list
5522337|NCT04307550|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5522338|NCT04307550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5522339|NCT04307550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5522340|NCT04307550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098593|NCT00925132|Alkylating Agents|alkylating agents|mesh-ancestor
6098594|NCT00925132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098595|NCT00925132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6098596|NCT00925132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6098597|NCT00925132|Antimetabolites|antimetabolites|mesh-ancestor
6098598|NCT00925132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6098599|NCT00925132|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6098600|NCT00925288|Vaccines|vaccines|mesh-list
6098601|NCT00925288|Immunologic Factors|immunologic factors|mesh-ancestor
6098602|NCT00925288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098603|NCT00925353|Lidocaine|lidocaine|mesh-list
6098604|NCT00925353|Anesthetics, Local|anesthetics, local|mesh-ancestor
6098605|NCT00925353|Anesthetics|anesthetics|mesh-ancestor
6098606|NCT00925353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6098607|NCT00925353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098608|NCT00925353|Sensory System Agents|sensory system agents|mesh-ancestor
6098609|NCT00925353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6098610|NCT00925353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6098611|NCT00925353|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6098612|NCT00925353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6098613|NCT00925353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6098614|NCT00925353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6464759|NCT00470704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6464760|NCT00470704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6464761|NCT00470704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5522341|NCT04307329|Trastuzumab|trastuzumab|mesh-list
6464762|NCT00470704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6464763|NCT00470743|Ibuprofen|ibuprofen|mesh-list
6464764|NCT00470743|Indomethacin|indomethacin|mesh-list
6464765|NCT00470743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6098615|NCT00925587|Darbepoetin alfa|darbepoetin alfa|mesh-list
6098616|NCT00925587|Hematinics|hematinics|mesh-ancestor
6098617|NCT00925600|Denosumab|denosumab|mesh-list
6098618|NCT00925600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6098619|NCT00925600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203697|NCT02059278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6203698|NCT02059434|Tiotropium Bromide|tiotropium bromide|mesh-list
6203699|NCT02059434|LAS190792|las190792|mesh-list
6203700|NCT02059434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6203701|NCT02059434|Autonomic Agents|autonomic agents|mesh-ancestor
6203702|NCT02059434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6203703|NCT02059434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203704|NCT02059434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6203705|NCT02059434|Respiratory System Agents|respiratory system agents|mesh-ancestor
6203706|NCT02059434|Parasympatholytics|parasympatholytics|mesh-ancestor
6203707|NCT02059434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6203708|NCT02059434|Cholinergic Agents|cholinergic agents|mesh-ancestor
6203709|NCT02059434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6203710|NCT02059434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203711|NCT02059434|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6203712|NCT02059434|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6203713|NCT02059434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6203714|NCT02059434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6203715|NCT02059434|Adrenergic Agents|adrenergic agents|mesh-ancestor
6203716|NCT02059642|Metadoxine|metadoxine|mesh-list
6203717|NCT02059642|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6203718|NCT02059902|Lidocaine|lidocaine|mesh-list
6203719|NCT02059902|Anesthetics, Local|anesthetics, local|mesh-ancestor
6203720|NCT02059902|Anesthetics|anesthetics|mesh-ancestor
6203721|NCT02059902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6203722|NCT02059902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203723|NCT02059902|Sensory System Agents|sensory system agents|mesh-ancestor
6203724|NCT02059902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6203725|NCT02059902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5522342|NCT04307329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5522343|NCT04307329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5522344|NCT04307511|Aspirin|aspirin|mesh-list
5522345|NCT04307511|Ticagrelor|ticagrelor|mesh-list
5522346|NCT04307511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6203726|NCT02059902|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6203727|NCT02059902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6203728|NCT02059902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6203729|NCT02059902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203730|NCT02060370|Sunitinib|sunitinib|mesh-list
6203731|NCT02060370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6203732|NCT02060370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6203733|NCT02060370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6203734|NCT02060370|Growth Substances|growth substances|mesh-ancestor
6203735|NCT02060370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203736|NCT02060370|Growth Inhibitors|growth inhibitors|mesh-ancestor
6203737|NCT02060370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6203738|NCT02060370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6203739|NCT02060370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203740|NCT02060383|Metformin|metformin|mesh-list
6203741|NCT02060383|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6203742|NCT02060383|Liraglutide|liraglutide|mesh-list
6203743|NCT02060383|Pasireotide|pasireotide|mesh-list
6203744|NCT02060383|Somatostatin|somatostatin|mesh-list
5522347|NCT04307511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5522348|NCT04307511|Analgesics|analgesics|mesh-ancestor
5522349|NCT04307511|Sensory System Agents|sensory system agents|mesh-ancestor
5522350|NCT04307511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5522351|NCT04307511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522352|NCT04307511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5522353|NCT04307511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6203745|NCT02060383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6203746|NCT02060383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203747|NCT02060383|Incretins|incretins|mesh-ancestor
6203748|NCT02060383|Hormones|hormones|mesh-ancestor
6203749|NCT02060383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5522354|NCT04307511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5522355|NCT04307511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5522356|NCT04307511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522357|NCT04307511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5522358|NCT04307511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5522359|NCT04307511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5522360|NCT04307511|Antipyretics|antipyretics|mesh-ancestor
5522361|NCT04307511|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5522362|NCT04307511|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5522363|NCT04307511|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5522364|NCT04307511|Purinergic Agents|purinergic agents|mesh-ancestor
6098620|NCT00925704|Calcitriol|calcitriol|mesh-list
6098621|NCT00925704|Sevelamer|sevelamer|mesh-list
6098622|NCT00925704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6098623|NCT00925704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098624|NCT00925704|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6098625|NCT00925704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6098626|NCT00925704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098627|NCT00925704|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6098628|NCT00925704|Vitamins|vitamins|mesh-ancestor
6098629|NCT00925704|Micronutrients|micronutrients|mesh-ancestor
6098630|NCT00925704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6098631|NCT00925704|Chelating Agents|chelating agents|mesh-ancestor
6098632|NCT00925704|Sequestering Agents|sequestering agents|mesh-ancestor
6098633|NCT00925756|Maraviroc|maraviroc|mesh-list
6098634|NCT00925756|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6098635|NCT00925756|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6098636|NCT00925756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098637|NCT00925756|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6098638|NCT00925756|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6098639|NCT00925756|Antiviral Agents|antiviral agents|mesh-ancestor
6098640|NCT00925756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6098641|NCT00925756|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6098642|NCT00925769|Bevacizumab|bevacizumab|mesh-list
6098643|NCT00925769|Capecitabine|capecitabine|mesh-list
6098644|NCT00925769|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6098645|NCT00925769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6098646|NCT00925769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6098647|NCT00925769|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6098648|NCT00925769|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6098649|NCT00925769|Growth Substances|growth substances|mesh-ancestor
6098650|NCT00925769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098651|NCT00925769|Growth Inhibitors|growth inhibitors|mesh-ancestor
6098652|NCT00925769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6098653|NCT00925769|Antimetabolites|antimetabolites|mesh-ancestor
6098654|NCT00925769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098655|NCT00925769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6098656|NCT00925769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6098657|NCT00925782|Melphalan|melphalan|mesh-list
6098658|NCT00925782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6098659|NCT00925782|Alkylating Agents|alkylating agents|mesh-ancestor
6098660|NCT00925782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098661|NCT00925782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6098662|NCT00925782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6098663|NCT00925782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6098664|NCT00925782|Immunologic Factors|immunologic factors|mesh-ancestor
6098665|NCT00925782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098666|NCT00925899|Melatonin|melatonin|mesh-list
6098667|NCT00925899|Antioxidants|antioxidants|mesh-ancestor
6098668|NCT00925899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098669|NCT00925899|Protective Agents|protective agents|mesh-ancestor
6098670|NCT00925899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098671|NCT00925899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6098672|NCT00925938|Misoprostol|misoprostol|mesh-list
5522365|NCT04307511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5522366|NCT04307485|Ticagrelor|ticagrelor|mesh-list
5522367|NCT04307485|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5522368|NCT04307485|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5522369|NCT04307485|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5522370|NCT04307485|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5522371|NCT04307485|Purinergic Agents|purinergic agents|mesh-ancestor
5522372|NCT04307485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5522373|NCT04307485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098673|NCT00925938|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6098674|NCT00925938|Abortifacient Agents|abortifacient agents|mesh-ancestor
6098675|NCT00925938|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6098676|NCT00925938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098677|NCT00925938|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6098678|NCT00925938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6098679|NCT00925938|Oxytocics|oxytocics|mesh-ancestor
5522374|NCT04307485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522375|NCT04307238|Anesthetics|anesthetics|mesh-list
5522376|NCT04307238|Propofol|propofol|mesh-list
5522377|NCT04307238|Sevoflurane|sevoflurane|mesh-list
5522378|NCT04307238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5522379|NCT04307238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522380|NCT04307238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5522381|NCT04307238|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5522382|NCT04307238|Anesthetics, General|anesthetics, general|mesh-ancestor
5522383|NCT04307238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6098680|NCT00925990|Ribavirin|ribavirin|mesh-list
6098681|NCT00925990|Antimetabolites|antimetabolites|mesh-ancestor
6098682|NCT00925990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098683|NCT00925990|Antiviral Agents|antiviral agents|mesh-ancestor
6098684|NCT00925990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6098685|NCT00926029|Listerine|listerine|mesh-list
6098686|NCT00926029|Triclosan|triclosan|mesh-list
5522384|NCT04307238|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5522385|NCT04307290|Dexmedetomidine|dexmedetomidine|mesh-list
5522386|NCT04307290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5522387|NCT04307290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5522388|NCT04307290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522389|NCT04307290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5522390|NCT04307290|Analgesics|analgesics|mesh-ancestor
5522391|NCT04307290|Sensory System Agents|sensory system agents|mesh-ancestor
5522392|NCT04307290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5522393|NCT04307290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5522394|NCT04307290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5522395|NCT04307290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5522396|NCT04307290|Adrenergic Agents|adrenergic agents|mesh-ancestor
5522397|NCT04307290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5522398|NCT04307290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522399|NCT04307147|Capecitabine|capecitabine|mesh-list
5522400|NCT04307147|Vinorelbine|vinorelbine|mesh-list
5522401|NCT04307147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5522402|NCT04307147|Antimetabolites|antimetabolites|mesh-ancestor
5522403|NCT04307147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522404|NCT04307147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5522405|NCT04307147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5522406|NCT04307147|Tubulin Modulators|tubulin modulators|mesh-ancestor
5522407|NCT04307147|Antimitotic Agents|antimitotic agents|mesh-ancestor
5522408|NCT04307147|Mitosis Modulators|mitosis modulators|mesh-ancestor
5522409|NCT04307082|Ibrexafungerp|ibrexafungerp|mesh-list
5522410|NCT04307082|Antifungal Agents|antifungal agents|mesh-ancestor
5522411|NCT04307082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5522412|NCT04307069|Oxytocin|oxytocin|mesh-list
5522413|NCT04307069|Oxytocics|oxytocics|mesh-ancestor
5522414|NCT04307069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5522415|NCT04307069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522416|NCT04306965|Apremilast|apremilast|mesh-list
5522417|NCT04306965|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5522418|NCT04306965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5522419|NCT04306965|Analgesics|analgesics|mesh-ancestor
5522420|NCT04306965|Sensory System Agents|sensory system agents|mesh-ancestor
5522421|NCT04306965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5522422|NCT04306965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522423|NCT04306965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5522424|NCT04306965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5522425|NCT04306965|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5522426|NCT04306965|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5522427|NCT04306965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5522428|NCT04306965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522429|NCT04306900|Gemcitabine|gemcitabine|mesh-list
5522430|NCT04306900|Paclitaxel|paclitaxel|mesh-list
5522431|NCT04306900|Docetaxel|docetaxel|mesh-list
5522432|NCT04306900|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5522433|NCT04306900|Pembrolizumab|pembrolizumab|mesh-list
5522434|NCT04306900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6098687|NCT00926029|Fluorides|fluorides|mesh-list
6098688|NCT00926029|Sodium Fluoride|sodium fluoride|mesh-list
6098689|NCT00926029|Cariostatic Agents|cariostatic agents|mesh-ancestor
6098690|NCT00926029|Protective Agents|protective agents|mesh-ancestor
6098691|NCT00926029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522435|NCT04306900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5522436|NCT04306900|Tubulin Modulators|tubulin modulators|mesh-ancestor
6098692|NCT00926029|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6098693|NCT00926029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6098694|NCT00926029|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6098695|NCT00926029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6098696|NCT00926029|Antimetabolites|antimetabolites|mesh-ancestor
6098697|NCT00926029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098698|NCT00926029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6098699|NCT00926185|Lifitegrast|lifitegrast|mesh-list
6098700|NCT00926185|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6098701|NCT00926185|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6098702|NCT00926263|Moxifloxacin|moxifloxacin|mesh-list
6098703|NCT00926263|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6098704|NCT00926263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6098705|NCT00926263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6098706|NCT00926263|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6098707|NCT00926263|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6098708|NCT00926263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6098709|NCT00926263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098710|NCT00926263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6098711|NCT00926263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098712|NCT00926263|Immunologic Factors|immunologic factors|mesh-ancestor
6098713|NCT00926289|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6098714|NCT00926289|Telmisartan|telmisartan|mesh-list
6098715|NCT00926289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6098716|NCT00926289|Diuretics|diuretics|mesh-ancestor
6098717|NCT00926289|Natriuretic Agents|natriuretic agents|mesh-ancestor
6098718|NCT00926289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098719|NCT00926289|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6098720|NCT00926289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6098721|NCT00926289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098722|NCT00926289|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6098723|NCT00926289|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6098724|NCT00926328|Triclosan|triclosan|mesh-list
6098725|NCT00926328|Fluorides|fluorides|mesh-list
6098726|NCT00926328|Cariostatic Agents|cariostatic agents|mesh-ancestor
6098727|NCT00926328|Protective Agents|protective agents|mesh-ancestor
6098728|NCT00926328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098729|NCT00926328|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6098730|NCT00926328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6098731|NCT00926328|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5522437|NCT04306900|Antimitotic Agents|antimitotic agents|mesh-ancestor
5522438|NCT04306900|Mitosis Modulators|mitosis modulators|mesh-ancestor
5522439|NCT04306900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522440|NCT04306900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5522441|NCT04306900|Antimetabolites|antimetabolites|mesh-ancestor
5522442|NCT04306900|Antiviral Agents|antiviral agents|mesh-ancestor
5522443|NCT04306900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5522444|NCT04306900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5522445|NCT04306900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5522446|NCT04306900|Immunologic Factors|immunologic factors|mesh-ancestor
5522447|NCT04306900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522448|NCT04306900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5522449|NCT04306913|Cardioplegic Solutions|cardioplegic solutions|mesh-list
5522450|NCT04306913|Esmolol|esmolol|mesh-list
5522451|NCT04306913|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5522452|NCT04306913|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5522453|NCT04306913|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5522454|NCT04306913|Adrenergic Agents|adrenergic agents|mesh-ancestor
5522455|NCT04306913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5522456|NCT04306913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098732|NCT00926328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6098733|NCT00926328|Antimetabolites|antimetabolites|mesh-ancestor
6098734|NCT00926328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098735|NCT00926328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6098736|NCT00926367|Clindamycin|clindamycin|mesh-list
6098737|NCT00926367|Clindamycin palmitate|clindamycin palmitate|mesh-list
6098738|NCT00926367|Clindamycin phosphate|clindamycin phosphate|mesh-list
6098739|NCT00926367|Adapalene|adapalene|mesh-list
6098740|NCT00926367|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6098741|NCT00926367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6098742|NCT00926367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6098743|NCT00926367|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6098744|NCT00926367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6098745|NCT00926367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098746|NCT00926367|Dermatologic Agents|dermatologic agents|mesh-ancestor
6098747|NCT00926367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6098748|NCT00926367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6098749|NCT00926367|Analgesics|analgesics|mesh-ancestor
6098750|NCT00926367|Sensory System Agents|sensory system agents|mesh-ancestor
6098751|NCT00926367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6098752|NCT00926367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098753|NCT00926367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6098754|NCT00926367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6098755|NCT00926380|Denosumab|denosumab|mesh-list
6098756|NCT00926380|Teriparatide|teriparatide|mesh-list
6098757|NCT00926380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6098758|NCT00926380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098759|NCT00926380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6098760|NCT00926393|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6098761|NCT00926393|Antidepressive Agents|antidepressive agents|mesh-ancestor
6098762|NCT00926393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6098763|NCT00926393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6098764|NCT00926393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5522457|NCT04306913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522458|NCT04306913|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5522459|NCT04306666|Anesthetics|anesthetics|mesh-list
5522460|NCT04306666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5522461|NCT04306666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522462|NCT04306653|Betamethasone|betamethasone|mesh-list
5522463|NCT04306653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5522464|NCT04306653|Glucocorticoids|glucocorticoids|mesh-ancestor
5522465|NCT04306653|Hormones|hormones|mesh-ancestor
5522466|NCT04306653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5522467|NCT04306653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098765|NCT00926393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6098766|NCT00926393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098767|NCT00926588|Analgesics|analgesics|mesh-list
6098768|NCT00926588|Sensory System Agents|sensory system agents|mesh-ancestor
6098769|NCT00926588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5522468|NCT04306653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6098770|NCT00926588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098771|NCT00926796|Azithromycin|azithromycin|mesh-list
6098772|NCT00926796|Gentamicins|gentamicins|mesh-list
6098773|NCT00926796|Gemifloxacin|gemifloxacin|mesh-list
6098774|NCT00926796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6098775|NCT00926796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6098776|NCT00926796|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6098777|NCT00926796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6098778|NCT00926796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098779|NCT00926796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6098780|NCT00926796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6098781|NCT00926796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6098782|NCT00926952|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
6098783|NCT00926952|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6098784|NCT00926952|Dermatologic Agents|dermatologic agents|mesh-ancestor
6098785|NCT00927069|Adalimumab|adalimumab|mesh-list
6098786|NCT00927069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6098787|NCT00927069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5522469|NCT04306653|Respiratory System Agents|respiratory system agents|mesh-ancestor
5522470|NCT04306731|Trimethoprim|trimethoprim|mesh-list
5522471|NCT04306731|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5522472|NCT04306731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5522473|NCT04306731|Renal Agents|renal agents|mesh-ancestor
5522474|NCT04306731|Antimalarials|antimalarials|mesh-ancestor
5522475|NCT04306731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5522476|NCT04306731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5522477|NCT04306731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5522478|NCT04306731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5522479|NCT04306731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522480|NCT04306731|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5522481|NCT04306731|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
5522482|NCT04306731|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5522483|NCT04306692|Inositol|inositol|mesh-list
5522484|NCT04306692|Clomiphene|clomiphene|mesh-list
5522485|NCT04306692|Enclomiphene|enclomiphene|mesh-list
5522486|NCT04306692|Zuclomiphene|zuclomiphene|mesh-list
5522487|NCT04306692|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5522488|NCT04306692|Hormone Antagonists|hormone antagonists|mesh-ancestor
5522489|NCT04306692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5522490|NCT04306692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522491|NCT04306692|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5522492|NCT04306692|Fertility Agents|fertility agents|mesh-ancestor
6098788|NCT00927082|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6464766|NCT00470743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6464767|NCT00470743|Analgesics|analgesics|mesh-ancestor
6665792|NCT01518855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6665793|NCT01518855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665794|NCT01518855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5522493|NCT04306692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6098789|NCT00927082|Antiviral Agents|antiviral agents|mesh-ancestor
6098790|NCT00927082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6098791|NCT00927095|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
6098792|NCT00927095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6098793|NCT00927095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098794|NCT00927186|Zoledronic Acid|zoledronic acid|mesh-list
6098795|NCT00927186|Teriparatide|teriparatide|mesh-list
6098796|NCT00927186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6098797|NCT00927186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098798|NCT00927186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6098799|NCT00927355|Pioglitazone|pioglitazone|mesh-list
6098800|NCT00927355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6098801|NCT00927355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098802|NCT00927394|Valsartan|valsartan|mesh-list
6098803|NCT00927394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5522494|NCT04306692|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5522495|NCT04306692|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5522496|NCT04306692|Vitamin B Complex|vitamin b complex|mesh-ancestor
5522497|NCT04306692|Vitamins|vitamins|mesh-ancestor
5522498|NCT04306692|Micronutrients|micronutrients|mesh-ancestor
5522499|NCT04306627|Amlodipine|amlodipine|mesh-list
5522500|NCT04306627|Perindopril|perindopril|mesh-list
5522501|NCT04306627|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
6098804|NCT00927394|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6098805|NCT00927394|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6098806|NCT00927394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098807|NCT00927472|Permethrin|permethrin|mesh-list
6098808|NCT00927472|Malathion|malathion|mesh-list
6098809|NCT00927472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6464768|NCT00470743|Sensory System Agents|sensory system agents|mesh-ancestor
6464769|NCT00470743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6464770|NCT00470743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522502|NCT04306627|Atorvastatin|atorvastatin|mesh-list
5522503|NCT04306627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5522504|NCT04306627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6464771|NCT00470743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6464772|NCT00470743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6464773|NCT00470743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6464774|NCT00470743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6098810|NCT00927472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098811|NCT00927472|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6098812|NCT00927472|Cholinergic Agents|cholinergic agents|mesh-ancestor
6098813|NCT00927472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6098814|NCT00927472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098815|NCT00927485|Curcumin|curcumin|mesh-list
6098816|NCT00927485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6098817|NCT00927485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6098818|NCT00927485|Analgesics|analgesics|mesh-ancestor
6098819|NCT00927485|Sensory System Agents|sensory system agents|mesh-ancestor
6098820|NCT00927485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6098821|NCT00927485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098822|NCT00927485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6098823|NCT00927485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6098824|NCT00927485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6098825|NCT00927485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5522505|NCT04306627|Antimetabolites|antimetabolites|mesh-ancestor
5522506|NCT04306627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522507|NCT04306627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5522508|NCT04306627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5522509|NCT04306627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5522510|NCT04306627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5522511|NCT04306627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5522512|NCT04306627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5522513|NCT04306627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5522514|NCT04306627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098826|NCT00927485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6464775|NCT00470743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6464776|NCT00470743|Gout Suppressants|gout suppressants|mesh-ancestor
6464777|NCT00470743|Tocolytic Agents|tocolytic agents|mesh-ancestor
6464778|NCT00470743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6464779|NCT00470821|Melatonin|melatonin|mesh-list
6464780|NCT00470821|Antioxidants|antioxidants|mesh-ancestor
6464781|NCT00470821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6464782|NCT00470821|Protective Agents|protective agents|mesh-ancestor
6464783|NCT00470821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464784|NCT00470821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6464785|NCT00470873|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6464786|NCT00470873|Vasodilator Agents|vasodilator agents|mesh-ancestor
6464787|NCT00470873|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6464788|NCT00470873|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6464789|NCT00470873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6464790|NCT00470873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6464791|NCT00470873|Urological Agents|urological agents|mesh-ancestor
5522515|NCT04306627|Vasodilator Agents|vasodilator agents|mesh-ancestor
5522516|NCT04306627|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6098827|NCT00927563|Tolcapone|tolcapone|mesh-list
6098828|NCT00927563|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6098829|NCT00927563|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6098830|NCT00927563|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6098831|NCT00927563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6098832|NCT00927563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098833|NCT00927589|Carboplatin|carboplatin|mesh-list
6098834|NCT00927589|Docetaxel|docetaxel|mesh-list
6098835|NCT00927589|Trastuzumab|trastuzumab|mesh-list
6098836|NCT00927589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6098837|NCT00927589|Tubulin Modulators|tubulin modulators|mesh-ancestor
6098838|NCT00927589|Antimitotic Agents|antimitotic agents|mesh-ancestor
6098839|NCT00927589|Mitosis Modulators|mitosis modulators|mesh-ancestor
5522517|NCT04306627|Protease Inhibitors|protease inhibitors|mesh-ancestor
5522518|NCT04306354|Oxytocin|oxytocin|mesh-list
5522519|NCT04306354|Oxytocics|oxytocics|mesh-ancestor
5522520|NCT04306354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5522521|NCT04306354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522522|NCT04306276|Dienogest|dienogest|mesh-list
5522523|NCT04306276|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5522524|NCT04306276|Contraceptive Agents|contraceptive agents|mesh-ancestor
5522525|NCT04306276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5522526|NCT04306276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522527|NCT04306276|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6098840|NCT00927589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522528|NCT04306276|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5522529|NCT04306276|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5522530|NCT04306276|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5522531|NCT04306276|Hormone Antagonists|hormone antagonists|mesh-ancestor
5522532|NCT04306276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5522533|NCT04306276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5522534|NCT04306276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5522535|NCT04306471|Evolocumab|evolocumab|mesh-list
5522536|NCT04306471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5522537|NCT04306471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5522538|NCT04306471|Antimetabolites|antimetabolites|mesh-ancestor
5522539|NCT04306471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522540|NCT04306471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5522541|NCT04306367|Pembrolizumab|pembrolizumab|mesh-list
5522542|NCT04306367|Olaparib|olaparib|mesh-list
5522543|NCT04306367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5522544|NCT04306367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5522545|NCT04306367|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5522546|NCT04306367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5522547|NCT04306367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522548|NCT04306393|Nitric Oxide|nitric oxide|mesh-list
5522549|NCT04306393|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6098841|NCT00927589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6098842|NCT00927758|Fluticasone|fluticasone|mesh-list
6098843|NCT00927758|Xhance|xhance|mesh-list
6098844|NCT00927758|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6098845|NCT00927758|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6098846|NCT00927758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6098847|NCT00927758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6098848|NCT00927758|Autonomic Agents|autonomic agents|mesh-ancestor
6098849|NCT00927758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6098850|NCT00927758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098851|NCT00927758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6098852|NCT00927758|Respiratory System Agents|respiratory system agents|mesh-ancestor
6098853|NCT00927758|Dermatologic Agents|dermatologic agents|mesh-ancestor
5522550|NCT04306393|Autonomic Agents|autonomic agents|mesh-ancestor
5522551|NCT04306393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5522552|NCT04306393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522553|NCT04306393|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5522554|NCT04306393|Respiratory System Agents|respiratory system agents|mesh-ancestor
5522555|NCT04306393|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5522556|NCT04306393|Antioxidants|antioxidants|mesh-ancestor
5522557|NCT04306393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522558|NCT04306393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6098854|NCT00927758|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6098855|NCT00927758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6098856|NCT00927758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6098857|NCT00927758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6098858|NCT00927758|Adrenergic Agents|adrenergic agents|mesh-ancestor
6098859|NCT00927758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6098860|NCT00927758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098861|NCT00927758|Glucocorticoids|glucocorticoids|mesh-ancestor
6098862|NCT00927758|Hormones|hormones|mesh-ancestor
6098863|NCT00927758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6098864|NCT00927758|Sympathomimetics|sympathomimetics|mesh-ancestor
6098865|NCT00927849|Nitroglycerin|nitroglycerin|mesh-list
6098866|NCT00927849|Botulinum Toxins|botulinum toxins|mesh-list
6098867|NCT00927849|Glycerol|glycerol|mesh-list
6098868|NCT00927849|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6098869|NCT00927849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6098870|NCT00927849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098871|NCT00927849|Cholinergic Agents|cholinergic agents|mesh-ancestor
6098872|NCT00927849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6098873|NCT00927849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098874|NCT00927849|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6098875|NCT00927849|Protective Agents|protective agents|mesh-ancestor
6098876|NCT00927849|Vasodilator Agents|vasodilator agents|mesh-ancestor
6098877|NCT00927862|Warfarin|warfarin|mesh-list
6098878|NCT00927862|Anticoagulants|anticoagulants|mesh-ancestor
6098879|NCT00927888|Bupivacaine|bupivacaine|mesh-list
6098880|NCT00927888|Anesthetics, Local|anesthetics, local|mesh-ancestor
6098881|NCT00927888|Anesthetics|anesthetics|mesh-ancestor
6098882|NCT00927888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6098883|NCT00927888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464792|NCT00470886|Telmisartan|telmisartan|mesh-list
6098884|NCT00927888|Sensory System Agents|sensory system agents|mesh-ancestor
6098885|NCT00927888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6098886|NCT00927901|Maleic acid|maleic acid|mesh-list
6098887|NCT00927901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6098888|NCT00927901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098889|NCT00928018|Cyclosporine|cyclosporine|mesh-list
6098890|NCT00928018|Sirolimus|sirolimus|mesh-list
5522559|NCT04306393|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5522560|NCT04306393|Vasodilator Agents|vasodilator agents|mesh-ancestor
5522561|NCT04306393|Gasotransmitters|gasotransmitters|mesh-ancestor
5522562|NCT04306393|Protective Agents|protective agents|mesh-ancestor
5522563|NCT04306159|Anesthetics|anesthetics|mesh-list
5522564|NCT04306159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5522565|NCT04306159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601057|NCT03707951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5601058|NCT03707951|Expectorants|expectorants|mesh-ancestor
5601059|NCT03707951|Respiratory System Agents|respiratory system agents|mesh-ancestor
6098891|NCT00928018|Mycophenolic Acid|mycophenolic acid|mesh-list
6098892|NCT00928018|Methotrexate|methotrexate|mesh-list
6098893|NCT00928018|Tacrolimus|tacrolimus|mesh-list
6098894|NCT00928018|Cyclosporins|cyclosporins|mesh-list
6098895|NCT00928018|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6098896|NCT00928018|Abortifacient Agents|abortifacient agents|mesh-ancestor
6098897|NCT00928018|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6098898|NCT00928018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098899|NCT00928018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6098900|NCT00928018|Antimetabolites|antimetabolites|mesh-ancestor
6098901|NCT00928018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098902|NCT00928018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6098903|NCT00928018|Dermatologic Agents|dermatologic agents|mesh-ancestor
6098904|NCT00928018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6098905|NCT00928018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6098906|NCT00928018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6098907|NCT00928018|Immunologic Factors|immunologic factors|mesh-ancestor
6098908|NCT00928018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6098909|NCT00928018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6098910|NCT00928018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6098911|NCT00928018|Antifungal Agents|antifungal agents|mesh-ancestor
6098912|NCT00928018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6098913|NCT00928018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6098914|NCT00928018|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6098915|NCT00928018|Antitubercular Agents|antitubercular agents|mesh-ancestor
6098916|NCT00928018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6098917|NCT00928070|Fesoterodine|fesoterodine|mesh-list
6098918|NCT00928070|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6098919|NCT00928070|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6098920|NCT00928070|Cholinergic Agents|cholinergic agents|mesh-ancestor
6098921|NCT00928070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6098922|NCT00928070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098923|NCT00928070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098924|NCT00928070|Urological Agents|urological agents|mesh-ancestor
6098925|NCT00928083|Artefenomel|artefenomel|mesh-list
6098926|NCT00928083|Antimalarials|antimalarials|mesh-ancestor
6098927|NCT00928083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6098928|NCT00928083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6098929|NCT00928083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6098930|NCT00928174|Fluorides|fluorides|mesh-list
6098931|NCT00928174|Cariostatic Agents|cariostatic agents|mesh-ancestor
6098932|NCT00928174|Protective Agents|protective agents|mesh-ancestor
6098933|NCT00928174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098934|NCT00928187|Ritonavir|ritonavir|mesh-list
6098935|NCT00928187|Lopinavir|lopinavir|mesh-list
6098936|NCT00928187|Darunavir|darunavir|mesh-list
6098937|NCT00928187|Tenofovir|tenofovir|mesh-list
6098938|NCT00928187|Emtricitabine|emtricitabine|mesh-list
6098939|NCT00928187|Abacavir|abacavir|mesh-list
6098940|NCT00928187|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6464793|NCT00470886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6464794|NCT00470886|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6464795|NCT00470886|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5601060|NCT03707951|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5601061|NCT03707951|Antioxidants|antioxidants|mesh-ancestor
6098941|NCT00928187|Didanosine|didanosine|mesh-list
6098942|NCT00928187|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6098943|NCT00928187|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6098944|NCT00928187|Protease Inhibitors|protease inhibitors|mesh-ancestor
6098945|NCT00928187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5522566|NCT04305743|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5522567|NCT04305743|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5522568|NCT04305743|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5522569|NCT04305743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5522570|NCT04305743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522571|NCT04305743|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5522572|NCT04305743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5522573|NCT04305743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522574|NCT04305743|Cholinergic Agents|cholinergic agents|mesh-ancestor
5522575|NCT04305743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5522576|NCT04305964|Silicon|silicon|mesh-list
5522577|NCT04305964|Trace Elements|trace elements|mesh-ancestor
5522578|NCT04305964|Micronutrients|micronutrients|mesh-ancestor
5522579|NCT04305964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522580|NCT04306042|Pembrolizumab|pembrolizumab|mesh-list
5522581|NCT04306042|Nivolumab|nivolumab|mesh-list
5522582|NCT04306042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5522583|NCT04306042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5522584|NCT04306042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5522585|NCT04306042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522586|NCT04305691|Ixazomib|ixazomib|mesh-list
5522587|NCT04305691|Glycine|glycine|mesh-list
6464796|NCT00470886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6464797|NCT00470912|Sunscreening Agents|sunscreening agents|mesh-list
6464798|NCT00470912|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5522588|NCT04305691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522589|NCT04305691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5522590|NCT04305691|Protease Inhibitors|protease inhibitors|mesh-ancestor
5522591|NCT04305691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5522592|NCT04305691|Glycine Agents|glycine agents|mesh-ancestor
5522593|NCT04305691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5522594|NCT04305691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522595|NCT04306081|Evolocumab|evolocumab|mesh-list
5522596|NCT04306081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5522597|NCT04306081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5522598|NCT04306081|Antimetabolites|antimetabolites|mesh-ancestor
5522599|NCT04306081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522600|NCT04306081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5522601|NCT04305587|Clopidogrel|clopidogrel|mesh-list
5522602|NCT04305587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6098946|NCT00928187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6464799|NCT00470912|Protective Agents|protective agents|mesh-ancestor
6464800|NCT00470912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464801|NCT00470912|Dermatologic Agents|dermatologic agents|mesh-ancestor
6464802|NCT00470977|Ranibizumab|ranibizumab|mesh-list
6464803|NCT00470977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6098947|NCT00928187|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6098948|NCT00928187|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6098949|NCT00928187|Antiviral Agents|antiviral agents|mesh-ancestor
6098950|NCT00928187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6098951|NCT00928187|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6098952|NCT00928187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6098953|NCT00928187|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6098954|NCT00928187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6098955|NCT00928187|Antimetabolites|antimetabolites|mesh-ancestor
6098956|NCT00928200|Cytarabine|cytarabine|mesh-list
6098957|NCT00928200|Dexamethasone|dexamethasone|mesh-list
6098958|NCT00928200|Dexamethasone acetate|dexamethasone acetate|mesh-list
6098959|NCT00928200|Doxorubicin|doxorubicin|mesh-list
6098960|NCT00928200|Methotrexate|methotrexate|mesh-list
6098961|NCT00928200|Vincristine|vincristine|mesh-list
6098962|NCT00928200|Asparaginase|asparaginase|mesh-list
6098963|NCT00928200|Dexrazoxane|dexrazoxane|mesh-list
6098964|NCT00928200|Razoxane|razoxane|mesh-list
6098965|NCT00928200|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
6098966|NCT00928200|BB 1101|bb 1101|mesh-list
6098967|NCT00928200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6098968|NCT00928200|Antiemetics|antiemetics|mesh-ancestor
6098969|NCT00928200|Autonomic Agents|autonomic agents|mesh-ancestor
6098970|NCT00928200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6098971|NCT00928200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6098972|NCT00928200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6098973|NCT00928200|Glucocorticoids|glucocorticoids|mesh-ancestor
5522603|NCT04305587|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6098974|NCT00928200|Hormones|hormones|mesh-ancestor
6098975|NCT00928200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6098976|NCT00928200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6098977|NCT00928200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6098978|NCT00928200|Protease Inhibitors|protease inhibitors|mesh-ancestor
6098979|NCT00928200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5522604|NCT04305587|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5522605|NCT04305587|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5522606|NCT04305587|Purinergic Agents|purinergic agents|mesh-ancestor
5522607|NCT04305587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5522608|NCT04305587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522609|NCT04305587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522610|NCT04305236|Fulvestrant|fulvestrant|mesh-list
5522611|NCT04305236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5522612|NCT04305236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5522613|NCT04305236|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5522614|NCT04305236|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5522615|NCT04305236|Hormone Antagonists|hormone antagonists|mesh-ancestor
5522616|NCT04305236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5522617|NCT04305236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522618|NCT04305444|Everolimus|everolimus|mesh-list
5522619|NCT04305444|Pomalidomide|pomalidomide|mesh-list
5522620|NCT04305444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5522621|NCT04305444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5522622|NCT04305444|Immunologic Factors|immunologic factors|mesh-ancestor
5522623|NCT04305444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522624|NCT04305444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6098980|NCT00928200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6098981|NCT00928200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6098982|NCT00928200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5522625|NCT04305444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5522626|NCT04305444|Growth Substances|growth substances|mesh-ancestor
5522627|NCT04305444|Growth Inhibitors|growth inhibitors|mesh-ancestor
5522628|NCT04305457|Nitric Oxide|nitric oxide|mesh-list
5522629|NCT04305457|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5522630|NCT04305457|Autonomic Agents|autonomic agents|mesh-ancestor
5522631|NCT04305457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5522632|NCT04305457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522633|NCT04305457|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6098983|NCT00928200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6098984|NCT00928200|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6098985|NCT00928200|Abortifacient Agents|abortifacient agents|mesh-ancestor
6098986|NCT00928200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6098987|NCT00928200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6098988|NCT00928200|Antimetabolites|antimetabolites|mesh-ancestor
6098989|NCT00928200|Dermatologic Agents|dermatologic agents|mesh-ancestor
5522634|NCT04305457|Respiratory System Agents|respiratory system agents|mesh-ancestor
5522635|NCT04305457|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5522636|NCT04305457|Antioxidants|antioxidants|mesh-ancestor
5522637|NCT04305457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522638|NCT04305457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5522639|NCT04305457|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5522640|NCT04305457|Vasodilator Agents|vasodilator agents|mesh-ancestor
5522641|NCT04305457|Gasotransmitters|gasotransmitters|mesh-ancestor
5522642|NCT04305457|Protective Agents|protective agents|mesh-ancestor
5522643|NCT04305158|Nitrous Oxide|nitrous oxide|mesh-list
5522644|NCT04305158|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5522645|NCT04305158|Anesthetics, General|anesthetics, general|mesh-ancestor
5522646|NCT04305158|Anesthetics|anesthetics|mesh-ancestor
5522647|NCT04305158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5522648|NCT04305158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522649|NCT04305158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5522650|NCT04305158|Analgesics|analgesics|mesh-ancestor
5522651|NCT04305158|Sensory System Agents|sensory system agents|mesh-ancestor
5522652|NCT04305158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5522653|NCT04305028|Aspirin|aspirin|mesh-list
5522654|NCT04305028|Rivaroxaban|rivaroxaban|mesh-list
5522655|NCT04305028|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6098990|NCT00928200|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6098991|NCT00928200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6098992|NCT00928200|Immunologic Factors|immunologic factors|mesh-ancestor
6098993|NCT00928200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6098994|NCT00928200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5522656|NCT04305028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5522657|NCT04305028|Analgesics|analgesics|mesh-ancestor
5522658|NCT04305028|Sensory System Agents|sensory system agents|mesh-ancestor
6098995|NCT00928200|Antiviral Agents|antiviral agents|mesh-ancestor
6098996|NCT00928200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6464804|NCT00470977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6464805|NCT00470977|Growth Substances|growth substances|mesh-ancestor
6464806|NCT00470977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464807|NCT00470977|Growth Inhibitors|growth inhibitors|mesh-ancestor
6464808|NCT00470977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6464809|NCT00470990|Acyline|acyline|mesh-list
6464810|NCT00470990|Hormone Antagonists|hormone antagonists|mesh-ancestor
6464811|NCT00470990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6464812|NCT00470990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522659|NCT04305028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5522660|NCT04305028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522661|NCT04305028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5522662|NCT04305028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5522663|NCT04305028|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5522664|NCT04305028|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5522665|NCT04305028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522666|NCT04305028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5522667|NCT04305028|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5522668|NCT04305028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5522669|NCT04305028|Antipyretics|antipyretics|mesh-ancestor
5522670|NCT04305028|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5522671|NCT04305028|Antithrombins|antithrombins|mesh-ancestor
6464813|NCT00471003|Telmisartan|telmisartan|mesh-list
6464814|NCT00471003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6464815|NCT00471003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6464816|NCT00471003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6464817|NCT00471003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6464818|NCT00471029|Esomeprazole|esomeprazole|mesh-list
6464819|NCT00471029|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6464820|NCT00471029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6464821|NCT00471029|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6464822|NCT00471029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6098997|NCT00928200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6098998|NCT00928200|Tubulin Modulators|tubulin modulators|mesh-ancestor
6098999|NCT00928200|Antimitotic Agents|antimitotic agents|mesh-ancestor
6099000|NCT00928200|Mitosis Modulators|mitosis modulators|mesh-ancestor
6099001|NCT00928200|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6099002|NCT00928200|Protective Agents|protective agents|mesh-ancestor
6099003|NCT00928252|Fluorides|fluorides|mesh-list
6099004|NCT00928252|Cariostatic Agents|cariostatic agents|mesh-ancestor
6099005|NCT00928252|Protective Agents|protective agents|mesh-ancestor
6099006|NCT00928252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099007|NCT00928408|Cinacalcet|cinacalcet|mesh-list
6099008|NCT00928408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6099009|NCT00928408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099010|NCT00928408|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6099011|NCT00928408|Hormone Antagonists|hormone antagonists|mesh-ancestor
6099012|NCT00928408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6099013|NCT00928421|Polidocanol|polidocanol|mesh-list
6099014|NCT00928421|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
5522672|NCT04305028|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5522673|NCT04305028|Protease Inhibitors|protease inhibitors|mesh-ancestor
5522674|NCT04305028|Anticoagulants|anticoagulants|mesh-ancestor
5522675|NCT04304807|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5522676|NCT04304807|Melatonin|melatonin|mesh-list
5522677|NCT04304807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5522678|NCT04304807|Antioxidants|antioxidants|mesh-ancestor
5522679|NCT04304807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522680|NCT04304807|Protective Agents|protective agents|mesh-ancestor
5522681|NCT04304807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099015|NCT00928421|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6099016|NCT00928434|Leuprolide|leuprolide|mesh-list
6099017|NCT00928434|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6099018|NCT00928434|Fertility Agents|fertility agents|mesh-ancestor
6099019|NCT00928434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6099020|NCT00928434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099021|NCT00928434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6099022|NCT00928434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6099023|NCT00928486|Dexamethasone|dexamethasone|mesh-list
6099024|NCT00928486|Lenalidomide|lenalidomide|mesh-list
6099025|NCT00928486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6099026|NCT00928486|Antiemetics|antiemetics|mesh-ancestor
6099027|NCT00928486|Autonomic Agents|autonomic agents|mesh-ancestor
6099028|NCT00928486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6099029|NCT00928486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464823|NCT00471029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6464824|NCT00471042|Buprenorphine|buprenorphine|mesh-list
6464825|NCT00471042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6099030|NCT00928486|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6099031|NCT00928486|Glucocorticoids|glucocorticoids|mesh-ancestor
6099032|NCT00928486|Hormones|hormones|mesh-ancestor
6099033|NCT00928486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6099034|NCT00928486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6099035|NCT00928486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6464826|NCT00471042|Narcotics|narcotics|mesh-ancestor
6464827|NCT00471042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6464828|NCT00471042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099036|NCT00928486|Immunologic Factors|immunologic factors|mesh-ancestor
5522682|NCT04304807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5522683|NCT04304794|Antithyroid Agents|antithyroid agents|mesh-list
5522684|NCT04304794|Hormone Antagonists|hormone antagonists|mesh-ancestor
5522685|NCT04304794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5522686|NCT04304794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099037|NCT00928486|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6099038|NCT00928486|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6099039|NCT00928486|Growth Substances|growth substances|mesh-ancestor
6099040|NCT00928486|Growth Inhibitors|growth inhibitors|mesh-ancestor
6099041|NCT00928564|Anesthetics|anesthetics|mesh-list
6099042|NCT00928564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6099043|NCT00928564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099044|NCT00928642|Gemcitabine|gemcitabine|mesh-list
6099045|NCT00928642|Imatinib Mesylate|imatinib mesylate|mesh-list
6099046|NCT00928642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6099047|NCT00928642|Antimetabolites|antimetabolites|mesh-ancestor
6099048|NCT00928642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099049|NCT00928642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6099050|NCT00928642|Antiviral Agents|antiviral agents|mesh-ancestor
6099051|NCT00928642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6099052|NCT00928642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6099053|NCT00928642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6099054|NCT00928642|Immunologic Factors|immunologic factors|mesh-ancestor
6099055|NCT00928642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099056|NCT00928642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6099057|NCT00928668|Olodaterol|olodaterol|mesh-list
6099058|NCT00928668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6099059|NCT00928668|Autonomic Agents|autonomic agents|mesh-ancestor
6099060|NCT00928668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6099061|NCT00928668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099062|NCT00928668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6099063|NCT00928668|Respiratory System Agents|respiratory system agents|mesh-ancestor
6099064|NCT00928694|Fenofibrate|fenofibrate|mesh-list
6099065|NCT00928694|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6099066|NCT00928694|Antimetabolites|antimetabolites|mesh-ancestor
6099067|NCT00928694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099068|NCT00928694|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6099069|NCT00928707|Hydroxyurea|hydroxyurea|mesh-list
6099070|NCT00928707|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
6099071|NCT00928707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6099072|NCT00928707|Antisickling Agents|antisickling agents|mesh-ancestor
6099073|NCT00928707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6099074|NCT00928707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099075|NCT00928707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6099076|NCT00928707|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6099077|NCT00928746|Bromides|bromides|mesh-list
6099078|NCT00928746|Ipratropium|ipratropium|mesh-list
6099079|NCT00928746|Anticonvulsants|anticonvulsants|mesh-ancestor
6099080|NCT00928746|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6099081|NCT00928746|Autonomic Agents|autonomic agents|mesh-ancestor
6099082|NCT00928746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6099083|NCT00928746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099084|NCT00928746|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6099085|NCT00928746|Respiratory System Agents|respiratory system agents|mesh-ancestor
6099086|NCT00928746|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6099087|NCT00928746|Cholinergic Agents|cholinergic agents|mesh-ancestor
6099088|NCT00928746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6099089|NCT00928746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099090|NCT00928772|Midazolam|midazolam|mesh-list
6099091|NCT00928772|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6099092|NCT00928772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6099093|NCT00928772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6099094|NCT00928772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099095|NCT00928772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6099096|NCT00928772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6099097|NCT00928772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6099098|NCT00928772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6099099|NCT00928772|Anesthetics, General|anesthetics, general|mesh-ancestor
6099100|NCT00928772|Anesthetics|anesthetics|mesh-ancestor
6099101|NCT00928772|GABA Modulators|gaba modulators|mesh-ancestor
6099102|NCT00928772|GABA Agents|gaba agents|mesh-ancestor
6099103|NCT00928772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6099104|NCT00928772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099105|NCT00928889|Acarbose|acarbose|mesh-list
6099106|NCT00928889|Nateglinide|nateglinide|mesh-list
6099107|NCT00928889|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6099108|NCT00928889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6099109|NCT00928889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099110|NCT00928889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6099111|NCT00928889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099112|NCT00928954|Gabapentin|gabapentin|mesh-list
6099113|NCT00928954|Memantine|memantine|mesh-list
6099114|NCT00928954|Analgesics|analgesics|mesh-ancestor
6099115|NCT00928954|Sensory System Agents|sensory system agents|mesh-ancestor
6099116|NCT00928954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6099117|NCT00928954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099118|NCT00928954|Anticonvulsants|anticonvulsants|mesh-ancestor
6099119|NCT00928954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6099120|NCT00928954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6099121|NCT00928954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6099122|NCT00928954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6099123|NCT00928954|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6099124|NCT00928954|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6099125|NCT00928954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6099126|NCT00928954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099127|NCT00928954|Antimanic Agents|antimanic agents|mesh-ancestor
6099128|NCT00928954|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6099129|NCT00928954|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6099130|NCT00928954|Dopamine Agents|dopamine agents|mesh-ancestor
6099131|NCT00929071|Lidocaine|lidocaine|mesh-list
6099132|NCT00929071|Anesthetics, Local|anesthetics, local|mesh-list
6099133|NCT00929071|Anesthetics|anesthetics|mesh-list
6099134|NCT00929071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6099135|NCT00929071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099136|NCT00929071|Sensory System Agents|sensory system agents|mesh-ancestor
6099137|NCT00929071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6099138|NCT00929071|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6099139|NCT00929071|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6099140|NCT00929071|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6099141|NCT00929071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6099142|NCT00929071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099143|NCT00929110|Glycopyrrolate|glycopyrrolate|mesh-list
6099144|NCT00929110|Bromides|bromides|mesh-list
6099145|NCT00929110|Tiotropium Bromide|tiotropium bromide|mesh-list
6099146|NCT00929110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6099147|NCT00929110|Autonomic Agents|autonomic agents|mesh-ancestor
6099148|NCT00929110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6099149|NCT00929110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099150|NCT00929110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6099151|NCT00929110|Respiratory System Agents|respiratory system agents|mesh-ancestor
6099152|NCT00929110|Parasympatholytics|parasympatholytics|mesh-ancestor
6099153|NCT00929110|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6099154|NCT00929110|Cholinergic Agents|cholinergic agents|mesh-ancestor
6099155|NCT00929110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6099156|NCT00929110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099157|NCT00929110|Anticonvulsants|anticonvulsants|mesh-ancestor
6099158|NCT00929110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6099159|NCT00929110|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6099160|NCT00929162|Paclitaxel|paclitaxel|mesh-list
6099161|NCT00929162|Carboplatin|carboplatin|mesh-list
6099162|NCT00929162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6099163|NCT00929162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6099164|NCT00929162|Tubulin Modulators|tubulin modulators|mesh-ancestor
6099165|NCT00929162|Antimitotic Agents|antimitotic agents|mesh-ancestor
5522687|NCT04305106|Bevacizumab|bevacizumab|mesh-list
5522688|NCT04305106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5522689|NCT04305106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5522690|NCT04305106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5522691|NCT04305106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5522692|NCT04305106|Growth Substances|growth substances|mesh-ancestor
5522693|NCT04305106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522694|NCT04305106|Growth Inhibitors|growth inhibitors|mesh-ancestor
5522695|NCT04305015|Analgesics, Opioid|analgesics, opioid|mesh-list
6099166|NCT00929162|Mitosis Modulators|mitosis modulators|mesh-ancestor
6099167|NCT00929162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099168|NCT00929201|Metformin|metformin|mesh-list
6099169|NCT00929201|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6099170|NCT00929201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6099171|NCT00929201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099172|NCT00929201|Incretins|incretins|mesh-ancestor
6099173|NCT00929201|Hormones|hormones|mesh-ancestor
6099174|NCT00929201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6099175|NCT00929201|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6099176|NCT00929201|Protease Inhibitors|protease inhibitors|mesh-ancestor
6099177|NCT00929201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6099178|NCT00929201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099179|NCT00929240|Bevacizumab|bevacizumab|mesh-list
6099180|NCT00929240|Capecitabine|capecitabine|mesh-list
6099181|NCT00929240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6099182|NCT00929240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6099183|NCT00929240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6099184|NCT00929240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6099185|NCT00929240|Growth Substances|growth substances|mesh-ancestor
6099186|NCT00929240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099187|NCT00929240|Growth Inhibitors|growth inhibitors|mesh-ancestor
6099188|NCT00929240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6099189|NCT00929240|Antimetabolites|antimetabolites|mesh-ancestor
6099190|NCT00929240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099191|NCT00929344|Pregabalin|pregabalin|mesh-list
6099192|NCT00929344|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6099193|NCT00929344|Analgesics|analgesics|mesh-ancestor
6099194|NCT00929344|Sensory System Agents|sensory system agents|mesh-ancestor
6099195|NCT00929344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6099196|NCT00929344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099197|NCT00929344|Anticonvulsants|anticonvulsants|mesh-ancestor
6099198|NCT00929344|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6099199|NCT00929344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5522696|NCT04305015|Narcotics|narcotics|mesh-ancestor
5522697|NCT04305015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5522698|NCT04305015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522699|NCT04305015|Analgesics|analgesics|mesh-ancestor
5522700|NCT04305015|Sensory System Agents|sensory system agents|mesh-ancestor
5522701|NCT04305015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5522702|NCT04304716|Anesthetics|anesthetics|mesh-list
6099200|NCT00929344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099201|NCT00929344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6464829|NCT00471042|Analgesics|analgesics|mesh-ancestor
6464830|NCT00471042|Sensory System Agents|sensory system agents|mesh-ancestor
6464831|NCT00471042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6464832|NCT00471042|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6464833|NCT00471055|Capsaicin|capsaicin|mesh-list
5522703|NCT04304716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6099202|NCT00929344|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6099203|NCT00929344|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6099204|NCT00929344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6099205|NCT00929344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6099206|NCT00929344|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6099207|NCT00929344|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6099208|NCT00929344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6099209|NCT00929344|Antidepressive Agents|antidepressive agents|mesh-ancestor
6099210|NCT00929344|Dopamine Agents|dopamine agents|mesh-ancestor
6464834|NCT00471055|Antipruritics|antipruritics|mesh-ancestor
5522704|NCT04304716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522705|NCT04305002|Exenatide|exenatide|mesh-list
5522706|NCT04305002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5522707|NCT04305002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522708|NCT04305002|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5522709|NCT04305002|Incretins|incretins|mesh-ancestor
5522710|NCT04305002|Hormones|hormones|mesh-ancestor
5522711|NCT04305002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5522712|NCT04304573|Calcium|calcium|mesh-list
5522713|NCT04304573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5522714|NCT04304573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522715|NCT04304560|Dapagliflozin|dapagliflozin|mesh-list
5522716|NCT04304560|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5522717|NCT04304560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522718|NCT04304560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5522719|NCT04304560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522720|NCT04304625|Tranexamic Acid|tranexamic acid|mesh-list
5522721|NCT04304625|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5522722|NCT04304625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5522723|NCT04304625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522724|NCT04304625|Hemostatics|hemostatics|mesh-ancestor
5522725|NCT04304625|Coagulants|coagulants|mesh-ancestor
5522726|NCT04304430|Dapagliflozin|dapagliflozin|mesh-list
5522727|NCT04304430|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
5522728|NCT04304430|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5522729|NCT04304430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099211|NCT00929383|Hemostatics|hemostatics|mesh-list
6099212|NCT00929383|Coagulants|coagulants|mesh-ancestor
6099213|NCT00929578|Fluphenazine|fluphenazine|mesh-list
6099214|NCT00929578|Fluphenazine depot|fluphenazine depot|mesh-list
6099215|NCT00929578|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
6099216|NCT00929578|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6099217|NCT00929578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6099218|NCT00929578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6099219|NCT00929578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099220|NCT00929578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6099221|NCT00929578|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6099222|NCT00929578|Dopamine Agents|dopamine agents|mesh-ancestor
6099223|NCT00929578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6099224|NCT00929578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099225|NCT00929669|Pasireotide|pasireotide|mesh-list
6099226|NCT00929669|Hormones|hormones|mesh-ancestor
6099227|NCT00929669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6099228|NCT00929669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099229|NCT00929695|Prednisone|prednisone|mesh-list
6099230|NCT00929695|Methylprednisolone|methylprednisolone|mesh-list
6099231|NCT00929695|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6099232|NCT00929695|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6099233|NCT00929695|Prednisolone|prednisolone|mesh-list
6099234|NCT00929695|Prednisolone acetate|prednisolone acetate|mesh-list
6099235|NCT00929695|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6099236|NCT00929695|Prednisolone phosphate|prednisolone phosphate|mesh-list
6099237|NCT00929695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6099238|NCT00929695|Glucocorticoids|glucocorticoids|mesh-ancestor
6099239|NCT00929695|Hormones|hormones|mesh-ancestor
6099240|NCT00929695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6099241|NCT00929695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099242|NCT00929695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6099243|NCT00929695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6099244|NCT00929695|Antiemetics|antiemetics|mesh-ancestor
6099245|NCT00929695|Autonomic Agents|autonomic agents|mesh-ancestor
6099246|NCT00929695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6099247|NCT00929695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6099248|NCT00929695|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6099249|NCT00929695|Protective Agents|protective agents|mesh-ancestor
6099250|NCT00929708|Formoterol Fumarate|formoterol fumarate|mesh-list
6099251|NCT00929708|AZD-3199|azd-3199|mesh-list
6099252|NCT00929708|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6099253|NCT00929708|Autonomic Agents|autonomic agents|mesh-ancestor
5522730|NCT04304430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5522731|NCT04304430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522732|NCT04304430|Protease Inhibitors|protease inhibitors|mesh-ancestor
5522733|NCT04304430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5522734|NCT04304209|Capecitabine|capecitabine|mesh-list
5522735|NCT04304209|Oxaliplatin|oxaliplatin|mesh-list
5522736|NCT04304209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5522737|NCT04304209|Antimetabolites|antimetabolites|mesh-ancestor
5522738|NCT04304209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522739|NCT04304209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5522740|NCT04304157|Dexmedetomidine|dexmedetomidine|mesh-list
6099254|NCT00929708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6099255|NCT00929708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099256|NCT00929708|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6099257|NCT00929708|Respiratory System Agents|respiratory system agents|mesh-ancestor
6099258|NCT00929708|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6099259|NCT00929708|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5522741|NCT04304157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5522742|NCT04304157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5522743|NCT04304157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522744|NCT04304157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5522745|NCT04304157|Analgesics|analgesics|mesh-ancestor
5522746|NCT04304157|Sensory System Agents|sensory system agents|mesh-ancestor
5522747|NCT04304157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5522748|NCT04304157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5522749|NCT04304157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5522750|NCT04304157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5522751|NCT04304157|Adrenergic Agents|adrenergic agents|mesh-ancestor
5522752|NCT04304157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5522753|NCT04304157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522754|NCT04304352|Cyclophosphamide|cyclophosphamide|mesh-list
5522755|NCT04304352|Capecitabine|capecitabine|mesh-list
5522756|NCT04304352|Vinorelbine|vinorelbine|mesh-list
5522757|NCT04304352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5522758|NCT04304352|Immunologic Factors|immunologic factors|mesh-ancestor
5522759|NCT04304352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522760|NCT04304352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5522761|NCT04304352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5522762|NCT04304352|Alkylating Agents|alkylating agents|mesh-ancestor
5522763|NCT04304352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522764|NCT04304352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5522765|NCT04304352|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6099260|NCT00929708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6099261|NCT00929708|Adrenergic Agents|adrenergic agents|mesh-ancestor
6099262|NCT00929708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6099263|NCT00929708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099264|NCT00929734|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6099265|NCT00929734|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
6099266|NCT00929734|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6099267|NCT00929734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6099268|NCT00929734|Antimetabolites|antimetabolites|mesh-ancestor
6099269|NCT00929734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099270|NCT00929734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6099271|NCT00929734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6099272|NCT00929864|Adalimumab|adalimumab|mesh-list
6099273|NCT00929864|Abatacept|abatacept|mesh-list
6099274|NCT00929864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6099275|NCT00929864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6099276|NCT00929864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6099277|NCT00929864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099278|NCT00929864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6099279|NCT00929864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6099280|NCT00929864|Immunologic Factors|immunologic factors|mesh-ancestor
6099281|NCT00929864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203750|NCT02060383|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6203751|NCT02060383|Protease Inhibitors|protease inhibitors|mesh-ancestor
6203752|NCT02060383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6203753|NCT02060383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203754|NCT02061202|Mometasone Furoate|mometasone furoate|mesh-list
6203755|NCT02061202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6203756|NCT02061202|Dermatologic Agents|dermatologic agents|mesh-ancestor
6203757|NCT02061202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6203758|NCT02061280|Fluticasone|fluticasone|mesh-list
6203759|NCT02061280|Xhance|xhance|mesh-list
6203760|NCT02061280|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6203761|NCT02061280|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6203762|NCT02061280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6203763|NCT02061280|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6203764|NCT02061280|Autonomic Agents|autonomic agents|mesh-ancestor
6203765|NCT02061280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6203766|NCT02061280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203767|NCT02061280|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6203768|NCT02061280|Respiratory System Agents|respiratory system agents|mesh-ancestor
5522766|NCT04304352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5522767|NCT04304352|Antimetabolites|antimetabolites|mesh-ancestor
5522768|NCT04304352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5522769|NCT04304352|Tubulin Modulators|tubulin modulators|mesh-ancestor
5522770|NCT04304352|Antimitotic Agents|antimitotic agents|mesh-ancestor
5522771|NCT04304352|Mitosis Modulators|mitosis modulators|mesh-ancestor
5522772|NCT04304261|Metformin|metformin|mesh-list
5522773|NCT04304261|Dapagliflozin|dapagliflozin|mesh-list
5522774|NCT04304261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5522775|NCT04304261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522776|NCT04304261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5522777|NCT04304261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522778|NCT04304248|Paclitaxel|paclitaxel|mesh-list
5522779|NCT04304248|Carboplatin|carboplatin|mesh-list
5522780|NCT04304248|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5522781|NCT04304248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6099282|NCT00929981|Methylprednisolone|methylprednisolone|mesh-list
6099283|NCT00929981|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6099284|NCT00929981|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6099285|NCT00929981|Prednisolone|prednisolone|mesh-list
6099286|NCT00929981|Prednisolone acetate|prednisolone acetate|mesh-list
6099287|NCT00929981|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6099288|NCT00929981|Prednisolone phosphate|prednisolone phosphate|mesh-list
6099289|NCT00929981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6099290|NCT00929981|Antiemetics|antiemetics|mesh-ancestor
6099291|NCT00929981|Autonomic Agents|autonomic agents|mesh-ancestor
6099292|NCT00929981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6099293|NCT00929981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099294|NCT00929981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6099295|NCT00929981|Glucocorticoids|glucocorticoids|mesh-ancestor
6099296|NCT00929981|Hormones|hormones|mesh-ancestor
6099297|NCT00929981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6099298|NCT00929981|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6099299|NCT00929981|Protective Agents|protective agents|mesh-ancestor
6099300|NCT00929981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6099301|NCT00929981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6099302|NCT00930046|Ropivacaine|ropivacaine|mesh-list
6099303|NCT00930046|Anesthetics, Local|anesthetics, local|mesh-ancestor
6099304|NCT00930046|Anesthetics|anesthetics|mesh-ancestor
6099305|NCT00930046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6099306|NCT00930046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099307|NCT00930046|Sensory System Agents|sensory system agents|mesh-ancestor
6099308|NCT00930046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6099309|NCT00930293|Dexetimide|dexetimide|mesh-list
6099310|NCT00930293|Citalopram|citalopram|mesh-list
6099311|NCT00930293|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6099312|NCT00930293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6099313|NCT00930293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6099314|NCT00930293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099315|NCT00930293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6099316|NCT00930293|Serotonin Agents|serotonin agents|mesh-ancestor
6099317|NCT00930293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099318|NCT00930293|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6099319|NCT00930293|Antidepressive Agents|antidepressive agents|mesh-ancestor
6099320|NCT00930293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6099321|NCT00930293|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6099322|NCT00930293|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6099323|NCT00930293|Parasympatholytics|parasympatholytics|mesh-ancestor
6099324|NCT00930293|Autonomic Agents|autonomic agents|mesh-ancestor
6099325|NCT00930293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6099326|NCT00930293|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6099327|NCT00930293|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6099328|NCT00930293|Cholinergic Agents|cholinergic agents|mesh-ancestor
6099329|NCT00930553|Alemtuzumab|alemtuzumab|mesh-list
6099330|NCT00930553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6099331|NCT00930553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6099332|NCT00930644|Teduglutide|teduglutide|mesh-list
6099333|NCT00930644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6099334|NCT00930644|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6099335|NCT00930644|Protective Agents|protective agents|mesh-ancestor
6099336|NCT00930644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099337|NCT00930930|Paclitaxel|paclitaxel|mesh-list
6099338|NCT00930930|Everolimus|everolimus|mesh-list
6099339|NCT00930930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6099340|NCT00930930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5522782|NCT04304248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6099341|NCT00930930|Tubulin Modulators|tubulin modulators|mesh-ancestor
6099342|NCT00930930|Antimitotic Agents|antimitotic agents|mesh-ancestor
6099343|NCT00930930|Mitosis Modulators|mitosis modulators|mesh-ancestor
6099344|NCT00930930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099345|NCT00930930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6099346|NCT00930930|Immunologic Factors|immunologic factors|mesh-ancestor
6099347|NCT00930930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464835|NCT00471055|Dermatologic Agents|dermatologic agents|mesh-ancestor
6464836|NCT00471055|Sensory System Agents|sensory system agents|mesh-ancestor
6464837|NCT00471055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6464838|NCT00471055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464839|NCT00471094|Lansoprazole|lansoprazole|mesh-list
6464840|NCT00471094|Dexlansoprazole|dexlansoprazole|mesh-list
6464841|NCT00471094|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6464842|NCT00471094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6464843|NCT00471094|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6464844|NCT00471094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6464845|NCT00471094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6464846|NCT00471159|Docetaxel|docetaxel|mesh-list
6464847|NCT00471159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6464848|NCT00471159|Tubulin Modulators|tubulin modulators|mesh-ancestor
6464849|NCT00471159|Antimitotic Agents|antimitotic agents|mesh-ancestor
6464850|NCT00471159|Mitosis Modulators|mitosis modulators|mesh-ancestor
6099348|NCT00930982|Ciprofloxacin|ciprofloxacin|mesh-list
6099349|NCT00930982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6099350|NCT00930982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6099351|NCT00930982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6099352|NCT00930982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6099353|NCT00930982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6099354|NCT00930982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099355|NCT00930982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6099356|NCT00930982|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6099357|NCT00930982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6099358|NCT00931164|Sodium Oxybate|sodium oxybate|mesh-list
6099359|NCT00931164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6099360|NCT00931164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6099361|NCT00931164|Anesthetics, General|anesthetics, general|mesh-ancestor
6099362|NCT00931164|Anesthetics|anesthetics|mesh-ancestor
6099363|NCT00931164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6099364|NCT00931164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099365|NCT00931242|Thalidomide|thalidomide|mesh-list
6099366|NCT00931242|Apremilast|apremilast|mesh-list
6099367|NCT00931242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6099368|NCT00931242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6099369|NCT00931242|Analgesics|analgesics|mesh-ancestor
6099370|NCT00931242|Sensory System Agents|sensory system agents|mesh-ancestor
6099371|NCT00931242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6099372|NCT00931242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099373|NCT00931242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6099374|NCT00931242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5522783|NCT04304248|Tubulin Modulators|tubulin modulators|mesh-ancestor
5522784|NCT04304248|Antimitotic Agents|antimitotic agents|mesh-ancestor
5522785|NCT04304248|Mitosis Modulators|mitosis modulators|mesh-ancestor
5522786|NCT04304248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099375|NCT00931242|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6099376|NCT00931242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6099377|NCT00931242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6099378|NCT00931242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099379|NCT00931242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6099380|NCT00931242|Immunologic Factors|immunologic factors|mesh-ancestor
6099381|NCT00931242|Leprostatic Agents|leprostatic agents|mesh-ancestor
6099382|NCT00931242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6099383|NCT00931242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6099384|NCT00931242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6099385|NCT00931242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6099386|NCT00931242|Growth Substances|growth substances|mesh-ancestor
5522787|NCT04304313|Sildenafil Citrate|sildenafil citrate|mesh-list
5522788|NCT04304313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522789|NCT04304313|Vasodilator Agents|vasodilator agents|mesh-ancestor
5522790|NCT04304313|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5522791|NCT04304313|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5522792|NCT04304313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5522793|NCT04304313|Urological Agents|urological agents|mesh-ancestor
5522794|NCT04304196|TEMPO|tempo|mesh-list
5522795|NCT04304196|Antioxidants|antioxidants|mesh-ancestor
6099387|NCT00931242|Growth Inhibitors|growth inhibitors|mesh-ancestor
6099388|NCT00931242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6099389|NCT00931255|Sirolimus|sirolimus|mesh-list
6099390|NCT00931255|Tacrolimus|tacrolimus|mesh-list
6099391|NCT00931255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6099392|NCT00931255|Immunologic Factors|immunologic factors|mesh-ancestor
6099393|NCT00931255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099394|NCT00931255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6099395|NCT00931255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6099396|NCT00931255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099397|NCT00931255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6099398|NCT00931255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6099399|NCT00931255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6099400|NCT00931255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6099401|NCT00931255|Antifungal Agents|antifungal agents|mesh-ancestor
6099402|NCT00931385|Formoterol Fumarate|formoterol fumarate|mesh-list
6099403|NCT00931385|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6099404|NCT00931385|Autonomic Agents|autonomic agents|mesh-ancestor
6099405|NCT00931385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6099406|NCT00931385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099407|NCT00931385|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6099408|NCT00931385|Respiratory System Agents|respiratory system agents|mesh-ancestor
6099409|NCT00931385|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6099410|NCT00931385|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6099411|NCT00931385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6099412|NCT00931385|Adrenergic Agents|adrenergic agents|mesh-ancestor
6099413|NCT00931385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6099414|NCT00931385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099415|NCT00931463|Ritonavir|ritonavir|mesh-list
6099416|NCT00931463|Lopinavir|lopinavir|mesh-list
6099417|NCT00931463|Raltegravir Potassium|raltegravir potassium|mesh-list
6099418|NCT00931463|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6099419|NCT00931463|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6099420|NCT00931463|Protease Inhibitors|protease inhibitors|mesh-ancestor
6099421|NCT00931463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6099422|NCT00931463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099423|NCT00931463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5522796|NCT04304196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522797|NCT04304196|Protective Agents|protective agents|mesh-ancestor
5522798|NCT04304196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601062|NCT03707951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601063|NCT03707951|Protective Agents|protective agents|mesh-ancestor
5601064|NCT03707951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601065|NCT03707951|Antidotes|antidotes|mesh-ancestor
5601066|NCT03707899|Amlodipine|amlodipine|mesh-list
5601067|NCT03707899|Telmisartan|telmisartan|mesh-list
5601068|NCT03707899|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
5601069|NCT03707899|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5601070|NCT03707899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5601071|NCT03707899|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5601072|NCT03707899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5601073|NCT03707899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601074|NCT03707899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5601075|NCT03707899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601076|NCT03707899|Vasodilator Agents|vasodilator agents|mesh-ancestor
5601077|NCT03707899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5601078|NCT03707899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5601079|NCT03707899|Antimetabolites|antimetabolites|mesh-ancestor
5601080|NCT03707899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5601081|NCT03707899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5601082|NCT03707899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5601083|NCT03707899|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5601084|NCT03707899|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5601085|NCT03707847|Etoposide|etoposide|mesh-list
5601086|NCT03707847|Crizotinib|crizotinib|mesh-list
6099424|NCT00931463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6099425|NCT00931463|Antiviral Agents|antiviral agents|mesh-ancestor
6099426|NCT00931463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6099427|NCT00931463|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6099428|NCT00931463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6099429|NCT00931463|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6099430|NCT00931463|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6099431|NCT00931489|Ranibizumab|ranibizumab|mesh-list
6099432|NCT00931489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6099433|NCT00931489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6099434|NCT00931489|Growth Substances|growth substances|mesh-ancestor
6099435|NCT00931489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099436|NCT00931489|Growth Inhibitors|growth inhibitors|mesh-ancestor
6099437|NCT00931489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6099438|NCT00931528|Tadalafil|tadalafil|mesh-list
6099439|NCT00931528|Vasodilator Agents|vasodilator agents|mesh-ancestor
6099440|NCT00931528|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6099441|NCT00931528|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6099442|NCT00931528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5522799|NCT04303741|Apatinib|apatinib|mesh-list
5522800|NCT04303741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5522801|NCT04303741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5522802|NCT04303741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5522803|NCT04303741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522804|NCT04303806|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5522805|NCT04303806|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5522806|NCT04303806|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5522807|NCT04303806|Antimetabolites|antimetabolites|mesh-ancestor
5522808|NCT04303806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522809|NCT04303806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5522810|NCT04303806|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6099443|NCT00931528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099444|NCT00931528|Urological Agents|urological agents|mesh-ancestor
6099445|NCT00931632|Nitric Oxide|nitric oxide|mesh-list
6099446|NCT00931632|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6099447|NCT00931632|Autonomic Agents|autonomic agents|mesh-ancestor
6099448|NCT00931632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5522811|NCT04303806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5522812|NCT04304040|Antibodies|antibodies|mesh-list
5522813|NCT04304040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5522814|NCT04304040|Immunologic Factors|immunologic factors|mesh-ancestor
5522815|NCT04304040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522816|NCT04303884|Pembrolizumab|pembrolizumab|mesh-list
5522817|NCT04303884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5522818|NCT04303884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5522819|NCT04303845|Erenumab|erenumab|mesh-list
5522820|NCT04303845|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
5522821|NCT04303845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522822|NCT04303845|Analgesics|analgesics|mesh-ancestor
5522823|NCT04303845|Sensory System Agents|sensory system agents|mesh-ancestor
5522824|NCT04303845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5522825|NCT04303845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099449|NCT00931632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099450|NCT00931632|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6099451|NCT00931632|Respiratory System Agents|respiratory system agents|mesh-ancestor
6099452|NCT00931632|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6099453|NCT00931632|Antioxidants|antioxidants|mesh-ancestor
6099454|NCT00931632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099455|NCT00931632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6099456|NCT00931632|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6099457|NCT00931632|Vasodilator Agents|vasodilator agents|mesh-ancestor
6099458|NCT00931632|Gasotransmitters|gasotransmitters|mesh-ancestor
6099459|NCT00931632|Protective Agents|protective agents|mesh-ancestor
6099460|NCT00931710|Losartan|losartan|mesh-list
6099461|NCT00931710|Amlodipine|amlodipine|mesh-list
6099462|NCT00931710|Valsartan|valsartan|mesh-list
6099463|NCT00931710|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6099464|NCT00931710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6099465|NCT00931710|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6099466|NCT00931710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6099467|NCT00931710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099468|NCT00931710|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6099469|NCT00931710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099470|NCT00931710|Vasodilator Agents|vasodilator agents|mesh-ancestor
6099471|NCT00931710|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6099472|NCT00931710|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6099473|NCT00931710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6099474|NCT00931710|Diuretics|diuretics|mesh-ancestor
6099475|NCT00931710|Natriuretic Agents|natriuretic agents|mesh-ancestor
6099476|NCT00931710|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6099477|NCT00931723|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6099478|NCT00931723|Antidepressive Agents|antidepressive agents|mesh-ancestor
6099479|NCT00931723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6099480|NCT00931723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6099481|NCT00931723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6099482|NCT00931723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6099483|NCT00931723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099484|NCT00931762|Panobinostat|panobinostat|mesh-list
6099485|NCT00931762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6099486|NCT00931762|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6099487|NCT00931762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6099488|NCT00931762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099489|NCT00931801|Tenofovir|tenofovir|mesh-list
6099490|NCT00931801|Emtricitabine|emtricitabine|mesh-list
6099491|NCT00931801|Raltegravir Potassium|raltegravir potassium|mesh-list
6099492|NCT00931801|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6099493|NCT00931801|Antiviral Agents|antiviral agents|mesh-ancestor
6099494|NCT00931801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6099495|NCT00931801|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6099496|NCT00931801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6099497|NCT00931801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6099498|NCT00931801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099499|NCT00931801|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6099500|NCT00931801|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6099501|NCT00931801|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6099502|NCT00931801|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6099503|NCT00931801|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6099504|NCT00931801|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6099505|NCT00931801|Protease Inhibitors|protease inhibitors|mesh-ancestor
6099506|NCT00931918|Prednisone|prednisone|mesh-list
5522826|NCT04303988|Bevacizumab|bevacizumab|mesh-list
5522827|NCT04303988|Carboplatin|carboplatin|mesh-list
5522828|NCT04303988|Temozolomide|temozolomide|mesh-list
5522829|NCT04303988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5522830|NCT04303988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5522831|NCT04303988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6099507|NCT00931918|Cyclophosphamide|cyclophosphamide|mesh-list
6099508|NCT00931918|Rituximab|rituximab|mesh-list
6099509|NCT00931918|Doxorubicin|doxorubicin|mesh-list
6099510|NCT00931918|Vincristine|vincristine|mesh-list
6099511|NCT00931918|Bortezomib|bortezomib|mesh-list
6099512|NCT00931918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6099513|NCT00931918|Immunologic Factors|immunologic factors|mesh-ancestor
6099514|NCT00931918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099515|NCT00931918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6099516|NCT00931918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6099517|NCT00931918|Alkylating Agents|alkylating agents|mesh-ancestor
6099518|NCT00931918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099519|NCT00931918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6099520|NCT00931918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6099521|NCT00931918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6099522|NCT00931918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5522832|NCT04303988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5522833|NCT04303988|Growth Substances|growth substances|mesh-ancestor
6099523|NCT00931918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6099524|NCT00931918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6099525|NCT00931918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6099526|NCT00931918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6099527|NCT00931918|Glucocorticoids|glucocorticoids|mesh-ancestor
6099528|NCT00931918|Hormones|hormones|mesh-ancestor
6099529|NCT00931918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6099530|NCT00931918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5522834|NCT04303988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522835|NCT04303988|Growth Inhibitors|growth inhibitors|mesh-ancestor
5522836|NCT04303988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5522837|NCT04303988|Alkylating Agents|alkylating agents|mesh-ancestor
6099531|NCT00931918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5522838|NCT04303988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522839|NCT04303819|Exenatide|exenatide|mesh-list
5522840|NCT04303819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5522841|NCT04303819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522842|NCT04303819|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5522843|NCT04303819|Incretins|incretins|mesh-ancestor
5522844|NCT04303819|Hormones|hormones|mesh-ancestor
5522845|NCT04303819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5522846|NCT04303767|Calcium|calcium|mesh-list
5522847|NCT04303767|Caseins|caseins|mesh-list
5522848|NCT04303767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5522849|NCT04303767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099532|NCT00931918|Tubulin Modulators|tubulin modulators|mesh-ancestor
6099533|NCT00931918|Antimitotic Agents|antimitotic agents|mesh-ancestor
6099534|NCT00931918|Mitosis Modulators|mitosis modulators|mesh-ancestor
6099535|NCT00931944|Pramipexole|pramipexole|mesh-list
6099536|NCT00931944|Antioxidants|antioxidants|mesh-ancestor
6099537|NCT00931944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099538|NCT00931944|Protective Agents|protective agents|mesh-ancestor
6099539|NCT00931944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099540|NCT00931944|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6099541|NCT00931944|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6099542|NCT00931944|Dopamine Agonists|dopamine agonists|mesh-ancestor
6099543|NCT00931944|Dopamine Agents|dopamine agents|mesh-ancestor
6099544|NCT00931944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6099545|NCT00931996|Antipsychotic Agents|antipsychotic agents|mesh-list
5522850|NCT04303767|Chelating Agents|chelating agents|mesh-ancestor
5522851|NCT04303767|Sequestering Agents|sequestering agents|mesh-ancestor
5522852|NCT04303767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522853|NCT04304014|Sulfalene|sulfalene|mesh-list
5522854|NCT04304014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6099546|NCT00931996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6099547|NCT00931996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6099548|NCT00931996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099549|NCT00931996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6099550|NCT00932022|Trospium chloride|trospium chloride|mesh-list
6099551|NCT00932022|Parasympatholytics|parasympatholytics|mesh-ancestor
5522855|NCT04304014|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5522856|NCT04304014|Renal Agents|renal agents|mesh-ancestor
5522857|NCT04304014|Antimalarials|antimalarials|mesh-ancestor
5522858|NCT04304014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5522859|NCT04304014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5522860|NCT04303520|Cyclophosphamide|cyclophosphamide|mesh-list
5522861|NCT04303520|Fludarabine|fludarabine|mesh-list
5522862|NCT04303520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6099552|NCT00932022|Autonomic Agents|autonomic agents|mesh-ancestor
6099553|NCT00932022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6099554|NCT00932022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099555|NCT00932022|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6099556|NCT00932022|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6099557|NCT00932022|Cholinergic Agents|cholinergic agents|mesh-ancestor
6099558|NCT00932022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6099559|NCT00932022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099560|NCT00932022|Urological Agents|urological agents|mesh-ancestor
6099561|NCT00932113|Folic Acid|folic acid|mesh-list
6099562|NCT00932113|Adalimumab|adalimumab|mesh-list
6464851|NCT00471159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522863|NCT04303520|Immunologic Factors|immunologic factors|mesh-ancestor
5522864|NCT04303520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522865|NCT04303520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5522866|NCT04303520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5522867|NCT04303520|Alkylating Agents|alkylating agents|mesh-ancestor
5522868|NCT04303520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522869|NCT04303520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5522870|NCT04303520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5522871|NCT04303390|Cefazolin|cefazolin|mesh-list
5522872|NCT04303390|Cefuroxime|cefuroxime|mesh-list
5522873|NCT04303390|Cefuroxime axetil|cefuroxime axetil|mesh-list
5522874|NCT04303390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5522875|NCT04303390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5522876|NCT04303377|Evolocumab|evolocumab|mesh-list
5522877|NCT04303377|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5522878|NCT04303377|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5522879|NCT04303377|Antimetabolites|antimetabolites|mesh-ancestor
5522880|NCT04303377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099563|NCT00932113|Methotrexate|methotrexate|mesh-list
6099564|NCT00932113|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6099565|NCT00932113|Abortifacient Agents|abortifacient agents|mesh-ancestor
6464852|NCT00471185|Acyline|acyline|mesh-list
6464853|NCT00471185|Hormone Antagonists|hormone antagonists|mesh-ancestor
6464854|NCT00471185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6464855|NCT00471185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464856|NCT00471289|Paclitaxel|paclitaxel|mesh-list
6464857|NCT00471289|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6464858|NCT00471289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6464859|NCT00471289|Tubulin Modulators|tubulin modulators|mesh-ancestor
6464860|NCT00471289|Antimitotic Agents|antimitotic agents|mesh-ancestor
6464861|NCT00471289|Mitosis Modulators|mitosis modulators|mesh-ancestor
6464862|NCT00471289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488419|NCT00584090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522881|NCT04303377|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5522882|NCT04303312|Benzydamine|benzydamine|mesh-list
5522883|NCT04303312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5522884|NCT04303494|Vaccines|vaccines|mesh-list
6099566|NCT00932113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6099567|NCT00932113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099568|NCT00932113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6099569|NCT00932113|Antimetabolites|antimetabolites|mesh-ancestor
6099570|NCT00932113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099571|NCT00932113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6099572|NCT00932113|Dermatologic Agents|dermatologic agents|mesh-ancestor
5522885|NCT04303494|Immunologic Factors|immunologic factors|mesh-ancestor
5522886|NCT04303494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522887|NCT04303403|Trametinib|trametinib|mesh-list
5522888|NCT04303403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6099573|NCT00932113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6099574|NCT00932113|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6099575|NCT00932113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6099576|NCT00932113|Immunologic Factors|immunologic factors|mesh-ancestor
6099577|NCT00932113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6099578|NCT00932113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6099579|NCT00932113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6099580|NCT00932113|Hematinics|hematinics|mesh-ancestor
6099581|NCT00932113|Vitamin B Complex|vitamin b complex|mesh-ancestor
6099582|NCT00932113|Vitamins|vitamins|mesh-ancestor
6099583|NCT00932113|Micronutrients|micronutrients|mesh-ancestor
6099584|NCT00932165|Exemestane|exemestane|mesh-list
6099585|NCT00932165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6099586|NCT00932165|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6099587|NCT00932165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6099588|NCT00932165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6099589|NCT00932165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099590|NCT00932165|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6099591|NCT00932165|Hormone Antagonists|hormone antagonists|mesh-ancestor
6099592|NCT00932165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6099593|NCT00932165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099594|NCT00932282|Omalizumab|omalizumab|mesh-list
6099595|NCT00932282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6099596|NCT00932282|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6099597|NCT00932282|Respiratory System Agents|respiratory system agents|mesh-ancestor
6099598|NCT00932321|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6099599|NCT00932321|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6099600|NCT00932321|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6099601|NCT00932321|Norethindrone|norethindrone|mesh-list
6099602|NCT00932321|Norethindrone Acetate|norethindrone acetate|mesh-list
6099603|NCT00932321|Estradiol|estradiol|mesh-list
6099604|NCT00932321|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6099605|NCT00932321|Estrogens|estrogens|mesh-ancestor
6099606|NCT00932321|Hormones|hormones|mesh-ancestor
6099607|NCT00932321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6099608|NCT00932321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099609|NCT00932321|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6099610|NCT00932321|Contraceptive Agents|contraceptive agents|mesh-ancestor
5522889|NCT04303403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5522890|NCT04303403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5601087|NCT03707847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6099611|NCT00932321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6099612|NCT00932321|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6099613|NCT00932321|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6099614|NCT00932321|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6099615|NCT00932321|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6099616|NCT00932373|Trastuzumab|trastuzumab|mesh-list
6099617|NCT00932373|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
6099618|NCT00932373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6099619|NCT00932373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6099620|NCT00932373|Tubulin Modulators|tubulin modulators|mesh-ancestor
6099621|NCT00932373|Antimitotic Agents|antimitotic agents|mesh-ancestor
6099622|NCT00932373|Mitosis Modulators|mitosis modulators|mesh-ancestor
6099623|NCT00932373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099624|NCT00932438|Leucovorin|leucovorin|mesh-list
6099625|NCT00932438|Bevacizumab|bevacizumab|mesh-list
6099626|NCT00932438|Fluorouracil|fluorouracil|mesh-list
6099627|NCT00932438|Oxaliplatin|oxaliplatin|mesh-list
6099628|NCT00932438|Irinotecan|irinotecan|mesh-list
6099629|NCT00932438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6099630|NCT00932438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6099631|NCT00932438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6099632|NCT00932438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6099633|NCT00932438|Growth Substances|growth substances|mesh-ancestor
6099634|NCT00932438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099635|NCT00932438|Growth Inhibitors|growth inhibitors|mesh-ancestor
6099636|NCT00932438|Antimetabolites|antimetabolites|mesh-ancestor
6099637|NCT00932438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099638|NCT00932438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6099639|NCT00932438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6099640|NCT00932438|Immunologic Factors|immunologic factors|mesh-ancestor
6099641|NCT00932438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6099642|NCT00932438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6099643|NCT00932438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6099644|NCT00932438|Antidotes|antidotes|mesh-ancestor
6099645|NCT00932438|Protective Agents|protective agents|mesh-ancestor
6099646|NCT00932438|Vitamin B Complex|vitamin b complex|mesh-ancestor
6099647|NCT00932438|Vitamins|vitamins|mesh-ancestor
6099648|NCT00932438|Micronutrients|micronutrients|mesh-ancestor
6099649|NCT00932451|Crizotinib|crizotinib|mesh-list
5522891|NCT04303403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522892|NCT04303429|Capecitabine|capecitabine|mesh-list
6099650|NCT00932451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6099651|NCT00932451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6099652|NCT00932451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6099653|NCT00932451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099654|NCT00932477|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6099655|NCT00932477|Lubricant Eye Drops|lubricant eye drops|mesh-list
6099656|NCT00932477|Glycerol|glycerol|mesh-list
6099657|NCT00932477|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6665795|NCT01518855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099658|NCT00932477|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6099659|NCT00932477|Laxatives|laxatives|mesh-ancestor
6099660|NCT00932477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6099661|NCT00932477|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6099662|NCT00932477|Protective Agents|protective agents|mesh-ancestor
6099663|NCT00932477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099664|NCT00932620|Simvastatin|simvastatin|mesh-list
6099665|NCT00932620|Ezetimibe|ezetimibe|mesh-list
6099666|NCT00932620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6099667|NCT00932620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6099668|NCT00932620|Antimetabolites|antimetabolites|mesh-ancestor
6099669|NCT00932620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099670|NCT00932620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6099671|NCT00932620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6099672|NCT00932620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6099673|NCT00932646|Olodaterol|olodaterol|mesh-list
5522893|NCT04303429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5522894|NCT04303429|Antimetabolites|antimetabolites|mesh-ancestor
5522895|NCT04303429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522896|NCT04303429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5522897|NCT04303598|Tenofovir|tenofovir|mesh-list
5522898|NCT04303598|Lamivudine|lamivudine|mesh-list
5522899|NCT04303598|Efavirenz|efavirenz|mesh-list
5522900|NCT04303598|Antiviral Agents|antiviral agents|mesh-ancestor
5522901|NCT04303598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5522902|NCT04303598|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5522903|NCT04303598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5522904|NCT04303598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5522905|NCT04303598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099674|NCT00932646|Formoterol Fumarate|formoterol fumarate|mesh-list
6099675|NCT00932646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6099676|NCT00932646|Autonomic Agents|autonomic agents|mesh-ancestor
6099677|NCT00932646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6099678|NCT00932646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099679|NCT00932646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6099680|NCT00932646|Respiratory System Agents|respiratory system agents|mesh-ancestor
6099681|NCT00932646|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6099682|NCT00932646|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6099683|NCT00932646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5522906|NCT04303598|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5522907|NCT04303598|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5522908|NCT04303598|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5522909|NCT04303598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5522910|NCT04303598|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5522911|NCT04303598|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5522912|NCT04303598|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5522913|NCT04303598|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5522914|NCT04302870|Memantine|memantine|mesh-list
5522915|NCT04302870|Trazodone|trazodone|mesh-list
5522916|NCT04302870|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5522917|NCT04302870|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5522918|NCT04302870|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5522919|NCT04302870|Dopamine Agents|dopamine agents|mesh-ancestor
5522920|NCT04302870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5522921|NCT04302870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522922|NCT04302870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522923|NCT04302870|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5522924|NCT04302870|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5522925|NCT04302870|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5522926|NCT04302870|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5522927|NCT04302870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5522928|NCT04302870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5522929|NCT04302870|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5522930|NCT04302870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5522931|NCT04302870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5522932|NCT04302870|Serotonin Agents|serotonin agents|mesh-ancestor
5522933|NCT04302870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5522934|NCT04302870|Antidepressive Agents|antidepressive agents|mesh-ancestor
5522935|NCT04303026|Zoledronic Acid|zoledronic acid|mesh-list
5522936|NCT04303026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5522937|NCT04303026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522938|NCT04303130|Endostar protein|endostar protein|mesh-list
5522939|NCT04303130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5522940|NCT04303130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5522941|NCT04303130|Growth Substances|growth substances|mesh-ancestor
5522942|NCT04303130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464863|NCT00471341|Celecoxib|celecoxib|mesh-list
6464864|NCT00471341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6464865|NCT00471341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6464866|NCT00471341|Analgesics|analgesics|mesh-ancestor
6464867|NCT00471341|Sensory System Agents|sensory system agents|mesh-ancestor
6464868|NCT00471341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6464869|NCT00471341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464870|NCT00471341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6464871|NCT00471341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6464872|NCT00471341|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6464873|NCT00471341|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5522943|NCT04303130|Growth Inhibitors|growth inhibitors|mesh-ancestor
5522944|NCT04303130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6099684|NCT00932646|Adrenergic Agents|adrenergic agents|mesh-ancestor
6099685|NCT00932646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6099686|NCT00932646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099687|NCT00932698|Ixazomib|ixazomib|mesh-list
6099688|NCT00932698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6099689|NCT00932698|Protease Inhibitors|protease inhibitors|mesh-ancestor
6099690|NCT00932698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6099691|NCT00932698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099692|NCT00932828|Immunologic Factors|immunologic factors|mesh-list
6099693|NCT00932828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099694|NCT00932893|Docetaxel|docetaxel|mesh-list
6099695|NCT00932893|Pemetrexed|pemetrexed|mesh-list
6099696|NCT00932893|Crizotinib|crizotinib|mesh-list
6099697|NCT00932893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6099698|NCT00932893|Tubulin Modulators|tubulin modulators|mesh-ancestor
6099699|NCT00932893|Antimitotic Agents|antimitotic agents|mesh-ancestor
6099700|NCT00932893|Mitosis Modulators|mitosis modulators|mesh-ancestor
6099701|NCT00932893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099702|NCT00932893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6099703|NCT00932893|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6099704|NCT00932893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6099705|NCT00932893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6099706|NCT00933244|Vitamin D|vitamin d|mesh-list
6099707|NCT00933244|Ergocalciferols|ergocalciferols|mesh-list
6099708|NCT00933244|Cholecalciferol|cholecalciferol|mesh-list
6099709|NCT00933244|Vitamins|vitamins|mesh-list
6099710|NCT00933244|Micronutrients|micronutrients|mesh-ancestor
6099711|NCT00933244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099712|NCT00933244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6099713|NCT00933244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6099714|NCT00933335|Tositumomab I-131|tositumomab i-131|mesh-list
6099715|NCT00933335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6099716|NCT00933608|Memantine|memantine|mesh-list
6099717|NCT00933608|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6099718|NCT00933608|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6099719|NCT00933608|Dopamine Agents|dopamine agents|mesh-ancestor
6099720|NCT00933608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6099721|NCT00933608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099722|NCT00933608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099723|NCT00933608|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6099724|NCT00933608|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6099725|NCT00934024|Varenicline|varenicline|mesh-list
6099726|NCT00934024|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6099727|NCT00934024|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6099728|NCT00934024|Cholinergic Agents|cholinergic agents|mesh-ancestor
6099729|NCT00934024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6099730|NCT00934024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099731|NCT00934024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099732|NCT00934050|Inositol|inositol|mesh-list
6099733|NCT00934050|Vitamin B Complex|vitamin b complex|mesh-ancestor
6099734|NCT00934050|Vitamins|vitamins|mesh-ancestor
5522945|NCT04303065|Dexamethasone|dexamethasone|mesh-list
5522946|NCT04303065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5522947|NCT04303065|Antiemetics|antiemetics|mesh-ancestor
5522948|NCT04303065|Autonomic Agents|autonomic agents|mesh-ancestor
5522949|NCT04303065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5522950|NCT04303065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522951|NCT04303065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5522952|NCT04303065|Glucocorticoids|glucocorticoids|mesh-ancestor
5522953|NCT04303065|Hormones|hormones|mesh-ancestor
5522954|NCT04303065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5522955|NCT04303065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5522956|NCT04303065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5522957|NCT04302805|Thymoglobulin|thymoglobulin|mesh-list
5522958|NCT04302805|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5522959|NCT04302805|Immunologic Factors|immunologic factors|mesh-ancestor
5522960|NCT04302805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522961|NCT04302805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5522962|NCT04302532|Ubiquinone|ubiquinone|mesh-list
5522963|NCT04302532|Coenzyme Q10|coenzyme q10|mesh-list
5522964|NCT04302532|Clomiphene|clomiphene|mesh-list
5522965|NCT04302532|Enclomiphene|enclomiphene|mesh-list
5522966|NCT04302532|Zuclomiphene|zuclomiphene|mesh-list
5522967|NCT04302532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5522968|NCT04302532|Hormone Antagonists|hormone antagonists|mesh-ancestor
5522969|NCT04302532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5522970|NCT04302532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522971|NCT04302532|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5522972|NCT04302532|Fertility Agents|fertility agents|mesh-ancestor
5522973|NCT04302532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5522974|NCT04302532|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5522975|NCT04302532|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5522976|NCT04302532|Micronutrients|micronutrients|mesh-ancestor
5522977|NCT04302532|Vitamins|vitamins|mesh-ancestor
5522978|NCT04302649|Dialysis Solutions|dialysis solutions|mesh-list
5522979|NCT04302649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5522980|NCT04302402|Rifaximin|rifaximin|mesh-list
5522981|NCT04302402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5522982|NCT04302402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5522983|NCT04302402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5522984|NCT04302441|Capecitabine|capecitabine|mesh-list
5522985|NCT04302441|Vinorelbine|vinorelbine|mesh-list
6099735|NCT00934050|Micronutrients|micronutrients|mesh-ancestor
5522986|NCT04302441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5522987|NCT04302441|Antimetabolites|antimetabolites|mesh-ancestor
5522988|NCT04302441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5522989|NCT04302441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5522990|NCT04302441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5522991|NCT04302441|Tubulin Modulators|tubulin modulators|mesh-ancestor
5522992|NCT04302441|Antimitotic Agents|antimitotic agents|mesh-ancestor
5522993|NCT04302441|Mitosis Modulators|mitosis modulators|mesh-ancestor
5522994|NCT04302454|Leuprolide|leuprolide|mesh-list
5522995|NCT04302454|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5522996|NCT04302454|Fertility Agents|fertility agents|mesh-ancestor
5522997|NCT04302454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5522998|NCT04302454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5522999|NCT04302454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5523000|NCT04302454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6099736|NCT00934050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099737|NCT00934089|Latanoprost|latanoprost|mesh-list
6099738|NCT00934089|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6099739|NCT00934089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6099740|NCT00934362|Pulmonary Surfactants|pulmonary surfactants|mesh-list
6099741|NCT00934362|Respiratory System Agents|respiratory system agents|mesh-ancestor
6099742|NCT00934375|Donepezil|donepezil|mesh-list
6099743|NCT00934375|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6099744|NCT00934375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6099745|NCT00934375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099746|NCT00934375|Cholinergic Agents|cholinergic agents|mesh-ancestor
6099747|NCT00934375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6099748|NCT00934375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099749|NCT00934375|Nootropic Agents|nootropic agents|mesh-ancestor
6099750|NCT00934440|Bevacizumab|bevacizumab|mesh-list
6099751|NCT00934440|Azacitidine|azacitidine|mesh-list
6099752|NCT00934440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6099753|NCT00934440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6099754|NCT00934440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5523001|NCT04302675|Vaccines|vaccines|mesh-list
5523002|NCT04302675|Immunologic Factors|immunologic factors|mesh-ancestor
5523003|NCT04302675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601088|NCT03707847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5601089|NCT03707847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5601090|NCT03707847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5601091|NCT03707847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5601092|NCT03707847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601093|NCT03707847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5601094|NCT03707808|Nivolumab|nivolumab|mesh-list
5601095|NCT03707808|Ipilimumab|ipilimumab|mesh-list
6099755|NCT00934440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6099756|NCT00934440|Growth Substances|growth substances|mesh-ancestor
6099757|NCT00934440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099758|NCT00934440|Growth Inhibitors|growth inhibitors|mesh-ancestor
6099759|NCT00934440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6099760|NCT00934440|Antimetabolites|antimetabolites|mesh-ancestor
6099761|NCT00934440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099762|NCT00934440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6099763|NCT00934635|Risperidone|risperidone|mesh-list
6099764|NCT00934635|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6099765|NCT00934635|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6099766|NCT00934635|Serotonin Agents|serotonin agents|mesh-ancestor
5601096|NCT03707808|Avelumab|avelumab|mesh-list
6099767|NCT00934635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6203769|NCT02061280|Dermatologic Agents|dermatologic agents|mesh-ancestor
5523004|NCT04302584|Vasopressins|vasopressins|mesh-list
5523005|NCT04302584|Arginine Vasopressin|arginine vasopressin|mesh-list
5523006|NCT04302584|Norepinephrine|norepinephrine|mesh-list
5523007|NCT04302584|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5523008|NCT04302584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5523009|NCT04302584|Adrenergic Agents|adrenergic agents|mesh-ancestor
5523010|NCT04302584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5523011|NCT04302584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523012|NCT04302584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523013|NCT04302584|Sympathomimetics|sympathomimetics|mesh-ancestor
5523014|NCT04302584|Autonomic Agents|autonomic agents|mesh-ancestor
5523015|NCT04302584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5523016|NCT04302584|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5523017|NCT04302584|Hemostatics|hemostatics|mesh-ancestor
5523018|NCT04302584|Coagulants|coagulants|mesh-ancestor
5523019|NCT04302584|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5523020|NCT04302584|Natriuretic Agents|natriuretic agents|mesh-ancestor
5523021|NCT04302350|Nitrous Oxide|nitrous oxide|mesh-list
5523022|NCT04302350|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5523023|NCT04302350|Anesthetics, General|anesthetics, general|mesh-ancestor
5523024|NCT04302350|Anesthetics|anesthetics|mesh-ancestor
5523025|NCT04302350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5523026|NCT04302350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523027|NCT04302350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5523028|NCT04302350|Analgesics|analgesics|mesh-ancestor
5523029|NCT04302350|Sensory System Agents|sensory system agents|mesh-ancestor
5523030|NCT04302350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5523031|NCT04302116|Prednisolone|prednisolone|mesh-list
5523032|NCT04302116|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5523033|NCT04302116|Methylprednisolone|methylprednisolone|mesh-list
5523034|NCT04302116|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6099768|NCT00934635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099769|NCT00934635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099770|NCT00934635|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6099771|NCT00934635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6099772|NCT00934635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6099773|NCT00934635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6099774|NCT00934635|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6099775|NCT00934635|Dopamine Agents|dopamine agents|mesh-ancestor
6099776|NCT00934635|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6099777|NCT00934635|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6099778|NCT00934648|Rituximab|rituximab|mesh-list
6099779|NCT00934648|Methotrexate|methotrexate|mesh-list
6099780|NCT00934648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5523035|NCT04302116|Prednisolone acetate|prednisolone acetate|mesh-list
5523036|NCT04302116|Vigabatrin|vigabatrin|mesh-list
5523037|NCT04302116|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5523038|NCT04302116|Prednisolone phosphate|prednisolone phosphate|mesh-list
5523039|NCT04302116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5523040|NCT04302116|Glucocorticoids|glucocorticoids|mesh-ancestor
5523041|NCT04302116|Hormones|hormones|mesh-ancestor
5523042|NCT04302116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5523043|NCT04302116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523044|NCT04302116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5523045|NCT04302116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5523046|NCT04302116|Antiemetics|antiemetics|mesh-ancestor
5523047|NCT04302116|Autonomic Agents|autonomic agents|mesh-ancestor
5523048|NCT04302116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5523049|NCT04302116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5523050|NCT04302116|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5523051|NCT04302116|Protective Agents|protective agents|mesh-ancestor
5523052|NCT04302116|Anticonvulsants|anticonvulsants|mesh-ancestor
5523053|NCT04302116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5523054|NCT04302116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523055|NCT04302116|GABA Agents|gaba agents|mesh-ancestor
5523056|NCT04302116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5523057|NCT04301908|Interferons|interferons|mesh-list
6099781|NCT00934648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6099782|NCT00934648|Immunologic Factors|immunologic factors|mesh-ancestor
6099783|NCT00934648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099784|NCT00934648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6099785|NCT00934648|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6099786|NCT00934648|Abortifacient Agents|abortifacient agents|mesh-ancestor
6099787|NCT00934648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6099788|NCT00934648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6099789|NCT00934648|Antimetabolites|antimetabolites|mesh-ancestor
6099790|NCT00934648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523058|NCT04301908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5523059|NCT04301908|Antiviral Agents|antiviral agents|mesh-ancestor
5523060|NCT04301908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5523061|NCT04302168|Choline|choline|mesh-list
5523062|NCT04302168|Lipotropic Agents|lipotropic agents|mesh-ancestor
5523063|NCT04302168|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5523064|NCT04302168|Antimetabolites|antimetabolites|mesh-ancestor
5523065|NCT04302168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523066|NCT04302168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5523067|NCT04302168|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5523068|NCT04302168|Nootropic Agents|nootropic agents|mesh-ancestor
5523069|NCT04302181|Ropivacaine|ropivacaine|mesh-list
5523070|NCT04302181|Anesthetics, Local|anesthetics, local|mesh-ancestor
5523071|NCT04302181|Anesthetics|anesthetics|mesh-ancestor
5523072|NCT04302181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5523073|NCT04302181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523074|NCT04302181|Sensory System Agents|sensory system agents|mesh-ancestor
5523075|NCT04302181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5523076|NCT04301895|Remifentanil|remifentanil|mesh-list
5523077|NCT04301895|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5523078|NCT04301895|Narcotics|narcotics|mesh-ancestor
5523079|NCT04301895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5523080|NCT04301895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523081|NCT04301895|Analgesics|analgesics|mesh-ancestor
5523082|NCT04301895|Sensory System Agents|sensory system agents|mesh-ancestor
5523083|NCT04301895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5523084|NCT04301882|Interferons|interferons|mesh-list
5523085|NCT04301882|Ribavirin|ribavirin|mesh-list
5523086|NCT04301882|Antiviral Agents|antiviral agents|mesh-list
5523087|NCT04301882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5523088|NCT04301882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5523089|NCT04301882|Antimetabolites|antimetabolites|mesh-ancestor
6099791|NCT00934648|Dermatologic Agents|dermatologic agents|mesh-ancestor
6099792|NCT00934648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6099793|NCT00934648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6099794|NCT00934648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6099795|NCT00934648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6099796|NCT00934661|Morphine|morphine|mesh-list
6099797|NCT00934661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6099798|NCT00934661|Narcotics|narcotics|mesh-ancestor
6099799|NCT00934661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6099800|NCT00934661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099801|NCT00934661|Analgesics|analgesics|mesh-ancestor
6099802|NCT00934661|Sensory System Agents|sensory system agents|mesh-ancestor
6099803|NCT00934661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6099804|NCT00934843|Methylprednisolone|methylprednisolone|mesh-list
6099805|NCT00934843|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6099806|NCT00934843|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6099807|NCT00934843|Prednisolone|prednisolone|mesh-list
6099808|NCT00934843|Prednisolone acetate|prednisolone acetate|mesh-list
6099809|NCT00934843|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6099810|NCT00934843|Prednisolone phosphate|prednisolone phosphate|mesh-list
6099811|NCT00934843|Glucocorticoids|glucocorticoids|mesh-list
6099812|NCT00934843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6099813|NCT00934843|Antiemetics|antiemetics|mesh-ancestor
6099814|NCT00934843|Autonomic Agents|autonomic agents|mesh-ancestor
6099815|NCT00934843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6099816|NCT00934843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099817|NCT00934843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6099818|NCT00934843|Hormones|hormones|mesh-ancestor
6099819|NCT00934843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6099820|NCT00934843|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6099821|NCT00934843|Protective Agents|protective agents|mesh-ancestor
6099822|NCT00934843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6099823|NCT00934843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6099824|NCT00934856|Docetaxel|docetaxel|mesh-list
6099825|NCT00934856|Trastuzumab|trastuzumab|mesh-list
6099826|NCT00934856|Pertuzumab|pertuzumab|mesh-list
6099827|NCT00934856|Maytansine|maytansine|mesh-list
6099828|NCT00934856|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
6099829|NCT00934856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6099830|NCT00934856|Tubulin Modulators|tubulin modulators|mesh-ancestor
6099831|NCT00934856|Antimitotic Agents|antimitotic agents|mesh-ancestor
6099832|NCT00934856|Mitosis Modulators|mitosis modulators|mesh-ancestor
6099833|NCT00934856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601097|NCT03707808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5523090|NCT04301882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523091|NCT04301869|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5523092|NCT04301869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5523093|NCT04301479|Hydrocortisone|hydrocortisone|mesh-list
6099834|NCT00934856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6099835|NCT00934856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6099836|NCT00934934|Anidulafungin|anidulafungin|mesh-list
6099837|NCT00934934|Antifungal Agents|antifungal agents|mesh-ancestor
6099838|NCT00934934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6099839|NCT00934947|Propranolol|propranolol|mesh-list
6099840|NCT00934947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6099841|NCT00934947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6099842|NCT00934947|Adrenergic Agents|adrenergic agents|mesh-ancestor
6099843|NCT00934947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6099844|NCT00934947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099845|NCT00934947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099846|NCT00934947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6099847|NCT00934947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6099848|NCT00934947|Vasodilator Agents|vasodilator agents|mesh-ancestor
6099849|NCT00935220|Linagliptin|linagliptin|mesh-list
6099850|NCT00935220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6099851|NCT00935220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099852|NCT00935220|Incretins|incretins|mesh-ancestor
6099853|NCT00935220|Hormones|hormones|mesh-ancestor
6099854|NCT00935220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6099855|NCT00935220|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6099856|NCT00935220|Protease Inhibitors|protease inhibitors|mesh-ancestor
6099857|NCT00935220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6099858|NCT00935220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099859|NCT00935259|Simvastatin|simvastatin|mesh-list
6099860|NCT00935259|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6099861|NCT00935259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6099862|NCT00935259|Antimetabolites|antimetabolites|mesh-ancestor
6099863|NCT00935259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099864|NCT00935259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6099865|NCT00935259|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5523094|NCT04301479|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
5523095|NCT04301479|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
5523096|NCT04301479|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
5523097|NCT04301479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5523098|NCT04301492|Vortioxetine|vortioxetine|mesh-list
5523099|NCT04301492|Antidepressive Agents|antidepressive agents|mesh-ancestor
5523100|NCT04301492|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5523101|NCT04301492|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5523102|NCT04301492|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5523103|NCT04301492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5523104|NCT04301492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523105|NCT04301492|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5523106|NCT04301492|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5523107|NCT04301492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5523108|NCT04301492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523109|NCT04301492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5523110|NCT04301492|Serotonin Agents|serotonin agents|mesh-ancestor
5523111|NCT04301492|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5523112|NCT04301492|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6099866|NCT00935259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6099867|NCT00935311|Acetaminophen|acetaminophen|mesh-list
6099868|NCT00935311|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
6099869|NCT00935311|Hydrocodone|hydrocodone|mesh-list
6099870|NCT00935311|Oxycodone|oxycodone|mesh-list
6099871|NCT00935311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6099872|NCT00935311|Analgesics|analgesics|mesh-ancestor
6099873|NCT00935311|Sensory System Agents|sensory system agents|mesh-ancestor
6099874|NCT00935311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6099875|NCT00935311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099876|NCT00935311|Antipyretics|antipyretics|mesh-ancestor
6099877|NCT00935311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6099878|NCT00935311|Narcotics|narcotics|mesh-ancestor
6099879|NCT00935311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6099880|NCT00935311|Antitussive Agents|antitussive agents|mesh-ancestor
6099881|NCT00935311|Respiratory System Agents|respiratory system agents|mesh-ancestor
6099882|NCT00935311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6099883|NCT00935311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5523113|NCT04301492|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5523114|NCT04301492|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5523115|NCT04301661|Tenofovir|tenofovir|mesh-list
5523116|NCT04301661|Lamivudine|lamivudine|mesh-list
5523117|NCT04301661|Emtricitabine|emtricitabine|mesh-list
5523118|NCT04301661|Abacavir|abacavir|mesh-list
5523119|NCT04301661|Antiviral Agents|antiviral agents|mesh-ancestor
5523120|NCT04301661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5523121|NCT04301661|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5523122|NCT04301661|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6099884|NCT00935311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6099885|NCT00935493|Guanfacine|guanfacine|mesh-list
6099886|NCT00935493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6099887|NCT00935493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6099888|NCT00935493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6099889|NCT00935493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6099890|NCT00935493|Adrenergic Agents|adrenergic agents|mesh-ancestor
6099891|NCT00935493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6099892|NCT00935493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099893|NCT00935493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099894|NCT00935532|Insulin|insulin|mesh-list
6099895|NCT00935532|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6099896|NCT00935532|Insulin Glargine|insulin glargine|mesh-list
6099897|NCT00935532|Exenatide|exenatide|mesh-list
6099898|NCT00935532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6099899|NCT00935532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099900|NCT00935532|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6099901|NCT00935532|Incretins|incretins|mesh-ancestor
6099902|NCT00935532|Hormones|hormones|mesh-ancestor
6099903|NCT00935532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6099904|NCT00935792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6099905|NCT00935792|Alemtuzumab|alemtuzumab|mesh-list
6099906|NCT00935792|Everolimus|everolimus|mesh-list
6099907|NCT00935792|Antibodies|antibodies|mesh-list
6099908|NCT00935792|Immunoglobulins|immunoglobulins|mesh-list
6099909|NCT00935792|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5523123|NCT04301661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5523124|NCT04301661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523125|NCT04301661|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5523126|NCT04301661|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5523127|NCT04301739|Paclitaxel|paclitaxel|mesh-list
5523128|NCT04301739|Cyclophosphamide|cyclophosphamide|mesh-list
5523129|NCT04301739|Carboplatin|carboplatin|mesh-list
5523130|NCT04301739|Doxorubicin|doxorubicin|mesh-list
5523131|NCT04301739|Epirubicin|epirubicin|mesh-list
5523132|NCT04301739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5523133|NCT04301739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5523134|NCT04301739|Tubulin Modulators|tubulin modulators|mesh-ancestor
5523135|NCT04301739|Antimitotic Agents|antimitotic agents|mesh-ancestor
5523136|NCT04301739|Mitosis Modulators|mitosis modulators|mesh-ancestor
5523137|NCT04301739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523138|NCT04301739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5523139|NCT04301739|Immunologic Factors|immunologic factors|mesh-ancestor
5523140|NCT04301739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523141|NCT04301739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5523142|NCT04301739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5523143|NCT04301739|Alkylating Agents|alkylating agents|mesh-ancestor
5523144|NCT04301739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6099910|NCT00935792|Immunologic Factors|immunologic factors|mesh-ancestor
6099911|NCT00935792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099912|NCT00935792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6099913|NCT00935792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6099914|NCT00935818|Bupropion|bupropion|mesh-list
6099915|NCT00935818|Varenicline|varenicline|mesh-list
6099916|NCT00935818|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6099917|NCT00935818|Antidepressive Agents|antidepressive agents|mesh-ancestor
6099918|NCT00935818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6099919|NCT00935818|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6099920|NCT00935818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6099921|NCT00935818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6099922|NCT00935818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523145|NCT04301739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5523146|NCT04301739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6099923|NCT00935818|Dopamine Agents|dopamine agents|mesh-ancestor
5523147|NCT04301739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5523148|NCT04301739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6099924|NCT00935818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6464874|NCT00471341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6464875|NCT00471341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6464876|NCT00471393|Diclofenac|diclofenac|mesh-list
6464877|NCT00471393|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
6464878|NCT00471393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6464879|NCT00471393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6464880|NCT00471393|Analgesics|analgesics|mesh-ancestor
6464881|NCT00471393|Sensory System Agents|sensory system agents|mesh-ancestor
6464882|NCT00471393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6464883|NCT00471393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464884|NCT00471393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6464885|NCT00471393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6464886|NCT00471393|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6464887|NCT00471393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6099925|NCT00935818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099926|NCT00935818|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6099927|NCT00935818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6099928|NCT00935818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6464888|NCT00471393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6464889|NCT00471393|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6464890|NCT00471393|Protective Agents|protective agents|mesh-ancestor
6464891|NCT00471393|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6464892|NCT00471393|Antioxidants|antioxidants|mesh-ancestor
6464893|NCT00471406|Verteporfin|verteporfin|mesh-list
6464894|NCT00471406|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6464895|NCT00471406|Dermatologic Agents|dermatologic agents|mesh-ancestor
6464896|NCT00471419|Rimexolone|rimexolone|mesh-list
6464897|NCT00471419|Glucocorticoids|glucocorticoids|mesh-ancestor
6464898|NCT00471419|Hormones|hormones|mesh-ancestor
6464899|NCT00471419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5523149|NCT04301583|Proanthocyanidin|proanthocyanidin|mesh-list
5523150|NCT04301583|Procyanidin|procyanidin|mesh-list
5523151|NCT04301583|Antioxidants|antioxidants|mesh-ancestor
5523152|NCT04301583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099929|NCT00935818|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6099930|NCT00935818|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6099931|NCT00935818|Cholinergic Agents|cholinergic agents|mesh-ancestor
6099932|NCT00935883|Eculizumab|eculizumab|mesh-list
6099933|NCT00935883|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5523153|NCT04301583|Protective Agents|protective agents|mesh-ancestor
5523154|NCT04301583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523155|NCT04301583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5523156|NCT04301583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5523157|NCT04301583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5523158|NCT04301557|Capecitabine|capecitabine|mesh-list
5523159|NCT04301557|Oxaliplatin|oxaliplatin|mesh-list
5523160|NCT04301557|Antibodies|antibodies|mesh-list
5523161|NCT04301557|Immunologic Factors|immunologic factors|mesh-ancestor
5523162|NCT04301557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523163|NCT04301557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5523164|NCT04301557|Antimetabolites|antimetabolites|mesh-ancestor
5523165|NCT04301557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523166|NCT04301557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5523167|NCT04301778|Durvalumab|durvalumab|mesh-list
5523168|NCT04301778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5523169|NCT04301778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5523170|NCT04301726|Tetrabenazine|tetrabenazine|mesh-list
5523171|NCT04301726|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5523172|NCT04301726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5523173|NCT04301726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5523174|NCT04301726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523175|NCT04301726|Adrenergic Agents|adrenergic agents|mesh-ancestor
5523176|NCT04301726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5523177|NCT04301726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523178|NCT04301349|Misoprostol|misoprostol|mesh-list
5523179|NCT04301349|Dinoprostone|dinoprostone|mesh-list
5523180|NCT04301349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5523181|NCT04301349|Abortifacient Agents|abortifacient agents|mesh-ancestor
5523182|NCT04301349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6099934|NCT00935883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6099935|NCT00935883|Immunologic Factors|immunologic factors|mesh-ancestor
6099936|NCT00935883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464900|NCT00471419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523183|NCT04301349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464901|NCT00471432|Docetaxel|docetaxel|mesh-list
6099937|NCT00936065|Etanercept|etanercept|mesh-list
6099938|NCT00936065|Acitretin|acitretin|mesh-list
6099939|NCT00936065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6099940|NCT00936065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6099941|NCT00936065|Analgesics|analgesics|mesh-ancestor
6099942|NCT00936065|Sensory System Agents|sensory system agents|mesh-ancestor
6099943|NCT00936065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6099944|NCT00936065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099945|NCT00936065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6099946|NCT00936065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6099947|NCT00936065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6099948|NCT00936065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6099949|NCT00936065|Immunologic Factors|immunologic factors|mesh-ancestor
6099950|NCT00936065|Keratolytic Agents|keratolytic agents|mesh-ancestor
6099951|NCT00936065|Dermatologic Agents|dermatologic agents|mesh-ancestor
6099952|NCT00936117|Posaconazole|posaconazole|mesh-list
6099953|NCT00936117|Antifungal Agents|antifungal agents|mesh-ancestor
6099954|NCT00936117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6099955|NCT00936117|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6099956|NCT00936117|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6099957|NCT00936117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6099958|NCT00936117|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6099959|NCT00936117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6099960|NCT00936117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6099961|NCT00936117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099962|NCT00936117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6099963|NCT00936117|Hormone Antagonists|hormone antagonists|mesh-ancestor
5523184|NCT04301349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5523185|NCT04301349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5523186|NCT04301349|Oxytocics|oxytocics|mesh-ancestor
6099964|NCT00936117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6099965|NCT00936117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099966|NCT00936221|Dacarbazine|dacarbazine|mesh-list
6099967|NCT00936221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6099968|NCT00936221|Alkylating Agents|alkylating agents|mesh-ancestor
6099969|NCT00936221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099970|NCT00936221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6099971|NCT00936299|Bupropion|bupropion|mesh-list
6099972|NCT00936299|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6099973|NCT00936299|Antidepressive Agents|antidepressive agents|mesh-ancestor
6099974|NCT00936299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6099975|NCT00936299|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6099976|NCT00936299|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6099977|NCT00936299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6099978|NCT00936299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099979|NCT00936299|Dopamine Agents|dopamine agents|mesh-ancestor
6099980|NCT00936299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6099981|NCT00936299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099982|NCT00936299|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6099983|NCT00936299|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6099984|NCT00936299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6099985|NCT00936377|Dexmedetomidine|dexmedetomidine|mesh-list
5523187|NCT04301336|Zinc|zinc|mesh-list
5523188|NCT04301336|Folic Acid|folic acid|mesh-list
5523189|NCT04301336|Vitamin B Complex|vitamin b complex|mesh-list
5523190|NCT04301336|Hydroxyurea|hydroxyurea|mesh-list
5523191|NCT04301336|Morphine|morphine|mesh-list
5523192|NCT04301336|Zinc Sulfate|zinc sulfate|mesh-list
5523193|NCT04301336|Simvastatin|simvastatin|mesh-list
5523194|NCT04301336|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5523195|NCT04301336|Narcotics|narcotics|mesh-ancestor
5523196|NCT04301336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5523197|NCT04301336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6099986|NCT00936377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6099987|NCT00936377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6099988|NCT00936377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464902|NCT00471432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6464903|NCT00471432|Tubulin Modulators|tubulin modulators|mesh-ancestor
6464904|NCT00471432|Antimitotic Agents|antimitotic agents|mesh-ancestor
6464905|NCT00471432|Mitosis Modulators|mitosis modulators|mesh-ancestor
6464906|NCT00471432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6464907|NCT00471471|Sargramostim|sargramostim|mesh-list
5523198|NCT04301336|Analgesics|analgesics|mesh-ancestor
5523199|NCT04301336|Sensory System Agents|sensory system agents|mesh-ancestor
5523200|NCT04301336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5523201|NCT04301336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5523202|NCT04301336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5523203|NCT04301336|Antimetabolites|antimetabolites|mesh-ancestor
5523204|NCT04301336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523205|NCT04301336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5523206|NCT04301336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6464908|NCT00471471|Immunologic Factors|immunologic factors|mesh-ancestor
6099989|NCT00936377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6099990|NCT00936377|Analgesics|analgesics|mesh-ancestor
6099991|NCT00936377|Sensory System Agents|sensory system agents|mesh-ancestor
6099992|NCT00936377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6099993|NCT00936377|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6099994|NCT00936377|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6099995|NCT00936377|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6099996|NCT00936377|Adrenergic Agents|adrenergic agents|mesh-ancestor
6099997|NCT00936377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6099998|NCT00936377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6099999|NCT00936611|Panobinostat|panobinostat|mesh-list
6100000|NCT00936611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6100001|NCT00936611|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6100002|NCT00936611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6100003|NCT00936611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100004|NCT00936663|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6100005|NCT00936663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6100006|NCT00936663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100007|NCT00936663|Incretins|incretins|mesh-ancestor
6100008|NCT00936663|Hormones|hormones|mesh-ancestor
6100009|NCT00936663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6100010|NCT00936663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6100011|NCT00936663|Protease Inhibitors|protease inhibitors|mesh-ancestor
6100012|NCT00936663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6100013|NCT00936663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100014|NCT00936702|Paclitaxel|paclitaxel|mesh-list
6100015|NCT00936702|Carboplatin|carboplatin|mesh-list
6100016|NCT00936702|Everolimus|everolimus|mesh-list
6100017|NCT00936702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6100018|NCT00936702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6100019|NCT00936702|Tubulin Modulators|tubulin modulators|mesh-ancestor
6100020|NCT00936702|Antimitotic Agents|antimitotic agents|mesh-ancestor
6100021|NCT00936702|Mitosis Modulators|mitosis modulators|mesh-ancestor
6100022|NCT00936702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100023|NCT00936702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6100024|NCT00936702|Immunologic Factors|immunologic factors|mesh-ancestor
6100025|NCT00936702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100026|NCT00936715|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6100027|NCT00936715|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6100028|NCT00936715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6100029|NCT00936715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6100030|NCT00936715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100031|NCT00936715|Antiviral Agents|antiviral agents|mesh-ancestor
6100032|NCT00936715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6100033|NCT00936715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6100034|NCT00936715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6100035|NCT00936741|Mifepristone|mifepristone|mesh-list
6100036|NCT00936741|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6100037|NCT00936741|Abortifacient Agents|abortifacient agents|mesh-ancestor
6100038|NCT00936741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6100039|NCT00936741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100040|NCT00936741|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6100041|NCT00936741|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6100042|NCT00936741|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6100043|NCT00936741|Contraceptive Agents|contraceptive agents|mesh-ancestor
6100044|NCT00936741|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6100045|NCT00936741|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6100046|NCT00936741|Hormone Antagonists|hormone antagonists|mesh-ancestor
6100047|NCT00936741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6100048|NCT00936741|Luteolytic Agents|luteolytic agents|mesh-ancestor
5523207|NCT04301336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5523208|NCT04301336|Trace Elements|trace elements|mesh-ancestor
5523209|NCT04301336|Micronutrients|micronutrients|mesh-ancestor
5523210|NCT04301336|Hematinics|hematinics|mesh-ancestor
5523211|NCT04301336|Vitamins|vitamins|mesh-ancestor
5523212|NCT04301336|Astringents|astringents|mesh-ancestor
5523213|NCT04301336|Dermatologic Agents|dermatologic agents|mesh-ancestor
5523214|NCT04301336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5523215|NCT04301336|Antisickling Agents|antisickling agents|mesh-ancestor
5523216|NCT04301336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5523217|NCT04301024|Nitrous Oxide|nitrous oxide|mesh-list
5523218|NCT04301024|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6100049|NCT00936741|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6100050|NCT00936741|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6100051|NCT00936858|Everolimus|everolimus|mesh-list
6100052|NCT00936858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6100053|NCT00936858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6100054|NCT00936858|Immunologic Factors|immunologic factors|mesh-ancestor
6100055|NCT00936858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100056|NCT00936884|Methylnaltrexone|methylnaltrexone|mesh-list
6100057|NCT00936884|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6100058|NCT00936884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100059|NCT00936884|Sensory System Agents|sensory system agents|mesh-ancestor
6100060|NCT00936884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6100061|NCT00936897|Denosumab|denosumab|mesh-list
6100062|NCT00936897|Ibandronic Acid|ibandronic acid|mesh-list
6100063|NCT00936897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6100064|NCT00936897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100065|NCT00936910|Amphotericin B|amphotericin b|mesh-list
6100066|NCT00936910|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6100067|NCT00936910|Amebicides|amebicides|mesh-ancestor
6100068|NCT00936910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6100069|NCT00936910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6100070|NCT00936910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6100071|NCT00936910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6100072|NCT00936910|Antifungal Agents|antifungal agents|mesh-ancestor
6100073|NCT00936975|Listerine|listerine|mesh-list
6100074|NCT00936975|Fluorides|fluorides|mesh-list
6100075|NCT00936975|Sodium Fluoride|sodium fluoride|mesh-list
6100076|NCT00936975|Cariostatic Agents|cariostatic agents|mesh-ancestor
6100077|NCT00936975|Protective Agents|protective agents|mesh-ancestor
6100078|NCT00936975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100079|NCT00936975|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6100080|NCT00936975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6100081|NCT00937157|Glatiramer Acetate|glatiramer acetate|mesh-list
5523219|NCT04301024|Anesthetics, General|anesthetics, general|mesh-ancestor
5523220|NCT04301024|Anesthetics|anesthetics|mesh-ancestor
5523221|NCT04301024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5523222|NCT04301024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523223|NCT04301024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5523224|NCT04301024|Analgesics|analgesics|mesh-ancestor
5523225|NCT04301024|Sensory System Agents|sensory system agents|mesh-ancestor
5523226|NCT04301024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5523227|NCT04301323|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5523228|NCT04301323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5523229|NCT04301310|Rifampin|rifampin|mesh-list
5523230|NCT04301310|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5523231|NCT04301310|Antitubercular Agents|antitubercular agents|mesh-ancestor
5523232|NCT04301310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5523233|NCT04301310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5523234|NCT04301310|Leprostatic Agents|leprostatic agents|mesh-ancestor
5523235|NCT04301310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5523236|NCT04301310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5523237|NCT04301310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523238|NCT04301310|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5523239|NCT04301310|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5523240|NCT04301310|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5523241|NCT04301310|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5523242|NCT04301310|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6100082|NCT00937157|(T,G)-A-L|(t,g)-a-l|mesh-list
6100083|NCT00937157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6100084|NCT00937157|Immunologic Factors|immunologic factors|mesh-ancestor
6464909|NCT00471471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464910|NCT00471484|Interferons|interferons|mesh-list
6464911|NCT00471484|Interferon-alpha|interferon-alpha|mesh-list
6464912|NCT00471484|Interferon alpha-2|interferon alpha-2|mesh-list
6464913|NCT00471484|Doxorubicin|doxorubicin|mesh-list
6464914|NCT00471484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6464915|NCT00471484|Fluorouracil|fluorouracil|mesh-list
6100085|NCT00937157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100086|NCT00937157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6464916|NCT00471484|Oxaliplatin|oxaliplatin|mesh-list
6464917|NCT00471484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6100087|NCT00937157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6100088|NCT00937235|Varenicline|varenicline|mesh-list
6100089|NCT00937235|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6100090|NCT00937235|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6100091|NCT00937235|Cholinergic Agents|cholinergic agents|mesh-ancestor
6100092|NCT00937235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6100093|NCT00937235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100094|NCT00937235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100095|NCT00937495|Bortezomib|bortezomib|mesh-list
5523243|NCT04301310|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5523244|NCT04300959|Gemcitabine|gemcitabine|mesh-list
5523245|NCT04300959|Cisplatin|cisplatin|mesh-list
6100096|NCT00937495|Vorinostat|vorinostat|mesh-list
6100097|NCT00937495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6100098|NCT00937495|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6100099|NCT00937495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6100100|NCT00937495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100101|NCT00937521|Antipyretics|antipyretics|mesh-list
6100102|NCT00937521|Vaccines|vaccines|mesh-list
6100103|NCT00937521|Immunologic Factors|immunologic factors|mesh-ancestor
6100104|NCT00937521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100105|NCT00937560|Paclitaxel|paclitaxel|mesh-list
6100106|NCT00937560|Bevacizumab|bevacizumab|mesh-list
6100107|NCT00937560|Carboplatin|carboplatin|mesh-list
6100108|NCT00937560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6100109|NCT00937560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6100110|NCT00937560|Tubulin Modulators|tubulin modulators|mesh-ancestor
6100111|NCT00937560|Antimitotic Agents|antimitotic agents|mesh-ancestor
6100112|NCT00937560|Mitosis Modulators|mitosis modulators|mesh-ancestor
6100113|NCT00937560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523246|NCT04300959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5523247|NCT04300959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5523248|NCT04300959|Antimetabolites|antimetabolites|mesh-ancestor
5523249|NCT04300959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523250|NCT04300959|Antiviral Agents|antiviral agents|mesh-ancestor
5523251|NCT04300959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5523252|NCT04300959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5523253|NCT04300959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5523254|NCT04300959|Immunologic Factors|immunologic factors|mesh-ancestor
5523255|NCT04300959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523256|NCT04301271|Simvastatin|simvastatin|mesh-list
5523257|NCT04301271|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5523258|NCT04301271|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5523259|NCT04301271|Antimetabolites|antimetabolites|mesh-ancestor
5523260|NCT04301271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523261|NCT04301271|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5523262|NCT04301271|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5523263|NCT04301271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6100114|NCT00937560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6100115|NCT00937560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6100116|NCT00937560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6100117|NCT00937560|Growth Substances|growth substances|mesh-ancestor
6100118|NCT00937560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100119|NCT00937560|Growth Inhibitors|growth inhibitors|mesh-ancestor
6100120|NCT00937768|Leuprolide|leuprolide|mesh-list
6100121|NCT00937768|Goserelin|goserelin|mesh-list
6100122|NCT00937768|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6100123|NCT00937768|Fertility Agents|fertility agents|mesh-ancestor
6100124|NCT00937768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6100125|NCT00937768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100126|NCT00937768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6100127|NCT00937768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6100128|NCT00938041|Tositumomab I-131|tositumomab i-131|mesh-list
6100129|NCT00938041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6100130|NCT00938314|Epoetin Alfa|epoetin alfa|mesh-list
6100131|NCT00938314|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5523264|NCT04301375|Paclitaxel|paclitaxel|mesh-list
5523265|NCT04301375|Trastuzumab|trastuzumab|mesh-list
6100132|NCT00938314|Hematinics|hematinics|mesh-ancestor
6100133|NCT00938314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6100134|NCT00938314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100135|NCT00938366|Cladribine|cladribine|mesh-list
6100136|NCT00938366|Pantoprazole|pantoprazole|mesh-list
5523266|NCT04301375|Pertuzumab|pertuzumab|mesh-list
6100137|NCT00938366|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6203770|NCT02061280|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5523267|NCT04301375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5523268|NCT04301375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5523269|NCT04301375|Tubulin Modulators|tubulin modulators|mesh-ancestor
5523270|NCT04301375|Antimitotic Agents|antimitotic agents|mesh-ancestor
5523271|NCT04301375|Mitosis Modulators|mitosis modulators|mesh-ancestor
5523272|NCT04301375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523273|NCT04301375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5523274|NCT04300686|Adalimumab|adalimumab|mesh-list
5523275|NCT04300686|Antibodies|antibodies|mesh-list
5523276|NCT04300686|Immunoglobulins|immunoglobulins|mesh-list
5523277|NCT04300686|Immunologic Factors|immunologic factors|mesh-ancestor
5523278|NCT04300686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523279|NCT04300686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5523280|NCT04300686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5523281|NCT04300881|Eplerenone|eplerenone|mesh-list
5523282|NCT04300881|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5523283|NCT04300881|Hormone Antagonists|hormone antagonists|mesh-ancestor
5523284|NCT04300881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5523285|NCT04300881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523286|NCT04300881|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5523287|NCT04300881|Diuretics|diuretics|mesh-ancestor
5523288|NCT04300881|Natriuretic Agents|natriuretic agents|mesh-ancestor
5523289|NCT04300881|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5601098|NCT03707808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5601099|NCT03707808|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5601100|NCT03707808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601101|NCT03707795|Betamethasone|betamethasone|mesh-list
5601102|NCT03707795|Betamethasone Valerate|betamethasone valerate|mesh-list
5601103|NCT03707795|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5601104|NCT03707795|Betamethasone benzoate|betamethasone benzoate|mesh-list
6100138|NCT00938366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6100139|NCT00938366|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6100140|NCT00938366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6100141|NCT00938366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100142|NCT00938366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6100143|NCT00938366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6100144|NCT00938366|Immunologic Factors|immunologic factors|mesh-ancestor
6100145|NCT00938366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100146|NCT00938392|Vaccines|vaccines|mesh-list
6100147|NCT00938392|Immunologic Factors|immunologic factors|mesh-ancestor
6100148|NCT00938392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100149|NCT00938431|Lacosamide|lacosamide|mesh-list
6100150|NCT00938431|Anticonvulsants|anticonvulsants|mesh-ancestor
6100151|NCT00938431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6100152|NCT00938431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6100153|NCT00938431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6100154|NCT00938431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100155|NCT00938470|Docetaxel|docetaxel|mesh-list
6100156|NCT00938470|Fluorouracil|fluorouracil|mesh-list
6100157|NCT00938470|Capecitabine|capecitabine|mesh-list
6100158|NCT00938470|Oxaliplatin|oxaliplatin|mesh-list
6100159|NCT00938470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6100160|NCT00938470|Tubulin Modulators|tubulin modulators|mesh-ancestor
6100161|NCT00938470|Antimitotic Agents|antimitotic agents|mesh-ancestor
6100162|NCT00938470|Mitosis Modulators|mitosis modulators|mesh-ancestor
6100163|NCT00938470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100164|NCT00938470|Antimetabolites|antimetabolites|mesh-ancestor
6100165|NCT00938470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6100166|NCT00938470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6100167|NCT00938470|Immunologic Factors|immunologic factors|mesh-ancestor
6100168|NCT00938470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100169|NCT00938548|Pregabalin|pregabalin|mesh-list
6100170|NCT00938548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100171|NCT00938548|Analgesics|analgesics|mesh-ancestor
6100172|NCT00938548|Sensory System Agents|sensory system agents|mesh-ancestor
6100173|NCT00938548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6100174|NCT00938548|Anticonvulsants|anticonvulsants|mesh-ancestor
6100175|NCT00938548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6100176|NCT00938548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6100177|NCT00938548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100178|NCT00938548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6100179|NCT00938548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6100180|NCT00938548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6100181|NCT00938548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6100182|NCT00938548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6464918|NCT00471484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6464919|NCT00471484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6464920|NCT00471484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6464921|NCT00471484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6464922|NCT00471484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6464923|NCT00471484|Antimetabolites|antimetabolites|mesh-ancestor
6464924|NCT00471484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6464925|NCT00471484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6464926|NCT00471484|Immunologic Factors|immunologic factors|mesh-ancestor
6464927|NCT00471484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464928|NCT00471484|Antiviral Agents|antiviral agents|mesh-ancestor
6464929|NCT00471484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6100183|NCT00938704|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6100184|NCT00938704|Hyaluronic Acid|hyaluronic acid|mesh-list
6100185|NCT00938704|Glycerol|glycerol|mesh-list
6100186|NCT00938704|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6100187|NCT00938704|Immunologic Factors|immunologic factors|mesh-ancestor
6100188|NCT00938704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100189|NCT00938704|Viscosupplements|viscosupplements|mesh-ancestor
6100190|NCT00938704|Protective Agents|protective agents|mesh-ancestor
6100191|NCT00938704|Laxatives|laxatives|mesh-ancestor
6100192|NCT00938704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6100193|NCT00938704|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6100194|NCT00938717|Linaclotide|linaclotide|mesh-list
6100195|NCT00938717|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
6100196|NCT00938717|Enzyme Activators|enzyme activators|mesh-ancestor
6100197|NCT00938717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523290|NCT04300452|Carbetocin|carbetocin|mesh-list
5523291|NCT04300452|Ergonovine|ergonovine|mesh-list
5523292|NCT04300452|Oxytocics|oxytocics|mesh-ancestor
5523293|NCT04300452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5523294|NCT04300452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523295|NCT04300374|Anesthetics|anesthetics|mesh-list
5523296|NCT04300374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5523297|NCT04300374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523298|NCT04300790|Metformin|metformin|mesh-list
5523299|NCT04300790|Fulvestrant|fulvestrant|mesh-list
5523300|NCT04300790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5523301|NCT04300790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523302|NCT04300790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5523303|NCT04300790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5523304|NCT04300790|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5523305|NCT04300790|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5523306|NCT04300790|Hormone Antagonists|hormone antagonists|mesh-ancestor
5523307|NCT04300790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5523308|NCT04300751|Analgesics, Opioid|analgesics, opioid|mesh-list
5523309|NCT04300751|Narcotics|narcotics|mesh-ancestor
5523310|NCT04300751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5523311|NCT04300751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523312|NCT04300751|Analgesics|analgesics|mesh-ancestor
5523313|NCT04300751|Sensory System Agents|sensory system agents|mesh-ancestor
5523314|NCT04300751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5523315|NCT04300322|Progesterone|progesterone|mesh-list
5523316|NCT04300322|Progestins|progestins|mesh-ancestor
5523317|NCT04300322|Hormones|hormones|mesh-ancestor
5523318|NCT04300322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5523319|NCT04300322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100198|NCT00938717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6100199|NCT00938860|Cyclosporine|cyclosporine|mesh-list
6100200|NCT00938860|Tacrolimus|tacrolimus|mesh-list
6100201|NCT00938860|Cyclosporins|cyclosporins|mesh-list
6100202|NCT00938860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6100203|NCT00938860|Immunologic Factors|immunologic factors|mesh-ancestor
6100204|NCT00938860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100205|NCT00938860|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6100206|NCT00938860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6100207|NCT00938860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100208|NCT00938860|Antifungal Agents|antifungal agents|mesh-ancestor
6100209|NCT00938860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6100210|NCT00938860|Dermatologic Agents|dermatologic agents|mesh-ancestor
5523320|NCT04300192|Vaccines|vaccines|mesh-list
5523321|NCT04300192|Immunologic Factors|immunologic factors|mesh-ancestor
5523322|NCT04300192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100211|NCT00938860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6100212|NCT00938886|Naltrexone|naltrexone|mesh-list
6464930|NCT00471510|Proteasome Inhibitors|proteasome inhibitors|mesh-list
6100213|NCT00938886|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6100214|NCT00938886|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6100215|NCT00938886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100216|NCT00938886|Sensory System Agents|sensory system agents|mesh-ancestor
6100217|NCT00938886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6100218|NCT00938964|Lidocaine|lidocaine|mesh-list
6100219|NCT00938964|Anesthetics, Local|anesthetics, local|mesh-ancestor
6100220|NCT00938964|Anesthetics|anesthetics|mesh-ancestor
6100221|NCT00938964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6100222|NCT00938964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100223|NCT00938964|Sensory System Agents|sensory system agents|mesh-ancestor
6100224|NCT00938964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6100225|NCT00938964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6100226|NCT00938964|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6100227|NCT00938964|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6100228|NCT00938964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6100229|NCT00938964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100230|NCT00939003|Adalimumab|adalimumab|mesh-list
6100231|NCT00939003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6100232|NCT00939003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6100233|NCT00939029|Nicotine|nicotine|mesh-list
6100234|NCT00939029|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6100235|NCT00939029|Autonomic Agents|autonomic agents|mesh-ancestor
6100236|NCT00939029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6100237|NCT00939029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100238|NCT00939029|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6100239|NCT00939029|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6100240|NCT00939029|Cholinergic Agents|cholinergic agents|mesh-ancestor
6100241|NCT00939029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6100242|NCT00939029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100243|NCT00939120|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6100244|NCT00939120|Dutasteride|dutasteride|mesh-list
6100245|NCT00939120|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6100246|NCT00939120|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6100247|NCT00939120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6100248|NCT00939120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100249|NCT00939120|Hormone Antagonists|hormone antagonists|mesh-ancestor
6100250|NCT00939120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6100251|NCT00939120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100252|NCT00939120|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6100253|NCT00939120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6100254|NCT00939120|Cholinergic Agents|cholinergic agents|mesh-ancestor
6100255|NCT00939120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6100256|NCT00939120|Urological Agents|urological agents|mesh-ancestor
6100257|NCT00939159|Panobinostat|panobinostat|mesh-list
6100258|NCT00939159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5523323|NCT04300231|Hydromorphone|hydromorphone|mesh-list
5523324|NCT04300231|Bupivacaine|bupivacaine|mesh-list
5523325|NCT04300231|Anesthetics, Local|anesthetics, local|mesh-ancestor
5523326|NCT04300231|Anesthetics|anesthetics|mesh-ancestor
5523327|NCT04300231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6100259|NCT00939159|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6100260|NCT00939159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6100261|NCT00939159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100262|NCT00939185|Azithromycin|azithromycin|mesh-list
6100263|NCT00939185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6100264|NCT00939185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6100265|NCT00939211|Tiotropium Bromide|tiotropium bromide|mesh-list
6100266|NCT00939211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6100267|NCT00939211|Autonomic Agents|autonomic agents|mesh-ancestor
6100268|NCT00939211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6100269|NCT00939211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100270|NCT00939211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6100271|NCT00939211|Respiratory System Agents|respiratory system agents|mesh-ancestor
6100272|NCT00939211|Parasympatholytics|parasympatholytics|mesh-ancestor
6100273|NCT00939211|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6100274|NCT00939211|Cholinergic Agents|cholinergic agents|mesh-ancestor
6100275|NCT00939211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6100276|NCT00939211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100277|NCT00939341|Budesonide|budesonide|mesh-list
6100278|NCT00939341|Formoterol Fumarate|formoterol fumarate|mesh-list
6100279|NCT00939341|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6464931|NCT00471510|Protease Inhibitors|protease inhibitors|mesh-ancestor
5523328|NCT04300231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100280|NCT00939341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6100281|NCT00939341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6100282|NCT00939341|Autonomic Agents|autonomic agents|mesh-ancestor
6100283|NCT00939341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6100284|NCT00939341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100285|NCT00939341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6100286|NCT00939341|Respiratory System Agents|respiratory system agents|mesh-ancestor
6100287|NCT00939341|Glucocorticoids|glucocorticoids|mesh-ancestor
6100288|NCT00939341|Hormones|hormones|mesh-ancestor
6100289|NCT00939341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6100290|NCT00939341|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6100291|NCT00939341|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6100292|NCT00939341|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6100293|NCT00939341|Adrenergic Agents|adrenergic agents|mesh-ancestor
6100294|NCT00939341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5523329|NCT04300231|Sensory System Agents|sensory system agents|mesh-ancestor
5523330|NCT04300231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5523331|NCT04300231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5523332|NCT04300231|Narcotics|narcotics|mesh-ancestor
5523333|NCT04300231|Analgesics|analgesics|mesh-ancestor
6100295|NCT00939341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100296|NCT00939367|Zolpidem|zolpidem|mesh-list
6100297|NCT00939367|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6100298|NCT00939367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6100299|NCT00939367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5523334|NCT04300049|Glucagon|glucagon|mesh-list
5523335|NCT04300049|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5523336|NCT04300049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6100300|NCT00939367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100301|NCT00939367|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6100302|NCT00939367|GABA Agonists|gaba agonists|mesh-ancestor
6100303|NCT00939367|GABA Agents|gaba agents|mesh-ancestor
6100304|NCT00939367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6100305|NCT00939367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100306|NCT00939510|Lenalidomide|lenalidomide|mesh-list
6100307|NCT00939510|Sargramostim|sargramostim|mesh-list
6100308|NCT00939510|Immunologic Factors|immunologic factors|mesh-ancestor
6100309|NCT00939510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100310|NCT00939510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6100311|NCT00939510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6100312|NCT00939510|Growth Substances|growth substances|mesh-ancestor
6100313|NCT00939510|Growth Inhibitors|growth inhibitors|mesh-ancestor
6100314|NCT00939510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5523337|NCT04300049|Hormones|hormones|mesh-ancestor
5523338|NCT04300049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6100315|NCT00939523|Lapatinib|lapatinib|mesh-list
6100316|NCT00939523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6100317|NCT00939523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6100318|NCT00939523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6100319|NCT00939523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523339|NCT04300049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523340|NCT04300049|Incretins|incretins|mesh-ancestor
5523341|NCT04300010|Benzoyl Peroxide|benzoyl peroxide|mesh-list
5523342|NCT04300010|Dermatologic Agents|dermatologic agents|mesh-ancestor
5523343|NCT04299971|Methotrexate|methotrexate|mesh-list
5523344|NCT04299971|Tofacitinib|tofacitinib|mesh-list
5523345|NCT04299971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5523346|NCT04299971|Abortifacient Agents|abortifacient agents|mesh-ancestor
5523347|NCT04299971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5523348|NCT04299971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100320|NCT00939536|Zolpidem|zolpidem|mesh-list
6100321|NCT00939536|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6100322|NCT00939536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6100323|NCT00939536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6100324|NCT00939536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100325|NCT00939536|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
5523349|NCT04299971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5523350|NCT04299971|Antimetabolites|antimetabolites|mesh-ancestor
5523351|NCT04299971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523352|NCT04299971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6100326|NCT00939536|GABA Agonists|gaba agonists|mesh-ancestor
6100327|NCT00939536|GABA Agents|gaba agents|mesh-ancestor
6100328|NCT00939536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6100329|NCT00939536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100330|NCT00939562|Doxycycline|doxycycline|mesh-list
6100331|NCT00939562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6100332|NCT00939562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6100333|NCT00939562|Antimalarials|antimalarials|mesh-ancestor
5523353|NCT04299971|Dermatologic Agents|dermatologic agents|mesh-ancestor
6100334|NCT00939562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6100335|NCT00939562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6100336|NCT00939627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6100337|NCT00939627|Cetuximab|cetuximab|mesh-list
6100338|NCT00939627|Sorafenib|sorafenib|mesh-list
6100339|NCT00939627|Antibodies|antibodies|mesh-list
6100340|NCT00939627|Immunoglobulins|immunoglobulins|mesh-list
6100341|NCT00939627|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6100342|NCT00939627|Immunologic Factors|immunologic factors|mesh-ancestor
6100343|NCT00939627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100344|NCT00939627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6100345|NCT00939627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6100346|NCT00939627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6100347|NCT00939627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100348|NCT00939653|Cytarabine|cytarabine|mesh-list
6100349|NCT00939653|Cyclophosphamide|cyclophosphamide|mesh-list
6100350|NCT00939653|Etoposide|etoposide|mesh-list
6100351|NCT00939653|Clofarabine|clofarabine|mesh-list
6100352|NCT00939653|Lenograstim|lenograstim|mesh-list
6100353|NCT00939653|Sargramostim|sargramostim|mesh-list
6100354|NCT00939653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6100355|NCT00939653|Immunologic Factors|immunologic factors|mesh-ancestor
6100356|NCT00939653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100357|NCT00939653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6100358|NCT00939653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6100359|NCT00939653|Alkylating Agents|alkylating agents|mesh-ancestor
6100360|NCT00939653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100361|NCT00939653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6100362|NCT00939653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6100363|NCT00939653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5523354|NCT04299971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5523355|NCT04299971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5523356|NCT04299971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5523357|NCT04299971|Immunologic Factors|immunologic factors|mesh-ancestor
5523358|NCT04299971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5523359|NCT04299971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5523360|NCT04299971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5523361|NCT04300127|Pioglitazone|pioglitazone|mesh-list
5523362|NCT04300127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5523363|NCT04300127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523364|NCT04299633|Calcium|calcium|mesh-list
6100364|NCT00939653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6100365|NCT00939653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6100366|NCT00939653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6100367|NCT00939653|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6100368|NCT00939653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6100369|NCT00939653|Antimetabolites|antimetabolites|mesh-ancestor
6100370|NCT00939653|Antiviral Agents|antiviral agents|mesh-ancestor
6100371|NCT00939653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6100372|NCT00939692|Topiramate|topiramate|mesh-list
6100373|NCT00939692|Anticonvulsants|anticonvulsants|mesh-ancestor
6100374|NCT00939692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6100375|NCT00939692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100376|NCT00939705|Topiramate|topiramate|mesh-list
6100377|NCT00939705|Anticonvulsants|anticonvulsants|mesh-ancestor
6100378|NCT00939705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6100379|NCT00939705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100380|NCT00939731|Crizotinib|crizotinib|mesh-list
6100381|NCT00939731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6100382|NCT00939731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6100383|NCT00939731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6100384|NCT00939731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523365|NCT04299633|Sevelamer|sevelamer|mesh-list
6100385|NCT00939770|Crizotinib|crizotinib|mesh-list
6100386|NCT00939770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6100387|NCT00939770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5523366|NCT04299633|Calcium acetate|calcium acetate|mesh-list
5523367|NCT04299633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5523368|NCT04299633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523369|NCT04299633|Chelating Agents|chelating agents|mesh-ancestor
5523370|NCT04299633|Sequestering Agents|sequestering agents|mesh-ancestor
5523371|NCT04299633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100388|NCT00939770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6100389|NCT00939770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100390|NCT00939822|Simvastatin|simvastatin|mesh-list
6100391|NCT00939822|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6100392|NCT00939822|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6100393|NCT00939822|Antimetabolites|antimetabolites|mesh-ancestor
6100394|NCT00939822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100395|NCT00939822|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6100396|NCT00939822|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6100397|NCT00939822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6100398|NCT00939874|Raltegravir Potassium|raltegravir potassium|mesh-list
6100399|NCT00939874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6100400|NCT00939874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6100401|NCT00939874|Antiviral Agents|antiviral agents|mesh-ancestor
6100402|NCT00939874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6100403|NCT00939874|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6100404|NCT00939874|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6100405|NCT00939874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6100406|NCT00939874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100407|NCT00939900|Zoledronic Acid|zoledronic acid|mesh-list
6100408|NCT00939900|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6100409|NCT00939900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100410|NCT00939952|Ertapenem|ertapenem|mesh-list
6100411|NCT00939952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6100412|NCT00939952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6100413|NCT00939991|Bevacizumab|bevacizumab|mesh-list
6100414|NCT00939991|Temozolomide|temozolomide|mesh-list
6100415|NCT00939991|Vorinostat|vorinostat|mesh-list
6100416|NCT00939991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6100417|NCT00939991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6100418|NCT00939991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6100419|NCT00939991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6100420|NCT00939991|Growth Substances|growth substances|mesh-ancestor
6100421|NCT00939991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100422|NCT00939991|Growth Inhibitors|growth inhibitors|mesh-ancestor
6100423|NCT00939991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6100424|NCT00939991|Alkylating Agents|alkylating agents|mesh-ancestor
6100425|NCT00939991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100426|NCT00939991|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6100427|NCT00939991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6100428|NCT00940017|Voriconazole|voriconazole|mesh-list
6100429|NCT00940017|Anidulafungin|anidulafungin|mesh-list
6100430|NCT00940017|Antifungal Agents|antifungal agents|mesh-ancestor
6100431|NCT00940017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6100432|NCT00940017|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6100433|NCT00940017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6100434|NCT00940017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6100435|NCT00940017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100436|NCT00940017|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6100437|NCT00940017|Hormone Antagonists|hormone antagonists|mesh-ancestor
6100438|NCT00940017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6100439|NCT00940017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523372|NCT04299854|Dinoprostone|dinoprostone|mesh-list
5523373|NCT04299854|Oxytocics|oxytocics|mesh-ancestor
5523374|NCT04299854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5523375|NCT04299854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523376|NCT04299438|Propranolol|propranolol|mesh-list
5523377|NCT04299438|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5523378|NCT04299438|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5523379|NCT04299438|Adrenergic Agents|adrenergic agents|mesh-ancestor
5523380|NCT04299438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5523381|NCT04299438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523382|NCT04299438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523383|NCT04299438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5523384|NCT04299438|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5523385|NCT04299438|Vasodilator Agents|vasodilator agents|mesh-ancestor
5523386|NCT04298983|Androgens|androgens|mesh-list
5523387|NCT04298983|Hormones|hormones|mesh-ancestor
5523388|NCT04298983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5523389|NCT04298983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523390|NCT04298775|Morphine|morphine|mesh-list
5523391|NCT04298775|Anesthetics|anesthetics|mesh-list
5523392|NCT04298775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5523393|NCT04298775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523394|NCT04298775|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5523395|NCT04298775|Narcotics|narcotics|mesh-ancestor
6100440|NCT00940017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6100441|NCT00940316|Irinotecan|irinotecan|mesh-list
6100442|NCT00940316|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6100443|NCT00940316|Panitumumab|panitumumab|mesh-list
6100444|NCT00940316|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6100445|NCT00940316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6100446|NCT00940316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6100447|NCT00940316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100448|NCT00940316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6100449|NCT00940316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6100450|NCT00940316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6100451|NCT00940342|Rituximab|rituximab|mesh-list
6100452|NCT00940342|Molgramostim|molgramostim|mesh-list
5523396|NCT04298775|Analgesics|analgesics|mesh-ancestor
5523397|NCT04298775|Sensory System Agents|sensory system agents|mesh-ancestor
5523398|NCT04298775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5601105|NCT03707795|Betamethasone acetate|betamethasone acetate|mesh-list
5601106|NCT03707795|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
5601107|NCT03707795|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
5601108|NCT03707795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5601109|NCT03707795|Glucocorticoids|glucocorticoids|mesh-ancestor
5601110|NCT03707795|Hormones|hormones|mesh-ancestor
5601111|NCT03707795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5601112|NCT03707795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601113|NCT03707795|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5601114|NCT03707795|Respiratory System Agents|respiratory system agents|mesh-ancestor
5601115|NCT03707795|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5601116|NCT03707795|Autonomic Agents|autonomic agents|mesh-ancestor
5601117|NCT03707795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5601118|NCT03707678|Albuterol|albuterol|mesh-list
5601119|NCT03707678|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5601120|NCT03707678|Autonomic Agents|autonomic agents|mesh-ancestor
5601121|NCT03707678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5601122|NCT03707678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601123|NCT03707678|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5601124|NCT03707678|Respiratory System Agents|respiratory system agents|mesh-ancestor
6100453|NCT00940342|Sargramostim|sargramostim|mesh-list
5601125|NCT03707678|Tocolytic Agents|tocolytic agents|mesh-ancestor
5601126|NCT03707678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6100454|NCT00940342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6100455|NCT00940342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6100456|NCT00940342|Immunologic Factors|immunologic factors|mesh-ancestor
6100457|NCT00940342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100458|NCT00940342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6100459|NCT00940485|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6100460|NCT00940485|Entecavir|entecavir|mesh-list
6100461|NCT00940485|Antiviral Agents|antiviral agents|mesh-ancestor
6100462|NCT00940485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6100463|NCT00940589|Melatonin|melatonin|mesh-list
6100464|NCT00940589|Antioxidants|antioxidants|mesh-ancestor
6100465|NCT00940589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100466|NCT00940589|Protective Agents|protective agents|mesh-ancestor
6100467|NCT00940589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100468|NCT00940589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6100469|NCT00940602|Deferasirox|deferasirox|mesh-list
6100470|NCT00940602|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6100471|NCT00940602|Chelating Agents|chelating agents|mesh-ancestor
6100472|NCT00940602|Sequestering Agents|sequestering agents|mesh-ancestor
6100473|NCT00940602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203771|NCT02061280|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6203772|NCT02061280|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6203773|NCT02061280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6203774|NCT02061280|Adrenergic Agents|adrenergic agents|mesh-ancestor
6203775|NCT02061280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6203776|NCT02061280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203777|NCT02061280|Glucocorticoids|glucocorticoids|mesh-ancestor
6203778|NCT02061280|Hormones|hormones|mesh-ancestor
6203779|NCT02061280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6203780|NCT02061280|Sympathomimetics|sympathomimetics|mesh-ancestor
6203781|NCT02061384|Calcitriol|calcitriol|mesh-list
6203782|NCT02061384|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
6203783|NCT02061384|Tretinoin|tretinoin|mesh-list
6203784|NCT02061384|Isotretinoin|isotretinoin|mesh-list
6203785|NCT02061384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6203786|NCT02061384|Keratolytic Agents|keratolytic agents|mesh-ancestor
6203787|NCT02061384|Dermatologic Agents|dermatologic agents|mesh-ancestor
6203788|NCT02061384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6203789|NCT02061384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203790|NCT02061384|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6203791|NCT02061384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6203792|NCT02061384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203793|NCT02061384|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6203794|NCT02061384|Vitamins|vitamins|mesh-ancestor
6203795|NCT02061384|Micronutrients|micronutrients|mesh-ancestor
6203796|NCT02061384|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6203797|NCT02061397|Sirolimus|sirolimus|mesh-list
6203798|NCT02061397|Everolimus|everolimus|mesh-list
6203799|NCT02061397|Simvastatin|simvastatin|mesh-list
6203800|NCT02061397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6203801|NCT02061397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6203802|NCT02061397|Immunologic Factors|immunologic factors|mesh-ancestor
6203803|NCT02061397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203804|NCT02061397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6203805|NCT02061397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6203806|NCT02061397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6203807|NCT02061397|Antifungal Agents|antifungal agents|mesh-ancestor
6203808|NCT02061397|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6203809|NCT02061397|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6203810|NCT02061397|Antimetabolites|antimetabolites|mesh-ancestor
6203811|NCT02061397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203812|NCT02061397|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6203813|NCT02061397|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6203814|NCT02061397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6207757|NCT02120157|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6207758|NCT02120157|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6207759|NCT02120157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6207760|NCT02120157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6207761|NCT02120157|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6207762|NCT02120157|Antitubercular Agents|antitubercular agents|mesh-ancestor
6207763|NCT02120157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6207764|NCT02120157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6207765|NCT02120261|Triamcinolone|triamcinolone|mesh-list
5523399|NCT04298528|Dronabinol|dronabinol|mesh-list
6207766|NCT02120261|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6100474|NCT00940771|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6100475|NCT00940771|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6100476|NCT00940771|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6100477|NCT00940771|Protease Inhibitors|protease inhibitors|mesh-ancestor
6100478|NCT00940771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6100479|NCT00940771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100480|NCT00940771|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6100481|NCT00940771|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6100482|NCT00940771|Antiviral Agents|antiviral agents|mesh-ancestor
6100483|NCT00940771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6100484|NCT00940875|Gemcitabine|gemcitabine|mesh-list
6100485|NCT00940875|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6100486|NCT00940875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6100487|NCT00940875|Antimetabolites|antimetabolites|mesh-ancestor
6100488|NCT00940875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100489|NCT00940875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6100490|NCT00940875|Antiviral Agents|antiviral agents|mesh-ancestor
6100491|NCT00940875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6100492|NCT00940875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6100493|NCT00940875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6100494|NCT00940875|Immunologic Factors|immunologic factors|mesh-ancestor
6100495|NCT00940875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100496|NCT00940875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6100497|NCT00940901|Sildenafil Citrate|sildenafil citrate|mesh-list
6100498|NCT00940901|Vasodilator Agents|vasodilator agents|mesh-ancestor
6100499|NCT00940901|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6100500|NCT00940901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6100501|NCT00940901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6100502|NCT00940901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100503|NCT00940901|Urological Agents|urological agents|mesh-ancestor
6100504|NCT00940927|Albuterol|albuterol|mesh-list
6100505|NCT00940927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6100506|NCT00940927|Autonomic Agents|autonomic agents|mesh-ancestor
6100507|NCT00940927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6100508|NCT00940927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100509|NCT00940927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6100510|NCT00940927|Respiratory System Agents|respiratory system agents|mesh-ancestor
6100511|NCT00940927|Tocolytic Agents|tocolytic agents|mesh-ancestor
6100512|NCT00940927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6100513|NCT00940927|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6100514|NCT00940927|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5523400|NCT04298528|Hallucinogens|hallucinogens|mesh-ancestor
5523401|NCT04298528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100515|NCT00940927|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6100516|NCT00940927|Adrenergic Agents|adrenergic agents|mesh-ancestor
6100517|NCT00940927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6100518|NCT00940927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665796|NCT01518855|Vasodilator Agents|vasodilator agents|mesh-ancestor
6665797|NCT01518855|Tocolytic Agents|tocolytic agents|mesh-ancestor
6665798|NCT01518855|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6665799|NCT01518933|Silybin|silybin|mesh-list
6665800|NCT01518933|Silymarin|silymarin|mesh-list
6665801|NCT01518933|Antioxidants|antioxidants|mesh-ancestor
6665802|NCT01518933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665803|NCT01518933|Protective Agents|protective agents|mesh-ancestor
6665804|NCT01518933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665805|NCT01518933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6100519|NCT00941031|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6100520|NCT00941031|Immunologic Factors|immunologic factors|mesh-ancestor
6100521|NCT00941031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100522|NCT00941070|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6100523|NCT00941070|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6100524|NCT00941070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100525|NCT00941304|Oxycodone|oxycodone|mesh-list
6100526|NCT00941304|Buprenorphine|buprenorphine|mesh-list
6100527|NCT00941304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6100528|NCT00941304|Narcotics|narcotics|mesh-ancestor
6100529|NCT00941304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6100530|NCT00941304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100531|NCT00941304|Analgesics|analgesics|mesh-ancestor
6100532|NCT00941304|Sensory System Agents|sensory system agents|mesh-ancestor
6100533|NCT00941304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6100534|NCT00941304|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6100535|NCT00941330|Cyclophosphamide|cyclophosphamide|mesh-list
6100536|NCT00941330|Docetaxel|docetaxel|mesh-list
5523402|NCT04298528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5523403|NCT04298528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5523404|NCT04298528|Analgesics|analgesics|mesh-ancestor
5523405|NCT04298528|Sensory System Agents|sensory system agents|mesh-ancestor
5523406|NCT04298528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6100537|NCT00941330|Exemestane|exemestane|mesh-list
6100538|NCT00941330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6100539|NCT00941330|Immunologic Factors|immunologic factors|mesh-ancestor
6100540|NCT00941330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100541|NCT00941330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6100542|NCT00941330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6100543|NCT00941330|Alkylating Agents|alkylating agents|mesh-ancestor
6100544|NCT00941330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100545|NCT00941330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6100546|NCT00941330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6100547|NCT00941330|Tubulin Modulators|tubulin modulators|mesh-ancestor
6100548|NCT00941330|Antimitotic Agents|antimitotic agents|mesh-ancestor
5523407|NCT04298528|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5523408|NCT04298528|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5523409|NCT04298528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5523410|NCT04298528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523411|NCT04298528|Hormones|hormones|mesh-ancestor
5523412|NCT04298528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5523413|NCT04298684|Metformin|metformin|mesh-list
5523414|NCT04298684|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5523415|NCT04298684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5523416|NCT04298684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523417|NCT04298684|Incretins|incretins|mesh-ancestor
5523418|NCT04298684|Hormones|hormones|mesh-ancestor
5523419|NCT04298684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5523420|NCT04298684|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5523421|NCT04298684|Protease Inhibitors|protease inhibitors|mesh-ancestor
5523422|NCT04298684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5523423|NCT04298684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523424|NCT04298372|Lenalidomide|lenalidomide|mesh-list
5523425|NCT04298372|Immunologic Factors|immunologic factors|mesh-ancestor
5523426|NCT04298372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523427|NCT04298372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5523428|NCT04298372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5523429|NCT04298372|Growth Substances|growth substances|mesh-ancestor
5523430|NCT04298372|Growth Inhibitors|growth inhibitors|mesh-ancestor
5523431|NCT04298372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5725241|NCT03181763|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5725242|NCT03181763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5725243|NCT03181763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5725244|NCT03181763|Adrenergic Agents|adrenergic agents|mesh-ancestor
5725245|NCT03181646|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
5725246|NCT03181646|Nootropic Agents|nootropic agents|mesh-ancestor
5725247|NCT03181685|Cetrorelix|cetrorelix|mesh-list
5725248|NCT03181685|Progesterone|progesterone|mesh-list
5725249|NCT03181685|Progestins|progestins|mesh-ancestor
5725250|NCT03181685|Hormones|hormones|mesh-ancestor
5725251|NCT03181685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5725252|NCT03181685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725253|NCT03181685|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5725254|NCT03181685|Fertility Agents|fertility agents|mesh-ancestor
5725255|NCT03181685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5725256|NCT03181685|Hormone Antagonists|hormone antagonists|mesh-ancestor
5725257|NCT03181464|Lidocaine|lidocaine|mesh-list
5725258|NCT03181464|Anesthetics, Local|anesthetics, local|mesh-ancestor
5725259|NCT03181464|Anesthetics|anesthetics|mesh-ancestor
5725260|NCT03181464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6100549|NCT00941330|Mitosis Modulators|mitosis modulators|mesh-ancestor
6100550|NCT00941330|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6100551|NCT00941330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6100552|NCT00941330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6100553|NCT00941330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6100554|NCT00941330|Hormone Antagonists|hormone antagonists|mesh-ancestor
6100555|NCT00941330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6100556|NCT00941655|Leucovorin|leucovorin|mesh-list
6100557|NCT00941655|Fluorouracil|fluorouracil|mesh-list
6100558|NCT00941655|Oxaliplatin|oxaliplatin|mesh-list
6100559|NCT00941655|Irinotecan|irinotecan|mesh-list
6100560|NCT00941655|Antimetabolites|antimetabolites|mesh-ancestor
6100561|NCT00941655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100562|NCT00941655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6100563|NCT00941655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6100564|NCT00941655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6100565|NCT00941655|Immunologic Factors|immunologic factors|mesh-ancestor
6100566|NCT00941655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100567|NCT00941655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6100568|NCT00941655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6100569|NCT00941655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6100570|NCT00941655|Antidotes|antidotes|mesh-ancestor
6100571|NCT00941655|Protective Agents|protective agents|mesh-ancestor
6100572|NCT00941655|Vitamin B Complex|vitamin b complex|mesh-ancestor
6100573|NCT00941655|Vitamins|vitamins|mesh-ancestor
6100574|NCT00941655|Micronutrients|micronutrients|mesh-ancestor
5523432|NCT04298463|Vancomycin|vancomycin|mesh-list
5523433|NCT04298463|Daptomycin|daptomycin|mesh-list
5523434|NCT04298463|Teicoplanin|teicoplanin|mesh-list
5523435|NCT04298463|Dalbavancin|dalbavancin|mesh-list
5523436|NCT04298463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5523437|NCT04298463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5523438|NCT04298541|Edotreotide|edotreotide|mesh-list
6100575|NCT00941668|Triclosan|triclosan|mesh-list
6100576|NCT00941668|Fluorides|fluorides|mesh-list
6100577|NCT00941668|Fluorophosphate|fluorophosphate|mesh-list
6100578|NCT00941668|Cariostatic Agents|cariostatic agents|mesh-ancestor
6100579|NCT00941668|Protective Agents|protective agents|mesh-ancestor
6100580|NCT00941668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100581|NCT00941668|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6100582|NCT00941668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6100583|NCT00941668|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6100584|NCT00941668|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6100585|NCT00941668|Antimetabolites|antimetabolites|mesh-ancestor
6100586|NCT00941668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100587|NCT00941668|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6100588|NCT00941720|Cyclophosphamide|cyclophosphamide|mesh-list
6100589|NCT00941720|Busulfan|busulfan|mesh-list
6100590|NCT00941720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6100591|NCT00941720|Immunologic Factors|immunologic factors|mesh-ancestor
6100592|NCT00941720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100593|NCT00941720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6100594|NCT00941720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6100595|NCT00941720|Alkylating Agents|alkylating agents|mesh-ancestor
6100596|NCT00941720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100597|NCT00941720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6100598|NCT00941720|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6100599|NCT00941798|Mometasone Furoate|mometasone furoate|mesh-list
6100600|NCT00941798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6100601|NCT00941798|Dermatologic Agents|dermatologic agents|mesh-ancestor
6100602|NCT00941798|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6100603|NCT00941863|Sorafenib|sorafenib|mesh-list
6100604|NCT00941863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6100605|NCT00941863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6100606|NCT00941863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6100607|NCT00941863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100608|NCT00942084|Acyclovir|acyclovir|mesh-list
6100609|NCT00942084|Antiviral Agents|antiviral agents|mesh-ancestor
6100610|NCT00942084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6100611|NCT00942149|Daptomycin|daptomycin|mesh-list
6100612|NCT00942149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6100613|NCT00942149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6100614|NCT00942175|Esomeprazole|esomeprazole|mesh-list
6100615|NCT00942175|Omeprazole|omeprazole|mesh-list
6100616|NCT00942175|Lansoprazole|lansoprazole|mesh-list
6100617|NCT00942175|Dexlansoprazole|dexlansoprazole|mesh-list
6100618|NCT00942175|Clopidogrel|clopidogrel|mesh-list
6100619|NCT00942175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6100620|NCT00942175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5523439|NCT04298541|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6100621|NCT00942175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6100622|NCT00942175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6100623|NCT00942175|Purinergic Agents|purinergic agents|mesh-ancestor
6100624|NCT00942175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6100625|NCT00942175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100626|NCT00942175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100627|NCT00942175|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6100628|NCT00942175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6100629|NCT00942175|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6100630|NCT00942175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6100631|NCT00942266|Calcium, Dietary|calcium, dietary|mesh-list
6100632|NCT00942266|Leucovorin|leucovorin|mesh-list
6100633|NCT00942266|Fluorouracil|fluorouracil|mesh-list
6100634|NCT00942266|Vorinostat|vorinostat|mesh-list
6100635|NCT00942266|Calcium|calcium|mesh-list
6100636|NCT00942266|Levoleucovorin|levoleucovorin|mesh-list
6100637|NCT00942266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6100638|NCT00942266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100639|NCT00942266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6100640|NCT00942266|Antimetabolites|antimetabolites|mesh-ancestor
6100641|NCT00942266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100642|NCT00942266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6100643|NCT00942266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6100644|NCT00942266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6100645|NCT00942266|Immunologic Factors|immunologic factors|mesh-ancestor
6100646|NCT00942266|Antidotes|antidotes|mesh-ancestor
6100647|NCT00942266|Protective Agents|protective agents|mesh-ancestor
6100648|NCT00942266|Vitamin B Complex|vitamin b complex|mesh-ancestor
6100649|NCT00942266|Vitamins|vitamins|mesh-ancestor
6100650|NCT00942266|Micronutrients|micronutrients|mesh-ancestor
6100651|NCT00942266|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6100652|NCT00942266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6100653|NCT00942305|Brincidofovir|brincidofovir|mesh-list
6100654|NCT00942305|Antiviral Agents|antiviral agents|mesh-ancestor
6100655|NCT00942305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6100656|NCT00942357|Paclitaxel|paclitaxel|mesh-list
6100657|NCT00942357|Cisplatin|cisplatin|mesh-list
6100658|NCT00942357|Carboplatin|carboplatin|mesh-list
5523440|NCT04298541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523441|NCT04298099|Ropivacaine|ropivacaine|mesh-list
5523442|NCT04298099|Anesthetics, Local|anesthetics, local|mesh-ancestor
5523443|NCT04298099|Anesthetics|anesthetics|mesh-ancestor
5523444|NCT04298099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6100659|NCT00942357|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6100660|NCT00942357|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6100661|NCT00942357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6100662|NCT00942357|Tubulin Modulators|tubulin modulators|mesh-ancestor
6100663|NCT00942357|Antimitotic Agents|antimitotic agents|mesh-ancestor
6100664|NCT00942357|Mitosis Modulators|mitosis modulators|mesh-ancestor
6100665|NCT00942357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100666|NCT00942422|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
6100667|NCT00942422|Antioxidants|antioxidants|mesh-ancestor
6100668|NCT00942422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100669|NCT00942422|Protective Agents|protective agents|mesh-ancestor
6100670|NCT00942422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100671|NCT00942422|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
6100672|NCT00942422|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6100673|NCT00942422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6100674|NCT00942422|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6100675|NCT00942448|Diclofenac|diclofenac|mesh-list
6100676|NCT00942448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6100677|NCT00942448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6100678|NCT00942448|Analgesics|analgesics|mesh-ancestor
6100679|NCT00942448|Sensory System Agents|sensory system agents|mesh-ancestor
6100680|NCT00942448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6100681|NCT00942448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100682|NCT00942448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6100683|NCT00942448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6100684|NCT00942448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6100685|NCT00942448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6100686|NCT00942448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100687|NCT00942578|Prednisone|prednisone|mesh-list
6100688|NCT00942578|Bevacizumab|bevacizumab|mesh-list
6100689|NCT00942578|Lenalidomide|lenalidomide|mesh-list
6100690|NCT00942578|Docetaxel|docetaxel|mesh-list
6100691|NCT00942578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6100692|NCT00942578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6100693|NCT00942578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6100694|NCT00942578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6100695|NCT00942578|Growth Substances|growth substances|mesh-ancestor
6100696|NCT00942578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100697|NCT00942578|Growth Inhibitors|growth inhibitors|mesh-ancestor
6100698|NCT00942578|Tubulin Modulators|tubulin modulators|mesh-ancestor
6100699|NCT00942578|Antimitotic Agents|antimitotic agents|mesh-ancestor
6100700|NCT00942578|Mitosis Modulators|mitosis modulators|mesh-ancestor
6100701|NCT00942578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100702|NCT00942578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6100703|NCT00942578|Glucocorticoids|glucocorticoids|mesh-ancestor
6100704|NCT00942578|Hormones|hormones|mesh-ancestor
6100705|NCT00942578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6100706|NCT00942578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6100707|NCT00942578|Immunologic Factors|immunologic factors|mesh-ancestor
6100708|NCT00942708|Fluoxetine|fluoxetine|mesh-list
6100709|NCT00942708|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6100710|NCT00942708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6100711|NCT00942708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6100712|NCT00942708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100713|NCT00942708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6100714|NCT00942708|Serotonin Agents|serotonin agents|mesh-ancestor
6100715|NCT00942708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100716|NCT00942708|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6100717|NCT00942708|Antidepressive Agents|antidepressive agents|mesh-ancestor
6100718|NCT00942708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6100719|NCT00942708|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6100720|NCT00942708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5523445|NCT04298099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100721|NCT00942708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6100722|NCT00942734|Everolimus|everolimus|mesh-list
6100723|NCT00942734|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6100724|NCT00942734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6100725|NCT00942734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6100726|NCT00942734|Immunologic Factors|immunologic factors|mesh-ancestor
6100727|NCT00942734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100728|NCT00942734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6100729|NCT00942734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6100730|NCT00942734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100731|NCT00942825|Cisplatin|cisplatin|mesh-list
6100732|NCT00942825|Pemetrexed|pemetrexed|mesh-list
6100733|NCT00942825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6100734|NCT00942825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6100735|NCT00942825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100736|NCT00942825|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5523446|NCT04298099|Sensory System Agents|sensory system agents|mesh-ancestor
5523447|NCT04298099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5523448|NCT04298697|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5523449|NCT04298697|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5523450|NCT04298697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5523451|NCT04298697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5523452|NCT04298697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523453|NCT04298697|Antiviral Agents|antiviral agents|mesh-ancestor
5523454|NCT04298697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5523455|NCT04298697|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5523456|NCT04298697|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5523457|NCT04298021|Durvalumab|durvalumab|mesh-list
5523458|NCT04298021|Olaparib|olaparib|mesh-list
5523459|NCT04298021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5523460|NCT04298021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5523461|NCT04298021|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5523462|NCT04298021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5523463|NCT04298021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523464|NCT04298008|Durvalumab|durvalumab|mesh-list
5523465|NCT04298008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5523466|NCT04298008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5523467|NCT04297839|Heparin|heparin|mesh-list
5523468|NCT04297839|Calcium heparin|calcium heparin|mesh-list
5523469|NCT04297839|Citric Acid|citric acid|mesh-list
6100737|NCT00942825|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6100738|NCT00942877|Cediranib|cediranib|mesh-list
6203815|NCT02061683|Bimatoprost|bimatoprost|mesh-list
5523470|NCT04297839|Sodium Citrate|sodium citrate|mesh-list
5523471|NCT04297839|Anticoagulants|anticoagulants|mesh-ancestor
5523472|NCT04297839|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5523473|NCT04297839|Chelating Agents|chelating agents|mesh-ancestor
6100739|NCT00942877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6100740|NCT00942877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6100741|NCT00942877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6100742|NCT00942877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100743|NCT00942968|Dalteparin|dalteparin|mesh-list
6100744|NCT00942968|Tinzaparin|tinzaparin|mesh-list
6100745|NCT00942968|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6100746|NCT00942968|Anticoagulants|anticoagulants|mesh-ancestor
6100747|NCT00942968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6100748|NCT00942968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6100749|NCT00942968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100750|NCT00942994|Amlodipine|amlodipine|mesh-list
6100751|NCT00942994|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6100752|NCT00942994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6100753|NCT00942994|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6100754|NCT00942994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6464932|NCT00471510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6464933|NCT00471510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6464934|NCT00471523|Metformin|metformin|mesh-list
6464935|NCT00471523|Clomiphene|clomiphene|mesh-list
6100755|NCT00942994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100756|NCT00942994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6100757|NCT00942994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100758|NCT00942994|Vasodilator Agents|vasodilator agents|mesh-ancestor
6100759|NCT00942994|Diuretics|diuretics|mesh-ancestor
6100760|NCT00942994|Natriuretic Agents|natriuretic agents|mesh-ancestor
6100761|NCT00942994|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6100762|NCT00943072|Aflibercept|aflibercept|mesh-list
6100763|NCT00943072|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6100764|NCT00943072|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6100765|NCT00943072|Growth Substances|growth substances|mesh-ancestor
6100766|NCT00943072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100767|NCT00943072|Growth Inhibitors|growth inhibitors|mesh-ancestor
6100768|NCT00943072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6100769|NCT00943098|Diclofenac|diclofenac|mesh-list
6100770|NCT00943098|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6100771|NCT00943098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6100772|NCT00943098|Analgesics|analgesics|mesh-ancestor
6100773|NCT00943098|Sensory System Agents|sensory system agents|mesh-ancestor
6100774|NCT00943098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6100775|NCT00943098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100776|NCT00943098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6100777|NCT00943098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6100778|NCT00943098|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6100779|NCT00943098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6464936|NCT00471523|Enclomiphene|enclomiphene|mesh-list
6464937|NCT00471523|Zuclomiphene|zuclomiphene|mesh-list
5523474|NCT04297839|Sequestering Agents|sequestering agents|mesh-ancestor
5523475|NCT04297839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523476|NCT04297839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5523477|NCT04297839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5523478|NCT04297215|Anti-Infective Agents|anti-infective agents|mesh-list
5523479|NCT04297215|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5523480|NCT04297215|Chitosan|chitosan|mesh-list
5523481|NCT04297215|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5523482|NCT04297215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5523483|NCT04297215|Antimetabolites|antimetabolites|mesh-ancestor
5523484|NCT04297215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523485|NCT04297215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5523486|NCT04297215|Chelating Agents|chelating agents|mesh-ancestor
5523487|NCT04297215|Sequestering Agents|sequestering agents|mesh-ancestor
5523488|NCT04297215|Hemostatics|hemostatics|mesh-ancestor
5523489|NCT04297215|Coagulants|coagulants|mesh-ancestor
5523490|NCT04297202|Apatinib|apatinib|mesh-list
5523491|NCT04297202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5523492|NCT04297202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5523493|NCT04297202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5523494|NCT04297202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523495|NCT04297176|Vancomycin|vancomycin|mesh-list
5523496|NCT04297176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5523497|NCT04297176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5523498|NCT04297254|Lenvatinib|lenvatinib|mesh-list
5523499|NCT04297254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5523500|NCT04297254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5523501|NCT04297254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5523502|NCT04297254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523503|NCT04297501|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
5523504|NCT04297501|Antiviral Agents|antiviral agents|mesh-ancestor
5523505|NCT04297501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5523506|NCT04297462|Oseltamivir|oseltamivir|mesh-list
5523507|NCT04297462|Antiviral Agents|antiviral agents|mesh-ancestor
5523508|NCT04297462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6464938|NCT00471523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6464939|NCT00471523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464940|NCT00471523|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6464941|NCT00471523|Hormone Antagonists|hormone antagonists|mesh-ancestor
6100780|NCT00943098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100781|NCT00943111|Eliglustat|eliglustat|mesh-list
6100782|NCT00943111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6100783|NCT00943111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100784|NCT00943124|Niacin|niacin|mesh-list
6100785|NCT00943124|Niacinamide|niacinamide|mesh-list
6100786|NCT00943124|Nicotinic Acids|nicotinic acids|mesh-list
6100787|NCT00943124|Simvastatin|simvastatin|mesh-list
6100788|NCT00943124|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6100789|NCT00943124|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6100790|NCT00943124|Antimetabolites|antimetabolites|mesh-ancestor
6100791|NCT00943124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100792|NCT00943124|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6100793|NCT00943124|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6100794|NCT00943124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6100795|NCT00943124|Vasodilator Agents|vasodilator agents|mesh-ancestor
6100796|NCT00943124|Vitamin B Complex|vitamin b complex|mesh-ancestor
6100797|NCT00943124|Vitamins|vitamins|mesh-ancestor
6100798|NCT00943124|Micronutrients|micronutrients|mesh-ancestor
6100799|NCT00943124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100800|NCT00943202|Vaccines|vaccines|mesh-list
6100801|NCT00943202|Immunologic Factors|immunologic factors|mesh-ancestor
6100802|NCT00943202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100803|NCT00943319|Fludarabine|fludarabine|mesh-list
6100804|NCT00943319|Busulfan|busulfan|mesh-list
6100805|NCT00943319|Alemtuzumab|alemtuzumab|mesh-list
6100806|NCT00943319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6100807|NCT00943319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100808|NCT00943319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6100809|NCT00943319|Immunologic Factors|immunologic factors|mesh-ancestor
6100810|NCT00943319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100811|NCT00943319|Alkylating Agents|alkylating agents|mesh-ancestor
6100812|NCT00943319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5523509|NCT04297462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5523510|NCT04297462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523511|NCT04297267|Gemcitabine|gemcitabine|mesh-list
5523512|NCT04297267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5523513|NCT04297267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5523514|NCT04297267|Antimetabolites|antimetabolites|mesh-ancestor
5523515|NCT04297267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523516|NCT04297267|Antiviral Agents|antiviral agents|mesh-ancestor
5523517|NCT04297267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5523518|NCT04297267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6100813|NCT00943319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5523519|NCT04297267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5523520|NCT04297267|Immunologic Factors|immunologic factors|mesh-ancestor
5523521|NCT04297267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523522|NCT04297332|Nicotine|nicotine|mesh-list
5523523|NCT04297332|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5523524|NCT04297332|Autonomic Agents|autonomic agents|mesh-ancestor
5523525|NCT04297332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5523526|NCT04297332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523527|NCT04297332|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5523528|NCT04297332|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5523529|NCT04297332|Cholinergic Agents|cholinergic agents|mesh-ancestor
6100814|NCT00943319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6100815|NCT00943592|Melphalan|melphalan|mesh-list
6100816|NCT00943592|Alemtuzumab|alemtuzumab|mesh-list
6100817|NCT00943592|Clofarabine|clofarabine|mesh-list
6100818|NCT00943592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6100819|NCT00943592|Alkylating Agents|alkylating agents|mesh-ancestor
6100820|NCT00943592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100821|NCT00943592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6100822|NCT00943592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6100823|NCT00943592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6100824|NCT00943592|Immunologic Factors|immunologic factors|mesh-ancestor
6100825|NCT00943592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100826|NCT00943592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6100827|NCT00943592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6100828|NCT00943592|Antimetabolites|antimetabolites|mesh-ancestor
6100829|NCT00943670|Trastuzumab|trastuzumab|mesh-list
6100830|NCT00943670|Pertuzumab|pertuzumab|mesh-list
6100831|NCT00943670|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
6100832|NCT00943670|Maytansine|maytansine|mesh-list
6100833|NCT00943670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6100834|NCT00943670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6100835|NCT00943670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6100836|NCT00943670|Tubulin Modulators|tubulin modulators|mesh-ancestor
6100837|NCT00943670|Antimitotic Agents|antimitotic agents|mesh-ancestor
6100838|NCT00943670|Mitosis Modulators|mitosis modulators|mesh-ancestor
6100839|NCT00943670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100840|NCT00943735|Fesoterodine|fesoterodine|mesh-list
6100841|NCT00943735|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6100842|NCT00943735|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6100843|NCT00943735|Cholinergic Agents|cholinergic agents|mesh-ancestor
6100844|NCT00943735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6100845|NCT00943735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100846|NCT00943735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100847|NCT00943735|Urological Agents|urological agents|mesh-ancestor
6100848|NCT00943761|Interferons|interferons|mesh-list
6100849|NCT00943761|Ribavirin|ribavirin|mesh-list
6100850|NCT00943761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6100851|NCT00943761|Antiviral Agents|antiviral agents|mesh-ancestor
6100852|NCT00943761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6100853|NCT00943761|Antimetabolites|antimetabolites|mesh-ancestor
6100854|NCT00943761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523530|NCT04297332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5523531|NCT04297332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601127|NCT03707678|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5601128|NCT03707678|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5601129|NCT03707678|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5601130|NCT03707678|Adrenergic Agents|adrenergic agents|mesh-ancestor
5601131|NCT03707678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5601132|NCT03707678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601133|NCT03707652|Vitamins|vitamins|mesh-list
5601134|NCT03707652|Niacinamide|niacinamide|mesh-list
5601135|NCT03707652|Niacin|niacin|mesh-list
5601136|NCT03707652|Nicotinic Acids|nicotinic acids|mesh-list
5601137|NCT03707652|Vitamin B Complex|vitamin b complex|mesh-list
5601138|NCT03707652|Micronutrients|micronutrients|mesh-ancestor
5601139|NCT03707652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601140|NCT03707652|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5601141|NCT03707652|Antimetabolites|antimetabolites|mesh-ancestor
5601142|NCT03707652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601143|NCT03707652|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5601144|NCT03707652|Vasodilator Agents|vasodilator agents|mesh-ancestor
5601145|NCT03707639|Apatinib|apatinib|mesh-list
5601146|NCT03707639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6100855|NCT00943787|Hypoglycemic Agents|hypoglycemic agents|mesh-list
5601147|NCT03707639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5523532|NCT04297072|Rivaroxaban|rivaroxaban|mesh-list
5523533|NCT04297072|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5523534|NCT04297072|Antithrombins|antithrombins|mesh-ancestor
5523535|NCT04297072|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5523536|NCT04297072|Protease Inhibitors|protease inhibitors|mesh-ancestor
5523537|NCT04297072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6100856|NCT00943787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100857|NCT00943800|Vidarabine|vidarabine|mesh-list
6100858|NCT00943800|Fludarabine|fludarabine|mesh-list
6100859|NCT00943800|Fludarabine phosphate|fludarabine phosphate|mesh-list
6100860|NCT00943800|Melphalan|melphalan|mesh-list
6100861|NCT00943800|Busulfan|busulfan|mesh-list
6100862|NCT00943800|Thiotepa|thiotepa|mesh-list
6100863|NCT00943800|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6100864|NCT00943800|Thymoglobulin|thymoglobulin|mesh-list
6100865|NCT00943800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6100866|NCT00943800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6100867|NCT00943800|Antimetabolites|antimetabolites|mesh-ancestor
6100868|NCT00943800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100869|NCT00943800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6100870|NCT00943800|Immunologic Factors|immunologic factors|mesh-ancestor
6100871|NCT00943800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100872|NCT00943800|Antiviral Agents|antiviral agents|mesh-ancestor
6100873|NCT00943800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6100874|NCT00943800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6100875|NCT00943800|Alkylating Agents|alkylating agents|mesh-ancestor
6100876|NCT00943800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6100877|NCT00943826|Bevacizumab|bevacizumab|mesh-list
6100878|NCT00943826|Temozolomide|temozolomide|mesh-list
6100879|NCT00943826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6100880|NCT00943826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6100881|NCT00943826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6100882|NCT00943826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6100883|NCT00943826|Growth Substances|growth substances|mesh-ancestor
6100884|NCT00943826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100885|NCT00943826|Growth Inhibitors|growth inhibitors|mesh-ancestor
6100886|NCT00943826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6100887|NCT00943826|Alkylating Agents|alkylating agents|mesh-ancestor
6100888|NCT00943826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523538|NCT04297072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523539|NCT04297072|Anticoagulants|anticoagulants|mesh-ancestor
5523540|NCT04296916|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5523541|NCT04296916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5523542|NCT04297033|Lovastatin|lovastatin|mesh-list
5523543|NCT04297033|L 647318|l 647318|mesh-list
6100889|NCT00943878|Vaccines|vaccines|mesh-list
6100890|NCT00943878|Immunologic Factors|immunologic factors|mesh-ancestor
6100891|NCT00943878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100892|NCT00943917|Exenatide|exenatide|mesh-list
6100893|NCT00943917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6100894|NCT00943917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100895|NCT00943917|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6100896|NCT00943917|Incretins|incretins|mesh-ancestor
6100897|NCT00943917|Hormones|hormones|mesh-ancestor
6100898|NCT00943917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6100899|NCT00944034|Vaccines|vaccines|mesh-list
6100900|NCT00944034|Immunologic Factors|immunologic factors|mesh-ancestor
6100901|NCT00944034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100902|NCT00944047|Paclitaxel|paclitaxel|mesh-list
6100903|NCT00944047|Cyclophosphamide|cyclophosphamide|mesh-list
6100904|NCT00944047|Doxorubicin|doxorubicin|mesh-list
6100905|NCT00944047|Trastuzumab|trastuzumab|mesh-list
6100906|NCT00944047|Mitogens|mitogens|mesh-list
6100907|NCT00944047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6100908|NCT00944047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6100909|NCT00944047|Tubulin Modulators|tubulin modulators|mesh-ancestor
6100910|NCT00944047|Antimitotic Agents|antimitotic agents|mesh-ancestor
6100911|NCT00944047|Mitosis Modulators|mitosis modulators|mesh-ancestor
6100912|NCT00944047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100913|NCT00944047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6100914|NCT00944047|Immunologic Factors|immunologic factors|mesh-ancestor
6100915|NCT00944047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100916|NCT00944047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6100917|NCT00944047|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6100918|NCT00944047|Alkylating Agents|alkylating agents|mesh-ancestor
6100919|NCT00944047|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5523544|NCT04297033|Dihydromevinolin|dihydromevinolin|mesh-list
6100920|NCT00944047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5523545|NCT04297033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5523546|NCT04297033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6100921|NCT00944047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6100922|NCT00944047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6100923|NCT00944047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6100924|NCT00944047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6100925|NCT00944450|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6100926|NCT00944450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6100927|NCT00944450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100928|NCT00944450|Incretins|incretins|mesh-ancestor
6100929|NCT00944450|Hormones|hormones|mesh-ancestor
6100930|NCT00944450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6100931|NCT00944450|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6100932|NCT00944450|Protease Inhibitors|protease inhibitors|mesh-ancestor
6100933|NCT00944450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6100934|NCT00944450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100935|NCT00944554|Varenicline|varenicline|mesh-list
6100936|NCT00944554|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6100937|NCT00944554|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6100938|NCT00944554|Cholinergic Agents|cholinergic agents|mesh-ancestor
6100939|NCT00944554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6100940|NCT00944554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100941|NCT00944554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100942|NCT00944645|Niacin|niacin|mesh-list
6100943|NCT00944645|Niacinamide|niacinamide|mesh-list
6100944|NCT00944645|Nicotinic Acids|nicotinic acids|mesh-list
6100945|NCT00944645|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6100946|NCT00944645|Antimetabolites|antimetabolites|mesh-ancestor
6100947|NCT00944645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100948|NCT00944645|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6100949|NCT00944645|Vasodilator Agents|vasodilator agents|mesh-ancestor
5523547|NCT04297033|Antimetabolites|antimetabolites|mesh-ancestor
5523548|NCT04297033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523549|NCT04297033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5523550|NCT04297033|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5523551|NCT04297033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5523552|NCT04296851|Niclosamide|niclosamide|mesh-list
5523553|NCT04296851|Anticestodal Agents|anticestodal agents|mesh-ancestor
5523554|NCT04296851|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5523555|NCT04296851|Anthelmintics|anthelmintics|mesh-ancestor
5523556|NCT04296851|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5523557|NCT04296851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5523558|NCT04296851|Antinematodal Agents|antinematodal agents|mesh-ancestor
5523559|NCT04296890|Maytansine|maytansine|mesh-list
5523560|NCT04296890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5523561|NCT04296890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5523562|NCT04296890|Tubulin Modulators|tubulin modulators|mesh-ancestor
6100950|NCT00944645|Vitamin B Complex|vitamin b complex|mesh-ancestor
6100951|NCT00944645|Vitamins|vitamins|mesh-ancestor
6100952|NCT00944645|Micronutrients|micronutrients|mesh-ancestor
6100953|NCT00944645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100954|NCT00944658|Apremilast|apremilast|mesh-list
6100955|NCT00944658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6100956|NCT00944658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6100957|NCT00944658|Analgesics|analgesics|mesh-ancestor
6100958|NCT00944658|Sensory System Agents|sensory system agents|mesh-ancestor
6100959|NCT00944658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6100960|NCT00944658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100961|NCT00944658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6100962|NCT00944658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6464942|NCT00471523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6464943|NCT00471523|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6464944|NCT00471523|Fertility Agents|fertility agents|mesh-ancestor
6464945|NCT00471523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6464946|NCT00471523|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6464947|NCT00471523|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6100963|NCT00944658|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6100964|NCT00944658|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6100965|NCT00944658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6100966|NCT00944658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100967|NCT00944671|Calcium, Dietary|calcium, dietary|mesh-list
6100968|NCT00944671|Calcium Carbonate|calcium carbonate|mesh-list
5523563|NCT04296890|Antimitotic Agents|antimitotic agents|mesh-ancestor
5523564|NCT04296890|Mitosis Modulators|mitosis modulators|mesh-ancestor
5523565|NCT04296890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523566|NCT04296422|Ibuprofen|ibuprofen|mesh-list
5523567|NCT04296422|Diclofenac|diclofenac|mesh-list
5523568|NCT04296422|Naproxen|naproxen|mesh-list
5523569|NCT04296422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
5523570|NCT04296422|Piroxicam|piroxicam|mesh-list
5523571|NCT04296422|Contraceptive Agents|contraceptive agents|mesh-list
5523572|NCT04296422|Contraceptives, Oral|contraceptives, oral|mesh-list
5523573|NCT04296422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5523574|NCT04296422|Analgesics|analgesics|mesh-ancestor
6100969|NCT00944671|Magnesium Hydroxide|magnesium hydroxide|mesh-list
6100970|NCT00944671|Famotidine|famotidine|mesh-list
6100971|NCT00944671|Calcium|calcium|mesh-list
6100972|NCT00944671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6100973|NCT00944671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100974|NCT00944671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6100975|NCT00944671|Antacids|antacids|mesh-ancestor
6100976|NCT00944671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6100977|NCT00944671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6100978|NCT00944671|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6100979|NCT00944671|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6100980|NCT00944671|Histamine Antagonists|histamine antagonists|mesh-ancestor
6100981|NCT00944671|Histamine Agents|histamine agents|mesh-ancestor
6100982|NCT00944671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6100983|NCT00944697|Oxycodone|oxycodone|mesh-list
6100984|NCT00944697|Naloxone|naloxone|mesh-list
6100985|NCT00944697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6100986|NCT00944697|Narcotics|narcotics|mesh-ancestor
6100987|NCT00944697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6100988|NCT00944697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6100989|NCT00944697|Analgesics|analgesics|mesh-ancestor
6100990|NCT00944697|Sensory System Agents|sensory system agents|mesh-ancestor
6100991|NCT00944697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6100992|NCT00944697|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6100993|NCT00944710|Atropine|atropine|mesh-list
6100994|NCT00944710|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6100995|NCT00944710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6100996|NCT00944710|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6100997|NCT00944710|Autonomic Agents|autonomic agents|mesh-ancestor
6100998|NCT00944710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6100999|NCT00944710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101000|NCT00944710|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6101001|NCT00944710|Respiratory System Agents|respiratory system agents|mesh-ancestor
6101002|NCT00944710|Mydriatics|mydriatics|mesh-ancestor
6101003|NCT00944710|Parasympatholytics|parasympatholytics|mesh-ancestor
6101004|NCT00944710|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6101005|NCT00944710|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6101006|NCT00944710|Cholinergic Agents|cholinergic agents|mesh-ancestor
6101007|NCT00944710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6101008|NCT00944710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101009|NCT00944749|Cyclosporine|cyclosporine|mesh-list
6101010|NCT00944749|Cyclosporins|cyclosporins|mesh-list
6101011|NCT00944749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6101012|NCT00944749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101013|NCT00944749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6101014|NCT00944749|Immunologic Factors|immunologic factors|mesh-ancestor
6101015|NCT00944749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101016|NCT00944749|Antifungal Agents|antifungal agents|mesh-ancestor
6101017|NCT00944749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6101018|NCT00944749|Dermatologic Agents|dermatologic agents|mesh-ancestor
6101019|NCT00944749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6101020|NCT00944749|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6101021|NCT00945009|Dactinomycin|dactinomycin|mesh-list
6101022|NCT00945009|Cactinomycin|cactinomycin|mesh-list
6101023|NCT00945009|Doxorubicin|doxorubicin|mesh-list
6101024|NCT00945009|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6101025|NCT00945009|Vincristine|vincristine|mesh-list
5523575|NCT04296422|Sensory System Agents|sensory system agents|mesh-ancestor
5523576|NCT04296422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6101026|NCT00945009|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5523577|NCT04296422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523578|NCT04296422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5523579|NCT04296422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5523580|NCT04296422|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5523581|NCT04296422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5523582|NCT04296422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523583|NCT04296422|Gout Suppressants|gout suppressants|mesh-ancestor
5523584|NCT04296422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6101027|NCT00945009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6101028|NCT00945009|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6101029|NCT00945009|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6101030|NCT00945009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6101031|NCT00945009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101032|NCT00945009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6101033|NCT00945009|Tubulin Modulators|tubulin modulators|mesh-ancestor
6101034|NCT00945009|Antimitotic Agents|antimitotic agents|mesh-ancestor
6101035|NCT00945009|Mitosis Modulators|mitosis modulators|mesh-ancestor
6101036|NCT00945009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6101037|NCT00945009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6101038|NCT00945009|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6101039|NCT00945009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6101040|NCT00945139|Bevacizumab|bevacizumab|mesh-list
6101041|NCT00945139|Doxorubicin|doxorubicin|mesh-list
6101042|NCT00945139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6101043|NCT00945139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6101044|NCT00945139|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6101045|NCT00945139|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6101046|NCT00945139|Growth Substances|growth substances|mesh-ancestor
6101047|NCT00945139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101048|NCT00945139|Growth Inhibitors|growth inhibitors|mesh-ancestor
6101049|NCT00945139|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6101050|NCT00945139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6101051|NCT00945139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6101052|NCT00945139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6101053|NCT00945139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101054|NCT00945191|Paclitaxel|paclitaxel|mesh-list
6101055|NCT00945191|Carboplatin|carboplatin|mesh-list
6101056|NCT00945191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6101057|NCT00945191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6101058|NCT00945191|Tubulin Modulators|tubulin modulators|mesh-ancestor
6101059|NCT00945191|Antimitotic Agents|antimitotic agents|mesh-ancestor
6101060|NCT00945191|Mitosis Modulators|mitosis modulators|mesh-ancestor
6101061|NCT00945191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101062|NCT00945256|Nitroprusside|nitroprusside|mesh-list
6101063|NCT00945256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6101064|NCT00945256|Vasodilator Agents|vasodilator agents|mesh-ancestor
6101065|NCT00945256|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6101066|NCT00945256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101067|NCT00945282|Ritonavir|ritonavir|mesh-list
6101068|NCT00945282|Lopinavir|lopinavir|mesh-list
6101069|NCT00945282|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6101070|NCT00945282|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6101071|NCT00945282|Protease Inhibitors|protease inhibitors|mesh-ancestor
6101072|NCT00945282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6101073|NCT00945282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101074|NCT00945282|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6101075|NCT00945282|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6101076|NCT00945282|Antiviral Agents|antiviral agents|mesh-ancestor
6101077|NCT00945282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6101078|NCT00945282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6101079|NCT00945282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6101080|NCT00945295|Botulinum Toxins|botulinum toxins|mesh-list
6101081|NCT00945295|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6101082|NCT00945295|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6101083|NCT00945295|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6101084|NCT00945295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6101085|NCT00945295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101086|NCT00945295|Cholinergic Agents|cholinergic agents|mesh-ancestor
6101087|NCT00945295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6101088|NCT00945295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101089|NCT00945295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6101090|NCT00945295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6101091|NCT00945321|Aprepitant|aprepitant|mesh-list
6464948|NCT00471549|Simvastatin|simvastatin|mesh-list
6464949|NCT00471549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6464950|NCT00471549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6464951|NCT00471549|Antimetabolites|antimetabolites|mesh-ancestor
6464952|NCT00471549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6464953|NCT00471549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6464954|NCT00471549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6464955|NCT00471549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6464956|NCT00471562|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
6464957|NCT00471562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6464958|NCT00471562|Vasodilator Agents|vasodilator agents|mesh-ancestor
6464959|NCT00471588|Pramipexole|pramipexole|mesh-list
6464960|NCT00471588|Amisulpride|amisulpride|mesh-list
6464961|NCT00471588|Antioxidants|antioxidants|mesh-ancestor
6464962|NCT00471588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6464963|NCT00471588|Protective Agents|protective agents|mesh-ancestor
6464964|NCT00471588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464965|NCT00471588|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6464966|NCT00471588|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6464967|NCT00471588|Dopamine Agonists|dopamine agonists|mesh-ancestor
6464968|NCT00471588|Dopamine Agents|dopamine agents|mesh-ancestor
6101092|NCT00945321|Fosaprepitant|fosaprepitant|mesh-list
6101093|NCT00945321|Antiemetics|antiemetics|mesh-ancestor
6101094|NCT00945321|Autonomic Agents|autonomic agents|mesh-ancestor
6101095|NCT00945321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6101096|NCT00945321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101097|NCT00945321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6101098|NCT00945321|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6101099|NCT00945321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6101100|NCT00945321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101101|NCT00945334|Rifaximin|rifaximin|mesh-list
6101102|NCT00945334|Neomycin|neomycin|mesh-list
6101103|NCT00945334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6101104|NCT00945334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6101105|NCT00945334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6101106|NCT00945334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6101107|NCT00945334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6101108|NCT00945334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101109|NCT00945555|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6101110|NCT00945555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6101111|NCT00945750|Famotidine|famotidine|mesh-list
6101112|NCT00945750|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6101113|NCT00945750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6101114|NCT00945750|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6101115|NCT00945750|Histamine Antagonists|histamine antagonists|mesh-ancestor
6101116|NCT00945750|Histamine Agents|histamine agents|mesh-ancestor
6101117|NCT00945750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6101118|NCT00945750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101119|NCT00945750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101120|NCT00945815|Cytarabine|cytarabine|mesh-list
6101121|NCT00945815|Clofarabine|clofarabine|mesh-list
6101122|NCT00945815|Epratuzumab|epratuzumab|mesh-list
6101123|NCT00945815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6101124|NCT00945815|Antimetabolites|antimetabolites|mesh-ancestor
6101125|NCT00945815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101126|NCT00945815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6101127|NCT00945815|Antiviral Agents|antiviral agents|mesh-ancestor
6101128|NCT00945815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6101129|NCT00945815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6101130|NCT00945815|Immunologic Factors|immunologic factors|mesh-ancestor
6101131|NCT00945815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101132|NCT00945815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6203816|NCT02061683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6203817|NCT02061774|Acetaminophen|acetaminophen|mesh-list
6203818|NCT02061774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6203819|NCT02061774|Analgesics|analgesics|mesh-ancestor
5523585|NCT04296422|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5523586|NCT04296578|Selenious Acid|selenious acid|mesh-list
5523587|NCT04296578|Sodium Selenite|sodium selenite|mesh-list
5523588|NCT04296578|Prednisone|prednisone|mesh-list
5523589|NCT04296578|Abiraterone Acetate|abiraterone acetate|mesh-list
5523590|NCT04296578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6203820|NCT02061774|Sensory System Agents|sensory system agents|mesh-ancestor
6464969|NCT00471588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5523591|NCT04296578|Glucocorticoids|glucocorticoids|mesh-ancestor
5523592|NCT04296578|Hormones|hormones|mesh-ancestor
6464970|NCT00471588|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6101133|NCT00945906|Fibrinolysin|fibrinolysin|mesh-list
6101134|NCT00945906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5523593|NCT04296578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5523594|NCT04296578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523595|NCT04296578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5523596|NCT04296578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5523597|NCT04296578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5523598|NCT04296578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5523599|NCT04296578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523600|NCT04296578|Hormone Antagonists|hormone antagonists|mesh-ancestor
5523601|NCT04296578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5523602|NCT04296578|Trace Elements|trace elements|mesh-ancestor
5523603|NCT04296578|Micronutrients|micronutrients|mesh-ancestor
5523604|NCT04296695|Tenofovir|tenofovir|mesh-list
5523605|NCT04296695|Efavirenz|efavirenz|mesh-list
5523606|NCT04296695|Antiviral Agents|antiviral agents|mesh-ancestor
5523607|NCT04296695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5523608|NCT04296695|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5523609|NCT04296695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6101135|NCT00945906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6101136|NCT00945906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101137|NCT00945945|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6101138|NCT00945945|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6101139|NCT00945945|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6101140|NCT00945945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6101141|NCT00945945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101142|NCT00945945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6101143|NCT00945945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101144|NCT00945945|Analgesics|analgesics|mesh-ancestor
6101145|NCT00945945|Sensory System Agents|sensory system agents|mesh-ancestor
6101146|NCT00945945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6101147|NCT00945945|Antidepressive Agents|antidepressive agents|mesh-ancestor
6101148|NCT00945945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6101149|NCT00945945|Dopamine Agents|dopamine agents|mesh-ancestor
6101150|NCT00946023|Mycophenolic Acid|mycophenolic acid|mesh-list
6101151|NCT00946023|Cyclophosphamide|cyclophosphamide|mesh-list
6101152|NCT00946023|Rituximab|rituximab|mesh-list
6101153|NCT00946023|Fludarabine|fludarabine|mesh-list
6101154|NCT00946023|Tacrolimus|tacrolimus|mesh-list
6101155|NCT00946023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6101156|NCT00946023|Immunologic Factors|immunologic factors|mesh-ancestor
6101157|NCT00946023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101158|NCT00946023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6101159|NCT00946023|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6101160|NCT00946023|Alkylating Agents|alkylating agents|mesh-ancestor
6101161|NCT00946023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101162|NCT00946023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6101163|NCT00946023|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6101164|NCT00946023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6101165|NCT00946023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6101166|NCT00946023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6101167|NCT00946023|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6101168|NCT00946023|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5523610|NCT04296695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5523611|NCT04296695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523612|NCT04296695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5523613|NCT04296695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5523614|NCT04296695|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5523615|NCT04296695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5523616|NCT04296695|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5523617|NCT04296695|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5523618|NCT04296695|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5523619|NCT04296695|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5523620|NCT04296214|Azacitidine|azacitidine|mesh-list
5523621|NCT04296214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5523622|NCT04296214|Antimetabolites|antimetabolites|mesh-ancestor
5523623|NCT04296214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523624|NCT04296214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5523625|NCT04296214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5523626|NCT04296240|Capecitabine|capecitabine|mesh-list
5523627|NCT04296240|Oxaliplatin|oxaliplatin|mesh-list
5523628|NCT04296240|Antiemetics|antiemetics|mesh-list
6101169|NCT00946023|Antitubercular Agents|antitubercular agents|mesh-ancestor
6101170|NCT00946023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6101171|NCT00946023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6101172|NCT00946088|Progesterone|progesterone|mesh-list
6101173|NCT00946088|Progestins|progestins|mesh-ancestor
6101174|NCT00946088|Hormones|hormones|mesh-ancestor
6101175|NCT00946088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6101176|NCT00946088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101177|NCT00946114|Sildenafil Citrate|sildenafil citrate|mesh-list
6101178|NCT00946114|Vasodilator Agents|vasodilator agents|mesh-ancestor
6101179|NCT00946114|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6101180|NCT00946114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6101181|NCT00946114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6101182|NCT00946114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101183|NCT00946114|Urological Agents|urological agents|mesh-ancestor
6101184|NCT00946153|Lenvatinib|lenvatinib|mesh-list
6101185|NCT00946153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6101186|NCT00946153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6101187|NCT00946153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6101188|NCT00946153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101189|NCT00946192|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6101190|NCT00946192|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6101191|NCT00946192|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6101192|NCT00946192|Desogestrel|desogestrel|mesh-list
6101193|NCT00946192|Estradiol|estradiol|mesh-list
6101194|NCT00946192|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6101195|NCT00946192|Progesterone|progesterone|mesh-list
6101196|NCT00946192|Estrogens|estrogens|mesh-ancestor
6101197|NCT00946192|Hormones|hormones|mesh-ancestor
6101198|NCT00946192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6101199|NCT00946192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101200|NCT00946192|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6101201|NCT00946192|Contraceptive Agents|contraceptive agents|mesh-ancestor
5523629|NCT04296240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5523630|NCT04296240|Antimetabolites|antimetabolites|mesh-ancestor
5523631|NCT04296240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523632|NCT04296240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5523633|NCT04296240|Autonomic Agents|autonomic agents|mesh-ancestor
5523634|NCT04296240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6101202|NCT00946192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6101203|NCT00946192|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6101204|NCT00946192|Progestins|progestins|mesh-ancestor
6101205|NCT00946192|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6101206|NCT00946192|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6101207|NCT00946192|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6101208|NCT00946270|Thalidomide|thalidomide|mesh-list
6101209|NCT00946270|Prednisone|prednisone|mesh-list
6101210|NCT00946270|Pomalidomide|pomalidomide|mesh-list
6101211|NCT00946270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6101212|NCT00946270|Glucocorticoids|glucocorticoids|mesh-ancestor
5523635|NCT04296240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523636|NCT04296240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6101213|NCT00946270|Hormones|hormones|mesh-ancestor
6101214|NCT00946270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6101215|NCT00946270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101216|NCT00946270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6101217|NCT00946270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6101218|NCT00946270|Immunologic Factors|immunologic factors|mesh-ancestor
6101219|NCT00946270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6101220|NCT00946270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6101221|NCT00946270|Growth Substances|growth substances|mesh-ancestor
6101222|NCT00946270|Growth Inhibitors|growth inhibitors|mesh-ancestor
5523637|NCT04296370|Apatinib|apatinib|mesh-list
5523638|NCT04296370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5523639|NCT04296370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5523640|NCT04296370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6101223|NCT00946270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6101224|NCT00946270|Leprostatic Agents|leprostatic agents|mesh-ancestor
6101225|NCT00946270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6101226|NCT00946270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6101227|NCT00946309|Sulforaphane|sulforaphane|mesh-list
5523641|NCT04296370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523642|NCT04296383|Azithromycin|azithromycin|mesh-list
6101228|NCT00946309|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6101229|NCT00946309|Protective Agents|protective agents|mesh-ancestor
6101230|NCT00946309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101231|NCT00946309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6101232|NCT00946348|Dronabinol|dronabinol|mesh-list
5523643|NCT04296383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5523644|NCT04296383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5523645|NCT04296006|Amphetamine|amphetamine|mesh-list
5523646|NCT04296006|Dextroamphetamine|dextroamphetamine|mesh-list
5523647|NCT04296006|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5523648|NCT04296006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523649|NCT04296006|Sympathomimetics|sympathomimetics|mesh-ancestor
6101233|NCT00946348|Hallucinogens|hallucinogens|mesh-ancestor
6101234|NCT00946348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101235|NCT00946348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6101236|NCT00946348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6101237|NCT00946348|Analgesics|analgesics|mesh-ancestor
6101238|NCT00946348|Sensory System Agents|sensory system agents|mesh-ancestor
6101239|NCT00946348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6101240|NCT00946348|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6101241|NCT00946348|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6101242|NCT00946348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6101243|NCT00946348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101244|NCT00946348|Hormones|hormones|mesh-ancestor
6101245|NCT00946348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6101246|NCT00946478|Pimecrolimus|pimecrolimus|mesh-list
6101247|NCT00946478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6101248|NCT00946478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6101249|NCT00946478|Analgesics|analgesics|mesh-ancestor
6101250|NCT00946478|Sensory System Agents|sensory system agents|mesh-ancestor
6101251|NCT00946478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6101252|NCT00946478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101253|NCT00946478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6101254|NCT00946478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6101255|NCT00946478|Dermatologic Agents|dermatologic agents|mesh-ancestor
6101256|NCT00946478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6101257|NCT00946478|Immunologic Factors|immunologic factors|mesh-ancestor
6101258|NCT00946478|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5523650|NCT04296006|Autonomic Agents|autonomic agents|mesh-ancestor
5523651|NCT04296006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5523652|NCT04296006|Dopamine Agents|dopamine agents|mesh-ancestor
5523653|NCT04296006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5523654|NCT04296006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523655|NCT04296006|Adrenergic Agents|adrenergic agents|mesh-ancestor
5523656|NCT04296006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5523657|NCT04296006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5523658|NCT04296006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5523659|NCT04296006|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5523660|NCT04296175|Paclitaxel|paclitaxel|mesh-list
5523661|NCT04296175|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5523662|NCT04296175|Carboplatin|carboplatin|mesh-list
5523663|NCT04296175|Epirubicin|epirubicin|mesh-list
6101259|NCT00946478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6101260|NCT00946478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101261|NCT00946647|Azacitidine|azacitidine|mesh-list
6101262|NCT00946647|Panobinostat|panobinostat|mesh-list
6101263|NCT00946647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6101264|NCT00946647|Antimetabolites|antimetabolites|mesh-ancestor
6101265|NCT00946647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101266|NCT00946647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6464971|NCT00471588|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6464972|NCT00471588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6464973|NCT00471588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6464974|NCT00471588|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6464975|NCT00471588|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6464976|NCT00471588|Antidepressive Agents|antidepressive agents|mesh-ancestor
6101267|NCT00946647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6101268|NCT00946647|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6101269|NCT00946712|Paclitaxel|paclitaxel|mesh-list
6101270|NCT00946712|Bevacizumab|bevacizumab|mesh-list
6101271|NCT00946712|Carboplatin|carboplatin|mesh-list
6101272|NCT00946712|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6101273|NCT00946712|Cetuximab|cetuximab|mesh-list
6101274|NCT00946712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6464977|NCT00471627|Pancrelipase|pancrelipase|mesh-list
5523664|NCT04296175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6464978|NCT00471627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6101275|NCT00946712|Endothelial Growth Factors|endothelial growth factors|mesh-list
5523665|NCT04296175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5523666|NCT04296175|Tubulin Modulators|tubulin modulators|mesh-ancestor
5523667|NCT04296175|Antimitotic Agents|antimitotic agents|mesh-ancestor
5523668|NCT04296175|Mitosis Modulators|mitosis modulators|mesh-ancestor
5523669|NCT04296175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101276|NCT00946712|Antibodies|antibodies|mesh-list
6101277|NCT00946712|Immunoglobulins|immunoglobulins|mesh-list
6101278|NCT00946712|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6101279|NCT00946712|Immunoglobulin G|immunoglobulin g|mesh-list
6101280|NCT00946712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6101281|NCT00946712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6101282|NCT00946712|Tubulin Modulators|tubulin modulators|mesh-ancestor
6101283|NCT00946712|Antimitotic Agents|antimitotic agents|mesh-ancestor
6101284|NCT00946712|Mitosis Modulators|mitosis modulators|mesh-ancestor
6101285|NCT00946712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101286|NCT00946712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6101287|NCT00946712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6101288|NCT00946712|Growth Substances|growth substances|mesh-ancestor
6101289|NCT00946712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101290|NCT00946712|Growth Inhibitors|growth inhibitors|mesh-ancestor
6101291|NCT00946712|Immunologic Factors|immunologic factors|mesh-ancestor
6101292|NCT00946920|Goserelin|goserelin|mesh-list
6101293|NCT00946920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6101294|NCT00946920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6101295|NCT00946998|Sertraline|sertraline|mesh-list
6101296|NCT00946998|Antidepressive Agents|antidepressive agents|mesh-ancestor
6101297|NCT00946998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6101298|NCT00946998|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6101299|NCT00946998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6101300|NCT00946998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6101301|NCT00946998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101302|NCT00946998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6101303|NCT00946998|Serotonin Agents|serotonin agents|mesh-ancestor
6101304|NCT00946998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101305|NCT00947154|Aripiprazole|aripiprazole|mesh-list
6101306|NCT00947154|Antidepressive Agents|antidepressive agents|mesh-ancestor
6101307|NCT00947154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6101308|NCT00947154|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6101309|NCT00947154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6101310|NCT00947154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6101311|NCT00947154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101312|NCT00947154|Dopamine Agonists|dopamine agonists|mesh-ancestor
6101313|NCT00947154|Dopamine Agents|dopamine agents|mesh-ancestor
6101314|NCT00947154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6101315|NCT00947154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6464979|NCT00471640|Dexamethasone|dexamethasone|mesh-list
6665806|NCT01518933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6665807|NCT01518959|Cholecalciferol|cholecalciferol|mesh-list
6665808|NCT01518959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6464980|NCT00471640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6464981|NCT00471640|Antiemetics|antiemetics|mesh-ancestor
6464982|NCT00471640|Autonomic Agents|autonomic agents|mesh-ancestor
6464983|NCT00471640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6464984|NCT00471640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6464985|NCT00471640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6464986|NCT00471640|Glucocorticoids|glucocorticoids|mesh-ancestor
6464987|NCT00471640|Hormones|hormones|mesh-ancestor
6101316|NCT00947154|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6101317|NCT00947154|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6101318|NCT00947154|Serotonin Agents|serotonin agents|mesh-ancestor
6101319|NCT00947154|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6101320|NCT00947154|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6101321|NCT00947154|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6101322|NCT00947154|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6101323|NCT00947167|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6101324|NCT00947167|Pertuzumab|pertuzumab|mesh-list
6101325|NCT00947167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6101326|NCT00947167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6101327|NCT00947167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6101328|NCT00947167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101329|NCT00947167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6101330|NCT00947297|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
5523670|NCT04296175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5523671|NCT04296175|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5523672|NCT04296175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5523673|NCT04296175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5523674|NCT04296162|Capecitabine|capecitabine|mesh-list
6101331|NCT00947297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6101332|NCT00947349|Interferons|interferons|mesh-list
6101333|NCT00947349|Ribavirin|ribavirin|mesh-list
6101334|NCT00947349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6101335|NCT00947349|Antiviral Agents|antiviral agents|mesh-ancestor
6101336|NCT00947349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6101337|NCT00947349|Antimetabolites|antimetabolites|mesh-ancestor
6101338|NCT00947349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101339|NCT00947427|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6101340|NCT00947427|Immunologic Factors|immunologic factors|mesh-ancestor
6101341|NCT00947427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101342|NCT00947531|Cerebrolysin|cerebrolysin|mesh-list
6101343|NCT00947531|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6101344|NCT00947531|Protective Agents|protective agents|mesh-ancestor
6101345|NCT00947531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101346|NCT00947531|Nootropic Agents|nootropic agents|mesh-ancestor
6101347|NCT00947544|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
6101348|NCT00947544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6101349|NCT00947752|Glatiramer Acetate|glatiramer acetate|mesh-list
6101350|NCT00947752|(T,G)-A-L|(t,g)-a-l|mesh-list
6101351|NCT00947752|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6101352|NCT00947752|Immunologic Factors|immunologic factors|mesh-ancestor
6101353|NCT00947752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101354|NCT00947752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6101355|NCT00947752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6101356|NCT00947765|Prednisolone|prednisolone|mesh-list
6101357|NCT00947765|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6101358|NCT00947765|Methylprednisolone|methylprednisolone|mesh-list
6101359|NCT00947765|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6101360|NCT00947765|Prednisolone acetate|prednisolone acetate|mesh-list
6101361|NCT00947765|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6101362|NCT00947765|Prednisolone phosphate|prednisolone phosphate|mesh-list
5523675|NCT04296162|Trastuzumab|trastuzumab|mesh-list
5523676|NCT04296162|Vinorelbine|vinorelbine|mesh-list
5523677|NCT04296162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5523678|NCT04296162|Antimetabolites|antimetabolites|mesh-ancestor
5523679|NCT04296162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523680|NCT04296162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5523681|NCT04296162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5523682|NCT04296162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5523683|NCT04296162|Tubulin Modulators|tubulin modulators|mesh-ancestor
5523684|NCT04296162|Antimitotic Agents|antimitotic agents|mesh-ancestor
5523685|NCT04296162|Mitosis Modulators|mitosis modulators|mesh-ancestor
5523686|NCT04295993|Norepinephrine|norepinephrine|mesh-list
6101363|NCT00947765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6101364|NCT00947765|Glucocorticoids|glucocorticoids|mesh-ancestor
6101365|NCT00947765|Hormones|hormones|mesh-ancestor
6101366|NCT00947765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6101367|NCT00947765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101368|NCT00947765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6101369|NCT00947765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6101370|NCT00947765|Antiemetics|antiemetics|mesh-ancestor
6101371|NCT00947765|Autonomic Agents|autonomic agents|mesh-ancestor
6101372|NCT00947765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5523687|NCT04295993|Methylene Blue|methylene blue|mesh-list
6101373|NCT00947765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6101374|NCT00947765|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6101375|NCT00947765|Protective Agents|protective agents|mesh-ancestor
6101376|NCT00947856|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6101377|NCT00947856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6101378|NCT00947856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6101379|NCT00948064|Azacitidine|azacitidine|mesh-list
6101380|NCT00948064|Vorinostat|vorinostat|mesh-list
6101381|NCT00948064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6101382|NCT00948064|Antimetabolites|antimetabolites|mesh-ancestor
6101383|NCT00948064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101384|NCT00948064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6101385|NCT00948064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6101386|NCT00948064|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6101387|NCT00948090|Cyclophosphamide|cyclophosphamide|mesh-list
6101388|NCT00948090|Busulfan|busulfan|mesh-list
6101389|NCT00948090|Etoposide|etoposide|mesh-list
6101390|NCT00948090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6101391|NCT00948090|Immunologic Factors|immunologic factors|mesh-ancestor
6101392|NCT00948090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101393|NCT00948090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6101394|NCT00948090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6101395|NCT00948090|Alkylating Agents|alkylating agents|mesh-ancestor
6101396|NCT00948090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101397|NCT00948090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6101398|NCT00948090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6101399|NCT00948090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6101400|NCT00948090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6101401|NCT00948090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6101402|NCT00948090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6101403|NCT00948155|Varenicline|varenicline|mesh-list
6101404|NCT00948155|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6101405|NCT00948155|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6101406|NCT00948155|Cholinergic Agents|cholinergic agents|mesh-ancestor
6101407|NCT00948155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6101408|NCT00948155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101409|NCT00948155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101410|NCT00948298|Vitamin D|vitamin d|mesh-list
6101411|NCT00948298|Vitamins|vitamins|mesh-ancestor
6101412|NCT00948298|Micronutrients|micronutrients|mesh-ancestor
6101413|NCT00948298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101414|NCT00948298|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6101415|NCT00948389|Dasatinib|dasatinib|mesh-list
6101416|NCT00948389|Lomustine|lomustine|mesh-list
6101417|NCT00948389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6101418|NCT00948389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6101419|NCT00948389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6101420|NCT00948389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101421|NCT00948389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6101422|NCT00948389|Alkylating Agents|alkylating agents|mesh-ancestor
6101423|NCT00948428|Imiquimod|imiquimod|mesh-list
6101424|NCT00948428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6101425|NCT00948428|Immunologic Factors|immunologic factors|mesh-ancestor
6101426|NCT00948428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101427|NCT00948428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6101428|NCT00948428|Interferon Inducers|interferon inducers|mesh-ancestor
6101429|NCT00948441|Ethanol|ethanol|mesh-list
6101430|NCT00948441|Heparin|heparin|mesh-list
6101431|NCT00948441|Anticoagulants|anticoagulants|mesh-ancestor
6101432|NCT00948441|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6101433|NCT00948441|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6101434|NCT00948441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101435|NCT00948441|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6101436|NCT00948441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6101437|NCT00948441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6101438|NCT00948441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101439|NCT00948506|Cidofovir|cidofovir|mesh-list
6101440|NCT00948506|Antiviral Agents|antiviral agents|mesh-ancestor
6101441|NCT00948506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6101442|NCT00948506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6101443|NCT00948506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101444|NCT00948610|Infliximab|infliximab|mesh-list
6101445|NCT00948610|Dermatologic Agents|dermatologic agents|mesh-ancestor
6101446|NCT00948610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6101447|NCT00948610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5601148|NCT03707639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6101448|NCT00948675|Paclitaxel|paclitaxel|mesh-list
6101449|NCT00948675|Bevacizumab|bevacizumab|mesh-list
5523688|NCT04295993|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6101450|NCT00948675|Carboplatin|carboplatin|mesh-list
6101451|NCT00948675|Pemetrexed|pemetrexed|mesh-list
6101452|NCT00948675|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6101453|NCT00948675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6101454|NCT00948675|Tubulin Modulators|tubulin modulators|mesh-ancestor
6101455|NCT00948675|Antimitotic Agents|antimitotic agents|mesh-ancestor
6101456|NCT00948675|Mitosis Modulators|mitosis modulators|mesh-ancestor
6101457|NCT00948675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101458|NCT00948675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6101459|NCT00948675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5523689|NCT04295993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5523690|NCT04295993|Adrenergic Agents|adrenergic agents|mesh-ancestor
5523691|NCT04295993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5523692|NCT04295993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523693|NCT04295993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101460|NCT00948675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6464988|NCT00471640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6464989|NCT00471640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6464990|NCT00471640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6101461|NCT00948675|Growth Substances|growth substances|mesh-ancestor
6101462|NCT00948675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101463|NCT00948675|Growth Inhibitors|growth inhibitors|mesh-ancestor
6101464|NCT00948675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6101465|NCT00948675|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6101466|NCT00948675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6101467|NCT00948688|Vorinostat|vorinostat|mesh-list
6101468|NCT00948688|Fluorouracil|fluorouracil|mesh-list
6101469|NCT00948688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6101470|NCT00948688|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6101471|NCT00948688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6101472|NCT00948688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101473|NCT00948688|Antimetabolites|antimetabolites|mesh-ancestor
6101474|NCT00948688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6101475|NCT00948688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6101476|NCT00948688|Immunologic Factors|immunologic factors|mesh-ancestor
5523694|NCT04295993|Sympathomimetics|sympathomimetics|mesh-ancestor
5523695|NCT04295993|Autonomic Agents|autonomic agents|mesh-ancestor
5523696|NCT04295993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5523697|NCT04295993|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5523698|NCT04295993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5523699|NCT04295850|Aspirin|aspirin|mesh-list
5523700|NCT04295850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5523701|NCT04295850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5523702|NCT04295850|Analgesics|analgesics|mesh-ancestor
5523703|NCT04295850|Sensory System Agents|sensory system agents|mesh-ancestor
5523704|NCT04295850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5523705|NCT04295850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523706|NCT04295850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5523707|NCT04295850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5523708|NCT04295850|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5523709|NCT04295850|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5523710|NCT04295850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523711|NCT04295850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5523712|NCT04295850|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5523713|NCT04295850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5523714|NCT04295850|Antipyretics|antipyretics|mesh-ancestor
5523715|NCT04295967|Formaldehyde|formaldehyde|mesh-list
5523716|NCT04295967|Disinfectants|disinfectants|mesh-ancestor
5523717|NCT04295967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5523718|NCT04296149|Octreotide|octreotide|mesh-list
5523719|NCT04296149|Edotreotide|edotreotide|mesh-list
5523720|NCT04296149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5523721|NCT04296149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5523722|NCT04296149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5523723|NCT04296149|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5523724|NCT04296149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523725|NCT04295408|Ropivacaine|ropivacaine|mesh-list
5523726|NCT04295408|Anesthetics, Local|anesthetics, local|mesh-ancestor
5523727|NCT04295408|Anesthetics|anesthetics|mesh-ancestor
5523728|NCT04295408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5523729|NCT04295408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523730|NCT04295408|Sensory System Agents|sensory system agents|mesh-ancestor
6101477|NCT00948688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101478|NCT00948766|Rivastigmine|rivastigmine|mesh-list
6101479|NCT00948766|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6101480|NCT00948766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6101481|NCT00948766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101482|NCT00948766|Cholinergic Agents|cholinergic agents|mesh-ancestor
6101483|NCT00948766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6101484|NCT00948766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101485|NCT00948766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6101486|NCT00948766|Protective Agents|protective agents|mesh-ancestor
6101487|NCT00948818|Linaclotide|linaclotide|mesh-list
6101488|NCT00948818|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
6101489|NCT00948818|Enzyme Activators|enzyme activators|mesh-ancestor
6101490|NCT00948818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101491|NCT00948818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6101492|NCT00948857|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
6101493|NCT00948857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6101494|NCT00948857|Immunologic Factors|immunologic factors|mesh-ancestor
6101495|NCT00948857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101496|NCT00948896|Pyrimethamine|pyrimethamine|mesh-list
6101497|NCT00948896|Piperaquine|piperaquine|mesh-list
6101498|NCT00948896|Sulfadoxine|sulfadoxine|mesh-list
6101499|NCT00948896|Trimethoprim|trimethoprim|mesh-list
6101500|NCT00948896|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6101501|NCT00948896|Artenimol|artenimol|mesh-list
6101502|NCT00948896|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6101503|NCT00948896|Sulfamethoxazole|sulfamethoxazole|mesh-list
6101504|NCT00948896|Antimalarials|antimalarials|mesh-ancestor
6101505|NCT00948896|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6101506|NCT00948896|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6101507|NCT00948896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6101508|NCT00948896|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6101509|NCT00948896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6101510|NCT00948896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101511|NCT00948896|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6101512|NCT00948896|Renal Agents|renal agents|mesh-ancestor
6101513|NCT00948896|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6101514|NCT00948896|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6101515|NCT00948896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6101516|NCT00948896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6101517|NCT00948922|Fludarabine|fludarabine|mesh-list
6101518|NCT00948922|Bortezomib|bortezomib|mesh-list
6101519|NCT00948922|Melphalan|melphalan|mesh-list
6101520|NCT00948922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6101521|NCT00948922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101522|NCT00948922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6101523|NCT00948922|Immunologic Factors|immunologic factors|mesh-ancestor
6101524|NCT00948922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101525|NCT00948922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6101526|NCT00948922|Alkylating Agents|alkylating agents|mesh-ancestor
6101527|NCT00948922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6101528|NCT00948935|Gemcitabine|gemcitabine|mesh-list
6101529|NCT00948935|Irinotecan|irinotecan|mesh-list
6101530|NCT00948935|Panitumumab|panitumumab|mesh-list
6101531|NCT00948935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6101532|NCT00948935|Antimetabolites|antimetabolites|mesh-ancestor
6101533|NCT00948935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101534|NCT00948935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6101535|NCT00948935|Antiviral Agents|antiviral agents|mesh-ancestor
6101536|NCT00948935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6101537|NCT00948935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6101538|NCT00948935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6101539|NCT00948935|Immunologic Factors|immunologic factors|mesh-ancestor
6101540|NCT00948935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101541|NCT00948935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6101542|NCT00948935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6101543|NCT00948935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5523731|NCT04295408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5523732|NCT04295486|Aspirin|aspirin|mesh-list
5523733|NCT04295486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6101544|NCT00949078|Omalizumab|omalizumab|mesh-list
6101545|NCT00949078|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6101546|NCT00949078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6101547|NCT00949078|Respiratory System Agents|respiratory system agents|mesh-ancestor
6101548|NCT00949117|Cyproheptadine|cyproheptadine|mesh-list
6101549|NCT00949117|Antipruritics|antipruritics|mesh-ancestor
6101550|NCT00949117|Dermatologic Agents|dermatologic agents|mesh-ancestor
6101551|NCT00949117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6101552|NCT00949117|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6101553|NCT00949117|Histamine Antagonists|histamine antagonists|mesh-ancestor
6101554|NCT00949117|Histamine Agents|histamine agents|mesh-ancestor
6101555|NCT00949117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6101556|NCT00949117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101557|NCT00949117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101558|NCT00949117|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6101559|NCT00949117|Serotonin Agents|serotonin agents|mesh-ancestor
6101560|NCT00949117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6101561|NCT00949234|Ritonavir|ritonavir|mesh-list
6101562|NCT00949234|Lopinavir|lopinavir|mesh-list
6101563|NCT00949234|Tenofovir|tenofovir|mesh-list
6101564|NCT00949234|Emtricitabine|emtricitabine|mesh-list
6101565|NCT00949234|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6101566|NCT00949234|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6101567|NCT00949234|Protease Inhibitors|protease inhibitors|mesh-ancestor
6101568|NCT00949234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6101569|NCT00949234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101570|NCT00949234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6101571|NCT00949234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6101572|NCT00949234|Antiviral Agents|antiviral agents|mesh-ancestor
6101573|NCT00949234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6101574|NCT00949234|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6101575|NCT00949234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6101576|NCT00949234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6101577|NCT00949234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6101578|NCT00949325|Sirolimus|sirolimus|mesh-list
6101579|NCT00949325|Doxorubicin|doxorubicin|mesh-list
6101580|NCT00949325|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6101581|NCT00949325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6101582|NCT00949325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6101583|NCT00949325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6101584|NCT00949325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6101585|NCT00949325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5523734|NCT04295486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5523735|NCT04295486|Analgesics|analgesics|mesh-ancestor
5523736|NCT04295486|Sensory System Agents|sensory system agents|mesh-ancestor
6101586|NCT00949325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101587|NCT00949325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6101588|NCT00949325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6101589|NCT00949325|Antifungal Agents|antifungal agents|mesh-ancestor
6101590|NCT00949325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6101591|NCT00949325|Immunologic Factors|immunologic factors|mesh-ancestor
6101592|NCT00949325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101593|NCT00949533|Oseltamivir|oseltamivir|mesh-list
6101594|NCT00949533|Antiviral Agents|antiviral agents|mesh-ancestor
6101595|NCT00949533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6101596|NCT00949533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6101597|NCT00949533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101598|NCT00949650|Pemetrexed|pemetrexed|mesh-list
6101599|NCT00949650|Afatinib|afatinib|mesh-list
6101600|NCT00949650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6101601|NCT00949650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6101602|NCT00949650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101603|NCT00949650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6101604|NCT00949650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6101605|NCT00949650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6101606|NCT00949702|Vemurafenib|vemurafenib|mesh-list
6101607|NCT00949702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6101608|NCT00949702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6101609|NCT00949702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6101610|NCT00949702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101611|NCT00949884|Losartan|losartan|mesh-list
6101612|NCT00949884|Olmesartan|olmesartan|mesh-list
6101613|NCT00949884|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6101614|NCT00949884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6101615|NCT00949884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6101616|NCT00949884|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6101617|NCT00949884|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6101618|NCT00949884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101619|NCT00949910|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6101620|NCT00949910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5523737|NCT04295486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6101621|NCT00949910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6464991|NCT00471653|Temozolomide|temozolomide|mesh-list
6464992|NCT00471653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6464993|NCT00471653|Alkylating Agents|alkylating agents|mesh-ancestor
6464994|NCT00471653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6464995|NCT00471653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6464996|NCT00471679|Ethanol|ethanol|mesh-list
6101622|NCT00949910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6101623|NCT00949910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101624|NCT00950170|Factor VIII|factor viii|mesh-list
6101625|NCT00950170|Coagulants|coagulants|mesh-ancestor
6101626|NCT00950248|Idebenone|idebenone|mesh-list
6101627|NCT00950248|Antioxidants|antioxidants|mesh-ancestor
6101628|NCT00950248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101629|NCT00950248|Protective Agents|protective agents|mesh-ancestor
6101630|NCT00950248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101631|NCT00950300|Cyclophosphamide|cyclophosphamide|mesh-list
6101632|NCT00950300|Docetaxel|docetaxel|mesh-list
6101633|NCT00950300|Fluorouracil|fluorouracil|mesh-list
6101634|NCT00950300|Trastuzumab|trastuzumab|mesh-list
6101635|NCT00950300|Epirubicin|epirubicin|mesh-list
6101636|NCT00950300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6101637|NCT00950300|Immunologic Factors|immunologic factors|mesh-ancestor
6101638|NCT00950300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101639|NCT00950300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6101640|NCT00950300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6101641|NCT00950300|Alkylating Agents|alkylating agents|mesh-ancestor
6101642|NCT00950300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101643|NCT00950300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6464997|NCT00471679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6464998|NCT00471679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6464999|NCT00471679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6101644|NCT00950300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6101645|NCT00950300|Tubulin Modulators|tubulin modulators|mesh-ancestor
6101646|NCT00950300|Antimitotic Agents|antimitotic agents|mesh-ancestor
6101647|NCT00950300|Mitosis Modulators|mitosis modulators|mesh-ancestor
6101648|NCT00950300|Antimetabolites|antimetabolites|mesh-ancestor
6101649|NCT00950300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6101650|NCT00950300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6101651|NCT00950300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5523738|NCT04295486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523739|NCT04295486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5523740|NCT04295486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5523741|NCT04295486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5523742|NCT04295486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5523743|NCT04295486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523744|NCT04295486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6101652|NCT00950300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6465000|NCT00471679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465001|NCT00471744|Levetiracetam|levetiracetam|mesh-list
6465002|NCT00471744|Sulthiame|sulthiame|mesh-list
6465003|NCT00471744|Anticonvulsants|anticonvulsants|mesh-ancestor
6465004|NCT00471744|Nootropic Agents|nootropic agents|mesh-ancestor
6465005|NCT00471783|Chlorhexidine|chlorhexidine|mesh-list
6465006|NCT00471783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6465007|NCT00471783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6465008|NCT00471783|Disinfectants|disinfectants|mesh-ancestor
6101653|NCT00950300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6101654|NCT00950300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6101655|NCT00950352|Choline|choline|mesh-list
6101656|NCT00950352|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
6101657|NCT00950352|Lipotropic Agents|lipotropic agents|mesh-ancestor
6101658|NCT00950352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6101659|NCT00950352|Antimetabolites|antimetabolites|mesh-ancestor
6101660|NCT00950352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101661|NCT00950352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6101662|NCT00950352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6101663|NCT00950352|Nootropic Agents|nootropic agents|mesh-ancestor
6101664|NCT00950365|Pemetrexed|pemetrexed|mesh-list
6101665|NCT00950365|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6101666|NCT00950365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6101667|NCT00950365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6101668|NCT00950365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101669|NCT00950365|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6101670|NCT00950365|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6465009|NCT00471809|Azithromycin|azithromycin|mesh-list
6465010|NCT00471809|Budesonide|budesonide|mesh-list
6101671|NCT00950365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6101672|NCT00950599|Saxagliptin|saxagliptin|mesh-list
6101673|NCT00950599|Incretins|incretins|mesh-ancestor
6101674|NCT00950599|Hormones|hormones|mesh-ancestor
6101675|NCT00950599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5523745|NCT04295486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5523746|NCT04295486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5523747|NCT04295486|Antipyretics|antipyretics|mesh-ancestor
5523748|NCT04295317|Capecitabine|capecitabine|mesh-list
5523749|NCT04295317|Antibodies|antibodies|mesh-list
5523750|NCT04295317|Antibodies, Blocking|antibodies, blocking|mesh-list
5523751|NCT04295317|Immunologic Factors|immunologic factors|mesh-ancestor
5523752|NCT04295317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523753|NCT04295317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5523754|NCT04295317|Antimetabolites|antimetabolites|mesh-ancestor
5523755|NCT04295317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523756|NCT04295317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5601149|NCT03707639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601150|NCT03707535|Infliximab|infliximab|mesh-list
5601151|NCT03707535|Dermatologic Agents|dermatologic agents|mesh-ancestor
5601152|NCT03707535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5601153|NCT03707535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5601154|NCT03707509|Gemcitabine|gemcitabine|mesh-list
5601155|NCT03707509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5601156|NCT03707509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5601157|NCT03707509|Antimetabolites|antimetabolites|mesh-ancestor
6101676|NCT00950599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101677|NCT00950599|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6101678|NCT00950599|Protease Inhibitors|protease inhibitors|mesh-ancestor
6101679|NCT00950599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6101680|NCT00950599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101681|NCT00950599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6101682|NCT00950651|Tramadol|tramadol|mesh-list
6101683|NCT00950651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6101684|NCT00950651|Narcotics|narcotics|mesh-ancestor
6101685|NCT00950651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6101686|NCT00950651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101687|NCT00950651|Analgesics|analgesics|mesh-ancestor
6101688|NCT00950651|Sensory System Agents|sensory system agents|mesh-ancestor
6101689|NCT00950651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6101690|NCT00950664|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6101691|NCT00950664|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6101692|NCT00950664|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6101693|NCT00950664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6101694|NCT00950664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101695|NCT00950664|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6101696|NCT00950664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6101697|NCT00950664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101698|NCT00950664|Cholinergic Agents|cholinergic agents|mesh-ancestor
6101699|NCT00950664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6101700|NCT00950742|Trastuzumab|trastuzumab|mesh-list
6101701|NCT00950742|Afatinib|afatinib|mesh-list
6101702|NCT00950742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6101703|NCT00950742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6101704|NCT00950742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6101705|NCT00950742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6101706|NCT00950742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101707|NCT00950755|Tositumomab I-131|tositumomab i-131|mesh-list
6101708|NCT00950755|Antibodies|antibodies|mesh-list
6101709|NCT00950755|Immunologic Factors|immunologic factors|mesh-ancestor
6101710|NCT00950755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101711|NCT00950755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6101712|NCT00950807|Tiotropium Bromide|tiotropium bromide|mesh-list
6101713|NCT00950807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6101714|NCT00950807|Autonomic Agents|autonomic agents|mesh-ancestor
6101715|NCT00950807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6101716|NCT00950807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101717|NCT00950807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6101718|NCT00950807|Respiratory System Agents|respiratory system agents|mesh-ancestor
6101719|NCT00950807|Parasympatholytics|parasympatholytics|mesh-ancestor
6101720|NCT00950807|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6101721|NCT00950807|Cholinergic Agents|cholinergic agents|mesh-ancestor
6101722|NCT00950807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5601158|NCT03707509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101723|NCT00950807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101724|NCT00950833|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6101725|NCT00950833|Immunologic Factors|immunologic factors|mesh-ancestor
6101726|NCT00950833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101727|NCT00950859|Dolutegravir|dolutegravir|mesh-list
6101728|NCT00950859|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5523757|NCT04295551|Ritonavir|ritonavir|mesh-list
5523758|NCT04295551|Lopinavir|lopinavir|mesh-list
5523759|NCT04295551|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5523760|NCT04295551|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5523761|NCT04295551|Protease Inhibitors|protease inhibitors|mesh-ancestor
5523762|NCT04295551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5523763|NCT04295551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523764|NCT04295551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5523765|NCT04295551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5523766|NCT04295551|Antiviral Agents|antiviral agents|mesh-ancestor
5523767|NCT04295551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5523768|NCT04295551|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5523769|NCT04295551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5523770|NCT04295330|Lidocaine|lidocaine|mesh-list
6101729|NCT00950859|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6101730|NCT00950859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6101731|NCT00950859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101732|NCT00950859|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6101733|NCT00950859|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6101734|NCT00950859|Antiviral Agents|antiviral agents|mesh-ancestor
6101735|NCT00950859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6101736|NCT00950911|Denosumab|denosumab|mesh-list
6101737|NCT00950911|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6101738|NCT00950911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523771|NCT04295330|Anesthetics, Local|anesthetics, local|mesh-ancestor
5523772|NCT04295330|Anesthetics|anesthetics|mesh-ancestor
5523773|NCT04295330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6101739|NCT00951015|Efavirenz|efavirenz|mesh-list
6101740|NCT00951015|Dolutegravir|dolutegravir|mesh-list
6101741|NCT00951015|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6101742|NCT00951015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6101743|NCT00951015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6101744|NCT00951015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101745|NCT00951015|Antiviral Agents|antiviral agents|mesh-ancestor
6101746|NCT00951015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6101747|NCT00951015|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6101748|NCT00951015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6101749|NCT00951015|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6101750|NCT00951015|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5523774|NCT04295330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523775|NCT04295330|Sensory System Agents|sensory system agents|mesh-ancestor
5523776|NCT04295330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5523777|NCT04295330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5523778|NCT04295330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5523779|NCT04295330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6101751|NCT00951015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6101752|NCT00951015|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6101753|NCT00951015|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6101754|NCT00951015|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6101755|NCT00951015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6101756|NCT00951015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6101757|NCT00951041|Vaccines|vaccines|mesh-list
6101758|NCT00951041|Immunologic Factors|immunologic factors|mesh-ancestor
5523780|NCT04295330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5523781|NCT04295330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523782|NCT04295629|Anesthetics|anesthetics|mesh-list
5523783|NCT04295629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5523784|NCT04295629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523785|NCT04295161|Abiraterone Acetate|abiraterone acetate|mesh-list
5523786|NCT04295161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5523787|NCT04295161|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5523788|NCT04295161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6101759|NCT00951041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101760|NCT00951275|Antirheumatic Agents|antirheumatic agents|mesh-list
6101761|NCT00951379|Pioglitazone|pioglitazone|mesh-list
6101762|NCT00951379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6101763|NCT00951379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101764|NCT00951483|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6101765|NCT00951483|Antidepressive Agents|antidepressive agents|mesh-ancestor
6101766|NCT00951483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6101767|NCT00951483|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6101768|NCT00951483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6101769|NCT00951483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6101770|NCT00951483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101771|NCT00951496|Paclitaxel|paclitaxel|mesh-list
6101772|NCT00951496|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6101773|NCT00951496|Bevacizumab|bevacizumab|mesh-list
6101774|NCT00951496|Cisplatin|cisplatin|mesh-list
6101775|NCT00951496|Carboplatin|carboplatin|mesh-list
6101776|NCT00951496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6101777|NCT00951496|Endothelial Growth Factors|endothelial growth factors|mesh-list
6101778|NCT00951496|Antibodies|antibodies|mesh-list
6101779|NCT00951496|Immunoglobulins|immunoglobulins|mesh-list
6101780|NCT00951496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6101781|NCT00951496|Immunoglobulin G|immunoglobulin g|mesh-list
6101782|NCT00951496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6101783|NCT00951496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6101784|NCT00951496|Tubulin Modulators|tubulin modulators|mesh-ancestor
6101785|NCT00951496|Antimitotic Agents|antimitotic agents|mesh-ancestor
6101786|NCT00951496|Mitosis Modulators|mitosis modulators|mesh-ancestor
6101787|NCT00951496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101788|NCT00951496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6101789|NCT00951496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6101790|NCT00951496|Growth Substances|growth substances|mesh-ancestor
6101791|NCT00951496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101792|NCT00951496|Growth Inhibitors|growth inhibitors|mesh-ancestor
6101793|NCT00951496|Immunologic Factors|immunologic factors|mesh-ancestor
6203821|NCT02061774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6203822|NCT02061774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523789|NCT04295161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523790|NCT04295161|Hormone Antagonists|hormone antagonists|mesh-ancestor
5523791|NCT04295161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5523792|NCT04295161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523793|NCT04295161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5523794|NCT04294784|Paclitaxel|paclitaxel|mesh-list
5523795|NCT04294784|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5523796|NCT04294784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5523797|NCT04294784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5523798|NCT04294784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5523799|NCT04294784|Tubulin Modulators|tubulin modulators|mesh-ancestor
5523800|NCT04294784|Antimitotic Agents|antimitotic agents|mesh-ancestor
5523801|NCT04294784|Mitosis Modulators|mitosis modulators|mesh-ancestor
5523802|NCT04294784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203823|NCT02061774|Antipyretics|antipyretics|mesh-ancestor
6203824|NCT02061969|Insulin Glargine|insulin glargine|mesh-list
6203825|NCT02061969|Linagliptin|linagliptin|mesh-list
6203826|NCT02061969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6203827|NCT02061969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203828|NCT02061969|Incretins|incretins|mesh-ancestor
6203829|NCT02061969|Hormones|hormones|mesh-ancestor
6203830|NCT02061969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6203831|NCT02061969|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6203832|NCT02061969|Protease Inhibitors|protease inhibitors|mesh-ancestor
6203833|NCT02061969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6203834|NCT02061969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203835|NCT02062177|Midazolam|midazolam|mesh-list
6203836|NCT02062177|Propofol|propofol|mesh-list
6203837|NCT02062177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6203838|NCT02062177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6203839|NCT02062177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203840|NCT02062177|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6203841|NCT02062177|Anesthetics, General|anesthetics, general|mesh-ancestor
6203842|NCT02062177|Anesthetics|anesthetics|mesh-ancestor
6203843|NCT02062177|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6203844|NCT02062177|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6203845|NCT02062177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6203846|NCT02062177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6203847|NCT02062177|GABA Modulators|gaba modulators|mesh-ancestor
6203848|NCT02062177|GABA Agents|gaba agents|mesh-ancestor
6203849|NCT02062177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6203850|NCT02062177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203851|NCT02062359|Aldesleukin|aldesleukin|mesh-list
5523803|NCT04294771|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5523804|NCT04294771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523805|NCT04294771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5523806|NCT04294823|Esomeprazole|esomeprazole|mesh-list
5523807|NCT04294823|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5523808|NCT04294823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5523809|NCT04294823|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5523810|NCT04294823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5523811|NCT04294823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523812|NCT04294836|Curcumin|curcumin|mesh-list
5523813|NCT04294836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5523814|NCT04294836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5523815|NCT04294836|Analgesics|analgesics|mesh-ancestor
5523816|NCT04294836|Sensory System Agents|sensory system agents|mesh-ancestor
5523817|NCT04294836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5523818|NCT04294836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523819|NCT04294836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6101794|NCT00951561|Ibuprofen|ibuprofen|mesh-list
6101795|NCT00951561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6101796|NCT00951561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6101797|NCT00951561|Analgesics|analgesics|mesh-ancestor
6101798|NCT00951561|Sensory System Agents|sensory system agents|mesh-ancestor
6101799|NCT00951561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6101800|NCT00951561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101801|NCT00951561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6101802|NCT00951561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6101803|NCT00951561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6101804|NCT00951561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6101805|NCT00951561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101806|NCT00951665|Paclitaxel|paclitaxel|mesh-list
6101807|NCT00951665|Maytansine|maytansine|mesh-list
6101808|NCT00951665|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
6101809|NCT00951665|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6101810|NCT00951665|Trastuzumab|trastuzumab|mesh-list
6101811|NCT00951665|Pertuzumab|pertuzumab|mesh-list
6101812|NCT00951665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6101813|NCT00951665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6101814|NCT00951665|Tubulin Modulators|tubulin modulators|mesh-ancestor
6101815|NCT00951665|Antimitotic Agents|antimitotic agents|mesh-ancestor
6101816|NCT00951665|Mitosis Modulators|mitosis modulators|mesh-ancestor
6101817|NCT00951665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101818|NCT00951665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6101819|NCT00951899|Metformin|metformin|mesh-list
6101820|NCT00951899|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
6101821|NCT00951899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6101822|NCT00951899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101823|NCT00951899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6101824|NCT00951899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6101825|NCT00951899|Antimetabolites|antimetabolites|mesh-ancestor
6101826|NCT00951899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101827|NCT00951899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6101828|NCT00951912|Genistein|genistein|mesh-list
6101829|NCT00951912|Daidzein|daidzein|mesh-list
6101830|NCT00951912|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6101831|NCT00951912|Protective Agents|protective agents|mesh-ancestor
6101832|NCT00951912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101833|NCT00951912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6101834|NCT00951912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6101835|NCT00951912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6101836|NCT00951912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101837|NCT00951912|Phytoestrogens|phytoestrogens|mesh-ancestor
6101838|NCT00951912|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6101839|NCT00951912|Estrogens|estrogens|mesh-ancestor
6101840|NCT00951912|Hormones|hormones|mesh-ancestor
6101841|NCT00951912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6101842|NCT00952068|Tramadol|tramadol|mesh-list
6101843|NCT00952068|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6101844|NCT00952068|Narcotics|narcotics|mesh-ancestor
6101845|NCT00952068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5523820|NCT04294836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5523821|NCT04294836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5523822|NCT04294836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5523823|NCT04294836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523824|NCT04294966|Dronabinol|dronabinol|mesh-list
5523825|NCT04294966|Hallucinogens|hallucinogens|mesh-ancestor
5523826|NCT04294966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523827|NCT04294966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5523828|NCT04294966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5523829|NCT04294966|Analgesics|analgesics|mesh-ancestor
5523830|NCT04294966|Sensory System Agents|sensory system agents|mesh-ancestor
5523831|NCT04294966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5523832|NCT04294966|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5523833|NCT04294966|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5523834|NCT04294966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5523835|NCT04294966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523836|NCT04294966|Hormones|hormones|mesh-ancestor
5523837|NCT04294966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5523838|NCT04294732|Bupivacaine|bupivacaine|mesh-list
5523839|NCT04294732|Anesthetics, Local|anesthetics, local|mesh-ancestor
5523840|NCT04294732|Anesthetics|anesthetics|mesh-ancestor
5523841|NCT04294732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5523842|NCT04294732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101846|NCT00952068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101847|NCT00952068|Analgesics|analgesics|mesh-ancestor
6101848|NCT00952068|Sensory System Agents|sensory system agents|mesh-ancestor
6101849|NCT00952068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6101850|NCT00952081|Clevidipine|clevidipine|mesh-list
6101851|NCT00952081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6101852|NCT00952081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6101853|NCT00952081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465011|NCT00471809|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6465012|NCT00471809|Montelukast|montelukast|mesh-list
6465013|NCT00471809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6465014|NCT00471809|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6465015|NCT00471809|Autonomic Agents|autonomic agents|mesh-ancestor
6465016|NCT00471809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6465017|NCT00471809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101854|NCT00952081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6101855|NCT00952081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101856|NCT00952133|Dexamethasone|dexamethasone|mesh-list
6101857|NCT00952133|Dexamethasone acetate|dexamethasone acetate|mesh-list
6101858|NCT00952133|Palonosetron|palonosetron|mesh-list
6101859|NCT00952133|BB 1101|bb 1101|mesh-list
6101860|NCT00952133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6101861|NCT00952133|Antiemetics|antiemetics|mesh-ancestor
6101862|NCT00952133|Autonomic Agents|autonomic agents|mesh-ancestor
6101863|NCT00952133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6101864|NCT00952133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101865|NCT00952133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6101866|NCT00952133|Glucocorticoids|glucocorticoids|mesh-ancestor
6101867|NCT00952133|Hormones|hormones|mesh-ancestor
6101868|NCT00952133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6101869|NCT00952133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6101870|NCT00952133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6101871|NCT00952133|Protease Inhibitors|protease inhibitors|mesh-ancestor
6101872|NCT00952133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6101873|NCT00952133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101874|NCT00952133|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6101875|NCT00952133|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6101876|NCT00952133|Serotonin Agents|serotonin agents|mesh-ancestor
6101877|NCT00952133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6101878|NCT00952276|Vaccines|vaccines|mesh-list
6101879|NCT00952276|Immunologic Factors|immunologic factors|mesh-ancestor
6101880|NCT00952276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523843|NCT04294732|Sensory System Agents|sensory system agents|mesh-ancestor
5523844|NCT04294732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5523845|NCT04294953|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5523846|NCT04294953|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5523847|NCT04294953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6101881|NCT00952341|Dexamethasone|dexamethasone|mesh-list
6101882|NCT00952341|Dexamethasone acetate|dexamethasone acetate|mesh-list
6101883|NCT00952341|Aprepitant|aprepitant|mesh-list
6101884|NCT00952341|Fosaprepitant|fosaprepitant|mesh-list
6101885|NCT00952341|Granisetron|granisetron|mesh-list
6101886|NCT00952341|BB 1101|bb 1101|mesh-list
6101887|NCT00952341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6101888|NCT00952341|Antiemetics|antiemetics|mesh-ancestor
6101889|NCT00952341|Autonomic Agents|autonomic agents|mesh-ancestor
6101890|NCT00952341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6101891|NCT00952341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101892|NCT00952341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6101893|NCT00952341|Glucocorticoids|glucocorticoids|mesh-ancestor
6101894|NCT00952341|Hormones|hormones|mesh-ancestor
6101895|NCT00952341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6101896|NCT00952341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5523848|NCT04294953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5523849|NCT04294953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523850|NCT04294953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5523851|NCT04294953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523852|NCT04294953|Analgesics|analgesics|mesh-ancestor
5523853|NCT04294953|Sensory System Agents|sensory system agents|mesh-ancestor
6101897|NCT00952341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6101898|NCT00952341|Protease Inhibitors|protease inhibitors|mesh-ancestor
6101899|NCT00952341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6101900|NCT00952341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101901|NCT00952341|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6101902|NCT00952341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6101903|NCT00952341|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6101904|NCT00952341|Serotonin Agents|serotonin agents|mesh-ancestor
6101905|NCT00952380|Dalteparin|dalteparin|mesh-list
6101906|NCT00952380|Tinzaparin|tinzaparin|mesh-list
6101907|NCT00952380|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6101908|NCT00952380|Anticoagulants|anticoagulants|mesh-ancestor
6101909|NCT00952380|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6101910|NCT00952380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6101911|NCT00952380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101912|NCT00952419|Vaccines|vaccines|mesh-list
6101913|NCT00952419|Immunologic Factors|immunologic factors|mesh-ancestor
6101914|NCT00952419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101915|NCT00952484|Immunoglobulin G|immunoglobulin g|mesh-list
6101916|NCT00952484|Immunologic Factors|immunologic factors|mesh-ancestor
6101917|NCT00952484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101918|NCT00952523|Adapalene|adapalene|mesh-list
6101919|NCT00952523|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
6101920|NCT00952523|Tretinoin|tretinoin|mesh-list
6101921|NCT00952523|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6101922|NCT00952523|Dermatologic Agents|dermatologic agents|mesh-ancestor
6101923|NCT00952523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6101924|NCT00952523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6101925|NCT00952523|Analgesics|analgesics|mesh-ancestor
6101926|NCT00952523|Sensory System Agents|sensory system agents|mesh-ancestor
6101927|NCT00952523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6101928|NCT00952523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101929|NCT00952523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6101930|NCT00952523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6101931|NCT00952523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6101932|NCT00952523|Keratolytic Agents|keratolytic agents|mesh-ancestor
6101933|NCT00952614|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
6101934|NCT00952614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6101935|NCT00952614|Glucocorticoids|glucocorticoids|mesh-ancestor
6101936|NCT00952614|Hormones|hormones|mesh-ancestor
6101937|NCT00952614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6101938|NCT00952614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101939|NCT00952653|Midazolam|midazolam|mesh-list
6101940|NCT00952653|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6101941|NCT00952653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6101942|NCT00952653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6101943|NCT00952653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6101944|NCT00952653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101945|NCT00952653|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6101946|NCT00952653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6101947|NCT00952653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6101948|NCT00952653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6101949|NCT00952653|Anesthetics, General|anesthetics, general|mesh-ancestor
6101950|NCT00952653|Anesthetics|anesthetics|mesh-ancestor
6101951|NCT00952653|GABA Modulators|gaba modulators|mesh-ancestor
6101952|NCT00952653|GABA Agents|gaba agents|mesh-ancestor
6101953|NCT00952653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6101954|NCT00952653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101955|NCT00952653|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6101956|NCT00952653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6101957|NCT00952653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6101958|NCT00952653|Antidepressive Agents|antidepressive agents|mesh-ancestor
6101959|NCT00952731|Tamoxifen|tamoxifen|mesh-list
6101960|NCT00952731|Afimoxifene|afimoxifene|mesh-list
6101961|NCT00952731|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6101962|NCT00952731|Hormone Antagonists|hormone antagonists|mesh-ancestor
6101963|NCT00952731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6101964|NCT00952731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101965|NCT00952731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6101966|NCT00952731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6101967|NCT00952731|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6101968|NCT00952731|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6101969|NCT00952731|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6101970|NCT00952822|Factor VIII|factor viii|mesh-list
6101971|NCT00952822|Coagulants|coagulants|mesh-ancestor
6101972|NCT00953017|Bisacodyl|bisacodyl|mesh-list
6101973|NCT00953017|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
6101974|NCT00953017|Lubiprostone|lubiprostone|mesh-list
6101975|NCT00953017|Cathartics|cathartics|mesh-ancestor
6101976|NCT00953017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6101977|NCT00953017|Laxatives|laxatives|mesh-ancestor
6101978|NCT00953017|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6101979|NCT00953017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6101980|NCT00953017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101981|NCT00953043|Lubiprostone|lubiprostone|mesh-list
6101982|NCT00953043|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6101983|NCT00953043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6465018|NCT00471809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5523854|NCT04294953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5523855|NCT04294953|Antidepressive Agents|antidepressive agents|mesh-ancestor
5523856|NCT04294953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5523857|NCT04294953|Dopamine Agents|dopamine agents|mesh-ancestor
5523858|NCT04294992|Ondansetron|ondansetron|mesh-list
5523859|NCT04294992|Antiemetics|antiemetics|mesh-ancestor
5523860|NCT04294992|Autonomic Agents|autonomic agents|mesh-ancestor
5523861|NCT04294992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6101984|NCT00953043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6101985|NCT00953056|Vaccines|vaccines|mesh-list
6101986|NCT00953056|Immunologic Factors|immunologic factors|mesh-ancestor
6101987|NCT00953056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101988|NCT00953121|Bevacizumab|bevacizumab|mesh-list
6101989|NCT00953121|Carboplatin|carboplatin|mesh-list
6101990|NCT00953121|Irinotecan|irinotecan|mesh-list
6101991|NCT00953121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6101992|NCT00953121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6101993|NCT00953121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6101994|NCT00953121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6101995|NCT00953121|Growth Substances|growth substances|mesh-ancestor
5523862|NCT04294992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523863|NCT04294992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5523864|NCT04294992|Antipruritics|antipruritics|mesh-ancestor
5523865|NCT04294992|Dermatologic Agents|dermatologic agents|mesh-ancestor
5523866|NCT04294992|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6101996|NCT00953121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6101997|NCT00953121|Growth Inhibitors|growth inhibitors|mesh-ancestor
6101998|NCT00953121|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6101999|NCT00953121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6102000|NCT00953121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6102001|NCT00953121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102002|NCT00953147|Ciclesonide|ciclesonide|mesh-list
6102003|NCT00953147|Glucocorticoids|glucocorticoids|mesh-ancestor
5523867|NCT04294992|Serotonin Agents|serotonin agents|mesh-ancestor
5523868|NCT04294992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5523869|NCT04294992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523870|NCT04294992|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5523871|NCT04294992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5523872|NCT04294992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6102004|NCT00953147|Hormones|hormones|mesh-ancestor
6102005|NCT00953147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6102006|NCT00953147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102007|NCT00953147|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6102008|NCT00953199|Lidocaine|lidocaine|mesh-list
6102009|NCT00953199|Anesthetics, Local|anesthetics, local|mesh-ancestor
6102010|NCT00953199|Anesthetics|anesthetics|mesh-ancestor
6102011|NCT00953199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6102012|NCT00953199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102013|NCT00953199|Sensory System Agents|sensory system agents|mesh-ancestor
6102014|NCT00953199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6102015|NCT00953199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6102016|NCT00953199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6102017|NCT00953199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6102018|NCT00953199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6102019|NCT00953199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102020|NCT00953212|Ascorbic Acid|ascorbic acid|mesh-list
6102021|NCT00953212|Amiodarone|amiodarone|mesh-list
6102022|NCT00953212|Metoprolol|metoprolol|mesh-list
6102023|NCT00953212|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
6102024|NCT00953212|Vitamins|vitamins|mesh-ancestor
6102025|NCT00953212|Micronutrients|micronutrients|mesh-ancestor
6102026|NCT00953212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102027|NCT00953212|Antioxidants|antioxidants|mesh-ancestor
6102028|NCT00953212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102029|NCT00953212|Protective Agents|protective agents|mesh-ancestor
6102030|NCT00953212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6102031|NCT00953212|Vasodilator Agents|vasodilator agents|mesh-ancestor
6102032|NCT00953212|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6102033|NCT00953212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6102034|NCT00953212|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6102035|NCT00953212|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6102036|NCT00953212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6102037|NCT00953212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6102038|NCT00953212|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6102039|NCT00953212|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6102040|NCT00953212|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6102041|NCT00953212|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6102042|NCT00953212|Adrenergic Agents|adrenergic agents|mesh-ancestor
6102043|NCT00953212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6102044|NCT00953212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6102045|NCT00953212|Sympatholytics|sympatholytics|mesh-ancestor
6102046|NCT00953212|Autonomic Agents|autonomic agents|mesh-ancestor
6102047|NCT00953212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6102048|NCT00953212|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6102049|NCT00953225|Vitamin D|vitamin d|mesh-list
6102050|NCT00953225|Cholecalciferol|cholecalciferol|mesh-list
6102051|NCT00953225|Vitamins|vitamins|mesh-ancestor
6102052|NCT00953225|Micronutrients|micronutrients|mesh-ancestor
6102053|NCT00953225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102054|NCT00953225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6102055|NCT00953225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6102056|NCT00953524|Vaccines|vaccines|mesh-list
6102057|NCT00953524|Immunologic Factors|immunologic factors|mesh-ancestor
6102058|NCT00953524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523873|NCT04294992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6102059|NCT00953576|Ketoconazole|ketoconazole|mesh-list
6102060|NCT00953576|Hydrocortisone|hydrocortisone|mesh-list
6102061|NCT00953576|Lapatinib|lapatinib|mesh-list
6465019|NCT00471809|Respiratory System Agents|respiratory system agents|mesh-ancestor
6465020|NCT00471809|Glucocorticoids|glucocorticoids|mesh-ancestor
6465021|NCT00471809|Hormones|hormones|mesh-ancestor
6102062|NCT00953576|Dutasteride|dutasteride|mesh-list
6102063|NCT00953576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6102064|NCT00953576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6102065|NCT00953576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6102066|NCT00953576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6102067|NCT00953576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102068|NCT00953576|Antifungal Agents|antifungal agents|mesh-ancestor
6102069|NCT00953576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6102070|NCT00953576|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6102071|NCT00953576|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5523874|NCT04294992|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5523875|NCT04294914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
5523876|NCT04294511|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5523877|NCT04294511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523878|NCT04294511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5523879|NCT04294576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5523880|NCT04294576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523881|NCT04294576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5523882|NCT04294537|Anesthetics|anesthetics|mesh-list
5523883|NCT04294537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5523884|NCT04294537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523885|NCT04294329|Bupivacaine|bupivacaine|mesh-list
5523886|NCT04294329|Anesthetics, Local|anesthetics, local|mesh-ancestor
5523887|NCT04294329|Anesthetics|anesthetics|mesh-ancestor
6102072|NCT00953576|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6102073|NCT00953576|Hormone Antagonists|hormone antagonists|mesh-ancestor
6102074|NCT00953576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6102075|NCT00953576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102076|NCT00953576|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6102077|NCT00953576|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6102078|NCT00953667|Niacin|niacin|mesh-list
6102079|NCT00953667|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6102080|NCT00953667|Antimetabolites|antimetabolites|mesh-ancestor
6102081|NCT00953667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102082|NCT00953667|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6102083|NCT00953667|Vasodilator Agents|vasodilator agents|mesh-ancestor
6102084|NCT00953667|Vitamin B Complex|vitamin b complex|mesh-ancestor
6102085|NCT00953667|Vitamins|vitamins|mesh-ancestor
6102086|NCT00953667|Micronutrients|micronutrients|mesh-ancestor
6102087|NCT00953667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102088|NCT00953706|Ivacaftor|ivacaftor|mesh-list
6102089|NCT00953706|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
5523888|NCT04294329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6102090|NCT00953706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6102091|NCT00953706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102092|NCT00953745|Aripiprazole|aripiprazole|mesh-list
6102093|NCT00953745|Citalopram|citalopram|mesh-list
6102094|NCT00953745|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6102095|NCT00953745|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6102096|NCT00953745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6102097|NCT00953745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102098|NCT00953745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6465022|NCT00471809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6102099|NCT00953745|Serotonin Agents|serotonin agents|mesh-ancestor
6102100|NCT00953745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102101|NCT00953745|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6102102|NCT00953745|Antidepressive Agents|antidepressive agents|mesh-ancestor
6102103|NCT00953745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6102104|NCT00953745|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6102105|NCT00953745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6102106|NCT00953745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6102107|NCT00953745|Dopamine Agonists|dopamine agonists|mesh-ancestor
6102108|NCT00953745|Dopamine Agents|dopamine agents|mesh-ancestor
6102109|NCT00953745|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6102110|NCT00953745|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6102111|NCT00953745|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6102112|NCT00953745|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6102113|NCT00953745|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6102114|NCT00953745|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6102115|NCT00953849|Calcitriol|calcitriol|mesh-list
6102116|NCT00953849|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
6102117|NCT00953849|Vitamin D|vitamin d|mesh-list
6102118|NCT00953849|Celecoxib|celecoxib|mesh-list
6102119|NCT00953849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6102120|NCT00953849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6102121|NCT00953849|Analgesics|analgesics|mesh-ancestor
6102122|NCT00953849|Sensory System Agents|sensory system agents|mesh-ancestor
6102123|NCT00953849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6102124|NCT00953849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102125|NCT00953849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6102126|NCT00953849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6102127|NCT00953849|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6102128|NCT00953849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6102129|NCT00953849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6102130|NCT00953849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465023|NCT00471809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6465024|NCT00471809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6465025|NCT00471809|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6465026|NCT00471809|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6465027|NCT00471809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6465028|NCT00471809|Adrenergic Agents|adrenergic agents|mesh-ancestor
6465029|NCT00471809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6465030|NCT00471809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523889|NCT04294329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102131|NCT00953849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6102132|NCT00953849|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6102133|NCT00953849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6102134|NCT00953849|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6102135|NCT00953849|Vitamins|vitamins|mesh-ancestor
6102136|NCT00953849|Micronutrients|micronutrients|mesh-ancestor
6102137|NCT00953849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6102138|NCT00953862|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6102139|NCT00953862|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6102140|NCT00953862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6102141|NCT00953862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6102142|NCT00953862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102143|NCT00953862|Adrenergic Agents|adrenergic agents|mesh-ancestor
6102144|NCT00953862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5523890|NCT04294329|Sensory System Agents|sensory system agents|mesh-ancestor
5523891|NCT04294329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5523892|NCT04294056|Propofol|propofol|mesh-list
5523893|NCT04294056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5523894|NCT04294056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5523895|NCT04294056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523896|NCT04294056|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5523897|NCT04294056|Anesthetics, General|anesthetics, general|mesh-ancestor
5523898|NCT04294056|Anesthetics|anesthetics|mesh-ancestor
5523899|NCT04294134|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
5523900|NCT04294134|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5523901|NCT04294134|Serotonin Agents|serotonin agents|mesh-ancestor
5523902|NCT04294134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5523903|NCT04294134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523904|NCT04294134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523905|NCT04294264|Trifluridine|trifluridine|mesh-list
5523906|NCT04294264|Oxaliplatin|oxaliplatin|mesh-list
5523907|NCT04294264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6102145|NCT00953862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102146|NCT00954122|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6102147|NCT00954122|Antidepressive Agents|antidepressive agents|mesh-ancestor
6102148|NCT00954122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6102149|NCT00954122|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6102150|NCT00954122|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6102151|NCT00954122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6102152|NCT00954122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102153|NCT00954174|Paclitaxel|paclitaxel|mesh-list
6102154|NCT00954174|Carboplatin|carboplatin|mesh-list
6102155|NCT00954174|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6102156|NCT00954174|Ifosfamide|ifosfamide|mesh-list
6102157|NCT00954174|Isophosphamide mustard|isophosphamide mustard|mesh-list
6102158|NCT00954174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6102159|NCT00954174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6102160|NCT00954174|Tubulin Modulators|tubulin modulators|mesh-ancestor
6102161|NCT00954174|Antimitotic Agents|antimitotic agents|mesh-ancestor
5523908|NCT04294264|Antimetabolites|antimetabolites|mesh-ancestor
5523909|NCT04294264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523910|NCT04294264|Antiviral Agents|antiviral agents|mesh-ancestor
5523911|NCT04294264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5523912|NCT04294147|Erenumab|erenumab|mesh-list
5523913|NCT04294147|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
5523914|NCT04294147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523915|NCT04294147|Analgesics|analgesics|mesh-ancestor
5523916|NCT04294147|Sensory System Agents|sensory system agents|mesh-ancestor
5523917|NCT04294147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5523918|NCT04294147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523919|NCT04293809|Bupivacaine|bupivacaine|mesh-list
5523920|NCT04293809|Anesthetics, Local|anesthetics, local|mesh-ancestor
5523921|NCT04293809|Anesthetics|anesthetics|mesh-ancestor
5523922|NCT04293809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5523923|NCT04293809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523924|NCT04293809|Sensory System Agents|sensory system agents|mesh-ancestor
5523925|NCT04293809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5523926|NCT04293822|Cetirizine|cetirizine|mesh-list
5523927|NCT04293822|Minoxidil|minoxidil|mesh-list
5523928|NCT04293822|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6102162|NCT00954174|Mitosis Modulators|mitosis modulators|mesh-ancestor
6102163|NCT00954174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102164|NCT00954174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6102165|NCT00954174|Alkylating Agents|alkylating agents|mesh-ancestor
6102166|NCT00954447|Linagliptin|linagliptin|mesh-list
6102167|NCT00954447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6102168|NCT00954447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102169|NCT00954447|Incretins|incretins|mesh-ancestor
6102170|NCT00954447|Hormones|hormones|mesh-ancestor
6102171|NCT00954447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6102172|NCT00954447|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6102173|NCT00954447|Protease Inhibitors|protease inhibitors|mesh-ancestor
6102174|NCT00954447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6102175|NCT00954447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102176|NCT00954512|Leucovorin|leucovorin|mesh-list
6102177|NCT00954512|Folic Acid|folic acid|mesh-list
6102178|NCT00954512|Gemcitabine|gemcitabine|mesh-list
6102179|NCT00954512|Carboplatin|carboplatin|mesh-list
6102180|NCT00954512|Trastuzumab|trastuzumab|mesh-list
6102181|NCT00954512|Irinotecan|irinotecan|mesh-list
6102182|NCT00954512|Cetuximab|cetuximab|mesh-list
6102183|NCT00954512|Everolimus|everolimus|mesh-list
6102184|NCT00954512|Epirubicin|epirubicin|mesh-list
6102185|NCT00954512|Levoleucovorin|levoleucovorin|mesh-list
5523929|NCT04293822|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5523930|NCT04293822|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5523931|NCT04293822|Histamine Antagonists|histamine antagonists|mesh-ancestor
5523932|NCT04293822|Histamine Agents|histamine agents|mesh-ancestor
6102186|NCT00954512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6102187|NCT00954512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102188|NCT00954512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6102189|NCT00954512|Antimetabolites|antimetabolites|mesh-ancestor
6102190|NCT00954512|Antiviral Agents|antiviral agents|mesh-ancestor
6102191|NCT00954512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6102192|NCT00954512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5523933|NCT04293822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6102193|NCT00954512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6102194|NCT00954512|Immunologic Factors|immunologic factors|mesh-ancestor
6102195|NCT00954512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523934|NCT04293822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523935|NCT04293822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523936|NCT04293822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5523937|NCT04293822|Vasodilator Agents|vasodilator agents|mesh-ancestor
5523938|NCT04293887|Interferons|interferons|mesh-list
5523939|NCT04293887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5523940|NCT04293887|Antiviral Agents|antiviral agents|mesh-ancestor
5523941|NCT04293887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5601159|NCT03707509|Antiviral Agents|antiviral agents|mesh-ancestor
5601160|NCT03707509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5601161|NCT03707509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5601162|NCT03707509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5601163|NCT03707509|Immunologic Factors|immunologic factors|mesh-ancestor
5601164|NCT03707509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601165|NCT03707483|Ascorbic Acid|ascorbic acid|mesh-list
5601166|NCT03707483|Vitamins|vitamins|mesh-ancestor
5601167|NCT03707483|Micronutrients|micronutrients|mesh-ancestor
5601168|NCT03707483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601169|NCT03707483|Antioxidants|antioxidants|mesh-ancestor
5601170|NCT03707483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601171|NCT03707483|Protective Agents|protective agents|mesh-ancestor
5601172|NCT03707457|Nivolumab|nivolumab|mesh-list
5601173|NCT03707457|Ipilimumab|ipilimumab|mesh-list
5601174|NCT03707457|Antibodies|antibodies|mesh-list
5601175|NCT03707457|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6102196|NCT00954512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6102197|NCT00954512|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6102198|NCT00954512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6102199|NCT00954512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6102200|NCT00954512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6102201|NCT00954512|Antidotes|antidotes|mesh-ancestor
6102202|NCT00954512|Protective Agents|protective agents|mesh-ancestor
6102203|NCT00954512|Vitamin B Complex|vitamin b complex|mesh-ancestor
6102204|NCT00954512|Vitamins|vitamins|mesh-ancestor
6102205|NCT00954512|Micronutrients|micronutrients|mesh-ancestor
6102206|NCT00954512|Hematinics|hematinics|mesh-ancestor
6102207|NCT00954681|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6465031|NCT00471809|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6465032|NCT00471809|Hormone Antagonists|hormone antagonists|mesh-ancestor
6465033|NCT00471809|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6465034|NCT00471809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6465035|NCT00471900|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
6465036|NCT00471900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6465037|NCT00471900|Immunologic Factors|immunologic factors|mesh-ancestor
6465038|NCT00471900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465039|NCT00471952|Caffeine|caffeine|mesh-list
6465040|NCT00471952|Rizatriptan|rizatriptan|mesh-list
6465041|NCT00471952|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6465042|NCT00471952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465043|NCT00471952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6465044|NCT00471952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6102208|NCT00954681|Antidepressive Agents|antidepressive agents|mesh-ancestor
6102209|NCT00954681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6102210|NCT00954681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6465045|NCT00471952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465046|NCT00471952|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6465047|NCT00471952|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6465048|NCT00471952|Purinergic Agents|purinergic agents|mesh-ancestor
6465049|NCT00471952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6465050|NCT00471952|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5601176|NCT03707457|Immunologic Factors|immunologic factors|mesh-ancestor
5601177|NCT03707457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725261|NCT03181464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725262|NCT03181464|Sensory System Agents|sensory system agents|mesh-ancestor
5725263|NCT03181464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5725264|NCT03181464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5725265|NCT03181464|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5725266|NCT03181464|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5725267|NCT03181464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5725268|NCT03181464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725709|NCT03178747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725710|NCT03178591|Dapagliflozin|dapagliflozin|mesh-list
5725711|NCT03178591|Vildagliptin|vildagliptin|mesh-list
5725712|NCT03178591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6102211|NCT00954681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5523942|NCT04293744|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5523943|NCT04293549|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5523944|NCT04293549|Mitogens|mitogens|mesh-list
5523945|NCT04293549|Mitosis Modulators|mitosis modulators|mesh-ancestor
5523946|NCT04293549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523947|NCT04293549|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5523948|NCT04293419|Durvalumab|durvalumab|mesh-list
5523949|NCT04293419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5523950|NCT04293419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5523951|NCT04293081|Maleic acid|maleic acid|mesh-list
6102212|NCT00954681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6102213|NCT00954681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102214|NCT00954707|Aspirin|aspirin|mesh-list
6102215|NCT00954707|Clopidogrel|clopidogrel|mesh-list
6102216|NCT00954707|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6102217|NCT00954707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6102218|NCT00954707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5523952|NCT04293081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5523953|NCT04293081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523954|NCT04292873|Vitamin D|vitamin d|mesh-list
5523955|NCT04292873|Vitamins|vitamins|mesh-ancestor
5523956|NCT04292873|Micronutrients|micronutrients|mesh-ancestor
5523957|NCT04292873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523958|NCT04292873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5523959|NCT04293172|Ticagrelor|ticagrelor|mesh-list
5523960|NCT04293172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5523961|NCT04293172|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5523962|NCT04293172|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5523963|NCT04293172|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5523964|NCT04293172|Purinergic Agents|purinergic agents|mesh-ancestor
5523965|NCT04293172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5523966|NCT04293172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523967|NCT04293172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523968|NCT04292990|Fentanyl|fentanyl|mesh-list
6102219|NCT00954707|Analgesics|analgesics|mesh-ancestor
6102220|NCT00954707|Sensory System Agents|sensory system agents|mesh-ancestor
6102221|NCT00954707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6102222|NCT00954707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523969|NCT04292990|Morphine|morphine|mesh-list
5523970|NCT04292990|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5523971|NCT04292990|Narcotics|narcotics|mesh-ancestor
5523972|NCT04292990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5523973|NCT04292990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523974|NCT04292990|Analgesics|analgesics|mesh-ancestor
5523975|NCT04292990|Sensory System Agents|sensory system agents|mesh-ancestor
5523976|NCT04292990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5523977|NCT04292990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5523978|NCT04292990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5523979|NCT04292990|Anesthetics, General|anesthetics, general|mesh-ancestor
5523980|NCT04292990|Anesthetics|anesthetics|mesh-ancestor
5523981|NCT04292886|Tamoxifen|tamoxifen|mesh-list
5523982|NCT04292886|Ascorbic Acid|ascorbic acid|mesh-list
5523983|NCT04292886|Vitamins|vitamins|mesh-ancestor
5523984|NCT04292886|Micronutrients|micronutrients|mesh-ancestor
5523985|NCT04292886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5523986|NCT04292886|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5523987|NCT04292886|Hormone Antagonists|hormone antagonists|mesh-ancestor
5523988|NCT04292886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5523989|NCT04292886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5523990|NCT04292886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5523991|NCT04292886|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5523992|NCT04292886|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5523993|NCT04292886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5523994|NCT04292886|Antioxidants|antioxidants|mesh-ancestor
5523995|NCT04292886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5523996|NCT04292886|Protective Agents|protective agents|mesh-ancestor
5523997|NCT04292756|Triamcinolone|triamcinolone|mesh-list
5523998|NCT04292756|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5523999|NCT04292756|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5524000|NCT04292756|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5524001|NCT04292756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5524002|NCT04292756|Glucocorticoids|glucocorticoids|mesh-ancestor
5524003|NCT04292756|Hormones|hormones|mesh-ancestor
5524004|NCT04292756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5725269|NCT03181243|Anesthetics|anesthetics|mesh-list
5524005|NCT04292756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524006|NCT04292756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5524007|NCT04292756|Immunologic Factors|immunologic factors|mesh-ancestor
5524008|NCT04292756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5524009|NCT04292756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524010|NCT04292743|Leucovorin|leucovorin|mesh-list
5524011|NCT04292743|Fluorouracil|fluorouracil|mesh-list
5524012|NCT04292743|Oxaliplatin|oxaliplatin|mesh-list
6102223|NCT00954707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6102224|NCT00954707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6102225|NCT00954707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6102226|NCT00954707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6102227|NCT00954707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102228|NCT00954707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6102229|NCT00954707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6102230|NCT00954707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6102231|NCT00954707|Antipyretics|antipyretics|mesh-ancestor
6102232|NCT00954707|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5524013|NCT04292743|Irinotecan|irinotecan|mesh-list
5524014|NCT04292743|Folfirinox|folfirinox|mesh-list
5524015|NCT04292743|Antimetabolites|antimetabolites|mesh-ancestor
5524016|NCT04292743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524017|NCT04292743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5524018|NCT04292743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5524019|NCT04292743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5524020|NCT04292743|Immunologic Factors|immunologic factors|mesh-ancestor
5524021|NCT04292743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524022|NCT04292743|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5524023|NCT04292743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5524024|NCT04292743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5524025|NCT04292743|Antidotes|antidotes|mesh-ancestor
6102233|NCT00954707|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6102234|NCT00954707|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6102235|NCT00954707|Purinergic Agents|purinergic agents|mesh-ancestor
6102236|NCT00954707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6102237|NCT00954941|Ondansetron|ondansetron|mesh-list
6102238|NCT00954941|Aprepitant|aprepitant|mesh-list
6102239|NCT00954941|Antiemetics|antiemetics|mesh-ancestor
6102240|NCT00954941|Autonomic Agents|autonomic agents|mesh-ancestor
6102241|NCT00954941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6102242|NCT00954941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102243|NCT00954941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6102244|NCT00954941|Antipruritics|antipruritics|mesh-ancestor
6102245|NCT00954941|Dermatologic Agents|dermatologic agents|mesh-ancestor
6102246|NCT00954941|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6102247|NCT00954941|Serotonin Agents|serotonin agents|mesh-ancestor
6102248|NCT00954941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6102249|NCT00954941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102250|NCT00954941|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6102251|NCT00954941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5524026|NCT04292743|Protective Agents|protective agents|mesh-ancestor
5524027|NCT04292743|Vitamin B Complex|vitamin b complex|mesh-ancestor
5524028|NCT04292743|Vitamins|vitamins|mesh-ancestor
5524029|NCT04292743|Micronutrients|micronutrients|mesh-ancestor
5524030|NCT04292418|Mycophenolic Acid|mycophenolic acid|mesh-list
5524031|NCT04292418|Tacrolimus|tacrolimus|mesh-list
5524032|NCT04292418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5524033|NCT04292418|Immunologic Factors|immunologic factors|mesh-ancestor
5524034|NCT04292418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524035|NCT04292418|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5524036|NCT04292418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5524037|NCT04292418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102252|NCT00954941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6102253|NCT00954941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6102254|NCT00954941|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6102255|NCT00954941|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6102256|NCT00955110|Oxymorphone|oxymorphone|mesh-list
6102257|NCT00955110|Oxycodone|oxycodone|mesh-list
6102258|NCT00955110|Hydromorphone|hydromorphone|mesh-list
6102259|NCT00955110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6102260|NCT00955110|Narcotics|narcotics|mesh-ancestor
6102261|NCT00955110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6102262|NCT00955110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102263|NCT00955110|Analgesics|analgesics|mesh-ancestor
6102264|NCT00955110|Sensory System Agents|sensory system agents|mesh-ancestor
5524038|NCT04292418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5524039|NCT04292418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5524040|NCT04292418|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5524041|NCT04292418|Antitubercular Agents|antitubercular agents|mesh-ancestor
5524042|NCT04292418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5524043|NCT04292418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5524044|NCT04292483|Nitric Oxide|nitric oxide|mesh-list
5524045|NCT04292483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5524046|NCT04292483|Autonomic Agents|autonomic agents|mesh-ancestor
6102265|NCT00955110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6102266|NCT00955110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6102267|NCT00955253|Guanfacine|guanfacine|mesh-list
6102268|NCT00955253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6102269|NCT00955253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6102270|NCT00955253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5524047|NCT04292483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5524048|NCT04292483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524049|NCT04292483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5524050|NCT04292483|Respiratory System Agents|respiratory system agents|mesh-ancestor
5524051|NCT04292483|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6102271|NCT00955253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6102272|NCT00955253|Adrenergic Agents|adrenergic agents|mesh-ancestor
6102273|NCT00955253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6102274|NCT00955253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102275|NCT00955253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102276|NCT00955266|Calcium|calcium|mesh-list
6102277|NCT00955266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6102278|NCT00955266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102279|NCT00955279|Golimumab|golimumab|mesh-list
6102280|NCT00955279|Ustekinumab|ustekinumab|mesh-list
6102281|NCT00955279|Dermatologic Agents|dermatologic agents|mesh-ancestor
6102282|NCT00955279|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6102283|NCT00955279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6102284|NCT00955279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6102285|NCT00955279|Immunologic Factors|immunologic factors|mesh-ancestor
6102286|NCT00955279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102287|NCT00955305|Paclitaxel|paclitaxel|mesh-list
5524052|NCT04292483|Antioxidants|antioxidants|mesh-ancestor
5524053|NCT04292483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524054|NCT04292483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5524055|NCT04292483|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5524056|NCT04292483|Vasodilator Agents|vasodilator agents|mesh-ancestor
5524057|NCT04292483|Gasotransmitters|gasotransmitters|mesh-ancestor
5524058|NCT04292483|Protective Agents|protective agents|mesh-ancestor
5524059|NCT04292457|Propofol|propofol|mesh-list
5524060|NCT04292457|Sevoflurane|sevoflurane|mesh-list
5524061|NCT04292457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5524062|NCT04292457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5524063|NCT04292457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524064|NCT04292457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5524065|NCT04292457|Anesthetics, General|anesthetics, general|mesh-ancestor
5524066|NCT04292457|Anesthetics|anesthetics|mesh-ancestor
5524067|NCT04292457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5524068|NCT04292457|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5524069|NCT04292444|Oxytocin|oxytocin|mesh-list
5524070|NCT04292444|Oxytocics|oxytocics|mesh-ancestor
5524071|NCT04292444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5524072|NCT04292444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524073|NCT04292808|Methoxyflurane|methoxyflurane|mesh-list
5524074|NCT04292808|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5524075|NCT04292808|Anesthetics, General|anesthetics, general|mesh-ancestor
6102288|NCT00955305|Bevacizumab|bevacizumab|mesh-list
6102289|NCT00955305|Carboplatin|carboplatin|mesh-list
6102290|NCT00955305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6102291|NCT00955305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5524076|NCT04292808|Anesthetics|anesthetics|mesh-ancestor
5524077|NCT04292808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5524078|NCT04292808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524079|NCT04292691|Ropivacaine|ropivacaine|mesh-list
5524080|NCT04292691|Anesthetics, Local|anesthetics, local|mesh-ancestor
5524081|NCT04292691|Anesthetics|anesthetics|mesh-ancestor
5524082|NCT04292691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5524083|NCT04292691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524084|NCT04292691|Sensory System Agents|sensory system agents|mesh-ancestor
5524085|NCT04292691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6102292|NCT00955305|Tubulin Modulators|tubulin modulators|mesh-ancestor
5524086|NCT04292769|Decitabine|decitabine|mesh-list
5524087|NCT04292769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6102293|NCT00955305|Antimitotic Agents|antimitotic agents|mesh-ancestor
6102294|NCT00955305|Mitosis Modulators|mitosis modulators|mesh-ancestor
6102295|NCT00955305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102296|NCT00955305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6102297|NCT00955305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6102298|NCT00955305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6102299|NCT00955305|Growth Substances|growth substances|mesh-ancestor
6102300|NCT00955305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102301|NCT00955305|Growth Inhibitors|growth inhibitors|mesh-ancestor
6102302|NCT00955357|Lacosamide|lacosamide|mesh-list
5524088|NCT04292769|Antimetabolites|antimetabolites|mesh-ancestor
5524089|NCT04292769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524090|NCT04292769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5524091|NCT04292769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5524092|NCT04292704|Clotrimazole|clotrimazole|mesh-list
5524093|NCT04292704|Miconazole|miconazole|mesh-list
5524094|NCT04292704|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5524095|NCT04292704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5524096|NCT04292704|Antifungal Agents|antifungal agents|mesh-ancestor
5524097|NCT04292704|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5524098|NCT04292704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5524099|NCT04292704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5524100|NCT04292704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524101|NCT04292704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5524102|NCT04292704|Hormone Antagonists|hormone antagonists|mesh-ancestor
5524103|NCT04292704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5524104|NCT04292704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524105|NCT04292704|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5524106|NCT04292704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5524107|NCT04292119|Crizotinib|crizotinib|mesh-list
5524108|NCT04292119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5524109|NCT04292119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5524110|NCT04292119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5524111|NCT04292119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524112|NCT04292184|Sodium thiosulfate|sodium thiosulfate|mesh-list
5524113|NCT04292184|Antidotes|antidotes|mesh-ancestor
6102303|NCT00955357|Anticonvulsants|anticonvulsants|mesh-ancestor
6102304|NCT00955357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6102305|NCT00955357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6102306|NCT00955357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6102307|NCT00955357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102308|NCT00955409|Saponin QA-21V1|saponin qa-21v1|mesh-list
6102309|NCT00955409|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6102310|NCT00955409|Immunologic Factors|immunologic factors|mesh-ancestor
6102311|NCT00955409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102312|NCT00955474|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6102313|NCT00955474|Citalopram|citalopram|mesh-list
6102314|NCT00955474|Sertraline|sertraline|mesh-list
6102315|NCT00955474|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6102316|NCT00955474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6102317|NCT00955474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6102318|NCT00955474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102319|NCT00955474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6102320|NCT00955474|Serotonin Agents|serotonin agents|mesh-ancestor
6102321|NCT00955474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102322|NCT00955474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6102323|NCT00955474|Antidepressive Agents|antidepressive agents|mesh-ancestor
6102324|NCT00955474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6102325|NCT00955474|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6102326|NCT00955474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6102327|NCT00955474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6102328|NCT00955487|Nitric Oxide|nitric oxide|mesh-list
5524114|NCT04292184|Protective Agents|protective agents|mesh-ancestor
5524115|NCT04292184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524116|NCT04292184|Antioxidants|antioxidants|mesh-ancestor
5524117|NCT04292184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524118|NCT04292184|Antitubercular Agents|antitubercular agents|mesh-ancestor
5524119|NCT04292184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5524120|NCT04292184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5524121|NCT04292184|Chelating Agents|chelating agents|mesh-ancestor
5524122|NCT04292184|Sequestering Agents|sequestering agents|mesh-ancestor
5524123|NCT04292236|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
5524124|NCT04292236|Perilla seed oil|perilla seed oil|mesh-list
5524125|NCT04292236|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5524126|NCT04292236|Protective Agents|protective agents|mesh-ancestor
5524127|NCT04292236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524128|NCT04292236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6102329|NCT00955487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6102330|NCT00955487|Autonomic Agents|autonomic agents|mesh-ancestor
6102331|NCT00955487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6102332|NCT00955487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102333|NCT00955487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6102334|NCT00955487|Respiratory System Agents|respiratory system agents|mesh-ancestor
6102335|NCT00955487|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6102336|NCT00955487|Antioxidants|antioxidants|mesh-ancestor
6102337|NCT00955487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102338|NCT00955487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6102339|NCT00955487|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6102340|NCT00955487|Vasodilator Agents|vasodilator agents|mesh-ancestor
6102341|NCT00955487|Gasotransmitters|gasotransmitters|mesh-ancestor
5524129|NCT04292054|Cefazolin|cefazolin|mesh-list
5524130|NCT04292054|Tazobactam|tazobactam|mesh-list
5524131|NCT04292054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5524132|NCT04292054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5524133|NCT04292054|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5524134|NCT04292054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5524135|NCT04292054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601178|NCT03707457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5601179|NCT03707457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5601180|NCT03707457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5601181|NCT03707457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601182|NCT03707418|Heparin|heparin|mesh-list
5601183|NCT03707418|Calcium heparin|calcium heparin|mesh-list
5601184|NCT03707418|Bivalirudin|bivalirudin|mesh-list
5601185|NCT03707418|Anticoagulants|anticoagulants|mesh-ancestor
5601186|NCT03707418|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5601187|NCT03707418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5601188|NCT03707418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601189|NCT03707418|Antithrombins|antithrombins|mesh-ancestor
6102342|NCT00955487|Protective Agents|protective agents|mesh-ancestor
6102343|NCT00955513|Diclofenac|diclofenac|mesh-list
6102344|NCT00955513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6102345|NCT00955513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6102346|NCT00955513|Analgesics|analgesics|mesh-ancestor
6102347|NCT00955513|Sensory System Agents|sensory system agents|mesh-ancestor
6102348|NCT00955513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6102349|NCT00955513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102350|NCT00955513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6102351|NCT00955513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6102352|NCT00955513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6102353|NCT00955513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6102354|NCT00955513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102355|NCT00955721|Gemcitabine|gemcitabine|mesh-list
6102356|NCT00955721|Oxaliplatin|oxaliplatin|mesh-list
6102357|NCT00955721|Sorafenib|sorafenib|mesh-list
6102358|NCT00955721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6102359|NCT00955721|Antimetabolites|antimetabolites|mesh-ancestor
6102360|NCT00955721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102361|NCT00955721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6102362|NCT00955721|Antiviral Agents|antiviral agents|mesh-ancestor
6102363|NCT00955721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6102364|NCT00955721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6102365|NCT00955721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6102366|NCT00955721|Immunologic Factors|immunologic factors|mesh-ancestor
6102367|NCT00955721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102368|NCT00955721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6102369|NCT00955747|Tagatose|tagatose|mesh-list
6102370|NCT00955747|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6102371|NCT00955747|Chelating Agents|chelating agents|mesh-ancestor
6102372|NCT00955747|Sequestering Agents|sequestering agents|mesh-ancestor
6102373|NCT00955747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102374|NCT00955877|Morphine|morphine|mesh-list
6102375|NCT00955877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6102376|NCT00955877|Narcotics|narcotics|mesh-ancestor
5601190|NCT03707418|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5601191|NCT03707418|Protease Inhibitors|protease inhibitors|mesh-ancestor
6102377|NCT00955877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6102378|NCT00955877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102379|NCT00955877|Analgesics|analgesics|mesh-ancestor
6102380|NCT00955877|Sensory System Agents|sensory system agents|mesh-ancestor
6102381|NCT00955877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6102382|NCT00955916|Cytarabine|cytarabine|mesh-list
6102383|NCT00955916|Imatinib Mesylate|imatinib mesylate|mesh-list
6102384|NCT00955916|Cladribine|cladribine|mesh-list
6102385|NCT00955916|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6102386|NCT00955916|Antimetabolites|antimetabolites|mesh-ancestor
6102387|NCT00955916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102388|NCT00955916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6102389|NCT00955916|Antiviral Agents|antiviral agents|mesh-ancestor
6102390|NCT00955916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6102391|NCT00955916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6102392|NCT00955916|Immunologic Factors|immunologic factors|mesh-ancestor
6102393|NCT00955916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102394|NCT00955916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6102395|NCT00955916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6102396|NCT00955968|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6102397|NCT00955968|Antiviral Agents|antiviral agents|mesh-ancestor
6102398|NCT00955968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6102399|NCT00956085|Memantine|memantine|mesh-list
6102400|NCT00956085|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6102401|NCT00956085|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6102402|NCT00956085|Dopamine Agents|dopamine agents|mesh-ancestor
5524136|NCT04292314|Hydroxyurea|hydroxyurea|mesh-list
5524137|NCT04292314|Deferoxamine|deferoxamine|mesh-list
5524138|NCT04292314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5524139|NCT04292314|Antisickling Agents|antisickling agents|mesh-ancestor
5524140|NCT04292314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5524141|NCT04292314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524142|NCT04292314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5524143|NCT04292314|Siderophores|siderophores|mesh-ancestor
5524144|NCT04292314|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5524145|NCT04292314|Chelating Agents|chelating agents|mesh-ancestor
5524146|NCT04292314|Sequestering Agents|sequestering agents|mesh-ancestor
5524147|NCT04291794|Propofol|propofol|mesh-list
5524148|NCT04291794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5524149|NCT04291794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5524150|NCT04291794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524151|NCT04291794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5524152|NCT04291794|Anesthetics, General|anesthetics, general|mesh-ancestor
5524153|NCT04291794|Anesthetics|anesthetics|mesh-ancestor
5524154|NCT04291729|Interferons|interferons|mesh-list
5524155|NCT04291729|Ritonavir|ritonavir|mesh-list
5524156|NCT04291729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5524157|NCT04291729|Antiviral Agents|antiviral agents|mesh-ancestor
5524158|NCT04291729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5524159|NCT04291729|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5524160|NCT04291729|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5524161|NCT04291729|Protease Inhibitors|protease inhibitors|mesh-ancestor
5524162|NCT04291729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5524163|NCT04291729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524164|NCT04291729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5524165|NCT04291729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5524166|NCT04291729|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5524167|NCT04291729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5524168|NCT04291768|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5524169|NCT04291768|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5524170|NCT04291768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5524171|NCT04291768|Antitubercular Agents|antitubercular agents|mesh-ancestor
5524172|NCT04291820|Anesthetics|anesthetics|mesh-list
5524173|NCT04291820|Sevoflurane|sevoflurane|mesh-list
5524174|NCT04291820|Desflurane|desflurane|mesh-list
5524175|NCT04291820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5524176|NCT04291820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524177|NCT04291820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5524178|NCT04291820|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6102403|NCT00956085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6102404|NCT00956085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102405|NCT00956085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102406|NCT00956085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6102407|NCT00956085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6102408|NCT00956254|Fentanyl|fentanyl|mesh-list
5524179|NCT04291820|Anesthetics, General|anesthetics, general|mesh-ancestor
5524180|NCT04291755|Pembrolizumab|pembrolizumab|mesh-list
5524181|NCT04291755|Nivolumab|nivolumab|mesh-list
6102409|NCT00956254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6102410|NCT00956254|Narcotics|narcotics|mesh-ancestor
6102411|NCT00956254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6102412|NCT00956254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102413|NCT00956254|Analgesics|analgesics|mesh-ancestor
6102414|NCT00956254|Sensory System Agents|sensory system agents|mesh-ancestor
6102415|NCT00956254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6102416|NCT00956254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6102417|NCT00956254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6102418|NCT00956254|Anesthetics, General|anesthetics, general|mesh-ancestor
6102419|NCT00956254|Anesthetics|anesthetics|mesh-ancestor
6102420|NCT00956293|Cyclosporine|cyclosporine|mesh-list
6102421|NCT00956293|Mycophenolic Acid|mycophenolic acid|mesh-list
6102422|NCT00956293|Everolimus|everolimus|mesh-list
6102423|NCT00956293|Cyclosporins|cyclosporins|mesh-list
6102424|NCT00956293|Basiliximab|basiliximab|mesh-list
6102425|NCT00956293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6102426|NCT00956293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102427|NCT00956293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6102428|NCT00956293|Immunologic Factors|immunologic factors|mesh-ancestor
6102429|NCT00956293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102430|NCT00956293|Antifungal Agents|antifungal agents|mesh-ancestor
6102431|NCT00956293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5524182|NCT04291755|Ipilimumab|ipilimumab|mesh-list
5524183|NCT04291755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5524184|NCT04291755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5524185|NCT04291755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5524186|NCT04291755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524187|NCT04291664|Prednisone|prednisone|mesh-list
6102432|NCT00956293|Dermatologic Agents|dermatologic agents|mesh-ancestor
6102433|NCT00956293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6102434|NCT00956293|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6102435|NCT00956293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6102436|NCT00956293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6102437|NCT00956293|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6102438|NCT00956293|Antitubercular Agents|antitubercular agents|mesh-ancestor
6102439|NCT00956293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6102440|NCT00956709|Ropivacaine|ropivacaine|mesh-list
6102441|NCT00956709|Levobupivacaine|levobupivacaine|mesh-list
6102442|NCT00956709|Anesthetics, Local|anesthetics, local|mesh-ancestor
6102443|NCT00956709|Anesthetics|anesthetics|mesh-ancestor
6102444|NCT00956709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6102445|NCT00956709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102446|NCT00956709|Sensory System Agents|sensory system agents|mesh-ancestor
6102447|NCT00956709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6203852|NCT02062359|Cyclophosphamide|cyclophosphamide|mesh-list
6203853|NCT02062359|Fludarabine|fludarabine|mesh-list
6203854|NCT02062359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6203855|NCT02062359|Immunologic Factors|immunologic factors|mesh-ancestor
6203856|NCT02062359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203857|NCT02062359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6203858|NCT02062359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6203859|NCT02062359|Alkylating Agents|alkylating agents|mesh-ancestor
6203860|NCT02062359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203861|NCT02062359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6203862|NCT02062359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6203863|NCT02062359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6203864|NCT02062359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6203865|NCT02062359|Antiviral Agents|antiviral agents|mesh-ancestor
6203866|NCT02062359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6203867|NCT02062632|Doxepin|doxepin|mesh-list
6203868|NCT02062632|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6203869|NCT02062632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6203870|NCT02062632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6203871|NCT02062632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203872|NCT02062632|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6203873|NCT02062632|Antidepressive Agents|antidepressive agents|mesh-ancestor
5524188|NCT04291664|Abiraterone Acetate|abiraterone acetate|mesh-list
5524189|NCT04291664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5524190|NCT04291664|Glucocorticoids|glucocorticoids|mesh-ancestor
6203874|NCT02062632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6203875|NCT02062632|Histamine Antagonists|histamine antagonists|mesh-ancestor
6203876|NCT02062632|Histamine Agents|histamine agents|mesh-ancestor
6203877|NCT02062632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5524191|NCT04291664|Hormones|hormones|mesh-ancestor
6203878|NCT02062632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524192|NCT04291664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5524193|NCT04291664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524194|NCT04291664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5524195|NCT04291664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5524196|NCT04291664|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5524197|NCT04291664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5524198|NCT04291664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524199|NCT04291664|Hormone Antagonists|hormone antagonists|mesh-ancestor
5524200|NCT04291664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5524201|NCT04291287|Fibrinolytic Agents|fibrinolytic agents|mesh-list
5524202|NCT04291287|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5524203|NCT04291287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524204|NCT04291313|Vitamin D|vitamin d|mesh-list
5524205|NCT04291313|Ergocalciferols|ergocalciferols|mesh-list
5524206|NCT04291313|Cholecalciferol|cholecalciferol|mesh-list
5524207|NCT04291313|Vitamins|vitamins|mesh-list
5524208|NCT04291313|Micronutrients|micronutrients|mesh-ancestor
5524209|NCT04291313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524210|NCT04291313|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5524211|NCT04291313|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5524212|NCT04291456|Minocycline|minocycline|mesh-list
5524213|NCT04291456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5524214|NCT04291456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5524215|NCT04291209|Acetylcysteine|acetylcysteine|mesh-list
5524216|NCT04291209|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5524217|NCT04291209|Antiviral Agents|antiviral agents|mesh-ancestor
5524218|NCT04291209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5524219|NCT04291209|Expectorants|expectorants|mesh-ancestor
5524220|NCT04291209|Respiratory System Agents|respiratory system agents|mesh-ancestor
5524221|NCT04291209|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5524222|NCT04291209|Antioxidants|antioxidants|mesh-ancestor
6102448|NCT00956839|Vitamin D|vitamin d|mesh-list
6102449|NCT00956839|Ergocalciferols|ergocalciferols|mesh-list
6102450|NCT00956839|Cholecalciferol|cholecalciferol|mesh-list
6102451|NCT00956839|Vitamins|vitamins|mesh-list
6102452|NCT00956839|Micronutrients|micronutrients|mesh-ancestor
6102453|NCT00956839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102454|NCT00956839|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6102455|NCT00956839|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6102456|NCT00956930|Doxorubicin|doxorubicin|mesh-list
6102457|NCT00956930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6102458|NCT00956930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6102459|NCT00956930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6102460|NCT00956930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6102461|NCT00956930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6102462|NCT00956930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6102463|NCT00956930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524223|NCT04291209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524224|NCT04291209|Protective Agents|protective agents|mesh-ancestor
5524225|NCT04291209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524226|NCT04291209|Antidotes|antidotes|mesh-ancestor
5524227|NCT04290819|Caffeine|caffeine|mesh-list
5524228|NCT04290819|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6102464|NCT00956943|Nicotine|nicotine|mesh-list
6102465|NCT00956943|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5524229|NCT04290819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524230|NCT04290819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5524231|NCT04290819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5524232|NCT04290819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524233|NCT04290819|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5524234|NCT04290819|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5524235|NCT04290819|Purinergic Agents|purinergic agents|mesh-ancestor
5524236|NCT04290819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5524237|NCT04290936|Tenofovir|tenofovir|mesh-list
5524238|NCT04290936|Antiviral Agents|antiviral agents|mesh-ancestor
5524239|NCT04290936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5524240|NCT04290936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5524241|NCT04290936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5524242|NCT04290936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5524243|NCT04290936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524244|NCT04290936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6102466|NCT00956943|Autonomic Agents|autonomic agents|mesh-ancestor
6102467|NCT00956943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6102468|NCT00956943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102469|NCT00956943|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6102470|NCT00956943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6102471|NCT00956943|Cholinergic Agents|cholinergic agents|mesh-ancestor
6102472|NCT00956943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6102473|NCT00956943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102474|NCT00957047|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
6102475|NCT00957047|Anticonvulsants|anticonvulsants|mesh-ancestor
6102476|NCT00957047|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6102477|NCT00957047|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6102478|NCT00957047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6102479|NCT00957047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102480|NCT00957242|Warfarin|warfarin|mesh-list
5524245|NCT04290936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5524246|NCT04290871|Nitric Oxide|nitric oxide|mesh-list
5524247|NCT04290871|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5524248|NCT04290871|Autonomic Agents|autonomic agents|mesh-ancestor
5524249|NCT04290871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5524250|NCT04290871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524251|NCT04290871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5524252|NCT04290871|Respiratory System Agents|respiratory system agents|mesh-ancestor
5524253|NCT04290871|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5524254|NCT04290871|Antioxidants|antioxidants|mesh-ancestor
5524255|NCT04290871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524256|NCT04290871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5524257|NCT04290871|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5524258|NCT04290871|Vasodilator Agents|vasodilator agents|mesh-ancestor
5524259|NCT04290871|Gasotransmitters|gasotransmitters|mesh-ancestor
5524260|NCT04290871|Protective Agents|protective agents|mesh-ancestor
5524261|NCT04291066|Acetylcysteine|acetylcysteine|mesh-list
5524262|NCT04291066|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5524263|NCT04291066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524264|NCT04291066|Antiviral Agents|antiviral agents|mesh-ancestor
6102481|NCT00957242|Anticoagulants|anticoagulants|mesh-ancestor
6102482|NCT00957268|Alogliptin|alogliptin|mesh-list
6102483|NCT00957268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6102484|NCT00957268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102485|NCT00957268|Incretins|incretins|mesh-ancestor
6102486|NCT00957268|Hormones|hormones|mesh-ancestor
6102487|NCT00957268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6102488|NCT00957268|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6102489|NCT00957268|Protease Inhibitors|protease inhibitors|mesh-ancestor
5524265|NCT04291066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6102490|NCT00957268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6102491|NCT00957268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102492|NCT00957333|Ketamine|ketamine|mesh-list
6102493|NCT00957333|Analgesics|analgesics|mesh-ancestor
6102494|NCT00957333|Sensory System Agents|sensory system agents|mesh-ancestor
6102495|NCT00957333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6102496|NCT00957333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102497|NCT00957333|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6102498|NCT00957333|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6102499|NCT00957333|Anesthetics, General|anesthetics, general|mesh-ancestor
6102500|NCT00957333|Anesthetics|anesthetics|mesh-ancestor
6102501|NCT00957333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6102502|NCT00957333|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6102503|NCT00957333|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6102504|NCT00957333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6102505|NCT00957333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102506|NCT00957359|Niacin|niacin|mesh-list
6102507|NCT00957359|Psilocybin|psilocybin|mesh-list
6102508|NCT00957359|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
6102509|NCT00957359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6102510|NCT00957359|Antimetabolites|antimetabolites|mesh-ancestor
6102511|NCT00957359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102512|NCT00957359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6102513|NCT00957359|Vasodilator Agents|vasodilator agents|mesh-ancestor
6102514|NCT00957359|Vitamin B Complex|vitamin b complex|mesh-ancestor
6102515|NCT00957359|Vitamins|vitamins|mesh-ancestor
6102516|NCT00957359|Micronutrients|micronutrients|mesh-ancestor
6102517|NCT00957359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102518|NCT00957359|Hallucinogens|hallucinogens|mesh-ancestor
6102519|NCT00957359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6102520|NCT00957359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6102521|NCT00957359|Serotonin Agents|serotonin agents|mesh-ancestor
6102522|NCT00957359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6102523|NCT00957359|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6102524|NCT00957372|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
6102525|NCT00957372|Anticonvulsants|anticonvulsants|mesh-ancestor
6102526|NCT00957372|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6102527|NCT00957372|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6102528|NCT00957372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6102529|NCT00957372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102530|NCT00957424|Nicotine|nicotine|mesh-list
6102531|NCT00957424|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6102532|NCT00957424|Autonomic Agents|autonomic agents|mesh-ancestor
6102533|NCT00957424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6102534|NCT00957424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102535|NCT00957424|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6102536|NCT00957424|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6102537|NCT00957424|Cholinergic Agents|cholinergic agents|mesh-ancestor
5524266|NCT04291066|Expectorants|expectorants|mesh-ancestor
5524267|NCT04291066|Respiratory System Agents|respiratory system agents|mesh-ancestor
5524268|NCT04291066|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5524269|NCT04291066|Antioxidants|antioxidants|mesh-ancestor
5524270|NCT04291066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524271|NCT04291066|Protective Agents|protective agents|mesh-ancestor
5524272|NCT04291066|Antidotes|antidotes|mesh-ancestor
5524273|NCT04291001|Ulipristal acetate|ulipristal acetate|mesh-list
5524274|NCT04291001|Etonogestrel|etonogestrel|mesh-list
5524275|NCT04291001|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5524276|NCT04291001|Contraceptive Agents|contraceptive agents|mesh-ancestor
5524277|NCT04291001|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5524278|NCT04291001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524279|NCT04291001|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5524280|NCT04290884|Tranexamic Acid|tranexamic acid|mesh-list
5524281|NCT04290884|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6102538|NCT00957424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6102539|NCT00957424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102540|NCT00957528|Methyltestosterone|methyltestosterone|mesh-list
6102541|NCT00957528|Testosterone|testosterone|mesh-list
6102542|NCT00957528|Testosterone undecanoate|testosterone undecanoate|mesh-list
6102543|NCT00957528|Testosterone enanthate|testosterone enanthate|mesh-list
6102544|NCT00957528|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6102545|NCT00957528|Androgens|androgens|mesh-ancestor
6102546|NCT00957528|Hormones|hormones|mesh-ancestor
6102547|NCT00957528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6102548|NCT00957528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102549|NCT00957528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6102550|NCT00957528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6102551|NCT00957528|Anabolic Agents|anabolic agents|mesh-ancestor
6102552|NCT00957580|Niacinamide|niacinamide|mesh-list
6102553|NCT00957580|Vitamin B Complex|vitamin b complex|mesh-ancestor
6102554|NCT00957580|Vitamins|vitamins|mesh-ancestor
6102555|NCT00957580|Micronutrients|micronutrients|mesh-ancestor
6102556|NCT00957580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102557|NCT00957593|Oxytocin|oxytocin|mesh-list
6102558|NCT00957593|Oxytocics|oxytocics|mesh-ancestor
5524282|NCT04290884|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5524283|NCT04290884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524284|NCT04290884|Hemostatics|hemostatics|mesh-ancestor
5524285|NCT04290884|Coagulants|coagulants|mesh-ancestor
5524286|NCT04290793|Cyclophosphamide|cyclophosphamide|mesh-list
5524287|NCT04290793|Trastuzumab|trastuzumab|mesh-list
6102559|NCT00957593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6102560|NCT00957593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102561|NCT00957671|Hormones|hormones|mesh-list
6102562|NCT00957671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6102563|NCT00957671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102564|NCT00957684|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
6102565|NCT00957684|Anticonvulsants|anticonvulsants|mesh-ancestor
6102566|NCT00957684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6102567|NCT00957684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6102568|NCT00957684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6102569|NCT00957684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102570|NCT00957801|Methylprednisolone|methylprednisolone|mesh-list
6102571|NCT00957801|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6102572|NCT00957801|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6102573|NCT00957801|Prednisolone|prednisolone|mesh-list
6102574|NCT00957801|Prednisolone acetate|prednisolone acetate|mesh-list
6102575|NCT00957801|Methyltestosterone|methyltestosterone|mesh-list
6102576|NCT00957801|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6102577|NCT00957801|Prednisolone phosphate|prednisolone phosphate|mesh-list
6102578|NCT00957801|Testosterone|testosterone|mesh-list
6102579|NCT00957801|Testosterone undecanoate|testosterone undecanoate|mesh-list
6102580|NCT00957801|Testosterone enanthate|testosterone enanthate|mesh-list
6102581|NCT00957801|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6102582|NCT00957801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6102583|NCT00957801|Antiemetics|antiemetics|mesh-ancestor
6102584|NCT00957801|Autonomic Agents|autonomic agents|mesh-ancestor
6102585|NCT00957801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6102586|NCT00957801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102587|NCT00957801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6102588|NCT00957801|Glucocorticoids|glucocorticoids|mesh-ancestor
6102589|NCT00957801|Hormones|hormones|mesh-ancestor
6102590|NCT00957801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6465051|NCT00471952|Serotonin Agents|serotonin agents|mesh-ancestor
6465052|NCT00471965|Leucovorin|leucovorin|mesh-list
5524288|NCT04290793|Epirubicin|epirubicin|mesh-list
5524289|NCT04290793|Taxane|taxane|mesh-list
5524290|NCT04290793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5524291|NCT04290793|Immunologic Factors|immunologic factors|mesh-ancestor
5524292|NCT04290793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465053|NCT00471965|Doxorubicin|doxorubicin|mesh-list
6465054|NCT00471965|Fluorouracil|fluorouracil|mesh-list
6465055|NCT00471965|Oxaliplatin|oxaliplatin|mesh-list
6465056|NCT00471965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6102591|NCT00957801|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6102592|NCT00957801|Protective Agents|protective agents|mesh-ancestor
6102593|NCT00957801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6102594|NCT00957801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6102595|NCT00957801|Androgens|androgens|mesh-ancestor
6102596|NCT00957801|Anabolic Agents|anabolic agents|mesh-ancestor
6102597|NCT00957853|Cetuximab|cetuximab|mesh-list
6102598|NCT00957853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6102599|NCT00957853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6102600|NCT00957905|Calcium, Dietary|calcium, dietary|mesh-list
6102601|NCT00957905|Leucovorin|leucovorin|mesh-list
6102602|NCT00957905|Folic Acid|folic acid|mesh-list
6102603|NCT00957905|Fluorouracil|fluorouracil|mesh-list
6102604|NCT00957905|Oxaliplatin|oxaliplatin|mesh-list
6102605|NCT00957905|Alvocidib|alvocidib|mesh-list
6102606|NCT00957905|Calcium|calcium|mesh-list
6102607|NCT00957905|Levoleucovorin|levoleucovorin|mesh-list
6102608|NCT00957905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6102609|NCT00957905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102610|NCT00957905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6102611|NCT00957905|Antimetabolites|antimetabolites|mesh-ancestor
6102612|NCT00957905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102613|NCT00957905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6102614|NCT00957905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6102615|NCT00957905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6102616|NCT00957905|Immunologic Factors|immunologic factors|mesh-ancestor
6102617|NCT00957905|Antidotes|antidotes|mesh-ancestor
6102618|NCT00957905|Protective Agents|protective agents|mesh-ancestor
6102619|NCT00957905|Vitamin B Complex|vitamin b complex|mesh-ancestor
6102620|NCT00957905|Vitamins|vitamins|mesh-ancestor
6102621|NCT00957905|Micronutrients|micronutrients|mesh-ancestor
6102622|NCT00957905|Hematinics|hematinics|mesh-ancestor
6102623|NCT00957905|Growth Inhibitors|growth inhibitors|mesh-ancestor
6102624|NCT00957905|Growth Substances|growth substances|mesh-ancestor
6102625|NCT00957905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6102626|NCT00957905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6102627|NCT00957944|Rotigotine|rotigotine|mesh-list
6102628|NCT00957944|Dopamine Agonists|dopamine agonists|mesh-ancestor
6102629|NCT00957944|Dopamine Agents|dopamine agents|mesh-ancestor
6102630|NCT00957944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6102631|NCT00957944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102632|NCT00957944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102633|NCT00957996|Peramivir|peramivir|mesh-list
6102634|NCT00957996|Antiviral Agents|antiviral agents|mesh-ancestor
6102635|NCT00957996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6102636|NCT00957996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6102637|NCT00957996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102638|NCT00958035|Bimatoprost|bimatoprost|mesh-list
6102639|NCT00958035|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5524293|NCT04290793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5601192|NCT03707418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6102640|NCT00958035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6102641|NCT00958074|Vorinostat|vorinostat|mesh-list
6465057|NCT00471965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6102642|NCT00958074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6102643|NCT00958074|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6102644|NCT00958074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6102645|NCT00958074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524294|NCT04290793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5524295|NCT04290793|Alkylating Agents|alkylating agents|mesh-ancestor
5524296|NCT04290793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524297|NCT04290793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5524298|NCT04290793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5524299|NCT04290793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5524300|NCT04290793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5524301|NCT04290793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5524302|NCT04290793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5524303|NCT04290793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5524304|NCT04291079|Antibodies|antibodies|mesh-list
5524305|NCT04291079|Immunologic Factors|immunologic factors|mesh-ancestor
5524306|NCT04291079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524307|NCT04290858|Nitric Oxide|nitric oxide|mesh-list
5524308|NCT04290858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5524309|NCT04290858|Autonomic Agents|autonomic agents|mesh-ancestor
5524310|NCT04290858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5524311|NCT04290858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524312|NCT04290858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5524313|NCT04290858|Respiratory System Agents|respiratory system agents|mesh-ancestor
5524314|NCT04290858|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5524315|NCT04290858|Antioxidants|antioxidants|mesh-ancestor
5524316|NCT04290858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524317|NCT04290858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5524318|NCT04290858|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5524319|NCT04290858|Vasodilator Agents|vasodilator agents|mesh-ancestor
5524320|NCT04290858|Gasotransmitters|gasotransmitters|mesh-ancestor
5524321|NCT04290858|Protective Agents|protective agents|mesh-ancestor
5524322|NCT04291118|Budesonide|budesonide|mesh-list
5524323|NCT04291118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5524324|NCT04291118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5524325|NCT04291118|Autonomic Agents|autonomic agents|mesh-ancestor
5524326|NCT04291118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5524327|NCT04291118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524328|NCT04291118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5524329|NCT04291118|Respiratory System Agents|respiratory system agents|mesh-ancestor
5524330|NCT04291118|Glucocorticoids|glucocorticoids|mesh-ancestor
5524331|NCT04291118|Hormones|hormones|mesh-ancestor
5524332|NCT04291118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5524333|NCT04290546|Ipilimumab|ipilimumab|mesh-list
5524334|NCT04290546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5524335|NCT04290546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5524336|NCT04290546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5524337|NCT04290546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524338|NCT04290442|Ropivacaine|ropivacaine|mesh-list
5524339|NCT04290442|Anesthetics, Local|anesthetics, local|mesh-ancestor
5524340|NCT04290442|Anesthetics|anesthetics|mesh-ancestor
6102646|NCT00958243|Vaccines|vaccines|mesh-list
6102647|NCT00958243|Immunologic Factors|immunologic factors|mesh-ancestor
6102648|NCT00958243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102649|NCT00958256|Cyclophosphamide|cyclophosphamide|mesh-list
6102650|NCT00958256|Rituximab|rituximab|mesh-list
6102651|NCT00958256|Bortezomib|bortezomib|mesh-list
6102652|NCT00958256|Lenograstim|lenograstim|mesh-list
6102653|NCT00958256|Sargramostim|sargramostim|mesh-list
6102654|NCT00958256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6102655|NCT00958256|Immunologic Factors|immunologic factors|mesh-ancestor
6102656|NCT00958256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102657|NCT00958256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6102658|NCT00958256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6102659|NCT00958256|Alkylating Agents|alkylating agents|mesh-ancestor
6102660|NCT00958256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102661|NCT00958256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6102662|NCT00958256|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6102663|NCT00958256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6102664|NCT00958256|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6102665|NCT00958282|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6102666|NCT00958282|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6102667|NCT00958282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102668|NCT00958282|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5524341|NCT04290442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5524342|NCT04290442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524343|NCT04290442|Sensory System Agents|sensory system agents|mesh-ancestor
6102669|NCT00958282|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6102670|NCT00958282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6102671|NCT00958282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102672|NCT00958282|Dopamine Agents|dopamine agents|mesh-ancestor
6102673|NCT00958282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6102674|NCT00958438|Rilonacept|rilonacept|mesh-list
6102675|NCT00958438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6102676|NCT00958568|Olanzapine|olanzapine|mesh-list
6102677|NCT00958568|Fluoxetine|fluoxetine|mesh-list
6102678|NCT00958568|Antiemetics|antiemetics|mesh-ancestor
6102679|NCT00958568|Autonomic Agents|autonomic agents|mesh-ancestor
6102680|NCT00958568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6102681|NCT00958568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102682|NCT00958568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6102683|NCT00958568|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6102684|NCT00958568|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6102685|NCT00958568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6102686|NCT00958568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6102687|NCT00958568|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6102688|NCT00958568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6102689|NCT00958568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6102690|NCT00958568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102691|NCT00958568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6102692|NCT00958568|Serotonin Agents|serotonin agents|mesh-ancestor
6102693|NCT00958568|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6102694|NCT00958568|Antidepressive Agents|antidepressive agents|mesh-ancestor
6102695|NCT00958568|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6102696|NCT00958568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6102697|NCT00958568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6102698|NCT00958581|Tranexamic Acid|tranexamic acid|mesh-list
6102699|NCT00958581|Aminocaproic Acid|aminocaproic acid|mesh-list
6102700|NCT00958581|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6102701|NCT00958581|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6102702|NCT00958581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102703|NCT00958581|Hemostatics|hemostatics|mesh-ancestor
6102704|NCT00958581|Coagulants|coagulants|mesh-ancestor
6102705|NCT00958724|Vinorelbine|vinorelbine|mesh-list
6102706|NCT00958724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6102707|NCT00958724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6102708|NCT00958724|Tubulin Modulators|tubulin modulators|mesh-ancestor
6102709|NCT00958724|Antimitotic Agents|antimitotic agents|mesh-ancestor
6102710|NCT00958724|Mitosis Modulators|mitosis modulators|mesh-ancestor
5524344|NCT04290442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5524345|NCT04290455|Castor Oil|castor oil|mesh-list
5524346|NCT04290455|Cathartics|cathartics|mesh-ancestor
5524347|NCT04290455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5524348|NCT04290429|Teduglutide|teduglutide|mesh-list
5524349|NCT04290429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6102711|NCT00958724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102712|NCT00958776|Peramivir|peramivir|mesh-list
6102713|NCT00958776|Antiviral Agents|antiviral agents|mesh-ancestor
6102714|NCT00958776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6102715|NCT00958776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6102716|NCT00958776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102717|NCT00958841|Pasireotide|pasireotide|mesh-list
6102718|NCT00958841|Hormones|hormones|mesh-ancestor
6102719|NCT00958841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6102720|NCT00958841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102721|NCT00958880|Yohimbine|yohimbine|mesh-list
6102722|NCT00958880|Mydriatics|mydriatics|mesh-ancestor
5524350|NCT04290429|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6102723|NCT00958880|Autonomic Agents|autonomic agents|mesh-ancestor
6102724|NCT00958880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6102725|NCT00958880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102726|NCT00958880|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6102727|NCT00958880|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6102728|NCT00958880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6102729|NCT00958880|Adrenergic Agents|adrenergic agents|mesh-ancestor
6102730|NCT00958880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5524351|NCT04290429|Protective Agents|protective agents|mesh-ancestor
6102731|NCT00958880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102732|NCT00958880|Urological Agents|urological agents|mesh-ancestor
6102733|NCT00958919|Naloxone|naloxone|mesh-list
6102734|NCT00958919|Endorphins|endorphins|mesh-list
6102735|NCT00958919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6102736|NCT00958919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102737|NCT00958919|Sensory System Agents|sensory system agents|mesh-ancestor
6102738|NCT00958919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6102739|NCT00958919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6102740|NCT00958919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102741|NCT00959049|Vaccines|vaccines|mesh-list
6102742|NCT00959049|Immunologic Factors|immunologic factors|mesh-ancestor
6102743|NCT00959049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102744|NCT00959192|Saponin QA-21V1|saponin qa-21v1|mesh-list
6102745|NCT00959192|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6102746|NCT00959192|Immunologic Factors|immunologic factors|mesh-ancestor
6102747|NCT00959192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465058|NCT00471965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6465059|NCT00471965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6465060|NCT00471965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6465061|NCT00471965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465062|NCT00471965|Antimetabolites|antimetabolites|mesh-ancestor
6465063|NCT00471965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6465064|NCT00471965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6465065|NCT00471965|Immunologic Factors|immunologic factors|mesh-ancestor
6465066|NCT00471965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465067|NCT00471965|Antidotes|antidotes|mesh-ancestor
6465068|NCT00471965|Protective Agents|protective agents|mesh-ancestor
6465069|NCT00471965|Vitamin B Complex|vitamin b complex|mesh-ancestor
6465070|NCT00471965|Vitamins|vitamins|mesh-ancestor
6465071|NCT00471965|Micronutrients|micronutrients|mesh-ancestor
6465072|NCT00471991|Dienogest|dienogest|mesh-list
6465073|NCT00471991|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6465074|NCT00471991|Estradiol|estradiol|mesh-list
6465075|NCT00471991|Estrogens|estrogens|mesh-ancestor
6465076|NCT00471991|Hormones|hormones|mesh-ancestor
6465077|NCT00471991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6465078|NCT00471991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465079|NCT00471991|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6465080|NCT00471991|Contraceptive Agents|contraceptive agents|mesh-ancestor
6465081|NCT00471991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6465082|NCT00471991|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6102748|NCT00959647|Bevacizumab|bevacizumab|mesh-list
6102749|NCT00959647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6102750|NCT00959647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6102751|NCT00959647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6102752|NCT00959647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6102753|NCT00959647|Growth Substances|growth substances|mesh-ancestor
6102754|NCT00959647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102755|NCT00959647|Growth Inhibitors|growth inhibitors|mesh-ancestor
6102756|NCT00959699|Interferons|interferons|mesh-list
6102757|NCT00959699|Ribavirin|ribavirin|mesh-list
6102758|NCT00959699|Interferon-alpha|interferon-alpha|mesh-list
6102759|NCT00959699|Interferon alpha-2|interferon alpha-2|mesh-list
5524352|NCT04290429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601193|NCT03707353|Vaccines|vaccines|mesh-list
5601194|NCT03707353|Immunologic Factors|immunologic factors|mesh-ancestor
5601195|NCT03707353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601196|NCT03707249|Ferric Compounds|ferric compounds|mesh-list
5601197|NCT03707249|Hematinics|hematinics|mesh-ancestor
5601198|NCT03707171|Liraglutide|liraglutide|mesh-list
5601199|NCT03707171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5601200|NCT03707171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601201|NCT03707171|Incretins|incretins|mesh-ancestor
5601202|NCT03707171|Hormones|hormones|mesh-ancestor
5601203|NCT03707171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6102760|NCT00959699|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6102761|NCT00959699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6102762|NCT00959699|Antiviral Agents|antiviral agents|mesh-ancestor
6102763|NCT00959699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6102764|NCT00959699|Antimetabolites|antimetabolites|mesh-ancestor
6102765|NCT00959699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102766|NCT00959699|Immunologic Factors|immunologic factors|mesh-ancestor
6102767|NCT00959699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102768|NCT00959764|Calcitonin|calcitonin|mesh-list
6102769|NCT00959764|Salmon calcitonin|salmon calcitonin|mesh-list
6102770|NCT00959764|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
5601204|NCT03707028|Paclitaxel|paclitaxel|mesh-list
6102771|NCT00959764|Katacalcin|katacalcin|mesh-list
6102772|NCT00959764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6102773|NCT00959764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102774|NCT00959764|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6102775|NCT00959764|Vasodilator Agents|vasodilator agents|mesh-ancestor
6102776|NCT00959894|Tenofovir|tenofovir|mesh-list
5524353|NCT04290572|Isotretinoin|isotretinoin|mesh-list
5524354|NCT04290572|Dermatologic Agents|dermatologic agents|mesh-ancestor
6102777|NCT00959894|Emtricitabine|emtricitabine|mesh-list
6102778|NCT00959894|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6102779|NCT00959894|Etravirine|etravirine|mesh-list
6102780|NCT00959894|Antiviral Agents|antiviral agents|mesh-ancestor
6102781|NCT00959894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6102782|NCT00959894|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6102783|NCT00959894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6102784|NCT00959894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6102785|NCT00959894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102786|NCT00959894|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6102787|NCT00959894|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6102788|NCT00959907|Botulinum Toxins|botulinum toxins|mesh-list
6102789|NCT00959907|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6102790|NCT00959907|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6102791|NCT00959907|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
6102792|NCT00959907|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6102793|NCT00959907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6102794|NCT00959907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102795|NCT00959907|Cholinergic Agents|cholinergic agents|mesh-ancestor
6102796|NCT00959907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5524355|NCT04290390|Itraconazole|itraconazole|mesh-list
5524356|NCT04290390|Rifampin|rifampin|mesh-list
5524357|NCT04290390|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5524358|NCT04290390|Estradiol|estradiol|mesh-list
5524359|NCT04290390|Estrogens|estrogens|mesh-ancestor
5524360|NCT04290390|Hormones|hormones|mesh-ancestor
5524361|NCT04290390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5524362|NCT04290390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524363|NCT04290390|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5524364|NCT04290390|Contraceptive Agents|contraceptive agents|mesh-ancestor
5524365|NCT04290390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5524366|NCT04290390|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5524367|NCT04290390|Antifungal Agents|antifungal agents|mesh-ancestor
5524368|NCT04290390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5524369|NCT04290390|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5524370|NCT04290390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5524371|NCT04290390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6102797|NCT00959907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102798|NCT00959907|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6102799|NCT00959907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6102800|NCT00959946|Capecitabine|capecitabine|mesh-list
6102801|NCT00959946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5524372|NCT04290390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524373|NCT04290390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5524374|NCT04290390|Hormone Antagonists|hormone antagonists|mesh-ancestor
5524375|NCT04290390|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5524376|NCT04290390|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5524377|NCT04290390|Antitubercular Agents|antitubercular agents|mesh-ancestor
5524378|NCT04290390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5524379|NCT04290390|Leprostatic Agents|leprostatic agents|mesh-ancestor
5601205|NCT03707028|Apatinib|apatinib|mesh-list
6102802|NCT00959946|Antimetabolites|antimetabolites|mesh-ancestor
6102803|NCT00959946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102804|NCT00959946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6102805|NCT00960063|Cyclophosphamide|cyclophosphamide|mesh-list
6102806|NCT00960063|Temozolomide|temozolomide|mesh-list
6102807|NCT00960063|Ifosfamide|ifosfamide|mesh-list
6102808|NCT00960063|Doxorubicin|doxorubicin|mesh-list
6102809|NCT00960063|Irinotecan|irinotecan|mesh-list
6102810|NCT00960063|Etoposide|etoposide|mesh-list
6102811|NCT00960063|Vincristine|vincristine|mesh-list
6102812|NCT00960063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6102813|NCT00960063|Immunologic Factors|immunologic factors|mesh-ancestor
6102814|NCT00960063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102815|NCT00960063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6102816|NCT00960063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6102817|NCT00960063|Alkylating Agents|alkylating agents|mesh-ancestor
6102818|NCT00960063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102819|NCT00960063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6102820|NCT00960063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6102821|NCT00960063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6102822|NCT00960063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6102823|NCT00960063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6102824|NCT00960063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6102825|NCT00960063|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6102826|NCT00960063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5524380|NCT04290390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5524381|NCT04290390|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5524382|NCT04290390|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5524383|NCT04290390|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5524384|NCT04290390|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5524385|NCT04290390|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5524386|NCT04290390|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5524387|NCT04290390|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5524388|NCT04290390|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5524389|NCT04290195|Aflibercept|aflibercept|mesh-list
6102827|NCT00960063|Tubulin Modulators|tubulin modulators|mesh-ancestor
6102828|NCT00960063|Antimitotic Agents|antimitotic agents|mesh-ancestor
6102829|NCT00960063|Mitosis Modulators|mitosis modulators|mesh-ancestor
6102830|NCT00960076|Metformin|metformin|mesh-list
6102831|NCT00960076|Saxagliptin|saxagliptin|mesh-list
6102832|NCT00960076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6102833|NCT00960076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102834|NCT00960076|Incretins|incretins|mesh-ancestor
6102835|NCT00960076|Hormones|hormones|mesh-ancestor
6102836|NCT00960076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6102837|NCT00960076|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5524390|NCT04290195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5524391|NCT04290195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5524392|NCT04290195|Growth Substances|growth substances|mesh-ancestor
5524393|NCT04290195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524394|NCT04290195|Growth Inhibitors|growth inhibitors|mesh-ancestor
5524395|NCT04290195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5524396|NCT04290013|Tranexamic Acid|tranexamic acid|mesh-list
5524397|NCT04290013|Norethindrone|norethindrone|mesh-list
5524398|NCT04290013|Norethindrone Acetate|norethindrone acetate|mesh-list
5524399|NCT04290013|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5524400|NCT04290013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5524401|NCT04290013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524402|NCT04290013|Hemostatics|hemostatics|mesh-ancestor
5524403|NCT04290013|Coagulants|coagulants|mesh-ancestor
5524404|NCT04290013|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5524405|NCT04290013|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5524406|NCT04290013|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5524407|NCT04290013|Contraceptive Agents|contraceptive agents|mesh-ancestor
5524408|NCT04290013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5524409|NCT04290013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524410|NCT04290013|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6102838|NCT00960076|Protease Inhibitors|protease inhibitors|mesh-ancestor
6102839|NCT00960076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6102840|NCT00960076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102841|NCT00960115|Cyclophosphamide|cyclophosphamide|mesh-list
6102842|NCT00960115|Immunologic Factors|immunologic factors|mesh-ancestor
6102843|NCT00960115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102844|NCT00960115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6102845|NCT00960115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6102846|NCT00960115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6102847|NCT00960115|Alkylating Agents|alkylating agents|mesh-ancestor
6102848|NCT00960115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524411|NCT04290013|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5524412|NCT04290208|Acetaminophen|acetaminophen|mesh-list
5524413|NCT04290208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5524414|NCT04290208|Analgesics|analgesics|mesh-ancestor
5524415|NCT04290208|Sensory System Agents|sensory system agents|mesh-ancestor
5524416|NCT04290208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5524417|NCT04290208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524418|NCT04290208|Antipyretics|antipyretics|mesh-ancestor
6102849|NCT00960115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6102850|NCT00960115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6102851|NCT00960193|Colchicine|colchicine|mesh-list
6102852|NCT00960193|Gout Suppressants|gout suppressants|mesh-ancestor
6102853|NCT00960193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6102854|NCT00960193|Tubulin Modulators|tubulin modulators|mesh-ancestor
6102855|NCT00960193|Antimitotic Agents|antimitotic agents|mesh-ancestor
6102856|NCT00960193|Mitosis Modulators|mitosis modulators|mesh-ancestor
6102857|NCT00960193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102858|NCT00960193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6102859|NCT00960323|Colchicine|colchicine|mesh-list
6102860|NCT00960323|Atorvastatin|atorvastatin|mesh-list
6102861|NCT00960323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6102862|NCT00960323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6102863|NCT00960323|Antimetabolites|antimetabolites|mesh-ancestor
6102864|NCT00960323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524419|NCT04290169|Botulinum Toxins|botulinum toxins|mesh-list
5524420|NCT04290169|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5524421|NCT04290169|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
5524422|NCT04290169|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5524423|NCT04290169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5524424|NCT04290169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524425|NCT04290169|Cholinergic Agents|cholinergic agents|mesh-ancestor
5524426|NCT04290169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5524427|NCT04290169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524428|NCT04290169|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5524429|NCT04290169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5524430|NCT04290104|Ampicillin|ampicillin|mesh-list
5524431|NCT04290104|Sulbactam|sulbactam|mesh-list
5524432|NCT04290104|Sultamicillin|sultamicillin|mesh-list
5524433|NCT04290104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5524434|NCT04290104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5524435|NCT04290104|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5524436|NCT04290104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5524437|NCT04290104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524438|NCT04290026|Metoclopramide|metoclopramide|mesh-list
5524439|NCT04290026|Granisetron|granisetron|mesh-list
5524440|NCT04290026|Antiemetics|antiemetics|mesh-ancestor
5524441|NCT04290026|Autonomic Agents|autonomic agents|mesh-ancestor
5524442|NCT04290026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5524443|NCT04290026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524444|NCT04290026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5524445|NCT04290026|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5524446|NCT04290026|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5524447|NCT04290026|Dopamine Agents|dopamine agents|mesh-ancestor
5524448|NCT04290026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5524449|NCT04290026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524450|NCT04290026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5524451|NCT04290026|Serotonin Agents|serotonin agents|mesh-ancestor
5524452|NCT04289805|Letrozole|letrozole|mesh-list
5524453|NCT04289805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6102865|NCT00960323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6102866|NCT00960323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6102867|NCT00960323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6102868|NCT00960323|Gout Suppressants|gout suppressants|mesh-ancestor
6102869|NCT00960323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6102870|NCT00960323|Tubulin Modulators|tubulin modulators|mesh-ancestor
6102871|NCT00960323|Antimitotic Agents|antimitotic agents|mesh-ancestor
6102872|NCT00960323|Mitosis Modulators|mitosis modulators|mesh-ancestor
6102873|NCT00960323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6102874|NCT00960440|Tofacitinib|tofacitinib|mesh-list
6102875|NCT00960440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6102876|NCT00960440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6102877|NCT00960440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102878|NCT00960531|Saponin QA-21V1|saponin qa-21v1|mesh-list
6102879|NCT00960531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6102880|NCT00960531|Immunologic Factors|immunologic factors|mesh-ancestor
5524454|NCT04289805|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6102881|NCT00960531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102882|NCT00960570|Efavirenz|efavirenz|mesh-list
6102883|NCT00960570|Fenofibric acid|fenofibric acid|mesh-list
6102884|NCT00960570|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6102885|NCT00960570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6102886|NCT00960570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6102887|NCT00960570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102888|NCT00960570|Antiviral Agents|antiviral agents|mesh-ancestor
6102889|NCT00960570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6102890|NCT00960570|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6102891|NCT00960570|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6102892|NCT00960570|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6102893|NCT00960570|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6102894|NCT00960570|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6102895|NCT00960570|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6102896|NCT00960570|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6102897|NCT00960570|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6102898|NCT00960570|Antimetabolites|antimetabolites|mesh-ancestor
6102899|NCT00960570|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6102900|NCT00960622|Tenofovir|tenofovir|mesh-list
6102901|NCT00960622|Lamivudine|lamivudine|mesh-list
6102902|NCT00960622|Zidovudine|zidovudine|mesh-list
6102903|NCT00960622|Emtricitabine|emtricitabine|mesh-list
6102904|NCT00960622|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6102905|NCT00960622|Abacavir|abacavir|mesh-list
6102906|NCT00960622|Dideoxynucleosides|dideoxynucleosides|mesh-list
6102907|NCT00960622|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6102908|NCT00960622|Antiviral Agents|antiviral agents|mesh-ancestor
6102909|NCT00960622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6102910|NCT00960622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6102911|NCT00960622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6102912|NCT00960622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6102913|NCT00960622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102914|NCT00960622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6102915|NCT00960622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6102916|NCT00960622|Antimetabolites|antimetabolites|mesh-ancestor
6102917|NCT00960661|Insulin|insulin|mesh-list
6102918|NCT00960661|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6102919|NCT00960661|Metformin|metformin|mesh-list
6102920|NCT00960661|Exenatide|exenatide|mesh-list
6102921|NCT00960661|Insulin Lispro|insulin lispro|mesh-list
6102922|NCT00960661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6102923|NCT00960661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102924|NCT00960661|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6102925|NCT00960661|Incretins|incretins|mesh-ancestor
6102926|NCT00960661|Hormones|hormones|mesh-ancestor
6102927|NCT00960661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6102928|NCT00960687|Fenofibrate|fenofibrate|mesh-list
6102929|NCT00960687|Fenofibric acid|fenofibric acid|mesh-list
6102930|NCT00960687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6102931|NCT00960687|Antimetabolites|antimetabolites|mesh-ancestor
6102932|NCT00960687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102933|NCT00960687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6102934|NCT00960687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6102935|NCT00960778|Nicotine|nicotine|mesh-list
6102936|NCT00960778|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6102937|NCT00960778|Autonomic Agents|autonomic agents|mesh-ancestor
6102938|NCT00960778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6102939|NCT00960778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524455|NCT04289805|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5524456|NCT04289805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6102940|NCT00960778|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6102941|NCT00960778|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6102942|NCT00960778|Cholinergic Agents|cholinergic agents|mesh-ancestor
6102943|NCT00960778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6102944|NCT00960778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102945|NCT00960804|Tanezumab|tanezumab|mesh-list
6102946|NCT00960804|Analgesics|analgesics|mesh-ancestor
6102947|NCT00960804|Sensory System Agents|sensory system agents|mesh-ancestor
6102948|NCT00960804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6102949|NCT00960804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102950|NCT00960856|Fenofibric acid|fenofibric acid|mesh-list
6102951|NCT00960856|Fenofibrate|fenofibrate|mesh-list
6102952|NCT00960856|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6102953|NCT00960856|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6102954|NCT00960856|Antimetabolites|antimetabolites|mesh-ancestor
6102955|NCT00960856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102956|NCT00960856|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6102957|NCT00960869|Aspirin|aspirin|mesh-list
6102958|NCT00960869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6102959|NCT00960869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6102960|NCT00960869|Analgesics|analgesics|mesh-ancestor
6102961|NCT00960869|Sensory System Agents|sensory system agents|mesh-ancestor
6102962|NCT00960869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6102963|NCT00960869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102964|NCT00960869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6102965|NCT00960869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6102966|NCT00960869|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6102967|NCT00960869|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6102968|NCT00960869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102969|NCT00960869|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6102970|NCT00960869|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6102971|NCT00960869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6102972|NCT00960869|Antipyretics|antipyretics|mesh-ancestor
6102973|NCT00960934|Vitamin D|vitamin d|mesh-list
6102974|NCT00960934|Cholecalciferol|cholecalciferol|mesh-list
6102975|NCT00960934|Calcium Carbonate|calcium carbonate|mesh-list
6102976|NCT00960934|Calcium|calcium|mesh-list
6102977|NCT00960934|Vitamins|vitamins|mesh-ancestor
6102978|NCT00960934|Micronutrients|micronutrients|mesh-ancestor
6102979|NCT00960934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102980|NCT00960934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6102981|NCT00960934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6102982|NCT00960934|Antacids|antacids|mesh-ancestor
6102983|NCT00960934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102984|NCT00960934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6102985|NCT00960986|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6102986|NCT00960986|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6102987|NCT00960986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6102988|NCT00960986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6102989|NCT00960986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6102990|NCT00960986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6102991|NCT00960986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6102992|NCT00960986|Analgesics|analgesics|mesh-ancestor
6102993|NCT00960986|Sensory System Agents|sensory system agents|mesh-ancestor
6102994|NCT00960986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6102995|NCT00960986|Antidepressive Agents|antidepressive agents|mesh-ancestor
6102996|NCT00960986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6102997|NCT00960986|Dopamine Agents|dopamine agents|mesh-ancestor
6102998|NCT00961116|Fenofibrate|fenofibrate|mesh-list
6102999|NCT00961116|Fenofibric acid|fenofibric acid|mesh-list
6103000|NCT00961116|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6103001|NCT00961116|Antimetabolites|antimetabolites|mesh-ancestor
6103002|NCT00961116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103003|NCT00961116|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6103004|NCT00961116|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6103005|NCT00961181|Paclitaxel|paclitaxel|mesh-list
6103006|NCT00961181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6103007|NCT00961181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6103008|NCT00961181|Tubulin Modulators|tubulin modulators|mesh-ancestor
6103009|NCT00961181|Antimitotic Agents|antimitotic agents|mesh-ancestor
6103010|NCT00961181|Mitosis Modulators|mitosis modulators|mesh-ancestor
6103011|NCT00961181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103012|NCT00961220|Carmustine|carmustine|mesh-list
5524457|NCT04289805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524458|NCT04289805|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5524459|NCT04289805|Hormone Antagonists|hormone antagonists|mesh-ancestor
6103013|NCT00961220|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
6103014|NCT00961220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6103015|NCT00961220|Alkylating Agents|alkylating agents|mesh-ancestor
6103016|NCT00961220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103017|NCT00961220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6103018|NCT00961220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6103019|NCT00961233|Budesonide|budesonide|mesh-list
6103020|NCT00961233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6103021|NCT00961233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6103022|NCT00961233|Autonomic Agents|autonomic agents|mesh-ancestor
5524460|NCT04289805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5524461|NCT04289805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524462|NCT04289675|Interferons|interferons|mesh-list
5524463|NCT04289675|Interferon-beta|interferon-beta|mesh-list
5524464|NCT04289675|Teriflunomide|teriflunomide|mesh-list
5524465|NCT04289675|Dimethyl Fumarate|dimethyl fumarate|mesh-list
5524466|NCT04289675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5524467|NCT04289675|Antiviral Agents|antiviral agents|mesh-ancestor
5524468|NCT04289675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6103023|NCT00961233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6103024|NCT00961233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103025|NCT00961233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6103026|NCT00961233|Respiratory System Agents|respiratory system agents|mesh-ancestor
6103027|NCT00961233|Glucocorticoids|glucocorticoids|mesh-ancestor
6103028|NCT00961233|Hormones|hormones|mesh-ancestor
6103029|NCT00961233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6103030|NCT00961259|Fenofibric acid|fenofibric acid|mesh-list
6103031|NCT00961259|Fenofibrate|fenofibrate|mesh-list
6103032|NCT00961259|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6103033|NCT00961259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6103034|NCT00961259|Antimetabolites|antimetabolites|mesh-ancestor
6103035|NCT00961259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103036|NCT00961259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6103037|NCT00961298|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6103038|NCT00961298|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6103039|NCT00961298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6103040|NCT00961298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6103041|NCT00961298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103042|NCT00961298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6103043|NCT00961298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524469|NCT04289675|Immunologic Factors|immunologic factors|mesh-ancestor
5524470|NCT04289675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524471|NCT04289675|Dermatologic Agents|dermatologic agents|mesh-ancestor
5524472|NCT04289675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6103044|NCT00961298|Analgesics|analgesics|mesh-ancestor
6103045|NCT00961298|Sensory System Agents|sensory system agents|mesh-ancestor
6103046|NCT00961298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6103047|NCT00961298|Antidepressive Agents|antidepressive agents|mesh-ancestor
6103048|NCT00961298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6103049|NCT00961298|Dopamine Agents|dopamine agents|mesh-ancestor
6103050|NCT00961350|Aspirin|aspirin|mesh-list
6103051|NCT00961350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6103052|NCT00961350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6103053|NCT00961350|Analgesics|analgesics|mesh-ancestor
6103054|NCT00961350|Sensory System Agents|sensory system agents|mesh-ancestor
6103055|NCT00961350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6103056|NCT00961350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103057|NCT00961350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6665809|NCT01518959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665810|NCT01518959|Vitamins|vitamins|mesh-ancestor
6665811|NCT01518959|Micronutrients|micronutrients|mesh-ancestor
6665812|NCT01518959|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5524473|NCT04289675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6103058|NCT00961350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6103059|NCT00961350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6103060|NCT00961350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5524474|NCT04289675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5524475|NCT04289675|Analgesics|analgesics|mesh-ancestor
5524476|NCT04289675|Sensory System Agents|sensory system agents|mesh-ancestor
5524477|NCT04289675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6665813|NCT01518998|Amlodipine|amlodipine|mesh-list
6103061|NCT00961350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103062|NCT00961350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6103063|NCT00961350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6103064|NCT00961350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6103065|NCT00961350|Antipyretics|antipyretics|mesh-ancestor
5524478|NCT04289675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5524479|NCT04289675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5524480|NCT04289974|Fulvestrant|fulvestrant|mesh-list
5524481|NCT04289974|Palbociclib|palbociclib|mesh-list
5524482|NCT04289974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5524483|NCT04289974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5524484|NCT04289974|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5524485|NCT04289974|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5524486|NCT04289974|Hormone Antagonists|hormone antagonists|mesh-ancestor
5524487|NCT04289974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5524488|NCT04289974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524489|NCT04289974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5524490|NCT04289974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5524491|NCT04289974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203879|NCT02062645|Amlodipine|amlodipine|mesh-list
6203880|NCT02062645|Valsartan|valsartan|mesh-list
6203881|NCT02062645|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
6203882|NCT02062645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6203883|NCT02062645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6203884|NCT02062645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6203885|NCT02062645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203886|NCT02062645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6203887|NCT02062645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203888|NCT02062645|Vasodilator Agents|vasodilator agents|mesh-ancestor
5524492|NCT04289883|Calcium|calcium|mesh-list
5524493|NCT04289883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5524494|NCT04289883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524495|NCT04289792|Gemcitabine|gemcitabine|mesh-list
5524496|NCT04289792|Paclitaxel|paclitaxel|mesh-list
5524497|NCT04289792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5524498|NCT04289792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5524499|NCT04289792|Tubulin Modulators|tubulin modulators|mesh-ancestor
5524500|NCT04289792|Antimitotic Agents|antimitotic agents|mesh-ancestor
5524501|NCT04289792|Mitosis Modulators|mitosis modulators|mesh-ancestor
5524502|NCT04289792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524503|NCT04289792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5524504|NCT04289792|Antimetabolites|antimetabolites|mesh-ancestor
5524505|NCT04289792|Antiviral Agents|antiviral agents|mesh-ancestor
5524506|NCT04289792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5524507|NCT04289792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5524508|NCT04289792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5524509|NCT04289792|Immunologic Factors|immunologic factors|mesh-ancestor
5524510|NCT04289792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524511|NCT04289103|Inolimomab|inolimomab|mesh-list
5524512|NCT04289103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5524513|NCT04289103|Immunologic Factors|immunologic factors|mesh-ancestor
5524514|NCT04289103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524515|NCT04289142|Dexmedetomidine|dexmedetomidine|mesh-list
5524516|NCT04289142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5524517|NCT04289142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5524518|NCT04289142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524519|NCT04289142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5524520|NCT04289142|Analgesics|analgesics|mesh-ancestor
5524521|NCT04289142|Sensory System Agents|sensory system agents|mesh-ancestor
5524522|NCT04289142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5524523|NCT04289142|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5524524|NCT04289142|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5524525|NCT04289142|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5524526|NCT04289142|Adrenergic Agents|adrenergic agents|mesh-ancestor
5524527|NCT04289142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5524528|NCT04289142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524529|NCT04289467|Fenfluramine|fenfluramine|mesh-list
5524530|NCT04289467|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5524531|NCT04289467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5524532|NCT04289467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5524533|NCT04289467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524534|NCT04289467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6103066|NCT00961415|Bevacizumab|bevacizumab|mesh-list
6103067|NCT00961415|Pemetrexed|pemetrexed|mesh-list
6103068|NCT00961415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6103069|NCT00961415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6103070|NCT00961415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5524535|NCT04289467|Serotonin Agents|serotonin agents|mesh-ancestor
5524536|NCT04289467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524537|NCT04289090|Propofol|propofol|mesh-list
5524538|NCT04289090|Sevoflurane|sevoflurane|mesh-list
5524539|NCT04289090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5524540|NCT04289090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6103071|NCT00961415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6103072|NCT00961415|Growth Substances|growth substances|mesh-ancestor
6103073|NCT00961415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465083|NCT00471991|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6465084|NCT00471991|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6465085|NCT00471991|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6465086|NCT00471991|Hormone Antagonists|hormone antagonists|mesh-ancestor
6465087|NCT00471991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6103074|NCT00961415|Growth Inhibitors|growth inhibitors|mesh-ancestor
5524541|NCT04289090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524542|NCT04289090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5524543|NCT04289090|Anesthetics, General|anesthetics, general|mesh-ancestor
5524544|NCT04289090|Anesthetics|anesthetics|mesh-ancestor
5524545|NCT04289090|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5524546|NCT04289090|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5524547|NCT04289194|Hydrogen Peroxide|hydrogen peroxide|mesh-list
5524548|NCT04289194|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5524549|NCT04289194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5524550|NCT04289207|Danazol|danazol|mesh-list
5524551|NCT04289207|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6103075|NCT00961415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6103076|NCT00961415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103077|NCT00961415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6103078|NCT00961415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6103079|NCT00961441|Levetiracetam|levetiracetam|mesh-list
6103080|NCT00961441|Anticonvulsants|anticonvulsants|mesh-ancestor
6103081|NCT00961441|Nootropic Agents|nootropic agents|mesh-ancestor
6103082|NCT00961532|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
6103083|NCT00961532|Hemostatics|hemostatics|mesh-ancestor
6103084|NCT00961532|Coagulants|coagulants|mesh-ancestor
6103085|NCT00961532|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6103086|NCT00961532|Natriuretic Agents|natriuretic agents|mesh-ancestor
6103087|NCT00961532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103088|NCT00961571|Capecitabine|capecitabine|mesh-list
6103089|NCT00961571|Sunitinib|sunitinib|mesh-list
6103090|NCT00961571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6103091|NCT00961571|Antimetabolites|antimetabolites|mesh-ancestor
6103092|NCT00961571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103093|NCT00961571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6103094|NCT00961571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6103095|NCT00961571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6103096|NCT00961571|Growth Substances|growth substances|mesh-ancestor
6103097|NCT00961571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103098|NCT00961571|Growth Inhibitors|growth inhibitors|mesh-ancestor
6103099|NCT00961571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6103100|NCT00961571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6103101|NCT00961636|Niacin|niacin|mesh-list
6103102|NCT00961636|Niacinamide|niacinamide|mesh-list
6103103|NCT00961636|Nicotinic Acids|nicotinic acids|mesh-list
6103104|NCT00961636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6103105|NCT00961636|Antimetabolites|antimetabolites|mesh-ancestor
6103106|NCT00961636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103107|NCT00961636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6103108|NCT00961636|Vasodilator Agents|vasodilator agents|mesh-ancestor
6103109|NCT00961636|Vitamin B Complex|vitamin b complex|mesh-ancestor
6103110|NCT00961636|Vitamins|vitamins|mesh-ancestor
6103111|NCT00961636|Micronutrients|micronutrients|mesh-ancestor
6103112|NCT00961636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465088|NCT00471991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6465089|NCT00472004|Tibolone|tibolone|mesh-list
6465090|NCT00472004|Estradiol|estradiol|mesh-list
6465091|NCT00472004|Estrogens|estrogens|mesh-ancestor
6465092|NCT00472004|Hormones|hormones|mesh-ancestor
5524552|NCT04289207|Hormone Antagonists|hormone antagonists|mesh-ancestor
6103113|NCT00961649|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6465093|NCT00472004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6103114|NCT00961649|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6103115|NCT00961649|Brinzolamide|brinzolamide|mesh-list
6103116|NCT00961649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6103117|NCT00961649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6103118|NCT00961649|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6103119|NCT00961649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6103120|NCT00961649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6103121|NCT00961649|Adrenergic Agents|adrenergic agents|mesh-ancestor
6103122|NCT00961649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6103123|NCT00961649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103124|NCT00961649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103125|NCT00961649|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6103126|NCT00961649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6103127|NCT00961662|Tagatose|tagatose|mesh-list
6103128|NCT00961662|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5524553|NCT04289207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5524554|NCT04289207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524555|NCT04288999|Capecitabine|capecitabine|mesh-list
5524556|NCT04288999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5524557|NCT04288999|Antimetabolites|antimetabolites|mesh-ancestor
5524558|NCT04288999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103129|NCT00961662|Chelating Agents|chelating agents|mesh-ancestor
6103130|NCT00961662|Sequestering Agents|sequestering agents|mesh-ancestor
6103131|NCT00961662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103132|NCT00961961|Lithium Carbonate|lithium carbonate|mesh-list
6103133|NCT00961961|Fluoxetine|fluoxetine|mesh-list
6103134|NCT00961961|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6103135|NCT00961961|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5524559|NCT04288999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5601206|NCT03707028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5601207|NCT03707028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5601208|NCT03707028|Tubulin Modulators|tubulin modulators|mesh-ancestor
5601209|NCT03707028|Antimitotic Agents|antimitotic agents|mesh-ancestor
5601210|NCT03707028|Mitosis Modulators|mitosis modulators|mesh-ancestor
5601211|NCT03707028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601212|NCT03707028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5601213|NCT03707028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5601214|NCT03706924|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5601215|NCT03706924|Elsulfavirine|elsulfavirine|mesh-list
5601216|NCT03706924|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5601217|NCT03706924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5601218|NCT03706924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5601219|NCT03706924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103136|NCT00961961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6103137|NCT00961961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103138|NCT00961961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6103139|NCT00961961|Serotonin Agents|serotonin agents|mesh-ancestor
6103140|NCT00961961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103141|NCT00961961|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6103142|NCT00961961|Antidepressive Agents|antidepressive agents|mesh-ancestor
6103143|NCT00961961|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6103144|NCT00961961|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6103145|NCT00961961|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6103146|NCT00961961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6103147|NCT00961961|Antimanic Agents|antimanic agents|mesh-ancestor
6103148|NCT00961961|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6103149|NCT00961961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6103150|NCT00962039|Citalopram|citalopram|mesh-list
6103151|NCT00962039|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6103152|NCT00962039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6103153|NCT00962039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6103154|NCT00962039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103155|NCT00962039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6103156|NCT00962039|Serotonin Agents|serotonin agents|mesh-ancestor
6103157|NCT00962039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103158|NCT00962039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6103159|NCT00962039|Antidepressive Agents|antidepressive agents|mesh-ancestor
6103160|NCT00962039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6103161|NCT00962065|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
5524560|NCT04288765|Dexamethasone|dexamethasone|mesh-list
5524561|NCT04288765|Lenalidomide|lenalidomide|mesh-list
6103162|NCT00962065|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6103163|NCT00962065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103164|NCT00962065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6103165|NCT00962065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103166|NCT00962104|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6465094|NCT00472004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465095|NCT00472004|Androgen Antagonists|androgen antagonists|mesh-ancestor
6465096|NCT00472004|Hormone Antagonists|hormone antagonists|mesh-ancestor
6465097|NCT00472004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5524562|NCT04288765|Daratumumab|daratumumab|mesh-list
5524563|NCT04288765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5524564|NCT04288765|Antiemetics|antiemetics|mesh-ancestor
5524565|NCT04288765|Autonomic Agents|autonomic agents|mesh-ancestor
5524566|NCT04288765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5524567|NCT04288765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524568|NCT04288765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5524569|NCT04288765|Glucocorticoids|glucocorticoids|mesh-ancestor
5524570|NCT04288765|Hormones|hormones|mesh-ancestor
5524571|NCT04288765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5524572|NCT04288765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5524573|NCT04288765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5524574|NCT04288765|Immunologic Factors|immunologic factors|mesh-ancestor
5524575|NCT04288765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5524576|NCT04288765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5524577|NCT04288765|Growth Substances|growth substances|mesh-ancestor
5524578|NCT04288765|Growth Inhibitors|growth inhibitors|mesh-ancestor
5524579|NCT04288895|Vortioxetine|vortioxetine|mesh-list
5524580|NCT04288895|Antidepressive Agents|antidepressive agents|mesh-ancestor
5524581|NCT04288895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5524582|NCT04288895|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5524583|NCT04288895|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5524584|NCT04288895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5524585|NCT04288895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524586|NCT04288895|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5524587|NCT04288895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5524588|NCT04288895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5524589|NCT04288895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524590|NCT04288895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5524591|NCT04288895|Serotonin Agents|serotonin agents|mesh-ancestor
5524592|NCT04288895|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5524593|NCT04288895|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5524594|NCT04288895|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5524595|NCT04288895|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5524596|NCT04288687|Niraparib|niraparib|mesh-list
5524597|NCT04288687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5524598|NCT04288687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5524599|NCT04288687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524600|NCT04288687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6465098|NCT00472004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6465099|NCT00472004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6465100|NCT00472004|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6103167|NCT00962104|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6103168|NCT00962104|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6103169|NCT00962104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6103170|NCT00962104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103171|NCT00962104|Adrenergic Agents|adrenergic agents|mesh-ancestor
5524601|NCT04288700|Timolol|timolol|mesh-list
6103172|NCT00962104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6465101|NCT00472004|Anabolic Agents|anabolic agents|mesh-ancestor
5524602|NCT04288700|Propranolol|propranolol|mesh-list
5524603|NCT04288700|Captopril|captopril|mesh-list
5524604|NCT04288700|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5524605|NCT04288700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5524606|NCT04288700|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5524607|NCT04288700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5524608|NCT04288700|Adrenergic Agents|adrenergic agents|mesh-ancestor
5524609|NCT04288700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5524610|NCT04288700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524611|NCT04288700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524612|NCT04288700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5524613|NCT04288700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5524614|NCT04288700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5524615|NCT04288700|Vasodilator Agents|vasodilator agents|mesh-ancestor
6103173|NCT00962104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103174|NCT00962390|Equol|equol|mesh-list
6103175|NCT00962390|Phytoestrogens|phytoestrogens|mesh-ancestor
6103176|NCT00962390|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6103177|NCT00962390|Estrogens|estrogens|mesh-ancestor
6103178|NCT00962390|Hormones|hormones|mesh-ancestor
6103179|NCT00962390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6103180|NCT00962390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103181|NCT00962585|Equol|equol|mesh-list
6103182|NCT00962585|Phytoestrogens|phytoestrogens|mesh-ancestor
6103183|NCT00962585|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6103184|NCT00962585|Estrogens|estrogens|mesh-ancestor
6103185|NCT00962585|Hormones|hormones|mesh-ancestor
6103186|NCT00962585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6103187|NCT00962585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103188|NCT00962741|Etanercept|etanercept|mesh-list
5524616|NCT04288700|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5524617|NCT04288700|Protease Inhibitors|protease inhibitors|mesh-ancestor
5524618|NCT04288323|Diethylenetriamine|diethylenetriamine|mesh-list
6103189|NCT00962741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6103190|NCT00962741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6103191|NCT00962741|Analgesics|analgesics|mesh-ancestor
6103192|NCT00962741|Sensory System Agents|sensory system agents|mesh-ancestor
6103193|NCT00962741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6103194|NCT00962741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103195|NCT00962741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6103196|NCT00962741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6103197|NCT00962741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6103198|NCT00962741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6103199|NCT00962741|Immunologic Factors|immunologic factors|mesh-ancestor
6103200|NCT00962780|Vaccines|vaccines|mesh-list
6103201|NCT00962780|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6103202|NCT00962780|Immunologic Factors|immunologic factors|mesh-ancestor
6103203|NCT00962780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524619|NCT04288323|Edetic Acid|edetic acid|mesh-list
5524620|NCT04288323|Pentetic Acid|pentetic acid|mesh-list
5524621|NCT04288323|Antidotes|antidotes|mesh-ancestor
5524622|NCT04288323|Protective Agents|protective agents|mesh-ancestor
5524623|NCT04288323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524624|NCT04288323|Chelating Agents|chelating agents|mesh-ancestor
5524625|NCT04288323|Sequestering Agents|sequestering agents|mesh-ancestor
5524626|NCT04288323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524627|NCT04288323|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5524628|NCT04288323|Anticoagulants|anticoagulants|mesh-ancestor
5524629|NCT04288323|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5524630|NCT04288323|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5524631|NCT04288349|Epinephrine|epinephrine|mesh-list
5524632|NCT04288349|Racepinephrine|racepinephrine|mesh-list
5524633|NCT04288349|Ropivacaine|ropivacaine|mesh-list
5524634|NCT04288349|Epinephryl borate|epinephryl borate|mesh-list
6103204|NCT00962871|Tenofovir|tenofovir|mesh-list
6103205|NCT00962871|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6103206|NCT00962871|Antiviral Agents|antiviral agents|mesh-ancestor
6103207|NCT00962871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6103208|NCT00962871|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5524635|NCT04288349|Anesthetics, Local|anesthetics, local|mesh-ancestor
5524636|NCT04288349|Anesthetics|anesthetics|mesh-ancestor
5524637|NCT04288349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5524638|NCT04288349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524639|NCT04288349|Sensory System Agents|sensory system agents|mesh-ancestor
6103209|NCT00962871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5524640|NCT04288349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5524641|NCT04288349|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6103210|NCT00962871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6103211|NCT00962871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103212|NCT00962871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6103213|NCT00962871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6103214|NCT00962949|Angiotensin II|angiotensin ii|mesh-list
6103215|NCT00962949|Giapreza|giapreza|mesh-list
6103216|NCT00962949|Angiotensinogen|angiotensinogen|mesh-list
6103217|NCT00962949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6103218|NCT00962949|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6103219|NCT00962949|Protease Inhibitors|protease inhibitors|mesh-ancestor
6103220|NCT00962949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6103221|NCT00962949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103222|NCT00963105|Lenalidomide|lenalidomide|mesh-list
6103223|NCT00963105|Immunologic Factors|immunologic factors|mesh-ancestor
6103224|NCT00963105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103225|NCT00963105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6103226|NCT00963105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6103227|NCT00963105|Growth Substances|growth substances|mesh-ancestor
6103228|NCT00963105|Growth Inhibitors|growth inhibitors|mesh-ancestor
6103229|NCT00963105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6103230|NCT00963235|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6103231|NCT00963235|Immunologic Factors|immunologic factors|mesh-ancestor
6103232|NCT00963235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103233|NCT00963508|Permethrin|permethrin|mesh-list
6103234|NCT00963508|Malathion|malathion|mesh-list
6103235|NCT00963508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6103236|NCT00963508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103237|NCT00963508|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6103238|NCT00963508|Cholinergic Agents|cholinergic agents|mesh-ancestor
5524642|NCT04288349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6103239|NCT00963508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6103240|NCT00963508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103241|NCT00963547|Trastuzumab|trastuzumab|mesh-list
6103242|NCT00963547|Lapatinib|lapatinib|mesh-list
6103243|NCT00963547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6103244|NCT00963547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6103245|NCT00963547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6103246|NCT00963547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6103247|NCT00963547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103248|NCT00963807|Deoxyglucose|deoxyglucose|mesh-list
6103249|NCT00963807|Alovudine|alovudine|mesh-list
6103250|NCT00963807|Dideoxynucleosides|dideoxynucleosides|mesh-list
6103251|NCT00963807|Cisplatin|cisplatin|mesh-list
6103252|NCT00963807|Docetaxel|docetaxel|mesh-list
6103253|NCT00963807|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6103254|NCT00963807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6103255|NCT00963807|Tubulin Modulators|tubulin modulators|mesh-ancestor
6103256|NCT00963807|Antimitotic Agents|antimitotic agents|mesh-ancestor
6103257|NCT00963807|Mitosis Modulators|mitosis modulators|mesh-ancestor
6103258|NCT00963807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103259|NCT00963807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6103260|NCT00963807|Antimetabolites|antimetabolites|mesh-ancestor
6103261|NCT00963807|Antiviral Agents|antiviral agents|mesh-ancestor
5524643|NCT04288349|Adrenergic Agents|adrenergic agents|mesh-ancestor
5524644|NCT04288349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5524645|NCT04288349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524646|NCT04288349|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5524647|NCT04288349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5524648|NCT04288349|Autonomic Agents|autonomic agents|mesh-ancestor
5524649|NCT04288349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5524650|NCT04288349|Respiratory System Agents|respiratory system agents|mesh-ancestor
5524651|NCT04288349|Mydriatics|mydriatics|mesh-ancestor
5524652|NCT04288349|Sympathomimetics|sympathomimetics|mesh-ancestor
5601220|NCT03706924|Antiviral Agents|antiviral agents|mesh-ancestor
6103262|NCT00963807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6103263|NCT00963807|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6103264|NCT00963807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6103265|NCT00963807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6103266|NCT00963820|Ixazomib|ixazomib|mesh-list
6103267|NCT00963820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103268|NCT00963820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6103269|NCT00963820|Protease Inhibitors|protease inhibitors|mesh-ancestor
6103270|NCT00963820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6103271|NCT00963872|Cyclophosphamide|cyclophosphamide|mesh-list
6103272|NCT00963872|Fludarabine|fludarabine|mesh-list
6103273|NCT00963872|Fludarabine phosphate|fludarabine phosphate|mesh-list
6103274|NCT00963872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6103275|NCT00963872|Immunologic Factors|immunologic factors|mesh-ancestor
6103276|NCT00963872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103277|NCT00963872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6103278|NCT00963872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6103279|NCT00963872|Alkylating Agents|alkylating agents|mesh-ancestor
6103280|NCT00963872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103281|NCT00963872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6103282|NCT00963872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6103283|NCT00963872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6103284|NCT00963872|Antimetabolites|antimetabolites|mesh-ancestor
6103285|NCT00963924|Cycloserine|cycloserine|mesh-list
6103286|NCT00963924|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6103287|NCT00963924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6103288|NCT00963924|Renal Agents|renal agents|mesh-ancestor
6103289|NCT00963924|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6103290|NCT00963924|Antitubercular Agents|antitubercular agents|mesh-ancestor
5524653|NCT04288349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5524654|NCT04288232|Aflibercept|aflibercept|mesh-list
5524655|NCT04288232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5524656|NCT04288232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5524657|NCT04288232|Growth Substances|growth substances|mesh-ancestor
5524658|NCT04288232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524659|NCT04288232|Growth Inhibitors|growth inhibitors|mesh-ancestor
5524660|NCT04288232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6103291|NCT00963924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6103292|NCT00963924|Antimetabolites|antimetabolites|mesh-ancestor
6103293|NCT00963924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103294|NCT00963937|Sumatriptan|sumatriptan|mesh-list
6103295|NCT00963937|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6103296|NCT00963937|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6103297|NCT00963937|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6103298|NCT00963937|Serotonin Agents|serotonin agents|mesh-ancestor
6103299|NCT00963937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6103300|NCT00963937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103301|NCT00963937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103302|NCT00964223|Clindamycin|clindamycin|mesh-list
6103303|NCT00964223|Clindamycin palmitate|clindamycin palmitate|mesh-list
6103304|NCT00964223|Clindamycin phosphate|clindamycin phosphate|mesh-list
6103305|NCT00964223|Adapalene|adapalene|mesh-list
6103306|NCT00964223|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
6103307|NCT00964223|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6103308|NCT00964223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6103309|NCT00964223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6103310|NCT00964223|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6103311|NCT00964223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6103312|NCT00964223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103313|NCT00964223|Dermatologic Agents|dermatologic agents|mesh-ancestor
6103314|NCT00964223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6103315|NCT00964223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6103316|NCT00964223|Analgesics|analgesics|mesh-ancestor
6103317|NCT00964223|Sensory System Agents|sensory system agents|mesh-ancestor
6103318|NCT00964223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6103319|NCT00964223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103320|NCT00964223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6103321|NCT00964223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6103322|NCT00964353|Warfarin|warfarin|mesh-list
6103323|NCT00964353|Anticoagulants|anticoagulants|mesh-ancestor
6103324|NCT00964366|Clindamycin|clindamycin|mesh-list
6103325|NCT00964366|Clindamycin palmitate|clindamycin palmitate|mesh-list
6103326|NCT00964366|Clindamycin phosphate|clindamycin phosphate|mesh-list
6103327|NCT00964366|Dapsone|dapsone|mesh-list
6103328|NCT00964366|Benzoyl Peroxide|benzoyl peroxide|mesh-list
5524661|NCT04288219|Nifedipine|nifedipine|mesh-list
6103329|NCT00964366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6103330|NCT00964366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5524662|NCT04288219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5524663|NCT04288219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5524664|NCT04288219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524665|NCT04288219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5524666|NCT04288219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524667|NCT04288219|Vasodilator Agents|vasodilator agents|mesh-ancestor
5524668|NCT04288219|Tocolytic Agents|tocolytic agents|mesh-ancestor
5524669|NCT04288219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5524670|NCT04288206|Cefazolin|cefazolin|mesh-list
5524671|NCT04288206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5524672|NCT04288206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5524673|NCT04287894|Pemetrexed|pemetrexed|mesh-list
5524674|NCT04287894|Durvalumab|durvalumab|mesh-list
5524675|NCT04287894|Tremelimumab|tremelimumab|mesh-list
5524676|NCT04287894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5524677|NCT04287894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5524678|NCT04287894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524679|NCT04287894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5524680|NCT04287894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5524681|NCT04287894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5524682|NCT04287803|Methoxyflurane|methoxyflurane|mesh-list
5524683|NCT04287803|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5524684|NCT04287803|Anesthetics, General|anesthetics, general|mesh-ancestor
5524685|NCT04287803|Anesthetics|anesthetics|mesh-ancestor
6103331|NCT00964366|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6103332|NCT00964366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6103333|NCT00964366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103334|NCT00964366|Dermatologic Agents|dermatologic agents|mesh-ancestor
6103335|NCT00964366|Antimalarials|antimalarials|mesh-ancestor
6103336|NCT00964366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6103337|NCT00964366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6103338|NCT00964366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6103339|NCT00964366|Leprostatic Agents|leprostatic agents|mesh-ancestor
6103340|NCT00964431|Celecoxib|celecoxib|mesh-list
6103341|NCT00964431|Indomethacin|indomethacin|mesh-list
6103342|NCT00964431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6103343|NCT00964431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6103344|NCT00964431|Analgesics|analgesics|mesh-ancestor
6103345|NCT00964431|Sensory System Agents|sensory system agents|mesh-ancestor
6665814|NCT01518998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6665815|NCT01518998|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6665816|NCT01518998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6665817|NCT01518998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665818|NCT01518998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6665819|NCT01518998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665820|NCT01518998|Vasodilator Agents|vasodilator agents|mesh-ancestor
6665821|NCT01519011|Azacitidine|azacitidine|mesh-list
6665822|NCT01519011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6103346|NCT00964431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6103347|NCT00964431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103348|NCT00964431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6103349|NCT00964431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6103350|NCT00964431|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6103351|NCT00964431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6103352|NCT00964431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6103353|NCT00964431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103354|NCT00964431|Gout Suppressants|gout suppressants|mesh-ancestor
6103355|NCT00964431|Tocolytic Agents|tocolytic agents|mesh-ancestor
6103356|NCT00964431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6103357|NCT00964496|Thalidomide|thalidomide|mesh-list
6103358|NCT00964496|Ferrous succinate|ferrous succinate|mesh-list
6103359|NCT00964496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6103360|NCT00964496|Immunologic Factors|immunologic factors|mesh-ancestor
6103361|NCT00964496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103362|NCT00964496|Leprostatic Agents|leprostatic agents|mesh-ancestor
6103363|NCT00964496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6103364|NCT00964496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6103365|NCT00964496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6103366|NCT00964496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6103367|NCT00964496|Growth Substances|growth substances|mesh-ancestor
6103368|NCT00964496|Growth Inhibitors|growth inhibitors|mesh-ancestor
6103369|NCT00964496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6103370|NCT00964496|Hematinics|hematinics|mesh-ancestor
6103371|NCT00964548|Dantrolene|dantrolene|mesh-list
6103372|NCT00964548|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6103373|NCT00964548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103374|NCT00964548|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6103375|NCT00964548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6103376|NCT00964678|Carvedilol|carvedilol|mesh-list
6103377|NCT00964678|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6103378|NCT00964678|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6103379|NCT00964678|Adrenergic Agents|adrenergic agents|mesh-ancestor
6103380|NCT00964678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6103381|NCT00964678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103382|NCT00964678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103383|NCT00964678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6103384|NCT00964678|Antioxidants|antioxidants|mesh-ancestor
6103385|NCT00964678|Protective Agents|protective agents|mesh-ancestor
6103386|NCT00964678|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6103387|NCT00964678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6103388|NCT00964678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6103389|NCT00964678|Vasodilator Agents|vasodilator agents|mesh-ancestor
6103390|NCT00964678|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5524686|NCT04287803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5524687|NCT04287803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524688|NCT04287790|Naltrexone|naltrexone|mesh-list
6103391|NCT00964678|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6103392|NCT00964743|Cytarabine|cytarabine|mesh-list
6103393|NCT00964743|Sorafenib|sorafenib|mesh-list
6103394|NCT00964743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6103395|NCT00964743|Antimetabolites|antimetabolites|mesh-ancestor
6103396|NCT00964743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103397|NCT00964743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5524689|NCT04287790|Disulfiram|disulfiram|mesh-list
5524690|NCT04287790|Acamprosate|acamprosate|mesh-list
5524691|NCT04287790|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5524692|NCT04287790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5524693|NCT04287790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524694|NCT04287790|Sensory System Agents|sensory system agents|mesh-ancestor
6103398|NCT00964743|Antiviral Agents|antiviral agents|mesh-ancestor
6103399|NCT00964743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6103400|NCT00964743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6103401|NCT00964743|Immunologic Factors|immunologic factors|mesh-ancestor
6103402|NCT00964743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103403|NCT00964743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6103404|NCT00964743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6103405|NCT00964782|Sildenafil Citrate|sildenafil citrate|mesh-list
6103406|NCT00964782|Vasodilator Agents|vasodilator agents|mesh-ancestor
6103407|NCT00964782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6103408|NCT00964782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6103409|NCT00964782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6103410|NCT00964782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103411|NCT00964782|Urological Agents|urological agents|mesh-ancestor
6103412|NCT00964795|Aflibercept|aflibercept|mesh-list
6103413|NCT00964795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6103414|NCT00964795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6103415|NCT00964795|Growth Substances|growth substances|mesh-ancestor
6103416|NCT00964795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103417|NCT00964795|Growth Inhibitors|growth inhibitors|mesh-ancestor
6103418|NCT00964795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6103419|NCT00964886|Benztropine|benztropine|mesh-list
6103420|NCT00964886|Desipramine|desipramine|mesh-list
6103421|NCT00964886|Clomipramine|clomipramine|mesh-list
6103422|NCT00964886|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6103423|NCT00964886|Antidepressive Agents|antidepressive agents|mesh-ancestor
6103424|NCT00964886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6103425|NCT00964886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6103426|NCT00964886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103427|NCT00964886|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6103428|NCT00964886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6103429|NCT00964886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6103430|NCT00964886|Adrenergic Agents|adrenergic agents|mesh-ancestor
6103431|NCT00964886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6103432|NCT00964886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103433|NCT00964886|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6103434|NCT00964886|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6103435|NCT00964886|Parasympatholytics|parasympatholytics|mesh-ancestor
6103436|NCT00964886|Autonomic Agents|autonomic agents|mesh-ancestor
6103437|NCT00964886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6103438|NCT00964886|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6103439|NCT00964886|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6103440|NCT00964886|Cholinergic Agents|cholinergic agents|mesh-ancestor
6103441|NCT00964886|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6103442|NCT00964886|Dopamine Agents|dopamine agents|mesh-ancestor
6103443|NCT00964886|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6103444|NCT00964886|Serotonin Agents|serotonin agents|mesh-ancestor
6103445|NCT00965081|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6103446|NCT00965081|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6103447|NCT00965081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6103448|NCT00965081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6103449|NCT00965081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103450|NCT00965081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6103451|NCT00965081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103452|NCT00965081|Analgesics|analgesics|mesh-ancestor
6103453|NCT00965081|Sensory System Agents|sensory system agents|mesh-ancestor
6103454|NCT00965081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6103455|NCT00965081|Antidepressive Agents|antidepressive agents|mesh-ancestor
6103456|NCT00965081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6103457|NCT00965081|Dopamine Agents|dopamine agents|mesh-ancestor
6103458|NCT00965094|Mycophenolic Acid|mycophenolic acid|mesh-list
5524695|NCT04287790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5524696|NCT04287790|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
5524697|NCT04287790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5524698|NCT04287790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524699|NCT04287777|Mupirocin|mupirocin|mesh-list
5524700|NCT04287777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5524701|NCT04287777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5524702|NCT04287777|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5524703|NCT04287777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5524704|NCT04287777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524705|NCT04287829|Pembrolizumab|pembrolizumab|mesh-list
5524706|NCT04287829|Lenvatinib|lenvatinib|mesh-list
6103459|NCT00965094|Everolimus|everolimus|mesh-list
6103460|NCT00965094|Tacrolimus|tacrolimus|mesh-list
6103461|NCT00965094|Basiliximab|basiliximab|mesh-list
6103462|NCT00965094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6103463|NCT00965094|Immunologic Factors|immunologic factors|mesh-ancestor
6103464|NCT00965094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103465|NCT00965094|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6103466|NCT00965094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6103467|NCT00965094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103468|NCT00965094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6103469|NCT00965094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6103470|NCT00965094|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6103471|NCT00965094|Antitubercular Agents|antitubercular agents|mesh-ancestor
6103472|NCT00965094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6103473|NCT00965094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6103474|NCT00965185|Atorvastatin|atorvastatin|mesh-list
6103475|NCT00965185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6103476|NCT00965185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6103477|NCT00965185|Antimetabolites|antimetabolites|mesh-ancestor
6103478|NCT00965185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103479|NCT00965185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6103480|NCT00965185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6465102|NCT00472043|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
6465103|NCT00472043|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6465104|NCT00472043|Dermatologic Agents|dermatologic agents|mesh-ancestor
6465105|NCT00472108|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
5524707|NCT04287829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6103481|NCT00965185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6103482|NCT00965263|Cocaine|cocaine|mesh-list
6103483|NCT00965263|Anesthetics, Local|anesthetics, local|mesh-ancestor
5524708|NCT04287829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5524709|NCT04287829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5524710|NCT04287829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5524711|NCT04287829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524712|NCT04287842|Sevoflurane|sevoflurane|mesh-list
5524713|NCT04287842|Desflurane|desflurane|mesh-list
5524714|NCT04287842|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5524715|NCT04287842|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6103484|NCT00965263|Anesthetics|anesthetics|mesh-ancestor
6103485|NCT00965263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6103486|NCT00965263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103487|NCT00965263|Sensory System Agents|sensory system agents|mesh-ancestor
6103488|NCT00965263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6103489|NCT00965263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6103490|NCT00965263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6103491|NCT00965263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6465106|NCT00472108|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6465107|NCT00472108|Dermatologic Agents|dermatologic agents|mesh-ancestor
6465108|NCT00472134|Bupivacaine|bupivacaine|mesh-list
6465109|NCT00472134|Anesthetics, Local|anesthetics, local|mesh-ancestor
6465110|NCT00472134|Anesthetics|anesthetics|mesh-ancestor
6465111|NCT00472134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5524716|NCT04287842|Anesthetics, General|anesthetics, general|mesh-ancestor
5524717|NCT04287842|Anesthetics|anesthetics|mesh-ancestor
5524718|NCT04287842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5524719|NCT04287842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524720|NCT04287426|Remifentanil|remifentanil|mesh-list
5524721|NCT04287426|Rocuronium|rocuronium|mesh-list
6103492|NCT00965263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6103493|NCT00965263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103494|NCT00965263|Dopamine Agents|dopamine agents|mesh-ancestor
6103495|NCT00965263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6103496|NCT00965341|Methyltestosterone|methyltestosterone|mesh-list
6103497|NCT00965341|Testosterone|testosterone|mesh-list
6103498|NCT00965341|Testosterone undecanoate|testosterone undecanoate|mesh-list
6103499|NCT00965341|Testosterone enanthate|testosterone enanthate|mesh-list
6103500|NCT00965341|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6103501|NCT00965341|Androgens|androgens|mesh-ancestor
6103502|NCT00965341|Hormones|hormones|mesh-ancestor
6103503|NCT00965341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6103504|NCT00965341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103505|NCT00965341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6103506|NCT00965341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6103507|NCT00965341|Anabolic Agents|anabolic agents|mesh-ancestor
6103508|NCT00965458|Alefacept|alefacept|mesh-list
6103509|NCT00965458|Dermatologic Agents|dermatologic agents|mesh-ancestor
6103510|NCT00965458|Immunologic Factors|immunologic factors|mesh-ancestor
6103511|NCT00965458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103512|NCT00965497|Citalopram|citalopram|mesh-list
6103513|NCT00965497|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6103514|NCT00965497|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6103515|NCT00965497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6103516|NCT00965497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103517|NCT00965497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6103518|NCT00965497|Serotonin Agents|serotonin agents|mesh-ancestor
6103519|NCT00965497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103520|NCT00965497|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5524722|NCT04287426|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5524723|NCT04287426|Narcotics|narcotics|mesh-ancestor
5524724|NCT04287426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5524725|NCT04287426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524726|NCT04287426|Analgesics|analgesics|mesh-ancestor
5524727|NCT04287426|Sensory System Agents|sensory system agents|mesh-ancestor
5524728|NCT04287426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6103521|NCT00965497|Antidepressive Agents|antidepressive agents|mesh-ancestor
6103522|NCT00965497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6103523|NCT00965562|Fluoxetine|fluoxetine|mesh-list
6103524|NCT00965562|Calcium|calcium|mesh-list
6103525|NCT00965562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6103526|NCT00965562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103527|NCT00965562|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6103528|NCT00965562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6103529|NCT00965562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6103530|NCT00965562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103531|NCT00965562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6103532|NCT00965562|Serotonin Agents|serotonin agents|mesh-ancestor
6103533|NCT00965562|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6103534|NCT00965562|Antidepressive Agents|antidepressive agents|mesh-ancestor
6103535|NCT00965562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6103536|NCT00965562|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6465112|NCT00472134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524729|NCT04287426|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6103537|NCT00965562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6103538|NCT00965562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6103539|NCT00965575|Melatonin|melatonin|mesh-list
6103540|NCT00965575|Antioxidants|antioxidants|mesh-ancestor
6103541|NCT00965575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103542|NCT00965575|Protective Agents|protective agents|mesh-ancestor
6103543|NCT00965575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103544|NCT00965575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6103545|NCT00965731|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6103546|NCT00965731|Crizotinib|crizotinib|mesh-list
6103547|NCT00965731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6103548|NCT00965731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6103549|NCT00965731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6103550|NCT00965731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103551|NCT00965848|Doripenem|doripenem|mesh-list
6103552|NCT00965848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6103553|NCT00965848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6103554|NCT00966277|Dalteparin|dalteparin|mesh-list
6103555|NCT00966277|Tinzaparin|tinzaparin|mesh-list
6103556|NCT00966277|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6103557|NCT00966277|Anticoagulants|anticoagulants|mesh-ancestor
6103558|NCT00966277|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6103559|NCT00966277|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6103560|NCT00966277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103561|NCT00966355|Octreotide|octreotide|mesh-list
6103562|NCT00966355|Terlipressin|terlipressin|mesh-list
6103563|NCT00966355|Somatostatin|somatostatin|mesh-list
6103564|NCT00966355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6103565|NCT00966355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6103566|NCT00966355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6103567|NCT00966355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6103568|NCT00966355|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6103569|NCT00966355|Hormones|hormones|mesh-ancestor
6103570|NCT00966355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6103571|NCT00966355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103572|NCT00966641|Naproxen|naproxen|mesh-list
6103573|NCT00966641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6103574|NCT00966641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6103575|NCT00966641|Analgesics|analgesics|mesh-ancestor
6103576|NCT00966641|Sensory System Agents|sensory system agents|mesh-ancestor
6103577|NCT00966641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6103578|NCT00966641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103579|NCT00966641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6103580|NCT00966641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6103581|NCT00966641|Gout Suppressants|gout suppressants|mesh-ancestor
6103582|NCT00966641|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6103583|NCT00966641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6103584|NCT00966641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103585|NCT00966693|Thalidomide|thalidomide|mesh-list
6103586|NCT00966693|Dexamethasone|dexamethasone|mesh-list
6103587|NCT00966693|Dexamethasone acetate|dexamethasone acetate|mesh-list
6103588|NCT00966693|Lenalidomide|lenalidomide|mesh-list
6103589|NCT00966693|Ichthammol|ichthammol|mesh-list
6103590|NCT00966693|BB 1101|bb 1101|mesh-list
6103591|NCT00966693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6103592|NCT00966693|Antiemetics|antiemetics|mesh-ancestor
6103593|NCT00966693|Autonomic Agents|autonomic agents|mesh-ancestor
6103594|NCT00966693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6103595|NCT00966693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103596|NCT00966693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6103597|NCT00966693|Glucocorticoids|glucocorticoids|mesh-ancestor
6103598|NCT00966693|Hormones|hormones|mesh-ancestor
6103599|NCT00966693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6103600|NCT00966693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6103601|NCT00966693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6103602|NCT00966693|Immunologic Factors|immunologic factors|mesh-ancestor
6103603|NCT00966693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6103604|NCT00966693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6103605|NCT00966693|Growth Substances|growth substances|mesh-ancestor
6103606|NCT00966693|Growth Inhibitors|growth inhibitors|mesh-ancestor
6103607|NCT00966693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6103608|NCT00966693|Leprostatic Agents|leprostatic agents|mesh-ancestor
6103609|NCT00966693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6103610|NCT00966693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6103611|NCT00966693|Protease Inhibitors|protease inhibitors|mesh-ancestor
6103612|NCT00966693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6103613|NCT00966693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103614|NCT00966693|Dermatologic Agents|dermatologic agents|mesh-ancestor
6103615|NCT00966875|Ixekizumab|ixekizumab|mesh-list
5524730|NCT04287426|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5524731|NCT04287426|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5524732|NCT04287543|Melatonin|melatonin|mesh-list
5524733|NCT04287543|Antioxidants|antioxidants|mesh-ancestor
5524734|NCT04287543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524735|NCT04287543|Protective Agents|protective agents|mesh-ancestor
5524736|NCT04287543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524737|NCT04287543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5524738|NCT04287361|Clonazepam|clonazepam|mesh-list
5524739|NCT04287361|Anticonvulsants|anticonvulsants|mesh-ancestor
5524740|NCT04287361|GABA Modulators|gaba modulators|mesh-ancestor
5524741|NCT04287361|GABA Agents|gaba agents|mesh-ancestor
6103616|NCT00966875|Dermatologic Agents|dermatologic agents|mesh-ancestor
6103617|NCT00966940|Travoprost|travoprost|mesh-list
6103618|NCT00966940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6103619|NCT00966940|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6103620|NCT00966940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6103621|NCT00967005|Acetylcysteine|acetylcysteine|mesh-list
6103622|NCT00967005|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5524742|NCT04287361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6103623|NCT00967005|Antiviral Agents|antiviral agents|mesh-ancestor
6103624|NCT00967005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6103625|NCT00967005|Expectorants|expectorants|mesh-ancestor
6103626|NCT00967005|Respiratory System Agents|respiratory system agents|mesh-ancestor
6103627|NCT00967005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5524743|NCT04287361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524744|NCT04287361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524745|NCT04287387|Pioglitazone|pioglitazone|mesh-list
5524746|NCT04287387|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5524747|NCT04287387|Metformin|metformin|mesh-list
5524748|NCT04287387|Dapagliflozin|dapagliflozin|mesh-list
5524749|NCT04287387|Glimepiride|glimepiride|mesh-list
6103628|NCT00967005|Antioxidants|antioxidants|mesh-ancestor
6103629|NCT00967005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103630|NCT00967005|Protective Agents|protective agents|mesh-ancestor
6103631|NCT00967005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103632|NCT00967005|Antidotes|antidotes|mesh-ancestor
6103633|NCT00967044|Everolimus|everolimus|mesh-list
6103634|NCT00967044|Panobinostat|panobinostat|mesh-list
6103635|NCT00967044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6103636|NCT00967044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6103637|NCT00967044|Immunologic Factors|immunologic factors|mesh-ancestor
6103638|NCT00967044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103639|NCT00967044|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6103640|NCT00967044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6103641|NCT00967044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103642|NCT00967226|Prednisolone|prednisolone|mesh-list
6103643|NCT00967226|Propranolol|propranolol|mesh-list
6103644|NCT00967226|Prednisolone phosphate|prednisolone phosphate|mesh-list
6465113|NCT00472134|Sensory System Agents|sensory system agents|mesh-ancestor
6465114|NCT00472134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6465115|NCT00472173|Calcium|calcium|mesh-list
5524750|NCT04287387|Acarbose|acarbose|mesh-list
6103645|NCT00967226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6103646|NCT00967226|Glucocorticoids|glucocorticoids|mesh-ancestor
6103647|NCT00967226|Hormones|hormones|mesh-ancestor
6665823|NCT01519011|Antimetabolites|antimetabolites|mesh-ancestor
6465116|NCT00472173|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6465117|NCT00472173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103648|NCT00967226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6103649|NCT00967226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103650|NCT00967226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6103651|NCT00967226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6103652|NCT00967226|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6103653|NCT00967226|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6103654|NCT00967226|Adrenergic Agents|adrenergic agents|mesh-ancestor
6103655|NCT00967226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6103656|NCT00967226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103657|NCT00967226|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6103658|NCT00967226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6103659|NCT00967226|Vasodilator Agents|vasodilator agents|mesh-ancestor
6465118|NCT00472225|Rituximab|rituximab|mesh-list
6465119|NCT00472225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6465120|NCT00472225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6465121|NCT00472225|Immunologic Factors|immunologic factors|mesh-ancestor
6465122|NCT00472225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465123|NCT00472225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6465124|NCT00472329|Fludarabine|fludarabine|mesh-list
6465125|NCT00472329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6465126|NCT00472355|Apomorphine|apomorphine|mesh-list
6465127|NCT00472355|Emetics|emetics|mesh-ancestor
5524751|NCT04287387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5524752|NCT04287387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524753|NCT04287387|Incretins|incretins|mesh-ancestor
5524754|NCT04287387|Hormones|hormones|mesh-ancestor
5524755|NCT04287387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5524756|NCT04287387|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5524757|NCT04287387|Protease Inhibitors|protease inhibitors|mesh-ancestor
5524758|NCT04287387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5524759|NCT04287387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524760|NCT04287387|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5524761|NCT04287387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5524762|NCT04287387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5524763|NCT04287387|Immunologic Factors|immunologic factors|mesh-ancestor
6465128|NCT00472355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465129|NCT00472355|Autonomic Agents|autonomic agents|mesh-ancestor
6465130|NCT00472355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6103660|NCT00967330|Bevacizumab|bevacizumab|mesh-list
6103661|NCT00967330|Irinotecan|irinotecan|mesh-list
5524764|NCT04287387|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
5524765|NCT04287205|Dydrogesterone|dydrogesterone|mesh-list
5524766|NCT04287205|Progestins|progestins|mesh-ancestor
5524767|NCT04287205|Hormones|hormones|mesh-ancestor
5524768|NCT04287205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5524769|NCT04287205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601221|NCT03706924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6103662|NCT00967330|Temozolomide|temozolomide|mesh-list
6465131|NCT00472355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6465132|NCT00472355|Dopamine Agonists|dopamine agonists|mesh-ancestor
5601222|NCT03706924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5601223|NCT03706924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5606707|NCT03847311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5606708|NCT03847311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5606709|NCT03847311|Analgesics|analgesics|mesh-ancestor
5606710|NCT03847311|Sensory System Agents|sensory system agents|mesh-ancestor
5606711|NCT03847311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5606712|NCT03847311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103663|NCT00967330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6103664|NCT00967330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6103665|NCT00967330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6103666|NCT00967330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6103667|NCT00967330|Growth Substances|growth substances|mesh-ancestor
6103668|NCT00967330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103669|NCT00967330|Growth Inhibitors|growth inhibitors|mesh-ancestor
6103670|NCT00967330|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6103671|NCT00967330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6103672|NCT00967330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6103673|NCT00967330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103674|NCT00967330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6103675|NCT00967330|Alkylating Agents|alkylating agents|mesh-ancestor
6203889|NCT02062645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6203890|NCT02062645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6203891|NCT02062658|Ketamine|ketamine|mesh-list
6203892|NCT02062658|Analgesics|analgesics|mesh-ancestor
6203893|NCT02062658|Sensory System Agents|sensory system agents|mesh-ancestor
6203894|NCT02062658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6203895|NCT02062658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203896|NCT02062658|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6203897|NCT02062658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6203898|NCT02062658|Anesthetics, General|anesthetics, general|mesh-ancestor
6203899|NCT02062658|Anesthetics|anesthetics|mesh-ancestor
6203900|NCT02062658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6203901|NCT02062658|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6203902|NCT02062658|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6203903|NCT02062658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6203904|NCT02062658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203905|NCT02062710|Diphenhydramine|diphenhydramine|mesh-list
6203906|NCT02062710|Promethazine|promethazine|mesh-list
6203907|NCT02062710|Phenylephrine|phenylephrine|mesh-list
6203908|NCT02062710|Oxymetazoline|oxymetazoline|mesh-list
6203909|NCT02062710|Dextromethorphan|dextromethorphan|mesh-list
6203910|NCT02062710|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6203911|NCT02062710|Mydriatics|mydriatics|mesh-ancestor
6203912|NCT02062710|Autonomic Agents|autonomic agents|mesh-ancestor
6203913|NCT02062710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6203914|NCT02062710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524770|NCT04287062|Suvorexant|suvorexant|mesh-list
5524771|NCT04287062|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5524772|NCT04287062|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5524773|NCT04287062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5524774|NCT04287062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524775|NCT04287062|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
6203915|NCT02062710|Sympathomimetics|sympathomimetics|mesh-ancestor
6203916|NCT02062710|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6203917|NCT02062710|Nasal Decongestants|nasal decongestants|mesh-ancestor
6203918|NCT02062710|Respiratory System Agents|respiratory system agents|mesh-ancestor
6203919|NCT02062710|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6203920|NCT02062710|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6203921|NCT02062710|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6203922|NCT02062710|Adrenergic Agents|adrenergic agents|mesh-ancestor
6203923|NCT02062710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6203924|NCT02062710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203925|NCT02062710|Protective Agents|protective agents|mesh-ancestor
6203926|NCT02062710|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6203927|NCT02062710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6203928|NCT02062710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6203929|NCT02062710|Anesthetics, Local|anesthetics, local|mesh-ancestor
6203930|NCT02062710|Anesthetics|anesthetics|mesh-ancestor
6203931|NCT02062710|Sensory System Agents|sensory system agents|mesh-ancestor
6203932|NCT02062710|Antiemetics|antiemetics|mesh-ancestor
6203933|NCT02062710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6203934|NCT02062710|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6203935|NCT02062710|Histamine Antagonists|histamine antagonists|mesh-ancestor
6203936|NCT02062710|Histamine Agents|histamine agents|mesh-ancestor
6203937|NCT02062710|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6203938|NCT02062710|Antipruritics|antipruritics|mesh-ancestor
6203939|NCT02062710|Dermatologic Agents|dermatologic agents|mesh-ancestor
6203940|NCT02062710|Antitussive Agents|antitussive agents|mesh-ancestor
6203941|NCT02062710|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6203942|NCT02062710|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6203943|NCT02062801|Ephedrine|ephedrine|mesh-list
6103676|NCT00967369|Carboplatin|carboplatin|mesh-list
6103677|NCT00967369|Etoposide|etoposide|mesh-list
6103678|NCT00967369|Bortezomib|bortezomib|mesh-list
6103679|NCT00967369|Etoposide phosphate|etoposide phosphate|mesh-list
6103680|NCT00967369|Ifosfamide|ifosfamide|mesh-list
6103681|NCT00967369|Isophosphamide mustard|isophosphamide mustard|mesh-list
6103682|NCT00967369|Podophyllotoxin|podophyllotoxin|mesh-list
6103683|NCT00967369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6103684|NCT00967369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6103685|NCT00967369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6103686|NCT00967369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6103687|NCT00967369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6103688|NCT00967369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103689|NCT00967369|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6103690|NCT00967369|Alkylating Agents|alkylating agents|mesh-ancestor
6103691|NCT00967369|Keratolytic Agents|keratolytic agents|mesh-ancestor
6103692|NCT00967369|Dermatologic Agents|dermatologic agents|mesh-ancestor
6103693|NCT00967369|Tubulin Modulators|tubulin modulators|mesh-ancestor
6103694|NCT00967369|Antimitotic Agents|antimitotic agents|mesh-ancestor
6103695|NCT00967369|Mitosis Modulators|mitosis modulators|mesh-ancestor
6103696|NCT00967499|Ondansetron|ondansetron|mesh-list
6103697|NCT00967499|Palonosetron|palonosetron|mesh-list
6103698|NCT00967499|Antiemetics|antiemetics|mesh-ancestor
6103699|NCT00967499|Autonomic Agents|autonomic agents|mesh-ancestor
6103700|NCT00967499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6103701|NCT00967499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103702|NCT00967499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6103703|NCT00967499|Antipruritics|antipruritics|mesh-ancestor
6103704|NCT00967499|Dermatologic Agents|dermatologic agents|mesh-ancestor
6103705|NCT00967499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6103706|NCT00967499|Serotonin Agents|serotonin agents|mesh-ancestor
6103707|NCT00967499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6103708|NCT00967499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103709|NCT00967499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6103710|NCT00967499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6103711|NCT00967499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5524776|NCT04287062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5524777|NCT04287062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103712|NCT00967499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6103713|NCT00967499|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6103714|NCT00967499|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6103715|NCT00967551|Zinc|zinc|mesh-list
6103716|NCT00967551|Trace Elements|trace elements|mesh-list
6103717|NCT00967551|Micronutrients|micronutrients|mesh-list
6103718|NCT00967551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103719|NCT00967616|Leucovorin|leucovorin|mesh-list
6103720|NCT00967616|Fluorouracil|fluorouracil|mesh-list
6103721|NCT00967616|Irinotecan|irinotecan|mesh-list
6103722|NCT00967616|Efatutazone|efatutazone|mesh-list
6103723|NCT00967616|Levoleucovorin|levoleucovorin|mesh-list
6103724|NCT00967616|Antimetabolites|antimetabolites|mesh-ancestor
6103725|NCT00967616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103726|NCT00967616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6103727|NCT00967616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6103728|NCT00967616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6103729|NCT00967616|Immunologic Factors|immunologic factors|mesh-ancestor
6103730|NCT00967616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103731|NCT00967616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6103732|NCT00967616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6103733|NCT00967616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6103734|NCT00967616|Antidotes|antidotes|mesh-ancestor
6103735|NCT00967616|Protective Agents|protective agents|mesh-ancestor
6103736|NCT00967616|Vitamin B Complex|vitamin b complex|mesh-ancestor
6103737|NCT00967616|Vitamins|vitamins|mesh-ancestor
6103738|NCT00967616|Micronutrients|micronutrients|mesh-ancestor
6103739|NCT00967694|Nitrous Oxide|nitrous oxide|mesh-list
6103740|NCT00967694|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6103741|NCT00967694|Anesthetics, General|anesthetics, general|mesh-ancestor
6103742|NCT00967694|Anesthetics|anesthetics|mesh-ancestor
6103743|NCT00967694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6103744|NCT00967694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103745|NCT00967694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6103746|NCT00967694|Analgesics|analgesics|mesh-ancestor
5524778|NCT04286711|Paclitaxel|paclitaxel|mesh-list
6103747|NCT00967694|Sensory System Agents|sensory system agents|mesh-ancestor
6103748|NCT00967694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6103749|NCT00967798|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6103750|NCT00967798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6103751|NCT00967798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524779|NCT04286711|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6103752|NCT00967798|Incretins|incretins|mesh-ancestor
6103753|NCT00967798|Hormones|hormones|mesh-ancestor
6103754|NCT00967798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6103755|NCT00967798|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6103756|NCT00967798|Protease Inhibitors|protease inhibitors|mesh-ancestor
6103757|NCT00967798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6103758|NCT00967798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103759|NCT00968071|Decitabine|decitabine|mesh-list
6103760|NCT00968071|Gemtuzumab|gemtuzumab|mesh-list
6103761|NCT00968071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6103762|NCT00968071|Antimetabolites|antimetabolites|mesh-ancestor
6103763|NCT00968071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103764|NCT00968071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6103765|NCT00968071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6103766|NCT00968071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6103767|NCT00968253|Cytarabine|cytarabine|mesh-list
6103768|NCT00968253|Dexamethasone|dexamethasone|mesh-list
6103769|NCT00968253|Methylprednisolone|methylprednisolone|mesh-list
6103770|NCT00968253|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5524780|NCT04286711|Apatinib|apatinib|mesh-list
5524781|NCT04286711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5524782|NCT04286711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5524783|NCT04286711|Tubulin Modulators|tubulin modulators|mesh-ancestor
5524784|NCT04286711|Antimitotic Agents|antimitotic agents|mesh-ancestor
5524785|NCT04286711|Mitosis Modulators|mitosis modulators|mesh-ancestor
5524786|NCT04286711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524787|NCT04286711|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5524788|NCT04286711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5524789|NCT04286399|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
5524790|NCT04286399|Angiotensin II|angiotensin ii|mesh-list
5524791|NCT04286399|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
5524792|NCT04286399|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
5524793|NCT04286399|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
5524794|NCT04286399|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5524795|NCT04286399|Adrenergic Agents|adrenergic agents|mesh-ancestor
5524796|NCT04286399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5524797|NCT04286399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524798|NCT04286399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524799|NCT04286399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5524800|NCT04286399|Protease Inhibitors|protease inhibitors|mesh-ancestor
5524801|NCT04286399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5524802|NCT04286399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5524803|NCT04286178|Coenzyme Q10|coenzyme q10|mesh-list
5524804|NCT04286178|Micronutrients|micronutrients|mesh-ancestor
5524805|NCT04286178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524806|NCT04286178|Vitamins|vitamins|mesh-ancestor
5524807|NCT04286503|Ritonavir|ritonavir|mesh-list
5524808|NCT04286503|Lopinavir|lopinavir|mesh-list
5524809|NCT04286503|Chloroquine|chloroquine|mesh-list
5524810|NCT04286503|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
5524811|NCT04286503|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5524812|NCT04286503|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5524813|NCT04286503|Protease Inhibitors|protease inhibitors|mesh-ancestor
5524814|NCT04286503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5524815|NCT04286503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524816|NCT04286503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5524817|NCT04286503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5524818|NCT04286503|Antiviral Agents|antiviral agents|mesh-ancestor
5524819|NCT04286503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5524820|NCT04286503|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5524821|NCT04286503|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6103771|NCT00968253|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6103772|NCT00968253|Prednisolone|prednisolone|mesh-list
6103773|NCT00968253|Prednisolone acetate|prednisolone acetate|mesh-list
6465133|NCT00472355|Dopamine Agents|dopamine agents|mesh-ancestor
5524822|NCT04286503|Amebicides|amebicides|mesh-ancestor
6103774|NCT00968253|Cyclophosphamide|cyclophosphamide|mesh-list
6103775|NCT00968253|Doxorubicin|doxorubicin|mesh-list
6103776|NCT00968253|Methotrexate|methotrexate|mesh-list
6103777|NCT00968253|Vincristine|vincristine|mesh-list
6103778|NCT00968253|Everolimus|everolimus|mesh-list
6103779|NCT00968253|Lenograstim|lenograstim|mesh-list
6103780|NCT00968253|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6103781|NCT00968253|Prednisolone phosphate|prednisolone phosphate|mesh-list
6103782|NCT00968253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6103783|NCT00968253|Immunologic Factors|immunologic factors|mesh-ancestor
6103784|NCT00968253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103785|NCT00968253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6103786|NCT00968253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6103787|NCT00968253|Alkylating Agents|alkylating agents|mesh-ancestor
6103788|NCT00968253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103789|NCT00968253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6103790|NCT00968253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6103791|NCT00968253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6103792|NCT00968253|Antiemetics|antiemetics|mesh-ancestor
6103793|NCT00968253|Autonomic Agents|autonomic agents|mesh-ancestor
6103794|NCT00968253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6103795|NCT00968253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5524823|NCT04286503|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5524824|NCT04286503|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5524825|NCT04286503|Antimalarials|antimalarials|mesh-ancestor
5524826|NCT04286503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5524827|NCT04286503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6103796|NCT00968253|Glucocorticoids|glucocorticoids|mesh-ancestor
6103797|NCT00968253|Hormones|hormones|mesh-ancestor
6103798|NCT00968253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6103799|NCT00968253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6103800|NCT00968253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6103801|NCT00968253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6465134|NCT00472355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6465135|NCT00472355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465136|NCT00472368|Panobinostat|panobinostat|mesh-list
6465137|NCT00472368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6465138|NCT00472368|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6465139|NCT00472368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6465140|NCT00472368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465141|NCT00472381|Insulin|insulin|mesh-list
6103802|NCT00968253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6103803|NCT00968253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6103804|NCT00968253|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6103805|NCT00968253|Abortifacient Agents|abortifacient agents|mesh-ancestor
6103806|NCT00968253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6103807|NCT00968253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6103808|NCT00968253|Antimetabolites|antimetabolites|mesh-ancestor
6103809|NCT00968253|Dermatologic Agents|dermatologic agents|mesh-ancestor
6103810|NCT00968253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6103811|NCT00968253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6103812|NCT00968253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6103813|NCT00968253|Antiviral Agents|antiviral agents|mesh-ancestor
6103814|NCT00968253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6465142|NCT00472381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5524828|NCT04286503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5524829|NCT04286503|Analgesics|analgesics|mesh-ancestor
5524830|NCT04286503|Sensory System Agents|sensory system agents|mesh-ancestor
5524831|NCT04286503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5524832|NCT04286503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524833|NCT04286503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5524834|NCT04286503|Filaricides|filaricides|mesh-ancestor
5524835|NCT04286503|Antinematodal Agents|antinematodal agents|mesh-ancestor
5524836|NCT04286503|Anthelmintics|anthelmintics|mesh-ancestor
5524837|NCT04285866|Durvalumab|durvalumab|mesh-list
5524838|NCT04285866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5524839|NCT04285866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5524840|NCT04286035|Bupivacaine|bupivacaine|mesh-list
5524841|NCT04286035|Anesthetics, Local|anesthetics, local|mesh-ancestor
5524842|NCT04286035|Anesthetics|anesthetics|mesh-ancestor
5524843|NCT04286035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6465143|NCT00472381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465144|NCT00472433|Alemtuzumab|alemtuzumab|mesh-list
6465145|NCT00472433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6465146|NCT00472433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6465147|NCT00472459|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
6465148|NCT00472459|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6465149|NCT00472459|Dermatologic Agents|dermatologic agents|mesh-ancestor
6465150|NCT00472472|Paclitaxel|paclitaxel|mesh-list
6465151|NCT00472472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6465152|NCT00472472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6465153|NCT00472472|Tubulin Modulators|tubulin modulators|mesh-ancestor
6465154|NCT00472472|Antimitotic Agents|antimitotic agents|mesh-ancestor
5601224|NCT03706781|Cetylpyridinium|cetylpyridinium|mesh-list
5524844|NCT04286035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524845|NCT04286035|Sensory System Agents|sensory system agents|mesh-ancestor
5524846|NCT04286035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5524847|NCT04286087|Anesthetics|anesthetics|mesh-list
5524848|NCT04286087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5524849|NCT04286087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524850|NCT04285671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5524851|NCT04285671|Trastuzumab|trastuzumab|mesh-list
5524852|NCT04285671|Necitumumab|necitumumab|mesh-list
5524853|NCT04285671|Cetuximab|cetuximab|mesh-list
5524854|NCT04285671|Osimertinib|osimertinib|mesh-list
5524855|NCT04285671|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
5524856|NCT04285671|Antibodies|antibodies|mesh-list
5524857|NCT04285671|Immunoglobulins|immunoglobulins|mesh-list
5524858|NCT04285671|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5524859|NCT04285671|Immunologic Factors|immunologic factors|mesh-ancestor
5524860|NCT04285671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524861|NCT04285671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5524862|NCT04285671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524863|NCT04285671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5524864|NCT04285671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6665824|NCT01519011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665825|NCT01519011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6665826|NCT01519011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6103815|NCT00968253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6103816|NCT00968253|Tubulin Modulators|tubulin modulators|mesh-ancestor
6103817|NCT00968253|Antimitotic Agents|antimitotic agents|mesh-ancestor
6103818|NCT00968253|Mitosis Modulators|mitosis modulators|mesh-ancestor
6103819|NCT00968253|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6103820|NCT00968253|Protective Agents|protective agents|mesh-ancestor
6103821|NCT00968539|Vaccines|vaccines|mesh-list
6103822|NCT00968539|Immunologic Factors|immunologic factors|mesh-ancestor
6103823|NCT00968539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103824|NCT00968617|Darbepoetin alfa|darbepoetin alfa|mesh-list
6103825|NCT00968617|Hematinics|hematinics|mesh-ancestor
6103826|NCT00968708|Alogliptin|alogliptin|mesh-list
6103827|NCT00968708|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6103828|NCT00968708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103829|NCT00968708|Incretins|incretins|mesh-ancestor
6103830|NCT00968708|Hormones|hormones|mesh-ancestor
5524865|NCT04285853|Oxycodone|oxycodone|mesh-list
6103831|NCT00968708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6103832|NCT00968708|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6103833|NCT00968708|Protease Inhibitors|protease inhibitors|mesh-ancestor
6103834|NCT00968708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6103835|NCT00968708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524866|NCT04285853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5524867|NCT04285853|Narcotics|narcotics|mesh-ancestor
5524868|NCT04285853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5524869|NCT04285853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103836|NCT00968799|Cisplatin|cisplatin|mesh-list
6103837|NCT00968799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6103838|NCT00968812|Metformin|metformin|mesh-list
6103839|NCT00968812|Glimepiride|glimepiride|mesh-list
6103840|NCT00968812|Canagliflozin|canagliflozin|mesh-list
6103841|NCT00968812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6103842|NCT00968812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103843|NCT00968812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6103844|NCT00968812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6103845|NCT00968812|Immunologic Factors|immunologic factors|mesh-ancestor
5524870|NCT04285853|Analgesics|analgesics|mesh-ancestor
5524871|NCT04285853|Sensory System Agents|sensory system agents|mesh-ancestor
6465155|NCT00472472|Mitosis Modulators|mitosis modulators|mesh-ancestor
6103846|NCT00968812|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6103847|NCT00968812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103848|NCT00968890|Vaccines|vaccines|mesh-list
6103849|NCT00968890|Immunologic Factors|immunologic factors|mesh-ancestor
6103850|NCT00968890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103851|NCT00968968|Trastuzumab|trastuzumab|mesh-list
6103852|NCT00968968|Lapatinib|lapatinib|mesh-list
6103853|NCT00968968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6103854|NCT00968968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6103855|NCT00968968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5524872|NCT04285853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5524873|NCT04286152|Mirabegron|mirabegron|mesh-list
5524874|NCT04286152|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
5524875|NCT04286152|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5524876|NCT04286152|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5524877|NCT04286152|Adrenergic Agents|adrenergic agents|mesh-ancestor
5524878|NCT04286152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5524879|NCT04286152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524880|NCT04286152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524881|NCT04286152|Urological Agents|urological agents|mesh-ancestor
5524882|NCT04285580|Bimatoprost|bimatoprost|mesh-list
5524883|NCT04285580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5524884|NCT04285528|Lidocaine|lidocaine|mesh-list
5524885|NCT04285528|Fentanyl|fentanyl|mesh-list
5524886|NCT04285528|Ketamine|ketamine|mesh-list
5524887|NCT04285528|Propofol|propofol|mesh-list
5524888|NCT04285528|Anesthetics, Local|anesthetics, local|mesh-ancestor
6665827|NCT01519037|Cinacalcet|cinacalcet|mesh-list
6665828|NCT01519037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6103856|NCT00968968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6103857|NCT00968968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103858|NCT00969150|Milnacipran|milnacipran|mesh-list
6103859|NCT00969150|Levomilnacipran|levomilnacipran|mesh-list
6103860|NCT00969150|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6103861|NCT00969150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6103862|NCT00969150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6103863|NCT00969150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103864|NCT00969150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6103865|NCT00969150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103866|NCT00969150|Antidepressive Agents|antidepressive agents|mesh-ancestor
6103867|NCT00969150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6103868|NCT00969150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6103869|NCT00969150|Analgesics|analgesics|mesh-ancestor
6103870|NCT00969150|Sensory System Agents|sensory system agents|mesh-ancestor
6665829|NCT01519037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665830|NCT01519037|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6665831|NCT01519037|Hormone Antagonists|hormone antagonists|mesh-ancestor
6665832|NCT01519037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6665833|NCT01519076|Coal Tar|coal tar|mesh-list
6665834|NCT01519076|Keratolytic Agents|keratolytic agents|mesh-ancestor
6665835|NCT01519076|Dermatologic Agents|dermatologic agents|mesh-ancestor
6665836|NCT01519102|Hormones|hormones|mesh-list
6665837|NCT01519102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6665838|NCT01519102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665839|NCT01519128|Rilpivirine|rilpivirine|mesh-list
6665840|NCT01519128|Digoxin|digoxin|mesh-list
6665841|NCT01519128|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6665842|NCT01519128|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6665843|NCT01519128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6665844|NCT01519128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665845|NCT01519128|Protective Agents|protective agents|mesh-ancestor
6665846|NCT01519128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665847|NCT01519128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5524889|NCT04285528|Anesthetics|anesthetics|mesh-ancestor
5524890|NCT04285528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6103871|NCT00969150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6103872|NCT00969618|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6103873|NCT00969618|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6103874|NCT00969618|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6103875|NCT00969618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6103876|NCT00969618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103877|NCT00969618|Adrenergic Agents|adrenergic agents|mesh-ancestor
6103878|NCT00969618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6103879|NCT00969618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103880|NCT00969709|Milnacipran|milnacipran|mesh-list
6103881|NCT00969709|Levomilnacipran|levomilnacipran|mesh-list
6103882|NCT00969709|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6103883|NCT00969709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6103884|NCT00969709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6103885|NCT00969709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103886|NCT00969709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6103887|NCT00969709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103888|NCT00969709|Antidepressive Agents|antidepressive agents|mesh-ancestor
6103889|NCT00969709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6103890|NCT00969709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6103891|NCT00969709|Analgesics|analgesics|mesh-ancestor
6103892|NCT00969709|Sensory System Agents|sensory system agents|mesh-ancestor
6103893|NCT00969709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6103894|NCT00969878|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6103895|NCT00969878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6103896|NCT00969878|Immunologic Factors|immunologic factors|mesh-ancestor
6103897|NCT00969878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103898|NCT00969878|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6103899|NCT00969878|Antacids|antacids|mesh-ancestor
6103900|NCT00969878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103901|NCT00969878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6103902|NCT00970073|Mycophenolic Acid|mycophenolic acid|mesh-list
6103903|NCT00970073|Tacrolimus|tacrolimus|mesh-list
6103904|NCT00970073|Thymoglobulin|thymoglobulin|mesh-list
6103905|NCT00970073|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6103906|NCT00970073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6103907|NCT00970073|Immunologic Factors|immunologic factors|mesh-ancestor
6103908|NCT00970073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103909|NCT00970073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6103910|NCT00970073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6103911|NCT00970073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103912|NCT00970073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6103913|NCT00970073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6103914|NCT00970073|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6103915|NCT00970073|Antitubercular Agents|antitubercular agents|mesh-ancestor
6103916|NCT00970073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6103917|NCT00970073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6103918|NCT00970203|Vaccines|vaccines|mesh-list
6103919|NCT00970203|Androgens|androgens|mesh-list
6103920|NCT00970203|Immunologic Factors|immunologic factors|mesh-ancestor
6103921|NCT00970203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103922|NCT00970203|Hormones|hormones|mesh-ancestor
6103923|NCT00970203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6103924|NCT00970216|Telbivudine|telbivudine|mesh-list
6103925|NCT00970216|Antiviral Agents|antiviral agents|mesh-ancestor
6103926|NCT00970216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6103927|NCT00970216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6103928|NCT00970216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6103929|NCT00970216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103930|NCT00970268|Bromides|bromides|mesh-list
6103931|NCT00970268|Anticonvulsants|anticonvulsants|mesh-ancestor
6103932|NCT00970281|Olanzapine|olanzapine|mesh-list
6103933|NCT00970281|Antiemetics|antiemetics|mesh-ancestor
6103934|NCT00970281|Autonomic Agents|autonomic agents|mesh-ancestor
5524891|NCT04285528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524892|NCT04285528|Sensory System Agents|sensory system agents|mesh-ancestor
5524893|NCT04285528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5524894|NCT04285528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5524895|NCT04285528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5524896|NCT04285528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5524897|NCT04285528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5524898|NCT04285528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601225|NCT03706781|Benzydamine|benzydamine|mesh-list
6103935|NCT00970281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6665848|NCT01519128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6665849|NCT01519128|Antiviral Agents|antiviral agents|mesh-ancestor
6665850|NCT01519128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6665851|NCT01519128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6665852|NCT01519128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6665853|NCT01519154|Ketamine|ketamine|mesh-list
6665854|NCT01519154|Propofol|propofol|mesh-list
6665855|NCT01519154|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6665856|NCT01519154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6103936|NCT00970281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103937|NCT00970281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6103938|NCT00970281|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6103939|NCT00970281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6103940|NCT00970281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6103941|NCT00970281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6103942|NCT00970281|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6103943|NCT00970281|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6103944|NCT00970281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6103945|NCT00970281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103946|NCT00970281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6103947|NCT00970281|Serotonin Agents|serotonin agents|mesh-ancestor
6103948|NCT00970307|Vaccines|vaccines|mesh-list
6103949|NCT00970307|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5524899|NCT04285528|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5524900|NCT04285528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5524901|NCT04285528|Anesthetics, General|anesthetics, general|mesh-ancestor
5524902|NCT04285528|Analgesics|analgesics|mesh-ancestor
6103950|NCT00970307|Immunologic Factors|immunologic factors|mesh-ancestor
6103951|NCT00970307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103952|NCT00970502|Celecoxib|celecoxib|mesh-list
6103953|NCT00970502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6103954|NCT00970502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6103955|NCT00970502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6103956|NCT00970502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6103957|NCT00970502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103958|NCT00970502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6103959|NCT00970502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6103960|NCT00970502|Analgesics|analgesics|mesh-ancestor
6103961|NCT00970502|Sensory System Agents|sensory system agents|mesh-ancestor
6103962|NCT00970502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6103963|NCT00970502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103964|NCT00970502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6103965|NCT00970502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6103966|NCT00970502|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6103967|NCT00970502|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5524903|NCT04285528|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5524904|NCT04285528|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5524905|NCT04285528|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5524906|NCT04285528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5524907|NCT04285528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5524908|NCT04285528|Narcotics|narcotics|mesh-ancestor
5524909|NCT04285528|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5524910|NCT04285450|Vitamin K|vitamin k|mesh-list
5524911|NCT04285450|Vitamins|vitamins|mesh-ancestor
5524912|NCT04285450|Micronutrients|micronutrients|mesh-ancestor
5524913|NCT04285450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103968|NCT00970632|Tadalafil|tadalafil|mesh-list
6103969|NCT00970632|Tamsulosin|tamsulosin|mesh-list
6103970|NCT00970632|Vasodilator Agents|vasodilator agents|mesh-ancestor
6103971|NCT00970632|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6103972|NCT00970632|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6103973|NCT00970632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6103974|NCT00970632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103975|NCT00970632|Urological Agents|urological agents|mesh-ancestor
6103976|NCT00970632|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6103977|NCT00970632|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6103978|NCT00970632|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6103979|NCT00970632|Adrenergic Agents|adrenergic agents|mesh-ancestor
6103980|NCT00970632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6103981|NCT00970632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103982|NCT00970684|Gemcitabine|gemcitabine|mesh-list
6103983|NCT00970684|Bevacizumab|bevacizumab|mesh-list
6103984|NCT00970684|Docetaxel|docetaxel|mesh-list
6103985|NCT00970684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6103986|NCT00970684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6103987|NCT00970684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6103988|NCT00970684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6103989|NCT00970684|Growth Substances|growth substances|mesh-ancestor
6103990|NCT00970684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6103991|NCT00970684|Growth Inhibitors|growth inhibitors|mesh-ancestor
6103992|NCT00970684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5524914|NCT04285450|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5524915|NCT04285450|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5524916|NCT04285450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524917|NCT04285450|Hemostatics|hemostatics|mesh-ancestor
5524918|NCT04285450|Coagulants|coagulants|mesh-ancestor
5524919|NCT04285229|Ixekizumab|ixekizumab|mesh-list
5524920|NCT04285229|Dermatologic Agents|dermatologic agents|mesh-ancestor
5524921|NCT04285281|Gabapentin|gabapentin|mesh-list
5524922|NCT04285281|Analgesics|analgesics|mesh-ancestor
5524923|NCT04285281|Sensory System Agents|sensory system agents|mesh-ancestor
5524924|NCT04285281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5524925|NCT04285281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524926|NCT04285281|Anticonvulsants|anticonvulsants|mesh-ancestor
5524927|NCT04285281|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6103993|NCT00970684|Antimetabolites|antimetabolites|mesh-ancestor
6103994|NCT00970684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6103995|NCT00970684|Antiviral Agents|antiviral agents|mesh-ancestor
6103996|NCT00970684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6103997|NCT00970684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6103998|NCT00970684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6103999|NCT00970684|Immunologic Factors|immunologic factors|mesh-ancestor
6104000|NCT00970684|Tubulin Modulators|tubulin modulators|mesh-ancestor
6104001|NCT00970684|Antimitotic Agents|antimitotic agents|mesh-ancestor
6104002|NCT00970684|Mitosis Modulators|mitosis modulators|mesh-ancestor
6104003|NCT00970814|Levetiracetam|levetiracetam|mesh-list
6104004|NCT00970814|Anticonvulsants|anticonvulsants|mesh-ancestor
6104005|NCT00970814|Nootropic Agents|nootropic agents|mesh-ancestor
6104006|NCT00970944|Amantadine|amantadine|mesh-list
6104007|NCT00970944|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6104008|NCT00970944|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6104009|NCT00970944|Antiviral Agents|antiviral agents|mesh-ancestor
6104010|NCT00970944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6104011|NCT00970944|Dopamine Agents|dopamine agents|mesh-ancestor
6104012|NCT00970944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6104013|NCT00970944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104014|NCT00970944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104015|NCT00970944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6104016|NCT00970944|Analgesics|analgesics|mesh-ancestor
6104017|NCT00970944|Sensory System Agents|sensory system agents|mesh-ancestor
6104018|NCT00970944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6104019|NCT00971178|Dexmedetomidine|dexmedetomidine|mesh-list
6104020|NCT00971178|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6104021|NCT00971178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6104022|NCT00971178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104023|NCT00971178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6104024|NCT00971178|Analgesics|analgesics|mesh-ancestor
6104025|NCT00971178|Sensory System Agents|sensory system agents|mesh-ancestor
6104026|NCT00971178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6104027|NCT00971178|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6104028|NCT00971178|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6104029|NCT00971178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6104030|NCT00971178|Adrenergic Agents|adrenergic agents|mesh-ancestor
6104031|NCT00971178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6104032|NCT00971178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104033|NCT00971243|Metformin|metformin|mesh-list
6104034|NCT00971243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6104035|NCT00971243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104036|NCT00971295|Metformin|metformin|mesh-list
6104037|NCT00971295|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
6104038|NCT00971295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6104039|NCT00971295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104040|NCT00971295|Anticonvulsants|anticonvulsants|mesh-ancestor
6104041|NCT00971295|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6104042|NCT00971295|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5524928|NCT04285281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5524929|NCT04285281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5524930|NCT04285281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5524931|NCT04285281|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5524932|NCT04285281|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5524933|NCT04285281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5524934|NCT04285281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524935|NCT04285281|Antimanic Agents|antimanic agents|mesh-ancestor
5524936|NCT04285073|Paclitaxel|paclitaxel|mesh-list
5524937|NCT04285073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5524938|NCT04285073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6104043|NCT00971295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6104044|NCT00971295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104045|NCT00971620|Botulinum Toxins|botulinum toxins|mesh-list
6104046|NCT00971620|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6104047|NCT00971620|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6104048|NCT00971620|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6104049|NCT00971620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6104050|NCT00971620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104051|NCT00971620|Cholinergic Agents|cholinergic agents|mesh-ancestor
6104052|NCT00971620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6104053|NCT00971620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104054|NCT00971620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6104055|NCT00971620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6104056|NCT00971633|Ondansetron|ondansetron|mesh-list
6104057|NCT00971633|Antiemetics|antiemetics|mesh-ancestor
6104058|NCT00971633|Autonomic Agents|autonomic agents|mesh-ancestor
6104059|NCT00971633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6104060|NCT00971633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104061|NCT00971633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6104062|NCT00971633|Antipruritics|antipruritics|mesh-ancestor
6104063|NCT00971633|Dermatologic Agents|dermatologic agents|mesh-ancestor
6104064|NCT00971633|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6104065|NCT00971633|Serotonin Agents|serotonin agents|mesh-ancestor
6104066|NCT00971633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6104067|NCT00971633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104068|NCT00971633|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6104069|NCT00971633|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6104070|NCT00971633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6104071|NCT00971633|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6104072|NCT00971633|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6104073|NCT00971737|Cyclophosphamide|cyclophosphamide|mesh-list
6104074|NCT00971737|Trastuzumab|trastuzumab|mesh-list
6104075|NCT00971737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6104076|NCT00971737|Immunologic Factors|immunologic factors|mesh-ancestor
6104077|NCT00971737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104078|NCT00971737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6104079|NCT00971737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6104080|NCT00971737|Alkylating Agents|alkylating agents|mesh-ancestor
6104081|NCT00971737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104082|NCT00971737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6104083|NCT00971737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6104084|NCT00971737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6104085|NCT00971789|Sirolimus|sirolimus|mesh-list
6104086|NCT00971789|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6104087|NCT00971789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6104088|NCT00971789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6104089|NCT00971789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6104090|NCT00971789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6104091|NCT00971789|Antifungal Agents|antifungal agents|mesh-ancestor
6104092|NCT00971789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6104093|NCT00971789|Immunologic Factors|immunologic factors|mesh-ancestor
6104094|NCT00971789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104095|NCT00971789|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6104096|NCT00971789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104097|NCT00971841|Paclitaxel|paclitaxel|mesh-list
6104098|NCT00971841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6104099|NCT00971841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6104100|NCT00971841|Tubulin Modulators|tubulin modulators|mesh-ancestor
6104101|NCT00971841|Antimitotic Agents|antimitotic agents|mesh-ancestor
6104102|NCT00971841|Mitosis Modulators|mitosis modulators|mesh-ancestor
6104103|NCT00971841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104104|NCT00971932|Carboplatin|carboplatin|mesh-list
6104105|NCT00971932|Fluorouracil|fluorouracil|mesh-list
6104106|NCT00971932|Cetuximab|cetuximab|mesh-list
6104107|NCT00971932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6104108|NCT00971932|Antimetabolites|antimetabolites|mesh-ancestor
6104109|NCT00971932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104110|NCT00971932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6104111|NCT00971932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6104112|NCT00971932|Immunologic Factors|immunologic factors|mesh-ancestor
6104113|NCT00971932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104114|NCT00971932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6104115|NCT00971945|Paclitaxel|paclitaxel|mesh-list
6104116|NCT00971945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6104117|NCT00971945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6104118|NCT00971945|Tubulin Modulators|tubulin modulators|mesh-ancestor
6104119|NCT00971945|Antimitotic Agents|antimitotic agents|mesh-ancestor
6104120|NCT00971945|Mitosis Modulators|mitosis modulators|mesh-ancestor
6104121|NCT00971945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104122|NCT00971997|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
6104123|NCT00971997|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6104124|NCT00971997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104125|NCT00972205|Paclitaxel|paclitaxel|mesh-list
6104126|NCT00972205|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
6104127|NCT00972205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6104128|NCT00972205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6104129|NCT00972205|Tubulin Modulators|tubulin modulators|mesh-ancestor
6104130|NCT00972205|Antimitotic Agents|antimitotic agents|mesh-ancestor
6104131|NCT00972205|Mitosis Modulators|mitosis modulators|mesh-ancestor
6104132|NCT00972205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104133|NCT00972205|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6104134|NCT00972244|Dapagliflozin|dapagliflozin|mesh-list
6104135|NCT00972244|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6104136|NCT00972244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104137|NCT00972244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6104138|NCT00972244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104139|NCT00972283|Insulin|insulin|mesh-list
6104140|NCT00972283|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6104141|NCT00972283|Insulin Glargine|insulin glargine|mesh-list
6104142|NCT00972283|Insulin Aspart|insulin aspart|mesh-list
6104143|NCT00972283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6104144|NCT00972283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104145|NCT00972335|Bevacizumab|bevacizumab|mesh-list
6104146|NCT00972335|Everolimus|everolimus|mesh-list
6104147|NCT00972335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6104148|NCT00972335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6104149|NCT00972335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6104150|NCT00972335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6104151|NCT00972335|Growth Substances|growth substances|mesh-ancestor
6104152|NCT00972335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104153|NCT00972335|Growth Inhibitors|growth inhibitors|mesh-ancestor
6104154|NCT00972335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5524939|NCT04285073|Tubulin Modulators|tubulin modulators|mesh-ancestor
5524940|NCT04285073|Antimitotic Agents|antimitotic agents|mesh-ancestor
5524941|NCT04285073|Mitosis Modulators|mitosis modulators|mesh-ancestor
5524942|NCT04285073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104155|NCT00972335|Immunologic Factors|immunologic factors|mesh-ancestor
6104156|NCT00972374|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6104157|NCT00972374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6104158|NCT00972374|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6104159|NCT00972374|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6104160|NCT00972374|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6104161|NCT00972374|Adrenergic Agents|adrenergic agents|mesh-ancestor
6104162|NCT00972374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6104163|NCT00972374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104164|NCT00972374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104165|NCT00972439|Contraceptive Agents|contraceptive agents|mesh-list
6104166|NCT00972439|Norinyl|norinyl|mesh-list
6104167|NCT00972439|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
6104168|NCT00972439|Contraceptives, Oral|contraceptives, oral|mesh-list
6104169|NCT00972439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6104170|NCT00972439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104171|NCT00972439|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6104172|NCT00972439|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6104173|NCT00972439|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6104174|NCT00972439|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6104175|NCT00972439|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
5524943|NCT04285268|Rituximab|rituximab|mesh-list
5524944|NCT04285268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5524945|NCT04285268|Bortezomib|bortezomib|mesh-list
5524946|NCT04285268|Venetoclax|venetoclax|mesh-list
6104176|NCT00972439|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6104177|NCT00972478|Prednisone|prednisone|mesh-list
6104178|NCT00972478|Cortisone|cortisone|mesh-list
6104179|NCT00972478|Cyclophosphamide|cyclophosphamide|mesh-list
6104180|NCT00972478|Rituximab|rituximab|mesh-list
6104181|NCT00972478|Doxorubicin|doxorubicin|mesh-list
6104182|NCT00972478|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6104183|NCT00972478|Vincristine|vincristine|mesh-list
6104184|NCT00972478|Vorinostat|vorinostat|mesh-list
5524947|NCT04285268|Antibodies|antibodies|mesh-list
6104185|NCT00972478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6104186|NCT00972478|Antibodies|antibodies|mesh-list
6104187|NCT00972478|Immunoglobulins|immunoglobulins|mesh-list
6104188|NCT00972478|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6104189|NCT00972478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6104190|NCT00972478|Immunologic Factors|immunologic factors|mesh-ancestor
6104191|NCT00972478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104192|NCT00972478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6104193|NCT00972478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5524948|NCT04285268|Immunoglobulins|immunoglobulins|mesh-list
5524949|NCT04285268|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5524950|NCT04285268|Immunologic Factors|immunologic factors|mesh-ancestor
5524951|NCT04285268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524952|NCT04285268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5524953|NCT04285268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5524954|NCT04285320|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5524955|NCT04285320|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6104194|NCT00972478|Alkylating Agents|alkylating agents|mesh-ancestor
6104195|NCT00972478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465156|NCT00472472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465157|NCT00472550|Esomeprazole|esomeprazole|mesh-list
6465158|NCT00472550|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6104196|NCT00972478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6104197|NCT00972478|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6104198|NCT00972478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6104199|NCT00972478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6104200|NCT00972478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6104201|NCT00972478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6104202|NCT00972478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6104203|NCT00972478|Glucocorticoids|glucocorticoids|mesh-ancestor
6104204|NCT00972478|Hormones|hormones|mesh-ancestor
6104205|NCT00972478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6104206|NCT00972478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6104207|NCT00972478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6104208|NCT00972478|Tubulin Modulators|tubulin modulators|mesh-ancestor
6104209|NCT00972478|Antimitotic Agents|antimitotic agents|mesh-ancestor
6104210|NCT00972478|Mitosis Modulators|mitosis modulators|mesh-ancestor
5524956|NCT04285320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5524957|NCT04285320|Antitubercular Agents|antitubercular agents|mesh-ancestor
5601226|NCT03706781|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5601227|NCT03706781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5601228|NCT03706781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5601229|NCT03706755|Norepinephrine|norepinephrine|mesh-list
6104211|NCT00972478|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6104212|NCT00972504|Cetirizine|cetirizine|mesh-list
6104213|NCT00972504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6104214|NCT00972504|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6104215|NCT00972504|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6104216|NCT00972504|Histamine Antagonists|histamine antagonists|mesh-ancestor
6104217|NCT00972504|Histamine Agents|histamine agents|mesh-ancestor
6104218|NCT00972504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6104219|NCT00972504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104220|NCT00972504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104221|NCT00972543|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6104222|NCT00972543|Immunologic Factors|immunologic factors|mesh-ancestor
6465159|NCT00472550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6465160|NCT00472550|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6465161|NCT00472550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6104223|NCT00972543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104224|NCT00972595|Ondansetron|ondansetron|mesh-list
6104225|NCT00972595|Antiemetics|antiemetics|mesh-ancestor
6104226|NCT00972595|Autonomic Agents|autonomic agents|mesh-ancestor
6104227|NCT00972595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6104228|NCT00972595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104229|NCT00972595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6104230|NCT00972595|Antipruritics|antipruritics|mesh-ancestor
6104231|NCT00972595|Dermatologic Agents|dermatologic agents|mesh-ancestor
6104232|NCT00972595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6104233|NCT00972595|Serotonin Agents|serotonin agents|mesh-ancestor
6104234|NCT00972595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6104235|NCT00972595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104236|NCT00972595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6104237|NCT00972595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6104238|NCT00972595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5524958|NCT04285346|Ganaxolone|ganaxolone|mesh-list
5524959|NCT04285346|Neurosteroids|neurosteroids|mesh-ancestor
5524960|NCT04285346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5524961|NCT04285346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524962|NCT04285346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524963|NCT04285346|GABA Modulators|gaba modulators|mesh-ancestor
5524964|NCT04285346|GABA Agents|gaba agents|mesh-ancestor
5524965|NCT04284839|Warfarin|warfarin|mesh-list
5524966|NCT04284839|Rivaroxaban|rivaroxaban|mesh-list
5524967|NCT04284839|Dabigatran|dabigatran|mesh-list
5524968|NCT04284839|Apixaban|apixaban|mesh-list
5524969|NCT04284839|Edoxaban|edoxaban|mesh-list
5524970|NCT04284839|Anticoagulants|anticoagulants|mesh-ancestor
5524971|NCT04284839|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5524972|NCT04284839|Antithrombins|antithrombins|mesh-ancestor
5524973|NCT04284839|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5524974|NCT04284839|Protease Inhibitors|protease inhibitors|mesh-ancestor
5524975|NCT04284839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5524976|NCT04284839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524977|NCT04284826|Mitomycins|mitomycins|mesh-list
5524978|NCT04284826|Mitomycin|mitomycin|mesh-list
5524979|NCT04284826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5524980|NCT04284826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5524981|NCT04284826|Alkylating Agents|alkylating agents|mesh-ancestor
6104239|NCT00972595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6104240|NCT00972595|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6104241|NCT00972725|Chloroquine|chloroquine|mesh-list
6104242|NCT00972725|Amebicides|amebicides|mesh-ancestor
6104243|NCT00972725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6104244|NCT00972725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6104245|NCT00972725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6104246|NCT00972725|Antimalarials|antimalarials|mesh-ancestor
6104247|NCT00972725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6104248|NCT00972777|Besifloxacin|besifloxacin|mesh-list
6104249|NCT00972777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6104250|NCT00972777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6104251|NCT00972777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6104252|NCT00972777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6104253|NCT00972777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6104254|NCT00972777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104255|NCT00972777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6104256|NCT00972959|Zoledronic Acid|zoledronic acid|mesh-list
6104257|NCT00972959|Dexamethasone|dexamethasone|mesh-list
6104258|NCT00972959|Bortezomib|bortezomib|mesh-list
5524982|NCT04284826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5524983|NCT04284826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5524984|NCT04284826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6104259|NCT00972959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6104260|NCT00972959|Antiemetics|antiemetics|mesh-ancestor
6104261|NCT00972959|Autonomic Agents|autonomic agents|mesh-ancestor
6104262|NCT00972959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6104263|NCT00972959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104264|NCT00972959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6104265|NCT00972959|Glucocorticoids|glucocorticoids|mesh-ancestor
5524985|NCT04284644|Propofol|propofol|mesh-list
5524986|NCT04284644|Sevoflurane|sevoflurane|mesh-list
6104266|NCT00972959|Hormones|hormones|mesh-ancestor
6104267|NCT00972959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6104268|NCT00972959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6104269|NCT00972959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6104270|NCT00972959|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6104271|NCT00973102|Estrogens|estrogens|mesh-list
6104272|NCT00973102|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6104273|NCT00973102|Hormones|hormones|mesh-ancestor
6104274|NCT00973102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6104275|NCT00973102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203944|NCT02062801|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6203945|NCT02062801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524987|NCT04284644|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5524988|NCT04284644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5524989|NCT04284644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524990|NCT04284644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5524991|NCT04284644|Anesthetics, General|anesthetics, general|mesh-ancestor
5524992|NCT04284644|Anesthetics|anesthetics|mesh-ancestor
5524993|NCT04284644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5524994|NCT04284644|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5524995|NCT04284722|Metformin|metformin|mesh-list
5524996|NCT04284722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5524997|NCT04284722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5524998|NCT04284761|Bicalutamide|bicalutamide|mesh-list
5524999|NCT04284761|Androgen Antagonists|androgen antagonists|mesh-ancestor
5525000|NCT04284761|Hormone Antagonists|hormone antagonists|mesh-ancestor
5525001|NCT04284761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5525002|NCT04284761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525003|NCT04284761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5525004|NCT04284852|Niraparib|niraparib|mesh-list
5525005|NCT04284852|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5525006|NCT04284852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5525007|NCT04284852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525008|NCT04284852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5525009|NCT04284514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5525010|NCT04284514|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5525011|NCT04284215|Paclitaxel|paclitaxel|mesh-list
5525012|NCT04284215|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5525013|NCT04284215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5525014|NCT04284215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5525015|NCT04284215|Tubulin Modulators|tubulin modulators|mesh-ancestor
5525016|NCT04284215|Antimitotic Agents|antimitotic agents|mesh-ancestor
5525017|NCT04284215|Mitosis Modulators|mitosis modulators|mesh-ancestor
5525018|NCT04284215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525019|NCT04284202|Dasatinib|dasatinib|mesh-list
5525020|NCT04284202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5525021|NCT04284202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5525022|NCT04284202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5525023|NCT04284202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203946|NCT02062801|Sympathomimetics|sympathomimetics|mesh-ancestor
6203947|NCT02062801|Autonomic Agents|autonomic agents|mesh-ancestor
6203948|NCT02062801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6203949|NCT02062801|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6203950|NCT02062801|Adrenergic Agents|adrenergic agents|mesh-ancestor
6203951|NCT02062801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6203952|NCT02062801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203953|NCT02062879|Ketamine|ketamine|mesh-list
6203954|NCT02062879|Hydromorphone|hydromorphone|mesh-list
6203955|NCT02062879|Analgesics|analgesics|mesh-ancestor
6203956|NCT02062879|Sensory System Agents|sensory system agents|mesh-ancestor
6203957|NCT02062879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6203958|NCT02062879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203959|NCT02062879|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6203960|NCT02062879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6203961|NCT02062879|Anesthetics, General|anesthetics, general|mesh-ancestor
6203962|NCT02062879|Anesthetics|anesthetics|mesh-ancestor
6203963|NCT02062879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6203964|NCT02062879|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6203965|NCT02062879|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6203966|NCT02062879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6203967|NCT02062879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203968|NCT02062879|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6203969|NCT02062879|Narcotics|narcotics|mesh-ancestor
6203970|NCT02062905|Dexamethasone|dexamethasone|mesh-list
6104276|NCT00973479|Golimumab|golimumab|mesh-list
6104277|NCT00973479|Methotrexate|methotrexate|mesh-list
6104278|NCT00973479|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6104279|NCT00973479|Abortifacient Agents|abortifacient agents|mesh-ancestor
6104280|NCT00973479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6104281|NCT00973479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104282|NCT00973479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6104283|NCT00973479|Antimetabolites|antimetabolites|mesh-ancestor
6104284|NCT00973479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104285|NCT00973479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6104286|NCT00973479|Dermatologic Agents|dermatologic agents|mesh-ancestor
6104287|NCT00973479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6104288|NCT00973479|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6104289|NCT00973479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6104290|NCT00973479|Immunologic Factors|immunologic factors|mesh-ancestor
6104291|NCT00973479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6104292|NCT00973479|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6104293|NCT00973479|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6104294|NCT00973479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6104295|NCT00973674|Estrogens|estrogens|mesh-list
6104296|NCT00973674|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6104297|NCT00973674|Hormones|hormones|mesh-ancestor
6104298|NCT00973674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5525040|NCT04284098|Dexmedetomidine|dexmedetomidine|mesh-list
5525041|NCT04284098|Bupivacaine|bupivacaine|mesh-list
5525042|NCT04284098|Anesthetics, Local|anesthetics, local|mesh-ancestor
5525043|NCT04284098|Anesthetics|anesthetics|mesh-ancestor
5525044|NCT04284098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5525045|NCT04284098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525046|NCT04284098|Sensory System Agents|sensory system agents|mesh-ancestor
5525047|NCT04284098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5525048|NCT04284098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5525049|NCT04284098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5525050|NCT04284098|Analgesics|analgesics|mesh-ancestor
5525051|NCT04284098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5525052|NCT04284098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5525053|NCT04284098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5525054|NCT04284098|Adrenergic Agents|adrenergic agents|mesh-ancestor
6104299|NCT00973674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104300|NCT00973739|Lapatinib|lapatinib|mesh-list
6104301|NCT00973739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6104302|NCT00973739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6104303|NCT00973739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6104304|NCT00973739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104305|NCT00973752|Cytarabine|cytarabine|mesh-list
6104306|NCT00973752|Prednisone|prednisone|mesh-list
6104307|NCT00973752|Doxorubicin|doxorubicin|mesh-list
6104308|NCT00973752|Methotrexate|methotrexate|mesh-list
6104309|NCT00973752|Vincristine|vincristine|mesh-list
6104310|NCT00973752|Asparaginase|asparaginase|mesh-list
6104311|NCT00973752|Mercaptopurine|mercaptopurine|mesh-list
6104312|NCT00973752|Clofarabine|clofarabine|mesh-list
6104313|NCT00973752|Pegaspargase|pegaspargase|mesh-list
6104314|NCT00973752|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6104315|NCT00973752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5525055|NCT04284098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5525056|NCT04284098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525057|NCT04284150|Midazolam|midazolam|mesh-list
5525058|NCT04284150|Dexmedetomidine|dexmedetomidine|mesh-list
5525059|NCT04284150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5525060|NCT04284150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5525061|NCT04284150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525062|NCT04284150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5525063|NCT04284150|Analgesics|analgesics|mesh-ancestor
5525064|NCT04284150|Sensory System Agents|sensory system agents|mesh-ancestor
5525065|NCT04284150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5525066|NCT04284150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5525067|NCT04284150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5525068|NCT04284150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6104316|NCT00973752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6104317|NCT00973752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6104318|NCT00973752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6104319|NCT00973752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104320|NCT00973752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6104321|NCT00973752|Glucocorticoids|glucocorticoids|mesh-ancestor
6104322|NCT00973752|Hormones|hormones|mesh-ancestor
5525069|NCT04284150|Adrenergic Agents|adrenergic agents|mesh-ancestor
6104323|NCT00973752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6104324|NCT00973752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104325|NCT00973752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6104326|NCT00973752|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6104327|NCT00973752|Abortifacient Agents|abortifacient agents|mesh-ancestor
6104328|NCT00973752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6104329|NCT00973752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6104330|NCT00973752|Antimetabolites|antimetabolites|mesh-ancestor
6104331|NCT00973752|Dermatologic Agents|dermatologic agents|mesh-ancestor
6104332|NCT00973752|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6104333|NCT00973752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5525070|NCT04284150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5525071|NCT04284150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525072|NCT04284150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6104334|NCT00973752|Immunologic Factors|immunologic factors|mesh-ancestor
6104335|NCT00973752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6104336|NCT00973752|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6104337|NCT00973752|Antiviral Agents|antiviral agents|mesh-ancestor
6104338|NCT00973752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6104339|NCT00973752|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6104340|NCT00973752|Tubulin Modulators|tubulin modulators|mesh-ancestor
6104341|NCT00973752|Antimitotic Agents|antimitotic agents|mesh-ancestor
6104342|NCT00973752|Mitosis Modulators|mitosis modulators|mesh-ancestor
6104343|NCT00973765|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6104344|NCT00973765|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6104345|NCT00973765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6104346|NCT00973765|Renal Agents|renal agents|mesh-ancestor
6104347|NCT00973765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6104348|NCT00973765|Antimalarials|antimalarials|mesh-ancestor
6104349|NCT00973765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6104350|NCT00973765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6104351|NCT00974051|Insulin|insulin|mesh-list
6104352|NCT00974051|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6104353|NCT00974051|Terbutaline|terbutaline|mesh-list
6104354|NCT00974051|Adrenergic Agonists|adrenergic agonists|mesh-list
6104355|NCT00974051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6104356|NCT00974051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104357|NCT00974051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6104358|NCT00974051|Autonomic Agents|autonomic agents|mesh-ancestor
6104359|NCT00974051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6104360|NCT00974051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6104361|NCT00974051|Respiratory System Agents|respiratory system agents|mesh-ancestor
6104362|NCT00974051|Sympathomimetics|sympathomimetics|mesh-ancestor
6104363|NCT00974051|Tocolytic Agents|tocolytic agents|mesh-ancestor
6104364|NCT00974051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5525073|NCT04284150|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5525074|NCT04284150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5525075|NCT04284150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5525076|NCT04284150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5525077|NCT04284150|Anesthetics, General|anesthetics, general|mesh-ancestor
5525078|NCT04284150|Anesthetics|anesthetics|mesh-ancestor
5525079|NCT04284150|GABA Modulators|gaba modulators|mesh-ancestor
5525080|NCT04284150|GABA Agents|gaba agents|mesh-ancestor
5525081|NCT04284059|Vitamin D|vitamin d|mesh-list
5525082|NCT04284059|Vitamins|vitamins|mesh-list
5525083|NCT04284059|Micronutrients|micronutrients|mesh-ancestor
5525084|NCT04284059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525085|NCT04284059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5525086|NCT04283916|Botulinum Toxins|botulinum toxins|mesh-list
5525087|NCT04283916|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5525088|NCT04283916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5525089|NCT04283916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525090|NCT04283916|Cholinergic Agents|cholinergic agents|mesh-ancestor
6104365|NCT00974051|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6104366|NCT00974051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6104367|NCT00974051|Adrenergic Agents|adrenergic agents|mesh-ancestor
6104368|NCT00974051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6104369|NCT00974051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104370|NCT00974090|Glimepiride|glimepiride|mesh-list
6104371|NCT00974090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6104372|NCT00974090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6104373|NCT00974090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104374|NCT00974090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6104375|NCT00974090|Immunologic Factors|immunologic factors|mesh-ancestor
5525091|NCT04283916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5525092|NCT04283916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525093|NCT04283747|Immunoglobulins|immunoglobulins|mesh-list
5525094|NCT04283747|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5525095|NCT04283747|Antibodies|antibodies|mesh-list
5525096|NCT04283747|Immunologic Factors|immunologic factors|mesh-ancestor
5525097|NCT04283747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525098|NCT04284007|Dexamethasone|dexamethasone|mesh-list
5525099|NCT04284007|Dexamethasone acetate|dexamethasone acetate|mesh-list
5525100|NCT04284007|Levobupivacaine|levobupivacaine|mesh-list
5525101|NCT04284007|BB 1101|bb 1101|mesh-list
5525102|NCT04284007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6104376|NCT00974142|Cyclosporine|cyclosporine|mesh-list
6104377|NCT00974142|Cyclosporins|cyclosporins|mesh-list
6104378|NCT00974142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6104379|NCT00974142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104380|NCT00974142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6104381|NCT00974142|Immunologic Factors|immunologic factors|mesh-ancestor
6104382|NCT00974142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104383|NCT00974142|Antifungal Agents|antifungal agents|mesh-ancestor
6104384|NCT00974142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6104385|NCT00974142|Dermatologic Agents|dermatologic agents|mesh-ancestor
5525103|NCT04284007|Antiemetics|antiemetics|mesh-ancestor
5525104|NCT04284007|Autonomic Agents|autonomic agents|mesh-ancestor
5525105|NCT04284007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5525106|NCT04284007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525107|NCT04284007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5525108|NCT04284007|Glucocorticoids|glucocorticoids|mesh-ancestor
5525109|NCT04284007|Hormones|hormones|mesh-ancestor
5525110|NCT04284007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6104386|NCT00974142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6104387|NCT00974142|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6104388|NCT00974220|Fentanyl|fentanyl|mesh-list
6104389|NCT00974220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6104390|NCT00974220|Narcotics|narcotics|mesh-ancestor
6104391|NCT00974220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6104392|NCT00974220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104393|NCT00974220|Analgesics|analgesics|mesh-ancestor
6465162|NCT00472550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465163|NCT00472758|Sifalimumab|sifalimumab|mesh-list
6465164|NCT00472758|Immunologic Factors|immunologic factors|mesh-ancestor
6465165|NCT00472758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465166|NCT00472810|Mitomycins|mitomycins|mesh-list
6465167|NCT00472810|Mitomycin|mitomycin|mesh-list
6465168|NCT00472810|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6465169|NCT00472810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6465170|NCT00472810|Alkylating Agents|alkylating agents|mesh-ancestor
6465171|NCT00472810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465172|NCT00472810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6465173|NCT00472810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6465174|NCT00472823|Vitamin D|vitamin d|mesh-list
6465175|NCT00472823|Cholecalciferol|cholecalciferol|mesh-list
6465176|NCT00472823|Calcium|calcium|mesh-list
6465177|NCT00472823|Vitamins|vitamins|mesh-ancestor
6465178|NCT00472823|Micronutrients|micronutrients|mesh-ancestor
5525111|NCT04284007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5525112|NCT04284007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5525113|NCT04284007|Protease Inhibitors|protease inhibitors|mesh-ancestor
6465179|NCT00472823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465180|NCT00472823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6465181|NCT00472823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6465182|NCT00472875|Glyburide|glyburide|mesh-list
6465183|NCT00472875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6465184|NCT00472875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465185|NCT00472901|Afamelanotide|afamelanotide|mesh-list
6465186|NCT00472901|Dermatologic Agents|dermatologic agents|mesh-ancestor
6465187|NCT00472927|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
5525114|NCT04284007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6104394|NCT00974220|Sensory System Agents|sensory system agents|mesh-ancestor
6104395|NCT00974220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6104396|NCT00974220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6104397|NCT00974220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6104398|NCT00974220|Anesthetics, General|anesthetics, general|mesh-ancestor
6104399|NCT00974220|Anesthetics|anesthetics|mesh-ancestor
6104400|NCT00974233|Rituximab|rituximab|mesh-list
6104401|NCT00974233|Lenalidomide|lenalidomide|mesh-list
6104402|NCT00974233|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6465188|NCT00472927|Estrogens|estrogens|mesh-ancestor
6465189|NCT00472927|Hormones|hormones|mesh-ancestor
6104403|NCT00974233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6104404|NCT00974233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6104405|NCT00974233|Immunologic Factors|immunologic factors|mesh-ancestor
6104406|NCT00974233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104407|NCT00974233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6104408|NCT00974233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6104409|NCT00974233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6104410|NCT00974233|Growth Substances|growth substances|mesh-ancestor
6104411|NCT00974233|Growth Inhibitors|growth inhibitors|mesh-ancestor
6104412|NCT00974233|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6104413|NCT00974233|Alkylating Agents|alkylating agents|mesh-ancestor
6104414|NCT00974233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104415|NCT00974246|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6104416|NCT00974246|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6104417|NCT00974246|Autonomic Agents|autonomic agents|mesh-ancestor
6104418|NCT00974246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6104419|NCT00974246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104420|NCT00974246|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6104421|NCT00974246|Respiratory System Agents|respiratory system agents|mesh-ancestor
6104422|NCT00974246|Glucocorticoids|glucocorticoids|mesh-ancestor
6104423|NCT00974246|Hormones|hormones|mesh-ancestor
6104424|NCT00974246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6104425|NCT00974246|Sympathomimetics|sympathomimetics|mesh-ancestor
6104426|NCT00974350|Bupivacaine|bupivacaine|mesh-list
6104427|NCT00974350|Anesthetics, Local|anesthetics, local|mesh-ancestor
6104428|NCT00974350|Anesthetics|anesthetics|mesh-ancestor
6104429|NCT00974350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6104430|NCT00974350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104431|NCT00974350|Sensory System Agents|sensory system agents|mesh-ancestor
6104432|NCT00974350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6104433|NCT00974376|Gabapentin|gabapentin|mesh-list
6104434|NCT00974376|Analgesics|analgesics|mesh-ancestor
6104435|NCT00974376|Sensory System Agents|sensory system agents|mesh-ancestor
6104436|NCT00974376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6104437|NCT00974376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104438|NCT00974376|Anticonvulsants|anticonvulsants|mesh-ancestor
6104439|NCT00974376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6104440|NCT00974376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6104441|NCT00974376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6104442|NCT00974376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6104443|NCT00974376|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6104444|NCT00974376|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6104445|NCT00974376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6203971|NCT02062905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5525115|NCT04284007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525116|NCT04284007|Anesthetics, Local|anesthetics, local|mesh-ancestor
5525117|NCT04284007|Anesthetics|anesthetics|mesh-ancestor
5525118|NCT04284007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5525119|NCT04284007|Sensory System Agents|sensory system agents|mesh-ancestor
5525120|NCT04283890|Nivolumab|nivolumab|mesh-list
5525121|NCT04283890|Ipilimumab|ipilimumab|mesh-list
5525122|NCT04283890|Melphalan|melphalan|mesh-list
5525123|NCT04283890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5525124|NCT04283890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5525125|NCT04283890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5525126|NCT04283890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525127|NCT04283890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5525128|NCT04283890|Alkylating Agents|alkylating agents|mesh-ancestor
5525129|NCT04283890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5525130|NCT04283890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5525131|NCT04283890|Immunologic Factors|immunologic factors|mesh-ancestor
5525132|NCT04283890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525133|NCT04283877|Methylphenidate|methylphenidate|mesh-list
5525134|NCT04283877|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5525135|NCT04283877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525136|NCT04283877|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5525137|NCT04283877|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5525138|NCT04283877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5525139|NCT04283877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525140|NCT04283877|Dopamine Agents|dopamine agents|mesh-ancestor
5525141|NCT04283877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5525142|NCT04283630|Ascorbic Acid|ascorbic acid|mesh-list
5525143|NCT04283630|Vitamins|vitamins|mesh-ancestor
6104446|NCT00974376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104447|NCT00974376|Antimanic Agents|antimanic agents|mesh-ancestor
6104448|NCT00974480|Tretinoin|tretinoin|mesh-list
6104449|NCT00974480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6104450|NCT00974480|Keratolytic Agents|keratolytic agents|mesh-ancestor
5525144|NCT04283630|Micronutrients|micronutrients|mesh-ancestor
5525145|NCT04283630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525146|NCT04283630|Antioxidants|antioxidants|mesh-ancestor
5525147|NCT04283630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525148|NCT04283630|Protective Agents|protective agents|mesh-ancestor
5525149|NCT04283604|Methylphenidate|methylphenidate|mesh-list
6104451|NCT00974480|Dermatologic Agents|dermatologic agents|mesh-ancestor
6104452|NCT00974493|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6104453|NCT00974493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5525150|NCT04283604|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5525151|NCT04283604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525152|NCT04283604|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5525153|NCT04283604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5525154|NCT04283604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5525155|NCT04283604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525156|NCT04283604|Dopamine Agents|dopamine agents|mesh-ancestor
5525157|NCT04283604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5525158|NCT04283487|Levan|levan|mesh-list
5525159|NCT04283487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5525160|NCT04283331|Proxymetacaine|proxymetacaine|mesh-list
5525161|NCT04283331|Propoxycaine|propoxycaine|mesh-list
5525162|NCT04283331|Anesthetics, Local|anesthetics, local|mesh-ancestor
6104454|NCT00974493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6104455|NCT00974493|Antitubercular Agents|antitubercular agents|mesh-ancestor
6104456|NCT00974675|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6104457|NCT00974675|Immunologic Factors|immunologic factors|mesh-ancestor
6104458|NCT00974675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104459|NCT00974818|Mitomycins|mitomycins|mesh-list
6104460|NCT00974818|Mitomycin|mitomycin|mesh-list
6104461|NCT00974818|BCG Vaccine|bcg vaccine|mesh-list
6104462|NCT00974818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6104463|NCT00974818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6104464|NCT00974818|Alkylating Agents|alkylating agents|mesh-ancestor
6104465|NCT00974818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104466|NCT00974818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6104467|NCT00974818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6104468|NCT00974818|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6104469|NCT00974818|Immunologic Factors|immunologic factors|mesh-ancestor
6104470|NCT00974818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104471|NCT00974974|Levodopa|levodopa|mesh-list
6104472|NCT00974974|Carbidopa|carbidopa|mesh-list
6104473|NCT00974974|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
6104474|NCT00974974|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6104475|NCT00974974|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5525163|NCT04283331|Anesthetics|anesthetics|mesh-ancestor
5525164|NCT04283331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5525165|NCT04283331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525166|NCT04283331|Sensory System Agents|sensory system agents|mesh-ancestor
5525167|NCT04283331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5525168|NCT04283435|Sildenafil Citrate|sildenafil citrate|mesh-list
5525169|NCT04283435|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6104476|NCT00974974|Dopamine Agents|dopamine agents|mesh-ancestor
6104477|NCT00974974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5525170|NCT04283435|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5525171|NCT04283435|Estradiol|estradiol|mesh-list
5525172|NCT04283435|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5525173|NCT04283435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525174|NCT04283435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525175|NCT04283435|Estrogens|estrogens|mesh-ancestor
6104478|NCT00974974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104479|NCT00974974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104480|NCT00974974|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6104481|NCT00974974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6104482|NCT00974974|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6104483|NCT00974974|Immunologic Factors|immunologic factors|mesh-ancestor
6104484|NCT00974974|Dopamine Agonists|dopamine agonists|mesh-ancestor
6104485|NCT00975000|Cinacalcet|cinacalcet|mesh-list
6104486|NCT00975000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5525176|NCT04283435|Hormones|hormones|mesh-ancestor
6104487|NCT00975000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104488|NCT00975000|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6104489|NCT00975000|Hormone Antagonists|hormone antagonists|mesh-ancestor
6104490|NCT00975000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6104491|NCT00975130|Golimumab|golimumab|mesh-list
6104492|NCT00975130|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6104493|NCT00975130|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6104494|NCT00975130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6104495|NCT00975130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6104496|NCT00975130|Immunologic Factors|immunologic factors|mesh-ancestor
6104497|NCT00975130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104498|NCT00975143|Isotretinoin|isotretinoin|mesh-list
6104499|NCT00975143|Dermatologic Agents|dermatologic agents|mesh-ancestor
6104500|NCT00975195|Fluticasone|fluticasone|mesh-list
6104501|NCT00975195|Xhance|xhance|mesh-list
6104502|NCT00975195|Tiotropium Bromide|tiotropium bromide|mesh-list
6104503|NCT00975195|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6104504|NCT00975195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6104505|NCT00975195|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6104506|NCT00975195|Autonomic Agents|autonomic agents|mesh-ancestor
6104507|NCT00975195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6104508|NCT00975195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104509|NCT00975195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6104510|NCT00975195|Respiratory System Agents|respiratory system agents|mesh-ancestor
5525177|NCT04283435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5525178|NCT04283435|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5525179|NCT04283435|Contraceptive Agents|contraceptive agents|mesh-ancestor
5525180|NCT04283435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5525181|NCT04283435|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5525182|NCT04283435|Vasodilator Agents|vasodilator agents|mesh-ancestor
5525183|NCT04283435|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5525184|NCT04283435|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5525185|NCT04283435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6104511|NCT00975195|Dermatologic Agents|dermatologic agents|mesh-ancestor
6104512|NCT00975195|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6104513|NCT00975195|Parasympatholytics|parasympatholytics|mesh-ancestor
6104514|NCT00975195|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6104515|NCT00975195|Cholinergic Agents|cholinergic agents|mesh-ancestor
5525186|NCT04283435|Urological Agents|urological agents|mesh-ancestor
5601230|NCT03706755|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5601231|NCT03706755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5601232|NCT03706755|Adrenergic Agents|adrenergic agents|mesh-ancestor
5601233|NCT03706755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5601234|NCT03706755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601235|NCT03706755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601236|NCT03706755|Sympathomimetics|sympathomimetics|mesh-ancestor
5601237|NCT03706755|Autonomic Agents|autonomic agents|mesh-ancestor
5601238|NCT03706755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5601239|NCT03706755|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5601240|NCT03706703|Carboplatin|carboplatin|mesh-list
6104516|NCT00975195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6104517|NCT00975195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104518|NCT00975195|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6104519|NCT00975195|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6104520|NCT00975195|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6104521|NCT00975195|Adrenergic Agents|adrenergic agents|mesh-ancestor
6104522|NCT00975221|Cinacalcet|cinacalcet|mesh-list
6104523|NCT00975221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6104524|NCT00975221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104525|NCT00975221|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6104526|NCT00975221|Hormone Antagonists|hormone antagonists|mesh-ancestor
6104527|NCT00975221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6104528|NCT00975286|Metformin|metformin|mesh-list
6104529|NCT00975286|Insulin Glargine|insulin glargine|mesh-list
6104530|NCT00975286|Lixisenatide|lixisenatide|mesh-list
6104531|NCT00975286|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
6104532|NCT00975286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6104533|NCT00975286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104534|NCT00975416|Oxytocin|oxytocin|mesh-list
6104535|NCT00975416|Oxytocics|oxytocics|mesh-ancestor
6104536|NCT00975416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6104537|NCT00975416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104538|NCT00975481|Alprazolam|alprazolam|mesh-list
6104539|NCT00975481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6104540|NCT00975481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6104541|NCT00975481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104542|NCT00975481|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6104543|NCT00975481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6104544|NCT00975481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6104545|NCT00975481|GABA Modulators|gaba modulators|mesh-ancestor
6104546|NCT00975481|GABA Agents|gaba agents|mesh-ancestor
6104547|NCT00975481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6104548|NCT00975481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104549|NCT00975637|Brodalumab|brodalumab|mesh-list
6104550|NCT00975637|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6104551|NCT00975637|Dermatologic Agents|dermatologic agents|mesh-ancestor
6104552|NCT00975637|Immunologic Factors|immunologic factors|mesh-ancestor
6104553|NCT00975637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104554|NCT00975650|Testosterone|testosterone|mesh-list
6104555|NCT00975650|Androgens|androgens|mesh-ancestor
6104556|NCT00975650|Hormones|hormones|mesh-ancestor
6104557|NCT00975650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6104558|NCT00975650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104559|NCT00975689|Acetylcysteine|acetylcysteine|mesh-list
6104560|NCT00975689|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6104561|NCT00975689|Antiviral Agents|antiviral agents|mesh-ancestor
6104562|NCT00975689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6104563|NCT00975689|Expectorants|expectorants|mesh-ancestor
6104564|NCT00975689|Respiratory System Agents|respiratory system agents|mesh-ancestor
6104565|NCT00975689|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6104566|NCT00975689|Antioxidants|antioxidants|mesh-ancestor
6104567|NCT00975689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104568|NCT00975689|Protective Agents|protective agents|mesh-ancestor
6104569|NCT00975689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104570|NCT00975689|Antidotes|antidotes|mesh-ancestor
6104571|NCT00975806|Lenalidomide|lenalidomide|mesh-list
6104572|NCT00975806|Sunitinib|sunitinib|mesh-list
6104573|NCT00975806|Immunologic Factors|immunologic factors|mesh-ancestor
6104574|NCT00975806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104575|NCT00975806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6104576|NCT00975806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6104577|NCT00975806|Growth Substances|growth substances|mesh-ancestor
6104578|NCT00975806|Growth Inhibitors|growth inhibitors|mesh-ancestor
6104579|NCT00975806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6104580|NCT00975806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6665857|NCT01519154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665858|NCT01519154|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6665859|NCT01519154|Anesthetics, General|anesthetics, general|mesh-ancestor
6665860|NCT01519154|Anesthetics|anesthetics|mesh-ancestor
6665861|NCT01519154|Analgesics|analgesics|mesh-ancestor
6104581|NCT00975806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6104582|NCT00975806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104583|NCT00975975|Basiliximab|basiliximab|mesh-list
6104584|NCT00975975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6104585|NCT00975975|Immunologic Factors|immunologic factors|mesh-ancestor
6104586|NCT00975975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104587|NCT00976027|Vaccines|vaccines|mesh-list
6104588|NCT00976027|Immunologic Factors|immunologic factors|mesh-ancestor
6104589|NCT00976027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104590|NCT00976183|Vorinostat|vorinostat|mesh-list
6104591|NCT00976183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6104592|NCT00976183|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6104593|NCT00976183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5525187|NCT04283292|Capsaicin|capsaicin|mesh-list
5525188|NCT04283292|Antipruritics|antipruritics|mesh-ancestor
5525189|NCT04283292|Dermatologic Agents|dermatologic agents|mesh-ancestor
5525190|NCT04283292|Sensory System Agents|sensory system agents|mesh-ancestor
6104594|NCT00976183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104595|NCT00976209|Phenylephrine|phenylephrine|mesh-list
6104596|NCT00976209|Oxymetazoline|oxymetazoline|mesh-list
6104597|NCT00976209|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6104598|NCT00976209|Mydriatics|mydriatics|mesh-ancestor
6104599|NCT00976209|Autonomic Agents|autonomic agents|mesh-ancestor
6104600|NCT00976209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6104601|NCT00976209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104602|NCT00976209|Sympathomimetics|sympathomimetics|mesh-ancestor
6104603|NCT00976209|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6104604|NCT00976209|Nasal Decongestants|nasal decongestants|mesh-ancestor
6104605|NCT00976209|Respiratory System Agents|respiratory system agents|mesh-ancestor
5525191|NCT04283292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6104606|NCT00976209|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5525192|NCT04283292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665862|NCT01519154|Sensory System Agents|sensory system agents|mesh-ancestor
6104607|NCT00976209|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6104608|NCT00976209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6104609|NCT00976209|Adrenergic Agents|adrenergic agents|mesh-ancestor
6104610|NCT00976209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5525193|NCT04283578|Oxytocin|oxytocin|mesh-list
5525194|NCT04283578|Oxytocics|oxytocics|mesh-ancestor
5525195|NCT04283578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6104611|NCT00976209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104612|NCT00976209|Protective Agents|protective agents|mesh-ancestor
6104613|NCT00976248|Everolimus|everolimus|mesh-list
6104614|NCT00976248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6104615|NCT00976248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6104616|NCT00976248|Immunologic Factors|immunologic factors|mesh-ancestor
6104617|NCT00976248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104618|NCT00976391|Insulin|insulin|mesh-list
6104619|NCT00976391|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6104620|NCT00976391|Insulin Glargine|insulin glargine|mesh-list
6104621|NCT00976391|Insulin Lispro|insulin lispro|mesh-list
5525196|NCT04283578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525197|NCT04283526|Decitabine|decitabine|mesh-list
5525198|NCT04283526|Spartalizumab|spartalizumab|mesh-list
5525199|NCT04283526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5525200|NCT04283526|Antimetabolites|antimetabolites|mesh-ancestor
5525201|NCT04283526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525202|NCT04283526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5525203|NCT04283526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5525204|NCT04283526|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5525205|NCT04283513|Ribavirin|ribavirin|mesh-list
5525206|NCT04283513|Antimetabolites|antimetabolites|mesh-ancestor
5525207|NCT04283513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525208|NCT04283513|Antiviral Agents|antiviral agents|mesh-ancestor
5525209|NCT04283513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5525210|NCT04283240|Sildenafil Citrate|sildenafil citrate|mesh-list
5525211|NCT04283240|Vasodilator Agents|vasodilator agents|mesh-ancestor
5525212|NCT04283240|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5525213|NCT04283240|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5525214|NCT04283240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5525215|NCT04283240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525216|NCT04283240|Urological Agents|urological agents|mesh-ancestor
5525217|NCT04282902|Pirfenidone|pirfenidone|mesh-list
5525218|NCT04282902|Analgesics|analgesics|mesh-ancestor
5525219|NCT04282902|Sensory System Agents|sensory system agents|mesh-ancestor
5525220|NCT04282902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5525221|NCT04282902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525222|NCT04282902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5525223|NCT04282902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5525224|NCT04282902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5525225|NCT04282902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5525226|NCT04282902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5525227|NCT04283162|Calcium, Dietary|calcium, dietary|mesh-list
5525228|NCT04283162|Calcium Dobesilate|calcium dobesilate|mesh-list
5525229|NCT04283162|Calcium|calcium|mesh-list
5525230|NCT04283162|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6104622|NCT00976391|rGLP-1 protein|rglp-1 protein|mesh-list
6104623|NCT00976391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6104624|NCT00976391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104625|NCT00976391|Incretins|incretins|mesh-ancestor
6104626|NCT00976391|Hormones|hormones|mesh-ancestor
6104627|NCT00976391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5525231|NCT04283162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525232|NCT04283162|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5525233|NCT04283162|Hemostatics|hemostatics|mesh-ancestor
5525234|NCT04283162|Coagulants|coagulants|mesh-ancestor
5525235|NCT04282824|Edetic Acid|edetic acid|mesh-list
5525236|NCT04282824|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5525237|NCT04282824|Chelating Agents|chelating agents|mesh-ancestor
6104628|NCT00976404|Raltegravir Potassium|raltegravir potassium|mesh-list
5525238|NCT04282824|Sequestering Agents|sequestering agents|mesh-ancestor
6104629|NCT00976404|Maraviroc|maraviroc|mesh-list
6104630|NCT00976404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6104631|NCT00976404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6104632|NCT00976404|Antiviral Agents|antiviral agents|mesh-ancestor
6104633|NCT00976404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6104634|NCT00976404|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6104635|NCT00976404|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6104636|NCT00976404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6104637|NCT00976404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104638|NCT00976404|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6104639|NCT00976404|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6104640|NCT00976404|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6104641|NCT00976456|Bevacizumab|bevacizumab|mesh-list
6104642|NCT00976456|Carboplatin|carboplatin|mesh-list
6104643|NCT00976456|Pemetrexed|pemetrexed|mesh-list
6104644|NCT00976456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6104645|NCT00976456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6104646|NCT00976456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6104647|NCT00976456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6104648|NCT00976456|Growth Substances|growth substances|mesh-ancestor
6104649|NCT00976456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104650|NCT00976456|Growth Inhibitors|growth inhibitors|mesh-ancestor
6104651|NCT00976456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6104652|NCT00976456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525239|NCT04282824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525240|NCT04282824|Anticoagulants|anticoagulants|mesh-ancestor
5525241|NCT04282824|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5525242|NCT04282824|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5525243|NCT04283058|Ketamine|ketamine|mesh-list
5525244|NCT04283058|Anesthetics|anesthetics|mesh-list
5525245|NCT04283058|Analgesics|analgesics|mesh-ancestor
5525246|NCT04283058|Sensory System Agents|sensory system agents|mesh-ancestor
5525247|NCT04283058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5525248|NCT04283058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525249|NCT04283058|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5525250|NCT04283058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5525251|NCT04283058|Anesthetics, General|anesthetics, general|mesh-ancestor
5525252|NCT04283058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5525253|NCT04283058|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5525254|NCT04283058|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5525255|NCT04283058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5525256|NCT04283058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525257|NCT04282954|Esomeprazole|esomeprazole|mesh-list
5525258|NCT04282954|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5525259|NCT04282954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5525260|NCT04282954|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6104653|NCT00976456|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6104654|NCT00976456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6104655|NCT00976495|Dapagliflozin|dapagliflozin|mesh-list
6104656|NCT00976495|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6104657|NCT00976495|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6104658|NCT00976495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104659|NCT00976495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6104660|NCT00976495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104661|NCT00976495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6104662|NCT00976495|Diuretics|diuretics|mesh-ancestor
6104663|NCT00976495|Natriuretic Agents|natriuretic agents|mesh-ancestor
6104664|NCT00976495|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6104665|NCT00976495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6104666|NCT00976521|Abciximab|abciximab|mesh-list
6104667|NCT00976521|Anticoagulants|anticoagulants|mesh-ancestor
6104668|NCT00976521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6104669|NCT00976573|Paclitaxel|paclitaxel|mesh-list
6104670|NCT00976573|Bevacizumab|bevacizumab|mesh-list
6104671|NCT00976573|Carboplatin|carboplatin|mesh-list
5525261|NCT04282954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5525262|NCT04282954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525263|NCT04282941|Ibuprofen|ibuprofen|mesh-list
5525264|NCT04282941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5525265|NCT04282941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5525266|NCT04282941|Analgesics|analgesics|mesh-ancestor
5525267|NCT04282941|Sensory System Agents|sensory system agents|mesh-ancestor
5525268|NCT04282941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6104672|NCT00976573|Everolimus|everolimus|mesh-list
6104673|NCT00976573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5525269|NCT04282941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525270|NCT04282941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5525271|NCT04282941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5525272|NCT04282941|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5525273|NCT04282941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6104674|NCT00976573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6104675|NCT00976573|Tubulin Modulators|tubulin modulators|mesh-ancestor
6104676|NCT00976573|Antimitotic Agents|antimitotic agents|mesh-ancestor
6104677|NCT00976573|Mitosis Modulators|mitosis modulators|mesh-ancestor
6104678|NCT00976573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104679|NCT00976573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6104680|NCT00976573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6104681|NCT00976573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6104682|NCT00976573|Growth Substances|growth substances|mesh-ancestor
6104683|NCT00976573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104684|NCT00976573|Growth Inhibitors|growth inhibitors|mesh-ancestor
6104685|NCT00976573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6104686|NCT00976573|Immunologic Factors|immunologic factors|mesh-ancestor
6104687|NCT00976599|Methotrexate|methotrexate|mesh-list
6104688|NCT00976599|Tofacitinib|tofacitinib|mesh-list
6104689|NCT00976599|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6104690|NCT00976599|Abortifacient Agents|abortifacient agents|mesh-ancestor
6104691|NCT00976599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6104692|NCT00976599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104693|NCT00976599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6104694|NCT00976599|Antimetabolites|antimetabolites|mesh-ancestor
6104695|NCT00976599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104696|NCT00976599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6104697|NCT00976599|Dermatologic Agents|dermatologic agents|mesh-ancestor
6104698|NCT00976599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6104699|NCT00976599|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6104700|NCT00976599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6104701|NCT00976599|Immunologic Factors|immunologic factors|mesh-ancestor
6104702|NCT00976599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6104703|NCT00976599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6104704|NCT00976599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6104705|NCT00976677|Paclitaxel|paclitaxel|mesh-list
6104706|NCT00976677|Bevacizumab|bevacizumab|mesh-list
6104707|NCT00976677|Carboplatin|carboplatin|mesh-list
6104708|NCT00976677|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6104709|NCT00976677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6104710|NCT00976677|Antibodies|antibodies|mesh-list
6104711|NCT00976677|Immunoglobulins|immunoglobulins|mesh-list
6104712|NCT00976677|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6104713|NCT00976677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6104714|NCT00976677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6104715|NCT00976677|Tubulin Modulators|tubulin modulators|mesh-ancestor
6104716|NCT00976677|Antimitotic Agents|antimitotic agents|mesh-ancestor
6104717|NCT00976677|Mitosis Modulators|mitosis modulators|mesh-ancestor
5525274|NCT04282941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525275|NCT04283110|Midazolam|midazolam|mesh-list
5525276|NCT04283110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5525277|NCT04283110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5525278|NCT04283110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5525279|NCT04283110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525280|NCT04283110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5525281|NCT04283110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6104718|NCT00976677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104719|NCT00976677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6104720|NCT00976677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6104721|NCT00976677|Growth Substances|growth substances|mesh-ancestor
6104722|NCT00976677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104723|NCT00976677|Growth Inhibitors|growth inhibitors|mesh-ancestor
6104724|NCT00976677|Immunologic Factors|immunologic factors|mesh-ancestor
6104725|NCT00976677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6104726|NCT00976677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6104727|NCT00976716|Celecoxib|celecoxib|mesh-list
6104728|NCT00976716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6104729|NCT00976716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6104730|NCT00976716|Analgesics|analgesics|mesh-ancestor
6104731|NCT00976716|Sensory System Agents|sensory system agents|mesh-ancestor
6104732|NCT00976716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6104733|NCT00976716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104734|NCT00976716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6104735|NCT00976716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6104736|NCT00976716|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6104737|NCT00976716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6104738|NCT00976716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6104739|NCT00976716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104740|NCT00976911|Paclitaxel|paclitaxel|mesh-list
6104741|NCT00976911|Bevacizumab|bevacizumab|mesh-list
6104742|NCT00976911|Doxorubicin|doxorubicin|mesh-list
6104743|NCT00976911|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6104744|NCT00976911|Topotecan|topotecan|mesh-list
6104745|NCT00976911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6104746|NCT00976911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6104747|NCT00976911|Tubulin Modulators|tubulin modulators|mesh-ancestor
6104748|NCT00976911|Antimitotic Agents|antimitotic agents|mesh-ancestor
6104749|NCT00976911|Mitosis Modulators|mitosis modulators|mesh-ancestor
6104750|NCT00976911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104751|NCT00976911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6104752|NCT00976911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6104753|NCT00976911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6104754|NCT00976911|Growth Substances|growth substances|mesh-ancestor
6104755|NCT00976911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104756|NCT00976911|Growth Inhibitors|growth inhibitors|mesh-ancestor
6104757|NCT00976911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6104758|NCT00976911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6104759|NCT00976911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6104760|NCT00976911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6104761|NCT00976911|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6104762|NCT00976937|Metformin|metformin|mesh-list
6104763|NCT00976937|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6104764|NCT00976937|Lixisenatide|lixisenatide|mesh-list
6104765|NCT00976937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6104766|NCT00976937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104767|NCT00976937|Incretins|incretins|mesh-ancestor
6665863|NCT01519154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6665864|NCT01519154|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6665865|NCT01519154|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6665866|NCT01519154|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6665867|NCT01519154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6665868|NCT01519154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672410|NCT01555879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672411|NCT01555879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6672412|NCT01555879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6672413|NCT01555879|Immunologic Factors|immunologic factors|mesh-ancestor
6672414|NCT01555879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104768|NCT00976937|Hormones|hormones|mesh-ancestor
6104769|NCT00976937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6104770|NCT00976937|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5525282|NCT04283110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5525283|NCT04283110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5525284|NCT04283110|Anesthetics, General|anesthetics, general|mesh-ancestor
5525285|NCT04283110|Anesthetics|anesthetics|mesh-ancestor
5525286|NCT04283110|GABA Modulators|gaba modulators|mesh-ancestor
5525287|NCT04283110|GABA Agents|gaba agents|mesh-ancestor
5525288|NCT04283110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5525289|NCT04283110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525290|NCT04282785|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5525291|NCT04282785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5525292|NCT04282746|Ketamine|ketamine|mesh-list
5525293|NCT04282746|Analgesics|analgesics|mesh-ancestor
5525294|NCT04282746|Sensory System Agents|sensory system agents|mesh-ancestor
5525295|NCT04282746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5525296|NCT04282746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601241|NCT03706703|Docetaxel|docetaxel|mesh-list
6104771|NCT00976937|Protease Inhibitors|protease inhibitors|mesh-ancestor
6104772|NCT00976937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6104773|NCT00976937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104774|NCT00976950|Ritonavir|ritonavir|mesh-list
6104775|NCT00976950|Tipranavir|tipranavir|mesh-list
6104776|NCT00976950|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6104777|NCT00976950|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6104778|NCT00976950|Protease Inhibitors|protease inhibitors|mesh-ancestor
6104779|NCT00976950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6104780|NCT00976950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104781|NCT00976950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6104782|NCT00976950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6104783|NCT00976950|Antiviral Agents|antiviral agents|mesh-ancestor
6104784|NCT00976950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6104785|NCT00976950|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6104786|NCT00976950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6104787|NCT00976989|Docetaxel|docetaxel|mesh-list
6104788|NCT00976989|Trastuzumab|trastuzumab|mesh-list
6104789|NCT00976989|Pertuzumab|pertuzumab|mesh-list
6104790|NCT00976989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6104791|NCT00976989|Tubulin Modulators|tubulin modulators|mesh-ancestor
6104792|NCT00976989|Antimitotic Agents|antimitotic agents|mesh-ancestor
6104793|NCT00976989|Mitosis Modulators|mitosis modulators|mesh-ancestor
6104794|NCT00976989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104795|NCT00976989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6104796|NCT00977080|Cinacalcet|cinacalcet|mesh-list
6104797|NCT00977080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6104798|NCT00977080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104799|NCT00977080|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6104800|NCT00977080|Hormone Antagonists|hormone antagonists|mesh-ancestor
6104801|NCT00977080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6104802|NCT00977171|Droxidopa|droxidopa|mesh-list
6104803|NCT00977171|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6104804|NCT00977171|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6104805|NCT00977197|Pregabalin|pregabalin|mesh-list
6104806|NCT00977197|Analgesics|analgesics|mesh-ancestor
6104807|NCT00977197|Sensory System Agents|sensory system agents|mesh-ancestor
6104808|NCT00977197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6104809|NCT00977197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104810|NCT00977197|Anticonvulsants|anticonvulsants|mesh-ancestor
6104811|NCT00977197|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6104812|NCT00977197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6104813|NCT00977197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104814|NCT00977197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6104815|NCT00977197|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6104816|NCT00977197|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6104817|NCT00977197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6104818|NCT00977197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6104819|NCT00977379|Capecitabine|capecitabine|mesh-list
6104820|NCT00977379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6104821|NCT00977379|Antimetabolites|antimetabolites|mesh-ancestor
5525297|NCT04282746|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5525298|NCT04282746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5525299|NCT04282746|Anesthetics, General|anesthetics, general|mesh-ancestor
5525300|NCT04282746|Anesthetics|anesthetics|mesh-ancestor
5525301|NCT04282746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5525302|NCT04282746|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5525303|NCT04282746|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5525304|NCT04282746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5525305|NCT04282746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525306|NCT04282291|Morphine|morphine|mesh-list
5525307|NCT04282291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5525308|NCT04282291|Narcotics|narcotics|mesh-ancestor
5525309|NCT04282291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5525310|NCT04282291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104822|NCT00977379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104823|NCT00977379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6465190|NCT00472927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6465191|NCT00472927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465192|NCT00472953|Insulin|insulin|mesh-list
6465193|NCT00472953|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6465194|NCT00472953|Insulin Aspart|insulin aspart|mesh-list
6465195|NCT00472953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5525311|NCT04282291|Analgesics|analgesics|mesh-ancestor
6465196|NCT00472953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525312|NCT04282291|Sensory System Agents|sensory system agents|mesh-ancestor
5525313|NCT04282291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5525314|NCT04282200|Ketorolac|ketorolac|mesh-list
6465197|NCT00472966|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
6465198|NCT00472966|Tretinoin|tretinoin|mesh-list
6465199|NCT00472966|Glycolic acid|glycolic acid|mesh-list
6465200|NCT00472966|Hydroquinone|hydroquinone|mesh-list
6465201|NCT00472966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6465202|NCT00472966|Keratolytic Agents|keratolytic agents|mesh-ancestor
6465203|NCT00472966|Dermatologic Agents|dermatologic agents|mesh-ancestor
6104824|NCT00977431|Temozolomide|temozolomide|mesh-list
6104825|NCT00977431|Afatinib|afatinib|mesh-list
6104826|NCT00977431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6104827|NCT00977431|Alkylating Agents|alkylating agents|mesh-ancestor
6104828|NCT00977431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104829|NCT00977431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6104830|NCT00977431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6104831|NCT00977431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6104832|NCT00977470|Hydroxychloroquine|hydroxychloroquine|mesh-list
6104833|NCT00977470|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6104834|NCT00977470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6104835|NCT00977470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6104836|NCT00977470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6104837|NCT00977470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104838|NCT00977470|Antimalarials|antimalarials|mesh-ancestor
6104839|NCT00977470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6104840|NCT00977470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6104841|NCT00977470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5525315|NCT04282200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5525316|NCT04282200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5525317|NCT04282200|Analgesics|analgesics|mesh-ancestor
5525318|NCT04282200|Sensory System Agents|sensory system agents|mesh-ancestor
5525319|NCT04282200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5525320|NCT04282200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525321|NCT04282200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5525322|NCT04282200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5525323|NCT04282200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5525324|NCT04282200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5525325|NCT04282200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104842|NCT00977470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6104843|NCT00977548|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6104844|NCT00977548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6104845|NCT00977548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6104846|NCT00977548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6104847|NCT00977548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104848|NCT00977561|Cisplatin|cisplatin|mesh-list
6104849|NCT00977561|Carboplatin|carboplatin|mesh-list
6104850|NCT00977561|Etoposide|etoposide|mesh-list
6104851|NCT00977561|Etoposide phosphate|etoposide phosphate|mesh-list
6104852|NCT00977561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6104853|NCT00977561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6104854|NCT00977561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6104855|NCT00977561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6104856|NCT00977561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6104857|NCT00977561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465204|NCT00472966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6465205|NCT00472966|Glucocorticoids|glucocorticoids|mesh-ancestor
5601242|NCT03706703|Pemetrexed|pemetrexed|mesh-list
6104858|NCT00977665|Rasagiline|rasagiline|mesh-list
5525335|NCT04282629|Milrinone|milrinone|mesh-list
5525336|NCT04282629|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5525337|NCT04282629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6104859|NCT00977665|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6104860|NCT00977665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6104861|NCT00977665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104862|NCT00977665|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6104863|NCT00977665|Protective Agents|protective agents|mesh-ancestor
6104864|NCT00977665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104865|NCT00977691|Sirolimus|sirolimus|mesh-list
6104866|NCT00977691|Cyclophosphamide|cyclophosphamide|mesh-list
6104867|NCT00977691|Alemtuzumab|alemtuzumab|mesh-list
6104868|NCT00977691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5525338|NCT04282629|Vasodilator Agents|vasodilator agents|mesh-ancestor
5525339|NCT04282629|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5525340|NCT04282629|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5525341|NCT04282629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5525342|NCT04282629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525343|NCT04282629|Protective Agents|protective agents|mesh-ancestor
5525344|NCT04282629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525345|NCT04282096|Caseins|caseins|mesh-list
5525346|NCT04282096|Chelating Agents|chelating agents|mesh-ancestor
5525347|NCT04282096|Sequestering Agents|sequestering agents|mesh-ancestor
6465206|NCT00472966|Hormones|hormones|mesh-ancestor
6465207|NCT00472966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6465208|NCT00472966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465209|NCT00472966|Antioxidants|antioxidants|mesh-ancestor
6465210|NCT00472966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465211|NCT00472966|Protective Agents|protective agents|mesh-ancestor
6465212|NCT00472966|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6465213|NCT00473005|Capecitabine|capecitabine|mesh-list
6465214|NCT00473005|Everolimus|everolimus|mesh-list
6465215|NCT00473005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6465216|NCT00473005|Antimetabolites|antimetabolites|mesh-ancestor
6465217|NCT00473005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104869|NCT00977691|Immunologic Factors|immunologic factors|mesh-ancestor
6104870|NCT00977691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104871|NCT00977691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6104872|NCT00977691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6104873|NCT00977691|Alkylating Agents|alkylating agents|mesh-ancestor
6104874|NCT00977691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104875|NCT00977691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6104876|NCT00977691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6104877|NCT00977691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6104878|NCT00977691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6104879|NCT00977691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6104880|NCT00977691|Antifungal Agents|antifungal agents|mesh-ancestor
6104881|NCT00977691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6104882|NCT00977769|Oxytocin|oxytocin|mesh-list
6104883|NCT00977769|Carbetocin|carbetocin|mesh-list
6104884|NCT00977769|Oxytocics|oxytocics|mesh-ancestor
6104885|NCT00977769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6104886|NCT00977769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104887|NCT00977938|Aspirin|aspirin|mesh-list
6104888|NCT00977938|Clopidogrel|clopidogrel|mesh-list
6104889|NCT00977938|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6104890|NCT00977938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6104891|NCT00977938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6104892|NCT00977938|Analgesics|analgesics|mesh-ancestor
6104893|NCT00977938|Sensory System Agents|sensory system agents|mesh-ancestor
6104894|NCT00977938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6104895|NCT00977938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104896|NCT00977938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6104897|NCT00977938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6104898|NCT00977938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6104899|NCT00977938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6104900|NCT00977938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465218|NCT00473005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5601243|NCT03706703|Endostar protein|endostar protein|mesh-list
6104901|NCT00977938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6104902|NCT00977938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6104903|NCT00977938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6104904|NCT00977938|Antipyretics|antipyretics|mesh-ancestor
6104905|NCT00977938|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5525348|NCT04282096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525349|NCT04282174|Cyclophosphamide|cyclophosphamide|mesh-list
5525350|NCT04282174|Melphalan|melphalan|mesh-list
5525351|NCT04282174|Busulfan|busulfan|mesh-list
5525352|NCT04282174|Thiotepa|thiotepa|mesh-list
5525353|NCT04282174|Fludarabine|fludarabine|mesh-list
5525354|NCT04282174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5525355|NCT04282174|Immunologic Factors|immunologic factors|mesh-ancestor
5525356|NCT04282174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525357|NCT04282174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5525358|NCT04282174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6104906|NCT00977938|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6104907|NCT00977938|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6104908|NCT00977938|Purinergic Agents|purinergic agents|mesh-ancestor
6104909|NCT00977938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6104910|NCT00978068|Ritonavir|ritonavir|mesh-list
6104911|NCT00978068|Lopinavir|lopinavir|mesh-list
6104912|NCT00978068|Nevirapine|nevirapine|mesh-list
6104913|NCT00978068|Efavirenz|efavirenz|mesh-list
6104914|NCT00978068|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
6104915|NCT00978068|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6104916|NCT00978068|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6104917|NCT00978068|Protease Inhibitors|protease inhibitors|mesh-ancestor
6104918|NCT00978068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6104919|NCT00978068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104920|NCT00978068|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6104921|NCT00978068|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6104922|NCT00978068|Antiviral Agents|antiviral agents|mesh-ancestor
6104923|NCT00978068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6104924|NCT00978068|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6104925|NCT00978068|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6104926|NCT00978068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6104927|NCT00978068|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6104928|NCT00978068|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6104929|NCT00978068|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6104930|NCT00978068|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6104931|NCT00978068|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6104932|NCT00978120|Vaccines|vaccines|mesh-list
6104933|NCT00978120|Immunologic Factors|immunologic factors|mesh-ancestor
6104934|NCT00978120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104935|NCT00978250|Tetrahydrouridine|tetrahydrouridine|mesh-list
6104936|NCT00978250|Antimetabolites|antimetabolites|mesh-ancestor
6104937|NCT00978250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104938|NCT00978341|Pregabalin|pregabalin|mesh-list
6104939|NCT00978341|Analgesics|analgesics|mesh-ancestor
6104940|NCT00978341|Sensory System Agents|sensory system agents|mesh-ancestor
6104941|NCT00978341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6104942|NCT00978341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104943|NCT00978341|Anticonvulsants|anticonvulsants|mesh-ancestor
6104944|NCT00978341|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6104945|NCT00978341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6104946|NCT00978341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104947|NCT00978341|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6104948|NCT00978341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6104949|NCT00978341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6104950|NCT00978341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6104951|NCT00978341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6465219|NCT00473005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5525359|NCT04282174|Alkylating Agents|alkylating agents|mesh-ancestor
5525360|NCT04282174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525361|NCT04282174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5525362|NCT04282174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5525363|NCT04281862|Prednisolone|prednisolone|mesh-list
5525364|NCT04281862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5525365|NCT04281862|Glucocorticoids|glucocorticoids|mesh-ancestor
5525366|NCT04281862|Hormones|hormones|mesh-ancestor
5601244|NCT03706703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6104952|NCT00978432|Everolimus|everolimus|mesh-list
6104953|NCT00978432|Panobinostat|panobinostat|mesh-list
6104954|NCT00978432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6104955|NCT00978432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6104956|NCT00978432|Immunologic Factors|immunologic factors|mesh-ancestor
6104957|NCT00978432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104958|NCT00978432|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6104959|NCT00978432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6104960|NCT00978432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104961|NCT00978562|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
6104962|NCT00978562|Hematinics|hematinics|mesh-ancestor
6104963|NCT00978562|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6104964|NCT00978562|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6203972|NCT02062905|Antiemetics|antiemetics|mesh-ancestor
6203973|NCT02062905|Autonomic Agents|autonomic agents|mesh-ancestor
6203974|NCT02062905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6203975|NCT02062905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203976|NCT02062905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6203977|NCT02062905|Glucocorticoids|glucocorticoids|mesh-ancestor
6203978|NCT02062905|Hormones|hormones|mesh-ancestor
6203979|NCT02062905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6203980|NCT02062905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6203981|NCT02062905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6203982|NCT02063035|Tranexamic Acid|tranexamic acid|mesh-list
6203983|NCT02063035|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6203984|NCT02063035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6203985|NCT02063035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6203986|NCT02063035|Hemostatics|hemostatics|mesh-ancestor
6203987|NCT02063035|Coagulants|coagulants|mesh-ancestor
6203988|NCT02063217|Sodium Oxybate|sodium oxybate|mesh-list
6203989|NCT02063217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6203990|NCT02063217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6203991|NCT02063217|Anesthetics, General|anesthetics, general|mesh-ancestor
6203992|NCT02063217|Anesthetics|anesthetics|mesh-ancestor
6203993|NCT02063217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6203994|NCT02063217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6203995|NCT02063698|Auranofin|auranofin|mesh-list
6203996|NCT02063698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6203997|NCT02063854|Risedronic Acid|risedronic acid|mesh-list
6203998|NCT02063854|Etidronic Acid|etidronic acid|mesh-list
6203999|NCT02063854|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6204000|NCT02063854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6204001|NCT02063854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204002|NCT02063854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6204003|NCT02063854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204004|NCT02063854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6204005|NCT02064166|Insulin|insulin|mesh-list
6204006|NCT02064166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6204007|NCT02064166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204008|NCT02064439|Rivaroxaban|rivaroxaban|mesh-list
6204009|NCT02064439|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6204010|NCT02064439|Antithrombins|antithrombins|mesh-ancestor
6204011|NCT02064439|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6204012|NCT02064439|Protease Inhibitors|protease inhibitors|mesh-ancestor
6204013|NCT02064439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6204014|NCT02064439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204015|NCT02064439|Anticoagulants|anticoagulants|mesh-ancestor
6204016|NCT02064582|Leuprolide|leuprolide|mesh-list
6204017|NCT02064582|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6204018|NCT02064582|Fertility Agents|fertility agents|mesh-ancestor
6204019|NCT02064582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6204020|NCT02064582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204021|NCT02064582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6204022|NCT02064582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6204023|NCT02064816|Interferon beta-1a|interferon beta-1a|mesh-list
6204024|NCT02064816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6665869|NCT01519297|Irbesartan|irbesartan|mesh-list
6665870|NCT01519297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6665871|NCT01519297|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6665872|NCT01519297|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6665873|NCT01519297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204025|NCT02064816|Immunologic Factors|immunologic factors|mesh-ancestor
6465220|NCT00473005|Immunologic Factors|immunologic factors|mesh-ancestor
6665874|NCT01519310|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5525367|NCT04281862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5525368|NCT04281862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204026|NCT02064816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465221|NCT00473005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665875|NCT01519310|Metronidazole|metronidazole|mesh-list
6104965|NCT00978627|Insulin|insulin|mesh-list
5525369|NCT04281862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5525370|NCT04281862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5525371|NCT04282031|Letrozole|letrozole|mesh-list
5525372|NCT04282031|Fulvestrant|fulvestrant|mesh-list
5525373|NCT04282031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5525374|NCT04282031|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5525375|NCT04282031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5525376|NCT04282031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5525377|NCT04282031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525378|NCT04282031|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5525379|NCT04282031|Hormone Antagonists|hormone antagonists|mesh-ancestor
5525380|NCT04282031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6104966|NCT00978627|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6104967|NCT00978627|Insulin Aspart|insulin aspart|mesh-list
6104968|NCT00978627|Insulin, Long-Acting|insulin, long-acting|mesh-list
6104969|NCT00978627|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6104970|NCT00978627|Insulin Detemir|insulin detemir|mesh-list
6104971|NCT00978627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6104972|NCT00978627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104973|NCT00978731|Dasatinib|dasatinib|mesh-list
6104974|NCT00978731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6104975|NCT00978731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6104976|NCT00978731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6104977|NCT00978731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104978|NCT00978757|Ketamine|ketamine|mesh-list
6104979|NCT00978757|Analgesics|analgesics|mesh-ancestor
6104980|NCT00978757|Sensory System Agents|sensory system agents|mesh-ancestor
6104981|NCT00978757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6104982|NCT00978757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104983|NCT00978757|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6104984|NCT00978757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6104985|NCT00978757|Anesthetics, General|anesthetics, general|mesh-ancestor
6104986|NCT00978757|Anesthetics|anesthetics|mesh-ancestor
6104987|NCT00978757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6104988|NCT00978757|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6104989|NCT00978757|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6488420|NCT00584090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601245|NCT03706703|Tubulin Modulators|tubulin modulators|mesh-ancestor
5525381|NCT04282031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525382|NCT04282031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5525383|NCT04282031|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5601246|NCT03706703|Antimitotic Agents|antimitotic agents|mesh-ancestor
5601247|NCT03706703|Mitosis Modulators|mitosis modulators|mesh-ancestor
5601248|NCT03706703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601249|NCT03706703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5601250|NCT03706703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5601251|NCT03706703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5601252|NCT03706703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5601253|NCT03706703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5601254|NCT03706703|Growth Substances|growth substances|mesh-ancestor
5601255|NCT03706703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6104990|NCT00978757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6104991|NCT00978757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6104992|NCT00979017|Bevacizumab|bevacizumab|mesh-list
6104993|NCT00979017|Irinotecan|irinotecan|mesh-list
6104994|NCT00979017|Temozolomide|temozolomide|mesh-list
6104995|NCT00979017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6104996|NCT00979017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6104997|NCT00979017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6104998|NCT00979017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6104999|NCT00979017|Growth Substances|growth substances|mesh-ancestor
6105000|NCT00979017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105001|NCT00979017|Growth Inhibitors|growth inhibitors|mesh-ancestor
6105002|NCT00979017|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6105003|NCT00979017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6105004|NCT00979017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6105005|NCT00979017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601256|NCT03706703|Growth Inhibitors|growth inhibitors|mesh-ancestor
5601257|NCT03706547|Cyclophosphamide|cyclophosphamide|mesh-list
5601258|NCT03706547|Fludarabine|fludarabine|mesh-list
5601259|NCT03706547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5601260|NCT03706547|Immunologic Factors|immunologic factors|mesh-ancestor
5601261|NCT03706547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601262|NCT03706547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5601263|NCT03706547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5601264|NCT03706547|Alkylating Agents|alkylating agents|mesh-ancestor
5601265|NCT03706547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601266|NCT03706547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6105006|NCT00979017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6105007|NCT00979017|Alkylating Agents|alkylating agents|mesh-ancestor
6105008|NCT00979121|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6105009|NCT00979121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6105010|NCT00979121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6105011|NCT00979121|Antimetabolites|antimetabolites|mesh-ancestor
6105012|NCT00979121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105013|NCT00979121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6105014|NCT00979121|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6105015|NCT00979121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6105016|NCT00979212|Paclitaxel|paclitaxel|mesh-list
6105017|NCT00979212|Carboplatin|carboplatin|mesh-list
6105018|NCT00979212|Panitumumab|panitumumab|mesh-list
6105019|NCT00979212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6105020|NCT00979212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6105021|NCT00979212|Tubulin Modulators|tubulin modulators|mesh-ancestor
6105022|NCT00979212|Antimitotic Agents|antimitotic agents|mesh-ancestor
6105023|NCT00979212|Mitosis Modulators|mitosis modulators|mesh-ancestor
6105024|NCT00979212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105025|NCT00979212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6105026|NCT00979407|Vaccines|vaccines|mesh-list
6105027|NCT00979407|Immunologic Factors|immunologic factors|mesh-ancestor
6488421|NCT00584090|Urological Agents|urological agents|mesh-ancestor
6105028|NCT00979407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105029|NCT00979576|Pemetrexed|pemetrexed|mesh-list
6105030|NCT00979576|Nintedanib|nintedanib|mesh-list
6105031|NCT00979576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6105032|NCT00979576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6105033|NCT00979576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105034|NCT00979576|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6105035|NCT00979576|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6105036|NCT00979576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6105037|NCT00979615|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
6105038|NCT00979615|Azelastine|azelastine|mesh-list
6105039|NCT00979615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6105040|NCT00979615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6105041|NCT00979615|Analgesics|analgesics|mesh-ancestor
6105042|NCT00979615|Sensory System Agents|sensory system agents|mesh-ancestor
6105043|NCT00979615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6105044|NCT00979615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105045|NCT00979615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6105046|NCT00979615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6105047|NCT00979615|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6105048|NCT00979615|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6105049|NCT00979615|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6105050|NCT00979615|Histamine Antagonists|histamine antagonists|mesh-ancestor
6105051|NCT00979615|Histamine Agents|histamine agents|mesh-ancestor
6105052|NCT00979615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6105053|NCT00979615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105054|NCT00979615|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6105055|NCT00979615|Autonomic Agents|autonomic agents|mesh-ancestor
6105056|NCT00979615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6105057|NCT00979615|Respiratory System Agents|respiratory system agents|mesh-ancestor
6105058|NCT00979615|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
5525384|NCT04281745|Botulinum Toxins|botulinum toxins|mesh-list
5525385|NCT04281745|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5525386|NCT04281745|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5525387|NCT04281745|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5525388|NCT04281745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5525389|NCT04281745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525390|NCT04281745|Cholinergic Agents|cholinergic agents|mesh-ancestor
5525391|NCT04281745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5525392|NCT04281745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525393|NCT04281745|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5525394|NCT04281745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5525395|NCT04281576|Capecitabine|capecitabine|mesh-list
5525396|NCT04281576|Oxaliplatin|oxaliplatin|mesh-list
5525397|NCT04281576|Trastuzumab|trastuzumab|mesh-list
5525398|NCT04281576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5525399|NCT04281576|Antimetabolites|antimetabolites|mesh-ancestor
5525400|NCT04281576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525401|NCT04281576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5525402|NCT04281576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5525403|NCT04281706|Propofol|propofol|mesh-list
5525404|NCT04281706|Etomidate|etomidate|mesh-list
5525405|NCT04281706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5525406|NCT04281706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5525407|NCT04281706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525408|NCT04281706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5525409|NCT04281706|Anesthetics, General|anesthetics, general|mesh-ancestor
5525410|NCT04281706|Anesthetics|anesthetics|mesh-ancestor
5525411|NCT04281628|Ketamine|ketamine|mesh-list
5525412|NCT04281628|Analgesics|analgesics|mesh-ancestor
5525413|NCT04281628|Sensory System Agents|sensory system agents|mesh-ancestor
5525414|NCT04281628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5525415|NCT04281628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525416|NCT04281628|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6105059|NCT00979615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6105060|NCT00979628|Insulin|insulin|mesh-list
6105061|NCT00979628|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6105062|NCT00979628|Insulin Glargine|insulin glargine|mesh-list
6105063|NCT00979628|Insulin glulisine|insulin glulisine|mesh-list
6105064|NCT00979628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6105065|NCT00979628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105066|NCT00979654|Sifalimumab|sifalimumab|mesh-list
6105067|NCT00979654|Immunologic Factors|immunologic factors|mesh-ancestor
5525417|NCT04281628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5525418|NCT04281628|Anesthetics, General|anesthetics, general|mesh-ancestor
6488422|NCT00584155|Ofloxacin|ofloxacin|mesh-list
5525419|NCT04281628|Anesthetics|anesthetics|mesh-ancestor
5525420|NCT04281628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5525421|NCT04281628|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5525422|NCT04281628|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5525423|NCT04281628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5525424|NCT04281628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525425|NCT04281667|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5525426|NCT04281667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5525427|NCT04281680|Octreotide|octreotide|mesh-list
5525428|NCT04281680|Pasireotide|pasireotide|mesh-list
5525429|NCT04281680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5525430|NCT04281680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5525431|NCT04281680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5525432|NCT04281680|Hormones|hormones|mesh-ancestor
5525433|NCT04281680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6105068|NCT00979654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105069|NCT00979732|Grape Seed Extract|grape seed extract|mesh-list
6105070|NCT00979732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6105071|NCT00979732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6105072|NCT00979732|Antioxidants|antioxidants|mesh-ancestor
6105073|NCT00979732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105074|NCT00979732|Protective Agents|protective agents|mesh-ancestor
6105075|NCT00979732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525434|NCT04281680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525435|NCT04281290|Bleomycin|bleomycin|mesh-list
5525436|NCT04281290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5525437|NCT04281290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5525438|NCT04281342|Moxifloxacin|moxifloxacin|mesh-list
5525439|NCT04281342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5525440|NCT04281342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5525441|NCT04281342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5525442|NCT04281342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5525443|NCT04281342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6105076|NCT00979745|Afamelanotide|afamelanotide|mesh-list
6105077|NCT00979745|Dermatologic Agents|dermatologic agents|mesh-ancestor
6105078|NCT00979875|Insulin|insulin|mesh-list
6105079|NCT00979875|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6105080|NCT00979875|Insulin Aspart|insulin aspart|mesh-list
6105081|NCT00979875|Insulin Lispro|insulin lispro|mesh-list
6105082|NCT00979875|Insulin glulisine|insulin glulisine|mesh-list
6105083|NCT00979875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6105084|NCT00979875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105085|NCT00979940|Atorvastatin|atorvastatin|mesh-list
6105086|NCT00979940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6105087|NCT00979940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6105088|NCT00979940|Antimetabolites|antimetabolites|mesh-ancestor
6105089|NCT00979940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105090|NCT00979940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6105091|NCT00979940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6105092|NCT00979940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6105093|NCT00979953|Oxycodone|oxycodone|mesh-list
6105094|NCT00979953|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6105095|NCT00979953|Narcotics|narcotics|mesh-ancestor
6105096|NCT00979953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6105097|NCT00979953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105098|NCT00979953|Analgesics|analgesics|mesh-ancestor
6105099|NCT00979953|Sensory System Agents|sensory system agents|mesh-ancestor
6105100|NCT00979953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6105101|NCT00979992|Sunitinib|sunitinib|mesh-list
6105102|NCT00979992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6105103|NCT00979992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6105104|NCT00979992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6105105|NCT00979992|Growth Substances|growth substances|mesh-ancestor
6105106|NCT00979992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105107|NCT00979992|Growth Inhibitors|growth inhibitors|mesh-ancestor
6105108|NCT00979992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6105109|NCT00979992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6105110|NCT00979992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105111|NCT00980044|Tramadol|tramadol|mesh-list
6465222|NCT00473070|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
5601267|NCT03706547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6105112|NCT00980044|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6105113|NCT00980044|Narcotics|narcotics|mesh-ancestor
6105114|NCT00980044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6465223|NCT00473070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6105115|NCT00980044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105116|NCT00980044|Analgesics|analgesics|mesh-ancestor
6105117|NCT00980044|Sensory System Agents|sensory system agents|mesh-ancestor
6105118|NCT00980044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6105119|NCT00980148|Azithromycin|azithromycin|mesh-list
6105120|NCT00980148|Doxycycline|doxycycline|mesh-list
6105121|NCT00980148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6105122|NCT00980148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6105123|NCT00980148|Antimalarials|antimalarials|mesh-ancestor
6105124|NCT00980148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6105125|NCT00980148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6105126|NCT00980174|Denosumab|denosumab|mesh-list
6105127|NCT00980174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5525444|NCT04281342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525445|NCT04281342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5525446|NCT04281082|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
5525447|NCT04281082|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5525448|NCT04281082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6105128|NCT00980174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465224|NCT00473070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6465225|NCT00473070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6465226|NCT00473070|Glucocorticoids|glucocorticoids|mesh-ancestor
6465227|NCT00473070|Hormones|hormones|mesh-ancestor
6105129|NCT00980330|Ribavirin|ribavirin|mesh-list
6105130|NCT00980330|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6105131|NCT00980330|Interferon alpha-2|interferon alpha-2|mesh-list
6105132|NCT00980330|Simeprevir|simeprevir|mesh-list
6105133|NCT00980330|Antimetabolites|antimetabolites|mesh-ancestor
6105134|NCT00980330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105135|NCT00980330|Antiviral Agents|antiviral agents|mesh-ancestor
6105136|NCT00980330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6105137|NCT00980330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6105138|NCT00980330|Protease Inhibitors|protease inhibitors|mesh-ancestor
6105139|NCT00980330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6105140|NCT00980395|Rituximab|rituximab|mesh-list
6105141|NCT00980395|Bortezomib|bortezomib|mesh-list
6105142|NCT00980395|Cladribine|cladribine|mesh-list
6105143|NCT00980395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5525451|NCT04280965|Quetiapine Fumarate|quetiapine fumarate|mesh-list
5525452|NCT04280965|Antidepressive Agents|antidepressive agents|mesh-ancestor
6105144|NCT00980395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6105145|NCT00980395|Immunologic Factors|immunologic factors|mesh-ancestor
6105146|NCT00980395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105147|NCT00980395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6105148|NCT00980395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6105149|NCT00980681|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
6105150|NCT00980681|Chelating Agents|chelating agents|mesh-ancestor
5525453|NCT04280965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5525454|NCT04280965|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5525455|NCT04280965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5525456|NCT04280965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6105151|NCT00980681|Sequestering Agents|sequestering agents|mesh-ancestor
6105152|NCT00980681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105153|NCT00980746|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
6105154|NCT00980746|Anticonvulsants|anticonvulsants|mesh-ancestor
6105155|NCT00980746|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6105156|NCT00980746|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6105157|NCT00980746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6105158|NCT00980746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105159|NCT00980785|Ramipril|ramipril|mesh-list
6105160|NCT00980785|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6105161|NCT00980785|Protease Inhibitors|protease inhibitors|mesh-ancestor
6105162|NCT00980785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6105163|NCT00980785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105164|NCT00980785|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6105165|NCT00980798|Hydromorphone|hydromorphone|mesh-list
6105166|NCT00980798|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6105167|NCT00980798|Narcotics|narcotics|mesh-ancestor
6105168|NCT00980798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6105169|NCT00980798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105170|NCT00980798|Analgesics|analgesics|mesh-ancestor
6105171|NCT00980798|Sensory System Agents|sensory system agents|mesh-ancestor
6105172|NCT00980798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6105173|NCT00980980|Chlorhexidine|chlorhexidine|mesh-list
6105174|NCT00980980|Mupirocin|mupirocin|mesh-list
6105175|NCT00980980|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6105176|NCT00980980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6105177|NCT00980980|Disinfectants|disinfectants|mesh-ancestor
6105178|NCT00980980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6105179|NCT00980980|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6105180|NCT00980980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6105181|NCT00980980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105182|NCT00981045|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6105183|NCT00981045|Hematinics|hematinics|mesh-ancestor
6105184|NCT00981084|Modafinil|modafinil|mesh-list
5525457|NCT04280965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525458|NCT04281017|Anesthetics|anesthetics|mesh-list
5525459|NCT04281017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5525460|NCT04281017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525461|NCT04281095|Botulinum Toxins|botulinum toxins|mesh-list
5525462|NCT04281095|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5525463|NCT04281095|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5525464|NCT04281095|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5525465|NCT04281095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5525466|NCT04281095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525467|NCT04281095|Cholinergic Agents|cholinergic agents|mesh-ancestor
5525468|NCT04281095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5525469|NCT04281095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525470|NCT04281095|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5525471|NCT04281095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5525472|NCT04280874|Dinoprostone|dinoprostone|mesh-list
5525473|NCT04280874|Oxytocics|oxytocics|mesh-ancestor
5525474|NCT04280874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5525475|NCT04280874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525476|NCT04280588|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
5525477|NCT04280588|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6665876|NCT01519310|Ciprofloxacin|ciprofloxacin|mesh-list
6665877|NCT01519310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6665878|NCT01519310|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6665879|NCT01519310|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6665880|NCT01519310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6665881|NCT01519310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6665882|NCT01519310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6665883|NCT01519310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665884|NCT01519310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6665885|NCT01519310|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6665886|NCT01519310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6665887|NCT01519336|Ritonavir|ritonavir|mesh-list
5525478|NCT04280588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525479|NCT04280588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6105185|NCT00981084|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6105186|NCT00981084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525480|NCT04280588|Immunologic Factors|immunologic factors|mesh-ancestor
5525481|NCT04280588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525482|NCT04280939|Anesthetics|anesthetics|mesh-list
5525483|NCT04280939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5525484|NCT04280939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525485|NCT04280562|Acetaminophen|acetaminophen|mesh-list
6105187|NCT00981084|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6105188|NCT00981084|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6105189|NCT00981084|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6105190|NCT00981084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105191|NCT00981149|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6105192|NCT00981149|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6105193|NCT00981149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6105194|NCT00981149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6488423|NCT00584155|Levofloxacin|levofloxacin|mesh-list
6488424|NCT00584155|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6488425|NCT00584155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6488426|NCT00584155|Renal Agents|renal agents|mesh-ancestor
6488427|NCT00584155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6488428|NCT00584155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6488429|NCT00584155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6488430|NCT00584155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6488431|NCT00584155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488432|NCT00584155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6488433|NCT00584155|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6105195|NCT00981149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105196|NCT00981149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6105197|NCT00981149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105198|NCT00981149|Analgesics|analgesics|mesh-ancestor
6105199|NCT00981149|Sensory System Agents|sensory system agents|mesh-ancestor
6105200|NCT00981149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6105201|NCT00981149|Antidepressive Agents|antidepressive agents|mesh-ancestor
6105202|NCT00981149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5525486|NCT04280562|Analgesics|analgesics|mesh-list
5525487|NCT04280562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5525488|NCT04280562|Sensory System Agents|sensory system agents|mesh-ancestor
5525489|NCT04280562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5525490|NCT04280562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525491|NCT04280562|Antipyretics|antipyretics|mesh-ancestor
5525492|NCT04280536|Trifluridine|trifluridine|mesh-list
6105203|NCT00981149|Dopamine Agents|dopamine agents|mesh-ancestor
6105204|NCT00981214|Pancrelipase|pancrelipase|mesh-list
6105205|NCT00981214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6105206|NCT00981227|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
6105207|NCT00981227|Anticonvulsants|anticonvulsants|mesh-ancestor
6105208|NCT00981227|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6105209|NCT00981227|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5525493|NCT04280536|Antimetabolites|antimetabolites|mesh-ancestor
5525494|NCT04280536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525495|NCT04280536|Antiviral Agents|antiviral agents|mesh-ancestor
5525496|NCT04280536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5525497|NCT04280406|Azithromycin|azithromycin|mesh-list
5525498|NCT04280406|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5525499|NCT04280406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5525500|NCT04280289|Cannabidiol|cannabidiol|mesh-list
5525501|NCT04280289|Anticonvulsants|anticonvulsants|mesh-ancestor
5525502|NCT04279938|Rituximab|rituximab|mesh-list
5525503|NCT04279938|Pembrolizumab|pembrolizumab|mesh-list
5525504|NCT04279938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5525505|NCT04279938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5525506|NCT04279938|Immunologic Factors|immunologic factors|mesh-ancestor
5525507|NCT04279938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525508|NCT04279938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5525509|NCT04280263|Caffeine|caffeine|mesh-list
5525510|NCT04280263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5525511|NCT04280263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525512|NCT04280263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5525513|NCT04280263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5525514|NCT04280263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525515|NCT04280263|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5525516|NCT04280263|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5525517|NCT04280263|Purinergic Agents|purinergic agents|mesh-ancestor
5525518|NCT04280263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5601268|NCT03706339|Tranexamic Acid|tranexamic acid|mesh-list
6105210|NCT00981227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6105211|NCT00981227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105212|NCT00981409|Heparin|heparin|mesh-list
6105213|NCT00981409|Calcium heparin|calcium heparin|mesh-list
6105214|NCT00981409|PENTA|penta|mesh-list
6105215|NCT00981409|Fondaparinux|fondaparinux|mesh-list
6105216|NCT00981409|Anticoagulants|anticoagulants|mesh-ancestor
6105217|NCT00981409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6105218|NCT00981409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6105219|NCT00981409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105220|NCT00981409|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6105221|NCT00981409|Antithrombins|antithrombins|mesh-ancestor
6105222|NCT00981409|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6105223|NCT00981409|Protease Inhibitors|protease inhibitors|mesh-ancestor
6105224|NCT00981409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6105225|NCT00981435|Prednisolone|prednisolone|mesh-list
6105226|NCT00981435|Prednisolone acetate|prednisolone acetate|mesh-list
6105227|NCT00981435|Ketorolac|ketorolac|mesh-list
6105228|NCT00981435|Lubricant Eye Drops|lubricant eye drops|mesh-list
6105229|NCT00981435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6105230|NCT00981435|Glucocorticoids|glucocorticoids|mesh-ancestor
6105231|NCT00981435|Hormones|hormones|mesh-ancestor
5601269|NCT03706339|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5601270|NCT03706339|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5601271|NCT03706339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105232|NCT00981435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6105233|NCT00981435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105234|NCT00981435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6105235|NCT00981435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5525519|NCT04280055|Psilocybin|psilocybin|mesh-list
5525520|NCT04280055|Hallucinogens|hallucinogens|mesh-ancestor
5525521|NCT04280055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525522|NCT04280055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5525523|NCT04279561|Edetic Acid|edetic acid|mesh-list
5525524|NCT04279561|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5525525|NCT04279561|Chelating Agents|chelating agents|mesh-ancestor
5525526|NCT04279561|Sequestering Agents|sequestering agents|mesh-ancestor
5525527|NCT04279561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525528|NCT04279561|Anticoagulants|anticoagulants|mesh-ancestor
5525529|NCT04279561|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5525530|NCT04279561|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5525531|NCT04279054|Morphine|morphine|mesh-list
5525532|NCT04279054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5525533|NCT04279054|Narcotics|narcotics|mesh-ancestor
5525534|NCT04279054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6105236|NCT00981435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6105237|NCT00981435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6105238|NCT00981435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6105239|NCT00981435|Analgesics|analgesics|mesh-ancestor
6105240|NCT00981435|Sensory System Agents|sensory system agents|mesh-ancestor
6105241|NCT00981435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6105242|NCT00981435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5525535|NCT04279054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525536|NCT04279054|Analgesics|analgesics|mesh-ancestor
6105243|NCT00981435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6105244|NCT00981435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105245|NCT00981435|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6105246|NCT00981435|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6105247|NCT00981526|Telmisartan|telmisartan|mesh-list
6105248|NCT00981526|Olanzapine|olanzapine|mesh-list
6105249|NCT00981526|Clozapine|clozapine|mesh-list
6105250|NCT00981526|Antiemetics|antiemetics|mesh-ancestor
6105251|NCT00981526|Autonomic Agents|autonomic agents|mesh-ancestor
6105252|NCT00981526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6105253|NCT00981526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105254|NCT00981526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6105255|NCT00981526|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6105256|NCT00981526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6105257|NCT00981526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6105258|NCT00981526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6105259|NCT00981526|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6105260|NCT00981526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6105261|NCT00981526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6105262|NCT00981526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105263|NCT00981526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5525537|NCT04279054|Sensory System Agents|sensory system agents|mesh-ancestor
6105264|NCT00981526|Serotonin Agents|serotonin agents|mesh-ancestor
6105265|NCT00981526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6105266|NCT00981526|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6465228|NCT00473070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6465229|NCT00473070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665888|NCT01519336|Darunavir|darunavir|mesh-list
5525538|NCT04279054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5525539|NCT04279379|Decitabine|decitabine|mesh-list
6105267|NCT00981526|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6105268|NCT00981526|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6105269|NCT00981526|GABA Antagonists|gaba antagonists|mesh-ancestor
6105270|NCT00981526|GABA Agents|gaba agents|mesh-ancestor
6105271|NCT00981669|Vaccines|vaccines|mesh-list
6105272|NCT00981669|Immunologic Factors|immunologic factors|mesh-ancestor
6105273|NCT00981669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105274|NCT00981747|Losartan|losartan|mesh-list
6105275|NCT00981747|Sildenafil Citrate|sildenafil citrate|mesh-list
6105276|NCT00981747|Vasodilator Agents|vasodilator agents|mesh-ancestor
6105277|NCT00981747|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6105278|NCT00981747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6105279|NCT00981747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6105280|NCT00981747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105281|NCT00981747|Urological Agents|urological agents|mesh-ancestor
6105282|NCT00981747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6105283|NCT00981747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6105284|NCT00981747|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6105285|NCT00981747|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5525540|NCT04279379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5525541|NCT04279379|Antimetabolites|antimetabolites|mesh-ancestor
5525542|NCT04279379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525543|NCT04279379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5525544|NCT04279379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6105286|NCT00981799|Cyclophosphamide|cyclophosphamide|mesh-list
6105287|NCT00981799|Methotrexate|methotrexate|mesh-list
6105288|NCT00981799|Etoposide|etoposide|mesh-list
6105289|NCT00981799|Lenograstim|lenograstim|mesh-list
6105290|NCT00981799|Sargramostim|sargramostim|mesh-list
6105291|NCT00981799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6105292|NCT00981799|Immunologic Factors|immunologic factors|mesh-ancestor
6105293|NCT00981799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105294|NCT00981799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5525545|NCT04279106|Chlorhexidine|chlorhexidine|mesh-list
5525546|NCT04279106|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5525547|NCT04279106|Listerine|listerine|mesh-list
5525548|NCT04279106|Fluorides|fluorides|mesh-list
5525549|NCT04279106|Sodium Fluoride|sodium fluoride|mesh-list
5525550|NCT04279106|Cariostatic Agents|cariostatic agents|mesh-ancestor
5525551|NCT04279106|Protective Agents|protective agents|mesh-ancestor
5525552|NCT04279106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525553|NCT04279106|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5525554|NCT04279106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5525555|NCT04279106|Disinfectants|disinfectants|mesh-ancestor
5525556|NCT04279106|Dermatologic Agents|dermatologic agents|mesh-ancestor
5525557|NCT04278950|Povidone-Iodine|povidone-iodine|mesh-list
5525558|NCT04278950|Povidone|povidone|mesh-list
5525559|NCT04278950|Plasma Substitutes|plasma substitutes|mesh-ancestor
5525560|NCT04278950|Blood Substitutes|blood substitutes|mesh-ancestor
5525561|NCT04278950|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5525562|NCT04278950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5525563|NCT04278729|Apixaban|apixaban|mesh-list
5525564|NCT04278729|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5525565|NCT04278729|Antithrombins|antithrombins|mesh-ancestor
5525566|NCT04278729|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5525567|NCT04278729|Protease Inhibitors|protease inhibitors|mesh-ancestor
5525568|NCT04278729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5525569|NCT04278729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525570|NCT04278729|Anticoagulants|anticoagulants|mesh-ancestor
5525571|NCT04278859|Antibodies|antibodies|mesh-list
5525572|NCT04278859|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5525573|NCT04278859|Immunologic Factors|immunologic factors|mesh-ancestor
5525574|NCT04278859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525575|NCT04278703|Oxycodone|oxycodone|mesh-list
5525576|NCT04278703|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5525577|NCT04278703|Narcotics|narcotics|mesh-ancestor
5525578|NCT04278703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5525579|NCT04278703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525580|NCT04278703|Analgesics|analgesics|mesh-ancestor
5525581|NCT04278703|Sensory System Agents|sensory system agents|mesh-ancestor
5525582|NCT04278703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5525583|NCT04278807|Anesthetics|anesthetics|mesh-list
5525584|NCT04278807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5525585|NCT04278807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105295|NCT00981799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6105296|NCT00981799|Alkylating Agents|alkylating agents|mesh-ancestor
6105297|NCT00981799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105298|NCT00981799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6105299|NCT00981799|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6105300|NCT00981799|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6105301|NCT00981799|Abortifacient Agents|abortifacient agents|mesh-ancestor
6105302|NCT00981799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6105303|NCT00981799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6105304|NCT00981799|Antimetabolites|antimetabolites|mesh-ancestor
6105305|NCT00981799|Dermatologic Agents|dermatologic agents|mesh-ancestor
6105306|NCT00981799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6105307|NCT00981799|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6105308|NCT00981799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6105309|NCT00981799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6105310|NCT00981799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6105311|NCT00981799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5525586|NCT04278677|Melatonin|melatonin|mesh-list
6105312|NCT00981799|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5525587|NCT04278677|Antioxidants|antioxidants|mesh-ancestor
5525588|NCT04278677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105313|NCT00981825|Listerine|listerine|mesh-list
6105314|NCT00981825|Triclosan|triclosan|mesh-list
6105315|NCT00981825|Fluorides|fluorides|mesh-list
6105316|NCT00981825|Sodium Fluoride|sodium fluoride|mesh-list
6105317|NCT00981825|Cariostatic Agents|cariostatic agents|mesh-ancestor
6105318|NCT00981825|Protective Agents|protective agents|mesh-ancestor
6105319|NCT00981825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105320|NCT00981825|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6105321|NCT00981825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6105322|NCT00981825|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6105323|NCT00981825|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6105324|NCT00981825|Antimetabolites|antimetabolites|mesh-ancestor
6105325|NCT00981825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105326|NCT00981825|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6105327|NCT00982007|Ferric Compounds|ferric compounds|mesh-list
6105328|NCT00982007|Hematinics|hematinics|mesh-ancestor
6105329|NCT00982020|Olanzapine|olanzapine|mesh-list
6105330|NCT00982020|Antiemetics|antiemetics|mesh-ancestor
6105331|NCT00982020|Autonomic Agents|autonomic agents|mesh-ancestor
6105332|NCT00982020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6105333|NCT00982020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105334|NCT00982020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6105335|NCT00982020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6105336|NCT00982020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6105337|NCT00982020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6105338|NCT00982020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6105339|NCT00982020|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6105340|NCT00982020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6105341|NCT00982020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6105342|NCT00982020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105343|NCT00982020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6105344|NCT00982020|Serotonin Agents|serotonin agents|mesh-ancestor
6105345|NCT00982072|Prednisolone|prednisolone|mesh-list
6105346|NCT00982072|Tacrolimus|tacrolimus|mesh-list
6105347|NCT00982072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6105348|NCT00982072|Immunologic Factors|immunologic factors|mesh-ancestor
6105349|NCT00982072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525589|NCT04278677|Protective Agents|protective agents|mesh-ancestor
5525590|NCT04278677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525591|NCT04278677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5525592|NCT04278625|Acetaminophen|acetaminophen|mesh-list
5525593|NCT04278625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5525594|NCT04278625|Analgesics|analgesics|mesh-ancestor
5525595|NCT04278625|Sensory System Agents|sensory system agents|mesh-ancestor
5525596|NCT04278625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5525597|NCT04278625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525598|NCT04278625|Antipyretics|antipyretics|mesh-ancestor
5525599|NCT04278833|Dexamethasone|dexamethasone|mesh-list
5525600|NCT04278833|Triamcinolone|triamcinolone|mesh-list
5525601|NCT04278833|Betamethasone|betamethasone|mesh-list
5525602|NCT04278833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6105350|NCT00982072|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6105351|NCT00982072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6105352|NCT00982072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105353|NCT00982072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6105354|NCT00982072|Glucocorticoids|glucocorticoids|mesh-ancestor
6105355|NCT00982072|Hormones|hormones|mesh-ancestor
6105356|NCT00982072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6105357|NCT00982072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6105358|NCT00982072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6105359|NCT00982189|Lisinopril|lisinopril|mesh-list
6105360|NCT00982189|Pravastatin|pravastatin|mesh-list
6105361|NCT00982189|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6105362|NCT00982189|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5525603|NCT04278833|Antiemetics|antiemetics|mesh-ancestor
5525604|NCT04278833|Autonomic Agents|autonomic agents|mesh-ancestor
5525605|NCT04278833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5525606|NCT04278833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105363|NCT00982189|Antimetabolites|antimetabolites|mesh-ancestor
6105364|NCT00982189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105365|NCT00982189|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6105366|NCT00982189|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6105367|NCT00982189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6105368|NCT00982189|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6105369|NCT00982189|Protease Inhibitors|protease inhibitors|mesh-ancestor
5525607|NCT04278833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6105370|NCT00982189|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6105371|NCT00982189|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6105372|NCT00982189|Protective Agents|protective agents|mesh-ancestor
6105373|NCT00982189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105374|NCT00982228|Insulin|insulin|mesh-list
6105375|NCT00982228|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6105376|NCT00982228|Insulin Glargine|insulin glargine|mesh-list
5525608|NCT04278833|Glucocorticoids|glucocorticoids|mesh-ancestor
5525609|NCT04278833|Hormones|hormones|mesh-ancestor
5525610|NCT04278833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5525611|NCT04278833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5525612|NCT04278833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5525613|NCT04278833|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5525614|NCT04278833|Respiratory System Agents|respiratory system agents|mesh-ancestor
6105377|NCT00982228|Insulin Aspart|insulin aspart|mesh-list
6105378|NCT00982228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6105379|NCT00982228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105380|NCT00982280|Tapentadol|tapentadol|mesh-list
6105381|NCT00982280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6105382|NCT00982280|Narcotics|narcotics|mesh-ancestor
6105383|NCT00982280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6105384|NCT00982280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105385|NCT00982280|Analgesics|analgesics|mesh-ancestor
6105386|NCT00982280|Sensory System Agents|sensory system agents|mesh-ancestor
6105387|NCT00982280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6105388|NCT00982280|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6105389|NCT00982280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6105390|NCT00982280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6105391|NCT00982280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105392|NCT00982280|Adrenergic Agents|adrenergic agents|mesh-ancestor
6105393|NCT00982280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5525615|NCT04278768|Azacitidine|azacitidine|mesh-list
5525616|NCT04278768|Venetoclax|venetoclax|mesh-list
5525617|NCT04278768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5525618|NCT04278768|Antimetabolites|antimetabolites|mesh-ancestor
6105394|NCT00982345|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6105395|NCT00982345|Antidepressive Agents|antidepressive agents|mesh-ancestor
6105396|NCT00982345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6105397|NCT00982345|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6105398|NCT00982345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6105399|NCT00982345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6105400|NCT00982345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105401|NCT00982423|Furosemide|furosemide|mesh-list
6105402|NCT00982423|Diuretics|diuretics|mesh-ancestor
6105403|NCT00982423|Natriuretic Agents|natriuretic agents|mesh-ancestor
6105404|NCT00982423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105405|NCT00982423|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6105406|NCT00982423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6105407|NCT00982423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105408|NCT00982488|Imatinib Mesylate|imatinib mesylate|mesh-list
6105409|NCT00982488|Dasatinib|dasatinib|mesh-list
6105410|NCT00982488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6105411|NCT00982488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6105412|NCT00982488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6105413|NCT00982488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105414|NCT00982553|Ribavirin|ribavirin|mesh-list
6105415|NCT00982553|Raltegravir Potassium|raltegravir potassium|mesh-list
6105416|NCT00982553|Antimetabolites|antimetabolites|mesh-ancestor
6105417|NCT00982553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105418|NCT00982553|Antiviral Agents|antiviral agents|mesh-ancestor
6105419|NCT00982553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6105420|NCT00982553|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6105421|NCT00982553|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6105422|NCT00982553|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6105423|NCT00982553|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6105424|NCT00982553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6105425|NCT00982592|Leucovorin|leucovorin|mesh-list
6105426|NCT00982592|Fluorouracil|fluorouracil|mesh-list
6105427|NCT00982592|Oxaliplatin|oxaliplatin|mesh-list
6105428|NCT00982592|Calcium|calcium|mesh-list
6105429|NCT00982592|Levoleucovorin|levoleucovorin|mesh-list
6105430|NCT00982592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6105431|NCT00982592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601272|NCT03706339|Hemostatics|hemostatics|mesh-ancestor
6105432|NCT00982592|Antimetabolites|antimetabolites|mesh-ancestor
6105433|NCT00982592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525619|NCT04278768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525620|NCT04278768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5525621|NCT04278768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5525622|NCT04278846|Bupivacaine|bupivacaine|mesh-list
5525623|NCT04278846|Anesthetics, Local|anesthetics, local|mesh-ancestor
5525624|NCT04278846|Anesthetics|anesthetics|mesh-ancestor
5525625|NCT04278846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5525626|NCT04278846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525627|NCT04278846|Sensory System Agents|sensory system agents|mesh-ancestor
5525628|NCT04278846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5525629|NCT04278599|Zinc|zinc|mesh-list
5525630|NCT04278599|Trace Elements|trace elements|mesh-ancestor
6105434|NCT00982592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6105435|NCT00982592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6105436|NCT00982592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6105437|NCT00982592|Immunologic Factors|immunologic factors|mesh-ancestor
6105438|NCT00982592|Antidotes|antidotes|mesh-ancestor
6105439|NCT00982592|Protective Agents|protective agents|mesh-ancestor
6105440|NCT00982592|Vitamin B Complex|vitamin b complex|mesh-ancestor
6105441|NCT00982592|Vitamins|vitamins|mesh-ancestor
5525631|NCT04278599|Micronutrients|micronutrients|mesh-ancestor
5525632|NCT04278599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525633|NCT04278937|Azithromycin|azithromycin|mesh-list
5525634|NCT04278937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5525635|NCT04278937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5525636|NCT04278378|Folic Acid|folic acid|mesh-list
5525637|NCT04278378|Riboflavin|riboflavin|mesh-list
5525638|NCT04278378|Hematinics|hematinics|mesh-ancestor
5525639|NCT04278378|Vitamin B Complex|vitamin b complex|mesh-ancestor
5525640|NCT04278378|Vitamins|vitamins|mesh-ancestor
5525641|NCT04278378|Micronutrients|micronutrients|mesh-ancestor
5525642|NCT04278378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525643|NCT04278378|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5525644|NCT04278378|Dermatologic Agents|dermatologic agents|mesh-ancestor
5525645|NCT04278755|Drospirenone|drospirenone|mesh-list
5525646|NCT04278755|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5525647|NCT04278755|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
5525648|NCT04278755|Estradiol|estradiol|mesh-list
5525649|NCT04278755|Estrogens|estrogens|mesh-ancestor
5525650|NCT04278755|Hormones|hormones|mesh-ancestor
5525651|NCT04278755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5525652|NCT04278755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525653|NCT04278755|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5525654|NCT04278755|Contraceptive Agents|contraceptive agents|mesh-ancestor
5525655|NCT04278755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5525656|NCT04278755|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5525657|NCT04278755|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5525658|NCT04278755|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5525659|NCT04278755|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5525660|NCT04278755|Hormone Antagonists|hormone antagonists|mesh-ancestor
5525661|NCT04278755|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5525662|NCT04278755|Diuretics|diuretics|mesh-ancestor
5525663|NCT04278755|Natriuretic Agents|natriuretic agents|mesh-ancestor
5525664|NCT04278287|Paclitaxel|paclitaxel|mesh-list
5525665|NCT04278287|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5525666|NCT04278287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6105442|NCT00982592|Micronutrients|micronutrients|mesh-ancestor
6105443|NCT00982644|Insulin|insulin|mesh-list
6105444|NCT00982644|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6105445|NCT00982644|Insulin Glargine|insulin glargine|mesh-list
5525667|NCT04278287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5525668|NCT04278287|Tubulin Modulators|tubulin modulators|mesh-ancestor
5525669|NCT04278287|Antimitotic Agents|antimitotic agents|mesh-ancestor
6105446|NCT00982644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6105447|NCT00982644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105448|NCT00982657|Sunitinib|sunitinib|mesh-list
5525670|NCT04278287|Mitosis Modulators|mitosis modulators|mesh-ancestor
5525671|NCT04278287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525672|NCT04278508|Progesterone|progesterone|mesh-list
6105449|NCT00982657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6105450|NCT00982657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6105451|NCT00982657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6105452|NCT00982657|Growth Substances|growth substances|mesh-ancestor
5525673|NCT04278508|Progestins|progestins|mesh-ancestor
5525674|NCT04278508|Hormones|hormones|mesh-ancestor
5525675|NCT04278508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5525676|NCT04278508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105453|NCT00982657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105454|NCT00982657|Growth Inhibitors|growth inhibitors|mesh-ancestor
6105455|NCT00982657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6105456|NCT00982657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6105457|NCT00982657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105458|NCT00982865|Niacinamide|niacinamide|mesh-list
6105459|NCT00982865|Vitamin B Complex|vitamin b complex|mesh-ancestor
6105460|NCT00982865|Vitamins|vitamins|mesh-ancestor
6105461|NCT00982865|Micronutrients|micronutrients|mesh-ancestor
6105462|NCT00982865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105463|NCT00982878|Maraviroc|maraviroc|mesh-list
5525677|NCT04278248|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5525678|NCT04278248|Immunologic Factors|immunologic factors|mesh-ancestor
5525679|NCT04278248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525680|NCT04278495|Losartan|losartan|mesh-list
5525681|NCT04278495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5525682|NCT04278495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5525683|NCT04278495|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5525684|NCT04278495|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5525685|NCT04278495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105464|NCT00982878|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6105465|NCT00982878|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6105466|NCT00982878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105467|NCT00982878|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6105468|NCT00982878|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6105469|NCT00982878|Antiviral Agents|antiviral agents|mesh-ancestor
6105470|NCT00982878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6105471|NCT00982878|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6105472|NCT00982930|Tobramycin|tobramycin|mesh-list
6105473|NCT00982930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6105474|NCT00982930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6105475|NCT00983073|Tapentadol|tapentadol|mesh-list
6105476|NCT00983073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6105477|NCT00983073|Narcotics|narcotics|mesh-ancestor
5525686|NCT04278469|Antineoplastic Agents|antineoplastic agents|mesh-list
5525687|NCT04278547|Valganciclovir|valganciclovir|mesh-list
5525688|NCT04278547|Antiviral Agents|antiviral agents|mesh-ancestor
5525689|NCT04278547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5601273|NCT03706339|Coagulants|coagulants|mesh-ancestor
5601274|NCT03706300|Phenylpropanolamine|phenylpropanolamine|mesh-list
6105478|NCT00983073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6105479|NCT00983073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105480|NCT00983073|Analgesics|analgesics|mesh-ancestor
6105481|NCT00983073|Sensory System Agents|sensory system agents|mesh-ancestor
6105482|NCT00983073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6105483|NCT00983073|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6105484|NCT00983073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6105485|NCT00983073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6105486|NCT00983073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105487|NCT00983073|Adrenergic Agents|adrenergic agents|mesh-ancestor
6105488|NCT00983073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6105489|NCT00983216|Ketoconazole|ketoconazole|mesh-list
6105490|NCT00983216|Colchicine|colchicine|mesh-list
6105491|NCT00983216|Gout Suppressants|gout suppressants|mesh-ancestor
6105492|NCT00983216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6105493|NCT00983216|Tubulin Modulators|tubulin modulators|mesh-ancestor
6105494|NCT00983216|Antimitotic Agents|antimitotic agents|mesh-ancestor
6105495|NCT00983216|Mitosis Modulators|mitosis modulators|mesh-ancestor
6105496|NCT00983216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105497|NCT00983216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6105498|NCT00983216|Antifungal Agents|antifungal agents|mesh-ancestor
6105499|NCT00983216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6105500|NCT00983216|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6105501|NCT00983216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6105502|NCT00983216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6105503|NCT00983216|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6105504|NCT00983216|Hormone Antagonists|hormone antagonists|mesh-ancestor
6105505|NCT00983216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6105506|NCT00983216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105507|NCT00983216|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5601275|NCT03706300|Pseudoephedrine|pseudoephedrine|mesh-list
5601276|NCT03706300|Ephedrine|ephedrine|mesh-list
5601277|NCT03706300|Guaifenesin|guaifenesin|mesh-list
5601278|NCT03706300|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
6105508|NCT00983242|Colchicine|colchicine|mesh-list
6105509|NCT00983242|Verapamil|verapamil|mesh-list
6105510|NCT00983242|Gout Suppressants|gout suppressants|mesh-ancestor
6105511|NCT00983242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6105512|NCT00983242|Tubulin Modulators|tubulin modulators|mesh-ancestor
6105513|NCT00983242|Antimitotic Agents|antimitotic agents|mesh-ancestor
6105514|NCT00983242|Mitosis Modulators|mitosis modulators|mesh-ancestor
6105515|NCT00983242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105516|NCT00983242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6105517|NCT00983242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6105518|NCT00983242|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6105519|NCT00983242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6105520|NCT00983242|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6105521|NCT00983242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105522|NCT00983242|Vasodilator Agents|vasodilator agents|mesh-ancestor
6105523|NCT00983294|Azithromycin|azithromycin|mesh-list
6105524|NCT00983294|Colchicine|colchicine|mesh-list
6105525|NCT00983294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6105526|NCT00983294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6105527|NCT00983294|Gout Suppressants|gout suppressants|mesh-ancestor
6105528|NCT00983294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6105529|NCT00983294|Tubulin Modulators|tubulin modulators|mesh-ancestor
6105530|NCT00983294|Antimitotic Agents|antimitotic agents|mesh-ancestor
6105531|NCT00983294|Mitosis Modulators|mitosis modulators|mesh-ancestor
6105532|NCT00983294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525690|NCT04278092|Paclitaxel|paclitaxel|mesh-list
5525691|NCT04278092|Cetuximab|cetuximab|mesh-list
5525692|NCT04278092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5525693|NCT04278092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5525694|NCT04278092|Tubulin Modulators|tubulin modulators|mesh-ancestor
5525695|NCT04278092|Antimitotic Agents|antimitotic agents|mesh-ancestor
5525696|NCT04278092|Mitosis Modulators|mitosis modulators|mesh-ancestor
5525697|NCT04278092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525698|NCT04278092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5525699|NCT04278053|Inositol|inositol|mesh-list
5525700|NCT04278053|Vitamin B Complex|vitamin b complex|mesh-ancestor
5525701|NCT04278053|Vitamins|vitamins|mesh-ancestor
5525702|NCT04278053|Micronutrients|micronutrients|mesh-ancestor
5525703|NCT04278053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525704|NCT04278040|Melphalan|melphalan|mesh-list
5525705|NCT04278040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6105533|NCT00983294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6105534|NCT00983307|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6105535|NCT00983307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6105536|NCT00983307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6105537|NCT00983307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5525706|NCT04278040|Alkylating Agents|alkylating agents|mesh-ancestor
5525707|NCT04278040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105538|NCT00983307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105539|NCT00983346|Bortezomib|bortezomib|mesh-list
6105540|NCT00983346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6105541|NCT00983372|Colchicine|colchicine|mesh-list
6465230|NCT00473070|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6465231|NCT00473070|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5525708|NCT04278040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5525709|NCT04278040|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5525710|NCT04278040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5525711|NCT04278040|Immunologic Factors|immunologic factors|mesh-ancestor
5525712|NCT04278040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525713|NCT04277884|Firibastat|firibastat|mesh-list
5525714|NCT04277884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5525715|NCT04277845|Dexamethasone|dexamethasone|mesh-list
5525716|NCT04277845|Bortezomib|bortezomib|mesh-list
5525717|NCT04277845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5525718|NCT04277845|Antiemetics|antiemetics|mesh-ancestor
5525719|NCT04277845|Autonomic Agents|autonomic agents|mesh-ancestor
5525720|NCT04277845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5525721|NCT04277845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525722|NCT04277845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5525723|NCT04277845|Glucocorticoids|glucocorticoids|mesh-ancestor
5525724|NCT04277845|Hormones|hormones|mesh-ancestor
5525725|NCT04277845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5525726|NCT04277845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5525727|NCT04277845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5525728|NCT04277858|Cisplatin|cisplatin|mesh-list
5525729|NCT04277858|Docetaxel|docetaxel|mesh-list
5525730|NCT04277858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5525731|NCT04277858|Tubulin Modulators|tubulin modulators|mesh-ancestor
6105542|NCT00983372|Diltiazem|diltiazem|mesh-list
6465232|NCT00473174|Ramipril|ramipril|mesh-list
6105543|NCT00983372|Gout Suppressants|gout suppressants|mesh-ancestor
6105544|NCT00983372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6105545|NCT00983372|Tubulin Modulators|tubulin modulators|mesh-ancestor
6105546|NCT00983372|Antimitotic Agents|antimitotic agents|mesh-ancestor
6105547|NCT00983372|Mitosis Modulators|mitosis modulators|mesh-ancestor
6105548|NCT00983372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105549|NCT00983372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6105550|NCT00983372|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6105551|NCT00983372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6105552|NCT00983372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6105553|NCT00983372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6105554|NCT00983372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105555|NCT00983372|Vasodilator Agents|vasodilator agents|mesh-ancestor
6105556|NCT00983385|Tapentadol|tapentadol|mesh-list
6105557|NCT00983385|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6105558|NCT00983385|Narcotics|narcotics|mesh-ancestor
6105559|NCT00983385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6105560|NCT00983385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105561|NCT00983385|Analgesics|analgesics|mesh-ancestor
6105562|NCT00983385|Sensory System Agents|sensory system agents|mesh-ancestor
6105563|NCT00983385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6105564|NCT00983385|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6105565|NCT00983385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6105566|NCT00983385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6105567|NCT00983385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105568|NCT00983385|Adrenergic Agents|adrenergic agents|mesh-ancestor
6105569|NCT00983385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6204027|NCT02064816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6204028|NCT02064816|Antiviral Agents|antiviral agents|mesh-ancestor
6204029|NCT02064816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6204030|NCT02064894|Ibuprofen|ibuprofen|mesh-list
6204031|NCT02064894|Morphine|morphine|mesh-list
6204032|NCT02064894|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6204033|NCT02064894|Narcotics|narcotics|mesh-ancestor
6204034|NCT02064894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6204035|NCT02064894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204036|NCT02064894|Analgesics|analgesics|mesh-ancestor
6204037|NCT02064894|Sensory System Agents|sensory system agents|mesh-ancestor
6204038|NCT02064894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6204039|NCT02064894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6204040|NCT02064894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6465233|NCT00473174|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6465234|NCT00473174|Protease Inhibitors|protease inhibitors|mesh-ancestor
6465235|NCT00473174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6465236|NCT00473174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465237|NCT00473174|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6465238|NCT00473213|Interferons|interferons|mesh-list
6465239|NCT00473213|Interferon-beta|interferon-beta|mesh-list
6465240|NCT00473213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6465241|NCT00473213|Antiviral Agents|antiviral agents|mesh-ancestor
6465242|NCT00473213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6465243|NCT00473213|Immunologic Factors|immunologic factors|mesh-ancestor
6465244|NCT00473213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465245|NCT00473239|Vitamin D|vitamin d|mesh-list
6465246|NCT00473239|Cholecalciferol|cholecalciferol|mesh-list
6465247|NCT00473239|Vitamins|vitamins|mesh-ancestor
5525732|NCT04277858|Antimitotic Agents|antimitotic agents|mesh-ancestor
6204041|NCT02064894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6204042|NCT02064894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6204043|NCT02064894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6204044|NCT02064894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6204045|NCT02064894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204046|NCT02064907|Dexlansoprazole|dexlansoprazole|mesh-list
6204047|NCT02064907|Lansoprazole|lansoprazole|mesh-list
6204048|NCT02064907|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5525733|NCT04277858|Mitosis Modulators|mitosis modulators|mesh-ancestor
5525734|NCT04277858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525735|NCT04277702|Montelukast|montelukast|mesh-list
5525736|NCT04277702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6204049|NCT02064907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6204050|NCT02064907|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6204051|NCT02064907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6204052|NCT02064907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204053|NCT02064920|Donepezil|donepezil|mesh-list
6105570|NCT00983515|Ritonavir|ritonavir|mesh-list
6105571|NCT00983515|Colchicine|colchicine|mesh-list
6105572|NCT00983515|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6105573|NCT00983515|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6105574|NCT00983515|Protease Inhibitors|protease inhibitors|mesh-ancestor
6105575|NCT00983515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6105576|NCT00983515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105577|NCT00983515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6105578|NCT00983515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5525737|NCT04277702|Respiratory System Agents|respiratory system agents|mesh-ancestor
5525738|NCT04277702|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5525739|NCT04277702|Hormone Antagonists|hormone antagonists|mesh-ancestor
5525740|NCT04277702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5525741|NCT04277702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525742|NCT04277702|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5525743|NCT04277702|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5525744|NCT04277702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525745|NCT04277663|Interferons|interferons|mesh-list
5525746|NCT04277663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5525747|NCT04277663|Antiviral Agents|antiviral agents|mesh-ancestor
6105579|NCT00983515|Antiviral Agents|antiviral agents|mesh-ancestor
6105580|NCT00983515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6105581|NCT00983515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6105582|NCT00983515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6105583|NCT00983515|Gout Suppressants|gout suppressants|mesh-ancestor
6105584|NCT00983515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6105585|NCT00983515|Tubulin Modulators|tubulin modulators|mesh-ancestor
6105586|NCT00983515|Antimitotic Agents|antimitotic agents|mesh-ancestor
6105587|NCT00983515|Mitosis Modulators|mitosis modulators|mesh-ancestor
6105588|NCT00983515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6105589|NCT00983528|Alemtuzumab|alemtuzumab|mesh-list
6105590|NCT00983528|Clofarabine|clofarabine|mesh-list
6105591|NCT00983528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6105592|NCT00983528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6105593|NCT00983528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6105594|NCT00983528|Antimetabolites|antimetabolites|mesh-ancestor
6105595|NCT00983528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105596|NCT00983541|Gemcitabine|gemcitabine|mesh-list
6105597|NCT00983541|Fluorouracil|fluorouracil|mesh-list
6105598|NCT00983541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6105599|NCT00983541|Antimetabolites|antimetabolites|mesh-ancestor
6105600|NCT00983541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105601|NCT00983541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6105602|NCT00983541|Antiviral Agents|antiviral agents|mesh-ancestor
6105603|NCT00983541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6105604|NCT00983541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6105605|NCT00983541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6105606|NCT00983541|Immunologic Factors|immunologic factors|mesh-ancestor
6105607|NCT00983541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105608|NCT00983580|Aspirin|aspirin|mesh-list
6105609|NCT00983580|Eflornithine|eflornithine|mesh-list
6105610|NCT00983580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6105611|NCT00983580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6105612|NCT00983580|Analgesics|analgesics|mesh-ancestor
6105613|NCT00983580|Sensory System Agents|sensory system agents|mesh-ancestor
5525748|NCT04277663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5525749|NCT04277923|SMOFlipid|smoflipid|mesh-list
5525750|NCT04277923|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
5525751|NCT04277923|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5525752|NCT04277923|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5525753|NCT04277533|Calcium|calcium|mesh-list
5525754|NCT04277533|Bilirubin|bilirubin|mesh-list
5525755|NCT04277533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5525756|NCT04277533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525757|NCT04277533|Antioxidants|antioxidants|mesh-ancestor
5525758|NCT04277533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525759|NCT04277533|Protective Agents|protective agents|mesh-ancestor
5525760|NCT04277247|Botulinum Toxins|botulinum toxins|mesh-list
5525761|NCT04277247|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5525762|NCT04277247|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5525763|NCT04277247|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5525764|NCT04277247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6105614|NCT00983580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6465248|NCT00473239|Micronutrients|micronutrients|mesh-ancestor
6105615|NCT00983580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105616|NCT00983580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5525765|NCT04277247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525766|NCT04277247|Cholinergic Agents|cholinergic agents|mesh-ancestor
6105617|NCT00983580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6105618|NCT00983580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6105619|NCT00983580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6105620|NCT00983580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105621|NCT00983580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6105622|NCT00983580|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6105623|NCT00983580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6105624|NCT00983580|Antipyretics|antipyretics|mesh-ancestor
6105625|NCT00983580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6105626|NCT00983580|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5525767|NCT04277247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5525768|NCT04277247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525769|NCT04277247|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5525770|NCT04277247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5525771|NCT04277143|Daptomycin|daptomycin|mesh-list
5525772|NCT04277143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5525773|NCT04277143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6105627|NCT00983580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6105628|NCT00983580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6105629|NCT00983580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6105630|NCT00983580|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
6105631|NCT00983619|Rituximab|rituximab|mesh-list
6105632|NCT00983619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6105633|NCT00983619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6105634|NCT00983619|Immunologic Factors|immunologic factors|mesh-ancestor
6105635|NCT00983619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105636|NCT00983619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6105637|NCT00983853|Ribavirin|ribavirin|mesh-list
6105638|NCT00983853|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6105639|NCT00983853|Antimetabolites|antimetabolites|mesh-ancestor
6105640|NCT00983853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105641|NCT00983853|Antiviral Agents|antiviral agents|mesh-ancestor
6105642|NCT00983853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6105643|NCT00983905|Colchicine|colchicine|mesh-list
6105644|NCT00983905|Theophylline|theophylline|mesh-list
6105645|NCT00983905|Gout Suppressants|gout suppressants|mesh-ancestor
5525781|NCT04276883|Dexmedetomidine|dexmedetomidine|mesh-list
5525782|NCT04276883|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5525783|NCT04276883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5525784|NCT04276883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105646|NCT00983905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6105647|NCT00983905|Tubulin Modulators|tubulin modulators|mesh-ancestor
6105648|NCT00983905|Antimitotic Agents|antimitotic agents|mesh-ancestor
6105649|NCT00983905|Mitosis Modulators|mitosis modulators|mesh-ancestor
6105650|NCT00983905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105651|NCT00983905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6105652|NCT00983905|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6105653|NCT00983905|Autonomic Agents|autonomic agents|mesh-ancestor
6105654|NCT00983905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6105655|NCT00983905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105656|NCT00983905|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6105657|NCT00983905|Respiratory System Agents|respiratory system agents|mesh-ancestor
6105658|NCT00983905|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6105659|NCT00983905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6105660|NCT00983905|Vasodilator Agents|vasodilator agents|mesh-ancestor
6105661|NCT00983905|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6105662|NCT00983905|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6105663|NCT00983905|Purinergic Agents|purinergic agents|mesh-ancestor
6105664|NCT00983905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6105665|NCT00983918|Propofol|propofol|mesh-list
6105666|NCT00983918|Sevoflurane|sevoflurane|mesh-list
6105667|NCT00983918|Desflurane|desflurane|mesh-list
6105668|NCT00983918|Isoflurane|isoflurane|mesh-list
6105669|NCT00983918|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6105670|NCT00983918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6105671|NCT00983918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105672|NCT00983918|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6105673|NCT00983918|Anesthetics, General|anesthetics, general|mesh-ancestor
6105674|NCT00983918|Anesthetics|anesthetics|mesh-ancestor
6105675|NCT00983918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6105676|NCT00983918|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6105677|NCT00983931|Cyclosporine|cyclosporine|mesh-list
6105678|NCT00983931|Colchicine|colchicine|mesh-list
6105679|NCT00983931|Cyclosporins|cyclosporins|mesh-list
6105680|NCT00983931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6105681|NCT00983931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105682|NCT00983931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6105683|NCT00983931|Immunologic Factors|immunologic factors|mesh-ancestor
6105684|NCT00983931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105685|NCT00983931|Antifungal Agents|antifungal agents|mesh-ancestor
6105686|NCT00983931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6105687|NCT00983931|Dermatologic Agents|dermatologic agents|mesh-ancestor
6105688|NCT00983931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6105689|NCT00983931|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6105690|NCT00983931|Gout Suppressants|gout suppressants|mesh-ancestor
6105691|NCT00983931|Tubulin Modulators|tubulin modulators|mesh-ancestor
6105692|NCT00983931|Antimitotic Agents|antimitotic agents|mesh-ancestor
6105693|NCT00983931|Mitosis Modulators|mitosis modulators|mesh-ancestor
6105694|NCT00983931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6105695|NCT00983957|Moxifloxacin|moxifloxacin|mesh-list
6105696|NCT00983957|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6105697|NCT00983957|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6105698|NCT00983957|Contraceptive Agents|contraceptive agents|mesh-ancestor
6105699|NCT00983957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6105700|NCT00983957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105701|NCT00983957|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6105702|NCT00983957|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6105703|NCT00983957|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6105704|NCT00983957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6105705|NCT00983957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6105706|NCT00983957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6105707|NCT00983957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6105708|NCT00983957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5525785|NCT04276883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5525786|NCT04276883|Analgesics|analgesics|mesh-ancestor
5525787|NCT04276883|Sensory System Agents|sensory system agents|mesh-ancestor
5525788|NCT04276883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5525789|NCT04276883|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5525790|NCT04276883|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5525791|NCT04276883|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5525792|NCT04276883|Adrenergic Agents|adrenergic agents|mesh-ancestor
5525793|NCT04276883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6105709|NCT00983957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105710|NCT00983957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6105711|NCT00984009|Colchicine|colchicine|mesh-list
6105712|NCT00984009|Gout Suppressants|gout suppressants|mesh-ancestor
6105713|NCT00984009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6105714|NCT00984009|Tubulin Modulators|tubulin modulators|mesh-ancestor
6105715|NCT00984009|Antimitotic Agents|antimitotic agents|mesh-ancestor
6105716|NCT00984009|Mitosis Modulators|mitosis modulators|mesh-ancestor
6105717|NCT00984009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105718|NCT00984009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6105719|NCT00984022|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6105720|NCT00984022|Laxatives|laxatives|mesh-ancestor
6105721|NCT00984022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6105722|NCT00984061|Clarithromycin|clarithromycin|mesh-list
6105723|NCT00984061|Colchicine|colchicine|mesh-list
6105724|NCT00984061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6105725|NCT00984061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6105726|NCT00984061|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6105727|NCT00984061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6105728|NCT00984061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105729|NCT00984061|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6105730|NCT00984061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6105731|NCT00984061|Gout Suppressants|gout suppressants|mesh-ancestor
6105732|NCT00984061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6105733|NCT00984061|Tubulin Modulators|tubulin modulators|mesh-ancestor
6105734|NCT00984061|Antimitotic Agents|antimitotic agents|mesh-ancestor
6105735|NCT00984061|Mitosis Modulators|mitosis modulators|mesh-ancestor
6105736|NCT00984061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6105737|NCT00984126|Factor VIII|factor viii|mesh-list
6105738|NCT00984126|Coagulants|coagulants|mesh-ancestor
6105739|NCT00984139|Vaccines|vaccines|mesh-list
6105740|NCT00984139|Immunologic Factors|immunologic factors|mesh-ancestor
6105741|NCT00984139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525794|NCT04276883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525795|NCT04276857|Leucovorin|leucovorin|mesh-list
5525796|NCT04276857|Gemcitabine|gemcitabine|mesh-list
5525797|NCT04276857|Paclitaxel|paclitaxel|mesh-list
5525798|NCT04276857|Oxaliplatin|oxaliplatin|mesh-list
5525799|NCT04276857|Irinotecan|irinotecan|mesh-list
5525800|NCT04276857|Folfirinox|folfirinox|mesh-list
5525801|NCT04276857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5525802|NCT04276857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5525803|NCT04276857|Tubulin Modulators|tubulin modulators|mesh-ancestor
5525804|NCT04276857|Antimitotic Agents|antimitotic agents|mesh-ancestor
5525805|NCT04276857|Mitosis Modulators|mitosis modulators|mesh-ancestor
5525806|NCT04276857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525807|NCT04276857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5525808|NCT04276857|Antimetabolites|antimetabolites|mesh-ancestor
5525809|NCT04276857|Antiviral Agents|antiviral agents|mesh-ancestor
5525810|NCT04276857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5525811|NCT04276857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5525812|NCT04276857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5525813|NCT04276857|Immunologic Factors|immunologic factors|mesh-ancestor
5525814|NCT04276857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105742|NCT00984256|Atovaquone|atovaquone|mesh-list
6105743|NCT00984256|Proguanil|proguanil|mesh-list
6105744|NCT00984256|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
6105745|NCT00984256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6105746|NCT00984256|Antimalarials|antimalarials|mesh-ancestor
6105747|NCT00984256|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6105748|NCT00984256|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6105749|NCT00984256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6105750|NCT00984256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105751|NCT00984256|Antimetabolites|antimetabolites|mesh-ancestor
6105752|NCT00984282|Sorafenib|sorafenib|mesh-list
6105753|NCT00984282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6105754|NCT00984282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6105755|NCT00984282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6105756|NCT00984282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105757|NCT00984334|Naloxone|naloxone|mesh-list
6105758|NCT00984334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6105759|NCT00984334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105760|NCT00984334|Sensory System Agents|sensory system agents|mesh-ancestor
6105761|NCT00984334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6105762|NCT00984542|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6105763|NCT00984542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6105764|NCT00984542|Alkylating Agents|alkylating agents|mesh-ancestor
6105765|NCT00984542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525815|NCT04276857|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5525816|NCT04276857|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5525817|NCT04276857|Antidotes|antidotes|mesh-ancestor
5525818|NCT04276857|Protective Agents|protective agents|mesh-ancestor
5525819|NCT04276857|Vitamin B Complex|vitamin b complex|mesh-ancestor
5525820|NCT04276857|Vitamins|vitamins|mesh-ancestor
5525821|NCT04276857|Micronutrients|micronutrients|mesh-ancestor
5525822|NCT04276688|Interferons|interferons|mesh-list
5525823|NCT04276688|Ritonavir|ritonavir|mesh-list
5525824|NCT04276688|Ribavirin|ribavirin|mesh-list
5525825|NCT04276688|Lopinavir|lopinavir|mesh-list
5525826|NCT04276688|Interferon-beta|interferon-beta|mesh-list
5525827|NCT04276688|Interferon beta-1b|interferon beta-1b|mesh-list
6105766|NCT00984542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6105767|NCT00984568|Aminosalicylic Acid|aminosalicylic acid|mesh-list
6105768|NCT00984568|Prednisolone|prednisolone|mesh-list
6105769|NCT00984568|Mesalamine|mesalamine|mesh-list
6105770|NCT00984568|Azathioprine|azathioprine|mesh-list
6105771|NCT00984568|Infliximab|infliximab|mesh-list
6105772|NCT00984568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6105773|NCT00984568|Glucocorticoids|glucocorticoids|mesh-ancestor
5525828|NCT04276688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5525829|NCT04276688|Antiviral Agents|antiviral agents|mesh-ancestor
5525830|NCT04276688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5525831|NCT04276688|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5525832|NCT04276688|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5525833|NCT04276688|Protease Inhibitors|protease inhibitors|mesh-ancestor
5525834|NCT04276688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5525835|NCT04276688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525836|NCT04276688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5525837|NCT04276688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5525838|NCT04276688|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5525839|NCT04276688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5525840|NCT04276688|Antimetabolites|antimetabolites|mesh-ancestor
5525841|NCT04276688|Immunologic Factors|immunologic factors|mesh-ancestor
6105774|NCT00984568|Hormones|hormones|mesh-ancestor
6105775|NCT00984568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6105776|NCT00984568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105777|NCT00984568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6105778|NCT00984568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6105779|NCT00984568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6105780|NCT00984568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6105781|NCT00984568|Dermatologic Agents|dermatologic agents|mesh-ancestor
6105782|NCT00984568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6105783|NCT00984568|Antimetabolites|antimetabolites|mesh-ancestor
6105784|NCT00984568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105785|NCT00984568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6105786|NCT00984568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6105787|NCT00984568|Immunologic Factors|immunologic factors|mesh-ancestor
6105788|NCT00984568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6105789|NCT00984568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6105790|NCT00984568|Analgesics|analgesics|mesh-ancestor
6105791|NCT00984568|Sensory System Agents|sensory system agents|mesh-ancestor
6105792|NCT00984568|Antitubercular Agents|antitubercular agents|mesh-ancestor
5525842|NCT04276688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525843|NCT04276688|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5525844|NCT04276649|Calcium Carbonate|calcium carbonate|mesh-list
6105793|NCT00984568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6105794|NCT00984568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6105795|NCT00984620|Interferons|interferons|mesh-list
6105796|NCT00984620|Ribavirin|ribavirin|mesh-list
6105797|NCT00984620|Interferon-alpha|interferon-alpha|mesh-list
6105798|NCT00984620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6105799|NCT00984620|Antiviral Agents|antiviral agents|mesh-ancestor
6105800|NCT00984620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6105801|NCT00984620|Antimetabolites|antimetabolites|mesh-ancestor
6105802|NCT00984620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105803|NCT00984620|Immunologic Factors|immunologic factors|mesh-ancestor
6105804|NCT00984620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105805|NCT00984659|Fluticasone|fluticasone|mesh-list
6105806|NCT00984659|Xhance|xhance|mesh-list
6105807|NCT00984659|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6105808|NCT00984659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6105809|NCT00984659|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6105810|NCT00984659|Autonomic Agents|autonomic agents|mesh-ancestor
6105811|NCT00984659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6105812|NCT00984659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105813|NCT00984659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6105814|NCT00984659|Respiratory System Agents|respiratory system agents|mesh-ancestor
6105815|NCT00984659|Dermatologic Agents|dermatologic agents|mesh-ancestor
6105816|NCT00984659|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6105817|NCT00984659|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6105818|NCT00984659|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6105819|NCT00984659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6105820|NCT00984659|Adrenergic Agents|adrenergic agents|mesh-ancestor
6465249|NCT00473239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525845|NCT04276649|Antacids|antacids|mesh-ancestor
5525846|NCT04276649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525847|NCT04276649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5525848|NCT04276636|Calcium Carbonate|calcium carbonate|mesh-list
6465250|NCT00473239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6465251|NCT00473239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6465252|NCT00473343|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
6465253|NCT00473343|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6465254|NCT00473343|Dermatologic Agents|dermatologic agents|mesh-ancestor
6465255|NCT00473460|Moxifloxacin|moxifloxacin|mesh-list
6465256|NCT00473460|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6465257|NCT00473460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6465258|NCT00473460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6465259|NCT00473460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6465260|NCT00473460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6465261|NCT00473460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6105821|NCT00984659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6105822|NCT00984659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105823|NCT00984867|Dapagliflozin|dapagliflozin|mesh-list
5525849|NCT04276636|Antacids|antacids|mesh-ancestor
5525850|NCT04276636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525851|NCT04276636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6105824|NCT00984867|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6105825|NCT00984867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105826|NCT00984867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6105827|NCT00984867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105828|NCT00985192|Everolimus|everolimus|mesh-list
6105829|NCT00985192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6105830|NCT00985192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6105831|NCT00985192|Immunologic Factors|immunologic factors|mesh-ancestor
6105832|NCT00985192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105833|NCT00985426|Vaccines|vaccines|mesh-list
6105834|NCT00985426|Immunologic Factors|immunologic factors|mesh-ancestor
6105835|NCT00985426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105836|NCT00985439|Celecoxib|celecoxib|mesh-list
6105837|NCT00985439|Diclofenac|diclofenac|mesh-list
6105838|NCT00985439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6105839|NCT00985439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6105840|NCT00985439|Analgesics|analgesics|mesh-ancestor
6105841|NCT00985439|Sensory System Agents|sensory system agents|mesh-ancestor
6105842|NCT00985439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6105843|NCT00985439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105844|NCT00985439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6105845|NCT00985439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6105846|NCT00985439|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6105847|NCT00985439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6105848|NCT00985439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6105849|NCT00985439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105850|NCT00985465|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6105851|NCT00985465|Immunologic Factors|immunologic factors|mesh-ancestor
6105852|NCT00985465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105853|NCT00985504|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6105854|NCT00985504|Citalopram|citalopram|mesh-list
6105855|NCT00985504|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6105856|NCT00985504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6105857|NCT00985504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6105858|NCT00985504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105859|NCT00985504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6105860|NCT00985504|Serotonin Agents|serotonin agents|mesh-ancestor
6105861|NCT00985504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525852|NCT04276389|Paclitaxel|paclitaxel|mesh-list
5525853|NCT04276389|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5525854|NCT04276389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5525855|NCT04276389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5525856|NCT04276389|Tubulin Modulators|tubulin modulators|mesh-ancestor
5525857|NCT04276389|Antimitotic Agents|antimitotic agents|mesh-ancestor
5525858|NCT04276389|Mitosis Modulators|mitosis modulators|mesh-ancestor
5525859|NCT04276389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525860|NCT04276376|Atezolizumab|atezolizumab|mesh-list
6105862|NCT00985504|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6105863|NCT00985504|Antidepressive Agents|antidepressive agents|mesh-ancestor
6105864|NCT00985504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6672415|NCT01555879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5525861|NCT04276376|Rucaparib|rucaparib|mesh-list
5525862|NCT04276376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5525863|NCT04276376|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5525864|NCT04276376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5525865|NCT04276376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525866|NCT04276298|Metronidazole|metronidazole|mesh-list
5525867|NCT04276298|Lidocaine|lidocaine|mesh-list
5525868|NCT04276298|Diltiazem|diltiazem|mesh-list
5525869|NCT04276298|Anesthetics, Local|anesthetics, local|mesh-ancestor
5525870|NCT04276298|Anesthetics|anesthetics|mesh-ancestor
5525871|NCT04276298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5525872|NCT04276298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525873|NCT04276298|Sensory System Agents|sensory system agents|mesh-ancestor
5525874|NCT04276298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5525875|NCT04276298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5525876|NCT04276298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5525877|NCT04276298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5525878|NCT04276298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5525879|NCT04276298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525880|NCT04276298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5525881|NCT04276298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5525882|NCT04276298|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5525883|NCT04276298|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5525884|NCT04276298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5525885|NCT04276298|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5525886|NCT04276298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5525887|NCT04276298|Vasodilator Agents|vasodilator agents|mesh-ancestor
5525888|NCT04276480|Tazobactam|tazobactam|mesh-list
5525889|NCT04276480|Piperacillin|piperacillin|mesh-list
5525890|NCT04276480|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
6105865|NCT00985504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6105866|NCT00985504|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6105867|NCT00985504|Analgesics|analgesics|mesh-ancestor
6105868|NCT00985504|Sensory System Agents|sensory system agents|mesh-ancestor
6105869|NCT00985504|Dopamine Agents|dopamine agents|mesh-ancestor
6105870|NCT00985543|Ritonavir|ritonavir|mesh-list
6105871|NCT00985543|Lopinavir|lopinavir|mesh-list
6105872|NCT00985543|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6105873|NCT00985543|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6105874|NCT00985543|Protease Inhibitors|protease inhibitors|mesh-ancestor
5525891|NCT04276480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5525892|NCT04276480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5525893|NCT04276480|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5525894|NCT04276480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5525895|NCT04276480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601279|NCT03706300|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5601280|NCT03706300|Autonomic Agents|autonomic agents|mesh-ancestor
5601281|NCT03706300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5601282|NCT03706300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601283|NCT03706300|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5601284|NCT03706300|Respiratory System Agents|respiratory system agents|mesh-ancestor
5601285|NCT03706300|Nasal Decongestants|nasal decongestants|mesh-ancestor
5601286|NCT03706300|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5601287|NCT03706300|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5601288|NCT03706300|Sympathomimetics|sympathomimetics|mesh-ancestor
6105875|NCT00985543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6105876|NCT00985543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105877|NCT00985543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6105878|NCT00985543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6105879|NCT00985543|Antiviral Agents|antiviral agents|mesh-ancestor
6105880|NCT00985543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5601289|NCT03706300|Adrenergic Agents|adrenergic agents|mesh-ancestor
5601290|NCT03706300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5601291|NCT03706300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601292|NCT03706300|Expectorants|expectorants|mesh-ancestor
5601293|NCT03706300|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6105881|NCT00985543|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6105882|NCT00985543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6105883|NCT00985621|Oxycodone|oxycodone|mesh-list
6105884|NCT00985621|Tanezumab|tanezumab|mesh-list
6105885|NCT00985621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6105886|NCT00985621|Narcotics|narcotics|mesh-ancestor
6105887|NCT00985621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6105888|NCT00985621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105889|NCT00985621|Analgesics|analgesics|mesh-ancestor
6105890|NCT00985621|Sensory System Agents|sensory system agents|mesh-ancestor
6105891|NCT00985621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6105892|NCT00985712|Insulin Lispro|insulin lispro|mesh-list
6105893|NCT00985712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6105894|NCT00985712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105895|NCT00985725|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6105896|NCT00985725|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6105897|NCT00985725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105898|NCT00985725|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6105899|NCT00985725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6105900|NCT00985725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6105901|NCT00985725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105902|NCT00985725|Dopamine Agents|dopamine agents|mesh-ancestor
6105903|NCT00985725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6105904|NCT00985751|Vaccines|vaccines|mesh-list
6105905|NCT00985751|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6105906|NCT00985751|Immunologic Factors|immunologic factors|mesh-ancestor
6105907|NCT00985751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105908|NCT00985907|Bortezomib|bortezomib|mesh-list
6105909|NCT00985907|Melphalan|melphalan|mesh-list
6105910|NCT00985907|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5601294|NCT03706300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5601295|NCT03706300|Appetite Depressants|appetite depressants|mesh-ancestor
5601296|NCT03706300|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5601297|NCT03706287|Cisplatin|cisplatin|mesh-list
5525896|NCT04276428|Insulin|insulin|mesh-list
5525897|NCT04276428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5525898|NCT04276428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525899|NCT04276597|Edotreotide|edotreotide|mesh-list
6105911|NCT00985907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6105912|NCT00985907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6105913|NCT00985907|Alkylating Agents|alkylating agents|mesh-ancestor
6105914|NCT00985907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105915|NCT00985907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6105916|NCT00985907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6105917|NCT00985907|Immunologic Factors|immunologic factors|mesh-ancestor
6105918|NCT00985907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105919|NCT00985907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6105920|NCT00985946|Panobinostat|panobinostat|mesh-list
6105921|NCT00985946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6105922|NCT00985946|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5525900|NCT04276597|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5525901|NCT04276597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525902|NCT04276363|Nicotine|nicotine|mesh-list
5525903|NCT04276363|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5525904|NCT04276363|Autonomic Agents|autonomic agents|mesh-ancestor
5525905|NCT04276363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5525906|NCT04276363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525907|NCT04276363|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5525908|NCT04276363|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5525909|NCT04276363|Cholinergic Agents|cholinergic agents|mesh-ancestor
5525910|NCT04276363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5525911|NCT04276363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525912|NCT04276545|Midazolam|midazolam|mesh-list
5525913|NCT04276545|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6105923|NCT00985946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6105924|NCT00985946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105925|NCT00985959|Prednisolone|prednisolone|mesh-list
6105926|NCT00985959|Bortezomib|bortezomib|mesh-list
6105927|NCT00985959|Melphalan|melphalan|mesh-list
6105928|NCT00985959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6105929|NCT00985959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6105930|NCT00985959|Alkylating Agents|alkylating agents|mesh-ancestor
6105931|NCT00985959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105932|NCT00985959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6105933|NCT00985959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6105934|NCT00985959|Immunologic Factors|immunologic factors|mesh-ancestor
6105935|NCT00985959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105936|NCT00985959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6105937|NCT00985959|Glucocorticoids|glucocorticoids|mesh-ancestor
6105938|NCT00985959|Hormones|hormones|mesh-ancestor
6105939|NCT00985959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6105940|NCT00985959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6105941|NCT00985985|Nicotine|nicotine|mesh-list
6105942|NCT00985985|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6105943|NCT00985985|Autonomic Agents|autonomic agents|mesh-ancestor
6105944|NCT00985985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6105945|NCT00985985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105946|NCT00985985|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6105947|NCT00985985|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6105948|NCT00985985|Cholinergic Agents|cholinergic agents|mesh-ancestor
6105949|NCT00985985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6105950|NCT00985985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105951|NCT00986102|Doripenem|doripenem|mesh-list
6105952|NCT00986102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6105953|NCT00986102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6105954|NCT00986154|Heparin|heparin|mesh-list
6105955|NCT00986154|Calcium heparin|calcium heparin|mesh-list
5525914|NCT04276545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5525915|NCT04276545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5525916|NCT04276545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525917|NCT04276545|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5525918|NCT04276545|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5525919|NCT04276545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5525920|NCT04276545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5525921|NCT04276545|Anesthetics, General|anesthetics, general|mesh-ancestor
5525922|NCT04276545|Anesthetics|anesthetics|mesh-ancestor
5525923|NCT04276545|GABA Modulators|gaba modulators|mesh-ancestor
5525924|NCT04276545|GABA Agents|gaba agents|mesh-ancestor
5525925|NCT04276545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5525926|NCT04276545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525927|NCT04276090|Dexamethasone|dexamethasone|mesh-list
5525928|NCT04276090|Floxuridine|floxuridine|mesh-list
5525929|NCT04276090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5525930|NCT04276090|Antiemetics|antiemetics|mesh-ancestor
5525931|NCT04276090|Autonomic Agents|autonomic agents|mesh-ancestor
5525932|NCT04276090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5525933|NCT04276090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525934|NCT04276090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5525935|NCT04276090|Glucocorticoids|glucocorticoids|mesh-ancestor
5525936|NCT04276090|Hormones|hormones|mesh-ancestor
5525937|NCT04276090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5525938|NCT04276090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5525939|NCT04276090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5525940|NCT04276090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5525941|NCT04276090|Antimetabolites|antimetabolites|mesh-ancestor
6105956|NCT00986154|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6105957|NCT00986154|Tinzaparin|tinzaparin|mesh-list
6105958|NCT00986154|Dalteparin|dalteparin|mesh-list
6105959|NCT00986154|Warfarin|warfarin|mesh-list
6105960|NCT00986154|Edoxaban|edoxaban|mesh-list
6105961|NCT00986154|Anticoagulants|anticoagulants|mesh-ancestor
6105962|NCT00986154|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6105963|NCT00986154|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6105964|NCT00986154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105965|NCT00986154|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6105966|NCT00986154|Antithrombins|antithrombins|mesh-ancestor
6105967|NCT00986154|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6105968|NCT00986154|Protease Inhibitors|protease inhibitors|mesh-ancestor
6465262|NCT00473460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465263|NCT00473460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6465264|NCT00473460|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6465265|NCT00473460|Contraceptive Agents|contraceptive agents|mesh-ancestor
5525942|NCT04276090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525943|NCT04276155|Anticoagulants|anticoagulants|mesh-list
5525944|NCT04276025|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5525945|NCT04276025|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5525946|NCT04276025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525947|NCT04275960|Selitrectinib|selitrectinib|mesh-list
5525948|NCT04275960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5525949|NCT04275960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525950|NCT04275661|Magnesium Sulfate|magnesium sulfate|mesh-list
5525951|NCT04275661|Ketamine|ketamine|mesh-list
5525952|NCT04275661|Levobupivacaine|levobupivacaine|mesh-list
5525953|NCT04275661|Analgesics|analgesics|mesh-ancestor
5525954|NCT04275661|Sensory System Agents|sensory system agents|mesh-ancestor
5525955|NCT04275661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5525956|NCT04275661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525957|NCT04275661|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5525958|NCT04275661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6672416|NCT01555918|Isavuconazole|isavuconazole|mesh-list
5525959|NCT04275661|Anesthetics, General|anesthetics, general|mesh-ancestor
6105969|NCT00986154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5525960|NCT04275661|Anesthetics|anesthetics|mesh-ancestor
5525961|NCT04275661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6465266|NCT00473460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6465267|NCT00473460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465268|NCT00473460|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6465269|NCT00473460|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6105970|NCT00986180|Oxycodone|oxycodone|mesh-list
6105971|NCT00986180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6105972|NCT00986180|Narcotics|narcotics|mesh-ancestor
6105973|NCT00986180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6105974|NCT00986180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105975|NCT00986180|Analgesics|analgesics|mesh-ancestor
6105976|NCT00986180|Sensory System Agents|sensory system agents|mesh-ancestor
6105977|NCT00986180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6105978|NCT00986245|Ropinirole|ropinirole|mesh-list
6105979|NCT00986245|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6105980|NCT00986245|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6105981|NCT00986245|Dopamine Agonists|dopamine agonists|mesh-ancestor
6105982|NCT00986245|Dopamine Agents|dopamine agents|mesh-ancestor
6105983|NCT00986245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6105984|NCT00986245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105985|NCT00986245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105986|NCT00986258|Tapentadol|tapentadol|mesh-list
6105987|NCT00986258|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6105988|NCT00986258|Narcotics|narcotics|mesh-ancestor
6105989|NCT00986258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6105990|NCT00986258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6105991|NCT00986258|Analgesics|analgesics|mesh-ancestor
6105992|NCT00986258|Sensory System Agents|sensory system agents|mesh-ancestor
6105993|NCT00986258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6105994|NCT00986258|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6105995|NCT00986258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6105996|NCT00986258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6105997|NCT00986258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6105998|NCT00986258|Adrenergic Agents|adrenergic agents|mesh-ancestor
6105999|NCT00986258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6106000|NCT00986401|Metformin|metformin|mesh-list
6106001|NCT00986401|Trospium chloride|trospium chloride|mesh-list
6106002|NCT00986401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5525962|NCT04275661|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5525963|NCT04275661|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5525964|NCT04275661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5525965|NCT04275661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525966|NCT04275661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5525967|NCT04275661|Anticonvulsants|anticonvulsants|mesh-ancestor
5525968|NCT04275661|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5525969|NCT04275661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5525970|NCT04275661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5525971|NCT04275661|Tocolytic Agents|tocolytic agents|mesh-ancestor
5525972|NCT04275661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5525973|NCT04275661|Anesthetics, Local|anesthetics, local|mesh-ancestor
5525974|NCT04275713|Metformin|metformin|mesh-list
6106003|NCT00986401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106004|NCT00986401|Parasympatholytics|parasympatholytics|mesh-ancestor
6106005|NCT00986401|Autonomic Agents|autonomic agents|mesh-ancestor
6106006|NCT00986401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6106007|NCT00986401|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6106008|NCT00986401|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6106009|NCT00986401|Cholinergic Agents|cholinergic agents|mesh-ancestor
6106010|NCT00986401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6106011|NCT00986401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106012|NCT00986401|Urological Agents|urological agents|mesh-ancestor
6106013|NCT00986427|Cyclosporine|cyclosporine|mesh-list
6106014|NCT00986427|Cyclosporins|cyclosporins|mesh-list
6106015|NCT00986427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6106016|NCT00986427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106017|NCT00986427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6106018|NCT00986427|Immunologic Factors|immunologic factors|mesh-ancestor
6106019|NCT00986427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106020|NCT00986427|Antifungal Agents|antifungal agents|mesh-ancestor
6106021|NCT00986427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5525975|NCT04275713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6106022|NCT00986427|Dermatologic Agents|dermatologic agents|mesh-ancestor
6106023|NCT00986427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6106024|NCT00986427|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6106025|NCT00986440|Efatutazone|efatutazone|mesh-list
6106026|NCT00986440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6106027|NCT00986570|Botulinum Toxins|botulinum toxins|mesh-list
5525976|NCT04275713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525977|NCT04275778|Hydroxychloroquine|hydroxychloroquine|mesh-list
5525978|NCT04275778|Antimalarials|antimalarials|mesh-ancestor
5525979|NCT04275778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5525980|NCT04275778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6106028|NCT00986570|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6106029|NCT00986570|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6106030|NCT00986570|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6106031|NCT00986570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6106032|NCT00986570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106033|NCT00986570|Cholinergic Agents|cholinergic agents|mesh-ancestor
6106034|NCT00986570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6106035|NCT00986570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106036|NCT00986570|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6106037|NCT00986570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6106038|NCT00986583|Succinylcholine|succinylcholine|mesh-list
6106039|NCT00986583|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
6106040|NCT00986583|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6106041|NCT00986583|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6106042|NCT00986583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6106043|NCT00986583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106044|NCT00986674|Paclitaxel|paclitaxel|mesh-list
6106045|NCT00986674|Carboplatin|carboplatin|mesh-list
5525981|NCT04275778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5525982|NCT04275778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5525983|NCT04275778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525984|NCT04275778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5525985|NCT04275414|Bevacizumab|bevacizumab|mesh-list
5525986|NCT04275414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5525987|NCT04275414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5525988|NCT04275414|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5525989|NCT04275414|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5525990|NCT04275414|Growth Substances|growth substances|mesh-ancestor
5525991|NCT04275414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5525992|NCT04275414|Growth Inhibitors|growth inhibitors|mesh-ancestor
5525993|NCT04275518|Cytarabine|cytarabine|mesh-list
5525994|NCT04275518|Azacitidine|azacitidine|mesh-list
5525995|NCT04275518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5525996|NCT04275518|Antimetabolites|antimetabolites|mesh-ancestor
6106046|NCT00986674|Cetuximab|cetuximab|mesh-list
6106047|NCT00986674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6106048|NCT00986674|Antibodies|antibodies|mesh-list
6106049|NCT00986674|Immunoglobulins|immunoglobulins|mesh-list
6106050|NCT00986674|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6106051|NCT00986674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6106052|NCT00986674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6106053|NCT00986674|Tubulin Modulators|tubulin modulators|mesh-ancestor
6106054|NCT00986674|Antimitotic Agents|antimitotic agents|mesh-ancestor
6106055|NCT00986674|Mitosis Modulators|mitosis modulators|mesh-ancestor
6106056|NCT00986674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106057|NCT00986674|Immunologic Factors|immunologic factors|mesh-ancestor
6106058|NCT00986674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106059|NCT00986856|Fusidic Acid|fusidic acid|mesh-list
6106060|NCT00986856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6106061|NCT00986856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6106062|NCT00986856|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6106063|NCT00986856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6106064|NCT00986856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106065|NCT00986921|Mifepristone|mifepristone|mesh-list
6106066|NCT00986921|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6106067|NCT00986921|Abortifacient Agents|abortifacient agents|mesh-ancestor
6106068|NCT00986921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6106069|NCT00986921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106070|NCT00986921|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6106071|NCT00986921|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6106072|NCT00986921|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6106073|NCT00986921|Contraceptive Agents|contraceptive agents|mesh-ancestor
6106074|NCT00986921|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6106075|NCT00986921|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6106076|NCT00986921|Hormone Antagonists|hormone antagonists|mesh-ancestor
5601298|NCT03706287|Carboplatin|carboplatin|mesh-list
6465270|NCT00473460|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6465271|NCT00473486|Carboplatin|carboplatin|mesh-list
5525997|NCT04275518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5525998|NCT04275518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5525999|NCT04275518|Antiviral Agents|antiviral agents|mesh-ancestor
5526000|NCT04275518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5526001|NCT04275518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5526002|NCT04275518|Immunologic Factors|immunologic factors|mesh-ancestor
5526003|NCT04275518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526004|NCT04275518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5526005|NCT04275375|Anesthetics|anesthetics|mesh-list
5526006|NCT04275375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5526007|NCT04275375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526008|NCT04275232|Plasminogen|plasminogen|mesh-list
6465272|NCT00473486|Pemetrexed|pemetrexed|mesh-list
6106077|NCT00986921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6106078|NCT00986921|Luteolytic Agents|luteolytic agents|mesh-ancestor
6106079|NCT00986921|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6106080|NCT00986921|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6106081|NCT00986986|Niacin|niacin|mesh-list
6106082|NCT00986986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6106083|NCT00986986|Antimetabolites|antimetabolites|mesh-ancestor
6106084|NCT00986986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106085|NCT00986986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6106086|NCT00986986|Vasodilator Agents|vasodilator agents|mesh-ancestor
6106087|NCT00986986|Vitamin B Complex|vitamin b complex|mesh-ancestor
6106088|NCT00986986|Vitamins|vitamins|mesh-ancestor
6106089|NCT00986986|Micronutrients|micronutrients|mesh-ancestor
6106090|NCT00986986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106091|NCT00987389|Glucocorticoids|glucocorticoids|mesh-list
6106092|NCT00987389|Hormones|hormones|mesh-ancestor
6106093|NCT00987389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6106094|NCT00987389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106095|NCT00987402|Ethanol|ethanol|mesh-list
6106096|NCT00987402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6106097|NCT00987402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6106098|NCT00987402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6465273|NCT00473486|Sorafenib|sorafenib|mesh-list
6465274|NCT00473486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6465275|NCT00473486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6465276|NCT00473486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526009|NCT04275232|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6106099|NCT00987402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106100|NCT00987415|Allopurinol|allopurinol|mesh-list
6106101|NCT00987415|Antimetabolites|antimetabolites|mesh-ancestor
6106102|NCT00987415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106103|NCT00987415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6106104|NCT00987415|Gout Suppressants|gout suppressants|mesh-ancestor
6106105|NCT00987415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6106106|NCT00987415|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6106107|NCT00987415|Antioxidants|antioxidants|mesh-ancestor
6106108|NCT00987415|Protective Agents|protective agents|mesh-ancestor
6106109|NCT00987415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106110|NCT00987467|Cyclosporine|cyclosporine|mesh-list
6106111|NCT00987467|Cyclosporins|cyclosporins|mesh-list
6106112|NCT00987467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6106113|NCT00987467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106114|NCT00987467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6106115|NCT00987467|Immunologic Factors|immunologic factors|mesh-ancestor
6106116|NCT00987467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106117|NCT00987467|Antifungal Agents|antifungal agents|mesh-ancestor
6106118|NCT00987467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6106119|NCT00987467|Dermatologic Agents|dermatologic agents|mesh-ancestor
6106120|NCT00987467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6106121|NCT00987467|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6106122|NCT00987480|Cyclosporine|cyclosporine|mesh-list
6106123|NCT00987480|Cyclophosphamide|cyclophosphamide|mesh-list
6106124|NCT00987480|Busulfan|busulfan|mesh-list
6106125|NCT00987480|Fludarabine|fludarabine|mesh-list
6106126|NCT00987480|Cyclosporins|cyclosporins|mesh-list
6106127|NCT00987480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6106128|NCT00987480|Immunologic Factors|immunologic factors|mesh-ancestor
6106129|NCT00987480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526010|NCT04275232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6106130|NCT00987480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6465277|NCT00473486|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6106131|NCT00987480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6106132|NCT00987480|Alkylating Agents|alkylating agents|mesh-ancestor
6106133|NCT00987480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106134|NCT00987480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6106135|NCT00987480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6106136|NCT00987480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6106137|NCT00987480|Antifungal Agents|antifungal agents|mesh-ancestor
6106138|NCT00987480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6106139|NCT00987480|Dermatologic Agents|dermatologic agents|mesh-ancestor
6106140|NCT00987480|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6106141|NCT00987558|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
5526011|NCT04275232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526012|NCT04275388|Interferons|interferons|mesh-list
5526013|NCT04275388|Ritonavir|ritonavir|mesh-list
5526014|NCT04275388|Lopinavir|lopinavir|mesh-list
5526015|NCT04275388|Interferon-alpha|interferon-alpha|mesh-list
5526016|NCT04275388|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
5526017|NCT04275388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5526018|NCT04275388|Antiviral Agents|antiviral agents|mesh-ancestor
5526019|NCT04275388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5526020|NCT04275388|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5526021|NCT04275388|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5526022|NCT04275388|Protease Inhibitors|protease inhibitors|mesh-ancestor
5526023|NCT04275388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5526024|NCT04275388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526025|NCT04275388|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5526026|NCT04275388|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5526027|NCT04275388|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5526028|NCT04275388|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5526029|NCT04275388|Immunologic Factors|immunologic factors|mesh-ancestor
5526030|NCT04275388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106142|NCT00987558|Simvastatin|simvastatin|mesh-list
6106143|NCT00987558|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6106144|NCT00987558|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5526031|NCT04275284|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5526032|NCT04275284|Immunologic Factors|immunologic factors|mesh-ancestor
5526033|NCT04275284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526034|NCT04275258|Analgesics, Opioid|analgesics, opioid|mesh-list
5526035|NCT04275258|Narcotics|narcotics|mesh-ancestor
5526036|NCT04275258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5526037|NCT04275258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526038|NCT04275258|Analgesics|analgesics|mesh-ancestor
5526039|NCT04275258|Sensory System Agents|sensory system agents|mesh-ancestor
5526040|NCT04275258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6106145|NCT00987558|Antimetabolites|antimetabolites|mesh-ancestor
6106146|NCT00987558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106147|NCT00987558|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6106148|NCT00987558|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6106149|NCT00987558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6106150|NCT00987558|Anticonvulsants|anticonvulsants|mesh-ancestor
6106151|NCT00987558|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6106152|NCT00987558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6106153|NCT00987558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6106154|NCT00987727|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6106155|NCT00987727|Hyaluronic Acid|hyaluronic acid|mesh-list
6106156|NCT00987727|Glycerol|glycerol|mesh-list
6106157|NCT00987727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6106158|NCT00987727|Immunologic Factors|immunologic factors|mesh-ancestor
5526041|NCT04275492|Pramipexole|pramipexole|mesh-list
5526042|NCT04275492|Antioxidants|antioxidants|mesh-ancestor
5526043|NCT04275492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526044|NCT04275492|Protective Agents|protective agents|mesh-ancestor
5601299|NCT03706287|Pemetrexed|pemetrexed|mesh-list
5725270|NCT03181243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5725271|NCT03181243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725272|NCT03181360|Tenecteplase|tenecteplase|mesh-list
5725273|NCT03181360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5725274|NCT03181360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5725275|NCT03181360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725276|NCT03181815|Cytarabine|cytarabine|mesh-list
5725277|NCT03181815|Cladribine|cladribine|mesh-list
5725278|NCT03181815|Aclarubicin|aclarubicin|mesh-list
5725279|NCT03181815|Aclacinomycins|aclacinomycins|mesh-list
5725280|NCT03181815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5725281|NCT03181815|Antimetabolites|antimetabolites|mesh-ancestor
6106159|NCT00987727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106160|NCT00987727|Viscosupplements|viscosupplements|mesh-ancestor
6106161|NCT00987727|Protective Agents|protective agents|mesh-ancestor
6106162|NCT00987727|Laxatives|laxatives|mesh-ancestor
6106163|NCT00987727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6106164|NCT00987727|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6106165|NCT00987831|Methylprednisolone|methylprednisolone|mesh-list
6106166|NCT00987831|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6106167|NCT00987831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6106168|NCT00987831|Antiemetics|antiemetics|mesh-ancestor
6106169|NCT00987831|Autonomic Agents|autonomic agents|mesh-ancestor
6106170|NCT00987831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6106171|NCT00987831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106172|NCT00987831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6106173|NCT00987831|Glucocorticoids|glucocorticoids|mesh-ancestor
6106174|NCT00987831|Hormones|hormones|mesh-ancestor
6106175|NCT00987831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6106176|NCT00987831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6106177|NCT00987831|Protective Agents|protective agents|mesh-ancestor
6106178|NCT00987935|Sorafenib|sorafenib|mesh-list
6106179|NCT00987935|Nintedanib|nintedanib|mesh-list
6106180|NCT00987935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6106181|NCT00987935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6106182|NCT00987935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6106183|NCT00987935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106184|NCT00987948|Maraviroc|maraviroc|mesh-list
6106185|NCT00987948|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6106186|NCT00987948|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6106187|NCT00987948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106188|NCT00987948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6106189|NCT00987948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6106190|NCT00987948|Antiviral Agents|antiviral agents|mesh-ancestor
6106191|NCT00987948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6106192|NCT00987948|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6204054|NCT02064920|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6204055|NCT02064920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6204056|NCT02064920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204057|NCT02064920|Cholinergic Agents|cholinergic agents|mesh-ancestor
6204058|NCT02064920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6204059|NCT02064920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204060|NCT02064920|Nootropic Agents|nootropic agents|mesh-ancestor
6204061|NCT02064985|Ticagrelor|ticagrelor|mesh-list
5526045|NCT04275492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526046|NCT04275492|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5526047|NCT04275492|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5526048|NCT04275492|Dopamine Agonists|dopamine agonists|mesh-ancestor
5526049|NCT04275492|Dopamine Agents|dopamine agents|mesh-ancestor
5526050|NCT04275492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5526051|NCT04275362|Cimetidine|cimetidine|mesh-list
5526052|NCT04275362|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5526053|NCT04275362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5526054|NCT04275362|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5526055|NCT04275362|Histamine Antagonists|histamine antagonists|mesh-ancestor
5526056|NCT04275362|Histamine Agents|histamine agents|mesh-ancestor
5526057|NCT04275362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5526058|NCT04275362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526059|NCT04275362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526060|NCT04275362|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5526061|NCT04275362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5526062|NCT04275362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5526063|NCT04275115|Midazolam|midazolam|mesh-list
5526064|NCT04275115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5526065|NCT04275115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5526066|NCT04275115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5526067|NCT04275115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526068|NCT04275115|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5526069|NCT04275115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5526070|NCT04275115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6204062|NCT02064985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6204063|NCT02064985|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6204064|NCT02064985|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6204065|NCT02064985|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6204066|NCT02064985|Purinergic Agents|purinergic agents|mesh-ancestor
6204067|NCT02064985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6207767|NCT02120261|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5526071|NCT04275115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5526072|NCT04275115|Anesthetics, General|anesthetics, general|mesh-ancestor
5526073|NCT04275115|Anesthetics|anesthetics|mesh-ancestor
5526074|NCT04275115|GABA Modulators|gaba modulators|mesh-ancestor
5526075|NCT04275115|GABA Agents|gaba agents|mesh-ancestor
5526076|NCT04275115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5526077|NCT04275115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526078|NCT04275180|Argatroban|argatroban|mesh-list
5526079|NCT04275180|Antithrombins|antithrombins|mesh-ancestor
5526080|NCT04275180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5526081|NCT04275180|Protease Inhibitors|protease inhibitors|mesh-ancestor
5526082|NCT04275180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5526083|NCT04275180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526084|NCT04275180|Anticoagulants|anticoagulants|mesh-ancestor
5526085|NCT04275180|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5526086|NCT04274933|Capecitabine|capecitabine|mesh-list
5526087|NCT04274933|Venetoclax|venetoclax|mesh-list
5526088|NCT04274933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5526089|NCT04274933|Antimetabolites|antimetabolites|mesh-ancestor
5526090|NCT04274933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526091|NCT04274933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5526092|NCT04274920|Calcium|calcium|mesh-list
5526093|NCT04274920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5526094|NCT04274920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526095|NCT04275024|Calcipotriene|calcipotriene|mesh-list
5526096|NCT04275024|Dermatologic Agents|dermatologic agents|mesh-ancestor
5526097|NCT04274907|Pembrolizumab|pembrolizumab|mesh-list
5526098|NCT04274907|Venetoclax|venetoclax|mesh-list
5526099|NCT04274907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5526100|NCT04274907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5601300|NCT03706287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5601301|NCT03706287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5601302|NCT03706287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601303|NCT03706287|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5601304|NCT03706287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5601305|NCT03706222|Grazoprevir|grazoprevir|mesh-list
5601306|NCT03706222|Antiviral Agents|antiviral agents|mesh-ancestor
5601307|NCT03706222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5601308|NCT03706157|Doxorubicin|doxorubicin|mesh-list
5601309|NCT03706157|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5601310|NCT03706157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5601311|NCT03706157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5601312|NCT03706157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5601313|NCT03706157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5601314|NCT03706157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5601315|NCT03706157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601316|NCT03706053|Midodrine|midodrine|mesh-list
5601317|NCT03706053|Sympathomimetics|sympathomimetics|mesh-ancestor
5601318|NCT03706053|Autonomic Agents|autonomic agents|mesh-ancestor
5601319|NCT03706053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6106193|NCT00988091|Hyaluronic Acid|hyaluronic acid|mesh-list
6106194|NCT00988091|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6106195|NCT00988091|Immunologic Factors|immunologic factors|mesh-ancestor
6106196|NCT00988091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106197|NCT00988091|Viscosupplements|viscosupplements|mesh-ancestor
6106198|NCT00988091|Protective Agents|protective agents|mesh-ancestor
6106199|NCT00988117|Rivastigmine|rivastigmine|mesh-list
6106200|NCT00988117|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6106201|NCT00988117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6106202|NCT00988117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106203|NCT00988117|Cholinergic Agents|cholinergic agents|mesh-ancestor
6106204|NCT00988117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6106205|NCT00988117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106206|NCT00988117|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6106207|NCT00988117|Protective Agents|protective agents|mesh-ancestor
6106208|NCT00988143|Vaccines|vaccines|mesh-list
6106209|NCT00988143|Immunologic Factors|immunologic factors|mesh-ancestor
6106210|NCT00988143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106211|NCT00988156|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
6106212|NCT00988156|Anticonvulsants|anticonvulsants|mesh-ancestor
6106213|NCT00988156|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6106214|NCT00988156|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6106215|NCT00988156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5601320|NCT03706053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601321|NCT03706053|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6207768|NCT02120261|Lidocaine|lidocaine|mesh-list
6106216|NCT00988156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106217|NCT00988169|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6106218|NCT00988169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6106219|NCT00988169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6106220|NCT00988169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6106221|NCT00988169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106222|NCT00988208|Prednisone|prednisone|mesh-list
6106223|NCT00988208|Docetaxel|docetaxel|mesh-list
6106224|NCT00988208|Lenalidomide|lenalidomide|mesh-list
6106225|NCT00988208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6106226|NCT00988208|Tubulin Modulators|tubulin modulators|mesh-ancestor
6106227|NCT00988208|Antimitotic Agents|antimitotic agents|mesh-ancestor
6106228|NCT00988208|Mitosis Modulators|mitosis modulators|mesh-ancestor
6106229|NCT00988208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106230|NCT00988208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6106231|NCT00988208|Glucocorticoids|glucocorticoids|mesh-ancestor
6106232|NCT00988208|Hormones|hormones|mesh-ancestor
6106233|NCT00988208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6106234|NCT00988208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106235|NCT00988208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6106236|NCT00988208|Immunologic Factors|immunologic factors|mesh-ancestor
6106237|NCT00988208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6106238|NCT00988208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6106239|NCT00988208|Growth Substances|growth substances|mesh-ancestor
6106240|NCT00988208|Growth Inhibitors|growth inhibitors|mesh-ancestor
6106241|NCT00988325|Oseltamivir|oseltamivir|mesh-list
6106242|NCT00988325|Antiviral Agents|antiviral agents|mesh-ancestor
6106243|NCT00988325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6106244|NCT00988325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6106245|NCT00988325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106246|NCT00988429|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
6106247|NCT00988429|Anticonvulsants|anticonvulsants|mesh-ancestor
6106248|NCT00988429|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6106249|NCT00988429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6106250|NCT00988429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6106251|NCT00988429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106252|NCT00988533|Ivermectin|ivermectin|mesh-list
6106253|NCT00988533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6106254|NCT00988533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6106255|NCT00988559|Imiquimod|imiquimod|mesh-list
6106256|NCT00988559|Vaccines|vaccines|mesh-list
6106257|NCT00988559|Immunologic Factors|immunologic factors|mesh-ancestor
6106258|NCT00988559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106259|NCT00988559|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6106260|NCT00988559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6106261|NCT00988559|Interferon Inducers|interferon inducers|mesh-ancestor
6106262|NCT00988637|Calcitriol|calcitriol|mesh-list
6106263|NCT00988637|Clobetasol|clobetasol|mesh-list
6106264|NCT00988637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6106265|NCT00988637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106266|NCT00988637|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6106267|NCT00988637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6106268|NCT00988637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106269|NCT00988637|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5526101|NCT04274608|Botulinum Toxins|botulinum toxins|mesh-list
5526102|NCT04274608|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5526103|NCT04274608|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5526104|NCT04274608|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5526105|NCT04274608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5526106|NCT04274608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526107|NCT04274608|Cholinergic Agents|cholinergic agents|mesh-ancestor
5526108|NCT04274608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5526109|NCT04274608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526110|NCT04274608|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5526111|NCT04274608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6106270|NCT00988637|Vitamins|vitamins|mesh-ancestor
6106271|NCT00988637|Micronutrients|micronutrients|mesh-ancestor
6106272|NCT00988637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6106273|NCT00988637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6106274|NCT00988637|Glucocorticoids|glucocorticoids|mesh-ancestor
6106275|NCT00988637|Hormones|hormones|mesh-ancestor
6106276|NCT00988637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6106277|NCT00988832|Infliximab|infliximab|mesh-list
6106278|NCT00988832|Dermatologic Agents|dermatologic agents|mesh-ancestor
6106279|NCT00988832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6106280|NCT00988832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6106281|NCT00988858|Pemetrexed|pemetrexed|mesh-list
6106282|NCT00988858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6106283|NCT00988858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6106284|NCT00988858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106285|NCT00988858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6106286|NCT00988858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6106287|NCT00989092|Darbepoetin alfa|darbepoetin alfa|mesh-list
6106288|NCT00989092|Hematinics|hematinics|mesh-ancestor
6106289|NCT00989157|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5526112|NCT04274595|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
5526113|NCT04274595|Antiviral Agents|antiviral agents|mesh-ancestor
5526114|NCT04274595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6106290|NCT00989157|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6106291|NCT00989157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6106292|NCT00989157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6106293|NCT00989157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106294|NCT00989157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6106295|NCT00989157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106296|NCT00989157|Analgesics|analgesics|mesh-ancestor
6106297|NCT00989157|Sensory System Agents|sensory system agents|mesh-ancestor
5526115|NCT04274816|Tremelimumab|tremelimumab|mesh-list
5526116|NCT04274816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5526117|NCT04274803|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
5526118|NCT04274803|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
5526119|NCT04274803|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5526120|NCT04274803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5526121|NCT04274335|Tranexamic Acid|tranexamic acid|mesh-list
6106298|NCT00989157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6106299|NCT00989157|Antidepressive Agents|antidepressive agents|mesh-ancestor
6106300|NCT00989157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6106301|NCT00989157|Dopamine Agents|dopamine agents|mesh-ancestor
6106302|NCT00989196|Factor VIII|factor viii|mesh-list
6106303|NCT00989196|Coagulants|coagulants|mesh-ancestor
6106304|NCT00989235|Abatacept|abatacept|mesh-list
6106305|NCT00989235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6106306|NCT00989235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106307|NCT00989235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6106308|NCT00989235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6106309|NCT00989235|Immunologic Factors|immunologic factors|mesh-ancestor
6106310|NCT00989235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106311|NCT00989235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6106312|NCT00989586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6106313|NCT00989586|Veltuzumab|veltuzumab|mesh-list
6106314|NCT00989586|Antibodies|antibodies|mesh-list
6106315|NCT00989586|Immunoglobulins|immunoglobulins|mesh-list
6106316|NCT00989586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6106317|NCT00989586|Immunologic Factors|immunologic factors|mesh-ancestor
6106318|NCT00989586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106319|NCT00989586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6106320|NCT00989664|Tositumomab I-131|tositumomab i-131|mesh-list
6106321|NCT00989664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6106322|NCT00989768|Botulinum Toxins|botulinum toxins|mesh-list
6106323|NCT00989768|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6106324|NCT00989768|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6106325|NCT00989768|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6106326|NCT00989768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5526122|NCT04274335|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5526123|NCT04274335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5526124|NCT04274335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526125|NCT04274335|Hemostatics|hemostatics|mesh-ancestor
5526126|NCT04274335|Coagulants|coagulants|mesh-ancestor
5526127|NCT04274270|Endostar protein|endostar protein|mesh-list
5526128|NCT04274270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5526129|NCT04274270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5526130|NCT04274270|Growth Substances|growth substances|mesh-ancestor
6106327|NCT00989768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106328|NCT00989768|Cholinergic Agents|cholinergic agents|mesh-ancestor
6106329|NCT00989768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6106330|NCT00989768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526131|NCT04274270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106331|NCT00989768|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6106332|NCT00989768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6106333|NCT00989781|Dexamethasone|dexamethasone|mesh-list
6106334|NCT00989781|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6106335|NCT00989781|Hormones|hormones|mesh-list
6106336|NCT00989781|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6106337|NCT00989781|Cosyntropin|cosyntropin|mesh-list
6106338|NCT00989781|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6106339|NCT00989781|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
6106340|NCT00989781|beta-Endorphin|beta-endorphin|mesh-list
6106341|NCT00989781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6106342|NCT00989781|Antiemetics|antiemetics|mesh-ancestor
6106343|NCT00989781|Autonomic Agents|autonomic agents|mesh-ancestor
6106344|NCT00989781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6106345|NCT00989781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106346|NCT00989781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6106347|NCT00989781|Glucocorticoids|glucocorticoids|mesh-ancestor
6106348|NCT00989781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6106349|NCT00989781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6106350|NCT00989781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6106351|NCT00989781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6106352|NCT00989781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6106353|NCT00989781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106354|NCT00989833|Budesonide|budesonide|mesh-list
6106355|NCT00989833|Terbutaline|terbutaline|mesh-list
6106356|NCT00989833|Formoterol Fumarate|formoterol fumarate|mesh-list
6106357|NCT00989833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6106358|NCT00989833|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6106359|NCT00989833|Autonomic Agents|autonomic agents|mesh-ancestor
6106360|NCT00989833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6106361|NCT00989833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106362|NCT00989833|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6106363|NCT00989833|Respiratory System Agents|respiratory system agents|mesh-ancestor
6106364|NCT00989833|Glucocorticoids|glucocorticoids|mesh-ancestor
6106365|NCT00989833|Hormones|hormones|mesh-ancestor
6106366|NCT00989833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6106367|NCT00989833|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6106368|NCT00989833|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6106369|NCT00989833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6106370|NCT00989833|Adrenergic Agents|adrenergic agents|mesh-ancestor
6106371|NCT00989833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6106372|NCT00989833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106373|NCT00989833|Sympathomimetics|sympathomimetics|mesh-ancestor
6106374|NCT00989833|Tocolytic Agents|tocolytic agents|mesh-ancestor
6106375|NCT00989833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6106376|NCT00989911|Bosentan|bosentan|mesh-list
6106377|NCT00989911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6106378|NCT00989911|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6106379|NCT00989911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106380|NCT00989950|Methylphenidate|methylphenidate|mesh-list
6106381|NCT00989950|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6106382|NCT00989950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526132|NCT04274270|Growth Inhibitors|growth inhibitors|mesh-ancestor
5526133|NCT04274270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5526134|NCT04274166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5526135|NCT04274166|Immunologic Factors|immunologic factors|mesh-ancestor
5526136|NCT04274166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526137|NCT04274413|Adrenergic Agents|adrenergic agents|mesh-list
5526138|NCT04274413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5526139|NCT04274413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526140|NCT04274413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526141|NCT04274257|Rituximab|rituximab|mesh-list
5526142|NCT04274257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5526143|NCT04274257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5526144|NCT04274257|Immunologic Factors|immunologic factors|mesh-ancestor
5526145|NCT04274257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526146|NCT04274257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5526147|NCT04274179|Lamotrigine|lamotrigine|mesh-list
6106383|NCT00989950|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6106384|NCT00989950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6106385|NCT00989950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6106386|NCT00989950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106387|NCT00989950|Dopamine Agents|dopamine agents|mesh-ancestor
6106388|NCT00989950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6106389|NCT00989963|Beraprost|beraprost|mesh-list
5526148|NCT04274179|Valproic Acid|valproic acid|mesh-list
5526149|NCT04274179|Ethosuximide|ethosuximide|mesh-list
6106390|NCT00989963|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6106391|NCT00989963|Vasodilator Agents|vasodilator agents|mesh-ancestor
6106392|NCT00989989|Ranibizumab|ranibizumab|mesh-list
6106393|NCT00989989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6106394|NCT00989989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6106395|NCT00989989|Growth Substances|growth substances|mesh-ancestor
6106396|NCT00989989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106397|NCT00989989|Growth Inhibitors|growth inhibitors|mesh-ancestor
6106398|NCT00989989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6106399|NCT00990106|Prazosin|prazosin|mesh-list
6106400|NCT00990106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6106401|NCT00990106|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6106402|NCT00990106|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6106403|NCT00990106|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6106404|NCT00990106|Adrenergic Agents|adrenergic agents|mesh-ancestor
6106405|NCT00990106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6106406|NCT00990106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106407|NCT00990106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106408|NCT00990184|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
6106409|NCT00990184|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6106410|NCT00990184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6106411|NCT00990184|Antimetabolites|antimetabolites|mesh-ancestor
6106412|NCT00990184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106413|NCT00990184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6106414|NCT00990236|Enoxaparin|enoxaparin|mesh-list
6106415|NCT00990236|Enoxaparin sodium|enoxaparin sodium|mesh-list
6106416|NCT00990236|Anticoagulants|anticoagulants|mesh-ancestor
6106417|NCT00990236|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6106418|NCT00990236|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6106419|NCT00990236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106420|NCT00990249|Busulfan|busulfan|mesh-list
6106421|NCT00990249|Clofarabine|clofarabine|mesh-list
6106422|NCT00990249|Thymoglobulin|thymoglobulin|mesh-list
6106423|NCT00990249|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6106424|NCT00990249|Alkylating Agents|alkylating agents|mesh-ancestor
6106425|NCT00990249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665889|NCT01519336|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6665890|NCT01519336|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6665891|NCT01519336|Protease Inhibitors|protease inhibitors|mesh-ancestor
6665892|NCT01519336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6665893|NCT01519336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665894|NCT01519336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6665895|NCT01519336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6665896|NCT01519336|Antiviral Agents|antiviral agents|mesh-ancestor
6665897|NCT01519336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6665898|NCT01519336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6665899|NCT01519336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6665900|NCT01519401|Drospirenone|drospirenone|mesh-list
6665901|NCT01519401|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6665902|NCT01519401|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6665903|NCT01519401|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6665904|NCT01519401|Estradiol|estradiol|mesh-list
6665905|NCT01519401|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6665906|NCT01519401|Estrogens|estrogens|mesh-ancestor
6665907|NCT01519401|Hormones|hormones|mesh-ancestor
6665908|NCT01519401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6672417|NCT01555918|Antifungal Agents|antifungal agents|mesh-ancestor
5526150|NCT04274179|Anticonvulsants|anticonvulsants|mesh-ancestor
5526151|NCT04274179|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5526152|NCT04274179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5526153|NCT04274179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526154|NCT04274179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5526155|NCT04274179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526156|NCT04274179|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5526157|NCT04274179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6665909|NCT01519401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665910|NCT01519401|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6106426|NCT00990249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6106427|NCT00990249|Immunologic Factors|immunologic factors|mesh-ancestor
6106428|NCT00990249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106429|NCT00990249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6106430|NCT00990249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6106431|NCT00990249|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6106432|NCT00990249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6106433|NCT00990249|Antimetabolites|antimetabolites|mesh-ancestor
6106434|NCT00990288|Thrombin|thrombin|mesh-list
6106435|NCT00990288|Hemostatics|hemostatics|mesh-list
6106436|NCT00990288|Coagulants|coagulants|mesh-ancestor
6106437|NCT00990314|Epoprostenol|epoprostenol|mesh-list
6106438|NCT00990314|Beraprost|beraprost|mesh-list
5526158|NCT04274179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5526159|NCT04274179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5526160|NCT04274179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5526161|NCT04274179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5526162|NCT04274179|GABA Agents|gaba agents|mesh-ancestor
5526163|NCT04274179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6106439|NCT00990314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6106440|NCT00990314|Vasodilator Agents|vasodilator agents|mesh-ancestor
6106441|NCT00990314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6106442|NCT00990561|Clobetasol|clobetasol|mesh-list
6106443|NCT00990561|Halobetasol|halobetasol|mesh-list
6106444|NCT00990561|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6106445|NCT00990561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5526164|NCT04274179|Antimanic Agents|antimanic agents|mesh-ancestor
5526165|NCT04273880|Ascorbic Acid|ascorbic acid|mesh-list
5526166|NCT04273880|Methylphenidate|methylphenidate|mesh-list
6106446|NCT00990561|Glucocorticoids|glucocorticoids|mesh-ancestor
6106447|NCT00990561|Hormones|hormones|mesh-ancestor
6106448|NCT00990561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6106449|NCT00990561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106450|NCT00990652|Bortezomib|bortezomib|mesh-list
6106451|NCT00990652|Temozolomide|temozolomide|mesh-list
6106452|NCT00990652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6106453|NCT00990652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6106454|NCT00990652|Alkylating Agents|alkylating agents|mesh-ancestor
6106455|NCT00990652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106456|NCT00990665|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
6106457|NCT00990665|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6106458|NCT00990665|Contraceptive Agents|contraceptive agents|mesh-ancestor
6106459|NCT00990665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6106460|NCT00990665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106461|NCT00990665|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6106462|NCT00990665|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6106463|NCT00990665|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6106464|NCT00990704|Maxacalcitol|maxacalcitol|mesh-list
6106465|NCT00990704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6106466|NCT00990704|Dermatologic Agents|dermatologic agents|mesh-ancestor
6106467|NCT00990704|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6106468|NCT00990704|Protective Agents|protective agents|mesh-ancestor
6106469|NCT00990704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106470|NCT00990769|Anesthetics|anesthetics|mesh-list
6106471|NCT00990769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6106472|NCT00990769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106473|NCT00990821|Midazolam|midazolam|mesh-list
6106474|NCT00990821|Aprepitant|aprepitant|mesh-list
6106475|NCT00990821|Fosaprepitant|fosaprepitant|mesh-list
6106476|NCT00990821|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6106477|NCT00990821|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6106478|NCT00990821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6106479|NCT00990821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106480|NCT00990821|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6106481|NCT00990821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6106482|NCT00990821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6106483|NCT00990821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6106484|NCT00990821|Anesthetics, General|anesthetics, general|mesh-ancestor
6106485|NCT00990821|Anesthetics|anesthetics|mesh-ancestor
6106486|NCT00990821|GABA Modulators|gaba modulators|mesh-ancestor
6106487|NCT00990821|GABA Agents|gaba agents|mesh-ancestor
6106488|NCT00990821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6106489|NCT00990821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106490|NCT00990821|Antiemetics|antiemetics|mesh-ancestor
6106491|NCT00990821|Autonomic Agents|autonomic agents|mesh-ancestor
6106492|NCT00990821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6106493|NCT00990821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6106494|NCT00990821|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6106495|NCT00991029|Clopidogrel|clopidogrel|mesh-list
6106496|NCT00991029|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6106497|NCT00991029|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6106498|NCT00991029|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6106499|NCT00991029|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6106500|NCT00991029|Purinergic Agents|purinergic agents|mesh-ancestor
6106501|NCT00991029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6106502|NCT00991029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106503|NCT00991029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106504|NCT00991081|Bupropion|bupropion|mesh-list
6106505|NCT00991081|Nicotine|nicotine|mesh-list
6106506|NCT00991081|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6106507|NCT00991081|Autonomic Agents|autonomic agents|mesh-ancestor
6106508|NCT00991081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6106509|NCT00991081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106510|NCT00991081|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6106511|NCT00991081|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6106512|NCT00991081|Cholinergic Agents|cholinergic agents|mesh-ancestor
6106513|NCT00991081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6106514|NCT00991081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106515|NCT00991081|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6106516|NCT00991081|Antidepressive Agents|antidepressive agents|mesh-ancestor
6106517|NCT00991081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6106518|NCT00991081|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6106519|NCT00991081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6106520|NCT00991081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6106521|NCT00991081|Dopamine Agents|dopamine agents|mesh-ancestor
6106522|NCT00991081|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6106523|NCT00991081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6106524|NCT00991081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6106525|NCT00991276|Pregabalin|pregabalin|mesh-list
6106526|NCT00991276|Pramipexole|pramipexole|mesh-list
6106527|NCT00991276|Analgesics|analgesics|mesh-ancestor
6106528|NCT00991276|Sensory System Agents|sensory system agents|mesh-ancestor
6106529|NCT00991276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6106530|NCT00991276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106531|NCT00991276|Anticonvulsants|anticonvulsants|mesh-ancestor
6106532|NCT00991276|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6106533|NCT00991276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6665911|NCT01519401|Contraceptive Agents|contraceptive agents|mesh-ancestor
6665912|NCT01519401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6665913|NCT01519401|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6665914|NCT01519401|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6665915|NCT01519401|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6665916|NCT01519401|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6665917|NCT01519401|Hormone Antagonists|hormone antagonists|mesh-ancestor
6106534|NCT00991276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106535|NCT00991276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6106536|NCT00991276|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6106537|NCT00991276|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6106538|NCT00991276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6106539|NCT00991276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6106540|NCT00991276|Antioxidants|antioxidants|mesh-ancestor
6106541|NCT00991276|Protective Agents|protective agents|mesh-ancestor
6106542|NCT00991276|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6106543|NCT00991276|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5526167|NCT04273880|Vitamins|vitamins|mesh-ancestor
5526168|NCT04273880|Micronutrients|micronutrients|mesh-ancestor
5526169|NCT04273880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526170|NCT04273880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5526171|NCT04273880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5526172|NCT04273880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5526173|NCT04273880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5526174|NCT04273880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526175|NCT04273880|Dopamine Agents|dopamine agents|mesh-ancestor
5526176|NCT04273880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5526177|NCT04273880|Antioxidants|antioxidants|mesh-ancestor
5526178|NCT04273880|Protective Agents|protective agents|mesh-ancestor
5526179|NCT04273932|Lithium Carbonate|lithium carbonate|mesh-list
5526180|NCT04273932|Antidepressive Agents|antidepressive agents|mesh-ancestor
5526181|NCT04273932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5526182|NCT04273932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5526183|NCT04273932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526184|NCT04273932|Antimanic Agents|antimanic agents|mesh-ancestor
5526185|NCT04273932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5526186|NCT04273932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5526187|NCT04273932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526188|NCT04273997|Metronidazole|metronidazole|mesh-list
5526189|NCT04273997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5526190|NCT04273997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5526191|NCT04273997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5526192|NCT04273997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5526193|NCT04273984|Misoprostol|misoprostol|mesh-list
5526194|NCT04273984|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5526195|NCT04273984|Abortifacient Agents|abortifacient agents|mesh-ancestor
5526196|NCT04273984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5526197|NCT04273984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526198|NCT04273984|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5526199|NCT04273984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5526200|NCT04273984|Oxytocics|oxytocics|mesh-ancestor
5526201|NCT04273776|Zolpidem|zolpidem|mesh-list
5526202|NCT04273776|Suvorexant|suvorexant|mesh-list
5526203|NCT04273776|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5526204|NCT04273776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5526205|NCT04273776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5526206|NCT04273776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106544|NCT00991276|Dopamine Agonists|dopamine agonists|mesh-ancestor
6106545|NCT00991276|Dopamine Agents|dopamine agents|mesh-ancestor
6106546|NCT00991276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6106547|NCT00991289|Interferons|interferons|mesh-list
6106548|NCT00991289|Ribavirin|ribavirin|mesh-list
6106549|NCT00991289|Interferon-alpha|interferon-alpha|mesh-list
6106550|NCT00991289|Interferon alpha-2|interferon alpha-2|mesh-list
6106551|NCT00991289|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6106552|NCT00991289|Nitazoxanide|nitazoxanide|mesh-list
6106553|NCT00991289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6106554|NCT00991289|Antiviral Agents|antiviral agents|mesh-ancestor
6106555|NCT00991289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6106556|NCT00991289|Antimetabolites|antimetabolites|mesh-ancestor
6106557|NCT00991289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106558|NCT00991289|Immunologic Factors|immunologic factors|mesh-ancestor
6106559|NCT00991289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106560|NCT00991289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6106561|NCT00991458|Cyclosporine|cyclosporine|mesh-list
6106562|NCT00991458|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6106563|NCT00991458|Cyclosporins|cyclosporins|mesh-list
6106564|NCT00991458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6106565|NCT00991458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106566|NCT00991458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6106567|NCT00991458|Immunologic Factors|immunologic factors|mesh-ancestor
6106568|NCT00991458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526207|NCT04273776|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
5526208|NCT04273776|GABA Agonists|gaba agonists|mesh-ancestor
5526209|NCT04273776|GABA Agents|gaba agents|mesh-ancestor
5526210|NCT04273776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5526211|NCT04273776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526212|NCT04273776|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
5526213|NCT04273763|Interferons|interferons|mesh-list
5526214|NCT04273763|Bromhexine|bromhexine|mesh-list
5526215|NCT04273763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5526216|NCT04273763|Antiviral Agents|antiviral agents|mesh-ancestor
6106569|NCT00991458|Antifungal Agents|antifungal agents|mesh-ancestor
6106570|NCT00991458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6106571|NCT00991458|Dermatologic Agents|dermatologic agents|mesh-ancestor
6106572|NCT00991458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6106573|NCT00991458|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6106574|NCT00991458|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6106575|NCT00991510|Mycophenolic Acid|mycophenolic acid|mesh-list
6106576|NCT00991510|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6106577|NCT00991510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6106578|NCT00991510|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6106579|NCT00991510|Antitubercular Agents|antitubercular agents|mesh-ancestor
6106580|NCT00991510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6106581|NCT00991510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6106582|NCT00991510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6106583|NCT00991510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106584|NCT00991809|Diphenhydramine|diphenhydramine|mesh-list
6106585|NCT00991809|Promethazine|promethazine|mesh-list
6106586|NCT00991809|Alfentanil|alfentanil|mesh-list
6106587|NCT00991809|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6106588|NCT00991809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6106589|NCT00991809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6106590|NCT00991809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106591|NCT00991809|Anesthetics, Local|anesthetics, local|mesh-ancestor
6106592|NCT00991809|Anesthetics|anesthetics|mesh-ancestor
6106593|NCT00991809|Sensory System Agents|sensory system agents|mesh-ancestor
6106594|NCT00991809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6106595|NCT00991809|Antiemetics|antiemetics|mesh-ancestor
6106596|NCT00991809|Autonomic Agents|autonomic agents|mesh-ancestor
6106597|NCT00991809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6106598|NCT00991809|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6106599|NCT00991809|Histamine Antagonists|histamine antagonists|mesh-ancestor
6106600|NCT00991809|Histamine Agents|histamine agents|mesh-ancestor
6106601|NCT00991809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6106602|NCT00991809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106603|NCT00991809|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6106604|NCT00991809|Antipruritics|antipruritics|mesh-ancestor
6106605|NCT00991809|Dermatologic Agents|dermatologic agents|mesh-ancestor
6106606|NCT00991809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6106607|NCT00991809|Narcotics|narcotics|mesh-ancestor
6106608|NCT00991809|Analgesics|analgesics|mesh-ancestor
6106609|NCT00991809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6106610|NCT00991809|Anesthetics, General|anesthetics, general|mesh-ancestor
6106611|NCT00991939|Dexamethasone|dexamethasone|mesh-list
6106612|NCT00991939|Prednisone|prednisone|mesh-list
6106613|NCT00991939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6106614|NCT00991939|Antiemetics|antiemetics|mesh-ancestor
6106615|NCT00991939|Autonomic Agents|autonomic agents|mesh-ancestor
6106616|NCT00991939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6106617|NCT00991939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106618|NCT00991939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6106619|NCT00991939|Glucocorticoids|glucocorticoids|mesh-ancestor
6106620|NCT00991939|Hormones|hormones|mesh-ancestor
6106621|NCT00991939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6106622|NCT00991939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6106623|NCT00991939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6106624|NCT00991952|Irinotecan|irinotecan|mesh-list
6106625|NCT00991952|Alvocidib|alvocidib|mesh-list
6106626|NCT00991952|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6106627|NCT00991952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6106628|NCT00991952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6106629|NCT00991952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106630|NCT00991952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6106631|NCT00991952|Growth Inhibitors|growth inhibitors|mesh-ancestor
6106632|NCT00991952|Growth Substances|growth substances|mesh-ancestor
6106633|NCT00991952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106634|NCT00991952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6106635|NCT00992056|Metoprolol|metoprolol|mesh-list
6106636|NCT00992056|Nebivolol|nebivolol|mesh-list
6106637|NCT00992056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6106638|NCT00992056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6106639|NCT00992056|Sympatholytics|sympatholytics|mesh-ancestor
6106640|NCT00992056|Autonomic Agents|autonomic agents|mesh-ancestor
6106641|NCT00992056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6106642|NCT00992056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106643|NCT00992056|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6106644|NCT00992056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6106645|NCT00992056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6106646|NCT00992056|Adrenergic Agents|adrenergic agents|mesh-ancestor
6106647|NCT00992056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6106648|NCT00992056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106649|NCT00992056|Vasodilator Agents|vasodilator agents|mesh-ancestor
6106650|NCT00992056|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6106651|NCT00992056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6106652|NCT00992056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6106653|NCT00992108|Lidocaine|lidocaine|mesh-list
6106654|NCT00992108|Anesthetics, Local|anesthetics, local|mesh-ancestor
6106655|NCT00992108|Anesthetics|anesthetics|mesh-ancestor
6106656|NCT00992108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6106657|NCT00992108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106658|NCT00992108|Sensory System Agents|sensory system agents|mesh-ancestor
6106659|NCT00992108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6106660|NCT00992108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6106661|NCT00992108|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6106662|NCT00992108|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6106663|NCT00992108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6106664|NCT00992108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106665|NCT00992394|Etanercept|etanercept|mesh-list
6106666|NCT00992394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6106667|NCT00992394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6106668|NCT00992394|Analgesics|analgesics|mesh-ancestor
6106669|NCT00992394|Sensory System Agents|sensory system agents|mesh-ancestor
6106670|NCT00992394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6106671|NCT00992394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106672|NCT00992394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6106673|NCT00992394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6106674|NCT00992394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6106675|NCT00992394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6106676|NCT00992394|Immunologic Factors|immunologic factors|mesh-ancestor
6106677|NCT00992407|Risperidone|risperidone|mesh-list
6106678|NCT00992407|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6106679|NCT00992407|Serotonin Agents|serotonin agents|mesh-ancestor
6106680|NCT00992407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6106681|NCT00992407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106682|NCT00992407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106683|NCT00992407|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6106684|NCT00992407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6106685|NCT00992407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6106686|NCT00992407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6106687|NCT00992407|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6106688|NCT00992407|Dopamine Agents|dopamine agents|mesh-ancestor
6106689|NCT00992446|Cytarabine|cytarabine|mesh-list
6106690|NCT00992446|Rituximab|rituximab|mesh-list
6106691|NCT00992446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6106692|NCT00992446|Etoposide|etoposide|mesh-list
6106693|NCT00992446|Bortezomib|bortezomib|mesh-list
6106694|NCT00992446|Etoposide phosphate|etoposide phosphate|mesh-list
6106695|NCT00992446|Melphalan|melphalan|mesh-list
6106696|NCT00992446|Mechlorethamine|mechlorethamine|mesh-list
6665918|NCT01519401|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6665919|NCT01519401|Diuretics|diuretics|mesh-ancestor
6665920|NCT01519401|Natriuretic Agents|natriuretic agents|mesh-ancestor
6665921|NCT01519544|Acetazolamide|acetazolamide|mesh-list
6665922|NCT01519544|Temazepam|temazepam|mesh-list
6665923|NCT01519544|Anticonvulsants|anticonvulsants|mesh-ancestor
6665924|NCT01519544|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6665925|NCT01519544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6106697|NCT00992446|Vorinostat|vorinostat|mesh-list
6106698|NCT00992446|Carmustine|carmustine|mesh-list
6106699|NCT00992446|Podophyllotoxin|podophyllotoxin|mesh-list
6106700|NCT00992446|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
6106701|NCT00992446|Antibodies|antibodies|mesh-list
6106702|NCT00992446|Immunoglobulins|immunoglobulins|mesh-list
6106703|NCT00992446|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6106704|NCT00992446|Immunologic Factors|immunologic factors|mesh-ancestor
6665926|NCT01519544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665927|NCT01519544|Diuretics|diuretics|mesh-ancestor
6106705|NCT00992446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106706|NCT00992446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6106707|NCT00992446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6106708|NCT00992446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6106709|NCT00992446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6106710|NCT00992446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6106711|NCT00992446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6106712|NCT00992446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106713|NCT00992446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6106714|NCT00992446|Antimetabolites|antimetabolites|mesh-ancestor
6106715|NCT00992446|Antiviral Agents|antiviral agents|mesh-ancestor
6106716|NCT00992446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6106717|NCT00992446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6106718|NCT00992446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6106719|NCT00992446|Alkylating Agents|alkylating agents|mesh-ancestor
6106720|NCT00992446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6106721|NCT00992446|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6106722|NCT00992446|Keratolytic Agents|keratolytic agents|mesh-ancestor
6106723|NCT00992446|Dermatologic Agents|dermatologic agents|mesh-ancestor
6106724|NCT00992446|Tubulin Modulators|tubulin modulators|mesh-ancestor
6106725|NCT00992446|Antimitotic Agents|antimitotic agents|mesh-ancestor
6106726|NCT00992446|Mitosis Modulators|mitosis modulators|mesh-ancestor
6106727|NCT00992459|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
6106728|NCT00992459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6106729|NCT00992511|Vaccines|vaccines|mesh-list
6106730|NCT00992511|Immunologic Factors|immunologic factors|mesh-ancestor
6106731|NCT00992511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106732|NCT00992589|Rabeprazole|rabeprazole|mesh-list
6106733|NCT00992589|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6106734|NCT00992589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6106735|NCT00992589|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5526217|NCT04273763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5526218|NCT04273763|Expectorants|expectorants|mesh-ancestor
5526219|NCT04273763|Respiratory System Agents|respiratory system agents|mesh-ancestor
5526220|NCT04273581|Thalidomide|thalidomide|mesh-list
5526221|NCT04273581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5526222|NCT04273581|Immunologic Factors|immunologic factors|mesh-ancestor
5526223|NCT04273581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526224|NCT04273581|Leprostatic Agents|leprostatic agents|mesh-ancestor
5526225|NCT04273581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5526226|NCT04273581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5526227|NCT04273581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5526228|NCT04273581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5526229|NCT04273581|Growth Substances|growth substances|mesh-ancestor
5526230|NCT04273581|Growth Inhibitors|growth inhibitors|mesh-ancestor
5526231|NCT04273581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5526232|NCT04273607|Heparin|heparin|mesh-list
6465278|NCT00473486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6465279|NCT00473486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6465280|NCT00473551|Vidarabine|vidarabine|mesh-list
6665928|NCT01519544|Natriuretic Agents|natriuretic agents|mesh-ancestor
5526233|NCT04273607|Calcium heparin|calcium heparin|mesh-list
5526234|NCT04273607|Enoxaparin|enoxaparin|mesh-list
5526235|NCT04273607|Anticoagulants|anticoagulants|mesh-ancestor
5526236|NCT04273607|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5526237|NCT04273607|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6106736|NCT00992589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6106737|NCT00992589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106738|NCT00992602|Cytarabine|cytarabine|mesh-list
6106739|NCT00992602|Methotrexate|methotrexate|mesh-list
6106740|NCT00992602|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6106741|NCT00992602|Abortifacient Agents|abortifacient agents|mesh-ancestor
6106742|NCT00992602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6106743|NCT00992602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106744|NCT00992602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6106745|NCT00992602|Antimetabolites|antimetabolites|mesh-ancestor
6106746|NCT00992602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106747|NCT00992602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5725282|NCT03181815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725283|NCT03181815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5725284|NCT03181815|Antiviral Agents|antiviral agents|mesh-ancestor
5725285|NCT03181815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5725286|NCT03181815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5725287|NCT03181815|Immunologic Factors|immunologic factors|mesh-ancestor
5526238|NCT04273607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106748|NCT00992602|Dermatologic Agents|dermatologic agents|mesh-ancestor
6106749|NCT00992602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6106750|NCT00992602|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6106751|NCT00992602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6106752|NCT00992602|Immunologic Factors|immunologic factors|mesh-ancestor
6106753|NCT00992602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6106754|NCT00992602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6106755|NCT00992602|Antiviral Agents|antiviral agents|mesh-ancestor
6106756|NCT00992602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5526239|NCT04273529|Thalidomide|thalidomide|mesh-list
5526240|NCT04273529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5526241|NCT04273529|Immunologic Factors|immunologic factors|mesh-ancestor
5526242|NCT04273529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526243|NCT04273529|Leprostatic Agents|leprostatic agents|mesh-ancestor
5526244|NCT04273529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5526245|NCT04273529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5526246|NCT04273529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5526247|NCT04273529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5526248|NCT04273529|Growth Substances|growth substances|mesh-ancestor
5526249|NCT04273529|Growth Inhibitors|growth inhibitors|mesh-ancestor
5526250|NCT04273529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5526251|NCT04273516|Rivaroxaban|rivaroxaban|mesh-list
5526252|NCT04273516|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5526253|NCT04273516|Antithrombins|antithrombins|mesh-ancestor
5526254|NCT04273516|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5526255|NCT04273516|Protease Inhibitors|protease inhibitors|mesh-ancestor
5526256|NCT04273516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5526257|NCT04273516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526258|NCT04273516|Anticoagulants|anticoagulants|mesh-ancestor
5526259|NCT04273321|Methylprednisolone|methylprednisolone|mesh-list
5526260|NCT04273321|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5526261|NCT04273321|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5526262|NCT04273321|Prednisolone|prednisolone|mesh-list
5526263|NCT04273321|Prednisolone acetate|prednisolone acetate|mesh-list
5526264|NCT04273321|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6106757|NCT00992992|Tositumomab I-131|tositumomab i-131|mesh-list
6106758|NCT00992992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6106759|NCT00993031|Ritonavir|ritonavir|mesh-list
6106760|NCT00993031|Lopinavir|lopinavir|mesh-list
6106761|NCT00993031|Lamivudine|lamivudine|mesh-list
5526265|NCT04273321|Prednisolone phosphate|prednisolone phosphate|mesh-list
5526266|NCT04273321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5526267|NCT04273321|Antiemetics|antiemetics|mesh-ancestor
5526268|NCT04273321|Autonomic Agents|autonomic agents|mesh-ancestor
5526269|NCT04273321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5526270|NCT04273321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526271|NCT04273321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6106762|NCT00993031|Zidovudine|zidovudine|mesh-list
6106763|NCT00993031|Efavirenz|efavirenz|mesh-list
6465281|NCT00473551|Sirolimus|sirolimus|mesh-list
6465282|NCT00473551|Cyclophosphamide|cyclophosphamide|mesh-list
6465283|NCT00473551|Rituximab|rituximab|mesh-list
6465284|NCT00473551|Fludarabine|fludarabine|mesh-list
6465285|NCT00473551|Fludarabine phosphate|fludarabine phosphate|mesh-list
6465286|NCT00473551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5526272|NCT04273321|Glucocorticoids|glucocorticoids|mesh-ancestor
6106764|NCT00993031|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6106765|NCT00993031|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6106766|NCT00993031|Protease Inhibitors|protease inhibitors|mesh-ancestor
6106767|NCT00993031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6106768|NCT00993031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106769|NCT00993031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6106770|NCT00993031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6106771|NCT00993031|Antiviral Agents|antiviral agents|mesh-ancestor
6106772|NCT00993031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6106773|NCT00993031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6106774|NCT00993031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6106775|NCT00993031|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6106776|NCT00993031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6106777|NCT00993031|Antimetabolites|antimetabolites|mesh-ancestor
6106778|NCT00993031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6106779|NCT00993031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6106780|NCT00993031|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6106781|NCT00993031|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6106782|NCT00993031|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6465287|NCT00473551|Immunologic Factors|immunologic factors|mesh-ancestor
5526273|NCT04273321|Hormones|hormones|mesh-ancestor
6465288|NCT00473551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106783|NCT00993044|Bevacizumab|bevacizumab|mesh-list
6106784|NCT00993044|Irinotecan|irinotecan|mesh-list
6106785|NCT00993044|Vincristine|vincristine|mesh-list
6106786|NCT00993044|Temozolomide|temozolomide|mesh-list
6106787|NCT00993044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6106788|NCT00993044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6106789|NCT00993044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6106790|NCT00993044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6106791|NCT00993044|Growth Substances|growth substances|mesh-ancestor
6106792|NCT00993044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106793|NCT00993044|Growth Inhibitors|growth inhibitors|mesh-ancestor
6106794|NCT00993044|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6106795|NCT00993044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6106796|NCT00993044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6106797|NCT00993044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106798|NCT00993044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6106799|NCT00993044|Tubulin Modulators|tubulin modulators|mesh-ancestor
6106800|NCT00993044|Antimitotic Agents|antimitotic agents|mesh-ancestor
6106801|NCT00993044|Mitosis Modulators|mitosis modulators|mesh-ancestor
6106802|NCT00993044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6106803|NCT00993044|Alkylating Agents|alkylating agents|mesh-ancestor
6106804|NCT00993148|Ritonavir|ritonavir|mesh-list
6106805|NCT00993148|Darunavir|darunavir|mesh-list
6106806|NCT00993148|Maraviroc|maraviroc|mesh-list
6106807|NCT00993148|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6106808|NCT00993148|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6106809|NCT00993148|Protease Inhibitors|protease inhibitors|mesh-ancestor
6106810|NCT00993148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6106811|NCT00993148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106812|NCT00993148|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6106813|NCT00993148|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6106814|NCT00993148|Antiviral Agents|antiviral agents|mesh-ancestor
6106815|NCT00993148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6106816|NCT00993148|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6106817|NCT00993148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6106818|NCT00993148|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6106819|NCT00993148|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6106820|NCT00993148|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6106821|NCT00993187|Metformin|metformin|mesh-list
6106822|NCT00993187|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6106823|NCT00993187|Glimepiride|glimepiride|mesh-list
6106824|NCT00993187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6106825|NCT00993187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106826|NCT00993187|Incretins|incretins|mesh-ancestor
6106827|NCT00993187|Hormones|hormones|mesh-ancestor
6106828|NCT00993187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6106829|NCT00993187|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5526274|NCT04273321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5526275|NCT04273321|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5526276|NCT04273321|Protective Agents|protective agents|mesh-ancestor
5526277|NCT04273321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5526278|NCT04273321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5526279|NCT04273282|Moxifloxacin|moxifloxacin|mesh-list
6106830|NCT00993187|Protease Inhibitors|protease inhibitors|mesh-ancestor
6106831|NCT00993187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6106832|NCT00993187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106833|NCT00993187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6106834|NCT00993187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6106835|NCT00993187|Immunologic Factors|immunologic factors|mesh-ancestor
6106836|NCT00993200|Warfarin|warfarin|mesh-list
6106837|NCT00993200|Anticoagulants|anticoagulants|mesh-ancestor
6106838|NCT00993226|Bupivacaine|bupivacaine|mesh-list
6106839|NCT00993226|Anesthetics, Local|anesthetics, local|mesh-ancestor
6106840|NCT00993226|Anesthetics|anesthetics|mesh-ancestor
6106841|NCT00993226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6106842|NCT00993226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106843|NCT00993226|Sensory System Agents|sensory system agents|mesh-ancestor
6106844|NCT00993226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6106845|NCT00993265|Acetylcysteine|acetylcysteine|mesh-list
6106846|NCT00993265|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6106847|NCT00993265|Antiviral Agents|antiviral agents|mesh-ancestor
6106848|NCT00993265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6106849|NCT00993265|Expectorants|expectorants|mesh-ancestor
6106850|NCT00993265|Respiratory System Agents|respiratory system agents|mesh-ancestor
6106851|NCT00993265|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6106852|NCT00993265|Antioxidants|antioxidants|mesh-ancestor
6106853|NCT00993265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106854|NCT00993265|Protective Agents|protective agents|mesh-ancestor
6106855|NCT00993265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106856|NCT00993265|Antidotes|antidotes|mesh-ancestor
6106857|NCT00993317|Methotrexate|methotrexate|mesh-list
6106858|NCT00993317|Certolizumab Pegol|certolizumab pegol|mesh-list
6106859|NCT00993317|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6106860|NCT00993317|Abortifacient Agents|abortifacient agents|mesh-ancestor
6106861|NCT00993317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6106862|NCT00993317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106863|NCT00993317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6106864|NCT00993317|Antimetabolites|antimetabolites|mesh-ancestor
6106865|NCT00993317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106866|NCT00993317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6106867|NCT00993317|Dermatologic Agents|dermatologic agents|mesh-ancestor
6106868|NCT00993317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6106869|NCT00993317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6106870|NCT00993317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6106871|NCT00993317|Immunologic Factors|immunologic factors|mesh-ancestor
6106872|NCT00993317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6106873|NCT00993317|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6106874|NCT00993421|Sibutramine|sibutramine|mesh-list
6106875|NCT00993421|Metoprolol|metoprolol|mesh-list
6106876|NCT00993421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5526280|NCT04273282|Dexamethasone|dexamethasone|mesh-list
5526281|NCT04273282|Prednisolone|prednisolone|mesh-list
5526282|NCT04273282|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5526283|NCT04273282|Methylprednisolone|methylprednisolone|mesh-list
5526284|NCT04273282|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5526285|NCT04273282|Prednisolone acetate|prednisolone acetate|mesh-list
5526286|NCT04273282|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5526287|NCT04273282|Prednisolone phosphate|prednisolone phosphate|mesh-list
6106877|NCT00993421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6106878|NCT00993421|Sympatholytics|sympatholytics|mesh-ancestor
6106879|NCT00993421|Autonomic Agents|autonomic agents|mesh-ancestor
6106880|NCT00993421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6106881|NCT00993421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106882|NCT00993421|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6106883|NCT00993421|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6106884|NCT00993421|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6106885|NCT00993421|Adrenergic Agents|adrenergic agents|mesh-ancestor
6106886|NCT00993421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6106887|NCT00993421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106888|NCT00993421|Antidepressive Agents|antidepressive agents|mesh-ancestor
5526288|NCT04273282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5526289|NCT04273282|Antiemetics|antiemetics|mesh-ancestor
5526290|NCT04273282|Autonomic Agents|autonomic agents|mesh-ancestor
5526291|NCT04273282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5526292|NCT04273282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526293|NCT04273282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5526294|NCT04273282|Glucocorticoids|glucocorticoids|mesh-ancestor
5526295|NCT04273282|Hormones|hormones|mesh-ancestor
5526296|NCT04273282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5526297|NCT04273282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5526298|NCT04273282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5526299|NCT04273282|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5526300|NCT04273282|Protective Agents|protective agents|mesh-ancestor
5526301|NCT04273282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5526302|NCT04273282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5526303|NCT04273282|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5526304|NCT04273282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5526305|NCT04273282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5526306|NCT04273282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601322|NCT03706053|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5601323|NCT03706053|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6106889|NCT00993421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6106890|NCT00993421|Appetite Depressants|appetite depressants|mesh-ancestor
6106891|NCT00993421|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6106892|NCT00993473|Insulin|insulin|mesh-list
6106893|NCT00993473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6106894|NCT00993473|Insulin Glargine|insulin glargine|mesh-list
6106895|NCT00993473|Insulin Lispro|insulin lispro|mesh-list
6106896|NCT00993473|Protamines|protamines|mesh-list
5601324|NCT03706053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5601325|NCT03706053|Adrenergic Agents|adrenergic agents|mesh-ancestor
6106897|NCT00993473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6106898|NCT00993473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106899|NCT00993473|Heparin Antagonists|heparin antagonists|mesh-ancestor
6106900|NCT00993473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106901|NCT00993473|Coagulants|coagulants|mesh-ancestor
6106902|NCT00993499|Sirolimus|sirolimus|mesh-list
6106903|NCT00993499|Afatinib|afatinib|mesh-list
5526307|NCT04273165|Etravirine|etravirine|mesh-list
5526308|NCT04273165|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5526309|NCT04273165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5526310|NCT04273165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5526311|NCT04273165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526312|NCT04273165|Antiviral Agents|antiviral agents|mesh-ancestor
5526313|NCT04273165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5526314|NCT04273256|Inositol|inositol|mesh-list
5526315|NCT04273256|Vitamin B Complex|vitamin b complex|mesh-ancestor
5526316|NCT04273256|Vitamins|vitamins|mesh-ancestor
5526317|NCT04273256|Micronutrients|micronutrients|mesh-ancestor
5526318|NCT04273256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526319|NCT04273191|Brexanolone|brexanolone|mesh-list
5526320|NCT04273191|Neurosteroids|neurosteroids|mesh-ancestor
5526321|NCT04273191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5526322|NCT04273191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526323|NCT04273191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526324|NCT04273191|GABA Modulators|gaba modulators|mesh-ancestor
5526325|NCT04273191|GABA Agents|gaba agents|mesh-ancestor
5526326|NCT04273100|Lenvatinib|lenvatinib|mesh-list
5526327|NCT04273100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5526328|NCT04273100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5526329|NCT04273100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5526330|NCT04273100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106904|NCT00993499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6106905|NCT00993499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6106906|NCT00993499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6106907|NCT00993499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6106908|NCT00993499|Antifungal Agents|antifungal agents|mesh-ancestor
6106909|NCT00993499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6106910|NCT00993499|Immunologic Factors|immunologic factors|mesh-ancestor
6106911|NCT00993499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106912|NCT00993499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6106913|NCT00993499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6106914|NCT00993499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204068|NCT02064985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204069|NCT02064985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204070|NCT02065245|Penicillins|penicillins|mesh-list
6204071|NCT02065245|Streptomycin|streptomycin|mesh-list
6204072|NCT02065245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6204073|NCT02065245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6204074|NCT02065245|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6204075|NCT02065245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6204076|NCT02065245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204077|NCT02065336|Chlorpheniramine|chlorpheniramine|mesh-list
6204078|NCT02065336|Entecavir|entecavir|mesh-list
6204079|NCT02065336|Antiviral Agents|antiviral agents|mesh-ancestor
6204080|NCT02065336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6204081|NCT02065336|Antipruritics|antipruritics|mesh-ancestor
6204082|NCT02065336|Dermatologic Agents|dermatologic agents|mesh-ancestor
6204083|NCT02065336|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6204084|NCT02065336|Histamine Antagonists|histamine antagonists|mesh-ancestor
6204085|NCT02065336|Histamine Agents|histamine agents|mesh-ancestor
6204086|NCT02065336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6204087|NCT02065336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204088|NCT02065336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106915|NCT00993616|Carboplatin|carboplatin|mesh-list
6106916|NCT00993616|Belinostat|belinostat|mesh-list
6106917|NCT00993616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6106918|NCT00993616|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6106919|NCT00993616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6106920|NCT00993616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526331|NCT04273035|Midazolam|midazolam|mesh-list
5526332|NCT04273035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5526333|NCT04273035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5526334|NCT04273035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5526335|NCT04273035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526336|NCT04273035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5526337|NCT04273035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5526338|NCT04273035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5526339|NCT04273035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5526340|NCT04273035|Anesthetics, General|anesthetics, general|mesh-ancestor
5526341|NCT04273035|Anesthetics|anesthetics|mesh-ancestor
6106921|NCT00993655|Paclitaxel|paclitaxel|mesh-list
6106922|NCT00993655|Carboplatin|carboplatin|mesh-list
6106923|NCT00993655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6106924|NCT00993655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6106925|NCT00993655|Tubulin Modulators|tubulin modulators|mesh-ancestor
6106926|NCT00993655|Antimitotic Agents|antimitotic agents|mesh-ancestor
6106927|NCT00993655|Mitosis Modulators|mitosis modulators|mesh-ancestor
6106928|NCT00993655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106929|NCT00993668|Certolizumab Pegol|certolizumab pegol|mesh-list
6106930|NCT00993668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6106931|NCT00993668|Immunologic Factors|immunologic factors|mesh-ancestor
6106932|NCT00993668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725288|NCT03181815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106933|NCT00993668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6106934|NCT00993798|Bupivacaine|bupivacaine|mesh-list
6106935|NCT00993798|Anesthetics, Local|anesthetics, local|mesh-ancestor
6106936|NCT00993798|Anesthetics|anesthetics|mesh-ancestor
6106937|NCT00993798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6106938|NCT00993798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106939|NCT00993798|Sensory System Agents|sensory system agents|mesh-ancestor
6106940|NCT00993798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6106941|NCT00993824|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
6106942|NCT00993824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6106943|NCT00993824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6106944|NCT00993824|Antimetabolites|antimetabolites|mesh-ancestor
6106945|NCT00993824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106946|NCT00993824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6106947|NCT00993915|Atorvastatin|atorvastatin|mesh-list
6106948|NCT00993915|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6106949|NCT00993915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6106950|NCT00993915|Antimetabolites|antimetabolites|mesh-ancestor
6106951|NCT00993915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106952|NCT00993915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6106953|NCT00993915|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6106954|NCT00993915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6106955|NCT00993967|Idebenone|idebenone|mesh-list
6106956|NCT00993967|Antioxidants|antioxidants|mesh-ancestor
6106957|NCT00993967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106958|NCT00993967|Protective Agents|protective agents|mesh-ancestor
6106959|NCT00993967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106960|NCT00994110|Pasireotide|pasireotide|mesh-list
6106961|NCT00994110|Hormones|hormones|mesh-ancestor
6106962|NCT00994110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6106963|NCT00994110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106964|NCT00994123|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6106965|NCT00994123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6106966|NCT00994123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6106967|NCT00994123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6106968|NCT00994123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106969|NCT00994175|Pioglitazone|pioglitazone|mesh-list
6106970|NCT00994175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6106971|NCT00994175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106972|NCT00994318|Ferric Compounds|ferric compounds|mesh-list
6106973|NCT00994318|Hematinics|hematinics|mesh-ancestor
6106974|NCT00994422|Ivermectin|ivermectin|mesh-list
6106975|NCT00994422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6665929|NCT01519544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526342|NCT04273035|GABA Modulators|gaba modulators|mesh-ancestor
6106976|NCT00994422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6106977|NCT00994448|Bupropion|bupropion|mesh-list
6106978|NCT00994448|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6106979|NCT00994448|Antidepressive Agents|antidepressive agents|mesh-ancestor
6106980|NCT00994448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6106981|NCT00994448|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6106982|NCT00994448|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6106983|NCT00994448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6106984|NCT00994448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106985|NCT00994448|Dopamine Agents|dopamine agents|mesh-ancestor
6106986|NCT00994448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6106987|NCT00994448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106988|NCT00994448|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6106989|NCT00994448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6106990|NCT00994448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6106991|NCT00994461|Celecoxib|celecoxib|mesh-list
5526343|NCT04273035|GABA Agents|gaba agents|mesh-ancestor
5526344|NCT04273035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5526345|NCT04273035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526346|NCT04273061|Atezolizumab|atezolizumab|mesh-list
5526347|NCT04273061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5526348|NCT04272801|Tamoxifen|tamoxifen|mesh-list
5526349|NCT04272801|Letrozole|letrozole|mesh-list
5526350|NCT04272801|Anastrozole|anastrozole|mesh-list
5526351|NCT04272801|Exemestane|exemestane|mesh-list
5526352|NCT04272801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5526353|NCT04272801|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5526354|NCT04272801|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5526355|NCT04272801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5526356|NCT04272801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6106992|NCT00994461|Loxoprofen|loxoprofen|mesh-list
6106993|NCT00994461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6106994|NCT00994461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6106995|NCT00994461|Analgesics|analgesics|mesh-ancestor
6106996|NCT00994461|Sensory System Agents|sensory system agents|mesh-ancestor
6106997|NCT00994461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6106998|NCT00994461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6106999|NCT00994461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6107000|NCT00994461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6107001|NCT00994461|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6107002|NCT00994461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6107003|NCT00994461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6107004|NCT00994461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6107005|NCT00994643|Aldesleukin|aldesleukin|mesh-list
6107006|NCT00994643|Rituximab|rituximab|mesh-list
6107007|NCT00994643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6107008|NCT00994643|Interleukin-2|interleukin-2|mesh-list
6107009|NCT00994643|Antibodies|antibodies|mesh-list
6107010|NCT00994643|Immunoglobulins|immunoglobulins|mesh-list
6107011|NCT00994643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6107012|NCT00994643|Immunologic Factors|immunologic factors|mesh-ancestor
6107013|NCT00994643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204089|NCT02065336|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6665930|NCT01519544|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6665931|NCT01519544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6665932|NCT01519544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6665933|NCT01519544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6665934|NCT01519544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6665935|NCT01519544|GABA Modulators|gaba modulators|mesh-ancestor
6665936|NCT01519544|GABA Agents|gaba agents|mesh-ancestor
6665937|NCT01519544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6107014|NCT00994643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6107015|NCT00994643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6107016|NCT00994643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6107017|NCT00994643|Analgesics|analgesics|mesh-ancestor
6107018|NCT00994643|Sensory System Agents|sensory system agents|mesh-ancestor
6107019|NCT00994643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6107020|NCT00994643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6107021|NCT00994643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6107022|NCT00994643|Antiviral Agents|antiviral agents|mesh-ancestor
6107023|NCT00994643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6107024|NCT00994682|Pioglitazone|pioglitazone|mesh-list
6107025|NCT00994682|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6107026|NCT00994682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107027|NCT00994760|Fentanyl|fentanyl|mesh-list
6107028|NCT00994760|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6107029|NCT00994760|Narcotics|narcotics|mesh-ancestor
6107030|NCT00994760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5526357|NCT04272801|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5526358|NCT04272801|Hormone Antagonists|hormone antagonists|mesh-ancestor
5526359|NCT04272801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5526360|NCT04272801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526361|NCT04272801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5526362|NCT04272801|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5526363|NCT04272801|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5526364|NCT04272801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5526365|NCT04272788|Infliximab|infliximab|mesh-list
5526366|NCT04272788|Dermatologic Agents|dermatologic agents|mesh-ancestor
5526367|NCT04272788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5526368|NCT04272788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5526369|NCT04272645|Atezolizumab|atezolizumab|mesh-list
6107031|NCT00994760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107032|NCT00994760|Analgesics|analgesics|mesh-ancestor
6107033|NCT00994760|Sensory System Agents|sensory system agents|mesh-ancestor
6107034|NCT00994760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6107035|NCT00994760|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6107036|NCT00994760|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6107037|NCT00994760|Anesthetics, General|anesthetics, general|mesh-ancestor
6107038|NCT00994760|Anesthetics|anesthetics|mesh-ancestor
6107039|NCT00994890|Tanezumab|tanezumab|mesh-list
6107040|NCT00994890|Analgesics|analgesics|mesh-ancestor
6107041|NCT00994890|Sensory System Agents|sensory system agents|mesh-ancestor
6107042|NCT00994890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6107043|NCT00994890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107044|NCT00994929|Oprelvekin|oprelvekin|mesh-list
6107045|NCT00994929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6107046|NCT00995007|Carboplatin|carboplatin|mesh-list
6107047|NCT00995007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6107048|NCT00995072|Metoprolol|metoprolol|mesh-list
6107049|NCT00995072|Nebivolol|nebivolol|mesh-list
6107050|NCT00995072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6107051|NCT00995072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6107052|NCT00995072|Sympatholytics|sympatholytics|mesh-ancestor
6107053|NCT00995072|Autonomic Agents|autonomic agents|mesh-ancestor
6107054|NCT00995072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6107055|NCT00995072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107056|NCT00995072|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6107057|NCT00995072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6107058|NCT00995072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6107059|NCT00995072|Adrenergic Agents|adrenergic agents|mesh-ancestor
6107060|NCT00995072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6107061|NCT00995072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6107062|NCT00995072|Vasodilator Agents|vasodilator agents|mesh-ancestor
5526370|NCT04272645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5526371|NCT04272567|Norepinephrine|norepinephrine|mesh-list
6107063|NCT00995072|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6107064|NCT00995072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6107065|NCT00995072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6107066|NCT00995085|Pyridoxine|pyridoxine|mesh-list
6107067|NCT00995085|Metadoxine|metadoxine|mesh-list
6107068|NCT00995085|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5526372|NCT04272567|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5526373|NCT04272567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5526374|NCT04272567|Adrenergic Agents|adrenergic agents|mesh-ancestor
6107069|NCT00995085|Vitamin B Complex|vitamin b complex|mesh-ancestor
6107070|NCT00995085|Vitamins|vitamins|mesh-ancestor
6107071|NCT00995085|Micronutrients|micronutrients|mesh-ancestor
6107072|NCT00995085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107073|NCT00995475|Fluticasone|fluticasone|mesh-list
5526375|NCT04272567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5526376|NCT04272567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526377|NCT04272567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526378|NCT04272567|Sympathomimetics|sympathomimetics|mesh-ancestor
6107074|NCT00995475|Xhance|xhance|mesh-list
6107075|NCT00995475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6107076|NCT00995475|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6107077|NCT00995475|Autonomic Agents|autonomic agents|mesh-ancestor
6107078|NCT00995475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6107079|NCT00995475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107080|NCT00995475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6107081|NCT00995475|Respiratory System Agents|respiratory system agents|mesh-ancestor
6107082|NCT00995475|Dermatologic Agents|dermatologic agents|mesh-ancestor
6107083|NCT00995475|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6107084|NCT00995488|Paclitaxel|paclitaxel|mesh-list
6107085|NCT00995488|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6107086|NCT00995488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6107087|NCT00995488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6665938|NCT01519687|Tofisopam|tofisopam|mesh-list
6665939|NCT01519687|Antidepressive Agents|antidepressive agents|mesh-ancestor
6665940|NCT01519687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6665941|NCT01519726|Midazolam|midazolam|mesh-list
6665942|NCT01519726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6665943|NCT01519726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6665944|NCT01519726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6665945|NCT01519726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665946|NCT01519726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6665947|NCT01519726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6665948|NCT01519726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6107088|NCT00995488|Tubulin Modulators|tubulin modulators|mesh-ancestor
6107089|NCT00995488|Antimitotic Agents|antimitotic agents|mesh-ancestor
6107090|NCT00995488|Mitosis Modulators|mitosis modulators|mesh-ancestor
6107091|NCT00995488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6107092|NCT00995501|Insulin|insulin|mesh-list
6107093|NCT00995501|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6107094|NCT00995501|Dexamethasone|dexamethasone|mesh-list
6107095|NCT00995501|Dexamethasone acetate|dexamethasone acetate|mesh-list
6107096|NCT00995501|Anesthetics|anesthetics|mesh-list
6107097|NCT00995501|Sodium sulfate|sodium sulfate|mesh-list
6665949|NCT01519726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6665950|NCT01519726|Anesthetics, General|anesthetics, general|mesh-ancestor
6665951|NCT01519726|Anesthetics|anesthetics|mesh-ancestor
6665952|NCT01519726|GABA Modulators|gaba modulators|mesh-ancestor
6665953|NCT01519726|GABA Agents|gaba agents|mesh-ancestor
6665954|NCT01519726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6665955|NCT01519726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665956|NCT01519752|Oxiconazole|oxiconazole|mesh-list
6665957|NCT01519752|Antifungal Agents|antifungal agents|mesh-ancestor
6665958|NCT01519752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6665959|NCT01519856|Piribedil|piribedil|mesh-list
6107098|NCT00995501|BB 1101|bb 1101|mesh-list
6107099|NCT00995501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6107100|NCT00995501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107101|NCT00995501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6107102|NCT00995501|Antiemetics|antiemetics|mesh-ancestor
6107103|NCT00995501|Autonomic Agents|autonomic agents|mesh-ancestor
6107104|NCT00995501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6107105|NCT00995501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6107106|NCT00995501|Glucocorticoids|glucocorticoids|mesh-ancestor
6107107|NCT00995501|Hormones|hormones|mesh-ancestor
6107108|NCT00995501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6107109|NCT00995501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6107110|NCT00995501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6107111|NCT00995501|Protease Inhibitors|protease inhibitors|mesh-ancestor
6107112|NCT00995501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6107113|NCT00995501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6107114|NCT00995501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6107115|NCT00995501|Cathartics|cathartics|mesh-ancestor
6107116|NCT00995566|Sitaxsentan|sitaxsentan|mesh-list
6107117|NCT00995566|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6107118|NCT00995566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6107119|NCT00995670|Ascorbic Acid|ascorbic acid|mesh-list
5526379|NCT04272567|Autonomic Agents|autonomic agents|mesh-ancestor
6107120|NCT00995670|Sevoflurane|sevoflurane|mesh-list
6107121|NCT00995670|Simvastatin|simvastatin|mesh-list
6107122|NCT00995670|Vitamins|vitamins|mesh-ancestor
6665960|NCT01519856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6665961|NCT01519856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6107123|NCT00995670|Micronutrients|micronutrients|mesh-ancestor
6107124|NCT00995670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107125|NCT00995670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6107126|NCT00995670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6107127|NCT00995670|Antimetabolites|antimetabolites|mesh-ancestor
6107128|NCT00995670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6107129|NCT00995670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6107130|NCT00995670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6107131|NCT00995670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6107132|NCT00995670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6107133|NCT00995670|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6107134|NCT00995670|Anesthetics, General|anesthetics, general|mesh-ancestor
6107135|NCT00995670|Anesthetics|anesthetics|mesh-ancestor
6107136|NCT00995670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6107137|NCT00995670|Antioxidants|antioxidants|mesh-ancestor
6107138|NCT00995670|Protective Agents|protective agents|mesh-ancestor
6107139|NCT00995709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6107140|NCT00995709|Immunologic Factors|immunologic factors|mesh-ancestor
6107141|NCT00995709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107142|NCT00995722|Prednisone|prednisone|mesh-list
6107143|NCT00995722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6107144|NCT00995722|Glucocorticoids|glucocorticoids|mesh-ancestor
6107145|NCT00995722|Hormones|hormones|mesh-ancestor
6107146|NCT00995722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6107147|NCT00995722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107148|NCT00995722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6107149|NCT00995722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6107150|NCT00995761|Cisplatin|cisplatin|mesh-list
6107151|NCT00995761|Docetaxel|docetaxel|mesh-list
6107152|NCT00995761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6107153|NCT00995761|Tubulin Modulators|tubulin modulators|mesh-ancestor
6107154|NCT00995761|Antimitotic Agents|antimitotic agents|mesh-ancestor
6107155|NCT00995761|Mitosis Modulators|mitosis modulators|mesh-ancestor
6107156|NCT00995761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6107157|NCT00996034|Nicotine|nicotine|mesh-list
6107158|NCT00996034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107159|NCT00996034|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6107160|NCT00996034|Autonomic Agents|autonomic agents|mesh-ancestor
6107161|NCT00996034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6107162|NCT00996034|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6107163|NCT00996034|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6107164|NCT00996034|Cholinergic Agents|cholinergic agents|mesh-ancestor
6107165|NCT00996034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6107166|NCT00996034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6107167|NCT00996203|Antirheumatic Agents|antirheumatic agents|mesh-list
6107168|NCT00996216|Antiviral Agents|antiviral agents|mesh-list
6107169|NCT00996216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6107170|NCT00996281|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6107171|NCT00996281|Olmesartan|olmesartan|mesh-list
6107172|NCT00996281|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6107173|NCT00996281|Chlorthalidone|chlorthalidone|mesh-list
6107174|NCT00996281|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
6107175|NCT00996281|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6107176|NCT00996281|Diuretics|diuretics|mesh-ancestor
5526380|NCT04272567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5526381|NCT04272567|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5526382|NCT04272476|Fluoxetine|fluoxetine|mesh-list
5526383|NCT04272476|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5526384|NCT04272476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5526385|NCT04272476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5526386|NCT04272476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526387|NCT04272476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5526388|NCT04272476|Serotonin Agents|serotonin agents|mesh-ancestor
5526389|NCT04272476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526390|NCT04272476|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5526391|NCT04272476|Antidepressive Agents|antidepressive agents|mesh-ancestor
5526392|NCT04272476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5526393|NCT04272476|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5526394|NCT04272476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5526395|NCT04272476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5526396|NCT04272359|Hypoglycemic Agents|hypoglycemic agents|mesh-list
5526397|NCT04272359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526398|NCT04272333|Nivolumab|nivolumab|mesh-list
6107177|NCT00996281|Natriuretic Agents|natriuretic agents|mesh-ancestor
6107178|NCT00996281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107179|NCT00996281|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6107180|NCT00996281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6107181|NCT00996281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6107182|NCT00996281|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6107183|NCT00996281|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6107184|NCT00996307|MF59 oil emulsion|mf59 oil emulsion|mesh-list
6107185|NCT00996307|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6107186|NCT00996307|Immunologic Factors|immunologic factors|mesh-ancestor
6107187|NCT00996307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107188|NCT00996346|Sirolimus|sirolimus|mesh-list
6107189|NCT00996346|Irinotecan|irinotecan|mesh-list
6107190|NCT00996346|Complement Factor H|complement factor h|mesh-list
6107191|NCT00996346|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6107192|NCT00996346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6107193|NCT00996346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6107194|NCT00996346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6107195|NCT00996346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6107196|NCT00996346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6107197|NCT00996346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6107198|NCT00996346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6107199|NCT00996346|Antifungal Agents|antifungal agents|mesh-ancestor
6107200|NCT00996346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6107201|NCT00996346|Immunologic Factors|immunologic factors|mesh-ancestor
6107202|NCT00996346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107203|NCT00996346|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6107204|NCT00996437|Ranibizumab|ranibizumab|mesh-list
6107205|NCT00996437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6107206|NCT00996437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6107207|NCT00996437|Growth Substances|growth substances|mesh-ancestor
6107208|NCT00996437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107209|NCT00996437|Growth Inhibitors|growth inhibitors|mesh-ancestor
6107210|NCT00996437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6107211|NCT00996476|Simeprevir|simeprevir|mesh-list
6107212|NCT00996476|Antiviral Agents|antiviral agents|mesh-ancestor
6107213|NCT00996476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6107214|NCT00996476|Protease Inhibitors|protease inhibitors|mesh-ancestor
6107215|NCT00996476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6107216|NCT00996476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6107217|NCT00996580|Levonorgestrel|levonorgestrel|mesh-list
6107218|NCT00996580|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6107219|NCT00996580|Estradiol|estradiol|mesh-list
6107220|NCT00996580|Estrogens|estrogens|mesh-ancestor
6107221|NCT00996580|Hormones|hormones|mesh-ancestor
6107222|NCT00996580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6107223|NCT00996580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107224|NCT00996580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6107225|NCT00996580|Contraceptive Agents|contraceptive agents|mesh-ancestor
6107226|NCT00996580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6107227|NCT00996580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6107228|NCT00996580|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6107229|NCT00996580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6107230|NCT00996580|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6107231|NCT00996593|Iodine|iodine|mesh-list
6107232|NCT00996593|Tositumomab I-131|tositumomab i-131|mesh-list
6107233|NCT00996593|Antibodies|antibodies|mesh-list
5526399|NCT04272333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5526400|NCT04272333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5526401|NCT04272333|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5526402|NCT04272333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526403|NCT04272372|Ketoprofen|ketoprofen|mesh-list
5526404|NCT04272372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5526405|NCT04272372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5526406|NCT04272372|Analgesics|analgesics|mesh-ancestor
5526407|NCT04272372|Sensory System Agents|sensory system agents|mesh-ancestor
5526408|NCT04272372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5526409|NCT04272372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526410|NCT04272372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5526411|NCT04272372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5526412|NCT04272372|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5526413|NCT04272372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5526414|NCT04272372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526415|NCT04272255|Scopolamine|scopolamine|mesh-list
5526416|NCT04272255|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
5526417|NCT04272255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5526418|NCT04272255|Antiemetics|antiemetics|mesh-ancestor
5526419|NCT04272255|Autonomic Agents|autonomic agents|mesh-ancestor
5526420|NCT04272255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5526421|NCT04272255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526422|NCT04272255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6107234|NCT00996593|Immunoglobulins|immunoglobulins|mesh-list
6107235|NCT00996593|Immunologic Factors|immunologic factors|mesh-ancestor
6107236|NCT00996593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107237|NCT00996593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6107238|NCT00996593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6107239|NCT00996593|Trace Elements|trace elements|mesh-ancestor
6107240|NCT00996593|Micronutrients|micronutrients|mesh-ancestor
6107241|NCT00996593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6107242|NCT00996658|Linagliptin|linagliptin|mesh-list
6107243|NCT00996658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6107244|NCT00996658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107245|NCT00996658|Incretins|incretins|mesh-ancestor
6107246|NCT00996658|Hormones|hormones|mesh-ancestor
6107247|NCT00996658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6107248|NCT00996658|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6107249|NCT00996658|Protease Inhibitors|protease inhibitors|mesh-ancestor
6107250|NCT00996658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6107251|NCT00996658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6107252|NCT00996736|Voriconazole|voriconazole|mesh-list
6107253|NCT00996736|Natamycin|natamycin|mesh-list
6107254|NCT00996736|Antifungal Agents|antifungal agents|mesh-ancestor
6107255|NCT00996736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5526423|NCT04272255|Mydriatics|mydriatics|mesh-ancestor
5526424|NCT04272255|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5526425|NCT04272255|Cholinergic Agents|cholinergic agents|mesh-ancestor
5526426|NCT04272255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5526427|NCT04272255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526428|NCT04272255|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5526429|NCT04272255|Parasympatholytics|parasympatholytics|mesh-ancestor
6107256|NCT00996736|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6107257|NCT00996736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6107258|NCT00996736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6107259|NCT00996736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6107260|NCT00996736|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6107261|NCT00996736|Hormone Antagonists|hormone antagonists|mesh-ancestor
6107262|NCT00996736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6107263|NCT00996736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465289|NCT00473551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5526430|NCT04272086|Bupivacaine|bupivacaine|mesh-list
5526431|NCT04272086|Anesthetics, Local|anesthetics, local|mesh-ancestor
5526432|NCT04272086|Anesthetics|anesthetics|mesh-ancestor
5526433|NCT04272086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5526434|NCT04272086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526435|NCT04272086|Sensory System Agents|sensory system agents|mesh-ancestor
5526436|NCT04272086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5526437|NCT04272320|Bupivacaine|bupivacaine|mesh-list
5526438|NCT04272320|Anesthetics, Local|anesthetics, local|mesh-ancestor
5526439|NCT04272320|Anesthetics|anesthetics|mesh-ancestor
5526440|NCT04272320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5526441|NCT04272320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526442|NCT04272320|Sensory System Agents|sensory system agents|mesh-ancestor
5526443|NCT04272320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5526444|NCT04271917|Acetaminophen|acetaminophen|mesh-list
5526445|NCT04271917|Ibuprofen|ibuprofen|mesh-list
5526446|NCT04271917|Cannabidiol|cannabidiol|mesh-list
5526447|NCT04271917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5526448|NCT04271917|Analgesics|analgesics|mesh-ancestor
5526449|NCT04271917|Sensory System Agents|sensory system agents|mesh-ancestor
5526450|NCT04271917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5526451|NCT04271917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526452|NCT04271917|Antipyretics|antipyretics|mesh-ancestor
5526453|NCT04271917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5526454|NCT04271917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5526455|NCT04271917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5526456|NCT04271917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5526457|NCT04271917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5526458|NCT04271917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526459|NCT04271917|Anticonvulsants|anticonvulsants|mesh-ancestor
5526460|NCT04271839|Fluticasone|fluticasone|mesh-list
5526461|NCT04271839|Formoterol Fumarate|formoterol fumarate|mesh-list
6107264|NCT00996736|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6107265|NCT00996736|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5526462|NCT04271839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5526463|NCT04271839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5526464|NCT04271839|Autonomic Agents|autonomic agents|mesh-ancestor
5526465|NCT04271839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5526466|NCT04271839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107266|NCT00996736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6107267|NCT00996801|Vitamin D|vitamin d|mesh-list
6107268|NCT00996801|Cholecalciferol|cholecalciferol|mesh-list
6107269|NCT00996801|Alendronate|alendronate|mesh-list
6107270|NCT00996801|Calcium Carbonate|calcium carbonate|mesh-list
6107271|NCT00996801|Calcium|calcium|mesh-list
6107272|NCT00996801|Vitamins|vitamins|mesh-ancestor
5526467|NCT04271839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6107273|NCT00996801|Micronutrients|micronutrients|mesh-ancestor
6107274|NCT00996801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107275|NCT00996801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6107276|NCT00996801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6107277|NCT00996801|Antacids|antacids|mesh-ancestor
6107278|NCT00996801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6107279|NCT00996801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6107280|NCT00996931|Lenalidomide|lenalidomide|mesh-list
6107281|NCT00996931|Immunologic Factors|immunologic factors|mesh-ancestor
6107282|NCT00996931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107283|NCT00996931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6107284|NCT00996931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6107285|NCT00996931|Growth Substances|growth substances|mesh-ancestor
6107286|NCT00996931|Growth Inhibitors|growth inhibitors|mesh-ancestor
6107287|NCT00996931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6107288|NCT00996944|Ropinirole|ropinirole|mesh-list
6107289|NCT00996944|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6107290|NCT00996944|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6107291|NCT00996944|Dopamine Agonists|dopamine agonists|mesh-ancestor
6107292|NCT00996944|Dopamine Agents|dopamine agents|mesh-ancestor
6107293|NCT00996944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6107294|NCT00996944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6107295|NCT00996944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107296|NCT00996996|Iodine|iodine|mesh-list
6107297|NCT00996996|Tositumomab I-131|tositumomab i-131|mesh-list
6107298|NCT00996996|Antibodies|antibodies|mesh-list
6107299|NCT00996996|Immunoglobulins|immunoglobulins|mesh-list
6107300|NCT00996996|Immunologic Factors|immunologic factors|mesh-ancestor
6107301|NCT00996996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107302|NCT00996996|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6107303|NCT00996996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6107304|NCT00996996|Trace Elements|trace elements|mesh-ancestor
6107305|NCT00996996|Micronutrients|micronutrients|mesh-ancestor
6107306|NCT00996996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6107307|NCT00997035|Voriconazole|voriconazole|mesh-list
6107308|NCT00997035|Antifungal Agents|antifungal agents|mesh-ancestor
6107309|NCT00997035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6107310|NCT00997035|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6107311|NCT00997035|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6107312|NCT00997035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6107313|NCT00997035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6107314|NCT00997035|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6107315|NCT00997035|Hormone Antagonists|hormone antagonists|mesh-ancestor
6107316|NCT00997035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6107317|NCT00997035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107318|NCT00997035|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6107319|NCT00997113|Alfentanil|alfentanil|mesh-list
6107320|NCT00997113|Propofol|propofol|mesh-list
6107321|NCT00997113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6107322|NCT00997113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6107323|NCT00997113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107324|NCT00997113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6107325|NCT00997113|Anesthetics, General|anesthetics, general|mesh-ancestor
6107326|NCT00997113|Anesthetics|anesthetics|mesh-ancestor
6107327|NCT00997113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6107328|NCT00997113|Narcotics|narcotics|mesh-ancestor
5526468|NCT04271839|Respiratory System Agents|respiratory system agents|mesh-ancestor
5526469|NCT04271839|Dermatologic Agents|dermatologic agents|mesh-ancestor
5526470|NCT04271839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5526471|NCT04271839|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6107329|NCT00997113|Analgesics|analgesics|mesh-ancestor
6107330|NCT00997113|Sensory System Agents|sensory system agents|mesh-ancestor
6107331|NCT00997113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6107332|NCT00997126|Alfentanil|alfentanil|mesh-list
6107333|NCT00997126|Propofol|propofol|mesh-list
6107334|NCT00997126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6107335|NCT00997126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6107336|NCT00997126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107337|NCT00997126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6107338|NCT00997126|Anesthetics, General|anesthetics, general|mesh-ancestor
6107339|NCT00997126|Anesthetics|anesthetics|mesh-ancestor
6107340|NCT00997126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6107341|NCT00997126|Narcotics|narcotics|mesh-ancestor
6107342|NCT00997126|Analgesics|analgesics|mesh-ancestor
6465290|NCT00473551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6465291|NCT00473551|Alkylating Agents|alkylating agents|mesh-ancestor
6465292|NCT00473551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465293|NCT00473551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6465294|NCT00473551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6465295|NCT00473551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6465296|NCT00473551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6465297|NCT00473551|Antimetabolites|antimetabolites|mesh-ancestor
6465298|NCT00473551|Antiviral Agents|antiviral agents|mesh-ancestor
6465299|NCT00473551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6465300|NCT00473551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6465301|NCT00473551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5526472|NCT04271839|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5526473|NCT04271839|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5526474|NCT04271839|Adrenergic Agents|adrenergic agents|mesh-ancestor
5526475|NCT04271839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5526476|NCT04271839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526477|NCT04272021|Methylphenidate|methylphenidate|mesh-list
5526478|NCT04272021|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5526479|NCT04272021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526480|NCT04272021|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5526481|NCT04272021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5526482|NCT04272021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5526483|NCT04272021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465302|NCT00473551|Antifungal Agents|antifungal agents|mesh-ancestor
6465303|NCT00473603|Heparin|heparin|mesh-list
6465304|NCT00473603|Anticoagulants|anticoagulants|mesh-ancestor
6465305|NCT00473603|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5526484|NCT04272021|Dopamine Agents|dopamine agents|mesh-ancestor
5526485|NCT04272021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5526486|NCT04271956|Zanubrutinib|zanubrutinib|mesh-list
6107343|NCT00997126|Sensory System Agents|sensory system agents|mesh-ancestor
6107344|NCT00997126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5526487|NCT04271956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5526488|NCT04271956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5526489|NCT04271956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6107345|NCT00997139|Polymyxins|polymyxins|mesh-list
6107346|NCT00997139|Bacitracin|bacitracin|mesh-list
6465306|NCT00473603|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6488434|NCT00584155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5526490|NCT04271956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601326|NCT03706053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5601327|NCT03706053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601328|NCT03705962|Tobramycin|tobramycin|mesh-list
5601329|NCT03705962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5601330|NCT03705962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5601331|NCT03705949|Lubricant Eye Drops|lubricant eye drops|mesh-list
5601332|NCT03705949|Hyaluronic Acid|hyaluronic acid|mesh-list
5601333|NCT03705949|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5601334|NCT03705949|Immunologic Factors|immunologic factors|mesh-ancestor
5601335|NCT03705949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601336|NCT03705949|Viscosupplements|viscosupplements|mesh-ancestor
5601337|NCT03705949|Protective Agents|protective agents|mesh-ancestor
6107347|NCT00997139|Neomycin|neomycin|mesh-list
6107348|NCT00997139|Polymyxin B|polymyxin b|mesh-list
6107349|NCT00997139|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
6107350|NCT00997139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6107351|NCT00997139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6107352|NCT00997139|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6107353|NCT00997139|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6107354|NCT00997139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6107355|NCT00997139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6107356|NCT00997204|Icatibant|icatibant|mesh-list
6107357|NCT00997204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6107358|NCT00997204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6107359|NCT00997204|Analgesics|analgesics|mesh-ancestor
6107360|NCT00997204|Sensory System Agents|sensory system agents|mesh-ancestor
6107361|NCT00997204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6107362|NCT00997204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107363|NCT00997204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6107364|NCT00997204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6107365|NCT00997204|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
6107366|NCT00997204|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
6107367|NCT00997204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6107368|NCT00997204|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6107369|NCT00997204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6107370|NCT00997204|Immunologic Factors|immunologic factors|mesh-ancestor
6107371|NCT00997243|Azacitidine|azacitidine|mesh-list
6107372|NCT00997243|Lintuzumab|lintuzumab|mesh-list
6107373|NCT00997243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6107374|NCT00997243|Antimetabolites|antimetabolites|mesh-ancestor
6107375|NCT00997243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6107376|NCT00997243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6107377|NCT00997243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6107378|NCT00997243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6107379|NCT00997321|Ketamine|ketamine|mesh-list
6107380|NCT00997321|Propofol|propofol|mesh-list
6107381|NCT00997321|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6107382|NCT00997321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6107383|NCT00997321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107384|NCT00997321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6107385|NCT00997321|Anesthetics, General|anesthetics, general|mesh-ancestor
6107386|NCT00997321|Anesthetics|anesthetics|mesh-ancestor
6107387|NCT00997321|Analgesics|analgesics|mesh-ancestor
6107388|NCT00997321|Sensory System Agents|sensory system agents|mesh-ancestor
5601338|NCT03705949|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5601339|NCT03705949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5601340|NCT03705884|Prednisolone|prednisolone|mesh-list
5601341|NCT03705884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5601342|NCT03705884|Glucocorticoids|glucocorticoids|mesh-ancestor
5601343|NCT03705884|Hormones|hormones|mesh-ancestor
5601344|NCT03705884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5601345|NCT03705884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107389|NCT00997321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6107390|NCT00997321|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6107391|NCT00997321|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6107392|NCT00997321|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6107393|NCT00997321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6107394|NCT00997321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6107395|NCT00997334|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6107396|NCT00997334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6107397|NCT00997334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6107398|NCT00997334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6107399|NCT00997334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6107400|NCT00997373|Letrozole|letrozole|mesh-list
5526491|NCT04271332|Baclofen|baclofen|mesh-list
5526492|NCT04271332|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5526493|NCT04271332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526494|NCT04271332|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5526495|NCT04271332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5526496|NCT04271332|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
5526497|NCT04271332|GABA Agonists|gaba agonists|mesh-ancestor
5526498|NCT04271332|GABA Agents|gaba agents|mesh-ancestor
5526499|NCT04271332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5526500|NCT04271332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526501|NCT04271007|Mometasone Furoate|mometasone furoate|mesh-list
5526502|NCT04271007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5526503|NCT04271007|Dermatologic Agents|dermatologic agents|mesh-ancestor
5526504|NCT04271007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5526505|NCT04270994|Misoprostol|misoprostol|mesh-list
5526506|NCT04270994|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5526507|NCT04270994|Abortifacient Agents|abortifacient agents|mesh-ancestor
5526508|NCT04270994|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5526509|NCT04270994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526510|NCT04270994|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5526511|NCT04270994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5526512|NCT04270994|Oxytocics|oxytocics|mesh-ancestor
5526513|NCT04271189|Metformin|metformin|mesh-list
5526514|NCT04271189|Pioglitazone|pioglitazone|mesh-list
5526515|NCT04271189|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5526516|NCT04271189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5526517|NCT04271189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526518|NCT04271189|Incretins|incretins|mesh-ancestor
5526519|NCT04271189|Hormones|hormones|mesh-ancestor
5526520|NCT04271189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5526521|NCT04271189|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6107401|NCT00997373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6107402|NCT00997373|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6107403|NCT00997373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6107404|NCT00997373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6107405|NCT00997373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6107406|NCT00997373|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6107407|NCT00997373|Hormone Antagonists|hormone antagonists|mesh-ancestor
6107408|NCT00997373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6107409|NCT00997373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107410|NCT00997438|Thioctic Acid|thioctic acid|mesh-list
6107411|NCT00997438|Antioxidants|antioxidants|mesh-ancestor
5526522|NCT04271189|Protease Inhibitors|protease inhibitors|mesh-ancestor
5526523|NCT04271189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5526524|NCT04271189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526525|NCT04271384|Nivolumab|nivolumab|mesh-list
5526526|NCT04271384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5526527|NCT04271384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5526528|NCT04271384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6107412|NCT00997438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6107413|NCT00997438|Protective Agents|protective agents|mesh-ancestor
6107414|NCT00997438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107415|NCT00997438|Vitamin B Complex|vitamin b complex|mesh-ancestor
6107416|NCT00997438|Vitamins|vitamins|mesh-ancestor
6107417|NCT00997438|Micronutrients|micronutrients|mesh-ancestor
5526529|NCT04271384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526530|NCT04271202|Erenumab|erenumab|mesh-list
5526531|NCT04271202|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
5526532|NCT04271202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526533|NCT04271202|Analgesics|analgesics|mesh-ancestor
6107418|NCT00997503|Aspirin|aspirin|mesh-list
5526534|NCT04271202|Sensory System Agents|sensory system agents|mesh-ancestor
5526535|NCT04271202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6107419|NCT00997503|Paclitaxel|paclitaxel|mesh-list
6107420|NCT00997503|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6107421|NCT00997503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6107422|NCT00997503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6107423|NCT00997503|Tubulin Modulators|tubulin modulators|mesh-ancestor
6107424|NCT00997503|Antimitotic Agents|antimitotic agents|mesh-ancestor
6107425|NCT00997503|Mitosis Modulators|mitosis modulators|mesh-ancestor
5526536|NCT04271202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526537|NCT04270864|Nivolumab|nivolumab|mesh-list
5526538|NCT04270864|Ipilimumab|ipilimumab|mesh-list
5526539|NCT04270864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5526540|NCT04270864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5526541|NCT04270864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5526542|NCT04270864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526543|NCT04270877|Naltrexone|naltrexone|mesh-list
5526544|NCT04270877|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5526545|NCT04270877|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5526546|NCT04270877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526547|NCT04270877|Sensory System Agents|sensory system agents|mesh-ancestor
5526548|NCT04270877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5526549|NCT04270968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
5526550|NCT04270929|Folfirinox|folfirinox|mesh-list
5526551|NCT04270929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5526552|NCT04270682|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
5526553|NCT04270682|Cathartics|cathartics|mesh-ancestor
5526554|NCT04270682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5526555|NCT04270656|Insulin|insulin|mesh-list
5526556|NCT04270656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5526557|NCT04270656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526558|NCT04270708|Dexmedetomidine|dexmedetomidine|mesh-list
5526559|NCT04270708|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5526560|NCT04270708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5526561|NCT04270708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526562|NCT04270708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5526563|NCT04270708|Analgesics|analgesics|mesh-ancestor
5526564|NCT04270708|Sensory System Agents|sensory system agents|mesh-ancestor
5526565|NCT04270708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6107426|NCT00997503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6107427|NCT00997503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6107428|NCT00997503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6107429|NCT00997503|Analgesics|analgesics|mesh-ancestor
6107430|NCT00997503|Sensory System Agents|sensory system agents|mesh-ancestor
6107431|NCT00997503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6107432|NCT00997503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107433|NCT00997503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6107434|NCT00997503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6107435|NCT00997503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6107436|NCT00997503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6107437|NCT00997503|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6107438|NCT00997503|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6107439|NCT00997503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5526566|NCT04270708|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5526567|NCT04270708|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5526568|NCT04270708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6107440|NCT00997503|Antipyretics|antipyretics|mesh-ancestor
6107441|NCT00997620|Fluticasone|fluticasone|mesh-list
6107442|NCT00997620|Xhance|xhance|mesh-list
6107443|NCT00997620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6107444|NCT00997620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6107445|NCT00997620|Autonomic Agents|autonomic agents|mesh-ancestor
6107446|NCT00997620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6107447|NCT00997620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107448|NCT00997620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6107449|NCT00997620|Respiratory System Agents|respiratory system agents|mesh-ancestor
6107450|NCT00997620|Dermatologic Agents|dermatologic agents|mesh-ancestor
6107451|NCT00997620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6107452|NCT00997672|Lithium Carbonate|lithium carbonate|mesh-list
6107453|NCT00997672|Antidepressive Agents|antidepressive agents|mesh-ancestor
6107454|NCT00997672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6107455|NCT00997672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6107456|NCT00997672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526569|NCT04270708|Adrenergic Agents|adrenergic agents|mesh-ancestor
5526570|NCT04270708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5526571|NCT04270708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526572|NCT04270552|Broncho-Vaxom|broncho-vaxom|mesh-list
5526573|NCT04270552|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5526574|NCT04270552|Immunologic Factors|immunologic factors|mesh-ancestor
5526575|NCT04270552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526576|NCT04270487|Octylonium|octylonium|mesh-list
5526577|NCT04270487|Bromides|bromides|mesh-list
5526578|NCT04270487|Anticonvulsants|anticonvulsants|mesh-ancestor
5526579|NCT04270487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5526580|NCT04270487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5526581|NCT04270487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526582|NCT04270487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5526583|NCT04270487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526584|NCT04270487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5526585|NCT04270487|Parasympatholytics|parasympatholytics|mesh-ancestor
6107457|NCT00997672|Antimanic Agents|antimanic agents|mesh-ancestor
6107458|NCT00997672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6107459|NCT00997672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6107460|NCT00997672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107461|NCT00997893|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6107462|NCT00997893|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6107463|NCT00997893|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6107464|NCT00997893|Medroxyprogesterone|medroxyprogesterone|mesh-list
6107465|NCT00997893|Estradiol|estradiol|mesh-list
6465307|NCT00473603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465308|NCT00473616|Irinotecan|irinotecan|mesh-list
6465309|NCT00473616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6465310|NCT00473616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6465311|NCT00473616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6465312|NCT00473616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465313|NCT00473616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6465314|NCT00473707|Oxytocin|oxytocin|mesh-list
6465315|NCT00473707|Oxytocics|oxytocics|mesh-ancestor
6465316|NCT00473707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5526586|NCT04270487|Autonomic Agents|autonomic agents|mesh-ancestor
6107466|NCT00997893|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6107467|NCT00997893|Estrogens|estrogens|mesh-list
6107468|NCT00997893|Phytoestrogens|phytoestrogens|mesh-list
6107469|NCT00997893|Hormones|hormones|mesh-ancestor
6107470|NCT00997893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6107471|NCT00997893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107472|NCT00997893|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6107473|NCT00997893|Contraceptive Agents|contraceptive agents|mesh-ancestor
6107474|NCT00997893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6107475|NCT00997893|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6107476|NCT00997893|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6107477|NCT00997893|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6107478|NCT00997893|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6107479|NCT00997893|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6107480|NCT00997893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6107481|NCT00997893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6107482|NCT00997893|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6107483|NCT00997932|Contraceptive Agents|contraceptive agents|mesh-list
6107484|NCT00997932|Levonorgestrel|levonorgestrel|mesh-list
6107485|NCT00997932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6107486|NCT00997932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107487|NCT00997932|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6107488|NCT00997932|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6107489|NCT00997932|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5526587|NCT04270487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5526588|NCT04270487|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5526589|NCT04270487|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5526590|NCT04270487|Cholinergic Agents|cholinergic agents|mesh-ancestor
6107490|NCT00997932|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6107491|NCT00997984|Guanfacine|guanfacine|mesh-list
6107492|NCT00997984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6107493|NCT00997984|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6107494|NCT00997984|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6107495|NCT00997984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6107496|NCT00997984|Adrenergic Agents|adrenergic agents|mesh-ancestor
6107497|NCT00997984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6107498|NCT00997984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6107499|NCT00997984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526591|NCT04270487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5526592|NCT04270370|Atorvastatin|atorvastatin|mesh-list
5526593|NCT04270370|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5526594|NCT04270370|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5526595|NCT04270370|Antimetabolites|antimetabolites|mesh-ancestor
5526596|NCT04270370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526597|NCT04270370|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5526598|NCT04270370|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5526599|NCT04270370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6107500|NCT00998010|Bortezomib|bortezomib|mesh-list
6107501|NCT00998010|Temozolomide|temozolomide|mesh-list
6107502|NCT00998010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6107503|NCT00998010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6107504|NCT00998010|Alkylating Agents|alkylating agents|mesh-ancestor
6107505|NCT00998010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6107506|NCT00998049|Plerixafor|plerixafor|mesh-list
6107507|NCT00998049|Lenograstim|lenograstim|mesh-list
6107508|NCT00998049|Sargramostim|sargramostim|mesh-list
6107509|NCT00998049|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6107510|NCT00998049|Immunologic Factors|immunologic factors|mesh-ancestor
6107511|NCT00998049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107512|NCT00998049|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6107513|NCT00998049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5526600|NCT04270279|Nitroglycerin|nitroglycerin|mesh-list
5526601|NCT04270279|Vasodilator Agents|vasodilator agents|mesh-ancestor
5526602|NCT04270344|Valsartan|valsartan|mesh-list
5526603|NCT04270344|Pitavastatin|pitavastatin|mesh-list
5526604|NCT04270344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5526605|NCT04270344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5526606|NCT04270344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5526607|NCT04270344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526608|NCT04270344|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5526609|NCT04270344|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5526610|NCT04270344|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5526611|NCT04270344|Antimetabolites|antimetabolites|mesh-ancestor
6107514|NCT00998049|Antiviral Agents|antiviral agents|mesh-ancestor
6107515|NCT00998049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6107516|NCT00998205|Atropine|atropine|mesh-list
6107517|NCT00998205|Dobutamine|dobutamine|mesh-list
6107518|NCT00998205|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6107519|NCT00998205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5526612|NCT04270344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5526613|NCT04270344|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5526614|NCT04270175|Dexamethasone|dexamethasone|mesh-list
5526615|NCT04270175|Daratumumab|daratumumab|mesh-list
5526616|NCT04270175|Pomalidomide|pomalidomide|mesh-list
5526617|NCT04270175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5526618|NCT04270175|Antiemetics|antiemetics|mesh-ancestor
5526619|NCT04270175|Autonomic Agents|autonomic agents|mesh-ancestor
5526620|NCT04270175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6107520|NCT00998205|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6665962|NCT01519856|Dopamine Agonists|dopamine agonists|mesh-ancestor
6665963|NCT01519856|Dopamine Agents|dopamine agents|mesh-ancestor
6665964|NCT01519856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6665965|NCT01519856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665966|NCT01519856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665967|NCT01519986|Vitamin D|vitamin d|mesh-list
6665968|NCT01519986|Cholecalciferol|cholecalciferol|mesh-list
6665969|NCT01519986|Vitamins|vitamins|mesh-ancestor
6107521|NCT00998205|Autonomic Agents|autonomic agents|mesh-ancestor
6107522|NCT00998205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6107523|NCT00998205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107524|NCT00998205|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6107525|NCT00998205|Respiratory System Agents|respiratory system agents|mesh-ancestor
6107526|NCT00998205|Mydriatics|mydriatics|mesh-ancestor
6107527|NCT00998205|Parasympatholytics|parasympatholytics|mesh-ancestor
6107528|NCT00998205|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6107529|NCT00998205|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6107530|NCT00998205|Cholinergic Agents|cholinergic agents|mesh-ancestor
6107531|NCT00998205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6107532|NCT00998205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6107533|NCT00998205|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6107534|NCT00998205|Sympathomimetics|sympathomimetics|mesh-ancestor
6107535|NCT00998205|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6107536|NCT00998205|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6107537|NCT00998205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6665970|NCT01519986|Micronutrients|micronutrients|mesh-ancestor
6107538|NCT00998205|Adrenergic Agents|adrenergic agents|mesh-ancestor
5526621|NCT04270175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526622|NCT04270175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5526623|NCT04270175|Glucocorticoids|glucocorticoids|mesh-ancestor
5526624|NCT04270175|Hormones|hormones|mesh-ancestor
5526625|NCT04270175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5526626|NCT04270175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5526627|NCT04270175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5526628|NCT04270175|Immunologic Factors|immunologic factors|mesh-ancestor
5526629|NCT04270175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5526630|NCT04270175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5526631|NCT04270175|Growth Substances|growth substances|mesh-ancestor
5526632|NCT04270175|Growth Inhibitors|growth inhibitors|mesh-ancestor
5526633|NCT04269954|Heparin|heparin|mesh-list
5526634|NCT04269954|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5526635|NCT04269954|Tinzaparin|tinzaparin|mesh-list
5526636|NCT04269954|Dalteparin|dalteparin|mesh-list
5526637|NCT04269954|Batroxobin|batroxobin|mesh-list
5526638|NCT04269954|Anticoagulants|anticoagulants|mesh-ancestor
5526639|NCT04269954|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6107539|NCT00998205|Protective Agents|protective agents|mesh-ancestor
6665971|NCT01519986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665972|NCT01519986|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6665973|NCT01519986|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6107540|NCT00998296|Nintedanib|nintedanib|mesh-list
6107541|NCT00998296|Afatinib|afatinib|mesh-list
6107542|NCT00998296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6107543|NCT00998296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6107544|NCT00998296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5526640|NCT04269954|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5526641|NCT04269954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526642|NCT04269954|Hemostatics|hemostatics|mesh-ancestor
5526643|NCT04269954|Coagulants|coagulants|mesh-ancestor
5526644|NCT04270318|Pemetrexed|pemetrexed|mesh-list
5526645|NCT04270318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6107545|NCT00998296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6107546|NCT00998309|Azithromycin|azithromycin|mesh-list
6107547|NCT00998309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6107548|NCT00998309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6465317|NCT00473707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465318|NCT00473720|Paclitaxel|paclitaxel|mesh-list
6465319|NCT00473720|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6465320|NCT00473720|Satraplatin|satraplatin|mesh-list
6465321|NCT00473720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6465322|NCT00473720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6465323|NCT00473720|Tubulin Modulators|tubulin modulators|mesh-ancestor
6465324|NCT00473720|Antimitotic Agents|antimitotic agents|mesh-ancestor
6465325|NCT00473720|Mitosis Modulators|mitosis modulators|mesh-ancestor
6465326|NCT00473720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204090|NCT02065479|Ticagrelor|ticagrelor|mesh-list
6204091|NCT02065479|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6204092|NCT02065479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6204093|NCT02065479|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6204094|NCT02065479|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6204095|NCT02065479|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6465327|NCT00473915|Fluticasone|fluticasone|mesh-list
5526646|NCT04270318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5526647|NCT04270318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526648|NCT04270318|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5526649|NCT04270318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5526650|NCT04270071|Nitroglycerin|nitroglycerin|mesh-list
5526651|NCT04270071|Vasodilator Agents|vasodilator agents|mesh-ancestor
5526652|NCT04270019|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
5526653|NCT04270019|Laxatives|laxatives|mesh-ancestor
5526654|NCT04270019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5526655|NCT04270214|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5526656|NCT04270214|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5526657|NCT04270214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5526658|NCT04270214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526659|NCT04270214|Cholinergic Agents|cholinergic agents|mesh-ancestor
5526660|NCT04270214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5526661|NCT04270214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526662|NCT04269863|Aspirin|aspirin|mesh-list
5526663|NCT04269863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6465328|NCT00473915|Xhance|xhance|mesh-list
5526664|NCT04269863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6465329|NCT00473915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6465330|NCT00473915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6465331|NCT00473915|Autonomic Agents|autonomic agents|mesh-ancestor
6465332|NCT00473915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6107549|NCT00998335|Insulin|insulin|mesh-list
6107550|NCT00998335|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6107551|NCT00998335|Insulin Aspart|insulin aspart|mesh-list
6107552|NCT00998335|Insulin, Long-Acting|insulin, long-acting|mesh-list
6107553|NCT00998335|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6107554|NCT00998335|Insulin Detemir|insulin detemir|mesh-list
6107555|NCT00998335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6107556|NCT00998335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107557|NCT00998426|Immunoglobulins|immunoglobulins|mesh-list
6107558|NCT00998426|Antibodies|antibodies|mesh-list
6665974|NCT01520012|Esomeprazole|esomeprazole|mesh-list
6107559|NCT00998426|gamma-Globulins|gamma-globulins|mesh-list
6107560|NCT00998426|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6107561|NCT00998426|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6107562|NCT00998426|Immunoglobulin G|immunoglobulin g|mesh-list
6107563|NCT00998426|Immunologic Factors|immunologic factors|mesh-ancestor
6107564|NCT00998426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107565|NCT00998582|Tenofovir|tenofovir|mesh-list
6107566|NCT00998582|Antiviral Agents|antiviral agents|mesh-ancestor
6107567|NCT00998582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6107568|NCT00998582|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6107569|NCT00998582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6107570|NCT00998582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6107571|NCT00998582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6107572|NCT00998582|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6107573|NCT00998582|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6107574|NCT00998946|Vitamins|vitamins|mesh-list
6107575|NCT00998946|Folic Acid|folic acid|mesh-list
6107576|NCT00998946|Vitamin B 12|vitamin b 12|mesh-list
6107577|NCT00998946|Hydroxocobalamin|hydroxocobalamin|mesh-list
6107578|NCT00998946|Vitamin B Complex|vitamin b complex|mesh-list
6107579|NCT00998946|10-deazaaminopterin|10-deazaaminopterin|mesh-list
6107580|NCT00998946|Micronutrients|micronutrients|mesh-ancestor
6107581|NCT00998946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526665|NCT04269863|Analgesics|analgesics|mesh-ancestor
5526666|NCT04269863|Sensory System Agents|sensory system agents|mesh-ancestor
5526667|NCT04269863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5725289|NCT03181815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5725290|NCT03181815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5725291|NCT03181815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5725292|NCT03181815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5725293|NCT03181815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5725294|NCT03181386|Warfarin|warfarin|mesh-list
5725295|NCT03181386|Rivaroxaban|rivaroxaban|mesh-list
5725296|NCT03181386|Dabigatran|dabigatran|mesh-list
5725297|NCT03181386|Apixaban|apixaban|mesh-list
5725298|NCT03181386|Anticoagulants|anticoagulants|mesh-ancestor
6107582|NCT00998946|Hematinics|hematinics|mesh-ancestor
6107583|NCT00998946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6107584|NCT00998946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6465333|NCT00473915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465334|NCT00473915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6465335|NCT00473915|Respiratory System Agents|respiratory system agents|mesh-ancestor
6465336|NCT00473915|Dermatologic Agents|dermatologic agents|mesh-ancestor
6465337|NCT00473915|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6465338|NCT00473980|Celecoxib|celecoxib|mesh-list
6465339|NCT00473980|Indomethacin|indomethacin|mesh-list
6465340|NCT00473980|Esomeprazole|esomeprazole|mesh-list
6465341|NCT00473980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6465342|NCT00473980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6465343|NCT00473980|Analgesics|analgesics|mesh-ancestor
6465344|NCT00473980|Sensory System Agents|sensory system agents|mesh-ancestor
6465345|NCT00473980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6465346|NCT00473980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465347|NCT00473980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6465348|NCT00473980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6465349|NCT00473980|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6465350|NCT00473980|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6107585|NCT00998946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6107586|NCT00998946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6107587|NCT00998985|Grazoprevir|grazoprevir|mesh-list
6107588|NCT00998985|Antiviral Agents|antiviral agents|mesh-ancestor
6107589|NCT00998985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6107590|NCT00999037|Sevelamer|sevelamer|mesh-list
6107591|NCT00999037|Chelating Agents|chelating agents|mesh-ancestor
6107592|NCT00999037|Sequestering Agents|sequestering agents|mesh-ancestor
6107593|NCT00999037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6107594|NCT00999102|Metoprolol|metoprolol|mesh-list
6107595|NCT00999102|Nebivolol|nebivolol|mesh-list
6107596|NCT00999102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6107597|NCT00999102|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6107598|NCT00999102|Sympatholytics|sympatholytics|mesh-ancestor
6107599|NCT00999102|Autonomic Agents|autonomic agents|mesh-ancestor
6107600|NCT00999102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6107601|NCT00999102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107602|NCT00999102|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5526668|NCT04269863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526669|NCT04269863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5526670|NCT04269863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5526671|NCT04269863|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5526672|NCT04269863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5526673|NCT04269863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526674|NCT04269863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5526675|NCT04269863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5526676|NCT04269863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5526677|NCT04269863|Antipyretics|antipyretics|mesh-ancestor
5526678|NCT04269928|Epinephrine|epinephrine|mesh-list
5526679|NCT04269928|Racepinephrine|racepinephrine|mesh-list
5526680|NCT04269928|Epinephryl borate|epinephryl borate|mesh-list
5526681|NCT04269928|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5526682|NCT04269928|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5526683|NCT04269928|Adrenergic Agents|adrenergic agents|mesh-ancestor
5526684|NCT04269928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5526685|NCT04269928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526686|NCT04269928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526687|NCT04269928|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5526688|NCT04269928|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5526689|NCT04269928|Autonomic Agents|autonomic agents|mesh-ancestor
5526690|NCT04269928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5526691|NCT04269928|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5526692|NCT04269928|Respiratory System Agents|respiratory system agents|mesh-ancestor
5526693|NCT04269928|Mydriatics|mydriatics|mesh-ancestor
5526694|NCT04269928|Sympathomimetics|sympathomimetics|mesh-ancestor
5526695|NCT04269928|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5601346|NCT03705884|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5601347|NCT03705884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5601348|NCT03705858|Lintuzumab|lintuzumab|mesh-list
5601349|NCT03705858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5601350|NCT03705858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6107603|NCT00999102|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6107604|NCT00999102|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6107605|NCT00999102|Adrenergic Agents|adrenergic agents|mesh-ancestor
6107606|NCT00999102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6107607|NCT00999102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6107608|NCT00999102|Vasodilator Agents|vasodilator agents|mesh-ancestor
6107609|NCT00999102|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6107610|NCT00999102|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6107611|NCT00999102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6107612|NCT00999518|Tanezumab|tanezumab|mesh-list
6107613|NCT00999518|Analgesics|analgesics|mesh-ancestor
5601351|NCT03705780|Fentanyl|fentanyl|mesh-list
5601352|NCT03705780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5601353|NCT03705780|Narcotics|narcotics|mesh-ancestor
5601354|NCT03705780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5601355|NCT03705780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601356|NCT03705780|Analgesics|analgesics|mesh-ancestor
5601357|NCT03705780|Sensory System Agents|sensory system agents|mesh-ancestor
5601358|NCT03705780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5601359|NCT03705780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5601360|NCT03705780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5601361|NCT03705780|Anesthetics, General|anesthetics, general|mesh-ancestor
6204096|NCT02065479|Purinergic Agents|purinergic agents|mesh-ancestor
5601362|NCT03705780|Anesthetics|anesthetics|mesh-ancestor
5601363|NCT03705728|Remifentanil|remifentanil|mesh-list
5601364|NCT03705728|Propofol|propofol|mesh-list
6107614|NCT00999518|Sensory System Agents|sensory system agents|mesh-ancestor
6107615|NCT00999518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6107616|NCT00999518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107617|NCT00999544|Oxycodone|oxycodone|mesh-list
6107618|NCT00999544|Aprepitant|aprepitant|mesh-list
6107619|NCT00999544|Fosaprepitant|fosaprepitant|mesh-list
6107620|NCT00999544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6107621|NCT00999544|Narcotics|narcotics|mesh-ancestor
6107622|NCT00999544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6107623|NCT00999544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107624|NCT00999544|Analgesics|analgesics|mesh-ancestor
6107625|NCT00999544|Sensory System Agents|sensory system agents|mesh-ancestor
6107626|NCT00999544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6107627|NCT00999544|Antiemetics|antiemetics|mesh-ancestor
6107628|NCT00999544|Autonomic Agents|autonomic agents|mesh-ancestor
6107629|NCT00999544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6107630|NCT00999544|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6107631|NCT00999544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6107632|NCT00999544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6107633|NCT00999713|Calfactant|calfactant|mesh-list
6107634|NCT00999713|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
6107635|NCT00999713|Respiratory System Agents|respiratory system agents|mesh-ancestor
6107636|NCT00999804|Trastuzumab|trastuzumab|mesh-list
6107637|NCT00999804|Letrozole|letrozole|mesh-list
6107638|NCT00999804|Lapatinib|lapatinib|mesh-list
6107639|NCT00999804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6107640|NCT00999804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6107641|NCT00999804|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6107642|NCT00999804|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6107643|NCT00999804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6107644|NCT00999804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6107645|NCT00999804|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6107646|NCT00999804|Hormone Antagonists|hormone antagonists|mesh-ancestor
6107647|NCT00999804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6107648|NCT00999804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107649|NCT00999804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6107650|NCT00999908|Tiotropium Bromide|tiotropium bromide|mesh-list
6107651|NCT00999908|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6107652|NCT00999908|Autonomic Agents|autonomic agents|mesh-ancestor
6107653|NCT00999908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6107654|NCT00999908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107655|NCT00999908|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6107656|NCT00999908|Respiratory System Agents|respiratory system agents|mesh-ancestor
6107657|NCT00999908|Parasympatholytics|parasympatholytics|mesh-ancestor
6107658|NCT00999908|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6107659|NCT00999908|Cholinergic Agents|cholinergic agents|mesh-ancestor
6107660|NCT00999908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6107661|NCT00999908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6107662|NCT00999921|Tamoxifen|tamoxifen|mesh-list
6107663|NCT00999921|Evening primrose oil|evening primrose oil|mesh-list
6107664|NCT00999921|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6107665|NCT00999921|Hormone Antagonists|hormone antagonists|mesh-ancestor
6107666|NCT00999921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6107667|NCT00999921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107668|NCT00999921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6107669|NCT00999921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6107670|NCT00999921|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6107671|NCT00999921|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6107672|NCT00999921|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6107673|NCT00999921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6107674|NCT00999921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6107675|NCT00999921|Analgesics|analgesics|mesh-ancestor
6107676|NCT00999921|Sensory System Agents|sensory system agents|mesh-ancestor
6107677|NCT00999921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6107678|NCT00999921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6107679|NCT00999921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6107680|NCT00999921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6107681|NCT00999921|Antimetabolites|antimetabolites|mesh-ancestor
6107682|NCT00999921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6107683|NCT00999921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6107684|NCT00999921|Dermatologic Agents|dermatologic agents|mesh-ancestor
6107685|NCT01000064|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6465351|NCT00473980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6488435|NCT00584168|Dexamethasone|dexamethasone|mesh-list
5526696|NCT04269369|Fluorouracil|fluorouracil|mesh-list
5526697|NCT04269369|Antimetabolites|antimetabolites|mesh-ancestor
5526698|NCT04269369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526699|NCT04269369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5526700|NCT04269369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5526701|NCT04269369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5526702|NCT04269369|Immunologic Factors|immunologic factors|mesh-ancestor
5526703|NCT04269369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526704|NCT04269460|Bupivacaine|bupivacaine|mesh-list
5526705|NCT04269460|Anesthetics, Local|anesthetics, local|mesh-ancestor
5526706|NCT04269460|Anesthetics|anesthetics|mesh-ancestor
5526707|NCT04269460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5526708|NCT04269460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526709|NCT04269460|Sensory System Agents|sensory system agents|mesh-ancestor
5526710|NCT04269460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5526711|NCT04269408|Nicardipine|nicardipine|mesh-list
5526712|NCT04269408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5526713|NCT04269408|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6107686|NCT01000064|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6107687|NCT01000064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107688|NCT01000064|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6107689|NCT01000064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6107690|NCT01000064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6107691|NCT01000064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6107692|NCT01000064|Dopamine Agents|dopamine agents|mesh-ancestor
6107693|NCT01000064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6107694|NCT01000155|Vorinostat|vorinostat|mesh-list
6107695|NCT01000155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6107696|NCT01000155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6107697|NCT01000155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6107698|NCT01000155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6107699|NCT01000285|Raltegravir Potassium|raltegravir potassium|mesh-list
6107700|NCT01000285|Prednisone|prednisone|mesh-list
6107701|NCT01000285|Cyclophosphamide|cyclophosphamide|mesh-list
6107702|NCT01000285|Doxorubicin|doxorubicin|mesh-list
6107703|NCT01000285|Etoposide|etoposide|mesh-list
6107704|NCT01000285|Vincristine|vincristine|mesh-list
6107705|NCT01000285|Bortezomib|bortezomib|mesh-list
6107706|NCT01000285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6107707|NCT01000285|Immunologic Factors|immunologic factors|mesh-ancestor
6107708|NCT01000285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107709|NCT01000285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6107710|NCT01000285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6107711|NCT01000285|Alkylating Agents|alkylating agents|mesh-ancestor
6107712|NCT01000285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6107713|NCT01000285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6107714|NCT01000285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6107715|NCT01000285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5526714|NCT04269408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5526715|NCT04269408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526716|NCT04269408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5601365|NCT03705728|Sevoflurane|sevoflurane|mesh-list
6107716|NCT01000285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6107717|NCT01000285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6107718|NCT01000285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6107719|NCT01000285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6107720|NCT01000285|Glucocorticoids|glucocorticoids|mesh-ancestor
6107721|NCT01000285|Hormones|hormones|mesh-ancestor
6107722|NCT01000285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6107723|NCT01000285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6107724|NCT01000285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6107725|NCT01000285|Tubulin Modulators|tubulin modulators|mesh-ancestor
6107726|NCT01000285|Antimitotic Agents|antimitotic agents|mesh-ancestor
6107727|NCT01000285|Mitosis Modulators|mitosis modulators|mesh-ancestor
6107728|NCT01000285|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6107729|NCT01000285|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6107730|NCT01000285|Antiviral Agents|antiviral agents|mesh-ancestor
6107731|NCT01000285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6107732|NCT01000285|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6107733|NCT01000285|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6107734|NCT01000311|Vaccines|vaccines|mesh-list
6107735|NCT01000311|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6107736|NCT01000311|Immunologic Factors|immunologic factors|mesh-ancestor
6488436|NCT00584168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6107737|NCT01000311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107738|NCT01000337|Propofol|propofol|mesh-list
6665975|NCT01520012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6665976|NCT01520012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6665977|NCT01520012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6665978|NCT01520012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6665979|NCT01520012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526717|NCT04269408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526718|NCT04269408|Vasodilator Agents|vasodilator agents|mesh-ancestor
5526719|NCT04269187|Theophylline|theophylline|mesh-list
5526720|NCT04269187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5526721|NCT04269187|Autonomic Agents|autonomic agents|mesh-ancestor
5526722|NCT04269187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5526723|NCT04269187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526724|NCT04269187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5526725|NCT04269187|Respiratory System Agents|respiratory system agents|mesh-ancestor
5526726|NCT04269187|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5526727|NCT04269187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5526728|NCT04269187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526729|NCT04269187|Vasodilator Agents|vasodilator agents|mesh-ancestor
5526730|NCT04269187|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5526731|NCT04269187|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5526732|NCT04269187|Purinergic Agents|purinergic agents|mesh-ancestor
6665980|NCT01520025|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6665981|NCT01520025|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6665982|NCT01520025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665983|NCT01520077|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
6665984|NCT01520077|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6665985|NCT01520077|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6665986|NCT01520077|Antimetabolites|antimetabolites|mesh-ancestor
6665987|NCT01520077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6665988|NCT01520077|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6665989|NCT01520103|Everolimus|everolimus|mesh-list
6665990|NCT01520103|Vinorelbine|vinorelbine|mesh-list
6665991|NCT01520103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6107739|NCT01000337|Sevoflurane|sevoflurane|mesh-list
6107740|NCT01000337|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6107741|NCT01000337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6107742|NCT01000337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107743|NCT01000337|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6107744|NCT01000337|Anesthetics, General|anesthetics, general|mesh-ancestor
6107745|NCT01000337|Anesthetics|anesthetics|mesh-ancestor
6107746|NCT01000337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6107747|NCT01000337|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6107748|NCT01000376|Ketoconazole|ketoconazole|mesh-list
6107749|NCT01000376|Antifungal Agents|antifungal agents|mesh-ancestor
6107750|NCT01000376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6107751|NCT01000376|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5526733|NCT04269187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5526734|NCT04268966|Brincidofovir|brincidofovir|mesh-list
5526735|NCT04268966|Antiviral Agents|antiviral agents|mesh-ancestor
5526736|NCT04268966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5526737|NCT04269278|Dexmedetomidine|dexmedetomidine|mesh-list
5526738|NCT04269278|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5526739|NCT04269278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5526740|NCT04269278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526741|NCT04269278|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5526742|NCT04269278|Analgesics|analgesics|mesh-ancestor
5526743|NCT04269278|Sensory System Agents|sensory system agents|mesh-ancestor
5725299|NCT03181386|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5725300|NCT03181386|Antithrombins|antithrombins|mesh-ancestor
5725301|NCT03181386|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5725302|NCT03181386|Protease Inhibitors|protease inhibitors|mesh-ancestor
5725303|NCT03181386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5725304|NCT03181386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725305|NCT03181178|Micronutrients|micronutrients|mesh-list
5725306|NCT03181178|Trace Elements|trace elements|mesh-list
5725307|NCT03181178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725308|NCT03181113|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5725309|NCT03181113|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
5725310|NCT03181113|Antiviral Agents|antiviral agents|mesh-ancestor
5725311|NCT03181113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5725312|NCT03181100|Paclitaxel|paclitaxel|mesh-list
5725313|NCT03181100|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6107752|NCT01000376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6107753|NCT01000376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6107754|NCT01000376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6107755|NCT01000376|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6107756|NCT01000376|Hormone Antagonists|hormone antagonists|mesh-ancestor
6107757|NCT01000376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6107758|NCT01000376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107759|NCT01000376|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6107760|NCT01000480|Pemetrexed|pemetrexed|mesh-list
6107761|NCT01000480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6107762|NCT01000480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6107763|NCT01000480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6107764|NCT01000480|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6107765|NCT01000480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6107766|NCT01000610|Methylprednisolone|methylprednisolone|mesh-list
6665992|NCT01520103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6665993|NCT01520103|Immunologic Factors|immunologic factors|mesh-ancestor
6665994|NCT01520103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6665995|NCT01520103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6665996|NCT01520103|Tubulin Modulators|tubulin modulators|mesh-ancestor
6665997|NCT01520103|Antimitotic Agents|antimitotic agents|mesh-ancestor
6665998|NCT01520103|Mitosis Modulators|mitosis modulators|mesh-ancestor
6665999|NCT01520103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666000|NCT01520116|Timolol|timolol|mesh-list
5526744|NCT04269278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5526745|NCT04269278|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5526746|NCT04269278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5526747|NCT04269278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5526748|NCT04269278|Adrenergic Agents|adrenergic agents|mesh-ancestor
5526749|NCT04269278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5526750|NCT04269278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526751|NCT04269109|Analgesics, Opioid|analgesics, opioid|mesh-list
5526752|NCT04269109|Narcotics|narcotics|mesh-ancestor
5526753|NCT04269109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5526754|NCT04269109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666001|NCT01520116|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6666002|NCT01520116|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6107767|NCT01000610|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6107768|NCT01000610|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6107769|NCT01000610|Prednisolone|prednisolone|mesh-list
6107770|NCT01000610|Prednisolone acetate|prednisolone acetate|mesh-list
6107771|NCT01000610|Rituximab|rituximab|mesh-list
6107772|NCT01000610|Methotrexate|methotrexate|mesh-list
6107773|NCT01000610|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6107774|NCT01000610|Prednisolone phosphate|prednisolone phosphate|mesh-list
6107775|NCT01000610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6107776|NCT01000610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6107777|NCT01000610|Immunologic Factors|immunologic factors|mesh-ancestor
6107778|NCT01000610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107779|NCT01000610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6107780|NCT01000610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6107781|NCT01000610|Abortifacient Agents|abortifacient agents|mesh-ancestor
6107782|NCT01000610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6107783|NCT01000610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6107784|NCT01000610|Antimetabolites|antimetabolites|mesh-ancestor
6107785|NCT01000610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6107786|NCT01000610|Dermatologic Agents|dermatologic agents|mesh-ancestor
6107787|NCT01000610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6107788|NCT01000610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6107789|NCT01000610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6107790|NCT01000610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6107791|NCT01000610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6107792|NCT01000610|Antiemetics|antiemetics|mesh-ancestor
6107793|NCT01000610|Autonomic Agents|autonomic agents|mesh-ancestor
6107794|NCT01000610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6107795|NCT01000610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6107796|NCT01000610|Glucocorticoids|glucocorticoids|mesh-ancestor
6107797|NCT01000610|Hormones|hormones|mesh-ancestor
6107798|NCT01000610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6107799|NCT01000610|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6107800|NCT01000610|Protective Agents|protective agents|mesh-ancestor
6107801|NCT01000610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6107802|NCT01000636|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
6107803|NCT01000636|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6107804|NCT01000636|Dermatologic Agents|dermatologic agents|mesh-ancestor
6107805|NCT01000649|Vasopressins|vasopressins|mesh-list
6107806|NCT01000649|Hemostatics|hemostatics|mesh-ancestor
6107807|NCT01000649|Coagulants|coagulants|mesh-ancestor
6107808|NCT01000649|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6107809|NCT01000649|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6107810|NCT01000649|Natriuretic Agents|natriuretic agents|mesh-ancestor
6107811|NCT01000649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107812|NCT01000727|Darapladib|darapladib|mesh-list
6107813|NCT01000727|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
6107814|NCT01000727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6107815|NCT01000727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6107816|NCT01000805|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6107817|NCT01000805|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6107818|NCT01000805|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6107819|NCT01000805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6107820|NCT01000805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6107821|NCT01000805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6107822|NCT01000805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107823|NCT01000805|Analgesics|analgesics|mesh-ancestor
6107824|NCT01000805|Sensory System Agents|sensory system agents|mesh-ancestor
6107825|NCT01000805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6107826|NCT01000805|Antidepressive Agents|antidepressive agents|mesh-ancestor
5526755|NCT04269109|Analgesics|analgesics|mesh-ancestor
5526756|NCT04269109|Sensory System Agents|sensory system agents|mesh-ancestor
5526757|NCT04269109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5526758|NCT04268888|Nivolumab|nivolumab|mesh-list
5526759|NCT04268888|Chlorotrianisene|chlorotrianisene|mesh-list
5526760|NCT04268888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5526761|NCT04268888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5526762|NCT04268888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5526763|NCT04268888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526764|NCT04268888|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
5526765|NCT04268888|Estrogens|estrogens|mesh-ancestor
5526766|NCT04268888|Hormones|hormones|mesh-ancestor
5526767|NCT04268888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5526768|NCT04268888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526769|NCT04268888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5526770|NCT04268927|Letrozole|letrozole|mesh-list
5526771|NCT04268927|LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|lhrh, n-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|mesh-list
5526772|NCT04268927|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
5526773|NCT04268927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5526774|NCT04268927|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5526775|NCT04268927|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5526776|NCT04268927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5526777|NCT04268927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526778|NCT04268927|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5526779|NCT04268927|Hormone Antagonists|hormone antagonists|mesh-ancestor
5526780|NCT04268927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5526781|NCT04268927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526782|NCT04268927|Hormones|hormones|mesh-ancestor
5526783|NCT04268771|Rituximab|rituximab|mesh-list
5526784|NCT04268771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5526785|NCT04268771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5526786|NCT04268771|Immunologic Factors|immunologic factors|mesh-ancestor
5526787|NCT04268771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526788|NCT04268771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5526789|NCT04268706|Fludarabine|fludarabine|mesh-list
5526790|NCT04268706|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5526791|NCT04268706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5526792|NCT04268706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526793|NCT04268706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5526794|NCT04268706|Alkylating Agents|alkylating agents|mesh-ancestor
5526795|NCT04268602|Anesthetics|anesthetics|mesh-list
5526796|NCT04268602|Anesthetics, Local|anesthetics, local|mesh-list
5526797|NCT04268602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5526798|NCT04268602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526799|NCT04268602|Sensory System Agents|sensory system agents|mesh-ancestor
5526800|NCT04268602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5526801|NCT04268407|Amoxicillin|amoxicillin|mesh-list
6107827|NCT01000805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6107828|NCT01000805|Dopamine Agents|dopamine agents|mesh-ancestor
6107829|NCT01000818|Raltegravir Potassium|raltegravir potassium|mesh-list
6107830|NCT01000818|Omeprazole|omeprazole|mesh-list
6107831|NCT01000818|Famotidine|famotidine|mesh-list
6107832|NCT01000818|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6107833|NCT01000818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6107834|NCT01000818|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6107835|NCT01000818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6107836|NCT01000818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6107837|NCT01000818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6107838|NCT01000818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6107839|NCT01000818|Antiviral Agents|antiviral agents|mesh-ancestor
6107840|NCT01000818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6107841|NCT01000818|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6107842|NCT01000818|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6107843|NCT01000818|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6107844|NCT01000818|Histamine Antagonists|histamine antagonists|mesh-ancestor
6107845|NCT01000818|Histamine Agents|histamine agents|mesh-ancestor
6107846|NCT01000818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6107847|NCT01000818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107848|NCT01000961|Cysteamine|cysteamine|mesh-list
6107849|NCT01000961|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
6107850|NCT01000961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6107851|NCT01000974|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6107852|NCT01000974|Immunologic Factors|immunologic factors|mesh-ancestor
6107853|NCT01000974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107854|NCT01000987|Varenicline|varenicline|mesh-list
6107855|NCT01000987|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6107856|NCT01000987|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6107857|NCT01000987|Cholinergic Agents|cholinergic agents|mesh-ancestor
6107858|NCT01000987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6107859|NCT01000987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6107860|NCT01000987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107861|NCT01001052|Colchicine|colchicine|mesh-list
6107862|NCT01001052|Gout Suppressants|gout suppressants|mesh-ancestor
6107863|NCT01001052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6107864|NCT01001052|Tubulin Modulators|tubulin modulators|mesh-ancestor
6107865|NCT01001052|Antimitotic Agents|antimitotic agents|mesh-ancestor
6107866|NCT01001052|Mitosis Modulators|mitosis modulators|mesh-ancestor
6107867|NCT01001052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6107868|NCT01001052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6107869|NCT01001104|Dulaglutide|dulaglutide|mesh-list
6107870|NCT01001104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6107871|NCT01001104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107872|NCT01001195|Bimatoprost|bimatoprost|mesh-list
6107873|NCT01001195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6107874|NCT01001195|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6107875|NCT01001195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6107876|NCT01001208|Etanercept|etanercept|mesh-list
6107877|NCT01001208|Methotrexate|methotrexate|mesh-list
6107878|NCT01001208|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6107879|NCT01001208|Abortifacient Agents|abortifacient agents|mesh-ancestor
6107880|NCT01001208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6107881|NCT01001208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107882|NCT01001208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6107883|NCT01001208|Antimetabolites|antimetabolites|mesh-ancestor
6107884|NCT01001208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6107885|NCT01001208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6107886|NCT01001208|Dermatologic Agents|dermatologic agents|mesh-ancestor
6107887|NCT01001208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6107888|NCT01001208|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6107889|NCT01001208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6107890|NCT01001208|Immunologic Factors|immunologic factors|mesh-ancestor
6107891|NCT01001208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6107892|NCT01001208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6107893|NCT01001208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6107894|NCT01001208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6107895|NCT01001208|Analgesics|analgesics|mesh-ancestor
5526802|NCT04268407|Clavulanic Acid|clavulanic acid|mesh-list
6107896|NCT01001208|Sensory System Agents|sensory system agents|mesh-ancestor
6107897|NCT01001208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6107898|NCT01001208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6107899|NCT01001208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6107900|NCT01001221|Gemcitabine|gemcitabine|mesh-list
6107901|NCT01001221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6107902|NCT01001221|Antimetabolites|antimetabolites|mesh-ancestor
5526803|NCT04268407|Clavulanic Acids|clavulanic acids|mesh-list
5526804|NCT04268407|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5526805|NCT04268407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5526806|NCT04268407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5526807|NCT04268407|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5526808|NCT04268407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5526809|NCT04268407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526810|NCT04268303|Dexmedetomidine|dexmedetomidine|mesh-list
5526811|NCT04268303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5526812|NCT04268303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5526813|NCT04268303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526814|NCT04268303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5526815|NCT04268303|Analgesics|analgesics|mesh-ancestor
5526816|NCT04268303|Sensory System Agents|sensory system agents|mesh-ancestor
5526817|NCT04268303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5526818|NCT04268303|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5526819|NCT04268303|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5526820|NCT04268303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5526821|NCT04268303|Adrenergic Agents|adrenergic agents|mesh-ancestor
5526822|NCT04268303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5526823|NCT04268303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526824|NCT04268524|Miltefosine|miltefosine|mesh-list
5526825|NCT04268524|Antifungal Agents|antifungal agents|mesh-ancestor
5526826|NCT04268524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5526827|NCT04268524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5526828|NCT04268524|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5526829|NCT04268524|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5526830|NCT04268563|Metformin|metformin|mesh-list
5526831|NCT04268563|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5526832|NCT04268563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5526833|NCT04268563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526834|NCT04268563|Incretins|incretins|mesh-ancestor
5526835|NCT04268563|Hormones|hormones|mesh-ancestor
5526836|NCT04268563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5526837|NCT04268563|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5526838|NCT04268563|Protease Inhibitors|protease inhibitors|mesh-ancestor
5526839|NCT04268563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5526840|NCT04268563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526841|NCT04268472|Darunavir|darunavir|mesh-list
5526842|NCT04268472|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5526843|NCT04268472|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5526844|NCT04268472|Protease Inhibitors|protease inhibitors|mesh-ancestor
5526845|NCT04268472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5526846|NCT04268472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526847|NCT04268472|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5526848|NCT04268472|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5526849|NCT04268472|Antiviral Agents|antiviral agents|mesh-ancestor
5526850|NCT04268472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5526851|NCT04268537|Antibodies|antibodies|mesh-list
5526852|NCT04268537|Antibodies, Blocking|antibodies, blocking|mesh-list
5526853|NCT04268537|Immunologic Factors|immunologic factors|mesh-ancestor
5526854|NCT04268537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526855|NCT04268394|Metformin|metformin|mesh-list
5526856|NCT04268394|Itraconazole|itraconazole|mesh-list
5526857|NCT04268394|Rifampin|rifampin|mesh-list
5526858|NCT04268394|Sulfasalazine|sulfasalazine|mesh-list
5526859|NCT04268394|Methotrexate|methotrexate|mesh-list
5526860|NCT04268394|Digoxin|digoxin|mesh-list
5526861|NCT04268394|Midazolam|midazolam|mesh-list
5526862|NCT04268394|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5526863|NCT04268394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6107903|NCT01001221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6107904|NCT01001221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6107905|NCT01001221|Antiviral Agents|antiviral agents|mesh-ancestor
5526864|NCT04268394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526865|NCT04268394|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5526866|NCT04268394|Abortifacient Agents|abortifacient agents|mesh-ancestor
5526867|NCT04268394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5526868|NCT04268394|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5526869|NCT04268394|Antimetabolites|antimetabolites|mesh-ancestor
5526870|NCT04268394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526871|NCT04268394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5526872|NCT04268394|Dermatologic Agents|dermatologic agents|mesh-ancestor
5526873|NCT04268394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5526874|NCT04268394|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6107906|NCT01001221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6107907|NCT01001221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6107908|NCT01001221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6107909|NCT01001221|Immunologic Factors|immunologic factors|mesh-ancestor
6107910|NCT01001221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107911|NCT01001377|Cetuximab|cetuximab|mesh-list
6107912|NCT01001377|Panitumumab|panitumumab|mesh-list
6107913|NCT01001377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6107914|NCT01001377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6107915|NCT01001403|Nafamostat|nafamostat|mesh-list
6107916|NCT01001403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6107917|NCT01001403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6107918|NCT01001403|Analgesics|analgesics|mesh-ancestor
6107919|NCT01001403|Sensory System Agents|sensory system agents|mesh-ancestor
6107920|NCT01001403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5526875|NCT04268394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5526876|NCT04268394|Immunologic Factors|immunologic factors|mesh-ancestor
5526877|NCT04268394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5526878|NCT04268394|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5526879|NCT04268394|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5526880|NCT04268394|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5526881|NCT04268394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5526882|NCT04268394|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5526883|NCT04268394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5526884|NCT04268394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6107921|NCT01001403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107922|NCT01001403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6107923|NCT01001403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6107924|NCT01001403|Anticoagulants|anticoagulants|mesh-ancestor
6107925|NCT01001403|Protease Inhibitors|protease inhibitors|mesh-ancestor
6107926|NCT01001403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6107927|NCT01001403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6107928|NCT01001403|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6107929|NCT01001403|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5526885|NCT04268394|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5526886|NCT04268394|Anesthetics, General|anesthetics, general|mesh-ancestor
5526887|NCT04268394|Anesthetics|anesthetics|mesh-ancestor
5526888|NCT04268394|GABA Modulators|gaba modulators|mesh-ancestor
5526889|NCT04268394|GABA Agents|gaba agents|mesh-ancestor
5526890|NCT04268394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6107930|NCT01001403|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6107931|NCT01001403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6107932|NCT01001403|Immunologic Factors|immunologic factors|mesh-ancestor
6107933|NCT01001429|Dexmedetomidine|dexmedetomidine|mesh-list
6107934|NCT01001429|Propofol|propofol|mesh-list
6107935|NCT01001429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6107936|NCT01001429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6107937|NCT01001429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107938|NCT01001429|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6107939|NCT01001429|Anesthetics, General|anesthetics, general|mesh-ancestor
6107940|NCT01001429|Anesthetics|anesthetics|mesh-ancestor
6107941|NCT01001429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6107942|NCT01001429|Analgesics|analgesics|mesh-ancestor
6107943|NCT01001429|Sensory System Agents|sensory system agents|mesh-ancestor
6107944|NCT01001429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5526891|NCT04268394|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5526892|NCT04268394|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5526893|NCT04268394|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5526894|NCT04268394|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5526895|NCT04268394|Antifungal Agents|antifungal agents|mesh-ancestor
5526896|NCT04268394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5526897|NCT04268394|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5526898|NCT04268394|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5526899|NCT04268394|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6107945|NCT01001429|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6107946|NCT01001429|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6107947|NCT01001429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6107948|NCT01001429|Adrenergic Agents|adrenergic agents|mesh-ancestor
6107949|NCT01001429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6107950|NCT01001429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6107951|NCT01001442|Maytansine|maytansine|mesh-list
6107952|NCT01001442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6107953|NCT01001442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5526900|NCT04268394|Hormone Antagonists|hormone antagonists|mesh-ancestor
5725314|NCT03181100|Bevacizumab|bevacizumab|mesh-list
5526901|NCT04268394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5526902|NCT04268394|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5526903|NCT04268394|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5526904|NCT04268394|Antitubercular Agents|antitubercular agents|mesh-ancestor
6107954|NCT01001442|Tubulin Modulators|tubulin modulators|mesh-ancestor
6107955|NCT01001442|Antimitotic Agents|antimitotic agents|mesh-ancestor
6107956|NCT01001442|Mitosis Modulators|mitosis modulators|mesh-ancestor
6107957|NCT01001442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6107958|NCT01001494|Bromides|bromides|mesh-list
6107959|NCT01001494|Anticonvulsants|anticonvulsants|mesh-ancestor
6107960|NCT01001520|Tolcapone|tolcapone|mesh-list
6107961|NCT01001520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6107962|NCT01001520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6107963|NCT01001520|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6107964|NCT01001520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6107965|NCT01001520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526905|NCT04268394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5526906|NCT04268394|Leprostatic Agents|leprostatic agents|mesh-ancestor
5526907|NCT04268394|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5526908|NCT04268394|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5526909|NCT04268394|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5526910|NCT04268394|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5526911|NCT04268394|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6107966|NCT01001559|Norepinephrine|norepinephrine|mesh-list
6107967|NCT01001559|Serotonin|serotonin|mesh-list
6107968|NCT01001559|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
6107969|NCT01001559|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
6107970|NCT01001559|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6107971|NCT01001559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6107972|NCT01001559|Adrenergic Agents|adrenergic agents|mesh-ancestor
6107973|NCT01001559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6107974|NCT01001559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6107975|NCT01001559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107976|NCT01001559|Sympathomimetics|sympathomimetics|mesh-ancestor
6107977|NCT01001559|Autonomic Agents|autonomic agents|mesh-ancestor
6107978|NCT01001559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6107979|NCT01001559|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6107980|NCT01001559|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6107981|NCT01001559|Serotonin Agents|serotonin agents|mesh-ancestor
6107982|NCT01001559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6107983|NCT01001559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6107984|NCT01001572|Amlodipine|amlodipine|mesh-list
6107985|NCT01001572|Valsartan|valsartan|mesh-list
6107986|NCT01001572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6107987|NCT01001572|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6107988|NCT01001572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6107989|NCT01001572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6107990|NCT01001572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6107991|NCT01001572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6107992|NCT01001572|Vasodilator Agents|vasodilator agents|mesh-ancestor
6107993|NCT01001572|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6107994|NCT01001572|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6107995|NCT01001598|Danazol|danazol|mesh-list
6107996|NCT01001598|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6107997|NCT01001598|Hormone Antagonists|hormone antagonists|mesh-ancestor
6107998|NCT01001598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6107999|NCT01001598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108000|NCT01001702|Aripiprazole|aripiprazole|mesh-list
6108001|NCT01001702|Antidepressive Agents|antidepressive agents|mesh-ancestor
6465352|NCT00473980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465353|NCT00473980|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6465354|NCT00473980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6465355|NCT00473980|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6465356|NCT00473980|Gout Suppressants|gout suppressants|mesh-ancestor
6465357|NCT00473980|Tocolytic Agents|tocolytic agents|mesh-ancestor
6108002|NCT01001702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6108003|NCT01001702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6108004|NCT01001702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6108005|NCT01001702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6108006|NCT01001702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108007|NCT01001702|Dopamine Agonists|dopamine agonists|mesh-ancestor
6465358|NCT00473980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6108008|NCT01001702|Dopamine Agents|dopamine agents|mesh-ancestor
6108009|NCT01001702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6108010|NCT01001702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108011|NCT01001702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6108012|NCT01001702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6108013|NCT01001702|Serotonin Agents|serotonin agents|mesh-ancestor
6108014|NCT01001702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6108015|NCT01001702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6108016|NCT01001702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6108017|NCT01001702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6108018|NCT01001806|Ketorolac|ketorolac|mesh-list
6108019|NCT01001806|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6108020|NCT01001806|Nepafenac|nepafenac|mesh-list
6108021|NCT01001806|Bromfenac|bromfenac|mesh-list
6108022|NCT01001806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6108023|NCT01001806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6108024|NCT01001806|Analgesics|analgesics|mesh-ancestor
6108025|NCT01001806|Sensory System Agents|sensory system agents|mesh-ancestor
5526912|NCT04268394|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5526913|NCT04268394|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5526914|NCT04268394|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5526915|NCT04268394|Protective Agents|protective agents|mesh-ancestor
5526916|NCT04268394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6108026|NCT01001806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6108027|NCT01001806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108028|NCT01001806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6108029|NCT01001806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6108030|NCT01001806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6108031|NCT01001806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6108032|NCT01001806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108033|NCT01001832|Abatacept|abatacept|mesh-list
6108034|NCT01001832|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6108035|NCT01001832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108036|NCT01001832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6108037|NCT01001832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6108038|NCT01001832|Immunologic Factors|immunologic factors|mesh-ancestor
6108039|NCT01001832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108040|NCT01001832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6108041|NCT01001910|Carboplatin|carboplatin|mesh-list
6108042|NCT01001910|Pemetrexed|pemetrexed|mesh-list
6108043|NCT01001910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6108044|NCT01001910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6108045|NCT01001910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108046|NCT01001910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6108047|NCT01001910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6108048|NCT01001975|Sunscreening Agents|sunscreening agents|mesh-list
6108049|NCT01001975|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6108050|NCT01001975|Protective Agents|protective agents|mesh-ancestor
6108051|NCT01001975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108052|NCT01001975|Dermatologic Agents|dermatologic agents|mesh-ancestor
5526917|NCT04268394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5526918|NCT04268394|Analgesics|analgesics|mesh-ancestor
5526919|NCT04268394|Sensory System Agents|sensory system agents|mesh-ancestor
5526920|NCT04268394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5526921|NCT04268394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5526922|NCT04268394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5526923|NCT04268199|Bortezomib|bortezomib|mesh-list
5526924|NCT04268199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5725315|NCT03181100|Atezolizumab|atezolizumab|mesh-list
6108053|NCT01002105|Baclofen|baclofen|mesh-list
6108054|NCT01002105|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6108055|NCT01002105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108056|NCT01002105|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6108057|NCT01002105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6108058|NCT01002105|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6108059|NCT01002105|GABA Agonists|gaba agonists|mesh-ancestor
6108060|NCT01002105|GABA Agents|gaba agents|mesh-ancestor
6108061|NCT01002105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6108062|NCT01002105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108063|NCT01002339|Mycophenolic Acid|mycophenolic acid|mesh-list
6108064|NCT01002339|Cyclosporine|cyclosporine|mesh-list
6108065|NCT01002339|Prednisone|prednisone|mesh-list
6465359|NCT00474006|Daunorubicin|daunorubicin|mesh-list
6108066|NCT01002339|Tacrolimus|tacrolimus|mesh-list
6465360|NCT00474006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5526925|NCT04267887|Ascorbic Acid|ascorbic acid|mesh-list
5526926|NCT04267887|Prednisone|prednisone|mesh-list
5526927|NCT04267887|Cortisone|cortisone|mesh-list
5526928|NCT04267887|Methyltestosterone|methyltestosterone|mesh-list
5526929|NCT04267887|Abiraterone Acetate|abiraterone acetate|mesh-list
5526930|NCT04267887|Hormones|hormones|mesh-list
5526931|NCT04267887|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
5526932|NCT04267887|Androgens|androgens|mesh-list
5526933|NCT04267887|Androgen Antagonists|androgen antagonists|mesh-list
5526934|NCT04267887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5526935|NCT04267887|Glucocorticoids|glucocorticoids|mesh-ancestor
5526936|NCT04267887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5526937|NCT04267887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108067|NCT01002339|Basiliximab|basiliximab|mesh-list
6108068|NCT01002339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6108069|NCT01002339|Immunologic Factors|immunologic factors|mesh-ancestor
6108070|NCT01002339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108071|NCT01002339|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6108072|NCT01002339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6108073|NCT01002339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108074|NCT01002339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6108075|NCT01002339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6108076|NCT01002339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6108077|NCT01002339|Antitubercular Agents|antitubercular agents|mesh-ancestor
6108078|NCT01002339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6108079|NCT01002339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6465361|NCT00474006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6465362|NCT00474006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6465363|NCT00474006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6465364|NCT00474006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6465365|NCT00474006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465366|NCT00474019|Esomeprazole|esomeprazole|mesh-list
6465367|NCT00474019|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6465368|NCT00474019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6465369|NCT00474019|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6465370|NCT00474019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6108080|NCT01002339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6108081|NCT01002339|Glucocorticoids|glucocorticoids|mesh-ancestor
6108082|NCT01002339|Hormones|hormones|mesh-ancestor
6108083|NCT01002339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6108084|NCT01002339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6108085|NCT01002339|Antifungal Agents|antifungal agents|mesh-ancestor
6108086|NCT01002339|Dermatologic Agents|dermatologic agents|mesh-ancestor
6108087|NCT01002339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6108088|NCT01002547|Vitamins|vitamins|mesh-list
6108089|NCT01002547|Vitamin E|vitamin e|mesh-list
6108090|NCT01002547|Tocopherols|tocopherols|mesh-list
6108091|NCT01002547|Tocotrienols|tocotrienols|mesh-list
6108092|NCT01002547|alpha-Tocopherol|alpha-tocopherol|mesh-list
6108093|NCT01002547|Pioglitazone|pioglitazone|mesh-list
6108094|NCT01002547|Micronutrients|micronutrients|mesh-ancestor
6108095|NCT01002547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108096|NCT01002547|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6108097|NCT01002547|Antioxidants|antioxidants|mesh-ancestor
6108098|NCT01002547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108099|NCT01002547|Protective Agents|protective agents|mesh-ancestor
6108100|NCT01002573|Acetaminophen|acetaminophen|mesh-list
6108101|NCT01002573|Ibuprofen|ibuprofen|mesh-list
6108102|NCT01002573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6108103|NCT01002573|Analgesics|analgesics|mesh-ancestor
6108104|NCT01002573|Sensory System Agents|sensory system agents|mesh-ancestor
6108105|NCT01002573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6108106|NCT01002573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108107|NCT01002573|Antipyretics|antipyretics|mesh-ancestor
6108108|NCT01002573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6108109|NCT01002573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6108110|NCT01002573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6108111|NCT01002573|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6108112|NCT01002573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6108113|NCT01002573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108114|NCT01002742|Mycophenolic Acid|mycophenolic acid|mesh-list
6108115|NCT01002742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6108116|NCT01002742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5526938|NCT04267887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5526939|NCT04267887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5526940|NCT04267887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6108117|NCT01002742|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6108118|NCT01002742|Antitubercular Agents|antitubercular agents|mesh-ancestor
6108119|NCT01002742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6108120|NCT01002742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6108121|NCT01002742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6108122|NCT01002742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108123|NCT01002755|Lenalidomide|lenalidomide|mesh-list
6108124|NCT01002755|Ofatumumab|ofatumumab|mesh-list
6108125|NCT01002755|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6108126|NCT01002755|Immunologic Factors|immunologic factors|mesh-ancestor
6108127|NCT01002755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108128|NCT01002755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6108129|NCT01002755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6108130|NCT01002755|Growth Substances|growth substances|mesh-ancestor
6108131|NCT01002755|Growth Inhibitors|growth inhibitors|mesh-ancestor
6108132|NCT01002755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6108133|NCT01003080|Hemostatics|hemostatics|mesh-list
6108134|NCT01003080|Coagulants|coagulants|mesh-ancestor
6108135|NCT01003106|Ranibizumab|ranibizumab|mesh-list
6108136|NCT01003106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6108137|NCT01003106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6108138|NCT01003106|Growth Substances|growth substances|mesh-ancestor
6108139|NCT01003106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108140|NCT01003106|Growth Inhibitors|growth inhibitors|mesh-ancestor
6108141|NCT01003106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6108142|NCT01003184|Exenatide|exenatide|mesh-list
6108143|NCT01003184|Insulin Detemir|insulin detemir|mesh-list
6108144|NCT01003184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6108145|NCT01003184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108146|NCT01003184|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6108147|NCT01003184|Incretins|incretins|mesh-ancestor
6108148|NCT01003184|Hormones|hormones|mesh-ancestor
6108149|NCT01003184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6108150|NCT01003249|Baclofen|baclofen|mesh-list
6108151|NCT01003249|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6108152|NCT01003249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108153|NCT01003249|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6108154|NCT01003249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6108155|NCT01003249|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6108156|NCT01003249|GABA Agonists|gaba agonists|mesh-ancestor
6108157|NCT01003249|GABA Agents|gaba agents|mesh-ancestor
6108158|NCT01003249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6108159|NCT01003249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108160|NCT01003301|Omalizumab|omalizumab|mesh-list
6108161|NCT01003301|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6108162|NCT01003301|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6108163|NCT01003301|Respiratory System Agents|respiratory system agents|mesh-ancestor
5526941|NCT04267887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5526942|NCT04267887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526943|NCT04267887|Hormone Antagonists|hormone antagonists|mesh-ancestor
5526944|NCT04267887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5526945|NCT04267887|Antioxidants|antioxidants|mesh-ancestor
5526946|NCT04267887|Protective Agents|protective agents|mesh-ancestor
5526947|NCT04267887|Vitamins|vitamins|mesh-ancestor
5526948|NCT04267887|Micronutrients|micronutrients|mesh-ancestor
5526949|NCT04267887|Estrogens|estrogens|mesh-ancestor
5526950|NCT04267887|Anabolic Agents|anabolic agents|mesh-ancestor
5526951|NCT04267991|Tacrolimus|tacrolimus|mesh-list
5526952|NCT04267991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5526953|NCT04267991|Immunologic Factors|immunologic factors|mesh-ancestor
5526954|NCT04267991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108164|NCT01003418|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6108165|NCT01003418|Immunologic Factors|immunologic factors|mesh-ancestor
6108166|NCT01003418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108167|NCT01003639|Aspirin|aspirin|mesh-list
6108168|NCT01003639|Acetaminophen|acetaminophen|mesh-list
6108169|NCT01003639|Ibuprofen|ibuprofen|mesh-list
6108170|NCT01003639|Naproxen|naproxen|mesh-list
6108171|NCT01003639|Acetazolamide|acetazolamide|mesh-list
6108172|NCT01003639|Codeine|codeine|mesh-list
6108173|NCT01003639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6108174|NCT01003639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6108175|NCT01003639|Analgesics|analgesics|mesh-ancestor
6108176|NCT01003639|Sensory System Agents|sensory system agents|mesh-ancestor
6108177|NCT01003639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6108178|NCT01003639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526955|NCT04267991|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5526956|NCT04267991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6108179|NCT01003639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6108180|NCT01003639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6108181|NCT01003639|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6108182|NCT01003639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6108183|NCT01003639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108184|NCT01003639|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6108185|NCT01003639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6108186|NCT01003639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6108187|NCT01003639|Antipyretics|antipyretics|mesh-ancestor
6108188|NCT01003639|Gout Suppressants|gout suppressants|mesh-ancestor
6108189|NCT01003639|Anticonvulsants|anticonvulsants|mesh-ancestor
6108190|NCT01003639|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6108191|NCT01003639|Diuretics|diuretics|mesh-ancestor
6108192|NCT01003639|Natriuretic Agents|natriuretic agents|mesh-ancestor
6108193|NCT01003639|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6108194|NCT01003639|Narcotics|narcotics|mesh-ancestor
6108195|NCT01003639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6108196|NCT01003639|Antitussive Agents|antitussive agents|mesh-ancestor
6108197|NCT01003639|Respiratory System Agents|respiratory system agents|mesh-ancestor
6108198|NCT01003769|Acetic Acid|acetic acid|mesh-list
6108199|NCT01003769|Lenalidomide|lenalidomide|mesh-list
6108200|NCT01003769|Retinol acetate|retinol acetate|mesh-list
6108201|NCT01003769|Gossypol acetic acid|gossypol acetic acid|mesh-list
6108202|NCT01003769|Gossypol|gossypol|mesh-list
6108203|NCT01003769|Immunologic Factors|immunologic factors|mesh-ancestor
6108204|NCT01003769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108205|NCT01003769|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6108206|NCT01003769|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6108207|NCT01003769|Growth Substances|growth substances|mesh-ancestor
6108208|NCT01003769|Growth Inhibitors|growth inhibitors|mesh-ancestor
6108209|NCT01003769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6108210|NCT01003769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6108211|NCT01003769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6108212|NCT01003769|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6108213|NCT01003769|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6108214|NCT01003769|Protective Agents|protective agents|mesh-ancestor
6108215|NCT01003769|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6108216|NCT01003769|Contraceptive Agents|contraceptive agents|mesh-ancestor
6108217|NCT01003769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6108218|NCT01003769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6108219|NCT01003769|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6108220|NCT01003769|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
6108221|NCT01003769|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
6108222|NCT01003886|Doxazosin|doxazosin|mesh-list
6108223|NCT01003886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6108224|NCT01003886|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6108225|NCT01003886|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6108226|NCT01003886|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6108227|NCT01003886|Adrenergic Agents|adrenergic agents|mesh-ancestor
6108228|NCT01003886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6108229|NCT01003886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108230|NCT01003886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204097|NCT02065479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6204098|NCT02065479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204099|NCT02065479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204100|NCT02065557|Adalimumab|adalimumab|mesh-list
6204101|NCT02065557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6204102|NCT02065557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6204103|NCT02065570|Adalimumab|adalimumab|mesh-list
6204104|NCT02065570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6204105|NCT02065570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6204106|NCT02065622|Adalimumab|adalimumab|mesh-list
6204107|NCT02065622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6204108|NCT02065622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6204109|NCT02065687|Metformin|metformin|mesh-list
6204110|NCT02065687|Paclitaxel|paclitaxel|mesh-list
6204111|NCT02065687|Carboplatin|carboplatin|mesh-list
6204112|NCT02065687|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6204113|NCT02065687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6204114|NCT02065687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6204115|NCT02065687|Tubulin Modulators|tubulin modulators|mesh-ancestor
6204116|NCT02065687|Antimitotic Agents|antimitotic agents|mesh-ancestor
6204117|NCT02065687|Mitosis Modulators|mitosis modulators|mesh-ancestor
6204118|NCT02065687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204119|NCT02065687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6204120|NCT02065687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108231|NCT01003899|Afatinib|afatinib|mesh-list
6108232|NCT01003899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6108233|NCT01003899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6108234|NCT01003899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6108235|NCT01003899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108236|NCT01003938|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6108237|NCT01003938|Topotecan|topotecan|mesh-list
6108238|NCT01003938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6108239|NCT01003938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6108240|NCT01003938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6108241|NCT01003938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108242|NCT01003938|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6108243|NCT01003938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6108244|NCT01003990|Ritonavir|ritonavir|mesh-list
6108245|NCT01003990|Lopinavir|lopinavir|mesh-list
6108246|NCT01003990|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6108247|NCT01003990|Tenofovir|tenofovir|mesh-list
6108248|NCT01003990|Emtricitabine|emtricitabine|mesh-list
6108249|NCT01003990|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6108250|NCT01003990|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6108251|NCT01003990|Protease Inhibitors|protease inhibitors|mesh-ancestor
6108252|NCT01003990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6108253|NCT01003990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108254|NCT01003990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6108255|NCT01003990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6108256|NCT01003990|Antiviral Agents|antiviral agents|mesh-ancestor
6108257|NCT01003990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6108258|NCT01003990|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6108259|NCT01003990|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5526957|NCT04267991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526958|NCT04268069|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5526959|NCT04268069|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5526960|NCT04267653|Lactoferrin|lactoferrin|mesh-list
5526961|NCT04267653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5526962|NCT04267679|Cannabidiol|cannabidiol|mesh-list
5526963|NCT04267679|Anticonvulsants|anticonvulsants|mesh-ancestor
5526964|NCT04267913|Dexamethasone|dexamethasone|mesh-list
5526965|NCT04267913|Dexamethasone acetate|dexamethasone acetate|mesh-list
5526966|NCT04267913|Docetaxel|docetaxel|mesh-list
5526967|NCT04267913|Ramucirumab|ramucirumab|mesh-list
5526968|NCT04267913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6108260|NCT01003990|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6108261|NCT01003990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6108262|NCT01004003|Sorafenib|sorafenib|mesh-list
6108263|NCT01004003|Nintedanib|nintedanib|mesh-list
6108264|NCT01004003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6108265|NCT01004003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6108266|NCT01004003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6108267|NCT01004003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108268|NCT01004029|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
6108269|NCT01004029|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
6108270|NCT01004029|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6108271|NCT01004029|Hormone Antagonists|hormone antagonists|mesh-ancestor
6108272|NCT01004029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6108273|NCT01004029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108274|NCT01004029|Progestins|progestins|mesh-ancestor
6108275|NCT01004029|Hormones|hormones|mesh-ancestor
6108276|NCT01004042|Botulinum Toxins|botulinum toxins|mesh-list
6108277|NCT01004042|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6108278|NCT01004042|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6108279|NCT01004042|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6108280|NCT01004042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6108281|NCT01004042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108282|NCT01004042|Cholinergic Agents|cholinergic agents|mesh-ancestor
6108283|NCT01004042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6108284|NCT01004042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108285|NCT01004042|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6108286|NCT01004042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6108287|NCT01004159|Irinotecan|irinotecan|mesh-list
6108288|NCT01004159|Cetuximab|cetuximab|mesh-list
6108289|NCT01004159|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6108290|NCT01004159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6108291|NCT01004159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5526969|NCT04267913|Antibodies|antibodies|mesh-list
5526970|NCT04267913|Immunoglobulins|immunoglobulins|mesh-list
5526971|NCT04267913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6108292|NCT01004159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108293|NCT01004159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6108294|NCT01004159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6108295|NCT01004172|Bevacizumab|bevacizumab|mesh-list
6108296|NCT01004172|Trastuzumab|trastuzumab|mesh-list
6108297|NCT01004172|Carboplatin|carboplatin|mesh-list
6108298|NCT01004172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5526972|NCT04267913|BB 1101|bb 1101|mesh-list
5526973|NCT04267913|Immunologic Factors|immunologic factors|mesh-ancestor
5526974|NCT04267913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526975|NCT04267913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5526976|NCT04267913|Antiemetics|antiemetics|mesh-ancestor
5526977|NCT04267913|Autonomic Agents|autonomic agents|mesh-ancestor
5526978|NCT04267913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5526979|NCT04267913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5526980|NCT04267913|Glucocorticoids|glucocorticoids|mesh-ancestor
5526981|NCT04267913|Hormones|hormones|mesh-ancestor
5526982|NCT04267913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5526983|NCT04267913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5526984|NCT04267913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5526985|NCT04267913|Protease Inhibitors|protease inhibitors|mesh-ancestor
5526986|NCT04267913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5526987|NCT04267913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5526988|NCT04267913|Tubulin Modulators|tubulin modulators|mesh-ancestor
5526989|NCT04267913|Antimitotic Agents|antimitotic agents|mesh-ancestor
5526990|NCT04267913|Mitosis Modulators|mitosis modulators|mesh-ancestor
5526991|NCT04267614|Etanercept|etanercept|mesh-list
5526992|NCT04267614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5526993|NCT04267614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5526994|NCT04267614|Analgesics|analgesics|mesh-ancestor
5526995|NCT04267614|Sensory System Agents|sensory system agents|mesh-ancestor
5526996|NCT04267614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5526997|NCT04267614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5526998|NCT04267614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5526999|NCT04267614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5527000|NCT04267614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5527001|NCT04267614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5527002|NCT04267614|Immunologic Factors|immunologic factors|mesh-ancestor
5527003|NCT04267809|Metformin|metformin|mesh-list
5527004|NCT04267809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5527005|NCT04267809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527006|NCT04267497|Amphotericin B|amphotericin b|mesh-list
5527007|NCT04267497|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
5527008|NCT04267497|Amebicides|amebicides|mesh-ancestor
5527009|NCT04267497|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5527010|NCT04267497|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5527011|NCT04267497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5527012|NCT04267497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5527013|NCT04267497|Antifungal Agents|antifungal agents|mesh-ancestor
5527014|NCT04267549|Paclitaxel|paclitaxel|mesh-list
5527015|NCT04267549|Apatinib|apatinib|mesh-list
5527016|NCT04267549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6488437|NCT00584168|Antiemetics|antiemetics|mesh-ancestor
5527017|NCT04267549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6204121|NCT02065713|Golimumab|golimumab|mesh-list
5527018|NCT04267549|Tubulin Modulators|tubulin modulators|mesh-ancestor
5527019|NCT04267549|Antimitotic Agents|antimitotic agents|mesh-ancestor
5527020|NCT04267549|Mitosis Modulators|mitosis modulators|mesh-ancestor
5527021|NCT04267549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5527022|NCT04267549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5527023|NCT04267549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6108299|NCT01004172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6108300|NCT01004172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6108301|NCT01004172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6108302|NCT01004172|Growth Substances|growth substances|mesh-ancestor
6108303|NCT01004172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108304|NCT01004172|Growth Inhibitors|growth inhibitors|mesh-ancestor
6108305|NCT01004185|Aminosalicylic Acid|aminosalicylic acid|mesh-list
6108306|NCT01004185|Mesalamine|mesalamine|mesh-list
6108307|NCT01004185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6108308|NCT01004185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6108309|NCT01004185|Analgesics|analgesics|mesh-ancestor
6108310|NCT01004185|Sensory System Agents|sensory system agents|mesh-ancestor
6108311|NCT01004185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6108312|NCT01004185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108313|NCT01004185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6108314|NCT01004185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6108315|NCT01004185|Antitubercular Agents|antitubercular agents|mesh-ancestor
6108316|NCT01004185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6108317|NCT01004185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6108318|NCT01004250|Bevacizumab|bevacizumab|mesh-list
6108319|NCT01004250|Pemetrexed|pemetrexed|mesh-list
6108320|NCT01004250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6108321|NCT01004250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6108322|NCT01004250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5527024|NCT04267926|Ubiquinone|ubiquinone|mesh-list
5527025|NCT04267926|Micronutrients|micronutrients|mesh-ancestor
5527026|NCT04267926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527027|NCT04267237|Atezolizumab|atezolizumab|mesh-list
5527028|NCT04267237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5527029|NCT04267224|Ticagrelor|ticagrelor|mesh-list
5527030|NCT04267224|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5527031|NCT04267224|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5527032|NCT04267224|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5527033|NCT04267224|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5527034|NCT04267224|Purinergic Agents|purinergic agents|mesh-ancestor
5527035|NCT04267224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5527036|NCT04267224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108323|NCT01004250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6108324|NCT01004250|Growth Substances|growth substances|mesh-ancestor
6108325|NCT01004250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108326|NCT01004250|Growth Inhibitors|growth inhibitors|mesh-ancestor
6108327|NCT01004250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6108328|NCT01004250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108329|NCT01004250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6108330|NCT01004250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6108331|NCT01004354|Ergocalciferols|ergocalciferols|mesh-list
6108332|NCT01004354|Vitamin D|vitamin d|mesh-list
6108333|NCT01004354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6108334|NCT01004354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108335|NCT01004354|Vitamins|vitamins|mesh-ancestor
6108336|NCT01004354|Micronutrients|micronutrients|mesh-ancestor
6108337|NCT01004354|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6108338|NCT01004393|Bromides|bromides|mesh-list
6108339|NCT01004393|Methylnaltrexone|methylnaltrexone|mesh-list
6108340|NCT01004393|Anticonvulsants|anticonvulsants|mesh-ancestor
6108341|NCT01004393|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6108342|NCT01004393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108343|NCT01004393|Sensory System Agents|sensory system agents|mesh-ancestor
6108344|NCT01004393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6108345|NCT01004406|Atorvastatin|atorvastatin|mesh-list
6465371|NCT00474019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465372|NCT00474032|Botulinum Toxins|botulinum toxins|mesh-list
6465373|NCT00474032|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6465374|NCT00474032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6465375|NCT00474032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5527037|NCT04267224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527038|NCT04267250|Levonorgestrel|levonorgestrel|mesh-list
6108346|NCT01004406|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
6465376|NCT00474032|Cholinergic Agents|cholinergic agents|mesh-ancestor
6465377|NCT00474032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5527039|NCT04267250|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5527040|NCT04267250|Estradiol|estradiol|mesh-list
5527041|NCT04267250|PF-06700841|pf-06700841|mesh-list
5527042|NCT04267250|Estrogens|estrogens|mesh-ancestor
5527043|NCT04267250|Hormones|hormones|mesh-ancestor
5527044|NCT04267250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5527045|NCT04267250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527046|NCT04267250|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5527047|NCT04267250|Contraceptive Agents|contraceptive agents|mesh-ancestor
5527048|NCT04267250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5527049|NCT04267250|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5527050|NCT04267250|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5527051|NCT04267250|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5527052|NCT04267250|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5527053|NCT04267250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5527054|NCT04267250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5527055|NCT04267250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5527056|NCT04267042|Budesonide|budesonide|mesh-list
5527057|NCT04267042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5527058|NCT04267042|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5527059|NCT04267042|Autonomic Agents|autonomic agents|mesh-ancestor
5527060|NCT04267042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5527061|NCT04267042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527062|NCT04267042|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5527063|NCT04267042|Respiratory System Agents|respiratory system agents|mesh-ancestor
6465378|NCT00474032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465379|NCT00474071|Remifentanil|remifentanil|mesh-list
6465380|NCT00474071|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6465381|NCT00474071|Narcotics|narcotics|mesh-ancestor
6465382|NCT00474071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6465383|NCT00474071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465384|NCT00474071|Analgesics|analgesics|mesh-ancestor
6465385|NCT00474071|Sensory System Agents|sensory system agents|mesh-ancestor
6108347|NCT01004406|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6108348|NCT01004406|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6108349|NCT01004406|Antimetabolites|antimetabolites|mesh-ancestor
6108350|NCT01004406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108351|NCT01004406|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6108352|NCT01004406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6108353|NCT01004432|Golimumab|golimumab|mesh-list
6108354|NCT01004432|Methotrexate|methotrexate|mesh-list
6108355|NCT01004432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6108356|NCT01004432|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6108357|NCT01004432|Abortifacient Agents|abortifacient agents|mesh-ancestor
6108358|NCT01004432|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6108359|NCT01004432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108360|NCT01004432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6108361|NCT01004432|Antimetabolites|antimetabolites|mesh-ancestor
6108362|NCT01004432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5527064|NCT04267042|Glucocorticoids|glucocorticoids|mesh-ancestor
5527065|NCT04267042|Hormones|hormones|mesh-ancestor
5527066|NCT04267042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5527067|NCT04267081|Venetoclax|venetoclax|mesh-list
5527068|NCT04267081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5527069|NCT04267146|Nivolumab|nivolumab|mesh-list
5527070|NCT04267146|Temozolomide|temozolomide|mesh-list
5527071|NCT04267146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5527072|NCT04267146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5527073|NCT04267146|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5527074|NCT04267146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5527075|NCT04267146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5527076|NCT04267146|Alkylating Agents|alkylating agents|mesh-ancestor
6108363|NCT01004432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6108364|NCT01004432|Dermatologic Agents|dermatologic agents|mesh-ancestor
6108365|NCT01004432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6108366|NCT01004432|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6108367|NCT01004432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6108368|NCT01004432|Immunologic Factors|immunologic factors|mesh-ancestor
6108369|NCT01004432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6108370|NCT01004432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6108371|NCT01004432|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6204122|NCT02065713|Methotrexate|methotrexate|mesh-list
6488438|NCT00584168|Autonomic Agents|autonomic agents|mesh-ancestor
5527077|NCT04266977|Dexamethasone|dexamethasone|mesh-list
5527078|NCT04266977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5527079|NCT04266977|Antiemetics|antiemetics|mesh-ancestor
5527080|NCT04266977|Autonomic Agents|autonomic agents|mesh-ancestor
5527081|NCT04266977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5527082|NCT04266977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527083|NCT04266977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5527084|NCT04266977|Glucocorticoids|glucocorticoids|mesh-ancestor
5527085|NCT04266977|Hormones|hormones|mesh-ancestor
5527086|NCT04266977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5527087|NCT04266977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5527088|NCT04266977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5527089|NCT04266938|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
5527090|NCT04266938|Antiviral Agents|antiviral agents|mesh-ancestor
5527091|NCT04266938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5527092|NCT04266756|Selexipag|selexipag|mesh-list
5527093|NCT04266756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5527094|NCT04266353|Resveratrol|resveratrol|mesh-list
5527095|NCT04266353|Antioxidants|antioxidants|mesh-ancestor
5527096|NCT04266353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5527097|NCT04266353|Protective Agents|protective agents|mesh-ancestor
6108372|NCT01004432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6108373|NCT01004614|Amlodipine|amlodipine|mesh-list
6108374|NCT01004614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6108375|NCT01004614|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6108376|NCT01004614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6108377|NCT01004614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108378|NCT01004614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6108379|NCT01004614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108380|NCT01004614|Vasodilator Agents|vasodilator agents|mesh-ancestor
6108381|NCT01004705|Aspirin|aspirin|mesh-list
6108382|NCT01004705|Ramipril|ramipril|mesh-list
6108383|NCT01004705|Simvastatin|simvastatin|mesh-list
6108384|NCT01004705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6108385|NCT01004705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6108386|NCT01004705|Antimetabolites|antimetabolites|mesh-ancestor
6108387|NCT01004705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108388|NCT01004705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6108389|NCT01004705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6108390|NCT01004705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6108391|NCT01004705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6108392|NCT01004705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6108393|NCT01004705|Analgesics|analgesics|mesh-ancestor
5527098|NCT04266353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527099|NCT04266353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5527100|NCT04266353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5527101|NCT04266509|Rifampin|rifampin|mesh-list
5527102|NCT04266509|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5527103|NCT04266509|Antitubercular Agents|antitubercular agents|mesh-ancestor
5527104|NCT04266509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5527105|NCT04266509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5527106|NCT04266509|Leprostatic Agents|leprostatic agents|mesh-ancestor
5527107|NCT04266509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6108394|NCT01004705|Sensory System Agents|sensory system agents|mesh-ancestor
6108395|NCT01004705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6108396|NCT01004705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108397|NCT01004705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6108398|NCT01004705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6108399|NCT01004705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6108400|NCT01004705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6108401|NCT01004705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6108402|NCT01004705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6108403|NCT01004705|Antipyretics|antipyretics|mesh-ancestor
6108404|NCT01004705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6108405|NCT01004705|Protease Inhibitors|protease inhibitors|mesh-ancestor
6108406|NCT01004705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6108407|NCT01004718|Deoxyglucose|deoxyglucose|mesh-list
6108408|NCT01004718|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6108409|NCT01004718|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6108410|NCT01004718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5527108|NCT04266509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5527109|NCT04266509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725316|NCT03181100|Vemurafenib|vemurafenib|mesh-list
6108411|NCT01004718|Antimetabolites|antimetabolites|mesh-ancestor
6108412|NCT01004718|Antiviral Agents|antiviral agents|mesh-ancestor
5527110|NCT04266509|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5527111|NCT04266509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5527112|NCT04266509|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5527113|NCT04266509|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5527114|NCT04266509|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5527115|NCT04266509|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5527116|NCT04266236|Ropivacaine|ropivacaine|mesh-list
5527117|NCT04266236|Anesthetics|anesthetics|mesh-ancestor
5527118|NCT04266236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5527119|NCT04266236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527120|NCT04266236|Anesthetics, Local|anesthetics, local|mesh-ancestor
5527121|NCT04266236|Sensory System Agents|sensory system agents|mesh-ancestor
5527122|NCT04266236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5527123|NCT04266288|Ketamine|ketamine|mesh-list
5527124|NCT04266288|Analgesics|analgesics|mesh-ancestor
5527125|NCT04266288|Sensory System Agents|sensory system agents|mesh-ancestor
5527126|NCT04266288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5527127|NCT04266288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527128|NCT04266288|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5527129|NCT04266288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5527130|NCT04266288|Anesthetics, General|anesthetics, general|mesh-ancestor
5527131|NCT04266288|Anesthetics|anesthetics|mesh-ancestor
5527132|NCT04266288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5527133|NCT04266288|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5527134|NCT04266288|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5527135|NCT04266288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5527136|NCT04266288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5527137|NCT04266340|Midazolam|midazolam|mesh-list
5527138|NCT04266340|Dexmedetomidine|dexmedetomidine|mesh-list
5527139|NCT04266340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5527140|NCT04266340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5527141|NCT04266340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527142|NCT04266340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5527143|NCT04266340|Analgesics|analgesics|mesh-ancestor
5527144|NCT04266340|Sensory System Agents|sensory system agents|mesh-ancestor
5527145|NCT04266340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5527146|NCT04266340|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5527147|NCT04266340|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5527148|NCT04266340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5527149|NCT04266340|Adrenergic Agents|adrenergic agents|mesh-ancestor
5527150|NCT04266340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5527151|NCT04266340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5527152|NCT04266340|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5725317|NCT03181100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5725318|NCT03181100|Endothelial Growth Factors|endothelial growth factors|mesh-list
5725319|NCT03181100|Antibodies|antibodies|mesh-list
5725320|NCT03181100|Immunoglobulins|immunoglobulins|mesh-list
5725321|NCT03181100|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5725322|NCT03181100|Immunoglobulin G|immunoglobulin g|mesh-list
5725323|NCT03181100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5725324|NCT03181100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5725325|NCT03181100|Tubulin Modulators|tubulin modulators|mesh-ancestor
5725326|NCT03181100|Antimitotic Agents|antimitotic agents|mesh-ancestor
5725327|NCT03181100|Mitosis Modulators|mitosis modulators|mesh-ancestor
5725328|NCT03181100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725329|NCT03181100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5725330|NCT03181100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5725331|NCT03181100|Growth Substances|growth substances|mesh-ancestor
5725332|NCT03181100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725333|NCT03181100|Growth Inhibitors|growth inhibitors|mesh-ancestor
5725334|NCT03181100|Immunologic Factors|immunologic factors|mesh-ancestor
5725335|NCT03181100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5725336|NCT03181100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5725337|NCT03180957|Adalimumab|adalimumab|mesh-list
5725338|NCT03180957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5725339|NCT03180957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5725340|NCT03180970|Lugol's solution|lugol's solution|mesh-list
5725341|NCT03180970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5725342|NCT03180970|Hemostatics|hemostatics|mesh-ancestor
5725343|NCT03180970|Coagulants|coagulants|mesh-ancestor
5725344|NCT03180879|Ibuprofen|ibuprofen|mesh-list
5725345|NCT03180879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5725346|NCT03180879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6108413|NCT01004718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6108414|NCT01004744|Anastrozole|anastrozole|mesh-list
6108415|NCT01004744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6108416|NCT01004744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6108417|NCT01004744|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6108418|NCT01004744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6108419|NCT01004744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6108420|NCT01004744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108421|NCT01004744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6108422|NCT01004744|Hormone Antagonists|hormone antagonists|mesh-ancestor
6108423|NCT01004744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6108424|NCT01004744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527153|NCT04266340|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5527154|NCT04266340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5527155|NCT04266340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5527156|NCT04266340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5527157|NCT04266340|Anesthetics, General|anesthetics, general|mesh-ancestor
5527158|NCT04266340|Anesthetics|anesthetics|mesh-ancestor
5527159|NCT04266340|GABA Modulators|gaba modulators|mesh-ancestor
5527160|NCT04266340|GABA Agents|gaba agents|mesh-ancestor
5601366|NCT03705728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5601367|NCT03705728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5601368|NCT03705728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108425|NCT01004874|Bevacizumab|bevacizumab|mesh-list
6108426|NCT01004874|Temozolomide|temozolomide|mesh-list
6108427|NCT01004874|Topotecan|topotecan|mesh-list
6108428|NCT01004874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6108429|NCT01004874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6108430|NCT01004874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6108431|NCT01004874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6108432|NCT01004874|Growth Substances|growth substances|mesh-ancestor
6108433|NCT01004874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108434|NCT01004874|Growth Inhibitors|growth inhibitors|mesh-ancestor
6108435|NCT01004874|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6108436|NCT01004874|Alkylating Agents|alkylating agents|mesh-ancestor
6108437|NCT01004874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108438|NCT01004874|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6108439|NCT01004874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6108440|NCT01004874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6108441|NCT01004939|PENTA|penta|mesh-list
6108442|NCT01004939|Fondaparinux|fondaparinux|mesh-list
6108443|NCT01004939|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6108444|NCT01004939|Antithrombins|antithrombins|mesh-ancestor
6108445|NCT01004939|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6108446|NCT01004939|Protease Inhibitors|protease inhibitors|mesh-ancestor
6108447|NCT01004939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6108448|NCT01004939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108449|NCT01004939|Anticoagulants|anticoagulants|mesh-ancestor
6108450|NCT01004939|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6108451|NCT01004939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6108452|NCT01004991|Prednisone|prednisone|mesh-list
6108453|NCT01004991|Cyclophosphamide|cyclophosphamide|mesh-list
6108454|NCT01004991|Rituximab|rituximab|mesh-list
6108455|NCT01004991|Doxorubicin|doxorubicin|mesh-list
6108456|NCT01004991|Vincristine|vincristine|mesh-list
6108457|NCT01004991|Azacitidine|azacitidine|mesh-list
6108458|NCT01004991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6108459|NCT01004991|Immunologic Factors|immunologic factors|mesh-ancestor
6108460|NCT01004991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108461|NCT01004991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6108462|NCT01004991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6108463|NCT01004991|Alkylating Agents|alkylating agents|mesh-ancestor
6108464|NCT01004991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108465|NCT01004991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6108466|NCT01004991|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6465386|NCT00474071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6465387|NCT00474110|Ketamine|ketamine|mesh-list
6465388|NCT00474110|Hydromorphone|hydromorphone|mesh-list
6108467|NCT01004991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6108468|NCT01004991|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6108469|NCT01004991|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6108470|NCT01004991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6108471|NCT01004991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5601369|NCT03705728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6108472|NCT01004991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6108473|NCT01004991|Glucocorticoids|glucocorticoids|mesh-ancestor
6108474|NCT01004991|Hormones|hormones|mesh-ancestor
6108475|NCT01004991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6108476|NCT01004991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6108477|NCT01004991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6108478|NCT01004991|Tubulin Modulators|tubulin modulators|mesh-ancestor
6108479|NCT01004991|Antimitotic Agents|antimitotic agents|mesh-ancestor
6108480|NCT01004991|Mitosis Modulators|mitosis modulators|mesh-ancestor
6108481|NCT01004991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6108482|NCT01004991|Antimetabolites|antimetabolites|mesh-ancestor
6108483|NCT01005251|Lesogaberan|lesogaberan|mesh-list
6108484|NCT01005251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6108485|NCT01005251|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6108486|NCT01005251|GABA Agonists|gaba agonists|mesh-ancestor
6108487|NCT01005251|GABA Agents|gaba agents|mesh-ancestor
6108488|NCT01005251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6108489|NCT01005251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108490|NCT01005251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108491|NCT01005290|Ramipril|ramipril|mesh-list
6108492|NCT01005290|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6108493|NCT01005290|Protease Inhibitors|protease inhibitors|mesh-ancestor
6108494|NCT01005290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6108495|NCT01005290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108496|NCT01005290|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6108497|NCT01005316|Mycophenolic Acid|mycophenolic acid|mesh-list
5527161|NCT04266132|Bupivacaine|bupivacaine|mesh-list
5527162|NCT04266132|Anesthetics, Local|anesthetics, local|mesh-ancestor
5527163|NCT04266132|Anesthetics|anesthetics|mesh-ancestor
6108498|NCT01005316|Prednisone|prednisone|mesh-list
6108499|NCT01005316|Tacrolimus|tacrolimus|mesh-list
6108500|NCT01005316|Immunoglobulins|immunoglobulins|mesh-list
6108501|NCT01005316|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6108502|NCT01005316|Antibodies|antibodies|mesh-list
6108503|NCT01005316|gamma-Globulins|gamma-globulins|mesh-list
6108504|NCT01005316|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6108505|NCT01005316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6108506|NCT01005316|Glucocorticoids|glucocorticoids|mesh-ancestor
6108507|NCT01005316|Hormones|hormones|mesh-ancestor
6108508|NCT01005316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6108509|NCT01005316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108510|NCT01005316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6108511|NCT01005316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6108512|NCT01005316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6108513|NCT01005316|Immunologic Factors|immunologic factors|mesh-ancestor
6108514|NCT01005316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6108515|NCT01005316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6108516|NCT01005316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108517|NCT01005316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6108518|NCT01005316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6108519|NCT01005316|Antitubercular Agents|antitubercular agents|mesh-ancestor
6108520|NCT01005316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6108521|NCT01005316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6108522|NCT01005329|Paclitaxel|paclitaxel|mesh-list
6108523|NCT01005329|Bevacizumab|bevacizumab|mesh-list
6108524|NCT01005329|Cisplatin|cisplatin|mesh-list
6108525|NCT01005329|Carboplatin|carboplatin|mesh-list
6108526|NCT01005329|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6108527|NCT01005329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6108528|NCT01005329|Endothelial Growth Factors|endothelial growth factors|mesh-list
6108529|NCT01005329|Antibodies|antibodies|mesh-list
6108530|NCT01005329|Immunoglobulins|immunoglobulins|mesh-list
6108531|NCT01005329|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6108532|NCT01005329|Immunoglobulin G|immunoglobulin g|mesh-list
6108533|NCT01005329|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6108534|NCT01005329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6108535|NCT01005329|Tubulin Modulators|tubulin modulators|mesh-ancestor
6108536|NCT01005329|Antimitotic Agents|antimitotic agents|mesh-ancestor
6108537|NCT01005329|Mitosis Modulators|mitosis modulators|mesh-ancestor
6108538|NCT01005329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108539|NCT01005329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6108540|NCT01005329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6108541|NCT01005329|Growth Substances|growth substances|mesh-ancestor
6108542|NCT01005329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108543|NCT01005329|Growth Inhibitors|growth inhibitors|mesh-ancestor
6108544|NCT01005329|Immunologic Factors|immunologic factors|mesh-ancestor
6108545|NCT01005355|Ramucirumab|ramucirumab|mesh-list
6108546|NCT01005355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6108547|NCT01005407|Vaccines|vaccines|mesh-list
5527164|NCT04266132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5527165|NCT04266132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527166|NCT04266132|Sensory System Agents|sensory system agents|mesh-ancestor
5527167|NCT04266132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5527168|NCT04266197|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
5527169|NCT04266197|Vasodilator Agents|vasodilator agents|mesh-ancestor
5527170|NCT04266197|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5527171|NCT04266197|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6108548|NCT01005407|Immunologic Factors|immunologic factors|mesh-ancestor
6108549|NCT01005407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108550|NCT01005459|Bupivacaine|bupivacaine|mesh-list
6108551|NCT01005459|Tetracaine|tetracaine|mesh-list
6108552|NCT01005459|Anesthetics, Local|anesthetics, local|mesh-ancestor
6108553|NCT01005459|Anesthetics|anesthetics|mesh-ancestor
6108554|NCT01005459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6108555|NCT01005459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108556|NCT01005459|Sensory System Agents|sensory system agents|mesh-ancestor
6108557|NCT01005459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6108558|NCT01005576|Fludarabine|fludarabine|mesh-list
6108559|NCT01005576|Melphalan|melphalan|mesh-list
6108560|NCT01005576|Alemtuzumab|alemtuzumab|mesh-list
6108561|NCT01005576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6108562|NCT01005576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108563|NCT01005576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6108564|NCT01005576|Immunologic Factors|immunologic factors|mesh-ancestor
6108565|NCT01005576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108566|NCT01005576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6108567|NCT01005576|Alkylating Agents|alkylating agents|mesh-ancestor
6108568|NCT01005576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6108569|NCT01005576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6108570|NCT01005602|Digoxin|digoxin|mesh-list
6108571|NCT01005602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6108572|NCT01005602|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6108573|NCT01005602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6108574|NCT01005602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108575|NCT01005602|Protective Agents|protective agents|mesh-ancestor
6108576|NCT01005602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108577|NCT01005680|Gemcitabine|gemcitabine|mesh-list
6108578|NCT01005680|Pemetrexed|pemetrexed|mesh-list
6108579|NCT01005680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6108580|NCT01005680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6108581|NCT01005680|Antimetabolites|antimetabolites|mesh-ancestor
6108582|NCT01005680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108583|NCT01005680|Antiviral Agents|antiviral agents|mesh-ancestor
6108584|NCT01005680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6108585|NCT01005680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6108586|NCT01005680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6108587|NCT01005680|Immunologic Factors|immunologic factors|mesh-ancestor
6108588|NCT01005680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108589|NCT01005680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6108590|NCT01005680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6108591|NCT01005706|Mycophenolic Acid|mycophenolic acid|mesh-list
6108592|NCT01005706|Sirolimus|sirolimus|mesh-list
6108593|NCT01005706|Tacrolimus|tacrolimus|mesh-list
6108594|NCT01005706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6108595|NCT01005706|Immunologic Factors|immunologic factors|mesh-ancestor
6108596|NCT01005706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108597|NCT01005706|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6108598|NCT01005706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6108599|NCT01005706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108600|NCT01005706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6108601|NCT01005706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6108602|NCT01005706|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6108603|NCT01005706|Antitubercular Agents|antitubercular agents|mesh-ancestor
6108604|NCT01005706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6108605|NCT01005706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6108606|NCT01005706|Antifungal Agents|antifungal agents|mesh-ancestor
6108607|NCT01005719|Omeprazole|omeprazole|mesh-list
6108608|NCT01005719|Lansoprazole|lansoprazole|mesh-list
6108609|NCT01005719|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
6108610|NCT01005719|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6108611|NCT01005719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6108612|NCT01005719|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6108613|NCT01005719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5527172|NCT04266197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6108614|NCT01005719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108615|NCT01005745|Aldesleukin|aldesleukin|mesh-list
6108616|NCT01005745|Interleukin-2|interleukin-2|mesh-list
6108617|NCT01005745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6108618|NCT01005745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6108619|NCT01005745|Analgesics|analgesics|mesh-ancestor
6108620|NCT01005745|Sensory System Agents|sensory system agents|mesh-ancestor
6108621|NCT01005745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6108622|NCT01005745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108623|NCT01005745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6108624|NCT01005745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5527173|NCT04266197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5527174|NCT04266197|Urological Agents|urological agents|mesh-ancestor
5527175|NCT04266145|Dexmedetomidine|dexmedetomidine|mesh-list
5527176|NCT04266145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5527177|NCT04266145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5527178|NCT04266145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527179|NCT04266145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5527180|NCT04266145|Analgesics|analgesics|mesh-ancestor
5527181|NCT04266145|Sensory System Agents|sensory system agents|mesh-ancestor
5527182|NCT04266145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5527183|NCT04266145|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5527184|NCT04266145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5527185|NCT04266145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5527186|NCT04266145|Adrenergic Agents|adrenergic agents|mesh-ancestor
5527187|NCT04266145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5527188|NCT04266145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5527189|NCT04265833|Calcium|calcium|mesh-list
5527190|NCT04265833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5527191|NCT04265833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527192|NCT04266002|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
5527193|NCT04266002|Antiviral Agents|antiviral agents|mesh-ancestor
5527194|NCT04266002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5527195|NCT04265872|Pembrolizumab|pembrolizumab|mesh-list
5527196|NCT04265872|Bortezomib|bortezomib|mesh-list
5527197|NCT04265872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5527198|NCT04265872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6108625|NCT01005745|Antiviral Agents|antiviral agents|mesh-ancestor
6108626|NCT01005745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6108627|NCT01005810|Acetylcysteine|acetylcysteine|mesh-list
6108628|NCT01005810|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6108629|NCT01005810|Antiviral Agents|antiviral agents|mesh-ancestor
6108630|NCT01005810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6108631|NCT01005810|Expectorants|expectorants|mesh-ancestor
6108632|NCT01005810|Respiratory System Agents|respiratory system agents|mesh-ancestor
6108633|NCT01005810|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6108634|NCT01005810|Antioxidants|antioxidants|mesh-ancestor
6465389|NCT00474110|Analgesics|analgesics|mesh-ancestor
6465390|NCT00474110|Sensory System Agents|sensory system agents|mesh-ancestor
6465391|NCT00474110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6465392|NCT00474110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465393|NCT00474110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6108635|NCT01005810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108636|NCT01005810|Protective Agents|protective agents|mesh-ancestor
6108637|NCT01005810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108638|NCT01005810|Antidotes|antidotes|mesh-ancestor
6108639|NCT01005875|Sorafenib|sorafenib|mesh-list
6108640|NCT01005875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5527199|NCT04265456|Acetaminophen|acetaminophen|mesh-list
5527200|NCT04265456|Pregabalin|pregabalin|mesh-list
5527201|NCT04265456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5527202|NCT04265456|Analgesics|analgesics|mesh-ancestor
5527203|NCT04265456|Sensory System Agents|sensory system agents|mesh-ancestor
6108641|NCT01005875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6108642|NCT01005875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6108643|NCT01005875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5527204|NCT04265456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6108644|NCT01005888|Complement C1s|complement c1s|mesh-list
6108645|NCT01005888|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
6108646|NCT01005888|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
6108647|NCT01005888|Immunologic Factors|immunologic factors|mesh-ancestor
6108648|NCT01005888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108649|NCT01005888|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6108650|NCT01005888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6108651|NCT01005901|Glycopyrrolate|glycopyrrolate|mesh-list
6108652|NCT01005901|Bromides|bromides|mesh-list
6108653|NCT01005901|Anticonvulsants|anticonvulsants|mesh-ancestor
6108654|NCT01005901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6108655|NCT01005901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6108656|NCT01005901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6108657|NCT01005901|Cholinergic Agents|cholinergic agents|mesh-ancestor
6108658|NCT01005901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6108659|NCT01005901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108660|NCT01005901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108661|NCT01005966|Listerine|listerine|mesh-list
6108662|NCT01005966|Fluorides|fluorides|mesh-list
6108663|NCT01005966|Sodium Fluoride|sodium fluoride|mesh-list
6108664|NCT01005966|Fluorophosphate|fluorophosphate|mesh-list
6108665|NCT01005966|Cariostatic Agents|cariostatic agents|mesh-ancestor
6108666|NCT01005966|Protective Agents|protective agents|mesh-ancestor
6108667|NCT01005966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108668|NCT01005966|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6108669|NCT01005966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6108670|NCT01006252|Paclitaxel|paclitaxel|mesh-list
6108671|NCT01006252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6108672|NCT01006252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6108673|NCT01006252|Tubulin Modulators|tubulin modulators|mesh-ancestor
6108674|NCT01006252|Antimitotic Agents|antimitotic agents|mesh-ancestor
6108675|NCT01006252|Mitosis Modulators|mitosis modulators|mesh-ancestor
6108676|NCT01006252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108677|NCT01006291|Insulin|insulin|mesh-list
6108678|NCT01006291|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6108679|NCT01006291|Insulin Glargine|insulin glargine|mesh-list
6108680|NCT01006291|Insulin, Long-Acting|insulin, long-acting|mesh-list
6108681|NCT01006291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6108682|NCT01006291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108683|NCT01006356|Hydromorphone|hydromorphone|mesh-list
6108684|NCT01006356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6108685|NCT01006356|Narcotics|narcotics|mesh-ancestor
5527205|NCT04265456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527206|NCT04265456|Antipyretics|antipyretics|mesh-ancestor
5527207|NCT04265456|Anticonvulsants|anticonvulsants|mesh-ancestor
5527208|NCT04265456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5527209|NCT04265456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5527210|NCT04265456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108686|NCT01006356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6108687|NCT01006356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108688|NCT01006356|Analgesics|analgesics|mesh-ancestor
6108689|NCT01006356|Sensory System Agents|sensory system agents|mesh-ancestor
6108690|NCT01006356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6108691|NCT01006369|Hydroxychloroquine|hydroxychloroquine|mesh-list
6108692|NCT01006369|Antimalarials|antimalarials|mesh-ancestor
6108693|NCT01006369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6108694|NCT01006369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6108695|NCT01006369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6108696|NCT01006369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6108697|NCT01006369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108698|NCT01006369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6108699|NCT01006538|Ranibizumab|ranibizumab|mesh-list
5527211|NCT04265456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5527212|NCT04265456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5527213|NCT04265456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5527214|NCT04265456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5527215|NCT04265456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5527216|NCT04265612|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
5527217|NCT04265612|Laxatives|laxatives|mesh-ancestor
5527218|NCT04265612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5527219|NCT04265508|Hemostatics|hemostatics|mesh-list
5527220|NCT04265508|Coagulants|coagulants|mesh-ancestor
5527221|NCT04265274|Copper|copper|mesh-list
5527222|NCT04265274|Disulfiram|disulfiram|mesh-list
5527223|NCT04265274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5527224|NCT04265274|Trace Elements|trace elements|mesh-ancestor
5527225|NCT04265274|Micronutrients|micronutrients|mesh-ancestor
5527226|NCT04265274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527227|NCT04265274|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5527228|NCT04265274|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
5527229|NCT04265274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5527230|NCT04265105|Fluticasone|fluticasone|mesh-list
5527231|NCT04265105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5527232|NCT04265105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5527233|NCT04265105|Autonomic Agents|autonomic agents|mesh-ancestor
5527234|NCT04265105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5527235|NCT04265105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527236|NCT04265105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5527237|NCT04265105|Respiratory System Agents|respiratory system agents|mesh-ancestor
5527238|NCT04265105|Dermatologic Agents|dermatologic agents|mesh-ancestor
5527239|NCT04265105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5527240|NCT04265001|Hyaluronic Acid|hyaluronic acid|mesh-list
5527241|NCT04265001|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5527242|NCT04265001|Immunologic Factors|immunologic factors|mesh-ancestor
5527243|NCT04265001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527244|NCT04265001|Viscosupplements|viscosupplements|mesh-ancestor
5527245|NCT04265001|Protective Agents|protective agents|mesh-ancestor
5527246|NCT04264858|Immunoglobulins|immunoglobulins|mesh-list
5527247|NCT04264858|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6108700|NCT01006538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6108701|NCT01006538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6108702|NCT01006538|Growth Substances|growth substances|mesh-ancestor
6108703|NCT01006538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527248|NCT04264858|Antibodies|antibodies|mesh-list
5527249|NCT04264858|gamma-Globulins|gamma-globulins|mesh-list
5527250|NCT04264858|Immunologic Factors|immunologic factors|mesh-ancestor
5527251|NCT04264858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527252|NCT04264988|Tin Fluorides|tin fluorides|mesh-list
5527253|NCT04264988|Cariostatic Agents|cariostatic agents|mesh-ancestor
5527254|NCT04264988|Protective Agents|protective agents|mesh-ancestor
5527255|NCT04264988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527256|NCT04265027|Opicapone|opicapone|mesh-list
5527257|NCT04265027|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
5527258|NCT04265027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5527259|NCT04265027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5527260|NCT04265027|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5527261|NCT04265027|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5527262|NCT04265053|Ketorolac|ketorolac|mesh-list
5527263|NCT04265053|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
5527264|NCT04265053|Estradiol|estradiol|mesh-list
5527265|NCT04265053|Testosterone|testosterone|mesh-list
5527266|NCT04265053|Ganirelix|ganirelix|mesh-list
5527267|NCT04265053|Estrogens|estrogens|mesh-ancestor
5527268|NCT04265053|Hormones|hormones|mesh-ancestor
5527269|NCT04265053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5527270|NCT04265053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527271|NCT04265053|Androgens|androgens|mesh-ancestor
5527272|NCT04265053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5527273|NCT04265053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5527274|NCT04265053|Analgesics|analgesics|mesh-ancestor
5527275|NCT04265053|Sensory System Agents|sensory system agents|mesh-ancestor
5527276|NCT04265053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5527277|NCT04265053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5527278|NCT04265053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5527279|NCT04265053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5527280|NCT04265053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5527281|NCT04265053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5527282|NCT04265053|Hormone Antagonists|hormone antagonists|mesh-ancestor
5527283|NCT04264806|Azacitidine|azacitidine|mesh-list
6108704|NCT01006538|Growth Inhibitors|growth inhibitors|mesh-ancestor
6108705|NCT01006538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6108706|NCT01006590|Metformin|metformin|mesh-list
6108707|NCT01006590|Saxagliptin|saxagliptin|mesh-list
6108708|NCT01006590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6108709|NCT01006590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108710|NCT01006590|Incretins|incretins|mesh-ancestor
6108711|NCT01006590|Hormones|hormones|mesh-ancestor
6108712|NCT01006590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5527284|NCT04264806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5527285|NCT04264806|Antimetabolites|antimetabolites|mesh-ancestor
5527286|NCT04264806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5527287|NCT04264806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5527288|NCT04264806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5527289|NCT04264676|Metronidazole|metronidazole|mesh-list
5527290|NCT04264676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5527291|NCT04264676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5527292|NCT04264676|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5527293|NCT04264676|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5601370|NCT03705728|Anesthetics, General|anesthetics, general|mesh-ancestor
5601371|NCT03705728|Anesthetics|anesthetics|mesh-ancestor
6108713|NCT01006590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6108714|NCT01006590|Protease Inhibitors|protease inhibitors|mesh-ancestor
6108715|NCT01006590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6108716|NCT01006590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108717|NCT01006603|Glimepiride|glimepiride|mesh-list
6108718|NCT01006603|Saxagliptin|saxagliptin|mesh-list
6108719|NCT01006603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6108720|NCT01006603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6108721|NCT01006603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108722|NCT01006603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6108723|NCT01006603|Immunologic Factors|immunologic factors|mesh-ancestor
6108724|NCT01006603|Incretins|incretins|mesh-ancestor
6108725|NCT01006603|Hormones|hormones|mesh-ancestor
6108726|NCT01006603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6108727|NCT01006603|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6108728|NCT01006603|Protease Inhibitors|protease inhibitors|mesh-ancestor
6108729|NCT01006603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6108730|NCT01006603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108731|NCT01006629|Palivizumab|palivizumab|mesh-list
6108732|NCT01006629|Antiviral Agents|antiviral agents|mesh-ancestor
6108733|NCT01006629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6108734|NCT01006655|Beclomethasone|beclomethasone|mesh-list
6108735|NCT01006655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6108736|NCT01006655|Glucocorticoids|glucocorticoids|mesh-ancestor
6108737|NCT01006655|Hormones|hormones|mesh-ancestor
6108738|NCT01006655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6108739|NCT01006655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108740|NCT01006655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6108741|NCT01006655|Respiratory System Agents|respiratory system agents|mesh-ancestor
6108742|NCT01006707|Ondansetron|ondansetron|mesh-list
6108743|NCT01006707|Antiemetics|antiemetics|mesh-ancestor
6108744|NCT01006707|Autonomic Agents|autonomic agents|mesh-ancestor
6108745|NCT01006707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6108746|NCT01006707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108747|NCT01006707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6108748|NCT01006707|Antipruritics|antipruritics|mesh-ancestor
6108749|NCT01006707|Dermatologic Agents|dermatologic agents|mesh-ancestor
5601372|NCT03705728|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5601373|NCT03705728|Narcotics|narcotics|mesh-ancestor
5601374|NCT03705728|Analgesics|analgesics|mesh-ancestor
5601375|NCT03705728|Sensory System Agents|sensory system agents|mesh-ancestor
5601376|NCT03705728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5601377|NCT03705728|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5601378|NCT03705728|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5601379|NCT03705585|Vaccines|vaccines|mesh-list
5601380|NCT03705585|Immunologic Factors|immunologic factors|mesh-ancestor
5601381|NCT03705585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601382|NCT03705559|Analgesics, Opioid|analgesics, opioid|mesh-list
5601383|NCT03705559|Narcotics|narcotics|mesh-ancestor
5601384|NCT03705559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5601385|NCT03705559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601386|NCT03705559|Analgesics|analgesics|mesh-ancestor
5601387|NCT03705559|Sensory System Agents|sensory system agents|mesh-ancestor
5601388|NCT03705559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6108750|NCT01006707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6108751|NCT01006707|Serotonin Agents|serotonin agents|mesh-ancestor
6108752|NCT01006707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6108753|NCT01006707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108754|NCT01006707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6108755|NCT01006707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6108756|NCT01006707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6108757|NCT01006707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6108758|NCT01006707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6108759|NCT01006889|Exenatide|exenatide|mesh-list
6108760|NCT01006889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6108761|NCT01006889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108762|NCT01006889|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6108763|NCT01006889|Incretins|incretins|mesh-ancestor
6108764|NCT01006889|Hormones|hormones|mesh-ancestor
6108765|NCT01006889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6108766|NCT01006980|Dacarbazine|dacarbazine|mesh-list
6108767|NCT01006980|Vemurafenib|vemurafenib|mesh-list
6108768|NCT01006980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6108769|NCT01006980|Alkylating Agents|alkylating agents|mesh-ancestor
6108770|NCT01006980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108771|NCT01006980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6108772|NCT01006980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6108773|NCT01006980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6108774|NCT01007071|Hormones|hormones|mesh-list
6108775|NCT01007071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6108776|NCT01007071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108777|NCT01007149|Omalizumab|omalizumab|mesh-list
6108778|NCT01007149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6108779|NCT01007149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6108780|NCT01007149|Respiratory System Agents|respiratory system agents|mesh-ancestor
6108781|NCT01007253|Fluticasone|fluticasone|mesh-list
6108782|NCT01007253|Xhance|xhance|mesh-list
6108783|NCT01007253|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
6108784|NCT01007253|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6108785|NCT01007253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6108786|NCT01007253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6108787|NCT01007253|Autonomic Agents|autonomic agents|mesh-ancestor
6108788|NCT01007253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6108789|NCT01007253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108790|NCT01007253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6108791|NCT01007253|Respiratory System Agents|respiratory system agents|mesh-ancestor
6108792|NCT01007253|Dermatologic Agents|dermatologic agents|mesh-ancestor
6108793|NCT01007253|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6108794|NCT01007253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6108795|NCT01007253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5527294|NCT04264481|Lidocaine|lidocaine|mesh-list
5527295|NCT04264481|Anesthetics, Local|anesthetics, local|mesh-ancestor
5527296|NCT04264481|Anesthetics|anesthetics|mesh-ancestor
5527297|NCT04264481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5527298|NCT04264481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527299|NCT04264481|Sensory System Agents|sensory system agents|mesh-ancestor
5527300|NCT04264481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5527301|NCT04264481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5527302|NCT04264481|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5527303|NCT04264481|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5527304|NCT04264481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5527305|NCT04264481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5527306|NCT04264624|Erythritol|erythritol|mesh-list
5527307|NCT04264624|Vasodilator Agents|vasodilator agents|mesh-ancestor
5527308|NCT04264637|Azelastine|azelastine|mesh-list
5527309|NCT04264637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5527310|NCT04264637|Autonomic Agents|autonomic agents|mesh-ancestor
5527311|NCT04264637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5527312|NCT04264637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527313|NCT04264637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6108796|NCT01007253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5527314|NCT04264637|Respiratory System Agents|respiratory system agents|mesh-ancestor
5527315|NCT04264637|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
5527316|NCT04264637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5527317|NCT04264637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5527318|NCT04264637|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5527319|NCT04264637|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5527320|NCT04264637|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5527321|NCT04264637|Histamine Antagonists|histamine antagonists|mesh-ancestor
6108797|NCT01007253|Analgesics|analgesics|mesh-ancestor
6108798|NCT01007253|Sensory System Agents|sensory system agents|mesh-ancestor
6108799|NCT01007253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6108800|NCT01007253|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6108801|NCT01007253|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6108802|NCT01007253|Histamine Antagonists|histamine antagonists|mesh-ancestor
6108803|NCT01007253|Histamine Agents|histamine agents|mesh-ancestor
6108804|NCT01007253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6108805|NCT01007253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5527322|NCT04264637|Histamine Agents|histamine agents|mesh-ancestor
5527323|NCT04264637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5527324|NCT04264078|Fludarabine|fludarabine|mesh-list
5527325|NCT04264078|Cyclophosphamide|cyclophosphamide|mesh-list
5527326|NCT04264078|Melphalan|melphalan|mesh-list
5527327|NCT04264078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5527328|NCT04264078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5527329|NCT04264078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5527330|NCT04264078|Immunologic Factors|immunologic factors|mesh-ancestor
5527331|NCT04264078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527332|NCT04264078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5527333|NCT04264078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5527334|NCT04264078|Alkylating Agents|alkylating agents|mesh-ancestor
5527335|NCT04264078|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5527336|NCT04264026|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
5527337|NCT04264026|Hallucinogens|hallucinogens|mesh-ancestor
6108806|NCT01007435|Methotrexate|methotrexate|mesh-list
6108807|NCT01007435|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6108808|NCT01007435|Abortifacient Agents|abortifacient agents|mesh-ancestor
5527338|NCT04264026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527339|NCT04264026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5527340|NCT04264026|Serotonin Agents|serotonin agents|mesh-ancestor
5527341|NCT04264026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5527342|NCT04264026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5527343|NCT04264026|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5527344|NCT04264026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5527345|NCT04264026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5527346|NCT04264026|Adrenergic Agents|adrenergic agents|mesh-ancestor
5527347|NCT04264039|Fludarabine|fludarabine|mesh-list
5527348|NCT04264039|Cyclophosphamide|cyclophosphamide|mesh-list
5527349|NCT04264039|Melphalan|melphalan|mesh-list
5527350|NCT04264039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5527351|NCT04264039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5527352|NCT04264039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5527353|NCT04264039|Immunologic Factors|immunologic factors|mesh-ancestor
5527354|NCT04264039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527355|NCT04264039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5527356|NCT04264039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5527357|NCT04264039|Alkylating Agents|alkylating agents|mesh-ancestor
5527358|NCT04264039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5527359|NCT04264260|Colchicine|colchicine|mesh-list
5527360|NCT04264260|Gout Suppressants|gout suppressants|mesh-ancestor
5527361|NCT04264260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5527362|NCT04264260|Tubulin Modulators|tubulin modulators|mesh-ancestor
5527363|NCT04264260|Antimitotic Agents|antimitotic agents|mesh-ancestor
5527364|NCT04264260|Mitosis Modulators|mitosis modulators|mesh-ancestor
5527365|NCT04264260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108809|NCT01007435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6108810|NCT01007435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108811|NCT01007435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6108812|NCT01007435|Antimetabolites|antimetabolites|mesh-ancestor
6108813|NCT01007435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108814|NCT01007435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5527366|NCT04264260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5527367|NCT04264130|Artesunate|artesunate|mesh-list
5527368|NCT04264130|Lumefantrine|lumefantrine|mesh-list
5527369|NCT04264130|Artemether|artemether|mesh-list
5527370|NCT04264130|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
5527371|NCT04264130|Pyronaridine|pyronaridine|mesh-list
5527372|NCT04264130|Artefenomel|artefenomel|mesh-list
5527373|NCT04264130|Ferroquine|ferroquine|mesh-list
5527374|NCT04264130|Antimalarials|antimalarials|mesh-ancestor
5527375|NCT04264130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5527376|NCT04264130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5527377|NCT04264130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5527378|NCT04264130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5527379|NCT04264130|Antiviral Agents|antiviral agents|mesh-ancestor
6108815|NCT01007435|Dermatologic Agents|dermatologic agents|mesh-ancestor
6108816|NCT01007435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6108817|NCT01007435|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6108818|NCT01007435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6108819|NCT01007435|Immunologic Factors|immunologic factors|mesh-ancestor
5527380|NCT04264130|Schistosomicides|schistosomicides|mesh-ancestor
5527381|NCT04264130|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5527382|NCT04264130|Anthelmintics|anthelmintics|mesh-ancestor
5527383|NCT04264286|Esmolol|esmolol|mesh-list
5527384|NCT04264286|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5527385|NCT04264286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5527386|NCT04264286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5527387|NCT04264286|Adrenergic Agents|adrenergic agents|mesh-ancestor
5527388|NCT04264286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5527389|NCT04264286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5527390|NCT04264286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527391|NCT04263870|Capecitabine|capecitabine|mesh-list
6108820|NCT01007435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6108821|NCT01007435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6108822|NCT01007448|Bexarotene|bexarotene|mesh-list
6108823|NCT01007448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6108824|NCT01007552|Gemcitabine|gemcitabine|mesh-list
6108825|NCT01007552|Bevacizumab|bevacizumab|mesh-list
5527392|NCT04263870|Oxaliplatin|oxaliplatin|mesh-list
5527393|NCT04263870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5527394|NCT04263870|Antimetabolites|antimetabolites|mesh-ancestor
5527395|NCT04263870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108826|NCT01007552|Capecitabine|capecitabine|mesh-list
6108827|NCT01007552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6108828|NCT01007552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6108829|NCT01007552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6108830|NCT01007552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6108831|NCT01007552|Growth Substances|growth substances|mesh-ancestor
6108832|NCT01007552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108833|NCT01007552|Growth Inhibitors|growth inhibitors|mesh-ancestor
6108834|NCT01007552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6108835|NCT01007552|Antimetabolites|antimetabolites|mesh-ancestor
6108836|NCT01007552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108837|NCT01007552|Antiviral Agents|antiviral agents|mesh-ancestor
6108838|NCT01007552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5527396|NCT04263870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5527397|NCT04263922|Valsartan|valsartan|mesh-list
5527398|NCT04263922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5527399|NCT04263922|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5527400|NCT04263922|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5527401|NCT04263922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108839|NCT01007552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6108840|NCT01007552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6108841|NCT01007552|Immunologic Factors|immunologic factors|mesh-ancestor
6108842|NCT01007591|Hydrocortisone|hydrocortisone|mesh-list
6108843|NCT01007591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6108844|NCT01007942|Trastuzumab|trastuzumab|mesh-list
5527402|NCT04263844|Midazolam|midazolam|mesh-list
5527403|NCT04263844|Dexmedetomidine|dexmedetomidine|mesh-list
5527404|NCT04263844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6108845|NCT01007942|Everolimus|everolimus|mesh-list
6108846|NCT01007942|Vinorelbine|vinorelbine|mesh-list
6108847|NCT01007942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6108848|NCT01007942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6108849|NCT01007942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6108850|NCT01007942|Immunologic Factors|immunologic factors|mesh-ancestor
6108851|NCT01007942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108852|NCT01007942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6108853|NCT01007942|Tubulin Modulators|tubulin modulators|mesh-ancestor
6108854|NCT01007942|Antimitotic Agents|antimitotic agents|mesh-ancestor
6108855|NCT01007942|Mitosis Modulators|mitosis modulators|mesh-ancestor
6108856|NCT01007942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108857|NCT01007994|Propranolol|propranolol|mesh-list
6108858|NCT01007994|Enalapril|enalapril|mesh-list
6108859|NCT01007994|Isradipine|isradipine|mesh-list
6108860|NCT01007994|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6108861|NCT01007994|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6108862|NCT01007994|Adrenergic Agents|adrenergic agents|mesh-ancestor
6108863|NCT01007994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6108864|NCT01007994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108865|NCT01007994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108866|NCT01007994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6108867|NCT01007994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6108868|NCT01007994|Vasodilator Agents|vasodilator agents|mesh-ancestor
5527405|NCT04263844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5527406|NCT04263844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527407|NCT04263844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5527408|NCT04263844|Analgesics|analgesics|mesh-ancestor
5527409|NCT04263844|Sensory System Agents|sensory system agents|mesh-ancestor
5527410|NCT04263844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5527411|NCT04263844|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5527412|NCT04263844|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5527413|NCT04263844|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5527414|NCT04263844|Adrenergic Agents|adrenergic agents|mesh-ancestor
5527415|NCT04263844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5527416|NCT04263844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5527417|NCT04263844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6108869|NCT01007994|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6108870|NCT01007994|Protease Inhibitors|protease inhibitors|mesh-ancestor
6108871|NCT01007994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6108872|NCT01007994|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6108873|NCT01007994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6108874|NCT01007994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6108875|NCT01008059|Alfentanil|alfentanil|mesh-list
6108876|NCT01008059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6108877|NCT01008059|Narcotics|narcotics|mesh-ancestor
6108878|NCT01008059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6108879|NCT01008059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108880|NCT01008059|Analgesics|analgesics|mesh-ancestor
6108881|NCT01008059|Sensory System Agents|sensory system agents|mesh-ancestor
6108882|NCT01008059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6108883|NCT01008059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6108884|NCT01008059|Anesthetics, General|anesthetics, general|mesh-ancestor
6108885|NCT01008059|Anesthetics|anesthetics|mesh-ancestor
6108886|NCT01008150|Paclitaxel|paclitaxel|mesh-list
6108887|NCT01008150|Cyclophosphamide|cyclophosphamide|mesh-list
6108888|NCT01008150|Doxorubicin|doxorubicin|mesh-list
5527418|NCT04263844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5527419|NCT04263844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5527420|NCT04263844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5527421|NCT04263844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5527422|NCT04263844|Anesthetics, General|anesthetics, general|mesh-ancestor
5527423|NCT04263844|Anesthetics|anesthetics|mesh-ancestor
5527424|NCT04263844|GABA Modulators|gaba modulators|mesh-ancestor
6108889|NCT01008150|Trastuzumab|trastuzumab|mesh-list
6108890|NCT01008150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5527425|NCT04263844|GABA Agents|gaba agents|mesh-ancestor
5527426|NCT04264208|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5527427|NCT04264208|Bombesin|bombesin|mesh-list
6108891|NCT01008150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6108892|NCT01008150|Tubulin Modulators|tubulin modulators|mesh-ancestor
6108893|NCT01008150|Antimitotic Agents|antimitotic agents|mesh-ancestor
6108894|NCT01008150|Mitosis Modulators|mitosis modulators|mesh-ancestor
6108895|NCT01008150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108896|NCT01008150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6108897|NCT01008150|Immunologic Factors|immunologic factors|mesh-ancestor
6108898|NCT01008150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108899|NCT01008150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6108900|NCT01008150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6108901|NCT01008150|Alkylating Agents|alkylating agents|mesh-ancestor
6108902|NCT01008150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6108903|NCT01008150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6108904|NCT01008150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6108905|NCT01008150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6108906|NCT01008150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6108907|NCT01008150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6108908|NCT01008280|Baclofen|baclofen|mesh-list
6108909|NCT01008280|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6108910|NCT01008280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108911|NCT01008280|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6108912|NCT01008280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6108913|NCT01008280|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6108914|NCT01008280|GABA Agonists|gaba agonists|mesh-ancestor
6108915|NCT01008280|GABA Agents|gaba agents|mesh-ancestor
6108916|NCT01008280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6108917|NCT01008280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108918|NCT01008319|Citric Acid|citric acid|mesh-list
6108919|NCT01008319|Sodium Citrate|sodium citrate|mesh-list
6108920|NCT01008319|Clomiphene|clomiphene|mesh-list
6108921|NCT01008319|Enclomiphene|enclomiphene|mesh-list
5527428|NCT04264208|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5527429|NCT04264208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5527430|NCT04264208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5527431|NCT04264208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527432|NCT04263610|Dimethyl Fumarate|dimethyl fumarate|mesh-list
5527433|NCT04263610|Dermatologic Agents|dermatologic agents|mesh-ancestor
5527434|NCT04263610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5527435|NCT04263610|Immunologic Factors|immunologic factors|mesh-ancestor
6108922|NCT01008319|Zuclomiphene|zuclomiphene|mesh-list
6465394|NCT00474110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6465395|NCT00474110|Anesthetics, General|anesthetics, general|mesh-ancestor
6465396|NCT00474110|Anesthetics|anesthetics|mesh-ancestor
6465397|NCT00474110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6465398|NCT00474110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6465399|NCT00474110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6465400|NCT00474110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6465401|NCT00474110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465402|NCT00474110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6465403|NCT00474110|Narcotics|narcotics|mesh-ancestor
6465404|NCT00474136|Diclofenac|diclofenac|mesh-list
6465405|NCT00474136|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6465406|NCT00474136|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6465407|NCT00474136|Analgesics|analgesics|mesh-ancestor
6465408|NCT00474136|Sensory System Agents|sensory system agents|mesh-ancestor
5527436|NCT04263610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527437|NCT04263519|Tacrolimus|tacrolimus|mesh-list
5527438|NCT04263519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5527439|NCT04263519|Immunologic Factors|immunologic factors|mesh-ancestor
5527440|NCT04263519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527441|NCT04263519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6108923|NCT01008319|Anticoagulants|anticoagulants|mesh-ancestor
6108924|NCT01008319|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6108925|NCT01008319|Chelating Agents|chelating agents|mesh-ancestor
6108926|NCT01008319|Sequestering Agents|sequestering agents|mesh-ancestor
6108927|NCT01008319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108928|NCT01008319|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6108929|NCT01008319|Hormone Antagonists|hormone antagonists|mesh-ancestor
6108930|NCT01008319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6108931|NCT01008319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108932|NCT01008319|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6108933|NCT01008319|Fertility Agents|fertility agents|mesh-ancestor
6108934|NCT01008319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5527442|NCT04263519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6465409|NCT00474136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5527443|NCT04263519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108935|NCT01008319|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6108936|NCT01008319|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6108937|NCT01008410|Budesonide|budesonide|mesh-list
6108938|NCT01008410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6108939|NCT01008410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6108940|NCT01008410|Autonomic Agents|autonomic agents|mesh-ancestor
6108941|NCT01008410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6108942|NCT01008410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108943|NCT01008410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6108944|NCT01008410|Respiratory System Agents|respiratory system agents|mesh-ancestor
6108945|NCT01008410|Glucocorticoids|glucocorticoids|mesh-ancestor
6108946|NCT01008410|Hormones|hormones|mesh-ancestor
6108947|NCT01008410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6108948|NCT01008423|Budesonide|budesonide|mesh-list
6108949|NCT01008423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6108950|NCT01008423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6108951|NCT01008423|Autonomic Agents|autonomic agents|mesh-ancestor
6108952|NCT01008423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6108953|NCT01008423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108954|NCT01008423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5527444|NCT04263402|Methylprednisolone|methylprednisolone|mesh-list
5527445|NCT04263402|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5527446|NCT04263402|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5527447|NCT04263402|Prednisolone|prednisolone|mesh-list
5527448|NCT04263402|Prednisolone acetate|prednisolone acetate|mesh-list
5527449|NCT04263402|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5527450|NCT04263402|Prednisolone phosphate|prednisolone phosphate|mesh-list
5527451|NCT04263402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5527452|NCT04263402|Antiemetics|antiemetics|mesh-ancestor
5527453|NCT04263402|Autonomic Agents|autonomic agents|mesh-ancestor
5527454|NCT04263402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5527455|NCT04263402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527456|NCT04263402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6108955|NCT01008423|Respiratory System Agents|respiratory system agents|mesh-ancestor
6108956|NCT01008423|Glucocorticoids|glucocorticoids|mesh-ancestor
6108957|NCT01008423|Hormones|hormones|mesh-ancestor
6108958|NCT01008423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6108959|NCT01008462|Cytarabine|cytarabine|mesh-list
6108960|NCT01008462|Mycophenolic Acid|mycophenolic acid|mesh-list
6108961|NCT01008462|Cyclophosphamide|cyclophosphamide|mesh-list
6108962|NCT01008462|Melphalan|melphalan|mesh-list
6108963|NCT01008462|Mechlorethamine|mechlorethamine|mesh-list
6108964|NCT01008462|Carmustine|carmustine|mesh-list
6108965|NCT01008462|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
6108966|NCT01008462|Fludarabine|fludarabine|mesh-list
6108967|NCT01008462|Fludarabine phosphate|fludarabine phosphate|mesh-list
6108968|NCT01008462|Etoposide|etoposide|mesh-list
6108969|NCT01008462|Etoposide phosphate|etoposide phosphate|mesh-list
6108970|NCT01008462|Podophyllotoxin|podophyllotoxin|mesh-list
6108971|NCT01008462|Tacrolimus|tacrolimus|mesh-list
6108972|NCT01008462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6108973|NCT01008462|Immunologic Factors|immunologic factors|mesh-ancestor
6108974|NCT01008462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6108975|NCT01008462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6108976|NCT01008462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6108977|NCT01008462|Alkylating Agents|alkylating agents|mesh-ancestor
6108978|NCT01008462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6108979|NCT01008462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6108980|NCT01008462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6108981|NCT01008462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6108982|NCT01008462|Antimetabolites|antimetabolites|mesh-ancestor
6108983|NCT01008462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6108984|NCT01008462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6108985|NCT01008462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6108986|NCT01008462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6108987|NCT01008462|Antiviral Agents|antiviral agents|mesh-ancestor
6108988|NCT01008462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6108989|NCT01008462|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6108990|NCT01008462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6108991|NCT01008462|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6108992|NCT01008462|Antitubercular Agents|antitubercular agents|mesh-ancestor
6108993|NCT01008462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5527457|NCT04263402|Glucocorticoids|glucocorticoids|mesh-ancestor
6108994|NCT01008462|Keratolytic Agents|keratolytic agents|mesh-ancestor
6108995|NCT01008462|Dermatologic Agents|dermatologic agents|mesh-ancestor
6108996|NCT01008462|Tubulin Modulators|tubulin modulators|mesh-ancestor
6108997|NCT01008462|Antimitotic Agents|antimitotic agents|mesh-ancestor
6108998|NCT01008462|Mitosis Modulators|mitosis modulators|mesh-ancestor
6108999|NCT01008475|Irinotecan|irinotecan|mesh-list
5527458|NCT04263402|Hormones|hormones|mesh-ancestor
5527459|NCT04263402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5527460|NCT04263402|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5527461|NCT04263402|Protective Agents|protective agents|mesh-ancestor
5527462|NCT04263402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6109000|NCT01008475|Cetuximab|cetuximab|mesh-list
6109001|NCT01008475|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6109002|NCT01008475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6109003|NCT01008475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6109004|NCT01008475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109005|NCT01008475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6109006|NCT01008475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6109007|NCT01008553|Fentanyl|fentanyl|mesh-list
6109008|NCT01008553|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6109009|NCT01008553|Narcotics|narcotics|mesh-ancestor
6109010|NCT01008553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6109011|NCT01008553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109012|NCT01008553|Analgesics|analgesics|mesh-ancestor
6109013|NCT01008553|Sensory System Agents|sensory system agents|mesh-ancestor
6109014|NCT01008553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6109015|NCT01008553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6109016|NCT01008553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6109017|NCT01008553|Anesthetics, General|anesthetics, general|mesh-ancestor
6109018|NCT01008553|Anesthetics|anesthetics|mesh-ancestor
6109019|NCT01008618|Fentanyl|fentanyl|mesh-list
6109020|NCT01008618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6109021|NCT01008618|Narcotics|narcotics|mesh-ancestor
6109022|NCT01008618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6109023|NCT01008618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109024|NCT01008618|Analgesics|analgesics|mesh-ancestor
6109025|NCT01008618|Sensory System Agents|sensory system agents|mesh-ancestor
6109026|NCT01008618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6109027|NCT01008618|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6109028|NCT01008618|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5527463|NCT04263402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5527464|NCT04263051|Nivolumab|nivolumab|mesh-list
5527465|NCT04263051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5527466|NCT04263051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5527467|NCT04263051|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5527468|NCT04263051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5527469|NCT04263298|Capecitabine|capecitabine|mesh-list
5527470|NCT04263298|Fulvestrant|fulvestrant|mesh-list
5527471|NCT04263298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5527472|NCT04263298|Antimetabolites|antimetabolites|mesh-ancestor
5527473|NCT04263298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5527474|NCT04263298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5527475|NCT04263298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5527476|NCT04263298|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6109029|NCT01008618|Anesthetics, General|anesthetics, general|mesh-ancestor
6109030|NCT01008618|Anesthetics|anesthetics|mesh-ancestor
6109031|NCT01008696|Rabeprazole|rabeprazole|mesh-list
6109032|NCT01008696|Lansoprazole|lansoprazole|mesh-list
6109033|NCT01008696|Dexlansoprazole|dexlansoprazole|mesh-list
6109034|NCT01008696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6109035|NCT01008696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6109036|NCT01008696|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6109037|NCT01008696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6109038|NCT01008696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109039|NCT01008748|Nicotine|nicotine|mesh-list
6109040|NCT01008748|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6109041|NCT01008748|Autonomic Agents|autonomic agents|mesh-ancestor
6109042|NCT01008748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6109043|NCT01008748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109044|NCT01008748|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6109045|NCT01008748|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6109046|NCT01008748|Cholinergic Agents|cholinergic agents|mesh-ancestor
6109047|NCT01008748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6109048|NCT01008748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109049|NCT01008904|Magnesium Oxide|magnesium oxide|mesh-list
6109050|NCT01008904|Antacids|antacids|mesh-ancestor
6109051|NCT01008904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109052|NCT01008904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6109053|NCT01008995|Ustekinumab|ustekinumab|mesh-list
6109054|NCT01008995|Dermatologic Agents|dermatologic agents|mesh-ancestor
6204123|NCT02065713|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6204124|NCT02065713|Abortifacient Agents|abortifacient agents|mesh-ancestor
5527477|NCT04263298|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5527478|NCT04263298|Hormone Antagonists|hormone antagonists|mesh-ancestor
5527479|NCT04263298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5527480|NCT04263298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527481|NCT04263064|Clonidine|clonidine|mesh-list
5527482|NCT04263064|Analgesics|analgesics|mesh-ancestor
5527483|NCT04263064|Sensory System Agents|sensory system agents|mesh-ancestor
5527484|NCT04263064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5527485|NCT04263064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527486|NCT04263064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5527487|NCT04263064|Sympatholytics|sympatholytics|mesh-ancestor
6204125|NCT02065713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6204126|NCT02065713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204127|NCT02065713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6204128|NCT02065713|Antimetabolites|antimetabolites|mesh-ancestor
6204129|NCT02065713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204130|NCT02065713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6204131|NCT02065713|Dermatologic Agents|dermatologic agents|mesh-ancestor
6204132|NCT02065713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6204133|NCT02065713|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6204134|NCT02065713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6204135|NCT02065713|Immunologic Factors|immunologic factors|mesh-ancestor
6204136|NCT02065713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6204137|NCT02065713|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6204138|NCT02065713|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6204139|NCT02065713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6204140|NCT02065791|Canagliflozin|canagliflozin|mesh-list
6204141|NCT02065791|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6204142|NCT02065791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204143|NCT02065791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6204144|NCT02065791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204145|NCT02066129|Fluticasone|fluticasone|mesh-list
6204146|NCT02066129|Xhance|xhance|mesh-list
6204147|NCT02066129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6204148|NCT02066129|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6204149|NCT02066129|Autonomic Agents|autonomic agents|mesh-ancestor
6204150|NCT02066129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6204151|NCT02066129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204152|NCT02066129|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6204153|NCT02066129|Respiratory System Agents|respiratory system agents|mesh-ancestor
6204154|NCT02066129|Dermatologic Agents|dermatologic agents|mesh-ancestor
6204155|NCT02066129|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6204156|NCT02066298|Mometasone Furoate|mometasone furoate|mesh-list
6204157|NCT02066298|Tiotropium Bromide|tiotropium bromide|mesh-list
6204158|NCT02066298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6204159|NCT02066298|Autonomic Agents|autonomic agents|mesh-ancestor
6204160|NCT02066298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6204161|NCT02066298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204162|NCT02066298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6204163|NCT02066298|Respiratory System Agents|respiratory system agents|mesh-ancestor
6204164|NCT02066298|Parasympatholytics|parasympatholytics|mesh-ancestor
5527488|NCT04263064|Autonomic Agents|autonomic agents|mesh-ancestor
5527489|NCT04263064|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5527490|NCT04263064|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5527491|NCT04263064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5527492|NCT04263064|Adrenergic Agents|adrenergic agents|mesh-ancestor
5527493|NCT04263064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5527494|NCT04263064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204165|NCT02066298|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6204166|NCT02066298|Cholinergic Agents|cholinergic agents|mesh-ancestor
6204167|NCT02066298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6204168|NCT02066298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204169|NCT02066298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6204170|NCT02066298|Dermatologic Agents|dermatologic agents|mesh-ancestor
6204171|NCT02066298|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6204172|NCT02066311|Nelfinavir|nelfinavir|mesh-list
6204173|NCT02066311|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6204174|NCT02066311|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6204175|NCT02066311|Protease Inhibitors|protease inhibitors|mesh-ancestor
6204176|NCT02066311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5601389|NCT03705533|Telmisartan|telmisartan|mesh-list
6109055|NCT01009047|Aripiprazole|aripiprazole|mesh-list
6109056|NCT01009047|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6109057|NCT01009047|Antidepressive Agents|antidepressive agents|mesh-ancestor
6109058|NCT01009047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6109059|NCT01009047|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6109060|NCT01009047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6109061|NCT01009047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6109062|NCT01009047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109063|NCT01009047|Dopamine Agonists|dopamine agonists|mesh-ancestor
6109064|NCT01009047|Dopamine Agents|dopamine agents|mesh-ancestor
6109065|NCT01009047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6109066|NCT01009047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109067|NCT01009047|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6109068|NCT01009047|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6109069|NCT01009047|Serotonin Agents|serotonin agents|mesh-ancestor
6109070|NCT01009047|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6109071|NCT01009047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6109072|NCT01009047|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6109073|NCT01009047|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6109074|NCT01009086|Ustekinumab|ustekinumab|mesh-list
6109075|NCT01009086|Dermatologic Agents|dermatologic agents|mesh-ancestor
6109076|NCT01009203|Sirolimus|sirolimus|mesh-list
6109077|NCT01009203|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6109078|NCT01009203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6109079|NCT01009203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6109080|NCT01009203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6109081|NCT01009203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109082|NCT01009203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6109083|NCT01009203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6109084|NCT01009203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6109085|NCT01009203|Antifungal Agents|antifungal agents|mesh-ancestor
6109086|NCT01009203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5527495|NCT04262999|Levetiracetam|levetiracetam|mesh-list
5527496|NCT04262999|Valproic Acid|valproic acid|mesh-list
5527497|NCT04262999|Anticonvulsants|anticonvulsants|mesh-ancestor
5527498|NCT04262999|Nootropic Agents|nootropic agents|mesh-ancestor
5527499|NCT04262999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5527500|NCT04262999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5527501|NCT04262999|GABA Agents|gaba agents|mesh-ancestor
5527502|NCT04262999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5527503|NCT04262999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527504|NCT04262999|Antimanic Agents|antimanic agents|mesh-ancestor
6109087|NCT01009203|Immunologic Factors|immunologic factors|mesh-ancestor
6109088|NCT01009203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109089|NCT01009346|Cisplatin|cisplatin|mesh-list
6109090|NCT01009346|Carboplatin|carboplatin|mesh-list
6109091|NCT01009346|Cetuximab|cetuximab|mesh-list
6109092|NCT01009346|Everolimus|everolimus|mesh-list
6109093|NCT01009346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6109094|NCT01009346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6109095|NCT01009346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6109096|NCT01009346|Immunologic Factors|immunologic factors|mesh-ancestor
6109097|NCT01009346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109098|NCT01009515|Paclitaxel|paclitaxel|mesh-list
6109099|NCT01009515|Carboplatin|carboplatin|mesh-list
6109100|NCT01009515|Temozolomide|temozolomide|mesh-list
6109101|NCT01009515|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6109102|NCT01009515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6109103|NCT01009515|Tubulin Modulators|tubulin modulators|mesh-ancestor
6109104|NCT01009515|Antimitotic Agents|antimitotic agents|mesh-ancestor
6109105|NCT01009515|Mitosis Modulators|mitosis modulators|mesh-ancestor
6109106|NCT01009515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109107|NCT01009515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6109108|NCT01009515|Alkylating Agents|alkylating agents|mesh-ancestor
6109109|NCT01009554|Listerine|listerine|mesh-list
6109110|NCT01009554|Fluorides|fluorides|mesh-list
6109111|NCT01009554|Sodium Fluoride|sodium fluoride|mesh-list
6109112|NCT01009554|Cariostatic Agents|cariostatic agents|mesh-ancestor
6109113|NCT01009554|Protective Agents|protective agents|mesh-ancestor
6109114|NCT01009554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109115|NCT01009554|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6109116|NCT01009554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6109117|NCT01009580|Insulin|insulin|mesh-list
5527505|NCT04262999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6109118|NCT01009580|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6109119|NCT01009580|Insulin Aspart|insulin aspart|mesh-list
6109120|NCT01009580|Insulin, Long-Acting|insulin, long-acting|mesh-list
6666003|NCT01520116|Adrenergic Agents|adrenergic agents|mesh-ancestor
6109121|NCT01009580|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6109122|NCT01009580|Biphasic Insulins|biphasic insulins|mesh-list
5527506|NCT04262999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5527507|NCT04262999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5527508|NCT04262934|Vitamin D|vitamin d|mesh-list
5527509|NCT04262934|Cholecalciferol|cholecalciferol|mesh-list
5527510|NCT04262934|Vitamins|vitamins|mesh-ancestor
5527511|NCT04262934|Micronutrients|micronutrients|mesh-ancestor
6109123|NCT01009580|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6109124|NCT01009580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5527512|NCT04262934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527513|NCT04262934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5527514|NCT04262934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5527515|NCT04262635|Capecitabine|capecitabine|mesh-list
5527516|NCT04262635|Cetuximab|cetuximab|mesh-list
5527517|NCT04262635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5527518|NCT04262635|Antimetabolites|antimetabolites|mesh-ancestor
5527519|NCT04262635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109125|NCT01009580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109126|NCT01009619|Azithromycin|azithromycin|mesh-list
6109127|NCT01009619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6109128|NCT01009619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6109129|NCT01009814|Ritonavir|ritonavir|mesh-list
6109130|NCT01009814|Fostemsavir|fostemsavir|mesh-list
6109131|NCT01009814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6109132|NCT01009814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6109133|NCT01009814|Protease Inhibitors|protease inhibitors|mesh-ancestor
6109134|NCT01009814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6109135|NCT01009814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109136|NCT01009814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6109137|NCT01009814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6109138|NCT01009814|Antiviral Agents|antiviral agents|mesh-ancestor
6109139|NCT01009814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6109140|NCT01009814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6109141|NCT01009814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6109142|NCT01009814|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6109143|NCT01009814|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6109144|NCT01009840|Bortezomib|bortezomib|mesh-list
6109145|NCT01009840|Busulfan|busulfan|mesh-list
5527520|NCT04262635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5527521|NCT04262635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5527522|NCT04262661|Insulin Glargine|insulin glargine|mesh-list
5527523|NCT04262661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5527524|NCT04262661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527525|NCT04262817|Nicotine|nicotine|mesh-list
5527526|NCT04262817|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5527527|NCT04262817|Autonomic Agents|autonomic agents|mesh-ancestor
5527528|NCT04262817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5527529|NCT04262817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527530|NCT04262817|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5527531|NCT04262817|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5527532|NCT04262817|Cholinergic Agents|cholinergic agents|mesh-ancestor
5527533|NCT04262817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5527534|NCT04262817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5527535|NCT04262843|Vidarabine|vidarabine|mesh-list
5725347|NCT03180879|Analgesics|analgesics|mesh-ancestor
5725348|NCT03180879|Sensory System Agents|sensory system agents|mesh-ancestor
5725349|NCT03180879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5725350|NCT03180879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725351|NCT03180879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5725352|NCT03180879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5725353|NCT03180879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5725354|NCT03180879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5725355|NCT03180879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725356|NCT03180944|Lugol's solution|lugol's solution|mesh-list
5725357|NCT03180944|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6109146|NCT01009840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6109147|NCT01009840|Alkylating Agents|alkylating agents|mesh-ancestor
6109148|NCT01009840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109149|NCT01009840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6109150|NCT01009840|Immunologic Factors|immunologic factors|mesh-ancestor
6109151|NCT01009840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109152|NCT01009840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6109153|NCT01009840|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6109154|NCT01009918|Carvedilol|carvedilol|mesh-list
6109155|NCT01009918|Lisinopril|lisinopril|mesh-list
6109156|NCT01009918|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6109157|NCT01009918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6109158|NCT01009918|Adrenergic Agents|adrenergic agents|mesh-ancestor
6109159|NCT01009918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6109160|NCT01009918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109161|NCT01009918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109162|NCT01009918|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6109163|NCT01009918|Antioxidants|antioxidants|mesh-ancestor
6109164|NCT01009918|Protective Agents|protective agents|mesh-ancestor
5527536|NCT04262843|Mycophenolic Acid|mycophenolic acid|mesh-list
5527537|NCT04262843|Cyclophosphamide|cyclophosphamide|mesh-list
6109165|NCT01009918|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6109166|NCT01009918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6109167|NCT01009918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6109168|NCT01009918|Vasodilator Agents|vasodilator agents|mesh-ancestor
6109169|NCT01009918|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6109170|NCT01009918|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6109171|NCT01009918|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6109172|NCT01009918|Protease Inhibitors|protease inhibitors|mesh-ancestor
6109173|NCT01009918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6109174|NCT01009918|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6109175|NCT01009983|Paclitaxel|paclitaxel|mesh-list
6109176|NCT01009983|Carboplatin|carboplatin|mesh-list
6109177|NCT01009983|Panitumumab|panitumumab|mesh-list
6109178|NCT01009983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6109179|NCT01009983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6109180|NCT01009983|Tubulin Modulators|tubulin modulators|mesh-ancestor
6109181|NCT01009983|Antimitotic Agents|antimitotic agents|mesh-ancestor
6109182|NCT01009983|Mitosis Modulators|mitosis modulators|mesh-ancestor
5527538|NCT04262843|Fludarabine|fludarabine|mesh-list
5527539|NCT04262843|Fludarabine phosphate|fludarabine phosphate|mesh-list
5527540|NCT04262843|Tacrolimus|tacrolimus|mesh-list
5527541|NCT04262843|Lenograstim|lenograstim|mesh-list
6109183|NCT01009983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109184|NCT01009983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6109185|NCT01010009|Resveratrol|resveratrol|mesh-list
6109186|NCT01010009|Antioxidants|antioxidants|mesh-ancestor
6109187|NCT01010009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109188|NCT01010009|Protective Agents|protective agents|mesh-ancestor
6109189|NCT01010009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109190|NCT01010009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6109191|NCT01010009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6109192|NCT01010061|Rituximab|rituximab|mesh-list
6109193|NCT01010061|Obinutuzumab|obinutuzumab|mesh-list
6109194|NCT01010061|Chlorambucil|chlorambucil|mesh-list
6109195|NCT01010061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6109196|NCT01010061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6109197|NCT01010061|Immunologic Factors|immunologic factors|mesh-ancestor
6109198|NCT01010061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109199|NCT01010061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6109200|NCT01010061|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6109201|NCT01010061|Alkylating Agents|alkylating agents|mesh-ancestor
6109202|NCT01010061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109203|NCT01010126|Sirolimus|sirolimus|mesh-list
6109204|NCT01010126|Bevacizumab|bevacizumab|mesh-list
6109205|NCT01010126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6109206|NCT01010126|Endothelial Growth Factors|endothelial growth factors|mesh-list
6109207|NCT01010126|Antibodies|antibodies|mesh-list
6109208|NCT01010126|Immunoglobulins|immunoglobulins|mesh-list
6109209|NCT01010126|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6109210|NCT01010126|Immunoglobulin G|immunoglobulin g|mesh-list
6109211|NCT01010126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6109212|NCT01010126|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6109213|NCT01010126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5527542|NCT04262843|Sargramostim|sargramostim|mesh-list
5725358|NCT03180944|Hemostatics|hemostatics|mesh-ancestor
6109214|NCT01010126|Growth Substances|growth substances|mesh-ancestor
6109215|NCT01010126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527543|NCT04262843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6109216|NCT01010126|Growth Inhibitors|growth inhibitors|mesh-ancestor
6109217|NCT01010126|Immunologic Factors|immunologic factors|mesh-ancestor
6109218|NCT01010126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6109219|NCT01010126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6109220|NCT01010126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6109221|NCT01010126|Antifungal Agents|antifungal agents|mesh-ancestor
6109222|NCT01010126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6109223|NCT01010204|Varenicline|varenicline|mesh-list
6109224|NCT01010204|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6109225|NCT01010204|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6109226|NCT01010204|Cholinergic Agents|cholinergic agents|mesh-ancestor
6109227|NCT01010204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5527544|NCT04262843|Immunologic Factors|immunologic factors|mesh-ancestor
5527545|NCT04262843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527546|NCT04262843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5527547|NCT04262843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5527548|NCT04262843|Alkylating Agents|alkylating agents|mesh-ancestor
5527549|NCT04262843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5527550|NCT04262843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5527551|NCT04262843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5527552|NCT04262843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5527553|NCT04262843|Antimetabolites|antimetabolites|mesh-ancestor
5527554|NCT04262843|Antiviral Agents|antiviral agents|mesh-ancestor
5527555|NCT04262843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5527556|NCT04262843|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5527557|NCT04262843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5527558|NCT04262843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5527559|NCT04262843|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6109228|NCT01010204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109229|NCT01010204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109230|NCT01010217|Vidarabine|vidarabine|mesh-list
6109231|NCT01010217|Mycophenolic Acid|mycophenolic acid|mesh-list
6109232|NCT01010217|Cyclophosphamide|cyclophosphamide|mesh-list
6109233|NCT01010217|Melphalan|melphalan|mesh-list
6109234|NCT01010217|Thiotepa|thiotepa|mesh-list
5527560|NCT04262843|Antitubercular Agents|antitubercular agents|mesh-ancestor
5527561|NCT04262843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5527562|NCT04262843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5527563|NCT04262765|Amlodipine|amlodipine|mesh-list
5527564|NCT04262765|Ramipril|ramipril|mesh-list
5527565|NCT04262765|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
5527566|NCT04262765|Atorvastatin|atorvastatin|mesh-list
5527567|NCT04262765|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5527568|NCT04262765|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5527569|NCT04262765|Antimetabolites|antimetabolites|mesh-ancestor
5527570|NCT04262765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109235|NCT01010217|Rituximab|rituximab|mesh-list
6109236|NCT01010217|Fludarabine|fludarabine|mesh-list
6109237|NCT01010217|Fludarabine phosphate|fludarabine phosphate|mesh-list
6109238|NCT01010217|Tacrolimus|tacrolimus|mesh-list
6109239|NCT01010217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6109240|NCT01010217|Immunologic Factors|immunologic factors|mesh-ancestor
6109241|NCT01010217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666004|NCT01520116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6666005|NCT01520116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666006|NCT01520116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666007|NCT01520116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6666008|NCT01520116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6666009|NCT01520181|Lactams|lactams|mesh-list
6666010|NCT01520181|beta-Lactams|beta-lactams|mesh-list
6666011|NCT01520181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6666012|NCT01520181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6666013|NCT01520285|Felodipine|felodipine|mesh-list
5527571|NCT04262765|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5527572|NCT04262765|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5527573|NCT04262765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5527574|NCT04262765|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5527575|NCT04262765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5527576|NCT04262765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5527577|NCT04262765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6109242|NCT01010217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6109243|NCT01010217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6666014|NCT01520285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5527578|NCT04262765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527579|NCT04262765|Vasodilator Agents|vasodilator agents|mesh-ancestor
5527580|NCT04262765|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5527581|NCT04262765|Protease Inhibitors|protease inhibitors|mesh-ancestor
5527582|NCT04262804|Gemcitabine|gemcitabine|mesh-list
5527583|NCT04262804|Capecitabine|capecitabine|mesh-list
5527584|NCT04262804|Trastuzumab|trastuzumab|mesh-list
5527585|NCT04262804|Vinorelbine|vinorelbine|mesh-list
5527586|NCT04262804|Margetuximab|margetuximab|mesh-list
5527587|NCT04262804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5527588|NCT04262804|Antimetabolites|antimetabolites|mesh-ancestor
5527589|NCT04262804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5527590|NCT04262804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5527591|NCT04262804|Antiviral Agents|antiviral agents|mesh-ancestor
5527592|NCT04262804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5527593|NCT04262804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5527594|NCT04262804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5527595|NCT04262804|Immunologic Factors|immunologic factors|mesh-ancestor
5527596|NCT04262804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527597|NCT04262804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5527598|NCT04262804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5527599|NCT04262804|Tubulin Modulators|tubulin modulators|mesh-ancestor
5527600|NCT04262804|Antimitotic Agents|antimitotic agents|mesh-ancestor
5527601|NCT04262804|Mitosis Modulators|mitosis modulators|mesh-ancestor
5527602|NCT04262687|Bevacizumab|bevacizumab|mesh-list
5527603|NCT04262687|Pembrolizumab|pembrolizumab|mesh-list
5527604|NCT04262687|Capecitabine|capecitabine|mesh-list
5527605|NCT04262687|Oxaliplatin|oxaliplatin|mesh-list
5527606|NCT04262687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5527607|NCT04262687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5527608|NCT04262687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5527609|NCT04262687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5527610|NCT04262687|Growth Substances|growth substances|mesh-ancestor
5527611|NCT04262687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527612|NCT04262687|Growth Inhibitors|growth inhibitors|mesh-ancestor
5527613|NCT04262687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5527614|NCT04262687|Antimetabolites|antimetabolites|mesh-ancestor
5527615|NCT04262687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5527616|NCT04262492|Rivaroxaban|rivaroxaban|mesh-list
5527617|NCT04262492|Apixaban|apixaban|mesh-list
5527618|NCT04262492|Edoxaban|edoxaban|mesh-list
6666015|NCT01520285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6666016|NCT01520285|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6666017|NCT01520285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6109244|NCT01010217|Alkylating Agents|alkylating agents|mesh-ancestor
6109245|NCT01010217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109246|NCT01010217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6109247|NCT01010217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6109248|NCT01010217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6109249|NCT01010217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6109250|NCT01010217|Antimetabolites|antimetabolites|mesh-ancestor
6109251|NCT01010217|Antiviral Agents|antiviral agents|mesh-ancestor
6109252|NCT01010217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6109253|NCT01010217|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5527619|NCT04262492|Dabigatran|dabigatran|mesh-list
5527620|NCT04262492|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5527621|NCT04262492|Antithrombins|antithrombins|mesh-ancestor
5527622|NCT04262492|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5527623|NCT04262492|Protease Inhibitors|protease inhibitors|mesh-ancestor
6109254|NCT01010217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6109255|NCT01010217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6109256|NCT01010217|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6109257|NCT01010217|Antitubercular Agents|antitubercular agents|mesh-ancestor
6109258|NCT01010217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6109259|NCT01010282|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6109260|NCT01010282|Lubricant Eye Drops|lubricant eye drops|mesh-list
6109261|NCT01010282|Glycerol|glycerol|mesh-list
6109262|NCT01010282|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6109263|NCT01010282|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6109264|NCT01010282|Laxatives|laxatives|mesh-ancestor
6109265|NCT01010282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6109266|NCT01010282|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6109267|NCT01010282|Protective Agents|protective agents|mesh-ancestor
5527624|NCT04262492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6666018|NCT01520285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5527625|NCT04262492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5527626|NCT04262492|Anticoagulants|anticoagulants|mesh-ancestor
5527627|NCT04262388|Durvalumab|durvalumab|mesh-list
5527628|NCT04262388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5527629|NCT04262388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5527630|NCT04262375|Durvalumab|durvalumab|mesh-list
5527631|NCT04262375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5527632|NCT04262375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5527633|NCT04262336|Sodium thiosulfate|sodium thiosulfate|mesh-list
5527634|NCT04262336|Hyaluronic Acid|hyaluronic acid|mesh-list
5527635|NCT04262336|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5527636|NCT04262336|Immunologic Factors|immunologic factors|mesh-ancestor
5527637|NCT04262336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527638|NCT04262336|Viscosupplements|viscosupplements|mesh-ancestor
5527639|NCT04262336|Protective Agents|protective agents|mesh-ancestor
5527640|NCT04262336|Antidotes|antidotes|mesh-ancestor
5527641|NCT04262336|Antioxidants|antioxidants|mesh-ancestor
5527642|NCT04262336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5527643|NCT04262336|Antitubercular Agents|antitubercular agents|mesh-ancestor
5527644|NCT04262336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5527645|NCT04262336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5527646|NCT04262336|Chelating Agents|chelating agents|mesh-ancestor
5527647|NCT04262336|Sequestering Agents|sequestering agents|mesh-ancestor
5527648|NCT04262193|Suvorexant|suvorexant|mesh-list
5527649|NCT04262193|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5527650|NCT04262193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5527651|NCT04262193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5527652|NCT04262193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527653|NCT04262193|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
6109268|NCT01010282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109269|NCT01010399|Ritonavir|ritonavir|mesh-list
6109270|NCT01010399|Fosamprenavir|fosamprenavir|mesh-list
6109271|NCT01010399|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6109272|NCT01010399|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6109273|NCT01010399|Protease Inhibitors|protease inhibitors|mesh-ancestor
6109274|NCT01010399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6109275|NCT01010399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109276|NCT01010399|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6109277|NCT01010399|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6109278|NCT01010399|Antiviral Agents|antiviral agents|mesh-ancestor
6109279|NCT01010399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6109280|NCT01010399|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6109281|NCT01010399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6109282|NCT01010477|Nicotine|nicotine|mesh-list
6109283|NCT01010477|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6109284|NCT01010477|Autonomic Agents|autonomic agents|mesh-ancestor
6109285|NCT01010477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6109286|NCT01010477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109287|NCT01010477|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6109288|NCT01010477|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6109289|NCT01010477|Cholinergic Agents|cholinergic agents|mesh-ancestor
6109290|NCT01010477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6109291|NCT01010477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109292|NCT01010568|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6109293|NCT01010568|Ofatumumab|ofatumumab|mesh-list
6109294|NCT01010568|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6109295|NCT01010568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6109296|NCT01010568|Alkylating Agents|alkylating agents|mesh-ancestor
6109297|NCT01010568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109298|NCT01010568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6109299|NCT01010568|Immunologic Factors|immunologic factors|mesh-ancestor
6109300|NCT01010568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109301|NCT01010633|Loteprednol Etabonate|loteprednol etabonate|mesh-list
6109302|NCT01010633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6109303|NCT01010750|Amphetamine|amphetamine|mesh-list
6109304|NCT01010750|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6109305|NCT01010750|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6109306|NCT01010750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109307|NCT01010750|Sympathomimetics|sympathomimetics|mesh-ancestor
6109308|NCT01010750|Autonomic Agents|autonomic agents|mesh-ancestor
6109309|NCT01010750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6109310|NCT01010750|Dopamine Agents|dopamine agents|mesh-ancestor
6109311|NCT01010750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6109312|NCT01010750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109313|NCT01010750|Adrenergic Agents|adrenergic agents|mesh-ancestor
5527654|NCT04262193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6109314|NCT01010750|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6109315|NCT01010750|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6109316|NCT01010750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6109317|NCT01010750|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6109318|NCT01010776|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6109319|NCT01010776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6109320|NCT01010776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6109321|NCT01010776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6109322|NCT01010776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109323|NCT01010776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6109324|NCT01010776|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6109325|NCT01010776|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6109326|NCT01010776|Serotonin Agents|serotonin agents|mesh-ancestor
6109327|NCT01010776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6109328|NCT01010776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109329|NCT01010776|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6109330|NCT01010776|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6109331|NCT01010776|Dopamine Agents|dopamine agents|mesh-ancestor
6109332|NCT01010932|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
6109333|NCT01010932|Chelating Agents|chelating agents|mesh-ancestor
6109334|NCT01010932|Sequestering Agents|sequestering agents|mesh-ancestor
6109335|NCT01010932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109336|NCT01010971|Ciclesonide|ciclesonide|mesh-list
6109337|NCT01010971|Glucocorticoids|glucocorticoids|mesh-ancestor
6109338|NCT01010971|Hormones|hormones|mesh-ancestor
6109339|NCT01010971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6109340|NCT01010971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109341|NCT01010971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6109342|NCT01010984|Doxorubicin|doxorubicin|mesh-list
6109343|NCT01010984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6109344|NCT01010984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6109345|NCT01010984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6109346|NCT01010984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6109347|NCT01010984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6109348|NCT01010984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109349|NCT01011049|Vaccines|vaccines|mesh-list
6109350|NCT01011049|Immunologic Factors|immunologic factors|mesh-ancestor
6109351|NCT01011049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109352|NCT01011075|Paclitaxel|paclitaxel|mesh-list
6109353|NCT01011075|Imatinib Mesylate|imatinib mesylate|mesh-list
6109354|NCT01011075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6109355|NCT01011075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6109356|NCT01011075|Tubulin Modulators|tubulin modulators|mesh-ancestor
6109357|NCT01011075|Antimitotic Agents|antimitotic agents|mesh-ancestor
6109358|NCT01011075|Mitosis Modulators|mitosis modulators|mesh-ancestor
6109359|NCT01011075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109360|NCT01011075|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6109361|NCT01011075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6109362|NCT01011218|Modafinil|modafinil|mesh-list
6109363|NCT01011218|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5527655|NCT04262193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109364|NCT01011218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109365|NCT01011218|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6109366|NCT01011218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6109367|NCT01011218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6109368|NCT01011218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109369|NCT01011283|Azacitidine|azacitidine|mesh-list
6109370|NCT01011283|Decitabine|decitabine|mesh-list
6109371|NCT01011283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6109372|NCT01011283|Antimetabolites|antimetabolites|mesh-ancestor
6109373|NCT01011283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109374|NCT01011283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6109375|NCT01011283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5527656|NCT04262206|Atorvastatin|atorvastatin|mesh-list
5527657|NCT04262206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5527658|NCT04262206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5527659|NCT04262206|Antimetabolites|antimetabolites|mesh-ancestor
5527660|NCT04262206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5527661|NCT04262206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5527662|NCT04262206|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5527663|NCT04262206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5527664|NCT04262089|Pembrolizumab|pembrolizumab|mesh-list
5527665|NCT04262089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5527666|NCT04262089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5527667|NCT04261790|Ocrelizumab|ocrelizumab|mesh-list
5527668|NCT04261790|Immunologic Factors|immunologic factors|mesh-ancestor
5527669|NCT04261790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527670|NCT04261907|Ritonavir|ritonavir|mesh-list
5527671|NCT04261907|Lopinavir|lopinavir|mesh-list
5527672|NCT04261907|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5527673|NCT04261907|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5527674|NCT04261907|Protease Inhibitors|protease inhibitors|mesh-ancestor
5527675|NCT04261907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5527676|NCT04261907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5527677|NCT04261907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6109376|NCT01011309|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
6109377|NCT01011309|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6109378|NCT01011309|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6109379|NCT01011309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6109380|NCT01011309|Schistosomicides|schistosomicides|mesh-ancestor
6109381|NCT01011309|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6109382|NCT01011309|Anthelmintics|anthelmintics|mesh-ancestor
6109383|NCT01011413|Efavirenz|efavirenz|mesh-list
6109384|NCT01011413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6109385|NCT01011413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6109386|NCT01011413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6109387|NCT01011413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109388|NCT01011413|Antiviral Agents|antiviral agents|mesh-ancestor
6109389|NCT01011413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6109390|NCT01011413|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6109391|NCT01011413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6109392|NCT01011413|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6109393|NCT01011413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6109394|NCT01011413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6109395|NCT01011413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6109396|NCT01011439|Maleic acid|maleic acid|mesh-list
5527678|NCT04261907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5527679|NCT04261907|Antiviral Agents|antiviral agents|mesh-ancestor
5527680|NCT04261907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5527681|NCT04261907|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5527682|NCT04261907|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5527683|NCT04261855|Avelumab|avelumab|mesh-list
5527684|NCT04261855|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
5527685|NCT04261855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5527686|NCT04261855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5527687|NCT04261855|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5527688|NCT04261855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5527689|NCT04261634|Mitogens|mitogens|mesh-list
6109397|NCT01011439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6109398|NCT01011439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109399|NCT01011465|Oxytocin|oxytocin|mesh-list
6109400|NCT01011465|Oxytocics|oxytocics|mesh-ancestor
6109401|NCT01011465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6109402|NCT01011465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527690|NCT04261634|Mitosis Modulators|mitosis modulators|mesh-ancestor
6109403|NCT01011556|Teriparatide|teriparatide|mesh-list
6109404|NCT01011556|Hormones|hormones|mesh-list
6109405|NCT01011556|Parathyroid Hormone|parathyroid hormone|mesh-list
6109406|NCT01011556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6109407|NCT01011556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109408|NCT01011556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6109409|NCT01011556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6109410|NCT01011673|Ketorolac|ketorolac|mesh-list
6109411|NCT01011673|Metoclopramide|metoclopramide|mesh-list
6109412|NCT01011673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5527691|NCT04261634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5527692|NCT04261426|Immunoglobulins|immunoglobulins|mesh-list
5527693|NCT04261426|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5527694|NCT04261426|Antibodies|antibodies|mesh-list
5527695|NCT04261426|gamma-Globulins|gamma-globulins|mesh-list
6109413|NCT01011673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6109414|NCT01011673|Analgesics|analgesics|mesh-ancestor
6109415|NCT01011673|Sensory System Agents|sensory system agents|mesh-ancestor
6109416|NCT01011673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6109417|NCT01011673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109418|NCT01011673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6109419|NCT01011673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6109420|NCT01011673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6109421|NCT01011673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6109422|NCT01011673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5527696|NCT04261426|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5527697|NCT04261426|Immunologic Factors|immunologic factors|mesh-ancestor
5527698|NCT04261426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527699|NCT04261478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
5527700|NCT04261465|Paclitaxel|paclitaxel|mesh-list
5527701|NCT04261465|Carboplatin|carboplatin|mesh-list
5527702|NCT04261465|Olaparib|olaparib|mesh-list
5527703|NCT04261465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5527704|NCT04261465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5527705|NCT04261465|Tubulin Modulators|tubulin modulators|mesh-ancestor
5527706|NCT04261465|Antimitotic Agents|antimitotic agents|mesh-ancestor
5527707|NCT04261465|Mitosis Modulators|mitosis modulators|mesh-ancestor
5527708|NCT04261465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5527709|NCT04261465|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5527710|NCT04261465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5527711|NCT04261517|Hydroxychloroquine|hydroxychloroquine|mesh-list
5527712|NCT04261517|Antimalarials|antimalarials|mesh-ancestor
5527713|NCT04261517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5527714|NCT04261517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5527715|NCT04261517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5527716|NCT04261517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5527717|NCT04261517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5527718|NCT04261517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5601390|NCT03705533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5601391|NCT03705533|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5601392|NCT03705533|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5601393|NCT03705533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601394|NCT05177666|Trastuzumab|trastuzumab|mesh-list
5601395|NCT05177666|Pertuzumab|pertuzumab|mesh-list
5601396|NCT05177666|Vemurafenib|vemurafenib|mesh-list
5601397|NCT05177666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5601398|NCT05177666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5601399|NCT05177666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5601400|NCT05177666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5601401|NCT05177666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601402|NCT05177614|Micronutrients|micronutrients|mesh-list
5601403|NCT05177614|Trace Elements|trace elements|mesh-list
5601404|NCT05177614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527719|NCT04261270|Ritonavir|ritonavir|mesh-list
5527720|NCT04261270|Oseltamivir|oseltamivir|mesh-list
6109423|NCT01011673|Antiemetics|antiemetics|mesh-ancestor
6109424|NCT01011673|Autonomic Agents|autonomic agents|mesh-ancestor
6109425|NCT01011673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6109426|NCT01011673|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6109427|NCT01011673|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6109428|NCT01011673|Dopamine Agents|dopamine agents|mesh-ancestor
6109429|NCT01011673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6109430|NCT01011816|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6109431|NCT01011816|Hemostatics|hemostatics|mesh-ancestor
6109432|NCT01011816|Coagulants|coagulants|mesh-ancestor
6109433|NCT01011829|Varenicline|varenicline|mesh-list
6109434|NCT01011829|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6109435|NCT01011829|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6109436|NCT01011829|Cholinergic Agents|cholinergic agents|mesh-ancestor
6109437|NCT01011829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6109438|NCT01011829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109439|NCT01011829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109440|NCT01011868|Empagliflozin|empagliflozin|mesh-list
6109441|NCT01011868|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6109442|NCT01011868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109443|NCT01011868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6109444|NCT01011868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109445|NCT01011894|Lenalidomide|lenalidomide|mesh-list
6109446|NCT01011894|Immunologic Factors|immunologic factors|mesh-ancestor
6109447|NCT01011894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109448|NCT01011894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6109449|NCT01011894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6109450|NCT01011894|Growth Substances|growth substances|mesh-ancestor
6109451|NCT01011894|Growth Inhibitors|growth inhibitors|mesh-ancestor
6109452|NCT01011894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6109453|NCT01011907|Varenicline|varenicline|mesh-list
6109454|NCT01011907|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6109455|NCT01011907|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6109456|NCT01011907|Cholinergic Agents|cholinergic agents|mesh-ancestor
6109457|NCT01011907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6109458|NCT01011907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109459|NCT01011907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109460|NCT01012037|Linagliptin|linagliptin|mesh-list
5527721|NCT04261270|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5527722|NCT04261270|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5527723|NCT04261270|Protease Inhibitors|protease inhibitors|mesh-ancestor
5527724|NCT04261270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5527725|NCT04261270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109461|NCT01012037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6109462|NCT01012037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109463|NCT01012037|Incretins|incretins|mesh-ancestor
6109464|NCT01012037|Hormones|hormones|mesh-ancestor
6109465|NCT01012037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6109466|NCT01012037|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6109467|NCT01012037|Protease Inhibitors|protease inhibitors|mesh-ancestor
6109468|NCT01012037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6109469|NCT01012037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109470|NCT01012089|Daptomycin|daptomycin|mesh-list
6109471|NCT01012089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6109472|NCT01012089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6109473|NCT01012219|Aspirin|aspirin|mesh-list
6109474|NCT01012219|Niacin|niacin|mesh-list
6109475|NCT01012219|Clopidogrel|clopidogrel|mesh-list
6109476|NCT01012219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6109477|NCT01012219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6109478|NCT01012219|Analgesics|analgesics|mesh-ancestor
6109479|NCT01012219|Sensory System Agents|sensory system agents|mesh-ancestor
5527726|NCT04261270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5527727|NCT04261270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5527728|NCT04261270|Antiviral Agents|antiviral agents|mesh-ancestor
5527729|NCT04261270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5527730|NCT04261270|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5527731|NCT04261270|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5527732|NCT04261023|Abatacept|abatacept|mesh-list
5527733|NCT04261023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5527734|NCT04261023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5527735|NCT04261023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5527736|NCT04261023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5527737|NCT04261023|Immunologic Factors|immunologic factors|mesh-ancestor
5527738|NCT04261023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527739|NCT04261023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5527740|NCT04261036|Ascorbic Acid|ascorbic acid|mesh-list
5527741|NCT04261036|Antioxidants|antioxidants|mesh-ancestor
5527742|NCT04261036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5527743|NCT04261036|Protective Agents|protective agents|mesh-ancestor
5527744|NCT04261036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527745|NCT04261036|Vitamins|vitamins|mesh-ancestor
5527746|NCT04261036|Micronutrients|micronutrients|mesh-ancestor
5527747|NCT04261049|Triamcinolone|triamcinolone|mesh-list
5527748|NCT04261049|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5527749|NCT04261049|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5527750|NCT04261049|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5527751|NCT04261049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5527752|NCT04261049|Glucocorticoids|glucocorticoids|mesh-ancestor
5527753|NCT04261049|Hormones|hormones|mesh-ancestor
5527754|NCT04261049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5527755|NCT04261049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527756|NCT04261049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5527757|NCT04261049|Immunologic Factors|immunologic factors|mesh-ancestor
5527758|NCT04261049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5527759|NCT04261049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109480|NCT01012219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6109481|NCT01012219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109482|NCT01012219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6109483|NCT01012219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6109484|NCT01012219|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6109485|NCT01012219|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6109486|NCT01012219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109487|NCT01012219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6109488|NCT01012219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6109489|NCT01012219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5527760|NCT04260828|Aspirin|aspirin|mesh-list
5527761|NCT04260828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5527762|NCT04260828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5527763|NCT04260828|Analgesics|analgesics|mesh-ancestor
5527764|NCT04260828|Sensory System Agents|sensory system agents|mesh-ancestor
5527765|NCT04260828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5527766|NCT04260828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527767|NCT04260828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5527768|NCT04260828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5527769|NCT04260828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5527770|NCT04260828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5527771|NCT04260828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5527772|NCT04260828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5527773|NCT04260828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5527774|NCT04260828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5527775|NCT04260828|Antipyretics|antipyretics|mesh-ancestor
5527776|NCT04260711|Interferons|interferons|mesh-list
5527777|NCT04260711|Teriflunomide|teriflunomide|mesh-list
6109490|NCT01012219|Antipyretics|antipyretics|mesh-ancestor
6109491|NCT01012219|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6109492|NCT01012219|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6109493|NCT01012219|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6109494|NCT01012219|Purinergic Agents|purinergic agents|mesh-ancestor
6109495|NCT01012219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6109496|NCT01012219|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6109497|NCT01012219|Antimetabolites|antimetabolites|mesh-ancestor
6109498|NCT01012219|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5527778|NCT04260711|Glatiramer Acetate|glatiramer acetate|mesh-list
5527779|NCT04260711|Dimethyl Fumarate|dimethyl fumarate|mesh-list
5527780|NCT04260711|(T,G)-A-L|(t,g)-a-l|mesh-list
5527781|NCT04260711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5527782|NCT04260711|Antiviral Agents|antiviral agents|mesh-ancestor
5527783|NCT04260711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6109499|NCT01012219|Vasodilator Agents|vasodilator agents|mesh-ancestor
6109500|NCT01012219|Vitamin B Complex|vitamin b complex|mesh-ancestor
6109501|NCT01012219|Vitamins|vitamins|mesh-ancestor
6109502|NCT01012219|Micronutrients|micronutrients|mesh-ancestor
6109503|NCT01012258|Cetuximab|cetuximab|mesh-list
6109504|NCT01012258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6109505|NCT01012258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6109506|NCT01012297|Gemcitabine|gemcitabine|mesh-list
6109507|NCT01012297|Bevacizumab|bevacizumab|mesh-list
6109508|NCT01012297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6109509|NCT01012297|Docetaxel|docetaxel|mesh-list
6109510|NCT01012297|Endothelial Growth Factors|endothelial growth factors|mesh-list
6109511|NCT01012297|Antibodies|antibodies|mesh-list
5527784|NCT04260711|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5527785|NCT04260711|Immunologic Factors|immunologic factors|mesh-ancestor
5527786|NCT04260711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527787|NCT04260711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5527788|NCT04260711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5527789|NCT04260711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5527790|NCT04260711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5527791|NCT04260711|Analgesics|analgesics|mesh-ancestor
5527792|NCT04260711|Sensory System Agents|sensory system agents|mesh-ancestor
5527793|NCT04260711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5527794|NCT04260711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5527795|NCT04260711|Dermatologic Agents|dermatologic agents|mesh-ancestor
6109512|NCT01012297|Immunoglobulins|immunoglobulins|mesh-list
6109513|NCT01012297|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6109514|NCT01012297|Lenograstim|lenograstim|mesh-list
6109515|NCT01012297|Immunoglobulin G|immunoglobulin g|mesh-list
6109516|NCT01012297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6109517|NCT01012297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6109518|NCT01012297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6109519|NCT01012297|Growth Substances|growth substances|mesh-ancestor
6109520|NCT01012297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109521|NCT01012297|Growth Inhibitors|growth inhibitors|mesh-ancestor
5527796|NCT04260607|Ketamine|ketamine|mesh-list
5527797|NCT04260607|Analgesics|analgesics|mesh-ancestor
5527798|NCT04260607|Sensory System Agents|sensory system agents|mesh-ancestor
5527799|NCT04260607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5527800|NCT04260607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527801|NCT04260607|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5527802|NCT04260607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5527803|NCT04260607|Anesthetics, General|anesthetics, general|mesh-ancestor
6109522|NCT01012297|Immunologic Factors|immunologic factors|mesh-ancestor
6109523|NCT01012297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6109524|NCT01012297|Antimetabolites|antimetabolites|mesh-ancestor
6109525|NCT01012297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109526|NCT01012297|Antiviral Agents|antiviral agents|mesh-ancestor
6109527|NCT01012297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6109528|NCT01012297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6109529|NCT01012297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6109530|NCT01012297|Tubulin Modulators|tubulin modulators|mesh-ancestor
6109531|NCT01012297|Antimitotic Agents|antimitotic agents|mesh-ancestor
6109532|NCT01012297|Mitosis Modulators|mitosis modulators|mesh-ancestor
6109533|NCT01012297|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6109534|NCT01012323|Immunoglobulins|immunoglobulins|mesh-list
6109535|NCT01012323|Immunologic Factors|immunologic factors|mesh-ancestor
6109536|NCT01012323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109537|NCT01012336|Dexamethasone|dexamethasone|mesh-list
6109538|NCT01012336|Aprepitant|aprepitant|mesh-list
6109539|NCT01012336|Ramosetron|ramosetron|mesh-list
6109540|NCT01012336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5527804|NCT04260607|Anesthetics|anesthetics|mesh-ancestor
5527805|NCT04260607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5527806|NCT04260607|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5527807|NCT04260607|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5527808|NCT04260607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6109541|NCT01012336|Antiemetics|antiemetics|mesh-ancestor
6109542|NCT01012336|Autonomic Agents|autonomic agents|mesh-ancestor
6109543|NCT01012336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6109544|NCT01012336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527809|NCT04260607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109545|NCT01012336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6109546|NCT01012336|Glucocorticoids|glucocorticoids|mesh-ancestor
6109547|NCT01012336|Hormones|hormones|mesh-ancestor
6109548|NCT01012336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6109549|NCT01012336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6109550|NCT01012336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6109551|NCT01012336|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6109552|NCT01012336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6109553|NCT01012336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109554|NCT01012336|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6109555|NCT01012336|Serotonin Agents|serotonin agents|mesh-ancestor
6109556|NCT01012492|Abatacept|abatacept|mesh-list
6109557|NCT01012492|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6109558|NCT01012492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109559|NCT01012492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6109560|NCT01012492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6109561|NCT01012492|Immunologic Factors|immunologic factors|mesh-ancestor
6109562|NCT01012492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109563|NCT01012492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6109564|NCT01012609|Irinotecan|irinotecan|mesh-list
6109565|NCT01012609|Cetuximab|cetuximab|mesh-list
6109566|NCT01012609|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6109567|NCT01012609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6109568|NCT01012609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6109569|NCT01012609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109570|NCT01012609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6109571|NCT01012609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6109572|NCT01012622|Methylphenidate|methylphenidate|mesh-list
6109573|NCT01012622|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5527810|NCT04260659|Lidocaine|lidocaine|mesh-list
5527811|NCT04260659|Magnesium Sulfate|magnesium sulfate|mesh-list
6109574|NCT01012622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527812|NCT04260659|Fentanyl|fentanyl|mesh-list
5527813|NCT04260659|Dexmedetomidine|dexmedetomidine|mesh-list
5527814|NCT04260659|Ketamine|ketamine|mesh-list
6109575|NCT01012622|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6109576|NCT01012622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6109577|NCT01012622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6109578|NCT01012622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109579|NCT01012622|Dopamine Agents|dopamine agents|mesh-ancestor
6109580|NCT01012622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6109581|NCT01012661|Lidocaine|lidocaine|mesh-list
6109582|NCT01012661|Anesthetics, Local|anesthetics, local|mesh-ancestor
6109583|NCT01012661|Anesthetics|anesthetics|mesh-ancestor
6109584|NCT01012661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6109585|NCT01012661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109586|NCT01012661|Sensory System Agents|sensory system agents|mesh-ancestor
6109587|NCT01012661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6109588|NCT01012661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6109589|NCT01012661|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6109590|NCT01012661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6109591|NCT01012661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6109592|NCT01012661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109593|NCT01012674|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
6109594|NCT01012674|Chelating Agents|chelating agents|mesh-ancestor
6109595|NCT01012674|Sequestering Agents|sequestering agents|mesh-ancestor
6109596|NCT01012674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109597|NCT01012713|Calcitriol|calcitriol|mesh-list
6109598|NCT01012713|Clobetasol|clobetasol|mesh-list
6109599|NCT01012713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6109600|NCT01012713|Glucocorticoids|glucocorticoids|mesh-ancestor
6109601|NCT01012713|Hormones|hormones|mesh-ancestor
6109602|NCT01012713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6109603|NCT01012713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109604|NCT01012713|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6109605|NCT01012713|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6109606|NCT01012713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6109607|NCT01012713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109608|NCT01012713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6109609|NCT01012713|Vitamins|vitamins|mesh-ancestor
5527815|NCT04260659|Remifentanil|remifentanil|mesh-list
5527816|NCT04260659|Anesthetics, Local|anesthetics, local|mesh-ancestor
5527817|NCT04260659|Anesthetics|anesthetics|mesh-ancestor
5527818|NCT04260659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5527819|NCT04260659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527820|NCT04260659|Sensory System Agents|sensory system agents|mesh-ancestor
5527821|NCT04260659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5527822|NCT04260659|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5527823|NCT04260659|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5527824|NCT04260659|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6109610|NCT01012713|Micronutrients|micronutrients|mesh-ancestor
6109611|NCT01012713|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6109612|NCT01012765|Tiotropium Bromide|tiotropium bromide|mesh-list
6109613|NCT01012765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6109614|NCT01012765|Autonomic Agents|autonomic agents|mesh-ancestor
6109615|NCT01012765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6109616|NCT01012765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109617|NCT01012765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6109618|NCT01012765|Respiratory System Agents|respiratory system agents|mesh-ancestor
6109619|NCT01012765|Parasympatholytics|parasympatholytics|mesh-ancestor
6109620|NCT01012765|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6109621|NCT01012765|Cholinergic Agents|cholinergic agents|mesh-ancestor
6109622|NCT01012765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6109623|NCT01012765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109624|NCT01012973|Aflibercept|aflibercept|mesh-list
6109625|NCT01012973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6109626|NCT01012973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6109627|NCT01012973|Growth Substances|growth substances|mesh-ancestor
6109628|NCT01012973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109629|NCT01012973|Growth Inhibitors|growth inhibitors|mesh-ancestor
6109630|NCT01012973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6109631|NCT01012999|Sufentanil|sufentanil|mesh-list
6109632|NCT01012999|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6109633|NCT01012999|Narcotics|narcotics|mesh-ancestor
6109634|NCT01012999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6109635|NCT01012999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109636|NCT01012999|Analgesics|analgesics|mesh-ancestor
6109637|NCT01012999|Sensory System Agents|sensory system agents|mesh-ancestor
6109638|NCT01012999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6109639|NCT01012999|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6109640|NCT01012999|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6109641|NCT01012999|Anesthetics, General|anesthetics, general|mesh-ancestor
6109642|NCT01012999|Anesthetics|anesthetics|mesh-ancestor
6109643|NCT01013285|Bevacizumab|bevacizumab|mesh-list
6109644|NCT01013285|Temozolomide|temozolomide|mesh-list
6109645|NCT01013285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6109646|NCT01013285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6109647|NCT01013285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6109648|NCT01013285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6109649|NCT01013285|Growth Substances|growth substances|mesh-ancestor
6109650|NCT01013285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109651|NCT01013285|Growth Inhibitors|growth inhibitors|mesh-ancestor
6109652|NCT01013285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6109653|NCT01013285|Alkylating Agents|alkylating agents|mesh-ancestor
6109654|NCT01013285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109655|NCT01013597|Panobinostat|panobinostat|mesh-list
6109656|NCT01013597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6109657|NCT01013597|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6109658|NCT01013597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6109659|NCT01013597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5527825|NCT04260659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5527826|NCT04260659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5527827|NCT04260659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5527828|NCT04260659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5527829|NCT04260659|Analgesics|analgesics|mesh-ancestor
5527830|NCT04260659|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5527831|NCT04260659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5527832|NCT04260659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5527833|NCT04260659|Adrenergic Agents|adrenergic agents|mesh-ancestor
5527834|NCT04260659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5527835|NCT04260659|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5527836|NCT04260659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5527837|NCT04260659|Anesthetics, General|anesthetics, general|mesh-ancestor
5527838|NCT04260659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5527839|NCT04260659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5527840|NCT04260659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5527841|NCT04260659|Narcotics|narcotics|mesh-ancestor
5527842|NCT04260659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6109660|NCT01013740|Capecitabine|capecitabine|mesh-list
6109661|NCT01013740|Vinorelbine|vinorelbine|mesh-list
6109662|NCT01013740|Lapatinib|lapatinib|mesh-list
6109663|NCT01013740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6109664|NCT01013740|Antimetabolites|antimetabolites|mesh-ancestor
6109665|NCT01013740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109666|NCT01013740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6109667|NCT01013740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6109668|NCT01013740|Tubulin Modulators|tubulin modulators|mesh-ancestor
6109669|NCT01013740|Antimitotic Agents|antimitotic agents|mesh-ancestor
6109670|NCT01013740|Mitosis Modulators|mitosis modulators|mesh-ancestor
6109671|NCT01013740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6109672|NCT01013740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6109673|NCT01013753|Formoterol Fumarate|formoterol fumarate|mesh-list
6109674|NCT01013753|Olodaterol|olodaterol|mesh-list
6109675|NCT01013753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6109676|NCT01013753|Autonomic Agents|autonomic agents|mesh-ancestor
6109677|NCT01013753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6109678|NCT01013753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109679|NCT01013753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6109680|NCT01013753|Respiratory System Agents|respiratory system agents|mesh-ancestor
6109681|NCT01013753|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6109682|NCT01013753|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6109683|NCT01013753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6109684|NCT01013753|Adrenergic Agents|adrenergic agents|mesh-ancestor
6109685|NCT01013753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6109686|NCT01013753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5527843|NCT04260659|Anticonvulsants|anticonvulsants|mesh-ancestor
5527844|NCT04260659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5527845|NCT04260659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5527846|NCT04260659|Tocolytic Agents|tocolytic agents|mesh-ancestor
5527847|NCT04260659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5527848|NCT04260516|Acetylcysteine|acetylcysteine|mesh-list
5527849|NCT04260516|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5527850|NCT04260516|Antiviral Agents|antiviral agents|mesh-ancestor
5527851|NCT04260516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5527852|NCT04260516|Expectorants|expectorants|mesh-ancestor
5527853|NCT04260516|Respiratory System Agents|respiratory system agents|mesh-ancestor
5527854|NCT04260516|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5527855|NCT04260516|Antioxidants|antioxidants|mesh-ancestor
5527856|NCT04260516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109687|NCT01013870|Atorvastatin|atorvastatin|mesh-list
6109688|NCT01013870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6109689|NCT01013870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6109690|NCT01013870|Antimetabolites|antimetabolites|mesh-ancestor
6109691|NCT01013870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109692|NCT01013870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6109693|NCT01013870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6109694|NCT01013870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6109695|NCT01013961|Rituximab|rituximab|mesh-list
6109696|NCT01013961|Alemtuzumab|alemtuzumab|mesh-list
6109697|NCT01013961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6109698|NCT01013961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6109699|NCT01013961|Immunologic Factors|immunologic factors|mesh-ancestor
6109700|NCT01013961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109701|NCT01013961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5527857|NCT04260516|Protective Agents|protective agents|mesh-ancestor
5527858|NCT04260516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527859|NCT04260516|Antidotes|antidotes|mesh-ancestor
5527860|NCT04260581|Amantadine|amantadine|mesh-list
5527861|NCT04260581|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5527862|NCT04260581|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5527863|NCT04260581|Antiviral Agents|antiviral agents|mesh-ancestor
5527864|NCT04260581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5527865|NCT04260581|Dopamine Agents|dopamine agents|mesh-ancestor
5527866|NCT04260581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6109702|NCT01014013|Ceftriaxone|ceftriaxone|mesh-list
6465410|NCT00474136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465411|NCT00474136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6465412|NCT00474136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6109703|NCT01014013|Ertapenem|ertapenem|mesh-list
6109704|NCT01014013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6109705|NCT01014013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6109706|NCT01014143|Chlorhexidine|chlorhexidine|mesh-list
6109707|NCT01014143|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6109708|NCT01014143|Triclosan|triclosan|mesh-list
6109709|NCT01014143|Fluorides|fluorides|mesh-list
6109710|NCT01014143|Cariostatic Agents|cariostatic agents|mesh-ancestor
6109711|NCT01014143|Protective Agents|protective agents|mesh-ancestor
6109712|NCT01014143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109713|NCT01014143|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6109714|NCT01014143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6109715|NCT01014143|Disinfectants|disinfectants|mesh-ancestor
6109716|NCT01014143|Dermatologic Agents|dermatologic agents|mesh-ancestor
6109717|NCT01014143|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6109718|NCT01014143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6109719|NCT01014143|Antimetabolites|antimetabolites|mesh-ancestor
6109720|NCT01014143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109721|NCT01014143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6109722|NCT01014208|Rituximab|rituximab|mesh-list
6109723|NCT01014208|Ofatumumab|ofatumumab|mesh-list
6109724|NCT01014208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6109725|NCT01014208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6109726|NCT01014208|Immunologic Factors|immunologic factors|mesh-ancestor
6109727|NCT01014208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109728|NCT01014208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6109729|NCT01014351|Paclitaxel|paclitaxel|mesh-list
6109730|NCT01014351|Carboplatin|carboplatin|mesh-list
6109731|NCT01014351|Everolimus|everolimus|mesh-list
6109732|NCT01014351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6109733|NCT01014351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6109734|NCT01014351|Tubulin Modulators|tubulin modulators|mesh-ancestor
6109735|NCT01014351|Antimitotic Agents|antimitotic agents|mesh-ancestor
6109736|NCT01014351|Mitosis Modulators|mitosis modulators|mesh-ancestor
6109737|NCT01014351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109738|NCT01014351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6109739|NCT01014351|Immunologic Factors|immunologic factors|mesh-ancestor
6109740|NCT01014351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109741|NCT01014403|Enoxaparin|enoxaparin|mesh-list
6109742|NCT01014403|Anticoagulants|anticoagulants|mesh-ancestor
6109743|NCT01014403|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6109744|NCT01014403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6109745|NCT01014403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109746|NCT01014442|Mycophenolic Acid|mycophenolic acid|mesh-list
6109747|NCT01014442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6109748|NCT01014442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6109749|NCT01014442|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6109750|NCT01014442|Antitubercular Agents|antitubercular agents|mesh-ancestor
6465413|NCT00474136|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6109751|NCT01014442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6109752|NCT01014442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6109753|NCT01014442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6109754|NCT01014442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109755|NCT01014533|Gabapentin|gabapentin|mesh-list
6109756|NCT01014533|Analgesics|analgesics|mesh-ancestor
6109757|NCT01014533|Sensory System Agents|sensory system agents|mesh-ancestor
6109758|NCT01014533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6109759|NCT01014533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109760|NCT01014533|Anticonvulsants|anticonvulsants|mesh-ancestor
6109761|NCT01014533|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6109762|NCT01014533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6109763|NCT01014533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6109764|NCT01014533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6109765|NCT01014533|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6109766|NCT01014533|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6109767|NCT01014533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6109768|NCT01014533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109769|NCT01014533|Antimanic Agents|antimanic agents|mesh-ancestor
6109770|NCT01014585|Milnacipran|milnacipran|mesh-list
6109771|NCT01014585|Levomilnacipran|levomilnacipran|mesh-list
6109772|NCT01014585|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6109773|NCT01014585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6109774|NCT01014585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6109775|NCT01014585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109776|NCT01014585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6109777|NCT01014585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109778|NCT01014585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6109779|NCT01014585|Analgesics|analgesics|mesh-ancestor
6109780|NCT01014585|Sensory System Agents|sensory system agents|mesh-ancestor
6109781|NCT01014585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6109782|NCT01014585|Antidepressive Agents|antidepressive agents|mesh-ancestor
6109783|NCT01014585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6109784|NCT01014624|Clopidogrel|clopidogrel|mesh-list
6109785|NCT01014624|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6109786|NCT01014624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5527867|NCT04260581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5527868|NCT04260581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527869|NCT04260581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5527870|NCT04260581|Analgesics|analgesics|mesh-ancestor
5527871|NCT04260581|Sensory System Agents|sensory system agents|mesh-ancestor
5527872|NCT04260581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6465414|NCT00474136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6465415|NCT00474136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465416|NCT00474162|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
6465417|NCT00474162|Plasma Substitutes|plasma substitutes|mesh-ancestor
6465418|NCT00474162|Blood Substitutes|blood substitutes|mesh-ancestor
6465419|NCT00474279|Hormones|hormones|mesh-list
6465420|NCT00474279|Secretagogues|secretagogues|mesh-list
6465421|NCT00474279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5527873|NCT04260412|Psyllium|psyllium|mesh-list
5527874|NCT04260412|Cathartics|cathartics|mesh-ancestor
5527875|NCT04260412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6109787|NCT01014624|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6109788|NCT01014624|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6109789|NCT01014624|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6109790|NCT01014624|Purinergic Agents|purinergic agents|mesh-ancestor
6109791|NCT01014624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6109792|NCT01014624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109793|NCT01014624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109794|NCT01014689|Lymecycline|lymecycline|mesh-list
6109795|NCT01014689|Adapalene|adapalene|mesh-list
6109796|NCT01014689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6109797|NCT01014689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6109798|NCT01014689|Analgesics|analgesics|mesh-ancestor
5527876|NCT04260685|Lidocaine|lidocaine|mesh-list
5527877|NCT04260685|Esmolol|esmolol|mesh-list
5527878|NCT04260685|Anesthetics, Local|anesthetics, local|mesh-ancestor
5527879|NCT04260685|Anesthetics|anesthetics|mesh-ancestor
5527880|NCT04260685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5527881|NCT04260685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109799|NCT01014689|Sensory System Agents|sensory system agents|mesh-ancestor
6109800|NCT01014689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6109801|NCT01014689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109802|NCT01014689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6109803|NCT01014689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6109804|NCT01014689|Dermatologic Agents|dermatologic agents|mesh-ancestor
6109805|NCT01014689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6109806|NCT01014689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6109807|NCT01014728|Propofol|propofol|mesh-list
6109808|NCT01014728|Sevoflurane|sevoflurane|mesh-list
6109809|NCT01014728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6109810|NCT01014728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6109811|NCT01014728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109812|NCT01014728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6465422|NCT00474279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109813|NCT01014728|Anesthetics, General|anesthetics, general|mesh-ancestor
6109814|NCT01014728|Anesthetics|anesthetics|mesh-ancestor
6109815|NCT01014728|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6109816|NCT01014728|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6109817|NCT01014741|Ibutilide|ibutilide|mesh-list
6109818|NCT01014741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6109819|NCT01014871|Botulinum Toxins|botulinum toxins|mesh-list
6109820|NCT01014871|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6109821|NCT01014871|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6109822|NCT01014871|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6109823|NCT01014871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6109824|NCT01014871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109825|NCT01014871|Cholinergic Agents|cholinergic agents|mesh-ancestor
6109826|NCT01014871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6109827|NCT01014871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109828|NCT01014871|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6109829|NCT01014871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6109830|NCT01014936|Tepotinib|tepotinib|mesh-list
6109831|NCT01014936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6109832|NCT01014975|Fibrinolysin|fibrinolysin|mesh-list
6109833|NCT01014975|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6109834|NCT01014975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6109835|NCT01014975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109836|NCT01014988|Zanamivir|zanamivir|mesh-list
6109837|NCT01014988|Antiviral Agents|antiviral agents|mesh-ancestor
6109838|NCT01014988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6109839|NCT01014988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6109840|NCT01014988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109841|NCT01015118|Paclitaxel|paclitaxel|mesh-list
6109842|NCT01015118|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6109843|NCT01015118|Carboplatin|carboplatin|mesh-list
6109844|NCT01015118|Nintedanib|nintedanib|mesh-list
6109845|NCT01015118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6109846|NCT01015118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6109847|NCT01015118|Tubulin Modulators|tubulin modulators|mesh-ancestor
6109848|NCT01015118|Antimitotic Agents|antimitotic agents|mesh-ancestor
6109849|NCT01015118|Mitosis Modulators|mitosis modulators|mesh-ancestor
6109850|NCT01015118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109851|NCT01015118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6109852|NCT01015118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6109853|NCT01015131|Alovudine|alovudine|mesh-list
6109854|NCT01015131|Antiviral Agents|antiviral agents|mesh-ancestor
6109855|NCT01015131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6109856|NCT01015170|Bupropion|bupropion|mesh-list
6109857|NCT01015170|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6109858|NCT01015170|Antidepressive Agents|antidepressive agents|mesh-ancestor
6109859|NCT01015170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6109860|NCT01015170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6109861|NCT01015170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6109862|NCT01015170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6109863|NCT01015170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109864|NCT01015170|Dopamine Agents|dopamine agents|mesh-ancestor
6109865|NCT01015170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6109866|NCT01015170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109867|NCT01015170|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6109868|NCT01015170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6109869|NCT01015170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6109870|NCT01015287|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6109871|NCT01015287|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6109872|NCT01015443|Cyclophosphamide|cyclophosphamide|mesh-list
6109873|NCT01015443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6109874|NCT01015443|Immunologic Factors|immunologic factors|mesh-ancestor
6109875|NCT01015443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109876|NCT01015443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6109877|NCT01015443|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6109878|NCT01015443|Alkylating Agents|alkylating agents|mesh-ancestor
6109879|NCT01015443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109880|NCT01015443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6109881|NCT01015443|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6109882|NCT01015534|Temozolomide|temozolomide|mesh-list
6109883|NCT01015534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6109884|NCT01015534|Alkylating Agents|alkylating agents|mesh-ancestor
6109885|NCT01015534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109886|NCT01015534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6109887|NCT01015560|Antibodies|antibodies|mesh-list
6109888|NCT01015560|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6109889|NCT01015560|Immunologic Factors|immunologic factors|mesh-ancestor
6109890|NCT01015560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109891|NCT01015586|Lamotrigine|lamotrigine|mesh-list
6109892|NCT01015586|Anticonvulsants|anticonvulsants|mesh-ancestor
6109893|NCT01015586|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6109894|NCT01015586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6109895|NCT01015586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109896|NCT01015586|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6109897|NCT01015586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109898|NCT01015586|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6109899|NCT01015586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6109900|NCT01015586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6109901|NCT01015586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6109902|NCT01015586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6109903|NCT01015638|Clindamycin|clindamycin|mesh-list
6109904|NCT01015638|Clindamycin palmitate|clindamycin palmitate|mesh-list
6109905|NCT01015638|Clindamycin phosphate|clindamycin phosphate|mesh-list
6109906|NCT01015638|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6109907|NCT01015638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6109908|NCT01015638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6109909|NCT01015638|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6109910|NCT01015638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6109911|NCT01015638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109912|NCT01015638|Dermatologic Agents|dermatologic agents|mesh-ancestor
6109913|NCT01015677|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6109914|NCT01015677|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6109915|NCT01015677|Estradiol|estradiol|mesh-list
6109916|NCT01015677|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6109917|NCT01015677|Estrogens|estrogens|mesh-ancestor
6109918|NCT01015677|Hormones|hormones|mesh-ancestor
6109919|NCT01015677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6109920|NCT01015677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109921|NCT01015677|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6109922|NCT01015677|Contraceptive Agents|contraceptive agents|mesh-ancestor
6109923|NCT01015677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6109924|NCT01015677|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6109925|NCT01015807|Clonidine|clonidine|mesh-list
6109926|NCT01015807|Bupivacaine|bupivacaine|mesh-list
6109927|NCT01015807|Anesthetics, Local|anesthetics, local|mesh-ancestor
6109928|NCT01015807|Anesthetics|anesthetics|mesh-ancestor
6109929|NCT01015807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6109930|NCT01015807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109931|NCT01015807|Sensory System Agents|sensory system agents|mesh-ancestor
6109932|NCT01015807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6109933|NCT01015807|Analgesics|analgesics|mesh-ancestor
6109934|NCT01015807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6109935|NCT01015807|Sympatholytics|sympatholytics|mesh-ancestor
6109936|NCT01015807|Autonomic Agents|autonomic agents|mesh-ancestor
6109937|NCT01015807|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5527882|NCT04260685|Sensory System Agents|sensory system agents|mesh-ancestor
5527883|NCT04260685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5527884|NCT04260685|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5527885|NCT04260685|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5527886|NCT04260685|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5527887|NCT04260685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5527888|NCT04260685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5527889|NCT04260685|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5527890|NCT04260685|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5527891|NCT04260685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5527892|NCT04260685|Adrenergic Agents|adrenergic agents|mesh-ancestor
5527893|NCT04260685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5527894|NCT04260464|PF-06700841|pf-06700841|mesh-list
5527895|NCT04260464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5527896|NCT04260464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5527897|NCT04260464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5527898|NCT04260360|Docetaxel|docetaxel|mesh-list
5527899|NCT04260360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5527900|NCT04260360|Tubulin Modulators|tubulin modulators|mesh-ancestor
5527901|NCT04260360|Antimitotic Agents|antimitotic agents|mesh-ancestor
5527902|NCT04260360|Mitosis Modulators|mitosis modulators|mesh-ancestor
5527903|NCT04260360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109938|NCT01015807|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6109939|NCT01015807|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6109940|NCT01015807|Adrenergic Agents|adrenergic agents|mesh-ancestor
6109941|NCT01015807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6109942|NCT01015807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109943|NCT01016015|Sirolimus|sirolimus|mesh-list
6109944|NCT01016015|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6109945|NCT01016015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6109946|NCT01016015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6109947|NCT01016015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6109948|NCT01016015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6109949|NCT01016015|Antifungal Agents|antifungal agents|mesh-ancestor
6109950|NCT01016015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6109951|NCT01016015|Immunologic Factors|immunologic factors|mesh-ancestor
6109952|NCT01016015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109953|NCT01016262|Mesalamine|mesalamine|mesh-list
6109954|NCT01016262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6109955|NCT01016262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6109956|NCT01016262|Analgesics|analgesics|mesh-ancestor
6109957|NCT01016262|Sensory System Agents|sensory system agents|mesh-ancestor
6109958|NCT01016262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6109959|NCT01016262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109960|NCT01016262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6109961|NCT01016262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6109962|NCT01016483|Gemcitabine|gemcitabine|mesh-list
6109963|NCT01016483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6109964|NCT01016483|Antimetabolites|antimetabolites|mesh-ancestor
6109965|NCT01016483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109966|NCT01016483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6109967|NCT01016483|Antiviral Agents|antiviral agents|mesh-ancestor
6109968|NCT01016483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6109969|NCT01016483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6109970|NCT01016483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6109971|NCT01016483|Immunologic Factors|immunologic factors|mesh-ancestor
6109972|NCT01016483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109973|NCT01016600|Lenalidomide|lenalidomide|mesh-list
6109974|NCT01016600|Azacitidine|azacitidine|mesh-list
6109975|NCT01016600|Immunologic Factors|immunologic factors|mesh-ancestor
6109976|NCT01016600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109977|NCT01016600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6109978|NCT01016600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6109979|NCT01016600|Growth Substances|growth substances|mesh-ancestor
6109980|NCT01016600|Growth Inhibitors|growth inhibitors|mesh-ancestor
6109981|NCT01016600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6109982|NCT01016600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6109983|NCT01016600|Antimetabolites|antimetabolites|mesh-ancestor
6109984|NCT01016600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109985|NCT01016600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6109986|NCT01016678|Naproxen|naproxen|mesh-list
6109987|NCT01016678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6109988|NCT01016678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6109989|NCT01016678|Analgesics|analgesics|mesh-ancestor
6109990|NCT01016678|Sensory System Agents|sensory system agents|mesh-ancestor
6109991|NCT01016678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6109992|NCT01016678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6109993|NCT01016678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6109994|NCT01016678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6109995|NCT01016678|Gout Suppressants|gout suppressants|mesh-ancestor
5527904|NCT04260035|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
5527905|NCT04260035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5527906|NCT04260035|Vasodilator Agents|vasodilator agents|mesh-ancestor
5527907|NCT04260035|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5527908|NCT04260035|Protective Agents|protective agents|mesh-ancestor
5527909|NCT04260035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527910|NCT04260269|Trifluridine|trifluridine|mesh-list
5527911|NCT04260269|Fluorouracil|fluorouracil|mesh-list
6109996|NCT01016678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6109997|NCT01016678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6109998|NCT01016678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6109999|NCT01016691|Bimatoprost|bimatoprost|mesh-list
6110000|NCT01016691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6110001|NCT01016769|Sirolimus|sirolimus|mesh-list
6110002|NCT01016769|Paclitaxel|paclitaxel|mesh-list
6110003|NCT01016769|Carboplatin|carboplatin|mesh-list
6110004|NCT01016769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6110005|NCT01016769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6110006|NCT01016769|Tubulin Modulators|tubulin modulators|mesh-ancestor
6110007|NCT01016769|Antimitotic Agents|antimitotic agents|mesh-ancestor
6110008|NCT01016769|Mitosis Modulators|mitosis modulators|mesh-ancestor
5527912|NCT04260269|Capecitabine|capecitabine|mesh-list
5527913|NCT04260269|Tegafur|tegafur|mesh-list
5527914|NCT04260269|Antimetabolites|antimetabolites|mesh-ancestor
5527915|NCT04260269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5527916|NCT04260269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5527917|NCT04260269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5527918|NCT04260269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5527919|NCT04260269|Immunologic Factors|immunologic factors|mesh-ancestor
5527920|NCT04260269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110009|NCT01016769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110010|NCT01016769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6110011|NCT01016769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6110012|NCT01016769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6110013|NCT01016769|Antifungal Agents|antifungal agents|mesh-ancestor
6110014|NCT01016769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5527921|NCT04260269|Antiviral Agents|antiviral agents|mesh-ancestor
5527922|NCT04260269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5527923|NCT04260113|Apatinib|apatinib|mesh-list
5527924|NCT04260113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5527925|NCT04260113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5527926|NCT04260113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5527927|NCT04260113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5527928|NCT04259684|Nitric Oxide|nitric oxide|mesh-list
5527929|NCT04259684|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5527930|NCT04259684|Autonomic Agents|autonomic agents|mesh-ancestor
6110015|NCT01016769|Immunologic Factors|immunologic factors|mesh-ancestor
6110016|NCT01016769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110017|NCT01016834|Sumatriptan|sumatriptan|mesh-list
6110018|NCT01016834|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6110019|NCT01016834|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6110020|NCT01016834|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6110021|NCT01016834|Serotonin Agents|serotonin agents|mesh-ancestor
6110022|NCT01016834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6110023|NCT01016834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110024|NCT01016834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110025|NCT01016912|Ribavirin|ribavirin|mesh-list
6110026|NCT01016912|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6110027|NCT01016912|Antimetabolites|antimetabolites|mesh-ancestor
6110028|NCT01016912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110029|NCT01016912|Antiviral Agents|antiviral agents|mesh-ancestor
6110030|NCT01016912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6110031|NCT01016977|Nicotinic Acids|nicotinic acids|mesh-list
6110032|NCT01016977|Clindamycin|clindamycin|mesh-list
6110033|NCT01016977|Clindamycin palmitate|clindamycin palmitate|mesh-list
6110034|NCT01016977|Clindamycin phosphate|clindamycin phosphate|mesh-list
6110035|NCT01016977|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6110036|NCT01016977|Tazarotene|tazarotene|mesh-list
6110037|NCT01016977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6110038|NCT01016977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6110039|NCT01016977|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6110040|NCT01016977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6110041|NCT01016977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110042|NCT01016977|Dermatologic Agents|dermatologic agents|mesh-ancestor
6110043|NCT01016977|Keratolytic Agents|keratolytic agents|mesh-ancestor
6110044|NCT01016977|Vitamin B Complex|vitamin b complex|mesh-ancestor
6110045|NCT01016977|Vitamins|vitamins|mesh-ancestor
6110046|NCT01016977|Micronutrients|micronutrients|mesh-ancestor
6110047|NCT01016977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110048|NCT01017003|Colchicine|colchicine|mesh-list
6110049|NCT01017003|Gout Suppressants|gout suppressants|mesh-ancestor
6110050|NCT01017003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6110051|NCT01017003|Tubulin Modulators|tubulin modulators|mesh-ancestor
6110052|NCT01017003|Antimitotic Agents|antimitotic agents|mesh-ancestor
6110053|NCT01017003|Mitosis Modulators|mitosis modulators|mesh-ancestor
5527931|NCT04259684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6110054|NCT01017003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110055|NCT01017003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6110056|NCT01017029|Mycophenolic Acid|mycophenolic acid|mesh-list
6110057|NCT01017029|Everolimus|everolimus|mesh-list
6110058|NCT01017029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6110059|NCT01017029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6110060|NCT01017029|Immunologic Factors|immunologic factors|mesh-ancestor
6110061|NCT01017029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110062|NCT01017029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6110063|NCT01017029|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6110064|NCT01017029|Antitubercular Agents|antitubercular agents|mesh-ancestor
6110065|NCT01017029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6110066|NCT01017029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6110067|NCT01017029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6110068|NCT01017029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110069|NCT01017042|Colchicine|colchicine|mesh-list
6110070|NCT01017042|Gout Suppressants|gout suppressants|mesh-ancestor
6110071|NCT01017042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5527932|NCT04259684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527933|NCT04259684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5527934|NCT04259684|Respiratory System Agents|respiratory system agents|mesh-ancestor
5527935|NCT04259684|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5527936|NCT04259684|Antioxidants|antioxidants|mesh-ancestor
5527937|NCT04259684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5527938|NCT04259684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5527939|NCT04259684|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5527940|NCT04259684|Vasodilator Agents|vasodilator agents|mesh-ancestor
5527941|NCT04259684|Gasotransmitters|gasotransmitters|mesh-ancestor
5527942|NCT04259684|Protective Agents|protective agents|mesh-ancestor
5527943|NCT04259606|Magnesium Oxide|magnesium oxide|mesh-list
5527944|NCT04259606|Antacids|antacids|mesh-ancestor
5527945|NCT04259606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5527946|NCT04259606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6110072|NCT01017042|Tubulin Modulators|tubulin modulators|mesh-ancestor
6110073|NCT01017042|Antimitotic Agents|antimitotic agents|mesh-ancestor
5527947|NCT04259775|Insulin|insulin|mesh-list
5527948|NCT04259775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5527949|NCT04259775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527950|NCT04259398|Propofol|propofol|mesh-list
6110074|NCT01017042|Mitosis Modulators|mitosis modulators|mesh-ancestor
6110075|NCT01017042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110076|NCT01017042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6110077|NCT01017120|Tazarotene|tazarotene|mesh-list
6110078|NCT01017120|Dermatologic Agents|dermatologic agents|mesh-ancestor
6110079|NCT01017120|Keratolytic Agents|keratolytic agents|mesh-ancestor
6110080|NCT01017146|Tazarotene|tazarotene|mesh-list
6110081|NCT01017146|Dermatologic Agents|dermatologic agents|mesh-ancestor
6110082|NCT01017146|Keratolytic Agents|keratolytic agents|mesh-ancestor
6110083|NCT01017237|Midazolam|midazolam|mesh-list
6110084|NCT01017237|Dexmedetomidine|dexmedetomidine|mesh-list
6110085|NCT01017237|Ketamine|ketamine|mesh-list
6110086|NCT01017237|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6110087|NCT01017237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6110088|NCT01017237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110089|NCT01017237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6110090|NCT01017237|Analgesics|analgesics|mesh-ancestor
6110091|NCT01017237|Sensory System Agents|sensory system agents|mesh-ancestor
6110092|NCT01017237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6110093|NCT01017237|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6110094|NCT01017237|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6110095|NCT01017237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6110096|NCT01017237|Adrenergic Agents|adrenergic agents|mesh-ancestor
6110097|NCT01017237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6110098|NCT01017237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110099|NCT01017237|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6110100|NCT01017237|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6110101|NCT01017237|Anesthetics, General|anesthetics, general|mesh-ancestor
6110102|NCT01017237|Anesthetics|anesthetics|mesh-ancestor
6110103|NCT01017237|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6110104|NCT01017237|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6110105|NCT01017237|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6110106|NCT01017237|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6110107|NCT01017237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5527951|NCT04259398|Sevoflurane|sevoflurane|mesh-list
5527952|NCT04259398|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6110108|NCT01017237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6110109|NCT01017237|GABA Modulators|gaba modulators|mesh-ancestor
6110110|NCT01017237|GABA Agents|gaba agents|mesh-ancestor
6110111|NCT01017250|Bevacizumab|bevacizumab|mesh-list
6110112|NCT01017250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6110113|NCT01017250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6110114|NCT01017250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6110115|NCT01017250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6110116|NCT01017250|Growth Substances|growth substances|mesh-ancestor
6110117|NCT01017250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110118|NCT01017250|Growth Inhibitors|growth inhibitors|mesh-ancestor
6110119|NCT01017575|Ribavirin|ribavirin|mesh-list
6110120|NCT01017575|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6110121|NCT01017575|Antimetabolites|antimetabolites|mesh-ancestor
6110122|NCT01017575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110123|NCT01017575|Antiviral Agents|antiviral agents|mesh-ancestor
6110124|NCT01017575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6110125|NCT01017653|Irinotecan|irinotecan|mesh-list
6110126|NCT01017653|Panitumumab|panitumumab|mesh-list
6110127|NCT01017653|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6110128|NCT01017653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6110129|NCT01017653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6110130|NCT01017653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110131|NCT01017653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6110132|NCT01017653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6110133|NCT01017731|Diphenhydramine|diphenhydramine|mesh-list
6110134|NCT01017731|Promethazine|promethazine|mesh-list
6110135|NCT01017731|Moxifloxacin|moxifloxacin|mesh-list
6110136|NCT01017731|Ramucirumab|ramucirumab|mesh-list
6110137|NCT01017731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6110138|NCT01017731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5527953|NCT04259398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5527954|NCT04259398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527955|NCT04259398|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5527956|NCT04259398|Anesthetics, General|anesthetics, general|mesh-ancestor
5527957|NCT04259398|Anesthetics|anesthetics|mesh-ancestor
5527958|NCT04259398|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5527959|NCT04259398|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5527960|NCT04259476|Ketamine|ketamine|mesh-list
5527961|NCT04259476|Analgesics|analgesics|mesh-ancestor
5527962|NCT04259476|Sensory System Agents|sensory system agents|mesh-ancestor
5527963|NCT04259476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5527964|NCT04259476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110139|NCT01017731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6110140|NCT01017731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6110141|NCT01017731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6110142|NCT01017731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110143|NCT01017731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6110144|NCT01017731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110145|NCT01017731|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6110146|NCT01017731|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6110147|NCT01017731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6110148|NCT01017731|Anesthetics, Local|anesthetics, local|mesh-ancestor
6110149|NCT01017731|Anesthetics|anesthetics|mesh-ancestor
6110150|NCT01017731|Sensory System Agents|sensory system agents|mesh-ancestor
6110151|NCT01017731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6110152|NCT01017731|Antiemetics|antiemetics|mesh-ancestor
6110153|NCT01017731|Autonomic Agents|autonomic agents|mesh-ancestor
6110154|NCT01017731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6110155|NCT01017731|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6110156|NCT01017731|Histamine Antagonists|histamine antagonists|mesh-ancestor
6110157|NCT01017731|Histamine Agents|histamine agents|mesh-ancestor
5527965|NCT04259476|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5527966|NCT04259476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5527967|NCT04259476|Anesthetics, General|anesthetics, general|mesh-ancestor
5527968|NCT04259476|Anesthetics|anesthetics|mesh-ancestor
5527969|NCT04259476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5527970|NCT04259476|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5527971|NCT04259476|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5527972|NCT04259476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5527973|NCT04259476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601405|NCT05177601|Cycloserine|cycloserine|mesh-list
6110158|NCT01017731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6110159|NCT01017731|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6110160|NCT01017731|Antipruritics|antipruritics|mesh-ancestor
6110161|NCT01017731|Dermatologic Agents|dermatologic agents|mesh-ancestor
6110162|NCT01017874|Pemetrexed|pemetrexed|mesh-list
5527974|NCT04259346|Ixekizumab|ixekizumab|mesh-list
5527975|NCT04259346|Dermatologic Agents|dermatologic agents|mesh-ancestor
5527976|NCT04259645|Bupivacaine|bupivacaine|mesh-list
5527977|NCT04259645|Anesthetics, Local|anesthetics, local|mesh-ancestor
5527978|NCT04259645|Anesthetics|anesthetics|mesh-ancestor
5527979|NCT04259645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5527980|NCT04259645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527981|NCT04259645|Sensory System Agents|sensory system agents|mesh-ancestor
5527982|NCT04259645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5527983|NCT04259333|Acetaminophen|acetaminophen|mesh-list
5527984|NCT04259333|Celecoxib|celecoxib|mesh-list
5527985|NCT04259333|Codeine|codeine|mesh-list
6110163|NCT01017874|Gefitinib|gefitinib|mesh-list
6110164|NCT01017874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5527986|NCT04259333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5527987|NCT04259333|Analgesics|analgesics|mesh-ancestor
5527988|NCT04259333|Sensory System Agents|sensory system agents|mesh-ancestor
5527989|NCT04259333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6110165|NCT01017874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6110166|NCT01017874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110167|NCT01017874|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6110168|NCT01017874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6110169|NCT01017874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6110170|NCT01018056|Riluzole|riluzole|mesh-list
6110171|NCT01018056|Anticonvulsants|anticonvulsants|mesh-ancestor
6110172|NCT01018056|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6110173|NCT01018056|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6110174|NCT01018056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6110175|NCT01018056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110176|NCT01018056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110177|NCT01018056|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6110178|NCT01018056|Protective Agents|protective agents|mesh-ancestor
6110179|NCT01018095|Metronidazole|metronidazole|mesh-list
6110180|NCT01018095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6110181|NCT01018095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6110182|NCT01018095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6110183|NCT01018095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6110184|NCT01018134|Desoximetasone|desoximetasone|mesh-list
6110185|NCT01018134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6110186|NCT01018134|Glucocorticoids|glucocorticoids|mesh-ancestor
6110187|NCT01018134|Hormones|hormones|mesh-ancestor
5527990|NCT04259333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5527991|NCT04259333|Antipyretics|antipyretics|mesh-ancestor
5527992|NCT04259333|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5527993|NCT04259333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5527994|NCT04259333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5527995|NCT04259333|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5527996|NCT04259333|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5527997|NCT04259333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5527998|NCT04259333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110188|NCT01018134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6110189|NCT01018134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110190|NCT01018186|Fluticasone|fluticasone|mesh-list
6110191|NCT01018186|Xhance|xhance|mesh-list
6110192|NCT01018186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6110193|NCT01018186|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6110194|NCT01018186|Autonomic Agents|autonomic agents|mesh-ancestor
6110195|NCT01018186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6110196|NCT01018186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110197|NCT01018186|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6110198|NCT01018186|Respiratory System Agents|respiratory system agents|mesh-ancestor
6110199|NCT01018186|Dermatologic Agents|dermatologic agents|mesh-ancestor
6110200|NCT01018186|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6110201|NCT01018264|Solifenacin Succinate|solifenacin succinate|mesh-list
6110202|NCT01018264|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6110203|NCT01018264|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6110204|NCT01018264|Cholinergic Agents|cholinergic agents|mesh-ancestor
5527999|NCT04259333|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5528000|NCT04259333|Narcotics|narcotics|mesh-ancestor
5528001|NCT04259333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5528002|NCT04259333|Antitussive Agents|antitussive agents|mesh-ancestor
5528003|NCT04259333|Respiratory System Agents|respiratory system agents|mesh-ancestor
6110205|NCT01018264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6207769|NCT02120261|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5528004|NCT04259658|Calcium|calcium|mesh-list
5528005|NCT04259658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6465423|NCT00474435|Tenofovir|tenofovir|mesh-list
6465424|NCT00474435|Emtricitabine|emtricitabine|mesh-list
6465425|NCT00474435|Efavirenz|efavirenz|mesh-list
6465426|NCT00474435|Antiviral Agents|antiviral agents|mesh-ancestor
6465427|NCT00474435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6465428|NCT00474435|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6465429|NCT00474435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6110206|NCT01018264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110207|NCT01018264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110208|NCT01018264|Urological Agents|urological agents|mesh-ancestor
6110209|NCT01018394|Nicotine|nicotine|mesh-list
6110210|NCT01018394|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6110211|NCT01018394|Autonomic Agents|autonomic agents|mesh-ancestor
6110212|NCT01018394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6110213|NCT01018394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110214|NCT01018394|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6110215|NCT01018394|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6110216|NCT01018394|Cholinergic Agents|cholinergic agents|mesh-ancestor
6110217|NCT01018394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6110218|NCT01018394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110219|NCT01018420|Moxifloxacin|moxifloxacin|mesh-list
5528006|NCT04259658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528007|NCT04259060|Hydroxocobalamin|hydroxocobalamin|mesh-list
5528008|NCT04259060|Vitamin B 12|vitamin b 12|mesh-list
5528009|NCT04259060|Hematinics|hematinics|mesh-ancestor
6110220|NCT01018420|Colchicine|colchicine|mesh-list
6110221|NCT01018420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6110222|NCT01018420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6110223|NCT01018420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6110224|NCT01018420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6110225|NCT01018420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6110226|NCT01018420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110227|NCT01018420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6110228|NCT01018420|Gout Suppressants|gout suppressants|mesh-ancestor
6110229|NCT01018420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6110230|NCT01018420|Tubulin Modulators|tubulin modulators|mesh-ancestor
6110231|NCT01018420|Antimitotic Agents|antimitotic agents|mesh-ancestor
6110232|NCT01018420|Mitosis Modulators|mitosis modulators|mesh-ancestor
6110233|NCT01018511|Tamsulosin|tamsulosin|mesh-list
6110234|NCT01018511|Solifenacin Succinate|solifenacin succinate|mesh-list
6110235|NCT01018511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6110236|NCT01018511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6110237|NCT01018511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6110238|NCT01018511|Adrenergic Agents|adrenergic agents|mesh-ancestor
6110239|NCT01018511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6110240|NCT01018511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110241|NCT01018511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110242|NCT01018511|Urological Agents|urological agents|mesh-ancestor
6110243|NCT01018511|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6110244|NCT01018511|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6110245|NCT01018511|Cholinergic Agents|cholinergic agents|mesh-ancestor
6110246|NCT01018680|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6110247|NCT01018680|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6110248|NCT01018680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6110249|NCT01018680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6110250|NCT01018680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110251|NCT01018680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6110252|NCT01018680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110253|NCT01018680|Analgesics|analgesics|mesh-ancestor
6110254|NCT01018680|Sensory System Agents|sensory system agents|mesh-ancestor
6110255|NCT01018680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6110256|NCT01018680|Antidepressive Agents|antidepressive agents|mesh-ancestor
6110257|NCT01018680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6110258|NCT01018680|Dopamine Agents|dopamine agents|mesh-ancestor
6110259|NCT01018732|Lactitol|lactitol|mesh-list
6110260|NCT01018732|Cathartics|cathartics|mesh-ancestor
6110261|NCT01018732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6110262|NCT01018862|Azelastine|azelastine|mesh-list
6110263|NCT01018862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6110264|NCT01018862|Autonomic Agents|autonomic agents|mesh-ancestor
6110265|NCT01018862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6110266|NCT01018862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110267|NCT01018862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6465430|NCT00474435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6465431|NCT00474435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110268|NCT01018862|Respiratory System Agents|respiratory system agents|mesh-ancestor
6110269|NCT01018862|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6110270|NCT01018862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6110271|NCT01018862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110272|NCT01018862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6110273|NCT01018862|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6110274|NCT01018862|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6110275|NCT01018862|Histamine Antagonists|histamine antagonists|mesh-ancestor
6110276|NCT01018862|Histamine Agents|histamine agents|mesh-ancestor
6110277|NCT01018862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6110278|NCT01019317|Vidarabine|vidarabine|mesh-list
6110279|NCT01019317|Cytarabine|cytarabine|mesh-list
6110280|NCT01019317|Fludarabine|fludarabine|mesh-list
6110281|NCT01019317|Fludarabine phosphate|fludarabine phosphate|mesh-list
5528010|NCT04259060|Vitamin B Complex|vitamin b complex|mesh-ancestor
5528011|NCT04259060|Vitamins|vitamins|mesh-ancestor
5528012|NCT04259060|Micronutrients|micronutrients|mesh-ancestor
5528013|NCT04259060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528014|NCT04259073|Pregabalin|pregabalin|mesh-list
5528015|NCT04259073|Analgesics|analgesics|mesh-ancestor
5528016|NCT04259073|Sensory System Agents|sensory system agents|mesh-ancestor
5528017|NCT04259073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5528018|NCT04259073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528019|NCT04259073|Anticonvulsants|anticonvulsants|mesh-ancestor
5528020|NCT04259073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5528021|NCT04259073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5528022|NCT04259073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528023|NCT04259073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5528024|NCT04259073|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5528025|NCT04259073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5528026|NCT04259073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5528027|NCT04259073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5528028|NCT04258956|Avelumab|avelumab|mesh-list
5528029|NCT04258956|Axitinib|axitinib|mesh-list
5528030|NCT04258956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5528031|NCT04258956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5528032|NCT04258956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5528033|NCT04258956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5528034|NCT04258956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110282|NCT01019317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6110283|NCT01019317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6110284|NCT01019317|Antimetabolites|antimetabolites|mesh-ancestor
6110285|NCT01019317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110286|NCT01019317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6110287|NCT01019317|Immunologic Factors|immunologic factors|mesh-ancestor
6110288|NCT01019317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110289|NCT01019317|Antiviral Agents|antiviral agents|mesh-ancestor
6110290|NCT01019317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6110291|NCT01019369|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6110292|NCT01019369|Medroxyprogesterone|medroxyprogesterone|mesh-list
6110293|NCT01019369|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6110294|NCT01019369|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6110295|NCT01019369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6110296|NCT01019369|Contraceptive Agents|contraceptive agents|mesh-ancestor
6110297|NCT01019369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6110298|NCT01019369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110299|NCT01019369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6110300|NCT01019369|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6110301|NCT01019369|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6110302|NCT01019369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6110303|NCT01019369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6110304|NCT01019486|Regadenoson|regadenoson|mesh-list
6110305|NCT01019486|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
6110306|NCT01019486|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
6110307|NCT01019486|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6110308|NCT01019486|Purinergic Agonists|purinergic agonists|mesh-ancestor
6110309|NCT01019486|Purinergic Agents|purinergic agents|mesh-ancestor
6110310|NCT01019486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6110311|NCT01019486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110312|NCT01019486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110313|NCT01019486|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6110314|NCT01019694|Albuterol|albuterol|mesh-list
5528035|NCT04259008|Manganese|manganese|mesh-list
6110315|NCT01019694|Ipratropium|ipratropium|mesh-list
6110316|NCT01019694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6110317|NCT01019694|Autonomic Agents|autonomic agents|mesh-ancestor
6110318|NCT01019694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6110319|NCT01019694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110320|NCT01019694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6110321|NCT01019694|Respiratory System Agents|respiratory system agents|mesh-ancestor
6110322|NCT01019694|Tocolytic Agents|tocolytic agents|mesh-ancestor
6110323|NCT01019694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6110324|NCT01019694|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6110325|NCT01019694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6110326|NCT01019694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6110327|NCT01019694|Adrenergic Agents|adrenergic agents|mesh-ancestor
6110328|NCT01019694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6110329|NCT01019694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110330|NCT01019694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6110331|NCT01019694|Cholinergic Agents|cholinergic agents|mesh-ancestor
6110332|NCT01019707|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6110333|NCT01019707|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5528036|NCT04259008|Trace Elements|trace elements|mesh-ancestor
5528037|NCT04259008|Micronutrients|micronutrients|mesh-ancestor
5528038|NCT04259008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528039|NCT04258930|Calcium|calcium|mesh-list
5528040|NCT04258930|Calcium acetate|calcium acetate|mesh-list
5528041|NCT04258930|Aluminum sulfate|aluminum sulfate|mesh-list
5528042|NCT04258930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5528043|NCT04258930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528044|NCT04258930|Chelating Agents|chelating agents|mesh-ancestor
5528045|NCT04258930|Sequestering Agents|sequestering agents|mesh-ancestor
5528046|NCT04258930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528047|NCT04258930|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5528048|NCT04258930|Immunologic Factors|immunologic factors|mesh-ancestor
5528049|NCT04258657|Paclitaxel|paclitaxel|mesh-list
5528050|NCT04258657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5528051|NCT04258657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5528052|NCT04258657|Tubulin Modulators|tubulin modulators|mesh-ancestor
5528053|NCT04258657|Antimitotic Agents|antimitotic agents|mesh-ancestor
5528054|NCT04258657|Mitosis Modulators|mitosis modulators|mesh-ancestor
5528055|NCT04258657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528056|NCT04258553|Antioxidants|antioxidants|mesh-list
5528057|NCT04258553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528058|NCT04258553|Protective Agents|protective agents|mesh-ancestor
5528059|NCT04258553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528060|NCT04258839|Brexpiprazole|brexpiprazole|mesh-list
6110334|NCT01019707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6110335|NCT01019707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6110336|NCT01019707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110337|NCT01019707|Adrenergic Agents|adrenergic agents|mesh-ancestor
6110338|NCT01019707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6110339|NCT01019707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110340|NCT01020006|Gemcitabine|gemcitabine|mesh-list
6110341|NCT01020006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6110342|NCT01020006|Antimetabolites|antimetabolites|mesh-ancestor
6110343|NCT01020006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110344|NCT01020006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6110345|NCT01020006|Antiviral Agents|antiviral agents|mesh-ancestor
6110346|NCT01020006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6110347|NCT01020006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6110348|NCT01020006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6110349|NCT01020006|Immunologic Factors|immunologic factors|mesh-ancestor
6110350|NCT01020006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110351|NCT01020019|Lofexidine|lofexidine|mesh-list
5528061|NCT04258839|Serotonin Agents|serotonin agents|mesh-ancestor
5528062|NCT04258839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5528063|NCT04258839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528064|NCT04258839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528065|NCT04258839|Dopamine Agonists|dopamine agonists|mesh-ancestor
5528066|NCT04258839|Dopamine Agents|dopamine agents|mesh-ancestor
5528067|NCT04258475|Raltegravir Potassium|raltegravir potassium|mesh-list
5528068|NCT04258475|Calcium|calcium|mesh-list
5528069|NCT04258475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5528070|NCT04258475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110352|NCT01020019|Dronabinol|dronabinol|mesh-list
6110353|NCT01020019|Hallucinogens|hallucinogens|mesh-ancestor
5528071|NCT04258475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6110354|NCT01020019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110355|NCT01020019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6110356|NCT01020019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6110357|NCT01020019|Analgesics|analgesics|mesh-ancestor
6110358|NCT01020019|Sensory System Agents|sensory system agents|mesh-ancestor
6110359|NCT01020019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6110360|NCT01020019|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6110361|NCT01020019|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6110362|NCT01020019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5528072|NCT04258475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5528073|NCT04258475|Antiviral Agents|antiviral agents|mesh-ancestor
5528074|NCT04258475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5528075|NCT04258475|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5528076|NCT04258475|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5528077|NCT04258475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5528078|NCT04258475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528079|NCT04258644|Paclitaxel|paclitaxel|mesh-list
5528080|NCT04258644|Apatinib|apatinib|mesh-list
5528081|NCT04258644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5528082|NCT04258644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5528083|NCT04258644|Tubulin Modulators|tubulin modulators|mesh-ancestor
5528084|NCT04258644|Antimitotic Agents|antimitotic agents|mesh-ancestor
5528085|NCT04258644|Mitosis Modulators|mitosis modulators|mesh-ancestor
5528086|NCT04258644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528087|NCT04258644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5528088|NCT04258644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5528089|NCT04258397|Pirfenidone|pirfenidone|mesh-list
5528090|NCT04258397|Analgesics|analgesics|mesh-ancestor
5528091|NCT04258397|Sensory System Agents|sensory system agents|mesh-ancestor
5528092|NCT04258397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5528093|NCT04258397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528094|NCT04258397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5528095|NCT04258397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5528096|NCT04258397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5528097|NCT04258397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5528098|NCT04258397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5528099|NCT04258683|Pembrolizumab|pembrolizumab|mesh-list
5528100|NCT04258683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5528101|NCT04258683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5528102|NCT04258631|Hydromorphone|hydromorphone|mesh-list
5528103|NCT04258631|Bupivacaine|bupivacaine|mesh-list
5528104|NCT04258631|Anesthetics, Local|anesthetics, local|mesh-ancestor
5528105|NCT04258631|Anesthetics|anesthetics|mesh-ancestor
5528106|NCT04258631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5528107|NCT04258631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528108|NCT04258631|Sensory System Agents|sensory system agents|mesh-ancestor
5528109|NCT04258631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5528110|NCT04258631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6110363|NCT01020019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110364|NCT01020019|Hormones|hormones|mesh-ancestor
6110365|NCT01020019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6110366|NCT01020019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6110367|NCT01020019|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6110368|NCT01020019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6110369|NCT01020019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6110370|NCT01020019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6110371|NCT01020019|Adrenergic Agents|adrenergic agents|mesh-ancestor
6110372|NCT01020123|Glipizide|glipizide|mesh-list
6110373|NCT01020123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6110374|NCT01020123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110375|NCT01020305|Sirolimus|sirolimus|mesh-list
6110376|NCT01020305|Bicalutamide|bicalutamide|mesh-list
5528111|NCT04258631|Narcotics|narcotics|mesh-ancestor
5528112|NCT04258631|Analgesics|analgesics|mesh-ancestor
6110377|NCT01020305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6110378|NCT01020305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6110379|NCT01020305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6110380|NCT01020305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6110381|NCT01020305|Antifungal Agents|antifungal agents|mesh-ancestor
6110382|NCT01020305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6110383|NCT01020305|Immunologic Factors|immunologic factors|mesh-ancestor
6110384|NCT01020305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110385|NCT01020305|Androgen Antagonists|androgen antagonists|mesh-ancestor
6110386|NCT01020305|Hormone Antagonists|hormone antagonists|mesh-ancestor
6110387|NCT01020305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6204177|NCT02066311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204178|NCT02066311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6204179|NCT02066311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6204180|NCT02066311|Antiviral Agents|antiviral agents|mesh-ancestor
6204181|NCT02066311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6204182|NCT02066389|Upadacitinib|upadacitinib|mesh-list
6204183|NCT02066389|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
6204184|NCT02066389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6204185|NCT02066389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6204186|NCT02066389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204187|NCT02066389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6204188|NCT02066402|Linezolid|linezolid|mesh-list
6204189|NCT02066402|Tedizolid|tedizolid|mesh-list
6204190|NCT02066402|Oxazolidinones|oxazolidinones|mesh-list
6204191|NCT02066402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6204192|NCT02066402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6204193|NCT02066402|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6204194|NCT02066402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6204195|NCT02066402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204196|NCT02066415|Erenumab|erenumab|mesh-list
6204197|NCT02066415|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
6204198|NCT02066415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204199|NCT02066415|Analgesics|analgesics|mesh-ancestor
6204200|NCT02066415|Sensory System Agents|sensory system agents|mesh-ancestor
6204201|NCT02066415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6204202|NCT02066415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204203|NCT02066727|Dexmedetomidine|dexmedetomidine|mesh-list
6204204|NCT02066727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6207770|NCT02120261|Anesthetics, Local|anesthetics, local|mesh-ancestor
5528113|NCT04258163|Gemcitabine|gemcitabine|mesh-list
5528114|NCT04258163|Capecitabine|capecitabine|mesh-list
5528115|NCT04258163|Doxorubicin|doxorubicin|mesh-list
5528116|NCT04258163|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5528117|NCT04258163|Letrozole|letrozole|mesh-list
5528118|NCT04258163|Fulvestrant|fulvestrant|mesh-list
5528119|NCT04258163|Anastrozole|anastrozole|mesh-list
5528120|NCT04258163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5528121|NCT04258163|Antimetabolites|antimetabolites|mesh-ancestor
5528122|NCT04258163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528123|NCT04258163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5528124|NCT04258163|Antiviral Agents|antiviral agents|mesh-ancestor
5528125|NCT04258163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5528126|NCT04258163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5528127|NCT04258163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5528128|NCT04258163|Immunologic Factors|immunologic factors|mesh-ancestor
5528129|NCT04258163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528130|NCT04258163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5528131|NCT04258163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5528132|NCT04258163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5528133|NCT04258163|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5528134|NCT04258163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5528135|NCT04258163|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5528136|NCT04258163|Hormone Antagonists|hormone antagonists|mesh-ancestor
5528137|NCT04258163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5528138|NCT04258163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5725359|NCT03180944|Coagulants|coagulants|mesh-ancestor
6110388|NCT01020448|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6110389|NCT01020448|Luteolytic Agents|luteolytic agents|mesh-ancestor
6110390|NCT01020448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6110391|NCT01020448|Contraceptive Agents|contraceptive agents|mesh-ancestor
6110392|NCT01020448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6110393|NCT01020448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110394|NCT01020448|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6110395|NCT01020448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6110396|NCT01020448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6110397|NCT01020474|Pregabalin|pregabalin|mesh-list
6110398|NCT01020474|Analgesics|analgesics|mesh-ancestor
6110399|NCT01020474|Sensory System Agents|sensory system agents|mesh-ancestor
6110400|NCT01020474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6110401|NCT01020474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110402|NCT01020474|Anticonvulsants|anticonvulsants|mesh-ancestor
6110403|NCT01020474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6110404|NCT01020474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6110405|NCT01020474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110406|NCT01020474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5528139|NCT04258163|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5528140|NCT04258241|Bupivacaine|bupivacaine|mesh-list
5528141|NCT04258241|Anesthetics, Local|anesthetics, local|mesh-list
5528142|NCT04258241|Anesthetics|anesthetics|mesh-list
5528143|NCT04258241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5528144|NCT04258241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5528145|NCT04258241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528146|NCT04258241|Sensory System Agents|sensory system agents|mesh-ancestor
5528147|NCT04258241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5528148|NCT04258423|Everolimus|everolimus|mesh-list
5528149|NCT04258423|Tacrolimus|tacrolimus|mesh-list
5528150|NCT04258423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6110407|NCT01020474|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6110408|NCT01020474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6110409|NCT01020474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6110410|NCT01020474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6110411|NCT01020526|Pregabalin|pregabalin|mesh-list
6110412|NCT01020526|Analgesics|analgesics|mesh-ancestor
6110413|NCT01020526|Sensory System Agents|sensory system agents|mesh-ancestor
6110414|NCT01020526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6110415|NCT01020526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110416|NCT01020526|Anticonvulsants|anticonvulsants|mesh-ancestor
6110417|NCT01020526|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6110418|NCT01020526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6110419|NCT01020526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110420|NCT01020526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6110421|NCT01020526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6110422|NCT01020526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6110423|NCT01020526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6110424|NCT01020526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6110425|NCT01020747|Bevacizumab|bevacizumab|mesh-list
6110426|NCT01020747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6110427|NCT01020747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6110428|NCT01020747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6110429|NCT01020747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6110430|NCT01020747|Growth Substances|growth substances|mesh-ancestor
6110431|NCT01020747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110432|NCT01020747|Growth Inhibitors|growth inhibitors|mesh-ancestor
6110433|NCT01020786|Carboplatin|carboplatin|mesh-list
6110434|NCT01020786|Pemetrexed|pemetrexed|mesh-list
6110435|NCT01020786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6110436|NCT01020786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6110437|NCT01020786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110438|NCT01020786|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6110439|NCT01020786|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6110440|NCT01020799|Citalopram|citalopram|mesh-list
6110441|NCT01020799|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6110442|NCT01020799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6110443|NCT01020799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6110444|NCT01020799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110445|NCT01020799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6110446|NCT01020799|Serotonin Agents|serotonin agents|mesh-ancestor
6110447|NCT01020799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528151|NCT04258423|Immunologic Factors|immunologic factors|mesh-ancestor
6110448|NCT01020799|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6110449|NCT01020799|Antidepressive Agents|antidepressive agents|mesh-ancestor
6666019|NCT01520285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6666020|NCT01520285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666021|NCT01520285|Vasodilator Agents|vasodilator agents|mesh-ancestor
6666022|NCT01520298|Acetaminophen|acetaminophen|mesh-list
6110450|NCT01020799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6110451|NCT01020877|Metronidazole|metronidazole|mesh-list
6110452|NCT01020877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6110453|NCT01020877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6110454|NCT01020877|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6110455|NCT01020877|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6110456|NCT01021020|Colchicine|colchicine|mesh-list
5528152|NCT04258423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110457|NCT01021020|Probenecid|probenecid|mesh-list
6110458|NCT01021020|Gout Suppressants|gout suppressants|mesh-ancestor
6110459|NCT01021020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6110460|NCT01021020|Tubulin Modulators|tubulin modulators|mesh-ancestor
6110461|NCT01021020|Antimitotic Agents|antimitotic agents|mesh-ancestor
6110462|NCT01021020|Mitosis Modulators|mitosis modulators|mesh-ancestor
6110463|NCT01021020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110464|NCT01021020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6110465|NCT01021020|Uricosuric Agents|uricosuric agents|mesh-ancestor
6110466|NCT01021020|Renal Agents|renal agents|mesh-ancestor
6110467|NCT01021215|Celecoxib|celecoxib|mesh-list
6110468|NCT01021215|Zileuton|zileuton|mesh-list
6110469|NCT01021215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6110470|NCT01021215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6110471|NCT01021215|Analgesics|analgesics|mesh-ancestor
6110472|NCT01021215|Sensory System Agents|sensory system agents|mesh-ancestor
6110473|NCT01021215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6110474|NCT01021215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110475|NCT01021215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6110476|NCT01021215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6110477|NCT01021215|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6110478|NCT01021215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6110479|NCT01021215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6110480|NCT01021215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110481|NCT01021215|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6110482|NCT01021215|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6110483|NCT01021215|Hormone Antagonists|hormone antagonists|mesh-ancestor
6110484|NCT01021215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6110485|NCT01021332|Tamsulosin|tamsulosin|mesh-list
6110486|NCT01021332|Solifenacin Succinate|solifenacin succinate|mesh-list
6110487|NCT01021332|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6110488|NCT01021332|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6110489|NCT01021332|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6110490|NCT01021332|Adrenergic Agents|adrenergic agents|mesh-ancestor
6110491|NCT01021332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6110492|NCT01021332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110493|NCT01021332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110494|NCT01021332|Urological Agents|urological agents|mesh-ancestor
6110495|NCT01021332|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6110496|NCT01021332|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6110497|NCT01021332|Cholinergic Agents|cholinergic agents|mesh-ancestor
6110498|NCT01021423|Lenalidomide|lenalidomide|mesh-list
6110499|NCT01021423|Immunologic Factors|immunologic factors|mesh-ancestor
6110500|NCT01021423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110501|NCT01021423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6110502|NCT01021423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6110503|NCT01021423|Growth Substances|growth substances|mesh-ancestor
6110504|NCT01021423|Growth Inhibitors|growth inhibitors|mesh-ancestor
6110505|NCT01021423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6110506|NCT01021553|Diketopiperazines|diketopiperazines|mesh-list
6110507|NCT01021553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6110508|NCT01021553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6110509|NCT01021618|Dipyridamole|dipyridamole|mesh-list
6110510|NCT01021618|Regadenoson|regadenoson|mesh-list
5528153|NCT04258423|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5528154|NCT04258423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5528155|NCT04258423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528156|NCT04258423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5528157|NCT04258306|Resveratrol|resveratrol|mesh-list
5528158|NCT04258306|Antioxidants|antioxidants|mesh-ancestor
5528159|NCT04258306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528160|NCT04258306|Protective Agents|protective agents|mesh-ancestor
6110511|NCT01021618|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
6110512|NCT01021618|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6110513|NCT01021618|Purinergic Agonists|purinergic agonists|mesh-ancestor
6110514|NCT01021618|Purinergic Agents|purinergic agents|mesh-ancestor
6110515|NCT01021618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6110516|NCT01021618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110517|NCT01021618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110518|NCT01021618|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6110519|NCT01021618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6110520|NCT01021618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6110521|NCT01021618|Vasodilator Agents|vasodilator agents|mesh-ancestor
6110522|NCT01021683|Itraconazole|itraconazole|mesh-list
6110523|NCT01021683|Antifungal Agents|antifungal agents|mesh-ancestor
6110524|NCT01021683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6110525|NCT01021683|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6110526|NCT01021683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6110527|NCT01021683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6110528|NCT01021683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110529|NCT01021683|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6110530|NCT01021683|Hormone Antagonists|hormone antagonists|mesh-ancestor
6110531|NCT01021683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6110532|NCT01021683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110533|NCT01021683|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6110534|NCT01021761|Ketorolac|ketorolac|mesh-list
6110535|NCT01021761|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6110536|NCT01021761|Nepafenac|nepafenac|mesh-list
6110537|NCT01021761|Bromfenac|bromfenac|mesh-list
6110538|NCT01021761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6110539|NCT01021761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6110540|NCT01021761|Analgesics|analgesics|mesh-ancestor
6110541|NCT01021761|Sensory System Agents|sensory system agents|mesh-ancestor
6110542|NCT01021761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6110543|NCT01021761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110544|NCT01021761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6110545|NCT01021761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6110546|NCT01021761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6110547|NCT01021761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5528161|NCT04258306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528162|NCT04258306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5528163|NCT04258306|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5528164|NCT04258150|Nivolumab|nivolumab|mesh-list
5528165|NCT04258150|Ipilimumab|ipilimumab|mesh-list
5528166|NCT04258150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5528167|NCT04258150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5528168|NCT04258150|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5528169|NCT04258150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528170|NCT04258371|Dapagliflozin|dapagliflozin|mesh-list
5528171|NCT04258371|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5528172|NCT04258371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528173|NCT04258371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5528174|NCT04258371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528175|NCT04258098|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6110548|NCT01021761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110549|NCT01021813|Suvorexant|suvorexant|mesh-list
6110550|NCT01021813|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6110551|NCT01021813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6110552|NCT01021813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6110553|NCT01021813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110554|NCT01021813|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
6110555|NCT01021813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6110556|NCT01021813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110557|NCT01021878|Icodextrin|icodextrin|mesh-list
5528176|NCT04258098|Metronidazole|metronidazole|mesh-list
5528177|NCT04258098|Streptomycin|streptomycin|mesh-list
6110558|NCT01021878|Dialysis Solutions|dialysis solutions|mesh-ancestor
6110559|NCT01021878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6110560|NCT01022190|Etoricoxib|etoricoxib|mesh-list
6110561|NCT01022190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6110562|NCT01022190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6110563|NCT01022190|Analgesics|analgesics|mesh-ancestor
6110564|NCT01022190|Sensory System Agents|sensory system agents|mesh-ancestor
6110565|NCT01022190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6110566|NCT01022190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110567|NCT01022190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6110568|NCT01022190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6110569|NCT01022190|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6110570|NCT01022190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6110571|NCT01022190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6110572|NCT01022190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110573|NCT01022424|Tolvaptan|tolvaptan|mesh-list
6110574|NCT01022424|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6110575|NCT01022424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110576|NCT01022424|Natriuretic Agents|natriuretic agents|mesh-ancestor
6110577|NCT01022424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110578|NCT01022567|Ertapenem|ertapenem|mesh-list
6110579|NCT01022567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6110580|NCT01022567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5528178|NCT04258098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5528179|NCT04258098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5528180|NCT04258098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5528181|NCT04258098|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5528182|NCT04258098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5528183|NCT04258098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528184|NCT04258111|Antibodies|antibodies|mesh-list
5528185|NCT04258111|Immunoglobulins|immunoglobulins|mesh-list
5528186|NCT04258111|Immunologic Factors|immunologic factors|mesh-ancestor
5528187|NCT04258111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528188|NCT04258046|Trametinib|trametinib|mesh-list
5528189|NCT04258046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5528190|NCT04258046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5528191|NCT04258046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5528192|NCT04258046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528193|NCT04258007|Neostigmine|neostigmine|mesh-list
5528194|NCT04258007|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5528195|NCT04258007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5528196|NCT04258007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110581|NCT01022580|Pulmonary Surfactants|pulmonary surfactants|mesh-list
6110582|NCT01022580|Calfactant|calfactant|mesh-list
6110583|NCT01022580|Respiratory System Agents|respiratory system agents|mesh-ancestor
6110584|NCT01022762|Repaglinide|repaglinide|mesh-list
5528197|NCT04258007|Cholinergic Agents|cholinergic agents|mesh-ancestor
5528198|NCT04258007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5528199|NCT04258007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528200|NCT04258007|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5528201|NCT04258007|Autonomic Agents|autonomic agents|mesh-ancestor
5528202|NCT04258007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5528203|NCT04257838|Meropenem|meropenem|mesh-list
5528204|NCT04257838|Tazobactam|tazobactam|mesh-list
5528205|NCT04257838|Piperacillin|piperacillin|mesh-list
5528206|NCT04257838|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
6110585|NCT01022762|Gliclazide|gliclazide|mesh-list
6110586|NCT01022762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6110587|NCT01022762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110588|NCT01022853|Nintedanib|nintedanib|mesh-list
6110589|NCT01022853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6110590|NCT01022853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6110591|NCT01022853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6110592|NCT01022853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110593|NCT01022996|Everolimus|everolimus|mesh-list
5528207|NCT04257838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5528208|NCT04257838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5528209|NCT04257838|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5528210|NCT04257838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5528211|NCT04257838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110594|NCT01022996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6110595|NCT01022996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6110596|NCT01022996|Immunologic Factors|immunologic factors|mesh-ancestor
5528212|NCT04257851|Sumatriptan|sumatriptan|mesh-list
5528213|NCT04257851|Theophylline|theophylline|mesh-list
5725360|NCT03180775|Glycine|glycine|mesh-list
5528214|NCT04257851|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5528215|NCT04257851|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5528216|NCT04257851|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5528217|NCT04257851|Serotonin Agents|serotonin agents|mesh-ancestor
5528218|NCT04257851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5528219|NCT04257851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528220|NCT04257851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528221|NCT04257851|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5528222|NCT04257851|Autonomic Agents|autonomic agents|mesh-ancestor
5528223|NCT04257851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5528224|NCT04257851|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6110597|NCT01022996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110598|NCT01023035|Ribavirin|ribavirin|mesh-list
6110599|NCT01023035|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6110600|NCT01023035|Epoetin Alfa|epoetin alfa|mesh-list
6110601|NCT01023035|Antimetabolites|antimetabolites|mesh-ancestor
5528225|NCT04257851|Respiratory System Agents|respiratory system agents|mesh-ancestor
5528226|NCT04257851|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5528227|NCT04257851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6110602|NCT01023035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110603|NCT01023035|Antiviral Agents|antiviral agents|mesh-ancestor
6110604|NCT01023035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6110605|NCT01023035|Hematinics|hematinics|mesh-ancestor
6110606|NCT01023061|Prednisone|prednisone|mesh-list
6110607|NCT01023061|Leuprolide|leuprolide|mesh-list
6110608|NCT01023061|Goserelin|goserelin|mesh-list
6110609|NCT01023061|Abiraterone Acetate|abiraterone acetate|mesh-list
6110610|NCT01023061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6110611|NCT01023061|Glucocorticoids|glucocorticoids|mesh-ancestor
6110612|NCT01023061|Hormones|hormones|mesh-ancestor
6110613|NCT01023061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6110614|NCT01023061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110615|NCT01023061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6110616|NCT01023061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6110617|NCT01023061|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6110618|NCT01023061|Fertility Agents|fertility agents|mesh-ancestor
6110619|NCT01023061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6110620|NCT01023061|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6110621|NCT01023061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6110622|NCT01023061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110623|NCT01023061|Hormone Antagonists|hormone antagonists|mesh-ancestor
6110624|NCT01023061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6110625|NCT01023178|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6110626|NCT01023178|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6110627|NCT01023178|Estradiol|estradiol|mesh-list
6110628|NCT01023178|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6110629|NCT01023178|Estrogens|estrogens|mesh-list
6110630|NCT01023178|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6110631|NCT01023178|Progesterone|progesterone|mesh-list
6110632|NCT01023178|Hormones|hormones|mesh-ancestor
6110633|NCT01023178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6110634|NCT01023178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110635|NCT01023178|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6110636|NCT01023178|Contraceptive Agents|contraceptive agents|mesh-ancestor
6110637|NCT01023178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6110638|NCT01023178|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6110639|NCT01023178|Progestins|progestins|mesh-ancestor
6110640|NCT01023217|Lamivudine|lamivudine|mesh-list
6110641|NCT01023217|Adefovir|adefovir|mesh-list
6110642|NCT01023217|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6110643|NCT01023217|Entecavir|entecavir|mesh-list
5528228|NCT04257851|Vasodilator Agents|vasodilator agents|mesh-ancestor
5528229|NCT04257851|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5528230|NCT04257851|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5528231|NCT04257851|Purinergic Agents|purinergic agents|mesh-ancestor
5528232|NCT04257812|Tazobactam|tazobactam|mesh-list
5528233|NCT04257812|Ceftolozane|ceftolozane|mesh-list
5528234|NCT04257812|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
5528235|NCT04257812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5528236|NCT04257812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5528237|NCT04257812|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5528238|NCT04257812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5725361|NCT03180775|Glycine Agents|glycine agents|mesh-ancestor
6110644|NCT01023217|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6110645|NCT01023217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6110646|NCT01023217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6110647|NCT01023217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110648|NCT01023217|Antiviral Agents|antiviral agents|mesh-ancestor
6110649|NCT01023217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6110650|NCT01023217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6110651|NCT01023217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6110652|NCT01023256|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6110653|NCT01023256|Immunologic Factors|immunologic factors|mesh-ancestor
6110654|NCT01023256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110655|NCT01023308|Dexamethasone|dexamethasone|mesh-list
6110656|NCT01023308|Bortezomib|bortezomib|mesh-list
6110657|NCT01023308|Panobinostat|panobinostat|mesh-list
6110658|NCT01023308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6110659|NCT01023308|Antiemetics|antiemetics|mesh-ancestor
6110660|NCT01023308|Autonomic Agents|autonomic agents|mesh-ancestor
6465432|NCT00474435|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6465433|NCT00474435|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6465434|NCT00474435|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6110661|NCT01023308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6110662|NCT01023308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110663|NCT01023308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6110664|NCT01023308|Glucocorticoids|glucocorticoids|mesh-ancestor
6110665|NCT01023308|Hormones|hormones|mesh-ancestor
6110666|NCT01023308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6110667|NCT01023308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6110668|NCT01023308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6110669|NCT01023308|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6110670|NCT01023308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6110671|NCT01023308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110672|NCT01023477|Chloroquine|chloroquine|mesh-list
6110673|NCT01023477|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
6110674|NCT01023477|Amebicides|amebicides|mesh-ancestor
6110675|NCT01023477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6110676|NCT01023477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6110677|NCT01023477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6110678|NCT01023477|Antimalarials|antimalarials|mesh-ancestor
6110679|NCT01023477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6110680|NCT01023477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6110681|NCT01023477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6110682|NCT01023477|Analgesics|analgesics|mesh-ancestor
6110683|NCT01023477|Sensory System Agents|sensory system agents|mesh-ancestor
6110684|NCT01023477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6110685|NCT01023477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110686|NCT01023477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6110687|NCT01023477|Filaricides|filaricides|mesh-ancestor
6110688|NCT01023477|Antinematodal Agents|antinematodal agents|mesh-ancestor
6110689|NCT01023477|Anthelmintics|anthelmintics|mesh-ancestor
6110690|NCT01023581|Metformin|metformin|mesh-list
6110691|NCT01023581|Alogliptin|alogliptin|mesh-list
6110692|NCT01023581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6110693|NCT01023581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110694|NCT01023581|Incretins|incretins|mesh-ancestor
6110695|NCT01023581|Hormones|hormones|mesh-ancestor
6110696|NCT01023581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6110697|NCT01023581|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6110698|NCT01023581|Protease Inhibitors|protease inhibitors|mesh-ancestor
6110699|NCT01023581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6110700|NCT01023581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110701|NCT01023659|Bupropion|bupropion|mesh-list
6110702|NCT01023659|Varenicline|varenicline|mesh-list
6110703|NCT01023659|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6110704|NCT01023659|Antidepressive Agents|antidepressive agents|mesh-ancestor
6110705|NCT01023659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6110706|NCT01023659|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6110707|NCT01023659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6110708|NCT01023659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6110709|NCT01023659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110710|NCT01023659|Dopamine Agents|dopamine agents|mesh-ancestor
6110711|NCT01023659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6110712|NCT01023659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110713|NCT01023659|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6110714|NCT01023659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6110715|NCT01023659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6110716|NCT01023659|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6110717|NCT01023659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6110718|NCT01023659|Cholinergic Agents|cholinergic agents|mesh-ancestor
6465435|NCT00474435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6465436|NCT00474435|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5528239|NCT04257812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528240|NCT04257812|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5528241|NCT04257812|Renal Agents|renal agents|mesh-ancestor
5601406|NCT05177601|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5601407|NCT05177601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5601408|NCT05177601|Renal Agents|renal agents|mesh-ancestor
5601409|NCT05177601|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5601410|NCT05177601|Antitubercular Agents|antitubercular agents|mesh-ancestor
5601411|NCT05177601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5601412|NCT05177601|Antimetabolites|antimetabolites|mesh-ancestor
5601413|NCT05177601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601414|NCT05177588|Metformin|metformin|mesh-list
5601415|NCT05177588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5601416|NCT05177588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601417|NCT05177510|Mifepristone|mifepristone|mesh-list
6465437|NCT00474435|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6465438|NCT00474435|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6465439|NCT00474435|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5601418|NCT05177510|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5601419|NCT05177510|Abortifacient Agents|abortifacient agents|mesh-ancestor
5601420|NCT05177510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5601421|NCT05177510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601422|NCT05177510|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5601423|NCT05177510|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5601424|NCT05177510|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5601425|NCT05177510|Contraceptive Agents|contraceptive agents|mesh-ancestor
5601426|NCT05177510|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5601427|NCT05177510|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5601428|NCT05177510|Hormone Antagonists|hormone antagonists|mesh-ancestor
5601429|NCT05177510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5601430|NCT05177510|Luteolytic Agents|luteolytic agents|mesh-ancestor
5601431|NCT05177510|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5601432|NCT05177510|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5606713|NCT03847311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5606714|NCT03847311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5606715|NCT03847311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5606716|NCT03823989|Mitomycins|mitomycins|mesh-list
5606717|NCT03823989|Mitomycin|mitomycin|mesh-list
5606718|NCT03823989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5606719|NCT03823989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5606720|NCT03823989|Alkylating Agents|alkylating agents|mesh-ancestor
5606721|NCT03823989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110719|NCT01023672|Modafinil|modafinil|mesh-list
6110720|NCT01023672|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6110721|NCT01023672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110722|NCT01023672|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6110723|NCT01023672|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6110724|NCT01023672|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6110725|NCT01023672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110726|NCT01023711|Vaccines|vaccines|mesh-list
6110727|NCT01023711|Immunologic Factors|immunologic factors|mesh-ancestor
6110728|NCT01023711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110729|NCT01023724|Ketorolac|ketorolac|mesh-list
6110730|NCT01023724|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6110731|NCT01023724|Bromfenac|bromfenac|mesh-list
6465440|NCT00474591|PENTA|penta|mesh-list
6110732|NCT01023724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6110733|NCT01023724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6110734|NCT01023724|Analgesics|analgesics|mesh-ancestor
6110735|NCT01023724|Sensory System Agents|sensory system agents|mesh-ancestor
6110736|NCT01023724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6110737|NCT01023724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110738|NCT01023724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6110739|NCT01023724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6110740|NCT01023724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6110741|NCT01023724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6110742|NCT01023724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110743|NCT01023776|Vaccines|vaccines|mesh-list
6110744|NCT01023776|Immunologic Factors|immunologic factors|mesh-ancestor
6110745|NCT01023776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110746|NCT01023815|Cyclosporine|cyclosporine|mesh-list
6110747|NCT01023815|Everolimus|everolimus|mesh-list
5528242|NCT04257396|Carbon Fiber|carbon fiber|mesh-list
5528243|NCT04257396|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5528244|NCT04257396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5528245|NCT04257461|Capecitabine|capecitabine|mesh-list
5528246|NCT04257461|Oxaliplatin|oxaliplatin|mesh-list
5528247|NCT04257461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5528248|NCT04257461|Antimetabolites|antimetabolites|mesh-ancestor
5528249|NCT04257461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528250|NCT04257461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5528251|NCT04257682|Bupivacaine|bupivacaine|mesh-list
5528252|NCT04257682|Ropivacaine|ropivacaine|mesh-list
5528253|NCT04257682|Anesthetics, Local|anesthetics, local|mesh-list
5528254|NCT04257682|Mepivacaine|mepivacaine|mesh-list
5528255|NCT04257682|Anesthetics|anesthetics|mesh-list
5528256|NCT04257682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5528257|NCT04257682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528258|NCT04257682|Sensory System Agents|sensory system agents|mesh-ancestor
5528259|NCT04257682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5528260|NCT04257578|Acalabrutinib|acalabrutinib|mesh-list
5528261|NCT04257578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5528262|NCT04257448|Gemcitabine|gemcitabine|mesh-list
5528263|NCT04257448|Paclitaxel|paclitaxel|mesh-list
5528264|NCT04257448|Lenalidomide|lenalidomide|mesh-list
6110748|NCT01023815|Cyclosporins|cyclosporins|mesh-list
6110749|NCT01023815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6110750|NCT01023815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110751|NCT01023815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6110752|NCT01023815|Immunologic Factors|immunologic factors|mesh-ancestor
6110753|NCT01023815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110754|NCT01023815|Antifungal Agents|antifungal agents|mesh-ancestor
6110755|NCT01023815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6110756|NCT01023815|Dermatologic Agents|dermatologic agents|mesh-ancestor
6110757|NCT01023815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6110758|NCT01023815|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6110759|NCT01023815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6110760|NCT01023841|Bimatoprost|bimatoprost|mesh-list
6110761|NCT01023841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6110762|NCT01023841|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6110763|NCT01023841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6110764|NCT01024010|Vidarabine|vidarabine|mesh-list
6110765|NCT01024010|Cyclophosphamide|cyclophosphamide|mesh-list
6110766|NCT01024010|Ofatumumab|ofatumumab|mesh-list
6110767|NCT01024010|Pentostatin|pentostatin|mesh-list
6110768|NCT01024010|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6110769|NCT01024010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6110770|NCT01024010|Immunologic Factors|immunologic factors|mesh-ancestor
6110771|NCT01024010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110772|NCT01024010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6110773|NCT01024010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6110774|NCT01024010|Alkylating Agents|alkylating agents|mesh-ancestor
6110775|NCT01024010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110776|NCT01024010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6110777|NCT01024010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6110778|NCT01024010|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
6110779|NCT01024010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6110780|NCT01024010|Antimetabolites|antimetabolites|mesh-ancestor
6110781|NCT01024010|Antiviral Agents|antiviral agents|mesh-ancestor
6110782|NCT01024010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5528265|NCT04257448|Azacitidine|azacitidine|mesh-list
5528266|NCT04257448|Durvalumab|durvalumab|mesh-list
5528267|NCT04257448|Romidepsin|romidepsin|mesh-list
5528268|NCT04257448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6110783|NCT01024036|Siltuximab|siltuximab|mesh-list
5528269|NCT04257448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6110784|NCT01024036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6110785|NCT01024231|Nivolumab|nivolumab|mesh-list
6110786|NCT01024231|Ipilimumab|ipilimumab|mesh-list
6110787|NCT01024231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6110788|NCT01024231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6110789|NCT01024231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6110790|NCT01024231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110791|NCT01024335|Naltrexone|naltrexone|mesh-list
6110792|NCT01024335|Dronabinol|dronabinol|mesh-list
6110793|NCT01024335|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6110794|NCT01024335|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6110795|NCT01024335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110796|NCT01024335|Sensory System Agents|sensory system agents|mesh-ancestor
6110797|NCT01024335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6110798|NCT01024335|Hallucinogens|hallucinogens|mesh-ancestor
6110799|NCT01024335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6110800|NCT01024335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6110801|NCT01024335|Analgesics|analgesics|mesh-ancestor
6110802|NCT01024335|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6110803|NCT01024335|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6110804|NCT01024335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6110805|NCT01024335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110806|NCT01024335|Hormones|hormones|mesh-ancestor
6110807|NCT01024335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6110808|NCT01024686|Vaccines|vaccines|mesh-list
6110809|NCT01024686|Immunologic Factors|immunologic factors|mesh-ancestor
6110810|NCT01024686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110811|NCT01024738|Chlorhexidine|chlorhexidine|mesh-list
6110812|NCT01024738|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6110813|NCT01024738|Triclosan|triclosan|mesh-list
6110814|NCT01024738|Fluorides|fluorides|mesh-list
6110815|NCT01024738|Cariostatic Agents|cariostatic agents|mesh-ancestor
6110816|NCT01024738|Protective Agents|protective agents|mesh-ancestor
6110817|NCT01024738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110818|NCT01024738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6110819|NCT01024738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6110820|NCT01024738|Disinfectants|disinfectants|mesh-ancestor
6110821|NCT01024738|Dermatologic Agents|dermatologic agents|mesh-ancestor
6110822|NCT01024738|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6110823|NCT01024738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6110824|NCT01024738|Antimetabolites|antimetabolites|mesh-ancestor
6110825|NCT01024738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110826|NCT01024738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6110827|NCT01024751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6110828|NCT01024920|Sunitinib|sunitinib|mesh-list
6110829|NCT01024920|Nintedanib|nintedanib|mesh-list
6110830|NCT01024920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6110831|NCT01024920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6110832|NCT01024920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6110833|NCT01024920|Growth Substances|growth substances|mesh-ancestor
6110834|NCT01024920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110835|NCT01024920|Growth Inhibitors|growth inhibitors|mesh-ancestor
6110836|NCT01024920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6110837|NCT01024920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6110838|NCT01024920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110839|NCT01024946|Everolimus|everolimus|mesh-list
6110840|NCT01024946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6110841|NCT01024946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6110842|NCT01024946|Immunologic Factors|immunologic factors|mesh-ancestor
6110843|NCT01024946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110844|NCT01024972|Mannitol|mannitol|mesh-list
6110845|NCT01024972|Dantrolene|dantrolene|mesh-list
6110846|NCT01024972|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6110847|NCT01024972|Diuretics|diuretics|mesh-ancestor
6110848|NCT01024972|Natriuretic Agents|natriuretic agents|mesh-ancestor
6110849|NCT01024972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110850|NCT01024972|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6110851|NCT01024972|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6110852|NCT01024972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6110853|NCT01025154|Cytarabine|cytarabine|mesh-list
6666023|NCT01520298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6666024|NCT01520298|Analgesics|analgesics|mesh-ancestor
6666025|NCT01520298|Sensory System Agents|sensory system agents|mesh-ancestor
6110854|NCT01025154|Clofarabine|clofarabine|mesh-list
6110855|NCT01025154|Idarubicin|idarubicin|mesh-list
6110856|NCT01025154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5528270|NCT04257448|Tubulin Modulators|tubulin modulators|mesh-ancestor
6110857|NCT01025154|Antimetabolites|antimetabolites|mesh-ancestor
6110858|NCT01025154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528271|NCT04257448|Antimitotic Agents|antimitotic agents|mesh-ancestor
5528272|NCT04257448|Mitosis Modulators|mitosis modulators|mesh-ancestor
5528273|NCT04257448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528274|NCT04257448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6110859|NCT01025154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6110860|NCT01025154|Antiviral Agents|antiviral agents|mesh-ancestor
6110861|NCT01025154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6110862|NCT01025154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6110863|NCT01025154|Immunologic Factors|immunologic factors|mesh-ancestor
6110864|NCT01025154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110865|NCT01025154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6110866|NCT01025154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6110867|NCT01025154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6110868|NCT01025154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6110869|NCT01025193|Belimumab|belimumab|mesh-list
6110870|NCT01025193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6110871|NCT01025193|Immunologic Factors|immunologic factors|mesh-ancestor
6110872|NCT01025193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110873|NCT01025232|Ranibizumab|ranibizumab|mesh-list
6110874|NCT01025232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6110875|NCT01025232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6110876|NCT01025232|Growth Substances|growth substances|mesh-ancestor
6110877|NCT01025232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110878|NCT01025232|Growth Inhibitors|growth inhibitors|mesh-ancestor
6110879|NCT01025232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6110880|NCT01025284|Sargramostim|sargramostim|mesh-list
6110881|NCT01025284|Lenograstim|lenograstim|mesh-list
6110882|NCT01025284|Immunologic Factors|immunologic factors|mesh-ancestor
6110883|NCT01025284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110884|NCT01025284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6110885|NCT01025427|Tenofovir|tenofovir|mesh-list
6110886|NCT01025427|Emtricitabine|emtricitabine|mesh-list
6110887|NCT01025427|Raltegravir Potassium|raltegravir potassium|mesh-list
6110888|NCT01025427|Antiviral Agents|antiviral agents|mesh-ancestor
6110889|NCT01025427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6110890|NCT01025427|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6110891|NCT01025427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6110892|NCT01025427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6110893|NCT01025427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110894|NCT01025427|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6110895|NCT01025427|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6110896|NCT01025427|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6110897|NCT01025427|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6110898|NCT01025453|Sirolimus|sirolimus|mesh-list
6110899|NCT01025453|Sorafenib|sorafenib|mesh-list
6110900|NCT01025453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6110901|NCT01025453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6110902|NCT01025453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6110903|NCT01025453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110904|NCT01025453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6110905|NCT01025453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6110906|NCT01025453|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6110907|NCT01025453|Antifungal Agents|antifungal agents|mesh-ancestor
5528275|NCT04257448|Antimetabolites|antimetabolites|mesh-ancestor
5528276|NCT04257448|Antiviral Agents|antiviral agents|mesh-ancestor
5528277|NCT04257448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5528278|NCT04257448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5528279|NCT04257448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5528280|NCT04257448|Immunologic Factors|immunologic factors|mesh-ancestor
5528281|NCT04257448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528282|NCT04257448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5528283|NCT04257448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5528284|NCT04257448|Growth Substances|growth substances|mesh-ancestor
6110908|NCT01025453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6110909|NCT01025453|Immunologic Factors|immunologic factors|mesh-ancestor
6110910|NCT01025453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110911|NCT01025635|Azelaic acid|azelaic acid|mesh-list
6110912|NCT01025635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6110913|NCT01025635|Dermatologic Agents|dermatologic agents|mesh-ancestor
6110914|NCT01025817|Mycophenolic Acid|mycophenolic acid|mesh-list
6110915|NCT01025817|Everolimus|everolimus|mesh-list
6110916|NCT01025817|Tacrolimus|tacrolimus|mesh-list
6110917|NCT01025817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6110918|NCT01025817|Immunologic Factors|immunologic factors|mesh-ancestor
5528285|NCT04257448|Growth Inhibitors|growth inhibitors|mesh-ancestor
5528286|NCT04257448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5528287|NCT04257448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5528288|NCT04257500|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5528289|NCT04257500|Etonogestrel|etonogestrel|mesh-list
5528290|NCT04257500|NuvaRing|nuvaring|mesh-list
5528291|NCT04257500|Estradiol|estradiol|mesh-list
5528292|NCT04257500|Estrogens|estrogens|mesh-ancestor
5528293|NCT04257500|Hormones|hormones|mesh-ancestor
5528294|NCT04257500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6110919|NCT01025817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110920|NCT01025817|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6110921|NCT01025817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6110922|NCT01025817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110923|NCT01025817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6110924|NCT01025817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6110925|NCT01025817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6110926|NCT01025817|Antitubercular Agents|antitubercular agents|mesh-ancestor
6110927|NCT01025817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6110928|NCT01025817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6110929|NCT01025830|Lamivudine|lamivudine|mesh-list
6110930|NCT01025830|Nevirapine|nevirapine|mesh-list
6110931|NCT01025830|Stavudine|stavudine|mesh-list
6110932|NCT01025830|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
6110933|NCT01025830|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6110934|NCT01025830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6110935|NCT01025830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6110936|NCT01025830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528295|NCT04257500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528296|NCT04257500|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5528297|NCT04257500|Contraceptive Agents|contraceptive agents|mesh-ancestor
5528298|NCT04257500|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5528299|NCT04257500|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5528300|NCT04257500|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5528301|NCT04257500|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5528302|NCT04257656|Remdesivir|remdesivir|mesh-list
5528303|NCT04257656|Antimetabolites|antimetabolites|mesh-ancestor
5528304|NCT04257656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528305|NCT04257656|Antiviral Agents|antiviral agents|mesh-ancestor
5528306|NCT04257656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5528307|NCT04257487|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
5528308|NCT04257487|Anticoagulants|anticoagulants|mesh-ancestor
5528309|NCT04257487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5528310|NCT04257487|Antimetabolites|antimetabolites|mesh-ancestor
5528311|NCT04257487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528312|NCT04257487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5528313|NCT04257487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5528314|NCT04257487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5528315|NCT04257487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6110937|NCT01025830|Antiviral Agents|antiviral agents|mesh-ancestor
6110938|NCT01025830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6110939|NCT01025830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6110940|NCT01025830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6110941|NCT01025830|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6110942|NCT01025830|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6110943|NCT01025830|Antimetabolites|antimetabolites|mesh-ancestor
6204205|NCT02066727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6204206|NCT02066727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204207|NCT02066727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6204208|NCT02066727|Analgesics|analgesics|mesh-ancestor
6204209|NCT02066727|Sensory System Agents|sensory system agents|mesh-ancestor
6204210|NCT02066727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6204211|NCT02066727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6204212|NCT02066727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6204213|NCT02066727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6204214|NCT02066727|Adrenergic Agents|adrenergic agents|mesh-ancestor
6204215|NCT02066727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6204216|NCT02066727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204217|NCT02066792|Cycloserine|cycloserine|mesh-list
6204218|NCT02066792|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6204219|NCT02066792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6204220|NCT02066792|Renal Agents|renal agents|mesh-ancestor
6204221|NCT02066792|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6204222|NCT02066792|Antitubercular Agents|antitubercular agents|mesh-ancestor
5528316|NCT04257487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528317|NCT04257188|Anesthetics|anesthetics|mesh-list
5528318|NCT04257188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5528319|NCT04257188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528320|NCT04256993|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
5528321|NCT04256993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6110944|NCT01025843|Candesartan|candesartan|mesh-list
6110945|NCT01025843|Candesartan cilexetil|candesartan cilexetil|mesh-list
6110946|NCT01025843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6110947|NCT01025843|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6110948|NCT01025843|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6110949|NCT01025843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110950|NCT01026012|Regadenoson|regadenoson|mesh-list
6110951|NCT01026012|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
6110952|NCT01026012|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6110953|NCT01026012|Purinergic Agonists|purinergic agonists|mesh-ancestor
6110954|NCT01026012|Purinergic Agents|purinergic agents|mesh-ancestor
6110955|NCT01026012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6110956|NCT01026012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528322|NCT04256824|Triclosan|triclosan|mesh-list
5528323|NCT04256824|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5528324|NCT04256824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5528325|NCT04256824|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5528326|NCT04256824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5528327|NCT04256824|Antimetabolites|antimetabolites|mesh-ancestor
5528328|NCT04256824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528329|NCT04256824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5528330|NCT04256798|Chlorhexidine|chlorhexidine|mesh-list
5528331|NCT04256798|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5528332|NCT04256798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6110957|NCT01026012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110958|NCT01026038|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6110959|NCT01026038|Immunologic Factors|immunologic factors|mesh-ancestor
6110960|NCT01026038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110961|NCT01026142|Capecitabine|capecitabine|mesh-list
6110962|NCT01026142|Trastuzumab|trastuzumab|mesh-list
5528333|NCT04256798|Disinfectants|disinfectants|mesh-ancestor
5528334|NCT04257032|Dabigatran|dabigatran|mesh-list
5528335|NCT04257032|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6110963|NCT01026142|Pertuzumab|pertuzumab|mesh-list
6110964|NCT01026142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6110965|NCT01026142|Antimetabolites|antimetabolites|mesh-ancestor
6110966|NCT01026142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110967|NCT01026142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6110968|NCT01026142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6110969|NCT01026194|Pioglitazone|pioglitazone|mesh-list
6110970|NCT01026194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6110971|NCT01026194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6110972|NCT01026324|Cyclin-Dependent Kinase Inhibitor Proteins|cyclin-dependent kinase inhibitor proteins|mesh-list
6110973|NCT01026324|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6110974|NCT01026324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6110975|NCT01026324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110976|NCT01026389|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
6110977|NCT01026389|Chelating Agents|chelating agents|mesh-ancestor
6110978|NCT01026389|Sequestering Agents|sequestering agents|mesh-ancestor
6110979|NCT01026389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110980|NCT01026454|Valacyclovir|valacyclovir|mesh-list
6110981|NCT01026454|Acyclovir|acyclovir|mesh-list
6110982|NCT01026454|Antiviral Agents|antiviral agents|mesh-ancestor
6110983|NCT01026454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6110984|NCT01026493|Temozolomide|temozolomide|mesh-list
6110985|NCT01026493|Veliparib|veliparib|mesh-list
6110986|NCT01026493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6110987|NCT01026493|Alkylating Agents|alkylating agents|mesh-ancestor
6110988|NCT01026493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6110989|NCT01026493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6110990|NCT01026493|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6110991|NCT01026493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6110992|NCT01026623|Sirolimus|sirolimus|mesh-list
6110993|NCT01026623|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6110994|NCT01026623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5528336|NCT04257032|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5528337|NCT04257032|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5528338|NCT04257032|Antimetabolites|antimetabolites|mesh-ancestor
5528339|NCT04257032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528340|NCT04257032|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5528341|NCT04257032|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5528342|NCT04257032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5528343|NCT04257032|Antithrombins|antithrombins|mesh-ancestor
5528344|NCT04257032|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5528345|NCT04257032|Protease Inhibitors|protease inhibitors|mesh-ancestor
5528346|NCT04257032|Anticoagulants|anticoagulants|mesh-ancestor
6110995|NCT01026623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6110996|NCT01026623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6110997|NCT01026623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6110998|NCT01026623|Antifungal Agents|antifungal agents|mesh-ancestor
6110999|NCT01026623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6111000|NCT01026623|Immunologic Factors|immunologic factors|mesh-ancestor
6111001|NCT01026623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111002|NCT01026792|Sirolimus|sirolimus|mesh-list
6111003|NCT01026792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6111004|NCT01026792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6111005|NCT01026792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6111006|NCT01026792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6111007|NCT01026792|Antifungal Agents|antifungal agents|mesh-ancestor
6111008|NCT01026792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6111009|NCT01026792|Immunologic Factors|immunologic factors|mesh-ancestor
6111010|NCT01026792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111011|NCT01026818|Tadalafil|tadalafil|mesh-list
6111012|NCT01026818|Vasodilator Agents|vasodilator agents|mesh-ancestor
6111013|NCT01026818|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6111014|NCT01026818|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6111015|NCT01026818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6111016|NCT01026818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111017|NCT01026818|Urological Agents|urological agents|mesh-ancestor
6111018|NCT01026831|Timolol|timolol|mesh-list
6111019|NCT01026831|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6111020|NCT01026831|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6111021|NCT01026831|Adrenergic Agents|adrenergic agents|mesh-ancestor
6111022|NCT01026831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6111023|NCT01026831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528347|NCT04256642|Morphine|morphine|mesh-list
5528348|NCT04256642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5528349|NCT04256642|Narcotics|narcotics|mesh-ancestor
5528350|NCT04256642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5528351|NCT04256642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528352|NCT04256642|Analgesics|analgesics|mesh-ancestor
5528353|NCT04256642|Sensory System Agents|sensory system agents|mesh-ancestor
5528354|NCT04256642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5528355|NCT04256733|Capsaicin|capsaicin|mesh-list
5528356|NCT04256733|Antipruritics|antipruritics|mesh-ancestor
5528357|NCT04256733|Dermatologic Agents|dermatologic agents|mesh-ancestor
5528358|NCT04256733|Sensory System Agents|sensory system agents|mesh-ancestor
6111024|NCT01026831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111025|NCT01026831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6111026|NCT01026831|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6111027|NCT01026844|Hydroxychloroquine|hydroxychloroquine|mesh-list
6111028|NCT01026844|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6111029|NCT01026844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6111030|NCT01026844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6111031|NCT01026844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6111032|NCT01026844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111033|NCT01026844|Antimalarials|antimalarials|mesh-ancestor
6111034|NCT01026844|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6111035|NCT01026844|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6111036|NCT01026844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6111037|NCT01026844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6111038|NCT01026909|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6111039|NCT01026909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6111040|NCT01026948|Dinoprostone|dinoprostone|mesh-list
6111041|NCT01026948|Oxytocics|oxytocics|mesh-ancestor
6111042|NCT01026948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6111043|NCT01026948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111044|NCT01027000|Sirolimus|sirolimus|mesh-list
6111045|NCT01027000|Cyclophosphamide|cyclophosphamide|mesh-list
6111046|NCT01027000|Busulfan|busulfan|mesh-list
6111047|NCT01027000|Rituximab|rituximab|mesh-list
6111048|NCT01027000|Methotrexate|methotrexate|mesh-list
6111049|NCT01027000|Fludarabine|fludarabine|mesh-list
5528359|NCT04256733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5528360|NCT04256733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528361|NCT04256473|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5528362|NCT04256473|Saruplase|saruplase|mesh-list
5528363|NCT04256473|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5528364|NCT04256473|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5528365|NCT04256473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528366|NCT04256343|Deuterium Oxide|deuterium oxide|mesh-list
5528367|NCT04256343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5528368|NCT04256343|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5528369|NCT04256343|Protective Agents|protective agents|mesh-ancestor
5528370|NCT04256343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528371|NCT04256252|Rituximab|rituximab|mesh-list
5528372|NCT04256252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5528373|NCT04256252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5528374|NCT04256252|Immunologic Factors|immunologic factors|mesh-ancestor
5528375|NCT04256252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528376|NCT04256252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5528377|NCT04256525|Aspirin|aspirin|mesh-list
5528378|NCT04256525|Heparin|heparin|mesh-list
5528379|NCT04256525|Rivaroxaban|rivaroxaban|mesh-list
5528380|NCT04256525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5528381|NCT04256525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5528382|NCT04256525|Analgesics|analgesics|mesh-ancestor
5528383|NCT04256525|Sensory System Agents|sensory system agents|mesh-ancestor
5528384|NCT04256525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5528385|NCT04256525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528386|NCT04256525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5528387|NCT04256525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5528388|NCT04256525|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5528389|NCT04256525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5528390|NCT04256525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528391|NCT04256525|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5528392|NCT04256525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5528393|NCT04256525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5528394|NCT04256525|Antipyretics|antipyretics|mesh-ancestor
5528395|NCT04256525|Anticoagulants|anticoagulants|mesh-ancestor
5528396|NCT04256525|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5528397|NCT04256525|Antithrombins|antithrombins|mesh-ancestor
5528398|NCT04256525|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5528399|NCT04256525|Protease Inhibitors|protease inhibitors|mesh-ancestor
5528400|NCT04256200|Dienogest|dienogest|mesh-list
5528401|NCT04256200|Contraceptive Agents|contraceptive agents|mesh-list
5528402|NCT04256200|Contraceptives, Oral|contraceptives, oral|mesh-list
5528403|NCT04256200|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
5528404|NCT04256200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5528405|NCT04256200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528406|NCT04256200|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5528407|NCT04256200|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5528408|NCT04256200|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6111050|NCT01027000|Fludarabine phosphate|fludarabine phosphate|mesh-list
6111051|NCT01027000|Tacrolimus|tacrolimus|mesh-list
6111052|NCT01027000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6111053|NCT01027000|Immunologic Factors|immunologic factors|mesh-ancestor
6111054|NCT01027000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111055|NCT01027000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6111056|NCT01027000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6111057|NCT01027000|Alkylating Agents|alkylating agents|mesh-ancestor
6111058|NCT01027000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111059|NCT01027000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6111060|NCT01027000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6111061|NCT01027000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6111062|NCT01027000|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6111063|NCT01027000|Abortifacient Agents|abortifacient agents|mesh-ancestor
6111064|NCT01027000|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6111065|NCT01027000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6111066|NCT01027000|Antimetabolites|antimetabolites|mesh-ancestor
6111067|NCT01027000|Dermatologic Agents|dermatologic agents|mesh-ancestor
6111068|NCT01027000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6111069|NCT01027000|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6111070|NCT01027000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6111071|NCT01027000|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6111072|NCT01027000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6111073|NCT01027000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6111074|NCT01027000|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6111075|NCT01027000|Antifungal Agents|antifungal agents|mesh-ancestor
6111076|NCT01027351|Vaccines|vaccines|mesh-list
6111077|NCT01027351|Immunologic Factors|immunologic factors|mesh-ancestor
6111078|NCT01027351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111079|NCT01027416|Tamoxifen|tamoxifen|mesh-list
6111080|NCT01027416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6111081|NCT01027416|Hormone Antagonists|hormone antagonists|mesh-ancestor
6111082|NCT01027416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6111083|NCT01027416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111084|NCT01027416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6111085|NCT01027416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6111086|NCT01027416|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6111087|NCT01027416|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6111088|NCT01027416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6111089|NCT01027468|Bevacizumab|bevacizumab|mesh-list
6111090|NCT01027468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6111091|NCT01027468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6111092|NCT01027468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6111093|NCT01027468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6111094|NCT01027468|Growth Substances|growth substances|mesh-ancestor
6111095|NCT01027468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111096|NCT01027468|Growth Inhibitors|growth inhibitors|mesh-ancestor
6111097|NCT01027559|Sertraline|sertraline|mesh-list
6111098|NCT01027559|Antidepressive Agents|antidepressive agents|mesh-ancestor
6111099|NCT01027559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6465441|NCT00474591|Fondaparinux|fondaparinux|mesh-list
6465442|NCT00474591|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6465443|NCT00474591|Antithrombins|antithrombins|mesh-ancestor
6465444|NCT00474591|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6465445|NCT00474591|Protease Inhibitors|protease inhibitors|mesh-ancestor
6465446|NCT00474591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5528409|NCT04256200|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5528410|NCT04256200|Hormone Antagonists|hormone antagonists|mesh-ancestor
5528411|NCT04256200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5528412|NCT04256200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5528413|NCT04256200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5528414|NCT04256018|Mogamulizumab|mogamulizumab|mesh-list
5528415|NCT04256018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5528416|NCT04256057|Magnesium Sulfate|magnesium sulfate|mesh-list
5528417|NCT04256057|Analgesics|analgesics|mesh-ancestor
5528418|NCT04256057|Sensory System Agents|sensory system agents|mesh-ancestor
5528419|NCT04256057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5528420|NCT04256057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528421|NCT04256057|Anesthetics|anesthetics|mesh-ancestor
5528422|NCT04256057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5528423|NCT04256057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5528424|NCT04256057|Anticonvulsants|anticonvulsants|mesh-ancestor
5528425|NCT04256057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5528426|NCT04256057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5528427|NCT04256057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528428|NCT04256057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5528429|NCT04256057|Tocolytic Agents|tocolytic agents|mesh-ancestor
5528430|NCT04256057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5528431|NCT04256213|Nivolumab|nivolumab|mesh-list
5528432|NCT04256213|Ipilimumab|ipilimumab|mesh-list
5528433|NCT04256213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5528434|NCT04256213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5528435|NCT04256213|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6465447|NCT00474591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465448|NCT00474591|Anticoagulants|anticoagulants|mesh-ancestor
6465449|NCT00474591|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6465450|NCT00474591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6465451|NCT00474669|Docetaxel|docetaxel|mesh-list
6465452|NCT00474669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6465453|NCT00474669|Tubulin Modulators|tubulin modulators|mesh-ancestor
6465454|NCT00474669|Antimitotic Agents|antimitotic agents|mesh-ancestor
6465455|NCT00474669|Mitosis Modulators|mitosis modulators|mesh-ancestor
6111100|NCT01027559|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6111101|NCT01027559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6111102|NCT01027559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6111103|NCT01027559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111104|NCT01027559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5528436|NCT04256213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601433|NCT05177419|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
5601434|NCT05177419|Hallucinogens|hallucinogens|mesh-ancestor
5601435|NCT05177419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601436|NCT05177419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5601437|NCT05177419|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5601438|NCT05177419|Serotonin Agents|serotonin agents|mesh-ancestor
5601439|NCT05177419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5601440|NCT05177419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601441|NCT05177419|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5601442|NCT05177406|Erenumab|erenumab|mesh-list
6111105|NCT01027559|Serotonin Agents|serotonin agents|mesh-ancestor
6111106|NCT01027559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111107|NCT01027598|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6111108|NCT01027598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5601443|NCT05177406|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
5601444|NCT05177406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111109|NCT01027598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6111110|NCT01027598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6111111|NCT01027598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111112|NCT01027650|Dexamethasone|dexamethasone|mesh-list
6111113|NCT01027650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6111114|NCT01027650|Antiemetics|antiemetics|mesh-ancestor
6111115|NCT01027650|Autonomic Agents|autonomic agents|mesh-ancestor
6111116|NCT01027650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6111117|NCT01027650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111118|NCT01027650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6111119|NCT01027650|Glucocorticoids|glucocorticoids|mesh-ancestor
6111120|NCT01027650|Hormones|hormones|mesh-ancestor
6111121|NCT01027650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6111122|NCT01027650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6111123|NCT01027650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6111124|NCT01027754|Varenicline|varenicline|mesh-list
6111125|NCT01027754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6111126|NCT01027754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6111127|NCT01027754|Cholinergic Agents|cholinergic agents|mesh-ancestor
6111128|NCT01027754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6111129|NCT01027754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111130|NCT01027754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111131|NCT01027793|Tretinoin|tretinoin|mesh-list
6111132|NCT01027793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6111133|NCT01027793|Keratolytic Agents|keratolytic agents|mesh-ancestor
6111134|NCT01027793|Dermatologic Agents|dermatologic agents|mesh-ancestor
6111135|NCT01027806|Montelukast|montelukast|mesh-list
5601445|NCT05177406|Analgesics|analgesics|mesh-ancestor
5601446|NCT05177406|Sensory System Agents|sensory system agents|mesh-ancestor
5601447|NCT05177406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5601448|NCT05177406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111136|NCT01027806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6111137|NCT01027806|Respiratory System Agents|respiratory system agents|mesh-ancestor
6111138|NCT01027806|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6111139|NCT01027806|Hormone Antagonists|hormone antagonists|mesh-ancestor
6111140|NCT01027806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6111141|NCT01027806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111142|NCT01027806|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6111143|NCT01027806|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6111144|NCT01027806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207771|NCT02120261|Anesthetics|anesthetics|mesh-ancestor
6465456|NCT00474669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528437|NCT04255992|Calcium, Dietary|calcium, dietary|mesh-list
5528438|NCT04255992|Vitamin D|vitamin d|mesh-list
5528439|NCT04255992|Calcium|calcium|mesh-list
6111145|NCT01027845|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6111146|NCT01027845|Immunologic Factors|immunologic factors|mesh-ancestor
6111147|NCT01027845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111148|NCT01027871|Insulin Glargine|insulin glargine|mesh-list
6111149|NCT01027871|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6111150|NCT01027871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111151|NCT01027884|Idebenone|idebenone|mesh-list
6111152|NCT01027884|Antioxidants|antioxidants|mesh-ancestor
6111153|NCT01027884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111154|NCT01027884|Protective Agents|protective agents|mesh-ancestor
6111155|NCT01027884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111156|NCT01027897|Doripenem|doripenem|mesh-list
6111157|NCT01027897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6111158|NCT01027897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6111159|NCT01027910|Doxorubicin|doxorubicin|mesh-list
6111160|NCT01027910|Abexinostat|abexinostat|mesh-list
6111161|NCT01027910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6111162|NCT01027910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6111163|NCT01027910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6111164|NCT01027910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6111165|NCT01027910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6111166|NCT01027910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111167|NCT01027910|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6111168|NCT01027949|Treprostinil|treprostinil|mesh-list
6111169|NCT01027949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6111170|NCT01028014|Pseudoephedrine|pseudoephedrine|mesh-list
6111171|NCT01028014|Ephedrine|ephedrine|mesh-list
6111172|NCT01028014|Cyclobenzaprine|cyclobenzaprine|mesh-list
6111173|NCT01028014|Imipramine|imipramine|mesh-list
6111174|NCT01028014|Tamsulosin|tamsulosin|mesh-list
6111175|NCT01028014|Solifenacin Succinate|solifenacin succinate|mesh-list
6111176|NCT01028014|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6111177|NCT01028014|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6111178|NCT01028014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6111179|NCT01028014|Adrenergic Agents|adrenergic agents|mesh-ancestor
6111180|NCT01028014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5528440|NCT04255992|Vitamins|vitamins|mesh-ancestor
5528441|NCT04255992|Micronutrients|micronutrients|mesh-ancestor
5528442|NCT04255992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528443|NCT04255992|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5528444|NCT04255992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5528445|NCT04255836|Durvalumab|durvalumab|mesh-list
5528446|NCT04255836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5528447|NCT04255836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5528448|NCT04255771|Gemcitabine|gemcitabine|mesh-list
5528449|NCT04255771|Cisplatin|cisplatin|mesh-list
5528450|NCT04255771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5528451|NCT04255771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5528452|NCT04255771|Antimetabolites|antimetabolites|mesh-ancestor
5528453|NCT04255771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528454|NCT04255771|Antiviral Agents|antiviral agents|mesh-ancestor
5528455|NCT04255771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6111181|NCT01028014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111182|NCT01028014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111183|NCT01028014|Urological Agents|urological agents|mesh-ancestor
6111184|NCT01028014|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6111185|NCT01028014|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6111186|NCT01028014|Cholinergic Agents|cholinergic agents|mesh-ancestor
6111187|NCT01028014|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6111188|NCT01028014|Autonomic Agents|autonomic agents|mesh-ancestor
6111189|NCT01028014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6111190|NCT01028014|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6111191|NCT01028014|Respiratory System Agents|respiratory system agents|mesh-ancestor
6111192|NCT01028014|Nasal Decongestants|nasal decongestants|mesh-ancestor
6111193|NCT01028014|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6111194|NCT01028014|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5528456|NCT04255771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5528457|NCT04255771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5528458|NCT04255771|Immunologic Factors|immunologic factors|mesh-ancestor
5528459|NCT04255771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528460|NCT04255407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
5528461|NCT04255602|Ticagrelor|ticagrelor|mesh-list
5601449|NCT05177276|Irinotecan|irinotecan|mesh-list
6111195|NCT01028014|Sympathomimetics|sympathomimetics|mesh-ancestor
5528462|NCT04255602|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5528463|NCT04255602|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6111196|NCT01028014|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6111197|NCT01028014|Antidepressive Agents|antidepressive agents|mesh-ancestor
6111198|NCT01028014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6111199|NCT01028014|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6111200|NCT01028014|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6111201|NCT01028014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6111202|NCT01028014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6111203|NCT01028014|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6111204|NCT01028014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6111205|NCT01028014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6111206|NCT01028027|Loteprednol Etabonate|loteprednol etabonate|mesh-list
6111207|NCT01028027|Tobramycin|tobramycin|mesh-list
6111208|NCT01028027|Dexamethasone|dexamethasone|mesh-list
6111209|NCT01028027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6111210|NCT01028027|Antiemetics|antiemetics|mesh-ancestor
6111211|NCT01028027|Autonomic Agents|autonomic agents|mesh-ancestor
6111212|NCT01028027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6111213|NCT01028027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111214|NCT01028027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6111215|NCT01028027|Glucocorticoids|glucocorticoids|mesh-ancestor
6111216|NCT01028027|Hormones|hormones|mesh-ancestor
6111217|NCT01028027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6111218|NCT01028027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6111219|NCT01028027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5528464|NCT04255602|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5528465|NCT04255602|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5528466|NCT04255602|Purinergic Agents|purinergic agents|mesh-ancestor
5528467|NCT04255602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5528468|NCT04255602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528469|NCT04255602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528470|NCT04255589|Ethanol|ethanol|mesh-list
5528471|NCT04255589|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5528472|NCT04255589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5528473|NCT04255589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5528474|NCT04255589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528475|NCT04255576|Vitamin D|vitamin d|mesh-list
5528476|NCT04255576|Calcium|calcium|mesh-list
5528477|NCT04255576|Vitamins|vitamins|mesh-ancestor
5528478|NCT04255576|Micronutrients|micronutrients|mesh-ancestor
5528479|NCT04255576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528480|NCT04255576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5528481|NCT04255576|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5528482|NCT04255498|Etanercept|etanercept|mesh-list
5528483|NCT04255498|Mifepristone|mifepristone|mesh-list
5528484|NCT04255498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5528485|NCT04255498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5528486|NCT04255498|Analgesics|analgesics|mesh-ancestor
5528487|NCT04255498|Sensory System Agents|sensory system agents|mesh-ancestor
6111220|NCT01028027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6111221|NCT01028027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6111222|NCT01028027|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6111223|NCT01028053|Flutemetamol|flutemetamol|mesh-list
6111224|NCT01028053|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5528488|NCT04255498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5528489|NCT04255498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528490|NCT04255498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5528491|NCT04255498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5528492|NCT04255498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6111225|NCT01028053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111226|NCT01028222|Dacarbazine|dacarbazine|mesh-list
6111227|NCT01028222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6111228|NCT01028222|Alkylating Agents|alkylating agents|mesh-ancestor
6111229|NCT01028222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528493|NCT04255498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5528494|NCT04255498|Immunologic Factors|immunologic factors|mesh-ancestor
5528495|NCT04255498|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5528496|NCT04255498|Abortifacient Agents|abortifacient agents|mesh-ancestor
5528497|NCT04255498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5528498|NCT04255498|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5528499|NCT04255498|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5528500|NCT04255498|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5528501|NCT04255498|Contraceptive Agents|contraceptive agents|mesh-ancestor
5528502|NCT04255498|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5528503|NCT04255498|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6666026|NCT01520298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6111230|NCT01028222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6111231|NCT01028352|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6111232|NCT01028352|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6111233|NCT01028352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6111234|NCT01028352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6111235|NCT01028352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111236|NCT01028352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6111237|NCT01028352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111238|NCT01028352|Analgesics|analgesics|mesh-ancestor
6111239|NCT01028352|Sensory System Agents|sensory system agents|mesh-ancestor
6111240|NCT01028352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6111241|NCT01028352|Antidepressive Agents|antidepressive agents|mesh-ancestor
6111242|NCT01028352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6111243|NCT01028352|Dopamine Agents|dopamine agents|mesh-ancestor
6666027|NCT01520298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666028|NCT01520298|Antipyretics|antipyretics|mesh-ancestor
6666029|NCT01520350|Aripiprazole|aripiprazole|mesh-list
6666030|NCT01520350|Antidepressive Agents|antidepressive agents|mesh-ancestor
6666031|NCT01520350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5528504|NCT04255498|Hormone Antagonists|hormone antagonists|mesh-ancestor
5528505|NCT04255498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5528506|NCT04255498|Luteolytic Agents|luteolytic agents|mesh-ancestor
5528507|NCT04255498|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5528508|NCT04255498|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5528509|NCT04255368|Choline|choline|mesh-list
5528510|NCT04255368|Lipotropic Agents|lipotropic agents|mesh-ancestor
5528511|NCT04255368|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5528512|NCT04255368|Antimetabolites|antimetabolites|mesh-ancestor
6111244|NCT01028391|Metformin|metformin|mesh-list
6111245|NCT01028391|Pioglitazone|pioglitazone|mesh-list
6111246|NCT01028391|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6111247|NCT01028391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6111248|NCT01028391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111249|NCT01028391|Incretins|incretins|mesh-ancestor
6111250|NCT01028391|Hormones|hormones|mesh-ancestor
6111251|NCT01028391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6111252|NCT01028391|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6111253|NCT01028391|Protease Inhibitors|protease inhibitors|mesh-ancestor
6111254|NCT01028391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6111255|NCT01028391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111256|NCT01028651|Treprostinil|treprostinil|mesh-list
6111257|NCT01028651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6666032|NCT01520350|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6666033|NCT01520350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6666034|NCT01520350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6666035|NCT01520350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666036|NCT01520350|Dopamine Agonists|dopamine agonists|mesh-ancestor
6111258|NCT01028677|Oxytocin|oxytocin|mesh-list
5528513|NCT04255368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528514|NCT04255368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5528515|NCT04255368|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5528516|NCT04255368|Nootropic Agents|nootropic agents|mesh-ancestor
5528517|NCT04255238|Dapagliflozin|dapagliflozin|mesh-list
5528518|NCT04255238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5528519|NCT04255238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528520|NCT04255238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5528521|NCT04255238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528522|NCT04255251|Fluorides|fluorides|mesh-list
6111259|NCT01028677|Oxytocics|oxytocics|mesh-ancestor
6111260|NCT01028677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6111261|NCT01028677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111262|NCT01028820|Aripiprazole|aripiprazole|mesh-list
5528523|NCT04255251|Fluorides, Topical|fluorides, topical|mesh-list
5528524|NCT04255251|Cariostatic Agents|cariostatic agents|mesh-ancestor
5528525|NCT04255251|Protective Agents|protective agents|mesh-ancestor
5528526|NCT04255251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528527|NCT04255160|Estradiol|estradiol|mesh-list
5528528|NCT04255160|Estrogens|estrogens|mesh-ancestor
5528529|NCT04255160|Hormones|hormones|mesh-ancestor
5528530|NCT04255160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5528531|NCT04255160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528532|NCT04255134|Adalimumab|adalimumab|mesh-list
5528533|NCT04255134|Abatacept|abatacept|mesh-list
5528534|NCT04255134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5528535|NCT04255134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5528536|NCT04255134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5528537|NCT04255134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528538|NCT04255134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5528539|NCT04255134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5528540|NCT04255134|Immunologic Factors|immunologic factors|mesh-ancestor
5528541|NCT04255134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528542|NCT04255017|Ritonavir|ritonavir|mesh-list
5528543|NCT04255017|Lopinavir|lopinavir|mesh-list
5528544|NCT04255017|Oseltamivir|oseltamivir|mesh-list
5528545|NCT04255017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5528546|NCT04255017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5528547|NCT04255017|Protease Inhibitors|protease inhibitors|mesh-ancestor
5528548|NCT04255017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5528549|NCT04255017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528550|NCT04255017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6111263|NCT01028820|Antidepressive Agents|antidepressive agents|mesh-ancestor
6111264|NCT01028820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6111265|NCT01028820|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6111266|NCT01028820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6111267|NCT01028820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6111268|NCT01028820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111269|NCT01028820|Dopamine Agonists|dopamine agonists|mesh-ancestor
6111270|NCT01028820|Dopamine Agents|dopamine agents|mesh-ancestor
6111271|NCT01028820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6111272|NCT01028820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111273|NCT01028820|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6111274|NCT01028820|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6111275|NCT01028820|Serotonin Agents|serotonin agents|mesh-ancestor
6111276|NCT01028820|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6111277|NCT01028820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6111278|NCT01028820|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6111279|NCT01028820|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6111280|NCT01029054|Dexamethasone|dexamethasone|mesh-list
6111281|NCT01029054|Dexamethasone acetate|dexamethasone acetate|mesh-list
6111282|NCT01029054|Lenalidomide|lenalidomide|mesh-list
6111283|NCT01029054|BB 1101|bb 1101|mesh-list
6111284|NCT01029054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6111285|NCT01029054|Antiemetics|antiemetics|mesh-ancestor
6111286|NCT01029054|Autonomic Agents|autonomic agents|mesh-ancestor
6111287|NCT01029054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6111288|NCT01029054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111289|NCT01029054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6111290|NCT01029054|Glucocorticoids|glucocorticoids|mesh-ancestor
6111291|NCT01029054|Hormones|hormones|mesh-ancestor
6111292|NCT01029054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6111293|NCT01029054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5528551|NCT04255017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5528552|NCT04255017|Antiviral Agents|antiviral agents|mesh-ancestor
6111294|NCT01029054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6111295|NCT01029054|Protease Inhibitors|protease inhibitors|mesh-ancestor
6111296|NCT01029054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6111297|NCT01029054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111298|NCT01029054|Immunologic Factors|immunologic factors|mesh-ancestor
6111299|NCT01029054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6111300|NCT01029054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6111301|NCT01029054|Growth Substances|growth substances|mesh-ancestor
5528553|NCT04255017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5528554|NCT04255017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5528555|NCT04255017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5528556|NCT04254835|Chlorhexidine, thymol drug combination|chlorhexidine, thymol drug combination|mesh-list
6111302|NCT01029054|Growth Inhibitors|growth inhibitors|mesh-ancestor
6111303|NCT01029262|Lenalidomide|lenalidomide|mesh-list
6111304|NCT01029262|Immunologic Factors|immunologic factors|mesh-ancestor
6111305|NCT01029262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528557|NCT04254835|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5528558|NCT04254835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5528559|NCT04255121|Lidocaine|lidocaine|mesh-list
5528560|NCT04255121|Epinephrine|epinephrine|mesh-list
5528561|NCT04255121|Racepinephrine|racepinephrine|mesh-list
5528562|NCT04255121|Epinephryl borate|epinephryl borate|mesh-list
5528563|NCT04255121|Anesthetics, Local|anesthetics, local|mesh-ancestor
5725362|NCT03180775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6111306|NCT01029262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6111307|NCT01029262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6111308|NCT01029262|Growth Substances|growth substances|mesh-ancestor
6111309|NCT01029262|Growth Inhibitors|growth inhibitors|mesh-ancestor
6111310|NCT01029262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6111311|NCT01029340|Factor VIII|factor viii|mesh-list
6111312|NCT01029340|Coagulants|coagulants|mesh-ancestor
6111313|NCT01029392|Vitamin D|vitamin d|mesh-list
6111314|NCT01029392|Cholecalciferol|cholecalciferol|mesh-list
6111315|NCT01029392|Vitamins|vitamins|mesh-ancestor
6111316|NCT01029392|Micronutrients|micronutrients|mesh-ancestor
6111317|NCT01029392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111318|NCT01029392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6111319|NCT01029392|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6111320|NCT01029535|Hyaluronic Acid|hyaluronic acid|mesh-list
6111321|NCT01029535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6111322|NCT01029535|Immunologic Factors|immunologic factors|mesh-ancestor
6111323|NCT01029535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111324|NCT01029535|Viscosupplements|viscosupplements|mesh-ancestor
6111325|NCT01029535|Protective Agents|protective agents|mesh-ancestor
6111326|NCT01029587|Eculizumab|eculizumab|mesh-list
6111327|NCT01029587|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6111328|NCT01029587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6111329|NCT01029587|Immunologic Factors|immunologic factors|mesh-ancestor
6111330|NCT01029587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111331|NCT01029652|Triamcinolone|triamcinolone|mesh-list
6111332|NCT01029652|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6111333|NCT01029652|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6111334|NCT01029652|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6111335|NCT01029652|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6111336|NCT01029652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6111337|NCT01029652|Glucocorticoids|glucocorticoids|mesh-ancestor
5528564|NCT04255121|Anesthetics|anesthetics|mesh-ancestor
5725363|NCT03180775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725364|NCT03180775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725365|NCT03180723|Cyclosporine|cyclosporine|mesh-list
5725366|NCT03180723|Rituximab|rituximab|mesh-list
5725367|NCT03180723|Cyclosporins|cyclosporins|mesh-list
5725368|NCT03180723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5725369|NCT03180723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5725370|NCT03180723|Immunologic Factors|immunologic factors|mesh-ancestor
6111338|NCT01029652|Hormones|hormones|mesh-ancestor
6111339|NCT01029652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6111340|NCT01029652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111341|NCT01029652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6111342|NCT01029652|Immunologic Factors|immunologic factors|mesh-ancestor
6111343|NCT01029652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6111344|NCT01029652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111345|NCT01029704|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
6111346|NCT01029704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111347|NCT01029704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6111348|NCT01029704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111349|NCT01029730|Rituximab|rituximab|mesh-list
6111350|NCT01029730|Bortezomib|bortezomib|mesh-list
6111351|NCT01029730|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6111352|NCT01029730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6111353|NCT01029730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6111354|NCT01029730|Immunologic Factors|immunologic factors|mesh-ancestor
6111355|NCT01029730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111356|NCT01029730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6111357|NCT01029730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6111358|NCT01029730|Alkylating Agents|alkylating agents|mesh-ancestor
5528565|NCT04255121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5528566|NCT04255121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528567|NCT04255121|Sensory System Agents|sensory system agents|mesh-ancestor
5528568|NCT04255121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5528569|NCT04255121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5528570|NCT04255121|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5528571|NCT04255121|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5528572|NCT04255121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5528573|NCT04255121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528574|NCT04255121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5528575|NCT04255121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5528576|NCT04255121|Adrenergic Agents|adrenergic agents|mesh-ancestor
5528577|NCT04255121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5528578|NCT04255121|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5528579|NCT04255121|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5528580|NCT04255121|Autonomic Agents|autonomic agents|mesh-ancestor
5528581|NCT04255121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5528582|NCT04255121|Respiratory System Agents|respiratory system agents|mesh-ancestor
5528583|NCT04255121|Mydriatics|mydriatics|mesh-ancestor
5528584|NCT04255121|Sympathomimetics|sympathomimetics|mesh-ancestor
5528585|NCT04255121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5528586|NCT04254822|Carvedilol|carvedilol|mesh-list
5528587|NCT04254822|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5528588|NCT04254822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5528589|NCT04254822|Adrenergic Agents|adrenergic agents|mesh-ancestor
5528590|NCT04254822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5528591|NCT04254822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528592|NCT04254822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528593|NCT04254822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5528594|NCT04254822|Antioxidants|antioxidants|mesh-ancestor
5528595|NCT04254822|Protective Agents|protective agents|mesh-ancestor
5528596|NCT04254822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5528597|NCT04254822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5528598|NCT04254822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5528599|NCT04254822|Vasodilator Agents|vasodilator agents|mesh-ancestor
5528600|NCT04254822|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6111359|NCT01029730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111360|NCT01029782|Cefazolin|cefazolin|mesh-list
6111361|NCT01029782|Cephalexin|cephalexin|mesh-list
6111362|NCT01029782|Probenecid|probenecid|mesh-list
6111363|NCT01029782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6111364|NCT01029782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5528601|NCT04254822|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5528602|NCT04255056|Cyclophosphamide|cyclophosphamide|mesh-list
5528603|NCT04255056|Epirubicin|epirubicin|mesh-list
5528604|NCT04255056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5528605|NCT04255056|Immunologic Factors|immunologic factors|mesh-ancestor
5528606|NCT04255056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528607|NCT04255056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5528608|NCT04255056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5528609|NCT04255056|Alkylating Agents|alkylating agents|mesh-ancestor
5528610|NCT04255056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111365|NCT01029782|Uricosuric Agents|uricosuric agents|mesh-ancestor
6111366|NCT01029782|Gout Suppressants|gout suppressants|mesh-ancestor
6111367|NCT01029782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5528611|NCT04255056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5528612|NCT04255056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5528613|NCT04255056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5528614|NCT04255056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5528615|NCT04255056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5528616|NCT04255056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5528617|NCT04254913|Edaravone|edaravone|mesh-list
5528618|NCT04254913|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5528619|NCT04254913|Antioxidants|antioxidants|mesh-ancestor
5528620|NCT04254913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528621|NCT04254913|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5528622|NCT04254913|Protective Agents|protective agents|mesh-ancestor
6111368|NCT01029782|Renal Agents|renal agents|mesh-ancestor
6111369|NCT01029795|Glyburide|glyburide|mesh-list
6111370|NCT01029795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6111371|NCT01029795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111372|NCT01029886|Liraglutide|liraglutide|mesh-list
6111373|NCT01029886|Exenatide|exenatide|mesh-list
6111374|NCT01029886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6111375|NCT01029886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111376|NCT01029886|Incretins|incretins|mesh-ancestor
6111377|NCT01029886|Hormones|hormones|mesh-ancestor
6111378|NCT01029886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5528623|NCT04254913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528624|NCT04254874|Interferons|interferons|mesh-list
5528625|NCT04254874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5528626|NCT04254874|Antiviral Agents|antiviral agents|mesh-ancestor
5528627|NCT04254874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5528628|NCT04254744|Sevoflurane|sevoflurane|mesh-list
5528629|NCT04254744|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5528630|NCT04254744|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5528631|NCT04254744|Anesthetics, General|anesthetics, general|mesh-ancestor
5528632|NCT04254744|Anesthetics|anesthetics|mesh-ancestor
5528633|NCT04254744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5528634|NCT04254744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528635|NCT04254523|Morphine|morphine|mesh-list
5528636|NCT04254523|Bupivacaine|bupivacaine|mesh-list
5528637|NCT04254523|Anesthetics, Local|anesthetics, local|mesh-ancestor
5528638|NCT04254523|Anesthetics|anesthetics|mesh-ancestor
5528639|NCT04254523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5528640|NCT04254523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111379|NCT01029886|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6111380|NCT01030458|Amlodipine|amlodipine|mesh-list
6111381|NCT01030458|Valsartan|valsartan|mesh-list
6111382|NCT01030458|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6111383|NCT01030458|Bisoprolol|bisoprolol|mesh-list
6111384|NCT01030458|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6111385|NCT01030458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6111386|NCT01030458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6111387|NCT01030458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111388|NCT01030458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6111389|NCT01030458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111390|NCT01030458|Vasodilator Agents|vasodilator agents|mesh-ancestor
6111391|NCT01030458|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6111392|NCT01030458|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6111393|NCT01030458|Diuretics|diuretics|mesh-ancestor
6111394|NCT01030458|Natriuretic Agents|natriuretic agents|mesh-ancestor
6111395|NCT01030458|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5528641|NCT04254523|Sensory System Agents|sensory system agents|mesh-ancestor
5528642|NCT04254523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5528643|NCT04254523|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5528644|NCT04254523|Narcotics|narcotics|mesh-ancestor
5528645|NCT04254523|Analgesics|analgesics|mesh-ancestor
5528646|NCT04254601|Erythromycin|erythromycin|mesh-list
5528647|NCT04254601|Erythromycin Estolate|erythromycin estolate|mesh-list
5528648|NCT04254601|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
6111396|NCT01030458|Sympatholytics|sympatholytics|mesh-ancestor
6111397|NCT01030458|Autonomic Agents|autonomic agents|mesh-ancestor
6111398|NCT01030458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6666037|NCT01520350|Dopamine Agents|dopamine agents|mesh-ancestor
5528649|NCT04254601|Erythromycin stearate|erythromycin stearate|mesh-list
5528650|NCT04254601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5528651|NCT04254601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5528652|NCT04254601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6465457|NCT00474695|Ranibizumab|ranibizumab|mesh-list
6111399|NCT01030458|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6111400|NCT01030458|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6111401|NCT01030458|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6111402|NCT01030458|Adrenergic Agents|adrenergic agents|mesh-ancestor
6111403|NCT01030458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6111404|NCT01030536|Immunotoxin HA22|immunotoxin ha22|mesh-list
6111405|NCT01030536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6111406|NCT01030575|Inositol|inositol|mesh-list
6111407|NCT01030575|Vitamin B Complex|vitamin b complex|mesh-ancestor
6111408|NCT01030575|Vitamins|vitamins|mesh-ancestor
6111409|NCT01030575|Micronutrients|micronutrients|mesh-ancestor
6111410|NCT01030575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111411|NCT01030653|Voriconazole|voriconazole|mesh-list
6111412|NCT01030653|Antifungal Agents|antifungal agents|mesh-ancestor
6111413|NCT01030653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6111414|NCT01030653|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6111415|NCT01030653|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6111416|NCT01030653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6111417|NCT01030653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111418|NCT01030653|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5528653|NCT04254601|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5528654|NCT04254601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5528655|NCT04254601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528656|NCT04254692|Bupivacaine|bupivacaine|mesh-list
5528657|NCT04254692|Anesthetics, Local|anesthetics, local|mesh-ancestor
6111419|NCT01030653|Hormone Antagonists|hormone antagonists|mesh-ancestor
6111420|NCT01030653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6111421|NCT01030653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111422|NCT01030653|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6111423|NCT01030666|Chlorhexidine|chlorhexidine|mesh-list
6111424|NCT01030666|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6111425|NCT01030666|Doxycycline|doxycycline|mesh-list
6111426|NCT01030666|Ibuprofen|ibuprofen|mesh-list
6111427|NCT01030666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5528658|NCT04254692|Anesthetics|anesthetics|mesh-ancestor
5528659|NCT04254692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5528660|NCT04254692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111428|NCT01030666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6111429|NCT01030666|Analgesics|analgesics|mesh-ancestor
6111430|NCT01030666|Sensory System Agents|sensory system agents|mesh-ancestor
6111431|NCT01030666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5528661|NCT04254692|Sensory System Agents|sensory system agents|mesh-ancestor
5528662|NCT04254692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5528663|NCT04254679|Analgesics, Opioid|analgesics, opioid|mesh-list
5528664|NCT04254679|Analgesics|analgesics|mesh-list
5528665|NCT04254679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
5528666|NCT04254679|Narcotics|narcotics|mesh-ancestor
5528667|NCT04254679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5528668|NCT04254679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111432|NCT01030666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111433|NCT01030666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6111434|NCT01030666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6111435|NCT01030666|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6111436|NCT01030666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6111437|NCT01030666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111438|NCT01030666|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6111439|NCT01030666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6111440|NCT01030666|Disinfectants|disinfectants|mesh-ancestor
6111441|NCT01030666|Dermatologic Agents|dermatologic agents|mesh-ancestor
6111442|NCT01030666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6111443|NCT01030666|Antimalarials|antimalarials|mesh-ancestor
6111444|NCT01030666|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6111445|NCT01030666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6111446|NCT01030718|Dasatinib|dasatinib|mesh-list
6111447|NCT01030718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6111448|NCT01030718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6111449|NCT01030718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6111450|NCT01030718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111451|NCT01030783|Sorafenib|sorafenib|mesh-list
6111452|NCT01030783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6111453|NCT01030783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6111454|NCT01030783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6111455|NCT01030783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111456|NCT01030822|Vaccines|vaccines|mesh-list
5528669|NCT04254679|Sensory System Agents|sensory system agents|mesh-ancestor
5528670|NCT04254679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5528671|NCT04254380|Insulin Lispro|insulin lispro|mesh-list
5528672|NCT04254380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5528673|NCT04254380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601450|NCT05177276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5601451|NCT05177276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5601452|NCT05177276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5601453|NCT05177276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601454|NCT05177276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5601455|NCT05177263|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5601456|NCT05177237|Endostar protein|endostar protein|mesh-list
5601457|NCT05177237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5601458|NCT05177237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6111457|NCT01030822|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6111458|NCT01030822|Immunologic Factors|immunologic factors|mesh-ancestor
6111459|NCT01030822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111460|NCT01030952|Acarbose|acarbose|mesh-list
6111461|NCT01030952|Nateglinide|nateglinide|mesh-list
6111462|NCT01030952|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6111463|NCT01030952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6111464|NCT01030952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111465|NCT01030952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5601459|NCT05177237|Growth Substances|growth substances|mesh-ancestor
5601460|NCT05177237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601461|NCT05177237|Growth Inhibitors|growth inhibitors|mesh-ancestor
5601462|NCT05177237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5601463|NCT05177146|Ketamine|ketamine|mesh-list
5601464|NCT05177146|Analgesics|analgesics|mesh-ancestor
5601465|NCT05177146|Sensory System Agents|sensory system agents|mesh-ancestor
5601466|NCT05177146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5601467|NCT05177146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601468|NCT05177146|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5601469|NCT05177146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5601470|NCT05177146|Anesthetics, General|anesthetics, general|mesh-ancestor
5601471|NCT05177146|Anesthetics|anesthetics|mesh-ancestor
5601472|NCT05177146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5601473|NCT05177146|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5601474|NCT05177146|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5601475|NCT05177146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5601476|NCT05177146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601477|NCT05177055|Methamphetamine|methamphetamine|mesh-list
6111466|NCT01030952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111467|NCT01031043|Bethanechol|bethanechol|mesh-list
6111468|NCT01031043|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6111469|NCT01031043|Autonomic Agents|autonomic agents|mesh-ancestor
6111470|NCT01031043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6111471|NCT01031043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111472|NCT01031043|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6111473|NCT01031043|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6111474|NCT01031043|Cholinergic Agents|cholinergic agents|mesh-ancestor
6111475|NCT01031043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6111476|NCT01031043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111477|NCT01031069|Vaccines|vaccines|mesh-list
6111478|NCT01031069|Immunologic Factors|immunologic factors|mesh-ancestor
6111479|NCT01031069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111480|NCT01031381|Bevacizumab|bevacizumab|mesh-list
6111481|NCT01031381|Everolimus|everolimus|mesh-list
6111482|NCT01031381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6111483|NCT01031381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6111484|NCT01031381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6111485|NCT01031381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6111486|NCT01031381|Growth Substances|growth substances|mesh-ancestor
6111487|NCT01031381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111488|NCT01031381|Growth Inhibitors|growth inhibitors|mesh-ancestor
6111489|NCT01031381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6111490|NCT01031381|Immunologic Factors|immunologic factors|mesh-ancestor
6111491|NCT01031420|Doxorubicin|doxorubicin|mesh-list
6111492|NCT01031420|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6111493|NCT01031420|Methotrexate|methotrexate|mesh-list
6111494|NCT01031420|Vinblastine|vinblastine|mesh-list
6111495|NCT01031420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6111496|NCT01031420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6111497|NCT01031420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6111498|NCT01031420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6111499|NCT01031420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6111500|NCT01031420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111501|NCT01031420|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6111502|NCT01031420|Abortifacient Agents|abortifacient agents|mesh-ancestor
6111503|NCT01031420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6111504|NCT01031420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111505|NCT01031420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6111506|NCT01031420|Antimetabolites|antimetabolites|mesh-ancestor
6111507|NCT01031420|Dermatologic Agents|dermatologic agents|mesh-ancestor
6111508|NCT01031420|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6111509|NCT01031420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6111510|NCT01031420|Immunologic Factors|immunologic factors|mesh-ancestor
6111511|NCT01031420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6111512|NCT01031420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6111513|NCT01031420|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6111514|NCT01031420|Tubulin Modulators|tubulin modulators|mesh-ancestor
6111515|NCT01031420|Antimitotic Agents|antimitotic agents|mesh-ancestor
6111516|NCT01031420|Mitosis Modulators|mitosis modulators|mesh-ancestor
6111517|NCT01031446|Paclitaxel|paclitaxel|mesh-list
6111518|NCT01031446|Everolimus|everolimus|mesh-list
6111519|NCT01031446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6111520|NCT01031446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6111521|NCT01031446|Tubulin Modulators|tubulin modulators|mesh-ancestor
6111522|NCT01031446|Antimitotic Agents|antimitotic agents|mesh-ancestor
6111523|NCT01031446|Mitosis Modulators|mitosis modulators|mesh-ancestor
6111524|NCT01031446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111525|NCT01031446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6111526|NCT01031446|Immunologic Factors|immunologic factors|mesh-ancestor
6111527|NCT01031446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204223|NCT02066792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6204224|NCT02066792|Antimetabolites|antimetabolites|mesh-ancestor
6204225|NCT02066792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204226|NCT02067663|Levonorgestrel|levonorgestrel|mesh-list
6204227|NCT02067663|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6204228|NCT02067663|Contraceptive Agents|contraceptive agents|mesh-ancestor
6204229|NCT02067663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5528674|NCT04254471|Carboplatin|carboplatin|mesh-list
5528675|NCT04254471|Etoposide|etoposide|mesh-list
5528676|NCT04254471|Rabeprazole|rabeprazole|mesh-list
6204230|NCT02067663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204231|NCT02067663|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6204232|NCT02067663|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6204233|NCT02067663|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6204234|NCT02067676|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6204235|NCT02067676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6204236|NCT02067676|Immunologic Factors|immunologic factors|mesh-ancestor
6204237|NCT02067676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204238|NCT02067676|Antacids|antacids|mesh-ancestor
6204239|NCT02067676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204240|NCT02067676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6204241|NCT02067806|Chloroprocaine|chloroprocaine|mesh-list
6204242|NCT02067806|Anesthetics, Local|anesthetics, local|mesh-ancestor
6204243|NCT02067806|Anesthetics|anesthetics|mesh-ancestor
6204244|NCT02067806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6204245|NCT02067806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204246|NCT02067806|Sensory System Agents|sensory system agents|mesh-ancestor
6204247|NCT02067806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6204248|NCT02068027|Clonidine|clonidine|mesh-list
6204249|NCT02068027|Analgesics|analgesics|mesh-ancestor
6204250|NCT02068027|Sensory System Agents|sensory system agents|mesh-ancestor
6204251|NCT02068027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6204252|NCT02068027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204253|NCT02068027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6204254|NCT02068027|Sympatholytics|sympatholytics|mesh-ancestor
6204255|NCT02068027|Autonomic Agents|autonomic agents|mesh-ancestor
6204256|NCT02068027|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6204257|NCT02068027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6204258|NCT02068027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6204259|NCT02068027|Adrenergic Agents|adrenergic agents|mesh-ancestor
6204260|NCT02068027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6204261|NCT02068027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204262|NCT02068157|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
6204263|NCT02068157|Trioxsalen|trioxsalen|mesh-list
6204264|NCT02068157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5528677|NCT04254471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5528678|NCT04254471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5528679|NCT04254471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5528680|NCT04254471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5528681|NCT04254471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5528682|NCT04254471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528683|NCT04254471|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5528684|NCT04254471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5528685|NCT04254471|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5528686|NCT04254640|Cytarabine|cytarabine|mesh-list
5528687|NCT04254640|Cladribine|cladribine|mesh-list
5528688|NCT04254640|Aclarubicin|aclarubicin|mesh-list
5528689|NCT04254640|Sargramostim|sargramostim|mesh-list
5528690|NCT04254640|Lenograstim|lenograstim|mesh-list
5528691|NCT04254640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5528692|NCT04254640|Antimetabolites|antimetabolites|mesh-ancestor
5528693|NCT04254640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528694|NCT04254640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5528695|NCT04254640|Antiviral Agents|antiviral agents|mesh-ancestor
5528696|NCT04254640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5528697|NCT04254640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5528698|NCT04254640|Immunologic Factors|immunologic factors|mesh-ancestor
6111528|NCT01031498|Ondansetron|ondansetron|mesh-list
6465458|NCT00474695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6465459|NCT00474695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6465460|NCT00474695|Growth Substances|growth substances|mesh-ancestor
6465461|NCT00474695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465462|NCT00474695|Growth Inhibitors|growth inhibitors|mesh-ancestor
6465463|NCT00474695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6465464|NCT00474721|Acetaminophen|acetaminophen|mesh-list
6465465|NCT00474721|Ibuprofen|ibuprofen|mesh-list
6465466|NCT00474721|Codeine|codeine|mesh-list
6111529|NCT01031498|Palonosetron|palonosetron|mesh-list
6111530|NCT01031498|Antiemetics|antiemetics|mesh-ancestor
6111531|NCT01031498|Autonomic Agents|autonomic agents|mesh-ancestor
6111532|NCT01031498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6111533|NCT01031498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111534|NCT01031498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6111535|NCT01031498|Antipruritics|antipruritics|mesh-ancestor
6111536|NCT01031498|Dermatologic Agents|dermatologic agents|mesh-ancestor
6111537|NCT01031498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6111538|NCT01031498|Serotonin Agents|serotonin agents|mesh-ancestor
6111539|NCT01031498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6111540|NCT01031498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111541|NCT01031498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6111542|NCT01031498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6111543|NCT01031498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6111544|NCT01031498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6111545|NCT01031498|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6111546|NCT01031498|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6111547|NCT01031680|Dapagliflozin|dapagliflozin|mesh-list
6111548|NCT01031680|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6111549|NCT01031680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111550|NCT01031680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6111551|NCT01031680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111552|NCT01031810|Tranylcypromine|tranylcypromine|mesh-list
6111553|NCT01031810|Antidepressive Agents|antidepressive agents|mesh-ancestor
6111554|NCT01031810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6111555|NCT01031810|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6111556|NCT01031810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6111557|NCT01031810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111558|NCT01031810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6111559|NCT01031810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6111560|NCT01031810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6111561|NCT01031810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111562|NCT01031836|Sifalimumab|sifalimumab|mesh-list
6111563|NCT01031836|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6111564|NCT01031836|Immunologic Factors|immunologic factors|mesh-ancestor
6111565|NCT01031836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111566|NCT01031953|Fosaprepitant|fosaprepitant|mesh-list
6111567|NCT01031953|Aprepitant|aprepitant|mesh-list
6111568|NCT01031953|Antiemetics|antiemetics|mesh-ancestor
6111569|NCT01031953|Autonomic Agents|autonomic agents|mesh-ancestor
6111570|NCT01031953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6465467|NCT00474721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5528699|NCT04254640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465468|NCT00474721|Analgesics|analgesics|mesh-ancestor
6465469|NCT00474721|Sensory System Agents|sensory system agents|mesh-ancestor
6465470|NCT00474721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6465471|NCT00474721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465472|NCT00474721|Antipyretics|antipyretics|mesh-ancestor
6465473|NCT00474721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6465474|NCT00474721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6465475|NCT00474721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6465476|NCT00474721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6465477|NCT00474721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6465478|NCT00474721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528700|NCT04254640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5528701|NCT04254640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5528702|NCT04254640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5528703|NCT04254640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5528704|NCT04254640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6465479|NCT00474721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6465480|NCT00474721|Narcotics|narcotics|mesh-ancestor
6465481|NCT00474721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6111571|NCT01031953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111572|NCT01031953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6111573|NCT01031953|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6111574|NCT01031953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6111575|NCT01031953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111576|NCT01031979|Yohimbine|yohimbine|mesh-list
6111577|NCT01031979|Mydriatics|mydriatics|mesh-ancestor
6111578|NCT01031979|Autonomic Agents|autonomic agents|mesh-ancestor
6111579|NCT01031979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6111580|NCT01031979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111581|NCT01031979|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6111582|NCT01031979|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6111583|NCT01031979|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6111584|NCT01031979|Adrenergic Agents|adrenergic agents|mesh-ancestor
6111585|NCT01031979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6111586|NCT01031979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111587|NCT01031979|Urological Agents|urological agents|mesh-ancestor
6111588|NCT01032018|Bupropion|bupropion|mesh-list
6111589|NCT01032018|Citalopram|citalopram|mesh-list
6111590|NCT01032018|Sertraline|sertraline|mesh-list
6111591|NCT01032018|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6111592|NCT01032018|Antidepressive Agents|antidepressive agents|mesh-ancestor
6111593|NCT01032018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6111594|NCT01032018|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6111595|NCT01032018|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6111596|NCT01032018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6111597|NCT01032018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111598|NCT01032018|Dopamine Agents|dopamine agents|mesh-ancestor
6111599|NCT01032018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6111600|NCT01032018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111601|NCT01032018|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6111602|NCT01032018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6111603|NCT01032018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6111604|NCT01032018|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6111605|NCT01032018|Serotonin Agents|serotonin agents|mesh-ancestor
6111606|NCT01032070|Etoposide|etoposide|mesh-list
6111607|NCT01032070|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6111608|NCT01032070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6111609|NCT01032070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6111610|NCT01032070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6111611|NCT01032070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6111612|NCT01032070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6111613|NCT01032070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111614|NCT01032070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6111615|NCT01032174|Azithromycin|azithromycin|mesh-list
6111616|NCT01032174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6111617|NCT01032174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6111618|NCT01032200|Modafinil|modafinil|mesh-list
6111619|NCT01032200|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6111620|NCT01032200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111621|NCT01032200|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6111622|NCT01032200|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6111623|NCT01032200|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6111624|NCT01032200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111625|NCT01032239|Baclofen|baclofen|mesh-list
6111626|NCT01032239|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6111627|NCT01032239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111628|NCT01032239|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6111629|NCT01032239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6111630|NCT01032239|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6111631|NCT01032239|GABA Agonists|gaba agonists|mesh-ancestor
6111632|NCT01032239|GABA Agents|gaba agents|mesh-ancestor
6111633|NCT01032239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6111634|NCT01032239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111635|NCT01032291|Lenalidomide|lenalidomide|mesh-list
6111636|NCT01032291|Cetuximab|cetuximab|mesh-list
6111637|NCT01032291|Immunologic Factors|immunologic factors|mesh-ancestor
6111638|NCT01032291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111639|NCT01032291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6111640|NCT01032291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6111641|NCT01032291|Growth Substances|growth substances|mesh-ancestor
6111642|NCT01032291|Growth Inhibitors|growth inhibitors|mesh-ancestor
6111643|NCT01032291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6111644|NCT01032291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6111645|NCT01032382|Gentamicins|gentamicins|mesh-list
6111646|NCT01032382|Paromomycin|paromomycin|mesh-list
6111647|NCT01032382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6111648|NCT01032382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6111649|NCT01032382|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6111650|NCT01032382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6111651|NCT01032382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528705|NCT04254042|Perindopril|perindopril|mesh-list
5528706|NCT04254042|Zofenopril|zofenopril|mesh-list
5528707|NCT04254042|Captopril|captopril|mesh-list
5528708|NCT04254042|Calcium|calcium|mesh-list
5528709|NCT04254042|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5528710|NCT04254042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528711|NCT04254042|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5528712|NCT04254042|Protease Inhibitors|protease inhibitors|mesh-ancestor
5528713|NCT04254042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6111652|NCT01032382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6111653|NCT01032382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6111654|NCT01032629|Canagliflozin|canagliflozin|mesh-list
6111655|NCT01032629|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6111656|NCT01032629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111657|NCT01032629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6111658|NCT01032629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111659|NCT01032694|Azithromycin|azithromycin|mesh-list
6111660|NCT01032694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6111661|NCT01032694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6111662|NCT01032759|Memantine|memantine|mesh-list
6111663|NCT01032759|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6111664|NCT01032759|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6111665|NCT01032759|Dopamine Agents|dopamine agents|mesh-ancestor
6111666|NCT01032759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6111667|NCT01032759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111668|NCT01032759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111669|NCT01032759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6111670|NCT01032759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6111671|NCT01032837|Oseltamivir|oseltamivir|mesh-list
6111672|NCT01032837|Antiviral Agents|antiviral agents|mesh-ancestor
6111673|NCT01032837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6111674|NCT01032837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6111675|NCT01032837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111676|NCT01032850|Capecitabine|capecitabine|mesh-list
6111677|NCT01032850|Sorafenib|sorafenib|mesh-list
6111678|NCT01032850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6111679|NCT01032850|Antimetabolites|antimetabolites|mesh-ancestor
6111680|NCT01032850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111681|NCT01032850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6111682|NCT01032850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6111683|NCT01032850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6111684|NCT01032889|Deoxycholic Acid|deoxycholic acid|mesh-list
6111685|NCT01032889|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6111686|NCT01032889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6465482|NCT00474721|Antitussive Agents|antitussive agents|mesh-ancestor
6465483|NCT00474721|Respiratory System Agents|respiratory system agents|mesh-ancestor
6465484|NCT00474773|Celecoxib|celecoxib|mesh-list
5601478|NCT05177055|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6465485|NCT00474773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6465486|NCT00474773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6465487|NCT00474773|Analgesics|analgesics|mesh-ancestor
6465488|NCT00474773|Sensory System Agents|sensory system agents|mesh-ancestor
6465489|NCT00474773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6465490|NCT00474773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465491|NCT00474773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5528714|NCT04254042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111687|NCT01032915|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6111688|NCT01032915|Immunologic Factors|immunologic factors|mesh-ancestor
6111689|NCT01032915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111690|NCT01032954|Botulinum Toxins|botulinum toxins|mesh-list
6111691|NCT01032954|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6111692|NCT01032954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6111693|NCT01032954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111694|NCT01032954|Cholinergic Agents|cholinergic agents|mesh-ancestor
6111695|NCT01032954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6111696|NCT01032954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111697|NCT01032993|Ubiquinone|ubiquinone|mesh-list
6111698|NCT01032993|Coenzyme Q10|coenzyme q10|mesh-list
6111699|NCT01032993|Micronutrients|micronutrients|mesh-ancestor
6111700|NCT01032993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111701|NCT01032993|Vitamins|vitamins|mesh-ancestor
6111702|NCT01033032|Amrubicin|amrubicin|mesh-list
6111703|NCT01033032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6111704|NCT01033071|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6111705|NCT01033071|Olmesartan|olmesartan|mesh-list
6111706|NCT01033071|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6111707|NCT01033071|Chlorthalidone|chlorthalidone|mesh-list
6111708|NCT01033071|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
6111709|NCT01033071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6111710|NCT01033071|Diuretics|diuretics|mesh-ancestor
6111711|NCT01033071|Natriuretic Agents|natriuretic agents|mesh-ancestor
6111712|NCT01033071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111713|NCT01033071|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6111714|NCT01033071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6111715|NCT01033071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111716|NCT01033071|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6111717|NCT01033071|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6111718|NCT01033240|Sorafenib|sorafenib|mesh-list
6111719|NCT01033240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6111720|NCT01033240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6111721|NCT01033240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6111722|NCT01033240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111723|NCT01033448|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6111724|NCT01033448|Antiviral Agents|antiviral agents|mesh-ancestor
6111725|NCT01033448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6111726|NCT01033565|Melatonin|melatonin|mesh-list
6111727|NCT01033565|Antioxidants|antioxidants|mesh-ancestor
6111728|NCT01033565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111729|NCT01033565|Protective Agents|protective agents|mesh-ancestor
6111730|NCT01033565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111731|NCT01033565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6111732|NCT01033734|Oseltamivir|oseltamivir|mesh-list
6111733|NCT01033734|Antiviral Agents|antiviral agents|mesh-ancestor
6111734|NCT01033734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6111735|NCT01033734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6111736|NCT01033734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111737|NCT01033747|Deferasirox|deferasirox|mesh-list
6111738|NCT01033747|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6111739|NCT01033747|Chelating Agents|chelating agents|mesh-ancestor
6111740|NCT01033747|Sequestering Agents|sequestering agents|mesh-ancestor
6111741|NCT01033747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528715|NCT04254042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5528716|NCT04254081|Lidocaine|lidocaine|mesh-list
5528717|NCT04254081|Buprenorphine|buprenorphine|mesh-list
5528718|NCT04254081|Anesthetics, Local|anesthetics, local|mesh-ancestor
5528719|NCT04254081|Anesthetics|anesthetics|mesh-ancestor
5528720|NCT04254081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5528721|NCT04254081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111742|NCT01033773|Metformin|metformin|mesh-list
6111743|NCT01033773|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6111744|NCT01033773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111745|NCT01033825|Ciclesonide|ciclesonide|mesh-list
6111746|NCT01033825|Dexamethasone|dexamethasone|mesh-list
6111747|NCT01033825|Dexamethasone acetate|dexamethasone acetate|mesh-list
6465492|NCT00474773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6111748|NCT01033825|BB 1101|bb 1101|mesh-list
5528722|NCT04254081|Sensory System Agents|sensory system agents|mesh-ancestor
5528723|NCT04254081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5528724|NCT04254081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5528725|NCT04254081|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5528726|NCT04254081|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5528727|NCT04254081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5528728|NCT04254081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528729|NCT04254081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6111749|NCT01033825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6111750|NCT01033825|Antiemetics|antiemetics|mesh-ancestor
6111751|NCT01033825|Autonomic Agents|autonomic agents|mesh-ancestor
6111752|NCT01033825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6111753|NCT01033825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111754|NCT01033825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6111755|NCT01033825|Glucocorticoids|glucocorticoids|mesh-ancestor
6111756|NCT01033825|Hormones|hormones|mesh-ancestor
6111757|NCT01033825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6111758|NCT01033825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6111759|NCT01033825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6111760|NCT01033825|Protease Inhibitors|protease inhibitors|mesh-ancestor
6111761|NCT01033825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5528730|NCT04254081|Narcotics|narcotics|mesh-ancestor
5528731|NCT04254081|Analgesics|analgesics|mesh-ancestor
5528732|NCT04254081|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5528733|NCT04253912|Povidone-Iodine|povidone-iodine|mesh-list
5528734|NCT04253912|Povidone|povidone|mesh-list
6111762|NCT01033825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111763|NCT01033825|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6111764|NCT01033864|Mycophenolic Acid|mycophenolic acid|mesh-list
6111765|NCT01033864|Prednisone|prednisone|mesh-list
6111766|NCT01033864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6111767|NCT01033864|Glucocorticoids|glucocorticoids|mesh-ancestor
6111768|NCT01033864|Hormones|hormones|mesh-ancestor
6111769|NCT01033864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6111770|NCT01033864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111771|NCT01033864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6111772|NCT01033864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6111773|NCT01033864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6111774|NCT01033864|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6111775|NCT01033864|Antitubercular Agents|antitubercular agents|mesh-ancestor
6111776|NCT01033864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6111777|NCT01033864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6111778|NCT01033864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6111779|NCT01033864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111780|NCT01033942|Tenofovir|tenofovir|mesh-list
6111781|NCT01033942|Emtricitabine|emtricitabine|mesh-list
6111782|NCT01033942|Antiviral Agents|antiviral agents|mesh-ancestor
6111783|NCT01033942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6111784|NCT01033942|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5528735|NCT04253912|Plasma Substitutes|plasma substitutes|mesh-ancestor
5528736|NCT04253912|Blood Substitutes|blood substitutes|mesh-ancestor
5528737|NCT04253912|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5528738|NCT04253912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5528739|NCT04253574|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5528740|NCT04253574|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5528741|NCT04253574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528742|NCT04253678|Vortioxetine|vortioxetine|mesh-list
5528743|NCT04253678|Antidepressive Agents|antidepressive agents|mesh-ancestor
5528744|NCT04253678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5528745|NCT04253678|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5528746|NCT04253678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5528747|NCT04253678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5528748|NCT04253678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528749|NCT04253678|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5528750|NCT04253678|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5528751|NCT04253678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5528752|NCT04253678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528753|NCT04253678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5528754|NCT04253678|Serotonin Agents|serotonin agents|mesh-ancestor
5528755|NCT04253678|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5528756|NCT04253678|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5528757|NCT04253678|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6204265|NCT02068157|Dermatologic Agents|dermatologic agents|mesh-ancestor
6111785|NCT01033942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6111786|NCT01033942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6111787|NCT01033942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111788|NCT01033942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6111789|NCT01033942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6111790|NCT01034111|Metformin|metformin|mesh-list
6111791|NCT01034111|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6111792|NCT01034111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6111793|NCT01034111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111794|NCT01034111|Incretins|incretins|mesh-ancestor
6111795|NCT01034111|Hormones|hormones|mesh-ancestor
6111796|NCT01034111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5528758|NCT04253678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5528759|NCT04253561|Trastuzumab|trastuzumab|mesh-list
5528760|NCT04253561|Pertuzumab|pertuzumab|mesh-list
5528761|NCT04253561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5528762|NCT04253561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5528763|NCT04253873|Temozolomide|temozolomide|mesh-list
5528764|NCT04253873|Apatinib|apatinib|mesh-list
5528765|NCT04253873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5528766|NCT04253873|Alkylating Agents|alkylating agents|mesh-ancestor
6111797|NCT01034111|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6111798|NCT01034111|Protease Inhibitors|protease inhibitors|mesh-ancestor
6111799|NCT01034111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6111800|NCT01034111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111801|NCT01034137|Methotrexate|methotrexate|mesh-list
6111802|NCT01034137|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6111803|NCT01034137|Abortifacient Agents|abortifacient agents|mesh-ancestor
6111804|NCT01034137|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6111805|NCT01034137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111806|NCT01034137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6111807|NCT01034137|Antimetabolites|antimetabolites|mesh-ancestor
5528767|NCT04253873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528768|NCT04253873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5528769|NCT04253873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5528770|NCT04253873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5528771|NCT04253132|Tolfenamic acid|tolfenamic acid|mesh-list
5528772|NCT04253132|Analgesics|analgesics|mesh-ancestor
5528773|NCT04253132|Sensory System Agents|sensory system agents|mesh-ancestor
5528774|NCT04253132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5528775|NCT04253132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528776|NCT04253132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5528777|NCT04253132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5528778|NCT04253132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5528779|NCT04253132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5528780|NCT04253132|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5528781|NCT04253132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5528782|NCT04253132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528783|NCT04253132|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5528784|NCT04253132|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
6111808|NCT01034137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111809|NCT01034137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6111810|NCT01034137|Dermatologic Agents|dermatologic agents|mesh-ancestor
6111811|NCT01034137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6111812|NCT01034137|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6111813|NCT01034137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6111814|NCT01034137|Immunologic Factors|immunologic factors|mesh-ancestor
6111815|NCT01034137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6111816|NCT01034137|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6111817|NCT01034163|Panobinostat|panobinostat|mesh-list
6111818|NCT01034163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6111819|NCT01034163|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6111820|NCT01034163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6111821|NCT01034163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111822|NCT01034176|Levofloxacin|levofloxacin|mesh-list
6111823|NCT01034176|Ofloxacin|ofloxacin|mesh-list
6111824|NCT01034176|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6111825|NCT01034176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6111826|NCT01034176|Renal Agents|renal agents|mesh-ancestor
6111827|NCT01034176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6111828|NCT01034176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6111829|NCT01034176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6111830|NCT01034176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6111831|NCT01034176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111832|NCT01034176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6111833|NCT01034176|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6111834|NCT01034176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6111835|NCT01034462|Milnacipran|milnacipran|mesh-list
6111836|NCT01034462|Levomilnacipran|levomilnacipran|mesh-list
6111837|NCT01034462|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6111838|NCT01034462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6111839|NCT01034462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6111840|NCT01034462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111841|NCT01034462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6111842|NCT01034462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465493|NCT00474773|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6465494|NCT00474773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6465495|NCT00474773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6111843|NCT01034462|Antidepressive Agents|antidepressive agents|mesh-ancestor
6111844|NCT01034462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6111845|NCT01034462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6111846|NCT01034462|Analgesics|analgesics|mesh-ancestor
6111847|NCT01034462|Sensory System Agents|sensory system agents|mesh-ancestor
6111848|NCT01034462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6111849|NCT01034553|Bortezomib|bortezomib|mesh-list
6111850|NCT01034553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6111851|NCT01034592|Lenalidomide|lenalidomide|mesh-list
6111852|NCT01034592|Immunologic Factors|immunologic factors|mesh-ancestor
6111853|NCT01034592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111854|NCT01034592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6111855|NCT01034592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6111856|NCT01034592|Growth Substances|growth substances|mesh-ancestor
6111857|NCT01034592|Growth Inhibitors|growth inhibitors|mesh-ancestor
6111858|NCT01034592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6111859|NCT01034631|Everolimus|everolimus|mesh-list
6111860|NCT01034631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6111861|NCT01034631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6111862|NCT01034631|Immunologic Factors|immunologic factors|mesh-ancestor
6111863|NCT01034631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111864|NCT01034657|Panobinostat|panobinostat|mesh-list
6111865|NCT01034657|Epoetin Alfa|epoetin alfa|mesh-list
6111866|NCT01034657|Hematinics|hematinics|mesh-ancestor
6111867|NCT01034657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6111868|NCT01034657|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6111869|NCT01034657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6111870|NCT01034657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111871|NCT01035099|Letrozole|letrozole|mesh-list
6111872|NCT01035099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6111873|NCT01035099|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6111874|NCT01035099|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6111875|NCT01035099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6111876|NCT01035099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111877|NCT01035099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6111878|NCT01035099|Hormone Antagonists|hormone antagonists|mesh-ancestor
6111879|NCT01035099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6111880|NCT01035099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111881|NCT01035229|Everolimus|everolimus|mesh-list
6111882|NCT01035229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6111883|NCT01035229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6111884|NCT01035229|Immunologic Factors|immunologic factors|mesh-ancestor
6111885|NCT01035229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111886|NCT01035255|Enalapril|enalapril|mesh-list
6111887|NCT01035255|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
6111888|NCT01035255|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6111889|NCT01035255|Protease Inhibitors|protease inhibitors|mesh-ancestor
6111890|NCT01035255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6111891|NCT01035255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111892|NCT01035255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6111893|NCT01035255|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6111894|NCT01035333|Orlistat|orlistat|mesh-list
6111895|NCT01035333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6111896|NCT01035333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111897|NCT01035333|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6111898|NCT01035333|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6111899|NCT01035346|Ibuprofen|ibuprofen|mesh-list
5528785|NCT04253132|Hormone Antagonists|hormone antagonists|mesh-ancestor
6111900|NCT01035346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6111901|NCT01035346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6111902|NCT01035346|Analgesics|analgesics|mesh-ancestor
6111903|NCT01035346|Sensory System Agents|sensory system agents|mesh-ancestor
6111904|NCT01035346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6111905|NCT01035346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111906|NCT01035346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6111907|NCT01035346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6111908|NCT01035346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6111909|NCT01035346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6111910|NCT01035346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111911|NCT01035463|Cytarabine|cytarabine|mesh-list
6111912|NCT01035463|Rituximab|rituximab|mesh-list
6111913|NCT01035463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5528786|NCT04253132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5528787|NCT04253132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5528788|NCT04253132|Serotonin Agents|serotonin agents|mesh-ancestor
5528789|NCT04253132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5528790|NCT04253145|Atezolizumab|atezolizumab|mesh-list
5528791|NCT04253145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5528792|NCT04253457|Triamcinolone|triamcinolone|mesh-list
5528793|NCT04253457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5528794|NCT04253457|Glucocorticoids|glucocorticoids|mesh-ancestor
5528795|NCT04253457|Hormones|hormones|mesh-ancestor
5528796|NCT04253457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5528797|NCT04253457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528798|NCT04253353|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5528799|NCT04253353|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5528800|NCT04253353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6111914|NCT01035463|Etoposide|etoposide|mesh-list
6111915|NCT01035463|Lenalidomide|lenalidomide|mesh-list
6111916|NCT01035463|Etoposide phosphate|etoposide phosphate|mesh-list
6111917|NCT01035463|Melphalan|melphalan|mesh-list
6111918|NCT01035463|Mechlorethamine|mechlorethamine|mesh-list
6111919|NCT01035463|Carmustine|carmustine|mesh-list
6111920|NCT01035463|Podophyllotoxin|podophyllotoxin|mesh-list
6111921|NCT01035463|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
6111922|NCT01035463|Antibodies|antibodies|mesh-list
6111923|NCT01035463|Immunoglobulins|immunoglobulins|mesh-list
6111924|NCT01035463|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6111925|NCT01035463|Immunologic Factors|immunologic factors|mesh-ancestor
6111926|NCT01035463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111927|NCT01035463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6111928|NCT01035463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6111929|NCT01035463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6111930|NCT01035463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6111931|NCT01035463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5528801|NCT04253353|Antimetabolites|antimetabolites|mesh-ancestor
5528802|NCT04253353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528803|NCT04253353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5528804|NCT04253353|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5528805|NCT04253353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5528806|NCT04253223|Volagidemab|volagidemab|mesh-list
5528807|NCT04253223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5528808|NCT04253223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528809|NCT04252963|Streptokinase|streptokinase|mesh-list
5528810|NCT04252963|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5528811|NCT04252963|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5528812|NCT04252963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528813|NCT04252664|Remdesivir|remdesivir|mesh-list
5528814|NCT04252664|Antimetabolites|antimetabolites|mesh-ancestor
5528815|NCT04252664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528816|NCT04252664|Antiviral Agents|antiviral agents|mesh-ancestor
5528817|NCT04252664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6111932|NCT01035463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6111933|NCT01035463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465496|NCT00474773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465497|NCT00474838|Metformin|metformin|mesh-list
6465498|NCT00474838|Glimepiride|glimepiride|mesh-list
6465499|NCT00474838|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6465500|NCT00474838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465501|NCT00474838|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6465502|NCT00474838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6465503|NCT00474838|Immunologic Factors|immunologic factors|mesh-ancestor
6111934|NCT01035463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6111935|NCT01035463|Antimetabolites|antimetabolites|mesh-ancestor
6111936|NCT01035463|Antiviral Agents|antiviral agents|mesh-ancestor
6111937|NCT01035463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6111938|NCT01035463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6111939|NCT01035463|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6111940|NCT01035463|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6111941|NCT01035463|Growth Substances|growth substances|mesh-ancestor
6111942|NCT01035463|Growth Inhibitors|growth inhibitors|mesh-ancestor
6111943|NCT01035463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6111944|NCT01035463|Alkylating Agents|alkylating agents|mesh-ancestor
5528818|NCT04252768|Paclitaxel|paclitaxel|mesh-list
5528819|NCT04252768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5528820|NCT04252768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5528821|NCT04252768|Tubulin Modulators|tubulin modulators|mesh-ancestor
5528822|NCT04252768|Antimitotic Agents|antimitotic agents|mesh-ancestor
5528823|NCT04252768|Mitosis Modulators|mitosis modulators|mesh-ancestor
5528824|NCT04252768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601479|NCT05177055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601480|NCT05177055|Sympathomimetics|sympathomimetics|mesh-ancestor
5601481|NCT05177055|Autonomic Agents|autonomic agents|mesh-ancestor
5601482|NCT05177055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5601483|NCT05177055|Dopamine Agents|dopamine agents|mesh-ancestor
5601484|NCT05177055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5601485|NCT05177055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601486|NCT05177055|Adrenergic Agents|adrenergic agents|mesh-ancestor
6111945|NCT01035463|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6111946|NCT01035463|Keratolytic Agents|keratolytic agents|mesh-ancestor
6111947|NCT01035463|Dermatologic Agents|dermatologic agents|mesh-ancestor
6111948|NCT01035463|Tubulin Modulators|tubulin modulators|mesh-ancestor
6111949|NCT01035463|Antimitotic Agents|antimitotic agents|mesh-ancestor
6111950|NCT01035463|Mitosis Modulators|mitosis modulators|mesh-ancestor
6111951|NCT01035658|Doxorubicin|doxorubicin|mesh-list
6111952|NCT01035658|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6111953|NCT01035658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6111954|NCT01035658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6111955|NCT01035658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6111956|NCT01035658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6111957|NCT01035658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6111958|NCT01035658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111959|NCT01035749|Vaccines|vaccines|mesh-list
6111960|NCT01035749|Immunologic Factors|immunologic factors|mesh-ancestor
6111961|NCT01035749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111962|NCT01036594|Ketoconazole|ketoconazole|mesh-list
6111963|NCT01036594|Dexamethasone|dexamethasone|mesh-list
6111964|NCT01036594|Dexamethasone acetate|dexamethasone acetate|mesh-list
6111965|NCT01036594|Hydrocortisone|hydrocortisone|mesh-list
6111966|NCT01036594|BB 1101|bb 1101|mesh-list
6111967|NCT01036594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6111968|NCT01036594|Antiemetics|antiemetics|mesh-ancestor
6111969|NCT01036594|Autonomic Agents|autonomic agents|mesh-ancestor
6111970|NCT01036594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6111971|NCT01036594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6111972|NCT01036594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6111973|NCT01036594|Glucocorticoids|glucocorticoids|mesh-ancestor
6111974|NCT01036594|Hormones|hormones|mesh-ancestor
6111975|NCT01036594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6111976|NCT01036594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6111977|NCT01036594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6111978|NCT01036594|Protease Inhibitors|protease inhibitors|mesh-ancestor
6111979|NCT01036594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5601487|NCT05177055|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6111980|NCT01036594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528825|NCT04252885|Ritonavir|ritonavir|mesh-list
5528826|NCT04252885|Lopinavir|lopinavir|mesh-list
5528827|NCT04252885|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5528828|NCT04252885|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5528829|NCT04252885|Protease Inhibitors|protease inhibitors|mesh-ancestor
6111981|NCT01036594|Antifungal Agents|antifungal agents|mesh-ancestor
6111982|NCT01036594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6111983|NCT01036594|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6111984|NCT01036594|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6111985|NCT01036594|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6111986|NCT01036594|Hormone Antagonists|hormone antagonists|mesh-ancestor
6111987|NCT01036594|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6111988|NCT01036802|Warfarin|warfarin|mesh-list
6111989|NCT01036802|Anticoagulants|anticoagulants|mesh-ancestor
6111990|NCT01037127|Trametinib|trametinib|mesh-list
6111991|NCT01037127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6111992|NCT01037127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6111993|NCT01037127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6111994|NCT01037127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6111995|NCT01037192|Vancomycin|vancomycin|mesh-list
6111996|NCT01037192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6111997|NCT01037192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6111998|NCT01037218|Udenafil|udenafil|mesh-list
6111999|NCT01037218|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6112000|NCT01037218|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6112001|NCT01037218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6112002|NCT01037218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112003|NCT01037244|Udenafil|udenafil|mesh-list
6112004|NCT01037244|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6112005|NCT01037244|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6112006|NCT01037244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6112007|NCT01037244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204266|NCT02068157|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6204267|NCT02068222|Ritonavir|ritonavir|mesh-list
6204268|NCT02068222|Ribavirin|ribavirin|mesh-list
6204269|NCT02068222|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6204270|NCT02068222|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6204271|NCT02068222|Protease Inhibitors|protease inhibitors|mesh-ancestor
6204272|NCT02068222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6204273|NCT02068222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204274|NCT02068222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6204275|NCT02068222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6204276|NCT02068222|Antiviral Agents|antiviral agents|mesh-ancestor
6204277|NCT02068222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6204278|NCT02068222|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6465504|NCT00474890|Pseudoephedrine|pseudoephedrine|mesh-list
6112008|NCT01037452|Calcium, Dietary|calcium, dietary|mesh-list
6112009|NCT01037452|Lansoprazole|lansoprazole|mesh-list
6112010|NCT01037452|Dexlansoprazole|dexlansoprazole|mesh-list
6112011|NCT01037452|Calcium Carbonate|calcium carbonate|mesh-list
5528830|NCT04252885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5528831|NCT04252885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528832|NCT04252885|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5528833|NCT04252885|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5528834|NCT04252885|Antiviral Agents|antiviral agents|mesh-ancestor
5528835|NCT04252885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5528836|NCT04252885|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5528837|NCT04252885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5528838|NCT04252586|Cannabidiol|cannabidiol|mesh-list
5528839|NCT04252586|Anticonvulsants|anticonvulsants|mesh-ancestor
5528840|NCT04252365|Pembrolizumab|pembrolizumab|mesh-list
5528841|NCT04252365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5528842|NCT04252365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5528843|NCT04252456|Leucovorin|leucovorin|mesh-list
5528844|NCT04252456|Folic Acid|folic acid|mesh-list
5528845|NCT04252456|Fluorouracil|fluorouracil|mesh-list
5528846|NCT04252456|Aflibercept|aflibercept|mesh-list
5528847|NCT04252456|Levoleucovorin|levoleucovorin|mesh-list
5528848|NCT04252456|Antimetabolites|antimetabolites|mesh-ancestor
5528849|NCT04252456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528850|NCT04252456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5528851|NCT04252456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5528852|NCT04252456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5528853|NCT04252456|Immunologic Factors|immunologic factors|mesh-ancestor
5528854|NCT04252456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112012|NCT01037452|Magnesium Hydroxide|magnesium hydroxide|mesh-list
6112013|NCT01037452|Calcium|calcium|mesh-list
6112014|NCT01037452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6112015|NCT01037452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112016|NCT01037452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6112017|NCT01037452|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6112018|NCT01037452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6112019|NCT01037452|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6112020|NCT01037452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6112021|NCT01037452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112022|NCT01037452|Antacids|antacids|mesh-ancestor
6112023|NCT01037790|Palbociclib|palbociclib|mesh-list
6112024|NCT01037790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6112025|NCT01037790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6112026|NCT01037790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6112027|NCT01037790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112028|NCT01037881|Pimecrolimus|pimecrolimus|mesh-list
6112029|NCT01037881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6112030|NCT01037881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6112031|NCT01037881|Analgesics|analgesics|mesh-ancestor
6112032|NCT01037881|Sensory System Agents|sensory system agents|mesh-ancestor
6112033|NCT01037881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6112034|NCT01037881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112035|NCT01037881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6112036|NCT01037881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6112037|NCT01037881|Dermatologic Agents|dermatologic agents|mesh-ancestor
6112038|NCT01037881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6112039|NCT01037881|Immunologic Factors|immunologic factors|mesh-ancestor
6112040|NCT01037881|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5528855|NCT04252456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5528856|NCT04252456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6112041|NCT01037881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5528857|NCT04252456|Growth Substances|growth substances|mesh-ancestor
5528858|NCT04252456|Growth Inhibitors|growth inhibitors|mesh-ancestor
5528859|NCT04252456|Antidotes|antidotes|mesh-ancestor
5528860|NCT04252456|Protective Agents|protective agents|mesh-ancestor
5528861|NCT04252456|Vitamin B Complex|vitamin b complex|mesh-ancestor
5528862|NCT04252456|Vitamins|vitamins|mesh-ancestor
5528863|NCT04252456|Micronutrients|micronutrients|mesh-ancestor
5528864|NCT04252456|Hematinics|hematinics|mesh-ancestor
5528865|NCT04252443|Analgesics, Opioid|analgesics, opioid|mesh-list
6112042|NCT01037881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112043|NCT01038128|Memantine|memantine|mesh-list
6112044|NCT01038128|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6112045|NCT01038128|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6112046|NCT01038128|Dopamine Agents|dopamine agents|mesh-ancestor
6112047|NCT01038128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6112048|NCT01038128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112049|NCT01038128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112050|NCT01038128|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6112051|NCT01038128|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6112052|NCT01038323|Milnacipran|milnacipran|mesh-list
6112053|NCT01038323|Levomilnacipran|levomilnacipran|mesh-list
6112054|NCT01038323|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6112055|NCT01038323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6112056|NCT01038323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6112057|NCT01038323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528866|NCT04252443|Analgesics|analgesics|mesh-list
5528867|NCT04252443|Narcotics|narcotics|mesh-ancestor
5528868|NCT04252443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5528869|NCT04252443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528870|NCT04252443|Sensory System Agents|sensory system agents|mesh-ancestor
5528871|NCT04252443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5528872|NCT04252248|Decitabine|decitabine|mesh-list
5528873|NCT04252248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5528874|NCT04252248|Antimetabolites|antimetabolites|mesh-ancestor
5528875|NCT04252248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528876|NCT04252248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5528877|NCT04252248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5528878|NCT04252274|Darunavir|darunavir|mesh-list
6112058|NCT01038323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6112059|NCT01038323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112060|NCT01038323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6112061|NCT01038323|Analgesics|analgesics|mesh-ancestor
6112062|NCT01038323|Sensory System Agents|sensory system agents|mesh-ancestor
6112063|NCT01038323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6112064|NCT01038323|Antidepressive Agents|antidepressive agents|mesh-ancestor
6112065|NCT01038323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6112066|NCT01038427|Mometasone Furoate|mometasone furoate|mesh-list
6112067|NCT01038427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6112068|NCT01038427|Dermatologic Agents|dermatologic agents|mesh-ancestor
6112069|NCT01038427|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6112070|NCT01038609|Acetaminophen|acetaminophen|mesh-list
6112071|NCT01038609|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
6112072|NCT01038609|Morphine|morphine|mesh-list
6112073|NCT01038609|Hydrocodone|hydrocodone|mesh-list
6112074|NCT01038609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6112075|NCT01038609|Narcotics|narcotics|mesh-ancestor
6112076|NCT01038609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6112077|NCT01038609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112078|NCT01038609|Analgesics|analgesics|mesh-ancestor
6112079|NCT01038609|Sensory System Agents|sensory system agents|mesh-ancestor
5528879|NCT04252274|Cobicistat|cobicistat|mesh-list
5528880|NCT04252274|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5528881|NCT04252274|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5528882|NCT04252274|Protease Inhibitors|protease inhibitors|mesh-ancestor
5528883|NCT04252274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5528884|NCT04252274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112080|NCT01038609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6112081|NCT01038609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6112082|NCT01038609|Antipyretics|antipyretics|mesh-ancestor
6112083|NCT01038609|Antitussive Agents|antitussive agents|mesh-ancestor
6112084|NCT01038609|Respiratory System Agents|respiratory system agents|mesh-ancestor
6112085|NCT01038609|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6112086|NCT01038609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6112087|NCT01038609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5528885|NCT04252274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6112088|NCT01038635|Lenalidomide|lenalidomide|mesh-list
6112089|NCT01038635|Azacitidine|azacitidine|mesh-list
6112090|NCT01038635|Immunologic Factors|immunologic factors|mesh-ancestor
6112091|NCT01038635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112092|NCT01038635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6112093|NCT01038635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6112094|NCT01038635|Growth Substances|growth substances|mesh-ancestor
6112095|NCT01038635|Growth Inhibitors|growth inhibitors|mesh-ancestor
6112096|NCT01038635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6112097|NCT01038635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6112098|NCT01038635|Antimetabolites|antimetabolites|mesh-ancestor
6112099|NCT01038635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112100|NCT01038635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6112101|NCT01038778|Aldesleukin|aldesleukin|mesh-list
6112102|NCT01038778|Deoxyglucose|deoxyglucose|mesh-list
6112103|NCT01038778|Interleukin-2|interleukin-2|mesh-list
6112104|NCT01038778|Entinostat|entinostat|mesh-list
6112105|NCT01038778|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6112106|NCT01038778|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
6112107|NCT01038778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6112108|NCT01038778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6112109|NCT01038778|Analgesics|analgesics|mesh-ancestor
6112110|NCT01038778|Sensory System Agents|sensory system agents|mesh-ancestor
6112111|NCT01038778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6112112|NCT01038778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112113|NCT01038778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6112114|NCT01038778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6112115|NCT01038778|Antiviral Agents|antiviral agents|mesh-ancestor
6112116|NCT01038778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6112117|NCT01038778|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6112118|NCT01038778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112119|NCT01038778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6112120|NCT01038778|Antimetabolites|antimetabolites|mesh-ancestor
6112121|NCT01038856|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6112122|NCT01038856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6112123|NCT01038856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6112124|NCT01038856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6112125|NCT01038856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112126|NCT01038869|Azelaic acid|azelaic acid|mesh-list
6112127|NCT01038869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6112128|NCT01038869|Dermatologic Agents|dermatologic agents|mesh-ancestor
6112129|NCT01038921|Melatonin|melatonin|mesh-list
6112130|NCT01038921|Antioxidants|antioxidants|mesh-ancestor
6112131|NCT01038921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112132|NCT01038921|Protective Agents|protective agents|mesh-ancestor
6112133|NCT01038921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112134|NCT01038921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6112135|NCT01039207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6112136|NCT01039207|Rilotumumab|rilotumumab|mesh-list
6112137|NCT01039207|Antibodies|antibodies|mesh-list
6112138|NCT01039207|Immunoglobulins|immunoglobulins|mesh-list
6112139|NCT01039207|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6112140|NCT01039207|Immunologic Factors|immunologic factors|mesh-ancestor
6112141|NCT01039207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112142|NCT01039207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6112143|NCT01039376|Ofatumumab|ofatumumab|mesh-list
6112144|NCT01039376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6112145|NCT01039584|Butoconazole|butoconazole|mesh-list
6112146|NCT01039584|Antifungal Agents|antifungal agents|mesh-ancestor
6112147|NCT01039584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6112148|NCT01039688|Antirheumatic Agents|antirheumatic agents|mesh-list
6112149|NCT01039688|Tofacitinib|tofacitinib|mesh-list
6112150|NCT01039688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6112151|NCT01039688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6112152|NCT01039688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112153|NCT01039792|Vitamin B 12|vitamin b 12|mesh-list
6112154|NCT01039792|Vitamins|vitamins|mesh-ancestor
6112155|NCT01039792|Micronutrients|micronutrients|mesh-ancestor
6112156|NCT01039792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112157|NCT01039792|Vitamin B Complex|vitamin b complex|mesh-ancestor
6112158|NCT01040130|Olodaterol|olodaterol|mesh-list
6112159|NCT01040130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6112160|NCT01040130|Autonomic Agents|autonomic agents|mesh-ancestor
6112161|NCT01040130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6112162|NCT01040130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112163|NCT01040130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6112164|NCT01040130|Respiratory System Agents|respiratory system agents|mesh-ancestor
6112165|NCT01040169|Calcium Carbonate|calcium carbonate|mesh-list
6112166|NCT01040169|Calcium|calcium|mesh-list
5528886|NCT04252274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5528887|NCT04252274|Antiviral Agents|antiviral agents|mesh-ancestor
5528888|NCT04252274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5528889|NCT04252274|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5528890|NCT04252274|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5528891|NCT04252300|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5528892|NCT04252300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5528893|NCT04252300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5528894|NCT04252300|Antimetabolites|antimetabolites|mesh-ancestor
5528895|NCT04252300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528896|NCT04252300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5528897|NCT04252300|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5528898|NCT04252300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5528899|NCT04252261|Sulforaphane|sulforaphane|mesh-list
5528900|NCT04252261|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5528901|NCT04252261|Protective Agents|protective agents|mesh-ancestor
5528902|NCT04252261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528903|NCT04252261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5528904|NCT04252521|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
5528905|NCT04252521|Ketoprofen|ketoprofen|mesh-list
5528906|NCT04252521|Metoclopramide|metoclopramide|mesh-list
5528907|NCT04252521|Antiemetics|antiemetics|mesh-ancestor
5528908|NCT04252521|Autonomic Agents|autonomic agents|mesh-ancestor
5528909|NCT04252521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5528910|NCT04252521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528911|NCT04252521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5528912|NCT04252521|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6112167|NCT01040169|Fluorides|fluorides|mesh-list
6112168|NCT01040169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6112169|NCT01040169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112170|NCT01040169|Cariostatic Agents|cariostatic agents|mesh-ancestor
6112171|NCT01040169|Protective Agents|protective agents|mesh-ancestor
6112172|NCT01040169|Antacids|antacids|mesh-ancestor
6112173|NCT01040169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112174|NCT01040169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6112175|NCT01040260|Nicotine|nicotine|mesh-list
6112176|NCT01040260|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6112177|NCT01040260|Autonomic Agents|autonomic agents|mesh-ancestor
6112178|NCT01040260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6112179|NCT01040260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112180|NCT01040260|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6112181|NCT01040260|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6112182|NCT01040260|Cholinergic Agents|cholinergic agents|mesh-ancestor
6112183|NCT01040260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6112184|NCT01040260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112185|NCT01040403|Bromides|bromides|mesh-list
6112186|NCT01040403|Tiotropium Bromide|tiotropium bromide|mesh-list
6112187|NCT01040403|Olodaterol|olodaterol|mesh-list
6112188|NCT01040403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6112189|NCT01040403|Autonomic Agents|autonomic agents|mesh-ancestor
6112190|NCT01040403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6112191|NCT01040403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112192|NCT01040403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6112193|NCT01040403|Respiratory System Agents|respiratory system agents|mesh-ancestor
6112194|NCT01040403|Parasympatholytics|parasympatholytics|mesh-ancestor
6112195|NCT01040403|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6112196|NCT01040403|Cholinergic Agents|cholinergic agents|mesh-ancestor
6112197|NCT01040403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6112198|NCT01040403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112199|NCT01040403|Anticonvulsants|anticonvulsants|mesh-ancestor
6112200|NCT01040689|Tiotropium Bromide|tiotropium bromide|mesh-list
6112201|NCT01040689|Olodaterol|olodaterol|mesh-list
6112202|NCT01040689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6112203|NCT01040689|Autonomic Agents|autonomic agents|mesh-ancestor
6112204|NCT01040689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6112205|NCT01040689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112206|NCT01040689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6112207|NCT01040689|Respiratory System Agents|respiratory system agents|mesh-ancestor
6112208|NCT01040689|Parasympatholytics|parasympatholytics|mesh-ancestor
6112209|NCT01040689|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6112210|NCT01040689|Cholinergic Agents|cholinergic agents|mesh-ancestor
6112211|NCT01040689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6112212|NCT01040689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112213|NCT01040728|Tiotropium Bromide|tiotropium bromide|mesh-list
6112214|NCT01040728|Olodaterol|olodaterol|mesh-list
5528913|NCT04252521|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5528914|NCT04252521|Dopamine Agents|dopamine agents|mesh-ancestor
5528915|NCT04252521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5528916|NCT04252521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528917|NCT04252521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5528918|NCT04252521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5528919|NCT04252521|Analgesics|analgesics|mesh-ancestor
5528920|NCT04252521|Sensory System Agents|sensory system agents|mesh-ancestor
5528921|NCT04252521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5528922|NCT04252521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5528923|NCT04252521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5528924|NCT04252521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5528925|NCT04251910|Dexmedetomidine|dexmedetomidine|mesh-list
5528926|NCT04251910|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5528927|NCT04251910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5528928|NCT04251910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528929|NCT04251910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5528930|NCT04251910|Analgesics|analgesics|mesh-ancestor
6112215|NCT01040728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6112216|NCT01040728|Autonomic Agents|autonomic agents|mesh-ancestor
6112217|NCT01040728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6112218|NCT01040728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112219|NCT01040728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6112220|NCT01040728|Respiratory System Agents|respiratory system agents|mesh-ancestor
6112221|NCT01040728|Parasympatholytics|parasympatholytics|mesh-ancestor
6112222|NCT01040728|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6112223|NCT01040728|Cholinergic Agents|cholinergic agents|mesh-ancestor
6112224|NCT01040728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6112225|NCT01040728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112226|NCT01040780|Gefitinib|gefitinib|mesh-list
6112227|NCT01040780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6112228|NCT01040780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6112229|NCT01040780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6112230|NCT01040780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112231|NCT01040793|Olodaterol|olodaterol|mesh-list
6112232|NCT01040793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6112233|NCT01040793|Autonomic Agents|autonomic agents|mesh-ancestor
6112234|NCT01040793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6112235|NCT01040793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112236|NCT01040793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6112237|NCT01040793|Respiratory System Agents|respiratory system agents|mesh-ancestor
6112238|NCT01040819|Pioglitazone|pioglitazone|mesh-list
6112239|NCT01040819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6112240|NCT01040819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112241|NCT01040832|Cetuximab|cetuximab|mesh-list
6112242|NCT01040832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6112243|NCT01040832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6112244|NCT01040845|Colchicine|colchicine|mesh-list
6112245|NCT01040845|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6112246|NCT01040845|Norethindrone|norethindrone|mesh-list
6112247|NCT01040845|Norethindrone Acetate|norethindrone acetate|mesh-list
6112248|NCT01040845|Estradiol|estradiol|mesh-list
6112249|NCT01040845|Estrogens|estrogens|mesh-ancestor
6112250|NCT01040845|Hormones|hormones|mesh-ancestor
6112251|NCT01040845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6112252|NCT01040845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112253|NCT01040845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5528931|NCT04251910|Sensory System Agents|sensory system agents|mesh-ancestor
5528932|NCT04251910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5528933|NCT04251910|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5528934|NCT04251910|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5528935|NCT04251910|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5528936|NCT04251910|Adrenergic Agents|adrenergic agents|mesh-ancestor
5528937|NCT04251910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5528938|NCT04251910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528939|NCT04252105|Antioxidants|antioxidants|mesh-list
5528940|NCT04252105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528941|NCT04252105|Protective Agents|protective agents|mesh-ancestor
5528942|NCT04252105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528943|NCT04251962|Fentanyl|fentanyl|mesh-list
5528944|NCT04251962|Bupivacaine|bupivacaine|mesh-list
5528945|NCT04251962|Anesthetics, Local|anesthetics, local|mesh-ancestor
5528946|NCT04251962|Anesthetics|anesthetics|mesh-ancestor
5528947|NCT04251962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6112254|NCT01040845|Contraceptive Agents|contraceptive agents|mesh-ancestor
6112255|NCT01040845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6112256|NCT01040845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6112257|NCT01040845|Gout Suppressants|gout suppressants|mesh-ancestor
6112258|NCT01040845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6112259|NCT01040845|Tubulin Modulators|tubulin modulators|mesh-ancestor
6112260|NCT01040845|Antimitotic Agents|antimitotic agents|mesh-ancestor
6112261|NCT01040845|Mitosis Modulators|mitosis modulators|mesh-ancestor
6112262|NCT01040845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112263|NCT01040845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6112264|NCT01040845|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6112265|NCT01040845|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6112266|NCT01040845|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5528948|NCT04251962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528949|NCT04251962|Sensory System Agents|sensory system agents|mesh-ancestor
5528950|NCT04251962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5528951|NCT04251962|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5528952|NCT04251962|Narcotics|narcotics|mesh-ancestor
5528953|NCT04251962|Analgesics|analgesics|mesh-ancestor
5528954|NCT04251962|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5528955|NCT04251962|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5528956|NCT04251962|Anesthetics, General|anesthetics, general|mesh-ancestor
5528957|NCT04251871|Interferons|interferons|mesh-list
5528958|NCT04251871|Ritonavir|ritonavir|mesh-list
5528959|NCT04251871|Lopinavir|lopinavir|mesh-list
5528960|NCT04251871|Interferon-alpha|interferon-alpha|mesh-list
5528961|NCT04251871|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
5528962|NCT04251871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5528963|NCT04251871|Antiviral Agents|antiviral agents|mesh-ancestor
5528964|NCT04251871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5528965|NCT04251871|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5528966|NCT04251871|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6112267|NCT01040871|Prednisone|prednisone|mesh-list
6112268|NCT01040871|Cyclophosphamide|cyclophosphamide|mesh-list
6112269|NCT01040871|Rituximab|rituximab|mesh-list
6112270|NCT01040871|Doxorubicin|doxorubicin|mesh-list
6112271|NCT01040871|Vincristine|vincristine|mesh-list
6112272|NCT01040871|Bortezomib|bortezomib|mesh-list
6112273|NCT01040871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5528967|NCT04251871|Protease Inhibitors|protease inhibitors|mesh-ancestor
5528968|NCT04251871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5528969|NCT04251871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528970|NCT04251871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6112274|NCT01040871|Immunologic Factors|immunologic factors|mesh-ancestor
6112275|NCT01040871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112276|NCT01040871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6112277|NCT01040871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6112278|NCT01040871|Alkylating Agents|alkylating agents|mesh-ancestor
6112279|NCT01040871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112280|NCT01040871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6112281|NCT01040871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6112282|NCT01040871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6112283|NCT01040871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5528971|NCT04251871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5528972|NCT04251871|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5528973|NCT04251871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5528974|NCT04251871|Immunologic Factors|immunologic factors|mesh-ancestor
5528975|NCT04251871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528976|NCT04251819|Baclofen|baclofen|mesh-list
5528977|NCT04251819|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5528978|NCT04251819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112284|NCT01040871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6112285|NCT01040871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6112286|NCT01040871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6112287|NCT01040871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6112288|NCT01040871|Glucocorticoids|glucocorticoids|mesh-ancestor
6112289|NCT01040871|Hormones|hormones|mesh-ancestor
6112290|NCT01040871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6112291|NCT01040871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6112292|NCT01040871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6112293|NCT01040871|Tubulin Modulators|tubulin modulators|mesh-ancestor
6112294|NCT01040871|Antimitotic Agents|antimitotic agents|mesh-ancestor
6112295|NCT01040871|Mitosis Modulators|mitosis modulators|mesh-ancestor
5528979|NCT04251819|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6112296|NCT01041209|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6112297|NCT01041209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6112298|NCT01041274|Citalopram|citalopram|mesh-list
6112299|NCT01041274|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6112300|NCT01041274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6112301|NCT01041274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6112302|NCT01041274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112303|NCT01041274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6112304|NCT01041274|Serotonin Agents|serotonin agents|mesh-ancestor
6112305|NCT01041274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528980|NCT04251819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5528981|NCT04251819|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
5528982|NCT04251819|GABA Agonists|gaba agonists|mesh-ancestor
5528983|NCT04251819|GABA Agents|gaba agents|mesh-ancestor
5528984|NCT04251819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5528985|NCT04251819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528986|NCT04251741|Adalimumab|adalimumab|mesh-list
5528987|NCT04251741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5528988|NCT04251741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5528989|NCT04251845|Melatonin|melatonin|mesh-list
5528990|NCT04251845|Antioxidants|antioxidants|mesh-ancestor
5528991|NCT04251845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5528992|NCT04251845|Protective Agents|protective agents|mesh-ancestor
5528993|NCT04251845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528994|NCT04251845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6112306|NCT01041274|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6112307|NCT01041274|Antidepressive Agents|antidepressive agents|mesh-ancestor
6112308|NCT01041274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6112309|NCT01041287|Metoprolol|metoprolol|mesh-list
6112310|NCT01041287|Nebivolol|nebivolol|mesh-list
6112311|NCT01041287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5528995|NCT04251832|Sodium thiosulfate|sodium thiosulfate|mesh-list
5528996|NCT04251832|Antidotes|antidotes|mesh-ancestor
5528997|NCT04251832|Protective Agents|protective agents|mesh-ancestor
5528998|NCT04251832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5528999|NCT04251832|Antioxidants|antioxidants|mesh-ancestor
5529000|NCT04251832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112312|NCT01041287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6112313|NCT01041287|Sympatholytics|sympatholytics|mesh-ancestor
6112314|NCT01041287|Autonomic Agents|autonomic agents|mesh-ancestor
6112315|NCT01041287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6112316|NCT01041287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112317|NCT01041287|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6112318|NCT01041287|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6112319|NCT01041287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6112320|NCT01041287|Adrenergic Agents|adrenergic agents|mesh-ancestor
6112321|NCT01041287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6112322|NCT01041287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112323|NCT01041287|Vasodilator Agents|vasodilator agents|mesh-ancestor
6112324|NCT01041287|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6112325|NCT01041287|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6112326|NCT01041287|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6112327|NCT01041404|Fluorouracil|fluorouracil|mesh-list
6112328|NCT01041404|Capecitabine|capecitabine|mesh-list
6112329|NCT01041404|Trastuzumab|trastuzumab|mesh-list
6112330|NCT01041404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6112331|NCT01041404|Antimetabolites|antimetabolites|mesh-ancestor
6112332|NCT01041404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112333|NCT01041404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6112334|NCT01041404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6112335|NCT01041404|Immunologic Factors|immunologic factors|mesh-ancestor
6112336|NCT01041404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112337|NCT01041404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6112338|NCT01041417|Molgramostim|molgramostim|mesh-list
6112339|NCT01041417|Sargramostim|sargramostim|mesh-list
6112340|NCT01041417|Immunologic Factors|immunologic factors|mesh-ancestor
6112341|NCT01041417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112342|NCT01041417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6112343|NCT01041495|Cyclobenzaprine|cyclobenzaprine|mesh-list
6112344|NCT01041495|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6112345|NCT01041495|Antidepressive Agents|antidepressive agents|mesh-ancestor
6112346|NCT01041495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6112347|NCT01041495|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6112348|NCT01041495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112349|NCT01041495|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6112350|NCT01041495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6112351|NCT01041495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6112352|NCT01041495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6112353|NCT01041573|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6112354|NCT01041573|Immunologic Factors|immunologic factors|mesh-ancestor
6112355|NCT01041573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112356|NCT01041638|Vitamin A|vitamin a|mesh-list
6112357|NCT01041638|Aldesleukin|aldesleukin|mesh-list
6112358|NCT01041638|Interleukin-2|interleukin-2|mesh-list
6112359|NCT01041638|Tretinoin|tretinoin|mesh-list
6112360|NCT01041638|Dinutuximab|dinutuximab|mesh-list
6112361|NCT01041638|Isotretinoin|isotretinoin|mesh-list
6112362|NCT01041638|Sargramostim|sargramostim|mesh-list
6112363|NCT01041638|Vitamins|vitamins|mesh-ancestor
6112364|NCT01041638|Micronutrients|micronutrients|mesh-ancestor
6112365|NCT01041638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112366|NCT01041638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6112367|NCT01041638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6112368|NCT01041638|Analgesics|analgesics|mesh-ancestor
6112369|NCT01041638|Sensory System Agents|sensory system agents|mesh-ancestor
6112370|NCT01041638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6112371|NCT01041638|Immunologic Factors|immunologic factors|mesh-ancestor
6112372|NCT01041638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6112373|NCT01041638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6112374|NCT01041638|Antiviral Agents|antiviral agents|mesh-ancestor
6112375|NCT01041638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6112376|NCT01041638|Keratolytic Agents|keratolytic agents|mesh-ancestor
6112377|NCT01041638|Dermatologic Agents|dermatologic agents|mesh-ancestor
6112378|NCT01041781|Gemcitabine|gemcitabine|mesh-list
6112379|NCT01041781|Celecoxib|celecoxib|mesh-list
6112380|NCT01041781|Carboplatin|carboplatin|mesh-list
6112381|NCT01041781|Pemetrexed|pemetrexed|mesh-list
6112382|NCT01041781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6112383|NCT01041781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6465505|NCT00474890|Ephedrine|ephedrine|mesh-list
6465506|NCT00474890|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6465507|NCT00474890|Autonomic Agents|autonomic agents|mesh-ancestor
6465508|NCT00474890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6465509|NCT00474890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465510|NCT00474890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6112384|NCT01041781|Antimetabolites|antimetabolites|mesh-ancestor
6112385|NCT01041781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112386|NCT01041781|Antiviral Agents|antiviral agents|mesh-ancestor
6112387|NCT01041781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6112388|NCT01041781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6112389|NCT01041781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6112390|NCT01041781|Immunologic Factors|immunologic factors|mesh-ancestor
6112391|NCT01041781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112392|NCT01041781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6112393|NCT01041781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6112394|NCT01041781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6112395|NCT01041781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6112396|NCT01041781|Analgesics|analgesics|mesh-ancestor
6112397|NCT01041781|Sensory System Agents|sensory system agents|mesh-ancestor
6112398|NCT01041781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6112399|NCT01041781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6112400|NCT01041781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6112401|NCT01041781|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6112402|NCT01041781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6112403|NCT01041859|Tapentadol|tapentadol|mesh-list
6112404|NCT01041859|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6112405|NCT01041859|Narcotics|narcotics|mesh-ancestor
6112406|NCT01041859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6112407|NCT01041859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112408|NCT01041859|Analgesics|analgesics|mesh-ancestor
6112409|NCT01041859|Sensory System Agents|sensory system agents|mesh-ancestor
6112410|NCT01041859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6112411|NCT01041859|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6112412|NCT01041859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6112413|NCT01041859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6112414|NCT01041859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112415|NCT01041859|Adrenergic Agents|adrenergic agents|mesh-ancestor
6112416|NCT01041859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6112417|NCT01042093|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6112418|NCT01042093|Clonidine|clonidine|mesh-list
6112419|NCT01042093|Epinephrine|epinephrine|mesh-list
6112420|NCT01042093|Ropivacaine|ropivacaine|mesh-list
6112421|NCT01042093|Anesthetics, Local|anesthetics, local|mesh-ancestor
6465511|NCT00474890|Respiratory System Agents|respiratory system agents|mesh-ancestor
6112422|NCT01042093|Anesthetics|anesthetics|mesh-ancestor
6112423|NCT01042093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6112424|NCT01042093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112425|NCT01042093|Sensory System Agents|sensory system agents|mesh-ancestor
6112426|NCT01042093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6112427|NCT01042093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6112428|NCT01042093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6112429|NCT01042093|Adrenergic Agents|adrenergic agents|mesh-ancestor
6112430|NCT01042093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6112431|NCT01042093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112432|NCT01042093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6112433|NCT01042093|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6112434|NCT01042093|Autonomic Agents|autonomic agents|mesh-ancestor
6112435|NCT01042093|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6112436|NCT01042093|Respiratory System Agents|respiratory system agents|mesh-ancestor
6112437|NCT01042093|Mydriatics|mydriatics|mesh-ancestor
6112438|NCT01042093|Sympathomimetics|sympathomimetics|mesh-ancestor
6112439|NCT01042093|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6112440|NCT01042093|Analgesics|analgesics|mesh-ancestor
6112441|NCT01042093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6112442|NCT01042093|Sympatholytics|sympatholytics|mesh-ancestor
6112443|NCT01042093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6112444|NCT01042093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6112445|NCT01042093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6112446|NCT01042093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6112447|NCT01042093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6112448|NCT01042093|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6112449|NCT01042093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6112450|NCT01042145|Dexamethasone|dexamethasone|mesh-list
6112451|NCT01042145|Prednisone|prednisone|mesh-list
6112452|NCT01042145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6112453|NCT01042145|Antiemetics|antiemetics|mesh-ancestor
6112454|NCT01042145|Autonomic Agents|autonomic agents|mesh-ancestor
6112455|NCT01042145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6112456|NCT01042145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112457|NCT01042145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6112458|NCT01042145|Glucocorticoids|glucocorticoids|mesh-ancestor
6112459|NCT01042145|Hormones|hormones|mesh-ancestor
6112460|NCT01042145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6112461|NCT01042145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6112462|NCT01042145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6112463|NCT01042158|Ambrisentan|ambrisentan|mesh-list
6112464|NCT01042158|Tadalafil|tadalafil|mesh-list
6112465|NCT01042158|Vasodilator Agents|vasodilator agents|mesh-ancestor
6112466|NCT01042158|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6112467|NCT01042158|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6112468|NCT01042158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6112469|NCT01042158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112470|NCT01042158|Urological Agents|urological agents|mesh-ancestor
6112471|NCT01042158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6465512|NCT00474890|Nasal Decongestants|nasal decongestants|mesh-ancestor
6465513|NCT00474890|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6465514|NCT00474890|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6465515|NCT00474890|Sympathomimetics|sympathomimetics|mesh-ancestor
6465516|NCT00474890|Adrenergic Agents|adrenergic agents|mesh-ancestor
6465517|NCT00474890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6465518|NCT00474890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465519|NCT00474916|KRN 5500|krn 5500|mesh-list
6465520|NCT00474916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6465521|NCT00474916|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6112472|NCT01042236|Fesoterodine|fesoterodine|mesh-list
6112473|NCT01042236|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6112474|NCT01042236|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6112475|NCT01042236|Cholinergic Agents|cholinergic agents|mesh-ancestor
6112476|NCT01042236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6112477|NCT01042236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112478|NCT01042236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112479|NCT01042236|Urological Agents|urological agents|mesh-ancestor
6112480|NCT01042288|Carboplatin|carboplatin|mesh-list
6112481|NCT01042288|Pemetrexed|pemetrexed|mesh-list
6112482|NCT01042288|Panitumumab|panitumumab|mesh-list
6112483|NCT01042288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6112484|NCT01042288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6112485|NCT01042288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112486|NCT01042288|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6465522|NCT00474916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5529001|NCT04251832|Antitubercular Agents|antitubercular agents|mesh-ancestor
5529002|NCT04251832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5529003|NCT04251832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5529004|NCT04251832|Chelating Agents|chelating agents|mesh-ancestor
5529005|NCT04251832|Sequestering Agents|sequestering agents|mesh-ancestor
5529006|NCT04251585|Insulin|insulin|mesh-list
5529007|NCT04251585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5529008|NCT04251585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5529009|NCT04251247|Fibrin fragment D|fibrin fragment d|mesh-list
5529010|NCT04251247|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5529011|NCT04251247|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5529012|NCT04251247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5529013|NCT04251247|Hemostatics|hemostatics|mesh-ancestor
5529014|NCT04251247|Coagulants|coagulants|mesh-ancestor
5529015|NCT04251169|Paclitaxel|paclitaxel|mesh-list
5529016|NCT04251169|Pembrolizumab|pembrolizumab|mesh-list
6112487|NCT01042288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6112488|NCT01042288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6112489|NCT01042366|Vaccines|vaccines|mesh-list
6112490|NCT01042366|Immunologic Factors|immunologic factors|mesh-ancestor
6112491|NCT01042366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112492|NCT01042392|Ramipril|ramipril|mesh-list
6112493|NCT01042392|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6112494|NCT01042392|Protease Inhibitors|protease inhibitors|mesh-ancestor
6112495|NCT01042392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6112496|NCT01042392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112497|NCT01042392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6112498|NCT01042496|Lamotrigine|lamotrigine|mesh-list
6112499|NCT01042496|Anticonvulsants|anticonvulsants|mesh-ancestor
6112500|NCT01042496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6112501|NCT01042496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6112502|NCT01042496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112503|NCT01042496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6112504|NCT01042496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112505|NCT01042496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6112506|NCT01042496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5529017|NCT04251169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5529018|NCT04251169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5529019|NCT04251169|Tubulin Modulators|tubulin modulators|mesh-ancestor
5529020|NCT04251169|Antimitotic Agents|antimitotic agents|mesh-ancestor
5529021|NCT04251169|Mitosis Modulators|mitosis modulators|mesh-ancestor
5529022|NCT04251169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5529023|NCT04251169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5529024|NCT04251364|Acetazolamide|acetazolamide|mesh-list
5529025|NCT04251364|Atorvastatin|atorvastatin|mesh-list
5529026|NCT04251364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5529027|NCT04251364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5529028|NCT04251364|Antimetabolites|antimetabolites|mesh-ancestor
5529029|NCT04251364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5529030|NCT04251364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5529031|NCT04251364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5529032|NCT04251364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5529033|NCT04251364|Anticonvulsants|anticonvulsants|mesh-ancestor
5529034|NCT04251364|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5529035|NCT04251364|Diuretics|diuretics|mesh-ancestor
5529036|NCT04251364|Natriuretic Agents|natriuretic agents|mesh-ancestor
5529037|NCT04251364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5529038|NCT04251117|Pembrolizumab|pembrolizumab|mesh-list
5529039|NCT04251117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5529040|NCT04251117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5529041|NCT04250948|Capecitabine|capecitabine|mesh-list
5529042|NCT04250948|Oxaliplatin|oxaliplatin|mesh-list
5529043|NCT04250948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5529044|NCT04250948|Antimetabolites|antimetabolites|mesh-ancestor
5529045|NCT04250948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112507|NCT01042496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6112508|NCT01042496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6112509|NCT01042496|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6112510|NCT01042509|Rituximab|rituximab|mesh-list
5529046|NCT04250948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5601488|NCT05177055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5601489|NCT05177055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5601490|NCT05177055|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5601491|NCT05176951|Treprostinil|treprostinil|mesh-list
6112511|NCT01042509|Alemtuzumab|alemtuzumab|mesh-list
6112512|NCT01042509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6112513|NCT01042509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6112514|NCT01042509|Immunologic Factors|immunologic factors|mesh-ancestor
6112515|NCT01042509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112516|NCT01042509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6112517|NCT01042535|Tryptophan|tryptophan|mesh-list
6112518|NCT01042535|Vaccines|vaccines|mesh-list
5529047|NCT05253508|Lidocaine|lidocaine|mesh-list
5529048|NCT05253508|Anesthetics, Local|anesthetics, local|mesh-ancestor
5529049|NCT05253508|Anesthetics|anesthetics|mesh-ancestor
5529050|NCT05253508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5529051|NCT05253508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5529052|NCT05253508|Sensory System Agents|sensory system agents|mesh-ancestor
5529053|NCT05253508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6112519|NCT01042535|Immunologic Factors|immunologic factors|mesh-ancestor
6112520|NCT01042535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112521|NCT01042535|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6112522|NCT01042535|Antidepressive Agents|antidepressive agents|mesh-ancestor
5529054|NCT05253508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5529055|NCT05253508|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5529056|NCT05253508|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5529057|NCT05253508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5529058|NCT05253508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5529059|NCT05253495|Cytarabine|cytarabine|mesh-list
5529060|NCT05253495|Etoposide|etoposide|mesh-list
5529061|NCT05253495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5529062|NCT05253495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5529063|NCT05253495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5529064|NCT05253495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5529065|NCT05253495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5529066|NCT05253495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5529067|NCT05253495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5529068|NCT05253495|Antimetabolites|antimetabolites|mesh-ancestor
5529069|NCT05253495|Antiviral Agents|antiviral agents|mesh-ancestor
5529070|NCT05253495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5529071|NCT05253495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5529072|NCT05253495|Immunologic Factors|immunologic factors|mesh-ancestor
5529073|NCT05253495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5529074|NCT05253417|Cannabidiol|cannabidiol|mesh-list
5529075|NCT05253417|Anticonvulsants|anticonvulsants|mesh-ancestor
5529076|NCT05253287|Hormones|hormones|mesh-list
5529077|NCT05253287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5529078|NCT05253287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5529079|NCT05253209|Plasma-lyte 148|plasma-lyte 148|mesh-list
5529080|NCT05253209|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5529081|NCT05253209|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5529082|NCT05253131|Durvalumab|durvalumab|mesh-list
5529083|NCT05253131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5529084|NCT05253131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5529085|NCT05253118|Pemetrexed|pemetrexed|mesh-list
5529086|NCT05253118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6112523|NCT01042535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6112524|NCT01042795|Sunitinib|sunitinib|mesh-list
6112525|NCT01042795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6112526|NCT01042795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6112527|NCT01042795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6112528|NCT01042795|Growth Substances|growth substances|mesh-ancestor
6112529|NCT01042795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112530|NCT01042795|Growth Inhibitors|growth inhibitors|mesh-ancestor
6112531|NCT01042795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6112532|NCT01042795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6112533|NCT01042795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112534|NCT01042938|Curcumin|curcumin|mesh-list
6112535|NCT01042938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6112536|NCT01042938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6112537|NCT01042938|Analgesics|analgesics|mesh-ancestor
6465523|NCT00474916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488439|NCT00584168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6488440|NCT00584168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112538|NCT01042938|Sensory System Agents|sensory system agents|mesh-ancestor
6112539|NCT01042938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6112540|NCT01042938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112541|NCT01042938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6112542|NCT01042938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6112543|NCT01042938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6112544|NCT01042938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6112545|NCT01042938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112546|NCT01042977|Dapagliflozin|dapagliflozin|mesh-list
6112547|NCT01042977|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6112548|NCT01042977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112549|NCT01042977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6112550|NCT01042977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112551|NCT01043094|Pitavastatin|pitavastatin|mesh-list
6112552|NCT01043094|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6112553|NCT01043094|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6112554|NCT01043094|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6112555|NCT01043094|Antimetabolites|antimetabolites|mesh-ancestor
6112556|NCT01043094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112557|NCT01043094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6112558|NCT01043094|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6112559|NCT01043185|Lesogaberan|lesogaberan|mesh-list
6112560|NCT01043185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6112561|NCT01043185|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6112562|NCT01043185|GABA Agonists|gaba agonists|mesh-ancestor
6112563|NCT01043185|GABA Agents|gaba agents|mesh-ancestor
6112564|NCT01043185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6112565|NCT01043185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112566|NCT01043185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112567|NCT01043393|Desoximetasone|desoximetasone|mesh-list
6112568|NCT01043393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6112569|NCT01043393|Glucocorticoids|glucocorticoids|mesh-ancestor
6112570|NCT01043393|Hormones|hormones|mesh-ancestor
6112571|NCT01043393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6112572|NCT01043393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112573|NCT01043640|Cyclosporine|cyclosporine|mesh-list
6112574|NCT01043640|Mycophenolic Acid|mycophenolic acid|mesh-list
6112575|NCT01043640|Cyclophosphamide|cyclophosphamide|mesh-list
6112576|NCT01043640|Busulfan|busulfan|mesh-list
6112577|NCT01043640|Alemtuzumab|alemtuzumab|mesh-list
6112578|NCT01043640|Cyclosporins|cyclosporins|mesh-list
6112579|NCT01043640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6112580|NCT01043640|Immunologic Factors|immunologic factors|mesh-ancestor
6112581|NCT01043640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112582|NCT01043640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6112583|NCT01043640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6112584|NCT01043640|Alkylating Agents|alkylating agents|mesh-ancestor
6112585|NCT01043640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112586|NCT01043640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6112587|NCT01043640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6112588|NCT01043640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6112589|NCT01043640|Antifungal Agents|antifungal agents|mesh-ancestor
6465524|NCT00475059|Cimetidine|cimetidine|mesh-list
6465525|NCT00475059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6465526|NCT00475059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6465527|NCT00475059|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6465528|NCT00475059|Histamine Antagonists|histamine antagonists|mesh-ancestor
6465529|NCT00475059|Histamine Agents|histamine agents|mesh-ancestor
6465530|NCT00475059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6465531|NCT00475059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465532|NCT00475059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465533|NCT00475059|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5529087|NCT05253118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6112590|NCT01043640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6112591|NCT01043640|Dermatologic Agents|dermatologic agents|mesh-ancestor
6112592|NCT01043640|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6112593|NCT01043640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6112594|NCT01043640|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6112595|NCT01043640|Antitubercular Agents|antitubercular agents|mesh-ancestor
6112596|NCT01043640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5529088|NCT05253118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5529089|NCT05253118|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5529090|NCT05253118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5529091|NCT05253066|Docetaxel|docetaxel|mesh-list
5529092|NCT05253066|Epirubicin|epirubicin|mesh-list
5529093|NCT05253066|Exemestane|exemestane|mesh-list
5529094|NCT05253066|Goserelin|goserelin|mesh-list
6112597|NCT01043640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5529095|NCT05253066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6112598|NCT01043926|Suvorexant|suvorexant|mesh-list
6112599|NCT01043926|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6112600|NCT01043926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6112601|NCT01043926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6112602|NCT01043926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112603|NCT01043926|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
6112604|NCT01043926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6112605|NCT01043926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112606|NCT01044212|Psyllium|psyllium|mesh-list
6112607|NCT01044212|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
6112608|NCT01044212|Cathartics|cathartics|mesh-ancestor
6112609|NCT01044212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6112610|NCT01044212|Antidiarrheals|antidiarrheals|mesh-ancestor
6112611|NCT01044264|Clindamycin|clindamycin|mesh-list
6112612|NCT01044264|Clindamycin palmitate|clindamycin palmitate|mesh-list
6112613|NCT01044264|Clindamycin phosphate|clindamycin phosphate|mesh-list
6112614|NCT01044264|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6112615|NCT01044264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6112616|NCT01044264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6112617|NCT01044264|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6112618|NCT01044264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6112619|NCT01044264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112620|NCT01044264|Dermatologic Agents|dermatologic agents|mesh-ancestor
6112621|NCT01044303|Mycophenolic Acid|mycophenolic acid|mesh-list
6112622|NCT01044303|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6112623|NCT01044303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6112624|NCT01044303|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6112625|NCT01044303|Antitubercular Agents|antitubercular agents|mesh-ancestor
6112626|NCT01044303|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6112627|NCT01044303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6112628|NCT01044303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6112629|NCT01044303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112630|NCT01044433|Capecitabine|capecitabine|mesh-list
6112631|NCT01044433|Lapatinib|lapatinib|mesh-list
6112632|NCT01044433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6112633|NCT01044433|Antimetabolites|antimetabolites|mesh-ancestor
6112634|NCT01044433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112635|NCT01044433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6112636|NCT01044433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6112637|NCT01044433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6112638|NCT01044459|Bromides|bromides|mesh-list
6112639|NCT01044459|Anticonvulsants|anticonvulsants|mesh-ancestor
6112640|NCT01044498|Norinyl|norinyl|mesh-list
6112641|NCT01044498|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
6112642|NCT01044498|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6112643|NCT01044498|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6112644|NCT01044498|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6112645|NCT01044498|Contraceptive Agents|contraceptive agents|mesh-ancestor
6112646|NCT01044498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6112647|NCT01044498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112648|NCT01044498|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6112649|NCT01044498|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6112650|NCT01044498|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
6112651|NCT01044498|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6112652|NCT01044693|Metoprolol|metoprolol|mesh-list
6112653|NCT01044693|Nebivolol|nebivolol|mesh-list
6112654|NCT01044693|Sildenafil Citrate|sildenafil citrate|mesh-list
6112655|NCT01044693|Vasodilator Agents|vasodilator agents|mesh-ancestor
6112656|NCT01044693|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6112657|NCT01044693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6112658|NCT01044693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6112659|NCT01044693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5529096|NCT05253066|Tubulin Modulators|tubulin modulators|mesh-ancestor
5529097|NCT05253066|Antimitotic Agents|antimitotic agents|mesh-ancestor
5529098|NCT05253066|Mitosis Modulators|mitosis modulators|mesh-ancestor
5529099|NCT05253066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5529100|NCT05253066|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5529101|NCT05253066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6112660|NCT01044693|Urological Agents|urological agents|mesh-ancestor
6112661|NCT01044693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6112662|NCT01044693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6112663|NCT01044693|Sympatholytics|sympatholytics|mesh-ancestor
6112664|NCT01044693|Autonomic Agents|autonomic agents|mesh-ancestor
6112665|NCT01044693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6112666|NCT01044693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112667|NCT01044693|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6112668|NCT01044693|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6112669|NCT01044693|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6112670|NCT01044693|Adrenergic Agents|adrenergic agents|mesh-ancestor
6112671|NCT01044693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6112672|NCT01044693|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6112673|NCT01044693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6112674|NCT01044693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6204279|NCT02068222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6204280|NCT02068222|Antimetabolites|antimetabolites|mesh-ancestor
6204281|NCT02068443|Metformin|metformin|mesh-list
6204282|NCT02068443|Alogliptin|alogliptin|mesh-list
6204283|NCT02068443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6204284|NCT02068443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204285|NCT02068443|Incretins|incretins|mesh-ancestor
6204286|NCT02068443|Hormones|hormones|mesh-ancestor
6204287|NCT02068443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6204288|NCT02068443|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6204289|NCT02068443|Protease Inhibitors|protease inhibitors|mesh-ancestor
6204290|NCT02068443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6204291|NCT02068443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207772|NCT02120261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6207773|NCT02120261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207774|NCT02120261|Sensory System Agents|sensory system agents|mesh-ancestor
6207775|NCT02120261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6207776|NCT02120261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6207777|NCT02120261|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6207778|NCT02120261|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6207779|NCT02120261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6207780|NCT02120261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207781|NCT02120261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6207782|NCT02120261|Glucocorticoids|glucocorticoids|mesh-ancestor
6207783|NCT02120261|Hormones|hormones|mesh-ancestor
6207784|NCT02120261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6207785|NCT02120261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6207786|NCT02120261|Immunologic Factors|immunologic factors|mesh-ancestor
6207787|NCT02120261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6207788|NCT02120287|Bevacizumab|bevacizumab|mesh-list
6207789|NCT02120287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6207790|NCT02120287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6207791|NCT02120287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6207792|NCT02120287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6207793|NCT02120287|Growth Substances|growth substances|mesh-ancestor
6207794|NCT02120287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207795|NCT02120287|Growth Inhibitors|growth inhibitors|mesh-ancestor
6207796|NCT02120300|Sofosbuvir|sofosbuvir|mesh-list
6207797|NCT02120300|Antiviral Agents|antiviral agents|mesh-ancestor
6207798|NCT02120300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6207799|NCT02120352|Rilpivirine|rilpivirine|mesh-list
6207800|NCT02120352|Cabotegravir|cabotegravir|mesh-list
6207801|NCT02120352|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6207802|NCT02120352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6207803|NCT02120352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6207804|NCT02120352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207805|NCT02120352|Antiviral Agents|antiviral agents|mesh-ancestor
6207806|NCT02120352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6207807|NCT02120352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6207808|NCT02120352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6207809|NCT02120352|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6207810|NCT02120352|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6207811|NCT02120417|Capecitabine|capecitabine|mesh-list
6207812|NCT02120417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6207813|NCT02120417|Antimetabolites|antimetabolites|mesh-ancestor
6207814|NCT02120417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207815|NCT02120417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6207816|NCT02120664|Corticosterone|corticosterone|mesh-list
6207817|NCT02120664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6207818|NCT02120794|Insulin|insulin|mesh-list
6207819|NCT02120794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6207820|NCT02120794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207821|NCT02120833|Decanoic acid|decanoic acid|mesh-list
6207822|NCT02120833|Antifungal Agents|antifungal agents|mesh-ancestor
6207823|NCT02120833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5529102|NCT05253066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5529103|NCT05253066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6112675|NCT01044706|Bicalutamide|bicalutamide|mesh-list
6112676|NCT01044706|Androgen Antagonists|androgen antagonists|mesh-ancestor
6112677|NCT01044706|Hormone Antagonists|hormone antagonists|mesh-ancestor
6112678|NCT01044706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6112679|NCT01044706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112680|NCT01044706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6112681|NCT01044745|Mycophenolic Acid|mycophenolic acid|mesh-list
6112682|NCT01044745|Cyclophosphamide|cyclophosphamide|mesh-list
6112683|NCT01044745|Busulfan|busulfan|mesh-list
6112684|NCT01044745|Rituximab|rituximab|mesh-list
6112685|NCT01044745|Fludarabine|fludarabine|mesh-list
6112686|NCT01044745|Fludarabine phosphate|fludarabine phosphate|mesh-list
6112687|NCT01044745|Tacrolimus|tacrolimus|mesh-list
6112688|NCT01044745|Thymoglobulin|thymoglobulin|mesh-list
6112689|NCT01044745|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6112690|NCT01044745|Immunosuppressive Agents|immunosuppressive agents|mesh-list
6112691|NCT01044745|Immunologic Factors|immunologic factors|mesh-ancestor
6112692|NCT01044745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112693|NCT01044745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6112694|NCT01044745|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6112695|NCT01044745|Alkylating Agents|alkylating agents|mesh-ancestor
6112696|NCT01044745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112697|NCT01044745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6112698|NCT01044745|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6112699|NCT01044745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6112700|NCT01044745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6112701|NCT01044745|Antimetabolites|antimetabolites|mesh-ancestor
6112702|NCT01044745|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6112703|NCT01044745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6112704|NCT01044745|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6112705|NCT01044745|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6112706|NCT01044745|Antitubercular Agents|antitubercular agents|mesh-ancestor
6112707|NCT01044745|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6112708|NCT01044745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6112709|NCT01044758|Levetiracetam|levetiracetam|mesh-list
6112710|NCT01044758|Anticonvulsants|anticonvulsants|mesh-ancestor
6112711|NCT01044758|Nootropic Agents|nootropic agents|mesh-ancestor
6112712|NCT01044771|Tenofovir|tenofovir|mesh-list
6112713|NCT01044771|Raltegravir Potassium|raltegravir potassium|mesh-list
6112714|NCT01044771|Antiviral Agents|antiviral agents|mesh-ancestor
6112715|NCT01044771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6112716|NCT01044771|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6112717|NCT01044771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6112718|NCT01044771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6112719|NCT01044771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112720|NCT01044771|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6112721|NCT01044771|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6112722|NCT01044771|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6112723|NCT01044771|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6112724|NCT01044862|Letrozole|letrozole|mesh-list
6112725|NCT01044862|Clomiphene|clomiphene|mesh-list
6112726|NCT01044862|Enclomiphene|enclomiphene|mesh-list
6112727|NCT01044862|Zuclomiphene|zuclomiphene|mesh-list
6112728|NCT01044862|Hormones|hormones|mesh-list
6112729|NCT01044862|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6112730|NCT01044862|Aromatase Inhibitors|aromatase inhibitors|mesh-list
6112731|NCT01044862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666038|NCT01520350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6666039|NCT01520350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666040|NCT01520350|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6666041|NCT01520350|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6666042|NCT01520350|Serotonin Agents|serotonin agents|mesh-ancestor
6112732|NCT01044862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6112733|NCT01044862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112734|NCT01044862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6112735|NCT01044862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6112736|NCT01044862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6112737|NCT01044862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6112738|NCT01044862|Hormone Antagonists|hormone antagonists|mesh-ancestor
6112739|NCT01044862|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6112740|NCT01044862|Fertility Agents|fertility agents|mesh-ancestor
6112741|NCT01044862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6112742|NCT01044862|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6112743|NCT01044862|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6112744|NCT01044966|Temozolomide|temozolomide|mesh-list
6112745|NCT01044966|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6112746|NCT01044966|Alkylating Agents|alkylating agents|mesh-ancestor
6112747|NCT01044966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112748|NCT01044966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6112749|NCT01045096|Dexlansoprazole|dexlansoprazole|mesh-list
6112750|NCT01045096|Lansoprazole|lansoprazole|mesh-list
6112751|NCT01045096|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6112752|NCT01045096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6112753|NCT01045096|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6112754|NCT01045096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6112755|NCT01045096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112756|NCT01045122|Dexmedetomidine|dexmedetomidine|mesh-list
6112757|NCT01045122|Propofol|propofol|mesh-list
6112758|NCT01045122|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6112759|NCT01045122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6112760|NCT01045122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112761|NCT01045122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6112762|NCT01045122|Anesthetics, General|anesthetics, general|mesh-ancestor
6112763|NCT01045122|Anesthetics|anesthetics|mesh-ancestor
6112764|NCT01045122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6112765|NCT01045122|Analgesics|analgesics|mesh-ancestor
6112766|NCT01045122|Sensory System Agents|sensory system agents|mesh-ancestor
6112767|NCT01045122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6112768|NCT01045122|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6112769|NCT01045122|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6112770|NCT01045122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6112771|NCT01045122|Adrenergic Agents|adrenergic agents|mesh-ancestor
5529104|NCT05253066|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5529105|NCT05253066|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5529106|NCT05253066|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6112772|NCT01045122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6112773|NCT01045122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112774|NCT01045161|Bromides|bromides|mesh-list
6112775|NCT01045161|Anticonvulsants|anticonvulsants|mesh-ancestor
6112776|NCT01045447|Insulin|insulin|mesh-list
6112777|NCT01045447|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6112778|NCT01045447|Insulin Glargine|insulin glargine|mesh-list
6112779|NCT01045447|Insulin Aspart|insulin aspart|mesh-list
6112780|NCT01045447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6112781|NCT01045447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112782|NCT01045460|Cyclophosphamide|cyclophosphamide|mesh-list
6112783|NCT01045460|Melphalan|melphalan|mesh-list
6112784|NCT01045460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6112785|NCT01045460|Immunologic Factors|immunologic factors|mesh-ancestor
6112786|NCT01045460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112787|NCT01045460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6112788|NCT01045460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6112789|NCT01045460|Alkylating Agents|alkylating agents|mesh-ancestor
6112790|NCT01045460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112791|NCT01045460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6112792|NCT01045460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6112793|NCT01045551|Apremilast|apremilast|mesh-list
6112794|NCT01045551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6112795|NCT01045551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6112796|NCT01045551|Analgesics|analgesics|mesh-ancestor
6112797|NCT01045551|Sensory System Agents|sensory system agents|mesh-ancestor
6112798|NCT01045551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6112799|NCT01045551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112800|NCT01045551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6112801|NCT01045551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6112802|NCT01045551|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6112803|NCT01045551|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6112804|NCT01045551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6112805|NCT01045551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112806|NCT01045707|Insulin|insulin|mesh-list
6112807|NCT01045707|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6112808|NCT01045707|Insulin Glargine|insulin glargine|mesh-list
6112809|NCT01045707|Insulin Aspart|insulin aspart|mesh-list
6112810|NCT01045707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6112811|NCT01045707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112812|NCT01045798|Caspofungin|caspofungin|mesh-list
5529107|NCT05253066|Hormone Antagonists|hormone antagonists|mesh-ancestor
6112813|NCT01045798|Antifungal Agents|antifungal agents|mesh-ancestor
6112814|NCT01045798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6112815|NCT01045798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6112816|NCT01045798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112817|NCT01045967|Lansoprazole|lansoprazole|mesh-list
6112818|NCT01045967|Dexlansoprazole|dexlansoprazole|mesh-list
6112819|NCT01045967|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6112820|NCT01045967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6112821|NCT01045967|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6112822|NCT01045967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6112823|NCT01045967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112824|NCT01045993|Analgesics|analgesics|mesh-list
6112825|NCT01045993|Sensory System Agents|sensory system agents|mesh-ancestor
6112826|NCT01045993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6112827|NCT01045993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112828|NCT01046084|Lansoprazole|lansoprazole|mesh-list
6112829|NCT01046084|Dexlansoprazole|dexlansoprazole|mesh-list
6112830|NCT01046084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6112831|NCT01046084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6112832|NCT01046084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6112833|NCT01046084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6112834|NCT01046084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112835|NCT01046110|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6112836|NCT01046110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6112837|NCT01046110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465534|NCT00475059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6465535|NCT00475059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6465536|NCT00475072|Ribavirin|ribavirin|mesh-list
6465537|NCT00475072|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6465538|NCT00475072|Antimetabolites|antimetabolites|mesh-ancestor
6465539|NCT00475072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465540|NCT00475072|Antiviral Agents|antiviral agents|mesh-ancestor
6465541|NCT00475072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6112838|NCT01046110|Incretins|incretins|mesh-ancestor
6112839|NCT01046110|Hormones|hormones|mesh-ancestor
6112840|NCT01046110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6112841|NCT01046110|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6112842|NCT01046110|Protease Inhibitors|protease inhibitors|mesh-ancestor
6112843|NCT01046110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6112844|NCT01046110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112845|NCT01046136|Phenylpropanolamine|phenylpropanolamine|mesh-list
6112846|NCT01046136|Guaifenesin|guaifenesin|mesh-list
6112847|NCT01046136|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
6112848|NCT01046136|Expectorants|expectorants|mesh-ancestor
6112849|NCT01046136|Respiratory System Agents|respiratory system agents|mesh-ancestor
6112850|NCT01046136|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6112851|NCT01046136|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6112852|NCT01046136|Adrenergic Agents|adrenergic agents|mesh-ancestor
6112853|NCT01046136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6112854|NCT01046136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112855|NCT01046136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112856|NCT01046136|Appetite Depressants|appetite depressants|mesh-ancestor
6112857|NCT01046136|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6112858|NCT01046136|Sympathomimetics|sympathomimetics|mesh-ancestor
6112859|NCT01046136|Autonomic Agents|autonomic agents|mesh-ancestor
6112860|NCT01046136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6112861|NCT01046136|Nasal Decongestants|nasal decongestants|mesh-ancestor
6112862|NCT01046136|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6112863|NCT01046253|Lansoprazole|lansoprazole|mesh-list
6112864|NCT01046253|Dexlansoprazole|dexlansoprazole|mesh-list
6112865|NCT01046253|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6112866|NCT01046253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6112867|NCT01046253|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6112868|NCT01046253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6112869|NCT01046253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112870|NCT01046396|Adapalene|adapalene|mesh-list
6112871|NCT01046396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6112872|NCT01046396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6112873|NCT01046396|Analgesics|analgesics|mesh-ancestor
6112874|NCT01046396|Sensory System Agents|sensory system agents|mesh-ancestor
6112875|NCT01046396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6112876|NCT01046396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112877|NCT01046396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5529108|NCT05253066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5529109|NCT05253066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465542|NCT00475098|Tinzaparin|tinzaparin|mesh-list
6112878|NCT01046396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5529110|NCT05253066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5529111|NCT05253053|Paclitaxel|paclitaxel|mesh-list
5529112|NCT05253053|Atezolizumab|atezolizumab|mesh-list
5529113|NCT05253053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6112879|NCT01046396|Dermatologic Agents|dermatologic agents|mesh-ancestor
6112880|NCT01046565|Adapalene|adapalene|mesh-list
6112881|NCT01046565|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6112882|NCT01046565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6112883|NCT01046565|Analgesics|analgesics|mesh-ancestor
6112884|NCT01046565|Sensory System Agents|sensory system agents|mesh-ancestor
6112885|NCT01046565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6112886|NCT01046565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112887|NCT01046565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6112888|NCT01046565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6112889|NCT01046565|Dermatologic Agents|dermatologic agents|mesh-ancestor
6112890|NCT01046643|Estradiol|estradiol|mesh-list
6112891|NCT01046643|Progesterone|progesterone|mesh-list
6112892|NCT01046643|Estrogens|estrogens|mesh-ancestor
6112893|NCT01046643|Hormones|hormones|mesh-ancestor
6112894|NCT01046643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6112895|NCT01046643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112896|NCT01046643|Progestins|progestins|mesh-ancestor
6112897|NCT01046682|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
6112898|NCT01046682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6112899|NCT01046682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6112900|NCT01046682|Analgesics|analgesics|mesh-ancestor
6112901|NCT01046682|Sensory System Agents|sensory system agents|mesh-ancestor
6112902|NCT01046682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6112903|NCT01046682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112904|NCT01046682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6112905|NCT01046682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6112906|NCT01046903|Dalteparin|dalteparin|mesh-list
6112907|NCT01046903|Tinzaparin|tinzaparin|mesh-list
6112908|NCT01046903|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6112909|NCT01046903|Anticoagulants|anticoagulants|mesh-ancestor
6112910|NCT01046903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6112911|NCT01046903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6112912|NCT01046903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112913|NCT01047007|Cisplatin|cisplatin|mesh-list
6112914|NCT01047007|Adavosertib|adavosertib|mesh-list
6112915|NCT01047007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6112916|NCT01047007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6112917|NCT01047007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112918|NCT01047189|Clindamycin|clindamycin|mesh-list
6112919|NCT01047189|Clindamycin palmitate|clindamycin palmitate|mesh-list
6112920|NCT01047189|Clindamycin phosphate|clindamycin phosphate|mesh-list
6112921|NCT01047189|Tretinoin|tretinoin|mesh-list
6112922|NCT01047189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6112923|NCT01047189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6112924|NCT01047189|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6112925|NCT01047189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6112926|NCT01047189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112927|NCT01047189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6112928|NCT01047189|Keratolytic Agents|keratolytic agents|mesh-ancestor
5529114|NCT05253053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5529115|NCT05253053|Tubulin Modulators|tubulin modulators|mesh-ancestor
5529116|NCT05253053|Antimitotic Agents|antimitotic agents|mesh-ancestor
5529117|NCT05253053|Mitosis Modulators|mitosis modulators|mesh-ancestor
5529118|NCT05253053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5529119|NCT05253014|Acetaminophen|acetaminophen|mesh-list
5529120|NCT05253014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5529121|NCT05253014|Analgesics|analgesics|mesh-ancestor
5529122|NCT05253014|Sensory System Agents|sensory system agents|mesh-ancestor
6112929|NCT01047189|Dermatologic Agents|dermatologic agents|mesh-ancestor
6112930|NCT01047241|Sufentanil|sufentanil|mesh-list
6112931|NCT01047241|Ketamine|ketamine|mesh-list
6112932|NCT01047241|Analgesics|analgesics|mesh-ancestor
6112933|NCT01047241|Sensory System Agents|sensory system agents|mesh-ancestor
6112934|NCT01047241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6112935|NCT01047241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112936|NCT01047241|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6112937|NCT01047241|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6112938|NCT01047241|Anesthetics, General|anesthetics, general|mesh-ancestor
6112939|NCT01047241|Anesthetics|anesthetics|mesh-ancestor
6112940|NCT01047241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6112941|NCT01047241|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6112942|NCT01047241|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6112943|NCT01047241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6112944|NCT01047241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112945|NCT01047241|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6112946|NCT01047241|Narcotics|narcotics|mesh-ancestor
6112947|NCT01047241|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6112948|NCT01047293|Leucovorin|leucovorin|mesh-list
6112949|NCT01047293|Bevacizumab|bevacizumab|mesh-list
6112950|NCT01047293|Oxaliplatin|oxaliplatin|mesh-list
6112951|NCT01047293|Everolimus|everolimus|mesh-list
6112952|NCT01047293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6112953|NCT01047293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6112954|NCT01047293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6112955|NCT01047293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6112956|NCT01047293|Growth Substances|growth substances|mesh-ancestor
6112957|NCT01047293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112958|NCT01047293|Growth Inhibitors|growth inhibitors|mesh-ancestor
6112959|NCT01047293|Antidotes|antidotes|mesh-ancestor
6112960|NCT01047293|Protective Agents|protective agents|mesh-ancestor
6112961|NCT01047293|Vitamin B Complex|vitamin b complex|mesh-ancestor
6112962|NCT01047293|Vitamins|vitamins|mesh-ancestor
6112963|NCT01047293|Micronutrients|micronutrients|mesh-ancestor
6112964|NCT01047293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6112965|NCT01047293|Immunologic Factors|immunologic factors|mesh-ancestor
6112966|NCT01047358|Exemestane|exemestane|mesh-list
5529123|NCT05253014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5529124|NCT05253014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5529125|NCT05253014|Antipyretics|antipyretics|mesh-ancestor
5529126|NCT05252988|Loperamide|loperamide|mesh-list
5529127|NCT05252988|Antidiarrheals|antidiarrheals|mesh-list
5529128|NCT05252988|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
5529129|NCT05252988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5529130|NCT05252988|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5529131|NCT05252988|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5529132|NCT05252988|Antimetabolites|antimetabolites|mesh-ancestor
5529133|NCT05252988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112967|NCT01047358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6112968|NCT01047358|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6112969|NCT01047358|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6112970|NCT01047358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6112971|NCT01047358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112972|NCT01047358|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6112973|NCT01047358|Hormone Antagonists|hormone antagonists|mesh-ancestor
6112974|NCT01047358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6112975|NCT01047358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112976|NCT01047436|Artemether|artemether|mesh-list
6112977|NCT01047436|Quinine|quinine|mesh-list
6112978|NCT01047436|Antimalarials|antimalarials|mesh-ancestor
6112979|NCT01047436|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6112980|NCT01047436|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6112981|NCT01047436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6112982|NCT01047436|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6112983|NCT01047436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112984|NCT01047436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6112985|NCT01047436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6112986|NCT01047436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6112987|NCT01047436|Analgesics|analgesics|mesh-ancestor
6112988|NCT01047436|Sensory System Agents|sensory system agents|mesh-ancestor
6112989|NCT01047527|Nicotine|nicotine|mesh-list
6112990|NCT01047527|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6112991|NCT01047527|Autonomic Agents|autonomic agents|mesh-ancestor
6112992|NCT01047527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6112993|NCT01047527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6112994|NCT01047527|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6112995|NCT01047527|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6112996|NCT01047527|Cholinergic Agents|cholinergic agents|mesh-ancestor
6112997|NCT01047527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6112998|NCT01047527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6112999|NCT01047553|Formoterol Fumarate|formoterol fumarate|mesh-list
6113000|NCT01047553|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6113001|NCT01047553|Autonomic Agents|autonomic agents|mesh-ancestor
6113002|NCT01047553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6113003|NCT01047553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113004|NCT01047553|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6113005|NCT01047553|Respiratory System Agents|respiratory system agents|mesh-ancestor
6113006|NCT01047553|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6113007|NCT01047553|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6113008|NCT01047553|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6113009|NCT01047553|Adrenergic Agents|adrenergic agents|mesh-ancestor
6113010|NCT01047553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6113011|NCT01047553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113012|NCT01048099|Trastuzumab|trastuzumab|mesh-list
6113013|NCT01048099|Pertuzumab|pertuzumab|mesh-list
6113014|NCT01048099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6113015|NCT01048099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5529134|NCT05252988|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5529135|NCT05252923|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
5529136|NCT05252923|Anticoagulants|anticoagulants|mesh-ancestor
5529137|NCT05252923|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5529138|NCT05252923|Antimetabolites|antimetabolites|mesh-ancestor
5529139|NCT05252923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5529140|NCT05252923|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5529141|NCT05252923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5529142|NCT05252923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5529143|NCT05252923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5529144|NCT05252923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5529145|NCT05252884|Calcium, Dietary|calcium, dietary|mesh-list
5529146|NCT05252884|Calcitriol|calcitriol|mesh-list
5529147|NCT05252884|Calcium Carbonate|calcium carbonate|mesh-list
6113016|NCT01048333|Formoterol Fumarate|formoterol fumarate|mesh-list
6113017|NCT01048333|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6113018|NCT01048333|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6113019|NCT01048333|Autonomic Agents|autonomic agents|mesh-ancestor
6113020|NCT01048333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6113021|NCT01048333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113022|NCT01048333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6113023|NCT01048333|Respiratory System Agents|respiratory system agents|mesh-ancestor
6113024|NCT01048333|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6113025|NCT01048333|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6113026|NCT01048333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6113027|NCT01048333|Adrenergic Agents|adrenergic agents|mesh-ancestor
6113028|NCT01048333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6113029|NCT01048333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113030|NCT01048502|Fenofibrate|fenofibrate|mesh-list
6113031|NCT01048502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6113032|NCT01048502|Antimetabolites|antimetabolites|mesh-ancestor
6113033|NCT01048502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113034|NCT01048502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6113035|NCT01048606|Phytoestrogens|phytoestrogens|mesh-list
6113036|NCT01048606|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6113037|NCT01048606|Estrogens|estrogens|mesh-ancestor
6113038|NCT01048606|Hormones|hormones|mesh-ancestor
5529148|NCT05252884|Calcium|calcium|mesh-list
5529149|NCT05252884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6113039|NCT01048606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6113040|NCT01048606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113041|NCT01048658|Sevoflurane|sevoflurane|mesh-list
6113042|NCT01048658|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6113043|NCT01048658|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6113044|NCT01048658|Anesthetics, General|anesthetics, general|mesh-ancestor
6113045|NCT01048658|Anesthetics|anesthetics|mesh-ancestor
6113046|NCT01048658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6113047|NCT01048658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113048|NCT01048671|Raltegravir Potassium|raltegravir potassium|mesh-list
6113049|NCT01048671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6113050|NCT01048671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6113051|NCT01048671|Antiviral Agents|antiviral agents|mesh-ancestor
6113052|NCT01048671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6113053|NCT01048671|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6113054|NCT01048671|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6113055|NCT01048671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6113056|NCT01048671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113057|NCT01048697|Ethambutol|ethambutol|mesh-list
6113058|NCT01048697|Antitubercular Agents|antitubercular agents|mesh-ancestor
6113059|NCT01048697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6113060|NCT01048697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6113061|NCT01048788|Tolvaptan|tolvaptan|mesh-list
6113062|NCT01048788|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6113063|NCT01048788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113064|NCT01048788|Natriuretic Agents|natriuretic agents|mesh-ancestor
6113065|NCT01048788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113066|NCT01048866|Acetaminophen|acetaminophen|mesh-list
6113067|NCT01048866|Flurbiprofen|flurbiprofen|mesh-list
6113068|NCT01048866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6113069|NCT01048866|Analgesics|analgesics|mesh-ancestor
6113070|NCT01048866|Sensory System Agents|sensory system agents|mesh-ancestor
6113071|NCT01048866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6113072|NCT01048866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113073|NCT01048866|Antipyretics|antipyretics|mesh-ancestor
6113074|NCT01048866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6113075|NCT01048866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6113076|NCT01048866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6113077|NCT01048866|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6113078|NCT01048866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6113079|NCT01048866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113080|NCT01048879|Oseltamivir|oseltamivir|mesh-list
6113081|NCT01048879|Dialysis Solutions|dialysis solutions|mesh-list
6113082|NCT01048879|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6113083|NCT01048879|Antiviral Agents|antiviral agents|mesh-ancestor
6113084|NCT01048879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6113085|NCT01048879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6113086|NCT01048879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113087|NCT01048944|Bupropion|bupropion|mesh-list
6113088|NCT01048944|Nicotine|nicotine|mesh-list
6113089|NCT01048944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6113090|NCT01048944|Autonomic Agents|autonomic agents|mesh-ancestor
6113091|NCT01048944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6113092|NCT01048944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113093|NCT01048944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6113094|NCT01048944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6113095|NCT01048944|Cholinergic Agents|cholinergic agents|mesh-ancestor
6113096|NCT01048944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6113097|NCT01048944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113098|NCT01048944|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6113099|NCT01048944|Antidepressive Agents|antidepressive agents|mesh-ancestor
6113100|NCT01048944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6113101|NCT01048944|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6113102|NCT01048944|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6113103|NCT01048944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6113104|NCT01048944|Dopamine Agents|dopamine agents|mesh-ancestor
6113105|NCT01048944|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6113106|NCT01048944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6113107|NCT01048944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6113108|NCT01049009|Metoprolol|metoprolol|mesh-list
6113109|NCT01049009|Nebivolol|nebivolol|mesh-list
6113110|NCT01049009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6113111|NCT01049009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6113112|NCT01049009|Sympatholytics|sympatholytics|mesh-ancestor
6113113|NCT01049009|Autonomic Agents|autonomic agents|mesh-ancestor
6113114|NCT01049009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6113115|NCT01049009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113116|NCT01049009|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6113117|NCT01049009|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6113118|NCT01049009|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6113119|NCT01049009|Adrenergic Agents|adrenergic agents|mesh-ancestor
6113120|NCT01049009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6113121|NCT01049009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113122|NCT01049009|Vasodilator Agents|vasodilator agents|mesh-ancestor
6113123|NCT01049009|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6113124|NCT01049009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6113125|NCT01049009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6113126|NCT01049217|Pregabalin|pregabalin|mesh-list
6113127|NCT01049217|Analgesics|analgesics|mesh-ancestor
6113128|NCT01049217|Sensory System Agents|sensory system agents|mesh-ancestor
6113129|NCT01049217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6113130|NCT01049217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113131|NCT01049217|Anticonvulsants|anticonvulsants|mesh-ancestor
6113132|NCT01049217|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6113133|NCT01049217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6113134|NCT01049217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113135|NCT01049217|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6113136|NCT01049217|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6113137|NCT01049217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6113138|NCT01049217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6113139|NCT01049217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6113140|NCT01049243|Fluocinonide|fluocinonide|mesh-list
6113141|NCT01049243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6113142|NCT01049243|Glucocorticoids|glucocorticoids|mesh-ancestor
6113143|NCT01049243|Hormones|hormones|mesh-ancestor
6113144|NCT01049243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6113145|NCT01049243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113146|NCT01049243|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6113147|NCT01049334|Flurbiprofen|flurbiprofen|mesh-list
6113148|NCT01049334|Analgesics|analgesics|mesh-ancestor
6113149|NCT01049334|Sensory System Agents|sensory system agents|mesh-ancestor
6113150|NCT01049334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6113151|NCT01049334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113152|NCT01049334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6113153|NCT01049334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6113154|NCT01049334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6113155|NCT01049334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6113156|NCT01049334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6113157|NCT01049334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6113158|NCT01049334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113159|NCT01049360|Formoterol Fumarate|formoterol fumarate|mesh-list
6113160|NCT01049360|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6113161|NCT01049360|Autonomic Agents|autonomic agents|mesh-ancestor
6113162|NCT01049360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6113163|NCT01049360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113164|NCT01049360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6113165|NCT01049360|Respiratory System Agents|respiratory system agents|mesh-ancestor
6113166|NCT01049360|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6113167|NCT01049360|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6113168|NCT01049360|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6113169|NCT01049360|Adrenergic Agents|adrenergic agents|mesh-ancestor
6113170|NCT01049360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6113171|NCT01049360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113172|NCT01049412|Insulin Glargine|insulin glargine|mesh-list
6113173|NCT01049412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6113174|NCT01049412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113175|NCT01049503|Fluorides|fluorides|mesh-list
6113176|NCT01049503|Cariostatic Agents|cariostatic agents|mesh-ancestor
6113177|NCT01049503|Protective Agents|protective agents|mesh-ancestor
6113178|NCT01049503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113179|NCT01049945|Dexamethasone|dexamethasone|mesh-list
6113180|NCT01049945|Lenalidomide|lenalidomide|mesh-list
6113181|NCT01049945|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6113182|NCT01049945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6113183|NCT01049945|Antiemetics|antiemetics|mesh-ancestor
6113184|NCT01049945|Autonomic Agents|autonomic agents|mesh-ancestor
6113185|NCT01049945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6113186|NCT01049945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113187|NCT01049945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6113188|NCT01049945|Glucocorticoids|glucocorticoids|mesh-ancestor
6113189|NCT01049945|Hormones|hormones|mesh-ancestor
6113190|NCT01049945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6113191|NCT01049945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6113192|NCT01049945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6113193|NCT01049945|Immunologic Factors|immunologic factors|mesh-ancestor
6113194|NCT01049945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6113195|NCT01049945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6113196|NCT01049945|Growth Substances|growth substances|mesh-ancestor
6113197|NCT01049945|Growth Inhibitors|growth inhibitors|mesh-ancestor
6113198|NCT01049945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6113199|NCT01049945|Alkylating Agents|alkylating agents|mesh-ancestor
6113200|NCT01049945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113201|NCT01049984|Rasagiline|rasagiline|mesh-list
6113202|NCT01049984|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6113203|NCT01049984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6113204|NCT01049984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113205|NCT01049984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6113206|NCT01049984|Protective Agents|protective agents|mesh-ancestor
6113207|NCT01049984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113208|NCT01050062|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6113209|NCT01050062|Telmisartan|telmisartan|mesh-list
6113210|NCT01050062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6113211|NCT01050062|Diuretics|diuretics|mesh-ancestor
6113212|NCT01050062|Natriuretic Agents|natriuretic agents|mesh-ancestor
6113213|NCT01050062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113214|NCT01050062|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6113215|NCT01050062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6113216|NCT01050062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113217|NCT01050062|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6113218|NCT01050062|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6113219|NCT01050153|Aspirin|aspirin|mesh-list
6113220|NCT01050153|Dalteparin|dalteparin|mesh-list
6113221|NCT01050153|Tinzaparin|tinzaparin|mesh-list
6113222|NCT01050153|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6113223|NCT01050153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6113224|NCT01050153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6113225|NCT01050153|Analgesics|analgesics|mesh-ancestor
6113226|NCT01050153|Sensory System Agents|sensory system agents|mesh-ancestor
6113227|NCT01050153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6113228|NCT01050153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113229|NCT01050153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6113230|NCT01050153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6113231|NCT01050153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6113232|NCT01050153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6113233|NCT01050153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113234|NCT01050153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6113235|NCT01050153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5529150|NCT05252884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5529151|NCT05252884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5529152|NCT05252884|Antacids|antacids|mesh-ancestor
5529153|NCT05252884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5529154|NCT05252884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5529155|NCT05252884|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
5529156|NCT05252884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5529157|NCT05252884|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5529158|NCT05252884|Vitamins|vitamins|mesh-ancestor
5529159|NCT05252884|Micronutrients|micronutrients|mesh-ancestor
5529160|NCT05252845|Vaccines|vaccines|mesh-list
5529161|NCT05252845|Immunologic Factors|immunologic factors|mesh-ancestor
5529162|NCT05252845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5529163|NCT05252754|Indomethacin|indomethacin|mesh-list
5529164|NCT05252754|Tacrolimus|tacrolimus|mesh-list
5529165|NCT05252754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5529166|NCT05252754|Immunologic Factors|immunologic factors|mesh-ancestor
6113236|NCT01050153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6113237|NCT01050153|Antipyretics|antipyretics|mesh-ancestor
6113238|NCT01050153|Anticoagulants|anticoagulants|mesh-ancestor
6113239|NCT01050257|Oseltamivir|oseltamivir|mesh-list
6113240|NCT01050257|Antiviral Agents|antiviral agents|mesh-ancestor
6113241|NCT01050257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5529167|NCT05252754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113242|NCT01050257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6113243|NCT01050257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113244|NCT01050530|Tolvaptan|tolvaptan|mesh-list
6113245|NCT01050530|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6113246|NCT01050530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113247|NCT01050530|Natriuretic Agents|natriuretic agents|mesh-ancestor
6113248|NCT01050530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113249|NCT01050543|Neostigmine|neostigmine|mesh-list
6113250|NCT01050543|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6113251|NCT01050543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6113252|NCT01050543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113253|NCT01050543|Cholinergic Agents|cholinergic agents|mesh-ancestor
6113254|NCT01050543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6113255|NCT01050543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113256|NCT01050543|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6113257|NCT01050543|Autonomic Agents|autonomic agents|mesh-ancestor
6113258|NCT01050543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6113259|NCT01050569|Nicotine|nicotine|mesh-list
6113260|NCT01050569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6113261|NCT01050569|Autonomic Agents|autonomic agents|mesh-ancestor
6113262|NCT01050569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6113263|NCT01050569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113264|NCT01050569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6113265|NCT01050569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6113266|NCT01050569|Cholinergic Agents|cholinergic agents|mesh-ancestor
6113267|NCT01050569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6113268|NCT01050569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113269|NCT01050582|Risperidone|risperidone|mesh-list
6113270|NCT01050582|Antipsychotic Agents|antipsychotic agents|mesh-list
6113271|NCT01050582|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6113272|NCT01050582|Serotonin Agents|serotonin agents|mesh-ancestor
6113273|NCT01050582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6113274|NCT01050582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5529168|NCT05252754|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5529169|NCT05252754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5529170|NCT05252754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5529171|NCT05252754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5529172|NCT05252754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5529173|NCT05252754|Analgesics|analgesics|mesh-ancestor
5529174|NCT05252754|Sensory System Agents|sensory system agents|mesh-ancestor
5529175|NCT05252754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5529176|NCT05252754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5529177|NCT05252754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5529178|NCT05252754|Gout Suppressants|gout suppressants|mesh-ancestor
5529179|NCT05252754|Tocolytic Agents|tocolytic agents|mesh-ancestor
5529180|NCT05252754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5529181|NCT05252754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5529182|NCT05252715|Vaccines|vaccines|mesh-list
5529183|NCT05252715|Immunologic Factors|immunologic factors|mesh-ancestor
5529184|NCT05252715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5529185|NCT05252598|Psilocybin|psilocybin|mesh-list
5529186|NCT05252598|Hallucinogens|hallucinogens|mesh-ancestor
5529187|NCT05252598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5529188|NCT05252598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5529189|NCT05252585|Everolimus|everolimus|mesh-list
5529190|NCT05252585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5529191|NCT05252585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5529192|NCT05252585|Immunologic Factors|immunologic factors|mesh-ancestor
5529193|NCT05252585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5529194|NCT05252546|Loperamide|loperamide|mesh-list
5529195|NCT05252546|Antidiarrheals|antidiarrheals|mesh-list
5529196|NCT05252546|Bentonite|bentonite|mesh-list
6113275|NCT01050582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113276|NCT01050582|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6113277|NCT01050582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6113278|NCT01050582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6113279|NCT01050582|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6113280|NCT01050582|Dopamine Agents|dopamine agents|mesh-ancestor
6113281|NCT01050634|Exemestane|exemestane|mesh-list
6113282|NCT01050634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6113283|NCT01050634|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6113284|NCT01050634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6113285|NCT01050634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5529197|NCT05252546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5529198|NCT05252546|Antidotes|antidotes|mesh-ancestor
5529199|NCT05252546|Protective Agents|protective agents|mesh-ancestor
6113286|NCT01050634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113287|NCT01050634|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6113288|NCT01050634|Hormone Antagonists|hormone antagonists|mesh-ancestor
6113289|NCT01050634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6113290|NCT01050634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113291|NCT01050647|Castor Oil|castor oil|mesh-list
6113292|NCT01050647|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
6113293|NCT01050647|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
6113294|NCT01050647|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6113295|NCT01050647|Hormone Antagonists|hormone antagonists|mesh-ancestor
6113296|NCT01050647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6113297|NCT01050647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113298|NCT01050647|Progestins|progestins|mesh-ancestor
6113299|NCT01050647|Hormones|hormones|mesh-ancestor
6113300|NCT01050647|Cathartics|cathartics|mesh-ancestor
6113301|NCT01050647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6113302|NCT01050660|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6113303|NCT01050660|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
6113304|NCT01050660|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6113305|NCT01050660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6113306|NCT01050764|Vidarabine|vidarabine|mesh-list
6113307|NCT01050764|Fludarabine|fludarabine|mesh-list
6113308|NCT01050764|Fludarabine phosphate|fludarabine phosphate|mesh-list
6113309|NCT01050764|Melphalan|melphalan|mesh-list
6113310|NCT01050764|Thiotepa|thiotepa|mesh-list
6113311|NCT01050764|Thymoglobulin|thymoglobulin|mesh-list
5529200|NCT05252546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5529201|NCT05252533|Ustekinumab|ustekinumab|mesh-list
5529202|NCT05252533|Dermatologic Agents|dermatologic agents|mesh-ancestor
5529203|NCT05252442|Vaccines|vaccines|mesh-list
5529204|NCT05252442|Immunologic Factors|immunologic factors|mesh-ancestor
5529205|NCT05252442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5529206|NCT05252429|Docetaxel|docetaxel|mesh-list
5529207|NCT05252429|Pembrolizumab|pembrolizumab|mesh-list
5529208|NCT05252429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5529209|NCT05252429|Tubulin Modulators|tubulin modulators|mesh-ancestor
5529210|NCT05252429|Antimitotic Agents|antimitotic agents|mesh-ancestor
5529211|NCT05252429|Mitosis Modulators|mitosis modulators|mesh-ancestor
5529212|NCT05252429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5529213|NCT05252429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5529214|NCT05252416|Carboplatin|carboplatin|mesh-list
5529215|NCT05252416|Fulvestrant|fulvestrant|mesh-list
5529216|NCT05252416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6113312|NCT01050764|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6113313|NCT01050764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6113314|NCT01050764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6113315|NCT01050764|Antimetabolites|antimetabolites|mesh-ancestor
6113316|NCT01050764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113317|NCT01050764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6113318|NCT01050764|Immunologic Factors|immunologic factors|mesh-ancestor
6113319|NCT01050764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113320|NCT01050764|Antiviral Agents|antiviral agents|mesh-ancestor
6113321|NCT01050764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6113322|NCT01050764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6113323|NCT01050764|Alkylating Agents|alkylating agents|mesh-ancestor
6113324|NCT01050764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6113325|NCT01050790|Lenalidomide|lenalidomide|mesh-list
6113326|NCT01050790|Azacitidine|azacitidine|mesh-list
6113327|NCT01050790|Immunologic Factors|immunologic factors|mesh-ancestor
6113328|NCT01050790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113329|NCT01050790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6113330|NCT01050790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6113331|NCT01050790|Growth Substances|growth substances|mesh-ancestor
6113332|NCT01050790|Growth Inhibitors|growth inhibitors|mesh-ancestor
6113333|NCT01050790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6113334|NCT01050790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6113335|NCT01050790|Antimetabolites|antimetabolites|mesh-ancestor
6113336|NCT01050790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113337|NCT01050790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5529217|NCT05252416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5529218|NCT05252416|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5529219|NCT05252416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5529220|NCT05252416|Hormone Antagonists|hormone antagonists|mesh-ancestor
5529221|NCT05252416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5529222|NCT05252416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5529223|NCT05252390|Olaparib|olaparib|mesh-list
6113338|NCT01050907|Miltefosine|miltefosine|mesh-list
6113339|NCT01050907|Antifungal Agents|antifungal agents|mesh-ancestor
6113340|NCT01050907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6113341|NCT01050907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6113342|NCT01050907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6113343|NCT01050907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6204292|NCT02068495|Amlodipine|amlodipine|mesh-list
6204293|NCT02068495|Candesartan|candesartan|mesh-list
6204294|NCT02068495|Candesartan cilexetil|candesartan cilexetil|mesh-list
6204295|NCT02068495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6204296|NCT02068495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6204297|NCT02068495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6204298|NCT02068495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204299|NCT02068495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6204300|NCT02068495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204301|NCT02068495|Vasodilator Agents|vasodilator agents|mesh-ancestor
6204302|NCT02068495|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6204303|NCT02068495|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6204304|NCT02068508|Pioglitazone|pioglitazone|mesh-list
6204305|NCT02068508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6204306|NCT02068508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204307|NCT02068820|Fluorophosphate|fluorophosphate|mesh-list
6204308|NCT02068820|Cariostatic Agents|cariostatic agents|mesh-ancestor
6204309|NCT02068820|Protective Agents|protective agents|mesh-ancestor
5529224|NCT05252390|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5529225|NCT05252390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5529226|NCT05252390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204310|NCT02068820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204311|NCT02068846|Ciprofloxacin|ciprofloxacin|mesh-list
6666043|NCT01520350|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6666044|NCT01520350|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5529227|NCT05252390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5529228|NCT05252325|Lidocaine|lidocaine|mesh-list
5529229|NCT05252325|Hyaluronic Acid|hyaluronic acid|mesh-list
5529230|NCT05252325|Anesthetics, Local|anesthetics, local|mesh-ancestor
6666045|NCT01520350|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6204312|NCT02068846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6204313|NCT02068846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6204314|NCT02068846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6204315|NCT02068846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6204316|NCT02068846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6204317|NCT02068846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204318|NCT02068846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6204319|NCT02068846|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6204320|NCT02068846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6204321|NCT02069041|Leucovorin|leucovorin|mesh-list
6204322|NCT02069041|Fluorouracil|fluorouracil|mesh-list
6204323|NCT02069041|Oxaliplatin|oxaliplatin|mesh-list
6204324|NCT02069041|Ramucirumab|ramucirumab|mesh-list
6204325|NCT02069041|Antimetabolites|antimetabolites|mesh-ancestor
6204326|NCT02069041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204327|NCT02069041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6204328|NCT02069041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6204329|NCT02069041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6204330|NCT02069041|Immunologic Factors|immunologic factors|mesh-ancestor
6666046|NCT01520350|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6666047|NCT01520389|Irinotecan|irinotecan|mesh-list
6113344|NCT01050998|Mavrilimumab|mavrilimumab|mesh-list
6113345|NCT01050998|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6113346|NCT01050998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6113347|NCT01050998|Immunologic Factors|immunologic factors|mesh-ancestor
6113348|NCT01050998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113349|NCT01051349|Daclizumab|daclizumab|mesh-list
6113350|NCT01051349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6113351|NCT01051349|Immunologic Factors|immunologic factors|mesh-ancestor
6113352|NCT01051349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113353|NCT01051440|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6113354|NCT01051440|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6113355|NCT01051440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113356|NCT01051440|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6113357|NCT01051440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6113358|NCT01051440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6113359|NCT01051440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113360|NCT01051440|Dopamine Agents|dopamine agents|mesh-ancestor
6113361|NCT01051440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6113362|NCT01051466|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6113363|NCT01051466|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6113364|NCT01051466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6113365|NCT01051466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6113366|NCT01051466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113367|NCT01051466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6113368|NCT01051466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113369|NCT01051466|Analgesics|analgesics|mesh-ancestor
6113370|NCT01051466|Sensory System Agents|sensory system agents|mesh-ancestor
6113371|NCT01051466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6113372|NCT01051466|Antidepressive Agents|antidepressive agents|mesh-ancestor
6113373|NCT01051466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5529231|NCT05252325|Anesthetics|anesthetics|mesh-ancestor
5529232|NCT05252325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5529233|NCT05252325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5529234|NCT05252325|Sensory System Agents|sensory system agents|mesh-ancestor
5529235|NCT05252325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5529236|NCT05252325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5529237|NCT05252325|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5529238|NCT05252325|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5529239|NCT05252325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5529240|NCT05252325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5529241|NCT05252325|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5529242|NCT05252325|Immunologic Factors|immunologic factors|mesh-ancestor
5529243|NCT05252325|Viscosupplements|viscosupplements|mesh-ancestor
5529244|NCT05252325|Protective Agents|protective agents|mesh-ancestor
6113374|NCT01051466|Dopamine Agents|dopamine agents|mesh-ancestor
6113375|NCT01051557|Sirolimus|sirolimus|mesh-list
6113376|NCT01051557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6113377|NCT01051557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6113378|NCT01051557|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6113379|NCT01051557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6113380|NCT01051557|Antifungal Agents|antifungal agents|mesh-ancestor
6113381|NCT01051557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6113382|NCT01051557|Immunologic Factors|immunologic factors|mesh-ancestor
6113383|NCT01051557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113384|NCT01051570|Prednisone|prednisone|mesh-list
6113385|NCT01051570|Carboplatin|carboplatin|mesh-list
6113386|NCT01051570|Everolimus|everolimus|mesh-list
6113387|NCT01051570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6113388|NCT01051570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6113389|NCT01051570|Glucocorticoids|glucocorticoids|mesh-ancestor
6113390|NCT01051570|Hormones|hormones|mesh-ancestor
5529245|NCT05252117|Mepivacaine|mepivacaine|mesh-list
5529246|NCT05252117|Carticaine|carticaine|mesh-list
5529247|NCT05252117|Anesthetics, Local|anesthetics, local|mesh-ancestor
5529248|NCT05252117|Anesthetics|anesthetics|mesh-ancestor
5529249|NCT05252117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5529250|NCT05252117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5529251|NCT05252117|Sensory System Agents|sensory system agents|mesh-ancestor
5529252|NCT05252117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5529253|NCT05251974|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
5529254|NCT05251974|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5529255|NCT05251974|Adrenergic Agents|adrenergic agents|mesh-ancestor
5529256|NCT05251974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6113391|NCT01051570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6113392|NCT01051570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113393|NCT01051570|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6113394|NCT01051570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6113395|NCT01051570|Immunologic Factors|immunologic factors|mesh-ancestor
6113396|NCT01051596|Temozolomide|temozolomide|mesh-list
6113397|NCT01051596|Veliparib|veliparib|mesh-list
6113398|NCT01051596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6113399|NCT01051596|Alkylating Agents|alkylating agents|mesh-ancestor
6113400|NCT01051596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113401|NCT01051596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6113402|NCT01051596|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6113403|NCT01051596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6113404|NCT01051661|Vaccines|vaccines|mesh-list
6113405|NCT01051661|Immunologic Factors|immunologic factors|mesh-ancestor
6113406|NCT01051661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113407|NCT01051778|Aspirin|aspirin|mesh-list
6113408|NCT01051778|Heparin|heparin|mesh-list
6113409|NCT01051778|Enoxaparin|enoxaparin|mesh-list
6113410|NCT01051778|Calcium heparin|calcium heparin|mesh-list
6113411|NCT01051778|Calcium|calcium|mesh-list
6113412|NCT01051778|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6113413|NCT01051778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113414|NCT01051778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6113415|NCT01051778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6113416|NCT01051778|Analgesics|analgesics|mesh-ancestor
6113417|NCT01051778|Sensory System Agents|sensory system agents|mesh-ancestor
6113418|NCT01051778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6113419|NCT01051778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6113420|NCT01051778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6113421|NCT01051778|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6113422|NCT01051778|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6113423|NCT01051778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113424|NCT01051778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6113425|NCT01051778|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6113426|NCT01051778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6113427|NCT01051778|Antipyretics|antipyretics|mesh-ancestor
6113428|NCT01051778|Anticoagulants|anticoagulants|mesh-ancestor
6113429|NCT01051791|Everolimus|everolimus|mesh-list
6113430|NCT01051791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6113431|NCT01051791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6113432|NCT01051791|Immunologic Factors|immunologic factors|mesh-ancestor
6113433|NCT01051791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113434|NCT01051960|Ambrisentan|ambrisentan|mesh-list
6113435|NCT01051960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6113436|NCT01052012|Bupivacaine|bupivacaine|mesh-list
6113437|NCT01052012|Anesthetics, Local|anesthetics, local|mesh-ancestor
6113438|NCT01052012|Anesthetics|anesthetics|mesh-ancestor
6113439|NCT01052012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6113440|NCT01052012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113441|NCT01052012|Sensory System Agents|sensory system agents|mesh-ancestor
6113442|NCT01052012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5529257|NCT05251974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5529258|NCT05251974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5529259|NCT05251948|Capecitabine|capecitabine|mesh-list
5529260|NCT05251948|Oxaliplatin|oxaliplatin|mesh-list
5529261|NCT05251948|Atezolizumab|atezolizumab|mesh-list
5529262|NCT05251948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5529263|NCT05251948|Antimetabolites|antimetabolites|mesh-ancestor
5529264|NCT05251948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5529265|NCT05251948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5529266|NCT05251909|Benralizumab|benralizumab|mesh-list
5529267|NCT05251909|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5529268|NCT05251909|Respiratory System Agents|respiratory system agents|mesh-ancestor
5529269|NCT05251766|Paclitaxel|paclitaxel|mesh-list
5529270|NCT05251766|Docetaxel|docetaxel|mesh-list
5529271|NCT05251766|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6113443|NCT01052038|Dexamethasone|dexamethasone|mesh-list
5529272|NCT05251766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5529273|NCT05251766|Tubulin Modulators|tubulin modulators|mesh-ancestor
5529274|NCT05251766|Antimitotic Agents|antimitotic agents|mesh-ancestor
5529275|NCT05251766|Mitosis Modulators|mitosis modulators|mesh-ancestor
5529276|NCT05251766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5529277|NCT05251714|Fulvestrant|fulvestrant|mesh-list
5529278|NCT05251714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5529279|NCT05251714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6113444|NCT01052038|Dexamethasone acetate|dexamethasone acetate|mesh-list
6113445|NCT01052038|BB 1101|bb 1101|mesh-list
6113446|NCT01052038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6113447|NCT01052038|Antiemetics|antiemetics|mesh-ancestor
6113448|NCT01052038|Autonomic Agents|autonomic agents|mesh-ancestor
6113449|NCT01052038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6113450|NCT01052038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113451|NCT01052038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6113452|NCT01052038|Glucocorticoids|glucocorticoids|mesh-ancestor
6113453|NCT01052038|Hormones|hormones|mesh-ancestor
6113454|NCT01052038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6113455|NCT01052038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6113456|NCT01052038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6113457|NCT01052038|Protease Inhibitors|protease inhibitors|mesh-ancestor
6113458|NCT01052038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6113459|NCT01052038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113460|NCT01052077|Antidepressive Agents|antidepressive agents|mesh-list
6113461|NCT01052077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6113462|NCT01052103|Olanzapine|olanzapine|mesh-list
6113463|NCT01052103|Antiemetics|antiemetics|mesh-ancestor
6113464|NCT01052103|Autonomic Agents|autonomic agents|mesh-ancestor
6113465|NCT01052103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6113466|NCT01052103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113467|NCT01052103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6113468|NCT01052103|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5529280|NCT05251714|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5529281|NCT05251714|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5529282|NCT05251714|Hormone Antagonists|hormone antagonists|mesh-ancestor
5529283|NCT05251714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5529284|NCT05251714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5529285|NCT05251662|Bevacizumab|bevacizumab|mesh-list
5529286|NCT05251662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5529287|NCT05251662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5529288|NCT05251662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5529289|NCT05251662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5529290|NCT05251662|Growth Substances|growth substances|mesh-ancestor
5529291|NCT05251662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5529292|NCT05251662|Growth Inhibitors|growth inhibitors|mesh-ancestor
5529293|NCT05251636|Aflibercept|aflibercept|mesh-list
5529294|NCT05251636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5529295|NCT05251636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5529296|NCT05251636|Growth Substances|growth substances|mesh-ancestor
5529297|NCT05251636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5529298|NCT05251636|Growth Inhibitors|growth inhibitors|mesh-ancestor
5529299|NCT05251636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5529300|NCT05251610|Propranolol|propranolol|mesh-list
5529301|NCT05251610|Oxytocin|oxytocin|mesh-list
5529302|NCT05251610|Oxytocics|oxytocics|mesh-ancestor
5529303|NCT05251610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6113469|NCT01052103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6113470|NCT01052103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6113471|NCT01052103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6113472|NCT01052103|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6465543|NCT00475098|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6465544|NCT00475098|Dalteparin|dalteparin|mesh-list
6465545|NCT00475098|Anticoagulants|anticoagulants|mesh-ancestor
6465546|NCT00475098|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6465547|NCT00475098|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6465548|NCT00475098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465549|NCT00475137|Lamotrigine|lamotrigine|mesh-list
6113473|NCT01052103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6113474|NCT01052103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6113475|NCT01052103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113476|NCT01052103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6113477|NCT01052103|Serotonin Agents|serotonin agents|mesh-ancestor
5529304|NCT05251610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465550|NCT00475137|Anticonvulsants|anticonvulsants|mesh-list
6113478|NCT01052272|Allopurinol|allopurinol|mesh-list
6113479|NCT01052272|Candesartan|candesartan|mesh-list
6113480|NCT01052272|Candesartan cilexetil|candesartan cilexetil|mesh-list
6113481|NCT01052272|Ramipril|ramipril|mesh-list
6113482|NCT01052272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6113483|NCT01052272|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6113484|NCT01052272|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6113485|NCT01052272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113486|NCT01052272|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6113487|NCT01052272|Protease Inhibitors|protease inhibitors|mesh-ancestor
6113488|NCT01052272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6113489|NCT01052272|Antimetabolites|antimetabolites|mesh-ancestor
6113490|NCT01052272|Gout Suppressants|gout suppressants|mesh-ancestor
6113491|NCT01052272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6113492|NCT01052272|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6113493|NCT01052272|Antioxidants|antioxidants|mesh-ancestor
6113494|NCT01052272|Protective Agents|protective agents|mesh-ancestor
6113495|NCT01052272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113496|NCT01052428|Metoprolol|metoprolol|mesh-list
6465551|NCT00475137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6465552|NCT00475137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6465553|NCT00475137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5529305|NCT05251610|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5529306|NCT05251610|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5529307|NCT05251610|Adrenergic Agents|adrenergic agents|mesh-ancestor
5529308|NCT05251610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5529309|NCT05251610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5529310|NCT05251610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5529311|NCT05251610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5529312|NCT05251610|Vasodilator Agents|vasodilator agents|mesh-ancestor
6488441|NCT00584168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6666048|NCT01520389|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6113497|NCT01052428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6113498|NCT01052428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6113499|NCT01052428|Sympatholytics|sympatholytics|mesh-ancestor
6113500|NCT01052428|Autonomic Agents|autonomic agents|mesh-ancestor
6113501|NCT01052428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6113502|NCT01052428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113503|NCT01052428|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6113504|NCT01052428|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6113505|NCT01052428|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6113506|NCT01052428|Adrenergic Agents|adrenergic agents|mesh-ancestor
6113507|NCT01052428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6113508|NCT01052428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113509|NCT01052493|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
6113510|NCT01052493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6113511|NCT01052493|Hormones|hormones|mesh-ancestor
6113512|NCT01052493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6113513|NCT01052493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113514|NCT01052662|Memantine|memantine|mesh-list
6113515|NCT01052662|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6113516|NCT01052662|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6113517|NCT01052662|Dopamine Agents|dopamine agents|mesh-ancestor
6113518|NCT01052662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6113519|NCT01052662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113520|NCT01052662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113521|NCT01052662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6113522|NCT01052662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6113523|NCT01052701|Ribavirin|ribavirin|mesh-list
6113524|NCT01052701|Abacavir|abacavir|mesh-list
6113525|NCT01052701|Antimetabolites|antimetabolites|mesh-ancestor
6204331|NCT02069041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666049|NCT01520389|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6666050|NCT01520389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6666051|NCT01520389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6666052|NCT01520389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113526|NCT01052701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113527|NCT01052701|Antiviral Agents|antiviral agents|mesh-ancestor
6113528|NCT01052701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6113529|NCT01052701|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6113530|NCT01052701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6113531|NCT01052701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6113532|NCT01052701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6113533|NCT01052701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6113534|NCT01052779|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
6113535|NCT01052779|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6113536|NCT01052779|Hematinics|hematinics|mesh-ancestor
6113537|NCT01052779|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6113538|NCT01052779|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6113539|NCT01052831|Naltrexone|naltrexone|mesh-list
6113540|NCT01052831|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6113541|NCT01052831|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6113542|NCT01052831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113543|NCT01052831|Sensory System Agents|sensory system agents|mesh-ancestor
6113544|NCT01052831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6113545|NCT01052844|Gabapentin|gabapentin|mesh-list
6113546|NCT01052844|Analgesics|analgesics|mesh-ancestor
6113547|NCT01052844|Sensory System Agents|sensory system agents|mesh-ancestor
6113548|NCT01052844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6113549|NCT01052844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113550|NCT01052844|Anticonvulsants|anticonvulsants|mesh-ancestor
6113551|NCT01052844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6113552|NCT01052844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6113553|NCT01052844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6113554|NCT01052844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6113555|NCT01052844|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6113556|NCT01052844|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6113557|NCT01052844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6113558|NCT01052844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113559|NCT01052844|Antimanic Agents|antimanic agents|mesh-ancestor
6113560|NCT01053000|Tazarotene|tazarotene|mesh-list
6113561|NCT01053000|Dermatologic Agents|dermatologic agents|mesh-ancestor
6113562|NCT01053000|Keratolytic Agents|keratolytic agents|mesh-ancestor
6113563|NCT01053078|Naltrexone|naltrexone|mesh-list
6113564|NCT01053078|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6113565|NCT01053078|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6113566|NCT01053078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113567|NCT01053078|Sensory System Agents|sensory system agents|mesh-ancestor
6113568|NCT01053078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6113569|NCT01053156|Minocycline|minocycline|mesh-list
6113570|NCT01053156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6113571|NCT01053156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6113572|NCT01053247|Tacrolimus|tacrolimus|mesh-list
5529313|NCT05231603|Ivermectin|ivermectin|mesh-list
5529314|NCT05231603|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5529315|NCT05231603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5529316|NCT05227664|Paclitaxel|paclitaxel|mesh-list
5529317|NCT05227664|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5529318|NCT05227664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5529319|NCT05227664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5529320|NCT05227664|Tubulin Modulators|tubulin modulators|mesh-ancestor
6113573|NCT01053247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6113574|NCT01053247|Immunologic Factors|immunologic factors|mesh-ancestor
6113575|NCT01053247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113576|NCT01053247|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6113577|NCT01053247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6113578|NCT01053247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113579|NCT01053312|Flutemetamol|flutemetamol|mesh-list
6113580|NCT01053312|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6113581|NCT01053312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113582|NCT01053429|Ziprasidone|ziprasidone|mesh-list
6113583|NCT01053429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6113584|NCT01053429|Serotonin Agents|serotonin agents|mesh-ancestor
6113585|NCT01053429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6113586|NCT01053429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113587|NCT01053429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113588|NCT01053429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6113589|NCT01053429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6113590|NCT01053429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6113591|NCT01053429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6465554|NCT00475137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6465555|NCT00475137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465556|NCT00475137|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6465557|NCT00475137|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6113592|NCT01053429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6113593|NCT01053429|Dopamine Agents|dopamine agents|mesh-ancestor
6113594|NCT01053507|Naproxen|naproxen|mesh-list
6113595|NCT01053507|Sumatriptan|sumatriptan|mesh-list
6113596|NCT01053507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6113597|NCT01053507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6113598|NCT01053507|Analgesics|analgesics|mesh-ancestor
6113599|NCT01053507|Sensory System Agents|sensory system agents|mesh-ancestor
6113600|NCT01053507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6113601|NCT01053507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113602|NCT01053507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6113603|NCT01053507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6113604|NCT01053507|Gout Suppressants|gout suppressants|mesh-ancestor
6113605|NCT01053507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6113606|NCT01053507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6113607|NCT01053507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113608|NCT01053507|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6113609|NCT01053507|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6113610|NCT01053507|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6113611|NCT01053507|Serotonin Agents|serotonin agents|mesh-ancestor
6113612|NCT01053507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6113613|NCT01053663|Oseltamivir|oseltamivir|mesh-list
6113614|NCT01053663|Antiviral Agents|antiviral agents|mesh-ancestor
6113615|NCT01053663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6113616|NCT01053663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6113617|NCT01053663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113618|NCT01053741|Plasma-lyte 148|plasma-lyte 148|mesh-list
6113619|NCT01053741|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6113620|NCT01053741|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6113621|NCT01053819|Etanercept|etanercept|mesh-list
6113622|NCT01053819|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6113623|NCT01053819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5529321|NCT05227664|Antimitotic Agents|antimitotic agents|mesh-ancestor
5529322|NCT05227664|Mitosis Modulators|mitosis modulators|mesh-ancestor
5529323|NCT05227664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5529324|NCT05222516|Broncho-Vaxom|broncho-vaxom|mesh-list
5529325|NCT05222516|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5529326|NCT05222516|Immunologic Factors|immunologic factors|mesh-ancestor
5529327|NCT05222516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5529328|NCT05221658|Cisplatin|cisplatin|mesh-list
5529329|NCT05221658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5529330|NCT05219799|Propranolol|propranolol|mesh-list
5529331|NCT05219799|Nitroprusside|nitroprusside|mesh-list
5529332|NCT05219799|Isoproterenol|isoproterenol|mesh-list
5529333|NCT05219799|Norepinephrine|norepinephrine|mesh-list
5529334|NCT05219799|Acetylcholine|acetylcholine|mesh-list
5529335|NCT05219799|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5529336|NCT05219799|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5529337|NCT05219799|Adrenergic Agents|adrenergic agents|mesh-ancestor
5529338|NCT05219799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5529339|NCT05219799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5529340|NCT05219799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113624|NCT01053819|Analgesics|analgesics|mesh-ancestor
6113625|NCT01053819|Sensory System Agents|sensory system agents|mesh-ancestor
6113626|NCT01053819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6113627|NCT01053819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113628|NCT01053819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6113629|NCT01053819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6113630|NCT01053819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6113631|NCT01053819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6113632|NCT01053819|Immunologic Factors|immunologic factors|mesh-ancestor
6113633|NCT01053962|Plecanatide|plecanatide|mesh-list
6113634|NCT01053962|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
6113635|NCT01053962|Enzyme Activators|enzyme activators|mesh-ancestor
6113636|NCT01053962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5529341|NCT05219799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5529342|NCT05219799|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5529343|NCT05219799|Vasodilator Agents|vasodilator agents|mesh-ancestor
6113637|NCT01053962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6113638|NCT01054079|Cinacalcet|cinacalcet|mesh-list
6113639|NCT01054079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6113640|NCT01054079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113641|NCT01054079|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6113642|NCT01054079|Hormone Antagonists|hormone antagonists|mesh-ancestor
6113643|NCT01054079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6113644|NCT01054144|Dexamethasone|dexamethasone|mesh-list
6113645|NCT01054144|Prednisone|prednisone|mesh-list
6113646|NCT01054144|Lenalidomide|lenalidomide|mesh-list
6113647|NCT01054144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6113648|NCT01054144|Antiemetics|antiemetics|mesh-ancestor
6113649|NCT01054144|Autonomic Agents|autonomic agents|mesh-ancestor
6113650|NCT01054144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6113651|NCT01054144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113652|NCT01054144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5529344|NCT05219799|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5529345|NCT05219799|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5529346|NCT05219799|Sympathomimetics|sympathomimetics|mesh-ancestor
5529347|NCT05219799|Autonomic Agents|autonomic agents|mesh-ancestor
5529348|NCT05219799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5529349|NCT05219799|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5529350|NCT05219799|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5529351|NCT05219799|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5529352|NCT05219799|Cholinergic Agents|cholinergic agents|mesh-ancestor
5529353|NCT05219799|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6113653|NCT01054144|Glucocorticoids|glucocorticoids|mesh-ancestor
6113654|NCT01054144|Hormones|hormones|mesh-ancestor
6113655|NCT01054144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6113656|NCT01054144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6113657|NCT01054144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6113658|NCT01054144|Immunologic Factors|immunologic factors|mesh-ancestor
6113659|NCT01054144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6113660|NCT01054144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6113661|NCT01054144|Growth Substances|growth substances|mesh-ancestor
6113662|NCT01054144|Growth Inhibitors|growth inhibitors|mesh-ancestor
6113663|NCT01054222|Fesoterodine|fesoterodine|mesh-list
6113664|NCT01054222|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6113665|NCT01054222|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5529354|NCT05219799|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5529355|NCT05219799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5529356|NCT05219799|Respiratory System Agents|respiratory system agents|mesh-ancestor
5529357|NCT05219799|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5529358|NCT05219799|Protective Agents|protective agents|mesh-ancestor
5529359|NCT05215951|Osimertinib|osimertinib|mesh-list
5529360|NCT05215951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5529361|NCT05215951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5529362|NCT05215951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5529363|NCT05215951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5529364|NCT05215340|Pembrolizumab|pembrolizumab|mesh-list
5529365|NCT05215340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5529366|NCT05215340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5529367|NCT05213507|Amikacin|amikacin|mesh-list
5529368|NCT05213507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5529369|NCT05213507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6113666|NCT01054222|Cholinergic Agents|cholinergic agents|mesh-ancestor
6113667|NCT01054222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6113668|NCT01054222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113669|NCT01054222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113670|NCT01054222|Urological Agents|urological agents|mesh-ancestor
6113671|NCT01054300|Ertugliflozin|ertugliflozin|mesh-list
6113672|NCT01054300|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6113673|NCT01054300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113674|NCT01054300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6113675|NCT01054300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113676|NCT01054404|Furosemide|furosemide|mesh-list
6113677|NCT01054404|Diuretics|diuretics|mesh-ancestor
6113678|NCT01054404|Natriuretic Agents|natriuretic agents|mesh-ancestor
6113679|NCT01054404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113680|NCT01054404|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6113681|NCT01054404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6113682|NCT01054404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113683|NCT01054573|Interferons|interferons|mesh-list
6113684|NCT01054573|Ribavirin|ribavirin|mesh-list
6113685|NCT01054573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6113686|NCT01054573|Antiviral Agents|antiviral agents|mesh-ancestor
6113687|NCT01054573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6113688|NCT01054573|Antimetabolites|antimetabolites|mesh-ancestor
6113689|NCT01054573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113690|NCT01054599|Memantine|memantine|mesh-list
6113691|NCT01054599|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6113692|NCT01054599|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6113693|NCT01054599|Dopamine Agents|dopamine agents|mesh-ancestor
6113694|NCT01054599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6113695|NCT01054599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113696|NCT01054599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113697|NCT01054599|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6113698|NCT01054599|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6113699|NCT01054625|Zalutumumab|zalutumumab|mesh-list
6113700|NCT01054625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6113701|NCT01054625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6113702|NCT01054729|Sofosbuvir|sofosbuvir|mesh-list
6113703|NCT01054729|Antiviral Agents|antiviral agents|mesh-ancestor
6113704|NCT01054729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6113705|NCT01054742|Ribavirin|ribavirin|mesh-list
6113706|NCT01054742|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6113707|NCT01054742|Antimetabolites|antimetabolites|mesh-ancestor
6113708|NCT01054742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113709|NCT01054742|Antiviral Agents|antiviral agents|mesh-ancestor
6113710|NCT01054742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6113711|NCT01054768|Thioctic Acid|thioctic acid|mesh-list
6113712|NCT01054768|Acetylcarnitine|acetylcarnitine|mesh-list
6113713|NCT01054768|Antioxidants|antioxidants|mesh-ancestor
6113714|NCT01054768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113715|NCT01054768|Protective Agents|protective agents|mesh-ancestor
5529390|NCT05194293|Durvalumab|durvalumab|mesh-list
5529391|NCT05194293|Immunoglobulins|immunoglobulins|mesh-list
5529392|NCT05194293|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5529393|NCT05194293|Immunoglobulin G|immunoglobulin g|mesh-list
5529394|NCT05194293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6113716|NCT01054768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113717|NCT01054768|Vitamin B Complex|vitamin b complex|mesh-ancestor
6113718|NCT01054768|Vitamins|vitamins|mesh-ancestor
6113719|NCT01054768|Micronutrients|micronutrients|mesh-ancestor
6113720|NCT01054768|Nootropic Agents|nootropic agents|mesh-ancestor
6113721|NCT01054820|Diclofenac|diclofenac|mesh-list
6113722|NCT01054820|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
6113723|NCT01054820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6113724|NCT01054820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6113725|NCT01054820|Analgesics|analgesics|mesh-ancestor
6113726|NCT01054820|Sensory System Agents|sensory system agents|mesh-ancestor
6113727|NCT01054820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6113728|NCT01054820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113729|NCT01054820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6113730|NCT01054820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6113731|NCT01054820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6113732|NCT01054820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6113733|NCT01054820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113734|NCT01054911|Sunitinib|sunitinib|mesh-list
6113735|NCT01054911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6113736|NCT01054911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6113737|NCT01054911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5529395|NCT05194293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5529396|NCT05194293|Immunologic Factors|immunologic factors|mesh-ancestor
5529397|NCT05194293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113738|NCT01054911|Growth Substances|growth substances|mesh-ancestor
6113739|NCT01054911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113740|NCT01054911|Growth Inhibitors|growth inhibitors|mesh-ancestor
6113741|NCT01054911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6113742|NCT01054911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6113743|NCT01054911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113744|NCT01054976|Galantamine|galantamine|mesh-list
6113745|NCT01054976|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6113746|NCT01054976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6113747|NCT01054976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113748|NCT01054976|Cholinergic Agents|cholinergic agents|mesh-ancestor
6113749|NCT01054976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6113750|NCT01054976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113751|NCT01054976|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6113752|NCT01054976|Autonomic Agents|autonomic agents|mesh-ancestor
6113753|NCT01054976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6113754|NCT01054976|Nootropic Agents|nootropic agents|mesh-ancestor
6113755|NCT01055028|Paclitaxel|paclitaxel|mesh-list
6113756|NCT01055028|Bevacizumab|bevacizumab|mesh-list
6113757|NCT01055028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6113758|NCT01055028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6113759|NCT01055028|Tubulin Modulators|tubulin modulators|mesh-ancestor
6113760|NCT01055028|Antimitotic Agents|antimitotic agents|mesh-ancestor
6113761|NCT01055028|Mitosis Modulators|mitosis modulators|mesh-ancestor
6113762|NCT01055028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113763|NCT01055028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6113764|NCT01055028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5529419|NCT05163041|Nivolumab|nivolumab|mesh-list
5529420|NCT05163041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5529421|NCT05163041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5529422|NCT05163041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5529423|NCT05163041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113765|NCT01055028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6113766|NCT01055028|Growth Substances|growth substances|mesh-ancestor
6113767|NCT01055028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113768|NCT01055028|Growth Inhibitors|growth inhibitors|mesh-ancestor
6113769|NCT01055171|Propranolol|propranolol|mesh-list
6113770|NCT01055171|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6113771|NCT01055171|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6113772|NCT01055171|Adrenergic Agents|adrenergic agents|mesh-ancestor
6113773|NCT01055171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6113774|NCT01055171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113775|NCT01055171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113776|NCT01055171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6113777|NCT01055171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6113778|NCT01055171|Vasodilator Agents|vasodilator agents|mesh-ancestor
5529438|NCT05141552|Dapagliflozin|dapagliflozin|mesh-list
6113779|NCT01055184|Vaccines|vaccines|mesh-list
6113780|NCT01055184|Immunologic Factors|immunologic factors|mesh-ancestor
6113781|NCT01055184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113782|NCT01055223|Troglitazone|troglitazone|mesh-list
6113783|NCT01055223|Amiloride|amiloride|mesh-list
6113784|NCT01055223|Spironolactone|spironolactone|mesh-list
6113785|NCT01055223|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6113786|NCT01055223|Hormone Antagonists|hormone antagonists|mesh-ancestor
6113787|NCT01055223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6113788|NCT01055223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113789|NCT01055223|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6113790|NCT01055223|Diuretics|diuretics|mesh-ancestor
6113791|NCT01055223|Natriuretic Agents|natriuretic agents|mesh-ancestor
6465558|NCT00475137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6465559|NCT00475137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6465560|NCT00475137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6465561|NCT00475189|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
6465562|NCT00475189|Norinyl|norinyl|mesh-list
6465563|NCT00475189|Mestranol|mestranol|mesh-list
6465564|NCT00475189|Norethindrone|norethindrone|mesh-list
6465565|NCT00475189|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6465566|NCT00475189|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6465567|NCT00475189|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6465568|NCT00475189|Contraceptive Agents|contraceptive agents|mesh-ancestor
6465569|NCT00475189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5529439|NCT05141552|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6113792|NCT01055223|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
6113793|NCT01055223|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6113794|NCT01055223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6113795|NCT01055223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113796|NCT01055223|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
6113797|NCT01055223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6113798|NCT01055314|Dactinomycin|dactinomycin|mesh-list
6113799|NCT01055314|Cyclophosphamide|cyclophosphamide|mesh-list
5529440|NCT05141552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5529441|NCT05141552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5529442|NCT05141552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5529443|NCT05121909|Listerine|listerine|mesh-list
5529444|NCT05121909|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
5529445|NCT05121909|Sodium Fluoride|sodium fluoride|mesh-list
6113800|NCT01055314|Temozolomide|temozolomide|mesh-list
6113801|NCT01055314|Ifosfamide|ifosfamide|mesh-list
6113802|NCT01055314|Isophosphamide mustard|isophosphamide mustard|mesh-list
6113803|NCT01055314|Doxorubicin|doxorubicin|mesh-list
6113804|NCT01055314|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6113805|NCT01055314|Irinotecan|irinotecan|mesh-list
6113806|NCT01055314|Etoposide|etoposide|mesh-list
6113807|NCT01055314|Vincristine|vincristine|mesh-list
5529446|NCT05121909|Cariostatic Agents|cariostatic agents|mesh-ancestor
5529447|NCT05121909|Protective Agents|protective agents|mesh-ancestor
5529448|NCT05121909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5529449|NCT05121909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6113808|NCT01055314|Etoposide phosphate|etoposide phosphate|mesh-list
6113809|NCT01055314|Podophyllotoxin|podophyllotoxin|mesh-list
6113810|NCT01055314|Camptothecin|camptothecin|mesh-list
6113811|NCT01055314|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5529454|NCT05082025|Fulvestrant|fulvestrant|mesh-list
5529455|NCT05082025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5529456|NCT05082025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5529457|NCT05082025|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5529458|NCT05082025|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5529459|NCT05082025|Hormone Antagonists|hormone antagonists|mesh-ancestor
5529460|NCT05082025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5529461|NCT05082025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113812|NCT01055314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6113813|NCT01055314|Immunologic Factors|immunologic factors|mesh-ancestor
6113814|NCT01055314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113815|NCT01055314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6113816|NCT01055314|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6113817|NCT01055314|Alkylating Agents|alkylating agents|mesh-ancestor
6113818|NCT01055314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113819|NCT01055314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6113820|NCT01055314|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6113821|NCT01055314|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6113822|NCT01055314|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6113823|NCT01055314|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6113824|NCT01055314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6113825|NCT01055314|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6113826|NCT01055314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6113827|NCT01055314|Tubulin Modulators|tubulin modulators|mesh-ancestor
6465570|NCT00475189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113828|NCT01055314|Antimitotic Agents|antimitotic agents|mesh-ancestor
6113829|NCT01055314|Mitosis Modulators|mitosis modulators|mesh-ancestor
6113830|NCT01055314|Keratolytic Agents|keratolytic agents|mesh-ancestor
6113831|NCT01055314|Dermatologic Agents|dermatologic agents|mesh-ancestor
6113832|NCT01055314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6113833|NCT01055314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6113834|NCT01055314|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6113835|NCT01055314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6113836|NCT01055457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6113837|NCT01055496|Gemcitabine|gemcitabine|mesh-list
6113838|NCT01055496|Dexamethasone|dexamethasone|mesh-list
6113839|NCT01055496|Prednisone|prednisone|mesh-list
6113840|NCT01055496|Cyclophosphamide|cyclophosphamide|mesh-list
6113841|NCT01055496|Rituximab|rituximab|mesh-list
6113842|NCT01055496|Vincristine|vincristine|mesh-list
6113843|NCT01055496|Cisplatin|cisplatin|mesh-list
6113844|NCT01055496|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
6113845|NCT01055496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6113846|NCT01055496|Immunologic Factors|immunologic factors|mesh-ancestor
6113847|NCT01055496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113848|NCT01055496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6113849|NCT01055496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6113850|NCT01055496|Alkylating Agents|alkylating agents|mesh-ancestor
6113851|NCT01055496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113852|NCT01055496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6113853|NCT01055496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6113854|NCT01055496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6113855|NCT01055496|Antiemetics|antiemetics|mesh-ancestor
6113856|NCT01055496|Autonomic Agents|autonomic agents|mesh-ancestor
6113857|NCT01055496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6113858|NCT01055496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6113859|NCT01055496|Glucocorticoids|glucocorticoids|mesh-ancestor
6113860|NCT01055496|Hormones|hormones|mesh-ancestor
6113861|NCT01055496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6113862|NCT01055496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6113863|NCT01055496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6113864|NCT01055496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6113865|NCT01055496|Antimetabolites|antimetabolites|mesh-ancestor
6113866|NCT01055496|Antiviral Agents|antiviral agents|mesh-ancestor
6113867|NCT01055496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6113868|NCT01055496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6113869|NCT01055496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5529467|NCT05050084|Leuprolide|leuprolide|mesh-list
5529468|NCT05050084|Goserelin|goserelin|mesh-list
5529469|NCT05050084|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5529470|NCT05050084|Flutamide|flutamide|mesh-list
5529471|NCT05050084|Bicalutamide|bicalutamide|mesh-list
5529472|NCT05050084|Tryptophan|tryptophan|mesh-list
5529473|NCT05050084|Buserelin|buserelin|mesh-list
6113870|NCT01055496|Tubulin Modulators|tubulin modulators|mesh-ancestor
6113871|NCT01055496|Antimitotic Agents|antimitotic agents|mesh-ancestor
6113872|NCT01055496|Mitosis Modulators|mitosis modulators|mesh-ancestor
6113873|NCT01055496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6113874|NCT01055613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6113875|NCT01055704|Naltrexone|naltrexone|mesh-list
6113876|NCT01055704|Codeine|codeine|mesh-list
6113877|NCT01055704|Methylnaltrexone|methylnaltrexone|mesh-list
6113878|NCT01055704|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6113879|NCT01055704|Narcotics|narcotics|mesh-ancestor
6113880|NCT01055704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6113881|NCT01055704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5529474|NCT05050084|Hormones|hormones|mesh-list
5529475|NCT05050084|Relugolix|relugolix|mesh-list
5601492|NCT05176951|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6113882|NCT01055704|Analgesics|analgesics|mesh-ancestor
6113883|NCT01055704|Sensory System Agents|sensory system agents|mesh-ancestor
6113884|NCT01055704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6113885|NCT01055704|Antitussive Agents|antitussive agents|mesh-ancestor
6113886|NCT01055704|Respiratory System Agents|respiratory system agents|mesh-ancestor
6113887|NCT01055704|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6113888|NCT01055704|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6113889|NCT01055769|Linezolid|linezolid|mesh-list
6113890|NCT01055769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6113891|NCT01055769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5529476|NCT05050084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5529477|NCT05050084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5529478|NCT05050084|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5529479|NCT05050084|Fertility Agents|fertility agents|mesh-ancestor
5529480|NCT05050084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5529481|NCT05050084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5529482|NCT05050084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5529483|NCT05050084|Androgen Antagonists|androgen antagonists|mesh-ancestor
5529484|NCT05050084|Hormone Antagonists|hormone antagonists|mesh-ancestor
5529485|NCT05050084|Luteolytic Agents|luteolytic agents|mesh-ancestor
5529486|NCT05050084|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5529487|NCT05050084|Contraceptive Agents|contraceptive agents|mesh-ancestor
5529488|NCT05050084|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5529489|NCT05050084|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5529490|NCT05050084|Antidepressive Agents|antidepressive agents|mesh-ancestor
5529491|NCT05050084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5529492|NCT05039619|Acetaminophen|acetaminophen|mesh-list
5529493|NCT05039619|Diphenhydramine|diphenhydramine|mesh-list
5529494|NCT05039619|Promethazine|promethazine|mesh-list
5529495|NCT05039619|Mycophenolic Acid|mycophenolic acid|mesh-list
5529496|NCT05039619|Prednisone|prednisone|mesh-list
5529497|NCT05039619|Methylprednisolone|methylprednisolone|mesh-list
5529498|NCT05039619|Obinutuzumab|obinutuzumab|mesh-list
5529499|NCT05039619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6113892|NCT01055769|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6113893|NCT01055769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6113894|NCT01055769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113895|NCT01055834|Eszopiclone|eszopiclone|mesh-list
6113896|NCT01055834|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6113897|NCT01055834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6113898|NCT01055834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113899|NCT01055886|Nicotine|nicotine|mesh-list
6113900|NCT01055886|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6113901|NCT01055886|Autonomic Agents|autonomic agents|mesh-ancestor
6113902|NCT01055886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6113903|NCT01055886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113904|NCT01055886|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6113905|NCT01055886|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6113906|NCT01055886|Cholinergic Agents|cholinergic agents|mesh-ancestor
6113907|NCT01055886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6204332|NCT02069041|Antidotes|antidotes|mesh-ancestor
6465571|NCT00475189|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6465572|NCT00475189|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6465573|NCT00475189|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
6465574|NCT00475189|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6465575|NCT00475189|Estrogens|estrogens|mesh-ancestor
6465576|NCT00475189|Hormones|hormones|mesh-ancestor
6465577|NCT00475189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6465578|NCT00475293|Panitumumab|panitumumab|mesh-list
6465579|NCT00475293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6465580|NCT00475293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6465581|NCT00475358|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6465582|NCT00475358|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6465583|NCT00475358|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6465584|NCT00475358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6465585|NCT00475358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465586|NCT00475358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6465587|NCT00475358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465588|NCT00475358|Analgesics|analgesics|mesh-ancestor
6465589|NCT00475358|Sensory System Agents|sensory system agents|mesh-ancestor
6465590|NCT00475358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6465591|NCT00475358|Antidepressive Agents|antidepressive agents|mesh-ancestor
6465592|NCT00475358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6113908|NCT01055886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113909|NCT01056107|Glucagon|glucagon|mesh-list
6113910|NCT01056107|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6113911|NCT01056107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6113912|NCT01056107|Hormones|hormones|mesh-ancestor
6113913|NCT01056107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6113914|NCT01056107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113915|NCT01056107|Incretins|incretins|mesh-ancestor
6113916|NCT01056263|Axitinib|axitinib|mesh-list
6113917|NCT01056263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6113918|NCT01056263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6113919|NCT01056263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6113920|NCT01056263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113921|NCT01056276|Dexamethasone|dexamethasone|mesh-list
6113922|NCT01056276|Bortezomib|bortezomib|mesh-list
6113923|NCT01056276|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6113924|NCT01056276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6113925|NCT01056276|Antiemetics|antiemetics|mesh-ancestor
6113926|NCT01056276|Autonomic Agents|autonomic agents|mesh-ancestor
6113927|NCT01056276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6113928|NCT01056276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113929|NCT01056276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6113930|NCT01056276|Glucocorticoids|glucocorticoids|mesh-ancestor
6113931|NCT01056276|Hormones|hormones|mesh-ancestor
6113932|NCT01056276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6113933|NCT01056276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6113934|NCT01056276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6113935|NCT01056276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6113936|NCT01056276|Alkylating Agents|alkylating agents|mesh-ancestor
6113937|NCT01056276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113938|NCT01056289|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6113939|NCT01056289|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6113940|NCT01056289|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6204333|NCT02069041|Protective Agents|protective agents|mesh-ancestor
6465593|NCT00475358|Dopamine Agents|dopamine agents|mesh-ancestor
6465594|NCT00475397|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6465595|NCT00475397|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6465596|NCT00475397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6465597|NCT00475397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5529500|NCT05039619|Glucocorticoids|glucocorticoids|mesh-ancestor
5529501|NCT05039619|Hormones|hormones|mesh-ancestor
5529502|NCT05039619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5529503|NCT05039619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5529504|NCT05039619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5529505|NCT05039619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5529506|NCT05039619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5529507|NCT05039619|Analgesics|analgesics|mesh-ancestor
5529508|NCT05039619|Sensory System Agents|sensory system agents|mesh-ancestor
6465598|NCT00475397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465599|NCT00475397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6465600|NCT00475397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465601|NCT00475397|Analgesics|analgesics|mesh-ancestor
6465602|NCT00475397|Sensory System Agents|sensory system agents|mesh-ancestor
6465603|NCT00475397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6465604|NCT00475397|Antidepressive Agents|antidepressive agents|mesh-ancestor
6465605|NCT00475397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6465606|NCT00475397|Dopamine Agents|dopamine agents|mesh-ancestor
6465607|NCT00475410|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
5529509|NCT05039619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5529510|NCT05039619|Antipyretics|antipyretics|mesh-ancestor
5529511|NCT05039619|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5529512|NCT05039619|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6465608|NCT00475410|Hemostatics|hemostatics|mesh-ancestor
6465609|NCT00475410|Coagulants|coagulants|mesh-ancestor
6465610|NCT00475462|Metoprolol|metoprolol|mesh-list
6465611|NCT00475462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6465612|NCT00475462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6465613|NCT00475462|Sympatholytics|sympatholytics|mesh-ancestor
6465614|NCT00475462|Autonomic Agents|autonomic agents|mesh-ancestor
6465615|NCT00475462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6465616|NCT00475462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465617|NCT00475462|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5529513|NCT05039619|Antitubercular Agents|antitubercular agents|mesh-ancestor
5529514|NCT05039619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5529515|NCT05039619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5529516|NCT05039619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5529517|NCT05039619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5529518|NCT05039619|Antiemetics|antiemetics|mesh-ancestor
5529519|NCT05039619|Autonomic Agents|autonomic agents|mesh-ancestor
5529520|NCT05039619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5529521|NCT05039619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5529522|NCT05039619|Protective Agents|protective agents|mesh-ancestor
5529523|NCT05039619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5529524|NCT05039619|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5529525|NCT05039619|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5529526|NCT05039619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6465618|NCT00475462|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6465619|NCT00475462|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6465620|NCT00475462|Adrenergic Agents|adrenergic agents|mesh-ancestor
6465621|NCT00475462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6465622|NCT00475462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465623|NCT00475514|Frovatriptan|frovatriptan|mesh-list
6465624|NCT00475514|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6465625|NCT00475514|Serotonin Agents|serotonin agents|mesh-ancestor
6465626|NCT00475514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6465627|NCT00475514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465628|NCT00475514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465629|NCT00475527|Amoxicillin|amoxicillin|mesh-list
6465630|NCT00475527|Metronidazole|metronidazole|mesh-list
6465631|NCT00475527|Clarithromycin|clarithromycin|mesh-list
6113941|NCT01056289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6113942|NCT01056289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5529527|NCT05039619|Anesthetics, Local|anesthetics, local|mesh-ancestor
5529528|NCT05039619|Anesthetics|anesthetics|mesh-ancestor
6113943|NCT01056289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6113944|NCT01056289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113945|NCT01056289|Antidepressive Agents|antidepressive agents|mesh-ancestor
6113946|NCT01056289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6204334|NCT02069041|Vitamin B Complex|vitamin b complex|mesh-ancestor
6204335|NCT02069041|Vitamins|vitamins|mesh-ancestor
6204336|NCT02069041|Micronutrients|micronutrients|mesh-ancestor
6204337|NCT02069093|Dexamethasone|dexamethasone|mesh-list
6204338|NCT02069093|Everolimus|everolimus|mesh-list
6204339|NCT02069093|Exemestane|exemestane|mesh-list
6204340|NCT02069093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6204341|NCT02069093|Antiemetics|antiemetics|mesh-ancestor
6204342|NCT02069093|Autonomic Agents|autonomic agents|mesh-ancestor
6204343|NCT02069093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6204344|NCT02069093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204345|NCT02069093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6465632|NCT00475527|Omeprazole|omeprazole|mesh-list
5529529|NCT05039619|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5529530|NCT05039619|Histamine Antagonists|histamine antagonists|mesh-ancestor
6113947|NCT01056341|Propranolol|propranolol|mesh-list
6113948|NCT01056341|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6113949|NCT01056341|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6113950|NCT01056341|Adrenergic Agents|adrenergic agents|mesh-ancestor
6113951|NCT01056341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6113952|NCT01056341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113953|NCT01056341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113954|NCT01056341|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6113955|NCT01056341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6113956|NCT01056341|Vasodilator Agents|vasodilator agents|mesh-ancestor
6113957|NCT01056380|Nitazoxanide|nitazoxanide|mesh-list
6113958|NCT01056380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6113959|NCT01056380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6113960|NCT01056510|Rituximab|rituximab|mesh-list
6113961|NCT01056510|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6113962|NCT01056510|Chlorambucil|chlorambucil|mesh-list
6113963|NCT01056510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6113964|NCT01056510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6113965|NCT01056510|Immunologic Factors|immunologic factors|mesh-ancestor
6113966|NCT01056510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113967|NCT01056510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6113968|NCT01056510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6113969|NCT01056510|Alkylating Agents|alkylating agents|mesh-ancestor
6113970|NCT01056510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113971|NCT01056523|Cytarabine|cytarabine|mesh-list
6113972|NCT01056523|Ribavirin|ribavirin|mesh-list
6113973|NCT01056523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6113974|NCT01056523|Antimetabolites|antimetabolites|mesh-ancestor
6113975|NCT01056523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113976|NCT01056523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6113977|NCT01056523|Antiviral Agents|antiviral agents|mesh-ancestor
6113978|NCT01056523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6113979|NCT01056523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6113980|NCT01056523|Immunologic Factors|immunologic factors|mesh-ancestor
6113981|NCT01056523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113982|NCT01056601|Bortezomib|bortezomib|mesh-list
6113983|NCT01056601|Panobinostat|panobinostat|mesh-list
6113984|NCT01056601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6113985|NCT01056601|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6113986|NCT01056601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6113987|NCT01056601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113988|NCT01056718|Nebivolol|nebivolol|mesh-list
6113989|NCT01056718|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6113990|NCT01056718|Vasodilator Agents|vasodilator agents|mesh-ancestor
6113991|NCT01056718|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6113992|NCT01056718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6113993|NCT01056718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6113994|NCT01056718|Adrenergic Agents|adrenergic agents|mesh-ancestor
6113995|NCT01056718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6113996|NCT01056718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6113997|NCT01056718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6113998|NCT01057017|Panitumumab|panitumumab|mesh-list
6113999|NCT01057017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6114000|NCT01057017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6114001|NCT01057225|Thalidomide|thalidomide|mesh-list
6114002|NCT01057225|Dexamethasone|dexamethasone|mesh-list
6114003|NCT01057225|Cyclophosphamide|cyclophosphamide|mesh-list
6114004|NCT01057225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6114005|NCT01057225|Immunologic Factors|immunologic factors|mesh-ancestor
6114006|NCT01057225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114007|NCT01057225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6114008|NCT01057225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6114009|NCT01057225|Alkylating Agents|alkylating agents|mesh-ancestor
6114010|NCT01057225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114011|NCT01057225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5529531|NCT05039619|Histamine Agents|histamine agents|mesh-ancestor
5529532|NCT05039619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5529533|NCT05039619|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5529534|NCT05039619|Antipruritics|antipruritics|mesh-ancestor
5529535|NCT05039619|Dermatologic Agents|dermatologic agents|mesh-ancestor
6114012|NCT01057225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6114013|NCT01057225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6114014|NCT01057225|Antiemetics|antiemetics|mesh-ancestor
6114015|NCT01057225|Autonomic Agents|autonomic agents|mesh-ancestor
6114016|NCT01057225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6114017|NCT01057225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6114018|NCT01057225|Glucocorticoids|glucocorticoids|mesh-ancestor
6114019|NCT01057225|Hormones|hormones|mesh-ancestor
6114020|NCT01057225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6114021|NCT01057225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6114022|NCT01057225|Leprostatic Agents|leprostatic agents|mesh-ancestor
6114023|NCT01057225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6114024|NCT01057225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6114025|NCT01057225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6114026|NCT01057225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6114027|NCT01057225|Growth Substances|growth substances|mesh-ancestor
6114028|NCT01057225|Growth Inhibitors|growth inhibitors|mesh-ancestor
6114029|NCT01057251|Nebivolol|nebivolol|mesh-list
6114030|NCT01057251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6114031|NCT01057251|Vasodilator Agents|vasodilator agents|mesh-ancestor
6114032|NCT01057251|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6114033|NCT01057251|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6114034|NCT01057251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6114035|NCT01057251|Adrenergic Agents|adrenergic agents|mesh-ancestor
6114036|NCT01057251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6114037|NCT01057251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114038|NCT01057251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114039|NCT01057277|Everolimus|everolimus|mesh-list
6114040|NCT01057277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6114041|NCT01057277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6114042|NCT01057277|Immunologic Factors|immunologic factors|mesh-ancestor
6114043|NCT01057277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114044|NCT01057381|Dexmedetomidine|dexmedetomidine|mesh-list
6114045|NCT01057381|Morphine|morphine|mesh-list
6114046|NCT01057381|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6114047|NCT01057381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6114048|NCT01057381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114049|NCT01057381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6114050|NCT01057381|Analgesics|analgesics|mesh-ancestor
6114051|NCT01057381|Sensory System Agents|sensory system agents|mesh-ancestor
6114052|NCT01057381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6114053|NCT01057381|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6114054|NCT01057381|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6114055|NCT01057381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6114056|NCT01057381|Adrenergic Agents|adrenergic agents|mesh-ancestor
6114057|NCT01057381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6114058|NCT01057381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114059|NCT01057381|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6114060|NCT01057381|Narcotics|narcotics|mesh-ancestor
6114061|NCT01057433|Ritonavir|ritonavir|mesh-list
6114062|NCT01057433|Lopinavir|lopinavir|mesh-list
5529573|NCT05025787|Celecoxib|celecoxib|mesh-list
5529574|NCT05025787|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5529575|NCT05025787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5529576|NCT05025787|Analgesics|analgesics|mesh-ancestor
5529577|NCT05025787|Sensory System Agents|sensory system agents|mesh-ancestor
5529578|NCT05025787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5529579|NCT05025787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5529580|NCT05025787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5529581|NCT05025787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5529582|NCT05025787|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5529583|NCT05025787|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5529584|NCT05025787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5529585|NCT05025787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114063|NCT01057433|Pitavastatin|pitavastatin|mesh-list
6114064|NCT01057433|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6114065|NCT01057433|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5529589|NCT04993352|Antibodies|antibodies|mesh-list
5529590|NCT04993352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5529591|NCT04993352|Mitogens|mitogens|mesh-list
5529592|NCT04993352|Endothelial Growth Factors|endothelial growth factors|mesh-list
5529593|NCT04993352|Immunologic Factors|immunologic factors|mesh-ancestor
5529594|NCT04993352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5529595|NCT04993352|Mitosis Modulators|mitosis modulators|mesh-ancestor
5529596|NCT04993352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5529597|NCT04993352|Growth Substances|growth substances|mesh-ancestor
6114066|NCT01057433|Protease Inhibitors|protease inhibitors|mesh-ancestor
6114067|NCT01057433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5529598|NCT04982354|Fludarabine|fludarabine|mesh-list
5529599|NCT04982354|Melphalan|melphalan|mesh-list
5529600|NCT04982354|Busulfan|busulfan|mesh-list
5529601|NCT04982354|Midostaurin|midostaurin|mesh-list
5529602|NCT04982354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5529603|NCT04982354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5529604|NCT04982354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5529605|NCT04982354|Immunologic Factors|immunologic factors|mesh-ancestor
6465633|NCT00475527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6465634|NCT00475527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6114068|NCT01057433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114069|NCT01057433|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6114070|NCT01057433|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6114071|NCT01057433|Antiviral Agents|antiviral agents|mesh-ancestor
6114072|NCT01057433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6114073|NCT01057433|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6114074|NCT01057433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6114075|NCT01057433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6114076|NCT01057433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6114077|NCT01057433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6114078|NCT01057433|Antimetabolites|antimetabolites|mesh-ancestor
6465635|NCT00475527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6465636|NCT00475527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6465637|NCT00475527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6465638|NCT00475527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6465639|NCT00475527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6465640|NCT00475527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6465641|NCT00475527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465642|NCT00475527|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6465643|NCT00475527|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6465644|NCT00475527|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6465645|NCT00475553|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6465646|NCT00475553|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6465647|NCT00475553|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6465648|NCT00475553|Etonogestrel|etonogestrel|mesh-list
6465649|NCT00475553|Desogestrel|desogestrel|mesh-list
6465650|NCT00475553|NuvaRing|nuvaring|mesh-list
6465651|NCT00475553|Estradiol|estradiol|mesh-list
6114079|NCT01057433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6114080|NCT01057589|Folic Acid|folic acid|mesh-list
5529606|NCT04982354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5529607|NCT04982354|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5529608|NCT04982354|Alkylating Agents|alkylating agents|mesh-ancestor
5529609|NCT04982354|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5529610|NCT04982354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5529611|NCT04982354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5529612|NCT04980027|Insulin Glargine|insulin glargine|mesh-list
5529613|NCT04980027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5529614|NCT04980027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5529615|NCT04978493|Ustekinumab|ustekinumab|mesh-list
5529616|NCT04978493|Dermatologic Agents|dermatologic agents|mesh-ancestor
6114081|NCT01057589|Vitamin B 12|vitamin b 12|mesh-list
6114082|NCT01057589|Hydroxocobalamin|hydroxocobalamin|mesh-list
6114083|NCT01057589|Pemetrexed|pemetrexed|mesh-list
6114084|NCT01057589|Cetuximab|cetuximab|mesh-list
5529621|NCT04962503|Afamelanotide|afamelanotide|mesh-list
5529622|NCT04962503|Dermatologic Agents|dermatologic agents|mesh-ancestor
6114085|NCT01057589|Vitamins|vitamins|mesh-ancestor
6114086|NCT01057589|Micronutrients|micronutrients|mesh-ancestor
6114087|NCT01057589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114088|NCT01057589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6114089|NCT01057589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6114090|NCT01057589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114091|NCT01057589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6114092|NCT01057589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6114093|NCT01057589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6114094|NCT01057589|Hematinics|hematinics|mesh-ancestor
6114095|NCT01057589|Vitamin B Complex|vitamin b complex|mesh-ancestor
6114096|NCT01057693|Pregabalin|pregabalin|mesh-list
6114097|NCT01057693|Analgesics|analgesics|mesh-ancestor
6114098|NCT01057693|Sensory System Agents|sensory system agents|mesh-ancestor
6114099|NCT01057693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6114100|NCT01057693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114101|NCT01057693|Anticonvulsants|anticonvulsants|mesh-ancestor
6114102|NCT01057693|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6114103|NCT01057693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6465652|NCT00475553|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6114104|NCT01057693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114105|NCT01057693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6114106|NCT01057693|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6114107|NCT01057693|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6114108|NCT01057693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6114109|NCT01057693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6465653|NCT00475553|Estrogens|estrogens|mesh-ancestor
6465654|NCT00475553|Hormones|hormones|mesh-ancestor
6465655|NCT00475553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6465656|NCT00475553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465657|NCT00475553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6465658|NCT00475553|Contraceptive Agents|contraceptive agents|mesh-ancestor
6465659|NCT00475553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6465660|NCT00475553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5529625|NCT04938882|Lidocaine|lidocaine|mesh-list
5529626|NCT04938882|Ropivacaine|ropivacaine|mesh-list
5529627|NCT04938882|Anesthetics, Local|anesthetics, local|mesh-ancestor
6465661|NCT00475553|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6465662|NCT00475553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6465663|NCT00475553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6465664|NCT00475553|Progestins|progestins|mesh-ancestor
6114110|NCT01057810|Ipilimumab|ipilimumab|mesh-list
6114111|NCT01057810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6114112|NCT01057810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6114113|NCT01057810|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6114114|NCT01057810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114115|NCT01057862|Naltrexone|naltrexone|mesh-list
6114116|NCT01057862|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6114117|NCT01057862|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6114118|NCT01057862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114119|NCT01057862|Sensory System Agents|sensory system agents|mesh-ancestor
6114120|NCT01057862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6114121|NCT01058005|Interferons|interferons|mesh-list
6114122|NCT01058005|Interferon-beta|interferon-beta|mesh-list
6114123|NCT01058005|Interferon beta-1a|interferon beta-1a|mesh-list
6114124|NCT01058005|Glatiramer Acetate|glatiramer acetate|mesh-list
6114125|NCT01058005|Natalizumab|natalizumab|mesh-list
5529628|NCT04938882|Anesthetics|anesthetics|mesh-ancestor
5529629|NCT04938882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5529630|NCT04938882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5529631|NCT04938882|Sensory System Agents|sensory system agents|mesh-ancestor
5529632|NCT04938882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5529633|NCT04938882|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5529634|NCT04938882|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5529635|NCT04938882|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5529636|NCT04938882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5529637|NCT04938882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5529638|NCT04933903|Nivolumab|nivolumab|mesh-list
5529639|NCT04933903|Ipilimumab|ipilimumab|mesh-list
5529640|NCT04933903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5529641|NCT04933903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5529642|NCT04933903|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5529643|NCT04933903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114126|NCT01058005|(T,G)-A-L|(t,g)-a-l|mesh-list
6114127|NCT01058005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6114128|NCT01058005|Antiviral Agents|antiviral agents|mesh-ancestor
6114129|NCT01058005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6114130|NCT01058005|Immunologic Factors|immunologic factors|mesh-ancestor
6114131|NCT01058005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114132|NCT01058005|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6114133|NCT01058005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6114134|NCT01058005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6114135|NCT01058096|Cariprazine|cariprazine|mesh-list
6114136|NCT01058096|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6114137|NCT01058096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6114138|NCT01058096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6114139|NCT01058096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114140|NCT01058096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6114141|NCT01058239|Rituximab|rituximab|mesh-list
6114142|NCT01058239|Bortezomib|bortezomib|mesh-list
6114143|NCT01058239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6114144|NCT01058239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6114145|NCT01058239|Immunologic Factors|immunologic factors|mesh-ancestor
5601493|NCT05176821|Amoxicillin|amoxicillin|mesh-list
6465665|NCT00475566|Everolimus|everolimus|mesh-list
6114146|NCT01058239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114147|NCT01058239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6114148|NCT01058395|Minocycline|minocycline|mesh-list
6114149|NCT01058395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6114150|NCT01058395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6114151|NCT01058655|Everolimus|everolimus|mesh-list
6114152|NCT01058655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6114153|NCT01058655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6114154|NCT01058655|Immunologic Factors|immunologic factors|mesh-ancestor
6114155|NCT01058655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114156|NCT01058668|Cariprazine|cariprazine|mesh-list
6114157|NCT01058668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6114158|NCT01058668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6114159|NCT01058668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6114160|NCT01058668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114161|NCT01058668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6114162|NCT01058863|Albuterol|albuterol|mesh-list
6114163|NCT01058863|Procaterol|procaterol|mesh-list
6114164|NCT01058863|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6114165|NCT01058863|Autonomic Agents|autonomic agents|mesh-ancestor
6114166|NCT01058863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6114167|NCT01058863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114168|NCT01058863|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6114169|NCT01058863|Respiratory System Agents|respiratory system agents|mesh-ancestor
6114170|NCT01058863|Tocolytic Agents|tocolytic agents|mesh-ancestor
6114171|NCT01058863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6114172|NCT01058863|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6114173|NCT01058863|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6114174|NCT01058863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6114175|NCT01058863|Adrenergic Agents|adrenergic agents|mesh-ancestor
6114176|NCT01058863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6114177|NCT01058863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114178|NCT01058863|Sympathomimetics|sympathomimetics|mesh-ancestor
6114179|NCT01058941|Thioctic Acid|thioctic acid|mesh-list
6114180|NCT01058941|Antioxidants|antioxidants|mesh-ancestor
6114181|NCT01058941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114182|NCT01058941|Protective Agents|protective agents|mesh-ancestor
5529686|NCT04915729|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5529687|NCT04915729|Tenecteplase|tenecteplase|mesh-list
5529688|NCT04915729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5529689|NCT04915729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5529690|NCT04915729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114183|NCT01058941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114184|NCT01058941|Vitamin B Complex|vitamin b complex|mesh-ancestor
6114185|NCT01058941|Vitamins|vitamins|mesh-ancestor
6114186|NCT01058941|Micronutrients|micronutrients|mesh-ancestor
6114187|NCT01058993|Plerixafor|plerixafor|mesh-list
6114188|NCT01058993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5601494|NCT05176821|Furazolidone|furazolidone|mesh-list
6114189|NCT01058993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6114190|NCT01058993|Antiviral Agents|antiviral agents|mesh-ancestor
6114191|NCT01058993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6114192|NCT01059071|Eflornithine|eflornithine|mesh-list
6114193|NCT01059071|Etoposide|etoposide|mesh-list
6114194|NCT01059071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6114195|NCT01059071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6114196|NCT01059071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6114197|NCT01059071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6114198|NCT01059071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6114199|NCT01059071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114200|NCT01059071|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6114201|NCT01059071|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6114202|NCT01059071|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6114203|NCT01059071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6114204|NCT01059071|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
6114205|NCT01059305|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6114206|NCT01059305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6114207|NCT01059305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6114208|NCT01059305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6114209|NCT01059305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114210|NCT01059318|Everolimus|everolimus|mesh-list
6114211|NCT01059318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6114212|NCT01059318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6114213|NCT01059318|Immunologic Factors|immunologic factors|mesh-ancestor
6114214|NCT01059318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114215|NCT01059526|Ecallantide|ecallantide|mesh-list
6114216|NCT01059526|Analgesics|analgesics|mesh-ancestor
6114217|NCT01059526|Sensory System Agents|sensory system agents|mesh-ancestor
6114218|NCT01059526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6114219|NCT01059526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114220|NCT01059526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6114221|NCT01059526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6114222|NCT01059526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6114223|NCT01059526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6114224|NCT01059539|Cariprazine|cariprazine|mesh-list
6114225|NCT01059539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6114226|NCT01059539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6114227|NCT01059539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6114228|NCT01059539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114229|NCT01059539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6114230|NCT01059617|Vaccines|vaccines|mesh-list
6114231|NCT01059617|Immunologic Factors|immunologic factors|mesh-ancestor
6114232|NCT01059617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114233|NCT01059630|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6114234|NCT01059630|Obinutuzumab|obinutuzumab|mesh-list
6114235|NCT01059630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6114236|NCT01059630|Alkylating Agents|alkylating agents|mesh-ancestor
6114237|NCT01059630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114238|NCT01059630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6114239|NCT01059630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6114240|NCT01059682|Dalcetrapib|dalcetrapib|mesh-list
6114241|NCT01059682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6114242|NCT01059682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6114243|NCT01059682|Antimetabolites|antimetabolites|mesh-ancestor
6114244|NCT01059682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114245|NCT01059682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6114246|NCT01059773|Methotrexate|methotrexate|mesh-list
6114247|NCT01059773|Ustekinumab|ustekinumab|mesh-list
6114248|NCT01059773|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6114249|NCT01059773|Abortifacient Agents|abortifacient agents|mesh-ancestor
6114250|NCT01059773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6114251|NCT01059773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114252|NCT01059773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6114253|NCT01059773|Antimetabolites|antimetabolites|mesh-ancestor
6114254|NCT01059773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114255|NCT01059773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6114256|NCT01059773|Dermatologic Agents|dermatologic agents|mesh-ancestor
6114257|NCT01059773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5529699|NCT04911517|Capecitabine|capecitabine|mesh-list
5529700|NCT04911517|Antibodies|antibodies|mesh-list
5529701|NCT04911517|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5529702|NCT04911517|Immunologic Factors|immunologic factors|mesh-ancestor
5529703|NCT04911517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114258|NCT01059773|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6114259|NCT01059773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6114260|NCT01059773|Immunologic Factors|immunologic factors|mesh-ancestor
6114261|NCT01059773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6114262|NCT01059773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6114263|NCT01059799|Insulin|insulin|mesh-list
6114264|NCT01059799|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6114265|NCT01059799|Insulin Glargine|insulin glargine|mesh-list
6114266|NCT01059799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6114267|NCT01059799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114268|NCT01059812|Insulin|insulin|mesh-list
6114269|NCT01059812|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6114270|NCT01059812|Insulin Aspart|insulin aspart|mesh-list
6114271|NCT01059812|Insulin, Long-Acting|insulin, long-acting|mesh-list
6114272|NCT01059812|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6114273|NCT01059812|Biphasic Insulins|biphasic insulins|mesh-list
6114274|NCT01059812|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6114275|NCT01059812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6114276|NCT01059812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114277|NCT01059825|Metformin|metformin|mesh-list
6114278|NCT01059825|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6114279|NCT01059825|Ertugliflozin|ertugliflozin|mesh-list
6114280|NCT01059825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5529704|NCT04911517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5529705|NCT04911517|Antimetabolites|antimetabolites|mesh-ancestor
5529706|NCT04911517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5529707|NCT04911517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5529708|NCT04910568|Dexamethasone|dexamethasone|mesh-list
5529709|NCT04910568|Daratumumab|daratumumab|mesh-list
5529710|NCT04910568|Pomalidomide|pomalidomide|mesh-list
5529711|NCT04910568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5529712|NCT04910568|Antiemetics|antiemetics|mesh-ancestor
5529713|NCT04910568|Autonomic Agents|autonomic agents|mesh-ancestor
5529714|NCT04910568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5529715|NCT04910568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5529716|NCT04910568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5529717|NCT04910568|Glucocorticoids|glucocorticoids|mesh-ancestor
5529718|NCT04910568|Hormones|hormones|mesh-ancestor
5529719|NCT04910568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6114281|NCT01059825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114282|NCT01059825|Incretins|incretins|mesh-ancestor
6114283|NCT01059825|Hormones|hormones|mesh-ancestor
6114284|NCT01059825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6114285|NCT01059825|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5529720|NCT04910568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5529721|NCT04910568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5529722|NCT04910568|Immunologic Factors|immunologic factors|mesh-ancestor
5529723|NCT04910568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6114286|NCT01059825|Protease Inhibitors|protease inhibitors|mesh-ancestor
6114287|NCT01059825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6114288|NCT01059825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114289|NCT01059825|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6114290|NCT01059851|Suvorexant|suvorexant|mesh-list
6114291|NCT01059851|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6114292|NCT01059851|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6114293|NCT01059851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6114294|NCT01059851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114295|NCT01059851|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
6114296|NCT01059851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6114297|NCT01059851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114298|NCT01059864|Atorvastatin|atorvastatin|mesh-list
6114299|NCT01059864|Tofacitinib|tofacitinib|mesh-list
6114300|NCT01059864|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5529724|NCT04910568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5529725|NCT04910568|Growth Substances|growth substances|mesh-ancestor
5529726|NCT04910568|Growth Inhibitors|growth inhibitors|mesh-ancestor
6114301|NCT01059864|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6114302|NCT01059864|Antimetabolites|antimetabolites|mesh-ancestor
6114303|NCT01059864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114304|NCT01059864|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6114305|NCT01059864|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6114306|NCT01059864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6114307|NCT01059864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6114308|NCT01059903|Rotigotine|rotigotine|mesh-list
6114309|NCT01059903|Dopamine Agonists|dopamine agonists|mesh-ancestor
6114310|NCT01059903|Dopamine Agents|dopamine agents|mesh-ancestor
6114311|NCT01059903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6114312|NCT01059903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114313|NCT01059903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114314|NCT01059929|Fentanyl|fentanyl|mesh-list
6114315|NCT01059929|Midazolam|midazolam|mesh-list
6114316|NCT01059929|Dexmedetomidine|dexmedetomidine|mesh-list
6114317|NCT01059929|Propofol|propofol|mesh-list
6114318|NCT01059929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6114319|NCT01059929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6114320|NCT01059929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204346|NCT02069093|Glucocorticoids|glucocorticoids|mesh-ancestor
5601495|NCT05176821|Potassium Citrate|potassium citrate|mesh-list
6114321|NCT01059929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6114322|NCT01059929|Anesthetics, General|anesthetics, general|mesh-ancestor
6114323|NCT01059929|Anesthetics|anesthetics|mesh-ancestor
6114324|NCT01059929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6114325|NCT01059929|Analgesics|analgesics|mesh-ancestor
6114326|NCT01059929|Sensory System Agents|sensory system agents|mesh-ancestor
6114327|NCT01059929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6114328|NCT01059929|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6114329|NCT01059929|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6114330|NCT01059929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6114331|NCT01059929|Adrenergic Agents|adrenergic agents|mesh-ancestor
6114332|NCT01059929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6114333|NCT01059929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114334|NCT01059929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6114335|NCT01059929|Narcotics|narcotics|mesh-ancestor
6114336|NCT01059929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6114337|NCT01059929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6114338|NCT01059929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6114339|NCT01059929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6114340|NCT01059929|GABA Modulators|gaba modulators|mesh-ancestor
6114341|NCT01059929|GABA Agents|gaba agents|mesh-ancestor
6114342|NCT01059994|Sildenafil Citrate|sildenafil citrate|mesh-list
6114343|NCT01059994|Vasodilator Agents|vasodilator agents|mesh-ancestor
6114344|NCT01059994|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6114345|NCT01059994|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6114346|NCT01059994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6114347|NCT01059994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114348|NCT01059994|Urological Agents|urological agents|mesh-ancestor
6114349|NCT01060007|Leucovorin|leucovorin|mesh-list
6114350|NCT01060007|Fluorouracil|fluorouracil|mesh-list
6114351|NCT01060007|Capecitabine|capecitabine|mesh-list
6114352|NCT01060007|Oxaliplatin|oxaliplatin|mesh-list
6114353|NCT01060007|Antimetabolites|antimetabolites|mesh-ancestor
5529742|NCT04886232|Lidocaine|lidocaine|mesh-list
5529743|NCT04886232|Anesthetics, Local|anesthetics, local|mesh-ancestor
5529744|NCT04886232|Anesthetics|anesthetics|mesh-ancestor
5529745|NCT04886232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5529746|NCT04886232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5529747|NCT04886232|Sensory System Agents|sensory system agents|mesh-ancestor
5529748|NCT04886232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5529749|NCT04886232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5529750|NCT04886232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5529751|NCT04886232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5529752|NCT04886232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5529753|NCT04886232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5529754|NCT04865978|Warfarin|warfarin|mesh-list
5529755|NCT04865978|Apixaban|apixaban|mesh-list
5529756|NCT04865978|Anticoagulants|anticoagulants|mesh-ancestor
5529757|NCT04865978|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5529758|NCT04865978|Antithrombins|antithrombins|mesh-ancestor
5529759|NCT04865978|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5529760|NCT04865978|Protease Inhibitors|protease inhibitors|mesh-ancestor
5529761|NCT04865978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5529762|NCT04865978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5529763|NCT04846868|BI 425809|bi 425809|mesh-list
5529764|NCT04846868|Nootropic Agents|nootropic agents|mesh-ancestor
6114354|NCT01060007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114355|NCT01060007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6114356|NCT01060007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6114357|NCT01060007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6114358|NCT01060007|Immunologic Factors|immunologic factors|mesh-ancestor
6114359|NCT01060007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114360|NCT01060007|Antidotes|antidotes|mesh-ancestor
6114361|NCT01060007|Protective Agents|protective agents|mesh-ancestor
5529765|NCT04816513|Ustekinumab|ustekinumab|mesh-list
6114362|NCT01060007|Vitamin B Complex|vitamin b complex|mesh-ancestor
6114363|NCT01060007|Vitamins|vitamins|mesh-ancestor
6114364|NCT01060007|Micronutrients|micronutrients|mesh-ancestor
6114365|NCT01060020|Sildenafil Citrate|sildenafil citrate|mesh-list
6114366|NCT01060020|Vasodilator Agents|vasodilator agents|mesh-ancestor
6114367|NCT01060020|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6114368|NCT01060020|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6114369|NCT01060020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6114370|NCT01060020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114371|NCT01060020|Urological Agents|urological agents|mesh-ancestor
6114372|NCT01060059|Exenatide|exenatide|mesh-list
6114373|NCT01060059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6114374|NCT01060059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114375|NCT01060059|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6114376|NCT01060059|Incretins|incretins|mesh-ancestor
6114377|NCT01060059|Hormones|hormones|mesh-ancestor
6114378|NCT01060059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6114379|NCT01060072|Loteprednol Etabonate|loteprednol etabonate|mesh-list
6114380|NCT01060072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6114381|NCT01060098|Adalimumab|adalimumab|mesh-list
6114382|NCT01060098|Etanercept|etanercept|mesh-list
6114383|NCT01060098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6114384|NCT01060098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6114385|NCT01060098|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6114386|NCT01060098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6114387|NCT01060098|Analgesics|analgesics|mesh-ancestor
6114388|NCT01060098|Sensory System Agents|sensory system agents|mesh-ancestor
6114389|NCT01060098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6114390|NCT01060098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114391|NCT01060098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6114392|NCT01060098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6114393|NCT01060098|Immunologic Factors|immunologic factors|mesh-ancestor
6114394|NCT01060111|Topiramate|topiramate|mesh-list
6114395|NCT01060111|Propranolol|propranolol|mesh-list
6114396|NCT01060111|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6114397|NCT01060111|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6114398|NCT01060111|Adrenergic Agents|adrenergic agents|mesh-ancestor
6114399|NCT01060111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6114400|NCT01060111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114401|NCT01060111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114402|NCT01060111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6114403|NCT01060111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6114404|NCT01060111|Vasodilator Agents|vasodilator agents|mesh-ancestor
6114405|NCT01060111|Anticonvulsants|anticonvulsants|mesh-ancestor
6114406|NCT01060111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6114407|NCT01060124|Fentanyl|fentanyl|mesh-list
6114408|NCT01060124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6114409|NCT01060124|Narcotics|narcotics|mesh-ancestor
6114410|NCT01060124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6114411|NCT01060124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114412|NCT01060124|Analgesics|analgesics|mesh-ancestor
6114413|NCT01060124|Sensory System Agents|sensory system agents|mesh-ancestor
5529766|NCT04816513|Dermatologic Agents|dermatologic agents|mesh-ancestor
5529767|NCT04804735|Anesthetics|anesthetics|mesh-list
5529768|NCT04804735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5529769|NCT04804735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114414|NCT01060124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6114415|NCT01060124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6114416|NCT01060124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6114417|NCT01060124|Anesthetics, General|anesthetics, general|mesh-ancestor
6114418|NCT01060124|Anesthetics|anesthetics|mesh-ancestor
6114419|NCT01060150|Methylphenidate|methylphenidate|mesh-list
6114420|NCT01060150|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6114421|NCT01060150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114422|NCT01060150|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6114423|NCT01060150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6114424|NCT01060150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6114425|NCT01060150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114426|NCT01060150|Dopamine Agents|dopamine agents|mesh-ancestor
6114427|NCT01060150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6114428|NCT01060384|Lenalidomide|lenalidomide|mesh-list
6114429|NCT01060384|Ofatumumab|ofatumumab|mesh-list
6114430|NCT01060384|Immunologic Factors|immunologic factors|mesh-ancestor
6114431|NCT01060384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114432|NCT01060384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6114433|NCT01060384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6114434|NCT01060384|Growth Substances|growth substances|mesh-ancestor
6114435|NCT01060384|Growth Inhibitors|growth inhibitors|mesh-ancestor
6114436|NCT01060384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6114437|NCT01061034|Aspirin|aspirin|mesh-list
6114438|NCT01061034|Omeprazole|omeprazole|mesh-list
6114439|NCT01061034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6114440|NCT01061034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6114441|NCT01061034|Analgesics|analgesics|mesh-ancestor
6114442|NCT01061034|Sensory System Agents|sensory system agents|mesh-ancestor
6114443|NCT01061034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6114444|NCT01061034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114445|NCT01061034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6114446|NCT01061034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6114447|NCT01061034|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6114448|NCT01061034|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6114449|NCT01061034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114450|NCT01061034|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6465666|NCT00475566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6465667|NCT00475566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6465668|NCT00475566|Immunologic Factors|immunologic factors|mesh-ancestor
6465669|NCT00475566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465670|NCT00475618|Fluorides|fluorides|mesh-list
6465671|NCT00475618|Fluorides, Topical|fluorides, topical|mesh-list
6465672|NCT00475618|Cariostatic Agents|cariostatic agents|mesh-ancestor
6465673|NCT00475618|Protective Agents|protective agents|mesh-ancestor
6465674|NCT00475618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465675|NCT00475696|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6465676|NCT00475696|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6114451|NCT01061034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6114452|NCT01061034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6114453|NCT01061034|Antipyretics|antipyretics|mesh-ancestor
6114454|NCT01061034|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6114455|NCT01061034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6114456|NCT01061034|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6114457|NCT01061333|Mometasone Furoate|mometasone furoate|mesh-list
6114458|NCT01061333|Nedocromil|nedocromil|mesh-list
6114459|NCT01061333|Montelukast|montelukast|mesh-list
6114460|NCT01061333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6114461|NCT01061333|Respiratory System Agents|respiratory system agents|mesh-ancestor
6114462|NCT01061333|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6114463|NCT01061333|Hormone Antagonists|hormone antagonists|mesh-ancestor
6114464|NCT01061333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6114465|NCT01061333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114466|NCT01061333|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6114467|NCT01061333|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6114468|NCT01061333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114469|NCT01061333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6114470|NCT01061333|Dermatologic Agents|dermatologic agents|mesh-ancestor
6114471|NCT01061333|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6114472|NCT01061333|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
6114473|NCT01061333|Immunologic Factors|immunologic factors|mesh-ancestor
6114474|NCT01061359|Epirubicin|epirubicin|mesh-list
6114475|NCT01061359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6114476|NCT01061359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6114477|NCT01061359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6114478|NCT01061359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6114479|NCT01061359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6114480|NCT01061359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114481|NCT01061528|Nicotine|nicotine|mesh-list
6114482|NCT01061528|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6114483|NCT01061528|Autonomic Agents|autonomic agents|mesh-ancestor
6114484|NCT01061528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6114485|NCT01061528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114486|NCT01061528|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6114487|NCT01061528|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6114488|NCT01061528|Cholinergic Agents|cholinergic agents|mesh-ancestor
6114489|NCT01061528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6114490|NCT01061528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114491|NCT01061606|Sirolimus|sirolimus|mesh-list
6114492|NCT01061606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6114493|NCT01061606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6114494|NCT01061606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6114495|NCT01061606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6114496|NCT01061606|Antifungal Agents|antifungal agents|mesh-ancestor
6114497|NCT01061606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6114498|NCT01061606|Immunologic Factors|immunologic factors|mesh-ancestor
6114499|NCT01061606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114500|NCT01061671|Simvastatin|simvastatin|mesh-list
6114501|NCT01061671|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6114502|NCT01061671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6114503|NCT01061671|Antimetabolites|antimetabolites|mesh-ancestor
6114504|NCT01061671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114505|NCT01061671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6114506|NCT01061671|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6114507|NCT01061671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6114508|NCT01061710|Varenicline|varenicline|mesh-list
6114509|NCT01061710|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6114510|NCT01061710|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6114511|NCT01061710|Cholinergic Agents|cholinergic agents|mesh-ancestor
6114512|NCT01061710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6114513|NCT01061710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114514|NCT01061710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114515|NCT01061736|Folic Acid|folic acid|mesh-list
6114516|NCT01061736|Methotrexate|methotrexate|mesh-list
6114517|NCT01061736|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6114518|NCT01061736|Abortifacient Agents|abortifacient agents|mesh-ancestor
6114519|NCT01061736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6114520|NCT01061736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114521|NCT01061736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6114522|NCT01061736|Antimetabolites|antimetabolites|mesh-ancestor
6114523|NCT01061736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114524|NCT01061736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6114525|NCT01061736|Dermatologic Agents|dermatologic agents|mesh-ancestor
6114526|NCT01061736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6114527|NCT01061736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6114528|NCT01061736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6114529|NCT01061736|Immunologic Factors|immunologic factors|mesh-ancestor
6114530|NCT01061736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5529826|NCT04740918|Trastuzumab|trastuzumab|mesh-list
5529827|NCT04740918|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
5529828|NCT04740918|Atezolizumab|atezolizumab|mesh-list
5529829|NCT04740918|Maytansine|maytansine|mesh-list
5529830|NCT04740918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5529831|NCT04740918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5529832|NCT04740918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5529833|NCT04740918|Tubulin Modulators|tubulin modulators|mesh-ancestor
5529834|NCT04740918|Antimitotic Agents|antimitotic agents|mesh-ancestor
5529835|NCT04740918|Mitosis Modulators|mitosis modulators|mesh-ancestor
5529836|NCT04740918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5529837|NCT04740671|Ranibizumab|ranibizumab|mesh-list
5529838|NCT04740671|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5529839|NCT04740671|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5529840|NCT04740671|Growth Substances|growth substances|mesh-ancestor
5529841|NCT04740671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5529842|NCT04740671|Growth Inhibitors|growth inhibitors|mesh-ancestor
5529843|NCT04740671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5529844|NCT04731844|Curcumin|curcumin|mesh-list
6114531|NCT01061736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6114532|NCT01061736|Hematinics|hematinics|mesh-ancestor
6114533|NCT01061736|Vitamin B Complex|vitamin b complex|mesh-ancestor
6114534|NCT01061736|Vitamins|vitamins|mesh-ancestor
6114535|NCT01061736|Micronutrients|micronutrients|mesh-ancestor
6114536|NCT01061775|Exenatide|exenatide|mesh-list
6114537|NCT01061775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6114538|NCT01061775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114539|NCT01061775|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6114540|NCT01061775|Incretins|incretins|mesh-ancestor
6114541|NCT01061775|Hormones|hormones|mesh-ancestor
6114542|NCT01061775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6114543|NCT01061866|Thalidomide|thalidomide|mesh-list
6114544|NCT01061866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6114545|NCT01061866|Immunologic Factors|immunologic factors|mesh-ancestor
6114546|NCT01061866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114547|NCT01061866|Leprostatic Agents|leprostatic agents|mesh-ancestor
6114548|NCT01061866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6114549|NCT01061866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6114550|NCT01061866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6114551|NCT01061866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5529845|NCT04731844|Piperine|piperine|mesh-list
5529846|NCT04731844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5529847|NCT04731844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6114552|NCT01061866|Growth Substances|growth substances|mesh-ancestor
6114553|NCT01061866|Growth Inhibitors|growth inhibitors|mesh-ancestor
5529848|NCT04731844|Analgesics|analgesics|mesh-ancestor
6114554|NCT01061866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6114555|NCT01062009|Zinc Sulfate|zinc sulfate|mesh-list
6114556|NCT01062009|Astringents|astringents|mesh-ancestor
6114557|NCT01062009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114558|NCT01062009|Dermatologic Agents|dermatologic agents|mesh-ancestor
6204347|NCT02069093|Hormones|hormones|mesh-ancestor
6204348|NCT02069093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6204349|NCT02069093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6204350|NCT02069093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6204351|NCT02069093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6204352|NCT02069093|Immunologic Factors|immunologic factors|mesh-ancestor
5529849|NCT04731844|Sensory System Agents|sensory system agents|mesh-ancestor
5529850|NCT04731844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5529851|NCT04731844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5529852|NCT04731844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5529853|NCT04731844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5529854|NCT04731844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6204353|NCT02069093|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6204354|NCT02069093|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6204355|NCT02069093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6204356|NCT02069093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204357|NCT02069093|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6204358|NCT02069093|Hormone Antagonists|hormone antagonists|mesh-ancestor
6204359|NCT02069184|Acetaminophen|acetaminophen|mesh-list
6204360|NCT02069184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6204361|NCT02069184|Analgesics|analgesics|mesh-ancestor
6204362|NCT02069184|Sensory System Agents|sensory system agents|mesh-ancestor
6204363|NCT02069184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6204364|NCT02069184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204365|NCT02069184|Antipyretics|antipyretics|mesh-ancestor
6204366|NCT02069379|Metformin|metformin|mesh-list
6204367|NCT02069379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6204368|NCT02069379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204369|NCT02069392|Nicotine|nicotine|mesh-list
5529855|NCT04731844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5529856|NCT04731844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5529857|NCT04731844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5529858|NCT04674670|Naltrexone|naltrexone|mesh-list
5529859|NCT04674670|Bromocriptine|bromocriptine|mesh-list
5529860|NCT04674670|Amisulpride|amisulpride|mesh-list
5529861|NCT04674670|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5529862|NCT04674670|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5529863|NCT04674670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5529864|NCT04674670|Sensory System Agents|sensory system agents|mesh-ancestor
5529865|NCT04674670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5529866|NCT04674670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5529867|NCT04674670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5529868|NCT04674670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5529869|NCT04674670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5529870|NCT04674670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6204370|NCT02069392|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6204371|NCT02069392|Autonomic Agents|autonomic agents|mesh-ancestor
6204372|NCT02069392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6204373|NCT02069392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204374|NCT02069392|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6204375|NCT02069392|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6204376|NCT02069392|Cholinergic Agents|cholinergic agents|mesh-ancestor
6204377|NCT02069392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6204378|NCT02069392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204379|NCT02069704|Leucovorin|leucovorin|mesh-list
6204380|NCT02069704|Folic Acid|folic acid|mesh-list
6204381|NCT02069704|Bevacizumab|bevacizumab|mesh-list
6204382|NCT02069704|Fluorouracil|fluorouracil|mesh-list
6204383|NCT02069704|Oxaliplatin|oxaliplatin|mesh-list
6204384|NCT02069704|Irinotecan|irinotecan|mesh-list
6204385|NCT02069704|Levoleucovorin|levoleucovorin|mesh-list
6204386|NCT02069704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6204387|NCT02069704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6204388|NCT02069704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6204389|NCT02069704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6204390|NCT02069704|Growth Substances|growth substances|mesh-ancestor
6204391|NCT02069704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204392|NCT02069704|Growth Inhibitors|growth inhibitors|mesh-ancestor
5529871|NCT04674670|Dopamine Agents|dopamine agents|mesh-ancestor
6204393|NCT02069704|Antimetabolites|antimetabolites|mesh-ancestor
6204394|NCT02069704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207824|NCT02120898|Imiquimod|imiquimod|mesh-list
6114559|NCT01062113|Celecoxib|celecoxib|mesh-list
6114560|NCT01062113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6114561|NCT01062113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6114562|NCT01062113|Analgesics|analgesics|mesh-ancestor
6114563|NCT01062113|Sensory System Agents|sensory system agents|mesh-ancestor
6114564|NCT01062113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6114565|NCT01062113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114566|NCT01062113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6114567|NCT01062113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6114568|NCT01062113|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6114569|NCT01062113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5529872|NCT04674670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5529873|NCT04674670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5529874|NCT04674670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5529875|NCT04674670|Antidepressive Agents|antidepressive agents|mesh-ancestor
5529876|NCT04674670|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5529877|NCT04674670|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5529878|NCT04674670|Hormone Antagonists|hormone antagonists|mesh-ancestor
5529879|NCT04674670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5529880|NCT04674670|Dopamine Agonists|dopamine agonists|mesh-ancestor
5529881|NCT04669132|Olanzapine|olanzapine|mesh-list
5529882|NCT04669132|Antiemetics|antiemetics|mesh-ancestor
5529883|NCT04669132|Autonomic Agents|autonomic agents|mesh-ancestor
5529884|NCT04669132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5529885|NCT04669132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5529886|NCT04669132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5529887|NCT04669132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5529888|NCT04669132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5529889|NCT04669132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5529890|NCT04669132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5529891|NCT04669132|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5529892|NCT04669132|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5529893|NCT04669132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5529894|NCT04669132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5529895|NCT04669132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6114570|NCT01062113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6114571|NCT01062113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114572|NCT01062165|Caspofungin|caspofungin|mesh-list
6114573|NCT01062165|Antifungal Agents|antifungal agents|mesh-ancestor
6114574|NCT01062165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6114575|NCT01062165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6114576|NCT01062165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114577|NCT01062230|Bortezomib|bortezomib|mesh-list
6114578|NCT01062230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6114579|NCT01062256|Phenylpropanolamine|phenylpropanolamine|mesh-list
6114580|NCT01062256|Guaifenesin|guaifenesin|mesh-list
6114581|NCT01062256|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
6114582|NCT01062256|Expectorants|expectorants|mesh-ancestor
6114583|NCT01062256|Respiratory System Agents|respiratory system agents|mesh-ancestor
6114584|NCT01062256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6114585|NCT01062256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6114586|NCT01062256|Adrenergic Agents|adrenergic agents|mesh-ancestor
6114587|NCT01062256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6114588|NCT01062256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114589|NCT01062256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114590|NCT01062256|Appetite Depressants|appetite depressants|mesh-ancestor
6114591|NCT01062256|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6114592|NCT01062256|Sympathomimetics|sympathomimetics|mesh-ancestor
6114593|NCT01062256|Autonomic Agents|autonomic agents|mesh-ancestor
6114594|NCT01062256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6114595|NCT01062256|Nasal Decongestants|nasal decongestants|mesh-ancestor
6114596|NCT01062256|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6114597|NCT01062269|Cholestyramine Resin|cholestyramine resin|mesh-list
6114598|NCT01062269|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6114599|NCT01062269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6114600|NCT01062269|Antimetabolites|antimetabolites|mesh-ancestor
6114601|NCT01062269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114602|NCT01062269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6114603|NCT01062399|Everolimus|everolimus|mesh-list
6114604|NCT01062399|Temozolomide|temozolomide|mesh-list
6114605|NCT01062399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6114606|NCT01062399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6114607|NCT01062399|Immunologic Factors|immunologic factors|mesh-ancestor
6114608|NCT01062399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114609|NCT01062399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6114610|NCT01062399|Alkylating Agents|alkylating agents|mesh-ancestor
6114611|NCT01062399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114612|NCT01062555|Cyclosporine|cyclosporine|mesh-list
6114613|NCT01062555|Sirolimus|sirolimus|mesh-list
6114614|NCT01062555|Mycophenolic Acid|mycophenolic acid|mesh-list
6114615|NCT01062555|Tacrolimus|tacrolimus|mesh-list
6114616|NCT01062555|Cyclosporins|cyclosporins|mesh-list
6114617|NCT01062555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6114618|NCT01062555|Immunologic Factors|immunologic factors|mesh-ancestor
6114619|NCT01062555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114620|NCT01062555|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6114621|NCT01062555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6114622|NCT01062555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114623|NCT01062555|Antifungal Agents|antifungal agents|mesh-ancestor
6114624|NCT01062555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6114625|NCT01062555|Dermatologic Agents|dermatologic agents|mesh-ancestor
6114626|NCT01062555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6114627|NCT01062555|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6114628|NCT01062555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6114629|NCT01062555|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6114630|NCT01062555|Antitubercular Agents|antitubercular agents|mesh-ancestor
6114631|NCT01062555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6114632|NCT01062568|Dexamethasone|dexamethasone|mesh-list
6114633|NCT01062568|Cosyntropin|cosyntropin|mesh-list
6114634|NCT01062568|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6114635|NCT01062568|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
6114636|NCT01062568|beta-Endorphin|beta-endorphin|mesh-list
6114637|NCT01062568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6114638|NCT01062568|Antiemetics|antiemetics|mesh-ancestor
6114639|NCT01062568|Autonomic Agents|autonomic agents|mesh-ancestor
5529896|NCT04669132|Serotonin Agents|serotonin agents|mesh-ancestor
5529897|NCT04666272|Trametinib|trametinib|mesh-list
5529898|NCT04666272|Dabrafenib|dabrafenib|mesh-list
5529899|NCT04666272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5529900|NCT04666272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5529901|NCT04666272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5529902|NCT04666272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5529903|NCT04648319|Nivolumab|nivolumab|mesh-list
5529904|NCT04648319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5529905|NCT04648319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5529906|NCT04648319|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6114640|NCT01062568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6114641|NCT01062568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114642|NCT01062568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6114643|NCT01062568|Glucocorticoids|glucocorticoids|mesh-ancestor
6114644|NCT01062568|Hormones|hormones|mesh-ancestor
6114645|NCT01062568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5529907|NCT04648319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114646|NCT01062568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6114647|NCT01062568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6114648|NCT01062568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6114649|NCT01062568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114650|NCT01062763|Spironolactone|spironolactone|mesh-list
6114651|NCT01062763|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6114652|NCT01062763|Hormone Antagonists|hormone antagonists|mesh-ancestor
5529908|NCT04647721|Hyaluronic Acid|hyaluronic acid|mesh-list
5529909|NCT04647721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5529910|NCT04647721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5529911|NCT04647721|Immunologic Factors|immunologic factors|mesh-ancestor
5529912|NCT04647721|Viscosupplements|viscosupplements|mesh-ancestor
5529913|NCT04647721|Protective Agents|protective agents|mesh-ancestor
6114653|NCT01062763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6114654|NCT01062763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114655|NCT01062763|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6114656|NCT01062763|Diuretics|diuretics|mesh-ancestor
6114657|NCT01062763|Natriuretic Agents|natriuretic agents|mesh-ancestor
6114658|NCT01062971|Timolol|timolol|mesh-list
6114659|NCT01062971|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6114660|NCT01062971|Dorzolamide|dorzolamide|mesh-list
6114661|NCT01062971|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6114662|NCT01062971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6114663|NCT01062971|Adrenergic Agents|adrenergic agents|mesh-ancestor
6114664|NCT01062971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6114665|NCT01062971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114666|NCT01062971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114667|NCT01062971|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6114668|NCT01062971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6114669|NCT01062971|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6114670|NCT01062971|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6114671|NCT01062971|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6114672|NCT01062971|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6114673|NCT01062971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6114674|NCT01063036|Tenofovir|tenofovir|mesh-list
6114675|NCT01063036|Entecavir|entecavir|mesh-list
6114676|NCT01063036|Antiviral Agents|antiviral agents|mesh-ancestor
6114677|NCT01063036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6114678|NCT01063036|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6114679|NCT01063036|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6114680|NCT01063036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6114681|NCT01063036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114682|NCT01063036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6114683|NCT01063036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6114684|NCT01063049|Bisacodyl|bisacodyl|mesh-list
6114685|NCT01063049|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
5529926|NCT04628767|Gemcitabine|gemcitabine|mesh-list
6114686|NCT01063049|Cathartics|cathartics|mesh-ancestor
6114687|NCT01063049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6114688|NCT01063049|Laxatives|laxatives|mesh-ancestor
6114689|NCT01063062|Methotrexate|methotrexate|mesh-list
6114690|NCT01063062|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6114691|NCT01063062|Abortifacient Agents|abortifacient agents|mesh-ancestor
6114692|NCT01063062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6114693|NCT01063062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114694|NCT01063062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6114695|NCT01063062|Antimetabolites|antimetabolites|mesh-ancestor
6114696|NCT01063062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114697|NCT01063062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6114698|NCT01063062|Dermatologic Agents|dermatologic agents|mesh-ancestor
6114699|NCT01063062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6114700|NCT01063062|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5529927|NCT04628767|Cisplatin|cisplatin|mesh-list
5529928|NCT04628767|Doxorubicin|doxorubicin|mesh-list
5529929|NCT04628767|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5529930|NCT04628767|Methotrexate|methotrexate|mesh-list
5529931|NCT04628767|Durvalumab|durvalumab|mesh-list
5529932|NCT04628767|Vinblastine|vinblastine|mesh-list
5529933|NCT04628767|Lenograstim|lenograstim|mesh-list
6114701|NCT01063062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6114702|NCT01063062|Immunologic Factors|immunologic factors|mesh-ancestor
6114703|NCT01063062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6114704|NCT01063062|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6114705|NCT01063075|Carboplatin|carboplatin|mesh-list
5529934|NCT04628767|Immunoglobulins|immunoglobulins|mesh-list
5529935|NCT04628767|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5529936|NCT04628767|Immunoglobulin G|immunoglobulin g|mesh-list
6114706|NCT01063075|Cetuximab|cetuximab|mesh-list
6114707|NCT01063075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6114708|NCT01063075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6114709|NCT01063153|Methylphenidate|methylphenidate|mesh-list
6114710|NCT01063153|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6114711|NCT01063153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114712|NCT01063153|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6114713|NCT01063153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6114714|NCT01063153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6114715|NCT01063153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114716|NCT01063153|Dopamine Agents|dopamine agents|mesh-ancestor
6114717|NCT01063153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6114718|NCT01063283|Bevacizumab|bevacizumab|mesh-list
6114719|NCT01063283|Carboplatin|carboplatin|mesh-list
6114720|NCT01063283|Pemetrexed|pemetrexed|mesh-list
6114721|NCT01063283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6114722|NCT01063283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6114723|NCT01063283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6114724|NCT01063283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6114725|NCT01063283|Growth Substances|growth substances|mesh-ancestor
6114726|NCT01063283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114727|NCT01063283|Growth Inhibitors|growth inhibitors|mesh-ancestor
6114728|NCT01063283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6114729|NCT01063283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114730|NCT01063283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6114731|NCT01063283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6114732|NCT01063348|Acetylcysteine|acetylcysteine|mesh-list
6114733|NCT01063348|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6114734|NCT01063348|Antiviral Agents|antiviral agents|mesh-ancestor
6114735|NCT01063348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6114736|NCT01063348|Expectorants|expectorants|mesh-ancestor
6114737|NCT01063348|Respiratory System Agents|respiratory system agents|mesh-ancestor
6114738|NCT01063348|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6114739|NCT01063348|Antioxidants|antioxidants|mesh-ancestor
6114740|NCT01063348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114741|NCT01063348|Protective Agents|protective agents|mesh-ancestor
6114742|NCT01063348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114743|NCT01063348|Antidotes|antidotes|mesh-ancestor
6114744|NCT01063764|Levetiracetam|levetiracetam|mesh-list
6114745|NCT01063764|Anticonvulsants|anticonvulsants|mesh-ancestor
6114746|NCT01063764|Nootropic Agents|nootropic agents|mesh-ancestor
6114747|NCT01063829|Letermovir|letermovir|mesh-list
6114748|NCT01063829|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6114749|NCT01063829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6114750|NCT01063829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114751|NCT01063829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6114752|NCT01063829|Antiviral Agents|antiviral agents|mesh-ancestor
5529937|NCT04628767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5529938|NCT04628767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5529939|NCT04628767|Antimetabolites|antimetabolites|mesh-ancestor
5529940|NCT04628767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5529941|NCT04628767|Antiviral Agents|antiviral agents|mesh-ancestor
5529942|NCT04628767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5529943|NCT04628767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5529944|NCT04628767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5529945|NCT04628767|Immunologic Factors|immunologic factors|mesh-ancestor
6114753|NCT01063829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6114754|NCT01063855|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
6114755|NCT01063855|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6114756|NCT01063855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6114757|NCT01063855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114758|NCT01063868|Oxycodone|oxycodone|mesh-list
6114759|NCT01063868|Tapentadol|tapentadol|mesh-list
6114760|NCT01063868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6114761|NCT01063868|Narcotics|narcotics|mesh-ancestor
6114762|NCT01063868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6114763|NCT01063868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114764|NCT01063868|Analgesics|analgesics|mesh-ancestor
6114765|NCT01063868|Sensory System Agents|sensory system agents|mesh-ancestor
6114766|NCT01063868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6114767|NCT01063868|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6114768|NCT01063868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6114769|NCT01063868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6114770|NCT01063868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114771|NCT01063868|Adrenergic Agents|adrenergic agents|mesh-ancestor
6114772|NCT01063868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6114773|NCT01063907|Bortezomib|bortezomib|mesh-list
6114774|NCT01063907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6114775|NCT01064167|Tranexamic Acid|tranexamic acid|mesh-list
6114776|NCT01064167|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6114777|NCT01064167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6114778|NCT01064167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114779|NCT01064167|Hemostatics|hemostatics|mesh-ancestor
6114780|NCT01064167|Coagulants|coagulants|mesh-ancestor
6114781|NCT01064284|Factor VIII|factor viii|mesh-list
6114782|NCT01064284|Coagulants|coagulants|mesh-ancestor
5529946|NCT04628767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5529947|NCT04628767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5529948|NCT04628767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5529949|NCT04628767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5529950|NCT04628767|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5529951|NCT04628767|Abortifacient Agents|abortifacient agents|mesh-ancestor
6114783|NCT01064297|Lamotrigine|lamotrigine|mesh-list
6114784|NCT01064297|Anticonvulsants|anticonvulsants|mesh-list
6114785|NCT01064297|Valproic Acid|valproic acid|mesh-list
6114786|NCT01064297|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6114787|NCT01064297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6114788|NCT01064297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114789|NCT01064297|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6114790|NCT01064297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114791|NCT01064297|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6114792|NCT01064297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6114793|NCT01064297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6114794|NCT01064297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6114795|NCT01064297|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6114796|NCT01064297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6114797|NCT01064297|GABA Agents|gaba agents|mesh-ancestor
6114798|NCT01064297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6114799|NCT01064297|Antimanic Agents|antimanic agents|mesh-ancestor
6114800|NCT01064310|Sunitinib|sunitinib|mesh-list
6114801|NCT01064310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6114802|NCT01064310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6114803|NCT01064310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6114804|NCT01064310|Growth Substances|growth substances|mesh-ancestor
6114805|NCT01064310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114806|NCT01064310|Growth Inhibitors|growth inhibitors|mesh-ancestor
6114807|NCT01064310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6114808|NCT01064310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6114809|NCT01064310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114810|NCT01064362|Heparin|heparin|mesh-list
6114811|NCT01064362|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6114812|NCT01064362|Tinzaparin|tinzaparin|mesh-list
6114813|NCT01064362|Dalteparin|dalteparin|mesh-list
6114814|NCT01064362|PENTA|penta|mesh-list
6114815|NCT01064362|Fondaparinux|fondaparinux|mesh-list
6114816|NCT01064362|Anticoagulants|anticoagulants|mesh-ancestor
5529952|NCT04628767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5529953|NCT04628767|Dermatologic Agents|dermatologic agents|mesh-ancestor
5529954|NCT04628767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5529955|NCT04628767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5529956|NCT04628767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6114817|NCT01064362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6114818|NCT01064362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6114819|NCT01064362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114820|NCT01064362|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6114821|NCT01064362|Antithrombins|antithrombins|mesh-ancestor
5529957|NCT04628767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5529958|NCT04628767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5529959|NCT04628767|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5529960|NCT04628767|Tubulin Modulators|tubulin modulators|mesh-ancestor
6114822|NCT01064362|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6114823|NCT01064362|Protease Inhibitors|protease inhibitors|mesh-ancestor
6114824|NCT01064362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6114825|NCT01064401|Interferons|interferons|mesh-list
6114826|NCT01064401|Interferon-beta|interferon-beta|mesh-list
6114827|NCT01064401|Interferon beta-1a|interferon beta-1a|mesh-list
6114828|NCT01064401|Daclizumab|daclizumab|mesh-list
6114829|NCT01064401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6114830|NCT01064401|Antiviral Agents|antiviral agents|mesh-ancestor
6114831|NCT01064401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6114832|NCT01064401|Immunologic Factors|immunologic factors|mesh-ancestor
6114833|NCT01064401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114834|NCT01064401|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6114835|NCT01064401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6114836|NCT01064414|Canagliflozin|canagliflozin|mesh-list
6114837|NCT01064414|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6114838|NCT01064414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114839|NCT01064414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6114840|NCT01064414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114841|NCT01064622|Gemcitabine|gemcitabine|mesh-list
6114842|NCT01064622|Hydrocortisone|hydrocortisone|mesh-list
5529961|NCT04628767|Antimitotic Agents|antimitotic agents|mesh-ancestor
5529962|NCT04628767|Mitosis Modulators|mitosis modulators|mesh-ancestor
5529963|NCT04625530|Tranexamic Acid|tranexamic acid|mesh-list
5529964|NCT04625530|Ferric Compounds|ferric compounds|mesh-list
5529965|NCT04625530|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6114843|NCT01064622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6114844|NCT01064622|Antimetabolites|antimetabolites|mesh-ancestor
6114845|NCT01064622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114846|NCT01064622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6114847|NCT01064622|Antiviral Agents|antiviral agents|mesh-ancestor
6114848|NCT01064622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6114849|NCT01064622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6114850|NCT01064622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6114851|NCT01064622|Immunologic Factors|immunologic factors|mesh-ancestor
6114852|NCT01064622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114853|NCT01064622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6114854|NCT01064687|Metformin|metformin|mesh-list
6114855|NCT01064687|Pioglitazone|pioglitazone|mesh-list
6114856|NCT01064687|Exenatide|exenatide|mesh-list
6114857|NCT01064687|Dulaglutide|dulaglutide|mesh-list
6114858|NCT01064687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6114859|NCT01064687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114860|NCT01064687|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6114861|NCT01064687|Incretins|incretins|mesh-ancestor
6114862|NCT01064687|Hormones|hormones|mesh-ancestor
6114863|NCT01064687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6465677|NCT00475696|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6465678|NCT00475696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6465679|NCT00475696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465680|NCT00475696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6465681|NCT00475696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465682|NCT00475696|Analgesics|analgesics|mesh-ancestor
6465683|NCT00475696|Sensory System Agents|sensory system agents|mesh-ancestor
6114864|NCT01064830|Cyclosporine|cyclosporine|mesh-list
6114865|NCT01064830|Cyclosporins|cyclosporins|mesh-list
6114866|NCT01064830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6114867|NCT01064830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114868|NCT01064830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5529966|NCT04625530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6114869|NCT01064830|Immunologic Factors|immunologic factors|mesh-ancestor
6114870|NCT01064830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114871|NCT01064830|Antifungal Agents|antifungal agents|mesh-ancestor
6114872|NCT01064830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6114873|NCT01064830|Dermatologic Agents|dermatologic agents|mesh-ancestor
6114874|NCT01064830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6114875|NCT01064830|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5529967|NCT04625530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5529968|NCT04625530|Hemostatics|hemostatics|mesh-ancestor
5529969|NCT04625530|Coagulants|coagulants|mesh-ancestor
5529970|NCT04625530|Hematinics|hematinics|mesh-ancestor
5529971|NCT04622254|Botulinum Toxins|botulinum toxins|mesh-list
5529972|NCT04622254|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5529973|NCT04622254|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5529974|NCT04622254|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
5529975|NCT04622254|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5529976|NCT04622254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5529977|NCT04622254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5529978|NCT04622254|Cholinergic Agents|cholinergic agents|mesh-ancestor
5529979|NCT04622254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5529980|NCT04622254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5529981|NCT04622254|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5529982|NCT04622254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5529983|NCT04594239|Lidocaine|lidocaine|mesh-list
5529984|NCT04594239|Hyaluronic Acid|hyaluronic acid|mesh-list
5529985|NCT04594239|Anesthetics, Local|anesthetics, local|mesh-ancestor
5529986|NCT04594239|Anesthetics|anesthetics|mesh-ancestor
5529987|NCT04594239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5529988|NCT04594239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5529989|NCT04594239|Sensory System Agents|sensory system agents|mesh-ancestor
5529990|NCT04594239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5529991|NCT04594239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5529992|NCT04594239|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6114876|NCT01064856|Adalimumab|adalimumab|mesh-list
6114877|NCT01064856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6114878|NCT01064856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6114879|NCT01064882|Bimatoprost|bimatoprost|mesh-list
6114880|NCT01064882|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6114881|NCT01064882|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6114882|NCT01064882|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6114883|NCT01064947|Retapamulin|retapamulin|mesh-list
6114884|NCT01064947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6114885|NCT01064947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6114886|NCT01065350|Ketamine|ketamine|mesh-list
6114887|NCT01065350|Propofol|propofol|mesh-list
6114888|NCT01065350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6114889|NCT01065350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6114890|NCT01065350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666053|NCT01520389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6666054|NCT01520389|Immunologic Factors|immunologic factors|mesh-ancestor
6666055|NCT01520389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666056|NCT01520415|Lidocaine|lidocaine|mesh-list
6666057|NCT01520415|Bupivacaine|bupivacaine|mesh-list
6666058|NCT01520415|Anesthetics, Local|anesthetics, local|mesh-ancestor
6666059|NCT01520415|Anesthetics|anesthetics|mesh-ancestor
6666060|NCT01520415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6666061|NCT01520415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666062|NCT01520415|Sensory System Agents|sensory system agents|mesh-ancestor
6666063|NCT01520415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6114891|NCT01065350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6114892|NCT01065350|Anesthetics, General|anesthetics, general|mesh-ancestor
6114893|NCT01065350|Anesthetics|anesthetics|mesh-ancestor
6114894|NCT01065350|Analgesics|analgesics|mesh-ancestor
6114895|NCT01065350|Sensory System Agents|sensory system agents|mesh-ancestor
6114896|NCT01065350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6114897|NCT01065350|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6114898|NCT01065350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6114899|NCT01065350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6114900|NCT01065350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6114901|NCT01065350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114902|NCT01065506|Nicotine|nicotine|mesh-list
6114903|NCT01065506|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6114904|NCT01065506|Autonomic Agents|autonomic agents|mesh-ancestor
6114905|NCT01065506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6114906|NCT01065506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114907|NCT01065506|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6114908|NCT01065506|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6114909|NCT01065506|Cholinergic Agents|cholinergic agents|mesh-ancestor
6114910|NCT01065506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6114911|NCT01065506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114912|NCT01065558|Ecopipam|ecopipam|mesh-list
6114913|NCT01065558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6114914|NCT01065558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6114915|NCT01065558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6114916|NCT01065558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114917|NCT01065558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6114918|NCT01065558|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6114919|NCT01065558|Dopamine Agents|dopamine agents|mesh-ancestor
6465684|NCT00475696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6465685|NCT00475696|Antidepressive Agents|antidepressive agents|mesh-ancestor
6465686|NCT00475696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6465687|NCT00475696|Dopamine Agents|dopamine agents|mesh-ancestor
6114920|NCT01065558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6114921|NCT01065558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114922|NCT01065766|Metformin|metformin|mesh-list
6114923|NCT01065766|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6114924|NCT01065766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6114925|NCT01065766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114926|NCT01065766|Incretins|incretins|mesh-ancestor
6114927|NCT01065766|Hormones|hormones|mesh-ancestor
6114928|NCT01065766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6114929|NCT01065766|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6114930|NCT01065766|Protease Inhibitors|protease inhibitors|mesh-ancestor
6114931|NCT01065766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6114932|NCT01065766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114933|NCT01065844|Nelfinavir|nelfinavir|mesh-list
6114934|NCT01065844|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6114935|NCT01065844|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6114936|NCT01065844|Protease Inhibitors|protease inhibitors|mesh-ancestor
6114937|NCT01065844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6114938|NCT01065844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114939|NCT01065844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6114940|NCT01065844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6114941|NCT01065844|Antiviral Agents|antiviral agents|mesh-ancestor
6114942|NCT01065844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6114943|NCT01066000|Epoetin Alfa|epoetin alfa|mesh-list
6465688|NCT00475800|Lumiracoxib|lumiracoxib|mesh-list
6465689|NCT00475800|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5529993|NCT04594239|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5529994|NCT04594239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5529995|NCT04594239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5529996|NCT04594239|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5529997|NCT04594239|Immunologic Factors|immunologic factors|mesh-ancestor
5529998|NCT04594239|Viscosupplements|viscosupplements|mesh-ancestor
5529999|NCT04594239|Protective Agents|protective agents|mesh-ancestor
5530000|NCT04594213|Botulinum Toxins|botulinum toxins|mesh-list
5530001|NCT04594213|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5530002|NCT04594213|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5530003|NCT04594213|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
5530004|NCT04594213|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5530005|NCT04594213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5530006|NCT04594213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5530007|NCT04594213|Cholinergic Agents|cholinergic agents|mesh-ancestor
5530008|NCT04594213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5530009|NCT04594213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5530010|NCT04594213|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6114944|NCT01066000|Hematinics|hematinics|mesh-ancestor
6114945|NCT01066026|Hyaluronic Acid|hyaluronic acid|mesh-list
6114946|NCT01066026|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6114947|NCT01066026|Immunologic Factors|immunologic factors|mesh-ancestor
6114948|NCT01066026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114949|NCT01066026|Viscosupplements|viscosupplements|mesh-ancestor
6114950|NCT01066026|Protective Agents|protective agents|mesh-ancestor
6114951|NCT01066039|Bisoprolol|bisoprolol|mesh-list
6114952|NCT01066039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6114953|NCT01066039|Sympatholytics|sympatholytics|mesh-ancestor
6114954|NCT01066039|Autonomic Agents|autonomic agents|mesh-ancestor
6114955|NCT01066039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6114956|NCT01066039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114957|NCT01066039|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6114958|NCT01066039|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6114959|NCT01066039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6114960|NCT01066039|Adrenergic Agents|adrenergic agents|mesh-ancestor
6114961|NCT01066039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6114962|NCT01066039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114963|NCT01066104|Omalizumab|omalizumab|mesh-list
6114964|NCT01066104|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6114965|NCT01066104|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6114966|NCT01066104|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5530011|NCT04594213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5530018|NCT04580121|Acetaminophen|acetaminophen|mesh-list
5530019|NCT04580121|Diphenhydramine|diphenhydramine|mesh-list
5530020|NCT04580121|Promethazine|promethazine|mesh-list
5530021|NCT04580121|Dexamethasone|dexamethasone|mesh-list
6114967|NCT01066104|Respiratory System Agents|respiratory system agents|mesh-ancestor
6114968|NCT01066104|Immunologic Factors|immunologic factors|mesh-ancestor
6114969|NCT01066104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114970|NCT01066143|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6114971|NCT01066143|Antidepressive Agents|antidepressive agents|mesh-ancestor
6114972|NCT01066143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6114973|NCT01066143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6114974|NCT01066143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6114975|NCT01066143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6114976|NCT01066143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114977|NCT01066156|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6114978|NCT01066156|Antidepressive Agents|antidepressive agents|mesh-ancestor
6114979|NCT01066156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6114980|NCT01066156|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6114981|NCT01066156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6114982|NCT01066156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6114983|NCT01066156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6114984|NCT01066364|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
6114985|NCT01066364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6114986|NCT01066364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6114987|NCT01066364|Antimetabolites|antimetabolites|mesh-ancestor
6114988|NCT01066364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6114989|NCT01066364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6114990|NCT01066520|Diclofenac|diclofenac|mesh-list
6114991|NCT01066520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6114992|NCT01066520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6114993|NCT01066520|Analgesics|analgesics|mesh-ancestor
6114994|NCT01066520|Sensory System Agents|sensory system agents|mesh-ancestor
6114995|NCT01066520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6114996|NCT01066520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488442|NCT00584168|Glucocorticoids|glucocorticoids|mesh-ancestor
6114997|NCT01066520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6114998|NCT01066520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6114999|NCT01066520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6115000|NCT01066520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6115001|NCT01066520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115002|NCT01066585|Ivermectin|ivermectin|mesh-list
6115003|NCT01066585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6115004|NCT01066585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6115005|NCT01066624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6115006|NCT01066624|Calcium|calcium|mesh-list
6115007|NCT01066624|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6115008|NCT01066624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115009|NCT01066793|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6115010|NCT01066793|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6115011|NCT01066793|Antiviral Agents|antiviral agents|mesh-ancestor
6115012|NCT01066793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6115013|NCT01066819|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6115014|NCT01066819|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6115015|NCT01066819|Antiviral Agents|antiviral agents|mesh-ancestor
6115016|NCT01066819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6115017|NCT01066897|Pramipexole|pramipexole|mesh-list
6115018|NCT01066897|Antioxidants|antioxidants|mesh-ancestor
6115019|NCT01066897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115020|NCT01066897|Protective Agents|protective agents|mesh-ancestor
6115021|NCT01066897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115022|NCT01066897|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6115023|NCT01066897|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6115024|NCT01066897|Dopamine Agonists|dopamine agonists|mesh-ancestor
6115025|NCT01066897|Dopamine Agents|dopamine agents|mesh-ancestor
6115026|NCT01066897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6115027|NCT01066923|Aspirin|aspirin|mesh-list
6115028|NCT01066923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6115029|NCT01066923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6115030|NCT01066923|Analgesics|analgesics|mesh-ancestor
6115031|NCT01066923|Sensory System Agents|sensory system agents|mesh-ancestor
6115032|NCT01066923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6115033|NCT01066923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115034|NCT01066923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6115035|NCT01066923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6115036|NCT01066923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6115037|NCT01066923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6115038|NCT01066923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115039|NCT01066923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6115040|NCT01066923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6115041|NCT01066923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6115042|NCT01066923|Antipyretics|antipyretics|mesh-ancestor
6115043|NCT01067105|Ciclesonide|ciclesonide|mesh-list
6115044|NCT01067105|Glucocorticoids|glucocorticoids|mesh-ancestor
6115045|NCT01067105|Hormones|hormones|mesh-ancestor
6115046|NCT01067105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6115047|NCT01067105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115048|NCT01067105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6115049|NCT01067144|Gabapentin|gabapentin|mesh-list
6115050|NCT01067144|Lorazepam|lorazepam|mesh-list
6115051|NCT01067144|Analgesics|analgesics|mesh-ancestor
6115052|NCT01067144|Sensory System Agents|sensory system agents|mesh-ancestor
6115053|NCT01067144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6115054|NCT01067144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115055|NCT01067144|Anticonvulsants|anticonvulsants|mesh-ancestor
6115056|NCT01067144|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6115057|NCT01067144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6115058|NCT01067144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6115059|NCT01067144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6115060|NCT01067144|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6115061|NCT01067144|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6115062|NCT01067144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6115063|NCT01067144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115064|NCT01067144|Antimanic Agents|antimanic agents|mesh-ancestor
6115065|NCT01067144|Antiemetics|antiemetics|mesh-ancestor
6115066|NCT01067144|Autonomic Agents|autonomic agents|mesh-ancestor
6115067|NCT01067144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6115068|NCT01067144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6115069|NCT01067144|GABA Modulators|gaba modulators|mesh-ancestor
6115070|NCT01067144|GABA Agents|gaba agents|mesh-ancestor
6115071|NCT01067339|Darapladib|darapladib|mesh-list
6115072|NCT01067339|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
6115073|NCT01067339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6115074|NCT01067339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115075|NCT01067352|Hormones|hormones|mesh-list
6115076|NCT01067352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6115077|NCT01067352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115078|NCT01067469|Bevacizumab|bevacizumab|mesh-list
6115079|NCT01067469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6115080|NCT01067469|Lomustine|lomustine|mesh-list
6115081|NCT01067469|Antibodies|antibodies|mesh-list
6115082|NCT01067469|Immunoglobulins|immunoglobulins|mesh-list
6115083|NCT01067469|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6115084|NCT01067469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6115085|NCT01067469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6115086|NCT01067469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6115087|NCT01067469|Growth Substances|growth substances|mesh-ancestor
6115088|NCT01067469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115089|NCT01067469|Growth Inhibitors|growth inhibitors|mesh-ancestor
6115090|NCT01067469|Immunologic Factors|immunologic factors|mesh-ancestor
6115091|NCT01067469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6115092|NCT01067469|Alkylating Agents|alkylating agents|mesh-ancestor
6115093|NCT01067469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115094|NCT01067846|Cycloserine|cycloserine|mesh-list
6115095|NCT01067846|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6115096|NCT01067846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6115097|NCT01067846|Renal Agents|renal agents|mesh-ancestor
5530022|NCT04580121|Dasatinib|dasatinib|mesh-list
5530023|NCT04580121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5530024|NCT04580121|Antiemetics|antiemetics|mesh-ancestor
5530025|NCT04580121|Autonomic Agents|autonomic agents|mesh-ancestor
5530026|NCT04580121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5530027|NCT04580121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5530028|NCT04580121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5530029|NCT04580121|Glucocorticoids|glucocorticoids|mesh-ancestor
5530030|NCT04580121|Hormones|hormones|mesh-ancestor
5530031|NCT04580121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5530032|NCT04580121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5530033|NCT04580121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5530034|NCT04580121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5530035|NCT04580121|Analgesics|analgesics|mesh-ancestor
5530036|NCT04580121|Sensory System Agents|sensory system agents|mesh-ancestor
5530037|NCT04580121|Antipyretics|antipyretics|mesh-ancestor
5530038|NCT04580121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5530039|NCT04580121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5530040|NCT04580121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5530041|NCT04580121|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5530042|NCT04580121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5530043|NCT04580121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5530044|NCT04580121|Anesthetics, Local|anesthetics, local|mesh-ancestor
5530045|NCT04580121|Anesthetics|anesthetics|mesh-ancestor
5530046|NCT04580121|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5601496|NCT05176821|Esomeprazole|esomeprazole|mesh-list
6115098|NCT01067846|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6115099|NCT01067846|Antitubercular Agents|antitubercular agents|mesh-ancestor
6115100|NCT01067846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6115101|NCT01067846|Antimetabolites|antimetabolites|mesh-ancestor
6115102|NCT01067846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115103|NCT01068158|Ivermectin|ivermectin|mesh-list
6115104|NCT01068158|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6465690|NCT00475800|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6465691|NCT00475800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6115105|NCT01068158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6115106|NCT01068418|Vitamin D|vitamin d|mesh-list
6115107|NCT01068418|Cholecalciferol|cholecalciferol|mesh-list
6115108|NCT01068418|Vitamins|vitamins|mesh-ancestor
6115109|NCT01068418|Micronutrients|micronutrients|mesh-ancestor
6115110|NCT01068418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115111|NCT01068418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6488443|NCT00584168|Hormones|hormones|mesh-ancestor
6115112|NCT01068418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6115113|NCT01068626|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6115114|NCT01068626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6115115|NCT01068626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6115116|NCT01068626|Antimetabolites|antimetabolites|mesh-ancestor
6115117|NCT01068626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115118|NCT01068626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6115119|NCT01068626|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6115120|NCT01068626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6115121|NCT01068652|Insulin|insulin|mesh-list
6115122|NCT01068652|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6115123|NCT01068652|Metformin|metformin|mesh-list
6115124|NCT01068652|Insulin Aspart|insulin aspart|mesh-list
6115125|NCT01068652|Insulin, Long-Acting|insulin, long-acting|mesh-list
6115126|NCT01068652|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6115127|NCT01068652|Insulin Detemir|insulin detemir|mesh-list
6115128|NCT01068652|Biphasic Insulins|biphasic insulins|mesh-list
6115129|NCT01068652|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6115130|NCT01068652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6115131|NCT01068652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465692|NCT00475800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465693|NCT00475800|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6465694|NCT00475800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6465695|NCT00475800|Analgesics|analgesics|mesh-ancestor
6465696|NCT00475800|Sensory System Agents|sensory system agents|mesh-ancestor
6465697|NCT00475800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6465698|NCT00475800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465699|NCT00475800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6465700|NCT00475800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6465701|NCT00475813|Fluticasone|fluticasone|mesh-list
6465702|NCT00475813|Xhance|xhance|mesh-list
6465703|NCT00475813|Formoterol Fumarate|formoterol fumarate|mesh-list
6115132|NCT01068665|Insulin|insulin|mesh-list
6115133|NCT01068665|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6115134|NCT01068665|Insulin Glargine|insulin glargine|mesh-list
6115135|NCT01068665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6115136|NCT01068665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204395|NCT02069704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6204396|NCT02069704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6204397|NCT02069704|Immunologic Factors|immunologic factors|mesh-ancestor
6204398|NCT02069704|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6204399|NCT02069704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6204400|NCT02069704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6204401|NCT02069704|Antidotes|antidotes|mesh-ancestor
6204402|NCT02069704|Protective Agents|protective agents|mesh-ancestor
6204403|NCT02069704|Vitamin B Complex|vitamin b complex|mesh-ancestor
6204404|NCT02069704|Vitamins|vitamins|mesh-ancestor
6204405|NCT02069704|Micronutrients|micronutrients|mesh-ancestor
6204406|NCT02069704|Hematinics|hematinics|mesh-ancestor
6204407|NCT02069847|Budesonide|budesonide|mesh-list
6204408|NCT02069847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6204409|NCT02069847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6204410|NCT02069847|Autonomic Agents|autonomic agents|mesh-ancestor
6204411|NCT02069847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6204412|NCT02069847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204413|NCT02069847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6204414|NCT02069847|Respiratory System Agents|respiratory system agents|mesh-ancestor
6204415|NCT02069847|Glucocorticoids|glucocorticoids|mesh-ancestor
6204416|NCT02069847|Hormones|hormones|mesh-ancestor
6204417|NCT02069847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6204418|NCT02070237|Enoxaparin|enoxaparin|mesh-list
6204419|NCT02070237|Anticoagulants|anticoagulants|mesh-ancestor
6204420|NCT02070237|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6204421|NCT02070237|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6204422|NCT02070237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204423|NCT02070302|Botulinum Toxins|botulinum toxins|mesh-list
6204424|NCT02070302|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6204425|NCT02070302|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6204426|NCT02070302|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6204427|NCT02070302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6204428|NCT02070302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204429|NCT02070302|Cholinergic Agents|cholinergic agents|mesh-ancestor
6204430|NCT02070302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6204431|NCT02070302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204432|NCT02070302|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6115137|NCT01068678|Insulin|insulin|mesh-list
6115138|NCT01068678|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6115139|NCT01068678|Insulin Glargine|insulin glargine|mesh-list
6115140|NCT01068678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6115141|NCT01068678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115142|NCT01068717|Metformin|metformin|mesh-list
6115143|NCT01068717|Saxagliptin|saxagliptin|mesh-list
6115144|NCT01068717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6115145|NCT01068717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115146|NCT01068717|Incretins|incretins|mesh-ancestor
6115147|NCT01068717|Hormones|hormones|mesh-ancestor
6115148|NCT01068717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6115149|NCT01068717|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6115150|NCT01068717|Protease Inhibitors|protease inhibitors|mesh-ancestor
6115151|NCT01068717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5530047|NCT04580121|Histamine Antagonists|histamine antagonists|mesh-ancestor
5530048|NCT04580121|Histamine Agents|histamine agents|mesh-ancestor
5530049|NCT04580121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5530050|NCT04580121|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5530051|NCT04580121|Antipruritics|antipruritics|mesh-ancestor
6115152|NCT01068717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115153|NCT01068730|Metformin|metformin|mesh-list
6115154|NCT01068730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6115155|NCT01068730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115156|NCT01068743|Metformin|metformin|mesh-list
6115157|NCT01068743|Saxagliptin|saxagliptin|mesh-list
6115158|NCT01068743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6115159|NCT01068743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115160|NCT01068743|Incretins|incretins|mesh-ancestor
6115161|NCT01068743|Hormones|hormones|mesh-ancestor
6115162|NCT01068743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6115163|NCT01068743|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6115164|NCT01068743|Protease Inhibitors|protease inhibitors|mesh-ancestor
6115165|NCT01068743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6115166|NCT01068743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115167|NCT01068860|Insulin|insulin|mesh-list
6115168|NCT01068860|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6115169|NCT01068860|Metformin|metformin|mesh-list
6115170|NCT01068860|Glimepiride|glimepiride|mesh-list
6666064|NCT01520415|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6666065|NCT01520415|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6666066|NCT01520415|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6666067|NCT01520415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5530052|NCT04580121|Dermatologic Agents|dermatologic agents|mesh-ancestor
5530053|NCT04539873|Colchicine|colchicine|mesh-list
5530054|NCT04539873|Gout Suppressants|gout suppressants|mesh-ancestor
5530055|NCT04539873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5530056|NCT04539873|Tubulin Modulators|tubulin modulators|mesh-ancestor
5530057|NCT04539873|Antimitotic Agents|antimitotic agents|mesh-ancestor
5530058|NCT04539873|Mitosis Modulators|mitosis modulators|mesh-ancestor
5530059|NCT04539873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5530060|NCT04539873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5530061|NCT04538092|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5530062|NCT04538092|Analgesics|analgesics|mesh-list
5530063|NCT04538092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5530064|NCT04538092|Sensory System Agents|sensory system agents|mesh-ancestor
5530065|NCT04538092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5530066|NCT04538092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5530067|NCT04498117|Paclitaxel|paclitaxel|mesh-list
6115171|NCT01068860|Insulin Lispro|insulin lispro|mesh-list
6115172|NCT01068860|Insulin, Isophane|insulin, isophane|mesh-list
6115173|NCT01068860|Glyburide|glyburide|mesh-list
6115174|NCT01068860|Glipizide|glipizide|mesh-list
6115175|NCT01068860|Troglitazone|troglitazone|mesh-list
6115176|NCT01068860|Tolbutamide|tolbutamide|mesh-list
6115177|NCT01068860|Acetohexamide|acetohexamide|mesh-list
6115178|NCT01068860|Chlorpropamide|chlorpropamide|mesh-list
6115179|NCT01068860|Tolazamide|tolazamide|mesh-list
6115180|NCT01068860|Insulin, Regular, Pork|insulin, regular, pork|mesh-list
6115181|NCT01068860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6115182|NCT01068860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6115183|NCT01068860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5530068|NCT04498117|Carboplatin|carboplatin|mesh-list
5530069|NCT04498117|Oregovomab|oregovomab|mesh-list
5530070|NCT04498117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6115184|NCT01068860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5601497|NCT05176821|Bismuth|bismuth|mesh-list
6115185|NCT01068860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6115186|NCT01068860|Immunologic Factors|immunologic factors|mesh-ancestor
6115187|NCT01068873|Ritonavir|ritonavir|mesh-list
5530071|NCT04498117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5530072|NCT04498117|Tubulin Modulators|tubulin modulators|mesh-ancestor
6115188|NCT01068873|Lopinavir|lopinavir|mesh-list
6115189|NCT01068873|Maraviroc|maraviroc|mesh-list
6115190|NCT01068873|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6115191|NCT01068873|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6115192|NCT01068873|Protease Inhibitors|protease inhibitors|mesh-ancestor
6115193|NCT01068873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6115194|NCT01068873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115195|NCT01068873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6115196|NCT01068873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6115197|NCT01068873|Antiviral Agents|antiviral agents|mesh-ancestor
6115198|NCT01068873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6115199|NCT01068873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6115200|NCT01068873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6115201|NCT01068873|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6115202|NCT01068873|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6115203|NCT01068873|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6115204|NCT01068912|Favipiravir|favipiravir|mesh-list
6115205|NCT01068912|Antiviral Agents|antiviral agents|mesh-ancestor
6115206|NCT01068912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6115207|NCT01068964|Timolol|timolol|mesh-list
6115208|NCT01068964|Bimatoprost|bimatoprost|mesh-list
6115209|NCT01068964|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6115210|NCT01068964|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6115211|NCT01068964|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6115212|NCT01068964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6115213|NCT01068964|Adrenergic Agents|adrenergic agents|mesh-ancestor
6115214|NCT01068964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6115215|NCT01068964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115216|NCT01068964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115217|NCT01068964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6115218|NCT01068964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6115219|NCT01069172|Dipivefrin|dipivefrin|mesh-list
6115220|NCT01069172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6115221|NCT01069172|Adrenergic Agents|adrenergic agents|mesh-ancestor
6115222|NCT01069172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6115223|NCT01069172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115224|NCT01069172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5530073|NCT04498117|Antimitotic Agents|antimitotic agents|mesh-ancestor
5530074|NCT04498117|Mitosis Modulators|mitosis modulators|mesh-ancestor
5530075|NCT04498117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5530076|NCT04498117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5530077|NCT04496219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5530078|NCT04496219|BCG Vaccine|bcg vaccine|mesh-list
6115225|NCT01069289|Budesonide|budesonide|mesh-list
6115226|NCT01069289|Formoterol Fumarate|formoterol fumarate|mesh-list
6115227|NCT01069289|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6115228|NCT01069289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6115229|NCT01069289|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6115230|NCT01069289|Autonomic Agents|autonomic agents|mesh-ancestor
6115231|NCT01069289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6115232|NCT01069289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115233|NCT01069289|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6115234|NCT01069289|Respiratory System Agents|respiratory system agents|mesh-ancestor
6115235|NCT01069289|Glucocorticoids|glucocorticoids|mesh-ancestor
6115236|NCT01069289|Hormones|hormones|mesh-ancestor
6115237|NCT01069289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6115238|NCT01069289|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6115239|NCT01069289|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6115240|NCT01069289|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6115241|NCT01069289|Adrenergic Agents|adrenergic agents|mesh-ancestor
6115242|NCT01069289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6115243|NCT01069289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5530079|NCT04496219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5530080|NCT04496219|Immunologic Factors|immunologic factors|mesh-ancestor
5530081|NCT04496219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5530082|NCT04494412|Zanamivir|zanamivir|mesh-list
5530083|NCT04494412|Antiviral Agents|antiviral agents|mesh-ancestor
5530084|NCT04494412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5530085|NCT04494412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5530086|NCT04494412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5530087|NCT04405349|Atezolizumab|atezolizumab|mesh-list
5530088|NCT04405349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6115244|NCT01069341|Ranibizumab|ranibizumab|mesh-list
6115245|NCT01069341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6115246|NCT01069341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6115247|NCT01069341|Growth Substances|growth substances|mesh-ancestor
6115248|NCT01069341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115249|NCT01069341|Growth Inhibitors|growth inhibitors|mesh-ancestor
6115250|NCT01069341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6115251|NCT01069354|Lidocaine|lidocaine|mesh-list
6115252|NCT01069354|Anesthetics, Local|anesthetics, local|mesh-ancestor
6115253|NCT01069354|Anesthetics|anesthetics|mesh-ancestor
6115254|NCT01069354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6115255|NCT01069354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115256|NCT01069354|Sensory System Agents|sensory system agents|mesh-ancestor
5530098|NCT04373564|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
5530099|NCT04373564|Chelating Agents|chelating agents|mesh-ancestor
5530100|NCT04373564|Sequestering Agents|sequestering agents|mesh-ancestor
5530101|NCT04373564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115257|NCT01069354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6115258|NCT01069354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6115259|NCT01069354|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6115260|NCT01069354|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6115261|NCT01069354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6115262|NCT01069354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115263|NCT01069510|Spironolactone|spironolactone|mesh-list
6115264|NCT01069510|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6115265|NCT01069510|Hormone Antagonists|hormone antagonists|mesh-ancestor
6115266|NCT01069510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6115267|NCT01069510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115268|NCT01069510|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6115269|NCT01069510|Diuretics|diuretics|mesh-ancestor
6115270|NCT01069510|Natriuretic Agents|natriuretic agents|mesh-ancestor
6115271|NCT01069523|Guanfacine|guanfacine|mesh-list
6115272|NCT01069523|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6115273|NCT01069523|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6115274|NCT01069523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6115275|NCT01069523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6115276|NCT01069523|Adrenergic Agents|adrenergic agents|mesh-ancestor
6115277|NCT01069523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6115278|NCT01069523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115279|NCT01069523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115280|NCT01069627|Bevacizumab|bevacizumab|mesh-list
6115281|NCT01069627|Fotemustine|fotemustine|mesh-list
6115282|NCT01069627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6115283|NCT01069627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6115284|NCT01069627|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6115285|NCT01069627|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6115286|NCT01069627|Growth Substances|growth substances|mesh-ancestor
6115287|NCT01069627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115288|NCT01069627|Growth Inhibitors|growth inhibitors|mesh-ancestor
6115289|NCT01069705|Tobramycin|tobramycin|mesh-list
6115290|NCT01069705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6115291|NCT01069705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6115292|NCT01069900|Amoxicillin|amoxicillin|mesh-list
6115293|NCT01069900|Moxifloxacin|moxifloxacin|mesh-list
6115294|NCT01069900|Clavulanic Acid|clavulanic acid|mesh-list
6115295|NCT01069900|Clavulanic Acids|clavulanic acids|mesh-list
6115296|NCT01069900|Ertapenem|ertapenem|mesh-list
6115297|NCT01069900|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6115298|NCT01069900|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6115299|NCT01069900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6115300|NCT01069900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6115301|NCT01069900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6115302|NCT01069900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6115303|NCT01069900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6115304|NCT01069900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115305|NCT01069900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6115306|NCT01069900|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6115307|NCT01069900|Contraceptive Agents|contraceptive agents|mesh-ancestor
6115308|NCT01069900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6115309|NCT01069900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115310|NCT01069900|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6115311|NCT01069900|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6115312|NCT01069900|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6115313|NCT01069900|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6115314|NCT01069939|Esomeprazole|esomeprazole|mesh-list
6115315|NCT01069939|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6115316|NCT01069939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6115317|NCT01069939|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6115318|NCT01069939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6115319|NCT01069939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115320|NCT01070043|Amlodipine|amlodipine|mesh-list
6115321|NCT01070043|Valsartan|valsartan|mesh-list
6666068|NCT01520415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666069|NCT01520441|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6666070|NCT01520441|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6666071|NCT01520441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6666072|NCT01520441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666073|NCT01520441|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6666074|NCT01520441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6666075|NCT01520441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666076|NCT01520441|Cholinergic Agents|cholinergic agents|mesh-ancestor
6666077|NCT01520441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6666078|NCT01520467|Anastrozole|anastrozole|mesh-list
6666079|NCT01520467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6666080|NCT01520467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6666081|NCT01520467|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6666082|NCT01520467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6115322|NCT01070043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6115323|NCT01070043|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6115324|NCT01070043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6115325|NCT01070043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115326|NCT01070043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6115327|NCT01070043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115328|NCT01070043|Vasodilator Agents|vasodilator agents|mesh-ancestor
6115329|NCT01070043|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6115330|NCT01070043|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6115331|NCT01070303|Adalimumab|adalimumab|mesh-list
6115332|NCT01070303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6115333|NCT01070303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6115334|NCT01070316|Everolimus|everolimus|mesh-list
6115335|NCT01070316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6115336|NCT01070316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6115337|NCT01070316|Immunologic Factors|immunologic factors|mesh-ancestor
6115338|NCT01070316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115339|NCT01070329|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6115340|NCT01070329|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6115341|NCT01070329|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6115342|NCT01070329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6115343|NCT01070329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115344|NCT01070329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6115345|NCT01070329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115346|NCT01070329|Analgesics|analgesics|mesh-ancestor
6115347|NCT01070329|Sensory System Agents|sensory system agents|mesh-ancestor
6115348|NCT01070329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6115349|NCT01070329|Antidepressive Agents|antidepressive agents|mesh-ancestor
6115350|NCT01070329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6115351|NCT01070329|Dopamine Agents|dopamine agents|mesh-ancestor
6115352|NCT01070394|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6115353|NCT01070394|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6115354|NCT01070394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115355|NCT01070394|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6115356|NCT01070394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6115357|NCT01070394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6115358|NCT01070394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115359|NCT01070394|Dopamine Agents|dopamine agents|mesh-ancestor
6115360|NCT01070394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6115361|NCT01070550|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6115362|NCT01070550|Antiviral Agents|antiviral agents|mesh-ancestor
6115363|NCT01070550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6115364|NCT01070784|Budesonide|budesonide|mesh-list
6115365|NCT01070784|Formoterol Fumarate|formoterol fumarate|mesh-list
6115366|NCT01070784|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6115367|NCT01070784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6115368|NCT01070784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6115369|NCT01070784|Autonomic Agents|autonomic agents|mesh-ancestor
6115370|NCT01070784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6115371|NCT01070784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115372|NCT01070784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6115373|NCT01070784|Respiratory System Agents|respiratory system agents|mesh-ancestor
6115374|NCT01070784|Glucocorticoids|glucocorticoids|mesh-ancestor
6115375|NCT01070784|Hormones|hormones|mesh-ancestor
6115376|NCT01070784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6115377|NCT01070784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6115378|NCT01070784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6115379|NCT01070784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6115380|NCT01070784|Adrenergic Agents|adrenergic agents|mesh-ancestor
6115381|NCT01070784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6115382|NCT01070784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115383|NCT01070810|Thiamine|thiamine|mesh-list
6115384|NCT01070810|Vitamin B Complex|vitamin b complex|mesh-ancestor
6115385|NCT01070810|Vitamins|vitamins|mesh-ancestor
6115386|NCT01070810|Micronutrients|micronutrients|mesh-ancestor
6666083|NCT01520467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6666084|NCT01520467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666085|NCT01520467|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6666086|NCT01520467|Hormone Antagonists|hormone antagonists|mesh-ancestor
6666087|NCT01520467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6666088|NCT01520467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666089|NCT01520584|Vitamins|vitamins|mesh-list
6666090|NCT01520584|Micronutrients|micronutrients|mesh-ancestor
6666091|NCT01520584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666092|NCT01520753|Insulin|insulin|mesh-list
6666093|NCT01520753|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6666094|NCT01520753|Insulin Aspart|insulin aspart|mesh-list
6115387|NCT01070810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115388|NCT01070888|Budesonide|budesonide|mesh-list
6115389|NCT01070888|Formoterol Fumarate|formoterol fumarate|mesh-list
6115390|NCT01070888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6115391|NCT01070888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6115392|NCT01070888|Autonomic Agents|autonomic agents|mesh-ancestor
6115393|NCT01070888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6115394|NCT01070888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115395|NCT01070888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6115396|NCT01070888|Respiratory System Agents|respiratory system agents|mesh-ancestor
6115397|NCT01070888|Glucocorticoids|glucocorticoids|mesh-ancestor
6115398|NCT01070888|Hormones|hormones|mesh-ancestor
6115399|NCT01070888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6115400|NCT01070888|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6115401|NCT01070888|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5530121|NCT04272242|Pyridoxine|pyridoxine|mesh-list
6115402|NCT01070888|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6115403|NCT01070888|Adrenergic Agents|adrenergic agents|mesh-ancestor
6115404|NCT01070888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6204433|NCT02070302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5530122|NCT04272242|Pyridoxal|pyridoxal|mesh-list
5530123|NCT04272242|Vitamin B 6|vitamin b 6|mesh-list
5530124|NCT04272242|Isoniazid|isoniazid|mesh-list
5530125|NCT04272242|Rifapentine|rifapentine|mesh-list
5530126|NCT04272242|Dolutegravir|dolutegravir|mesh-list
5530127|NCT04272242|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
5530128|NCT04272242|Vitamins|vitamins|mesh-ancestor
5530129|NCT04272242|Micronutrients|micronutrients|mesh-ancestor
5530130|NCT04272242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5530131|NCT04272242|Vitamin B Complex|vitamin b complex|mesh-ancestor
5530132|NCT04272242|Antitubercular Agents|antitubercular agents|mesh-ancestor
5530133|NCT04272242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5530134|NCT04272242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5530135|NCT04272242|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5530136|NCT04272242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5530137|NCT04272242|Antimetabolites|antimetabolites|mesh-ancestor
5530138|NCT04272242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115405|NCT01070888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115406|NCT01070979|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6115407|NCT01070979|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6115408|NCT01070979|Estradiol|estradiol|mesh-list
6115409|NCT01070979|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6115410|NCT01070979|Estrogens|estrogens|mesh-list
6115411|NCT01070979|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6115412|NCT01070979|Hormones|hormones|mesh-ancestor
6115413|NCT01070979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6115414|NCT01070979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115415|NCT01070979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6115416|NCT01070979|Contraceptive Agents|contraceptive agents|mesh-ancestor
6115417|NCT01070979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6115418|NCT01070979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6115419|NCT01071044|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6115420|NCT01071044|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6115421|NCT01071044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115422|NCT01071044|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6115423|NCT01071044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6115424|NCT01071044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6115425|NCT01071044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115426|NCT01071044|Dopamine Agents|dopamine agents|mesh-ancestor
6115427|NCT01071044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6115428|NCT01071083|Interferons|interferons|mesh-list
6115429|NCT01071083|Interferon-beta|interferon-beta|mesh-list
6115430|NCT01071083|Interferon beta-1a|interferon beta-1a|mesh-list
6115431|NCT01071083|Methylprednisolone|methylprednisolone|mesh-list
6115432|NCT01071083|Glatiramer Acetate|glatiramer acetate|mesh-list
6115433|NCT01071083|Natalizumab|natalizumab|mesh-list
6115434|NCT01071083|(T,G)-A-L|(t,g)-a-l|mesh-list
6115435|NCT01071083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6115436|NCT01071083|Antiviral Agents|antiviral agents|mesh-ancestor
6115437|NCT01071083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6115438|NCT01071083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6115439|NCT01071083|Antiemetics|antiemetics|mesh-ancestor
6115440|NCT01071083|Autonomic Agents|autonomic agents|mesh-ancestor
6115441|NCT01071083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6115442|NCT01071083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115443|NCT01071083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6115444|NCT01071083|Glucocorticoids|glucocorticoids|mesh-ancestor
6115445|NCT01071083|Hormones|hormones|mesh-ancestor
6115446|NCT01071083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6115447|NCT01071083|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6115448|NCT01071083|Protective Agents|protective agents|mesh-ancestor
6115449|NCT01071083|Immunologic Factors|immunologic factors|mesh-ancestor
6115450|NCT01071083|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6115451|NCT01071083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6115452|NCT01071083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6115453|NCT01071096|Botulinum Toxins|botulinum toxins|mesh-list
6115454|NCT01071096|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6115455|NCT01071096|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6115456|NCT01071096|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6115457|NCT01071096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6115458|NCT01071096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115459|NCT01071096|Cholinergic Agents|cholinergic agents|mesh-ancestor
6115460|NCT01071096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6115461|NCT01071096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115462|NCT01071096|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5530139|NCT04272242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5530140|NCT04272242|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6115463|NCT01071096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5530141|NCT04272242|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5530142|NCT04272242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5530143|NCT04272242|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5530144|NCT04272242|Antiviral Agents|antiviral agents|mesh-ancestor
5530145|NCT04272242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5530146|NCT04272242|Leprostatic Agents|leprostatic agents|mesh-ancestor
5530147|NCT04233801|Empagliflozin|empagliflozin|mesh-list
5530148|NCT04233801|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5530149|NCT04233801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5530150|NCT04233801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5530151|NCT04233801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115464|NCT01071200|Hormones|hormones|mesh-list
6115465|NCT01071200|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6115466|NCT01071200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6115467|NCT01071200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115468|NCT01071317|Naproxen|naproxen|mesh-list
6115469|NCT01071317|Sumatriptan|sumatriptan|mesh-list
6115470|NCT01071317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6115471|NCT01071317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6115472|NCT01071317|Analgesics|analgesics|mesh-ancestor
6115473|NCT01071317|Sensory System Agents|sensory system agents|mesh-ancestor
6115474|NCT01071317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6115475|NCT01071317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115476|NCT01071317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6115477|NCT01071317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6115478|NCT01071317|Gout Suppressants|gout suppressants|mesh-ancestor
6115479|NCT01071317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6115480|NCT01071317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6115481|NCT01071317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5530157|NCT04191499|Fulvestrant|fulvestrant|mesh-list
5530158|NCT04191499|Palbociclib|palbociclib|mesh-list
5530159|NCT04191499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5530160|NCT04191499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5530161|NCT04191499|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6115482|NCT01071317|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6115483|NCT01071317|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6115484|NCT01071317|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6115485|NCT01071317|Serotonin Agents|serotonin agents|mesh-ancestor
6115486|NCT01071317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6115487|NCT01071395|Amantadine|amantadine|mesh-list
6115488|NCT01071395|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6115489|NCT01071395|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5530162|NCT04191499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5530163|NCT04191499|Hormone Antagonists|hormone antagonists|mesh-ancestor
5530164|NCT04191499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5530165|NCT04191499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5530166|NCT04191499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5530167|NCT04191499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5530168|NCT04191499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5530169|NCT04191304|Benralizumab|benralizumab|mesh-list
5530170|NCT04191304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5530171|NCT04191304|Respiratory System Agents|respiratory system agents|mesh-ancestor
6115490|NCT01071395|Antiviral Agents|antiviral agents|mesh-ancestor
6115491|NCT01071395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6115492|NCT01071395|Dopamine Agents|dopamine agents|mesh-ancestor
6115493|NCT01071395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6115494|NCT01071395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115495|NCT01071395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115496|NCT01071395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6115497|NCT01071395|Analgesics|analgesics|mesh-ancestor
6115498|NCT01071395|Sensory System Agents|sensory system agents|mesh-ancestor
5530172|NCT04173312|Bupivacaine|bupivacaine|mesh-list
5530173|NCT04173312|Anesthetics, Local|anesthetics, local|mesh-ancestor
5530174|NCT04173312|Anesthetics|anesthetics|mesh-ancestor
5530175|NCT04173312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5530176|NCT04173312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115499|NCT01071395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6115500|NCT01071512|Natalizumab|natalizumab|mesh-list
6115501|NCT01071512|Immunologic Factors|immunologic factors|mesh-ancestor
6115502|NCT01071512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5530177|NCT04173312|Sensory System Agents|sensory system agents|mesh-ancestor
5530178|NCT04173312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5530179|NCT04171453|Pregabalin|pregabalin|mesh-list
6115503|NCT01071538|Buprenorphine|buprenorphine|mesh-list
6115504|NCT01071538|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6115505|NCT01071538|Narcotics|narcotics|mesh-ancestor
6115506|NCT01071538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6115507|NCT01071538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115508|NCT01071538|Analgesics|analgesics|mesh-ancestor
6115509|NCT01071538|Sensory System Agents|sensory system agents|mesh-ancestor
6115510|NCT01071538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6115511|NCT01071538|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6115512|NCT01071798|Rituximab|rituximab|mesh-list
6115513|NCT01071798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6115514|NCT01071798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6115515|NCT01071798|Immunologic Factors|immunologic factors|mesh-ancestor
6115516|NCT01071798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115517|NCT01071798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6115518|NCT01072136|Azithromycin|azithromycin|mesh-list
6115519|NCT01072136|Cefixime|cefixime|mesh-list
6115520|NCT01072136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6115521|NCT01072136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6115522|NCT01072149|Fluticasone|fluticasone|mesh-list
6115523|NCT01072149|Xhance|xhance|mesh-list
6115524|NCT01072149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6115525|NCT01072149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6115526|NCT01072149|Autonomic Agents|autonomic agents|mesh-ancestor
6115527|NCT01072149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6115528|NCT01072149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115529|NCT01072149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6115530|NCT01072149|Respiratory System Agents|respiratory system agents|mesh-ancestor
6115531|NCT01072149|Dermatologic Agents|dermatologic agents|mesh-ancestor
6115532|NCT01072149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6115533|NCT01072188|Calcium Carbonate|calcium carbonate|mesh-list
6115534|NCT01072188|Calcium|calcium|mesh-list
6115535|NCT01072188|Fluorides|fluorides|mesh-list
6115536|NCT01072188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6115537|NCT01072188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115538|NCT01072188|Cariostatic Agents|cariostatic agents|mesh-ancestor
6115539|NCT01072188|Protective Agents|protective agents|mesh-ancestor
6115540|NCT01072188|Antacids|antacids|mesh-ancestor
6115541|NCT01072188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115542|NCT01072188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6115543|NCT01072201|Triclosan|triclosan|mesh-list
6115544|NCT01072201|Fluorides|fluorides|mesh-list
6115545|NCT01072201|Cariostatic Agents|cariostatic agents|mesh-ancestor
6115546|NCT01072201|Protective Agents|protective agents|mesh-ancestor
6115547|NCT01072201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115548|NCT01072201|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6115549|NCT01072201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6115550|NCT01072201|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6115551|NCT01072201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6115552|NCT01072201|Antimetabolites|antimetabolites|mesh-ancestor
6115553|NCT01072201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115554|NCT01072201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6115555|NCT01072357|Bevacizumab|bevacizumab|mesh-list
6115556|NCT01072357|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6115557|NCT01072357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6115558|NCT01072357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6115559|NCT01072357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6115560|NCT01072357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6115561|NCT01072357|Growth Substances|growth substances|mesh-ancestor
6115562|NCT01072357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115563|NCT01072357|Growth Inhibitors|growth inhibitors|mesh-ancestor
6115564|NCT01072357|Laxatives|laxatives|mesh-ancestor
6115565|NCT01072357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6115566|NCT01072396|Tiotropium Bromide|tiotropium bromide|mesh-list
6115567|NCT01072396|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6115568|NCT01072396|Autonomic Agents|autonomic agents|mesh-ancestor
6115569|NCT01072396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6115570|NCT01072396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115571|NCT01072396|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6115572|NCT01072396|Respiratory System Agents|respiratory system agents|mesh-ancestor
6115573|NCT01072396|Parasympatholytics|parasympatholytics|mesh-ancestor
6115574|NCT01072396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6115575|NCT01072396|Cholinergic Agents|cholinergic agents|mesh-ancestor
6115576|NCT01072396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6115577|NCT01072396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115578|NCT01072539|Tigecycline|tigecycline|mesh-list
6115579|NCT01072539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6115580|NCT01072539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6115581|NCT01072539|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6115582|NCT01072539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5530180|NCT04171453|Analgesics|analgesics|mesh-ancestor
5530181|NCT04171453|Sensory System Agents|sensory system agents|mesh-ancestor
5530182|NCT04171453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5530183|NCT04171453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5530184|NCT04171453|Anticonvulsants|anticonvulsants|mesh-ancestor
5530185|NCT04171453|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6115583|NCT01072539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115584|NCT01072630|Modafinil|modafinil|mesh-list
6115585|NCT01072630|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6115586|NCT01072630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115587|NCT01072630|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6115588|NCT01072630|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6115589|NCT01072630|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6115590|NCT01072630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115591|NCT01072643|Dexmedetomidine|dexmedetomidine|mesh-list
6115592|NCT01072643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6115593|NCT01072643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6115594|NCT01072643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115595|NCT01072643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6115596|NCT01072643|Analgesics|analgesics|mesh-ancestor
6115597|NCT01072643|Sensory System Agents|sensory system agents|mesh-ancestor
6115598|NCT01072643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6115599|NCT01072643|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6115600|NCT01072643|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6115601|NCT01072643|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6115602|NCT01072643|Adrenergic Agents|adrenergic agents|mesh-ancestor
6115603|NCT01072643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6115604|NCT01072643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115605|NCT01072669|Ambrisentan|ambrisentan|mesh-list
6115606|NCT01072669|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6115607|NCT01072773|Dexamethasone|dexamethasone|mesh-list
6115608|NCT01072773|Cyclophosphamide|cyclophosphamide|mesh-list
6115609|NCT01072773|Bortezomib|bortezomib|mesh-list
6115610|NCT01072773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6115611|NCT01072773|Immunologic Factors|immunologic factors|mesh-ancestor
6115612|NCT01072773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115613|NCT01072773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6115614|NCT01072773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6115615|NCT01072773|Alkylating Agents|alkylating agents|mesh-ancestor
6115616|NCT01072773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115617|NCT01072773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6115618|NCT01072773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6115619|NCT01072773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6115620|NCT01072773|Antiemetics|antiemetics|mesh-ancestor
6115621|NCT01072773|Autonomic Agents|autonomic agents|mesh-ancestor
6115622|NCT01072773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6115623|NCT01072773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6115624|NCT01072773|Glucocorticoids|glucocorticoids|mesh-ancestor
6115625|NCT01072773|Hormones|hormones|mesh-ancestor
6115626|NCT01072773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6115627|NCT01072773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6115628|NCT01072877|Polidocanol|polidocanol|mesh-list
6115629|NCT01072877|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
6115630|NCT01072877|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6115631|NCT01072929|Modafinil|modafinil|mesh-list
6115632|NCT01072929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6115633|NCT01072929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115634|NCT01072929|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6115635|NCT01072929|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6115636|NCT01072929|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6115637|NCT01072929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115638|NCT01073163|Rituximab|rituximab|mesh-list
5530186|NCT04171453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5530187|NCT04171453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5530188|NCT04171453|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5530189|NCT04171453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5530190|NCT04171453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5530191|NCT04171453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5530192|NCT04171453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6115639|NCT01073163|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6115640|NCT01073163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6115641|NCT01073163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6115642|NCT01073163|Immunologic Factors|immunologic factors|mesh-ancestor
6115643|NCT01073163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115644|NCT01073163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6115645|NCT01073163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6115646|NCT01073163|Alkylating Agents|alkylating agents|mesh-ancestor
6115647|NCT01073163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115648|NCT01073566|Insulin|insulin|mesh-list
6115649|NCT01073566|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5530206|NCT04160325|Azathioprine|azathioprine|mesh-list
5530207|NCT04160325|Antimetabolites|antimetabolites|mesh-ancestor
5530208|NCT04160325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5530209|NCT04160325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5530210|NCT04160325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5530211|NCT04160325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5530212|NCT04160325|Immunologic Factors|immunologic factors|mesh-ancestor
5530213|NCT04160325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115650|NCT01073566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6115651|NCT01073566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115652|NCT01073618|Voriconazole|voriconazole|mesh-list
6115653|NCT01073618|Antifungal Agents|antifungal agents|mesh-ancestor
6115654|NCT01073618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6115655|NCT01073618|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6115656|NCT01073618|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6115657|NCT01073618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6115658|NCT01073618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115659|NCT01073618|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6115660|NCT01073618|Hormone Antagonists|hormone antagonists|mesh-ancestor
6115661|NCT01073618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6115662|NCT01073618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115663|NCT01073618|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6115664|NCT01073631|Voriconazole|voriconazole|mesh-list
6115665|NCT01073631|Antifungal Agents|antifungal agents|mesh-ancestor
6115666|NCT01073631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6115667|NCT01073631|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6115668|NCT01073631|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6115669|NCT01073631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6115670|NCT01073631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5530214|NCT04160325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5530215|NCT04157348|Benralizumab|benralizumab|mesh-list
5530216|NCT04157348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5530217|NCT04157348|Respiratory System Agents|respiratory system agents|mesh-ancestor
5530218|NCT04136353|Hormones|hormones|mesh-list
5530219|NCT04136353|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
5530220|NCT04136353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5530221|NCT04136353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5530222|NCT04126083|Lofexidine|lofexidine|mesh-list
5530223|NCT04126083|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5530224|NCT04126083|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5530225|NCT04126083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5530226|NCT04126083|Sensory System Agents|sensory system agents|mesh-ancestor
5530227|NCT04126083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5530228|NCT04126083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5530229|NCT04126083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5530230|NCT04126083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5530231|NCT04126083|Adrenergic Agents|adrenergic agents|mesh-ancestor
6115671|NCT01073631|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6115672|NCT01073631|Hormone Antagonists|hormone antagonists|mesh-ancestor
6115673|NCT01073631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6115674|NCT01073631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115675|NCT01073631|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6115676|NCT01073865|Goserelin|goserelin|mesh-list
6115677|NCT01073865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6115678|NCT01073865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6115679|NCT01073930|Bisacodyl|bisacodyl|mesh-list
6115680|NCT01073930|Picosulfate sodium|picosulfate sodium|mesh-list
6115681|NCT01073930|Cathartics|cathartics|mesh-ancestor
6115682|NCT01073930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6115683|NCT01073930|Laxatives|laxatives|mesh-ancestor
5530232|NCT04126083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6115684|NCT01073943|Bisacodyl|bisacodyl|mesh-list
6115685|NCT01073943|Picosulfate sodium|picosulfate sodium|mesh-list
6115686|NCT01073943|Cathartics|cathartics|mesh-ancestor
6115687|NCT01073943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6115688|NCT01073943|Laxatives|laxatives|mesh-ancestor
6115689|NCT01074008|Ritonavir|ritonavir|mesh-list
6115690|NCT01074008|Ribavirin|ribavirin|mesh-list
6115691|NCT01074008|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6115692|NCT01074008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6115693|NCT01074008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6115694|NCT01074008|Protease Inhibitors|protease inhibitors|mesh-ancestor
6115695|NCT01074008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6115696|NCT01074008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115697|NCT01074008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6115698|NCT01074008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6115699|NCT01074008|Antiviral Agents|antiviral agents|mesh-ancestor
6115700|NCT01074008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5530233|NCT04126083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5530234|NCT04122625|Nivolumab|nivolumab|mesh-list
5530235|NCT04122625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5530236|NCT04122625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5530237|NCT04122625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5530238|NCT04122625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5530239|NCT04099797|Cyclophosphamide|cyclophosphamide|mesh-list
5530240|NCT04099797|Fludarabine|fludarabine|mesh-list
5530241|NCT04099797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5530242|NCT04099797|Immunologic Factors|immunologic factors|mesh-ancestor
5530243|NCT04099797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5530244|NCT04099797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5530245|NCT04099797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5530246|NCT04099797|Alkylating Agents|alkylating agents|mesh-ancestor
5530247|NCT04099797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5530248|NCT04099797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5530249|NCT04099797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5530250|NCT04098744|Artesunate|artesunate|mesh-list
5530251|NCT04098744|Artemisinins|artemisinins|mesh-list
5530252|NCT04098744|Artemisinin|artemisinin|mesh-list
5530253|NCT04098744|Antimalarials|antimalarials|mesh-ancestor
5530254|NCT04098744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5530255|NCT04098744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5530256|NCT04098744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5530257|NCT04098744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5530258|NCT04098744|Antiviral Agents|antiviral agents|mesh-ancestor
6115701|NCT01074008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6115702|NCT01074008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6115703|NCT01074008|Antimetabolites|antimetabolites|mesh-ancestor
6115704|NCT01074047|Azacitidine|azacitidine|mesh-list
6115705|NCT01074047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6115706|NCT01074047|Antimetabolites|antimetabolites|mesh-ancestor
6115707|NCT01074047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115708|NCT01074047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6115709|NCT01074047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6115710|NCT01074177|Afatinib|afatinib|mesh-list
6115711|NCT01074177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6115712|NCT01074177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6115713|NCT01074177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6115714|NCT01074177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5530259|NCT04098744|Schistosomicides|schistosomicides|mesh-ancestor
5530260|NCT04098744|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5530261|NCT04098744|Anthelmintics|anthelmintics|mesh-ancestor
6115715|NCT01074216|Vitamin D|vitamin d|mesh-list
6115716|NCT01074216|Ergocalciferols|ergocalciferols|mesh-list
6115717|NCT01074216|Cholecalciferol|cholecalciferol|mesh-list
6115718|NCT01074216|Vitamins|vitamins|mesh-list
6115719|NCT01074216|Micronutrients|micronutrients|mesh-ancestor
6115720|NCT01074216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115721|NCT01074216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6115722|NCT01074216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6204434|NCT02070692|Tamoxifen|tamoxifen|mesh-list
6204435|NCT02070692|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6204436|NCT02070692|Hormone Antagonists|hormone antagonists|mesh-ancestor
6204437|NCT02070692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6204438|NCT02070692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204439|NCT02070692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6204440|NCT02070692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6204441|NCT02070692|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6115723|NCT01074229|Ropivacaine|ropivacaine|mesh-list
6115724|NCT01074229|Anesthetics, Local|anesthetics, local|mesh-ancestor
6115725|NCT01074229|Anesthetics|anesthetics|mesh-ancestor
6115726|NCT01074229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6115727|NCT01074229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115728|NCT01074229|Sensory System Agents|sensory system agents|mesh-ancestor
6115729|NCT01074229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6115730|NCT01074255|Aprepitant|aprepitant|mesh-list
6115731|NCT01074255|Antiemetics|antiemetics|mesh-ancestor
6115732|NCT01074255|Autonomic Agents|autonomic agents|mesh-ancestor
6115733|NCT01074255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6115734|NCT01074255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115735|NCT01074255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6115736|NCT01074255|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6115737|NCT01074255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6115738|NCT01074255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115739|NCT01074268|Insulin|insulin|mesh-list
6115740|NCT01074268|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6115741|NCT01074268|Insulin Aspart|insulin aspart|mesh-list
6115742|NCT01074268|Insulin Detemir|insulin detemir|mesh-list
6115743|NCT01074268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6115744|NCT01074268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115745|NCT01074307|Bisoprolol|bisoprolol|mesh-list
6115746|NCT01074307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6115747|NCT01074307|Sympatholytics|sympatholytics|mesh-ancestor
6115748|NCT01074307|Autonomic Agents|autonomic agents|mesh-ancestor
6115749|NCT01074307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6115750|NCT01074307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115751|NCT01074307|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6115752|NCT01074307|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6115753|NCT01074307|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6115754|NCT01074307|Adrenergic Agents|adrenergic agents|mesh-ancestor
6115755|NCT01074307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6115756|NCT01074307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115757|NCT01074450|Pramipexole|pramipexole|mesh-list
6115758|NCT01074450|Antioxidants|antioxidants|mesh-ancestor
6115759|NCT01074450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115760|NCT01074450|Protective Agents|protective agents|mesh-ancestor
6115761|NCT01074450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115762|NCT01074450|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6115763|NCT01074450|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6115764|NCT01074450|Dopamine Agonists|dopamine agonists|mesh-ancestor
6115765|NCT01074450|Dopamine Agents|dopamine agents|mesh-ancestor
6115766|NCT01074450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6115767|NCT01074463|Pramipexole|pramipexole|mesh-list
6115768|NCT01074463|Antioxidants|antioxidants|mesh-ancestor
6115769|NCT01074463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115770|NCT01074463|Protective Agents|protective agents|mesh-ancestor
6115771|NCT01074463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115772|NCT01074463|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6115773|NCT01074463|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6115774|NCT01074463|Dopamine Agonists|dopamine agonists|mesh-ancestor
6115775|NCT01074463|Dopamine Agents|dopamine agents|mesh-ancestor
6115776|NCT01074463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6115777|NCT01074554|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6115778|NCT01074554|Azithromycin|azithromycin|mesh-list
6115779|NCT01074554|Levofloxacin|levofloxacin|mesh-list
6115780|NCT01074554|Rifampin|rifampin|mesh-list
6115781|NCT01074554|Ethambutol|ethambutol|mesh-list
6115782|NCT01074554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6115783|NCT01074554|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6115784|NCT01074554|Antitubercular Agents|antitubercular agents|mesh-ancestor
6115785|NCT01074554|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6115786|NCT01074554|Renal Agents|renal agents|mesh-ancestor
6115787|NCT01074554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6115788|NCT01074554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6115789|NCT01074554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6115790|NCT01074554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115791|NCT01074554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6115792|NCT01074554|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6115793|NCT01074554|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6115794|NCT01074554|Leprostatic Agents|leprostatic agents|mesh-ancestor
6115795|NCT01074554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6115796|NCT01074554|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6115797|NCT01074554|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6115798|NCT01074554|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6115799|NCT01074554|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6115800|NCT01074554|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6115801|NCT01074554|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6115802|NCT01074931|Ritonavir|ritonavir|mesh-list
6115803|NCT01074931|Lopinavir|lopinavir|mesh-list
6115804|NCT01074931|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6115805|NCT01074931|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6115806|NCT01074931|Protease Inhibitors|protease inhibitors|mesh-ancestor
6115807|NCT01074931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6115808|NCT01074931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115809|NCT01074931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6115810|NCT01074931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6115811|NCT01074931|Antiviral Agents|antiviral agents|mesh-ancestor
6115812|NCT01074931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6115813|NCT01074931|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6115814|NCT01074931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6115815|NCT01074944|Eliglustat|eliglustat|mesh-list
6115816|NCT01074944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6115817|NCT01074944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115818|NCT01075048|Irinotecan|irinotecan|mesh-list
6115819|NCT01075048|Cetuximab|cetuximab|mesh-list
6115820|NCT01075048|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6115821|NCT01075048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6115822|NCT01075048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6115823|NCT01075048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115824|NCT01075048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6115825|NCT01075048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6115826|NCT01075087|Ropivacaine|ropivacaine|mesh-list
6115827|NCT01075087|Anesthetics, Local|anesthetics, local|mesh-ancestor
6115828|NCT01075087|Anesthetics|anesthetics|mesh-ancestor
6115829|NCT01075087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6115830|NCT01075087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115831|NCT01075087|Sensory System Agents|sensory system agents|mesh-ancestor
6115832|NCT01075087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6115833|NCT01075100|Carboplatin|carboplatin|mesh-list
6115834|NCT01075100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6115835|NCT01075152|Lamivudine|lamivudine|mesh-list
6115836|NCT01075152|Zidovudine|zidovudine|mesh-list
6115837|NCT01075152|Efavirenz|efavirenz|mesh-list
6115838|NCT01075152|Stavudine|stavudine|mesh-list
6115839|NCT01075152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6115840|NCT01075152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6115841|NCT01075152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6115842|NCT01075152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115843|NCT01075152|Antiviral Agents|antiviral agents|mesh-ancestor
6115844|NCT01075152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6115845|NCT01075152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6115846|NCT01075152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6115847|NCT01075152|Antimetabolites|antimetabolites|mesh-ancestor
6115848|NCT01075152|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6115849|NCT01075152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6115850|NCT01075152|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6115851|NCT01075152|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6115852|NCT01075152|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6115853|NCT01075152|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6115854|NCT01075204|Clarithromycin|clarithromycin|mesh-list
6115855|NCT01075204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6115856|NCT01075204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6115857|NCT01075204|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6115858|NCT01075204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6115859|NCT01075204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115860|NCT01075204|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6115861|NCT01075204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6115862|NCT01075243|Acetaminophen|acetaminophen|mesh-list
6115863|NCT01075243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6115864|NCT01075243|Analgesics|analgesics|mesh-ancestor
6115865|NCT01075243|Sensory System Agents|sensory system agents|mesh-ancestor
6115866|NCT01075243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6115867|NCT01075243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115868|NCT01075243|Antipyretics|antipyretics|mesh-ancestor
6115869|NCT01075256|Calcium, Dietary|calcium, dietary|mesh-list
6115870|NCT01075256|Calcium|calcium|mesh-list
6115871|NCT01075256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6115872|NCT01075256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5530295|NCT04075292|Rituximab|rituximab|mesh-list
5530296|NCT04075292|Acalabrutinib|acalabrutinib|mesh-list
5530297|NCT04075292|Chlorambucil|chlorambucil|mesh-list
5530298|NCT04075292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5530299|NCT04075292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5530300|NCT04075292|Immunologic Factors|immunologic factors|mesh-ancestor
5530301|NCT04075292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5530302|NCT04075292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5530303|NCT04075292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5530304|NCT04075292|Alkylating Agents|alkylating agents|mesh-ancestor
5530305|NCT04075292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115873|NCT01075256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6115874|NCT01075282|Metformin|metformin|mesh-list
6115875|NCT01075282|Insulin Glargine|insulin glargine|mesh-list
5530309|NCT04004845|Misoprostol|misoprostol|mesh-list
5530310|NCT04004845|Oxytocin|oxytocin|mesh-list
5530311|NCT04004845|Oxytocics|oxytocics|mesh-ancestor
5530312|NCT04004845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5530313|NCT04004845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5530314|NCT04004845|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5530315|NCT04004845|Abortifacient Agents|abortifacient agents|mesh-ancestor
5530316|NCT04004845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5530317|NCT04004845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6115876|NCT01075282|Glimepiride|glimepiride|mesh-list
6115877|NCT01075282|Dulaglutide|dulaglutide|mesh-list
6115878|NCT01075282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6115879|NCT01075282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115880|NCT01075282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6115881|NCT01075282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6115882|NCT01075282|Immunologic Factors|immunologic factors|mesh-ancestor
6115883|NCT01075321|Lenalidomide|lenalidomide|mesh-list
6115884|NCT01075321|Everolimus|everolimus|mesh-list
6115885|NCT01075321|Immunologic Factors|immunologic factors|mesh-ancestor
6115886|NCT01075321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5530329|NCT03899857|Pembrolizumab|pembrolizumab|mesh-list
6115887|NCT01075321|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6115888|NCT01075321|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6115889|NCT01075321|Growth Substances|growth substances|mesh-ancestor
6115890|NCT01075321|Growth Inhibitors|growth inhibitors|mesh-ancestor
6115891|NCT01075321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6115892|NCT01075321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6115893|NCT01075399|Imidazole|imidazole|mesh-list
6115894|NCT01075399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6115895|NCT01075399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115896|NCT01075646|Ropivacaine|ropivacaine|mesh-list
6115897|NCT01075646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6115898|NCT01075646|Anesthetics, Local|anesthetics, local|mesh-ancestor
6115899|NCT01075646|Anesthetics|anesthetics|mesh-ancestor
6115900|NCT01075646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6115901|NCT01075646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115902|NCT01075646|Sensory System Agents|sensory system agents|mesh-ancestor
6115903|NCT01075646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6115904|NCT01075763|Interferons|interferons|mesh-list
6115905|NCT01075763|Interferon-beta|interferon-beta|mesh-list
6115906|NCT01075763|Interferon beta-1a|interferon beta-1a|mesh-list
5530330|NCT03899857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5725371|NCT03180723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725372|NCT03180723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5725373|NCT03180723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5725374|NCT03180723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725375|NCT03180723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5725376|NCT03180723|Antifungal Agents|antifungal agents|mesh-ancestor
5725377|NCT03180723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5725378|NCT03180723|Dermatologic Agents|dermatologic agents|mesh-ancestor
5725379|NCT03180723|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5725380|NCT03180736|Dexamethasone|dexamethasone|mesh-list
5725381|NCT03180736|Daratumumab|daratumumab|mesh-list
5725382|NCT03180736|Pomalidomide|pomalidomide|mesh-list
5725383|NCT03180736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5725384|NCT03180736|Antiemetics|antiemetics|mesh-ancestor
5725385|NCT03180736|Autonomic Agents|autonomic agents|mesh-ancestor
5725386|NCT03180736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5725387|NCT03180736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725388|NCT03180736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6115907|NCT01075763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6115908|NCT01075763|Antiviral Agents|antiviral agents|mesh-ancestor
5530331|NCT03899857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5530332|NCT03870880|Risperidone|risperidone|mesh-list
5530333|NCT03870880|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5530334|NCT03870880|Serotonin Agents|serotonin agents|mesh-ancestor
5530335|NCT03870880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5530336|NCT03870880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5530337|NCT03870880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115909|NCT01075763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6115910|NCT01075763|Immunologic Factors|immunologic factors|mesh-ancestor
6115911|NCT01075763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115912|NCT01075763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6115913|NCT01075815|Hormones|hormones|mesh-list
6115914|NCT01075815|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6115915|NCT01075815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6115916|NCT01075815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115917|NCT01075971|Buprenorphine|buprenorphine|mesh-list
6115918|NCT01075971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6115919|NCT01075971|Narcotics|narcotics|mesh-ancestor
6115920|NCT01075971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6115921|NCT01075971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115922|NCT01075971|Analgesics|analgesics|mesh-ancestor
6115923|NCT01075971|Sensory System Agents|sensory system agents|mesh-ancestor
6115924|NCT01075971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6115925|NCT01075971|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6115926|NCT01075984|Posaconazole|posaconazole|mesh-list
6115927|NCT01075984|Antifungal Agents|antifungal agents|mesh-ancestor
6115928|NCT01075984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6115929|NCT01075984|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6115930|NCT01075984|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6115931|NCT01075984|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6115932|NCT01075984|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6115933|NCT01075984|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6115934|NCT01075984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6115935|NCT01075984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115936|NCT01075984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6115937|NCT01075984|Hormone Antagonists|hormone antagonists|mesh-ancestor
6115938|NCT01075984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6115939|NCT01075984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115940|NCT01076010|Sorafenib|sorafenib|mesh-list
6115941|NCT01076010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6115942|NCT01076010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6115943|NCT01076010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6115944|NCT01076010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115945|NCT01076075|Metformin|metformin|mesh-list
6115946|NCT01076075|Pioglitazone|pioglitazone|mesh-list
6115947|NCT01076075|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6115948|NCT01076075|Glimepiride|glimepiride|mesh-list
6115949|NCT01076075|Gliclazide|gliclazide|mesh-list
6115950|NCT01076075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6115951|NCT01076075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115952|NCT01076075|Incretins|incretins|mesh-ancestor
6115953|NCT01076075|Hormones|hormones|mesh-ancestor
6115954|NCT01076075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6115955|NCT01076075|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6115956|NCT01076075|Protease Inhibitors|protease inhibitors|mesh-ancestor
6115957|NCT01076075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6115958|NCT01076075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115959|NCT01076075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6115960|NCT01076075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6115961|NCT01076075|Immunologic Factors|immunologic factors|mesh-ancestor
5530338|NCT03870880|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5530339|NCT03870880|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5530340|NCT03870880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5530341|NCT03870880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5530342|NCT03870880|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5530343|NCT03870880|Dopamine Agents|dopamine agents|mesh-ancestor
5530344|NCT03854019|Quinidine|quinidine|mesh-list
5530345|NCT03854019|Dextromethorphan|dextromethorphan|mesh-list
5530346|NCT03854019|Antitussive Agents|antitussive agents|mesh-ancestor
6115962|NCT01076088|Metformin|metformin|mesh-list
6115963|NCT01076088|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6115964|NCT01076088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6115965|NCT01076088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6115966|NCT01076088|Incretins|incretins|mesh-ancestor
6115967|NCT01076088|Hormones|hormones|mesh-ancestor
6115968|NCT01076088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6115969|NCT01076088|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6115970|NCT01076088|Protease Inhibitors|protease inhibitors|mesh-ancestor
6115971|NCT01076088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6115972|NCT01076088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115973|NCT01076153|Clarithromycin|clarithromycin|mesh-list
6115974|NCT01076153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6115975|NCT01076153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6115976|NCT01076153|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6115977|NCT01076153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6115978|NCT01076153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115979|NCT01076153|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6115980|NCT01076153|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6115981|NCT01076166|Clarithromycin|clarithromycin|mesh-list
6115982|NCT01076166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6115983|NCT01076166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6115984|NCT01076166|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6115985|NCT01076166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6115986|NCT01076166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115987|NCT01076166|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6115988|NCT01076166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6115989|NCT01076231|Etoposide|etoposide|mesh-list
6115990|NCT01076231|Etoposide phosphate|etoposide phosphate|mesh-list
6115991|NCT01076231|Podophyllotoxin|podophyllotoxin|mesh-list
6115992|NCT01076231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6115993|NCT01076231|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6115994|NCT01076231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6115995|NCT01076231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6115996|NCT01076231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6115997|NCT01076231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6115998|NCT01076231|Keratolytic Agents|keratolytic agents|mesh-ancestor
6115999|NCT01076231|Dermatologic Agents|dermatologic agents|mesh-ancestor
6116000|NCT01076231|Tubulin Modulators|tubulin modulators|mesh-ancestor
6116001|NCT01076231|Antimitotic Agents|antimitotic agents|mesh-ancestor
6116002|NCT01076231|Mitosis Modulators|mitosis modulators|mesh-ancestor
6116003|NCT01076270|Plerixafor|plerixafor|mesh-list
5530347|NCT03854019|Respiratory System Agents|respiratory system agents|mesh-ancestor
5530348|NCT03854019|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5530349|NCT03854019|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5530350|NCT03854019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5530351|NCT03854019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5530352|NCT03854019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5530353|NCT03854019|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5530354|NCT03854019|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5530355|NCT03854019|Adrenergic Agents|adrenergic agents|mesh-ancestor
5530356|NCT03854019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5530357|NCT03854019|Antimalarials|antimalarials|mesh-ancestor
6116004|NCT01076270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6116005|NCT01076270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6116006|NCT01076270|Antiviral Agents|antiviral agents|mesh-ancestor
5530358|NCT03854019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5530359|NCT03854019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5530360|NCT03854019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5530361|NCT03854019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5530362|NCT03854019|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5530363|NCT03854019|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5530364|NCT03854019|Cholinergic Agents|cholinergic agents|mesh-ancestor
5530365|NCT03854019|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5530366|NCT03854019|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5530367|NCT03854019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5530368|NCT03854019|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5530369|NCT03854019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5530370|NCT03850782|Bimatoprost|bimatoprost|mesh-list
5530371|NCT03850782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6116007|NCT01076270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6116008|NCT01076283|Cyproheptadine|cyproheptadine|mesh-list
6116009|NCT01076283|Baclofen|baclofen|mesh-list
6116010|NCT01076283|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6116011|NCT01076283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116012|NCT01076283|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6116013|NCT01076283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6116014|NCT01076283|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6116015|NCT01076283|GABA Agonists|gaba agonists|mesh-ancestor
6116016|NCT01076283|GABA Agents|gaba agents|mesh-ancestor
6116017|NCT01076283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6116018|NCT01076283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116019|NCT01076283|Antipruritics|antipruritics|mesh-ancestor
6116020|NCT01076283|Dermatologic Agents|dermatologic agents|mesh-ancestor
6116021|NCT01076283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6116022|NCT01076283|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6116023|NCT01076283|Histamine Antagonists|histamine antagonists|mesh-ancestor
6116024|NCT01076283|Histamine Agents|histamine agents|mesh-ancestor
6116025|NCT01076283|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6116026|NCT01076283|Serotonin Agents|serotonin agents|mesh-ancestor
5530392|NCT03809429|Cetrorelix|cetrorelix|mesh-list
6116027|NCT01076283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6116028|NCT01076335|Docetaxel|docetaxel|mesh-list
6116029|NCT01076335|Leuprolide|leuprolide|mesh-list
6116030|NCT01076335|Goserelin|goserelin|mesh-list
6116031|NCT01076335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6116032|NCT01076335|Tubulin Modulators|tubulin modulators|mesh-ancestor
6116033|NCT01076335|Antimitotic Agents|antimitotic agents|mesh-ancestor
6116034|NCT01076335|Mitosis Modulators|mitosis modulators|mesh-ancestor
6116035|NCT01076335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116036|NCT01076335|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6116037|NCT01076335|Fertility Agents|fertility agents|mesh-ancestor
6116038|NCT01076335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6116039|NCT01076335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116040|NCT01076335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5530393|NCT03809429|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
5530394|NCT03809429|Hormones|hormones|mesh-ancestor
5530395|NCT03809429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5530396|NCT03809429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5530397|NCT03809429|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6116041|NCT01076400|Topotecan|topotecan|mesh-list
6116042|NCT01076400|Adavosertib|adavosertib|mesh-list
6116043|NCT01076400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6116044|NCT01076400|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6116045|NCT01076400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6116046|NCT01076400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6116047|NCT01076400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116048|NCT01076504|Carboplatin|carboplatin|mesh-list
6116049|NCT01076504|Amrubicin|amrubicin|mesh-list
6116050|NCT01076504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6116051|NCT01076543|Sirolimus|sirolimus|mesh-list
6116052|NCT01076543|Lenalidomide|lenalidomide|mesh-list
6116053|NCT01076543|Immunologic Factors|immunologic factors|mesh-ancestor
6116054|NCT01076543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116055|NCT01076543|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6116056|NCT01076543|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6116057|NCT01076543|Growth Substances|growth substances|mesh-ancestor
6116058|NCT01076543|Growth Inhibitors|growth inhibitors|mesh-ancestor
6116059|NCT01076543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6116060|NCT01076543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6116061|NCT01076543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6116062|NCT01076543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6116063|NCT01076543|Antifungal Agents|antifungal agents|mesh-ancestor
5530398|NCT03809429|Fertility Agents|fertility agents|mesh-ancestor
5530399|NCT03809429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5530400|NCT03809429|Hormone Antagonists|hormone antagonists|mesh-ancestor
6116064|NCT01076543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6116065|NCT01076647|Insulin|insulin|mesh-list
6116066|NCT01076647|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6116067|NCT01076647|Insulin Glargine|insulin glargine|mesh-list
6116068|NCT01076647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6116069|NCT01076647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116070|NCT01076972|Ritonavir|ritonavir|mesh-list
6116071|NCT01076972|Lopinavir|lopinavir|mesh-list
6116072|NCT01076972|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6116073|NCT01076972|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6116074|NCT01076972|Protease Inhibitors|protease inhibitors|mesh-ancestor
6116075|NCT01076972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6116076|NCT01076972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116077|NCT01076972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6116078|NCT01076972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6116079|NCT01076972|Antiviral Agents|antiviral agents|mesh-ancestor
6116080|NCT01076972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6116081|NCT01076972|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6116082|NCT01076972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6116083|NCT01076985|Ritonavir|ritonavir|mesh-list
6116084|NCT01076985|Lopinavir|lopinavir|mesh-list
6116085|NCT01076985|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6116086|NCT01076985|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6116087|NCT01076985|Protease Inhibitors|protease inhibitors|mesh-ancestor
6116088|NCT01076985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6116089|NCT01076985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116090|NCT01076985|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6116091|NCT01076985|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6116092|NCT01076985|Antiviral Agents|antiviral agents|mesh-ancestor
6116093|NCT01076985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6116094|NCT01076985|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6116095|NCT01076985|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6116096|NCT01077076|Omeprazole|omeprazole|mesh-list
6116097|NCT01077076|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
6116098|NCT01077076|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6116099|NCT01077076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6116100|NCT01077076|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6116101|NCT01077076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6116102|NCT01077076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116103|NCT01077154|Denosumab|denosumab|mesh-list
6116104|NCT01077154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6116105|NCT01077154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116106|NCT01077284|Allopurinol|allopurinol|mesh-list
6116107|NCT01077284|Febuxostat|febuxostat|mesh-list
6116108|NCT01077284|Antimetabolites|antimetabolites|mesh-ancestor
6116109|NCT01077284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116110|NCT01077284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6116111|NCT01077284|Gout Suppressants|gout suppressants|mesh-ancestor
6116112|NCT01077284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5530431|NCT03737370|Docetaxel|docetaxel|mesh-list
5530432|NCT03737370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5530433|NCT03737370|Tubulin Modulators|tubulin modulators|mesh-ancestor
5530434|NCT03737370|Antimitotic Agents|antimitotic agents|mesh-ancestor
5530435|NCT03737370|Mitosis Modulators|mitosis modulators|mesh-ancestor
5530436|NCT03737370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116113|NCT01077284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6116114|NCT01077284|Antioxidants|antioxidants|mesh-ancestor
6116115|NCT01077284|Protective Agents|protective agents|mesh-ancestor
6116116|NCT01077284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116117|NCT01077310|Naltrexone|naltrexone|mesh-list
6116118|NCT01077310|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6116119|NCT01077310|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6116120|NCT01077310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116121|NCT01077310|Sensory System Agents|sensory system agents|mesh-ancestor
6116122|NCT01077310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6116123|NCT01077323|Exenatide|exenatide|mesh-list
6116124|NCT01077323|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6116125|NCT01077323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116126|NCT01077323|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6116127|NCT01077323|Incretins|incretins|mesh-ancestor
6116128|NCT01077323|Hormones|hormones|mesh-ancestor
6116129|NCT01077323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6116130|NCT01077362|Ustekinumab|ustekinumab|mesh-list
6666095|NCT01520753|Insulin, Long-Acting|insulin, long-acting|mesh-list
6116131|NCT01077362|Dermatologic Agents|dermatologic agents|mesh-ancestor
6116132|NCT01077375|Milnacipran|milnacipran|mesh-list
6116133|NCT01077375|Levomilnacipran|levomilnacipran|mesh-list
6116134|NCT01077375|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6116135|NCT01077375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6116136|NCT01077375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6116137|NCT01077375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116138|NCT01077375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6116139|NCT01077375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116140|NCT01077375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6116141|NCT01077375|Analgesics|analgesics|mesh-ancestor
6116142|NCT01077375|Sensory System Agents|sensory system agents|mesh-ancestor
6116143|NCT01077375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5530451|NCT03678545|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5530452|NCT03678545|Immunologic Factors|immunologic factors|mesh-ancestor
5530453|NCT03678545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5530454|NCT03662022|Rifampin|rifampin|mesh-list
5530455|NCT03662022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5530456|NCT03662022|Antitubercular Agents|antitubercular agents|mesh-ancestor
5530457|NCT03662022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5530458|NCT03662022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5530459|NCT03662022|Leprostatic Agents|leprostatic agents|mesh-ancestor
5530460|NCT03662022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5530461|NCT03662022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5530462|NCT03662022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5530463|NCT03662022|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5530464|NCT03662022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5530465|NCT03662022|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5530466|NCT03662022|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6116144|NCT01077375|Antidepressive Agents|antidepressive agents|mesh-ancestor
6116145|NCT01077375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6116146|NCT01077401|Ranibizumab|ranibizumab|mesh-list
6116147|NCT01077401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6116148|NCT01077401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6116149|NCT01077401|Growth Substances|growth substances|mesh-ancestor
6116150|NCT01077401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116151|NCT01077401|Growth Inhibitors|growth inhibitors|mesh-ancestor
6116152|NCT01077401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6116153|NCT01077518|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6116154|NCT01077518|Ofatumumab|ofatumumab|mesh-list
6116155|NCT01077518|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6116156|NCT01077518|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6116157|NCT01077518|Alkylating Agents|alkylating agents|mesh-ancestor
6116158|NCT01077518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116159|NCT01077518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6116160|NCT01077518|Immunologic Factors|immunologic factors|mesh-ancestor
6116161|NCT01077518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116162|NCT01077596|Bupropion|bupropion|mesh-list
6116163|NCT01077596|Antidepressive Agents|antidepressive agents|mesh-list
6116164|NCT01077596|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
6116165|NCT01077596|Serotonin|serotonin|mesh-list
6116166|NCT01077596|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
6116167|NCT01077596|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6116168|NCT01077596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6116169|NCT01077596|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5530467|NCT03662022|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5530468|NCT03662022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5530469|NCT03659136|Everolimus|everolimus|mesh-list
5530470|NCT03659136|Exemestane|exemestane|mesh-list
5530471|NCT03659136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6116170|NCT01077596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6116171|NCT01077596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6116172|NCT01077596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116173|NCT01077596|Dopamine Agents|dopamine agents|mesh-ancestor
6116174|NCT01077596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6116175|NCT01077596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116176|NCT01077596|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6116177|NCT01077596|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6116178|NCT01077596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6116179|NCT01077596|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6116180|NCT01077596|Serotonin Agents|serotonin agents|mesh-ancestor
5530472|NCT03659136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6116181|NCT01077622|Ofatumumab|ofatumumab|mesh-list
5530473|NCT03659136|Immunologic Factors|immunologic factors|mesh-ancestor
5530474|NCT03659136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5530475|NCT03659136|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5530476|NCT03659136|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6116182|NCT01077622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6116183|NCT01077713|Gemcitabine|gemcitabine|mesh-list
6465704|NCT00475813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6465705|NCT00475813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6465706|NCT00475813|Autonomic Agents|autonomic agents|mesh-ancestor
6465707|NCT00475813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6116184|NCT01077713|Bevacizumab|bevacizumab|mesh-list
6116185|NCT01077713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6116186|NCT01077713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6116187|NCT01077713|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6116188|NCT01077713|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6116189|NCT01077713|Growth Substances|growth substances|mesh-ancestor
6116190|NCT01077713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116191|NCT01077713|Growth Inhibitors|growth inhibitors|mesh-ancestor
6116192|NCT01077713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6116193|NCT01077713|Antimetabolites|antimetabolites|mesh-ancestor
6116194|NCT01077713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116195|NCT01077713|Antiviral Agents|antiviral agents|mesh-ancestor
6116196|NCT01077713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6116197|NCT01077713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6116198|NCT01077713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6116199|NCT01077713|Immunologic Factors|immunologic factors|mesh-ancestor
6116200|NCT01077739|Leucovorin|leucovorin|mesh-list
6116201|NCT01077739|Bevacizumab|bevacizumab|mesh-list
6116202|NCT01077739|Fluorouracil|fluorouracil|mesh-list
6116203|NCT01077739|Capecitabine|capecitabine|mesh-list
6116204|NCT01077739|Oxaliplatin|oxaliplatin|mesh-list
6116205|NCT01077739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6116206|NCT01077739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6116207|NCT01077739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5530477|NCT03659136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5530478|NCT03659136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5530479|NCT03659136|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5530480|NCT03659136|Hormone Antagonists|hormone antagonists|mesh-ancestor
5530481|NCT03659136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5530482|NCT03640312|Candesartan|candesartan|mesh-list
5530483|NCT03640312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5530484|NCT03640312|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5530485|NCT03640312|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5530486|NCT03640312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5530487|NCT03623321|Pimavanserin|pimavanserin|mesh-list
5530488|NCT03623321|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6116208|NCT01077739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6116209|NCT01077739|Growth Substances|growth substances|mesh-ancestor
6116210|NCT01077739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116211|NCT01077739|Growth Inhibitors|growth inhibitors|mesh-ancestor
6116212|NCT01077739|Antimetabolites|antimetabolites|mesh-ancestor
6116213|NCT01077739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116214|NCT01077739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6116215|NCT01077739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6116216|NCT01077739|Immunologic Factors|immunologic factors|mesh-ancestor
6116217|NCT01077739|Antidotes|antidotes|mesh-ancestor
6116218|NCT01077739|Protective Agents|protective agents|mesh-ancestor
6116219|NCT01077739|Vitamin B Complex|vitamin b complex|mesh-ancestor
6116220|NCT01077739|Vitamins|vitamins|mesh-ancestor
6116221|NCT01077739|Micronutrients|micronutrients|mesh-ancestor
6116222|NCT01077921|Propranolol|propranolol|mesh-list
6116223|NCT01077921|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6116224|NCT01077921|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6116225|NCT01077921|Adrenergic Agents|adrenergic agents|mesh-ancestor
6116226|NCT01077921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6116227|NCT01077921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116228|NCT01077921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116229|NCT01077921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6116230|NCT01077921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6116231|NCT01077921|Vasodilator Agents|vasodilator agents|mesh-ancestor
6116232|NCT01077960|Hormones|hormones|mesh-list
6116233|NCT01077960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6116234|NCT01077960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116235|NCT01077973|Ibuprofen|ibuprofen|mesh-list
6116236|NCT01077973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6116237|NCT01077973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6116238|NCT01077973|Analgesics|analgesics|mesh-ancestor
6116239|NCT01077973|Sensory System Agents|sensory system agents|mesh-ancestor
6116240|NCT01077973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6116241|NCT01077973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116242|NCT01077973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6116243|NCT01077973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6116244|NCT01077973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6116245|NCT01077973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6116246|NCT01077973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116247|NCT01078168|Acitretin|acitretin|mesh-list
6116248|NCT01078168|Keratolytic Agents|keratolytic agents|mesh-ancestor
6116249|NCT01078168|Dermatologic Agents|dermatologic agents|mesh-ancestor
6116250|NCT01078298|Varenicline|varenicline|mesh-list
6116251|NCT01078298|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6116252|NCT01078298|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6116253|NCT01078298|Cholinergic Agents|cholinergic agents|mesh-ancestor
6116254|NCT01078298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6116255|NCT01078298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116256|NCT01078298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116257|NCT01078363|Ramipril|ramipril|mesh-list
6116258|NCT01078363|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6116259|NCT01078363|Protease Inhibitors|protease inhibitors|mesh-ancestor
6116260|NCT01078363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6116261|NCT01078363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116262|NCT01078363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6116263|NCT01078376|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
6116264|NCT01078376|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6116265|NCT01078376|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6116266|NCT01078376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116267|NCT01078389|Febuxostat|febuxostat|mesh-list
6116268|NCT01078389|Gout Suppressants|gout suppressants|mesh-ancestor
6116269|NCT01078389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6204442|NCT02070692|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6465708|NCT00475813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465709|NCT00475813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6465710|NCT00475813|Respiratory System Agents|respiratory system agents|mesh-ancestor
6465711|NCT00475813|Dermatologic Agents|dermatologic agents|mesh-ancestor
6465712|NCT00475813|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6465713|NCT00475813|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6465714|NCT00475813|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6465715|NCT00475813|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6204443|NCT02070692|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6204444|NCT02070744|Ivacaftor|ivacaftor|mesh-list
6204445|NCT02070744|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6204446|NCT02070744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6204447|NCT02070744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204448|NCT02070757|Meropenem|meropenem|mesh-list
6204449|NCT02070757|Tazobactam|tazobactam|mesh-list
6204450|NCT02070757|Ceftolozane|ceftolozane|mesh-list
6204451|NCT02070757|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
6204452|NCT02070757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6204453|NCT02070757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6204454|NCT02070757|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6204455|NCT02070757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6204456|NCT02070757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204457|NCT02070757|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6204458|NCT02070757|Renal Agents|renal agents|mesh-ancestor
6204459|NCT02070991|Macitentan|macitentan|mesh-list
6204460|NCT02070991|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
6204461|NCT02070991|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5530489|NCT03623321|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5530490|NCT03623321|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5530491|NCT03623321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5530492|NCT03623321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5530493|NCT03623321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5530494|NCT03623321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5530495|NCT03623321|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5530496|NCT03623321|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5530497|NCT03623321|Serotonin Agents|serotonin agents|mesh-ancestor
5530498|NCT03623321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5725389|NCT03180736|Glucocorticoids|glucocorticoids|mesh-ancestor
6116270|NCT01078441|Dexamethasone|dexamethasone|mesh-list
6116271|NCT01078441|Cyclophosphamide|cyclophosphamide|mesh-list
6116272|NCT01078441|Doxorubicin|doxorubicin|mesh-list
6116273|NCT01078441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6116274|NCT01078441|Bortezomib|bortezomib|mesh-list
6116275|NCT01078441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6116276|NCT01078441|Immunologic Factors|immunologic factors|mesh-ancestor
6116277|NCT01078441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5530499|NCT03623321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5530500|NCT03611868|Pembrolizumab|pembrolizumab|mesh-list
5530501|NCT03611868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5530502|NCT03611868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5530503|NCT03568994|Cytarabine|cytarabine|mesh-list
5530504|NCT03568994|Atovaquone|atovaquone|mesh-list
5530505|NCT03568994|Etoposide|etoposide|mesh-list
5530506|NCT03568994|Daunorubicin|daunorubicin|mesh-list
5530507|NCT03568994|Gemtuzumab|gemtuzumab|mesh-list
5530508|NCT03568994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5530509|NCT03568994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5530510|NCT03568994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6116278|NCT01078441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6116279|NCT01078441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6116280|NCT01078441|Alkylating Agents|alkylating agents|mesh-ancestor
6116281|NCT01078441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116282|NCT01078441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6116283|NCT01078441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6116284|NCT01078441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6116285|NCT01078441|Antiemetics|antiemetics|mesh-ancestor
6116286|NCT01078441|Autonomic Agents|autonomic agents|mesh-ancestor
6116287|NCT01078441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6116288|NCT01078441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6116289|NCT01078441|Glucocorticoids|glucocorticoids|mesh-ancestor
6116290|NCT01078441|Hormones|hormones|mesh-ancestor
5530511|NCT03568994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5530512|NCT03568994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5530513|NCT03568994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5530514|NCT03568994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5530515|NCT03568994|Antimetabolites|antimetabolites|mesh-ancestor
5530516|NCT03568994|Antiviral Agents|antiviral agents|mesh-ancestor
5530517|NCT03568994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5530518|NCT03568994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5530519|NCT03568994|Immunologic Factors|immunologic factors|mesh-ancestor
5530520|NCT03568994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5530521|NCT03568994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5530522|NCT03568994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5530523|NCT03568994|Antimalarials|antimalarials|mesh-ancestor
5530524|NCT03568994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5530525|NCT03568994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5530526|NCT03564340|Cemiplimab|cemiplimab|mesh-list
5530527|NCT03564340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5530528|NCT03564340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5530529|NCT03539744|Dexamethasone|dexamethasone|mesh-list
5530530|NCT03539744|Venetoclax|venetoclax|mesh-list
5530531|NCT03539744|Pomalidomide|pomalidomide|mesh-list
6116291|NCT01078441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6116292|NCT01078441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6116293|NCT01078441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6116294|NCT01078441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6116295|NCT01078441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6116296|NCT01078441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6116297|NCT01078545|Leuprolide|leuprolide|mesh-list
6116298|NCT01078545|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6116299|NCT01078545|Fertility Agents|fertility agents|mesh-ancestor
6116300|NCT01078545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6116301|NCT01078545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116302|NCT01078545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6116303|NCT01078545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6116304|NCT01078571|Adalimumab|adalimumab|mesh-list
6116305|NCT01078571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6116306|NCT01078571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6116307|NCT01078623|Formoterol Fumarate|formoterol fumarate|mesh-list
6116308|NCT01078623|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6116309|NCT01078623|Autonomic Agents|autonomic agents|mesh-ancestor
6116310|NCT01078623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5530532|NCT03539744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5530533|NCT03539744|Antiemetics|antiemetics|mesh-ancestor
5530534|NCT03539744|Autonomic Agents|autonomic agents|mesh-ancestor
5725390|NCT03180736|Hormones|hormones|mesh-ancestor
5530535|NCT03539744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6116311|NCT01078623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116312|NCT01078623|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6116313|NCT01078623|Respiratory System Agents|respiratory system agents|mesh-ancestor
6116314|NCT01078623|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6116315|NCT01078623|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6116316|NCT01078623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6116317|NCT01078623|Adrenergic Agents|adrenergic agents|mesh-ancestor
6116318|NCT01078623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6116319|NCT01078623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116320|NCT01078662|Olaparib|olaparib|mesh-list
6116321|NCT01078662|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6116322|NCT01078662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6116323|NCT01078662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116324|NCT01078662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6116325|NCT01078675|Calcium, Dietary|calcium, dietary|mesh-list
6116326|NCT01078675|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6116327|NCT01078675|Calcium|calcium|mesh-list
6116328|NCT01078675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6116329|NCT01078675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116330|NCT01078675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6116331|NCT01078675|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6116332|NCT01078675|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6116333|NCT01078675|Antimetabolites|antimetabolites|mesh-ancestor
6116334|NCT01078675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116335|NCT01078675|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6116336|NCT01078675|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6116337|NCT01078675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6116338|NCT01078753|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
6116339|NCT01078753|Hemostatics|hemostatics|mesh-ancestor
6116340|NCT01078753|Coagulants|coagulants|mesh-ancestor
6116341|NCT01078753|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6116342|NCT01078753|Natriuretic Agents|natriuretic agents|mesh-ancestor
6116343|NCT01078753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5530536|NCT03539744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5530537|NCT03539744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5530538|NCT03539744|Glucocorticoids|glucocorticoids|mesh-ancestor
5530539|NCT03539744|Hormones|hormones|mesh-ancestor
5530540|NCT03539744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5530541|NCT03539744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5530542|NCT03539744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5530543|NCT03539744|Immunologic Factors|immunologic factors|mesh-ancestor
5530544|NCT03539744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5530545|NCT03539744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5530546|NCT03539744|Growth Substances|growth substances|mesh-ancestor
5530547|NCT03539744|Growth Inhibitors|growth inhibitors|mesh-ancestor
6116344|NCT01078805|Teriparatide|teriparatide|mesh-list
6116345|NCT01078805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6116346|NCT01078805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116347|NCT01078805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6116348|NCT01078922|Ofatumumab|ofatumumab|mesh-list
6116349|NCT01078922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6116350|NCT01078974|Dexamethasone|dexamethasone|mesh-list
6116351|NCT01078974|Rituximab|rituximab|mesh-list
6116352|NCT01078974|Pomalidomide|pomalidomide|mesh-list
6116353|NCT01078974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6116354|NCT01078974|Antiemetics|antiemetics|mesh-ancestor
5530548|NCT03538899|Busulfan|busulfan|mesh-list
5530549|NCT03538899|Alkylating Agents|alkylating agents|mesh-ancestor
6116355|NCT01078974|Autonomic Agents|autonomic agents|mesh-ancestor
6116356|NCT01078974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6116357|NCT01078974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116358|NCT01078974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6116359|NCT01078974|Glucocorticoids|glucocorticoids|mesh-ancestor
6116360|NCT01078974|Hormones|hormones|mesh-ancestor
6116361|NCT01078974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6116362|NCT01078974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6116363|NCT01078974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6116364|NCT01078974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6116365|NCT01078974|Immunologic Factors|immunologic factors|mesh-ancestor
6116366|NCT01078974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6116367|NCT01078974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6116368|NCT01078974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6116369|NCT01078974|Growth Substances|growth substances|mesh-ancestor
5530550|NCT03538899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5530551|NCT03538899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5530552|NCT03538899|Immunologic Factors|immunologic factors|mesh-ancestor
5530553|NCT03538899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5530554|NCT03538899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5530555|NCT03538899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6116370|NCT01078974|Growth Inhibitors|growth inhibitors|mesh-ancestor
6116371|NCT01079130|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6116372|NCT01079130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6116373|NCT01079130|Autonomic Agents|autonomic agents|mesh-ancestor
6116374|NCT01079130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6116375|NCT01079130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116376|NCT01079130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6116377|NCT01079130|Respiratory System Agents|respiratory system agents|mesh-ancestor
6116378|NCT01079130|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6116379|NCT01079130|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6116380|NCT01079130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6116381|NCT01079130|Adrenergic Agents|adrenergic agents|mesh-ancestor
6116382|NCT01079130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6116383|NCT01079130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116384|NCT01079143|Cyclosporine|cyclosporine|mesh-list
6116385|NCT01079143|Mycophenolic Acid|mycophenolic acid|mesh-list
6116386|NCT01079143|Everolimus|everolimus|mesh-list
6116387|NCT01079143|Cyclosporins|cyclosporins|mesh-list
6116388|NCT01079143|Basiliximab|basiliximab|mesh-list
6116389|NCT01079143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6116390|NCT01079143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116391|NCT01079143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6116392|NCT01079143|Immunologic Factors|immunologic factors|mesh-ancestor
6116393|NCT01079143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116394|NCT01079143|Antifungal Agents|antifungal agents|mesh-ancestor
6116395|NCT01079143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6116396|NCT01079143|Dermatologic Agents|dermatologic agents|mesh-ancestor
6116397|NCT01079143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6116398|NCT01079143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6116399|NCT01079143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6116400|NCT01079143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6116401|NCT01079143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6116402|NCT01079143|Antitubercular Agents|antitubercular agents|mesh-ancestor
5530556|NCT03538899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5530557|NCT03432897|Olaparib|olaparib|mesh-list
5530558|NCT03432897|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5530559|NCT03432897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5530560|NCT03432897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5530561|NCT03432897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6116403|NCT01079143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6116404|NCT01079234|Insulin|insulin|mesh-list
6116405|NCT01079234|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6116406|NCT01079234|Insulin Glargine|insulin glargine|mesh-list
6116407|NCT01079234|Insulin Aspart|insulin aspart|mesh-list
6116408|NCT01079234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6116409|NCT01079234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116410|NCT01079663|Chlorhexidine|chlorhexidine|mesh-list
6116411|NCT01079663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6116412|NCT01079663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6116413|NCT01079663|Disinfectants|disinfectants|mesh-ancestor
6116414|NCT01079741|Poly I-C|poly i-c|mesh-list
6116415|NCT01079741|Mineral Oil|mineral oil|mesh-list
6116416|NCT01079741|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6116417|NCT01079741|Poly ICLC|poly iclc|mesh-list
6116418|NCT01079741|Freund's Adjuvant|freund's adjuvant|mesh-list
5530578|NCT03355157|Tamoxifen|tamoxifen|mesh-list
5530579|NCT03355157|Paclitaxel|paclitaxel|mesh-list
6116419|NCT01079741|Interferon Inducers|interferon inducers|mesh-ancestor
6116420|NCT01079741|Immunologic Factors|immunologic factors|mesh-ancestor
6116421|NCT01079741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116422|NCT01079741|Laxatives|laxatives|mesh-ancestor
6116423|NCT01079741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6116424|NCT01079741|Antiviral Agents|antiviral agents|mesh-ancestor
6116425|NCT01079741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6116426|NCT01079741|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6116427|NCT01079741|Emollients|emollients|mesh-ancestor
6116428|NCT01079741|Dermatologic Agents|dermatologic agents|mesh-ancestor
5530580|NCT03355157|Vinorelbine|vinorelbine|mesh-list
6116429|NCT01079806|Entecavir|entecavir|mesh-list
6116430|NCT01079806|Antiviral Agents|antiviral agents|mesh-ancestor
6116431|NCT01079806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6116432|NCT01079936|Lenalidomide|lenalidomide|mesh-list
5530581|NCT03355157|Capecitabine|capecitabine|mesh-list
5530582|NCT03355157|Letrozole|letrozole|mesh-list
5530583|NCT03355157|Epirubicin|epirubicin|mesh-list
5530584|NCT03355157|Fulvestrant|fulvestrant|mesh-list
5530585|NCT03355157|Palbociclib|palbociclib|mesh-list
5530586|NCT03355157|Exemestane|exemestane|mesh-list
5530587|NCT03355157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5530588|NCT03355157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5530589|NCT03355157|Tubulin Modulators|tubulin modulators|mesh-ancestor
5530590|NCT03355157|Antimitotic Agents|antimitotic agents|mesh-ancestor
5530591|NCT03355157|Mitosis Modulators|mitosis modulators|mesh-ancestor
5530592|NCT03355157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5530593|NCT03355157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5530594|NCT03355157|Antimetabolites|antimetabolites|mesh-ancestor
6116433|NCT01079936|Melphalan|melphalan|mesh-list
6116434|NCT01079936|Immunologic Factors|immunologic factors|mesh-ancestor
6116435|NCT01079936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116436|NCT01079936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6116437|NCT01079936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6116438|NCT01079936|Growth Substances|growth substances|mesh-ancestor
6116439|NCT01079936|Growth Inhibitors|growth inhibitors|mesh-ancestor
6116440|NCT01079936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6116441|NCT01079936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6116442|NCT01079936|Alkylating Agents|alkylating agents|mesh-ancestor
6465716|NCT00475813|Adrenergic Agents|adrenergic agents|mesh-ancestor
6465717|NCT00475813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6465718|NCT00475813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465719|NCT00475826|Ezetimibe|ezetimibe|mesh-list
5725391|NCT03180736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5725392|NCT03180736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5725393|NCT03180736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5725394|NCT03180736|Immunologic Factors|immunologic factors|mesh-ancestor
5725395|NCT03180736|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5725396|NCT03180736|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5725397|NCT03180736|Growth Substances|growth substances|mesh-ancestor
5725398|NCT03180736|Growth Inhibitors|growth inhibitors|mesh-ancestor
5725399|NCT03180710|Insulin Lispro|insulin lispro|mesh-list
5725400|NCT03180710|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6116443|NCT01079936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465720|NCT00475826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6465721|NCT00475826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6465722|NCT00475826|Antimetabolites|antimetabolites|mesh-ancestor
6465723|NCT00475826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465724|NCT00475826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6465725|NCT00475917|Gemcitabine|gemcitabine|mesh-list
6465726|NCT00475917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5530595|NCT03355157|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6116444|NCT01079936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6116445|NCT01079936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6116446|NCT01079949|Cetrorelix|cetrorelix|mesh-list
6116447|NCT01079949|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6116448|NCT01079949|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6116449|NCT01079949|Fertility Agents|fertility agents|mesh-ancestor
6116450|NCT01079949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6116451|NCT01079949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116452|NCT01079949|Hormone Antagonists|hormone antagonists|mesh-ancestor
6116453|NCT01079949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6116454|NCT01079962|Atenolol|atenolol|mesh-list
6116455|NCT01079962|Bisoprolol|bisoprolol|mesh-list
6116456|NCT01079962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6116457|NCT01079962|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6116458|NCT01079962|Sympatholytics|sympatholytics|mesh-ancestor
6116459|NCT01079962|Autonomic Agents|autonomic agents|mesh-ancestor
6116460|NCT01079962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6116461|NCT01079962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116462|NCT01079962|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6116463|NCT01079962|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6116464|NCT01079962|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6116465|NCT01079962|Adrenergic Agents|adrenergic agents|mesh-ancestor
6116466|NCT01079962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6116467|NCT01079962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116468|NCT01079988|Cyclosporine|cyclosporine|mesh-list
6116469|NCT01079988|Methotrexate|methotrexate|mesh-list
5530596|NCT03355157|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6116470|NCT01079988|Cyclosporins|cyclosporins|mesh-list
6116471|NCT01079988|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6116472|NCT01079988|Abortifacient Agents|abortifacient agents|mesh-ancestor
6116473|NCT01079988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6116474|NCT01079988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5530597|NCT03355157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5530598|NCT03355157|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5530599|NCT03355157|Hormone Antagonists|hormone antagonists|mesh-ancestor
5530600|NCT03355157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5530601|NCT03355157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5530602|NCT03355157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5530603|NCT03355157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6116475|NCT01079988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6116476|NCT01079988|Antimetabolites|antimetabolites|mesh-ancestor
6116477|NCT01079988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116478|NCT01079988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6116479|NCT01079988|Dermatologic Agents|dermatologic agents|mesh-ancestor
6116480|NCT01079988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6116481|NCT01079988|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6116482|NCT01079988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5530604|NCT03355157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5530605|NCT03355157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5530606|NCT03355157|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5530607|NCT03355157|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5530608|NCT03355157|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5530609|NCT03355157|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5530610|NCT03355157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5530611|NCT03324035|Tramadol|tramadol|mesh-list
5530612|NCT03324035|Amitriptyline|amitriptyline|mesh-list
5530613|NCT03324035|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6116483|NCT01079988|Immunologic Factors|immunologic factors|mesh-ancestor
6116484|NCT01079988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6116485|NCT01079988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5530614|NCT03324035|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5530615|NCT03324035|Narcotics|narcotics|mesh-ancestor
5530616|NCT03324035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5530617|NCT03324035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5530618|NCT03324035|Analgesics|analgesics|mesh-ancestor
5530619|NCT03324035|Sensory System Agents|sensory system agents|mesh-ancestor
5530620|NCT03324035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5530621|NCT03324035|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5530622|NCT03324035|Antidepressive Agents|antidepressive agents|mesh-ancestor
5530623|NCT03324035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5530624|NCT03324035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5530625|NCT03324035|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5530626|NCT03324035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5530627|NCT03324035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5530628|NCT03324035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5530629|NCT03324035|Adrenergic Agents|adrenergic agents|mesh-ancestor
5530630|NCT03324035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5530631|NCT03324035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6465727|NCT00475917|Antimetabolites|antimetabolites|mesh-ancestor
6666096|NCT01520753|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6666097|NCT01520753|Biphasic Insulins|biphasic insulins|mesh-list
6666098|NCT01520753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6666099|NCT01520753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116486|NCT01079988|Antifungal Agents|antifungal agents|mesh-ancestor
6116487|NCT01079988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6116488|NCT01079988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6116489|NCT01080131|Triamcinolone|triamcinolone|mesh-list
6116490|NCT01080131|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6116491|NCT01080131|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6116492|NCT01080131|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6116493|NCT01080131|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6116494|NCT01080131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6116495|NCT01080131|Glucocorticoids|glucocorticoids|mesh-ancestor
6116496|NCT01080131|Hormones|hormones|mesh-ancestor
6116497|NCT01080131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6116498|NCT01080131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116499|NCT01080131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6116500|NCT01080131|Immunologic Factors|immunologic factors|mesh-ancestor
6116501|NCT01080131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6116502|NCT01080131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116503|NCT01080248|Gemcitabine|gemcitabine|mesh-list
6116504|NCT01080248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6116505|NCT01080248|Antimetabolites|antimetabolites|mesh-ancestor
6116506|NCT01080248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116507|NCT01080248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6116508|NCT01080248|Antiviral Agents|antiviral agents|mesh-ancestor
6116509|NCT01080248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6116510|NCT01080248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6116511|NCT01080248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6116512|NCT01080248|Immunologic Factors|immunologic factors|mesh-ancestor
6116513|NCT01080248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116514|NCT01080300|Gabapentin|gabapentin|mesh-list
6116515|NCT01080300|Analgesics|analgesics|mesh-ancestor
5530632|NCT03324035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5530633|NCT03320018|Minocycline|minocycline|mesh-list
6116516|NCT01080300|Sensory System Agents|sensory system agents|mesh-ancestor
6116517|NCT01080300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6116518|NCT01080300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5530634|NCT03320018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5530635|NCT03320018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5530636|NCT03315039|Annamycin|annamycin|mesh-list
6116519|NCT01080300|Anticonvulsants|anticonvulsants|mesh-ancestor
6116520|NCT01080300|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6116521|NCT01080300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6116522|NCT01080300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6116523|NCT01080300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6116524|NCT01080300|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6116525|NCT01080300|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6116526|NCT01080300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6116527|NCT01080300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116528|NCT01080300|Antimanic Agents|antimanic agents|mesh-ancestor
6116529|NCT01080391|Dexamethasone|dexamethasone|mesh-list
6116530|NCT01080391|Lenalidomide|lenalidomide|mesh-list
6116531|NCT01080391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6116532|NCT01080391|Antiemetics|antiemetics|mesh-ancestor
6116533|NCT01080391|Autonomic Agents|autonomic agents|mesh-ancestor
6116534|NCT01080391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6116535|NCT01080391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116536|NCT01080391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6116537|NCT01080391|Glucocorticoids|glucocorticoids|mesh-ancestor
6116538|NCT01080391|Hormones|hormones|mesh-ancestor
6116539|NCT01080391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6116540|NCT01080391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6116541|NCT01080391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6116542|NCT01080391|Immunologic Factors|immunologic factors|mesh-ancestor
6116543|NCT01080391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6116544|NCT01080391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6116545|NCT01080391|Growth Substances|growth substances|mesh-ancestor
6116546|NCT01080391|Growth Inhibitors|growth inhibitors|mesh-ancestor
6116547|NCT01080625|Phenylephrine|phenylephrine|mesh-list
6116548|NCT01080625|Epinephrine|epinephrine|mesh-list
6116549|NCT01080625|Oxymetazoline|oxymetazoline|mesh-list
6116550|NCT01080625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6116551|NCT01080625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5530637|NCT03315039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5530638|NCT03315039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5530639|NCT03259165|Diuretics|diuretics|mesh-list
5530640|NCT03259165|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
5530641|NCT03259165|Natriuretic Agents|natriuretic agents|mesh-ancestor
5530642|NCT03259165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5530643|NCT03259165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5530644|NCT03259165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5530645|NCT03255174|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
5530646|NCT03255174|Hemostatics|hemostatics|mesh-ancestor
5530647|NCT03255174|Coagulants|coagulants|mesh-ancestor
5530648|NCT03248531|Adalimumab|adalimumab|mesh-list
5530649|NCT03248531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5530650|NCT03248531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6116552|NCT01080625|Adrenergic Agents|adrenergic agents|mesh-ancestor
6116553|NCT01080625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6116554|NCT01080625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116555|NCT01080625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116556|NCT01080625|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6116557|NCT01080625|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6116558|NCT01080625|Autonomic Agents|autonomic agents|mesh-ancestor
6116559|NCT01080625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6116560|NCT01080625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6116561|NCT01080625|Respiratory System Agents|respiratory system agents|mesh-ancestor
6116562|NCT01080625|Mydriatics|mydriatics|mesh-ancestor
6116563|NCT01080625|Sympathomimetics|sympathomimetics|mesh-ancestor
6116564|NCT01080625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6116565|NCT01080625|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6116566|NCT01080625|Nasal Decongestants|nasal decongestants|mesh-ancestor
6116567|NCT01080625|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6116568|NCT01080625|Protective Agents|protective agents|mesh-ancestor
6116569|NCT01080677|Propranolol|propranolol|mesh-list
6116570|NCT01080677|Caffeine|caffeine|mesh-list
6116571|NCT01080677|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6116572|NCT01080677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116573|NCT01080677|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6116574|NCT01080677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6116575|NCT01080677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116576|NCT01080677|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6116577|NCT01080677|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6116578|NCT01080677|Purinergic Agents|purinergic agents|mesh-ancestor
6116579|NCT01080677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6116580|NCT01080677|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6116581|NCT01080677|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6116582|NCT01080677|Adrenergic Agents|adrenergic agents|mesh-ancestor
6116583|NCT01080677|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6116584|NCT01080677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6116585|NCT01080677|Vasodilator Agents|vasodilator agents|mesh-ancestor
6116586|NCT01080716|Vaccines|vaccines|mesh-list
6116587|NCT01080716|Complement Factor H|complement factor h|mesh-list
6116588|NCT01080716|Immunologic Factors|immunologic factors|mesh-ancestor
6116589|NCT01080716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116590|NCT01080716|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6116591|NCT01080716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5530670|NCT03196180|Fluorouracil|fluorouracil|mesh-list
5530671|NCT03196180|Imiquimod|imiquimod|mesh-list
5530672|NCT03196180|Antimetabolites|antimetabolites|mesh-ancestor
5530673|NCT03196180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116592|NCT01080807|Modafinil|modafinil|mesh-list
6116593|NCT01080807|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6116594|NCT01080807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116595|NCT01080807|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6116596|NCT01080807|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6116597|NCT01080807|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6116598|NCT01080807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116599|NCT01081041|Carboplatin|carboplatin|mesh-list
5530674|NCT03196180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5530675|NCT03196180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5530676|NCT03196180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6116600|NCT01081041|Fluorouracil|fluorouracil|mesh-list
6116601|NCT01081041|Cetuximab|cetuximab|mesh-list
6116602|NCT01081041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5530677|NCT03196180|Immunologic Factors|immunologic factors|mesh-ancestor
6116603|NCT01081041|Antimetabolites|antimetabolites|mesh-ancestor
6116604|NCT01081041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116605|NCT01081041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6116606|NCT01081041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6116607|NCT01081041|Immunologic Factors|immunologic factors|mesh-ancestor
6116608|NCT01081041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116609|NCT01081041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5530678|NCT03196180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5530679|NCT03196180|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5530680|NCT03196180|Interferon Inducers|interferon inducers|mesh-ancestor
5530681|NCT03187210|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5530682|NCT03187210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5530683|NCT03187210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5530684|NCT03075423|Nivolumab|nivolumab|mesh-list
5530685|NCT03075423|Ipilimumab|ipilimumab|mesh-list
5530686|NCT03075423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5530687|NCT03075423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5530688|NCT03075423|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5530689|NCT03075423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5530690|NCT02980731|Venetoclax|venetoclax|mesh-list
5530691|NCT02980731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5530692|NCT02923947|Osimertinib|osimertinib|mesh-list
5530693|NCT02923947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5530694|NCT02923947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5530695|NCT02923947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5530696|NCT02923947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5530697|NCT02819141|Dexmedetomidine|dexmedetomidine|mesh-list
5530698|NCT02819141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5530699|NCT02819141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5530700|NCT02819141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5530701|NCT02819141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5530702|NCT02819141|Analgesics|analgesics|mesh-ancestor
5530703|NCT02819141|Sensory System Agents|sensory system agents|mesh-ancestor
5530704|NCT02819141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5530705|NCT02819141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5530706|NCT02819141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5530707|NCT02819141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6116610|NCT01081132|Guanfacine|guanfacine|mesh-list
6116611|NCT01081132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6116612|NCT01081132|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6116613|NCT01081132|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6116614|NCT01081132|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6116615|NCT01081132|Adrenergic Agents|adrenergic agents|mesh-ancestor
6116616|NCT01081132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6116617|NCT01081132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116618|NCT01081132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116619|NCT01081145|Guanfacine|guanfacine|mesh-list
6116620|NCT01081145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6116621|NCT01081145|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6116622|NCT01081145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6116623|NCT01081145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5530708|NCT02819141|Adrenergic Agents|adrenergic agents|mesh-ancestor
5530709|NCT02819141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5530710|NCT02819141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5530711|NCT02796937|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
6116624|NCT01081145|Adrenergic Agents|adrenergic agents|mesh-ancestor
6666100|NCT01520766|Methamphetamine|methamphetamine|mesh-list
5530712|NCT02796937|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5530713|NCT02796937|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5530714|NCT02796937|Protease Inhibitors|protease inhibitors|mesh-ancestor
5530715|NCT02796937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5530716|NCT02796937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5530717|NCT02725593|Dapagliflozin|dapagliflozin|mesh-list
5530718|NCT02725593|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5530719|NCT02725593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5530720|NCT02725593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5530721|NCT02725593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5530722|NCT02636946|Bimatoprost|bimatoprost|mesh-list
5530723|NCT02636946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5530724|NCT02631941|Budesonide|budesonide|mesh-list
5530725|NCT02631941|Formoterol Fumarate|formoterol fumarate|mesh-list
5530726|NCT02631941|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6116625|NCT01081145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6116626|NCT01081145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116627|NCT01081145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116628|NCT01081249|Oxytocin|oxytocin|mesh-list
6116629|NCT01081249|Oxytocics|oxytocics|mesh-ancestor
6116630|NCT01081249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6116631|NCT01081249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116632|NCT01081626|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6116633|NCT01081626|Hormones|hormones|mesh-ancestor
6116634|NCT01081626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6116635|NCT01081626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116636|NCT01081769|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6116637|NCT01081769|Antipsychotic Agents|antipsychotic agents|mesh-list
6116638|NCT01081769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6116639|NCT01081769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5530727|NCT02631941|Charcoal|charcoal|mesh-list
5530728|NCT02631941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5530729|NCT02631941|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5530730|NCT02631941|Autonomic Agents|autonomic agents|mesh-ancestor
5530731|NCT02631941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5530732|NCT02631941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5530733|NCT02631941|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6116640|NCT01081769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116641|NCT01081769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6116642|NCT01081769|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6116643|NCT01081769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6116644|NCT01081769|Serotonin Agents|serotonin agents|mesh-ancestor
5530734|NCT02631941|Respiratory System Agents|respiratory system agents|mesh-ancestor
5530735|NCT02631941|Glucocorticoids|glucocorticoids|mesh-ancestor
5530736|NCT02631941|Hormones|hormones|mesh-ancestor
5530737|NCT02631941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5530738|NCT02631941|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5530739|NCT02631941|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5530740|NCT02631941|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5530741|NCT02631941|Adrenergic Agents|adrenergic agents|mesh-ancestor
5530742|NCT02631941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5530743|NCT02631941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116645|NCT01081769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6116646|NCT01081769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116647|NCT01081769|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6116648|NCT01081769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6116649|NCT01081769|Dopamine Agents|dopamine agents|mesh-ancestor
6116650|NCT01081795|Topiramate|topiramate|mesh-list
6116651|NCT01081795|Anticonvulsants|anticonvulsants|mesh-ancestor
6116652|NCT01081795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6116653|NCT01081795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116654|NCT01081834|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6116655|NCT01081834|Canagliflozin|canagliflozin|mesh-list
6116656|NCT01081834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6116657|NCT01081834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116658|NCT01081834|Incretins|incretins|mesh-ancestor
6116659|NCT01081834|Hormones|hormones|mesh-ancestor
6116660|NCT01081834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6116661|NCT01081834|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6116662|NCT01081834|Protease Inhibitors|protease inhibitors|mesh-ancestor
6116663|NCT01081834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6116664|NCT01081834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116665|NCT01081834|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6116666|NCT01081873|Leuprolide|leuprolide|mesh-list
6116667|NCT01081873|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6116668|NCT01081873|Fertility Agents|fertility agents|mesh-ancestor
6116669|NCT01081873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6116670|NCT01081873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116671|NCT01081873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6116672|NCT01081873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6116673|NCT01081912|Hydrocodone|hydrocodone|mesh-list
6116674|NCT01081912|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6116675|NCT01081912|Narcotics|narcotics|mesh-ancestor
6116676|NCT01081912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6116677|NCT01081912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116678|NCT01081912|Analgesics|analgesics|mesh-ancestor
5530744|NCT02631941|Antidotes|antidotes|mesh-ancestor
5530745|NCT02631941|Protective Agents|protective agents|mesh-ancestor
5530746|NCT02623972|Cyclophosphamide|cyclophosphamide|mesh-list
5530747|NCT02623972|Doxorubicin|doxorubicin|mesh-list
5530748|NCT02623972|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6116679|NCT01081912|Sensory System Agents|sensory system agents|mesh-ancestor
6116680|NCT01081912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6116681|NCT01081912|Antitussive Agents|antitussive agents|mesh-ancestor
6116682|NCT01081912|Respiratory System Agents|respiratory system agents|mesh-ancestor
6116683|NCT01081951|Paclitaxel|paclitaxel|mesh-list
6116684|NCT01081951|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6116685|NCT01081951|Carboplatin|carboplatin|mesh-list
6116686|NCT01081951|Olaparib|olaparib|mesh-list
6116687|NCT01081951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6116688|NCT01081951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6116689|NCT01081951|Tubulin Modulators|tubulin modulators|mesh-ancestor
6116690|NCT01081951|Antimitotic Agents|antimitotic agents|mesh-ancestor
6116691|NCT01081951|Mitosis Modulators|mitosis modulators|mesh-ancestor
6116692|NCT01081951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116693|NCT01081951|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6116694|NCT01081951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6116695|NCT01082081|Acetaminophen|acetaminophen|mesh-list
6116696|NCT01082081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6116697|NCT01082081|Analgesics|analgesics|mesh-ancestor
6116698|NCT01082081|Sensory System Agents|sensory system agents|mesh-ancestor
6116699|NCT01082081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6116700|NCT01082081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116701|NCT01082081|Antipyretics|antipyretics|mesh-ancestor
6116702|NCT01082380|Crizotinib|crizotinib|mesh-list
6116703|NCT01082380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6116704|NCT01082380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6116705|NCT01082380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6116706|NCT01082380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116707|NCT01082588|Pravastatin|pravastatin|mesh-list
6116708|NCT01082588|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6116709|NCT01082588|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6116710|NCT01082588|Antimetabolites|antimetabolites|mesh-ancestor
6116711|NCT01082588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116712|NCT01082588|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6116713|NCT01082588|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6116714|NCT01082588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6116715|NCT01082640|Febuxostat|febuxostat|mesh-list
6116716|NCT01082640|Gout Suppressants|gout suppressants|mesh-ancestor
6116717|NCT01082640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6116718|NCT01082874|Aspirin|aspirin|mesh-list
6116719|NCT01082874|Clonidine|clonidine|mesh-list
6116720|NCT01082874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6116721|NCT01082874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6116722|NCT01082874|Analgesics|analgesics|mesh-ancestor
6116723|NCT01082874|Sensory System Agents|sensory system agents|mesh-ancestor
6116724|NCT01082874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6116725|NCT01082874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116726|NCT01082874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6116727|NCT01082874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6116728|NCT01082874|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6116729|NCT01082874|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6116730|NCT01082874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116731|NCT01082874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6116732|NCT01082874|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6116733|NCT01082874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6116734|NCT01082874|Antipyretics|antipyretics|mesh-ancestor
5530749|NCT02623972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6116735|NCT01082874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6116736|NCT01082874|Sympatholytics|sympatholytics|mesh-ancestor
6116737|NCT01082874|Autonomic Agents|autonomic agents|mesh-ancestor
6116738|NCT01082874|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6116739|NCT01082874|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6116740|NCT01082874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6116741|NCT01082874|Adrenergic Agents|adrenergic agents|mesh-ancestor
6116742|NCT01082874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6116743|NCT01082939|Vidarabine|vidarabine|mesh-list
6116744|NCT01082939|Cyclophosphamide|cyclophosphamide|mesh-list
5530750|NCT02623972|Immunologic Factors|immunologic factors|mesh-ancestor
5530751|NCT02623972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5530752|NCT02623972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5530753|NCT02623972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5530754|NCT02623972|Alkylating Agents|alkylating agents|mesh-ancestor
5530755|NCT02623972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5530756|NCT02623972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5530757|NCT02623972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5530758|NCT02623972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5530759|NCT02623972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5530760|NCT02623972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5530761|NCT02623972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6116745|NCT01082939|Rituximab|rituximab|mesh-list
6116746|NCT01082939|Fludarabine|fludarabine|mesh-list
6116747|NCT01082939|Fludarabine phosphate|fludarabine phosphate|mesh-list
6116748|NCT01082939|Alemtuzumab|alemtuzumab|mesh-list
6116749|NCT01082939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6116750|NCT01082939|Immunologic Factors|immunologic factors|mesh-ancestor
6116751|NCT01082939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116752|NCT01082939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6116753|NCT01082939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6116754|NCT01082939|Alkylating Agents|alkylating agents|mesh-ancestor
6116755|NCT01082939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116756|NCT01082939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6116757|NCT01082939|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6116758|NCT01082939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6116759|NCT01082939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6116760|NCT01082939|Antimetabolites|antimetabolites|mesh-ancestor
5530762|NCT02562378|Doxorubicin|doxorubicin|mesh-list
5530763|NCT02562378|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5530764|NCT02562378|Trastuzumab|trastuzumab|mesh-list
5530765|NCT02562378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5530766|NCT02562378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5530767|NCT02562378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5530768|NCT02562378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5530769|NCT02562378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5530770|NCT02562378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5530771|NCT02562378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5530772|NCT02527434|Durvalumab|durvalumab|mesh-list
5530773|NCT02527434|Tremelimumab|tremelimumab|mesh-list
5530774|NCT02527434|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5530775|NCT02527434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5530776|NCT02527434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5530777|NCT02527434|Immunologic Factors|immunologic factors|mesh-ancestor
5530778|NCT02527434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5530779|NCT02387099|Everolimus|everolimus|mesh-list
5530780|NCT02387099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5530781|NCT02387099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5530782|NCT02387099|Immunologic Factors|immunologic factors|mesh-ancestor
5530783|NCT02387099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5530784|NCT02299414|Antihypertensive Agents|antihypertensive agents|mesh-list
5530785|NCT02299414|Nifedipine|nifedipine|mesh-list
5530786|NCT02299414|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5530787|NCT02299414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5530788|NCT02299414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5530789|NCT02299414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6116761|NCT01082939|Antiviral Agents|antiviral agents|mesh-ancestor
6116762|NCT01082939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5530790|NCT02299414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5530791|NCT02299414|Vasodilator Agents|vasodilator agents|mesh-ancestor
5530792|NCT02299414|Tocolytic Agents|tocolytic agents|mesh-ancestor
5530793|NCT02299414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5530794|NCT02258659|Paclitaxel|paclitaxel|mesh-list
5530795|NCT02258659|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5530796|NCT02258659|Carboplatin|carboplatin|mesh-list
6116763|NCT01082965|Donepezil|donepezil|mesh-list
5530797|NCT02258659|Fluorouracil|fluorouracil|mesh-list
5530798|NCT02258659|Hydroxyurea|hydroxyurea|mesh-list
5530799|NCT02258659|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5530800|NCT02258659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5530801|NCT02258659|Tubulin Modulators|tubulin modulators|mesh-ancestor
5530802|NCT02258659|Antimitotic Agents|antimitotic agents|mesh-ancestor
5530803|NCT02258659|Mitosis Modulators|mitosis modulators|mesh-ancestor
5530804|NCT02258659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5530805|NCT02258659|Antimetabolites|antimetabolites|mesh-ancestor
5530806|NCT02258659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5530807|NCT02258659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5530808|NCT02258659|Immunologic Factors|immunologic factors|mesh-ancestor
5530809|NCT02258659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5530810|NCT02258659|Antisickling Agents|antisickling agents|mesh-ancestor
5530811|NCT02258659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5530812|NCT02258659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5530813|NCT02237508|Budesonide|budesonide|mesh-list
5530814|NCT02237508|Formoterol Fumarate|formoterol fumarate|mesh-list
5530815|NCT02237508|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
5530816|NCT02237508|Charcoal|charcoal|mesh-list
5530817|NCT02237508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5530818|NCT02237508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5530819|NCT02237508|Autonomic Agents|autonomic agents|mesh-ancestor
5530820|NCT02237508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5530821|NCT02237508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5530822|NCT02237508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5530823|NCT02237508|Respiratory System Agents|respiratory system agents|mesh-ancestor
5530824|NCT02237508|Glucocorticoids|glucocorticoids|mesh-ancestor
5530825|NCT02237508|Hormones|hormones|mesh-ancestor
5725401|NCT03180710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725402|NCT03180476|Apatinib|apatinib|mesh-list
5725403|NCT03180476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5725404|NCT03180476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5725405|NCT03180476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5725406|NCT03180476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725407|NCT03180632|Lorazepam|lorazepam|mesh-list
5725408|NCT03180632|Anticonvulsants|anticonvulsants|mesh-ancestor
5725409|NCT03180632|Antiemetics|antiemetics|mesh-ancestor
5725410|NCT03180632|Autonomic Agents|autonomic agents|mesh-ancestor
5725411|NCT03180632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5725412|NCT03180632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725413|NCT03180632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5725414|NCT03180632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5725415|NCT03180632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5725416|NCT03180632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5725417|NCT03180632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5725418|NCT03180632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5725419|NCT03180632|GABA Modulators|gaba modulators|mesh-ancestor
5725420|NCT03180632|GABA Agents|gaba agents|mesh-ancestor
5725421|NCT03180632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5725422|NCT03180632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725423|NCT03180671|Salicylic Acid|salicylic acid|mesh-list
5725424|NCT03180671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5725425|NCT03180671|Antifungal Agents|antifungal agents|mesh-ancestor
5725426|NCT03180671|Keratolytic Agents|keratolytic agents|mesh-ancestor
5725427|NCT03180671|Dermatologic Agents|dermatologic agents|mesh-ancestor
5725428|NCT03180593|Valsartan|valsartan|mesh-list
5725429|NCT03180593|Nebivolol|nebivolol|mesh-list
6116764|NCT01082965|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6116765|NCT01082965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6116766|NCT01082965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116767|NCT01082965|Cholinergic Agents|cholinergic agents|mesh-ancestor
6116768|NCT01082965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6116769|NCT01082965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116770|NCT01082965|Nootropic Agents|nootropic agents|mesh-ancestor
6116771|NCT01083316|Dexamethasone|dexamethasone|mesh-list
5530826|NCT02237508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5530827|NCT02237508|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5530828|NCT02237508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5530829|NCT02237508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5530830|NCT02237508|Adrenergic Agents|adrenergic agents|mesh-ancestor
5530831|NCT02237508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5530832|NCT02237508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5530833|NCT02237508|Antidotes|antidotes|mesh-ancestor
5530834|NCT02237508|Protective Agents|protective agents|mesh-ancestor
5530835|NCT02197234|Osimertinib|osimertinib|mesh-list
5530836|NCT02197234|Simvastatin|simvastatin|mesh-list
5530837|NCT02197234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5530838|NCT02197234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5530839|NCT02197234|Antimetabolites|antimetabolites|mesh-ancestor
5530840|NCT02197234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116772|NCT01083316|Bortezomib|bortezomib|mesh-list
6116773|NCT01083316|Melphalan|melphalan|mesh-list
6116774|NCT01083316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6116775|NCT01083316|Antiemetics|antiemetics|mesh-ancestor
6116776|NCT01083316|Autonomic Agents|autonomic agents|mesh-ancestor
6116777|NCT01083316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6116778|NCT01083316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116779|NCT01083316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6116780|NCT01083316|Glucocorticoids|glucocorticoids|mesh-ancestor
6116781|NCT01083316|Hormones|hormones|mesh-ancestor
6116782|NCT01083316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6116783|NCT01083316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6116784|NCT01083316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6116785|NCT01083316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6116786|NCT01083316|Alkylating Agents|alkylating agents|mesh-ancestor
6116787|NCT01083316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116788|NCT01083316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6116789|NCT01083316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6116790|NCT01083316|Immunologic Factors|immunologic factors|mesh-ancestor
6116791|NCT01083368|Sirolimus|sirolimus|mesh-list
6116792|NCT01083368|Bevacizumab|bevacizumab|mesh-list
6116793|NCT01083368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6116794|NCT01083368|Antibodies|antibodies|mesh-list
6116795|NCT01083368|Immunoglobulins|immunoglobulins|mesh-list
6116796|NCT01083368|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6116797|NCT01083368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6116798|NCT01083368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6116799|NCT01083368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6116800|NCT01083368|Growth Substances|growth substances|mesh-ancestor
6116801|NCT01083368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116802|NCT01083368|Growth Inhibitors|growth inhibitors|mesh-ancestor
6116803|NCT01083368|Immunologic Factors|immunologic factors|mesh-ancestor
6116804|NCT01083368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6116805|NCT01083368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6116806|NCT01083368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6116807|NCT01083368|Antifungal Agents|antifungal agents|mesh-ancestor
6116808|NCT01083368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6116809|NCT01083485|Oxycodone|oxycodone|mesh-list
6116810|NCT01083485|Naloxone|naloxone|mesh-list
6116811|NCT01083485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6116812|NCT01083485|Narcotics|narcotics|mesh-ancestor
6116813|NCT01083485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6116814|NCT01083485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116815|NCT01083485|Analgesics|analgesics|mesh-ancestor
6116816|NCT01083485|Sensory System Agents|sensory system agents|mesh-ancestor
6116817|NCT01083485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6116818|NCT01083485|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6116819|NCT01083576|Gentamicins|gentamicins|mesh-list
6116820|NCT01083576|Paromomycin|paromomycin|mesh-list
5530841|NCT02197234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5606722|NCT03823989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6116821|NCT01083576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6116822|NCT01083576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6116823|NCT01083576|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6116824|NCT01083576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6116825|NCT01083576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116826|NCT01083576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6116827|NCT01083576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6116828|NCT01083602|Dexamethasone|dexamethasone|mesh-list
6116829|NCT01083602|Bortezomib|bortezomib|mesh-list
6116830|NCT01083602|Panobinostat|panobinostat|mesh-list
6116831|NCT01083602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6116832|NCT01083602|Antiemetics|antiemetics|mesh-ancestor
6116833|NCT01083602|Autonomic Agents|autonomic agents|mesh-ancestor
6116834|NCT01083602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6116835|NCT01083602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116836|NCT01083602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6116837|NCT01083602|Glucocorticoids|glucocorticoids|mesh-ancestor
6116838|NCT01083602|Hormones|hormones|mesh-ancestor
6116839|NCT01083602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6116840|NCT01083602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6116841|NCT01083602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6116842|NCT01083602|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6116843|NCT01083602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6116844|NCT01083602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116845|NCT01083641|Estradiol|estradiol|mesh-list
6116846|NCT01083641|Estrogens|estrogens|mesh-ancestor
6116847|NCT01083641|Hormones|hormones|mesh-ancestor
6116848|NCT01083641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6116849|NCT01083641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116850|NCT01083667|Pyrimethamine|pyrimethamine|mesh-list
6116851|NCT01083667|Antimalarials|antimalarials|mesh-ancestor
6116852|NCT01083667|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6116853|NCT01083667|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6116854|NCT01083667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6116855|NCT01083667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6116856|NCT01083667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6116857|NCT01083667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116858|NCT01083706|Azacitidine|azacitidine|mesh-list
6116859|NCT01083706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6116860|NCT01083706|Antimetabolites|antimetabolites|mesh-ancestor
6116861|NCT01083706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116862|NCT01083706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5530842|NCT02197234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5530843|NCT02197234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5530844|NCT02197234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5530845|NCT02197234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5530846|NCT02163733|Osimertinib|osimertinib|mesh-list
5530847|NCT02163733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5530848|NCT02163733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5530849|NCT02163733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5530850|NCT02163733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5530851|NCT02157883|Itraconazole|itraconazole|mesh-list
5530852|NCT02157883|Osimertinib|osimertinib|mesh-list
5530853|NCT02157883|Antifungal Agents|antifungal agents|mesh-ancestor
5530854|NCT02157883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5530855|NCT02157883|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5530856|NCT02157883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5530857|NCT02157883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5530858|NCT02157883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5530859|NCT02157883|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5530860|NCT02157883|Hormone Antagonists|hormone antagonists|mesh-ancestor
5530861|NCT02157883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5530862|NCT02157883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5530863|NCT02157883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5530864|NCT02157883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5530865|NCT02157883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5530866|NCT01996449|Amlodipine|amlodipine|mesh-list
6116863|NCT01083706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6116864|NCT01083732|Dabigatran|dabigatran|mesh-list
6116865|NCT01083732|Antithrombins|antithrombins|mesh-ancestor
6116866|NCT01083732|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6116867|NCT01083732|Protease Inhibitors|protease inhibitors|mesh-ancestor
6116868|NCT01083732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6116869|NCT01083732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5530867|NCT01996449|Eplerenone|eplerenone|mesh-list
5530868|NCT01996449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6116870|NCT01083732|Anticoagulants|anticoagulants|mesh-ancestor
6116871|NCT01083810|Ritonavir|ritonavir|mesh-list
6116872|NCT01083810|Lopinavir|lopinavir|mesh-list
6116873|NCT01083810|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6116874|NCT01083810|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6116875|NCT01083810|Protease Inhibitors|protease inhibitors|mesh-ancestor
6116876|NCT01083810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6116877|NCT01083810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116878|NCT01083810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6116879|NCT01083810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6116880|NCT01083810|Antiviral Agents|antiviral agents|mesh-ancestor
6116881|NCT01083810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6116882|NCT01083810|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6116883|NCT01083810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6116884|NCT01084005|Linagliptin|linagliptin|mesh-list
6116885|NCT01084005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6116886|NCT01084005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116887|NCT01084005|Incretins|incretins|mesh-ancestor
6116888|NCT01084005|Hormones|hormones|mesh-ancestor
6116889|NCT01084005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6116890|NCT01084005|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6116891|NCT01084005|Protease Inhibitors|protease inhibitors|mesh-ancestor
6116892|NCT01084005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6116893|NCT01084005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116894|NCT01084083|Paclitaxel|paclitaxel|mesh-list
6116895|NCT01084083|Cetuximab|cetuximab|mesh-list
6116896|NCT01084083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6116897|NCT01084083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6116898|NCT01084083|Tubulin Modulators|tubulin modulators|mesh-ancestor
6116899|NCT01084083|Antimitotic Agents|antimitotic agents|mesh-ancestor
6116900|NCT01084083|Mitosis Modulators|mitosis modulators|mesh-ancestor
6116901|NCT01084083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116902|NCT01084083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6116903|NCT01084135|Rivastigmine|rivastigmine|mesh-list
6116904|NCT01084135|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6116905|NCT01084135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6116906|NCT01084135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116907|NCT01084135|Cholinergic Agents|cholinergic agents|mesh-ancestor
6116908|NCT01084135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6116909|NCT01084135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116910|NCT01084135|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6116911|NCT01084135|Protective Agents|protective agents|mesh-ancestor
6116912|NCT01084148|V0034CR|v0034cr|mesh-list
5530869|NCT01996449|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5530870|NCT01996449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5530871|NCT01996449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5530872|NCT01996449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5530873|NCT01996449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5530874|NCT01996449|Vasodilator Agents|vasodilator agents|mesh-ancestor
5530875|NCT01996449|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5530876|NCT01996449|Hormone Antagonists|hormone antagonists|mesh-ancestor
5530877|NCT01996449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5530878|NCT01996449|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5530879|NCT01996449|Diuretics|diuretics|mesh-ancestor
5530880|NCT01996449|Natriuretic Agents|natriuretic agents|mesh-ancestor
5530881|NCT01983241|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
6116913|NCT01084148|Emollients|emollients|mesh-ancestor
6116914|NCT01084148|Dermatologic Agents|dermatologic agents|mesh-ancestor
6204462|NCT02070991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204463|NCT02070991|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
6204464|NCT02071082|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6204465|NCT02071082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6204466|NCT02071082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6204467|NCT02071082|Antiviral Agents|antiviral agents|mesh-ancestor
6204468|NCT02071082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6204469|NCT02071095|Poly I-C|poly i-c|mesh-list
6204470|NCT02071095|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6204471|NCT02071095|Poly ICLC|poly iclc|mesh-list
6204472|NCT02071095|Interferon Inducers|interferon inducers|mesh-ancestor
6204473|NCT02071095|Immunologic Factors|immunologic factors|mesh-ancestor
6204474|NCT02071095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204475|NCT02071095|Laxatives|laxatives|mesh-ancestor
6204476|NCT02071095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6116915|NCT01084252|Dexamethasone|dexamethasone|mesh-list
6116916|NCT01084252|Dexamethasone acetate|dexamethasone acetate|mesh-list
6116917|NCT01084252|BB 1101|bb 1101|mesh-list
6116918|NCT01084252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6116919|NCT01084252|Antiemetics|antiemetics|mesh-ancestor
6116920|NCT01084252|Autonomic Agents|autonomic agents|mesh-ancestor
6116921|NCT01084252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6116922|NCT01084252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116923|NCT01084252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6116924|NCT01084252|Glucocorticoids|glucocorticoids|mesh-ancestor
6116925|NCT01084252|Hormones|hormones|mesh-ancestor
6116926|NCT01084252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6116927|NCT01084252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6116928|NCT01084252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6116929|NCT01084252|Protease Inhibitors|protease inhibitors|mesh-ancestor
6116930|NCT01084252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6116931|NCT01084252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116932|NCT01084265|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5530882|NCT01983241|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5530883|NCT01983241|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5530884|NCT01983241|Protease Inhibitors|protease inhibitors|mesh-ancestor
5530885|NCT01983241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5530886|NCT01983241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5530887|NCT01822288|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
5530888|NCT01822288|Tibolone|tibolone|mesh-list
5530889|NCT01822288|Medroxyprogesterone|medroxyprogesterone|mesh-list
5530890|NCT01822288|Estradiol|estradiol|mesh-list
5530891|NCT01822288|Estrogens|estrogens|mesh-ancestor
5530892|NCT01822288|Hormones|hormones|mesh-ancestor
5530893|NCT01822288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5530894|NCT01822288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5530895|NCT01822288|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5530896|NCT01822288|Contraceptive Agents|contraceptive agents|mesh-ancestor
5530897|NCT01822288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5530898|NCT01822288|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5530899|NCT01822288|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5530900|NCT01822288|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5530901|NCT01822288|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5530902|NCT01822288|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5530903|NCT01822288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5530904|NCT01822288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5530905|NCT01822288|Androgen Antagonists|androgen antagonists|mesh-ancestor
5530906|NCT01822288|Hormone Antagonists|hormone antagonists|mesh-ancestor
5530907|NCT01822288|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5530908|NCT01822288|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5530909|NCT01822288|Anabolic Agents|anabolic agents|mesh-ancestor
5530910|NCT01802632|Osimertinib|osimertinib|mesh-list
5530911|NCT01802632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5530912|NCT01802632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5530913|NCT01802632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5725430|NCT03180593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5725431|NCT03180593|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5725432|NCT03180593|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5725433|NCT03180593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725434|NCT03180593|Vasodilator Agents|vasodilator agents|mesh-ancestor
5725435|NCT03180593|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5725436|NCT03180593|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5725437|NCT03180593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5725438|NCT03180593|Adrenergic Agents|adrenergic agents|mesh-ancestor
5725439|NCT03180593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5725440|NCT03180593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725441|NCT03180294|Bupropion|bupropion|mesh-list
5725442|NCT03180294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5725443|NCT03180294|Antidepressive Agents|antidepressive agents|mesh-ancestor
5725444|NCT03180294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5725445|NCT03180294|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5530914|NCT01802632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5530915|NCT01625286|Paclitaxel|paclitaxel|mesh-list
5530916|NCT01625286|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5530917|NCT01625286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5530918|NCT01625286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5530919|NCT01625286|Tubulin Modulators|tubulin modulators|mesh-ancestor
5530920|NCT01625286|Antimitotic Agents|antimitotic agents|mesh-ancestor
5530921|NCT01625286|Mitosis Modulators|mitosis modulators|mesh-ancestor
5530922|NCT01625286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5530923|NCT01583283|Dexamethasone|dexamethasone|mesh-list
5530924|NCT01583283|Lenalidomide|lenalidomide|mesh-list
5530925|NCT01583283|Ricolinostat|ricolinostat|mesh-list
5530926|NCT01583283|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
5530927|NCT01583283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5530928|NCT01583283|Antiemetics|antiemetics|mesh-ancestor
5530929|NCT01583283|Autonomic Agents|autonomic agents|mesh-ancestor
5530930|NCT01583283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5530931|NCT01583283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5530932|NCT01583283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5530933|NCT01583283|Glucocorticoids|glucocorticoids|mesh-ancestor
5530934|NCT01583283|Hormones|hormones|mesh-ancestor
5530935|NCT01583283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5530936|NCT01583283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5530937|NCT01583283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5530938|NCT01583283|Immunologic Factors|immunologic factors|mesh-ancestor
5530939|NCT01583283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5530940|NCT01583283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5530941|NCT01583283|Growth Substances|growth substances|mesh-ancestor
5530942|NCT01583283|Growth Inhibitors|growth inhibitors|mesh-ancestor
5530943|NCT01583283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5530944|NCT01583283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5530945|NCT01341600|Omeprazole|omeprazole|mesh-list
5530946|NCT01341600|Clopidogrel|clopidogrel|mesh-list
5530947|NCT01341600|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5530948|NCT01341600|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5530949|NCT01341600|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5606723|NCT03823989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5725446|NCT03180294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5725447|NCT03180294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5725448|NCT03180294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725449|NCT03180294|Dopamine Agents|dopamine agents|mesh-ancestor
5725450|NCT03180294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5725451|NCT03180294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725452|NCT03180294|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5725453|NCT03180294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5725454|NCT03180294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5725455|NCT03180229|Granisetron|granisetron|mesh-list
5725456|NCT03180229|Antiemetics|antiemetics|mesh-ancestor
5725457|NCT03180229|Autonomic Agents|autonomic agents|mesh-ancestor
5725458|NCT03180229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5725459|NCT03180229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725460|NCT03180229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5725461|NCT03180229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5725462|NCT03180229|Serotonin Agents|serotonin agents|mesh-ancestor
5725463|NCT03180229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5725464|NCT03180229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725465|NCT03180346|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
5725466|NCT03180346|Laxatives|laxatives|mesh-ancestor
5725467|NCT03180346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5725468|NCT03180359|Vaccines|vaccines|mesh-list
5725469|NCT03180359|Immunologic Factors|immunologic factors|mesh-ancestor
5725470|NCT03180359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725471|NCT03180125|Lidocaine|lidocaine|mesh-list
5725472|NCT03180125|Hyaluronic Acid|hyaluronic acid|mesh-list
5725473|NCT03180125|Anesthetics, Local|anesthetics, local|mesh-ancestor
5725474|NCT03180125|Anesthetics|anesthetics|mesh-ancestor
5725475|NCT03180125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5725476|NCT03180125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725477|NCT03180125|Sensory System Agents|sensory system agents|mesh-ancestor
5725478|NCT03180125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5725479|NCT03180125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5725480|NCT03180125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5530950|NCT01341600|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5530951|NCT01341600|Purinergic Agents|purinergic agents|mesh-ancestor
5530952|NCT01341600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6116933|NCT01084265|Hormones|hormones|mesh-list
6116934|NCT01084265|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6116935|NCT01084265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6116936|NCT01084265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116937|NCT01084265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6116938|NCT01084278|Colchicine|colchicine|mesh-list
6116939|NCT01084278|Gout Suppressants|gout suppressants|mesh-ancestor
6116940|NCT01084278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6116941|NCT01084278|Tubulin Modulators|tubulin modulators|mesh-ancestor
6116942|NCT01084278|Antimitotic Agents|antimitotic agents|mesh-ancestor
6116943|NCT01084278|Mitosis Modulators|mitosis modulators|mesh-ancestor
6116944|NCT01084278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116945|NCT01084278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6116946|NCT01084499|Letrozole|letrozole|mesh-list
6116947|NCT01084499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6116948|NCT01084499|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6116949|NCT01084499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6116950|NCT01084499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6116951|NCT01084499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116952|NCT01084499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6116953|NCT01084499|Hormone Antagonists|hormone antagonists|mesh-ancestor
6116954|NCT01084499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6116955|NCT01084499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116956|NCT01084538|Ergocalciferols|ergocalciferols|mesh-list
6116957|NCT01084538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6116958|NCT01084538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116959|NCT01084538|Vitamins|vitamins|mesh-ancestor
6116960|NCT01084538|Micronutrients|micronutrients|mesh-ancestor
6116961|NCT01084538|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6116962|NCT01084603|Nicotine|nicotine|mesh-list
6116963|NCT01084603|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6116964|NCT01084603|Autonomic Agents|autonomic agents|mesh-ancestor
6116965|NCT01084603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6116966|NCT01084603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116967|NCT01084603|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6116968|NCT01084603|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6116969|NCT01084603|Cholinergic Agents|cholinergic agents|mesh-ancestor
6116970|NCT01084603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5530953|NCT01341600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5530954|NCT01341600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5530955|NCT01341600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5530956|NCT01341600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5530957|NCT01341600|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6116971|NCT01084603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116972|NCT01084655|Prednisone|prednisone|mesh-list
6116973|NCT01084655|Docetaxel|docetaxel|mesh-list
6116974|NCT01084655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6116975|NCT01084655|Tubulin Modulators|tubulin modulators|mesh-ancestor
6116976|NCT01084655|Antimitotic Agents|antimitotic agents|mesh-ancestor
6116977|NCT01084655|Mitosis Modulators|mitosis modulators|mesh-ancestor
6116978|NCT01084655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116979|NCT01084655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6116980|NCT01084655|Glucocorticoids|glucocorticoids|mesh-ancestor
6116981|NCT01084655|Hormones|hormones|mesh-ancestor
6116982|NCT01084655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6116983|NCT01084655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116984|NCT01084655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6116985|NCT01084707|Nicotine|nicotine|mesh-list
6116986|NCT01084707|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6116987|NCT01084707|Autonomic Agents|autonomic agents|mesh-ancestor
6116988|NCT01084707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6116989|NCT01084707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6116990|NCT01084707|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6116991|NCT01084707|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6116992|NCT01084707|Cholinergic Agents|cholinergic agents|mesh-ancestor
6116993|NCT01084707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6116994|NCT01084707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6116995|NCT01084759|Etoposide|etoposide|mesh-list
6116996|NCT01084759|Methyltestosterone|methyltestosterone|mesh-list
5530958|NCT01341600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6116997|NCT01084759|Testosterone|testosterone|mesh-list
5530959|NCT01328626|Venetoclax|venetoclax|mesh-list
5530960|NCT01328626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5530961|NCT01297400|Sulfadiazine|sulfadiazine|mesh-list
6116998|NCT01084759|Testosterone undecanoate|testosterone undecanoate|mesh-list
6116999|NCT01084759|Testosterone enanthate|testosterone enanthate|mesh-list
6117000|NCT01084759|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6117001|NCT01084759|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6117002|NCT01084759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6117003|NCT01084759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6117004|NCT01084759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6117005|NCT01084759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6117006|NCT01084759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117007|NCT01084759|Androgens|androgens|mesh-ancestor
6117008|NCT01084759|Hormones|hormones|mesh-ancestor
6117009|NCT01084759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6117010|NCT01084759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117011|NCT01084759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6117012|NCT01084759|Anabolic Agents|anabolic agents|mesh-ancestor
6117013|NCT01085006|Tranexamic Acid|tranexamic acid|mesh-list
6117014|NCT01085006|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6117015|NCT01085006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6117016|NCT01085006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117017|NCT01085006|Hemostatics|hemostatics|mesh-ancestor
6117018|NCT01085006|Coagulants|coagulants|mesh-ancestor
6117019|NCT01085045|Bromides|bromides|mesh-list
6117020|NCT01085045|Formoterol Fumarate|formoterol fumarate|mesh-list
6117021|NCT01085045|Tiotropium Bromide|tiotropium bromide|mesh-list
6117022|NCT01085045|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6117023|NCT01085045|Autonomic Agents|autonomic agents|mesh-ancestor
6465728|NCT00475917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465729|NCT00475917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6465730|NCT00475917|Antiviral Agents|antiviral agents|mesh-ancestor
6465731|NCT00475917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6465732|NCT00475917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6465733|NCT00475917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6465734|NCT00475917|Immunologic Factors|immunologic factors|mesh-ancestor
6465735|NCT00475917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465736|NCT00475930|Chlorhexidine|chlorhexidine|mesh-list
6465737|NCT00475930|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6666101|NCT01520766|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6666102|NCT01520766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5530962|NCT01297400|Silver Sulfadiazine|silver sulfadiazine|mesh-list
6117024|NCT01085045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6117025|NCT01085045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117026|NCT01085045|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6117027|NCT01085045|Respiratory System Agents|respiratory system agents|mesh-ancestor
6117028|NCT01085045|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6117029|NCT01085045|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6117030|NCT01085045|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6117031|NCT01085045|Adrenergic Agents|adrenergic agents|mesh-ancestor
6117032|NCT01085045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6117033|NCT01085045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117034|NCT01085045|Parasympatholytics|parasympatholytics|mesh-ancestor
6117035|NCT01085045|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6117036|NCT01085045|Cholinergic Agents|cholinergic agents|mesh-ancestor
6117037|NCT01085045|Anticonvulsants|anticonvulsants|mesh-ancestor
6117038|NCT01085136|Afatinib|afatinib|mesh-list
6117039|NCT01085136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6117040|NCT01085136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6117041|NCT01085136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6117042|NCT01085136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117043|NCT01085201|Regadenoson|regadenoson|mesh-list
6117044|NCT01085201|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
6117045|NCT01085201|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6117046|NCT01085201|Purinergic Agonists|purinergic agonists|mesh-ancestor
6117047|NCT01085201|Purinergic Agents|purinergic agents|mesh-ancestor
6117048|NCT01085201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6117049|NCT01085201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117050|NCT01085201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117051|NCT01085344|Factor VIII|factor viii|mesh-list
6117052|NCT01085344|Coagulants|coagulants|mesh-ancestor
6117053|NCT01085591|Vancomycin|vancomycin|mesh-list
6117054|NCT01085591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6465738|NCT00475930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6117055|NCT01085591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6117056|NCT01085630|Pemetrexed|pemetrexed|mesh-list
5530963|NCT01297400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5530964|NCT01297400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5530965|NCT01297400|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5530966|NCT01297400|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5530967|NCT01297400|Coccidiostats|coccidiostats|mesh-ancestor
5530968|NCT01297400|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6117057|NCT01085630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6117058|NCT01085630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6117059|NCT01085630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117060|NCT01085630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6117061|NCT01085630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6117062|NCT01085734|Bevacizumab|bevacizumab|mesh-list
6117063|NCT01085734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6117064|NCT01085734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6117065|NCT01085734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6117066|NCT01085734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6117067|NCT01085734|Growth Substances|growth substances|mesh-ancestor
6117068|NCT01085734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117069|NCT01085734|Growth Inhibitors|growth inhibitors|mesh-ancestor
6117070|NCT01085760|Metronidazole|metronidazole|mesh-list
6117071|NCT01085760|Vancomycin|vancomycin|mesh-list
6117072|NCT01085760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6117073|NCT01085760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6117074|NCT01085760|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6117075|NCT01085760|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6117076|NCT01085786|Amoxicillin|amoxicillin|mesh-list
6117077|NCT01085786|Metronidazole|metronidazole|mesh-list
5530969|NCT00781612|Paclitaxel|paclitaxel|mesh-list
5530970|NCT00781612|Maytansine|maytansine|mesh-list
5530971|NCT00781612|Docetaxel|docetaxel|mesh-list
5530972|NCT00781612|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
5530973|NCT00781612|Trastuzumab|trastuzumab|mesh-list
5530974|NCT00781612|Atezolizumab|atezolizumab|mesh-list
5530975|NCT00781612|Pertuzumab|pertuzumab|mesh-list
5530976|NCT00781612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5530977|NCT00781612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5530978|NCT00781612|Tubulin Modulators|tubulin modulators|mesh-ancestor
5530979|NCT00781612|Antimitotic Agents|antimitotic agents|mesh-ancestor
6117078|NCT01085786|Clarithromycin|clarithromycin|mesh-list
6117079|NCT01085786|Esomeprazole|esomeprazole|mesh-list
6117080|NCT01085786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6117081|NCT01085786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6117082|NCT01085786|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6117083|NCT01085786|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6117084|NCT01085786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6117085|NCT01085786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6117086|NCT01085786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6117087|NCT01085786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6117088|NCT01085786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117089|NCT01085786|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6117090|NCT01085786|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5530980|NCT00781612|Mitosis Modulators|mitosis modulators|mesh-ancestor
5530981|NCT00781612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5530982|NCT00781612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5530983|NCT00769379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5530984|NCT00769379|Trastuzumab|trastuzumab|mesh-list
5530985|NCT00769379|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
5530986|NCT00769379|Antibodies|antibodies|mesh-list
5530987|NCT00769379|Immunoglobulins|immunoglobulins|mesh-list
5530988|NCT00769379|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5530989|NCT00769379|Immunologic Factors|immunologic factors|mesh-ancestor
5530990|NCT00769379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5530991|NCT00769379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5530992|NCT00529113|Gemcitabine|gemcitabine|mesh-list
5530993|NCT00529113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6117091|NCT01085786|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6117092|NCT01085812|Milnacipran|milnacipran|mesh-list
6117093|NCT01085812|Levomilnacipran|levomilnacipran|mesh-list
6117094|NCT01085812|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6117095|NCT01085812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6117096|NCT01085812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5530994|NCT00529113|Antimetabolites|antimetabolites|mesh-ancestor
5530995|NCT00529113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5530996|NCT00529113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5530997|NCT00529113|Antiviral Agents|antiviral agents|mesh-ancestor
6117097|NCT01085812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117098|NCT01085812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6117099|NCT01085812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117100|NCT01085812|Antidepressive Agents|antidepressive agents|mesh-ancestor
6117101|NCT01085812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6117102|NCT01085812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6117103|NCT01085812|Analgesics|analgesics|mesh-ancestor
6117104|NCT01085812|Sensory System Agents|sensory system agents|mesh-ancestor
6117105|NCT01085812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6117106|NCT01085903|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
6117107|NCT01085903|Modafinil|modafinil|mesh-list
6117108|NCT01085903|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6117109|NCT01085903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117110|NCT01085903|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6117111|NCT01085903|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6117112|NCT01085903|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6117113|NCT01085903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117114|NCT01086150|Lidocaine|lidocaine|mesh-list
6117115|NCT01086150|Anesthetics, Local|anesthetics, local|mesh-ancestor
6117116|NCT01086150|Anesthetics|anesthetics|mesh-ancestor
6117117|NCT01086150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6117118|NCT01086150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117119|NCT01086150|Sensory System Agents|sensory system agents|mesh-ancestor
6117120|NCT01086150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6117121|NCT01086150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6117122|NCT01086150|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6117123|NCT01086150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6117124|NCT01086150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6117125|NCT01086150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117126|NCT01086358|Naproxen|naproxen|mesh-list
6117127|NCT01086358|Sumatriptan|sumatriptan|mesh-list
6117128|NCT01086358|Naratriptan|naratriptan|mesh-list
6117129|NCT01086358|Zolmitriptan|zolmitriptan|mesh-list
6117130|NCT01086358|Rizatriptan|rizatriptan|mesh-list
6117131|NCT01086358|Eletriptan|eletriptan|mesh-list
6117132|NCT01086358|Almotriptan|almotriptan|mesh-list
6117133|NCT01086358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6117134|NCT01086358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6117135|NCT01086358|Analgesics|analgesics|mesh-ancestor
5530998|NCT00529113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5530999|NCT00529113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5531000|NCT00529113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5531001|NCT00529113|Immunologic Factors|immunologic factors|mesh-ancestor
5531002|NCT00529113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531003|NCT00288080|Dexamethasone|dexamethasone|mesh-list
5531004|NCT00288080|Prednisone|prednisone|mesh-list
5531005|NCT00288080|Docetaxel|docetaxel|mesh-list
5531006|NCT00288080|Androgen Antagonists|androgen antagonists|mesh-list
5531007|NCT00288080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5531008|NCT00288080|Antiemetics|antiemetics|mesh-ancestor
5531009|NCT00288080|Autonomic Agents|autonomic agents|mesh-ancestor
5531010|NCT00288080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5531011|NCT00288080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117136|NCT01086358|Sensory System Agents|sensory system agents|mesh-ancestor
6117137|NCT01086358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6117138|NCT01086358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117139|NCT01086358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6117140|NCT01086358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6117141|NCT01086358|Gout Suppressants|gout suppressants|mesh-ancestor
6117142|NCT01086358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6117143|NCT01086358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6117144|NCT01086358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117145|NCT01086358|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6117146|NCT01086358|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6117147|NCT01086358|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6117148|NCT01086358|Serotonin Agents|serotonin agents|mesh-ancestor
6117149|NCT01086358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6117150|NCT01086384|Fluticasone|fluticasone|mesh-list
6117151|NCT01086384|Xhance|xhance|mesh-list
6117152|NCT01086384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6117153|NCT01086384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6117154|NCT01086384|Autonomic Agents|autonomic agents|mesh-ancestor
6117155|NCT01086384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6117156|NCT01086384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531012|NCT00288080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5531013|NCT00288080|Glucocorticoids|glucocorticoids|mesh-ancestor
5531014|NCT00288080|Hormones|hormones|mesh-ancestor
5531015|NCT00288080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5531016|NCT00288080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5531017|NCT00288080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5531018|NCT00288080|Tubulin Modulators|tubulin modulators|mesh-ancestor
5531019|NCT00288080|Antimitotic Agents|antimitotic agents|mesh-ancestor
5531020|NCT00288080|Mitosis Modulators|mitosis modulators|mesh-ancestor
5531021|NCT00288080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531022|NCT00288080|Hormone Antagonists|hormone antagonists|mesh-ancestor
5531023|NCT00099437|Fulvestrant|fulvestrant|mesh-list
6117157|NCT01086384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6117158|NCT01086384|Respiratory System Agents|respiratory system agents|mesh-ancestor
6117159|NCT01086384|Dermatologic Agents|dermatologic agents|mesh-ancestor
6117160|NCT01086384|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6117161|NCT01086410|Fluticasone|fluticasone|mesh-list
6117162|NCT01086410|Xhance|xhance|mesh-list
6117163|NCT01086410|Prednisolone|prednisolone|mesh-list
6117164|NCT01086410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6117165|NCT01086410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6117166|NCT01086410|Autonomic Agents|autonomic agents|mesh-ancestor
6117167|NCT01086410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6117168|NCT01086410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117169|NCT01086410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6117170|NCT01086410|Respiratory System Agents|respiratory system agents|mesh-ancestor
6117171|NCT01086410|Dermatologic Agents|dermatologic agents|mesh-ancestor
6117172|NCT01086410|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6117173|NCT01086410|Glucocorticoids|glucocorticoids|mesh-ancestor
6117174|NCT01086410|Hormones|hormones|mesh-ancestor
6117175|NCT01086410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6117176|NCT01086410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6117177|NCT01086410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6117178|NCT01086475|Cycloserine|cycloserine|mesh-list
6117179|NCT01086475|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6117180|NCT01086475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6117181|NCT01086475|Renal Agents|renal agents|mesh-ancestor
6117182|NCT01086475|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5531024|NCT00099437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5531025|NCT00099437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5531026|NCT00099437|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5531027|NCT00099437|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5531028|NCT00099437|Hormone Antagonists|hormone antagonists|mesh-ancestor
5531029|NCT00099437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5531030|NCT00099437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601498|NCT05176821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117183|NCT01086475|Antitubercular Agents|antitubercular agents|mesh-ancestor
6117184|NCT01086475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6117185|NCT01086475|Antimetabolites|antimetabolites|mesh-ancestor
6117186|NCT01086475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117187|NCT01086540|Acetaminophen|acetaminophen|mesh-list
6117188|NCT01086540|Diphenhydramine|diphenhydramine|mesh-list
6117189|NCT01086540|Promethazine|promethazine|mesh-list
6117190|NCT01086540|Prednisone|prednisone|mesh-list
6117191|NCT01086540|Methylprednisolone|methylprednisolone|mesh-list
5601499|NCT05176821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5601500|NCT05176821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5601501|NCT05176821|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5601502|NCT05176821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5601503|NCT05176821|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5601504|NCT05176821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5601505|NCT05176821|Antacids|antacids|mesh-ancestor
5601506|NCT05176821|Diuretics|diuretics|mesh-ancestor
5601507|NCT05176821|Natriuretic Agents|natriuretic agents|mesh-ancestor
5601508|NCT05176821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601509|NCT05176821|Expectorants|expectorants|mesh-ancestor
5601510|NCT05176821|Respiratory System Agents|respiratory system agents|mesh-ancestor
5601511|NCT05176821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5601512|NCT05176821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5601513|NCT05176821|Renal Agents|renal agents|mesh-ancestor
5601514|NCT05176821|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
5601515|NCT05176821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5601516|NCT05176821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5601517|NCT05176821|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6117192|NCT01086540|Rituximab|rituximab|mesh-list
6117193|NCT01086540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6117194|NCT01086540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6117195|NCT01086540|Immunologic Factors|immunologic factors|mesh-ancestor
6117196|NCT01086540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117197|NCT01086540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6117198|NCT01086540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6117199|NCT01086540|Glucocorticoids|glucocorticoids|mesh-ancestor
6117200|NCT01086540|Hormones|hormones|mesh-ancestor
6117201|NCT01086540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5531031|NCT04250792|Naltrexone|naltrexone|mesh-list
5531032|NCT04250792|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5531033|NCT04250792|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5531034|NCT04250792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531035|NCT04250792|Sensory System Agents|sensory system agents|mesh-ancestor
5531036|NCT04250792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5531037|NCT04250831|Chromium|chromium|mesh-list
5531038|NCT04250831|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
5531039|NCT04250831|Trace Elements|trace elements|mesh-ancestor
6117202|NCT01086540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6117203|NCT01086540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6117204|NCT01086540|Analgesics|analgesics|mesh-ancestor
6117205|NCT01086540|Sensory System Agents|sensory system agents|mesh-ancestor
6117206|NCT01086540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6117207|NCT01086540|Antipyretics|antipyretics|mesh-ancestor
6117208|NCT01086540|Antiemetics|antiemetics|mesh-ancestor
6117209|NCT01086540|Autonomic Agents|autonomic agents|mesh-ancestor
6117210|NCT01086540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6117211|NCT01086540|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6117212|NCT01086540|Protective Agents|protective agents|mesh-ancestor
6117213|NCT01086540|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6117214|NCT01086540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6117215|NCT01086540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6117216|NCT01086540|Anesthetics, Local|anesthetics, local|mesh-ancestor
6117217|NCT01086540|Anesthetics|anesthetics|mesh-ancestor
6117218|NCT01086540|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6117219|NCT01086540|Histamine Antagonists|histamine antagonists|mesh-ancestor
5531040|NCT04250831|Micronutrients|micronutrients|mesh-ancestor
5531041|NCT04250831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531042|NCT04250831|Cathartics|cathartics|mesh-ancestor
5531043|NCT04250831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5531044|NCT04250506|Moxifloxacin|moxifloxacin|mesh-list
5531045|NCT04250506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5531046|NCT04250506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6117220|NCT01086540|Histamine Agents|histamine agents|mesh-ancestor
6117221|NCT01086540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6117222|NCT01086540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117223|NCT01086540|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6117224|NCT01086540|Antipruritics|antipruritics|mesh-ancestor
6117225|NCT01086540|Dermatologic Agents|dermatologic agents|mesh-ancestor
6117226|NCT01086605|Pixantrone|pixantrone|mesh-list
6117227|NCT01086605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6117228|NCT01086605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6117229|NCT01086605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6117230|NCT01086605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117231|NCT01086605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6117232|NCT01087489|Lidocaine|lidocaine|mesh-list
6117233|NCT01087489|Anesthetics, Local|anesthetics, local|mesh-ancestor
6117234|NCT01087489|Anesthetics|anesthetics|mesh-ancestor
6117235|NCT01087489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6117236|NCT01087489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117237|NCT01087489|Sensory System Agents|sensory system agents|mesh-ancestor
6117238|NCT01087489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6117239|NCT01087489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6117240|NCT01087489|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6117241|NCT01087489|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6117242|NCT01087489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6117243|NCT01087489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117244|NCT01087502|Glimepiride|glimepiride|mesh-list
6117245|NCT01087502|Linagliptin|linagliptin|mesh-list
6117246|NCT01087502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6117247|NCT01087502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6117248|NCT01087502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531047|NCT04250506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5531048|NCT04250506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5531049|NCT04250506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6117249|NCT01087502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6117250|NCT01087502|Immunologic Factors|immunologic factors|mesh-ancestor
6117251|NCT01087502|Incretins|incretins|mesh-ancestor
6117252|NCT01087502|Hormones|hormones|mesh-ancestor
6117253|NCT01087502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6117254|NCT01087502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6117255|NCT01087502|Protease Inhibitors|protease inhibitors|mesh-ancestor
6117256|NCT01087502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6117257|NCT01087502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117258|NCT01087723|Heparin|heparin|mesh-list
6117259|NCT01087723|Bivalirudin|bivalirudin|mesh-list
6666103|NCT01520766|Sympathomimetics|sympathomimetics|mesh-ancestor
6666104|NCT01520766|Autonomic Agents|autonomic agents|mesh-ancestor
6666105|NCT01520766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6117260|NCT01087723|Anticoagulants|anticoagulants|mesh-ancestor
6117261|NCT01087723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6117262|NCT01087723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6117263|NCT01087723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117264|NCT01087723|Antithrombins|antithrombins|mesh-ancestor
6117265|NCT01087723|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6117266|NCT01087723|Protease Inhibitors|protease inhibitors|mesh-ancestor
6117267|NCT01087723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6117268|NCT01087736|Topiramate|topiramate|mesh-list
6117269|NCT01087736|Anticonvulsants|anticonvulsants|mesh-ancestor
6117270|NCT01087736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6117271|NCT01087736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117272|NCT01087762|Certolizumab Pegol|certolizumab pegol|mesh-list
6117273|NCT01087762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6117274|NCT01087762|Immunologic Factors|immunologic factors|mesh-ancestor
6117275|NCT01087762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117276|NCT01087762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6117277|NCT01087788|Certolizumab Pegol|certolizumab pegol|mesh-list
6117278|NCT01087788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6117279|NCT01087788|Immunologic Factors|immunologic factors|mesh-ancestor
6117280|NCT01087788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117281|NCT01087788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5531050|NCT04250506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531051|NCT04250506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5531052|NCT04250519|Sodium Hypochlorite|sodium hypochlorite|mesh-list
5531053|NCT04250519|Eusol|eusol|mesh-list
5531054|NCT04250519|Disinfectants|disinfectants|mesh-ancestor
5531055|NCT04250519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5531056|NCT04250493|Insulin|insulin|mesh-list
5531057|NCT04250493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5531058|NCT04250493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117282|NCT01087814|Efavirenz|efavirenz|mesh-list
6117283|NCT01087814|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6117284|NCT01087814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6117285|NCT01087814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6117286|NCT01087814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117287|NCT01087814|Antiviral Agents|antiviral agents|mesh-ancestor
6117288|NCT01087814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6117289|NCT01087814|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6117290|NCT01087814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6117291|NCT01087814|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6117292|NCT01087814|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6117293|NCT01087814|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6117294|NCT01087814|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6117295|NCT01087905|Nicotine|nicotine|mesh-list
6117296|NCT01087905|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6117297|NCT01087905|Autonomic Agents|autonomic agents|mesh-ancestor
6117298|NCT01087905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6117299|NCT01087905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117300|NCT01087905|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6117301|NCT01087905|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6117302|NCT01087905|Cholinergic Agents|cholinergic agents|mesh-ancestor
6117303|NCT01087905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5531059|NCT04250246|Nivolumab|nivolumab|mesh-list
6117304|NCT01087905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117305|NCT01087931|Bupivacaine|bupivacaine|mesh-list
6117306|NCT01087931|Anesthetics, Local|anesthetics, local|mesh-ancestor
6117307|NCT01087931|Anesthetics|anesthetics|mesh-ancestor
6117308|NCT01087931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6117309|NCT01087931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531060|NCT04250246|Ipilimumab|ipilimumab|mesh-list
5531061|NCT04250246|Guadecitabine|guadecitabine|mesh-list
5531062|NCT04250246|Azacitidine|azacitidine|mesh-list
6117310|NCT01087931|Sensory System Agents|sensory system agents|mesh-ancestor
6117311|NCT01087931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6117312|NCT01087970|Carboplatin|carboplatin|mesh-list
6117313|NCT01087970|Pemetrexed|pemetrexed|mesh-list
6117314|NCT01087970|Cetuximab|cetuximab|mesh-list
6117315|NCT01087970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6117316|NCT01087970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6117317|NCT01087970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117318|NCT01087970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6117319|NCT01087970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6117320|NCT01087970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6117321|NCT01088048|Rituximab|rituximab|mesh-list
6117322|NCT01088048|Fludarabine|fludarabine|mesh-list
6117323|NCT01088048|Lenalidomide|lenalidomide|mesh-list
6117324|NCT01088048|Everolimus|everolimus|mesh-list
6117325|NCT01088048|Bortezomib|bortezomib|mesh-list
6117326|NCT01088048|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6117327|NCT01088048|Ofatumumab|ofatumumab|mesh-list
6117328|NCT01088048|Idelalisib|idelalisib|mesh-list
5531063|NCT04250246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5531064|NCT04250246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5531065|NCT04250246|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5531066|NCT04250246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531067|NCT04250246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5531068|NCT04250246|Antimetabolites|antimetabolites|mesh-ancestor
5531069|NCT04250246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5531070|NCT04250142|Methamphetamine|methamphetamine|mesh-list
5531071|NCT04250142|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5531072|NCT04250142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531073|NCT04250142|Sympathomimetics|sympathomimetics|mesh-ancestor
5531074|NCT04250142|Autonomic Agents|autonomic agents|mesh-ancestor
5531075|NCT04250142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5531076|NCT04250142|Dopamine Agents|dopamine agents|mesh-ancestor
5531077|NCT04250142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5531078|NCT04250142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531079|NCT04250142|Adrenergic Agents|adrenergic agents|mesh-ancestor
5531080|NCT04250142|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6117329|NCT01088048|Chlorambucil|chlorambucil|mesh-list
6117330|NCT01088048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6117331|NCT01088048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6117332|NCT01088048|Immunologic Factors|immunologic factors|mesh-ancestor
6117333|NCT01088048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117334|NCT01088048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6117335|NCT01088048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117336|NCT01088048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6117337|NCT01088048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6117338|NCT01088048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6117339|NCT01088048|Growth Substances|growth substances|mesh-ancestor
6117340|NCT01088048|Growth Inhibitors|growth inhibitors|mesh-ancestor
5531081|NCT04250142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5531082|NCT04250142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5531083|NCT04250142|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5531084|NCT04250116|Apixaban|apixaban|mesh-list
5531085|NCT04250116|Clopidogrel|clopidogrel|mesh-list
5531086|NCT04250116|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5531087|NCT04250116|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5531088|NCT04250116|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5531089|NCT04250116|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5531090|NCT04250116|Purinergic Agents|purinergic agents|mesh-ancestor
5531091|NCT04250116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5531092|NCT04250116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531093|NCT04250116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531094|NCT04250116|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6117341|NCT01088048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6117342|NCT01088048|Alkylating Agents|alkylating agents|mesh-ancestor
5531095|NCT04250116|Antithrombins|antithrombins|mesh-ancestor
6117343|NCT01088048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6117344|NCT01088243|Mesalamine|mesalamine|mesh-list
6117345|NCT01088243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6117346|NCT01088243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6117347|NCT01088243|Analgesics|analgesics|mesh-ancestor
6117348|NCT01088243|Sensory System Agents|sensory system agents|mesh-ancestor
6117349|NCT01088243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6117350|NCT01088243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117351|NCT01088243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6117352|NCT01088243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6117353|NCT01088295|Telmisartan|telmisartan|mesh-list
6117354|NCT01088295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6117355|NCT01088295|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6117356|NCT01088295|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6117357|NCT01088295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117358|NCT01088464|Necitumumab|necitumumab|mesh-list
6117359|NCT01088464|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6117360|NCT01088464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6117361|NCT01088464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6117362|NCT01088464|Immunologic Factors|immunologic factors|mesh-ancestor
6117363|NCT01088464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117364|NCT01088529|Prednisone|prednisone|mesh-list
6117365|NCT01088529|Leuprolide|leuprolide|mesh-list
6117366|NCT01088529|Goserelin|goserelin|mesh-list
6117367|NCT01088529|Abiraterone Acetate|abiraterone acetate|mesh-list
6117368|NCT01088529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6117369|NCT01088529|Glucocorticoids|glucocorticoids|mesh-ancestor
6117370|NCT01088529|Hormones|hormones|mesh-ancestor
6117371|NCT01088529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6117372|NCT01088529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117373|NCT01088529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5531096|NCT04250116|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5531097|NCT04250116|Protease Inhibitors|protease inhibitors|mesh-ancestor
5531098|NCT04250116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5531099|NCT04250116|Anticoagulants|anticoagulants|mesh-ancestor
5531100|NCT04250064|Bevacizumab|bevacizumab|mesh-list
5531101|NCT04250064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5531102|NCT04250064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5531103|NCT04250064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5531104|NCT04250064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5531105|NCT04250064|Growth Substances|growth substances|mesh-ancestor
5531106|NCT04250064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531107|NCT04250064|Growth Inhibitors|growth inhibitors|mesh-ancestor
5531108|NCT04250051|Vidarabine|vidarabine|mesh-list
5531109|NCT04250051|Cytarabine|cytarabine|mesh-list
5531110|NCT04250051|Fludarabine|fludarabine|mesh-list
5531111|NCT04250051|Fludarabine phosphate|fludarabine phosphate|mesh-list
5531112|NCT04250051|Ivosidenib|ivosidenib|mesh-list
5531113|NCT04250051|Lenograstim|lenograstim|mesh-list
5531114|NCT04250051|Sargramostim|sargramostim|mesh-list
5531115|NCT04250051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5531116|NCT04250051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5531117|NCT04250051|Antimetabolites|antimetabolites|mesh-ancestor
5531118|NCT04250051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531119|NCT04250051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5531120|NCT04250051|Immunologic Factors|immunologic factors|mesh-ancestor
6117374|NCT01088529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6117375|NCT01088529|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6117376|NCT01088529|Fertility Agents|fertility agents|mesh-ancestor
6117377|NCT01088529|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6117378|NCT01088529|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6117379|NCT01088529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6117380|NCT01088529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117381|NCT01088529|Hormone Antagonists|hormone antagonists|mesh-ancestor
6117382|NCT01088529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6117383|NCT01088984|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6117384|NCT01088984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6117385|NCT01088984|Alkylating Agents|alkylating agents|mesh-ancestor
6117386|NCT01088984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117387|NCT01088984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6117388|NCT01088997|Milrinone|milrinone|mesh-list
6117389|NCT01088997|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6117390|NCT01088997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5531121|NCT04250051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531122|NCT04250051|Antiviral Agents|antiviral agents|mesh-ancestor
6117391|NCT01088997|Vasodilator Agents|vasodilator agents|mesh-ancestor
6117392|NCT01088997|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6117393|NCT01088997|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6117394|NCT01088997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6117395|NCT01088997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117396|NCT01088997|Protective Agents|protective agents|mesh-ancestor
6117397|NCT01088997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117398|NCT01089062|Dihydroergotamine|dihydroergotamine|mesh-list
6117399|NCT01089062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6117400|NCT01089062|Dopamine Agonists|dopamine agonists|mesh-ancestor
6117401|NCT01089062|Dopamine Agents|dopamine agents|mesh-ancestor
6117402|NCT01089062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6117403|NCT01089062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531123|NCT04250051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5531124|NCT04250051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5531125|NCT04250051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5531126|NCT04249713|Brodalumab|brodalumab|mesh-list
5531127|NCT04249713|Dermatologic Agents|dermatologic agents|mesh-ancestor
6117404|NCT01089062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117405|NCT01089062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6117406|NCT01089062|Analgesics|analgesics|mesh-ancestor
6117407|NCT01089062|Sensory System Agents|sensory system agents|mesh-ancestor
6117408|NCT01089062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6117409|NCT01089127|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6117410|NCT01089127|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6117411|NCT01089127|Autonomic Agents|autonomic agents|mesh-ancestor
6117412|NCT01089127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6117413|NCT01089127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531128|NCT04249908|Maleic acid|maleic acid|mesh-list
5531129|NCT04249908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5531130|NCT04249908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531131|NCT04249882|Naltrexone|naltrexone|mesh-list
5531132|NCT04249882|Varenicline|varenicline|mesh-list
5531133|NCT04249882|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5531134|NCT04249882|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5531135|NCT04249882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117414|NCT01089127|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6117415|NCT01089127|Respiratory System Agents|respiratory system agents|mesh-ancestor
6117416|NCT01089127|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6117417|NCT01089127|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6117418|NCT01089127|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6117419|NCT01089127|Adrenergic Agents|adrenergic agents|mesh-ancestor
6117420|NCT01089127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6117421|NCT01089127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117422|NCT01089361|Ketamine|ketamine|mesh-list
6117423|NCT01089361|Analgesics|analgesics|mesh-ancestor
5531136|NCT04249882|Sensory System Agents|sensory system agents|mesh-ancestor
5531137|NCT04249882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5531138|NCT04249882|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6117424|NCT01089361|Sensory System Agents|sensory system agents|mesh-ancestor
6117425|NCT01089361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6117426|NCT01089361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117427|NCT01089361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6117428|NCT01089361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6117429|NCT01089361|Anesthetics, General|anesthetics, general|mesh-ancestor
6117430|NCT01089361|Anesthetics|anesthetics|mesh-ancestor
6117431|NCT01089361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6117432|NCT01089361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5531139|NCT04249882|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5531140|NCT04249882|Cholinergic Agents|cholinergic agents|mesh-ancestor
5531141|NCT04249882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6117433|NCT01089361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6117434|NCT01089361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6117435|NCT01089361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117436|NCT01089413|Bevacizumab|bevacizumab|mesh-list
6117437|NCT01089413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6117438|NCT01089413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6117439|NCT01089413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6117440|NCT01089413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6117441|NCT01089413|Growth Substances|growth substances|mesh-ancestor
6117442|NCT01089413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117443|NCT01089413|Growth Inhibitors|growth inhibitors|mesh-ancestor
6117444|NCT01089504|Phenobarbital|phenobarbital|mesh-list
6117445|NCT01089504|Anticonvulsants|anticonvulsants|mesh-ancestor
6117446|NCT01089504|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6117447|NCT01089504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6117448|NCT01089504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117449|NCT01089504|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6117450|NCT01089504|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6117451|NCT01089504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6117452|NCT01089504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117453|NCT01089504|GABA Modulators|gaba modulators|mesh-ancestor
6117454|NCT01089504|GABA Agents|gaba agents|mesh-ancestor
6117455|NCT01089504|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6117456|NCT01089504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6117457|NCT01089504|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6117458|NCT01089517|Ranibizumab|ranibizumab|mesh-list
6117459|NCT01089517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6117460|NCT01089517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6117461|NCT01089517|Growth Substances|growth substances|mesh-ancestor
6117462|NCT01089517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117463|NCT01089517|Growth Inhibitors|growth inhibitors|mesh-ancestor
6117464|NCT01089517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6117465|NCT01089543|Rabeprazole|rabeprazole|mesh-list
6117466|NCT01089543|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6117467|NCT01089543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6117468|NCT01089543|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6117469|NCT01089543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6117470|NCT01089543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117471|NCT01089556|Pregabalin|pregabalin|mesh-list
6117472|NCT01089556|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6117473|NCT01089556|Analgesics|analgesics|mesh-ancestor
6117474|NCT01089556|Sensory System Agents|sensory system agents|mesh-ancestor
6117475|NCT01089556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6117476|NCT01089556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117477|NCT01089556|Anticonvulsants|anticonvulsants|mesh-ancestor
6117478|NCT01089556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5531142|NCT04249882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117479|NCT01089556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6117480|NCT01089556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117481|NCT01089556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6465739|NCT00475930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6465740|NCT00475930|Disinfectants|disinfectants|mesh-ancestor
6465741|NCT00475930|Dermatologic Agents|dermatologic agents|mesh-ancestor
6117482|NCT01089556|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6117483|NCT01089556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6117484|NCT01089556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6117485|NCT01089556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6117486|NCT01089556|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6117487|NCT01089556|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6117488|NCT01089556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6117489|NCT01089556|Antidepressive Agents|antidepressive agents|mesh-ancestor
6117490|NCT01089556|Dopamine Agents|dopamine agents|mesh-ancestor
6117491|NCT01089569|Insulin Glargine|insulin glargine|mesh-list
6117492|NCT01089569|Exenatide|exenatide|mesh-list
6117493|NCT01089569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6117494|NCT01089569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117495|NCT01089569|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6117496|NCT01089569|Incretins|incretins|mesh-ancestor
6117497|NCT01089569|Hormones|hormones|mesh-ancestor
6117498|NCT01089569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6117499|NCT01089595|Imatinib Mesylate|imatinib mesylate|mesh-list
6117500|NCT01089595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6117501|NCT01089595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6117502|NCT01089595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6117503|NCT01089595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117504|NCT01089608|Azithromycin|azithromycin|mesh-list
6117505|NCT01089608|Povidone|povidone|mesh-list
6117506|NCT01089608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6117507|NCT01089608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5531143|NCT04249570|Povidone-Iodine|povidone-iodine|mesh-list
5531144|NCT04249570|Povidone|povidone|mesh-list
5531145|NCT04249570|Plasma Substitutes|plasma substitutes|mesh-ancestor
5531146|NCT04249570|Blood Substitutes|blood substitutes|mesh-ancestor
5531147|NCT04249570|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5531148|NCT04249570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5531149|NCT04249778|Dapagliflozin|dapagliflozin|mesh-list
5531150|NCT04249778|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5531151|NCT04249778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117508|NCT01089608|Plasma Substitutes|plasma substitutes|mesh-ancestor
6117509|NCT01089608|Blood Substitutes|blood substitutes|mesh-ancestor
6117510|NCT01089647|Budesonide|budesonide|mesh-list
6117511|NCT01089647|Montelukast|montelukast|mesh-list
6117512|NCT01089647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6117513|NCT01089647|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6117514|NCT01089647|Autonomic Agents|autonomic agents|mesh-ancestor
6117515|NCT01089647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6117516|NCT01089647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117517|NCT01089647|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6117518|NCT01089647|Respiratory System Agents|respiratory system agents|mesh-ancestor
6117519|NCT01089647|Glucocorticoids|glucocorticoids|mesh-ancestor
6117520|NCT01089647|Hormones|hormones|mesh-ancestor
6117521|NCT01089647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6117522|NCT01089647|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6117523|NCT01089647|Hormone Antagonists|hormone antagonists|mesh-ancestor
6117524|NCT01089647|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6117525|NCT01089647|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6117526|NCT01089647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117527|NCT01089725|Tanezumab|tanezumab|mesh-list
6117528|NCT01089725|Analgesics|analgesics|mesh-ancestor
6117529|NCT01089725|Sensory System Agents|sensory system agents|mesh-ancestor
6117530|NCT01089725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6117531|NCT01089725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117532|NCT01089751|Trospium chloride|trospium chloride|mesh-list
6117533|NCT01089751|Parasympatholytics|parasympatholytics|mesh-ancestor
6117534|NCT01089751|Autonomic Agents|autonomic agents|mesh-ancestor
6117535|NCT01089751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5531152|NCT04249778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5531153|NCT04249778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531154|NCT04249804|Magnesium Sulfate|magnesium sulfate|mesh-list
5531155|NCT04249804|Analgesics|analgesics|mesh-ancestor
6117536|NCT01089751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465742|NCT00475956|Cediranib|cediranib|mesh-list
5531156|NCT04249804|Sensory System Agents|sensory system agents|mesh-ancestor
6117537|NCT01089751|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6117538|NCT01089751|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6117539|NCT01089751|Cholinergic Agents|cholinergic agents|mesh-ancestor
6117540|NCT01089751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6117541|NCT01089751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117542|NCT01089751|Urological Agents|urological agents|mesh-ancestor
6204477|NCT02071095|Antiviral Agents|antiviral agents|mesh-ancestor
6204478|NCT02071095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5531157|NCT04249804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5531158|NCT04249804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531159|NCT04249804|Anesthetics|anesthetics|mesh-ancestor
5531160|NCT04249804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5531161|NCT04249804|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5531162|NCT04249804|Anticonvulsants|anticonvulsants|mesh-ancestor
5531163|NCT04249804|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5531164|NCT04249804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5531165|NCT04249804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531166|NCT04249804|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5531167|NCT04249804|Tocolytic Agents|tocolytic agents|mesh-ancestor
5531168|NCT04249804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5531169|NCT04249544|Pramipexole|pramipexole|mesh-list
5531170|NCT04249544|Antioxidants|antioxidants|mesh-ancestor
5531171|NCT04249544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531172|NCT04249544|Protective Agents|protective agents|mesh-ancestor
5531173|NCT04249544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531174|NCT04249544|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6204479|NCT02071225|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6204480|NCT02071225|Obinutuzumab|obinutuzumab|mesh-list
6204481|NCT02071225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6204482|NCT02071225|Alkylating Agents|alkylating agents|mesh-ancestor
5531175|NCT04249544|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5531176|NCT04249544|Dopamine Agonists|dopamine agonists|mesh-ancestor
5531177|NCT04249544|Dopamine Agents|dopamine agents|mesh-ancestor
6204483|NCT02071225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204484|NCT02071225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6204485|NCT02071225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6204486|NCT02071810|Opicapone|opicapone|mesh-list
6204487|NCT02071810|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6204488|NCT02071810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6204489|NCT02071810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204490|NCT02071810|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6204491|NCT02071810|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6204492|NCT02071823|Opicapone|opicapone|mesh-list
6204493|NCT02071823|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6204494|NCT02071823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6204495|NCT02071823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204496|NCT02071823|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6204497|NCT02071823|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6204498|NCT02072096|Metformin|metformin|mesh-list
6204499|NCT02072096|Insulin Glargine|insulin glargine|mesh-list
5531178|NCT04249544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5531179|NCT04249531|Amikacin|amikacin|mesh-list
5531180|NCT04249531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5531181|NCT04249531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5531182|NCT04249427|Erenumab|erenumab|mesh-list
5531183|NCT04249427|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
6204500|NCT02072096|Pioglitazone|pioglitazone|mesh-list
6204501|NCT02072096|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6204502|NCT02072096|Liraglutide|liraglutide|mesh-list
6204503|NCT02072096|Exenatide|exenatide|mesh-list
6204504|NCT02072096|Glimepiride|glimepiride|mesh-list
6117543|NCT01090011|Cetuximab|cetuximab|mesh-list
6117544|NCT01090011|Afatinib|afatinib|mesh-list
6117545|NCT01090011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6117546|NCT01090011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6117547|NCT01090011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6117548|NCT01090011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6117549|NCT01090011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117550|NCT01090050|Naproxen|naproxen|mesh-list
6117551|NCT01090050|Sumatriptan|sumatriptan|mesh-list
6117552|NCT01090050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6117553|NCT01090050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6117554|NCT01090050|Analgesics|analgesics|mesh-ancestor
6117555|NCT01090050|Sensory System Agents|sensory system agents|mesh-ancestor
6117556|NCT01090050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6117557|NCT01090050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117558|NCT01090050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6117559|NCT01090050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6117560|NCT01090050|Gout Suppressants|gout suppressants|mesh-ancestor
6117561|NCT01090050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6117562|NCT01090050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6117563|NCT01090050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531184|NCT04249427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531185|NCT04249427|Analgesics|analgesics|mesh-ancestor
5531186|NCT04249427|Sensory System Agents|sensory system agents|mesh-ancestor
6117564|NCT01090050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6117565|NCT01090050|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6117566|NCT01090050|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6117567|NCT01090050|Serotonin Agents|serotonin agents|mesh-ancestor
6117568|NCT01090050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6117569|NCT01090063|Ustekinumab|ustekinumab|mesh-list
6117570|NCT01090063|Dermatologic Agents|dermatologic agents|mesh-ancestor
6117571|NCT01090102|Aminosalicylic Acid|aminosalicylic acid|mesh-list
6117572|NCT01090102|Mesalamine|mesalamine|mesh-list
6117573|NCT01090102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6117574|NCT01090102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6117575|NCT01090102|Analgesics|analgesics|mesh-ancestor
6117576|NCT01090102|Sensory System Agents|sensory system agents|mesh-ancestor
6117577|NCT01090102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6117578|NCT01090102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117579|NCT01090102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6117580|NCT01090102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6117581|NCT01090102|Antitubercular Agents|antitubercular agents|mesh-ancestor
6117582|NCT01090102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6117583|NCT01090102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6117584|NCT01090180|Dexamethasone|dexamethasone|mesh-list
6117585|NCT01090180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6117586|NCT01090180|Antiemetics|antiemetics|mesh-ancestor
6117587|NCT01090180|Autonomic Agents|autonomic agents|mesh-ancestor
6117588|NCT01090180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6117589|NCT01090180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117590|NCT01090180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6117591|NCT01090180|Glucocorticoids|glucocorticoids|mesh-ancestor
6117592|NCT01090180|Hormones|hormones|mesh-ancestor
6117593|NCT01090180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6117594|NCT01090180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6117595|NCT01090180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6117596|NCT01090323|Deferasirox|deferasirox|mesh-list
6117597|NCT01090323|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6117598|NCT01090323|Chelating Agents|chelating agents|mesh-ancestor
6117599|NCT01090323|Sequestering Agents|sequestering agents|mesh-ancestor
6117600|NCT01090323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117601|NCT01090414|Idelalisib|idelalisib|mesh-list
6117602|NCT01090414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6117603|NCT01090414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6117604|NCT01090414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117605|NCT01090427|Ustekinumab|ustekinumab|mesh-list
6117606|NCT01090427|Dermatologic Agents|dermatologic agents|mesh-ancestor
6117607|NCT01090453|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6117608|NCT01090453|Immunologic Factors|immunologic factors|mesh-ancestor
6117609|NCT01090453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117610|NCT01090479|Chlorhexidine|chlorhexidine|mesh-list
6117611|NCT01090479|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6117612|NCT01090479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6117613|NCT01090479|Disinfectants|disinfectants|mesh-ancestor
6117614|NCT01090752|Metformin|metformin|mesh-list
5601518|NCT05176626|Phentermine|phentermine|mesh-list
5531187|NCT04249427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5531188|NCT04249427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531189|NCT04249622|Rifaximin|rifaximin|mesh-list
5531190|NCT04249622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5531191|NCT04249622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5531192|NCT04249622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5531193|NCT04249232|Abaloparatide|abaloparatide|mesh-list
6117615|NCT01090752|Pioglitazone|pioglitazone|mesh-list
6117616|NCT01090752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6117617|NCT01090752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531194|NCT04249232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5531195|NCT04249232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531196|NCT04249154|Leuprolide|leuprolide|mesh-list
5531197|NCT04249154|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5531198|NCT04249154|Fertility Agents|fertility agents|mesh-ancestor
5531199|NCT04249154|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5531200|NCT04249154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531201|NCT04249154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5531202|NCT04249154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5531203|NCT04249284|BMS-986165|bms-986165|mesh-list
5531204|NCT04249284|Dermatologic Agents|dermatologic agents|mesh-ancestor
5531205|NCT04249284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5531206|NCT04249284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5531207|NCT04249284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531208|NCT04248998|Metformin|metformin|mesh-list
5531209|NCT04248998|Paclitaxel|paclitaxel|mesh-list
5531210|NCT04248998|Cyclophosphamide|cyclophosphamide|mesh-list
5531211|NCT04248998|Doxorubicin|doxorubicin|mesh-list
5531212|NCT04248998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5531213|NCT04248998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5531214|NCT04248998|Tubulin Modulators|tubulin modulators|mesh-ancestor
5531215|NCT04248998|Antimitotic Agents|antimitotic agents|mesh-ancestor
5531216|NCT04248998|Mitosis Modulators|mitosis modulators|mesh-ancestor
5531217|NCT04248998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531218|NCT04248998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5531219|NCT04248998|Immunologic Factors|immunologic factors|mesh-ancestor
5531220|NCT04248998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531221|NCT04248998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5531222|NCT04248998|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5531223|NCT04248998|Alkylating Agents|alkylating agents|mesh-ancestor
5531224|NCT04248998|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5531225|NCT04248998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5531226|NCT04248998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5531227|NCT04248998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5531228|NCT04248998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5531229|NCT04248998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5601519|NCT05176626|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5601520|NCT05176626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601521|NCT05176626|Appetite Depressants|appetite depressants|mesh-ancestor
5601522|NCT05176626|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5601523|NCT05176626|Sympathomimetics|sympathomimetics|mesh-ancestor
5601524|NCT05176626|Autonomic Agents|autonomic agents|mesh-ancestor
5601525|NCT05176626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5601526|NCT05176626|Adrenergic Agents|adrenergic agents|mesh-ancestor
5601527|NCT05176626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6117618|NCT01090921|Bortezomib|bortezomib|mesh-list
6117619|NCT01090921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6117620|NCT01090973|Panobinostat|panobinostat|mesh-list
6117621|NCT01090973|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
6117622|NCT01090973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6117623|NCT01090973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6117624|NCT01090973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117625|NCT01091116|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2H-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2h-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|mesh-list
6117626|NCT01091116|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
6117627|NCT01091116|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
6117628|NCT01091116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117629|NCT01091116|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6117630|NCT01091116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6117631|NCT01091116|Immunologic Factors|immunologic factors|mesh-ancestor
6465743|NCT00475956|Saracatinib|saracatinib|mesh-list
6465744|NCT00475956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5606724|NCT03818737|Methylprednisolone|methylprednisolone|mesh-list
6465745|NCT00475956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5531230|NCT04249063|Lidocaine|lidocaine|mesh-list
5531231|NCT04249063|Anesthetics|anesthetics|mesh-list
5531232|NCT04249063|Anesthetics, Local|anesthetics, local|mesh-list
5531233|NCT04249063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5531234|NCT04249063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531235|NCT04249063|Sensory System Agents|sensory system agents|mesh-ancestor
5531236|NCT04249063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5531237|NCT04249063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5531238|NCT04249063|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6465746|NCT00475956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6465747|NCT00475956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465748|NCT00475969|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6465749|NCT00475969|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6465750|NCT00475969|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6117632|NCT01091116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117633|NCT01091168|Alkylating Agents|alkylating agents|mesh-list
6117634|NCT01091168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117635|NCT01091259|Bevacizumab|bevacizumab|mesh-list
6117636|NCT01091259|Irinotecan|irinotecan|mesh-list
6117637|NCT01091259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6117638|NCT01091259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6117639|NCT01091259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6117640|NCT01091259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6117641|NCT01091259|Growth Substances|growth substances|mesh-ancestor
6117642|NCT01091259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117643|NCT01091259|Growth Inhibitors|growth inhibitors|mesh-ancestor
5531239|NCT04249063|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5531240|NCT04249063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5531241|NCT04249063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531242|NCT04248712|Loratadine|loratadine|mesh-list
5531243|NCT04248712|Famotidine|famotidine|mesh-list
6117644|NCT01091259|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6117645|NCT01091259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6117646|NCT01091259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6117647|NCT01091259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117648|NCT01091428|Paclitaxel|paclitaxel|mesh-list
6204505|NCT02072096|Linagliptin|linagliptin|mesh-list
6465751|NCT00475969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6465752|NCT00475969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465753|NCT00475969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6465754|NCT00475969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465755|NCT00475969|Analgesics|analgesics|mesh-ancestor
6465756|NCT00475969|Sensory System Agents|sensory system agents|mesh-ancestor
6465757|NCT00475969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6465758|NCT00475969|Antidepressive Agents|antidepressive agents|mesh-ancestor
5531244|NCT04248712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6465759|NCT00475969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6465760|NCT00475969|Dopamine Agents|dopamine agents|mesh-ancestor
6465761|NCT00476034|Lumiracoxib|lumiracoxib|mesh-list
6465762|NCT00476034|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6465763|NCT00476034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6465764|NCT00476034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6465765|NCT00476034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465766|NCT00476034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6465767|NCT00476034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6465768|NCT00476034|Analgesics|analgesics|mesh-ancestor
6465769|NCT00476034|Sensory System Agents|sensory system agents|mesh-ancestor
6465770|NCT00476034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6465771|NCT00476034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531245|NCT04248712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5531246|NCT04248712|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5531247|NCT04248712|Histamine Antagonists|histamine antagonists|mesh-ancestor
5531248|NCT04248712|Histamine Agents|histamine agents|mesh-ancestor
5531249|NCT04248712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5531250|NCT04248712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531251|NCT04248712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531252|NCT04248712|Antipruritics|antipruritics|mesh-ancestor
5531253|NCT04248712|Dermatologic Agents|dermatologic agents|mesh-ancestor
5531254|NCT04248712|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5531255|NCT04248712|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5531256|NCT04248712|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6465772|NCT00476034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6117649|NCT01091428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6117650|NCT01091428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6117651|NCT01091428|Tubulin Modulators|tubulin modulators|mesh-ancestor
6117652|NCT01091428|Antimitotic Agents|antimitotic agents|mesh-ancestor
6117653|NCT01091428|Mitosis Modulators|mitosis modulators|mesh-ancestor
6117654|NCT01091428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117655|NCT01091454|Cisplatin|cisplatin|mesh-list
6117656|NCT01091454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6117657|NCT01091519|Fesoterodine|fesoterodine|mesh-list
6117658|NCT01091519|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6117659|NCT01091519|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6117660|NCT01091519|Cholinergic Agents|cholinergic agents|mesh-ancestor
6117661|NCT01091519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6117662|NCT01091519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117663|NCT01091519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117664|NCT01091519|Urological Agents|urological agents|mesh-ancestor
6117665|NCT01091662|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
6117666|NCT01091662|Anticonvulsants|anticonvulsants|mesh-ancestor
6117667|NCT01091662|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6117668|NCT01091662|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6117669|NCT01091662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6117670|NCT01091662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117671|NCT01091675|Etoricoxib|etoricoxib|mesh-list
6117672|NCT01091675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6117673|NCT01091675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6117674|NCT01091675|Analgesics|analgesics|mesh-ancestor
6117675|NCT01091675|Sensory System Agents|sensory system agents|mesh-ancestor
6117676|NCT01091675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6117677|NCT01091675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117678|NCT01091675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6117679|NCT01091675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6117680|NCT01091675|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6117681|NCT01091675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6117682|NCT01091675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6117683|NCT01091675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117684|NCT01091974|Modafinil|modafinil|mesh-list
6117685|NCT01091974|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6117686|NCT01091974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117687|NCT01091974|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6117688|NCT01091974|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6117689|NCT01091974|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6117690|NCT01091974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117691|NCT01092182|Prednisone|prednisone|mesh-list
6117692|NCT01092182|Cyclophosphamide|cyclophosphamide|mesh-list
6117693|NCT01092182|Rituximab|rituximab|mesh-list
6117694|NCT01092182|Doxorubicin|doxorubicin|mesh-list
6117695|NCT01092182|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6117696|NCT01092182|Etoposide|etoposide|mesh-list
6117697|NCT01092182|Etoposide phosphate|etoposide phosphate|mesh-list
6117698|NCT01092182|Vincristine|vincristine|mesh-list
6117699|NCT01092182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6117700|NCT01092182|Immunologic Factors|immunologic factors|mesh-ancestor
6117701|NCT01092182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117702|NCT01092182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6117703|NCT01092182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6117704|NCT01092182|Alkylating Agents|alkylating agents|mesh-ancestor
5531257|NCT04249037|Tenofovir|tenofovir|mesh-list
5531258|NCT04249037|Emtricitabine|emtricitabine|mesh-list
5531259|NCT04249037|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
6117705|NCT01092182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531260|NCT04249037|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6117706|NCT01092182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6117707|NCT01092182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6117708|NCT01092182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6117709|NCT01092182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6117710|NCT01092182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6117711|NCT01092182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6117712|NCT01092182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6117713|NCT01092182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6117714|NCT01092182|Glucocorticoids|glucocorticoids|mesh-ancestor
6117715|NCT01092182|Hormones|hormones|mesh-ancestor
6117716|NCT01092182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6117717|NCT01092182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6117718|NCT01092182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6117719|NCT01092182|Tubulin Modulators|tubulin modulators|mesh-ancestor
6117720|NCT01092182|Antimitotic Agents|antimitotic agents|mesh-ancestor
5531261|NCT04249037|Antiviral Agents|antiviral agents|mesh-ancestor
5531262|NCT04249037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5531263|NCT04249037|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5531264|NCT04249037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5531265|NCT04249037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5531266|NCT04249037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531267|NCT04249037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5531268|NCT04248569|Nivolumab|nivolumab|mesh-list
5531269|NCT04248569|Ipilimumab|ipilimumab|mesh-list
5531270|NCT04248569|Poly ICLC|poly iclc|mesh-list
5531271|NCT04248569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5531272|NCT04248569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5531273|NCT04248569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5531274|NCT04248569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531275|NCT04248569|Interferon Inducers|interferon inducers|mesh-ancestor
5531276|NCT04248569|Immunologic Factors|immunologic factors|mesh-ancestor
5531277|NCT04248569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531278|NCT04248621|Goserelin|goserelin|mesh-list
6117721|NCT01092182|Mitosis Modulators|mitosis modulators|mesh-ancestor
6117722|NCT01092338|Vitamin D|vitamin d|mesh-list
6117723|NCT01092338|Cholecalciferol|cholecalciferol|mesh-list
6117724|NCT01092338|Vitamins|vitamins|mesh-ancestor
5531279|NCT04248621|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5531280|NCT04248621|Leuprolide|leuprolide|mesh-list
5531281|NCT04248621|Flutamide|flutamide|mesh-list
5531282|NCT04248621|Bicalutamide|bicalutamide|mesh-list
5531283|NCT04248621|Androgen Antagonists|androgen antagonists|mesh-list
5531284|NCT04248621|Androgens|androgens|mesh-list
5531285|NCT04248621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5531286|NCT04248621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5531287|NCT04248621|Hormone Antagonists|hormone antagonists|mesh-ancestor
6117725|NCT01092338|Micronutrients|micronutrients|mesh-ancestor
6117726|NCT01092338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117727|NCT01092338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6117728|NCT01092338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6117729|NCT01092507|Vaccines|vaccines|mesh-list
6117730|NCT01092507|Immunologic Factors|immunologic factors|mesh-ancestor
6117731|NCT01092507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117732|NCT01092546|Flutemetamol|flutemetamol|mesh-list
6117733|NCT01092546|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6117734|NCT01092546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117735|NCT01092559|Nitric Oxide|nitric oxide|mesh-list
6117736|NCT01092559|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6117737|NCT01092559|Autonomic Agents|autonomic agents|mesh-ancestor
6117738|NCT01092559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6117739|NCT01092559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117740|NCT01092559|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6117741|NCT01092559|Respiratory System Agents|respiratory system agents|mesh-ancestor
6117742|NCT01092559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6117743|NCT01092559|Antioxidants|antioxidants|mesh-ancestor
6117744|NCT01092559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117745|NCT01092559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6117746|NCT01092559|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6117747|NCT01092559|Vasodilator Agents|vasodilator agents|mesh-ancestor
6117748|NCT01092559|Gasotransmitters|gasotransmitters|mesh-ancestor
6117749|NCT01092559|Protective Agents|protective agents|mesh-ancestor
5531288|NCT04248621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5531289|NCT04248621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531290|NCT04248621|Hormones|hormones|mesh-ancestor
5531291|NCT04248621|Luteolytic Agents|luteolytic agents|mesh-ancestor
5531292|NCT04248621|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5531293|NCT04248621|Contraceptive Agents|contraceptive agents|mesh-ancestor
5531294|NCT04248621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5531295|NCT04248621|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5531296|NCT04248621|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5531297|NCT04248621|Fertility Agents|fertility agents|mesh-ancestor
6117750|NCT01092663|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6117751|NCT01092663|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
6117752|NCT01092663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6117753|NCT01092663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117754|NCT01092663|Incretins|incretins|mesh-ancestor
6117755|NCT01092663|Hormones|hormones|mesh-ancestor
6117756|NCT01092663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6117757|NCT01092663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6117758|NCT01092663|Protease Inhibitors|protease inhibitors|mesh-ancestor
6117759|NCT01092663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6117760|NCT01092663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117761|NCT01092663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6117762|NCT01092663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6117763|NCT01092663|Antimetabolites|antimetabolites|mesh-ancestor
6117764|NCT01092663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6117765|NCT01092676|Ibuprofen|ibuprofen|mesh-list
6117766|NCT01092676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6117767|NCT01092676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6117768|NCT01092676|Analgesics|analgesics|mesh-ancestor
5531298|NCT04248608|Morphine|morphine|mesh-list
5531299|NCT04248608|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5531300|NCT04248608|Narcotics|narcotics|mesh-ancestor
5531301|NCT04248608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5531302|NCT04248608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531303|NCT04248608|Analgesics|analgesics|mesh-ancestor
5531304|NCT04248608|Sensory System Agents|sensory system agents|mesh-ancestor
5531305|NCT04248608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5531306|NCT04248595|Azacitidine|azacitidine|mesh-list
5531307|NCT04248595|Homoharringtonine|homoharringtonine|mesh-list
5531308|NCT04248595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5531309|NCT04248595|Antimetabolites|antimetabolites|mesh-ancestor
5531310|NCT04248595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531311|NCT04248595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5531312|NCT04248595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5531313|NCT04248595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5531314|NCT04248595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5531315|NCT04248348|Heparin|heparin|mesh-list
5531316|NCT04248348|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6117769|NCT01092676|Sensory System Agents|sensory system agents|mesh-ancestor
6117770|NCT01092676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6117771|NCT01092676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117772|NCT01092676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6117773|NCT01092676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6117774|NCT01092676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6117775|NCT01092676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6117776|NCT01092676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117777|NCT01092702|Varenicline|varenicline|mesh-list
6117778|NCT01092702|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6117779|NCT01092702|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6117780|NCT01092702|Cholinergic Agents|cholinergic agents|mesh-ancestor
6117781|NCT01092702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6117782|NCT01092702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117783|NCT01092702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117784|NCT01092728|Dasatinib|dasatinib|mesh-list
6117785|NCT01092728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6117786|NCT01092728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6117787|NCT01092728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6117788|NCT01092728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117789|NCT01092780|Modafinil|modafinil|mesh-list
6117790|NCT01092780|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6117791|NCT01092780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204506|NCT02072096|Acarbose|acarbose|mesh-list
5531317|NCT04248348|Tinzaparin|tinzaparin|mesh-list
5531318|NCT04248348|Dalteparin|dalteparin|mesh-list
5531319|NCT04248348|Anticoagulants|anticoagulants|mesh-ancestor
5531320|NCT04248348|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5531321|NCT04248348|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5531322|NCT04248348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531323|NCT04248335|Midazolam|midazolam|mesh-list
5531324|NCT04248335|Pantoprazole|pantoprazole|mesh-list
5531325|NCT04248335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5531326|NCT04248335|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5531327|NCT04248335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5531328|NCT04248335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531329|NCT04248335|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5531330|NCT04248335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6117792|NCT01092780|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6117793|NCT01092780|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6117794|NCT01092780|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6117795|NCT01092780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117796|NCT01092832|Voriconazole|voriconazole|mesh-list
6117797|NCT01092832|Antifungal Agents|antifungal agents|mesh-ancestor
6117798|NCT01092832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6117799|NCT01092832|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6117800|NCT01092832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6117801|NCT01092832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5531331|NCT04248335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5531332|NCT04248335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5531333|NCT04248335|Anesthetics, General|anesthetics, general|mesh-ancestor
5531334|NCT04248335|Anesthetics|anesthetics|mesh-ancestor
5531335|NCT04248335|GABA Modulators|gaba modulators|mesh-ancestor
5531336|NCT04248335|GABA Agents|gaba agents|mesh-ancestor
5531337|NCT04248335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5531338|NCT04248335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531339|NCT04248335|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5531340|NCT04248335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5531341|NCT04248335|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5531342|NCT04248335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5531343|NCT04248452|Calcium, Dietary|calcium, dietary|mesh-list
5531344|NCT04248452|Leucovorin|leucovorin|mesh-list
5531345|NCT04248452|Folic Acid|folic acid|mesh-list
5531346|NCT04248452|Fluorouracil|fluorouracil|mesh-list
5531347|NCT04248452|Capecitabine|capecitabine|mesh-list
5531348|NCT04248452|Oxaliplatin|oxaliplatin|mesh-list
5531349|NCT04248452|Calcium|calcium|mesh-list
5531350|NCT04248452|Levoleucovorin|levoleucovorin|mesh-list
5531351|NCT04248452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5531352|NCT04248452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117802|NCT01092832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117803|NCT01092832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6117804|NCT01092832|Hormone Antagonists|hormone antagonists|mesh-ancestor
6117805|NCT01092832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6117806|NCT01092832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117807|NCT01092832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6117808|NCT01092923|Sevoflurane|sevoflurane|mesh-list
6117809|NCT01092923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6117810|NCT01092923|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6117811|NCT01092923|Anesthetics, General|anesthetics, general|mesh-ancestor
6117812|NCT01092923|Anesthetics|anesthetics|mesh-ancestor
6117813|NCT01092923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6117814|NCT01092923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117815|NCT01093183|Cyclophosphamide|cyclophosphamide|mesh-list
6117816|NCT01093183|Lenalidomide|lenalidomide|mesh-list
6117817|NCT01093183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5531353|NCT04248452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5531354|NCT04248452|Antimetabolites|antimetabolites|mesh-ancestor
5531355|NCT04248452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117818|NCT01093183|Immunologic Factors|immunologic factors|mesh-ancestor
6117819|NCT01093183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117820|NCT01093183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6117821|NCT01093183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6117822|NCT01093183|Alkylating Agents|alkylating agents|mesh-ancestor
6117823|NCT01093183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117824|NCT01093183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6117825|NCT01093183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6117826|NCT01093183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6117827|NCT01093183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6117828|NCT01093183|Growth Substances|growth substances|mesh-ancestor
6117829|NCT01093183|Growth Inhibitors|growth inhibitors|mesh-ancestor
6117830|NCT01093222|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6117831|NCT01093222|Sorafenib|sorafenib|mesh-list
6117832|NCT01093222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6117833|NCT01093222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6117834|NCT01093222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6117835|NCT01093222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117836|NCT01093417|Vitamin D|vitamin d|mesh-list
6117837|NCT01093417|Vitamins|vitamins|mesh-ancestor
6117838|NCT01093417|Micronutrients|micronutrients|mesh-ancestor
6117839|NCT01093417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117840|NCT01093417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6117841|NCT01093469|Decanoic acid|decanoic acid|mesh-list
6117842|NCT01093469|Petrolatum|petrolatum|mesh-list
6117843|NCT01093469|Emollients|emollients|mesh-ancestor
6117844|NCT01093469|Dermatologic Agents|dermatologic agents|mesh-ancestor
6117845|NCT01093469|Antifungal Agents|antifungal agents|mesh-ancestor
6117846|NCT01093469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6117847|NCT01093521|Gallium nitrate|gallium nitrate|mesh-list
6117848|NCT01093521|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6117849|NCT01093521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117850|NCT01093521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6117851|NCT01093534|Solifenacin Succinate|solifenacin succinate|mesh-list
6117852|NCT01093534|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6117853|NCT01093534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6117854|NCT01093534|Cholinergic Agents|cholinergic agents|mesh-ancestor
6117855|NCT01093534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6117856|NCT01093534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117857|NCT01093534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117858|NCT01093534|Urological Agents|urological agents|mesh-ancestor
6117859|NCT01093573|Azacitidine|azacitidine|mesh-list
6117860|NCT01093573|Midostaurin|midostaurin|mesh-list
6117861|NCT01093573|Staurosporine|staurosporine|mesh-list
6117862|NCT01093573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6117863|NCT01093573|Antimetabolites|antimetabolites|mesh-ancestor
6117864|NCT01093573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117865|NCT01093573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6117866|NCT01093573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6117867|NCT01093573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6117868|NCT01093586|Cyclosporine|cyclosporine|mesh-list
6117869|NCT01093586|Mycophenolic Acid|mycophenolic acid|mesh-list
6117870|NCT01093586|Methylprednisolone|methylprednisolone|mesh-list
6117871|NCT01093586|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6117872|NCT01093586|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6117873|NCT01093586|Prednisolone|prednisolone|mesh-list
6117874|NCT01093586|Prednisolone acetate|prednisolone acetate|mesh-list
6117875|NCT01093586|Cyclophosphamide|cyclophosphamide|mesh-list
5531356|NCT04248452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5531357|NCT04248452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5531358|NCT04248452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5531359|NCT04248452|Immunologic Factors|immunologic factors|mesh-ancestor
5531360|NCT04248452|Antidotes|antidotes|mesh-ancestor
5531361|NCT04248452|Protective Agents|protective agents|mesh-ancestor
5531362|NCT04248452|Vitamin B Complex|vitamin b complex|mesh-ancestor
5531363|NCT04248452|Vitamins|vitamins|mesh-ancestor
5531364|NCT04248452|Micronutrients|micronutrients|mesh-ancestor
5531365|NCT04248452|Hematinics|hematinics|mesh-ancestor
6117876|NCT01093586|Busulfan|busulfan|mesh-list
6117877|NCT01093586|Cyclosporins|cyclosporins|mesh-list
6117878|NCT01093586|Thymoglobulin|thymoglobulin|mesh-list
6117879|NCT01093586|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6117880|NCT01093586|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6117881|NCT01093586|Prednisolone phosphate|prednisolone phosphate|mesh-list
6117882|NCT01093586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6117883|NCT01093586|Immunologic Factors|immunologic factors|mesh-ancestor
6117884|NCT01093586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117885|NCT01093586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6117886|NCT01093586|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6117887|NCT01093586|Alkylating Agents|alkylating agents|mesh-ancestor
6117888|NCT01093586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117889|NCT01093586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6117890|NCT01093586|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5531366|NCT04248309|Progesterone|progesterone|mesh-list
6117891|NCT01093586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6117892|NCT01093586|Antifungal Agents|antifungal agents|mesh-ancestor
6117893|NCT01093586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6117894|NCT01093586|Dermatologic Agents|dermatologic agents|mesh-ancestor
6117895|NCT01093586|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6117896|NCT01093586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5531367|NCT04248309|Progestins|progestins|mesh-ancestor
5531368|NCT04248309|Hormones|hormones|mesh-ancestor
5531369|NCT04248309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5531370|NCT04248309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531371|NCT04247867|Psyllium|psyllium|mesh-list
5531372|NCT04247867|Cathartics|cathartics|mesh-ancestor
5531373|NCT04247867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5531374|NCT04248205|Ketamine|ketamine|mesh-list
5531375|NCT04248205|Analgesics|analgesics|mesh-ancestor
5531376|NCT04248205|Sensory System Agents|sensory system agents|mesh-ancestor
6117897|NCT01093586|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6117898|NCT01093586|Antitubercular Agents|antitubercular agents|mesh-ancestor
6117899|NCT01093586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6117900|NCT01093586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6117901|NCT01093586|Antiemetics|antiemetics|mesh-ancestor
6117902|NCT01093586|Autonomic Agents|autonomic agents|mesh-ancestor
6117903|NCT01093586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6117904|NCT01093586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6117905|NCT01093586|Glucocorticoids|glucocorticoids|mesh-ancestor
6117906|NCT01093586|Hormones|hormones|mesh-ancestor
6117907|NCT01093586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6117908|NCT01093586|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6117909|NCT01093586|Protective Agents|protective agents|mesh-ancestor
6117910|NCT01093586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6117911|NCT01093651|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6117912|NCT01093651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6117913|NCT01093651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531377|NCT04248205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5531378|NCT04248205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531379|NCT04248205|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5531380|NCT04248205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6117914|NCT01093651|Incretins|incretins|mesh-ancestor
6117915|NCT01093651|Hormones|hormones|mesh-ancestor
6117916|NCT01093651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6117917|NCT01093651|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6117918|NCT01093651|Protease Inhibitors|protease inhibitors|mesh-ancestor
6117919|NCT01093651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6117920|NCT01093651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117921|NCT01093690|Metoclopramide|metoclopramide|mesh-list
6117922|NCT01093690|Antiemetics|antiemetics|mesh-ancestor
6117923|NCT01093690|Autonomic Agents|autonomic agents|mesh-ancestor
6117924|NCT01093690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6117925|NCT01093690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117926|NCT01093690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6117927|NCT01093690|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6117928|NCT01093690|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6117929|NCT01093690|Dopamine Agents|dopamine agents|mesh-ancestor
6117930|NCT01093690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6117931|NCT01093690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117932|NCT01093755|Omeprazole|omeprazole|mesh-list
6117933|NCT01093755|Dexlansoprazole|dexlansoprazole|mesh-list
6117934|NCT01093755|Lansoprazole|lansoprazole|mesh-list
6117935|NCT01093755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6117936|NCT01093755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6117937|NCT01093755|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6117938|NCT01093755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6117939|NCT01093755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117940|NCT01093794|Metformin|metformin|mesh-list
6117941|NCT01093794|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6117942|NCT01093794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6117943|NCT01093794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117944|NCT01093794|Incretins|incretins|mesh-ancestor
6117945|NCT01093794|Hormones|hormones|mesh-ancestor
6117946|NCT01093794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6117947|NCT01093794|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6117948|NCT01093794|Protease Inhibitors|protease inhibitors|mesh-ancestor
6117949|NCT01093794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5531381|NCT04248205|Anesthetics, General|anesthetics, general|mesh-ancestor
5531382|NCT04248205|Anesthetics|anesthetics|mesh-ancestor
6117950|NCT01093794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117951|NCT01093885|Ambrisentan|ambrisentan|mesh-list
6117952|NCT01093885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6117953|NCT01093976|Dronabinol|dronabinol|mesh-list
6117954|NCT01093976|Hallucinogens|hallucinogens|mesh-ancestor
6117955|NCT01093976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117956|NCT01093976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6117957|NCT01093976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6117958|NCT01093976|Analgesics|analgesics|mesh-ancestor
6117959|NCT01093976|Sensory System Agents|sensory system agents|mesh-ancestor
6117960|NCT01093976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6117961|NCT01093976|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6117962|NCT01093976|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6117963|NCT01093976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6117964|NCT01093976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117965|NCT01093976|Hormones|hormones|mesh-ancestor
6117966|NCT01093976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6117967|NCT01094106|Ropivacaine|ropivacaine|mesh-list
6117968|NCT01094106|Anesthetics, Local|anesthetics, local|mesh-ancestor
6117969|NCT01094106|Anesthetics|anesthetics|mesh-ancestor
6117970|NCT01094106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5531383|NCT04248205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5531384|NCT04248205|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5531385|NCT04248205|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5531386|NCT04248205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5531387|NCT04248205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531388|NCT04247984|Bevacizumab|bevacizumab|mesh-list
5531389|NCT04247984|Fluorouracil|fluorouracil|mesh-list
5531390|NCT04247984|Capecitabine|capecitabine|mesh-list
5531391|NCT04247984|Irinotecan|irinotecan|mesh-list
5531392|NCT04247984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5531393|NCT04247984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5531394|NCT04247984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5531395|NCT04247984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5531396|NCT04247984|Growth Substances|growth substances|mesh-ancestor
5531397|NCT04247984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531398|NCT04247984|Growth Inhibitors|growth inhibitors|mesh-ancestor
5531399|NCT04247984|Antimetabolites|antimetabolites|mesh-ancestor
5531400|NCT04247984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531401|NCT04247984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5531402|NCT04247984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5531403|NCT04247984|Immunologic Factors|immunologic factors|mesh-ancestor
5531404|NCT04247984|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5531405|NCT04247984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5531406|NCT04247984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5531407|NCT04248101|Silver Nitrate|silver nitrate|mesh-list
5531408|NCT04248101|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6117971|NCT01094106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117972|NCT01094106|Sensory System Agents|sensory system agents|mesh-ancestor
6117973|NCT01094106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6117974|NCT01094184|Paclitaxel|paclitaxel|mesh-list
6117975|NCT01094184|Docetaxel|docetaxel|mesh-list
6117976|NCT01094184|Bevacizumab|bevacizumab|mesh-list
6117977|NCT01094184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6117978|NCT01094184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6117979|NCT01094184|Tubulin Modulators|tubulin modulators|mesh-ancestor
6117980|NCT01094184|Antimitotic Agents|antimitotic agents|mesh-ancestor
6117981|NCT01094184|Mitosis Modulators|mitosis modulators|mesh-ancestor
6117982|NCT01094184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117983|NCT01094184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6117984|NCT01094184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6117985|NCT01094184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6117986|NCT01094184|Growth Substances|growth substances|mesh-ancestor
6117987|NCT01094184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6117988|NCT01094184|Growth Inhibitors|growth inhibitors|mesh-ancestor
6117989|NCT01094288|Docetaxel|docetaxel|mesh-list
6117990|NCT01094288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6117991|NCT01094288|Tubulin Modulators|tubulin modulators|mesh-ancestor
6117992|NCT01094288|Antimitotic Agents|antimitotic agents|mesh-ancestor
6117993|NCT01094288|Mitosis Modulators|mitosis modulators|mesh-ancestor
6117994|NCT01094288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6117995|NCT01094522|Morphine|morphine|mesh-list
6117996|NCT01094522|Methadone|methadone|mesh-list
6117997|NCT01094522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6117998|NCT01094522|Narcotics|narcotics|mesh-ancestor
6117999|NCT01094522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6118000|NCT01094522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118001|NCT01094522|Analgesics|analgesics|mesh-ancestor
6118002|NCT01094522|Sensory System Agents|sensory system agents|mesh-ancestor
6118003|NCT01094522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6118004|NCT01094522|Antitussive Agents|antitussive agents|mesh-ancestor
6118005|NCT01094522|Respiratory System Agents|respiratory system agents|mesh-ancestor
6118006|NCT01094548|Cyclophosphamide|cyclophosphamide|mesh-list
6118007|NCT01094548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6118008|NCT01094548|Immunologic Factors|immunologic factors|mesh-ancestor
6118009|NCT01094548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118010|NCT01094548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6118011|NCT01094548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6118012|NCT01094548|Alkylating Agents|alkylating agents|mesh-ancestor
6118013|NCT01094548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118014|NCT01094548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6118015|NCT01094548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6118016|NCT01094574|Propranolol|propranolol|mesh-list
6118017|NCT01094574|Alfentanil|alfentanil|mesh-list
6118018|NCT01094574|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6118019|NCT01094574|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6118020|NCT01094574|Adrenergic Agents|adrenergic agents|mesh-ancestor
6118021|NCT01094574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6118022|NCT01094574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118023|NCT01094574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118024|NCT01094574|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6118025|NCT01094574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6118026|NCT01094574|Vasodilator Agents|vasodilator agents|mesh-ancestor
6118027|NCT01094574|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6118028|NCT01094574|Narcotics|narcotics|mesh-ancestor
6118029|NCT01094574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6118030|NCT01094574|Analgesics|analgesics|mesh-ancestor
6118031|NCT01094574|Sensory System Agents|sensory system agents|mesh-ancestor
6118032|NCT01094574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6118033|NCT01094574|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6118034|NCT01094574|Anesthetics, General|anesthetics, general|mesh-ancestor
6118035|NCT01094574|Anesthetics|anesthetics|mesh-ancestor
6118036|NCT01094717|Tazarotene|tazarotene|mesh-list
6118037|NCT01094717|Acitretin|acitretin|mesh-list
5531409|NCT04248101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5531410|NCT04248179|Sufentanil|sufentanil|mesh-list
5531411|NCT04248179|Ropivacaine|ropivacaine|mesh-list
5531412|NCT04248179|Anesthetics, Local|anesthetics, local|mesh-ancestor
5531413|NCT04248179|Anesthetics|anesthetics|mesh-ancestor
5531414|NCT04248179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6118038|NCT01094717|Dermatologic Agents|dermatologic agents|mesh-ancestor
6118039|NCT01094717|Keratolytic Agents|keratolytic agents|mesh-ancestor
6118040|NCT01094808|Pregabalin|pregabalin|mesh-list
6118041|NCT01094808|Analgesics|analgesics|mesh-ancestor
6118042|NCT01094808|Sensory System Agents|sensory system agents|mesh-ancestor
6118043|NCT01094808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6118044|NCT01094808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118045|NCT01094808|Anticonvulsants|anticonvulsants|mesh-ancestor
6118046|NCT01094808|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6118047|NCT01094808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6118048|NCT01094808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118049|NCT01094808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6118050|NCT01094808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6118051|NCT01094808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6118052|NCT01094808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6118053|NCT01094808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6118054|NCT01094886|Rivaroxaban|rivaroxaban|mesh-list
6118055|NCT01094886|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6118056|NCT01094886|Antithrombins|antithrombins|mesh-ancestor
6118057|NCT01094886|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6118058|NCT01094886|Protease Inhibitors|protease inhibitors|mesh-ancestor
6118059|NCT01094886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6118060|NCT01094886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118061|NCT01094886|Anticoagulants|anticoagulants|mesh-ancestor
6118062|NCT01095003|Capecitabine|capecitabine|mesh-list
6118063|NCT01095003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6118064|NCT01095003|Antimetabolites|antimetabolites|mesh-ancestor
6118065|NCT01095003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118066|NCT01095003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6118067|NCT01095094|Ritonavir|ritonavir|mesh-list
6118068|NCT01095094|Lopinavir|lopinavir|mesh-list
6118069|NCT01095094|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6204507|NCT02072096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5531415|NCT04248179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531416|NCT04248179|Sensory System Agents|sensory system agents|mesh-ancestor
5531417|NCT04248179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5531418|NCT04248179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5531419|NCT04248179|Narcotics|narcotics|mesh-ancestor
5531420|NCT04248179|Analgesics|analgesics|mesh-ancestor
5531421|NCT04248179|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6465773|NCT00476034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6465774|NCT00476073|Fluticasone|fluticasone|mesh-list
6465775|NCT00476073|Xhance|xhance|mesh-list
6465776|NCT00476073|Formoterol Fumarate|formoterol fumarate|mesh-list
6465777|NCT00476073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5531422|NCT04248179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5531423|NCT04248179|Anesthetics, General|anesthetics, general|mesh-ancestor
5531424|NCT04247633|Palbociclib|palbociclib|mesh-list
5531425|NCT04247633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5531426|NCT04247633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5531427|NCT04247633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5531428|NCT04247633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531429|NCT04247646|Melatonin|melatonin|mesh-list
5531430|NCT04247646|Antioxidants|antioxidants|mesh-ancestor
5531431|NCT04247646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531432|NCT04247646|Protective Agents|protective agents|mesh-ancestor
5531433|NCT04247646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531434|NCT04247646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6465778|NCT00476073|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6465779|NCT00476073|Autonomic Agents|autonomic agents|mesh-ancestor
6465780|NCT00476073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6465781|NCT00476073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118070|NCT01095094|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6118071|NCT01095094|Protease Inhibitors|protease inhibitors|mesh-ancestor
6118072|NCT01095094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6118073|NCT01095094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118074|NCT01095094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6118075|NCT01095094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6118076|NCT01095094|Antiviral Agents|antiviral agents|mesh-ancestor
6118077|NCT01095094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6118078|NCT01095094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6118079|NCT01095094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6118080|NCT01095497|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
6118081|NCT01095497|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6118082|NCT01095497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6118083|NCT01095497|Immunologic Factors|immunologic factors|mesh-ancestor
6118084|NCT01095497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118085|NCT01095510|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
6118086|NCT01095510|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6118087|NCT01095510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6118088|NCT01095510|Immunologic Factors|immunologic factors|mesh-ancestor
6118089|NCT01095510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118090|NCT01095653|Metformin|metformin|mesh-list
6118091|NCT01095653|Dapagliflozin|dapagliflozin|mesh-list
6118092|NCT01095653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6118093|NCT01095653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118094|NCT01095653|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6118095|NCT01095653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118096|NCT01095666|Metformin|metformin|mesh-list
6118097|NCT01095666|Pioglitazone|pioglitazone|mesh-list
6118098|NCT01095666|Dapagliflozin|dapagliflozin|mesh-list
6118099|NCT01095666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6118100|NCT01095666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118101|NCT01095666|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6118102|NCT01095666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118103|NCT01095757|Plerixafor|plerixafor|mesh-list
5531435|NCT04247815|Methotrexate|methotrexate|mesh-list
5531436|NCT04247815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5531437|NCT04247815|Abortifacient Agents|abortifacient agents|mesh-ancestor
5531438|NCT04247815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5531439|NCT04247815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118104|NCT01095757|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6118105|NCT01095757|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6118106|NCT01095757|Antiviral Agents|antiviral agents|mesh-ancestor
6465782|NCT00476073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6465783|NCT00476073|Respiratory System Agents|respiratory system agents|mesh-ancestor
5531440|NCT04247815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6118107|NCT01095757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6118108|NCT01095796|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6118109|NCT01095796|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6118110|NCT01095796|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6118111|NCT01095796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6118112|NCT01095796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5531441|NCT04247815|Antimetabolites|antimetabolites|mesh-ancestor
5531442|NCT04247815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531443|NCT04247815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5531444|NCT04247815|Dermatologic Agents|dermatologic agents|mesh-ancestor
5531445|NCT04247815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5531446|NCT04247815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5531447|NCT04247815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5531448|NCT04247815|Immunologic Factors|immunologic factors|mesh-ancestor
5531449|NCT04247815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5531450|NCT04247815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5531451|NCT04247373|Ropivacaine|ropivacaine|mesh-list
5531452|NCT04247373|Anesthetics, Local|anesthetics, local|mesh-ancestor
6118113|NCT01095796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118114|NCT01095796|Antiviral Agents|antiviral agents|mesh-ancestor
6118115|NCT01095796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6118116|NCT01095796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6118117|NCT01095796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6118118|NCT01095835|Interferons|interferons|mesh-list
6118119|NCT01095835|Lamivudine|lamivudine|mesh-list
6118120|NCT01095835|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6118121|NCT01095835|Interferon-alpha|interferon-alpha|mesh-list
6118122|NCT01095835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6118123|NCT01095835|Antiviral Agents|antiviral agents|mesh-ancestor
6118124|NCT01095835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6666106|NCT01520766|Dopamine Agents|dopamine agents|mesh-ancestor
5531453|NCT04247373|Anesthetics|anesthetics|mesh-ancestor
6118125|NCT01095835|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6118126|NCT01095835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6118127|NCT01095835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6118128|NCT01095835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118129|NCT01095835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6118130|NCT01095835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6118131|NCT01095835|Immunologic Factors|immunologic factors|mesh-ancestor
6118132|NCT01095835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531454|NCT04247373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5531455|NCT04247373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531456|NCT04247373|Sensory System Agents|sensory system agents|mesh-ancestor
5531457|NCT04247373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5531458|NCT04247230|Tetracaine|tetracaine|mesh-list
5531459|NCT04247230|Anesthetics, Local|anesthetics, local|mesh-ancestor
5531460|NCT04247230|Anesthetics|anesthetics|mesh-ancestor
5531461|NCT04247230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5531462|NCT04247230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531463|NCT04247230|Sensory System Agents|sensory system agents|mesh-ancestor
5531464|NCT04247230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5601528|NCT05176626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601529|NCT05176548|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5601530|NCT05176548|Myeloma Proteins|myeloma proteins|mesh-list
5601531|NCT05176548|Paraproteins|paraproteins|mesh-list
5601532|NCT05176548|Immunologic Factors|immunologic factors|mesh-ancestor
5601533|NCT05176548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601537|NCT05176418|Nicotine|nicotine|mesh-list
5601538|NCT05176418|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5601539|NCT05176418|Autonomic Agents|autonomic agents|mesh-ancestor
5601540|NCT05176418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5601541|NCT05176418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601542|NCT05176418|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6118133|NCT01095887|Eculizumab|eculizumab|mesh-list
6118134|NCT01095887|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6118135|NCT01095887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6118136|NCT01095887|Immunologic Factors|immunologic factors|mesh-ancestor
6118137|NCT01095887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118138|NCT01095978|Clarithromycin|clarithromycin|mesh-list
6118139|NCT01095978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6118140|NCT01095978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6118141|NCT01095978|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6118142|NCT01095978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6118143|NCT01095978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118144|NCT01095978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6118145|NCT01095978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6118146|NCT01096017|Albuterol|albuterol|mesh-list
6118147|NCT01096017|Terbutaline|terbutaline|mesh-list
6118148|NCT01096017|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6118149|NCT01096017|Autonomic Agents|autonomic agents|mesh-ancestor
6118150|NCT01096017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6118151|NCT01096017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118152|NCT01096017|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6118153|NCT01096017|Respiratory System Agents|respiratory system agents|mesh-ancestor
6118154|NCT01096017|Tocolytic Agents|tocolytic agents|mesh-ancestor
6118155|NCT01096017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6118156|NCT01096017|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6118157|NCT01096017|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6118158|NCT01096017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6118159|NCT01096017|Adrenergic Agents|adrenergic agents|mesh-ancestor
6118160|NCT01096017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6118161|NCT01096017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118162|NCT01096017|Sympathomimetics|sympathomimetics|mesh-ancestor
6118163|NCT01096056|Vaccines|vaccines|mesh-list
6118164|NCT01096056|Immunologic Factors|immunologic factors|mesh-ancestor
6118165|NCT01096056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204508|NCT02072096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204509|NCT02072096|Incretins|incretins|mesh-ancestor
6204510|NCT02072096|Hormones|hormones|mesh-ancestor
6465784|NCT00476073|Dermatologic Agents|dermatologic agents|mesh-ancestor
6465785|NCT00476073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6465786|NCT00476073|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6465787|NCT00476073|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6465788|NCT00476073|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6465789|NCT00476073|Adrenergic Agents|adrenergic agents|mesh-ancestor
5531465|NCT04247087|Vitamin K|vitamin k|mesh-list
5531466|NCT04247087|Vitamin K 1|vitamin k 1|mesh-list
5531467|NCT04247087|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5531468|NCT04247087|Vitamins|vitamins|mesh-ancestor
5531469|NCT04247087|Micronutrients|micronutrients|mesh-ancestor
5531470|NCT04247087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531471|NCT04247087|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5531472|NCT04247087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6204511|NCT02072096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6204512|NCT02072096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6204513|NCT02072096|Protease Inhibitors|protease inhibitors|mesh-ancestor
6204514|NCT02072096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6204515|NCT02072096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204516|NCT02072096|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6204517|NCT02072096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6204518|NCT02072096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6204519|NCT02072096|Immunologic Factors|immunologic factors|mesh-ancestor
6204520|NCT02072096|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6204521|NCT02072200|Prednisone|prednisone|mesh-list
6204522|NCT02072200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6204523|NCT02072200|Glucocorticoids|glucocorticoids|mesh-ancestor
6204524|NCT02072200|Hormones|hormones|mesh-ancestor
6204525|NCT02072200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6204526|NCT02072200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531473|NCT04247087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531474|NCT04247087|Hemostatics|hemostatics|mesh-ancestor
5531475|NCT04247087|Coagulants|coagulants|mesh-ancestor
5531476|NCT04247165|Gemcitabine|gemcitabine|mesh-list
5531477|NCT04247165|Paclitaxel|paclitaxel|mesh-list
6204527|NCT02072200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6204528|NCT02072200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6204529|NCT02072226|Aspirin|aspirin|mesh-list
6204530|NCT02072226|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6204531|NCT02072226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6204532|NCT02072226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6204533|NCT02072226|Analgesics|analgesics|mesh-ancestor
6204534|NCT02072226|Sensory System Agents|sensory system agents|mesh-ancestor
6204535|NCT02072226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6465790|NCT00476073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5531478|NCT04247165|Nivolumab|nivolumab|mesh-list
6118166|NCT01096186|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
6118167|NCT01096186|Carbidopa|carbidopa|mesh-list
6118168|NCT01096186|Levodopa|levodopa|mesh-list
6118169|NCT01096186|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6118170|NCT01096186|Immunologic Factors|immunologic factors|mesh-ancestor
6118171|NCT01096186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118172|NCT01096186|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6118173|NCT01096186|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6118174|NCT01096186|Dopamine Agonists|dopamine agonists|mesh-ancestor
6118175|NCT01096186|Dopamine Agents|dopamine agents|mesh-ancestor
6118176|NCT01096186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6118177|NCT01096186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118178|NCT01096186|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6118179|NCT01096186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6118180|NCT01096290|Lubiprostone|lubiprostone|mesh-list
6118181|NCT01096290|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6118182|NCT01096290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6118183|NCT01096290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118184|NCT01096342|Cyclin-Dependent Kinase Inhibitor Proteins|cyclin-dependent kinase inhibitor proteins|mesh-list
6118185|NCT01096342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6118186|NCT01096342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6118187|NCT01096342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118188|NCT01096446|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6118189|NCT01096446|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
6118190|NCT01096446|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6118191|NCT01096446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6118192|NCT01096589|Monensin|monensin|mesh-list
6118193|NCT01096589|Antifungal Agents|antifungal agents|mesh-ancestor
6118194|NCT01096589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6118195|NCT01096589|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6118196|NCT01096589|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6118197|NCT01096589|Coccidiostats|coccidiostats|mesh-ancestor
6118198|NCT01096589|Proton Ionophores|proton ionophores|mesh-ancestor
6118199|NCT01096589|Uncoupling Agents|uncoupling agents|mesh-ancestor
6118200|NCT01096589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6118201|NCT01096589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118202|NCT01096589|Ionophores|ionophores|mesh-ancestor
6118203|NCT01096589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6118204|NCT01096589|Sodium Ionophores|sodium ionophores|mesh-ancestor
6118205|NCT01096667|Ertugliflozin|ertugliflozin|mesh-list
6118206|NCT01096667|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6118207|NCT01096667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6118208|NCT01096667|Diuretics|diuretics|mesh-ancestor
6118209|NCT01096667|Natriuretic Agents|natriuretic agents|mesh-ancestor
6118210|NCT01096667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118211|NCT01096667|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6118212|NCT01096667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6118213|NCT01096667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118214|NCT01096667|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6118215|NCT01096667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6118216|NCT01096680|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6118217|NCT01096680|Modafinil|modafinil|mesh-list
6118218|NCT01096680|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6118219|NCT01096680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118220|NCT01096680|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6118221|NCT01096680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6118222|NCT01096680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6118223|NCT01096680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118224|NCT01096680|Dopamine Agents|dopamine agents|mesh-ancestor
6118225|NCT01096680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6118226|NCT01096680|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6118227|NCT01096680|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6118228|NCT01096680|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6118229|NCT01096771|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6118230|NCT01096771|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6118231|NCT01096771|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6118232|NCT01096771|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6118233|NCT01096784|Mecasermin|mecasermin|mesh-list
6118234|NCT01096784|Growth Substances|growth substances|mesh-ancestor
6118235|NCT01096784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118236|NCT01096849|Levofloxacin|levofloxacin|mesh-list
6118237|NCT01096849|Ofloxacin|ofloxacin|mesh-list
6118238|NCT01096849|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6118239|NCT01096849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6118240|NCT01096849|Renal Agents|renal agents|mesh-ancestor
6118241|NCT01096849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6118242|NCT01096849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6118243|NCT01096849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6118244|NCT01096849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6118245|NCT01096849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118246|NCT01096849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6118247|NCT01096849|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6118248|NCT01096849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6118249|NCT01096875|Atorvastatin|atorvastatin|mesh-list
6118250|NCT01096875|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6118251|NCT01096875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6118252|NCT01096875|Antimetabolites|antimetabolites|mesh-ancestor
6118253|NCT01096875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118254|NCT01096875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6118255|NCT01096875|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6118256|NCT01096875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6118257|NCT01096992|Vidarabine|vidarabine|mesh-list
6118258|NCT01096992|Rituximab|rituximab|mesh-list
6118259|NCT01096992|Fludarabine|fludarabine|mesh-list
6118260|NCT01096992|Fludarabine phosphate|fludarabine phosphate|mesh-list
6118261|NCT01096992|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6118262|NCT01096992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6118263|NCT01096992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6118264|NCT01096992|Immunologic Factors|immunologic factors|mesh-ancestor
6118265|NCT01096992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118266|NCT01096992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6118267|NCT01096992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6118268|NCT01096992|Antimetabolites|antimetabolites|mesh-ancestor
6118269|NCT01096992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118270|NCT01096992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6118271|NCT01096992|Antiviral Agents|antiviral agents|mesh-ancestor
6118272|NCT01096992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6118273|NCT01096992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6118274|NCT01096992|Alkylating Agents|alkylating agents|mesh-ancestor
6118275|NCT01097044|Afamelanotide|afamelanotide|mesh-list
6118276|NCT01097044|Dermatologic Agents|dermatologic agents|mesh-ancestor
6118277|NCT01097057|Plerixafor|plerixafor|mesh-list
6118278|NCT01097057|Rituximab|rituximab|mesh-list
6118279|NCT01097057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6118280|NCT01097057|Carboplatin|carboplatin|mesh-list
6118281|NCT01097057|Etoposide|etoposide|mesh-list
6118282|NCT01097057|Etoposide phosphate|etoposide phosphate|mesh-list
6118283|NCT01097057|Ifosfamide|ifosfamide|mesh-list
6118284|NCT01097057|Isophosphamide mustard|isophosphamide mustard|mesh-list
6118285|NCT01097057|Podophyllotoxin|podophyllotoxin|mesh-list
5531479|NCT04247165|Ipilimumab|ipilimumab|mesh-list
6118286|NCT01097057|Antibodies|antibodies|mesh-list
6118287|NCT01097057|Immunoglobulins|immunoglobulins|mesh-list
6118288|NCT01097057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6118289|NCT01097057|Lenograstim|lenograstim|mesh-list
6118290|NCT01097057|Immunologic Factors|immunologic factors|mesh-ancestor
6118291|NCT01097057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118292|NCT01097057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6118293|NCT01097057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6118294|NCT01097057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6118295|NCT01097057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6118296|NCT01097057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6118297|NCT01097057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6118298|NCT01097057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118299|NCT01097057|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6118300|NCT01097057|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6118301|NCT01097057|Alkylating Agents|alkylating agents|mesh-ancestor
6118302|NCT01097057|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6118303|NCT01097057|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6118304|NCT01097057|Antiviral Agents|antiviral agents|mesh-ancestor
6118305|NCT01097057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6118306|NCT01097057|Keratolytic Agents|keratolytic agents|mesh-ancestor
6118307|NCT01097057|Dermatologic Agents|dermatologic agents|mesh-ancestor
6118308|NCT01097057|Tubulin Modulators|tubulin modulators|mesh-ancestor
5531480|NCT04247165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5531481|NCT04247165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5531482|NCT04247165|Tubulin Modulators|tubulin modulators|mesh-ancestor
5531483|NCT04247165|Antimitotic Agents|antimitotic agents|mesh-ancestor
5531484|NCT04247165|Mitosis Modulators|mitosis modulators|mesh-ancestor
5531485|NCT04247165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531486|NCT04247165|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5531487|NCT04247165|Antimetabolites|antimetabolites|mesh-ancestor
5531488|NCT04247165|Antiviral Agents|antiviral agents|mesh-ancestor
5531489|NCT04247165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5531490|NCT04247165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5531491|NCT04247165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5531492|NCT04247165|Immunologic Factors|immunologic factors|mesh-ancestor
5531493|NCT04247165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118309|NCT01097057|Antimitotic Agents|antimitotic agents|mesh-ancestor
6118310|NCT01097057|Mitosis Modulators|mitosis modulators|mesh-ancestor
6118311|NCT01097304|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
6118312|NCT01097304|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6118313|NCT01097304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6118314|NCT01097330|Amiodarone|amiodarone|mesh-list
6118315|NCT01097330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6118316|NCT01097330|Vasodilator Agents|vasodilator agents|mesh-ancestor
6118317|NCT01097330|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6118318|NCT01097330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6118319|NCT01097330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118320|NCT01097330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6118321|NCT01097330|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6118322|NCT01097330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6118323|NCT01097330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6118324|NCT01097330|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6118325|NCT01097330|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6118326|NCT01097330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6118327|NCT01097343|Clopidogrel|clopidogrel|mesh-list
6118328|NCT01097343|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6118329|NCT01097343|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6118330|NCT01097343|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6118331|NCT01097343|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6118332|NCT01097343|Purinergic Agents|purinergic agents|mesh-ancestor
6118333|NCT01097343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6118334|NCT01097343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118335|NCT01097343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118336|NCT01097395|Ribavirin|ribavirin|mesh-list
6118337|NCT01097395|Antimetabolites|antimetabolites|mesh-ancestor
6118338|NCT01097395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118339|NCT01097395|Antiviral Agents|antiviral agents|mesh-ancestor
6118340|NCT01097395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6118341|NCT01097421|Pramipexole|pramipexole|mesh-list
5531494|NCT04247165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5531495|NCT04247165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5531496|NCT04246905|Sulforaphane|sulforaphane|mesh-list
5531497|NCT04246905|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5531498|NCT04246905|Protective Agents|protective agents|mesh-ancestor
5531499|NCT04246905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531500|NCT04246905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5531501|NCT04246619|Pregabalin|pregabalin|mesh-list
6118342|NCT01097421|Antioxidants|antioxidants|mesh-ancestor
6118343|NCT01097421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118344|NCT01097421|Protective Agents|protective agents|mesh-ancestor
6118345|NCT01097421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531502|NCT04246619|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5531503|NCT04246619|Analgesics|analgesics|mesh-ancestor
5531504|NCT04246619|Sensory System Agents|sensory system agents|mesh-ancestor
5531505|NCT04246619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5531506|NCT04246619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531507|NCT04246619|Anticonvulsants|anticonvulsants|mesh-ancestor
5531508|NCT04246619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5531509|NCT04246619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5531510|NCT04246619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531511|NCT04246619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5531512|NCT04246619|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5531513|NCT04246619|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5531514|NCT04246619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5531515|NCT04246619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5531516|NCT04246619|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5531517|NCT04246619|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5531518|NCT04246619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5531519|NCT04246619|Antidepressive Agents|antidepressive agents|mesh-ancestor
5531520|NCT04246619|Dopamine Agents|dopamine agents|mesh-ancestor
5531521|NCT04246723|Ritonavir|ritonavir|mesh-list
5531522|NCT04246723|Sofosbuvir|sofosbuvir|mesh-list
5531523|NCT04246723|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5531524|NCT04246723|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5531525|NCT04246723|Protease Inhibitors|protease inhibitors|mesh-ancestor
6118346|NCT01097421|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6118347|NCT01097421|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6118348|NCT01097421|Dopamine Agonists|dopamine agonists|mesh-ancestor
6118349|NCT01097421|Dopamine Agents|dopamine agents|mesh-ancestor
6118350|NCT01097421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6118351|NCT01097460|Trastuzumab|trastuzumab|mesh-list
6118352|NCT01097460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6118353|NCT01097460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6118354|NCT01097577|Pregabalin|pregabalin|mesh-list
6118355|NCT01097577|Analgesics|analgesics|mesh-ancestor
6118356|NCT01097577|Sensory System Agents|sensory system agents|mesh-ancestor
6118357|NCT01097577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6118358|NCT01097577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118359|NCT01097577|Anticonvulsants|anticonvulsants|mesh-ancestor
6118360|NCT01097577|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6118361|NCT01097577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5531526|NCT04246723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5531527|NCT04246723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531528|NCT04246723|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5531529|NCT04246723|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5531530|NCT04246723|Antiviral Agents|antiviral agents|mesh-ancestor
5531531|NCT04246723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5531532|NCT04246723|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5531533|NCT04246723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5531534|NCT04246684|Leucovorin|leucovorin|mesh-list
5531535|NCT04246684|Folic Acid|folic acid|mesh-list
5531536|NCT04246684|Capecitabine|capecitabine|mesh-list
5531537|NCT04246684|Fluorouracil|fluorouracil|mesh-list
5531538|NCT04246684|Oxaliplatin|oxaliplatin|mesh-list
5531539|NCT04246684|Levoleucovorin|levoleucovorin|mesh-list
5531540|NCT04246684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5531541|NCT04246684|Antimetabolites|antimetabolites|mesh-ancestor
5531542|NCT04246684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531543|NCT04246684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5531544|NCT04246684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5531545|NCT04246684|Immunologic Factors|immunologic factors|mesh-ancestor
5531546|NCT04246684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531547|NCT04246684|Antidotes|antidotes|mesh-ancestor
5531548|NCT04246684|Protective Agents|protective agents|mesh-ancestor
5531549|NCT04246684|Vitamin B Complex|vitamin b complex|mesh-ancestor
5531550|NCT04246684|Vitamins|vitamins|mesh-ancestor
5531551|NCT04246684|Micronutrients|micronutrients|mesh-ancestor
5531552|NCT04246684|Hematinics|hematinics|mesh-ancestor
5531553|NCT04246567|Fentanyl|fentanyl|mesh-list
5531554|NCT04246567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5531555|NCT04246567|Narcotics|narcotics|mesh-ancestor
5531556|NCT04246567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5531557|NCT04246567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531558|NCT04246567|Analgesics|analgesics|mesh-ancestor
5531559|NCT04246567|Sensory System Agents|sensory system agents|mesh-ancestor
5531560|NCT04246567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5531561|NCT04246567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5531562|NCT04246567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6118362|NCT01097577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118363|NCT01097577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6118364|NCT01097577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6118365|NCT01097577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6118366|NCT01097577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6118367|NCT01097577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6118368|NCT01097616|Suvorexant|suvorexant|mesh-list
6118369|NCT01097616|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6118370|NCT01097616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6118371|NCT01097616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6118372|NCT01097616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118373|NCT01097616|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
6118374|NCT01097616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6118375|NCT01097616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531563|NCT04246567|Anesthetics, General|anesthetics, general|mesh-ancestor
5531564|NCT04246567|Anesthetics|anesthetics|mesh-ancestor
5531565|NCT04246697|Acetaminophen|acetaminophen|mesh-list
5531566|NCT04246697|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
5531567|NCT04246697|Morphine|morphine|mesh-list
5531568|NCT04246697|Oxycodone|oxycodone|mesh-list
5531569|NCT04246697|Gabapentin|gabapentin|mesh-list
5531570|NCT04246697|Bupivacaine|bupivacaine|mesh-list
5531571|NCT04246697|Anesthetics, Local|anesthetics, local|mesh-ancestor
5531572|NCT04246697|Anesthetics|anesthetics|mesh-ancestor
5531573|NCT04246697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5531574|NCT04246697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531575|NCT04246697|Sensory System Agents|sensory system agents|mesh-ancestor
6118376|NCT01097629|Suvorexant|suvorexant|mesh-list
6118377|NCT01097629|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6118378|NCT01097629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6118379|NCT01097629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6118380|NCT01097629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118381|NCT01097629|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
6118382|NCT01097629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5531576|NCT04246697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5531577|NCT04246697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5531578|NCT04246697|Narcotics|narcotics|mesh-ancestor
6118383|NCT01097629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118384|NCT01097642|Cetuximab|cetuximab|mesh-list
6118385|NCT01097642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6118386|NCT01097642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6118387|NCT01097694|Imatinib Mesylate|imatinib mesylate|mesh-list
6118388|NCT01097694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6118389|NCT01097694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6118390|NCT01097694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6118391|NCT01097694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118392|NCT01097785|Simvastatin|simvastatin|mesh-list
6118393|NCT01097785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5531579|NCT04246697|Analgesics|analgesics|mesh-ancestor
5531580|NCT04246697|Anticonvulsants|anticonvulsants|mesh-ancestor
5531581|NCT04246697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5531582|NCT04246697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6118394|NCT01097785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6118395|NCT01097785|Antimetabolites|antimetabolites|mesh-ancestor
6118396|NCT01097785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118397|NCT01097785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6118398|NCT01097785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6118399|NCT01097785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5531583|NCT04246697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5531584|NCT04246697|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5531585|NCT04246697|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5531586|NCT04246697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6118400|NCT01098032|Acetylcysteine|acetylcysteine|mesh-list
6118401|NCT01098032|Antiviral Agents|antiviral agents|mesh-ancestor
6118402|NCT01098032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6118403|NCT01098032|Expectorants|expectorants|mesh-ancestor
6118404|NCT01098032|Respiratory System Agents|respiratory system agents|mesh-ancestor
6118405|NCT01098032|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6118406|NCT01098032|Antioxidants|antioxidants|mesh-ancestor
6118407|NCT01098032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118408|NCT01098032|Protective Agents|protective agents|mesh-ancestor
5531587|NCT04246697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531588|NCT04246697|Antimanic Agents|antimanic agents|mesh-ancestor
5531589|NCT04246697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5531590|NCT04246697|Antipyretics|antipyretics|mesh-ancestor
5531591|NCT04246697|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5531592|NCT04246697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5531593|NCT04246697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5531594|NCT04246697|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5531595|NCT04246697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5531596|NCT04246502|Capecitabine|capecitabine|mesh-list
5531597|NCT04246502|Trastuzumab|trastuzumab|mesh-list
5531598|NCT04246502|Pertuzumab|pertuzumab|mesh-list
5531599|NCT04246502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5531600|NCT04246502|Antimetabolites|antimetabolites|mesh-ancestor
6118409|NCT01098032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118410|NCT01098097|Ribavirin|ribavirin|mesh-list
6118411|NCT01098097|Antimetabolites|antimetabolites|mesh-ancestor
6118412|NCT01098097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118413|NCT01098097|Antiviral Agents|antiviral agents|mesh-ancestor
6118414|NCT01098097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6118415|NCT01098305|Varenicline|varenicline|mesh-list
6118416|NCT01098305|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6118417|NCT01098305|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6118418|NCT01098305|Cholinergic Agents|cholinergic agents|mesh-ancestor
6118419|NCT01098305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6118420|NCT01098305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118421|NCT01098305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118422|NCT01098318|Sertraline|sertraline|mesh-list
6118423|NCT01098318|Antidepressive Agents|antidepressive agents|mesh-ancestor
6118424|NCT01098318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6118425|NCT01098318|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6118426|NCT01098318|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6118427|NCT01098318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6118428|NCT01098318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118429|NCT01098318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6118430|NCT01098318|Serotonin Agents|serotonin agents|mesh-ancestor
6118431|NCT01098318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118432|NCT01098461|rGLP-1 protein|rglp-1 protein|mesh-list
6118433|NCT01098461|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5531601|NCT04246502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531602|NCT04246502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5531603|NCT04246502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5531604|NCT04246437|Carbidopa|carbidopa|mesh-list
5531605|NCT04246437|Entacapone|entacapone|mesh-list
5531606|NCT04246437|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5531607|NCT04246437|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5531608|NCT04246437|Dopamine Agents|dopamine agents|mesh-ancestor
5531609|NCT04246437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5531610|NCT04246437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531611|NCT04246437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118434|NCT01098461|Incretins|incretins|mesh-ancestor
6118435|NCT01098461|Hormones|hormones|mesh-ancestor
6118436|NCT01098461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6118437|NCT01098461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118438|NCT01098474|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6118439|NCT01098474|Immunologic Factors|immunologic factors|mesh-ancestor
6118440|NCT01098474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118441|NCT01098539|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6118442|NCT01098539|rGLP-1 protein|rglp-1 protein|mesh-list
6118443|NCT01098539|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6118444|NCT01098539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118445|NCT01098539|Incretins|incretins|mesh-ancestor
6118446|NCT01098539|Hormones|hormones|mesh-ancestor
5531612|NCT04246437|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5531613|NCT04246437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5531614|NCT04246437|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
5531615|NCT04246255|Lidocaine|lidocaine|mesh-list
5531616|NCT04246255|Anesthetics, Local|anesthetics, local|mesh-ancestor
5531617|NCT04246255|Anesthetics|anesthetics|mesh-ancestor
5531618|NCT04246255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5531619|NCT04246255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531620|NCT04246255|Sensory System Agents|sensory system agents|mesh-ancestor
5531621|NCT04246255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5531622|NCT04246255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5531623|NCT04246255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5531624|NCT04246255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5531625|NCT04246255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5531626|NCT04246255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531627|NCT04246229|Bilirubin|bilirubin|mesh-list
5531628|NCT04246229|Antioxidants|antioxidants|mesh-ancestor
5531629|NCT04246229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531630|NCT04246229|Protective Agents|protective agents|mesh-ancestor
5531631|NCT04246229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531632|NCT04246359|Interferons|interferons|mesh-list
5531633|NCT04246359|Rituximab|rituximab|mesh-list
5531634|NCT04246359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5531635|NCT04246359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5531636|NCT04246359|Immunologic Factors|immunologic factors|mesh-ancestor
5531637|NCT04246359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531638|NCT04246359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5531639|NCT04246359|Antiviral Agents|antiviral agents|mesh-ancestor
5531640|NCT04246359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5531641|NCT04245787|Fluorides|fluorides|mesh-list
5531642|NCT04245787|Cariostatic Agents|cariostatic agents|mesh-ancestor
5531643|NCT04245787|Protective Agents|protective agents|mesh-ancestor
5531644|NCT04245787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531645|NCT04245774|Bupivacaine|bupivacaine|mesh-list
5531646|NCT04245774|Levobupivacaine|levobupivacaine|mesh-list
5531647|NCT04245774|Anesthetics, Local|anesthetics, local|mesh-ancestor
5531648|NCT04245774|Anesthetics|anesthetics|mesh-ancestor
5531649|NCT04245774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5531650|NCT04245774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531651|NCT04245774|Sensory System Agents|sensory system agents|mesh-ancestor
5531652|NCT04245774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5531653|NCT04245371|Lidocaine|lidocaine|mesh-list
5531654|NCT04245371|Anesthetics, Local|anesthetics, local|mesh-ancestor
5531655|NCT04245371|Anesthetics|anesthetics|mesh-ancestor
5531656|NCT04245371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5531657|NCT04245371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531658|NCT04245371|Sensory System Agents|sensory system agents|mesh-ancestor
5531659|NCT04245371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5531660|NCT04245371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5531661|NCT04245371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5531662|NCT04245371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6118447|NCT01098539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6118448|NCT01098539|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6118449|NCT01098539|Protease Inhibitors|protease inhibitors|mesh-ancestor
6118450|NCT01098539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6118451|NCT01098539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118452|NCT01098747|Ibuprofen|ibuprofen|mesh-list
6118453|NCT01098747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6118454|NCT01098747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6118455|NCT01098747|Analgesics|analgesics|mesh-ancestor
6118456|NCT01098747|Sensory System Agents|sensory system agents|mesh-ancestor
6118457|NCT01098747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6118458|NCT01098747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118459|NCT01098747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6118460|NCT01098747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6118461|NCT01098747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6118462|NCT01098747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6118463|NCT01098747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118464|NCT01099202|Epoetin Alfa|epoetin alfa|mesh-list
6118465|NCT01099202|Hematinics|hematinics|mesh-ancestor
6118466|NCT01099358|Fluorouracil|fluorouracil|mesh-list
6118467|NCT01099358|Cetuximab|cetuximab|mesh-list
6118468|NCT01099358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6118469|NCT01099358|Antimetabolites|antimetabolites|mesh-ancestor
6118470|NCT01099358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118471|NCT01099358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6118472|NCT01099358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6118473|NCT01099358|Immunologic Factors|immunologic factors|mesh-ancestor
6118474|NCT01099358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531663|NCT04245371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5531664|NCT04245371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531665|NCT04245722|Cyclophosphamide|cyclophosphamide|mesh-list
5531666|NCT04245722|Rituximab|rituximab|mesh-list
5531667|NCT04245722|Fludarabine|fludarabine|mesh-list
5531668|NCT04245722|Obinutuzumab|obinutuzumab|mesh-list
6118475|NCT01099358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6118476|NCT01099449|Oxaliplatin|oxaliplatin|mesh-list
6118477|NCT01099449|Magnesium Sulfate|magnesium sulfate|mesh-list
5531669|NCT04245722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6118478|NCT01099449|Calcium|calcium|mesh-list
6118479|NCT01099449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6118480|NCT01099449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118481|NCT01099449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6118482|NCT01099449|Analgesics|analgesics|mesh-ancestor
6118483|NCT01099449|Sensory System Agents|sensory system agents|mesh-ancestor
6118484|NCT01099449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6118485|NCT01099449|Anesthetics|anesthetics|mesh-ancestor
6118486|NCT01099449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6118487|NCT01099449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6118488|NCT01099449|Anticonvulsants|anticonvulsants|mesh-ancestor
6118489|NCT01099449|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6118490|NCT01099449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6118491|NCT01099449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118492|NCT01099449|Tocolytic Agents|tocolytic agents|mesh-ancestor
6118493|NCT01099449|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6118494|NCT01099579|Ritonavir|ritonavir|mesh-list
6118495|NCT01099579|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6118496|NCT01099579|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6118497|NCT01099579|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6118498|NCT01099579|Protease Inhibitors|protease inhibitors|mesh-ancestor
6118499|NCT01099579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6118500|NCT01099579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118501|NCT01099579|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6118502|NCT01099579|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6118503|NCT01099579|Antiviral Agents|antiviral agents|mesh-ancestor
6118504|NCT01099579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6118505|NCT01099579|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6118506|NCT01099579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6118507|NCT01099618|Metformin|metformin|mesh-list
6118508|NCT01099618|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6118509|NCT01099618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6118510|NCT01099618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118511|NCT01099618|Incretins|incretins|mesh-ancestor
6118512|NCT01099618|Hormones|hormones|mesh-ancestor
6118513|NCT01099618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6118514|NCT01099618|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6118515|NCT01099618|Protease Inhibitors|protease inhibitors|mesh-ancestor
6118516|NCT01099618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6118517|NCT01099618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118518|NCT01099709|Oxycodone|oxycodone|mesh-list
6118519|NCT01099709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6118520|NCT01099709|Narcotics|narcotics|mesh-ancestor
6118521|NCT01099709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6118522|NCT01099709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118523|NCT01099709|Analgesics|analgesics|mesh-ancestor
6118524|NCT01099709|Sensory System Agents|sensory system agents|mesh-ancestor
6118525|NCT01099709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6118526|NCT01099774|Bimatoprost|bimatoprost|mesh-list
6118527|NCT01099774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6118528|NCT01099774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6118529|NCT01099774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6118530|NCT01100034|Etanercept|etanercept|mesh-list
6118531|NCT01100034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6118532|NCT01100034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6118533|NCT01100034|Analgesics|analgesics|mesh-ancestor
6118534|NCT01100034|Sensory System Agents|sensory system agents|mesh-ancestor
6118535|NCT01100034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6118536|NCT01100034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118537|NCT01100034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6118538|NCT01100034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6118539|NCT01100034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6118540|NCT01100034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6118541|NCT01100034|Immunologic Factors|immunologic factors|mesh-ancestor
6465791|NCT00476073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465792|NCT00476099|Budesonide|budesonide|mesh-list
6465793|NCT00476099|Beclomethasone|beclomethasone|mesh-list
6118542|NCT01100086|Oxycodone|oxycodone|mesh-list
5531670|NCT04245722|Immunologic Factors|immunologic factors|mesh-ancestor
5531671|NCT04245722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531672|NCT04245722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5531673|NCT04245722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5531674|NCT04245722|Alkylating Agents|alkylating agents|mesh-ancestor
5531675|NCT04245722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531676|NCT04245722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5531677|NCT04245722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5531678|NCT04245722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5531679|NCT04245618|Gemcitabine|gemcitabine|mesh-list
5531680|NCT04245618|Cisplatin|cisplatin|mesh-list
5531681|NCT04245618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5531682|NCT04245618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5531683|NCT04245618|Antimetabolites|antimetabolites|mesh-ancestor
5531684|NCT04245618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531685|NCT04245618|Antiviral Agents|antiviral agents|mesh-ancestor
5531686|NCT04245618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5531687|NCT04245618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5531688|NCT04245618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5531689|NCT04245618|Immunologic Factors|immunologic factors|mesh-ancestor
5531690|NCT04245618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531691|NCT04245709|Clenbuterol|clenbuterol|mesh-list
5531692|NCT04245709|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5531693|NCT04245709|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5531694|NCT04245709|Adrenergic Agents|adrenergic agents|mesh-ancestor
5531695|NCT04245709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5531696|NCT04245709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531697|NCT04245709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118543|NCT01100086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6118544|NCT01100086|Narcotics|narcotics|mesh-ancestor
6118545|NCT01100086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6118546|NCT01100086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118547|NCT01100086|Analgesics|analgesics|mesh-ancestor
6118548|NCT01100086|Sensory System Agents|sensory system agents|mesh-ancestor
6118549|NCT01100086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6118550|NCT01100112|Budesonide|budesonide|mesh-list
6118551|NCT01100112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6118552|NCT01100112|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6118553|NCT01100112|Autonomic Agents|autonomic agents|mesh-ancestor
6118554|NCT01100112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6118555|NCT01100112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118556|NCT01100112|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6118557|NCT01100112|Respiratory System Agents|respiratory system agents|mesh-ancestor
6118558|NCT01100112|Glucocorticoids|glucocorticoids|mesh-ancestor
6118559|NCT01100112|Hormones|hormones|mesh-ancestor
6118560|NCT01100112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6118561|NCT01100242|Bortezomib|bortezomib|mesh-list
6118562|NCT01100242|Sorafenib|sorafenib|mesh-list
6118563|NCT01100242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6118564|NCT01100242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6118565|NCT01100242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6118566|NCT01100242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118567|NCT01100255|Ketamine|ketamine|mesh-list
6118568|NCT01100255|Analgesics|analgesics|mesh-ancestor
6118569|NCT01100255|Sensory System Agents|sensory system agents|mesh-ancestor
6118570|NCT01100255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6118571|NCT01100255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118572|NCT01100255|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6118573|NCT01100255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6118574|NCT01100255|Anesthetics, General|anesthetics, general|mesh-ancestor
6118575|NCT01100255|Anesthetics|anesthetics|mesh-ancestor
6118576|NCT01100255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6118577|NCT01100255|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6118578|NCT01100255|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6118579|NCT01100255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6118580|NCT01100255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118581|NCT01100268|Methylphenidate|methylphenidate|mesh-list
6118582|NCT01100268|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6118583|NCT01100268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118584|NCT01100268|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6118585|NCT01100268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6465794|NCT00476099|Formoterol Fumarate|formoterol fumarate|mesh-list
6118586|NCT01100268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6118587|NCT01100268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118588|NCT01100268|Dopamine Agents|dopamine agents|mesh-ancestor
6118589|NCT01100268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6118590|NCT01100320|Oxycodone|oxycodone|mesh-list
6118591|NCT01100320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6118592|NCT01100320|Narcotics|narcotics|mesh-ancestor
6118593|NCT01100320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6118594|NCT01100320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118595|NCT01100320|Analgesics|analgesics|mesh-ancestor
5531698|NCT04245709|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5531699|NCT04245709|Autonomic Agents|autonomic agents|mesh-ancestor
5531700|NCT04245709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5531701|NCT04245709|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5531702|NCT04245709|Respiratory System Agents|respiratory system agents|mesh-ancestor
5531703|NCT04245709|Sympathomimetics|sympathomimetics|mesh-ancestor
5531704|NCT04245644|Aspirin|aspirin|mesh-list
5531705|NCT04245644|Metformin|metformin|mesh-list
5531706|NCT04245644|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6118596|NCT01100320|Sensory System Agents|sensory system agents|mesh-ancestor
6118597|NCT01100320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6118598|NCT01100437|Naltrexone|naltrexone|mesh-list
6118599|NCT01100437|Morphine|morphine|mesh-list
6118600|NCT01100437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6118601|NCT01100437|Narcotics|narcotics|mesh-ancestor
6118602|NCT01100437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6118603|NCT01100437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118604|NCT01100437|Analgesics|analgesics|mesh-ancestor
6118605|NCT01100437|Sensory System Agents|sensory system agents|mesh-ancestor
6118606|NCT01100437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6118607|NCT01100437|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6118608|NCT01100437|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6118609|NCT01100502|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6118610|NCT01100502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6118611|NCT01100502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6118612|NCT01100528|Interferons|interferons|mesh-list
6118613|NCT01100528|Interferon-alpha|interferon-alpha|mesh-list
6118614|NCT01100528|Interferon alpha-2|interferon alpha-2|mesh-list
6118615|NCT01100528|Dacarbazine|dacarbazine|mesh-list
6118616|NCT01100528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6118617|NCT01100528|Antiviral Agents|antiviral agents|mesh-ancestor
6118618|NCT01100528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6118619|NCT01100528|Immunologic Factors|immunologic factors|mesh-ancestor
6118620|NCT01100528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118621|NCT01100528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6118622|NCT01100528|Alkylating Agents|alkylating agents|mesh-ancestor
6118623|NCT01100528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118624|NCT01100606|Pancrelipase|pancrelipase|mesh-list
6118625|NCT01100606|Pancreatin|pancreatin|mesh-list
6118626|NCT01100606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6118627|NCT01100723|Vitamin D|vitamin d|mesh-list
6118628|NCT01100723|Calcitriol|calcitriol|mesh-list
6118629|NCT01100723|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
6118630|NCT01100723|Cinacalcet|cinacalcet|mesh-list
6118631|NCT01100723|Vitamins|vitamins|mesh-ancestor
6118632|NCT01100723|Micronutrients|micronutrients|mesh-ancestor
6118633|NCT01100723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118634|NCT01100723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6118635|NCT01100723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6118636|NCT01100723|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6118637|NCT01100723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6118638|NCT01100723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666107|NCT01520766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6666108|NCT01520766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531707|NCT04245644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6118639|NCT01100723|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6118640|NCT01100723|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6118641|NCT01100723|Hormone Antagonists|hormone antagonists|mesh-ancestor
6118642|NCT01100723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6118643|NCT01100853|Naltrexone|naltrexone|mesh-list
6118644|NCT01100853|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6118645|NCT01100853|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6118646|NCT01100853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118647|NCT01100853|Sensory System Agents|sensory system agents|mesh-ancestor
6118648|NCT01100853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6118649|NCT01100931|Paclitaxel|paclitaxel|mesh-list
6118650|NCT01100931|Carboplatin|carboplatin|mesh-list
5531708|NCT04245644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531709|NCT04245644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5531710|NCT04245644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6118651|NCT01100931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6118652|NCT01100931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6118653|NCT01100931|Tubulin Modulators|tubulin modulators|mesh-ancestor
6118654|NCT01100931|Antimitotic Agents|antimitotic agents|mesh-ancestor
6118655|NCT01100931|Mitosis Modulators|mitosis modulators|mesh-ancestor
6118656|NCT01100931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118657|NCT01100944|Cyclophosphamide|cyclophosphamide|mesh-list
6666109|NCT01520766|Adrenergic Agents|adrenergic agents|mesh-ancestor
6666110|NCT01520766|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6666111|NCT01520766|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6666112|NCT01520766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6666113|NCT01520766|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6666114|NCT01520792|Acetaminophen|acetaminophen|mesh-list
5531711|NCT04245644|Analgesics|analgesics|mesh-ancestor
6118658|NCT01100944|Doxorubicin|doxorubicin|mesh-list
6118659|NCT01100944|Belinostat|belinostat|mesh-list
6118660|NCT01100944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6118661|NCT01100944|Immunologic Factors|immunologic factors|mesh-ancestor
6118662|NCT01100944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118663|NCT01100944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6118664|NCT01100944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6118665|NCT01100944|Alkylating Agents|alkylating agents|mesh-ancestor
5531712|NCT04245644|Sensory System Agents|sensory system agents|mesh-ancestor
5531713|NCT04245644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5531714|NCT04245644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5531715|NCT04245644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5531716|NCT04245644|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5531717|NCT04245644|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5531718|NCT04245644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118666|NCT01100944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118667|NCT01100944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6118668|NCT01100944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6118669|NCT01100944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6118670|NCT01100944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6118671|NCT01100944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6118672|NCT01100944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6118673|NCT01100944|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6118674|NCT01101022|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6118675|NCT01101022|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6118676|NCT01101022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118677|NCT01101022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5531719|NCT04245644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5531720|NCT04245644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5531721|NCT04245644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5531722|NCT04245644|Antipyretics|antipyretics|mesh-ancestor
5531723|NCT04245644|Protease Inhibitors|protease inhibitors|mesh-ancestor
5601543|NCT05176418|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6118678|NCT01101022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6118679|NCT01101022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6118680|NCT01101022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118681|NCT01101022|Dopamine Agents|dopamine agents|mesh-ancestor
6118682|NCT01101022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6118683|NCT01101035|Allopurinol|allopurinol|mesh-list
6118684|NCT01101035|Febuxostat|febuxostat|mesh-list
6118685|NCT01101035|Antimetabolites|antimetabolites|mesh-ancestor
6118686|NCT01101035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601544|NCT05176418|Cholinergic Agents|cholinergic agents|mesh-ancestor
5601545|NCT05176418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5601546|NCT05176418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601547|NCT05176379|Fluconazole|fluconazole|mesh-list
5601548|NCT05176379|Antifungal Agents|antifungal agents|mesh-ancestor
5601549|NCT05176379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5601550|NCT05176379|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5601551|NCT05176379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5601552|NCT05176379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5601553|NCT05176379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601554|NCT05176379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5601555|NCT05176379|Hormone Antagonists|hormone antagonists|mesh-ancestor
6118687|NCT01101035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6118688|NCT01101035|Gout Suppressants|gout suppressants|mesh-ancestor
6118689|NCT01101035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6118690|NCT01101035|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6118691|NCT01101035|Antioxidants|antioxidants|mesh-ancestor
6118692|NCT01101035|Protective Agents|protective agents|mesh-ancestor
6118693|NCT01101035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118694|NCT01101100|Brodalumab|brodalumab|mesh-list
6118695|NCT01101100|Dermatologic Agents|dermatologic agents|mesh-ancestor
6118696|NCT01101165|Oxycodone|oxycodone|mesh-list
6118697|NCT01101165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6118698|NCT01101165|Narcotics|narcotics|mesh-ancestor
6118699|NCT01101165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6118700|NCT01101165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118701|NCT01101165|Analgesics|analgesics|mesh-ancestor
6118702|NCT01101165|Sensory System Agents|sensory system agents|mesh-ancestor
6118703|NCT01101165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6118704|NCT01101178|Oxycodone|oxycodone|mesh-list
6118705|NCT01101178|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6118706|NCT01101178|Narcotics|narcotics|mesh-ancestor
6118707|NCT01101178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6118708|NCT01101178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118709|NCT01101178|Analgesics|analgesics|mesh-ancestor
6118710|NCT01101178|Sensory System Agents|sensory system agents|mesh-ancestor
6118711|NCT01101178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6118712|NCT01101191|Oxycodone|oxycodone|mesh-list
6118713|NCT01101191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6118714|NCT01101191|Narcotics|narcotics|mesh-ancestor
6118715|NCT01101191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6118716|NCT01101191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118717|NCT01101191|Analgesics|analgesics|mesh-ancestor
6118718|NCT01101191|Sensory System Agents|sensory system agents|mesh-ancestor
6118719|NCT01101191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6118720|NCT01101308|Oxycodone|oxycodone|mesh-list
6118721|NCT01101308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6118722|NCT01101308|Narcotics|narcotics|mesh-ancestor
6118723|NCT01101308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6118724|NCT01101308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118725|NCT01101308|Analgesics|analgesics|mesh-ancestor
5531724|NCT04246151|Vancomycin|vancomycin|mesh-list
5531725|NCT04246151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5531726|NCT04246151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5531727|NCT04245046|Amlodipine|amlodipine|mesh-list
5531728|NCT04245046|Candesartan|candesartan|mesh-list
5531729|NCT04245046|Atorvastatin|atorvastatin|mesh-list
5531730|NCT04245046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6118726|NCT01101308|Sensory System Agents|sensory system agents|mesh-ancestor
5725481|NCT03180125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5725482|NCT03180125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5725483|NCT03180125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725484|NCT03180125|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6118727|NCT01101308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6118728|NCT01101321|Oxycodone|oxycodone|mesh-list
6118729|NCT01101321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6118730|NCT01101321|Narcotics|narcotics|mesh-ancestor
6118731|NCT01101321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6118732|NCT01101321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118733|NCT01101321|Analgesics|analgesics|mesh-ancestor
6118734|NCT01101321|Sensory System Agents|sensory system agents|mesh-ancestor
6118735|NCT01101321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6118736|NCT01101334|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6118737|NCT01101334|Efatutazone|efatutazone|mesh-list
6118738|NCT01101334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6118739|NCT01101334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6118740|NCT01101334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6118741|NCT01101334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204536|NCT02072226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204537|NCT02072226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6204538|NCT02072226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6204539|NCT02072226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6204540|NCT02072226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6204541|NCT02072226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204542|NCT02072226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6204543|NCT02072226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6204544|NCT02072226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5531731|NCT04245046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5531732|NCT04245046|Antimetabolites|antimetabolites|mesh-ancestor
6118742|NCT01101750|Vaccines|vaccines|mesh-list
6118743|NCT01101750|Immunologic Factors|immunologic factors|mesh-ancestor
6118744|NCT01101750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118745|NCT01101841|Paroxetine|paroxetine|mesh-list
6118746|NCT01101841|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6118747|NCT01101841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6118748|NCT01101841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6118749|NCT01101841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118750|NCT01101841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6118751|NCT01101841|Serotonin Agents|serotonin agents|mesh-ancestor
6118752|NCT01101841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118753|NCT01101841|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6118754|NCT01101841|Antidepressive Agents|antidepressive agents|mesh-ancestor
6118755|NCT01101841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6118756|NCT01101841|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6118757|NCT01101841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6118758|NCT01101841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6118759|NCT01101867|Insulin Aspart|insulin aspart|mesh-list
6118760|NCT01101867|Insulin, Long-Acting|insulin, long-acting|mesh-list
6118761|NCT01101867|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6118762|NCT01101867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6118763|NCT01101867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118764|NCT01101880|Cytarabine|cytarabine|mesh-list
6118765|NCT01101880|Clofarabine|clofarabine|mesh-list
6118766|NCT01101880|Immunologic Factors|immunologic factors|mesh-ancestor
6118767|NCT01101880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118768|NCT01101880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6118769|NCT01101880|Antimetabolites|antimetabolites|mesh-ancestor
6118770|NCT01101880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118771|NCT01101880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6118772|NCT01101880|Antiviral Agents|antiviral agents|mesh-ancestor
6118773|NCT01101880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6118774|NCT01101880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6118775|NCT01102218|Pentoxifylline|pentoxifylline|mesh-list
6118776|NCT01102218|Epoetin Alfa|epoetin alfa|mesh-list
6118777|NCT01102218|Hematinics|hematinics|mesh-ancestor
6118778|NCT01102218|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6118779|NCT01102218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6118780|NCT01102218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118781|NCT01102218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5531733|NCT04245046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531734|NCT04245046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5531735|NCT04245046|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5531736|NCT04245046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5531737|NCT04245046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5531738|NCT04245046|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5531739|NCT04245046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5531740|NCT04245046|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5531741|NCT04245046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531742|NCT04245046|Vasodilator Agents|vasodilator agents|mesh-ancestor
5531743|NCT04245046|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5531744|NCT04245046|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6118782|NCT01102218|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6118783|NCT01102218|Protective Agents|protective agents|mesh-ancestor
5531747|NCT04245319|Acitretin|acitretin|mesh-list
5531748|NCT04245319|Keratolytic Agents|keratolytic agents|mesh-ancestor
5531749|NCT04245319|Dermatologic Agents|dermatologic agents|mesh-ancestor
5531750|NCT04244981|Thrombin|thrombin|mesh-list
5531751|NCT04244981|Hemostatics|hemostatics|mesh-ancestor
5531752|NCT04244981|Coagulants|coagulants|mesh-ancestor
6118784|NCT01102218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118785|NCT01102218|Vasodilator Agents|vasodilator agents|mesh-ancestor
6118786|NCT01102218|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6118787|NCT01102218|Antioxidants|antioxidants|mesh-ancestor
6118788|NCT01102231|Cetuximab|cetuximab|mesh-list
6118789|NCT01102231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6118790|NCT01102231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6118791|NCT01102270|Eszopiclone|eszopiclone|mesh-list
6118792|NCT01102270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6118793|NCT01102270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6465795|NCT00476099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5531753|NCT04245280|Ropivacaine|ropivacaine|mesh-list
5531754|NCT04245280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5531755|NCT04245280|Anesthetics, Local|anesthetics, local|mesh-ancestor
5531756|NCT04245280|Anesthetics|anesthetics|mesh-ancestor
5531757|NCT04245280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5531758|NCT04245280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531759|NCT04245280|Sensory System Agents|sensory system agents|mesh-ancestor
6118794|NCT01102270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118795|NCT01102374|Vitamin D|vitamin d|mesh-list
6118796|NCT01102374|Ergocalciferols|ergocalciferols|mesh-list
6118797|NCT01102374|Vitamins|vitamins|mesh-list
6118798|NCT01102374|Micronutrients|micronutrients|mesh-ancestor
6118799|NCT01102374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118800|NCT01102374|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6118801|NCT01102374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6118802|NCT01102426|Dexamethasone|dexamethasone|mesh-list
6118803|NCT01102426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6118804|NCT01102426|Antiemetics|antiemetics|mesh-ancestor
6118805|NCT01102426|Autonomic Agents|autonomic agents|mesh-ancestor
6118806|NCT01102426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6118807|NCT01102426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118808|NCT01102426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6118809|NCT01102426|Glucocorticoids|glucocorticoids|mesh-ancestor
6118810|NCT01102426|Hormones|hormones|mesh-ancestor
6118811|NCT01102426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6118812|NCT01102426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6118813|NCT01102426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6118814|NCT01102491|Ramosetron|ramosetron|mesh-list
6118815|NCT01102491|Antiemetics|antiemetics|mesh-ancestor
6118816|NCT01102491|Autonomic Agents|autonomic agents|mesh-ancestor
6118817|NCT01102491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6118818|NCT01102491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118819|NCT01102491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6118820|NCT01102491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6118821|NCT01102491|Serotonin Agents|serotonin agents|mesh-ancestor
6118822|NCT01102491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6118823|NCT01102491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118824|NCT01102803|Cycloserine|cycloserine|mesh-list
6118825|NCT01102803|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6118826|NCT01102803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6118827|NCT01102803|Renal Agents|renal agents|mesh-ancestor
6118828|NCT01102803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6118829|NCT01102803|Antitubercular Agents|antitubercular agents|mesh-ancestor
6118830|NCT01102803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6118831|NCT01102803|Antimetabolites|antimetabolites|mesh-ancestor
6118832|NCT01102803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118833|NCT01102972|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6118834|NCT01102972|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6118835|NCT01102972|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6118836|NCT01102972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6118837|NCT01102972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6118838|NCT01102972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118839|NCT01102972|Antiviral Agents|antiviral agents|mesh-ancestor
6118840|NCT01102972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6118841|NCT01102972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6118842|NCT01102972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5531760|NCT04245280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5531761|NCT04245033|Piperaquine|piperaquine|mesh-list
5531762|NCT04245033|Artenimol|artenimol|mesh-list
5531763|NCT04245033|Antimalarials|antimalarials|mesh-ancestor
5531764|NCT04245033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5531765|NCT04245033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6118843|NCT01102972|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6118844|NCT01102972|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6118845|NCT01102972|Protease Inhibitors|protease inhibitors|mesh-ancestor
6118846|NCT01103063|Azithromycin|azithromycin|mesh-list
6118847|NCT01103063|Chloroquine|chloroquine|mesh-list
6118848|NCT01103063|Pyrimethamine|pyrimethamine|mesh-list
6118849|NCT01103063|Sulfadoxine|sulfadoxine|mesh-list
6118850|NCT01103063|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6118851|NCT01103063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6118852|NCT01103063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6118853|NCT01103063|Amebicides|amebicides|mesh-ancestor
6118854|NCT01103063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6118855|NCT01103063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6118856|NCT01103063|Antimalarials|antimalarials|mesh-ancestor
6118857|NCT01103063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6118858|NCT01103063|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6465796|NCT00476099|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6465797|NCT00476099|Autonomic Agents|autonomic agents|mesh-ancestor
6465798|NCT00476099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6118859|NCT01103063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6118860|NCT01103063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118861|NCT01103063|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6118862|NCT01103063|Renal Agents|renal agents|mesh-ancestor
6118863|NCT01103245|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6118864|NCT01103245|Spironolactone|spironolactone|mesh-list
6118865|NCT01103245|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6118866|NCT01103245|Diuretics|diuretics|mesh-ancestor
6118867|NCT01103245|Natriuretic Agents|natriuretic agents|mesh-ancestor
6118868|NCT01103245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118869|NCT01103245|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6118870|NCT01103245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6118871|NCT01103245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118872|NCT01103245|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6118873|NCT01103245|Hormone Antagonists|hormone antagonists|mesh-ancestor
6118874|NCT01103245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6118875|NCT01103245|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6118876|NCT01103414|Pioglitazone|pioglitazone|mesh-list
6118877|NCT01103414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6118878|NCT01103414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118879|NCT01103440|polysaccharide-K|polysaccharide-k|mesh-list
6118880|NCT01103440|Tirofiban|tirofiban|mesh-list
6118881|NCT01103440|Ticlopidine|ticlopidine|mesh-list
6118882|NCT01103440|Abciximab|abciximab|mesh-list
6118883|NCT01103440|Clopidogrel|clopidogrel|mesh-list
6118884|NCT01103440|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6465799|NCT00476099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465800|NCT00476099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6118885|NCT01103440|Cangrelor|cangrelor|mesh-list
6118886|NCT01103440|Eptifibatide|eptifibatide|mesh-list
6118887|NCT01103440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6118888|NCT01103440|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6118889|NCT01103440|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6118890|NCT01103440|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6118891|NCT01103440|Purinergic Agents|purinergic agents|mesh-ancestor
6118892|NCT01103440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6118893|NCT01103440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118894|NCT01103440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118895|NCT01103440|Anticoagulants|anticoagulants|mesh-ancestor
6118896|NCT01103440|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6118897|NCT01103440|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6118898|NCT01103440|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6118899|NCT01103440|Immunologic Factors|immunologic factors|mesh-ancestor
6118900|NCT01103440|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6118901|NCT01103440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6118902|NCT01103440|Antiviral Agents|antiviral agents|mesh-ancestor
6118903|NCT01103440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6118904|NCT01103440|Interferon Inducers|interferon inducers|mesh-ancestor
6118905|NCT01103440|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6118906|NCT01103440|Protective Agents|protective agents|mesh-ancestor
6118907|NCT01103440|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6118908|NCT01103440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6118909|NCT01103440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6118910|NCT01103713|Azithromycin|azithromycin|mesh-list
6118911|NCT01103713|Chloroquine|chloroquine|mesh-list
6465801|NCT00476099|Respiratory System Agents|respiratory system agents|mesh-ancestor
6118912|NCT01103713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6118913|NCT01103713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6118914|NCT01103713|Amebicides|amebicides|mesh-ancestor
6118915|NCT01103713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6118916|NCT01103713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6118917|NCT01103713|Antimalarials|antimalarials|mesh-ancestor
6118918|NCT01103713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6118919|NCT01103778|Bortezomib|bortezomib|mesh-list
6118920|NCT01103778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6118921|NCT01103934|Vitamin D|vitamin d|mesh-list
6118922|NCT01103934|Cholecalciferol|cholecalciferol|mesh-list
6118923|NCT01103934|Fluticasone|fluticasone|mesh-list
6118924|NCT01103934|Xhance|xhance|mesh-list
6118925|NCT01103934|Vitamins|vitamins|mesh-ancestor
6118926|NCT01103934|Micronutrients|micronutrients|mesh-ancestor
6118927|NCT01103934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118928|NCT01103934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6118929|NCT01103934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6118930|NCT01103934|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6118931|NCT01103934|Autonomic Agents|autonomic agents|mesh-ancestor
6118932|NCT01103934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6118933|NCT01103934|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6118934|NCT01103934|Respiratory System Agents|respiratory system agents|mesh-ancestor
6118935|NCT01103934|Dermatologic Agents|dermatologic agents|mesh-ancestor
6118936|NCT01103934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6118937|NCT01103934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6118938|NCT01103960|Amlodipine|amlodipine|mesh-list
6118939|NCT01103960|Telmisartan|telmisartan|mesh-list
6118940|NCT01103960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6118941|NCT01103960|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6118942|NCT01103960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6118943|NCT01103960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118944|NCT01103960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6118945|NCT01103960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118946|NCT01103960|Vasodilator Agents|vasodilator agents|mesh-ancestor
6118947|NCT01103960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6118948|NCT01103960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6118949|NCT01104025|Dexamethasone|dexamethasone|mesh-list
6118950|NCT01104025|Hydrocortisone|hydrocortisone|mesh-list
6118951|NCT01104025|Methotrexate|methotrexate|mesh-list
6118952|NCT01104025|Etoposide|etoposide|mesh-list
6118953|NCT01104025|Thymoglobulin|thymoglobulin|mesh-list
6118954|NCT01104025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6118955|NCT01104025|Antiemetics|antiemetics|mesh-ancestor
6118956|NCT01104025|Autonomic Agents|autonomic agents|mesh-ancestor
6118957|NCT01104025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6118958|NCT01104025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118959|NCT01104025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6118960|NCT01104025|Glucocorticoids|glucocorticoids|mesh-ancestor
6118961|NCT01104025|Hormones|hormones|mesh-ancestor
6118962|NCT01104025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5531766|NCT04245033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5531767|NCT04244695|Dexamethasone|dexamethasone|mesh-list
6118963|NCT01104025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6118964|NCT01104025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6118965|NCT01104025|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6118966|NCT01104025|Abortifacient Agents|abortifacient agents|mesh-ancestor
6118967|NCT01104025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6118968|NCT01104025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6118969|NCT01104025|Antimetabolites|antimetabolites|mesh-ancestor
6118970|NCT01104025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118971|NCT01104025|Dermatologic Agents|dermatologic agents|mesh-ancestor
6118972|NCT01104025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6118973|NCT01104025|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6118974|NCT01104025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6118975|NCT01104025|Immunologic Factors|immunologic factors|mesh-ancestor
6118976|NCT01104025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6204545|NCT02072226|Antipyretics|antipyretics|mesh-ancestor
6465802|NCT00476099|Glucocorticoids|glucocorticoids|mesh-ancestor
6118977|NCT01104025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6118978|NCT01104025|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6118979|NCT01104025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6118980|NCT01104025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6118981|NCT01104155|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6118982|NCT01104155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6118983|NCT01104155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6118984|NCT01104155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6118985|NCT01104155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118986|NCT01104246|Testosterone|testosterone|mesh-list
6118987|NCT01104246|Androgens|androgens|mesh-ancestor
6118988|NCT01104246|Hormones|hormones|mesh-ancestor
6118989|NCT01104246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6118990|NCT01104246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6118991|NCT01104376|Efavirenz|efavirenz|mesh-list
6118992|NCT01104376|Voriconazole|voriconazole|mesh-list
6118993|NCT01104376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6118994|NCT01104376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6118995|NCT01104376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6118996|NCT01104376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6118997|NCT01104376|Antiviral Agents|antiviral agents|mesh-ancestor
6118998|NCT01104376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6118999|NCT01104376|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6119000|NCT01104376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6119001|NCT01104376|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6119002|NCT01104376|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6119003|NCT01104376|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6119004|NCT01104376|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6119005|NCT01104376|Antifungal Agents|antifungal agents|mesh-ancestor
6119006|NCT01104376|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6119007|NCT01104376|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6119008|NCT01104376|Hormone Antagonists|hormone antagonists|mesh-ancestor
6119009|NCT01104376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6119010|NCT01104376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119011|NCT01104376|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6119012|NCT01104558|Bisoprolol|bisoprolol|mesh-list
6119013|NCT01104558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6119014|NCT01104558|Sympatholytics|sympatholytics|mesh-ancestor
6119015|NCT01104558|Autonomic Agents|autonomic agents|mesh-ancestor
6119016|NCT01104558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6119017|NCT01104558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119018|NCT01104558|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6119019|NCT01104558|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6119020|NCT01104558|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6119021|NCT01104558|Adrenergic Agents|adrenergic agents|mesh-ancestor
6119022|NCT01104558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6119023|NCT01104558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119024|NCT01104636|Varenicline|varenicline|mesh-list
6119025|NCT01104636|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6119026|NCT01104636|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6119027|NCT01104636|Cholinergic Agents|cholinergic agents|mesh-ancestor
6119028|NCT01104636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6119029|NCT01104636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119030|NCT01104636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119031|NCT01104662|Vancomycin|vancomycin|mesh-list
6119032|NCT01104662|Daptomycin|daptomycin|mesh-list
6119033|NCT01104662|Penicillins|penicillins|mesh-list
6119034|NCT01104662|Cloxacillin|cloxacillin|mesh-list
6119035|NCT01104662|Oxacillin|oxacillin|mesh-list
6119036|NCT01104662|Nafcillin|nafcillin|mesh-list
6119037|NCT01104662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6119038|NCT01104662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6119039|NCT01104701|Exenatide|exenatide|mesh-list
6119040|NCT01104701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6119041|NCT01104701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119042|NCT01104701|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6119043|NCT01104701|Incretins|incretins|mesh-ancestor
6119044|NCT01104701|Hormones|hormones|mesh-ancestor
6119045|NCT01104701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6119046|NCT01104766|Aripiprazole|aripiprazole|mesh-list
6119047|NCT01104766|Cariprazine|cariprazine|mesh-list
6119048|NCT01104766|Antidepressive Agents|antidepressive agents|mesh-ancestor
6119049|NCT01104766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6119050|NCT01104766|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6119051|NCT01104766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6119052|NCT01104766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6119053|NCT01104766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119054|NCT01104766|Dopamine Agonists|dopamine agonists|mesh-ancestor
6119055|NCT01104766|Dopamine Agents|dopamine agents|mesh-ancestor
6119056|NCT01104766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6119057|NCT01104766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119058|NCT01104766|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6119059|NCT01104766|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6119060|NCT01104766|Serotonin Agents|serotonin agents|mesh-ancestor
6119061|NCT01104766|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6119062|NCT01104766|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6119063|NCT01104766|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6119064|NCT01104766|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6119065|NCT01104779|Cariprazine|cariprazine|mesh-list
6119066|NCT01104779|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6119067|NCT01104779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6119068|NCT01104779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6119069|NCT01104779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119070|NCT01104779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6119071|NCT01104792|Cariprazine|cariprazine|mesh-list
6119072|NCT01104792|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6119073|NCT01104792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6119074|NCT01104792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6119075|NCT01104792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531768|NCT04244695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5531769|NCT04244695|Antiemetics|antiemetics|mesh-ancestor
5531770|NCT04244695|Autonomic Agents|autonomic agents|mesh-ancestor
5531771|NCT04244695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5531772|NCT04244695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531773|NCT04244695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5531774|NCT04244695|Glucocorticoids|glucocorticoids|mesh-ancestor
5531775|NCT04244695|Hormones|hormones|mesh-ancestor
5531776|NCT04244695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5531777|NCT04244695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5531778|NCT04244695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5531779|NCT04244591|Methylprednisolone|methylprednisolone|mesh-list
5531780|NCT04244591|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5531781|NCT04244591|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5531782|NCT04244591|Prednisolone|prednisolone|mesh-list
5531783|NCT04244591|Prednisolone acetate|prednisolone acetate|mesh-list
6119076|NCT01104792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6119077|NCT01104870|Treprostinil|treprostinil|mesh-list
6119078|NCT01104870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6119079|NCT01105065|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6119080|NCT01105065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6119081|NCT01105065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6119082|NCT01105065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6119083|NCT01105065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6119084|NCT01105065|Adrenergic Agents|adrenergic agents|mesh-ancestor
6119085|NCT01105065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6119086|NCT01105065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119087|NCT01105065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119088|NCT01105091|Epoprostenol|epoprostenol|mesh-list
6119089|NCT01105091|Tezosentan|tezosentan|mesh-list
6119090|NCT01105091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6119091|NCT01105091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6119092|NCT01105091|Vasodilator Agents|vasodilator agents|mesh-ancestor
6119093|NCT01105117|Epoprostenol|epoprostenol|mesh-list
6119094|NCT01105117|Tezosentan|tezosentan|mesh-list
6119095|NCT01105117|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6119096|NCT01105117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6119097|NCT01105117|Vasodilator Agents|vasodilator agents|mesh-ancestor
6119098|NCT01105312|Letrozole|letrozole|mesh-list
6119099|NCT01105312|Panobinostat|panobinostat|mesh-list
6119100|NCT01105312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6119101|NCT01105312|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6119102|NCT01105312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6119103|NCT01105312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6119104|NCT01105312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119105|NCT01105312|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6119106|NCT01105312|Hormone Antagonists|hormone antagonists|mesh-ancestor
6119107|NCT01105312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6204546|NCT02072434|Enoxaparin|enoxaparin|mesh-list
5531784|NCT04244591|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6465803|NCT00476099|Hormones|hormones|mesh-ancestor
6465804|NCT00476099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6465805|NCT00476099|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6465806|NCT00476099|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6465807|NCT00476099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6465808|NCT00476099|Adrenergic Agents|adrenergic agents|mesh-ancestor
5531785|NCT04244591|Prednisolone phosphate|prednisolone phosphate|mesh-list
5531786|NCT04244591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5531787|NCT04244591|Antiemetics|antiemetics|mesh-ancestor
5531788|NCT04244591|Autonomic Agents|autonomic agents|mesh-ancestor
5531789|NCT04244591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5531790|NCT04244591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531791|NCT04244591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6465809|NCT00476099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6465810|NCT00476099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465811|NCT00476138|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
6465812|NCT00476138|Antioxidants|antioxidants|mesh-ancestor
6465813|NCT00476138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119108|NCT01105312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119109|NCT01105312|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6119110|NCT01105377|Azacitidine|azacitidine|mesh-list
6119111|NCT01105377|Entinostat|entinostat|mesh-list
6119112|NCT01105377|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
6119113|NCT01105377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5531792|NCT04244591|Glucocorticoids|glucocorticoids|mesh-ancestor
5531793|NCT04244591|Hormones|hormones|mesh-ancestor
5531794|NCT04244591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5531795|NCT04244591|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5531796|NCT04244591|Protective Agents|protective agents|mesh-ancestor
5531797|NCT04244591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5531798|NCT04244591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5531799|NCT04244708|Temozolomide|temozolomide|mesh-list
5531800|NCT04244708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5531801|NCT04244708|Alkylating Agents|alkylating agents|mesh-ancestor
5531802|NCT04244708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531803|NCT04244708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6119114|NCT01105377|Antimetabolites|antimetabolites|mesh-ancestor
6119115|NCT01105377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119116|NCT01105377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6119117|NCT01105377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6119118|NCT01105650|Cyclosporine|cyclosporine|mesh-list
6119119|NCT01105650|Methylprednisolone|methylprednisolone|mesh-list
6119120|NCT01105650|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6119121|NCT01105650|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6119122|NCT01105650|Prednisolone|prednisolone|mesh-list
6119123|NCT01105650|Prednisolone acetate|prednisolone acetate|mesh-list
5531804|NCT04244448|Emtricitabine|emtricitabine|mesh-list
5531805|NCT04244448|Antiviral Agents|antiviral agents|mesh-ancestor
5531806|NCT04244448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5531807|NCT04244448|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5531808|NCT04244448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5531809|NCT04244448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5531810|NCT04244448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531811|NCT04244448|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5531812|NCT04244448|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5531813|NCT04244630|Antioxidants|antioxidants|mesh-list
5531814|NCT04244630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531815|NCT04244630|Protective Agents|protective agents|mesh-ancestor
5531816|NCT04244630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531817|NCT04243954|Morphine|morphine|mesh-list
5531818|NCT04243954|Hydromorphone|hydromorphone|mesh-list
5531819|NCT04243954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5531820|NCT04243954|Narcotics|narcotics|mesh-ancestor
5531821|NCT04243954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5531822|NCT04243954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531823|NCT04243954|Analgesics|analgesics|mesh-ancestor
5531824|NCT04243954|Sensory System Agents|sensory system agents|mesh-ancestor
5531825|NCT04243954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5531826|NCT04244058|Amantadine|amantadine|mesh-list
6119124|NCT01105650|Cyclophosphamide|cyclophosphamide|mesh-list
6119125|NCT01105650|Fludarabine|fludarabine|mesh-list
6119126|NCT01105650|Interleukin-2|interleukin-2|mesh-list
6119127|NCT01105650|Cyclosporins|cyclosporins|mesh-list
6119128|NCT01105650|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6119129|NCT01105650|Prednisolone phosphate|prednisolone phosphate|mesh-list
5531827|NCT04244058|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5531828|NCT04244058|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5531829|NCT04244058|Antiviral Agents|antiviral agents|mesh-ancestor
6119130|NCT01105650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6119131|NCT01105650|Immunologic Factors|immunologic factors|mesh-ancestor
6119132|NCT01105650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119133|NCT01105650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6119134|NCT01105650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6119135|NCT01105650|Alkylating Agents|alkylating agents|mesh-ancestor
6119136|NCT01105650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531830|NCT04244058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5531831|NCT04244058|Dopamine Agents|dopamine agents|mesh-ancestor
5531832|NCT04244058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5531833|NCT04244058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531834|NCT04244058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531835|NCT04244058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5531836|NCT04244058|Analgesics|analgesics|mesh-ancestor
5531837|NCT04244058|Sensory System Agents|sensory system agents|mesh-ancestor
5531838|NCT04244058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5531839|NCT04244097|Bupivacaine|bupivacaine|mesh-list
5531840|NCT04244097|Neostigmine|neostigmine|mesh-list
5531841|NCT04244097|Anesthetics, Local|anesthetics, local|mesh-ancestor
5531842|NCT04244097|Anesthetics|anesthetics|mesh-ancestor
5531843|NCT04244097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5531844|NCT04244097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531845|NCT04244097|Sensory System Agents|sensory system agents|mesh-ancestor
5531846|NCT04244097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5531847|NCT04244097|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6119137|NCT01105650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6119138|NCT01105650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6119139|NCT01105650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5531848|NCT04244097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5531849|NCT04244097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531850|NCT04244097|Cholinergic Agents|cholinergic agents|mesh-ancestor
5531851|NCT04244097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5531852|NCT04244097|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5531853|NCT04244097|Autonomic Agents|autonomic agents|mesh-ancestor
5531854|NCT04243993|Calcium|calcium|mesh-list
5531855|NCT04243993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5531856|NCT04243993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531857|NCT04243616|Paclitaxel|paclitaxel|mesh-list
5531858|NCT04243616|Cyclophosphamide|cyclophosphamide|mesh-list
5531859|NCT04243616|Carboplatin|carboplatin|mesh-list
5531860|NCT04243616|Doxorubicin|doxorubicin|mesh-list
5531861|NCT04243616|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6119140|NCT01105650|Antifungal Agents|antifungal agents|mesh-ancestor
6119141|NCT01105650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6119142|NCT01105650|Dermatologic Agents|dermatologic agents|mesh-ancestor
6119143|NCT01105650|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6119144|NCT01105650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6119145|NCT01105650|Antiemetics|antiemetics|mesh-ancestor
6119146|NCT01105650|Autonomic Agents|autonomic agents|mesh-ancestor
6119147|NCT01105650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6119148|NCT01105650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6119149|NCT01105650|Glucocorticoids|glucocorticoids|mesh-ancestor
6119150|NCT01105650|Hormones|hormones|mesh-ancestor
5531862|NCT04243616|Cemiplimab|cemiplimab|mesh-list
5531863|NCT04243616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6119151|NCT01105650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6119152|NCT01105650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6119153|NCT01105650|Protective Agents|protective agents|mesh-ancestor
6119154|NCT01105650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6119155|NCT01105650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5531864|NCT04243616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5531865|NCT04243616|Tubulin Modulators|tubulin modulators|mesh-ancestor
5531866|NCT04243616|Antimitotic Agents|antimitotic agents|mesh-ancestor
6119156|NCT01105650|Analgesics|analgesics|mesh-ancestor
6119157|NCT01105650|Sensory System Agents|sensory system agents|mesh-ancestor
6119158|NCT01105702|Bevacizumab|bevacizumab|mesh-list
6119159|NCT01105702|Temozolomide|temozolomide|mesh-list
6119160|NCT01105702|Lithium Carbonate|lithium carbonate|mesh-list
6119161|NCT01105702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6119162|NCT01105702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6119163|NCT01105702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6119164|NCT01105702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6119165|NCT01105702|Growth Substances|growth substances|mesh-ancestor
6119166|NCT01105702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119167|NCT01105702|Growth Inhibitors|growth inhibitors|mesh-ancestor
6119168|NCT01105702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6119169|NCT01105702|Alkylating Agents|alkylating agents|mesh-ancestor
6119170|NCT01105702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119171|NCT01105702|Antidepressive Agents|antidepressive agents|mesh-ancestor
6119172|NCT01105702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6119173|NCT01105702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6119174|NCT01105702|Antimanic Agents|antimanic agents|mesh-ancestor
6119175|NCT01105702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6119176|NCT01105702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6119177|NCT01105767|Chlorhexidine|chlorhexidine|mesh-list
6119178|NCT01105767|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6119179|NCT01105767|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6119180|NCT01105767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6119181|NCT01105767|Disinfectants|disinfectants|mesh-ancestor
6119182|NCT01105767|Dermatologic Agents|dermatologic agents|mesh-ancestor
6119183|NCT01105936|Acetaminophen|acetaminophen|mesh-list
6119184|NCT01105936|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6119185|NCT01105936|Analgesics|analgesics|mesh-ancestor
6119186|NCT01105936|Sensory System Agents|sensory system agents|mesh-ancestor
6119187|NCT01105936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6119188|NCT01105936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119189|NCT01105936|Antipyretics|antipyretics|mesh-ancestor
6119190|NCT01105975|Atorvastatin|atorvastatin|mesh-list
6119191|NCT01105975|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6119192|NCT01105975|Simvastatin|simvastatin|mesh-list
6119193|NCT01105975|Evacetrapib|evacetrapib|mesh-list
6119194|NCT01105975|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6119195|NCT01105975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6119196|NCT01105975|Antimetabolites|antimetabolites|mesh-ancestor
6119197|NCT01105975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119198|NCT01105975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6119199|NCT01105975|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5531867|NCT04243616|Mitosis Modulators|mitosis modulators|mesh-ancestor
5531868|NCT04243616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531869|NCT04243616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5531870|NCT04243616|Immunologic Factors|immunologic factors|mesh-ancestor
5531871|NCT04243616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531872|NCT04243616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5531873|NCT04243616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5531874|NCT04243616|Alkylating Agents|alkylating agents|mesh-ancestor
5531875|NCT04243616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5531876|NCT04243616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5531877|NCT04243616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5531878|NCT04243616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6119200|NCT01105975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6119201|NCT01106014|Selexipag|selexipag|mesh-list
6119202|NCT01106014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6119203|NCT01106027|Eculizumab|eculizumab|mesh-list
6119204|NCT01106027|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6119205|NCT01106027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6119206|NCT01106027|Immunologic Factors|immunologic factors|mesh-ancestor
6119207|NCT01106027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119208|NCT01106092|Vaccines|vaccines|mesh-list
6119209|NCT01106092|Immunologic Factors|immunologic factors|mesh-ancestor
6119210|NCT01106092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119211|NCT01106157|Thymoglobulin|thymoglobulin|mesh-list
6119212|NCT01106157|Immunologic Factors|immunologic factors|mesh-ancestor
6119213|NCT01106157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119214|NCT01106157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6119215|NCT01106352|Docetaxel|docetaxel|mesh-list
6119216|NCT01106352|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
6119217|NCT01106352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6119218|NCT01106352|Tubulin Modulators|tubulin modulators|mesh-ancestor
6119219|NCT01106352|Antimitotic Agents|antimitotic agents|mesh-ancestor
5531879|NCT04243616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5531880|NCT04243616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5531881|NCT04243850|Empagliflozin|empagliflozin|mesh-list
5531882|NCT04243850|Caffeine|caffeine|mesh-list
5531883|NCT04243850|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5531884|NCT04243850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531885|NCT04243850|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5531886|NCT04243850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5531887|NCT04243850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531888|NCT04243850|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5531889|NCT04243850|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5531890|NCT04243850|Purinergic Agents|purinergic agents|mesh-ancestor
5531891|NCT04243850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5531892|NCT04243850|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5531893|NCT04243850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5601556|NCT05176379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5601557|NCT05176379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601558|NCT05176379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5601559|NCT05176379|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5601560|NCT05176288|Palbociclib|palbociclib|mesh-list
5601561|NCT05176288|Avelumab|avelumab|mesh-list
5601562|NCT05176288|Axitinib|axitinib|mesh-list
5601563|NCT05176288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5601564|NCT05176288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6119220|NCT01106352|Mitosis Modulators|mitosis modulators|mesh-ancestor
6119221|NCT01106352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119222|NCT01106430|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6119223|NCT01106430|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6119224|NCT01106430|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6119225|NCT01106430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6119226|NCT01106430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6119227|NCT01106430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119228|NCT01106430|Adrenergic Agents|adrenergic agents|mesh-ancestor
6119229|NCT01106430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6119230|NCT01106430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119231|NCT01106430|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6119232|NCT01106430|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6119233|NCT01106430|Dopamine Agents|dopamine agents|mesh-ancestor
6119234|NCT01106586|Ritonavir|ritonavir|mesh-list
6119235|NCT01106586|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6119236|NCT01106586|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6119237|NCT01106586|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6119238|NCT01106586|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6119239|NCT01106586|Protease Inhibitors|protease inhibitors|mesh-ancestor
6119240|NCT01106586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6119241|NCT01106586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119242|NCT01106586|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6119243|NCT01106586|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6119244|NCT01106586|Antiviral Agents|antiviral agents|mesh-ancestor
6119245|NCT01106586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6119246|NCT01106586|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6119247|NCT01106586|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6119248|NCT01106586|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6119249|NCT01106586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6119250|NCT01106625|Metformin|metformin|mesh-list
6119251|NCT01106625|Canagliflozin|canagliflozin|mesh-list
6119252|NCT01106625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6119253|NCT01106625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119254|NCT01106625|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6119255|NCT01106625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119256|NCT01106651|Canagliflozin|canagliflozin|mesh-list
6119257|NCT01106651|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6119258|NCT01106651|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6119259|NCT01106651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119260|NCT01106651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119261|NCT01106677|Metformin|metformin|mesh-list
6119262|NCT01106677|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6119263|NCT01106677|Canagliflozin|canagliflozin|mesh-list
6119264|NCT01106677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6119265|NCT01106677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119266|NCT01106677|Incretins|incretins|mesh-ancestor
6119267|NCT01106677|Hormones|hormones|mesh-ancestor
6119268|NCT01106677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6119269|NCT01106677|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6119270|NCT01106677|Protease Inhibitors|protease inhibitors|mesh-ancestor
6119271|NCT01106677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6119272|NCT01106677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119273|NCT01106677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6119274|NCT01106690|Metformin|metformin|mesh-list
6119275|NCT01106690|Pioglitazone|pioglitazone|mesh-list
6119276|NCT01106690|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6119277|NCT01106690|Canagliflozin|canagliflozin|mesh-list
6119278|NCT01106690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6119279|NCT01106690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119280|NCT01106690|Incretins|incretins|mesh-ancestor
6119281|NCT01106690|Hormones|hormones|mesh-ancestor
6119282|NCT01106690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5531894|NCT04243733|Pemetrexed|pemetrexed|mesh-list
5531895|NCT04243733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5531896|NCT04243733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5531897|NCT04243733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531898|NCT04243733|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5531899|NCT04243733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5531900|NCT04243811|Anesthetics|anesthetics|mesh-list
5531901|NCT04243811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5531902|NCT04243811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531903|NCT04243434|Prednisone|prednisone|mesh-list
5531904|NCT04243434|Cyclophosphamide|cyclophosphamide|mesh-list
5531905|NCT04243434|Doxorubicin|doxorubicin|mesh-list
5531906|NCT04243434|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5531907|NCT04243434|Vincristine|vincristine|mesh-list
5531908|NCT04243434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5531909|NCT04243434|Immunologic Factors|immunologic factors|mesh-ancestor
5531910|NCT04243434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119283|NCT01106690|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6119284|NCT01106690|Protease Inhibitors|protease inhibitors|mesh-ancestor
6119285|NCT01106690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6119286|NCT01106690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119287|NCT01106690|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6119288|NCT01106833|Sirolimus|sirolimus|mesh-list
6119289|NCT01106833|Prednisone|prednisone|mesh-list
6119290|NCT01106833|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
6119291|NCT01106833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6119292|NCT01106833|Glucocorticoids|glucocorticoids|mesh-ancestor
6119293|NCT01106833|Hormones|hormones|mesh-ancestor
6119294|NCT01106833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6119295|NCT01106833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119296|NCT01106833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6119297|NCT01106833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6119298|NCT01106833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6119299|NCT01106833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6119300|NCT01106833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6119301|NCT01106833|Antifungal Agents|antifungal agents|mesh-ancestor
6119302|NCT01106833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6119303|NCT01106833|Immunologic Factors|immunologic factors|mesh-ancestor
6119304|NCT01106833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6119305|NCT01106833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119306|NCT01106846|Ketamine|ketamine|mesh-list
6119307|NCT01106846|Analgesics|analgesics|mesh-ancestor
6119308|NCT01106846|Sensory System Agents|sensory system agents|mesh-ancestor
6119309|NCT01106846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6119310|NCT01106846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119311|NCT01106846|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6119312|NCT01106846|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6119313|NCT01106846|Anesthetics, General|anesthetics, general|mesh-ancestor
6119314|NCT01106846|Anesthetics|anesthetics|mesh-ancestor
6119315|NCT01106846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6119316|NCT01106846|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6119317|NCT01106846|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6119318|NCT01106846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6119319|NCT01106846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531911|NCT04243434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5531912|NCT04243434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6119320|NCT01106859|Zolpidem|zolpidem|mesh-list
6119321|NCT01106859|Zopiclone|zopiclone|mesh-list
6119322|NCT01106859|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6119323|NCT01106859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6119324|NCT01106859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5531913|NCT04243434|Alkylating Agents|alkylating agents|mesh-ancestor
5531914|NCT04243434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531915|NCT04243434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5531916|NCT04243434|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5531917|NCT04243434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6119325|NCT01106859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119326|NCT01106859|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6119327|NCT01106859|GABA Agonists|gaba agonists|mesh-ancestor
6119328|NCT01106859|GABA Agents|gaba agents|mesh-ancestor
6119329|NCT01106859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6119330|NCT01106859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119331|NCT01106898|Paclitaxel|paclitaxel|mesh-list
6119332|NCT01106898|Cyclophosphamide|cyclophosphamide|mesh-list
5531918|NCT04243434|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5531919|NCT04243434|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5531920|NCT04243434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5531921|NCT04243434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5531922|NCT04243434|Glucocorticoids|glucocorticoids|mesh-ancestor
5531923|NCT04243434|Hormones|hormones|mesh-ancestor
5531924|NCT04243434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5531925|NCT04243434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5531926|NCT04243434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5531927|NCT04243434|Tubulin Modulators|tubulin modulators|mesh-ancestor
5531928|NCT04243434|Antimitotic Agents|antimitotic agents|mesh-ancestor
5531929|NCT04243434|Mitosis Modulators|mitosis modulators|mesh-ancestor
5531930|NCT04243109|Dexamethasone|dexamethasone|mesh-list
5531931|NCT04243109|Cyclophosphamide|cyclophosphamide|mesh-list
6119333|NCT01106898|Trastuzumab|trastuzumab|mesh-list
6119334|NCT01106898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6119335|NCT01106898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6119336|NCT01106898|Tubulin Modulators|tubulin modulators|mesh-ancestor
6119337|NCT01106898|Antimitotic Agents|antimitotic agents|mesh-ancestor
6119338|NCT01106898|Mitosis Modulators|mitosis modulators|mesh-ancestor
6119339|NCT01106898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119340|NCT01106898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6119341|NCT01106898|Immunologic Factors|immunologic factors|mesh-ancestor
6119342|NCT01106898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119343|NCT01106898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6119344|NCT01106898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6119345|NCT01106898|Alkylating Agents|alkylating agents|mesh-ancestor
6119346|NCT01106898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6119347|NCT01106898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6204547|NCT02072434|Warfarin|warfarin|mesh-list
6204548|NCT02072434|Edoxaban|edoxaban|mesh-list
6204549|NCT02072434|Anticoagulants|anticoagulants|mesh-ancestor
6204550|NCT02072434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6204551|NCT02072434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6204552|NCT02072434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204553|NCT02072434|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6204554|NCT02072434|Antithrombins|antithrombins|mesh-ancestor
6204555|NCT02072434|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6204556|NCT02072434|Protease Inhibitors|protease inhibitors|mesh-ancestor
6204557|NCT02072434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6204558|NCT02072668|Rivaroxaban|rivaroxaban|mesh-list
6204559|NCT02072668|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6204560|NCT02072668|Antithrombins|antithrombins|mesh-ancestor
6204561|NCT02072668|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6204562|NCT02072668|Protease Inhibitors|protease inhibitors|mesh-ancestor
6204563|NCT02072668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6204564|NCT02072668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204565|NCT02072668|Anticoagulants|anticoagulants|mesh-ancestor
6204566|NCT02072824|Pregabalin|pregabalin|mesh-list
6204567|NCT02072824|Analgesics|analgesics|mesh-ancestor
6204568|NCT02072824|Sensory System Agents|sensory system agents|mesh-ancestor
6204569|NCT02072824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6204570|NCT02072824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204571|NCT02072824|Anticonvulsants|anticonvulsants|mesh-ancestor
6204572|NCT02072824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6204573|NCT02072824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6204574|NCT02072824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119348|NCT01106950|Cyclophosphamide|cyclophosphamide|mesh-list
6119349|NCT01106950|Fludarabine|fludarabine|mesh-list
5531932|NCT04243109|Pomalidomide|pomalidomide|mesh-list
5531933|NCT04243109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5531934|NCT04243109|Immunologic Factors|immunologic factors|mesh-ancestor
5531935|NCT04243109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119350|NCT01106950|Interleukin-2|interleukin-2|mesh-list
6119351|NCT01106950|Denileukin diftitox|denileukin diftitox|mesh-list
6119352|NCT01106950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6119353|NCT01106950|Immunologic Factors|immunologic factors|mesh-ancestor
6119354|NCT01106950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119355|NCT01106950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6119356|NCT01106950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6119357|NCT01106950|Alkylating Agents|alkylating agents|mesh-ancestor
6119358|NCT01106950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119359|NCT01106950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6119360|NCT01106950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6119361|NCT01106950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6119362|NCT01106950|Analgesics|analgesics|mesh-ancestor
6119363|NCT01106950|Sensory System Agents|sensory system agents|mesh-ancestor
6119364|NCT01106950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6119365|NCT01107353|Imipramine|imipramine|mesh-list
6119366|NCT01107353|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6119367|NCT01107353|Antidepressive Agents|antidepressive agents|mesh-ancestor
6119368|NCT01107353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6119369|NCT01107353|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6119370|NCT01107353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6119371|NCT01107353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6119372|NCT01107353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119373|NCT01107353|Adrenergic Agents|adrenergic agents|mesh-ancestor
6119374|NCT01107353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6119375|NCT01107353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119376|NCT01107392|Botulinum Toxins|botulinum toxins|mesh-list
6119377|NCT01107392|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6119378|NCT01107392|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6119379|NCT01107392|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6119380|NCT01107392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6119381|NCT01107392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119382|NCT01107392|Cholinergic Agents|cholinergic agents|mesh-ancestor
6119383|NCT01107392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6119384|NCT01107392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465814|NCT00476138|Protective Agents|protective agents|mesh-ancestor
6465815|NCT00476138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119385|NCT01107392|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6119386|NCT01107392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6119387|NCT01107405|Loteprednol Etabonate|loteprednol etabonate|mesh-list
6119388|NCT01107405|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6465816|NCT00476138|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
6465817|NCT00476138|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6465818|NCT00476138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5531936|NCT04243109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5531937|NCT04243109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5531938|NCT04243109|Alkylating Agents|alkylating agents|mesh-ancestor
5531939|NCT04243109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531940|NCT04243109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5531941|NCT04243109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5531942|NCT04243109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5531943|NCT04243109|Antiemetics|antiemetics|mesh-ancestor
5531944|NCT04243109|Autonomic Agents|autonomic agents|mesh-ancestor
5531945|NCT04243109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5531946|NCT04243109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5531947|NCT04243109|Glucocorticoids|glucocorticoids|mesh-ancestor
5531948|NCT04243109|Hormones|hormones|mesh-ancestor
5531949|NCT04243109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6465819|NCT00476138|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6465820|NCT00476164|Rituximab|rituximab|mesh-list
6465821|NCT00476164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6465822|NCT00476164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6465823|NCT00476164|Immunologic Factors|immunologic factors|mesh-ancestor
6119389|NCT01107444|Docetaxel|docetaxel|mesh-list
6119390|NCT01107444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6119391|NCT01107444|Tubulin Modulators|tubulin modulators|mesh-ancestor
6119392|NCT01107444|Antimitotic Agents|antimitotic agents|mesh-ancestor
6119393|NCT01107444|Mitosis Modulators|mitosis modulators|mesh-ancestor
6119394|NCT01107444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119395|NCT01107457|Ixekizumab|ixekizumab|mesh-list
6119396|NCT01107457|Dermatologic Agents|dermatologic agents|mesh-ancestor
6119397|NCT01107535|Palivizumab|palivizumab|mesh-list
6119398|NCT01107535|Antibodies|antibodies|mesh-list
6119399|NCT01107535|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6119400|NCT01107535|Immunologic Factors|immunologic factors|mesh-ancestor
6119401|NCT01107535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119402|NCT01107535|Antiviral Agents|antiviral agents|mesh-ancestor
6119403|NCT01107535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6119404|NCT01107626|Paclitaxel|paclitaxel|mesh-list
6119405|NCT01107626|Bevacizumab|bevacizumab|mesh-list
6119406|NCT01107626|Carboplatin|carboplatin|mesh-list
6119407|NCT01107626|Pemetrexed|pemetrexed|mesh-list
6119408|NCT01107626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6119409|NCT01107626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6119410|NCT01107626|Tubulin Modulators|tubulin modulators|mesh-ancestor
6119411|NCT01107626|Antimitotic Agents|antimitotic agents|mesh-ancestor
6119412|NCT01107626|Mitosis Modulators|mitosis modulators|mesh-ancestor
6119413|NCT01107626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119414|NCT01107626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6119415|NCT01107626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6119416|NCT01107626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6119417|NCT01107626|Growth Substances|growth substances|mesh-ancestor
6119418|NCT01107626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119419|NCT01107626|Growth Inhibitors|growth inhibitors|mesh-ancestor
6119420|NCT01107626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6119421|NCT01107626|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6119422|NCT01107626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6119423|NCT01107665|Paclitaxel|paclitaxel|mesh-list
6119424|NCT01107665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6119425|NCT01107665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6119426|NCT01107665|Tubulin Modulators|tubulin modulators|mesh-ancestor
6119427|NCT01107665|Antimitotic Agents|antimitotic agents|mesh-ancestor
6119428|NCT01107665|Mitosis Modulators|mitosis modulators|mesh-ancestor
6119429|NCT01107665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119430|NCT01107730|Ascorbic Acid|ascorbic acid|mesh-list
6119431|NCT01107730|Vitamins|vitamins|mesh-ancestor
6119432|NCT01107730|Micronutrients|micronutrients|mesh-ancestor
6119433|NCT01107730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119434|NCT01107730|Antioxidants|antioxidants|mesh-ancestor
6119435|NCT01107730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119436|NCT01107730|Protective Agents|protective agents|mesh-ancestor
6119437|NCT01107743|Amlodipine|amlodipine|mesh-list
6119438|NCT01107743|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
6119439|NCT01107743|Atorvastatin|atorvastatin|mesh-list
6119440|NCT01107743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6119441|NCT01107743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6119442|NCT01107743|Antimetabolites|antimetabolites|mesh-ancestor
6119443|NCT01107743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119444|NCT01107743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6119445|NCT01107743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6119446|NCT01107743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6119447|NCT01107743|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6119448|NCT01107743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6119449|NCT01107743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6119450|NCT01107743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5531950|NCT04243109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5531951|NCT04243109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5531952|NCT04243109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5531953|NCT04243109|Growth Substances|growth substances|mesh-ancestor
5531954|NCT04243109|Growth Inhibitors|growth inhibitors|mesh-ancestor
5531955|NCT04243278|Aspirin|aspirin|mesh-list
5531956|NCT04243278|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5531957|NCT04243278|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5531958|NCT04243278|Analgesics|analgesics|mesh-ancestor
5531959|NCT04243278|Sensory System Agents|sensory system agents|mesh-ancestor
5531960|NCT04243278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5531961|NCT04243278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5531962|NCT04243278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5531963|NCT04243278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5531964|NCT04243278|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6119451|NCT01107743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119452|NCT01107743|Vasodilator Agents|vasodilator agents|mesh-ancestor
6119453|NCT01107886|Saxagliptin|saxagliptin|mesh-list
6119454|NCT01107886|Incretins|incretins|mesh-ancestor
6119455|NCT01107886|Hormones|hormones|mesh-ancestor
6119456|NCT01107886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6119457|NCT01107886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119458|NCT01107886|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6119459|NCT01107886|Protease Inhibitors|protease inhibitors|mesh-ancestor
6119460|NCT01107886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6119461|NCT01107886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119462|NCT01107886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6119463|NCT01107899|Clopidogrel|clopidogrel|mesh-list
6119464|NCT01107899|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6119465|NCT01107899|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6119466|NCT01107899|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6119467|NCT01107899|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5531965|NCT04243278|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5531966|NCT04243278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531967|NCT04243278|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5531968|NCT04243278|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5531969|NCT04243278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5531970|NCT04243278|Antipyretics|antipyretics|mesh-ancestor
5531971|NCT04242914|Midazolam|midazolam|mesh-list
5531972|NCT04242914|Ketamine|ketamine|mesh-list
5531973|NCT04242914|Analgesics|analgesics|mesh-ancestor
5531974|NCT04242914|Sensory System Agents|sensory system agents|mesh-ancestor
5531975|NCT04242914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6119468|NCT01107899|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6119469|NCT01107899|Purinergic Agents|purinergic agents|mesh-ancestor
6119470|NCT01107899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6119471|NCT01107899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119472|NCT01107899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119473|NCT01107912|Clopidogrel|clopidogrel|mesh-list
6119474|NCT01107912|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6119475|NCT01107912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6119476|NCT01107912|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6119477|NCT01107912|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6119478|NCT01107912|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6119479|NCT01107912|Purinergic Agents|purinergic agents|mesh-ancestor
6119480|NCT01107912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5531976|NCT04242914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601565|NCT05176288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6119481|NCT01107912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119482|NCT01107912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119483|NCT01107925|Clopidogrel|clopidogrel|mesh-list
6119484|NCT01107925|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6119485|NCT01107925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6119486|NCT01107925|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6119487|NCT01107925|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6119488|NCT01107925|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6119489|NCT01107925|Purinergic Agents|purinergic agents|mesh-ancestor
6119490|NCT01107925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6119491|NCT01107925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119492|NCT01107925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119493|NCT01108068|Lithium Carbonate|lithium carbonate|mesh-list
6119494|NCT01108068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465824|NCT00476164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465825|NCT00476164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6465826|NCT00476190|Cytarabine|cytarabine|mesh-list
6465827|NCT00476190|Dexamethasone|dexamethasone|mesh-list
6465828|NCT00476190|Hydrocortisone|hydrocortisone|mesh-list
6465829|NCT00476190|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6465830|NCT00476190|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6119495|NCT01108068|Antidepressive Agents|antidepressive agents|mesh-ancestor
6119496|NCT01108068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6119497|NCT01108068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6119498|NCT01108068|Antimanic Agents|antimanic agents|mesh-ancestor
6119499|NCT01108068|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6119500|NCT01108068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6119501|NCT01108068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119502|NCT01108094|Itraconazole|itraconazole|mesh-list
6119503|NCT01108094|Antifungal Agents|antifungal agents|mesh-ancestor
6119504|NCT01108094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6119505|NCT01108094|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6119506|NCT01108094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6119507|NCT01108094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6119508|NCT01108094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119509|NCT01108094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6119510|NCT01108094|Hormone Antagonists|hormone antagonists|mesh-ancestor
6119511|NCT01108094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6119512|NCT01108094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119513|NCT01108094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6119514|NCT01108341|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6119515|NCT01108341|Ofatumumab|ofatumumab|mesh-list
6119516|NCT01108341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6119517|NCT01108341|Alkylating Agents|alkylating agents|mesh-ancestor
6119518|NCT01108341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119519|NCT01108341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6119520|NCT01108445|Everolimus|everolimus|mesh-list
6119521|NCT01108445|Sunitinib|sunitinib|mesh-list
6119522|NCT01108445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6119523|NCT01108445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6119524|NCT01108445|Immunologic Factors|immunologic factors|mesh-ancestor
6119525|NCT01108445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119526|NCT01108445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6119527|NCT01108445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6119528|NCT01108445|Growth Substances|growth substances|mesh-ancestor
6119529|NCT01108445|Growth Inhibitors|growth inhibitors|mesh-ancestor
6119530|NCT01108445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6119531|NCT01108445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6119532|NCT01108445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119533|NCT01108458|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6119534|NCT01108458|Pertuzumab|pertuzumab|mesh-list
6119535|NCT01108458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6119536|NCT01108458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6119537|NCT01108458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5531977|NCT04242914|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5531978|NCT04242914|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5531979|NCT04242914|Anesthetics, General|anesthetics, general|mesh-ancestor
5531980|NCT04242914|Anesthetics|anesthetics|mesh-ancestor
6119538|NCT01108458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119539|NCT01108458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6119540|NCT01108510|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6119541|NCT01108510|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6119542|NCT01108510|Cobicistat|cobicistat|mesh-list
6119543|NCT01108510|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6119544|NCT01108510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6119545|NCT01108510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6119546|NCT01108510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119547|NCT01108510|Antiviral Agents|antiviral agents|mesh-ancestor
6119548|NCT01108510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6119549|NCT01108510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6119550|NCT01108510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6119551|NCT01108510|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6119552|NCT01108510|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6119553|NCT01108510|Protease Inhibitors|protease inhibitors|mesh-ancestor
6119554|NCT01108510|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6119555|NCT01108510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6119556|NCT01108731|Milnacipran|milnacipran|mesh-list
6119557|NCT01108731|Levomilnacipran|levomilnacipran|mesh-list
6119558|NCT01108731|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6119559|NCT01108731|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6119560|NCT01108731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6119561|NCT01108731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119562|NCT01108731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6119563|NCT01108731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119564|NCT01108731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6119565|NCT01108731|Analgesics|analgesics|mesh-ancestor
5531981|NCT04242914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5531982|NCT04242914|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5531983|NCT04242914|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6119566|NCT01108731|Sensory System Agents|sensory system agents|mesh-ancestor
6119567|NCT01108731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5531984|NCT04242914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5531985|NCT04242914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531986|NCT04242914|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5531987|NCT04242914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6119568|NCT01108731|Antidepressive Agents|antidepressive agents|mesh-ancestor
6119569|NCT01108731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6119570|NCT01108757|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6119571|NCT01108757|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6119572|NCT01108757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6119573|NCT01108757|Renal Agents|renal agents|mesh-ancestor
6119574|NCT01108757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6119575|NCT01108757|Antimalarials|antimalarials|mesh-ancestor
6119576|NCT01108757|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6119577|NCT01108757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6119578|NCT01108809|Telmisartan|telmisartan|mesh-list
6119579|NCT01108809|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6119580|NCT01108809|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6119581|NCT01108809|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6119582|NCT01108809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5531988|NCT04242914|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5531989|NCT04242914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5531990|NCT04242914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5531991|NCT04242914|GABA Modulators|gaba modulators|mesh-ancestor
5531992|NCT04242914|GABA Agents|gaba agents|mesh-ancestor
5531993|NCT04242927|Nicotinic Acids|nicotinic acids|mesh-list
5531994|NCT04242927|Niacin|niacin|mesh-list
5531995|NCT04242927|Niacinamide|niacinamide|mesh-list
5531996|NCT04242927|Vitamin B Complex|vitamin b complex|mesh-ancestor
5531997|NCT04242927|Vitamins|vitamins|mesh-ancestor
5531998|NCT04242927|Micronutrients|micronutrients|mesh-ancestor
5531999|NCT04242927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532000|NCT04242927|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5532001|NCT04242927|Antimetabolites|antimetabolites|mesh-ancestor
5532002|NCT04242927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5532003|NCT04242927|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5532004|NCT04242927|Vasodilator Agents|vasodilator agents|mesh-ancestor
5532005|NCT04242433|Antiviral Agents|antiviral agents|mesh-list
5532006|NCT04242433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5532007|NCT04242758|Dapagliflozin|dapagliflozin|mesh-list
5532008|NCT04242758|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5532009|NCT04242758|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5532010|NCT04242758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5532011|NCT04242758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6119583|NCT01109056|Cyclosporine|cyclosporine|mesh-list
6119584|NCT01109056|Cyclosporins|cyclosporins|mesh-list
6119585|NCT01109056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6119586|NCT01109056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119587|NCT01109056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6119588|NCT01109056|Immunologic Factors|immunologic factors|mesh-ancestor
6119589|NCT01109056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119590|NCT01109056|Antifungal Agents|antifungal agents|mesh-ancestor
6119591|NCT01109056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6119592|NCT01109056|Dermatologic Agents|dermatologic agents|mesh-ancestor
6119593|NCT01109056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6119594|NCT01109056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6119595|NCT01109173|Nepafenac|nepafenac|mesh-list
6119596|NCT01109173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6119597|NCT01109173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6119598|NCT01109173|Analgesics|analgesics|mesh-ancestor
6119599|NCT01109173|Sensory System Agents|sensory system agents|mesh-ancestor
6119600|NCT01109173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6119601|NCT01109173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119602|NCT01109173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6119603|NCT01109173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6119604|NCT01109316|Insulin|insulin|mesh-list
6119605|NCT01109316|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6119606|NCT01109316|Insulin Aspart|insulin aspart|mesh-list
6119607|NCT01109316|Insulin Lispro|insulin lispro|mesh-list
6119608|NCT01109316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6119609|NCT01109316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119610|NCT01109524|Cetuximab|cetuximab|mesh-list
6119611|NCT01109524|Vinorelbine|vinorelbine|mesh-list
6119612|NCT01109524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6119613|NCT01109524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6119614|NCT01109524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6119615|NCT01109524|Tubulin Modulators|tubulin modulators|mesh-ancestor
6119616|NCT01109524|Antimitotic Agents|antimitotic agents|mesh-ancestor
6119617|NCT01109524|Mitosis Modulators|mitosis modulators|mesh-ancestor
6119618|NCT01109524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119619|NCT01109849|Methylphenidate|methylphenidate|mesh-list
6119620|NCT01109849|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
6119621|NCT01109849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119622|NCT01109849|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6119623|NCT01109849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6119624|NCT01109849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6119625|NCT01109849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119626|NCT01109849|Dopamine Agents|dopamine agents|mesh-ancestor
6119627|NCT01109849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6119628|NCT01109979|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6119629|NCT01109979|Drospirenone|drospirenone|mesh-list
6119630|NCT01109979|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6119631|NCT01109979|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6119632|NCT01109979|Medroxyprogesterone|medroxyprogesterone|mesh-list
5532012|NCT04242758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119633|NCT01109979|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
6119634|NCT01109979|Estradiol|estradiol|mesh-list
6119635|NCT01109979|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6119636|NCT01109979|Estrogens|estrogens|mesh-ancestor
6119637|NCT01109979|Hormones|hormones|mesh-ancestor
6119638|NCT01109979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6119639|NCT01109979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119640|NCT01109979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6119641|NCT01109979|Contraceptive Agents|contraceptive agents|mesh-ancestor
6119642|NCT01109979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6119643|NCT01109979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6119644|NCT01109979|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6119645|NCT01109979|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6119646|NCT01109979|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6119647|NCT01109979|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6119648|NCT01109979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6119649|NCT01109979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6119650|NCT01109979|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6119651|NCT01109979|Hormone Antagonists|hormone antagonists|mesh-ancestor
6119652|NCT01109979|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6119653|NCT01109979|Diuretics|diuretics|mesh-ancestor
6119654|NCT01109979|Natriuretic Agents|natriuretic agents|mesh-ancestor
6119655|NCT01109992|Regadenoson|regadenoson|mesh-list
6119656|NCT01109992|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
6119657|NCT01109992|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6119658|NCT01109992|Purinergic Agonists|purinergic agonists|mesh-ancestor
6119659|NCT01109992|Purinergic Agents|purinergic agents|mesh-ancestor
6119660|NCT01109992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6119661|NCT01109992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119662|NCT01109992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119663|NCT01110005|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6119664|NCT01110135|Dexamethasone|dexamethasone|mesh-list
6119665|NCT01110135|Etoposide|etoposide|mesh-list
6119666|NCT01110135|Etoposide phosphate|etoposide phosphate|mesh-list
6119667|NCT01110135|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6119668|NCT01110135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6119669|NCT01110135|Antiemetics|antiemetics|mesh-ancestor
6119670|NCT01110135|Autonomic Agents|autonomic agents|mesh-ancestor
6119671|NCT01110135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6119672|NCT01110135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119673|NCT01110135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6119674|NCT01110135|Glucocorticoids|glucocorticoids|mesh-ancestor
6119675|NCT01110135|Hormones|hormones|mesh-ancestor
6119676|NCT01110135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6119677|NCT01110135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6119678|NCT01110135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6119679|NCT01110135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6119680|NCT01110135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6119681|NCT01110135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6119682|NCT01110135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6119683|NCT01110135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119684|NCT01110135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6119685|NCT01110135|Alkylating Agents|alkylating agents|mesh-ancestor
6119686|NCT01110187|Lacosamide|lacosamide|mesh-list
6119687|NCT01110187|Fosphenytoin|fosphenytoin|mesh-list
6119688|NCT01110187|Anticonvulsants|anticonvulsants|mesh-ancestor
6119689|NCT01110187|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6465831|NCT00476190|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6465832|NCT00476190|Cyclophosphamide|cyclophosphamide|mesh-list
6465833|NCT00476190|Doxorubicin|doxorubicin|mesh-list
6465834|NCT00476190|Methotrexate|methotrexate|mesh-list
6465835|NCT00476190|Etoposide|etoposide|mesh-list
6465836|NCT00476190|Vincristine|vincristine|mesh-list
6465837|NCT00476190|Asparaginase|asparaginase|mesh-list
6465838|NCT00476190|Pegaspargase|pegaspargase|mesh-list
6465839|NCT00476190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6465840|NCT00476190|Immunologic Factors|immunologic factors|mesh-ancestor
6465841|NCT00476190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465842|NCT00476190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6465843|NCT00476190|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6465844|NCT00476190|Alkylating Agents|alkylating agents|mesh-ancestor
6465845|NCT00476190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465846|NCT00476190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6465847|NCT00476190|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6465848|NCT00476190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6465849|NCT00476190|Antiemetics|antiemetics|mesh-ancestor
6465850|NCT00476190|Autonomic Agents|autonomic agents|mesh-ancestor
6465851|NCT00476190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6465852|NCT00476190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6465853|NCT00476190|Glucocorticoids|glucocorticoids|mesh-ancestor
6465854|NCT00476190|Hormones|hormones|mesh-ancestor
6465855|NCT00476190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5532013|NCT04242758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5532014|NCT04242758|Diuretics|diuretics|mesh-ancestor
5532015|NCT04242758|Natriuretic Agents|natriuretic agents|mesh-ancestor
5532016|NCT04242758|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5532017|NCT04242758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5532018|NCT04242212|Misoprostol|misoprostol|mesh-list
5532019|NCT04242212|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5532020|NCT04242212|Abortifacient Agents|abortifacient agents|mesh-ancestor
5725485|NCT03180125|Immunologic Factors|immunologic factors|mesh-ancestor
6119690|NCT01110187|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6119691|NCT01110187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6119692|NCT01110187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465856|NCT00476190|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6465857|NCT00476190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6465858|NCT00476190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6465859|NCT00476190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6465860|NCT00476190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6465861|NCT00476190|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6465862|NCT00476190|Abortifacient Agents|abortifacient agents|mesh-ancestor
6465863|NCT00476190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6465864|NCT00476190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6465865|NCT00476190|Antimetabolites|antimetabolites|mesh-ancestor
6465866|NCT00476190|Dermatologic Agents|dermatologic agents|mesh-ancestor
6119693|NCT01110200|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6119694|NCT01110200|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6119695|NCT01110200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6119696|NCT01110200|Autonomic Agents|autonomic agents|mesh-ancestor
6119697|NCT01110200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6119698|NCT01110200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119699|NCT01110200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6119700|NCT01110200|Respiratory System Agents|respiratory system agents|mesh-ancestor
6119701|NCT01110200|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6119702|NCT01110200|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6119703|NCT01110200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6119704|NCT01110200|Adrenergic Agents|adrenergic agents|mesh-ancestor
6119705|NCT01110200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6119706|NCT01110200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119707|NCT01110200|Glucocorticoids|glucocorticoids|mesh-ancestor
6119708|NCT01110200|Hormones|hormones|mesh-ancestor
6465867|NCT00476190|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6465868|NCT00476190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6119709|NCT01110200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6119710|NCT01110200|Sympathomimetics|sympathomimetics|mesh-ancestor
6465869|NCT00476190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6465870|NCT00476190|Antiviral Agents|antiviral agents|mesh-ancestor
6465871|NCT00476190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6465872|NCT00476190|Tubulin Modulators|tubulin modulators|mesh-ancestor
6465873|NCT00476190|Antimitotic Agents|antimitotic agents|mesh-ancestor
6465874|NCT00476190|Mitosis Modulators|mitosis modulators|mesh-ancestor
6119711|NCT01110330|Ketoconazole|ketoconazole|mesh-list
6119712|NCT01110330|Antifungal Agents|antifungal agents|mesh-ancestor
6119713|NCT01110330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6465875|NCT00476216|Fondaparinux|fondaparinux|mesh-list
6119714|NCT01110330|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6119715|NCT01110330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6119716|NCT01110330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6119717|NCT01110330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119718|NCT01110330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6119719|NCT01110330|Hormone Antagonists|hormone antagonists|mesh-ancestor
6119720|NCT01110330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6119721|NCT01110330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119722|NCT01110330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6119723|NCT01110382|Amoxicillin|amoxicillin|mesh-list
6119724|NCT01110382|Meropenem|meropenem|mesh-list
6119725|NCT01110382|Clavulanic Acid|clavulanic acid|mesh-list
6119726|NCT01110382|Clavulanic Acids|clavulanic acids|mesh-list
6119727|NCT01110382|Doripenem|doripenem|mesh-list
6119728|NCT01110382|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6119729|NCT01110382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6119730|NCT01110382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6119731|NCT01110382|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6119732|NCT01110382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6119733|NCT01110382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119734|NCT01110408|Amoxicillin|amoxicillin|mesh-list
6119735|NCT01110408|Clavulanic Acid|clavulanic acid|mesh-list
6119736|NCT01110408|Clavulanic Acids|clavulanic acids|mesh-list
6119737|NCT01110408|Cefepime|cefepime|mesh-list
6119738|NCT01110408|Doripenem|doripenem|mesh-list
6119739|NCT01110408|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6119740|NCT01110408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6119741|NCT01110408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6119742|NCT01110408|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6119743|NCT01110408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6119744|NCT01110408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119745|NCT01110421|Amoxicillin|amoxicillin|mesh-list
6119746|NCT01110421|Clavulanic Acid|clavulanic acid|mesh-list
6119747|NCT01110421|Clavulanic Acids|clavulanic acids|mesh-list
6119748|NCT01110421|Cefepime|cefepime|mesh-list
6119749|NCT01110421|Doripenem|doripenem|mesh-list
6119750|NCT01110421|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6119751|NCT01110421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6119752|NCT01110421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6119753|NCT01110421|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6119754|NCT01110421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6119755|NCT01110421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119756|NCT01110434|Topiramate|topiramate|mesh-list
6119757|NCT01110434|Anticonvulsants|anticonvulsants|mesh-ancestor
6119758|NCT01110434|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6119759|NCT01110434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119760|NCT01110499|Bimatoprost|bimatoprost|mesh-list
6119761|NCT01110499|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6119762|NCT01110499|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6119763|NCT01110499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6119764|NCT01110707|Hormones|hormones|mesh-list
6119765|NCT01110707|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6119766|NCT01110707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6119767|NCT01110707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119768|NCT01110876|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6119769|NCT01110876|Temozolomide|temozolomide|mesh-list
6119770|NCT01110876|Vorinostat|vorinostat|mesh-list
6119771|NCT01110876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6119772|NCT01110876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6119773|NCT01110876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6119774|NCT01110876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119775|NCT01110876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6119776|NCT01110876|Alkylating Agents|alkylating agents|mesh-ancestor
6119777|NCT01110876|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6119778|NCT01111058|Everolimus|everolimus|mesh-list
6119779|NCT01111058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6119780|NCT01111058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6119781|NCT01111058|Immunologic Factors|immunologic factors|mesh-ancestor
6465876|NCT00476216|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6119782|NCT01111058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119783|NCT01111123|Halobetasol|halobetasol|mesh-list
6119784|NCT01111123|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6119785|NCT01111149|Bupropion|bupropion|mesh-list
5532021|NCT04242212|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5532022|NCT04242212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119786|NCT01111149|Varenicline|varenicline|mesh-list
6119787|NCT01111149|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6119788|NCT01111149|Antidepressive Agents|antidepressive agents|mesh-ancestor
6119789|NCT01111149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6119790|NCT01111149|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6119791|NCT01111149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6119792|NCT01111149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6119793|NCT01111149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119794|NCT01111149|Dopamine Agents|dopamine agents|mesh-ancestor
6119795|NCT01111149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6119796|NCT01111149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119797|NCT01111149|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6119798|NCT01111149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6119799|NCT01111149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6119800|NCT01111149|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6119801|NCT01111149|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6119802|NCT01111149|Cholinergic Agents|cholinergic agents|mesh-ancestor
6119803|NCT01111162|Vaccines|vaccines|mesh-list
6119804|NCT01111162|Immunologic Factors|immunologic factors|mesh-ancestor
6119805|NCT01111162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119806|NCT01111292|Inositol|inositol|mesh-list
6119807|NCT01111292|Vitamin B Complex|vitamin b complex|mesh-ancestor
6119808|NCT01111292|Vitamins|vitamins|mesh-ancestor
6119809|NCT01111292|Micronutrients|micronutrients|mesh-ancestor
6119810|NCT01111292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119811|NCT01111318|Empagliflozin|empagliflozin|mesh-list
6119812|NCT01111318|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6119813|NCT01111318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119814|NCT01111318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6119815|NCT01111318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119816|NCT01111331|Empagliflozin|empagliflozin|mesh-list
6119817|NCT01111331|Warfarin|warfarin|mesh-list
6119818|NCT01111331|Anticoagulants|anticoagulants|mesh-ancestor
6465877|NCT00476216|Antithrombins|antithrombins|mesh-ancestor
6465878|NCT00476216|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6465879|NCT00476216|Protease Inhibitors|protease inhibitors|mesh-ancestor
6465880|NCT00476216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6465881|NCT00476216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465882|NCT00476216|Anticoagulants|anticoagulants|mesh-ancestor
6119819|NCT01111331|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6119820|NCT01111331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119821|NCT01111331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6119822|NCT01111331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119823|NCT01111461|Lenvatinib|lenvatinib|mesh-list
6119824|NCT01111461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6119825|NCT01111461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6119826|NCT01111461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6119827|NCT01111461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119828|NCT01111526|Panobinostat|panobinostat|mesh-list
6119829|NCT01111526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6119830|NCT01111526|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6119831|NCT01111526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6465883|NCT00476268|Beclomethasone|beclomethasone|mesh-list
6119832|NCT01111526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119833|NCT01111539|Aripiprazole|aripiprazole|mesh-list
6119834|NCT01111539|Citalopram|citalopram|mesh-list
6119835|NCT01111539|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6119836|NCT01111539|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6119837|NCT01111539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6119838|NCT01111539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5532023|NCT04242212|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5532024|NCT04242212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5532025|NCT04242212|Oxytocics|oxytocics|mesh-ancestor
5532026|NCT04242368|Fluticasone|fluticasone|mesh-list
5532027|NCT04242368|Xhance|xhance|mesh-list
5532028|NCT04242368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5532029|NCT04242368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5532030|NCT04242368|Autonomic Agents|autonomic agents|mesh-ancestor
5532031|NCT04242368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5532032|NCT04242368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532033|NCT04242368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5532034|NCT04242368|Respiratory System Agents|respiratory system agents|mesh-ancestor
5532035|NCT04242368|Dermatologic Agents|dermatologic agents|mesh-ancestor
6119839|NCT01111539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6119840|NCT01111539|Serotonin Agents|serotonin agents|mesh-ancestor
6119841|NCT01111539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119842|NCT01111539|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6119843|NCT01111539|Antidepressive Agents|antidepressive agents|mesh-ancestor
6119844|NCT01111539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6119845|NCT01111539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6119846|NCT01111539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6119847|NCT01111539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6119848|NCT01111539|Dopamine Agonists|dopamine agonists|mesh-ancestor
6119849|NCT01111539|Dopamine Agents|dopamine agents|mesh-ancestor
6119850|NCT01111539|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6119851|NCT01111539|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6119852|NCT01111539|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6119853|NCT01111539|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6119854|NCT01111539|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6119855|NCT01111539|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6119856|NCT01111552|Aripiprazole|aripiprazole|mesh-list
6119857|NCT01111552|Citalopram|citalopram|mesh-list
6119858|NCT01111552|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6119859|NCT01111552|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6119860|NCT01111552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6119861|NCT01111552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119862|NCT01111552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6119863|NCT01111552|Serotonin Agents|serotonin agents|mesh-ancestor
6119864|NCT01111552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119865|NCT01111552|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6119866|NCT01111552|Antidepressive Agents|antidepressive agents|mesh-ancestor
6119867|NCT01111552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6119868|NCT01111552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6119869|NCT01111552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6119870|NCT01111552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6119871|NCT01111552|Dopamine Agonists|dopamine agonists|mesh-ancestor
6119872|NCT01111552|Dopamine Agents|dopamine agents|mesh-ancestor
6119873|NCT01111552|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6119874|NCT01111552|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6119875|NCT01111552|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6119876|NCT01111552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6119877|NCT01111552|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6119878|NCT01111552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6465884|NCT00476268|Formoterol Fumarate|formoterol fumarate|mesh-list
5532036|NCT04242368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6119879|NCT01111604|Ramucirumab|ramucirumab|mesh-list
6119880|NCT01111604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6119881|NCT01111825|Sirolimus|sirolimus|mesh-list
6119882|NCT01111825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6119883|NCT01111825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6119884|NCT01111825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6119885|NCT01111825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6119886|NCT01111825|Antifungal Agents|antifungal agents|mesh-ancestor
6119887|NCT01111825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6119888|NCT01111825|Immunologic Factors|immunologic factors|mesh-ancestor
6119889|NCT01111825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119890|NCT01111851|Dexamethasone|dexamethasone|mesh-list
6119891|NCT01111851|Dexamethasone acetate|dexamethasone acetate|mesh-list
6119892|NCT01111851|Ondansetron|ondansetron|mesh-list
6119893|NCT01111851|Aprepitant|aprepitant|mesh-list
6119894|NCT01111851|Fosaprepitant|fosaprepitant|mesh-list
6119895|NCT01111851|BB 1101|bb 1101|mesh-list
6119896|NCT01111851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6119897|NCT01111851|Antiemetics|antiemetics|mesh-ancestor
6119898|NCT01111851|Autonomic Agents|autonomic agents|mesh-ancestor
6119899|NCT01111851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6119900|NCT01111851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119901|NCT01111851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5532037|NCT04242017|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5532038|NCT04242017|Luteolytic Agents|luteolytic agents|mesh-ancestor
5532039|NCT04242017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5532040|NCT04242017|Contraceptive Agents|contraceptive agents|mesh-ancestor
5532041|NCT04242017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5532042|NCT04242017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532043|NCT04242017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5532044|NCT04242017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5532045|NCT04242017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5601566|NCT05176288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601567|NCT05176288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5601568|NCT05176223|Edetic Acid|edetic acid|mesh-list
5601569|NCT05176223|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5601570|NCT05176223|Chelating Agents|chelating agents|mesh-ancestor
5601571|NCT05176223|Sequestering Agents|sequestering agents|mesh-ancestor
5606725|NCT03818737|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6119902|NCT01111851|Glucocorticoids|glucocorticoids|mesh-ancestor
6119903|NCT01111851|Hormones|hormones|mesh-ancestor
6119904|NCT01111851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6119905|NCT01111851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6119906|NCT01111851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6119907|NCT01111851|Protease Inhibitors|protease inhibitors|mesh-ancestor
6119908|NCT01111851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6119909|NCT01111851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119910|NCT01111851|Antipruritics|antipruritics|mesh-ancestor
6119911|NCT01111851|Dermatologic Agents|dermatologic agents|mesh-ancestor
6119912|NCT01111851|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6119913|NCT01111851|Serotonin Agents|serotonin agents|mesh-ancestor
6119914|NCT01111851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6119915|NCT01111851|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6119916|NCT01111851|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6119917|NCT01111851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6119918|NCT01111851|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6465885|NCT00476268|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6465886|NCT00476268|Autonomic Agents|autonomic agents|mesh-ancestor
6465887|NCT00476268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6465888|NCT00476268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465889|NCT00476268|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6465890|NCT00476268|Respiratory System Agents|respiratory system agents|mesh-ancestor
6465891|NCT00476268|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6465892|NCT00476268|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6465893|NCT00476268|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6465894|NCT00476268|Adrenergic Agents|adrenergic agents|mesh-ancestor
6465895|NCT00476268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6465896|NCT00476268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465897|NCT00476268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6465898|NCT00476268|Glucocorticoids|glucocorticoids|mesh-ancestor
6465899|NCT00476268|Hormones|hormones|mesh-ancestor
6465900|NCT00476268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6465901|NCT00476346|Vitamin D|vitamin d|mesh-list
6465902|NCT00476346|Calcium|calcium|mesh-list
6119919|NCT01111851|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6119920|NCT01111851|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6119921|NCT01112059|Doxycycline|doxycycline|mesh-list
6119922|NCT01112059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6119923|NCT01112059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6119924|NCT01112059|Antimalarials|antimalarials|mesh-ancestor
6119925|NCT01112059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6119926|NCT01112059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6119927|NCT01112241|Albuterol|albuterol|mesh-list
6119928|NCT01112241|Tiotropium Bromide|tiotropium bromide|mesh-list
6119929|NCT01112241|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5532046|NCT04241705|Lumefantrine|lumefantrine|mesh-list
6119930|NCT01112241|Autonomic Agents|autonomic agents|mesh-ancestor
6119931|NCT01112241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5532047|NCT04241705|Artemether|artemether|mesh-list
5532048|NCT04241705|Primaquine|primaquine|mesh-list
5532049|NCT04241705|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
5532050|NCT04241705|Antimalarials|antimalarials|mesh-ancestor
5532051|NCT04241705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5532052|NCT04241705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6119932|NCT01112241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119933|NCT01112241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6119934|NCT01112241|Respiratory System Agents|respiratory system agents|mesh-ancestor
6119935|NCT01112241|Parasympatholytics|parasympatholytics|mesh-ancestor
6119936|NCT01112241|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6119937|NCT01112241|Cholinergic Agents|cholinergic agents|mesh-ancestor
6119938|NCT01112241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6119939|NCT01112241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119940|NCT01112241|Tocolytic Agents|tocolytic agents|mesh-ancestor
6119941|NCT01112241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6119942|NCT01112241|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6119943|NCT01112241|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6119944|NCT01112241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6119945|NCT01112241|Adrenergic Agents|adrenergic agents|mesh-ancestor
6119946|NCT01112267|Acetaminophen|acetaminophen|mesh-list
6119947|NCT01112267|Tramadol|tramadol|mesh-list
6119948|NCT01112267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6119949|NCT01112267|Analgesics|analgesics|mesh-ancestor
6119950|NCT01112267|Sensory System Agents|sensory system agents|mesh-ancestor
6119951|NCT01112267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6119952|NCT01112267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119953|NCT01112267|Antipyretics|antipyretics|mesh-ancestor
6119954|NCT01112267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6119955|NCT01112267|Narcotics|narcotics|mesh-ancestor
6119956|NCT01112267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6119957|NCT01112358|Cetrorelix|cetrorelix|mesh-list
6119958|NCT01112358|Progesterone|progesterone|mesh-list
6119959|NCT01112358|Progestins|progestins|mesh-ancestor
6119960|NCT01112358|Hormones|hormones|mesh-ancestor
6119961|NCT01112358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6119962|NCT01112358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119963|NCT01112358|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6119964|NCT01112358|Fertility Agents|fertility agents|mesh-ancestor
6119965|NCT01112358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6119966|NCT01112358|Hormone Antagonists|hormone antagonists|mesh-ancestor
6204575|NCT02072824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6204576|NCT02072824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6204577|NCT02072824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6204578|NCT02072824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6204579|NCT02072824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6204580|NCT02072928|Botulinum Toxins|botulinum toxins|mesh-list
6204581|NCT02072928|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6465903|NCT00476346|Vitamins|vitamins|mesh-ancestor
5532053|NCT04241705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6119967|NCT01112670|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6119968|NCT01112670|Atorvastatin|atorvastatin|mesh-list
6119969|NCT01112670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6119970|NCT01112670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6119971|NCT01112670|Antimetabolites|antimetabolites|mesh-ancestor
6119972|NCT01112670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119973|NCT01112670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6119974|NCT01112670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6119975|NCT01112670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6119976|NCT01112670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5532054|NCT04241640|Nefopam|nefopam|mesh-list
5532055|NCT04241640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5532056|NCT04241640|Analgesics|analgesics|mesh-ancestor
6119977|NCT01112670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119978|NCT01112670|Incretins|incretins|mesh-ancestor
6119979|NCT01112670|Hormones|hormones|mesh-ancestor
6119980|NCT01112670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6119981|NCT01112670|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6119982|NCT01112670|Protease Inhibitors|protease inhibitors|mesh-ancestor
6119983|NCT01112683|Memantine|memantine|mesh-list
6119984|NCT01112683|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6119985|NCT01112683|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6119986|NCT01112683|Dopamine Agents|dopamine agents|mesh-ancestor
6119987|NCT01112683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6119988|NCT01112683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6119989|NCT01112683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6119990|NCT01112683|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6119991|NCT01112683|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6119992|NCT01112735|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6119993|NCT01112735|Hemostatics|hemostatics|mesh-ancestor
5532057|NCT04241640|Sensory System Agents|sensory system agents|mesh-ancestor
5532058|NCT04241640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5532059|NCT04241640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532060|NCT04241653|Sevoflurane|sevoflurane|mesh-list
5532061|NCT04241653|Anesthetics|anesthetics|mesh-ancestor
6119994|NCT01112735|Coagulants|coagulants|mesh-ancestor
6119995|NCT01112982|Colchicine|colchicine|mesh-list
6119996|NCT01112982|Febuxostat|febuxostat|mesh-list
6119997|NCT01112982|Gout Suppressants|gout suppressants|mesh-ancestor
6119998|NCT01112982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6119999|NCT01112982|Tubulin Modulators|tubulin modulators|mesh-ancestor
6120000|NCT01112982|Antimitotic Agents|antimitotic agents|mesh-ancestor
6120001|NCT01112982|Mitosis Modulators|mitosis modulators|mesh-ancestor
6120002|NCT01112982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120003|NCT01112982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6120004|NCT01113398|Bevacizumab|bevacizumab|mesh-list
6120005|NCT01113398|Rilotumumab|rilotumumab|mesh-list
6120006|NCT01113398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6120007|NCT01113398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6120008|NCT01113398|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6120009|NCT01113398|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6120010|NCT01113398|Growth Substances|growth substances|mesh-ancestor
6120011|NCT01113398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120012|NCT01113398|Growth Inhibitors|growth inhibitors|mesh-ancestor
6120013|NCT01113541|Ziprasidone|ziprasidone|mesh-list
6120014|NCT01113541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6120015|NCT01113541|Serotonin Agents|serotonin agents|mesh-ancestor
6120016|NCT01113541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6120017|NCT01113541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120018|NCT01113541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120019|NCT01113541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6120020|NCT01113541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6120021|NCT01113541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6120022|NCT01113541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6120023|NCT01113541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6120024|NCT01113541|Dopamine Agents|dopamine agents|mesh-ancestor
6120025|NCT01113632|Ofatumumab|ofatumumab|mesh-list
6120026|NCT01113632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6120027|NCT01113710|Rotigotine|rotigotine|mesh-list
6120028|NCT01113710|Dopamine Agonists|dopamine agonists|mesh-ancestor
6120029|NCT01113710|Dopamine Agents|dopamine agents|mesh-ancestor
6120030|NCT01113710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6465904|NCT00476346|Micronutrients|micronutrients|mesh-ancestor
5532062|NCT04241653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6120031|NCT01113710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120032|NCT01113710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120033|NCT01113931|Doxycycline|doxycycline|mesh-list
6120034|NCT01113931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6120035|NCT01113931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6120036|NCT01113931|Antimalarials|antimalarials|mesh-ancestor
6120037|NCT01113931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6120038|NCT01113931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6120039|NCT01114139|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
6120040|NCT01114139|Hematinics|hematinics|mesh-ancestor
6120041|NCT01114139|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6120042|NCT01114139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6120043|NCT01114204|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
6120044|NCT01114204|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6120045|NCT01114204|Hematinics|hematinics|mesh-ancestor
6120046|NCT01114204|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6120047|NCT01114204|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6120048|NCT01114217|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
6120049|NCT01114217|Hematinics|hematinics|mesh-ancestor
6120050|NCT01114217|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6120051|NCT01114217|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6120052|NCT01114360|Melatonin|melatonin|mesh-list
6120053|NCT01114360|Antioxidants|antioxidants|mesh-ancestor
6120054|NCT01114360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120055|NCT01114360|Protective Agents|protective agents|mesh-ancestor
6120056|NCT01114360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120057|NCT01114360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6120058|NCT01114373|Melatonin|melatonin|mesh-list
6120059|NCT01114373|Antioxidants|antioxidants|mesh-ancestor
6120060|NCT01114373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120061|NCT01114373|Protective Agents|protective agents|mesh-ancestor
6120062|NCT01114373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120063|NCT01114373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6120064|NCT01114503|Methylprednisolone|methylprednisolone|mesh-list
6120065|NCT01114503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5532063|NCT04241653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532064|NCT04241653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5532065|NCT04241653|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5532066|NCT04241653|Anesthetics, General|anesthetics, general|mesh-ancestor
5532067|NCT04241731|Cetuximab|cetuximab|mesh-list
5532068|NCT04241731|Raltitrexed|raltitrexed|mesh-list
5532069|NCT04241731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5532070|NCT04241731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5532071|NCT04241731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5532072|NCT04241731|Antimetabolites|antimetabolites|mesh-ancestor
5532073|NCT04241731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5532074|NCT04241731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5532075|NCT04241731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5532076|NCT04241744|Vancomycin|vancomycin|mesh-list
5532077|NCT04241744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6120066|NCT01114503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6120067|NCT01114503|Prednisolone|prednisolone|mesh-list
6120068|NCT01114503|Prednisolone acetate|prednisolone acetate|mesh-list
6120069|NCT01114503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6120070|NCT01114503|Prednisolone phosphate|prednisolone phosphate|mesh-list
6120071|NCT01114503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6120072|NCT01114503|Antiemetics|antiemetics|mesh-ancestor
6120073|NCT01114503|Autonomic Agents|autonomic agents|mesh-ancestor
6120074|NCT01114503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6120075|NCT01114503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120076|NCT01114503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6120077|NCT01114503|Glucocorticoids|glucocorticoids|mesh-ancestor
6120078|NCT01114503|Hormones|hormones|mesh-ancestor
6120079|NCT01114503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6120080|NCT01114503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5532078|NCT04241744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5532079|NCT04241887|Anesthetics|anesthetics|mesh-list
5532080|NCT04241887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5532081|NCT04241887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532082|NCT04241601|Aldesleukin|aldesleukin|mesh-list
5532083|NCT04241601|Interleukin-2|interleukin-2|mesh-list
5532084|NCT04241601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5532085|NCT04241601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5532086|NCT04241601|Analgesics|analgesics|mesh-ancestor
5532087|NCT04241601|Sensory System Agents|sensory system agents|mesh-ancestor
5725486|NCT03180125|Viscosupplements|viscosupplements|mesh-ancestor
6120081|NCT01114503|Protective Agents|protective agents|mesh-ancestor
6204582|NCT02072928|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6120082|NCT01114503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6120083|NCT01114503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6120084|NCT01114516|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5532088|NCT04241601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5532089|NCT04241601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532090|NCT04241601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5532091|NCT04241601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5532092|NCT04241601|Antiviral Agents|antiviral agents|mesh-ancestor
6120085|NCT01114516|Clindamycin|clindamycin|mesh-list
6120086|NCT01114516|Clindamycin palmitate|clindamycin palmitate|mesh-list
6120087|NCT01114516|Clindamycin phosphate|clindamycin phosphate|mesh-list
5532093|NCT04241601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5532094|NCT04241562|Mitogens|mitogens|mesh-list
5532095|NCT04241562|Mitosis Modulators|mitosis modulators|mesh-ancestor
5532096|NCT04241562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120088|NCT01114516|Cefazolin|cefazolin|mesh-list
6120089|NCT01114516|Indomethacin|indomethacin|mesh-list
6120090|NCT01114516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6120091|NCT01114516|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6120092|NCT01114516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6120093|NCT01114516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120094|NCT01114516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6120095|NCT01114516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6120096|NCT01114516|Analgesics|analgesics|mesh-ancestor
6120097|NCT01114516|Sensory System Agents|sensory system agents|mesh-ancestor
6120098|NCT01114516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5532097|NCT04241523|Lenvatinib|lenvatinib|mesh-list
5532098|NCT04241523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5532099|NCT04241523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6465905|NCT00476346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465906|NCT00476346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6465907|NCT00476346|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6465908|NCT00476359|Lopinavir|lopinavir|mesh-list
6465909|NCT00476359|Saquinavir|saquinavir|mesh-list
6465910|NCT00476359|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6465911|NCT00476359|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6465912|NCT00476359|Protease Inhibitors|protease inhibitors|mesh-ancestor
6465913|NCT00476359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6465914|NCT00476359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465915|NCT00476359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6120099|NCT01114516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120100|NCT01114516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6120101|NCT01114516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6120102|NCT01114516|Gout Suppressants|gout suppressants|mesh-ancestor
6120103|NCT01114516|Tocolytic Agents|tocolytic agents|mesh-ancestor
6120104|NCT01114516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6120105|NCT01114516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6120106|NCT01114529|Cyclosporine|cyclosporine|mesh-list
6120107|NCT01114529|Everolimus|everolimus|mesh-list
6120108|NCT01114529|Tacrolimus|tacrolimus|mesh-list
6120109|NCT01114529|Cyclosporins|cyclosporins|mesh-list
6120110|NCT01114529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6120111|NCT01114529|Immunologic Factors|immunologic factors|mesh-ancestor
6120112|NCT01114529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120113|NCT01114529|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6120114|NCT01114529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6120115|NCT01114529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120116|NCT01114529|Antifungal Agents|antifungal agents|mesh-ancestor
6120117|NCT01114529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6120118|NCT01114529|Dermatologic Agents|dermatologic agents|mesh-ancestor
5532100|NCT04241523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5532101|NCT04241523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5532102|NCT04241380|Heparin|heparin|mesh-list
5532103|NCT04241380|Anticoagulants|anticoagulants|mesh-list
5532104|NCT04241380|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5532105|NCT04241380|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5532106|NCT04241380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5532107|NCT04241380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5532108|NCT04241211|Denosumab|denosumab|mesh-list
5532109|NCT04241211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5532110|NCT04241211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532111|NCT04241458|Midazolam|midazolam|mesh-list
5532112|NCT04241458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5532113|NCT04241458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5725487|NCT03180125|Protective Agents|protective agents|mesh-ancestor
6120119|NCT01114529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6120120|NCT01114529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6120121|NCT01114555|Bevacizumab|bevacizumab|mesh-list
6120122|NCT01114555|Irinotecan|irinotecan|mesh-list
6120123|NCT01114555|Temozolomide|temozolomide|mesh-list
6120124|NCT01114555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6120125|NCT01114555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6120126|NCT01114555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6120127|NCT01114555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6120128|NCT01114555|Growth Substances|growth substances|mesh-ancestor
6120129|NCT01114555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120130|NCT01114555|Growth Inhibitors|growth inhibitors|mesh-ancestor
6120131|NCT01114555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6120132|NCT01114555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6120133|NCT01114555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6120134|NCT01114555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120135|NCT01114555|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6120136|NCT01114555|Alkylating Agents|alkylating agents|mesh-ancestor
6120137|NCT01114581|Phenylpropanolamine|phenylpropanolamine|mesh-list
6120138|NCT01114581|Guaifenesin|guaifenesin|mesh-list
6120139|NCT01114581|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
6120140|NCT01114581|Expectorants|expectorants|mesh-ancestor
6120141|NCT01114581|Respiratory System Agents|respiratory system agents|mesh-ancestor
6120142|NCT01114581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6120143|NCT01114581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6120144|NCT01114581|Adrenergic Agents|adrenergic agents|mesh-ancestor
6120145|NCT01114581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6120146|NCT01114581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120147|NCT01114581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120148|NCT01114581|Appetite Depressants|appetite depressants|mesh-ancestor
6120149|NCT01114581|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6120150|NCT01114581|Sympathomimetics|sympathomimetics|mesh-ancestor
6120151|NCT01114581|Autonomic Agents|autonomic agents|mesh-ancestor
5532114|NCT04241458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5532115|NCT04241458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532116|NCT04241458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5532117|NCT04241458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5532118|NCT04241458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5532119|NCT04241458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5532120|NCT04241458|Anesthetics, General|anesthetics, general|mesh-ancestor
5532121|NCT04241458|Anesthetics|anesthetics|mesh-ancestor
5532122|NCT04241458|GABA Modulators|gaba modulators|mesh-ancestor
5532123|NCT04241458|GABA Agents|gaba agents|mesh-ancestor
5532124|NCT04241458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5532125|NCT04241458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5532126|NCT04241276|Gemcitabine|gemcitabine|mesh-list
5532127|NCT04241276|Paclitaxel|paclitaxel|mesh-list
6120152|NCT01114581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6120153|NCT01114581|Nasal Decongestants|nasal decongestants|mesh-ancestor
6120154|NCT01114581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6120155|NCT01114672|Ergocalciferols|ergocalciferols|mesh-list
6120156|NCT01114672|Vitamin D|vitamin d|mesh-list
6120157|NCT01114672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6120158|NCT01114672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120159|NCT01114672|Vitamins|vitamins|mesh-ancestor
6120160|NCT01114672|Micronutrients|micronutrients|mesh-ancestor
6120161|NCT01114672|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6120162|NCT01114737|Verapamil|verapamil|mesh-list
5532128|NCT04241276|Tretinoin|tretinoin|mesh-list
5532129|NCT04241276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5532130|NCT04241276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5532131|NCT04241276|Tubulin Modulators|tubulin modulators|mesh-ancestor
5532132|NCT04241276|Antimitotic Agents|antimitotic agents|mesh-ancestor
5532133|NCT04241276|Mitosis Modulators|mitosis modulators|mesh-ancestor
5532134|NCT04241276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120163|NCT01114737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6120164|NCT01114737|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6120165|NCT01114737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6120166|NCT01114737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120167|NCT01114737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6120168|NCT01114737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120169|NCT01114737|Vasodilator Agents|vasodilator agents|mesh-ancestor
6120170|NCT01114828|Tolvaptan|tolvaptan|mesh-list
6120171|NCT01114828|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6120172|NCT01114828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120173|NCT01114828|Natriuretic Agents|natriuretic agents|mesh-ancestor
6120174|NCT01114828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120175|NCT01114880|Adalimumab|adalimumab|mesh-list
6120176|NCT01114880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6120177|NCT01114880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6120178|NCT01114893|Travoprost|travoprost|mesh-list
6120179|NCT01114893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6120180|NCT01114971|Labetalol|labetalol|mesh-list
6120181|NCT01114971|Fentanyl|fentanyl|mesh-list
6120182|NCT01114971|Esmolol|esmolol|mesh-list
6120183|NCT01114971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6120184|NCT01114971|Narcotics|narcotics|mesh-ancestor
6120185|NCT01114971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6120186|NCT01114971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120187|NCT01114971|Analgesics|analgesics|mesh-ancestor
6120188|NCT01114971|Sensory System Agents|sensory system agents|mesh-ancestor
6120189|NCT01114971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6120190|NCT01114971|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6120191|NCT01114971|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6120192|NCT01114971|Anesthetics, General|anesthetics, general|mesh-ancestor
6120193|NCT01114971|Anesthetics|anesthetics|mesh-ancestor
6120194|NCT01114971|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6120195|NCT01114971|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6120196|NCT01114971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6120197|NCT01114971|Adrenergic Agents|adrenergic agents|mesh-ancestor
6120198|NCT01114971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6120199|NCT01114971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120200|NCT01114971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6120201|NCT01114971|Sympathomimetics|sympathomimetics|mesh-ancestor
5532135|NCT04241276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5532136|NCT04241276|Antimetabolites|antimetabolites|mesh-ancestor
5532137|NCT04241276|Antiviral Agents|antiviral agents|mesh-ancestor
5532138|NCT04241276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5532139|NCT04241276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5532140|NCT04241276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5532141|NCT04241276|Immunologic Factors|immunologic factors|mesh-ancestor
5532142|NCT04241276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120202|NCT01114971|Autonomic Agents|autonomic agents|mesh-ancestor
6120203|NCT01114971|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6120204|NCT01114971|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6120205|NCT01114997|Lidocaine|lidocaine|mesh-list
6120206|NCT01114997|Esmolol|esmolol|mesh-list
6120207|NCT01114997|Anesthetics, Local|anesthetics, local|mesh-ancestor
6120208|NCT01114997|Anesthetics|anesthetics|mesh-ancestor
6120209|NCT01114997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6120210|NCT01114997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120211|NCT01114997|Sensory System Agents|sensory system agents|mesh-ancestor
6120212|NCT01114997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6120213|NCT01114997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6120214|NCT01114997|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6120215|NCT01114997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6120216|NCT01114997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6120217|NCT01114997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120218|NCT01114997|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6120219|NCT01114997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6120220|NCT01114997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6120221|NCT01114997|Adrenergic Agents|adrenergic agents|mesh-ancestor
6120222|NCT01114997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6120223|NCT01115101|Pirinitramide|pirinitramide|mesh-list
5532143|NCT04241276|Keratolytic Agents|keratolytic agents|mesh-ancestor
5532144|NCT04241276|Dermatologic Agents|dermatologic agents|mesh-ancestor
5532145|NCT04240821|Theophylline|theophylline|mesh-list
5532146|NCT04240821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5532147|NCT04240821|Autonomic Agents|autonomic agents|mesh-ancestor
5532148|NCT04240821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6120224|NCT01115101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6120225|NCT01115101|Narcotics|narcotics|mesh-ancestor
6120226|NCT01115101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6120227|NCT01115101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120228|NCT01115101|Analgesics|analgesics|mesh-ancestor
6120229|NCT01115101|Sensory System Agents|sensory system agents|mesh-ancestor
6120230|NCT01115101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6120231|NCT01115491|Bevacizumab|bevacizumab|mesh-list
6465916|NCT00476359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6465917|NCT00476359|Antiviral Agents|antiviral agents|mesh-ancestor
6465918|NCT00476359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6465919|NCT00476359|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6465920|NCT00476359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6465921|NCT00476424|Efavirenz|efavirenz|mesh-list
6465922|NCT00476424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5532149|NCT04240821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532150|NCT04240821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5532151|NCT04240821|Respiratory System Agents|respiratory system agents|mesh-ancestor
5532152|NCT04240821|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5532153|NCT04240821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5532154|NCT04240821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5532155|NCT04240821|Vasodilator Agents|vasodilator agents|mesh-ancestor
5532156|NCT04240821|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5532157|NCT04240821|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5532158|NCT04240821|Purinergic Agents|purinergic agents|mesh-ancestor
5532159|NCT04240821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5532160|NCT04240756|Amphetamine|amphetamine|mesh-list
5532161|NCT04240756|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5532162|NCT04240756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532163|NCT04240756|Sympathomimetics|sympathomimetics|mesh-ancestor
5532164|NCT04240756|Autonomic Agents|autonomic agents|mesh-ancestor
5532165|NCT04240756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5532166|NCT04240756|Dopamine Agents|dopamine agents|mesh-ancestor
5532167|NCT04240756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5532168|NCT04240756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5532169|NCT04240756|Adrenergic Agents|adrenergic agents|mesh-ancestor
5532170|NCT04240756|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5532171|NCT04240756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5532172|NCT04240756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5532173|NCT04240756|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5532174|NCT04240834|Aspirin|aspirin|mesh-list
6465923|NCT00476424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6465924|NCT00476424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6465925|NCT00476424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465926|NCT00476424|Antiviral Agents|antiviral agents|mesh-ancestor
6465927|NCT00476424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6465928|NCT00476424|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6465929|NCT00476424|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6120232|NCT01115491|Temozolomide|temozolomide|mesh-list
6120233|NCT01115491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6120234|NCT01115491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6120235|NCT01115491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6120236|NCT01115491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6120237|NCT01115491|Growth Substances|growth substances|mesh-ancestor
6120238|NCT01115491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120239|NCT01115491|Growth Inhibitors|growth inhibitors|mesh-ancestor
6120240|NCT01115491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6120241|NCT01115491|Alkylating Agents|alkylating agents|mesh-ancestor
6120242|NCT01115491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120243|NCT01115517|Bevacizumab|bevacizumab|mesh-list
6120244|NCT01115517|Mitomycins|mitomycins|mesh-list
6120245|NCT01115517|Mitomycin|mitomycin|mesh-list
5532175|NCT04240834|Ticagrelor|ticagrelor|mesh-list
5532176|NCT04240834|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5532177|NCT04240834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5532178|NCT04240834|Analgesics|analgesics|mesh-ancestor
5532179|NCT04240834|Sensory System Agents|sensory system agents|mesh-ancestor
5532180|NCT04240834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6120246|NCT01115517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6120247|NCT01115517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6120248|NCT01115517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6120249|NCT01115517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6120250|NCT01115517|Growth Substances|growth substances|mesh-ancestor
6120251|NCT01115517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120252|NCT01115517|Growth Inhibitors|growth inhibitors|mesh-ancestor
6120253|NCT01115517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6120254|NCT01115517|Alkylating Agents|alkylating agents|mesh-ancestor
6120255|NCT01115517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120256|NCT01115517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6120257|NCT01115517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6120258|NCT01115556|Ranibizumab|ranibizumab|mesh-list
6120259|NCT01115556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6120260|NCT01115556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6120261|NCT01115556|Growth Substances|growth substances|mesh-ancestor
6120262|NCT01115556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120263|NCT01115556|Growth Inhibitors|growth inhibitors|mesh-ancestor
6120264|NCT01115556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6120265|NCT01115569|Hydrocodone|hydrocodone|mesh-list
6120266|NCT01115569|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6120267|NCT01115569|Narcotics|narcotics|mesh-ancestor
6120268|NCT01115569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6120269|NCT01115569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120270|NCT01115569|Analgesics|analgesics|mesh-ancestor
6120271|NCT01115569|Sensory System Agents|sensory system agents|mesh-ancestor
6120272|NCT01115569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6120273|NCT01115569|Antitussive Agents|antitussive agents|mesh-ancestor
6120274|NCT01115569|Respiratory System Agents|respiratory system agents|mesh-ancestor
6120275|NCT01115582|Cholic Acids|cholic acids|mesh-list
6120276|NCT01115582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6120277|NCT01115673|Acetaminophen|acetaminophen|mesh-list
6120278|NCT01115673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6120279|NCT01115673|Analgesics|analgesics|mesh-ancestor
6120280|NCT01115673|Sensory System Agents|sensory system agents|mesh-ancestor
6120281|NCT01115673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6120282|NCT01115673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532181|NCT04240834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532182|NCT04240834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5532183|NCT04240834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5532184|NCT04240834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5532185|NCT04240834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6120283|NCT01115673|Antipyretics|antipyretics|mesh-ancestor
6120284|NCT01115738|Clopidogrel|clopidogrel|mesh-list
6120285|NCT01115738|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
5532186|NCT04240834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5532187|NCT04240834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5532188|NCT04240834|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5532189|NCT04240834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5532190|NCT04240834|Antipyretics|antipyretics|mesh-ancestor
5532191|NCT04240834|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5532192|NCT04240834|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5532193|NCT04240834|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5532194|NCT04240834|Purinergic Agents|purinergic agents|mesh-ancestor
5532195|NCT04240834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5532196|NCT04240496|Clozapine|clozapine|mesh-list
5532197|NCT04240496|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5532198|NCT04240496|Serotonin Agents|serotonin agents|mesh-ancestor
5532199|NCT04240496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5532200|NCT04240496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725488|NCT03180242|Trastuzumab|trastuzumab|mesh-list
6120286|NCT01115738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6120287|NCT01115738|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6120288|NCT01115738|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6120289|NCT01115738|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6120290|NCT01115738|Purinergic Agents|purinergic agents|mesh-ancestor
6120291|NCT01115738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6120292|NCT01115738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120293|NCT01115738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120294|NCT01115803|Everolimus|everolimus|mesh-list
6120295|NCT01115803|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6120296|NCT01115803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6120297|NCT01115803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6120298|NCT01115803|Immunologic Factors|immunologic factors|mesh-ancestor
6120299|NCT01115803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120300|NCT01115803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6120301|NCT01115803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6120302|NCT01115803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120303|NCT01115855|Eplerenone|eplerenone|mesh-list
6120304|NCT01115855|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6120305|NCT01115855|Hormone Antagonists|hormone antagonists|mesh-ancestor
6120306|NCT01115855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6120307|NCT01115855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120308|NCT01115855|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6120309|NCT01115855|Diuretics|diuretics|mesh-ancestor
6120310|NCT01115855|Natriuretic Agents|natriuretic agents|mesh-ancestor
6120311|NCT01115855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6120312|NCT01116102|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6120313|NCT01116401|Leuprolide|leuprolide|mesh-list
6120314|NCT01116401|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6120315|NCT01116401|Fertility Agents|fertility agents|mesh-ancestor
6120316|NCT01116401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6120317|NCT01116401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120318|NCT01116401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6120319|NCT01116401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6120320|NCT01116427|Abatacept|abatacept|mesh-list
6120321|NCT01116427|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6120322|NCT01116427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120323|NCT01116427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6120324|NCT01116427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5532201|NCT04240496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532202|NCT04240496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5532203|NCT04240496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5532204|NCT04240496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5532205|NCT04240496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5532206|NCT04240496|GABA Antagonists|gaba antagonists|mesh-ancestor
5532207|NCT04240496|GABA Agents|gaba agents|mesh-ancestor
5532208|NCT04240626|Acetaminophen|acetaminophen|mesh-list
5532209|NCT04240626|Scopolamine|scopolamine|mesh-list
5532210|NCT04240626|Oxycodone|oxycodone|mesh-list
5532211|NCT04240626|Gabapentin|gabapentin|mesh-list
5532212|NCT04240626|Hydromorphone|hydromorphone|mesh-list
5532213|NCT04240626|Hydrocodone|hydrocodone|mesh-list
5532214|NCT04240626|Bupivacaine|bupivacaine|mesh-list
5532215|NCT04240626|Cyclobenzaprine|cyclobenzaprine|mesh-list
5532216|NCT04240626|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
5532217|NCT04240626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6120325|NCT01116427|Immunologic Factors|immunologic factors|mesh-ancestor
6120326|NCT01116427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120327|NCT01116427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6120328|NCT01116687|R04929097|r04929097|mesh-list
6120329|NCT01116687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6120330|NCT01116687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120331|NCT01116739|Fluorides|fluorides|mesh-list
6120332|NCT01116739|Fluorides, Topical|fluorides, topical|mesh-list
6120333|NCT01116739|Cariostatic Agents|cariostatic agents|mesh-ancestor
6120334|NCT01116739|Protective Agents|protective agents|mesh-ancestor
6120335|NCT01116739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120336|NCT01116921|Pulmonary Surfactants|pulmonary surfactants|mesh-list
6120337|NCT01116921|Respiratory System Agents|respiratory system agents|mesh-ancestor
6120338|NCT01116986|Nicotine|nicotine|mesh-list
6120339|NCT01116986|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6120340|NCT01116986|Autonomic Agents|autonomic agents|mesh-ancestor
6120341|NCT01116986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6120342|NCT01116986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120343|NCT01116986|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6120344|NCT01116986|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6120345|NCT01116986|Cholinergic Agents|cholinergic agents|mesh-ancestor
6120346|NCT01116986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6120347|NCT01116986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120348|NCT01117012|Ivacaftor|ivacaftor|mesh-list
6120349|NCT01117012|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6120350|NCT01117012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6120351|NCT01117012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120352|NCT01117051|Prucalopride|prucalopride|mesh-list
6120353|NCT01117051|Laxatives|laxatives|mesh-ancestor
6120354|NCT01117051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6120355|NCT01117051|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
6120356|NCT01117051|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6120357|NCT01117051|Serotonin Agents|serotonin agents|mesh-ancestor
6120358|NCT01117051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6120359|NCT01117051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120360|NCT01117051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120361|NCT01117181|Methylphenidate|methylphenidate|mesh-list
5532218|NCT04240626|Analgesics|analgesics|mesh-ancestor
5532219|NCT04240626|Sensory System Agents|sensory system agents|mesh-ancestor
5532220|NCT04240626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5532221|NCT04240626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532222|NCT04240626|Antipyretics|antipyretics|mesh-ancestor
5532223|NCT04240626|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5532224|NCT04240626|Narcotics|narcotics|mesh-ancestor
5532225|NCT04240626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5532226|NCT04240626|Anticonvulsants|anticonvulsants|mesh-ancestor
5532227|NCT04240626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5532228|NCT04240626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5532229|NCT04240626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5532230|NCT04240626|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5532231|NCT04240626|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5532232|NCT04240626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5532233|NCT04240626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120362|NCT01117181|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6120363|NCT01117181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120364|NCT01117181|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6120365|NCT01117181|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6120366|NCT01117181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6120367|NCT01117181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5532234|NCT04240626|Antimanic Agents|antimanic agents|mesh-ancestor
5532235|NCT04240626|Anesthetics, Local|anesthetics, local|mesh-ancestor
5532236|NCT04240626|Anesthetics|anesthetics|mesh-ancestor
5532237|NCT04240626|Antiemetics|antiemetics|mesh-ancestor
5532238|NCT04240626|Autonomic Agents|autonomic agents|mesh-ancestor
5532239|NCT04240626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5532240|NCT04240626|Antitussive Agents|antitussive agents|mesh-ancestor
5532241|NCT04240626|Respiratory System Agents|respiratory system agents|mesh-ancestor
5532242|NCT04240626|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5532243|NCT04240626|Mydriatics|mydriatics|mesh-ancestor
5532244|NCT04240626|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5532245|NCT04240626|Cholinergic Agents|cholinergic agents|mesh-ancestor
5532246|NCT04240626|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5532247|NCT04240626|Parasympatholytics|parasympatholytics|mesh-ancestor
5532248|NCT04240626|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5532249|NCT04240626|Antidepressive Agents|antidepressive agents|mesh-ancestor
5532250|NCT04240626|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6120368|NCT01117181|Dopamine Agents|dopamine agents|mesh-ancestor
6120369|NCT01117181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6120370|NCT01117350|Metformin|metformin|mesh-list
6120371|NCT01117350|Insulin Glargine|insulin glargine|mesh-list
6120372|NCT01117350|Liraglutide|liraglutide|mesh-list
6120373|NCT01117350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6120374|NCT01117350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120375|NCT01117350|Incretins|incretins|mesh-ancestor
6120376|NCT01117350|Hormones|hormones|mesh-ancestor
6120377|NCT01117350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6120378|NCT01117454|Flecainide|flecainide|mesh-list
6120379|NCT01117454|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
6120380|NCT01117454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6120381|NCT01117454|Adrenergic Agents|adrenergic agents|mesh-ancestor
6120382|NCT01117454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6120383|NCT01117454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120384|NCT01117454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120385|NCT01117454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6120386|NCT01117454|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6120387|NCT01117454|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6120388|NCT01117454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6120389|NCT01117766|Pregabalin|pregabalin|mesh-list
6120390|NCT01117766|Analgesics|analgesics|mesh-ancestor
6120391|NCT01117766|Sensory System Agents|sensory system agents|mesh-ancestor
6120392|NCT01117766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6120393|NCT01117766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120394|NCT01117766|Anticonvulsants|anticonvulsants|mesh-ancestor
6120395|NCT01117766|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6120396|NCT01117766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6120397|NCT01117766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120398|NCT01117766|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6120399|NCT01117766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6120400|NCT01117766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6120401|NCT01117766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6120402|NCT01117766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5532251|NCT04240626|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5532252|NCT04240535|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6120403|NCT01117857|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6120404|NCT01117857|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6120405|NCT01117857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6120406|NCT01117857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6120407|NCT01117857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120408|NCT01117857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6120409|NCT01117857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120410|NCT01117857|Analgesics|analgesics|mesh-ancestor
6120411|NCT01117857|Sensory System Agents|sensory system agents|mesh-ancestor
6120412|NCT01117857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6120413|NCT01117857|Antidepressive Agents|antidepressive agents|mesh-ancestor
6120414|NCT01117857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5532253|NCT04240535|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5532254|NCT04240535|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5532255|NCT04240535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5532256|NCT04240535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532257|NCT04240535|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5532258|NCT04240535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6120415|NCT01117857|Dopamine Agents|dopamine agents|mesh-ancestor
6120416|NCT01117948|Lornoxicam|lornoxicam|mesh-list
6120417|NCT01117948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6120418|NCT01117948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6120419|NCT01117948|Analgesics|analgesics|mesh-ancestor
6120420|NCT01117948|Sensory System Agents|sensory system agents|mesh-ancestor
6120421|NCT01117948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6120422|NCT01117948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120423|NCT01117948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6120424|NCT01117948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5532259|NCT04240535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5532260|NCT04240535|Cholinergic Agents|cholinergic agents|mesh-ancestor
5532261|NCT04240535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5601572|NCT05176223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601573|NCT05176223|Anticoagulants|anticoagulants|mesh-ancestor
6120425|NCT01117987|Imatinib Mesylate|imatinib mesylate|mesh-list
6120426|NCT01117987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6120427|NCT01117987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6120428|NCT01117987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6120429|NCT01117987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120430|NCT01118091|Aldesleukin|aldesleukin|mesh-list
6120431|NCT01118091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6120432|NCT01118091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6120433|NCT01118091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6120434|NCT01118091|Antiviral Agents|antiviral agents|mesh-ancestor
6120435|NCT01118091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6204583|NCT02072928|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6204584|NCT02072928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6204585|NCT02072928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204586|NCT02072928|Cholinergic Agents|cholinergic agents|mesh-ancestor
6204587|NCT02072928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6204588|NCT02072928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204589|NCT02072928|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6204590|NCT02072928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6204591|NCT02073448|Adapalene|adapalene|mesh-list
6204592|NCT02073448|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6204593|NCT02073448|Dermatologic Agents|dermatologic agents|mesh-ancestor
6204594|NCT02073448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6204595|NCT02073448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6204596|NCT02073448|Analgesics|analgesics|mesh-ancestor
6204597|NCT02073448|Sensory System Agents|sensory system agents|mesh-ancestor
6204598|NCT02073448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6204599|NCT02073448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204600|NCT02073448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6204601|NCT02073448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6204602|NCT02073461|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6204603|NCT02073461|Dermatologic Agents|dermatologic agents|mesh-ancestor
6204604|NCT02073487|Paclitaxel|paclitaxel|mesh-list
6204605|NCT02073487|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
6204606|NCT02073487|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6204607|NCT02073487|Trastuzumab|trastuzumab|mesh-list
6204608|NCT02073487|Lapatinib|lapatinib|mesh-list
6204609|NCT02073487|Pertuzumab|pertuzumab|mesh-list
6204610|NCT02073487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6204611|NCT02073487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6204612|NCT02073487|Tubulin Modulators|tubulin modulators|mesh-ancestor
6120436|NCT01118273|Diphenhydramine|diphenhydramine|mesh-list
5532262|NCT04239794|Propofol|propofol|mesh-list
5532263|NCT04239794|Sevoflurane|sevoflurane|mesh-list
5532264|NCT04239794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5532265|NCT04239794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5532266|NCT04239794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532267|NCT04239794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6120437|NCT01118273|Promethazine|promethazine|mesh-list
6120438|NCT01118273|Ibuprofen|ibuprofen|mesh-list
6120439|NCT01118273|Naproxen|naproxen|mesh-list
6120440|NCT01118273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120441|NCT01118273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6120442|NCT01118273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6120443|NCT01118273|Analgesics|analgesics|mesh-ancestor
6120444|NCT01118273|Sensory System Agents|sensory system agents|mesh-ancestor
6120445|NCT01118273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6120446|NCT01118273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120447|NCT01118273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6120448|NCT01118273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6120449|NCT01118273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6120450|NCT01118273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6120451|NCT01118273|Gout Suppressants|gout suppressants|mesh-ancestor
6120452|NCT01118273|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6120453|NCT01118273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6120454|NCT01118273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6120455|NCT01118273|Anesthetics, Local|anesthetics, local|mesh-ancestor
6120456|NCT01118273|Anesthetics|anesthetics|mesh-ancestor
6120457|NCT01118273|Antiemetics|antiemetics|mesh-ancestor
6120458|NCT01118273|Autonomic Agents|autonomic agents|mesh-ancestor
6120459|NCT01118273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6120460|NCT01118273|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5532268|NCT04239794|Anesthetics, General|anesthetics, general|mesh-ancestor
5532269|NCT04239794|Anesthetics|anesthetics|mesh-ancestor
5532270|NCT04239794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5532271|NCT04239794|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5532272|NCT04239833|Gefitinib|gefitinib|mesh-list
5532273|NCT04239833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5532274|NCT04239833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5532275|NCT04239833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5532276|NCT04239833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5532277|NCT04239872|Calcium, Dietary|calcium, dietary|mesh-list
5532278|NCT04239872|Calcium|calcium|mesh-list
5532279|NCT04239872|Fluorides|fluorides|mesh-list
5532280|NCT04239872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5532281|NCT04239872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532282|NCT04239872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6120461|NCT01118273|Histamine Antagonists|histamine antagonists|mesh-ancestor
6120462|NCT01118273|Histamine Agents|histamine agents|mesh-ancestor
6120463|NCT01118273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6120464|NCT01118273|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6120465|NCT01118273|Antipruritics|antipruritics|mesh-ancestor
6120466|NCT01118273|Dermatologic Agents|dermatologic agents|mesh-ancestor
6120467|NCT01118312|Mometasone Furoate|mometasone furoate|mesh-list
6120468|NCT01118312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6120469|NCT01118312|Dermatologic Agents|dermatologic agents|mesh-ancestor
6120470|NCT01118312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6120471|NCT01118325|Clopidogrel|clopidogrel|mesh-list
6120472|NCT01118325|Ticagrelor|ticagrelor|mesh-list
6120473|NCT01118325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6120474|NCT01118325|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6120475|NCT01118325|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6120476|NCT01118325|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6120477|NCT01118325|Purinergic Agents|purinergic agents|mesh-ancestor
6120478|NCT01118325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5532283|NCT04239872|Cariostatic Agents|cariostatic agents|mesh-ancestor
5532284|NCT04239872|Protective Agents|protective agents|mesh-ancestor
5532285|NCT04240106|Niraparib|niraparib|mesh-list
5532286|NCT04240106|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5532287|NCT04240106|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5532288|NCT04240106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5532289|NCT04240106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5532290|NCT04240106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5532291|NCT04240106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6120479|NCT01118325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120480|NCT01118325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120481|NCT01118351|Sunitinib|sunitinib|mesh-list
6120482|NCT01118351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6120483|NCT01118351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6120484|NCT01118351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6120485|NCT01118351|Growth Substances|growth substances|mesh-ancestor
6120486|NCT01118351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120487|NCT01118351|Growth Inhibitors|growth inhibitors|mesh-ancestor
6120488|NCT01118351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6120489|NCT01118351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6120490|NCT01118351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120491|NCT01118377|Capecitabine|capecitabine|mesh-list
6120492|NCT01118377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6120493|NCT01118377|Antimetabolites|antimetabolites|mesh-ancestor
6465930|NCT00476424|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6465931|NCT00476424|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6465932|NCT00476424|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6120494|NCT01118377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120495|NCT01118377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6120496|NCT01118455|Anticonvulsants|anticonvulsants|mesh-list
6120497|NCT01118520|Amlodipine|amlodipine|mesh-list
6120498|NCT01118520|Perindopril|perindopril|mesh-list
6120499|NCT01118520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6120500|NCT01118520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6120501|NCT01118520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6120502|NCT01118520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120503|NCT01118520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6120504|NCT01118520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120505|NCT01118520|Vasodilator Agents|vasodilator agents|mesh-ancestor
6120506|NCT01118520|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6120507|NCT01118520|Protease Inhibitors|protease inhibitors|mesh-ancestor
6120508|NCT01118520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6120509|NCT01118624|Vitamins|vitamins|mesh-list
6120510|NCT01118624|Folic Acid|folic acid|mesh-list
6120511|NCT01118624|Vitamin B 12|vitamin b 12|mesh-list
6120512|NCT01118624|Hydroxocobalamin|hydroxocobalamin|mesh-list
6120513|NCT01118624|Vitamin B Complex|vitamin b complex|mesh-list
6120514|NCT01118624|10-deazaaminopterin|10-deazaaminopterin|mesh-list
6120515|NCT01118624|Aminopterin|aminopterin|mesh-list
6120516|NCT01118624|Micronutrients|micronutrients|mesh-ancestor
6120517|NCT01118624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120518|NCT01118624|Hematinics|hematinics|mesh-ancestor
6120519|NCT01118624|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6120520|NCT01118624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6120521|NCT01118624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120522|NCT01118624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5532292|NCT04240106|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5532293|NCT04240106|Hormone Antagonists|hormone antagonists|mesh-ancestor
5532294|NCT04240106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5532295|NCT04240106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532296|NCT04239950|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
5532297|NCT04239950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5532298|NCT04239950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5532299|NCT04239859|Cyclosporine|cyclosporine|mesh-list
5532300|NCT04239859|Methotrexate|methotrexate|mesh-list
5532301|NCT04239859|Acitretin|acitretin|mesh-list
5532302|NCT04239859|Cyclosporins|cyclosporins|mesh-list
5532303|NCT04239859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5532304|NCT04239859|Abortifacient Agents|abortifacient agents|mesh-ancestor
6120523|NCT01118663|Acetylcysteine|acetylcysteine|mesh-list
6120524|NCT01118663|Edetic Acid|edetic acid|mesh-list
6120525|NCT01118663|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6120526|NCT01118663|Pentetic Acid|pentetic acid|mesh-list
6120527|NCT01118663|Antiviral Agents|antiviral agents|mesh-ancestor
6120528|NCT01118663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6120529|NCT01118663|Expectorants|expectorants|mesh-ancestor
6120530|NCT01118663|Respiratory System Agents|respiratory system agents|mesh-ancestor
6120531|NCT01118663|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5532305|NCT04239859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5532306|NCT04239859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532307|NCT04239859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5532308|NCT04239859|Antimetabolites|antimetabolites|mesh-ancestor
5532309|NCT04239859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120532|NCT01118663|Antioxidants|antioxidants|mesh-ancestor
6120533|NCT01118663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120534|NCT01118663|Protective Agents|protective agents|mesh-ancestor
6204613|NCT02073487|Antimitotic Agents|antimitotic agents|mesh-ancestor
6120535|NCT01118663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120536|NCT01118663|Antidotes|antidotes|mesh-ancestor
6120537|NCT01118663|Anticoagulants|anticoagulants|mesh-ancestor
6120538|NCT01118663|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6120539|NCT01118663|Chelating Agents|chelating agents|mesh-ancestor
6120540|NCT01118663|Sequestering Agents|sequestering agents|mesh-ancestor
6120541|NCT01118663|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6120542|NCT01118741|Disulfiram|disulfiram|mesh-list
6120543|NCT01118741|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6120544|NCT01118741|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
5532310|NCT04239859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5532311|NCT04239859|Dermatologic Agents|dermatologic agents|mesh-ancestor
5532312|NCT04239859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5532313|NCT04239859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5532314|NCT04239859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5532315|NCT04239859|Immunologic Factors|immunologic factors|mesh-ancestor
6120545|NCT01118741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6120546|NCT01118741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120547|NCT01118780|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6120548|NCT01118780|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6120549|NCT01118780|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6120550|NCT01118780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6120551|NCT01118780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120552|NCT01118780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6120553|NCT01118780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120554|NCT01118780|Analgesics|analgesics|mesh-ancestor
6120555|NCT01118780|Sensory System Agents|sensory system agents|mesh-ancestor
6120556|NCT01118780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6120557|NCT01118780|Antidepressive Agents|antidepressive agents|mesh-ancestor
6120558|NCT01118780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6120559|NCT01118780|Dopamine Agents|dopamine agents|mesh-ancestor
6120560|NCT01118845|Rituximab|rituximab|mesh-list
6120561|NCT01118845|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6120562|NCT01118845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6120563|NCT01118845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6120564|NCT01118845|Immunologic Factors|immunologic factors|mesh-ancestor
6120565|NCT01118845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120566|NCT01118845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6120567|NCT01118845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6120568|NCT01118845|Alkylating Agents|alkylating agents|mesh-ancestor
6120569|NCT01118845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120570|NCT01118949|Lacosamide|lacosamide|mesh-list
6120571|NCT01118949|Anticonvulsants|anticonvulsants|mesh-ancestor
6120572|NCT01118949|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6120573|NCT01118949|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6120574|NCT01118949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6120575|NCT01118949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120576|NCT01118962|Lacosamide|lacosamide|mesh-list
6120577|NCT01118962|Anticonvulsants|anticonvulsants|mesh-ancestor
6120578|NCT01118962|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6120579|NCT01118962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6120580|NCT01118962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6120581|NCT01118962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120582|NCT01118975|Lapatinib|lapatinib|mesh-list
6120583|NCT01118975|Vorinostat|vorinostat|mesh-list
6120584|NCT01118975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6120585|NCT01118975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6120586|NCT01118975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6120587|NCT01118975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120588|NCT01118975|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6120589|NCT01119105|Vancomycin|vancomycin|mesh-list
6120590|NCT01119105|Lefamulin|lefamulin|mesh-list
6120591|NCT01119105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6120592|NCT01119105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6120593|NCT01119131|Vitamin D|vitamin d|mesh-list
6120594|NCT01119131|Cholecalciferol|cholecalciferol|mesh-list
6120595|NCT01119131|Calcium|calcium|mesh-list
6120596|NCT01119131|Vitamins|vitamins|mesh-ancestor
6120597|NCT01119131|Micronutrients|micronutrients|mesh-ancestor
6120598|NCT01119131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120599|NCT01119131|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6120600|NCT01119131|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6120601|NCT01119222|Diphenhydramine|diphenhydramine|mesh-list
6120602|NCT01119222|Promethazine|promethazine|mesh-list
5532316|NCT04239859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6120603|NCT01119222|Morphine|morphine|mesh-list
6120604|NCT01119222|Gabapentin|gabapentin|mesh-list
6120605|NCT01119222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6120606|NCT01119222|Narcotics|narcotics|mesh-ancestor
6120607|NCT01119222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6120608|NCT01119222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120609|NCT01119222|Analgesics|analgesics|mesh-ancestor
6120610|NCT01119222|Sensory System Agents|sensory system agents|mesh-ancestor
6120611|NCT01119222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6120612|NCT01119222|Anticonvulsants|anticonvulsants|mesh-ancestor
6120613|NCT01119222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6120614|NCT01119222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6120615|NCT01119222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6120616|NCT01119222|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6120617|NCT01119222|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6120618|NCT01119222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5532317|NCT04239859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5532318|NCT04239859|Antifungal Agents|antifungal agents|mesh-ancestor
6120619|NCT01119222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120620|NCT01119222|Antimanic Agents|antimanic agents|mesh-ancestor
6120621|NCT01119222|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6120622|NCT01119222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6120623|NCT01119222|Anesthetics, Local|anesthetics, local|mesh-ancestor
6120624|NCT01119222|Anesthetics|anesthetics|mesh-ancestor
6120625|NCT01119222|Antiemetics|antiemetics|mesh-ancestor
6120626|NCT01119222|Autonomic Agents|autonomic agents|mesh-ancestor
6120627|NCT01119222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6120628|NCT01119222|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6120629|NCT01119222|Histamine Antagonists|histamine antagonists|mesh-ancestor
6120630|NCT01119222|Histamine Agents|histamine agents|mesh-ancestor
6120631|NCT01119222|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6120632|NCT01119222|Antipruritics|antipruritics|mesh-ancestor
6120633|NCT01119222|Dermatologic Agents|dermatologic agents|mesh-ancestor
6120634|NCT01119287|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
6120635|NCT01119287|Dexamethasone|dexamethasone|mesh-list
6120636|NCT01119287|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6120637|NCT01119287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6120638|NCT01119287|Antiemetics|antiemetics|mesh-ancestor
6120639|NCT01119287|Autonomic Agents|autonomic agents|mesh-ancestor
6120640|NCT01119287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6120641|NCT01119287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120642|NCT01119287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6120643|NCT01119287|Glucocorticoids|glucocorticoids|mesh-ancestor
6120644|NCT01119287|Hormones|hormones|mesh-ancestor
6120645|NCT01119287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6120646|NCT01119287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6120647|NCT01119287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6120648|NCT01119287|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6120649|NCT01119287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6120650|NCT01119287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6120651|NCT01119287|Analgesics|analgesics|mesh-ancestor
5532319|NCT04239859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5532320|NCT04239859|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5532321|NCT04239859|Keratolytic Agents|keratolytic agents|mesh-ancestor
5532322|NCT04239560|Boron|boron|mesh-list
5532323|NCT04239560|Trace Elements|trace elements|mesh-ancestor
5532324|NCT04239560|Micronutrients|micronutrients|mesh-ancestor
5532325|NCT04239560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532326|NCT04239599|Leuprolide|leuprolide|mesh-list
5532327|NCT04239599|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5532328|NCT04239599|Fertility Agents|fertility agents|mesh-ancestor
5532329|NCT04239599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5532330|NCT04239599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532331|NCT04239599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5532332|NCT04239599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5532333|NCT04239625|Vitamin A|vitamin a|mesh-list
5532334|NCT04239625|Retinol acetate|retinol acetate|mesh-list
5532335|NCT04239625|Vitamins|vitamins|mesh-ancestor
5532336|NCT04239625|Micronutrients|micronutrients|mesh-ancestor
5532337|NCT04239625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532338|NCT04239625|Protective Agents|protective agents|mesh-ancestor
6120652|NCT01119287|Sensory System Agents|sensory system agents|mesh-ancestor
6120653|NCT01119287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6120654|NCT01119287|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5532339|NCT04239625|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5532340|NCT04239625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6120655|NCT01119287|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6120656|NCT01119287|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5532341|NCT04239625|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5532342|NCT04239625|Immunologic Factors|immunologic factors|mesh-ancestor
5532343|NCT04239586|Glyburide|glyburide|mesh-list
5532344|NCT04239586|Glipizide|glipizide|mesh-list
5532345|NCT04239586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5532346|NCT04239586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120657|NCT01119287|Histamine Antagonists|histamine antagonists|mesh-ancestor
6120658|NCT01119287|Histamine Agents|histamine agents|mesh-ancestor
6120659|NCT01119287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6120660|NCT01119287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120661|NCT01119508|Temozolomide|temozolomide|mesh-list
6120662|NCT01119508|Ipilimumab|ipilimumab|mesh-list
5532347|NCT04239755|Doxycycline|doxycycline|mesh-list
5532348|NCT04239755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5532349|NCT04239755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5532350|NCT04239755|Antimalarials|antimalarials|mesh-ancestor
5532351|NCT04239755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5532352|NCT04239755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5532353|NCT04239443|Apatinib|apatinib|mesh-list
5532354|NCT04239443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5532355|NCT04239443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6120663|NCT01119508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6120664|NCT01119508|Alkylating Agents|alkylating agents|mesh-ancestor
6120665|NCT01119508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120666|NCT01119508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6120667|NCT01119508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6120668|NCT01119508|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6120669|NCT01119625|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6120670|NCT01119625|Immunologic Factors|immunologic factors|mesh-ancestor
6120671|NCT01119625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120672|NCT01119703|Vaccines|vaccines|mesh-list
6120673|NCT01119703|Immunologic Factors|immunologic factors|mesh-ancestor
6120674|NCT01119703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120675|NCT01119768|Esomeprazole|esomeprazole|mesh-list
6120676|NCT01119768|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6120677|NCT01119768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6120678|NCT01119768|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6120679|NCT01119768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6120680|NCT01119768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120681|NCT01119794|Bortezomib|bortezomib|mesh-list
6120682|NCT01119794|Ofatumumab|ofatumumab|mesh-list
6120683|NCT01119794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6120684|NCT01119846|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6120685|NCT01119846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6120686|NCT01119846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120687|NCT01119846|Incretins|incretins|mesh-ancestor
6120688|NCT01119846|Hormones|hormones|mesh-ancestor
6120689|NCT01119846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6120690|NCT01119846|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6120691|NCT01119846|Protease Inhibitors|protease inhibitors|mesh-ancestor
6120692|NCT01119846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6120693|NCT01119846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120694|NCT01119859|Adalimumab|adalimumab|mesh-list
6120695|NCT01119859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6120696|NCT01119859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6120697|NCT01119898|Diclofenac|diclofenac|mesh-list
6120698|NCT01119898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6120699|NCT01119898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6120700|NCT01119898|Analgesics|analgesics|mesh-ancestor
6120701|NCT01119898|Sensory System Agents|sensory system agents|mesh-ancestor
6120702|NCT01119898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6120703|NCT01119898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120704|NCT01119898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6120705|NCT01119898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6120706|NCT01119898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6120707|NCT01119898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6120708|NCT01119898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120709|NCT01119937|Glycopyrrolate|glycopyrrolate|mesh-list
6120710|NCT01119937|Tiotropium Bromide|tiotropium bromide|mesh-list
6120711|NCT01119937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6120712|NCT01119937|Autonomic Agents|autonomic agents|mesh-ancestor
6120713|NCT01119937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6120714|NCT01119937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120715|NCT01119937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5532356|NCT04239443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5532357|NCT04239443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6120716|NCT01119937|Respiratory System Agents|respiratory system agents|mesh-ancestor
6120717|NCT01119937|Parasympatholytics|parasympatholytics|mesh-ancestor
6120718|NCT01119937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6120719|NCT01119937|Cholinergic Agents|cholinergic agents|mesh-ancestor
6120720|NCT01119937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6120721|NCT01119937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120722|NCT01119937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6120723|NCT01119937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6120724|NCT01119950|Glycopyrrolate|glycopyrrolate|mesh-list
6120725|NCT01119950|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6120726|NCT01119950|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6120727|NCT01119950|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6120728|NCT01119950|Cholinergic Agents|cholinergic agents|mesh-ancestor
6120729|NCT01119950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6120730|NCT01119950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120731|NCT01119950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120732|NCT01119963|Castor Oil|castor oil|mesh-list
6120733|NCT01119963|Progesterone|progesterone|mesh-list
5532358|NCT04239443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5532359|NCT04238936|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5532360|NCT04238936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5532361|NCT04238988|Paclitaxel|paclitaxel|mesh-list
5532362|NCT04238988|Carboplatin|carboplatin|mesh-list
5532363|NCT04238988|Pembrolizumab|pembrolizumab|mesh-list
5532364|NCT04238988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5532365|NCT04238988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5532366|NCT04238988|Tubulin Modulators|tubulin modulators|mesh-ancestor
5532367|NCT04238988|Antimitotic Agents|antimitotic agents|mesh-ancestor
5532368|NCT04238988|Mitosis Modulators|mitosis modulators|mesh-ancestor
5532369|NCT04238988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5532370|NCT04238988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5532371|NCT04239053|Bupivacaine|bupivacaine|mesh-list
5532372|NCT04239053|Anesthetics, Local|anesthetics, local|mesh-ancestor
5532373|NCT04239053|Anesthetics|anesthetics|mesh-ancestor
5532374|NCT04239053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5532375|NCT04239053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532376|NCT04239053|Sensory System Agents|sensory system agents|mesh-ancestor
5532377|NCT04239053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5532378|NCT04239118|Hemostatics|hemostatics|mesh-list
5532379|NCT04239118|Coagulants|coagulants|mesh-ancestor
5532380|NCT04239170|Gemcitabine|gemcitabine|mesh-list
5532381|NCT04239170|Oxaliplatin|oxaliplatin|mesh-list
5532382|NCT04239170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5532383|NCT04239170|Antimetabolites|antimetabolites|mesh-ancestor
5532384|NCT04239170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5532385|NCT04239170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5532386|NCT04239170|Antiviral Agents|antiviral agents|mesh-ancestor
5532387|NCT04239170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5532388|NCT04239170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5532389|NCT04239170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5532390|NCT04239170|Immunologic Factors|immunologic factors|mesh-ancestor
5532391|NCT04239170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532392|NCT04239014|Olaparib|olaparib|mesh-list
6120734|NCT01119963|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
5532393|NCT04239014|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5532394|NCT04239014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5532395|NCT04239014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5532396|NCT04239014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5532397|NCT04238923|Vancomycin|vancomycin|mesh-list
5532398|NCT04238923|Gentamicins|gentamicins|mesh-list
5532399|NCT04238923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5532400|NCT04238923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5532401|NCT04238923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5532402|NCT04238923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5532403|NCT04238923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5532404|NCT04238975|Vaccines|vaccines|mesh-list
5532405|NCT04238975|Immunologic Factors|immunologic factors|mesh-ancestor
5532406|NCT04238975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532407|NCT04238767|Dolutegravir|dolutegravir|mesh-list
5532408|NCT04238767|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6120735|NCT01119963|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
6120736|NCT01119963|Progestins|progestins|mesh-ancestor
5532409|NCT04238767|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5532410|NCT04238767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5532411|NCT04238767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120737|NCT01119963|Hormones|hormones|mesh-ancestor
6120738|NCT01119963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6120739|NCT01119963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120740|NCT01119963|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6120741|NCT01119963|Hormone Antagonists|hormone antagonists|mesh-ancestor
6120742|NCT01119963|Cathartics|cathartics|mesh-ancestor
6120743|NCT01119963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6120744|NCT01120028|Sirolimus|sirolimus|mesh-list
6120745|NCT01120028|Alemtuzumab|alemtuzumab|mesh-list
6120746|NCT01120028|Tacrolimus|tacrolimus|mesh-list
6120747|NCT01120028|Basiliximab|basiliximab|mesh-list
6120748|NCT01120028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6120749|NCT01120028|Immunologic Factors|immunologic factors|mesh-ancestor
6120750|NCT01120028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120751|NCT01120028|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6120752|NCT01120028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6120753|NCT01120028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120754|NCT01120028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6120755|NCT01120028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6120756|NCT01120028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6120757|NCT01120028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6120758|NCT01120028|Antifungal Agents|antifungal agents|mesh-ancestor
6120759|NCT01120028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6120760|NCT01120093|Bromides|bromides|mesh-list
6120761|NCT01120093|Formoterol Fumarate|formoterol fumarate|mesh-list
6120762|NCT01120093|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6120763|NCT01120093|Autonomic Agents|autonomic agents|mesh-ancestor
6120764|NCT01120093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6120765|NCT01120093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120766|NCT01120093|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6120767|NCT01120093|Respiratory System Agents|respiratory system agents|mesh-ancestor
6120768|NCT01120093|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6120769|NCT01120093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6120770|NCT01120093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6120771|NCT01120093|Adrenergic Agents|adrenergic agents|mesh-ancestor
6120772|NCT01120093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6120773|NCT01120093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120774|NCT01120093|Anticonvulsants|anticonvulsants|mesh-ancestor
6120775|NCT01120184|Paclitaxel|paclitaxel|mesh-list
6120776|NCT01120184|Maytansine|maytansine|mesh-list
6120777|NCT01120184|Docetaxel|docetaxel|mesh-list
5532412|NCT04238767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5532413|NCT04238767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5532414|NCT04238767|Antiviral Agents|antiviral agents|mesh-ancestor
5532415|NCT04238767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5532416|NCT04238754|Cannabidiol|cannabidiol|mesh-list
5532417|NCT04238754|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6120778|NCT01120184|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
6120779|NCT01120184|Trastuzumab|trastuzumab|mesh-list
6120780|NCT01120184|Pertuzumab|pertuzumab|mesh-list
6120781|NCT01120184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6120782|NCT01120184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6120783|NCT01120184|Tubulin Modulators|tubulin modulators|mesh-ancestor
6120784|NCT01120184|Antimitotic Agents|antimitotic agents|mesh-ancestor
6120785|NCT01120184|Mitosis Modulators|mitosis modulators|mesh-ancestor
6120786|NCT01120184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120787|NCT01120184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6120788|NCT01120236|Leuprolide|leuprolide|mesh-list
6120789|NCT01120236|Goserelin|goserelin|mesh-list
6120790|NCT01120236|Bicalutamide|bicalutamide|mesh-list
6120791|NCT01120236|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6120792|NCT01120236|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6120793|NCT01120236|Fertility Agents|fertility agents|mesh-ancestor
6120794|NCT01120236|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6120795|NCT01120236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120796|NCT01120236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6120797|NCT01120236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6120798|NCT01120236|Androgen Antagonists|androgen antagonists|mesh-ancestor
6120799|NCT01120236|Hormone Antagonists|hormone antagonists|mesh-ancestor
6120800|NCT01120236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6120801|NCT01120236|Immunologic Factors|immunologic factors|mesh-ancestor
6120802|NCT01120275|R04929097|r04929097|mesh-list
6120803|NCT01120275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6120804|NCT01120275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120805|NCT01120405|Sevoflurane|sevoflurane|mesh-list
6120806|NCT01120405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6120807|NCT01120405|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6120808|NCT01120405|Anesthetics, General|anesthetics, general|mesh-ancestor
6120809|NCT01120405|Anesthetics|anesthetics|mesh-ancestor
5532418|NCT04238754|Anticonvulsants|anticonvulsants|mesh-ancestor
5532419|NCT04238806|Desflurane|desflurane|mesh-list
5532420|NCT04238806|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5532421|NCT04238806|Anesthetics, General|anesthetics, general|mesh-ancestor
5532422|NCT04238806|Anesthetics|anesthetics|mesh-ancestor
5532423|NCT04238806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5532424|NCT04238806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532425|NCT04238832|Nicotine|nicotine|mesh-list
5532426|NCT04238832|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5532427|NCT04238832|Autonomic Agents|autonomic agents|mesh-ancestor
5532428|NCT04238832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5532429|NCT04238832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532430|NCT04238832|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5532431|NCT04238832|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5532432|NCT04238832|Cholinergic Agents|cholinergic agents|mesh-ancestor
5532433|NCT04238832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5532434|NCT04238832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5532435|NCT04238884|Voriconazole|voriconazole|mesh-list
5532436|NCT04238884|Antifungal Agents|antifungal agents|mesh-ancestor
5532437|NCT04238884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5532438|NCT04238884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5532439|NCT04238884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5532440|NCT04238884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5532441|NCT04238884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5532442|NCT04238884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5532443|NCT04238884|Hormone Antagonists|hormone antagonists|mesh-ancestor
5532444|NCT04238884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5532445|NCT04238884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532446|NCT04238884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5532447|NCT04238637|Durvalumab|durvalumab|mesh-list
5532448|NCT04238637|Tremelimumab|tremelimumab|mesh-list
5532449|NCT04238637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5532450|NCT04238637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5532451|NCT04238845|Vitamin A|vitamin a|mesh-list
5532452|NCT04238845|Vitamins|vitamins|mesh-ancestor
5532453|NCT04238845|Micronutrients|micronutrients|mesh-ancestor
5532454|NCT04238845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532455|NCT04238702|Empagliflozin|empagliflozin|mesh-list
5532456|NCT04238702|Losartan|losartan|mesh-list
5532457|NCT04238702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6120810|NCT01120405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6120811|NCT01120405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120812|NCT01120600|Vitamin D|vitamin d|mesh-list
6120813|NCT01120600|Cholecalciferol|cholecalciferol|mesh-list
6120814|NCT01120600|Calcium Carbonate|calcium carbonate|mesh-list
6120815|NCT01120600|Calcium|calcium|mesh-list
6120816|NCT01120600|Vitamins|vitamins|mesh-ancestor
6120817|NCT01120600|Micronutrients|micronutrients|mesh-ancestor
6120818|NCT01120600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120819|NCT01120600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6120820|NCT01120600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6120821|NCT01120600|Antacids|antacids|mesh-ancestor
6120822|NCT01120600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120823|NCT01120600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6120824|NCT01120626|Donepezil|donepezil|mesh-list
6120825|NCT01120626|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5532458|NCT04238702|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5532459|NCT04238702|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5532460|NCT04238702|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5532461|NCT04238702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5532462|NCT04238702|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5532463|NCT04238702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5532464|NCT04238702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532465|NCT04238208|Lidocaine|lidocaine|mesh-list
5532466|NCT04238208|Capsaicin|capsaicin|mesh-list
5532467|NCT04238208|Anesthetics, Local|anesthetics, local|mesh-ancestor
5532468|NCT04238208|Anesthetics|anesthetics|mesh-ancestor
5532469|NCT04238208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5532470|NCT04238208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532471|NCT04238208|Sensory System Agents|sensory system agents|mesh-ancestor
5532472|NCT04238208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5532473|NCT04238208|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5532474|NCT04238208|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5532475|NCT04238208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5532476|NCT04238208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5532477|NCT04238208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5532478|NCT04238208|Antipruritics|antipruritics|mesh-ancestor
5532479|NCT04238208|Dermatologic Agents|dermatologic agents|mesh-ancestor
5532480|NCT04238221|Doxofylline|doxofylline|mesh-list
5532481|NCT04238221|Antitussive Agents|antitussive agents|mesh-ancestor
5532482|NCT04238221|Respiratory System Agents|respiratory system agents|mesh-ancestor
5532483|NCT04238221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5532484|NCT04238221|Autonomic Agents|autonomic agents|mesh-ancestor
5532485|NCT04238221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5532486|NCT04238221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532487|NCT04238221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5532488|NCT04238221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5532489|NCT04238221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5532490|NCT04238221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601574|NCT05176223|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5601575|NCT05176223|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5601576|NCT05176119|Ketamine|ketamine|mesh-list
5601577|NCT05176119|Nalbuphine|nalbuphine|mesh-list
5601578|NCT05176119|Analgesics|analgesics|mesh-ancestor
5601579|NCT05176119|Sensory System Agents|sensory system agents|mesh-ancestor
5601580|NCT05176119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5601581|NCT05176119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601582|NCT05176119|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5601583|NCT05176119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5601584|NCT05176119|Anesthetics, General|anesthetics, general|mesh-ancestor
5601585|NCT05176119|Anesthetics|anesthetics|mesh-ancestor
5601586|NCT05176119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5601587|NCT05176119|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5601588|NCT05176119|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5601589|NCT05176119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5601590|NCT05176119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601591|NCT05176119|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5601592|NCT05176119|Narcotics|narcotics|mesh-ancestor
5601593|NCT05175703|Paclitaxel|paclitaxel|mesh-list
5601594|NCT05175703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5601595|NCT05175703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5601596|NCT05175703|Tubulin Modulators|tubulin modulators|mesh-ancestor
5601597|NCT05175703|Antimitotic Agents|antimitotic agents|mesh-ancestor
5601598|NCT05175703|Mitosis Modulators|mitosis modulators|mesh-ancestor
5601599|NCT05175703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601600|NCT05175625|Myeloma Proteins|myeloma proteins|mesh-list
5601601|NCT05175625|Paraproteins|paraproteins|mesh-list
5601602|NCT05175625|Immunologic Factors|immunologic factors|mesh-ancestor
5601603|NCT05175625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601604|NCT05175547|Clevidipine|clevidipine|mesh-list
5601605|NCT05175547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5601606|NCT05175547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5601607|NCT05175547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601608|NCT05175547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6120826|NCT01120626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6120827|NCT01120626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120828|NCT01120626|Cholinergic Agents|cholinergic agents|mesh-ancestor
6120829|NCT01120626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6120830|NCT01120626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120831|NCT01120626|Nootropic Agents|nootropic agents|mesh-ancestor
6120832|NCT01120639|Temozolomide|temozolomide|mesh-list
5532491|NCT04238169|Bevacizumab|bevacizumab|mesh-list
5532492|NCT04238169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5532493|NCT04238169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5532494|NCT04238169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5532495|NCT04238169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5532496|NCT04238169|Growth Substances|growth substances|mesh-ancestor
5532497|NCT04238169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532498|NCT04238169|Growth Inhibitors|growth inhibitors|mesh-ancestor
6120833|NCT01120639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6120834|NCT01120639|Alkylating Agents|alkylating agents|mesh-ancestor
6120835|NCT01120639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120836|NCT01120639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6120837|NCT01120691|Glycopyrrolate|glycopyrrolate|mesh-list
6120838|NCT01120691|Albuterol|albuterol|mesh-list
6120839|NCT01120691|Tiotropium Bromide|tiotropium bromide|mesh-list
6120840|NCT01120691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6120841|NCT01120691|Autonomic Agents|autonomic agents|mesh-ancestor
6120842|NCT01120691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6120843|NCT01120691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120844|NCT01120691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5532499|NCT04238195|Moxifloxacin|moxifloxacin|mesh-list
5532500|NCT04238195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5532501|NCT04238195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6120845|NCT01120691|Respiratory System Agents|respiratory system agents|mesh-ancestor
6120846|NCT01120691|Parasympatholytics|parasympatholytics|mesh-ancestor
6120847|NCT01120691|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6120848|NCT01120691|Cholinergic Agents|cholinergic agents|mesh-ancestor
6120849|NCT01120691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6120850|NCT01120691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120851|NCT01120691|Tocolytic Agents|tocolytic agents|mesh-ancestor
6120852|NCT01120691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5532502|NCT04238195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5532503|NCT04238195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5532504|NCT04238195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5532505|NCT04238195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5532506|NCT04238195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5532507|NCT04238078|Contraceptive Agents|contraceptive agents|mesh-list
5532508|NCT04238078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5532509|NCT04238078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532510|NCT04238143|Complement Factor H|complement factor h|mesh-list
5532511|NCT04238143|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5532512|NCT04238143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5532513|NCT04238143|Immunologic Factors|immunologic factors|mesh-ancestor
5532514|NCT04238143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532515|NCT04237987|Cyclosporine|cyclosporine|mesh-list
5532516|NCT04237987|Aldesleukin|aldesleukin|mesh-list
5532517|NCT04237987|Interleukin-2|interleukin-2|mesh-list
5532518|NCT04237987|Cyclosporins|cyclosporins|mesh-list
5532519|NCT04237987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6120853|NCT01120691|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6120854|NCT01120691|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6120855|NCT01120691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6120856|NCT01120691|Adrenergic Agents|adrenergic agents|mesh-ancestor
6120857|NCT01120691|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6120858|NCT01120691|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6120859|NCT01120704|Nicotine|nicotine|mesh-list
6120860|NCT01120704|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6120861|NCT01120704|Autonomic Agents|autonomic agents|mesh-ancestor
5532520|NCT04237987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5532521|NCT04237987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5532522|NCT04237987|Immunologic Factors|immunologic factors|mesh-ancestor
5532523|NCT04237987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532524|NCT04237987|Antifungal Agents|antifungal agents|mesh-ancestor
6120862|NCT01120704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6120863|NCT01120704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120864|NCT01120704|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6120865|NCT01120704|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6120866|NCT01120704|Cholinergic Agents|cholinergic agents|mesh-ancestor
6120867|NCT01120704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6120868|NCT01120704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120869|NCT01120834|Azacitidine|azacitidine|mesh-list
6120870|NCT01120834|Vorinostat|vorinostat|mesh-list
6120871|NCT01120834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6120872|NCT01120834|Antimetabolites|antimetabolites|mesh-ancestor
6120873|NCT01120834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120874|NCT01120834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5532525|NCT04237987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5532526|NCT04237987|Dermatologic Agents|dermatologic agents|mesh-ancestor
5532527|NCT04237987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5532528|NCT04237987|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5532529|NCT04237987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5532530|NCT04237987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5532531|NCT04237987|Analgesics|analgesics|mesh-ancestor
5532532|NCT04237987|Sensory System Agents|sensory system agents|mesh-ancestor
5532533|NCT04237987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5532534|NCT04237987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5532535|NCT04237987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5532536|NCT04237987|Antiviral Agents|antiviral agents|mesh-ancestor
5532537|NCT04237922|Clopidogrel|clopidogrel|mesh-list
5532538|NCT04237922|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
5532539|NCT04237922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5532540|NCT04237922|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5532541|NCT04237922|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5532542|NCT04237922|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5532543|NCT04237922|Purinergic Agents|purinergic agents|mesh-ancestor
5532544|NCT04237922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5532545|NCT04237922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5532546|NCT04237922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532547|NCT04237935|Clopidogrel|clopidogrel|mesh-list
5532548|NCT04237935|Ticagrelor|ticagrelor|mesh-list
5532549|NCT04237935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5532550|NCT04237935|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5532551|NCT04237935|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5532552|NCT04237935|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5532553|NCT04237935|Purinergic Agents|purinergic agents|mesh-ancestor
5532554|NCT04237935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5532555|NCT04237935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5532556|NCT04237935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120875|NCT01120834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6120876|NCT01120834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6120877|NCT01120899|Minocycline|minocycline|mesh-list
6120878|NCT01120899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6120879|NCT01120899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6120880|NCT01121211|Testosterone|testosterone|mesh-list
6120881|NCT01121211|Androgens|androgens|mesh-ancestor
6120882|NCT01121211|Hormones|hormones|mesh-ancestor
6120883|NCT01121211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6120884|NCT01121211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120885|NCT01121224|Clopidogrel|clopidogrel|mesh-list
6120886|NCT01121224|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6120887|NCT01121224|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6120888|NCT01121224|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6120889|NCT01121224|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6120890|NCT01121224|Purinergic Agents|purinergic agents|mesh-ancestor
6120891|NCT01121224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6120892|NCT01121224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120893|NCT01121224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120894|NCT01121393|Gemcitabine|gemcitabine|mesh-list
6120895|NCT01121393|Afatinib|afatinib|mesh-list
6120896|NCT01121393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5532557|NCT04237623|Sargramostim|sargramostim|mesh-list
5532558|NCT04237623|Immunologic Factors|immunologic factors|mesh-ancestor
5532559|NCT04237623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532560|NCT04237597|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
5532561|NCT04237597|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5532562|NCT04237597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5532563|NCT04237597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5532564|NCT04237597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532565|NCT04237532|Dexmedetomidine|dexmedetomidine|mesh-list
5532566|NCT04237532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5532567|NCT04237532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5532568|NCT04237532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532569|NCT04237532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5532570|NCT04237532|Analgesics|analgesics|mesh-ancestor
5532571|NCT04237532|Sensory System Agents|sensory system agents|mesh-ancestor
6120897|NCT01121393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6120898|NCT01121393|Antimetabolites|antimetabolites|mesh-ancestor
6120899|NCT01121393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120900|NCT01121393|Antiviral Agents|antiviral agents|mesh-ancestor
6120901|NCT01121393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6120902|NCT01121393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6120903|NCT01121393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6120904|NCT01121393|Immunologic Factors|immunologic factors|mesh-ancestor
6120905|NCT01121393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120906|NCT01121393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6120907|NCT01121406|Gemcitabine|gemcitabine|mesh-list
6120908|NCT01121406|Paclitaxel|paclitaxel|mesh-list
6120909|NCT01121406|Doxorubicin|doxorubicin|mesh-list
6120910|NCT01121406|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6120911|NCT01121406|Topotecan|topotecan|mesh-list
6120912|NCT01121406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6120913|NCT01121406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6120914|NCT01121406|Tubulin Modulators|tubulin modulators|mesh-ancestor
6120915|NCT01121406|Antimitotic Agents|antimitotic agents|mesh-ancestor
6120916|NCT01121406|Mitosis Modulators|mitosis modulators|mesh-ancestor
6120917|NCT01121406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120918|NCT01121406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6120919|NCT01121406|Antimetabolites|antimetabolites|mesh-ancestor
6120920|NCT01121406|Antiviral Agents|antiviral agents|mesh-ancestor
6120921|NCT01121406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6120922|NCT01121406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6120923|NCT01121406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6120924|NCT01121406|Immunologic Factors|immunologic factors|mesh-ancestor
6120925|NCT01121406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120926|NCT01121406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6120927|NCT01121406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6120928|NCT01121406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6120929|NCT01121406|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6120930|NCT01121484|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6120931|NCT01121484|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6120932|NCT01121484|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6120933|NCT01121484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6120934|NCT01121484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120935|NCT01121484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6120936|NCT01121484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120937|NCT01121484|Antidepressive Agents|antidepressive agents|mesh-ancestor
6120938|NCT01121484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6120939|NCT01121536|Modafinil|modafinil|mesh-list
6120940|NCT01121536|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6120941|NCT01121536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120942|NCT01121536|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6120943|NCT01121536|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6120944|NCT01121536|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6120945|NCT01121536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120946|NCT01121549|Exemestane|exemestane|mesh-list
6120947|NCT01121549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6120948|NCT01121549|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6120949|NCT01121549|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6120950|NCT01121549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6120951|NCT01121549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120952|NCT01121549|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6120953|NCT01121549|Hormone Antagonists|hormone antagonists|mesh-ancestor
6120954|NCT01121549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6120955|NCT01121549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120956|NCT01121562|Sunitinib|sunitinib|mesh-list
6120957|NCT01121562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6120958|NCT01121562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6120959|NCT01121562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6120960|NCT01121562|Growth Substances|growth substances|mesh-ancestor
6120961|NCT01121562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120962|NCT01121562|Growth Inhibitors|growth inhibitors|mesh-ancestor
6120963|NCT01121562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6120964|NCT01121562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5532572|NCT04237532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5532573|NCT04237532|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5532574|NCT04237532|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5532575|NCT04237532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5532576|NCT04237532|Adrenergic Agents|adrenergic agents|mesh-ancestor
5532577|NCT04237532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6120965|NCT01121562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120966|NCT01121575|Crizotinib|crizotinib|mesh-list
6120967|NCT01121575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6120968|NCT01121575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6120969|NCT01121575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5532578|NCT04237532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5532579|NCT04237675|Anesthetics|anesthetics|mesh-list
5532580|NCT04237675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5532581|NCT04237675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532582|NCT04237246|Tacrolimus|tacrolimus|mesh-list
5532583|NCT04237246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6120970|NCT01121575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120971|NCT01121666|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6120972|NCT01121666|Hormones|hormones|mesh-ancestor
6120973|NCT01121666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6120974|NCT01121666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120975|NCT01121757|Lenalidomide|lenalidomide|mesh-list
6120976|NCT01121757|Azacitidine|azacitidine|mesh-list
6120977|NCT01121757|Immunologic Factors|immunologic factors|mesh-ancestor
6120978|NCT01121757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120979|NCT01121757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6120980|NCT01121757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6120981|NCT01121757|Growth Substances|growth substances|mesh-ancestor
6120982|NCT01121757|Growth Inhibitors|growth inhibitors|mesh-ancestor
6120983|NCT01121757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6120984|NCT01121757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6120985|NCT01121757|Antimetabolites|antimetabolites|mesh-ancestor
6120986|NCT01121757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120987|NCT01121757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6120988|NCT01121900|Trazodone|trazodone|mesh-list
6120989|NCT01121900|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6120990|NCT01121900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6120991|NCT01121900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6120992|NCT01121900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6120993|NCT01121900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6120994|NCT01121900|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6120995|NCT01121900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6120996|NCT01121900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6120997|NCT01121900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6120998|NCT01121900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6120999|NCT01121900|Serotonin Agents|serotonin agents|mesh-ancestor
6121000|NCT01121900|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6121001|NCT01121900|Antidepressive Agents|antidepressive agents|mesh-ancestor
6121002|NCT01121913|Trazodone|trazodone|mesh-list
6121003|NCT01121913|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6121004|NCT01121913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6121005|NCT01121913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5532584|NCT04237246|Immunologic Factors|immunologic factors|mesh-ancestor
6121006|NCT01121913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121007|NCT01121913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6121008|NCT01121913|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6121009|NCT01121913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6121010|NCT01121913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6121011|NCT01121913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121012|NCT01121913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6121013|NCT01121913|Serotonin Agents|serotonin agents|mesh-ancestor
6121014|NCT01121913|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6121015|NCT01121913|Antidepressive Agents|antidepressive agents|mesh-ancestor
6121016|NCT01121926|Trazodone|trazodone|mesh-list
6121017|NCT01121926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6121018|NCT01121926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6121019|NCT01121926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6121020|NCT01121926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121021|NCT01121926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6121022|NCT01121926|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5532585|NCT04237246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532586|NCT04237246|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5532587|NCT04237246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5532588|NCT04237246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5532589|NCT04237376|Tenofovir|tenofovir|mesh-list
5532590|NCT04237376|Antiviral Agents|antiviral agents|mesh-ancestor
5532591|NCT04237376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5532592|NCT04237376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5532593|NCT04237376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5532594|NCT04237376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5532595|NCT04237376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5532596|NCT04237376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5532597|NCT04237376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5532598|NCT04237493|Insulin|insulin|mesh-list
5532599|NCT04237493|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5532600|NCT04237493|Metformin|metformin|mesh-list
5532601|NCT04237493|Insulin Glargine|insulin glargine|mesh-list
5532602|NCT04237493|Glimepiride|glimepiride|mesh-list
5532603|NCT04237493|Vildagliptin|vildagliptin|mesh-list
5532604|NCT04237493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5532605|NCT04237493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532606|NCT04237493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5532607|NCT04237493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5532608|NCT04237493|Immunologic Factors|immunologic factors|mesh-ancestor
5532609|NCT04237493|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5532610|NCT04237493|Protease Inhibitors|protease inhibitors|mesh-ancestor
5532611|NCT04237493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5532612|NCT04237493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5532613|NCT04237480|Vitamin D|vitamin d|mesh-list
5532614|NCT04237480|Ergocalciferols|ergocalciferols|mesh-list
5532615|NCT04237480|Vitamins|vitamins|mesh-list
5532616|NCT04237480|Micronutrients|micronutrients|mesh-ancestor
5532617|NCT04237480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532618|NCT04237480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5532619|NCT04237480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5532620|NCT04237129|Insulin Aspart|insulin aspart|mesh-list
5532621|NCT04237129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5532622|NCT04237129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532623|NCT04237103|Methotrexate|methotrexate|mesh-list
5532624|NCT04237103|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5532625|NCT04237103|Abortifacient Agents|abortifacient agents|mesh-ancestor
5532626|NCT04237103|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5532627|NCT04237103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532628|NCT04237103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5532629|NCT04237103|Antimetabolites|antimetabolites|mesh-ancestor
5532630|NCT04237103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5532631|NCT04237103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5532632|NCT04237103|Dermatologic Agents|dermatologic agents|mesh-ancestor
5532633|NCT04237103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5532634|NCT04237103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5532635|NCT04237103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5532636|NCT04237103|Immunologic Factors|immunologic factors|mesh-ancestor
5532637|NCT04237103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6121023|NCT01121926|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6121024|NCT01121926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6121025|NCT01121926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121026|NCT01121926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5532638|NCT04237103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5532639|NCT04237090|Diphenhydramine|diphenhydramine|mesh-list
5532640|NCT04237090|Promethazine|promethazine|mesh-list
5532641|NCT04237090|Cetirizine|cetirizine|mesh-list
5532642|NCT04237090|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5532643|NCT04237090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5532644|NCT04237090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5532645|NCT04237090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532646|NCT04237090|Anesthetics, Local|anesthetics, local|mesh-ancestor
5532647|NCT04237090|Anesthetics|anesthetics|mesh-ancestor
5532648|NCT04237090|Sensory System Agents|sensory system agents|mesh-ancestor
5532649|NCT04237090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5532650|NCT04237090|Antiemetics|antiemetics|mesh-ancestor
5532651|NCT04237090|Autonomic Agents|autonomic agents|mesh-ancestor
5532652|NCT04237090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6121027|NCT01121926|Serotonin Agents|serotonin agents|mesh-ancestor
6121028|NCT01121926|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6121029|NCT01121926|Antidepressive Agents|antidepressive agents|mesh-ancestor
6121030|NCT01121939|Bevacizumab|bevacizumab|mesh-list
6121031|NCT01121939|Pertuzumab|pertuzumab|mesh-list
6121032|NCT01121939|Octreotide|octreotide|mesh-list
6121033|NCT01121939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6121034|NCT01121939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6121035|NCT01121939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6121036|NCT01121939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6121037|NCT01121939|Growth Substances|growth substances|mesh-ancestor
6121038|NCT01121939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121039|NCT01121939|Growth Inhibitors|growth inhibitors|mesh-ancestor
6121040|NCT01121939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6121041|NCT01121939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6121042|NCT01121991|Hormones|hormones|mesh-list
6121043|NCT01121991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6121044|NCT01121991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121045|NCT01122108|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
6121046|NCT01122108|Cholestyramine Resin|cholestyramine resin|mesh-list
6121047|NCT01122108|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6121048|NCT01122108|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6121049|NCT01122108|Antimetabolites|antimetabolites|mesh-ancestor
6121050|NCT01122108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121051|NCT01122108|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6121052|NCT01122160|Omeprazole|omeprazole|mesh-list
6121053|NCT01122160|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6121054|NCT01122160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6121055|NCT01122160|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6121056|NCT01122160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6121057|NCT01122160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121058|NCT01122238|Nicotine|nicotine|mesh-list
6121059|NCT01122238|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6121060|NCT01122238|Autonomic Agents|autonomic agents|mesh-ancestor
6121061|NCT01122238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6121062|NCT01122238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121063|NCT01122238|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6121064|NCT01122238|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6121065|NCT01122238|Cholinergic Agents|cholinergic agents|mesh-ancestor
6121066|NCT01122238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6121067|NCT01122238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121068|NCT01122264|Sildenafil Citrate|sildenafil citrate|mesh-list
6121069|NCT01122264|Tadalafil|tadalafil|mesh-list
6121070|NCT01122264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121071|NCT01122264|Vasodilator Agents|vasodilator agents|mesh-ancestor
6121072|NCT01122264|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5532653|NCT04237090|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5532654|NCT04237090|Histamine Antagonists|histamine antagonists|mesh-ancestor
5532655|NCT04237090|Histamine Agents|histamine agents|mesh-ancestor
5532656|NCT04237090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5532657|NCT04237090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5532658|NCT04237090|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5532659|NCT04237090|Antipruritics|antipruritics|mesh-ancestor
6121073|NCT01122264|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6121074|NCT01122264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6121075|NCT01122264|Urological Agents|urological agents|mesh-ancestor
5532660|NCT04237090|Dermatologic Agents|dermatologic agents|mesh-ancestor
6121076|NCT01122316|Metformin|metformin|mesh-list
5532661|NCT04237090|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6121077|NCT01122316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6121078|NCT01122316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121079|NCT01122680|Bromides|bromides|mesh-list
6121080|NCT01122680|Tiotropium Bromide|tiotropium bromide|mesh-list
6121081|NCT01122680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6121082|NCT01122680|Autonomic Agents|autonomic agents|mesh-ancestor
6121083|NCT01122680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6121084|NCT01122680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121085|NCT01122680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6121086|NCT01122680|Respiratory System Agents|respiratory system agents|mesh-ancestor
6121087|NCT01122680|Parasympatholytics|parasympatholytics|mesh-ancestor
6121088|NCT01122680|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6121089|NCT01122680|Cholinergic Agents|cholinergic agents|mesh-ancestor
6121090|NCT01122680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6121091|NCT01122680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121092|NCT01122680|Anticonvulsants|anticonvulsants|mesh-ancestor
6204614|NCT02073487|Mitosis Modulators|mitosis modulators|mesh-ancestor
6204615|NCT02073487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204616|NCT02073487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6204617|NCT02073487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6204618|NCT02073487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6204619|NCT02073565|Everolimus|everolimus|mesh-list
6204620|NCT02073565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6204621|NCT02073565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6204622|NCT02073565|Immunologic Factors|immunologic factors|mesh-ancestor
6204623|NCT02073565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204624|NCT02073656|Sofosbuvir|sofosbuvir|mesh-list
6204625|NCT02073656|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
6204626|NCT02073656|Ledipasvir|ledipasvir|mesh-list
6204627|NCT02073656|Antiviral Agents|antiviral agents|mesh-ancestor
6204628|NCT02073656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6204629|NCT02073682|Heparin|heparin|mesh-list
6204630|NCT02073682|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6204631|NCT02073682|Tinzaparin|tinzaparin|mesh-list
6204632|NCT02073682|Dalteparin|dalteparin|mesh-list
6204633|NCT02073682|Edoxaban|edoxaban|mesh-list
6204634|NCT02073682|Anticoagulants|anticoagulants|mesh-ancestor
6204635|NCT02073682|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6204636|NCT02073682|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6204637|NCT02073682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204638|NCT02073682|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6204639|NCT02073682|Antithrombins|antithrombins|mesh-ancestor
6204640|NCT02073682|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6204641|NCT02073682|Protease Inhibitors|protease inhibitors|mesh-ancestor
6204642|NCT02073682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6204643|NCT02073747|Albuterol|albuterol|mesh-list
6204644|NCT02073747|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6204645|NCT02073747|Autonomic Agents|autonomic agents|mesh-ancestor
6204646|NCT02073747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6204647|NCT02073747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204648|NCT02073747|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5532662|NCT04236895|Insulin Glargine|insulin glargine|mesh-list
5532663|NCT04236895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5532664|NCT04236895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532665|NCT04236778|Vancomycin|vancomycin|mesh-list
5532666|NCT04236778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5532667|NCT04236778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5532668|NCT04237012|Dexamethasone|dexamethasone|mesh-list
5532669|NCT04237012|Lubricant Eye Drops|lubricant eye drops|mesh-list
5532670|NCT04237012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5532671|NCT04237012|Antiemetics|antiemetics|mesh-ancestor
5532672|NCT04237012|Autonomic Agents|autonomic agents|mesh-ancestor
5532673|NCT04237012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5532674|NCT04237012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532675|NCT04237012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5532676|NCT04237012|Glucocorticoids|glucocorticoids|mesh-ancestor
5532677|NCT04237012|Hormones|hormones|mesh-ancestor
5532678|NCT04237012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5532679|NCT04237012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5532680|NCT04237012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5532681|NCT04237012|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5532682|NCT04237012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5532683|NCT04236609|Sirolimus|sirolimus|mesh-list
5532684|NCT04236609|Everolimus|everolimus|mesh-list
5532685|NCT04236609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6204649|NCT02073747|Respiratory System Agents|respiratory system agents|mesh-ancestor
6204650|NCT02073747|Tocolytic Agents|tocolytic agents|mesh-ancestor
6204651|NCT02073747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6121093|NCT01122862|Chlorhexidine|chlorhexidine|mesh-list
6121094|NCT01122862|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6121095|NCT01122862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6121096|NCT01122862|Disinfectants|disinfectants|mesh-ancestor
6121097|NCT01122901|R04929097|r04929097|mesh-list
6121098|NCT01122901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6121099|NCT01122901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121100|NCT01122927|Aripiprazole|aripiprazole|mesh-list
6121101|NCT01122927|Antidepressive Agents|antidepressive agents|mesh-ancestor
6121102|NCT01122927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6121103|NCT01122927|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6121104|NCT01122927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6121105|NCT01122927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6121106|NCT01122927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121107|NCT01122927|Dopamine Agonists|dopamine agonists|mesh-ancestor
6121108|NCT01122927|Dopamine Agents|dopamine agents|mesh-ancestor
6121109|NCT01122927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6121110|NCT01122927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121111|NCT01122927|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6121112|NCT01122927|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6121113|NCT01122927|Serotonin Agents|serotonin agents|mesh-ancestor
6121114|NCT01122927|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6121115|NCT01122927|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6121116|NCT01122927|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6121117|NCT01122927|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6121118|NCT01123070|Rituximab|rituximab|mesh-list
6121119|NCT01123070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6121120|NCT01123070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6121121|NCT01123070|Immunologic Factors|immunologic factors|mesh-ancestor
6121122|NCT01123070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121123|NCT01123070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6121124|NCT01123083|Muromonab-CD3|muromonab-cd3|mesh-list
6121125|NCT01123083|Immunologic Factors|immunologic factors|mesh-ancestor
6121126|NCT01123083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121127|NCT01123083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6121128|NCT01123356|Lenalidomide|lenalidomide|mesh-list
6121129|NCT01123356|Ofatumumab|ofatumumab|mesh-list
6121130|NCT01123356|Immunologic Factors|immunologic factors|mesh-ancestor
6121131|NCT01123356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121132|NCT01123356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6121133|NCT01123356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6121134|NCT01123356|Growth Substances|growth substances|mesh-ancestor
6121135|NCT01123356|Growth Inhibitors|growth inhibitors|mesh-ancestor
6121136|NCT01123356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6121137|NCT01123395|Colchicine|colchicine|mesh-list
6121138|NCT01123395|Gout Suppressants|gout suppressants|mesh-ancestor
5532686|NCT04236609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5532687|NCT04236609|Immunologic Factors|immunologic factors|mesh-ancestor
5532688|NCT04236609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532689|NCT04236609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5532690|NCT04236609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5532691|NCT04236609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5532692|NCT04236609|Antifungal Agents|antifungal agents|mesh-ancestor
5601609|NCT05175547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606726|NCT03818737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5606727|NCT03818737|Antiemetics|antiemetics|mesh-ancestor
5606728|NCT03818737|Autonomic Agents|autonomic agents|mesh-ancestor
6121139|NCT01123395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6121140|NCT01123395|Tubulin Modulators|tubulin modulators|mesh-ancestor
6121141|NCT01123395|Antimitotic Agents|antimitotic agents|mesh-ancestor
6121142|NCT01123395|Mitosis Modulators|mitosis modulators|mesh-ancestor
6121143|NCT01123395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121144|NCT01123395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6121145|NCT01123889|Lidocaine|lidocaine|mesh-list
6121146|NCT01123889|Ropivacaine|ropivacaine|mesh-list
6121147|NCT01123889|Anesthetics, Local|anesthetics, local|mesh-ancestor
6121148|NCT01123889|Anesthetics|anesthetics|mesh-ancestor
6121149|NCT01123889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6121150|NCT01123889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606729|NCT03818737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5606730|NCT03818737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606731|NCT03818737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6121151|NCT01123889|Sensory System Agents|sensory system agents|mesh-ancestor
6121152|NCT01123889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6121153|NCT01123889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6204652|NCT02073747|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6121154|NCT01123889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6121155|NCT01123889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6121156|NCT01123889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6121157|NCT01123889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121158|NCT01123980|Insulin|insulin|mesh-list
6121159|NCT01123980|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6121160|NCT01123980|Metformin|metformin|mesh-list
6121161|NCT01123980|Insulin Glargine|insulin glargine|mesh-list
6121162|NCT01123980|Insulin Aspart|insulin aspart|mesh-list
6121163|NCT01123980|Glimepiride|glimepiride|mesh-list
6121164|NCT01123980|Biphasic Insulins|biphasic insulins|mesh-list
6121165|NCT01123980|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
5532693|NCT04236453|Tenofovir|tenofovir|mesh-list
5532694|NCT04236453|Emtricitabine|emtricitabine|mesh-list
5532695|NCT04236453|Darunavir|darunavir|mesh-list
5532696|NCT04236453|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5532697|NCT04236453|Cobicistat|cobicistat|mesh-list
5532698|NCT04236453|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
5532699|NCT04236453|Antiviral Agents|antiviral agents|mesh-ancestor
5532700|NCT04236453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5532701|NCT04236453|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5532702|NCT04236453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5532703|NCT04236453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5532704|NCT04236453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5532705|NCT04236453|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5532706|NCT04236453|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5532707|NCT04236453|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5532708|NCT04236453|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5532709|NCT04236453|Protease Inhibitors|protease inhibitors|mesh-ancestor
5532710|NCT04236453|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5532711|NCT04236453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5532712|NCT04236323|Remifentanil|remifentanil|mesh-list
5532713|NCT04236323|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5532714|NCT04236323|Narcotics|narcotics|mesh-ancestor
5532715|NCT04236323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5532716|NCT04236323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532717|NCT04236323|Analgesics|analgesics|mesh-ancestor
5532718|NCT04236323|Sensory System Agents|sensory system agents|mesh-ancestor
5532719|NCT04236323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5532720|NCT04236310|Trastuzumab|trastuzumab|mesh-list
5532721|NCT04236310|Anastrozole|anastrozole|mesh-list
5532722|NCT04236310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5532723|NCT04236310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5532724|NCT04236310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5532725|NCT04236310|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5532726|NCT04236310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5532727|NCT04236310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5532728|NCT04236310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5532729|NCT04236310|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5532730|NCT04236310|Hormone Antagonists|hormone antagonists|mesh-ancestor
5532731|NCT04236310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5532732|NCT04236310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532733|NCT04236219|Rasburicase|rasburicase|mesh-list
5532734|NCT04236219|Gout Suppressants|gout suppressants|mesh-ancestor
5532735|NCT04236219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5532736|NCT04236115|Felypressin|felypressin|mesh-list
5532737|NCT04236115|Carticaine|carticaine|mesh-list
5532738|NCT04236115|Anesthetics, Local|anesthetics, local|mesh-ancestor
6121166|NCT01123980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6121167|NCT01123980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121168|NCT01123980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6121169|NCT01123980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6121170|NCT01123980|Immunologic Factors|immunologic factors|mesh-ancestor
6121171|NCT01124045|Prednisolone|prednisolone|mesh-list
6121172|NCT01124045|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6121173|NCT01124045|Methylprednisolone|methylprednisolone|mesh-list
5532739|NCT04236115|Anesthetics|anesthetics|mesh-ancestor
5532740|NCT04236115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5532741|NCT04236115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532742|NCT04236115|Sensory System Agents|sensory system agents|mesh-ancestor
5532743|NCT04236115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5532744|NCT04236115|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5532745|NCT04235985|Chlorhexidine|chlorhexidine|mesh-list
5532746|NCT04235985|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6121174|NCT01124045|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6121175|NCT01124045|Prednisolone acetate|prednisolone acetate|mesh-list
6121176|NCT01124045|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5532747|NCT04235985|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5532748|NCT04235985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5532749|NCT04235985|Disinfectants|disinfectants|mesh-ancestor
5532750|NCT04235985|Dermatologic Agents|dermatologic agents|mesh-ancestor
5532751|NCT04235816|Azithromycin|azithromycin|mesh-list
5532752|NCT04235816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5532753|NCT04235816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5532754|NCT04236258|Enalapril|enalapril|mesh-list
5532755|NCT04236258|Nifedipine|nifedipine|mesh-list
5532756|NCT04236258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5532757|NCT04236258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5532758|NCT04236258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5532759|NCT04236258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5532760|NCT04236258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532761|NCT04236258|Vasodilator Agents|vasodilator agents|mesh-ancestor
5532762|NCT04236258|Tocolytic Agents|tocolytic agents|mesh-ancestor
5532763|NCT04236258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5532764|NCT04236258|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5532765|NCT04236258|Protease Inhibitors|protease inhibitors|mesh-ancestor
5532766|NCT04236258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5532767|NCT04236258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5532768|NCT04235868|Mitogens|mitogens|mesh-list
5532769|NCT04235868|Mitosis Modulators|mitosis modulators|mesh-ancestor
6121177|NCT01124045|Prednisolone phosphate|prednisolone phosphate|mesh-list
6121178|NCT01124045|Difluprednate|difluprednate|mesh-list
6121179|NCT01124045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6121180|NCT01124045|Glucocorticoids|glucocorticoids|mesh-ancestor
6121181|NCT01124045|Hormones|hormones|mesh-ancestor
6121182|NCT01124045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6121183|NCT01124045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121184|NCT01124045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6121185|NCT01124045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6121186|NCT01124045|Antiemetics|antiemetics|mesh-ancestor
6121187|NCT01124045|Autonomic Agents|autonomic agents|mesh-ancestor
6121188|NCT01124045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6121189|NCT01124045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6121190|NCT01124045|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6121191|NCT01124045|Protective Agents|protective agents|mesh-ancestor
6121192|NCT01124097|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
6121193|NCT01124097|Anticonvulsants|anticonvulsants|mesh-ancestor
6121194|NCT01124097|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6121195|NCT01124097|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6121196|NCT01124097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6121197|NCT01124097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121198|NCT01124149|Mesalamine|mesalamine|mesh-list
6121199|NCT01124149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6121200|NCT01124149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6121201|NCT01124149|Analgesics|analgesics|mesh-ancestor
6121202|NCT01124149|Sensory System Agents|sensory system agents|mesh-ancestor
6465933|NCT00476424|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5532770|NCT04235868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5532771|NCT04235959|Tirzepatide|tirzepatide|mesh-list
5532772|NCT04235959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5532773|NCT04235959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532774|NCT04235959|Incretins|incretins|mesh-ancestor
5532775|NCT04235959|Hormones|hormones|mesh-ancestor
5532776|NCT04235959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5532777|NCT04235478|Triamcinolone|triamcinolone|mesh-list
5532778|NCT04235478|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5532779|NCT04235478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5532780|NCT04235478|Glucocorticoids|glucocorticoids|mesh-ancestor
5532781|NCT04235478|Hormones|hormones|mesh-ancestor
5532782|NCT04235478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5532783|NCT04235478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532784|NCT04235478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5532785|NCT04235478|Immunologic Factors|immunologic factors|mesh-ancestor
5532786|NCT04235426|Vitamin B 12|vitamin b 12|mesh-list
5532787|NCT04235426|Hydroxocobalamin|hydroxocobalamin|mesh-list
5532788|NCT04235426|Diclofenac|diclofenac|mesh-list
5532789|NCT04235426|Vitamins|vitamins|mesh-ancestor
5532790|NCT04235426|Micronutrients|micronutrients|mesh-ancestor
5532791|NCT04235426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121203|NCT01124149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6465934|NCT00476437|Insulin|insulin|mesh-list
5532792|NCT04235426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5532793|NCT04235426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5532794|NCT04235426|Analgesics|analgesics|mesh-ancestor
5532795|NCT04235426|Sensory System Agents|sensory system agents|mesh-ancestor
6121204|NCT01124149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121205|NCT01124149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6121206|NCT01124149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6121207|NCT01124162|Losartan|losartan|mesh-list
6121208|NCT01124162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6121209|NCT01124162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6121210|NCT01124162|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6121211|NCT01124162|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6121212|NCT01124162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121213|NCT01124175|Losartan|losartan|mesh-list
6121214|NCT01124175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6121215|NCT01124175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6121216|NCT01124175|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6121217|NCT01124175|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6121218|NCT01124175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121219|NCT01124188|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6121220|NCT01124188|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6121221|NCT01124188|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6121222|NCT01124188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6121223|NCT01124188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121224|NCT01124188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6121225|NCT01124188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121226|NCT01124188|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6121227|NCT01124188|Antidepressive Agents|antidepressive agents|mesh-ancestor
6121228|NCT01124188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6121229|NCT01124422|Fluticasone|fluticasone|mesh-list
6121230|NCT01124422|Xhance|xhance|mesh-list
6121231|NCT01124422|Bromides|bromides|mesh-list
6121232|NCT01124422|Tiotropium Bromide|tiotropium bromide|mesh-list
6121233|NCT01124422|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6121234|NCT01124422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6121235|NCT01124422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6121236|NCT01124422|Autonomic Agents|autonomic agents|mesh-ancestor
6121237|NCT01124422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6121238|NCT01124422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121239|NCT01124422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6121240|NCT01124422|Respiratory System Agents|respiratory system agents|mesh-ancestor
6121241|NCT01124422|Dermatologic Agents|dermatologic agents|mesh-ancestor
6121242|NCT01124422|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6121243|NCT01124422|Parasympatholytics|parasympatholytics|mesh-ancestor
6121244|NCT01124422|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6121245|NCT01124422|Cholinergic Agents|cholinergic agents|mesh-ancestor
6121246|NCT01124422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6121247|NCT01124422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121248|NCT01124422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6121249|NCT01124422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6121250|NCT01124422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6121251|NCT01124422|Adrenergic Agents|adrenergic agents|mesh-ancestor
6121252|NCT01124422|Anticonvulsants|anticonvulsants|mesh-ancestor
6121253|NCT01124448|TFF1 protein, human|tff1 protein, human|mesh-list
6121254|NCT01124448|Growth Inhibitors|growth inhibitors|mesh-ancestor
6121255|NCT01124448|Growth Substances|growth substances|mesh-ancestor
6121256|NCT01124448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121257|NCT01124604|Tapentadol|tapentadol|mesh-list
6121258|NCT01124604|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6121259|NCT01124604|Narcotics|narcotics|mesh-ancestor
6121260|NCT01124604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6121261|NCT01124604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121262|NCT01124604|Analgesics|analgesics|mesh-ancestor
6121263|NCT01124604|Sensory System Agents|sensory system agents|mesh-ancestor
6121264|NCT01124604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6121265|NCT01124604|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6121266|NCT01124604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6121267|NCT01124604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6121268|NCT01124604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121269|NCT01124604|Adrenergic Agents|adrenergic agents|mesh-ancestor
6121270|NCT01124604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6121271|NCT01124617|Tapentadol|tapentadol|mesh-list
5601610|NCT05175508|Azacitidine|azacitidine|mesh-list
5532796|NCT04235426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5532797|NCT04235426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5532798|NCT04235426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6121272|NCT01124617|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6121273|NCT01124617|Narcotics|narcotics|mesh-ancestor
6121274|NCT01124617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6121275|NCT01124617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121276|NCT01124617|Analgesics|analgesics|mesh-ancestor
6121277|NCT01124617|Sensory System Agents|sensory system agents|mesh-ancestor
6121278|NCT01124617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6121279|NCT01124617|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6121280|NCT01124617|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6121281|NCT01124617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6121282|NCT01124617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121283|NCT01124617|Adrenergic Agents|adrenergic agents|mesh-ancestor
6121284|NCT01124617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6121285|NCT01124734|Temozolomide|temozolomide|mesh-list
6121286|NCT01124734|Interleukin-2|interleukin-2|mesh-list
6121287|NCT01124734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6121288|NCT01124734|Alkylating Agents|alkylating agents|mesh-ancestor
6121289|NCT01124734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121290|NCT01124734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6121291|NCT01124734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6121292|NCT01124734|Analgesics|analgesics|mesh-ancestor
6121293|NCT01124734|Sensory System Agents|sensory system agents|mesh-ancestor
6121294|NCT01124734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6121295|NCT01124734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121296|NCT01124786|Gemcitabine|gemcitabine|mesh-list
6121297|NCT01124786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6121298|NCT01124786|Antimetabolites|antimetabolites|mesh-ancestor
6121299|NCT01124786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121300|NCT01124786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6121301|NCT01124786|Antiviral Agents|antiviral agents|mesh-ancestor
5532799|NCT04235426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5532800|NCT04235426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5532801|NCT04235426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5532802|NCT04235426|Vitamin B Complex|vitamin b complex|mesh-ancestor
5532803|NCT04235426|Hematinics|hematinics|mesh-ancestor
5532804|NCT04235569|Enoxaparin|enoxaparin|mesh-list
5532805|NCT04235569|Warfarin|warfarin|mesh-list
5532806|NCT04235569|Enoxaparin sodium|enoxaparin sodium|mesh-list
6121302|NCT01124786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6121303|NCT01124786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6121304|NCT01124786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6121305|NCT01124786|Immunologic Factors|immunologic factors|mesh-ancestor
6121306|NCT01124786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121307|NCT01124838|Prednisone|prednisone|mesh-list
6121308|NCT01124838|Adalimumab|adalimumab|mesh-list
6121309|NCT01124838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6121310|NCT01124838|Glucocorticoids|glucocorticoids|mesh-ancestor
6121311|NCT01124838|Hormones|hormones|mesh-ancestor
6121312|NCT01124838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6121313|NCT01124838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121314|NCT01124838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6121315|NCT01124838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6121316|NCT01124838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6121317|NCT01125046|Bevacizumab|bevacizumab|mesh-list
6121318|NCT01125046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6121319|NCT01125046|Antibodies|antibodies|mesh-list
6121320|NCT01125046|Immunoglobulins|immunoglobulins|mesh-list
6121321|NCT01125046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6121322|NCT01125046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6121323|NCT01125046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6121324|NCT01125046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6121325|NCT01125046|Growth Substances|growth substances|mesh-ancestor
6121326|NCT01125046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121327|NCT01125046|Growth Inhibitors|growth inhibitors|mesh-ancestor
6121328|NCT01125046|Immunologic Factors|immunologic factors|mesh-ancestor
6121329|NCT01125098|Amoxicillin|amoxicillin|mesh-list
6121330|NCT01125098|Clavulanic Acid|clavulanic acid|mesh-list
6121331|NCT01125098|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6121332|NCT01125098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6465935|NCT00476437|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5532807|NCT04235569|Anticoagulants|anticoagulants|mesh-ancestor
6121333|NCT01125098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6465936|NCT00476437|Insulin Aspart|insulin aspart|mesh-list
5532808|NCT04235569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5532809|NCT04235569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5532810|NCT04235569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5532811|NCT04235673|Melatonin|melatonin|mesh-list
5532812|NCT04235673|Antioxidants|antioxidants|mesh-ancestor
5532813|NCT04235673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5532814|NCT04235673|Protective Agents|protective agents|mesh-ancestor
5532815|NCT04235673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532816|NCT04235673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5532817|NCT04235270|Tadalafil|tadalafil|mesh-list
5532818|NCT04235270|Macitentan|macitentan|mesh-list
5532819|NCT04235270|Vasodilator Agents|vasodilator agents|mesh-ancestor
5532820|NCT04235270|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5532821|NCT04235270|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5532822|NCT04235270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5532823|NCT04235270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5532824|NCT04235270|Urological Agents|urological agents|mesh-ancestor
5532825|NCT04235270|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
5532826|NCT04235270|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5532827|NCT04235270|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
5532828|NCT04235296|Mitogens|mitogens|mesh-list
5532829|NCT04235296|Mitosis Modulators|mitosis modulators|mesh-ancestor
5532830|NCT04235296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5532831|NCT04235894|Propofol|propofol|mesh-list
5532832|NCT04235894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6121334|NCT01125098|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6121335|NCT01125098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6121336|NCT01125098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121337|NCT01125163|Iron|iron|mesh-list
6121338|NCT01125163|Trace Elements|trace elements|mesh-ancestor
6121339|NCT01125163|Micronutrients|micronutrients|mesh-ancestor
6121340|NCT01125163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121341|NCT01125189|Interferons|interferons|mesh-list
6121342|NCT01125189|Ribavirin|ribavirin|mesh-list
6121343|NCT01125189|Interferon-alpha|interferon-alpha|mesh-list
6121344|NCT01125189|Interferon alpha-2|interferon alpha-2|mesh-list
6465937|NCT00476437|Biphasic Insulins|biphasic insulins|mesh-list
6465938|NCT00476437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6465939|NCT00476437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465940|NCT00476463|Emtricitabine|emtricitabine|mesh-list
6465941|NCT00476463|Antiviral Agents|antiviral agents|mesh-ancestor
6465942|NCT00476463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6465943|NCT00476463|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6465944|NCT00476463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6465945|NCT00476463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6465946|NCT00476463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465947|NCT00476463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6121345|NCT01125189|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5532833|NCT04235894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5532834|NCT04235894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532835|NCT04235894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5532836|NCT04235894|Anesthetics, General|anesthetics, general|mesh-ancestor
5532837|NCT04235894|Anesthetics|anesthetics|mesh-ancestor
5532838|NCT04236050|Rocuronium|rocuronium|mesh-list
5532839|NCT04236050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532840|NCT04236050|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5532841|NCT04236050|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5532842|NCT04236050|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5532843|NCT04236050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5532844|NCT04235439|Insulin Lispro|insulin lispro|mesh-list
5532845|NCT04235439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5532846|NCT04235439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532847|NCT04235114|Nimotuzumab|nimotuzumab|mesh-list
5532848|NCT04235114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5532849|NCT04235114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5532850|NCT04234776|Ketamine|ketamine|mesh-list
5532851|NCT04234776|Aripiprazole|aripiprazole|mesh-list
5532852|NCT04234776|Citalopram|citalopram|mesh-list
5532853|NCT04234776|Analgesics|analgesics|mesh-ancestor
5532854|NCT04234776|Sensory System Agents|sensory system agents|mesh-ancestor
5532855|NCT04234776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6121346|NCT01125189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6121347|NCT01125189|Antiviral Agents|antiviral agents|mesh-ancestor
6121348|NCT01125189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6121349|NCT01125189|Antimetabolites|antimetabolites|mesh-ancestor
6121350|NCT01125189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121351|NCT01125189|Immunologic Factors|immunologic factors|mesh-ancestor
6121352|NCT01125189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121353|NCT01125293|Rituximab|rituximab|mesh-list
6121354|NCT01125293|Everolimus|everolimus|mesh-list
6121355|NCT01125293|Bortezomib|bortezomib|mesh-list
5532856|NCT04234776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532857|NCT04234776|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5532858|NCT04234776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5532859|NCT04234776|Anesthetics, General|anesthetics, general|mesh-ancestor
5532860|NCT04234776|Anesthetics|anesthetics|mesh-ancestor
6121356|NCT01125293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6121357|NCT01125293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6121358|NCT01125293|Immunologic Factors|immunologic factors|mesh-ancestor
6121359|NCT01125293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121360|NCT01125293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6121361|NCT01125293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6121362|NCT01125514|Furosemide|furosemide|mesh-list
6121363|NCT01125514|Diuretics|diuretics|mesh-ancestor
6121364|NCT01125514|Natriuretic Agents|natriuretic agents|mesh-ancestor
6121365|NCT01125514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121366|NCT01125514|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6121367|NCT01125514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6121368|NCT01125514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121369|NCT01125566|Trastuzumab|trastuzumab|mesh-list
6121370|NCT01125566|Vinorelbine|vinorelbine|mesh-list
6121371|NCT01125566|Afatinib|afatinib|mesh-list
6121372|NCT01125566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6121373|NCT01125566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6121374|NCT01125566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6121375|NCT01125566|Tubulin Modulators|tubulin modulators|mesh-ancestor
6121376|NCT01125566|Antimitotic Agents|antimitotic agents|mesh-ancestor
6121377|NCT01125566|Mitosis Modulators|mitosis modulators|mesh-ancestor
6121378|NCT01125566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121379|NCT01125566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6121380|NCT01125566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6121381|NCT01125748|Omalizumab|omalizumab|mesh-list
6121382|NCT01125748|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6121383|NCT01125748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5532861|NCT04234776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5532862|NCT04234776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5532863|NCT04234776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5532864|NCT04234776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5532865|NCT04234776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5532866|NCT04234776|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5532867|NCT04234776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5532868|NCT04234776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6121384|NCT01125748|Respiratory System Agents|respiratory system agents|mesh-ancestor
6121385|NCT01125813|Factor VIII|factor viii|mesh-list
6121386|NCT01125813|Coagulants|coagulants|mesh-ancestor
6121387|NCT01125917|Buprenorphine|buprenorphine|mesh-list
6121388|NCT01125917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6121389|NCT01125917|Narcotics|narcotics|mesh-ancestor
6121390|NCT01125917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6121391|NCT01125917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121392|NCT01125917|Analgesics|analgesics|mesh-ancestor
5532869|NCT04234776|Serotonin Agents|serotonin agents|mesh-ancestor
5532870|NCT04234776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5532871|NCT04234776|Antidepressive Agents|antidepressive agents|mesh-ancestor
5532872|NCT04234776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5532873|NCT04234776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5532874|NCT04234776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5532875|NCT04234776|Dopamine Agonists|dopamine agonists|mesh-ancestor
6121393|NCT01125917|Sensory System Agents|sensory system agents|mesh-ancestor
6121394|NCT01125917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6121395|NCT01125917|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6121396|NCT01125930|Tretinoin|tretinoin|mesh-list
6121397|NCT01125930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6121398|NCT01125930|Keratolytic Agents|keratolytic agents|mesh-ancestor
6121399|NCT01125930|Dermatologic Agents|dermatologic agents|mesh-ancestor
6121400|NCT01126060|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6121401|NCT01126060|Hemostatics|hemostatics|mesh-ancestor
6121402|NCT01126060|Coagulants|coagulants|mesh-ancestor
6121403|NCT01126099|Prazosin|prazosin|mesh-list
6121404|NCT01126099|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6121405|NCT01126099|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5532876|NCT04234776|Dopamine Agents|dopamine agents|mesh-ancestor
5532877|NCT04234776|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5532878|NCT04234776|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5532879|NCT04234776|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5532880|NCT04234776|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5532881|NCT04234776|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5532882|NCT04234776|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5601611|NCT05175508|Tretinoin|tretinoin|mesh-list
5601612|NCT05175508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5601613|NCT05175508|Antimetabolites|antimetabolites|mesh-ancestor
5601614|NCT05175508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601615|NCT05175508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5601616|NCT05175508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5601617|NCT05175508|Keratolytic Agents|keratolytic agents|mesh-ancestor
5601618|NCT05175508|Dermatologic Agents|dermatologic agents|mesh-ancestor
5601619|NCT05175430|Paroxetine|paroxetine|mesh-list
5601620|NCT05175430|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
5601621|NCT05175430|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5601622|NCT05175430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5601623|NCT05175430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5601624|NCT05175430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601625|NCT05175430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5601626|NCT05175430|Serotonin Agents|serotonin agents|mesh-ancestor
5601627|NCT05175430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601628|NCT05175430|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6121406|NCT01126099|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6121407|NCT01126099|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6121408|NCT01126099|Adrenergic Agents|adrenergic agents|mesh-ancestor
6121409|NCT01126099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5601629|NCT05175430|Antidepressive Agents|antidepressive agents|mesh-ancestor
6121410|NCT01126099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121411|NCT01126099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121412|NCT01126268|Retapamulin|retapamulin|mesh-list
6121413|NCT01126268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6121414|NCT01126268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6121415|NCT01126359|Lidocaine|lidocaine|mesh-list
6121416|NCT01126359|Anesthetics, Local|anesthetics, local|mesh-ancestor
6121417|NCT01126359|Anesthetics|anesthetics|mesh-ancestor
6121418|NCT01126359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6121419|NCT01126359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121420|NCT01126359|Sensory System Agents|sensory system agents|mesh-ancestor
5532883|NCT04235036|Rituximab|rituximab|mesh-list
5532884|NCT04235036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5532885|NCT04235036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5532886|NCT04235036|Immunologic Factors|immunologic factors|mesh-ancestor
5532887|NCT04235036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532888|NCT04235036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5532889|NCT04235062|Furosemide|furosemide|mesh-list
5532890|NCT04235062|Calcium|calcium|mesh-list
5532891|NCT04235062|Diuretics|diuretics|mesh-list
5532892|NCT04235062|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
5532893|NCT04235062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5532894|NCT04235062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532895|NCT04235062|Natriuretic Agents|natriuretic agents|mesh-ancestor
5532896|NCT04235062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5532897|NCT04235062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5532898|NCT04234867|Dapagliflozin|dapagliflozin|mesh-list
5532899|NCT04234867|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5532900|NCT04234867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5532901|NCT04234867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5532902|NCT04234867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532903|NCT04234997|Suvorexant|suvorexant|mesh-list
5532904|NCT04234997|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5532905|NCT04234997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5532906|NCT04234997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5532907|NCT04234997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121421|NCT01126359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6121422|NCT01126359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5532908|NCT04234997|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
5532909|NCT04234997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5532910|NCT04234997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5532911|NCT04234932|Latanoprost|latanoprost|mesh-list
6121423|NCT01126359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6121424|NCT01126359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6121425|NCT01126359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6121426|NCT01126359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121427|NCT01126424|Solifenacin Succinate|solifenacin succinate|mesh-list
6121428|NCT01126424|Oxybutynin|oxybutynin|mesh-list
6121429|NCT01126424|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6121430|NCT01126424|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6121431|NCT01126424|Cholinergic Agents|cholinergic agents|mesh-ancestor
6121432|NCT01126424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6121433|NCT01126424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121434|NCT01126424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121435|NCT01126424|Urological Agents|urological agents|mesh-ancestor
6121436|NCT01126424|Parasympatholytics|parasympatholytics|mesh-ancestor
6121437|NCT01126424|Autonomic Agents|autonomic agents|mesh-ancestor
6121438|NCT01126424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6121439|NCT01126437|Tiotropium Bromide|tiotropium bromide|mesh-list
6121440|NCT01126437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6121441|NCT01126437|Autonomic Agents|autonomic agents|mesh-ancestor
6121442|NCT01126437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6121443|NCT01126437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121444|NCT01126437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6121445|NCT01126437|Respiratory System Agents|respiratory system agents|mesh-ancestor
6121446|NCT01126437|Parasympatholytics|parasympatholytics|mesh-ancestor
6121447|NCT01126437|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6121448|NCT01126437|Cholinergic Agents|cholinergic agents|mesh-ancestor
6121449|NCT01126437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6121450|NCT01126437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121451|NCT01126541|Rituximab|rituximab|mesh-list
6121452|NCT01126541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6121453|NCT01126541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6121454|NCT01126541|Immunologic Factors|immunologic factors|mesh-ancestor
6121455|NCT01126541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121456|NCT01126541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6121457|NCT01126580|Metformin|metformin|mesh-list
6121458|NCT01126580|Dulaglutide|dulaglutide|mesh-list
6121459|NCT01126580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6121460|NCT01126580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121461|NCT01126593|Bupivacaine|bupivacaine|mesh-list
6121462|NCT01126593|Anesthetics, Local|anesthetics, local|mesh-ancestor
6121463|NCT01126593|Anesthetics|anesthetics|mesh-ancestor
6121464|NCT01126593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6121465|NCT01126593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121466|NCT01126593|Sensory System Agents|sensory system agents|mesh-ancestor
6121467|NCT01126593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6121468|NCT01126671|Vitamin D|vitamin d|mesh-list
6121469|NCT01126671|Vitamins|vitamins|mesh-ancestor
6121470|NCT01126671|Micronutrients|micronutrients|mesh-ancestor
6121471|NCT01126671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121472|NCT01126671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6121473|NCT01127165|Zonisamide|zonisamide|mesh-list
6121474|NCT01127165|Anticonvulsants|anticonvulsants|mesh-ancestor
6121475|NCT01127165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6121476|NCT01127165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6121477|NCT01127165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121478|NCT01127165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6121479|NCT01127165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121480|NCT01127438|Fospropofol|fospropofol|mesh-list
6121481|NCT01127438|Propofol|propofol|mesh-list
6121482|NCT01127438|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6121483|NCT01127438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6121484|NCT01127438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121485|NCT01127438|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6121486|NCT01127438|Anesthetics, General|anesthetics, general|mesh-ancestor
6121487|NCT01127438|Anesthetics|anesthetics|mesh-ancestor
6121488|NCT01127581|Dinoprostone|dinoprostone|mesh-list
6121489|NCT01127581|Oxytocics|oxytocics|mesh-ancestor
6121490|NCT01127581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6121491|NCT01127581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532912|NCT04234932|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5532913|NCT04234932|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5532914|NCT04234321|Mitogens|mitogens|mesh-list
5532915|NCT04234321|Mitosis Modulators|mitosis modulators|mesh-ancestor
5532916|NCT04234321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5532917|NCT04234594|Panitumumab|panitumumab|mesh-list
5532918|NCT04234594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5532919|NCT04234594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5532920|NCT04234607|Carboplatin|carboplatin|mesh-list
5532921|NCT04234607|Etoposide|etoposide|mesh-list
6121492|NCT01127607|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6121493|NCT01127607|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6121494|NCT01127607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121495|NCT01127607|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6121496|NCT01127607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6121497|NCT01127607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6121498|NCT01127607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121499|NCT01127607|Dopamine Agents|dopamine agents|mesh-ancestor
6121500|NCT01127607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6121501|NCT01127646|Methylphenidate|methylphenidate|mesh-list
6121502|NCT01127646|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6121503|NCT01127646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6121504|NCT01127646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121505|NCT01127646|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6121506|NCT01127646|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6121507|NCT01127646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6121508|NCT01127646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121509|NCT01127646|Dopamine Agents|dopamine agents|mesh-ancestor
6121510|NCT01127646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6121511|NCT01127646|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6121512|NCT01127646|Adrenergic Agents|adrenergic agents|mesh-ancestor
6121513|NCT01127659|Testosterone|testosterone|mesh-list
6121514|NCT01127659|Androgens|androgens|mesh-ancestor
6121515|NCT01127659|Hormones|hormones|mesh-ancestor
6121516|NCT01127659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6121517|NCT01127659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121518|NCT01127763|Carboplatin|carboplatin|mesh-list
6121519|NCT01127763|Everolimus|everolimus|mesh-list
6121520|NCT01127763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6121521|NCT01127763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6121522|NCT01127763|Immunologic Factors|immunologic factors|mesh-ancestor
6121523|NCT01127763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121524|NCT01127893|Tanezumab|tanezumab|mesh-list
6121525|NCT01127893|Analgesics|analgesics|mesh-ancestor
6121526|NCT01127893|Sensory System Agents|sensory system agents|mesh-ancestor
6121527|NCT01127893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6121528|NCT01127893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532922|NCT04234607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6121529|NCT01128153|Saxagliptin|saxagliptin|mesh-list
6121530|NCT01128153|Incretins|incretins|mesh-ancestor
6121531|NCT01128153|Hormones|hormones|mesh-ancestor
6121532|NCT01128153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6121533|NCT01128153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121534|NCT01128153|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6121535|NCT01128153|Protease Inhibitors|protease inhibitors|mesh-ancestor
6121536|NCT01128153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6121537|NCT01128153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121538|NCT01128153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6121539|NCT01128192|Pasireotide|pasireotide|mesh-list
6121540|NCT01128192|Hormones|hormones|mesh-ancestor
6121541|NCT01128192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6121542|NCT01128192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121543|NCT01128244|Pyridoxine|pyridoxine|mesh-list
6121544|NCT01128244|Pyridoxal|pyridoxal|mesh-list
6121545|NCT01128244|Vitamin B 6|vitamin b 6|mesh-list
6121546|NCT01128244|Vitamins|vitamins|mesh-ancestor
6121547|NCT01128244|Micronutrients|micronutrients|mesh-ancestor
6121548|NCT01128244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121549|NCT01128244|Vitamin B Complex|vitamin b complex|mesh-ancestor
6121550|NCT01128270|Chloral Hydrate|chloral hydrate|mesh-list
6121551|NCT01128270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6121552|NCT01128270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6121553|NCT01128270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121554|NCT01128296|Gemcitabine|gemcitabine|mesh-list
6121555|NCT01128296|Hydroxychloroquine|hydroxychloroquine|mesh-list
6121556|NCT01128296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6121557|NCT01128296|Antimetabolites|antimetabolites|mesh-ancestor
6121558|NCT01128296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121559|NCT01128296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6121560|NCT01128296|Antiviral Agents|antiviral agents|mesh-ancestor
6121561|NCT01128296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6121562|NCT01128296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6121563|NCT01128296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6121564|NCT01128296|Immunologic Factors|immunologic factors|mesh-ancestor
6121565|NCT01128296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121566|NCT01128296|Antimalarials|antimalarials|mesh-ancestor
6121567|NCT01128296|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6121568|NCT01128296|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6121569|NCT01128296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6121570|NCT01128387|Panitumumab|panitumumab|mesh-list
6121571|NCT01128387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6121572|NCT01128387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6121573|NCT01128543|Vinorelbine|vinorelbine|mesh-list
6121574|NCT01128543|Lapatinib|lapatinib|mesh-list
6121575|NCT01128543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6121576|NCT01128543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6121577|NCT01128543|Tubulin Modulators|tubulin modulators|mesh-ancestor
6121578|NCT01128543|Antimitotic Agents|antimitotic agents|mesh-ancestor
6121579|NCT01128543|Mitosis Modulators|mitosis modulators|mesh-ancestor
6121580|NCT01128543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121581|NCT01128543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6121582|NCT01128543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6121583|NCT01128569|Fluticasone|fluticasone|mesh-list
6121584|NCT01128569|Xhance|xhance|mesh-list
6121585|NCT01128569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5532923|NCT04234607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5532924|NCT04234607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5532925|NCT04234607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5532926|NCT04234607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5532927|NCT04234607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5532928|NCT04234516|Morphine|morphine|mesh-list
5532929|NCT04234516|Buprenorphine|buprenorphine|mesh-list
5532930|NCT04234516|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
5532931|NCT04234516|Naloxone|naloxone|mesh-list
5532932|NCT04234516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5532933|NCT04234516|Narcotics|narcotics|mesh-ancestor
5532934|NCT04234516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5532935|NCT04234516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532936|NCT04234516|Analgesics|analgesics|mesh-ancestor
6121586|NCT01128569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6121587|NCT01128569|Autonomic Agents|autonomic agents|mesh-ancestor
6121588|NCT01128569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6121589|NCT01128569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121590|NCT01128569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6121591|NCT01128569|Respiratory System Agents|respiratory system agents|mesh-ancestor
6121592|NCT01128569|Dermatologic Agents|dermatologic agents|mesh-ancestor
6121593|NCT01128569|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6121594|NCT01128595|Fluticasone|fluticasone|mesh-list
6121595|NCT01128595|Xhance|xhance|mesh-list
6666115|NCT01520792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6666116|NCT01520792|Analgesics|analgesics|mesh-ancestor
6666117|NCT01520792|Sensory System Agents|sensory system agents|mesh-ancestor
6666118|NCT01520792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6666119|NCT01520792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532937|NCT04234516|Sensory System Agents|sensory system agents|mesh-ancestor
5532938|NCT04234516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6121596|NCT01128595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6121597|NCT01128595|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6121598|NCT01128595|Autonomic Agents|autonomic agents|mesh-ancestor
6121599|NCT01128595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6121600|NCT01128595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532939|NCT04234516|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5532940|NCT04234217|Niacin|niacin|mesh-list
5532941|NCT04234217|Niacinamide|niacinamide|mesh-list
5532942|NCT04234217|Nicotinic Acids|nicotinic acids|mesh-list
5532943|NCT04234217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5532944|NCT04234217|Antimetabolites|antimetabolites|mesh-ancestor
5532945|NCT04234217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5532946|NCT04234217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5532947|NCT04234217|Vasodilator Agents|vasodilator agents|mesh-ancestor
5532948|NCT04234217|Vitamin B Complex|vitamin b complex|mesh-ancestor
6121601|NCT01128595|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6121602|NCT01128595|Respiratory System Agents|respiratory system agents|mesh-ancestor
6121603|NCT01128595|Dermatologic Agents|dermatologic agents|mesh-ancestor
6121604|NCT01128595|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6121605|NCT01128621|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6121606|NCT01128621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6121607|NCT01128621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121608|NCT01128621|Incretins|incretins|mesh-ancestor
5532949|NCT04234217|Vitamins|vitamins|mesh-ancestor
5532950|NCT04234217|Micronutrients|micronutrients|mesh-ancestor
5601630|NCT05175430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6121609|NCT01128621|Hormones|hormones|mesh-ancestor
6121610|NCT01128621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6121611|NCT01128621|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6121612|NCT01128621|Protease Inhibitors|protease inhibitors|mesh-ancestor
6121613|NCT01128621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6121614|NCT01128621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204653|NCT02073747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6204654|NCT02073747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6204655|NCT02073747|Adrenergic Agents|adrenergic agents|mesh-ancestor
6204656|NCT02073747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6666120|NCT01520792|Antipyretics|antipyretics|mesh-ancestor
6121615|NCT01128842|Capecitabine|capecitabine|mesh-list
6121616|NCT01128842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6121617|NCT01128842|Antimetabolites|antimetabolites|mesh-ancestor
6121618|NCT01128842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5532951|NCT04234217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532952|NCT04234113|Pembrolizumab|pembrolizumab|mesh-list
5532953|NCT04234113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6121619|NCT01128842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6121620|NCT01128894|Liraglutide|liraglutide|mesh-list
6121621|NCT01128894|rGLP-1 protein|rglp-1 protein|mesh-list
6121622|NCT01128894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6121623|NCT01128894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121624|NCT01128894|Incretins|incretins|mesh-ancestor
6121625|NCT01128894|Hormones|hormones|mesh-ancestor
6121626|NCT01128894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6121627|NCT01128959|Carbamazepine|carbamazepine|mesh-list
6121628|NCT01128959|Anticonvulsants|anticonvulsants|mesh-ancestor
6121629|NCT01128959|Antimanic Agents|antimanic agents|mesh-ancestor
6121630|NCT01128959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6121631|NCT01128959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6121632|NCT01128959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121633|NCT01128959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6121634|NCT01128959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6121635|NCT01128959|Analgesics|analgesics|mesh-ancestor
6121636|NCT01128959|Sensory System Agents|sensory system agents|mesh-ancestor
6121637|NCT01128959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6121638|NCT01128959|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6121639|NCT01128959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6121640|NCT01128959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121641|NCT01128959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6121642|NCT01128959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6121643|NCT01128972|Listerine|listerine|mesh-list
6121644|NCT01128972|Fluorides|fluorides|mesh-list
6121645|NCT01128972|Sodium Fluoride|sodium fluoride|mesh-list
6121646|NCT01128972|Cariostatic Agents|cariostatic agents|mesh-ancestor
6121647|NCT01128972|Protective Agents|protective agents|mesh-ancestor
6121648|NCT01128972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121649|NCT01128972|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6121650|NCT01128972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6121651|NCT01129011|Naproxen|naproxen|mesh-list
6121652|NCT01129011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6121653|NCT01129011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6121654|NCT01129011|Analgesics|analgesics|mesh-ancestor
6121655|NCT01129011|Sensory System Agents|sensory system agents|mesh-ancestor
6121656|NCT01129011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6121657|NCT01129011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121658|NCT01129011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6121659|NCT01129011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6121660|NCT01129011|Gout Suppressants|gout suppressants|mesh-ancestor
6121661|NCT01129011|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6121662|NCT01129011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6121663|NCT01129011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121664|NCT01129206|Deoxyglucose|deoxyglucose|mesh-list
6121665|NCT01129206|Docetaxel|docetaxel|mesh-list
6121666|NCT01129206|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6121667|NCT01129206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6121668|NCT01129206|Tubulin Modulators|tubulin modulators|mesh-ancestor
6121669|NCT01129206|Antimitotic Agents|antimitotic agents|mesh-ancestor
6121670|NCT01129206|Mitosis Modulators|mitosis modulators|mesh-ancestor
6121671|NCT01129206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121672|NCT01129206|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6121673|NCT01129206|Antimetabolites|antimetabolites|mesh-ancestor
6121674|NCT01129206|Antiviral Agents|antiviral agents|mesh-ancestor
5532954|NCT04234113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5532955|NCT04234191|Buprenorphine|buprenorphine|mesh-list
5532956|NCT04234191|Hydromorphone|hydromorphone|mesh-list
5532957|NCT04234191|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
5532958|NCT04234191|Naloxone|naloxone|mesh-list
5532959|NCT04234191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5532960|NCT04234191|Narcotics|narcotics|mesh-ancestor
5532961|NCT04234191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5532962|NCT04234191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5532963|NCT04234191|Analgesics|analgesics|mesh-ancestor
5532964|NCT04234191|Sensory System Agents|sensory system agents|mesh-ancestor
5532965|NCT04234191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5532966|NCT04234191|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5532967|NCT04233996|Meropenem|meropenem|mesh-list
5532968|NCT04233996|Tazobactam|tazobactam|mesh-list
5532969|NCT04233996|Piperacillin|piperacillin|mesh-list
5532970|NCT04233996|Cefepime|cefepime|mesh-list
5532971|NCT04233996|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
5532972|NCT04233996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5532973|NCT04233996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5532974|NCT04233996|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5532975|NCT04233996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5532976|NCT04233996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5532977|NCT04233866|Calcium, Dietary|calcium, dietary|mesh-list
5532978|NCT04233866|Leucovorin|leucovorin|mesh-list
5532979|NCT04233866|Folic Acid|folic acid|mesh-list
5532980|NCT04233866|Gemcitabine|gemcitabine|mesh-list
5532981|NCT04233866|Paclitaxel|paclitaxel|mesh-list
5532982|NCT04233866|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5532983|NCT04233866|Fluorouracil|fluorouracil|mesh-list
5532984|NCT04233866|Irinotecan|irinotecan|mesh-list
5532985|NCT04233866|Calcium|calcium|mesh-list
5532986|NCT04233866|Levoleucovorin|levoleucovorin|mesh-list
5532987|NCT04233866|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6121675|NCT01129206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6121676|NCT01129245|Celecoxib|celecoxib|mesh-list
6121677|NCT01129245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6121678|NCT01129245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6121679|NCT01129245|Analgesics|analgesics|mesh-ancestor
6465948|NCT00476463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6465949|NCT00476515|Rituximab|rituximab|mesh-list
6465950|NCT00476515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5532988|NCT04233866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5532989|NCT04233866|Tubulin Modulators|tubulin modulators|mesh-ancestor
5532990|NCT04233866|Antimitotic Agents|antimitotic agents|mesh-ancestor
5532991|NCT04233866|Mitosis Modulators|mitosis modulators|mesh-ancestor
5532992|NCT04233866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5532993|NCT04233866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6121680|NCT01129245|Sensory System Agents|sensory system agents|mesh-ancestor
5532994|NCT04233866|Antimetabolites|antimetabolites|mesh-ancestor
5532995|NCT04233866|Antiviral Agents|antiviral agents|mesh-ancestor
6666121|NCT01520818|Insulin|insulin|mesh-list
6465951|NCT00476515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6465952|NCT00476515|Immunologic Factors|immunologic factors|mesh-ancestor
6465953|NCT00476515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465954|NCT00476515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6465955|NCT00476541|Gemtuzumab|gemtuzumab|mesh-list
6121681|NCT01129245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6121682|NCT01129245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121683|NCT01129245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5532996|NCT04233866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5532997|NCT04233866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5532998|NCT04233866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5532999|NCT04233866|Immunologic Factors|immunologic factors|mesh-ancestor
5533000|NCT04233866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533001|NCT04233866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5533002|NCT04233866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5533003|NCT04233866|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5533004|NCT04233866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5533005|NCT04233866|Antidotes|antidotes|mesh-ancestor
5533006|NCT04233866|Protective Agents|protective agents|mesh-ancestor
5533007|NCT04233866|Vitamin B Complex|vitamin b complex|mesh-ancestor
5533008|NCT04233866|Vitamins|vitamins|mesh-ancestor
6121684|NCT01129245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6121685|NCT01129245|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6121686|NCT01129245|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6121687|NCT01129245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6121688|NCT01129245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121689|NCT01129284|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6121690|NCT01129284|Hormones|hormones|mesh-ancestor
6121691|NCT01129284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6121692|NCT01129284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121693|NCT01129336|Zoledronic Acid|zoledronic acid|mesh-list
6121694|NCT01129336|Diphosphonates|diphosphonates|mesh-list
6121695|NCT01129336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6121696|NCT01129336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121697|NCT01129440|Fluorides|fluorides|mesh-list
6121698|NCT01129440|Fluorides, Topical|fluorides, topical|mesh-list
6121699|NCT01129440|Cariostatic Agents|cariostatic agents|mesh-ancestor
6121700|NCT01129440|Protective Agents|protective agents|mesh-ancestor
6121701|NCT01129440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121702|NCT01129557|Valsartan|valsartan|mesh-list
6121703|NCT01129557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6121704|NCT01129557|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6121705|NCT01129557|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6121706|NCT01129557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121707|NCT01129583|Botulinum Toxins|botulinum toxins|mesh-list
6121708|NCT01129583|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6121709|NCT01129583|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6121710|NCT01129583|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6121711|NCT01129583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6121712|NCT01129583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121713|NCT01129583|Cholinergic Agents|cholinergic agents|mesh-ancestor
6121714|NCT01129583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6121715|NCT01129583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121716|NCT01129583|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6121717|NCT01129583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6121718|NCT01129622|Letrozole|letrozole|mesh-list
6121719|NCT01129622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6121720|NCT01129622|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6121721|NCT01129622|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6121722|NCT01129622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6121723|NCT01129622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121724|NCT01129622|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6121725|NCT01129622|Hormone Antagonists|hormone antagonists|mesh-ancestor
6207825|NCT02120898|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5533009|NCT04233866|Micronutrients|micronutrients|mesh-ancestor
5533010|NCT04233866|Hematinics|hematinics|mesh-ancestor
5533011|NCT04234048|Fenretinide|fenretinide|mesh-list
5533012|NCT04234048|Retinamide|retinamide|mesh-list
5533013|NCT04234048|Tretinoin|tretinoin|mesh-list
5533014|NCT04234048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5533015|NCT04234048|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5533016|NCT04234048|Protective Agents|protective agents|mesh-ancestor
6465956|NCT00476541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5533017|NCT04234048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533018|NCT04234048|Keratolytic Agents|keratolytic agents|mesh-ancestor
5533019|NCT04234048|Dermatologic Agents|dermatologic agents|mesh-ancestor
5533020|NCT04233697|Romidepsin|romidepsin|mesh-list
5533021|NCT04233697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5533022|NCT04233697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5533023|NCT04233892|Estrogens|estrogens|mesh-list
5533024|NCT04233892|Hormones|hormones|mesh-ancestor
5533025|NCT04233892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5533026|NCT04233892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121726|NCT01129622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6121727|NCT01129622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121728|NCT01129778|Omeprazole|omeprazole|mesh-list
6121729|NCT01129778|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
6121730|NCT01129778|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
6121731|NCT01129778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6121732|NCT01129778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6121733|NCT01129778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6121734|NCT01129778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121735|NCT01129882|Aripiprazole|aripiprazole|mesh-list
6121736|NCT01129882|Antidepressive Agents|antidepressive agents|mesh-ancestor
6121737|NCT01129882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6121738|NCT01129882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6121739|NCT01129882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6121740|NCT01129882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6121741|NCT01129882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121742|NCT01129882|Dopamine Agonists|dopamine agonists|mesh-ancestor
6121743|NCT01129882|Dopamine Agents|dopamine agents|mesh-ancestor
6121744|NCT01129882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6121745|NCT01129882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121746|NCT01129882|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6121747|NCT01129882|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6121748|NCT01129882|Serotonin Agents|serotonin agents|mesh-ancestor
6121749|NCT01129882|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6121750|NCT01129882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6121751|NCT01129882|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6121752|NCT01129882|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6121753|NCT01129960|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
6121754|NCT01129960|Anticonvulsants|anticonvulsants|mesh-ancestor
6121755|NCT01129960|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6121756|NCT01129960|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6121757|NCT01129960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6121758|NCT01129960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121759|NCT01130051|Colchicine|colchicine|mesh-list
6121760|NCT01130051|Gout Suppressants|gout suppressants|mesh-ancestor
6121761|NCT01130051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6121762|NCT01130051|Tubulin Modulators|tubulin modulators|mesh-ancestor
6121763|NCT01130051|Antimitotic Agents|antimitotic agents|mesh-ancestor
6121764|NCT01130051|Mitosis Modulators|mitosis modulators|mesh-ancestor
6121765|NCT01130051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121766|NCT01130051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6121767|NCT01130103|Paroxetine|paroxetine|mesh-list
6121768|NCT01130103|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6121769|NCT01130103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6121770|NCT01130103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6121771|NCT01130103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121772|NCT01130103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6121773|NCT01130103|Serotonin Agents|serotonin agents|mesh-ancestor
6121774|NCT01130103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121775|NCT01130103|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6121776|NCT01130103|Antidepressive Agents|antidepressive agents|mesh-ancestor
6121777|NCT01130103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6121778|NCT01130103|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6121779|NCT01130103|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6121780|NCT01130103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6121781|NCT01130168|Amlodipine|amlodipine|mesh-list
6121782|NCT01130168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6121783|NCT01130168|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6121784|NCT01130168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6121785|NCT01130168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121786|NCT01130168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6121787|NCT01130168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121788|NCT01130168|Vasodilator Agents|vasodilator agents|mesh-ancestor
6121789|NCT01130272|Eluxadoline|eluxadoline|mesh-list
6121790|NCT01130272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6121791|NCT01130337|Capecitabine|capecitabine|mesh-list
6121792|NCT01130337|Oxaliplatin|oxaliplatin|mesh-list
6121793|NCT01130337|Trastuzumab|trastuzumab|mesh-list
6121794|NCT01130337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6121795|NCT01130337|Antimetabolites|antimetabolites|mesh-ancestor
6121796|NCT01130337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121797|NCT01130337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6121798|NCT01130337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6121799|NCT01130493|Levodopa|levodopa|mesh-list
6121800|NCT01130493|Carbidopa|carbidopa|mesh-list
6121801|NCT01130493|Entacapone|entacapone|mesh-list
6121802|NCT01130493|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
6121803|NCT01130493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6121804|NCT01130493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6121805|NCT01130493|Dopamine Agents|dopamine agents|mesh-ancestor
5533033|NCT04233294|Decitabine|decitabine|mesh-list
5533034|NCT04233294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5533035|NCT04233294|Antimetabolites|antimetabolites|mesh-ancestor
5533036|NCT04233294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5533037|NCT04233294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5533038|NCT04233294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5533039|NCT04233463|Budesonide|budesonide|mesh-list
5533040|NCT04233463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5533041|NCT04233463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5533042|NCT04233463|Autonomic Agents|autonomic agents|mesh-ancestor
5533043|NCT04233463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5533044|NCT04233463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533045|NCT04233463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5533046|NCT04233463|Respiratory System Agents|respiratory system agents|mesh-ancestor
5533047|NCT04233463|Glucocorticoids|glucocorticoids|mesh-ancestor
5533048|NCT04233463|Hormones|hormones|mesh-ancestor
5533049|NCT04233463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5533050|NCT04233346|Ponatinib|ponatinib|mesh-list
5533051|NCT04233346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5533052|NCT04233346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5533053|NCT04233346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5533054|NCT04233346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5533055|NCT04233203|Insulin|insulin|mesh-list
5533056|NCT04233203|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5533057|NCT04233203|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5533058|NCT04233203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533059|NCT04233580|Chlorhexidine|chlorhexidine|mesh-list
5533060|NCT04233580|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6121806|NCT01130493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6121807|NCT01130493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121808|NCT01130493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121809|NCT01130493|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6121810|NCT01130493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6121811|NCT01130493|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6121812|NCT01130493|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6121813|NCT01130493|Immunologic Factors|immunologic factors|mesh-ancestor
6121814|NCT01130493|Dopamine Agonists|dopamine agonists|mesh-ancestor
6121815|NCT01130532|Tadalafil|tadalafil|mesh-list
6121816|NCT01130532|Vasodilator Agents|vasodilator agents|mesh-ancestor
6121817|NCT01130532|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6121818|NCT01130532|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6121819|NCT01130532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6121820|NCT01130532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121821|NCT01130532|Urological Agents|urological agents|mesh-ancestor
6121822|NCT01130597|Spironolactone|spironolactone|mesh-list
6121823|NCT01130597|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6121824|NCT01130597|Hormone Antagonists|hormone antagonists|mesh-ancestor
6121825|NCT01130597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6121826|NCT01130597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121827|NCT01130597|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6121828|NCT01130597|Diuretics|diuretics|mesh-ancestor
6121829|NCT01130597|Natriuretic Agents|natriuretic agents|mesh-ancestor
6121830|NCT01130844|Mesalamine|mesalamine|mesh-list
6121831|NCT01130844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6121832|NCT01130844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6121833|NCT01130844|Analgesics|analgesics|mesh-ancestor
5533061|NCT04233580|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5533062|NCT04233580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5533063|NCT04233580|Disinfectants|disinfectants|mesh-ancestor
5533064|NCT04233580|Dermatologic Agents|dermatologic agents|mesh-ancestor
5533065|NCT04233359|Anesthetics|anesthetics|mesh-list
5533066|NCT04233359|Anesthetics, Local|anesthetics, local|mesh-list
5533067|NCT04233359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5533068|NCT04233359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121834|NCT01130844|Sensory System Agents|sensory system agents|mesh-ancestor
6121835|NCT01130844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6121836|NCT01130844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121837|NCT01130844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6121838|NCT01130844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6121839|NCT01131052|Insulin|insulin|mesh-list
6121840|NCT01131052|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6121841|NCT01131052|Insulin Glargine|insulin glargine|mesh-list
6121842|NCT01131052|Insulin glulisine|insulin glulisine|mesh-list
6121843|NCT01131052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6121844|NCT01131052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121845|NCT01131065|Immunoglobulins|immunoglobulins|mesh-list
6121846|NCT01131065|Antibodies|antibodies|mesh-list
6121847|NCT01131065|gamma-Globulins|gamma-globulins|mesh-list
6121848|NCT01131065|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6121849|NCT01131065|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6121850|NCT01131065|Immunologic Factors|immunologic factors|mesh-ancestor
6121851|NCT01131065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465957|NCT00476541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6465958|NCT00476606|Ritonavir|ritonavir|mesh-list
6465959|NCT00476606|Nelfinavir|nelfinavir|mesh-list
6465960|NCT00476606|Indinavir|indinavir|mesh-list
6465961|NCT00476606|Saquinavir|saquinavir|mesh-list
6465962|NCT00476606|Lamivudine|lamivudine|mesh-list
6465963|NCT00476606|Zidovudine|zidovudine|mesh-list
6465964|NCT00476606|Nevirapine|nevirapine|mesh-list
6465965|NCT00476606|Stavudine|stavudine|mesh-list
6465966|NCT00476606|Didanosine|didanosine|mesh-list
6121852|NCT01131078|Bevacizumab|bevacizumab|mesh-list
6121853|NCT01131078|Capecitabine|capecitabine|mesh-list
6121854|NCT01131078|Irinotecan|irinotecan|mesh-list
6121855|NCT01131078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6121856|NCT01131078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6121857|NCT01131078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6121858|NCT01131078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6121859|NCT01131078|Growth Substances|growth substances|mesh-ancestor
6121860|NCT01131078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121861|NCT01131078|Growth Inhibitors|growth inhibitors|mesh-ancestor
6121862|NCT01131078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6121863|NCT01131078|Antimetabolites|antimetabolites|mesh-ancestor
6121864|NCT01131078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121865|NCT01131078|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6121866|NCT01131078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6121867|NCT01131078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6121868|NCT01131104|Sildenafil Citrate|sildenafil citrate|mesh-list
6121869|NCT01131104|Tadalafil|tadalafil|mesh-list
6121870|NCT01131104|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6465967|NCT00476606|Efavirenz|efavirenz|mesh-list
6121871|NCT01131104|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
6121872|NCT01131104|Vasodilator Agents|vasodilator agents|mesh-ancestor
6465968|NCT00476606|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6465969|NCT00476606|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6465970|NCT00476606|Protease Inhibitors|protease inhibitors|mesh-ancestor
6121873|NCT01131104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6121874|NCT01131104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6121875|NCT01131104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121876|NCT01131104|Urological Agents|urological agents|mesh-ancestor
6121877|NCT01131182|Metformin|metformin|mesh-list
6121878|NCT01131182|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6121879|NCT01131182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6121880|NCT01131182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121881|NCT01131182|Incretins|incretins|mesh-ancestor
6121882|NCT01131182|Hormones|hormones|mesh-ancestor
6121883|NCT01131182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6121884|NCT01131182|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6121885|NCT01131182|Protease Inhibitors|protease inhibitors|mesh-ancestor
6121886|NCT01131182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6121887|NCT01131182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121888|NCT01131507|Pancrelipase|pancrelipase|mesh-list
6121889|NCT01131507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6121890|NCT01131585|Ranibizumab|ranibizumab|mesh-list
6121891|NCT01131585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6121892|NCT01131585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6121893|NCT01131585|Growth Substances|growth substances|mesh-ancestor
6121894|NCT01131585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121895|NCT01131585|Growth Inhibitors|growth inhibitors|mesh-ancestor
6121896|NCT01131585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6121897|NCT01131676|Empagliflozin|empagliflozin|mesh-list
6121898|NCT01131676|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6121899|NCT01131676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121900|NCT01131676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6121901|NCT01131676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121902|NCT01132118|Hydroxychloroquine|hydroxychloroquine|mesh-list
6121903|NCT01132118|Antimalarials|antimalarials|mesh-ancestor
6121904|NCT01132118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6121905|NCT01132118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6121906|NCT01132118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6121907|NCT01132118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6121908|NCT01132118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121909|NCT01132118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6121910|NCT01132313|Ribavirin|ribavirin|mesh-list
6121911|NCT01132313|Antimetabolites|antimetabolites|mesh-ancestor
6121912|NCT01132313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121913|NCT01132313|Antiviral Agents|antiviral agents|mesh-ancestor
6121914|NCT01132313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6121915|NCT01132326|Droxidopa|droxidopa|mesh-list
6121916|NCT01132326|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6121917|NCT01132326|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6121918|NCT01132482|Sildenafil Citrate|sildenafil citrate|mesh-list
6121919|NCT01132482|Vasodilator Agents|vasodilator agents|mesh-ancestor
6121920|NCT01132482|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6121921|NCT01132482|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6121922|NCT01132482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6121923|NCT01132482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121924|NCT01132482|Urological Agents|urological agents|mesh-ancestor
6121925|NCT01132547|Cyproheptadine|cyproheptadine|mesh-list
6121926|NCT01132547|Antipruritics|antipruritics|mesh-ancestor
6121927|NCT01132547|Dermatologic Agents|dermatologic agents|mesh-ancestor
6121928|NCT01132547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6121929|NCT01132547|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5533069|NCT04233359|Sensory System Agents|sensory system agents|mesh-ancestor
5533070|NCT04233359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5533071|NCT04233229|Insulin|insulin|mesh-list
5533072|NCT04233229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5533073|NCT04233229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533074|NCT04233515|Anticoagulants|anticoagulants|mesh-list
5533075|NCT04233476|Arginyl-glycyl-aspartic acid|arginyl-glycyl-aspartic acid|mesh-list
5533076|NCT04233476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5533077|NCT04233502|Melatonin|melatonin|mesh-list
5533078|NCT04233502|Antioxidants|antioxidants|mesh-ancestor
5533079|NCT04233502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5533080|NCT04233502|Protective Agents|protective agents|mesh-ancestor
5533081|NCT04233502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533082|NCT04233502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5533083|NCT04232800|Riboflavin|riboflavin|mesh-list
6121930|NCT01132547|Histamine Antagonists|histamine antagonists|mesh-ancestor
6121931|NCT01132547|Histamine Agents|histamine agents|mesh-ancestor
6121932|NCT01132547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5533084|NCT04232800|Vitamins|vitamins|mesh-ancestor
5533085|NCT04232800|Micronutrients|micronutrients|mesh-ancestor
5533086|NCT04232800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533087|NCT04232800|Vitamin B Complex|vitamin b complex|mesh-ancestor
5533088|NCT04232800|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5533089|NCT04232800|Dermatologic Agents|dermatologic agents|mesh-ancestor
5601631|NCT05175430|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5601632|NCT05175430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5601633|NCT05175430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5601634|NCT05175430|Hallucinogens|hallucinogens|mesh-ancestor
5601635|NCT05175430|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5601636|NCT05175430|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5601637|NCT05175235|Nivolumab|nivolumab|mesh-list
5601638|NCT05175235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5601639|NCT05175235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5601640|NCT05175235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5601641|NCT05175235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601642|NCT05175131|Mebeverine|mebeverine|mesh-list
5601643|NCT05175131|Simethicone|simethicone|mesh-list
5601644|NCT05175131|Alverine|alverine|mesh-list
5601645|NCT05175131|Antifoaming Agents|antifoaming agents|mesh-ancestor
5601646|NCT05175131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121933|NCT01132547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121934|NCT01132547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121935|NCT01132547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6121936|NCT01132547|Serotonin Agents|serotonin agents|mesh-ancestor
6121937|NCT01132547|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6121938|NCT01132664|Capecitabine|capecitabine|mesh-list
6121939|NCT01132664|Trastuzumab|trastuzumab|mesh-list
6121940|NCT01132664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6121941|NCT01132664|Antimetabolites|antimetabolites|mesh-ancestor
5601647|NCT05175131|Emollients|emollients|mesh-ancestor
5601648|NCT05175131|Dermatologic Agents|dermatologic agents|mesh-ancestor
5601649|NCT05175131|Anticonvulsants|anticonvulsants|mesh-ancestor
5601650|NCT05175131|Parasympatholytics|parasympatholytics|mesh-ancestor
5601651|NCT05175131|Autonomic Agents|autonomic agents|mesh-ancestor
5601652|NCT05175131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5601653|NCT05175131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601654|NCT05175066|Bisoprolol|bisoprolol|mesh-list
5601655|NCT05175066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5601656|NCT05175066|Sympatholytics|sympatholytics|mesh-ancestor
5601657|NCT05175066|Autonomic Agents|autonomic agents|mesh-ancestor
5601658|NCT05175066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5601659|NCT05175066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601660|NCT05175066|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6121942|NCT01132664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121943|NCT01132664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6121944|NCT01132664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6121945|NCT01132807|Prednisone|prednisone|mesh-list
6121946|NCT01132807|Cyclophosphamide|cyclophosphamide|mesh-list
6121947|NCT01132807|Dacarbazine|dacarbazine|mesh-list
6121948|NCT01132807|Doxorubicin|doxorubicin|mesh-list
6121949|NCT01132807|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5601661|NCT05175066|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5601662|NCT05175066|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5601663|NCT05175066|Adrenergic Agents|adrenergic agents|mesh-ancestor
6121950|NCT01132807|Etoposide|etoposide|mesh-list
6121951|NCT01132807|Bleomycin|bleomycin|mesh-list
6121952|NCT01132807|Vinblastine|vinblastine|mesh-list
6121953|NCT01132807|Etoposide phosphate|etoposide phosphate|mesh-list
6121954|NCT01132807|Procarbazine|procarbazine|mesh-list
6121955|NCT01132807|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6121956|NCT01132807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6121957|NCT01132807|Immunologic Factors|immunologic factors|mesh-ancestor
6121958|NCT01132807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121959|NCT01132807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6121960|NCT01132807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6121961|NCT01132807|Alkylating Agents|alkylating agents|mesh-ancestor
6121962|NCT01132807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121963|NCT01132807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6121964|NCT01132807|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6121965|NCT01132807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6121966|NCT01132807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6121967|NCT01132807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6121968|NCT01132807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6121969|NCT01132807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5601664|NCT05175066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5533090|NCT04232943|Vaccines|vaccines|mesh-list
5533091|NCT04232943|Immunologic Factors|immunologic factors|mesh-ancestor
5533092|NCT04232943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121970|NCT01132807|Glucocorticoids|glucocorticoids|mesh-ancestor
6121971|NCT01132807|Hormones|hormones|mesh-ancestor
6121972|NCT01132807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6121973|NCT01132807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6121974|NCT01132807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6121975|NCT01132807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6121976|NCT01132807|Tubulin Modulators|tubulin modulators|mesh-ancestor
6121977|NCT01132807|Antimitotic Agents|antimitotic agents|mesh-ancestor
6121978|NCT01132807|Mitosis Modulators|mitosis modulators|mesh-ancestor
6121979|NCT01132820|Cediranib|cediranib|mesh-list
5533093|NCT04232813|Estradiol|estradiol|mesh-list
5533094|NCT04232813|Estrogens|estrogens|mesh-ancestor
5533095|NCT04232813|Hormones|hormones|mesh-ancestor
5533096|NCT04232813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5533097|NCT04232813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533098|NCT04233112|Melatonin|melatonin|mesh-list
5533099|NCT04233112|Antioxidants|antioxidants|mesh-ancestor
5533100|NCT04233112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5533101|NCT04233112|Protective Agents|protective agents|mesh-ancestor
5533102|NCT04233112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533103|NCT04233112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5533104|NCT04233021|Osimertinib|osimertinib|mesh-list
5533105|NCT04233021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6121980|NCT01132820|Maleic acid|maleic acid|mesh-list
6121981|NCT01132820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6121982|NCT01132820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121983|NCT01132820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6121984|NCT01132820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6121985|NCT01132846|Dopamine|dopamine|mesh-list
6121986|NCT01132846|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6121987|NCT01132846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6121988|NCT01132846|Sympathomimetics|sympathomimetics|mesh-ancestor
6121989|NCT01132846|Autonomic Agents|autonomic agents|mesh-ancestor
6121990|NCT01132846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6121991|NCT01132846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6121992|NCT01132846|Dopamine Agents|dopamine agents|mesh-ancestor
6121993|NCT01132846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6121994|NCT01132846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6121995|NCT01132846|Protective Agents|protective agents|mesh-ancestor
6121996|NCT01132846|Natriuretic Agents|natriuretic agents|mesh-ancestor
6121997|NCT01133158|Dexamethasone|dexamethasone|mesh-list
6121998|NCT01133158|Rituximab|rituximab|mesh-list
6121999|NCT01133158|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6122000|NCT01133158|Mitoxantrone|mitoxantrone|mesh-list
6122001|NCT01133158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6122002|NCT01133158|Antiemetics|antiemetics|mesh-ancestor
6122003|NCT01133158|Autonomic Agents|autonomic agents|mesh-ancestor
6122004|NCT01133158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6122005|NCT01133158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122006|NCT01133158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6122007|NCT01133158|Glucocorticoids|glucocorticoids|mesh-ancestor
6122008|NCT01133158|Hormones|hormones|mesh-ancestor
6122009|NCT01133158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6122010|NCT01133158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6122011|NCT01133158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6122012|NCT01133158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6122013|NCT01133158|Immunologic Factors|immunologic factors|mesh-ancestor
6122014|NCT01133158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5533106|NCT04233021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5533107|NCT04233021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5533108|NCT04233021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5533109|NCT04232969|Exenatide|exenatide|mesh-list
5533110|NCT04232969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5533111|NCT04232969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533112|NCT04232969|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5533113|NCT04232969|Incretins|incretins|mesh-ancestor
5533114|NCT04232969|Hormones|hormones|mesh-ancestor
5533115|NCT04232969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5533116|NCT04232644|Amphetamine|amphetamine|mesh-list
5533117|NCT04232644|Dextroamphetamine|dextroamphetamine|mesh-list
5533118|NCT04232644|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6122015|NCT01133158|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6122016|NCT01133158|Alkylating Agents|alkylating agents|mesh-ancestor
6122017|NCT01133158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122018|NCT01133158|Analgesics|analgesics|mesh-ancestor
6122019|NCT01133158|Sensory System Agents|sensory system agents|mesh-ancestor
6122020|NCT01133158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6122021|NCT01133158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6122022|NCT01133158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6122023|NCT01133275|Prednisone|prednisone|mesh-list
6122024|NCT01133275|Lenalidomide|lenalidomide|mesh-list
6122025|NCT01133275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6122026|NCT01133275|Glucocorticoids|glucocorticoids|mesh-ancestor
5533119|NCT04232644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533120|NCT04232644|Sympathomimetics|sympathomimetics|mesh-ancestor
5533121|NCT04232644|Autonomic Agents|autonomic agents|mesh-ancestor
5533122|NCT04232644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5533123|NCT04232644|Dopamine Agents|dopamine agents|mesh-ancestor
5533124|NCT04232644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5533125|NCT04232644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5533126|NCT04232644|Adrenergic Agents|adrenergic agents|mesh-ancestor
5533127|NCT04232644|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5533128|NCT04232644|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6122027|NCT01133275|Hormones|hormones|mesh-ancestor
6122028|NCT01133275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6122029|NCT01133275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122030|NCT01133275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6122031|NCT01133275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6122032|NCT01133275|Immunologic Factors|immunologic factors|mesh-ancestor
5533129|NCT04232644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5533130|NCT04232644|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5533131|NCT04232657|Denosumab|denosumab|mesh-list
5533132|NCT04232657|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5533133|NCT04232657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533134|NCT04232683|Tamsulosin|tamsulosin|mesh-list
5533135|NCT04232683|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5533136|NCT04232683|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5533137|NCT04232683|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5533138|NCT04232683|Adrenergic Agents|adrenergic agents|mesh-ancestor
6122033|NCT01133275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6122034|NCT01133275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6122035|NCT01133275|Growth Substances|growth substances|mesh-ancestor
6122036|NCT01133275|Growth Inhibitors|growth inhibitors|mesh-ancestor
6122037|NCT01133379|Fluorides|fluorides|mesh-list
6122038|NCT01133379|Cariostatic Agents|cariostatic agents|mesh-ancestor
6122039|NCT01133379|Protective Agents|protective agents|mesh-ancestor
6122040|NCT01133379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122041|NCT01133392|Insulin|insulin|mesh-list
6122042|NCT01133392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6122043|NCT01133392|Insulin Lispro|insulin lispro|mesh-list
6122044|NCT01133392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6122045|NCT01133392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122046|NCT01133522|Evolocumab|evolocumab|mesh-list
6122047|NCT01133522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6122048|NCT01133522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6122049|NCT01133522|Antimetabolites|antimetabolites|mesh-ancestor
6122050|NCT01133522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122051|NCT01133522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5533139|NCT04232683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5533140|NCT04232683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5533141|NCT04232683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533142|NCT04232683|Urological Agents|urological agents|mesh-ancestor
5533143|NCT04232722|Sorafenib|sorafenib|mesh-list
5533144|NCT04232722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5533145|NCT04232722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5533146|NCT04232722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5533147|NCT04232722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5533148|NCT04232358|Anesthetics|anesthetics|mesh-list
5533149|NCT04232358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5533150|NCT04232358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533151|NCT04232332|Mitogens|mitogens|mesh-list
6122052|NCT01133626|Prednisone|prednisone|mesh-list
6122053|NCT01133626|Beclomethasone|beclomethasone|mesh-list
6122054|NCT01133626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6122055|NCT01133626|Glucocorticoids|glucocorticoids|mesh-ancestor
6122056|NCT01133626|Hormones|hormones|mesh-ancestor
6122057|NCT01133626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6122058|NCT01133626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122059|NCT01133626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6122060|NCT01133626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6122061|NCT01133626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6122062|NCT01133626|Respiratory System Agents|respiratory system agents|mesh-ancestor
6122063|NCT01133665|Lenalidomide|lenalidomide|mesh-list
6122064|NCT01133665|Cetuximab|cetuximab|mesh-list
6122065|NCT01133665|Immunologic Factors|immunologic factors|mesh-ancestor
6122066|NCT01133665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122067|NCT01133665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6122068|NCT01133665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6122069|NCT01133665|Growth Substances|growth substances|mesh-ancestor
6122070|NCT01133665|Growth Inhibitors|growth inhibitors|mesh-ancestor
6122071|NCT01133665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6122072|NCT01133665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6122073|NCT01133678|Paclitaxel|paclitaxel|mesh-list
6122074|NCT01133678|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6122075|NCT01133678|Cisplatin|cisplatin|mesh-list
6122076|NCT01133678|Cetuximab|cetuximab|mesh-list
6122077|NCT01133678|Everolimus|everolimus|mesh-list
6122078|NCT01133678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6122079|NCT01133678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6122080|NCT01133678|Tubulin Modulators|tubulin modulators|mesh-ancestor
6122081|NCT01133678|Antimitotic Agents|antimitotic agents|mesh-ancestor
6122082|NCT01133678|Mitosis Modulators|mitosis modulators|mesh-ancestor
6122083|NCT01133678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122084|NCT01133678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6122085|NCT01133678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6122086|NCT01133678|Immunologic Factors|immunologic factors|mesh-ancestor
6122087|NCT01133678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122088|NCT01133756|Gemcitabine|gemcitabine|mesh-list
6122089|NCT01133756|Carboplatin|carboplatin|mesh-list
6122090|NCT01133756|Lenvatinib|lenvatinib|mesh-list
6122091|NCT01133756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6122092|NCT01133756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6122093|NCT01133756|Antimetabolites|antimetabolites|mesh-ancestor
6122094|NCT01133756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5533152|NCT04232332|Mitosis Modulators|mitosis modulators|mesh-ancestor
5533153|NCT04232332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5533154|NCT04232306|Bupivacaine|bupivacaine|mesh-list
5533155|NCT04232306|Anesthetics, Local|anesthetics, local|mesh-ancestor
5533156|NCT04232306|Anesthetics|anesthetics|mesh-ancestor
5533157|NCT04232306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5533158|NCT04232306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533159|NCT04232306|Sensory System Agents|sensory system agents|mesh-ancestor
6122095|NCT01133756|Antiviral Agents|antiviral agents|mesh-ancestor
6122096|NCT01133756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6122097|NCT01133756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6122098|NCT01133756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6122099|NCT01133756|Immunologic Factors|immunologic factors|mesh-ancestor
6122100|NCT01133756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122101|NCT01133756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6122102|NCT01133821|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6122103|NCT01133821|Antidepressive Agents|antidepressive agents|mesh-ancestor
6122104|NCT01133821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6122105|NCT01133821|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6122106|NCT01133821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6122107|NCT01133821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6122108|NCT01133821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122109|NCT01133847|Guanfacine|guanfacine|mesh-list
6122110|NCT01133847|Methylphenidate|methylphenidate|mesh-list
6122111|NCT01133847|Amphetamine|amphetamine|mesh-list
6122112|NCT01133847|Adderall|adderall|mesh-list
6122113|NCT01133847|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6122114|NCT01133847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6122115|NCT01133847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122116|NCT01133847|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6122117|NCT01133847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6122118|NCT01133847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6122119|NCT01133847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122120|NCT01133847|Dopamine Agents|dopamine agents|mesh-ancestor
6122121|NCT01133847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6122122|NCT01133847|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6122123|NCT01133847|Adrenergic Agents|adrenergic agents|mesh-ancestor
6122124|NCT01133847|Sympathomimetics|sympathomimetics|mesh-ancestor
6122125|NCT01133847|Autonomic Agents|autonomic agents|mesh-ancestor
6207826|NCT02120898|Immunologic Factors|immunologic factors|mesh-ancestor
6122126|NCT01133847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6122127|NCT01133847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6122128|NCT01133847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6122129|NCT01133847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6122130|NCT01133847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6122131|NCT01133977|Lenvatinib|lenvatinib|mesh-list
6122132|NCT01133977|Dacarbazine|dacarbazine|mesh-list
6122133|NCT01133977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6122134|NCT01133977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6122135|NCT01133977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6122136|NCT01133977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122137|NCT01133977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6122138|NCT01133977|Alkylating Agents|alkylating agents|mesh-ancestor
6122139|NCT01134042|Fluticasone|fluticasone|mesh-list
6122140|NCT01134042|Xhance|xhance|mesh-list
6122141|NCT01134042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6122142|NCT01134042|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6122143|NCT01134042|Autonomic Agents|autonomic agents|mesh-ancestor
6122144|NCT01134042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6122145|NCT01134042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122146|NCT01134042|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6122147|NCT01134042|Respiratory System Agents|respiratory system agents|mesh-ancestor
6122148|NCT01134042|Dermatologic Agents|dermatologic agents|mesh-ancestor
6122149|NCT01134042|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6122150|NCT01134055|Ranibizumab|ranibizumab|mesh-list
6122151|NCT01134055|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6122152|NCT01134055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6122153|NCT01134055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6122154|NCT01134055|Growth Substances|growth substances|mesh-ancestor
6122155|NCT01134055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122156|NCT01134055|Growth Inhibitors|growth inhibitors|mesh-ancestor
6122157|NCT01134055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6122158|NCT01134055|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6122159|NCT01134107|Insulin|insulin|mesh-list
6122160|NCT01134107|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6122161|NCT01134107|Insulin Aspart|insulin aspart|mesh-list
6465971|NCT00476606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6465972|NCT00476606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465973|NCT00476606|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6465974|NCT00476606|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6666122|NCT01520818|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6666123|NCT01520818|Insulin Aspart|insulin aspart|mesh-list
6122162|NCT01134107|Insulin Lispro|insulin lispro|mesh-list
6122163|NCT01134107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6122164|NCT01134107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122165|NCT01134198|Mifepristone|mifepristone|mesh-list
6122166|NCT01134198|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6122167|NCT01134198|Abortifacient Agents|abortifacient agents|mesh-ancestor
6122168|NCT01134198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6122169|NCT01134198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122170|NCT01134198|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6122171|NCT01134198|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6122172|NCT01134198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6122173|NCT01134198|Contraceptive Agents|contraceptive agents|mesh-ancestor
6122174|NCT01134198|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6122175|NCT01134198|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6122176|NCT01134198|Hormone Antagonists|hormone antagonists|mesh-ancestor
6122177|NCT01134198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6122178|NCT01134198|Luteolytic Agents|luteolytic agents|mesh-ancestor
6122179|NCT01134198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6122180|NCT01134198|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6204657|NCT02073747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204658|NCT02073929|Liraglutide|liraglutide|mesh-list
6204659|NCT02073929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6204660|NCT02073929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204661|NCT02073929|Incretins|incretins|mesh-ancestor
6204662|NCT02073929|Hormones|hormones|mesh-ancestor
6204663|NCT02073929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6204664|NCT02074358|Apixaban|apixaban|mesh-list
6204665|NCT02074358|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6204666|NCT02074358|Antithrombins|antithrombins|mesh-ancestor
6204667|NCT02074358|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6204668|NCT02074358|Protease Inhibitors|protease inhibitors|mesh-ancestor
6204669|NCT02074358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6204670|NCT02074358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122181|NCT01134263|Vaccines|vaccines|mesh-list
6122182|NCT01134263|Immunologic Factors|immunologic factors|mesh-ancestor
6122183|NCT01134263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122184|NCT01134315|Calcitriol|calcitriol|mesh-list
5533160|NCT04232306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5533161|NCT04232007|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
5533162|NCT04232150|Midazolam|midazolam|mesh-list
5533163|NCT04232150|Anesthetics|anesthetics|mesh-list
5533164|NCT04232150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5533165|NCT04232150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533166|NCT04232150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5533167|NCT04232150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5533168|NCT04232150|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5533169|NCT04232150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5533170|NCT04232150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5533171|NCT04232150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5533172|NCT04232150|Anesthetics, General|anesthetics, general|mesh-ancestor
5533173|NCT04232150|GABA Modulators|gaba modulators|mesh-ancestor
5533174|NCT04232150|GABA Agents|gaba agents|mesh-ancestor
5533175|NCT04232150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5533176|NCT04232150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122185|NCT01134315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6122186|NCT01134315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122187|NCT01134315|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6122188|NCT01134315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6122189|NCT01134315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122190|NCT01134315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6122191|NCT01134315|Vitamins|vitamins|mesh-ancestor
6122192|NCT01134315|Micronutrients|micronutrients|mesh-ancestor
6122193|NCT01134315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6122194|NCT01134393|Amlodipine|amlodipine|mesh-list
6122195|NCT01134393|Telmisartan|telmisartan|mesh-list
6122196|NCT01134393|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
6122197|NCT01134393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6122198|NCT01134393|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6122199|NCT01134393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6122200|NCT01134393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122201|NCT01134393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6122202|NCT01134393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122203|NCT01134393|Vasodilator Agents|vasodilator agents|mesh-ancestor
6122204|NCT01134393|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5533177|NCT04231864|Durvalumab|durvalumab|mesh-list
5533178|NCT04231864|Immunoglobulins|immunoglobulins|mesh-list
5533179|NCT04231864|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5533180|NCT04231864|Immunoglobulin G|immunoglobulin g|mesh-list
5533181|NCT04231864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5533182|NCT04231864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5533183|NCT04231864|Immunologic Factors|immunologic factors|mesh-ancestor
6122205|NCT01134393|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6122206|NCT01134510|Complement C1s|complement c1s|mesh-list
6122207|NCT01134510|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
6122208|NCT01134510|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
6122209|NCT01134510|Immunologic Factors|immunologic factors|mesh-ancestor
6122210|NCT01134510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122211|NCT01134510|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6122212|NCT01134510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5533184|NCT04231864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533185|NCT04232033|Mitogens|mitogens|mesh-list
5533186|NCT04232033|Mitosis Modulators|mitosis modulators|mesh-ancestor
5533187|NCT04232033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5533188|NCT04232085|Mycophenolic Acid|mycophenolic acid|mesh-list
5533189|NCT04232085|Cyclophosphamide|cyclophosphamide|mesh-list
5533190|NCT04232085|Melphalan|melphalan|mesh-list
5533191|NCT04232085|Fludarabine|fludarabine|mesh-list
5533192|NCT04232085|Alemtuzumab|alemtuzumab|mesh-list
5533193|NCT04232085|Tacrolimus|tacrolimus|mesh-list
5533194|NCT04232085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6122213|NCT01134575|Rituximab|rituximab|mesh-list
6122214|NCT01134575|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
6122215|NCT01134575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6122216|NCT01134575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6122217|NCT01134575|Immunologic Factors|immunologic factors|mesh-ancestor
6122218|NCT01134575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533195|NCT04232085|Immunologic Factors|immunologic factors|mesh-ancestor
5533196|NCT04232085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533197|NCT04232085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5533198|NCT04232085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5533199|NCT04232085|Alkylating Agents|alkylating agents|mesh-ancestor
5533200|NCT04232085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5533201|NCT04232085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5533202|NCT04232085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5533203|NCT04232085|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5533204|NCT04232085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5533205|NCT04232085|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5533206|NCT04232085|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5533207|NCT04232085|Antitubercular Agents|antitubercular agents|mesh-ancestor
5533208|NCT04232085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5533209|NCT04232085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5533210|NCT04232085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5533211|NCT04231968|Ziresovir|ziresovir|mesh-list
5533212|NCT04231968|Antiviral Agents|antiviral agents|mesh-ancestor
5533213|NCT04231968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5533214|NCT04231851|Cytarabine|cytarabine|mesh-list
5533215|NCT04231851|Daunorubicin|daunorubicin|mesh-list
5533216|NCT04231851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5533217|NCT04231851|Antimetabolites|antimetabolites|mesh-ancestor
5533218|NCT04231851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5533219|NCT04231851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6122219|NCT01134575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6122220|NCT01134575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6122221|NCT01134614|Ipilimumab|ipilimumab|mesh-list
6122222|NCT01134614|Sargramostim|sargramostim|mesh-list
6122223|NCT01134614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6122224|NCT01134614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6122225|NCT01134614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6122226|NCT01134614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122227|NCT01134614|Immunologic Factors|immunologic factors|mesh-ancestor
6122228|NCT01134614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122229|NCT01134627|Minocycline|minocycline|mesh-list
6122230|NCT01134627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5533220|NCT04231851|Antiviral Agents|antiviral agents|mesh-ancestor
5533221|NCT04231851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5533222|NCT04231851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5533223|NCT04231851|Immunologic Factors|immunologic factors|mesh-ancestor
5533224|NCT04231851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533225|NCT04231851|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5533226|NCT04231851|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5533227|NCT04231851|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5533228|NCT04231851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5533229|NCT04231643|Dronabinol|dronabinol|mesh-list
5533230|NCT04231643|Cannabidiol|cannabidiol|mesh-list
5533231|NCT04231643|Hallucinogens|hallucinogens|mesh-ancestor
5533232|NCT04231643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533233|NCT04231643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5533234|NCT04231643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5533235|NCT04231643|Analgesics|analgesics|mesh-ancestor
5533236|NCT04231643|Sensory System Agents|sensory system agents|mesh-ancestor
5533237|NCT04231643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5533238|NCT04231643|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5533239|NCT04231643|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5533240|NCT04231643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5533241|NCT04231643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5533242|NCT04231643|Hormones|hormones|mesh-ancestor
5533243|NCT04231643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5533244|NCT04231643|Anticonvulsants|anticonvulsants|mesh-ancestor
5533245|NCT04231526|Pembrolizumab|pembrolizumab|mesh-list
5533246|NCT04231526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5533247|NCT04231526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5533248|NCT04231435|Metformin|metformin|mesh-list
5533249|NCT04231435|Digoxin|digoxin|mesh-list
5533250|NCT04231435|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5533251|NCT04231435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5533252|NCT04231435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533253|NCT04231435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5533254|NCT04231435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5533255|NCT04231435|Antimetabolites|antimetabolites|mesh-ancestor
5533256|NCT04231435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5533257|NCT04231435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5533258|NCT04231435|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5533259|NCT04231435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5533260|NCT04231435|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5533261|NCT04231435|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6122231|NCT01134627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6122232|NCT01134705|Beclomethasone|beclomethasone|mesh-list
6122233|NCT01134705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6122234|NCT01134705|Glucocorticoids|glucocorticoids|mesh-ancestor
6122235|NCT01134705|Hormones|hormones|mesh-ancestor
6122236|NCT01134705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6122237|NCT01134705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122238|NCT01134705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6122239|NCT01134705|Respiratory System Agents|respiratory system agents|mesh-ancestor
6122240|NCT01134731|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6122241|NCT01134731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6122242|NCT01134731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122243|NCT01134731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6122244|NCT01134731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5533262|NCT04231435|Protective Agents|protective agents|mesh-ancestor
5533263|NCT04231617|Glyburide|glyburide|mesh-list
5533264|NCT04231617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5533265|NCT04231617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533266|NCT04231682|Denosumab|denosumab|mesh-list
5533267|NCT04231682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5533268|NCT04231682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533269|NCT04231539|Nicotine|nicotine|mesh-list
5533270|NCT04231539|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5533271|NCT04231539|Autonomic Agents|autonomic agents|mesh-ancestor
6122245|NCT01134731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122246|NCT01134731|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6122247|NCT01134731|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6122248|NCT01134731|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6122249|NCT01134731|Serotonin Agents|serotonin agents|mesh-ancestor
6122250|NCT01134731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6122251|NCT01134731|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6122252|NCT01134731|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6122253|NCT01134731|Dopamine Agents|dopamine agents|mesh-ancestor
6122254|NCT01134952|Mycophenolic Acid|mycophenolic acid|mesh-list
6122255|NCT01134952|Sirolimus|sirolimus|mesh-list
6122256|NCT01134952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6122257|NCT01134952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6122258|NCT01134952|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6122259|NCT01134952|Antitubercular Agents|antitubercular agents|mesh-ancestor
6122260|NCT01134952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6122261|NCT01134952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6122262|NCT01134952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6122263|NCT01134952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122264|NCT01134952|Antifungal Agents|antifungal agents|mesh-ancestor
6122265|NCT01134952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6122266|NCT01134952|Immunologic Factors|immunologic factors|mesh-ancestor
6122267|NCT01134952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122268|NCT01135017|Dronedarone|dronedarone|mesh-list
6122269|NCT01135017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6122270|NCT01135069|Tretinoin|tretinoin|mesh-list
6122271|NCT01135069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6122272|NCT01135069|Keratolytic Agents|keratolytic agents|mesh-ancestor
6122273|NCT01135069|Dermatologic Agents|dermatologic agents|mesh-ancestor
6122274|NCT01135186|Verapamil|verapamil|mesh-list
6122275|NCT01135186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6122276|NCT01135186|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6122277|NCT01135186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6122278|NCT01135186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122279|NCT01135186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6122280|NCT01135186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122281|NCT01135186|Vasodilator Agents|vasodilator agents|mesh-ancestor
6122282|NCT01135329|Mycophenolic Acid|mycophenolic acid|mesh-list
6122283|NCT01135329|Cyclophosphamide|cyclophosphamide|mesh-list
6122284|NCT01135329|Busulfan|busulfan|mesh-list
6122285|NCT01135329|Fludarabine|fludarabine|mesh-list
6122286|NCT01135329|Tacrolimus|tacrolimus|mesh-list
6122287|NCT01135329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6122288|NCT01135329|Immunologic Factors|immunologic factors|mesh-ancestor
6122289|NCT01135329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122290|NCT01135329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6122291|NCT01135329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5533272|NCT04231539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5606732|NCT03818737|Glucocorticoids|glucocorticoids|mesh-ancestor
5533273|NCT04231539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533274|NCT04231539|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5533275|NCT04231539|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5533276|NCT04231539|Cholinergic Agents|cholinergic agents|mesh-ancestor
5533277|NCT04231539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5533278|NCT04231539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5533279|NCT04231448|Prednisone|prednisone|mesh-list
5533280|NCT04231448|Cyclophosphamide|cyclophosphamide|mesh-list
5533281|NCT04231448|Rituximab|rituximab|mesh-list
6122292|NCT01135329|Alkylating Agents|alkylating agents|mesh-ancestor
6122293|NCT01135329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122294|NCT01135329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6122295|NCT01135329|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6122296|NCT01135329|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6122297|NCT01135329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6122298|NCT01135329|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6122299|NCT01135329|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6122300|NCT01135329|Antitubercular Agents|antitubercular agents|mesh-ancestor
6122301|NCT01135329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5533282|NCT04231448|Doxorubicin|doxorubicin|mesh-list
5533283|NCT04231448|Vincristine|vincristine|mesh-list
5533284|NCT04231448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5533285|NCT04231448|Immunologic Factors|immunologic factors|mesh-ancestor
5533286|NCT04231448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533287|NCT04231448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5533288|NCT04231448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5533289|NCT04231448|Alkylating Agents|alkylating agents|mesh-ancestor
5533290|NCT04231448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5533291|NCT04231448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5533292|NCT04231448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5533293|NCT04231448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5533294|NCT04231448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6122302|NCT01135329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6122303|NCT01135368|Lansoprazole|lansoprazole|mesh-list
6122304|NCT01135368|Dexlansoprazole|dexlansoprazole|mesh-list
6122305|NCT01135368|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6122306|NCT01135368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6122307|NCT01135368|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6122308|NCT01135368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6122309|NCT01135368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5533295|NCT04231448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5533296|NCT04231448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5533297|NCT04231448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5533298|NCT04231448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5533299|NCT04231448|Glucocorticoids|glucocorticoids|mesh-ancestor
5533300|NCT04231448|Hormones|hormones|mesh-ancestor
5533301|NCT04231448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5533302|NCT04231448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5533303|NCT04231448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5533304|NCT04231448|Tubulin Modulators|tubulin modulators|mesh-ancestor
5533305|NCT04231448|Antimitotic Agents|antimitotic agents|mesh-ancestor
5533306|NCT04231448|Mitosis Modulators|mitosis modulators|mesh-ancestor
5533307|NCT04231370|Lenalidomide|lenalidomide|mesh-list
6122310|NCT01135394|Pioglitazone|pioglitazone|mesh-list
6122311|NCT01135394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6122312|NCT01135394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533308|NCT04231370|Immunologic Factors|immunologic factors|mesh-ancestor
5533309|NCT04231370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533310|NCT04231370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5533311|NCT04231370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5533312|NCT04231370|Growth Substances|growth substances|mesh-ancestor
5533313|NCT04231370|Growth Inhibitors|growth inhibitors|mesh-ancestor
5533314|NCT04231370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5601665|NCT05175066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601666|NCT05175027|Povidone-Iodine|povidone-iodine|mesh-list
5601667|NCT05175027|Povidone|povidone|mesh-list
5601668|NCT05175027|Plasma Substitutes|plasma substitutes|mesh-ancestor
5601669|NCT05175027|Blood Substitutes|blood substitutes|mesh-ancestor
5601670|NCT05175027|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5601671|NCT05175027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5601672|NCT05175001|Betamethasone|betamethasone|mesh-list
5601673|NCT05175001|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
5601674|NCT05175001|Ropivacaine|ropivacaine|mesh-list
6122313|NCT01135498|Bevacizumab|bevacizumab|mesh-list
6122314|NCT01135498|Capecitabine|capecitabine|mesh-list
6122315|NCT01135498|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6122316|NCT01135498|Oxaliplatin|oxaliplatin|mesh-list
6122317|NCT01135498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6122318|NCT01135498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6122319|NCT01135498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6122320|NCT01135498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6122321|NCT01135498|Growth Substances|growth substances|mesh-ancestor
6122322|NCT01135498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122323|NCT01135498|Growth Inhibitors|growth inhibitors|mesh-ancestor
6122324|NCT01135498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6122325|NCT01135498|Antimetabolites|antimetabolites|mesh-ancestor
6122326|NCT01135498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5533315|NCT04231214|Tiotropium Bromide|tiotropium bromide|mesh-list
5533316|NCT04231214|Olodaterol|olodaterol|mesh-list
5533317|NCT04231214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5533318|NCT04231214|Autonomic Agents|autonomic agents|mesh-ancestor
5533319|NCT04231214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5533320|NCT04231214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533321|NCT04231214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5533322|NCT04231214|Respiratory System Agents|respiratory system agents|mesh-ancestor
5533323|NCT04231214|Parasympatholytics|parasympatholytics|mesh-ancestor
5533324|NCT04231214|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5533325|NCT04231214|Cholinergic Agents|cholinergic agents|mesh-ancestor
5533326|NCT04231214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5533327|NCT04231214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5533328|NCT04231123|Anesthetics|anesthetics|mesh-list
5533329|NCT04231123|Anesthetics, Local|anesthetics, local|mesh-list
5533330|NCT04231123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5533331|NCT04231123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122327|NCT01135498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6122328|NCT01135498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6122329|NCT01135511|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6122330|NCT01135511|Tofacitinib|tofacitinib|mesh-list
6122331|NCT01135511|Hyaluronic Acid|hyaluronic acid|mesh-list
6122332|NCT01135511|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6122333|NCT01135511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5533332|NCT04231123|Sensory System Agents|sensory system agents|mesh-ancestor
5533333|NCT04231123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5533334|NCT04231279|Secretin|secretin|mesh-list
6122334|NCT01135511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6122335|NCT01135511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5533335|NCT04231279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5533336|NCT04231279|Hormones|hormones|mesh-ancestor
5533337|NCT04231279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5533338|NCT04231279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533339|NCT04230980|Gabapentin|gabapentin|mesh-list
5533340|NCT04230980|Analgesics|analgesics|mesh-ancestor
5533341|NCT04230980|Sensory System Agents|sensory system agents|mesh-ancestor
5533342|NCT04230980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5533343|NCT04230980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533344|NCT04230980|Anticonvulsants|anticonvulsants|mesh-ancestor
5533345|NCT04230980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5533346|NCT04230980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5533347|NCT04230980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5533348|NCT04230980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5533349|NCT04230980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5533350|NCT04230980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5533351|NCT04230980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5533352|NCT04230980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5533353|NCT04230980|Antimanic Agents|antimanic agents|mesh-ancestor
5533354|NCT04230681|Fentanyl|fentanyl|mesh-list
5533355|NCT04230681|Hydromorphone|hydromorphone|mesh-list
5533356|NCT04230681|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5533357|NCT04230681|Narcotics|narcotics|mesh-ancestor
5533358|NCT04230681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5533359|NCT04230681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122336|NCT01135511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6122337|NCT01135511|Immunologic Factors|immunologic factors|mesh-ancestor
5533360|NCT04230681|Analgesics|analgesics|mesh-ancestor
5533361|NCT04230681|Sensory System Agents|sensory system agents|mesh-ancestor
5533362|NCT04230681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5533363|NCT04230681|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5533364|NCT04230681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5533365|NCT04230681|Anesthetics, General|anesthetics, general|mesh-ancestor
6204671|NCT02074358|Anticoagulants|anticoagulants|mesh-ancestor
5533366|NCT04230681|Anesthetics|anesthetics|mesh-ancestor
5533367|NCT04230564|Azacitidine|azacitidine|mesh-list
5533368|NCT04230564|Venetoclax|venetoclax|mesh-list
5533369|NCT04230564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5533370|NCT04230564|Antimetabolites|antimetabolites|mesh-ancestor
5533371|NCT04230564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5533372|NCT04230564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5533373|NCT04230564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5533374|NCT04230759|Fluorouracil|fluorouracil|mesh-list
5533375|NCT04230759|Durvalumab|durvalumab|mesh-list
5533376|NCT04230759|Mitomycins|mitomycins|mesh-list
5533377|NCT04230759|Mitomycin|mitomycin|mesh-list
5533378|NCT04230759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5533379|NCT04230759|Antimetabolites|antimetabolites|mesh-ancestor
6122338|NCT01135511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122339|NCT01135511|Viscosupplements|viscosupplements|mesh-ancestor
6122340|NCT01135511|Protective Agents|protective agents|mesh-ancestor
6122341|NCT01135524|Buprenorphine|buprenorphine|mesh-list
6122342|NCT01135524|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6122343|NCT01135524|Narcotics|narcotics|mesh-ancestor
6122344|NCT01135524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6122345|NCT01135524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122346|NCT01135524|Analgesics|analgesics|mesh-ancestor
6122347|NCT01135524|Sensory System Agents|sensory system agents|mesh-ancestor
6122348|NCT01135524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6122349|NCT01135524|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6122350|NCT01135537|Thymoglobulin|thymoglobulin|mesh-list
6122351|NCT01135537|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6122352|NCT01135537|Immunologic Factors|immunologic factors|mesh-ancestor
5533380|NCT04230759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5533381|NCT04230759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5533382|NCT04230759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5533383|NCT04230759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5533384|NCT04230759|Immunologic Factors|immunologic factors|mesh-ancestor
5533385|NCT04230759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533386|NCT04230759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5533387|NCT04230759|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5533388|NCT04230759|Alkylating Agents|alkylating agents|mesh-ancestor
5533389|NCT04230759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5533390|NCT04230759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5533391|NCT04230460|Ethanol|ethanol|mesh-list
5533392|NCT04230460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5533393|NCT04230460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5533394|NCT04230460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5533395|NCT04230460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533396|NCT04230330|Gemcitabine|gemcitabine|mesh-list
5533397|NCT04230330|Dexamethasone|dexamethasone|mesh-list
5533398|NCT04230330|Nivolumab|nivolumab|mesh-list
5533399|NCT04230330|Asparaginase|asparaginase|mesh-list
5533400|NCT04230330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5533401|NCT04230330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5533402|NCT04230330|Antiemetics|antiemetics|mesh-ancestor
5533403|NCT04230330|Autonomic Agents|autonomic agents|mesh-ancestor
5533404|NCT04230330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5533405|NCT04230330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533406|NCT04230330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5533407|NCT04230330|Glucocorticoids|glucocorticoids|mesh-ancestor
5533408|NCT04230330|Hormones|hormones|mesh-ancestor
6122353|NCT01135537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122354|NCT01135537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6122355|NCT01135914|Ranibizumab|ranibizumab|mesh-list
6122356|NCT01135914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6122357|NCT01135914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6122358|NCT01135914|Growth Substances|growth substances|mesh-ancestor
6122359|NCT01135914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122360|NCT01135914|Growth Inhibitors|growth inhibitors|mesh-ancestor
6122361|NCT01135914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6122362|NCT01135992|Insulin|insulin|mesh-list
6122363|NCT01135992|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6122364|NCT01135992|Insulin Glargine|insulin glargine|mesh-list
6122365|NCT01135992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6122366|NCT01135992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122367|NCT01136174|Nintedanib|nintedanib|mesh-list
6122368|NCT01136174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6122369|NCT01136174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6122370|NCT01136174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5533409|NCT04230330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5601675|NCT05175001|Anesthetics, Local|anesthetics, local|mesh-ancestor
6122371|NCT01136174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122372|NCT01136226|Leuprolide|leuprolide|mesh-list
6122373|NCT01136226|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6122374|NCT01136226|Fertility Agents|fertility agents|mesh-ancestor
6122375|NCT01136226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6122376|NCT01136226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122377|NCT01136226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6122378|NCT01136226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6122379|NCT01136356|Morphine|morphine|mesh-list
6122380|NCT01136356|Buprenorphine|buprenorphine|mesh-list
6122381|NCT01136356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6122382|NCT01136356|Narcotics|narcotics|mesh-ancestor
6122383|NCT01136356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6122384|NCT01136356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122385|NCT01136356|Analgesics|analgesics|mesh-ancestor
6122386|NCT01136356|Sensory System Agents|sensory system agents|mesh-ancestor
6122387|NCT01136356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6122388|NCT01136356|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6122389|NCT01136382|Budesonide|budesonide|mesh-list
6122390|NCT01136382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6122391|NCT01136382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5533410|NCT04230330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5533411|NCT04230330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5533412|NCT04230330|Antimetabolites|antimetabolites|mesh-ancestor
5533413|NCT04230330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5533414|NCT04230330|Antiviral Agents|antiviral agents|mesh-ancestor
5533415|NCT04230330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5533416|NCT04230330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5533417|NCT04230330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5533418|NCT04230330|Immunologic Factors|immunologic factors|mesh-ancestor
5533419|NCT04230330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5533420|NCT04230330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5533421|NCT04230304|Daratumumab|daratumumab|mesh-list
5533422|NCT04230304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5533423|NCT04230252|Acetaminophen|acetaminophen|mesh-list
6122392|NCT01136382|Autonomic Agents|autonomic agents|mesh-ancestor
6122393|NCT01136382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6122394|NCT01136382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122395|NCT01136382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6122396|NCT01136382|Respiratory System Agents|respiratory system agents|mesh-ancestor
6122397|NCT01136382|Glucocorticoids|glucocorticoids|mesh-ancestor
6122398|NCT01136382|Hormones|hormones|mesh-ancestor
5533424|NCT04230252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5533425|NCT04230252|Analgesics|analgesics|mesh-ancestor
5533426|NCT04230252|Sensory System Agents|sensory system agents|mesh-ancestor
5533427|NCT04230252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5533428|NCT04230252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533429|NCT04230252|Antipyretics|antipyretics|mesh-ancestor
5533430|NCT04230083|Dienogest|dienogest|mesh-list
5533431|NCT04230083|Nandrolone|nandrolone|mesh-list
5533432|NCT04230083|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5533433|NCT04230083|Contraceptive Agents|contraceptive agents|mesh-ancestor
5533434|NCT04230083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5533435|NCT04230083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533436|NCT04230083|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5533437|NCT04230083|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6122399|NCT01136382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6122400|NCT01136408|Warfarin|warfarin|mesh-list
6122401|NCT01136408|Dabigatran|dabigatran|mesh-list
6122402|NCT01136408|Anticoagulants|anticoagulants|mesh-ancestor
6122403|NCT01136408|Antithrombins|antithrombins|mesh-ancestor
6122404|NCT01136408|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6122405|NCT01136408|Protease Inhibitors|protease inhibitors|mesh-ancestor
6122406|NCT01136408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6122407|NCT01136408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122408|NCT01136655|Budesonide|budesonide|mesh-list
6122409|NCT01136655|Formoterol Fumarate|formoterol fumarate|mesh-list
6122410|NCT01136655|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6122411|NCT01136655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6122412|NCT01136655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5533438|NCT04230083|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5533439|NCT04230083|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5533440|NCT04230083|Hormone Antagonists|hormone antagonists|mesh-ancestor
5533441|NCT04230083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5533442|NCT04230083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6122413|NCT01136655|Autonomic Agents|autonomic agents|mesh-ancestor
6122414|NCT01136655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6122415|NCT01136655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122416|NCT01136655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6122417|NCT01136655|Respiratory System Agents|respiratory system agents|mesh-ancestor
6122418|NCT01136655|Glucocorticoids|glucocorticoids|mesh-ancestor
6122419|NCT01136655|Hormones|hormones|mesh-ancestor
6122420|NCT01136655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6122421|NCT01136655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6122422|NCT01136655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6122423|NCT01136655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6122424|NCT01136655|Adrenergic Agents|adrenergic agents|mesh-ancestor
6122425|NCT01136655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6122426|NCT01136655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122427|NCT01136733|Everolimus|everolimus|mesh-list
6122428|NCT01136733|Lenvatinib|lenvatinib|mesh-list
6122429|NCT01136733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6122430|NCT01136733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6122431|NCT01136733|Immunologic Factors|immunologic factors|mesh-ancestor
6122432|NCT01136733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122433|NCT01136733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6122434|NCT01136733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6122435|NCT01136733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122436|NCT01136746|Insulin|insulin|mesh-list
6122437|NCT01136746|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6122438|NCT01136746|Insulin Glargine|insulin glargine|mesh-list
6122439|NCT01136746|Insulin Lispro|insulin lispro|mesh-list
6122440|NCT01136746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6122441|NCT01136746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122442|NCT01136772|Haloperidol|haloperidol|mesh-list
6122443|NCT01136772|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6122444|NCT01136772|Haloperidol decanoate|haloperidol decanoate|mesh-list
6122445|NCT01136772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6122446|NCT01136772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6122447|NCT01136772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6122448|NCT01136772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122449|NCT01136772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6122450|NCT01136772|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6122451|NCT01136772|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6122452|NCT01136772|Serotonin Agents|serotonin agents|mesh-ancestor
6122453|NCT01136772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6122454|NCT01136772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122455|NCT01136772|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6122456|NCT01136772|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6122457|NCT01136772|Dopamine Agents|dopamine agents|mesh-ancestor
6122458|NCT01136772|Antiemetics|antiemetics|mesh-ancestor
6122459|NCT01136772|Autonomic Agents|autonomic agents|mesh-ancestor
6122460|NCT01136772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6122461|NCT01136772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5533443|NCT04230083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5533444|NCT04230083|Androgens|androgens|mesh-ancestor
5533445|NCT04230083|Hormones|hormones|mesh-ancestor
5533446|NCT04230083|Anabolic Agents|anabolic agents|mesh-ancestor
5533447|NCT04230070|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5533448|NCT04230070|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5533449|NCT04230070|Levonorgestrel|levonorgestrel|mesh-list
5533450|NCT04230070|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5533451|NCT04230070|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
5533452|NCT04230070|Estradiol|estradiol|mesh-list
5533453|NCT04230070|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5533454|NCT04230070|Estrogens|estrogens|mesh-ancestor
5533455|NCT04230070|Hormones|hormones|mesh-ancestor
5533456|NCT04230070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5533457|NCT04230070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533458|NCT04230070|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5533459|NCT04230070|Contraceptive Agents|contraceptive agents|mesh-ancestor
5533460|NCT04230070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5533461|NCT04230070|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5533462|NCT04230070|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5533463|NCT04230070|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5533464|NCT04230070|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6122462|NCT01136772|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6122463|NCT01136798|Exenatide|exenatide|mesh-list
6122464|NCT01136798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5533465|NCT04230070|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6122465|NCT01136798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122466|NCT01136798|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6122467|NCT01136798|Incretins|incretins|mesh-ancestor
6122468|NCT01136798|Hormones|hormones|mesh-ancestor
6122469|NCT01136798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6122470|NCT01136954|Zonisamide|zonisamide|mesh-list
6122471|NCT01136954|Anticonvulsants|anticonvulsants|mesh-ancestor
6122472|NCT01136954|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6122473|NCT01136954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6122474|NCT01136954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122475|NCT01136954|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6122476|NCT01136954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122477|NCT01137071|Antibodies|antibodies|mesh-list
6122478|NCT01137071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6122479|NCT01137071|Immunologic Factors|immunologic factors|mesh-ancestor
6122480|NCT01137071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122481|NCT01137292|Voriconazole|voriconazole|mesh-list
6122482|NCT01137292|Antifungal Agents|antifungal agents|mesh-ancestor
6122483|NCT01137292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6122484|NCT01137292|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6122485|NCT01137292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6122486|NCT01137292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6122487|NCT01137292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122488|NCT01137292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6122489|NCT01137292|Hormone Antagonists|hormone antagonists|mesh-ancestor
6122490|NCT01137292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6122491|NCT01137292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122492|NCT01137292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6122493|NCT01137396|Modafinil|modafinil|mesh-list
6122494|NCT01137396|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6122495|NCT01137396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122496|NCT01137396|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6122497|NCT01137396|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6122498|NCT01137396|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6122499|NCT01137396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122500|NCT01137474|Dapagliflozin|dapagliflozin|mesh-list
6122501|NCT01137474|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6122502|NCT01137474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122503|NCT01137474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6122504|NCT01137474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122505|NCT01137604|Bevacizumab|bevacizumab|mesh-list
6122506|NCT01137604|Lenvatinib|lenvatinib|mesh-list
6122507|NCT01137604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6122508|NCT01137604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6122509|NCT01137604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6122510|NCT01137604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6122511|NCT01137604|Growth Substances|growth substances|mesh-ancestor
6122512|NCT01137604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533466|NCT04230187|Leucovorin|leucovorin|mesh-list
5533467|NCT04230187|Bevacizumab|bevacizumab|mesh-list
5533468|NCT04230187|Fluorouracil|fluorouracil|mesh-list
5533469|NCT04230187|Oxaliplatin|oxaliplatin|mesh-list
5533470|NCT04230187|Irinotecan|irinotecan|mesh-list
5533471|NCT04230187|Levoleucovorin|levoleucovorin|mesh-list
5533472|NCT04230187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5533473|NCT04230187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5533474|NCT04230187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5533475|NCT04230187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5533476|NCT04230187|Growth Substances|growth substances|mesh-ancestor
5533477|NCT04230187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533478|NCT04230187|Growth Inhibitors|growth inhibitors|mesh-ancestor
5533479|NCT04230187|Antimetabolites|antimetabolites|mesh-ancestor
5533480|NCT04230187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5533481|NCT04230187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5533482|NCT04230187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5533483|NCT04230187|Immunologic Factors|immunologic factors|mesh-ancestor
5533484|NCT04230187|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5533485|NCT04230187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5533486|NCT04230187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5533487|NCT04230187|Antidotes|antidotes|mesh-ancestor
5533488|NCT04230187|Protective Agents|protective agents|mesh-ancestor
5533489|NCT04230187|Vitamin B Complex|vitamin b complex|mesh-ancestor
5533490|NCT04230187|Vitamins|vitamins|mesh-ancestor
6122513|NCT01137604|Growth Inhibitors|growth inhibitors|mesh-ancestor
6122514|NCT01137604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6122515|NCT01137604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6122516|NCT01137604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122517|NCT01137682|Octreotide|octreotide|mesh-list
6122518|NCT01137682|Lanreotide|lanreotide|mesh-list
6122519|NCT01137682|Pasireotide|pasireotide|mesh-list
6122520|NCT01137682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6122521|NCT01137682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6122522|NCT01137682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6122523|NCT01137682|Hormones|hormones|mesh-ancestor
6122524|NCT01137682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6122525|NCT01137682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122526|NCT01137812|Metformin|metformin|mesh-list
6122527|NCT01137812|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6122528|NCT01137812|Canagliflozin|canagliflozin|mesh-list
6122529|NCT01137812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6122530|NCT01137812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122531|NCT01137812|Incretins|incretins|mesh-ancestor
6122532|NCT01137812|Hormones|hormones|mesh-ancestor
6122533|NCT01137812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6122534|NCT01137812|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6122535|NCT01137812|Protease Inhibitors|protease inhibitors|mesh-ancestor
6122536|NCT01137812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6122537|NCT01137812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122538|NCT01137812|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6122539|NCT01137890|Zonisamide|zonisamide|mesh-list
6122540|NCT01137890|Cocaine|cocaine|mesh-list
6122541|NCT01137890|Anticonvulsants|anticonvulsants|mesh-ancestor
6122542|NCT01137890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6122543|NCT01137890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6122544|NCT01137890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122545|NCT01137890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6122546|NCT01137890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122547|NCT01137890|Anesthetics, Local|anesthetics, local|mesh-ancestor
6122548|NCT01137890|Anesthetics|anesthetics|mesh-ancestor
6122549|NCT01137890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6122550|NCT01137890|Sensory System Agents|sensory system agents|mesh-ancestor
6122551|NCT01137890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6122552|NCT01137890|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6122553|NCT01137890|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6122554|NCT01137890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6122555|NCT01137890|Dopamine Agents|dopamine agents|mesh-ancestor
5533491|NCT04230187|Micronutrients|micronutrients|mesh-ancestor
5533492|NCT04230031|Daratumumab|daratumumab|mesh-list
5533493|NCT04230031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5533494|NCT04229979|Cytarabine|cytarabine|mesh-list
5533495|NCT04229979|Azacitidine|azacitidine|mesh-list
5533496|NCT04229979|Decitabine|decitabine|mesh-list
5533497|NCT04229979|Venetoclax|venetoclax|mesh-list
5533498|NCT04229979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5533499|NCT04229979|Antimetabolites|antimetabolites|mesh-ancestor
5533500|NCT04229979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5533501|NCT04229979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5533502|NCT04229979|Antiviral Agents|antiviral agents|mesh-ancestor
5533503|NCT04229979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5533504|NCT04229979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5533505|NCT04229979|Immunologic Factors|immunologic factors|mesh-ancestor
5533506|NCT04229979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533507|NCT04229979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5533508|NCT04230213|Adalimumab|adalimumab|mesh-list
5533509|NCT04230213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5533510|NCT04230213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5533511|NCT04229758|Anticoagulants|anticoagulants|mesh-list
5533512|NCT04229719|Melatonin|melatonin|mesh-list
5533513|NCT04229719|Antioxidants|antioxidants|mesh-ancestor
5533514|NCT04229719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5533515|NCT04229719|Protective Agents|protective agents|mesh-ancestor
5533516|NCT04229719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533517|NCT04229719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5533518|NCT04229615|Apatinib|apatinib|mesh-list
5533519|NCT04229615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6122556|NCT01137890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5533520|NCT04229615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6122557|NCT01138046|Paclitaxel|paclitaxel|mesh-list
6122558|NCT01138046|Lapatinib|lapatinib|mesh-list
6204672|NCT02074514|Sofosbuvir|sofosbuvir|mesh-list
5533521|NCT04229615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5533522|NCT04229615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5533523|NCT04229459|Nivolumab|nivolumab|mesh-list
5533524|NCT04229459|Cetuximab|cetuximab|mesh-list
5533525|NCT04229459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5533526|NCT04229459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6122559|NCT01138046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6122560|NCT01138046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6122561|NCT01138046|Tubulin Modulators|tubulin modulators|mesh-ancestor
6122562|NCT01138046|Antimitotic Agents|antimitotic agents|mesh-ancestor
6122563|NCT01138046|Mitosis Modulators|mitosis modulators|mesh-ancestor
6122564|NCT01138046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122565|NCT01138046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6122566|NCT01138046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6122567|NCT01138124|Gabapentin|gabapentin|mesh-list
6122568|NCT01138124|Analgesics|analgesics|mesh-ancestor
6122569|NCT01138124|Sensory System Agents|sensory system agents|mesh-ancestor
6122570|NCT01138124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6122571|NCT01138124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122572|NCT01138124|Anticonvulsants|anticonvulsants|mesh-ancestor
6122573|NCT01138124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6122574|NCT01138124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6122575|NCT01138124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6122576|NCT01138124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6122577|NCT01138124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6122578|NCT01138124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6122579|NCT01138124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6122580|NCT01138124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122581|NCT01138124|Antimanic Agents|antimanic agents|mesh-ancestor
6122582|NCT01138150|Naproxen|naproxen|mesh-list
6122583|NCT01138150|Sumatriptan|sumatriptan|mesh-list
6122584|NCT01138150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6122585|NCT01138150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6122586|NCT01138150|Analgesics|analgesics|mesh-ancestor
6122587|NCT01138150|Sensory System Agents|sensory system agents|mesh-ancestor
6122588|NCT01138150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6122589|NCT01138150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122590|NCT01138150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6122591|NCT01138150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6122592|NCT01138150|Gout Suppressants|gout suppressants|mesh-ancestor
6122593|NCT01138150|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6122594|NCT01138150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6122595|NCT01138150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122596|NCT01138150|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6122597|NCT01138150|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6122598|NCT01138150|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6122599|NCT01138150|Serotonin Agents|serotonin agents|mesh-ancestor
6122600|NCT01138150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6122601|NCT01138475|Cholecalciferol|cholecalciferol|mesh-list
6122602|NCT01138475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6122603|NCT01138475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122604|NCT01138475|Vitamins|vitamins|mesh-ancestor
6122605|NCT01138475|Micronutrients|micronutrients|mesh-ancestor
5533527|NCT04229459|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5533528|NCT04229459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5533529|NCT04229212|Cimetidine|cimetidine|mesh-list
5533530|NCT04229212|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5533531|NCT04229212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5533532|NCT04229212|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5533533|NCT04229212|Histamine Antagonists|histamine antagonists|mesh-ancestor
5533534|NCT04229212|Histamine Agents|histamine agents|mesh-ancestor
5533535|NCT04229212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5533536|NCT04229212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5533537|NCT04229212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533538|NCT04229212|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5533539|NCT04229212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5533540|NCT04229212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5533541|NCT04229264|Apixaban|apixaban|mesh-list
5533542|NCT04229264|Clopidogrel|clopidogrel|mesh-list
5533543|NCT04229264|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5601676|NCT05175001|Anesthetics|anesthetics|mesh-ancestor
6122606|NCT01138475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6122607|NCT01138501|Factor VIII|factor viii|mesh-list
6666124|NCT01520818|Insulin, Long-Acting|insulin, long-acting|mesh-list
6122608|NCT01138501|Coagulants|coagulants|mesh-ancestor
6122609|NCT01138514|Clindamycin|clindamycin|mesh-list
6122610|NCT01138514|Clindamycin palmitate|clindamycin palmitate|mesh-list
6122611|NCT01138514|Clindamycin phosphate|clindamycin phosphate|mesh-list
6122612|NCT01138514|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6122613|NCT01138514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6122614|NCT01138514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6122615|NCT01138514|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5533544|NCT04229264|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5533545|NCT04229264|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5533546|NCT04229264|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5533547|NCT04229264|Purinergic Agents|purinergic agents|mesh-ancestor
5533548|NCT04229264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6122616|NCT01138514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6122617|NCT01138514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122618|NCT01138514|Dermatologic Agents|dermatologic agents|mesh-ancestor
6122619|NCT01138657|Prednisone|prednisone|mesh-list
6122620|NCT01138657|Adalimumab|adalimumab|mesh-list
6122621|NCT01138657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5533549|NCT04229264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5533550|NCT04229264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533551|NCT04229264|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6122622|NCT01138657|Glucocorticoids|glucocorticoids|mesh-ancestor
6122623|NCT01138657|Hormones|hormones|mesh-ancestor
6122624|NCT01138657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6122625|NCT01138657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122626|NCT01138657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6122627|NCT01138657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6122628|NCT01138657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6122629|NCT01138735|Adapalene|adapalene|mesh-list
6122630|NCT01138735|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
6122631|NCT01138735|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6122632|NCT01138735|Dermatologic Agents|dermatologic agents|mesh-ancestor
6122633|NCT01138735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6122634|NCT01138735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6122635|NCT01138735|Analgesics|analgesics|mesh-ancestor
6122636|NCT01138735|Sensory System Agents|sensory system agents|mesh-ancestor
6122637|NCT01138735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6122638|NCT01138735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122639|NCT01138735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6122640|NCT01138735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6122641|NCT01138826|Amlodipine|amlodipine|mesh-list
6122642|NCT01138826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6122643|NCT01138826|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6122644|NCT01138826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6122645|NCT01138826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122646|NCT01138826|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6122647|NCT01138826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122648|NCT01138826|Vasodilator Agents|vasodilator agents|mesh-ancestor
6122649|NCT01138969|Esomeprazole|esomeprazole|mesh-list
6122650|NCT01138969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6122651|NCT01138969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6122652|NCT01138969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6122653|NCT01138969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6122654|NCT01138969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122655|NCT01139008|Metronidazole|metronidazole|mesh-list
6122656|NCT01139008|Azelaic acid|azelaic acid|mesh-list
6122657|NCT01139008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6122658|NCT01139008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6122659|NCT01139008|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6122660|NCT01139008|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6122661|NCT01139008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6122662|NCT01139008|Dermatologic Agents|dermatologic agents|mesh-ancestor
6122663|NCT01139047|Metronidazole|metronidazole|mesh-list
6122664|NCT01139047|Azelaic acid|azelaic acid|mesh-list
6122665|NCT01139047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6122666|NCT01139047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6122667|NCT01139047|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6122668|NCT01139047|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6122669|NCT01139047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6122670|NCT01139047|Dermatologic Agents|dermatologic agents|mesh-ancestor
6122671|NCT01139190|Naproxen|naproxen|mesh-list
6122672|NCT01139190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6122673|NCT01139190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6122674|NCT01139190|Analgesics|analgesics|mesh-ancestor
6122675|NCT01139190|Sensory System Agents|sensory system agents|mesh-ancestor
6122676|NCT01139190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6122677|NCT01139190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122678|NCT01139190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6122679|NCT01139190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6122680|NCT01139190|Gout Suppressants|gout suppressants|mesh-ancestor
6122681|NCT01139190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6122682|NCT01139190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6122683|NCT01139190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122684|NCT01139450|Tacrolimus|tacrolimus|mesh-list
6122685|NCT01139450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6122686|NCT01139450|Immunologic Factors|immunologic factors|mesh-ancestor
6122687|NCT01139450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122688|NCT01139450|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6122689|NCT01139450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6122690|NCT01139450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122691|NCT01139515|Eletriptan|eletriptan|mesh-list
6122692|NCT01139515|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6122693|NCT01139515|Serotonin Agents|serotonin agents|mesh-ancestor
6122694|NCT01139515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6122695|NCT01139515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122696|NCT01139515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122697|NCT01139580|Calcipotriene|calcipotriene|mesh-list
6122698|NCT01139580|Dermatologic Agents|dermatologic agents|mesh-ancestor
6122699|NCT01139762|Tadalafil|tadalafil|mesh-list
6122700|NCT01139762|Finasteride|finasteride|mesh-list
6122701|NCT01139762|Vasodilator Agents|vasodilator agents|mesh-ancestor
6122702|NCT01139762|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6122703|NCT01139762|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6122704|NCT01139762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6122705|NCT01139762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122706|NCT01139762|Urological Agents|urological agents|mesh-ancestor
6122707|NCT01139762|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6122708|NCT01139762|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6122709|NCT01139762|Hormone Antagonists|hormone antagonists|mesh-ancestor
6122710|NCT01139762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6122711|NCT01139762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122712|NCT01139775|Pemetrexed|pemetrexed|mesh-list
6122713|NCT01139775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6122714|NCT01139775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6122715|NCT01139775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122716|NCT01139775|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6122717|NCT01139775|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6122718|NCT01139801|Misoprostol|misoprostol|mesh-list
6122719|NCT01139801|Oxytocin|oxytocin|mesh-list
6122720|NCT01139801|Oxytocics|oxytocics|mesh-ancestor
6122721|NCT01139801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6122722|NCT01139801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122723|NCT01139801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6122724|NCT01139801|Abortifacient Agents|abortifacient agents|mesh-ancestor
6122725|NCT01139801|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6122726|NCT01139801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6122727|NCT01140061|MK 0873|mk 0873|mesh-list
6122728|NCT01140061|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6122729|NCT01140061|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6122730|NCT01140061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6122731|NCT01140061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122732|NCT01140191|Gentamicins|gentamicins|mesh-list
6122733|NCT01140191|Paromomycin|paromomycin|mesh-list
6122734|NCT01140191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6122735|NCT01140191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6122736|NCT01140191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6122737|NCT01140191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6122738|NCT01140191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122739|NCT01140191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6122740|NCT01140191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6122741|NCT01140347|Ramucirumab|ramucirumab|mesh-list
6122742|NCT01140347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6122743|NCT01140360|Imatinib Mesylate|imatinib mesylate|mesh-list
6122744|NCT01140360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6122745|NCT01140360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6122746|NCT01140360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6122747|NCT01140360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204673|NCT02074514|Antiviral Agents|antiviral agents|mesh-ancestor
6204674|NCT02074514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6204675|NCT02074709|Bupivacaine|bupivacaine|mesh-list
6204676|NCT02074709|Anesthetics, Local|anesthetics, local|mesh-ancestor
6204677|NCT02074709|Anesthetics|anesthetics|mesh-ancestor
6204678|NCT02074709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6204679|NCT02074709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204680|NCT02074709|Sensory System Agents|sensory system agents|mesh-ancestor
6204681|NCT02074709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6204682|NCT02074735|Choline|choline|mesh-list
6204683|NCT02074735|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
6204684|NCT02074735|Lipotropic Agents|lipotropic agents|mesh-ancestor
6204685|NCT02074735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6204686|NCT02074735|Antimetabolites|antimetabolites|mesh-ancestor
6204687|NCT02074735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204688|NCT02074735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6204689|NCT02074735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6204690|NCT02074735|Nootropic Agents|nootropic agents|mesh-ancestor
6204691|NCT02074982|Ustekinumab|ustekinumab|mesh-list
6204692|NCT02074982|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6204693|NCT02074982|Immunologic Factors|immunologic factors|mesh-ancestor
6204694|NCT02074982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204695|NCT02074982|Dermatologic Agents|dermatologic agents|mesh-ancestor
6204696|NCT02075047|Ziprasidone|ziprasidone|mesh-list
6465975|NCT00476606|Antiviral Agents|antiviral agents|mesh-ancestor
6465976|NCT00476606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6465977|NCT00476606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6465978|NCT00476606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6465979|NCT00476606|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6465980|NCT00476606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6465981|NCT00476606|Antimetabolites|antimetabolites|mesh-ancestor
6465982|NCT00476606|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6465983|NCT00476606|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6465984|NCT00476606|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6465985|NCT00476606|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6465986|NCT00476606|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6204697|NCT02075047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6204698|NCT02075047|Serotonin Agents|serotonin agents|mesh-ancestor
6204699|NCT02075047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6204700|NCT02075047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204701|NCT02075047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204702|NCT02075047|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6204703|NCT02075047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6204704|NCT02075047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6204705|NCT02075047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6204706|NCT02075047|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6465987|NCT00476619|Epoetin Alfa|epoetin alfa|mesh-list
6465988|NCT00476619|Hematinics|hematinics|mesh-ancestor
6465989|NCT00476710|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
6465990|NCT00476710|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6465991|NCT00476710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6204707|NCT02075047|Dopamine Agents|dopamine agents|mesh-ancestor
6204708|NCT02075073|Trastuzumab|trastuzumab|mesh-list
6204709|NCT02075073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6204710|NCT02075073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6204711|NCT02075125|Ticagrelor|ticagrelor|mesh-list
6204712|NCT02075125|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6465992|NCT00476710|Antimetabolites|antimetabolites|mesh-ancestor
6204713|NCT02075125|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5533552|NCT04229264|Antithrombins|antithrombins|mesh-ancestor
5533553|NCT04229264|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5533554|NCT04229264|Protease Inhibitors|protease inhibitors|mesh-ancestor
5533555|NCT04229264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5533556|NCT04229264|Anticoagulants|anticoagulants|mesh-ancestor
5533557|NCT04229355|Sorafenib|sorafenib|mesh-list
5533558|NCT04229355|Chlorotrianisene|chlorotrianisene|mesh-list
5533559|NCT04229355|Lenvatinib|lenvatinib|mesh-list
5533560|NCT04229355|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5533561|NCT04229355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5533562|NCT04229355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5533563|NCT04229355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5533564|NCT04229355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5533565|NCT04229355|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
5533566|NCT04229355|Estrogens|estrogens|mesh-ancestor
5533567|NCT04229355|Hormones|hormones|mesh-ancestor
5533568|NCT04229355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5533569|NCT04229355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533570|NCT04229355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5601677|NCT05175001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5601678|NCT05175001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601679|NCT05175001|Sensory System Agents|sensory system agents|mesh-ancestor
6122748|NCT01140503|Apremilast|apremilast|mesh-list
6122749|NCT01140503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6122750|NCT01140503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6122751|NCT01140503|Analgesics|analgesics|mesh-ancestor
6122752|NCT01140503|Sensory System Agents|sensory system agents|mesh-ancestor
6122753|NCT01140503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6122754|NCT01140503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122755|NCT01140503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6122756|NCT01140503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6122757|NCT01140503|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6122758|NCT01140503|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6122759|NCT01140503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6122760|NCT01140503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122761|NCT01140880|Tenofovir|tenofovir|mesh-list
6122762|NCT01140880|Emtricitabine|emtricitabine|mesh-list
6122763|NCT01140880|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6122764|NCT01140880|Antiviral Agents|antiviral agents|mesh-ancestor
6122765|NCT01140880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6122766|NCT01140880|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6122767|NCT01140880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6122768|NCT01140880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6122769|NCT01140880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122770|NCT01140880|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6122771|NCT01140880|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6122772|NCT01140906|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6122773|NCT01140906|Vortioxetine|vortioxetine|mesh-list
6122774|NCT01140906|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6122775|NCT01140906|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6122776|NCT01140906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6122777|NCT01140906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122778|NCT01140906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6122779|NCT01140906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122780|NCT01140906|Analgesics|analgesics|mesh-ancestor
6122781|NCT01140906|Sensory System Agents|sensory system agents|mesh-ancestor
6122782|NCT01140906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6122783|NCT01140906|Antidepressive Agents|antidepressive agents|mesh-ancestor
6122784|NCT01140906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6122785|NCT01140906|Dopamine Agents|dopamine agents|mesh-ancestor
6122786|NCT01140906|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6122787|NCT01140906|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6122788|NCT01140906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6122789|NCT01140906|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6122790|NCT01140906|Serotonin Agents|serotonin agents|mesh-ancestor
6122791|NCT01140906|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6122792|NCT01140906|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6122793|NCT01140906|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6122794|NCT01140906|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6122795|NCT01141049|Gabapentin|gabapentin|mesh-list
6122796|NCT01141049|Analgesics|analgesics|mesh-ancestor
6122797|NCT01141049|Sensory System Agents|sensory system agents|mesh-ancestor
5601680|NCT05175001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6122798|NCT01141049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6122799|NCT01141049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122800|NCT01141049|Anticonvulsants|anticonvulsants|mesh-ancestor
6122801|NCT01141049|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6122802|NCT01141049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6122803|NCT01141049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6122804|NCT01141049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6122805|NCT01141049|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6122806|NCT01141049|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6122807|NCT01141049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6122808|NCT01141049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122809|NCT01141049|Antimanic Agents|antimanic agents|mesh-ancestor
6122810|NCT01141283|Buprenorphine|buprenorphine|mesh-list
6122811|NCT01141283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6122812|NCT01141283|Narcotics|narcotics|mesh-ancestor
6122813|NCT01141283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6122814|NCT01141283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122815|NCT01141283|Analgesics|analgesics|mesh-ancestor
6122816|NCT01141283|Sensory System Agents|sensory system agents|mesh-ancestor
6122817|NCT01141283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6122818|NCT01141283|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6122819|NCT01141478|Sorafenib|sorafenib|mesh-list
6122820|NCT01141478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6122821|NCT01141478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6122822|NCT01141478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6122823|NCT01141478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122824|NCT01141491|Vaccines|vaccines|mesh-list
6122825|NCT01141491|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
6122826|NCT01141491|Immunologic Factors|immunologic factors|mesh-ancestor
6122827|NCT01141491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122828|NCT01141569|R04929097|r04929097|mesh-list
6122829|NCT01141569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6122830|NCT01141569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122831|NCT01141595|Verapamil|verapamil|mesh-list
6122832|NCT01141595|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6122833|NCT01141595|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5533571|NCT04229368|Vitamin D|vitamin d|mesh-list
5533572|NCT04229368|Cholecalciferol|cholecalciferol|mesh-list
5533573|NCT04229368|Vitamins|vitamins|mesh-ancestor
5533574|NCT04229368|Micronutrients|micronutrients|mesh-ancestor
5533575|NCT04229368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533576|NCT04229368|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5533577|NCT04229368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5533578|NCT04229602|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
5533579|NCT04229602|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5533580|NCT04229602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5533581|NCT04229602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5533582|NCT04229602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5533583|NCT04229602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6122834|NCT01141595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6122835|NCT01141595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122836|NCT01141595|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6122837|NCT01141595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122838|NCT01141595|Vasodilator Agents|vasodilator agents|mesh-ancestor
6122839|NCT01141725|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6122840|NCT01141725|Idarubicin|idarubicin|mesh-list
6122841|NCT01141725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6122842|NCT01141725|Alkylating Agents|alkylating agents|mesh-ancestor
6122843|NCT01141725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122844|NCT01141725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5533584|NCT04229602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533585|NCT04229602|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5533586|NCT04229602|Antidepressive Agents|antidepressive agents|mesh-ancestor
5533587|NCT04229602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5533588|NCT04229498|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5533589|NCT04229498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5533590|NCT04229407|Vitamins|vitamins|mesh-list
5533591|NCT04229407|Vitamin B Complex|vitamin b complex|mesh-list
5533592|NCT04229407|Micronutrients|micronutrients|mesh-ancestor
5533593|NCT04229407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533594|NCT04228926|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5533595|NCT04228926|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5533596|NCT04228757|Phytoestrogens|phytoestrogens|mesh-list
6122845|NCT01141725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6122846|NCT01141725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6122847|NCT01141725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6122848|NCT01141725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5533597|NCT04228757|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
5533598|NCT04228757|Estrogens|estrogens|mesh-ancestor
5533599|NCT04228757|Hormones|hormones|mesh-ancestor
5533600|NCT04228757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5533601|NCT04228757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533602|NCT04228315|Primaquine|primaquine|mesh-list
5533603|NCT04228315|Antimalarials|antimalarials|mesh-ancestor
5533604|NCT04228315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5533605|NCT04228315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5533606|NCT04228315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5533607|NCT04228263|Aspirin|aspirin|mesh-list
5533608|NCT04228263|Folic Acid|folic acid|mesh-list
5533609|NCT04228263|Hydroxychloroquine|hydroxychloroquine|mesh-list
5533610|NCT04228263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5533611|NCT04228263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5533612|NCT04228263|Analgesics|analgesics|mesh-ancestor
5533613|NCT04228263|Sensory System Agents|sensory system agents|mesh-ancestor
5533614|NCT04228263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5533615|NCT04228263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533616|NCT04228263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5533617|NCT04228263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5533618|NCT04228263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5533619|NCT04228263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5533620|NCT04228263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5533621|NCT04228263|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5533622|NCT04228263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5533623|NCT04228263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5533624|NCT04228263|Antipyretics|antipyretics|mesh-ancestor
5533625|NCT04228263|Antimalarials|antimalarials|mesh-ancestor
5533626|NCT04228263|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5533627|NCT04228263|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5533628|NCT04228263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5533629|NCT04228263|Hematinics|hematinics|mesh-ancestor
5533630|NCT04228263|Vitamin B Complex|vitamin b complex|mesh-ancestor
5533631|NCT04228263|Vitamins|vitamins|mesh-ancestor
6122849|NCT01142089|Rifamycins|rifamycins|mesh-list
6122850|NCT01142089|Rifamycin SV|rifamycin sv|mesh-list
6122851|NCT01142089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6122852|NCT01142089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6122853|NCT01142089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6122854|NCT01142193|Topiramate|topiramate|mesh-list
6122855|NCT01142193|Anticonvulsants|anticonvulsants|mesh-ancestor
6122856|NCT01142193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6122857|NCT01142193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122858|NCT01142232|Lenalidomide|lenalidomide|mesh-list
6122859|NCT01142232|Melphalan|melphalan|mesh-list
6122860|NCT01142232|Immunologic Factors|immunologic factors|mesh-ancestor
6122861|NCT01142232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122862|NCT01142232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6122863|NCT01142232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6122864|NCT01142232|Growth Substances|growth substances|mesh-ancestor
6122865|NCT01142232|Growth Inhibitors|growth inhibitors|mesh-ancestor
6122866|NCT01142232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6122867|NCT01142232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6122868|NCT01142232|Alkylating Agents|alkylating agents|mesh-ancestor
6122869|NCT01142232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122870|NCT01142232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6122871|NCT01142232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6122872|NCT01142310|Lamotrigine|lamotrigine|mesh-list
6122873|NCT01142310|Anticonvulsants|anticonvulsants|mesh-ancestor
6122874|NCT01142310|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6122875|NCT01142310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6122876|NCT01142310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122877|NCT01142310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6122878|NCT01142310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122879|NCT01142310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6122880|NCT01142310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6122881|NCT01142310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6122882|NCT01142310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5533632|NCT04228263|Micronutrients|micronutrients|mesh-ancestor
5533633|NCT04228393|Mercaptopurine|mercaptopurine|mesh-list
5533634|NCT04228393|Antimetabolites|antimetabolites|mesh-ancestor
5601681|NCT05175001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6122883|NCT01142310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6122884|NCT01142323|Fenofibrate|fenofibrate|mesh-list
6122885|NCT01142323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6122886|NCT01142323|Antimetabolites|antimetabolites|mesh-ancestor
6122887|NCT01142323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122888|NCT01142323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6122889|NCT01142336|Simvastatin|simvastatin|mesh-list
6122890|NCT01142336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6122891|NCT01142336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6122892|NCT01142336|Antimetabolites|antimetabolites|mesh-ancestor
6122893|NCT01142336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122894|NCT01142336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6122895|NCT01142336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6122896|NCT01142336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6122897|NCT01142388|Paclitaxel|paclitaxel|mesh-list
6122898|NCT01142388|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6122899|NCT01142388|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6122900|NCT01142388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6122901|NCT01142388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6122902|NCT01142388|Tubulin Modulators|tubulin modulators|mesh-ancestor
6122903|NCT01142388|Antimitotic Agents|antimitotic agents|mesh-ancestor
6122904|NCT01142388|Mitosis Modulators|mitosis modulators|mesh-ancestor
6122905|NCT01142388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122906|NCT01142388|Immunologic Factors|immunologic factors|mesh-ancestor
6122907|NCT01142388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122908|NCT01142466|Interferons|interferons|mesh-list
6122909|NCT01142466|Interferon-beta|interferon-beta|mesh-list
6122910|NCT01142466|Interferon beta-1a|interferon beta-1a|mesh-list
6122911|NCT01142466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6122912|NCT01142466|Antiviral Agents|antiviral agents|mesh-ancestor
6122913|NCT01142466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6122914|NCT01142466|Immunologic Factors|immunologic factors|mesh-ancestor
6122915|NCT01142466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122916|NCT01142466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6122917|NCT01142726|Methotrexate|methotrexate|mesh-list
6122918|NCT01142726|Abatacept|abatacept|mesh-list
6122919|NCT01142726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6122920|NCT01142726|Abortifacient Agents|abortifacient agents|mesh-ancestor
6122921|NCT01142726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6122922|NCT01142726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122923|NCT01142726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6122924|NCT01142726|Antimetabolites|antimetabolites|mesh-ancestor
6122925|NCT01142726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122926|NCT01142726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6122927|NCT01142726|Dermatologic Agents|dermatologic agents|mesh-ancestor
6122928|NCT01142726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6122929|NCT01142726|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6122930|NCT01142726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6122931|NCT01142726|Immunologic Factors|immunologic factors|mesh-ancestor
6122932|NCT01142726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6122933|NCT01142726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6122934|NCT01142726|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6122935|NCT01142947|Beclomethasone|beclomethasone|mesh-list
6122936|NCT01142947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6122937|NCT01142947|Glucocorticoids|glucocorticoids|mesh-ancestor
6122938|NCT01142947|Hormones|hormones|mesh-ancestor
6122939|NCT01142947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6122940|NCT01142947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122941|NCT01142947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6122942|NCT01142947|Respiratory System Agents|respiratory system agents|mesh-ancestor
6122943|NCT01143051|Epinephrine|epinephrine|mesh-list
6122944|NCT01143051|Racepinephrine|racepinephrine|mesh-list
6122945|NCT01143051|Epinephryl borate|epinephryl borate|mesh-list
6122946|NCT01143051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6122947|NCT01143051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6122948|NCT01143051|Adrenergic Agents|adrenergic agents|mesh-ancestor
6122949|NCT01143051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6122950|NCT01143051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122951|NCT01143051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122952|NCT01143051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6122953|NCT01143051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6122954|NCT01143051|Autonomic Agents|autonomic agents|mesh-ancestor
6122955|NCT01143051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6122956|NCT01143051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6122957|NCT01143051|Respiratory System Agents|respiratory system agents|mesh-ancestor
5533635|NCT04228393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5533636|NCT04228393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5533637|NCT04228393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6122958|NCT01143051|Mydriatics|mydriatics|mesh-ancestor
6122959|NCT01143051|Sympathomimetics|sympathomimetics|mesh-ancestor
6122960|NCT01143051|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6122961|NCT01143077|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
6122962|NCT01143077|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6122963|NCT01143077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6122964|NCT01143077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6122965|NCT01143077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122966|NCT01143077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6122967|NCT01143077|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6122968|NCT01143077|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6122969|NCT01143077|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6122970|NCT01143077|Adrenergic Agents|adrenergic agents|mesh-ancestor
6122971|NCT01143077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6122972|NCT01143077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122973|NCT01143077|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6122974|NCT01143077|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6122975|NCT01143077|Serotonin Agents|serotonin agents|mesh-ancestor
6122976|NCT01143077|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5533638|NCT04228393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5533639|NCT04228393|Immunologic Factors|immunologic factors|mesh-ancestor
5533640|NCT04228393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122977|NCT01143077|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6122978|NCT01143077|Dopamine Agents|dopamine agents|mesh-ancestor
6122979|NCT01143090|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
6122980|NCT01143090|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6122981|NCT01143090|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6122982|NCT01143090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6122983|NCT01143090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6122984|NCT01143090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6122985|NCT01143090|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6122986|NCT01143090|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6122987|NCT01143090|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6122988|NCT01143090|Adrenergic Agents|adrenergic agents|mesh-ancestor
6122989|NCT01143090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6122990|NCT01143090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6122991|NCT01143090|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6122992|NCT01143090|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6122993|NCT01143090|Serotonin Agents|serotonin agents|mesh-ancestor
6122994|NCT01143090|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6122995|NCT01143090|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6122996|NCT01143090|Dopamine Agents|dopamine agents|mesh-ancestor
6122997|NCT01143181|Brincidofovir|brincidofovir|mesh-list
6122998|NCT01143181|Antiviral Agents|antiviral agents|mesh-ancestor
5533641|NCT04228393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5533642|NCT04228393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5533643|NCT04228289|Oxytocin|oxytocin|mesh-list
5533644|NCT04228289|Oxytocics|oxytocics|mesh-ancestor
5533645|NCT04228289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5533646|NCT04228289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533647|NCT04227990|Cyclophosphamide|cyclophosphamide|mesh-list
5533648|NCT04227990|Docetaxel|docetaxel|mesh-list
5533649|NCT04227990|Doxorubicin|doxorubicin|mesh-list
5533650|NCT04227990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5533651|NCT04227990|Immunologic Factors|immunologic factors|mesh-ancestor
6122999|NCT01143181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6123000|NCT01143207|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6123001|NCT01143207|Medroxyprogesterone|medroxyprogesterone|mesh-list
6123002|NCT01143207|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6123003|NCT01143207|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6123004|NCT01143207|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6123005|NCT01143207|Contraceptive Agents|contraceptive agents|mesh-ancestor
6123006|NCT01143207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6123007|NCT01143207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123008|NCT01143207|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6123009|NCT01143207|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6123010|NCT01143207|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6123011|NCT01143207|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6123012|NCT01143207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5533652|NCT04227990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123013|NCT01143259|Alvimopan|alvimopan|mesh-list
6123014|NCT01143259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6123015|NCT01143337|Methotrexate|methotrexate|mesh-list
6123016|NCT01143337|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6123017|NCT01143337|Abortifacient Agents|abortifacient agents|mesh-ancestor
6123018|NCT01143337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6123019|NCT01143337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123020|NCT01143337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6123021|NCT01143337|Antimetabolites|antimetabolites|mesh-ancestor
6123022|NCT01143337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123023|NCT01143337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6123024|NCT01143337|Dermatologic Agents|dermatologic agents|mesh-ancestor
6123025|NCT01143337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6123026|NCT01143337|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6123027|NCT01143337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6123028|NCT01143337|Immunologic Factors|immunologic factors|mesh-ancestor
6123029|NCT01143337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6123030|NCT01143337|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6123031|NCT01143389|Riboflavin|riboflavin|mesh-list
6123032|NCT01143389|Vitamin B Complex|vitamin b complex|mesh-ancestor
6123033|NCT01143389|Vitamins|vitamins|mesh-ancestor
6123034|NCT01143389|Micronutrients|micronutrients|mesh-ancestor
6123035|NCT01143389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123036|NCT01143389|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6123037|NCT01143389|Dermatologic Agents|dermatologic agents|mesh-ancestor
6123038|NCT01143402|Temozolomide|temozolomide|mesh-list
6123039|NCT01143402|Dacarbazine|dacarbazine|mesh-list
6123040|NCT01143402|Imidazole|imidazole|mesh-list
6123041|NCT01143402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6123042|NCT01143402|Alkylating Agents|alkylating agents|mesh-ancestor
6123043|NCT01143402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123044|NCT01143402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6123045|NCT01143402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6123046|NCT01143688|Albuterol|albuterol|mesh-list
6123047|NCT01143688|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6123048|NCT01143688|Autonomic Agents|autonomic agents|mesh-ancestor
6123049|NCT01143688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6123050|NCT01143688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123051|NCT01143688|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6123052|NCT01143688|Respiratory System Agents|respiratory system agents|mesh-ancestor
6123053|NCT01143688|Tocolytic Agents|tocolytic agents|mesh-ancestor
5533653|NCT04227990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5533654|NCT04227990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5533655|NCT04227990|Alkylating Agents|alkylating agents|mesh-ancestor
5533656|NCT04227990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5533657|NCT04227990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5533658|NCT04227990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5533659|NCT04227990|Tubulin Modulators|tubulin modulators|mesh-ancestor
5533660|NCT04227990|Antimitotic Agents|antimitotic agents|mesh-ancestor
5533661|NCT04227990|Mitosis Modulators|mitosis modulators|mesh-ancestor
6123054|NCT01143688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6123055|NCT01143688|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6123056|NCT01143688|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6123057|NCT01143688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6123058|NCT01143688|Adrenergic Agents|adrenergic agents|mesh-ancestor
6123059|NCT01143688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6123060|NCT01143688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123061|NCT01143714|Petrolatum|petrolatum|mesh-list
6123062|NCT01143714|Emollients|emollients|mesh-ancestor
6123063|NCT01143714|Dermatologic Agents|dermatologic agents|mesh-ancestor
6123064|NCT01143766|Gabapentin|gabapentin|mesh-list
6123065|NCT01143766|Analgesics|analgesics|mesh-ancestor
6123066|NCT01143766|Sensory System Agents|sensory system agents|mesh-ancestor
6123067|NCT01143766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6123068|NCT01143766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123069|NCT01143766|Anticonvulsants|anticonvulsants|mesh-ancestor
6123070|NCT01143766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6123071|NCT01143766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6123072|NCT01143766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6123073|NCT01143766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6123074|NCT01143766|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6123075|NCT01143766|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6123076|NCT01143766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6123077|NCT01143766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123078|NCT01143766|Antimanic Agents|antimanic agents|mesh-ancestor
5533662|NCT04227990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5533663|NCT04227990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5533664|NCT04227990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5533665|NCT04227990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5533666|NCT04228042|Infigratinib|infigratinib|mesh-list
5533667|NCT04228042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5533668|NCT04227886|Capecitabine|capecitabine|mesh-list
5533669|NCT04227886|Irinotecan|irinotecan|mesh-list
6123079|NCT01143818|Methyltestosterone|methyltestosterone|mesh-list
6123080|NCT01143818|Testosterone|testosterone|mesh-list
6123081|NCT01143818|Testosterone undecanoate|testosterone undecanoate|mesh-list
6123082|NCT01143818|Testosterone enanthate|testosterone enanthate|mesh-list
6123083|NCT01143818|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6123084|NCT01143818|Androgens|androgens|mesh-ancestor
6123085|NCT01143818|Hormones|hormones|mesh-ancestor
6123086|NCT01143818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6123087|NCT01143818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123088|NCT01143818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6123089|NCT01143818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6123090|NCT01143818|Anabolic Agents|anabolic agents|mesh-ancestor
6123091|NCT01144052|Interferons|interferons|mesh-list
6123092|NCT01144052|Interferon-beta|interferon-beta|mesh-list
6123093|NCT01144052|Natalizumab|natalizumab|mesh-list
6123094|NCT01144052|Interferon beta-1b|interferon beta-1b|mesh-list
6123095|NCT01144052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6123096|NCT01144052|Antiviral Agents|antiviral agents|mesh-ancestor
6123097|NCT01144052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6123098|NCT01144052|Immunologic Factors|immunologic factors|mesh-ancestor
6123099|NCT01144052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123100|NCT01144052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6123101|NCT01144143|Methylprednisolone|methylprednisolone|mesh-list
6123102|NCT01144143|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6123103|NCT01144143|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6123104|NCT01144143|Prednisolone|prednisolone|mesh-list
6123105|NCT01144143|Prednisolone acetate|prednisolone acetate|mesh-list
6123106|NCT01144143|Infliximab|infliximab|mesh-list
6123107|NCT01144143|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6123108|NCT01144143|Prednisolone phosphate|prednisolone phosphate|mesh-list
6123109|NCT01144143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6123110|NCT01144143|Antiemetics|antiemetics|mesh-ancestor
6123111|NCT01144143|Autonomic Agents|autonomic agents|mesh-ancestor
6123112|NCT01144143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6123113|NCT01144143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123114|NCT01144143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6123115|NCT01144143|Glucocorticoids|glucocorticoids|mesh-ancestor
6123116|NCT01144143|Hormones|hormones|mesh-ancestor
6123117|NCT01144143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6123118|NCT01144143|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6123119|NCT01144143|Protective Agents|protective agents|mesh-ancestor
6123120|NCT01144143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6123121|NCT01144143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6123122|NCT01144143|Dermatologic Agents|dermatologic agents|mesh-ancestor
6123123|NCT01144143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6123124|NCT01144338|Exenatide|exenatide|mesh-list
6123125|NCT01144338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6123126|NCT01144338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123127|NCT01144338|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6123128|NCT01144338|Incretins|incretins|mesh-ancestor
6123129|NCT01144338|Hormones|hormones|mesh-ancestor
6123130|NCT01144338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6123131|NCT01144364|Rituximab|rituximab|mesh-list
6123132|NCT01144364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5533670|NCT04227886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5533671|NCT04227886|Antimetabolites|antimetabolites|mesh-ancestor
5533672|NCT04227886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5533673|NCT04227886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5533674|NCT04227886|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5533675|NCT04227886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5533676|NCT04227886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5533677|NCT04227808|Lenvatinib|lenvatinib|mesh-list
5533678|NCT04227808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6123133|NCT01144364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6123134|NCT01144364|Immunologic Factors|immunologic factors|mesh-ancestor
6123135|NCT01144364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123136|NCT01144364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6123137|NCT01144403|Cyclophosphamide|cyclophosphamide|mesh-list
6123138|NCT01144403|Rituximab|rituximab|mesh-list
6123139|NCT01144403|Fludarabine|fludarabine|mesh-list
5533679|NCT04227808|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5533680|NCT04227808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5533681|NCT04227808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5533682|NCT04227678|Heparin|heparin|mesh-list
5533683|NCT04227678|Anticoagulants|anticoagulants|mesh-ancestor
5533684|NCT04227678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5533685|NCT04227678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5533686|NCT04227678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5533687|NCT04227704|Ketamine|ketamine|mesh-list
5533688|NCT04227704|Analgesics|analgesics|mesh-ancestor
5533689|NCT04227704|Sensory System Agents|sensory system agents|mesh-ancestor
5533690|NCT04227704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5533691|NCT04227704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533692|NCT04227704|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5533693|NCT04227704|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5533694|NCT04227704|Anesthetics, General|anesthetics, general|mesh-ancestor
5533695|NCT04227704|Anesthetics|anesthetics|mesh-ancestor
5533696|NCT04227704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5533697|NCT04227704|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5533698|NCT04227704|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5533699|NCT04227704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5533700|NCT04227704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5533701|NCT04227769|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5533702|NCT04227769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5533703|NCT04227756|Psilocybin|psilocybin|mesh-list
5533704|NCT04227756|Mescaline|mescaline|mesh-list
5533705|NCT04227756|Hallucinogens|hallucinogens|mesh-ancestor
5533706|NCT04227756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533707|NCT04227756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5533708|NCT04227756|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5533709|NCT04227756|Serotonin Agents|serotonin agents|mesh-ancestor
5533710|NCT04227756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5533711|NCT04227756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5533712|NCT04227912|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
5533713|NCT04227912|Anesthetics|anesthetics|mesh-list
5533714|NCT04227912|Anesthetics, Local|anesthetics, local|mesh-list
5533715|NCT04227912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5533716|NCT04227912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533717|NCT04227912|Sensory System Agents|sensory system agents|mesh-ancestor
5533718|NCT04227912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5533719|NCT04227912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5533720|NCT04227912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5533721|NCT04227912|Analgesics|analgesics|mesh-ancestor
6123140|NCT01144403|Mitoxantrone|mitoxantrone|mesh-list
6123141|NCT01144403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6123142|NCT01144403|Immunologic Factors|immunologic factors|mesh-ancestor
6123143|NCT01144403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123144|NCT01144403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5533722|NCT04227912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5533723|NCT04227912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5533724|NCT04227652|Ibuprofen|ibuprofen|mesh-list
5533725|NCT04227652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5533726|NCT04227652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5533727|NCT04227652|Analgesics|analgesics|mesh-ancestor
5533728|NCT04227652|Sensory System Agents|sensory system agents|mesh-ancestor
5533729|NCT04227652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5533730|NCT04227652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533731|NCT04227652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5533732|NCT04227652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5533733|NCT04227652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5533734|NCT04227652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5533735|NCT04227652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601682|NCT05175001|Glucocorticoids|glucocorticoids|mesh-ancestor
6123145|NCT01144403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6123146|NCT01144403|Alkylating Agents|alkylating agents|mesh-ancestor
6123147|NCT01144403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123148|NCT01144403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6123149|NCT01144403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6123150|NCT01144403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6123151|NCT01144403|Analgesics|analgesics|mesh-ancestor
6123152|NCT01144403|Sensory System Agents|sensory system agents|mesh-ancestor
6123153|NCT01144403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6123154|NCT01144403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6123155|NCT01144403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6123156|NCT01144403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6123157|NCT01144442|Paclitaxel|paclitaxel|mesh-list
6123158|NCT01144442|Carboplatin|carboplatin|mesh-list
6123159|NCT01144442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6123160|NCT01144442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6123161|NCT01144442|Tubulin Modulators|tubulin modulators|mesh-ancestor
6123162|NCT01144442|Antimitotic Agents|antimitotic agents|mesh-ancestor
6123163|NCT01144442|Mitosis Modulators|mitosis modulators|mesh-ancestor
6123164|NCT01144442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123165|NCT01144455|Gemcitabine|gemcitabine|mesh-list
6123166|NCT01144455|Phosphoramide Mustards|phosphoramide mustards|mesh-list
6123167|NCT01144455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6123168|NCT01144455|Antimetabolites|antimetabolites|mesh-ancestor
6123169|NCT01144455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123170|NCT01144455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6123171|NCT01144455|Antiviral Agents|antiviral agents|mesh-ancestor
6123172|NCT01144455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6123173|NCT01144455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6123174|NCT01144455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6123175|NCT01144455|Immunologic Factors|immunologic factors|mesh-ancestor
6123176|NCT01144455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123177|NCT01144455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6123178|NCT01144455|Alkylating Agents|alkylating agents|mesh-ancestor
6123179|NCT01144494|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6123180|NCT01144494|Lubricant Eye Drops|lubricant eye drops|mesh-list
6123181|NCT01144494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6123182|NCT01144494|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6123183|NCT01144494|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6123184|NCT01144494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6123185|NCT01144494|Adrenergic Agents|adrenergic agents|mesh-ancestor
6123186|NCT01144494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6123187|NCT01144494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123188|NCT01144494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123189|NCT01144494|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6123190|NCT01144494|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6123191|NCT01144949|Silodosin|silodosin|mesh-list
6123192|NCT01144949|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6123193|NCT01144949|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6123194|NCT01144949|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6123195|NCT01144949|Adrenergic Agents|adrenergic agents|mesh-ancestor
6123196|NCT01144949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6123197|NCT01144949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123198|NCT01144949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123199|NCT01144949|Urological Agents|urological agents|mesh-ancestor
6123200|NCT01145001|Nicotine|nicotine|mesh-list
6123201|NCT01145001|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6123202|NCT01145001|Autonomic Agents|autonomic agents|mesh-ancestor
6123203|NCT01145001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6123204|NCT01145001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123205|NCT01145001|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6123206|NCT01145001|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6123207|NCT01145001|Cholinergic Agents|cholinergic agents|mesh-ancestor
6123208|NCT01145001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6123209|NCT01145001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123210|NCT01145066|Borage oil|borage oil|mesh-list
6123211|NCT01145066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6123212|NCT01145183|Doxazosin|doxazosin|mesh-list
6123213|NCT01145183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6123214|NCT01145183|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6123215|NCT01145183|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6123216|NCT01145183|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6123217|NCT01145183|Adrenergic Agents|adrenergic agents|mesh-ancestor
6123218|NCT01145183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6123219|NCT01145183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123220|NCT01145183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123221|NCT01145209|Cyclophosphamide|cyclophosphamide|mesh-list
6123222|NCT01145209|Fludarabine|fludarabine|mesh-list
6123223|NCT01145209|Fludarabine phosphate|fludarabine phosphate|mesh-list
6123224|NCT01145209|Ofatumumab|ofatumumab|mesh-list
6123225|NCT01145209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6123226|NCT01145209|Immunologic Factors|immunologic factors|mesh-ancestor
6123227|NCT01145209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123228|NCT01145209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6123229|NCT01145209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6123230|NCT01145209|Alkylating Agents|alkylating agents|mesh-ancestor
6123231|NCT01145209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123232|NCT01145209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6123233|NCT01145209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6123234|NCT01145209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6123235|NCT01145209|Antimetabolites|antimetabolites|mesh-ancestor
6123236|NCT01145222|Midazolam|midazolam|mesh-list
6123237|NCT01145222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6123238|NCT01145222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6123239|NCT01145222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6123240|NCT01145222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123241|NCT01145222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6123242|NCT01145222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6123243|NCT01145222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6123244|NCT01145222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6123245|NCT01145222|Anesthetics, General|anesthetics, general|mesh-ancestor
6123246|NCT01145222|Anesthetics|anesthetics|mesh-ancestor
6123247|NCT01145222|GABA Modulators|gaba modulators|mesh-ancestor
6123248|NCT01145222|GABA Agents|gaba agents|mesh-ancestor
6123249|NCT01145222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6123250|NCT01145222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123251|NCT01145352|Etanercept|etanercept|mesh-list
6123252|NCT01145352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6123253|NCT01145352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6123254|NCT01145352|Analgesics|analgesics|mesh-ancestor
6123255|NCT01145352|Sensory System Agents|sensory system agents|mesh-ancestor
6123256|NCT01145352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6123257|NCT01145352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123258|NCT01145352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6123259|NCT01145352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6123260|NCT01145352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6123261|NCT01145352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6123262|NCT01145352|Immunologic Factors|immunologic factors|mesh-ancestor
6123263|NCT01145417|Pregabalin|pregabalin|mesh-list
6123264|NCT01145417|Analgesics|analgesics|mesh-ancestor
6123265|NCT01145417|Sensory System Agents|sensory system agents|mesh-ancestor
6123266|NCT01145417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6123267|NCT01145417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123268|NCT01145417|Anticonvulsants|anticonvulsants|mesh-ancestor
6123269|NCT01145417|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6123270|NCT01145417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6123271|NCT01145417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123272|NCT01145417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5533736|NCT04227210|Vaccines|vaccines|mesh-list
5533737|NCT04227210|Immunologic Factors|immunologic factors|mesh-ancestor
5533738|NCT04227210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533739|NCT04227275|Cyclophosphamide|cyclophosphamide|mesh-list
5533740|NCT04227275|Fludarabine|fludarabine|mesh-list
5533741|NCT04227275|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5533742|NCT04227275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5533743|NCT04227275|Immunologic Factors|immunologic factors|mesh-ancestor
5533744|NCT04227275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533745|NCT04227275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5533746|NCT04227275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5533747|NCT04227275|Alkylating Agents|alkylating agents|mesh-ancestor
5533748|NCT04227275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5533749|NCT04227275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5533750|NCT04227275|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5533751|NCT04227483|Prednisolone|prednisolone|mesh-list
5533752|NCT04227483|Deflazacort|deflazacort|mesh-list
5533753|NCT04227483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5533754|NCT04227483|Glucocorticoids|glucocorticoids|mesh-ancestor
5533755|NCT04227483|Hormones|hormones|mesh-ancestor
5533756|NCT04227483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5533757|NCT04227483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533758|NCT04227483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5533759|NCT04227483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5533760|NCT04227483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5533761|NCT04227483|Immunologic Factors|immunologic factors|mesh-ancestor
5533762|NCT04227522|Rucaparib|rucaparib|mesh-list
5533763|NCT04227522|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5533764|NCT04227522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5533765|NCT04227522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123273|NCT01145417|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6123274|NCT01145417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6123275|NCT01145417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6123276|NCT01145417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6123277|NCT01145482|Insulin|insulin|mesh-list
6123278|NCT01145482|Insulin Aspart|insulin aspart|mesh-list
6123279|NCT01145482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6123280|NCT01145482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123281|NCT01145508|Metronidazole|metronidazole|mesh-list
6123282|NCT01145508|Prednisone|prednisone|mesh-list
5533766|NCT04227522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5533767|NCT04227509|Pembrolizumab|pembrolizumab|mesh-list
5533768|NCT04227509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5533769|NCT04227509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5533770|NCT04227184|Trospium chloride|trospium chloride|mesh-list
5533771|NCT04227184|Parasympatholytics|parasympatholytics|mesh-ancestor
5533772|NCT04227184|Autonomic Agents|autonomic agents|mesh-ancestor
5533773|NCT04227184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5533774|NCT04227184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123283|NCT01145508|Cortisone|cortisone|mesh-list
6123284|NCT01145508|Docetaxel|docetaxel|mesh-list
6123285|NCT01145508|Vaccines|vaccines|mesh-list
6123286|NCT01145508|Immunologic Factors|immunologic factors|mesh-ancestor
6123287|NCT01145508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123288|NCT01145508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6123289|NCT01145508|Tubulin Modulators|tubulin modulators|mesh-ancestor
6123290|NCT01145508|Antimitotic Agents|antimitotic agents|mesh-ancestor
6123291|NCT01145508|Mitosis Modulators|mitosis modulators|mesh-ancestor
6123292|NCT01145508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123293|NCT01145508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6123294|NCT01145508|Glucocorticoids|glucocorticoids|mesh-ancestor
6123295|NCT01145508|Hormones|hormones|mesh-ancestor
6123296|NCT01145508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6123297|NCT01145508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6123298|NCT01145508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6123299|NCT01145508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6123300|NCT01145508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6123301|NCT01145508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6123302|NCT01145625|Minoxidil|minoxidil|mesh-list
6123303|NCT01145625|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6123304|NCT01145625|Vasodilator Agents|vasodilator agents|mesh-ancestor
5533775|NCT04227184|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5533776|NCT04227184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5533777|NCT04227184|Cholinergic Agents|cholinergic agents|mesh-ancestor
5533778|NCT04227184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5533779|NCT04227184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5533780|NCT04227184|Urological Agents|urological agents|mesh-ancestor
5533781|NCT04227431|Insulin|insulin|mesh-list
5533782|NCT04227431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6123305|NCT01145638|Iron|iron|mesh-list
6123306|NCT01145638|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
6123307|NCT01145638|Trace Elements|trace elements|mesh-ancestor
6123308|NCT01145638|Micronutrients|micronutrients|mesh-ancestor
6123309|NCT01145638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123310|NCT01145638|Hematinics|hematinics|mesh-ancestor
6123311|NCT01145755|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6123312|NCT01145755|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6123313|NCT01145755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6123314|NCT01145755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6123315|NCT01145755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123316|NCT01145755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6123317|NCT01145755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123318|NCT01145755|Analgesics|analgesics|mesh-ancestor
6123319|NCT01145755|Sensory System Agents|sensory system agents|mesh-ancestor
6123320|NCT01145755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6123321|NCT01145755|Antidepressive Agents|antidepressive agents|mesh-ancestor
6123322|NCT01145755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6123323|NCT01145755|Dopamine Agents|dopamine agents|mesh-ancestor
6123324|NCT01145898|Timolol|timolol|mesh-list
6123325|NCT01145898|Dorzolamide|dorzolamide|mesh-list
6123326|NCT01145898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6123327|NCT01145898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6123328|NCT01145898|Adrenergic Agents|adrenergic agents|mesh-ancestor
6123329|NCT01145898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6123330|NCT01145898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601683|NCT05175001|Hormones|hormones|mesh-ancestor
6123331|NCT01145898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123332|NCT01145898|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6123333|NCT01145898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6123334|NCT01145898|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6123335|NCT01145898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6204714|NCT02075125|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6204715|NCT02075125|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6204716|NCT02075125|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6204717|NCT02075125|Purinergic Agents|purinergic agents|mesh-ancestor
6204718|NCT02075125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6204719|NCT02075125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204720|NCT02075125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204721|NCT02075203|BCG Vaccine|bcg vaccine|mesh-list
6204722|NCT02075203|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6204723|NCT02075203|Immunologic Factors|immunologic factors|mesh-ancestor
6204724|NCT02075203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204725|NCT02075255|Benralizumab|benralizumab|mesh-list
6204726|NCT02075255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6204727|NCT02075255|Respiratory System Agents|respiratory system agents|mesh-ancestor
6204728|NCT02075515|Vaccines|vaccines|mesh-list
6204729|NCT02075515|Immunologic Factors|immunologic factors|mesh-ancestor
6204730|NCT02075515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204731|NCT02075606|Lanreotide|lanreotide|mesh-list
6204732|NCT02075606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6204733|NCT02075632|Alclometasone dipropionate|alclometasone dipropionate|mesh-list
6204734|NCT02075632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6204735|NCT02075632|Glucocorticoids|glucocorticoids|mesh-ancestor
6204736|NCT02075632|Hormones|hormones|mesh-ancestor
6204737|NCT02075632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6204738|NCT02075632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204739|NCT02076100|Ruzasvir|ruzasvir|mesh-list
6204740|NCT02076100|Antiviral Agents|antiviral agents|mesh-ancestor
6204741|NCT02076100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6204742|NCT02076152|Bevacizumab|bevacizumab|mesh-list
6204743|NCT02076152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6204744|NCT02076152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6204745|NCT02076152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6204746|NCT02076152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6204747|NCT02076152|Growth Substances|growth substances|mesh-ancestor
6204748|NCT02076152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204749|NCT02076152|Growth Inhibitors|growth inhibitors|mesh-ancestor
6204750|NCT02076243|Paclitaxel|paclitaxel|mesh-list
6204751|NCT02076243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6204752|NCT02076243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6204753|NCT02076243|Tubulin Modulators|tubulin modulators|mesh-ancestor
6204754|NCT02076243|Antimitotic Agents|antimitotic agents|mesh-ancestor
6204755|NCT02076243|Mitosis Modulators|mitosis modulators|mesh-ancestor
6204756|NCT02076243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204757|NCT02076321|Acetaminophen|acetaminophen|mesh-list
6204758|NCT02076321|Ibuprofen|ibuprofen|mesh-list
6204759|NCT02076321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6204760|NCT02076321|Analgesics|analgesics|mesh-ancestor
6204761|NCT02076321|Sensory System Agents|sensory system agents|mesh-ancestor
6204762|NCT02076321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6204763|NCT02076321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204764|NCT02076321|Antipyretics|antipyretics|mesh-ancestor
6204765|NCT02076321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6204766|NCT02076321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6204767|NCT02076321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6204768|NCT02076321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6204769|NCT02076321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6204770|NCT02076321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207827|NCT02120898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207828|NCT02120898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6207829|NCT02120898|Interferon Inducers|interferon inducers|mesh-ancestor
6207830|NCT02120924|Azelaic acid|azelaic acid|mesh-list
6207831|NCT02120924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6207832|NCT02120924|Dermatologic Agents|dermatologic agents|mesh-ancestor
6207833|NCT02120950|Aflibercept|aflibercept|mesh-list
6207834|NCT02120950|Verteporfin|verteporfin|mesh-list
6207835|NCT02120950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6207836|NCT02120950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6207837|NCT02120950|Growth Substances|growth substances|mesh-ancestor
6207838|NCT02120950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207839|NCT02120950|Growth Inhibitors|growth inhibitors|mesh-ancestor
6207840|NCT02120950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6123336|NCT01146054|Gemcitabine|gemcitabine|mesh-list
6123337|NCT01146054|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6123338|NCT01146054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6123339|NCT01146054|Antimetabolites|antimetabolites|mesh-ancestor
6123340|NCT01146054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123341|NCT01146054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6123342|NCT01146054|Antiviral Agents|antiviral agents|mesh-ancestor
6123343|NCT01146054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6123344|NCT01146054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6123345|NCT01146054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6123346|NCT01146054|Immunologic Factors|immunologic factors|mesh-ancestor
6123347|NCT01146054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123348|NCT01146054|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6123349|NCT01146288|Furosemide|furosemide|mesh-list
6123350|NCT01146288|Acetazolamide|acetazolamide|mesh-list
6123351|NCT01146288|Diuretics|diuretics|mesh-ancestor
6123352|NCT01146288|Natriuretic Agents|natriuretic agents|mesh-ancestor
6123353|NCT01146288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123354|NCT01146288|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6123355|NCT01146288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6123356|NCT01146288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123357|NCT01146288|Anticonvulsants|anticonvulsants|mesh-ancestor
6123358|NCT01146288|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6123359|NCT01146288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6123360|NCT01146457|Morphine|morphine|mesh-list
6123361|NCT01146457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6123362|NCT01146457|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6123363|NCT01146457|Narcotics|narcotics|mesh-ancestor
6123364|NCT01146457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5533783|NCT04227431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533784|NCT04227093|Acetazolamide|acetazolamide|mesh-list
5533785|NCT04227093|Anticonvulsants|anticonvulsants|mesh-ancestor
5533786|NCT04227093|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5533787|NCT04227093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5533788|NCT04227093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5533789|NCT04227093|Diuretics|diuretics|mesh-ancestor
5533790|NCT04227093|Natriuretic Agents|natriuretic agents|mesh-ancestor
5533791|NCT04227093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533792|NCT04227041|Capecitabine|capecitabine|mesh-list
5533793|NCT04227041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6123365|NCT01146457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123366|NCT01146457|Analgesics|analgesics|mesh-ancestor
6123367|NCT01146457|Sensory System Agents|sensory system agents|mesh-ancestor
6123368|NCT01146457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6123369|NCT01146561|Tanezumab|tanezumab|mesh-list
6123370|NCT01146561|Analgesics|analgesics|mesh-ancestor
6123371|NCT01146561|Sensory System Agents|sensory system agents|mesh-ancestor
6123372|NCT01146561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6123373|NCT01146561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123374|NCT01146600|Clarithromycin|clarithromycin|mesh-list
6123375|NCT01146600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6123376|NCT01146600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6123377|NCT01146600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6123378|NCT01146600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6123379|NCT01146600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123380|NCT01146600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6123381|NCT01146600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6123382|NCT01146613|Varenicline|varenicline|mesh-list
5533794|NCT04227041|Antimetabolites|antimetabolites|mesh-ancestor
5533795|NCT04227041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5533796|NCT04227041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5533797|NCT04226963|Ketamine|ketamine|mesh-list
5533798|NCT04226963|Analgesics|analgesics|mesh-ancestor
5533799|NCT04226963|Sensory System Agents|sensory system agents|mesh-ancestor
5533800|NCT04226963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5533801|NCT04226963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533802|NCT04226963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5533803|NCT04226963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5533804|NCT04226963|Anesthetics, General|anesthetics, general|mesh-ancestor
5533805|NCT04226963|Anesthetics|anesthetics|mesh-ancestor
5533806|NCT04226963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5533807|NCT04226963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6123383|NCT01146613|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6123384|NCT01146613|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6123385|NCT01146613|Cholinergic Agents|cholinergic agents|mesh-ancestor
6123386|NCT01146613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6123387|NCT01146613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123388|NCT01146613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123389|NCT01146795|Paclitaxel|paclitaxel|mesh-list
6123390|NCT01146795|Bevacizumab|bevacizumab|mesh-list
6123391|NCT01146795|Carboplatin|carboplatin|mesh-list
6123392|NCT01146795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6123393|NCT01146795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6123394|NCT01146795|Tubulin Modulators|tubulin modulators|mesh-ancestor
6123395|NCT01146795|Antimitotic Agents|antimitotic agents|mesh-ancestor
6123396|NCT01146795|Mitosis Modulators|mitosis modulators|mesh-ancestor
6123397|NCT01146795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123398|NCT01146795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6123399|NCT01146795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6123400|NCT01146795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6123401|NCT01146795|Growth Substances|growth substances|mesh-ancestor
6123402|NCT01146795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123403|NCT01146795|Growth Inhibitors|growth inhibitors|mesh-ancestor
6123404|NCT01146808|Adefovir|adefovir|mesh-list
6123405|NCT01146808|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6123406|NCT01146808|Antiviral Agents|antiviral agents|mesh-ancestor
6123407|NCT01146808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6123408|NCT01146808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6123409|NCT01146808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6123410|NCT01146808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6123411|NCT01146808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123412|NCT01146834|Plerixafor|plerixafor|mesh-list
6123413|NCT01146834|Cyclophosphamide|cyclophosphamide|mesh-list
6123414|NCT01146834|Bortezomib|bortezomib|mesh-list
6123415|NCT01146834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6123416|NCT01146834|Immunologic Factors|immunologic factors|mesh-ancestor
6123417|NCT01146834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123418|NCT01146834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6123419|NCT01146834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6123420|NCT01146834|Alkylating Agents|alkylating agents|mesh-ancestor
6123421|NCT01146834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123422|NCT01146834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6123423|NCT01146834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6123424|NCT01146834|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5533808|NCT04226963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5533809|NCT04226963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5533810|NCT04226963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5533811|NCT04226885|Fentanyl|fentanyl|mesh-list
5533812|NCT04226885|Midazolam|midazolam|mesh-list
5533813|NCT04226885|Dexmedetomidine|dexmedetomidine|mesh-list
5533814|NCT04226885|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5533815|NCT04226885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5533816|NCT04226885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533817|NCT04226885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5533818|NCT04226885|Analgesics|analgesics|mesh-ancestor
5533819|NCT04226885|Sensory System Agents|sensory system agents|mesh-ancestor
6123425|NCT01146834|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6123426|NCT01146834|Antiviral Agents|antiviral agents|mesh-ancestor
6123427|NCT01146834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6123428|NCT01146873|Ritonavir|ritonavir|mesh-list
6123429|NCT01146873|Lopinavir|lopinavir|mesh-list
6123430|NCT01146873|Abacavir|abacavir|mesh-list
6123431|NCT01146873|Stavudine|stavudine|mesh-list
6123432|NCT01146873|Efavirenz|efavirenz|mesh-list
5533820|NCT04226885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5533821|NCT04226885|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5533822|NCT04226885|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5533823|NCT04226885|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5533824|NCT04226885|Adrenergic Agents|adrenergic agents|mesh-ancestor
5533825|NCT04226885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5533826|NCT04226885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5533827|NCT04226885|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5533828|NCT04226885|Narcotics|narcotics|mesh-ancestor
5533829|NCT04226885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5533830|NCT04226885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5533831|NCT04226885|Anesthetics, General|anesthetics, general|mesh-ancestor
5533832|NCT04226885|Anesthetics|anesthetics|mesh-ancestor
6123433|NCT01146873|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6123434|NCT01146873|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6123435|NCT01146873|Protease Inhibitors|protease inhibitors|mesh-ancestor
6123436|NCT01146873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6123437|NCT01146873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123438|NCT01146873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6123439|NCT01146873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6123440|NCT01146873|Antiviral Agents|antiviral agents|mesh-ancestor
5533833|NCT04226885|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5533834|NCT04226885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6123441|NCT01146873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6123442|NCT01146873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6123443|NCT01146873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6123444|NCT01146873|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6123445|NCT01146873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6123446|NCT01146873|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6123447|NCT01146873|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6123448|NCT01146873|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6123449|NCT01146873|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6123450|NCT01146873|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6123451|NCT01146873|Antimetabolites|antimetabolites|mesh-ancestor
6123452|NCT01146951|Rufinamide|rufinamide|mesh-list
6123453|NCT01146951|Anticonvulsants|anticonvulsants|mesh-ancestor
6123454|NCT01146951|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6123455|NCT01146951|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6123456|NCT01146951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6123457|NCT01146951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123458|NCT01147055|Rifampin|rifampin|mesh-list
6123459|NCT01147055|Crizotinib|crizotinib|mesh-list
6123460|NCT01147055|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6123461|NCT01147055|Antitubercular Agents|antitubercular agents|mesh-ancestor
6123462|NCT01147055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6123463|NCT01147055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6123464|NCT01147055|Leprostatic Agents|leprostatic agents|mesh-ancestor
6123465|NCT01147055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6123466|NCT01147055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6123467|NCT01147055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123468|NCT01147055|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6123469|NCT01147055|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6123470|NCT01147055|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6123471|NCT01147055|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6123472|NCT01147055|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6123473|NCT01147055|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6123474|NCT01147055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6123475|NCT01147055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6123476|NCT01147068|Hemagglutinins|hemagglutinins|mesh-list
6123477|NCT01147068|Agglutinins|agglutinins|mesh-ancestor
6123478|NCT01147068|Immunologic Factors|immunologic factors|mesh-ancestor
6123479|NCT01147068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123480|NCT01147107|Efavirenz|efavirenz|mesh-list
6123481|NCT01147107|Raltegravir Potassium|raltegravir potassium|mesh-list
6123482|NCT01147107|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6123483|NCT01147107|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6123484|NCT01147107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6123485|NCT01147107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123486|NCT01147107|Antiviral Agents|antiviral agents|mesh-ancestor
6123487|NCT01147107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6123488|NCT01147107|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6123489|NCT01147107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6123490|NCT01147107|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6123491|NCT01147107|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6123492|NCT01147107|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6123493|NCT01147107|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6123494|NCT01147107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6123495|NCT01147107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6123496|NCT01147107|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6123497|NCT01147107|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6123498|NCT01147250|Lixisenatide|lixisenatide|mesh-list
6123499|NCT01147250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6123500|NCT01147250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123501|NCT01147302|Complement C1s|complement c1s|mesh-list
6123502|NCT01147302|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
6123503|NCT01147302|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
6123504|NCT01147302|Immunologic Factors|immunologic factors|mesh-ancestor
6123505|NCT01147302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123506|NCT01147302|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6123507|NCT01147302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6123508|NCT01147341|Certolizumab Pegol|certolizumab pegol|mesh-list
6123509|NCT01147341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6123510|NCT01147341|Immunologic Factors|immunologic factors|mesh-ancestor
6123511|NCT01147341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123512|NCT01147341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6123513|NCT01147380|Vaccines|vaccines|mesh-list
6123514|NCT01147380|Immunologic Factors|immunologic factors|mesh-ancestor
6123515|NCT01147380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123516|NCT01147458|Naproxen|naproxen|mesh-list
6123517|NCT01147458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6123518|NCT01147458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6123519|NCT01147458|Analgesics|analgesics|mesh-ancestor
6123520|NCT01147458|Sensory System Agents|sensory system agents|mesh-ancestor
6123521|NCT01147458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6123522|NCT01147458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123523|NCT01147458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6123524|NCT01147458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6123525|NCT01147458|Gout Suppressants|gout suppressants|mesh-ancestor
6123526|NCT01147458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6123527|NCT01147458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6123528|NCT01147458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123529|NCT01147497|Misoprostol|misoprostol|mesh-list
6123530|NCT01147497|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6123531|NCT01147497|Abortifacient Agents|abortifacient agents|mesh-ancestor
6123532|NCT01147497|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6123533|NCT01147497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123534|NCT01147497|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6123535|NCT01147497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6123536|NCT01147497|Oxytocics|oxytocics|mesh-ancestor
6123537|NCT01147601|Timolol|timolol|mesh-list
6123538|NCT01147601|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6123539|NCT01147601|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6123540|NCT01147601|Adrenergic Agents|adrenergic agents|mesh-ancestor
6123541|NCT01147601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6123542|NCT01147601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123543|NCT01147601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123544|NCT01147601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6123545|NCT01147601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6123546|NCT01147627|Insulin|insulin|mesh-list
6123547|NCT01147627|Pioglitazone|pioglitazone|mesh-list
6123548|NCT01147627|Exenatide|exenatide|mesh-list
6123549|NCT01147627|Insulin Lispro|insulin lispro|mesh-list
6123550|NCT01147627|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6123551|NCT01147627|Protamines|protamines|mesh-list
5533835|NCT04226885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5533836|NCT04226885|GABA Modulators|gaba modulators|mesh-ancestor
5533837|NCT04226885|GABA Agents|gaba agents|mesh-ancestor
5533838|NCT04226495|Sufentanil|sufentanil|mesh-list
5533839|NCT04226495|Dsuvia|dsuvia|mesh-list
5533840|NCT04226495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5533841|NCT04226495|Narcotics|narcotics|mesh-ancestor
5533842|NCT04226495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5533843|NCT04226495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533844|NCT04226495|Analgesics|analgesics|mesh-ancestor
5533845|NCT04226495|Sensory System Agents|sensory system agents|mesh-ancestor
5533846|NCT04226495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5533847|NCT04226495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6123552|NCT01147627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6123553|NCT01147627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123554|NCT01147627|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6123555|NCT01147627|Incretins|incretins|mesh-ancestor
6123556|NCT01147627|Hormones|hormones|mesh-ancestor
5533848|NCT04226495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5533849|NCT04226495|Anesthetics, General|anesthetics, general|mesh-ancestor
5533850|NCT04226495|Anesthetics|anesthetics|mesh-ancestor
5533851|NCT04226625|Propofol|propofol|mesh-list
5533852|NCT04226625|Desflurane|desflurane|mesh-list
5533853|NCT04226625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5533854|NCT04226625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5533855|NCT04226625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533856|NCT04226625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5533857|NCT04226625|Anesthetics, General|anesthetics, general|mesh-ancestor
5533858|NCT04226625|Anesthetics|anesthetics|mesh-ancestor
5533859|NCT04226625|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5533860|NCT04226456|Acetylcysteine|acetylcysteine|mesh-list
5533861|NCT04226456|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5533862|NCT04226456|Antiviral Agents|antiviral agents|mesh-ancestor
5533863|NCT04226456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5533864|NCT04226456|Expectorants|expectorants|mesh-ancestor
5533865|NCT04226456|Respiratory System Agents|respiratory system agents|mesh-ancestor
5533866|NCT04226456|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5533867|NCT04226456|Antioxidants|antioxidants|mesh-ancestor
5533868|NCT04226456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5533869|NCT04226456|Protective Agents|protective agents|mesh-ancestor
5533870|NCT04226456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533871|NCT04226456|Antidotes|antidotes|mesh-ancestor
5533872|NCT04226443|Midazolam|midazolam|mesh-list
5533873|NCT04226443|Remifentanil|remifentanil|mesh-list
5533874|NCT04226443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5533875|NCT04226443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5533876|NCT04226443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5533877|NCT04226443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533878|NCT04226443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5533879|NCT04226443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5533880|NCT04226443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5533881|NCT04226443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5533882|NCT04226443|Anesthetics, General|anesthetics, general|mesh-ancestor
5533883|NCT04226443|Anesthetics|anesthetics|mesh-ancestor
5533884|NCT04226443|GABA Modulators|gaba modulators|mesh-ancestor
5533885|NCT04226443|GABA Agents|gaba agents|mesh-ancestor
5533886|NCT04226443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5533887|NCT04226443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123557|NCT01147627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6123558|NCT01147627|Heparin Antagonists|heparin antagonists|mesh-ancestor
6123559|NCT01147627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123560|NCT01147627|Coagulants|coagulants|mesh-ancestor
6123561|NCT01147640|Metronidazole|metronidazole|mesh-list
6123562|NCT01147640|Meropenem|meropenem|mesh-list
6123563|NCT01147640|Tazobactam|tazobactam|mesh-list
6123564|NCT01147640|Ceftolozane|ceftolozane|mesh-list
6123565|NCT01147640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6123566|NCT01147640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6123567|NCT01147640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5533888|NCT04226443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5533889|NCT04226443|Narcotics|narcotics|mesh-ancestor
5533890|NCT04226443|Analgesics|analgesics|mesh-ancestor
5533891|NCT04226443|Sensory System Agents|sensory system agents|mesh-ancestor
5533892|NCT04226443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5533893|NCT04226105|Insulin|insulin|mesh-list
5533894|NCT04226105|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5533895|NCT04226105|Insulin Aspart|insulin aspart|mesh-list
5533896|NCT04226105|Insulin, Long-Acting|insulin, long-acting|mesh-list
6123568|NCT01147640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6123569|NCT01147640|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6123570|NCT01147640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6123571|NCT01147640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123572|NCT01147744|Fluticasone|fluticasone|mesh-list
6123573|NCT01147744|Xhance|xhance|mesh-list
6123574|NCT01147744|Montelukast|montelukast|mesh-list
6123575|NCT01147744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6123576|NCT01147744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6123577|NCT01147744|Autonomic Agents|autonomic agents|mesh-ancestor
6123578|NCT01147744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6123579|NCT01147744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123580|NCT01147744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5533897|NCT04226105|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
5533898|NCT04226105|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
5533899|NCT04226105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5533900|NCT04226105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533901|NCT04226365|Nortriptyline|nortriptyline|mesh-list
5533902|NCT04226365|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5533903|NCT04226365|Antidepressive Agents|antidepressive agents|mesh-ancestor
5533904|NCT04226365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5533905|NCT04226365|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6123581|NCT01147744|Respiratory System Agents|respiratory system agents|mesh-ancestor
6123582|NCT01147744|Dermatologic Agents|dermatologic agents|mesh-ancestor
6123583|NCT01147744|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6123584|NCT01147744|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6123585|NCT01147744|Hormone Antagonists|hormone antagonists|mesh-ancestor
6123586|NCT01147744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6123587|NCT01147744|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6123588|NCT01147744|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6123589|NCT01147744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123590|NCT01147848|Fluticasone|fluticasone|mesh-list
6123591|NCT01147848|Xhance|xhance|mesh-list
6123592|NCT01147848|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6123593|NCT01147848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6123594|NCT01147848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6123595|NCT01147848|Autonomic Agents|autonomic agents|mesh-ancestor
6123596|NCT01147848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6123597|NCT01147848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533906|NCT04226365|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5533907|NCT04226365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5533908|NCT04226365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5533909|NCT04226365|Adrenergic Agents|adrenergic agents|mesh-ancestor
5533910|NCT04226365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5533911|NCT04226365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533912|NCT04225780|Ganciclovir|ganciclovir|mesh-list
5533913|NCT04225780|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
5533914|NCT04225780|Antiviral Agents|antiviral agents|mesh-ancestor
5533915|NCT04225780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5533916|NCT04225780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5533917|NCT04225780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5533918|NCT04225780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123598|NCT01147848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6123599|NCT01147848|Respiratory System Agents|respiratory system agents|mesh-ancestor
6123600|NCT01147848|Dermatologic Agents|dermatologic agents|mesh-ancestor
6123601|NCT01147848|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6123602|NCT01147848|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6123603|NCT01147848|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6123604|NCT01147848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6123605|NCT01147848|Adrenergic Agents|adrenergic agents|mesh-ancestor
6123606|NCT01147848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6123607|NCT01147848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123608|NCT01147926|Prucalopride|prucalopride|mesh-list
6123609|NCT01147926|Laxatives|laxatives|mesh-ancestor
6123610|NCT01147926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6123611|NCT01147926|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
6123612|NCT01147926|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6123613|NCT01147926|Serotonin Agents|serotonin agents|mesh-ancestor
6123614|NCT01147926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6204771|NCT02076919|Acrizanib|acrizanib|mesh-list
6123615|NCT01147926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123616|NCT01147926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123617|NCT01148225|Adalimumab|adalimumab|mesh-list
6123618|NCT01148225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6123619|NCT01148225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6123620|NCT01148420|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6123621|NCT01148420|Medroxyprogesterone|medroxyprogesterone|mesh-list
6123622|NCT01148420|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6123623|NCT01148420|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6123624|NCT01148420|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6123625|NCT01148420|Contraceptive Agents|contraceptive agents|mesh-ancestor
6123626|NCT01148420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6123627|NCT01148420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123628|NCT01148420|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6123629|NCT01148420|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6123630|NCT01148420|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6123631|NCT01148420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6123632|NCT01148420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6123633|NCT01148459|Vaccines|vaccines|mesh-list
6123634|NCT01148459|Immunologic Factors|immunologic factors|mesh-ancestor
6123635|NCT01148459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123636|NCT01148511|Ranibizumab|ranibizumab|mesh-list
6123637|NCT01148511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6123638|NCT01148511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6123639|NCT01148511|Growth Substances|growth substances|mesh-ancestor
5533919|NCT04225611|Dexamethasone|dexamethasone|mesh-list
5533920|NCT04225611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5533921|NCT04225611|Antiemetics|antiemetics|mesh-ancestor
5533922|NCT04225611|Autonomic Agents|autonomic agents|mesh-ancestor
5533923|NCT04225611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6123640|NCT01148511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123641|NCT01148511|Growth Inhibitors|growth inhibitors|mesh-ancestor
6123642|NCT01148511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6123643|NCT01148524|Vaccines|vaccines|mesh-list
6123644|NCT01148524|Immunologic Factors|immunologic factors|mesh-ancestor
6123645|NCT01148524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123646|NCT01148537|Moxifloxacin|moxifloxacin|mesh-list
6123647|NCT01148537|Buprenorphine|buprenorphine|mesh-list
6123648|NCT01148537|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6123649|NCT01148537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6123650|NCT01148537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6123651|NCT01148537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6123652|NCT01148537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6123653|NCT01148537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6123654|NCT01148537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123655|NCT01148537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6123656|NCT01148537|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6123657|NCT01148537|Contraceptive Agents|contraceptive agents|mesh-ancestor
6123658|NCT01148537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5533924|NCT04225611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533925|NCT04225611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5533926|NCT04225611|Glucocorticoids|glucocorticoids|mesh-ancestor
5533927|NCT04225611|Hormones|hormones|mesh-ancestor
5533928|NCT04225611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5533929|NCT04225611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5533930|NCT04225611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5601684|NCT05175001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5601685|NCT05175001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5601686|NCT05175001|Respiratory System Agents|respiratory system agents|mesh-ancestor
5601687|NCT05174884|Etonogestrel|etonogestrel|mesh-list
6123659|NCT01148537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123660|NCT01148537|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6123661|NCT01148537|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6123662|NCT01148537|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6123663|NCT01148537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6123664|NCT01148537|Narcotics|narcotics|mesh-ancestor
5533931|NCT04225598|Buprenorphine|buprenorphine|mesh-list
5533932|NCT04225598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5533933|NCT04225598|Narcotics|narcotics|mesh-ancestor
5533934|NCT04225598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5533935|NCT04225598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533936|NCT04225598|Analgesics|analgesics|mesh-ancestor
5533937|NCT04225598|Sensory System Agents|sensory system agents|mesh-ancestor
5533938|NCT04225598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5533939|NCT04225598|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5533940|NCT04225819|Vitamin D|vitamin d|mesh-list
5533941|NCT04225819|Cholecalciferol|cholecalciferol|mesh-list
5533942|NCT04225819|Vitamins|vitamins|mesh-ancestor
5533943|NCT04225819|Micronutrients|micronutrients|mesh-ancestor
5533944|NCT04225819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533945|NCT04225819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5533946|NCT04225819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5533947|NCT04225767|Calcium|calcium|mesh-list
5533948|NCT04225767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5533949|NCT04225767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533950|NCT04225728|Iron|iron|mesh-list
5533951|NCT04225728|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
5533952|NCT04225728|Teferrol|teferrol|mesh-list
5533953|NCT04225728|Trace Elements|trace elements|mesh-ancestor
5533954|NCT04225728|Micronutrients|micronutrients|mesh-ancestor
5533955|NCT04225728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533956|NCT04225728|Hematinics|hematinics|mesh-ancestor
5533957|NCT04225390|Dacarbazine|dacarbazine|mesh-list
5533958|NCT04225390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5533959|NCT04225390|Alkylating Agents|alkylating agents|mesh-ancestor
5533960|NCT04225390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5533961|NCT04225390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5533962|NCT04225468|Analgesics, Opioid|analgesics, opioid|mesh-list
5533963|NCT04225468|Narcotics|narcotics|mesh-ancestor
5533964|NCT04225468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5533965|NCT04225468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5533966|NCT04225468|Analgesics|analgesics|mesh-ancestor
5533967|NCT04225468|Sensory System Agents|sensory system agents|mesh-ancestor
5533968|NCT04225468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5533969|NCT04225364|Paclitaxel|paclitaxel|mesh-list
5533970|NCT04225364|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5533971|NCT04225364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5533972|NCT04225364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5533973|NCT04225364|Tubulin Modulators|tubulin modulators|mesh-ancestor
5533974|NCT04225364|Antimitotic Agents|antimitotic agents|mesh-ancestor
5533975|NCT04225364|Mitosis Modulators|mitosis modulators|mesh-ancestor
5533976|NCT04225364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5533977|NCT04225325|Dolutegravir|dolutegravir|mesh-list
5533978|NCT04225325|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
5533979|NCT04225325|Emtricitabine|emtricitabine|mesh-list
5533980|NCT04225325|Darunavir|darunavir|mesh-list
5533981|NCT04225325|Cobicistat|cobicistat|mesh-list
5533982|NCT04225325|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5533983|NCT04225325|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5533984|NCT04225325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5533985|NCT04225325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5533986|NCT04225325|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5533987|NCT04225325|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5533988|NCT04225325|Antiviral Agents|antiviral agents|mesh-ancestor
5533989|NCT04225325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5533990|NCT04225325|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5533991|NCT04225325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5533992|NCT04225325|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5533993|NCT04225325|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5533994|NCT04225325|Protease Inhibitors|protease inhibitors|mesh-ancestor
6123665|NCT01148537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6123666|NCT01148537|Analgesics|analgesics|mesh-ancestor
6123667|NCT01148537|Sensory System Agents|sensory system agents|mesh-ancestor
6123668|NCT01148537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6123669|NCT01148537|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6123670|NCT01148693|Gentamicins|gentamicins|mesh-list
6123671|NCT01148693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6123672|NCT01148693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6123673|NCT01148693|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6123674|NCT01148693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6123675|NCT01148693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123676|NCT01148745|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
6123677|NCT01148745|Hematinics|hematinics|mesh-ancestor
6123678|NCT01148745|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6123679|NCT01148745|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6123680|NCT01148771|Ertapenem|ertapenem|mesh-list
6123681|NCT01148771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6123682|NCT01148771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6123683|NCT01148810|Siponimod|siponimod|mesh-list
5533995|NCT04225325|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5533996|NCT04225325|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5533997|NCT04225312|Natalizumab|natalizumab|mesh-list
5533998|NCT04225312|Immunologic Factors|immunologic factors|mesh-ancestor
5533999|NCT04225312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534000|NCT04224922|Paclitaxel|paclitaxel|mesh-list
5534001|NCT04224922|Cyclophosphamide|cyclophosphamide|mesh-list
5534002|NCT04224922|Epirubicin|epirubicin|mesh-list
5534003|NCT04224922|Carboplatin|carboplatin|mesh-list
5534004|NCT04224922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5534005|NCT04224922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5534006|NCT04224922|Tubulin Modulators|tubulin modulators|mesh-ancestor
5534007|NCT04224922|Antimitotic Agents|antimitotic agents|mesh-ancestor
5534008|NCT04224922|Mitosis Modulators|mitosis modulators|mesh-ancestor
5534009|NCT04224922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534010|NCT04224922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5534011|NCT04224922|Immunologic Factors|immunologic factors|mesh-ancestor
5534012|NCT04224922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534013|NCT04224922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5534014|NCT04224922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5534015|NCT04224922|Alkylating Agents|alkylating agents|mesh-ancestor
5534016|NCT04224922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5534017|NCT04224922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5534018|NCT04224922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5534019|NCT04224922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5534020|NCT04224922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5534021|NCT04225221|Leuprolide|leuprolide|mesh-list
5534022|NCT04225221|Estradiol|estradiol|mesh-list
5534023|NCT04225221|Progesterone|progesterone|mesh-list
5534024|NCT04225221|Estrogens|estrogens|mesh-ancestor
5534025|NCT04225221|Hormones|hormones|mesh-ancestor
5534026|NCT04225221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5534027|NCT04225221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534028|NCT04225221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5534029|NCT04225221|Progestins|progestins|mesh-ancestor
5534030|NCT04225221|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5534031|NCT04225221|Fertility Agents|fertility agents|mesh-ancestor
5534032|NCT04225221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5534033|NCT04225221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5534034|NCT04225195|Amphotericin B|amphotericin b|mesh-list
5534035|NCT04225195|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
5534036|NCT04225195|Cholesteryl sulfate|cholesteryl sulfate|mesh-list
5534037|NCT04225195|Amebicides|amebicides|mesh-ancestor
5534038|NCT04225195|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5534039|NCT04225195|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5534040|NCT04225195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5534041|NCT04225195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5534042|NCT04225195|Antifungal Agents|antifungal agents|mesh-ancestor
5534043|NCT04225195|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5534044|NCT04225195|Protease Inhibitors|protease inhibitors|mesh-ancestor
5534045|NCT04225195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5534046|NCT04225195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534047|NCT04225195|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5534048|NCT04225195|Protective Agents|protective agents|mesh-ancestor
5534049|NCT04225195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534050|NCT04225195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5534051|NCT04225052|Varenicline|varenicline|mesh-list
5534052|NCT04225052|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5534053|NCT04225052|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5534054|NCT04225052|Cholinergic Agents|cholinergic agents|mesh-ancestor
5534055|NCT04225052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5534056|NCT04225052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534057|NCT04225052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534058|NCT04225065|Chlorhexidine|chlorhexidine|mesh-list
5534059|NCT04225065|Povidone-Iodine|povidone-iodine|mesh-list
6204772|NCT02076919|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5534060|NCT04225065|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5534061|NCT04225065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5534062|NCT04225065|Disinfectants|disinfectants|mesh-ancestor
5534063|NCT04224831|Mitogens|mitogens|mesh-list
5534064|NCT04224831|Mitosis Modulators|mitosis modulators|mesh-ancestor
5534065|NCT04224831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534066|NCT04224818|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5534067|NCT04224818|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5534068|NCT04224818|Luteolytic Agents|luteolytic agents|mesh-ancestor
5534069|NCT04224818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5534070|NCT04224818|Contraceptive Agents|contraceptive agents|mesh-ancestor
5534071|NCT04224818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5534072|NCT04224818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534073|NCT04224818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5534074|NCT04224818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5534075|NCT04224818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5534076|NCT04224701|Vaccines|vaccines|mesh-list
5534077|NCT04224701|Immunologic Factors|immunologic factors|mesh-ancestor
6123684|NCT01148810|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6123685|NCT01148810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123686|NCT01148810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6123687|NCT01148810|Immunologic Factors|immunologic factors|mesh-ancestor
6123688|NCT01148810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123689|NCT01148836|Ubiquinone|ubiquinone|mesh-list
6123690|NCT01148836|Coenzyme Q10|coenzyme q10|mesh-list
6123691|NCT01148836|Micronutrients|micronutrients|mesh-ancestor
6123692|NCT01148836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123693|NCT01148836|Vitamins|vitamins|mesh-ancestor
6123694|NCT01148979|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6123695|NCT01148979|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6123696|NCT01148979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123697|NCT01148979|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6123698|NCT01148979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6123699|NCT01148979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6123700|NCT01148979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123701|NCT01148979|Dopamine Agents|dopamine agents|mesh-ancestor
6123702|NCT01148979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6123703|NCT01149096|Lenograstim|lenograstim|mesh-list
6123704|NCT01149096|Sargramostim|sargramostim|mesh-list
6123705|NCT01149096|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6123706|NCT01149096|Immunologic Factors|immunologic factors|mesh-ancestor
6123707|NCT01149096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123708|NCT01149369|Aprepitant|aprepitant|mesh-list
6123709|NCT01149369|Antiemetics|antiemetics|mesh-ancestor
6123710|NCT01149369|Autonomic Agents|autonomic agents|mesh-ancestor
5534078|NCT04224701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534079|NCT04224649|Lidocaine|lidocaine|mesh-list
5534080|NCT04224649|Hyaluronic Acid|hyaluronic acid|mesh-list
5534081|NCT04224649|Anesthetics, Local|anesthetics, local|mesh-ancestor
6123711|NCT01149369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6123712|NCT01149369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123713|NCT01149369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6123714|NCT01149369|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6123715|NCT01149369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6123716|NCT01149369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123717|NCT01149421|Dulaglutide|dulaglutide|mesh-list
6123718|NCT01149421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6123719|NCT01149421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123720|NCT01149434|Everolimus|everolimus|mesh-list
6123721|NCT01149434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6123722|NCT01149434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6123723|NCT01149434|Immunologic Factors|immunologic factors|mesh-ancestor
6123724|NCT01149434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123725|NCT01149460|Valacyclovir|valacyclovir|mesh-list
6123726|NCT01149460|Antiviral Agents|antiviral agents|mesh-ancestor
6123727|NCT01149460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6123728|NCT01149473|Losartan|losartan|mesh-list
6123729|NCT01149473|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6123730|NCT01149473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6123731|NCT01149473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6123732|NCT01149473|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6123733|NCT01149473|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6123734|NCT01149473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534082|NCT04224649|Anesthetics|anesthetics|mesh-ancestor
5601688|NCT05174884|Desogestrel|desogestrel|mesh-list
6123735|NCT01149473|Diuretics|diuretics|mesh-ancestor
6123736|NCT01149473|Natriuretic Agents|natriuretic agents|mesh-ancestor
5534083|NCT04224649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5534084|NCT04224649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534085|NCT04224649|Sensory System Agents|sensory system agents|mesh-ancestor
5534086|NCT04224649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5534087|NCT04224649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5534088|NCT04224649|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5534089|NCT04224649|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5534090|NCT04224649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5534091|NCT04224649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534092|NCT04224649|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5534093|NCT04224649|Immunologic Factors|immunologic factors|mesh-ancestor
5534094|NCT04224649|Viscosupplements|viscosupplements|mesh-ancestor
5534095|NCT04224649|Protective Agents|protective agents|mesh-ancestor
5534096|NCT04224636|Bevacizumab|bevacizumab|mesh-list
5534097|NCT04224636|Atezolizumab|atezolizumab|mesh-list
5534098|NCT04224636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5534099|NCT04224636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5534100|NCT04224636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5534101|NCT04224636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5534102|NCT04224636|Growth Substances|growth substances|mesh-ancestor
5534103|NCT04224636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534104|NCT04224636|Growth Inhibitors|growth inhibitors|mesh-ancestor
6123737|NCT01149473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123738|NCT01149473|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6123739|NCT01149473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6123740|NCT01149486|Losartan|losartan|mesh-list
6123741|NCT01149486|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6123742|NCT01149486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6123743|NCT01149486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6123744|NCT01149486|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6123745|NCT01149486|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6123746|NCT01149486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123747|NCT01149486|Diuretics|diuretics|mesh-ancestor
6123748|NCT01149486|Natriuretic Agents|natriuretic agents|mesh-ancestor
6123749|NCT01149486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123750|NCT01149486|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6123751|NCT01149486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6123752|NCT01149538|Choline|choline|mesh-list
6123753|NCT01149538|Lipotropic Agents|lipotropic agents|mesh-ancestor
6123754|NCT01149538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6123755|NCT01149538|Antimetabolites|antimetabolites|mesh-ancestor
6123756|NCT01149538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123757|NCT01149538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6123758|NCT01149538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6123759|NCT01149538|Nootropic Agents|nootropic agents|mesh-ancestor
6123760|NCT01149616|Dexamethasone|dexamethasone|mesh-list
6123761|NCT01149616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6123762|NCT01149616|Antiemetics|antiemetics|mesh-ancestor
6123763|NCT01149616|Autonomic Agents|autonomic agents|mesh-ancestor
6123764|NCT01149616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6123765|NCT01149616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123766|NCT01149616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6123767|NCT01149616|Glucocorticoids|glucocorticoids|mesh-ancestor
6123768|NCT01149616|Hormones|hormones|mesh-ancestor
6123769|NCT01149616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6123770|NCT01149616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6123771|NCT01149616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6123772|NCT01149655|Aripiprazole|aripiprazole|mesh-list
6123773|NCT01149655|Antidepressive Agents|antidepressive agents|mesh-ancestor
5534105|NCT04224571|Rituximab|rituximab|mesh-list
5534106|NCT04224571|Bortezomib|bortezomib|mesh-list
5534107|NCT04224571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5534108|NCT04224571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5534109|NCT04224571|Immunologic Factors|immunologic factors|mesh-ancestor
5606733|NCT03818737|Hormones|hormones|mesh-ancestor
6123774|NCT01149655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6123775|NCT01149655|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6123776|NCT01149655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6123777|NCT01149655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6123778|NCT01149655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123779|NCT01149655|Dopamine Agonists|dopamine agonists|mesh-ancestor
6123780|NCT01149655|Dopamine Agents|dopamine agents|mesh-ancestor
5534110|NCT04224571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534111|NCT04224571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5534112|NCT04224480|Pembrolizumab|pembrolizumab|mesh-list
5534113|NCT04224480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5534114|NCT04224480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5534115|NCT04224493|Rituximab|rituximab|mesh-list
5534116|NCT04224493|Lenalidomide|lenalidomide|mesh-list
5534117|NCT04224493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5534118|NCT04224493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5534119|NCT04224493|Immunologic Factors|immunologic factors|mesh-ancestor
6123781|NCT01149655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6123782|NCT01149655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123783|NCT01149655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6123784|NCT01149655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6123785|NCT01149655|Serotonin Agents|serotonin agents|mesh-ancestor
6123786|NCT01149655|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6123787|NCT01149655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6123788|NCT01149655|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5534120|NCT04224493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534121|NCT04224493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5534122|NCT04224493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5534123|NCT04224493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5534124|NCT04224493|Growth Substances|growth substances|mesh-ancestor
5534125|NCT04224493|Growth Inhibitors|growth inhibitors|mesh-ancestor
5534126|NCT04224558|Acetaminophen|acetaminophen|mesh-list
5534127|NCT04224558|Diphenhydramine|diphenhydramine|mesh-list
5534128|NCT04224558|Promethazine|promethazine|mesh-list
5534129|NCT04224558|Methylprednisolone|methylprednisolone|mesh-list
5534130|NCT04224558|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5534131|NCT04224558|Cyclophosphamide|cyclophosphamide|mesh-list
6123789|NCT01149655|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6123790|NCT01149733|Tamsulosin|tamsulosin|mesh-list
6123791|NCT01149733|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6123792|NCT01149733|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6123793|NCT01149733|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6123794|NCT01149733|Adrenergic Agents|adrenergic agents|mesh-ancestor
6123795|NCT01149733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6123796|NCT01149733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123797|NCT01149733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123798|NCT01149733|Urological Agents|urological agents|mesh-ancestor
6123799|NCT01149759|Cyclosporine|cyclosporine|mesh-list
6123800|NCT01149759|Cyclosporins|cyclosporins|mesh-list
6123801|NCT01149759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6123802|NCT01149759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123803|NCT01149759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6123804|NCT01149759|Immunologic Factors|immunologic factors|mesh-ancestor
6123805|NCT01149759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123806|NCT01149759|Antifungal Agents|antifungal agents|mesh-ancestor
6123807|NCT01149759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6123808|NCT01149759|Dermatologic Agents|dermatologic agents|mesh-ancestor
6123809|NCT01149759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6123810|NCT01149759|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6123811|NCT01149785|Ketoconazole|ketoconazole|mesh-list
6123812|NCT01149785|Crizotinib|crizotinib|mesh-list
6123813|NCT01149785|Antifungal Agents|antifungal agents|mesh-ancestor
6123814|NCT01149785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6123815|NCT01149785|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6123816|NCT01149785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6123817|NCT01149785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6123818|NCT01149785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123819|NCT01149785|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6123820|NCT01149785|Hormone Antagonists|hormone antagonists|mesh-ancestor
6123821|NCT01149785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6123822|NCT01149785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123823|NCT01149785|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6123824|NCT01149785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6123825|NCT01149785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6123826|NCT01149863|Plerixafor|plerixafor|mesh-list
5534132|NCT04224558|Fludarabine|fludarabine|mesh-list
5534133|NCT04224558|Thymoglobulin|thymoglobulin|mesh-list
5534134|NCT04224558|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5534135|NCT04224558|Immunoglobulins|immunoglobulins|mesh-list
5534136|NCT04224558|Antibodies|antibodies|mesh-list
5534137|NCT04224558|gamma-Globulins|gamma-globulins|mesh-list
5534138|NCT04224558|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5534139|NCT04224558|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5534140|NCT04224558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5534141|NCT04224558|Immunologic Factors|immunologic factors|mesh-ancestor
6123827|NCT01149863|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6123828|NCT01149863|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6123829|NCT01149863|Antiviral Agents|antiviral agents|mesh-ancestor
6123830|NCT01149863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6123831|NCT01149876|Tretinoin|tretinoin|mesh-list
6123832|NCT01149876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6123833|NCT01149876|Keratolytic Agents|keratolytic agents|mesh-ancestor
6123834|NCT01149876|Dermatologic Agents|dermatologic agents|mesh-ancestor
6123835|NCT01150045|Leucovorin|leucovorin|mesh-list
6123836|NCT01150045|Celecoxib|celecoxib|mesh-list
6123837|NCT01150045|Fluorouracil|fluorouracil|mesh-list
6123838|NCT01150045|Oxaliplatin|oxaliplatin|mesh-list
6123839|NCT01150045|Antimetabolites|antimetabolites|mesh-ancestor
6123840|NCT01150045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123841|NCT01150045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6123842|NCT01150045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6123843|NCT01150045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6123844|NCT01150045|Immunologic Factors|immunologic factors|mesh-ancestor
6123845|NCT01150045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123846|NCT01150045|Antidotes|antidotes|mesh-ancestor
6123847|NCT01150045|Protective Agents|protective agents|mesh-ancestor
6123848|NCT01150045|Vitamin B Complex|vitamin b complex|mesh-ancestor
6123849|NCT01150045|Vitamins|vitamins|mesh-ancestor
6123850|NCT01150045|Micronutrients|micronutrients|mesh-ancestor
6123851|NCT01150045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6123852|NCT01150045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6123853|NCT01150045|Analgesics|analgesics|mesh-ancestor
6123854|NCT01150045|Sensory System Agents|sensory system agents|mesh-ancestor
6123855|NCT01150045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6123856|NCT01150045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6123857|NCT01150045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6123858|NCT01150045|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6123859|NCT01150045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6123860|NCT01150045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6123861|NCT01150097|Everolimus|everolimus|mesh-list
6123862|NCT01150097|Tacrolimus|tacrolimus|mesh-list
6123863|NCT01150097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6123864|NCT01150097|Immunologic Factors|immunologic factors|mesh-ancestor
6123865|NCT01150097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123866|NCT01150097|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6123867|NCT01150097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6123868|NCT01150097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123869|NCT01150097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6123870|NCT01150123|Vaccines|vaccines|mesh-list
6123871|NCT01150123|Immunologic Factors|immunologic factors|mesh-ancestor
6123872|NCT01150123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123873|NCT01150461|Losartan|losartan|mesh-list
6123874|NCT01150461|Angiotensin II|angiotensin ii|mesh-list
6123875|NCT01150461|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
6123876|NCT01150461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6123877|NCT01150461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6123878|NCT01150461|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6123879|NCT01150461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123880|NCT01150461|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6123881|NCT01150500|Sirolimus|sirolimus|mesh-list
6123882|NCT01150500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6123883|NCT01150500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6123884|NCT01150500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6123885|NCT01150500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6123886|NCT01150500|Antifungal Agents|antifungal agents|mesh-ancestor
5534142|NCT04224558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534143|NCT04224558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5534144|NCT04224558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5534145|NCT04224558|Alkylating Agents|alkylating agents|mesh-ancestor
5534146|NCT04224558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534147|NCT04224558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5534148|NCT04224558|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5534149|NCT04224558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6123887|NCT01150500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6123888|NCT01150500|Immunologic Factors|immunologic factors|mesh-ancestor
6123889|NCT01150500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123890|NCT01150760|Alvimopan|alvimopan|mesh-list
6123891|NCT01150760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6123892|NCT01150838|Propofol|propofol|mesh-list
6123893|NCT01150838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6123894|NCT01150838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6123895|NCT01150838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123896|NCT01150838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6123897|NCT01150838|Anesthetics, General|anesthetics, general|mesh-ancestor
6123898|NCT01150838|Anesthetics|anesthetics|mesh-ancestor
6123899|NCT01150981|Rosiglitazone|rosiglitazone|mesh-list
6123900|NCT01150981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5534150|NCT04224558|Analgesics|analgesics|mesh-ancestor
5534151|NCT04224558|Sensory System Agents|sensory system agents|mesh-ancestor
5534152|NCT04224558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5534153|NCT04224558|Antipyretics|antipyretics|mesh-ancestor
5534154|NCT04224558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5534155|NCT04224558|Antiemetics|antiemetics|mesh-ancestor
5534156|NCT04224558|Autonomic Agents|autonomic agents|mesh-ancestor
5534157|NCT04224558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5534158|NCT04224558|Glucocorticoids|glucocorticoids|mesh-ancestor
5534159|NCT04224558|Hormones|hormones|mesh-ancestor
5534160|NCT04224558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5534161|NCT04224558|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5534162|NCT04224558|Protective Agents|protective agents|mesh-ancestor
6123901|NCT01150981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123902|NCT01151046|Exemestane|exemestane|mesh-list
6123903|NCT01151046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6123904|NCT01151046|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6123905|NCT01151046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6123906|NCT01151046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6123907|NCT01151046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123908|NCT01151046|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5534163|NCT04224558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5534164|NCT04224558|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5534165|NCT04224558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5534166|NCT04224558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5534167|NCT04224558|Anesthetics, Local|anesthetics, local|mesh-ancestor
5534168|NCT04224558|Anesthetics|anesthetics|mesh-ancestor
5534169|NCT04224558|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5534170|NCT04224558|Histamine Antagonists|histamine antagonists|mesh-ancestor
5534171|NCT04224558|Histamine Agents|histamine agents|mesh-ancestor
5534172|NCT04224558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5534173|NCT04224558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5534174|NCT04224558|Antipruritics|antipruritics|mesh-ancestor
5534175|NCT04224558|Dermatologic Agents|dermatologic agents|mesh-ancestor
5534176|NCT04224675|Atenolol|atenolol|mesh-list
5534177|NCT04224675|Captopril|captopril|mesh-list
5534178|NCT04224675|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5534179|NCT04224675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5534180|NCT04224675|Sympatholytics|sympatholytics|mesh-ancestor
5534181|NCT04224675|Autonomic Agents|autonomic agents|mesh-ancestor
5534182|NCT04224675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5534183|NCT04224675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534184|NCT04224675|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6123909|NCT01151046|Hormone Antagonists|hormone antagonists|mesh-ancestor
6123910|NCT01151046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6123911|NCT01151046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123912|NCT01151085|Voriconazole|voriconazole|mesh-list
6123913|NCT01151085|Antifungal Agents|antifungal agents|mesh-ancestor
5534185|NCT04224675|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5534186|NCT04224675|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5534187|NCT04224675|Adrenergic Agents|adrenergic agents|mesh-ancestor
6123914|NCT01151085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6123915|NCT01151085|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6123916|NCT01151085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6123917|NCT01151085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6123918|NCT01151085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123919|NCT01151085|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6123920|NCT01151085|Hormone Antagonists|hormone antagonists|mesh-ancestor
6123921|NCT01151085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6123922|NCT01151085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123923|NCT01151085|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6123924|NCT01151098|Buprenorphine|buprenorphine|mesh-list
6123925|NCT01151098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6123926|NCT01151098|Narcotics|narcotics|mesh-ancestor
6123927|NCT01151098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6123928|NCT01151098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123929|NCT01151098|Analgesics|analgesics|mesh-ancestor
6123930|NCT01151098|Sensory System Agents|sensory system agents|mesh-ancestor
6123931|NCT01151098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6123932|NCT01151098|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6123933|NCT01151137|Dronedarone|dronedarone|mesh-list
6123934|NCT01151137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6123935|NCT01151215|Anastrozole|anastrozole|mesh-list
6123936|NCT01151215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6123937|NCT01151215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6123938|NCT01151215|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6123939|NCT01151215|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6123940|NCT01151215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6123941|NCT01151215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123942|NCT01151215|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6123943|NCT01151215|Hormone Antagonists|hormone antagonists|mesh-ancestor
6123944|NCT01151215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6123945|NCT01151215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123946|NCT01151410|Enalapril|enalapril|mesh-list
6123947|NCT01151410|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6123948|NCT01151410|Protease Inhibitors|protease inhibitors|mesh-ancestor
6123949|NCT01151410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6123950|NCT01151410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123951|NCT01151410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6204773|NCT02076919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6204774|NCT02076919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6204775|NCT02076919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6204776|NCT02076919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204777|NCT02076997|Methotrexate|methotrexate|mesh-list
6204778|NCT02076997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6204779|NCT02076997|Abortifacient Agents|abortifacient agents|mesh-ancestor
6123952|NCT01151436|Hyaluronic Acid|hyaluronic acid|mesh-list
6123953|NCT01151436|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6123954|NCT01151436|Immunologic Factors|immunologic factors|mesh-ancestor
6123955|NCT01151436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123956|NCT01151436|Viscosupplements|viscosupplements|mesh-ancestor
6123957|NCT01151436|Protective Agents|protective agents|mesh-ancestor
6123958|NCT01151449|R04929097|r04929097|mesh-list
6123959|NCT01151449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6123960|NCT01151449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123961|NCT01151540|Rufinamide|rufinamide|mesh-list
6123962|NCT01151540|Anticonvulsants|anticonvulsants|mesh-ancestor
6123963|NCT01151540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6123964|NCT01151540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5534188|NCT04224675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5534189|NCT04224675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534190|NCT04224675|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5534191|NCT04224675|Protease Inhibitors|protease inhibitors|mesh-ancestor
5534192|NCT04224675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5534193|NCT04224337|Doxorubicin|doxorubicin|mesh-list
6123965|NCT01151540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6123966|NCT01151540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123967|NCT01151579|Albuterol|albuterol|mesh-list
6123968|NCT01151579|Ipratropium|ipratropium|mesh-list
6123969|NCT01151579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6123970|NCT01151579|Autonomic Agents|autonomic agents|mesh-ancestor
6123971|NCT01151579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6123972|NCT01151579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6123973|NCT01151579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6123974|NCT01151579|Respiratory System Agents|respiratory system agents|mesh-ancestor
6123975|NCT01151579|Tocolytic Agents|tocolytic agents|mesh-ancestor
6123976|NCT01151579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6123977|NCT01151579|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6123978|NCT01151579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6123979|NCT01151579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6123980|NCT01151579|Adrenergic Agents|adrenergic agents|mesh-ancestor
6123981|NCT01151579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6123982|NCT01151579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123983|NCT01151579|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6123984|NCT01151579|Cholinergic Agents|cholinergic agents|mesh-ancestor
6123985|NCT01151761|Gemcitabine|gemcitabine|mesh-list
6123986|NCT01151761|Cisplatin|cisplatin|mesh-list
6123987|NCT01151761|Carboplatin|carboplatin|mesh-list
6123988|NCT01151761|Fluorouracil|fluorouracil|mesh-list
6123989|NCT01151761|Capecitabine|capecitabine|mesh-list
6123990|NCT01151761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6123991|NCT01151761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6123992|NCT01151761|Antimetabolites|antimetabolites|mesh-ancestor
6123993|NCT01151761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6123994|NCT01151761|Antiviral Agents|antiviral agents|mesh-ancestor
6123995|NCT01151761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6123996|NCT01151761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6123997|NCT01151761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6123998|NCT01151761|Immunologic Factors|immunologic factors|mesh-ancestor
6123999|NCT01151761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124000|NCT01151813|Varenicline|varenicline|mesh-list
6124001|NCT01151813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6124002|NCT01151813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6124003|NCT01151813|Cholinergic Agents|cholinergic agents|mesh-ancestor
6124004|NCT01151813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6124005|NCT01151813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124006|NCT01151813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6465993|NCT00476710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6465994|NCT00476710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6465995|NCT00476853|Nevirapine|nevirapine|mesh-list
5534194|NCT04224337|Durvalumab|durvalumab|mesh-list
6124007|NCT01151852|Imatinib Mesylate|imatinib mesylate|mesh-list
6124008|NCT01151852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6124009|NCT01151852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6124010|NCT01151852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6124011|NCT01151852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124012|NCT01152021|Dexmedetomidine|dexmedetomidine|mesh-list
5534195|NCT04224337|Ifosfamide|ifosfamide|mesh-list
6124013|NCT01152021|Propofol|propofol|mesh-list
6124014|NCT01152021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6124015|NCT01152021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6124016|NCT01152021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124017|NCT01152021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6124018|NCT01152021|Anesthetics, General|anesthetics, general|mesh-ancestor
6124019|NCT01152021|Anesthetics|anesthetics|mesh-ancestor
5534196|NCT04224337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5534197|NCT04224337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5534198|NCT04224337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5534199|NCT04224337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5534200|NCT04224337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5534201|NCT04224337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534202|NCT04224337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5534203|NCT04224337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5534204|NCT04224337|Alkylating Agents|alkylating agents|mesh-ancestor
5534205|NCT04224441|Temozolomide|temozolomide|mesh-list
5534206|NCT04224441|Chlorpromazine|chlorpromazine|mesh-list
5534207|NCT04224441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5534208|NCT04224441|Alkylating Agents|alkylating agents|mesh-ancestor
6124020|NCT01152021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6124021|NCT01152021|Analgesics|analgesics|mesh-ancestor
6124022|NCT01152021|Sensory System Agents|sensory system agents|mesh-ancestor
6124023|NCT01152021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6124024|NCT01152021|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6124025|NCT01152021|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6124026|NCT01152021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6124027|NCT01152021|Adrenergic Agents|adrenergic agents|mesh-ancestor
5534209|NCT04224441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534210|NCT04224441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5534211|NCT04224441|Antiemetics|antiemetics|mesh-ancestor
5534212|NCT04224441|Autonomic Agents|autonomic agents|mesh-ancestor
5534213|NCT04224441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5534214|NCT04224441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534215|NCT04224441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5534216|NCT04224441|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5534217|NCT04224441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5534218|NCT04224441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5534219|NCT04224441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5534220|NCT04224441|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5534221|NCT04224441|Dopamine Agents|dopamine agents|mesh-ancestor
5534222|NCT04224441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5534223|NCT04224194|Adalimumab|adalimumab|mesh-list
5534224|NCT04224194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6124028|NCT01152021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6124029|NCT01152021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124030|NCT01152190|Tadalafil|tadalafil|mesh-list
6124031|NCT01152190|Vasodilator Agents|vasodilator agents|mesh-ancestor
5534225|NCT04224194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5534226|NCT04224415|Irinotecan|irinotecan|mesh-list
5534227|NCT04224415|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6124032|NCT01152190|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6124033|NCT01152190|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6124034|NCT01152190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6124035|NCT01152190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124036|NCT01152190|Urological Agents|urological agents|mesh-ancestor
6124037|NCT01152437|Cetuximab|cetuximab|mesh-list
5534228|NCT04224415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5534229|NCT04224415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5534230|NCT04224415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534231|NCT04224415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5534232|NCT04224428|Fexofenadine|fexofenadine|mesh-list
5534233|NCT04224428|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6124038|NCT01152437|Afatinib|afatinib|mesh-list
6124039|NCT01152437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6124040|NCT01152437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6124041|NCT01152437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6124042|NCT01152437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6124043|NCT01152437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124044|NCT01152450|Tiotropium Bromide|tiotropium bromide|mesh-list
6124045|NCT01152450|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6124046|NCT01152450|Autonomic Agents|autonomic agents|mesh-ancestor
6124047|NCT01152450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6124048|NCT01152450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124049|NCT01152450|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6124050|NCT01152450|Respiratory System Agents|respiratory system agents|mesh-ancestor
6124051|NCT01152450|Parasympatholytics|parasympatholytics|mesh-ancestor
5534234|NCT04224428|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5534235|NCT04224428|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5534236|NCT04224428|Histamine Antagonists|histamine antagonists|mesh-ancestor
5534237|NCT04224428|Histamine Agents|histamine agents|mesh-ancestor
5534238|NCT04224428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5534239|NCT04224428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534240|NCT04224428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534241|NCT04224051|Metformin|metformin|mesh-list
6124052|NCT01152450|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6124053|NCT01152450|Cholinergic Agents|cholinergic agents|mesh-ancestor
6124054|NCT01152450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6124055|NCT01152450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124056|NCT01152515|Remifentanil|remifentanil|mesh-list
6124057|NCT01152515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6124058|NCT01152515|Narcotics|narcotics|mesh-ancestor
5534242|NCT04224051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5534243|NCT04224051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534244|NCT04224103|Nitric Oxide|nitric oxide|mesh-list
6124059|NCT01152515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6124060|NCT01152515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124061|NCT01152515|Analgesics|analgesics|mesh-ancestor
5534245|NCT04224103|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5534246|NCT04224103|Autonomic Agents|autonomic agents|mesh-ancestor
5534247|NCT04224103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5534248|NCT04224103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534249|NCT04224103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5534250|NCT04224103|Respiratory System Agents|respiratory system agents|mesh-ancestor
5534251|NCT04224103|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5534252|NCT04224103|Antioxidants|antioxidants|mesh-ancestor
6124062|NCT01152515|Sensory System Agents|sensory system agents|mesh-ancestor
6124063|NCT01152515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6124064|NCT01152580|Melatonin|melatonin|mesh-list
6124065|NCT01152580|Antioxidants|antioxidants|mesh-ancestor
6124066|NCT01152580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124067|NCT01152580|Protective Agents|protective agents|mesh-ancestor
6124068|NCT01152580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124069|NCT01152580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6124070|NCT01152697|Haloperidol|haloperidol|mesh-list
6124071|NCT01152697|Haloperidol decanoate|haloperidol decanoate|mesh-list
6124072|NCT01152697|Antiemetics|antiemetics|mesh-ancestor
6124073|NCT01152697|Autonomic Agents|autonomic agents|mesh-ancestor
6124074|NCT01152697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6124075|NCT01152697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124076|NCT01152697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6124077|NCT01152697|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6124078|NCT01152697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6124079|NCT01152697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6124080|NCT01152697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6124081|NCT01152697|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6124082|NCT01152697|Dopamine Agents|dopamine agents|mesh-ancestor
6124083|NCT01152697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6124084|NCT01152697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124085|NCT01152697|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6124086|NCT01152788|Dacarbazine|dacarbazine|mesh-list
6124087|NCT01152788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6124088|NCT01152788|Alkylating Agents|alkylating agents|mesh-ancestor
6124089|NCT01152788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124090|NCT01152788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6124091|NCT01152996|Vortioxetine|vortioxetine|mesh-list
6124092|NCT01152996|Antidepressive Agents|antidepressive agents|mesh-ancestor
6124093|NCT01152996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6124094|NCT01152996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5534253|NCT04224103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534254|NCT04224103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5534255|NCT04224103|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5534256|NCT04224103|Vasodilator Agents|vasodilator agents|mesh-ancestor
5534257|NCT04224103|Gasotransmitters|gasotransmitters|mesh-ancestor
5534258|NCT04224103|Protective Agents|protective agents|mesh-ancestor
5534259|NCT04224272|Fulvestrant|fulvestrant|mesh-list
5534260|NCT04224272|Palbociclib|palbociclib|mesh-list
5534261|NCT04224272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5534262|NCT04224272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5534263|NCT04224272|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5534264|NCT04224272|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5534265|NCT04224272|Hormone Antagonists|hormone antagonists|mesh-ancestor
5534266|NCT04224272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5534267|NCT04224272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534268|NCT04224272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5534269|NCT04224272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5534270|NCT04224272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601689|NCT05174884|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6124095|NCT01152996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6124096|NCT01152996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6124097|NCT01152996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124098|NCT01152996|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6124099|NCT01152996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6124100|NCT01152996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6124101|NCT01152996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124102|NCT01152996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6124103|NCT01152996|Serotonin Agents|serotonin agents|mesh-ancestor
6124104|NCT01152996|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5601690|NCT05174884|Contraceptive Agents|contraceptive agents|mesh-ancestor
5601691|NCT05174884|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5601692|NCT05174884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601693|NCT05174884|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5601694|NCT05174884|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5601695|NCT05174884|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5601696|NCT05174884|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5601697|NCT05174884|Progestins|progestins|mesh-ancestor
5601698|NCT05174884|Hormones|hormones|mesh-ancestor
5601699|NCT05174884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5601700|NCT05174845|Ascorbic Acid|ascorbic acid|mesh-list
5601701|NCT05174845|Antioxidants|antioxidants|mesh-ancestor
5601702|NCT05174845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601703|NCT05174845|Protective Agents|protective agents|mesh-ancestor
5601704|NCT05174845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601705|NCT05174845|Vitamins|vitamins|mesh-ancestor
5601706|NCT05174845|Micronutrients|micronutrients|mesh-ancestor
5601707|NCT05174832|Paclitaxel|paclitaxel|mesh-list
5601708|NCT05174832|Pembrolizumab|pembrolizumab|mesh-list
5601709|NCT05174832|Olaparib|olaparib|mesh-list
5601710|NCT05174832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5601711|NCT05174832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5601712|NCT05174832|Tubulin Modulators|tubulin modulators|mesh-ancestor
5601713|NCT05174832|Antimitotic Agents|antimitotic agents|mesh-ancestor
5601714|NCT05174832|Mitosis Modulators|mitosis modulators|mesh-ancestor
5601715|NCT05174832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601716|NCT05174832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6124105|NCT01152996|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6124106|NCT01152996|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6124107|NCT01152996|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5601717|NCT05174832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5601718|NCT05174832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5601719|NCT05174650|Atezolizumab|atezolizumab|mesh-list
5601720|NCT05174650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5601721|NCT05174637|Immunoconjugates|immunoconjugates|mesh-list
5601722|NCT05174637|Immunologic Factors|immunologic factors|mesh-ancestor
5601723|NCT05174637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601724|NCT05174611|Vitamin D|vitamin d|mesh-list
5601725|NCT05174611|Cholecalciferol|cholecalciferol|mesh-list
5601726|NCT05174611|Vitamins|vitamins|mesh-ancestor
5601727|NCT05174611|Micronutrients|micronutrients|mesh-ancestor
5601728|NCT05174611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124108|NCT01153009|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5601729|NCT05174611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5601730|NCT05174611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6124109|NCT01153009|Vortioxetine|vortioxetine|mesh-list
6124110|NCT01153009|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6124111|NCT01153009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6124112|NCT01153009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6124113|NCT01153009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124114|NCT01153009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6124115|NCT01153009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124116|NCT01153009|Analgesics|analgesics|mesh-ancestor
6124117|NCT01153009|Sensory System Agents|sensory system agents|mesh-ancestor
6465996|NCT00476853|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6465997|NCT00476853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6124118|NCT01153009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6124119|NCT01153009|Antidepressive Agents|antidepressive agents|mesh-ancestor
6124120|NCT01153009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6124121|NCT01153009|Dopamine Agents|dopamine agents|mesh-ancestor
6124122|NCT01153009|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6124123|NCT01153009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6124124|NCT01153009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6124125|NCT01153009|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6124126|NCT01153009|Serotonin Agents|serotonin agents|mesh-ancestor
6124127|NCT01153009|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6124128|NCT01153009|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6124129|NCT01153009|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6124130|NCT01153009|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6124131|NCT01153269|Ritonavir|ritonavir|mesh-list
6124132|NCT01153269|Lopinavir|lopinavir|mesh-list
6124133|NCT01153269|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6124134|NCT01153269|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6124135|NCT01153269|Protease Inhibitors|protease inhibitors|mesh-ancestor
6124136|NCT01153269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6124137|NCT01153269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124138|NCT01153269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6124139|NCT01153269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6124140|NCT01153269|Antiviral Agents|antiviral agents|mesh-ancestor
6124141|NCT01153269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6124142|NCT01153269|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6124143|NCT01153269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6124144|NCT01153425|Zoledronic Acid|zoledronic acid|mesh-list
6124145|NCT01153425|Teriparatide|teriparatide|mesh-list
6124146|NCT01153425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6124147|NCT01153425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124148|NCT01153425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6124149|NCT01153581|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6124150|NCT01153581|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6124151|NCT01153581|Estradiol|estradiol|mesh-list
6124152|NCT01153581|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6124153|NCT01153581|Progesterone|progesterone|mesh-list
6124154|NCT01153581|Ganirelix|ganirelix|mesh-list
6124155|NCT01153581|Estrogens|estrogens|mesh-ancestor
6124156|NCT01153581|Hormones|hormones|mesh-ancestor
6124157|NCT01153581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6124158|NCT01153581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124159|NCT01153581|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6124160|NCT01153581|Contraceptive Agents|contraceptive agents|mesh-ancestor
6124161|NCT01153581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6124162|NCT01153581|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6124163|NCT01153581|Progestins|progestins|mesh-ancestor
6124164|NCT01153581|Hormone Antagonists|hormone antagonists|mesh-ancestor
6124165|NCT01153620|Polihexanide|polihexanide|mesh-list
6124166|NCT01153620|Disinfectants|disinfectants|mesh-ancestor
6124167|NCT01153620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6124168|NCT01153672|Letrozole|letrozole|mesh-list
6124169|NCT01153672|Vorinostat|vorinostat|mesh-list
6124170|NCT01153672|Anastrozole|anastrozole|mesh-list
6124171|NCT01153672|Exemestane|exemestane|mesh-list
6124172|NCT01153672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6124173|NCT01153672|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6124174|NCT01153672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6124175|NCT01153672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6124176|NCT01153672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124177|NCT01153672|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6124178|NCT01153672|Hormone Antagonists|hormone antagonists|mesh-ancestor
6124179|NCT01153672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6124180|NCT01153672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124181|NCT01153672|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6124182|NCT01153672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5534271|NCT04224116|Tranexamic Acid|tranexamic acid|mesh-list
5534272|NCT04224116|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5534273|NCT04224116|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5534274|NCT04224116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534275|NCT04224116|Hemostatics|hemostatics|mesh-ancestor
6124183|NCT01153698|Dabigatran|dabigatran|mesh-list
6124184|NCT01153698|Antithrombins|antithrombins|mesh-ancestor
6124185|NCT01153698|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6124186|NCT01153698|Protease Inhibitors|protease inhibitors|mesh-ancestor
6124187|NCT01153698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6124188|NCT01153698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124189|NCT01153698|Anticoagulants|anticoagulants|mesh-ancestor
5534276|NCT04224116|Coagulants|coagulants|mesh-ancestor
5534277|NCT04224350|Tacrolimus|tacrolimus|mesh-list
5534278|NCT04224350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5534279|NCT04224350|Immunologic Factors|immunologic factors|mesh-ancestor
5534280|NCT04224350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534281|NCT04224350|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5534282|NCT04224350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5534283|NCT04224350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534284|NCT04224246|Sodium Oxybate|sodium oxybate|mesh-list
5534285|NCT04224246|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5534286|NCT04224246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5534287|NCT04224246|Anesthetics, General|anesthetics, general|mesh-ancestor
5534288|NCT04224246|Anesthetics|anesthetics|mesh-ancestor
6124190|NCT01153711|Ketoconazole|ketoconazole|mesh-list
6124191|NCT01153711|Antifungal Agents|antifungal agents|mesh-ancestor
6124192|NCT01153711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6124193|NCT01153711|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6124194|NCT01153711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6124195|NCT01153711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6124196|NCT01153711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124197|NCT01153711|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6124198|NCT01153711|Hormone Antagonists|hormone antagonists|mesh-ancestor
6124199|NCT01153711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6124200|NCT01153711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124201|NCT01153711|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5534289|NCT04224246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5534290|NCT04224246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534291|NCT04223973|Insulin|insulin|mesh-list
5534292|NCT04223973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5534293|NCT04223973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534294|NCT04223778|Islatravir|islatravir|mesh-list
5534295|NCT04223778|Antiviral Agents|antiviral agents|mesh-ancestor
5534296|NCT04223778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5534297|NCT04223778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5534298|NCT04223778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534299|NCT04223778|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5534300|NCT04223778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5534301|NCT04223778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5534302|NCT04223791|Islatravir|islatravir|mesh-list
5534303|NCT04223791|Antiviral Agents|antiviral agents|mesh-ancestor
5534304|NCT04223791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5534305|NCT04223791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5534306|NCT04223791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534307|NCT04223791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5534308|NCT04223791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5534309|NCT04223791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5534310|NCT04223752|Tazobactam|tazobactam|mesh-list
5534311|NCT04223752|Ceftolozane|ceftolozane|mesh-list
5534312|NCT04223752|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
5534313|NCT04223752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5534314|NCT04223752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5534315|NCT04223752|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5534316|NCT04223752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6124202|NCT01153724|Fluconazole|fluconazole|mesh-list
5534317|NCT04223752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534318|NCT04223752|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5534319|NCT04223752|Renal Agents|renal agents|mesh-ancestor
5534320|NCT04223518|Immunoglobulins|immunoglobulins|mesh-list
5534321|NCT04223518|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5534322|NCT04223518|Antibodies|antibodies|mesh-list
5534323|NCT04223518|Immunologic Factors|immunologic factors|mesh-ancestor
5534324|NCT04223518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534325|NCT04223739|Amiodarone|amiodarone|mesh-list
5534326|NCT04223739|Landiolol|landiolol|mesh-list
5534327|NCT04223739|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5534328|NCT04223739|Vasodilator Agents|vasodilator agents|mesh-ancestor
5534329|NCT04223739|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5534330|NCT04223739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5534331|NCT04223739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534332|NCT04223739|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5534333|NCT04223739|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5534334|NCT04223739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5534335|NCT04223739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5534336|NCT04223739|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5534337|NCT04223739|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5534338|NCT04223739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6124203|NCT01153724|Antifungal Agents|antifungal agents|mesh-ancestor
6124204|NCT01153724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6124205|NCT01153724|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6124206|NCT01153724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6124207|NCT01153724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6124208|NCT01153724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124209|NCT01153724|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6124210|NCT01153724|Hormone Antagonists|hormone antagonists|mesh-ancestor
6124211|NCT01153724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6124212|NCT01153724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124213|NCT01153724|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6124214|NCT01153724|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6124215|NCT01153763|Dabrafenib|dabrafenib|mesh-list
6124216|NCT01153763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6124217|NCT01153763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6124218|NCT01153763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6124219|NCT01153763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124220|NCT01153815|Botulinum Toxins|botulinum toxins|mesh-list
6124221|NCT01153815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6124222|NCT01153815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6124223|NCT01153815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6124224|NCT01153815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6124225|NCT01153815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124226|NCT01153815|Cholinergic Agents|cholinergic agents|mesh-ancestor
6124227|NCT01153815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6124228|NCT01153815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124229|NCT01153815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6124230|NCT01153815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6124231|NCT01153893|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6124232|NCT01153893|Immunologic Factors|immunologic factors|mesh-ancestor
6124233|NCT01153893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124234|NCT01153958|Metronidazole|metronidazole|mesh-list
6124235|NCT01153958|Chlorquinaldol|chlorquinaldol|mesh-list
6124236|NCT01153958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6124237|NCT01153958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6124238|NCT01153958|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6124239|NCT01153958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6124240|NCT01153971|Rituximab|rituximab|mesh-list
6124241|NCT01153971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6124242|NCT01153971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6124243|NCT01153971|Immunologic Factors|immunologic factors|mesh-ancestor
6124244|NCT01153971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124245|NCT01153971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6124246|NCT01153984|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5534339|NCT04223739|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5534340|NCT04223739|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5534341|NCT04223739|Adrenergic Agents|adrenergic agents|mesh-ancestor
5534342|NCT04223739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5534343|NCT04223739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534344|NCT04223219|Magnesium Sulfate|magnesium sulfate|mesh-list
5534345|NCT04223219|Fentanyl|fentanyl|mesh-list
5534346|NCT04223219|Dexmedetomidine|dexmedetomidine|mesh-list
5534347|NCT04223219|Ketamine|ketamine|mesh-list
5534348|NCT04223219|Propofol|propofol|mesh-list
5534349|NCT04223219|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5534350|NCT04223219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5534351|NCT04223219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534352|NCT04223219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6124247|NCT01153984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6124248|NCT01153984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5534353|NCT04223219|Anesthetics, General|anesthetics, general|mesh-ancestor
5534354|NCT04223219|Anesthetics|anesthetics|mesh-ancestor
5534355|NCT04223219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5534356|NCT04223219|Analgesics|analgesics|mesh-ancestor
5534357|NCT04223219|Sensory System Agents|sensory system agents|mesh-ancestor
5534358|NCT04223219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5534359|NCT04223219|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5534360|NCT04223219|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5534361|NCT04223219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5534362|NCT04223219|Adrenergic Agents|adrenergic agents|mesh-ancestor
5534363|NCT04223219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5534364|NCT04223219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534365|NCT04223219|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5534366|NCT04223219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5534367|NCT04223219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5534368|NCT04223219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5534369|NCT04223219|Narcotics|narcotics|mesh-ancestor
6124249|NCT01153984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6124250|NCT01153984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124251|NCT01154127|Glycopyrrolate|glycopyrrolate|mesh-list
6124252|NCT01154127|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6124253|NCT01154127|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6124254|NCT01154127|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6124255|NCT01154127|Cholinergic Agents|cholinergic agents|mesh-ancestor
6124256|NCT01154127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6124257|NCT01154127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124258|NCT01154127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124259|NCT01154153|Loratadine|loratadine|mesh-list
6124260|NCT01154153|Triamcinolone|triamcinolone|mesh-list
6124261|NCT01154153|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6124262|NCT01154153|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6124263|NCT01154153|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6124264|NCT01154153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6124265|NCT01154153|Glucocorticoids|glucocorticoids|mesh-ancestor
6124266|NCT01154153|Hormones|hormones|mesh-ancestor
6124267|NCT01154153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6124268|NCT01154153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124269|NCT01154153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6124270|NCT01154153|Immunologic Factors|immunologic factors|mesh-ancestor
6124271|NCT01154153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6124272|NCT01154153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124273|NCT01154153|Antipruritics|antipruritics|mesh-ancestor
6124274|NCT01154153|Dermatologic Agents|dermatologic agents|mesh-ancestor
6124275|NCT01154153|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6124276|NCT01154153|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6124277|NCT01154153|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6124278|NCT01154153|Histamine Antagonists|histamine antagonists|mesh-ancestor
6124279|NCT01154153|Histamine Agents|histamine agents|mesh-ancestor
6124280|NCT01154153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6124281|NCT01154166|Ropinirole|ropinirole|mesh-list
6124282|NCT01154166|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6124283|NCT01154166|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5534370|NCT04223219|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5534371|NCT04223219|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5534372|NCT04223219|Anticonvulsants|anticonvulsants|mesh-ancestor
5534373|NCT04223219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5534374|NCT04223219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5534375|NCT04223219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6124284|NCT01154166|Dopamine Agonists|dopamine agonists|mesh-ancestor
6124285|NCT01154166|Dopamine Agents|dopamine agents|mesh-ancestor
6124286|NCT01154166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6124287|NCT01154166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124288|NCT01154166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534376|NCT04223219|Tocolytic Agents|tocolytic agents|mesh-ancestor
5534377|NCT04223219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6124289|NCT01154192|Dexamethasone|dexamethasone|mesh-list
6124290|NCT01154192|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6124291|NCT01154192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6124292|NCT01154192|Antiemetics|antiemetics|mesh-ancestor
6124293|NCT01154192|Autonomic Agents|autonomic agents|mesh-ancestor
6124294|NCT01154192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6124295|NCT01154192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124296|NCT01154192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6124297|NCT01154192|Glucocorticoids|glucocorticoids|mesh-ancestor
6124298|NCT01154192|Hormones|hormones|mesh-ancestor
6124299|NCT01154192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6124300|NCT01154192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6124301|NCT01154192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6124302|NCT01154192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6124303|NCT01154218|Crizotinib|crizotinib|mesh-list
5534378|NCT04223076|Chlorhexidine|chlorhexidine|mesh-list
5534379|NCT04223076|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5534380|NCT04223076|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5534381|NCT04223076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5534382|NCT04223076|Disinfectants|disinfectants|mesh-ancestor
5534383|NCT04223076|Dermatologic Agents|dermatologic agents|mesh-ancestor
5534384|NCT04223037|Vaccines|vaccines|mesh-list
5534385|NCT04223037|Immunologic Factors|immunologic factors|mesh-ancestor
5534386|NCT04223037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534387|NCT04222842|Vorolanib|vorolanib|mesh-list
5534388|NCT04222842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5534389|NCT04222842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5534390|NCT04222842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534391|NCT04222855|Diltiazem|diltiazem|mesh-list
5534392|NCT04222855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5534393|NCT04222855|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5534394|NCT04222855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5534395|NCT04222855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534396|NCT04222855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5534397|NCT04222855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534398|NCT04222855|Vasodilator Agents|vasodilator agents|mesh-ancestor
5534399|NCT04222920|Adalimumab|adalimumab|mesh-list
5534400|NCT04222920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5534401|NCT04222920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5534402|NCT04222517|Hemostatics|hemostatics|mesh-list
6124304|NCT01154218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6124305|NCT01154218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6124306|NCT01154218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6124307|NCT01154218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124308|NCT01154335|Everolimus|everolimus|mesh-list
6124309|NCT01154335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6124310|NCT01154335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6124311|NCT01154335|Immunologic Factors|immunologic factors|mesh-ancestor
6124312|NCT01154335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124313|NCT01154452|R04929097|r04929097|mesh-list
6124314|NCT01154452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6124315|NCT01154452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124316|NCT01154673|Ritonavir|ritonavir|mesh-list
6124317|NCT01154673|Lopinavir|lopinavir|mesh-list
6124318|NCT01154673|Tenofovir|tenofovir|mesh-list
6124319|NCT01154673|Emtricitabine|emtricitabine|mesh-list
6124320|NCT01154673|Raltegravir Potassium|raltegravir potassium|mesh-list
5534403|NCT04222517|Coagulants|coagulants|mesh-ancestor
5534404|NCT04222595|Vaccines|vaccines|mesh-list
5534405|NCT04222595|Immunologic Factors|immunologic factors|mesh-ancestor
5534406|NCT04222595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534407|NCT04222686|Losartan|losartan|mesh-list
5534408|NCT04222686|Perindopril|perindopril|mesh-list
5534409|NCT04222686|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6124321|NCT01154673|Maraviroc|maraviroc|mesh-list
6465998|NCT00476853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6465999|NCT00476853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466000|NCT00476853|Antiviral Agents|antiviral agents|mesh-ancestor
6466001|NCT00476853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6466002|NCT00476853|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5534410|NCT04222686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5534411|NCT04222686|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5534412|NCT04222686|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5534413|NCT04222686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534414|NCT04222686|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6124322|NCT01154673|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6124323|NCT01154673|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6466003|NCT00476853|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6466004|NCT00476853|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6466005|NCT00476853|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6488444|NCT00584168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6488445|NCT00584168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6488446|NCT00584168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5534415|NCT04222686|Protease Inhibitors|protease inhibitors|mesh-ancestor
6124324|NCT01154673|Protease Inhibitors|protease inhibitors|mesh-ancestor
6124325|NCT01154673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6124326|NCT01154673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124327|NCT01154673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6124328|NCT01154673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6124329|NCT01154673|Antiviral Agents|antiviral agents|mesh-ancestor
6124330|NCT01154673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6124331|NCT01154673|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6124332|NCT01154673|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6124333|NCT01154673|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6124334|NCT01154673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6124335|NCT01154673|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6124336|NCT01154673|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6124337|NCT01154673|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6124338|NCT01154673|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6124339|NCT01154673|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6124340|NCT01155063|Exemestane|exemestane|mesh-list
6124341|NCT01155063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6124342|NCT01155063|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6124343|NCT01155063|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6124344|NCT01155063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6124345|NCT01155063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124346|NCT01155063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6124347|NCT01155063|Hormone Antagonists|hormone antagonists|mesh-ancestor
6124348|NCT01155063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6124349|NCT01155063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124350|NCT01155154|Clindamycin|clindamycin|mesh-list
6124351|NCT01155154|Clindamycin palmitate|clindamycin palmitate|mesh-list
6124352|NCT01155154|Clindamycin phosphate|clindamycin phosphate|mesh-list
5534416|NCT04222686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5534417|NCT04222062|Carmustine|carmustine|mesh-list
5534418|NCT04222062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5534419|NCT04222062|Alkylating Agents|alkylating agents|mesh-ancestor
5534420|NCT04222062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534421|NCT04222062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5534422|NCT04222348|Metformin|metformin|mesh-list
5534423|NCT04222348|Insulin Detemir|insulin detemir|mesh-list
6124353|NCT01155154|Cephalexin|cephalexin|mesh-list
6124354|NCT01155154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6124355|NCT01155154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6124356|NCT01155154|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6124357|NCT01155154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5534424|NCT04222348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5534425|NCT04222348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534426|NCT04222257|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5534427|NCT04222257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5534428|NCT04222257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5534429|NCT04222257|Antitubercular Agents|antitubercular agents|mesh-ancestor
5534430|NCT04222114|Catumaxomab|catumaxomab|mesh-list
5534431|NCT04222114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5601731|NCT05174598|Calcitriol|calcitriol|mesh-list
5601732|NCT05174598|Calcipotriene|calcipotriene|mesh-list
5601733|NCT05174598|Dermatologic Agents|dermatologic agents|mesh-ancestor
5601734|NCT05174598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5601735|NCT05174598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601736|NCT05174598|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
5601737|NCT05174598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5601738|NCT05174598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601739|NCT05174598|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5601740|NCT05174598|Vitamins|vitamins|mesh-ancestor
5601741|NCT05174598|Micronutrients|micronutrients|mesh-ancestor
5601742|NCT05174598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5601743|NCT05174585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5601744|NCT05174585|Pembrolizumab|pembrolizumab|mesh-list
5601745|NCT05174585|Antibodies|antibodies|mesh-list
5601746|NCT05174585|Immunoglobulins|immunoglobulins|mesh-list
5601747|NCT05174585|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6124358|NCT01155154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124359|NCT01155167|Lidocaine|lidocaine|mesh-list
6124360|NCT01155167|Nitroglycerin|nitroglycerin|mesh-list
6124361|NCT01155167|Anesthetics, Local|anesthetics, local|mesh-ancestor
6124362|NCT01155167|Anesthetics|anesthetics|mesh-ancestor
6124363|NCT01155167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6124364|NCT01155167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124365|NCT01155167|Sensory System Agents|sensory system agents|mesh-ancestor
6124366|NCT01155167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6124367|NCT01155167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6124368|NCT01155167|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6124369|NCT01155167|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6124370|NCT01155167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6124371|NCT01155167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124372|NCT01155167|Vasodilator Agents|vasodilator agents|mesh-ancestor
6124373|NCT01155219|Latanoprost|latanoprost|mesh-list
6124374|NCT01155219|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6124375|NCT01155219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6124376|NCT01155284|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6124377|NCT01155284|Lansoprazole|lansoprazole|mesh-list
6124378|NCT01155284|Dexlansoprazole|dexlansoprazole|mesh-list
6124379|NCT01155284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6124380|NCT01155284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124381|NCT01155284|Incretins|incretins|mesh-ancestor
6124382|NCT01155284|Hormones|hormones|mesh-ancestor
6124383|NCT01155284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6124384|NCT01155284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6124385|NCT01155284|Protease Inhibitors|protease inhibitors|mesh-ancestor
6466006|NCT00476918|Triamcinolone|triamcinolone|mesh-list
6466007|NCT00476918|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6466008|NCT00476918|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6466009|NCT00476918|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6466010|NCT00476918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6466011|NCT00476918|Glucocorticoids|glucocorticoids|mesh-ancestor
6466012|NCT00476918|Hormones|hormones|mesh-ancestor
6466013|NCT00476918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5534432|NCT04222088|Chloroquine|chloroquine|mesh-list
5534433|NCT04222088|Lumefantrine|lumefantrine|mesh-list
5534434|NCT04222088|Amebicides|amebicides|mesh-ancestor
5534435|NCT04222088|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5534436|NCT04222088|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5534437|NCT04222088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5534438|NCT04222088|Antimalarials|antimalarials|mesh-ancestor
5534439|NCT04222088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5534440|NCT04222023|Immunoglobulins|immunoglobulins|mesh-list
5534441|NCT04222023|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5534442|NCT04222023|Antibodies|antibodies|mesh-list
5534443|NCT04222023|gamma-Globulins|gamma-globulins|mesh-list
5534444|NCT04222023|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5534445|NCT04222023|Immunologic Factors|immunologic factors|mesh-ancestor
5534446|NCT04222023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534447|NCT04221906|Betamethasone|betamethasone|mesh-list
5534448|NCT04221906|Calcipotriene|calcipotriene|mesh-list
5534449|NCT04221906|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
5534450|NCT04221906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5534451|NCT04221906|Glucocorticoids|glucocorticoids|mesh-ancestor
5534452|NCT04221906|Hormones|hormones|mesh-ancestor
5534453|NCT04221906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5534454|NCT04221906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534455|NCT04221906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5534456|NCT04221906|Respiratory System Agents|respiratory system agents|mesh-ancestor
6466014|NCT00476918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466015|NCT00476918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6124386|NCT01155284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6124387|NCT01155284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124388|NCT01155284|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6124389|NCT01155284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6124390|NCT01155284|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6124391|NCT01155466|Rasagiline|rasagiline|mesh-list
6124392|NCT01155466|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6124393|NCT01155466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6124394|NCT01155466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124395|NCT01155466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6466016|NCT00476918|Immunologic Factors|immunologic factors|mesh-ancestor
5534457|NCT04221906|Dermatologic Agents|dermatologic agents|mesh-ancestor
5534458|NCT04222283|Emtricitabine|emtricitabine|mesh-list
5534459|NCT04222283|Antiviral Agents|antiviral agents|mesh-ancestor
5534460|NCT04222283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6124396|NCT01155466|Protective Agents|protective agents|mesh-ancestor
6124397|NCT01155466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124398|NCT01155479|Rasagiline|rasagiline|mesh-list
6124399|NCT01155479|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6124400|NCT01155479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5534461|NCT04222283|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5534462|NCT04222283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5534463|NCT04222283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5534464|NCT04222283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534465|NCT04222283|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5534466|NCT04222283|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5534467|NCT04221919|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
5534468|NCT04221919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5534469|NCT04221919|Adrenergic Agents|adrenergic agents|mesh-ancestor
5534470|NCT04221919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5534471|NCT04221919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534472|NCT04221919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534473|NCT04221971|Cyclophosphamide|cyclophosphamide|mesh-list
5534474|NCT04221971|Fludarabine|fludarabine|mesh-list
6124401|NCT01155479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124402|NCT01155479|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6124403|NCT01155479|Protective Agents|protective agents|mesh-ancestor
6124404|NCT01155479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124405|NCT01155531|Sertraline|sertraline|mesh-list
6124406|NCT01155531|Telenzepine|telenzepine|mesh-list
6124407|NCT01155531|Antidepressive Agents|antidepressive agents|mesh-ancestor
6124408|NCT01155531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6124409|NCT01155531|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6124410|NCT01155531|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6124411|NCT01155531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6124412|NCT01155531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124413|NCT01155531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6124414|NCT01155531|Serotonin Agents|serotonin agents|mesh-ancestor
6124415|NCT01155531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124416|NCT01155531|Parasympatholytics|parasympatholytics|mesh-ancestor
5534475|NCT04221971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5534476|NCT04221971|Immunologic Factors|immunologic factors|mesh-ancestor
5534477|NCT04221971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534478|NCT04221971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5534479|NCT04221971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5534480|NCT04221971|Alkylating Agents|alkylating agents|mesh-ancestor
5534481|NCT04221971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534482|NCT04221971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5534483|NCT04221971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5534484|NCT04221828|Paclitaxel|paclitaxel|mesh-list
5534485|NCT04221828|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5534486|NCT04221828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5534487|NCT04221828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5534488|NCT04221828|Tubulin Modulators|tubulin modulators|mesh-ancestor
5534489|NCT04221828|Antimitotic Agents|antimitotic agents|mesh-ancestor
5534490|NCT04221828|Mitosis Modulators|mitosis modulators|mesh-ancestor
5534491|NCT04221828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534492|NCT04222010|Anesthetics|anesthetics|mesh-list
5534493|NCT04222010|Ropivacaine|ropivacaine|mesh-list
5534494|NCT04222010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5534495|NCT04222010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534496|NCT04222010|Anesthetics, Local|anesthetics, local|mesh-ancestor
5534497|NCT04222010|Sensory System Agents|sensory system agents|mesh-ancestor
5534498|NCT04222010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5534499|NCT04221880|Lidocaine|lidocaine|mesh-list
5534500|NCT04221880|Bupivacaine|bupivacaine|mesh-list
5534501|NCT04221880|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5534502|NCT04221880|Anesthetics, Local|anesthetics, local|mesh-ancestor
5534503|NCT04221880|Anesthetics|anesthetics|mesh-ancestor
5534504|NCT04221880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5534505|NCT04221880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534506|NCT04221880|Sensory System Agents|sensory system agents|mesh-ancestor
5534507|NCT04221880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5534508|NCT04221880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5534509|NCT04221880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5534510|NCT04221880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6124417|NCT01155531|Autonomic Agents|autonomic agents|mesh-ancestor
6124418|NCT01155531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6124419|NCT01155583|Dexamethasone|dexamethasone|mesh-list
6124420|NCT01155583|Lenalidomide|lenalidomide|mesh-list
6124421|NCT01155583|Azacitidine|azacitidine|mesh-list
6124422|NCT01155583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6124423|NCT01155583|Antiemetics|antiemetics|mesh-ancestor
6124424|NCT01155583|Autonomic Agents|autonomic agents|mesh-ancestor
6124425|NCT01155583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6124426|NCT01155583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124427|NCT01155583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6124428|NCT01155583|Glucocorticoids|glucocorticoids|mesh-ancestor
6124429|NCT01155583|Hormones|hormones|mesh-ancestor
6124430|NCT01155583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6124431|NCT01155583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6124432|NCT01155583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6124433|NCT01155583|Immunologic Factors|immunologic factors|mesh-ancestor
6124434|NCT01155583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6124435|NCT01155583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6124436|NCT01155583|Growth Substances|growth substances|mesh-ancestor
6124437|NCT01155583|Growth Inhibitors|growth inhibitors|mesh-ancestor
6124438|NCT01155583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6124439|NCT01155583|Antimetabolites|antimetabolites|mesh-ancestor
6124440|NCT01155583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124441|NCT01155583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6124442|NCT01155661|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
6124443|NCT01155661|Serotonin|serotonin|mesh-list
6124444|NCT01155661|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
6124445|NCT01155661|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6124446|NCT01155661|Serotonin Agents|serotonin agents|mesh-ancestor
6124447|NCT01155661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6124448|NCT01155661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124449|NCT01155661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124450|NCT01155661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6124451|NCT01155661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5534511|NCT04221880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5534512|NCT04221880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534513|NCT04221555|Docetaxel|docetaxel|mesh-list
5534514|NCT04221555|Oxaliplatin|oxaliplatin|mesh-list
5534515|NCT04221555|Durvalumab|durvalumab|mesh-list
5534516|NCT04221555|Tremelimumab|tremelimumab|mesh-list
5534517|NCT04221555|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5534518|NCT04221555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5534519|NCT04221555|Tubulin Modulators|tubulin modulators|mesh-ancestor
5534520|NCT04221555|Antimitotic Agents|antimitotic agents|mesh-ancestor
5534521|NCT04221555|Mitosis Modulators|mitosis modulators|mesh-ancestor
5534522|NCT04221555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534523|NCT04221555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5534524|NCT04221555|Immunologic Factors|immunologic factors|mesh-ancestor
5534525|NCT04221555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534526|NCT04221672|Terlipressin|terlipressin|mesh-list
5534527|NCT04221672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5534528|NCT04221672|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5534529|NCT04221503|Niraparib|niraparib|mesh-list
5534530|NCT04221503|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5534531|NCT04221503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6124452|NCT01155661|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6124453|NCT01155661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6124454|NCT01155661|Disinfectants|disinfectants|mesh-ancestor
6124455|NCT01155869|Naltrexone|naltrexone|mesh-list
6124456|NCT01155869|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6124457|NCT01155869|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6124458|NCT01155869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124459|NCT01155869|Sensory System Agents|sensory system agents|mesh-ancestor
6124460|NCT01155869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6124461|NCT01155999|Tobramycin|tobramycin|mesh-list
6124462|NCT01155999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6124463|NCT01155999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6124464|NCT01156051|Guanfacine|guanfacine|mesh-list
6124465|NCT01156051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6666125|NCT01520818|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6666126|NCT01520818|Biphasic Insulins|biphasic insulins|mesh-list
6666127|NCT01520818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5534532|NCT04221503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124466|NCT01156051|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6124467|NCT01156051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6124468|NCT01156051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6124469|NCT01156051|Adrenergic Agents|adrenergic agents|mesh-ancestor
5534533|NCT04221503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5534534|NCT04221477|Acetaminophen|acetaminophen|mesh-list
5534535|NCT04221477|Diphenhydramine|diphenhydramine|mesh-list
5534536|NCT04221477|Promethazine|promethazine|mesh-list
5534537|NCT04221477|Prednisone|prednisone|mesh-list
5534538|NCT04221477|Methylprednisolone|methylprednisolone|mesh-list
5534539|NCT04221477|Obinutuzumab|obinutuzumab|mesh-list
5534540|NCT04221477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5534541|NCT04221477|Glucocorticoids|glucocorticoids|mesh-ancestor
6124470|NCT01156051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6124471|NCT01156051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124472|NCT01156051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124473|NCT01156142|Doxepin|doxepin|mesh-list
6124474|NCT01156142|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6124475|NCT01156142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6124476|NCT01156142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6124477|NCT01156142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124478|NCT01156142|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6124479|NCT01156142|Antidepressive Agents|antidepressive agents|mesh-ancestor
6124480|NCT01156142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6124481|NCT01156142|Histamine Antagonists|histamine antagonists|mesh-ancestor
6124482|NCT01156142|Histamine Agents|histamine agents|mesh-ancestor
6124483|NCT01156142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6124484|NCT01156142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124485|NCT01156311|Dimethyl Fumarate|dimethyl fumarate|mesh-list
6124486|NCT01156311|Dermatologic Agents|dermatologic agents|mesh-ancestor
6124487|NCT01156311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6124488|NCT01156311|Immunologic Factors|immunologic factors|mesh-ancestor
6124489|NCT01156311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124490|NCT01156363|Epoetin Alfa|epoetin alfa|mesh-list
6124491|NCT01156363|Hematinics|hematinics|mesh-ancestor
6124492|NCT01156376|Listerine|listerine|mesh-list
6124493|NCT01156376|Fluorides|fluorides|mesh-list
6124494|NCT01156376|Cariostatic Agents|cariostatic agents|mesh-ancestor
6124495|NCT01156376|Protective Agents|protective agents|mesh-ancestor
6124496|NCT01156376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124497|NCT01156376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6124498|NCT01156376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6124499|NCT01156480|Hydrocortisone|hydrocortisone|mesh-list
6124500|NCT01156480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6204780|NCT02076997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6204781|NCT02076997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204782|NCT02076997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6204783|NCT02076997|Antimetabolites|antimetabolites|mesh-ancestor
6204784|NCT02076997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204785|NCT02076997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6204786|NCT02076997|Dermatologic Agents|dermatologic agents|mesh-ancestor
6204787|NCT02076997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6204788|NCT02076997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6204789|NCT02076997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6204790|NCT02076997|Immunologic Factors|immunologic factors|mesh-ancestor
5534542|NCT04221477|Hormones|hormones|mesh-ancestor
5534543|NCT04221477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5534544|NCT04221477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534545|NCT04221477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5534546|NCT04221477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5534547|NCT04221477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5534548|NCT04221477|Analgesics|analgesics|mesh-ancestor
5534549|NCT04221477|Sensory System Agents|sensory system agents|mesh-ancestor
5534550|NCT04221477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5534551|NCT04221477|Antipyretics|antipyretics|mesh-ancestor
5534552|NCT04221477|Antiemetics|antiemetics|mesh-ancestor
5534553|NCT04221477|Autonomic Agents|autonomic agents|mesh-ancestor
5534554|NCT04221477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6204791|NCT02076997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6204792|NCT02076997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6204793|NCT02077465|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6204794|NCT02077465|Immunologic Factors|immunologic factors|mesh-ancestor
6204795|NCT02077465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204796|NCT02078102|Meloxicam|meloxicam|mesh-list
5534555|NCT04221477|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6204797|NCT02078102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204798|NCT02078102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5534556|NCT04221477|Protective Agents|protective agents|mesh-ancestor
5534557|NCT04221477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5534558|NCT04221477|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5534559|NCT04221477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5534560|NCT04221477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5534561|NCT04221477|Anesthetics, Local|anesthetics, local|mesh-ancestor
5534562|NCT04221477|Anesthetics|anesthetics|mesh-ancestor
5534563|NCT04221477|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5534564|NCT04221477|Histamine Antagonists|histamine antagonists|mesh-ancestor
5534565|NCT04221477|Histamine Agents|histamine agents|mesh-ancestor
5534566|NCT04221477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5534567|NCT04221477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124501|NCT01156571|Clopidogrel|clopidogrel|mesh-list
6124502|NCT01156571|Cangrelor|cangrelor|mesh-list
6124503|NCT01156571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6124504|NCT01156571|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6124505|NCT01156571|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6124506|NCT01156571|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6124507|NCT01156571|Purinergic Agents|purinergic agents|mesh-ancestor
6124508|NCT01156571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6124509|NCT01156571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124510|NCT01156571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124511|NCT01156597|Pioglitazone|pioglitazone|mesh-list
6124512|NCT01156597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6124513|NCT01156597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124514|NCT01156701|Zanamivir|zanamivir|mesh-list
6124515|NCT01156701|Antiviral Agents|antiviral agents|mesh-ancestor
6124516|NCT01156701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6124517|NCT01156701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6124518|NCT01156701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124519|NCT01156792|Montelukast|montelukast|mesh-list
6124520|NCT01156792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6124521|NCT01156792|Respiratory System Agents|respiratory system agents|mesh-ancestor
6124522|NCT01156792|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6124523|NCT01156792|Hormone Antagonists|hormone antagonists|mesh-ancestor
6124524|NCT01156792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6124525|NCT01156792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124526|NCT01156792|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6124527|NCT01156792|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6124528|NCT01156792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124529|NCT01157065|Ranibizumab|ranibizumab|mesh-list
6124530|NCT01157065|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5534568|NCT04221477|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5534569|NCT04221477|Antipruritics|antipruritics|mesh-ancestor
6124531|NCT01157065|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6124532|NCT01157065|Growth Substances|growth substances|mesh-ancestor
6124533|NCT01157065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124534|NCT01157065|Growth Inhibitors|growth inhibitors|mesh-ancestor
5534570|NCT04221477|Dermatologic Agents|dermatologic agents|mesh-ancestor
5534571|NCT04221438|Alovudine|alovudine|mesh-list
5534572|NCT04221438|Antiviral Agents|antiviral agents|mesh-ancestor
5534573|NCT04221438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5534574|NCT04221750|Metformin|metformin|mesh-list
5534575|NCT04221750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5534576|NCT04221750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124535|NCT01157065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6124536|NCT01157117|Omalizumab|omalizumab|mesh-list
6124537|NCT01157117|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6124538|NCT01157117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6124539|NCT01157117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6466017|NCT00476918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6466018|NCT00476918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466019|NCT00476983|Ritonavir|ritonavir|mesh-list
6466020|NCT00476983|Saquinavir|saquinavir|mesh-list
6466021|NCT00476983|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6466022|NCT00476983|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6466023|NCT00476983|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6466024|NCT00476983|Protease Inhibitors|protease inhibitors|mesh-ancestor
6466025|NCT00476983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6466026|NCT00476983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466027|NCT00476983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6466028|NCT00476983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6466029|NCT00476983|Antiviral Agents|antiviral agents|mesh-ancestor
6466030|NCT00476983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6124540|NCT01157117|Respiratory System Agents|respiratory system agents|mesh-ancestor
5534577|NCT04221282|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
5534578|NCT04221282|Anticonvulsants|anticonvulsants|mesh-ancestor
5534579|NCT04221282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5534580|NCT04221282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5534581|NCT04221282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5534582|NCT04221282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534583|NCT04221256|Citalopram|citalopram|mesh-list
5534584|NCT04221256|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5534585|NCT04221256|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5534586|NCT04221256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5534587|NCT04221256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534588|NCT04221256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5534589|NCT04221256|Serotonin Agents|serotonin agents|mesh-ancestor
5534590|NCT04221256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124541|NCT01157117|Immunologic Factors|immunologic factors|mesh-ancestor
6124542|NCT01157117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124543|NCT01157169|Buprenorphine|buprenorphine|mesh-list
6124544|NCT01157169|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6124545|NCT01157169|Narcotics|narcotics|mesh-ancestor
6666128|NCT01520818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666129|NCT01520831|Insulin|insulin|mesh-list
5534591|NCT04221256|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6124546|NCT01157169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6124547|NCT01157169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124548|NCT01157169|Analgesics|analgesics|mesh-ancestor
6124549|NCT01157169|Sensory System Agents|sensory system agents|mesh-ancestor
6124550|NCT01157169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6124551|NCT01157169|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6124552|NCT01157182|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6124553|NCT01157182|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6124554|NCT01157182|Norethindrone|norethindrone|mesh-list
6124555|NCT01157182|Norethindrone Acetate|norethindrone acetate|mesh-list
5534592|NCT04221256|Antidepressive Agents|antidepressive agents|mesh-ancestor
5534593|NCT04221256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5534594|NCT04221191|Dimethyl Fumarate|dimethyl fumarate|mesh-list
5534595|NCT04221191|Dermatologic Agents|dermatologic agents|mesh-ancestor
5534596|NCT04221191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5534597|NCT04221191|Immunologic Factors|immunologic factors|mesh-ancestor
5534598|NCT04221191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534599|NCT04221165|Analgesics, Opioid|analgesics, opioid|mesh-list
5534600|NCT04221165|Narcotics|narcotics|mesh-ancestor
5534601|NCT04221165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5534602|NCT04221165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534603|NCT04221165|Analgesics|analgesics|mesh-ancestor
5534604|NCT04221165|Sensory System Agents|sensory system agents|mesh-ancestor
5534605|NCT04221165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5534606|NCT04221321|Atorvastatin|atorvastatin|mesh-list
5534607|NCT04221321|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5534608|NCT04221321|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5534609|NCT04221321|Antimetabolites|antimetabolites|mesh-ancestor
5534610|NCT04221321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534611|NCT04221321|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5534612|NCT04221321|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5534613|NCT04221321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5534614|NCT04221126|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5534615|NCT04221126|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5534616|NCT04221126|Dermatologic Agents|dermatologic agents|mesh-ancestor
5534617|NCT04221529|Atezolizumab|atezolizumab|mesh-list
5534618|NCT04221529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5534619|NCT04221152|Empagliflozin|empagliflozin|mesh-list
5534620|NCT04221152|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5601748|NCT05174585|Immunologic Factors|immunologic factors|mesh-ancestor
6124556|NCT01157182|Estradiol|estradiol|mesh-list
6124557|NCT01157182|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6124558|NCT01157182|Estrogens|estrogens|mesh-ancestor
6124559|NCT01157182|Hormones|hormones|mesh-ancestor
6124560|NCT01157182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6124561|NCT01157182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124562|NCT01157182|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6124563|NCT01157182|Contraceptive Agents|contraceptive agents|mesh-ancestor
6124564|NCT01157182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6124565|NCT01157182|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6124566|NCT01157182|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6124567|NCT01157182|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6124568|NCT01157182|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6124569|NCT01157234|Metoprolol|metoprolol|mesh-list
6124570|NCT01157234|Nebivolol|nebivolol|mesh-list
6124571|NCT01157234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6124572|NCT01157234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6124573|NCT01157234|Sympatholytics|sympatholytics|mesh-ancestor
6124574|NCT01157234|Autonomic Agents|autonomic agents|mesh-ancestor
6124575|NCT01157234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6124576|NCT01157234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124577|NCT01157234|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6124578|NCT01157234|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6124579|NCT01157234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6124580|NCT01157234|Adrenergic Agents|adrenergic agents|mesh-ancestor
6124581|NCT01157234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6124582|NCT01157234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124583|NCT01157234|Vasodilator Agents|vasodilator agents|mesh-ancestor
6124584|NCT01157234|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6124585|NCT01157234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6124586|NCT01157234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6124587|NCT01157351|Olanzapine|olanzapine|mesh-list
6124588|NCT01157351|Risperidone|risperidone|mesh-list
6124589|NCT01157351|Quetiapine Fumarate|quetiapine fumarate|mesh-list
5534621|NCT04221152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534622|NCT04221152|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5534623|NCT04221152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534624|NCT04220931|Botulinum Toxins|botulinum toxins|mesh-list
5534625|NCT04220931|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5534626|NCT04220931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5534627|NCT04220931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534628|NCT04220931|Cholinergic Agents|cholinergic agents|mesh-ancestor
5534629|NCT04220931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5534630|NCT04220931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534631|NCT04221087|Dexamethasone|dexamethasone|mesh-list
5534632|NCT04221087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5534633|NCT04221087|Antiemetics|antiemetics|mesh-ancestor
5534634|NCT04221087|Autonomic Agents|autonomic agents|mesh-ancestor
5534635|NCT04221087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5534636|NCT04221087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534637|NCT04221087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5534638|NCT04221087|Glucocorticoids|glucocorticoids|mesh-ancestor
5534639|NCT04221087|Hormones|hormones|mesh-ancestor
5534640|NCT04221087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5534641|NCT04221087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5534642|NCT04221087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5534643|NCT04221035|Cyclophosphamide|cyclophosphamide|mesh-list
5534644|NCT04221035|Melphalan|melphalan|mesh-list
6124590|NCT01157351|Aripiprazole|aripiprazole|mesh-list
6124591|NCT01157351|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6124592|NCT01157351|Perphenazine|perphenazine|mesh-list
6124593|NCT01157351|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6124594|NCT01157351|Serotonin Agents|serotonin agents|mesh-ancestor
6124595|NCT01157351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5534645|NCT04221035|Busulfan|busulfan|mesh-list
5534646|NCT04221035|Ifosfamide|ifosfamide|mesh-list
5534647|NCT04221035|Thiotepa|thiotepa|mesh-list
5534648|NCT04221035|Dacarbazine|dacarbazine|mesh-list
5534649|NCT04221035|Carboplatin|carboplatin|mesh-list
5534650|NCT04221035|Doxorubicin|doxorubicin|mesh-list
5534651|NCT04221035|Etoposide|etoposide|mesh-list
5534652|NCT04221035|Vincristine|vincristine|mesh-list
5534653|NCT04221035|Vindesine|vindesine|mesh-list
5534654|NCT04221035|Dinutuximab|dinutuximab|mesh-list
5534655|NCT04221035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5534656|NCT04221035|Immunologic Factors|immunologic factors|mesh-ancestor
5534657|NCT04221035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534658|NCT04221035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5534659|NCT04221035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5534660|NCT04221035|Alkylating Agents|alkylating agents|mesh-ancestor
5534661|NCT04221035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534662|NCT04221035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5534663|NCT04221035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6124596|NCT01157351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124597|NCT01157351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124598|NCT01157351|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5534664|NCT04221035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6124599|NCT01157351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6124600|NCT01157351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6124601|NCT01157351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5534665|NCT04221035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5534666|NCT04221035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5534667|NCT04221035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5534668|NCT04221035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5534669|NCT04221035|Tubulin Modulators|tubulin modulators|mesh-ancestor
5534670|NCT04221035|Antimitotic Agents|antimitotic agents|mesh-ancestor
5534671|NCT04221035|Mitosis Modulators|mitosis modulators|mesh-ancestor
5534672|NCT04220996|Vortioxetine|vortioxetine|mesh-list
5534673|NCT04220996|Antidepressive Agents|antidepressive agents|mesh-ancestor
5534674|NCT04220996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5534675|NCT04220996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5534676|NCT04220996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5534677|NCT04220996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5534678|NCT04220996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534679|NCT04220996|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5534680|NCT04220996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5534681|NCT04220996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5534682|NCT04220996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534683|NCT04220996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5534684|NCT04220996|Serotonin Agents|serotonin agents|mesh-ancestor
5534685|NCT04220996|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5534686|NCT04220996|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5534687|NCT04220996|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5534688|NCT04220996|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6124602|NCT01157351|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6124603|NCT01157351|Dopamine Agents|dopamine agents|mesh-ancestor
6124604|NCT01157351|Antiemetics|antiemetics|mesh-ancestor
6124605|NCT01157351|Autonomic Agents|autonomic agents|mesh-ancestor
6124606|NCT01157351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6124607|NCT01157351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6124608|NCT01157351|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6124609|NCT01157351|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6124610|NCT01157351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6124611|NCT01157351|Antidepressive Agents|antidepressive agents|mesh-ancestor
6124612|NCT01157351|Dopamine Agonists|dopamine agonists|mesh-ancestor
6124613|NCT01157351|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6124614|NCT01157351|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6124615|NCT01157351|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6124616|NCT01157351|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6124617|NCT01157364|Bimatoprost|bimatoprost|mesh-list
6124618|NCT01157364|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6124619|NCT01157416|Cycloserine|cycloserine|mesh-list
6124620|NCT01157416|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6124621|NCT01157416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5534689|NCT04220827|Paclitaxel|paclitaxel|mesh-list
6124622|NCT01157416|Renal Agents|renal agents|mesh-ancestor
6124623|NCT01157416|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6124624|NCT01157416|Antitubercular Agents|antitubercular agents|mesh-ancestor
6124625|NCT01157416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6124626|NCT01157416|Antimetabolites|antimetabolites|mesh-ancestor
6124627|NCT01157416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124628|NCT01157429|Cycloserine|cycloserine|mesh-list
6124629|NCT01157429|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6124630|NCT01157429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6124631|NCT01157429|Renal Agents|renal agents|mesh-ancestor
6124632|NCT01157429|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6124633|NCT01157429|Antitubercular Agents|antitubercular agents|mesh-ancestor
6124634|NCT01157429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6124635|NCT01157429|Antimetabolites|antimetabolites|mesh-ancestor
6124636|NCT01157429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124637|NCT01158118|Plerixafor|plerixafor|mesh-list
6124638|NCT01158118|Sargramostim|sargramostim|mesh-list
6124639|NCT01158118|Immunologic Factors|immunologic factors|mesh-ancestor
6124640|NCT01158118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124641|NCT01158118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6124642|NCT01158118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6124643|NCT01158118|Antiviral Agents|antiviral agents|mesh-ancestor
6124644|NCT01158118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6124645|NCT01158222|Sunitinib|sunitinib|mesh-list
6124646|NCT01158222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6124647|NCT01158222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6124648|NCT01158222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6124649|NCT01158222|Growth Substances|growth substances|mesh-ancestor
5534690|NCT04220827|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5534691|NCT04220827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5534692|NCT04220827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5534693|NCT04220827|Tubulin Modulators|tubulin modulators|mesh-ancestor
5534694|NCT04220827|Antimitotic Agents|antimitotic agents|mesh-ancestor
5534695|NCT04220827|Mitosis Modulators|mitosis modulators|mesh-ancestor
5534696|NCT04220827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534697|NCT04220892|Pembrolizumab|pembrolizumab|mesh-list
5534698|NCT04220892|Pemetrexed|pemetrexed|mesh-list
5534699|NCT04220892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5534700|NCT04220892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5534701|NCT04220892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5534702|NCT04220892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534703|NCT04220892|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5534704|NCT04220892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5534705|NCT04220866|Pembrolizumab|pembrolizumab|mesh-list
5534706|NCT04220866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5534707|NCT04220866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6124650|NCT01158222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124651|NCT01158222|Growth Inhibitors|growth inhibitors|mesh-ancestor
6124652|NCT01158222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6124653|NCT01158222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6124654|NCT01158222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466031|NCT00476983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6466032|NCT00476983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6466033|NCT00476983|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6124655|NCT01158261|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6124656|NCT01158261|Hemostatics|hemostatics|mesh-ancestor
6124657|NCT01158261|Coagulants|coagulants|mesh-ancestor
6124658|NCT01158534|Interferons|interferons|mesh-list
6124659|NCT01158534|Interferon-alpha|interferon-alpha|mesh-list
6124660|NCT01158534|Interferon alpha-2|interferon alpha-2|mesh-list
6124661|NCT01158534|Celecoxib|celecoxib|mesh-list
6124662|NCT01158534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6124663|NCT01158534|Antiviral Agents|antiviral agents|mesh-ancestor
5534708|NCT04220528|Capecitabine|capecitabine|mesh-list
5534709|NCT04220528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5534710|NCT04220528|Antimetabolites|antimetabolites|mesh-ancestor
6124664|NCT01158534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6124665|NCT01158534|Immunologic Factors|immunologic factors|mesh-ancestor
6124666|NCT01158534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124667|NCT01158534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6124668|NCT01158534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6124669|NCT01158534|Analgesics|analgesics|mesh-ancestor
6124670|NCT01158534|Sensory System Agents|sensory system agents|mesh-ancestor
6124671|NCT01158534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5534711|NCT04220528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534712|NCT04220528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5534713|NCT04220398|Hormones|hormones|mesh-list
5534714|NCT04220398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5534715|NCT04220398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534716|NCT04220606|Nitroglycerin|nitroglycerin|mesh-list
5534717|NCT04220606|Vasodilator Agents|vasodilator agents|mesh-ancestor
5601749|NCT05174585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601750|NCT05174585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5601751|NCT05173441|Immunoglobulins|immunoglobulins|mesh-list
5601752|NCT05173441|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5601753|NCT05173441|Antibodies|antibodies|mesh-list
5601754|NCT05173441|Immunologic Factors|immunologic factors|mesh-ancestor
5601755|NCT05173441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601756|NCT05170919|Olanzapine|olanzapine|mesh-list
5601757|NCT05170919|Mirtazapine|mirtazapine|mesh-list
5601758|NCT05170919|Antiemetics|antiemetics|mesh-ancestor
5601759|NCT05170919|Autonomic Agents|autonomic agents|mesh-ancestor
5601760|NCT05170919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5601761|NCT05170919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601762|NCT05170919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5601763|NCT05170919|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5601764|NCT05170919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5601765|NCT05170919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5601766|NCT05170919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5601767|NCT05170919|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6124672|NCT01158534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6124673|NCT01158534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5534718|NCT04220632|Prednisone|prednisone|mesh-list
5534719|NCT04220632|Methylprednisolone|methylprednisolone|mesh-list
5534720|NCT04220632|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5534721|NCT04220632|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5534722|NCT04220632|Prednisolone|prednisolone|mesh-list
5534723|NCT04220632|Prednisolone acetate|prednisolone acetate|mesh-list
5534724|NCT04220632|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5534725|NCT04220632|Prednisolone phosphate|prednisolone phosphate|mesh-list
5534726|NCT04220632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5534727|NCT04220632|Glucocorticoids|glucocorticoids|mesh-ancestor
5534728|NCT04220632|Hormones|hormones|mesh-ancestor
5534729|NCT04220632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5534730|NCT04220632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534731|NCT04220632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5534732|NCT04220632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5534733|NCT04220632|Antiemetics|antiemetics|mesh-ancestor
5534734|NCT04220632|Autonomic Agents|autonomic agents|mesh-ancestor
5534735|NCT04220632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5534736|NCT04220632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5534737|NCT04220632|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5534738|NCT04220632|Protective Agents|protective agents|mesh-ancestor
5534739|NCT04220476|Letrozole|letrozole|mesh-list
5534740|NCT04220476|Palbociclib|palbociclib|mesh-list
5534741|NCT04220476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5534742|NCT04220476|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5534743|NCT04220476|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5534744|NCT04220476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5534745|NCT04220476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534746|NCT04220476|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5534747|NCT04220476|Hormone Antagonists|hormone antagonists|mesh-ancestor
5534748|NCT04220476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5534749|NCT04220476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534750|NCT04220476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5534751|NCT04220281|Nitroglycerin|nitroglycerin|mesh-list
5534752|NCT04220281|Propofol|propofol|mesh-list
5534753|NCT04220281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5534754|NCT04220281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5534755|NCT04220281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124674|NCT01158534|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6124675|NCT01158534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6124676|NCT01158534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6124677|NCT01158534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124678|NCT01158651|Everolimus|everolimus|mesh-list
6124679|NCT01158651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6124680|NCT01158651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6124681|NCT01158651|Immunologic Factors|immunologic factors|mesh-ancestor
6124682|NCT01158651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124683|NCT01158703|Aspirin|aspirin|mesh-list
6124684|NCT01158703|Clopidogrel|clopidogrel|mesh-list
6466034|NCT00476983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6466035|NCT00477035|Gemcitabine|gemcitabine|mesh-list
6466036|NCT00477035|Cyclophosphamide|cyclophosphamide|mesh-list
6466037|NCT00477035|Melphalan|melphalan|mesh-list
6466038|NCT00477035|Carmustine|carmustine|mesh-list
6466039|NCT00477035|Etoposide|etoposide|mesh-list
6466040|NCT00477035|Vinorelbine|vinorelbine|mesh-list
6124685|NCT01158703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6124686|NCT01158703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6124687|NCT01158703|Analgesics|analgesics|mesh-ancestor
6124688|NCT01158703|Sensory System Agents|sensory system agents|mesh-ancestor
6124689|NCT01158703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6124690|NCT01158703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124691|NCT01158703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6124692|NCT01158703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6124693|NCT01158703|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6124694|NCT01158703|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6124695|NCT01158703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124696|NCT01158703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6124697|NCT01158703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6124698|NCT01158703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6124699|NCT01158703|Antipyretics|antipyretics|mesh-ancestor
6124700|NCT01158703|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6124701|NCT01158703|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6124702|NCT01158703|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6124703|NCT01158703|Purinergic Agents|purinergic agents|mesh-ancestor
6466041|NCT00477035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6124704|NCT01158703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6124705|NCT01158820|Diphenhydramine|diphenhydramine|mesh-list
6124706|NCT01158820|Fentanyl|fentanyl|mesh-list
6124707|NCT01158820|Midazolam|midazolam|mesh-list
6124708|NCT01158820|Dexmedetomidine|dexmedetomidine|mesh-list
5534756|NCT04220281|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5534757|NCT04220281|Anesthetics, General|anesthetics, general|mesh-ancestor
5534758|NCT04220281|Anesthetics|anesthetics|mesh-ancestor
5534759|NCT04220281|Vasodilator Agents|vasodilator agents|mesh-ancestor
5534760|NCT04220008|Gemcitabine|gemcitabine|mesh-list
5534761|NCT04220008|Mycophenolic Acid|mycophenolic acid|mesh-list
5534762|NCT04220008|Cyclophosphamide|cyclophosphamide|mesh-list
6124709|NCT01158820|Ketamine|ketamine|mesh-list
6124710|NCT01158820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6124711|NCT01158820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6124712|NCT01158820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124713|NCT01158820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6124714|NCT01158820|Analgesics|analgesics|mesh-ancestor
6124715|NCT01158820|Sensory System Agents|sensory system agents|mesh-ancestor
6124716|NCT01158820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6124717|NCT01158820|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6124718|NCT01158820|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6124719|NCT01158820|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6124720|NCT01158820|Adrenergic Agents|adrenergic agents|mesh-ancestor
6124721|NCT01158820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6124722|NCT01158820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124723|NCT01158820|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6124724|NCT01158820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6124725|NCT01158820|Anesthetics, General|anesthetics, general|mesh-ancestor
5534763|NCT04220008|Busulfan|busulfan|mesh-list
5534764|NCT04220008|Rituximab|rituximab|mesh-list
5534765|NCT04220008|Vorinostat|vorinostat|mesh-list
5534766|NCT04220008|Clofarabine|clofarabine|mesh-list
5534767|NCT04220008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5534768|NCT04220008|Tacrolimus|tacrolimus|mesh-list
5534769|NCT04220008|Antibodies|antibodies|mesh-list
5534770|NCT04220008|Immunoglobulins|immunoglobulins|mesh-list
5534771|NCT04220008|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5534772|NCT04220008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5534773|NCT04220008|Immunologic Factors|immunologic factors|mesh-ancestor
5534774|NCT04220008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534775|NCT04220008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5534776|NCT04220008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5534777|NCT04220008|Alkylating Agents|alkylating agents|mesh-ancestor
5534778|NCT04220008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534779|NCT04220008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5534780|NCT04220008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6124726|NCT01158820|Anesthetics|anesthetics|mesh-ancestor
6124727|NCT01158820|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6124728|NCT01158820|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6124729|NCT01158820|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6124730|NCT01158820|Narcotics|narcotics|mesh-ancestor
6124731|NCT01158820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6124732|NCT01158820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6124733|NCT01158820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6124734|NCT01158820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6124735|NCT01158820|GABA Modulators|gaba modulators|mesh-ancestor
5534781|NCT04220008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5534782|NCT04220008|Antimetabolites|antimetabolites|mesh-ancestor
5534783|NCT04220008|Antiviral Agents|antiviral agents|mesh-ancestor
5534784|NCT04220008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5534785|NCT04220008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5534786|NCT04220008|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5534787|NCT04220008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6666130|NCT01520831|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6666131|NCT01520831|Insulin Aspart|insulin aspart|mesh-list
6666132|NCT01520831|Insulin, Long-Acting|insulin, long-acting|mesh-list
6666133|NCT01520831|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6666134|NCT01520831|Biphasic Insulins|biphasic insulins|mesh-list
6124736|NCT01158820|GABA Agents|gaba agents|mesh-ancestor
5534788|NCT04220008|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6466042|NCT00477035|Immunologic Factors|immunologic factors|mesh-ancestor
6466043|NCT00477035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466044|NCT00477035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6466045|NCT00477035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6466046|NCT00477035|Alkylating Agents|alkylating agents|mesh-ancestor
6466047|NCT00477035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466048|NCT00477035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6124737|NCT01158820|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6124738|NCT01158820|Anesthetics, Local|anesthetics, local|mesh-ancestor
6124739|NCT01158820|Antiemetics|antiemetics|mesh-ancestor
6466049|NCT00477035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6466050|NCT00477035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6466051|NCT00477035|Antimetabolites|antimetabolites|mesh-ancestor
6466052|NCT00477035|Antiviral Agents|antiviral agents|mesh-ancestor
6466053|NCT00477035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6666135|NCT01520831|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6124740|NCT01158820|Autonomic Agents|autonomic agents|mesh-ancestor
6124741|NCT01158820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6124742|NCT01158820|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6124743|NCT01158820|Histamine Antagonists|histamine antagonists|mesh-ancestor
6124744|NCT01158820|Histamine Agents|histamine agents|mesh-ancestor
6124745|NCT01158820|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5534789|NCT04220008|Antitubercular Agents|antitubercular agents|mesh-ancestor
5534790|NCT04220008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5534791|NCT04220008|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5534792|NCT04220021|Metformin|metformin|mesh-list
5534793|NCT04220021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6124746|NCT01158885|Cytarabine|cytarabine|mesh-list
6124747|NCT01158885|Methotrexate|methotrexate|mesh-list
6124748|NCT01158885|Clofarabine|clofarabine|mesh-list
5534794|NCT04220021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534795|NCT04219969|Deoxyglucose|deoxyglucose|mesh-list
5534796|NCT04219969|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5534797|NCT04219969|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5534798|NCT04219969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534799|NCT04219969|Antimetabolites|antimetabolites|mesh-ancestor
5534800|NCT04219969|Antiviral Agents|antiviral agents|mesh-ancestor
5534801|NCT04219969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5534802|NCT04220125|Midazolam|midazolam|mesh-list
5534803|NCT04220125|Ketamine|ketamine|mesh-list
5534804|NCT04220125|Analgesics|analgesics|mesh-ancestor
5534805|NCT04220125|Sensory System Agents|sensory system agents|mesh-ancestor
5534806|NCT04220125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5534807|NCT04220125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534808|NCT04220125|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5534809|NCT04220125|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5534810|NCT04220125|Anesthetics, General|anesthetics, general|mesh-ancestor
5534811|NCT04220125|Anesthetics|anesthetics|mesh-ancestor
5534812|NCT04220125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6124749|NCT01158885|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6124750|NCT01158885|Abortifacient Agents|abortifacient agents|mesh-ancestor
6124751|NCT01158885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6124752|NCT01158885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124753|NCT01158885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6124754|NCT01158885|Antimetabolites|antimetabolites|mesh-ancestor
6124755|NCT01158885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124756|NCT01158885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6124757|NCT01158885|Dermatologic Agents|dermatologic agents|mesh-ancestor
6124758|NCT01158885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6124759|NCT01158885|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6124760|NCT01158885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6124761|NCT01158885|Immunologic Factors|immunologic factors|mesh-ancestor
6124762|NCT01158885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6124763|NCT01158885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6124764|NCT01158885|Antiviral Agents|antiviral agents|mesh-ancestor
6124765|NCT01158885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6124766|NCT01158950|Tolcapone|tolcapone|mesh-list
6124767|NCT01158950|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6124768|NCT01158950|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6124769|NCT01158950|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6124770|NCT01158950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6124771|NCT01158950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124772|NCT01159054|Niacin|niacin|mesh-list
6124773|NCT01159054|Nicotinic Acids|nicotinic acids|mesh-list
6466054|NCT00477035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6466055|NCT00477035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6466056|NCT00477035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6466057|NCT00477035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6466058|NCT00477035|Tubulin Modulators|tubulin modulators|mesh-ancestor
6466059|NCT00477035|Antimitotic Agents|antimitotic agents|mesh-ancestor
6466060|NCT00477035|Mitosis Modulators|mitosis modulators|mesh-ancestor
6466061|NCT00477048|Saquinavir|saquinavir|mesh-list
6466062|NCT00477048|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6124774|NCT01159054|Niacinamide|niacinamide|mesh-list
6124775|NCT01159054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6124776|NCT01159054|Antimetabolites|antimetabolites|mesh-ancestor
5534813|NCT04220125|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5534814|NCT04220125|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5534815|NCT04220125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5534816|NCT04220125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534817|NCT04220125|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5534818|NCT04220125|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5534819|NCT04220125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5534820|NCT04220125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5534821|NCT04220125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5534822|NCT04220125|GABA Modulators|gaba modulators|mesh-ancestor
5534823|NCT04220125|GABA Agents|gaba agents|mesh-ancestor
5534824|NCT04220073|Antibodies|antibodies|mesh-list
6124777|NCT01159054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124778|NCT01159054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6124779|NCT01159054|Vasodilator Agents|vasodilator agents|mesh-ancestor
6124780|NCT01159054|Vitamin B Complex|vitamin b complex|mesh-ancestor
6124781|NCT01159054|Vitamins|vitamins|mesh-ancestor
6124782|NCT01159054|Micronutrients|micronutrients|mesh-ancestor
6124783|NCT01159054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124784|NCT01159067|Deferasirox|deferasirox|mesh-list
6124785|NCT01159067|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6124786|NCT01159067|Chelating Agents|chelating agents|mesh-ancestor
6124787|NCT01159067|Sequestering Agents|sequestering agents|mesh-ancestor
6124788|NCT01159067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124789|NCT01159171|Bevacizumab|bevacizumab|mesh-list
6124790|NCT01159171|Capecitabine|capecitabine|mesh-list
6124791|NCT01159171|Oxaliplatin|oxaliplatin|mesh-list
6124792|NCT01159171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6124793|NCT01159171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6124794|NCT01159171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6124795|NCT01159171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6124796|NCT01159171|Growth Substances|growth substances|mesh-ancestor
6124797|NCT01159171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124798|NCT01159171|Growth Inhibitors|growth inhibitors|mesh-ancestor
6124799|NCT01159171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6124800|NCT01159171|Antimetabolites|antimetabolites|mesh-ancestor
5534825|NCT04220073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5534826|NCT04220073|Immunologic Factors|immunologic factors|mesh-ancestor
5534827|NCT04220073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124801|NCT01159171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124802|NCT01159262|Fentanyl|fentanyl|mesh-list
6124803|NCT01159262|Midazolam|midazolam|mesh-list
6124804|NCT01159262|Dexmedetomidine|dexmedetomidine|mesh-list
6124805|NCT01159262|Morphine|morphine|mesh-list
6124806|NCT01159262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6124807|NCT01159262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6124808|NCT01159262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124809|NCT01159262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6124810|NCT01159262|Analgesics|analgesics|mesh-ancestor
6124811|NCT01159262|Sensory System Agents|sensory system agents|mesh-ancestor
6124812|NCT01159262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6124813|NCT01159262|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6124814|NCT01159262|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6124815|NCT01159262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6124816|NCT01159262|Adrenergic Agents|adrenergic agents|mesh-ancestor
6124817|NCT01159262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6124818|NCT01159262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124819|NCT01159262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6124820|NCT01159262|Narcotics|narcotics|mesh-ancestor
6124821|NCT01159262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6124822|NCT01159262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6124823|NCT01159262|Anesthetics, General|anesthetics, general|mesh-ancestor
6124824|NCT01159262|Anesthetics|anesthetics|mesh-ancestor
6124825|NCT01159262|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5534828|NCT04219995|Methylprednisolone|methylprednisolone|mesh-list
5534829|NCT04219995|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5534830|NCT04219995|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5534831|NCT04219995|Prednisolone|prednisolone|mesh-list
5534832|NCT04219995|Prednisolone acetate|prednisolone acetate|mesh-list
5534833|NCT04219995|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6124826|NCT01159262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6124827|NCT01159262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6124828|NCT01159262|GABA Modulators|gaba modulators|mesh-ancestor
6124829|NCT01159262|GABA Agents|gaba agents|mesh-ancestor
6466063|NCT00477048|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6466064|NCT00477048|Protease Inhibitors|protease inhibitors|mesh-ancestor
6466065|NCT00477048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6466066|NCT00477048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466067|NCT00477048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6466068|NCT00477048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6466069|NCT00477048|Antiviral Agents|antiviral agents|mesh-ancestor
6466070|NCT00477048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6466071|NCT00477048|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6466072|NCT00477048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6466073|NCT00477061|Morphine|morphine|mesh-list
6124830|NCT01159574|Clarithromycin|clarithromycin|mesh-list
6124831|NCT01159574|Dexamethasone|dexamethasone|mesh-list
6124832|NCT01159574|Pomalidomide|pomalidomide|mesh-list
6124833|NCT01159574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6124834|NCT01159574|Antiemetics|antiemetics|mesh-ancestor
6124835|NCT01159574|Autonomic Agents|autonomic agents|mesh-ancestor
6124836|NCT01159574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6124837|NCT01159574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124838|NCT01159574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6124839|NCT01159574|Glucocorticoids|glucocorticoids|mesh-ancestor
6124840|NCT01159574|Hormones|hormones|mesh-ancestor
6124841|NCT01159574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6124842|NCT01159574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6124843|NCT01159574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6124844|NCT01159574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6124845|NCT01159574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6124846|NCT01159574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6124847|NCT01159574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6124848|NCT01159574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124849|NCT01159574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6124850|NCT01159574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6124851|NCT01159574|Immunologic Factors|immunologic factors|mesh-ancestor
6124852|NCT01159574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6124853|NCT01159574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6124854|NCT01159574|Growth Substances|growth substances|mesh-ancestor
6124855|NCT01159574|Growth Inhibitors|growth inhibitors|mesh-ancestor
6124856|NCT01159600|Empagliflozin|empagliflozin|mesh-list
6124857|NCT01159600|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6124858|NCT01159600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124859|NCT01159600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6124860|NCT01159600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124861|NCT01159665|Plasminogen|plasminogen|mesh-list
6124862|NCT01159665|Fibrinolysin|fibrinolysin|mesh-list
6124863|NCT01159665|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6124864|NCT01159665|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6666136|NCT01520831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6666137|NCT01520831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666138|NCT01520896|Ketoconazole|ketoconazole|mesh-list
6666139|NCT01520896|Naloxegol|naloxegol|mesh-list
6666140|NCT01520896|Antifungal Agents|antifungal agents|mesh-ancestor
6666141|NCT01520896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6666142|NCT01520896|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6666143|NCT01520896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6666144|NCT01520896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6666145|NCT01520896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534834|NCT04219995|Prednisolone phosphate|prednisolone phosphate|mesh-list
5534835|NCT04219995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6124865|NCT01159665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124866|NCT01159769|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
6124867|NCT01159769|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6124868|NCT01159769|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6124869|NCT01159769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6124870|NCT01159769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6124871|NCT01159769|Analgesics|analgesics|mesh-ancestor
6124872|NCT01159769|Sensory System Agents|sensory system agents|mesh-ancestor
5534836|NCT04219995|Antiemetics|antiemetics|mesh-ancestor
5534837|NCT04219995|Autonomic Agents|autonomic agents|mesh-ancestor
5534838|NCT04219995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5534839|NCT04219995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534840|NCT04219995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5534841|NCT04219995|Glucocorticoids|glucocorticoids|mesh-ancestor
6124873|NCT01159769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6666146|NCT01520896|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6466074|NCT00477061|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6466075|NCT00477061|Narcotics|narcotics|mesh-ancestor
5534842|NCT04219995|Hormones|hormones|mesh-ancestor
6124874|NCT01159769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124875|NCT01159769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6124876|NCT01159769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6124877|NCT01159769|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6124878|NCT01159769|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6124879|NCT01159769|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6124880|NCT01159769|Histamine Antagonists|histamine antagonists|mesh-ancestor
6124881|NCT01159769|Histamine Agents|histamine agents|mesh-ancestor
6124882|NCT01159769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6124883|NCT01159769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124884|NCT01159912|Fluticasone|fluticasone|mesh-list
6124885|NCT01159912|Xhance|xhance|mesh-list
6124886|NCT01159912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6124887|NCT01159912|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6124888|NCT01159912|Autonomic Agents|autonomic agents|mesh-ancestor
6124889|NCT01159912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6124890|NCT01159912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124891|NCT01159912|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6124892|NCT01159912|Respiratory System Agents|respiratory system agents|mesh-ancestor
6124893|NCT01159912|Dermatologic Agents|dermatologic agents|mesh-ancestor
6124894|NCT01159912|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6124895|NCT01159938|Insulin Lispro|insulin lispro|mesh-list
6124896|NCT01159938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6124897|NCT01159938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124898|NCT01160198|Ascorbic Acid|ascorbic acid|mesh-list
6124899|NCT01160198|Chelating Agents|chelating agents|mesh-list
6124900|NCT01160198|Glycine|glycine|mesh-list
6124901|NCT01160198|Sequestering Agents|sequestering agents|mesh-ancestor
6124902|NCT01160198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124903|NCT01160198|Glycine Agents|glycine agents|mesh-ancestor
6124904|NCT01160198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6124905|NCT01160198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124906|NCT01160198|Antioxidants|antioxidants|mesh-ancestor
6124907|NCT01160198|Protective Agents|protective agents|mesh-ancestor
6124908|NCT01160198|Vitamins|vitamins|mesh-ancestor
6124909|NCT01160198|Micronutrients|micronutrients|mesh-ancestor
6124910|NCT01160211|Trastuzumab|trastuzumab|mesh-list
6124911|NCT01160211|Lapatinib|lapatinib|mesh-list
6124912|NCT01160211|Aromatase Inhibitors|aromatase inhibitors|mesh-list
6124913|NCT01160211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6124914|NCT01160211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6124915|NCT01160211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6124916|NCT01160211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6124917|NCT01160211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124918|NCT01160211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6124919|NCT01160211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6124920|NCT01160211|Hormone Antagonists|hormone antagonists|mesh-ancestor
6124921|NCT01160211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6124922|NCT01160211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124923|NCT01160289|Tadalafil|tadalafil|mesh-list
6124924|NCT01160289|Vasodilator Agents|vasodilator agents|mesh-ancestor
6124925|NCT01160289|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6124926|NCT01160289|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6124927|NCT01160289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6124928|NCT01160289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124929|NCT01160289|Urological Agents|urological agents|mesh-ancestor
6124930|NCT01160354|Plerixafor|plerixafor|mesh-list
6124931|NCT01160354|Clofarabine|clofarabine|mesh-list
6124932|NCT01160354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6124933|NCT01160354|Antimetabolites|antimetabolites|mesh-ancestor
6124934|NCT01160354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124935|NCT01160354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6124936|NCT01160354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6124937|NCT01160354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5534843|NCT04219995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6124938|NCT01160354|Antiviral Agents|antiviral agents|mesh-ancestor
6124939|NCT01160354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6124940|NCT01160380|Modafinil|modafinil|mesh-list
6124941|NCT01160380|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6124942|NCT01160380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124943|NCT01160380|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6124944|NCT01160380|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6124945|NCT01160380|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6124946|NCT01160380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6124947|NCT01160445|Aldesleukin|aldesleukin|mesh-list
6124948|NCT01160445|Zanolimumab|zanolimumab|mesh-list
6124949|NCT01160445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6124950|NCT01160445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6124951|NCT01160445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6124952|NCT01160445|Antiviral Agents|antiviral agents|mesh-ancestor
6124953|NCT01160445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6124954|NCT01160445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6124955|NCT01160484|Lenalidomide|lenalidomide|mesh-list
5534844|NCT04219995|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5534845|NCT04219995|Protective Agents|protective agents|mesh-ancestor
5534846|NCT04219995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5534847|NCT04219995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5534848|NCT04219865|Edaravone|edaravone|mesh-list
5534849|NCT04219865|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6124956|NCT01160484|Immunologic Factors|immunologic factors|mesh-ancestor
6124957|NCT01160484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124958|NCT01160484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6124959|NCT01160484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6124960|NCT01160484|Growth Substances|growth substances|mesh-ancestor
6124961|NCT01160484|Growth Inhibitors|growth inhibitors|mesh-ancestor
6124962|NCT01160484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6124963|NCT01160614|Oxycodone|oxycodone|mesh-list
6124964|NCT01160614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6124965|NCT01160614|Narcotics|narcotics|mesh-ancestor
6124966|NCT01160614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6124967|NCT01160614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6124968|NCT01160614|Analgesics|analgesics|mesh-ancestor
6124969|NCT01160614|Sensory System Agents|sensory system agents|mesh-ancestor
6124970|NCT01160614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6124971|NCT01160640|Metronidazole|metronidazole|mesh-list
6124972|NCT01160640|Doxycycline|doxycycline|mesh-list
6124973|NCT01160640|Ceftriaxone|ceftriaxone|mesh-list
6124974|NCT01160640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6124975|NCT01160640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6124976|NCT01160640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6124977|NCT01160640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6124978|NCT01160640|Antimalarials|antimalarials|mesh-ancestor
6124979|NCT01160744|Gemcitabine|gemcitabine|mesh-list
6124980|NCT01160744|Carboplatin|carboplatin|mesh-list
6124981|NCT01160744|Pemetrexed|pemetrexed|mesh-list
6124982|NCT01160744|Ramucirumab|ramucirumab|mesh-list
6124983|NCT01160744|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6124984|NCT01160744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6124985|NCT01160744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6124986|NCT01160744|Antimetabolites|antimetabolites|mesh-ancestor
6124987|NCT01160744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666147|NCT01520896|Hormone Antagonists|hormone antagonists|mesh-ancestor
5534850|NCT04219865|Antioxidants|antioxidants|mesh-ancestor
5534851|NCT04219865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534852|NCT04219865|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5534853|NCT04219865|Protective Agents|protective agents|mesh-ancestor
5534854|NCT04219865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534855|NCT04219982|Scopolamine|scopolamine|mesh-list
5534856|NCT04219982|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
6124988|NCT01160744|Antiviral Agents|antiviral agents|mesh-ancestor
6124989|NCT01160744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6124990|NCT01160744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6124991|NCT01160744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6124992|NCT01160744|Immunologic Factors|immunologic factors|mesh-ancestor
5534857|NCT04219982|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5534858|NCT04219982|Antiemetics|antiemetics|mesh-ancestor
6124993|NCT01160744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534859|NCT04219982|Autonomic Agents|autonomic agents|mesh-ancestor
6124994|NCT01160744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6488447|NCT00584298|Octreotide|octreotide|mesh-list
6488448|NCT00584298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6488449|NCT00584298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6488450|NCT00584298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6488451|NCT00584376|Pregabalin|pregabalin|mesh-list
6488452|NCT00584376|Analgesics|analgesics|mesh-ancestor
6488453|NCT00584376|Sensory System Agents|sensory system agents|mesh-ancestor
6488454|NCT00584376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6488455|NCT00584376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488456|NCT00584376|Anticonvulsants|anticonvulsants|mesh-ancestor
6488457|NCT00584376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6124995|NCT01160744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6124996|NCT01160770|Clobazam|clobazam|mesh-list
6124997|NCT01160770|Anticonvulsants|anticonvulsants|mesh-ancestor
6124998|NCT01160770|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6124999|NCT01160770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6125000|NCT01160770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6125001|NCT01160770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125002|NCT01160770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6125003|NCT01160770|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6125004|NCT01160770|GABA Agonists|gaba agonists|mesh-ancestor
6125005|NCT01160770|GABA Agents|gaba agents|mesh-ancestor
6125006|NCT01160770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6125007|NCT01160770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125008|NCT01160822|Naproxen|naproxen|mesh-list
6125009|NCT01160822|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6125010|NCT01160822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6125011|NCT01160822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6125012|NCT01160822|Analgesics|analgesics|mesh-ancestor
6125013|NCT01160822|Sensory System Agents|sensory system agents|mesh-ancestor
6125014|NCT01160822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6125015|NCT01160822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125016|NCT01160822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6125017|NCT01160822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6125018|NCT01160822|Gout Suppressants|gout suppressants|mesh-ancestor
6125019|NCT01160822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6125020|NCT01160822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6125021|NCT01160822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125022|NCT01160822|Immunologic Factors|immunologic factors|mesh-ancestor
6125023|NCT01160848|Ethanol|ethanol|mesh-list
6125024|NCT01160848|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5534860|NCT04219982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5534861|NCT04219982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534862|NCT04219982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5534863|NCT04219982|Mydriatics|mydriatics|mesh-ancestor
5534864|NCT04219982|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6666148|NCT01520896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5534865|NCT04219982|Cholinergic Agents|cholinergic agents|mesh-ancestor
6125025|NCT01160848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6125026|NCT01160848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6125027|NCT01160848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125028|NCT01161121|Adenosine|adenosine|mesh-list
6125029|NCT01161121|Regadenoson|regadenoson|mesh-list
6125030|NCT01161121|Analgesics|analgesics|mesh-ancestor
6125031|NCT01161121|Sensory System Agents|sensory system agents|mesh-ancestor
6125032|NCT01161121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6125033|NCT01161121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125034|NCT01161121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6125035|NCT01161121|Vasodilator Agents|vasodilator agents|mesh-ancestor
6125036|NCT01161121|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6125037|NCT01161121|Purinergic Agonists|purinergic agonists|mesh-ancestor
6125038|NCT01161121|Purinergic Agents|purinergic agents|mesh-ancestor
6125039|NCT01161121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6125040|NCT01161121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125041|NCT01161121|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
6125042|NCT01161173|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6125043|NCT01161173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6125044|NCT01161173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6125045|NCT01161173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6125046|NCT01161173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125047|NCT01161407|Calcium Carbonate|calcium carbonate|mesh-list
6125048|NCT01161407|Calcium|calcium|mesh-list
6125049|NCT01161407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6125050|NCT01161407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125051|NCT01161407|Antacids|antacids|mesh-ancestor
6125052|NCT01161407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125053|NCT01161407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6125054|NCT01161446|Antibodies|antibodies|mesh-list
6125055|NCT01161446|Immunoglobulins|immunoglobulins|mesh-list
6125056|NCT01161446|Immunologic Factors|immunologic factors|mesh-ancestor
6125057|NCT01161446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125058|NCT01161472|Alprazolam|alprazolam|mesh-list
5534866|NCT04219982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6125059|NCT01161472|Fesoterodine|fesoterodine|mesh-list
6125060|NCT01161472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6125061|NCT01161472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6125062|NCT01161472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125063|NCT01161472|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6125064|NCT01161472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6125065|NCT01161472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6125066|NCT01161472|GABA Modulators|gaba modulators|mesh-ancestor
6125067|NCT01161472|GABA Agents|gaba agents|mesh-ancestor
6125068|NCT01161472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6125069|NCT01161472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125070|NCT01161472|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6125071|NCT01161472|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6125072|NCT01161472|Cholinergic Agents|cholinergic agents|mesh-ancestor
6125073|NCT01161472|Urological Agents|urological agents|mesh-ancestor
6466076|NCT00477061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6466077|NCT00477061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466078|NCT00477061|Analgesics|analgesics|mesh-ancestor
6466079|NCT00477061|Sensory System Agents|sensory system agents|mesh-ancestor
6466080|NCT00477061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6466081|NCT00477126|Ritonavir|ritonavir|mesh-list
6466082|NCT00477126|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6125074|NCT01161498|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
6125075|NCT01161498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6125076|NCT01161498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6125077|NCT01161537|Ivacaftor|ivacaftor|mesh-list
6125078|NCT01161537|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6125079|NCT01161537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6125080|NCT01161537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125081|NCT01161563|Leuprolide|leuprolide|mesh-list
6125082|NCT01161563|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6125083|NCT01161563|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6125084|NCT01161563|Fertility Agents|fertility agents|mesh-ancestor
6125085|NCT01161563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6125086|NCT01161563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125087|NCT01161563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6125088|NCT01161563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6125089|NCT01161563|Luteolytic Agents|luteolytic agents|mesh-ancestor
6125090|NCT01161563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6125091|NCT01161563|Contraceptive Agents|contraceptive agents|mesh-ancestor
6125092|NCT01161563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6125093|NCT01161628|Rituximab|rituximab|mesh-list
6125094|NCT01161628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6125095|NCT01161628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6125096|NCT01161628|Immunologic Factors|immunologic factors|mesh-ancestor
6125097|NCT01161628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125098|NCT01161628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6125099|NCT01161862|Glucagon|glucagon|mesh-list
6125100|NCT01161862|Pancrelipase|pancrelipase|mesh-list
6125101|NCT01161862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125102|NCT01161862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6125103|NCT01161862|Hormones|hormones|mesh-ancestor
6125104|NCT01161862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6125105|NCT01162005|Tacrolimus|tacrolimus|mesh-list
6125106|NCT01162005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6125107|NCT01162005|Immunologic Factors|immunologic factors|mesh-ancestor
6125108|NCT01162005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125109|NCT01162005|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6125110|NCT01162005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6125111|NCT01162005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125112|NCT01162122|Vaccines|vaccines|mesh-list
6125113|NCT01162122|Immunologic Factors|immunologic factors|mesh-ancestor
6125114|NCT01162122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125115|NCT01162135|Digoxin|digoxin|mesh-list
6125116|NCT01162135|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6125117|NCT01162135|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6125118|NCT01162135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6125119|NCT01162135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125120|NCT01162135|Protective Agents|protective agents|mesh-ancestor
6125121|NCT01162135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125122|NCT01162239|Varenicline|varenicline|mesh-list
6125123|NCT01162239|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5534867|NCT04219982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534868|NCT04219982|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6125124|NCT01162239|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6125125|NCT01162239|Cholinergic Agents|cholinergic agents|mesh-ancestor
6125126|NCT01162239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6125127|NCT01162239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125128|NCT01162239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125129|NCT01162421|Adalimumab|adalimumab|mesh-list
6125130|NCT01162421|Methotrexate|methotrexate|mesh-list
6125131|NCT01162421|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5534869|NCT04219982|Parasympatholytics|parasympatholytics|mesh-ancestor
5534870|NCT04219904|Deoxyglucose|deoxyglucose|mesh-list
5534871|NCT04219904|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5534872|NCT04219904|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5534873|NCT04219904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125132|NCT01162421|Abortifacient Agents|abortifacient agents|mesh-ancestor
6125133|NCT01162421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6125134|NCT01162421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125135|NCT01162421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6125136|NCT01162421|Antimetabolites|antimetabolites|mesh-ancestor
5534874|NCT04219904|Antimetabolites|antimetabolites|mesh-ancestor
5534875|NCT04219904|Antiviral Agents|antiviral agents|mesh-ancestor
5534876|NCT04219904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5534877|NCT04219579|Antithrombins|antithrombins|mesh-list
5534878|NCT04219579|Antithrombin III|antithrombin iii|mesh-list
5534879|NCT04219579|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5534880|NCT04219579|Protease Inhibitors|protease inhibitors|mesh-ancestor
5534881|NCT04219579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5534882|NCT04219579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534883|NCT04219579|Anticoagulants|anticoagulants|mesh-ancestor
5534884|NCT04219553|Anti-Infective Agents|anti-infective agents|mesh-list
5534885|NCT04219553|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5534886|NCT04219735|Minocycline|minocycline|mesh-list
5534887|NCT04219735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5534888|NCT04219735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5534889|NCT04219722|Hyaluronic Acid|hyaluronic acid|mesh-list
5534890|NCT04219722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5534891|NCT04219722|Immunologic Factors|immunologic factors|mesh-ancestor
5534892|NCT04219722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534893|NCT04219722|Viscosupplements|viscosupplements|mesh-ancestor
6125137|NCT01162421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125138|NCT01162421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6125139|NCT01162421|Dermatologic Agents|dermatologic agents|mesh-ancestor
6125140|NCT01162421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6125141|NCT01162421|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6125142|NCT01162421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5534894|NCT04219722|Protective Agents|protective agents|mesh-ancestor
5534895|NCT04219449|Protein C|protein c|mesh-list
5534896|NCT04219449|Anticoagulants|anticoagulants|mesh-ancestor
5534897|NCT04219449|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5534898|NCT04219449|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5534899|NCT04219449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534900|NCT04219124|Dapagliflozin|dapagliflozin|mesh-list
5534901|NCT04219124|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
5534902|NCT04219124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534903|NCT04219124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5534904|NCT04219124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534905|NCT04219358|Imiquimod|imiquimod|mesh-list
5534906|NCT04219358|Sunscreening Agents|sunscreening agents|mesh-list
5534907|NCT04219358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5534908|NCT04219358|Immunologic Factors|immunologic factors|mesh-ancestor
5534909|NCT04219358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534910|NCT04219358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5534911|NCT04219358|Interferon Inducers|interferon inducers|mesh-ancestor
5534912|NCT04219358|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5534913|NCT04219358|Protective Agents|protective agents|mesh-ancestor
5534914|NCT04219358|Dermatologic Agents|dermatologic agents|mesh-ancestor
5534915|NCT04219280|Methylphenidate|methylphenidate|mesh-list
6125143|NCT01162421|Immunologic Factors|immunologic factors|mesh-ancestor
6125144|NCT01162421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6125145|NCT01162421|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6125146|NCT01162421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6125147|NCT01162473|Caseins|caseins|mesh-list
6125148|NCT01162473|Chelating Agents|chelating agents|mesh-ancestor
6125149|NCT01162473|Sequestering Agents|sequestering agents|mesh-ancestor
6125150|NCT01162473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534916|NCT04219280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5534917|NCT04219280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534918|NCT04219280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5534919|NCT04219280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5534920|NCT04219280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6125151|NCT01162486|Rifampin|rifampin|mesh-list
6125152|NCT01162486|Rifapentine|rifapentine|mesh-list
6125153|NCT01162486|Midazolam|midazolam|mesh-list
5534921|NCT04219280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534922|NCT04219280|Dopamine Agents|dopamine agents|mesh-ancestor
5534923|NCT04219280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5534924|NCT04219046|Naloxegol|naloxegol|mesh-list
5534925|NCT04219046|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5534926|NCT04219046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534927|NCT04219046|Sensory System Agents|sensory system agents|mesh-ancestor
5534928|NCT04219046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5534929|NCT04218890|Lipoprotein-associated coagulation inhibitor|lipoprotein-associated coagulation inhibitor|mesh-list
5534930|NCT04218890|Thromboplastin|thromboplastin|mesh-list
5534931|NCT04218890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5534932|NCT04218890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5534933|NCT04218890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534934|NCT04218890|Hemostatics|hemostatics|mesh-ancestor
5534935|NCT04218890|Coagulants|coagulants|mesh-ancestor
6125154|NCT01162486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6125155|NCT01162486|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5534936|NCT04218890|Anticoagulants|anticoagulants|mesh-ancestor
5534937|NCT04218890|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5534938|NCT04218890|Protease Inhibitors|protease inhibitors|mesh-ancestor
5534939|NCT04218890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5534940|NCT04218890|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5534941|NCT04218890|Antithrombins|antithrombins|mesh-ancestor
5534942|NCT04218981|Antipsychotic Agents|antipsychotic agents|mesh-list
5534943|NCT04218981|Paroxetine|paroxetine|mesh-list
5534944|NCT04218981|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5534945|NCT04218981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5534946|NCT04218981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5534947|NCT04218981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534948|NCT04218981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5534949|NCT04218981|Serotonin Agents|serotonin agents|mesh-ancestor
5534950|NCT04218981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534951|NCT04218981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5534952|NCT04218981|Antidepressive Agents|antidepressive agents|mesh-ancestor
5534953|NCT04218981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5534954|NCT04218981|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5534955|NCT04218981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5534956|NCT04218981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5534957|NCT04218981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5534958|NCT04218981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5534959|NCT04218968|Carvedilol|carvedilol|mesh-list
5534960|NCT04218968|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5534961|NCT04218968|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6125156|NCT01162486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6125157|NCT01162486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125158|NCT01162486|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6125159|NCT01162486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6125160|NCT01162486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6125161|NCT01162486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6125162|NCT01162486|Anesthetics, General|anesthetics, general|mesh-ancestor
6125163|NCT01162486|Anesthetics|anesthetics|mesh-ancestor
6125164|NCT01162486|GABA Modulators|gaba modulators|mesh-ancestor
6125165|NCT01162486|GABA Agents|gaba agents|mesh-ancestor
6125166|NCT01162486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6125167|NCT01162486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534962|NCT04218968|Adrenergic Agents|adrenergic agents|mesh-ancestor
5534963|NCT04218968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5534964|NCT04218968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534965|NCT04218968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534966|NCT04218968|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5534967|NCT04218968|Antioxidants|antioxidants|mesh-ancestor
6125168|NCT01162486|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6125169|NCT01162486|Antitubercular Agents|antitubercular agents|mesh-ancestor
6125170|NCT01162486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6125171|NCT01162486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6125172|NCT01162486|Leprostatic Agents|leprostatic agents|mesh-ancestor
6125173|NCT01162486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6125174|NCT01162486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6125175|NCT01162486|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6125176|NCT01162486|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6125177|NCT01162486|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6125178|NCT01162486|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6125179|NCT01162486|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6125180|NCT01162486|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6125181|NCT01162551|Sirolimus|sirolimus|mesh-list
6125182|NCT01162551|Methotrexate|methotrexate|mesh-list
6125183|NCT01162551|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6125184|NCT01162551|Abortifacient Agents|abortifacient agents|mesh-ancestor
6125185|NCT01162551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6125186|NCT01162551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125187|NCT01162551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6125188|NCT01162551|Antimetabolites|antimetabolites|mesh-ancestor
6125189|NCT01162551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125190|NCT01162551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6125191|NCT01162551|Dermatologic Agents|dermatologic agents|mesh-ancestor
6125192|NCT01162551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6125193|NCT01162551|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6125194|NCT01162551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6125195|NCT01162551|Immunologic Factors|immunologic factors|mesh-ancestor
6125196|NCT01162551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6125197|NCT01162551|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6125198|NCT01162551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6125199|NCT01162551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6125200|NCT01162551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6125201|NCT01162551|Antifungal Agents|antifungal agents|mesh-ancestor
6125202|NCT01162733|Vancomycin|vancomycin|mesh-list
6125203|NCT01162733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6125204|NCT01162733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6204799|NCT02078102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6204800|NCT02078102|Analgesics|analgesics|mesh-ancestor
6204801|NCT02078102|Sensory System Agents|sensory system agents|mesh-ancestor
6204802|NCT02078102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5534968|NCT04218968|Protective Agents|protective agents|mesh-ancestor
5534969|NCT04218968|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5534970|NCT04218968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5534971|NCT04218968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5534972|NCT04218968|Vasodilator Agents|vasodilator agents|mesh-ancestor
5534973|NCT04218968|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5534974|NCT04218968|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5601768|NCT05170919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5601769|NCT05170919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5601770|NCT05170919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601771|NCT05170919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5601772|NCT05170919|Serotonin Agents|serotonin agents|mesh-ancestor
5601773|NCT05170919|Antidepressive Agents|antidepressive agents|mesh-ancestor
5601774|NCT05170919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5601775|NCT05170919|Histamine Antagonists|histamine antagonists|mesh-ancestor
5601776|NCT05170919|Histamine Agents|histamine agents|mesh-ancestor
5601777|NCT05170919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5601778|NCT05170919|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5601779|NCT05170919|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5601780|NCT05170919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5601781|NCT05170919|Adrenergic Agents|adrenergic agents|mesh-ancestor
5601782|NCT05170919|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5601783|NCT05170919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5601784|NCT05170919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5601785|NCT05156684|Zinc|zinc|mesh-list
5601786|NCT05156684|Pentoxifylline|pentoxifylline|mesh-list
5601787|NCT05156684|Zinc Sulfate|zinc sulfate|mesh-list
5601788|NCT05156684|Trace Elements|trace elements|mesh-ancestor
5601789|NCT05156684|Micronutrients|micronutrients|mesh-ancestor
5601790|NCT05156684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204803|NCT02078102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6204804|NCT02078102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6204805|NCT02078102|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6204806|NCT02078102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6204807|NCT02078102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6204808|NCT02078102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204809|NCT02078180|Bupropion|bupropion|mesh-list
6204810|NCT02078180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6204811|NCT02078180|Antidepressive Agents|antidepressive agents|mesh-ancestor
6204812|NCT02078180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6125205|NCT01162863|Lubiprostone|lubiprostone|mesh-list
6125206|NCT01162863|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6125207|NCT01162863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6125208|NCT01162863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125209|NCT01163097|Heparin|heparin|mesh-list
6125210|NCT01163097|Anticoagulants|anticoagulants|mesh-ancestor
6125211|NCT01163097|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6125212|NCT01163097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6125213|NCT01163097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125214|NCT01163149|Immunoglobulin G|immunoglobulin g|mesh-list
6125215|NCT01163149|Immunologic Factors|immunologic factors|mesh-ancestor
6125216|NCT01163149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125217|NCT01163214|Ropivacaine|ropivacaine|mesh-list
5534975|NCT04218513|Edaravone|edaravone|mesh-list
5534976|NCT04218513|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5534977|NCT04218513|Antioxidants|antioxidants|mesh-ancestor
5534978|NCT04218513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534979|NCT04218513|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5534980|NCT04218513|Protective Agents|protective agents|mesh-ancestor
5534981|NCT04218513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5534982|NCT04218500|Niacinamide|niacinamide|mesh-list
5534983|NCT04218500|Niacin|niacin|mesh-list
5534984|NCT04218500|Nicotinic Acids|nicotinic acids|mesh-list
5534985|NCT04218500|Vitamin B Complex|vitamin b complex|mesh-ancestor
6125218|NCT01163214|Anesthetics, Local|anesthetics, local|mesh-ancestor
6125219|NCT01163214|Anesthetics|anesthetics|mesh-ancestor
6125220|NCT01163214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6125221|NCT01163214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125222|NCT01163214|Sensory System Agents|sensory system agents|mesh-ancestor
6125223|NCT01163214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5534986|NCT04218500|Vitamins|vitamins|mesh-ancestor
5534987|NCT04218500|Micronutrients|micronutrients|mesh-ancestor
5534988|NCT04218500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125224|NCT01163253|Tofacitinib|tofacitinib|mesh-list
6125225|NCT01163253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6125226|NCT01163253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6125227|NCT01163253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125228|NCT01163266|Vortioxetine|vortioxetine|mesh-list
6125229|NCT01163266|Antidepressive Agents|antidepressive agents|mesh-ancestor
6125230|NCT01163266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6125231|NCT01163266|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6125232|NCT01163266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6125233|NCT01163266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6125234|NCT01163266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125235|NCT01163266|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6125236|NCT01163266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6125237|NCT01163266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6125238|NCT01163266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125239|NCT01163266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6125240|NCT01163266|Serotonin Agents|serotonin agents|mesh-ancestor
6125241|NCT01163266|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6125242|NCT01163266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6125243|NCT01163266|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6125244|NCT01163266|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6125245|NCT01163604|Aspirin|aspirin|mesh-list
6125246|NCT01163604|Argatroban|argatroban|mesh-list
6125247|NCT01163604|Clopidogrel|clopidogrel|mesh-list
6125248|NCT01163604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6125249|NCT01163604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6125250|NCT01163604|Analgesics|analgesics|mesh-ancestor
6125251|NCT01163604|Sensory System Agents|sensory system agents|mesh-ancestor
6125252|NCT01163604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6125253|NCT01163604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125254|NCT01163604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6125255|NCT01163604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6125256|NCT01163604|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5534989|NCT04218500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5534990|NCT04218500|Antimetabolites|antimetabolites|mesh-ancestor
5534991|NCT04218500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534992|NCT04218500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5534993|NCT04218500|Vasodilator Agents|vasodilator agents|mesh-ancestor
5534994|NCT04218435|Valsartan|valsartan|mesh-list
5534995|NCT04218435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5534996|NCT04218435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6125257|NCT01163604|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5534997|NCT04218435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5534998|NCT04218435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5534999|NCT04218760|Isosorbide|isosorbide|mesh-list
5535000|NCT04218760|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
5535001|NCT04218760|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
5535002|NCT04218760|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5535003|NCT04218760|Diuretics|diuretics|mesh-ancestor
5535004|NCT04218760|Natriuretic Agents|natriuretic agents|mesh-ancestor
5535005|NCT04218760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535006|NCT04218760|Vasodilator Agents|vasodilator agents|mesh-ancestor
5535007|NCT04218760|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5535008|NCT04218760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535009|NCT04218552|Amlodipine|amlodipine|mesh-list
5535010|NCT04218552|Telmisartan|telmisartan|mesh-list
5535011|NCT04218552|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5535012|NCT04218552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5535013|NCT04218552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5535014|NCT04218552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535015|NCT04218552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5535016|NCT04218552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535017|NCT04218552|Vasodilator Agents|vasodilator agents|mesh-ancestor
5535018|NCT04218552|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5535019|NCT04218552|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5535020|NCT04218565|Golimumab|golimumab|mesh-list
5535021|NCT04218565|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
5535022|NCT04218565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5535023|NCT04218565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5535024|NCT04218565|Immunologic Factors|immunologic factors|mesh-ancestor
6125258|NCT01163604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125259|NCT01163604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6125260|NCT01163604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6125261|NCT01163604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6125262|NCT01163604|Antipyretics|antipyretics|mesh-ancestor
6125263|NCT01163604|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6125264|NCT01163604|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6125265|NCT01163604|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6125266|NCT01163604|Purinergic Agents|purinergic agents|mesh-ancestor
6125267|NCT01163604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6125268|NCT01163604|Antithrombins|antithrombins|mesh-ancestor
5535025|NCT04218565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535026|NCT04218734|Metformin|metformin|mesh-list
6125269|NCT01163604|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6125270|NCT01163604|Protease Inhibitors|protease inhibitors|mesh-ancestor
6125271|NCT01163604|Anticoagulants|anticoagulants|mesh-ancestor
6125272|NCT01163617|Adalimumab|adalimumab|mesh-list
6125273|NCT01163617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6125274|NCT01163617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6125275|NCT01163656|Cobalt|cobalt|mesh-list
6125276|NCT01163656|Trace Elements|trace elements|mesh-ancestor
6125277|NCT01163656|Micronutrients|micronutrients|mesh-ancestor
6125278|NCT01163656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125279|NCT01163721|Ranolazine|ranolazine|mesh-list
6125280|NCT01163721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5535027|NCT04218734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5535028|NCT04218734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535029|NCT04218695|Ceftriaxone|ceftriaxone|mesh-list
5535030|NCT04218695|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5535031|NCT04218695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5535032|NCT04218149|Bupivacaine|bupivacaine|mesh-list
5535033|NCT04218149|Anesthetics, Local|anesthetics, local|mesh-ancestor
5535034|NCT04218149|Anesthetics|anesthetics|mesh-ancestor
5535035|NCT04218149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5535036|NCT04218149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535037|NCT04218149|Sensory System Agents|sensory system agents|mesh-ancestor
5535038|NCT04218149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5535039|NCT04218162|Lasmiditan|lasmiditan|mesh-list
5535040|NCT04218162|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5535041|NCT04218162|Serotonin Agents|serotonin agents|mesh-ancestor
5535042|NCT04218162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5535043|NCT04218162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535044|NCT04218162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535045|NCT04217733|Ethosuximide|ethosuximide|mesh-list
5535046|NCT04217733|Mebeverine|mebeverine|mesh-list
5535047|NCT04217733|Alverine|alverine|mesh-list
6125281|NCT01163721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6125282|NCT01163721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125283|NCT01163747|Methotrexate|methotrexate|mesh-list
6125284|NCT01163747|Vaccines|vaccines|mesh-list
6125285|NCT01163747|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6125286|NCT01163747|Immunologic Factors|immunologic factors|mesh-ancestor
6125287|NCT01163747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125288|NCT01163747|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6125289|NCT01163747|Abortifacient Agents|abortifacient agents|mesh-ancestor
6125290|NCT01163747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6125291|NCT01163747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6125292|NCT01163747|Antimetabolites|antimetabolites|mesh-ancestor
6125293|NCT01163747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125294|NCT01163747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6125295|NCT01163747|Dermatologic Agents|dermatologic agents|mesh-ancestor
6125296|NCT01163747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6125297|NCT01163747|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6125298|NCT01163747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6125299|NCT01163747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5535048|NCT04217733|Anticonvulsants|anticonvulsants|mesh-ancestor
5535049|NCT04217733|Parasympatholytics|parasympatholytics|mesh-ancestor
5535050|NCT04217733|Autonomic Agents|autonomic agents|mesh-ancestor
5535051|NCT04217733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6125300|NCT01163747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6125301|NCT01163786|Bortezomib|bortezomib|mesh-list
6125302|NCT01163786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6125303|NCT01163851|Bococizumab|bococizumab|mesh-list
6125304|NCT01163851|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6125305|NCT01163851|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6125306|NCT01163851|Antimetabolites|antimetabolites|mesh-ancestor
6125307|NCT01163851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125308|NCT01163851|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6125309|NCT01164007|Bevacizumab|bevacizumab|mesh-list
6125310|NCT01164007|Dacarbazine|dacarbazine|mesh-list
6125311|NCT01164007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6125312|NCT01164007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6125313|NCT01164007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6125314|NCT01164007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6125315|NCT01164007|Growth Substances|growth substances|mesh-ancestor
6125316|NCT01164007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125317|NCT01164007|Growth Inhibitors|growth inhibitors|mesh-ancestor
6125318|NCT01164007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6125319|NCT01164007|Alkylating Agents|alkylating agents|mesh-ancestor
6125320|NCT01164007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125321|NCT01164098|Rituximab|rituximab|mesh-list
6125322|NCT01164098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6125323|NCT01164098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6125324|NCT01164098|Immunologic Factors|immunologic factors|mesh-ancestor
6125325|NCT01164098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125326|NCT01164098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6125327|NCT01164475|Plerixafor|plerixafor|mesh-list
6125328|NCT01164475|Lenograstim|lenograstim|mesh-list
6125329|NCT01164475|Sargramostim|sargramostim|mesh-list
6125330|NCT01164475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6125331|NCT01164475|Immunologic Factors|immunologic factors|mesh-ancestor
6125332|NCT01164475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125333|NCT01164475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6125334|NCT01164475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6125335|NCT01164475|Antiviral Agents|antiviral agents|mesh-ancestor
6125336|NCT01164475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6125337|NCT01164501|Empagliflozin|empagliflozin|mesh-list
6125338|NCT01164501|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6125339|NCT01164501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125340|NCT01164501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6125341|NCT01164501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125342|NCT01164579|Methotrexate|methotrexate|mesh-list
5535052|NCT04217733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125343|NCT01164579|Tofacitinib|tofacitinib|mesh-list
6125344|NCT01164579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6125345|NCT01164579|Abortifacient Agents|abortifacient agents|mesh-ancestor
6125346|NCT01164579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6125347|NCT01164579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125348|NCT01164579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6125349|NCT01164579|Antimetabolites|antimetabolites|mesh-ancestor
6125350|NCT01164579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125351|NCT01164579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6125352|NCT01164579|Dermatologic Agents|dermatologic agents|mesh-ancestor
6125353|NCT01164579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6125354|NCT01164579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6125355|NCT01164579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6125356|NCT01164579|Immunologic Factors|immunologic factors|mesh-ancestor
6125357|NCT01164579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6125358|NCT01164579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6125359|NCT01164579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6125360|NCT01164956|Methylphenidate|methylphenidate|mesh-list
6125361|NCT01164956|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6125362|NCT01164956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125363|NCT01164956|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6125364|NCT01164956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6125365|NCT01164956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6125366|NCT01164956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466083|NCT00477126|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6466084|NCT00477126|Protease Inhibitors|protease inhibitors|mesh-ancestor
6466085|NCT00477126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6466086|NCT00477126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466087|NCT00477126|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6466088|NCT00477126|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6466089|NCT00477126|Antiviral Agents|antiviral agents|mesh-ancestor
6466090|NCT00477126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6466091|NCT00477126|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6466092|NCT00477126|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6466093|NCT00477217|Zoledronic Acid|zoledronic acid|mesh-list
5535053|NCT04217798|Etoposide|etoposide|mesh-list
5535054|NCT04217798|Niraparib|niraparib|mesh-list
5535055|NCT04217798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5535056|NCT04217798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5535057|NCT04217798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5535058|NCT04217798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6125367|NCT01164956|Dopamine Agents|dopamine agents|mesh-ancestor
6125368|NCT01164956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6125369|NCT01165021|Folic Acid|folic acid|mesh-list
6125370|NCT01165021|Vitamin B 12|vitamin b 12|mesh-list
6125371|NCT01165021|Hydroxocobalamin|hydroxocobalamin|mesh-list
6125372|NCT01165021|Dexamethasone|dexamethasone|mesh-list
6125373|NCT01165021|Pemetrexed|pemetrexed|mesh-list
6125374|NCT01165021|Vitamins|vitamins|mesh-ancestor
6125375|NCT01165021|Micronutrients|micronutrients|mesh-ancestor
6125376|NCT01165021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125377|NCT01165021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6125378|NCT01165021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6125379|NCT01165021|Antiemetics|antiemetics|mesh-ancestor
6125380|NCT01165021|Autonomic Agents|autonomic agents|mesh-ancestor
6125381|NCT01165021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6125382|NCT01165021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6125383|NCT01165021|Glucocorticoids|glucocorticoids|mesh-ancestor
6125384|NCT01165021|Hormones|hormones|mesh-ancestor
6125385|NCT01165021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6125386|NCT01165021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6125387|NCT01165021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6125388|NCT01165021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125389|NCT01165021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6125390|NCT01165021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6125391|NCT01165021|Hematinics|hematinics|mesh-ancestor
6125392|NCT01165021|Vitamin B Complex|vitamin b complex|mesh-ancestor
6125393|NCT01165047|Nitric Oxide|nitric oxide|mesh-list
6125394|NCT01165047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6125395|NCT01165047|Autonomic Agents|autonomic agents|mesh-ancestor
6125396|NCT01165047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6125397|NCT01165047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535059|NCT04217798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6125398|NCT01165047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6125399|NCT01165047|Respiratory System Agents|respiratory system agents|mesh-ancestor
6125400|NCT01165047|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6125401|NCT01165047|Antioxidants|antioxidants|mesh-ancestor
6125402|NCT01165047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125403|NCT01165047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6125404|NCT01165047|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6125405|NCT01165047|Vasodilator Agents|vasodilator agents|mesh-ancestor
6125406|NCT01165047|Gasotransmitters|gasotransmitters|mesh-ancestor
6125407|NCT01165047|Protective Agents|protective agents|mesh-ancestor
6125408|NCT01165112|Rituximab|rituximab|mesh-list
6125409|NCT01165112|Carboplatin|carboplatin|mesh-list
6125410|NCT01165112|Etoposide|etoposide|mesh-list
6125411|NCT01165112|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6125412|NCT01165112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6125413|NCT01165112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6125414|NCT01165112|Immunologic Factors|immunologic factors|mesh-ancestor
6125415|NCT01165112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125416|NCT01165112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6125417|NCT01165112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6125418|NCT01165112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6125419|NCT01165112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6125420|NCT01165112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6125421|NCT01165112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125422|NCT01165112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6125423|NCT01165112|Alkylating Agents|alkylating agents|mesh-ancestor
6125424|NCT01165138|Fluticasone|fluticasone|mesh-list
6125425|NCT01165138|Xhance|xhance|mesh-list
6125426|NCT01165138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6125427|NCT01165138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6125428|NCT01165138|Autonomic Agents|autonomic agents|mesh-ancestor
6125429|NCT01165138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6125430|NCT01165138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125431|NCT01165138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6125432|NCT01165138|Respiratory System Agents|respiratory system agents|mesh-ancestor
6125433|NCT01165138|Dermatologic Agents|dermatologic agents|mesh-ancestor
6125434|NCT01165138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6125435|NCT01165203|Vaccines|vaccines|mesh-list
6125436|NCT01165203|Immunologic Factors|immunologic factors|mesh-ancestor
6125437|NCT01165203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125438|NCT01165216|Paclitaxel|paclitaxel|mesh-list
6125439|NCT01165216|Carboplatin|carboplatin|mesh-list
6125440|NCT01165216|Ipilimumab|ipilimumab|mesh-list
6125441|NCT01165216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6125442|NCT01165216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6125443|NCT01165216|Tubulin Modulators|tubulin modulators|mesh-ancestor
6125444|NCT01165216|Antimitotic Agents|antimitotic agents|mesh-ancestor
6125445|NCT01165216|Mitosis Modulators|mitosis modulators|mesh-ancestor
6125446|NCT01165216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125447|NCT01165216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6125448|NCT01165216|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6125449|NCT01165281|Oxycodone|oxycodone|mesh-list
6125450|NCT01165281|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6125451|NCT01165281|Narcotics|narcotics|mesh-ancestor
6125452|NCT01165281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5535060|NCT04217798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535061|NCT04217798|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5535062|NCT04217668|Isosorbide|isosorbide|mesh-list
5535063|NCT04217668|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
5535064|NCT04217668|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
5535065|NCT04217668|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5535066|NCT04217668|Diuretics|diuretics|mesh-ancestor
5535067|NCT04217668|Natriuretic Agents|natriuretic agents|mesh-ancestor
5535068|NCT04217668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125453|NCT01165281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125454|NCT01165281|Analgesics|analgesics|mesh-ancestor
6125455|NCT01165281|Sensory System Agents|sensory system agents|mesh-ancestor
6125456|NCT01165281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6125457|NCT01165307|Naproxen|naproxen|mesh-list
6125458|NCT01165307|Levonorgestrel|levonorgestrel|mesh-list
6125459|NCT01165307|Contraceptive Agents|contraceptive agents|mesh-list
6125460|NCT01165307|Contraceptives, Oral|contraceptives, oral|mesh-list
6125461|NCT01165307|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
6125462|NCT01165307|Estradiol|estradiol|mesh-list
6125463|NCT01165307|Estrogens|estrogens|mesh-ancestor
6125464|NCT01165307|Hormones|hormones|mesh-ancestor
6125465|NCT01165307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6125466|NCT01165307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125467|NCT01165307|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6125468|NCT01165307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6125469|NCT01165307|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6125470|NCT01165307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6125471|NCT01165307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6125472|NCT01165307|Analgesics|analgesics|mesh-ancestor
6125473|NCT01165307|Sensory System Agents|sensory system agents|mesh-ancestor
6125474|NCT01165307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6125475|NCT01165307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6125476|NCT01165307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6125477|NCT01165307|Gout Suppressants|gout suppressants|mesh-ancestor
6125478|NCT01165307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6125479|NCT01165307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6125480|NCT01165307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125481|NCT01165307|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6125482|NCT01165320|Caspofungin|caspofungin|mesh-list
6125483|NCT01165320|Antifungal Agents|antifungal agents|mesh-ancestor
6125484|NCT01165320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6125485|NCT01165320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6125486|NCT01165320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125487|NCT01165541|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6125488|NCT01165541|Mirtazapine|mirtazapine|mesh-list
6125489|NCT01165541|Antidepressive Agents|antidepressive agents|mesh-ancestor
6125490|NCT01165541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6125491|NCT01165541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6125492|NCT01165541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6125493|NCT01165541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6125494|NCT01165541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125495|NCT01165541|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6125496|NCT01165541|Histamine Antagonists|histamine antagonists|mesh-ancestor
6125497|NCT01165541|Histamine Agents|histamine agents|mesh-ancestor
6125498|NCT01165541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6125499|NCT01165541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535069|NCT04217668|Vasodilator Agents|vasodilator agents|mesh-ancestor
5535070|NCT04217668|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5535071|NCT04217668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535072|NCT04217694|Memantine|memantine|mesh-list
5535073|NCT04217694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5535074|NCT04217694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5535075|NCT04217694|Dopamine Agents|dopamine agents|mesh-ancestor
5535076|NCT04217694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5535077|NCT04217694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535078|NCT04217694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535079|NCT04217694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6125500|NCT01165541|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6125501|NCT01165541|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6125502|NCT01165541|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6125503|NCT01165541|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6125504|NCT01165541|Adrenergic Agents|adrenergic agents|mesh-ancestor
6125505|NCT01165541|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6125506|NCT01165541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6125507|NCT01165541|Serotonin Agents|serotonin agents|mesh-ancestor
6125508|NCT01165541|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6125509|NCT01165554|Flutemetamol|flutemetamol|mesh-list
6125510|NCT01165554|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6125511|NCT01165554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125512|NCT01165684|Insulin|insulin|mesh-list
6125513|NCT01165684|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6125514|NCT01165684|Insulin Aspart|insulin aspart|mesh-list
6125515|NCT01165684|Insulin, Long-Acting|insulin, long-acting|mesh-list
6125516|NCT01165684|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6125517|NCT01165684|Insulin Detemir|insulin detemir|mesh-list
6125518|NCT01165684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6125519|NCT01165684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125520|NCT01165840|Dapsone|dapsone|mesh-list
6125521|NCT01165840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6125522|NCT01165840|Antimalarials|antimalarials|mesh-ancestor
6125523|NCT01165840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6125524|NCT01165840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6125525|NCT01165840|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6125526|NCT01165840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6125527|NCT01165840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535080|NCT04217694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5535081|NCT04217785|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5535082|NCT04217785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6125528|NCT01165840|Leprostatic Agents|leprostatic agents|mesh-ancestor
6125529|NCT01165840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6125530|NCT01165996|Decitabine|decitabine|mesh-list
6125531|NCT01165996|Azacitidine|azacitidine|mesh-list
6125532|NCT01165996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6125533|NCT01165996|Antimetabolites|antimetabolites|mesh-ancestor
6125534|NCT01165996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125535|NCT01165996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6125536|NCT01165996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6125537|NCT01166126|Sirolimus|sirolimus|mesh-list
6666149|NCT01520896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535083|NCT04217265|Letrozole|letrozole|mesh-list
5535084|NCT04217265|Misoprostol|misoprostol|mesh-list
5535085|NCT04217265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5535086|NCT04217265|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5535087|NCT04217265|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5535088|NCT04217265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5535089|NCT04217265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535090|NCT04217265|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5535091|NCT04217265|Hormone Antagonists|hormone antagonists|mesh-ancestor
5535092|NCT04217265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5535093|NCT04217265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535094|NCT04217265|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5535095|NCT04217265|Abortifacient Agents|abortifacient agents|mesh-ancestor
5535096|NCT04217265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5535097|NCT04217265|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5535098|NCT04217265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5535099|NCT04217265|Oxytocics|oxytocics|mesh-ancestor
5535100|NCT04217447|Aspirin|aspirin|mesh-list
5535101|NCT04217447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5535102|NCT04217447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5535103|NCT04217447|Analgesics|analgesics|mesh-ancestor
5535104|NCT04217447|Sensory System Agents|sensory system agents|mesh-ancestor
6666150|NCT01520896|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6666151|NCT01520896|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6666152|NCT01520896|Sensory System Agents|sensory system agents|mesh-ancestor
6666153|NCT01520896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6672418|NCT01555918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6672419|NCT01555970|Acetylcysteine|acetylcysteine|mesh-list
6672420|NCT01555970|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6125538|NCT01166126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6125539|NCT01166126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6125540|NCT01166126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6125541|NCT01166126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6125542|NCT01166126|Antifungal Agents|antifungal agents|mesh-ancestor
6125543|NCT01166126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6125544|NCT01166126|Immunologic Factors|immunologic factors|mesh-ancestor
6125545|NCT01166126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125546|NCT01166282|Adalimumab|adalimumab|mesh-list
6125547|NCT01166282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6125548|NCT01166282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6125549|NCT01166438|Solifenacin Succinate|solifenacin succinate|mesh-list
6125550|NCT01166438|Trospium chloride|trospium chloride|mesh-list
6125551|NCT01166438|Botulinum Toxins|botulinum toxins|mesh-list
6125552|NCT01166438|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6125553|NCT01166438|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6125554|NCT01166438|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6125555|NCT01166438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6125556|NCT01166438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125557|NCT01166438|Cholinergic Agents|cholinergic agents|mesh-ancestor
6125558|NCT01166438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6125559|NCT01166438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125560|NCT01166438|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6125561|NCT01166438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6125562|NCT01166438|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6125563|NCT01166438|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6125564|NCT01166438|Urological Agents|urological agents|mesh-ancestor
6125565|NCT01166438|Parasympatholytics|parasympatholytics|mesh-ancestor
6125566|NCT01166438|Autonomic Agents|autonomic agents|mesh-ancestor
6672421|NCT01555970|Antiviral Agents|antiviral agents|mesh-ancestor
5535105|NCT04217447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6125567|NCT01166646|Clobetasol|clobetasol|mesh-list
6125568|NCT01166646|Halobetasol|halobetasol|mesh-list
5535106|NCT04217447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535107|NCT04217447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6125569|NCT01166646|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6125570|NCT01166646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6125571|NCT01166646|Glucocorticoids|glucocorticoids|mesh-ancestor
6125572|NCT01166646|Hormones|hormones|mesh-ancestor
6125573|NCT01166646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6125574|NCT01166646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535108|NCT04217447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5535109|NCT04217447|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5535110|NCT04217447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5535111|NCT04217447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535112|NCT04217447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5535113|NCT04217447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5535114|NCT04217447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5535115|NCT04217447|Antipyretics|antipyretics|mesh-ancestor
6125575|NCT01166763|Vitamin D|vitamin d|mesh-list
6125576|NCT01166763|Cholecalciferol|cholecalciferol|mesh-list
6125577|NCT01166763|Vitamins|vitamins|mesh-ancestor
5535116|NCT04217421|Allopurinol|allopurinol|mesh-list
5535117|NCT04217421|Mannitol|mannitol|mesh-list
5535118|NCT04217421|Antimetabolites|antimetabolites|mesh-ancestor
5535119|NCT04217421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535120|NCT04217421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5535121|NCT04217421|Gout Suppressants|gout suppressants|mesh-ancestor
5535122|NCT04217421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5535123|NCT04217421|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5535124|NCT04217421|Antioxidants|antioxidants|mesh-ancestor
5535125|NCT04217421|Protective Agents|protective agents|mesh-ancestor
5535126|NCT04217421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535127|NCT04217421|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5535128|NCT04217421|Diuretics|diuretics|mesh-ancestor
5535129|NCT04217421|Natriuretic Agents|natriuretic agents|mesh-ancestor
5535130|NCT04217512|Pantoprazole|pantoprazole|mesh-list
6125578|NCT01166763|Micronutrients|micronutrients|mesh-ancestor
6125579|NCT01166763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125580|NCT01166763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6125581|NCT01166763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6125582|NCT01166945|Amoxicillin|amoxicillin|mesh-list
6125583|NCT01166945|Clavulanic Acid|clavulanic acid|mesh-list
6125584|NCT01166945|Clavulanic Acids|clavulanic acids|mesh-list
6125585|NCT01166945|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6125586|NCT01166945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6125587|NCT01166945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5535131|NCT04217512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5535132|NCT04217512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5535133|NCT04217512|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5535134|NCT04217512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5535135|NCT04217512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535136|NCT04217317|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5535137|NCT04217317|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5535138|NCT04217317|Alkylating Agents|alkylating agents|mesh-ancestor
5535139|NCT04217317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535140|NCT04217317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5535141|NCT04217356|Hydroxyurea|hydroxyurea|mesh-list
5535142|NCT04217356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5535143|NCT04217356|Antisickling Agents|antisickling agents|mesh-ancestor
5535144|NCT04217356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5535145|NCT04217356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535146|NCT04217356|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5535147|NCT04217148|Dexamethasone|dexamethasone|mesh-list
5535148|NCT04217148|Dexamethasone acetate|dexamethasone acetate|mesh-list
5535149|NCT04217148|Tretinoin|tretinoin|mesh-list
5535150|NCT04217148|BB 1101|bb 1101|mesh-list
5535151|NCT04217148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5535152|NCT04217148|Antiemetics|antiemetics|mesh-ancestor
5535153|NCT04217148|Autonomic Agents|autonomic agents|mesh-ancestor
5535154|NCT04217148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5535155|NCT04217148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535156|NCT04217148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5535157|NCT04217148|Glucocorticoids|glucocorticoids|mesh-ancestor
5535158|NCT04217148|Hormones|hormones|mesh-ancestor
5535159|NCT04217148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5535160|NCT04217148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6125588|NCT01166945|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5535161|NCT04217148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5535162|NCT04217148|Protease Inhibitors|protease inhibitors|mesh-ancestor
5535163|NCT04217148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5535164|NCT04217148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535165|NCT04217148|Keratolytic Agents|keratolytic agents|mesh-ancestor
6125589|NCT01166945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6125590|NCT01166945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125591|NCT01166958|Teriparatide|teriparatide|mesh-list
6125592|NCT01166958|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
6125593|NCT01166958|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6125594|NCT01166958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125595|NCT01166958|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6125596|NCT01166958|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6125597|NCT01166958|Hormone Antagonists|hormone antagonists|mesh-ancestor
6125598|NCT01166958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6125599|NCT01166958|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5535166|NCT04217148|Dermatologic Agents|dermatologic agents|mesh-ancestor
5535167|NCT04216836|Magnesium Oxide|magnesium oxide|mesh-list
5535168|NCT04216836|Antacids|antacids|mesh-ancestor
5535169|NCT04216836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535170|NCT04216836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5601791|NCT05156684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6125600|NCT01166958|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6125601|NCT01166997|Heparin|heparin|mesh-list
6125602|NCT01166997|Calcium heparin|calcium heparin|mesh-list
6125603|NCT01166997|Anticoagulants|anticoagulants|mesh-ancestor
6125604|NCT01166997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6125605|NCT01166997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6125606|NCT01166997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125607|NCT01167023|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
5601792|NCT05156684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5601793|NCT05156684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601794|NCT05156684|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5601795|NCT05156684|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5601796|NCT05156684|Protective Agents|protective agents|mesh-ancestor
5601797|NCT05156684|Vasodilator Agents|vasodilator agents|mesh-ancestor
5601798|NCT05156684|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5601799|NCT05156684|Antioxidants|antioxidants|mesh-ancestor
5601800|NCT05156684|Astringents|astringents|mesh-ancestor
5601801|NCT05156684|Dermatologic Agents|dermatologic agents|mesh-ancestor
5601802|NCT05155540|Plasminogen|plasminogen|mesh-list
5601803|NCT05155540|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5601804|NCT05155540|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5601805|NCT05155540|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5601806|NCT05155540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125608|NCT01167023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6125609|NCT01167153|Amlodipine|amlodipine|mesh-list
6125610|NCT01167153|Valsartan|valsartan|mesh-list
6125611|NCT01167153|Nifedipine|nifedipine|mesh-list
6125612|NCT01167153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6125613|NCT01167153|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6125614|NCT01167153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6125615|NCT01167153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125616|NCT01167153|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6125617|NCT01167153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125618|NCT01167153|Vasodilator Agents|vasodilator agents|mesh-ancestor
6125619|NCT01167153|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6125620|NCT01167153|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6125621|NCT01167153|Tocolytic Agents|tocolytic agents|mesh-ancestor
6125622|NCT01167153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6125623|NCT01167192|Carboplatin|carboplatin|mesh-list
6125624|NCT01167192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6125625|NCT01167257|Botulinum Toxins|botulinum toxins|mesh-list
6125626|NCT01167257|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6125627|NCT01167257|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6125628|NCT01167257|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6125629|NCT01167257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6125630|NCT01167257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125631|NCT01167257|Cholinergic Agents|cholinergic agents|mesh-ancestor
6125632|NCT01167257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6125633|NCT01167257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125634|NCT01167257|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6666154|NCT01521130|Levetiracetam|levetiracetam|mesh-list
6125635|NCT01167257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6125636|NCT01167426|Glatiramer Acetate|glatiramer acetate|mesh-list
6125637|NCT01167426|(T,G)-A-L|(t,g)-a-l|mesh-list
6125638|NCT01167426|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6125639|NCT01167426|Immunologic Factors|immunologic factors|mesh-ancestor
6125640|NCT01167426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125641|NCT01167426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6125642|NCT01167426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6125643|NCT01167452|Trimethoprim|trimethoprim|mesh-list
6125644|NCT01167452|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6125645|NCT01167452|Sulfamethoxazole|sulfamethoxazole|mesh-list
6125646|NCT01167452|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6125647|NCT01167452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6125648|NCT01167452|Renal Agents|renal agents|mesh-ancestor
6125649|NCT01167452|Antimalarials|antimalarials|mesh-ancestor
6125650|NCT01167452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6125651|NCT01167452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6125652|NCT01167452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6125653|NCT01167452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6125654|NCT01167452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125655|NCT01167452|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6125656|NCT01167452|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6125657|NCT01167452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6125658|NCT01167452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6125659|NCT01167569|Ascorbic Acid|ascorbic acid|mesh-list
6125660|NCT01167569|Vitamins|vitamins|mesh-ancestor
6125661|NCT01167569|Micronutrients|micronutrients|mesh-ancestor
6125662|NCT01167569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125663|NCT01167569|Antioxidants|antioxidants|mesh-ancestor
6125664|NCT01167569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125665|NCT01167569|Protective Agents|protective agents|mesh-ancestor
6125666|NCT01167712|Paclitaxel|paclitaxel|mesh-list
6125667|NCT01167712|Bevacizumab|bevacizumab|mesh-list
6125668|NCT01167712|Carboplatin|carboplatin|mesh-list
6125669|NCT01167712|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6125670|NCT01167712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6125671|NCT01167712|Endothelial Growth Factors|endothelial growth factors|mesh-list
6125672|NCT01167712|Antibodies|antibodies|mesh-list
5535171|NCT04216953|Atezolizumab|atezolizumab|mesh-list
5535172|NCT04216953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5535173|NCT04216927|Nitric Oxide|nitric oxide|mesh-list
5535174|NCT04216927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5535175|NCT04216927|Autonomic Agents|autonomic agents|mesh-ancestor
5535176|NCT04216927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5535177|NCT04216927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535178|NCT04216927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5535179|NCT04216927|Respiratory System Agents|respiratory system agents|mesh-ancestor
5535180|NCT04216927|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5535181|NCT04216927|Antioxidants|antioxidants|mesh-ancestor
5535182|NCT04216927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535183|NCT04216927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5535184|NCT04216927|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5535185|NCT04216927|Vasodilator Agents|vasodilator agents|mesh-ancestor
5535186|NCT04216927|Gasotransmitters|gasotransmitters|mesh-ancestor
5535187|NCT04216927|Protective Agents|protective agents|mesh-ancestor
5535188|NCT04217096|Paclitaxel|paclitaxel|mesh-list
5535189|NCT04217096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5535190|NCT04217096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5535191|NCT04217096|Tubulin Modulators|tubulin modulators|mesh-ancestor
6125673|NCT01167712|Immunoglobulins|immunoglobulins|mesh-list
6125674|NCT01167712|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6125675|NCT01167712|Immunoglobulin G|immunoglobulin g|mesh-list
6125676|NCT01167712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6125677|NCT01167712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6125678|NCT01167712|Tubulin Modulators|tubulin modulators|mesh-ancestor
6125679|NCT01167712|Antimitotic Agents|antimitotic agents|mesh-ancestor
6125680|NCT01167712|Mitosis Modulators|mitosis modulators|mesh-ancestor
6125681|NCT01167712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125682|NCT01167712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6125683|NCT01167712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6125684|NCT01167712|Growth Substances|growth substances|mesh-ancestor
6125685|NCT01167712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125686|NCT01167712|Growth Inhibitors|growth inhibitors|mesh-ancestor
6125687|NCT01167712|Immunologic Factors|immunologic factors|mesh-ancestor
6125688|NCT01167829|Testosterone|testosterone|mesh-list
6125689|NCT01167829|Acyline|acyline|mesh-list
6125690|NCT01167829|Androgens|androgens|mesh-ancestor
6125691|NCT01167829|Hormones|hormones|mesh-ancestor
6125692|NCT01167829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6125693|NCT01167829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125694|NCT01167829|Hormone Antagonists|hormone antagonists|mesh-ancestor
6466094|NCT00477217|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6466095|NCT00477217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466096|NCT00477282|Topotecan|topotecan|mesh-list
6466097|NCT00477282|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6466098|NCT00477282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6466099|NCT00477282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6466100|NCT00477282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466101|NCT00477282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6466102|NCT00477347|Anesthetics|anesthetics|mesh-list
6125695|NCT01167881|Glimepiride|glimepiride|mesh-list
6125696|NCT01167881|Empagliflozin|empagliflozin|mesh-list
6125697|NCT01167881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6125698|NCT01167881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6125699|NCT01167881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125700|NCT01167881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5535192|NCT04217096|Antimitotic Agents|antimitotic agents|mesh-ancestor
5535193|NCT04217096|Mitosis Modulators|mitosis modulators|mesh-ancestor
5535194|NCT04217096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535195|NCT04216758|Gemcitabine|gemcitabine|mesh-list
5535196|NCT04216758|Paclitaxel|paclitaxel|mesh-list
5535197|NCT04216758|Tegafur|tegafur|mesh-list
5535198|NCT04216758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5535199|NCT04216758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5535200|NCT04216758|Tubulin Modulators|tubulin modulators|mesh-ancestor
5535201|NCT04216758|Antimitotic Agents|antimitotic agents|mesh-ancestor
5535202|NCT04216758|Mitosis Modulators|mitosis modulators|mesh-ancestor
5535203|NCT04216758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535204|NCT04216758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5535205|NCT04216758|Antimetabolites|antimetabolites|mesh-ancestor
5535206|NCT04216758|Antiviral Agents|antiviral agents|mesh-ancestor
5535207|NCT04216758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5535208|NCT04216758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5535209|NCT04216758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5535210|NCT04216758|Immunologic Factors|immunologic factors|mesh-ancestor
5535211|NCT04216758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535212|NCT04216784|Furosemide|furosemide|mesh-list
5535213|NCT04216784|Diuretics|diuretics|mesh-ancestor
5535214|NCT04216784|Natriuretic Agents|natriuretic agents|mesh-ancestor
5535215|NCT04216784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535216|NCT04216784|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5535217|NCT04216784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5535218|NCT04216784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535219|NCT04216706|Calcium Channel Blockers|calcium channel blockers|mesh-list
6125701|NCT01167881|Immunologic Factors|immunologic factors|mesh-ancestor
6125702|NCT01167881|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6125703|NCT01167881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125704|NCT01167907|Ropivacaine|ropivacaine|mesh-list
6125705|NCT01167907|Anesthetics, Local|anesthetics, local|mesh-ancestor
6125706|NCT01167907|Anesthetics|anesthetics|mesh-ancestor
6125707|NCT01167907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6125708|NCT01167907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125709|NCT01167907|Sensory System Agents|sensory system agents|mesh-ancestor
6125710|NCT01167907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6125711|NCT01168232|Epothilones|epothilones|mesh-list
6125712|NCT01168232|Epothilone B|epothilone b|mesh-list
6125713|NCT01168232|Tubulin Modulators|tubulin modulators|mesh-ancestor
6125714|NCT01168232|Antimitotic Agents|antimitotic agents|mesh-ancestor
6125715|NCT01168232|Mitosis Modulators|mitosis modulators|mesh-ancestor
6125716|NCT01168232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125717|NCT01168232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6125718|NCT01168349|Epoetin Alfa|epoetin alfa|mesh-list
6125719|NCT01168349|Hematinics|hematinics|mesh-ancestor
6125720|NCT01168596|Rasagiline|rasagiline|mesh-list
6125721|NCT01168596|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6125722|NCT01168596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6125723|NCT01168596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125724|NCT01168596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6125725|NCT01168596|Protective Agents|protective agents|mesh-ancestor
6125726|NCT01168596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125727|NCT01168674|Ziprasidone|ziprasidone|mesh-list
6666155|NCT01521130|Anticonvulsants|anticonvulsants|mesh-ancestor
5535220|NCT04216706|Sympatholytics|sympatholytics|mesh-list
5535221|NCT04216706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5535222|NCT04216706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535223|NCT04216706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5535224|NCT04216706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535225|NCT04216706|Autonomic Agents|autonomic agents|mesh-ancestor
5535226|NCT04216706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6125728|NCT01168674|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6125729|NCT01168674|Serotonin Agents|serotonin agents|mesh-ancestor
6125730|NCT01168674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6125731|NCT01168674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125732|NCT01168674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125733|NCT01168674|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6125734|NCT01168674|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6125735|NCT01168674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6125736|NCT01168674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6125737|NCT01168674|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6125738|NCT01168674|Dopamine Agents|dopamine agents|mesh-ancestor
6125739|NCT01168687|Levetiracetam|levetiracetam|mesh-list
6125740|NCT01168687|Anticonvulsants|anticonvulsants|mesh-ancestor
6125741|NCT01168687|Nootropic Agents|nootropic agents|mesh-ancestor
5535227|NCT04216797|Diazepam|diazepam|mesh-list
5535228|NCT04216797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5535229|NCT04216797|Anticonvulsants|anticonvulsants|mesh-ancestor
5535230|NCT04216797|Antiemetics|antiemetics|mesh-ancestor
5535231|NCT04216797|Autonomic Agents|autonomic agents|mesh-ancestor
5535232|NCT04216797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5535233|NCT04216797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535234|NCT04216797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5535235|NCT04216797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5535236|NCT04216797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5535237|NCT04216797|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5535238|NCT04216797|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5535239|NCT04216797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5535240|NCT04216797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6204813|NCT02078180|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6204814|NCT02078180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6204815|NCT02078180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6204816|NCT02078180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204817|NCT02078180|Dopamine Agents|dopamine agents|mesh-ancestor
6204818|NCT02078180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6204819|NCT02078180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204820|NCT02078180|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6204821|NCT02078180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6204822|NCT02078180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6204823|NCT02078193|Abatacept|abatacept|mesh-list
6204824|NCT02078193|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6204825|NCT02078193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204826|NCT02078193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6204827|NCT02078193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6204828|NCT02078193|Immunologic Factors|immunologic factors|mesh-ancestor
6204829|NCT02078193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204830|NCT02078193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6204831|NCT02078219|Allopurinol|allopurinol|mesh-list
6204832|NCT02078219|Verinurad|verinurad|mesh-list
6204833|NCT02078219|Antimetabolites|antimetabolites|mesh-ancestor
6204834|NCT02078219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204835|NCT02078219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6204836|NCT02078219|Gout Suppressants|gout suppressants|mesh-ancestor
6204837|NCT02078219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6204838|NCT02078219|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6204839|NCT02078219|Antioxidants|antioxidants|mesh-ancestor
6204840|NCT02078219|Protective Agents|protective agents|mesh-ancestor
6204841|NCT02078219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204842|NCT02078284|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
6204843|NCT02078284|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6204844|NCT02078284|Protective Agents|protective agents|mesh-ancestor
5535241|NCT04216797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5535242|NCT04216797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5535243|NCT04216797|Anesthetics, General|anesthetics, general|mesh-ancestor
5535244|NCT04216797|Anesthetics|anesthetics|mesh-ancestor
5535245|NCT04216797|GABA Modulators|gaba modulators|mesh-ancestor
5535246|NCT04216797|GABA Agents|gaba agents|mesh-ancestor
5535247|NCT04216797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5535248|NCT04216797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535249|NCT04216888|Ketamine|ketamine|mesh-list
5535250|NCT04216888|Analgesics|analgesics|mesh-ancestor
6125742|NCT01168908|Sildenafil Citrate|sildenafil citrate|mesh-list
6125743|NCT01168908|Vasodilator Agents|vasodilator agents|mesh-ancestor
6125744|NCT01168908|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6125745|NCT01168908|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6125746|NCT01168908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6125747|NCT01168908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125748|NCT01168908|Urological Agents|urological agents|mesh-ancestor
6125749|NCT01168934|Crizotinib|crizotinib|mesh-list
6125750|NCT01168934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6125751|NCT01168934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6125752|NCT01168934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6125753|NCT01168934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125754|NCT01168973|Docetaxel|docetaxel|mesh-list
6125755|NCT01168973|Ramucirumab|ramucirumab|mesh-list
6125756|NCT01168973|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6125757|NCT01168973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6125758|NCT01168973|Tubulin Modulators|tubulin modulators|mesh-ancestor
6125759|NCT01168973|Antimitotic Agents|antimitotic agents|mesh-ancestor
5535251|NCT04216888|Sensory System Agents|sensory system agents|mesh-ancestor
6125760|NCT01168973|Mitosis Modulators|mitosis modulators|mesh-ancestor
6125761|NCT01168973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125762|NCT01168973|Immunologic Factors|immunologic factors|mesh-ancestor
6125763|NCT01168973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125764|NCT01169038|Azithromycin|azithromycin|mesh-list
6125765|NCT01169038|Rifampin|rifampin|mesh-list
6125766|NCT01169038|Ethambutol|ethambutol|mesh-list
6125767|NCT01169038|Levofloxacin|levofloxacin|mesh-list
6125768|NCT01169038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6125769|NCT01169038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6125770|NCT01169038|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6125771|NCT01169038|Antitubercular Agents|antitubercular agents|mesh-ancestor
6125772|NCT01169038|Leprostatic Agents|leprostatic agents|mesh-ancestor
6125773|NCT01169038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6125774|NCT01169038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6125775|NCT01169038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125776|NCT01169038|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6125777|NCT01169038|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6125778|NCT01169038|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6125779|NCT01169038|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6125780|NCT01169038|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6125781|NCT01169038|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6125782|NCT01169038|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6125783|NCT01169038|Renal Agents|renal agents|mesh-ancestor
6125784|NCT01169038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6125785|NCT01169038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6125786|NCT01169038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6125787|NCT01169038|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6666156|NCT01521130|Nootropic Agents|nootropic agents|mesh-ancestor
5535252|NCT04216888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6125788|NCT01169038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6125789|NCT01169103|Hormones|hormones|mesh-list
6125790|NCT01169103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6125791|NCT01169103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125792|NCT01169259|Vitamin D|vitamin d|mesh-list
6125793|NCT01169259|Ergocalciferols|ergocalciferols|mesh-list
5535253|NCT04216888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535254|NCT04216888|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5535255|NCT04216888|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6125794|NCT01169259|Cholecalciferol|cholecalciferol|mesh-list
6125795|NCT01169259|Vitamins|vitamins|mesh-list
6125796|NCT01169259|Micronutrients|micronutrients|mesh-ancestor
6125797|NCT01169259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125798|NCT01169259|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6125799|NCT01169259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6125800|NCT01169337|Lenalidomide|lenalidomide|mesh-list
6125801|NCT01169337|Immunologic Factors|immunologic factors|mesh-ancestor
6125802|NCT01169337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125803|NCT01169337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6125804|NCT01169337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6125805|NCT01169337|Growth Substances|growth substances|mesh-ancestor
6125806|NCT01169337|Growth Inhibitors|growth inhibitors|mesh-ancestor
6125807|NCT01169337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6125808|NCT01169350|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6125809|NCT01169350|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6125810|NCT01169350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125811|NCT01169467|Dexmedetomidine|dexmedetomidine|mesh-list
6125812|NCT01169467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6125813|NCT01169467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6125814|NCT01169467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125815|NCT01169467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6125816|NCT01169467|Analgesics|analgesics|mesh-ancestor
6125817|NCT01169467|Sensory System Agents|sensory system agents|mesh-ancestor
6125818|NCT01169467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6125819|NCT01169467|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6125820|NCT01169467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6125821|NCT01169467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6125822|NCT01169467|Adrenergic Agents|adrenergic agents|mesh-ancestor
6125823|NCT01169467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6125824|NCT01169467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125825|NCT01169519|Sildenafil Citrate|sildenafil citrate|mesh-list
6125826|NCT01169519|Vasodilator Agents|vasodilator agents|mesh-ancestor
6125827|NCT01169519|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6125828|NCT01169519|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6125829|NCT01169519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6125830|NCT01169519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125831|NCT01169519|Urological Agents|urological agents|mesh-ancestor
6125832|NCT01169532|Vorinostat|vorinostat|mesh-list
6125833|NCT01169532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6125834|NCT01169532|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6125835|NCT01169532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6666157|NCT01521299|Hydroxyurea|hydroxyurea|mesh-list
5535256|NCT04216888|Anesthetics, General|anesthetics, general|mesh-ancestor
5535257|NCT04216888|Anesthetics|anesthetics|mesh-ancestor
5535258|NCT04216888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5535259|NCT04216888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5535260|NCT04216888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5535261|NCT04216888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5535262|NCT04216888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535263|NCT04216628|Oxytocin|oxytocin|mesh-list
5535264|NCT04216628|Oxytocics|oxytocics|mesh-ancestor
5535265|NCT04216628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5535266|NCT04216628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535267|NCT04216693|Digoxin|digoxin|mesh-list
5535268|NCT04216693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5535269|NCT04216693|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5535270|NCT04216693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5535271|NCT04216693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535272|NCT04216693|Protective Agents|protective agents|mesh-ancestor
5535273|NCT04216693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535274|NCT04216511|Autoantibodies|autoantibodies|mesh-list
5535275|NCT04216511|Immunologic Factors|immunologic factors|mesh-ancestor
5535276|NCT04216511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535277|NCT04216459|Cholecalciferol|cholecalciferol|mesh-list
6125836|NCT01169532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125837|NCT01169558|Bevacizumab|bevacizumab|mesh-list
6125838|NCT01169558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6125839|NCT01169558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6125840|NCT01169558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6125841|NCT01169558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6125842|NCT01169558|Growth Substances|growth substances|mesh-ancestor
6125843|NCT01169558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125844|NCT01169558|Growth Inhibitors|growth inhibitors|mesh-ancestor
6125845|NCT01169636|Carboplatin|carboplatin|mesh-list
6125846|NCT01169636|Etoposide|etoposide|mesh-list
6125847|NCT01169636|Ifosfamide|ifosfamide|mesh-list
6125848|NCT01169636|Panobinostat|panobinostat|mesh-list
6125849|NCT01169636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6125850|NCT01169636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6125851|NCT01169636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6125852|NCT01169636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6125853|NCT01169636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5535278|NCT04216459|Ascorbic Acid|ascorbic acid|mesh-list
5535279|NCT04216459|Thiamine|thiamine|mesh-list
5535280|NCT04216459|Vitamins|vitamins|mesh-ancestor
6125854|NCT01169636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125855|NCT01169636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6125856|NCT01169636|Alkylating Agents|alkylating agents|mesh-ancestor
6125857|NCT01169636|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6125858|NCT01169675|Pemetrexed|pemetrexed|mesh-list
6125859|NCT01169675|Afatinib|afatinib|mesh-list
6125860|NCT01169675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6125861|NCT01169675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5535281|NCT04216459|Micronutrients|micronutrients|mesh-ancestor
5535282|NCT04216459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535283|NCT04216459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5535284|NCT04216459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5535285|NCT04216459|Antioxidants|antioxidants|mesh-ancestor
5535286|NCT04216459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125862|NCT01169675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125863|NCT01169675|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6125864|NCT01169675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6125865|NCT01169675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6125866|NCT01169701|Mycophenolic Acid|mycophenolic acid|mesh-list
5535287|NCT04216459|Protective Agents|protective agents|mesh-ancestor
5535288|NCT04216459|Vitamin B Complex|vitamin b complex|mesh-ancestor
5535289|NCT04216355|Azacitidine|azacitidine|mesh-list
5535290|NCT04216355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5535291|NCT04216355|Antimetabolites|antimetabolites|mesh-ancestor
5535292|NCT04216355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535293|NCT04216355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5535294|NCT04216355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5535295|NCT04216251|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
6125867|NCT01169701|Everolimus|everolimus|mesh-list
6125868|NCT01169701|Tacrolimus|tacrolimus|mesh-list
6125869|NCT01169701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6125870|NCT01169701|Immunologic Factors|immunologic factors|mesh-ancestor
6125871|NCT01169701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125872|NCT01169701|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6125873|NCT01169701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6125874|NCT01169701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125875|NCT01169701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6125876|NCT01169701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6125877|NCT01169701|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6125878|NCT01169701|Antitubercular Agents|antitubercular agents|mesh-ancestor
6125879|NCT01169701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6125880|NCT01169701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6125881|NCT01169779|Metformin|metformin|mesh-list
6125882|NCT01169779|Lixisenatide|lixisenatide|mesh-list
6125883|NCT01169779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6125884|NCT01169779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535296|NCT04216251|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5535297|NCT04216251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5535298|NCT04216771|Cytarabine|cytarabine|mesh-list
5535299|NCT04216771|Idarubicin|idarubicin|mesh-list
5535300|NCT04216771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6125885|NCT01170039|Lubiprostone|lubiprostone|mesh-list
6125886|NCT01170039|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6125887|NCT01170039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6125888|NCT01170039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125889|NCT01170065|Nintedanib|nintedanib|mesh-list
6125890|NCT01170065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6125891|NCT01170065|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6125892|NCT01170065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6125893|NCT01170065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125894|NCT01170117|Olanzapine|olanzapine|mesh-list
6125895|NCT01170117|Antiemetics|antiemetics|mesh-ancestor
6125896|NCT01170117|Autonomic Agents|autonomic agents|mesh-ancestor
6125897|NCT01170117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6125898|NCT01170117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125899|NCT01170117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6125900|NCT01170117|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6125901|NCT01170117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6125902|NCT01170117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6125903|NCT01170117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6125904|NCT01170117|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6125905|NCT01170117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6125906|NCT01170117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6125907|NCT01170117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125908|NCT01170117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6125909|NCT01170117|Serotonin Agents|serotonin agents|mesh-ancestor
6125910|NCT01170208|Insulin|insulin|mesh-list
6125911|NCT01170208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6125912|NCT01170208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125913|NCT01170221|Linezolid|linezolid|mesh-list
6125914|NCT01170221|Tedizolid phosphate|tedizolid phosphate|mesh-list
6125915|NCT01170221|Tedizolid|tedizolid|mesh-list
6125916|NCT01170221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6125917|NCT01170221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6125918|NCT01170221|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6125919|NCT01170221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6125920|NCT01170221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125921|NCT01170247|Ketamine|ketamine|mesh-list
6125922|NCT01170247|Analgesics|analgesics|mesh-ancestor
6125923|NCT01170247|Sensory System Agents|sensory system agents|mesh-ancestor
6125924|NCT01170247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6125925|NCT01170247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125926|NCT01170247|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6125927|NCT01170247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6125928|NCT01170247|Anesthetics, General|anesthetics, general|mesh-ancestor
6125929|NCT01170247|Anesthetics|anesthetics|mesh-ancestor
6125930|NCT01170247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6125931|NCT01170247|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6125932|NCT01170247|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6125933|NCT01170247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5535301|NCT04216771|Antimetabolites|antimetabolites|mesh-ancestor
5535302|NCT04216771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535303|NCT04216771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5535304|NCT04216771|Antiviral Agents|antiviral agents|mesh-ancestor
5535305|NCT04216771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5535306|NCT04216771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5535307|NCT04216771|Immunologic Factors|immunologic factors|mesh-ancestor
5535308|NCT04216771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535309|NCT04216771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5535310|NCT04216771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5535311|NCT04216771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5535312|NCT04216771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5535313|NCT04216550|Apatinib|apatinib|mesh-list
5535314|NCT04216550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5535315|NCT04216550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5535316|NCT04216550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6125934|NCT01170247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125935|NCT01170273|Vitamin D|vitamin d|mesh-list
6125936|NCT01170273|Vitamins|vitamins|mesh-ancestor
6125937|NCT01170273|Micronutrients|micronutrients|mesh-ancestor
6125938|NCT01170273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125939|NCT01170273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6125940|NCT01170364|Sibutramine|sibutramine|mesh-list
6125941|NCT01170364|Antidepressive Agents|antidepressive agents|mesh-ancestor
6125942|NCT01170364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6125943|NCT01170364|Appetite Depressants|appetite depressants|mesh-ancestor
5535317|NCT04216550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535318|NCT04216472|Paclitaxel|paclitaxel|mesh-list
6125944|NCT01170364|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6125945|NCT01170390|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6125946|NCT01170390|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6125947|NCT01170390|Levonorgestrel|levonorgestrel|mesh-list
5535319|NCT04216472|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5535320|NCT04216472|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
5535321|NCT04216472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6125948|NCT01170390|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6125949|NCT01170390|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
6125950|NCT01170390|Estradiol|estradiol|mesh-list
6125951|NCT01170390|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6125952|NCT01170390|Estrogens|estrogens|mesh-ancestor
6125953|NCT01170390|Hormones|hormones|mesh-ancestor
6125954|NCT01170390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6125955|NCT01170390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125956|NCT01170390|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6125957|NCT01170390|Contraceptive Agents|contraceptive agents|mesh-ancestor
6125958|NCT01170390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6125959|NCT01170390|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6125960|NCT01170390|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6125961|NCT01170390|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6125962|NCT01170390|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6125963|NCT01170390|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6125964|NCT01170533|Omeprazole|omeprazole|mesh-list
6125965|NCT01170533|Pantoprazole|pantoprazole|mesh-list
6125966|NCT01170533|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6125967|NCT01170533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6125968|NCT01170533|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6125969|NCT01170533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6125970|NCT01170533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125971|NCT01170663|Paclitaxel|paclitaxel|mesh-list
6125972|NCT01170663|Ramucirumab|ramucirumab|mesh-list
6125973|NCT01170663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6125974|NCT01170663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6125975|NCT01170663|Tubulin Modulators|tubulin modulators|mesh-ancestor
6125976|NCT01170663|Antimitotic Agents|antimitotic agents|mesh-ancestor
6125977|NCT01170663|Mitosis Modulators|mitosis modulators|mesh-ancestor
6125978|NCT01170663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6125979|NCT01170715|Etanercept|etanercept|mesh-list
6125980|NCT01170715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6125981|NCT01170715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6125982|NCT01170715|Analgesics|analgesics|mesh-ancestor
6125983|NCT01170715|Sensory System Agents|sensory system agents|mesh-ancestor
6125984|NCT01170715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6125985|NCT01170715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6125986|NCT01170715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6125987|NCT01170715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6125988|NCT01170715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6125989|NCT01170715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6125990|NCT01170715|Immunologic Factors|immunologic factors|mesh-ancestor
6125991|NCT01170754|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
6125992|NCT01170754|Laxatives|laxatives|mesh-ancestor
6125993|NCT01170754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6125994|NCT01170884|Timolol|timolol|mesh-list
5535322|NCT04216472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5535323|NCT04216472|Tubulin Modulators|tubulin modulators|mesh-ancestor
5535324|NCT04216472|Antimitotic Agents|antimitotic agents|mesh-ancestor
5535325|NCT04216472|Mitosis Modulators|mitosis modulators|mesh-ancestor
5535326|NCT04216472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535327|NCT04216472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5535328|NCT04216043|Caseins|caseins|mesh-list
5535329|NCT04216043|Chelating Agents|chelating agents|mesh-ancestor
5535330|NCT04216043|Sequestering Agents|sequestering agents|mesh-ancestor
5535331|NCT04216043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535332|NCT04216186|Ubiquinone|ubiquinone|mesh-list
5535333|NCT04216186|Coenzyme Q10|coenzyme q10|mesh-list
5535334|NCT04216186|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
5535335|NCT04216186|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5535336|NCT04216186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5535337|NCT04216186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5535338|NCT04216186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535339|NCT04216186|Adrenergic Agents|adrenergic agents|mesh-ancestor
5535340|NCT04216186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5535341|NCT04216186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535342|NCT04216186|Micronutrients|micronutrients|mesh-ancestor
5535343|NCT04216186|Vitamins|vitamins|mesh-ancestor
5535344|NCT04216017|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5535345|NCT04216017|Lidocaine|lidocaine|mesh-list
5535346|NCT04216017|Anesthetics, Local|anesthetics, local|mesh-ancestor
5535347|NCT04216017|Anesthetics|anesthetics|mesh-ancestor
5535348|NCT04216017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5535349|NCT04216017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535350|NCT04216017|Sensory System Agents|sensory system agents|mesh-ancestor
5535351|NCT04216017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6125995|NCT01170884|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6125996|NCT01170884|Bimatoprost|bimatoprost|mesh-list
6125997|NCT01170884|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6125998|NCT01170884|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6125999|NCT01170884|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6126000|NCT01170884|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6126001|NCT01170884|Adrenergic Agents|adrenergic agents|mesh-ancestor
6126002|NCT01170884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6126003|NCT01170884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126004|NCT01170884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126005|NCT01170884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6126006|NCT01170884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6126007|NCT01170884|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6126008|NCT01170884|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6126009|NCT01170884|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6126010|NCT01170949|Miltefosine|miltefosine|mesh-list
6126011|NCT01170949|Antifungal Agents|antifungal agents|mesh-ancestor
6126012|NCT01170949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6126013|NCT01170949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6126014|NCT01170949|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6126015|NCT01170949|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6126016|NCT01170962|Ribavirin|ribavirin|mesh-list
6126017|NCT01170962|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6126018|NCT01170962|Antimetabolites|antimetabolites|mesh-ancestor
6126019|NCT01170962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126020|NCT01170962|Antiviral Agents|antiviral agents|mesh-ancestor
6126021|NCT01170962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6126022|NCT01171118|Physostigmine|physostigmine|mesh-list
6126023|NCT01171118|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6126024|NCT01171118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6126025|NCT01171118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126026|NCT01171118|Cholinergic Agents|cholinergic agents|mesh-ancestor
6126027|NCT01171118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6126028|NCT01171118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126029|NCT01171118|Miotics|miotics|mesh-ancestor
6126030|NCT01171118|Autonomic Agents|autonomic agents|mesh-ancestor
6126031|NCT01171118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6126032|NCT01171183|Carvedilol|carvedilol|mesh-list
5535352|NCT04216017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5535353|NCT04216017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5535354|NCT04216017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5535355|NCT04216017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5535356|NCT04216017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535357|NCT04216017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5535358|NCT04216017|Glucocorticoids|glucocorticoids|mesh-ancestor
5535359|NCT04216017|Hormones|hormones|mesh-ancestor
5535360|NCT04216017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5535361|NCT04216017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5535362|NCT04216017|Immunologic Factors|immunologic factors|mesh-ancestor
5535363|NCT04215965|Dialysis Solutions|dialysis solutions|mesh-list
5535364|NCT04215965|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5535365|NCT04215653|Rabeprazole|rabeprazole|mesh-list
5535366|NCT04215653|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5535367|NCT04215653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5535368|NCT04215653|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5535369|NCT04215653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5535370|NCT04215653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535371|NCT04215731|Leucovorin|leucovorin|mesh-list
5535372|NCT04215731|Bevacizumab|bevacizumab|mesh-list
5535373|NCT04215731|Fluorouracil|fluorouracil|mesh-list
5535374|NCT04215731|Oxaliplatin|oxaliplatin|mesh-list
5535375|NCT04215731|Irinotecan|irinotecan|mesh-list
5535376|NCT04215731|Levoleucovorin|levoleucovorin|mesh-list
5535377|NCT04215731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5535378|NCT04215731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6126033|NCT01171183|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6126034|NCT01171183|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5535379|NCT04215731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6126035|NCT01171183|Adrenergic Agents|adrenergic agents|mesh-ancestor
6126036|NCT01171183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6126037|NCT01171183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126038|NCT01171183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126039|NCT01171183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6126040|NCT01171183|Antioxidants|antioxidants|mesh-ancestor
6126041|NCT01171183|Protective Agents|protective agents|mesh-ancestor
6126042|NCT01171183|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6126043|NCT01171183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6126044|NCT01171183|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6126045|NCT01171183|Vasodilator Agents|vasodilator agents|mesh-ancestor
6126046|NCT01171183|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6126047|NCT01171183|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6126048|NCT01171690|Teriparatide|teriparatide|mesh-list
6126049|NCT01171690|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6126050|NCT01171690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126051|NCT01171690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6126052|NCT01171794|Ibuprofen|ibuprofen|mesh-list
6126053|NCT01171794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6126054|NCT01171794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6126055|NCT01171794|Analgesics|analgesics|mesh-ancestor
6126056|NCT01171794|Sensory System Agents|sensory system agents|mesh-ancestor
6126057|NCT01171794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6126058|NCT01171794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126059|NCT01171794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6126060|NCT01171794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6126061|NCT01171794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6126062|NCT01171794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6126063|NCT01171794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126064|NCT01171963|Vaccines|vaccines|mesh-list
6126065|NCT01171963|Immunologic Factors|immunologic factors|mesh-ancestor
6126066|NCT01171963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126067|NCT01171976|Ranibizumab|ranibizumab|mesh-list
6126068|NCT01171976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6126069|NCT01171976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6126070|NCT01171976|Growth Substances|growth substances|mesh-ancestor
6126071|NCT01171976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126072|NCT01171976|Growth Inhibitors|growth inhibitors|mesh-ancestor
6126073|NCT01171976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6126074|NCT01172145|Modafinil|modafinil|mesh-list
6126075|NCT01172145|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6666158|NCT01521299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6666159|NCT01521299|Antisickling Agents|antisickling agents|mesh-ancestor
6666160|NCT01521299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6666161|NCT01521299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666162|NCT01521299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6666163|NCT01521312|Saxagliptin|saxagliptin|mesh-list
6666164|NCT01521312|Incretins|incretins|mesh-ancestor
6666165|NCT01521312|Hormones|hormones|mesh-ancestor
6666166|NCT01521312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6666167|NCT01521312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666168|NCT01521312|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6666169|NCT01521312|Protease Inhibitors|protease inhibitors|mesh-ancestor
6666170|NCT01521312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6672422|NCT01555970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6126076|NCT01172145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535380|NCT04215731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5535381|NCT04215731|Growth Substances|growth substances|mesh-ancestor
5535382|NCT04215731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535383|NCT04215731|Growth Inhibitors|growth inhibitors|mesh-ancestor
5535384|NCT04215731|Antimetabolites|antimetabolites|mesh-ancestor
5535385|NCT04215731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535386|NCT04215731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6126077|NCT01172145|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6126078|NCT01172145|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6126079|NCT01172145|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6126080|NCT01172145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126081|NCT01172197|Ropivacaine|ropivacaine|mesh-list
6126082|NCT01172197|Levobupivacaine|levobupivacaine|mesh-list
6126083|NCT01172197|Anesthetics, Local|anesthetics, local|mesh-ancestor
6126084|NCT01172197|Anesthetics|anesthetics|mesh-ancestor
6126085|NCT01172197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6126086|NCT01172197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126087|NCT01172197|Sensory System Agents|sensory system agents|mesh-ancestor
6126088|NCT01172197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6126089|NCT01172275|Acetylcysteine|acetylcysteine|mesh-list
6126090|NCT01172275|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6126091|NCT01172275|Antiviral Agents|antiviral agents|mesh-ancestor
6126092|NCT01172275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6126093|NCT01172275|Expectorants|expectorants|mesh-ancestor
6126094|NCT01172275|Respiratory System Agents|respiratory system agents|mesh-ancestor
6126095|NCT01172275|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6126096|NCT01172275|Antioxidants|antioxidants|mesh-ancestor
6126097|NCT01172275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126098|NCT01172275|Protective Agents|protective agents|mesh-ancestor
6126099|NCT01172275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126100|NCT01172275|Antidotes|antidotes|mesh-ancestor
6126101|NCT01172288|Acetylcysteine|acetylcysteine|mesh-list
6126102|NCT01172288|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6126103|NCT01172288|Antiviral Agents|antiviral agents|mesh-ancestor
6126104|NCT01172288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6126105|NCT01172288|Expectorants|expectorants|mesh-ancestor
6126106|NCT01172288|Respiratory System Agents|respiratory system agents|mesh-ancestor
6126107|NCT01172288|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6126108|NCT01172288|Antioxidants|antioxidants|mesh-ancestor
6126109|NCT01172288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126110|NCT01172288|Protective Agents|protective agents|mesh-ancestor
6126111|NCT01172288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126112|NCT01172288|Antidotes|antidotes|mesh-ancestor
6126113|NCT01172418|Alemtuzumab|alemtuzumab|mesh-list
6126114|NCT01172418|Thymoglobulin|thymoglobulin|mesh-list
6126115|NCT01172418|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6126116|NCT01172418|Daclizumab|daclizumab|mesh-list
6126117|NCT01172418|Immunologic Factors|immunologic factors|mesh-ancestor
6126118|NCT01172418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126119|NCT01172418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6126120|NCT01172418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6126121|NCT01172418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6126122|NCT01172522|Fexofenadine|fexofenadine|mesh-list
6126123|NCT01172522|Terfenadine|terfenadine|mesh-list
6126124|NCT01172522|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5535387|NCT04215731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5535388|NCT04215731|Immunologic Factors|immunologic factors|mesh-ancestor
5535389|NCT04215731|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5535390|NCT04215731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6126125|NCT01172522|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6126126|NCT01172522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6126127|NCT01172522|Histamine Antagonists|histamine antagonists|mesh-ancestor
6126128|NCT01172522|Histamine Agents|histamine agents|mesh-ancestor
6126129|NCT01172522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6126130|NCT01172522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126131|NCT01172522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126132|NCT01172535|Ritonavir|ritonavir|mesh-list
6126133|NCT01172535|Lopinavir|lopinavir|mesh-list
6126134|NCT01172535|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6126135|NCT01172535|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6126136|NCT01172535|Protease Inhibitors|protease inhibitors|mesh-ancestor
6126137|NCT01172535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6126138|NCT01172535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126139|NCT01172535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6126140|NCT01172535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6126141|NCT01172535|Antiviral Agents|antiviral agents|mesh-ancestor
6126142|NCT01172535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6126143|NCT01172535|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6126144|NCT01172535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6126145|NCT01172600|Nitrous Oxide|nitrous oxide|mesh-list
6126146|NCT01172600|Entonox|entonox|mesh-list
6126147|NCT01172600|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6126148|NCT01172600|Anesthetics, General|anesthetics, general|mesh-ancestor
5535391|NCT04215731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5535392|NCT04215731|Antidotes|antidotes|mesh-ancestor
5535393|NCT04215731|Protective Agents|protective agents|mesh-ancestor
5535394|NCT04215731|Vitamin B Complex|vitamin b complex|mesh-ancestor
5535395|NCT04215731|Vitamins|vitamins|mesh-ancestor
5535396|NCT04215731|Micronutrients|micronutrients|mesh-ancestor
6126149|NCT01172600|Anesthetics|anesthetics|mesh-ancestor
6126150|NCT01172600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5535397|NCT04215614|Lidocaine|lidocaine|mesh-list
5535398|NCT04215614|Bupivacaine|bupivacaine|mesh-list
6126151|NCT01172600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126152|NCT01172600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6126153|NCT01172600|Analgesics|analgesics|mesh-ancestor
6126154|NCT01172600|Sensory System Agents|sensory system agents|mesh-ancestor
6126155|NCT01172600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6126156|NCT01172600|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
6126157|NCT01172639|Sulfasalazine|sulfasalazine|mesh-list
6126158|NCT01172639|Prednisone|prednisone|mesh-list
6126159|NCT01172639|Methotrexate|methotrexate|mesh-list
6126160|NCT01172639|Leflunomide|leflunomide|mesh-list
6126161|NCT01172639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6126162|NCT01172639|Glucocorticoids|glucocorticoids|mesh-ancestor
6126163|NCT01172639|Hormones|hormones|mesh-ancestor
6126164|NCT01172639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5535399|NCT04215614|Anesthetics, Local|anesthetics, local|mesh-ancestor
5535400|NCT04215614|Anesthetics|anesthetics|mesh-ancestor
5535401|NCT04215614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5535402|NCT04215614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535403|NCT04215614|Sensory System Agents|sensory system agents|mesh-ancestor
5535404|NCT04215614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5535405|NCT04215614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6126165|NCT01172639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126166|NCT01172639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6126167|NCT01172639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6126168|NCT01172639|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6126169|NCT01172639|Abortifacient Agents|abortifacient agents|mesh-ancestor
6126170|NCT01172639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6126171|NCT01172639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6126172|NCT01172639|Antimetabolites|antimetabolites|mesh-ancestor
6126173|NCT01172639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126174|NCT01172639|Dermatologic Agents|dermatologic agents|mesh-ancestor
6126175|NCT01172639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6126176|NCT01172639|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6126177|NCT01172639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6126178|NCT01172639|Immunologic Factors|immunologic factors|mesh-ancestor
5535406|NCT04215614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5535407|NCT04215614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5535408|NCT04215614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5535409|NCT04215614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535410|NCT04215588|Hemostatics|hemostatics|mesh-list
5535411|NCT04215588|Coagulants|coagulants|mesh-ancestor
5535412|NCT04215835|Letrozole|letrozole|mesh-list
5535413|NCT04215835|Misoprostol|misoprostol|mesh-list
5535414|NCT04215835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5535415|NCT04215835|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5535416|NCT04215835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5535417|NCT04215835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5535418|NCT04215835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535419|NCT04215835|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5535420|NCT04215835|Hormone Antagonists|hormone antagonists|mesh-ancestor
5535421|NCT04215835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5535422|NCT04215835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535423|NCT04215835|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5535424|NCT04215835|Abortifacient Agents|abortifacient agents|mesh-ancestor
5535425|NCT04215835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5535426|NCT04215835|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5535427|NCT04215835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5535428|NCT04215835|Oxytocics|oxytocics|mesh-ancestor
5535429|NCT04215770|Penicillins|penicillins|mesh-list
6126179|NCT01172639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6126180|NCT01172639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6126181|NCT01172639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6126182|NCT01172639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6126183|NCT01172639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6126184|NCT01172639|Analgesics|analgesics|mesh-ancestor
5535430|NCT04215770|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5535431|NCT04215770|Penicillin G|penicillin g|mesh-list
5535432|NCT04215770|Penicillin G Benzathine|penicillin g benzathine|mesh-list
5535433|NCT04215770|Penicillin G Procaine|penicillin g procaine|mesh-list
5535434|NCT04215770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5535435|NCT04215770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5535436|NCT04215770|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6126185|NCT01172639|Sensory System Agents|sensory system agents|mesh-ancestor
6126186|NCT01172639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6126187|NCT01172639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5535437|NCT04215770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5535438|NCT04215770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535439|NCT04215536|Empagliflozin|empagliflozin|mesh-list
5535440|NCT04215536|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
5535441|NCT04215536|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5535442|NCT04215536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535443|NCT04215536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5535444|NCT04215536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535445|NCT04215536|Protease Inhibitors|protease inhibitors|mesh-ancestor
5535446|NCT04215536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5535447|NCT04215471|Antibodies|antibodies|mesh-list
6126188|NCT01172808|Tiotropium Bromide|tiotropium bromide|mesh-list
6126189|NCT01172808|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6126190|NCT01172808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6126191|NCT01172808|Autonomic Agents|autonomic agents|mesh-ancestor
6126192|NCT01172808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6126193|NCT01172808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126194|NCT01172808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6126195|NCT01172808|Respiratory System Agents|respiratory system agents|mesh-ancestor
6126196|NCT01172808|Parasympatholytics|parasympatholytics|mesh-ancestor
6126197|NCT01172808|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6126198|NCT01172808|Cholinergic Agents|cholinergic agents|mesh-ancestor
6126199|NCT01172808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6126200|NCT01172808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126201|NCT01172808|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6126202|NCT01172808|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6126203|NCT01172808|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6126204|NCT01172808|Adrenergic Agents|adrenergic agents|mesh-ancestor
6126205|NCT01172821|Tiotropium Bromide|tiotropium bromide|mesh-list
6126206|NCT01172821|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6126207|NCT01172821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6126208|NCT01172821|Autonomic Agents|autonomic agents|mesh-ancestor
6126209|NCT01172821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6126210|NCT01172821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126211|NCT01172821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6126212|NCT01172821|Respiratory System Agents|respiratory system agents|mesh-ancestor
6126213|NCT01172821|Parasympatholytics|parasympatholytics|mesh-ancestor
6126214|NCT01172821|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6126215|NCT01172821|Cholinergic Agents|cholinergic agents|mesh-ancestor
6126216|NCT01172821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6126217|NCT01172821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126218|NCT01172821|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6126219|NCT01172821|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6126220|NCT01172821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6126221|NCT01172821|Adrenergic Agents|adrenergic agents|mesh-ancestor
6126222|NCT01172847|Oseltamivir|oseltamivir|mesh-list
6126223|NCT01172847|Rimantadine|rimantadine|mesh-list
6126224|NCT01172847|Antiviral Agents|antiviral agents|mesh-ancestor
6126225|NCT01172847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6126226|NCT01172847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6126227|NCT01172847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126228|NCT01172847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6126229|NCT01172873|Cycloserine|cycloserine|mesh-list
6126230|NCT01172873|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6126231|NCT01172873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6126232|NCT01172873|Renal Agents|renal agents|mesh-ancestor
6126233|NCT01172873|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6126234|NCT01172873|Antitubercular Agents|antitubercular agents|mesh-ancestor
6126235|NCT01172873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6126236|NCT01172873|Antimetabolites|antimetabolites|mesh-ancestor
6126237|NCT01172873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126238|NCT01172938|Thalidomide|thalidomide|mesh-list
6126239|NCT01172938|Apremilast|apremilast|mesh-list
6126240|NCT01172938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6126241|NCT01172938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6126242|NCT01172938|Analgesics|analgesics|mesh-ancestor
6126243|NCT01172938|Sensory System Agents|sensory system agents|mesh-ancestor
6126244|NCT01172938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6126245|NCT01172938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126246|NCT01172938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6126247|NCT01172938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6126248|NCT01172938|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6126249|NCT01172938|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6126250|NCT01172938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5535448|NCT04215471|Immunoglobulins|immunoglobulins|mesh-list
5535449|NCT04215471|Immunologic Factors|immunologic factors|mesh-ancestor
5535450|NCT04215471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535451|NCT04215393|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5535452|NCT04215393|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5601807|NCT05149781|Antihypertensive Agents|antihypertensive agents|mesh-list
5601808|NCT05148637|Lidocaine|lidocaine|mesh-list
5601809|NCT05148637|Fentanyl|fentanyl|mesh-list
5601810|NCT05148637|Anesthetics|anesthetics|mesh-list
5601811|NCT05148637|Sevoflurane|sevoflurane|mesh-list
5601812|NCT05148637|Desflurane|desflurane|mesh-list
5601813|NCT05148637|Anesthetics, Local|anesthetics, local|mesh-ancestor
5601814|NCT05148637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6126251|NCT01172938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126252|NCT01172938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6126253|NCT01172938|Immunologic Factors|immunologic factors|mesh-ancestor
6126254|NCT01172938|Leprostatic Agents|leprostatic agents|mesh-ancestor
6126255|NCT01172938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6126256|NCT01172938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6126257|NCT01172938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6126258|NCT01172938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6126259|NCT01172938|Growth Substances|growth substances|mesh-ancestor
5601815|NCT05148637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601816|NCT05148637|Sensory System Agents|sensory system agents|mesh-ancestor
5601817|NCT05148637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5601818|NCT05148637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5601819|NCT05148637|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5601820|NCT05148637|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5601821|NCT05148637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5601822|NCT05148637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601823|NCT05148637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5601824|NCT05148637|Narcotics|narcotics|mesh-ancestor
5601825|NCT05148637|Analgesics|analgesics|mesh-ancestor
5601826|NCT05148637|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6126260|NCT01172938|Growth Inhibitors|growth inhibitors|mesh-ancestor
6126261|NCT01172938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6126262|NCT01173029|Antihypertensive Agents|antihypertensive agents|mesh-list
6126263|NCT01173029|Calcium Channel Blockers|calcium channel blockers|mesh-list
6126264|NCT01173029|Diuretics|diuretics|mesh-list
6126265|NCT01173029|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6126266|NCT01173029|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
6126267|NCT01173029|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
6126268|NCT01173029|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
6126269|NCT01173029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6126270|NCT01173029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126271|NCT01173029|Natriuretic Agents|natriuretic agents|mesh-ancestor
6126272|NCT01173029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601827|NCT05148637|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5601828|NCT05148637|Anesthetics, General|anesthetics, general|mesh-ancestor
5601829|NCT05148637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5601830|NCT05148637|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5601831|NCT05147558|Pembrolizumab|pembrolizumab|mesh-list
5601832|NCT05147558|Lenvatinib|lenvatinib|mesh-list
5601833|NCT05147558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5601834|NCT05147558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5601835|NCT05147558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5601836|NCT05147558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5601837|NCT05147558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606734|NCT03818737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5606735|NCT03818737|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5606736|NCT03818737|Protective Agents|protective agents|mesh-ancestor
5606737|NCT03815643|Avelumab|avelumab|mesh-list
5606738|NCT03815643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5606739|NCT03815643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5606740|NCT03800602|Metformin|metformin|mesh-list
5606741|NCT03800602|Nivolumab|nivolumab|mesh-list
5606742|NCT03800602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5606743|NCT03800602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606744|NCT03800602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5606745|NCT03800602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5606746|NCT03800602|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5606747|NCT03800602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606748|NCT03786783|Vitamin A|vitamin a|mesh-list
5535453|NCT04215159|Gemcitabine|gemcitabine|mesh-list
5535454|NCT04215159|Trastuzumab|trastuzumab|mesh-list
5535455|NCT04215159|Irinotecan|irinotecan|mesh-list
5535456|NCT04215159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5535457|NCT04215159|Antimetabolites|antimetabolites|mesh-ancestor
5535458|NCT04215159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535459|NCT04215159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5535460|NCT04215159|Antiviral Agents|antiviral agents|mesh-ancestor
5535461|NCT04215159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5535462|NCT04215159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5535463|NCT04215159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5535464|NCT04215159|Immunologic Factors|immunologic factors|mesh-ancestor
5535465|NCT04215159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535466|NCT04215159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5535467|NCT04215159|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5535468|NCT04215159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5535469|NCT04215523|Dapagliflozin|dapagliflozin|mesh-list
5535470|NCT04215523|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
5535471|NCT04215523|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5535472|NCT04215523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535473|NCT04215523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5535474|NCT04215523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535475|NCT04215523|Protease Inhibitors|protease inhibitors|mesh-ancestor
5535476|NCT04215523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6126273|NCT01173029|Protease Inhibitors|protease inhibitors|mesh-ancestor
6126274|NCT01173029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6126275|NCT01173029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6126276|NCT01173029|Hormone Antagonists|hormone antagonists|mesh-ancestor
6126277|NCT01173029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6126278|NCT01173029|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6126279|NCT01173055|Milnacipran|milnacipran|mesh-list
6126280|NCT01173055|Levomilnacipran|levomilnacipran|mesh-list
6126281|NCT01173055|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6126282|NCT01173055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6126283|NCT01173055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6126284|NCT01173055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126285|NCT01173055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6126286|NCT01173055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126287|NCT01173055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6126288|NCT01173055|Analgesics|analgesics|mesh-ancestor
6126289|NCT01173055|Sensory System Agents|sensory system agents|mesh-ancestor
6126290|NCT01173055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6126291|NCT01173055|Antidepressive Agents|antidepressive agents|mesh-ancestor
6126292|NCT01173055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5535477|NCT04215445|Empagliflozin|empagliflozin|mesh-list
5535478|NCT04215445|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5535479|NCT04215445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126293|NCT01173120|Abatacept|abatacept|mesh-list
6126294|NCT01173120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6126295|NCT01173120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126296|NCT01173120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6126297|NCT01173120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6126298|NCT01173120|Immunologic Factors|immunologic factors|mesh-ancestor
6126299|NCT01173120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126300|NCT01173120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6126301|NCT01173211|Vaccines|vaccines|mesh-list
6126302|NCT01173211|Immunologic Factors|immunologic factors|mesh-ancestor
6126303|NCT01173211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126304|NCT01173471|Niacinamide|niacinamide|mesh-list
6126305|NCT01173471|Vitamin B Complex|vitamin b complex|mesh-ancestor
6126306|NCT01173471|Vitamins|vitamins|mesh-ancestor
6126307|NCT01173471|Micronutrients|micronutrients|mesh-ancestor
6126308|NCT01173471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126309|NCT01173601|Serotonin|serotonin|mesh-list
6126310|NCT01173601|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
6126311|NCT01173601|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6126312|NCT01173601|Serotonin Agents|serotonin agents|mesh-ancestor
6126313|NCT01173601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6126314|NCT01173601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126315|NCT01173601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126316|NCT01173601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6126317|NCT01173601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5535480|NCT04215445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5535481|NCT04215445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535482|NCT04215432|Propolis|propolis|mesh-list
5535483|NCT04215432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5535484|NCT04215237|Atorvastatin|atorvastatin|mesh-list
5535485|NCT04215237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5535486|NCT04215237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5535487|NCT04215237|Antimetabolites|antimetabolites|mesh-ancestor
5535488|NCT04215237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535489|NCT04215237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5535490|NCT04215237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5535491|NCT04215237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5535492|NCT04214938|Lidocaine|lidocaine|mesh-list
5535493|NCT04214938|Xylometazoline|xylometazoline|mesh-list
5535494|NCT04214938|Anesthetics, Local|anesthetics, local|mesh-ancestor
5535495|NCT04214938|Anesthetics|anesthetics|mesh-ancestor
5535496|NCT04214938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5535497|NCT04214938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535498|NCT04214938|Sensory System Agents|sensory system agents|mesh-ancestor
6126318|NCT01173679|Rituximab|rituximab|mesh-list
6126319|NCT01173679|Fludarabine|fludarabine|mesh-list
6126320|NCT01173679|Dasatinib|dasatinib|mesh-list
6126321|NCT01173679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6126322|NCT01173679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6126323|NCT01173679|Immunologic Factors|immunologic factors|mesh-ancestor
6126324|NCT01173679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126325|NCT01173679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6126326|NCT01173679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126327|NCT01173679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6126328|NCT01173679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6126329|NCT01173692|Minocycline|minocycline|mesh-list
6126330|NCT01173692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6126331|NCT01173692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6126332|NCT01173848|Cholecalciferol|cholecalciferol|mesh-list
6126333|NCT01173848|Ergocalciferols|ergocalciferols|mesh-list
6126334|NCT01173848|Vitamin D|vitamin d|mesh-list
6126335|NCT01173848|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6126336|NCT01173848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126337|NCT01173848|Vitamins|vitamins|mesh-ancestor
6126338|NCT01173848|Micronutrients|micronutrients|mesh-ancestor
6126339|NCT01173848|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6126340|NCT01174004|Pimavanserin|pimavanserin|mesh-list
6126341|NCT01174004|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6126342|NCT01174004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6126343|NCT01174004|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6126344|NCT01174004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6126345|NCT01174004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6126346|NCT01174004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126347|NCT01174004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6126348|NCT01174004|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6126349|NCT01174004|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6126350|NCT01174004|Serotonin Agents|serotonin agents|mesh-ancestor
6126351|NCT01174004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6126352|NCT01174004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126353|NCT01174043|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6126354|NCT01174043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6126355|NCT01174043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6126356|NCT01174043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6126357|NCT01174043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126358|NCT01174082|Vaccines|vaccines|mesh-list
6126359|NCT01174082|Sargramostim|sargramostim|mesh-list
6126360|NCT01174082|Immunologic Factors|immunologic factors|mesh-ancestor
6126361|NCT01174082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126362|NCT01174173|Ranolazine|ranolazine|mesh-list
5535499|NCT04214938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6126363|NCT01174173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6126364|NCT01174173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6126365|NCT01174173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126366|NCT01174186|Adalimumab|adalimumab|mesh-list
6126367|NCT01174186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6126368|NCT01174186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6126369|NCT01174238|Paclitaxel|paclitaxel|mesh-list
6126370|NCT01174238|Carboplatin|carboplatin|mesh-list
6126371|NCT01174238|Axitinib|axitinib|mesh-list
6126372|NCT01174238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6126373|NCT01174238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6126374|NCT01174238|Tubulin Modulators|tubulin modulators|mesh-ancestor
6126375|NCT01174238|Antimitotic Agents|antimitotic agents|mesh-ancestor
6126376|NCT01174238|Mitosis Modulators|mitosis modulators|mesh-ancestor
6126377|NCT01174238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126378|NCT01174238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6126379|NCT01174238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6204845|NCT02078284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204846|NCT02078284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6204847|NCT02078284|Antioxidants|antioxidants|mesh-ancestor
6204848|NCT02078284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204849|NCT02078492|Ketorolac|ketorolac|mesh-list
6204850|NCT02078492|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6204851|NCT02078492|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6204852|NCT02078492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6204853|NCT02078492|Analgesics|analgesics|mesh-ancestor
6204854|NCT02078492|Sensory System Agents|sensory system agents|mesh-ancestor
6204855|NCT02078492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6204856|NCT02078492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204857|NCT02078492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6204858|NCT02078492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6204859|NCT02078492|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6204860|NCT02078492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6204861|NCT02078492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204862|NCT02078713|Contraceptive Agents|contraceptive agents|mesh-list
6204863|NCT02078713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6204864|NCT02078713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204865|NCT02078726|Glucagon|glucagon|mesh-list
6204866|NCT02078726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6204867|NCT02078726|Hormones|hormones|mesh-ancestor
5535500|NCT04214938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5535501|NCT04214938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5535502|NCT04214938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5535503|NCT04214938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5535504|NCT04214938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535505|NCT04214938|Nasal Decongestants|nasal decongestants|mesh-ancestor
5535506|NCT04214938|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5535507|NCT04214938|Respiratory System Agents|respiratory system agents|mesh-ancestor
5535508|NCT04214990|Aspirin|aspirin|mesh-list
5535509|NCT04214990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5535510|NCT04214990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5535511|NCT04214990|Analgesics|analgesics|mesh-ancestor
5535512|NCT04214990|Sensory System Agents|sensory system agents|mesh-ancestor
5535513|NCT04214990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6204868|NCT02078726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6204869|NCT02078726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204870|NCT02078817|Ketamine|ketamine|mesh-list
6204871|NCT02078817|Analgesics|analgesics|mesh-ancestor
6204872|NCT02078817|Sensory System Agents|sensory system agents|mesh-ancestor
6204873|NCT02078817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6204874|NCT02078817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204875|NCT02078817|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6204876|NCT02078817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6204877|NCT02078817|Anesthetics, General|anesthetics, general|mesh-ancestor
6204878|NCT02078817|Anesthetics|anesthetics|mesh-ancestor
6204879|NCT02078817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6204880|NCT02078817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6204881|NCT02078817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6204882|NCT02078817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6204883|NCT02078817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204884|NCT02078882|Abatacept|abatacept|mesh-list
6204885|NCT02078882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6204886|NCT02078882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601838|NCT05133310|Simvastatin|simvastatin|mesh-list
6204887|NCT02078882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5535514|NCT04214990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535515|NCT04214990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5535516|NCT04214990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5535517|NCT04214990|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5535518|NCT04214990|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5535519|NCT04214990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535520|NCT04214990|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5535521|NCT04214990|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5535522|NCT04214990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5535523|NCT04214990|Antipyretics|antipyretics|mesh-ancestor
5535524|NCT04214886|Cyclophosphamide|cyclophosphamide|mesh-list
5535525|NCT04214886|Fludarabine|fludarabine|mesh-list
5535526|NCT04214886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5535527|NCT04214886|Immunologic Factors|immunologic factors|mesh-ancestor
5535528|NCT04214886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535529|NCT04214886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5535530|NCT04214886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6126380|NCT01174823|Bepotastine besilate|bepotastine besilate|mesh-list
6126381|NCT01174823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6126382|NCT01174823|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6126383|NCT01174823|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6126384|NCT01175018|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6126385|NCT01175018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6126386|NCT01175135|Risperidone|risperidone|mesh-list
6126387|NCT01175135|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6126388|NCT01175135|Serotonin Agents|serotonin agents|mesh-ancestor
6126389|NCT01175135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6126390|NCT01175135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126391|NCT01175135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126392|NCT01175135|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6126393|NCT01175135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6126394|NCT01175135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6126395|NCT01175135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6126396|NCT01175135|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6126397|NCT01175135|Dopamine Agents|dopamine agents|mesh-ancestor
6126398|NCT01175148|Atorvastatin|atorvastatin|mesh-list
6126399|NCT01175148|Calcium|calcium|mesh-list
6126400|NCT01175148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6126401|NCT01175148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126402|NCT01175148|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6126403|NCT01175148|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6126404|NCT01175148|Antimetabolites|antimetabolites|mesh-ancestor
6126405|NCT01175148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126406|NCT01175148|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6126407|NCT01175148|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6126408|NCT01175148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6126409|NCT01175213|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6126410|NCT01175213|gamma-Globulins|gamma-globulins|mesh-list
6126411|NCT01175213|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5535531|NCT04214886|Alkylating Agents|alkylating agents|mesh-ancestor
5535532|NCT04214886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535533|NCT04214886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5535534|NCT04214886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5535535|NCT04214977|Anesthetics|anesthetics|mesh-list
5535536|NCT04214977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6126412|NCT01175213|Immunologic Factors|immunologic factors|mesh-ancestor
6126413|NCT01175213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126414|NCT01175343|R04929097|r04929097|mesh-list
6126415|NCT01175343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6126416|NCT01175343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126417|NCT01175356|Cyclophosphamide|cyclophosphamide|mesh-list
6126418|NCT01175356|Melphalan|melphalan|mesh-list
6126419|NCT01175356|Busulfan|busulfan|mesh-list
6126420|NCT01175356|Doxorubicin|doxorubicin|mesh-list
6126421|NCT01175356|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6126422|NCT01175356|Etoposide|etoposide|mesh-list
6126423|NCT01175356|Vincristine|vincristine|mesh-list
6126424|NCT01175356|Topotecan|topotecan|mesh-list
5535537|NCT04214977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535538|NCT04214821|Moxifloxacin|moxifloxacin|mesh-list
5535539|NCT04214821|Levofloxacin|levofloxacin|mesh-list
5535540|NCT04214821|Ofloxacin|ofloxacin|mesh-list
5535541|NCT04214821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5535542|NCT04214821|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5535543|NCT04214821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5535544|NCT04214821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6126425|NCT01175356|Etoposide phosphate|etoposide phosphate|mesh-list
5535545|NCT04214821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5535546|NCT04214821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5535547|NCT04214821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5535548|NCT04214821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535549|NCT04214821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5535550|NCT04214821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5535551|NCT04214821|Renal Agents|renal agents|mesh-ancestor
6126426|NCT01175356|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
6126427|NCT01175356|Isotretinoin|isotretinoin|mesh-list
6126428|NCT01175356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6126429|NCT01175356|Immunologic Factors|immunologic factors|mesh-ancestor
6126430|NCT01175356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126431|NCT01175356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6126432|NCT01175356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6126433|NCT01175356|Alkylating Agents|alkylating agents|mesh-ancestor
6126434|NCT01175356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126435|NCT01175356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6126436|NCT01175356|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6126437|NCT01175356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6126438|NCT01175356|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6126439|NCT01175356|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6126440|NCT01175356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6126441|NCT01175356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6126442|NCT01175356|Tubulin Modulators|tubulin modulators|mesh-ancestor
6126443|NCT01175356|Antimitotic Agents|antimitotic agents|mesh-ancestor
6126444|NCT01175356|Mitosis Modulators|mitosis modulators|mesh-ancestor
6126445|NCT01175356|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6126446|NCT01175356|Dermatologic Agents|dermatologic agents|mesh-ancestor
6126447|NCT01175356|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6126448|NCT01175382|Tamsulosin|tamsulosin|mesh-list
6126449|NCT01175382|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6126450|NCT01175382|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6126451|NCT01175382|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6126452|NCT01175382|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6126453|NCT01175382|Adrenergic Agents|adrenergic agents|mesh-ancestor
6126454|NCT01175382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6126455|NCT01175382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126456|NCT01175382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126457|NCT01175382|Urological Agents|urological agents|mesh-ancestor
6126458|NCT01175382|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6126459|NCT01175382|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6126460|NCT01175382|Cholinergic Agents|cholinergic agents|mesh-ancestor
6126461|NCT01175395|Triamcinolone|triamcinolone|mesh-list
6126462|NCT01175395|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6126463|NCT01175395|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6126464|NCT01175395|Ranibizumab|ranibizumab|mesh-list
6126465|NCT01175395|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6126466|NCT01175395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6126467|NCT01175395|Glucocorticoids|glucocorticoids|mesh-ancestor
6126468|NCT01175395|Hormones|hormones|mesh-ancestor
6126469|NCT01175395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6126470|NCT01175395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126471|NCT01175395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6126472|NCT01175395|Immunologic Factors|immunologic factors|mesh-ancestor
6126473|NCT01175395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6126474|NCT01175395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126475|NCT01175395|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6126476|NCT01175395|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6126477|NCT01175395|Growth Substances|growth substances|mesh-ancestor
6126478|NCT01175395|Growth Inhibitors|growth inhibitors|mesh-ancestor
6126479|NCT01175395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6126480|NCT01175473|Metformin|metformin|mesh-list
6126481|NCT01175473|Liraglutide|liraglutide|mesh-list
6126482|NCT01175473|Lixisenatide|lixisenatide|mesh-list
5535552|NCT04214821|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5535553|NCT04214821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5535554|NCT04214808|Dutasteride|dutasteride|mesh-list
5535555|NCT04214808|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
5535556|NCT04214808|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5535557|NCT04214808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5535558|NCT04214808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535559|NCT04214808|Hormone Antagonists|hormone antagonists|mesh-ancestor
5535560|NCT04214808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6126483|NCT01175473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6126484|NCT01175473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126485|NCT01175473|Incretins|incretins|mesh-ancestor
6126486|NCT01175473|Hormones|hormones|mesh-ancestor
6126487|NCT01175473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6126488|NCT01175590|Besifloxacin|besifloxacin|mesh-list
6126489|NCT01175590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6126490|NCT01175590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6126491|NCT01175590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6126492|NCT01175590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6126493|NCT01175590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6126494|NCT01175590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126495|NCT01175590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6126496|NCT01175668|Clonidine|clonidine|mesh-list
6126497|NCT01175668|Phenobarbital|phenobarbital|mesh-list
6126498|NCT01175668|Analgesics|analgesics|mesh-ancestor
6126499|NCT01175668|Sensory System Agents|sensory system agents|mesh-ancestor
6126500|NCT01175668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6126501|NCT01175668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126502|NCT01175668|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6126503|NCT01175668|Sympatholytics|sympatholytics|mesh-ancestor
6126504|NCT01175668|Autonomic Agents|autonomic agents|mesh-ancestor
6126505|NCT01175668|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6126506|NCT01175668|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6126507|NCT01175668|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6466103|NCT00477347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6466104|NCT00477347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466105|NCT00477373|Valproic Acid|valproic acid|mesh-list
6466106|NCT00477373|Anticonvulsants|anticonvulsants|mesh-ancestor
6466107|NCT00477373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6126508|NCT01175668|Adrenergic Agents|adrenergic agents|mesh-ancestor
6126509|NCT01175668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6126510|NCT01175668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126511|NCT01175668|Anticonvulsants|anticonvulsants|mesh-ancestor
6126512|NCT01175668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6126513|NCT01175668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6126514|NCT01175668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6126515|NCT01175668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6126516|NCT01175668|GABA Modulators|gaba modulators|mesh-ancestor
6126517|NCT01175668|GABA Agents|gaba agents|mesh-ancestor
6126518|NCT01175668|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6126519|NCT01175668|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6126520|NCT01175668|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6126521|NCT01175707|Vancomycin|vancomycin|mesh-list
6126522|NCT01175707|Daptomycin|daptomycin|mesh-list
6126523|NCT01175707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6126524|NCT01175707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6126525|NCT01175798|Vitamin D|vitamin d|mesh-list
6126526|NCT01175798|Cholecalciferol|cholecalciferol|mesh-list
6126527|NCT01175798|Vitamins|vitamins|mesh-ancestor
6126528|NCT01175798|Micronutrients|micronutrients|mesh-ancestor
6126529|NCT01175798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126530|NCT01175798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6126531|NCT01175798|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6126532|NCT01175811|Insulin|insulin|mesh-list
6126533|NCT01175811|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6126534|NCT01175811|Insulin Glargine|insulin glargine|mesh-list
6126535|NCT01175811|Insulin Lispro|insulin lispro|mesh-list
6126536|NCT01175811|Insulin, Isophane|insulin, isophane|mesh-list
6126537|NCT01175811|Biphasic Insulins|biphasic insulins|mesh-list
6126538|NCT01175811|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
6126539|NCT01175811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6126540|NCT01175811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126541|NCT01175824|Insulin|insulin|mesh-list
6126542|NCT01175824|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6126543|NCT01175824|Insulin Glargine|insulin glargine|mesh-list
6126544|NCT01175824|Insulin Lispro|insulin lispro|mesh-list
6126545|NCT01175824|Protamines|protamines|mesh-list
6126546|NCT01175824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6126547|NCT01175824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126548|NCT01175824|Heparin Antagonists|heparin antagonists|mesh-ancestor
6126549|NCT01175824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126550|NCT01175824|Coagulants|coagulants|mesh-ancestor
6126551|NCT01175902|Timolol|timolol|mesh-list
6126552|NCT01175902|Dorzolamide|dorzolamide|mesh-list
6126553|NCT01175902|Latanoprost|latanoprost|mesh-list
6126554|NCT01175902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6126555|NCT01175902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6126556|NCT01175902|Adrenergic Agents|adrenergic agents|mesh-ancestor
6126557|NCT01175902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6126558|NCT01175902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126559|NCT01175902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126560|NCT01175902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6126561|NCT01175902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6126562|NCT01175902|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6126563|NCT01175902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5535561|NCT04214808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535562|NCT04214665|Thioctic Acid|thioctic acid|mesh-list
5535563|NCT04214665|Antioxidants|antioxidants|mesh-ancestor
5535564|NCT04214665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535565|NCT04214665|Protective Agents|protective agents|mesh-ancestor
5535566|NCT04214665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535567|NCT04214665|Vitamin B Complex|vitamin b complex|mesh-ancestor
5535568|NCT04214665|Vitamins|vitamins|mesh-ancestor
5535569|NCT04214665|Micronutrients|micronutrients|mesh-ancestor
6126564|NCT01175902|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6126565|NCT01175902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6126566|NCT01175980|Vorinostat|vorinostat|mesh-list
5535570|NCT04214834|Morphine|morphine|mesh-list
5535571|NCT04214834|Methadone|methadone|mesh-list
5535572|NCT04214834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5535573|NCT04214834|Narcotics|narcotics|mesh-ancestor
5535574|NCT04214834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6126567|NCT01175980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6126568|NCT01175980|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6126569|NCT01175980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5535575|NCT04214834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535576|NCT04214834|Analgesics|analgesics|mesh-ancestor
5535577|NCT04214834|Sensory System Agents|sensory system agents|mesh-ancestor
5535578|NCT04214834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5535579|NCT04214834|Antitussive Agents|antitussive agents|mesh-ancestor
5535580|NCT04214834|Respiratory System Agents|respiratory system agents|mesh-ancestor
5535581|NCT04214626|Prednisone|prednisone|mesh-list
5535582|NCT04214626|Cyclophosphamide|cyclophosphamide|mesh-list
5535583|NCT04214626|Rituximab|rituximab|mesh-list
5535584|NCT04214626|Methotrexate|methotrexate|mesh-list
5535585|NCT04214626|Vincristine|vincristine|mesh-list
5535586|NCT04214626|Lenalidomide|lenalidomide|mesh-list
6126570|NCT01175980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126571|NCT01176032|Losartan|losartan|mesh-list
6126572|NCT01176032|Amlodipine|amlodipine|mesh-list
6126573|NCT01176032|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6126574|NCT01176032|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6126575|NCT01176032|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6126576|NCT01176032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6126577|NCT01176032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126578|NCT01176032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6126579|NCT01176032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126580|NCT01176032|Vasodilator Agents|vasodilator agents|mesh-ancestor
6126581|NCT01176032|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6126582|NCT01176032|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6126583|NCT01176032|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6126584|NCT01176032|Diuretics|diuretics|mesh-ancestor
6126585|NCT01176032|Natriuretic Agents|natriuretic agents|mesh-ancestor
6126586|NCT01176032|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6126587|NCT01176058|Fluconazole|fluconazole|mesh-list
6126588|NCT01176058|Anidulafungin|anidulafungin|mesh-list
6466108|NCT00477373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126589|NCT01176058|Antifungal Agents|antifungal agents|mesh-ancestor
6126590|NCT01176058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6126591|NCT01176058|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6126592|NCT01176058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6126593|NCT01176058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6126594|NCT01176058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126595|NCT01176058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6126596|NCT01176058|Hormone Antagonists|hormone antagonists|mesh-ancestor
6126597|NCT01176058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6126598|NCT01176058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126599|NCT01176058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6126600|NCT01176058|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6126601|NCT01176240|Mannitol|mannitol|mesh-list
6126602|NCT01176240|Droxidopa|droxidopa|mesh-list
6126603|NCT01176240|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6126604|NCT01176240|Diuretics|diuretics|mesh-ancestor
6126605|NCT01176240|Natriuretic Agents|natriuretic agents|mesh-ancestor
6126606|NCT01176240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126607|NCT01176240|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6126608|NCT01176240|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6126609|NCT01176435|Levodopa|levodopa|mesh-list
6466109|NCT00477373|GABA Agents|gaba agents|mesh-ancestor
6466110|NCT00477373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6466111|NCT00477373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466112|NCT00477373|Antimanic Agents|antimanic agents|mesh-ancestor
6466113|NCT00477373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6466114|NCT00477373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6466115|NCT00477373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6466116|NCT00477503|Pentetic Acid|pentetic acid|mesh-list
6466117|NCT00477503|Gallium citrate|gallium citrate|mesh-list
6466118|NCT00477503|Chelating Agents|chelating agents|mesh-ancestor
5535587|NCT04214626|Epirubicin|epirubicin|mesh-list
5535588|NCT04214626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5535589|NCT04214626|Immunologic Factors|immunologic factors|mesh-ancestor
5535590|NCT04214626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535591|NCT04214626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5535592|NCT04214626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5535593|NCT04214626|Alkylating Agents|alkylating agents|mesh-ancestor
6126610|NCT01176435|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6126611|NCT01176435|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6126612|NCT01176435|Dopamine Agents|dopamine agents|mesh-ancestor
6126613|NCT01176435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6126614|NCT01176435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126615|NCT01176435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126616|NCT01176565|Nicardipine|nicardipine|mesh-list
6126617|NCT01176565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6126618|NCT01176565|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6126619|NCT01176565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6126620|NCT01176565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126621|NCT01176565|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6126622|NCT01176565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126623|NCT01176565|Vasodilator Agents|vasodilator agents|mesh-ancestor
6126624|NCT01176591|Aprepitant|aprepitant|mesh-list
6126625|NCT01176591|Fosaprepitant|fosaprepitant|mesh-list
6126626|NCT01176591|Antiemetics|antiemetics|mesh-ancestor
6126627|NCT01176591|Autonomic Agents|autonomic agents|mesh-ancestor
6126628|NCT01176591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6126629|NCT01176591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126630|NCT01176591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6126631|NCT01176591|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6126632|NCT01176591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6126633|NCT01176591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126634|NCT01176773|Hyaluronic Acid|hyaluronic acid|mesh-list
6126635|NCT01176773|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6126636|NCT01176773|Immunologic Factors|immunologic factors|mesh-ancestor
6126637|NCT01176773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126638|NCT01176773|Viscosupplements|viscosupplements|mesh-ancestor
6126639|NCT01176773|Protective Agents|protective agents|mesh-ancestor
6126640|NCT01176916|Exemestane|exemestane|mesh-list
6126641|NCT01176916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6126642|NCT01176916|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6126643|NCT01176916|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6126644|NCT01176916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6126645|NCT01176916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126646|NCT01176916|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6126647|NCT01176916|Hormone Antagonists|hormone antagonists|mesh-ancestor
6126648|NCT01176916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6466119|NCT00477503|Sequestering Agents|sequestering agents|mesh-ancestor
6666171|NCT01521312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535594|NCT04214626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535595|NCT04214626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5535596|NCT04214626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5535597|NCT04214626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5535598|NCT04214626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5535599|NCT04214626|Glucocorticoids|glucocorticoids|mesh-ancestor
5535600|NCT04214626|Hormones|hormones|mesh-ancestor
5535601|NCT04214626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5535602|NCT04214626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5535603|NCT04214626|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5535604|NCT04214626|Abortifacient Agents|abortifacient agents|mesh-ancestor
5535605|NCT04214626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5535606|NCT04214626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5535607|NCT04214626|Antimetabolites|antimetabolites|mesh-ancestor
5535608|NCT04214626|Dermatologic Agents|dermatologic agents|mesh-ancestor
5535609|NCT04214626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6466120|NCT00477503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466121|NCT00477503|Antidotes|antidotes|mesh-ancestor
6466122|NCT00477503|Protective Agents|protective agents|mesh-ancestor
6126649|NCT01176916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126650|NCT01176955|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6126651|NCT01176955|Dermatologic Agents|dermatologic agents|mesh-ancestor
6126652|NCT01176968|Eplerenone|eplerenone|mesh-list
6126653|NCT01176968|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6126654|NCT01176968|Hormone Antagonists|hormone antagonists|mesh-ancestor
6126655|NCT01176968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6126656|NCT01176968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126657|NCT01176968|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6126658|NCT01176968|Diuretics|diuretics|mesh-ancestor
6126659|NCT01176968|Natriuretic Agents|natriuretic agents|mesh-ancestor
6126660|NCT01176968|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6126661|NCT01176981|Methotrexate|methotrexate|mesh-list
5535610|NCT04214626|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5535611|NCT04214626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5535612|NCT04214626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6126662|NCT01176981|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6126663|NCT01176981|Abortifacient Agents|abortifacient agents|mesh-ancestor
6126664|NCT01176981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6126665|NCT01176981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126666|NCT01176981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6126667|NCT01176981|Antimetabolites|antimetabolites|mesh-ancestor
6126668|NCT01176981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126669|NCT01176981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6126670|NCT01176981|Dermatologic Agents|dermatologic agents|mesh-ancestor
6126671|NCT01176981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6126672|NCT01176981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6126673|NCT01176981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6126674|NCT01176981|Immunologic Factors|immunologic factors|mesh-ancestor
6126675|NCT01176981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6126676|NCT01176981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6126677|NCT01177098|Timolol|timolol|mesh-list
6126678|NCT01177098|Bimatoprost|bimatoprost|mesh-list
6126679|NCT01177098|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6126680|NCT01177098|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6126681|NCT01177098|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6126682|NCT01177098|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6126683|NCT01177098|Adrenergic Agents|adrenergic agents|mesh-ancestor
6466123|NCT00477503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466124|NCT00477503|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6466125|NCT00477503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6466126|NCT00477516|Dialysis Solutions|dialysis solutions|mesh-list
6466127|NCT00477516|Calcium|calcium|mesh-list
6466128|NCT00477516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6466129|NCT00477516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466130|NCT00477516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6466131|NCT00477542|Clofarabine|clofarabine|mesh-list
6466132|NCT00477542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6466133|NCT00477542|Antimetabolites|antimetabolites|mesh-ancestor
6466134|NCT00477542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466135|NCT00477542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6466136|NCT00477581|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5535613|NCT04214626|Tubulin Modulators|tubulin modulators|mesh-ancestor
5535614|NCT04214626|Antimitotic Agents|antimitotic agents|mesh-ancestor
5535615|NCT04214626|Mitosis Modulators|mitosis modulators|mesh-ancestor
5535616|NCT04214626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5535617|NCT04214626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5535618|NCT04214626|Growth Substances|growth substances|mesh-ancestor
5535619|NCT04214626|Growth Inhibitors|growth inhibitors|mesh-ancestor
5535620|NCT04214626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5535621|NCT04214626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6126684|NCT01177098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6126685|NCT01177098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126686|NCT01177098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126687|NCT01177098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6126688|NCT01177098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6126689|NCT01177189|Ascorbic Acid|ascorbic acid|mesh-list
6126690|NCT01177189|Thioctic Acid|thioctic acid|mesh-list
6126691|NCT01177189|Vitamins|vitamins|mesh-ancestor
6126692|NCT01177189|Micronutrients|micronutrients|mesh-ancestor
6126693|NCT01177189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126694|NCT01177189|Antioxidants|antioxidants|mesh-ancestor
6126695|NCT01177189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126696|NCT01177189|Protective Agents|protective agents|mesh-ancestor
6126697|NCT01177189|Vitamin B Complex|vitamin b complex|mesh-ancestor
6126698|NCT01177228|Vedolizumab|vedolizumab|mesh-list
6126699|NCT01177228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6126700|NCT01177293|Amlodipine|amlodipine|mesh-list
6126701|NCT01177293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6126702|NCT01177293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6126703|NCT01177293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6126704|NCT01177293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126705|NCT01177293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6126706|NCT01177293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126707|NCT01177293|Vasodilator Agents|vasodilator agents|mesh-ancestor
6126708|NCT01177384|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6126709|NCT01177384|Glimepiride|glimepiride|mesh-list
6126710|NCT01177384|Acarbose|acarbose|mesh-list
6126711|NCT01177384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6126712|NCT01177384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126713|NCT01177384|Incretins|incretins|mesh-ancestor
6126714|NCT01177384|Hormones|hormones|mesh-ancestor
6126715|NCT01177384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6126716|NCT01177384|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6126717|NCT01177384|Protease Inhibitors|protease inhibitors|mesh-ancestor
6126718|NCT01177384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6126719|NCT01177384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126720|NCT01177384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6126721|NCT01177384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6126722|NCT01177384|Immunologic Factors|immunologic factors|mesh-ancestor
6126723|NCT01177384|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6126724|NCT01177410|Mesalamine|mesalamine|mesh-list
6126725|NCT01177410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6126726|NCT01177410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6126727|NCT01177410|Analgesics|analgesics|mesh-ancestor
6126728|NCT01177410|Sensory System Agents|sensory system agents|mesh-ancestor
6126729|NCT01177410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6126730|NCT01177410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535622|NCT04214626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5535623|NCT04214678|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
5535624|NCT04214678|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
5535625|NCT04214678|beta-Endorphin|beta-endorphin|mesh-list
5535626|NCT04214678|Hormones|hormones|mesh-ancestor
5535627|NCT04214678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5535628|NCT04214678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535629|NCT04214678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5535630|NCT04214678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535631|NCT04214353|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5535632|NCT04214353|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5601839|NCT05133310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6126731|NCT01177410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6126732|NCT01177410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6126733|NCT01177709|Metformin|metformin|mesh-list
6126734|NCT01177709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6126735|NCT01177709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126736|NCT01177722|Vaccines|vaccines|mesh-list
6126737|NCT01177722|Immunologic Factors|immunologic factors|mesh-ancestor
6126738|NCT01177722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126739|NCT01177735|Pomalidomide|pomalidomide|mesh-list
6126740|NCT01177735|Immunologic Factors|immunologic factors|mesh-ancestor
6126741|NCT01177735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126742|NCT01177735|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6126743|NCT01177735|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6126744|NCT01177735|Growth Substances|growth substances|mesh-ancestor
6126745|NCT01177735|Growth Inhibitors|growth inhibitors|mesh-ancestor
6126746|NCT01177735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6126747|NCT01177800|Infliximab|infliximab|mesh-list
6126748|NCT01177800|Dermatologic Agents|dermatologic agents|mesh-ancestor
6126749|NCT01177800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6126750|NCT01177800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6126751|NCT01177813|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6126752|NCT01177813|Empagliflozin|empagliflozin|mesh-list
6126753|NCT01177813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6126754|NCT01177813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126755|NCT01177813|Incretins|incretins|mesh-ancestor
6126756|NCT01177813|Hormones|hormones|mesh-ancestor
6126757|NCT01177813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6126758|NCT01177813|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6126759|NCT01177813|Protease Inhibitors|protease inhibitors|mesh-ancestor
6126760|NCT01177813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5535633|NCT04214353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535634|NCT04214145|Phenylephrine|phenylephrine|mesh-list
5535635|NCT04214145|Vasopressins|vasopressins|mesh-list
5535636|NCT04214145|Arginine Vasopressin|arginine vasopressin|mesh-list
5535637|NCT04214145|Oxymetazoline|oxymetazoline|mesh-list
5535638|NCT04214145|Norepinephrine|norepinephrine|mesh-list
5535639|NCT04214145|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5535640|NCT04214145|Mydriatics|mydriatics|mesh-ancestor
5535641|NCT04214145|Autonomic Agents|autonomic agents|mesh-ancestor
5535642|NCT04214145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5535643|NCT04214145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535644|NCT04214145|Sympathomimetics|sympathomimetics|mesh-ancestor
5535645|NCT04214145|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5535646|NCT04214145|Nasal Decongestants|nasal decongestants|mesh-ancestor
5535647|NCT04214145|Respiratory System Agents|respiratory system agents|mesh-ancestor
5535648|NCT04214145|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5535649|NCT04214145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5535650|NCT04214145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5535651|NCT04214145|Adrenergic Agents|adrenergic agents|mesh-ancestor
5535652|NCT04214145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5535653|NCT04214145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535654|NCT04214145|Protective Agents|protective agents|mesh-ancestor
5535655|NCT04214145|Hemostatics|hemostatics|mesh-ancestor
5535656|NCT04214145|Coagulants|coagulants|mesh-ancestor
5535657|NCT04214145|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5535658|NCT04214145|Natriuretic Agents|natriuretic agents|mesh-ancestor
5535659|NCT04214444|Vaccines|vaccines|mesh-list
5535660|NCT04214444|Immunologic Factors|immunologic factors|mesh-ancestor
5535661|NCT04214444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535662|NCT04214106|Thiamine|thiamine|mesh-list
5535663|NCT04214106|Vitamin B Complex|vitamin b complex|mesh-ancestor
5535664|NCT04214106|Vitamins|vitamins|mesh-ancestor
5535665|NCT04214106|Micronutrients|micronutrients|mesh-ancestor
5535666|NCT04214106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535667|NCT04213924|Ibuprofen|ibuprofen|mesh-list
5535668|NCT04213924|Lidocaine|lidocaine|mesh-list
5535669|NCT04213924|Bupivacaine|bupivacaine|mesh-list
5535670|NCT04213924|Anesthetics, Local|anesthetics, local|mesh-ancestor
5535671|NCT04213924|Anesthetics|anesthetics|mesh-ancestor
5535672|NCT04213924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5535673|NCT04213924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535674|NCT04213924|Sensory System Agents|sensory system agents|mesh-ancestor
5535675|NCT04213924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5535676|NCT04213924|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6126761|NCT01177813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126762|NCT01177813|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6126763|NCT01177943|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
5535677|NCT04213924|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5535678|NCT04213924|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5535679|NCT04213924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5535680|NCT04213924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126764|NCT01177943|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6126765|NCT01177943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6126766|NCT01177943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6126767|NCT01177943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126768|NCT01177943|Adrenergic Agents|adrenergic agents|mesh-ancestor
6126769|NCT01177943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6126770|NCT01177943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126771|NCT01177956|Fluorouracil|fluorouracil|mesh-list
6126772|NCT01177956|Cetuximab|cetuximab|mesh-list
6126773|NCT01177956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6126774|NCT01177956|Antimetabolites|antimetabolites|mesh-ancestor
6126775|NCT01177956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126776|NCT01177956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6126777|NCT01177956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6126778|NCT01177956|Immunologic Factors|immunologic factors|mesh-ancestor
6126779|NCT01177956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126780|NCT01177956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6126781|NCT01178073|Ambrisentan|ambrisentan|mesh-list
6126782|NCT01178073|Tadalafil|tadalafil|mesh-list
6126783|NCT01178073|Vasodilator Agents|vasodilator agents|mesh-ancestor
6126784|NCT01178073|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6126785|NCT01178073|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6126786|NCT01178073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6126787|NCT01178073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126788|NCT01178073|Urological Agents|urological agents|mesh-ancestor
6126789|NCT01178073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6126790|NCT01178086|Rituximab|rituximab|mesh-list
6126791|NCT01178086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6126792|NCT01178086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6126793|NCT01178086|Immunologic Factors|immunologic factors|mesh-ancestor
6126794|NCT01178086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126795|NCT01178086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6126796|NCT01178099|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6126797|NCT01178099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6126798|NCT01178138|Prazosin|prazosin|mesh-list
6126799|NCT01178138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6126800|NCT01178138|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6126801|NCT01178138|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6126802|NCT01178138|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6126803|NCT01178138|Adrenergic Agents|adrenergic agents|mesh-ancestor
6126804|NCT01178138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6126805|NCT01178138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126806|NCT01178138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126807|NCT01178216|Rituximab|rituximab|mesh-list
6126808|NCT01178216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6126809|NCT01178216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6126810|NCT01178216|Immunologic Factors|immunologic factors|mesh-ancestor
5535681|NCT04213924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5535682|NCT04213924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5535683|NCT04213924|Analgesics|analgesics|mesh-ancestor
5535684|NCT04213924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5535685|NCT04213924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5535686|NCT04213924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5535687|NCT04213924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5535688|NCT04213937|Paclitaxel|paclitaxel|mesh-list
5535689|NCT04213937|Topotecan|topotecan|mesh-list
5535690|NCT04213937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5535691|NCT04213937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5535692|NCT04213937|Tubulin Modulators|tubulin modulators|mesh-ancestor
5535693|NCT04213937|Antimitotic Agents|antimitotic agents|mesh-ancestor
5535694|NCT04213937|Mitosis Modulators|mitosis modulators|mesh-ancestor
5535695|NCT04213937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535696|NCT04213937|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5535697|NCT04213937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5535698|NCT04213937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5535699|NCT04214054|Calcium|calcium|mesh-list
5535700|NCT04214054|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5535701|NCT04214054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535702|NCT04213794|Sodium thiosulfate|sodium thiosulfate|mesh-list
5535703|NCT04213794|Cisplatin|cisplatin|mesh-list
5535704|NCT04213794|Doxorubicin|doxorubicin|mesh-list
5535705|NCT04213794|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5535706|NCT04213794|Daunorubicin|daunorubicin|mesh-list
5535707|NCT04213794|Antidotes|antidotes|mesh-list
5535708|NCT04213794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5535709|NCT04213794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5535710|NCT04213794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5535711|NCT04213794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5535712|NCT04213794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5535713|NCT04213794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535714|NCT04213794|Protective Agents|protective agents|mesh-ancestor
5535715|NCT04213794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535716|NCT04213794|Antioxidants|antioxidants|mesh-ancestor
6126811|NCT01178216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126812|NCT01178216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6126813|NCT01178281|Thalidomide|thalidomide|mesh-list
6126814|NCT01178281|Pomalidomide|pomalidomide|mesh-list
6126815|NCT01178281|Immunologic Factors|immunologic factors|mesh-ancestor
6126816|NCT01178281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126817|NCT01178281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6126818|NCT01178281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6126819|NCT01178281|Growth Substances|growth substances|mesh-ancestor
6126820|NCT01178281|Growth Inhibitors|growth inhibitors|mesh-ancestor
6126821|NCT01178281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6126822|NCT01178281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6126823|NCT01178281|Leprostatic Agents|leprostatic agents|mesh-ancestor
6126824|NCT01178281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6126825|NCT01178281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6126826|NCT01178528|Carvedilol|carvedilol|mesh-list
6126827|NCT01178528|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6126828|NCT01178528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6126829|NCT01178528|Adrenergic Agents|adrenergic agents|mesh-ancestor
6126830|NCT01178528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6126831|NCT01178528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126832|NCT01178528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126833|NCT01178528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6126834|NCT01178528|Antioxidants|antioxidants|mesh-ancestor
6126835|NCT01178528|Protective Agents|protective agents|mesh-ancestor
6126836|NCT01178528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6126837|NCT01178528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6126838|NCT01178528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6126839|NCT01178528|Vasodilator Agents|vasodilator agents|mesh-ancestor
6126840|NCT01178528|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6126841|NCT01178528|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6126842|NCT01178671|Mirtazapine|mirtazapine|mesh-list
6126843|NCT01178671|Sertraline|sertraline|mesh-list
6126844|NCT01178671|Antidepressive Agents|antidepressive agents|mesh-ancestor
6126845|NCT01178671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6126846|NCT01178671|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6126847|NCT01178671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6126848|NCT01178671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6126849|NCT01178671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126850|NCT01178671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6126851|NCT01178671|Serotonin Agents|serotonin agents|mesh-ancestor
6126852|NCT01178671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126853|NCT01178671|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6126854|NCT01178671|Histamine Antagonists|histamine antagonists|mesh-ancestor
6126855|NCT01178671|Histamine Agents|histamine agents|mesh-ancestor
6126856|NCT01178671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6126857|NCT01178671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6126858|NCT01178671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6126859|NCT01178671|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6126860|NCT01178671|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6126861|NCT01178671|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6126862|NCT01178671|Adrenergic Agents|adrenergic agents|mesh-ancestor
6126863|NCT01178671|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6126864|NCT01178671|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6126865|NCT01178671|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6126866|NCT01178762|Azithromycin|azithromycin|mesh-list
6126867|NCT01178762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6126868|NCT01178762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6126869|NCT01178827|Mandelic Acids|mandelic acids|mesh-list
6126870|NCT01178827|Oxybutynin|oxybutynin|mesh-list
6126871|NCT01178827|Trospium chloride|trospium chloride|mesh-list
6126872|NCT01178827|Parasympatholytics|parasympatholytics|mesh-ancestor
6126873|NCT01178827|Autonomic Agents|autonomic agents|mesh-ancestor
6126874|NCT01178827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6126875|NCT01178827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126876|NCT01178827|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6126877|NCT01178827|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6126878|NCT01178827|Cholinergic Agents|cholinergic agents|mesh-ancestor
6126879|NCT01178827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6126880|NCT01178827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535717|NCT04213794|Antitubercular Agents|antitubercular agents|mesh-ancestor
5535718|NCT04213794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5535719|NCT04213794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6126881|NCT01178827|Urological Agents|urological agents|mesh-ancestor
6126882|NCT01178827|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6126883|NCT01178827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6126884|NCT01178827|Renal Agents|renal agents|mesh-ancestor
6126885|NCT01178853|Warfarin|warfarin|mesh-list
6126886|NCT01178853|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6126887|NCT01178853|Pitavastatin|pitavastatin|mesh-list
5535720|NCT04213794|Chelating Agents|chelating agents|mesh-ancestor
5535721|NCT04213794|Sequestering Agents|sequestering agents|mesh-ancestor
5535722|NCT04213898|Paclitaxel|paclitaxel|mesh-list
5535723|NCT04213898|Epirubicin|epirubicin|mesh-list
5535724|NCT04213898|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5535725|NCT04213898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5535726|NCT04213898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5535727|NCT04213898|Tubulin Modulators|tubulin modulators|mesh-ancestor
5535728|NCT04213898|Antimitotic Agents|antimitotic agents|mesh-ancestor
5535729|NCT04213898|Mitosis Modulators|mitosis modulators|mesh-ancestor
5535730|NCT04213898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535731|NCT04213898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5535732|NCT04213898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6126888|NCT01178853|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6126889|NCT01178853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6126890|NCT01178853|Antimetabolites|antimetabolites|mesh-ancestor
6126891|NCT01178853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126892|NCT01178853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6126893|NCT01178853|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6126894|NCT01178853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6126895|NCT01178853|Anticoagulants|anticoagulants|mesh-ancestor
6126896|NCT01178944|Oxaliplatin|oxaliplatin|mesh-list
6126897|NCT01178944|10-deazaaminopterin|10-deazaaminopterin|mesh-list
6126898|NCT01178944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6126899|NCT01178944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6126900|NCT01178944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6126901|NCT01178944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126902|NCT01179048|Liraglutide|liraglutide|mesh-list
6126903|NCT01179048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6126904|NCT01179048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126905|NCT01179048|Incretins|incretins|mesh-ancestor
6126906|NCT01179048|Hormones|hormones|mesh-ancestor
6126907|NCT01179048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6126908|NCT01179113|Esmolol|esmolol|mesh-list
6126909|NCT01179113|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6126910|NCT01179113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6126911|NCT01179113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6126912|NCT01179113|Adrenergic Agents|adrenergic agents|mesh-ancestor
6126913|NCT01179113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6126914|NCT01179113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126915|NCT01179113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126916|NCT01179191|Naltrexone|naltrexone|mesh-list
6126917|NCT01179191|Morphine|morphine|mesh-list
5535733|NCT04213898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5535734|NCT04213898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5535735|NCT04213833|Lidocaine|lidocaine|mesh-list
5535736|NCT04213833|Dexmedetomidine|dexmedetomidine|mesh-list
5535737|NCT04213833|Propofol|propofol|mesh-list
5535738|NCT04213833|Anesthetics, Local|anesthetics, local|mesh-ancestor
5535739|NCT04213833|Anesthetics|anesthetics|mesh-ancestor
5535740|NCT04213833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5535741|NCT04213833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535742|NCT04213833|Sensory System Agents|sensory system agents|mesh-ancestor
5535743|NCT04213833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5535744|NCT04213833|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6126918|NCT01179191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6126919|NCT01179191|Narcotics|narcotics|mesh-ancestor
6126920|NCT01179191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6126921|NCT01179191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126922|NCT01179191|Analgesics|analgesics|mesh-ancestor
6126923|NCT01179191|Sensory System Agents|sensory system agents|mesh-ancestor
6126924|NCT01179191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6126925|NCT01179191|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6126926|NCT01179191|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6126927|NCT01179334|Sildenafil Citrate|sildenafil citrate|mesh-list
6126928|NCT01179334|Riociguat|riociguat|mesh-list
6126929|NCT01179334|Vasodilator Agents|vasodilator agents|mesh-ancestor
6126930|NCT01179334|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6126931|NCT01179334|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6126932|NCT01179334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6126933|NCT01179334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126934|NCT01179334|Urological Agents|urological agents|mesh-ancestor
6126935|NCT01179334|Enzyme Activators|enzyme activators|mesh-ancestor
6126936|NCT01179347|Tiotropium Bromide|tiotropium bromide|mesh-list
6126937|NCT01179347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6126938|NCT01179347|Autonomic Agents|autonomic agents|mesh-ancestor
6126939|NCT01179347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6126940|NCT01179347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126941|NCT01179347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6126942|NCT01179347|Respiratory System Agents|respiratory system agents|mesh-ancestor
6126943|NCT01179347|Parasympatholytics|parasympatholytics|mesh-ancestor
6126944|NCT01179347|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6126945|NCT01179347|Cholinergic Agents|cholinergic agents|mesh-ancestor
6126946|NCT01179347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6126947|NCT01179347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535745|NCT04213833|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5535746|NCT04213833|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5535747|NCT04213833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5535748|NCT04213833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535749|NCT04213833|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5535750|NCT04213833|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5535751|NCT04213833|Anesthetics, General|anesthetics, general|mesh-ancestor
5535752|NCT04213833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5535753|NCT04213833|Analgesics|analgesics|mesh-ancestor
5535754|NCT04213833|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5535755|NCT04213833|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5535756|NCT04213833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5535757|NCT04213833|Adrenergic Agents|adrenergic agents|mesh-ancestor
5535758|NCT04213833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5535759|NCT04213781|Sufentanil|sufentanil|mesh-list
5535760|NCT04213781|Propofol|propofol|mesh-list
5535761|NCT04213781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5535762|NCT04213781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5535763|NCT04213781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535764|NCT04213781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5535765|NCT04213781|Anesthetics, General|anesthetics, general|mesh-ancestor
5535766|NCT04213781|Anesthetics|anesthetics|mesh-ancestor
5535767|NCT04213781|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5535768|NCT04213781|Narcotics|narcotics|mesh-ancestor
6126948|NCT01179490|Prednisolone|prednisolone|mesh-list
6126949|NCT01179490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6126950|NCT01179490|Glucocorticoids|glucocorticoids|mesh-ancestor
6126951|NCT01179490|Hormones|hormones|mesh-ancestor
6126952|NCT01179490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6126953|NCT01179490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126954|NCT01179490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6466137|NCT00477581|Exenatide|exenatide|mesh-list
5535769|NCT04213781|Analgesics|analgesics|mesh-ancestor
5535770|NCT04213781|Sensory System Agents|sensory system agents|mesh-ancestor
5535771|NCT04213781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6126955|NCT01179490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6126956|NCT01179516|Vortioxetine|vortioxetine|mesh-list
6126957|NCT01179516|Antidepressive Agents|antidepressive agents|mesh-ancestor
6126958|NCT01179516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6126959|NCT01179516|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6126960|NCT01179516|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6126961|NCT01179516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6126962|NCT01179516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126963|NCT01179516|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6126964|NCT01179516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6126965|NCT01179516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6126966|NCT01179516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126967|NCT01179516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6126968|NCT01179516|Serotonin Agents|serotonin agents|mesh-ancestor
6126969|NCT01179516|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6126970|NCT01179516|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6126971|NCT01179516|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6126972|NCT01179516|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6126973|NCT01179568|Citalopram|citalopram|mesh-list
6126974|NCT01179568|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6126975|NCT01179568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6126976|NCT01179568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6126977|NCT01179568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126978|NCT01179568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6126979|NCT01179568|Serotonin Agents|serotonin agents|mesh-ancestor
6126980|NCT01179568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126981|NCT01179568|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6126982|NCT01179568|Antidepressive Agents|antidepressive agents|mesh-ancestor
6126983|NCT01179568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6126984|NCT01179672|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6126985|NCT01179672|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6126986|NCT01179672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6126987|NCT01179672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6126988|NCT01179672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6126989|NCT01179672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6126990|NCT01179672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6126991|NCT01179672|Analgesics|analgesics|mesh-ancestor
6126992|NCT01179672|Sensory System Agents|sensory system agents|mesh-ancestor
6126993|NCT01179672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6126994|NCT01179672|Antidepressive Agents|antidepressive agents|mesh-ancestor
6126995|NCT01179672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6126996|NCT01179672|Dopamine Agents|dopamine agents|mesh-ancestor
6126997|NCT01179919|Oseltamivir|oseltamivir|mesh-list
6126998|NCT01179919|Antiviral Agents|antiviral agents|mesh-ancestor
6126999|NCT01179919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6127000|NCT01179919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6127001|NCT01179919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127002|NCT01180036|Cyclosporine|cyclosporine|mesh-list
6127003|NCT01180036|Rituximab|rituximab|mesh-list
6127004|NCT01180036|Cyclosporins|cyclosporins|mesh-list
6127005|NCT01180036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6127006|NCT01180036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6127007|NCT01180036|Immunologic Factors|immunologic factors|mesh-ancestor
6127008|NCT01180036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127009|NCT01180036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6127010|NCT01180036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5535772|NCT04213781|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5535773|NCT04213885|Riboflavin|riboflavin|mesh-list
5535774|NCT04213885|Vitamin B Complex|vitamin b complex|mesh-ancestor
6127011|NCT01180036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127012|NCT01180036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6127013|NCT01180036|Antifungal Agents|antifungal agents|mesh-ancestor
6127014|NCT01180036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6127015|NCT01180036|Dermatologic Agents|dermatologic agents|mesh-ancestor
6127016|NCT01180036|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6127017|NCT01180049|Sirolimus|sirolimus|mesh-list
6127018|NCT01180049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6127019|NCT01180049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6127020|NCT01180049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6127021|NCT01180049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6127022|NCT01180049|Antifungal Agents|antifungal agents|mesh-ancestor
6127023|NCT01180049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6127024|NCT01180049|Immunologic Factors|immunologic factors|mesh-ancestor
6127025|NCT01180049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204888|NCT02078882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6204889|NCT02078882|Immunologic Factors|immunologic factors|mesh-ancestor
6204890|NCT02078882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204891|NCT02078882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6204892|NCT02078960|Homoharringtonine|homoharringtonine|mesh-list
6204893|NCT02078960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6204894|NCT02078960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6204895|NCT02078960|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5535775|NCT04213885|Vitamins|vitamins|mesh-ancestor
5535776|NCT04213885|Micronutrients|micronutrients|mesh-ancestor
5535777|NCT04213885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535778|NCT04213885|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5535779|NCT04213885|Dermatologic Agents|dermatologic agents|mesh-ancestor
5601840|NCT05133310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5601841|NCT05133310|Antimetabolites|antimetabolites|mesh-ancestor
5601842|NCT05133310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601843|NCT05133310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5601844|NCT05133310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5601845|NCT05133310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5601846|NCT05122559|Acetylcysteine|acetylcysteine|mesh-list
5601847|NCT05122559|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5601848|NCT05122559|Antiviral Agents|antiviral agents|mesh-ancestor
5601849|NCT05122559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5601850|NCT05122559|Expectorants|expectorants|mesh-ancestor
5601851|NCT05122559|Respiratory System Agents|respiratory system agents|mesh-ancestor
5601852|NCT05122559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5601853|NCT05122559|Antioxidants|antioxidants|mesh-ancestor
5601854|NCT05122559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601855|NCT05122559|Protective Agents|protective agents|mesh-ancestor
5601856|NCT05122559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204896|NCT02078960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6204897|NCT02078960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204898|NCT02079077|Aspirin|aspirin|mesh-list
6204899|NCT02079077|Hydroxychloroquine|hydroxychloroquine|mesh-list
6204900|NCT02079077|Antimalarials|antimalarials|mesh-ancestor
6204901|NCT02079077|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6204902|NCT02079077|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6204903|NCT02079077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6204904|NCT02079077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6204905|NCT02079077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601857|NCT05122559|Antidotes|antidotes|mesh-ancestor
5601858|NCT05109520|Insulin Glargine|insulin glargine|mesh-list
5601859|NCT05109520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5601860|NCT05109520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601861|NCT05104983|Sirolimus|sirolimus|mesh-list
5601862|NCT05104983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5601863|NCT05104983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5601864|NCT05104983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5601865|NCT05104983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5601866|NCT05104983|Antifungal Agents|antifungal agents|mesh-ancestor
5601867|NCT05104983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5601868|NCT05104983|Immunologic Factors|immunologic factors|mesh-ancestor
5601869|NCT05104983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601870|NCT05095831|Pancrelipase|pancrelipase|mesh-list
6204906|NCT02079077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6204907|NCT02079077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6204908|NCT02079077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6204909|NCT02079077|Analgesics|analgesics|mesh-ancestor
6204910|NCT02079077|Sensory System Agents|sensory system agents|mesh-ancestor
6204911|NCT02079077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6204912|NCT02079077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204913|NCT02079077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6204914|NCT02079077|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6204915|NCT02079077|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6204916|NCT02079077|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6204917|NCT02079077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6204918|NCT02079077|Antipyretics|antipyretics|mesh-ancestor
6204919|NCT02079519|Bevacizumab|bevacizumab|mesh-list
6204920|NCT02079519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6204921|NCT02079519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6466138|NCT00477581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5601871|NCT05095831|Pancreatin|pancreatin|mesh-list
5601872|NCT05095831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5601873|NCT05084248|Vitamin D|vitamin d|mesh-list
5601874|NCT05084248|Ergocalciferols|ergocalciferols|mesh-list
5601875|NCT05084248|Vitamins|vitamins|mesh-ancestor
6127026|NCT01180296|Progesterone|progesterone|mesh-list
6127027|NCT01180296|Progestins|progestins|mesh-ancestor
6127028|NCT01180296|Hormones|hormones|mesh-ancestor
6127029|NCT01180296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6127030|NCT01180296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127031|NCT01180647|Naltrexone|naltrexone|mesh-list
6127032|NCT01180647|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6127033|NCT01180647|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6127034|NCT01180647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127035|NCT01180647|Sensory System Agents|sensory system agents|mesh-ancestor
6127036|NCT01180647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6127037|NCT01180660|Lidocaine|lidocaine|mesh-list
6127038|NCT01180660|Anesthetics, Local|anesthetics, local|mesh-ancestor
6127039|NCT01180660|Anesthetics|anesthetics|mesh-ancestor
6127040|NCT01180660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6127041|NCT01180660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127042|NCT01180660|Sensory System Agents|sensory system agents|mesh-ancestor
6127043|NCT01180660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6127044|NCT01180660|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6127045|NCT01180660|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6127046|NCT01180660|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6127047|NCT01180660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6127048|NCT01180660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127049|NCT01180790|Interferons|interferons|mesh-list
6127050|NCT01180790|Ribavirin|ribavirin|mesh-list
6127051|NCT01180790|Interferon-alpha|interferon-alpha|mesh-list
6127052|NCT01180790|Interferon alpha-2|interferon alpha-2|mesh-list
6127053|NCT01180790|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6127054|NCT01180790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6127055|NCT01180790|Antiviral Agents|antiviral agents|mesh-ancestor
6127056|NCT01180790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6127057|NCT01180790|Antimetabolites|antimetabolites|mesh-ancestor
5535780|NCT04213378|Paclitaxel|paclitaxel|mesh-list
5535781|NCT04213378|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5535782|NCT04213378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5535783|NCT04213378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6127058|NCT01180790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127059|NCT01180790|Immunologic Factors|immunologic factors|mesh-ancestor
6127060|NCT01180790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127061|NCT01180894|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
5535784|NCT04213378|Tubulin Modulators|tubulin modulators|mesh-ancestor
5535785|NCT04213378|Antimitotic Agents|antimitotic agents|mesh-ancestor
5535786|NCT04213378|Mitosis Modulators|mitosis modulators|mesh-ancestor
5535787|NCT04213378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535788|NCT04213716|Calcium, Dietary|calcium, dietary|mesh-list
5535789|NCT04213716|Calcium|calcium|mesh-list
5535790|NCT04213716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5535791|NCT04213716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535792|NCT04213716|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5535793|NCT04213612|Cyclophosphamide|cyclophosphamide|mesh-list
5535794|NCT04213612|Doxorubicin|doxorubicin|mesh-list
5535795|NCT04213612|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5535796|NCT04213612|Vincristine|vincristine|mesh-list
6127062|NCT01180894|Hematinics|hematinics|mesh-ancestor
6127063|NCT01181011|Amlodipine|amlodipine|mesh-list
6127064|NCT01181011|Telmisartan|telmisartan|mesh-list
6127065|NCT01181011|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
6127066|NCT01181011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6127067|NCT01181011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6127068|NCT01181011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6127069|NCT01181011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127070|NCT01181011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6127071|NCT01181011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127072|NCT01181011|Vasodilator Agents|vasodilator agents|mesh-ancestor
6127073|NCT01181011|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6127074|NCT01181011|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6127075|NCT01181102|Enoxaparin|enoxaparin|mesh-list
6127076|NCT01181102|Enoxaparin sodium|enoxaparin sodium|mesh-list
6127077|NCT01181102|Edoxaban|edoxaban|mesh-list
6127078|NCT01181102|Anticoagulants|anticoagulants|mesh-ancestor
6127079|NCT01181102|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6127080|NCT01181102|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6666172|NCT01521312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5535797|NCT04213612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5535798|NCT04213612|Immunologic Factors|immunologic factors|mesh-ancestor
5535799|NCT04213612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127081|NCT01181102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127082|NCT01181102|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6127083|NCT01181102|Antithrombins|antithrombins|mesh-ancestor
6127084|NCT01181102|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6127085|NCT01181102|Protease Inhibitors|protease inhibitors|mesh-ancestor
6127086|NCT01181102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6127087|NCT01181128|Factor VIII|factor viii|mesh-list
6127088|NCT01181128|Coagulants|coagulants|mesh-ancestor
6127089|NCT01181141|Enoxaparin|enoxaparin|mesh-list
6127090|NCT01181141|Enoxaparin sodium|enoxaparin sodium|mesh-list
6127091|NCT01181141|Edoxaban|edoxaban|mesh-list
6127092|NCT01181141|Anticoagulants|anticoagulants|mesh-ancestor
6127093|NCT01181141|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6127094|NCT01181141|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6127095|NCT01181141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127096|NCT01181141|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6127097|NCT01181141|Antithrombins|antithrombins|mesh-ancestor
6127098|NCT01181141|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5535800|NCT04213612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5535801|NCT04213612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5535802|NCT04213612|Alkylating Agents|alkylating agents|mesh-ancestor
5535803|NCT04213612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535804|NCT04213612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5535805|NCT04213612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5535806|NCT04213612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5535807|NCT04213612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5535808|NCT04213612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5535809|NCT04213612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5535810|NCT04213612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5535811|NCT04213612|Tubulin Modulators|tubulin modulators|mesh-ancestor
5535812|NCT04213612|Antimitotic Agents|antimitotic agents|mesh-ancestor
5535813|NCT04213612|Mitosis Modulators|mitosis modulators|mesh-ancestor
5535814|NCT04213495|Anesthetics|anesthetics|mesh-list
5535815|NCT04213495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5535816|NCT04213495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535817|NCT04213170|Bevacizumab|bevacizumab|mesh-list
5535818|NCT04213170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5535819|NCT04213170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5535820|NCT04213170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5535821|NCT04213170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5535822|NCT04213170|Growth Substances|growth substances|mesh-ancestor
5535823|NCT04213170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535824|NCT04213170|Growth Inhibitors|growth inhibitors|mesh-ancestor
5535825|NCT04213404|Spartalizumab|spartalizumab|mesh-list
5535826|NCT04213404|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5535827|NCT04213404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535828|NCT04213404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6127099|NCT01181141|Protease Inhibitors|protease inhibitors|mesh-ancestor
6127100|NCT01181141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6127101|NCT01181167|Enoxaparin|enoxaparin|mesh-list
6127102|NCT01181167|Enoxaparin sodium|enoxaparin sodium|mesh-list
6127103|NCT01181167|Edoxaban|edoxaban|mesh-list
6127104|NCT01181167|Anticoagulants|anticoagulants|mesh-ancestor
6127105|NCT01181167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6127106|NCT01181167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6127107|NCT01181167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127108|NCT01181167|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6127109|NCT01181167|Antithrombins|antithrombins|mesh-ancestor
6127110|NCT01181167|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6127111|NCT01181167|Protease Inhibitors|protease inhibitors|mesh-ancestor
6127112|NCT01181167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6127113|NCT01181258|Methylprednisolone|methylprednisolone|mesh-list
6127114|NCT01181258|Cyclophosphamide|cyclophosphamide|mesh-list
6127115|NCT01181258|Rituximab|rituximab|mesh-list
6127116|NCT01181258|Fludarabine|fludarabine|mesh-list
6127117|NCT01181258|Interleukin-2|interleukin-2|mesh-list
6127118|NCT01181258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6127119|NCT01181258|Immunologic Factors|immunologic factors|mesh-ancestor
6127120|NCT01181258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127121|NCT01181258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6127122|NCT01181258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6127123|NCT01181258|Alkylating Agents|alkylating agents|mesh-ancestor
6127124|NCT01181258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127125|NCT01181258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6127126|NCT01181258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6127127|NCT01181258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5535829|NCT04213573|Fluorides|fluorides|mesh-list
5535830|NCT04213573|Cariostatic Agents|cariostatic agents|mesh-ancestor
5535831|NCT04213573|Protective Agents|protective agents|mesh-ancestor
5535832|NCT04213573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535833|NCT04213287|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
5535834|NCT04213287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535835|NCT04213287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5535836|NCT04213287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5535837|NCT04213287|Analgesics|analgesics|mesh-ancestor
5535838|NCT04213287|Sensory System Agents|sensory system agents|mesh-ancestor
6127128|NCT01181258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6127129|NCT01181258|Antiemetics|antiemetics|mesh-ancestor
6127130|NCT01181258|Autonomic Agents|autonomic agents|mesh-ancestor
6127131|NCT01181258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6127132|NCT01181258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6127133|NCT01181258|Glucocorticoids|glucocorticoids|mesh-ancestor
6127134|NCT01181258|Hormones|hormones|mesh-ancestor
6127135|NCT01181258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6127136|NCT01181258|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6127137|NCT01181258|Protective Agents|protective agents|mesh-ancestor
6127138|NCT01181258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6127139|NCT01181258|Analgesics|analgesics|mesh-ancestor
6127140|NCT01181258|Sensory System Agents|sensory system agents|mesh-ancestor
6127141|NCT01181271|Sirolimus|sirolimus|mesh-list
6127142|NCT01181271|Cyclophosphamide|cyclophosphamide|mesh-list
6127143|NCT01181271|Busulfan|busulfan|mesh-list
6127144|NCT01181271|Methotrexate|methotrexate|mesh-list
6127145|NCT01181271|Fludarabine|fludarabine|mesh-list
6127146|NCT01181271|Etoposide|etoposide|mesh-list
6127147|NCT01181271|Tacrolimus|tacrolimus|mesh-list
6127148|NCT01181271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6127149|NCT01181271|Immunologic Factors|immunologic factors|mesh-ancestor
6127150|NCT01181271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127151|NCT01181271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6127152|NCT01181271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6127153|NCT01181271|Alkylating Agents|alkylating agents|mesh-ancestor
6127154|NCT01181271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127155|NCT01181271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6127156|NCT01181271|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6127157|NCT01181271|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6127158|NCT01181271|Abortifacient Agents|abortifacient agents|mesh-ancestor
6127159|NCT01181271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6127160|NCT01181271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6127161|NCT01181271|Antimetabolites|antimetabolites|mesh-ancestor
6127162|NCT01181271|Dermatologic Agents|dermatologic agents|mesh-ancestor
6127163|NCT01181271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6127164|NCT01181271|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6127165|NCT01181271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6127166|NCT01181271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6127167|NCT01181271|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6127168|NCT01181271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6127169|NCT01181271|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6127170|NCT01181271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6127171|NCT01181271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6127172|NCT01181271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6127173|NCT01181271|Antifungal Agents|antifungal agents|mesh-ancestor
6127174|NCT01181323|Vaccines|vaccines|mesh-list
6127175|NCT01181323|Immunologic Factors|immunologic factors|mesh-ancestor
6127176|NCT01181323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127177|NCT01181349|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
6127178|NCT01181349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6127179|NCT01181349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6127180|NCT01181349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127181|NCT01181531|Vitamin D|vitamin d|mesh-list
6127182|NCT01181531|Cinacalcet|cinacalcet|mesh-list
6127183|NCT01181531|Vitamins|vitamins|mesh-ancestor
5535839|NCT04213287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5535840|NCT04213287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5535841|NCT04213287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5535842|NCT04213209|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5535843|NCT04213209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5535844|NCT04213209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5535845|NCT04213391|Sulforaphane|sulforaphane|mesh-list
5535846|NCT04213391|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6127184|NCT01181531|Micronutrients|micronutrients|mesh-ancestor
6127185|NCT01181531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127186|NCT01181531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6127187|NCT01181531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6127188|NCT01181531|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6127189|NCT01181531|Hormone Antagonists|hormone antagonists|mesh-ancestor
6127190|NCT01181531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6127191|NCT01181609|Bevacizumab|bevacizumab|mesh-list
6127192|NCT01181609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6127193|NCT01181609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6127194|NCT01181609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5535847|NCT04213391|Protective Agents|protective agents|mesh-ancestor
5535848|NCT04213391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535849|NCT04213391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5535850|NCT04213222|Bevacizumab|bevacizumab|mesh-list
5535851|NCT04213222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5535852|NCT04213222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5535853|NCT04213222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5535854|NCT04213222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5535855|NCT04213222|Growth Substances|growth substances|mesh-ancestor
5535856|NCT04213222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535857|NCT04213222|Growth Inhibitors|growth inhibitors|mesh-ancestor
5535858|NCT04213105|Denosumab|denosumab|mesh-list
5535859|NCT04213105|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5535860|NCT04213105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535861|NCT04212793|Bevacizumab|bevacizumab|mesh-list
5535862|NCT04212793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5535863|NCT04212793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5535864|NCT04212793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6127195|NCT01181609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6127196|NCT01181609|Growth Substances|growth substances|mesh-ancestor
6127197|NCT01181609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127198|NCT01181609|Growth Inhibitors|growth inhibitors|mesh-ancestor
6127199|NCT01181674|Insulin|insulin|mesh-list
6127200|NCT01181674|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6127201|NCT01181674|Metformin|metformin|mesh-list
6127202|NCT01181674|Insulin Glargine|insulin glargine|mesh-list
6127203|NCT01181674|Acarbose|acarbose|mesh-list
6127204|NCT01181674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5535865|NCT04212793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5535866|NCT04212793|Growth Substances|growth substances|mesh-ancestor
5535867|NCT04212793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127205|NCT01181674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127206|NCT01181674|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6127207|NCT01181674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6127208|NCT01181674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127209|NCT01181726|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6127210|NCT01181726|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6127211|NCT01181726|Norethindrone|norethindrone|mesh-list
5535868|NCT04212793|Growth Inhibitors|growth inhibitors|mesh-ancestor
5535869|NCT04212832|Bupivacaine|bupivacaine|mesh-list
5535870|NCT04212832|Anesthetics, Local|anesthetics, local|mesh-ancestor
5535871|NCT04212832|Anesthetics|anesthetics|mesh-ancestor
5535872|NCT04212832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5535873|NCT04212832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535874|NCT04212832|Sensory System Agents|sensory system agents|mesh-ancestor
5535875|NCT04212832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5535876|NCT04212845|Dexamethasone|dexamethasone|mesh-list
5535877|NCT04212845|Bupivacaine|bupivacaine|mesh-list
5535878|NCT04212845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6127212|NCT01181726|Norethindrone Acetate|norethindrone acetate|mesh-list
6127213|NCT01181726|Estradiol|estradiol|mesh-list
6127214|NCT01181726|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6127215|NCT01181726|Estrogens|estrogens|mesh-ancestor
6127216|NCT01181726|Hormones|hormones|mesh-ancestor
6127217|NCT01181726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6127218|NCT01181726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127219|NCT01181726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6127220|NCT01181726|Contraceptive Agents|contraceptive agents|mesh-ancestor
6127221|NCT01181726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6127222|NCT01181726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6127223|NCT01181726|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6127224|NCT01181726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6127225|NCT01181726|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6127226|NCT01181895|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6127227|NCT01181895|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6127228|NCT01181895|Autonomic Agents|autonomic agents|mesh-ancestor
6127229|NCT01181895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6127230|NCT01181895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127231|NCT01181895|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6127232|NCT01181895|Respiratory System Agents|respiratory system agents|mesh-ancestor
6127233|NCT01181895|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6127234|NCT01181895|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6127235|NCT01181895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6127236|NCT01181895|Adrenergic Agents|adrenergic agents|mesh-ancestor
6127237|NCT01181895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6127238|NCT01181895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127239|NCT01181986|Exenatide|exenatide|mesh-list
6127240|NCT01181986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6127241|NCT01181986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127242|NCT01181986|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6127243|NCT01181986|Incretins|incretins|mesh-ancestor
6127244|NCT01181986|Hormones|hormones|mesh-ancestor
6127245|NCT01181986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6127246|NCT01182181|Anastrozole|anastrozole|mesh-list
6127247|NCT01182181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6127248|NCT01182181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6127249|NCT01182181|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6127250|NCT01182181|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6127251|NCT01182181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5535879|NCT04212845|Antiemetics|antiemetics|mesh-ancestor
5535880|NCT04212845|Autonomic Agents|autonomic agents|mesh-ancestor
5535881|NCT04212845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5535882|NCT04212845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535883|NCT04212845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5535884|NCT04212845|Glucocorticoids|glucocorticoids|mesh-ancestor
5535885|NCT04212845|Hormones|hormones|mesh-ancestor
5535886|NCT04212845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5535887|NCT04212845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5535888|NCT04212845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5535889|NCT04212845|Anesthetics, Local|anesthetics, local|mesh-ancestor
5535890|NCT04212845|Anesthetics|anesthetics|mesh-ancestor
5535891|NCT04212845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5535892|NCT04212845|Sensory System Agents|sensory system agents|mesh-ancestor
5535893|NCT04212702|Everolimus|everolimus|mesh-list
5535894|NCT04212702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5535895|NCT04212702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5535896|NCT04212702|Immunologic Factors|immunologic factors|mesh-ancestor
5535897|NCT04212702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535898|NCT04212429|Moxifloxacin|moxifloxacin|mesh-list
5535899|NCT04212429|Levofloxacin|levofloxacin|mesh-list
5535900|NCT04212429|Ofloxacin|ofloxacin|mesh-list
5535901|NCT04212429|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5535902|NCT04212429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5535903|NCT04212429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5535904|NCT04212429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5535905|NCT04212429|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5535906|NCT04212429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5535907|NCT04212429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5535908|NCT04212429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535909|NCT04212429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6127252|NCT01182181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127253|NCT01182181|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6127254|NCT01182181|Hormone Antagonists|hormone antagonists|mesh-ancestor
6127255|NCT01182181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6127256|NCT01182181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127257|NCT01182194|Drospirenone|drospirenone|mesh-list
5535910|NCT04212429|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5535911|NCT04212429|Renal Agents|renal agents|mesh-ancestor
5535912|NCT04212429|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5535913|NCT04212429|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6127258|NCT01182194|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6127259|NCT01182194|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6127260|NCT01182194|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6127261|NCT01182194|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
6127262|NCT01182194|Estradiol|estradiol|mesh-list
6127263|NCT01182194|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6127264|NCT01182194|Estrogens|estrogens|mesh-ancestor
6127265|NCT01182194|Hormones|hormones|mesh-ancestor
6127266|NCT01182194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6127267|NCT01182194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127268|NCT01182194|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6127269|NCT01182194|Contraceptive Agents|contraceptive agents|mesh-ancestor
6127270|NCT01182194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6127271|NCT01182194|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6127272|NCT01182194|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6127273|NCT01182194|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6127274|NCT01182194|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6127275|NCT01182194|Hormone Antagonists|hormone antagonists|mesh-ancestor
6127276|NCT01182194|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6127277|NCT01182194|Diuretics|diuretics|mesh-ancestor
6127278|NCT01182194|Natriuretic Agents|natriuretic agents|mesh-ancestor
6127279|NCT01182207|Drospirenone|drospirenone|mesh-list
6127280|NCT01182207|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6127281|NCT01182207|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6127282|NCT01182207|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6127283|NCT01182207|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
6127284|NCT01182207|Estradiol|estradiol|mesh-list
6127285|NCT01182207|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6127286|NCT01182207|Estrogens|estrogens|mesh-ancestor
6127287|NCT01182207|Hormones|hormones|mesh-ancestor
6127288|NCT01182207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6127289|NCT01182207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127290|NCT01182207|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6127291|NCT01182207|Contraceptive Agents|contraceptive agents|mesh-ancestor
6127292|NCT01182207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6127293|NCT01182207|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6127294|NCT01182207|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6127295|NCT01182207|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6127296|NCT01182207|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6127297|NCT01182207|Hormone Antagonists|hormone antagonists|mesh-ancestor
6127298|NCT01182207|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6127299|NCT01182207|Diuretics|diuretics|mesh-ancestor
6127300|NCT01182207|Natriuretic Agents|natriuretic agents|mesh-ancestor
6127301|NCT01182285|Valproic Acid|valproic acid|mesh-list
6127302|NCT01182285|Anticonvulsants|anticonvulsants|mesh-ancestor
6127303|NCT01182285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5535914|NCT04212416|Leflunomide|leflunomide|mesh-list
6127304|NCT01182285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127305|NCT01182285|GABA Agents|gaba agents|mesh-ancestor
6127306|NCT01182285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6127307|NCT01182285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127308|NCT01182285|Antimanic Agents|antimanic agents|mesh-ancestor
5535915|NCT04212416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5535916|NCT04212416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535917|NCT04212416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5535918|NCT04212416|Immunologic Factors|immunologic factors|mesh-ancestor
5535919|NCT04212416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535920|NCT04212650|Losartan|losartan|mesh-list
5535921|NCT04212650|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5535922|NCT04212650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6127309|NCT01182285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6127310|NCT01182285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6127311|NCT01182285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6127312|NCT01182350|Bevacizumab|bevacizumab|mesh-list
6127313|NCT01182350|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6127314|NCT01182350|Temozolomide|temozolomide|mesh-list
5535923|NCT04212650|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5535924|NCT04212650|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5535925|NCT04212650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535926|NCT04212403|Levofloxacin|levofloxacin|mesh-list
5535927|NCT04212403|Ofloxacin|ofloxacin|mesh-list
5535928|NCT04212403|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5535929|NCT04212403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5535930|NCT04212403|Renal Agents|renal agents|mesh-ancestor
5535931|NCT04212403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5535932|NCT04212403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5535933|NCT04212403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5535934|NCT04212403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5535935|NCT04212403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535936|NCT04212403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5535937|NCT04212403|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5535938|NCT04212403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5535939|NCT04212533|Vitamin D|vitamin d|mesh-list
5535940|NCT04212533|Vitamins|vitamins|mesh-ancestor
5535941|NCT04212533|Micronutrients|micronutrients|mesh-ancestor
5535942|NCT04212533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127315|NCT01182350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6127316|NCT01182350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6127317|NCT01182350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6127318|NCT01182350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6127319|NCT01182350|Growth Substances|growth substances|mesh-ancestor
6127320|NCT01182350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127321|NCT01182350|Growth Inhibitors|growth inhibitors|mesh-ancestor
6127322|NCT01182350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6127323|NCT01182350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6127324|NCT01182350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466139|NCT00477581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466140|NCT00477581|Incretins|incretins|mesh-ancestor
5535943|NCT04212533|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5601876|NCT05084248|Micronutrients|micronutrients|mesh-ancestor
5601877|NCT05084248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601878|NCT05084248|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5601879|NCT05084248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5601880|NCT05065801|Folfirinox|folfirinox|mesh-list
5601881|NCT05065801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5601882|NCT05052307|Vaccines|vaccines|mesh-list
5601883|NCT05052307|Immunologic Factors|immunologic factors|mesh-ancestor
5601884|NCT05052307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601885|NCT05051436|Tadalafil|tadalafil|mesh-list
5601886|NCT05051436|Mirabegron|mirabegron|mesh-list
5601887|NCT05051436|Vasodilator Agents|vasodilator agents|mesh-ancestor
5601888|NCT05051436|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5601889|NCT05051436|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5601890|NCT05051436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5601891|NCT05051436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601892|NCT05051436|Urological Agents|urological agents|mesh-ancestor
5601893|NCT05051436|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
5601894|NCT05051436|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5601895|NCT05051436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5601896|NCT05051436|Adrenergic Agents|adrenergic agents|mesh-ancestor
5601897|NCT05051436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5601898|NCT05051436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601899|NCT05047172|Aspirin|aspirin|mesh-list
5601900|NCT05047172|Rivaroxaban|rivaroxaban|mesh-list
5601901|NCT05047172|Clopidogrel|clopidogrel|mesh-list
5601902|NCT05047172|Ticagrelor|ticagrelor|mesh-list
5601903|NCT05047172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5601904|NCT05047172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5601905|NCT05047172|Analgesics|analgesics|mesh-ancestor
5601906|NCT05047172|Sensory System Agents|sensory system agents|mesh-ancestor
5601907|NCT05047172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5601908|NCT05047172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601909|NCT05047172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5601910|NCT05047172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5601911|NCT05047172|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5535944|NCT04211896|Nivolumab|nivolumab|mesh-list
5535945|NCT04211896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5535946|NCT04211896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5535947|NCT04211896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5535948|NCT04211896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535949|NCT04212026|Nivolumab|nivolumab|mesh-list
5606749|NCT03786783|Cyclophosphamide|cyclophosphamide|mesh-list
6127325|NCT01182350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6127326|NCT01182350|Alkylating Agents|alkylating agents|mesh-ancestor
6127327|NCT01182376|Dronedarone|dronedarone|mesh-list
6127328|NCT01182376|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6127329|NCT01182441|Warfarin|warfarin|mesh-list
6466141|NCT00477581|Hormones|hormones|mesh-ancestor
6466142|NCT00477581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6466143|NCT00477581|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6466144|NCT00477581|Protease Inhibitors|protease inhibitors|mesh-ancestor
6466145|NCT00477581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6466146|NCT00477581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466147|NCT00477581|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6466148|NCT00477711|Capecitabine|capecitabine|mesh-list
6466149|NCT00477711|Cetuximab|cetuximab|mesh-list
6466150|NCT00477711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6466151|NCT00477711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6466152|NCT00477711|Antimetabolites|antimetabolites|mesh-ancestor
6127330|NCT01182441|Anticoagulants|anticoagulants|mesh-ancestor
6127331|NCT01182493|Insulin|insulin|mesh-list
6127332|NCT01182493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6127333|NCT01182493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127334|NCT01182675|Plerixafor|plerixafor|mesh-list
6127335|NCT01182675|Alemtuzumab|alemtuzumab|mesh-list
6127336|NCT01182675|Lenograstim|lenograstim|mesh-list
6127337|NCT01182675|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6127338|NCT01182675|Immunologic Factors|immunologic factors|mesh-ancestor
6127339|NCT01182675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127340|NCT01182675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6127341|NCT01182675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6127342|NCT01182675|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6127343|NCT01182675|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6127344|NCT01182675|Antiviral Agents|antiviral agents|mesh-ancestor
6127345|NCT01182675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6127346|NCT01182727|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
6127347|NCT01182727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6127348|NCT01182727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6127349|NCT01182727|Analgesics|analgesics|mesh-ancestor
6127350|NCT01182727|Sensory System Agents|sensory system agents|mesh-ancestor
6127351|NCT01182727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6127352|NCT01182727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127353|NCT01182727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6127354|NCT01182727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6127355|NCT01183013|Pioglitazone|pioglitazone|mesh-list
6127356|NCT01183013|Linagliptin|linagliptin|mesh-list
6127357|NCT01183013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6127358|NCT01183013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127359|NCT01183013|Incretins|incretins|mesh-ancestor
6127360|NCT01183013|Hormones|hormones|mesh-ancestor
6127361|NCT01183013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6127362|NCT01183013|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6127363|NCT01183013|Protease Inhibitors|protease inhibitors|mesh-ancestor
6127364|NCT01183013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6127365|NCT01183013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127366|NCT01183065|Folic Acid|folic acid|mesh-list
6127367|NCT01183065|Vitamin B 12|vitamin b 12|mesh-list
6127368|NCT01183065|Hydroxocobalamin|hydroxocobalamin|mesh-list
6127369|NCT01183065|Vitamins|vitamins|mesh-ancestor
5535950|NCT04212026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6466153|NCT00477711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466154|NCT00477711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6466155|NCT00477737|Propofol|propofol|mesh-list
6466156|NCT00477737|Sevoflurane|sevoflurane|mesh-list
6466157|NCT00477737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6127370|NCT01183065|Micronutrients|micronutrients|mesh-ancestor
6127371|NCT01183065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127372|NCT01183065|Hematinics|hematinics|mesh-ancestor
6127373|NCT01183065|Vitamin B Complex|vitamin b complex|mesh-ancestor
6127374|NCT01183104|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6127375|NCT01183104|Glimepiride|glimepiride|mesh-list
5535951|NCT04212026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5535952|NCT04212026|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5535953|NCT04212026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535954|NCT04212039|Bupivacaine|bupivacaine|mesh-list
5535955|NCT04212039|Anesthetics, Local|anesthetics, local|mesh-ancestor
6127376|NCT01183104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6127377|NCT01183104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127378|NCT01183104|Incretins|incretins|mesh-ancestor
6127379|NCT01183104|Hormones|hormones|mesh-ancestor
6127380|NCT01183104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6127381|NCT01183104|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6127382|NCT01183104|Protease Inhibitors|protease inhibitors|mesh-ancestor
6127383|NCT01183104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6127384|NCT01183104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127385|NCT01183104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6127386|NCT01183104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6127387|NCT01183104|Immunologic Factors|immunologic factors|mesh-ancestor
6127388|NCT01183143|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6127389|NCT01183143|Hormones|hormones|mesh-ancestor
6127390|NCT01183143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6127391|NCT01183143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127392|NCT01183169|Ribavirin|ribavirin|mesh-list
6127393|NCT01183169|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6127394|NCT01183169|Antimetabolites|antimetabolites|mesh-ancestor
6127395|NCT01183169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127396|NCT01183169|Antiviral Agents|antiviral agents|mesh-ancestor
6127397|NCT01183169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6127398|NCT01183234|Methylphenidate|methylphenidate|mesh-list
6127399|NCT01183234|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6127400|NCT01183234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127401|NCT01183234|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6127402|NCT01183234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6127403|NCT01183234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6127404|NCT01183234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127405|NCT01183234|Dopamine Agents|dopamine agents|mesh-ancestor
6127406|NCT01183234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6127407|NCT01183312|Flumazenil|flumazenil|mesh-list
6127408|NCT01183312|Antidotes|antidotes|mesh-ancestor
6127409|NCT01183312|Protective Agents|protective agents|mesh-ancestor
6127410|NCT01183312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127411|NCT01183312|GABA Modulators|gaba modulators|mesh-ancestor
6127412|NCT01183312|GABA Agents|gaba agents|mesh-ancestor
6466158|NCT00477737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6466159|NCT00477737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466160|NCT00477737|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6466161|NCT00477737|Anesthetics, General|anesthetics, general|mesh-ancestor
6466162|NCT00477737|Anesthetics|anesthetics|mesh-ancestor
6466163|NCT00477737|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6466164|NCT00477737|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6466165|NCT00477763|Cyclosporine|cyclosporine|mesh-list
6466166|NCT00477763|Cyclosporins|cyclosporins|mesh-list
6466167|NCT00477763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6466168|NCT00477763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466169|NCT00477763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6466170|NCT00477763|Immunologic Factors|immunologic factors|mesh-ancestor
6466171|NCT00477763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466172|NCT00477763|Antifungal Agents|antifungal agents|mesh-ancestor
6466173|NCT00477763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6466174|NCT00477763|Dermatologic Agents|dermatologic agents|mesh-ancestor
6466175|NCT00477763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6466176|NCT00477763|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6466177|NCT00477776|Metoclopramide|metoclopramide|mesh-list
5535956|NCT04212039|Anesthetics|anesthetics|mesh-ancestor
5535957|NCT04212039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5535958|NCT04212039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535959|NCT04212039|Sensory System Agents|sensory system agents|mesh-ancestor
5535960|NCT04212039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5535961|NCT04212078|Levofloxacin|levofloxacin|mesh-list
5535962|NCT04212078|Ofloxacin|ofloxacin|mesh-list
5535963|NCT04212078|Cefuroxime|cefuroxime|mesh-list
5535964|NCT04212078|Cefuroxime axetil|cefuroxime axetil|mesh-list
5535965|NCT04212078|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5535966|NCT04212078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5535967|NCT04212078|Renal Agents|renal agents|mesh-ancestor
5535968|NCT04212078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5535969|NCT04212078|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5535970|NCT04212078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5535971|NCT04212078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6127413|NCT01183312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6127414|NCT01183312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127415|NCT01183390|Anastrozole|anastrozole|mesh-list
6127416|NCT01183390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6127417|NCT01183390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6127418|NCT01183390|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6127419|NCT01183390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5535972|NCT04212078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535973|NCT04212078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5535974|NCT04212078|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5535975|NCT04212078|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5535976|NCT04211961|Scopolamine|scopolamine|mesh-list
5535977|NCT04211961|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
5535978|NCT04211961|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5535979|NCT04211961|Antiemetics|antiemetics|mesh-ancestor
5535980|NCT04211961|Autonomic Agents|autonomic agents|mesh-ancestor
5535981|NCT04211961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5535982|NCT04211961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5535983|NCT04211961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5535984|NCT04211961|Mydriatics|mydriatics|mesh-ancestor
5535985|NCT04211961|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5535986|NCT04211961|Cholinergic Agents|cholinergic agents|mesh-ancestor
5535987|NCT04211961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5535988|NCT04211961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535989|NCT04211961|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5535990|NCT04211961|Parasympatholytics|parasympatholytics|mesh-ancestor
5535991|NCT04211987|Cytarabine|cytarabine|mesh-list
5535992|NCT04211987|Methotrexate|methotrexate|mesh-list
5535993|NCT04211987|Etoposide|etoposide|mesh-list
5535994|NCT04211987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5535995|NCT04211987|Antimetabolites|antimetabolites|mesh-ancestor
5535996|NCT04211987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5535997|NCT04211987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5535998|NCT04211987|Antiviral Agents|antiviral agents|mesh-ancestor
5535999|NCT04211987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6127420|NCT01183390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6127421|NCT01183390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127422|NCT01183390|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6127423|NCT01183390|Hormone Antagonists|hormone antagonists|mesh-ancestor
6127424|NCT01183390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5536000|NCT04211987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5536001|NCT04211987|Immunologic Factors|immunologic factors|mesh-ancestor
5536002|NCT04211987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536003|NCT04211987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5536004|NCT04211987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5536005|NCT04211987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5536006|NCT04211987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5536007|NCT04211987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5536008|NCT04211987|Abortifacient Agents|abortifacient agents|mesh-ancestor
5536009|NCT04211987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5536010|NCT04211987|Dermatologic Agents|dermatologic agents|mesh-ancestor
5536011|NCT04211987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5536012|NCT04211987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5536013|NCT04211987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5536014|NCT04212065|Buprenorphine|buprenorphine|mesh-list
5536015|NCT04212065|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5536016|NCT04212065|Narcotics|narcotics|mesh-ancestor
5536017|NCT04212065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6127425|NCT01183390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127426|NCT01183481|Aprepitant|aprepitant|mesh-list
6127427|NCT01183481|Granisetron|granisetron|mesh-list
6127428|NCT01183481|Antiemetics|antiemetics|mesh-ancestor
6127429|NCT01183481|Autonomic Agents|autonomic agents|mesh-ancestor
6127430|NCT01183481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6127431|NCT01183481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127432|NCT01183481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6127433|NCT01183481|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6127434|NCT01183481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6127435|NCT01183481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127436|NCT01183481|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6127437|NCT01183481|Serotonin Agents|serotonin agents|mesh-ancestor
6127438|NCT01183533|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6127439|NCT01183533|Plasminogen|plasminogen|mesh-list
6127440|NCT01183533|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6466178|NCT00477776|Antiemetics|antiemetics|mesh-ancestor
6466179|NCT00477776|Autonomic Agents|autonomic agents|mesh-ancestor
6466180|NCT00477776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6466181|NCT00477776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466182|NCT00477776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6466183|NCT00477776|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6466184|NCT00477776|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6466185|NCT00477776|Dopamine Agents|dopamine agents|mesh-ancestor
6466186|NCT00477776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6466187|NCT00477776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466188|NCT00477789|Allopurinol|allopurinol|mesh-list
6466189|NCT00477789|Antimetabolites|antimetabolites|mesh-ancestor
6466190|NCT00477789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466191|NCT00477789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6466192|NCT00477789|Gout Suppressants|gout suppressants|mesh-ancestor
6466193|NCT00477789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6466194|NCT00477789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6466195|NCT00477789|Antioxidants|antioxidants|mesh-ancestor
6466196|NCT00477789|Protective Agents|protective agents|mesh-ancestor
6466197|NCT00477789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466198|NCT00477802|Botulinum Toxins|botulinum toxins|mesh-list
6466199|NCT00477802|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6466200|NCT00477802|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6466201|NCT00477802|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5536018|NCT04212065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127441|NCT01183533|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6127442|NCT01183533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127443|NCT01183559|Paclitaxel|paclitaxel|mesh-list
6127444|NCT01183559|Carboplatin|carboplatin|mesh-list
6127445|NCT01183559|Fluorouracil|fluorouracil|mesh-list
6127446|NCT01183559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6127447|NCT01183559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6127448|NCT01183559|Tubulin Modulators|tubulin modulators|mesh-ancestor
6127449|NCT01183559|Antimitotic Agents|antimitotic agents|mesh-ancestor
6127450|NCT01183559|Mitosis Modulators|mitosis modulators|mesh-ancestor
6127451|NCT01183559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127452|NCT01183559|Antimetabolites|antimetabolites|mesh-ancestor
6127453|NCT01183559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6127454|NCT01183559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6127455|NCT01183559|Immunologic Factors|immunologic factors|mesh-ancestor
6127456|NCT01183559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127457|NCT01183650|Tadalafil|tadalafil|mesh-list
6127458|NCT01183650|Vasodilator Agents|vasodilator agents|mesh-ancestor
6127459|NCT01183650|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6127460|NCT01183650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5536019|NCT04212065|Analgesics|analgesics|mesh-ancestor
6127461|NCT01183650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6127462|NCT01183650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127463|NCT01183650|Urological Agents|urological agents|mesh-ancestor
6127464|NCT01183780|Leucovorin|leucovorin|mesh-list
6127465|NCT01183780|Folic Acid|folic acid|mesh-list
6127466|NCT01183780|Fluorouracil|fluorouracil|mesh-list
6127467|NCT01183780|Irinotecan|irinotecan|mesh-list
6127468|NCT01183780|Ramucirumab|ramucirumab|mesh-list
6127469|NCT01183780|Levoleucovorin|levoleucovorin|mesh-list
6127470|NCT01183780|Antimetabolites|antimetabolites|mesh-ancestor
6127471|NCT01183780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127472|NCT01183780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6127473|NCT01183780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6127474|NCT01183780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5536020|NCT04212065|Sensory System Agents|sensory system agents|mesh-ancestor
5536021|NCT04212065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5536022|NCT04212065|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5536023|NCT04212000|Ketoconazole|ketoconazole|mesh-list
6127475|NCT01183780|Immunologic Factors|immunologic factors|mesh-ancestor
6127476|NCT01183780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127477|NCT01183780|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6127478|NCT01183780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6127479|NCT01183780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6127480|NCT01183780|Antidotes|antidotes|mesh-ancestor
6127481|NCT01183780|Protective Agents|protective agents|mesh-ancestor
6127482|NCT01183780|Vitamin B Complex|vitamin b complex|mesh-ancestor
6127483|NCT01183780|Vitamins|vitamins|mesh-ancestor
5536024|NCT04212000|Antifungal Agents|antifungal agents|mesh-ancestor
5536025|NCT04212000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5536026|NCT04212000|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5536027|NCT04212000|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5536028|NCT04212000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5536029|NCT04212000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536030|NCT04212000|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5536031|NCT04212000|Hormone Antagonists|hormone antagonists|mesh-ancestor
5536032|NCT04212000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5536033|NCT04212000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536034|NCT04212000|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5536035|NCT04211805|Tenofovir|tenofovir|mesh-list
6127484|NCT01183780|Micronutrients|micronutrients|mesh-ancestor
6127485|NCT01183780|Hematinics|hematinics|mesh-ancestor
6127486|NCT01183858|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6127487|NCT01183858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6127488|NCT01183858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6127489|NCT01183858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6127490|NCT01183858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127491|NCT01184014|Insulin|insulin|mesh-list
6127492|NCT01184014|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6127493|NCT01184014|Insulin Glargine|insulin glargine|mesh-list
6127494|NCT01184014|Insulin Lispro|insulin lispro|mesh-list
6127495|NCT01184014|Insulin, Isophane|insulin, isophane|mesh-list
6127496|NCT01184014|Isophane Insulin, Human|isophane insulin, human|mesh-list
6127497|NCT01184014|Isophane insulin, beef|isophane insulin, beef|mesh-list
5536036|NCT04211805|Vaccines|vaccines|mesh-list
5536037|NCT04211805|Immunologic Factors|immunologic factors|mesh-ancestor
5536038|NCT04211805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536039|NCT04211805|Antiviral Agents|antiviral agents|mesh-ancestor
5536040|NCT04211805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5536041|NCT04211805|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5536042|NCT04211805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5536043|NCT04211805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5536044|NCT04211805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536045|NCT04211805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6127498|NCT01184014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6127499|NCT01184014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127500|NCT01184053|Arsenic Trioxide|arsenic trioxide|mesh-list
6127501|NCT01184053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6127502|NCT01184079|Vaccines|vaccines|mesh-list
6127503|NCT01184079|Immunologic Factors|immunologic factors|mesh-ancestor
6127504|NCT01184079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127505|NCT01184118|Fluticasone|fluticasone|mesh-list
6127506|NCT01184118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6127507|NCT01184118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6127508|NCT01184118|Autonomic Agents|autonomic agents|mesh-ancestor
6127509|NCT01184118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6127510|NCT01184118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127511|NCT01184118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5536046|NCT04211805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5536047|NCT04211558|Ozanimod|ozanimod|mesh-list
5536048|NCT04211558|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5536049|NCT04211558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536050|NCT04211558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5536051|NCT04211558|Immunologic Factors|immunologic factors|mesh-ancestor
5536052|NCT04211558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536053|NCT04211844|Sofosbuvir|sofosbuvir|mesh-list
5536054|NCT04211844|Ledipasvir|ledipasvir|mesh-list
5536055|NCT04211844|Antiviral Agents|antiviral agents|mesh-ancestor
5536056|NCT04211844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5536057|NCT04211545|Rabeprazole|rabeprazole|mesh-list
6127512|NCT01184118|Respiratory System Agents|respiratory system agents|mesh-ancestor
5536058|NCT04211545|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5536059|NCT04211545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5536060|NCT04211545|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5536061|NCT04211545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5536062|NCT04211545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536063|NCT04211272|Sildenafil Citrate|sildenafil citrate|mesh-list
5536064|NCT04211272|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6127513|NCT01184118|Dermatologic Agents|dermatologic agents|mesh-ancestor
6127514|NCT01184118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6127515|NCT01184326|Everolimus|everolimus|mesh-list
6127516|NCT01184326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6127517|NCT01184326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6127518|NCT01184326|Immunologic Factors|immunologic factors|mesh-ancestor
6127519|NCT01184326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127520|NCT01184417|Phenobarbital|phenobarbital|mesh-list
6127521|NCT01184417|Anticonvulsants|anticonvulsants|mesh-ancestor
6127522|NCT01184417|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6127523|NCT01184417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6127524|NCT01184417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127525|NCT01184417|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6127526|NCT01184417|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6127527|NCT01184417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6127528|NCT01184417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127529|NCT01184417|GABA Modulators|gaba modulators|mesh-ancestor
6127530|NCT01184417|GABA Agents|gaba agents|mesh-ancestor
6127531|NCT01184417|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6127532|NCT01184417|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6127533|NCT01184417|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6127534|NCT01184846|Immunoglobulins|immunoglobulins|mesh-list
6127535|NCT01184846|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6127536|NCT01184846|Antibodies|antibodies|mesh-list
6127537|NCT01184846|Immunologic Factors|immunologic factors|mesh-ancestor
6127538|NCT01184846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127539|NCT01184859|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
6127540|NCT01184859|Hemostatics|hemostatics|mesh-ancestor
6127541|NCT01184859|Coagulants|coagulants|mesh-ancestor
6127542|NCT01184859|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6127543|NCT01184859|Natriuretic Agents|natriuretic agents|mesh-ancestor
6127544|NCT01184859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127545|NCT01184872|Vancomycin|vancomycin|mesh-list
6127546|NCT01184872|Daptomycin|daptomycin|mesh-list
6127547|NCT01184872|Penicillins|penicillins|mesh-list
6127548|NCT01184872|Floxacillin|floxacillin|mesh-list
6127549|NCT01184872|Cloxacillin|cloxacillin|mesh-list
6127550|NCT01184872|Oxacillin|oxacillin|mesh-list
6127551|NCT01184872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6127552|NCT01184872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6127553|NCT01184885|Sirolimus|sirolimus|mesh-list
6127554|NCT01184885|Cyclophosphamide|cyclophosphamide|mesh-list
6127555|NCT01184885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6127556|NCT01184885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6466202|NCT00477802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6127557|NCT01184885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127558|NCT01184885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6127559|NCT01184885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5536065|NCT04211272|Macitentan|macitentan|mesh-list
5536066|NCT04211272|Riociguat|riociguat|mesh-list
5536067|NCT04211272|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5536068|NCT04211272|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5536069|NCT04211272|Antimetabolites|antimetabolites|mesh-ancestor
5536070|NCT04211272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536071|NCT04211272|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5536072|NCT04211272|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5536073|NCT04211272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5536074|NCT04211272|Vasodilator Agents|vasodilator agents|mesh-ancestor
5536075|NCT04211272|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6127560|NCT01184885|Antifungal Agents|antifungal agents|mesh-ancestor
6127561|NCT01184885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6127562|NCT01184885|Immunologic Factors|immunologic factors|mesh-ancestor
6127563|NCT01184885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127564|NCT01184885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6127565|NCT01184885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6127566|NCT01184885|Alkylating Agents|alkylating agents|mesh-ancestor
6127567|NCT01184885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6127568|NCT01184898|Cytarabine|cytarabine|mesh-list
6127569|NCT01184898|Sirolimus|sirolimus|mesh-list
6127570|NCT01184898|Etoposide|etoposide|mesh-list
6127571|NCT01184898|Mitoxantrone|mitoxantrone|mesh-list
6127572|NCT01184898|Etoposide phosphate|etoposide phosphate|mesh-list
6127573|NCT01184898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6127574|NCT01184898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6127575|NCT01184898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6127576|NCT01184898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6127577|NCT01184898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6127578|NCT01184898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127579|NCT01184898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6127580|NCT01184898|Antimetabolites|antimetabolites|mesh-ancestor
6127581|NCT01184898|Antiviral Agents|antiviral agents|mesh-ancestor
6127582|NCT01184898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6127583|NCT01184898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6127584|NCT01184898|Immunologic Factors|immunologic factors|mesh-ancestor
6127585|NCT01184898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536076|NCT04211272|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5536077|NCT04211272|Urological Agents|urological agents|mesh-ancestor
5536078|NCT04211272|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
5536079|NCT04211272|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6127586|NCT01184898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6127587|NCT01184898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6127588|NCT01184898|Antifungal Agents|antifungal agents|mesh-ancestor
6127589|NCT01184898|Analgesics|analgesics|mesh-ancestor
6127590|NCT01184898|Sensory System Agents|sensory system agents|mesh-ancestor
6127591|NCT01184898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6127592|NCT01184989|Dabigatran|dabigatran|mesh-list
6127593|NCT01184989|Antithrombins|antithrombins|mesh-ancestor
6127594|NCT01184989|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5536080|NCT04211272|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
5536081|NCT04211272|Enzyme Activators|enzyme activators|mesh-ancestor
5536082|NCT04211259|Loratadine|loratadine|mesh-list
5536083|NCT04211259|Antipruritics|antipruritics|mesh-ancestor
5536084|NCT04211259|Dermatologic Agents|dermatologic agents|mesh-ancestor
5536085|NCT04211259|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5536086|NCT04211259|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5536087|NCT04211259|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5536088|NCT04211259|Histamine Antagonists|histamine antagonists|mesh-ancestor
5536089|NCT04211259|Histamine Agents|histamine agents|mesh-ancestor
5536090|NCT04211259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5536091|NCT04211259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536092|NCT04211259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536093|NCT04211298|Dexmedetomidine|dexmedetomidine|mesh-list
5536094|NCT04211298|Propofol|propofol|mesh-list
5536095|NCT04211298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5536096|NCT04211298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6127595|NCT01184989|Protease Inhibitors|protease inhibitors|mesh-ancestor
6127596|NCT01184989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6127597|NCT01184989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127598|NCT01184989|Anticoagulants|anticoagulants|mesh-ancestor
6127599|NCT01185028|Interferons|interferons|mesh-list
6127600|NCT01185028|Ribavirin|ribavirin|mesh-list
6127601|NCT01185028|Nitazoxanide|nitazoxanide|mesh-list
6466203|NCT00477802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127602|NCT01185028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6127603|NCT01185028|Antiviral Agents|antiviral agents|mesh-ancestor
6127604|NCT01185028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6127605|NCT01185028|Antimetabolites|antimetabolites|mesh-ancestor
6127606|NCT01185028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127607|NCT01185028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6127608|NCT01185080|Adenosine|adenosine|mesh-list
6127609|NCT01185080|Analgesics|analgesics|mesh-ancestor
6127610|NCT01185080|Sensory System Agents|sensory system agents|mesh-ancestor
6127611|NCT01185080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6127612|NCT01185080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127613|NCT01185080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6127614|NCT01185080|Vasodilator Agents|vasodilator agents|mesh-ancestor
6127615|NCT01185080|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6127616|NCT01185080|Purinergic Agonists|purinergic agonists|mesh-ancestor
6127617|NCT01185080|Purinergic Agents|purinergic agents|mesh-ancestor
6127618|NCT01185080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6127619|NCT01185080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127620|NCT01185171|Gefitinib|gefitinib|mesh-list
6127621|NCT01185171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6127622|NCT01185171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6127623|NCT01185171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6127624|NCT01185171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127625|NCT01185288|Adalimumab|adalimumab|mesh-list
6127626|NCT01185288|Methotrexate|methotrexate|mesh-list
6127627|NCT01185288|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6127628|NCT01185288|Abortifacient Agents|abortifacient agents|mesh-ancestor
6127629|NCT01185288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6127630|NCT01185288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127631|NCT01185288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6127632|NCT01185288|Antimetabolites|antimetabolites|mesh-ancestor
6127633|NCT01185288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127634|NCT01185288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6127635|NCT01185288|Dermatologic Agents|dermatologic agents|mesh-ancestor
5536097|NCT04211298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536098|NCT04211298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5536099|NCT04211298|Anesthetics, General|anesthetics, general|mesh-ancestor
6127636|NCT01185288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6127637|NCT01185288|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6127638|NCT01185288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6127639|NCT01185288|Immunologic Factors|immunologic factors|mesh-ancestor
6127640|NCT01185288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6127641|NCT01185288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6127642|NCT01185288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6127643|NCT01185301|Adalimumab|adalimumab|mesh-list
6127644|NCT01185301|Methotrexate|methotrexate|mesh-list
6127645|NCT01185301|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6127646|NCT01185301|Abortifacient Agents|abortifacient agents|mesh-ancestor
6127647|NCT01185301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6127648|NCT01185301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127649|NCT01185301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6127650|NCT01185301|Antimetabolites|antimetabolites|mesh-ancestor
6127651|NCT01185301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127652|NCT01185301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6127653|NCT01185301|Dermatologic Agents|dermatologic agents|mesh-ancestor
6127654|NCT01185301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6127655|NCT01185301|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6127656|NCT01185301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6127657|NCT01185301|Immunologic Factors|immunologic factors|mesh-ancestor
6127658|NCT01185301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6127659|NCT01185301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6127660|NCT01185301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6127661|NCT01185340|Serotonin|serotonin|mesh-list
6127662|NCT01185340|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
6127663|NCT01185340|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6127664|NCT01185340|Serotonin Agents|serotonin agents|mesh-ancestor
6127665|NCT01185340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6127666|NCT01185340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127667|NCT01185340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127668|NCT01185340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6127669|NCT01185340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6127670|NCT01185353|Methotrexate|methotrexate|mesh-list
6127671|NCT01185353|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6127672|NCT01185353|Abortifacient Agents|abortifacient agents|mesh-ancestor
5536100|NCT04211298|Anesthetics|anesthetics|mesh-ancestor
6127673|NCT01185353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6127674|NCT01185353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127675|NCT01185353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6127676|NCT01185353|Antimetabolites|antimetabolites|mesh-ancestor
6127677|NCT01185353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127678|NCT01185353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6127679|NCT01185353|Dermatologic Agents|dermatologic agents|mesh-ancestor
6127680|NCT01185353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6127681|NCT01185353|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6127682|NCT01185353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6127683|NCT01185353|Immunologic Factors|immunologic factors|mesh-ancestor
6127684|NCT01185353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6127685|NCT01185353|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6127686|NCT01185366|Everolimus|everolimus|mesh-list
5536101|NCT04211298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5536102|NCT04211298|Analgesics|analgesics|mesh-ancestor
5536103|NCT04211298|Sensory System Agents|sensory system agents|mesh-ancestor
5536104|NCT04211298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5536105|NCT04211298|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5536106|NCT04211298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5536107|NCT04211298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5536108|NCT04211298|Adrenergic Agents|adrenergic agents|mesh-ancestor
5536109|NCT04211298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5536110|NCT04211298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536111|NCT04211012|Paclitaxel|paclitaxel|mesh-list
5536112|NCT04211012|Cisplatin|cisplatin|mesh-list
5536113|NCT04211012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5536114|NCT04211012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5536115|NCT04211012|Tubulin Modulators|tubulin modulators|mesh-ancestor
5536116|NCT04211012|Antimitotic Agents|antimitotic agents|mesh-ancestor
5536117|NCT04211012|Mitosis Modulators|mitosis modulators|mesh-ancestor
5536118|NCT04211012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536119|NCT04211103|Pembrolizumab|pembrolizumab|mesh-list
5536120|NCT04211103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5536121|NCT04211103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5536122|NCT04211168|Lenvatinib|lenvatinib|mesh-list
5536123|NCT04211168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5536124|NCT04211168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5536125|NCT04211168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5536126|NCT04211168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536127|NCT04211090|Carboplatin|carboplatin|mesh-list
5536128|NCT04211090|Pemetrexed|pemetrexed|mesh-list
5536129|NCT04211090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5536130|NCT04211090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5536131|NCT04211090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127687|NCT01185366|Sunitinib|sunitinib|mesh-list
6127688|NCT01185366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6127689|NCT01185366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5536132|NCT04211090|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5536133|NCT04211090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5536134|NCT04210713|Minocycline|minocycline|mesh-list
5536135|NCT04210713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5536136|NCT04210713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5536137|NCT04210739|Betamethasone|betamethasone|mesh-list
5536138|NCT04210739|Betamethasone Valerate|betamethasone valerate|mesh-list
5536139|NCT04210739|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5536140|NCT04210739|Betamethasone benzoate|betamethasone benzoate|mesh-list
5536141|NCT04210739|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
5536142|NCT04210739|Glucocorticoids|glucocorticoids|mesh-ancestor
5536143|NCT04210739|Hormones|hormones|mesh-ancestor
5536144|NCT04210739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5536145|NCT04210739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536146|NCT04210739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5536147|NCT04210739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5536148|NCT04210739|Respiratory System Agents|respiratory system agents|mesh-ancestor
6127690|NCT01185366|Immunologic Factors|immunologic factors|mesh-ancestor
6127691|NCT01185366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127692|NCT01185366|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6127693|NCT01185366|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6127694|NCT01185366|Growth Substances|growth substances|mesh-ancestor
6127695|NCT01185366|Growth Inhibitors|growth inhibitors|mesh-ancestor
6127696|NCT01185366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6127697|NCT01185366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5536149|NCT04210505|Povidone-Iodine|povidone-iodine|mesh-list
5536150|NCT04210505|Povidone|povidone|mesh-list
6127698|NCT01185366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536151|NCT04210505|Plasma Substitutes|plasma substitutes|mesh-ancestor
5536152|NCT04210505|Blood Substitutes|blood substitutes|mesh-ancestor
5536153|NCT04210505|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5536154|NCT04210505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5601912|NCT05047172|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5601913|NCT05047172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601914|NCT05047172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5601915|NCT05047172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5601916|NCT05047172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5601917|NCT05047172|Antipyretics|antipyretics|mesh-ancestor
5601918|NCT05047172|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5601919|NCT05047172|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5601920|NCT05047172|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5601921|NCT05047172|Purinergic Agents|purinergic agents|mesh-ancestor
5601922|NCT05047172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5601923|NCT05047172|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5601924|NCT05047172|Antithrombins|antithrombins|mesh-ancestor
5601925|NCT05047172|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5601926|NCT05047172|Protease Inhibitors|protease inhibitors|mesh-ancestor
5601927|NCT05047172|Anticoagulants|anticoagulants|mesh-ancestor
5601928|NCT05041842|Trastuzumab|trastuzumab|mesh-list
5601929|NCT05041842|Pertuzumab|pertuzumab|mesh-list
5601930|NCT05041842|Tucatinib|tucatinib|mesh-list
5601931|NCT05041842|Hormones|hormones|mesh-list
6127699|NCT01185509|Trastuzumab|trastuzumab|mesh-list
6127700|NCT01185509|Vinorelbine|vinorelbine|mesh-list
6127701|NCT01185509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6127702|NCT01185509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6127703|NCT01185509|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6127704|NCT01185509|Tubulin Modulators|tubulin modulators|mesh-ancestor
6127705|NCT01185509|Antimitotic Agents|antimitotic agents|mesh-ancestor
6127706|NCT01185509|Mitosis Modulators|mitosis modulators|mesh-ancestor
6127707|NCT01185509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127708|NCT01185548|Tolbutamide|tolbutamide|mesh-list
6127709|NCT01185548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6127710|NCT01185548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127711|NCT01185704|Cetrorelix|cetrorelix|mesh-list
6127712|NCT01185704|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6127713|NCT01185704|Hormones|hormones|mesh-list
6127714|NCT01185704|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6127715|NCT01185704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6127716|NCT01185704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127717|NCT01185704|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6127718|NCT01185704|Fertility Agents|fertility agents|mesh-ancestor
6127719|NCT01185704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6127720|NCT01185704|Hormone Antagonists|hormone antagonists|mesh-ancestor
6204922|NCT02079519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6204923|NCT02079519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6204924|NCT02079519|Growth Substances|growth substances|mesh-ancestor
6204925|NCT02079519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204926|NCT02079519|Growth Inhibitors|growth inhibitors|mesh-ancestor
6204927|NCT02079532|Rituximab|rituximab|mesh-list
6204928|NCT02079532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6204929|NCT02079532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6204930|NCT02079532|Immunologic Factors|immunologic factors|mesh-ancestor
6204931|NCT02079532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204932|NCT02079532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6204933|NCT02079636|Gemcitabine|gemcitabine|mesh-list
6204934|NCT02079636|Pembrolizumab|pembrolizumab|mesh-list
6204935|NCT02079636|Pemetrexed|pemetrexed|mesh-list
6204936|NCT02079636|Ramucirumab|ramucirumab|mesh-list
6204937|NCT02079636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6204938|NCT02079636|Antimetabolites|antimetabolites|mesh-ancestor
6204939|NCT02079636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204940|NCT02079636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6204941|NCT02079636|Antiviral Agents|antiviral agents|mesh-ancestor
6204942|NCT02079636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6204943|NCT02079636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6204944|NCT02079636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6204945|NCT02079636|Immunologic Factors|immunologic factors|mesh-ancestor
6204946|NCT02079636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204947|NCT02079636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6204948|NCT02079636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6204949|NCT02079636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6204950|NCT02079649|Dexamethasone|dexamethasone|mesh-list
6127721|NCT01185782|Gonadotropins, Pituitary|gonadotropins, pituitary|mesh-list
6127722|NCT01185782|Hormones|hormones|mesh-list
6127723|NCT01185782|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6127724|NCT01185782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6127725|NCT01185782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127726|NCT01185782|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6127727|NCT01185782|Fertility Agents|fertility agents|mesh-ancestor
6127728|NCT01185782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6127729|NCT01185782|Fertility Agents, Male|fertility agents, male|mesh-ancestor
6127730|NCT01185821|Siponimod|siponimod|mesh-list
6127731|NCT01185821|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6127732|NCT01185821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127733|NCT01185821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6127734|NCT01185821|Immunologic Factors|immunologic factors|mesh-ancestor
6127735|NCT01185821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127736|NCT01185964|Doxorubicin|doxorubicin|mesh-list
6127737|NCT01185964|Olaratumab|olaratumab|mesh-list
6127738|NCT01185964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6127739|NCT01185964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6127740|NCT01185964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6127741|NCT01185964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6127742|NCT01185964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6127743|NCT01185964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127744|NCT01186250|Pioglitazone|pioglitazone|mesh-list
6127745|NCT01186250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6127746|NCT01186250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127747|NCT01186328|Cytarabine|cytarabine|mesh-list
6127748|NCT01186328|Prednisone|prednisone|mesh-list
6127749|NCT01186328|Hydrocortisone|hydrocortisone|mesh-list
6127750|NCT01186328|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6127751|NCT01186328|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6127752|NCT01186328|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6127753|NCT01186328|Cortisone|cortisone|mesh-list
6127754|NCT01186328|Doxorubicin|doxorubicin|mesh-list
6127755|NCT01186328|Methotrexate|methotrexate|mesh-list
6127756|NCT01186328|Vincristine|vincristine|mesh-list
6127757|NCT01186328|Asparaginase|asparaginase|mesh-list
6127758|NCT01186328|Pegaspargase|pegaspargase|mesh-list
6127759|NCT01186328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6127760|NCT01186328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6127761|NCT01186328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6127762|NCT01186328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6127763|NCT01186328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6127764|NCT01186328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127765|NCT01186328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5536155|NCT04210427|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
5536156|NCT04210427|Laxatives|laxatives|mesh-ancestor
5536157|NCT04210427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5536158|NCT04210453|Ascorbic Acid|ascorbic acid|mesh-list
5536159|NCT04210453|Vitamins|vitamins|mesh-ancestor
5536160|NCT04210453|Micronutrients|micronutrients|mesh-ancestor
6127766|NCT01186328|Glucocorticoids|glucocorticoids|mesh-ancestor
6127767|NCT01186328|Hormones|hormones|mesh-ancestor
6127768|NCT01186328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6127769|NCT01186328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127770|NCT01186328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6127771|NCT01186328|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6127772|NCT01186328|Abortifacient Agents|abortifacient agents|mesh-ancestor
6127773|NCT01186328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6127774|NCT01186328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5536161|NCT04210453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536162|NCT04210453|Antioxidants|antioxidants|mesh-ancestor
5536163|NCT04210453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536164|NCT04210453|Protective Agents|protective agents|mesh-ancestor
5536165|NCT04210765|Clomiphene|clomiphene|mesh-list
5536166|NCT04210765|Enclomiphene|enclomiphene|mesh-list
5536167|NCT04210765|Zuclomiphene|zuclomiphene|mesh-list
5536168|NCT04210765|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5536169|NCT04210765|Hormone Antagonists|hormone antagonists|mesh-ancestor
5536170|NCT04210765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5536171|NCT04210765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536172|NCT04210765|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5536173|NCT04210765|Fertility Agents|fertility agents|mesh-ancestor
5536174|NCT04210765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5536175|NCT04210765|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5536176|NCT04210765|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5536177|NCT04210544|Caseins|caseins|mesh-list
5536178|NCT04210544|Chelating Agents|chelating agents|mesh-ancestor
5536179|NCT04210544|Sequestering Agents|sequestering agents|mesh-ancestor
6127775|NCT01186328|Antimetabolites|antimetabolites|mesh-ancestor
6127776|NCT01186328|Dermatologic Agents|dermatologic agents|mesh-ancestor
6127777|NCT01186328|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6127778|NCT01186328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6127779|NCT01186328|Immunologic Factors|immunologic factors|mesh-ancestor
6127780|NCT01186328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6127781|NCT01186328|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6127782|NCT01186328|Antiviral Agents|antiviral agents|mesh-ancestor
6127783|NCT01186328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6127784|NCT01186328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6127785|NCT01186328|Tubulin Modulators|tubulin modulators|mesh-ancestor
6127786|NCT01186328|Antimitotic Agents|antimitotic agents|mesh-ancestor
6127787|NCT01186328|Mitosis Modulators|mitosis modulators|mesh-ancestor
6127788|NCT01186406|Bevacizumab|bevacizumab|mesh-list
6127789|NCT01186406|Temozolomide|temozolomide|mesh-list
5536180|NCT04210544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536181|NCT04210310|Oxytocin|oxytocin|mesh-list
5536182|NCT04210310|Oxytocics|oxytocics|mesh-ancestor
5536183|NCT04210310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6127790|NCT01186406|Carmustine|carmustine|mesh-list
6127791|NCT01186406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6127792|NCT01186406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6127793|NCT01186406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6127794|NCT01186406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6127795|NCT01186406|Growth Substances|growth substances|mesh-ancestor
6127796|NCT01186406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127797|NCT01186406|Growth Inhibitors|growth inhibitors|mesh-ancestor
6127798|NCT01186406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6127799|NCT01186406|Alkylating Agents|alkylating agents|mesh-ancestor
6127800|NCT01186406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127801|NCT01186458|Rituximab|rituximab|mesh-list
6127802|NCT01186458|Fludarabine|fludarabine|mesh-list
6127803|NCT01186458|Bortezomib|bortezomib|mesh-list
6127804|NCT01186458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6127805|NCT01186458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6127806|NCT01186458|Immunologic Factors|immunologic factors|mesh-ancestor
6127807|NCT01186458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127808|NCT01186458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6127809|NCT01186562|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6127810|NCT01186562|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6127811|NCT01186562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127812|NCT01186562|Incretins|incretins|mesh-ancestor
6127813|NCT01186562|Hormones|hormones|mesh-ancestor
6127814|NCT01186562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6127815|NCT01186562|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6127816|NCT01186562|Protease Inhibitors|protease inhibitors|mesh-ancestor
6127817|NCT01186562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6127818|NCT01186562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127819|NCT01186744|Tofacitinib|tofacitinib|mesh-list
6127820|NCT01186744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6127821|NCT01186744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6127822|NCT01186744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127823|NCT01186770|Methylnaltrexone|methylnaltrexone|mesh-list
6127824|NCT01186770|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6127825|NCT01186770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127826|NCT01186770|Sensory System Agents|sensory system agents|mesh-ancestor
6127827|NCT01186770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6127828|NCT01186796|Fulvestrant|fulvestrant|mesh-list
6127829|NCT01186796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6127830|NCT01186796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6127831|NCT01186796|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6127832|NCT01186796|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6127833|NCT01186796|Hormone Antagonists|hormone antagonists|mesh-ancestor
6127834|NCT01186796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6127835|NCT01186796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127836|NCT01186939|Azacitidine|azacitidine|mesh-list
6127837|NCT01186939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5536184|NCT04210310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536185|NCT04209933|Potassium Citrate|potassium citrate|mesh-list
5536186|NCT04209933|Bismuth|bismuth|mesh-list
6127838|NCT01186939|Antimetabolites|antimetabolites|mesh-ancestor
6127839|NCT01186939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127840|NCT01186939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6127841|NCT01186939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6127842|NCT01187017|Cyclophosphamide|cyclophosphamide|mesh-list
6127843|NCT01187017|Fludarabine|fludarabine|mesh-list
6127844|NCT01187017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5536187|NCT04209933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536188|NCT04209933|Antacids|antacids|mesh-ancestor
5536189|NCT04209933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5536190|NCT04209933|Diuretics|diuretics|mesh-ancestor
5536191|NCT04209933|Natriuretic Agents|natriuretic agents|mesh-ancestor
5536192|NCT04209933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536193|NCT04209933|Expectorants|expectorants|mesh-ancestor
5536194|NCT04209933|Respiratory System Agents|respiratory system agents|mesh-ancestor
5536195|NCT04209920|Chromium|chromium|mesh-list
5536196|NCT04209920|Nickel|nickel|mesh-list
5536197|NCT04209920|Trace Elements|trace elements|mesh-ancestor
5536198|NCT04209920|Micronutrients|micronutrients|mesh-ancestor
5536199|NCT04209920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536200|NCT04209699|BMS-986165|bms-986165|mesh-list
6127845|NCT01187017|Immunologic Factors|immunologic factors|mesh-ancestor
6127846|NCT01187017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127847|NCT01187017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6127848|NCT01187017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6127849|NCT01187017|Alkylating Agents|alkylating agents|mesh-ancestor
6127850|NCT01187017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127851|NCT01187017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6127852|NCT01187017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6127853|NCT01187355|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6127854|NCT01187381|Trastuzumab|trastuzumab|mesh-list
5536201|NCT04209699|Famotidine|famotidine|mesh-list
5536202|NCT04209699|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5536203|NCT04209699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5536204|NCT04209699|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5536205|NCT04209699|Histamine Antagonists|histamine antagonists|mesh-ancestor
5536206|NCT04209699|Histamine Agents|histamine agents|mesh-ancestor
5536207|NCT04209699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5536208|NCT04209699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536209|NCT04209699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536210|NCT04209699|Dermatologic Agents|dermatologic agents|mesh-ancestor
6127855|NCT01187381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6127856|NCT01187381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6127857|NCT01187407|Serotonin|serotonin|mesh-list
6127858|NCT01187407|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
6127859|NCT01187407|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6127860|NCT01187407|Serotonin Agents|serotonin agents|mesh-ancestor
6127861|NCT01187407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6127862|NCT01187407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536211|NCT04209699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5536212|NCT04209699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5536213|NCT04209777|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5536214|NCT04209777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5536215|NCT04209959|Nifekalant|nifekalant|mesh-list
5536216|NCT04209959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5536217|NCT04209803|Minoxidil|minoxidil|mesh-list
6127863|NCT01187407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127864|NCT01187407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6127865|NCT01187407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6127866|NCT01187433|Vaccines|vaccines|mesh-list
6127867|NCT01187433|Immunologic Factors|immunologic factors|mesh-ancestor
6127868|NCT01187433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127869|NCT01187446|Vorinostat|vorinostat|mesh-list
6127870|NCT01187446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6127871|NCT01187446|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6127872|NCT01187446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6127873|NCT01187446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127874|NCT01187498|Oxybutynin|oxybutynin|mesh-list
6127875|NCT01187498|Parasympatholytics|parasympatholytics|mesh-ancestor
6127876|NCT01187498|Autonomic Agents|autonomic agents|mesh-ancestor
6127877|NCT01187498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6127878|NCT01187498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127879|NCT01187498|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6127880|NCT01187498|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5536218|NCT04209803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5536219|NCT04209803|Vasodilator Agents|vasodilator agents|mesh-ancestor
5536220|NCT04209595|Rucaparib|rucaparib|mesh-list
6127881|NCT01187498|Cholinergic Agents|cholinergic agents|mesh-ancestor
6127882|NCT01187498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6127883|NCT01187498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127884|NCT01187498|Urological Agents|urological agents|mesh-ancestor
6127885|NCT01187550|Hormones|hormones|mesh-list
6127886|NCT01187550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6127887|NCT01187550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127888|NCT01187901|Sulindac|sulindac|mesh-list
6127889|NCT01187901|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6127890|NCT01187901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6127891|NCT01187901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6127892|NCT01187901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5536221|NCT04209595|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5536222|NCT04209595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5536223|NCT04209595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536224|NCT04209595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5536225|NCT04209439|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
5536226|NCT04209439|Bupivacaine|bupivacaine|mesh-list
5536227|NCT04209439|Anesthetics, Local|anesthetics, local|mesh-ancestor
5536228|NCT04209439|Anesthetics|anesthetics|mesh-ancestor
5536229|NCT04209439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5536230|NCT04209439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536231|NCT04209439|Sensory System Agents|sensory system agents|mesh-ancestor
6127893|NCT01187901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127894|NCT01187901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6127895|NCT01187901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6127896|NCT01187901|Analgesics|analgesics|mesh-ancestor
6127897|NCT01187901|Sensory System Agents|sensory system agents|mesh-ancestor
6127898|NCT01187901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5536232|NCT04209439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5536233|NCT04209439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5536234|NCT04209439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5536235|NCT04209439|Analgesics|analgesics|mesh-ancestor
5536236|NCT04209439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5536237|NCT04209439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5536238|NCT04209478|Morphine|morphine|mesh-list
5536239|NCT04209478|Tramadol|tramadol|mesh-list
5536240|NCT04209478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5536241|NCT04209478|Narcotics|narcotics|mesh-ancestor
5536242|NCT04209478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5536243|NCT04209478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536244|NCT04209478|Analgesics|analgesics|mesh-ancestor
5536245|NCT04209478|Sensory System Agents|sensory system agents|mesh-ancestor
6127899|NCT01187901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127900|NCT01187901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6127901|NCT01187901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6127902|NCT01187901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6127903|NCT01187953|Tacrolimus|tacrolimus|mesh-list
6127904|NCT01187953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6127905|NCT01187953|Immunologic Factors|immunologic factors|mesh-ancestor
6127906|NCT01187953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127907|NCT01187953|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6127908|NCT01187953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6127909|NCT01187953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536246|NCT04209478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5536247|NCT04209686|Paclitaxel|paclitaxel|mesh-list
5536248|NCT04209686|Pembrolizumab|pembrolizumab|mesh-list
5536249|NCT04209686|Olaparib|olaparib|mesh-list
5536250|NCT04209686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6127910|NCT01188109|Gemcitabine|gemcitabine|mesh-list
6127911|NCT01188109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6127912|NCT01188109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6127913|NCT01188109|Antimetabolites|antimetabolites|mesh-ancestor
6127914|NCT01188109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127915|NCT01188109|Antiviral Agents|antiviral agents|mesh-ancestor
6127916|NCT01188109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6127917|NCT01188109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6127918|NCT01188109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6127919|NCT01188109|Immunologic Factors|immunologic factors|mesh-ancestor
6127920|NCT01188109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127921|NCT01188369|Simendan|simendan|mesh-list
6127922|NCT01188369|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5536251|NCT04209686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5536252|NCT04209686|Tubulin Modulators|tubulin modulators|mesh-ancestor
5536253|NCT04209686|Antimitotic Agents|antimitotic agents|mesh-ancestor
5536254|NCT04209686|Mitosis Modulators|mitosis modulators|mesh-ancestor
5536255|NCT04209686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536256|NCT04209686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6127923|NCT01188369|Vasodilator Agents|vasodilator agents|mesh-ancestor
6127924|NCT01188369|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6127925|NCT01188369|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6127926|NCT01188369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6127927|NCT01188369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127928|NCT01188369|Protective Agents|protective agents|mesh-ancestor
6127929|NCT01188369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127930|NCT01188421|Clonidine|clonidine|mesh-list
6127931|NCT01188421|Buprenorphine|buprenorphine|mesh-list
6127932|NCT01188421|Tramadol|tramadol|mesh-list
6127933|NCT01188421|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6127934|NCT01188421|Naloxone|naloxone|mesh-list
6127935|NCT01188421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6127936|NCT01188421|Narcotics|narcotics|mesh-ancestor
6127937|NCT01188421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6127938|NCT01188421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127939|NCT01188421|Analgesics|analgesics|mesh-ancestor
6127940|NCT01188421|Sensory System Agents|sensory system agents|mesh-ancestor
6127941|NCT01188421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6127942|NCT01188421|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6127943|NCT01188421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6127944|NCT01188421|Sympatholytics|sympatholytics|mesh-ancestor
6127945|NCT01188421|Autonomic Agents|autonomic agents|mesh-ancestor
6127946|NCT01188421|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6127947|NCT01188421|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6127948|NCT01188421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6127949|NCT01188421|Adrenergic Agents|adrenergic agents|mesh-ancestor
6127950|NCT01188421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6127951|NCT01188421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127952|NCT01188538|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
6127953|NCT01188538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6127954|NCT01188538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6127955|NCT01188538|Analgesics|analgesics|mesh-ancestor
6127956|NCT01188538|Sensory System Agents|sensory system agents|mesh-ancestor
6127957|NCT01188538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6127958|NCT01188538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536257|NCT04209686|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5536258|NCT04209686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5536259|NCT04209140|Lithium Carbonate|lithium carbonate|mesh-list
5536260|NCT04209140|Antidepressive Agents|antidepressive agents|mesh-ancestor
5536261|NCT04209140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5536262|NCT04209140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5536263|NCT04209140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536264|NCT04209140|Antimanic Agents|antimanic agents|mesh-ancestor
5536265|NCT04209140|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5536266|NCT04209140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5536267|NCT04209140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536268|NCT04209296|Ketamine|ketamine|mesh-list
6127959|NCT01188538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6127960|NCT01188538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6127961|NCT01188538|Dermatologic Agents|dermatologic agents|mesh-ancestor
6127962|NCT01188551|Fentanyl|fentanyl|mesh-list
6127963|NCT01188551|Midazolam|midazolam|mesh-list
6127964|NCT01188551|Dexmedetomidine|dexmedetomidine|mesh-list
6127965|NCT01188551|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6127966|NCT01188551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6127967|NCT01188551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466204|NCT00477802|Cholinergic Agents|cholinergic agents|mesh-ancestor
6466205|NCT00477802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6466206|NCT00477802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466207|NCT00477802|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6466208|NCT00477802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6466209|NCT00477815|Rituximab|rituximab|mesh-list
6127968|NCT01188551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6127969|NCT01188551|Analgesics|analgesics|mesh-ancestor
6127970|NCT01188551|Sensory System Agents|sensory system agents|mesh-ancestor
6127971|NCT01188551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6127972|NCT01188551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6127973|NCT01188551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6127974|NCT01188551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6127975|NCT01188551|Adrenergic Agents|adrenergic agents|mesh-ancestor
6127976|NCT01188551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6127977|NCT01188551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127978|NCT01188551|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6127979|NCT01188551|Narcotics|narcotics|mesh-ancestor
6127980|NCT01188551|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6127981|NCT01188551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6127982|NCT01188551|Anesthetics, General|anesthetics, general|mesh-ancestor
6127983|NCT01188551|Anesthetics|anesthetics|mesh-ancestor
6127984|NCT01188551|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6127985|NCT01188551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6127986|NCT01188551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6127987|NCT01188551|GABA Modulators|gaba modulators|mesh-ancestor
6127988|NCT01188551|GABA Agents|gaba agents|mesh-ancestor
6127989|NCT01188577|Epinephrine|epinephrine|mesh-list
6127990|NCT01188577|Racepinephrine|racepinephrine|mesh-list
6127991|NCT01188577|Epinephryl borate|epinephryl borate|mesh-list
6127992|NCT01188577|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6127993|NCT01188577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6127994|NCT01188577|Adrenergic Agents|adrenergic agents|mesh-ancestor
6127995|NCT01188577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6127996|NCT01188577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6127997|NCT01188577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6127998|NCT01188577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6127999|NCT01188577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6128000|NCT01188577|Autonomic Agents|autonomic agents|mesh-ancestor
6128001|NCT01188577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6128002|NCT01188577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6128003|NCT01188577|Respiratory System Agents|respiratory system agents|mesh-ancestor
6128004|NCT01188577|Mydriatics|mydriatics|mesh-ancestor
6466210|NCT00477815|Melphalan|melphalan|mesh-list
6466211|NCT00477815|Sargramostim|sargramostim|mesh-list
6466212|NCT00477815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6466213|NCT00477815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5536269|NCT04209296|Analgesics|analgesics|mesh-ancestor
6128005|NCT01188577|Sympathomimetics|sympathomimetics|mesh-ancestor
6128006|NCT01188577|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6128007|NCT01188655|Etanercept|etanercept|mesh-list
6128008|NCT01188655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6128009|NCT01188655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6128010|NCT01188655|Analgesics|analgesics|mesh-ancestor
6128011|NCT01188655|Sensory System Agents|sensory system agents|mesh-ancestor
6128012|NCT01188655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6128013|NCT01188655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128014|NCT01188655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6128015|NCT01188655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6128016|NCT01188655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6128017|NCT01188655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6128018|NCT01188655|Immunologic Factors|immunologic factors|mesh-ancestor
6128019|NCT01188668|Aripiprazole|aripiprazole|mesh-list
6128020|NCT01188668|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6128021|NCT01188668|Antidepressive Agents|antidepressive agents|mesh-ancestor
6128022|NCT01188668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6128023|NCT01188668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6128024|NCT01188668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6128025|NCT01188668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6466214|NCT00477815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5536270|NCT04209296|Sensory System Agents|sensory system agents|mesh-ancestor
5536271|NCT04209296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5536272|NCT04209296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536273|NCT04209296|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5536274|NCT04209296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5536275|NCT04209296|Anesthetics, General|anesthetics, general|mesh-ancestor
5536276|NCT04209296|Anesthetics|anesthetics|mesh-ancestor
6466215|NCT00477815|Immunologic Factors|immunologic factors|mesh-ancestor
5536277|NCT04209296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5536278|NCT04209296|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5536279|NCT04209296|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6128026|NCT01188668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128027|NCT01188668|Dopamine Agonists|dopamine agonists|mesh-ancestor
6128028|NCT01188668|Dopamine Agents|dopamine agents|mesh-ancestor
6128029|NCT01188668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6128030|NCT01188668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128031|NCT01188668|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6128032|NCT01188668|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6128033|NCT01188668|Serotonin Agents|serotonin agents|mesh-ancestor
6128034|NCT01188668|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6128035|NCT01188668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6128036|NCT01188668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6128037|NCT01188668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6128038|NCT01188668|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6128039|NCT01188668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6128040|NCT01188668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6128041|NCT01188681|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6128042|NCT01188681|Immunoglobulin G|immunoglobulin g|mesh-list
6128043|NCT01188681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6128044|NCT01188681|Alkylating Agents|alkylating agents|mesh-ancestor
6128045|NCT01188681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128046|NCT01188681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6128047|NCT01188681|Immunologic Factors|immunologic factors|mesh-ancestor
6128048|NCT01188681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128049|NCT01188694|Methylene Blue|methylene blue|mesh-list
6128050|NCT01188694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6128051|NCT01188694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128052|NCT01188772|Sofosbuvir|sofosbuvir|mesh-list
6128053|NCT01188772|Antiviral Agents|antiviral agents|mesh-ancestor
6128054|NCT01188772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6128055|NCT01188811|Thioctic Acid|thioctic acid|mesh-list
6128056|NCT01188811|Antioxidants|antioxidants|mesh-ancestor
6128057|NCT01188811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128058|NCT01188811|Protective Agents|protective agents|mesh-ancestor
6128059|NCT01188811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128060|NCT01188811|Vitamin B Complex|vitamin b complex|mesh-ancestor
6128061|NCT01188811|Vitamins|vitamins|mesh-ancestor
6128062|NCT01188811|Micronutrients|micronutrients|mesh-ancestor
6128063|NCT01188876|Folic Acid|folic acid|mesh-list
6128064|NCT01188876|Vitamin B 12|vitamin b 12|mesh-list
6128065|NCT01188876|Hydroxocobalamin|hydroxocobalamin|mesh-list
6128066|NCT01188876|Carboplatin|carboplatin|mesh-list
6128067|NCT01188876|Vitamins|vitamins|mesh-ancestor
6128068|NCT01188876|Micronutrients|micronutrients|mesh-ancestor
6128069|NCT01188876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128070|NCT01188876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6128071|NCT01188876|Hematinics|hematinics|mesh-ancestor
6128072|NCT01188876|Vitamin B Complex|vitamin b complex|mesh-ancestor
6128073|NCT01188928|Betamethasone|betamethasone|mesh-list
6128074|NCT01188928|Betamethasone Valerate|betamethasone valerate|mesh-list
6128075|NCT01188928|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
6128076|NCT01188928|Betamethasone benzoate|betamethasone benzoate|mesh-list
6128077|NCT01188928|Calcipotriene|calcipotriene|mesh-list
6128078|NCT01188928|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
6128079|NCT01188928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6128080|NCT01188928|Glucocorticoids|glucocorticoids|mesh-ancestor
6128081|NCT01188928|Hormones|hormones|mesh-ancestor
6128082|NCT01188928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6128083|NCT01188928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128084|NCT01188928|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6128085|NCT01188928|Respiratory System Agents|respiratory system agents|mesh-ancestor
6128086|NCT01188928|Dermatologic Agents|dermatologic agents|mesh-ancestor
6128087|NCT01189032|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6128088|NCT01189032|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6128089|NCT01189201|Linagliptin|linagliptin|mesh-list
6128090|NCT01189201|Empagliflozin|empagliflozin|mesh-list
6128091|NCT01189201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6128092|NCT01189201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128093|NCT01189201|Incretins|incretins|mesh-ancestor
6128094|NCT01189201|Hormones|hormones|mesh-ancestor
6128095|NCT01189201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6128096|NCT01189201|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6466216|NCT00477815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128097|NCT01189201|Protease Inhibitors|protease inhibitors|mesh-ancestor
6128098|NCT01189201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6128099|NCT01189201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128100|NCT01189201|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6128101|NCT01189240|Bevacizumab|bevacizumab|mesh-list
6128102|NCT01189240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6128103|NCT01189240|Antibodies|antibodies|mesh-list
6128104|NCT01189240|Immunoglobulins|immunoglobulins|mesh-list
6128105|NCT01189240|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6128106|NCT01189240|R04929097|r04929097|mesh-list
6128107|NCT01189240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6128108|NCT01189240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6128109|NCT01189240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6128110|NCT01189240|Growth Substances|growth substances|mesh-ancestor
6128111|NCT01189240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128112|NCT01189240|Growth Inhibitors|growth inhibitors|mesh-ancestor
5536280|NCT04209296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5536281|NCT04209296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536282|NCT04209426|Tacrine|tacrine|mesh-list
5536283|NCT04209426|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5536284|NCT04209426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5536285|NCT04209426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536286|NCT04209426|Cholinergic Agents|cholinergic agents|mesh-ancestor
5536287|NCT04209426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5536288|NCT04209426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536289|NCT04209426|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5536290|NCT04209426|Autonomic Agents|autonomic agents|mesh-ancestor
6128113|NCT01189240|Immunologic Factors|immunologic factors|mesh-ancestor
6128114|NCT01189240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6128115|NCT01189240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128116|NCT01189266|Vorinostat|vorinostat|mesh-list
6128117|NCT01189266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6128118|NCT01189266|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6128119|NCT01189266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6128120|NCT01189266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128121|NCT01189279|Bimatoprost|bimatoprost|mesh-list
6128122|NCT01189279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6128123|NCT01189292|Dexamethasone|dexamethasone|mesh-list
6128124|NCT01189292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6128125|NCT01189292|Antiemetics|antiemetics|mesh-ancestor
6128126|NCT01189292|Autonomic Agents|autonomic agents|mesh-ancestor
6128127|NCT01189292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6128128|NCT01189292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128129|NCT01189292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6128130|NCT01189292|Glucocorticoids|glucocorticoids|mesh-ancestor
6128131|NCT01189292|Hormones|hormones|mesh-ancestor
6128132|NCT01189292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6128133|NCT01189292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6128134|NCT01189292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6128135|NCT01189370|Sorafenib|sorafenib|mesh-list
6128136|NCT01189370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6128137|NCT01189370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6128138|NCT01189370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6128139|NCT01189370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128140|NCT01189409|Sennosides|sennosides|mesh-list
6128141|NCT01189409|Laxatives|laxatives|mesh-ancestor
6128142|NCT01189409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6128143|NCT01189487|Ampicillin|ampicillin|mesh-list
6128144|NCT01189487|Sulbactam|sulbactam|mesh-list
6128145|NCT01189487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6128146|NCT01189487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6128147|NCT01189487|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6128148|NCT01189487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6128149|NCT01189487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128150|NCT01189500|Tamoxifen|tamoxifen|mesh-list
6128151|NCT01189500|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6128152|NCT01189500|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6128153|NCT01189500|Hormone Antagonists|hormone antagonists|mesh-ancestor
6128154|NCT01189500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6128155|NCT01189500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128156|NCT01189500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6128157|NCT01189500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6128158|NCT01189500|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6128159|NCT01189500|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6128160|NCT01189500|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6128161|NCT01189500|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6128162|NCT01189500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6128163|NCT01189500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6128164|NCT01189500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128165|NCT01189500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6128166|NCT01189500|Antidepressive Agents|antidepressive agents|mesh-ancestor
6128167|NCT01189500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6128168|NCT01189604|Propofol|propofol|mesh-list
6128169|NCT01189604|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6128170|NCT01189604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6128171|NCT01189604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128172|NCT01189604|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6128173|NCT01189604|Anesthetics, General|anesthetics, general|mesh-ancestor
6128174|NCT01189604|Anesthetics|anesthetics|mesh-ancestor
6128175|NCT01189747|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6128176|NCT01189747|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6128177|NCT01189747|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6128178|NCT01189747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6128179|NCT01189747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128180|NCT01189747|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6128181|NCT01189747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6128182|NCT01189747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128183|NCT01189747|Cholinergic Agents|cholinergic agents|mesh-ancestor
6128184|NCT01189747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6128185|NCT01189760|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6128186|NCT01189760|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6128187|NCT01189760|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6128188|NCT01189760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6128189|NCT01189760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128190|NCT01189760|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6128191|NCT01189760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6128192|NCT01189760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128193|NCT01189760|Cholinergic Agents|cholinergic agents|mesh-ancestor
6128194|NCT01189760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6128195|NCT01189812|Lithium Carbonate|lithium carbonate|mesh-list
6128196|NCT01189812|Citalopram|citalopram|mesh-list
6128197|NCT01189812|Antidepressive Agents|antidepressive agents|mesh-ancestor
6128198|NCT01189812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6128199|NCT01189812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6128200|NCT01189812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128201|NCT01189812|Antimanic Agents|antimanic agents|mesh-ancestor
6128202|NCT01189812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6128203|NCT01189812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6128204|NCT01189812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666173|NCT01521325|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6666174|NCT01521325|Immunologic Factors|immunologic factors|mesh-ancestor
6666175|NCT01521325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666176|NCT01521377|Moxifloxacin|moxifloxacin|mesh-list
6128205|NCT01189812|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6128206|NCT01189812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6128207|NCT01189812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6128208|NCT01189812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6128209|NCT01189812|Serotonin Agents|serotonin agents|mesh-ancestor
6128210|NCT01189812|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6128211|NCT01189890|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6128212|NCT01189890|Glimepiride|glimepiride|mesh-list
6128213|NCT01189890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6128214|NCT01189890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128215|NCT01189890|Incretins|incretins|mesh-ancestor
6128216|NCT01189890|Hormones|hormones|mesh-ancestor
6128217|NCT01189890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6128218|NCT01189890|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6128219|NCT01189890|Protease Inhibitors|protease inhibitors|mesh-ancestor
6672423|NCT01555970|Expectorants|expectorants|mesh-ancestor
5536291|NCT04209426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5536292|NCT04209426|Nootropic Agents|nootropic agents|mesh-ancestor
5536293|NCT04209218|Dexamethasone|dexamethasone|mesh-list
5536294|NCT04209218|Glucocorticoids|glucocorticoids|mesh-list
5536295|NCT04209218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5536296|NCT04209218|Antiemetics|antiemetics|mesh-ancestor
5536297|NCT04209218|Autonomic Agents|autonomic agents|mesh-ancestor
5536298|NCT04209218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5536299|NCT04209218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536300|NCT04209218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5536301|NCT04209218|Hormones|hormones|mesh-ancestor
5536302|NCT04209218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5536303|NCT04209218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5536304|NCT04209218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5536305|NCT04209166|Norepinephrine|norepinephrine|mesh-list
5536306|NCT04209166|Quetiapine Fumarate|quetiapine fumarate|mesh-list
5536307|NCT04209166|Serotonin|serotonin|mesh-list
5536308|NCT04209166|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
5536309|NCT04209166|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
5536310|NCT04209166|Antidepressive Agents|antidepressive agents|mesh-ancestor
5536311|NCT04209166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5536312|NCT04209166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5536313|NCT04209166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5536314|NCT04209166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5536315|NCT04209166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128220|NCT01189890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6128221|NCT01189890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128222|NCT01189890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6128223|NCT01189890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6128224|NCT01189890|Immunologic Factors|immunologic factors|mesh-ancestor
6128225|NCT01190007|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
6128226|NCT01190007|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6128227|NCT01190007|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6128228|NCT01190007|Antimetabolites|antimetabolites|mesh-ancestor
5536316|NCT04209166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5536317|NCT04209166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5536318|NCT04209166|Adrenergic Agents|adrenergic agents|mesh-ancestor
5536319|NCT04209166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5536320|NCT04209166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536321|NCT04209166|Sympathomimetics|sympathomimetics|mesh-ancestor
6128229|NCT01190007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128230|NCT01190007|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6128231|NCT01190007|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6128232|NCT01190007|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6128233|NCT01190007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6128234|NCT01190007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6128235|NCT01190007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128236|NCT01190007|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6128237|NCT01190007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6128238|NCT01190020|Lubiprostone|lubiprostone|mesh-list
6128239|NCT01190020|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6128240|NCT01190020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6128241|NCT01190020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128242|NCT01190098|Lacosamide|lacosamide|mesh-list
6128243|NCT01190098|Anticonvulsants|anticonvulsants|mesh-ancestor
6128244|NCT01190098|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6128245|NCT01190098|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6128246|NCT01190098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6128247|NCT01190098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128248|NCT01190150|Tranexamic Acid|tranexamic acid|mesh-list
6128249|NCT01190150|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6128250|NCT01190150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6128251|NCT01190150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128252|NCT01190150|Hemostatics|hemostatics|mesh-ancestor
6128253|NCT01190150|Coagulants|coagulants|mesh-ancestor
6128254|NCT01190228|Vaccines|vaccines|mesh-list
6128255|NCT01190228|Immunologic Factors|immunologic factors|mesh-ancestor
6128256|NCT01190228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128257|NCT01190410|Certolizumab Pegol|certolizumab pegol|mesh-list
6128258|NCT01190410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6128259|NCT01190410|Immunologic Factors|immunologic factors|mesh-ancestor
6128260|NCT01190410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128261|NCT01190410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6128262|NCT01190436|Bisoprolol|bisoprolol|mesh-list
6128263|NCT01190436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6128264|NCT01190436|Sympatholytics|sympatholytics|mesh-ancestor
6128265|NCT01190436|Autonomic Agents|autonomic agents|mesh-ancestor
6128266|NCT01190436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6128267|NCT01190436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536322|NCT04209166|Autonomic Agents|autonomic agents|mesh-ancestor
6128268|NCT01190436|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6128269|NCT01190436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6128270|NCT01190436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6128271|NCT01190436|Adrenergic Agents|adrenergic agents|mesh-ancestor
5536323|NCT04209166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5536324|NCT04209166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5536325|NCT04209166|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5536326|NCT04209166|Serotonin Agents|serotonin agents|mesh-ancestor
5536327|NCT04209166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5536328|NCT04209166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5536329|NCT04209075|Metformin|metformin|mesh-list
5536330|NCT04209075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5536331|NCT04209075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536332|NCT04209192|Amikacin|amikacin|mesh-list
5536333|NCT04209192|Fosfomycin|fosfomycin|mesh-list
5536334|NCT04209192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5536335|NCT04209192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5536336|NCT04208997|Amiodarone|amiodarone|mesh-list
5536337|NCT04208997|Sotalol|sotalol|mesh-list
5536338|NCT04208997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
5536339|NCT04208997|Vasodilator Agents|vasodilator agents|mesh-ancestor
5536340|NCT04208997|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5536341|NCT04208997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5536342|NCT04208997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536343|NCT04208997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5536344|NCT04208997|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5536345|NCT04208997|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6128272|NCT01190436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6128273|NCT01190436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128274|NCT01190449|Ofatumumab|ofatumumab|mesh-list
6128275|NCT01190449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6128276|NCT01190514|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6128277|NCT01190514|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6128278|NCT01190514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6128279|NCT01190514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6128280|NCT01190514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128281|NCT01190514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6128282|NCT01190514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128283|NCT01190514|Antidepressive Agents|antidepressive agents|mesh-ancestor
6128284|NCT01190514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6128285|NCT01190813|Levodopa|levodopa|mesh-list
6128286|NCT01190813|Carbidopa|carbidopa|mesh-list
6128287|NCT01190813|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6128288|NCT01190813|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6128289|NCT01190813|Dopamine Agents|dopamine agents|mesh-ancestor
6128290|NCT01190813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6128291|NCT01190813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666177|NCT01521377|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6666178|NCT01521377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6666179|NCT01521377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6666180|NCT01521377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6666181|NCT01521377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6666182|NCT01521377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6666183|NCT01521377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666184|NCT01521377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6666185|NCT01521377|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6666186|NCT01521377|Contraceptive Agents|contraceptive agents|mesh-ancestor
5536346|NCT04208997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6128292|NCT01190813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128293|NCT01190813|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5606750|NCT03786783|Melphalan|melphalan|mesh-list
6128294|NCT01190813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6128295|NCT01190839|Infliximab|infliximab|mesh-list
6128296|NCT01190839|Dermatologic Agents|dermatologic agents|mesh-ancestor
6128297|NCT01190839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6128298|NCT01190839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6128299|NCT01190878|Bromfenac|bromfenac|mesh-list
6128300|NCT01190878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6128301|NCT01190878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6128302|NCT01190878|Analgesics|analgesics|mesh-ancestor
6128303|NCT01190878|Sensory System Agents|sensory system agents|mesh-ancestor
6128304|NCT01190878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6128305|NCT01190878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536347|NCT04208997|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5536348|NCT04208997|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5536349|NCT04208997|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6128306|NCT01190878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6128307|NCT01190878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6128308|NCT01190930|Calcium, Dietary|calcium, dietary|mesh-list
6128309|NCT01190930|Leucovorin|leucovorin|mesh-list
6128310|NCT01190930|Folic Acid|folic acid|mesh-list
6128311|NCT01190930|Cytarabine|cytarabine|mesh-list
6128312|NCT01190930|Dexamethasone|dexamethasone|mesh-list
6128313|NCT01190930|Dexamethasone acetate|dexamethasone acetate|mesh-list
6128314|NCT01190930|Cyclophosphamide|cyclophosphamide|mesh-list
6128315|NCT01190930|Doxorubicin|doxorubicin|mesh-list
6128316|NCT01190930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6128317|NCT01190930|Methotrexate|methotrexate|mesh-list
6128318|NCT01190930|Vincristine|vincristine|mesh-list
6128319|NCT01190930|Asparaginase|asparaginase|mesh-list
5536350|NCT04208997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5536351|NCT04208997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5536352|NCT04208997|Adrenergic Agents|adrenergic agents|mesh-ancestor
5536353|NCT04208997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5536354|NCT04208997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536355|NCT04208997|Sympatholytics|sympatholytics|mesh-ancestor
5536356|NCT04208997|Autonomic Agents|autonomic agents|mesh-ancestor
5536357|NCT04208997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5536358|NCT04208841|Sulfamethazine|sulfamethazine|mesh-list
5536359|NCT04208841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5536360|NCT04208854|Vinorelbine|vinorelbine|mesh-list
5536361|NCT04208854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5536362|NCT04208854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5536363|NCT04208854|Tubulin Modulators|tubulin modulators|mesh-ancestor
5536364|NCT04208854|Antimitotic Agents|antimitotic agents|mesh-ancestor
5536365|NCT04208854|Mitosis Modulators|mitosis modulators|mesh-ancestor
5536366|NCT04208854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536367|NCT04208776|Propranolol|propranolol|mesh-list
5536368|NCT04208776|Midodrine|midodrine|mesh-list
5536369|NCT04208776|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5536370|NCT04208776|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5536371|NCT04208776|Adrenergic Agents|adrenergic agents|mesh-ancestor
5536372|NCT04208776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5536373|NCT04208776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536374|NCT04208776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536375|NCT04208776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5536376|NCT04208776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5536377|NCT04208776|Vasodilator Agents|vasodilator agents|mesh-ancestor
5536378|NCT04208776|Sympathomimetics|sympathomimetics|mesh-ancestor
5536379|NCT04208776|Autonomic Agents|autonomic agents|mesh-ancestor
5536380|NCT04208776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6128320|NCT01190930|Mercaptopurine|mercaptopurine|mesh-list
6128321|NCT01190930|Pegaspargase|pegaspargase|mesh-list
6128322|NCT01190930|Thioguanine|thioguanine|mesh-list
6128323|NCT01190930|BB 1101|bb 1101|mesh-list
6128324|NCT01190930|Calcium|calcium|mesh-list
6128325|NCT01190930|2-Aminopurine|2-aminopurine|mesh-list
6466217|NCT00477815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5536381|NCT04208776|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5536382|NCT04208776|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5536383|NCT04208776|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5536384|NCT04208776|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5536385|NCT04208945|Colistin|colistin|mesh-list
5536386|NCT04208945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6128326|NCT01190930|Levoleucovorin|levoleucovorin|mesh-list
6128327|NCT01190930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6128328|NCT01190930|Immunologic Factors|immunologic factors|mesh-ancestor
6128329|NCT01190930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128330|NCT01190930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6466218|NCT00477815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6466219|NCT00477815|Alkylating Agents|alkylating agents|mesh-ancestor
6466220|NCT00477815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466221|NCT00477815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6666187|NCT01521377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6128331|NCT01190930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6128332|NCT01190930|Alkylating Agents|alkylating agents|mesh-ancestor
6128333|NCT01190930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128334|NCT01190930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6128335|NCT01190930|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6128336|NCT01190930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6128337|NCT01190930|Antiemetics|antiemetics|mesh-ancestor
6128338|NCT01190930|Autonomic Agents|autonomic agents|mesh-ancestor
6128339|NCT01190930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6128340|NCT01190930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6128341|NCT01190930|Glucocorticoids|glucocorticoids|mesh-ancestor
6128342|NCT01190930|Hormones|hormones|mesh-ancestor
6128343|NCT01190930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6128344|NCT01190930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6128345|NCT01190930|Protease Inhibitors|protease inhibitors|mesh-ancestor
6128346|NCT01190930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6128347|NCT01190930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6128348|NCT01190930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6128349|NCT01190930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6128350|NCT01190930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6128351|NCT01190930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6128352|NCT01190930|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6128353|NCT01190930|Abortifacient Agents|abortifacient agents|mesh-ancestor
6128354|NCT01190930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6128355|NCT01190930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5536387|NCT04208945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5601932|NCT05041842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5601933|NCT05041842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5601934|NCT05041842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5601935|NCT05041842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601936|NCT05041842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5601937|NCT05041842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6128356|NCT01190930|Antimetabolites|antimetabolites|mesh-ancestor
6128357|NCT01190930|Dermatologic Agents|dermatologic agents|mesh-ancestor
6128358|NCT01190930|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6128359|NCT01190930|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6128360|NCT01190930|Antiviral Agents|antiviral agents|mesh-ancestor
6128361|NCT01190930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6128362|NCT01190930|Antidotes|antidotes|mesh-ancestor
6128363|NCT01190930|Protective Agents|protective agents|mesh-ancestor
6128364|NCT01190930|Vitamin B Complex|vitamin b complex|mesh-ancestor
6128365|NCT01190930|Vitamins|vitamins|mesh-ancestor
6128366|NCT01190930|Micronutrients|micronutrients|mesh-ancestor
6128367|NCT01190930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6128368|NCT01190930|Tubulin Modulators|tubulin modulators|mesh-ancestor
6128369|NCT01190930|Antimitotic Agents|antimitotic agents|mesh-ancestor
6128370|NCT01190930|Mitosis Modulators|mitosis modulators|mesh-ancestor
6128371|NCT01190930|Hematinics|hematinics|mesh-ancestor
6204951|NCT02079649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6204952|NCT02079649|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6204953|NCT02079649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6204954|NCT02079649|Antiemetics|antiemetics|mesh-ancestor
6204955|NCT02079649|Autonomic Agents|autonomic agents|mesh-ancestor
6204956|NCT02079649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6204957|NCT02079649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204958|NCT02079649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6204959|NCT02079649|Glucocorticoids|glucocorticoids|mesh-ancestor
6204960|NCT02079649|Hormones|hormones|mesh-ancestor
6204961|NCT02079649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6204962|NCT02079649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6204963|NCT02079649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6204964|NCT02079805|Telmisartan|telmisartan|mesh-list
6204965|NCT02079805|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
6204966|NCT02079805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6204967|NCT02079805|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6204968|NCT02079805|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6204969|NCT02079805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536388|NCT04208958|Vancomycin|vancomycin|mesh-list
6128372|NCT01191008|Timolol|timolol|mesh-list
6128373|NCT01191008|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6128374|NCT01191008|Latanoprost|latanoprost|mesh-list
6128375|NCT01191008|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6128376|NCT01191008|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6128377|NCT01191008|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6128378|NCT01191008|Adrenergic Agents|adrenergic agents|mesh-ancestor
6128379|NCT01191008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6128380|NCT01191008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128381|NCT01191008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128382|NCT01191008|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6128383|NCT01191008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6128384|NCT01191086|Topiramate|topiramate|mesh-list
6128385|NCT01191086|Anticonvulsants|anticonvulsants|mesh-ancestor
6128386|NCT01191086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6128387|NCT01191086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128388|NCT01191190|Ofatumumab|ofatumumab|mesh-list
6128389|NCT01191190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6128390|NCT01191255|Sevelamer|sevelamer|mesh-list
6128391|NCT01191255|Chelating Agents|chelating agents|mesh-ancestor
6128392|NCT01191255|Sequestering Agents|sequestering agents|mesh-ancestor
6128393|NCT01191255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128394|NCT01191268|Insulin|insulin|mesh-list
6128395|NCT01191268|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6128396|NCT01191268|Insulin Glargine|insulin glargine|mesh-list
6128397|NCT01191268|Insulin Lispro|insulin lispro|mesh-list
6128398|NCT01191268|Dulaglutide|dulaglutide|mesh-list
6128399|NCT01191268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6128400|NCT01191268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128401|NCT01191320|Enclomiphene|enclomiphene|mesh-list
6128402|NCT01191320|Clomiphene|clomiphene|mesh-list
6128403|NCT01191320|Zuclomiphene|zuclomiphene|mesh-list
6128404|NCT01191320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6128405|NCT01191320|Hormone Antagonists|hormone antagonists|mesh-ancestor
6128406|NCT01191320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5536389|NCT04208958|Nivolumab|nivolumab|mesh-list
5536390|NCT04208958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5536391|NCT04208958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5536392|NCT04208958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5536393|NCT04208958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536394|NCT04208958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5536395|NCT04208958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5536396|NCT04208594|Propranolol|propranolol|mesh-list
5536397|NCT04208594|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5536398|NCT04208594|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6128407|NCT01191320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128408|NCT01191320|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6128409|NCT01191320|Fertility Agents|fertility agents|mesh-ancestor
6128410|NCT01191320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6128411|NCT01191320|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6128412|NCT01191320|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6128413|NCT01191398|Atropine|atropine|mesh-list
6128414|NCT01191398|Glycopyrrolate|glycopyrrolate|mesh-list
6128415|NCT01191398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6128416|NCT01191398|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6128417|NCT01191398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6128418|NCT01191398|Autonomic Agents|autonomic agents|mesh-ancestor
6128419|NCT01191398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6128420|NCT01191398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128421|NCT01191398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6128422|NCT01191398|Respiratory System Agents|respiratory system agents|mesh-ancestor
6128423|NCT01191398|Mydriatics|mydriatics|mesh-ancestor
6128424|NCT01191398|Parasympatholytics|parasympatholytics|mesh-ancestor
6128425|NCT01191398|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6128426|NCT01191398|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6128427|NCT01191398|Cholinergic Agents|cholinergic agents|mesh-ancestor
6128428|NCT01191398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6128429|NCT01191398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128430|NCT01191476|Propofol|propofol|mesh-list
6128431|NCT01191476|Sevoflurane|sevoflurane|mesh-list
6128432|NCT01191476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6128433|NCT01191476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6128434|NCT01191476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128435|NCT01191476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6128436|NCT01191476|Anesthetics, General|anesthetics, general|mesh-ancestor
6128437|NCT01191476|Anesthetics|anesthetics|mesh-ancestor
6128438|NCT01191476|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6128439|NCT01191476|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6128440|NCT01191723|Moxifloxacin|moxifloxacin|mesh-list
6128441|NCT01191723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6128442|NCT01191723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6128443|NCT01191723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6128444|NCT01191723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6128445|NCT01191723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6128446|NCT01191723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128447|NCT01191723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6128448|NCT01191749|Alemtuzumab|alemtuzumab|mesh-list
6128449|NCT01191749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6128450|NCT01191749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6128451|NCT01191762|Sevelamer|sevelamer|mesh-list
6128452|NCT01191762|Chelating Agents|chelating agents|mesh-ancestor
6128453|NCT01191762|Sequestering Agents|sequestering agents|mesh-ancestor
6128454|NCT01191762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128455|NCT01191801|Cytarabine|cytarabine|mesh-list
6128456|NCT01191801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6128457|NCT01191801|Antimetabolites|antimetabolites|mesh-ancestor
6128458|NCT01191801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128459|NCT01191801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6128460|NCT01191801|Antiviral Agents|antiviral agents|mesh-ancestor
6128461|NCT01191801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6128462|NCT01191801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6128463|NCT01191801|Immunologic Factors|immunologic factors|mesh-ancestor
6128464|NCT01191801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128465|NCT01191840|Vancomycin|vancomycin|mesh-list
6128466|NCT01191840|Cefazolin|cefazolin|mesh-list
6128467|NCT01191840|Daptomycin|daptomycin|mesh-list
6128468|NCT01191840|Cloxacillin|cloxacillin|mesh-list
6128469|NCT01191840|Oxacillin|oxacillin|mesh-list
6128470|NCT01191840|Nafcillin|nafcillin|mesh-list
6128471|NCT01191840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6128472|NCT01191840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6128473|NCT01191944|Pramipexole|pramipexole|mesh-list
6128474|NCT01191944|Antioxidants|antioxidants|mesh-ancestor
5536399|NCT04208594|Adrenergic Agents|adrenergic agents|mesh-ancestor
5536400|NCT04208594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5536401|NCT04208594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536402|NCT04208594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536403|NCT04208594|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5536404|NCT04208594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5536405|NCT04208594|Vasodilator Agents|vasodilator agents|mesh-ancestor
5536406|NCT04208555|Terconazole|terconazole|mesh-list
5536407|NCT04208555|Antifungal Agents|antifungal agents|mesh-ancestor
5536408|NCT04208555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5536409|NCT04208763|Imipenem|imipenem|mesh-list
5536410|NCT04208763|Colistin|colistin|mesh-list
5536411|NCT04208763|Tigecycline|tigecycline|mesh-list
5536412|NCT04208763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6128475|NCT01191944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128476|NCT01191944|Protective Agents|protective agents|mesh-ancestor
6128477|NCT01191944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128478|NCT01191944|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6128479|NCT01191944|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6128480|NCT01191944|Dopamine Agonists|dopamine agonists|mesh-ancestor
6128481|NCT01191944|Dopamine Agents|dopamine agents|mesh-ancestor
5536413|NCT04208763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5536414|NCT04208763|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5536415|NCT04208763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5536416|NCT04208763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536417|NCT04208373|Itraconazole|itraconazole|mesh-list
5536418|NCT04208373|Etravirine|etravirine|mesh-list
5536419|NCT04208373|Antifungal Agents|antifungal agents|mesh-ancestor
5536420|NCT04208373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5536421|NCT04208373|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5536422|NCT04208373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5536423|NCT04208373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5536424|NCT04208373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536425|NCT04208373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5536426|NCT04208373|Hormone Antagonists|hormone antagonists|mesh-ancestor
6128482|NCT01191944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6128483|NCT01192139|Metformin|metformin|mesh-list
6128484|NCT01192139|Saxagliptin|saxagliptin|mesh-list
6128485|NCT01192139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6128486|NCT01192139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601938|NCT05041842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128487|NCT01192139|Incretins|incretins|mesh-ancestor
6128488|NCT01192139|Hormones|hormones|mesh-ancestor
6128489|NCT01192139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6128490|NCT01192139|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6128491|NCT01192139|Protease Inhibitors|protease inhibitors|mesh-ancestor
6128492|NCT01192139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6128493|NCT01192139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128494|NCT01192152|Metformin|metformin|mesh-list
6128495|NCT01192152|Saxagliptin|saxagliptin|mesh-list
6128496|NCT01192152|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6128497|NCT01192152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128498|NCT01192152|Incretins|incretins|mesh-ancestor
6128499|NCT01192152|Hormones|hormones|mesh-ancestor
6128500|NCT01192152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6128501|NCT01192152|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6128502|NCT01192152|Protease Inhibitors|protease inhibitors|mesh-ancestor
6128503|NCT01192152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6128504|NCT01192152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128505|NCT01192178|Fluticasone|fluticasone|mesh-list
6128506|NCT01192178|Xhance|xhance|mesh-list
6128507|NCT01192178|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6128508|NCT01192178|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6128509|NCT01192178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6128510|NCT01192178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6128511|NCT01192178|Autonomic Agents|autonomic agents|mesh-ancestor
6128512|NCT01192178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6128513|NCT01192178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128514|NCT01192178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6128515|NCT01192178|Respiratory System Agents|respiratory system agents|mesh-ancestor
6128516|NCT01192178|Dermatologic Agents|dermatologic agents|mesh-ancestor
6128517|NCT01192178|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6128518|NCT01192178|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6128519|NCT01192178|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6128520|NCT01192178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6128521|NCT01192178|Adrenergic Agents|adrenergic agents|mesh-ancestor
6128522|NCT01192178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6128523|NCT01192178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128524|NCT01192178|Glucocorticoids|glucocorticoids|mesh-ancestor
6128525|NCT01192178|Hormones|hormones|mesh-ancestor
6128526|NCT01192178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6128527|NCT01192178|Sympathomimetics|sympathomimetics|mesh-ancestor
6128528|NCT01192191|Fluticasone|fluticasone|mesh-list
6128529|NCT01192191|Xhance|xhance|mesh-list
6128530|NCT01192191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6128531|NCT01192191|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6128532|NCT01192191|Autonomic Agents|autonomic agents|mesh-ancestor
6128533|NCT01192191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6128534|NCT01192191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128535|NCT01192191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6128536|NCT01192191|Respiratory System Agents|respiratory system agents|mesh-ancestor
6466222|NCT00477815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6466223|NCT00477854|Chromium|chromium|mesh-list
6466224|NCT00477854|Picolinic acid|picolinic acid|mesh-list
6466225|NCT00477854|Trace Elements|trace elements|mesh-ancestor
6466226|NCT00477854|Micronutrients|micronutrients|mesh-ancestor
6466227|NCT00477854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466228|NCT00477854|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6466229|NCT00477854|Chelating Agents|chelating agents|mesh-ancestor
6466230|NCT00477854|Sequestering Agents|sequestering agents|mesh-ancestor
6128537|NCT01192191|Dermatologic Agents|dermatologic agents|mesh-ancestor
6128538|NCT01192191|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6128539|NCT01192295|Oxycodone|oxycodone|mesh-list
6128540|NCT01192295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6128541|NCT01192295|Narcotics|narcotics|mesh-ancestor
6128542|NCT01192295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6128543|NCT01192295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128544|NCT01192295|Analgesics|analgesics|mesh-ancestor
6128545|NCT01192295|Sensory System Agents|sensory system agents|mesh-ancestor
6128546|NCT01192295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6128547|NCT01192399|Eculizumab|eculizumab|mesh-list
6128548|NCT01192399|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6128549|NCT01192399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6128550|NCT01192399|Immunologic Factors|immunologic factors|mesh-ancestor
6128551|NCT01192399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128552|NCT01192698|Interferons|interferons|mesh-list
6128553|NCT01192698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6128554|NCT01192698|Antiviral Agents|antiviral agents|mesh-ancestor
6128555|NCT01192698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6128556|NCT01192815|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6128557|NCT01192815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6128558|NCT01192815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6128559|NCT01192815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6128560|NCT01192815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128561|NCT01193049|Prednisone|prednisone|mesh-list
6128562|NCT01193049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6128563|NCT01193049|Glucocorticoids|glucocorticoids|mesh-ancestor
6128564|NCT01193049|Hormones|hormones|mesh-ancestor
6128565|NCT01193049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6128566|NCT01193049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128567|NCT01193049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6128568|NCT01193049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6128569|NCT01193101|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
6128570|NCT01193101|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6128571|NCT01193101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128572|NCT01193127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
6128573|NCT01193127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6128574|NCT01193127|Mydriatics|mydriatics|mesh-list
5536427|NCT04208373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5536428|NCT04208373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536429|NCT04208373|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5536430|NCT04208373|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5536431|NCT04208373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5536432|NCT04208373|Antiviral Agents|antiviral agents|mesh-ancestor
5536433|NCT04208581|Fluticasone|fluticasone|mesh-list
5536434|NCT04208581|Xhance|xhance|mesh-list
5536435|NCT04208581|Budesonide|budesonide|mesh-list
5536436|NCT04208581|Bromides|bromides|mesh-list
5536437|NCT04208581|Formoterol Fumarate|formoterol fumarate|mesh-list
5536438|NCT04208581|Tiotropium Bromide|tiotropium bromide|mesh-list
6128575|NCT01193127|Autonomic Agents|autonomic agents|mesh-ancestor
6128576|NCT01193127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6128577|NCT01193127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128578|NCT01193153|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6128579|NCT01193153|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6128580|NCT01193153|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6128581|NCT01193153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6128582|NCT01193153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128583|NCT01193153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6128584|NCT01193153|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6128585|NCT01193153|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6128586|NCT01193153|Serotonin Agents|serotonin agents|mesh-ancestor
6128587|NCT01193153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6204970|NCT02079844|Antipsychotic Agents|antipsychotic agents|mesh-list
6466231|NCT00477854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466232|NCT00477880|Cetuximab|cetuximab|mesh-list
5536439|NCT04208581|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6128588|NCT01193153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128589|NCT01193153|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6128590|NCT01193153|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6128591|NCT01193153|Dopamine Agents|dopamine agents|mesh-ancestor
6128592|NCT01193218|Empagliflozin|empagliflozin|mesh-list
6128593|NCT01193218|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6128594|NCT01193218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128595|NCT01193218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6128596|NCT01193218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128597|NCT01193244|Prednisone|prednisone|mesh-list
6128598|NCT01193244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6128599|NCT01193244|Glucocorticoids|glucocorticoids|mesh-ancestor
6128600|NCT01193244|Hormones|hormones|mesh-ancestor
6128601|NCT01193244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6128602|NCT01193244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128603|NCT01193244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6128604|NCT01193244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6128605|NCT01193257|Prednisone|prednisone|mesh-list
6128606|NCT01193257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6128607|NCT01193257|Glucocorticoids|glucocorticoids|mesh-ancestor
6128608|NCT01193257|Hormones|hormones|mesh-ancestor
6128609|NCT01193257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6128610|NCT01193257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128611|NCT01193257|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6128612|NCT01193257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6128613|NCT01193283|Cyclosporine|cyclosporine|mesh-list
6128614|NCT01193283|Cyclophosphamide|cyclophosphamide|mesh-list
6128615|NCT01193283|Cyclosporins|cyclosporins|mesh-list
5536440|NCT04208581|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
5536441|NCT04208581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5536442|NCT04208581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5536443|NCT04208581|Autonomic Agents|autonomic agents|mesh-ancestor
5536444|NCT04208581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5536445|NCT04208581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536446|NCT04208581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5536447|NCT04208581|Respiratory System Agents|respiratory system agents|mesh-ancestor
5536448|NCT04208581|Dermatologic Agents|dermatologic agents|mesh-ancestor
5536449|NCT04208581|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6128616|NCT01193283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6128617|NCT01193283|Immunologic Factors|immunologic factors|mesh-ancestor
6128618|NCT01193283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128619|NCT01193283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6128620|NCT01193283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6128621|NCT01193283|Alkylating Agents|alkylating agents|mesh-ancestor
6666188|NCT01521377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666189|NCT01521377|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6666190|NCT01521377|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6666191|NCT01521377|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6666192|NCT01521403|Metronidazole|metronidazole|mesh-list
5536450|NCT04208581|Glucocorticoids|glucocorticoids|mesh-ancestor
5536451|NCT04208581|Hormones|hormones|mesh-ancestor
5536452|NCT04208581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5536453|NCT04208581|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5536454|NCT04208581|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5536455|NCT04208581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5536456|NCT04208581|Adrenergic Agents|adrenergic agents|mesh-ancestor
5536457|NCT04208581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5536458|NCT04208581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536459|NCT04208581|Parasympatholytics|parasympatholytics|mesh-ancestor
5536460|NCT04208581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5536461|NCT04208581|Cholinergic Agents|cholinergic agents|mesh-ancestor
5536462|NCT04208581|Anticonvulsants|anticonvulsants|mesh-ancestor
5536463|NCT04208334|Curcumin|curcumin|mesh-list
5601939|NCT05038904|Acalabrutinib|acalabrutinib|mesh-list
6128622|NCT01193283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666193|NCT01521403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6666194|NCT01521403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6666195|NCT01521403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6666196|NCT01521403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6666197|NCT01521455|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6666198|NCT01521455|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6666199|NCT01521455|Autonomic Agents|autonomic agents|mesh-ancestor
6666200|NCT01521455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6666201|NCT01521455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666202|NCT01521455|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5536464|NCT04208334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5536465|NCT04208334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5536466|NCT04208334|Analgesics|analgesics|mesh-ancestor
5536467|NCT04208334|Sensory System Agents|sensory system agents|mesh-ancestor
5536468|NCT04208334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5536469|NCT04208334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536470|NCT04208334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5536471|NCT04208334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5536472|NCT04208334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6128623|NCT01193283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6128624|NCT01193283|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6128625|NCT01193283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5536473|NCT04208334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5536474|NCT04208334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536475|NCT04208516|Dexamethasone|dexamethasone|mesh-list
5536476|NCT04208516|Lidocaine|lidocaine|mesh-list
5536477|NCT04208516|Dexmedetomidine|dexmedetomidine|mesh-list
5536478|NCT04208516|Ropivacaine|ropivacaine|mesh-list
6128626|NCT01193283|Antifungal Agents|antifungal agents|mesh-ancestor
6128627|NCT01193283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6128628|NCT01193283|Dermatologic Agents|dermatologic agents|mesh-ancestor
6128629|NCT01193283|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6128630|NCT01193335|Vaccines|vaccines|mesh-list
6128631|NCT01193335|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6128632|NCT01193335|Immunologic Factors|immunologic factors|mesh-ancestor
6128633|NCT01193335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128634|NCT01193348|Eculizumab|eculizumab|mesh-list
6128635|NCT01193348|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6128636|NCT01193348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6128637|NCT01193348|Immunologic Factors|immunologic factors|mesh-ancestor
6128638|NCT01193348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128639|NCT01193517|Capecitabine|capecitabine|mesh-list
6128640|NCT01193517|Azacitidine|azacitidine|mesh-list
6128641|NCT01193517|Decitabine|decitabine|mesh-list
6128642|NCT01193517|Oxaliplatin|oxaliplatin|mesh-list
6128643|NCT01193517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6128644|NCT01193517|Antimetabolites|antimetabolites|mesh-ancestor
6128645|NCT01193517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128646|NCT01193517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6128647|NCT01193517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6128648|NCT01193582|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6128649|NCT01193582|Immunologic Factors|immunologic factors|mesh-ancestor
6128650|NCT01193582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128651|NCT01193660|Epoetin Alfa|epoetin alfa|mesh-list
6128652|NCT01193660|Hematinics|hematinics|mesh-ancestor
6128653|NCT01193868|R04929097|r04929097|mesh-list
6128654|NCT01193868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6128655|NCT01193868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536479|NCT04208516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5536480|NCT04208516|Antiemetics|antiemetics|mesh-ancestor
5536481|NCT04208516|Autonomic Agents|autonomic agents|mesh-ancestor
5536482|NCT04208516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6128656|NCT01193920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6128657|NCT01193920|Vaccines|vaccines|mesh-list
6128658|NCT01193920|Immunologic Factors|immunologic factors|mesh-ancestor
6128659|NCT01193920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128660|NCT01194089|Nicotine|nicotine|mesh-list
6128661|NCT01194089|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6128662|NCT01194089|Autonomic Agents|autonomic agents|mesh-ancestor
6128663|NCT01194089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6128664|NCT01194089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128665|NCT01194089|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6128666|NCT01194089|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6666203|NCT01521455|Respiratory System Agents|respiratory system agents|mesh-ancestor
5606751|NCT03786783|Mechlorethamine|mechlorethamine|mesh-list
6128667|NCT01194089|Cholinergic Agents|cholinergic agents|mesh-ancestor
6128668|NCT01194089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5536483|NCT04208516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536484|NCT04208516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5536485|NCT04208516|Glucocorticoids|glucocorticoids|mesh-ancestor
5536486|NCT04208516|Hormones|hormones|mesh-ancestor
5536487|NCT04208516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5536488|NCT04208516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5536489|NCT04208516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5536490|NCT04208516|Anesthetics, Local|anesthetics, local|mesh-ancestor
5536491|NCT04208516|Anesthetics|anesthetics|mesh-ancestor
5536492|NCT04208516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5536493|NCT04208516|Sensory System Agents|sensory system agents|mesh-ancestor
6128669|NCT01194089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128670|NCT01194154|Epoetin Alfa|epoetin alfa|mesh-list
6128671|NCT01194154|Hematinics|hematinics|mesh-ancestor
6128672|NCT01194219|Apremilast|apremilast|mesh-list
6128673|NCT01194219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6128674|NCT01194219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6128675|NCT01194219|Analgesics|analgesics|mesh-ancestor
6128676|NCT01194219|Sensory System Agents|sensory system agents|mesh-ancestor
6128677|NCT01194219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6128678|NCT01194219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128679|NCT01194219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6128680|NCT01194219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6128681|NCT01194219|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6128682|NCT01194219|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6128683|NCT01194219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6128684|NCT01194219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128685|NCT01194245|Insulin|insulin|mesh-list
6128686|NCT01194245|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6128687|NCT01194245|Insulin Glargine|insulin glargine|mesh-list
5536494|NCT04208516|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5536495|NCT04208516|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5536496|NCT04208516|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5536497|NCT04208516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6128688|NCT01194245|Insulin Aspart|insulin aspart|mesh-list
6128689|NCT01194245|Insulin Lispro|insulin lispro|mesh-list
6128690|NCT01194245|Insulin glulisine|insulin glulisine|mesh-list
6128691|NCT01194245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6128692|NCT01194245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128693|NCT01194258|Insulin|insulin|mesh-list
6128694|NCT01194258|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6128695|NCT01194258|Insulin Glargine|insulin glargine|mesh-list
6128696|NCT01194258|Insulin Aspart|insulin aspart|mesh-list
6128697|NCT01194258|Insulin Lispro|insulin lispro|mesh-list
6128698|NCT01194258|Insulin glulisine|insulin glulisine|mesh-list
6128699|NCT01194258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6128700|NCT01194258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128701|NCT01194271|Ipilimumab|ipilimumab|mesh-list
6128702|NCT01194271|Leuprolide|leuprolide|mesh-list
6128703|NCT01194271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6128704|NCT01194271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6128705|NCT01194271|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6128706|NCT01194271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128707|NCT01194271|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6128708|NCT01194271|Fertility Agents|fertility agents|mesh-ancestor
6128709|NCT01194271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6128710|NCT01194271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128711|NCT01194271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6128712|NCT01194297|Vaccines|vaccines|mesh-list
6128713|NCT01194297|Immunologic Factors|immunologic factors|mesh-ancestor
6128714|NCT01194297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128715|NCT01194414|Antirheumatic Agents|antirheumatic agents|mesh-list
6128716|NCT01194440|Zoledronic Acid|zoledronic acid|mesh-list
6128717|NCT01194440|Letrozole|letrozole|mesh-list
6128718|NCT01194440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6128719|NCT01194440|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6128720|NCT01194440|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6128721|NCT01194440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6128722|NCT01194440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128723|NCT01194440|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6128724|NCT01194440|Hormone Antagonists|hormone antagonists|mesh-ancestor
5536498|NCT04208516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128725|NCT01194440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6128726|NCT01194440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204971|NCT02079844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6128727|NCT01194440|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6128728|NCT01194453|Folic Acid|folic acid|mesh-list
6128729|NCT01194453|Vitamin B 12|vitamin b 12|mesh-list
5536499|NCT04208516|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5536500|NCT04208516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5536501|NCT04208516|Analgesics|analgesics|mesh-ancestor
5536502|NCT04208516|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5536503|NCT04208516|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5536504|NCT04208516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5536505|NCT04208516|Adrenergic Agents|adrenergic agents|mesh-ancestor
5536506|NCT04208516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5536507|NCT04208347|Oxaliplatin|oxaliplatin|mesh-list
5536508|NCT04208347|Apatinib|apatinib|mesh-list
5536509|NCT04208347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5536510|NCT04208347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5536511|NCT04208347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5536512|NCT04208347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536513|NCT04208178|Trastuzumab|trastuzumab|mesh-list
5536514|NCT04208178|Pertuzumab|pertuzumab|mesh-list
5536515|NCT04208178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5536516|NCT04208178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5536517|NCT04207944|Sulindac|sulindac|mesh-list
5536518|NCT04207944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5536519|NCT04207944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5536520|NCT04207944|Analgesics|analgesics|mesh-ancestor
5536521|NCT04207944|Sensory System Agents|sensory system agents|mesh-ancestor
5536522|NCT04207944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6128730|NCT01194453|Hydroxocobalamin|hydroxocobalamin|mesh-list
6128731|NCT01194453|Gemcitabine|gemcitabine|mesh-list
6128732|NCT01194453|Dexamethasone|dexamethasone|mesh-list
6128733|NCT01194453|Cisplatin|cisplatin|mesh-list
6128734|NCT01194453|Vitamins|vitamins|mesh-ancestor
6128735|NCT01194453|Micronutrients|micronutrients|mesh-ancestor
6128736|NCT01194453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128737|NCT01194453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6128738|NCT01194453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6128739|NCT01194453|Antiemetics|antiemetics|mesh-ancestor
6128740|NCT01194453|Autonomic Agents|autonomic agents|mesh-ancestor
6128741|NCT01194453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6128742|NCT01194453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6128743|NCT01194453|Glucocorticoids|glucocorticoids|mesh-ancestor
6128744|NCT01194453|Hormones|hormones|mesh-ancestor
6666204|NCT01521455|Glucocorticoids|glucocorticoids|mesh-ancestor
5536523|NCT04207944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536524|NCT04207944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5536525|NCT04207944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5536526|NCT04207944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5536527|NCT04207944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5536528|NCT04207944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5536529|NCT04207944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536530|NCT04208061|Ritonavir|ritonavir|mesh-list
5536531|NCT04208061|Darunavir|darunavir|mesh-list
5536532|NCT04208061|Dabigatran|dabigatran|mesh-list
5536533|NCT04208061|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5536534|NCT04208061|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5536535|NCT04208061|Protease Inhibitors|protease inhibitors|mesh-ancestor
5536536|NCT04208061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5536537|NCT04208061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536538|NCT04208061|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5536539|NCT04208061|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5536540|NCT04208061|Antiviral Agents|antiviral agents|mesh-ancestor
5536541|NCT04208061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5536542|NCT04208061|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5536543|NCT04208061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5536544|NCT04208061|Antithrombins|antithrombins|mesh-ancestor
5536545|NCT04208061|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5536546|NCT04208061|Anticoagulants|anticoagulants|mesh-ancestor
5536547|NCT04207957|Olorofim|olorofim|mesh-list
5536548|NCT04207957|Antifungal Agents|antifungal agents|mesh-ancestor
5536549|NCT04207957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5536550|NCT04207710|Ethyl Chloride|ethyl chloride|mesh-list
5536551|NCT04207710|Anesthetics, Local|anesthetics, local|mesh-ancestor
5536552|NCT04207710|Anesthetics|anesthetics|mesh-ancestor
5536553|NCT04207710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5536554|NCT04207710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536555|NCT04207710|Sensory System Agents|sensory system agents|mesh-ancestor
6128745|NCT01194453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6128746|NCT01194453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5536556|NCT04207710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5536557|NCT04207632|Botulinum Toxins|botulinum toxins|mesh-list
5536558|NCT04207632|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6128747|NCT01194453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6128748|NCT01194453|Antimetabolites|antimetabolites|mesh-ancestor
6128749|NCT01194453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128750|NCT01194453|Antiviral Agents|antiviral agents|mesh-ancestor
6128751|NCT01194453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6128752|NCT01194453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6128753|NCT01194453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6128754|NCT01194453|Immunologic Factors|immunologic factors|mesh-ancestor
6128755|NCT01194453|Hematinics|hematinics|mesh-ancestor
6128756|NCT01194453|Vitamin B Complex|vitamin b complex|mesh-ancestor
6128757|NCT01194479|Formoterol Fumarate|formoterol fumarate|mesh-list
6128758|NCT01194479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6128759|NCT01194479|Autonomic Agents|autonomic agents|mesh-ancestor
6128760|NCT01194479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6128761|NCT01194479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128762|NCT01194479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6128763|NCT01194479|Respiratory System Agents|respiratory system agents|mesh-ancestor
6128764|NCT01194479|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6128765|NCT01194479|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6128766|NCT01194479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6128767|NCT01194479|Adrenergic Agents|adrenergic agents|mesh-ancestor
6128768|NCT01194479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6128769|NCT01194479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128770|NCT01194674|Plasminogen|plasminogen|mesh-list
6128771|NCT01194674|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6128772|NCT01194674|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6128773|NCT01194674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128774|NCT01194804|Eculizumab|eculizumab|mesh-list
6128775|NCT01194804|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6128776|NCT01194804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6128777|NCT01194804|Immunologic Factors|immunologic factors|mesh-ancestor
6128778|NCT01194804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128779|NCT01194830|Linagliptin|linagliptin|mesh-list
6128780|NCT01194830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6128781|NCT01194830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128782|NCT01194830|Incretins|incretins|mesh-ancestor
6128783|NCT01194830|Hormones|hormones|mesh-ancestor
6128784|NCT01194830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6128785|NCT01194830|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6128786|NCT01194830|Protease Inhibitors|protease inhibitors|mesh-ancestor
6128787|NCT01194830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6128788|NCT01194830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128789|NCT01194869|Paclitaxel|paclitaxel|mesh-list
6128790|NCT01194869|Cisplatin|cisplatin|mesh-list
6128791|NCT01194869|Sorafenib|sorafenib|mesh-list
6128792|NCT01194869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6128793|NCT01194869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6128794|NCT01194869|Tubulin Modulators|tubulin modulators|mesh-ancestor
6128795|NCT01194869|Antimitotic Agents|antimitotic agents|mesh-ancestor
6128796|NCT01194869|Mitosis Modulators|mitosis modulators|mesh-ancestor
6128797|NCT01194869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128798|NCT01194869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6128799|NCT01194869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6128800|NCT01194973|Eculizumab|eculizumab|mesh-list
6128801|NCT01194973|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6128802|NCT01194973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6128803|NCT01194973|Immunologic Factors|immunologic factors|mesh-ancestor
6128804|NCT01194973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128805|NCT01195025|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
6128806|NCT01195025|Plasma Substitutes|plasma substitutes|mesh-ancestor
5536559|NCT04207632|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5536560|NCT04207632|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5536561|NCT04207632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5536562|NCT04207632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536563|NCT04207632|Cholinergic Agents|cholinergic agents|mesh-ancestor
5536564|NCT04207632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5536565|NCT04207632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536566|NCT04207632|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5536567|NCT04207632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5536568|NCT04207619|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6128807|NCT01195025|Blood Substitutes|blood substitutes|mesh-ancestor
6128808|NCT01195090|Pioglitazone|pioglitazone|mesh-list
6128809|NCT01195090|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6128810|NCT01195090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6128811|NCT01195090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128812|NCT01195090|Incretins|incretins|mesh-ancestor
6128813|NCT01195090|Hormones|hormones|mesh-ancestor
6128814|NCT01195090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6128815|NCT01195090|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6128816|NCT01195090|Protease Inhibitors|protease inhibitors|mesh-ancestor
6128817|NCT01195090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6128818|NCT01195090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128819|NCT01195103|Fentanyl|fentanyl|mesh-list
6128820|NCT01195103|Midazolam|midazolam|mesh-list
6128821|NCT01195103|Propofol|propofol|mesh-list
6128822|NCT01195103|Fospropofol|fospropofol|mesh-list
6128823|NCT01195103|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6128824|NCT01195103|Narcotics|narcotics|mesh-ancestor
5536569|NCT04207619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536570|NCT04207684|Testosterone|testosterone|mesh-list
5536571|NCT04207684|Androgens|androgens|mesh-ancestor
5536572|NCT04207684|Hormones|hormones|mesh-ancestor
5536573|NCT04207684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5536574|NCT04207684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536575|NCT04207411|Lidocaine|lidocaine|mesh-list
5536576|NCT04207411|Bupivacaine|bupivacaine|mesh-list
5536577|NCT04207411|Anesthetics, Local|anesthetics, local|mesh-ancestor
5536578|NCT04207411|Anesthetics|anesthetics|mesh-ancestor
5536579|NCT04207411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5536580|NCT04207411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128825|NCT01195103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6128826|NCT01195103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128827|NCT01195103|Analgesics|analgesics|mesh-ancestor
6128828|NCT01195103|Sensory System Agents|sensory system agents|mesh-ancestor
6128829|NCT01195103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6128830|NCT01195103|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6128831|NCT01195103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6128832|NCT01195103|Anesthetics, General|anesthetics, general|mesh-ancestor
6128833|NCT01195103|Anesthetics|anesthetics|mesh-ancestor
6128834|NCT01195103|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6128835|NCT01195103|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6128836|NCT01195103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6128837|NCT01195103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6128838|NCT01195103|GABA Modulators|gaba modulators|mesh-ancestor
6128839|NCT01195103|GABA Agents|gaba agents|mesh-ancestor
6128840|NCT01195103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6128841|NCT01195103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128842|NCT01195116|Dexmedetomidine|dexmedetomidine|mesh-list
6128843|NCT01195116|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6128844|NCT01195116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6128845|NCT01195116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128846|NCT01195116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6128847|NCT01195116|Analgesics|analgesics|mesh-ancestor
6128848|NCT01195116|Sensory System Agents|sensory system agents|mesh-ancestor
6128849|NCT01195116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6128850|NCT01195116|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6128851|NCT01195116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6128852|NCT01195116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6128853|NCT01195116|Adrenergic Agents|adrenergic agents|mesh-ancestor
6128854|NCT01195116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6128855|NCT01195116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128856|NCT01195363|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6128857|NCT01195363|Antidepressive Agents|antidepressive agents|mesh-ancestor
6128858|NCT01195363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6128859|NCT01195363|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6128860|NCT01195363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6128861|NCT01195363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6128862|NCT01195363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128863|NCT01195415|Gemcitabine|gemcitabine|mesh-list
6128864|NCT01195415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6128865|NCT01195415|Antimetabolites|antimetabolites|mesh-ancestor
6128866|NCT01195415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128867|NCT01195415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6128868|NCT01195415|Antiviral Agents|antiviral agents|mesh-ancestor
6128869|NCT01195415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6128870|NCT01195415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5536581|NCT04207411|Sensory System Agents|sensory system agents|mesh-ancestor
5536582|NCT04207411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5536583|NCT04207411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5536584|NCT04207411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5536585|NCT04207411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5536586|NCT04207411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5536587|NCT04207411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536588|NCT04207385|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
5536589|NCT04207385|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5536590|NCT04207385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5536591|NCT04207385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5536592|NCT04207385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536593|NCT04207385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5536594|NCT04207385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536595|NCT04207385|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5536596|NCT04207385|Antidepressive Agents|antidepressive agents|mesh-ancestor
5536597|NCT04207385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6128871|NCT01195415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6128872|NCT01195415|Immunologic Factors|immunologic factors|mesh-ancestor
6128873|NCT01195415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128874|NCT01195467|Tenofovir|tenofovir|mesh-list
6128875|NCT01195467|Emtricitabine|emtricitabine|mesh-list
6128876|NCT01195467|Efavirenz|efavirenz|mesh-list
6128877|NCT01195467|Raltegravir Potassium|raltegravir potassium|mesh-list
6128878|NCT01195467|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6128879|NCT01195467|Antiviral Agents|antiviral agents|mesh-ancestor
6128880|NCT01195467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6128881|NCT01195467|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5536598|NCT04207515|Anesthetics|anesthetics|mesh-list
5536599|NCT04207515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5536600|NCT04207515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536601|NCT04207450|Glutaral|glutaral|mesh-list
5536602|NCT04207450|Disinfectants|disinfectants|mesh-ancestor
5536603|NCT04207450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5536604|NCT04207398|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
5536605|NCT04207398|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6128882|NCT01195467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6128883|NCT01195467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6128884|NCT01195467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128885|NCT01195467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6128886|NCT01195467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6128887|NCT01195467|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6128888|NCT01195467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6128889|NCT01195467|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6128890|NCT01195467|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6128891|NCT01195467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6128892|NCT01195467|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6128893|NCT01195467|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6128894|NCT01195467|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6128895|NCT01195597|Nicotine|nicotine|mesh-list
6128896|NCT01195597|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6128897|NCT01195597|Autonomic Agents|autonomic agents|mesh-ancestor
6128898|NCT01195597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6128899|NCT01195597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128900|NCT01195597|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6128901|NCT01195597|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6128902|NCT01195597|Cholinergic Agents|cholinergic agents|mesh-ancestor
6128903|NCT01195597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6128904|NCT01195597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128905|NCT01195662|Dapagliflozin|dapagliflozin|mesh-list
6128906|NCT01195662|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6128907|NCT01195662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128908|NCT01195662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6128909|NCT01195662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128910|NCT01195675|Empagliflozin|empagliflozin|mesh-list
6128911|NCT01195675|Moxifloxacin|moxifloxacin|mesh-list
6128912|NCT01195675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6128913|NCT01195675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6128914|NCT01195675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6128915|NCT01195675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6128916|NCT01195675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6204972|NCT02079844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6128917|NCT01195675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128918|NCT01195675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6128919|NCT01195675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128920|NCT01195675|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6128921|NCT01195675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6128922|NCT01195779|Vaccines|vaccines|mesh-list
6128923|NCT01195779|Immunologic Factors|immunologic factors|mesh-ancestor
6128924|NCT01195779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128925|NCT01195831|Calcipotriene|calcipotriene|mesh-list
6128926|NCT01195831|Dermatologic Agents|dermatologic agents|mesh-ancestor
6128927|NCT01195922|Sirolimus|sirolimus|mesh-list
5536606|NCT04207398|Adrenergic Agents|adrenergic agents|mesh-ancestor
5536607|NCT04207398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5536608|NCT04207398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536609|NCT04207398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536610|NCT04207723|Paroxetine|paroxetine|mesh-list
5536611|NCT04207723|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5536612|NCT04207723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5536613|NCT04207723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5536614|NCT04207723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536615|NCT04207723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5536616|NCT04207723|Serotonin Agents|serotonin agents|mesh-ancestor
5536617|NCT04207723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536618|NCT04207723|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5536619|NCT04207723|Antidepressive Agents|antidepressive agents|mesh-ancestor
5536620|NCT04207723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5536621|NCT04207723|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5536622|NCT04207723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5536623|NCT04207723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5536624|NCT04207125|Psychotropic Drugs|psychotropic drugs|mesh-list
5536625|NCT04207112|Moxifloxacin|moxifloxacin|mesh-list
5536626|NCT04207112|Linezolid|linezolid|mesh-list
5536627|NCT04207112|Bedaquiline|bedaquiline|mesh-list
5536628|NCT04207112|Clofazimine|clofazimine|mesh-list
5536629|NCT04207112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5536630|NCT04207112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5536631|NCT04207112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5536632|NCT04207112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5536633|NCT04207112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5536634|NCT04207112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536635|NCT04207112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5536636|NCT04207112|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5536637|NCT04207112|Antitubercular Agents|antitubercular agents|mesh-ancestor
5536638|NCT04207112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5536639|NCT04207112|Leprostatic Agents|leprostatic agents|mesh-ancestor
5536640|NCT04207021|Curcumin|curcumin|mesh-list
5536641|NCT04207021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5536642|NCT04207021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5536643|NCT04207021|Analgesics|analgesics|mesh-ancestor
5536644|NCT04207021|Sensory System Agents|sensory system agents|mesh-ancestor
5536645|NCT04207021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5536646|NCT04207021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536647|NCT04207021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5536648|NCT04207021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5536649|NCT04207021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5536650|NCT04207021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5536651|NCT04207021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536652|NCT04206865|Valsartan|valsartan|mesh-list
5536653|NCT04206865|Vasodilator Agents|vasodilator agents|mesh-list
5536654|NCT04206865|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5536655|NCT04206865|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5536656|NCT04206865|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5536657|NCT04206865|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5536658|NCT04206865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536659|NCT04207060|Indomethacin|indomethacin|mesh-list
5536660|NCT04207060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5536661|NCT04207060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5536662|NCT04207060|Analgesics|analgesics|mesh-ancestor
6128928|NCT01195922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6128929|NCT01195922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6128930|NCT01195922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6128931|NCT01195922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6128932|NCT01195922|Antifungal Agents|antifungal agents|mesh-ancestor
6128933|NCT01195922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6128934|NCT01195922|Immunologic Factors|immunologic factors|mesh-ancestor
6128935|NCT01195922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204973|NCT02079844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204974|NCT02079844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5536663|NCT04207060|Sensory System Agents|sensory system agents|mesh-ancestor
5536664|NCT04207060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5536665|NCT04207060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536666|NCT04207060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5536667|NCT04207060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5536668|NCT04207060|Gout Suppressants|gout suppressants|mesh-ancestor
5536669|NCT04207060|Tocolytic Agents|tocolytic agents|mesh-ancestor
5536670|NCT04207060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5536671|NCT04207060|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5536672|NCT04207060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5536673|NCT04207060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204975|NCT02080195|Mycophenolic Acid|mycophenolic acid|mesh-list
6204976|NCT02080195|Cyclophosphamide|cyclophosphamide|mesh-list
6204977|NCT02080195|Fludarabine|fludarabine|mesh-list
6204978|NCT02080195|Tacrolimus|tacrolimus|mesh-list
6204979|NCT02080195|Thymoglobulin|thymoglobulin|mesh-list
6204980|NCT02080195|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6204981|NCT02080195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6204982|NCT02080195|Immunologic Factors|immunologic factors|mesh-ancestor
6204983|NCT02080195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6204984|NCT02080195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6204985|NCT02080195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6204986|NCT02080195|Alkylating Agents|alkylating agents|mesh-ancestor
6204987|NCT02080195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6204988|NCT02080195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6204989|NCT02080195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6204990|NCT02080195|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6204991|NCT02080195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6204992|NCT02080195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6204993|NCT02080195|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6204994|NCT02080195|Antitubercular Agents|antitubercular agents|mesh-ancestor
6204995|NCT02080195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6204996|NCT02080195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6204997|NCT02080221|Leucovorin|leucovorin|mesh-list
6204998|NCT02080221|Oxaliplatin|oxaliplatin|mesh-list
6204999|NCT02080221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6205000|NCT02080221|Antidotes|antidotes|mesh-ancestor
6205001|NCT02080221|Protective Agents|protective agents|mesh-ancestor
6205002|NCT02080221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205003|NCT02080221|Vitamin B Complex|vitamin b complex|mesh-ancestor
6205004|NCT02080221|Vitamins|vitamins|mesh-ancestor
6205005|NCT02080221|Micronutrients|micronutrients|mesh-ancestor
6205006|NCT02080273|Listerine|listerine|mesh-list
6205007|NCT02080273|Sodium Fluoride|sodium fluoride|mesh-list
6205008|NCT02080273|Cariostatic Agents|cariostatic agents|mesh-ancestor
6205009|NCT02080273|Protective Agents|protective agents|mesh-ancestor
5536674|NCT04207177|Mycophenolic Acid|mycophenolic acid|mesh-list
5536675|NCT04207177|Tacrolimus|tacrolimus|mesh-list
5536676|NCT04207177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5536677|NCT04207177|Immunologic Factors|immunologic factors|mesh-ancestor
5536678|NCT04207177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536679|NCT04207177|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5536680|NCT04207177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5536681|NCT04207177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536682|NCT04207177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6205010|NCT02080273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536683|NCT04207177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5536684|NCT04207177|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5536685|NCT04207177|Antitubercular Agents|antitubercular agents|mesh-ancestor
5536686|NCT04207177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5536687|NCT04207177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5601940|NCT05038904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5601941|NCT05035277|Aspirin|aspirin|mesh-list
5601942|NCT05035277|Rivaroxaban|rivaroxaban|mesh-list
5601943|NCT05035277|Apixaban|apixaban|mesh-list
5601944|NCT05035277|Edoxaban|edoxaban|mesh-list
5601945|NCT05035277|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5601946|NCT05035277|Antithrombins|antithrombins|mesh-ancestor
5601947|NCT05035277|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5601948|NCT05035277|Protease Inhibitors|protease inhibitors|mesh-ancestor
6205011|NCT02080273|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6205012|NCT02080273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6205013|NCT02080403|Chlorhexidine|chlorhexidine|mesh-list
5536688|NCT04206618|Denosumab|denosumab|mesh-list
5536689|NCT04206618|Teriparatide|teriparatide|mesh-list
5536690|NCT04206618|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5536691|NCT04206618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536692|NCT04206618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5536693|NCT04206631|Doxycycline|doxycycline|mesh-list
5536694|NCT04206631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5536695|NCT04206631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5536696|NCT04206631|Antimalarials|antimalarials|mesh-ancestor
5536697|NCT04206631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6128936|NCT01196052|Trastuzumab|trastuzumab|mesh-list
6128937|NCT01196052|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
6128938|NCT01196052|Maytansine|maytansine|mesh-list
6128939|NCT01196052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6128940|NCT01196052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6128941|NCT01196052|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5536698|NCT04206631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5536699|NCT04206228|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
5536700|NCT04206228|Hematinics|hematinics|mesh-ancestor
5536701|NCT04206163|Edotreotide|edotreotide|mesh-list
5536702|NCT04206163|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5536703|NCT04206163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536704|NCT04206358|Molgramostim|molgramostim|mesh-list
5536705|NCT04206358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5536706|NCT04206046|Anesthetics|anesthetics|mesh-list
5536707|NCT04206046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5536708|NCT04206046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536709|NCT04206176|Ticagrelor|ticagrelor|mesh-list
5536710|NCT04206176|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5536711|NCT04206176|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5536712|NCT04206176|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5536713|NCT04206176|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6128942|NCT01196052|Tubulin Modulators|tubulin modulators|mesh-ancestor
6128943|NCT01196052|Antimitotic Agents|antimitotic agents|mesh-ancestor
6128944|NCT01196052|Mitosis Modulators|mitosis modulators|mesh-ancestor
6128945|NCT01196052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128946|NCT01196078|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6128947|NCT01196078|Vinorelbine|vinorelbine|mesh-list
6128948|NCT01196078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6128949|NCT01196078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6128950|NCT01196078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6128951|NCT01196078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128952|NCT01196078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6128953|NCT01196078|Tubulin Modulators|tubulin modulators|mesh-ancestor
6128954|NCT01196078|Antimitotic Agents|antimitotic agents|mesh-ancestor
6128955|NCT01196078|Mitosis Modulators|mitosis modulators|mesh-ancestor
6128956|NCT01196091|Antimalarials|antimalarials|mesh-list
6128957|NCT01196091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
6128958|NCT01196091|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
6128959|NCT01196091|Immunosuppressive Agents|immunosuppressive agents|mesh-list
6128960|NCT01196091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6128961|NCT01196091|Analgesics|analgesics|mesh-ancestor
6128962|NCT01196091|Sensory System Agents|sensory system agents|mesh-ancestor
6128963|NCT01196091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6128964|NCT01196091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128965|NCT01196091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6128966|NCT01196091|Immunologic Factors|immunologic factors|mesh-ancestor
5536714|NCT04206176|Purinergic Agents|purinergic agents|mesh-ancestor
5536715|NCT04206176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5536716|NCT04206176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128967|NCT01196091|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6128968|NCT01196091|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6128969|NCT01196091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6128970|NCT01196104|Insulin|insulin|mesh-list
6128971|NCT01196104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6128972|NCT01196104|Insulin Glargine|insulin glargine|mesh-list
6128973|NCT01196104|Insulin Aspart|insulin aspart|mesh-list
6128974|NCT01196104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6128975|NCT01196104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128976|NCT01196377|Albuterol|albuterol|mesh-list
6128977|NCT01196377|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5536717|NCT04206176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128978|NCT01196377|Autonomic Agents|autonomic agents|mesh-ancestor
6128979|NCT01196377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6128980|NCT01196377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6128981|NCT01196377|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6128982|NCT01196377|Respiratory System Agents|respiratory system agents|mesh-ancestor
6128983|NCT01196377|Tocolytic Agents|tocolytic agents|mesh-ancestor
6128984|NCT01196377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6128985|NCT01196377|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6128986|NCT01196377|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6128987|NCT01196377|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6128988|NCT01196377|Adrenergic Agents|adrenergic agents|mesh-ancestor
6128989|NCT01196377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6128990|NCT01196377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128991|NCT01196416|Cisplatin|cisplatin|mesh-list
6128992|NCT01196416|Temozolomide|temozolomide|mesh-list
6128993|NCT01196416|Vinblastine|vinblastine|mesh-list
6128994|NCT01196416|R04929097|r04929097|mesh-list
6128995|NCT01196416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6128996|NCT01196416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6128997|NCT01196416|Alkylating Agents|alkylating agents|mesh-ancestor
6128998|NCT01196416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6128999|NCT01196416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6129000|NCT01196416|Tubulin Modulators|tubulin modulators|mesh-ancestor
6129001|NCT01196416|Antimitotic Agents|antimitotic agents|mesh-ancestor
6129002|NCT01196416|Mitosis Modulators|mitosis modulators|mesh-ancestor
6129003|NCT01196416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6129004|NCT01196429|Sirolimus|sirolimus|mesh-list
6129005|NCT01196429|Paclitaxel|paclitaxel|mesh-list
6129006|NCT01196429|Docetaxel|docetaxel|mesh-list
6129007|NCT01196429|Carboplatin|carboplatin|mesh-list
6129008|NCT01196429|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6129009|NCT01196429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6129010|NCT01196429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5536718|NCT04206059|Dexmedetomidine|dexmedetomidine|mesh-list
5536719|NCT04206059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5536720|NCT04206059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5536721|NCT04206059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536722|NCT04206059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5536723|NCT04206059|Analgesics|analgesics|mesh-ancestor
5536724|NCT04206059|Sensory System Agents|sensory system agents|mesh-ancestor
5536725|NCT04206059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5536726|NCT04206059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5536727|NCT04206059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5536728|NCT04206059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5536729|NCT04206059|Adrenergic Agents|adrenergic agents|mesh-ancestor
6129011|NCT01196429|Tubulin Modulators|tubulin modulators|mesh-ancestor
6129012|NCT01196429|Antimitotic Agents|antimitotic agents|mesh-ancestor
6129013|NCT01196429|Mitosis Modulators|mitosis modulators|mesh-ancestor
6129014|NCT01196429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129015|NCT01196429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6129016|NCT01196429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6129017|NCT01196429|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6129018|NCT01196429|Antifungal Agents|antifungal agents|mesh-ancestor
6129019|NCT01196429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5536730|NCT04206059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5536731|NCT04206059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536732|NCT04205916|Moxifloxacin|moxifloxacin|mesh-list
5536733|NCT04205916|Dexamethasone|dexamethasone|mesh-list
5536734|NCT04205916|Ketorolac|ketorolac|mesh-list
5536735|NCT04205916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5536736|NCT04205916|Antiemetics|antiemetics|mesh-ancestor
5536737|NCT04205916|Autonomic Agents|autonomic agents|mesh-ancestor
6129020|NCT01196429|Immunologic Factors|immunologic factors|mesh-ancestor
6129021|NCT01196429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129022|NCT01196741|Paclitaxel|paclitaxel|mesh-list
6129023|NCT01196741|Saracatinib|saracatinib|mesh-list
6129024|NCT01196741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6129025|NCT01196741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6129026|NCT01196741|Tubulin Modulators|tubulin modulators|mesh-ancestor
6129027|NCT01196741|Antimitotic Agents|antimitotic agents|mesh-ancestor
6129028|NCT01196741|Mitosis Modulators|mitosis modulators|mesh-ancestor
6129029|NCT01196741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129030|NCT01196741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6129031|NCT01196936|Tamoxifen|tamoxifen|mesh-list
6129032|NCT01196936|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6129033|NCT01196936|Hormone Antagonists|hormone antagonists|mesh-ancestor
5536738|NCT04205916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6129034|NCT01196936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6129035|NCT01196936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129036|NCT01196936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6129037|NCT01196936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6129038|NCT01196936|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6129039|NCT01196936|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6129040|NCT01196936|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6129041|NCT01196975|Vaccines|vaccines|mesh-list
6129042|NCT01196975|Immunologic Factors|immunologic factors|mesh-ancestor
6129043|NCT01196975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129044|NCT01196988|Vaccines|vaccines|mesh-list
6129045|NCT01196988|Immunologic Factors|immunologic factors|mesh-ancestor
6129046|NCT01196988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129047|NCT01197300|Zoledronic Acid|zoledronic acid|mesh-list
6129048|NCT01197300|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6129049|NCT01197300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129050|NCT01197378|Cysteamine|cysteamine|mesh-list
6129051|NCT01197378|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
6129052|NCT01197378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129053|NCT01197417|Magnesium Sulfate|magnesium sulfate|mesh-list
6129054|NCT01197417|Analgesics|analgesics|mesh-ancestor
6129055|NCT01197417|Sensory System Agents|sensory system agents|mesh-ancestor
6129056|NCT01197417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6129057|NCT01197417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129058|NCT01197417|Anesthetics|anesthetics|mesh-ancestor
6129059|NCT01197417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6129060|NCT01197417|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6129061|NCT01197417|Anticonvulsants|anticonvulsants|mesh-ancestor
6129062|NCT01197417|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6129063|NCT01197417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6129064|NCT01197417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129065|NCT01197417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6129066|NCT01197417|Tocolytic Agents|tocolytic agents|mesh-ancestor
6129067|NCT01197417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6129068|NCT01197495|Hyaluronic Acid|hyaluronic acid|mesh-list
6129069|NCT01197495|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6129070|NCT01197495|Immunologic Factors|immunologic factors|mesh-ancestor
6129071|NCT01197495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129072|NCT01197495|Viscosupplements|viscosupplements|mesh-ancestor
6129073|NCT01197495|Protective Agents|protective agents|mesh-ancestor
6129074|NCT01197560|Gemcitabine|gemcitabine|mesh-list
6129075|NCT01197560|Rituximab|rituximab|mesh-list
6129076|NCT01197560|Oxaliplatin|oxaliplatin|mesh-list
6129077|NCT01197560|Etoposide|etoposide|mesh-list
6129078|NCT01197560|Lenalidomide|lenalidomide|mesh-list
6129079|NCT01197560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6129080|NCT01197560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6129081|NCT01197560|Immunologic Factors|immunologic factors|mesh-ancestor
6129082|NCT01197560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129083|NCT01197560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6129084|NCT01197560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6129085|NCT01197560|Antimetabolites|antimetabolites|mesh-ancestor
6129086|NCT01197560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129087|NCT01197560|Antiviral Agents|antiviral agents|mesh-ancestor
6129088|NCT01197560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6129089|NCT01197560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6129090|NCT01197560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6129091|NCT01197560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6129092|NCT01197560|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6129093|NCT01197560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6129094|NCT01197560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6129095|NCT01197560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6129096|NCT01197560|Growth Substances|growth substances|mesh-ancestor
6129097|NCT01197560|Growth Inhibitors|growth inhibitors|mesh-ancestor
6129098|NCT01197573|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6129099|NCT01197573|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6129100|NCT01197573|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6129101|NCT01197573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129102|NCT01197612|Budesonide|budesonide|mesh-list
6129103|NCT01197612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6129104|NCT01197612|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6129105|NCT01197612|Autonomic Agents|autonomic agents|mesh-ancestor
6129106|NCT01197612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6129107|NCT01197612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129108|NCT01197612|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5536739|NCT04205916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536740|NCT04205916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6666205|NCT01521455|Hormones|hormones|mesh-ancestor
6129109|NCT01197612|Respiratory System Agents|respiratory system agents|mesh-ancestor
6129110|NCT01197612|Glucocorticoids|glucocorticoids|mesh-ancestor
6129111|NCT01197612|Hormones|hormones|mesh-ancestor
6129112|NCT01197612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6129113|NCT01197833|Polidocanol|polidocanol|mesh-list
6129114|NCT01197833|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
6129115|NCT01197833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5536741|NCT04205916|Glucocorticoids|glucocorticoids|mesh-ancestor
5536742|NCT04205916|Hormones|hormones|mesh-ancestor
5536743|NCT04205916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5536744|NCT04205916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5536745|NCT04205916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5536746|NCT04205916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6129116|NCT01198002|Methotrexate|methotrexate|mesh-list
6129117|NCT01198002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6129118|NCT01198002|Abortifacient Agents|abortifacient agents|mesh-ancestor
6129119|NCT01198002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6129120|NCT01198002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536747|NCT04205916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5536748|NCT04205916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5536749|NCT04205916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5536750|NCT04205916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5536751|NCT04205916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536752|NCT04205916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5536753|NCT04205916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5536754|NCT04205916|Analgesics|analgesics|mesh-ancestor
5536755|NCT04205916|Sensory System Agents|sensory system agents|mesh-ancestor
6129121|NCT01198002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6129122|NCT01198002|Antimetabolites|antimetabolites|mesh-ancestor
6129123|NCT01198002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129124|NCT01198002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6129125|NCT01198002|Dermatologic Agents|dermatologic agents|mesh-ancestor
6129126|NCT01198002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6129127|NCT01198002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6129128|NCT01198002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6129129|NCT01198002|Immunologic Factors|immunologic factors|mesh-ancestor
6129130|NCT01198002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6129131|NCT01198002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6129132|NCT01198028|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6129133|NCT01198028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6129134|NCT01198028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6129135|NCT01198028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6129136|NCT01198028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129137|NCT01198132|Vitamin D|vitamin d|mesh-list
6129138|NCT01198132|Ergocalciferols|ergocalciferols|mesh-list
6129139|NCT01198132|Cholecalciferol|cholecalciferol|mesh-list
6129140|NCT01198132|Vitamins|vitamins|mesh-list
6129141|NCT01198132|Interferons|interferons|mesh-list
6129142|NCT01198132|Interferon-beta|interferon-beta|mesh-list
6129143|NCT01198132|Interferon beta-1a|interferon beta-1a|mesh-list
6129144|NCT01198132|Micronutrients|micronutrients|mesh-ancestor
6129145|NCT01198132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129146|NCT01198132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5536756|NCT04205916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5536757|NCT04205916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5536758|NCT04205903|Paclitaxel|paclitaxel|mesh-list
5536759|NCT04205903|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5601949|NCT05035277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6129147|NCT01198132|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6129148|NCT01198132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6129149|NCT01198132|Antiviral Agents|antiviral agents|mesh-ancestor
6129150|NCT01198132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6129151|NCT01198132|Immunologic Factors|immunologic factors|mesh-ancestor
6129152|NCT01198132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6129153|NCT01198145|Sulfasalazine|sulfasalazine|mesh-list
6129154|NCT01198145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6129155|NCT01198145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6129156|NCT01198145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6129157|NCT01198145|Analgesics|analgesics|mesh-ancestor
6129158|NCT01198145|Sensory System Agents|sensory system agents|mesh-ancestor
6129159|NCT01198145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6129160|NCT01198145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129161|NCT01198145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6129162|NCT01198145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6129163|NCT01198145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6129164|NCT01198158|Bevacizumab|bevacizumab|mesh-list
6129165|NCT01198158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6129166|NCT01198158|Everolimus|everolimus|mesh-list
6129167|NCT01198158|Endothelial Growth Factors|endothelial growth factors|mesh-list
6129168|NCT01198158|Antibodies|antibodies|mesh-list
6129169|NCT01198158|Immunoglobulins|immunoglobulins|mesh-list
6129170|NCT01198158|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6129171|NCT01198158|Immunoglobulin G|immunoglobulin g|mesh-list
6129172|NCT01198158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6129173|NCT01198158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6129174|NCT01198158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6129175|NCT01198158|Growth Substances|growth substances|mesh-ancestor
6129176|NCT01198158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129177|NCT01198158|Growth Inhibitors|growth inhibitors|mesh-ancestor
6129178|NCT01198158|Immunologic Factors|immunologic factors|mesh-ancestor
6129179|NCT01198158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6129180|NCT01198275|Amiodarone|amiodarone|mesh-list
6129181|NCT01198275|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6129182|NCT01198275|Vasodilator Agents|vasodilator agents|mesh-ancestor
6129183|NCT01198275|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6129184|NCT01198275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6129185|NCT01198275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129186|NCT01198275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6129187|NCT01198275|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6129188|NCT01198275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6129189|NCT01198275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6129190|NCT01198275|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6129191|NCT01198275|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6129192|NCT01198275|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5536760|NCT04205903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5536761|NCT04205903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5536762|NCT04205903|Tubulin Modulators|tubulin modulators|mesh-ancestor
5536763|NCT04205903|Antimitotic Agents|antimitotic agents|mesh-ancestor
5536764|NCT04205903|Mitosis Modulators|mitosis modulators|mesh-ancestor
5536765|NCT04205903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536766|NCT04205929|Curcumin|curcumin|mesh-list
5606752|NCT03786783|Thiotepa|thiotepa|mesh-list
6129193|NCT01198327|Ranibizumab|ranibizumab|mesh-list
6129194|NCT01198327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6129195|NCT01198327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6129196|NCT01198327|Growth Substances|growth substances|mesh-ancestor
6129197|NCT01198327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129198|NCT01198327|Growth Inhibitors|growth inhibitors|mesh-ancestor
6129199|NCT01198327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6129200|NCT01198509|Vancomycin|vancomycin|mesh-list
6129201|NCT01198509|Doxycycline|doxycycline|mesh-list
6129202|NCT01198509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6129203|NCT01198509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6129204|NCT01198509|Antimalarials|antimalarials|mesh-ancestor
6129205|NCT01198509|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6129206|NCT01198509|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6129207|NCT01198574|Vitamins|vitamins|mesh-list
6129208|NCT01198574|Folic Acid|folic acid|mesh-list
6129209|NCT01198574|Vitamin A|vitamin a|mesh-list
6129210|NCT01198574|Iron|iron|mesh-list
6129211|NCT01198574|Retinol palmitate|retinol palmitate|mesh-list
6129212|NCT01198574|Micronutrients|micronutrients|mesh-ancestor
6129213|NCT01198574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129214|NCT01198574|Trace Elements|trace elements|mesh-ancestor
6129215|NCT01198574|Hematinics|hematinics|mesh-ancestor
6129216|NCT01198574|Vitamin B Complex|vitamin b complex|mesh-ancestor
6129217|NCT01198574|Antioxidants|antioxidants|mesh-ancestor
6129218|NCT01198574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129219|NCT01198574|Protective Agents|protective agents|mesh-ancestor
6129220|NCT01198574|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6129221|NCT01198574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6129222|NCT01198587|Zinc Sulfate|zinc sulfate|mesh-list
6129223|NCT01198587|Astringents|astringents|mesh-ancestor
6129224|NCT01198587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129225|NCT01198587|Dermatologic Agents|dermatologic agents|mesh-ancestor
6129226|NCT01198756|Vaccines|vaccines|mesh-list
6129227|NCT01198756|Immunologic Factors|immunologic factors|mesh-ancestor
6129228|NCT01198756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129229|NCT01198795|Citalopram|citalopram|mesh-list
6129230|NCT01198795|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6129231|NCT01198795|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6129232|NCT01198795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6205014|NCT02080403|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6129233|NCT01198795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129234|NCT01198795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6129235|NCT01198795|Serotonin Agents|serotonin agents|mesh-ancestor
6129236|NCT01198795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536767|NCT04205929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5536768|NCT04205929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5536769|NCT04205929|Analgesics|analgesics|mesh-ancestor
5536770|NCT04205929|Sensory System Agents|sensory system agents|mesh-ancestor
5536771|NCT04205929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5536772|NCT04205929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536773|NCT04205929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5536774|NCT04205929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5536775|NCT04205929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5536776|NCT04205929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5536777|NCT04205929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536778|NCT04205643|Infliximab|infliximab|mesh-list
5536779|NCT04205643|Dermatologic Agents|dermatologic agents|mesh-ancestor
5536780|NCT04205643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5536781|NCT04205643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5536782|NCT04205890|Ketamine|ketamine|mesh-list
5536783|NCT04205890|Analgesics|analgesics|mesh-ancestor
6129237|NCT01198795|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6129238|NCT01198795|Antidepressive Agents|antidepressive agents|mesh-ancestor
5536784|NCT04205890|Sensory System Agents|sensory system agents|mesh-ancestor
5536785|NCT04205890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5536786|NCT04205890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536787|NCT04205890|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5536788|NCT04205890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5536789|NCT04205890|Anesthetics, General|anesthetics, general|mesh-ancestor
5536790|NCT04205890|Anesthetics|anesthetics|mesh-ancestor
5536791|NCT04205890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5536792|NCT04205890|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5536793|NCT04205890|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5536794|NCT04205890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6129239|NCT01198795|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6129240|NCT01198873|Dronedarone|dronedarone|mesh-list
6129241|NCT01198873|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6129242|NCT01199055|Paclitaxel|paclitaxel|mesh-list
6129243|NCT01199055|Carboplatin|carboplatin|mesh-list
6129244|NCT01199055|Efatutazone|efatutazone|mesh-list
6129245|NCT01199055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6129246|NCT01199055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6129247|NCT01199055|Tubulin Modulators|tubulin modulators|mesh-ancestor
6129248|NCT01199055|Antimitotic Agents|antimitotic agents|mesh-ancestor
6129249|NCT01199055|Mitosis Modulators|mitosis modulators|mesh-ancestor
5536795|NCT04205890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536796|NCT04205682|Cannabidiol|cannabidiol|mesh-list
5536797|NCT04205682|Anticonvulsants|anticonvulsants|mesh-ancestor
5536798|NCT04205578|3-n-butylphthalide|3-n-butylphthalide|mesh-list
5536799|NCT04205578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5536800|NCT04205578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5536801|NCT04205578|Protective Agents|protective agents|mesh-ancestor
5536802|NCT04205578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536803|NCT04205565|Oxiracetam|oxiracetam|mesh-list
5536804|NCT04205565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5536805|NCT04205565|Nootropic Agents|nootropic agents|mesh-ancestor
5536806|NCT04205539|Dexmedetomidine|dexmedetomidine|mesh-list
5536807|NCT04205539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5536808|NCT04205539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5536809|NCT04205539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536810|NCT04205539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5536811|NCT04205539|Analgesics|analgesics|mesh-ancestor
5536812|NCT04205539|Sensory System Agents|sensory system agents|mesh-ancestor
6129250|NCT01199055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129251|NCT01199068|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6129252|NCT01199068|Efatutazone|efatutazone|mesh-list
6129253|NCT01199068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6129254|NCT01199068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6129255|NCT01199068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6129256|NCT01199068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129257|NCT01199146|Abiraterone Acetate|abiraterone acetate|mesh-list
6129258|NCT01199146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6129259|NCT01199146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6129260|NCT01199146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5536813|NCT04205539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5536814|NCT04205539|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5536815|NCT04205539|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6129261|NCT01199146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129262|NCT01199146|Hormone Antagonists|hormone antagonists|mesh-ancestor
6129263|NCT01199146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6129264|NCT01199146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129265|NCT01199146|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6129266|NCT01199198|Tolvaptan|tolvaptan|mesh-list
6129267|NCT01199198|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6129268|NCT01199198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129269|NCT01199198|Natriuretic Agents|natriuretic agents|mesh-ancestor
6129270|NCT01199198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129271|NCT01199237|Glycopyrrolate|glycopyrrolate|mesh-list
6129272|NCT01199237|Sevoflurane|sevoflurane|mesh-list
6129273|NCT01199237|Desflurane|desflurane|mesh-list
6129274|NCT01199237|Rocuronium|rocuronium|mesh-list
6129275|NCT01199237|Neostigmine|neostigmine|mesh-list
6129276|NCT01199237|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6129277|NCT01199237|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6129278|NCT01199237|Anesthetics, General|anesthetics, general|mesh-ancestor
6129279|NCT01199237|Anesthetics|anesthetics|mesh-ancestor
6129280|NCT01199237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6129281|NCT01199237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129282|NCT01199237|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6129283|NCT01199237|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6129284|NCT01199237|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6129285|NCT01199237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6129286|NCT01199237|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6129287|NCT01199237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6129288|NCT01199237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129289|NCT01199237|Cholinergic Agents|cholinergic agents|mesh-ancestor
6129290|NCT01199237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6129291|NCT01199237|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6129292|NCT01199237|Autonomic Agents|autonomic agents|mesh-ancestor
6129293|NCT01199237|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6129294|NCT01199237|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6129295|NCT01199237|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6129296|NCT01199263|Paclitaxel|paclitaxel|mesh-list
6129297|NCT01199263|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6129298|NCT01199263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6129299|NCT01199263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6129300|NCT01199263|Tubulin Modulators|tubulin modulators|mesh-ancestor
6129301|NCT01199263|Antimitotic Agents|antimitotic agents|mesh-ancestor
6129302|NCT01199263|Mitosis Modulators|mitosis modulators|mesh-ancestor
6129303|NCT01199263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129304|NCT01199289|Brodalumab|brodalumab|mesh-list
6129305|NCT01199289|Dermatologic Agents|dermatologic agents|mesh-ancestor
6129306|NCT01199380|Nicotine|nicotine|mesh-list
6129307|NCT01199380|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6129308|NCT01199380|Autonomic Agents|autonomic agents|mesh-ancestor
6129309|NCT01199380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6129310|NCT01199380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129311|NCT01199380|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6129312|NCT01199380|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6129313|NCT01199380|Cholinergic Agents|cholinergic agents|mesh-ancestor
6129314|NCT01199380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6129315|NCT01199380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129316|NCT01199575|Rituximab|rituximab|mesh-list
6129317|NCT01199575|Lenalidomide|lenalidomide|mesh-list
6129318|NCT01199575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6129319|NCT01199575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6129320|NCT01199575|Immunologic Factors|immunologic factors|mesh-ancestor
6129321|NCT01199575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129322|NCT01199575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6129323|NCT01199575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6129324|NCT01199575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6466233|NCT00477880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6466234|NCT00477880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6466235|NCT00477893|Adalimumab|adalimumab|mesh-list
6129325|NCT01199575|Growth Substances|growth substances|mesh-ancestor
6129326|NCT01199575|Growth Inhibitors|growth inhibitors|mesh-ancestor
6129327|NCT01199705|Immunoglobulins|immunoglobulins|mesh-list
6129328|NCT01199705|Antibodies|antibodies|mesh-list
6129329|NCT01199705|gamma-Globulins|gamma-globulins|mesh-list
6129330|NCT01199705|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6129331|NCT01199705|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5536816|NCT04205539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6129332|NCT01199705|Immunologic Factors|immunologic factors|mesh-ancestor
6129333|NCT01199705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129334|NCT01199731|Etravirine|etravirine|mesh-list
6129335|NCT01199731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6129336|NCT01199731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6129337|NCT01199731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6129338|NCT01199731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536817|NCT04205539|Adrenergic Agents|adrenergic agents|mesh-ancestor
5536818|NCT04205539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5536819|NCT04205539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536820|NCT04205552|Nivolumab|nivolumab|mesh-list
5536821|NCT04205552|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6129339|NCT01199731|Antiviral Agents|antiviral agents|mesh-ancestor
6129340|NCT01199731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6129341|NCT01199744|Zanamivir|zanamivir|mesh-list
6129342|NCT01199744|Antiviral Agents|antiviral agents|mesh-ancestor
6129343|NCT01199744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6129344|NCT01199744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6129345|NCT01199744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129346|NCT01199822|Olaratumab|olaratumab|mesh-list
6129347|NCT01199822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6129348|NCT01199861|Vaccines|vaccines|mesh-list
6129349|NCT01199861|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6129350|NCT01199861|Immunologic Factors|immunologic factors|mesh-ancestor
6129351|NCT01199861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129352|NCT01199861|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6129353|NCT01199861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129354|NCT01199861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6129355|NCT01199926|Vitamin D|vitamin d|mesh-list
6129356|NCT01199926|Cholecalciferol|cholecalciferol|mesh-list
6129357|NCT01199926|Vitamins|vitamins|mesh-ancestor
6129358|NCT01199926|Micronutrients|micronutrients|mesh-ancestor
6129359|NCT01199926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129360|NCT01199926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6129361|NCT01199926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6129362|NCT01199939|Ritonavir|ritonavir|mesh-list
6129363|NCT01199939|Darunavir|darunavir|mesh-list
6129364|NCT01199939|Etravirine|etravirine|mesh-list
6129365|NCT01199939|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6129366|NCT01199939|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6129367|NCT01199939|Protease Inhibitors|protease inhibitors|mesh-ancestor
6129368|NCT01199939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6129369|NCT01199939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129370|NCT01199939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6129371|NCT01199939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6129372|NCT01199939|Antiviral Agents|antiviral agents|mesh-ancestor
6129373|NCT01199939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6129374|NCT01199939|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6129375|NCT01199939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6129376|NCT01199939|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6129377|NCT01199939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6129378|NCT01199965|Dihydroergotamine|dihydroergotamine|mesh-list
6129379|NCT01199965|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6129380|NCT01199965|Dopamine Agonists|dopamine agonists|mesh-ancestor
6129381|NCT01199965|Dopamine Agents|dopamine agents|mesh-ancestor
6129382|NCT01199965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6129383|NCT01199965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129384|NCT01199965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129385|NCT01199965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6129386|NCT01199965|Analgesics|analgesics|mesh-ancestor
5536822|NCT04205552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5536823|NCT04205552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5536824|NCT04205552|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5536825|NCT04205552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536826|NCT04205240|Mycophenolic Acid|mycophenolic acid|mesh-list
5536827|NCT04205240|Cyclophosphamide|cyclophosphamide|mesh-list
5536828|NCT04205240|Melphalan|melphalan|mesh-list
5536829|NCT04205240|Mechlorethamine|mechlorethamine|mesh-list
5536830|NCT04205240|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
5536831|NCT04205240|Fludarabine|fludarabine|mesh-list
5536832|NCT04205240|Daratumumab|daratumumab|mesh-list
6129387|NCT01199965|Sensory System Agents|sensory system agents|mesh-ancestor
6129388|NCT01199965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6129389|NCT01200069|Ibuprofen|ibuprofen|mesh-list
6129390|NCT01200069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6129391|NCT01200069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6129392|NCT01200069|Analgesics|analgesics|mesh-ancestor
6129393|NCT01200069|Sensory System Agents|sensory system agents|mesh-ancestor
6129394|NCT01200069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6129395|NCT01200069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129396|NCT01200069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6129397|NCT01200069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6129398|NCT01200069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6129399|NCT01200069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6129400|NCT01200069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129401|NCT01200160|Niacin|niacin|mesh-list
6129402|NCT01200160|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6129403|NCT01200160|Antimetabolites|antimetabolites|mesh-ancestor
6466236|NCT00477893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6466237|NCT00477893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6466238|NCT00477945|Clofarabine|clofarabine|mesh-list
6466239|NCT00477945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6466240|NCT00477945|Antimetabolites|antimetabolites|mesh-ancestor
6466241|NCT00477945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466242|NCT00477945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6466243|NCT00477984|Ethanol|ethanol|mesh-list
6466244|NCT00477984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6466245|NCT00477984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6466246|NCT00477984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6466247|NCT00477984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466248|NCT00477997|Hormones|hormones|mesh-list
6129404|NCT01200160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129405|NCT01200160|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6129406|NCT01200160|Vasodilator Agents|vasodilator agents|mesh-ancestor
6129407|NCT01200160|Vitamin B Complex|vitamin b complex|mesh-ancestor
6129408|NCT01200160|Vitamins|vitamins|mesh-ancestor
6129409|NCT01200160|Micronutrients|micronutrients|mesh-ancestor
6129410|NCT01200160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129411|NCT01200329|Gemcitabine|gemcitabine|mesh-list
6129412|NCT01200329|Melphalan|melphalan|mesh-list
6129413|NCT01200329|Busulfan|busulfan|mesh-list
6129414|NCT01200329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6129415|NCT01200329|Antimetabolites|antimetabolites|mesh-ancestor
6129416|NCT01200329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129417|NCT01200329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6129418|NCT01200329|Antiviral Agents|antiviral agents|mesh-ancestor
6129419|NCT01200329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6129420|NCT01200329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6129421|NCT01200329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6129422|NCT01200329|Immunologic Factors|immunologic factors|mesh-ancestor
6129423|NCT01200329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129424|NCT01200329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6129425|NCT01200329|Alkylating Agents|alkylating agents|mesh-ancestor
6129426|NCT01200329|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6129427|NCT01200342|Paclitaxel|paclitaxel|mesh-list
6129428|NCT01200342|Carboplatin|carboplatin|mesh-list
6129429|NCT01200342|Oblimersen|oblimersen|mesh-list
6129430|NCT01200342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5536833|NCT04205240|Tacrolimus|tacrolimus|mesh-list
6129431|NCT01200342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6129432|NCT01200342|Tubulin Modulators|tubulin modulators|mesh-ancestor
6129433|NCT01200342|Antimitotic Agents|antimitotic agents|mesh-ancestor
6129434|NCT01200342|Mitosis Modulators|mitosis modulators|mesh-ancestor
6129435|NCT01200342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129436|NCT01200355|Posaconazole|posaconazole|mesh-list
6129437|NCT01200355|Micafungin|micafungin|mesh-list
6129438|NCT01200355|Antifungal Agents|antifungal agents|mesh-ancestor
6129439|NCT01200355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6129440|NCT01200355|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6129441|NCT01200355|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5536834|NCT04205240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5536835|NCT04205240|Immunologic Factors|immunologic factors|mesh-ancestor
5536836|NCT04205240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536837|NCT04205240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5536838|NCT04205240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5536839|NCT04205240|Alkylating Agents|alkylating agents|mesh-ancestor
5536840|NCT04205240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129442|NCT01200355|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6129443|NCT01200355|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6129444|NCT01200355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6129445|NCT01200355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6129446|NCT01200355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129447|NCT01200355|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6129448|NCT01200355|Hormone Antagonists|hormone antagonists|mesh-ancestor
6129449|NCT01200355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6129450|NCT01200355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129451|NCT01200368|Vaccines|vaccines|mesh-list
6129452|NCT01200368|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6129453|NCT01200368|Immunologic Factors|immunologic factors|mesh-ancestor
6129454|NCT01200368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129455|NCT01200407|Amlodipine|amlodipine|mesh-list
6129456|NCT01200407|Olmesartan|olmesartan|mesh-list
6129457|NCT01200407|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6129458|NCT01200407|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6129459|NCT01200407|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6129460|NCT01200407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6129461|NCT01200407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466249|NCT00477997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6466250|NCT00477997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466251|NCT00478049|Docetaxel|docetaxel|mesh-list
6466252|NCT00478049|Gefitinib|gefitinib|mesh-list
6466253|NCT00478049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6466254|NCT00478049|Tubulin Modulators|tubulin modulators|mesh-ancestor
6466255|NCT00478049|Antimitotic Agents|antimitotic agents|mesh-ancestor
6466256|NCT00478049|Mitosis Modulators|mitosis modulators|mesh-ancestor
6129462|NCT01200407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6129463|NCT01200407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129464|NCT01200407|Vasodilator Agents|vasodilator agents|mesh-ancestor
6129465|NCT01200407|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6129466|NCT01200407|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6129467|NCT01200433|Dexmedetomidine|dexmedetomidine|mesh-list
6129468|NCT01200433|Propofol|propofol|mesh-list
6129469|NCT01200433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6129470|NCT01200433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6129471|NCT01200433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129472|NCT01200433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6129473|NCT01200433|Anesthetics, General|anesthetics, general|mesh-ancestor
6129474|NCT01200433|Anesthetics|anesthetics|mesh-ancestor
6129475|NCT01200433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6129476|NCT01200433|Analgesics|analgesics|mesh-ancestor
6129477|NCT01200433|Sensory System Agents|sensory system agents|mesh-ancestor
6129478|NCT01200433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6129479|NCT01200433|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6129480|NCT01200433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6129481|NCT01200433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6129482|NCT01200433|Adrenergic Agents|adrenergic agents|mesh-ancestor
6129483|NCT01200433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6129484|NCT01200433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129485|NCT01200485|Allopurinol|allopurinol|mesh-list
6129486|NCT01200485|Rasburicase|rasburicase|mesh-list
6129487|NCT01200485|Antimetabolites|antimetabolites|mesh-ancestor
6129488|NCT01200485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129489|NCT01200485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6129490|NCT01200485|Gout Suppressants|gout suppressants|mesh-ancestor
6129491|NCT01200485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6129492|NCT01200485|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6129493|NCT01200485|Antioxidants|antioxidants|mesh-ancestor
6129494|NCT01200485|Protective Agents|protective agents|mesh-ancestor
6129495|NCT01200485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129496|NCT01200589|Rituximab|rituximab|mesh-list
6129497|NCT01200589|Ofatumumab|ofatumumab|mesh-list
6129498|NCT01200589|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6129499|NCT01200589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6129500|NCT01200589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6129501|NCT01200589|Immunologic Factors|immunologic factors|mesh-ancestor
6129502|NCT01200589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129503|NCT01200589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6129504|NCT01200758|Prednisone|prednisone|mesh-list
5536841|NCT04205240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5536842|NCT04205240|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5536843|NCT04205240|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5536844|NCT04205240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5536845|NCT04205240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5536846|NCT04205240|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5536847|NCT04205240|Antitubercular Agents|antitubercular agents|mesh-ancestor
5536848|NCT04205240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5536849|NCT04205240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5536850|NCT04205201|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6129505|NCT01200758|Prednisolone|prednisolone|mesh-list
6129506|NCT01200758|Cyclophosphamide|cyclophosphamide|mesh-list
6129507|NCT01200758|Rituximab|rituximab|mesh-list
6129508|NCT01200758|Doxorubicin|doxorubicin|mesh-list
6129509|NCT01200758|Vincristine|vincristine|mesh-list
6129510|NCT01200758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6129511|NCT01200758|Immunologic Factors|immunologic factors|mesh-ancestor
6129512|NCT01200758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129513|NCT01200758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6129514|NCT01200758|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6129515|NCT01200758|Alkylating Agents|alkylating agents|mesh-ancestor
6129516|NCT01200758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129517|NCT01200758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6129518|NCT01200758|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6129519|NCT01200758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6129520|NCT01200758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6129521|NCT01200758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6129522|NCT01200758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6129523|NCT01200758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6129524|NCT01200758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6129525|NCT01200758|Glucocorticoids|glucocorticoids|mesh-ancestor
6129526|NCT01200758|Hormones|hormones|mesh-ancestor
6129527|NCT01200758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6129528|NCT01200758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6129529|NCT01200758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6129530|NCT01200758|Tubulin Modulators|tubulin modulators|mesh-ancestor
6129531|NCT01200758|Antimitotic Agents|antimitotic agents|mesh-ancestor
6129532|NCT01200758|Mitosis Modulators|mitosis modulators|mesh-ancestor
6129533|NCT01200810|Bicalutamide|bicalutamide|mesh-list
6129534|NCT01200810|R04929097|r04929097|mesh-list
6129535|NCT01200810|Androgen Antagonists|androgen antagonists|mesh-ancestor
6129536|NCT01200810|Hormone Antagonists|hormone antagonists|mesh-ancestor
6129537|NCT01200810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6129538|NCT01200810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129539|NCT01200810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6129540|NCT01200810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6129541|NCT01200810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205015|NCT02080403|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6205016|NCT02080403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6205017|NCT02080403|Disinfectants|disinfectants|mesh-ancestor
5536851|NCT04205201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5536852|NCT04205201|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5536853|NCT04205201|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5536854|NCT04205201|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5536855|NCT04205201|Adrenergic Agents|adrenergic agents|mesh-ancestor
5536856|NCT04205201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5536857|NCT04205201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536858|NCT04205201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536859|NCT04205227|Pembrolizumab|pembrolizumab|mesh-list
5536860|NCT04205227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6129542|NCT01200992|Mitomycins|mitomycins|mesh-list
6129543|NCT01200992|Mitomycin|mitomycin|mesh-list
6129544|NCT01200992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6129545|NCT01200992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6129546|NCT01200992|Alkylating Agents|alkylating agents|mesh-ancestor
6129547|NCT01200992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129548|NCT01200992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6129549|NCT01200992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6129550|NCT01201265|Gemcitabine|gemcitabine|mesh-list
6129551|NCT01201265|Bevacizumab|bevacizumab|mesh-list
6129552|NCT01201265|Carboplatin|carboplatin|mesh-list
6129553|NCT01201265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6129554|NCT01201265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6129555|NCT01201265|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6129556|NCT01201265|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6129557|NCT01201265|Growth Substances|growth substances|mesh-ancestor
6129558|NCT01201265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129559|NCT01201265|Growth Inhibitors|growth inhibitors|mesh-ancestor
6129560|NCT01201265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6129561|NCT01201265|Antimetabolites|antimetabolites|mesh-ancestor
6129562|NCT01201265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129563|NCT01201265|Antiviral Agents|antiviral agents|mesh-ancestor
6129564|NCT01201265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6129565|NCT01201265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6129566|NCT01201265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6129567|NCT01201265|Immunologic Factors|immunologic factors|mesh-ancestor
6129568|NCT01201343|Interferons|interferons|mesh-list
6129569|NCT01201343|Interferon-beta|interferon-beta|mesh-list
6129570|NCT01201343|Interferon beta-1a|interferon beta-1a|mesh-list
6129571|NCT01201343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6129572|NCT01201343|Antiviral Agents|antiviral agents|mesh-ancestor
6129573|NCT01201343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6129574|NCT01201343|Immunologic Factors|immunologic factors|mesh-ancestor
6129575|NCT01201343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129576|NCT01201343|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6129577|NCT01201356|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6129578|NCT01201356|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6129579|NCT01201356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129580|NCT01201356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6129581|NCT01201356|Immunologic Factors|immunologic factors|mesh-ancestor
6129582|NCT01201356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129583|NCT01201759|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
6129584|NCT01201759|Sodium Salicylate|sodium salicylate|mesh-list
6129585|NCT01201759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6129586|NCT01201759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6129587|NCT01201759|Analgesics|analgesics|mesh-ancestor
6129588|NCT01201759|Sensory System Agents|sensory system agents|mesh-ancestor
6129589|NCT01201759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6129590|NCT01201759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129591|NCT01201759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6129592|NCT01201759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6129593|NCT01201759|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6129594|NCT01201759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6129595|NCT01201759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129596|NCT01201772|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6129597|NCT01201772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6129598|NCT01201785|Aspirin|aspirin|mesh-list
6129599|NCT01201785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5536861|NCT04205227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5601950|NCT05035277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601951|NCT05035277|Anticoagulants|anticoagulants|mesh-ancestor
5601952|NCT05035277|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5601953|NCT05035277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6129600|NCT01201785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5536862|NCT04205305|Labetalol|labetalol|mesh-list
5536863|NCT04205305|Nicardipine|nicardipine|mesh-list
5536864|NCT04205305|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5536865|NCT04205305|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5536866|NCT04205305|Adrenergic Agents|adrenergic agents|mesh-ancestor
5536867|NCT04205305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5536868|NCT04205305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536869|NCT04205305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536870|NCT04205305|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5536871|NCT04205305|Sympathomimetics|sympathomimetics|mesh-ancestor
5536872|NCT04205305|Autonomic Agents|autonomic agents|mesh-ancestor
5536873|NCT04205305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5536874|NCT04205305|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5536875|NCT04205305|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5536876|NCT04205305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5536877|NCT04205305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5536878|NCT04205305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5536879|NCT04205305|Vasodilator Agents|vasodilator agents|mesh-ancestor
5536880|NCT04205344|Bupivacaine|bupivacaine|mesh-list
5536881|NCT04205344|Anesthetics, Local|anesthetics, local|mesh-ancestor
5536882|NCT04205344|Anesthetics|anesthetics|mesh-ancestor
5536883|NCT04205344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5536884|NCT04205344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536885|NCT04205344|Sensory System Agents|sensory system agents|mesh-ancestor
5536886|NCT04205344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5536887|NCT04205357|Sulfasalazine|sulfasalazine|mesh-list
5536888|NCT04205357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5536889|NCT04205357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6129601|NCT01201785|Analgesics|analgesics|mesh-ancestor
6129602|NCT01201785|Sensory System Agents|sensory system agents|mesh-ancestor
6129603|NCT01201785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6129604|NCT01201785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129605|NCT01201785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6129606|NCT01201785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6129607|NCT01201785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6129608|NCT01201785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6129609|NCT01201785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129610|NCT01201785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6129611|NCT01201785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6129612|NCT01201785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6129613|NCT01201785|Antipyretics|antipyretics|mesh-ancestor
6129614|NCT01201798|Prednisolone|prednisolone|mesh-list
6129615|NCT01201798|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6129616|NCT01201798|Methylprednisolone|methylprednisolone|mesh-list
6129617|NCT01201798|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6129618|NCT01201798|Prednisolone acetate|prednisolone acetate|mesh-list
6129619|NCT01201798|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6129620|NCT01201798|Prednisolone phosphate|prednisolone phosphate|mesh-list
6129621|NCT01201798|Difluprednate|difluprednate|mesh-list
6129622|NCT01201798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6129623|NCT01201798|Glucocorticoids|glucocorticoids|mesh-ancestor
6129624|NCT01201798|Hormones|hormones|mesh-ancestor
6129625|NCT01201798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6666206|NCT01521455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6666207|NCT01521455|Sympathomimetics|sympathomimetics|mesh-ancestor
6666208|NCT01521481|Anesthetics|anesthetics|mesh-list
6129626|NCT01201798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129627|NCT01201798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6129628|NCT01201798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6129629|NCT01201798|Antiemetics|antiemetics|mesh-ancestor
6129630|NCT01201798|Autonomic Agents|autonomic agents|mesh-ancestor
6129631|NCT01201798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6466257|NCT00478049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129632|NCT01201798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6129633|NCT01201798|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6129634|NCT01201798|Protective Agents|protective agents|mesh-ancestor
6129635|NCT01201811|Azacitidine|azacitidine|mesh-list
6129636|NCT01201811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6129637|NCT01201811|Antimetabolites|antimetabolites|mesh-ancestor
6129638|NCT01201811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129639|NCT01201811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6129640|NCT01201811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6129641|NCT01201850|Bevacizumab|bevacizumab|mesh-list
6205018|NCT02080403|Dermatologic Agents|dermatologic agents|mesh-ancestor
6129642|NCT01201850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6129643|NCT01201850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6129644|NCT01201850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6129645|NCT01201850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6129646|NCT01201850|Growth Substances|growth substances|mesh-ancestor
6129647|NCT01201850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129648|NCT01201850|Growth Inhibitors|growth inhibitors|mesh-ancestor
6129649|NCT01201863|Testosterone|testosterone|mesh-list
6129650|NCT01201863|Androgens|androgens|mesh-ancestor
6129651|NCT01201863|Hormones|hormones|mesh-ancestor
6129652|NCT01201863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6129653|NCT01201863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129654|NCT01202071|Rabeprazole|rabeprazole|mesh-list
6129655|NCT01202071|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6129656|NCT01202071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6129657|NCT01202071|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6129658|NCT01202071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6129659|NCT01202071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129660|NCT01202162|Sevoflurane|sevoflurane|mesh-list
6129661|NCT01202162|Desflurane|desflurane|mesh-list
6129662|NCT01202162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6129663|NCT01202162|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6129664|NCT01202162|Anesthetics, General|anesthetics, general|mesh-ancestor
6129665|NCT01202162|Anesthetics|anesthetics|mesh-ancestor
6129666|NCT01202162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6129667|NCT01202162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129668|NCT01202175|Nebivolol|nebivolol|mesh-list
6129669|NCT01202175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6129670|NCT01202175|Vasodilator Agents|vasodilator agents|mesh-ancestor
6129671|NCT01202175|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6129672|NCT01202175|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6129673|NCT01202175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6129674|NCT01202175|Adrenergic Agents|adrenergic agents|mesh-ancestor
6129675|NCT01202175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6129676|NCT01202175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129677|NCT01202175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129678|NCT01202188|Glycopyrrolate|glycopyrrolate|mesh-list
6129679|NCT01202188|Tiotropium Bromide|tiotropium bromide|mesh-list
6129680|NCT01202188|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6129681|NCT01202188|Autonomic Agents|autonomic agents|mesh-ancestor
6129682|NCT01202188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6129683|NCT01202188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129684|NCT01202188|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6129685|NCT01202188|Respiratory System Agents|respiratory system agents|mesh-ancestor
6129686|NCT01202188|Parasympatholytics|parasympatholytics|mesh-ancestor
6129687|NCT01202188|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6129688|NCT01202188|Cholinergic Agents|cholinergic agents|mesh-ancestor
6129689|NCT01202188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6129690|NCT01202188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129691|NCT01202188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5536890|NCT04205357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5536891|NCT04205357|Analgesics|analgesics|mesh-ancestor
5536892|NCT04205357|Sensory System Agents|sensory system agents|mesh-ancestor
5536893|NCT04205357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5536894|NCT04205357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536895|NCT04205357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5536896|NCT04205357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5536897|NCT04205357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5536898|NCT04205097|Neostigmine|neostigmine|mesh-list
5536899|NCT04205097|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5536900|NCT04205097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5536901|NCT04205097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536902|NCT04205097|Cholinergic Agents|cholinergic agents|mesh-ancestor
5536903|NCT04205097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5536904|NCT04205097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536905|NCT04205097|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5536906|NCT04205097|Autonomic Agents|autonomic agents|mesh-ancestor
5536907|NCT04205097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6129692|NCT01202188|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6129693|NCT01202227|Pregabalin|pregabalin|mesh-list
6129694|NCT01202227|Analgesics|analgesics|mesh-ancestor
6129695|NCT01202227|Sensory System Agents|sensory system agents|mesh-ancestor
6129696|NCT01202227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6129697|NCT01202227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129698|NCT01202227|Anticonvulsants|anticonvulsants|mesh-ancestor
6466258|NCT00478049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6129699|NCT01202227|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6129700|NCT01202227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5536908|NCT04204837|Nivolumab|nivolumab|mesh-list
5536909|NCT04204837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5536910|NCT04204837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5536911|NCT04204837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5536912|NCT04204837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536913|NCT04204980|Daratumumab|daratumumab|mesh-list
6129701|NCT01202227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466259|NCT00478049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6129702|NCT01202227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6129703|NCT01202227|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6129704|NCT01202227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6129705|NCT01202227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6129706|NCT01202227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6129707|NCT01202253|Anidulafungin|anidulafungin|mesh-list
6129708|NCT01202253|Antifungal Agents|antifungal agents|mesh-ancestor
6129709|NCT01202253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6129710|NCT01202279|Phenylpropanolamine|phenylpropanolamine|mesh-list
6129711|NCT01202279|Pseudoephedrine|pseudoephedrine|mesh-list
6129712|NCT01202279|Guaifenesin|guaifenesin|mesh-list
6129713|NCT01202279|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
6129714|NCT01202279|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6129715|NCT01202279|Autonomic Agents|autonomic agents|mesh-ancestor
6129716|NCT01202279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6129717|NCT01202279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129718|NCT01202279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6129719|NCT01202279|Respiratory System Agents|respiratory system agents|mesh-ancestor
6129720|NCT01202279|Nasal Decongestants|nasal decongestants|mesh-ancestor
6129721|NCT01202279|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6129722|NCT01202279|Sympathomimetics|sympathomimetics|mesh-ancestor
6129723|NCT01202279|Adrenergic Agents|adrenergic agents|mesh-ancestor
6129724|NCT01202279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6129725|NCT01202279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129726|NCT01202279|Expectorants|expectorants|mesh-ancestor
6129727|NCT01202279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6129728|NCT01202279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6129729|NCT01202279|Appetite Depressants|appetite depressants|mesh-ancestor
6129730|NCT01202279|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6129731|NCT01202409|Panitumumab|panitumumab|mesh-list
6129732|NCT01202409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6129733|NCT01202409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6129734|NCT01202591|Fulvestrant|fulvestrant|mesh-list
6129735|NCT01202591|Exemestane|exemestane|mesh-list
6129736|NCT01202591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6129737|NCT01202591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5536914|NCT04204980|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6129738|NCT01202591|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6129739|NCT01202591|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6129740|NCT01202591|Hormone Antagonists|hormone antagonists|mesh-ancestor
6129741|NCT01202591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6129742|NCT01202591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129743|NCT01202591|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6129744|NCT01202591|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6129745|NCT01202591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6129746|NCT01202591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129747|NCT01202643|Lenograstim|lenograstim|mesh-list
6466260|NCT00478075|Bortezomib|bortezomib|mesh-list
5536915|NCT04204980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6129748|NCT01202643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6129749|NCT01202643|Immunologic Factors|immunologic factors|mesh-ancestor
6129750|NCT01202643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129751|NCT01202656|Lenograstim|lenograstim|mesh-list
6129752|NCT01202656|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6129753|NCT01202656|Immunologic Factors|immunologic factors|mesh-ancestor
6129754|NCT01202656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129755|NCT01202721|Atenolol|atenolol|mesh-list
6129756|NCT01202721|Telmisartan|telmisartan|mesh-list
6129757|NCT01202721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6129758|NCT01202721|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6129759|NCT01202721|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6129760|NCT01202721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129761|NCT01202721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6129762|NCT01202721|Sympatholytics|sympatholytics|mesh-ancestor
6129763|NCT01202721|Autonomic Agents|autonomic agents|mesh-ancestor
6129764|NCT01202721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6666209|NCT01521481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6666210|NCT01521481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666211|NCT01521520|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
6666212|NCT01521520|Hematinics|hematinics|mesh-ancestor
6666213|NCT01521520|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6666214|NCT01521520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6666215|NCT01521572|Albuterol|albuterol|mesh-list
6666216|NCT01521572|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6129765|NCT01202721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536916|NCT04204980|Immunologic Factors|immunologic factors|mesh-ancestor
5536917|NCT04204980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536918|NCT04204954|Ciprofloxacin|ciprofloxacin|mesh-list
5536919|NCT04204954|Tea Tree Oil|tea tree oil|mesh-list
5536920|NCT04204954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5536921|NCT04204954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5536922|NCT04204954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5536923|NCT04204954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5536924|NCT04204954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5536925|NCT04204954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129766|NCT01202721|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6129767|NCT01202721|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6129768|NCT01202721|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6129769|NCT01202721|Adrenergic Agents|adrenergic agents|mesh-ancestor
6129770|NCT01202721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6129771|NCT01202877|Azacitidine|azacitidine|mesh-list
6129772|NCT01202877|Midostaurin|midostaurin|mesh-list
6129773|NCT01202877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6129774|NCT01202877|Antimetabolites|antimetabolites|mesh-ancestor
6129775|NCT01202877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129776|NCT01202877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6129777|NCT01202877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6129778|NCT01202877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6129779|NCT01202903|Omalizumab|omalizumab|mesh-list
6129780|NCT01202903|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6129781|NCT01202903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5536926|NCT04204954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5536927|NCT04204954|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5536928|NCT04204954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5536929|NCT04204954|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5536930|NCT04205058|Caffeine|caffeine|mesh-list
5536931|NCT04205058|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5536932|NCT04205058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536933|NCT04205058|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5536934|NCT04205058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5536935|NCT04205058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536936|NCT04205058|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5536937|NCT04205058|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5536938|NCT04205058|Purinergic Agents|purinergic agents|mesh-ancestor
5536939|NCT04205058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5536940|NCT04204798|Dexmedetomidine|dexmedetomidine|mesh-list
5536941|NCT04204798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5536942|NCT04204798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5536943|NCT04204798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536944|NCT04204798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5536945|NCT04204798|Analgesics|analgesics|mesh-ancestor
5536946|NCT04204798|Sensory System Agents|sensory system agents|mesh-ancestor
5536947|NCT04204798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5536948|NCT04204798|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5536949|NCT04204798|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5536950|NCT04204798|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5536951|NCT04204798|Adrenergic Agents|adrenergic agents|mesh-ancestor
5536952|NCT04204798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5536953|NCT04204798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536954|NCT04204772|Charcoal|charcoal|mesh-list
5536955|NCT04204772|Antidotes|antidotes|mesh-ancestor
5536956|NCT04204772|Protective Agents|protective agents|mesh-ancestor
5536957|NCT04204772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536958|NCT04204577|Apatinib|apatinib|mesh-list
5536959|NCT04204577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5536960|NCT04204577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5536961|NCT04204577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5536962|NCT04204577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536963|NCT04204902|Tepotinib|tepotinib|mesh-list
5536964|NCT04204902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5536965|NCT04204278|Hyaluronic Acid|hyaluronic acid|mesh-list
5536966|NCT04204278|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5536967|NCT04204278|Immunologic Factors|immunologic factors|mesh-ancestor
5536968|NCT04204278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536969|NCT04204278|Viscosupplements|viscosupplements|mesh-ancestor
5536970|NCT04204278|Protective Agents|protective agents|mesh-ancestor
6129782|NCT01202903|Respiratory System Agents|respiratory system agents|mesh-ancestor
6129783|NCT01202955|Tolcapone|tolcapone|mesh-list
6129784|NCT01202955|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6129785|NCT01202955|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6129786|NCT01202955|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6129787|NCT01202955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6129788|NCT01202955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129789|NCT01202994|Flutemetamol|flutemetamol|mesh-list
6666217|NCT01521572|Autonomic Agents|autonomic agents|mesh-ancestor
6666218|NCT01521572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6666219|NCT01521572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536971|NCT04204382|Levofloxacin|levofloxacin|mesh-list
5536972|NCT04204382|Ofloxacin|ofloxacin|mesh-list
5536973|NCT04204382|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5536974|NCT04204382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5536975|NCT04204382|Renal Agents|renal agents|mesh-ancestor
5536976|NCT04204382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5536977|NCT04204382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5536978|NCT04204382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5536979|NCT04204382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5536980|NCT04204382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536981|NCT04204382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6129790|NCT01202994|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6466261|NCT00478075|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
6466262|NCT00478075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6466263|NCT00478075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6466264|NCT00478075|Analgesics|analgesics|mesh-ancestor
6129791|NCT01202994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129792|NCT01203046|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6129793|NCT01203046|Ertapenem|ertapenem|mesh-list
6129794|NCT01203046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6129795|NCT01203072|Edoxaban|edoxaban|mesh-list
6129796|NCT01203072|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6129797|NCT01203072|Antithrombins|antithrombins|mesh-ancestor
6129798|NCT01203072|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6129799|NCT01203072|Protease Inhibitors|protease inhibitors|mesh-ancestor
6129800|NCT01203072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6129801|NCT01203072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129802|NCT01203072|Anticoagulants|anticoagulants|mesh-ancestor
6129803|NCT01203098|Enoxaparin|enoxaparin|mesh-list
6129804|NCT01203098|Enoxaparin sodium|enoxaparin sodium|mesh-list
6129805|NCT01203098|Edoxaban|edoxaban|mesh-list
6129806|NCT01203098|Anticoagulants|anticoagulants|mesh-ancestor
6129807|NCT01203098|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6129808|NCT01203098|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6129809|NCT01203098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129810|NCT01203098|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6129811|NCT01203098|Antithrombins|antithrombins|mesh-ancestor
6129812|NCT01203098|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6129813|NCT01203098|Protease Inhibitors|protease inhibitors|mesh-ancestor
6129814|NCT01203098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6129815|NCT01203189|Ketoconazole|ketoconazole|mesh-list
6129816|NCT01203189|Antifungal Agents|antifungal agents|mesh-ancestor
6129817|NCT01203189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6129818|NCT01203189|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6129819|NCT01203189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6129820|NCT01203189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6129821|NCT01203189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129822|NCT01203189|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6129823|NCT01203189|Hormone Antagonists|hormone antagonists|mesh-ancestor
6129824|NCT01203189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6129825|NCT01203189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129826|NCT01203189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6129827|NCT01203319|Vaccines|vaccines|mesh-list
6129828|NCT01203319|Immunologic Factors|immunologic factors|mesh-ancestor
6129829|NCT01203319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129830|NCT01203644|Bupivacaine|bupivacaine|mesh-list
6129831|NCT01203644|Anesthetics, Local|anesthetics, local|mesh-ancestor
6129832|NCT01203644|Anesthetics|anesthetics|mesh-ancestor
6129833|NCT01203644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6129834|NCT01203644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129835|NCT01203644|Sensory System Agents|sensory system agents|mesh-ancestor
6129836|NCT01203644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6129837|NCT01203774|Insulin Glargine|insulin glargine|mesh-list
6129838|NCT01203774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6129839|NCT01203774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129840|NCT01203787|Sorafenib|sorafenib|mesh-list
6129841|NCT01203787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6466265|NCT00478075|Sensory System Agents|sensory system agents|mesh-ancestor
6466266|NCT00478075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6129842|NCT01203787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6129843|NCT01203787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6129844|NCT01203787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129845|NCT01203852|Metoprolol|metoprolol|mesh-list
6129846|NCT01203852|Chlorthalidone|chlorthalidone|mesh-list
6129847|NCT01203852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6129848|NCT01203852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6129849|NCT01203852|Sympatholytics|sympatholytics|mesh-ancestor
6129850|NCT01203852|Autonomic Agents|autonomic agents|mesh-ancestor
6466267|NCT00478075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466268|NCT00478101|Fentanyl|fentanyl|mesh-list
6466269|NCT00478101|Oxycodone|oxycodone|mesh-list
6129851|NCT01203852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6129852|NCT01203852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536982|NCT04204382|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5536983|NCT04204382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5536984|NCT04204252|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
5536985|NCT04204252|Protein C Inhibitor|protein c inhibitor|mesh-list
5536986|NCT04204252|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6129853|NCT01203852|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6129854|NCT01203852|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6129855|NCT01203852|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6129856|NCT01203852|Adrenergic Agents|adrenergic agents|mesh-ancestor
6129857|NCT01203852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6129858|NCT01203852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129859|NCT01203852|Diuretics|diuretics|mesh-ancestor
6129860|NCT01203852|Natriuretic Agents|natriuretic agents|mesh-ancestor
6129861|NCT01203852|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6129862|NCT01203852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6129863|NCT01203878|Imiquimod|imiquimod|mesh-list
6129864|NCT01203878|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6129865|NCT01203878|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6129866|NCT01203878|Immunologic Factors|immunologic factors|mesh-ancestor
6129867|NCT01203878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129868|NCT01203878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6129869|NCT01203878|Interferon Inducers|interferon inducers|mesh-ancestor
6129870|NCT01203878|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5536987|NCT04204252|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5536988|NCT04204252|Protease Inhibitors|protease inhibitors|mesh-ancestor
5536989|NCT04204252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5536990|NCT04204252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5536991|NCT04204083|Hyaluronic Acid|hyaluronic acid|mesh-list
5536992|NCT04204083|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5536993|NCT04204083|Immunologic Factors|immunologic factors|mesh-ancestor
5536994|NCT04204083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5536995|NCT04204083|Viscosupplements|viscosupplements|mesh-ancestor
5536996|NCT04204083|Protective Agents|protective agents|mesh-ancestor
5536997|NCT04204096|Vaccines|vaccines|mesh-list
6129871|NCT01203878|Dermatologic Agents|dermatologic agents|mesh-ancestor
6129872|NCT01203917|Gefitinib|gefitinib|mesh-list
6129873|NCT01203917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6129874|NCT01203917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6129875|NCT01203917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6129876|NCT01203917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129877|NCT01203930|Rituximab|rituximab|mesh-list
5536998|NCT04204096|Immunologic Factors|immunologic factors|mesh-ancestor
5536999|NCT04204096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537000|NCT04204304|Isotretinoin|isotretinoin|mesh-list
5537001|NCT04204304|Dermatologic Agents|dermatologic agents|mesh-ancestor
5537002|NCT04204343|Bupivacaine|bupivacaine|mesh-list
5537003|NCT04204343|Anesthetics, Local|anesthetics, local|mesh-ancestor
5537004|NCT04204343|Anesthetics|anesthetics|mesh-ancestor
5537005|NCT04204343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5537006|NCT04204343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537007|NCT04204343|Sensory System Agents|sensory system agents|mesh-ancestor
6129878|NCT01203930|Idelalisib|idelalisib|mesh-list
6129879|NCT01203930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6129880|NCT01203930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6129881|NCT01203930|Immunologic Factors|immunologic factors|mesh-ancestor
6129882|NCT01203930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129883|NCT01203930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5537008|NCT04204343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5537009|NCT04204044|Folic Acid|folic acid|mesh-list
5537010|NCT04204044|Vitamin B Complex|vitamin b complex|mesh-list
5537011|NCT04204044|Inositol|inositol|mesh-list
5537012|NCT04204044|Metformin|metformin|mesh-list
5537013|NCT04204044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5537014|NCT04204044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129884|NCT01203930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6129885|NCT01203930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129886|NCT01204203|Zoledronic Acid|zoledronic acid|mesh-list
6129887|NCT01204203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6129888|NCT01204203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129889|NCT01204255|Diphenhydramine|diphenhydramine|mesh-list
6129890|NCT01204255|Promethazine|promethazine|mesh-list
6129891|NCT01204255|Lorazepam|lorazepam|mesh-list
5537015|NCT04204044|Hematinics|hematinics|mesh-ancestor
6129892|NCT01204255|Haloperidol|haloperidol|mesh-list
6129893|NCT01204255|Haloperidol decanoate|haloperidol decanoate|mesh-list
5537016|NCT04204044|Vitamins|vitamins|mesh-ancestor
5537017|NCT04204044|Micronutrients|micronutrients|mesh-ancestor
6466270|NCT00478101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6466271|NCT00478101|Narcotics|narcotics|mesh-ancestor
6466272|NCT00478101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6466273|NCT00478101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466274|NCT00478101|Analgesics|analgesics|mesh-ancestor
6466275|NCT00478101|Sensory System Agents|sensory system agents|mesh-ancestor
6466276|NCT00478101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6466277|NCT00478101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6466278|NCT00478101|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6466279|NCT00478101|Anesthetics, General|anesthetics, general|mesh-ancestor
6466280|NCT00478101|Anesthetics|anesthetics|mesh-ancestor
6466281|NCT00478114|Sorafenib|sorafenib|mesh-list
6466282|NCT00478114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6466283|NCT00478114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6466284|NCT00478114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6466285|NCT00478114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466286|NCT00478270|Ibandronic Acid|ibandronic acid|mesh-list
6466287|NCT00478270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6129894|NCT01204255|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6129895|NCT01204255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6129896|NCT01204255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6129897|NCT01204255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129898|NCT01204255|Anesthetics, Local|anesthetics, local|mesh-ancestor
6129899|NCT01204255|Anesthetics|anesthetics|mesh-ancestor
6129900|NCT01204255|Sensory System Agents|sensory system agents|mesh-ancestor
6129901|NCT01204255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6129902|NCT01204255|Antiemetics|antiemetics|mesh-ancestor
6129903|NCT01204255|Autonomic Agents|autonomic agents|mesh-ancestor
6129904|NCT01204255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6129905|NCT01204255|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6129906|NCT01204255|Histamine Antagonists|histamine antagonists|mesh-ancestor
6129907|NCT01204255|Histamine Agents|histamine agents|mesh-ancestor
6129908|NCT01204255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6129909|NCT01204255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129910|NCT01204255|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6129911|NCT01204255|Antipruritics|antipruritics|mesh-ancestor
6129912|NCT01204255|Dermatologic Agents|dermatologic agents|mesh-ancestor
6129913|NCT01204255|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6129914|NCT01204255|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6129915|NCT01204255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6129916|NCT01204255|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6129917|NCT01204255|Dopamine Agents|dopamine agents|mesh-ancestor
6129918|NCT01204255|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6129919|NCT01204255|Anticonvulsants|anticonvulsants|mesh-ancestor
6129920|NCT01204255|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6129921|NCT01204255|GABA Modulators|gaba modulators|mesh-ancestor
6129922|NCT01204255|GABA Agents|gaba agents|mesh-ancestor
6129923|NCT01204294|Metformin|metformin|mesh-list
6129924|NCT01204294|Linagliptin|linagliptin|mesh-list
6129925|NCT01204294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6129926|NCT01204294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129927|NCT01204294|Incretins|incretins|mesh-ancestor
6129928|NCT01204294|Hormones|hormones|mesh-ancestor
6466288|NCT00478270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466289|NCT00478374|Doxorubicin|doxorubicin|mesh-list
6466290|NCT00478374|Sorafenib|sorafenib|mesh-list
6466291|NCT00478374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6466292|NCT00478374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6466293|NCT00478374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6466294|NCT00478374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6466295|NCT00478374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6466296|NCT00478374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466297|NCT00478374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6466298|NCT00478452|Cyclophosphamide|cyclophosphamide|mesh-list
6466299|NCT00478452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6466300|NCT00478452|Immunologic Factors|immunologic factors|mesh-ancestor
6466301|NCT00478452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466302|NCT00478452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6466303|NCT00478452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5537018|NCT04204265|Hyaluronic Acid|hyaluronic acid|mesh-list
5537019|NCT04204265|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5537020|NCT04204265|Immunologic Factors|immunologic factors|mesh-ancestor
5537021|NCT04204265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537022|NCT04204265|Viscosupplements|viscosupplements|mesh-ancestor
6129929|NCT01204294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6129930|NCT01204294|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6129931|NCT01204294|Protease Inhibitors|protease inhibitors|mesh-ancestor
6129932|NCT01204294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6129933|NCT01204294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129934|NCT01204398|Amlodipine|amlodipine|mesh-list
6129935|NCT01204398|Telmisartan|telmisartan|mesh-list
6129936|NCT01204398|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
6129937|NCT01204398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6129938|NCT01204398|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6129939|NCT01204398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6129940|NCT01204398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129941|NCT01204398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6129942|NCT01204398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129943|NCT01204398|Vasodilator Agents|vasodilator agents|mesh-ancestor
6129944|NCT01204398|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6129945|NCT01204398|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6129946|NCT01204658|Vaccines|vaccines|mesh-list
6129947|NCT01204658|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6129948|NCT01204658|Immunologic Factors|immunologic factors|mesh-ancestor
6129949|NCT01204658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129950|NCT01204671|Vaccines|vaccines|mesh-list
6129951|NCT01204671|Immunologic Factors|immunologic factors|mesh-ancestor
6129952|NCT01204671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129953|NCT01204697|Docetaxel|docetaxel|mesh-list
6129954|NCT01204697|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6129955|NCT01204697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5537023|NCT04204265|Protective Agents|protective agents|mesh-ancestor
5537024|NCT04203641|Doxorubicin|doxorubicin|mesh-list
5537025|NCT04203641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5537026|NCT04203641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5537027|NCT04203641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5537028|NCT04203641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5537029|NCT04203641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5537030|NCT04203641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129956|NCT01204697|Tubulin Modulators|tubulin modulators|mesh-ancestor
6129957|NCT01204697|Antimitotic Agents|antimitotic agents|mesh-ancestor
6129958|NCT01204697|Mitosis Modulators|mitosis modulators|mesh-ancestor
6129959|NCT01204697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129960|NCT01204697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6129961|NCT01204697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6129962|NCT01204710|Prednisone|prednisone|mesh-list
6129963|NCT01204710|Mitoxantrone|mitoxantrone|mesh-list
6129964|NCT01204710|Olaratumab|olaratumab|mesh-list
6129965|NCT01204710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6129966|NCT01204710|Glucocorticoids|glucocorticoids|mesh-ancestor
6129967|NCT01204710|Hormones|hormones|mesh-ancestor
6129968|NCT01204710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6129969|NCT01204710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129970|NCT01204710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6129971|NCT01204710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6129972|NCT01204710|Analgesics|analgesics|mesh-ancestor
6129973|NCT01204710|Sensory System Agents|sensory system agents|mesh-ancestor
6129974|NCT01204710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6129975|NCT01204710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6129976|NCT01204710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6129977|NCT01204710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6129978|NCT01204710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129979|NCT01204775|Metformin|metformin|mesh-list
6129980|NCT01204775|Saxagliptin|saxagliptin|mesh-list
6129981|NCT01204775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6129982|NCT01204775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6129983|NCT01204775|Incretins|incretins|mesh-ancestor
6129984|NCT01204775|Hormones|hormones|mesh-ancestor
6129985|NCT01204775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6129986|NCT01204775|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6129987|NCT01204775|Protease Inhibitors|protease inhibitors|mesh-ancestor
6129988|NCT01204775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6129989|NCT01204775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129990|NCT01204853|Sitaxsentan|sitaxsentan|mesh-list
6129991|NCT01204853|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6129992|NCT01204853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6129993|NCT01204905|Raltegravir Potassium|raltegravir potassium|mesh-list
6129994|NCT01204905|Maraviroc|maraviroc|mesh-list
6129995|NCT01204905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6129996|NCT01204905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5537031|NCT04203732|Anesthetics|anesthetics|mesh-list
6129997|NCT01204905|Antiviral Agents|antiviral agents|mesh-ancestor
6129998|NCT01204905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6129999|NCT01204905|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6130000|NCT01204905|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6130001|NCT01204905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6130002|NCT01204905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6130003|NCT01204905|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6130004|NCT01204905|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6130005|NCT01204905|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6130006|NCT01204918|Riluzole|riluzole|mesh-list
6130007|NCT01204918|Anticonvulsants|anticonvulsants|mesh-ancestor
6130008|NCT01204918|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6130009|NCT01204918|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6130010|NCT01204918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6130011|NCT01204918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6130012|NCT01204918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130013|NCT01204918|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6130014|NCT01204918|Protective Agents|protective agents|mesh-ancestor
6130015|NCT01205035|Ranibizumab|ranibizumab|mesh-list
6130016|NCT01205035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6130017|NCT01205035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6130018|NCT01205035|Growth Substances|growth substances|mesh-ancestor
6130019|NCT01205035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130020|NCT01205035|Growth Inhibitors|growth inhibitors|mesh-ancestor
6130021|NCT01205035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6130022|NCT01205126|Oxycodone|oxycodone|mesh-list
6130023|NCT01205126|Hydromorphone|hydromorphone|mesh-list
6130024|NCT01205126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6130025|NCT01205126|Narcotics|narcotics|mesh-ancestor
6130026|NCT01205126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6130027|NCT01205126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130028|NCT01205126|Analgesics|analgesics|mesh-ancestor
6130029|NCT01205126|Sensory System Agents|sensory system agents|mesh-ancestor
6130030|NCT01205126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6130031|NCT01205451|Botulinum Toxins|botulinum toxins|mesh-list
6130032|NCT01205451|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5537032|NCT04203732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5537033|NCT04203732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537034|NCT04203771|Ibuprofen|ibuprofen|mesh-list
5537035|NCT04203771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5537036|NCT04203771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5537037|NCT04203771|Analgesics|analgesics|mesh-ancestor
5537038|NCT04203771|Sensory System Agents|sensory system agents|mesh-ancestor
5537039|NCT04203771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5537040|NCT04203771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537041|NCT04203771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5537042|NCT04203771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5537043|NCT04203771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5537044|NCT04203771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5537045|NCT04203771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6130033|NCT01205451|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6130034|NCT01205451|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6130035|NCT01205451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6130036|NCT01205451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6130037|NCT01205451|Cholinergic Agents|cholinergic agents|mesh-ancestor
5537046|NCT04203914|Empagliflozin|empagliflozin|mesh-list
5537047|NCT04203914|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5537048|NCT04203914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5537049|NCT04203914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5537050|NCT04203914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537051|NCT04203680|Cardioplegic Solutions|cardioplegic solutions|mesh-list
5537052|NCT04203680|Tryptophan|tryptophan|mesh-list
5537053|NCT04203680|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5537054|NCT04203680|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5537055|NCT04203680|Antidepressive Agents|antidepressive agents|mesh-ancestor
5537056|NCT04203680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5537057|NCT04203186|Lumefantrine|lumefantrine|mesh-list
5537058|NCT04203186|Artemether|artemether|mesh-list
5537059|NCT04203186|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
5537060|NCT04203186|Atovaquone|atovaquone|mesh-list
6130038|NCT01205451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6130039|NCT01205451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130040|NCT01205451|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5537061|NCT04203186|Proguanil|proguanil|mesh-list
5537062|NCT04203186|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
5537063|NCT04203186|Antimalarials|antimalarials|mesh-ancestor
6130041|NCT01205451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6130042|NCT01205503|Cyclophosphamide|cyclophosphamide|mesh-list
6130043|NCT01205503|Doxorubicin|doxorubicin|mesh-list
6130044|NCT01205503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6130045|NCT01205503|Immunologic Factors|immunologic factors|mesh-ancestor
6130046|NCT01205503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130047|NCT01205503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6130048|NCT01205503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6130049|NCT01205503|Alkylating Agents|alkylating agents|mesh-ancestor
6466304|NCT00478452|Alkylating Agents|alkylating agents|mesh-ancestor
6466305|NCT00478452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466306|NCT00478452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6466307|NCT00478452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6466308|NCT00478465|Valganciclovir|valganciclovir|mesh-list
6466309|NCT00478465|Antiviral Agents|antiviral agents|mesh-ancestor
5537064|NCT04203186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5537065|NCT04203186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5537066|NCT04203186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6666220|NCT01521572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6130050|NCT01205503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6130051|NCT01205503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6130052|NCT01205503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5537067|NCT04203186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5537068|NCT04203186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5537069|NCT04203186|Antimetabolites|antimetabolites|mesh-ancestor
5537070|NCT04203342|Ketoconazole|ketoconazole|mesh-list
5537071|NCT04203342|Antifungal Agents|antifungal agents|mesh-ancestor
5537072|NCT04203342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5537073|NCT04203342|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5537074|NCT04203342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5537075|NCT04203342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5537076|NCT04203342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5537077|NCT04203342|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5537078|NCT04203342|Hormone Antagonists|hormone antagonists|mesh-ancestor
5537079|NCT04203342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6130053|NCT01205503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6130054|NCT01205503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6130055|NCT01205503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6130056|NCT01205503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6130057|NCT01205529|Procainamide|procainamide|mesh-list
6130058|NCT01205529|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6130059|NCT01205529|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6130060|NCT01205529|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6130061|NCT01205529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6130062|NCT01205529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6130063|NCT01205581|Vaccines|vaccines|mesh-list
6130064|NCT01205581|Immunologic Factors|immunologic factors|mesh-ancestor
6130065|NCT01205581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130066|NCT01205646|Zoledronic Acid|zoledronic acid|mesh-list
6130067|NCT01205646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6130068|NCT01205646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130069|NCT01205685|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6130070|NCT01205685|Letrozole|letrozole|mesh-list
6130071|NCT01205685|Goserelin|goserelin|mesh-list
6130072|NCT01205685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6130073|NCT01205685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6130074|NCT01205685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6130075|NCT01205685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6130076|NCT01205685|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6130077|NCT01205685|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6130078|NCT01205685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6130079|NCT01205685|Hormone Antagonists|hormone antagonists|mesh-ancestor
5537080|NCT04203342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537081|NCT04203342|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5537082|NCT04203368|Adenosine|adenosine|mesh-list
5537083|NCT04203368|Verapamil|verapamil|mesh-list
5537084|NCT04203368|Analgesics|analgesics|mesh-ancestor
5537085|NCT04203368|Sensory System Agents|sensory system agents|mesh-ancestor
5537086|NCT04203368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6466310|NCT00478465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6466311|NCT00478504|Letrozole|letrozole|mesh-list
6466312|NCT00478504|Clomiphene|clomiphene|mesh-list
6666221|NCT01521572|Respiratory System Agents|respiratory system agents|mesh-ancestor
6666222|NCT01521572|Tocolytic Agents|tocolytic agents|mesh-ancestor
5537087|NCT04203368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537088|NCT04203368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5537089|NCT04203368|Vasodilator Agents|vasodilator agents|mesh-ancestor
5537090|NCT04203368|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5537091|NCT04203368|Purinergic Agonists|purinergic agonists|mesh-ancestor
5537092|NCT04203368|Purinergic Agents|purinergic agents|mesh-ancestor
5537093|NCT04203368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5537094|NCT04203368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5537095|NCT04203368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5537096|NCT04203368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5537097|NCT04203368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5601954|NCT05035277|Analgesics|analgesics|mesh-ancestor
5601955|NCT05035277|Sensory System Agents|sensory system agents|mesh-ancestor
5601956|NCT05035277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5601957|NCT05035277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601958|NCT05035277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5601959|NCT05035277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5601960|NCT05035277|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6666223|NCT01521572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6666224|NCT01521572|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6666225|NCT01521572|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6666226|NCT01521572|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6666227|NCT01521572|Adrenergic Agents|adrenergic agents|mesh-ancestor
6666228|NCT01521572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6666229|NCT01521572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666230|NCT01521624|Metformin|metformin|mesh-list
6666231|NCT01521624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6666232|NCT01521624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666233|NCT01521689|Rituximab|rituximab|mesh-list
6666234|NCT01521689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6666235|NCT01521689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6666236|NCT01521689|Immunologic Factors|immunologic factors|mesh-ancestor
6666237|NCT01521689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666238|NCT01521689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6666239|NCT01521767|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6666240|NCT01521767|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6666241|NCT01521767|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6666242|NCT01521767|Cholinergic Agents|cholinergic agents|mesh-ancestor
6666243|NCT01521767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6666244|NCT01521767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666245|NCT01521767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601961|NCT05035277|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5601962|NCT05035277|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5601963|NCT05035277|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5601964|NCT05035277|Antipyretics|antipyretics|mesh-ancestor
5601965|NCT05031806|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5601966|NCT05031806|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5601967|NCT05022147|Dopamine|dopamine|mesh-list
6666246|NCT01521767|Urological Agents|urological agents|mesh-ancestor
6666247|NCT01521793|Retinol acetate|retinol acetate|mesh-list
6666248|NCT01521793|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6666249|NCT01521793|Immunologic Factors|immunologic factors|mesh-ancestor
6666250|NCT01521793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666251|NCT01521793|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6666252|NCT01521793|Protective Agents|protective agents|mesh-ancestor
6666253|NCT01521793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6666254|NCT01521819|Ranibizumab|ranibizumab|mesh-list
6666255|NCT01521819|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6666256|NCT01521819|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6666257|NCT01521819|Growth Substances|growth substances|mesh-ancestor
6666258|NCT01521819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666259|NCT01521819|Growth Inhibitors|growth inhibitors|mesh-ancestor
6666260|NCT01521819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6666261|NCT01521936|Vitamin D|vitamin d|mesh-list
6666262|NCT01521936|Ergocalciferols|ergocalciferols|mesh-list
6666263|NCT01521936|Cholecalciferol|cholecalciferol|mesh-list
6666264|NCT01521936|Vitamins|vitamins|mesh-list
6666265|NCT01521936|Micronutrients|micronutrients|mesh-ancestor
6666266|NCT01521936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666267|NCT01521936|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5601968|NCT05022147|Dopamine Agonists|dopamine agonists|mesh-list
6205019|NCT02080455|Atorvastatin|atorvastatin|mesh-list
6666268|NCT01521936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6130080|NCT01205685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6130081|NCT01205685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130082|NCT01205685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6130083|NCT01205828|Temozolomide|temozolomide|mesh-list
6130084|NCT01205828|Veliparib|veliparib|mesh-list
6130085|NCT01205828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6130086|NCT01205828|Alkylating Agents|alkylating agents|mesh-ancestor
6130087|NCT01205828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6130088|NCT01205828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6130089|NCT01205828|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6130090|NCT01205828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6130091|NCT01206140|Sirolimus|sirolimus|mesh-list
6130092|NCT01206140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6130093|NCT01206140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6130094|NCT01206140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6130095|NCT01206140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6130096|NCT01206140|Antifungal Agents|antifungal agents|mesh-ancestor
6130097|NCT01206140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6130098|NCT01206140|Immunologic Factors|immunologic factors|mesh-ancestor
6130099|NCT01206140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130100|NCT01206322|Insulin|insulin|mesh-list
6130101|NCT01206322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6130102|NCT01206322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130103|NCT01206387|Desoximetasone|desoximetasone|mesh-list
6130104|NCT01206387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6130105|NCT01206387|Glucocorticoids|glucocorticoids|mesh-ancestor
6130106|NCT01206387|Hormones|hormones|mesh-ancestor
6130107|NCT01206387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6130108|NCT01206387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130109|NCT01206452|Prednisone|prednisone|mesh-list
6130110|NCT01206452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6130111|NCT01206452|Glucocorticoids|glucocorticoids|mesh-ancestor
6130112|NCT01206452|Hormones|hormones|mesh-ancestor
6130113|NCT01206452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6130114|NCT01206452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130115|NCT01206452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6130116|NCT01206452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6466313|NCT00478504|Enclomiphene|enclomiphene|mesh-list
6466314|NCT00478504|Zuclomiphene|zuclomiphene|mesh-list
6466315|NCT00478504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466316|NCT00478504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6466317|NCT00478504|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6130117|NCT01206465|Fluorouracil|fluorouracil|mesh-list
6130118|NCT01206465|Antimetabolites|antimetabolites|mesh-ancestor
6130119|NCT01206465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6130120|NCT01206465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6130121|NCT01206465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6130122|NCT01206465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6130123|NCT01206465|Immunologic Factors|immunologic factors|mesh-ancestor
6130124|NCT01206465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130125|NCT01206478|Megestrol|megestrol|mesh-list
5537098|NCT04203472|Budesonide|budesonide|mesh-list
5537099|NCT04203472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5537100|NCT04203472|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5537101|NCT04203472|Autonomic Agents|autonomic agents|mesh-ancestor
5537102|NCT04203472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5537103|NCT04203472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537104|NCT04203472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5537105|NCT04203472|Respiratory System Agents|respiratory system agents|mesh-ancestor
5537106|NCT04203472|Glucocorticoids|glucocorticoids|mesh-ancestor
6130126|NCT01206478|Amitriptyline|amitriptyline|mesh-list
6466318|NCT00478504|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5537107|NCT04203472|Hormones|hormones|mesh-ancestor
6130127|NCT01206478|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6130128|NCT01206478|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6130129|NCT01206478|Antidepressive Agents|antidepressive agents|mesh-ancestor
6130130|NCT01206478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6130131|NCT01206478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6130132|NCT01206478|Analgesics|analgesics|mesh-ancestor
6130133|NCT01206478|Sensory System Agents|sensory system agents|mesh-ancestor
6130134|NCT01206478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6130135|NCT01206478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130136|NCT01206478|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6130137|NCT01206478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6130138|NCT01206478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6130139|NCT01206478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6130140|NCT01206478|Adrenergic Agents|adrenergic agents|mesh-ancestor
6130141|NCT01206478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6130142|NCT01206478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6130143|NCT01206478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6130144|NCT01206478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6130145|NCT01206478|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6130146|NCT01206478|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6130147|NCT01206478|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6130148|NCT01206478|Contraceptive Agents|contraceptive agents|mesh-ancestor
6130149|NCT01206478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6130150|NCT01206478|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6130151|NCT01206478|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6130152|NCT01206478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6130153|NCT01206478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6130154|NCT01206595|Bupivacaine|bupivacaine|mesh-list
6130155|NCT01206595|Anesthetics, Local|anesthetics, local|mesh-ancestor
6130156|NCT01206595|Anesthetics|anesthetics|mesh-ancestor
6130157|NCT01206595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6130158|NCT01206595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130159|NCT01206595|Sensory System Agents|sensory system agents|mesh-ancestor
6130160|NCT01206595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6130161|NCT01206608|Bupivacaine|bupivacaine|mesh-list
5537108|NCT04203472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5537109|NCT04203212|Goserelin|goserelin|mesh-list
5537110|NCT04203212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5537111|NCT04203212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5537112|NCT04203056|Aripiprazole|aripiprazole|mesh-list
5537113|NCT04203056|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
6130162|NCT01206608|Anesthetics, Local|anesthetics, local|mesh-ancestor
6130163|NCT01206608|Anesthetics|anesthetics|mesh-ancestor
6130164|NCT01206608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6130165|NCT01206608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130166|NCT01206608|Sensory System Agents|sensory system agents|mesh-ancestor
6130167|NCT01206608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6130168|NCT01206660|Desoximetasone|desoximetasone|mesh-list
6130169|NCT01206660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6130170|NCT01206660|Glucocorticoids|glucocorticoids|mesh-ancestor
6130171|NCT01206660|Hormones|hormones|mesh-ancestor
6130172|NCT01206660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6130173|NCT01206660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130174|NCT01206764|Everolimus|everolimus|mesh-list
6130175|NCT01206764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6130176|NCT01206764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6130177|NCT01206764|Immunologic Factors|immunologic factors|mesh-ancestor
6130178|NCT01206764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130179|NCT01206777|Rituximab|rituximab|mesh-list
6130180|NCT01206777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6130181|NCT01206777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6130182|NCT01206777|Immunologic Factors|immunologic factors|mesh-ancestor
6466319|NCT00478504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6466320|NCT00478504|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6466321|NCT00478504|Hormone Antagonists|hormone antagonists|mesh-ancestor
6130183|NCT01206777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130184|NCT01206777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6130185|NCT01206816|Afatinib|afatinib|mesh-list
6130186|NCT01206816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6130187|NCT01206816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6130188|NCT01206816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6130189|NCT01206816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205020|NCT02080455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6205021|NCT02080455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5537114|NCT04203056|Antidepressive Agents|antidepressive agents|mesh-ancestor
5537115|NCT04203056|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5537116|NCT04203056|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5537117|NCT04203056|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5537118|NCT04203056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5537119|NCT04203056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537120|NCT04203056|Dopamine Agonists|dopamine agonists|mesh-ancestor
5537121|NCT04203056|Dopamine Agents|dopamine agents|mesh-ancestor
5537122|NCT04203056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6205022|NCT02080455|Antimetabolites|antimetabolites|mesh-ancestor
6205023|NCT02080455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205024|NCT02080455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6205025|NCT02080455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6205026|NCT02080455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6205027|NCT02080468|Norgestimate|norgestimate|mesh-list
6205028|NCT02080468|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6205029|NCT02080468|Contraceptive Agents|contraceptive agents|mesh-ancestor
6205030|NCT02080468|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6205031|NCT02080468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205032|NCT02080468|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6205033|NCT02080468|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6205034|NCT02080468|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6205035|NCT02080637|Ambrisentan|ambrisentan|mesh-list
6466322|NCT00478504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6466323|NCT00478504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466324|NCT00478504|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6466325|NCT00478504|Fertility Agents|fertility agents|mesh-ancestor
6466326|NCT00478504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6466327|NCT00478504|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6466328|NCT00478504|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6466329|NCT00478517|Epoetin Alfa|epoetin alfa|mesh-list
6466330|NCT00478517|Hematinics|hematinics|mesh-ancestor
6466331|NCT00478543|Furosemide|furosemide|mesh-list
6466332|NCT00478543|Diuretics|diuretics|mesh-ancestor
6466333|NCT00478543|Natriuretic Agents|natriuretic agents|mesh-ancestor
6466334|NCT00478543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466335|NCT00478543|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6466336|NCT00478543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6466337|NCT00478543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466338|NCT00478621|Vaccines|vaccines|mesh-list
6466339|NCT00478621|Immunologic Factors|immunologic factors|mesh-ancestor
6466340|NCT00478621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466341|NCT00478634|Irinotecan|irinotecan|mesh-list
5601969|NCT05022147|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6466342|NCT00478634|Cetuximab|cetuximab|mesh-list
6466343|NCT00478634|Everolimus|everolimus|mesh-list
6466344|NCT00478634|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5537123|NCT04203056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5537124|NCT04203056|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5537125|NCT04203056|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5537126|NCT04203056|Serotonin Agents|serotonin agents|mesh-ancestor
5537127|NCT04203056|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5537128|NCT04203056|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5537129|NCT04203056|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5537130|NCT04203056|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5537131|NCT04203043|Pycnogenols|pycnogenols|mesh-list
5537132|NCT04203043|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6466345|NCT00478634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6130190|NCT01207388|Blinatumomab|blinatumomab|mesh-list
6130191|NCT01207388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6130192|NCT01207401|Lidocaine|lidocaine|mesh-list
6130193|NCT01207401|Anesthetics, Local|anesthetics, local|mesh-ancestor
6130194|NCT01207401|Anesthetics|anesthetics|mesh-ancestor
6130195|NCT01207401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6130196|NCT01207401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537133|NCT04203043|Immunologic Factors|immunologic factors|mesh-ancestor
5537134|NCT04203043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537135|NCT04203043|Antioxidants|antioxidants|mesh-ancestor
5537136|NCT04203043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5537137|NCT04203043|Protective Agents|protective agents|mesh-ancestor
5537138|NCT04203043|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5537139|NCT04203290|Bupivacaine|bupivacaine|mesh-list
5537140|NCT04203290|Sevoflurane|sevoflurane|mesh-list
5537141|NCT04203290|Anesthetics, Local|anesthetics, local|mesh-ancestor
5537142|NCT04203290|Anesthetics|anesthetics|mesh-ancestor
5537143|NCT04203290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6130197|NCT01207401|Sensory System Agents|sensory system agents|mesh-ancestor
6130198|NCT01207401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6130199|NCT01207401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6130200|NCT01207401|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6130201|NCT01207401|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6130202|NCT01207401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6130203|NCT01207401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6130204|NCT01207414|Iloperidone|iloperidone|mesh-list
6130205|NCT01207414|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6130206|NCT01207414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6130207|NCT01207414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6130208|NCT01207414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130209|NCT01207414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6130210|NCT01207440|Ponatinib|ponatinib|mesh-list
6130211|NCT01207440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6130212|NCT01207440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6130213|NCT01207440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6130214|NCT01207440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6130215|NCT01207453|Milnacipran|milnacipran|mesh-list
6130216|NCT01207453|Levomilnacipran|levomilnacipran|mesh-list
6130217|NCT01207453|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6130218|NCT01207453|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6130219|NCT01207453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6130220|NCT01207453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6130221|NCT01207453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6130222|NCT01207453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130223|NCT01207453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6130224|NCT01207453|Analgesics|analgesics|mesh-ancestor
6130225|NCT01207453|Sensory System Agents|sensory system agents|mesh-ancestor
6130226|NCT01207453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6130227|NCT01207453|Antidepressive Agents|antidepressive agents|mesh-ancestor
6130228|NCT01207453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6130229|NCT01207596|Hydromorphone|hydromorphone|mesh-list
6130230|NCT01207596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6130231|NCT01207596|Narcotics|narcotics|mesh-ancestor
6130232|NCT01207596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6130233|NCT01207596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466346|NCT00478634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6466347|NCT00478634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466348|NCT00478634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6466349|NCT00478634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6130234|NCT01207596|Analgesics|analgesics|mesh-ancestor
6130235|NCT01207596|Sensory System Agents|sensory system agents|mesh-ancestor
6130236|NCT01207596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6130237|NCT01207687|Bevacizumab|bevacizumab|mesh-list
6130238|NCT01207687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6130239|NCT01207687|Antibodies|antibodies|mesh-list
6130240|NCT01207687|Immunoglobulins|immunoglobulins|mesh-list
6130241|NCT01207687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6130242|NCT01207687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6130243|NCT01207687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6130244|NCT01207687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6130245|NCT01207687|Growth Substances|growth substances|mesh-ancestor
6130246|NCT01207687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130247|NCT01207687|Growth Inhibitors|growth inhibitors|mesh-ancestor
6130248|NCT01207687|Immunologic Factors|immunologic factors|mesh-ancestor
6130249|NCT01207752|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6130250|NCT01207752|Lubricant Eye Drops|lubricant eye drops|mesh-list
6130251|NCT01207752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6130252|NCT01207765|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6130253|NCT01207765|Immunologic Factors|immunologic factors|mesh-ancestor
6130254|NCT01207765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130255|NCT01207908|Mecasermin|mecasermin|mesh-list
6130256|NCT01207908|Growth Substances|growth substances|mesh-ancestor
6130257|NCT01207908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130258|NCT01208038|Methyltestosterone|methyltestosterone|mesh-list
6130259|NCT01208038|Testosterone|testosterone|mesh-list
6130260|NCT01208038|Testosterone undecanoate|testosterone undecanoate|mesh-list
6130261|NCT01208038|Testosterone enanthate|testosterone enanthate|mesh-list
6130262|NCT01208038|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6130263|NCT01208038|Androgens|androgens|mesh-ancestor
6130264|NCT01208038|Hormones|hormones|mesh-ancestor
6130265|NCT01208038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6130266|NCT01208038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130267|NCT01208038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6130268|NCT01208038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6130269|NCT01208038|Anabolic Agents|anabolic agents|mesh-ancestor
6130270|NCT01208051|Lenalidomide|lenalidomide|mesh-list
6130271|NCT01208051|Cediranib|cediranib|mesh-list
6130272|NCT01208051|Maleic acid|maleic acid|mesh-list
6130273|NCT01208051|Immunologic Factors|immunologic factors|mesh-ancestor
6130274|NCT01208051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130275|NCT01208051|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6130276|NCT01208051|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6130277|NCT01208051|Growth Substances|growth substances|mesh-ancestor
6130278|NCT01208051|Growth Inhibitors|growth inhibitors|mesh-ancestor
6130279|NCT01208051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6130280|NCT01208051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6130281|NCT01208051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6130282|NCT01208051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6130283|NCT01208103|Bevacizumab|bevacizumab|mesh-list
6130284|NCT01208103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6130285|NCT01208103|Capecitabine|capecitabine|mesh-list
6130286|NCT01208103|Oxaliplatin|oxaliplatin|mesh-list
6130287|NCT01208103|Endothelial Growth Factors|endothelial growth factors|mesh-list
6130288|NCT01208103|Antibodies|antibodies|mesh-list
6130289|NCT01208103|Immunoglobulins|immunoglobulins|mesh-list
6130290|NCT01208103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6130291|NCT01208103|Immunoglobulin G|immunoglobulin g|mesh-list
6130292|NCT01208103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6130293|NCT01208103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6130294|NCT01208103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6130295|NCT01208103|Growth Substances|growth substances|mesh-ancestor
6130296|NCT01208103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130297|NCT01208103|Growth Inhibitors|growth inhibitors|mesh-ancestor
6130298|NCT01208103|Immunologic Factors|immunologic factors|mesh-ancestor
6130299|NCT01208103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6130300|NCT01208103|Antimetabolites|antimetabolites|mesh-ancestor
6130301|NCT01208103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6130302|NCT01208233|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1H)-one|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1h)-one|mesh-list
6130303|NCT01208233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6130304|NCT01208233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6130305|NCT01208233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6130306|NCT01208233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6130307|NCT01208324|Estrogens|estrogens|mesh-list
6130308|NCT01208324|Hormones|hormones|mesh-ancestor
6130309|NCT01208324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6130310|NCT01208324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130311|NCT01208337|Alemtuzumab|alemtuzumab|mesh-list
6130312|NCT01208337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6130313|NCT01208337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6130314|NCT01208402|Esmolol|esmolol|mesh-list
6130315|NCT01208402|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6130316|NCT01208402|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6130317|NCT01208402|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6666269|NCT01521962|Alogliptin|alogliptin|mesh-list
6666270|NCT01521962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6666271|NCT01521962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666272|NCT01521962|Incretins|incretins|mesh-ancestor
6130318|NCT01208402|Adrenergic Agents|adrenergic agents|mesh-ancestor
6130319|NCT01208402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6130320|NCT01208402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6130321|NCT01208402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130322|NCT01208922|Ciprofloxacin|ciprofloxacin|mesh-list
6130323|NCT01208922|Rifamycins|rifamycins|mesh-list
6130324|NCT01208922|Rifamycin SV|rifamycin sv|mesh-list
6130325|NCT01208922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6130326|NCT01208922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6130327|NCT01208922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6130328|NCT01208922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6130329|NCT01208922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6130330|NCT01208922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6130331|NCT01208922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6130332|NCT01208922|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6130333|NCT01208922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6130334|NCT01208922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5537144|NCT04203290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537145|NCT04203290|Sensory System Agents|sensory system agents|mesh-ancestor
5537146|NCT04203290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5537147|NCT04203290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5537148|NCT04203290|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5537149|NCT04203290|Anesthetics, General|anesthetics, general|mesh-ancestor
5537150|NCT04202809|Durvalumab|durvalumab|mesh-list
5537151|NCT04202809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5537152|NCT04202809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5537153|NCT04202978|Capecitabine|capecitabine|mesh-list
5537154|NCT04202978|Oxaliplatin|oxaliplatin|mesh-list
5537155|NCT04202978|Apatinib|apatinib|mesh-list
5537156|NCT04202978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5537157|NCT04202978|Antimetabolites|antimetabolites|mesh-ancestor
5537158|NCT04202978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5537159|NCT04202978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5537160|NCT04202978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5537161|NCT04202978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5537162|NCT04203511|Paclitaxel|paclitaxel|mesh-list
5537163|NCT04203511|Etoposide|etoposide|mesh-list
5537164|NCT04203511|Carboplatin|carboplatin|mesh-list
5537165|NCT04203511|Pemetrexed|pemetrexed|mesh-list
5537166|NCT04203511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5537167|NCT04203511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5537168|NCT04203511|Tubulin Modulators|tubulin modulators|mesh-ancestor
5537169|NCT04203511|Antimitotic Agents|antimitotic agents|mesh-ancestor
5537170|NCT04203511|Mitosis Modulators|mitosis modulators|mesh-ancestor
5537171|NCT04203511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6130335|NCT01209078|Linezolid|linezolid|mesh-list
6130336|NCT01209078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6130337|NCT01209078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6130338|NCT01209078|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6130339|NCT01209078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6130340|NCT01209078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6130341|NCT01209143|Rosiglitazone|rosiglitazone|mesh-list
6130342|NCT01209143|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6130343|NCT01209143|Norethindrone|norethindrone|mesh-list
6130344|NCT01209143|Norethindrone Acetate|norethindrone acetate|mesh-list
6130345|NCT01209143|Estradiol|estradiol|mesh-list
6130346|NCT01209143|Estrogens|estrogens|mesh-ancestor
6130347|NCT01209143|Hormones|hormones|mesh-ancestor
6130348|NCT01209143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6666273|NCT01521962|Hormones|hormones|mesh-ancestor
5537172|NCT04203511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5537173|NCT04203511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5537174|NCT04203511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5537175|NCT04203511|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5537176|NCT04203511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5537177|NCT04202952|Sofosbuvir|sofosbuvir|mesh-list
5537178|NCT04202952|Antiviral Agents|antiviral agents|mesh-ancestor
6130349|NCT01209143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130350|NCT01209143|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6130351|NCT01209143|Contraceptive Agents|contraceptive agents|mesh-ancestor
6130352|NCT01209143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6130353|NCT01209143|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6130354|NCT01209143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6130355|NCT01209143|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6130356|NCT01209143|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6130357|NCT01209143|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6130358|NCT01209195|Paclitaxel|paclitaxel|mesh-list
6130359|NCT01209195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5537179|NCT04202952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5537180|NCT04202835|Cyclophosphamide|cyclophosphamide|mesh-list
5537181|NCT04202835|Thymoglobulin|thymoglobulin|mesh-list
6130360|NCT01209195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6130361|NCT01209195|Tubulin Modulators|tubulin modulators|mesh-ancestor
6130362|NCT01209195|Antimitotic Agents|antimitotic agents|mesh-ancestor
6130363|NCT01209195|Mitosis Modulators|mitosis modulators|mesh-ancestor
6130364|NCT01209195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6130365|NCT01209286|Blinatumomab|blinatumomab|mesh-list
6130366|NCT01209286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6130367|NCT01209442|Bevacizumab|bevacizumab|mesh-list
5537182|NCT04202835|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5537183|NCT04202835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5537184|NCT04202835|Immunologic Factors|immunologic factors|mesh-ancestor
5537185|NCT04202835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537186|NCT04202835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5537187|NCT04202835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5537188|NCT04202835|Alkylating Agents|alkylating agents|mesh-ancestor
5537189|NCT04202835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5537190|NCT04202835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5537191|NCT04202835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5537192|NCT04203485|Paclitaxel|paclitaxel|mesh-list
5537193|NCT04203485|Carboplatin|carboplatin|mesh-list
5537194|NCT04203485|Pemetrexed|pemetrexed|mesh-list
5537195|NCT04203485|Apatinib|apatinib|mesh-list
5537196|NCT04203485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5537197|NCT04203485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5537198|NCT04203485|Tubulin Modulators|tubulin modulators|mesh-ancestor
5537199|NCT04203485|Antimitotic Agents|antimitotic agents|mesh-ancestor
5537200|NCT04203485|Mitosis Modulators|mitosis modulators|mesh-ancestor
5537201|NCT04203485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6130368|NCT01209442|Temozolomide|temozolomide|mesh-list
6130369|NCT01209442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6130370|NCT01209442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5537202|NCT04203485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5537203|NCT04203485|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5537204|NCT04203485|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5537205|NCT04203485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5537206|NCT04202692|Magnesium trisilicate|magnesium trisilicate|mesh-list
5537207|NCT04202692|Hyaluronic Acid|hyaluronic acid|mesh-list
5537208|NCT04202692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5537209|NCT04202692|Immunologic Factors|immunologic factors|mesh-ancestor
5537210|NCT04202692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130371|NCT01209442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6130372|NCT01209442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6130373|NCT01209442|Growth Substances|growth substances|mesh-ancestor
6130374|NCT01209442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130375|NCT01209442|Growth Inhibitors|growth inhibitors|mesh-ancestor
6130376|NCT01209442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6130377|NCT01209442|Alkylating Agents|alkylating agents|mesh-ancestor
6466350|NCT00478634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6466351|NCT00478634|Immunologic Factors|immunologic factors|mesh-ancestor
6466352|NCT00478634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466353|NCT00478660|Adalimumab|adalimumab|mesh-list
6466354|NCT00478660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6466355|NCT00478660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6466356|NCT00478699|Gemcitabine|gemcitabine|mesh-list
6466357|NCT00478699|Cisplatin|cisplatin|mesh-list
5537211|NCT04202692|Viscosupplements|viscosupplements|mesh-ancestor
6130378|NCT01209442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466358|NCT00478699|Docetaxel|docetaxel|mesh-list
6466359|NCT00478699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6466360|NCT00478699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6466361|NCT00478699|Antimetabolites|antimetabolites|mesh-ancestor
6130379|NCT01209598|Palbociclib|palbociclib|mesh-list
6130380|NCT01209598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6130381|NCT01209598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6130382|NCT01209598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6130383|NCT01209598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6130384|NCT01209832|Midazolam|midazolam|mesh-list
6130385|NCT01209832|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6130386|NCT01209832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6130387|NCT01209832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6130388|NCT01209832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130389|NCT01209832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6130390|NCT01209832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6130391|NCT01209832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6130392|NCT01209832|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6130393|NCT01209832|Anesthetics, General|anesthetics, general|mesh-ancestor
6130394|NCT01209832|Anesthetics|anesthetics|mesh-ancestor
6130395|NCT01209832|GABA Modulators|gaba modulators|mesh-ancestor
6130396|NCT01209832|GABA Agents|gaba agents|mesh-ancestor
6130397|NCT01209832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6130398|NCT01209832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6130399|NCT01209949|Adapalene|adapalene|mesh-list
5537212|NCT04202692|Protective Agents|protective agents|mesh-ancestor
5537213|NCT04202692|Antacids|antacids|mesh-ancestor
5537214|NCT04202692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5537215|NCT04202692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5537216|NCT04202887|Fentanyl|fentanyl|mesh-list
5537217|NCT04202887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5537218|NCT04202887|Narcotics|narcotics|mesh-ancestor
5537219|NCT04202887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5537220|NCT04202887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537221|NCT04202887|Analgesics|analgesics|mesh-ancestor
5537222|NCT04202887|Sensory System Agents|sensory system agents|mesh-ancestor
5537223|NCT04202887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5537224|NCT04202887|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5537225|NCT04202887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5537226|NCT04202887|Anesthetics, General|anesthetics, general|mesh-ancestor
5537227|NCT04202887|Anesthetics|anesthetics|mesh-ancestor
5537228|NCT04202861|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5537229|NCT04202861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5537230|NCT04202536|Tenofovir|tenofovir|mesh-list
5537231|NCT04202536|Antiviral Agents|antiviral agents|mesh-ancestor
5537232|NCT04202536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5537233|NCT04202536|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5537234|NCT04202536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5537235|NCT04202536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5537236|NCT04202536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5537237|NCT04202536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5537238|NCT04202536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5537239|NCT04202484|Oxaliplatin|oxaliplatin|mesh-list
6130400|NCT01209949|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6130401|NCT01209949|Dermatologic Agents|dermatologic agents|mesh-ancestor
6130402|NCT01209949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6130403|NCT01209949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6130404|NCT01209949|Analgesics|analgesics|mesh-ancestor
6130405|NCT01209949|Sensory System Agents|sensory system agents|mesh-ancestor
5537240|NCT04202484|Tegafur|tegafur|mesh-list
5537241|NCT04202484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5537242|NCT04202484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5537243|NCT04202484|Antimetabolites|antimetabolites|mesh-ancestor
5537244|NCT04202484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5537245|NCT04202380|Azithromycin|azithromycin|mesh-list
5537246|NCT04202380|Ampicillin|ampicillin|mesh-list
5537247|NCT04202380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5537248|NCT04202380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5537249|NCT04202367|Bupivacaine|bupivacaine|mesh-list
5537250|NCT04202367|Anesthetics, Local|anesthetics, local|mesh-ancestor
5537251|NCT04202367|Anesthetics|anesthetics|mesh-ancestor
5537252|NCT04202367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5537253|NCT04202367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537254|NCT04202367|Sensory System Agents|sensory system agents|mesh-ancestor
5537255|NCT04202367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6466362|NCT00478699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5537256|NCT04202471|Chlorhexidine|chlorhexidine|mesh-list
6130406|NCT01209949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6130407|NCT01209949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130408|NCT01209949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6130409|NCT01209949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6130410|NCT01210001|Empagliflozin|empagliflozin|mesh-list
6130411|NCT01210001|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6130412|NCT01210001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466363|NCT00478699|Antiviral Agents|antiviral agents|mesh-ancestor
6466364|NCT00478699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6466365|NCT00478699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6466366|NCT00478699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6466367|NCT00478699|Immunologic Factors|immunologic factors|mesh-ancestor
6466368|NCT00478699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466369|NCT00478699|Tubulin Modulators|tubulin modulators|mesh-ancestor
6466370|NCT00478699|Antimitotic Agents|antimitotic agents|mesh-ancestor
6466371|NCT00478699|Mitosis Modulators|mitosis modulators|mesh-ancestor
6466372|NCT00478764|Triamcinolone|triamcinolone|mesh-list
6466373|NCT00478764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5537257|NCT04202471|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5537258|NCT04202471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6130413|NCT01210001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5537259|NCT04202471|Disinfectants|disinfectants|mesh-ancestor
5537260|NCT04202289|Sulfadiazine|sulfadiazine|mesh-list
5537261|NCT04202289|Silver Sulfadiazine|silver sulfadiazine|mesh-list
5537262|NCT04202289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6130414|NCT01210001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130415|NCT01210079|Gabapentin|gabapentin|mesh-list
6130416|NCT01210079|Analgesics|analgesics|mesh-ancestor
6130417|NCT01210079|Sensory System Agents|sensory system agents|mesh-ancestor
6130418|NCT01210079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6130419|NCT01210079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130420|NCT01210079|Anticonvulsants|anticonvulsants|mesh-ancestor
6130421|NCT01210079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6130422|NCT01210079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6130423|NCT01210079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6130424|NCT01210079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6130425|NCT01210079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6130426|NCT01210079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6130427|NCT01210079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6130428|NCT01210079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6130429|NCT01210079|Antimanic Agents|antimanic agents|mesh-ancestor
6130430|NCT01210144|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6130431|NCT01210144|Hormones|hormones|mesh-list
6130432|NCT01210144|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
5537263|NCT04202289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5537264|NCT04202289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5537265|NCT04202289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6130433|NCT01210144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6130434|NCT01210144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130435|NCT01210144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6130436|NCT01210170|Mometasone Furoate|mometasone furoate|mesh-list
6130437|NCT01210170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6130438|NCT01210170|Dermatologic Agents|dermatologic agents|mesh-ancestor
6130439|NCT01210170|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6130440|NCT01210222|Trebananib|trebananib|mesh-list
6130441|NCT01210222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5537266|NCT04202289|Coccidiostats|coccidiostats|mesh-ancestor
5537267|NCT04202289|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5537268|NCT04202406|Acetaminophen|acetaminophen|mesh-list
5537269|NCT04202406|Codeine|codeine|mesh-list
5537270|NCT04202406|Caffeine|caffeine|mesh-list
5537271|NCT04202406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5537272|NCT04202406|Analgesics|analgesics|mesh-ancestor
6130442|NCT01210222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6130443|NCT01210222|Growth Substances|growth substances|mesh-ancestor
6130444|NCT01210222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130445|NCT01210222|Growth Inhibitors|growth inhibitors|mesh-ancestor
6130446|NCT01210222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6130447|NCT01210352|Oxymorphone|oxymorphone|mesh-list
6130448|NCT01210352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6130449|NCT01210352|Narcotics|narcotics|mesh-ancestor
6130450|NCT01210352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6130451|NCT01210352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130452|NCT01210352|Analgesics|analgesics|mesh-ancestor
6466374|NCT00478764|Glucocorticoids|glucocorticoids|mesh-ancestor
6466375|NCT00478764|Hormones|hormones|mesh-ancestor
5537273|NCT04202406|Sensory System Agents|sensory system agents|mesh-ancestor
6130453|NCT01210352|Sensory System Agents|sensory system agents|mesh-ancestor
6130454|NCT01210352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6130455|NCT01210352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6130456|NCT01210443|Sitaxsentan|sitaxsentan|mesh-list
6130457|NCT01210443|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6130458|NCT01210443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6130459|NCT01210495|Axitinib|axitinib|mesh-list
6130460|NCT01210495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6130461|NCT01210495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5537274|NCT04202406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5537275|NCT04202406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537276|NCT04202406|Antipyretics|antipyretics|mesh-ancestor
5537277|NCT04202406|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5537278|NCT04202406|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5537279|NCT04202406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5537280|NCT04202406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5537281|NCT04202406|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5537282|NCT04202406|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5537283|NCT04202406|Purinergic Agents|purinergic agents|mesh-ancestor
5537284|NCT04202406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5537285|NCT04202406|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5537286|NCT04202406|Narcotics|narcotics|mesh-ancestor
5537287|NCT04202406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5537288|NCT04202406|Antitussive Agents|antitussive agents|mesh-ancestor
5537289|NCT04202406|Respiratory System Agents|respiratory system agents|mesh-ancestor
5537290|NCT04202224|Acetaminophen|acetaminophen|mesh-list
5537291|NCT04202224|Ibuprofen|ibuprofen|mesh-list
6130462|NCT01210495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6130463|NCT01210495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6130464|NCT01210560|Tolvaptan|tolvaptan|mesh-list
6130465|NCT01210560|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6130466|NCT01210560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6130467|NCT01210560|Natriuretic Agents|natriuretic agents|mesh-ancestor
6130468|NCT01210560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130469|NCT01211145|Oxazolidinones|oxazolidinones|mesh-list
6130470|NCT01211145|Zolmitriptan|zolmitriptan|mesh-list
6130471|NCT01211145|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6130472|NCT01211145|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6130473|NCT01211145|Serotonin Agents|serotonin agents|mesh-ancestor
6130474|NCT01211145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6130475|NCT01211145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6130476|NCT01211145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130477|NCT01211145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6130478|NCT01211145|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6130479|NCT01211145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6130480|NCT01211197|Metformin|metformin|mesh-list
6130481|NCT01211197|Empagliflozin|empagliflozin|mesh-list
6130482|NCT01211197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6130483|NCT01211197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130484|NCT01211197|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6130485|NCT01211197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6130486|NCT01211483|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6130487|NCT01211483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6130488|NCT01211483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6130489|NCT01211483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6130490|NCT01211483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6130491|NCT01211522|Haloperidol|haloperidol|mesh-list
5537292|NCT04202224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5537293|NCT04202224|Analgesics|analgesics|mesh-ancestor
5537294|NCT04202224|Sensory System Agents|sensory system agents|mesh-ancestor
5537295|NCT04202224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6130492|NCT01211522|Haloperidol decanoate|haloperidol decanoate|mesh-list
6130493|NCT01211522|Ziprasidone|ziprasidone|mesh-list
6130494|NCT01211522|Antiemetics|antiemetics|mesh-ancestor
6130495|NCT01211522|Autonomic Agents|autonomic agents|mesh-ancestor
6130496|NCT01211522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6130497|NCT01211522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130498|NCT01211522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6130499|NCT01211522|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6130500|NCT01211522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6130501|NCT01211522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6130502|NCT01211522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5601970|NCT05022147|Sympathomimetics|sympathomimetics|mesh-ancestor
6130503|NCT01211522|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6130504|NCT01211522|Dopamine Agents|dopamine agents|mesh-ancestor
6130505|NCT01211522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6130506|NCT01211522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5537296|NCT04202224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537297|NCT04202224|Antipyretics|antipyretics|mesh-ancestor
5537298|NCT04202224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5537299|NCT04202224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5537300|NCT04202224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5537301|NCT04202224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5537302|NCT04202224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5537303|NCT04202224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5537304|NCT04201964|Tenecteplase|tenecteplase|mesh-list
5537305|NCT04201964|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5537306|NCT04201964|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5537307|NCT04201964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6130507|NCT01211522|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6130508|NCT01211522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6130509|NCT01211522|Serotonin Agents|serotonin agents|mesh-ancestor
6130510|NCT01211535|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6130511|NCT01211665|Methylprednisolone|methylprednisolone|mesh-list
6130512|NCT01211665|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6130513|NCT01211665|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6130514|NCT01211665|Prednisolone|prednisolone|mesh-list
6130515|NCT01211665|Prednisolone acetate|prednisolone acetate|mesh-list
6130516|NCT01211665|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6130517|NCT01211665|Prednisolone phosphate|prednisolone phosphate|mesh-list
6130518|NCT01211665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6130519|NCT01211665|Antiemetics|antiemetics|mesh-ancestor
6130520|NCT01211665|Autonomic Agents|autonomic agents|mesh-ancestor
6130521|NCT01211665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6130522|NCT01211665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130523|NCT01211665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6130524|NCT01211665|Glucocorticoids|glucocorticoids|mesh-ancestor
6130525|NCT01211665|Hormones|hormones|mesh-ancestor
6130526|NCT01211665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6130527|NCT01211665|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6130528|NCT01211665|Protective Agents|protective agents|mesh-ancestor
6130529|NCT01211665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6130530|NCT01211665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6130531|NCT01211730|Insulin|insulin|mesh-list
6130532|NCT01211730|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5537308|NCT04201951|Tranexamic Acid|tranexamic acid|mesh-list
5537309|NCT04201951|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5537310|NCT04201951|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6130533|NCT01211730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6130534|NCT01211730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130535|NCT01211769|Naltrexone|naltrexone|mesh-list
6130536|NCT01211769|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6130537|NCT01211769|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6130538|NCT01211769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130539|NCT01211769|Sensory System Agents|sensory system agents|mesh-ancestor
6130540|NCT01211769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6130541|NCT01211873|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
5537311|NCT04201951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5537312|NCT04201951|Hemostatics|hemostatics|mesh-ancestor
5537313|NCT04201951|Coagulants|coagulants|mesh-ancestor
5537314|NCT04202068|Ceftriaxone|ceftriaxone|mesh-list
5537315|NCT04202068|Sulbactam|sulbactam|mesh-list
6130542|NCT01211873|Chelating Agents|chelating agents|mesh-ancestor
6130543|NCT01211873|Sequestering Agents|sequestering agents|mesh-ancestor
6130544|NCT01211873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6130545|NCT01212094|Rituximab|rituximab|mesh-list
6130546|NCT01212094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6130547|NCT01212094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6130548|NCT01212094|Immunologic Factors|immunologic factors|mesh-ancestor
6130549|NCT01212094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130550|NCT01212094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6130551|NCT01212185|Oxytocin|oxytocin|mesh-list
6130552|NCT01212185|Oxytocics|oxytocics|mesh-ancestor
6130553|NCT01212185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6130554|NCT01212185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537316|NCT04202068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5537317|NCT04202068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6130555|NCT01212302|Aspirin|aspirin|mesh-list
6130556|NCT01212302|Clopidogrel|clopidogrel|mesh-list
6130557|NCT01212302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6130558|NCT01212302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6130559|NCT01212302|Analgesics|analgesics|mesh-ancestor
6130560|NCT01212302|Sensory System Agents|sensory system agents|mesh-ancestor
6130561|NCT01212302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6130562|NCT01212302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130563|NCT01212302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6130564|NCT01212302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6130565|NCT01212302|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6130566|NCT01212302|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6130567|NCT01212302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6130568|NCT01212302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6130569|NCT01212302|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6130570|NCT01212302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6130571|NCT01212302|Antipyretics|antipyretics|mesh-ancestor
6130572|NCT01212302|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6130573|NCT01212302|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6130574|NCT01212302|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5537318|NCT04202068|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5537319|NCT04202068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5537320|NCT04202068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5537321|NCT04201808|Tenofovir|tenofovir|mesh-list
5537322|NCT04201808|Antiviral Agents|antiviral agents|mesh-ancestor
5537323|NCT04201808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5537324|NCT04201808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5537325|NCT04201808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5537326|NCT04201808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5537327|NCT04201808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5537328|NCT04201808|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5537329|NCT04201808|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5537330|NCT04201873|Poly I-C|poly i-c|mesh-list
5537331|NCT04201873|Pembrolizumab|pembrolizumab|mesh-list
5537332|NCT04201873|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6130575|NCT01212302|Purinergic Agents|purinergic agents|mesh-ancestor
6130576|NCT01212302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6130577|NCT01212445|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
6130578|NCT01212445|Laxatives|laxatives|mesh-list
6130579|NCT01212445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6130580|NCT01212471|Bromfenac|bromfenac|mesh-list
6130581|NCT01212471|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6130582|NCT01212471|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6130583|NCT01212471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6130584|NCT01212471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6130585|NCT01212471|Analgesics|analgesics|mesh-ancestor
6130586|NCT01212471|Sensory System Agents|sensory system agents|mesh-ancestor
6130587|NCT01212471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6130588|NCT01212471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130589|NCT01212471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6130590|NCT01212471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6130591|NCT01212484|Carbidopa|carbidopa|mesh-list
6130592|NCT01212484|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6130593|NCT01212484|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6130594|NCT01212484|Dopamine Agents|dopamine agents|mesh-ancestor
6130595|NCT01212484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6130596|NCT01212484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6130597|NCT01212484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130598|NCT01212484|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5537333|NCT04201873|Vaccines|vaccines|mesh-list
5537334|NCT04201873|Poly ICLC|poly iclc|mesh-list
5537335|NCT04201873|Immunologic Factors|immunologic factors|mesh-ancestor
5537336|NCT04201873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130599|NCT01212484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6130600|NCT01212588|Mifepristone|mifepristone|mesh-list
6130601|NCT01212588|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6130602|NCT01212588|Abortifacient Agents|abortifacient agents|mesh-ancestor
6130603|NCT01212588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6130604|NCT01212588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130605|NCT01212588|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6130606|NCT01212588|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6130607|NCT01212588|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6130608|NCT01212588|Contraceptive Agents|contraceptive agents|mesh-ancestor
5537337|NCT04201873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5537338|NCT04201873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5537339|NCT04201873|Interferon Inducers|interferon inducers|mesh-ancestor
5537340|NCT04201873|Laxatives|laxatives|mesh-ancestor
5537341|NCT04201873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5537342|NCT04201873|Antiviral Agents|antiviral agents|mesh-ancestor
5537343|NCT04201873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5537344|NCT04201860|Hemostatics|hemostatics|mesh-list
5537345|NCT04201860|Coagulants|coagulants|mesh-ancestor
5537346|NCT04201990|Apatinib|apatinib|mesh-list
5537347|NCT04201990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5537348|NCT04201990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5537349|NCT04201990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5537350|NCT04201990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5537351|NCT04201665|Oxytocin|oxytocin|mesh-list
6130609|NCT01212588|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6130610|NCT01212588|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6130611|NCT01212588|Hormone Antagonists|hormone antagonists|mesh-ancestor
6130612|NCT01212588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6130613|NCT01212588|Luteolytic Agents|luteolytic agents|mesh-ancestor
6130614|NCT01212588|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6130615|NCT01212588|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5537352|NCT04201665|Carbetocin|carbetocin|mesh-list
5537353|NCT04201665|Oxytocics|oxytocics|mesh-ancestor
5537354|NCT04201665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5537355|NCT04201665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537356|NCT04201678|Anesthetics|anesthetics|mesh-list
5537357|NCT04201678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5537358|NCT04201678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537359|NCT04201769|Dexamethasone|dexamethasone|mesh-list
5537360|NCT04201769|Palonosetron|palonosetron|mesh-list
5537361|NCT04201769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5537362|NCT04201769|Antiemetics|antiemetics|mesh-ancestor
5537363|NCT04201769|Autonomic Agents|autonomic agents|mesh-ancestor
5537364|NCT04201769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5537365|NCT04201769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537366|NCT04201769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5537367|NCT04201769|Glucocorticoids|glucocorticoids|mesh-ancestor
5537368|NCT04201769|Hormones|hormones|mesh-ancestor
5537369|NCT04201769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5537370|NCT04201769|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5537371|NCT04201769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5537372|NCT04201769|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5537373|NCT04201769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6130616|NCT01212757|Thalidomide|thalidomide|mesh-list
6130617|NCT01212757|Apremilast|apremilast|mesh-list
6130618|NCT01212757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6130619|NCT01212757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6130620|NCT01212757|Analgesics|analgesics|mesh-ancestor
6130621|NCT01212757|Sensory System Agents|sensory system agents|mesh-ancestor
6130622|NCT01212757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6130623|NCT01212757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130624|NCT01212757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6130625|NCT01212757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6130626|NCT01212757|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6130627|NCT01212757|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6130628|NCT01212757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6130629|NCT01212757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6130630|NCT01212757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6130631|NCT01212757|Immunologic Factors|immunologic factors|mesh-ancestor
6130632|NCT01212757|Leprostatic Agents|leprostatic agents|mesh-ancestor
6130633|NCT01212757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6130634|NCT01212757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6130635|NCT01212757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6130636|NCT01212757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6130637|NCT01212757|Growth Substances|growth substances|mesh-ancestor
6130638|NCT01212757|Growth Inhibitors|growth inhibitors|mesh-ancestor
6130639|NCT01212757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6130640|NCT01212770|Thalidomide|thalidomide|mesh-list
6130641|NCT01212770|Apremilast|apremilast|mesh-list
6130642|NCT01212770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6130643|NCT01212770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6130644|NCT01212770|Analgesics|analgesics|mesh-ancestor
5537374|NCT04201769|Serotonin Agents|serotonin agents|mesh-ancestor
5537375|NCT04201769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5537376|NCT04201769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601971|NCT05022147|Autonomic Agents|autonomic agents|mesh-ancestor
6130645|NCT01212770|Sensory System Agents|sensory system agents|mesh-ancestor
6130646|NCT01212770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6130647|NCT01212770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130648|NCT01212770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6130649|NCT01212770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6130650|NCT01212770|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6130651|NCT01212770|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6130652|NCT01212770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6130653|NCT01212770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6130654|NCT01212770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6130655|NCT01212770|Immunologic Factors|immunologic factors|mesh-ancestor
6130656|NCT01212770|Leprostatic Agents|leprostatic agents|mesh-ancestor
6130657|NCT01212770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6130658|NCT01212770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6130659|NCT01212770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6130660|NCT01212770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6130661|NCT01212770|Growth Substances|growth substances|mesh-ancestor
6130662|NCT01212770|Growth Inhibitors|growth inhibitors|mesh-ancestor
6130663|NCT01212770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6130664|NCT01212874|Nitroglycerin|nitroglycerin|mesh-list
6130665|NCT01212874|Esmolol|esmolol|mesh-list
6130666|NCT01212874|Vasodilator Agents|vasodilator agents|mesh-ancestor
6130667|NCT01212874|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6130668|NCT01212874|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6130669|NCT01212874|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6130670|NCT01212874|Adrenergic Agents|adrenergic agents|mesh-ancestor
6130671|NCT01212874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6130672|NCT01212874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6130673|NCT01212874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130674|NCT01212900|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
6130675|NCT01212900|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6130676|NCT01212900|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6130677|NCT01212900|Antimetabolites|antimetabolites|mesh-ancestor
6130678|NCT01212900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6130679|NCT01212900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6130680|NCT01212900|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6130681|NCT01212952|Dexamethasone|dexamethasone|mesh-list
6130682|NCT01212952|Bortezomib|bortezomib|mesh-list
6130683|NCT01212952|Pomalidomide|pomalidomide|mesh-list
6130684|NCT01212952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6130685|NCT01212952|Antiemetics|antiemetics|mesh-ancestor
6130686|NCT01212952|Autonomic Agents|autonomic agents|mesh-ancestor
6130687|NCT01212952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6130688|NCT01212952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130689|NCT01212952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6130690|NCT01212952|Glucocorticoids|glucocorticoids|mesh-ancestor
6130691|NCT01212952|Hormones|hormones|mesh-ancestor
6130692|NCT01212952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6130693|NCT01212952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6130694|NCT01212952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6130695|NCT01212952|Immunologic Factors|immunologic factors|mesh-ancestor
6130696|NCT01212952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6130697|NCT01212952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6130698|NCT01212952|Growth Substances|growth substances|mesh-ancestor
6130699|NCT01212952|Growth Inhibitors|growth inhibitors|mesh-ancestor
6130700|NCT01213043|Protease Inhibitors|protease inhibitors|mesh-list
6130701|NCT01213043|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
6130702|NCT01213043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6130703|NCT01213043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6130704|NCT01213043|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6130705|NCT01213043|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6130706|NCT01213082|Bevacizumab|bevacizumab|mesh-list
6130707|NCT01213082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6130708|NCT01213082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6130709|NCT01213082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6130710|NCT01213082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6130711|NCT01213082|Growth Substances|growth substances|mesh-ancestor
6130712|NCT01213082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130713|NCT01213082|Growth Inhibitors|growth inhibitors|mesh-ancestor
6130714|NCT01213173|Metoprolol|metoprolol|mesh-list
6130715|NCT01213173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6130716|NCT01213173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6130717|NCT01213173|Sympatholytics|sympatholytics|mesh-ancestor
6130718|NCT01213173|Autonomic Agents|autonomic agents|mesh-ancestor
6130719|NCT01213173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6130720|NCT01213173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130721|NCT01213173|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6130722|NCT01213173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6130723|NCT01213173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6130724|NCT01213173|Adrenergic Agents|adrenergic agents|mesh-ancestor
6130725|NCT01213173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6130726|NCT01213173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6130727|NCT01213199|Adapalene|adapalene|mesh-list
6130728|NCT01213199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6130729|NCT01213199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6130730|NCT01213199|Analgesics|analgesics|mesh-ancestor
6130731|NCT01213199|Sensory System Agents|sensory system agents|mesh-ancestor
6130732|NCT01213199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6130733|NCT01213199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130734|NCT01213199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6130735|NCT01213199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5537377|NCT04201756|Afatinib|afatinib|mesh-list
5537378|NCT04201756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5537379|NCT04201756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5537380|NCT04201756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5537381|NCT04201756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5537382|NCT04201561|Selenious Acid|selenious acid|mesh-list
5537383|NCT04201561|Sodium Selenite|sodium selenite|mesh-list
5537384|NCT04201561|Paclitaxel|paclitaxel|mesh-list
5537385|NCT04201561|Carboplatin|carboplatin|mesh-list
5537386|NCT04201561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5537387|NCT04201561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5537388|NCT04201561|Tubulin Modulators|tubulin modulators|mesh-ancestor
5537389|NCT04201561|Antimitotic Agents|antimitotic agents|mesh-ancestor
6130736|NCT01213199|Dermatologic Agents|dermatologic agents|mesh-ancestor
6130737|NCT01213264|Anesthetics|anesthetics|mesh-list
6130738|NCT01213264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6130739|NCT01213264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130740|NCT01213316|Raltegravir Potassium|raltegravir potassium|mesh-list
6130741|NCT01213316|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6130742|NCT01213316|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6130743|NCT01213316|Antiviral Agents|antiviral agents|mesh-ancestor
6130744|NCT01213316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6130745|NCT01213316|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6130746|NCT01213316|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6130747|NCT01213316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6130748|NCT01213316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205036|NCT02080637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6205037|NCT02080780|Clarithromycin|clarithromycin|mesh-list
6205038|NCT02080780|Diltiazem|diltiazem|mesh-list
6205039|NCT02080780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6205040|NCT02080780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6205041|NCT02080780|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6205042|NCT02080780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6205043|NCT02080780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205044|NCT02080780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6205045|NCT02080780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6205046|NCT02080780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6205047|NCT02080780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6205048|NCT02080780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5537390|NCT04201561|Mitosis Modulators|mitosis modulators|mesh-ancestor
5537391|NCT04201561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5537392|NCT04201561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537393|NCT04201561|Trace Elements|trace elements|mesh-ancestor
5537394|NCT04201561|Micronutrients|micronutrients|mesh-ancestor
5537395|NCT04201457|Hydroxychloroquine|hydroxychloroquine|mesh-list
5537396|NCT04201457|Trametinib|trametinib|mesh-list
5537397|NCT04201457|Dabrafenib|dabrafenib|mesh-list
5537398|NCT04201457|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
5537399|NCT04201457|Antimalarials|antimalarials|mesh-ancestor
5537400|NCT04201457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5537401|NCT04201457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5537402|NCT04201457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5537403|NCT04201457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5537404|NCT04201457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5537405|NCT04201457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5537406|NCT04201457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5537407|NCT04201457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5537408|NCT04201457|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
5537409|NCT04201457|Protective Agents|protective agents|mesh-ancestor
5537410|NCT04201457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130749|NCT01213524|Nicotine|nicotine|mesh-list
6130750|NCT01213524|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6130751|NCT01213524|Autonomic Agents|autonomic agents|mesh-ancestor
6130752|NCT01213524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6130753|NCT01213524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130754|NCT01213524|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6130755|NCT01213524|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6130756|NCT01213524|Cholinergic Agents|cholinergic agents|mesh-ancestor
6130757|NCT01213524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6130758|NCT01213524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6130759|NCT01213576|Ivermectin|ivermectin|mesh-list
6130760|NCT01213576|Albendazole|albendazole|mesh-list
6130761|NCT01213576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5537411|NCT04201457|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5537412|NCT04201457|Antioxidants|antioxidants|mesh-ancestor
5537413|NCT04201652|Anesthetics|anesthetics|mesh-list
5537414|NCT04201652|Anesthetics, Local|anesthetics, local|mesh-list
5537415|NCT04201652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5537416|NCT04201652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537417|NCT04201652|Sensory System Agents|sensory system agents|mesh-ancestor
5537418|NCT04201652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5537419|NCT04201054|Fluconazole|fluconazole|mesh-list
5537420|NCT04201054|Antifungal Agents|antifungal agents|mesh-ancestor
5537421|NCT04201054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5537422|NCT04201054|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5537423|NCT04201054|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6130762|NCT01213576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6130763|NCT01213576|Anthelmintics|anthelmintics|mesh-ancestor
6130764|NCT01213576|Anticestodal Agents|anticestodal agents|mesh-ancestor
6130765|NCT01213576|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6130766|NCT01213576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6130767|NCT01213576|Tubulin Modulators|tubulin modulators|mesh-ancestor
6130768|NCT01213576|Antimitotic Agents|antimitotic agents|mesh-ancestor
6130769|NCT01213576|Mitosis Modulators|mitosis modulators|mesh-ancestor
6130770|NCT01213576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6130771|NCT01213576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6130772|NCT01213836|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6130773|NCT01213836|Antidepressive Agents|antidepressive agents|mesh-ancestor
6130774|NCT01213836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6130775|NCT01213836|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6130776|NCT01213836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6130777|NCT01213836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6130778|NCT01213836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130779|NCT01213966|Artefenomel|artefenomel|mesh-list
6130780|NCT01213966|Antimalarials|antimalarials|mesh-ancestor
6130781|NCT01213966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6130782|NCT01213966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6130783|NCT01213966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6130784|NCT01214044|Dexetimide|dexetimide|mesh-list
6130785|NCT01214044|Citalopram|citalopram|mesh-list
6130786|NCT01214044|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6130787|NCT01214044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6130788|NCT01214044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6130789|NCT01214044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5537424|NCT04201054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5537425|NCT04201054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5537426|NCT04201054|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5537427|NCT04201054|Hormone Antagonists|hormone antagonists|mesh-ancestor
5537428|NCT04201054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6130790|NCT01214044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6130791|NCT01214044|Serotonin Agents|serotonin agents|mesh-ancestor
6130792|NCT01214044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130793|NCT01214044|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6130794|NCT01214044|Antidepressive Agents|antidepressive agents|mesh-ancestor
6130795|NCT01214044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6130796|NCT01214044|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6130797|NCT01214044|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6130798|NCT01214044|Parasympatholytics|parasympatholytics|mesh-ancestor
6130799|NCT01214044|Autonomic Agents|autonomic agents|mesh-ancestor
6130800|NCT01214044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6130801|NCT01214044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6130802|NCT01214044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6130803|NCT01214044|Cholinergic Agents|cholinergic agents|mesh-ancestor
6130804|NCT01214057|Remifentanil|remifentanil|mesh-list
6130805|NCT01214057|Propofol|propofol|mesh-list
6130806|NCT01214057|Sevoflurane|sevoflurane|mesh-list
6130807|NCT01214057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5537429|NCT04201054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537430|NCT04201054|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5537431|NCT04201054|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5537432|NCT04201145|Pembrolizumab|pembrolizumab|mesh-list
5537433|NCT04201145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5537434|NCT04201145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5537435|NCT04201249|Piroxicam|piroxicam|mesh-list
5537436|NCT04201249|Lidocaine|lidocaine|mesh-list
6130808|NCT01214057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6130809|NCT01214057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130810|NCT01214057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6130811|NCT01214057|Anesthetics, General|anesthetics, general|mesh-ancestor
6130812|NCT01214057|Anesthetics|anesthetics|mesh-ancestor
6130813|NCT01214057|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6130814|NCT01214057|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6130815|NCT01214057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6130816|NCT01214057|Narcotics|narcotics|mesh-ancestor
6130817|NCT01214057|Analgesics|analgesics|mesh-ancestor
6130818|NCT01214057|Sensory System Agents|sensory system agents|mesh-ancestor
6130819|NCT01214057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5537437|NCT04201249|Anesthetics, Local|anesthetics, local|mesh-ancestor
5537438|NCT04201249|Anesthetics|anesthetics|mesh-ancestor
5537439|NCT04201249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5537440|NCT04201249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537441|NCT04201249|Sensory System Agents|sensory system agents|mesh-ancestor
5537442|NCT04201249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5537443|NCT04201249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5537444|NCT04201249|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5537445|NCT04201249|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5537446|NCT04201249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5537447|NCT04201249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5537448|NCT04201249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5537449|NCT04201249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5537450|NCT04201249|Analgesics|analgesics|mesh-ancestor
5537451|NCT04201249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5537452|NCT04201249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5537453|NCT04201249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5537454|NCT04201249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5537455|NCT04200885|Dexamethasone|dexamethasone|mesh-list
5537456|NCT04200885|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
5537457|NCT04200885|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
5537458|NCT04200885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5537459|NCT04200885|Antiemetics|antiemetics|mesh-ancestor
5537460|NCT04200885|Autonomic Agents|autonomic agents|mesh-ancestor
5537461|NCT04200885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5537462|NCT04200885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537463|NCT04200885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5537464|NCT04200885|Glucocorticoids|glucocorticoids|mesh-ancestor
5537465|NCT04200885|Hormones|hormones|mesh-ancestor
5537466|NCT04200885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5537467|NCT04200885|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5537468|NCT04200885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6130820|NCT01214083|Acetylcysteine|acetylcysteine|mesh-list
6130821|NCT01214083|Naltrexone|naltrexone|mesh-list
6130822|NCT01214083|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6130823|NCT01214083|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6130824|NCT01214083|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6130825|NCT01214083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130826|NCT01214083|Sensory System Agents|sensory system agents|mesh-ancestor
6130827|NCT01214083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6130828|NCT01214083|Antiviral Agents|antiviral agents|mesh-ancestor
6130829|NCT01214083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6130830|NCT01214083|Expectorants|expectorants|mesh-ancestor
6130831|NCT01214083|Respiratory System Agents|respiratory system agents|mesh-ancestor
6130832|NCT01214083|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6130833|NCT01214083|Antioxidants|antioxidants|mesh-ancestor
6130834|NCT01214083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6130835|NCT01214083|Protective Agents|protective agents|mesh-ancestor
6130836|NCT01214083|Antidotes|antidotes|mesh-ancestor
6130837|NCT01214109|Pramipexole|pramipexole|mesh-list
6130838|NCT01214109|Antioxidants|antioxidants|mesh-ancestor
6130839|NCT01214109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6130840|NCT01214109|Protective Agents|protective agents|mesh-ancestor
6130841|NCT01214109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130842|NCT01214109|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6130843|NCT01214109|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6130844|NCT01214109|Dopamine Agonists|dopamine agonists|mesh-ancestor
6130845|NCT01214109|Dopamine Agents|dopamine agents|mesh-ancestor
6130846|NCT01214109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6130847|NCT01214161|Lidocaine|lidocaine|mesh-list
6130848|NCT01214161|Anesthetics, Local|anesthetics, local|mesh-ancestor
6130849|NCT01214161|Anesthetics|anesthetics|mesh-ancestor
6130850|NCT01214161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6130851|NCT01214161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130852|NCT01214161|Sensory System Agents|sensory system agents|mesh-ancestor
6130853|NCT01214161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6130854|NCT01214161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6130855|NCT01214161|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6130856|NCT01214161|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6130857|NCT01214161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6130858|NCT01214161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6130859|NCT01214187|Carbon Monoxide|carbon monoxide|mesh-list
6130860|NCT01214187|Antimetabolites|antimetabolites|mesh-ancestor
6130861|NCT01214187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6130862|NCT01214187|Gasotransmitters|gasotransmitters|mesh-ancestor
6130863|NCT01214187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6130864|NCT01214187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130865|NCT01214239|Linagliptin|linagliptin|mesh-list
6130866|NCT01214239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6466376|NCT00478764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6466377|NCT00478764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466378|NCT00478816|Vaccines|vaccines|mesh-list
5537469|NCT04200885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5537470|NCT04200885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5537471|NCT04200885|Analgesics|analgesics|mesh-ancestor
5537472|NCT04200885|Sensory System Agents|sensory system agents|mesh-ancestor
5537473|NCT04200885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5537474|NCT04200833|Golimumab|golimumab|mesh-list
5537475|NCT04200833|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
5537476|NCT04200833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5537477|NCT04200833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5537478|NCT04200833|Immunologic Factors|immunologic factors|mesh-ancestor
5537479|NCT04200833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537480|NCT04200599|Oxytocin|oxytocin|mesh-list
5537481|NCT04200599|Oxytocics|oxytocics|mesh-ancestor
5537482|NCT04200599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5537483|NCT04200599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537484|NCT04200651|Dexamethasone|dexamethasone|mesh-list
5537485|NCT04200651|Prednisolone|prednisolone|mesh-list
5537486|NCT04200651|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5537487|NCT04200651|Methylprednisolone|methylprednisolone|mesh-list
5537488|NCT04200651|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6466379|NCT00478816|Immunologic Factors|immunologic factors|mesh-ancestor
6130867|NCT01214239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130868|NCT01214239|Incretins|incretins|mesh-ancestor
6130869|NCT01214239|Hormones|hormones|mesh-ancestor
6130870|NCT01214239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6130871|NCT01214239|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6130872|NCT01214239|Protease Inhibitors|protease inhibitors|mesh-ancestor
6130873|NCT01214239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6130874|NCT01214239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6130875|NCT01214317|Mitoxantrone|mitoxantrone|mesh-list
6130876|NCT01214317|Analgesics|analgesics|mesh-ancestor
6130877|NCT01214317|Sensory System Agents|sensory system agents|mesh-ancestor
6130878|NCT01214317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6130879|NCT01214317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130880|NCT01214317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6130881|NCT01214317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6130882|NCT01214317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6130883|NCT01214317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6130884|NCT01214317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466380|NCT00478816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537489|NCT04200651|Prednisolone acetate|prednisolone acetate|mesh-list
6130885|NCT01214356|Vitamin D|vitamin d|mesh-list
6130886|NCT01214356|Ergocalciferols|ergocalciferols|mesh-list
6130887|NCT01214356|Cholecalciferol|cholecalciferol|mesh-list
6130888|NCT01214356|Vitamins|vitamins|mesh-list
5537490|NCT04200651|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5537491|NCT04200651|Prednisolone phosphate|prednisolone phosphate|mesh-list
5537492|NCT04200651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5537493|NCT04200651|Antiemetics|antiemetics|mesh-ancestor
5537494|NCT04200651|Autonomic Agents|autonomic agents|mesh-ancestor
5537495|NCT04200651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5537496|NCT04200651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537497|NCT04200651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5537498|NCT04200651|Glucocorticoids|glucocorticoids|mesh-ancestor
6130889|NCT01214356|Micronutrients|micronutrients|mesh-ancestor
6130890|NCT01214356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130891|NCT01214356|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6130892|NCT01214356|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6130893|NCT01214395|Tea Tree Oil|tea tree oil|mesh-list
6130894|NCT01214395|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6130895|NCT01214395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6130896|NCT01214421|Tolvaptan|tolvaptan|mesh-list
6130897|NCT01214421|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6130898|NCT01214421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5537499|NCT04200651|Hormones|hormones|mesh-ancestor
5537500|NCT04200651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5537501|NCT04200651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5537502|NCT04200651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5537503|NCT04200651|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6130899|NCT01214421|Natriuretic Agents|natriuretic agents|mesh-ancestor
6130900|NCT01214421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130901|NCT01214434|Emollients|emollients|mesh-list
6130902|NCT01214434|Dermatologic Agents|dermatologic agents|mesh-ancestor
6130903|NCT01214616|Vinorelbine|vinorelbine|mesh-list
5537504|NCT04200651|Protective Agents|protective agents|mesh-ancestor
5537505|NCT04200417|Mitomycins|mitomycins|mesh-list
5537506|NCT04200417|Mitomycin|mitomycin|mesh-list
5537507|NCT04200417|Ethiodized Oil|ethiodized oil|mesh-list
6130904|NCT01214616|Afatinib|afatinib|mesh-list
6130905|NCT01214616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6130906|NCT01214616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6130907|NCT01214616|Tubulin Modulators|tubulin modulators|mesh-ancestor
6130908|NCT01214616|Antimitotic Agents|antimitotic agents|mesh-ancestor
6130909|NCT01214616|Mitosis Modulators|mitosis modulators|mesh-ancestor
6130910|NCT01214616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6130911|NCT01214616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6130912|NCT01214616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6130913|NCT01214668|Doxorubicin|doxorubicin|mesh-list
6130914|NCT01214668|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6130915|NCT01214668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6130916|NCT01214668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6130917|NCT01214668|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5537508|NCT04200417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5537509|NCT04200417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5537510|NCT04200417|Alkylating Agents|alkylating agents|mesh-ancestor
5537511|NCT04200417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5537512|NCT04200417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5537513|NCT04200417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6130918|NCT01214668|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6130919|NCT01214668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6130920|NCT01214668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6130921|NCT01214720|Bevacizumab|bevacizumab|mesh-list
6130922|NCT01214720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6130923|NCT01214720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6130924|NCT01214720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6130925|NCT01214720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6130926|NCT01214720|Growth Substances|growth substances|mesh-ancestor
6130927|NCT01214720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130928|NCT01214720|Growth Inhibitors|growth inhibitors|mesh-ancestor
6130929|NCT01214759|Tenofovir|tenofovir|mesh-list
6130930|NCT01214759|Emtricitabine|emtricitabine|mesh-list
6130931|NCT01214759|Raltegravir Potassium|raltegravir potassium|mesh-list
6130932|NCT01214759|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6130933|NCT01214759|Antiviral Agents|antiviral agents|mesh-ancestor
6130934|NCT01214759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6466381|NCT00478855|Piperacillin|piperacillin|mesh-list
5537514|NCT04200586|Dapagliflozin|dapagliflozin|mesh-list
6130935|NCT01214759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6130936|NCT01214759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6130937|NCT01214759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6130938|NCT01214759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6130939|NCT01214759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6130940|NCT01214759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6130941|NCT01214759|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6130942|NCT01214759|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6130943|NCT01214850|Vaccines|vaccines|mesh-list
6130944|NCT01214850|Immunologic Factors|immunologic factors|mesh-ancestor
6130945|NCT01214850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130946|NCT01214915|Anagrelide|anagrelide|mesh-list
6130947|NCT01214915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6130948|NCT01214915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6130949|NCT01214915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6130950|NCT01214915|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6130951|NCT01215032|Metformin|metformin|mesh-list
6130952|NCT01215032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6130953|NCT01215032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130954|NCT01215097|Linagliptin|linagliptin|mesh-list
6130955|NCT01215097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6130956|NCT01215097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130957|NCT01215097|Incretins|incretins|mesh-ancestor
6130958|NCT01215097|Hormones|hormones|mesh-ancestor
6130959|NCT01215097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6130960|NCT01215097|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6130961|NCT01215097|Protease Inhibitors|protease inhibitors|mesh-ancestor
6130962|NCT01215097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6130963|NCT01215097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6130964|NCT01215110|Bedaquiline|bedaquiline|mesh-list
6130965|NCT01215110|Antitubercular Agents|antitubercular agents|mesh-ancestor
6130966|NCT01215110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6130967|NCT01215110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6130968|NCT01215123|Bevacizumab|bevacizumab|mesh-list
6130969|NCT01215123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6130970|NCT01215123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6130971|NCT01215123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6130972|NCT01215123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6130973|NCT01215123|Growth Substances|growth substances|mesh-ancestor
6130974|NCT01215123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130975|NCT01215123|Growth Inhibitors|growth inhibitors|mesh-ancestor
6130976|NCT01215175|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6130977|NCT01215175|Immunologic Factors|immunologic factors|mesh-ancestor
6130978|NCT01215175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537515|NCT04200586|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5537516|NCT04200586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5537517|NCT04200586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5537518|NCT04200586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537519|NCT04200235|Dexmedetomidine|dexmedetomidine|mesh-list
5537520|NCT04200235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6130979|NCT01215188|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6130980|NCT01215188|Immunologic Factors|immunologic factors|mesh-ancestor
6130981|NCT01215188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130982|NCT01215227|Rasagiline|rasagiline|mesh-list
6130983|NCT01215227|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6130984|NCT01215227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6130985|NCT01215227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6130986|NCT01215227|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6130987|NCT01215227|Protective Agents|protective agents|mesh-ancestor
6130988|NCT01215227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6130989|NCT01215253|Ranolazine|ranolazine|mesh-list
6130990|NCT01215253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6130991|NCT01215253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6130992|NCT01215253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6130993|NCT01215292|Ketoconazole|ketoconazole|mesh-list
6130994|NCT01215292|Anastrozole|anastrozole|mesh-list
6130995|NCT01215292|Testosterone|testosterone|mesh-list
6130996|NCT01215292|Dutasteride|dutasteride|mesh-list
6130997|NCT01215292|Acyline|acyline|mesh-list
6130998|NCT01215292|Androgens|androgens|mesh-ancestor
6130999|NCT01215292|Hormones|hormones|mesh-ancestor
6131000|NCT01215292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6131001|NCT01215292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131002|NCT01215292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6131003|NCT01215292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6131004|NCT01215292|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6131005|NCT01215292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6131006|NCT01215292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6131007|NCT01215292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131008|NCT01215292|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6131009|NCT01215292|Hormone Antagonists|hormone antagonists|mesh-ancestor
6131010|NCT01215292|Antifungal Agents|antifungal agents|mesh-ancestor
6131011|NCT01215292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6131012|NCT01215292|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6131013|NCT01215292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6131014|NCT01215292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6131015|NCT01215292|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6131016|NCT01215318|Silicon|silicon|mesh-list
6131017|NCT01215318|Trace Elements|trace elements|mesh-ancestor
6131018|NCT01215318|Micronutrients|micronutrients|mesh-ancestor
6131019|NCT01215318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131020|NCT01215344|Diphosphonates|diphosphonates|mesh-list
6131021|NCT01215344|Dexamethasone|dexamethasone|mesh-list
6131022|NCT01215344|Dexamethasone acetate|dexamethasone acetate|mesh-list
6131023|NCT01215344|Doxorubicin|doxorubicin|mesh-list
6131024|NCT01215344|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6131025|NCT01215344|Lenalidomide|lenalidomide|mesh-list
6131026|NCT01215344|Bortezomib|bortezomib|mesh-list
6131027|NCT01215344|BB 1101|bb 1101|mesh-list
6131028|NCT01215344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6131029|NCT01215344|Antiemetics|antiemetics|mesh-ancestor
6131030|NCT01215344|Autonomic Agents|autonomic agents|mesh-ancestor
6131031|NCT01215344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6131032|NCT01215344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131033|NCT01215344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6131034|NCT01215344|Glucocorticoids|glucocorticoids|mesh-ancestor
6131035|NCT01215344|Hormones|hormones|mesh-ancestor
6131036|NCT01215344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6131037|NCT01215344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6131038|NCT01215344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6131039|NCT01215344|Protease Inhibitors|protease inhibitors|mesh-ancestor
6131040|NCT01215344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6131041|NCT01215344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131042|NCT01215344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6131043|NCT01215344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6131044|NCT01215344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6131045|NCT01215344|Immunologic Factors|immunologic factors|mesh-ancestor
6131046|NCT01215344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6131047|NCT01215344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6131048|NCT01215344|Growth Substances|growth substances|mesh-ancestor
6131049|NCT01215344|Growth Inhibitors|growth inhibitors|mesh-ancestor
6131050|NCT01215344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6131051|NCT01215357|Ecopipam|ecopipam|mesh-list
6131052|NCT01215357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6131053|NCT01215357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6131054|NCT01215357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6131055|NCT01215357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131056|NCT01215357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6131057|NCT01215357|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6131058|NCT01215357|Dopamine Agents|dopamine agents|mesh-ancestor
6131059|NCT01215357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5537521|NCT04200235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5537522|NCT04200235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537523|NCT04200235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5537524|NCT04200235|Analgesics|analgesics|mesh-ancestor
5537525|NCT04200235|Sensory System Agents|sensory system agents|mesh-ancestor
5537526|NCT04200235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5537527|NCT04200235|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5537528|NCT04200235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5537529|NCT04200235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5537530|NCT04200235|Adrenergic Agents|adrenergic agents|mesh-ancestor
5537531|NCT04200235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5537532|NCT04200235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5537533|NCT04200092|Granisetron|granisetron|mesh-list
6131060|NCT01215357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131061|NCT01215435|Insulin|insulin|mesh-list
6131062|NCT01215435|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6131063|NCT01215435|Insulin Aspart|insulin aspart|mesh-list
6131064|NCT01215435|Insulin, Long-Acting|insulin, long-acting|mesh-list
6131065|NCT01215435|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6131066|NCT01215435|Biphasic Insulins|biphasic insulins|mesh-list
6131067|NCT01215435|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
5537534|NCT04200092|Antiemetics|antiemetics|mesh-ancestor
5537535|NCT04200092|Autonomic Agents|autonomic agents|mesh-ancestor
5537536|NCT04200092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5537537|NCT04200092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537538|NCT04200092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5537539|NCT04200092|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5537540|NCT04200092|Serotonin Agents|serotonin agents|mesh-ancestor
5537541|NCT04200092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5537542|NCT04200092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5537543|NCT04200222|Vanadium|vanadium|mesh-list
5537544|NCT04200222|Trace Elements|trace elements|mesh-ancestor
5537545|NCT04200222|Micronutrients|micronutrients|mesh-ancestor
6131068|NCT01215435|Insulin, Isophane|insulin, isophane|mesh-list
6131069|NCT01215435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6131070|NCT01215435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537546|NCT04200222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131071|NCT01215643|Ribavirin|ribavirin|mesh-list
6131072|NCT01215643|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6131073|NCT01215643|Antimetabolites|antimetabolites|mesh-ancestor
6131074|NCT01215643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131075|NCT01215643|Antiviral Agents|antiviral agents|mesh-ancestor
6131076|NCT01215643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5537547|NCT04200040|Dacarbazine|dacarbazine|mesh-list
5537548|NCT04200040|Molgramostim|molgramostim|mesh-list
5537549|NCT04200040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6131077|NCT01215721|Solifenacin Succinate|solifenacin succinate|mesh-list
6131078|NCT01215721|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6131079|NCT01215721|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6131080|NCT01215721|Cholinergic Agents|cholinergic agents|mesh-ancestor
6131081|NCT01215721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6131082|NCT01215721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131083|NCT01215721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131084|NCT01215721|Urological Agents|urological agents|mesh-ancestor
6131085|NCT01215734|Vaccines|vaccines|mesh-list
6131086|NCT01215734|Immunologic Factors|immunologic factors|mesh-ancestor
6131087|NCT01215734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131088|NCT01215786|Timolol|timolol|mesh-list
5537550|NCT04200040|Alkylating Agents|alkylating agents|mesh-ancestor
5537551|NCT04200040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5537552|NCT04200040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5601972|NCT05022147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5601973|NCT05022147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601974|NCT05022147|Dopamine Agents|dopamine agents|mesh-ancestor
5601975|NCT05022147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5601976|NCT05022147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601977|NCT05022147|Protective Agents|protective agents|mesh-ancestor
5601978|NCT05005559|Myeloma Proteins|myeloma proteins|mesh-list
5601979|NCT05005559|Paraproteins|paraproteins|mesh-list
5601980|NCT05005559|Immunologic Factors|immunologic factors|mesh-ancestor
5601981|NCT05005559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5601982|NCT05003037|Carboplatin|carboplatin|mesh-list
5601983|NCT05003037|Pemetrexed|pemetrexed|mesh-list
5601984|NCT05003037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5601985|NCT05003037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5601986|NCT05003037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601987|NCT05003037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6131089|NCT01215786|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6131090|NCT01215786|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6131091|NCT01215786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6131092|NCT01215786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6131093|NCT01215786|Adrenergic Agents|adrenergic agents|mesh-ancestor
6131094|NCT01215786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6131095|NCT01215786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131096|NCT01215786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131097|NCT01215786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6131098|NCT01215786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6131099|NCT01215851|Moxifloxacin|moxifloxacin|mesh-list
6131100|NCT01215851|Pyrazinamide|pyrazinamide|mesh-list
6131101|NCT01215851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6131102|NCT01215851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6131103|NCT01215851|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6131104|NCT01215851|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6131105|NCT01215851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6131106|NCT01215851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131107|NCT01215851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6131108|NCT01215851|Antitubercular Agents|antitubercular agents|mesh-ancestor
6131109|NCT01215916|Pemetrexed|pemetrexed|mesh-list
6131110|NCT01215916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6131111|NCT01215916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6131112|NCT01215916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131113|NCT01215916|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6131114|NCT01215916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6131115|NCT01215929|Dextroamphetamine|dextroamphetamine|mesh-list
6131116|NCT01215929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6131117|NCT01215929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131118|NCT01215929|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6131119|NCT01215929|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6131120|NCT01215929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6131121|NCT01215929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131122|NCT01215929|Dopamine Agents|dopamine agents|mesh-ancestor
6131123|NCT01215929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6131124|NCT01215955|Insulin Lispro|insulin lispro|mesh-list
6131125|NCT01215955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6131126|NCT01215955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131127|NCT01215968|Dulaglutide|dulaglutide|mesh-list
6131128|NCT01215968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6131129|NCT01215968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131130|NCT01215981|Vaccines|vaccines|mesh-list
6131131|NCT01215981|Immunologic Factors|immunologic factors|mesh-ancestor
6131132|NCT01215981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131133|NCT01216072|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6131134|NCT01216072|Interferon beta-1b|interferon beta-1b|mesh-list
6131135|NCT01216072|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5537553|NCT04199819|Entecavir|entecavir|mesh-list
5537554|NCT04199819|Antiviral Agents|antiviral agents|mesh-ancestor
5537555|NCT04199819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5537556|NCT04199494|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5537557|NCT04199494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6131136|NCT01216072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131137|NCT01216072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6131138|NCT01216072|Immunologic Factors|immunologic factors|mesh-ancestor
6131139|NCT01216072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131140|NCT01216072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6131141|NCT01216163|Acetaminophen|acetaminophen|mesh-list
6131142|NCT01216163|Ibuprofen|ibuprofen|mesh-list
6131143|NCT01216163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6131144|NCT01216163|Analgesics|analgesics|mesh-ancestor
6131145|NCT01216163|Sensory System Agents|sensory system agents|mesh-ancestor
6131146|NCT01216163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6131147|NCT01216163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131148|NCT01216163|Antipyretics|antipyretics|mesh-ancestor
6131149|NCT01216163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6131150|NCT01216163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6131151|NCT01216163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6131152|NCT01216163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6131153|NCT01216163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6131154|NCT01216163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131155|NCT01216176|Anastrozole|anastrozole|mesh-list
6131156|NCT01216176|Saracatinib|saracatinib|mesh-list
6131157|NCT01216176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6131158|NCT01216176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6131159|NCT01216176|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6131160|NCT01216176|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6131161|NCT01216176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5537558|NCT04199624|Ascorbic Acid|ascorbic acid|mesh-list
5537559|NCT04199624|Omeprazole|omeprazole|mesh-list
5537560|NCT04199624|Vitamins|vitamins|mesh-ancestor
5537561|NCT04199624|Micronutrients|micronutrients|mesh-ancestor
5537562|NCT04199624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537563|NCT04199624|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5537564|NCT04199624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5537565|NCT04199624|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5537566|NCT04199624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5537567|NCT04199624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5537568|NCT04199624|Antioxidants|antioxidants|mesh-ancestor
5537569|NCT04199624|Protective Agents|protective agents|mesh-ancestor
5537570|NCT04199364|Poractant alfa|poractant alfa|mesh-list
5537571|NCT04199364|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
5537572|NCT04199364|Respiratory System Agents|respiratory system agents|mesh-ancestor
5537573|NCT04199572|Acetaminophen|acetaminophen|mesh-list
6466382|NCT00478855|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
6466383|NCT00478855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6466384|NCT00478855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6466385|NCT00478855|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5537574|NCT04199572|Diclofenac|diclofenac|mesh-list
5537575|NCT04199572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5537576|NCT04199572|Analgesics|analgesics|mesh-ancestor
5537577|NCT04199572|Sensory System Agents|sensory system agents|mesh-ancestor
6131162|NCT01216176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131163|NCT01216176|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6131164|NCT01216176|Hormone Antagonists|hormone antagonists|mesh-ancestor
6131165|NCT01216176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6131166|NCT01216176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131167|NCT01216241|Daptomycin|daptomycin|mesh-list
6131168|NCT01216241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6131169|NCT01216241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6131170|NCT01216332|Vaccines|vaccines|mesh-list
6131171|NCT01216332|Immunologic Factors|immunologic factors|mesh-ancestor
6131172|NCT01216332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131173|NCT01216397|Metformin|metformin|mesh-list
6131174|NCT01216397|Linagliptin|linagliptin|mesh-list
6131175|NCT01216397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6131176|NCT01216397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131177|NCT01216397|Incretins|incretins|mesh-ancestor
6131178|NCT01216397|Hormones|hormones|mesh-ancestor
6131179|NCT01216397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6131180|NCT01216397|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6131181|NCT01216397|Protease Inhibitors|protease inhibitors|mesh-ancestor
6131182|NCT01216397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6131183|NCT01216397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131184|NCT01216410|Phenylephrine|phenylephrine|mesh-list
6131185|NCT01216410|Oxymetazoline|oxymetazoline|mesh-list
6131186|NCT01216410|Ondansetron|ondansetron|mesh-list
6131187|NCT01216410|Metoclopramide|metoclopramide|mesh-list
6131188|NCT01216410|Antiemetics|antiemetics|mesh-ancestor
6131189|NCT01216410|Autonomic Agents|autonomic agents|mesh-ancestor
6131190|NCT01216410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6131191|NCT01216410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537578|NCT04199572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5537579|NCT04199572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537580|NCT04199572|Antipyretics|antipyretics|mesh-ancestor
5537581|NCT04199572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5537582|NCT04199572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5537583|NCT04199572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5537584|NCT04199572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6131192|NCT01216410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6131193|NCT01216410|Antipruritics|antipruritics|mesh-ancestor
6131194|NCT01216410|Dermatologic Agents|dermatologic agents|mesh-ancestor
6131195|NCT01216410|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6131196|NCT01216410|Serotonin Agents|serotonin agents|mesh-ancestor
6131197|NCT01216410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6131198|NCT01216410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131199|NCT01216410|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6131200|NCT01216410|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6131201|NCT01216410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6131202|NCT01216410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6131203|NCT01216410|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6466386|NCT00478855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6466387|NCT00478855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466388|NCT00478907|Ketamine|ketamine|mesh-list
5537585|NCT04199572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5537586|NCT04199572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5537587|NCT04199325|Uric Acid|uric acid|mesh-list
6466389|NCT00478907|Thiopental|thiopental|mesh-list
6466390|NCT00478907|Propofol|propofol|mesh-list
6466391|NCT00478907|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5537588|NCT04199325|Antioxidants|antioxidants|mesh-ancestor
5537589|NCT04199325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131204|NCT01216410|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6131205|NCT01216410|Mydriatics|mydriatics|mesh-ancestor
5537590|NCT04199325|Protective Agents|protective agents|mesh-ancestor
5537591|NCT04199325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537592|NCT04199221|Vaccines|vaccines|mesh-list
5537593|NCT04199221|Immunologic Factors|immunologic factors|mesh-ancestor
5537594|NCT04199221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537595|NCT04199143|Nitrous Oxide|nitrous oxide|mesh-list
5537596|NCT04199143|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5537597|NCT04199143|Anesthetics, General|anesthetics, general|mesh-ancestor
5537598|NCT04199143|Anesthetics|anesthetics|mesh-ancestor
6131206|NCT01216410|Sympathomimetics|sympathomimetics|mesh-ancestor
6131207|NCT01216410|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6131208|NCT01216410|Nasal Decongestants|nasal decongestants|mesh-ancestor
6131209|NCT01216410|Respiratory System Agents|respiratory system agents|mesh-ancestor
6131210|NCT01216410|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6131211|NCT01216410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6131212|NCT01216410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6131213|NCT01216410|Adrenergic Agents|adrenergic agents|mesh-ancestor
5537599|NCT04199143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5537600|NCT04199143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537601|NCT04199143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5537602|NCT04199143|Analgesics|analgesics|mesh-ancestor
5537603|NCT04199143|Sensory System Agents|sensory system agents|mesh-ancestor
5537604|NCT04199143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5537605|NCT04199013|Fentanyl|fentanyl|mesh-list
6131214|NCT01216410|Protective Agents|protective agents|mesh-ancestor
5537606|NCT04199013|Ropivacaine|ropivacaine|mesh-list
5537607|NCT04199013|Anesthetics, Local|anesthetics, local|mesh-ancestor
6131215|NCT01216410|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6131216|NCT01216410|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6131217|NCT01216410|Dopamine Agents|dopamine agents|mesh-ancestor
6131218|NCT01216683|Rituximab|rituximab|mesh-list
6131219|NCT01216683|Lenalidomide|lenalidomide|mesh-list
6131220|NCT01216683|Bortezomib|bortezomib|mesh-list
6131221|NCT01216683|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6131222|NCT01216683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6131223|NCT01216683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6131224|NCT01216683|Immunologic Factors|immunologic factors|mesh-ancestor
6131225|NCT01216683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131226|NCT01216683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6131227|NCT01216683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6131228|NCT01216683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6131229|NCT01216683|Growth Substances|growth substances|mesh-ancestor
6131230|NCT01216683|Growth Inhibitors|growth inhibitors|mesh-ancestor
6131231|NCT01216683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6131232|NCT01216683|Alkylating Agents|alkylating agents|mesh-ancestor
6131233|NCT01216683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131234|NCT01216735|Fluticasone|fluticasone|mesh-list
6131235|NCT01216735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6131236|NCT01216735|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6131237|NCT01216735|Autonomic Agents|autonomic agents|mesh-ancestor
6131238|NCT01216735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6131239|NCT01216735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131240|NCT01216735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6131241|NCT01216735|Respiratory System Agents|respiratory system agents|mesh-ancestor
6131242|NCT01216735|Dermatologic Agents|dermatologic agents|mesh-ancestor
6131243|NCT01216735|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6131244|NCT01216761|Iodine|iodine|mesh-list
6131245|NCT01216761|Chlorhexidine|chlorhexidine|mesh-list
6131246|NCT01216761|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6131247|NCT01216761|Cadexomer iodine|cadexomer iodine|mesh-list
6131248|NCT01216761|Povidone-Iodine|povidone-iodine|mesh-list
6131249|NCT01216761|Povidone|povidone|mesh-list
6131250|NCT01216761|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6131251|NCT01216761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6131252|NCT01216761|Disinfectants|disinfectants|mesh-ancestor
6131253|NCT01216761|Dermatologic Agents|dermatologic agents|mesh-ancestor
6131254|NCT01216761|Trace Elements|trace elements|mesh-ancestor
6131255|NCT01216761|Micronutrients|micronutrients|mesh-ancestor
6131256|NCT01216761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131257|NCT01216761|Plasma Substitutes|plasma substitutes|mesh-ancestor
6131258|NCT01216761|Blood Substitutes|blood substitutes|mesh-ancestor
6131259|NCT01216943|Timolol|timolol|mesh-list
6131260|NCT01216943|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6131261|NCT01216943|Bimatoprost|bimatoprost|mesh-list
6131262|NCT01216943|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6131263|NCT01216943|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6131264|NCT01216943|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6131265|NCT01216943|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5537608|NCT04199013|Anesthetics|anesthetics|mesh-ancestor
5537609|NCT04199013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5537610|NCT04199013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537611|NCT04199013|Sensory System Agents|sensory system agents|mesh-ancestor
5537612|NCT04199013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5537613|NCT04199013|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5537614|NCT04199013|Narcotics|narcotics|mesh-ancestor
5537615|NCT04199013|Analgesics|analgesics|mesh-ancestor
5537616|NCT04199013|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5537617|NCT04199013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5537618|NCT04199013|Anesthetics, General|anesthetics, general|mesh-ancestor
5537619|NCT04199169|Vaccines|vaccines|mesh-list
5537620|NCT04199169|Immunologic Factors|immunologic factors|mesh-ancestor
5537621|NCT04199169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537622|NCT04198844|Warfarin|warfarin|mesh-list
5537623|NCT04198844|Apixaban|apixaban|mesh-list
6131266|NCT01216943|Adrenergic Agents|adrenergic agents|mesh-ancestor
6131267|NCT01216943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6131268|NCT01216943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131269|NCT01216943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131270|NCT01216943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6131271|NCT01216943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6131272|NCT01216943|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6131273|NCT01216943|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6131274|NCT01216943|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6466392|NCT00478907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6466393|NCT00478907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466394|NCT00478907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6466395|NCT00478907|Anesthetics, General|anesthetics, general|mesh-ancestor
6131275|NCT01217073|Metformin|metformin|mesh-list
6131276|NCT01217073|Pioglitazone|pioglitazone|mesh-list
6131277|NCT01217073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6131278|NCT01217073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131279|NCT01217112|Cannabidiol|cannabidiol|mesh-list
6131280|NCT01217112|Anticonvulsants|anticonvulsants|mesh-ancestor
6466396|NCT00478907|Anesthetics|anesthetics|mesh-ancestor
6466397|NCT00478907|Analgesics|analgesics|mesh-ancestor
6466398|NCT00478907|Sensory System Agents|sensory system agents|mesh-ancestor
6466399|NCT00478907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6466400|NCT00478907|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6466401|NCT00478907|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6466402|NCT00478907|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6131281|NCT01217190|Ondansetron|ondansetron|mesh-list
6131282|NCT01217190|Antiemetics|antiemetics|mesh-ancestor
6131283|NCT01217190|Autonomic Agents|autonomic agents|mesh-ancestor
6131284|NCT01217190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6131285|NCT01217190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131286|NCT01217190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6131287|NCT01217190|Antipruritics|antipruritics|mesh-ancestor
6131288|NCT01217190|Dermatologic Agents|dermatologic agents|mesh-ancestor
6131289|NCT01217190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5537624|NCT04198844|Anticoagulants|anticoagulants|mesh-ancestor
5537625|NCT04198844|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6466403|NCT00478907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5537626|NCT04198844|Antithrombins|antithrombins|mesh-ancestor
5537627|NCT04198844|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5537628|NCT04198844|Protease Inhibitors|protease inhibitors|mesh-ancestor
5537629|NCT04198844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5537630|NCT04198844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5537631|NCT04198662|Epinephrine|epinephrine|mesh-list
5537632|NCT04198662|Ropivacaine|ropivacaine|mesh-list
5537633|NCT04198662|Anesthetics, Local|anesthetics, local|mesh-ancestor
5537634|NCT04198662|Anesthetics|anesthetics|mesh-ancestor
5537635|NCT04198662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5537636|NCT04198662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537637|NCT04198662|Sensory System Agents|sensory system agents|mesh-ancestor
5537638|NCT04198662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5537639|NCT04198662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5537640|NCT04198662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6131290|NCT01217190|Serotonin Agents|serotonin agents|mesh-ancestor
6131291|NCT01217190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5537641|NCT04198662|Adrenergic Agents|adrenergic agents|mesh-ancestor
5537642|NCT04198662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5537643|NCT04198662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5537644|NCT04198662|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5537645|NCT04198662|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5537646|NCT04198662|Autonomic Agents|autonomic agents|mesh-ancestor
5537647|NCT04198662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5537648|NCT04198662|Respiratory System Agents|respiratory system agents|mesh-ancestor
5537649|NCT04198662|Mydriatics|mydriatics|mesh-ancestor
5537650|NCT04198662|Sympathomimetics|sympathomimetics|mesh-ancestor
6131292|NCT01217190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131293|NCT01217190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6131294|NCT01217190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5537651|NCT04198662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5537652|NCT04198727|Capecitabine|capecitabine|mesh-list
5537653|NCT04198727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5537654|NCT04198727|Antimetabolites|antimetabolites|mesh-ancestor
5537655|NCT04198727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5537656|NCT04198727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5537657|NCT04198506|Tacrolimus|tacrolimus|mesh-list
5537658|NCT04198506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5537659|NCT04198506|Immunologic Factors|immunologic factors|mesh-ancestor
5537660|NCT04198506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537661|NCT04198506|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5537662|NCT04198506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5537663|NCT04198506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131295|NCT01217190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6131296|NCT01217190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6131297|NCT01217190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6131298|NCT01217307|Metformin|metformin|mesh-list
6131299|NCT01217307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6131300|NCT01217307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131301|NCT01217411|R04929097|r04929097|mesh-list
5537664|NCT04198571|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
5537665|NCT04198571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5537666|NCT04198571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5537667|NCT04198636|Denosumab|denosumab|mesh-list
5537668|NCT04198636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5537669|NCT04198636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537670|NCT04198467|Hyaluronic Acid|hyaluronic acid|mesh-list
5537671|NCT04198467|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5537672|NCT04198467|Immunologic Factors|immunologic factors|mesh-ancestor
5537673|NCT04198467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537674|NCT04198467|Viscosupplements|viscosupplements|mesh-ancestor
5537675|NCT04198467|Protective Agents|protective agents|mesh-ancestor
5537676|NCT04198129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5537677|NCT04198129|Amoxicillin|amoxicillin|mesh-list
5537678|NCT04198129|Clindamycin|clindamycin|mesh-list
5537679|NCT04198129|Clindamycin palmitate|clindamycin palmitate|mesh-list
5537680|NCT04198129|Clindamycin phosphate|clindamycin phosphate|mesh-list
5537681|NCT04198129|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6131302|NCT01217411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6131303|NCT01217411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131304|NCT01217437|Bevacizumab|bevacizumab|mesh-list
6131305|NCT01217437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6131306|NCT01217437|Irinotecan|irinotecan|mesh-list
6131307|NCT01217437|Temozolomide|temozolomide|mesh-list
6131308|NCT01217437|Camptothecin|camptothecin|mesh-list
5537682|NCT04198129|Ampicillin|ampicillin|mesh-list
5537683|NCT04198129|Sultamicillin|sultamicillin|mesh-list
5537684|NCT04198129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5537685|NCT04198129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5537686|NCT04198129|Antitubercular Agents|antitubercular agents|mesh-ancestor
5537687|NCT04198129|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5537688|NCT04198129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5537689|NCT04198129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5537690|NCT04198129|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5537691|NCT04198233|Diazepam|diazepam|mesh-list
5537692|NCT04198233|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5537693|NCT04198233|Anticonvulsants|anticonvulsants|mesh-ancestor
5537694|NCT04198233|Antiemetics|antiemetics|mesh-ancestor
5537695|NCT04198233|Autonomic Agents|autonomic agents|mesh-ancestor
5537696|NCT04198233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5537697|NCT04198233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537698|NCT04198233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5537699|NCT04198233|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5537700|NCT04198233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5537701|NCT04198233|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5537702|NCT04198233|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5537703|NCT04198233|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5537704|NCT04198233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5537705|NCT04198233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5537706|NCT04198233|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5537707|NCT04198233|Anesthetics, General|anesthetics, general|mesh-ancestor
5537708|NCT04198233|Anesthetics|anesthetics|mesh-ancestor
5537709|NCT04198233|GABA Modulators|gaba modulators|mesh-ancestor
5537710|NCT04198233|GABA Agents|gaba agents|mesh-ancestor
5537711|NCT04198233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5537712|NCT04198233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601988|NCT05003037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5601989|NCT04996771|Cisplatin|cisplatin|mesh-list
5601990|NCT04996771|Etoposide|etoposide|mesh-list
5601991|NCT04996771|Etoposide phosphate|etoposide phosphate|mesh-list
5601992|NCT04996771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5601993|NCT04996771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5601994|NCT04996771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5601995|NCT04996771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5601996|NCT04996771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5601997|NCT04996771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5601998|NCT04982029|Cannabidiol|cannabidiol|mesh-list
5601999|NCT04982029|Anticonvulsants|anticonvulsants|mesh-ancestor
5602000|NCT04977232|Citalopram|citalopram|mesh-list
5602001|NCT04977232|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5602002|NCT04977232|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5602003|NCT04977232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5602004|NCT04977232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602005|NCT04977232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5602006|NCT04977232|Serotonin Agents|serotonin agents|mesh-ancestor
5602007|NCT04977232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131309|NCT01217437|Endothelial Growth Factors|endothelial growth factors|mesh-list
6131310|NCT01217437|Antibodies|antibodies|mesh-list
6131311|NCT01217437|Immunoglobulins|immunoglobulins|mesh-list
6131312|NCT01217437|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6131313|NCT01217437|Immunoglobulin G|immunoglobulin g|mesh-list
6131314|NCT01217437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6131315|NCT01217437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6131316|NCT01217437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6131317|NCT01217437|Growth Substances|growth substances|mesh-ancestor
6131318|NCT01217437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131319|NCT01217437|Growth Inhibitors|growth inhibitors|mesh-ancestor
6131320|NCT01217437|Immunologic Factors|immunologic factors|mesh-ancestor
6131321|NCT01217437|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6131322|NCT01217437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6131323|NCT01217437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6131324|NCT01217437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131325|NCT01217437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6131326|NCT01217437|Alkylating Agents|alkylating agents|mesh-ancestor
6131327|NCT01217437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6131328|NCT01217515|Diltiazem|diltiazem|mesh-list
6131329|NCT01217515|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5537713|NCT04197817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5537714|NCT04197817|Antibodies|antibodies|mesh-list
5537715|NCT04197817|Immunoglobulins|immunoglobulins|mesh-list
5537716|NCT04197817|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5537717|NCT04197817|Immunologic Factors|immunologic factors|mesh-ancestor
5537718|NCT04197817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537719|NCT04197817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5537720|NCT04197752|Anesthetics|anesthetics|mesh-list
5537721|NCT04197752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5537722|NCT04197752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537723|NCT04197570|Analgesics, Opioid|analgesics, opioid|mesh-list
5537724|NCT04197570|Analgesics|analgesics|mesh-list
6131330|NCT01217515|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6131331|NCT01217515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6131332|NCT01217515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131333|NCT01217515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6131334|NCT01217515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131335|NCT01217515|Vasodilator Agents|vasodilator agents|mesh-ancestor
6131336|NCT01217606|Timolol|timolol|mesh-list
6131337|NCT01217606|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6131338|NCT01217606|Bimatoprost|bimatoprost|mesh-list
6131339|NCT01217606|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6131340|NCT01217606|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6131341|NCT01217606|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6131342|NCT01217606|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6131343|NCT01217606|Adrenergic Agents|adrenergic agents|mesh-ancestor
6131344|NCT01217606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5537725|NCT04197570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
5537726|NCT04197570|Anesthetics|anesthetics|mesh-list
5537727|NCT04197570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5537728|NCT04197570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537729|NCT04197570|Narcotics|narcotics|mesh-ancestor
5537730|NCT04197570|Sensory System Agents|sensory system agents|mesh-ancestor
5537731|NCT04197570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5537732|NCT04197882|Molgramostim|molgramostim|mesh-list
5537733|NCT04197882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5537734|NCT04197622|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5537735|NCT04197622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5537736|NCT04197622|Diuretics|diuretics|mesh-ancestor
5537737|NCT04197622|Natriuretic Agents|natriuretic agents|mesh-ancestor
5537738|NCT04197622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537739|NCT04197622|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5537740|NCT04197622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5537741|NCT04197622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5537742|NCT04197739|Amikacin|amikacin|mesh-list
5537743|NCT04197739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5537744|NCT04197739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5537745|NCT04197323|Alprostadil|alprostadil|mesh-list
5537746|NCT04197323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5537747|NCT04197323|Vasodilator Agents|vasodilator agents|mesh-ancestor
5537748|NCT04197323|Urological Agents|urological agents|mesh-ancestor
5537749|NCT04197349|Sumatriptan|sumatriptan|mesh-list
5537750|NCT04197349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5537751|NCT04197349|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5537752|NCT04197349|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5537753|NCT04197349|Serotonin Agents|serotonin agents|mesh-ancestor
5537754|NCT04197349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5537755|NCT04197349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5537756|NCT04197349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131345|NCT01217606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131346|NCT01217606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131347|NCT01217606|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6131348|NCT01217606|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6131349|NCT01217606|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5537757|NCT04197089|Vitamin D|vitamin d|mesh-list
5537758|NCT04197089|Cholecalciferol|cholecalciferol|mesh-list
6131350|NCT01217606|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6131351|NCT01217606|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6131352|NCT01217749|Ofatumumab|ofatumumab|mesh-list
6131353|NCT01217749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6131354|NCT01217801|Ondansetron|ondansetron|mesh-list
6131355|NCT01217801|Antiemetics|antiemetics|mesh-ancestor
6131356|NCT01217801|Autonomic Agents|autonomic agents|mesh-ancestor
6131357|NCT01217801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6131358|NCT01217801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131359|NCT01217801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6131360|NCT01217801|Antipruritics|antipruritics|mesh-ancestor
6131361|NCT01217801|Dermatologic Agents|dermatologic agents|mesh-ancestor
6131362|NCT01217801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6131363|NCT01217801|Serotonin Agents|serotonin agents|mesh-ancestor
6131364|NCT01217801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6131365|NCT01217801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131366|NCT01217801|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6131367|NCT01217801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6131368|NCT01217801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6131369|NCT01217801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6131370|NCT01217801|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6466404|NCT00478907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466405|NCT00478907|Anticonvulsants|anticonvulsants|mesh-ancestor
6466406|NCT00478907|GABA Modulators|gaba modulators|mesh-ancestor
6466407|NCT00478907|GABA Agents|gaba agents|mesh-ancestor
6488458|NCT00584376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6488459|NCT00584376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488460|NCT00584376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6488461|NCT00584376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6488462|NCT00584376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6488463|NCT00584376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6488464|NCT00584376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6488465|NCT00584389|Rimonabant|rimonabant|mesh-list
6488466|NCT00584389|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6488467|NCT00584389|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
6488468|NCT00584389|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6488469|NCT00584389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6672424|NCT01555970|Respiratory System Agents|respiratory system agents|mesh-ancestor
5537759|NCT04197089|Vitamins|vitamins|mesh-ancestor
6131371|NCT01217814|Leucovorin|leucovorin|mesh-list
5537760|NCT04197089|Micronutrients|micronutrients|mesh-ancestor
5537761|NCT04197089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537762|NCT04197089|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5537763|NCT04197089|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5537764|NCT04197219|Pembrolizumab|pembrolizumab|mesh-list
5537765|NCT04197219|Axitinib|axitinib|mesh-list
5537766|NCT04197219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5537767|NCT04197219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5537768|NCT04197219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5537769|NCT04197219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5537770|NCT04197219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5537771|NCT04196855|Teriparatide|teriparatide|mesh-list
5537772|NCT04196855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6131372|NCT01217814|Folic Acid|folic acid|mesh-list
6131373|NCT01217814|Golimumab|golimumab|mesh-list
6131374|NCT01217814|Methotrexate|methotrexate|mesh-list
6131375|NCT01217814|Levoleucovorin|levoleucovorin|mesh-list
6131376|NCT01217814|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6131377|NCT01217814|Abortifacient Agents|abortifacient agents|mesh-ancestor
6131378|NCT01217814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6131379|NCT01217814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131380|NCT01217814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6131381|NCT01217814|Antimetabolites|antimetabolites|mesh-ancestor
6131382|NCT01217814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131383|NCT01217814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6131384|NCT01217814|Dermatologic Agents|dermatologic agents|mesh-ancestor
6131385|NCT01217814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6131386|NCT01217814|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6131387|NCT01217814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6131388|NCT01217814|Immunologic Factors|immunologic factors|mesh-ancestor
6131389|NCT01217814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6131390|NCT01217814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6131391|NCT01217814|Antidotes|antidotes|mesh-ancestor
6131392|NCT01217814|Protective Agents|protective agents|mesh-ancestor
6131393|NCT01217814|Vitamin B Complex|vitamin b complex|mesh-ancestor
6131394|NCT01217814|Vitamins|vitamins|mesh-ancestor
6131395|NCT01217814|Micronutrients|micronutrients|mesh-ancestor
6131396|NCT01217814|Hematinics|hematinics|mesh-ancestor
6131397|NCT01217814|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6131398|NCT01217814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6131399|NCT01217840|Vitamin D|vitamin d|mesh-list
6131400|NCT01217840|Ergocalciferols|ergocalciferols|mesh-list
6131401|NCT01217840|Vitamins|vitamins|mesh-ancestor
6131402|NCT01217840|Micronutrients|micronutrients|mesh-ancestor
6131403|NCT01217840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537773|NCT04196855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537774|NCT04196855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5537775|NCT04196829|Fluorides|fluorides|mesh-list
6131404|NCT01217840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6131405|NCT01217840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6205049|NCT02080780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6205050|NCT02080780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205051|NCT02080780|Vasodilator Agents|vasodilator agents|mesh-ancestor
6205052|NCT02080819|Levodopa|levodopa|mesh-list
6205053|NCT02080819|Carbidopa|carbidopa|mesh-list
6205054|NCT02080819|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6205055|NCT02080819|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6205056|NCT02080819|Dopamine Agents|dopamine agents|mesh-ancestor
6205057|NCT02080819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6205058|NCT02080819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205059|NCT02080819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205060|NCT02080819|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6205061|NCT02080819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6205062|NCT02080832|Dexetimide|dexetimide|mesh-list
6205063|NCT02080832|Citalopram|citalopram|mesh-list
6205064|NCT02080832|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6205065|NCT02080832|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6205066|NCT02080832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6205067|NCT02080832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205068|NCT02080832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5537776|NCT04196829|Cariostatic Agents|cariostatic agents|mesh-ancestor
5537777|NCT04196829|Protective Agents|protective agents|mesh-ancestor
5537778|NCT04196829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537779|NCT04196946|Fentanyl|fentanyl|mesh-list
5537780|NCT04196946|Alfentanil|alfentanil|mesh-list
6205069|NCT02080832|Serotonin Agents|serotonin agents|mesh-ancestor
6205070|NCT02080832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205071|NCT02080832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6205072|NCT02080832|Antidepressive Agents|antidepressive agents|mesh-ancestor
6205073|NCT02080832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6205074|NCT02080832|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6205075|NCT02080832|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6205076|NCT02080832|Parasympatholytics|parasympatholytics|mesh-ancestor
6205077|NCT02080832|Autonomic Agents|autonomic agents|mesh-ancestor
6666274|NCT01521962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6666275|NCT01521962|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6666276|NCT01521962|Protease Inhibitors|protease inhibitors|mesh-ancestor
6666277|NCT01521962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6205078|NCT02080832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6205079|NCT02080832|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6205080|NCT02080832|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6205081|NCT02080832|Cholinergic Agents|cholinergic agents|mesh-ancestor
6205082|NCT02081001|Glucagon|glucagon|mesh-list
6205083|NCT02081001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6205084|NCT02081001|Hormones|hormones|mesh-ancestor
6205085|NCT02081001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6205086|NCT02081001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205087|NCT02081014|Glucagon|glucagon|mesh-list
6466408|NCT00478946|Leucovorin|leucovorin|mesh-list
6131406|NCT01217892|Metformin|metformin|mesh-list
6131407|NCT01217892|Dapagliflozin|dapagliflozin|mesh-list
6131408|NCT01217892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6131409|NCT01217892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131410|NCT01217892|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6131411|NCT01217892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131412|NCT01217944|Ranibizumab|ranibizumab|mesh-list
6131413|NCT01217944|Verteporfin|verteporfin|mesh-list
6131414|NCT01217944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6131415|NCT01217944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6131416|NCT01217944|Growth Substances|growth substances|mesh-ancestor
6131417|NCT01217944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131418|NCT01217944|Growth Inhibitors|growth inhibitors|mesh-ancestor
6131419|NCT01217944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6131420|NCT01217944|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6131421|NCT01217944|Dermatologic Agents|dermatologic agents|mesh-ancestor
6131422|NCT01217957|Dexamethasone|dexamethasone|mesh-list
6131423|NCT01217957|Lenalidomide|lenalidomide|mesh-list
6131424|NCT01217957|Ixazomib|ixazomib|mesh-list
6131425|NCT01217957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6131426|NCT01217957|Antiemetics|antiemetics|mesh-ancestor
6131427|NCT01217957|Autonomic Agents|autonomic agents|mesh-ancestor
6131428|NCT01217957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6131429|NCT01217957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131430|NCT01217957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6131431|NCT01217957|Glucocorticoids|glucocorticoids|mesh-ancestor
6131432|NCT01217957|Hormones|hormones|mesh-ancestor
6131433|NCT01217957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6131434|NCT01217957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6131435|NCT01217957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6131436|NCT01217957|Immunologic Factors|immunologic factors|mesh-ancestor
5537781|NCT04196946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5537782|NCT04196946|Narcotics|narcotics|mesh-ancestor
5537783|NCT04196946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5537784|NCT04196946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131437|NCT01217957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6131438|NCT01217957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6131439|NCT01217957|Growth Substances|growth substances|mesh-ancestor
6131440|NCT01217957|Growth Inhibitors|growth inhibitors|mesh-ancestor
6131441|NCT01217957|Protease Inhibitors|protease inhibitors|mesh-ancestor
6131442|NCT01217957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6131443|NCT01217957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131444|NCT01218009|Albuterol|albuterol|mesh-list
6131445|NCT01218009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6131446|NCT01218009|Autonomic Agents|autonomic agents|mesh-ancestor
5537785|NCT04196946|Analgesics|analgesics|mesh-ancestor
5537786|NCT04196946|Sensory System Agents|sensory system agents|mesh-ancestor
5537787|NCT04196946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5537788|NCT04196946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5537789|NCT04196946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5537790|NCT04196946|Anesthetics, General|anesthetics, general|mesh-ancestor
5537791|NCT04196946|Anesthetics|anesthetics|mesh-ancestor
5537792|NCT04197050|Valsartan|valsartan|mesh-list
5537793|NCT04197050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5537794|NCT04197050|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5537795|NCT04197050|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5537796|NCT04197050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5537797|NCT04197115|Vitamins|vitamins|mesh-list
5537798|NCT04197115|Ascorbic Acid|ascorbic acid|mesh-list
5537799|NCT04197115|Vitamin B Complex|vitamin b complex|mesh-list
5537800|NCT04197115|Hydrocortisone|hydrocortisone|mesh-list
5537801|NCT04197115|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
5537802|NCT04197115|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
5537803|NCT04197115|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
5537804|NCT04197115|Micronutrients|micronutrients|mesh-ancestor
5537805|NCT04197115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537806|NCT04197115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6131447|NCT01218009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6131448|NCT01218009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131449|NCT01218009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6131450|NCT01218009|Respiratory System Agents|respiratory system agents|mesh-ancestor
6131451|NCT01218009|Tocolytic Agents|tocolytic agents|mesh-ancestor
6131452|NCT01218009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6131453|NCT01218009|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6131454|NCT01218009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5537807|NCT04197115|Antioxidants|antioxidants|mesh-ancestor
5537808|NCT04197115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5537809|NCT04197115|Protective Agents|protective agents|mesh-ancestor
5537810|NCT04196998|Tenofovir|tenofovir|mesh-list
5537811|NCT04196998|Entecavir|entecavir|mesh-list
5537812|NCT04196998|Antiviral Agents|antiviral agents|mesh-ancestor
5537813|NCT04196998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5537814|NCT04196998|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5537815|NCT04196998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5537816|NCT04196998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5537817|NCT04196998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5537818|NCT04196998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6131455|NCT01218009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6131456|NCT01218009|Adrenergic Agents|adrenergic agents|mesh-ancestor
5537819|NCT04196998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5537820|NCT04196621|Lubricant Eye Drops|lubricant eye drops|mesh-list
5537821|NCT04196621|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5537822|NCT04196621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5537823|NCT04196452|Ipilimumab|ipilimumab|mesh-list
5537824|NCT04196452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5537825|NCT04196452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5537826|NCT04196452|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5537827|NCT04196452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5537828|NCT04196400|Betamethasone|betamethasone|mesh-list
5537829|NCT04196400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5537830|NCT04196400|Glucocorticoids|glucocorticoids|mesh-ancestor
6131457|NCT01218009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6131458|NCT01218009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131459|NCT01218048|Carboplatin|carboplatin|mesh-list
6131460|NCT01218048|Cetuximab|cetuximab|mesh-list
6131461|NCT01218048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6131462|NCT01218048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6131463|NCT01218100|Lisinopril|lisinopril|mesh-list
6131464|NCT01218100|Nebivolol|nebivolol|mesh-list
6131465|NCT01218100|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6131466|NCT01218100|Protease Inhibitors|protease inhibitors|mesh-ancestor
6131467|NCT01218100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6131468|NCT01218100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131469|NCT01218100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6131470|NCT01218100|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6131471|NCT01218100|Protective Agents|protective agents|mesh-ancestor
6131472|NCT01218100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131473|NCT01218100|Vasodilator Agents|vasodilator agents|mesh-ancestor
6131474|NCT01218100|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6131475|NCT01218100|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6131476|NCT01218100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6131477|NCT01218100|Adrenergic Agents|adrenergic agents|mesh-ancestor
6131478|NCT01218100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6131479|NCT01218204|Atorvastatin|atorvastatin|mesh-list
6131480|NCT01218204|Ezetimibe|ezetimibe|mesh-list
6131481|NCT01218204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6131482|NCT01218204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6131483|NCT01218204|Antimetabolites|antimetabolites|mesh-ancestor
6131484|NCT01218204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131485|NCT01218204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6131486|NCT01218204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6131487|NCT01218204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6131488|NCT01218308|Vaccines|vaccines|mesh-list
6131489|NCT01218308|Immunologic Factors|immunologic factors|mesh-ancestor
6131490|NCT01218308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131491|NCT01218399|Budesonide|budesonide|mesh-list
6131492|NCT01218399|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6131493|NCT01218399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6131494|NCT01218399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6131495|NCT01218399|Autonomic Agents|autonomic agents|mesh-ancestor
6131496|NCT01218399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6466409|NCT00478946|Antidotes|antidotes|mesh-ancestor
5537831|NCT04196400|Hormones|hormones|mesh-ancestor
5537832|NCT04196400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5537833|NCT04196400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537834|NCT04196400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5537835|NCT04196400|Respiratory System Agents|respiratory system agents|mesh-ancestor
5537836|NCT04196426|Calcium|calcium|mesh-list
5537837|NCT04196426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5537838|NCT04196426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537839|NCT04196309|Heparin|heparin|mesh-list
6131497|NCT01218399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131498|NCT01218399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6131499|NCT01218399|Respiratory System Agents|respiratory system agents|mesh-ancestor
6131500|NCT01218399|Glucocorticoids|glucocorticoids|mesh-ancestor
6131501|NCT01218399|Hormones|hormones|mesh-ancestor
6131502|NCT01218399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6131503|NCT01218438|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6131504|NCT01218438|Immunoglobulins|immunoglobulins|mesh-list
6131505|NCT01218438|Antibodies|antibodies|mesh-list
6131506|NCT01218438|gamma-Globulins|gamma-globulins|mesh-list
6131507|NCT01218438|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6131508|NCT01218438|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6131509|NCT01218438|Immunoglobulin G|immunoglobulin g|mesh-list
6131510|NCT01218438|Immunologic Factors|immunologic factors|mesh-ancestor
6131511|NCT01218438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131512|NCT01218477|Dasatinib|dasatinib|mesh-list
6131513|NCT01218477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6131514|NCT01218477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6131515|NCT01218477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6131516|NCT01218477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131517|NCT01218516|Paclitaxel|paclitaxel|mesh-list
6131518|NCT01218516|Carboplatin|carboplatin|mesh-list
6131519|NCT01218516|Pemetrexed|pemetrexed|mesh-list
6131520|NCT01218516|Farletuzumab|farletuzumab|mesh-list
6131521|NCT01218516|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6131522|NCT01218516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6131523|NCT01218516|Tubulin Modulators|tubulin modulators|mesh-ancestor
6131524|NCT01218516|Antimitotic Agents|antimitotic agents|mesh-ancestor
6131525|NCT01218516|Mitosis Modulators|mitosis modulators|mesh-ancestor
6131526|NCT01218516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131527|NCT01218516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6131528|NCT01218516|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6131529|NCT01218516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6131530|NCT01218594|Endostatins|endostatins|mesh-list
6131531|NCT01218594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6131532|NCT01218594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6131533|NCT01218594|Growth Substances|growth substances|mesh-ancestor
6131534|NCT01218594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131535|NCT01218594|Growth Inhibitors|growth inhibitors|mesh-ancestor
6131536|NCT01218594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6131537|NCT01218646|Vaccines|vaccines|mesh-list
6131538|NCT01218646|Immunologic Factors|immunologic factors|mesh-ancestor
5537840|NCT04196309|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5537841|NCT04196309|Tinzaparin|tinzaparin|mesh-list
5537842|NCT04196309|Dalteparin|dalteparin|mesh-list
5537843|NCT04196309|Anticoagulants|anticoagulants|mesh-ancestor
5537844|NCT04196309|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5537845|NCT04196309|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5537846|NCT04196309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131539|NCT01218646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131540|NCT01218802|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6131541|NCT01218802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6131542|NCT01218802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6131543|NCT01218802|Antimetabolites|antimetabolites|mesh-ancestor
6131544|NCT01218802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131545|NCT01218802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6131546|NCT01218802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6131547|NCT01218802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6131548|NCT01218867|Aldesleukin|aldesleukin|mesh-list
6131549|NCT01218867|Cyclophosphamide|cyclophosphamide|mesh-list
6131550|NCT01218867|Fludarabine|fludarabine|mesh-list
6131551|NCT01218867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6131552|NCT01218867|Immunologic Factors|immunologic factors|mesh-ancestor
6131553|NCT01218867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131554|NCT01218867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6131555|NCT01218867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6131556|NCT01218867|Alkylating Agents|alkylating agents|mesh-ancestor
6131557|NCT01218867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131558|NCT01218867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6131559|NCT01218867|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6131560|NCT01218867|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6131561|NCT01218867|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6131562|NCT01218867|Antiviral Agents|antiviral agents|mesh-ancestor
6131563|NCT01218867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6131564|NCT01218958|Naltrexone|naltrexone|mesh-list
6131565|NCT01218958|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6131566|NCT01218958|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6131567|NCT01218958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131568|NCT01218958|Sensory System Agents|sensory system agents|mesh-ancestor
6131569|NCT01218958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6131570|NCT01218971|Naltrexone|naltrexone|mesh-list
6131571|NCT01218971|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6131572|NCT01218971|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6131573|NCT01218971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131574|NCT01218971|Sensory System Agents|sensory system agents|mesh-ancestor
6131575|NCT01218971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6131576|NCT01218984|Naltrexone|naltrexone|mesh-list
6131577|NCT01218984|Hydromorphone|hydromorphone|mesh-list
6131578|NCT01218984|Naloxone|naloxone|mesh-list
6131579|NCT01218984|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6131580|NCT01218984|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6131581|NCT01218984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131582|NCT01218984|Sensory System Agents|sensory system agents|mesh-ancestor
6131583|NCT01218984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6131584|NCT01218984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6131585|NCT01218984|Narcotics|narcotics|mesh-ancestor
6131586|NCT01218984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6131587|NCT01218984|Analgesics|analgesics|mesh-ancestor
6131588|NCT01218997|Naltrexone|naltrexone|mesh-list
6131589|NCT01218997|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6131590|NCT01218997|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6131591|NCT01218997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131592|NCT01218997|Sensory System Agents|sensory system agents|mesh-ancestor
6131593|NCT01218997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6131594|NCT01219738|Budesonide|budesonide|mesh-list
6131595|NCT01219738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6131596|NCT01219738|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5537847|NCT04196530|Atezolizumab|atezolizumab|mesh-list
5537848|NCT04196530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5537849|NCT04196608|Tazobactam|tazobactam|mesh-list
5537850|NCT04196608|Imipenem|imipenem|mesh-list
5537851|NCT04196608|Ceftolozane|ceftolozane|mesh-list
6131597|NCT01219738|Autonomic Agents|autonomic agents|mesh-ancestor
6131598|NCT01219738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6131599|NCT01219738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131600|NCT01219738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6131601|NCT01219738|Respiratory System Agents|respiratory system agents|mesh-ancestor
6131602|NCT01219738|Glucocorticoids|glucocorticoids|mesh-ancestor
6131603|NCT01219738|Hormones|hormones|mesh-ancestor
6131604|NCT01219738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6131605|NCT01219777|Paclitaxel|paclitaxel|mesh-list
5537852|NCT04196608|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
5537853|NCT04196608|Relebactam|relebactam|mesh-list
5537854|NCT04196608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5537855|NCT04196608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5537856|NCT04196608|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5537857|NCT04196608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5537858|NCT04196608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5537859|NCT04196608|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5537860|NCT04196608|Renal Agents|renal agents|mesh-ancestor
5537861|NCT04196270|Ropivacaine|ropivacaine|mesh-list
5537862|NCT04196270|Anesthetics, Local|anesthetics, local|mesh-ancestor
5537863|NCT04196270|Anesthetics|anesthetics|mesh-ancestor
5537864|NCT04196270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5537865|NCT04196270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537866|NCT04196270|Sensory System Agents|sensory system agents|mesh-ancestor
5537867|NCT04196270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5537868|NCT04196439|Anesthetics|anesthetics|mesh-list
5537869|NCT04196439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5537870|NCT04196439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602008|NCT04977232|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5602009|NCT04977232|Antidepressive Agents|antidepressive agents|mesh-ancestor
5602010|NCT04977232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5602011|NCT04976790|Flurbiprofen|flurbiprofen|mesh-list
5602012|NCT04976790|Analgesics|analgesics|mesh-ancestor
6131606|NCT01219777|Bevacizumab|bevacizumab|mesh-list
6131607|NCT01219777|Carboplatin|carboplatin|mesh-list
6131608|NCT01219777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6131609|NCT01219777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6131610|NCT01219777|Tubulin Modulators|tubulin modulators|mesh-ancestor
6131611|NCT01219777|Antimitotic Agents|antimitotic agents|mesh-ancestor
5602013|NCT04976790|Sensory System Agents|sensory system agents|mesh-ancestor
6131612|NCT01219777|Mitosis Modulators|mitosis modulators|mesh-ancestor
5602014|NCT04976790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5537871|NCT04196491|Cyclophosphamide|cyclophosphamide|mesh-list
5537872|NCT04196491|Fludarabine|fludarabine|mesh-list
5537873|NCT04196491|Lenalidomide|lenalidomide|mesh-list
5537874|NCT04196491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5537875|NCT04196491|Immunologic Factors|immunologic factors|mesh-ancestor
5537876|NCT04196491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537877|NCT04196491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5537878|NCT04196491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5537879|NCT04196491|Alkylating Agents|alkylating agents|mesh-ancestor
5537880|NCT04196491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5537881|NCT04196491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5537882|NCT04196491|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6131613|NCT01219777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131614|NCT01219777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6131615|NCT01219777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6131616|NCT01219777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6131617|NCT01219777|Growth Substances|growth substances|mesh-ancestor
6131618|NCT01219777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131619|NCT01219777|Growth Inhibitors|growth inhibitors|mesh-ancestor
6131620|NCT01219881|Sevoflurane|sevoflurane|mesh-list
6131621|NCT01219881|Desflurane|desflurane|mesh-list
6131622|NCT01219881|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6131623|NCT01219881|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6131624|NCT01219881|Anesthetics, General|anesthetics, general|mesh-ancestor
6131625|NCT01219881|Anesthetics|anesthetics|mesh-ancestor
6131626|NCT01219881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6131627|NCT01219881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131628|NCT01219933|Methylprednisolone|methylprednisolone|mesh-list
6131629|NCT01219933|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6131630|NCT01219933|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6131631|NCT01219933|Prednisolone|prednisolone|mesh-list
6131632|NCT01219933|Prednisolone acetate|prednisolone acetate|mesh-list
6131633|NCT01219933|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5537883|NCT04196491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5537884|NCT04196491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5537885|NCT04196491|Growth Substances|growth substances|mesh-ancestor
5537886|NCT04196491|Growth Inhibitors|growth inhibitors|mesh-ancestor
5537887|NCT04195945|Cytarabine|cytarabine|mesh-list
6131634|NCT01219933|Prednisolone phosphate|prednisolone phosphate|mesh-list
6131635|NCT01219933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6131636|NCT01219933|Antiemetics|antiemetics|mesh-ancestor
6131637|NCT01219933|Autonomic Agents|autonomic agents|mesh-ancestor
6131638|NCT01219933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6131639|NCT01219933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131640|NCT01219933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6131641|NCT01219933|Glucocorticoids|glucocorticoids|mesh-ancestor
6131642|NCT01219933|Hormones|hormones|mesh-ancestor
6131643|NCT01219933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6131644|NCT01219933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6131645|NCT01219933|Protective Agents|protective agents|mesh-ancestor
6131646|NCT01219933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6131647|NCT01219933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6131648|NCT01219959|Icodextrin|icodextrin|mesh-list
6131649|NCT01219959|Dialysis Solutions|dialysis solutions|mesh-ancestor
6131650|NCT01219959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6131651|NCT01220024|Bupivacaine|bupivacaine|mesh-list
6131652|NCT01220024|Anesthetics, Local|anesthetics, local|mesh-ancestor
6131653|NCT01220024|Anesthetics|anesthetics|mesh-ancestor
6131654|NCT01220024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5537888|NCT04195945|Daunorubicin|daunorubicin|mesh-list
5537889|NCT04195945|Mitoxantrone|mitoxantrone|mesh-list
5537890|NCT04195945|Cladribine|cladribine|mesh-list
5537891|NCT04195945|Sargramostim|sargramostim|mesh-list
5537892|NCT04195945|Lenograstim|lenograstim|mesh-list
5537893|NCT04195945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5537894|NCT04195945|Antimetabolites|antimetabolites|mesh-ancestor
5537895|NCT04195945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5537896|NCT04195945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5537897|NCT04195945|Antiviral Agents|antiviral agents|mesh-ancestor
5537898|NCT04195945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5537899|NCT04195945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5537900|NCT04195945|Immunologic Factors|immunologic factors|mesh-ancestor
5537901|NCT04195945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537902|NCT04195945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5537903|NCT04195945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6131655|NCT01220024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537904|NCT04195945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5537905|NCT04195945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5537906|NCT04195945|Analgesics|analgesics|mesh-ancestor
6131656|NCT01220024|Sensory System Agents|sensory system agents|mesh-ancestor
6131657|NCT01220024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6131658|NCT01220128|Paclitaxel|paclitaxel|mesh-list
6131659|NCT01220128|Docetaxel|docetaxel|mesh-list
6131660|NCT01220128|Cyclophosphamide|cyclophosphamide|mesh-list
6131661|NCT01220128|Carboplatin|carboplatin|mesh-list
6131662|NCT01220128|Doxorubicin|doxorubicin|mesh-list
6131663|NCT01220128|Fluorouracil|fluorouracil|mesh-list
6131664|NCT01220128|Trastuzumab|trastuzumab|mesh-list
6131665|NCT01220128|Epirubicin|epirubicin|mesh-list
6131666|NCT01220128|Aromatase Inhibitors|aromatase inhibitors|mesh-list
6131667|NCT01220128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6131668|NCT01220128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6131669|NCT01220128|Tubulin Modulators|tubulin modulators|mesh-ancestor
6131670|NCT01220128|Antimitotic Agents|antimitotic agents|mesh-ancestor
6131671|NCT01220128|Mitosis Modulators|mitosis modulators|mesh-ancestor
6131672|NCT01220128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131673|NCT01220128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6131674|NCT01220128|Immunologic Factors|immunologic factors|mesh-ancestor
6131675|NCT01220128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131676|NCT01220128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6131677|NCT01220128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6131678|NCT01220128|Alkylating Agents|alkylating agents|mesh-ancestor
6131679|NCT01220128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6131680|NCT01220128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6131681|NCT01220128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6131682|NCT01220128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6131683|NCT01220128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6131684|NCT01220128|Antimetabolites|antimetabolites|mesh-ancestor
6131685|NCT01220128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6131686|NCT01220128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6466410|NCT00478946|Protective Agents|protective agents|mesh-ancestor
5537907|NCT04195945|Sensory System Agents|sensory system agents|mesh-ancestor
5537908|NCT04195945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5537909|NCT04195945|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6466411|NCT00478946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466412|NCT00478946|Vitamin B Complex|vitamin b complex|mesh-ancestor
6466413|NCT00478946|Vitamins|vitamins|mesh-ancestor
6466414|NCT00478946|Micronutrients|micronutrients|mesh-ancestor
6466415|NCT00478959|Lenalidomide|lenalidomide|mesh-list
6466416|NCT00478959|Immunologic Factors|immunologic factors|mesh-ancestor
6131687|NCT01220128|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6131688|NCT01220128|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6131689|NCT01220128|Hormone Antagonists|hormone antagonists|mesh-ancestor
6131690|NCT01220128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6131691|NCT01220167|Ondansetron|ondansetron|mesh-list
6131692|NCT01220167|Antiemetics|antiemetics|mesh-ancestor
6131693|NCT01220167|Autonomic Agents|autonomic agents|mesh-ancestor
6131694|NCT01220167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6131695|NCT01220167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131696|NCT01220167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6131697|NCT01220167|Antipruritics|antipruritics|mesh-ancestor
6666278|NCT01521962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666279|NCT01521975|Adefovir|adefovir|mesh-list
5537910|NCT04196231|Insulin|insulin|mesh-list
5537911|NCT04196231|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5537912|NCT04196231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6131698|NCT01220167|Dermatologic Agents|dermatologic agents|mesh-ancestor
6466417|NCT00478959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466418|NCT00478959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6666280|NCT01521975|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6131699|NCT01220167|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6131700|NCT01220167|Serotonin Agents|serotonin agents|mesh-ancestor
6131701|NCT01220167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6131702|NCT01220167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131703|NCT01220167|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6131704|NCT01220167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6131705|NCT01220167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6131706|NCT01220167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6131707|NCT01220167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6131708|NCT01220180|Pregabalin|pregabalin|mesh-list
6131709|NCT01220180|Analgesics|analgesics|mesh-ancestor
6131710|NCT01220180|Sensory System Agents|sensory system agents|mesh-ancestor
6131711|NCT01220180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6131712|NCT01220180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131713|NCT01220180|Anticonvulsants|anticonvulsants|mesh-ancestor
6131714|NCT01220180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6131715|NCT01220180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6131716|NCT01220180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131717|NCT01220180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6131718|NCT01220180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6131719|NCT01220180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6131720|NCT01220180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6131721|NCT01220180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6131722|NCT01220297|Mycophenolic Acid|mycophenolic acid|mesh-list
6131723|NCT01220297|Sirolimus|sirolimus|mesh-list
6131724|NCT01220297|Cyclophosphamide|cyclophosphamide|mesh-list
6131725|NCT01220297|Carmustine|carmustine|mesh-list
6131726|NCT01220297|Etoposide|etoposide|mesh-list
6131727|NCT01220297|Etoposide phosphate|etoposide phosphate|mesh-list
6131728|NCT01220297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6131729|NCT01220297|Immunologic Factors|immunologic factors|mesh-ancestor
6131730|NCT01220297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131731|NCT01220297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6131732|NCT01220297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6131733|NCT01220297|Alkylating Agents|alkylating agents|mesh-ancestor
6131734|NCT01220297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131735|NCT01220297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6131736|NCT01220297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6131737|NCT01220297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6131738|NCT01220297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6131739|NCT01220297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6131740|NCT01220297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6131741|NCT01220297|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5537913|NCT04196231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537914|NCT04195958|Omalizumab|omalizumab|mesh-list
5537915|NCT04195958|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5537916|NCT04195958|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5537917|NCT04195958|Respiratory System Agents|respiratory system agents|mesh-ancestor
5537918|NCT04195997|Heparin|heparin|mesh-list
5537919|NCT04195997|Bivalirudin|bivalirudin|mesh-list
5537920|NCT04195997|Anticoagulants|anticoagulants|mesh-ancestor
5537921|NCT04195997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5537922|NCT04195997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5537923|NCT04195997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5537924|NCT04195997|Antithrombins|antithrombins|mesh-ancestor
5537925|NCT04195997|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5537926|NCT04195997|Protease Inhibitors|protease inhibitors|mesh-ancestor
5537927|NCT04195997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5537928|NCT04195828|Paclitaxel|paclitaxel|mesh-list
5537929|NCT04195828|Apatinib|apatinib|mesh-list
5537930|NCT04195828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5537931|NCT04195828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5537932|NCT04195828|Tubulin Modulators|tubulin modulators|mesh-ancestor
5537933|NCT04195828|Antimitotic Agents|antimitotic agents|mesh-ancestor
5537934|NCT04195828|Mitosis Modulators|mitosis modulators|mesh-ancestor
5537935|NCT04195828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131742|NCT01220297|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6131743|NCT01220297|Antitubercular Agents|antitubercular agents|mesh-ancestor
6131744|NCT01220297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5537936|NCT04195828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5537937|NCT04195828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5537938|NCT04195698|Upadacitinib|upadacitinib|mesh-list
6131745|NCT01220297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5537939|NCT04195698|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
5537940|NCT04195698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5537941|NCT04195698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6131746|NCT01220297|Antifungal Agents|antifungal agents|mesh-ancestor
6131747|NCT01220414|Naltrexone|naltrexone|mesh-list
6131748|NCT01220414|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6131749|NCT01220414|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5537942|NCT04195698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5537943|NCT04195698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5537944|NCT04195867|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5537945|NCT04195867|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5537946|NCT04195867|Autonomic Agents|autonomic agents|mesh-ancestor
5537947|NCT04195867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5537948|NCT04195867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537949|NCT04195867|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5537950|NCT04195867|Respiratory System Agents|respiratory system agents|mesh-ancestor
5537951|NCT04195867|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5537952|NCT04195867|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5537953|NCT04195867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5537954|NCT04195867|Adrenergic Agents|adrenergic agents|mesh-ancestor
5537955|NCT04195867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5537956|NCT04195867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5537957|NCT04195373|Flucytosine|flucytosine|mesh-list
5537958|NCT04195373|Antifungal Agents|antifungal agents|mesh-ancestor
6131750|NCT01220414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131751|NCT01220414|Sensory System Agents|sensory system agents|mesh-ancestor
6131752|NCT01220414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6131753|NCT01220557|Insulin|insulin|mesh-list
6131754|NCT01220557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6131755|NCT01220557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131756|NCT01220609|Epothilones|epothilones|mesh-list
6131757|NCT01220609|Tubulin Modulators|tubulin modulators|mesh-ancestor
6131758|NCT01220609|Antimitotic Agents|antimitotic agents|mesh-ancestor
6131759|NCT01220609|Mitosis Modulators|mitosis modulators|mesh-ancestor
6131760|NCT01220609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131761|NCT01220609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6131762|NCT01220687|Nitric Oxide|nitric oxide|mesh-list
6131763|NCT01220687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6131764|NCT01220687|Autonomic Agents|autonomic agents|mesh-ancestor
6131765|NCT01220687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6131766|NCT01220687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131767|NCT01220687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6131768|NCT01220687|Respiratory System Agents|respiratory system agents|mesh-ancestor
6131769|NCT01220687|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6131770|NCT01220687|Antioxidants|antioxidants|mesh-ancestor
6131771|NCT01220687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131772|NCT01220687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6131773|NCT01220687|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6131774|NCT01220687|Vasodilator Agents|vasodilator agents|mesh-ancestor
6131775|NCT01220687|Gasotransmitters|gasotransmitters|mesh-ancestor
6131776|NCT01220687|Protective Agents|protective agents|mesh-ancestor
6131777|NCT01220973|Celecoxib|celecoxib|mesh-list
6131778|NCT01220973|Atorvastatin|atorvastatin|mesh-list
6131779|NCT01220973|Calcium|calcium|mesh-list
6131780|NCT01220973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6131781|NCT01220973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131782|NCT01220973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6131783|NCT01220973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6131784|NCT01220973|Antimetabolites|antimetabolites|mesh-ancestor
6131785|NCT01220973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131786|NCT01220973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6131787|NCT01220973|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6131788|NCT01220973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6131789|NCT01220973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6131790|NCT01220973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6131791|NCT01220973|Analgesics|analgesics|mesh-ancestor
6131792|NCT01220973|Sensory System Agents|sensory system agents|mesh-ancestor
6131793|NCT01220973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6131794|NCT01220973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6131795|NCT01220973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6131796|NCT01220973|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6131797|NCT01220973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6131798|NCT01221181|Eculizumab|eculizumab|mesh-list
5537959|NCT04195373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5537960|NCT04195373|Antimetabolites|antimetabolites|mesh-ancestor
5537961|NCT04195373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131799|NCT01221181|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6131800|NCT01221181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6131801|NCT01221181|Immunologic Factors|immunologic factors|mesh-ancestor
6131802|NCT01221181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131803|NCT01221207|Calpastatin|calpastatin|mesh-list
6131804|NCT01221207|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
6131805|NCT01221207|Protease Inhibitors|protease inhibitors|mesh-ancestor
6131806|NCT01221207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6131807|NCT01221207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131808|NCT01221272|Ranolazine|ranolazine|mesh-list
6131809|NCT01221272|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6131810|NCT01221272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6131811|NCT01221272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131812|NCT01221298|Ritonavir|ritonavir|mesh-list
6131813|NCT01221298|Ribavirin|ribavirin|mesh-list
6131814|NCT01221298|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6131815|NCT01221298|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6131816|NCT01221298|Protease Inhibitors|protease inhibitors|mesh-ancestor
6131817|NCT01221298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6131818|NCT01221298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131819|NCT01221298|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5537962|NCT04195139|Nivolumab|nivolumab|mesh-list
5537963|NCT04195139|Temozolomide|temozolomide|mesh-list
5537964|NCT04195139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5537965|NCT04195139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5537966|NCT04195139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5537967|NCT04195139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5537968|NCT04195139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6131820|NCT01221298|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6131821|NCT01221298|Antiviral Agents|antiviral agents|mesh-ancestor
6131822|NCT01221298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6131823|NCT01221298|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6131824|NCT01221298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6131825|NCT01221298|Antimetabolites|antimetabolites|mesh-ancestor
6131826|NCT01221350|Thioctic Acid|thioctic acid|mesh-list
6131827|NCT01221350|Antioxidants|antioxidants|mesh-ancestor
6131828|NCT01221350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131829|NCT01221350|Protective Agents|protective agents|mesh-ancestor
6131830|NCT01221350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131831|NCT01221350|Vitamin B Complex|vitamin b complex|mesh-ancestor
6131832|NCT01221350|Vitamins|vitamins|mesh-ancestor
6131833|NCT01221350|Micronutrients|micronutrients|mesh-ancestor
6131834|NCT01221727|Denosumab|denosumab|mesh-list
6131835|NCT01221727|Midazolam|midazolam|mesh-list
6131836|NCT01221727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6131837|NCT01221727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5537969|NCT04195139|Alkylating Agents|alkylating agents|mesh-ancestor
5537970|NCT04195243|Dapagliflozin|dapagliflozin|mesh-list
5537971|NCT04195243|Empagliflozin|empagliflozin|mesh-list
5537972|NCT04195243|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5537973|NCT04195243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5537974|NCT04195243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5537975|NCT04195243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537976|NCT04195100|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5537977|NCT04195100|Pilocarpine|pilocarpine|mesh-list
5537978|NCT04195100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5537979|NCT04195100|Miotics|miotics|mesh-ancestor
5537980|NCT04195100|Autonomic Agents|autonomic agents|mesh-ancestor
5537981|NCT04195100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5537982|NCT04195100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537983|NCT04195100|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
5537984|NCT04195100|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5537985|NCT04195100|Cholinergic Agents|cholinergic agents|mesh-ancestor
5537986|NCT04195100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5537987|NCT04195100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5537988|NCT04195321|Phenylephrine|phenylephrine|mesh-list
5537989|NCT04195321|Oxymetazoline|oxymetazoline|mesh-list
5537990|NCT04195321|Norepinephrine|norepinephrine|mesh-list
5537991|NCT04195321|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5537992|NCT04195321|Mydriatics|mydriatics|mesh-ancestor
5537993|NCT04195321|Autonomic Agents|autonomic agents|mesh-ancestor
5537994|NCT04195321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5537995|NCT04195321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5537996|NCT04195321|Sympathomimetics|sympathomimetics|mesh-ancestor
6131838|NCT01221727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5537997|NCT04195321|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6131839|NCT01221727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131840|NCT01221727|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6131841|NCT01221727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6131842|NCT01221727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6131843|NCT01221727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6131844|NCT01221727|Anesthetics, General|anesthetics, general|mesh-ancestor
6131845|NCT01221727|Anesthetics|anesthetics|mesh-ancestor
6131846|NCT01221727|GABA Modulators|gaba modulators|mesh-ancestor
6131847|NCT01221727|GABA Agents|gaba agents|mesh-ancestor
6131848|NCT01221727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6131849|NCT01221727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131850|NCT01221727|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6131851|NCT01221753|Carboplatin|carboplatin|mesh-list
6131852|NCT01221753|Docetaxel|docetaxel|mesh-list
6131853|NCT01221753|Fluorouracil|fluorouracil|mesh-list
6131854|NCT01221753|Cetuximab|cetuximab|mesh-list
5537998|NCT04195321|Nasal Decongestants|nasal decongestants|mesh-ancestor
5537999|NCT04195321|Respiratory System Agents|respiratory system agents|mesh-ancestor
5538000|NCT04195321|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5538001|NCT04195321|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5538002|NCT04195321|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5538003|NCT04195321|Adrenergic Agents|adrenergic agents|mesh-ancestor
5538004|NCT04195321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6131855|NCT01221753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6131856|NCT01221753|Tubulin Modulators|tubulin modulators|mesh-ancestor
6131857|NCT01221753|Antimitotic Agents|antimitotic agents|mesh-ancestor
6131858|NCT01221753|Mitosis Modulators|mitosis modulators|mesh-ancestor
6131859|NCT01221753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131860|NCT01221753|Antimetabolites|antimetabolites|mesh-ancestor
6131861|NCT01221753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6131862|NCT01221753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6131863|NCT01221753|Immunologic Factors|immunologic factors|mesh-ancestor
6131864|NCT01221753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131865|NCT01221753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6131866|NCT01222091|Propranolol|propranolol|mesh-list
6131867|NCT01222091|Remifentanil|remifentanil|mesh-list
6131868|NCT01222091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5538005|NCT04195321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538006|NCT04195321|Protective Agents|protective agents|mesh-ancestor
6131869|NCT01222091|Narcotics|narcotics|mesh-ancestor
6131870|NCT01222091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6131871|NCT01222091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131872|NCT01222091|Analgesics|analgesics|mesh-ancestor
6131873|NCT01222091|Sensory System Agents|sensory system agents|mesh-ancestor
6131874|NCT01222091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6131875|NCT01222091|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6131876|NCT01222091|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6131877|NCT01222091|Adrenergic Agents|adrenergic agents|mesh-ancestor
6131878|NCT01222091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6131879|NCT01222091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131880|NCT01222091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6131881|NCT01222091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6131882|NCT01222091|Vasodilator Agents|vasodilator agents|mesh-ancestor
6131883|NCT01222117|Plasminogen|plasminogen|mesh-list
6131884|NCT01222117|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6131885|NCT01222117|Fibrinolysin|fibrinolysin|mesh-list
6131886|NCT01222117|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6131887|NCT01222117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6131888|NCT01222117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131889|NCT01222195|Lenalidomide|lenalidomide|mesh-list
6131890|NCT01222195|Darbepoetin alfa|darbepoetin alfa|mesh-list
6131891|NCT01222195|Immunologic Factors|immunologic factors|mesh-ancestor
6131892|NCT01222195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131893|NCT01222195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6131894|NCT01222195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6131895|NCT01222195|Growth Substances|growth substances|mesh-ancestor
6131896|NCT01222195|Growth Inhibitors|growth inhibitors|mesh-ancestor
6131897|NCT01222195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6131898|NCT01222195|Hematinics|hematinics|mesh-ancestor
6131899|NCT01222234|Vitamin D|vitamin d|mesh-list
6131900|NCT01222234|Ergocalciferols|ergocalciferols|mesh-list
6131901|NCT01222234|Cholecalciferol|cholecalciferol|mesh-list
6131902|NCT01222234|Calcitriol|calcitriol|mesh-list
6131903|NCT01222234|Vitamins|vitamins|mesh-list
6131904|NCT01222234|Micronutrients|micronutrients|mesh-ancestor
6131905|NCT01222234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466419|NCT00478959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6131906|NCT01222234|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5538007|NCT04195074|Tenofovir|tenofovir|mesh-list
5538008|NCT04195074|Entecavir|entecavir|mesh-list
5538009|NCT04195074|Antiviral Agents|antiviral agents|mesh-ancestor
5538010|NCT04195074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5538011|NCT04195074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5538012|NCT04195074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6131907|NCT01222234|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6131908|NCT01222234|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6131909|NCT01222234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6131910|NCT01222234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131911|NCT01222234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6131912|NCT01222260|Dexamethasone|dexamethasone|mesh-list
6131913|NCT01222260|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6131914|NCT01222260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6131915|NCT01222260|Antiemetics|antiemetics|mesh-ancestor
6131916|NCT01222260|Autonomic Agents|autonomic agents|mesh-ancestor
6131917|NCT01222260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6131918|NCT01222260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131919|NCT01222260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6131920|NCT01222260|Glucocorticoids|glucocorticoids|mesh-ancestor
6131921|NCT01222260|Hormones|hormones|mesh-ancestor
5538013|NCT04195074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5538014|NCT04195074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538015|NCT04195074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5538016|NCT04195074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5538017|NCT04194827|Adalimumab|adalimumab|mesh-list
5538018|NCT04194827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5538019|NCT04194827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5538020|NCT04194957|Fluorouracil|fluorouracil|mesh-list
5538021|NCT04194957|Capecitabine|capecitabine|mesh-list
5538022|NCT04194957|Antimetabolites|antimetabolites|mesh-ancestor
5538023|NCT04194957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538024|NCT04194957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6131922|NCT01222260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6131923|NCT01222260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6131924|NCT01222260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6131925|NCT01222260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6131926|NCT01222260|Alkylating Agents|alkylating agents|mesh-ancestor
6131927|NCT01222260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131928|NCT01222273|Vitamin D|vitamin d|mesh-list
6131929|NCT01222273|Cholecalciferol|cholecalciferol|mesh-list
6131930|NCT01222273|Vitamins|vitamins|mesh-ancestor
6131931|NCT01222273|Micronutrients|micronutrients|mesh-ancestor
6131932|NCT01222273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538025|NCT04194957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5538026|NCT04194957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5538027|NCT04194957|Immunologic Factors|immunologic factors|mesh-ancestor
5538028|NCT04194957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538029|NCT04194905|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5538030|NCT04194905|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5538031|NCT04194905|Levonorgestrel|levonorgestrel|mesh-list
5538032|NCT04194905|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5538033|NCT04194905|Estradiol|estradiol|mesh-list
5538034|NCT04194905|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6131933|NCT01222273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6131934|NCT01222273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6131935|NCT01222299|Bepotastine besilate|bepotastine besilate|mesh-list
6131936|NCT01222299|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6131937|NCT01222403|Vaccines|vaccines|mesh-list
5538035|NCT04194905|Estrogens|estrogens|mesh-ancestor
5538036|NCT04194905|Hormones|hormones|mesh-ancestor
5538037|NCT04194905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5538038|NCT04194905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538039|NCT04194905|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6131938|NCT01222403|MF59 oil emulsion|mf59 oil emulsion|mesh-list
6131939|NCT01222403|Immunologic Factors|immunologic factors|mesh-ancestor
6131940|NCT01222403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131941|NCT01222403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6131942|NCT01222416|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
6131943|NCT01222416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131944|NCT01222520|Amlodipine|amlodipine|mesh-list
6131945|NCT01222520|Telmisartan|telmisartan|mesh-list
6131946|NCT01222520|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
6666281|NCT01521975|Telbivudine|telbivudine|mesh-list
6666282|NCT01521975|Antiviral Agents|antiviral agents|mesh-ancestor
5538040|NCT04194905|Contraceptive Agents|contraceptive agents|mesh-ancestor
6131947|NCT01222520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6131948|NCT01222520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6131949|NCT01222520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6131950|NCT01222520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131951|NCT01222520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6131952|NCT01222520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131953|NCT01222520|Vasodilator Agents|vasodilator agents|mesh-ancestor
6131954|NCT01222520|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6131955|NCT01222520|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6131956|NCT01222533|Tiotropium Bromide|tiotropium bromide|mesh-list
6131957|NCT01222533|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6131958|NCT01222533|Autonomic Agents|autonomic agents|mesh-ancestor
6131959|NCT01222533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6131960|NCT01222533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131961|NCT01222533|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6131962|NCT01222533|Respiratory System Agents|respiratory system agents|mesh-ancestor
6131963|NCT01222533|Parasympatholytics|parasympatholytics|mesh-ancestor
6131964|NCT01222533|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6131965|NCT01222533|Cholinergic Agents|cholinergic agents|mesh-ancestor
6131966|NCT01222533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6131967|NCT01222533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131968|NCT01222572|Etoposide|etoposide|mesh-list
6131969|NCT01222572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6131970|NCT01222572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6131971|NCT01222572|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6131972|NCT01222572|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6131973|NCT01222572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6131974|NCT01222572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131975|NCT01222585|Metronidazole|metronidazole|mesh-list
6131976|NCT01222585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6131977|NCT01222585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6131978|NCT01222585|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6131979|NCT01222585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6131980|NCT01222689|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6131981|NCT01222689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6131982|NCT01222689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6131983|NCT01222689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6131984|NCT01222689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6131985|NCT01222715|Sirolimus|sirolimus|mesh-list
6131986|NCT01222715|Cyclophosphamide|cyclophosphamide|mesh-list
6131987|NCT01222715|Bevacizumab|bevacizumab|mesh-list
6131988|NCT01222715|Vinorelbine|vinorelbine|mesh-list
6131989|NCT01222715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6131990|NCT01222715|Antibodies|antibodies|mesh-list
6131991|NCT01222715|Immunoglobulins|immunoglobulins|mesh-list
6131992|NCT01222715|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6131993|NCT01222715|Immunoglobulin G|immunoglobulin g|mesh-list
6131994|NCT01222715|Endothelial Growth Factors|endothelial growth factors|mesh-list
6131995|NCT01222715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6131996|NCT01222715|Immunologic Factors|immunologic factors|mesh-ancestor
6131997|NCT01222715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6131998|NCT01222715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6131999|NCT01222715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6132000|NCT01222715|Alkylating Agents|alkylating agents|mesh-ancestor
6132001|NCT01222715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132002|NCT01222715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6132003|NCT01222715|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6132004|NCT01222715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6132005|NCT01222715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6132006|NCT01222715|Growth Substances|growth substances|mesh-ancestor
6132007|NCT01222715|Growth Inhibitors|growth inhibitors|mesh-ancestor
6132008|NCT01222715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6132009|NCT01222715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6132010|NCT01222715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6132011|NCT01222715|Antifungal Agents|antifungal agents|mesh-ancestor
6132012|NCT01222715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6132013|NCT01222715|Tubulin Modulators|tubulin modulators|mesh-ancestor
6132014|NCT01222715|Antimitotic Agents|antimitotic agents|mesh-ancestor
6132015|NCT01222715|Mitosis Modulators|mitosis modulators|mesh-ancestor
6132016|NCT01222832|Bacitracin|bacitracin|mesh-list
6132017|NCT01222832|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6132018|NCT01222832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6132019|NCT01222832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6132020|NCT01222884|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
5538041|NCT04194905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5538042|NCT04194905|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5538043|NCT04194905|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5538044|NCT04194905|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5538045|NCT04194905|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6132021|NCT01222884|Hematinics|hematinics|mesh-ancestor
6132022|NCT01223027|Sorafenib|sorafenib|mesh-list
6132023|NCT01223027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6132024|NCT01223027|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6132025|NCT01223027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6132026|NCT01223027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132027|NCT01223196|Pioglitazone|pioglitazone|mesh-list
6132028|NCT01223196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6132029|NCT01223196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132030|NCT01223235|Bevacizumab|bevacizumab|mesh-list
6132031|NCT01223235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6132032|NCT01223235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6132033|NCT01223235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6132034|NCT01223235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6132035|NCT01223235|Growth Substances|growth substances|mesh-ancestor
6132036|NCT01223235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132037|NCT01223235|Growth Inhibitors|growth inhibitors|mesh-ancestor
6132038|NCT01223352|Bosentan|bosentan|mesh-list
6132039|NCT01223352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5538046|NCT04194658|Letrozole|letrozole|mesh-list
6132040|NCT01223352|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6132041|NCT01223352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132042|NCT01223365|Hydrocodone|hydrocodone|mesh-list
6132043|NCT01223365|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6132044|NCT01223365|Narcotics|narcotics|mesh-ancestor
6132045|NCT01223365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6132046|NCT01223365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132047|NCT01223365|Analgesics|analgesics|mesh-ancestor
6132048|NCT01223365|Sensory System Agents|sensory system agents|mesh-ancestor
6132049|NCT01223365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6132050|NCT01223365|Antitussive Agents|antitussive agents|mesh-ancestor
6132051|NCT01223365|Respiratory System Agents|respiratory system agents|mesh-ancestor
6132052|NCT01223378|Latanoprost|latanoprost|mesh-list
6132053|NCT01223378|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5538047|NCT04194658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5538048|NCT04194658|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5538049|NCT04194658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5538050|NCT04194658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5538051|NCT04194658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538052|NCT04194658|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6132054|NCT01223378|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6205088|NCT02081014|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6205089|NCT02081014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6205090|NCT02081014|Hormones|hormones|mesh-ancestor
6205091|NCT02081014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6205092|NCT02081014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205093|NCT02081014|Incretins|incretins|mesh-ancestor
6205094|NCT02081079|Sofosbuvir|sofosbuvir|mesh-list
6205095|NCT02081079|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
6205096|NCT02081079|Ledipasvir|ledipasvir|mesh-list
6205097|NCT02081079|Antiviral Agents|antiviral agents|mesh-ancestor
6205098|NCT02081079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6205099|NCT02081443|Ticagrelor|ticagrelor|mesh-list
6205100|NCT02081443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6205101|NCT02081443|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6205102|NCT02081443|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6205103|NCT02081443|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6205104|NCT02081443|Purinergic Agents|purinergic agents|mesh-ancestor
6205105|NCT02081443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6205106|NCT02081443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205107|NCT02081443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205108|NCT02081599|Insulin|insulin|mesh-list
6205109|NCT02081599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6205110|NCT02081599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205111|NCT02081638|Aspirin|aspirin|mesh-list
6205112|NCT02081638|Atorvastatin|atorvastatin|mesh-list
6205113|NCT02081638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6205114|NCT02081638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6205115|NCT02081638|Analgesics|analgesics|mesh-ancestor
6205116|NCT02081638|Sensory System Agents|sensory system agents|mesh-ancestor
5538053|NCT04194658|Hormone Antagonists|hormone antagonists|mesh-ancestor
5538054|NCT04194658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5538055|NCT04194658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538056|NCT04194684|Paclitaxel|paclitaxel|mesh-list
5538057|NCT04194684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5538058|NCT04194684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5538059|NCT04194684|Tubulin Modulators|tubulin modulators|mesh-ancestor
5538060|NCT04194684|Antimitotic Agents|antimitotic agents|mesh-ancestor
5538061|NCT04194684|Mitosis Modulators|mitosis modulators|mesh-ancestor
6132055|NCT01223404|Mecamylamine|mecamylamine|mesh-list
6132056|NCT01223404|Nicotine|nicotine|mesh-list
6132057|NCT01223404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6132058|NCT01223404|Autonomic Agents|autonomic agents|mesh-ancestor
6132059|NCT01223404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6132060|NCT01223404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132061|NCT01223404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6132062|NCT01223404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6132063|NCT01223404|Cholinergic Agents|cholinergic agents|mesh-ancestor
6132064|NCT01223404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6132065|NCT01223404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132066|NCT01223404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6132067|NCT01223404|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
6132068|NCT01223404|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
6132069|NCT01223404|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6132070|NCT01223937|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
6132071|NCT01223937|Hemostatics|hemostatics|mesh-ancestor
6132072|NCT01223937|Coagulants|coagulants|mesh-ancestor
6132073|NCT01223937|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6132074|NCT01223937|Natriuretic Agents|natriuretic agents|mesh-ancestor
6132075|NCT01223937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132076|NCT01224015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6132077|NCT01224015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6132078|NCT01224015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6132079|NCT01224015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6132080|NCT01224015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132081|NCT01224015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6132082|NCT01224015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6132083|NCT01224015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132084|NCT01224015|Cholinergic Agents|cholinergic agents|mesh-ancestor
6132085|NCT01224015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6132086|NCT01224145|Bupivacaine|bupivacaine|mesh-list
6132087|NCT01224145|Anesthetics, Local|anesthetics, local|mesh-ancestor
6132088|NCT01224145|Anesthetics|anesthetics|mesh-ancestor
6132089|NCT01224145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6132090|NCT01224145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132091|NCT01224145|Sensory System Agents|sensory system agents|mesh-ancestor
6132092|NCT01224145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6132093|NCT01224171|Vedolizumab|vedolizumab|mesh-list
5538062|NCT04194684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538063|NCT04194515|Metformin|metformin|mesh-list
5538064|NCT04194515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5538065|NCT04194515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602015|NCT04976790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602016|NCT04976790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5602017|NCT04976790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5602018|NCT04976790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5602019|NCT04976790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5602020|NCT04976790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5602021|NCT04976790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5602022|NCT04976790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602023|NCT04974996|Prednisone|prednisone|mesh-list
5602024|NCT04974996|Cyclophosphamide|cyclophosphamide|mesh-list
5602025|NCT04974996|Rituximab|rituximab|mesh-list
5602026|NCT04974996|Doxorubicin|doxorubicin|mesh-list
5602027|NCT04974996|Vincristine|vincristine|mesh-list
5602028|NCT04974996|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
5602029|NCT04974996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5602030|NCT04974996|Immunologic Factors|immunologic factors|mesh-ancestor
5602031|NCT04974996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602032|NCT04974996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5602033|NCT04974996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5602034|NCT04974996|Alkylating Agents|alkylating agents|mesh-ancestor
5602035|NCT04974996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132094|NCT01224171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6132095|NCT01224210|Ambrisentan|ambrisentan|mesh-list
5538066|NCT04194359|Capecitabine|capecitabine|mesh-list
5538067|NCT04194359|Oxaliplatin|oxaliplatin|mesh-list
5538068|NCT04194359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5538069|NCT04194359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5538070|NCT04194359|Antimetabolites|antimetabolites|mesh-ancestor
5538071|NCT04194359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538072|NCT04194424|Metformin|metformin|mesh-list
5538073|NCT04194424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5538074|NCT04194424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538075|NCT04194294|Lidocaine|lidocaine|mesh-list
5538076|NCT04194294|Anesthetics, Local|anesthetics, local|mesh-ancestor
5538077|NCT04194294|Anesthetics|anesthetics|mesh-ancestor
5538078|NCT04194294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5538079|NCT04194294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538080|NCT04194294|Sensory System Agents|sensory system agents|mesh-ancestor
5538081|NCT04194294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6132096|NCT01224210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6132097|NCT01224431|Lidocaine|lidocaine|mesh-list
6132098|NCT01224431|Anesthetics, Local|anesthetics, local|mesh-ancestor
6132099|NCT01224431|Anesthetics|anesthetics|mesh-ancestor
6132100|NCT01224431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6132101|NCT01224431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132102|NCT01224431|Sensory System Agents|sensory system agents|mesh-ancestor
6132103|NCT01224431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6132104|NCT01224431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6132105|NCT01224431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6132106|NCT01224431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6132107|NCT01224431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6132108|NCT01224431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132109|NCT01224626|Linezolid|linezolid|mesh-list
6132110|NCT01224626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6132111|NCT01224626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6132112|NCT01224626|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6132113|NCT01224626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5538082|NCT04194294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5538083|NCT04194294|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5538084|NCT04194294|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5538085|NCT04194294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5538086|NCT04194294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538087|NCT04194125|Edotreotide|edotreotide|mesh-list
5538088|NCT04194125|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5538089|NCT04194125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538090|NCT04194086|Posaconazole|posaconazole|mesh-list
5538091|NCT04194086|Antifungal Agents|antifungal agents|mesh-ancestor
5538092|NCT04194086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5538093|NCT04194086|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5538094|NCT04194086|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5538095|NCT04194086|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5538096|NCT04194086|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5538097|NCT04194086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5538098|NCT04194086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5538099|NCT04194086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538100|NCT04194086|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5538101|NCT04194086|Hormone Antagonists|hormone antagonists|mesh-ancestor
5538102|NCT04194086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6132114|NCT01224626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132115|NCT01224639|Vaccines|vaccines|mesh-list
6132116|NCT01224639|Immunologic Factors|immunologic factors|mesh-ancestor
6132117|NCT01224639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132118|NCT01224678|Vitamin D|vitamin d|mesh-list
6132119|NCT01224678|Vitamins|vitamins|mesh-ancestor
6132120|NCT01224678|Micronutrients|micronutrients|mesh-ancestor
6132121|NCT01224678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132122|NCT01224678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6132123|NCT01224821|Tositumomab I-131|tositumomab i-131|mesh-list
6132124|NCT01224821|Antibodies|antibodies|mesh-list
6132125|NCT01224821|Immunologic Factors|immunologic factors|mesh-ancestor
6132126|NCT01224821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132127|NCT01224821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6132128|NCT01225055|Teriparatide|teriparatide|mesh-list
6132129|NCT01225055|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5538103|NCT04194086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538104|NCT04194216|Clindamycin|clindamycin|mesh-list
5538105|NCT04194216|Clindamycin palmitate|clindamycin palmitate|mesh-list
5538106|NCT04194216|Clindamycin phosphate|clindamycin phosphate|mesh-list
5538107|NCT04194216|Cephalexin|cephalexin|mesh-list
5538108|NCT04194216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5538109|NCT04194216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5538110|NCT04194216|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5538111|NCT04194216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5538112|NCT04194216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538113|NCT04194034|Flucytosine|flucytosine|mesh-list
5538114|NCT04194034|Antifungal Agents|antifungal agents|mesh-ancestor
5538115|NCT04194034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5538116|NCT04194034|Antimetabolites|antimetabolites|mesh-ancestor
5538117|NCT04194034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538118|NCT04194255|Ferrous fumarate|ferrous fumarate|mesh-list
5538119|NCT04194255|Trace Elements|trace elements|mesh-ancestor
5538120|NCT04194255|Micronutrients|micronutrients|mesh-ancestor
5538121|NCT04194255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538122|NCT04193930|Letrozole|letrozole|mesh-list
5538123|NCT04193930|Menotropins|menotropins|mesh-list
5538124|NCT04193930|Hormones|hormones|mesh-list
5538125|NCT04193930|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5538126|NCT04193930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5538127|NCT04193930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538128|NCT04193930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5538129|NCT04193930|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5538130|NCT04193930|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5538131|NCT04193930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5538132|NCT04193930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538133|NCT04193930|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5538134|NCT04193930|Hormone Antagonists|hormone antagonists|mesh-ancestor
5538135|NCT04193930|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5538136|NCT04193930|Fertility Agents|fertility agents|mesh-ancestor
5538137|NCT04193930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5538138|NCT04193878|Budesonide|budesonide|mesh-list
5538139|NCT04193878|Formoterol Fumarate|formoterol fumarate|mesh-list
6666283|NCT01521975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6666284|NCT01521975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6666285|NCT01521975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6666286|NCT01521975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6666287|NCT01521975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666288|NCT01522040|Magnesium Sulfate|magnesium sulfate|mesh-list
6666289|NCT01522040|Analgesics|analgesics|mesh-ancestor
6132130|NCT01225055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132131|NCT01225055|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6132132|NCT01225068|Milnacipran|milnacipran|mesh-list
6132133|NCT01225068|Levomilnacipran|levomilnacipran|mesh-list
6132134|NCT01225068|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6132135|NCT01225068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6132136|NCT01225068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6132137|NCT01225068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132138|NCT01225068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6132139|NCT01225068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132140|NCT01225068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6132141|NCT01225068|Analgesics|analgesics|mesh-ancestor
6132142|NCT01225068|Sensory System Agents|sensory system agents|mesh-ancestor
6132143|NCT01225068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6132144|NCT01225068|Antidepressive Agents|antidepressive agents|mesh-ancestor
6132145|NCT01225068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6132146|NCT01225146|Ranibizumab|ranibizumab|mesh-list
6132147|NCT01225146|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6132148|NCT01225146|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6132149|NCT01225146|Growth Substances|growth substances|mesh-ancestor
6132150|NCT01225146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132151|NCT01225146|Growth Inhibitors|growth inhibitors|mesh-ancestor
6132152|NCT01225146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6132153|NCT01225172|Letrozole|letrozole|mesh-list
6132154|NCT01225172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6132155|NCT01225172|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6132156|NCT01225172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6132157|NCT01225172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6132158|NCT01225172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132159|NCT01225172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6132160|NCT01225172|Hormone Antagonists|hormone antagonists|mesh-ancestor
6205117|NCT02081638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6132161|NCT01225172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6132162|NCT01225172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132163|NCT01225211|Ivacaftor|ivacaftor|mesh-list
6132164|NCT01225211|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6132165|NCT01225211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6132166|NCT01225211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132167|NCT01225263|Vitamin D|vitamin d|mesh-list
6132168|NCT01225263|Simvastatin|simvastatin|mesh-list
6132169|NCT01225263|Vitamins|vitamins|mesh-ancestor
6132170|NCT01225263|Micronutrients|micronutrients|mesh-ancestor
6132171|NCT01225263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132172|NCT01225263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6132173|NCT01225263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6132174|NCT01225263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6132175|NCT01225263|Antimetabolites|antimetabolites|mesh-ancestor
6132176|NCT01225263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132177|NCT01225263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6132178|NCT01225263|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6132179|NCT01225263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6132180|NCT01225289|Vitamin A|vitamin a|mesh-list
5538140|NCT04193878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5538141|NCT04193878|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5538142|NCT04193878|Autonomic Agents|autonomic agents|mesh-ancestor
6132181|NCT01225289|Retinol palmitate|retinol palmitate|mesh-list
6132182|NCT01225289|Vitamins|vitamins|mesh-ancestor
6132183|NCT01225289|Micronutrients|micronutrients|mesh-ancestor
6132184|NCT01225289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132185|NCT01225289|Antioxidants|antioxidants|mesh-ancestor
6132186|NCT01225289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132187|NCT01225289|Protective Agents|protective agents|mesh-ancestor
6132188|NCT01225289|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6132189|NCT01225289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6132190|NCT01225354|Calcium|calcium|mesh-list
6132191|NCT01225354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6132192|NCT01225354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132193|NCT01225549|Budesonide|budesonide|mesh-list
6132194|NCT01225549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6132195|NCT01225549|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6132196|NCT01225549|Autonomic Agents|autonomic agents|mesh-ancestor
6132197|NCT01225549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6132198|NCT01225549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132199|NCT01225549|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6132200|NCT01225549|Respiratory System Agents|respiratory system agents|mesh-ancestor
6132201|NCT01225549|Glucocorticoids|glucocorticoids|mesh-ancestor
6132202|NCT01225549|Hormones|hormones|mesh-ancestor
6132203|NCT01225549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6132204|NCT01225562|Ticagrelor|ticagrelor|mesh-list
6132205|NCT01225562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6132206|NCT01225562|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6132207|NCT01225562|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6132208|NCT01225562|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6132209|NCT01225562|Purinergic Agents|purinergic agents|mesh-ancestor
6132210|NCT01225562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6132211|NCT01225562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132212|NCT01225562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132213|NCT01225822|Enoxaparin|enoxaparin|mesh-list
6132214|NCT01225822|Dabigatran|dabigatran|mesh-list
6132215|NCT01225822|Anticoagulants|anticoagulants|mesh-ancestor
6132216|NCT01225822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6132217|NCT01225822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6132218|NCT01225822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132219|NCT01225822|Antithrombins|antithrombins|mesh-ancestor
6132220|NCT01225822|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6132221|NCT01225822|Protease Inhibitors|protease inhibitors|mesh-ancestor
5538143|NCT04193878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5538144|NCT04193878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538145|NCT04193878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5538146|NCT04193878|Respiratory System Agents|respiratory system agents|mesh-ancestor
5538147|NCT04193878|Glucocorticoids|glucocorticoids|mesh-ancestor
5538148|NCT04193878|Hormones|hormones|mesh-ancestor
5538149|NCT04193878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5538150|NCT04193878|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5538151|NCT04193878|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5538152|NCT04193878|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6132222|NCT01225822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6132223|NCT01225835|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6132224|NCT01225835|Cetrorelix|cetrorelix|mesh-list
6132225|NCT01225835|Menotropins|menotropins|mesh-list
6132226|NCT01225835|Progesterone|progesterone|mesh-list
6132227|NCT01225835|Progestins|progestins|mesh-ancestor
6132228|NCT01225835|Hormones|hormones|mesh-ancestor
6132229|NCT01225835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6132230|NCT01225835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132231|NCT01225835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6132232|NCT01225835|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6132233|NCT01225835|Fertility Agents|fertility agents|mesh-ancestor
6132234|NCT01225835|Hormone Antagonists|hormone antagonists|mesh-ancestor
6132235|NCT01225887|Nintedanib|nintedanib|mesh-list
6132236|NCT01225887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6132237|NCT01225887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6132238|NCT01225887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6132239|NCT01225887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538153|NCT04193878|Adrenergic Agents|adrenergic agents|mesh-ancestor
5538154|NCT04193878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5538155|NCT04193878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538156|NCT04193774|Benoxinate|benoxinate|mesh-list
5538157|NCT04193774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5538158|NCT04193774|Lubricant Eye Drops|lubricant eye drops|mesh-list
5538159|NCT04193774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5538160|NCT04193774|Anesthetics, Local|anesthetics, local|mesh-ancestor
5538161|NCT04193774|Anesthetics|anesthetics|mesh-ancestor
5538162|NCT04193774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5538163|NCT04193774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538164|NCT04193774|Sensory System Agents|sensory system agents|mesh-ancestor
5538165|NCT04193774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5538166|NCT04193982|Vitamin E|vitamin e|mesh-list
5538167|NCT04193982|Vitamins|vitamins|mesh-ancestor
5538168|NCT04193982|Micronutrients|micronutrients|mesh-ancestor
5538169|NCT04193982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538170|NCT04193982|Antioxidants|antioxidants|mesh-ancestor
5538171|NCT04193982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538172|NCT04193982|Protective Agents|protective agents|mesh-ancestor
6132240|NCT01225991|Milnacipran|milnacipran|mesh-list
6132241|NCT01225991|Levomilnacipran|levomilnacipran|mesh-list
6132242|NCT01225991|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6132243|NCT01225991|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6132244|NCT01225991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6132245|NCT01225991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132246|NCT01225991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6132247|NCT01225991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132248|NCT01225991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6132249|NCT01225991|Analgesics|analgesics|mesh-ancestor
6132250|NCT01225991|Sensory System Agents|sensory system agents|mesh-ancestor
6132251|NCT01225991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6132252|NCT01225991|Antidepressive Agents|antidepressive agents|mesh-ancestor
6132253|NCT01225991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6132254|NCT01226043|Insulin Glargine|insulin glargine|mesh-list
6132255|NCT01226043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6132256|NCT01226043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132257|NCT01226420|Alefacept|alefacept|mesh-list
6132258|NCT01226420|Dermatologic Agents|dermatologic agents|mesh-ancestor
6132259|NCT01226420|Immunologic Factors|immunologic factors|mesh-ancestor
6132260|NCT01226420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132261|NCT01226459|Minoxidil|minoxidil|mesh-list
6132262|NCT01226459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6132263|NCT01226459|Vasodilator Agents|vasodilator agents|mesh-ancestor
6132264|NCT01226472|Mogamulizumab|mogamulizumab|mesh-list
6132265|NCT01226472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6132266|NCT01226511|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5538173|NCT04193852|Dienogest|dienogest|mesh-list
5538174|NCT04193852|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5538175|NCT04193852|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5538176|NCT04193852|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5538177|NCT04193852|Estradiol|estradiol|mesh-list
5538178|NCT04193852|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5538179|NCT04193852|Nandrolone|nandrolone|mesh-list
5538180|NCT04193852|Estrogens|estrogens|mesh-ancestor
5538181|NCT04193852|Hormones|hormones|mesh-ancestor
6132267|NCT01226511|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6466420|NCT00478959|Growth Substances|growth substances|mesh-ancestor
5538182|NCT04193852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5538183|NCT04193852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538184|NCT04193852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5538185|NCT04193852|Contraceptive Agents|contraceptive agents|mesh-ancestor
5538186|NCT04193852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5538187|NCT04193852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5538188|NCT04193852|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5538189|NCT04193852|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5538190|NCT04193852|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5538191|NCT04193852|Hormone Antagonists|hormone antagonists|mesh-ancestor
5538192|NCT04193852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5538193|NCT04193852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5538194|NCT04193852|Androgens|androgens|mesh-ancestor
5538195|NCT04193852|Anabolic Agents|anabolic agents|mesh-ancestor
5538196|NCT04193631|Cannabidiol|cannabidiol|mesh-list
6132268|NCT01226511|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6132269|NCT01226511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6132270|NCT01226511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132271|NCT01226511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6132272|NCT01226511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132273|NCT01226511|Analgesics|analgesics|mesh-ancestor
6132274|NCT01226511|Sensory System Agents|sensory system agents|mesh-ancestor
6132275|NCT01226511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5538197|NCT04193631|Anticonvulsants|anticonvulsants|mesh-ancestor
5538198|NCT04193592|Pirfenidone|pirfenidone|mesh-list
5538199|NCT04193592|Analgesics|analgesics|mesh-ancestor
5538200|NCT04193592|Sensory System Agents|sensory system agents|mesh-ancestor
5538201|NCT04193592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5538202|NCT04193592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538203|NCT04193592|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5538204|NCT04193592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5538205|NCT04193592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5538206|NCT04193592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5538207|NCT04193592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5538208|NCT04193501|Melatonin|melatonin|mesh-list
5538209|NCT04193501|Antioxidants|antioxidants|mesh-ancestor
5538210|NCT04193501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538211|NCT04193501|Protective Agents|protective agents|mesh-ancestor
5538212|NCT04193501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538213|NCT04193501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5538214|NCT04193553|Lenvatinib|lenvatinib|mesh-list
5538215|NCT04193553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5538216|NCT04193553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6132276|NCT01226511|Antidepressive Agents|antidepressive agents|mesh-ancestor
6132277|NCT01226511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6132278|NCT01226511|Dopamine Agents|dopamine agents|mesh-ancestor
6132279|NCT01226706|Botulinum Toxins|botulinum toxins|mesh-list
6132280|NCT01226706|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6132281|NCT01226706|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6132282|NCT01226706|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6132283|NCT01226706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6132284|NCT01226706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132285|NCT01226706|Cholinergic Agents|cholinergic agents|mesh-ancestor
6132286|NCT01226706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6132287|NCT01226706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132288|NCT01226706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6132289|NCT01226706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6132290|NCT01226719|Leucovorin|leucovorin|mesh-list
6132291|NCT01226719|Fluorouracil|fluorouracil|mesh-list
6132292|NCT01226719|Oxaliplatin|oxaliplatin|mesh-list
6132293|NCT01226719|Irinotecan|irinotecan|mesh-list
6132294|NCT01226719|Panitumumab|panitumumab|mesh-list
6132295|NCT01226719|Antimetabolites|antimetabolites|mesh-ancestor
6132296|NCT01226719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132297|NCT01226719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6132298|NCT01226719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6132299|NCT01226719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6132300|NCT01226719|Immunologic Factors|immunologic factors|mesh-ancestor
6132301|NCT01226719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132302|NCT01226719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6132303|NCT01226719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5538217|NCT04193553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5538218|NCT04193553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538219|NCT04193319|Fluconazole|fluconazole|mesh-list
5538220|NCT04193319|Antifungal Agents|antifungal agents|mesh-ancestor
6132304|NCT01226719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6132305|NCT01226719|Antidotes|antidotes|mesh-ancestor
6132306|NCT01226719|Protective Agents|protective agents|mesh-ancestor
6132307|NCT01226719|Vitamin B Complex|vitamin b complex|mesh-ancestor
6132308|NCT01226719|Vitamins|vitamins|mesh-ancestor
6132309|NCT01226719|Micronutrients|micronutrients|mesh-ancestor
6132310|NCT01226719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6132311|NCT01226732|Capecitabine|capecitabine|mesh-list
6132312|NCT01226732|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6132313|NCT01226732|Antimetabolites|antimetabolites|mesh-ancestor
6132314|NCT01226732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132315|NCT01226732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6132316|NCT01226745|Ceralifimod|ceralifimod|mesh-list
6132317|NCT01226745|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6132318|NCT01226745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132319|NCT01226745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6132320|NCT01226745|Immunologic Factors|immunologic factors|mesh-ancestor
6132321|NCT01226745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132322|NCT01227044|Naltrexone|naltrexone|mesh-list
6132323|NCT01227044|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6132324|NCT01227044|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6132325|NCT01227044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132326|NCT01227044|Sensory System Agents|sensory system agents|mesh-ancestor
6132327|NCT01227044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6132328|NCT01227278|Benralizumab|benralizumab|mesh-list
6132329|NCT01227278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6132330|NCT01227278|Respiratory System Agents|respiratory system agents|mesh-ancestor
6132331|NCT01227395|Azithromycin|azithromycin|mesh-list
6132332|NCT01227395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6132333|NCT01227395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6132334|NCT01227421|Nitazoxanide|nitazoxanide|mesh-list
6132335|NCT01227421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6132336|NCT01227421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6132337|NCT01227434|Palbociclib|palbociclib|mesh-list
6132338|NCT01227434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6132339|NCT01227434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6132340|NCT01227434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6132341|NCT01227434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132342|NCT01227512|Tolvaptan|tolvaptan|mesh-list
6132343|NCT01227512|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6132344|NCT01227512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132345|NCT01227512|Natriuretic Agents|natriuretic agents|mesh-ancestor
6132346|NCT01227512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132347|NCT01227564|Saponin QA-21V1|saponin qa-21v1|mesh-list
6132348|NCT01227564|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6132349|NCT01227564|Immunologic Factors|immunologic factors|mesh-ancestor
6132350|NCT01227564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132351|NCT01227616|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
6132352|NCT01227616|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6132353|NCT01227616|Hematinics|hematinics|mesh-ancestor
6132354|NCT01227616|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6132355|NCT01227616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6132356|NCT01227629|Warfarin|warfarin|mesh-list
6132357|NCT01227629|Dabigatran|dabigatran|mesh-list
6132358|NCT01227629|Anticoagulants|anticoagulants|mesh-ancestor
6132359|NCT01227629|Antithrombins|antithrombins|mesh-ancestor
6132360|NCT01227629|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6132361|NCT01227629|Protease Inhibitors|protease inhibitors|mesh-ancestor
6132362|NCT01227629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6132363|NCT01227629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132364|NCT01227655|Levodopa|levodopa|mesh-list
6132365|NCT01227655|Carbidopa|carbidopa|mesh-list
6132366|NCT01227655|Opicapone|opicapone|mesh-list
6132367|NCT01227655|Benserazide|benserazide|mesh-list
6132368|NCT01227655|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6132369|NCT01227655|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6132370|NCT01227655|Dopamine Agents|dopamine agents|mesh-ancestor
6132371|NCT01227655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6132372|NCT01227655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132373|NCT01227655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132374|NCT01227655|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6132375|NCT01227655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6132376|NCT01227655|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6132377|NCT01227668|Aripiprazole|aripiprazole|mesh-list
6132378|NCT01227668|Antidepressive Agents|antidepressive agents|mesh-ancestor
6132379|NCT01227668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6132380|NCT01227668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6132381|NCT01227668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6132382|NCT01227668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6132383|NCT01227668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132384|NCT01227668|Dopamine Agonists|dopamine agonists|mesh-ancestor
6132385|NCT01227668|Dopamine Agents|dopamine agents|mesh-ancestor
5538221|NCT04193319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5538222|NCT04193319|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5538223|NCT04193319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5538224|NCT04193319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5538225|NCT04193319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538226|NCT04193319|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6132386|NCT01227668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6132387|NCT01227668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132388|NCT01227668|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6132389|NCT01227668|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6132390|NCT01227668|Serotonin Agents|serotonin agents|mesh-ancestor
6132391|NCT01227668|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6132392|NCT01227668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6132393|NCT01227668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6132394|NCT01227668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6132395|NCT01227681|Lenograstim|lenograstim|mesh-list
6132396|NCT01227681|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6132397|NCT01227681|Immunologic Factors|immunologic factors|mesh-ancestor
6132398|NCT01227681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132399|NCT01227707|Leucovorin|leucovorin|mesh-list
6132400|NCT01227707|Bevacizumab|bevacizumab|mesh-list
6132401|NCT01227707|Fluorouracil|fluorouracil|mesh-list
6132402|NCT01227707|Capecitabine|capecitabine|mesh-list
5538227|NCT04193319|Hormone Antagonists|hormone antagonists|mesh-ancestor
5538228|NCT04193319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5538229|NCT04193319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132403|NCT01227707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6132404|NCT01227707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6132405|NCT01227707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6132406|NCT01227707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6132407|NCT01227707|Growth Substances|growth substances|mesh-ancestor
6132408|NCT01227707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132409|NCT01227707|Growth Inhibitors|growth inhibitors|mesh-ancestor
6132410|NCT01227707|Antimetabolites|antimetabolites|mesh-ancestor
6132411|NCT01227707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132412|NCT01227707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6132413|NCT01227707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6132414|NCT01227707|Immunologic Factors|immunologic factors|mesh-ancestor
6132415|NCT01227707|Antidotes|antidotes|mesh-ancestor
6132416|NCT01227707|Protective Agents|protective agents|mesh-ancestor
6132417|NCT01227707|Vitamin B Complex|vitamin b complex|mesh-ancestor
6132418|NCT01227707|Vitamins|vitamins|mesh-ancestor
6132419|NCT01227707|Micronutrients|micronutrients|mesh-ancestor
6132420|NCT01227824|Raltegravir Potassium|raltegravir potassium|mesh-list
6132421|NCT01227824|Dolutegravir|dolutegravir|mesh-list
6132422|NCT01227824|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6132423|NCT01227824|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6132424|NCT01227824|Antiviral Agents|antiviral agents|mesh-ancestor
6132425|NCT01227824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6132426|NCT01227824|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6132427|NCT01227824|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6132428|NCT01227824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6132429|NCT01227824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132430|NCT01227889|Dacarbazine|dacarbazine|mesh-list
6132431|NCT01227889|Dabrafenib|dabrafenib|mesh-list
6132432|NCT01227889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6132433|NCT01227889|Alkylating Agents|alkylating agents|mesh-ancestor
6132434|NCT01227889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132435|NCT01227889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6132436|NCT01227889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6132437|NCT01227889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6132438|NCT01227902|Ezogabine|ezogabine|mesh-list
6132439|NCT01227902|Anticonvulsants|anticonvulsants|mesh-ancestor
6132440|NCT01227902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6132441|NCT01227902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132442|NCT01227967|Ribavirin|ribavirin|mesh-list
6132443|NCT01227967|Oseltamivir|oseltamivir|mesh-list
6132444|NCT01227967|Amantadine|amantadine|mesh-list
6132445|NCT01227967|Antimetabolites|antimetabolites|mesh-ancestor
5538230|NCT04193319|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5538231|NCT04193319|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5538232|NCT04193566|Dapagliflozin|dapagliflozin|mesh-list
5538233|NCT04193566|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5538234|NCT04193566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538235|NCT04193566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5538236|NCT04193566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538237|NCT04193293|Pembrolizumab|pembrolizumab|mesh-list
5538238|NCT04193293|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5538239|NCT04193293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5538240|NCT04193293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5538241|NCT04193293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538242|NCT04193215|Vaccines|vaccines|mesh-list
5538243|NCT04193215|Immunologic Factors|immunologic factors|mesh-ancestor
5538244|NCT04193215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538245|NCT04193228|Carbon Fiber|carbon fiber|mesh-list
5538246|NCT04193228|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6132446|NCT01227967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132447|NCT01227967|Antiviral Agents|antiviral agents|mesh-ancestor
6132448|NCT01227967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6132449|NCT01227967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6132450|NCT01227967|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6132451|NCT01227967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6132452|NCT01227967|Dopamine Agents|dopamine agents|mesh-ancestor
6132453|NCT01227967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6132454|NCT01227967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132455|NCT01227967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6132456|NCT01227967|Analgesics|analgesics|mesh-ancestor
5538247|NCT04193228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5538248|NCT04192981|GDC-0084|gdc-0084|mesh-list
5538249|NCT04192981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5538250|NCT04192981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538251|NCT04193137|Captopril|captopril|mesh-list
5538252|NCT04193137|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5538253|NCT04193137|Protease Inhibitors|protease inhibitors|mesh-ancestor
5538254|NCT04193137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5538255|NCT04193137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538256|NCT04193137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5538257|NCT04192903|Cisplatin|cisplatin|mesh-list
5538258|NCT04192903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5538259|NCT04193059|Paclitaxel|paclitaxel|mesh-list
5538260|NCT04193059|Docetaxel|docetaxel|mesh-list
5538261|NCT04193059|Cyclophosphamide|cyclophosphamide|mesh-list
5538262|NCT04193059|Carboplatin|carboplatin|mesh-list
6132457|NCT01227967|Sensory System Agents|sensory system agents|mesh-ancestor
6132458|NCT01227967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6132459|NCT01227993|Finasteride|finasteride|mesh-list
6132460|NCT01227993|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6132461|NCT01227993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6132462|NCT01227993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6132463|NCT01227993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132464|NCT01227993|Hormone Antagonists|hormone antagonists|mesh-ancestor
5538263|NCT04193059|Trastuzumab|trastuzumab|mesh-list
5538264|NCT04193059|Epirubicin|epirubicin|mesh-list
5538265|NCT04193059|Pertuzumab|pertuzumab|mesh-list
5538266|NCT04193059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5538267|NCT04193059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5538268|NCT04193059|Tubulin Modulators|tubulin modulators|mesh-ancestor
5538269|NCT04193059|Antimitotic Agents|antimitotic agents|mesh-ancestor
5538270|NCT04193059|Mitosis Modulators|mitosis modulators|mesh-ancestor
5538271|NCT04193059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538272|NCT04193059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5538273|NCT04193059|Immunologic Factors|immunologic factors|mesh-ancestor
5538274|NCT04193059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538275|NCT04193059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5538276|NCT04193059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5538277|NCT04193059|Alkylating Agents|alkylating agents|mesh-ancestor
5538278|NCT04193059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5538279|NCT04193059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5538280|NCT04193059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5538281|NCT04193059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5538282|NCT04193059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5538283|NCT04193059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6466421|NCT00478959|Growth Inhibitors|growth inhibitors|mesh-ancestor
5538284|NCT04192916|Rivaroxaban|rivaroxaban|mesh-list
5538285|NCT04192916|Apixaban|apixaban|mesh-list
5538286|NCT04192916|Edoxaban|edoxaban|mesh-list
5538287|NCT04192916|Dabigatran|dabigatran|mesh-list
5538288|NCT04192916|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5538289|NCT04192916|Antithrombins|antithrombins|mesh-ancestor
5538290|NCT04192916|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5538291|NCT04192916|Protease Inhibitors|protease inhibitors|mesh-ancestor
5538292|NCT04192916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5538293|NCT04192916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132465|NCT01227993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6132466|NCT01227993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132467|NCT01227993|Urological Agents|urological agents|mesh-ancestor
6132468|NCT01228019|Niacin|niacin|mesh-list
6132469|NCT01228019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6132470|NCT01228019|Antimetabolites|antimetabolites|mesh-ancestor
6132471|NCT01228019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132472|NCT01228019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6132473|NCT01228019|Vasodilator Agents|vasodilator agents|mesh-ancestor
6132474|NCT01228019|Vitamin B Complex|vitamin b complex|mesh-ancestor
5538294|NCT04192916|Anticoagulants|anticoagulants|mesh-ancestor
5538295|NCT04192812|Leuprolide|leuprolide|mesh-list
5538296|NCT04192812|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5538297|NCT04192812|Fertility Agents|fertility agents|mesh-ancestor
5538298|NCT04192812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5538299|NCT04192812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538300|NCT04192812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5538301|NCT04192812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5538302|NCT04192617|Methotrexate|methotrexate|mesh-list
5538303|NCT04192617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5538304|NCT04192617|Abortifacient Agents|abortifacient agents|mesh-ancestor
5538305|NCT04192617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5538306|NCT04192617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538307|NCT04192617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5538308|NCT04192617|Antimetabolites|antimetabolites|mesh-ancestor
6132475|NCT01228019|Vitamins|vitamins|mesh-ancestor
6132476|NCT01228019|Micronutrients|micronutrients|mesh-ancestor
6132477|NCT01228019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132478|NCT01228071|Testosterone|testosterone|mesh-list
6132479|NCT01228071|Androgens|androgens|mesh-ancestor
6132480|NCT01228071|Hormones|hormones|mesh-ancestor
6132481|NCT01228071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6132482|NCT01228071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132483|NCT01228084|Sulforaphane|sulforaphane|mesh-list
6132484|NCT01228084|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6132485|NCT01228084|Protective Agents|protective agents|mesh-ancestor
6132486|NCT01228084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132487|NCT01228084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6132488|NCT01228149|Acetazolamide|acetazolamide|mesh-list
6132489|NCT01228149|Anticonvulsants|anticonvulsants|mesh-ancestor
6132490|NCT01228149|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6132491|NCT01228149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6132492|NCT01228149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132493|NCT01228149|Diuretics|diuretics|mesh-ancestor
6132494|NCT01228149|Natriuretic Agents|natriuretic agents|mesh-ancestor
6132495|NCT01228149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132496|NCT01228175|Riboflavin|riboflavin|mesh-list
6132497|NCT01228175|Varenicline|varenicline|mesh-list
5538309|NCT04192617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538310|NCT04192617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5538311|NCT04192617|Dermatologic Agents|dermatologic agents|mesh-ancestor
6132498|NCT01228175|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6132499|NCT01228175|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6132500|NCT01228175|Cholinergic Agents|cholinergic agents|mesh-ancestor
6132501|NCT01228175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6132502|NCT01228175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132503|NCT01228175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132504|NCT01228175|Vitamin B Complex|vitamin b complex|mesh-ancestor
6132505|NCT01228175|Vitamins|vitamins|mesh-ancestor
6132506|NCT01228175|Micronutrients|micronutrients|mesh-ancestor
6132507|NCT01228175|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6132508|NCT01228175|Dermatologic Agents|dermatologic agents|mesh-ancestor
6132509|NCT01228318|Zoledronic Acid|zoledronic acid|mesh-list
6132510|NCT01228318|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6132511|NCT01228318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132512|NCT01228734|Leucovorin|leucovorin|mesh-list
6132513|NCT01228734|Folic Acid|folic acid|mesh-list
6132514|NCT01228734|Fluorouracil|fluorouracil|mesh-list
6132515|NCT01228734|Oxaliplatin|oxaliplatin|mesh-list
6132516|NCT01228734|Cetuximab|cetuximab|mesh-list
6132517|NCT01228734|Levoleucovorin|levoleucovorin|mesh-list
6132518|NCT01228734|Antimetabolites|antimetabolites|mesh-ancestor
6132519|NCT01228734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132520|NCT01228734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6132521|NCT01228734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6132522|NCT01228734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6132523|NCT01228734|Immunologic Factors|immunologic factors|mesh-ancestor
6132524|NCT01228734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132525|NCT01228734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6132526|NCT01228734|Antidotes|antidotes|mesh-ancestor
6132527|NCT01228734|Protective Agents|protective agents|mesh-ancestor
6132528|NCT01228734|Vitamin B Complex|vitamin b complex|mesh-ancestor
6132529|NCT01228734|Vitamins|vitamins|mesh-ancestor
6132530|NCT01228734|Micronutrients|micronutrients|mesh-ancestor
6132531|NCT01228734|Hematinics|hematinics|mesh-ancestor
6132532|NCT01228747|Levetiracetam|levetiracetam|mesh-list
6132533|NCT01228747|Anticonvulsants|anticonvulsants|mesh-ancestor
6132534|NCT01228747|Nootropic Agents|nootropic agents|mesh-ancestor
6132535|NCT01228903|Allopurinol|allopurinol|mesh-list
6132536|NCT01228903|Antimetabolites|antimetabolites|mesh-ancestor
6132537|NCT01228903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132538|NCT01228903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6132539|NCT01228903|Gout Suppressants|gout suppressants|mesh-ancestor
6132540|NCT01228903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6132541|NCT01228903|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6132542|NCT01228903|Antioxidants|antioxidants|mesh-ancestor
6132543|NCT01228903|Protective Agents|protective agents|mesh-ancestor
6132544|NCT01228903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132545|NCT01229111|Leucovorin|leucovorin|mesh-list
6132546|NCT01229111|Fluorouracil|fluorouracil|mesh-list
6132547|NCT01229111|Oxaliplatin|oxaliplatin|mesh-list
6132548|NCT01229111|Cediranib|cediranib|mesh-list
6132549|NCT01229111|Calcium|calcium|mesh-list
6132550|NCT01229111|Levoleucovorin|levoleucovorin|mesh-list
6132551|NCT01229111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6132552|NCT01229111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132553|NCT01229111|Antimetabolites|antimetabolites|mesh-ancestor
6132554|NCT01229111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132555|NCT01229111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6132556|NCT01229111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6132557|NCT01229111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6132558|NCT01229111|Immunologic Factors|immunologic factors|mesh-ancestor
6132559|NCT01229111|Antidotes|antidotes|mesh-ancestor
6132560|NCT01229111|Protective Agents|protective agents|mesh-ancestor
6132561|NCT01229111|Vitamin B Complex|vitamin b complex|mesh-ancestor
6132562|NCT01229111|Vitamins|vitamins|mesh-ancestor
6132563|NCT01229111|Micronutrients|micronutrients|mesh-ancestor
6132564|NCT01229111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6132565|NCT01229111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6132566|NCT01229150|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6132567|NCT01229150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6132568|NCT01229150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6132569|NCT01229150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6132570|NCT01229150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132571|NCT01229176|Vaccines|vaccines|mesh-list
6132572|NCT01229176|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5538312|NCT04192617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5538313|NCT04192617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5538314|NCT04192617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5538315|NCT04192617|Immunologic Factors|immunologic factors|mesh-ancestor
5538316|NCT04192617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6132573|NCT01229176|Immunologic Factors|immunologic factors|mesh-ancestor
6132574|NCT01229176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132575|NCT01229228|Naproxen|naproxen|mesh-list
6132576|NCT01229228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6132577|NCT01229228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6132578|NCT01229228|Analgesics|analgesics|mesh-ancestor
6132579|NCT01229228|Sensory System Agents|sensory system agents|mesh-ancestor
6132580|NCT01229228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6132581|NCT01229228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132582|NCT01229228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6132583|NCT01229228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6132584|NCT01229228|Gout Suppressants|gout suppressants|mesh-ancestor
6132585|NCT01229228|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6132586|NCT01229228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6132587|NCT01229228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538317|NCT04192617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5538318|NCT04192773|Lidocaine|lidocaine|mesh-list
5538319|NCT04192773|Anesthetics, Local|anesthetics, local|mesh-ancestor
5538320|NCT04192773|Anesthetics|anesthetics|mesh-ancestor
5538321|NCT04192773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5538322|NCT04192773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538323|NCT04192773|Sensory System Agents|sensory system agents|mesh-ancestor
6132588|NCT01229254|Amiodarone|amiodarone|mesh-list
6132589|NCT01229254|Betrixaban|betrixaban|mesh-list
6132590|NCT01229254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6132591|NCT01229254|Vasodilator Agents|vasodilator agents|mesh-ancestor
6132592|NCT01229254|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6132593|NCT01229254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6132594|NCT01229254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132595|NCT01229254|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6132596|NCT01229254|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5538324|NCT04192773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5538325|NCT04192773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5538326|NCT04192773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5538327|NCT04192773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5538328|NCT04192773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5538329|NCT04192773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602036|NCT04974996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5602037|NCT04974996|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6132597|NCT01229254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6132598|NCT01229254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6132599|NCT01229254|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6132600|NCT01229254|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6132601|NCT01229254|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6132602|NCT01229254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6132603|NCT01229254|Antithrombins|antithrombins|mesh-ancestor
6132604|NCT01229254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6132605|NCT01229254|Protease Inhibitors|protease inhibitors|mesh-ancestor
6132606|NCT01229254|Anticoagulants|anticoagulants|mesh-ancestor
6132607|NCT01229267|Vaccines|vaccines|mesh-list
6132608|NCT01229267|Immunologic Factors|immunologic factors|mesh-ancestor
6132609|NCT01229267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602038|NCT04974996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5602039|NCT04974996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6132610|NCT01229371|Vaccines|vaccines|mesh-list
6132611|NCT01229371|Immunologic Factors|immunologic factors|mesh-ancestor
6132612|NCT01229371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132613|NCT01229410|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6132614|NCT01229410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6132615|NCT01229410|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6132616|NCT01229410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6132617|NCT01229410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6132618|NCT01229410|Adrenergic Agents|adrenergic agents|mesh-ancestor
6132619|NCT01229410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6132620|NCT01229410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132621|NCT01229410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132622|NCT01229423|Bimatoprost|bimatoprost|mesh-list
6132623|NCT01229423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6132624|NCT01229449|Acetaminophen|acetaminophen|mesh-list
6132625|NCT01229449|Ibuprofen|ibuprofen|mesh-list
6132626|NCT01229449|Codeine|codeine|mesh-list
6132627|NCT01229449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6132628|NCT01229449|Analgesics|analgesics|mesh-ancestor
6132629|NCT01229449|Sensory System Agents|sensory system agents|mesh-ancestor
6132630|NCT01229449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6132631|NCT01229449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132632|NCT01229449|Antipyretics|antipyretics|mesh-ancestor
6132633|NCT01229449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6132634|NCT01229449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5602040|NCT04974996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5602041|NCT04974996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6132635|NCT01229449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6132636|NCT01229449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6132637|NCT01229449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6132638|NCT01229449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132639|NCT01229449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6132640|NCT01229449|Narcotics|narcotics|mesh-ancestor
6132641|NCT01229449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5538330|NCT04192643|Tranexamic Acid|tranexamic acid|mesh-list
5538331|NCT04192643|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5538332|NCT04192643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5538333|NCT04192643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538334|NCT04192643|Hemostatics|hemostatics|mesh-ancestor
5538335|NCT04192643|Coagulants|coagulants|mesh-ancestor
5538336|NCT04192266|Estradiol|estradiol|mesh-list
5538337|NCT04192266|Estrogens|estrogens|mesh-ancestor
5538338|NCT04192266|Hormones|hormones|mesh-ancestor
5538339|NCT04192266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6132642|NCT01229449|Antitussive Agents|antitussive agents|mesh-ancestor
6132643|NCT01229449|Respiratory System Agents|respiratory system agents|mesh-ancestor
6132644|NCT01229462|Timolol|timolol|mesh-list
6132645|NCT01229462|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6132646|NCT01229462|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6132647|NCT01229462|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6132648|NCT01229462|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6132649|NCT01229462|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6132650|NCT01229462|Adrenergic Agents|adrenergic agents|mesh-ancestor
6132651|NCT01229462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6132652|NCT01229462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132653|NCT01229462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132654|NCT01229462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6132655|NCT01229462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6132656|NCT01229462|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6132657|NCT01229462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6132658|NCT01229462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6132659|NCT01229527|Meperidine|meperidine|mesh-list
6132660|NCT01229527|Remifentanil|remifentanil|mesh-list
6132661|NCT01229527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6132662|NCT01229527|Narcotics|narcotics|mesh-ancestor
6132663|NCT01229527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6132664|NCT01229527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132665|NCT01229527|Analgesics|analgesics|mesh-ancestor
6132666|NCT01229527|Sensory System Agents|sensory system agents|mesh-ancestor
6132667|NCT01229527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6132668|NCT01229527|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6132669|NCT01229735|Topiramate|topiramate|mesh-list
6132670|NCT01229735|Levetiracetam|levetiracetam|mesh-list
6132671|NCT01229735|Anticonvulsants|anticonvulsants|mesh-ancestor
6132672|NCT01229735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6132673|NCT01229735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132674|NCT01229735|Nootropic Agents|nootropic agents|mesh-ancestor
6132675|NCT01229891|Vitamin D|vitamin d|mesh-list
6132676|NCT01229891|Ergocalciferols|ergocalciferols|mesh-list
6132677|NCT01229891|Vitamins|vitamins|mesh-list
6132678|NCT01229891|Calcium|calcium|mesh-list
6132679|NCT01229891|Micronutrients|micronutrients|mesh-ancestor
6132680|NCT01229891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132681|NCT01229891|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6132682|NCT01229891|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6132683|NCT01229943|Bevacizumab|bevacizumab|mesh-list
6132684|NCT01229943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6132685|NCT01229943|Everolimus|everolimus|mesh-list
6132686|NCT01229943|Octreotide|octreotide|mesh-list
6132687|NCT01229943|Endothelial Growth Factors|endothelial growth factors|mesh-list
6132688|NCT01229943|Antibodies|antibodies|mesh-list
6132689|NCT01229943|Immunoglobulins|immunoglobulins|mesh-list
6132690|NCT01229943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6132691|NCT01229943|Immunoglobulin G|immunoglobulin g|mesh-list
6132692|NCT01229943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6132693|NCT01229943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6132694|NCT01229943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6132695|NCT01229943|Growth Substances|growth substances|mesh-ancestor
6132696|NCT01229943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538340|NCT04192266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538341|NCT04192435|Tranexamic Acid|tranexamic acid|mesh-list
5538342|NCT04192435|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5538343|NCT04192435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6132697|NCT01229943|Growth Inhibitors|growth inhibitors|mesh-ancestor
6132698|NCT01229943|Immunologic Factors|immunologic factors|mesh-ancestor
6132699|NCT01229943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6132700|NCT01229943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6132701|NCT01229943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6132702|NCT01230177|Etanercept|etanercept|mesh-list
6132703|NCT01230177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6132704|NCT01230177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6132705|NCT01230177|Analgesics|analgesics|mesh-ancestor
6132706|NCT01230177|Sensory System Agents|sensory system agents|mesh-ancestor
6132707|NCT01230177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6132708|NCT01230177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132709|NCT01230177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6132710|NCT01230177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6132711|NCT01230177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6132712|NCT01230177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6132713|NCT01230177|Immunologic Factors|immunologic factors|mesh-ancestor
6132714|NCT01230424|Triamcinolone|triamcinolone|mesh-list
6132715|NCT01230424|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6132716|NCT01230424|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6132717|NCT01230424|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6132718|NCT01230424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6132719|NCT01230424|Glucocorticoids|glucocorticoids|mesh-ancestor
6132720|NCT01230424|Hormones|hormones|mesh-ancestor
6132721|NCT01230424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6132722|NCT01230424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132723|NCT01230424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6132724|NCT01230424|Immunologic Factors|immunologic factors|mesh-ancestor
6132725|NCT01230424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6132726|NCT01230424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132727|NCT01230502|Mycophenolic Acid|mycophenolic acid|mesh-list
6132728|NCT01230502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6132729|NCT01230502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6132730|NCT01230502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5538344|NCT04192435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538345|NCT04192435|Hemostatics|hemostatics|mesh-ancestor
5538346|NCT04192435|Coagulants|coagulants|mesh-ancestor
5538347|NCT04192292|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5538348|NCT04192292|Gliclazide|gliclazide|mesh-list
5538349|NCT04192292|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
5538350|NCT04192292|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5538351|NCT04192292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538352|NCT04192292|Incretins|incretins|mesh-ancestor
5538353|NCT04192292|Hormones|hormones|mesh-ancestor
5538354|NCT04192292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5538355|NCT04192292|Protease Inhibitors|protease inhibitors|mesh-ancestor
5538356|NCT04192292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5538357|NCT04192292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132731|NCT01230502|Antitubercular Agents|antitubercular agents|mesh-ancestor
6132732|NCT01230502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6132733|NCT01230502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6132734|NCT01230502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6132735|NCT01230502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132736|NCT01230593|Tobramycin|tobramycin|mesh-list
6132737|NCT01230593|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
6132738|NCT01230593|Dexamethasone|dexamethasone|mesh-list
5538358|NCT04192253|Paclitaxel|paclitaxel|mesh-list
5538359|NCT04192253|Carboplatin|carboplatin|mesh-list
5538360|NCT04192253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5538361|NCT04192253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5538362|NCT04192253|Tubulin Modulators|tubulin modulators|mesh-ancestor
5538363|NCT04192253|Antimitotic Agents|antimitotic agents|mesh-ancestor
5538364|NCT04192253|Mitosis Modulators|mitosis modulators|mesh-ancestor
5538365|NCT04192253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538366|NCT04192656|Methylprednisolone|methylprednisolone|mesh-list
5538367|NCT04192656|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5538368|NCT04192656|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5538369|NCT04192656|Prednisolone|prednisolone|mesh-list
6132739|NCT01230593|Dexamethasone acetate|dexamethasone acetate|mesh-list
5538370|NCT04192656|Prednisolone acetate|prednisolone acetate|mesh-list
5538371|NCT04192656|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6132740|NCT01230593|BB 1101|bb 1101|mesh-list
6132741|NCT01230593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6132742|NCT01230593|Antiemetics|antiemetics|mesh-ancestor
6132743|NCT01230593|Autonomic Agents|autonomic agents|mesh-ancestor
6132744|NCT01230593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6132745|NCT01230593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132746|NCT01230593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6132747|NCT01230593|Glucocorticoids|glucocorticoids|mesh-ancestor
6132748|NCT01230593|Hormones|hormones|mesh-ancestor
6132749|NCT01230593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6132750|NCT01230593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6132751|NCT01230593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6132752|NCT01230593|Protease Inhibitors|protease inhibitors|mesh-ancestor
6132753|NCT01230593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6132754|NCT01230593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132755|NCT01230593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6132756|NCT01230593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6132757|NCT01230593|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6132758|NCT01230593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6132759|NCT01230710|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6132760|NCT01230710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6132761|NCT01230710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6132762|NCT01230710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6132763|NCT01230710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132764|NCT01230749|Pioglitazone|pioglitazone|mesh-list
6132765|NCT01230749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6132766|NCT01230749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132767|NCT01230814|Metronidazole|metronidazole|mesh-list
6132768|NCT01230814|Miconazole|miconazole|mesh-list
6132769|NCT01230814|Clotrimazole|clotrimazole|mesh-list
6132770|NCT01230814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6132771|NCT01230814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6132772|NCT01230814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6132773|NCT01230814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6132774|NCT01230814|Antifungal Agents|antifungal agents|mesh-ancestor
6132775|NCT01230814|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6132776|NCT01230814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6132777|NCT01230814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6132778|NCT01230814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132779|NCT01230814|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6132780|NCT01230814|Hormone Antagonists|hormone antagonists|mesh-ancestor
6132781|NCT01230814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6132782|NCT01230814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132783|NCT01230814|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6132784|NCT01230814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6132785|NCT01230814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6132786|NCT01230827|Golimumab|golimumab|mesh-list
6132787|NCT01230827|Methotrexate|methotrexate|mesh-list
6132788|NCT01230827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6132789|NCT01230827|Abortifacient Agents|abortifacient agents|mesh-ancestor
6132790|NCT01230827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6132791|NCT01230827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132792|NCT01230827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6132793|NCT01230827|Antimetabolites|antimetabolites|mesh-ancestor
6132794|NCT01230827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132795|NCT01230827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6132796|NCT01230827|Dermatologic Agents|dermatologic agents|mesh-ancestor
6132797|NCT01230827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6132798|NCT01230827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6132799|NCT01230827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6132800|NCT01230827|Immunologic Factors|immunologic factors|mesh-ancestor
6132801|NCT01230827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6132802|NCT01230827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6132803|NCT01230827|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6132804|NCT01230827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6132805|NCT01230892|Atenolol|atenolol|mesh-list
6132806|NCT01230892|Nebivolol|nebivolol|mesh-list
6132807|NCT01230892|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5538372|NCT04192656|Prednisolone phosphate|prednisolone phosphate|mesh-list
5538373|NCT04192656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5538374|NCT04192656|Antiemetics|antiemetics|mesh-ancestor
5538375|NCT04192656|Autonomic Agents|autonomic agents|mesh-ancestor
5538376|NCT04192656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5538377|NCT04192656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132808|NCT01230892|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6132809|NCT01230892|Sympatholytics|sympatholytics|mesh-ancestor
6132810|NCT01230892|Autonomic Agents|autonomic agents|mesh-ancestor
5538378|NCT04192656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5538379|NCT04192656|Glucocorticoids|glucocorticoids|mesh-ancestor
5538380|NCT04192656|Hormones|hormones|mesh-ancestor
5538381|NCT04192656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5538382|NCT04192656|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5538383|NCT04192656|Protective Agents|protective agents|mesh-ancestor
5538384|NCT04192656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5538385|NCT04192656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5538386|NCT04191889|Apatinib|apatinib|mesh-list
5538387|NCT04191889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5538388|NCT04191889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5538389|NCT04191889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5538390|NCT04191889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538391|NCT04191954|Fasudil|fasudil|mesh-list
5538392|NCT04191954|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5538393|NCT04191954|Lubricant Eye Drops|lubricant eye drops|mesh-list
5538394|NCT04191954|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5538395|NCT04191954|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5538396|NCT04191954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5538397|NCT04191954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538398|NCT04191954|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5538399|NCT04191954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538400|NCT04191954|Vasodilator Agents|vasodilator agents|mesh-ancestor
5538401|NCT04191954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5538402|NCT04191954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5538403|NCT04192032|Nicotine|nicotine|mesh-list
5538404|NCT04192032|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5538405|NCT04192032|Autonomic Agents|autonomic agents|mesh-ancestor
5538406|NCT04192032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5538407|NCT04192032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538408|NCT04192032|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5538409|NCT04192032|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5538410|NCT04192032|Cholinergic Agents|cholinergic agents|mesh-ancestor
5538411|NCT04192032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6132811|NCT01230892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6132812|NCT01230892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132813|NCT01230892|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6132814|NCT01230892|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6132815|NCT01230892|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6132816|NCT01230892|Adrenergic Agents|adrenergic agents|mesh-ancestor
6132817|NCT01230892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6132818|NCT01230892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132819|NCT01230892|Vasodilator Agents|vasodilator agents|mesh-ancestor
6132820|NCT01230892|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6132821|NCT01230892|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6132822|NCT01230892|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6132823|NCT01231230|Fluticasone|fluticasone|mesh-list
6132824|NCT01231230|Xhance|xhance|mesh-list
6132825|NCT01231230|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5538412|NCT04192032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538413|NCT04192019|Glucagon|glucagon|mesh-list
5538414|NCT04192019|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5538415|NCT04192019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5538416|NCT04192019|Hormones|hormones|mesh-ancestor
5538417|NCT04192019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6132826|NCT01231230|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6132827|NCT01231230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6132828|NCT01231230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6132829|NCT01231230|Autonomic Agents|autonomic agents|mesh-ancestor
6132830|NCT01231230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6132831|NCT01231230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132832|NCT01231230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6132833|NCT01231230|Respiratory System Agents|respiratory system agents|mesh-ancestor
6132834|NCT01231230|Dermatologic Agents|dermatologic agents|mesh-ancestor
6132835|NCT01231230|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6132836|NCT01231230|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6132837|NCT01231230|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6132838|NCT01231230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6132839|NCT01231230|Adrenergic Agents|adrenergic agents|mesh-ancestor
5538418|NCT04192019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538419|NCT04192019|Incretins|incretins|mesh-ancestor
5538420|NCT04192331|Paclitaxel|paclitaxel|mesh-list
5538421|NCT04192331|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5538422|NCT04192331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5538423|NCT04192331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5538424|NCT04192331|Tubulin Modulators|tubulin modulators|mesh-ancestor
6132840|NCT01231230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6132841|NCT01231230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132842|NCT01231230|Glucocorticoids|glucocorticoids|mesh-ancestor
6132843|NCT01231230|Hormones|hormones|mesh-ancestor
6132844|NCT01231230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6132845|NCT01231230|Sympathomimetics|sympathomimetics|mesh-ancestor
6132846|NCT01231321|Adalimumab|adalimumab|mesh-list
6132847|NCT01231321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6132848|NCT01231321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6132849|NCT01231334|Clindamycin|clindamycin|mesh-list
6132850|NCT01231334|Clindamycin palmitate|clindamycin palmitate|mesh-list
6132851|NCT01231334|Clindamycin phosphate|clindamycin phosphate|mesh-list
6132852|NCT01231334|Dapsone|dapsone|mesh-list
6132853|NCT01231334|Adapalene|adapalene|mesh-list
6132854|NCT01231334|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6132855|NCT01231334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6132856|NCT01231334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5538425|NCT04192331|Antimitotic Agents|antimitotic agents|mesh-ancestor
5538426|NCT04192331|Mitosis Modulators|mitosis modulators|mesh-ancestor
5538427|NCT04192331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538428|NCT04191694|Ondansetron|ondansetron|mesh-list
5538429|NCT04191694|Antiemetics|antiemetics|mesh-ancestor
5538430|NCT04191694|Autonomic Agents|autonomic agents|mesh-ancestor
5538431|NCT04191694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5538432|NCT04191694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538433|NCT04191694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5538434|NCT04191694|Antipruritics|antipruritics|mesh-ancestor
5538435|NCT04191694|Dermatologic Agents|dermatologic agents|mesh-ancestor
5538436|NCT04191694|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5538437|NCT04191694|Serotonin Agents|serotonin agents|mesh-ancestor
6132857|NCT01231334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6132858|NCT01231334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6132859|NCT01231334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132860|NCT01231334|Dermatologic Agents|dermatologic agents|mesh-ancestor
6132861|NCT01231334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6132862|NCT01231334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6132863|NCT01231334|Analgesics|analgesics|mesh-ancestor
6132864|NCT01231334|Sensory System Agents|sensory system agents|mesh-ancestor
6132865|NCT01231334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6132866|NCT01231334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132867|NCT01231334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6132868|NCT01231334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6132869|NCT01231334|Antimalarials|antimalarials|mesh-ancestor
6132870|NCT01231334|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6132871|NCT01231334|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6132872|NCT01231334|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6132873|NCT01231334|Leprostatic Agents|leprostatic agents|mesh-ancestor
6132874|NCT01231373|Polidocanol|polidocanol|mesh-list
6132875|NCT01231373|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
6132876|NCT01231373|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6132877|NCT01231399|Calcium, Dietary|calcium, dietary|mesh-list
5538438|NCT04191694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5538439|NCT04191694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538440|NCT04191694|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5538441|NCT04191694|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5602042|NCT04974996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6132878|NCT01231399|Leucovorin|leucovorin|mesh-list
6132879|NCT01231399|Fluorouracil|fluorouracil|mesh-list
6132880|NCT01231399|Oxaliplatin|oxaliplatin|mesh-list
6132881|NCT01231399|Everolimus|everolimus|mesh-list
6132882|NCT01231399|Calcium|calcium|mesh-list
6132883|NCT01231399|Levoleucovorin|levoleucovorin|mesh-list
6132884|NCT01231399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6132885|NCT01231399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132886|NCT01231399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6132887|NCT01231399|Antimetabolites|antimetabolites|mesh-ancestor
6132888|NCT01231399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132889|NCT01231399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6132890|NCT01231399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6132891|NCT01231399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6132892|NCT01231399|Immunologic Factors|immunologic factors|mesh-ancestor
6132893|NCT01231399|Antidotes|antidotes|mesh-ancestor
6132894|NCT01231399|Protective Agents|protective agents|mesh-ancestor
6132895|NCT01231399|Vitamin B Complex|vitamin b complex|mesh-ancestor
6132896|NCT01231399|Vitamins|vitamins|mesh-ancestor
6132897|NCT01231399|Micronutrients|micronutrients|mesh-ancestor
6132898|NCT01231412|Cyclosporine|cyclosporine|mesh-list
6132899|NCT01231412|Sirolimus|sirolimus|mesh-list
6132900|NCT01231412|Mycophenolic Acid|mycophenolic acid|mesh-list
6132901|NCT01231412|Fludarabine|fludarabine|mesh-list
6132902|NCT01231412|Fludarabine phosphate|fludarabine phosphate|mesh-list
5538442|NCT04191694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5538443|NCT04191694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5538444|NCT04191694|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5538445|NCT04191681|Valsartan|valsartan|mesh-list
6132903|NCT01231412|Cyclosporins|cyclosporins|mesh-list
6132904|NCT01231412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6132905|NCT01231412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6132906|NCT01231412|Antimetabolites|antimetabolites|mesh-ancestor
6132907|NCT01231412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132908|NCT01231412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6132909|NCT01231412|Immunologic Factors|immunologic factors|mesh-ancestor
6132910|NCT01231412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132911|NCT01231412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6132912|NCT01231412|Antifungal Agents|antifungal agents|mesh-ancestor
6132913|NCT01231412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6132914|NCT01231412|Dermatologic Agents|dermatologic agents|mesh-ancestor
6132915|NCT01231412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6132916|NCT01231412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6132917|NCT01231412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6666290|NCT01522040|Sensory System Agents|sensory system agents|mesh-ancestor
6666291|NCT01522040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6666292|NCT01522040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666293|NCT01522040|Anesthetics|anesthetics|mesh-ancestor
6666294|NCT01522040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6666295|NCT01522040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6666296|NCT01522040|Anticonvulsants|anticonvulsants|mesh-ancestor
6666297|NCT01522040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6666298|NCT01522040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6666299|NCT01522040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666300|NCT01522040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6666301|NCT01522040|Tocolytic Agents|tocolytic agents|mesh-ancestor
6666302|NCT01522040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6666303|NCT01522092|Citalopram|citalopram|mesh-list
6666304|NCT01522092|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6666305|NCT01522092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6666306|NCT01522092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6666307|NCT01522092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666308|NCT01522092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6666309|NCT01522092|Serotonin Agents|serotonin agents|mesh-ancestor
6132918|NCT01231412|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6132919|NCT01231412|Antitubercular Agents|antitubercular agents|mesh-ancestor
6132920|NCT01231412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6132921|NCT01231464|Fluticasone|fluticasone|mesh-list
6132922|NCT01231464|Xhance|xhance|mesh-list
6132923|NCT01231464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6132924|NCT01231464|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6132925|NCT01231464|Autonomic Agents|autonomic agents|mesh-ancestor
6132926|NCT01231464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6132927|NCT01231464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132928|NCT01231464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6132929|NCT01231464|Respiratory System Agents|respiratory system agents|mesh-ancestor
6132930|NCT01231464|Dermatologic Agents|dermatologic agents|mesh-ancestor
6132931|NCT01231464|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6132932|NCT01231503|Vaccines|vaccines|mesh-list
6132933|NCT01231503|Immunologic Factors|immunologic factors|mesh-ancestor
5538446|NCT04191681|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5538447|NCT04191681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5538448|NCT04191681|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5538449|NCT04191681|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5538450|NCT04191681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538451|NCT04191863|Valproic Acid|valproic acid|mesh-list
5538452|NCT04191863|Anticonvulsants|anticonvulsants|mesh-ancestor
5538453|NCT04191863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5538454|NCT04191863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538455|NCT04191863|GABA Agents|gaba agents|mesh-ancestor
5538456|NCT04191863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5538457|NCT04191863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538458|NCT04191863|Antimanic Agents|antimanic agents|mesh-ancestor
5538459|NCT04191863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5538460|NCT04191863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5538461|NCT04191863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5538462|NCT04191447|Budesonide|budesonide|mesh-list
5538463|NCT04191447|Formoterol Fumarate|formoterol fumarate|mesh-list
5538464|NCT04191447|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
5538465|NCT04191447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6132934|NCT01231503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132935|NCT01231516|Raltegravir Potassium|raltegravir potassium|mesh-list
6132936|NCT01231516|Dolutegravir|dolutegravir|mesh-list
6132937|NCT01231516|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6132938|NCT01231516|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6132939|NCT01231516|Antiviral Agents|antiviral agents|mesh-ancestor
6132940|NCT01231516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6132941|NCT01231516|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6132942|NCT01231516|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6132943|NCT01231516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6132944|NCT01231516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132945|NCT01231555|Efavirenz|efavirenz|mesh-list
6132946|NCT01231555|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6132947|NCT01231555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6132948|NCT01231555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6132949|NCT01231555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132950|NCT01231555|Antiviral Agents|antiviral agents|mesh-ancestor
6132951|NCT01231555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6132952|NCT01231555|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6132953|NCT01231555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6132954|NCT01231555|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6132955|NCT01231555|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6132956|NCT01231555|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6132957|NCT01231555|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6132958|NCT01231581|Gemcitabine|gemcitabine|mesh-list
6132959|NCT01231581|Trametinib|trametinib|mesh-list
6132960|NCT01231581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6132961|NCT01231581|Antimetabolites|antimetabolites|mesh-ancestor
6132962|NCT01231581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132963|NCT01231581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6132964|NCT01231581|Antiviral Agents|antiviral agents|mesh-ancestor
6132965|NCT01231581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6132966|NCT01231581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6132967|NCT01231581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6132968|NCT01231581|Immunologic Factors|immunologic factors|mesh-ancestor
6132969|NCT01231581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132970|NCT01231581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6132971|NCT01231607|Finasteride|finasteride|mesh-list
5538466|NCT04191447|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5538467|NCT04191447|Autonomic Agents|autonomic agents|mesh-ancestor
5538468|NCT04191447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5538469|NCT04191447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538470|NCT04191447|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5538471|NCT04191447|Respiratory System Agents|respiratory system agents|mesh-ancestor
5538472|NCT04191447|Glucocorticoids|glucocorticoids|mesh-ancestor
5538473|NCT04191447|Hormones|hormones|mesh-ancestor
5538474|NCT04191447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5538475|NCT04191447|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5538476|NCT04191447|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5538477|NCT04191447|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5538478|NCT04191447|Adrenergic Agents|adrenergic agents|mesh-ancestor
5538479|NCT04191447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5538480|NCT04191447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538481|NCT04191434|Budesonide|budesonide|mesh-list
5538482|NCT04191434|Formoterol Fumarate|formoterol fumarate|mesh-list
5538483|NCT04191434|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
5538484|NCT04191434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5538485|NCT04191434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5538486|NCT04191434|Autonomic Agents|autonomic agents|mesh-ancestor
6132972|NCT01231607|Dutasteride|dutasteride|mesh-list
6132973|NCT01231607|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6132974|NCT01231607|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6132975|NCT01231607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6132976|NCT01231607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132977|NCT01231607|Hormone Antagonists|hormone antagonists|mesh-ancestor
6132978|NCT01231607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6132979|NCT01231607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132980|NCT01231607|Urological Agents|urological agents|mesh-ancestor
5538487|NCT04191434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5538488|NCT04191434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538489|NCT04191434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5538490|NCT04191434|Respiratory System Agents|respiratory system agents|mesh-ancestor
5538491|NCT04191434|Glucocorticoids|glucocorticoids|mesh-ancestor
5538492|NCT04191434|Hormones|hormones|mesh-ancestor
6132981|NCT01231620|Oseltamivir|oseltamivir|mesh-list
6132982|NCT01231620|Zanamivir|zanamivir|mesh-list
6132983|NCT01231620|Antiviral Agents|antiviral agents|mesh-ancestor
6132984|NCT01231620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6132985|NCT01231620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6132986|NCT01231620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6132987|NCT01231633|Dexamethasone|dexamethasone|mesh-list
6132988|NCT01231633|Bevacizumab|bevacizumab|mesh-list
6132989|NCT01231633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5538493|NCT04191434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5538494|NCT04191434|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5538495|NCT04191434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5538496|NCT04191434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5538497|NCT04191434|Adrenergic Agents|adrenergic agents|mesh-ancestor
5538498|NCT04191434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5538499|NCT04191434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538500|NCT04191382|Letrozole|letrozole|mesh-list
5538501|NCT04191382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5538502|NCT04191382|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5538503|NCT04191382|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5538504|NCT04191382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5538505|NCT04191382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538506|NCT04191382|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5538507|NCT04191382|Hormone Antagonists|hormone antagonists|mesh-ancestor
5538508|NCT04191382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5538509|NCT04191382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538510|NCT04190927|Estradiol|estradiol|mesh-list
5538511|NCT04190927|Progesterone|progesterone|mesh-list
5538512|NCT04190927|Estrogens|estrogens|mesh-ancestor
5538513|NCT04190927|Hormones|hormones|mesh-ancestor
5538514|NCT04190927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5538515|NCT04190927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538516|NCT04190927|Progestins|progestins|mesh-ancestor
5538517|NCT04191135|Gemcitabine|gemcitabine|mesh-list
5538518|NCT04191135|Carboplatin|carboplatin|mesh-list
5538519|NCT04191135|Pembrolizumab|pembrolizumab|mesh-list
5538520|NCT04191135|Olaparib|olaparib|mesh-list
5538521|NCT04191135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6132990|NCT01231633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6132991|NCT01231633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6132992|NCT01231633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6132993|NCT01231633|Growth Substances|growth substances|mesh-ancestor
6132994|NCT01231633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6132995|NCT01231633|Growth Inhibitors|growth inhibitors|mesh-ancestor
6132996|NCT01231633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6132997|NCT01231633|Antiemetics|antiemetics|mesh-ancestor
6132998|NCT01231633|Autonomic Agents|autonomic agents|mesh-ancestor
6132999|NCT01231633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6133000|NCT01231633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6133001|NCT01231633|Glucocorticoids|glucocorticoids|mesh-ancestor
6133002|NCT01231633|Hormones|hormones|mesh-ancestor
6133003|NCT01231633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6133004|NCT01231633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6133005|NCT01231659|Everolimus|everolimus|mesh-list
6133006|NCT01231659|Letrozole|letrozole|mesh-list
6133007|NCT01231659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6133008|NCT01231659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6133009|NCT01231659|Immunologic Factors|immunologic factors|mesh-ancestor
6133010|NCT01231659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133011|NCT01231659|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6133012|NCT01231659|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6133013|NCT01231659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6133014|NCT01231659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133015|NCT01231659|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6133016|NCT01231659|Hormone Antagonists|hormone antagonists|mesh-ancestor
6133017|NCT01231659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6133018|NCT01231841|Cyclosporine|cyclosporine|mesh-list
6133019|NCT01231841|Cyclosporins|cyclosporins|mesh-list
6133020|NCT01231841|Thymoglobulin|thymoglobulin|mesh-list
6133021|NCT01231841|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6133022|NCT01231841|Immunoglobulins|immunoglobulins|mesh-list
6133023|NCT01231841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6133024|NCT01231841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133025|NCT01231841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6133026|NCT01231841|Immunologic Factors|immunologic factors|mesh-ancestor
6133027|NCT01231841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133028|NCT01231841|Antifungal Agents|antifungal agents|mesh-ancestor
6133029|NCT01231841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6133030|NCT01231841|Dermatologic Agents|dermatologic agents|mesh-ancestor
6133031|NCT01231841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6133032|NCT01231841|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6133033|NCT01231906|Cyclophosphamide|cyclophosphamide|mesh-list
6133034|NCT01231906|Ifosfamide|ifosfamide|mesh-list
6133035|NCT01231906|Isophosphamide mustard|isophosphamide mustard|mesh-list
6133036|NCT01231906|Doxorubicin|doxorubicin|mesh-list
6466422|NCT00478959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6466423|NCT00478985|Imatinib Mesylate|imatinib mesylate|mesh-list
6466424|NCT00478985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6466425|NCT00478985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6466426|NCT00478985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6466427|NCT00478985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466428|NCT00478998|Tamsulosin|tamsulosin|mesh-list
6466429|NCT00478998|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6466430|NCT00478998|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5538522|NCT04191135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6133037|NCT01231906|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6133038|NCT01231906|Etoposide|etoposide|mesh-list
6133039|NCT01231906|Vincristine|vincristine|mesh-list
6133040|NCT01231906|Etoposide phosphate|etoposide phosphate|mesh-list
6133041|NCT01231906|Topotecan|topotecan|mesh-list
6133042|NCT01231906|Podophyllotoxin|podophyllotoxin|mesh-list
6133043|NCT01231906|Dexrazoxane|dexrazoxane|mesh-list
6133044|NCT01231906|Razoxane|razoxane|mesh-list
6133045|NCT01231906|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|mesh-list
6133046|NCT01231906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6133047|NCT01231906|Immunologic Factors|immunologic factors|mesh-ancestor
5538523|NCT04191135|Antimetabolites|antimetabolites|mesh-ancestor
5538524|NCT04191135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538525|NCT04191135|Antiviral Agents|antiviral agents|mesh-ancestor
5538526|NCT04191135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5538527|NCT04191135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5538528|NCT04191135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6133048|NCT01231906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133049|NCT01231906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6466431|NCT00478998|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6133050|NCT01231906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6133051|NCT01231906|Alkylating Agents|alkylating agents|mesh-ancestor
6133052|NCT01231906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538529|NCT04191135|Immunologic Factors|immunologic factors|mesh-ancestor
5538530|NCT04191135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538531|NCT04191135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6133053|NCT01231906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6133054|NCT01231906|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6133055|NCT01231906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6133056|NCT01231906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6133057|NCT01231906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6133058|NCT01231906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6133059|NCT01231906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6133060|NCT01231906|Tubulin Modulators|tubulin modulators|mesh-ancestor
6133061|NCT01231906|Antimitotic Agents|antimitotic agents|mesh-ancestor
6133062|NCT01231906|Mitosis Modulators|mitosis modulators|mesh-ancestor
6133063|NCT01231906|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6133064|NCT01231906|Keratolytic Agents|keratolytic agents|mesh-ancestor
6133065|NCT01231906|Dermatologic Agents|dermatologic agents|mesh-ancestor
6133066|NCT01231906|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5538532|NCT04191135|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5538533|NCT04191148|Calcium|calcium|mesh-list
5538534|NCT04191148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5538535|NCT04191148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538536|NCT04191278|Varenicline|varenicline|mesh-list
5538537|NCT04191278|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5538538|NCT04191278|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5538539|NCT04191278|Cholinergic Agents|cholinergic agents|mesh-ancestor
5538540|NCT04191278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5538541|NCT04191278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538542|NCT04191278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538543|NCT04191096|Pembrolizumab|pembrolizumab|mesh-list
5538544|NCT04191096|Androgens|androgens|mesh-list
5538545|NCT04191096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5538546|NCT04191096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5538547|NCT04191096|Hormones|hormones|mesh-ancestor
5538548|NCT04191096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5538549|NCT04191096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602043|NCT04974996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5602044|NCT04974996|Glucocorticoids|glucocorticoids|mesh-ancestor
5602045|NCT04974996|Hormones|hormones|mesh-ancestor
5602046|NCT04974996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6133067|NCT01231906|Protective Agents|protective agents|mesh-ancestor
6133068|NCT01232127|Ritonavir|ritonavir|mesh-list
6133069|NCT01232127|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6133070|NCT01232127|Tenofovir|tenofovir|mesh-list
6133071|NCT01232127|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
6133072|NCT01232127|Famotidine|famotidine|mesh-list
5602047|NCT04974996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5602048|NCT04974996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5602049|NCT04974996|Tubulin Modulators|tubulin modulators|mesh-ancestor
5602050|NCT04974996|Antimitotic Agents|antimitotic agents|mesh-ancestor
5602051|NCT04974996|Mitosis Modulators|mitosis modulators|mesh-ancestor
5606753|NCT03786783|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
5606754|NCT03786783|Cisplatin|cisplatin|mesh-list
5606755|NCT03786783|Carboplatin|carboplatin|mesh-list
5606756|NCT03786783|Doxorubicin|doxorubicin|mesh-list
5606757|NCT03786783|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5606758|NCT03786783|Etoposide|etoposide|mesh-list
5606759|NCT03786783|Vincristine|vincristine|mesh-list
5606760|NCT03786783|Etoposide phosphate|etoposide phosphate|mesh-list
6133073|NCT01232127|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6133074|NCT01232127|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6133075|NCT01232127|Protease Inhibitors|protease inhibitors|mesh-ancestor
6133076|NCT01232127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6133077|NCT01232127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133078|NCT01232127|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6133079|NCT01232127|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5606761|NCT03786783|Topotecan|topotecan|mesh-list
5606762|NCT03786783|Daunorubicin|daunorubicin|mesh-list
5606763|NCT03786783|Tretinoin|tretinoin|mesh-list
5606764|NCT03786783|Podophyllotoxin|podophyllotoxin|mesh-list
5606765|NCT03786783|Dinutuximab|dinutuximab|mesh-list
5606766|NCT03786783|Dexrazoxane|dexrazoxane|mesh-list
6133080|NCT01232127|Antiviral Agents|antiviral agents|mesh-ancestor
5606767|NCT03786783|Razoxane|razoxane|mesh-list
5606768|NCT03786783|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|mesh-list
6133081|NCT01232127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6133082|NCT01232127|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6133083|NCT01232127|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6133084|NCT01232127|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6133085|NCT01232127|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6133086|NCT01232127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6666310|NCT01522092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666311|NCT01522092|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6666312|NCT01522092|Antidepressive Agents|antidepressive agents|mesh-ancestor
6666313|NCT01522092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6666314|NCT01522105|Daptomycin|daptomycin|mesh-list
6666315|NCT01522105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5538550|NCT04190745|Paclitaxel|paclitaxel|mesh-list
5538551|NCT04190745|Apatinib|apatinib|mesh-list
5538552|NCT04190745|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5538553|NCT04190745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5538554|NCT04190745|Tubulin Modulators|tubulin modulators|mesh-ancestor
5538555|NCT04190745|Antimitotic Agents|antimitotic agents|mesh-ancestor
5538556|NCT04190745|Mitosis Modulators|mitosis modulators|mesh-ancestor
5538557|NCT04190745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538558|NCT04190745|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5538559|NCT04190745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5538560|NCT04190173|Prucalopride|prucalopride|mesh-list
5538561|NCT04190173|Laxatives|laxatives|mesh-ancestor
5538562|NCT04190173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5538563|NCT04190173|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
5538564|NCT04190173|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5538565|NCT04190173|Serotonin Agents|serotonin agents|mesh-ancestor
5538566|NCT04190173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5538567|NCT04190173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538568|NCT04190173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538569|NCT04189900|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5538570|NCT04189900|Luteolytic Agents|luteolytic agents|mesh-ancestor
5538571|NCT04189900|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5538572|NCT04189900|Contraceptive Agents|contraceptive agents|mesh-ancestor
5538573|NCT04189900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5538574|NCT04189900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538575|NCT04189900|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5538576|NCT04189900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5538577|NCT04189900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5538578|NCT04190160|Xultophy|xultophy|mesh-list
5538579|NCT04190160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5538580|NCT04190160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538581|NCT04190160|Incretins|incretins|mesh-ancestor
5538582|NCT04190160|Hormones|hormones|mesh-ancestor
5538583|NCT04190160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5538584|NCT04190004|Vasopressins|vasopressins|mesh-list
5538585|NCT04190004|Arginine Vasopressin|arginine vasopressin|mesh-list
5538586|NCT04190004|Hemostatics|hemostatics|mesh-ancestor
6666316|NCT01522105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6666317|NCT01522326|Ibuprofen|ibuprofen|mesh-list
6666318|NCT01522326|Metoclopramide|metoclopramide|mesh-list
6666319|NCT01522326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6133087|NCT01232127|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6133088|NCT01232127|Histamine Antagonists|histamine antagonists|mesh-ancestor
6133089|NCT01232127|Histamine Agents|histamine agents|mesh-ancestor
6133090|NCT01232127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6133091|NCT01232127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133092|NCT01232205|Micronutrients|micronutrients|mesh-list
6133093|NCT01232205|Trace Elements|trace elements|mesh-list
6133094|NCT01232205|Antioxidants|antioxidants|mesh-list
6133095|NCT01232205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133096|NCT01232205|Protective Agents|protective agents|mesh-ancestor
6133097|NCT01232205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133098|NCT01232283|Apremilast|apremilast|mesh-list
6133099|NCT01232283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6133100|NCT01232283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5538587|NCT04190004|Coagulants|coagulants|mesh-ancestor
5538588|NCT04190004|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5538589|NCT04190004|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5538590|NCT04190004|Natriuretic Agents|natriuretic agents|mesh-ancestor
5538591|NCT04190004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538592|NCT04189757|Acalabrutinib|acalabrutinib|mesh-list
5538593|NCT04189757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5538594|NCT04189744|Metronidazole|metronidazole|mesh-list
5538595|NCT04189744|Pyrimethamine|pyrimethamine|mesh-list
5538596|NCT04189744|Piperaquine|piperaquine|mesh-list
5538597|NCT04189744|Sulfadoxine|sulfadoxine|mesh-list
5538598|NCT04189744|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6133101|NCT01232283|Analgesics|analgesics|mesh-ancestor
6133102|NCT01232283|Sensory System Agents|sensory system agents|mesh-ancestor
6133103|NCT01232283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6133104|NCT01232283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133105|NCT01232283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6133106|NCT01232283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6133107|NCT01232283|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6133108|NCT01232283|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6133109|NCT01232283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6133110|NCT01232283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133111|NCT01232296|Sorafenib|sorafenib|mesh-list
6133112|NCT01232296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6133113|NCT01232296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6133114|NCT01232296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6133115|NCT01232296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133116|NCT01232452|Pemetrexed|pemetrexed|mesh-list
6133117|NCT01232452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6133118|NCT01232452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6133119|NCT01232452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133120|NCT01232452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6133121|NCT01232452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6133122|NCT01232491|Insulin Detemir|insulin detemir|mesh-list
6133123|NCT01232491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6133124|NCT01232491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133125|NCT01232504|Molgramostim|molgramostim|mesh-list
6133126|NCT01232504|Sargramostim|sargramostim|mesh-list
6133127|NCT01232504|Lenograstim|lenograstim|mesh-list
6133128|NCT01232504|Immunologic Factors|immunologic factors|mesh-ancestor
6133129|NCT01232504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133130|NCT01232504|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6133131|NCT01232504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6133132|NCT01232556|Gemcitabine|gemcitabine|mesh-list
5538599|NCT04189744|Artenimol|artenimol|mesh-list
5538600|NCT04189744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5538601|NCT04189744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6133133|NCT01232556|Rituximab|rituximab|mesh-list
6133134|NCT01232556|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
6133135|NCT01232556|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6133136|NCT01232556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6133137|NCT01232556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6133138|NCT01232556|Immunologic Factors|immunologic factors|mesh-ancestor
6133139|NCT01232556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133140|NCT01232556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6133141|NCT01232556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6133142|NCT01232556|Antimetabolites|antimetabolites|mesh-ancestor
6133143|NCT01232556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133144|NCT01232556|Antiviral Agents|antiviral agents|mesh-ancestor
6133145|NCT01232556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6133146|NCT01232556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6133147|NCT01232556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5538602|NCT04189744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5538603|NCT04189744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5538604|NCT04189744|Antimalarials|antimalarials|mesh-ancestor
5538605|NCT04189744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5538606|NCT04189744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5538607|NCT04189744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538608|NCT04189744|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5538609|NCT04189744|Renal Agents|renal agents|mesh-ancestor
5538610|NCT04189588|Diphenhydramine|diphenhydramine|mesh-list
5538611|NCT04189588|Promethazine|promethazine|mesh-list
5538612|NCT04189588|Cetirizine|cetirizine|mesh-list
5538613|NCT04189588|Paclitaxel|paclitaxel|mesh-list
5538614|NCT04189588|Rituximab|rituximab|mesh-list
5538615|NCT04189588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5538616|NCT04189588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5538617|NCT04189588|Tubulin Modulators|tubulin modulators|mesh-ancestor
5538618|NCT04189588|Antimitotic Agents|antimitotic agents|mesh-ancestor
5538619|NCT04189588|Mitosis Modulators|mitosis modulators|mesh-ancestor
5538620|NCT04189588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538621|NCT04189588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5538622|NCT04189588|Immunologic Factors|immunologic factors|mesh-ancestor
5538623|NCT04189588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538624|NCT04189588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6466432|NCT00478998|Adrenergic Agents|adrenergic agents|mesh-ancestor
6466433|NCT00478998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6466434|NCT00478998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466435|NCT00478998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466436|NCT00478998|Urological Agents|urological agents|mesh-ancestor
6466437|NCT00479076|Aflibercept|aflibercept|mesh-list
6466438|NCT00479076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6466439|NCT00479076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6466440|NCT00479076|Growth Substances|growth substances|mesh-ancestor
6466441|NCT00479076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466442|NCT00479076|Growth Inhibitors|growth inhibitors|mesh-ancestor
6466443|NCT00479076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6466444|NCT00479128|Gemcitabine|gemcitabine|mesh-list
6466445|NCT00479128|Doxorubicin|doxorubicin|mesh-list
6466446|NCT00479128|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6466447|NCT00479128|Bortezomib|bortezomib|mesh-list
6466448|NCT00479128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6466449|NCT00479128|Antimetabolites|antimetabolites|mesh-ancestor
6133148|NCT01232556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6133149|NCT01232556|Alkylating Agents|alkylating agents|mesh-ancestor
6133150|NCT01232556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6133151|NCT01232738|Rasagiline|rasagiline|mesh-list
6133152|NCT01232738|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6133153|NCT01232738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6133154|NCT01232738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133155|NCT01232738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6133156|NCT01232738|Protective Agents|protective agents|mesh-ancestor
6133157|NCT01232738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133158|NCT01232790|Acetylcysteine|acetylcysteine|mesh-list
6133159|NCT01232790|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6133160|NCT01232790|Antiviral Agents|antiviral agents|mesh-ancestor
6133161|NCT01232790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6133162|NCT01232790|Expectorants|expectorants|mesh-ancestor
6133163|NCT01232790|Respiratory System Agents|respiratory system agents|mesh-ancestor
6133164|NCT01232790|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6133165|NCT01232790|Antioxidants|antioxidants|mesh-ancestor
6133166|NCT01232790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133167|NCT01232790|Protective Agents|protective agents|mesh-ancestor
6133168|NCT01232790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133169|NCT01232790|Antidotes|antidotes|mesh-ancestor
6133170|NCT01232829|R04929097|r04929097|mesh-list
6133171|NCT01232829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6133172|NCT01232829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133173|NCT01232920|Mycophenolic Acid|mycophenolic acid|mesh-list
6133174|NCT01232920|Methotrexate|methotrexate|mesh-list
6133175|NCT01232920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6133176|NCT01232920|Abortifacient Agents|abortifacient agents|mesh-ancestor
6133177|NCT01232920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6133178|NCT01232920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133179|NCT01232920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6133180|NCT01232920|Antimetabolites|antimetabolites|mesh-ancestor
6133181|NCT01232920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538625|NCT04189588|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5538626|NCT04189588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5538627|NCT04189588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5538628|NCT04189588|Anesthetics, Local|anesthetics, local|mesh-ancestor
5538629|NCT04189588|Anesthetics|anesthetics|mesh-ancestor
5538630|NCT04189588|Sensory System Agents|sensory system agents|mesh-ancestor
5538631|NCT04189588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5538632|NCT04189588|Antiemetics|antiemetics|mesh-ancestor
5538633|NCT04189588|Autonomic Agents|autonomic agents|mesh-ancestor
5538634|NCT04189588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5538635|NCT04189588|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5538636|NCT04189588|Histamine Antagonists|histamine antagonists|mesh-ancestor
6133182|NCT01232920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6133183|NCT01232920|Dermatologic Agents|dermatologic agents|mesh-ancestor
6133184|NCT01232920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6133185|NCT01232920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6133186|NCT01232920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6133187|NCT01232920|Immunologic Factors|immunologic factors|mesh-ancestor
6133188|NCT01232920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6133189|NCT01232920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6133190|NCT01232920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6133191|NCT01232920|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6133192|NCT01232920|Antitubercular Agents|antitubercular agents|mesh-ancestor
6133193|NCT01232920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6133194|NCT01232920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6133195|NCT01232946|Insulin|insulin|mesh-list
6133196|NCT01232946|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6133197|NCT01232946|Liraglutide|liraglutide|mesh-list
6133198|NCT01232946|Insulin Detemir|insulin detemir|mesh-list
6133199|NCT01232946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6133200|NCT01232946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133201|NCT01232946|Incretins|incretins|mesh-ancestor
6133202|NCT01232946|Hormones|hormones|mesh-ancestor
6133203|NCT01232946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6133204|NCT01233050|Ethanol|ethanol|mesh-list
6133205|NCT01233050|Chlorhexidine|chlorhexidine|mesh-list
6133206|NCT01233050|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6133207|NCT01233050|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6133208|NCT01233050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6133209|NCT01233050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6133210|NCT01233050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133211|NCT01233050|Disinfectants|disinfectants|mesh-ancestor
6133212|NCT01233050|Dermatologic Agents|dermatologic agents|mesh-ancestor
6133213|NCT01233258|Factor VIII|factor viii|mesh-list
6133214|NCT01233258|Coagulants|coagulants|mesh-ancestor
6133215|NCT01233284|Bromides|bromides|mesh-list
6133216|NCT01233284|Tiotropium Bromide|tiotropium bromide|mesh-list
6133217|NCT01233284|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6133218|NCT01233284|Autonomic Agents|autonomic agents|mesh-ancestor
6133219|NCT01233284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6133220|NCT01233284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133221|NCT01233284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6133222|NCT01233284|Respiratory System Agents|respiratory system agents|mesh-ancestor
6133223|NCT01233284|Parasympatholytics|parasympatholytics|mesh-ancestor
6133224|NCT01233284|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6133225|NCT01233284|Cholinergic Agents|cholinergic agents|mesh-ancestor
6133226|NCT01233284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6133227|NCT01233284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133228|NCT01233284|Anticonvulsants|anticonvulsants|mesh-ancestor
6133229|NCT01233609|Valproic Acid|valproic acid|mesh-list
6133230|NCT01233609|Anticonvulsants|anticonvulsants|mesh-ancestor
6133231|NCT01233609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6133232|NCT01233609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538637|NCT04189588|Histamine Agents|histamine agents|mesh-ancestor
5538638|NCT04189588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5538639|NCT04189588|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5538640|NCT04189588|Antipruritics|antipruritics|mesh-ancestor
5538641|NCT04189588|Dermatologic Agents|dermatologic agents|mesh-ancestor
5538642|NCT04189588|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5538643|NCT04189783|Bupivacaine|bupivacaine|mesh-list
5538644|NCT04189783|Anesthetics, Local|anesthetics, local|mesh-ancestor
5538645|NCT04189783|Anesthetics|anesthetics|mesh-ancestor
6133233|NCT01233609|GABA Agents|gaba agents|mesh-ancestor
6133234|NCT01233609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6133235|NCT01233609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133236|NCT01233609|Antimanic Agents|antimanic agents|mesh-ancestor
6133237|NCT01233609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6133238|NCT01233609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6133239|NCT01233609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6133240|NCT01233687|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6133241|NCT01233687|Rilotumumab|rilotumumab|mesh-list
6133242|NCT01233687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6133243|NCT01233687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6133244|NCT01233687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6133245|NCT01233687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538646|NCT04189783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5538647|NCT04189783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538648|NCT04189783|Sensory System Agents|sensory system agents|mesh-ancestor
5538649|NCT04189783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5538650|NCT04189601|Complement System Proteins|complement system proteins|mesh-list
5538651|NCT04189601|Immunologic Factors|immunologic factors|mesh-ancestor
5538652|NCT04189601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538653|NCT04189133|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5538654|NCT04189133|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5538655|NCT04189133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538656|NCT04189250|Carbon Monoxide|carbon monoxide|mesh-list
5538657|NCT04189250|Antimetabolites|antimetabolites|mesh-ancestor
6666320|NCT01522326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6133246|NCT01233687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6133247|NCT01233921|Mitogens|mitogens|mesh-list
5538658|NCT04189250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538659|NCT04189250|Gasotransmitters|gasotransmitters|mesh-ancestor
5538660|NCT04189250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5538661|NCT04189250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538662|NCT04189484|Evolocumab|evolocumab|mesh-list
6133248|NCT01233921|Mitosis Modulators|mitosis modulators|mesh-ancestor
6133249|NCT01233921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133250|NCT01233999|Botulinum Toxins|botulinum toxins|mesh-list
6133251|NCT01233999|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6133252|NCT01233999|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6133253|NCT01233999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6133254|NCT01233999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6133255|NCT01233999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133256|NCT01233999|Cholinergic Agents|cholinergic agents|mesh-ancestor
6133257|NCT01233999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6133258|NCT01233999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133259|NCT01233999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6133260|NCT01233999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6133261|NCT01234337|Capecitabine|capecitabine|mesh-list
5538663|NCT04189484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5538664|NCT04189484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5538665|NCT04189484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6133262|NCT01234337|Sorafenib|sorafenib|mesh-list
6133263|NCT01234337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6133264|NCT01234337|Antimetabolites|antimetabolites|mesh-ancestor
6133265|NCT01234337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133266|NCT01234337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6133267|NCT01234337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6133268|NCT01234337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6133269|NCT01234402|Capecitabine|capecitabine|mesh-list
6133270|NCT01234402|Ramucirumab|ramucirumab|mesh-list
6133271|NCT01234402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6133272|NCT01234402|Antimetabolites|antimetabolites|mesh-ancestor
6133273|NCT01234402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133274|NCT01234402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6133275|NCT01234467|Rituximab|rituximab|mesh-list
6133276|NCT01234467|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6133277|NCT01234467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6133278|NCT01234467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6133279|NCT01234467|Immunologic Factors|immunologic factors|mesh-ancestor
6133280|NCT01234467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133281|NCT01234467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6133282|NCT01234467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5538666|NCT04189484|Antimetabolites|antimetabolites|mesh-ancestor
5538667|NCT04189484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538668|NCT04189484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5538669|NCT04189484|Immunologic Factors|immunologic factors|mesh-ancestor
5538670|NCT04189484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538671|NCT04189302|Pyrithione zinc|pyrithione zinc|mesh-list
5538672|NCT04189302|Keratolytic Agents|keratolytic agents|mesh-ancestor
6133283|NCT01234467|Alkylating Agents|alkylating agents|mesh-ancestor
6133284|NCT01234467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133285|NCT01234649|Metformin|metformin|mesh-list
6133286|NCT01234649|Liraglutide|liraglutide|mesh-list
6133287|NCT01234649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6133288|NCT01234649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133289|NCT01234649|Incretins|incretins|mesh-ancestor
6133290|NCT01234649|Hormones|hormones|mesh-ancestor
6133291|NCT01234649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6133292|NCT01234675|Milnacipran|milnacipran|mesh-list
6133293|NCT01234675|Levomilnacipran|levomilnacipran|mesh-list
6133294|NCT01234675|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6133295|NCT01234675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6133296|NCT01234675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6133297|NCT01234675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133298|NCT01234675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6133299|NCT01234675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466450|NCT00479128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466451|NCT00479128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6466452|NCT00479128|Antiviral Agents|antiviral agents|mesh-ancestor
6466453|NCT00479128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6466454|NCT00479128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6466455|NCT00479128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6466456|NCT00479128|Immunologic Factors|immunologic factors|mesh-ancestor
6466457|NCT00479128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466458|NCT00479128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6466459|NCT00479128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6466460|NCT00479128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6466461|NCT00479193|Bacitracin|bacitracin|mesh-list
6466462|NCT00479193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6466463|NCT00479193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6466464|NCT00479193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6133300|NCT01234675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5538673|NCT04189302|Dermatologic Agents|dermatologic agents|mesh-ancestor
5538674|NCT04189211|Trastuzumab|trastuzumab|mesh-list
5538675|NCT04189211|Maytansine|maytansine|mesh-list
5538676|NCT04189211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5538677|NCT04189211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5538678|NCT04189211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5538679|NCT04189211|Tubulin Modulators|tubulin modulators|mesh-ancestor
5538680|NCT04189211|Antimitotic Agents|antimitotic agents|mesh-ancestor
5538681|NCT04189211|Mitosis Modulators|mitosis modulators|mesh-ancestor
5538682|NCT04189211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538683|NCT04189263|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5538684|NCT04189263|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5538685|NCT04189263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5538686|NCT04189263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538687|NCT04189263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5538688|NCT04189263|Hormone Antagonists|hormone antagonists|mesh-ancestor
5538689|NCT04189263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5538690|NCT04189263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538691|NCT04189276|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
5538692|NCT04189276|Antiviral Agents|antiviral agents|mesh-ancestor
5538693|NCT04189276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6133301|NCT01234675|Analgesics|analgesics|mesh-ancestor
6133302|NCT01234675|Sensory System Agents|sensory system agents|mesh-ancestor
6133303|NCT01234675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6133304|NCT01234675|Antidepressive Agents|antidepressive agents|mesh-ancestor
6133305|NCT01234675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6133306|NCT01234714|Liver Extracts|liver extracts|mesh-list
6133307|NCT01234714|Hematinics|hematinics|mesh-ancestor
6133308|NCT01234766|Rituximab|rituximab|mesh-list
6133309|NCT01234766|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6133310|NCT01234766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6133311|NCT01234766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6133312|NCT01234766|Immunologic Factors|immunologic factors|mesh-ancestor
6133313|NCT01234766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133314|NCT01234766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6133315|NCT01234766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6133316|NCT01234766|Alkylating Agents|alkylating agents|mesh-ancestor
6133317|NCT01234766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133318|NCT01234870|Adenosine|adenosine|mesh-list
6133319|NCT01234870|Analgesics|analgesics|mesh-ancestor
6133320|NCT01234870|Sensory System Agents|sensory system agents|mesh-ancestor
6133321|NCT01234870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6133322|NCT01234870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133323|NCT01234870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6133324|NCT01234870|Vasodilator Agents|vasodilator agents|mesh-ancestor
6133325|NCT01234870|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6133326|NCT01234870|Purinergic Agonists|purinergic agonists|mesh-ancestor
6133327|NCT01234870|Purinergic Agents|purinergic agents|mesh-ancestor
6133328|NCT01234870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6133329|NCT01234870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133330|NCT01234883|Plasma-lyte 148|plasma-lyte 148|mesh-list
6133331|NCT01234883|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6133332|NCT01234883|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5538711|NCT04189094|Etoposide|etoposide|mesh-list
5538712|NCT04189094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6133333|NCT01234922|Losartan|losartan|mesh-list
6133334|NCT01234922|Ramipril|ramipril|mesh-list
6133335|NCT01234922|Lisinopril|lisinopril|mesh-list
6133336|NCT01234922|Benazepril|benazepril|mesh-list
6133337|NCT01234922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6133338|NCT01234922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6133339|NCT01234922|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6466465|NCT00479206|Artesunate|artesunate|mesh-list
5538713|NCT04189094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6133340|NCT01234922|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6666321|NCT01522326|Analgesics|analgesics|mesh-ancestor
6133341|NCT01234922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133342|NCT01234922|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6133343|NCT01234922|Protease Inhibitors|protease inhibitors|mesh-ancestor
6133344|NCT01234922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6133345|NCT01234922|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6666322|NCT01522326|Sensory System Agents|sensory system agents|mesh-ancestor
6666323|NCT01522326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6666324|NCT01522326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666325|NCT01522326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6666326|NCT01522326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6666327|NCT01522326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6666328|NCT01522326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6666329|NCT01522326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538714|NCT04189094|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5538715|NCT04189094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5538716|NCT04189094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5538717|NCT04189094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538718|NCT04189055|Irinotecan|irinotecan|mesh-list
5538719|NCT04189055|Cetuximab|cetuximab|mesh-list
5538720|NCT04189055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5538721|NCT04189055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5538722|NCT04189055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5538723|NCT04189055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538724|NCT04189055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5538725|NCT04189055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5602052|NCT04973930|Citalopram|citalopram|mesh-list
5602053|NCT04973930|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
5602054|NCT04973930|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5602055|NCT04973930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5602056|NCT04973930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5602057|NCT04973930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602058|NCT04973930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5602059|NCT04973930|Serotonin Agents|serotonin agents|mesh-ancestor
5602060|NCT04973930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602061|NCT04973930|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6666330|NCT01522326|Antiemetics|antiemetics|mesh-ancestor
6666331|NCT01522326|Autonomic Agents|autonomic agents|mesh-ancestor
6666332|NCT01522326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6666333|NCT01522326|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6666334|NCT01522326|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6666335|NCT01522326|Dopamine Agents|dopamine agents|mesh-ancestor
6666336|NCT01522326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6666337|NCT01522378|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
6666338|NCT01522378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6666339|NCT01522378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6666340|NCT01522378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602062|NCT04973930|Antidepressive Agents|antidepressive agents|mesh-ancestor
5602063|NCT04973930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5602064|NCT04973930|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5602065|NCT04973670|Sivelestat|sivelestat|mesh-list
5602066|NCT04973670|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5602067|NCT04973670|Protease Inhibitors|protease inhibitors|mesh-ancestor
6666341|NCT01522378|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6666342|NCT01522534|Morphine|morphine|mesh-list
6666343|NCT01522534|Mepivacaine|mepivacaine|mesh-list
6666344|NCT01522534|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6666345|NCT01522534|Narcotics|narcotics|mesh-ancestor
5602068|NCT04973670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5602069|NCT04973670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602070|NCT04969198|Nicotine|nicotine|mesh-list
5602071|NCT04969198|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5602072|NCT04969198|Autonomic Agents|autonomic agents|mesh-ancestor
5602073|NCT04969198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5602074|NCT04969198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602075|NCT04969198|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5602076|NCT04969198|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5602077|NCT04969198|Cholinergic Agents|cholinergic agents|mesh-ancestor
5602078|NCT04969198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5602079|NCT04969198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602080|NCT04952402|Vaccines|vaccines|mesh-list
5602081|NCT04952402|Immunologic Factors|immunologic factors|mesh-ancestor
6133346|NCT01234922|Protective Agents|protective agents|mesh-ancestor
6666346|NCT01522534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6133347|NCT01234922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133348|NCT01235195|Sertraline|sertraline|mesh-list
6133349|NCT01235195|Antidepressive Agents|antidepressive agents|mesh-ancestor
6133350|NCT01235195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6133351|NCT01235195|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6133352|NCT01235195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6133353|NCT01235195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6133354|NCT01235195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133355|NCT01235195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6133356|NCT01235195|Serotonin Agents|serotonin agents|mesh-ancestor
6133357|NCT01235195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133358|NCT01235338|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6133359|NCT01235338|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6133360|NCT01235338|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5538726|NCT04188847|Apatinib|apatinib|mesh-list
5538727|NCT04188847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5538728|NCT04188847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5538729|NCT04188847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6133361|NCT01235338|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6133362|NCT01235338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6133363|NCT01235338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538730|NCT04188847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538731|NCT04188951|Pembrolizumab|pembrolizumab|mesh-list
5538732|NCT04188951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5538733|NCT04188951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5538734|NCT04188782|Sevoflurane|sevoflurane|mesh-list
5538735|NCT04188782|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5538736|NCT04188782|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5538737|NCT04188782|Anesthetics, General|anesthetics, general|mesh-ancestor
5538738|NCT04188782|Anesthetics|anesthetics|mesh-ancestor
5538739|NCT04188782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6133364|NCT01235338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6133365|NCT01235338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133366|NCT01235338|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6133367|NCT01235338|Antidepressive Agents|antidepressive agents|mesh-ancestor
6133368|NCT01235338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6133369|NCT01235338|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6133370|NCT01235338|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6133371|NCT01235338|Dopamine Agents|dopamine agents|mesh-ancestor
6133372|NCT01235351|Clopidogrel|clopidogrel|mesh-list
6133373|NCT01235351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6133374|NCT01235351|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6133375|NCT01235351|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6133376|NCT01235351|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6133377|NCT01235351|Purinergic Agents|purinergic agents|mesh-ancestor
6133378|NCT01235351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6133379|NCT01235351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133380|NCT01235351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133381|NCT01235403|Lacosamide|lacosamide|mesh-list
6133382|NCT01235403|Anticonvulsants|anticonvulsants|mesh-ancestor
6133383|NCT01235403|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5538740|NCT04188782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538741|NCT04188860|Paclitaxel|paclitaxel|mesh-list
5538742|NCT04188860|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5538743|NCT04188860|Antibodies|antibodies|mesh-list
5538744|NCT04188860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5538745|NCT04188860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5538746|NCT04188860|Tubulin Modulators|tubulin modulators|mesh-ancestor
5538747|NCT04188860|Antimitotic Agents|antimitotic agents|mesh-ancestor
5538748|NCT04188860|Mitosis Modulators|mitosis modulators|mesh-ancestor
5538749|NCT04188860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538750|NCT04188860|Immunologic Factors|immunologic factors|mesh-ancestor
5538751|NCT04188860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538752|NCT04189666|Melatonin|melatonin|mesh-list
6133384|NCT01235403|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6133385|NCT01235403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6133386|NCT01235403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133387|NCT01235442|Etanercept|etanercept|mesh-list
6133388|NCT01235442|Clobetasol|clobetasol|mesh-list
6466466|NCT00479206|Antimalarials|antimalarials|mesh-ancestor
6466467|NCT00479206|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5538753|NCT04189666|Rivastigmine|rivastigmine|mesh-list
5538754|NCT04189666|Antioxidants|antioxidants|mesh-ancestor
6133389|NCT01235442|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6133390|NCT01235442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6133391|NCT01235442|Analgesics|analgesics|mesh-ancestor
6133392|NCT01235442|Sensory System Agents|sensory system agents|mesh-ancestor
6133393|NCT01235442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6133394|NCT01235442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133395|NCT01235442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6133396|NCT01235442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6133397|NCT01235442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6133398|NCT01235442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6133399|NCT01235442|Immunologic Factors|immunologic factors|mesh-ancestor
6133400|NCT01235442|Glucocorticoids|glucocorticoids|mesh-ancestor
6133401|NCT01235442|Hormones|hormones|mesh-ancestor
6133402|NCT01235442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6133403|NCT01235507|Methotrexate|methotrexate|mesh-list
6133404|NCT01235507|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6133405|NCT01235507|Abortifacient Agents|abortifacient agents|mesh-ancestor
6133406|NCT01235507|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6133407|NCT01235507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133408|NCT01235507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6133409|NCT01235507|Antimetabolites|antimetabolites|mesh-ancestor
6133410|NCT01235507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133411|NCT01235507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6133412|NCT01235507|Dermatologic Agents|dermatologic agents|mesh-ancestor
6133413|NCT01235507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6133414|NCT01235507|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6133415|NCT01235507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6133416|NCT01235507|Immunologic Factors|immunologic factors|mesh-ancestor
6133417|NCT01235507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6133418|NCT01235507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6205118|NCT02081638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205119|NCT02081638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6205120|NCT02081638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5538755|NCT04189666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538756|NCT04189666|Protective Agents|protective agents|mesh-ancestor
5538757|NCT04189666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538758|NCT04189666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5538759|NCT04189666|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5538760|NCT04189666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5538761|NCT04189666|Cholinergic Agents|cholinergic agents|mesh-ancestor
5538762|NCT04189666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5538763|NCT04189666|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5538764|NCT04189198|Bupivacaine|bupivacaine|mesh-list
5538765|NCT04189198|Carticaine|carticaine|mesh-list
5538766|NCT04189198|Anesthetics, Local|anesthetics, local|mesh-ancestor
5538767|NCT04189198|Anesthetics|anesthetics|mesh-ancestor
5538768|NCT04189198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6205121|NCT02081638|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6205122|NCT02081638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6205123|NCT02081638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205124|NCT02081638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6205125|NCT02081638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6205126|NCT02081638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6205127|NCT02081638|Antipyretics|antipyretics|mesh-ancestor
5538769|NCT04189198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538770|NCT04189198|Sensory System Agents|sensory system agents|mesh-ancestor
5538771|NCT04189198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5538772|NCT04188730|Lofexidine|lofexidine|mesh-list
5538773|NCT04188730|Clonidine|clonidine|mesh-list
5538774|NCT04188730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5538775|NCT04188730|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5538776|NCT04188730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538777|NCT04188730|Sensory System Agents|sensory system agents|mesh-ancestor
5538778|NCT04188730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5538779|NCT04188730|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5538780|NCT04188730|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5538781|NCT04188730|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5538782|NCT04188730|Adrenergic Agents|adrenergic agents|mesh-ancestor
5538783|NCT04188730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5538784|NCT04188730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538785|NCT04188730|Analgesics|analgesics|mesh-ancestor
5538786|NCT04188730|Sympatholytics|sympatholytics|mesh-ancestor
5538787|NCT04188730|Autonomic Agents|autonomic agents|mesh-ancestor
5538788|NCT04188691|Vaccines|vaccines|mesh-list
6133419|NCT01235546|Azithromycin|azithromycin|mesh-list
6133420|NCT01235546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6133421|NCT01235546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6133422|NCT01235598|Certolizumab Pegol|certolizumab pegol|mesh-list
6133423|NCT01235598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6133424|NCT01235598|Immunologic Factors|immunologic factors|mesh-ancestor
6133425|NCT01235598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133426|NCT01235598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6133427|NCT01235689|Prednisone|prednisone|mesh-list
6133428|NCT01235689|Adalimumab|adalimumab|mesh-list
6133429|NCT01235689|Azathioprine|azathioprine|mesh-list
6133430|NCT01235689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6133431|NCT01235689|Glucocorticoids|glucocorticoids|mesh-ancestor
6133432|NCT01235689|Hormones|hormones|mesh-ancestor
6133433|NCT01235689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6133434|NCT01235689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538789|NCT04188691|Immunologic Factors|immunologic factors|mesh-ancestor
5538790|NCT04188691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538791|NCT04188665|Lectins|lectins|mesh-list
5538792|NCT04188665|Agglutinins|agglutinins|mesh-ancestor
5538793|NCT04188665|Immunologic Factors|immunologic factors|mesh-ancestor
5538794|NCT04188665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538795|NCT04188665|Coagulants|coagulants|mesh-ancestor
6133435|NCT01235689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6133436|NCT01235689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6133437|NCT01235689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6133438|NCT01235689|Antimetabolites|antimetabolites|mesh-ancestor
6133439|NCT01235689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133440|NCT01235689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6133441|NCT01235689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6133442|NCT01235689|Immunologic Factors|immunologic factors|mesh-ancestor
6133443|NCT01235715|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6133444|NCT01235715|Hemostatics|hemostatics|mesh-ancestor
6133445|NCT01235715|Coagulants|coagulants|mesh-ancestor
6133446|NCT01235728|Calcitriol|calcitriol|mesh-list
6133447|NCT01235728|MK 0873|mk 0873|mesh-list
6133448|NCT01235728|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6133449|NCT01235728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133450|NCT01235728|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6133451|NCT01235728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6133452|NCT01235728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133453|NCT01235728|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6133454|NCT01235728|Vitamins|vitamins|mesh-ancestor
6133455|NCT01235728|Micronutrients|micronutrients|mesh-ancestor
6133456|NCT01235728|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6133457|NCT01235728|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6133458|NCT01235728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6133459|NCT01235728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6133460|NCT01235741|Pramlintide|pramlintide|mesh-list
6133461|NCT01235741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6133462|NCT01235741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133463|NCT01235793|Temozolomide|temozolomide|mesh-list
6133464|NCT01235793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6133465|NCT01235793|Alkylating Agents|alkylating agents|mesh-ancestor
6133466|NCT01235793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133467|NCT01235793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6666347|NCT01522534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666348|NCT01522534|Analgesics|analgesics|mesh-ancestor
6666349|NCT01522534|Sensory System Agents|sensory system agents|mesh-ancestor
6133468|NCT01235897|Paclitaxel|paclitaxel|mesh-list
6133469|NCT01235897|Trastuzumab|trastuzumab|mesh-list
6666350|NCT01522534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6666351|NCT01522534|Anesthetics, Local|anesthetics, local|mesh-ancestor
6666352|NCT01522534|Anesthetics|anesthetics|mesh-ancestor
6666353|NCT01522547|Pomalidomide|pomalidomide|mesh-list
6666354|NCT01522547|Immunologic Factors|immunologic factors|mesh-ancestor
6666355|NCT01522547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666356|NCT01522547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6666357|NCT01522547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6133470|NCT01235897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6133471|NCT01235897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6133472|NCT01235897|Tubulin Modulators|tubulin modulators|mesh-ancestor
6133473|NCT01235897|Antimitotic Agents|antimitotic agents|mesh-ancestor
6133474|NCT01235897|Mitosis Modulators|mitosis modulators|mesh-ancestor
5538796|NCT04188483|Selenium|selenium|mesh-list
6133475|NCT01235897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666358|NCT01522547|Growth Substances|growth substances|mesh-ancestor
6133476|NCT01235897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6133477|NCT01235910|Cyclosporine|cyclosporine|mesh-list
5538797|NCT04188483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538798|NCT04188483|Antioxidants|antioxidants|mesh-ancestor
5538799|NCT04188483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538800|NCT04188483|Protective Agents|protective agents|mesh-ancestor
6133478|NCT01235910|Cyclosporins|cyclosporins|mesh-list
6133479|NCT01235910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6133480|NCT01235910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133481|NCT01235910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6133482|NCT01235910|Immunologic Factors|immunologic factors|mesh-ancestor
5538801|NCT04188483|Trace Elements|trace elements|mesh-ancestor
5538802|NCT04188483|Micronutrients|micronutrients|mesh-ancestor
5538803|NCT04188392|Pimavanserin|pimavanserin|mesh-list
5538804|NCT04188392|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5538805|NCT04188392|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5538806|NCT04188392|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5538807|NCT04188392|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5538808|NCT04188392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5538809|NCT04188392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538810|NCT04188392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5538811|NCT04188392|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5538812|NCT04188392|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5538813|NCT04188392|Serotonin Agents|serotonin agents|mesh-ancestor
5538814|NCT04188392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5538815|NCT04188392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538816|NCT04188431|Dexamethasone|dexamethasone|mesh-list
5538817|NCT04188431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5538818|NCT04188431|Antiemetics|antiemetics|mesh-ancestor
5538819|NCT04188431|Autonomic Agents|autonomic agents|mesh-ancestor
6133483|NCT01235910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133484|NCT01235910|Antifungal Agents|antifungal agents|mesh-ancestor
6133485|NCT01235910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6133486|NCT01235910|Dermatologic Agents|dermatologic agents|mesh-ancestor
6133487|NCT01235910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6133488|NCT01235910|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6133489|NCT01235923|Epoetin Alfa|epoetin alfa|mesh-list
6133490|NCT01235923|Hematinics|hematinics|mesh-ancestor
6133491|NCT01235949|Acetaminophen|acetaminophen|mesh-list
6133492|NCT01235949|Ibuprofen|ibuprofen|mesh-list
6133493|NCT01235949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6133494|NCT01235949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6133495|NCT01235949|Analgesics|analgesics|mesh-ancestor
6133496|NCT01235949|Sensory System Agents|sensory system agents|mesh-ancestor
6133497|NCT01235949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6133498|NCT01235949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133499|NCT01235949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6133500|NCT01235949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6133501|NCT01235949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6133502|NCT01235949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6133503|NCT01235949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133504|NCT01235949|Antipyretics|antipyretics|mesh-ancestor
6133505|NCT01236001|Lacosamide|lacosamide|mesh-list
6133506|NCT01236001|Anticonvulsants|anticonvulsants|mesh-ancestor
6133507|NCT01236001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6133508|NCT01236001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6133509|NCT01236001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6133510|NCT01236001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133511|NCT01236053|Gabapentin|gabapentin|mesh-list
6133512|NCT01236053|Analgesics|analgesics|mesh-ancestor
6133513|NCT01236053|Sensory System Agents|sensory system agents|mesh-ancestor
6466468|NCT00479206|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6133514|NCT01236053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6133515|NCT01236053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133516|NCT01236053|Anticonvulsants|anticonvulsants|mesh-ancestor
6133517|NCT01236053|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6133518|NCT01236053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6133519|NCT01236053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6133520|NCT01236053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6133521|NCT01236053|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6133522|NCT01236053|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6133523|NCT01236053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6133524|NCT01236053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133525|NCT01236053|Antimanic Agents|antimanic agents|mesh-ancestor
6133526|NCT01236105|Charcoal|charcoal|mesh-list
6133527|NCT01236105|Antidotes|antidotes|mesh-ancestor
6133528|NCT01236105|Protective Agents|protective agents|mesh-ancestor
6133529|NCT01236105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133530|NCT01236118|Ixekizumab|ixekizumab|mesh-list
5538820|NCT04188431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5538821|NCT04188431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538822|NCT04188431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5538823|NCT04188431|Glucocorticoids|glucocorticoids|mesh-ancestor
5538824|NCT04188431|Hormones|hormones|mesh-ancestor
5538825|NCT04188431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5538826|NCT04188431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5538827|NCT04188431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5538828|NCT04188561|Hyaluronic Acid|hyaluronic acid|mesh-list
5538829|NCT04188561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5538830|NCT04188561|Immunologic Factors|immunologic factors|mesh-ancestor
5538831|NCT04188561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538832|NCT04188561|Viscosupplements|viscosupplements|mesh-ancestor
5538833|NCT04188561|Protective Agents|protective agents|mesh-ancestor
5538834|NCT04188353|Mannitol|mannitol|mesh-list
5538835|NCT04188353|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5538836|NCT04188353|Diuretics|diuretics|mesh-ancestor
5538837|NCT04188353|Natriuretic Agents|natriuretic agents|mesh-ancestor
5538838|NCT04188353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133531|NCT01236118|Dermatologic Agents|dermatologic agents|mesh-ancestor
6133532|NCT01236365|Atorvastatin|atorvastatin|mesh-list
6133533|NCT01236365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6133534|NCT01236365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6133535|NCT01236365|Antimetabolites|antimetabolites|mesh-ancestor
6133536|NCT01236365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133537|NCT01236365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6133538|NCT01236365|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6133539|NCT01236365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6133540|NCT01236378|Sirolimus|sirolimus|mesh-list
6133541|NCT01236378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6133542|NCT01236378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6133543|NCT01236378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5538839|NCT04188106|Hydroxyzine|hydroxyzine|mesh-list
5538840|NCT04188106|Varenicline|varenicline|mesh-list
5538841|NCT04188106|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5538842|NCT04188106|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6133544|NCT01236378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6133545|NCT01236378|Antifungal Agents|antifungal agents|mesh-ancestor
6133546|NCT01236378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6133547|NCT01236378|Immunologic Factors|immunologic factors|mesh-ancestor
6133548|NCT01236378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133549|NCT01236521|Analgesics|analgesics|mesh-list
6133550|NCT01236521|Sensory System Agents|sensory system agents|mesh-ancestor
6133551|NCT01236521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6133552|NCT01236521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133553|NCT01236534|Lubiprostone|lubiprostone|mesh-list
6133554|NCT01236534|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6133555|NCT01236534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6133556|NCT01236534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133557|NCT01236547|Paclitaxel|paclitaxel|mesh-list
6133558|NCT01236547|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6133559|NCT01236547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5538843|NCT04188106|Cholinergic Agents|cholinergic agents|mesh-ancestor
5538844|NCT04188106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5538845|NCT04188106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538846|NCT04188106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133560|NCT01236547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6133561|NCT01236547|Tubulin Modulators|tubulin modulators|mesh-ancestor
6133562|NCT01236547|Antimitotic Agents|antimitotic agents|mesh-ancestor
6133563|NCT01236547|Mitosis Modulators|mitosis modulators|mesh-ancestor
6133564|NCT01236547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133565|NCT01236560|Bevacizumab|bevacizumab|mesh-list
6133566|NCT01236560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6133567|NCT01236560|Temozolomide|temozolomide|mesh-list
6133568|NCT01236560|Vorinostat|vorinostat|mesh-list
6133569|NCT01236560|Endothelial Growth Factors|endothelial growth factors|mesh-list
6133570|NCT01236560|Antibodies|antibodies|mesh-list
5538847|NCT04188106|Antipruritics|antipruritics|mesh-ancestor
5538848|NCT04188106|Dermatologic Agents|dermatologic agents|mesh-ancestor
5538849|NCT04188106|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5538850|NCT04188106|Histamine Antagonists|histamine antagonists|mesh-ancestor
5538851|NCT04188106|Histamine Agents|histamine agents|mesh-ancestor
5538852|NCT04188249|Golimumab|golimumab|mesh-list
5538853|NCT04188249|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
5538854|NCT04188249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5538855|NCT04188249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5538856|NCT04188249|Immunologic Factors|immunologic factors|mesh-ancestor
5538857|NCT04188249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538858|NCT04188119|Aspirin|aspirin|mesh-list
5538859|NCT04188119|Avelumab|avelumab|mesh-list
6133571|NCT01236560|Immunoglobulins|immunoglobulins|mesh-list
6133572|NCT01236560|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6133573|NCT01236560|Immunoglobulin G|immunoglobulin g|mesh-list
6133574|NCT01236560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6133575|NCT01236560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6133576|NCT01236560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6133577|NCT01236560|Growth Substances|growth substances|mesh-ancestor
6133578|NCT01236560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133579|NCT01236560|Growth Inhibitors|growth inhibitors|mesh-ancestor
6133580|NCT01236560|Immunologic Factors|immunologic factors|mesh-ancestor
6133581|NCT01236560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6133582|NCT01236560|Alkylating Agents|alkylating agents|mesh-ancestor
6133583|NCT01236560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133584|NCT01236560|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6133585|NCT01236560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6133586|NCT01236573|Cyclophosphamide|cyclophosphamide|mesh-list
6133587|NCT01236573|Fludarabine|fludarabine|mesh-list
6133588|NCT01236573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6133589|NCT01236573|Immunologic Factors|immunologic factors|mesh-ancestor
6133590|NCT01236573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133591|NCT01236573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6133592|NCT01236573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6133593|NCT01236573|Alkylating Agents|alkylating agents|mesh-ancestor
6133594|NCT01236573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133595|NCT01236573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6133596|NCT01236573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6133597|NCT01236768|Contraceptive Agents|contraceptive agents|mesh-list
6133598|NCT01236768|Contraceptives, Oral|contraceptives, oral|mesh-list
6133599|NCT01236768|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-list
6133600|NCT01236768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6133601|NCT01236768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133602|NCT01236768|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6133603|NCT01236768|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6133604|NCT01237041|Niacin|niacin|mesh-list
6133605|NCT01237041|Niacinamide|niacinamide|mesh-list
6133606|NCT01237041|Nicotinic Acids|nicotinic acids|mesh-list
6133607|NCT01237041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6133608|NCT01237041|Antimetabolites|antimetabolites|mesh-ancestor
6133609|NCT01237041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133610|NCT01237041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6133611|NCT01237041|Vasodilator Agents|vasodilator agents|mesh-ancestor
6133612|NCT01237041|Vitamin B Complex|vitamin b complex|mesh-ancestor
6133613|NCT01237041|Vitamins|vitamins|mesh-ancestor
6133614|NCT01237041|Micronutrients|micronutrients|mesh-ancestor
6133615|NCT01237041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133616|NCT01237054|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6133617|NCT01237054|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6133618|NCT01237054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133619|NCT01237197|Exenatide|exenatide|mesh-list
6133620|NCT01237197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6133621|NCT01237197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133622|NCT01237197|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6133623|NCT01237197|Incretins|incretins|mesh-ancestor
6133624|NCT01237197|Hormones|hormones|mesh-ancestor
5538860|NCT04188119|Lansoprazole|lansoprazole|mesh-list
5538861|NCT04188119|Dexlansoprazole|dexlansoprazole|mesh-list
6133625|NCT01237197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6133626|NCT01237223|Amlodipine|amlodipine|mesh-list
6133627|NCT01237223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6133628|NCT01237223|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5538862|NCT04188119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5538863|NCT04188119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5538864|NCT04188119|Analgesics|analgesics|mesh-ancestor
6133629|NCT01237223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6133630|NCT01237223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133631|NCT01237223|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6133632|NCT01237223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133633|NCT01237223|Vasodilator Agents|vasodilator agents|mesh-ancestor
6133634|NCT01237327|Exemestane|exemestane|mesh-list
6133635|NCT01237327|Megestrol|megestrol|mesh-list
6133636|NCT01237327|Megestrol Acetate|megestrol acetate|mesh-list
6133637|NCT01237327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6133638|NCT01237327|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6133639|NCT01237327|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6133640|NCT01237327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6133641|NCT01237327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133642|NCT01237327|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6133643|NCT01237327|Hormone Antagonists|hormone antagonists|mesh-ancestor
6133644|NCT01237327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6133645|NCT01237327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133646|NCT01237327|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6133647|NCT01237327|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6133648|NCT01237327|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6133649|NCT01237327|Contraceptive Agents|contraceptive agents|mesh-ancestor
6133650|NCT01237327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6133651|NCT01237327|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6133652|NCT01237327|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6133653|NCT01237327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6133654|NCT01237327|Appetite Stimulants|appetite stimulants|mesh-ancestor
6133655|NCT01237327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6133656|NCT01237353|Rabeprazole|rabeprazole|mesh-list
6133657|NCT01237353|Betaine|betaine|mesh-list
6133658|NCT01237353|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6133659|NCT01237353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6133660|NCT01237353|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6133661|NCT01237353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6133662|NCT01237353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133663|NCT01237353|Lipotropic Agents|lipotropic agents|mesh-ancestor
6133664|NCT01237353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6133665|NCT01237353|Antimetabolites|antimetabolites|mesh-ancestor
6133666|NCT01237353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6133667|NCT01237587|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6133668|NCT01237587|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6133669|NCT01237587|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6133670|NCT01237587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6133671|NCT01237587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133672|NCT01237587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6133673|NCT01237587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133674|NCT01237587|Analgesics|analgesics|mesh-ancestor
6133675|NCT01237587|Sensory System Agents|sensory system agents|mesh-ancestor
6133676|NCT01237587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6133677|NCT01237587|Antidepressive Agents|antidepressive agents|mesh-ancestor
6133678|NCT01237587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6133679|NCT01237587|Dopamine Agents|dopamine agents|mesh-ancestor
6133680|NCT01237678|Carboplatin|carboplatin|mesh-list
6133681|NCT01237678|Etoposide|etoposide|mesh-list
6133682|NCT01237678|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
6133683|NCT01237678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6133684|NCT01237678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6133685|NCT01237678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6133686|NCT01237678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6133687|NCT01237678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6133688|NCT01237678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466469|NCT00479206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6466470|NCT00479206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6466471|NCT00479206|Antiviral Agents|antiviral agents|mesh-ancestor
6466472|NCT00479206|Schistosomicides|schistosomicides|mesh-ancestor
6666359|NCT01522547|Growth Inhibitors|growth inhibitors|mesh-ancestor
6133689|NCT01237678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6133690|NCT01237899|Eplerenone|eplerenone|mesh-list
6133691|NCT01237899|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6133692|NCT01237899|Hormone Antagonists|hormone antagonists|mesh-ancestor
6133693|NCT01237899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6133694|NCT01237899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133695|NCT01237899|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6133696|NCT01237899|Diuretics|diuretics|mesh-ancestor
6133697|NCT01237899|Natriuretic Agents|natriuretic agents|mesh-ancestor
6133698|NCT01237899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6133699|NCT01237951|Gemcitabine|gemcitabine|mesh-list
6133700|NCT01237951|Dexamethasone|dexamethasone|mesh-list
6133701|NCT01237951|Melphalan|melphalan|mesh-list
6133702|NCT01237951|Busulfan|busulfan|mesh-list
6133703|NCT01237951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6133704|NCT01237951|Antiemetics|antiemetics|mesh-ancestor
6133705|NCT01237951|Autonomic Agents|autonomic agents|mesh-ancestor
6133706|NCT01237951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6133707|NCT01237951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133708|NCT01237951|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6133709|NCT01237951|Glucocorticoids|glucocorticoids|mesh-ancestor
6133710|NCT01237951|Hormones|hormones|mesh-ancestor
6133711|NCT01237951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6133712|NCT01237951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6133713|NCT01237951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6133714|NCT01237951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6133715|NCT01237951|Antimetabolites|antimetabolites|mesh-ancestor
6133716|NCT01237951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133717|NCT01237951|Antiviral Agents|antiviral agents|mesh-ancestor
6133718|NCT01237951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6133719|NCT01237951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6133720|NCT01237951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6133721|NCT01237951|Immunologic Factors|immunologic factors|mesh-ancestor
6133722|NCT01237951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6133723|NCT01237951|Alkylating Agents|alkylating agents|mesh-ancestor
6133724|NCT01237951|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6133725|NCT01238120|Ibuprofen|ibuprofen|mesh-list
6133726|NCT01238120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
6133727|NCT01238120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
6133728|NCT01238120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6133729|NCT01238120|Analgesics|analgesics|mesh-ancestor
6133730|NCT01238120|Sensory System Agents|sensory system agents|mesh-ancestor
5538865|NCT04188119|Sensory System Agents|sensory system agents|mesh-ancestor
5538866|NCT04188119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5538867|NCT04188119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538868|NCT04188119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5538869|NCT04188119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5538870|NCT04188119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5538871|NCT04188119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5538872|NCT04188119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538873|NCT04188119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5538874|NCT04188119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5538875|NCT04188119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6133731|NCT01238120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6133732|NCT01238120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133733|NCT01238120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6133734|NCT01238120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6133735|NCT01238120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6133736|NCT01238120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133737|NCT01238471|Propranolol|propranolol|mesh-list
6466473|NCT00479206|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6466474|NCT00479206|Anthelmintics|anthelmintics|mesh-ancestor
6466475|NCT00479323|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6466476|NCT00479323|Immunologic Factors|immunologic factors|mesh-ancestor
6466477|NCT00479323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466478|NCT00479362|Aspirin|aspirin|mesh-list
6466479|NCT00479362|Warfarin|warfarin|mesh-list
6466480|NCT00479362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6133738|NCT01238471|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6133739|NCT01238471|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6133740|NCT01238471|Adrenergic Agents|adrenergic agents|mesh-ancestor
6133741|NCT01238471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6133742|NCT01238471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133743|NCT01238471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133744|NCT01238471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6133745|NCT01238471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6133746|NCT01238471|Vasodilator Agents|vasodilator agents|mesh-ancestor
6133747|NCT01238536|Dexamethasone|dexamethasone|mesh-list
6133748|NCT01238536|Betamethasone|betamethasone|mesh-list
6133749|NCT01238536|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6133750|NCT01238536|Lidocaine|lidocaine|mesh-list
6133751|NCT01238536|Anesthetics, Local|anesthetics, local|mesh-list
6133752|NCT01238536|Anesthetics|anesthetics|mesh-list
6133753|NCT01238536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6133754|NCT01238536|Antiemetics|antiemetics|mesh-ancestor
6133755|NCT01238536|Autonomic Agents|autonomic agents|mesh-ancestor
6133756|NCT01238536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6133757|NCT01238536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538876|NCT04188119|Antipyretics|antipyretics|mesh-ancestor
5538877|NCT04188119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5538878|NCT04188119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5538879|NCT04188119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5538880|NCT04188119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5538881|NCT04188119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5538882|NCT04188158|Capecitabine|capecitabine|mesh-list
5538883|NCT04188158|Oxaliplatin|oxaliplatin|mesh-list
5538884|NCT04188158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5538885|NCT04188158|Antimetabolites|antimetabolites|mesh-ancestor
5538886|NCT04188158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538887|NCT04188158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5538888|NCT04188184|Epinephrine|epinephrine|mesh-list
5538889|NCT04188184|Tranexamic Acid|tranexamic acid|mesh-list
5538890|NCT04188184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5538891|NCT04188184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5538892|NCT04188184|Adrenergic Agents|adrenergic agents|mesh-ancestor
5538893|NCT04188184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5538894|NCT04188184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133758|NCT01238536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6133759|NCT01238536|Glucocorticoids|glucocorticoids|mesh-ancestor
6133760|NCT01238536|Hormones|hormones|mesh-ancestor
6133761|NCT01238536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6133762|NCT01238536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6133763|NCT01238536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6133764|NCT01238536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133765|NCT01238536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6133766|NCT01238536|Sensory System Agents|sensory system agents|mesh-ancestor
6133767|NCT01238536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6133768|NCT01238536|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6133769|NCT01238536|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6133770|NCT01238536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6133771|NCT01238536|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6133772|NCT01238536|Respiratory System Agents|respiratory system agents|mesh-ancestor
6133773|NCT01238575|Guanfacine|guanfacine|mesh-list
6133774|NCT01238575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6133775|NCT01238575|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6133776|NCT01238575|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6466481|NCT00479362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6133777|NCT01238575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6133778|NCT01238575|Adrenergic Agents|adrenergic agents|mesh-ancestor
6133779|NCT01238575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6133780|NCT01238575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133781|NCT01238575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133782|NCT01238588|Sevelamer|sevelamer|mesh-list
6133783|NCT01238588|Chelating Agents|chelating agents|mesh-ancestor
6133784|NCT01238588|Sequestering Agents|sequestering agents|mesh-ancestor
6133785|NCT01238588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133786|NCT01238640|Nicotine|nicotine|mesh-list
6133787|NCT01238640|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6133788|NCT01238640|Autonomic Agents|autonomic agents|mesh-ancestor
6133789|NCT01238640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6133790|NCT01238640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133791|NCT01238640|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6133792|NCT01238640|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6133793|NCT01238640|Cholinergic Agents|cholinergic agents|mesh-ancestor
6133794|NCT01238640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6133795|NCT01238640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133796|NCT01238822|Methylphenidate|methylphenidate|mesh-list
6133797|NCT01238822|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6133798|NCT01238822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133799|NCT01238822|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6133800|NCT01238822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6133801|NCT01238822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6133802|NCT01238822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133803|NCT01238822|Dopamine Agents|dopamine agents|mesh-ancestor
6133804|NCT01238822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6133805|NCT01238861|Benralizumab|benralizumab|mesh-list
6133806|NCT01238861|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6133807|NCT01238861|Respiratory System Agents|respiratory system agents|mesh-ancestor
6133808|NCT01239212|Levetiracetam|levetiracetam|mesh-list
6133809|NCT01239212|Anticonvulsants|anticonvulsants|mesh-ancestor
6133810|NCT01239212|Nootropic Agents|nootropic agents|mesh-ancestor
6133811|NCT01239342|Everolimus|everolimus|mesh-list
6133812|NCT01239342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6133813|NCT01239342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6133814|NCT01239342|Immunologic Factors|immunologic factors|mesh-ancestor
6133815|NCT01239342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133816|NCT01239394|Ofatumumab|ofatumumab|mesh-list
6133817|NCT01239394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6133818|NCT01239472|Everolimus|everolimus|mesh-list
6133819|NCT01239472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6133820|NCT01239472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6133821|NCT01239472|Immunologic Factors|immunologic factors|mesh-ancestor
6133822|NCT01239472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133823|NCT01239732|Paclitaxel|paclitaxel|mesh-list
6133824|NCT01239732|Bevacizumab|bevacizumab|mesh-list
6133825|NCT01239732|Carboplatin|carboplatin|mesh-list
6133826|NCT01239732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6133827|NCT01239732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6133828|NCT01239732|Tubulin Modulators|tubulin modulators|mesh-ancestor
6133829|NCT01239732|Antimitotic Agents|antimitotic agents|mesh-ancestor
6133830|NCT01239732|Mitosis Modulators|mitosis modulators|mesh-ancestor
6133831|NCT01239732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133832|NCT01239732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6133833|NCT01239732|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6133834|NCT01239732|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6133835|NCT01239732|Growth Substances|growth substances|mesh-ancestor
6133836|NCT01239732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133837|NCT01239732|Growth Inhibitors|growth inhibitors|mesh-ancestor
6133838|NCT01239745|Exemestane|exemestane|mesh-list
6133839|NCT01239745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6133840|NCT01239745|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6133841|NCT01239745|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6133842|NCT01239745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6133843|NCT01239745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133844|NCT01239745|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6133845|NCT01239745|Hormone Antagonists|hormone antagonists|mesh-ancestor
6133846|NCT01239745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6133847|NCT01239745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133848|NCT01239797|Dexamethasone|dexamethasone|mesh-list
5606769|NCT03786783|Isotretinoin|isotretinoin|mesh-list
6133849|NCT01239797|Dexamethasone acetate|dexamethasone acetate|mesh-list
6133850|NCT01239797|Lenalidomide|lenalidomide|mesh-list
6133851|NCT01239797|Elotuzumab|elotuzumab|mesh-list
6133852|NCT01239797|BB 1101|bb 1101|mesh-list
6133853|NCT01239797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6133854|NCT01239797|Antiemetics|antiemetics|mesh-ancestor
6133855|NCT01239797|Autonomic Agents|autonomic agents|mesh-ancestor
6133856|NCT01239797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6133857|NCT01239797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133858|NCT01239797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6133859|NCT01239797|Glucocorticoids|glucocorticoids|mesh-ancestor
6133860|NCT01239797|Hormones|hormones|mesh-ancestor
6133861|NCT01239797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6133862|NCT01239797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6133863|NCT01239797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6133864|NCT01239797|Protease Inhibitors|protease inhibitors|mesh-ancestor
6133865|NCT01239797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6133866|NCT01239797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133867|NCT01239797|Immunologic Factors|immunologic factors|mesh-ancestor
6133868|NCT01239797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6133869|NCT01239797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6133870|NCT01239797|Growth Substances|growth substances|mesh-ancestor
6133871|NCT01239797|Growth Inhibitors|growth inhibitors|mesh-ancestor
6133872|NCT01239992|Niacin|niacin|mesh-list
5538895|NCT04188184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538896|NCT04188184|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5538897|NCT04188184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6133873|NCT01239992|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6133874|NCT01239992|Antimetabolites|antimetabolites|mesh-ancestor
6133875|NCT01239992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133876|NCT01239992|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6466482|NCT00479362|Analgesics|analgesics|mesh-ancestor
6466483|NCT00479362|Sensory System Agents|sensory system agents|mesh-ancestor
6466484|NCT00479362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6466485|NCT00479362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466486|NCT00479362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6133877|NCT01239992|Vasodilator Agents|vasodilator agents|mesh-ancestor
6133878|NCT01239992|Vitamin B Complex|vitamin b complex|mesh-ancestor
6133879|NCT01239992|Vitamins|vitamins|mesh-ancestor
6133880|NCT01239992|Micronutrients|micronutrients|mesh-ancestor
6133881|NCT01239992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133882|NCT01240135|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6133883|NCT01240200|Insulin Glargine|insulin glargine|mesh-list
6133884|NCT01240200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6133885|NCT01240200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133886|NCT01240382|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6133887|NCT01240382|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6133888|NCT01240382|Hyaluronic Acid|hyaluronic acid|mesh-list
6133889|NCT01240382|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6133890|NCT01240382|Immunologic Factors|immunologic factors|mesh-ancestor
6133891|NCT01240382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133892|NCT01240382|Viscosupplements|viscosupplements|mesh-ancestor
6133893|NCT01240382|Protective Agents|protective agents|mesh-ancestor
6133894|NCT01240590|Cisplatin|cisplatin|mesh-list
6133895|NCT01240590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6133896|NCT01240746|Vaccines|vaccines|mesh-list
6133897|NCT01240746|Immunologic Factors|immunologic factors|mesh-ancestor
6133898|NCT01240746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133899|NCT01240785|Metformin|metformin|mesh-list
6133900|NCT01240785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6133901|NCT01240785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133902|NCT01240811|Copper|copper|mesh-list
6133903|NCT01240811|Levonorgestrel|levonorgestrel|mesh-list
6133904|NCT01240811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6133905|NCT01240811|Contraceptive Agents|contraceptive agents|mesh-ancestor
6133906|NCT01240811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6133907|NCT01240811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133908|NCT01240811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6133909|NCT01240811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6133910|NCT01240811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6133911|NCT01240811|Trace Elements|trace elements|mesh-ancestor
6133912|NCT01240811|Micronutrients|micronutrients|mesh-ancestor
6133913|NCT01240863|Hydrocodone|hydrocodone|mesh-list
6133914|NCT01240863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6133915|NCT01240863|Narcotics|narcotics|mesh-ancestor
6133916|NCT01240863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6466487|NCT00479362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6133917|NCT01240863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133918|NCT01240863|Analgesics|analgesics|mesh-ancestor
6133919|NCT01240863|Sensory System Agents|sensory system agents|mesh-ancestor
6133920|NCT01240863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6133921|NCT01240863|Antitussive Agents|antitussive agents|mesh-ancestor
6133922|NCT01240863|Respiratory System Agents|respiratory system agents|mesh-ancestor
6133923|NCT01241240|Timolol|timolol|mesh-list
6133924|NCT01241240|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6133925|NCT01241240|Bimatoprost|bimatoprost|mesh-list
6133926|NCT01241240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6133927|NCT01241240|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6133928|NCT01241240|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6133929|NCT01241240|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6133930|NCT01241240|Adrenergic Agents|adrenergic agents|mesh-ancestor
6133931|NCT01241240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6133932|NCT01241240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133933|NCT01241240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133934|NCT01241240|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6133935|NCT01241240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6133936|NCT01241240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6133937|NCT01241240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6133938|NCT01241240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6133939|NCT01241292|Elotuzumab|elotuzumab|mesh-list
6133940|NCT01241292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6133941|NCT01241318|Chlorhexidine|chlorhexidine|mesh-list
6466488|NCT00479362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6466489|NCT00479362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6466490|NCT00479362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466491|NCT00479362|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6466492|NCT00479362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6466493|NCT00479362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6466494|NCT00479362|Antipyretics|antipyretics|mesh-ancestor
6466495|NCT00479362|Anticoagulants|anticoagulants|mesh-ancestor
6466496|NCT00479479|Vitamin B 12|vitamin b 12|mesh-list
6133942|NCT01241318|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6133943|NCT01241318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6133944|NCT01241318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6133945|NCT01241318|Disinfectants|disinfectants|mesh-ancestor
6133946|NCT01241318|Dermatologic Agents|dermatologic agents|mesh-ancestor
6133947|NCT01241344|Brincidofovir|brincidofovir|mesh-list
6133948|NCT01241344|Antiviral Agents|antiviral agents|mesh-ancestor
6133949|NCT01241344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6205128|NCT02081638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6205129|NCT02081638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6205130|NCT02081638|Antimetabolites|antimetabolites|mesh-ancestor
6205131|NCT02081638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6205132|NCT02081638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6205133|NCT02081690|Macitentan|macitentan|mesh-list
6205134|NCT02081690|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
6205135|NCT02081690|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6205136|NCT02081690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205137|NCT02081690|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
6205138|NCT02081950|Enoxaparin|enoxaparin|mesh-list
6205139|NCT02081950|Enoxaparin sodium|enoxaparin sodium|mesh-list
6205140|NCT02081950|Anticoagulants|anticoagulants|mesh-ancestor
6205141|NCT02081950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6205142|NCT02081950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6205143|NCT02081950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205144|NCT02081963|Amikacin|amikacin|mesh-list
6205145|NCT02081963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6205146|NCT02081963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6205147|NCT02082210|Ramucirumab|ramucirumab|mesh-list
6205148|NCT02082210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6205149|NCT02082392|Citalopram|citalopram|mesh-list
6205150|NCT02082392|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6205151|NCT02082392|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6205152|NCT02082392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6205153|NCT02082392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205154|NCT02082392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6205155|NCT02082392|Serotonin Agents|serotonin agents|mesh-ancestor
6205156|NCT02082392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205157|NCT02082392|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6205158|NCT02082392|Antidepressive Agents|antidepressive agents|mesh-ancestor
6205159|NCT02082392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6205160|NCT02082522|Gemcitabine|gemcitabine|mesh-list
6205161|NCT02082522|Cisplatin|cisplatin|mesh-list
6205162|NCT02082522|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
6205163|NCT02082522|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
6133950|NCT01241539|Dabigatran|dabigatran|mesh-list
6133951|NCT01241539|Antithrombins|antithrombins|mesh-ancestor
6133952|NCT01241539|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6133953|NCT01241539|Protease Inhibitors|protease inhibitors|mesh-ancestor
6133954|NCT01241539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6133955|NCT01241539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133956|NCT01241539|Anticoagulants|anticoagulants|mesh-ancestor
6133957|NCT01241552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6133958|NCT01241552|Immunologic Factors|immunologic factors|mesh-ancestor
6133959|NCT01241552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133960|NCT01241591|Etanercept|etanercept|mesh-list
5538898|NCT04188184|Autonomic Agents|autonomic agents|mesh-ancestor
5538899|NCT04188184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5538900|NCT04188184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5538901|NCT04188184|Respiratory System Agents|respiratory system agents|mesh-ancestor
5538902|NCT04188184|Mydriatics|mydriatics|mesh-ancestor
5538903|NCT04188184|Sympathomimetics|sympathomimetics|mesh-ancestor
5538904|NCT04188184|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5538905|NCT04188184|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5538906|NCT04188184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5538907|NCT04188184|Hemostatics|hemostatics|mesh-ancestor
5538908|NCT04188184|Coagulants|coagulants|mesh-ancestor
5538909|NCT04188171|Polidocanol|polidocanol|mesh-list
5538910|NCT04188171|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
5538911|NCT04188171|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5538912|NCT04187833|Nivolumab|nivolumab|mesh-list
5538913|NCT04187833|Talazoparib|talazoparib|mesh-list
5538914|NCT04187833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5538915|NCT04187833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5538916|NCT04187833|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5538917|NCT04187833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538918|NCT04187833|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5538919|NCT04187833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5538920|NCT04188223|Vaccines|vaccines|mesh-list
5538921|NCT04188223|Immunologic Factors|immunologic factors|mesh-ancestor
5538922|NCT04188223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538923|NCT04188314|Desflurane|desflurane|mesh-list
5538924|NCT04188314|Isoflurane|isoflurane|mesh-list
6133961|NCT01241591|Tofacitinib|tofacitinib|mesh-list
6133962|NCT01241591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6133963|NCT01241591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6133964|NCT01241591|Analgesics|analgesics|mesh-ancestor
6133965|NCT01241591|Sensory System Agents|sensory system agents|mesh-ancestor
6133966|NCT01241591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6133967|NCT01241591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538925|NCT04188314|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5538926|NCT04188314|Anesthetics, General|anesthetics, general|mesh-ancestor
5538927|NCT04188314|Anesthetics|anesthetics|mesh-ancestor
5538928|NCT04188314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5538929|NCT04188314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538930|NCT04187872|Pembrolizumab|pembrolizumab|mesh-list
5538931|NCT04187872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6133968|NCT01241591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6133969|NCT01241591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6133970|NCT01241591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6133971|NCT01241591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6133972|NCT01241591|Immunologic Factors|immunologic factors|mesh-ancestor
6133973|NCT01241591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6133974|NCT01241591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6133975|NCT01241591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133976|NCT01241760|Interferons|interferons|mesh-list
6133977|NCT01241760|Ribavirin|ribavirin|mesh-list
6133978|NCT01241760|Interferon-alpha|interferon-alpha|mesh-list
6133979|NCT01241760|Interferon alpha-2|interferon alpha-2|mesh-list
6133980|NCT01241760|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6133981|NCT01241760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6133982|NCT01241760|Antiviral Agents|antiviral agents|mesh-ancestor
6133983|NCT01241760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6133984|NCT01241760|Antimetabolites|antimetabolites|mesh-ancestor
6133985|NCT01241760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133986|NCT01241760|Immunologic Factors|immunologic factors|mesh-ancestor
6133987|NCT01241760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6133988|NCT01241903|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6133989|NCT01241903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5538932|NCT04187872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5538933|NCT04187755|Ceftazidime|ceftazidime|mesh-list
5538934|NCT04187755|Cefepime|cefepime|mesh-list
6133990|NCT01241903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5538935|NCT04187755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5538936|NCT04187755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5538937|NCT04187807|Melatonin|melatonin|mesh-list
6133991|NCT01241903|Antimetabolites|antimetabolites|mesh-ancestor
6133992|NCT01241903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133993|NCT01241903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6133994|NCT01241903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6133995|NCT01241903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6133996|NCT01242176|Empagliflozin|empagliflozin|mesh-list
6133997|NCT01242176|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6133998|NCT01242176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6133999|NCT01242176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6134000|NCT01242176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134001|NCT01242241|Propofol|propofol|mesh-list
6134002|NCT01242241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6134003|NCT01242241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6134004|NCT01242241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134005|NCT01242241|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6134006|NCT01242241|Anesthetics, General|anesthetics, general|mesh-ancestor
6134007|NCT01242241|Anesthetics|anesthetics|mesh-ancestor
6134008|NCT01242644|Ketorolac|ketorolac|mesh-list
6134009|NCT01242644|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6134010|NCT01242644|Morphine|morphine|mesh-list
6134011|NCT01242644|Ropivacaine|ropivacaine|mesh-list
6134012|NCT01242644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6134013|NCT01242644|Narcotics|narcotics|mesh-ancestor
6134014|NCT01242644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6134015|NCT01242644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134016|NCT01242644|Analgesics|analgesics|mesh-ancestor
6134017|NCT01242644|Sensory System Agents|sensory system agents|mesh-ancestor
6134018|NCT01242644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6134019|NCT01242644|Anesthetics, Local|anesthetics, local|mesh-ancestor
6134020|NCT01242644|Anesthetics|anesthetics|mesh-ancestor
6134021|NCT01242644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6134022|NCT01242644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6134023|NCT01242644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6134024|NCT01242644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6134025|NCT01242644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6134026|NCT01242644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6134027|NCT01242644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134028|NCT01242748|Goserelin|goserelin|mesh-list
6134029|NCT01242748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5538938|NCT04187807|Antioxidants|antioxidants|mesh-ancestor
5538939|NCT04187807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538940|NCT04187807|Protective Agents|protective agents|mesh-ancestor
5538941|NCT04187807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134030|NCT01242748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6134031|NCT01243112|Lidocaine|lidocaine|mesh-list
6134032|NCT01243112|Epinephrine|epinephrine|mesh-list
6134033|NCT01243112|Racepinephrine|racepinephrine|mesh-list
6134034|NCT01243112|Bupivacaine|bupivacaine|mesh-list
6134035|NCT01243112|Epinephryl borate|epinephryl borate|mesh-list
6134036|NCT01243112|Anesthetics, Local|anesthetics, local|mesh-ancestor
6134037|NCT01243112|Anesthetics|anesthetics|mesh-ancestor
6134038|NCT01243112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6134039|NCT01243112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134040|NCT01243112|Sensory System Agents|sensory system agents|mesh-ancestor
6134041|NCT01243112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6134042|NCT01243112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6134043|NCT01243112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6134044|NCT01243112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6134045|NCT01243112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6134046|NCT01243112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134047|NCT01243112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6134048|NCT01243112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6134049|NCT01243112|Adrenergic Agents|adrenergic agents|mesh-ancestor
6134050|NCT01243112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6134051|NCT01243112|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6134052|NCT01243112|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6134053|NCT01243112|Autonomic Agents|autonomic agents|mesh-ancestor
6134054|NCT01243112|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6134055|NCT01243112|Respiratory System Agents|respiratory system agents|mesh-ancestor
6134056|NCT01243112|Mydriatics|mydriatics|mesh-ancestor
6134057|NCT01243112|Sympathomimetics|sympathomimetics|mesh-ancestor
6134058|NCT01243112|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6134059|NCT01243151|Bococizumab|bococizumab|mesh-list
6134060|NCT01243151|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6134061|NCT01243151|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6134062|NCT01243151|Antimetabolites|antimetabolites|mesh-ancestor
6134063|NCT01243151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134064|NCT01243151|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6134065|NCT01243177|Lacosamide|lacosamide|mesh-list
6134066|NCT01243177|Carbamazepine|carbamazepine|mesh-list
6134067|NCT01243177|Anticonvulsants|anticonvulsants|mesh-ancestor
6134068|NCT01243177|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6134069|NCT01243177|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6134070|NCT01243177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6134071|NCT01243177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134072|NCT01243177|Antimanic Agents|antimanic agents|mesh-ancestor
6134073|NCT01243177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5538942|NCT04187807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5538943|NCT04187898|Cyclophosphamide|cyclophosphamide|mesh-list
5538944|NCT04187898|Docetaxel|docetaxel|mesh-list
5538945|NCT04187898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5538946|NCT04187898|Immunologic Factors|immunologic factors|mesh-ancestor
5538947|NCT04187898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538948|NCT04187898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5538949|NCT04187898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5538950|NCT04187898|Alkylating Agents|alkylating agents|mesh-ancestor
5538951|NCT04187898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538952|NCT04187898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5538953|NCT04187898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5538954|NCT04187898|Tubulin Modulators|tubulin modulators|mesh-ancestor
5538955|NCT04187898|Antimitotic Agents|antimitotic agents|mesh-ancestor
5538956|NCT04187898|Mitosis Modulators|mitosis modulators|mesh-ancestor
6134074|NCT01243177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6134075|NCT01243177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134076|NCT01243177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6134077|NCT01243177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6134078|NCT01243177|Analgesics|analgesics|mesh-ancestor
6134079|NCT01243177|Sensory System Agents|sensory system agents|mesh-ancestor
6134080|NCT01243177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6134081|NCT01243177|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6134082|NCT01243177|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6134083|NCT01243242|Metadoxine|metadoxine|mesh-list
6134084|NCT01243242|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6134085|NCT01243268|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
6134086|NCT01243268|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6134087|NCT01243268|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6134088|NCT01243268|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6134089|NCT01243268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134090|NCT01243333|Deoxyglucose|deoxyglucose|mesh-list
6134091|NCT01243333|Alovudine|alovudine|mesh-list
6134092|NCT01243333|Dideoxynucleosides|dideoxynucleosides|mesh-list
6134093|NCT01243333|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6134094|NCT01243333|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6134095|NCT01243333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134096|NCT01243333|Antimetabolites|antimetabolites|mesh-ancestor
6134097|NCT01243333|Antiviral Agents|antiviral agents|mesh-ancestor
6134098|NCT01243333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6134099|NCT01243333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6134100|NCT01243333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6134101|NCT01243333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6134102|NCT01243424|Glimepiride|glimepiride|mesh-list
5538957|NCT04187469|Moxifloxacin|moxifloxacin|mesh-list
5538958|NCT04187469|Rifampin|rifampin|mesh-list
5538959|NCT04187469|Isoniazid|isoniazid|mesh-list
5538960|NCT04187469|Pyrazinamide|pyrazinamide|mesh-list
5538961|NCT04187469|Ethambutol|ethambutol|mesh-list
5538962|NCT04187469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5538963|NCT04187469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5538964|NCT04187469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5538965|NCT04187469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5538966|NCT04187469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5538967|NCT04187469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538968|NCT04187469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5538969|NCT04187469|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5538970|NCT04187469|Antitubercular Agents|antitubercular agents|mesh-ancestor
5538971|NCT04187469|Leprostatic Agents|leprostatic agents|mesh-ancestor
5538972|NCT04187469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5538973|NCT04187469|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5538974|NCT04187469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5538975|NCT04187469|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5538976|NCT04187469|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5538977|NCT04187469|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6134103|NCT01243424|Linagliptin|linagliptin|mesh-list
6134104|NCT01243424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6134105|NCT01243424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6134106|NCT01243424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134107|NCT01243424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6134108|NCT01243424|Immunologic Factors|immunologic factors|mesh-ancestor
6134109|NCT01243424|Incretins|incretins|mesh-ancestor
6134110|NCT01243424|Hormones|hormones|mesh-ancestor
6134111|NCT01243424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6134112|NCT01243424|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6134113|NCT01243424|Protease Inhibitors|protease inhibitors|mesh-ancestor
6134114|NCT01243424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6134115|NCT01243424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134116|NCT01243450|Tretinoin|tretinoin|mesh-list
6134117|NCT01243450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6134118|NCT01243450|Keratolytic Agents|keratolytic agents|mesh-ancestor
6134119|NCT01243450|Dermatologic Agents|dermatologic agents|mesh-ancestor
6134120|NCT01243567|Timolol|timolol|mesh-list
6134121|NCT01243567|Bimatoprost|bimatoprost|mesh-list
6134122|NCT01243567|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6134123|NCT01243567|Latanoprost|latanoprost|mesh-list
6134124|NCT01243567|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6134125|NCT01243567|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6134126|NCT01243567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5538978|NCT04187469|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5538979|NCT04187469|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5538980|NCT04187469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6134127|NCT01243567|Adrenergic Agents|adrenergic agents|mesh-ancestor
6134128|NCT01243567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6134129|NCT01243567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134130|NCT01243567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466497|NCT00479479|Hydroxocobalamin|hydroxocobalamin|mesh-list
6466498|NCT00479479|Vitamins|vitamins|mesh-ancestor
6466499|NCT00479479|Micronutrients|micronutrients|mesh-ancestor
6134131|NCT01243567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6134132|NCT01243567|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6134133|NCT01243580|Moxifloxacin|moxifloxacin|mesh-list
6134134|NCT01243580|Contraceptive Agents|contraceptive agents|mesh-list
6134135|NCT01243580|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
5538981|NCT04187469|Antimetabolites|antimetabolites|mesh-ancestor
5538982|NCT04187469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5538983|NCT04187703|Azacitidine|azacitidine|mesh-list
5538984|NCT04187703|Decitabine|decitabine|mesh-list
5538985|NCT04187703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5538986|NCT04187703|Antimetabolites|antimetabolites|mesh-ancestor
5538987|NCT04187703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538988|NCT04187703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5538989|NCT04187703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5538990|NCT04187352|Cisplatin|cisplatin|mesh-list
5538991|NCT04187352|Fluorouracil|fluorouracil|mesh-list
5538992|NCT04187352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5538993|NCT04187352|Antimetabolites|antimetabolites|mesh-ancestor
5538994|NCT04187352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5538995|NCT04187352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5538996|NCT04187352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5538997|NCT04187352|Immunologic Factors|immunologic factors|mesh-ancestor
5538998|NCT04187352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5538999|NCT04187417|Tetracaine|tetracaine|mesh-list
5539000|NCT04187417|Anesthetics, Local|anesthetics, local|mesh-ancestor
5539001|NCT04187417|Anesthetics|anesthetics|mesh-ancestor
5539002|NCT04187417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5539003|NCT04187417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539004|NCT04187417|Sensory System Agents|sensory system agents|mesh-ancestor
5539005|NCT04187417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5602082|NCT04952402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134136|NCT01243580|Contraceptives, Oral|contraceptives, oral|mesh-list
6134137|NCT01243580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6134138|NCT01243580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602083|NCT04949399|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6466500|NCT00479479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134139|NCT01243580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6134140|NCT01243580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6134141|NCT01243580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6134142|NCT01243580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6134143|NCT01243580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6134144|NCT01243580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6134145|NCT01243580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539006|NCT04187144|Nitrofurantoin|nitrofurantoin|mesh-list
5539007|NCT04187144|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5539008|NCT04187144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5539009|NCT04187144|Renal Agents|renal agents|mesh-ancestor
5539010|NCT04187144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5539011|NCT04187456|Midazolam|midazolam|mesh-list
5539012|NCT04187456|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5539013|NCT04187456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5539014|NCT04187456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5539015|NCT04187456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539016|NCT04187456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5539017|NCT04187456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5539018|NCT04187456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5539019|NCT04187456|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5539020|NCT04187456|Anesthetics, General|anesthetics, general|mesh-ancestor
5539021|NCT04187456|Anesthetics|anesthetics|mesh-ancestor
5539022|NCT04187456|GABA Modulators|gaba modulators|mesh-ancestor
5539023|NCT04187456|GABA Agents|gaba agents|mesh-ancestor
5539024|NCT04187456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5539025|NCT04187456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539026|NCT04187105|Cyclophosphamide|cyclophosphamide|mesh-list
5539027|NCT04187105|Fludarabine|fludarabine|mesh-list
5539028|NCT04187105|Tacrolimus|tacrolimus|mesh-list
5539029|NCT04187105|Complement Factor H|complement factor h|mesh-list
6134146|NCT01243580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6134147|NCT01243580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6134148|NCT01243580|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6134149|NCT01243593|Anesthetics|anesthetics|mesh-list
6134150|NCT01243593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6134151|NCT01243593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134152|NCT01243671|Adalimumab|adalimumab|mesh-list
6134153|NCT01243671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6134154|NCT01243671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6134155|NCT01243775|Docetaxel|docetaxel|mesh-list
6134156|NCT01243775|Oxaliplatin|oxaliplatin|mesh-list
6134157|NCT01243775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6134158|NCT01243775|Tubulin Modulators|tubulin modulators|mesh-ancestor
6134159|NCT01243775|Antimitotic Agents|antimitotic agents|mesh-ancestor
6466501|NCT00479479|Vitamin B Complex|vitamin b complex|mesh-ancestor
6466502|NCT00479479|Hematinics|hematinics|mesh-ancestor
6466503|NCT00479609|Testosterone|testosterone|mesh-list
6466504|NCT00479609|Androgens|androgens|mesh-ancestor
6466505|NCT00479609|Hormones|hormones|mesh-ancestor
6466506|NCT00479609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6466507|NCT00479609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466508|NCT00479661|Dexmedetomidine|dexmedetomidine|mesh-list
6466509|NCT00479661|Propofol|propofol|mesh-list
6466510|NCT00479661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6466511|NCT00479661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6466512|NCT00479661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466513|NCT00479661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6466514|NCT00479661|Anesthetics, General|anesthetics, general|mesh-ancestor
6466515|NCT00479661|Anesthetics|anesthetics|mesh-ancestor
6466516|NCT00479661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6466517|NCT00479661|Analgesics|analgesics|mesh-ancestor
6466518|NCT00479661|Sensory System Agents|sensory system agents|mesh-ancestor
6466519|NCT00479661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6466520|NCT00479661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6466521|NCT00479661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6466522|NCT00479661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6466523|NCT00479661|Adrenergic Agents|adrenergic agents|mesh-ancestor
6466524|NCT00479661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6466525|NCT00479661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466526|NCT00479726|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6466527|NCT00479726|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6466528|NCT00479726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5539030|NCT04187105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5539031|NCT04187105|Immunologic Factors|immunologic factors|mesh-ancestor
5602084|NCT04949399|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5539032|NCT04187105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539033|NCT04187105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5539034|NCT04187105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5539035|NCT04187105|Alkylating Agents|alkylating agents|mesh-ancestor
5539036|NCT04187105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539037|NCT04187105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5539038|NCT04187105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5539039|NCT04187105|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5539040|NCT04187105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5539041|NCT04187105|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5539042|NCT04186702|Ranibizumab|ranibizumab|mesh-list
5539043|NCT04186702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5539044|NCT04186702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5539045|NCT04186702|Growth Substances|growth substances|mesh-ancestor
5539046|NCT04186702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539047|NCT04186702|Growth Inhibitors|growth inhibitors|mesh-ancestor
5539048|NCT04186702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5539049|NCT04186936|Simethicone|simethicone|mesh-list
5539050|NCT04186936|Loperamide|loperamide|mesh-list
5539051|NCT04186936|Antidiarrheals|antidiarrheals|mesh-list
5539052|NCT04186936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5539053|NCT04186936|Antifoaming Agents|antifoaming agents|mesh-ancestor
5539054|NCT04186936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539055|NCT04186936|Emollients|emollients|mesh-ancestor
5539056|NCT04186936|Dermatologic Agents|dermatologic agents|mesh-ancestor
5539057|NCT04187053|Methylene Blue|methylene blue|mesh-list
5539058|NCT04187053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5539059|NCT04187053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539060|NCT04187014|Tranexamic Acid|tranexamic acid|mesh-list
5539061|NCT04187014|Aminocaproic Acid|aminocaproic acid|mesh-list
5539062|NCT04187014|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5539063|NCT04187014|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5539064|NCT04187014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539065|NCT04187014|Hemostatics|hemostatics|mesh-ancestor
5539066|NCT04187014|Coagulants|coagulants|mesh-ancestor
5539067|NCT04186598|Nifedipine|nifedipine|mesh-list
5539068|NCT04186598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5539069|NCT04186598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5539070|NCT04186598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539071|NCT04186598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5539072|NCT04186598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539073|NCT04186598|Vasodilator Agents|vasodilator agents|mesh-ancestor
5539074|NCT04186598|Tocolytic Agents|tocolytic agents|mesh-ancestor
6466529|NCT00479726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6466530|NCT00479726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466531|NCT00479726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6466532|NCT00479726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466533|NCT00479726|Analgesics|analgesics|mesh-ancestor
6466534|NCT00479726|Sensory System Agents|sensory system agents|mesh-ancestor
6466535|NCT00479726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6466536|NCT00479726|Antidepressive Agents|antidepressive agents|mesh-ancestor
6466537|NCT00479726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6466538|NCT00479726|Dopamine Agents|dopamine agents|mesh-ancestor
6466539|NCT00479739|Fluticasone|fluticasone|mesh-list
6466540|NCT00479739|Xhance|xhance|mesh-list
6466541|NCT00479739|Budesonide|budesonide|mesh-list
6466542|NCT00479739|Formoterol Fumarate|formoterol fumarate|mesh-list
6466543|NCT00479739|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6466544|NCT00479739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6466545|NCT00479739|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6466546|NCT00479739|Autonomic Agents|autonomic agents|mesh-ancestor
6466547|NCT00479739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6466548|NCT00479739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134160|NCT01243775|Mitosis Modulators|mitosis modulators|mesh-ancestor
6134161|NCT01243775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134162|NCT01243944|Lenalidomide|lenalidomide|mesh-list
6134163|NCT01243944|Pomalidomide|pomalidomide|mesh-list
6134164|NCT01243944|Hydroxyurea|hydroxyurea|mesh-list
6134165|NCT01243944|Pipobroman|pipobroman|mesh-list
6466549|NCT00479739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5539075|NCT04186598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5539076|NCT04186559|Pentoxifylline|pentoxifylline|mesh-list
5539077|NCT04186559|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5539078|NCT04186559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6134166|NCT01243944|Anagrelide|anagrelide|mesh-list
6134167|NCT01243944|Immunologic Factors|immunologic factors|mesh-ancestor
6134168|NCT01243944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134169|NCT01243944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5539079|NCT04186559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539080|NCT04186559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5539081|NCT04186559|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5539082|NCT04186559|Protective Agents|protective agents|mesh-ancestor
5539083|NCT04186559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539084|NCT04186559|Vasodilator Agents|vasodilator agents|mesh-ancestor
5539085|NCT04186559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5539086|NCT04186559|Antioxidants|antioxidants|mesh-ancestor
5539087|NCT04186897|Salicylic Acid|salicylic acid|mesh-list
5539088|NCT04186897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6134170|NCT01243944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6134171|NCT01243944|Growth Substances|growth substances|mesh-ancestor
6134172|NCT01243944|Growth Inhibitors|growth inhibitors|mesh-ancestor
6134173|NCT01243944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6134174|NCT01243944|Antisickling Agents|antisickling agents|mesh-ancestor
6134175|NCT01243944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6134176|NCT01243944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539089|NCT04186897|Antifungal Agents|antifungal agents|mesh-ancestor
5539090|NCT04186897|Keratolytic Agents|keratolytic agents|mesh-ancestor
5539091|NCT04186897|Dermatologic Agents|dermatologic agents|mesh-ancestor
5539092|NCT04186663|Fluorides|fluorides|mesh-list
5539093|NCT04186663|Cariostatic Agents|cariostatic agents|mesh-ancestor
5539094|NCT04186663|Protective Agents|protective agents|mesh-ancestor
5539095|NCT04186663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539096|NCT04186247|Azithromycin|azithromycin|mesh-list
6134177|NCT01243944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6134178|NCT01243944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6134179|NCT01243944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6134180|NCT01243944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6134181|NCT01243944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6134182|NCT01243944|Alkylating Agents|alkylating agents|mesh-ancestor
6134183|NCT01243957|Fluoxetine|fluoxetine|mesh-list
6134184|NCT01243957|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6134185|NCT01243957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6205164|NCT02082522|Trioxsalen|trioxsalen|mesh-list
5539097|NCT04186247|Metronidazole|metronidazole|mesh-list
5539098|NCT04186247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5539099|NCT04186247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5539100|NCT04186247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5539101|NCT04186247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5539102|NCT04186299|Clonidine|clonidine|mesh-list
5539103|NCT04186299|Epinephrine|epinephrine|mesh-list
5539104|NCT04186299|Carticaine|carticaine|mesh-list
5539105|NCT04186299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5539106|NCT04186299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5539107|NCT04186299|Adrenergic Agents|adrenergic agents|mesh-ancestor
5539108|NCT04186299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5539109|NCT04186299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539110|NCT04186299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539111|NCT04186299|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5539112|NCT04186299|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5539113|NCT04186299|Autonomic Agents|autonomic agents|mesh-ancestor
5539114|NCT04186299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5539115|NCT04186299|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5539116|NCT04186299|Respiratory System Agents|respiratory system agents|mesh-ancestor
5539117|NCT04186299|Mydriatics|mydriatics|mesh-ancestor
5539118|NCT04186299|Sympathomimetics|sympathomimetics|mesh-ancestor
5539119|NCT04186299|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5539120|NCT04186299|Analgesics|analgesics|mesh-ancestor
5539121|NCT04186299|Sensory System Agents|sensory system agents|mesh-ancestor
5539122|NCT04186299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5539123|NCT04186299|Sympatholytics|sympatholytics|mesh-ancestor
5539124|NCT04186299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5539125|NCT04186299|Anesthetics, Local|anesthetics, local|mesh-ancestor
5539126|NCT04186299|Anesthetics|anesthetics|mesh-ancestor
5539127|NCT04186299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5539128|NCT04186442|Botulinum Toxins|botulinum toxins|mesh-list
5539129|NCT04186442|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5539130|NCT04186442|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5539131|NCT04186442|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5539132|NCT04186442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5539133|NCT04186442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539134|NCT04186442|Cholinergic Agents|cholinergic agents|mesh-ancestor
5539135|NCT04186442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6134186|NCT01243957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6134187|NCT01243957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134188|NCT01243957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6134189|NCT01243957|Serotonin Agents|serotonin agents|mesh-ancestor
6134190|NCT01243957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134191|NCT01243957|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6134192|NCT01243957|Antidepressive Agents|antidepressive agents|mesh-ancestor
6134193|NCT01243957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6134194|NCT01243957|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6134195|NCT01243957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6134196|NCT01243957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6134197|NCT01244061|Varenicline|varenicline|mesh-list
6134198|NCT01244061|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6134199|NCT01244061|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6134200|NCT01244061|Cholinergic Agents|cholinergic agents|mesh-ancestor
6134201|NCT01244061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5539136|NCT04186442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539137|NCT04186442|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5539138|NCT04186442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5539139|NCT04186013|Atezolizumab|atezolizumab|mesh-list
5539140|NCT04186013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5539141|NCT04186026|Glucagon|glucagon|mesh-list
5539142|NCT04186026|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5539143|NCT04186026|Incretins|incretins|mesh-ancestor
5539144|NCT04186026|Hormones|hormones|mesh-ancestor
5539145|NCT04186026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5539146|NCT04186026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539147|NCT04186026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5539148|NCT04185857|Olmesartan|olmesartan|mesh-list
5539149|NCT04185857|Canrenone|canrenone|mesh-list
5539150|NCT04185857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5539151|NCT04185857|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6134202|NCT01244061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134203|NCT01244061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134204|NCT01244126|Fentanyl|fentanyl|mesh-list
6134205|NCT01244126|Morphine|morphine|mesh-list
6134206|NCT01244126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6134207|NCT01244126|Narcotics|narcotics|mesh-ancestor
6134208|NCT01244126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6134209|NCT01244126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134210|NCT01244126|Analgesics|analgesics|mesh-ancestor
6134211|NCT01244126|Sensory System Agents|sensory system agents|mesh-ancestor
6134212|NCT01244126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6134213|NCT01244126|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6134214|NCT01244126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6134215|NCT01244126|Anesthetics, General|anesthetics, general|mesh-ancestor
6134216|NCT01244126|Anesthetics|anesthetics|mesh-ancestor
5539152|NCT04185857|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5539153|NCT04185857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539154|NCT04185857|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5539155|NCT04185857|Hormone Antagonists|hormone antagonists|mesh-ancestor
5539156|NCT04185857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5539157|NCT04185857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134217|NCT01244191|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6134218|NCT01244191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6134219|NCT01244191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6134220|NCT01244191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6134221|NCT01244191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134222|NCT01244425|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6134223|NCT01244425|Hemostatics|hemostatics|mesh-ancestor
6134224|NCT01244425|Coagulants|coagulants|mesh-ancestor
6134225|NCT01244451|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6134226|NCT01244451|Ofatumumab|ofatumumab|mesh-list
6134227|NCT01244451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6134228|NCT01244451|Alkylating Agents|alkylating agents|mesh-ancestor
6134229|NCT01244451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134230|NCT01244451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6134231|NCT01244490|Guanfacine|guanfacine|mesh-list
6134232|NCT01244490|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6134233|NCT01244490|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6134234|NCT01244490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5539158|NCT04185857|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5539159|NCT04185857|Diuretics|diuretics|mesh-ancestor
6134235|NCT01244490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6134236|NCT01244490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134237|NCT01244490|Adrenergic Agents|adrenergic agents|mesh-ancestor
6134238|NCT01244490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6134239|NCT01244490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134240|NCT01244490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6134241|NCT01244490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6134242|NCT01244490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6134243|NCT01244490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6134244|NCT01244633|Ecopipam|ecopipam|mesh-list
6134245|NCT01244633|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6134246|NCT01244633|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6134247|NCT01244633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6134248|NCT01244633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134249|NCT01244633|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6134250|NCT01244633|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6134251|NCT01244633|Dopamine Agents|dopamine agents|mesh-ancestor
6134252|NCT01244633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6134253|NCT01244633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134254|NCT01244711|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6134255|NCT01244711|Antidepressive Agents|antidepressive agents|mesh-ancestor
6134256|NCT01244711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6134257|NCT01244711|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6134258|NCT01244711|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6134259|NCT01244711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6134260|NCT01244711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134261|NCT01244724|Citalopram|citalopram|mesh-list
6134262|NCT01244724|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6134263|NCT01244724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6134264|NCT01244724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6134265|NCT01244724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134266|NCT01244724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6134267|NCT01244724|Serotonin Agents|serotonin agents|mesh-ancestor
6134268|NCT01244724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134269|NCT01244724|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6134270|NCT01244724|Antidepressive Agents|antidepressive agents|mesh-ancestor
6134271|NCT01244724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6134272|NCT01244984|Fluticasone|fluticasone|mesh-list
6134273|NCT01244984|Xhance|xhance|mesh-list
6134274|NCT01244984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6134275|NCT01244984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6134276|NCT01244984|Autonomic Agents|autonomic agents|mesh-ancestor
6134277|NCT01244984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6134278|NCT01244984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134279|NCT01244984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6134280|NCT01244984|Respiratory System Agents|respiratory system agents|mesh-ancestor
6134281|NCT01244984|Dermatologic Agents|dermatologic agents|mesh-ancestor
6134282|NCT01244984|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6134283|NCT01245062|Trametinib|trametinib|mesh-list
6134284|NCT01245062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6134285|NCT01245062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6134286|NCT01245062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6134287|NCT01245062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134288|NCT01245101|Raltegravir Potassium|raltegravir potassium|mesh-list
6134289|NCT01245101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6134290|NCT01245101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6134291|NCT01245101|Antiviral Agents|antiviral agents|mesh-ancestor
6134292|NCT01245101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6134293|NCT01245101|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6134294|NCT01245101|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6134295|NCT01245101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6134296|NCT01245101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134297|NCT01245140|Alitretinoin|alitretinoin|mesh-list
6134298|NCT01245140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6134299|NCT01245140|Dermatologic Agents|dermatologic agents|mesh-ancestor
6134300|NCT01245595|Aminophylline|aminophylline|mesh-list
6134301|NCT01245595|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5539160|NCT04185857|Natriuretic Agents|natriuretic agents|mesh-ancestor
6134302|NCT01245595|Autonomic Agents|autonomic agents|mesh-ancestor
6134303|NCT01245595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6134304|NCT01245595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134305|NCT01245595|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6134306|NCT01245595|Respiratory System Agents|respiratory system agents|mesh-ancestor
6134307|NCT01245595|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5539161|NCT04185675|Anesthetics|anesthetics|mesh-list
5539162|NCT04185675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6134308|NCT01245595|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6134309|NCT01245595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6134310|NCT01245595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134311|NCT01245595|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6134312|NCT01245595|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6134313|NCT01245595|Purinergic Agents|purinergic agents|mesh-ancestor
6134314|NCT01245595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6134315|NCT01245595|Protective Agents|protective agents|mesh-ancestor
6134316|NCT01245647|Naltrexone|naltrexone|mesh-list
6134317|NCT01245647|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6134318|NCT01245647|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6134319|NCT01245647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134320|NCT01245647|Sensory System Agents|sensory system agents|mesh-ancestor
6134321|NCT01245647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6134322|NCT01245673|Lenalidomide|lenalidomide|mesh-list
6134323|NCT01245673|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6134324|NCT01245673|Poly ICLC|poly iclc|mesh-list
6134325|NCT01245673|Immunologic Factors|immunologic factors|mesh-ancestor
5539163|NCT04185675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539164|NCT04185766|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5539165|NCT04185831|Everolimus|everolimus|mesh-list
5539166|NCT04185831|Atezolizumab|atezolizumab|mesh-list
5539167|NCT04185831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5539168|NCT04185831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6134326|NCT01245673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134327|NCT01245673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6134328|NCT01245673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5539169|NCT04185831|Immunologic Factors|immunologic factors|mesh-ancestor
5539170|NCT04185831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602085|NCT04949399|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5602086|NCT04949399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5602087|NCT04949399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602088|NCT04949399|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5602089|NCT04949399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5602090|NCT04949399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602091|NCT04949399|Cholinergic Agents|cholinergic agents|mesh-ancestor
5602092|NCT04949399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5602093|NCT04944368|Myeloma Proteins|myeloma proteins|mesh-list
5602094|NCT04944368|Paraproteins|paraproteins|mesh-list
5602095|NCT04944368|Immunologic Factors|immunologic factors|mesh-ancestor
5602096|NCT04944368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602097|NCT04940338|Dexamethasone|dexamethasone|mesh-list
6134329|NCT01245673|Growth Substances|growth substances|mesh-ancestor
6134330|NCT01245673|Growth Inhibitors|growth inhibitors|mesh-ancestor
6134331|NCT01245673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6134332|NCT01245673|Interferon Inducers|interferon inducers|mesh-ancestor
6134333|NCT01246063|Dexamethasone|dexamethasone|mesh-list
6134334|NCT01246063|Doxorubicin|doxorubicin|mesh-list
5602098|NCT04940338|Dexamethasone acetate|dexamethasone acetate|mesh-list
5602099|NCT04940338|Bromfenac|bromfenac|mesh-list
5602100|NCT04940338|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5602101|NCT04940338|BB 1101|bb 1101|mesh-list
5602102|NCT04940338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5602103|NCT04940338|Antiemetics|antiemetics|mesh-ancestor
5602104|NCT04940338|Autonomic Agents|autonomic agents|mesh-ancestor
5602105|NCT04940338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5602106|NCT04940338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602107|NCT04940338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5602108|NCT04940338|Glucocorticoids|glucocorticoids|mesh-ancestor
5602109|NCT04940338|Hormones|hormones|mesh-ancestor
5602110|NCT04940338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5602111|NCT04940338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5602112|NCT04940338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5602113|NCT04940338|Protease Inhibitors|protease inhibitors|mesh-ancestor
5602114|NCT04940338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5602115|NCT04940338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134335|NCT01246063|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6134336|NCT01246063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6134337|NCT01246063|Antiemetics|antiemetics|mesh-ancestor
6134338|NCT01246063|Autonomic Agents|autonomic agents|mesh-ancestor
6134339|NCT01246063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6134340|NCT01246063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134341|NCT01246063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6134342|NCT01246063|Glucocorticoids|glucocorticoids|mesh-ancestor
6134343|NCT01246063|Hormones|hormones|mesh-ancestor
6134344|NCT01246063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6134345|NCT01246063|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6134346|NCT01246063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6134347|NCT01246063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6134348|NCT01246063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5539171|NCT04185649|Capecitabine|capecitabine|mesh-list
5539172|NCT04185649|Lapatinib|lapatinib|mesh-list
5539173|NCT04185649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5539174|NCT04185649|Antimetabolites|antimetabolites|mesh-ancestor
5539175|NCT04185649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539176|NCT04185649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5539177|NCT04185649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5539178|NCT04185649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5539179|NCT04185350|Exenatide|exenatide|mesh-list
5539180|NCT04185350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5539181|NCT04185350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134349|NCT01246063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6134350|NCT01246063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6134351|NCT01246063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134352|NCT01246076|Lenalidomide|lenalidomide|mesh-list
6134353|NCT01246076|Immunologic Factors|immunologic factors|mesh-ancestor
5539182|NCT04185350|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5539183|NCT04185350|Incretins|incretins|mesh-ancestor
5539184|NCT04185350|Hormones|hormones|mesh-ancestor
5539185|NCT04185350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5539186|NCT04185402|Azithromycin|azithromycin|mesh-list
5539187|NCT04185402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5539188|NCT04185402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6134354|NCT01246076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134355|NCT01246076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6134356|NCT01246076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6134357|NCT01246076|Growth Substances|growth substances|mesh-ancestor
6134358|NCT01246076|Growth Inhibitors|growth inhibitors|mesh-ancestor
6134359|NCT01246076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6134360|NCT01246206|Tacrolimus|tacrolimus|mesh-list
6134361|NCT01246206|Thymoglobulin|thymoglobulin|mesh-list
6134362|NCT01246206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6134363|NCT01246206|Immunologic Factors|immunologic factors|mesh-ancestor
6134364|NCT01246206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134365|NCT01246206|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6134366|NCT01246206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6134367|NCT01246206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134368|NCT01246401|Naltrexone|naltrexone|mesh-list
6134369|NCT01246401|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6134370|NCT01246401|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6134371|NCT01246401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134372|NCT01246401|Sensory System Agents|sensory system agents|mesh-ancestor
6134373|NCT01246401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6134374|NCT01246583|Tofacitinib|tofacitinib|mesh-list
6134375|NCT01246583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6134376|NCT01246583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6134377|NCT01246583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134378|NCT01246713|Acetaminophen|acetaminophen|mesh-list
6134379|NCT01246713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6134380|NCT01246713|Analgesics|analgesics|mesh-ancestor
6134381|NCT01246713|Sensory System Agents|sensory system agents|mesh-ancestor
6134382|NCT01246713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6134383|NCT01246713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134384|NCT01246713|Antipyretics|antipyretics|mesh-ancestor
6134385|NCT01246791|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6134386|NCT01246791|Norethindrone|norethindrone|mesh-list
6134387|NCT01246791|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
6134388|NCT01246791|Norinyl|norinyl|mesh-list
6134389|NCT01246791|Estradiol|estradiol|mesh-list
6134390|NCT01246791|Estrogens|estrogens|mesh-ancestor
6134391|NCT01246791|Hormones|hormones|mesh-ancestor
6134392|NCT01246791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6134393|NCT01246791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134394|NCT01246791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6134395|NCT01246791|Contraceptive Agents|contraceptive agents|mesh-ancestor
6134396|NCT01246791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6134397|NCT01246791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6134398|NCT01246791|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6134399|NCT01246791|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6134400|NCT01246791|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6134401|NCT01246791|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6134402|NCT01246791|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
5539189|NCT04185233|Nitrous Oxide|nitrous oxide|mesh-list
5539190|NCT04185233|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5539191|NCT04185233|Anesthetics, General|anesthetics, general|mesh-ancestor
5539192|NCT04185233|Anesthetics|anesthetics|mesh-ancestor
5539193|NCT04185233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5539194|NCT04185233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539195|NCT04185233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5539196|NCT04185233|Analgesics|analgesics|mesh-ancestor
5539197|NCT04185233|Sensory System Agents|sensory system agents|mesh-ancestor
5539198|NCT04185233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5539199|NCT04184947|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
5539200|NCT04184947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539201|NCT04184947|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5539202|NCT04184947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539203|NCT04185077|Heparin|heparin|mesh-list
5539204|NCT04185077|Calcium heparin|calcium heparin|mesh-list
5539205|NCT04185077|Bivalirudin|bivalirudin|mesh-list
5539206|NCT04185077|Antithrombins|antithrombins|mesh-list
5539207|NCT04185077|Thrombin|thrombin|mesh-list
5539208|NCT04185077|Anticoagulants|anticoagulants|mesh-ancestor
5539209|NCT04185077|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5539210|NCT04185077|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5539211|NCT04185077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539212|NCT04185077|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5539213|NCT04185077|Protease Inhibitors|protease inhibitors|mesh-ancestor
5539214|NCT04185077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5539215|NCT04185077|Hemostatics|hemostatics|mesh-ancestor
5539216|NCT04185077|Coagulants|coagulants|mesh-ancestor
5539217|NCT04185194|Lidocaine|lidocaine|mesh-list
5539218|NCT04185194|Anesthetics, Local|anesthetics, local|mesh-ancestor
5539219|NCT04185194|Anesthetics|anesthetics|mesh-ancestor
5539220|NCT04185194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5539221|NCT04185194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539222|NCT04185194|Sensory System Agents|sensory system agents|mesh-ancestor
5539223|NCT04185194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6134403|NCT01246960|Leucovorin|leucovorin|mesh-list
6134404|NCT01246960|Fluorouracil|fluorouracil|mesh-list
6134405|NCT01246960|Oxaliplatin|oxaliplatin|mesh-list
6134406|NCT01246960|Ramucirumab|ramucirumab|mesh-list
6134407|NCT01246960|Antimetabolites|antimetabolites|mesh-ancestor
6134408|NCT01246960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134409|NCT01246960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6134410|NCT01246960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6134411|NCT01246960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6134412|NCT01246960|Immunologic Factors|immunologic factors|mesh-ancestor
6134413|NCT01246960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134414|NCT01246960|Antidotes|antidotes|mesh-ancestor
6134415|NCT01246960|Protective Agents|protective agents|mesh-ancestor
6134416|NCT01246960|Vitamin B Complex|vitamin b complex|mesh-ancestor
6134417|NCT01246960|Vitamins|vitamins|mesh-ancestor
6134418|NCT01246960|Micronutrients|micronutrients|mesh-ancestor
6134419|NCT01246973|Curcumin|curcumin|mesh-list
6134420|NCT01246973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6134421|NCT01246973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6134422|NCT01246973|Analgesics|analgesics|mesh-ancestor
6134423|NCT01246973|Sensory System Agents|sensory system agents|mesh-ancestor
6134424|NCT01246973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6134425|NCT01246973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134426|NCT01246973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6134427|NCT01246973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6134428|NCT01246973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6134429|NCT01246973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6134430|NCT01246973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134431|NCT01246986|Sorafenib|sorafenib|mesh-list
6134432|NCT01246986|Ramucirumab|ramucirumab|mesh-list
6134433|NCT01246986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6134434|NCT01246986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5539224|NCT04185194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5539225|NCT04185194|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5539226|NCT04185194|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5539227|NCT04185194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6134435|NCT01246986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5539228|NCT04185194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539229|NCT04184869|Atazanavir Sulfate|atazanavir sulfate|mesh-list
5539230|NCT04184869|Belinostat|belinostat|mesh-list
5539231|NCT04184869|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5539232|NCT04184869|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5539233|NCT04184869|Protease Inhibitors|protease inhibitors|mesh-ancestor
5539234|NCT04184869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6134436|NCT01246986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134437|NCT01246999|Vaccines|vaccines|mesh-list
6134438|NCT01246999|Immunologic Factors|immunologic factors|mesh-ancestor
6134439|NCT01246999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134440|NCT01247064|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6134441|NCT01247090|Vasopressins|vasopressins|mesh-list
6134442|NCT01247090|Arginine Vasopressin|arginine vasopressin|mesh-list
6134443|NCT01247090|Hemostatics|hemostatics|mesh-ancestor
5539235|NCT04184869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539236|NCT04184869|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5539237|NCT04184869|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5539238|NCT04184869|Antiviral Agents|antiviral agents|mesh-ancestor
5539239|NCT04184869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5539240|NCT04184869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5539241|NCT04184869|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5539242|NCT04185103|Valsartan|valsartan|mesh-list
5539243|NCT04185103|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5539244|NCT04185103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5539245|NCT04185103|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5539246|NCT04185103|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5539247|NCT04185103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539248|NCT04184921|Aspirin|aspirin|mesh-list
5539249|NCT04184921|Osimertinib|osimertinib|mesh-list
5539250|NCT04184921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5539251|NCT04184921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5539252|NCT04184921|Analgesics|analgesics|mesh-ancestor
5539253|NCT04184921|Sensory System Agents|sensory system agents|mesh-ancestor
5539254|NCT04184921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5539255|NCT04184921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539256|NCT04184921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5539257|NCT04184921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5539258|NCT04184921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6134444|NCT01247090|Coagulants|coagulants|mesh-ancestor
6134445|NCT01247090|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6134446|NCT01247090|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6134447|NCT01247090|Natriuretic Agents|natriuretic agents|mesh-ancestor
6134448|NCT01247090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134449|NCT01247220|Ranibizumab|ranibizumab|mesh-list
6134450|NCT01247220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6134451|NCT01247220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6134452|NCT01247220|Growth Substances|growth substances|mesh-ancestor
6134453|NCT01247220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134454|NCT01247220|Growth Inhibitors|growth inhibitors|mesh-ancestor
6134455|NCT01247220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6134456|NCT01247272|Fluoxetine|fluoxetine|mesh-list
6134457|NCT01247272|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6134458|NCT01247272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6134459|NCT01247272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6134460|NCT01247272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134461|NCT01247272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6134462|NCT01247272|Serotonin Agents|serotonin agents|mesh-ancestor
6134463|NCT01247272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134464|NCT01247272|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6134465|NCT01247272|Antidepressive Agents|antidepressive agents|mesh-ancestor
6134466|NCT01247272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6134467|NCT01247272|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6134468|NCT01247272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6134469|NCT01247272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6134470|NCT01247285|Fluoxetine|fluoxetine|mesh-list
6134471|NCT01247285|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6134472|NCT01247285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6134473|NCT01247285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6134474|NCT01247285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539259|NCT04184921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5539260|NCT04184921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539261|NCT04184921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6666360|NCT01522547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6666361|NCT01522612|Leucovorin|leucovorin|mesh-list
6134475|NCT01247285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6134476|NCT01247285|Serotonin Agents|serotonin agents|mesh-ancestor
6134477|NCT01247285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134478|NCT01247285|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6134479|NCT01247285|Antidepressive Agents|antidepressive agents|mesh-ancestor
6134480|NCT01247285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6134481|NCT01247285|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6134482|NCT01247285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6134483|NCT01247285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6134484|NCT01247363|Globalagliatin|globalagliatin|mesh-list
6134485|NCT01247363|Enzyme Activators|enzyme activators|mesh-ancestor
6134486|NCT01247363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205165|NCT02082522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6205166|NCT02082522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6205167|NCT02082522|Antimetabolites|antimetabolites|mesh-ancestor
6205168|NCT02082522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205169|NCT02082522|Antiviral Agents|antiviral agents|mesh-ancestor
6205170|NCT02082522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6205171|NCT02082522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6205172|NCT02082522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6205173|NCT02082522|Immunologic Factors|immunologic factors|mesh-ancestor
6205174|NCT02082522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205175|NCT02082522|Dermatologic Agents|dermatologic agents|mesh-ancestor
6205176|NCT02082522|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6205177|NCT02082678|Ondansetron|ondansetron|mesh-list
6205178|NCT02082678|Antiemetics|antiemetics|mesh-ancestor
6205179|NCT02082678|Autonomic Agents|autonomic agents|mesh-ancestor
6205180|NCT02082678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6205181|NCT02082678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205182|NCT02082678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6205183|NCT02082678|Antipruritics|antipruritics|mesh-ancestor
6205184|NCT02082678|Dermatologic Agents|dermatologic agents|mesh-ancestor
6205185|NCT02082678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6205186|NCT02082678|Serotonin Agents|serotonin agents|mesh-ancestor
6205187|NCT02082678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6205188|NCT02082678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205189|NCT02082678|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6205190|NCT02082678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6205191|NCT02082678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6205192|NCT02082678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6205193|NCT02082678|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6205194|NCT02082769|Allopurinol|allopurinol|mesh-list
6205195|NCT02082769|Febuxostat|febuxostat|mesh-list
6205196|NCT02082769|Antimetabolites|antimetabolites|mesh-ancestor
6205197|NCT02082769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205198|NCT02082769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5539262|NCT04184921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5539263|NCT04184921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5539264|NCT04184921|Antipyretics|antipyretics|mesh-ancestor
5539265|NCT04184921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5539266|NCT04184921|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5539267|NCT04184609|Bromides|bromides|mesh-list
6205199|NCT02082769|Gout Suppressants|gout suppressants|mesh-ancestor
6205200|NCT02082769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6205201|NCT02082769|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6205202|NCT02082769|Antioxidants|antioxidants|mesh-ancestor
6205203|NCT02082769|Protective Agents|protective agents|mesh-ancestor
6466550|NCT00479739|Respiratory System Agents|respiratory system agents|mesh-ancestor
6466551|NCT00479739|Dermatologic Agents|dermatologic agents|mesh-ancestor
6466552|NCT00479739|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5539268|NCT04184609|Albuterol|albuterol|mesh-list
6466553|NCT00479739|Glucocorticoids|glucocorticoids|mesh-ancestor
6466554|NCT00479739|Hormones|hormones|mesh-ancestor
6466555|NCT00479739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6466556|NCT00479739|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6466557|NCT00479739|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6466558|NCT00479739|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6466559|NCT00479739|Adrenergic Agents|adrenergic agents|mesh-ancestor
6466560|NCT00479739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6466561|NCT00479739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466562|NCT00479752|Oxaliplatin|oxaliplatin|mesh-list
6466563|NCT00479752|Cetuximab|cetuximab|mesh-list
6466564|NCT00479752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6134487|NCT01247922|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6134488|NCT01247922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6134489|NCT01247922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6134490|NCT01247922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6134491|NCT01247922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134492|NCT01248065|Vitamin D|vitamin d|mesh-list
6134493|NCT01248065|Cholecalciferol|cholecalciferol|mesh-list
6134494|NCT01248065|Ciclesonide|ciclesonide|mesh-list
6134495|NCT01248065|Vitamins|vitamins|mesh-ancestor
6134496|NCT01248065|Micronutrients|micronutrients|mesh-ancestor
6134497|NCT01248065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134498|NCT01248065|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6134499|NCT01248065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6134500|NCT01248065|Glucocorticoids|glucocorticoids|mesh-ancestor
6134501|NCT01248065|Hormones|hormones|mesh-ancestor
6134502|NCT01248065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6134503|NCT01248065|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6134504|NCT01248104|Tranexamic Acid|tranexamic acid|mesh-list
6134505|NCT01248104|Aminocaproic Acid|aminocaproic acid|mesh-list
6134506|NCT01248104|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6134507|NCT01248104|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6134508|NCT01248104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134509|NCT01248104|Hemostatics|hemostatics|mesh-ancestor
6134510|NCT01248104|Coagulants|coagulants|mesh-ancestor
6134511|NCT01248364|Empagliflozin|empagliflozin|mesh-list
6134512|NCT01248364|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6134513|NCT01248364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134514|NCT01248364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6134515|NCT01248364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134516|NCT01248416|Letrozole|letrozole|mesh-list
6134517|NCT01248416|Anastrozole|anastrozole|mesh-list
6134518|NCT01248416|Hormones|hormones|mesh-list
6134519|NCT01248416|Aromatase Inhibitors|aromatase inhibitors|mesh-list
6134520|NCT01248416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6134521|NCT01248416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134522|NCT01248416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6134523|NCT01248416|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6134524|NCT01248416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6134525|NCT01248416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134526|NCT01248416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6134527|NCT01248416|Hormone Antagonists|hormone antagonists|mesh-ancestor
6134528|NCT01248416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6134529|NCT01248468|Aspirin|aspirin|mesh-list
6134530|NCT01248468|Acetaminophen|acetaminophen|mesh-list
6134531|NCT01248468|Sumatriptan|sumatriptan|mesh-list
5539269|NCT04184609|Ipratropium|ipratropium|mesh-list
5539270|NCT04184609|Anticonvulsants|anticonvulsants|mesh-ancestor
5539271|NCT04184609|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5539272|NCT04184609|Autonomic Agents|autonomic agents|mesh-ancestor
5539273|NCT04184609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5539274|NCT04184609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539275|NCT04184609|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5539276|NCT04184609|Respiratory System Agents|respiratory system agents|mesh-ancestor
5539277|NCT04184609|Tocolytic Agents|tocolytic agents|mesh-ancestor
5539278|NCT04184609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5539279|NCT04184609|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5539280|NCT04184609|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6134532|NCT01248468|Caffeine|caffeine|mesh-list
6134533|NCT01248468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6134534|NCT01248468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6134535|NCT01248468|Analgesics|analgesics|mesh-ancestor
6466565|NCT00479752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6466566|NCT00479778|Bazedoxifene|bazedoxifene|mesh-list
6466567|NCT00479778|Estrogens|estrogens|mesh-list
6466568|NCT00479778|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6466569|NCT00479778|Hormones|hormones|mesh-ancestor
6466570|NCT00479778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6466571|NCT00479778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466572|NCT00479778|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6466573|NCT00479778|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5539281|NCT04184609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6134536|NCT01248468|Sensory System Agents|sensory system agents|mesh-ancestor
6134537|NCT01248468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6134538|NCT01248468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466574|NCT00479778|Hormone Antagonists|hormone antagonists|mesh-ancestor
6134539|NCT01248468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6134540|NCT01248468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6134541|NCT01248468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6134542|NCT01248468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6134543|NCT01248468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134544|NCT01248468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6134545|NCT01248468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6134546|NCT01248468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6134547|NCT01248468|Antipyretics|antipyretics|mesh-ancestor
6134548|NCT01248468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6134549|NCT01248468|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6134550|NCT01248468|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6134551|NCT01248468|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6134552|NCT01248468|Purinergic Agents|purinergic agents|mesh-ancestor
6134553|NCT01248468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6134554|NCT01248468|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5725489|NCT03180242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5725490|NCT03180242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5725491|NCT03180281|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5725492|NCT03180281|Glimepiride|glimepiride|mesh-list
5725493|NCT03180281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5725494|NCT03180281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725495|NCT03180281|Incretins|incretins|mesh-ancestor
5725496|NCT03180281|Hormones|hormones|mesh-ancestor
5725497|NCT03180281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6134555|NCT01248468|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6134556|NCT01248468|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6134557|NCT01248468|Serotonin Agents|serotonin agents|mesh-ancestor
6134558|NCT01248585|Dexamethasone|dexamethasone|mesh-list
6134559|NCT01248585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6134560|NCT01248585|Antiemetics|antiemetics|mesh-ancestor
6134561|NCT01248585|Autonomic Agents|autonomic agents|mesh-ancestor
6134562|NCT01248585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6134563|NCT01248585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134564|NCT01248585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6134565|NCT01248585|Glucocorticoids|glucocorticoids|mesh-ancestor
6134566|NCT01248585|Hormones|hormones|mesh-ancestor
6134567|NCT01248585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6134568|NCT01248585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6134569|NCT01248585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6134570|NCT01248715|Oseltamivir|oseltamivir|mesh-list
6134571|NCT01248715|Antiviral Agents|antiviral agents|mesh-ancestor
6134572|NCT01248715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6134573|NCT01248715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6134574|NCT01248715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134575|NCT01248780|Golimumab|golimumab|mesh-list
6134576|NCT01248780|Methotrexate|methotrexate|mesh-list
6134577|NCT01248780|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6134578|NCT01248780|Abortifacient Agents|abortifacient agents|mesh-ancestor
6134579|NCT01248780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6134580|NCT01248780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134581|NCT01248780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6134582|NCT01248780|Antimetabolites|antimetabolites|mesh-ancestor
6134583|NCT01248780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134584|NCT01248780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5539282|NCT04184609|Adrenergic Agents|adrenergic agents|mesh-ancestor
5539283|NCT04184609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5539284|NCT04184609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539285|NCT04184609|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5539286|NCT04184609|Cholinergic Agents|cholinergic agents|mesh-ancestor
5539287|NCT04184518|Durvalumab|durvalumab|mesh-list
5539288|NCT04184518|Cediranib|cediranib|mesh-list
5539289|NCT04184518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6134585|NCT01248780|Dermatologic Agents|dermatologic agents|mesh-ancestor
6134586|NCT01248780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6134587|NCT01248780|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6134588|NCT01248780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6134589|NCT01248780|Immunologic Factors|immunologic factors|mesh-ancestor
6134590|NCT01248780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6134591|NCT01248780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6134592|NCT01248780|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6134593|NCT01248780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6134594|NCT01248793|Golimumab|golimumab|mesh-list
6134595|NCT01248793|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6134596|NCT01248793|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
5539290|NCT04184518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5539291|NCT04184518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5539292|NCT04184518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539293|NCT04184518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6134597|NCT01248793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6134598|NCT01248793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6134599|NCT01248793|Immunologic Factors|immunologic factors|mesh-ancestor
6134600|NCT01248793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134601|NCT01248884|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6134602|NCT01248884|Immunologic Factors|immunologic factors|mesh-ancestor
6134603|NCT01248884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539294|NCT04184466|Insulin|insulin|mesh-list
5539295|NCT04184466|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5539296|NCT04184466|Insulin Aspart|insulin aspart|mesh-list
5539297|NCT04184466|Insulin, Long-Acting|insulin, long-acting|mesh-list
5539298|NCT04184466|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
5539299|NCT04184466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5539300|NCT04184466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539301|NCT04184492|Insulin|insulin|mesh-list
5539302|NCT04184492|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5539303|NCT04184492|Insulin Aspart|insulin aspart|mesh-list
5539304|NCT04184492|Insulin, Long-Acting|insulin, long-acting|mesh-list
5539305|NCT04184492|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
5539306|NCT04184492|Biphasic Insulins|biphasic insulins|mesh-list
5539307|NCT04184492|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
5539308|NCT04184492|Insulin, Isophane|insulin, isophane|mesh-list
5539309|NCT04184492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5539310|NCT04184492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134604|NCT01248949|Paclitaxel|paclitaxel|mesh-list
6134605|NCT01248949|Bevacizumab|bevacizumab|mesh-list
6134606|NCT01248949|Carboplatin|carboplatin|mesh-list
6134607|NCT01248949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6134608|NCT01248949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6134609|NCT01248949|Tubulin Modulators|tubulin modulators|mesh-ancestor
6134610|NCT01248949|Antimitotic Agents|antimitotic agents|mesh-ancestor
5539311|NCT04184401|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5539312|NCT04184505|Azacitidine|azacitidine|mesh-list
5539313|NCT04184505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5539314|NCT04184505|Antimetabolites|antimetabolites|mesh-ancestor
5539315|NCT04184505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134611|NCT01248949|Mitosis Modulators|mitosis modulators|mesh-ancestor
6134612|NCT01248949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134613|NCT01248949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6134614|NCT01248949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6134615|NCT01248949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6134616|NCT01248949|Growth Substances|growth substances|mesh-ancestor
6134617|NCT01248949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134618|NCT01248949|Growth Inhibitors|growth inhibitors|mesh-ancestor
6134619|NCT01248962|Carboplatin|carboplatin|mesh-list
6134620|NCT01248962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6134621|NCT01249027|Everolimus|everolimus|mesh-list
6134622|NCT01249027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6134623|NCT01249027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6134624|NCT01249027|Immunologic Factors|immunologic factors|mesh-ancestor
6134625|NCT01249027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134626|NCT01249092|Pentoxifylline|pentoxifylline|mesh-list
6134627|NCT01249092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6134628|NCT01249092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6134629|NCT01249092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134630|NCT01249092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6134631|NCT01249092|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6134632|NCT01249092|Protective Agents|protective agents|mesh-ancestor
6134633|NCT01249092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134634|NCT01249092|Vasodilator Agents|vasodilator agents|mesh-ancestor
6134635|NCT01249092|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6134636|NCT01249092|Antioxidants|antioxidants|mesh-ancestor
6134637|NCT01249261|Risedronic Acid|risedronic acid|mesh-list
6134638|NCT01249261|Etidronic Acid|etidronic acid|mesh-list
6134639|NCT01249261|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6134640|NCT01249261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6134641|NCT01249261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134642|NCT01249261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5539316|NCT04184505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5539317|NCT04184505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5539318|NCT04183881|Brodalumab|brodalumab|mesh-list
5539319|NCT04183881|Dermatologic Agents|dermatologic agents|mesh-ancestor
5539320|NCT04184141|Alprazolam|alprazolam|mesh-list
5539321|NCT04184141|Hydroxyzine|hydroxyzine|mesh-list
5539322|NCT04184141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6134643|NCT01249261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134644|NCT01249261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6134645|NCT01249274|Progesterone|progesterone|mesh-list
6134646|NCT01249274|Progestins|progestins|mesh-ancestor
6134647|NCT01249274|Hormones|hormones|mesh-ancestor
6134648|NCT01249274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6134649|NCT01249274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134650|NCT01249404|Botulinum Toxins|botulinum toxins|mesh-list
6134651|NCT01249404|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6134652|NCT01249404|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6134653|NCT01249404|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6134654|NCT01249404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6134655|NCT01249404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134656|NCT01249404|Cholinergic Agents|cholinergic agents|mesh-ancestor
6134657|NCT01249404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6134658|NCT01249404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134659|NCT01249404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6134660|NCT01249404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6134661|NCT01249417|Botulinum Toxins|botulinum toxins|mesh-list
6134662|NCT01249417|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6134663|NCT01249417|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6134664|NCT01249417|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6134665|NCT01249417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6134666|NCT01249417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134667|NCT01249417|Cholinergic Agents|cholinergic agents|mesh-ancestor
6134668|NCT01249417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6134669|NCT01249417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134670|NCT01249417|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6134671|NCT01249417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6134672|NCT01249651|Esomeprazole|esomeprazole|mesh-list
6134673|NCT01249651|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6134674|NCT01249651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6134675|NCT01249651|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6134676|NCT01249651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6134677|NCT01249651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134678|NCT01249664|Aflibercept|aflibercept|mesh-list
6134679|NCT01249664|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6134680|NCT01249664|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6134681|NCT01249664|Growth Substances|growth substances|mesh-ancestor
6134682|NCT01249664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134683|NCT01249664|Growth Inhibitors|growth inhibitors|mesh-ancestor
6134684|NCT01249664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6134685|NCT01249833|Oseltamivir|oseltamivir|mesh-list
6134686|NCT01249833|Antiviral Agents|antiviral agents|mesh-ancestor
6134687|NCT01249833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6134688|NCT01249833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6466575|NCT00479778|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6466576|NCT00479895|HBOC 201|hboc 201|mesh-list
6466577|NCT00479895|Blood Substitutes|blood substitutes|mesh-ancestor
6466578|NCT00479908|Sildenafil Citrate|sildenafil citrate|mesh-list
6466579|NCT00479908|Nitroglycerin|nitroglycerin|mesh-list
5539323|NCT04184141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5539324|NCT04184141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539325|NCT04184141|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5539326|NCT04184141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5539327|NCT04184141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5539328|NCT04184141|GABA Modulators|gaba modulators|mesh-ancestor
5539329|NCT04184141|GABA Agents|gaba agents|mesh-ancestor
5539330|NCT04184141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5539331|NCT04184141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539332|NCT04184141|Antipruritics|antipruritics|mesh-ancestor
5539333|NCT04184141|Dermatologic Agents|dermatologic agents|mesh-ancestor
5539334|NCT04184141|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5539335|NCT04184141|Histamine Antagonists|histamine antagonists|mesh-ancestor
5539336|NCT04184141|Histamine Agents|histamine agents|mesh-ancestor
5539337|NCT04184115|Scopolamine|scopolamine|mesh-list
5539338|NCT04184115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5539339|NCT04184115|Antiemetics|antiemetics|mesh-ancestor
5539340|NCT04184115|Autonomic Agents|autonomic agents|mesh-ancestor
5539341|NCT04184115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5539342|NCT04184115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539343|NCT04184115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5539344|NCT04184115|Mydriatics|mydriatics|mesh-ancestor
5539345|NCT04184115|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5539346|NCT04184115|Cholinergic Agents|cholinergic agents|mesh-ancestor
5539347|NCT04184115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5539348|NCT04184115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539349|NCT04184115|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6466580|NCT00479908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466581|NCT00479908|Vasodilator Agents|vasodilator agents|mesh-ancestor
6466582|NCT00479908|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6466583|NCT00479908|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6134689|NCT01249833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134690|NCT01249872|Morphine|morphine|mesh-list
6134691|NCT01249872|Levobupivacaine|levobupivacaine|mesh-list
6134692|NCT01249872|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6134693|NCT01249872|Narcotics|narcotics|mesh-ancestor
6134694|NCT01249872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6134695|NCT01249872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134696|NCT01249872|Analgesics|analgesics|mesh-ancestor
5602116|NCT04940338|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5602117|NCT04940338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5602118|NCT04940338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5602119|NCT04940338|Analgesics|analgesics|mesh-ancestor
5602120|NCT04940338|Sensory System Agents|sensory system agents|mesh-ancestor
5602121|NCT04940338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5602122|NCT04927390|Mycophenolic Acid|mycophenolic acid|mesh-list
6134697|NCT01249872|Sensory System Agents|sensory system agents|mesh-ancestor
6134698|NCT01249872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6134699|NCT01249872|Anesthetics, Local|anesthetics, local|mesh-ancestor
6134700|NCT01249872|Anesthetics|anesthetics|mesh-ancestor
6134701|NCT01250002|Lidocaine|lidocaine|mesh-list
6134702|NCT01250002|Anesthetics, Local|anesthetics, local|mesh-ancestor
6134703|NCT01250002|Anesthetics|anesthetics|mesh-ancestor
6134704|NCT01250002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6134705|NCT01250002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134706|NCT01250002|Sensory System Agents|sensory system agents|mesh-ancestor
6134707|NCT01250002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6134708|NCT01250002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5602123|NCT04927390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5602124|NCT04927390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5602125|NCT04927390|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5602126|NCT04927390|Antitubercular Agents|antitubercular agents|mesh-ancestor
5602127|NCT04927390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5602128|NCT04927390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5602129|NCT04927390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5602130|NCT04927390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134709|NCT01250002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6134710|NCT01250002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6134711|NCT01250002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6134712|NCT01250002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134713|NCT01250119|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6134714|NCT01250119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5602131|NCT04911361|Dexamethasone|dexamethasone|mesh-list
5602132|NCT04911361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5602133|NCT04911361|Antiemetics|antiemetics|mesh-ancestor
5602134|NCT04911361|Autonomic Agents|autonomic agents|mesh-ancestor
5602135|NCT04911361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5602136|NCT04911361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134715|NCT01250119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6134716|NCT01250119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6134717|NCT01250119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602137|NCT04911361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5602138|NCT04911361|Glucocorticoids|glucocorticoids|mesh-ancestor
6134718|NCT01250145|Teriparatide|teriparatide|mesh-list
6134719|NCT01250145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6134720|NCT01250145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134721|NCT01250145|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6134722|NCT01250184|Lidocaine|lidocaine|mesh-list
6134723|NCT01250184|Anesthetics, Local|anesthetics, local|mesh-ancestor
6134724|NCT01250184|Anesthetics|anesthetics|mesh-ancestor
6134725|NCT01250184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6134726|NCT01250184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134727|NCT01250184|Sensory System Agents|sensory system agents|mesh-ancestor
6134728|NCT01250184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5539350|NCT04183634|Rotigotine|rotigotine|mesh-list
5539351|NCT04183634|Dopamine Agonists|dopamine agonists|mesh-ancestor
5539352|NCT04183634|Dopamine Agents|dopamine agents|mesh-ancestor
5539353|NCT04183634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5539354|NCT04183634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539355|NCT04183634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539356|NCT04183556|Naproxen|naproxen|mesh-list
5539357|NCT04183556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
5539358|NCT04183556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
5539359|NCT04183556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5539360|NCT04183556|Analgesics|analgesics|mesh-ancestor
5539361|NCT04183556|Sensory System Agents|sensory system agents|mesh-ancestor
5539362|NCT04183556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5539363|NCT04183556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539364|NCT04183556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5539365|NCT04183556|Gout Suppressants|gout suppressants|mesh-ancestor
5539366|NCT04183556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5539367|NCT04183556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6466584|NCT00479908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6466585|NCT00479908|Urological Agents|urological agents|mesh-ancestor
6466586|NCT00479934|Imatinib Mesylate|imatinib mesylate|mesh-list
6466587|NCT00479934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6466588|NCT00479934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6466589|NCT00479934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6466590|NCT00479934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466591|NCT00479986|Pioglitazone|pioglitazone|mesh-list
6466592|NCT00479986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6666362|NCT01522612|Fluorouracil|fluorouracil|mesh-list
6666363|NCT01522612|Cetuximab|cetuximab|mesh-list
5539368|NCT04183556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134729|NCT01250184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6134730|NCT01250184|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6134731|NCT01250184|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6134732|NCT01250184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6134733|NCT01250184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134734|NCT01250210|Levonorgestrel|levonorgestrel|mesh-list
6134735|NCT01250210|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6134736|NCT01250210|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
6134737|NCT01250210|Estradiol|estradiol|mesh-list
6134738|NCT01250210|Estrogens|estrogens|mesh-ancestor
6134739|NCT01250210|Hormones|hormones|mesh-ancestor
6134740|NCT01250210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6134741|NCT01250210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134742|NCT01250210|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6134743|NCT01250210|Contraceptive Agents|contraceptive agents|mesh-ancestor
6134744|NCT01250210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6134745|NCT01250210|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6134746|NCT01250210|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6134747|NCT01250210|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6134748|NCT01250210|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6134749|NCT01250210|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6134750|NCT01250379|Bevacizumab|bevacizumab|mesh-list
6134751|NCT01250379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5539369|NCT04183725|Oseltamivir|oseltamivir|mesh-list
5539370|NCT04183725|Antiviral Agents|antiviral agents|mesh-ancestor
5539371|NCT04183725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6134752|NCT01250379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6134753|NCT01250379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6134754|NCT01250379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6134755|NCT01250379|Growth Substances|growth substances|mesh-ancestor
6134756|NCT01250379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134757|NCT01250379|Growth Inhibitors|growth inhibitors|mesh-ancestor
6666364|NCT01522612|Antimetabolites|antimetabolites|mesh-ancestor
5539372|NCT04183725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5539373|NCT04183725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539374|NCT04183608|Adalimumab|adalimumab|mesh-list
5539375|NCT04183608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5539376|NCT04183608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5539377|NCT04183738|Ritonavir|ritonavir|mesh-list
5539378|NCT04183738|Darunavir|darunavir|mesh-list
6134758|NCT01250418|Ketamine|ketamine|mesh-list
6134759|NCT01250418|Analgesics|analgesics|mesh-ancestor
6134760|NCT01250418|Sensory System Agents|sensory system agents|mesh-ancestor
6134761|NCT01250418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6134762|NCT01250418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134763|NCT01250418|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6134764|NCT01250418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6134765|NCT01250418|Anesthetics, General|anesthetics, general|mesh-ancestor
6134766|NCT01250418|Anesthetics|anesthetics|mesh-ancestor
6134767|NCT01250418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6134768|NCT01250418|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6134769|NCT01250418|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6134770|NCT01250418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6134771|NCT01250418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539379|NCT04183738|Dolutegravir|dolutegravir|mesh-list
5539380|NCT04183738|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5539381|NCT04183738|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5539382|NCT04183738|Protease Inhibitors|protease inhibitors|mesh-ancestor
5539383|NCT04183738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5539384|NCT04183738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539385|NCT04183738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5539386|NCT04183738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5539387|NCT04183738|Antiviral Agents|antiviral agents|mesh-ancestor
5539388|NCT04183738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5539389|NCT04183738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5539390|NCT04183738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5539391|NCT04183738|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5539392|NCT04183738|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5539393|NCT04183491|Interferons|interferons|mesh-list
5539394|NCT04183491|Interferon-beta|interferon-beta|mesh-list
5539395|NCT04183491|Interferon beta-1a|interferon beta-1a|mesh-list
5539396|NCT04183491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6134772|NCT01250717|Dexamethasone|dexamethasone|mesh-list
6134773|NCT01250717|Goserelin|goserelin|mesh-list
6134774|NCT01250717|Estramustine|estramustine|mesh-list
6134775|NCT01250717|Docetaxel|docetaxel|mesh-list
6134776|NCT01250717|Bicalutamide|bicalutamide|mesh-list
6134777|NCT01250717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6134778|NCT01250717|Antiemetics|antiemetics|mesh-ancestor
6134779|NCT01250717|Autonomic Agents|autonomic agents|mesh-ancestor
6134780|NCT01250717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6134781|NCT01250717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134782|NCT01250717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6134783|NCT01250717|Glucocorticoids|glucocorticoids|mesh-ancestor
6134784|NCT01250717|Hormones|hormones|mesh-ancestor
6134785|NCT01250717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6134786|NCT01250717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6134787|NCT01250717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6134788|NCT01250717|Tubulin Modulators|tubulin modulators|mesh-ancestor
6134789|NCT01250717|Antimitotic Agents|antimitotic agents|mesh-ancestor
6134790|NCT01250717|Mitosis Modulators|mitosis modulators|mesh-ancestor
6134791|NCT01250717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134792|NCT01250717|Androgen Antagonists|androgen antagonists|mesh-ancestor
6134793|NCT01250717|Hormone Antagonists|hormone antagonists|mesh-ancestor
6134794|NCT01250717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6134795|NCT01250717|Alkylating Agents|alkylating agents|mesh-ancestor
6134796|NCT01250730|Crizotinib|crizotinib|mesh-list
6134797|NCT01250730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6134798|NCT01250730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6466593|NCT00479986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466594|NCT00480064|Cytarabine|cytarabine|mesh-list
6134799|NCT01250730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6134800|NCT01250730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134801|NCT01250756|Vaccines|vaccines|mesh-list
5539397|NCT04183491|Antiviral Agents|antiviral agents|mesh-ancestor
5539398|NCT04183491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5539399|NCT04183491|Immunologic Factors|immunologic factors|mesh-ancestor
6134802|NCT01250756|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6134803|NCT01250756|Immunologic Factors|immunologic factors|mesh-ancestor
6466595|NCT00480064|Lomustine|lomustine|mesh-list
6134804|NCT01250756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134805|NCT01250834|Dulaglutide|dulaglutide|mesh-list
6134806|NCT01250834|Atorvastatin|atorvastatin|mesh-list
6134807|NCT01250834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6134808|NCT01250834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6134809|NCT01250834|Antimetabolites|antimetabolites|mesh-ancestor
6134810|NCT01250834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134811|NCT01250834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5539400|NCT04183491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539401|NCT04183491|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5539402|NCT04183361|Cortisone|cortisone|mesh-list
5539403|NCT04183361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5539404|NCT04183192|Reslizumab|reslizumab|mesh-list
5539405|NCT04183192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5539406|NCT04183192|Respiratory System Agents|respiratory system agents|mesh-ancestor
5539407|NCT04183322|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5539408|NCT04183322|Immunologic Factors|immunologic factors|mesh-ancestor
5539409|NCT04183322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539410|NCT04183387|Simvastatin|simvastatin|mesh-list
5539411|NCT04183387|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6134812|NCT01250834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6134813|NCT01250834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6134814|NCT01250834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6134815|NCT01250834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134816|NCT01250873|Sertraline|sertraline|mesh-list
6134817|NCT01250873|Antidepressive Agents|antidepressive agents|mesh-ancestor
6134818|NCT01250873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6134819|NCT01250873|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6134820|NCT01250873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6134821|NCT01250873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6134822|NCT01250873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134823|NCT01250873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6134824|NCT01250873|Serotonin Agents|serotonin agents|mesh-ancestor
6134825|NCT01250873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134826|NCT01250899|Vitamin D|vitamin d|mesh-list
6134827|NCT01250899|Vitamins|vitamins|mesh-ancestor
6134828|NCT01250899|Micronutrients|micronutrients|mesh-ancestor
6134829|NCT01250899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539412|NCT04183387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5539413|NCT04183387|Antimetabolites|antimetabolites|mesh-ancestor
5539414|NCT04183387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539415|NCT04183387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5539416|NCT04183387|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5539417|NCT04183387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5539418|NCT04183114|Vaccines|vaccines|mesh-list
5539419|NCT04183114|Immunologic Factors|immunologic factors|mesh-ancestor
5539420|NCT04183114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539421|NCT04183075|Vitamins|vitamins|mesh-list
5539422|NCT04183075|Ascorbic Acid|ascorbic acid|mesh-list
5539423|NCT04183075|Micronutrients|micronutrients|mesh-ancestor
5539424|NCT04183075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539425|NCT04183075|Antioxidants|antioxidants|mesh-ancestor
5539426|NCT04183075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539427|NCT04183075|Protective Agents|protective agents|mesh-ancestor
5539428|NCT04183257|Vitamin D|vitamin d|mesh-list
5539429|NCT04183257|Ergocalciferols|ergocalciferols|mesh-list
5539430|NCT04183257|Vitamins|vitamins|mesh-list
5539431|NCT04183257|Micronutrients|micronutrients|mesh-ancestor
5539432|NCT04183257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539433|NCT04183257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5539434|NCT04183257|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5539435|NCT04183296|Propofol|propofol|mesh-list
5539436|NCT04183296|Sevoflurane|sevoflurane|mesh-list
6134830|NCT01250899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6134831|NCT01250977|Donepezil|donepezil|mesh-list
5539437|NCT04183296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5539438|NCT04183296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5602139|NCT04911361|Hormones|hormones|mesh-ancestor
6134832|NCT01250977|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6134833|NCT01250977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6134834|NCT01250977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134835|NCT01250977|Cholinergic Agents|cholinergic agents|mesh-ancestor
6134836|NCT01250977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6134837|NCT01250977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134838|NCT01250977|Nootropic Agents|nootropic agents|mesh-ancestor
6134839|NCT01250990|Niacin|niacin|mesh-list
6134840|NCT01250990|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6134841|NCT01250990|Antimetabolites|antimetabolites|mesh-ancestor
6466596|NCT00480064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6466597|NCT00480064|Antimetabolites|antimetabolites|mesh-ancestor
6466598|NCT00480064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466599|NCT00480064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6466600|NCT00480064|Antiviral Agents|antiviral agents|mesh-ancestor
6466601|NCT00480064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6134842|NCT01250990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134843|NCT01250990|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6134844|NCT01250990|Vasodilator Agents|vasodilator agents|mesh-ancestor
6134845|NCT01250990|Vitamin B Complex|vitamin b complex|mesh-ancestor
6134846|NCT01250990|Vitamins|vitamins|mesh-ancestor
6134847|NCT01250990|Micronutrients|micronutrients|mesh-ancestor
6134848|NCT01250990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134849|NCT01251146|Atenolol|atenolol|mesh-list
6134850|NCT01251146|Bisoprolol|bisoprolol|mesh-list
6134851|NCT01251146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6134852|NCT01251146|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6134853|NCT01251146|Sympatholytics|sympatholytics|mesh-ancestor
6134854|NCT01251146|Autonomic Agents|autonomic agents|mesh-ancestor
6134855|NCT01251146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6466602|NCT00480064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6466603|NCT00480064|Immunologic Factors|immunologic factors|mesh-ancestor
6466604|NCT00480064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466605|NCT00480064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6466606|NCT00480064|Alkylating Agents|alkylating agents|mesh-ancestor
6134856|NCT01251146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134857|NCT01251146|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5539439|NCT04183296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539440|NCT04183296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5539441|NCT04183296|Anesthetics, General|anesthetics, general|mesh-ancestor
5539442|NCT04183296|Anesthetics|anesthetics|mesh-ancestor
5539443|NCT04183296|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5539444|NCT04183296|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5539445|NCT04182984|Mycophenolic Acid|mycophenolic acid|mesh-list
6134858|NCT01251146|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6134859|NCT01251146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6134860|NCT01251146|Adrenergic Agents|adrenergic agents|mesh-ancestor
6134861|NCT01251146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6134862|NCT01251146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134863|NCT01251315|Acetylcysteine|acetylcysteine|mesh-list
6134864|NCT01251315|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6134865|NCT01251315|Antiviral Agents|antiviral agents|mesh-ancestor
6134866|NCT01251315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6134867|NCT01251315|Expectorants|expectorants|mesh-ancestor
6134868|NCT01251315|Respiratory System Agents|respiratory system agents|mesh-ancestor
6134869|NCT01251315|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6134870|NCT01251315|Antioxidants|antioxidants|mesh-ancestor
5539446|NCT04182984|Prednisone|prednisone|mesh-list
5539447|NCT04182984|Azathioprine|azathioprine|mesh-list
5539448|NCT04182984|Bromides|bromides|mesh-list
5539449|NCT04182984|Tacrolimus|tacrolimus|mesh-list
5539450|NCT04182984|Immunosuppressive Agents|immunosuppressive agents|mesh-list
5539451|NCT04182984|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
5539452|NCT04182984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5539453|NCT04182984|Glucocorticoids|glucocorticoids|mesh-ancestor
5539454|NCT04182984|Hormones|hormones|mesh-ancestor
5539455|NCT04182984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5539456|NCT04182984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539457|NCT04182984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5539458|NCT04182984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6134871|NCT01251315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134872|NCT01251315|Protective Agents|protective agents|mesh-ancestor
6134873|NCT01251315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134874|NCT01251315|Antidotes|antidotes|mesh-ancestor
5539459|NCT04182984|Immunologic Factors|immunologic factors|mesh-ancestor
5539460|NCT04182984|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5539461|NCT04182984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5539462|NCT04182984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539463|NCT04182984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5539464|NCT04182984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5539465|NCT04182984|Antitubercular Agents|antitubercular agents|mesh-ancestor
5539466|NCT04182984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5539467|NCT04182984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5539468|NCT04182984|Anticonvulsants|anticonvulsants|mesh-ancestor
5539469|NCT04182984|Antimetabolites|antimetabolites|mesh-ancestor
5539470|NCT04182984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5539471|NCT04182984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5539472|NCT04182984|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5539473|NCT04182984|Cholinergic Agents|cholinergic agents|mesh-ancestor
5539474|NCT04182984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5539475|NCT04183062|Gemcitabine|gemcitabine|mesh-list
5539476|NCT04183062|Docetaxel|docetaxel|mesh-list
5539477|NCT04183062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5539478|NCT04183062|Antimetabolites|antimetabolites|mesh-ancestor
5539479|NCT04183062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539480|NCT04183062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5539481|NCT04183062|Antiviral Agents|antiviral agents|mesh-ancestor
5539482|NCT04183062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5539483|NCT04183062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5539484|NCT04183062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5539485|NCT04183062|Immunologic Factors|immunologic factors|mesh-ancestor
5539486|NCT04183062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539487|NCT04183062|Tubulin Modulators|tubulin modulators|mesh-ancestor
5539488|NCT04183062|Antimitotic Agents|antimitotic agents|mesh-ancestor
5539489|NCT04183062|Mitosis Modulators|mitosis modulators|mesh-ancestor
5539490|NCT04182932|Vaccines|vaccines|mesh-list
5539491|NCT04182932|Immunologic Factors|immunologic factors|mesh-ancestor
6134875|NCT01251367|Botulinum Toxins|botulinum toxins|mesh-list
6134876|NCT01251367|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6134877|NCT01251367|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6134878|NCT01251367|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6134879|NCT01251367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6134880|NCT01251367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539492|NCT04182932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539493|NCT04182737|Immunoglobulins|immunoglobulins|mesh-list
5539494|NCT04182737|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5539495|NCT04182737|Antibodies|antibodies|mesh-list
6134881|NCT01251367|Cholinergic Agents|cholinergic agents|mesh-ancestor
6134882|NCT01251367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6134883|NCT01251367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134884|NCT01251367|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6134885|NCT01251367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5539496|NCT04182737|Immunologic Factors|immunologic factors|mesh-ancestor
5539497|NCT04182737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539498|NCT04182568|Paclitaxel|paclitaxel|mesh-list
5539499|NCT04182568|Docetaxel|docetaxel|mesh-list
5539500|NCT04182568|Cyclophosphamide|cyclophosphamide|mesh-list
6134886|NCT01251380|Botulinum Toxins|botulinum toxins|mesh-list
6134887|NCT01251380|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6134888|NCT01251380|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6134889|NCT01251380|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6134890|NCT01251380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6134891|NCT01251380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134892|NCT01251380|Cholinergic Agents|cholinergic agents|mesh-ancestor
6134893|NCT01251380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6134894|NCT01251380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134895|NCT01251380|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6134896|NCT01251380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6134897|NCT01251393|Biperiden|biperiden|mesh-list
6134898|NCT01251393|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6134899|NCT01251393|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6134900|NCT01251393|Parasympatholytics|parasympatholytics|mesh-ancestor
6466607|NCT00480090|Cytarabine|cytarabine|mesh-list
6466608|NCT00480090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6466609|NCT00480090|Antimetabolites|antimetabolites|mesh-ancestor
6466610|NCT00480090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466611|NCT00480090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6466612|NCT00480090|Antiviral Agents|antiviral agents|mesh-ancestor
5539501|NCT04182568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5539502|NCT04182568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6466613|NCT00480090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6666365|NCT01522612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666366|NCT01522612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6666367|NCT01522612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6666368|NCT01522612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6666369|NCT01522612|Immunologic Factors|immunologic factors|mesh-ancestor
6666370|NCT01522612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666371|NCT01522612|Antidotes|antidotes|mesh-ancestor
6666372|NCT01522612|Protective Agents|protective agents|mesh-ancestor
6666373|NCT01522612|Vitamin B Complex|vitamin b complex|mesh-ancestor
6666374|NCT01522612|Vitamins|vitamins|mesh-ancestor
6666375|NCT01522612|Micronutrients|micronutrients|mesh-ancestor
6134901|NCT01251393|Autonomic Agents|autonomic agents|mesh-ancestor
6134902|NCT01251393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6134903|NCT01251393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134904|NCT01251393|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6134905|NCT01251393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6134906|NCT01251393|Cholinergic Agents|cholinergic agents|mesh-ancestor
6134907|NCT01251393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6134908|NCT01251393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134909|NCT01251536|Cetuximab|cetuximab|mesh-list
6134910|NCT01251536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6134911|NCT01251536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6134912|NCT01251575|Cyclosporine|cyclosporine|mesh-list
6134913|NCT01251575|Sirolimus|sirolimus|mesh-list
6134914|NCT01251575|Mycophenolic Acid|mycophenolic acid|mesh-list
6134915|NCT01251575|Fludarabine|fludarabine|mesh-list
6134916|NCT01251575|Fludarabine phosphate|fludarabine phosphate|mesh-list
6134917|NCT01251575|Cyclosporins|cyclosporins|mesh-list
5539503|NCT04182568|Tubulin Modulators|tubulin modulators|mesh-ancestor
5539504|NCT04182568|Antimitotic Agents|antimitotic agents|mesh-ancestor
5539505|NCT04182568|Mitosis Modulators|mitosis modulators|mesh-ancestor
5539506|NCT04182568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539507|NCT04182568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5539508|NCT04182568|Immunologic Factors|immunologic factors|mesh-ancestor
6134918|NCT01251575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6134919|NCT01251575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6134920|NCT01251575|Antimetabolites|antimetabolites|mesh-ancestor
6134921|NCT01251575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134922|NCT01251575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6134923|NCT01251575|Immunologic Factors|immunologic factors|mesh-ancestor
6466614|NCT00480090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6466615|NCT00480090|Immunologic Factors|immunologic factors|mesh-ancestor
6466616|NCT00480090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466617|NCT00480103|Mineral Oil|mineral oil|mesh-list
6466618|NCT00480103|Emollients|emollients|mesh-ancestor
6466619|NCT00480103|Dermatologic Agents|dermatologic agents|mesh-ancestor
6466620|NCT00480116|Vaccines|vaccines|mesh-list
6466621|NCT00480116|Immunologic Factors|immunologic factors|mesh-ancestor
6134924|NCT01251575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134925|NCT01251575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6134926|NCT01251575|Antifungal Agents|antifungal agents|mesh-ancestor
6134927|NCT01251575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6134928|NCT01251575|Dermatologic Agents|dermatologic agents|mesh-ancestor
6134929|NCT01251575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6134930|NCT01251575|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6134931|NCT01251575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6134932|NCT01251575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6134933|NCT01251575|Antitubercular Agents|antitubercular agents|mesh-ancestor
6134934|NCT01251575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6134935|NCT01251614|Adalimumab|adalimumab|mesh-list
6134936|NCT01251614|Methotrexate|methotrexate|mesh-list
5539509|NCT04182568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539510|NCT04182568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5539511|NCT04182568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5539512|NCT04182568|Alkylating Agents|alkylating agents|mesh-ancestor
5539513|NCT04182568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6134937|NCT01251614|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6134938|NCT01251614|Abortifacient Agents|abortifacient agents|mesh-ancestor
6134939|NCT01251614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6134940|NCT01251614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466622|NCT00480116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466623|NCT00480142|Oxycodone|oxycodone|mesh-list
6666376|NCT01522612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6134941|NCT01251614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6666377|NCT01522625|Tenofovir|tenofovir|mesh-list
6466624|NCT00480142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5539514|NCT04182854|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5539515|NCT04182854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5539516|NCT04182854|Diuretics|diuretics|mesh-ancestor
5539517|NCT04182854|Natriuretic Agents|natriuretic agents|mesh-ancestor
5539518|NCT04182854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539519|NCT04182854|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5539520|NCT04182854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5539521|NCT04182854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539522|NCT04182724|Paclitaxel|paclitaxel|mesh-list
5539523|NCT04182724|Apatinib|apatinib|mesh-list
5539524|NCT04182724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6466625|NCT00480142|Narcotics|narcotics|mesh-ancestor
6466626|NCT00480142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6466627|NCT00480142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466628|NCT00480142|Analgesics|analgesics|mesh-ancestor
6466629|NCT00480142|Sensory System Agents|sensory system agents|mesh-ancestor
6466630|NCT00480142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6466631|NCT00480181|Nabilone|nabilone|mesh-list
6134942|NCT01251614|Antimetabolites|antimetabolites|mesh-ancestor
6134943|NCT01251614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539525|NCT04182724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5539526|NCT04182724|Tubulin Modulators|tubulin modulators|mesh-ancestor
5539527|NCT04182724|Antimitotic Agents|antimitotic agents|mesh-ancestor
5539528|NCT04182724|Mitosis Modulators|mitosis modulators|mesh-ancestor
5539529|NCT04182724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539530|NCT04182724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5539531|NCT04182724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5539532|NCT04182555|Bilirubin|bilirubin|mesh-list
5539533|NCT04182555|Antioxidants|antioxidants|mesh-ancestor
5539534|NCT04182555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539535|NCT04182555|Protective Agents|protective agents|mesh-ancestor
5539536|NCT04182555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539537|NCT04182828|Lidocaine|lidocaine|mesh-list
5539538|NCT04182828|Anesthetics, Local|anesthetics, local|mesh-ancestor
5539539|NCT04182828|Anesthetics|anesthetics|mesh-ancestor
5539540|NCT04182828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5539541|NCT04182828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539542|NCT04182828|Sensory System Agents|sensory system agents|mesh-ancestor
5539543|NCT04182828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5539544|NCT04182828|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5539545|NCT04182828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5539546|NCT04182828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5539547|NCT04182828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5539548|NCT04182828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539549|NCT04182191|Tenoxicam|tenoxicam|mesh-list
5539550|NCT04182191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5539551|NCT04182191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5539552|NCT04182191|Analgesics|analgesics|mesh-ancestor
5539553|NCT04182191|Sensory System Agents|sensory system agents|mesh-ancestor
5539554|NCT04182191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5539555|NCT04182191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539556|NCT04182191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5539557|NCT04182191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5539558|NCT04182191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5539559|NCT04182191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5539560|NCT04182191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539561|NCT04182373|Antithrombins|antithrombins|mesh-list
6134944|NCT01251614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6134945|NCT01251614|Dermatologic Agents|dermatologic agents|mesh-ancestor
6134946|NCT01251614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6134947|NCT01251614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6134948|NCT01251614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6134949|NCT01251614|Immunologic Factors|immunologic factors|mesh-ancestor
6134950|NCT01251614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6134951|NCT01251614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6134952|NCT01251614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6134953|NCT01251653|Gemcitabine|gemcitabine|mesh-list
6134954|NCT01251653|Docetaxel|docetaxel|mesh-list
6134955|NCT01251653|Afatinib|afatinib|mesh-list
6134956|NCT01251653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6134957|NCT01251653|Antimetabolites|antimetabolites|mesh-ancestor
6134958|NCT01251653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134959|NCT01251653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6466632|NCT00480181|Antiemetics|antiemetics|mesh-ancestor
6466633|NCT00480181|Autonomic Agents|autonomic agents|mesh-ancestor
6466634|NCT00480181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6466635|NCT00480181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466636|NCT00480181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6466637|NCT00480181|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6466638|NCT00480181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6466639|NCT00480181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6466640|NCT00480181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6466641|NCT00480194|Xylometazoline|xylometazoline|mesh-list
6466642|NCT00480194|Bromides|bromides|mesh-list
6466643|NCT00480194|Ipratropium|ipratropium|mesh-list
6466644|NCT00480194|Anticonvulsants|anticonvulsants|mesh-ancestor
6466645|NCT00480194|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6466646|NCT00480194|Autonomic Agents|autonomic agents|mesh-ancestor
6466647|NCT00480194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6466648|NCT00480194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466649|NCT00480194|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6466650|NCT00480194|Respiratory System Agents|respiratory system agents|mesh-ancestor
6466651|NCT00480194|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6466652|NCT00480194|Cholinergic Agents|cholinergic agents|mesh-ancestor
6134960|NCT01251653|Antiviral Agents|antiviral agents|mesh-ancestor
6466653|NCT00480194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6466654|NCT00480194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466655|NCT00480194|Nasal Decongestants|nasal decongestants|mesh-ancestor
6466656|NCT00480194|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6466657|NCT00480207|Folic Acid|folic acid|mesh-list
6466658|NCT00480207|Vitamin B Complex|vitamin b complex|mesh-list
6466659|NCT00480207|Hematinics|hematinics|mesh-ancestor
6466660|NCT00480207|Vitamins|vitamins|mesh-ancestor
6466661|NCT00480207|Micronutrients|micronutrients|mesh-ancestor
6466662|NCT00480207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466663|NCT00480246|Perphenazine|perphenazine|mesh-list
6466664|NCT00480246|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6466665|NCT00480246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6466666|NCT00480246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6466667|NCT00480246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466668|NCT00480246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6466669|NCT00480246|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6466670|NCT00480246|Dopamine Agents|dopamine agents|mesh-ancestor
6466671|NCT00480246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6134961|NCT01251653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6134962|NCT01251653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6134963|NCT01251653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6134964|NCT01251653|Immunologic Factors|immunologic factors|mesh-ancestor
6134965|NCT01251653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134966|NCT01251653|Tubulin Modulators|tubulin modulators|mesh-ancestor
6134967|NCT01251653|Antimitotic Agents|antimitotic agents|mesh-ancestor
6134968|NCT01251653|Mitosis Modulators|mitosis modulators|mesh-ancestor
6134969|NCT01251653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6134970|NCT01251861|Bicalutamide|bicalutamide|mesh-list
6134971|NCT01251861|Androgen Antagonists|androgen antagonists|mesh-ancestor
6134972|NCT01251861|Hormone Antagonists|hormone antagonists|mesh-ancestor
6134973|NCT01251861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6134974|NCT01251861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134975|NCT01251861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6134976|NCT01251978|Ranibizumab|ranibizumab|mesh-list
6134977|NCT01251978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6134978|NCT01251978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6134979|NCT01251978|Growth Substances|growth substances|mesh-ancestor
6134980|NCT01251978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134981|NCT01251978|Growth Inhibitors|growth inhibitors|mesh-ancestor
6134982|NCT01251978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6134983|NCT01252134|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6134984|NCT01252186|Contraceptive Agents|contraceptive agents|mesh-list
6466672|NCT00480246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6134985|NCT01252186|Levonorgestrel|levonorgestrel|mesh-list
6134986|NCT01252186|Desogestrel|desogestrel|mesh-list
6466673|NCT00480272|Prednisone|prednisone|mesh-list
6134987|NCT01252186|Contraceptives, Oral|contraceptives, oral|mesh-list
6134988|NCT01252186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6134989|NCT01252186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6134990|NCT01252186|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6134991|NCT01252186|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6134992|NCT01252186|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6134993|NCT01252186|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6134994|NCT01252186|Progestins|progestins|mesh-ancestor
6134995|NCT01252186|Hormones|hormones|mesh-ancestor
5539562|NCT04182373|Antithrombin III|antithrombin iii|mesh-list
5539563|NCT04182373|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5539564|NCT04182373|Protease Inhibitors|protease inhibitors|mesh-ancestor
5539565|NCT04182373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5539566|NCT04182373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539567|NCT04182373|Anticoagulants|anticoagulants|mesh-ancestor
5539568|NCT04182399|Zonisamide|zonisamide|mesh-list
5539569|NCT04182399|Anticonvulsants|anticonvulsants|mesh-ancestor
5539570|NCT04182399|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5539571|NCT04182399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5539572|NCT04182399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539573|NCT04182399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5539574|NCT04182399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539575|NCT04181996|Colchicine|colchicine|mesh-list
5539576|NCT04181996|Gout Suppressants|gout suppressants|mesh-ancestor
5539577|NCT04181996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5539578|NCT04181996|Tubulin Modulators|tubulin modulators|mesh-ancestor
5539579|NCT04181996|Antimitotic Agents|antimitotic agents|mesh-ancestor
5539580|NCT04181996|Mitosis Modulators|mitosis modulators|mesh-ancestor
5539581|NCT04181996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539582|NCT04181996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5602140|NCT04911361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5602141|NCT04911361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5602142|NCT04911361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5602143|NCT04901689|Leronlimab|leronlimab|mesh-list
6134996|NCT01252186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6134997|NCT01252238|Amlodipine|amlodipine|mesh-list
6134998|NCT01252238|Valsartan|valsartan|mesh-list
5602144|NCT04901689|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5602145|NCT04901689|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5602146|NCT04901689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602147|NCT04901689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5602148|NCT04901689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5602149|NCT04901689|Antiviral Agents|antiviral agents|mesh-ancestor
6134999|NCT01252238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6135000|NCT01252238|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6135001|NCT01252238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6135002|NCT01252238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6135003|NCT01252238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6135004|NCT01252238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466674|NCT00480272|Adalimumab|adalimumab|mesh-list
6466675|NCT00480272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6466676|NCT00480272|Glucocorticoids|glucocorticoids|mesh-ancestor
5602150|NCT04901689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5602151|NCT04901676|Leronlimab|leronlimab|mesh-list
5602152|NCT04901676|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5602153|NCT04901676|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5602154|NCT04901676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602155|NCT04901676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5602156|NCT04901676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5602157|NCT04901676|Antiviral Agents|antiviral agents|mesh-ancestor
6466677|NCT00480272|Hormones|hormones|mesh-ancestor
6466678|NCT00480272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6466679|NCT00480272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466680|NCT00480272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5602158|NCT04901676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5602159|NCT04899193|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5602160|NCT04899193|Hormones|hormones|mesh-ancestor
5602161|NCT04899193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6466681|NCT00480272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5602162|NCT04899193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602163|NCT04895280|Triamcinolone|triamcinolone|mesh-list
5602164|NCT04895280|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5539583|NCT04182204|Gemcitabine|gemcitabine|mesh-list
6135005|NCT01252238|Vasodilator Agents|vasodilator agents|mesh-ancestor
6135006|NCT01252238|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6135007|NCT01252238|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6135008|NCT01252251|Everolimus|everolimus|mesh-list
6135009|NCT01252251|Pasireotide|pasireotide|mesh-list
6135010|NCT01252251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6135011|NCT01252251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6135012|NCT01252251|Immunologic Factors|immunologic factors|mesh-ancestor
6135013|NCT01252251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135014|NCT01252251|Hormones|hormones|mesh-ancestor
6135015|NCT01252251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5539584|NCT04182204|Rituximab|rituximab|mesh-list
5539585|NCT04182204|Oxaliplatin|oxaliplatin|mesh-list
5539586|NCT04182204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5539587|NCT04182204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5539588|NCT04182204|Immunologic Factors|immunologic factors|mesh-ancestor
5539589|NCT04182204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539590|NCT04182204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5539591|NCT04182204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5539592|NCT04182204|Antimetabolites|antimetabolites|mesh-ancestor
5539593|NCT04182204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539594|NCT04182204|Antiviral Agents|antiviral agents|mesh-ancestor
6135016|NCT01252355|Interferons|interferons|mesh-list
6135017|NCT01252355|Interferon-beta|interferon-beta|mesh-list
6135018|NCT01252355|Teriflunomide|teriflunomide|mesh-list
6135019|NCT01252355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6135020|NCT01252355|Antiviral Agents|antiviral agents|mesh-ancestor
6135021|NCT01252355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6135022|NCT01252355|Immunologic Factors|immunologic factors|mesh-ancestor
6135023|NCT01252355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135024|NCT01252355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6135025|NCT01252355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6135026|NCT01252355|Analgesics|analgesics|mesh-ancestor
6135027|NCT01252355|Sensory System Agents|sensory system agents|mesh-ancestor
6135028|NCT01252355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6135029|NCT01252355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6135030|NCT01252355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6135031|NCT01252355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6135032|NCT01252563|Amlodipine|amlodipine|mesh-list
6135033|NCT01252563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6135034|NCT01252563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6135035|NCT01252563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6135036|NCT01252563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6135037|NCT01252563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6135038|NCT01252563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135039|NCT01252563|Vasodilator Agents|vasodilator agents|mesh-ancestor
6135040|NCT01252667|Cyclosporine|cyclosporine|mesh-list
5539595|NCT04182204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5539596|NCT04182204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5539597|NCT04182204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6135041|NCT01252667|Mycophenolic Acid|mycophenolic acid|mesh-list
6135042|NCT01252667|Clofarabine|clofarabine|mesh-list
5539598|NCT04181957|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
5539599|NCT04181957|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5539600|NCT04181957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539601|NCT04181957|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5539602|NCT04181957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5539603|NCT04181957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5539604|NCT04181957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539605|NCT04181957|Dopamine Agents|dopamine agents|mesh-ancestor
5539606|NCT04181957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5539607|NCT04181645|Gemcitabine|gemcitabine|mesh-list
5539608|NCT04181645|Paclitaxel|paclitaxel|mesh-list
5539609|NCT04181645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5539610|NCT04181645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5539611|NCT04181645|Tubulin Modulators|tubulin modulators|mesh-ancestor
5539612|NCT04181645|Antimitotic Agents|antimitotic agents|mesh-ancestor
5539613|NCT04181645|Mitosis Modulators|mitosis modulators|mesh-ancestor
5539614|NCT04181645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539615|NCT04181645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5539616|NCT04181645|Antimetabolites|antimetabolites|mesh-ancestor
5539617|NCT04181645|Antiviral Agents|antiviral agents|mesh-ancestor
5539618|NCT04181645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6135043|NCT01252667|Cyclosporins|cyclosporins|mesh-list
5725498|NCT03180281|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5725499|NCT03180281|Protease Inhibitors|protease inhibitors|mesh-ancestor
5725500|NCT03180281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5725501|NCT03180281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725502|NCT03180281|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5725503|NCT03180281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5725504|NCT03180281|Immunologic Factors|immunologic factors|mesh-ancestor
5725505|NCT03180255|Dexamethasone|dexamethasone|mesh-list
5725506|NCT03180255|Sodium Citrate|sodium citrate|mesh-list
5725507|NCT03180255|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
5725508|NCT03180255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6135044|NCT01252667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6135045|NCT01252667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6135046|NCT01252667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6135047|NCT01252667|Immunologic Factors|immunologic factors|mesh-ancestor
6135048|NCT01252667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135049|NCT01252667|Antifungal Agents|antifungal agents|mesh-ancestor
6135050|NCT01252667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6135051|NCT01252667|Dermatologic Agents|dermatologic agents|mesh-ancestor
6135052|NCT01252667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6135053|NCT01252667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6135054|NCT01252667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6135055|NCT01252667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6135056|NCT01252667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6135057|NCT01252667|Antitubercular Agents|antitubercular agents|mesh-ancestor
6135058|NCT01252667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6135059|NCT01252667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6135060|NCT01252667|Antimetabolites|antimetabolites|mesh-ancestor
6135061|NCT01252732|Vancomycin|vancomycin|mesh-list
6135062|NCT01252732|Oritavancin|oritavancin|mesh-list
6135063|NCT01252732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6135064|NCT01252732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6135065|NCT01252745|Methyltestosterone|methyltestosterone|mesh-list
6135066|NCT01252745|Testosterone|testosterone|mesh-list
6135067|NCT01252745|Testosterone undecanoate|testosterone undecanoate|mesh-list
6135068|NCT01252745|Testosterone enanthate|testosterone enanthate|mesh-list
6135069|NCT01252745|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6135070|NCT01252745|Androgens|androgens|mesh-ancestor
6135071|NCT01252745|Hormones|hormones|mesh-ancestor
6135072|NCT01252745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6135073|NCT01252745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135074|NCT01252745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6135075|NCT01252745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6135076|NCT01252745|Anabolic Agents|anabolic agents|mesh-ancestor
5539619|NCT04181645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5539620|NCT04181645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5539621|NCT04181645|Immunologic Factors|immunologic factors|mesh-ancestor
6135077|NCT01252940|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
6135078|NCT01252940|Antiviral Agents|antiviral agents|mesh-ancestor
6135079|NCT01252940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6135080|NCT01252940|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6135081|NCT01252940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5539622|NCT04181645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539623|NCT04181567|S 20098|s 20098|mesh-list
5539624|NCT04181567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5539625|NCT04181567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5539626|NCT04181567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539627|NCT04181736|Guanfacine|guanfacine|mesh-list
5539628|NCT04181736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5539629|NCT04181736|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6135082|NCT01252940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6135083|NCT01252940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6135084|NCT01252940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6135085|NCT01252940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6135086|NCT01252953|Oxazolidinones|oxazolidinones|mesh-list
6135087|NCT01252953|Anacetrapib|anacetrapib|mesh-list
6135088|NCT01252953|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6135089|NCT01252953|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6135090|NCT01252953|Antimetabolites|antimetabolites|mesh-ancestor
6135091|NCT01252953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6135092|NCT01252953|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5539630|NCT04181736|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5539631|NCT04181736|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5539632|NCT04181736|Adrenergic Agents|adrenergic agents|mesh-ancestor
5725509|NCT03180255|Antiemetics|antiemetics|mesh-ancestor
5539633|NCT04181736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5539634|NCT04181736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539635|NCT04181736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539636|NCT04181749|Aspirin|aspirin|mesh-list
5539637|NCT04181749|Atorvastatin|atorvastatin|mesh-list
5539638|NCT04181749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5539639|NCT04181749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5539640|NCT04181749|Analgesics|analgesics|mesh-ancestor
6135093|NCT01252953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6135094|NCT01252953|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6135095|NCT01252953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6135096|NCT01253070|Cytarabine|cytarabine|mesh-list
6135097|NCT01253070|Sorafenib|sorafenib|mesh-list
6135098|NCT01253070|Daunorubicin|daunorubicin|mesh-list
6135099|NCT01253070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6135100|NCT01253070|Antimetabolites|antimetabolites|mesh-ancestor
6135101|NCT01253070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6135102|NCT01253070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6135103|NCT01253070|Antiviral Agents|antiviral agents|mesh-ancestor
6135104|NCT01253070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6135105|NCT01253070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6135106|NCT01253070|Immunologic Factors|immunologic factors|mesh-ancestor
6135107|NCT01253070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135108|NCT01253070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6135109|NCT01253070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6135110|NCT01253070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6135111|NCT01253070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6135112|NCT01253070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6135113|NCT01253135|Petrolatum|petrolatum|mesh-list
6135114|NCT01253135|Emollients|emollients|mesh-ancestor
6135115|NCT01253135|Dermatologic Agents|dermatologic agents|mesh-ancestor
6135116|NCT01253174|Tetrahydrofolates|tetrahydrofolates|mesh-list
6135117|NCT01253174|Drospirenone|drospirenone|mesh-list
6135118|NCT01253174|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6135119|NCT01253174|Hormone Antagonists|hormone antagonists|mesh-ancestor
6135120|NCT01253174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6135121|NCT01253174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135122|NCT01253174|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6135123|NCT01253174|Diuretics|diuretics|mesh-ancestor
6135124|NCT01253174|Natriuretic Agents|natriuretic agents|mesh-ancestor
6135125|NCT01253174|Vitamin B Complex|vitamin b complex|mesh-ancestor
6135126|NCT01253174|Vitamins|vitamins|mesh-ancestor
6135127|NCT01253174|Micronutrients|micronutrients|mesh-ancestor
6205204|NCT02082769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205205|NCT02082912|Cycloserine|cycloserine|mesh-list
6205206|NCT02082912|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6205207|NCT02082912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6205208|NCT02082912|Renal Agents|renal agents|mesh-ancestor
6205209|NCT02082912|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5539641|NCT04181749|Sensory System Agents|sensory system agents|mesh-ancestor
5539642|NCT04181749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5539643|NCT04181749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539644|NCT04181749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5539645|NCT04181749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6205210|NCT02082912|Antitubercular Agents|antitubercular agents|mesh-ancestor
6205211|NCT02082912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6205212|NCT02082912|Antimetabolites|antimetabolites|mesh-ancestor
6205213|NCT02082912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205214|NCT02083107|Misoprostol|misoprostol|mesh-list
6205215|NCT02083107|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6466682|NCT00480272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6466683|NCT00480298|Methylprednisolone|methylprednisolone|mesh-list
6466684|NCT00480298|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6466685|NCT00480298|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6205216|NCT02083107|Abortifacient Agents|abortifacient agents|mesh-ancestor
5539646|NCT04181749|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5539647|NCT04181749|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5539648|NCT04181749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539649|NCT04181749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5539650|NCT04181749|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5539651|NCT04181749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5539652|NCT04181749|Antipyretics|antipyretics|mesh-ancestor
5539653|NCT04181749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6205217|NCT02083107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6205218|NCT02083107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135128|NCT01253187|Tetrahydrofolates|tetrahydrofolates|mesh-list
6135129|NCT01253187|Drospirenone|drospirenone|mesh-list
6135130|NCT01253187|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6135131|NCT01253187|Hormone Antagonists|hormone antagonists|mesh-ancestor
6135132|NCT01253187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6135133|NCT01253187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135134|NCT01253187|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6135135|NCT01253187|Diuretics|diuretics|mesh-ancestor
6135136|NCT01253187|Natriuretic Agents|natriuretic agents|mesh-ancestor
6135137|NCT01253187|Vitamin B Complex|vitamin b complex|mesh-ancestor
6135138|NCT01253187|Vitamins|vitamins|mesh-ancestor
6135139|NCT01253187|Micronutrients|micronutrients|mesh-ancestor
6135140|NCT01253200|Acifluorfen|acifluorfen|mesh-list
6466686|NCT00480298|Prednisolone|prednisolone|mesh-list
6466687|NCT00480298|Prednisolone acetate|prednisolone acetate|mesh-list
6466688|NCT00480298|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6466689|NCT00480298|Prednisolone phosphate|prednisolone phosphate|mesh-list
6466690|NCT00480298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6466691|NCT00480298|Antiemetics|antiemetics|mesh-ancestor
6466692|NCT00480298|Autonomic Agents|autonomic agents|mesh-ancestor
6135141|NCT01253200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6135142|NCT01253200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6135143|NCT01253226|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6135144|NCT01253226|Immunologic Factors|immunologic factors|mesh-ancestor
6135145|NCT01253226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466693|NCT00480298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6466694|NCT00480298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466695|NCT00480298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6466696|NCT00480298|Glucocorticoids|glucocorticoids|mesh-ancestor
6466697|NCT00480298|Hormones|hormones|mesh-ancestor
6466698|NCT00480298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6466699|NCT00480298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6466700|NCT00480298|Protective Agents|protective agents|mesh-ancestor
6466701|NCT00480298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6466702|NCT00480298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6466703|NCT00480363|Dexamethasone|dexamethasone|mesh-list
6466704|NCT00480363|Lenalidomide|lenalidomide|mesh-list
6466705|NCT00480363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6466706|NCT00480363|Antiemetics|antiemetics|mesh-ancestor
6466707|NCT00480363|Autonomic Agents|autonomic agents|mesh-ancestor
6466708|NCT00480363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6466709|NCT00480363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466710|NCT00480363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6466711|NCT00480363|Glucocorticoids|glucocorticoids|mesh-ancestor
6466712|NCT00480363|Hormones|hormones|mesh-ancestor
6466713|NCT00480363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6466714|NCT00480363|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6466715|NCT00480363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6466716|NCT00480363|Immunologic Factors|immunologic factors|mesh-ancestor
6466717|NCT00480363|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5539654|NCT04181749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6135146|NCT01253265|Ixekizumab|ixekizumab|mesh-list
6135147|NCT01253265|Dermatologic Agents|dermatologic agents|mesh-ancestor
6135148|NCT01253304|Dulaglutide|dulaglutide|mesh-list
6135149|NCT01253304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6135150|NCT01253304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135151|NCT01253317|Mecasermin|mecasermin|mesh-list
6135152|NCT01253317|Growth Substances|growth substances|mesh-ancestor
6135153|NCT01253317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135154|NCT01253408|Dronabinol|dronabinol|mesh-list
6135155|NCT01253408|Hallucinogens|hallucinogens|mesh-ancestor
6135156|NCT01253408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135157|NCT01253408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6135158|NCT01253408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6135159|NCT01253408|Analgesics|analgesics|mesh-ancestor
6135160|NCT01253408|Sensory System Agents|sensory system agents|mesh-ancestor
6135161|NCT01253408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5539655|NCT04181749|Antimetabolites|antimetabolites|mesh-ancestor
5539656|NCT04181749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5539657|NCT04181749|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5539658|NCT04181359|Nitric Oxide|nitric oxide|mesh-list
5539659|NCT04181359|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5539660|NCT04181359|Autonomic Agents|autonomic agents|mesh-ancestor
6135162|NCT01253408|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6135163|NCT01253408|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6135164|NCT01253408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6466718|NCT00480363|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6135165|NCT01253408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6135166|NCT01253408|Hormones|hormones|mesh-ancestor
6135167|NCT01253408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6135168|NCT01253421|Amisulpride|amisulpride|mesh-list
6135169|NCT01253421|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6135170|NCT01253421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6135171|NCT01253421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6135172|NCT01253421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135173|NCT01253421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6135174|NCT01253421|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6135175|NCT01253421|Dopamine Agents|dopamine agents|mesh-ancestor
6135176|NCT01253421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6466719|NCT00480363|Growth Substances|growth substances|mesh-ancestor
6466720|NCT00480363|Growth Inhibitors|growth inhibitors|mesh-ancestor
6466721|NCT00480376|Gentamicins|gentamicins|mesh-list
6466722|NCT00480376|Ofloxacin|ofloxacin|mesh-list
6466723|NCT00480376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6466724|NCT00480376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6135177|NCT01253421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6135178|NCT01253421|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6135179|NCT01253421|Antidepressive Agents|antidepressive agents|mesh-ancestor
6135180|NCT01253460|Cyclophosphamide|cyclophosphamide|mesh-list
6135181|NCT01253460|Rituximab|rituximab|mesh-list
6135182|NCT01253460|Sapacitabine|sapacitabine|mesh-list
6135183|NCT01253460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6135184|NCT01253460|Immunologic Factors|immunologic factors|mesh-ancestor
6135185|NCT01253460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135186|NCT01253460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6135187|NCT01253460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6135188|NCT01253460|Alkylating Agents|alkylating agents|mesh-ancestor
6135189|NCT01253460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6135190|NCT01253460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6135191|NCT01253460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6135192|NCT01253460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6135193|NCT01253525|Paclitaxel|paclitaxel|mesh-list
6135194|NCT01253525|Ramucirumab|ramucirumab|mesh-list
6135195|NCT01253525|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6466725|NCT00480376|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6466726|NCT00480376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6466727|NCT00480376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466728|NCT00480376|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6466729|NCT00480376|Renal Agents|renal agents|mesh-ancestor
6466730|NCT00480376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6466731|NCT00480376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6466732|NCT00480376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6466733|NCT00480376|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6466734|NCT00480376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6466735|NCT00480389|Sorafenib|sorafenib|mesh-list
6466736|NCT00480389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6466737|NCT00480389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6466738|NCT00480389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6466739|NCT00480389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466740|NCT00480402|Progesterone|progesterone|mesh-list
6466741|NCT00480402|Progestins|progestins|mesh-ancestor
6466742|NCT00480402|Hormones|hormones|mesh-ancestor
6466743|NCT00480402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6466744|NCT00480402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466745|NCT00480454|Vaccines|vaccines|mesh-list
6466746|NCT00480454|Immunologic Factors|immunologic factors|mesh-ancestor
6466747|NCT00480454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539661|NCT04181359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5539662|NCT04181359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539663|NCT04181359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5539664|NCT04181359|Respiratory System Agents|respiratory system agents|mesh-ancestor
5539665|NCT04181359|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5539666|NCT04181359|Antioxidants|antioxidants|mesh-ancestor
5539667|NCT04181359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539668|NCT04181359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5539669|NCT04181359|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5539670|NCT04181359|Vasodilator Agents|vasodilator agents|mesh-ancestor
5539671|NCT04181359|Gasotransmitters|gasotransmitters|mesh-ancestor
5539672|NCT04181359|Protective Agents|protective agents|mesh-ancestor
5539673|NCT04181255|Poractant alfa|poractant alfa|mesh-list
5539674|NCT04181255|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
5539675|NCT04181255|Respiratory System Agents|respiratory system agents|mesh-ancestor
5539676|NCT04181385|Bromocriptine|bromocriptine|mesh-list
5539677|NCT04181385|Olanzapine|olanzapine|mesh-list
5539678|NCT04181385|Antiemetics|antiemetics|mesh-ancestor
5539679|NCT04181385|Autonomic Agents|autonomic agents|mesh-ancestor
5539680|NCT04181385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5539681|NCT04181385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539682|NCT04181385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5539683|NCT04181385|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5539684|NCT04181385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5539685|NCT04181385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5539686|NCT04181385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5539687|NCT04181385|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6466748|NCT00480558|Vaccines|vaccines|mesh-list
6466749|NCT00480558|Immunologic Factors|immunologic factors|mesh-ancestor
6466750|NCT00480558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466751|NCT00480571|Perphenazine|perphenazine|mesh-list
6466752|NCT00480571|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
6135196|NCT01253525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5539688|NCT04181385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5539689|NCT04181385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6135197|NCT01253525|Tubulin Modulators|tubulin modulators|mesh-ancestor
6135198|NCT01253525|Antimitotic Agents|antimitotic agents|mesh-ancestor
6135199|NCT01253525|Mitosis Modulators|mitosis modulators|mesh-ancestor
6135200|NCT01253525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6135201|NCT01253642|Docetaxel|docetaxel|mesh-list
6135202|NCT01253642|Phenelzine|phenelzine|mesh-list
6135203|NCT01253642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6135204|NCT01253642|Tubulin Modulators|tubulin modulators|mesh-ancestor
6135205|NCT01253642|Antimitotic Agents|antimitotic agents|mesh-ancestor
6135206|NCT01253642|Mitosis Modulators|mitosis modulators|mesh-ancestor
6135207|NCT01253642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6135208|NCT01253642|Antidepressive Agents|antidepressive agents|mesh-ancestor
6135209|NCT01253642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6466753|NCT00480571|GABA Agents|gaba agents|mesh-ancestor
6466754|NCT00480571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6466755|NCT00480571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466756|NCT00480571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135210|NCT01253642|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6135211|NCT01253642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6135212|NCT01253824|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6135213|NCT01253824|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6135214|NCT01253824|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6135215|NCT01253824|Norethindrone|norethindrone|mesh-list
6135216|NCT01253824|Norethindrone Acetate|norethindrone acetate|mesh-list
6466757|NCT00480571|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6466758|NCT00480571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6466759|NCT00480571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6466760|NCT00480571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6466761|NCT00480571|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6466762|NCT00480571|Dopamine Agents|dopamine agents|mesh-ancestor
6466763|NCT00480584|Gemcitabine|gemcitabine|mesh-list
6466764|NCT00480584|Capecitabine|capecitabine|mesh-list
6466765|NCT00480584|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6466766|NCT00480584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6466767|NCT00480584|Antimetabolites|antimetabolites|mesh-ancestor
6466768|NCT00480584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466769|NCT00480584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6466770|NCT00480584|Antiviral Agents|antiviral agents|mesh-ancestor
5539690|NCT04181385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466771|NCT00480584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6466772|NCT00480584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6466773|NCT00480584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6466774|NCT00480584|Immunologic Factors|immunologic factors|mesh-ancestor
6466775|NCT00480584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466776|NCT00480584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5539691|NCT04181385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5539692|NCT04181385|Serotonin Agents|serotonin agents|mesh-ancestor
5539693|NCT04181385|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5539694|NCT04181385|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5539695|NCT04181385|Hormone Antagonists|hormone antagonists|mesh-ancestor
5539696|NCT04181385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5539697|NCT04181385|Dopamine Agonists|dopamine agonists|mesh-ancestor
5539698|NCT04181385|Dopamine Agents|dopamine agents|mesh-ancestor
5539699|NCT04181489|Prednisolone|prednisolone|mesh-list
5539700|NCT04181489|Cyclophosphamide|cyclophosphamide|mesh-list
5539701|NCT04181489|Rituximab|rituximab|mesh-list
5539702|NCT04181489|Doxorubicin|doxorubicin|mesh-list
5539703|NCT04181489|Vincristine|vincristine|mesh-list
5539704|NCT04181489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5539705|NCT04181489|Immunologic Factors|immunologic factors|mesh-ancestor
5539706|NCT04181489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539707|NCT04181489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6466777|NCT00480597|Gemcitabine|gemcitabine|mesh-list
6466778|NCT00480597|Capecitabine|capecitabine|mesh-list
6466779|NCT00480597|Vinorelbine|vinorelbine|mesh-list
6466780|NCT00480597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6466781|NCT00480597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6466782|NCT00480597|Antimetabolites|antimetabolites|mesh-ancestor
6466783|NCT00480597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466784|NCT00480597|Antiviral Agents|antiviral agents|mesh-ancestor
6466785|NCT00480597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6466786|NCT00480597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6466787|NCT00480597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6466788|NCT00480597|Immunologic Factors|immunologic factors|mesh-ancestor
6466789|NCT00480597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466790|NCT00480597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6466791|NCT00480597|Tubulin Modulators|tubulin modulators|mesh-ancestor
6466792|NCT00480597|Antimitotic Agents|antimitotic agents|mesh-ancestor
6466793|NCT00480597|Mitosis Modulators|mitosis modulators|mesh-ancestor
5539708|NCT04181489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5539709|NCT04181489|Alkylating Agents|alkylating agents|mesh-ancestor
5539710|NCT04181489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539711|NCT04181489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5539712|NCT04181489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5539713|NCT04181489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5539714|NCT04181489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5539715|NCT04181489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5539716|NCT04181489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5539717|NCT04181489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5539718|NCT04181489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5539719|NCT04181489|Tubulin Modulators|tubulin modulators|mesh-ancestor
5539720|NCT04181489|Antimitotic Agents|antimitotic agents|mesh-ancestor
5539721|NCT04181489|Mitosis Modulators|mitosis modulators|mesh-ancestor
5539722|NCT04181489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5539723|NCT04181489|Glucocorticoids|glucocorticoids|mesh-ancestor
5539724|NCT04181489|Hormones|hormones|mesh-ancestor
5539725|NCT04181489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5539726|NCT04181489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6466794|NCT00480610|Tacrolimus|tacrolimus|mesh-list
6466795|NCT00480610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6466796|NCT00480610|Immunologic Factors|immunologic factors|mesh-ancestor
6466797|NCT00480610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466798|NCT00480610|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6466799|NCT00480610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6466800|NCT00480610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466801|NCT00480623|Satraplatin|satraplatin|mesh-list
6466802|NCT00480623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6466803|NCT00480649|Fluticasone|fluticasone|mesh-list
6466804|NCT00480649|Xhance|xhance|mesh-list
6466805|NCT00480649|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6466806|NCT00480649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6466807|NCT00480649|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5539727|NCT04181346|Pregabalin|pregabalin|mesh-list
5539728|NCT04181346|Analgesics|analgesics|mesh-ancestor
6466808|NCT00480649|Autonomic Agents|autonomic agents|mesh-ancestor
6666378|NCT01522625|Antiviral Agents|antiviral agents|mesh-ancestor
5539729|NCT04181346|Sensory System Agents|sensory system agents|mesh-ancestor
5539730|NCT04181346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6466809|NCT00480649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6466810|NCT00480649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466811|NCT00480649|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6466812|NCT00480649|Respiratory System Agents|respiratory system agents|mesh-ancestor
6466813|NCT00480649|Dermatologic Agents|dermatologic agents|mesh-ancestor
6466814|NCT00480649|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6466815|NCT00480649|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6466816|NCT00480649|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6466817|NCT00480649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5539731|NCT04181346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539732|NCT04181346|Anticonvulsants|anticonvulsants|mesh-ancestor
5539733|NCT04181346|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5539734|NCT04181346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5539735|NCT04181346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539736|NCT04181346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5539737|NCT04181346|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5539738|NCT04181346|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5539739|NCT04181346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5539740|NCT04181346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5539741|NCT04181203|Leuprolide|leuprolide|mesh-list
5539742|NCT04181203|Goserelin|goserelin|mesh-list
5539743|NCT04181203|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5539744|NCT04181203|Hormones|hormones|mesh-list
5539745|NCT04181203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5539746|NCT04181203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539747|NCT04181203|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5539748|NCT04181203|Fertility Agents|fertility agents|mesh-ancestor
5539749|NCT04181203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5539750|NCT04181203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5539751|NCT04181203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5539752|NCT04181203|Luteolytic Agents|luteolytic agents|mesh-ancestor
5539753|NCT04181203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5539754|NCT04181203|Contraceptive Agents|contraceptive agents|mesh-ancestor
6466818|NCT00480649|Adrenergic Agents|adrenergic agents|mesh-ancestor
6466819|NCT00480649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6466820|NCT00480649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466821|NCT00480675|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6466822|NCT00480675|Methylprednisolone|methylprednisolone|mesh-list
6466823|NCT00480675|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6135217|NCT01253824|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
6135218|NCT01253824|Norinyl|norinyl|mesh-list
6135219|NCT01253824|Mestranol|mestranol|mesh-list
6135220|NCT01253824|Estradiol|estradiol|mesh-list
6135221|NCT01253824|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6135222|NCT01253824|Estrogens|estrogens|mesh-ancestor
6135223|NCT01253824|Hormones|hormones|mesh-ancestor
6135224|NCT01253824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6135225|NCT01253824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135226|NCT01253824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6135227|NCT01253824|Contraceptive Agents|contraceptive agents|mesh-ancestor
6135228|NCT01253824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6135229|NCT01253824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6135230|NCT01253824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6135231|NCT01253824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6135232|NCT01253824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6135233|NCT01253824|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5606770|NCT03786783|Sargramostim|sargramostim|mesh-list
6466824|NCT00480675|Prednisolone|prednisolone|mesh-list
5539755|NCT04181203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5539756|NCT04180982|Febuxostat|febuxostat|mesh-list
5539757|NCT04180982|Gout Suppressants|gout suppressants|mesh-ancestor
5539758|NCT04180982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5539759|NCT04180943|Bupivacaine|bupivacaine|mesh-list
5539760|NCT04180943|Anesthetics, Local|anesthetics, local|mesh-ancestor
5539761|NCT04180943|Anesthetics|anesthetics|mesh-ancestor
5539762|NCT04180943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5539763|NCT04180943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539764|NCT04180943|Sensory System Agents|sensory system agents|mesh-ancestor
5539765|NCT04180943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5539766|NCT04181008|Amiloride|amiloride|mesh-list
5539767|NCT04181008|Diuretics|diuretics|mesh-ancestor
5539768|NCT04181008|Natriuretic Agents|natriuretic agents|mesh-ancestor
5539769|NCT04181008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539770|NCT04181008|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
5539771|NCT04181008|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5539772|NCT04181008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5539773|NCT04181008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539774|NCT04181008|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
5539775|NCT04181008|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5539776|NCT04180657|Protein C|protein c|mesh-list
5539777|NCT04180657|Anticoagulants|anticoagulants|mesh-ancestor
5539778|NCT04180657|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5539779|NCT04180657|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5539780|NCT04180657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539781|NCT04180397|Furosemide|furosemide|mesh-list
5539782|NCT04180397|Diuretics|diuretics|mesh-ancestor
5539783|NCT04180397|Natriuretic Agents|natriuretic agents|mesh-ancestor
5539784|NCT04180397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539785|NCT04180397|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5539786|NCT04180397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5539787|NCT04180397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539788|NCT04180384|Paclitaxel|paclitaxel|mesh-list
5539789|NCT04180384|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5539790|NCT04180384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5539791|NCT04180384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5539792|NCT04180384|Tubulin Modulators|tubulin modulators|mesh-ancestor
6466825|NCT00480675|Prednisolone acetate|prednisolone acetate|mesh-list
6466826|NCT00480675|Bupivacaine|bupivacaine|mesh-list
6466827|NCT00480675|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6466828|NCT00480675|Prednisolone phosphate|prednisolone phosphate|mesh-list
6466829|NCT00480675|Anesthetics, Local|anesthetics, local|mesh-ancestor
6466830|NCT00480675|Anesthetics|anesthetics|mesh-ancestor
6466831|NCT00480675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6466832|NCT00480675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466833|NCT00480675|Sensory System Agents|sensory system agents|mesh-ancestor
6466834|NCT00480675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6466835|NCT00480675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6466836|NCT00480675|Antiemetics|antiemetics|mesh-ancestor
6466837|NCT00480675|Autonomic Agents|autonomic agents|mesh-ancestor
6466838|NCT00480675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6466839|NCT00480675|Glucocorticoids|glucocorticoids|mesh-ancestor
6466840|NCT00480675|Hormones|hormones|mesh-ancestor
6466841|NCT00480675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6466842|NCT00480675|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6466843|NCT00480675|Protective Agents|protective agents|mesh-ancestor
6466844|NCT00480675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6466845|NCT00480675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6488470|NCT00584389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488471|NCT00584389|Hormones|hormones|mesh-ancestor
6488472|NCT00584389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6488473|NCT00584389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488474|NCT00584493|Tremelimumab|tremelimumab|mesh-list
5539793|NCT04180384|Antimitotic Agents|antimitotic agents|mesh-ancestor
5539794|NCT04180384|Mitosis Modulators|mitosis modulators|mesh-ancestor
5539795|NCT04180384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602165|NCT04895280|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5602166|NCT04895280|Ketorolac|ketorolac|mesh-list
5602167|NCT04895280|Bupivacaine|bupivacaine|mesh-list
6488475|NCT00584493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6488476|NCT00584532|Genistein|genistein|mesh-list
6488477|NCT00584532|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5602168|NCT04895280|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5539796|NCT04180085|Abatacept|abatacept|mesh-list
6135234|NCT01253824|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
6135235|NCT01253902|Bimatoprost|bimatoprost|mesh-list
6666379|NCT01522625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6666380|NCT01522625|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6666381|NCT01522625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6666382|NCT01522625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6666383|NCT01522625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666384|NCT01522625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6666385|NCT01522625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6666386|NCT01522677|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6666387|NCT01522677|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6666388|NCT01522677|Dermatologic Agents|dermatologic agents|mesh-ancestor
6666389|NCT01522729|Fentanyl|fentanyl|mesh-list
6135236|NCT01253902|Travoprost|travoprost|mesh-list
6135237|NCT01253902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6135238|NCT01253902|Latanoprost|latanoprost|mesh-list
6135239|NCT01253902|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6135240|NCT01253902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6135241|NCT01253980|Amoxicillin|amoxicillin|mesh-list
6135242|NCT01253980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6135243|NCT01253980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6135244|NCT01254045|Oxytocin|oxytocin|mesh-list
6135245|NCT01254045|Oxytocics|oxytocics|mesh-ancestor
6135246|NCT01254045|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6135247|NCT01254045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135248|NCT01254227|Deferasirox|deferasirox|mesh-list
6135249|NCT01254227|Deferoxamine|deferoxamine|mesh-list
6135250|NCT01254227|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6135251|NCT01254227|Chelating Agents|chelating agents|mesh-ancestor
6135252|NCT01254227|Sequestering Agents|sequestering agents|mesh-ancestor
6135253|NCT01254227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6135254|NCT01254227|Siderophores|siderophores|mesh-ancestor
6135255|NCT01254292|Levonorgestrel|levonorgestrel|mesh-list
6135256|NCT01254292|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6135257|NCT01254292|Contraceptive Agents|contraceptive agents|mesh-ancestor
6135258|NCT01254292|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6135259|NCT01254292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135260|NCT01254292|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6135261|NCT01254292|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5725510|NCT03180255|Autonomic Agents|autonomic agents|mesh-ancestor
5725511|NCT03180255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5725512|NCT03180255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466846|NCT00480753|Nitroglycerin|nitroglycerin|mesh-list
6466847|NCT00480753|Vasodilator Agents|vasodilator agents|mesh-ancestor
6466848|NCT00480844|Risperidone|risperidone|mesh-list
6466849|NCT00480844|Sertindole|sertindole|mesh-list
6466850|NCT00480844|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6466851|NCT00480844|Serotonin Agents|serotonin agents|mesh-ancestor
6466852|NCT00480844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6466853|NCT00480844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466854|NCT00480844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539797|NCT04180085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5539798|NCT04180085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539799|NCT04180085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5539800|NCT04180085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5539801|NCT04180085|Immunologic Factors|immunologic factors|mesh-ancestor
6466855|NCT00480844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6466856|NCT00480844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6466857|NCT00480844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6466858|NCT00480844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6466859|NCT00480844|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5539802|NCT04180085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539803|NCT04180085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6135262|NCT01254292|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6135263|NCT01254305|Milnacipran|milnacipran|mesh-list
6135264|NCT01254305|Sertraline|sertraline|mesh-list
5539804|NCT04180072|Bevacizumab|bevacizumab|mesh-list
5539805|NCT04180072|Atezolizumab|atezolizumab|mesh-list
5539806|NCT04180072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5539807|NCT04180072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6135265|NCT01254305|Fluoxetine|fluoxetine|mesh-list
6135266|NCT01254305|Paroxetine|paroxetine|mesh-list
6135267|NCT01254305|Citalopram|citalopram|mesh-list
6135268|NCT01254305|Levomilnacipran|levomilnacipran|mesh-list
6135269|NCT01254305|Antidepressive Agents|antidepressive agents|mesh-ancestor
6135270|NCT01254305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6466860|NCT00480844|Dopamine Agents|dopamine agents|mesh-ancestor
6466861|NCT00480870|Donepezil|donepezil|mesh-list
6135271|NCT01254305|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6135272|NCT01254305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6135273|NCT01254305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6135274|NCT01254305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6135275|NCT01254305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6135276|NCT01254305|Serotonin Agents|serotonin agents|mesh-ancestor
6135277|NCT01254305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135278|NCT01254305|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6135279|NCT01254305|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6135280|NCT01254305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6135281|NCT01254305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6135282|NCT01254305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6135283|NCT01254305|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6135284|NCT01254305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6135285|NCT01254305|Analgesics|analgesics|mesh-ancestor
6135286|NCT01254305|Sensory System Agents|sensory system agents|mesh-ancestor
6135287|NCT01254344|Metronidazole|metronidazole|mesh-list
6135288|NCT01254344|Ceftriaxone|ceftriaxone|mesh-list
6135289|NCT01254344|Ertapenem|ertapenem|mesh-list
6466862|NCT00480870|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6466863|NCT00480870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6466864|NCT00480870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466865|NCT00480870|Cholinergic Agents|cholinergic agents|mesh-ancestor
6466866|NCT00480870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6466867|NCT00480870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466868|NCT00480870|Nootropic Agents|nootropic agents|mesh-ancestor
6466869|NCT00480883|Meglumine Antimoniate|meglumine antimoniate|mesh-list
6466870|NCT00480883|Allopurinol|allopurinol|mesh-list
6466871|NCT00480883|Antimetabolites|antimetabolites|mesh-ancestor
6466872|NCT00480883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466873|NCT00480883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6466874|NCT00480883|Gout Suppressants|gout suppressants|mesh-ancestor
6466875|NCT00480883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6466876|NCT00480883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6466877|NCT00480883|Antioxidants|antioxidants|mesh-ancestor
6466878|NCT00480883|Protective Agents|protective agents|mesh-ancestor
6466879|NCT00480883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466880|NCT00480883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6466881|NCT00480883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6466882|NCT00480883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6135290|NCT01254344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6135291|NCT01254344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6135292|NCT01254344|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6135293|NCT01254344|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6135294|NCT01254396|Sildenafil Citrate|sildenafil citrate|mesh-list
6135295|NCT01254396|Vasodilator Agents|vasodilator agents|mesh-ancestor
6135296|NCT01254396|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6135297|NCT01254396|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6135298|NCT01254396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6135299|NCT01254396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6135300|NCT01254396|Urological Agents|urological agents|mesh-ancestor
6466883|NCT00480896|Tacrolimus|tacrolimus|mesh-list
6466884|NCT00480896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6466885|NCT00480896|Immunologic Factors|immunologic factors|mesh-ancestor
6466886|NCT00480896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466887|NCT00480896|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6466888|NCT00480896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6466889|NCT00480896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466890|NCT00480935|Sunitinib|sunitinib|mesh-list
6466891|NCT00480935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6466892|NCT00480935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6466893|NCT00480935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6466894|NCT00480935|Growth Substances|growth substances|mesh-ancestor
6135301|NCT01254422|Vaccines|vaccines|mesh-list
6135302|NCT01254422|Immunologic Factors|immunologic factors|mesh-ancestor
6135303|NCT01254422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135304|NCT01254552|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
6135305|NCT01254552|Chelating Agents|chelating agents|mesh-ancestor
6135306|NCT01254552|Sequestering Agents|sequestering agents|mesh-ancestor
6135307|NCT01254552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6135308|NCT01254604|Timolol|timolol|mesh-list
6135309|NCT01254604|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6135310|NCT01254604|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6135311|NCT01254604|Adrenergic Agents|adrenergic agents|mesh-ancestor
6135312|NCT01254604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6135313|NCT01254604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6135314|NCT01254604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135315|NCT01254604|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6135316|NCT01254604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6135317|NCT01254630|Vaccines|vaccines|mesh-list
6466895|NCT00480935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539808|NCT04180072|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5539809|NCT04180072|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5539810|NCT04180072|Growth Substances|growth substances|mesh-ancestor
5539811|NCT04180072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539812|NCT04180072|Growth Inhibitors|growth inhibitors|mesh-ancestor
5539813|NCT04180150|Entecavir|entecavir|mesh-list
5539814|NCT04180150|Antiviral Agents|antiviral agents|mesh-ancestor
5539815|NCT04180150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5539816|NCT04180007|Apatinib|apatinib|mesh-list
5539817|NCT04180007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5539818|NCT04180007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5539819|NCT04180007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5539820|NCT04180007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539821|NCT04179747|Sildenafil Citrate|sildenafil citrate|mesh-list
5539822|NCT04179747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539823|NCT04179747|Vasodilator Agents|vasodilator agents|mesh-ancestor
5539824|NCT04179747|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5539825|NCT04179747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5539826|NCT04179747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5539827|NCT04179747|Urological Agents|urological agents|mesh-ancestor
5539828|NCT04179942|Nitric Oxide|nitric oxide|mesh-list
5539829|NCT04179942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6466896|NCT00480935|Growth Inhibitors|growth inhibitors|mesh-ancestor
6466897|NCT00480935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6466898|NCT00480935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6466899|NCT00480935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466900|NCT00481013|Valproic Acid|valproic acid|mesh-list
6466901|NCT00481013|Anticonvulsants|anticonvulsants|mesh-ancestor
6466902|NCT00481013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6466903|NCT00481013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466904|NCT00481013|GABA Agents|gaba agents|mesh-ancestor
6466905|NCT00481013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6466906|NCT00481013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466907|NCT00481013|Antimanic Agents|antimanic agents|mesh-ancestor
6466908|NCT00481013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6466909|NCT00481013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6466910|NCT00481013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6466911|NCT00481091|Navitoclax|navitoclax|mesh-list
6466912|NCT00481091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5539830|NCT04179942|Autonomic Agents|autonomic agents|mesh-ancestor
5539831|NCT04179942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5539832|NCT04179942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539833|NCT04179942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5539834|NCT04179942|Respiratory System Agents|respiratory system agents|mesh-ancestor
5539835|NCT04179942|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5539836|NCT04179942|Antioxidants|antioxidants|mesh-ancestor
5539837|NCT04179942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539838|NCT04179942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5539839|NCT04179942|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5539840|NCT04179942|Vasodilator Agents|vasodilator agents|mesh-ancestor
5539841|NCT04179942|Gasotransmitters|gasotransmitters|mesh-ancestor
5539842|NCT04179942|Protective Agents|protective agents|mesh-ancestor
5539843|NCT04179604|Simendan|simendan|mesh-list
5539844|NCT04179604|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5539845|NCT04179604|Vasodilator Agents|vasodilator agents|mesh-ancestor
5539846|NCT04179604|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6135318|NCT01254630|Immunologic Factors|immunologic factors|mesh-ancestor
6135319|NCT01254630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466913|NCT00481143|Deferasirox|deferasirox|mesh-list
5539847|NCT04179604|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6135320|NCT01254656|Efavirenz|efavirenz|mesh-list
6135321|NCT01254656|Etravirine|etravirine|mesh-list
6135322|NCT01254656|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6135323|NCT01254656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6135324|NCT01254656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6135325|NCT01254656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539848|NCT04179604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6135326|NCT01254656|Antiviral Agents|antiviral agents|mesh-ancestor
6135327|NCT01254656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6135328|NCT01254656|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6135329|NCT01254656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6135330|NCT01254656|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6135331|NCT01254656|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6135332|NCT01254656|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6135333|NCT01254656|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6135334|NCT01254669|Vaccines|vaccines|mesh-list
6135335|NCT01254669|Immunologic Factors|immunologic factors|mesh-ancestor
6135336|NCT01254669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135337|NCT01254721|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6135338|NCT01254721|Antidepressive Agents|antidepressive agents|mesh-ancestor
6135339|NCT01254721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6135340|NCT01254721|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6135341|NCT01254721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6135342|NCT01254721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6135343|NCT01254721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135344|NCT01254877|Ondansetron|ondansetron|mesh-list
6135345|NCT01254877|Antiemetics|antiemetics|mesh-ancestor
6135346|NCT01254877|Autonomic Agents|autonomic agents|mesh-ancestor
6135347|NCT01254877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6135348|NCT01254877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135349|NCT01254877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6135350|NCT01254877|Antipruritics|antipruritics|mesh-ancestor
6135351|NCT01254877|Dermatologic Agents|dermatologic agents|mesh-ancestor
6135352|NCT01254877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6135353|NCT01254877|Serotonin Agents|serotonin agents|mesh-ancestor
6135354|NCT01254877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6135355|NCT01254877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6135356|NCT01254877|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6135357|NCT01254877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6135358|NCT01254877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6135359|NCT01254877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6135360|NCT01254877|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6135361|NCT01254890|Sorafenib|sorafenib|mesh-list
6135362|NCT01254890|Azacitidine|azacitidine|mesh-list
6135363|NCT01254890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6135364|NCT01254890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6135365|NCT01254890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6135366|NCT01254890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6135367|NCT01254890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6135368|NCT01254890|Antimetabolites|antimetabolites|mesh-ancestor
6135369|NCT01255137|Axitinib|axitinib|mesh-list
6135370|NCT01255137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6135371|NCT01255137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6135372|NCT01255137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6135373|NCT01255137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6135374|NCT01255163|Exenatide|exenatide|mesh-list
6135375|NCT01255163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6135376|NCT01255163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135377|NCT01255163|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6135378|NCT01255163|Incretins|incretins|mesh-ancestor
6135379|NCT01255163|Hormones|hormones|mesh-ancestor
6135380|NCT01255163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6135381|NCT01255306|Brimonidine Tartrate|brimonidine tartrate|mesh-list
5539849|NCT04179604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539850|NCT04179604|Protective Agents|protective agents|mesh-ancestor
5539851|NCT04179604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539852|NCT04179500|Moxifloxacin|moxifloxacin|mesh-list
5539853|NCT04179500|Pyrazinamide|pyrazinamide|mesh-list
5539854|NCT04179500|Bedaquiline|bedaquiline|mesh-list
6135382|NCT01255306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6135383|NCT01255306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5539855|NCT04179500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5539856|NCT04179500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5539857|NCT04179500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5539858|NCT04179500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5539859|NCT04179500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5539860|NCT04179500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539861|NCT04179500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5539862|NCT04179500|Antitubercular Agents|antitubercular agents|mesh-ancestor
5539863|NCT04179513|Methotrexate|methotrexate|mesh-list
5539864|NCT04179513|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6135384|NCT01255306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6135385|NCT01255306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6135386|NCT01255306|Adrenergic Agents|adrenergic agents|mesh-ancestor
6135387|NCT01255306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6135388|NCT01255306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6135389|NCT01255306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135390|NCT01255423|Diclofenac|diclofenac|mesh-list
6135391|NCT01255423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6135392|NCT01255423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6135393|NCT01255423|Analgesics|analgesics|mesh-ancestor
6135394|NCT01255423|Sensory System Agents|sensory system agents|mesh-ancestor
6135395|NCT01255423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6135396|NCT01255423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135397|NCT01255423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6135398|NCT01255423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6135399|NCT01255423|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6135400|NCT01255423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6135401|NCT01255423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6135402|NCT01255449|Albuterol|albuterol|mesh-list
6135403|NCT01255449|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6135404|NCT01255449|Autonomic Agents|autonomic agents|mesh-ancestor
6135405|NCT01255449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6466914|NCT00481143|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6466915|NCT00481143|Chelating Agents|chelating agents|mesh-ancestor
6466916|NCT00481143|Sequestering Agents|sequestering agents|mesh-ancestor
6466917|NCT00481143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466918|NCT00481169|Bazedoxifene|bazedoxifene|mesh-list
6135406|NCT01255449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135407|NCT01255449|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6135408|NCT01255449|Respiratory System Agents|respiratory system agents|mesh-ancestor
6135409|NCT01255449|Tocolytic Agents|tocolytic agents|mesh-ancestor
6135410|NCT01255449|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6135411|NCT01255449|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6135412|NCT01255449|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6135413|NCT01255449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6135414|NCT01255449|Adrenergic Agents|adrenergic agents|mesh-ancestor
6135415|NCT01255449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6466919|NCT00481169|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6466920|NCT00481169|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6466921|NCT00481169|Hormone Antagonists|hormone antagonists|mesh-ancestor
6466922|NCT00481169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6466923|NCT00481169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488478|NCT00584532|Protective Agents|protective agents|mesh-ancestor
5539865|NCT04179513|Abortifacient Agents|abortifacient agents|mesh-ancestor
6135416|NCT01255449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6135417|NCT01255670|Metronidazole|metronidazole|mesh-list
6135418|NCT01255670|Penicillins|penicillins|mesh-list
6135419|NCT01255670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6135420|NCT01255670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6135421|NCT01255670|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6135422|NCT01255670|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6135423|NCT01255761|Certolizumab Pegol|certolizumab pegol|mesh-list
6135424|NCT01255761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6135425|NCT01255761|Immunologic Factors|immunologic factors|mesh-ancestor
6135426|NCT01255761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135427|NCT01255761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6135428|NCT01255787|Vortioxetine|vortioxetine|mesh-list
6135429|NCT01255787|Antidepressive Agents|antidepressive agents|mesh-ancestor
5539866|NCT04179513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5539867|NCT04179513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539868|NCT04179513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6135430|NCT01255787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6135431|NCT01255787|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6135432|NCT01255787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6135433|NCT01255787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6135434|NCT01255787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135435|NCT01255787|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6135436|NCT01255787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6135437|NCT01255787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6135438|NCT01255787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6135439|NCT01255787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6135440|NCT01255787|Serotonin Agents|serotonin agents|mesh-ancestor
6205219|NCT02083107|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6135441|NCT01255787|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6135442|NCT01255787|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6135443|NCT01255787|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6666390|NCT01522729|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6666391|NCT01522729|Narcotics|narcotics|mesh-ancestor
6666392|NCT01522729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6666393|NCT01522729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666394|NCT01522729|Analgesics|analgesics|mesh-ancestor
6666395|NCT01522729|Sensory System Agents|sensory system agents|mesh-ancestor
5539869|NCT04179513|Antimetabolites|antimetabolites|mesh-ancestor
5539870|NCT04179513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539871|NCT04179513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5539872|NCT04179513|Dermatologic Agents|dermatologic agents|mesh-ancestor
5539873|NCT04179513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5539874|NCT04179513|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5539875|NCT04179513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5539876|NCT04179513|Immunologic Factors|immunologic factors|mesh-ancestor
5539877|NCT04179513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5539878|NCT04179513|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5539879|NCT04179617|Nicotine|nicotine|mesh-list
5539880|NCT04179617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5539881|NCT04179617|Autonomic Agents|autonomic agents|mesh-ancestor
5539882|NCT04179617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5539883|NCT04179617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539884|NCT04179617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5539885|NCT04179617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5539886|NCT04179617|Cholinergic Agents|cholinergic agents|mesh-ancestor
5539887|NCT04179617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5539888|NCT04179617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539889|NCT04179071|Famotidine|famotidine|mesh-list
5539890|NCT04179071|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5539891|NCT04179071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5539892|NCT04179071|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5539893|NCT04179071|Histamine Antagonists|histamine antagonists|mesh-ancestor
5539894|NCT04179071|Histamine Agents|histamine agents|mesh-ancestor
5539895|NCT04179071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5539896|NCT04179071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539897|NCT04179071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539898|NCT04178863|Timolol|timolol|mesh-list
5539899|NCT04178863|Latanoprost|latanoprost|mesh-list
5539900|NCT04178863|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5539901|NCT04178863|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5539902|NCT04178863|Adrenergic Agents|adrenergic agents|mesh-ancestor
5539903|NCT04178863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5539904|NCT04178863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539905|NCT04178863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539906|NCT04178863|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5539907|NCT04178863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5539908|NCT04178863|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5539909|NCT04178863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5539910|NCT04179045|Sirolimus|sirolimus|mesh-list
6135444|NCT01255787|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6135445|NCT01255904|Dexmedetomidine|dexmedetomidine|mesh-list
6135446|NCT01255904|Chloral Hydrate|chloral hydrate|mesh-list
6135447|NCT01255904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6135448|NCT01255904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6135449|NCT01255904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135450|NCT01255904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6135451|NCT01255904|Analgesics|analgesics|mesh-ancestor
6135452|NCT01255904|Sensory System Agents|sensory system agents|mesh-ancestor
6135453|NCT01255904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6135454|NCT01255904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6135455|NCT01255904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6135456|NCT01255904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6135457|NCT01255904|Adrenergic Agents|adrenergic agents|mesh-ancestor
6135458|NCT01255904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6135459|NCT01255904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6135460|NCT01256060|Oxytocin|oxytocin|mesh-list
6135461|NCT01256060|Oxytocics|oxytocics|mesh-ancestor
6135462|NCT01256060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6135463|NCT01256060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135464|NCT01256164|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
5539911|NCT04179045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6466924|NCT00481169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6466925|NCT00481182|Ritonavir|ritonavir|mesh-list
6466926|NCT00481182|Fosamprenavir|fosamprenavir|mesh-list
6466927|NCT00481182|Methadone|methadone|mesh-list
6466928|NCT00481182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6466929|NCT00481182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6466930|NCT00481182|Protease Inhibitors|protease inhibitors|mesh-ancestor
6466931|NCT00481182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6466932|NCT00481182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466933|NCT00481182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6466934|NCT00481182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6466935|NCT00481182|Antiviral Agents|antiviral agents|mesh-ancestor
6466936|NCT00481182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6466937|NCT00481182|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6466938|NCT00481182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6466939|NCT00481182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6466940|NCT00481182|Narcotics|narcotics|mesh-ancestor
5539912|NCT04179045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5539913|NCT04179045|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5539914|NCT04179045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6466941|NCT00481182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6466942|NCT00481182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466943|NCT00481182|Analgesics|analgesics|mesh-ancestor
6466944|NCT00481182|Sensory System Agents|sensory system agents|mesh-ancestor
6466945|NCT00481182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6466946|NCT00481182|Antitussive Agents|antitussive agents|mesh-ancestor
6466947|NCT00481182|Respiratory System Agents|respiratory system agents|mesh-ancestor
6466948|NCT00481273|Azacitidine|azacitidine|mesh-list
6466949|NCT00481273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6466950|NCT00481273|Antimetabolites|antimetabolites|mesh-ancestor
6466951|NCT00481273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466952|NCT00481273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6466953|NCT00481273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6466954|NCT00481312|Midazolam|midazolam|mesh-list
6466955|NCT00481312|Dexmedetomidine|dexmedetomidine|mesh-list
6466956|NCT00481312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6466957|NCT00481312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6466958|NCT00481312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466959|NCT00481312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6466960|NCT00481312|Analgesics|analgesics|mesh-ancestor
6135465|NCT01256164|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
6135466|NCT01256164|Hemostatics|hemostatics|mesh-ancestor
6135467|NCT01256164|Coagulants|coagulants|mesh-ancestor
6135468|NCT01256177|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6135469|NCT01256177|Antidepressive Agents|antidepressive agents|mesh-ancestor
6135470|NCT01256177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6135471|NCT01256177|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6135472|NCT01256177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6135473|NCT01256177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6466961|NCT00481312|Sensory System Agents|sensory system agents|mesh-ancestor
6466962|NCT00481312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6466963|NCT00481312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6466964|NCT00481312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6466965|NCT00481312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6466966|NCT00481312|Adrenergic Agents|adrenergic agents|mesh-ancestor
6466967|NCT00481312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6466968|NCT00481312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466969|NCT00481312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6466970|NCT00481312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6466971|NCT00481312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6466972|NCT00481312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6466973|NCT00481312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6466974|NCT00481312|Anesthetics, General|anesthetics, general|mesh-ancestor
6466975|NCT00481312|Anesthetics|anesthetics|mesh-ancestor
6466976|NCT00481312|GABA Modulators|gaba modulators|mesh-ancestor
6466977|NCT00481312|GABA Agents|gaba agents|mesh-ancestor
6466978|NCT00481364|Atorvastatin|atorvastatin|mesh-list
6466979|NCT00481364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6466980|NCT00481364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6466981|NCT00481364|Antimetabolites|antimetabolites|mesh-ancestor
6466982|NCT00481364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6466983|NCT00481364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6466984|NCT00481364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5539915|NCT04179045|Antifungal Agents|antifungal agents|mesh-ancestor
6466985|NCT00481364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6466986|NCT00481429|Rosiglitazone|rosiglitazone|mesh-list
6466987|NCT00481429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6466988|NCT00481429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466989|NCT00481442|Phenylephrine|phenylephrine|mesh-list
6466990|NCT00481442|Oxymetazoline|oxymetazoline|mesh-list
6466991|NCT00481442|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6466992|NCT00481442|Mydriatics|mydriatics|mesh-ancestor
6466993|NCT00481442|Autonomic Agents|autonomic agents|mesh-ancestor
6466994|NCT00481442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6466995|NCT00481442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6466996|NCT00481442|Sympathomimetics|sympathomimetics|mesh-ancestor
6466997|NCT00481442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6466998|NCT00481442|Nasal Decongestants|nasal decongestants|mesh-ancestor
6466999|NCT00481442|Respiratory System Agents|respiratory system agents|mesh-ancestor
6467000|NCT00481442|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6467001|NCT00481442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6467002|NCT00481442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6666396|NCT01522729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6666397|NCT01522729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6666398|NCT01522729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6135474|NCT01256177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135475|NCT01256190|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6135476|NCT01256190|Fibrin Foam|fibrin foam|mesh-list
6135477|NCT01256190|Hemostatics|hemostatics|mesh-ancestor
6135478|NCT01256190|Coagulants|coagulants|mesh-ancestor
6135479|NCT01256294|Tacrolimus|tacrolimus|mesh-list
6135480|NCT01256294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6135481|NCT01256294|Immunologic Factors|immunologic factors|mesh-ancestor
6135482|NCT01256294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135483|NCT01256294|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6135484|NCT01256294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6135485|NCT01256294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666399|NCT01522729|Anesthetics, General|anesthetics, general|mesh-ancestor
6666400|NCT01522729|Anesthetics|anesthetics|mesh-ancestor
6135486|NCT01256385|Sirolimus|sirolimus|mesh-list
6467003|NCT00481442|Adrenergic Agents|adrenergic agents|mesh-ancestor
6467004|NCT00481442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6467005|NCT00481442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467006|NCT00481442|Protective Agents|protective agents|mesh-ancestor
6467007|NCT00481455|Temozolomide|temozolomide|mesh-list
6467008|NCT00481455|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
6467009|NCT00481455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6467010|NCT00481455|Alkylating Agents|alkylating agents|mesh-ancestor
6467011|NCT00481455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467012|NCT00481455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6135487|NCT01256385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6135488|NCT01256385|Cetuximab|cetuximab|mesh-list
6135489|NCT01256385|Antibodies|antibodies|mesh-list
6135490|NCT01256385|Immunoglobulins|immunoglobulins|mesh-list
6135491|NCT01256385|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6135492|NCT01256385|Immunologic Factors|immunologic factors|mesh-ancestor
6135493|NCT01256385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135494|NCT01256385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6135495|NCT01256385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6135496|NCT01256385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6135497|NCT01256385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6135498|NCT01256385|Antifungal Agents|antifungal agents|mesh-ancestor
6135499|NCT01256385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6135500|NCT01256398|Calcium, Dietary|calcium, dietary|mesh-list
6135501|NCT01256398|Leucovorin|leucovorin|mesh-list
6135502|NCT01256398|Folic Acid|folic acid|mesh-list
6135503|NCT01256398|Cytarabine|cytarabine|mesh-list
6135504|NCT01256398|Dexamethasone|dexamethasone|mesh-list
6135505|NCT01256398|Dexamethasone acetate|dexamethasone acetate|mesh-list
6135506|NCT01256398|Cyclophosphamide|cyclophosphamide|mesh-list
6467013|NCT00481455|Tubulin Modulators|tubulin modulators|mesh-ancestor
6467014|NCT00481455|Antimitotic Agents|antimitotic agents|mesh-ancestor
6467015|NCT00481455|Mitosis Modulators|mitosis modulators|mesh-ancestor
6467016|NCT00481481|Tacrolimus|tacrolimus|mesh-list
6467017|NCT00481481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6135507|NCT01256398|Melphalan|melphalan|mesh-list
6135508|NCT01256398|Mechlorethamine|mechlorethamine|mesh-list
6135509|NCT01256398|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
6467018|NCT00481481|Immunologic Factors|immunologic factors|mesh-ancestor
6467019|NCT00481481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467020|NCT00481481|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6666401|NCT01522768|Paclitaxel|paclitaxel|mesh-list
6135510|NCT01256398|Methotrexate|methotrexate|mesh-list
6135511|NCT01256398|Fludarabine|fludarabine|mesh-list
6135512|NCT01256398|Fludarabine phosphate|fludarabine phosphate|mesh-list
6666402|NCT01522768|Afatinib|afatinib|mesh-list
5539916|NCT04179045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5539917|NCT04179045|Immunologic Factors|immunologic factors|mesh-ancestor
5539918|NCT04179045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539919|NCT04179006|Antidepressive Agents|antidepressive agents|mesh-list
5539920|NCT04179006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5539921|NCT04178980|Simvastatin|simvastatin|mesh-list
5539922|NCT04178980|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5539923|NCT04178980|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5539924|NCT04178980|Antimetabolites|antimetabolites|mesh-ancestor
5539925|NCT04178980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6135513|NCT01256398|Etoposide|etoposide|mesh-list
6135514|NCT01256398|Vincristine|vincristine|mesh-list
6135515|NCT01256398|Daunorubicin|daunorubicin|mesh-list
6135516|NCT01256398|Dasatinib|dasatinib|mesh-list
6135517|NCT01256398|Mercaptopurine|mercaptopurine|mesh-list
6135518|NCT01256398|Alemtuzumab|alemtuzumab|mesh-list
6135519|NCT01256398|Etoposide phosphate|etoposide phosphate|mesh-list
6135520|NCT01256398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6135521|NCT01256398|Tacrolimus|tacrolimus|mesh-list
6135522|NCT01256398|Antibodies|antibodies|mesh-list
6135523|NCT01256398|Immunoglobulins|immunoglobulins|mesh-list
6135524|NCT01256398|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6135525|NCT01256398|Lenograstim|lenograstim|mesh-list
5539926|NCT04178980|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5539927|NCT04178980|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5539928|NCT04178980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5539929|NCT04178850|Folic Acid|folic acid|mesh-list
5539930|NCT04178850|Vitamin B Complex|vitamin b complex|mesh-list
5539931|NCT04178850|Infliximab|infliximab|mesh-list
6135526|NCT01256398|BB 1101|bb 1101|mesh-list
6135527|NCT01256398|Calcium|calcium|mesh-list
6135528|NCT01256398|Levoleucovorin|levoleucovorin|mesh-list
6135529|NCT01256398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6135530|NCT01256398|Immunologic Factors|immunologic factors|mesh-ancestor
6135531|NCT01256398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135532|NCT01256398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6135533|NCT01256398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6135534|NCT01256398|Alkylating Agents|alkylating agents|mesh-ancestor
6135535|NCT01256398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6135536|NCT01256398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6135537|NCT01256398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6467021|NCT00481481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6467022|NCT00481481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467023|NCT00481533|Oxytocin|oxytocin|mesh-list
6467024|NCT00481533|Ergonovine|ergonovine|mesh-list
6467025|NCT00481533|Oxytocics|oxytocics|mesh-ancestor
6467026|NCT00481533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6467027|NCT00481533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467028|NCT00481572|Terlipressin|terlipressin|mesh-list
6467029|NCT00481572|Vasopressins|vasopressins|mesh-list
5539932|NCT04178850|Dermatologic Agents|dermatologic agents|mesh-ancestor
6135538|NCT01256398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6135539|NCT01256398|Antiemetics|antiemetics|mesh-ancestor
6135540|NCT01256398|Autonomic Agents|autonomic agents|mesh-ancestor
5539933|NCT04178850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5539934|NCT04178850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5539935|NCT04178850|Hematinics|hematinics|mesh-ancestor
5539936|NCT04178850|Vitamins|vitamins|mesh-ancestor
5539937|NCT04178850|Micronutrients|micronutrients|mesh-ancestor
5539938|NCT04178850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539939|NCT04178876|Ethanol|ethanol|mesh-list
5539940|NCT04178876|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5539941|NCT04178876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5539942|NCT04178876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5539943|NCT04178876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539944|NCT04178655|Tranexamic Acid|tranexamic acid|mesh-list
5539945|NCT04178655|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5539946|NCT04178655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5539947|NCT04178655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539948|NCT04178655|Hemostatics|hemostatics|mesh-ancestor
5539949|NCT04178655|Coagulants|coagulants|mesh-ancestor
5539950|NCT04178785|Remifentanil|remifentanil|mesh-list
6135541|NCT01256398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5539951|NCT04178785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5539952|NCT04178785|Narcotics|narcotics|mesh-ancestor
6135542|NCT01256398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6135543|NCT01256398|Glucocorticoids|glucocorticoids|mesh-ancestor
6135544|NCT01256398|Hormones|hormones|mesh-ancestor
6135545|NCT01256398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6467030|NCT00481572|Arginine Vasopressin|arginine vasopressin|mesh-list
5539953|NCT04178785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5539954|NCT04178785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5539955|NCT04178785|Analgesics|analgesics|mesh-ancestor
5539956|NCT04178785|Sensory System Agents|sensory system agents|mesh-ancestor
5539957|NCT04178785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5539958|NCT04178642|Idarubicin|idarubicin|mesh-list
5539959|NCT04178642|Ethiodized Oil|ethiodized oil|mesh-list
5539960|NCT04178642|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5539961|NCT04178642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6135546|NCT01256398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6135547|NCT01256398|Protease Inhibitors|protease inhibitors|mesh-ancestor
6135548|NCT01256398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6135549|NCT01256398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6135550|NCT01256398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6135551|NCT01256398|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6135552|NCT01256398|Abortifacient Agents|abortifacient agents|mesh-ancestor
6135553|NCT01256398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6135554|NCT01256398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6135555|NCT01256398|Antimetabolites|antimetabolites|mesh-ancestor
6135556|NCT01256398|Dermatologic Agents|dermatologic agents|mesh-ancestor
6135557|NCT01256398|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6135558|NCT01256398|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6135559|NCT01256398|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6135560|NCT01256398|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6135561|NCT01256398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6135562|NCT01256398|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6135563|NCT01256398|Antiviral Agents|antiviral agents|mesh-ancestor
6135564|NCT01256398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6135565|NCT01256398|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6135566|NCT01256398|Antidotes|antidotes|mesh-ancestor
6135567|NCT01256398|Protective Agents|protective agents|mesh-ancestor
6135568|NCT01256398|Vitamin B Complex|vitamin b complex|mesh-ancestor
5539962|NCT04178642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5539963|NCT04178642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5539964|NCT04178642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5539965|NCT04178642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602169|NCT04895280|Anesthetics, Local|anesthetics, local|mesh-ancestor
5602170|NCT04895280|Anesthetics|anesthetics|mesh-ancestor
5602171|NCT04895280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5602172|NCT04895280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602173|NCT04895280|Sensory System Agents|sensory system agents|mesh-ancestor
5602174|NCT04895280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5602175|NCT04895280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5602176|NCT04895280|Glucocorticoids|glucocorticoids|mesh-ancestor
5602177|NCT04895280|Hormones|hormones|mesh-ancestor
6135569|NCT01256398|Vitamins|vitamins|mesh-ancestor
6135570|NCT01256398|Micronutrients|micronutrients|mesh-ancestor
6135571|NCT01256398|Tubulin Modulators|tubulin modulators|mesh-ancestor
6135572|NCT01256398|Antimitotic Agents|antimitotic agents|mesh-ancestor
6135573|NCT01256398|Mitosis Modulators|mitosis modulators|mesh-ancestor
6135574|NCT01256398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6135575|NCT01256398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6135576|NCT01256398|Hematinics|hematinics|mesh-ancestor
6135577|NCT01256411|Amlodipine|amlodipine|mesh-list
6135578|NCT01256411|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6135579|NCT01256411|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
6135580|NCT01256411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6135581|NCT01256411|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6135582|NCT01256411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6135583|NCT01256411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6135584|NCT01256411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6135585|NCT01256411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467031|NCT00481572|Norepinephrine|norepinephrine|mesh-list
6467032|NCT00481572|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6467033|NCT00481572|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5602178|NCT04895280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5602179|NCT04895280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5602180|NCT04895280|Immunologic Factors|immunologic factors|mesh-ancestor
5602181|NCT04895280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5602182|NCT04895280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602183|NCT04895280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5602184|NCT04895280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5602185|NCT04895280|Analgesics|analgesics|mesh-ancestor
6467034|NCT00481572|Adrenergic Agents|adrenergic agents|mesh-ancestor
6467035|NCT00481572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6467036|NCT00481572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467037|NCT00481572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467038|NCT00481572|Sympathomimetics|sympathomimetics|mesh-ancestor
6467039|NCT00481572|Autonomic Agents|autonomic agents|mesh-ancestor
6467040|NCT00481572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6467041|NCT00481572|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6467042|NCT00481572|Hemostatics|hemostatics|mesh-ancestor
6467043|NCT00481572|Coagulants|coagulants|mesh-ancestor
6135586|NCT01256411|Vasodilator Agents|vasodilator agents|mesh-ancestor
6135587|NCT01256411|Diuretics|diuretics|mesh-ancestor
6135588|NCT01256411|Natriuretic Agents|natriuretic agents|mesh-ancestor
5539966|NCT04178291|Erythritol|erythritol|mesh-list
5539967|NCT04178291|Vasodilator Agents|vasodilator agents|mesh-ancestor
5539968|NCT04178512|Dexamethasone|dexamethasone|mesh-list
5539969|NCT04178512|Dexamethasone acetate|dexamethasone acetate|mesh-list
5539970|NCT04178512|Fentanyl|fentanyl|mesh-list
5539971|NCT04178512|BB 1101|bb 1101|mesh-list
5539972|NCT04178512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5539973|NCT04178512|Antiemetics|antiemetics|mesh-ancestor
5539974|NCT04178512|Autonomic Agents|autonomic agents|mesh-ancestor
5539975|NCT04178512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5539976|NCT04178512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135589|NCT01256411|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6135590|NCT01256411|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6135591|NCT01256450|Buprenorphine|buprenorphine|mesh-list
6467044|NCT00481572|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6467045|NCT00481572|Natriuretic Agents|natriuretic agents|mesh-ancestor
6467046|NCT00481572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6467047|NCT00481624|Epoetin Alfa|epoetin alfa|mesh-list
6467048|NCT00481624|Ferric gluconate|ferric gluconate|mesh-list
6467049|NCT00481624|Hematinics|hematinics|mesh-ancestor
6135592|NCT01256450|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6135593|NCT01256450|Narcotics|narcotics|mesh-ancestor
6135594|NCT01256450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6135595|NCT01256450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135596|NCT01256450|Analgesics|analgesics|mesh-ancestor
6135597|NCT01256450|Sensory System Agents|sensory system agents|mesh-ancestor
6135598|NCT01256450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6135599|NCT01256450|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6135600|NCT01256476|Pravastatin|pravastatin|mesh-list
6135601|NCT01256476|Pitavastatin|pitavastatin|mesh-list
6135602|NCT01256476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6135603|NCT01256476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6135604|NCT01256476|Antimetabolites|antimetabolites|mesh-ancestor
6135605|NCT01256476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6135606|NCT01256476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6135607|NCT01256476|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6135608|NCT01256476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6135609|NCT01256567|Docetaxel|docetaxel|mesh-list
6135610|NCT01256567|Ramucirumab|ramucirumab|mesh-list
6135611|NCT01256567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6135612|NCT01256567|Tubulin Modulators|tubulin modulators|mesh-ancestor
6135613|NCT01256567|Antimitotic Agents|antimitotic agents|mesh-ancestor
6135614|NCT01256567|Mitosis Modulators|mitosis modulators|mesh-ancestor
6467050|NCT00481663|Metformin|metformin|mesh-list
6467051|NCT00481663|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6467052|NCT00481663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6135615|NCT01256567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6135616|NCT01256593|Pregabalin|pregabalin|mesh-list
5539977|NCT04178512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5539978|NCT04178512|Glucocorticoids|glucocorticoids|mesh-ancestor
5539979|NCT04178512|Hormones|hormones|mesh-ancestor
5539980|NCT04178512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5539981|NCT04178512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5539982|NCT04178512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5539983|NCT04178512|Protease Inhibitors|protease inhibitors|mesh-ancestor
5539984|NCT04178512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5539985|NCT04178512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5539986|NCT04178512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5539987|NCT04178512|Narcotics|narcotics|mesh-ancestor
5539988|NCT04178512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5539989|NCT04178512|Analgesics|analgesics|mesh-ancestor
5539990|NCT04178512|Sensory System Agents|sensory system agents|mesh-ancestor
5539991|NCT04178512|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6135617|NCT01256593|Analgesics|analgesics|mesh-ancestor
6467053|NCT00481663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135618|NCT01256593|Sensory System Agents|sensory system agents|mesh-ancestor
6135619|NCT01256593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6135620|NCT01256593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467054|NCT00481663|Incretins|incretins|mesh-ancestor
6467055|NCT00481663|Hormones|hormones|mesh-ancestor
6467056|NCT00481663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6467057|NCT00481663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6467058|NCT00481663|Protease Inhibitors|protease inhibitors|mesh-ancestor
5539992|NCT04178512|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5539993|NCT04178512|Anesthetics, General|anesthetics, general|mesh-ancestor
5539994|NCT04178512|Anesthetics|anesthetics|mesh-ancestor
5539995|NCT04178148|Amikacin|amikacin|mesh-list
5539996|NCT04178148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5539997|NCT04178148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5539998|NCT04178200|Lidocaine|lidocaine|mesh-list
5539999|NCT04178200|Bupivacaine|bupivacaine|mesh-list
5540000|NCT04178200|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5540001|NCT04178200|Anesthetics, Local|anesthetics, local|mesh-ancestor
5540002|NCT04178200|Anesthetics|anesthetics|mesh-ancestor
5540003|NCT04178200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6467059|NCT00481663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6467060|NCT00481663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540004|NCT04178200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540005|NCT04178200|Sensory System Agents|sensory system agents|mesh-ancestor
5540006|NCT04178200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5540007|NCT04178200|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5540008|NCT04178200|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6467061|NCT00481689|Ciprofloxacin|ciprofloxacin|mesh-list
6467062|NCT00481689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6467063|NCT00481689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6467064|NCT00481689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6467065|NCT00481689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6467066|NCT00481689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6467067|NCT00481689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467068|NCT00481689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6467069|NCT00481689|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6467070|NCT00481689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6467071|NCT00481702|Metronidazole|metronidazole|mesh-list
6467072|NCT00481702|Ceftriaxone|ceftriaxone|mesh-list
6467073|NCT00481702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6467074|NCT00481702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6467075|NCT00481702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6467076|NCT00481702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6467077|NCT00481728|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6467078|NCT00481728|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5540009|NCT04178200|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5540010|NCT04178200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6135621|NCT01256593|Anticonvulsants|anticonvulsants|mesh-ancestor
6135622|NCT01256593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6135623|NCT01256593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6135624|NCT01256593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6135625|NCT01256593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6135626|NCT01256593|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6135627|NCT01256593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6135628|NCT01256593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6135629|NCT01256593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6135630|NCT01256658|Lumefantrine|lumefantrine|mesh-list
6135631|NCT01256658|Artemether|artemether|mesh-list
6135632|NCT01256658|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6135633|NCT01256658|Antimalarials|antimalarials|mesh-ancestor
6135634|NCT01256658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6135635|NCT01256658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6135636|NCT01256658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6135637|NCT01256671|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
5540011|NCT04178200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540012|NCT04177953|Carboplatin|carboplatin|mesh-list
5540013|NCT04177953|Nivolumab|nivolumab|mesh-list
5540014|NCT04177953|Pemetrexed|pemetrexed|mesh-list
5540015|NCT04177953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5540016|NCT04177953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5540017|NCT04177953|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5540018|NCT04177953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6135638|NCT01256671|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6135639|NCT01256671|Immunologic Factors|immunologic factors|mesh-ancestor
5540019|NCT04177953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5540020|NCT04177953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5540021|NCT04177953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5540022|NCT04178057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5540023|NCT04178057|Antibodies|antibodies|mesh-list
5540024|NCT04178057|Immunoglobulins|immunoglobulins|mesh-list
5540025|NCT04178057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6135640|NCT01256671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135641|NCT01256684|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
6135642|NCT01256684|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6135643|NCT01256684|Immunologic Factors|immunologic factors|mesh-ancestor
6135644|NCT01256684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135645|NCT01256879|Cimetidine|cimetidine|mesh-list
6135646|NCT01256879|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6135647|NCT01256879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6135648|NCT01256879|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6135649|NCT01256879|Histamine Antagonists|histamine antagonists|mesh-ancestor
6135650|NCT01256879|Histamine Agents|histamine agents|mesh-ancestor
5540026|NCT04178057|Mitogens|mitogens|mesh-list
5540027|NCT04178057|Endothelial Growth Factors|endothelial growth factors|mesh-list
5540028|NCT04178057|Immunologic Factors|immunologic factors|mesh-ancestor
5540029|NCT04178057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540030|NCT04178057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5540031|NCT04178057|Mitosis Modulators|mitosis modulators|mesh-ancestor
5540032|NCT04178057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540033|NCT04178057|Growth Substances|growth substances|mesh-ancestor
5540034|NCT04177680|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
6135651|NCT01256879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6135652|NCT01256879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6135653|NCT01256879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135654|NCT01256879|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6135655|NCT01256879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6135656|NCT01256879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6135657|NCT01257087|Insulin|insulin|mesh-list
6135658|NCT01257087|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6135659|NCT01257087|Insulin Glargine|insulin glargine|mesh-list
6135660|NCT01257087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6135661|NCT01257087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135662|NCT01257204|Interferons|interferons|mesh-list
6135663|NCT01257204|Ribavirin|ribavirin|mesh-list
6135664|NCT01257204|Interferon-alpha|interferon-alpha|mesh-list
6135665|NCT01257204|Interferon alpha-2|interferon alpha-2|mesh-list
6135666|NCT01257204|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6135667|NCT01257204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6135668|NCT01257204|Antiviral Agents|antiviral agents|mesh-ancestor
6135669|NCT01257204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6135670|NCT01257204|Antimetabolites|antimetabolites|mesh-ancestor
6135671|NCT01257204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6135672|NCT01257204|Immunologic Factors|immunologic factors|mesh-ancestor
6135673|NCT01257204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135674|NCT01257230|Tiotropium Bromide|tiotropium bromide|mesh-list
6135675|NCT01257230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6135676|NCT01257230|Autonomic Agents|autonomic agents|mesh-ancestor
6135677|NCT01257230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6135678|NCT01257230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135679|NCT01257230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6135680|NCT01257230|Respiratory System Agents|respiratory system agents|mesh-ancestor
6135681|NCT01257230|Parasympatholytics|parasympatholytics|mesh-ancestor
5540035|NCT04177680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5540036|NCT04177680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5540037|NCT04177875|Paclitaxel|paclitaxel|mesh-list
5540038|NCT04177875|Docetaxel|docetaxel|mesh-list
5540039|NCT04177875|Cisplatin|cisplatin|mesh-list
5540040|NCT04177875|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5540041|NCT04177875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5540042|NCT04177875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5540043|NCT04177875|Tubulin Modulators|tubulin modulators|mesh-ancestor
5540044|NCT04177875|Antimitotic Agents|antimitotic agents|mesh-ancestor
5540045|NCT04177875|Mitosis Modulators|mitosis modulators|mesh-ancestor
5540046|NCT04177875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540047|NCT04177641|Antioxidants|antioxidants|mesh-list
5540048|NCT04177641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540049|NCT04177641|Protective Agents|protective agents|mesh-ancestor
6135682|NCT01257230|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6135683|NCT01257230|Cholinergic Agents|cholinergic agents|mesh-ancestor
6135684|NCT01257230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6467079|NCT00481728|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6467080|NCT00481728|Cholinergic Agents|cholinergic agents|mesh-ancestor
6467081|NCT00481728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6467082|NCT00481728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467083|NCT00481728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467084|NCT00481728|Urological Agents|urological agents|mesh-ancestor
6467085|NCT00481741|Hemostatics|hemostatics|mesh-list
6467086|NCT00481741|Coagulants|coagulants|mesh-ancestor
6467087|NCT00481819|Mycophenolic Acid|mycophenolic acid|mesh-list
6467088|NCT00481819|Methylprednisolone|methylprednisolone|mesh-list
6467089|NCT00481819|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6467090|NCT00481819|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6467091|NCT00481819|Prednisolone|prednisolone|mesh-list
6135685|NCT01257230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6135686|NCT01257425|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6135687|NCT01257425|Luteolytic Agents|luteolytic agents|mesh-ancestor
6135688|NCT01257425|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6135689|NCT01257425|Contraceptive Agents|contraceptive agents|mesh-ancestor
6135690|NCT01257425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6135691|NCT01257425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135692|NCT01257425|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6135693|NCT01257425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6135694|NCT01257425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6135695|NCT01257542|Dextromethorphan|dextromethorphan|mesh-list
6135696|NCT01257542|Antitussive Agents|antitussive agents|mesh-ancestor
6135697|NCT01257542|Respiratory System Agents|respiratory system agents|mesh-ancestor
6467092|NCT00481819|Prednisolone acetate|prednisolone acetate|mesh-list
6467093|NCT00481819|Tacrolimus|tacrolimus|mesh-list
6467094|NCT00481819|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6135698|NCT01257542|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6135699|NCT01257542|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6135700|NCT01257542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6135701|NCT01257542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6135702|NCT01257542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135703|NCT01257581|Tamoxifen|tamoxifen|mesh-list
6135704|NCT01257581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6135705|NCT01257581|Hormone Antagonists|hormone antagonists|mesh-ancestor
6135706|NCT01257581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6135707|NCT01257581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135708|NCT01257581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6135709|NCT01257581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6135710|NCT01257581|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6135711|NCT01257581|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6135712|NCT01257581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6467095|NCT00481819|Prednisolone phosphate|prednisolone phosphate|mesh-list
6467096|NCT00481819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6135713|NCT01257698|Timolol|timolol|mesh-list
6135714|NCT01257698|Dorzolamide|dorzolamide|mesh-list
6135715|NCT01257698|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6135716|NCT01257698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6135717|NCT01257698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6135718|NCT01257698|Adrenergic Agents|adrenergic agents|mesh-ancestor
6135719|NCT01257698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6135720|NCT01257698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6135721|NCT01257698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135722|NCT01257698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6135723|NCT01257698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6135724|NCT01257698|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6135725|NCT01257698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6135726|NCT01257698|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6135727|NCT01257737|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
6135728|NCT01257737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6135729|NCT01257802|Leuprolide|leuprolide|mesh-list
6135730|NCT01257802|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6135731|NCT01257802|Fertility Agents|fertility agents|mesh-ancestor
6135732|NCT01257802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6135733|NCT01257802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135734|NCT01257802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6135735|NCT01257802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6205220|NCT02083107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6467097|NCT00481819|Immunologic Factors|immunologic factors|mesh-ancestor
6467098|NCT00481819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467099|NCT00481819|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6467100|NCT00481819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6467101|NCT00481819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467102|NCT00481819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6467103|NCT00481819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6467104|NCT00481819|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6467105|NCT00481819|Antitubercular Agents|antitubercular agents|mesh-ancestor
6467106|NCT00481819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6467107|NCT00481819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6467108|NCT00481819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6467109|NCT00481819|Antiemetics|antiemetics|mesh-ancestor
6467110|NCT00481819|Autonomic Agents|autonomic agents|mesh-ancestor
6135736|NCT01258049|Artemether|artemether|mesh-list
6135737|NCT01258049|Quinine|quinine|mesh-list
6135738|NCT01258049|Antimalarials|antimalarials|mesh-ancestor
6135739|NCT01258049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6135740|NCT01258049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6135741|NCT01258049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6467111|NCT00481819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6467112|NCT00481819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6467113|NCT00481819|Glucocorticoids|glucocorticoids|mesh-ancestor
6467114|NCT00481819|Hormones|hormones|mesh-ancestor
6467115|NCT00481819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6467116|NCT00481819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6467117|NCT00481819|Protective Agents|protective agents|mesh-ancestor
6467118|NCT00481819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6467119|NCT00481884|Petrolatum|petrolatum|mesh-list
6467120|NCT00481884|Emollients|emollients|mesh-ancestor
6467121|NCT00481884|Dermatologic Agents|dermatologic agents|mesh-ancestor
6467122|NCT00481923|Rimonabant|rimonabant|mesh-list
6467123|NCT00481923|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6467124|NCT00481923|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
6467125|NCT00481923|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6467126|NCT00481923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6467127|NCT00481923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467128|NCT00481923|Hormones|hormones|mesh-ancestor
6467129|NCT00481923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6467130|NCT00481923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467131|NCT00481962|Tigecycline|tigecycline|mesh-list
6467132|NCT00481962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6467133|NCT00481962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6135742|NCT01258049|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6135743|NCT01258049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135744|NCT01258049|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6135745|NCT01258049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6135746|NCT01258049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6135747|NCT01258049|Analgesics|analgesics|mesh-ancestor
6135748|NCT01258049|Sensory System Agents|sensory system agents|mesh-ancestor
6135749|NCT01258075|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
6135750|NCT01258075|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6135751|NCT01258075|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6135752|NCT01258075|Antimetabolites|antimetabolites|mesh-ancestor
6135753|NCT01258075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6135754|NCT01258075|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6135755|NCT01258101|Ribavirin|ribavirin|mesh-list
6135756|NCT01258101|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6135757|NCT01258101|Interferon-alpha|interferon-alpha|mesh-list
6135758|NCT01258101|Antimetabolites|antimetabolites|mesh-ancestor
6135759|NCT01258101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6135760|NCT01258101|Antiviral Agents|antiviral agents|mesh-ancestor
6135761|NCT01258101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6135762|NCT01258101|Immunologic Factors|immunologic factors|mesh-ancestor
6135763|NCT01258101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135764|NCT01258153|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6135765|NCT01258153|MEN 11420|men 11420|mesh-list
6135766|NCT01258153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6135767|NCT01258153|Autonomic Agents|autonomic agents|mesh-ancestor
6135768|NCT01258153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6135769|NCT01258153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135770|NCT01258153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6135771|NCT01258153|Respiratory System Agents|respiratory system agents|mesh-ancestor
6135772|NCT01258348|Sunitinib|sunitinib|mesh-list
6135773|NCT01258348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6135774|NCT01258348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6467134|NCT00481962|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6467135|NCT00481962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6467136|NCT00481962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467137|NCT00481975|Rimonabant|rimonabant|mesh-list
6467138|NCT00481975|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6467139|NCT00481975|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
6467140|NCT00481975|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6467141|NCT00481975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6467142|NCT00481975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467143|NCT00481975|Hormones|hormones|mesh-ancestor
6467144|NCT00481975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6467145|NCT00481975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467146|NCT00482027|Vaccines|vaccines|mesh-list
6467147|NCT00482027|Immunologic Factors|immunologic factors|mesh-ancestor
6467148|NCT00482027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467149|NCT00482066|Abatacept|abatacept|mesh-list
6467150|NCT00482066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6467151|NCT00482066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467152|NCT00482066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6467153|NCT00482066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6467154|NCT00482066|Immunologic Factors|immunologic factors|mesh-ancestor
6467155|NCT00482066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467156|NCT00482066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6467157|NCT00482079|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6467158|NCT00482079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6467159|NCT00482079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467160|NCT00482079|Incretins|incretins|mesh-ancestor
6467161|NCT00482079|Hormones|hormones|mesh-ancestor
6467162|NCT00482079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6467163|NCT00482079|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6467164|NCT00482079|Protease Inhibitors|protease inhibitors|mesh-ancestor
6467165|NCT00482079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6467166|NCT00482079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467167|NCT00482183|Pioglitazone|pioglitazone|mesh-list
6467168|NCT00482183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6467169|NCT00482183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540050|NCT04177641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540051|NCT04178109|Acetaminophen|acetaminophen|mesh-list
5540052|NCT04178109|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
5540053|NCT04178109|Tramadol|tramadol|mesh-list
5540054|NCT04178109|Ropivacaine|ropivacaine|mesh-list
5540055|NCT04178109|Levobupivacaine|levobupivacaine|mesh-list
5540056|NCT04178109|Anesthetics, Local|anesthetics, local|mesh-ancestor
5540057|NCT04178109|Anesthetics|anesthetics|mesh-ancestor
6467170|NCT00482209|Misoprostol|misoprostol|mesh-list
6467171|NCT00482209|Mifepristone|mifepristone|mesh-list
6467172|NCT00482209|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6467173|NCT00482209|Abortifacient Agents|abortifacient agents|mesh-ancestor
5540058|NCT04178109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5540059|NCT04178109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540060|NCT04178109|Sensory System Agents|sensory system agents|mesh-ancestor
5540061|NCT04178109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5540062|NCT04178109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5540063|NCT04178109|Analgesics|analgesics|mesh-ancestor
5540064|NCT04178109|Antipyretics|antipyretics|mesh-ancestor
5540065|NCT04178109|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5540066|NCT04178109|Narcotics|narcotics|mesh-ancestor
5540067|NCT04178109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6467174|NCT00482209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6467175|NCT00482209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135775|NCT01258348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6135776|NCT01258348|Growth Substances|growth substances|mesh-ancestor
6135777|NCT01258348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135778|NCT01258348|Growth Inhibitors|growth inhibitors|mesh-ancestor
6135779|NCT01258348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6135780|NCT01258348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6135781|NCT01258348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467176|NCT00482209|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6467177|NCT00482209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6467178|NCT00482209|Oxytocics|oxytocics|mesh-ancestor
5540068|NCT04178109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6135782|NCT01258374|Raltegravir Potassium|raltegravir potassium|mesh-list
5540069|NCT04178109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5540070|NCT04177810|Plerixafor|plerixafor|mesh-list
6135783|NCT01258374|Darunavir|darunavir|mesh-list
6135784|NCT01258374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5540071|NCT04177810|Cemiplimab|cemiplimab|mesh-list
5540072|NCT04177810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5540073|NCT04177810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5540074|NCT04177810|Antiviral Agents|antiviral agents|mesh-ancestor
5540075|NCT04177810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5540076|NCT04177810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5540077|NCT04177810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5540078|NCT04177693|Letrozole|letrozole|mesh-list
5540079|NCT04177693|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
5540080|NCT04177693|Clomiphene|clomiphene|mesh-list
5540081|NCT04177693|Enclomiphene|enclomiphene|mesh-list
5540082|NCT04177693|Zuclomiphene|zuclomiphene|mesh-list
6135785|NCT01258374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6135786|NCT01258374|Antiviral Agents|antiviral agents|mesh-ancestor
6135787|NCT01258374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6135788|NCT01258374|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6135789|NCT01258374|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6135790|NCT01258374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6135791|NCT01258374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6135792|NCT01258374|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6135793|NCT01258374|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6135794|NCT01258374|Protease Inhibitors|protease inhibitors|mesh-ancestor
6135795|NCT01258387|Mitogens|mitogens|mesh-list
6135796|NCT01258387|Mitosis Modulators|mitosis modulators|mesh-ancestor
6135797|NCT01258387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6135798|NCT01258595|Vaccines|vaccines|mesh-list
6135799|NCT01258595|Immunologic Factors|immunologic factors|mesh-ancestor
6135800|NCT01258595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135801|NCT01258608|Sorafenib|sorafenib|mesh-list
6135802|NCT01258608|Mapatumumab|mapatumumab|mesh-list
6135803|NCT01258608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6135804|NCT01258608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6135805|NCT01258608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6135806|NCT01258608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6135807|NCT01258660|Folic Acid|folic acid|mesh-list
6135808|NCT01258660|Vitamin B Complex|vitamin b complex|mesh-list
6135809|NCT01258660|Drospirenone|drospirenone|mesh-list
6135810|NCT01258660|Hematinics|hematinics|mesh-ancestor
6135811|NCT01258660|Vitamins|vitamins|mesh-ancestor
6135812|NCT01258660|Micronutrients|micronutrients|mesh-ancestor
6135813|NCT01258660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135814|NCT01258660|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5540083|NCT04177693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540084|NCT04177693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5540085|NCT04177693|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5540086|NCT04177693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5540087|NCT04177693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5540088|NCT04177693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6135815|NCT01258660|Hormone Antagonists|hormone antagonists|mesh-ancestor
6135816|NCT01258660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6135817|NCT01258660|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6135818|NCT01258660|Diuretics|diuretics|mesh-ancestor
6467179|NCT00482209|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6467180|NCT00482209|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6467181|NCT00482209|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6467182|NCT00482209|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6467183|NCT00482209|Contraceptive Agents|contraceptive agents|mesh-ancestor
6467184|NCT00482209|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6467185|NCT00482209|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6467186|NCT00482209|Hormone Antagonists|hormone antagonists|mesh-ancestor
6467187|NCT00482209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6467188|NCT00482209|Luteolytic Agents|luteolytic agents|mesh-ancestor
5540089|NCT04177693|Hormone Antagonists|hormone antagonists|mesh-ancestor
5540090|NCT04177693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5540091|NCT04177693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540092|NCT04177693|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5540093|NCT04177693|Fertility Agents|fertility agents|mesh-ancestor
5540094|NCT04177693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5540095|NCT04177693|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5540096|NCT04177693|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6135819|NCT01258660|Natriuretic Agents|natriuretic agents|mesh-ancestor
5540097|NCT04177693|Antioxidants|antioxidants|mesh-ancestor
6135820|NCT01258738|Etanercept|etanercept|mesh-list
6205221|NCT02083107|Oxytocics|oxytocics|mesh-ancestor
6467189|NCT00482209|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5540098|NCT04177693|Protective Agents|protective agents|mesh-ancestor
5540099|NCT04177693|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
5540100|NCT04177693|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5540101|NCT04177693|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5540102|NCT04177719|Oxytocin|oxytocin|mesh-list
5540103|NCT04177719|Oxytocics|oxytocics|mesh-ancestor
5540104|NCT04177719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5540105|NCT04177719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540106|NCT04177602|Trifluridine|trifluridine|mesh-list
5540107|NCT04177602|Capecitabine|capecitabine|mesh-list
5540108|NCT04177602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5540109|NCT04177602|Antimetabolites|antimetabolites|mesh-ancestor
5602186|NCT04895280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6135821|NCT01258738|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
6135822|NCT01258738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6135823|NCT01258738|Analgesics|analgesics|mesh-ancestor
6135824|NCT01258738|Sensory System Agents|sensory system agents|mesh-ancestor
6135825|NCT01258738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6135826|NCT01258738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135827|NCT01258738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6135828|NCT01258738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6467190|NCT00482209|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6467191|NCT00482222|Leucovorin|leucovorin|mesh-list
6467192|NCT00482222|Fluorouracil|fluorouracil|mesh-list
6467193|NCT00482222|Capecitabine|capecitabine|mesh-list
6467194|NCT00482222|Oxaliplatin|oxaliplatin|mesh-list
6467195|NCT00482222|Cetuximab|cetuximab|mesh-list
6467196|NCT00482222|Calcium|calcium|mesh-list
6467197|NCT00482222|Levoleucovorin|levoleucovorin|mesh-list
6467198|NCT00482222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6467199|NCT00482222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467200|NCT00482222|Antimetabolites|antimetabolites|mesh-ancestor
6467201|NCT00482222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467202|NCT00482222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6467203|NCT00482222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6467204|NCT00482222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6467205|NCT00482222|Immunologic Factors|immunologic factors|mesh-ancestor
6467206|NCT00482222|Antidotes|antidotes|mesh-ancestor
6467207|NCT00482222|Protective Agents|protective agents|mesh-ancestor
6467208|NCT00482222|Vitamin B Complex|vitamin b complex|mesh-ancestor
6467209|NCT00482222|Vitamins|vitamins|mesh-ancestor
6467210|NCT00482222|Micronutrients|micronutrients|mesh-ancestor
6467211|NCT00482222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6467212|NCT00482248|Omalizumab|omalizumab|mesh-list
6467213|NCT00482248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6467214|NCT00482248|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6467215|NCT00482248|Respiratory System Agents|respiratory system agents|mesh-ancestor
6467216|NCT00482261|Aspirin|aspirin|mesh-list
6467217|NCT00482261|Dexamethasone|dexamethasone|mesh-list
6467218|NCT00482261|Lenalidomide|lenalidomide|mesh-list
6467219|NCT00482261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6467220|NCT00482261|Antiemetics|antiemetics|mesh-ancestor
6467221|NCT00482261|Autonomic Agents|autonomic agents|mesh-ancestor
6467222|NCT00482261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6467223|NCT00482261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467224|NCT00482261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6467225|NCT00482261|Glucocorticoids|glucocorticoids|mesh-ancestor
6467226|NCT00482261|Hormones|hormones|mesh-ancestor
6467227|NCT00482261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6467228|NCT00482261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6467229|NCT00482261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6467230|NCT00482261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6467231|NCT00482261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6467232|NCT00482261|Analgesics|analgesics|mesh-ancestor
6467233|NCT00482261|Sensory System Agents|sensory system agents|mesh-ancestor
6467234|NCT00482261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6467235|NCT00482261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6467236|NCT00482261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6467237|NCT00482261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467238|NCT00482261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5540110|NCT04177602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540111|NCT04177602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5540112|NCT04177602|Antiviral Agents|antiviral agents|mesh-ancestor
5540113|NCT04177602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5540114|NCT04177498|ON 01910|on 01910|mesh-list
5540115|NCT04177498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5540116|NCT04177498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5540117|NCT04177498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5540118|NCT04177498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540119|NCT04177342|Fentanyl|fentanyl|mesh-list
5540120|NCT04177342|Oxycodone|oxycodone|mesh-list
5540121|NCT04177342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5540122|NCT04177342|Narcotics|narcotics|mesh-ancestor
5540123|NCT04177342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5540124|NCT04177342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540125|NCT04177342|Analgesics|analgesics|mesh-ancestor
5540126|NCT04177342|Sensory System Agents|sensory system agents|mesh-ancestor
5540127|NCT04177342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6467239|NCT00482261|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6467240|NCT00482261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6467241|NCT00482261|Antipyretics|antipyretics|mesh-ancestor
6467242|NCT00482261|Immunologic Factors|immunologic factors|mesh-ancestor
6467243|NCT00482261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6467244|NCT00482261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6467245|NCT00482261|Growth Substances|growth substances|mesh-ancestor
6467246|NCT00482261|Growth Inhibitors|growth inhibitors|mesh-ancestor
6467247|NCT00482313|Methylphenidate|methylphenidate|mesh-list
6467248|NCT00482313|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6467249|NCT00482313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467250|NCT00482313|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6467251|NCT00482313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6467252|NCT00482313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6467253|NCT00482313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467254|NCT00482313|Dopamine Agents|dopamine agents|mesh-ancestor
6467255|NCT00482313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6467256|NCT00482378|Zoledronic Acid|zoledronic acid|mesh-list
6467257|NCT00482378|Pamidronate|pamidronate|mesh-list
6467258|NCT00482378|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6467259|NCT00482378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467260|NCT00482456|Nitrous Oxide|nitrous oxide|mesh-list
6467261|NCT00482456|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6467262|NCT00482456|Anesthetics, General|anesthetics, general|mesh-ancestor
6467263|NCT00482456|Anesthetics|anesthetics|mesh-ancestor
6467264|NCT00482456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6467265|NCT00482456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467266|NCT00482456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6467267|NCT00482456|Analgesics|analgesics|mesh-ancestor
6467268|NCT00482456|Sensory System Agents|sensory system agents|mesh-ancestor
6467269|NCT00482456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6488479|NCT00584532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488480|NCT00584532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6488481|NCT00584532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6488482|NCT00584532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6488483|NCT00584532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488484|NCT00584532|Phytoestrogens|phytoestrogens|mesh-ancestor
6488485|NCT00584532|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6488486|NCT00584532|Estrogens|estrogens|mesh-ancestor
6488487|NCT00584532|Hormones|hormones|mesh-ancestor
6666403|NCT01522768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6666404|NCT01522768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5540128|NCT04177342|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5540129|NCT04177342|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5540130|NCT04177342|Anesthetics, General|anesthetics, general|mesh-ancestor
5540131|NCT04177342|Anesthetics|anesthetics|mesh-ancestor
5540132|NCT04177173|Methotrexate|methotrexate|mesh-list
5540133|NCT04177173|Simvastatin|simvastatin|mesh-list
5540134|NCT04177173|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5540135|NCT04177173|Abortifacient Agents|abortifacient agents|mesh-ancestor
5540136|NCT04177173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5540137|NCT04177173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540138|NCT04177173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6467270|NCT00482495|Bevacizumab|bevacizumab|mesh-list
6467271|NCT00482495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6467272|NCT00482495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6467273|NCT00482495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6467274|NCT00482495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6467275|NCT00482495|Growth Substances|growth substances|mesh-ancestor
6467276|NCT00482495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467277|NCT00482495|Growth Inhibitors|growth inhibitors|mesh-ancestor
6467278|NCT00482508|Omalizumab|omalizumab|mesh-list
6467279|NCT00482508|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6467280|NCT00482508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6467281|NCT00482508|Respiratory System Agents|respiratory system agents|mesh-ancestor
6467282|NCT00482521|Pomalidomide|pomalidomide|mesh-list
6467283|NCT00482521|Immunologic Factors|immunologic factors|mesh-ancestor
6467284|NCT00482521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467285|NCT00482521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6467286|NCT00482521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6467287|NCT00482521|Growth Substances|growth substances|mesh-ancestor
6467288|NCT00482521|Growth Inhibitors|growth inhibitors|mesh-ancestor
6467289|NCT00482521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6467290|NCT00482573|Epinephrine|epinephrine|mesh-list
5540139|NCT04177173|Antimetabolites|antimetabolites|mesh-ancestor
5540140|NCT04177173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540141|NCT04177173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5540142|NCT04177173|Dermatologic Agents|dermatologic agents|mesh-ancestor
5540143|NCT04177173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5540144|NCT04177173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5540145|NCT04177173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5540146|NCT04177173|Immunologic Factors|immunologic factors|mesh-ancestor
5540147|NCT04177173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6467291|NCT00482573|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
6467292|NCT00482573|Anesthetics|anesthetics|mesh-list
6135829|NCT01258738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6135830|NCT01258738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5540148|NCT04177173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5540149|NCT04177173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5540150|NCT04177173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5540151|NCT04177173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5540152|NCT04177173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5540153|NCT04177433|Methylprednisolone|methylprednisolone|mesh-list
5540154|NCT04177433|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5540155|NCT04177433|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5540156|NCT04177433|Prednisolone|prednisolone|mesh-list
6135831|NCT01258738|Immunologic Factors|immunologic factors|mesh-ancestor
6135832|NCT01258855|Aldesleukin|aldesleukin|mesh-list
6135833|NCT01258855|Aflibercept|aflibercept|mesh-list
6135834|NCT01258855|Interleukin-2|interleukin-2|mesh-list
6135835|NCT01258855|Endothelial Growth Factors|endothelial growth factors|mesh-list
6135836|NCT01258855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6135837|NCT01258855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6135838|NCT01258855|Growth Substances|growth substances|mesh-ancestor
6135839|NCT01258855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135840|NCT01258855|Growth Inhibitors|growth inhibitors|mesh-ancestor
6135841|NCT01258855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6135842|NCT01258855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6135843|NCT01258855|Analgesics|analgesics|mesh-ancestor
6135844|NCT01258855|Sensory System Agents|sensory system agents|mesh-ancestor
6135845|NCT01258855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6135846|NCT01258855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6135847|NCT01258855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6135848|NCT01258855|Antiviral Agents|antiviral agents|mesh-ancestor
6135849|NCT01258855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6135850|NCT01259063|Gemcitabine|gemcitabine|mesh-list
6135851|NCT01259063|Everolimus|everolimus|mesh-list
6135852|NCT01259063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6135853|NCT01259063|Antimetabolites|antimetabolites|mesh-ancestor
6135854|NCT01259063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6135855|NCT01259063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6135856|NCT01259063|Antiviral Agents|antiviral agents|mesh-ancestor
6135857|NCT01259063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6467293|NCT00482573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5540157|NCT04177433|Prednisolone acetate|prednisolone acetate|mesh-list
5540158|NCT04177433|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5540159|NCT04177433|Prednisolone phosphate|prednisolone phosphate|mesh-list
5540160|NCT04177433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5540161|NCT04177433|Antiemetics|antiemetics|mesh-ancestor
5540162|NCT04177433|Autonomic Agents|autonomic agents|mesh-ancestor
5540163|NCT04177433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5540164|NCT04177433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540165|NCT04177433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5540166|NCT04177433|Glucocorticoids|glucocorticoids|mesh-ancestor
5540167|NCT04177433|Hormones|hormones|mesh-ancestor
5540168|NCT04177433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5540169|NCT04177433|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5540170|NCT04177433|Protective Agents|protective agents|mesh-ancestor
5540171|NCT04177433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5540172|NCT04177433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5540173|NCT04177186|Botulinum Toxins|botulinum toxins|mesh-list
5540174|NCT04177186|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5540175|NCT04177186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5540176|NCT04177186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540177|NCT04177186|Cholinergic Agents|cholinergic agents|mesh-ancestor
5540178|NCT04177186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5540179|NCT04177186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540180|NCT04177004|Sirolimus|sirolimus|mesh-list
5540181|NCT04177004|Cyclophosphamide|cyclophosphamide|mesh-list
5540182|NCT04177004|Etoposide|etoposide|mesh-list
5540183|NCT04177004|Etoposide phosphate|etoposide phosphate|mesh-list
5540184|NCT04177004|Podophyllotoxin|podophyllotoxin|mesh-list
5540185|NCT04177004|Tacrolimus|tacrolimus|mesh-list
5540186|NCT04177004|Mitogens|mitogens|mesh-list
5540187|NCT04177004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5540188|NCT04177004|Immunologic Factors|immunologic factors|mesh-ancestor
5540189|NCT04177004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540190|NCT04177004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5540191|NCT04177004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5540192|NCT04177004|Alkylating Agents|alkylating agents|mesh-ancestor
5540193|NCT04177004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540194|NCT04177004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5540195|NCT04177004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5540196|NCT04177004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5540197|NCT04177004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5540198|NCT04177004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5540199|NCT04177004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5540200|NCT04177004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5540201|NCT04177004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6467294|NCT00482573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467295|NCT00482573|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6467296|NCT00482573|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6467297|NCT00482573|Adrenergic Agents|adrenergic agents|mesh-ancestor
6467298|NCT00482573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5540202|NCT04177004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5540203|NCT04177004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5540204|NCT04177004|Antifungal Agents|antifungal agents|mesh-ancestor
5540205|NCT04177004|Mitosis Modulators|mitosis modulators|mesh-ancestor
5540206|NCT04177004|Keratolytic Agents|keratolytic agents|mesh-ancestor
6467299|NCT00482573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467300|NCT00482573|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6467301|NCT00482573|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6467302|NCT00482573|Autonomic Agents|autonomic agents|mesh-ancestor
6467303|NCT00482573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6666405|NCT01522768|Tubulin Modulators|tubulin modulators|mesh-ancestor
5540207|NCT04177004|Dermatologic Agents|dermatologic agents|mesh-ancestor
6135858|NCT01259063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6135859|NCT01259063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6135860|NCT01259063|Immunologic Factors|immunologic factors|mesh-ancestor
6135861|NCT01259063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135862|NCT01259089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6135863|NCT01259089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6135864|NCT01259089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6135865|NCT01259089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6135866|NCT01259089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6135867|NCT01259102|Buprenorphine|buprenorphine|mesh-list
6135868|NCT01259102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6135869|NCT01259102|Narcotics|narcotics|mesh-ancestor
6135870|NCT01259102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6135871|NCT01259102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135872|NCT01259102|Analgesics|analgesics|mesh-ancestor
6135873|NCT01259102|Sensory System Agents|sensory system agents|mesh-ancestor
6135874|NCT01259102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6135875|NCT01259102|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6135876|NCT01259115|Ketoconazole|ketoconazole|mesh-list
6135877|NCT01259115|Buprenorphine|buprenorphine|mesh-list
6135878|NCT01259115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6135879|NCT01259115|Narcotics|narcotics|mesh-ancestor
5540208|NCT04177004|Tubulin Modulators|tubulin modulators|mesh-ancestor
5540209|NCT04177004|Antimitotic Agents|antimitotic agents|mesh-ancestor
5540210|NCT04177303|Metformin|metformin|mesh-list
5540211|NCT04177303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5540212|NCT04177303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540213|NCT04177043|Antibodies|antibodies|mesh-list
5540214|NCT04177043|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
5540215|NCT04177043|Immunologic Factors|immunologic factors|mesh-ancestor
5540216|NCT04177043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540217|NCT04177082|Riboflavin|riboflavin|mesh-list
5540218|NCT04177082|Vitamin B Complex|vitamin b complex|mesh-ancestor
5540219|NCT04177082|Vitamins|vitamins|mesh-ancestor
5540220|NCT04177082|Micronutrients|micronutrients|mesh-ancestor
5540221|NCT04177082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540222|NCT04177082|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5540223|NCT04177082|Dermatologic Agents|dermatologic agents|mesh-ancestor
5540224|NCT04176835|Oxytocin|oxytocin|mesh-list
5540225|NCT04176835|Oxytocics|oxytocics|mesh-ancestor
5540226|NCT04176835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6135880|NCT01259115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6135881|NCT01259115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135882|NCT01259115|Analgesics|analgesics|mesh-ancestor
6135883|NCT01259115|Sensory System Agents|sensory system agents|mesh-ancestor
6135884|NCT01259115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6135885|NCT01259115|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6135886|NCT01259115|Antifungal Agents|antifungal agents|mesh-ancestor
6135887|NCT01259115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6135888|NCT01259115|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6135889|NCT01259115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6135890|NCT01259115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6135891|NCT01259115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540227|NCT04176835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540228|NCT04177095|Sirolimus|sirolimus|mesh-list
5540229|NCT04177095|Prednisone|prednisone|mesh-list
5540230|NCT04177095|Everolimus|everolimus|mesh-list
5540231|NCT04177095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5540232|NCT04177095|Glucocorticoids|glucocorticoids|mesh-ancestor
5540233|NCT04177095|Hormones|hormones|mesh-ancestor
5540234|NCT04177095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5540235|NCT04177095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540236|NCT04177095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5540237|NCT04177095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5540238|NCT04177095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6467304|NCT00482573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5540239|NCT04177095|Immunologic Factors|immunologic factors|mesh-ancestor
6467305|NCT00482573|Respiratory System Agents|respiratory system agents|mesh-ancestor
6467306|NCT00482573|Mydriatics|mydriatics|mesh-ancestor
5540240|NCT04177095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5540241|NCT04177095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5540242|NCT04177095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5540243|NCT04177095|Antifungal Agents|antifungal agents|mesh-ancestor
5540244|NCT04176887|Phenytoin|phenytoin|mesh-list
5540245|NCT04176887|Levetiracetam|levetiracetam|mesh-list
6467307|NCT00482573|Sympathomimetics|sympathomimetics|mesh-ancestor
6467308|NCT00482690|Nicotine|nicotine|mesh-list
6467309|NCT00482690|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6467310|NCT00482690|Autonomic Agents|autonomic agents|mesh-ancestor
6467311|NCT00482690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6467312|NCT00482690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467313|NCT00482690|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6467314|NCT00482690|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6467315|NCT00482690|Cholinergic Agents|cholinergic agents|mesh-ancestor
6467316|NCT00482690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6467317|NCT00482690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467318|NCT00482716|Iron|iron|mesh-list
6467319|NCT00482716|Dextrans|dextrans|mesh-list
6467320|NCT00482716|Epoetin Alfa|epoetin alfa|mesh-list
6467321|NCT00482716|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6467322|NCT00482716|Iron-Dextran Complex|iron-dextran complex|mesh-list
6467323|NCT00482716|Trace Elements|trace elements|mesh-ancestor
6467324|NCT00482716|Micronutrients|micronutrients|mesh-ancestor
6467325|NCT00482716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467326|NCT00482716|Hematinics|hematinics|mesh-ancestor
6467327|NCT00482716|Anticoagulants|anticoagulants|mesh-ancestor
6467328|NCT00482716|Plasma Substitutes|plasma substitutes|mesh-ancestor
6135892|NCT01259115|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6135893|NCT01259115|Hormone Antagonists|hormone antagonists|mesh-ancestor
6135894|NCT01259115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6135895|NCT01259115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6135896|NCT01259297|Amlodipine|amlodipine|mesh-list
6135897|NCT01259297|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6135898|NCT01259297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6135899|NCT01259297|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6135900|NCT01259297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6135901|NCT01259297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6135902|NCT01259297|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6135903|NCT01259297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135904|NCT01259297|Vasodilator Agents|vasodilator agents|mesh-ancestor
6135905|NCT01259297|Diuretics|diuretics|mesh-ancestor
6135906|NCT01259297|Natriuretic Agents|natriuretic agents|mesh-ancestor
6205222|NCT02083185|Leuprolide|leuprolide|mesh-list
6467329|NCT00482716|Blood Substitutes|blood substitutes|mesh-ancestor
5540246|NCT04176887|Anticonvulsants|anticonvulsants|mesh-ancestor
5540247|NCT04176887|Nootropic Agents|nootropic agents|mesh-ancestor
5540248|NCT04176887|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5540249|NCT04176887|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5540250|NCT04176887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5540251|NCT04176887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540252|NCT04176887|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6467330|NCT00482755|Sunitinib|sunitinib|mesh-list
6467331|NCT00482755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6467332|NCT00482755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6467333|NCT00482755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6467334|NCT00482755|Growth Substances|growth substances|mesh-ancestor
6467335|NCT00482755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467336|NCT00482755|Growth Inhibitors|growth inhibitors|mesh-ancestor
6467337|NCT00482755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5540253|NCT04176887|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5540254|NCT04176978|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6467338|NCT00482755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6467339|NCT00482755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467340|NCT00482807|Docetaxel|docetaxel|mesh-list
6467341|NCT00482807|Goserelin|goserelin|mesh-list
6467342|NCT00482807|Bicalutamide|bicalutamide|mesh-list
6467343|NCT00482807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6467344|NCT00482807|Tubulin Modulators|tubulin modulators|mesh-ancestor
6467345|NCT00482807|Antimitotic Agents|antimitotic agents|mesh-ancestor
6467346|NCT00482807|Mitosis Modulators|mitosis modulators|mesh-ancestor
6467347|NCT00482807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467348|NCT00482807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6467349|NCT00482807|Androgen Antagonists|androgen antagonists|mesh-ancestor
6467350|NCT00482807|Hormone Antagonists|hormone antagonists|mesh-ancestor
6666406|NCT01522768|Antimitotic Agents|antimitotic agents|mesh-ancestor
5540255|NCT04176978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5540256|NCT04176978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5540257|NCT04176978|Antimetabolites|antimetabolites|mesh-ancestor
5540258|NCT04176978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540259|NCT04176978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5540260|NCT04176978|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5540261|NCT04176978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5540262|NCT04176783|Analgesics, Opioid|analgesics, opioid|mesh-list
6666407|NCT01522768|Mitosis Modulators|mitosis modulators|mesh-ancestor
6666408|NCT01522768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666409|NCT01522768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6666410|NCT01522768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6672425|NCT01555970|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5540263|NCT04176783|Narcotics|narcotics|mesh-ancestor
5540264|NCT04176783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5540265|NCT04176783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540266|NCT04176783|Analgesics|analgesics|mesh-ancestor
5540267|NCT04176783|Sensory System Agents|sensory system agents|mesh-ancestor
5540268|NCT04176783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5602187|NCT04895280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5602188|NCT04893343|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5602189|NCT04893343|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5602190|NCT04893343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5602191|NCT04893343|Antitubercular Agents|antitubercular agents|mesh-ancestor
5602192|NCT04889716|Obinutuzumab|obinutuzumab|mesh-list
5602193|NCT04889716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6672426|NCT01555970|Antioxidants|antioxidants|mesh-ancestor
5602194|NCT04889716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6135907|NCT01259297|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6135908|NCT01259375|Amrubicin|amrubicin|mesh-list
6467351|NCT00482807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6467352|NCT00482807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467353|NCT00482846|Melphalan|melphalan|mesh-list
6467354|NCT00482846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6467355|NCT00482846|Alkylating Agents|alkylating agents|mesh-ancestor
6467356|NCT00482846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467357|NCT00482846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6467358|NCT00482846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6467359|NCT00482846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5602195|NCT04870034|Palbociclib|palbociclib|mesh-list
5602196|NCT04870034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5602197|NCT04870034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5602198|NCT04870034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5602199|NCT04870034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602200|NCT04869371|Prednisone|prednisone|mesh-list
5602201|NCT04869371|Docetaxel|docetaxel|mesh-list
5602202|NCT04869371|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5602203|NCT04869371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5602204|NCT04869371|Tubulin Modulators|tubulin modulators|mesh-ancestor
5602205|NCT04869371|Antimitotic Agents|antimitotic agents|mesh-ancestor
5602206|NCT04869371|Mitosis Modulators|mitosis modulators|mesh-ancestor
5602207|NCT04869371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602208|NCT04869371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5602209|NCT04869371|Glucocorticoids|glucocorticoids|mesh-ancestor
5602210|NCT04869371|Hormones|hormones|mesh-ancestor
5602211|NCT04869371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5602212|NCT04869371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602213|NCT04869371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5602214|NCT04869371|Luteolytic Agents|luteolytic agents|mesh-ancestor
5602215|NCT04869371|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5602216|NCT04869371|Contraceptive Agents|contraceptive agents|mesh-ancestor
5602217|NCT04869371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5602218|NCT04869371|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5602219|NCT04869124|Dapagliflozin|dapagliflozin|mesh-list
5602220|NCT04869124|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5602221|NCT04869124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602222|NCT04869124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5602223|NCT04869124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602224|NCT04860518|Dexamethasone|dexamethasone|mesh-list
5602225|NCT04860518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5602226|NCT04860518|Antiemetics|antiemetics|mesh-ancestor
6135909|NCT01259375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6467360|NCT00482846|Immunologic Factors|immunologic factors|mesh-ancestor
6467361|NCT00482846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467362|NCT00482963|Efavirenz|efavirenz|mesh-list
6467363|NCT00482963|Levonorgestrel|levonorgestrel|mesh-list
6467364|NCT00482963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6467365|NCT00482963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6135910|NCT01259388|Lithium Carbonate|lithium carbonate|mesh-list
6135911|NCT01259388|Antidepressive Agents|antidepressive agents|mesh-ancestor
6135912|NCT01259388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6135913|NCT01259388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6135914|NCT01259388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6135915|NCT01259388|Antimanic Agents|antimanic agents|mesh-ancestor
6135916|NCT01259388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6135917|NCT01259388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6135918|NCT01259388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205223|NCT02083185|Relugolix|relugolix|mesh-list
6205224|NCT02083185|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6205225|NCT02083185|Fertility Agents|fertility agents|mesh-ancestor
6205226|NCT02083185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6205227|NCT02083185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205228|NCT02083185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6205229|NCT02083185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6205230|NCT02083185|Androgen Antagonists|androgen antagonists|mesh-ancestor
6205231|NCT02083185|Hormone Antagonists|hormone antagonists|mesh-ancestor
6205232|NCT02083185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6205233|NCT02083380|Piperaquine|piperaquine|mesh-list
6205234|NCT02083380|Artefenomel|artefenomel|mesh-list
6205235|NCT02083380|Antimalarials|antimalarials|mesh-ancestor
6205236|NCT02083380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6205237|NCT02083380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6205238|NCT02083380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6205239|NCT02083406|Artefenomel|artefenomel|mesh-list
6205240|NCT02083406|Antimalarials|antimalarials|mesh-ancestor
6205241|NCT02083406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6205242|NCT02083406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6205243|NCT02083406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6205244|NCT02083653|Fluorouracil|fluorouracil|mesh-list
6205245|NCT02083653|Capecitabine|capecitabine|mesh-list
6205246|NCT02083653|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6205247|NCT02083653|Antimetabolites|antimetabolites|mesh-ancestor
6205248|NCT02083653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205249|NCT02083653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6205250|NCT02083653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6205251|NCT02083653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6205252|NCT02083653|Immunologic Factors|immunologic factors|mesh-ancestor
6205253|NCT02083653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205254|NCT02083679|Gemcitabine|gemcitabine|mesh-list
6205255|NCT02083679|Paclitaxel|paclitaxel|mesh-list
6205256|NCT02083679|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6205257|NCT02083679|Cisplatin|cisplatin|mesh-list
6205258|NCT02083679|Carboplatin|carboplatin|mesh-list
6205259|NCT02083679|Pemetrexed|pemetrexed|mesh-list
6205260|NCT02083679|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6205261|NCT02083679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6467366|NCT00482963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6467367|NCT00482963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205262|NCT02083679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6467368|NCT00482963|Antiviral Agents|antiviral agents|mesh-ancestor
6467369|NCT00482963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6467370|NCT00482963|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6467371|NCT00482963|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5540269|NCT04176354|Letrozole|letrozole|mesh-list
5540270|NCT04176354|Palbociclib|palbociclib|mesh-list
5540271|NCT04176354|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5540272|NCT04176354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5540273|NCT04176354|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5540274|NCT04176354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5540275|NCT04176354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540276|NCT04176354|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5540277|NCT04176354|Hormone Antagonists|hormone antagonists|mesh-ancestor
5540278|NCT04176354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5540279|NCT04176354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540280|NCT04176354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6467372|NCT00482963|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6467373|NCT00482963|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6467374|NCT00482963|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6467375|NCT00482963|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6467376|NCT00482963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6467377|NCT00482963|Contraceptive Agents|contraceptive agents|mesh-ancestor
6467378|NCT00482963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6467379|NCT00482963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467380|NCT00482963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6135919|NCT01259466|Nicotine|nicotine|mesh-list
5540281|NCT04176224|Edaravone|edaravone|mesh-list
5540282|NCT04176224|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5540283|NCT04176224|Antioxidants|antioxidants|mesh-ancestor
5540284|NCT04176224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540285|NCT04176224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6135920|NCT01259466|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6135921|NCT01259466|Autonomic Agents|autonomic agents|mesh-ancestor
6135922|NCT01259466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6135923|NCT01259466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135924|NCT01259466|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6135925|NCT01259466|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6135926|NCT01259466|Cholinergic Agents|cholinergic agents|mesh-ancestor
6135927|NCT01259466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6135928|NCT01259466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6135929|NCT01259492|Methylphenidate|methylphenidate|mesh-list
6135930|NCT01259492|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6135931|NCT01259492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135932|NCT01259492|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6135933|NCT01259492|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5540286|NCT04176224|Protective Agents|protective agents|mesh-ancestor
5540287|NCT04176224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540288|NCT04176393|Ivosidenib|ivosidenib|mesh-list
6135934|NCT01259492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6135935|NCT01259492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6135936|NCT01259492|Dopamine Agents|dopamine agents|mesh-ancestor
6135937|NCT01259492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6135938|NCT01259713|Amphotericin B|amphotericin b|mesh-list
6135939|NCT01259713|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6135940|NCT01259713|Amebicides|amebicides|mesh-ancestor
6135941|NCT01259713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6135942|NCT01259713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6135943|NCT01259713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6467381|NCT00482963|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6467382|NCT00482963|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6467383|NCT00482976|Ruboxistaurin|ruboxistaurin|mesh-list
6467384|NCT00482976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6467385|NCT00482976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467386|NCT00482989|Sifalimumab|sifalimumab|mesh-list
6467387|NCT00482989|Immunologic Factors|immunologic factors|mesh-ancestor
6467388|NCT00482989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467389|NCT00483028|Donepezil|donepezil|mesh-list
6467390|NCT00483028|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6467391|NCT00483028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6467392|NCT00483028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540289|NCT04176393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5540290|NCT04176393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6135944|NCT01259713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6135945|NCT01259713|Antifungal Agents|antifungal agents|mesh-ancestor
6135946|NCT01259856|Aspirin|aspirin|mesh-list
6135947|NCT01259856|Interferons|interferons|mesh-list
6135948|NCT01259856|Interferon-alpha|interferon-alpha|mesh-list
6135949|NCT01259856|Interferon alpha-2|interferon alpha-2|mesh-list
6135950|NCT01259856|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6135951|NCT01259856|Hydroxyurea|hydroxyurea|mesh-list
6135952|NCT01259856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6135953|NCT01259856|Antiviral Agents|antiviral agents|mesh-ancestor
6135954|NCT01259856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6135955|NCT01259856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6135956|NCT01259856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6135957|NCT01259856|Analgesics|analgesics|mesh-ancestor
5540291|NCT04176393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540292|NCT04176367|Nicergoline|nicergoline|mesh-list
5540293|NCT04176367|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5540294|NCT04176367|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5540295|NCT04176367|Adrenergic Agents|adrenergic agents|mesh-ancestor
5540296|NCT04176367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5540297|NCT04176367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540298|NCT04176367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540299|NCT04176367|Vasodilator Agents|vasodilator agents|mesh-ancestor
5540300|NCT04176367|Nootropic Agents|nootropic agents|mesh-ancestor
5540301|NCT04176016|Edetic Acid|edetic acid|mesh-list
5540302|NCT04176016|Pentetic Acid|pentetic acid|mesh-list
5540303|NCT04176016|Antidotes|antidotes|mesh-ancestor
5540304|NCT04176016|Protective Agents|protective agents|mesh-ancestor
5540305|NCT04176016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540306|NCT04176016|Chelating Agents|chelating agents|mesh-ancestor
5540307|NCT04176016|Sequestering Agents|sequestering agents|mesh-ancestor
5540308|NCT04176016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6135958|NCT01259856|Sensory System Agents|sensory system agents|mesh-ancestor
6135959|NCT01259856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6135960|NCT01259856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135961|NCT01259856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6135962|NCT01259856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6135963|NCT01259856|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6467393|NCT00483028|Cholinergic Agents|cholinergic agents|mesh-ancestor
6467394|NCT00483028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6467395|NCT00483028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467396|NCT00483028|Nootropic Agents|nootropic agents|mesh-ancestor
6467397|NCT00483054|Efavirenz|efavirenz|mesh-list
6467398|NCT00483054|Nevirapine|nevirapine|mesh-list
6467399|NCT00483054|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6467400|NCT00483054|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6467401|NCT00483054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6467402|NCT00483054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467403|NCT00483054|Antiviral Agents|antiviral agents|mesh-ancestor
6467404|NCT00483054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6467405|NCT00483054|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6467406|NCT00483054|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6467407|NCT00483054|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6467408|NCT00483054|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6467409|NCT00483054|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6467410|NCT00483054|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6467411|NCT00483054|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6467412|NCT00483054|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6467413|NCT00483067|Cytarabine|cytarabine|mesh-list
6467414|NCT00483067|Cladribine|cladribine|mesh-list
6467415|NCT00483067|Lenograstim|lenograstim|mesh-list
6467416|NCT00483067|Sargramostim|sargramostim|mesh-list
6467417|NCT00483067|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6467418|NCT00483067|Immunologic Factors|immunologic factors|mesh-ancestor
6467419|NCT00483067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467420|NCT00483067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6467421|NCT00483067|Antimetabolites|antimetabolites|mesh-ancestor
5540309|NCT04176016|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5540310|NCT04176016|Anticoagulants|anticoagulants|mesh-ancestor
5540311|NCT04176016|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5540312|NCT04175990|Dydrogesterone|dydrogesterone|mesh-list
5540313|NCT04175990|Progestins|progestins|mesh-ancestor
5540314|NCT04175990|Hormones|hormones|mesh-ancestor
5540315|NCT04175990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6135964|NCT01259856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6135965|NCT01259856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467422|NCT00483067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467423|NCT00483067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6467424|NCT00483067|Antiviral Agents|antiviral agents|mesh-ancestor
6467425|NCT00483067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6467426|NCT00483067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6467427|NCT00483093|Cisplatin|cisplatin|mesh-list
6135966|NCT01259856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6135967|NCT01259856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6135968|NCT01259856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6135969|NCT01259856|Antipyretics|antipyretics|mesh-ancestor
6135970|NCT01259856|Immunologic Factors|immunologic factors|mesh-ancestor
6135971|NCT01259856|Antisickling Agents|antisickling agents|mesh-ancestor
6135972|NCT01259856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6135973|NCT01260142|Propofol|propofol|mesh-list
6135974|NCT01260142|Fospropofol|fospropofol|mesh-list
6135975|NCT01260142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6135976|NCT01260142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6135977|NCT01260142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135978|NCT01260142|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6135979|NCT01260142|Anesthetics, General|anesthetics, general|mesh-ancestor
6135980|NCT01260142|Anesthetics|anesthetics|mesh-ancestor
6135981|NCT01260181|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6135982|NCT01260181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6135983|NCT01260181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6135984|NCT01260181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5540316|NCT04175990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540317|NCT04176328|Teicoplanin|teicoplanin|mesh-list
5540318|NCT04176328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5540319|NCT04176328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5540320|NCT04176055|Haloperidol|haloperidol|mesh-list
5540321|NCT04176055|Haloperidol decanoate|haloperidol decanoate|mesh-list
5540322|NCT04176055|Antiemetics|antiemetics|mesh-ancestor
5540323|NCT04176055|Autonomic Agents|autonomic agents|mesh-ancestor
5540324|NCT04176055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5540325|NCT04176055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540326|NCT04176055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5540327|NCT04176055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5540328|NCT04176055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5540329|NCT04176055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5540330|NCT04176055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5540331|NCT04176055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5540332|NCT04176055|Dopamine Agents|dopamine agents|mesh-ancestor
5540333|NCT04176055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5540334|NCT04176055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540335|NCT04176055|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5540336|NCT04176068|Calcium|calcium|mesh-list
6135985|NCT01260181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6135986|NCT01260194|Trastuzumab|trastuzumab|mesh-list
6135987|NCT01260194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6135988|NCT01260194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6135989|NCT01260311|Fesoterodine|fesoterodine|mesh-list
6135990|NCT01260311|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6135991|NCT01260311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5540337|NCT04176068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5540338|NCT04176068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6135992|NCT01260311|Cholinergic Agents|cholinergic agents|mesh-ancestor
6135993|NCT01260311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6135994|NCT01260311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6135995|NCT01260311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540343|NCT04175925|Famotidine|famotidine|mesh-list
5540344|NCT04175925|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5540345|NCT04175925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5540346|NCT04175925|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5540347|NCT04175925|Histamine Antagonists|histamine antagonists|mesh-ancestor
5540348|NCT04175925|Histamine Agents|histamine agents|mesh-ancestor
6467428|NCT00483093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5540349|NCT04175925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6135996|NCT01260311|Urological Agents|urological agents|mesh-ancestor
6135997|NCT01260350|Sofosbuvir|sofosbuvir|mesh-list
6135998|NCT01260350|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
6467429|NCT00483106|Methylphenidate|methylphenidate|mesh-list
6467430|NCT00483106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6467431|NCT00483106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467432|NCT00483106|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6467433|NCT00483106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6467434|NCT00483106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6467435|NCT00483106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467436|NCT00483106|Dopamine Agents|dopamine agents|mesh-ancestor
6467437|NCT00483106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6467438|NCT00483132|Interferons|interferons|mesh-list
6467439|NCT00483132|Interferon-alpha|interferon-alpha|mesh-list
6467440|NCT00483132|Interferon alpha-2|interferon alpha-2|mesh-list
6467441|NCT00483132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6467442|NCT00483132|Antiviral Agents|antiviral agents|mesh-ancestor
6467443|NCT00483132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6467444|NCT00483132|Immunologic Factors|immunologic factors|mesh-ancestor
6467445|NCT00483132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467446|NCT00483145|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
6467447|NCT00483145|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6467448|NCT00483145|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5540350|NCT04175925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6135999|NCT01260350|Ledipasvir|ledipasvir|mesh-list
6136000|NCT01260350|Antiviral Agents|antiviral agents|mesh-ancestor
6136001|NCT01260350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6136002|NCT01260454|Capsaicin|capsaicin|mesh-list
6136003|NCT01260454|Antipruritics|antipruritics|mesh-ancestor
6136004|NCT01260454|Dermatologic Agents|dermatologic agents|mesh-ancestor
6136005|NCT01260454|Sensory System Agents|sensory system agents|mesh-ancestor
6136006|NCT01260454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6136007|NCT01260454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136008|NCT01260467|Memantine|memantine|mesh-list
6136009|NCT01260467|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6136010|NCT01260467|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6136011|NCT01260467|Dopamine Agents|dopamine agents|mesh-ancestor
6136012|NCT01260467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6136013|NCT01260467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136014|NCT01260467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136015|NCT01260467|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6136016|NCT01260467|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6136017|NCT01260584|Clopidogrel|clopidogrel|mesh-list
6136018|NCT01260584|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6136019|NCT01260584|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6136020|NCT01260584|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6136021|NCT01260584|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6136022|NCT01260584|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6136023|NCT01260584|Purinergic Agents|purinergic agents|mesh-ancestor
6136024|NCT01260584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5540351|NCT04175925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540352|NCT04175496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6136025|NCT01260584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136026|NCT01260584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136027|NCT01260649|Ketamine|ketamine|mesh-list
6136028|NCT01260649|Anesthetics|anesthetics|mesh-list
6136029|NCT01260649|Analgesics|analgesics|mesh-ancestor
6136030|NCT01260649|Sensory System Agents|sensory system agents|mesh-ancestor
6136031|NCT01260649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6136032|NCT01260649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136033|NCT01260649|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6136034|NCT01260649|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6136035|NCT01260649|Anesthetics, General|anesthetics, general|mesh-ancestor
6136036|NCT01260649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6136037|NCT01260649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6136038|NCT01260649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6136039|NCT01260649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6136040|NCT01260649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136041|NCT01260662|Ketamine|ketamine|mesh-list
6136042|NCT01260662|Propofol|propofol|mesh-list
6136043|NCT01260662|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6136044|NCT01260662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6136045|NCT01260662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136046|NCT01260662|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6136047|NCT01260662|Anesthetics, General|anesthetics, general|mesh-ancestor
5540353|NCT04175522|Immunoglobulins|immunoglobulins|mesh-list
5540354|NCT04175522|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5540355|NCT04175522|Antibodies|antibodies|mesh-list
5540356|NCT04175522|Immunoglobulin G|immunoglobulin g|mesh-list
5540357|NCT04175522|Immunologic Factors|immunologic factors|mesh-ancestor
6136048|NCT01260662|Anesthetics|anesthetics|mesh-ancestor
6136049|NCT01260662|Analgesics|analgesics|mesh-ancestor
6136050|NCT01260662|Sensory System Agents|sensory system agents|mesh-ancestor
6136051|NCT01260662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6467449|NCT00483145|Dermatologic Agents|dermatologic agents|mesh-ancestor
6467450|NCT00483158|Finafloxacin|finafloxacin|mesh-list
6467451|NCT00483158|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6467452|NCT00483158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6467453|NCT00483158|Renal Agents|renal agents|mesh-ancestor
6136052|NCT01260662|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6136053|NCT01260662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6136054|NCT01260662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6136055|NCT01260662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6136056|NCT01260662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136057|NCT01260688|Dasatinib|dasatinib|mesh-list
6136058|NCT01260688|Cediranib|cediranib|mesh-list
6136059|NCT01260688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6136060|NCT01260688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6136061|NCT01260688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6136062|NCT01260688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467454|NCT00483158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6467455|NCT00483158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6467456|NCT00483158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6467457|NCT00483158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6467458|NCT00483158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467459|NCT00483158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6467460|NCT00483210|Fenofibrate|fenofibrate|mesh-list
6136063|NCT01260883|Ketorolac|ketorolac|mesh-list
6136064|NCT01260883|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6136065|NCT01260883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6136066|NCT01260883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6136067|NCT01260883|Analgesics|analgesics|mesh-ancestor
6136068|NCT01260883|Sensory System Agents|sensory system agents|mesh-ancestor
6136069|NCT01260883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6136070|NCT01260883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136071|NCT01260883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6136072|NCT01260883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6136073|NCT01260883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6136074|NCT01260883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6136075|NCT01260883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136076|NCT01260896|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6136077|NCT01260896|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6136078|NCT01260896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6136079|NCT01260896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6136080|NCT01260896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136081|NCT01260896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6136082|NCT01260896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136083|NCT01260896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6136084|NCT01260896|Antidepressive Agents|antidepressive agents|mesh-ancestor
6136085|NCT01260896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6136086|NCT01260922|Donepezil|donepezil|mesh-list
6136087|NCT01260922|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6136088|NCT01260922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6136089|NCT01260922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136090|NCT01260922|Cholinergic Agents|cholinergic agents|mesh-ancestor
6136091|NCT01260922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6136092|NCT01260922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136093|NCT01260922|Nootropic Agents|nootropic agents|mesh-ancestor
6136094|NCT01260948|Donepezil|donepezil|mesh-list
6136095|NCT01260948|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6136096|NCT01260948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6136097|NCT01260948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136098|NCT01260948|Cholinergic Agents|cholinergic agents|mesh-ancestor
5540358|NCT04175522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540359|NCT04175587|Tretinoin|tretinoin|mesh-list
5540360|NCT04175587|Arsenic Trioxide|arsenic trioxide|mesh-list
6467461|NCT00483210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6467462|NCT00483210|Antimetabolites|antimetabolites|mesh-ancestor
5540361|NCT04175587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5540362|NCT04175587|Keratolytic Agents|keratolytic agents|mesh-ancestor
5540363|NCT04175587|Dermatologic Agents|dermatologic agents|mesh-ancestor
5540364|NCT04175470|Tocotrienols|tocotrienols|mesh-list
5540365|NCT04175470|Vitamin E|vitamin e|mesh-list
5540366|NCT04175470|Tocopherols|tocopherols|mesh-list
5540367|NCT04175470|Bevacizumab|bevacizumab|mesh-list
5540368|NCT04175470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5540369|NCT04175470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5540370|NCT04175470|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6136099|NCT01260948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6136100|NCT01260948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136101|NCT01260948|Nootropic Agents|nootropic agents|mesh-ancestor
6136102|NCT01261325|Brivaracetam|brivaracetam|mesh-list
6136103|NCT01261325|Anticonvulsants|anticonvulsants|mesh-list
6136104|NCT01261338|Sucrose polyester|sucrose polyester|mesh-list
6136105|NCT01261338|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6136106|NCT01261338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6136107|NCT01261338|Antimetabolites|antimetabolites|mesh-ancestor
6136108|NCT01261338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136109|NCT01261338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6136110|NCT01261611|Botulinum Toxins|botulinum toxins|mesh-list
6136111|NCT01261611|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6136112|NCT01261611|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6136113|NCT01261611|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6136114|NCT01261611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6136115|NCT01261611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136116|NCT01261611|Cholinergic Agents|cholinergic agents|mesh-ancestor
6136117|NCT01261611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6136118|NCT01261611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136119|NCT01261611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6136120|NCT01261611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6136121|NCT01261793|Epratuzumab|epratuzumab|mesh-list
6467463|NCT00483210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136122|NCT01261793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6136123|NCT01261793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5540371|NCT04175470|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5540372|NCT04175470|Growth Substances|growth substances|mesh-ancestor
5540373|NCT04175470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540374|NCT04175470|Growth Inhibitors|growth inhibitors|mesh-ancestor
5540375|NCT04175470|Antioxidants|antioxidants|mesh-ancestor
5540376|NCT04175470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540377|NCT04175470|Protective Agents|protective agents|mesh-ancestor
5540378|NCT04175470|Vitamins|vitamins|mesh-ancestor
5540379|NCT04175470|Micronutrients|micronutrients|mesh-ancestor
5540380|NCT04175626|Sirolimus|sirolimus|mesh-list
5540381|NCT04175626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5540382|NCT04175626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6136124|NCT01262092|Buprenorphine|buprenorphine|mesh-list
6136125|NCT01262092|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6136126|NCT01262092|Narcotics|narcotics|mesh-ancestor
6136127|NCT01262092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6136128|NCT01262092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467464|NCT00483210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6467465|NCT00483275|Alfacalcidol|alfacalcidol|mesh-list
6467466|NCT00483275|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
6467467|NCT00483275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6467468|NCT00483275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467469|NCT00483275|Vitamins|vitamins|mesh-ancestor
6467470|NCT00483275|Micronutrients|micronutrients|mesh-ancestor
6467471|NCT00483301|Sorafenib|sorafenib|mesh-list
6467472|NCT00483301|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6467473|NCT00483301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6467474|NCT00483301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6467475|NCT00483301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6467476|NCT00483301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467477|NCT00483314|Acetylcysteine|acetylcysteine|mesh-list
6136129|NCT01262092|Analgesics|analgesics|mesh-ancestor
6136130|NCT01262092|Sensory System Agents|sensory system agents|mesh-ancestor
6136131|NCT01262092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6136132|NCT01262092|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6136133|NCT01262118|Tofacitinib|tofacitinib|mesh-list
6136134|NCT01262118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6136135|NCT01262118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6136136|NCT01262118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136137|NCT01262287|Dutasteride|dutasteride|mesh-list
6136138|NCT01262287|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6136139|NCT01262287|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6136140|NCT01262287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6136141|NCT01262287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136142|NCT01262287|Hormone Antagonists|hormone antagonists|mesh-ancestor
6136143|NCT01262287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6136144|NCT01262287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136145|NCT01262352|Ivacaftor|ivacaftor|mesh-list
6136146|NCT01262352|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6136147|NCT01262352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6136148|NCT01262352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136149|NCT01262365|Epratuzumab|epratuzumab|mesh-list
6136150|NCT01262365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6136151|NCT01262365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6136152|NCT01262456|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
6136153|NCT01262456|Hemostatics|hemostatics|mesh-ancestor
6136154|NCT01262456|Coagulants|coagulants|mesh-ancestor
6136155|NCT01262456|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6136156|NCT01262456|Natriuretic Agents|natriuretic agents|mesh-ancestor
6136157|NCT01262456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136158|NCT01262638|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
6136159|NCT01262638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6136160|NCT01262638|Antimetabolites|antimetabolites|mesh-ancestor
6136161|NCT01262638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136162|NCT01262638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6136163|NCT01262638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6136164|NCT01262638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6136165|NCT01262638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136166|NCT01262651|Nabiximols|nabiximols|mesh-list
6467478|NCT00483314|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6467479|NCT00483314|Antiviral Agents|antiviral agents|mesh-ancestor
6467480|NCT00483314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6467481|NCT00483314|Expectorants|expectorants|mesh-ancestor
6467482|NCT00483314|Respiratory System Agents|respiratory system agents|mesh-ancestor
6467483|NCT00483314|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6467484|NCT00483314|Antioxidants|antioxidants|mesh-ancestor
6467485|NCT00483314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467486|NCT00483314|Protective Agents|protective agents|mesh-ancestor
6467487|NCT00483314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540383|NCT04175626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5540384|NCT04175626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5540385|NCT04175626|Antifungal Agents|antifungal agents|mesh-ancestor
6467488|NCT00483314|Antidotes|antidotes|mesh-ancestor
6467489|NCT00483366|Gemcitabine|gemcitabine|mesh-list
6467490|NCT00483366|Capecitabine|capecitabine|mesh-list
6467491|NCT00483366|Imatinib Mesylate|imatinib mesylate|mesh-list
6467492|NCT00483366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6136167|NCT01262651|Analgesics|analgesics|mesh-ancestor
6136168|NCT01262651|Sensory System Agents|sensory system agents|mesh-ancestor
6136169|NCT01262651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6136170|NCT01262651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136171|NCT01262677|Pregabalin|pregabalin|mesh-list
6136172|NCT01262677|Analgesics|analgesics|mesh-ancestor
6136173|NCT01262677|Sensory System Agents|sensory system agents|mesh-ancestor
6136174|NCT01262677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6136175|NCT01262677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136176|NCT01262677|Anticonvulsants|anticonvulsants|mesh-ancestor
6136177|NCT01262677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6136178|NCT01262677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6136179|NCT01262677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136180|NCT01262677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6136181|NCT01262677|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6136182|NCT01262677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6205263|NCT02083679|Tubulin Modulators|tubulin modulators|mesh-ancestor
6467493|NCT00483366|Antimetabolites|antimetabolites|mesh-ancestor
6136183|NCT01262677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6136184|NCT01262677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6136185|NCT01262872|Vaccines|vaccines|mesh-list
6136186|NCT01262872|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6467494|NCT00483366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467495|NCT00483366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6467496|NCT00483366|Antiviral Agents|antiviral agents|mesh-ancestor
6467497|NCT00483366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6467498|NCT00483366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6467499|NCT00483366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6467500|NCT00483366|Immunologic Factors|immunologic factors|mesh-ancestor
6467501|NCT00483366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540386|NCT04175626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6136187|NCT01262872|Immunologic Factors|immunologic factors|mesh-ancestor
6136188|NCT01262872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136189|NCT01263015|Lamivudine|lamivudine|mesh-list
6136190|NCT01263015|Abacavir|abacavir|mesh-list
6136191|NCT01263015|Dideoxynucleosides|dideoxynucleosides|mesh-list
6136192|NCT01263015|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5540387|NCT04175626|Immunologic Factors|immunologic factors|mesh-ancestor
5540388|NCT04175626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540389|NCT04175171|Trastuzumab|trastuzumab|mesh-list
5540390|NCT04175171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5540391|NCT04175171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5540392|NCT04175093|N,N-dimethylarginine|n,n-dimethylarginine|mesh-list
5540393|NCT04175093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5540394|NCT04175093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540395|NCT04175158|Bevacizumab|bevacizumab|mesh-list
5540396|NCT04175158|Endothelial Growth Factors|endothelial growth factors|mesh-list
5540397|NCT04175158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5540398|NCT04175158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6136193|NCT01263015|Dolutegravir|dolutegravir|mesh-list
6136194|NCT01263015|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6136195|NCT01263015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6136196|NCT01263015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6136197|NCT01263015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136198|NCT01263015|Antiviral Agents|antiviral agents|mesh-ancestor
6136199|NCT01263015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6136200|NCT01263015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6136201|NCT01263015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6136202|NCT01263015|Antimetabolites|antimetabolites|mesh-ancestor
6136203|NCT01263015|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6136204|NCT01263015|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6136205|NCT01263093|Clopidogrel|clopidogrel|mesh-list
6136206|NCT01263093|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6136207|NCT01263093|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6136208|NCT01263093|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5540399|NCT04175158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5540400|NCT04175158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5540401|NCT04175158|Growth Substances|growth substances|mesh-ancestor
5540402|NCT04175158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136209|NCT01263093|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6136210|NCT01263093|Purinergic Agents|purinergic agents|mesh-ancestor
6136211|NCT01263093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6136212|NCT01263093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136213|NCT01263093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136214|NCT01263106|Theophylline|theophylline|mesh-list
6136215|NCT01263106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6136216|NCT01263106|Autonomic Agents|autonomic agents|mesh-ancestor
6136217|NCT01263106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6136218|NCT01263106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136219|NCT01263106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6136220|NCT01263106|Respiratory System Agents|respiratory system agents|mesh-ancestor
6136221|NCT01263106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6136222|NCT01263106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6136223|NCT01263106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136224|NCT01263106|Vasodilator Agents|vasodilator agents|mesh-ancestor
6136225|NCT01263106|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6136226|NCT01263106|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6136227|NCT01263106|Purinergic Agents|purinergic agents|mesh-ancestor
6136228|NCT01263106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6136229|NCT01263119|Warfarin|warfarin|mesh-list
5540403|NCT04175158|Growth Inhibitors|growth inhibitors|mesh-ancestor
5540404|NCT04174937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5540405|NCT04174937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6467502|NCT00483366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6467503|NCT00483392|Metformin|metformin|mesh-list
6467504|NCT00483392|Rosiglitazone|rosiglitazone|mesh-list
6467505|NCT00483392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6467506|NCT00483392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467507|NCT00483457|Enzyme Inhibitors|enzyme inhibitors|mesh-list
6467508|NCT00483457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467509|NCT00483470|Vaccines|vaccines|mesh-list
6467510|NCT00483470|Immunologic Factors|immunologic factors|mesh-ancestor
6467511|NCT00483470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467512|NCT00483600|PENTA|penta|mesh-list
6467513|NCT00483600|Fondaparinux|fondaparinux|mesh-list
6467514|NCT00483600|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6467515|NCT00483600|Antithrombins|antithrombins|mesh-ancestor
6467516|NCT00483600|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6467517|NCT00483600|Protease Inhibitors|protease inhibitors|mesh-ancestor
6467518|NCT00483600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6467519|NCT00483600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467520|NCT00483600|Anticoagulants|anticoagulants|mesh-ancestor
6467521|NCT00483600|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6467522|NCT00483600|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6136230|NCT01263119|Anticoagulants|anticoagulants|mesh-ancestor
6136231|NCT01263132|Thiamine|thiamine|mesh-list
6136232|NCT01263132|Vitamin B 12|vitamin b 12|mesh-list
6136233|NCT01263132|Gabapentin|gabapentin|mesh-list
6136234|NCT01263132|Analgesics|analgesics|mesh-ancestor
6467523|NCT00483626|Sildenafil Citrate|sildenafil citrate|mesh-list
6467524|NCT00483626|Vasodilator Agents|vasodilator agents|mesh-ancestor
6467525|NCT00483626|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6467526|NCT00483626|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6467527|NCT00483626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6467528|NCT00483626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467529|NCT00483626|Urological Agents|urological agents|mesh-ancestor
6467530|NCT00483730|Actovegin|actovegin|mesh-list
6467531|NCT00483730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6467532|NCT00483730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467533|NCT00483730|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6467534|NCT00483730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6136235|NCT01263132|Sensory System Agents|sensory system agents|mesh-ancestor
5540406|NCT04175067|Antioxidants|antioxidants|mesh-list
5540407|NCT04175067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540408|NCT04175067|Protective Agents|protective agents|mesh-ancestor
5540409|NCT04175067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540410|NCT04175002|Progesterone|progesterone|mesh-list
5540411|NCT04175002|Progestins|progestins|mesh-ancestor
5540412|NCT04175002|Hormones|hormones|mesh-ancestor
5540413|NCT04175002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5540414|NCT04175002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602227|NCT04860518|Autonomic Agents|autonomic agents|mesh-ancestor
5602228|NCT04860518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5602229|NCT04860518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602230|NCT04860518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5602231|NCT04860518|Glucocorticoids|glucocorticoids|mesh-ancestor
5602232|NCT04860518|Hormones|hormones|mesh-ancestor
5602233|NCT04860518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5602234|NCT04860518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6136236|NCT01263132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6136237|NCT01263132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136238|NCT01263132|Anticonvulsants|anticonvulsants|mesh-ancestor
6136239|NCT01263132|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6467535|NCT00483730|Antioxidants|antioxidants|mesh-ancestor
6467536|NCT00483730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602235|NCT04860518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5602236|NCT04817254|Nivolumab|nivolumab|mesh-list
5602237|NCT04817254|Ipilimumab|ipilimumab|mesh-list
5602238|NCT04817254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5602239|NCT04817254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5602240|NCT04817254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5602241|NCT04817254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602242|NCT04792190|Dapagliflozin|dapagliflozin|mesh-list
5602243|NCT04792190|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5606771|NCT03786783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6136240|NCT01263132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6136241|NCT01263132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6136242|NCT01263132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6467537|NCT00483730|Protective Agents|protective agents|mesh-ancestor
6467538|NCT00483730|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6467539|NCT00483743|Budesonide|budesonide|mesh-list
6136243|NCT01263132|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6136244|NCT01263132|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6136245|NCT01263132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6467540|NCT00483743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6136246|NCT01263132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136247|NCT01263132|Antimanic Agents|antimanic agents|mesh-ancestor
5540415|NCT04174872|Midazolam|midazolam|mesh-list
5540416|NCT04174872|Dexmedetomidine|dexmedetomidine|mesh-list
5540417|NCT04174872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5540418|NCT04174872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5540419|NCT04174872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540420|NCT04174872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5540421|NCT04174872|Analgesics|analgesics|mesh-ancestor
5540422|NCT04174872|Sensory System Agents|sensory system agents|mesh-ancestor
5540423|NCT04174872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5540424|NCT04174872|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5540425|NCT04174872|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5540426|NCT04174872|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5540427|NCT04174872|Adrenergic Agents|adrenergic agents|mesh-ancestor
5540428|NCT04174872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5540429|NCT04174872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540430|NCT04174872|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5540431|NCT04174872|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5540432|NCT04174872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5540433|NCT04174872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5540434|NCT04174872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5540435|NCT04174872|Anesthetics, General|anesthetics, general|mesh-ancestor
5540436|NCT04174872|Anesthetics|anesthetics|mesh-ancestor
5540437|NCT04174872|GABA Modulators|gaba modulators|mesh-ancestor
5540438|NCT04174872|GABA Agents|gaba agents|mesh-ancestor
6136248|NCT01263132|Vitamin B Complex|vitamin b complex|mesh-ancestor
6136249|NCT01263132|Vitamins|vitamins|mesh-ancestor
6136250|NCT01263132|Micronutrients|micronutrients|mesh-ancestor
6136251|NCT01263197|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
6136252|NCT01263197|Propranolol|propranolol|mesh-list
6136253|NCT01263197|Albuterol|albuterol|mesh-list
6136254|NCT01263197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6136255|NCT01263197|Autonomic Agents|autonomic agents|mesh-ancestor
6136256|NCT01263197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6136257|NCT01263197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136258|NCT01263197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6467541|NCT00483743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6467542|NCT00483743|Autonomic Agents|autonomic agents|mesh-ancestor
6467543|NCT00483743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6467544|NCT00483743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540439|NCT04174339|Apatinib|apatinib|mesh-list
5540440|NCT04174339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5540441|NCT04174339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5540442|NCT04174339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5540443|NCT04174339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540444|NCT04174378|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5540445|NCT04174378|Luteolytic Agents|luteolytic agents|mesh-ancestor
5540446|NCT04174378|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6136259|NCT01263197|Respiratory System Agents|respiratory system agents|mesh-ancestor
6467545|NCT00483743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6467546|NCT00483743|Respiratory System Agents|respiratory system agents|mesh-ancestor
6467547|NCT00483743|Glucocorticoids|glucocorticoids|mesh-ancestor
6467548|NCT00483743|Hormones|hormones|mesh-ancestor
6467549|NCT00483743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6467550|NCT00483769|Insulin Glargine|insulin glargine|mesh-list
6467551|NCT00483769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6467552|NCT00483769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467553|NCT00483782|Paclitaxel|paclitaxel|mesh-list
6467554|NCT00483782|Bevacizumab|bevacizumab|mesh-list
6666411|NCT01522820|Sirolimus|sirolimus|mesh-list
6666412|NCT01522820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6136260|NCT01263197|Tocolytic Agents|tocolytic agents|mesh-ancestor
6136261|NCT01263197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6136262|NCT01263197|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6467555|NCT00483782|Carboplatin|carboplatin|mesh-list
6467556|NCT00483782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6666413|NCT01522820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6467557|NCT00483782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6467558|NCT00483782|Tubulin Modulators|tubulin modulators|mesh-ancestor
6467559|NCT00483782|Antimitotic Agents|antimitotic agents|mesh-ancestor
6467560|NCT00483782|Mitosis Modulators|mitosis modulators|mesh-ancestor
6467561|NCT00483782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467562|NCT00483782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6136263|NCT01263197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6136264|NCT01263197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6136265|NCT01263197|Adrenergic Agents|adrenergic agents|mesh-ancestor
6136266|NCT01263197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6136267|NCT01263197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136268|NCT01263197|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6136269|NCT01263197|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6136270|NCT01263197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6136271|NCT01263197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6136272|NCT01263197|Vasodilator Agents|vasodilator agents|mesh-ancestor
6136273|NCT01263197|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6136274|NCT01263197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6136275|NCT01263197|Disinfectants|disinfectants|mesh-ancestor
6205264|NCT02083679|Antimitotic Agents|antimitotic agents|mesh-ancestor
6205265|NCT02083679|Mitosis Modulators|mitosis modulators|mesh-ancestor
6205266|NCT02083679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205267|NCT02083679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5540447|NCT04174378|Contraceptive Agents|contraceptive agents|mesh-ancestor
5540448|NCT04174378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5540449|NCT04174378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540450|NCT04174378|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5540451|NCT04174378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5540452|NCT04174378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5540453|NCT04174365|Brexpiprazole|brexpiprazole|mesh-list
5540454|NCT04174365|Serotonin Agents|serotonin agents|mesh-ancestor
5540455|NCT04174365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5540456|NCT04174365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205268|NCT02083679|Antimetabolites|antimetabolites|mesh-ancestor
6205269|NCT02083679|Antiviral Agents|antiviral agents|mesh-ancestor
6205270|NCT02083679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6205271|NCT02083679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6205272|NCT02083679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6467563|NCT00483782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6467564|NCT00483782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6467565|NCT00483782|Growth Substances|growth substances|mesh-ancestor
6467566|NCT00483782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467567|NCT00483782|Growth Inhibitors|growth inhibitors|mesh-ancestor
6467568|NCT00483795|Citric Acid|citric acid|mesh-list
6467569|NCT00483795|Sodium Citrate|sodium citrate|mesh-list
6467570|NCT00483795|Anticoagulants|anticoagulants|mesh-ancestor
6467571|NCT00483795|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6467572|NCT00483795|Chelating Agents|chelating agents|mesh-ancestor
6467573|NCT00483795|Sequestering Agents|sequestering agents|mesh-ancestor
6467574|NCT00483795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540457|NCT04174365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540458|NCT04174365|Dopamine Agonists|dopamine agonists|mesh-ancestor
5540459|NCT04174365|Dopamine Agents|dopamine agents|mesh-ancestor
5540460|NCT04174352|Tamoxifen|tamoxifen|mesh-list
5540461|NCT04174352|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6467575|NCT00483834|Bevacizumab|bevacizumab|mesh-list
6467576|NCT00483834|Capecitabine|capecitabine|mesh-list
6467577|NCT00483834|Irinotecan|irinotecan|mesh-list
6467578|NCT00483834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6467579|NCT00483834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6467580|NCT00483834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6467581|NCT00483834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6205273|NCT02083679|Immunologic Factors|immunologic factors|mesh-ancestor
6205274|NCT02083679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205275|NCT02083679|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6205276|NCT02083679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6205277|NCT02083783|Amphetamine|amphetamine|mesh-list
6205278|NCT02083783|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6205279|NCT02083783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205280|NCT02083783|Sympathomimetics|sympathomimetics|mesh-ancestor
6205281|NCT02083783|Autonomic Agents|autonomic agents|mesh-ancestor
6467582|NCT00483834|Growth Substances|growth substances|mesh-ancestor
6467583|NCT00483834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467584|NCT00483834|Growth Inhibitors|growth inhibitors|mesh-ancestor
6136276|NCT01263444|Timolol|timolol|mesh-list
6136277|NCT01263444|Bimatoprost|bimatoprost|mesh-list
6136278|NCT01263444|Travoprost|travoprost|mesh-list
6136279|NCT01263444|Latanoprost|latanoprost|mesh-list
6136280|NCT01263444|Brinzolamide|brinzolamide|mesh-list
6136281|NCT01263444|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6136282|NCT01263444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6136283|NCT01263444|Adrenergic Agents|adrenergic agents|mesh-ancestor
6136284|NCT01263444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6136285|NCT01263444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136286|NCT01263444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467585|NCT00483834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6467586|NCT00483834|Antimetabolites|antimetabolites|mesh-ancestor
6467587|NCT00483834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467588|NCT00483834|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6467589|NCT00483834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6467590|NCT00483834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6467591|NCT00483860|Topotecan|topotecan|mesh-list
6467592|NCT00483860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6467593|NCT00483860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6467594|NCT00483860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5540462|NCT04174352|Hormone Antagonists|hormone antagonists|mesh-ancestor
5540463|NCT04174352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5540464|NCT04174352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540465|NCT04174352|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5540466|NCT04174352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5540467|NCT04174352|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5540468|NCT04174352|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5540469|NCT04174352|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5540470|NCT04174261|Clopidogrel|clopidogrel|mesh-list
6467595|NCT00483860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467596|NCT00483860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6467597|NCT00483886|Prucalopride|prucalopride|mesh-list
6467598|NCT00483886|Laxatives|laxatives|mesh-ancestor
6467599|NCT00483886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6467600|NCT00483886|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
6467601|NCT00483886|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6467602|NCT00483886|Serotonin Agents|serotonin agents|mesh-ancestor
6467603|NCT00483886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6467604|NCT00483886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467605|NCT00483886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467606|NCT00483964|Olanzapine|olanzapine|mesh-list
5540471|NCT04174261|Ticagrelor|ticagrelor|mesh-list
5540472|NCT04174261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5540473|NCT04174261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5540474|NCT04174261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5540475|NCT04174261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5540476|NCT04174261|Purinergic Agents|purinergic agents|mesh-ancestor
5540477|NCT04174261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6136287|NCT01263444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6467607|NCT00483964|Antiemetics|antiemetics|mesh-ancestor
6467608|NCT00483964|Autonomic Agents|autonomic agents|mesh-ancestor
6467609|NCT00483964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6467610|NCT00483964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467611|NCT00483964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6467612|NCT00483964|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6467613|NCT00483964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6467614|NCT00483964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6467615|NCT00483964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6467616|NCT00483964|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6467617|NCT00483964|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6467618|NCT00483964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6467619|NCT00483964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467620|NCT00483964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6467621|NCT00483964|Serotonin Agents|serotonin agents|mesh-ancestor
6467622|NCT00483990|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
6467623|NCT00483990|Anesthetics, Local|anesthetics, local|mesh-ancestor
6467624|NCT00483990|Anesthetics|anesthetics|mesh-ancestor
6467625|NCT00483990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6467626|NCT00483990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467627|NCT00483990|Sensory System Agents|sensory system agents|mesh-ancestor
6467628|NCT00483990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6467629|NCT00483990|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
5540478|NCT04174261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540479|NCT04174261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540480|NCT04173871|Snake venom protein C activator|snake venom protein c activator|mesh-list
5540481|NCT04173871|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5540482|NCT04173871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5540483|NCT04173871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467630|NCT00484003|Pimecrolimus|pimecrolimus|mesh-list
6467631|NCT00484003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6467632|NCT00484003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5540484|NCT04173832|Amantadine|amantadine|mesh-list
5540485|NCT04173832|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5540486|NCT04173832|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5540487|NCT04173832|Antiviral Agents|antiviral agents|mesh-ancestor
5540488|NCT04173832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5540489|NCT04173832|Dopamine Agents|dopamine agents|mesh-ancestor
5540490|NCT04173832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5540491|NCT04173832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540492|NCT04173832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540493|NCT04173832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5540494|NCT04173832|Analgesics|analgesics|mesh-ancestor
5540495|NCT04173832|Sensory System Agents|sensory system agents|mesh-ancestor
5540496|NCT04173832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5540497|NCT04174131|Lidocaine|lidocaine|mesh-list
5540498|NCT04174131|Hyaluronic Acid|hyaluronic acid|mesh-list
5540499|NCT04174131|Anesthetics, Local|anesthetics, local|mesh-ancestor
5540500|NCT04174131|Anesthetics|anesthetics|mesh-ancestor
5540501|NCT04174131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5540502|NCT04174131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540503|NCT04174131|Sensory System Agents|sensory system agents|mesh-ancestor
5540504|NCT04174131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5540505|NCT04174131|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5540506|NCT04174131|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5540507|NCT04174131|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5540508|NCT04174131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5540509|NCT04174131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540510|NCT04174131|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5540511|NCT04174131|Immunologic Factors|immunologic factors|mesh-ancestor
5540512|NCT04174131|Viscosupplements|viscosupplements|mesh-ancestor
5540513|NCT04174131|Protective Agents|protective agents|mesh-ancestor
5540514|NCT04173858|Naloxegol|naloxegol|mesh-list
6467633|NCT00484003|Analgesics|analgesics|mesh-ancestor
6467634|NCT00484003|Sensory System Agents|sensory system agents|mesh-ancestor
6467635|NCT00484003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6467636|NCT00484003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467637|NCT00484003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6467638|NCT00484003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6467639|NCT00484003|Dermatologic Agents|dermatologic agents|mesh-ancestor
5540515|NCT04173858|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5540516|NCT04173858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540517|NCT04173858|Sensory System Agents|sensory system agents|mesh-ancestor
5540518|NCT04173858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6467640|NCT00484003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6467641|NCT00484003|Immunologic Factors|immunologic factors|mesh-ancestor
6467642|NCT00484003|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6467643|NCT00484003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6467644|NCT00484003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467645|NCT00484055|Gentamicins|gentamicins|mesh-list
6467646|NCT00484055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6467647|NCT00484055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6467648|NCT00484055|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6467649|NCT00484055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6467650|NCT00484055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467651|NCT00484068|Enalapril|enalapril|mesh-list
6467652|NCT00484068|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5540519|NCT04173962|Midazolam|midazolam|mesh-list
5540520|NCT04173962|Ketamine|ketamine|mesh-list
5540521|NCT04173962|Analgesics|analgesics|mesh-ancestor
5540522|NCT04173962|Sensory System Agents|sensory system agents|mesh-ancestor
5540523|NCT04173962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5540524|NCT04173962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540525|NCT04173962|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5540526|NCT04173962|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5540527|NCT04173962|Anesthetics, General|anesthetics, general|mesh-ancestor
5540528|NCT04173962|Anesthetics|anesthetics|mesh-ancestor
6467653|NCT00484068|Protease Inhibitors|protease inhibitors|mesh-ancestor
6467654|NCT00484068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6467655|NCT00484068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467656|NCT00484068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6467657|NCT00484107|Estrogens|estrogens|mesh-list
6467658|NCT00484107|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6467659|NCT00484107|Hormones|hormones|mesh-ancestor
5540529|NCT04173962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5540530|NCT04173962|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5540531|NCT04173962|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5540532|NCT04173962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5540533|NCT04173962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540534|NCT04173962|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5540535|NCT04173962|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5540536|NCT04173962|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5540537|NCT04173962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5540538|NCT04173962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5540539|NCT04173962|GABA Modulators|gaba modulators|mesh-ancestor
5540540|NCT04173962|GABA Agents|gaba agents|mesh-ancestor
5540541|NCT04174170|Sertraline|sertraline|mesh-list
5540542|NCT04174170|Brexpiprazole|brexpiprazole|mesh-list
5540543|NCT04174170|Antidepressive Agents|antidepressive agents|mesh-ancestor
5540544|NCT04174170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5540545|NCT04174170|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5540546|NCT04174170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5540547|NCT04174170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5540548|NCT04174170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540549|NCT04174170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5540550|NCT04174170|Serotonin Agents|serotonin agents|mesh-ancestor
5540551|NCT04174170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540552|NCT04174170|Dopamine Agonists|dopamine agonists|mesh-ancestor
5540553|NCT04174170|Dopamine Agents|dopamine agents|mesh-ancestor
5540554|NCT04173988|Cyclophosphamide|cyclophosphamide|mesh-list
5540555|NCT04173988|Fludarabine|fludarabine|mesh-list
5540556|NCT04173988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5540557|NCT04173988|Immunologic Factors|immunologic factors|mesh-ancestor
5540558|NCT04173988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540559|NCT04173988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6136288|NCT01263444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6136289|NCT01263444|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6136290|NCT01263444|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6136291|NCT01263444|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6136292|NCT01263444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6136293|NCT01263470|Alogliptin|alogliptin|mesh-list
6136294|NCT01263470|Voglibose|voglibose|mesh-list
6136295|NCT01263470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6136296|NCT01263470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136297|NCT01263470|Incretins|incretins|mesh-ancestor
6467660|NCT00484107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6467661|NCT00484107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467662|NCT00484120|Diclofenac|diclofenac|mesh-list
6467663|NCT00484120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6467664|NCT00484120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6467665|NCT00484120|Analgesics|analgesics|mesh-ancestor
6467666|NCT00484120|Sensory System Agents|sensory system agents|mesh-ancestor
6467667|NCT00484120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6467668|NCT00484120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467669|NCT00484120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6467670|NCT00484120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6467671|NCT00484120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6467672|NCT00484120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6467673|NCT00484120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467674|NCT00484133|Dobutamine|dobutamine|mesh-list
6467675|NCT00484133|Dopamine|dopamine|mesh-list
6136298|NCT01263470|Hormones|hormones|mesh-ancestor
6136299|NCT01263470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6136300|NCT01263470|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6136301|NCT01263470|Protease Inhibitors|protease inhibitors|mesh-ancestor
6136302|NCT01263470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6136303|NCT01263470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136304|NCT01263470|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6136305|NCT01263483|Inositol|inositol|mesh-list
6136306|NCT01263483|Alogliptin|alogliptin|mesh-list
6136307|NCT01263483|Voglibose|voglibose|mesh-list
6136308|NCT01263483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6467676|NCT00484133|Enoximone|enoximone|mesh-list
5540560|NCT04173988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5540561|NCT04173988|Alkylating Agents|alkylating agents|mesh-ancestor
5540562|NCT04173988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540563|NCT04173988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5540564|NCT04173988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5540565|NCT04173949|Ramipril|ramipril|mesh-list
5540566|NCT04173949|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5540567|NCT04173949|Protease Inhibitors|protease inhibitors|mesh-ancestor
5540568|NCT04173949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5540569|NCT04173949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540570|NCT04173949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5540571|NCT04173793|Ezetimibe|ezetimibe|mesh-list
5540572|NCT04173793|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5540573|NCT04173793|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5540574|NCT04173793|Antimetabolites|antimetabolites|mesh-ancestor
5540575|NCT04173793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540576|NCT04173793|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5540577|NCT04173780|Atropine|atropine|mesh-list
5540578|NCT04173780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5540579|NCT04173780|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5540580|NCT04173780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5540581|NCT04173780|Autonomic Agents|autonomic agents|mesh-ancestor
5540582|NCT04173780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5540583|NCT04173780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136309|NCT01263483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136310|NCT01263483|Incretins|incretins|mesh-ancestor
6136311|NCT01263483|Hormones|hormones|mesh-ancestor
6136312|NCT01263483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6136313|NCT01263483|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6136314|NCT01263483|Protease Inhibitors|protease inhibitors|mesh-ancestor
6136315|NCT01263483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6136316|NCT01263483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136317|NCT01263483|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6467677|NCT00484133|Norepinephrine|norepinephrine|mesh-list
6467678|NCT00484133|Nitroglycerin|nitroglycerin|mesh-list
6467679|NCT00484133|Vasodilator Agents|vasodilator agents|mesh-ancestor
6467680|NCT00484133|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6467681|NCT00484133|Sympathomimetics|sympathomimetics|mesh-ancestor
6467682|NCT00484133|Autonomic Agents|autonomic agents|mesh-ancestor
6467683|NCT00484133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6467684|NCT00484133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467685|NCT00484133|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6467686|NCT00484133|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6467687|NCT00484133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6467688|NCT00484133|Adrenergic Agents|adrenergic agents|mesh-ancestor
6467689|NCT00484133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6467690|NCT00484133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467691|NCT00484133|Protective Agents|protective agents|mesh-ancestor
6467692|NCT00484133|Dopamine Agents|dopamine agents|mesh-ancestor
6467693|NCT00484133|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6467694|NCT00484133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6467695|NCT00484133|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6467696|NCT00484133|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5540584|NCT04173780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5540585|NCT04173780|Respiratory System Agents|respiratory system agents|mesh-ancestor
5540586|NCT04173780|Mydriatics|mydriatics|mesh-ancestor
5540587|NCT04173780|Parasympatholytics|parasympatholytics|mesh-ancestor
5540588|NCT04173780|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5540589|NCT04173780|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5540590|NCT04173780|Cholinergic Agents|cholinergic agents|mesh-ancestor
5540591|NCT04173780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5540592|NCT04173780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136318|NCT01263483|Vitamin B Complex|vitamin b complex|mesh-ancestor
6136319|NCT01263483|Vitamins|vitamins|mesh-ancestor
6136320|NCT01263483|Micronutrients|micronutrients|mesh-ancestor
6136321|NCT01263496|Alogliptin|alogliptin|mesh-list
6136322|NCT01263496|Voglibose|voglibose|mesh-list
6136323|NCT01263496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6136324|NCT01263496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136325|NCT01263496|Incretins|incretins|mesh-ancestor
6136326|NCT01263496|Hormones|hormones|mesh-ancestor
6136327|NCT01263496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6136328|NCT01263496|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6136329|NCT01263496|Protease Inhibitors|protease inhibitors|mesh-ancestor
5540593|NCT04173416|Analgesics, Opioid|analgesics, opioid|mesh-list
5540594|NCT04173416|Narcotics|narcotics|mesh-ancestor
5540595|NCT04173416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5540596|NCT04173416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540597|NCT04173416|Analgesics|analgesics|mesh-ancestor
5540598|NCT04173416|Sensory System Agents|sensory system agents|mesh-ancestor
5540599|NCT04173416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5540600|NCT04173403|Ezetimibe|ezetimibe|mesh-list
5540601|NCT04173403|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5540602|NCT04173403|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5540603|NCT04173403|Antimetabolites|antimetabolites|mesh-ancestor
5540604|NCT04173403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540605|NCT04173403|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5540606|NCT04173585|Bortezomib|bortezomib|mesh-list
5540607|NCT04173585|Gemtuzumab|gemtuzumab|mesh-list
5540608|NCT04173585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5540609|NCT04173585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5540610|NCT04173390|Pregabalin|pregabalin|mesh-list
5540611|NCT04173390|Analgesics|analgesics|mesh-ancestor
5540612|NCT04173390|Sensory System Agents|sensory system agents|mesh-ancestor
5540613|NCT04173390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5540614|NCT04173390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540615|NCT04173390|Anticonvulsants|anticonvulsants|mesh-ancestor
5540616|NCT04173390|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5540617|NCT04173390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5540618|NCT04173390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540619|NCT04173390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5540620|NCT04173390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5540621|NCT04173390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5540622|NCT04173390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5540623|NCT04173390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5540624|NCT04173507|Avelumab|avelumab|mesh-list
5540625|NCT04173507|Talazoparib|talazoparib|mesh-list
5540626|NCT04173507|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5540627|NCT04173507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6467697|NCT00484133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6467698|NCT00484237|Etanercept|etanercept|mesh-list
6467699|NCT00484237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6467700|NCT00484237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6467701|NCT00484237|Analgesics|analgesics|mesh-ancestor
6136330|NCT01263496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6136331|NCT01263496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136332|NCT01263496|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6467702|NCT00484237|Sensory System Agents|sensory system agents|mesh-ancestor
6467703|NCT00484237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6467704|NCT00484237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467705|NCT00484237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6467706|NCT00484237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6467707|NCT00484237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6467708|NCT00484237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6467709|NCT00484237|Immunologic Factors|immunologic factors|mesh-ancestor
6467710|NCT00484250|Metronidazole|metronidazole|mesh-list
6467711|NCT00484250|Doxycycline|doxycycline|mesh-list
6467712|NCT00484250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6467713|NCT00484250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6467714|NCT00484250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6467715|NCT00484250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6467716|NCT00484250|Antimalarials|antimalarials|mesh-ancestor
6488488|NCT00584532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6488489|NCT00584571|Dexetimide|dexetimide|mesh-list
6488490|NCT00584571|Citalopram|citalopram|mesh-list
6488491|NCT00584571|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6488492|NCT00584571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6488493|NCT00584571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6488494|NCT00584571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488495|NCT00584571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6488496|NCT00584571|Serotonin Agents|serotonin agents|mesh-ancestor
6488497|NCT00584571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488498|NCT00584571|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6488499|NCT00584571|Antidepressive Agents|antidepressive agents|mesh-ancestor
6136333|NCT01263509|Inositol|inositol|mesh-list
6136334|NCT01263509|Alogliptin|alogliptin|mesh-list
6136335|NCT01263509|Voglibose|voglibose|mesh-list
5540628|NCT04173507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6136336|NCT01263509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6488500|NCT00584571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6136337|NCT01263509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136338|NCT01263509|Incretins|incretins|mesh-ancestor
6136339|NCT01263509|Hormones|hormones|mesh-ancestor
6136340|NCT01263509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6136341|NCT01263509|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6467717|NCT00484328|Ribavirin|ribavirin|mesh-list
6467718|NCT00484328|Antimetabolites|antimetabolites|mesh-ancestor
6467719|NCT00484328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467720|NCT00484328|Antiviral Agents|antiviral agents|mesh-ancestor
6467721|NCT00484328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6467722|NCT00484341|Doxorubicin|doxorubicin|mesh-list
6467723|NCT00484341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6467724|NCT00484341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6467725|NCT00484341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6467726|NCT00484341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6467727|NCT00484341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6467728|NCT00484341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467729|NCT00484432|Doxorubicin|doxorubicin|mesh-list
6467730|NCT00484432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6467731|NCT00484432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6467732|NCT00484432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6467733|NCT00484432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6467734|NCT00484432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6467735|NCT00484432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467736|NCT00484471|Valproic Acid|valproic acid|mesh-list
6136342|NCT01263509|Protease Inhibitors|protease inhibitors|mesh-ancestor
5540629|NCT04173507|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5540630|NCT04173507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5540631|NCT04173507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540632|NCT04173507|Immunologic Factors|immunologic factors|mesh-ancestor
5540633|NCT04173507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540634|NCT04173611|Bupivacaine|bupivacaine|mesh-list
5540635|NCT04173611|Anesthetics, Local|anesthetics, local|mesh-ancestor
5540636|NCT04173611|Anesthetics|anesthetics|mesh-ancestor
5540637|NCT04173611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5540638|NCT04173611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540639|NCT04173611|Sensory System Agents|sensory system agents|mesh-ancestor
5540640|NCT04173611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6136343|NCT01263509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6136344|NCT01263509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467737|NCT00484471|Aripiprazole|aripiprazole|mesh-list
6467738|NCT00484471|Antidepressive Agents|antidepressive agents|mesh-ancestor
5725513|NCT03180255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5725514|NCT03180255|Glucocorticoids|glucocorticoids|mesh-ancestor
5725515|NCT03180255|Hormones|hormones|mesh-ancestor
5725516|NCT03180255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5725517|NCT03180255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5725518|NCT03180255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5725519|NCT03180255|Anticoagulants|anticoagulants|mesh-ancestor
5725520|NCT03180190|Hydroxychloroquine|hydroxychloroquine|mesh-list
5725521|NCT03180190|Antimalarials|antimalarials|mesh-ancestor
5725522|NCT03180190|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5725523|NCT03180190|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5725524|NCT03180190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5725525|NCT03180190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5540641|NCT04173364|Ropivacaine|ropivacaine|mesh-list
5540642|NCT04173364|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5540643|NCT04173364|Anesthetics, Local|anesthetics, local|mesh-ancestor
5540644|NCT04173364|Anesthetics|anesthetics|mesh-ancestor
5540645|NCT04173364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5540646|NCT04173364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540647|NCT04173364|Sensory System Agents|sensory system agents|mesh-ancestor
5540648|NCT04173364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5540649|NCT04173338|Pemetrexed|pemetrexed|mesh-list
5540650|NCT04173338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5540651|NCT04173338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5540652|NCT04173338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540653|NCT04173338|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5540654|NCT04173338|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5540655|NCT04173325|Nivolumab|nivolumab|mesh-list
5540656|NCT04173325|Irinotecan|irinotecan|mesh-list
6467739|NCT00484471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5540657|NCT04173325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5725722|NCT03178292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6467740|NCT00484471|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6467741|NCT00484471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6467742|NCT00484471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6467743|NCT00484471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467744|NCT00484471|Dopamine Agonists|dopamine agonists|mesh-ancestor
6467745|NCT00484471|Dopamine Agents|dopamine agents|mesh-ancestor
6467746|NCT00484471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6467747|NCT00484471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467748|NCT00484471|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6467749|NCT00484471|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5540658|NCT04173325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5540659|NCT04173325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5540660|NCT04173325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540661|NCT04173325|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5540662|NCT04173325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5540663|NCT04173325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5540664|NCT04173039|Antibodies|antibodies|mesh-list
5540665|NCT04173039|Immunologic Factors|immunologic factors|mesh-ancestor
6467750|NCT00484471|Serotonin Agents|serotonin agents|mesh-ancestor
6467751|NCT00484471|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5725526|NCT03180190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725527|NCT03180190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5725528|NCT03180099|Bupivacaine|bupivacaine|mesh-list
5725529|NCT03180099|Anesthetics, Local|anesthetics, local|mesh-ancestor
6467752|NCT00484471|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6467753|NCT00484471|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6467754|NCT00484471|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6467755|NCT00484471|Anticonvulsants|anticonvulsants|mesh-ancestor
6467756|NCT00484471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6467757|NCT00484471|GABA Agents|gaba agents|mesh-ancestor
6467758|NCT00484471|Antimanic Agents|antimanic agents|mesh-ancestor
6467759|NCT00484484|Ketamine|ketamine|mesh-list
6467760|NCT00484484|Analgesics|analgesics|mesh-ancestor
6467761|NCT00484484|Sensory System Agents|sensory system agents|mesh-ancestor
6467762|NCT00484484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6467763|NCT00484484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467764|NCT00484484|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6467765|NCT00484484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6467766|NCT00484484|Anesthetics, General|anesthetics, general|mesh-ancestor
6467767|NCT00484484|Anesthetics|anesthetics|mesh-ancestor
6467768|NCT00484484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6467769|NCT00484484|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6467770|NCT00484484|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6467771|NCT00484484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6467772|NCT00484484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540666|NCT04173039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540667|NCT04172961|Cyclosporine|cyclosporine|mesh-list
5540668|NCT04172961|Lifitegrast|lifitegrast|mesh-list
5540669|NCT04172961|Cyclosporins|cyclosporins|mesh-list
5540670|NCT04172961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5540671|NCT04172961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540672|NCT04172961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5540673|NCT04172961|Immunologic Factors|immunologic factors|mesh-ancestor
5540674|NCT04172961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540675|NCT04172961|Antifungal Agents|antifungal agents|mesh-ancestor
5540676|NCT04172961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6467773|NCT00484510|Ascorbic Acid|ascorbic acid|mesh-list
6467774|NCT00484510|Vitamins|vitamins|mesh-ancestor
6467775|NCT00484510|Micronutrients|micronutrients|mesh-ancestor
6467776|NCT00484510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467777|NCT00484510|Antioxidants|antioxidants|mesh-ancestor
6467778|NCT00484510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467779|NCT00484510|Protective Agents|protective agents|mesh-ancestor
6467780|NCT00484575|Propofol|propofol|mesh-list
6467781|NCT00484575|Sevoflurane|sevoflurane|mesh-list
6467782|NCT00484575|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6467783|NCT00484575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6467784|NCT00484575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467785|NCT00484575|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6467786|NCT00484575|Anesthetics, General|anesthetics, general|mesh-ancestor
6467787|NCT00484575|Anesthetics|anesthetics|mesh-ancestor
6467788|NCT00484575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6467789|NCT00484575|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5540677|NCT04172961|Dermatologic Agents|dermatologic agents|mesh-ancestor
5540678|NCT04172961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6467790|NCT00484601|Doxorubicin|doxorubicin|mesh-list
6467791|NCT00484601|Ifosfamide|ifosfamide|mesh-list
6467792|NCT00484601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5540679|NCT04172961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5540680|NCT04172961|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5540681|NCT04172961|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5540682|NCT04172987|Tirzepatide|tirzepatide|mesh-list
5540683|NCT04172987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5540684|NCT04172987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540685|NCT04172987|Incretins|incretins|mesh-ancestor
5540686|NCT04172987|Hormones|hormones|mesh-ancestor
5540687|NCT04172987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5602244|NCT04792190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602245|NCT04792190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5602246|NCT04792190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602247|NCT04763928|Decitabine|decitabine|mesh-list
5602248|NCT04763928|Venetoclax|venetoclax|mesh-list
5602249|NCT04763928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5602250|NCT04763928|Antimetabolites|antimetabolites|mesh-ancestor
6467793|NCT00484601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6467794|NCT00484601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6467795|NCT00484601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5725530|NCT03180099|Anesthetics|anesthetics|mesh-ancestor
5725531|NCT03180099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5602251|NCT04763928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602252|NCT04763928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5602253|NCT04763928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5602254|NCT04761822|Vaccines|vaccines|mesh-list
5602255|NCT04761822|Immunologic Factors|immunologic factors|mesh-ancestor
5602256|NCT04761822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602257|NCT04749108|Folfirinox|folfirinox|mesh-list
5602258|NCT04749108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5602259|NCT04748224|Dexmedetomidine|dexmedetomidine|mesh-list
5725532|NCT03180099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725533|NCT03180099|Sensory System Agents|sensory system agents|mesh-ancestor
5725534|NCT03180099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6136345|NCT01263509|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
5602260|NCT04748224|Bupivacaine|bupivacaine|mesh-list
5602261|NCT04748224|Anesthetics, Local|anesthetics, local|mesh-ancestor
5602262|NCT04748224|Anesthetics|anesthetics|mesh-ancestor
5602263|NCT04748224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5602264|NCT04748224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602265|NCT04748224|Sensory System Agents|sensory system agents|mesh-ancestor
5602266|NCT04748224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5602267|NCT04748224|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5602268|NCT04748224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6136346|NCT01263509|Vitamin B Complex|vitamin b complex|mesh-ancestor
6136347|NCT01263509|Vitamins|vitamins|mesh-ancestor
6136348|NCT01263509|Micronutrients|micronutrients|mesh-ancestor
6136349|NCT01263691|Vaccines|vaccines|mesh-list
6136350|NCT01263691|Immunologic Factors|immunologic factors|mesh-ancestor
6136351|NCT01263691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136352|NCT01263704|Cyclophosphamide|cyclophosphamide|mesh-list
6136353|NCT01263704|Rituximab|rituximab|mesh-list
6136354|NCT01263704|Fludarabine|fludarabine|mesh-list
6136355|NCT01263704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6136356|NCT01263704|Immunologic Factors|immunologic factors|mesh-ancestor
6136357|NCT01263704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540688|NCT04172922|Sirolimus|sirolimus|mesh-list
5540689|NCT04172922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5540690|NCT04172922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5540691|NCT04172922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5540692|NCT04172922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5540693|NCT04172922|Antifungal Agents|antifungal agents|mesh-ancestor
5540694|NCT04172922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5540695|NCT04172922|Immunologic Factors|immunologic factors|mesh-ancestor
5540696|NCT04172922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540697|NCT04172727|Bupivacaine|bupivacaine|mesh-list
5540698|NCT04172727|Anesthetics, Local|anesthetics, local|mesh-ancestor
6136358|NCT01263704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6136359|NCT01263704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6136360|NCT01263704|Alkylating Agents|alkylating agents|mesh-ancestor
6136361|NCT01263704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136362|NCT01263704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6136363|NCT01263704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6136364|NCT01263704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6136365|NCT01263717|Hormones|hormones|mesh-list
6136366|NCT01263717|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
6136367|NCT01263717|Tesamorelin|tesamorelin|mesh-list
6136368|NCT01263717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6136369|NCT01263717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467796|NCT00484601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6467797|NCT00484601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467798|NCT00484601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6467799|NCT00484601|Alkylating Agents|alkylating agents|mesh-ancestor
6467800|NCT00484640|Warfarin|warfarin|mesh-list
6467801|NCT00484640|Anticoagulants|anticoagulants|mesh-ancestor
6467802|NCT00484692|Bupropion|bupropion|mesh-list
6467803|NCT00484692|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6467804|NCT00484692|Antidepressive Agents|antidepressive agents|mesh-ancestor
6467805|NCT00484692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6467806|NCT00484692|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6467807|NCT00484692|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6467808|NCT00484692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6136370|NCT01263717|Growth Substances|growth substances|mesh-ancestor
6136371|NCT01263782|Bevacizumab|bevacizumab|mesh-list
6136372|NCT01263782|Carboplatin|carboplatin|mesh-list
6136373|NCT01263782|Pemetrexed|pemetrexed|mesh-list
5540699|NCT04172727|Anesthetics|anesthetics|mesh-ancestor
5540700|NCT04172727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5540701|NCT04172727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540702|NCT04172727|Sensory System Agents|sensory system agents|mesh-ancestor
5540703|NCT04172727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5540704|NCT04172844|Azacitidine|azacitidine|mesh-list
5540705|NCT04172844|Venetoclax|venetoclax|mesh-list
5540706|NCT04172844|Enzyme Inhibitors|enzyme inhibitors|mesh-list
5540707|NCT04172844|Pevonedistat|pevonedistat|mesh-list
5540708|NCT04172844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5540709|NCT04172844|Antimetabolites|antimetabolites|mesh-ancestor
5540710|NCT04172844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540711|NCT04172844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5540712|NCT04172831|Cyclobenzaprine|cyclobenzaprine|mesh-list
5540713|NCT04172831|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5540714|NCT04172831|Antidepressive Agents|antidepressive agents|mesh-ancestor
5540715|NCT04172831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5540716|NCT04172831|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5540717|NCT04172831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540718|NCT04172831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5540719|NCT04172831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5540720|NCT04172831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5540721|NCT04172831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5540722|NCT04172779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6136374|NCT01263782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6136375|NCT01263782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6136376|NCT01263782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6136377|NCT01263782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6136378|NCT01263782|Growth Substances|growth substances|mesh-ancestor
6136379|NCT01263782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540723|NCT04172779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5540724|NCT04172779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5540725|NCT04172779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5540726|NCT04172779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540727|NCT04172701|Cholinergic Agents|cholinergic agents|mesh-list
6136380|NCT01263782|Growth Inhibitors|growth inhibitors|mesh-ancestor
6136381|NCT01263782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6136382|NCT01263782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467809|NCT00484692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467810|NCT00484692|Dopamine Agents|dopamine agents|mesh-ancestor
6467811|NCT00484692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6467812|NCT00484692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467813|NCT00484692|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6467814|NCT00484692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6136383|NCT01263782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6136384|NCT01263782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6136385|NCT01263925|Pentoxifylline|pentoxifylline|mesh-list
6136386|NCT01263925|Alprostadil|alprostadil|mesh-list
6136387|NCT01263925|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6136388|NCT01263925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6136389|NCT01263925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136390|NCT01263925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6136391|NCT01263925|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6467815|NCT00484692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6467816|NCT00484731|Bupivacaine|bupivacaine|mesh-list
6136392|NCT01263925|Protective Agents|protective agents|mesh-ancestor
6136393|NCT01263925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136394|NCT01263925|Vasodilator Agents|vasodilator agents|mesh-ancestor
6136395|NCT01263925|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6136396|NCT01263925|Antioxidants|antioxidants|mesh-ancestor
6136397|NCT01263925|Urological Agents|urological agents|mesh-ancestor
6136398|NCT01263938|Atorvastatin|atorvastatin|mesh-list
6136399|NCT01263938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6136400|NCT01263938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6136401|NCT01263938|Antimetabolites|antimetabolites|mesh-ancestor
6136402|NCT01263938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136403|NCT01263938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6136404|NCT01263938|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6136405|NCT01263938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6136406|NCT01264081|Lapatinib|lapatinib|mesh-list
6136407|NCT01264081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6136408|NCT01264081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6136409|NCT01264081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6136410|NCT01264081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136411|NCT01264705|Sorafenib|sorafenib|mesh-list
5540728|NCT04172701|Muscarinic Antagonists|muscarinic antagonists|mesh-list
5540729|NCT04172701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5540730|NCT04172701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540731|NCT04172701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540732|NCT04172701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5540733|NCT04172740|Calcium|calcium|mesh-list
5540734|NCT04172740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5540735|NCT04172740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540736|NCT04172363|Octenidine|octenidine|mesh-list
5540737|NCT04172363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5540738|NCT04172363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5540739|NCT04172311|Levetiracetam|levetiracetam|mesh-list
5540740|NCT04172311|Anticonvulsants|anticonvulsants|mesh-ancestor
5540741|NCT04172311|Nootropic Agents|nootropic agents|mesh-ancestor
5540742|NCT04172220|Midazolam|midazolam|mesh-list
5540743|NCT04172220|Anesthetics|anesthetics|mesh-list
5540744|NCT04172220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5540745|NCT04172220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540746|NCT04172220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5540747|NCT04172220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5540748|NCT04172220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5540749|NCT04172220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5540750|NCT04172220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6136412|NCT01264705|Bavituximab|bavituximab|mesh-list
6136413|NCT01264705|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6136414|NCT01264705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6136415|NCT01264705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6136416|NCT01264705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6136417|NCT01264705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136418|NCT01264705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5540751|NCT04172220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5540752|NCT04172220|Anesthetics, General|anesthetics, general|mesh-ancestor
5540753|NCT04172220|GABA Modulators|gaba modulators|mesh-ancestor
5540754|NCT04172220|GABA Agents|gaba agents|mesh-ancestor
6136419|NCT01264705|Immunologic Factors|immunologic factors|mesh-ancestor
6136420|NCT01264705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540755|NCT04172220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5540756|NCT04172220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540757|NCT04172064|Dobutamine|dobutamine|mesh-list
5540758|NCT04172064|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5540759|NCT04172064|Sympathomimetics|sympathomimetics|mesh-ancestor
5540760|NCT04172064|Autonomic Agents|autonomic agents|mesh-ancestor
5540761|NCT04172064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5540762|NCT04172064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540763|NCT04172064|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5540764|NCT04172064|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5540765|NCT04172064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5540766|NCT04172064|Adrenergic Agents|adrenergic agents|mesh-ancestor
5540767|NCT04172064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5540768|NCT04172064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136421|NCT01264770|Adalimumab|adalimumab|mesh-list
6136422|NCT01264770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6467817|NCT00484731|Anesthetics, Local|anesthetics, local|mesh-ancestor
6467818|NCT00484731|Anesthetics|anesthetics|mesh-ancestor
6467819|NCT00484731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6467820|NCT00484731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467821|NCT00484731|Sensory System Agents|sensory system agents|mesh-ancestor
6467822|NCT00484731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6467823|NCT00484744|Acetaminophen|acetaminophen|mesh-list
6467824|NCT00484744|Ibuprofen|ibuprofen|mesh-list
6136423|NCT01264770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6136424|NCT01264887|Tapentadol|tapentadol|mesh-list
6136425|NCT01264887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6136426|NCT01264887|Narcotics|narcotics|mesh-ancestor
6136427|NCT01264887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6136428|NCT01264887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540769|NCT04172064|Protective Agents|protective agents|mesh-ancestor
5540770|NCT04172259|Cyclophosphamide|cyclophosphamide|mesh-list
5540771|NCT04172259|Docetaxel|docetaxel|mesh-list
5540772|NCT04172259|Doxorubicin|doxorubicin|mesh-list
5540773|NCT04172259|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5540774|NCT04172259|Trastuzumab|trastuzumab|mesh-list
5540775|NCT04172259|Epirubicin|epirubicin|mesh-list
5540776|NCT04172259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5540777|NCT04172259|Immunologic Factors|immunologic factors|mesh-ancestor
5540778|NCT04172259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540779|NCT04172259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5540780|NCT04172259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5540781|NCT04172259|Alkylating Agents|alkylating agents|mesh-ancestor
5540782|NCT04172259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540783|NCT04172259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5540784|NCT04172259|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5540785|NCT04172259|Tubulin Modulators|tubulin modulators|mesh-ancestor
5540786|NCT04172259|Antimitotic Agents|antimitotic agents|mesh-ancestor
5540787|NCT04172259|Mitosis Modulators|mitosis modulators|mesh-ancestor
6136429|NCT01264887|Analgesics|analgesics|mesh-ancestor
6136430|NCT01264887|Sensory System Agents|sensory system agents|mesh-ancestor
6136431|NCT01264887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6136432|NCT01264887|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6136433|NCT01264887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6136434|NCT01264887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6136435|NCT01264887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136436|NCT01264887|Adrenergic Agents|adrenergic agents|mesh-ancestor
6136437|NCT01264887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6136438|NCT01264939|Omalizumab|omalizumab|mesh-list
6136439|NCT01264939|Diphenhydramine|diphenhydramine|mesh-list
6136440|NCT01264939|Promethazine|promethazine|mesh-list
6136441|NCT01264939|Leukotriene Antagonists|leukotriene antagonists|mesh-list
6136442|NCT01264939|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
6136443|NCT01264939|Histamine Antagonists|histamine antagonists|mesh-list
6136444|NCT01264939|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6136445|NCT01264939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6136446|NCT01264939|Respiratory System Agents|respiratory system agents|mesh-ancestor
6136447|NCT01264939|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6136448|NCT01264939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6136449|NCT01264939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5540788|NCT04172259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5540789|NCT04172259|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5540790|NCT04172259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6136450|NCT01264939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136451|NCT01264939|Anesthetics, Local|anesthetics, local|mesh-ancestor
6136452|NCT01264939|Anesthetics|anesthetics|mesh-ancestor
6136453|NCT01264939|Sensory System Agents|sensory system agents|mesh-ancestor
5540791|NCT04172259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5540792|NCT04172259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5540793|NCT04172246|Zanubrutinib|zanubrutinib|mesh-list
5540794|NCT04172246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5540795|NCT04172246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5540796|NCT04172246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5540797|NCT04172246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540798|NCT04171791|Venetoclax|venetoclax|mesh-list
5540799|NCT04171791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5540800|NCT04171726|Edoxaban|edoxaban|mesh-list
5540801|NCT04171726|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5540802|NCT04171726|Antithrombins|antithrombins|mesh-ancestor
5540803|NCT04171726|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5540804|NCT04171726|Protease Inhibitors|protease inhibitors|mesh-ancestor
5540805|NCT04171726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5540806|NCT04171726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540807|NCT04171726|Anticoagulants|anticoagulants|mesh-ancestor
5540808|NCT04171622|Pembrolizumab|pembrolizumab|mesh-list
5540809|NCT04171622|Lenvatinib|lenvatinib|mesh-list
5540810|NCT04171622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5540811|NCT04171622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5540812|NCT04171622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5540813|NCT04171622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5540814|NCT04171622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540815|NCT04171817|Chlorhexidine|chlorhexidine|mesh-list
5540816|NCT04171817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5540817|NCT04171817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6136454|NCT01264939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6136455|NCT01264939|Antiemetics|antiemetics|mesh-ancestor
6136456|NCT01264939|Autonomic Agents|autonomic agents|mesh-ancestor
6136457|NCT01264939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6136458|NCT01264939|Histamine Agents|histamine agents|mesh-ancestor
6136459|NCT01264939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6136460|NCT01264939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136461|NCT01264939|Antipruritics|antipruritics|mesh-ancestor
6136462|NCT01264939|Dermatologic Agents|dermatologic agents|mesh-ancestor
6136463|NCT01264939|Hormone Antagonists|hormone antagonists|mesh-ancestor
6136464|NCT01264939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6136465|NCT01265056|Gabapentin|gabapentin|mesh-list
6136466|NCT01265056|Analgesics|analgesics|mesh-ancestor
6136467|NCT01265056|Sensory System Agents|sensory system agents|mesh-ancestor
6136468|NCT01265056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6136469|NCT01265056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136470|NCT01265056|Anticonvulsants|anticonvulsants|mesh-ancestor
6136471|NCT01265056|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6136472|NCT01265056|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6136473|NCT01265056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6136474|NCT01265056|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6467825|NCT00484744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6467826|NCT00484744|Analgesics|analgesics|mesh-ancestor
6467827|NCT00484744|Sensory System Agents|sensory system agents|mesh-ancestor
6467828|NCT00484744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6467829|NCT00484744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467830|NCT00484744|Antipyretics|antipyretics|mesh-ancestor
6467831|NCT00484744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6467832|NCT00484744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6467833|NCT00484744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6467834|NCT00484744|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6467835|NCT00484744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5540818|NCT04171817|Disinfectants|disinfectants|mesh-ancestor
6136475|NCT01265056|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5540819|NCT04171687|Clopidogrel|clopidogrel|mesh-list
5540820|NCT04171687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5540821|NCT04171687|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5540822|NCT04171687|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5540823|NCT04171687|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5540824|NCT04171687|Purinergic Agents|purinergic agents|mesh-ancestor
5602269|NCT04748224|Analgesics|analgesics|mesh-ancestor
6136476|NCT01265056|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6136477|NCT01265056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6467836|NCT00484744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136478|NCT01265056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136479|NCT01265056|Antimanic Agents|antimanic agents|mesh-ancestor
6136480|NCT01265394|Flutemetamol|flutemetamol|mesh-list
6136481|NCT01265394|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6136482|NCT01265394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136483|NCT01265446|Lidocaine|lidocaine|mesh-list
6136484|NCT01265446|Anesthetics, Local|anesthetics, local|mesh-ancestor
6136485|NCT01265446|Anesthetics|anesthetics|mesh-ancestor
6136486|NCT01265446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6136487|NCT01265446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136488|NCT01265446|Sensory System Agents|sensory system agents|mesh-ancestor
6136489|NCT01265446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6136490|NCT01265446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6136491|NCT01265446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6136492|NCT01265446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6136493|NCT01265446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6136494|NCT01265446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136495|NCT01265498|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
6136496|NCT01265498|Cathartics|cathartics|mesh-ancestor
6136497|NCT01265498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6136498|NCT01265511|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6467837|NCT00484770|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6467838|NCT00484770|Natriuretic Agents|natriuretic agents|mesh-ancestor
6467839|NCT00484770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467840|NCT00484809|Etanercept|etanercept|mesh-list
6467841|NCT00484809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6467842|NCT00484809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5540825|NCT04171687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5540826|NCT04171687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540827|NCT04171687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540828|NCT04171843|Cyclophosphamide|cyclophosphamide|mesh-list
5540829|NCT04171843|Fludarabine|fludarabine|mesh-list
5540830|NCT04171843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6467843|NCT00484809|Analgesics|analgesics|mesh-ancestor
6467844|NCT00484809|Sensory System Agents|sensory system agents|mesh-ancestor
6467845|NCT00484809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5540831|NCT04171843|Immunologic Factors|immunologic factors|mesh-ancestor
5540832|NCT04171843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540833|NCT04171843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5540834|NCT04171843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5540835|NCT04171843|Alkylating Agents|alkylating agents|mesh-ancestor
5540836|NCT04171843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540837|NCT04171843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5540838|NCT04171843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5540839|NCT04171388|Micronutrients|micronutrients|mesh-list
5540840|NCT04171388|Trace Elements|trace elements|mesh-list
5540841|NCT04171388|Azithromycin|azithromycin|mesh-list
5540842|NCT04171388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5540843|NCT04171388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6467846|NCT00484809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467847|NCT00484809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6467848|NCT00484809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6467849|NCT00484809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6467850|NCT00484809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6467851|NCT00484809|Immunologic Factors|immunologic factors|mesh-ancestor
6467852|NCT00484822|Heparin|heparin|mesh-list
6467853|NCT00484822|Calcium heparin|calcium heparin|mesh-list
6467854|NCT00484822|Anticoagulants|anticoagulants|mesh-ancestor
6467855|NCT00484822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6467856|NCT00484822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6467857|NCT00484822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467858|NCT00484900|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6467859|NCT00484900|Antimalarials|antimalarials|mesh-ancestor
6467860|NCT00484900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6467861|NCT00484900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6467862|NCT00484900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6467863|NCT00484926|Aspirin|aspirin|mesh-list
6467864|NCT00484926|Clopidogrel|clopidogrel|mesh-list
6467865|NCT00484926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6467866|NCT00484926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6467867|NCT00484926|Analgesics|analgesics|mesh-ancestor
6467868|NCT00484926|Sensory System Agents|sensory system agents|mesh-ancestor
6467869|NCT00484926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5540844|NCT04171388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467870|NCT00484926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467871|NCT00484926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6467872|NCT00484926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6467873|NCT00484926|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6467874|NCT00484926|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6467875|NCT00484926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467876|NCT00484926|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6467877|NCT00484926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6467878|NCT00484926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6467879|NCT00484926|Antipyretics|antipyretics|mesh-ancestor
6467880|NCT00484926|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6467881|NCT00484926|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6467882|NCT00484926|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6467883|NCT00484926|Purinergic Agents|purinergic agents|mesh-ancestor
6467884|NCT00484926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6467885|NCT00484991|Verapamil|verapamil|mesh-list
6136499|NCT01265511|Antiviral Agents|antiviral agents|mesh-ancestor
6136500|NCT01265511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6136501|NCT01265537|Tacrolimus|tacrolimus|mesh-list
6136502|NCT01265537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5540845|NCT04171427|Lithium Carbonate|lithium carbonate|mesh-list
5540846|NCT04171427|Antidepressive Agents|antidepressive agents|mesh-ancestor
5540847|NCT04171427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5540848|NCT04171427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5540849|NCT04171427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136503|NCT01265537|Immunologic Factors|immunologic factors|mesh-ancestor
6467886|NCT00484991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6467887|NCT00484991|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6467888|NCT00484991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6467889|NCT00484991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467890|NCT00484991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6467891|NCT00484991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467892|NCT00484991|Vasodilator Agents|vasodilator agents|mesh-ancestor
6467893|NCT00485004|Sirolimus|sirolimus|mesh-list
6467894|NCT00485004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6467895|NCT00485004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6467896|NCT00485004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6467897|NCT00485004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6467898|NCT00485004|Antifungal Agents|antifungal agents|mesh-ancestor
6467899|NCT00485004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5540850|NCT04171427|Antimanic Agents|antimanic agents|mesh-ancestor
5540851|NCT04171427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5540852|NCT04171427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5540853|NCT04171427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540854|NCT04171739|Itraconazole|itraconazole|mesh-list
5540855|NCT04171739|Olorofim|olorofim|mesh-list
5540856|NCT04171739|Rifampin|rifampin|mesh-list
5540857|NCT04171739|Antifungal Agents|antifungal agents|mesh-ancestor
5540858|NCT04171739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5540859|NCT04171739|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5540860|NCT04171739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6467900|NCT00485004|Immunologic Factors|immunologic factors|mesh-ancestor
6467901|NCT00485004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136504|NCT01265537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136505|NCT01265537|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6136506|NCT01265537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6136507|NCT01265537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136508|NCT01265550|Baclofen|baclofen|mesh-list
6136509|NCT01265550|Desipramine|desipramine|mesh-list
6136510|NCT01265550|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6136511|NCT01265550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136512|NCT01265550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6136513|NCT01265550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6136514|NCT01265550|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6136515|NCT01265550|GABA Agonists|gaba agonists|mesh-ancestor
6136516|NCT01265550|GABA Agents|gaba agents|mesh-ancestor
6467902|NCT00485030|Sirolimus|sirolimus|mesh-list
6467903|NCT00485030|Everolimus|everolimus|mesh-list
6467904|NCT00485030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6467905|NCT00485030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6467906|NCT00485030|Immunologic Factors|immunologic factors|mesh-ancestor
6467907|NCT00485030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467908|NCT00485030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6467909|NCT00485030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5540861|NCT04171739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6467910|NCT00485030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5540862|NCT04171739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540863|NCT04171739|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5540864|NCT04171739|Hormone Antagonists|hormone antagonists|mesh-ancestor
5540865|NCT04171739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5540866|NCT04171739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540867|NCT04171739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5540868|NCT04171739|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5540869|NCT04171739|Antitubercular Agents|antitubercular agents|mesh-ancestor
6467911|NCT00485030|Antifungal Agents|antifungal agents|mesh-ancestor
6467912|NCT00485056|Pioglitazone|pioglitazone|mesh-list
6467913|NCT00485056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6467914|NCT00485056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467915|NCT00485108|Prednisolone|prednisolone|mesh-list
6136517|NCT01265550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6136518|NCT01265550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136519|NCT01265550|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6136520|NCT01265550|Antidepressive Agents|antidepressive agents|mesh-ancestor
6136521|NCT01265550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6136522|NCT01265550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6666414|NCT01522820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5540870|NCT04171739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5540871|NCT04171739|Leprostatic Agents|leprostatic agents|mesh-ancestor
5540872|NCT04171739|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5540873|NCT04171739|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5540874|NCT04171739|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5540875|NCT04171739|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5540876|NCT04171739|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5540877|NCT04171739|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5540878|NCT04171739|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5540879|NCT04171674|Ceftobiprole|ceftobiprole|mesh-list
5540880|NCT04171674|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
5540881|NCT04171674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5540882|NCT04171674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5540883|NCT04171466|Metronidazole|metronidazole|mesh-list
5540884|NCT04171466|Ciprofloxacin|ciprofloxacin|mesh-list
5540885|NCT04171466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5540886|NCT04171466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5540887|NCT04171466|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6666415|NCT01522820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6666416|NCT01522820|Antifungal Agents|antifungal agents|mesh-ancestor
6136523|NCT01265550|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6136524|NCT01265550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6136525|NCT01265550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6467916|NCT00485108|Ketorolac|ketorolac|mesh-list
6467917|NCT00485108|Lubricant Eye Drops|lubricant eye drops|mesh-list
6467918|NCT00485108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6467919|NCT00485108|Glucocorticoids|glucocorticoids|mesh-ancestor
6467920|NCT00485108|Hormones|hormones|mesh-ancestor
6467921|NCT00485108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6467922|NCT00485108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467923|NCT00485108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6467924|NCT00485108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6467925|NCT00485108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6467926|NCT00485108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6467927|NCT00485108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6467928|NCT00485108|Analgesics|analgesics|mesh-ancestor
6467929|NCT00485108|Sensory System Agents|sensory system agents|mesh-ancestor
6467930|NCT00485108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6467931|NCT00485108|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6467932|NCT00485108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6467933|NCT00485108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467934|NCT00485108|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6467935|NCT00485108|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6666417|NCT01522820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6136526|NCT01265550|Adrenergic Agents|adrenergic agents|mesh-ancestor
5540888|NCT04171466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5540889|NCT04171466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5540890|NCT04171466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5540891|NCT04171466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5540892|NCT04171466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540893|NCT04171466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6136527|NCT01265563|Acetylcysteine|acetylcysteine|mesh-list
6136528|NCT01265563|Silybin|silybin|mesh-list
6136529|NCT01265563|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6136530|NCT01265563|Antiviral Agents|antiviral agents|mesh-ancestor
6136531|NCT01265563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6136532|NCT01265563|Expectorants|expectorants|mesh-ancestor
6136533|NCT01265563|Respiratory System Agents|respiratory system agents|mesh-ancestor
6136534|NCT01265563|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6136535|NCT01265563|Antioxidants|antioxidants|mesh-ancestor
6136536|NCT01265563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136537|NCT01265563|Protective Agents|protective agents|mesh-ancestor
6136538|NCT01265563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136539|NCT01265563|Antidotes|antidotes|mesh-ancestor
6136540|NCT01265563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6136541|NCT01265563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6136542|NCT01265615|Cholecalciferol|cholecalciferol|mesh-list
6136543|NCT01265615|Calcitriol|calcitriol|mesh-list
6136544|NCT01265615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6136545|NCT01265615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136546|NCT01265615|Vitamins|vitamins|mesh-ancestor
6136547|NCT01265615|Micronutrients|micronutrients|mesh-ancestor
6136548|NCT01265615|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6136549|NCT01265615|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6136550|NCT01265615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6136551|NCT01265615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136552|NCT01265615|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5540894|NCT04171466|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5540895|NCT04171466|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5540896|NCT04171180|Budesonide|budesonide|mesh-list
5540897|NCT04171180|Formoterol Fumarate|formoterol fumarate|mesh-list
5540898|NCT04171180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5540899|NCT04171180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5540900|NCT04171180|Autonomic Agents|autonomic agents|mesh-ancestor
5540901|NCT04171180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5540902|NCT04171180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540903|NCT04171180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5540904|NCT04171180|Respiratory System Agents|respiratory system agents|mesh-ancestor
5540905|NCT04171180|Glucocorticoids|glucocorticoids|mesh-ancestor
5540906|NCT04171180|Hormones|hormones|mesh-ancestor
5540907|NCT04171180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5540908|NCT04171180|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5540909|NCT04171180|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5540910|NCT04171180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5540911|NCT04171180|Adrenergic Agents|adrenergic agents|mesh-ancestor
5540912|NCT04171180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5540913|NCT04171180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602270|NCT04748224|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5602271|NCT04748224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5602272|NCT04748224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5602273|NCT04748224|Adrenergic Agents|adrenergic agents|mesh-ancestor
5602274|NCT04748224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5602275|NCT04748224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602276|NCT04744116|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
5602277|NCT04744116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5602278|NCT04744116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6136553|NCT01265823|Adalimumab|adalimumab|mesh-list
6136554|NCT01265823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6136555|NCT01265823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6136556|NCT01265875|Secretin|secretin|mesh-list
6136557|NCT01265875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6136558|NCT01265875|Hormones|hormones|mesh-ancestor
6136559|NCT01265875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6136560|NCT01265875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136561|NCT01265953|Sulforaphane|sulforaphane|mesh-list
6136562|NCT01265953|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6136563|NCT01265953|Protective Agents|protective agents|mesh-ancestor
6136564|NCT01265953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136565|NCT01265953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6136566|NCT01266148|Cyclosporine|cyclosporine|mesh-list
6666418|NCT01522820|Immunologic Factors|immunologic factors|mesh-ancestor
6666419|NCT01522820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666420|NCT01522846|Heparin|heparin|mesh-list
6666421|NCT01522846|Anticoagulants|anticoagulants|mesh-ancestor
6666422|NCT01522846|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6666423|NCT01522846|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5540914|NCT04171193|Isoflurane|isoflurane|mesh-list
5540915|NCT04171193|Sertraline|sertraline|mesh-list
5540916|NCT04171193|Antidepressive Agents|antidepressive agents|mesh-ancestor
5540917|NCT04171193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5540918|NCT04171193|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5540919|NCT04171193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5540920|NCT04171193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5540921|NCT04171193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540922|NCT04171193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5540923|NCT04171193|Serotonin Agents|serotonin agents|mesh-ancestor
5540924|NCT04171193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540925|NCT04171193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5540926|NCT04171193|Anesthetics, General|anesthetics, general|mesh-ancestor
6666424|NCT01522846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666425|NCT01522872|Dexamethasone|dexamethasone|mesh-list
6666426|NCT01522872|Dexamethasone acetate|dexamethasone acetate|mesh-list
6666427|NCT01522872|Bortezomib|bortezomib|mesh-list
6666428|NCT01522872|Pomalidomide|pomalidomide|mesh-list
6136567|NCT01266148|Mycophenolic Acid|mycophenolic acid|mesh-list
6136568|NCT01266148|Everolimus|everolimus|mesh-list
6136569|NCT01266148|Cyclosporins|cyclosporins|mesh-list
6136570|NCT01266148|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6136571|NCT01266148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6136572|NCT01266148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666429|NCT01522872|Phosphoramide Mustards|phosphoramide mustards|mesh-list
6666430|NCT01522872|BB 1101|bb 1101|mesh-list
5540927|NCT04171193|Anesthetics|anesthetics|mesh-ancestor
5540928|NCT04171193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5540929|NCT04171258|Botulinum Toxins|botulinum toxins|mesh-list
5540930|NCT04171258|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5540931|NCT04171258|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5540932|NCT04171258|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5540933|NCT04171258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5540934|NCT04171258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540935|NCT04171258|Cholinergic Agents|cholinergic agents|mesh-ancestor
5540936|NCT04171258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5540937|NCT04171258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540938|NCT04171258|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5540939|NCT04171258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5540940|NCT04171349|Dexmedetomidine|dexmedetomidine|mesh-list
5540941|NCT04171349|Carticaine|carticaine|mesh-list
5540942|NCT04171349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5540943|NCT04171349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5540944|NCT04171349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540945|NCT04171349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5540946|NCT04171349|Analgesics|analgesics|mesh-ancestor
5540947|NCT04171349|Sensory System Agents|sensory system agents|mesh-ancestor
6666431|NCT01522872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6666432|NCT01522872|Antiemetics|antiemetics|mesh-ancestor
6666433|NCT01522872|Autonomic Agents|autonomic agents|mesh-ancestor
5540948|NCT04171349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5540949|NCT04171349|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5540950|NCT04171349|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5540951|NCT04171349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5540952|NCT04171349|Adrenergic Agents|adrenergic agents|mesh-ancestor
5540953|NCT04171349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5540954|NCT04171349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540955|NCT04171349|Anesthetics, Local|anesthetics, local|mesh-ancestor
5540956|NCT04171349|Anesthetics|anesthetics|mesh-ancestor
5540957|NCT04171284|Docetaxel|docetaxel|mesh-list
5540958|NCT04171284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6666434|NCT01522872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6136573|NCT01266148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6136574|NCT01266148|Immunologic Factors|immunologic factors|mesh-ancestor
6136575|NCT01266148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136576|NCT01266148|Antifungal Agents|antifungal agents|mesh-ancestor
6136577|NCT01266148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6136578|NCT01266148|Dermatologic Agents|dermatologic agents|mesh-ancestor
6136579|NCT01266148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6136580|NCT01266148|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6136581|NCT01266148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6136582|NCT01266148|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6136583|NCT01266148|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6136584|NCT01266148|Antitubercular Agents|antitubercular agents|mesh-ancestor
6136585|NCT01266148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6666435|NCT01522872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136586|NCT01266161|Ibuprofen|ibuprofen|mesh-list
6136587|NCT01266161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6136588|NCT01266161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6136589|NCT01266161|Analgesics|analgesics|mesh-ancestor
6136590|NCT01266161|Sensory System Agents|sensory system agents|mesh-ancestor
6136591|NCT01266161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6136592|NCT01266161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136593|NCT01266161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6136594|NCT01266161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6136595|NCT01266161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6136596|NCT01266161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6136597|NCT01266161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136598|NCT01266265|Treprostinil|treprostinil|mesh-list
6136599|NCT01266265|Bosentan|bosentan|mesh-list
6136600|NCT01266265|Ambrisentan|ambrisentan|mesh-list
6136601|NCT01266265|Epoprostenol|epoprostenol|mesh-list
6136602|NCT01266265|Sildenafil Citrate|sildenafil citrate|mesh-list
6136603|NCT01266265|Tadalafil|tadalafil|mesh-list
6136604|NCT01266265|Iloprost|iloprost|mesh-list
6136605|NCT01266265|Tezosentan|tezosentan|mesh-list
6136606|NCT01266265|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
5540959|NCT04171284|Tubulin Modulators|tubulin modulators|mesh-ancestor
5540960|NCT04171284|Antimitotic Agents|antimitotic agents|mesh-ancestor
5540961|NCT04171284|Mitosis Modulators|mitosis modulators|mesh-ancestor
5540962|NCT04171284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540963|NCT04171050|Anesthetics|anesthetics|mesh-list
5540964|NCT04171050|Anesthetics, Local|anesthetics, local|mesh-list
5540965|NCT04171050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5540966|NCT04171050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540967|NCT04171050|Sensory System Agents|sensory system agents|mesh-ancestor
5540968|NCT04171050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5540969|NCT04170855|Furosemide|furosemide|mesh-list
5540970|NCT04170855|Diuretics|diuretics|mesh-ancestor
5540971|NCT04170855|Natriuretic Agents|natriuretic agents|mesh-ancestor
5540972|NCT04170855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540973|NCT04170855|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5540974|NCT04170855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5540975|NCT04170855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540976|NCT04170751|Vasopressins|vasopressins|mesh-list
5540977|NCT04170751|Arginine Vasopressin|arginine vasopressin|mesh-list
6136607|NCT01266265|Vasodilator Agents|vasodilator agents|mesh-ancestor
6136608|NCT01266265|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6136609|NCT01266265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6136610|NCT01266265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136611|NCT01266265|Urological Agents|urological agents|mesh-ancestor
6136612|NCT01266265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6136613|NCT01266265|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6136614|NCT01266265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6136615|NCT01266291|Vigabatrin|vigabatrin|mesh-list
6136616|NCT01266291|Anticonvulsants|anticonvulsants|mesh-ancestor
6136617|NCT01266291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6136618|NCT01266291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136619|NCT01266291|GABA Agents|gaba agents|mesh-ancestor
6136620|NCT01266291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6136621|NCT01266291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136622|NCT01266317|Rituximab|rituximab|mesh-list
6136623|NCT01266317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6136624|NCT01266317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6467936|NCT00485121|Ezetimibe|ezetimibe|mesh-list
6467937|NCT00485121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6136625|NCT01266317|Immunologic Factors|immunologic factors|mesh-ancestor
6136626|NCT01266317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136627|NCT01266317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5540978|NCT04170751|Norepinephrine|norepinephrine|mesh-list
5540979|NCT04170751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5540980|NCT04170751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5540981|NCT04170751|Adrenergic Agents|adrenergic agents|mesh-ancestor
5540982|NCT04170751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6136628|NCT01266447|Topotecan|topotecan|mesh-list
6136629|NCT01266447|Veliparib|veliparib|mesh-list
6136630|NCT01266447|Lenograstim|lenograstim|mesh-list
6136631|NCT01266447|Sargramostim|sargramostim|mesh-list
6136632|NCT01266447|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6136633|NCT01266447|Immunologic Factors|immunologic factors|mesh-ancestor
6136634|NCT01266447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136635|NCT01266447|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6136636|NCT01266447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6136637|NCT01266447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6136638|NCT01266447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136639|NCT01266447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6136640|NCT01266447|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6136641|NCT01266460|Vaccines|vaccines|mesh-list
6136642|NCT01266460|Immunologic Factors|immunologic factors|mesh-ancestor
6136643|NCT01266460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136644|NCT01266590|Digoxin|digoxin|mesh-list
6136645|NCT01266590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6136646|NCT01266590|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6136647|NCT01266590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6136648|NCT01266590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136649|NCT01266590|Protective Agents|protective agents|mesh-ancestor
6136650|NCT01266590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136651|NCT01266603|Aldesleukin|aldesleukin|mesh-list
6136652|NCT01266603|Interleukin-2|interleukin-2|mesh-list
5540983|NCT04170751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5540984|NCT04170751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5540985|NCT04170751|Sympathomimetics|sympathomimetics|mesh-ancestor
5540986|NCT04170751|Autonomic Agents|autonomic agents|mesh-ancestor
5540987|NCT04170751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5540988|NCT04170751|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5540989|NCT04170751|Hemostatics|hemostatics|mesh-ancestor
5540990|NCT04170751|Coagulants|coagulants|mesh-ancestor
5540991|NCT04170751|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5540992|NCT04170751|Natriuretic Agents|natriuretic agents|mesh-ancestor
5540993|NCT04171219|Pembrolizumab|pembrolizumab|mesh-list
5540994|NCT04171219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5540995|NCT04171219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5540996|NCT04170946|Talazoparib|talazoparib|mesh-list
5540997|NCT04170946|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5540998|NCT04170946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5540999|NCT04170946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136653|NCT01266603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6136654|NCT01266603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6136655|NCT01266603|Analgesics|analgesics|mesh-ancestor
6136656|NCT01266603|Sensory System Agents|sensory system agents|mesh-ancestor
6136657|NCT01266603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6136658|NCT01266603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136659|NCT01266603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6136660|NCT01266603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6136661|NCT01266603|Antiviral Agents|antiviral agents|mesh-ancestor
6136662|NCT01266603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6136663|NCT01266902|Rilpivirine|rilpivirine|mesh-list
6136664|NCT01266902|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6136665|NCT01266902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6666436|NCT01522872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5541000|NCT04170946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5541001|NCT04170959|Metformin|metformin|mesh-list
5541002|NCT04170959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5541003|NCT04170959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541004|NCT04170595|Trastuzumab|trastuzumab|mesh-list
5541005|NCT04170595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5541006|NCT04170595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5541007|NCT04170530|Oxaliplatin|oxaliplatin|mesh-list
5541008|NCT04170530|Irinotecan|irinotecan|mesh-list
5541009|NCT04170530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6136666|NCT01266902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6136667|NCT01266902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136668|NCT01266902|Antiviral Agents|antiviral agents|mesh-ancestor
5541010|NCT04170530|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5541011|NCT04170530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5541012|NCT04170530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5541013|NCT04170530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541014|NCT04170790|Saxagliptin|saxagliptin|mesh-list
5541015|NCT04170790|Sildenafil Citrate|sildenafil citrate|mesh-list
5541016|NCT04170790|Vasodilator Agents|vasodilator agents|mesh-ancestor
5541017|NCT04170790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5541018|NCT04170790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6136669|NCT01266902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6136670|NCT01266902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6136671|NCT01266902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6136672|NCT01266967|Dabrafenib|dabrafenib|mesh-list
6136673|NCT01266967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6136674|NCT01266967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6136675|NCT01266967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6136676|NCT01266967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136677|NCT01267136|Acetaminophen|acetaminophen|mesh-list
6136678|NCT01267136|Tramadol|tramadol|mesh-list
5541019|NCT04170790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5541020|NCT04170790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541021|NCT04170790|Urological Agents|urological agents|mesh-ancestor
6136679|NCT01267136|Codeine|codeine|mesh-list
6136680|NCT01267136|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6136681|NCT01267136|Analgesics|analgesics|mesh-ancestor
6136682|NCT01267136|Sensory System Agents|sensory system agents|mesh-ancestor
6136683|NCT01267136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6136684|NCT01267136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136685|NCT01267136|Antipyretics|antipyretics|mesh-ancestor
6467938|NCT00485121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6467939|NCT00485121|Antimetabolites|antimetabolites|mesh-ancestor
6467940|NCT00485121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467941|NCT00485121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6467942|NCT00485160|Ibuprofen|ibuprofen|mesh-list
6467943|NCT00485160|Indomethacin|indomethacin|mesh-list
6467944|NCT00485160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6467945|NCT00485160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6467946|NCT00485160|Analgesics|analgesics|mesh-ancestor
6467947|NCT00485160|Sensory System Agents|sensory system agents|mesh-ancestor
6467948|NCT00485160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6467949|NCT00485160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467950|NCT00485160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6136686|NCT01267136|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6136687|NCT01267136|Narcotics|narcotics|mesh-ancestor
6136688|NCT01267136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6136689|NCT01267136|Antitussive Agents|antitussive agents|mesh-ancestor
6136690|NCT01267136|Respiratory System Agents|respiratory system agents|mesh-ancestor
6136691|NCT01267175|Insulin|insulin|mesh-list
6136692|NCT01267175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6136693|NCT01267175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136694|NCT01267201|Methylprednisolone|methylprednisolone|mesh-list
6136695|NCT01267201|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6136696|NCT01267201|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6136697|NCT01267201|Prednisolone|prednisolone|mesh-list
6136698|NCT01267201|Prednisolone acetate|prednisolone acetate|mesh-list
6136699|NCT01267201|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6136700|NCT01267201|Prednisolone phosphate|prednisolone phosphate|mesh-list
6136701|NCT01267201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6136702|NCT01267201|Antiemetics|antiemetics|mesh-ancestor
6136703|NCT01267201|Autonomic Agents|autonomic agents|mesh-ancestor
6136704|NCT01267201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6136705|NCT01267201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136706|NCT01267201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5541022|NCT04170790|Incretins|incretins|mesh-ancestor
5541023|NCT04170790|Hormones|hormones|mesh-ancestor
5541024|NCT04170790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5541025|NCT04170790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541026|NCT04170790|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5541027|NCT04170790|Protease Inhibitors|protease inhibitors|mesh-ancestor
5541028|NCT04170790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5541029|NCT04170647|Plasminogen|plasminogen|mesh-list
5541030|NCT04170647|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5541031|NCT04170647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5541032|NCT04170647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541033|NCT04170439|Chromium|chromium|mesh-list
5541034|NCT04170439|Metformin|metformin|mesh-list
5541035|NCT04170439|Citric Acid|citric acid|mesh-list
5541036|NCT04170439|Sodium Citrate|sodium citrate|mesh-list
5541037|NCT04170439|Clomiphene|clomiphene|mesh-list
5541038|NCT04170439|Enclomiphene|enclomiphene|mesh-list
5541039|NCT04170439|Zuclomiphene|zuclomiphene|mesh-list
5541040|NCT04170439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5541041|NCT04170439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541042|NCT04170439|Anticoagulants|anticoagulants|mesh-ancestor
5541043|NCT04170439|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5541044|NCT04170439|Chelating Agents|chelating agents|mesh-ancestor
5541045|NCT04170439|Sequestering Agents|sequestering agents|mesh-ancestor
5541046|NCT04170439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541047|NCT04170439|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5541048|NCT04170439|Hormone Antagonists|hormone antagonists|mesh-ancestor
5541049|NCT04170439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5541050|NCT04170439|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5541051|NCT04170439|Fertility Agents|fertility agents|mesh-ancestor
5541052|NCT04170439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5541053|NCT04170439|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5541054|NCT04170439|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6136707|NCT01267201|Glucocorticoids|glucocorticoids|mesh-ancestor
6136708|NCT01267201|Hormones|hormones|mesh-ancestor
6136709|NCT01267201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6136710|NCT01267201|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6136711|NCT01267201|Protective Agents|protective agents|mesh-ancestor
6136712|NCT01267201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6136713|NCT01267201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5541055|NCT04170439|Trace Elements|trace elements|mesh-ancestor
5541056|NCT04170439|Micronutrients|micronutrients|mesh-ancestor
5541057|NCT04170504|Methotrexate|methotrexate|mesh-list
5541058|NCT04170504|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5541059|NCT04170504|Abortifacient Agents|abortifacient agents|mesh-ancestor
5541060|NCT04170504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5541061|NCT04170504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541062|NCT04170504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5541063|NCT04170504|Antimetabolites|antimetabolites|mesh-ancestor
5541064|NCT04170504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541065|NCT04170504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5541066|NCT04170504|Dermatologic Agents|dermatologic agents|mesh-ancestor
5541067|NCT04170504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6136714|NCT01267240|Capecitabine|capecitabine|mesh-list
6136715|NCT01267240|Vorinostat|vorinostat|mesh-list
6136716|NCT01267240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6136717|NCT01267240|Antimetabolites|antimetabolites|mesh-ancestor
6136718|NCT01267240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136719|NCT01267240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6136720|NCT01267240|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6136721|NCT01267240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6136722|NCT01267266|Hydrocortisone|hydrocortisone|mesh-list
6136723|NCT01267266|Saracatinib|saracatinib|mesh-list
5541068|NCT04170504|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5541069|NCT04170504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6136724|NCT01267266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6136725|NCT01267266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6136726|NCT01267266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6136727|NCT01267266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136728|NCT01267279|Zoledronic Acid|zoledronic acid|mesh-list
6136729|NCT01267279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6136730|NCT01267279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136731|NCT01267292|Buspirone|buspirone|mesh-list
5541070|NCT04170504|Immunologic Factors|immunologic factors|mesh-ancestor
5541071|NCT04170504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5606772|NCT03786783|Immunologic Factors|immunologic factors|mesh-ancestor
6136732|NCT01267292|Methylphenidate|methylphenidate|mesh-list
6136733|NCT01267292|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6136734|NCT01267292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136735|NCT01267292|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6136736|NCT01267292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6136737|NCT01267292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6136738|NCT01267292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136739|NCT01267292|Dopamine Agents|dopamine agents|mesh-ancestor
6136740|NCT01267292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6136741|NCT01267292|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6136742|NCT01267292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6136743|NCT01267292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6136744|NCT01267292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6136745|NCT01267292|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6136746|NCT01267292|Serotonin Agents|serotonin agents|mesh-ancestor
6136747|NCT01267656|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6136748|NCT01267656|Lubricant Eye Drops|lubricant eye drops|mesh-list
6136749|NCT01267656|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6136750|NCT01267864|Ketorolac|ketorolac|mesh-list
6136751|NCT01267864|Valproic Acid|valproic acid|mesh-list
6136752|NCT01267864|Metoclopramide|metoclopramide|mesh-list
6136753|NCT01267864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6136754|NCT01267864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6136755|NCT01267864|Analgesics|analgesics|mesh-ancestor
6136756|NCT01267864|Sensory System Agents|sensory system agents|mesh-ancestor
5541072|NCT04170504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5541073|NCT04170556|Nivolumab|nivolumab|mesh-list
5541074|NCT04170556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5541075|NCT04170556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5541076|NCT04170556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5541077|NCT04170556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541078|NCT04170270|Omeprazole|omeprazole|mesh-list
5541079|NCT04170270|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5541080|NCT04170270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5541081|NCT04170270|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5541082|NCT04170270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6136757|NCT01267864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6136758|NCT01267864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136759|NCT01267864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6136760|NCT01267864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6136761|NCT01267864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6136762|NCT01267864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6136763|NCT01267864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136764|NCT01267864|Anticonvulsants|anticonvulsants|mesh-ancestor
6136765|NCT01267864|GABA Agents|gaba agents|mesh-ancestor
6136766|NCT01267864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6136767|NCT01267864|Antimanic Agents|antimanic agents|mesh-ancestor
6136768|NCT01267864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6136769|NCT01267864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6136770|NCT01267864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6136771|NCT01267864|Antiemetics|antiemetics|mesh-ancestor
6136772|NCT01267864|Autonomic Agents|autonomic agents|mesh-ancestor
6136773|NCT01267864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6136774|NCT01267864|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6136775|NCT01267864|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6136776|NCT01267864|Dopamine Agents|dopamine agents|mesh-ancestor
6136777|NCT01267994|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6136778|NCT01267994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6467951|NCT00485160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6467952|NCT00485160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6467953|NCT00485160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6467954|NCT00485160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467955|NCT00485160|Gout Suppressants|gout suppressants|mesh-ancestor
6467956|NCT00485160|Tocolytic Agents|tocolytic agents|mesh-ancestor
6467957|NCT00485160|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6467958|NCT00485238|Acetazolamide|acetazolamide|mesh-list
6467959|NCT00485238|Anticonvulsants|anticonvulsants|mesh-ancestor
6467960|NCT00485238|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6467961|NCT00485238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6467962|NCT00485238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467963|NCT00485238|Diuretics|diuretics|mesh-ancestor
6467964|NCT00485238|Natriuretic Agents|natriuretic agents|mesh-ancestor
6467965|NCT00485238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467966|NCT00485342|Interferons|interferons|mesh-list
5606773|NCT03786783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467967|NCT00485342|Ribavirin|ribavirin|mesh-list
6467968|NCT00485342|Interferon-alpha|interferon-alpha|mesh-list
6467969|NCT00485342|Interferon alpha-2|interferon alpha-2|mesh-list
6467970|NCT00485342|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5541083|NCT04170270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541084|NCT04170179|Lenvatinib|lenvatinib|mesh-list
5541085|NCT04170179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5541086|NCT04170179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5541087|NCT04170179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5541088|NCT04170179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541089|NCT04170465|Metformin|metformin|mesh-list
5541090|NCT04170465|Paclitaxel|paclitaxel|mesh-list
5541091|NCT04170465|Cyclophosphamide|cyclophosphamide|mesh-list
5541092|NCT04170465|Doxorubicin|doxorubicin|mesh-list
5541093|NCT04170465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5541094|NCT04170465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5541095|NCT04170465|Tubulin Modulators|tubulin modulators|mesh-ancestor
5541096|NCT04170465|Antimitotic Agents|antimitotic agents|mesh-ancestor
5541097|NCT04170465|Mitosis Modulators|mitosis modulators|mesh-ancestor
5541098|NCT04170465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541099|NCT04170465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5541100|NCT04170465|Immunologic Factors|immunologic factors|mesh-ancestor
6136779|NCT01268046|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6136780|NCT01268046|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6136781|NCT01268046|Estradiol|estradiol|mesh-list
6136782|NCT01268046|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6136783|NCT01268046|Estrogens|estrogens|mesh-list
6136784|NCT01268046|Hormones|hormones|mesh-ancestor
6136785|NCT01268046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6136786|NCT01268046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136787|NCT01268046|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5541101|NCT04170465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541102|NCT04170465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5541103|NCT04170465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5541104|NCT04170465|Alkylating Agents|alkylating agents|mesh-ancestor
5541105|NCT04170465|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5541106|NCT04170465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5541107|NCT04170465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5541108|NCT04170465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5541109|NCT04170465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5541110|NCT04170465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6136788|NCT01268046|Contraceptive Agents|contraceptive agents|mesh-ancestor
6136789|NCT01268046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6136790|NCT01268046|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6136791|NCT01268059|Paclitaxel|paclitaxel|mesh-list
6136792|NCT01268059|Carboplatin|carboplatin|mesh-list
6136793|NCT01268059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6136794|NCT01268059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6136795|NCT01268059|Tubulin Modulators|tubulin modulators|mesh-ancestor
6136796|NCT01268059|Antimitotic Agents|antimitotic agents|mesh-ancestor
6136797|NCT01268059|Mitosis Modulators|mitosis modulators|mesh-ancestor
6136798|NCT01268059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136799|NCT01268111|Ergocalciferols|ergocalciferols|mesh-list
6136800|NCT01268111|Vitamin D|vitamin d|mesh-list
6136801|NCT01268111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6136802|NCT01268111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136803|NCT01268111|Vitamins|vitamins|mesh-ancestor
6136804|NCT01268111|Micronutrients|micronutrients|mesh-ancestor
6136805|NCT01268111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6136806|NCT01268293|Lenvatinib|lenvatinib|mesh-list
5541111|NCT04170309|Ceftobiprole|ceftobiprole|mesh-list
5541112|NCT04170309|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
5541113|NCT04170309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5541114|NCT04170309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5541115|NCT04170088|Tranexamic Acid|tranexamic acid|mesh-list
5541116|NCT04170088|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5541117|NCT04170088|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5541118|NCT04170088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541119|NCT04170088|Hemostatics|hemostatics|mesh-ancestor
6136807|NCT01268293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6136808|NCT01268293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6136809|NCT01268293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6136810|NCT01268293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541120|NCT04170088|Coagulants|coagulants|mesh-ancestor
5541121|NCT04169945|Erythritol|erythritol|mesh-list
6467971|NCT00485342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6467972|NCT00485342|Antiviral Agents|antiviral agents|mesh-ancestor
5541122|NCT04169945|Vasodilator Agents|vasodilator agents|mesh-ancestor
5541123|NCT04169867|Nivolumab|nivolumab|mesh-list
5541124|NCT04169867|Ipilimumab|ipilimumab|mesh-list
6136811|NCT01268527|Calcipotriene|calcipotriene|mesh-list
6467973|NCT00485342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6467974|NCT00485342|Antimetabolites|antimetabolites|mesh-ancestor
6467975|NCT00485342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467976|NCT00485342|Immunologic Factors|immunologic factors|mesh-ancestor
6467977|NCT00485342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467978|NCT00485368|Perindopril|perindopril|mesh-list
6467979|NCT00485368|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6467980|NCT00485368|Protease Inhibitors|protease inhibitors|mesh-ancestor
6467981|NCT00485368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6467982|NCT00485368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467983|NCT00485368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6467984|NCT00485407|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6467985|NCT00485407|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6467986|NCT00485407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6467987|NCT00485407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5541125|NCT04169867|Atezolizumab|atezolizumab|mesh-list
5541126|NCT04169867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5541127|NCT04169867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5541128|NCT04169867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5541129|NCT04169867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541130|NCT04169854|Lidocaine|lidocaine|mesh-list
5541131|NCT04169854|Anesthetics, Local|anesthetics, local|mesh-ancestor
5541132|NCT04169854|Anesthetics|anesthetics|mesh-ancestor
5541133|NCT04169854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5541134|NCT04169854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541135|NCT04169854|Sensory System Agents|sensory system agents|mesh-ancestor
5541136|NCT04169854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5541137|NCT04169854|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5541138|NCT04169854|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5541139|NCT04169854|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5541140|NCT04169854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5541141|NCT04169854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467988|NCT00485407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467989|NCT00485407|Adrenergic Agents|adrenergic agents|mesh-ancestor
6467990|NCT00485407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6136812|NCT01268527|Dermatologic Agents|dermatologic agents|mesh-ancestor
6136813|NCT01268553|Treprostinil|treprostinil|mesh-list
6136814|NCT01268553|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6205282|NCT02083783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6467991|NCT00485407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6467992|NCT00485459|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6467993|NCT00485459|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6467994|NCT00485459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6467995|NCT00485459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6205283|NCT02083783|Dopamine Agents|dopamine agents|mesh-ancestor
6205284|NCT02083783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6205285|NCT02083783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205286|NCT02083783|Adrenergic Agents|adrenergic agents|mesh-ancestor
6205287|NCT02083783|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5541147|NCT04169841|Durvalumab|durvalumab|mesh-list
5541148|NCT04169841|Olaparib|olaparib|mesh-list
5541149|NCT04169841|Tremelimumab|tremelimumab|mesh-list
6467996|NCT00485459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6467997|NCT00485459|Adrenergic Agents|adrenergic agents|mesh-ancestor
6467998|NCT00485459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6467999|NCT00485459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468000|NCT00485498|Olanzapine|olanzapine|mesh-list
6468001|NCT00485498|Risperidone|risperidone|mesh-list
6468002|NCT00485498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6468003|NCT00485498|Serotonin Agents|serotonin agents|mesh-ancestor
6468004|NCT00485498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6468005|NCT00485498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468006|NCT00485498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468007|NCT00485498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6468008|NCT00485498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6468009|NCT00485498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6468010|NCT00485498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5541150|NCT04169841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6468011|NCT00485498|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6468012|NCT00485498|Dopamine Agents|dopamine agents|mesh-ancestor
6468013|NCT00485498|Antiemetics|antiemetics|mesh-ancestor
6468014|NCT00485498|Autonomic Agents|autonomic agents|mesh-ancestor
6468015|NCT00485498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6468016|NCT00485498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6468017|NCT00485498|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6468018|NCT00485498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6666437|NCT01522872|Glucocorticoids|glucocorticoids|mesh-ancestor
6136815|NCT01268683|Glyburide|glyburide|mesh-list
6136816|NCT01268683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6136817|NCT01268683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136818|NCT01268891|Rasagiline|rasagiline|mesh-list
6136819|NCT01268891|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6136820|NCT01268891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6136821|NCT01268891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136822|NCT01268891|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6136823|NCT01268891|Protective Agents|protective agents|mesh-ancestor
6136824|NCT01268891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136825|NCT01268943|Capecitabine|capecitabine|mesh-list
6136826|NCT01268943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6136827|NCT01268943|Antimetabolites|antimetabolites|mesh-ancestor
6136828|NCT01268943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136829|NCT01268943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6136830|NCT01269047|Exenatide|exenatide|mesh-list
6136831|NCT01269047|Pramlintide|pramlintide|mesh-list
5541151|NCT04169841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5541152|NCT04169841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5541153|NCT04169841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5541154|NCT04169841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541155|NCT04169919|Povidone-Iodine|povidone-iodine|mesh-list
5541156|NCT04169919|Povidone|povidone|mesh-list
5541157|NCT04169919|Plasma Substitutes|plasma substitutes|mesh-ancestor
5541158|NCT04169919|Blood Substitutes|blood substitutes|mesh-ancestor
6136832|NCT01269047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6136833|NCT01269047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136834|NCT01269047|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6136835|NCT01269047|Incretins|incretins|mesh-ancestor
6136836|NCT01269047|Hormones|hormones|mesh-ancestor
6136837|NCT01269047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6136838|NCT01269125|Leuprolide|leuprolide|mesh-list
6468019|NCT00485498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6666438|NCT01522872|Hormones|hormones|mesh-ancestor
6666439|NCT01522872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6666440|NCT01522872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6666441|NCT01522872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6666442|NCT01522872|Protease Inhibitors|protease inhibitors|mesh-ancestor
6666443|NCT01522872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6666444|NCT01522872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666445|NCT01522872|Immunologic Factors|immunologic factors|mesh-ancestor
6666446|NCT01522872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6666447|NCT01522872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6666448|NCT01522872|Growth Substances|growth substances|mesh-ancestor
6666449|NCT01522872|Growth Inhibitors|growth inhibitors|mesh-ancestor
6666450|NCT01522872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6666451|NCT01522872|Alkylating Agents|alkylating agents|mesh-ancestor
6666452|NCT01522989|Fluorouracil|fluorouracil|mesh-list
6666453|NCT01522989|Oxaliplatin|oxaliplatin|mesh-list
5541159|NCT04169919|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5541160|NCT04169919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5541161|NCT04169763|Nelfinavir|nelfinavir|mesh-list
5541162|NCT04169763|Cisplatin|cisplatin|mesh-list
6666454|NCT01522989|Palbociclib|palbociclib|mesh-list
6468020|NCT00485511|Hydroxyurea|hydroxyurea|mesh-list
6468021|NCT00485511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6468022|NCT00485511|Antisickling Agents|antisickling agents|mesh-ancestor
6468023|NCT00485511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6468024|NCT00485511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468025|NCT00485511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6468026|NCT00485550|Methylphenidate|methylphenidate|mesh-list
6468027|NCT00485550|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6468028|NCT00485550|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6468029|NCT00485550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468030|NCT00485550|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6468031|NCT00485550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6468032|NCT00485550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6468033|NCT00485550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666455|NCT01522989|Antimetabolites|antimetabolites|mesh-ancestor
6666456|NCT01522989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666457|NCT01522989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6468034|NCT00485550|Dopamine Agents|dopamine agents|mesh-ancestor
6468035|NCT00485550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6468036|NCT00485550|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6468037|NCT00485550|Adrenergic Agents|adrenergic agents|mesh-ancestor
6468038|NCT00485576|Eculizumab|eculizumab|mesh-list
6468039|NCT00485576|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6468040|NCT00485576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6468041|NCT00485576|Immunologic Factors|immunologic factors|mesh-ancestor
6468042|NCT00485576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666458|NCT01522989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6666459|NCT01522989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6666460|NCT01522989|Immunologic Factors|immunologic factors|mesh-ancestor
6136839|NCT01269125|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6136840|NCT01269125|Fertility Agents|fertility agents|mesh-ancestor
6136841|NCT01269125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6136842|NCT01269125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136843|NCT01269125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6136844|NCT01269125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6136845|NCT01269385|Rituximab|rituximab|mesh-list
6136846|NCT01269385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6136847|NCT01269385|Alemtuzumab|alemtuzumab|mesh-list
6136848|NCT01269385|Antibodies|antibodies|mesh-list
6136849|NCT01269385|Immunoglobulins|immunoglobulins|mesh-list
6136850|NCT01269385|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5541163|NCT04169763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5541164|NCT04169763|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5541165|NCT04169763|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5541166|NCT04169763|Protease Inhibitors|protease inhibitors|mesh-ancestor
5541167|NCT04169763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5541168|NCT04169763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541169|NCT04169763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5541170|NCT04169763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5541171|NCT04169763|Antiviral Agents|antiviral agents|mesh-ancestor
5541172|NCT04169763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5602279|NCT04744116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602280|NCT04735913|Abiraterone Acetate|abiraterone acetate|mesh-list
5602281|NCT04735913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5602282|NCT04735913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5602283|NCT04735913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5602284|NCT04735913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602285|NCT04735913|Hormone Antagonists|hormone antagonists|mesh-ancestor
5602286|NCT04735913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5602287|NCT04735913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602288|NCT04735913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5602289|NCT04724668|Melatonin|melatonin|mesh-list
5602290|NCT04724668|Antioxidants|antioxidants|mesh-ancestor
5602291|NCT04724668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602292|NCT04724668|Protective Agents|protective agents|mesh-ancestor
5602293|NCT04724668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136851|NCT01269385|Immunologic Factors|immunologic factors|mesh-ancestor
6136852|NCT01269385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136853|NCT01269385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6136854|NCT01269385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6136855|NCT01269801|Botulinum Toxins|botulinum toxins|mesh-list
6136856|NCT01269801|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5541173|NCT04169438|Petrolatum|petrolatum|mesh-list
5541174|NCT04169438|Emollients|emollients|mesh-ancestor
5541175|NCT04169438|Dermatologic Agents|dermatologic agents|mesh-ancestor
5541176|NCT04169256|Bupivacaine|bupivacaine|mesh-list
5541177|NCT04169256|Anesthetics, Local|anesthetics, local|mesh-ancestor
5541178|NCT04169256|Anesthetics|anesthetics|mesh-ancestor
5541179|NCT04169256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5541180|NCT04169256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541181|NCT04169256|Sensory System Agents|sensory system agents|mesh-ancestor
5541182|NCT04169256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5541183|NCT04169347|Leucovorin|leucovorin|mesh-list
5541184|NCT04169347|Oxaliplatin|oxaliplatin|mesh-list
5541185|NCT04169347|Irinotecan|irinotecan|mesh-list
5541186|NCT04169347|Panitumumab|panitumumab|mesh-list
5541187|NCT04169347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5541188|NCT04169347|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5541189|NCT04169347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6136857|NCT01269801|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6136858|NCT01269801|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6136859|NCT01269801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6136860|NCT01269801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136861|NCT01269801|Cholinergic Agents|cholinergic agents|mesh-ancestor
6136862|NCT01269801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6136863|NCT01269801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136864|NCT01269801|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6136865|NCT01269801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6136866|NCT01269918|Dexmedetomidine|dexmedetomidine|mesh-list
6136867|NCT01269918|Remifentanil|remifentanil|mesh-list
6136868|NCT01269918|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6136869|NCT01269918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6136870|NCT01269918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136871|NCT01269918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6136872|NCT01269918|Analgesics|analgesics|mesh-ancestor
6136873|NCT01269918|Sensory System Agents|sensory system agents|mesh-ancestor
5541190|NCT04169347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5541191|NCT04169347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541192|NCT04169347|Antidotes|antidotes|mesh-ancestor
5541193|NCT04169347|Protective Agents|protective agents|mesh-ancestor
5541194|NCT04169347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541195|NCT04169347|Vitamin B Complex|vitamin b complex|mesh-ancestor
5541196|NCT04169347|Vitamins|vitamins|mesh-ancestor
5541197|NCT04169347|Micronutrients|micronutrients|mesh-ancestor
5541198|NCT04169347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5541199|NCT04169451|Letrozole|letrozole|mesh-list
5541200|NCT04169451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5541201|NCT04169451|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6468043|NCT00485628|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6468044|NCT00485628|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6468045|NCT00485628|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6136874|NCT01269918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6136875|NCT01269918|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6136876|NCT01269918|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6468046|NCT00485628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6468047|NCT00485628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541202|NCT04169451|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5541203|NCT04169451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5541204|NCT04169451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541205|NCT04169451|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5541206|NCT04169451|Hormone Antagonists|hormone antagonists|mesh-ancestor
5541207|NCT04169451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5541208|NCT04169451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541209|NCT04169464|Sofosbuvir|sofosbuvir|mesh-list
6468048|NCT00485628|Adrenergic Agents|adrenergic agents|mesh-ancestor
6468049|NCT00485628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6468050|NCT00485628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468051|NCT00485667|Moxifloxacin|moxifloxacin|mesh-list
6468052|NCT00485667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6468053|NCT00485667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5541210|NCT04169464|Antiviral Agents|antiviral agents|mesh-ancestor
5541211|NCT04169464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5541212|NCT04169230|Citalopram|citalopram|mesh-list
6468054|NCT00485667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6468055|NCT00485667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6468056|NCT00485667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6136877|NCT01269918|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6136878|NCT01269918|Adrenergic Agents|adrenergic agents|mesh-ancestor
6136879|NCT01269918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6136880|NCT01269918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136881|NCT01269918|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6136882|NCT01269918|Narcotics|narcotics|mesh-ancestor
6136883|NCT01270256|Budesonide|budesonide|mesh-list
6136884|NCT01270256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6136885|NCT01270256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6136886|NCT01270256|Autonomic Agents|autonomic agents|mesh-ancestor
6136887|NCT01270256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6136888|NCT01270256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136889|NCT01270256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6136890|NCT01270256|Respiratory System Agents|respiratory system agents|mesh-ancestor
6136891|NCT01270256|Glucocorticoids|glucocorticoids|mesh-ancestor
6136892|NCT01270256|Hormones|hormones|mesh-ancestor
6136893|NCT01270256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6136894|NCT01270321|Everolimus|everolimus|mesh-list
6136895|NCT01270321|Pasireotide|pasireotide|mesh-list
6136896|NCT01270321|Somatostatin|somatostatin|mesh-list
6136897|NCT01270321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6136898|NCT01270321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6468057|NCT00485667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468058|NCT00485667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6468059|NCT00485680|Olanzapine|olanzapine|mesh-list
6468060|NCT00485680|Lithium Carbonate|lithium carbonate|mesh-list
6468061|NCT00485680|Antiemetics|antiemetics|mesh-ancestor
5541213|NCT04169230|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5541214|NCT04169230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6136899|NCT01270321|Immunologic Factors|immunologic factors|mesh-ancestor
6468062|NCT00485680|Autonomic Agents|autonomic agents|mesh-ancestor
6468063|NCT00485680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6468064|NCT00485680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468065|NCT00485680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6468066|NCT00485680|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6468067|NCT00485680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6468068|NCT00485680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6468069|NCT00485680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6136900|NCT01270321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136901|NCT01270321|Hormones|hormones|mesh-ancestor
6136902|NCT01270321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6136903|NCT01270464|Reslizumab|reslizumab|mesh-list
6136904|NCT01270464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6136905|NCT01270464|Respiratory System Agents|respiratory system agents|mesh-ancestor
6136906|NCT01270542|Bevacizumab|bevacizumab|mesh-list
6136907|NCT01270542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6136908|NCT01270542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6136909|NCT01270542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6136910|NCT01270542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6136911|NCT01270542|Growth Substances|growth substances|mesh-ancestor
6136912|NCT01270542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136913|NCT01270542|Growth Inhibitors|growth inhibitors|mesh-ancestor
6136914|NCT01270555|Bupropion|bupropion|mesh-list
6136915|NCT01270555|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6136916|NCT01270555|Antidepressive Agents|antidepressive agents|mesh-ancestor
6136917|NCT01270555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6136918|NCT01270555|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6136919|NCT01270555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6136920|NCT01270555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6136921|NCT01270555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136922|NCT01270555|Dopamine Agents|dopamine agents|mesh-ancestor
6136923|NCT01270555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6136924|NCT01270555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136925|NCT01270555|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6136926|NCT01270555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6136927|NCT01270555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6136928|NCT01270620|Propofol|propofol|mesh-list
6136929|NCT01270620|Desflurane|desflurane|mesh-list
6136930|NCT01270620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6136931|NCT01270620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6468070|NCT00485680|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6136932|NCT01270620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541215|NCT04169230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5541216|NCT04169230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541217|NCT04169230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5541218|NCT04169230|Serotonin Agents|serotonin agents|mesh-ancestor
5541219|NCT04169230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541220|NCT04169230|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5541221|NCT04169230|Antidepressive Agents|antidepressive agents|mesh-ancestor
5541222|NCT04169230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5541223|NCT04169269|Enoxaparin|enoxaparin|mesh-list
5541224|NCT04169269|Rivaroxaban|rivaroxaban|mesh-list
5541225|NCT04169269|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5541226|NCT04169269|Antithrombins|antithrombins|mesh-ancestor
5541227|NCT04169269|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5541228|NCT04169269|Protease Inhibitors|protease inhibitors|mesh-ancestor
6136933|NCT01270620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6136934|NCT01270620|Anesthetics, General|anesthetics, general|mesh-ancestor
6136935|NCT01270620|Anesthetics|anesthetics|mesh-ancestor
6136936|NCT01270620|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6136937|NCT01270659|Acetaminophen|acetaminophen|mesh-list
6136938|NCT01270659|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
6136939|NCT01270659|Fentanyl|fentanyl|mesh-list
6136940|NCT01270659|Oxycodone|oxycodone|mesh-list
6136941|NCT01270659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6136942|NCT01270659|Narcotics|narcotics|mesh-ancestor
6136943|NCT01270659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6136944|NCT01270659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136945|NCT01270659|Analgesics|analgesics|mesh-ancestor
6136946|NCT01270659|Sensory System Agents|sensory system agents|mesh-ancestor
6136947|NCT01270659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6136948|NCT01270659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6136949|NCT01270659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6136950|NCT01270659|Anesthetics, General|anesthetics, general|mesh-ancestor
6136951|NCT01270659|Anesthetics|anesthetics|mesh-ancestor
6136952|NCT01270659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6136953|NCT01270659|Antipyretics|antipyretics|mesh-ancestor
6136954|NCT01270659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6136955|NCT01270659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6136956|NCT01270659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6136957|NCT01270802|Tenofovir|tenofovir|mesh-list
6136958|NCT01270802|Emtricitabine|emtricitabine|mesh-list
6136959|NCT01270802|Efavirenz|efavirenz|mesh-list
6136960|NCT01270802|Raltegravir Potassium|raltegravir potassium|mesh-list
6136961|NCT01270802|Antiviral Agents|antiviral agents|mesh-ancestor
6136962|NCT01270802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6136963|NCT01270802|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6136964|NCT01270802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6136965|NCT01270802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6136966|NCT01270802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136967|NCT01270802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6136968|NCT01270802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6136969|NCT01270802|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6136970|NCT01270802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6136971|NCT01270802|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6136972|NCT01270802|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6136973|NCT01270802|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6136974|NCT01270802|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6136975|NCT01270802|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6136976|NCT01270802|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6136977|NCT01270828|Pregabalin|pregabalin|mesh-list
6136978|NCT01270828|Analgesics|analgesics|mesh-ancestor
6136979|NCT01270828|Sensory System Agents|sensory system agents|mesh-ancestor
6136980|NCT01270828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6136981|NCT01270828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136982|NCT01270828|Anticonvulsants|anticonvulsants|mesh-ancestor
6136983|NCT01270828|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6136984|NCT01270828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6136985|NCT01270828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6136986|NCT01270828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6136987|NCT01270828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6136988|NCT01270828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6136989|NCT01270828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6136990|NCT01270828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6136991|NCT01270841|Enclomiphene|enclomiphene|mesh-list
6136992|NCT01270841|Clomiphene|clomiphene|mesh-list
6136993|NCT01270841|Zuclomiphene|zuclomiphene|mesh-list
6136994|NCT01270841|Testosterone|testosterone|mesh-list
6136995|NCT01270841|Androgens|androgens|mesh-ancestor
6136996|NCT01270841|Hormones|hormones|mesh-ancestor
6136997|NCT01270841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6136998|NCT01270841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6136999|NCT01270841|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6137000|NCT01270841|Hormone Antagonists|hormone antagonists|mesh-ancestor
6137001|NCT01270841|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6137002|NCT01270841|Fertility Agents|fertility agents|mesh-ancestor
6137003|NCT01270841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6137004|NCT01270841|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6137005|NCT01270841|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6137006|NCT01270971|Tavaborole|tavaborole|mesh-list
6137007|NCT01270971|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5541229|NCT04169269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5541230|NCT04169269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541231|NCT04169269|Anticoagulants|anticoagulants|mesh-ancestor
5541232|NCT04169269|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5541233|NCT04169269|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5541234|NCT04168931|Trastuzumab|trastuzumab|mesh-list
5541235|NCT04168931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5541236|NCT04168931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5541237|NCT04169100|Prednisone|prednisone|mesh-list
5541238|NCT04169100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5541239|NCT04169100|Glucocorticoids|glucocorticoids|mesh-ancestor
5541240|NCT04169100|Hormones|hormones|mesh-ancestor
5541241|NCT04169100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5541242|NCT04169100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541243|NCT04169100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5541244|NCT04169100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5541245|NCT04168879|Bupivacaine|bupivacaine|mesh-list
5541246|NCT04168879|Anesthetics, Local|anesthetics, local|mesh-ancestor
5541247|NCT04168879|Anesthetics|anesthetics|mesh-ancestor
5541248|NCT04168879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5541249|NCT04168879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541250|NCT04168879|Sensory System Agents|sensory system agents|mesh-ancestor
5541251|NCT04168879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5541252|NCT04168944|Lenvatinib|lenvatinib|mesh-list
5541253|NCT04168944|Immunosuppressive Agents|immunosuppressive agents|mesh-list
5541254|NCT04168944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6137008|NCT01270971|Antifungal Agents|antifungal agents|mesh-ancestor
6137009|NCT01270971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6137010|NCT01271010|Cyclophosphamide|cyclophosphamide|mesh-list
6137011|NCT01271010|Rituximab|rituximab|mesh-list
6137012|NCT01271010|Fludarabine|fludarabine|mesh-list
6137013|NCT01271010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5541255|NCT04168944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5541256|NCT04168944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5541257|NCT04168944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541258|NCT04168944|Immunologic Factors|immunologic factors|mesh-ancestor
5541259|NCT04168944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541260|NCT04168723|Moxifloxacin|moxifloxacin|mesh-list
5541261|NCT04168723|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6137014|NCT01271010|Immunologic Factors|immunologic factors|mesh-ancestor
6137015|NCT01271010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137016|NCT01271010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6137017|NCT01271010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6137018|NCT01271010|Alkylating Agents|alkylating agents|mesh-ancestor
6137019|NCT01271010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137020|NCT01271010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6137021|NCT01271010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6137022|NCT01271010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6137023|NCT01271244|Citalopram|citalopram|mesh-list
6137024|NCT01271244|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6137025|NCT01271244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6137026|NCT01271244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6137027|NCT01271244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137028|NCT01271244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6137029|NCT01271244|Serotonin Agents|serotonin agents|mesh-ancestor
6137030|NCT01271244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137031|NCT01271244|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6137032|NCT01271244|Antidepressive Agents|antidepressive agents|mesh-ancestor
5541262|NCT04168723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6137033|NCT01271244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6137034|NCT01271452|Botulinum Toxins|botulinum toxins|mesh-list
6137035|NCT01271452|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6137036|NCT01271452|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6137037|NCT01271452|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6137038|NCT01271452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6137039|NCT01271452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137040|NCT01271452|Cholinergic Agents|cholinergic agents|mesh-ancestor
6137041|NCT01271452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6137042|NCT01271452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137043|NCT01271452|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6137044|NCT01271452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6137045|NCT01271504|Sorafenib|sorafenib|mesh-list
6137046|NCT01271504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6137047|NCT01271504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6137048|NCT01271504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6137049|NCT01271504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137050|NCT01271686|Bimatoprost|bimatoprost|mesh-list
6137051|NCT01271686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6137052|NCT01271725|Paclitaxel|paclitaxel|mesh-list
5541263|NCT04168723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5541264|NCT04168723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5541265|NCT04168723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5541266|NCT04168723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5541267|NCT04168723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541268|NCT04168723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5541269|NCT04168723|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5541270|NCT04168723|Contraceptive Agents|contraceptive agents|mesh-ancestor
5541271|NCT04168723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5541272|NCT04168723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541273|NCT04168723|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5541274|NCT04168723|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5541275|NCT04168723|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5541276|NCT04168866|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5541277|NCT04168866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5541278|NCT04168619|Methotrexate|methotrexate|mesh-list
5541279|NCT04168619|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5541280|NCT04168619|Abortifacient Agents|abortifacient agents|mesh-ancestor
5541281|NCT04168619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5541282|NCT04168619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541283|NCT04168619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5541284|NCT04168619|Antimetabolites|antimetabolites|mesh-ancestor
5541285|NCT04168619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541286|NCT04168619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5541287|NCT04168619|Dermatologic Agents|dermatologic agents|mesh-ancestor
5541288|NCT04168619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5541289|NCT04168619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5541290|NCT04168619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5541291|NCT04168619|Immunologic Factors|immunologic factors|mesh-ancestor
5541292|NCT04168619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5541293|NCT04168619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5541294|NCT04168203|Apixaban|apixaban|mesh-list
5541295|NCT04168203|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5541296|NCT04168203|Antithrombins|antithrombins|mesh-ancestor
5541297|NCT04168203|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5541298|NCT04168203|Protease Inhibitors|protease inhibitors|mesh-ancestor
5541299|NCT04168203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5541300|NCT04168203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541301|NCT04168203|Anticoagulants|anticoagulants|mesh-ancestor
6137053|NCT01271725|Vinorelbine|vinorelbine|mesh-list
6137054|NCT01271725|Afatinib|afatinib|mesh-list
6137055|NCT01271725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6137056|NCT01271725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6137057|NCT01271725|Tubulin Modulators|tubulin modulators|mesh-ancestor
6137058|NCT01271725|Antimitotic Agents|antimitotic agents|mesh-ancestor
6137059|NCT01271725|Mitosis Modulators|mitosis modulators|mesh-ancestor
6137060|NCT01271725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137061|NCT01271725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6137062|NCT01271725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6468071|NCT00485680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6468072|NCT00485680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6488501|NCT00584571|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5541302|NCT04168294|Propofol|propofol|mesh-list
5541303|NCT04168294|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6468073|NCT00485680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468074|NCT00485680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6468075|NCT00485680|Serotonin Agents|serotonin agents|mesh-ancestor
6468076|NCT00485680|Antidepressive Agents|antidepressive agents|mesh-ancestor
6468077|NCT00485680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6468078|NCT00485680|Antimanic Agents|antimanic agents|mesh-ancestor
6468079|NCT00485706|Dialysis Solutions|dialysis solutions|mesh-list
6468080|NCT00485706|Calcium|calcium|mesh-list
6468081|NCT00485706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6468082|NCT00485706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468083|NCT00485706|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6468084|NCT00485771|Lamotrigine|lamotrigine|mesh-list
6468085|NCT00485771|Olanzapine|olanzapine|mesh-list
6468086|NCT00485771|Fluoxetine|fluoxetine|mesh-list
6468087|NCT00485771|Antiemetics|antiemetics|mesh-ancestor
6137063|NCT01271803|Vemurafenib|vemurafenib|mesh-list
6137064|NCT01271803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6137065|NCT01271803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6137066|NCT01271803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6137067|NCT01271803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468088|NCT00485771|Autonomic Agents|autonomic agents|mesh-ancestor
6468089|NCT00485771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6468090|NCT00485771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468091|NCT00485771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6468092|NCT00485771|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6468093|NCT00485771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6468094|NCT00485771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5541304|NCT04168294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5541305|NCT04168294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541306|NCT04168294|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5541307|NCT04168294|Anesthetics, General|anesthetics, general|mesh-ancestor
5541308|NCT04168294|Anesthetics|anesthetics|mesh-ancestor
5541309|NCT04168190|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5541310|NCT04168190|Immunologic Factors|immunologic factors|mesh-ancestor
5541311|NCT04168190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541312|NCT04168138|Cytarabine|cytarabine|mesh-list
5541313|NCT04168138|Decitabine|decitabine|mesh-list
5541314|NCT04168138|Aclarubicin|aclarubicin|mesh-list
5541315|NCT04168138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5541316|NCT04168138|Antimetabolites|antimetabolites|mesh-ancestor
5541317|NCT04168138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541318|NCT04168138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5541319|NCT04168138|Antiviral Agents|antiviral agents|mesh-ancestor
5541320|NCT04168138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5541321|NCT04168138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5541322|NCT04168138|Immunologic Factors|immunologic factors|mesh-ancestor
5541323|NCT04168138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541324|NCT04168138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6137068|NCT01271855|Glycerol|glycerol|mesh-list
6137069|NCT01271855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137070|NCT01271855|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6137071|NCT01271855|Protective Agents|protective agents|mesh-ancestor
6137072|NCT01271907|Aldesleukin|aldesleukin|mesh-list
6137073|NCT01271907|Cyclophosphamide|cyclophosphamide|mesh-list
6137074|NCT01271907|Fludarabine|fludarabine|mesh-list
5541325|NCT04168138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5541326|NCT04168138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5541327|NCT04168138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5541328|NCT04168099|Cefotaxime|cefotaxime|mesh-list
5541329|NCT04168099|Cefoxitin|cefoxitin|mesh-list
5541330|NCT04168099|Gemifloxacin|gemifloxacin|mesh-list
5541331|NCT04168099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5541332|NCT04168099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5541333|NCT04168099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5541334|NCT04168099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5541335|NCT04168099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5541336|NCT04168099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541337|NCT04168099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5541338|NCT04167813|Ondansetron|ondansetron|mesh-list
5541339|NCT04167813|Antiemetics|antiemetics|mesh-ancestor
5541340|NCT04167813|Autonomic Agents|autonomic agents|mesh-ancestor
5541341|NCT04167813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5541342|NCT04167813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541343|NCT04167813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6137075|NCT01271907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6137076|NCT01271907|Immunologic Factors|immunologic factors|mesh-ancestor
6468095|NCT00485771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5541344|NCT04167813|Antipruritics|antipruritics|mesh-ancestor
5541345|NCT04167813|Dermatologic Agents|dermatologic agents|mesh-ancestor
5541346|NCT04167813|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6137077|NCT01271907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137078|NCT01271907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6137079|NCT01271907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6137080|NCT01271907|Alkylating Agents|alkylating agents|mesh-ancestor
6137081|NCT01271907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468096|NCT00485771|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6468097|NCT00485771|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6468098|NCT00485771|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6468099|NCT00485771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468100|NCT00485771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6468101|NCT00485771|Serotonin Agents|serotonin agents|mesh-ancestor
6468102|NCT00485771|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6468103|NCT00485771|Antidepressive Agents|antidepressive agents|mesh-ancestor
6468104|NCT00485771|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6468105|NCT00485771|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6468106|NCT00485771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6468107|NCT00485771|Anticonvulsants|anticonvulsants|mesh-ancestor
6468108|NCT00485771|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6468109|NCT00485771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6468110|NCT00485771|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6468111|NCT00485797|Methylphenidate|methylphenidate|mesh-list
6468112|NCT00485797|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6468113|NCT00485797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468114|NCT00485797|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6468115|NCT00485797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6468116|NCT00485797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6468117|NCT00485797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468118|NCT00485797|Dopamine Agents|dopamine agents|mesh-ancestor
6468119|NCT00485797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6468120|NCT00485810|Olanzapine|olanzapine|mesh-list
6468121|NCT00485810|Antiemetics|antiemetics|mesh-ancestor
6468122|NCT00485810|Autonomic Agents|autonomic agents|mesh-ancestor
6468123|NCT00485810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6137082|NCT01271907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5541347|NCT04167813|Serotonin Agents|serotonin agents|mesh-ancestor
5541348|NCT04167813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5541349|NCT04167813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541350|NCT04167813|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5541351|NCT04167813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5541352|NCT04167813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5541353|NCT04167813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5541354|NCT04167813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5541355|NCT04167774|Paclitaxel|paclitaxel|mesh-list
6137083|NCT01271907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6137084|NCT01271907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6137085|NCT01271907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6137086|NCT01271907|Antiviral Agents|antiviral agents|mesh-ancestor
6137087|NCT01271907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6137088|NCT01271933|Pregabalin|pregabalin|mesh-list
6137089|NCT01271933|Analgesics|analgesics|mesh-ancestor
6137090|NCT01271933|Sensory System Agents|sensory system agents|mesh-ancestor
6137091|NCT01271933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6137092|NCT01271933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137093|NCT01271933|Anticonvulsants|anticonvulsants|mesh-ancestor
5541356|NCT04167774|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5541357|NCT04167774|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5541358|NCT04167774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5541359|NCT04167774|Tubulin Modulators|tubulin modulators|mesh-ancestor
5541360|NCT04167774|Antimitotic Agents|antimitotic agents|mesh-ancestor
5541361|NCT04167774|Mitosis Modulators|mitosis modulators|mesh-ancestor
5541362|NCT04167774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602294|NCT04724668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5602295|NCT04722848|Imatinib Mesylate|imatinib mesylate|mesh-list
5602296|NCT04722848|Blinatumomab|blinatumomab|mesh-list
5602297|NCT04722848|Ponatinib|ponatinib|mesh-list
5602298|NCT04722848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5602299|NCT04722848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5602300|NCT04722848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5602301|NCT04722848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137094|NCT01271933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5541363|NCT04167670|Amoxicillin|amoxicillin|mesh-list
5541364|NCT04167670|Clarithromycin|clarithromycin|mesh-list
6137095|NCT01271933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6137096|NCT01271933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137097|NCT01271933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6137098|NCT01271933|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6137099|NCT01271933|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6137100|NCT01271933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6137101|NCT01271933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6468124|NCT00485810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468125|NCT00485810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6468126|NCT00485810|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6468127|NCT00485810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6468128|NCT00485810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6468129|NCT00485810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6468130|NCT00485810|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6468131|NCT00485810|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6468132|NCT00485810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6468133|NCT00485810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468134|NCT00485810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6468135|NCT00485810|Serotonin Agents|serotonin agents|mesh-ancestor
6468136|NCT00485823|Olanzapine|olanzapine|mesh-list
6468137|NCT00485823|Antiemetics|antiemetics|mesh-ancestor
6468138|NCT00485823|Autonomic Agents|autonomic agents|mesh-ancestor
6468139|NCT00485823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6468140|NCT00485823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468141|NCT00485823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6468142|NCT00485823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6468143|NCT00485823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6468144|NCT00485823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6468145|NCT00485823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6468146|NCT00485823|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5541365|NCT04167670|Lansoprazole|lansoprazole|mesh-list
6137102|NCT01272180|Vaccines|vaccines|mesh-list
6137103|NCT01272180|Immunologic Factors|immunologic factors|mesh-ancestor
6137104|NCT01272180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137105|NCT01272193|Insulin|insulin|mesh-list
6137106|NCT01272193|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6137107|NCT01272193|Insulin Glargine|insulin glargine|mesh-list
6137108|NCT01272193|Insulin Aspart|insulin aspart|mesh-list
6137109|NCT01272193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6137110|NCT01272193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137111|NCT01272219|Liraglutide|liraglutide|mesh-list
6137112|NCT01272219|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6137113|NCT01272219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137114|NCT01272219|Incretins|incretins|mesh-ancestor
6137115|NCT01272219|Hormones|hormones|mesh-ancestor
6137116|NCT01272219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6137117|NCT01272232|Liraglutide|liraglutide|mesh-list
5541366|NCT04167670|Dexlansoprazole|dexlansoprazole|mesh-list
5541367|NCT04167670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5541368|NCT04167670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5541369|NCT04167670|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5541370|NCT04167670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5541371|NCT04167670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137118|NCT01272232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6137119|NCT01272232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137120|NCT01272232|Incretins|incretins|mesh-ancestor
6137121|NCT01272232|Hormones|hormones|mesh-ancestor
6137122|NCT01272232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6137123|NCT01272245|Cytarabine|cytarabine|mesh-list
6137124|NCT01272245|Homoharringtonine|homoharringtonine|mesh-list
6137125|NCT01272245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6137126|NCT01272245|Antimetabolites|antimetabolites|mesh-ancestor
6137127|NCT01272245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137128|NCT01272245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6137129|NCT01272245|Antiviral Agents|antiviral agents|mesh-ancestor
6137130|NCT01272245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5541372|NCT04167670|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5541373|NCT04167670|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5541374|NCT04167670|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5541375|NCT04167670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5541376|NCT04167670|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5541377|NCT04167982|Isotretinoin|isotretinoin|mesh-list
5541378|NCT04167982|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6137131|NCT01272245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6137132|NCT01272245|Immunologic Factors|immunologic factors|mesh-ancestor
6137133|NCT01272245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137134|NCT01272245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6137135|NCT01272245|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6137136|NCT01272245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6137137|NCT01272388|Tadalafil|tadalafil|mesh-list
5541379|NCT04167982|Dermatologic Agents|dermatologic agents|mesh-ancestor
5541380|NCT04167982|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5541381|NCT04167566|Artemisinins|artemisinins|mesh-list
5541382|NCT04167566|Artemisinin|artemisinin|mesh-list
5541383|NCT04167566|Antimalarials|antimalarials|mesh-ancestor
5541384|NCT04167566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5541385|NCT04167566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5541386|NCT04167566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5541387|NCT04167306|Bupropion|bupropion|mesh-list
5541388|NCT04167306|Varenicline|varenicline|mesh-list
5541389|NCT04167306|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5541390|NCT04167306|Antidepressive Agents|antidepressive agents|mesh-ancestor
5541391|NCT04167306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5541392|NCT04167306|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6137138|NCT01272388|Vasodilator Agents|vasodilator agents|mesh-ancestor
6137139|NCT01272388|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6137140|NCT01272388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6137141|NCT01272388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6137142|NCT01272388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137143|NCT01272388|Urological Agents|urological agents|mesh-ancestor
6137144|NCT01272583|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6137145|NCT01272583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6137146|NCT01272583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137147|NCT01272583|Incretins|incretins|mesh-ancestor
6137148|NCT01272583|Hormones|hormones|mesh-ancestor
6137149|NCT01272583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6137150|NCT01272583|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6137151|NCT01272583|Protease Inhibitors|protease inhibitors|mesh-ancestor
6137152|NCT01272583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6137153|NCT01272583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137154|NCT01272635|Azithromycin|azithromycin|mesh-list
6137155|NCT01272635|Prednisolone|prednisolone|mesh-list
6137156|NCT01272635|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6137157|NCT01272635|Methylprednisolone|methylprednisolone|mesh-list
6137158|NCT01272635|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6137159|NCT01272635|Prednisolone acetate|prednisolone acetate|mesh-list
6137160|NCT01272635|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6137161|NCT01272635|Prednisolone phosphate|prednisolone phosphate|mesh-list
6137162|NCT01272635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6137163|NCT01272635|Glucocorticoids|glucocorticoids|mesh-ancestor
6137164|NCT01272635|Hormones|hormones|mesh-ancestor
6137165|NCT01272635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6137166|NCT01272635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137167|NCT01272635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6137168|NCT01272635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6137169|NCT01272635|Antiemetics|antiemetics|mesh-ancestor
6137170|NCT01272635|Autonomic Agents|autonomic agents|mesh-ancestor
6137171|NCT01272635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6137172|NCT01272635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6137173|NCT01272635|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6137174|NCT01272635|Protective Agents|protective agents|mesh-ancestor
6137175|NCT01272635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6137176|NCT01272635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6137177|NCT01272908|Rituximab|rituximab|mesh-list
6137178|NCT01272908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6137179|NCT01272908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6137180|NCT01272908|Immunologic Factors|immunologic factors|mesh-ancestor
6137181|NCT01272908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137182|NCT01272908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6137183|NCT01272921|Bupivacaine|bupivacaine|mesh-list
6137184|NCT01272921|Ropivacaine|ropivacaine|mesh-list
6137185|NCT01272921|Anesthetics, Local|anesthetics, local|mesh-ancestor
6137186|NCT01272921|Anesthetics|anesthetics|mesh-ancestor
6137187|NCT01272921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6137188|NCT01272921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137189|NCT01272921|Sensory System Agents|sensory system agents|mesh-ancestor
6137190|NCT01272921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6137191|NCT01272934|Diclofenac|diclofenac|mesh-list
6137192|NCT01272934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6137193|NCT01272934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6137194|NCT01272934|Analgesics|analgesics|mesh-ancestor
6137195|NCT01272934|Sensory System Agents|sensory system agents|mesh-ancestor
6137196|NCT01272934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6137197|NCT01272934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137198|NCT01272934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6137199|NCT01272934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6137200|NCT01272934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6137201|NCT01272934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5541393|NCT04167306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5541394|NCT04167306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6137202|NCT01272934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137203|NCT01272947|Diclofenac|diclofenac|mesh-list
6137204|NCT01272947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6137205|NCT01272947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6137206|NCT01272947|Analgesics|analgesics|mesh-ancestor
6137207|NCT01272947|Sensory System Agents|sensory system agents|mesh-ancestor
6137208|NCT01272947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6137209|NCT01272947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137210|NCT01272947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6137211|NCT01272947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6137212|NCT01272947|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6137213|NCT01272947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6137214|NCT01272947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137215|NCT01272960|Levonorgestrel|levonorgestrel|mesh-list
5541395|NCT04167306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541396|NCT04167306|Dopamine Agents|dopamine agents|mesh-ancestor
5541397|NCT04167306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5541398|NCT04167306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541399|NCT04167306|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5541400|NCT04167306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5541401|NCT04167306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5541402|NCT04167306|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5541403|NCT04167306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5541404|NCT04167306|Cholinergic Agents|cholinergic agents|mesh-ancestor
5541405|NCT04167696|Cyclophosphamide|cyclophosphamide|mesh-list
5541406|NCT04167696|Fludarabine|fludarabine|mesh-list
5541407|NCT04167696|Fludarabine phosphate|fludarabine phosphate|mesh-list
5541408|NCT04167696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6137216|NCT01272960|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6137217|NCT01272960|Contraceptive Agents|contraceptive agents|mesh-ancestor
6137218|NCT01272960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6137219|NCT01272960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137220|NCT01272960|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6137221|NCT01272960|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6137222|NCT01272960|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6468147|NCT00485823|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6468148|NCT00485823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6468149|NCT00485823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468150|NCT00485823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6468151|NCT00485823|Serotonin Agents|serotonin agents|mesh-ancestor
6468152|NCT00485849|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6468153|NCT00485849|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6468154|NCT00485849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6468155|NCT00485849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6137223|NCT01273155|Belinostat|belinostat|mesh-list
6137224|NCT01273155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6137225|NCT01273155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6137226|NCT01273155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6137227|NCT01273155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137228|NCT01273181|Aldesleukin|aldesleukin|mesh-list
6137229|NCT01273181|Cyclophosphamide|cyclophosphamide|mesh-list
6137230|NCT01273181|Fludarabine|fludarabine|mesh-list
6137231|NCT01273181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6137232|NCT01273181|Immunologic Factors|immunologic factors|mesh-ancestor
6137233|NCT01273181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137234|NCT01273181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6137235|NCT01273181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6137236|NCT01273181|Alkylating Agents|alkylating agents|mesh-ancestor
6137237|NCT01273181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137238|NCT01273181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6137239|NCT01273181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6137240|NCT01273181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6137241|NCT01273181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6137242|NCT01273181|Antiviral Agents|antiviral agents|mesh-ancestor
6137243|NCT01273181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6137244|NCT01273207|Cyclosporine|cyclosporine|mesh-list
6137245|NCT01273207|Cyclosporins|cyclosporins|mesh-list
6137246|NCT01273207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6137247|NCT01273207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137248|NCT01273207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6137249|NCT01273207|Immunologic Factors|immunologic factors|mesh-ancestor
6137250|NCT01273207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137251|NCT01273207|Antifungal Agents|antifungal agents|mesh-ancestor
6137252|NCT01273207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6137253|NCT01273207|Dermatologic Agents|dermatologic agents|mesh-ancestor
6137254|NCT01273207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6137255|NCT01273207|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6137256|NCT01273766|Deferasirox|deferasirox|mesh-list
6137257|NCT01273766|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6137258|NCT01273766|Chelating Agents|chelating agents|mesh-ancestor
6137259|NCT01273766|Sequestering Agents|sequestering agents|mesh-ancestor
6137260|NCT01273766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468156|NCT00485849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468157|NCT00485849|Adrenergic Agents|adrenergic agents|mesh-ancestor
6468158|NCT00485849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6468159|NCT00485849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468160|NCT00485862|Sertraline|sertraline|mesh-list
6468161|NCT00485862|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6468162|NCT00485862|Antidepressive Agents|antidepressive agents|mesh-ancestor
6468163|NCT00485862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6468164|NCT00485862|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6468165|NCT00485862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6468166|NCT00485862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6468167|NCT00485862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468168|NCT00485862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6468169|NCT00485862|Serotonin Agents|serotonin agents|mesh-ancestor
6468170|NCT00485862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468171|NCT00485862|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6468172|NCT00485862|Adrenergic Agents|adrenergic agents|mesh-ancestor
6468173|NCT00485875|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6468174|NCT00485875|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6468175|NCT00485875|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6468176|NCT00485875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6468177|NCT00485875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468178|NCT00485875|Adrenergic Agents|adrenergic agents|mesh-ancestor
6468179|NCT00485875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6468180|NCT00485875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468181|NCT00485888|Citalopram|citalopram|mesh-list
5541409|NCT04167696|Immunologic Factors|immunologic factors|mesh-ancestor
5541410|NCT04167696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541411|NCT04167696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5541412|NCT04167696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5541413|NCT04167696|Alkylating Agents|alkylating agents|mesh-ancestor
5541414|NCT04167696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541415|NCT04167696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5541416|NCT04167696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5541417|NCT04167696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5541418|NCT04167696|Antimetabolites|antimetabolites|mesh-ancestor
5541419|NCT04167592|Benzydamine|benzydamine|mesh-list
5541420|NCT04167592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5541421|NCT04167137|Atezolizumab|atezolizumab|mesh-list
5541422|NCT04167137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5541423|NCT04167228|Ceftazidime|ceftazidime|mesh-list
5541424|NCT04167228|Avibactam|avibactam|mesh-list
5541425|NCT04167228|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
5541426|NCT04167228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5541427|NCT04167228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5541428|NCT04167228|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5541429|NCT04167228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5541430|NCT04167228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541431|NCT04167163|Abaloparatide|abaloparatide|mesh-list
5541432|NCT04167163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5541433|NCT04167163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541434|NCT04167280|Ipratropium|ipratropium|mesh-list
5541435|NCT04167280|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6137261|NCT01273805|Hydroxychloroquine|hydroxychloroquine|mesh-list
6137262|NCT01273805|Antimalarials|antimalarials|mesh-ancestor
6137263|NCT01273805|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5541436|NCT04167280|Autonomic Agents|autonomic agents|mesh-ancestor
5541437|NCT04167280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5541438|NCT04167280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541439|NCT04167280|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5541440|NCT04167280|Respiratory System Agents|respiratory system agents|mesh-ancestor
5541441|NCT04167280|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5541442|NCT04167280|Cholinergic Agents|cholinergic agents|mesh-ancestor
5541443|NCT04167280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5541444|NCT04167280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541445|NCT04167085|Doxycycline|doxycycline|mesh-list
5541446|NCT04167085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5541447|NCT04167085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5541448|NCT04167085|Antimalarials|antimalarials|mesh-ancestor
5541449|NCT04167085|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5541450|NCT04167085|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5541451|NCT04167111|Vitamin D|vitamin d|mesh-list
5541452|NCT04167111|Cholecalciferol|cholecalciferol|mesh-list
5541453|NCT04167111|Vitamins|vitamins|mesh-ancestor
5541454|NCT04167111|Micronutrients|micronutrients|mesh-ancestor
5541455|NCT04167111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137264|NCT01273805|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6137265|NCT01273805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6137266|NCT01273805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6137267|NCT01273805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137268|NCT01273805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6137269|NCT01273818|Gentamicins|gentamicins|mesh-list
6137270|NCT01273818|Cefazolin|cefazolin|mesh-list
6468182|NCT00485888|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6468183|NCT00485888|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6468184|NCT00485888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6468185|NCT00485888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468186|NCT00485888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6468187|NCT00485888|Serotonin Agents|serotonin agents|mesh-ancestor
6468188|NCT00485888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468189|NCT00485888|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6468190|NCT00485888|Antidepressive Agents|antidepressive agents|mesh-ancestor
5541456|NCT04167111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5541457|NCT04167111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5541458|NCT04166721|Atezolizumab|atezolizumab|mesh-list
6468191|NCT00485888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6468192|NCT00485901|Haloperidol|haloperidol|mesh-list
6468193|NCT00485901|Olanzapine|olanzapine|mesh-list
6468194|NCT00485901|Haloperidol decanoate|haloperidol decanoate|mesh-list
6468195|NCT00485901|Antiemetics|antiemetics|mesh-ancestor
5541459|NCT04166721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5541460|NCT04166734|Pembrolizumab|pembrolizumab|mesh-list
6137271|NCT01273818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6137272|NCT01273818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6137273|NCT01273818|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6137274|NCT01273818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6137275|NCT01273818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541461|NCT04166734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5541462|NCT04166734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5541463|NCT04166890|Epinephrine|epinephrine|mesh-list
5541464|NCT04166890|Carticaine|carticaine|mesh-list
5541465|NCT04166890|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5541466|NCT04166890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5541467|NCT04166890|Adrenergic Agents|adrenergic agents|mesh-ancestor
5541468|NCT04166890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5541469|NCT04166890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541470|NCT04166890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541471|NCT04166890|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5541472|NCT04166890|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5541473|NCT04166890|Autonomic Agents|autonomic agents|mesh-ancestor
5541474|NCT04166890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5541475|NCT04166890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5541476|NCT04166890|Respiratory System Agents|respiratory system agents|mesh-ancestor
5541477|NCT04166890|Mydriatics|mydriatics|mesh-ancestor
5541478|NCT04166890|Sympathomimetics|sympathomimetics|mesh-ancestor
5541479|NCT04166890|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6468196|NCT00485901|Autonomic Agents|autonomic agents|mesh-ancestor
5541480|NCT04166890|Anesthetics, Local|anesthetics, local|mesh-ancestor
5541481|NCT04166890|Anesthetics|anesthetics|mesh-ancestor
5541482|NCT04166890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5541483|NCT04166890|Sensory System Agents|sensory system agents|mesh-ancestor
5541484|NCT04166877|Magnesium Sulfate|magnesium sulfate|mesh-list
5541485|NCT04166877|Analgesics|analgesics|mesh-ancestor
5541486|NCT04166877|Sensory System Agents|sensory system agents|mesh-ancestor
5541487|NCT04166877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5541488|NCT04166877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541489|NCT04166877|Anesthetics|anesthetics|mesh-ancestor
5541490|NCT04166877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5541491|NCT04166877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5541492|NCT04166877|Anticonvulsants|anticonvulsants|mesh-ancestor
5541493|NCT04166877|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5541494|NCT04166877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5541495|NCT04166877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541496|NCT04166877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5541497|NCT04166877|Tocolytic Agents|tocolytic agents|mesh-ancestor
5541498|NCT04166877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5541499|NCT04166604|Trifluridine|trifluridine|mesh-list
5541500|NCT04166604|Antimetabolites|antimetabolites|mesh-ancestor
5541501|NCT04166604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541502|NCT04166604|Antiviral Agents|antiviral agents|mesh-ancestor
5541503|NCT04166604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5541504|NCT04167007|Gemcitabine|gemcitabine|mesh-list
5541505|NCT04167007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5541506|NCT04167007|Antimetabolites|antimetabolites|mesh-ancestor
5541507|NCT04167007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137276|NCT01274182|Rituximab|rituximab|mesh-list
6137277|NCT01274182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6137278|NCT01274182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6137279|NCT01274182|Immunologic Factors|immunologic factors|mesh-ancestor
6137280|NCT01274182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137281|NCT01274182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6137282|NCT01274338|Interferons|interferons|mesh-list
6137283|NCT01274338|Interferon-alpha|interferon-alpha|mesh-list
6137284|NCT01274338|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
6137285|NCT01274338|Ipilimumab|ipilimumab|mesh-list
6137286|NCT01274338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6137287|NCT01274338|Antiviral Agents|antiviral agents|mesh-ancestor
6137288|NCT01274338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6137289|NCT01274338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6137290|NCT01274338|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6137291|NCT01274338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541508|NCT04167007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5541509|NCT04167007|Antiviral Agents|antiviral agents|mesh-ancestor
6137292|NCT01274338|Immunologic Factors|immunologic factors|mesh-ancestor
6137293|NCT01274338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137294|NCT01274637|Dalteparin|dalteparin|mesh-list
6137295|NCT01274637|Tinzaparin|tinzaparin|mesh-list
6137296|NCT01274637|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6137297|NCT01274637|Anticoagulants|anticoagulants|mesh-ancestor
6137298|NCT01274637|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6137299|NCT01274637|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6137300|NCT01274637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137301|NCT01274897|Lactitol|lactitol|mesh-list
6137302|NCT01274897|Cathartics|cathartics|mesh-ancestor
6137303|NCT01274897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6137304|NCT01275131|Insulin Aspart|insulin aspart|mesh-list
6137305|NCT01275131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6137306|NCT01275131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137307|NCT01275144|Lorazepam|lorazepam|mesh-list
6137308|NCT01275144|Anticonvulsants|anticonvulsants|mesh-ancestor
6137309|NCT01275144|Antiemetics|antiemetics|mesh-ancestor
6137310|NCT01275144|Autonomic Agents|autonomic agents|mesh-ancestor
6137311|NCT01275144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6137312|NCT01275144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137313|NCT01275144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6137314|NCT01275144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6137315|NCT01275144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6137316|NCT01275144|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6137317|NCT01275144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6137318|NCT01275144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6137319|NCT01275144|GABA Modulators|gaba modulators|mesh-ancestor
6137320|NCT01275144|GABA Agents|gaba agents|mesh-ancestor
6137321|NCT01275144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6137322|NCT01275144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137323|NCT01275170|Imipenem|imipenem|mesh-list
6137324|NCT01275170|Relebactam|relebactam|mesh-list
6137325|NCT01275170|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
6137326|NCT01275170|Midazolam|midazolam|mesh-list
6137327|NCT01275170|Caffeine|caffeine|mesh-list
6137328|NCT01275170|Omeprazole|omeprazole|mesh-list
5541510|NCT04167007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5541511|NCT04167007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5541512|NCT04167007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5541513|NCT04167007|Immunologic Factors|immunologic factors|mesh-ancestor
5541514|NCT04167007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541515|NCT04166786|Ethanol|ethanol|mesh-list
5541516|NCT04166786|Methyltestosterone|methyltestosterone|mesh-list
5541517|NCT04166786|Petrolatum|petrolatum|mesh-list
5541518|NCT04166786|Testosterone|testosterone|mesh-list
6137329|NCT01275170|Cilastatin|cilastatin|mesh-list
6137330|NCT01275170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6137331|NCT01275170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6137332|NCT01275170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6137333|NCT01275170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541519|NCT04166786|Testosterone undecanoate|testosterone undecanoate|mesh-list
5541520|NCT04166786|Testosterone enanthate|testosterone enanthate|mesh-list
5541521|NCT04166786|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5541522|NCT04166786|Androgens|androgens|mesh-ancestor
5541523|NCT04166786|Hormones|hormones|mesh-ancestor
5541524|NCT04166786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5541525|NCT04166786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137334|NCT01275170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6137335|NCT01275170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6137336|NCT01275170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6137337|NCT01275170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6137338|NCT01275170|Anesthetics, General|anesthetics, general|mesh-ancestor
6468197|NCT00485901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6468198|NCT00485901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137339|NCT01275170|Anesthetics|anesthetics|mesh-ancestor
6137340|NCT01275170|GABA Modulators|gaba modulators|mesh-ancestor
6137341|NCT01275170|GABA Agents|gaba agents|mesh-ancestor
6137342|NCT01275170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6137343|NCT01275170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137344|NCT01275170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6137345|NCT01275170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6137346|NCT01275170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6137347|NCT01275170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6137348|NCT01275170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6137349|NCT01275170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6137350|NCT01275170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6137351|NCT01275170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6137352|NCT01275170|Purinergic Agents|purinergic agents|mesh-ancestor
6137353|NCT01275170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6137354|NCT01275170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6137355|NCT01275170|Protease Inhibitors|protease inhibitors|mesh-ancestor
6137356|NCT01275170|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6137357|NCT01275196|Imatinib Mesylate|imatinib mesylate|mesh-list
6137358|NCT01275196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6137359|NCT01275196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6137360|NCT01275196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6137361|NCT01275196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137362|NCT01275222|Everolimus|everolimus|mesh-list
6137363|NCT01275222|Imatinib Mesylate|imatinib mesylate|mesh-list
6137364|NCT01275222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6137365|NCT01275222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6137366|NCT01275222|Immunologic Factors|immunologic factors|mesh-ancestor
6137367|NCT01275222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137368|NCT01275222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6137369|NCT01275222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6137370|NCT01275222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468199|NCT00485901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6468200|NCT00485901|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6468201|NCT00485901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6468202|NCT00485901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6468203|NCT00485901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6468204|NCT00485901|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6468205|NCT00485901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6468206|NCT00485901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6205288|NCT02083783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5541526|NCT04166786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6468207|NCT00485901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468208|NCT00485901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6468209|NCT00485901|Serotonin Agents|serotonin agents|mesh-ancestor
6468210|NCT00485901|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6468211|NCT00485901|Dopamine Agents|dopamine agents|mesh-ancestor
6468212|NCT00485901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6488502|NCT00584571|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6488503|NCT00584571|Parasympatholytics|parasympatholytics|mesh-ancestor
6137371|NCT01275300|Aspirin|aspirin|mesh-list
6137372|NCT01275300|Niacin|niacin|mesh-list
6137373|NCT01275300|Niacinamide|niacinamide|mesh-list
6137374|NCT01275300|Nicotinic Acids|nicotinic acids|mesh-list
6137375|NCT01275300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6137376|NCT01275300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6137377|NCT01275300|Analgesics|analgesics|mesh-ancestor
6137378|NCT01275300|Sensory System Agents|sensory system agents|mesh-ancestor
6137379|NCT01275300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6137380|NCT01275300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137381|NCT01275300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6137382|NCT01275300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6488504|NCT00584571|Autonomic Agents|autonomic agents|mesh-ancestor
6488505|NCT00584571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6488506|NCT00584571|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6488507|NCT00584571|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6488508|NCT00584571|Cholinergic Agents|cholinergic agents|mesh-ancestor
6488509|NCT00584610|Copper|copper|mesh-list
6488510|NCT00584610|Levonorgestrel|levonorgestrel|mesh-list
6137383|NCT01275300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6137384|NCT01275300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6137385|NCT01275300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137386|NCT01275300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6137387|NCT01275300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6137388|NCT01275300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6137389|NCT01275300|Antipyretics|antipyretics|mesh-ancestor
6137390|NCT01275300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6137391|NCT01275300|Antimetabolites|antimetabolites|mesh-ancestor
6137392|NCT01275300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6137393|NCT01275300|Vasodilator Agents|vasodilator agents|mesh-ancestor
6137394|NCT01275300|Vitamin B Complex|vitamin b complex|mesh-ancestor
6137395|NCT01275300|Vitamins|vitamins|mesh-ancestor
6137396|NCT01275300|Micronutrients|micronutrients|mesh-ancestor
6137397|NCT01275339|Tadalafil|tadalafil|mesh-list
6137398|NCT01275339|Vasodilator Agents|vasodilator agents|mesh-ancestor
5541527|NCT04166786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5541528|NCT04166786|Anabolic Agents|anabolic agents|mesh-ancestor
5541529|NCT04166786|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5541530|NCT04166786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5541531|NCT04166786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5541532|NCT04166786|Emollients|emollients|mesh-ancestor
5541533|NCT04166786|Dermatologic Agents|dermatologic agents|mesh-ancestor
5541534|NCT04166812|Nitric Oxide|nitric oxide|mesh-list
5541535|NCT04166812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5541536|NCT04166812|Autonomic Agents|autonomic agents|mesh-ancestor
5541537|NCT04166812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5541538|NCT04166812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541539|NCT04166812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5541540|NCT04166812|Respiratory System Agents|respiratory system agents|mesh-ancestor
5541541|NCT04166812|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5541542|NCT04166812|Antioxidants|antioxidants|mesh-ancestor
5541543|NCT04166812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541544|NCT04166812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5541545|NCT04166812|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5541546|NCT04166812|Vasodilator Agents|vasodilator agents|mesh-ancestor
5541547|NCT04166812|Gasotransmitters|gasotransmitters|mesh-ancestor
5541548|NCT04166812|Protective Agents|protective agents|mesh-ancestor
5541549|NCT04166435|Temozolomide|temozolomide|mesh-list
5541550|NCT04166435|Olaparib|olaparib|mesh-list
6137399|NCT01275339|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6137400|NCT01275339|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6137401|NCT01275339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6137402|NCT01275339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137403|NCT01275339|Urological Agents|urological agents|mesh-ancestor
6137404|NCT01275365|Methyltestosterone|methyltestosterone|mesh-list
6137405|NCT01275365|Testosterone|testosterone|mesh-list
6137406|NCT01275365|Testosterone undecanoate|testosterone undecanoate|mesh-list
6137407|NCT01275365|Testosterone enanthate|testosterone enanthate|mesh-list
6137408|NCT01275365|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6488511|NCT00584610|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6468213|NCT00485940|Prucalopride|prucalopride|mesh-list
6468214|NCT00485940|Laxatives|laxatives|mesh-ancestor
6468215|NCT00485940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6468216|NCT00485940|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
6468217|NCT00485940|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6468218|NCT00485940|Serotonin Agents|serotonin agents|mesh-ancestor
6468219|NCT00485940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6468220|NCT00485940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468221|NCT00485940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468222|NCT00485979|Docetaxel|docetaxel|mesh-list
6468223|NCT00485979|Trastuzumab|trastuzumab|mesh-list
6468224|NCT00485979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6468225|NCT00485979|Tubulin Modulators|tubulin modulators|mesh-ancestor
6468226|NCT00485979|Antimitotic Agents|antimitotic agents|mesh-ancestor
6468227|NCT00485979|Mitosis Modulators|mitosis modulators|mesh-ancestor
6468228|NCT00485979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468229|NCT00485979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6468230|NCT00486005|Olanzapine|olanzapine|mesh-list
6468231|NCT00486005|Nizatidine|nizatidine|mesh-list
6468232|NCT00486005|Antiemetics|antiemetics|mesh-ancestor
6468233|NCT00486005|Autonomic Agents|autonomic agents|mesh-ancestor
6468234|NCT00486005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6468235|NCT00486005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468236|NCT00486005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6468237|NCT00486005|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6468238|NCT00486005|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6468239|NCT00486005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6468240|NCT00486005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6468241|NCT00486005|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6137409|NCT01275365|Androgens|androgens|mesh-ancestor
6137410|NCT01275365|Hormones|hormones|mesh-ancestor
6137411|NCT01275365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5541551|NCT04166435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5541552|NCT04166435|Alkylating Agents|alkylating agents|mesh-ancestor
5541553|NCT04166435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541554|NCT04166435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5541555|NCT04166435|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5541556|NCT04166435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5541557|NCT04166578|Lidocaine|lidocaine|mesh-list
5541558|NCT04166578|Anesthetics, Local|anesthetics, local|mesh-ancestor
5541559|NCT04166578|Anesthetics|anesthetics|mesh-ancestor
5541560|NCT04166578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5541561|NCT04166578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137412|NCT01275365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137413|NCT01275365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6137414|NCT01275365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6137415|NCT01275365|Anabolic Agents|anabolic agents|mesh-ancestor
6137416|NCT01275625|Maraviroc|maraviroc|mesh-list
6137417|NCT01275625|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6137418|NCT01275625|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6137419|NCT01275625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137420|NCT01275625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6137421|NCT01275625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6137422|NCT01275625|Antiviral Agents|antiviral agents|mesh-ancestor
6137423|NCT01275625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6468242|NCT00486005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6468243|NCT00486005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6468244|NCT00486005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468245|NCT00486005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6468246|NCT00486005|Serotonin Agents|serotonin agents|mesh-ancestor
6137424|NCT01275625|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6137425|NCT01275664|Dexamethasone|dexamethasone|mesh-list
6137426|NCT01275664|Dexamethasone acetate|dexamethasone acetate|mesh-list
6137427|NCT01275664|Cisplatin|cisplatin|mesh-list
6137428|NCT01275664|Carboplatin|carboplatin|mesh-list
6137429|NCT01275664|Aprepitant|aprepitant|mesh-list
6137430|NCT01275664|Granisetron|granisetron|mesh-list
6137431|NCT01275664|Ichthammol|ichthammol|mesh-list
6137432|NCT01275664|BB 1101|bb 1101|mesh-list
5541562|NCT04166578|Sensory System Agents|sensory system agents|mesh-ancestor
5541563|NCT04166578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5541564|NCT04166578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5541565|NCT04166578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6137433|NCT01275664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6137434|NCT01275664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5541566|NCT04166578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5541567|NCT04166578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5541568|NCT04166578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541569|NCT04166396|Resveratrol|resveratrol|mesh-list
5541570|NCT04166396|Antioxidants|antioxidants|mesh-ancestor
5541571|NCT04166396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541572|NCT04166396|Protective Agents|protective agents|mesh-ancestor
5541573|NCT04166396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541574|NCT04166396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6137435|NCT01275664|Antiemetics|antiemetics|mesh-ancestor
6137436|NCT01275664|Autonomic Agents|autonomic agents|mesh-ancestor
6137437|NCT01275664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6137438|NCT01275664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137439|NCT01275664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6137440|NCT01275664|Glucocorticoids|glucocorticoids|mesh-ancestor
6137441|NCT01275664|Hormones|hormones|mesh-ancestor
6137442|NCT01275664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6137443|NCT01275664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6137444|NCT01275664|Protease Inhibitors|protease inhibitors|mesh-ancestor
6137445|NCT01275664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6137446|NCT01275664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137447|NCT01275664|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5541575|NCT04166396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5541576|NCT04166474|Dolutegravir|dolutegravir|mesh-list
5541577|NCT04166474|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5541578|NCT04166474|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5541579|NCT04166474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5541580|NCT04166474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541581|NCT04166474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5541582|NCT04166474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5541583|NCT04166474|Antiviral Agents|antiviral agents|mesh-ancestor
5541584|NCT04166474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5541585|NCT04166565|Dexamethasone|dexamethasone|mesh-list
5541586|NCT04166565|Cyclophosphamide|cyclophosphamide|mesh-list
5541587|NCT04166565|Bortezomib|bortezomib|mesh-list
5541588|NCT04166565|Daratumumab|daratumumab|mesh-list
5541589|NCT04166565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5541590|NCT04166565|Immunologic Factors|immunologic factors|mesh-ancestor
5541591|NCT04166565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541592|NCT04166565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5541593|NCT04166565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5541594|NCT04166565|Alkylating Agents|alkylating agents|mesh-ancestor
5541595|NCT04166565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541596|NCT04166565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6137448|NCT01275664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6137449|NCT01275664|Dermatologic Agents|dermatologic agents|mesh-ancestor
6137450|NCT01275664|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6137451|NCT01275664|Serotonin Agents|serotonin agents|mesh-ancestor
6137452|NCT01276041|Paclitaxel|paclitaxel|mesh-list
6137453|NCT01276041|Trastuzumab|trastuzumab|mesh-list
6137454|NCT01276041|Pertuzumab|pertuzumab|mesh-list
6137455|NCT01276041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6137456|NCT01276041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6137457|NCT01276041|Tubulin Modulators|tubulin modulators|mesh-ancestor
6137458|NCT01276041|Antimitotic Agents|antimitotic agents|mesh-ancestor
6137459|NCT01276041|Mitosis Modulators|mitosis modulators|mesh-ancestor
6137460|NCT01276041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137461|NCT01276041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6137462|NCT01276223|Fluprednisolone|fluprednisolone|mesh-list
6137463|NCT01276223|Difluprednate|difluprednate|mesh-list
6137464|NCT01276223|Glucocorticoids|glucocorticoids|mesh-ancestor
6137465|NCT01276223|Hormones|hormones|mesh-ancestor
6205289|NCT02083783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6468247|NCT00486005|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6468248|NCT00486005|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6468249|NCT00486005|Histamine Antagonists|histamine antagonists|mesh-ancestor
6468250|NCT00486005|Histamine Agents|histamine agents|mesh-ancestor
6468251|NCT00486083|Methylphenidate|methylphenidate|mesh-list
6468252|NCT00486083|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6468253|NCT00486083|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6468254|NCT00486083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468255|NCT00486083|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6468256|NCT00486083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5541597|NCT04166565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5541598|NCT04166565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6468257|NCT00486083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5541599|NCT04166565|Antiemetics|antiemetics|mesh-ancestor
5541600|NCT04166565|Autonomic Agents|autonomic agents|mesh-ancestor
5541601|NCT04166565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5541602|NCT04166565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6137466|NCT01276223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6137467|NCT01276223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137468|NCT01276223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6137469|NCT01276236|Maraviroc|maraviroc|mesh-list
6137470|NCT01276236|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6137471|NCT01276236|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6137472|NCT01276236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137473|NCT01276236|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6137474|NCT01276236|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6137475|NCT01276236|Antiviral Agents|antiviral agents|mesh-ancestor
6137476|NCT01276236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6137477|NCT01276236|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6137478|NCT01276288|Empagliflozin|empagliflozin|mesh-list
6137479|NCT01276288|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6137480|NCT01276288|Torsemide|torsemide|mesh-list
6137481|NCT01276288|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6137482|NCT01276288|Diuretics|diuretics|mesh-ancestor
6137483|NCT01276288|Natriuretic Agents|natriuretic agents|mesh-ancestor
6137484|NCT01276288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137485|NCT01276288|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6137486|NCT01276288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6137487|NCT01276288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137488|NCT01276288|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6137489|NCT01276288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6137490|NCT01276288|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6137491|NCT01276301|Empagliflozin|empagliflozin|mesh-list
6137492|NCT01276301|Verapamil|verapamil|mesh-list
6137493|NCT01276301|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6137494|NCT01276301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137495|NCT01276301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6137496|NCT01276301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137497|NCT01276301|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6137498|NCT01276301|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6137499|NCT01276301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6137500|NCT01276301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6137501|NCT01276301|Vasodilator Agents|vasodilator agents|mesh-ancestor
6137502|NCT01276314|Prednisolone|prednisolone|mesh-list
6137503|NCT01276314|Etanercept|etanercept|mesh-list
6137504|NCT01276314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6137505|NCT01276314|Glucocorticoids|glucocorticoids|mesh-ancestor
6137506|NCT01276314|Hormones|hormones|mesh-ancestor
6137507|NCT01276314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6137508|NCT01276314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137509|NCT01276314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6137510|NCT01276314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6137511|NCT01276314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6137512|NCT01276314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6137513|NCT01276314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6137514|NCT01276314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6137515|NCT01276314|Analgesics|analgesics|mesh-ancestor
6137516|NCT01276314|Sensory System Agents|sensory system agents|mesh-ancestor
6137517|NCT01276314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6137518|NCT01276314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6137519|NCT01276314|Immunologic Factors|immunologic factors|mesh-ancestor
6137520|NCT01276327|Pioglitazone|pioglitazone|mesh-list
6137521|NCT01276327|Linagliptin|linagliptin|mesh-list
6137522|NCT01276327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6137523|NCT01276327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541603|NCT04166565|Glucocorticoids|glucocorticoids|mesh-ancestor
5541604|NCT04166565|Hormones|hormones|mesh-ancestor
5541605|NCT04166565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5541606|NCT04166565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5541607|NCT04166487|Paclitaxel|paclitaxel|mesh-list
5541608|NCT04166487|Carboplatin|carboplatin|mesh-list
5541609|NCT04166487|Pembrolizumab|pembrolizumab|mesh-list
5541610|NCT04166487|Pemetrexed|pemetrexed|mesh-list
5602302|NCT04684511|Rofecoxib|rofecoxib|mesh-list
6137524|NCT01276327|Incretins|incretins|mesh-ancestor
6137525|NCT01276327|Hormones|hormones|mesh-ancestor
6205290|NCT02083783|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6137526|NCT01276327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6137527|NCT01276327|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6137528|NCT01276327|Protease Inhibitors|protease inhibitors|mesh-ancestor
6137529|NCT01276327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5541611|NCT04166487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5541612|NCT04166487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5541613|NCT04166487|Tubulin Modulators|tubulin modulators|mesh-ancestor
5541614|NCT04166487|Antimitotic Agents|antimitotic agents|mesh-ancestor
5541615|NCT04166487|Mitosis Modulators|mitosis modulators|mesh-ancestor
5541616|NCT04166487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541617|NCT04166487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5541618|NCT04166487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5541619|NCT04166487|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5541620|NCT04166487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5541621|NCT04166006|Interleukin-2|interleukin-2|mesh-list
5541622|NCT04166006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5541623|NCT04166006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5541624|NCT04166006|Analgesics|analgesics|mesh-ancestor
5541625|NCT04166006|Sensory System Agents|sensory system agents|mesh-ancestor
5541626|NCT04166006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5541627|NCT04166006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602303|NCT04684511|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5602304|NCT04684511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5602305|NCT04684511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5602306|NCT04684511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602307|NCT04684511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6137530|NCT01276327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137531|NCT01276353|Donepezil|donepezil|mesh-list
6468258|NCT00486083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468259|NCT00486083|Dopamine Agents|dopamine agents|mesh-ancestor
6468260|NCT00486083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6468261|NCT00486083|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6468262|NCT00486083|Adrenergic Agents|adrenergic agents|mesh-ancestor
6468263|NCT00486122|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6137532|NCT01276353|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6137533|NCT01276353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6137534|NCT01276353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137535|NCT01276353|Cholinergic Agents|cholinergic agents|mesh-ancestor
6137536|NCT01276353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6137537|NCT01276353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137538|NCT01276353|Nootropic Agents|nootropic agents|mesh-ancestor
6137539|NCT01276379|Leucovorin|leucovorin|mesh-list
6137540|NCT01276379|Folic Acid|folic acid|mesh-list
6137541|NCT01276379|Fluorouracil|fluorouracil|mesh-list
6137542|NCT01276379|Oxaliplatin|oxaliplatin|mesh-list
6137543|NCT01276379|Irinotecan|irinotecan|mesh-list
6137544|NCT01276379|Cetuximab|cetuximab|mesh-list
6137545|NCT01276379|Levoleucovorin|levoleucovorin|mesh-list
6137546|NCT01276379|Antimetabolites|antimetabolites|mesh-ancestor
6205291|NCT02083809|Oxytocin|oxytocin|mesh-list
6137547|NCT01276379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137548|NCT01276379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6137549|NCT01276379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6137550|NCT01276379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6137551|NCT01276379|Immunologic Factors|immunologic factors|mesh-ancestor
6137552|NCT01276379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137553|NCT01276379|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6137554|NCT01276379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6137555|NCT01276379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6137556|NCT01276379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6137557|NCT01276379|Antidotes|antidotes|mesh-ancestor
6137558|NCT01276379|Protective Agents|protective agents|mesh-ancestor
6137559|NCT01276379|Vitamin B Complex|vitamin b complex|mesh-ancestor
6137560|NCT01276379|Vitamins|vitamins|mesh-ancestor
6137561|NCT01276379|Micronutrients|micronutrients|mesh-ancestor
5541628|NCT04166110|Oxymetazoline|oxymetazoline|mesh-list
5541629|NCT04166110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5541630|NCT04166110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5541631|NCT04166110|Adrenergic Agents|adrenergic agents|mesh-ancestor
5541632|NCT04166110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5541633|NCT04166110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137562|NCT01276379|Hematinics|hematinics|mesh-ancestor
6137563|NCT01276457|Cyclosporine|cyclosporine|mesh-list
6137564|NCT01276457|Everolimus|everolimus|mesh-list
6137565|NCT01276457|Cyclosporins|cyclosporins|mesh-list
6137566|NCT01276457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6137567|NCT01276457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137568|NCT01276457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6137569|NCT01276457|Immunologic Factors|immunologic factors|mesh-ancestor
6137570|NCT01276457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137571|NCT01276457|Antifungal Agents|antifungal agents|mesh-ancestor
6137572|NCT01276457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6137573|NCT01276457|Dermatologic Agents|dermatologic agents|mesh-ancestor
6137574|NCT01276457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5541634|NCT04166110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541635|NCT04166110|Sympathomimetics|sympathomimetics|mesh-ancestor
5541636|NCT04166110|Autonomic Agents|autonomic agents|mesh-ancestor
5541637|NCT04166110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5541638|NCT04166110|Nasal Decongestants|nasal decongestants|mesh-ancestor
5541639|NCT04166110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5541640|NCT04166110|Respiratory System Agents|respiratory system agents|mesh-ancestor
5541641|NCT04166292|Lidocaine|lidocaine|mesh-list
5541642|NCT04166292|Anesthetics, Local|anesthetics, local|mesh-ancestor
5541643|NCT04166292|Anesthetics|anesthetics|mesh-ancestor
5541644|NCT04166292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5541645|NCT04166292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541646|NCT04166292|Sensory System Agents|sensory system agents|mesh-ancestor
5541647|NCT04166292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5541648|NCT04166292|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5541649|NCT04166292|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5541650|NCT04166292|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5541651|NCT04166292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5541652|NCT04166292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541653|NCT04166253|Vitamin D|vitamin d|mesh-list
5541654|NCT04166253|Alfacalcidol|alfacalcidol|mesh-list
5541655|NCT04166253|Vitamins|vitamins|mesh-ancestor
5541656|NCT04166253|Micronutrients|micronutrients|mesh-ancestor
5606774|NCT03786783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6468264|NCT00486122|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6468265|NCT00486122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6468266|NCT00486122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6468267|NCT00486122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468268|NCT00486122|Adrenergic Agents|adrenergic agents|mesh-ancestor
6137575|NCT01276457|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6137576|NCT01276457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6137577|NCT01276639|Tofacitinib|tofacitinib|mesh-list
6137578|NCT01276639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6137579|NCT01276639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6468269|NCT00486122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6468270|NCT00486122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468271|NCT00486174|Methylene Blue|methylene blue|mesh-list
6468272|NCT00486174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6468273|NCT00486174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468274|NCT00486187|Metformin|metformin|mesh-list
6468275|NCT00486187|Rosiglitazone|rosiglitazone|mesh-list
6468276|NCT00486187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6468277|NCT00486187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468278|NCT00486213|Pyridoxine|pyridoxine|mesh-list
6468279|NCT00486213|Vitamin B 6|vitamin b 6|mesh-list
6468280|NCT00486213|Vitamin B Complex|vitamin b complex|mesh-ancestor
5725535|NCT03179995|Octreotide|octreotide|mesh-list
6137580|NCT01276639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137581|NCT01276756|Interferons|interferons|mesh-list
6137582|NCT01276756|Ribavirin|ribavirin|mesh-list
6137583|NCT01276756|Interferon-alpha|interferon-alpha|mesh-list
6137584|NCT01276756|Interferon alpha-2|interferon alpha-2|mesh-list
6137585|NCT01276756|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6137586|NCT01276756|Nitazoxanide|nitazoxanide|mesh-list
6137587|NCT01276756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6137588|NCT01276756|Antiviral Agents|antiviral agents|mesh-ancestor
6137589|NCT01276756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6137590|NCT01276756|Antimetabolites|antimetabolites|mesh-ancestor
6137591|NCT01276756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468281|NCT00486213|Vitamins|vitamins|mesh-ancestor
6468282|NCT00486213|Micronutrients|micronutrients|mesh-ancestor
6137592|NCT01276756|Immunologic Factors|immunologic factors|mesh-ancestor
6137593|NCT01276756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137594|NCT01276756|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6468283|NCT00486213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137595|NCT01276821|Epinephrine|epinephrine|mesh-list
6137596|NCT01276821|Racepinephrine|racepinephrine|mesh-list
6137597|NCT01276821|Epinephryl borate|epinephryl borate|mesh-list
6137598|NCT01276821|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6137599|NCT01276821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6137600|NCT01276821|Adrenergic Agents|adrenergic agents|mesh-ancestor
6137601|NCT01276821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6137602|NCT01276821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137603|NCT01276821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137604|NCT01276821|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6137605|NCT01276821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6137606|NCT01276821|Autonomic Agents|autonomic agents|mesh-ancestor
6137607|NCT01276821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6137608|NCT01276821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6137609|NCT01276821|Respiratory System Agents|respiratory system agents|mesh-ancestor
6137610|NCT01276821|Mydriatics|mydriatics|mesh-ancestor
6137611|NCT01276821|Sympathomimetics|sympathomimetics|mesh-ancestor
6137612|NCT01276821|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6137613|NCT01276847|Etanercept|etanercept|mesh-list
6137614|NCT01276847|Ustekinumab|ustekinumab|mesh-list
6468284|NCT00486317|Calcitonin|calcitonin|mesh-list
6468285|NCT00486317|Salmon calcitonin|salmon calcitonin|mesh-list
6468286|NCT00486317|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
6468287|NCT00486317|Katacalcin|katacalcin|mesh-list
6468288|NCT00486317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6468289|NCT00486317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468290|NCT00486317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6468291|NCT00486317|Vasodilator Agents|vasodilator agents|mesh-ancestor
6468292|NCT00486343|Zileuton|zileuton|mesh-list
6468293|NCT00486343|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6468294|NCT00486343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6468295|NCT00486343|Analgesics|analgesics|mesh-ancestor
6468296|NCT00486343|Sensory System Agents|sensory system agents|mesh-ancestor
6666461|NCT01522989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137615|NCT01276847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6137616|NCT01276847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6137617|NCT01276847|Analgesics|analgesics|mesh-ancestor
6137618|NCT01276847|Sensory System Agents|sensory system agents|mesh-ancestor
6137619|NCT01276847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6137620|NCT01276847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137621|NCT01276847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6137622|NCT01276847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6137623|NCT01276847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5725723|NCT03178292|Renal Agents|renal agents|mesh-ancestor
6137624|NCT01276847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6137625|NCT01276847|Immunologic Factors|immunologic factors|mesh-ancestor
6137626|NCT01276847|Dermatologic Agents|dermatologic agents|mesh-ancestor
6137627|NCT01277081|Acetaminophen|acetaminophen|mesh-list
6137628|NCT01277081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6137629|NCT01277081|Analgesics|analgesics|mesh-ancestor
6137630|NCT01277081|Sensory System Agents|sensory system agents|mesh-ancestor
6137631|NCT01277081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6666462|NCT01522989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6666463|NCT01522989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6137632|NCT01277081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137633|NCT01277081|Antipyretics|antipyretics|mesh-ancestor
6137634|NCT01277159|Dexamethasone|dexamethasone|mesh-list
6137635|NCT01277159|Dexamethasone acetate|dexamethasone acetate|mesh-list
6137636|NCT01277159|Buprenorphine|buprenorphine|mesh-list
6137637|NCT01277159|BB 1101|bb 1101|mesh-list
6137638|NCT01277159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6137639|NCT01277159|Antiemetics|antiemetics|mesh-ancestor
6137640|NCT01277159|Autonomic Agents|autonomic agents|mesh-ancestor
6137641|NCT01277159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6137642|NCT01277159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137643|NCT01277159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6137644|NCT01277159|Glucocorticoids|glucocorticoids|mesh-ancestor
6137645|NCT01277159|Hormones|hormones|mesh-ancestor
6137646|NCT01277159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6137647|NCT01277159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6137648|NCT01277159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6137649|NCT01277159|Protease Inhibitors|protease inhibitors|mesh-ancestor
6137650|NCT01277159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6137651|NCT01277159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137652|NCT01277159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6137653|NCT01277159|Narcotics|narcotics|mesh-ancestor
6137654|NCT01277159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6137655|NCT01277159|Analgesics|analgesics|mesh-ancestor
6137656|NCT01277159|Sensory System Agents|sensory system agents|mesh-ancestor
6137657|NCT01277159|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6137658|NCT01277302|Ranibizumab|ranibizumab|mesh-list
6137659|NCT01277302|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6468297|NCT00486343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6666464|NCT01523002|Artesunate|artesunate|mesh-list
6666465|NCT01523002|Pyronaridine|pyronaridine|mesh-list
6666466|NCT01523002|Metoprolol|metoprolol|mesh-list
6666467|NCT01523002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6666468|NCT01523002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6666469|NCT01523002|Sympatholytics|sympatholytics|mesh-ancestor
6666470|NCT01523002|Autonomic Agents|autonomic agents|mesh-ancestor
6666471|NCT01523002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6666472|NCT01523002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541657|NCT04166253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541658|NCT04166253|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5541659|NCT04165967|Nivolumab|nivolumab|mesh-list
5541660|NCT04165967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5541661|NCT04165967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5541662|NCT04165967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5541663|NCT04165967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541664|NCT04166318|Fluorouracil|fluorouracil|mesh-list
5541665|NCT04166318|Capecitabine|capecitabine|mesh-list
5541666|NCT04166318|Mitomycins|mitomycins|mesh-list
5541667|NCT04166318|Mitomycin|mitomycin|mesh-list
5541668|NCT04166318|Antimetabolites|antimetabolites|mesh-ancestor
5541669|NCT04166318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541670|NCT04166318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5541671|NCT04166318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5541672|NCT04166318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5541673|NCT04166318|Immunologic Factors|immunologic factors|mesh-ancestor
5541674|NCT04166318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541675|NCT04166318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5541676|NCT04166318|Alkylating Agents|alkylating agents|mesh-ancestor
5541677|NCT04166318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5541678|NCT04166318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6137660|NCT01277302|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6137661|NCT01277302|Growth Substances|growth substances|mesh-ancestor
6137662|NCT01277302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541679|NCT04165902|Hyaluronic Acid|hyaluronic acid|mesh-list
5541680|NCT04165902|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5541681|NCT04165902|Immunologic Factors|immunologic factors|mesh-ancestor
5541682|NCT04165902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541683|NCT04165902|Viscosupplements|viscosupplements|mesh-ancestor
5541684|NCT04165902|Protective Agents|protective agents|mesh-ancestor
5541685|NCT04165850|Ciprofloxacin|ciprofloxacin|mesh-list
5541686|NCT04165850|Celecoxib|celecoxib|mesh-list
5541687|NCT04165850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5541688|NCT04165850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5541689|NCT04165850|Analgesics|analgesics|mesh-ancestor
5541690|NCT04165850|Sensory System Agents|sensory system agents|mesh-ancestor
6137663|NCT01277302|Growth Inhibitors|growth inhibitors|mesh-ancestor
6137664|NCT01277302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6137665|NCT01277341|Bepotastine besilate|bepotastine besilate|mesh-list
6468298|NCT00486343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468299|NCT00486343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6468300|NCT00486343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6468301|NCT00486343|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6468302|NCT00486343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5541691|NCT04165850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6137666|NCT01277341|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6137667|NCT01277510|Cinacalcet|cinacalcet|mesh-list
6137668|NCT01277510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6137669|NCT01277510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137670|NCT01277510|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
5541692|NCT04165850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137671|NCT01277510|Hormone Antagonists|hormone antagonists|mesh-ancestor
6137672|NCT01277510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6137673|NCT01277523|Tiotropium Bromide|tiotropium bromide|mesh-list
6137674|NCT01277523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6137675|NCT01277523|Autonomic Agents|autonomic agents|mesh-ancestor
6137676|NCT01277523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6137677|NCT01277523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137678|NCT01277523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6137679|NCT01277523|Respiratory System Agents|respiratory system agents|mesh-ancestor
6137680|NCT01277523|Parasympatholytics|parasympatholytics|mesh-ancestor
6137681|NCT01277523|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6137682|NCT01277523|Cholinergic Agents|cholinergic agents|mesh-ancestor
6137683|NCT01277523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6137684|NCT01277523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137685|NCT01277601|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6137686|NCT01277601|Antiviral Agents|antiviral agents|mesh-ancestor
6137687|NCT01277601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6137688|NCT01277718|Rabeprazole|rabeprazole|mesh-list
6137689|NCT01277718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6137690|NCT01277718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6137691|NCT01277718|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6488512|NCT00584610|Contraceptive Agents|contraceptive agents|mesh-ancestor
6137692|NCT01277718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6137693|NCT01277718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137694|NCT01277744|Cisplatin|cisplatin|mesh-list
5541693|NCT04165850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5541694|NCT04165850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5541695|NCT04165850|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5541696|NCT04165850|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5541697|NCT04165850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5541698|NCT04165850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137695|NCT01277744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6137696|NCT01277861|Fentanyl|fentanyl|mesh-list
6137697|NCT01277861|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6137698|NCT01277861|Narcotics|narcotics|mesh-ancestor
6137699|NCT01277861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6137700|NCT01277861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137701|NCT01277861|Analgesics|analgesics|mesh-ancestor
5541699|NCT04165850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5541700|NCT04165850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5541701|NCT04165850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5541702|NCT04165850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5541703|NCT04165850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5541704|NCT04165850|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5541705|NCT04165850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5541706|NCT04165512|Triamcinolone|triamcinolone|mesh-list
5541707|NCT04165512|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6137702|NCT01277861|Sensory System Agents|sensory system agents|mesh-ancestor
6137703|NCT01277861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6137704|NCT01277861|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6137705|NCT01277861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6137706|NCT01277861|Anesthetics, General|anesthetics, general|mesh-ancestor
6137707|NCT01277861|Anesthetics|anesthetics|mesh-ancestor
5541708|NCT04165512|Bupivacaine|bupivacaine|mesh-list
5541709|NCT04165512|Anesthetics, Local|anesthetics, local|mesh-ancestor
5541710|NCT04165512|Anesthetics|anesthetics|mesh-ancestor
5541711|NCT04165512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5541712|NCT04165512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541713|NCT04165512|Sensory System Agents|sensory system agents|mesh-ancestor
5541714|NCT04165512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5541715|NCT04165512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5541716|NCT04165512|Glucocorticoids|glucocorticoids|mesh-ancestor
5541717|NCT04165512|Hormones|hormones|mesh-ancestor
5541718|NCT04165512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5541719|NCT04165512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5541720|NCT04165512|Immunologic Factors|immunologic factors|mesh-ancestor
5541721|NCT04165629|Aspirin|aspirin|mesh-list
5541722|NCT04165629|Clopidogrel|clopidogrel|mesh-list
5541723|NCT04165629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5541724|NCT04165629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5541725|NCT04165629|Analgesics|analgesics|mesh-ancestor
5541726|NCT04165629|Sensory System Agents|sensory system agents|mesh-ancestor
5541727|NCT04165629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5541728|NCT04165629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541729|NCT04165629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5541730|NCT04165629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5541731|NCT04165629|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6137708|NCT01278160|Insulin|insulin|mesh-list
6137709|NCT01278160|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6137710|NCT01278160|Metformin|metformin|mesh-list
6137711|NCT01278160|Insulin Aspart|insulin aspart|mesh-list
6468303|NCT00486343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541732|NCT04165629|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6666473|NCT01523002|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6666474|NCT01523002|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6666475|NCT01523002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6666476|NCT01523002|Adrenergic Agents|adrenergic agents|mesh-ancestor
6666477|NCT01523002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6666478|NCT01523002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666479|NCT01523002|Antimalarials|antimalarials|mesh-ancestor
6666480|NCT01523002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6666481|NCT01523002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6666482|NCT01523002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6137712|NCT01278160|Insulin, Long-Acting|insulin, long-acting|mesh-list
6137713|NCT01278160|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6137714|NCT01278160|Biphasic Insulins|biphasic insulins|mesh-list
6137715|NCT01278160|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6137716|NCT01278160|Insulin, Isophane|insulin, isophane|mesh-list
6137717|NCT01278160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6137718|NCT01278160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137719|NCT01278173|Vigabatrin|vigabatrin|mesh-list
6137720|NCT01278173|Anticonvulsants|anticonvulsants|mesh-ancestor
6137721|NCT01278173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6137722|NCT01278173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137723|NCT01278173|GABA Agents|gaba agents|mesh-ancestor
5541733|NCT04165629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541734|NCT04165629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6666483|NCT01523002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5541735|NCT04165629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5541736|NCT04165629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5541737|NCT04165629|Antipyretics|antipyretics|mesh-ancestor
5541738|NCT04165629|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5541739|NCT04165629|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5541740|NCT04165629|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5541741|NCT04165629|Purinergic Agents|purinergic agents|mesh-ancestor
5541742|NCT04165629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5541743|NCT04165330|Nivolumab|nivolumab|mesh-list
5541744|NCT04165330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5541745|NCT04165330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5541746|NCT04165330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5541747|NCT04165330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541748|NCT04165174|Apatinib|apatinib|mesh-list
6137724|NCT01278173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6137725|NCT01278173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137726|NCT01278342|Octreotide|octreotide|mesh-list
6137727|NCT01278342|Cabergoline|cabergoline|mesh-list
6137728|NCT01278342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6137729|NCT01278342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6137730|NCT01278342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6137731|NCT01278342|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6137732|NCT01278342|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6137733|NCT01278342|Dopamine Agonists|dopamine agonists|mesh-ancestor
6137734|NCT01278342|Dopamine Agents|dopamine agents|mesh-ancestor
6137735|NCT01278342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6137736|NCT01278342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137737|NCT01278342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137738|NCT01278394|Tavaborole|tavaborole|mesh-list
6137739|NCT01278394|Antifungal Agents|antifungal agents|mesh-ancestor
6137740|NCT01278394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6137741|NCT01278407|Donepezil|donepezil|mesh-list
6137742|NCT01278407|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6137743|NCT01278407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6137744|NCT01278407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137745|NCT01278407|Cholinergic Agents|cholinergic agents|mesh-ancestor
6137746|NCT01278407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6137747|NCT01278407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137748|NCT01278407|Nootropic Agents|nootropic agents|mesh-ancestor
6137749|NCT01278745|Rituximab|rituximab|mesh-list
6137750|NCT01278745|Tacrolimus|tacrolimus|mesh-list
6137751|NCT01278745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6137752|NCT01278745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6137753|NCT01278745|Immunologic Factors|immunologic factors|mesh-ancestor
6137754|NCT01278745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137755|NCT01278745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6137756|NCT01278745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6137757|NCT01278745|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6137758|NCT01278745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6137759|NCT01278745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137760|NCT01278797|Amlodipine|amlodipine|mesh-list
6137761|NCT01278797|Telmisartan|telmisartan|mesh-list
6137762|NCT01278797|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
6137763|NCT01278797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6137764|NCT01278797|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6137765|NCT01278797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6137766|NCT01278797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137767|NCT01278797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6137768|NCT01278797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137769|NCT01278797|Vasodilator Agents|vasodilator agents|mesh-ancestor
6137770|NCT01278797|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6137771|NCT01278797|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6137772|NCT01279057|Fluticasone|fluticasone|mesh-list
6137773|NCT01279057|Xhance|xhance|mesh-list
6137774|NCT01279057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6137775|NCT01279057|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6137776|NCT01279057|Autonomic Agents|autonomic agents|mesh-ancestor
6137777|NCT01279057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6137778|NCT01279057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137779|NCT01279057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6137780|NCT01279057|Respiratory System Agents|respiratory system agents|mesh-ancestor
6137781|NCT01279057|Dermatologic Agents|dermatologic agents|mesh-ancestor
6137782|NCT01279057|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6137783|NCT01279187|Teriparatide|teriparatide|mesh-list
6137784|NCT01279187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6137785|NCT01279187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137786|NCT01279187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6137787|NCT01279317|Acetic Acid|acetic acid|mesh-list
6137788|NCT01279317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6137789|NCT01279317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6137790|NCT01279343|Misoprostol|misoprostol|mesh-list
6137791|NCT01279343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6137792|NCT01279343|Abortifacient Agents|abortifacient agents|mesh-ancestor
6468304|NCT00486343|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6468305|NCT00486343|Hormone Antagonists|hormone antagonists|mesh-ancestor
6468306|NCT00486343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6468307|NCT00486356|Carboplatin|carboplatin|mesh-list
5541749|NCT04165174|Antibodies|antibodies|mesh-list
5541750|NCT04165174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5541751|NCT04165174|Immunologic Factors|immunologic factors|mesh-ancestor
5541752|NCT04165174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541753|NCT04165174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5541754|NCT04165174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5541755|NCT04165174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5541756|NCT04165174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541757|NCT04164979|Pembrolizumab|pembrolizumab|mesh-list
5541758|NCT04164979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5541759|NCT04164979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5541760|NCT04164849|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5541761|NCT04164849|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5541762|NCT04164849|Dermatologic Agents|dermatologic agents|mesh-ancestor
5541763|NCT04164823|Analgesics|analgesics|mesh-list
5541764|NCT04164823|Sensory System Agents|sensory system agents|mesh-ancestor
6468308|NCT00486356|Capecitabine|capecitabine|mesh-list
6468309|NCT00486356|Epirubicin|epirubicin|mesh-list
6468310|NCT00486356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6468311|NCT00486356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5725536|NCT03179995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6205292|NCT02083809|Oxytocics|oxytocics|mesh-ancestor
6468312|NCT00486356|Antimetabolites|antimetabolites|mesh-ancestor
6468313|NCT00486356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468314|NCT00486356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6468315|NCT00486356|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6468316|NCT00486356|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6468317|NCT00486356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6468318|NCT00486369|Calcitonin|calcitonin|mesh-list
6468319|NCT00486369|Salmon calcitonin|salmon calcitonin|mesh-list
6468320|NCT00486369|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
6468321|NCT00486369|Katacalcin|katacalcin|mesh-list
6468322|NCT00486369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6468323|NCT00486369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468324|NCT00486369|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6468325|NCT00486369|Vasodilator Agents|vasodilator agents|mesh-ancestor
6468326|NCT00486421|Prednisone|prednisone|mesh-list
6468327|NCT00486421|Rituximab|rituximab|mesh-list
5541765|NCT04164823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5541766|NCT04164823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541767|NCT04164615|Capecitabine|capecitabine|mesh-list
5725537|NCT03179995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5725538|NCT03179995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5725539|NCT03179839|Fluvoxamine|fluvoxamine|mesh-list
5725540|NCT03179839|Sertraline|sertraline|mesh-list
5725541|NCT03179839|Antidepressive Agents|antidepressive agents|mesh-ancestor
5725542|NCT03179839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6468328|NCT00486421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6468329|NCT00486421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6468330|NCT00486421|Immunologic Factors|immunologic factors|mesh-ancestor
6468331|NCT00486421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468332|NCT00486421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6468333|NCT00486421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6468334|NCT00486421|Glucocorticoids|glucocorticoids|mesh-ancestor
6468335|NCT00486421|Hormones|hormones|mesh-ancestor
6468336|NCT00486421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6468337|NCT00486421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6666484|NCT01523002|Antiviral Agents|antiviral agents|mesh-ancestor
5725543|NCT03179839|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5725544|NCT03179839|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5725545|NCT03179839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5541768|NCT04164615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5541769|NCT04164615|Antimetabolites|antimetabolites|mesh-ancestor
5541770|NCT04164615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541771|NCT04164615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5541772|NCT04164524|Gentamicins|gentamicins|mesh-list
5541773|NCT04164524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5541774|NCT04164524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5541775|NCT04164524|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5541776|NCT04164524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5541777|NCT04164524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541778|NCT04164797|Endostar protein|endostar protein|mesh-list
5541779|NCT04164797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5541780|NCT04164797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5541781|NCT04164797|Growth Substances|growth substances|mesh-ancestor
5541782|NCT04164797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725546|NCT03179839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725547|NCT03179839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5725548|NCT03179839|Serotonin Agents|serotonin agents|mesh-ancestor
6468338|NCT00486460|Gemcitabine|gemcitabine|mesh-list
5541783|NCT04164797|Growth Inhibitors|growth inhibitors|mesh-ancestor
5541784|NCT04164797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5541785|NCT04164745|Pembrolizumab|pembrolizumab|mesh-list
5541786|NCT04164745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5541787|NCT04164745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5541788|NCT04164459|Latanoprost|latanoprost|mesh-list
5541789|NCT04164459|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5541790|NCT04164459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5541791|NCT04164719|Cyclobenzaprine|cyclobenzaprine|mesh-list
5541792|NCT04164719|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5541793|NCT04164719|Antidepressive Agents|antidepressive agents|mesh-ancestor
5541794|NCT04164719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5541795|NCT04164719|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5541796|NCT04164719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541797|NCT04164719|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6468339|NCT00486460|Curcumin|curcumin|mesh-list
6666485|NCT01523002|Schistosomicides|schistosomicides|mesh-ancestor
6666486|NCT01523002|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6666487|NCT01523002|Anthelmintics|anthelmintics|mesh-ancestor
6666488|NCT01523015|Docetaxel|docetaxel|mesh-list
6666489|NCT01523015|Fluorouracil|fluorouracil|mesh-list
6666490|NCT01523015|Oxaliplatin|oxaliplatin|mesh-list
6666491|NCT01523015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6666492|NCT01523015|Tubulin Modulators|tubulin modulators|mesh-ancestor
6666493|NCT01523015|Antimitotic Agents|antimitotic agents|mesh-ancestor
6666494|NCT01523015|Mitosis Modulators|mitosis modulators|mesh-ancestor
6666495|NCT01523015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666496|NCT01523015|Antimetabolites|antimetabolites|mesh-ancestor
6666497|NCT01523015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6666498|NCT01523015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6468340|NCT00486460|Celecoxib|celecoxib|mesh-list
6468341|NCT00486460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6468342|NCT00486460|Antimetabolites|antimetabolites|mesh-ancestor
6468343|NCT00486460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468344|NCT00486460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6468345|NCT00486460|Antiviral Agents|antiviral agents|mesh-ancestor
6468346|NCT00486460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6468347|NCT00486460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6468348|NCT00486460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6468349|NCT00486460|Immunologic Factors|immunologic factors|mesh-ancestor
6468350|NCT00486460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468351|NCT00486460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6468352|NCT00486460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6468353|NCT00486460|Analgesics|analgesics|mesh-ancestor
6468354|NCT00486460|Sensory System Agents|sensory system agents|mesh-ancestor
6468355|NCT00486460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6468356|NCT00486460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6468357|NCT00486460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6468358|NCT00486460|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6468359|NCT00486460|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6468360|NCT00486486|Timolol|timolol|mesh-list
6468361|NCT00486486|Bimatoprost|bimatoprost|mesh-list
6468362|NCT00486486|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6137793|NCT01279343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6468363|NCT00486486|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6468364|NCT00486486|Adrenergic Agents|adrenergic agents|mesh-ancestor
6468365|NCT00486486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6468366|NCT00486486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468367|NCT00486486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468368|NCT00486486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6468369|NCT00486486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6468370|NCT00486564|Nifurtimox|nifurtimox|mesh-list
6468371|NCT00486564|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6468372|NCT00486564|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6468373|NCT00486564|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5541798|NCT04164719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5541799|NCT04164719|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5541800|NCT04164719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5541801|NCT04164693|Heparin|heparin|mesh-list
5541802|NCT04164693|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5541803|NCT04164693|Tinzaparin|tinzaparin|mesh-list
5541804|NCT04164693|Dalteparin|dalteparin|mesh-list
5541805|NCT04164693|Warfarin|warfarin|mesh-list
5541806|NCT04164693|Anticoagulants|anticoagulants|mesh-ancestor
5541807|NCT04164693|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5541808|NCT04164693|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5541809|NCT04164693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541810|NCT04164238|Paclitaxel|paclitaxel|mesh-list
5541811|NCT04164238|Carboplatin|carboplatin|mesh-list
5541812|NCT04164238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6468374|NCT00486564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6468375|NCT00486668|Paclitaxel|paclitaxel|mesh-list
6468376|NCT00486668|Cyclophosphamide|cyclophosphamide|mesh-list
6468377|NCT00486668|Doxorubicin|doxorubicin|mesh-list
6468378|NCT00486668|Trastuzumab|trastuzumab|mesh-list
6468379|NCT00486668|Lapatinib|lapatinib|mesh-list
6468380|NCT00486668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6468381|NCT00486668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6468382|NCT00486668|Tubulin Modulators|tubulin modulators|mesh-ancestor
6666499|NCT01523015|Immunologic Factors|immunologic factors|mesh-ancestor
5541813|NCT04164238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6468383|NCT00486668|Antimitotic Agents|antimitotic agents|mesh-ancestor
6468384|NCT00486668|Mitosis Modulators|mitosis modulators|mesh-ancestor
6468385|NCT00486668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468386|NCT00486668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6137794|NCT01279343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137795|NCT01279343|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6137796|NCT01279343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5541814|NCT04164238|Tubulin Modulators|tubulin modulators|mesh-ancestor
5541815|NCT04164238|Antimitotic Agents|antimitotic agents|mesh-ancestor
5541816|NCT04164238|Mitosis Modulators|mitosis modulators|mesh-ancestor
5541817|NCT04164238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541818|NCT04164212|Vaccines|vaccines|mesh-list
6137797|NCT01279343|Oxytocics|oxytocics|mesh-ancestor
6137798|NCT01279447|Bupivacaine|bupivacaine|mesh-list
6137799|NCT01279447|Anesthetics, Local|anesthetics, local|mesh-ancestor
6137800|NCT01279447|Anesthetics|anesthetics|mesh-ancestor
6468387|NCT00486668|Immunologic Factors|immunologic factors|mesh-ancestor
6468388|NCT00486668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468389|NCT00486668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6468390|NCT00486668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6468391|NCT00486668|Alkylating Agents|alkylating agents|mesh-ancestor
6468392|NCT00486668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6468393|NCT00486668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6468394|NCT00486668|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6468395|NCT00486668|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6468396|NCT00486668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6468397|NCT00486668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6468398|NCT00486668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6468399|NCT00486694|Artesunate|artesunate|mesh-list
6468400|NCT00486694|Chloroquine|chloroquine|mesh-list
6468401|NCT00486694|Pyrimethamine|pyrimethamine|mesh-list
6468402|NCT00486694|Sulfadoxine|sulfadoxine|mesh-list
6468403|NCT00486694|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6468404|NCT00486694|Antimalarials|antimalarials|mesh-ancestor
6468405|NCT00486694|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6468406|NCT00486694|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6468407|NCT00486694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6468408|NCT00486694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6468409|NCT00486694|Antiviral Agents|antiviral agents|mesh-ancestor
6468410|NCT00486694|Schistosomicides|schistosomicides|mesh-ancestor
6468411|NCT00486694|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6468412|NCT00486694|Anthelmintics|anthelmintics|mesh-ancestor
6468413|NCT00486694|Amebicides|amebicides|mesh-ancestor
6468414|NCT00486694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6468415|NCT00486694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6468416|NCT00486694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6468417|NCT00486694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541819|NCT04164212|Immunologic Factors|immunologic factors|mesh-ancestor
5541820|NCT04164212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541821|NCT04164355|Tadalafil|tadalafil|mesh-list
5541822|NCT04164355|Vasodilator Agents|vasodilator agents|mesh-ancestor
5541823|NCT04164355|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5541824|NCT04164355|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5541825|NCT04164355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5541826|NCT04164355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541827|NCT04164355|Urological Agents|urological agents|mesh-ancestor
5602308|NCT04684511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5602309|NCT04684511|Analgesics|analgesics|mesh-ancestor
5602310|NCT04684511|Sensory System Agents|sensory system agents|mesh-ancestor
5602311|NCT04684511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5602312|NCT04684511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602313|NCT04684511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5602314|NCT04684511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5602315|NCT04682860|Scopolamine|scopolamine|mesh-list
5602316|NCT04682860|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
5602317|NCT04682860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5602318|NCT04682860|Antiemetics|antiemetics|mesh-ancestor
5602319|NCT04682860|Autonomic Agents|autonomic agents|mesh-ancestor
6137801|NCT01279447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6468418|NCT00486694|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6468419|NCT00486694|Renal Agents|renal agents|mesh-ancestor
6468420|NCT00486772|Calcium|calcium|mesh-list
6468421|NCT00486772|Sevelamer|sevelamer|mesh-list
5602320|NCT04682860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6137802|NCT01279447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137803|NCT01279447|Sensory System Agents|sensory system agents|mesh-ancestor
6137804|NCT01279447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6137805|NCT01279681|Leucovorin|leucovorin|mesh-list
6137806|NCT01279681|Bevacizumab|bevacizumab|mesh-list
6137807|NCT01279681|Fluorouracil|fluorouracil|mesh-list
6137808|NCT01279681|Capecitabine|capecitabine|mesh-list
6468422|NCT00486772|Calcium acetate|calcium acetate|mesh-list
6468423|NCT00486772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6468424|NCT00486772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468425|NCT00486772|Chelating Agents|chelating agents|mesh-ancestor
6468426|NCT00486772|Sequestering Agents|sequestering agents|mesh-ancestor
6468427|NCT00486772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468428|NCT00486785|Alfuzosin|alfuzosin|mesh-list
6468429|NCT00486785|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6468430|NCT00486785|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6468431|NCT00486785|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6468432|NCT00486785|Adrenergic Agents|adrenergic agents|mesh-ancestor
6468433|NCT00486785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6468434|NCT00486785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468435|NCT00486785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468436|NCT00486785|Urological Agents|urological agents|mesh-ancestor
6468437|NCT00486798|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6468438|NCT00486798|Antidepressive Agents|antidepressive agents|mesh-ancestor
6468439|NCT00486798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6468440|NCT00486798|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6468441|NCT00486798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5541828|NCT04164368|Lenalidomide|lenalidomide|mesh-list
5541829|NCT04164368|Immunologic Factors|immunologic factors|mesh-ancestor
5541830|NCT04164368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541831|NCT04164368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5541832|NCT04164368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5541833|NCT04164368|Growth Substances|growth substances|mesh-ancestor
6468442|NCT00486798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6468443|NCT00486798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468444|NCT00486876|Tofisopam|tofisopam|mesh-list
6468445|NCT00486876|Antidepressive Agents|antidepressive agents|mesh-ancestor
6468446|NCT00486876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6468447|NCT00486980|Peramivir|peramivir|mesh-list
6137809|NCT01279681|Oxaliplatin|oxaliplatin|mesh-list
6137810|NCT01279681|Calcium|calcium|mesh-list
6137811|NCT01279681|Levoleucovorin|levoleucovorin|mesh-list
6137812|NCT01279681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5541834|NCT04164368|Growth Inhibitors|growth inhibitors|mesh-ancestor
6137813|NCT01279681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6137814|NCT01279681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6137815|NCT01279681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6137816|NCT01279681|Growth Substances|growth substances|mesh-ancestor
6137817|NCT01279681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137818|NCT01279681|Growth Inhibitors|growth inhibitors|mesh-ancestor
6137819|NCT01279681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6137820|NCT01279681|Antimetabolites|antimetabolites|mesh-ancestor
6137821|NCT01279681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137822|NCT01279681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6137823|NCT01279681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6137824|NCT01279681|Immunologic Factors|immunologic factors|mesh-ancestor
6137825|NCT01279681|Antidotes|antidotes|mesh-ancestor
6468448|NCT00486980|Antiviral Agents|antiviral agents|mesh-ancestor
6468449|NCT00486980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6468450|NCT00486980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6468451|NCT00486980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137826|NCT01279681|Protective Agents|protective agents|mesh-ancestor
6468452|NCT00487032|Fluticasone|fluticasone|mesh-list
6468453|NCT00487032|Xhance|xhance|mesh-list
6468454|NCT00487032|Prazosin|prazosin|mesh-list
6468455|NCT00487032|Phenylephrine|phenylephrine|mesh-list
6468456|NCT00487032|Oxymetazoline|oxymetazoline|mesh-list
6468457|NCT00487032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6468458|NCT00487032|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6468459|NCT00487032|Autonomic Agents|autonomic agents|mesh-ancestor
6468460|NCT00487032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6468461|NCT00487032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468462|NCT00487032|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6468463|NCT00487032|Respiratory System Agents|respiratory system agents|mesh-ancestor
6468464|NCT00487032|Dermatologic Agents|dermatologic agents|mesh-ancestor
6468465|NCT00487032|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5541835|NCT04164368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5541836|NCT04164329|Anesthetics|anesthetics|mesh-list
5541837|NCT04164329|Anesthetics, General|anesthetics, general|mesh-list
5541838|NCT04164329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5541839|NCT04164329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541840|NCT04164264|Propofol|propofol|mesh-list
5541841|NCT04164264|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5541842|NCT04164264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5541843|NCT04164264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541844|NCT04164264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5541845|NCT04164264|Anesthetics, General|anesthetics, general|mesh-ancestor
5541846|NCT04164264|Anesthetics|anesthetics|mesh-ancestor
6137827|NCT01279681|Vitamin B Complex|vitamin b complex|mesh-ancestor
6137828|NCT01279681|Vitamins|vitamins|mesh-ancestor
5541847|NCT04164199|Capecitabine|capecitabine|mesh-list
5541848|NCT04164199|Pemetrexed|pemetrexed|mesh-list
5541849|NCT04164199|Temozolomide|temozolomide|mesh-list
5541850|NCT04164199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5541851|NCT04164199|Antimetabolites|antimetabolites|mesh-ancestor
5541852|NCT04164199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541853|NCT04164199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5541854|NCT04164199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5541855|NCT04164199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5541856|NCT04164199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5541857|NCT04164199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5541858|NCT04164199|Alkylating Agents|alkylating agents|mesh-ancestor
5541859|NCT04163978|Budesonide|budesonide|mesh-list
5541860|NCT04163978|Nitric Oxide|nitric oxide|mesh-list
5541861|NCT04163978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5541862|NCT04163978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5541863|NCT04163978|Autonomic Agents|autonomic agents|mesh-ancestor
5541864|NCT04163978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5541865|NCT04163978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541866|NCT04163978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5541867|NCT04163978|Respiratory System Agents|respiratory system agents|mesh-ancestor
5541868|NCT04163978|Glucocorticoids|glucocorticoids|mesh-ancestor
5541869|NCT04163978|Hormones|hormones|mesh-ancestor
5541870|NCT04163978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5541871|NCT04163978|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5541872|NCT04163978|Antioxidants|antioxidants|mesh-ancestor
5541873|NCT04163978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541874|NCT04163978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5541875|NCT04163978|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5541876|NCT04163978|Vasodilator Agents|vasodilator agents|mesh-ancestor
5541877|NCT04163978|Gasotransmitters|gasotransmitters|mesh-ancestor
5541878|NCT04163978|Protective Agents|protective agents|mesh-ancestor
5541879|NCT04163783|Zanubrutinib|zanubrutinib|mesh-list
5541880|NCT04163783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5541881|NCT04163783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5541882|NCT04163783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5541883|NCT04163783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541884|NCT04163536|Methylprednisolone|methylprednisolone|mesh-list
5541885|NCT04163536|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5541886|NCT04163536|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5541887|NCT04163536|Prednisolone|prednisolone|mesh-list
5541888|NCT04163536|Prednisolone acetate|prednisolone acetate|mesh-list
5541889|NCT04163536|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5541890|NCT04163536|Prednisolone phosphate|prednisolone phosphate|mesh-list
5541891|NCT04163536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5541892|NCT04163536|Antiemetics|antiemetics|mesh-ancestor
5541893|NCT04163536|Autonomic Agents|autonomic agents|mesh-ancestor
5541894|NCT04163536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5541895|NCT04163536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541896|NCT04163536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5541897|NCT04163536|Glucocorticoids|glucocorticoids|mesh-ancestor
5541898|NCT04163536|Hormones|hormones|mesh-ancestor
5602321|NCT04682860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137829|NCT01279681|Micronutrients|micronutrients|mesh-ancestor
6137830|NCT01279850|Pregabalin|pregabalin|mesh-list
6137831|NCT01279850|Analgesics|analgesics|mesh-ancestor
6137832|NCT01279850|Sensory System Agents|sensory system agents|mesh-ancestor
6137833|NCT01279850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6137834|NCT01279850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137835|NCT01279850|Anticonvulsants|anticonvulsants|mesh-ancestor
6468466|NCT00487032|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6137836|NCT01279850|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6137837|NCT01279850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6137838|NCT01279850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468467|NCT00487032|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6468468|NCT00487032|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6468469|NCT00487032|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6468470|NCT00487032|Adrenergic Agents|adrenergic agents|mesh-ancestor
6468471|NCT00487032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6468472|NCT00487032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468473|NCT00487032|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6468474|NCT00487032|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6468475|NCT00487032|Sympathomimetics|sympathomimetics|mesh-ancestor
6468476|NCT00487032|Nasal Decongestants|nasal decongestants|mesh-ancestor
6468477|NCT00487032|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6468478|NCT00487032|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6468479|NCT00487032|Mydriatics|mydriatics|mesh-ancestor
6468480|NCT00487032|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6468481|NCT00487032|Protective Agents|protective agents|mesh-ancestor
6468482|NCT00487110|Acetaminophen|acetaminophen|mesh-list
6468483|NCT00487110|Tropisetron|tropisetron|mesh-list
6468484|NCT00487110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6468485|NCT00487110|Analgesics|analgesics|mesh-ancestor
6468486|NCT00487110|Sensory System Agents|sensory system agents|mesh-ancestor
6468487|NCT00487110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6468488|NCT00487110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468489|NCT00487110|Antipyretics|antipyretics|mesh-ancestor
6468490|NCT00487110|Antiemetics|antiemetics|mesh-ancestor
6468491|NCT00487110|Autonomic Agents|autonomic agents|mesh-ancestor
6137839|NCT01279850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6137840|NCT01279850|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6137841|NCT01279850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6137842|NCT01279850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5541899|NCT04163536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5541900|NCT04163536|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5541901|NCT04163536|Protective Agents|protective agents|mesh-ancestor
5541902|NCT04163536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6137843|NCT01279850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6137844|NCT01279954|Abatacept|abatacept|mesh-list
6137845|NCT01279954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6137846|NCT01279954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137847|NCT01279954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6137848|NCT01279954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6137849|NCT01279954|Immunologic Factors|immunologic factors|mesh-ancestor
6137850|NCT01279954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137851|NCT01279954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6137852|NCT01280058|Paclitaxel|paclitaxel|mesh-list
6137853|NCT01280058|Carboplatin|carboplatin|mesh-list
6137854|NCT01280058|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6137855|NCT01280058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6137856|NCT01280058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6137857|NCT01280058|Tubulin Modulators|tubulin modulators|mesh-ancestor
6468492|NCT00487110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6468493|NCT00487110|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6468494|NCT00487110|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6468495|NCT00487110|Serotonin Agents|serotonin agents|mesh-ancestor
6468496|NCT00487110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6468497|NCT00487110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468498|NCT00487123|Valsartan|valsartan|mesh-list
6468499|NCT00487123|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6468500|NCT00487123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6468501|NCT00487123|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6468502|NCT00487123|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6468503|NCT00487123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468504|NCT00487123|Diuretics|diuretics|mesh-ancestor
6468505|NCT00487123|Natriuretic Agents|natriuretic agents|mesh-ancestor
6468506|NCT00487123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468507|NCT00487123|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6468508|NCT00487123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6468509|NCT00487136|Warfarin|warfarin|mesh-list
6468510|NCT00487136|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6468511|NCT00487136|Fenofibric acid|fenofibric acid|mesh-list
6666500|NCT01523015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137858|NCT01280058|Antimitotic Agents|antimitotic agents|mesh-ancestor
6468512|NCT00487136|Fenofibrate|fenofibrate|mesh-list
5541903|NCT04163536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5541904|NCT04163523|Zanubrutinib|zanubrutinib|mesh-list
5541905|NCT04163523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5541906|NCT04163523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5541907|NCT04163523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6666501|NCT01523041|Insulin|insulin|mesh-list
6666502|NCT01523041|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6666503|NCT01523041|Insulin Aspart|insulin aspart|mesh-list
6666504|NCT01523041|Insulin, Long-Acting|insulin, long-acting|mesh-list
6666505|NCT01523041|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6666506|NCT01523041|Biphasic Insulins|biphasic insulins|mesh-list
6666507|NCT01523041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6666508|NCT01523041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666509|NCT01523054|Metoprolol|metoprolol|mesh-list
6666510|NCT01523054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6666511|NCT01523054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5541908|NCT04163523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541909|NCT04163432|Carboplatin|carboplatin|mesh-list
6468513|NCT00487136|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6468514|NCT00487136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6468515|NCT00487136|Antimetabolites|antimetabolites|mesh-ancestor
6468516|NCT00487136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468517|NCT00487136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6468518|NCT00487136|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6468519|NCT00487136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6468520|NCT00487136|Anticoagulants|anticoagulants|mesh-ancestor
6468521|NCT00487175|Tramadol|tramadol|mesh-list
6468522|NCT00487175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6468523|NCT00487175|Narcotics|narcotics|mesh-ancestor
6468524|NCT00487175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6468525|NCT00487175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468526|NCT00487175|Analgesics|analgesics|mesh-ancestor
6468527|NCT00487175|Sensory System Agents|sensory system agents|mesh-ancestor
5541910|NCT04163432|Pemetrexed|pemetrexed|mesh-list
5541911|NCT04163432|Durvalumab|durvalumab|mesh-list
5541912|NCT04163432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5541913|NCT04163432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5541914|NCT04163432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541915|NCT04163432|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6137859|NCT01280058|Mitosis Modulators|mitosis modulators|mesh-ancestor
6468528|NCT00487175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6468529|NCT00487227|Caffeine|caffeine|mesh-list
6468530|NCT00487227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6468531|NCT00487227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468532|NCT00487227|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6468533|NCT00487227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6468534|NCT00487227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468535|NCT00487227|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6468536|NCT00487227|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6468537|NCT00487227|Purinergic Agents|purinergic agents|mesh-ancestor
6468538|NCT00487227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6468539|NCT00487253|Miltefosine|miltefosine|mesh-list
6468540|NCT00487253|Meglumine Antimoniate|meglumine antimoniate|mesh-list
6468541|NCT00487253|Antifungal Agents|antifungal agents|mesh-ancestor
6468542|NCT00487253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6468543|NCT00487253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6468544|NCT00487253|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6468545|NCT00487253|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6468546|NCT00487422|Prucalopride|prucalopride|mesh-list
6468547|NCT00487422|Laxatives|laxatives|mesh-ancestor
6468548|NCT00487422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6468549|NCT00487422|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
6468550|NCT00487422|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6468551|NCT00487422|Serotonin Agents|serotonin agents|mesh-ancestor
6468552|NCT00487422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6468553|NCT00487422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468554|NCT00487422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137860|NCT01280058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137861|NCT01280110|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6137862|NCT01280110|Laxatives|laxatives|mesh-ancestor
6137863|NCT01280110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6137864|NCT01280123|Pioglitazone|pioglitazone|mesh-list
6137865|NCT01280123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6137866|NCT01280123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666512|NCT01523054|Sympatholytics|sympatholytics|mesh-ancestor
6137867|NCT01280266|Amlodipine|amlodipine|mesh-list
6137868|NCT01280266|Udenafil|udenafil|mesh-list
6137869|NCT01280266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6137870|NCT01280266|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6137871|NCT01280266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6137872|NCT01280266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137873|NCT01280266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6137874|NCT01280266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137875|NCT01280266|Vasodilator Agents|vasodilator agents|mesh-ancestor
6137876|NCT01280266|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6137877|NCT01280266|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6137878|NCT01280266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5541916|NCT04163432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5541917|NCT04163432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5541918|NCT04163419|Tanezumab|tanezumab|mesh-list
5541919|NCT04163419|Analgesics|analgesics|mesh-ancestor
5541920|NCT04163419|Sensory System Agents|sensory system agents|mesh-ancestor
5541921|NCT04163419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5541922|NCT04163419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541923|NCT04163471|Hemostatics|hemostatics|mesh-list
5541924|NCT04163471|Coagulants|coagulants|mesh-ancestor
5541925|NCT04163458|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5541926|NCT04163458|Menotropins|menotropins|mesh-list
5541927|NCT04163458|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5541928|NCT04163458|Fertility Agents|fertility agents|mesh-ancestor
5541929|NCT04163458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5541930|NCT04163458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541931|NCT04163354|Listerine|listerine|mesh-list
5541932|NCT04163354|Fluorides|fluorides|mesh-list
5541933|NCT04163354|Sodium Fluoride|sodium fluoride|mesh-list
5541934|NCT04163354|Fluorides, Topical|fluorides, topical|mesh-list
5541935|NCT04163354|Cariostatic Agents|cariostatic agents|mesh-ancestor
5541936|NCT04163354|Protective Agents|protective agents|mesh-ancestor
5541937|NCT04163354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541938|NCT04163354|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5541939|NCT04163354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5541940|NCT04163276|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5541941|NCT04163276|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5541942|NCT04163276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541943|NCT04163588|Metolazone|metolazone|mesh-list
5541944|NCT04163588|Diuretics|diuretics|mesh-list
5541945|NCT04163588|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
5541946|NCT04163588|Natriuretic Agents|natriuretic agents|mesh-ancestor
5541947|NCT04163588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541948|NCT04163588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5541949|NCT04163588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541950|NCT04163588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6137879|NCT01280409|Metformin|metformin|mesh-list
6137880|NCT01280409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6137881|NCT01280409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137882|NCT01280591|Naproxen|naproxen|mesh-list
6137883|NCT01280591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6137884|NCT01280591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6137885|NCT01280591|Analgesics|analgesics|mesh-ancestor
6137886|NCT01280591|Sensory System Agents|sensory system agents|mesh-ancestor
6468555|NCT00487448|Cytarabine|cytarabine|mesh-list
6468556|NCT00487448|Fludarabine|fludarabine|mesh-list
5541951|NCT04163588|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5541952|NCT04163237|Sorafenib|sorafenib|mesh-list
5541953|NCT04163237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5541954|NCT04163237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5541955|NCT04163237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5541956|NCT04163237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541957|NCT04163016|Certolizumab Pegol|certolizumab pegol|mesh-list
5541958|NCT04163016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6137887|NCT01280591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6137888|NCT01280591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137889|NCT01280591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6137890|NCT01280591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6137891|NCT01280591|Gout Suppressants|gout suppressants|mesh-ancestor
6137892|NCT01280591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6137893|NCT01280591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6137894|NCT01280591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137895|NCT01280604|Fenofibrate|fenofibrate|mesh-list
6468557|NCT00487448|Idarubicin|idarubicin|mesh-list
6468558|NCT00487448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6468559|NCT00487448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6468560|NCT00487448|Antimetabolites|antimetabolites|mesh-ancestor
6468561|NCT00487448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468562|NCT00487448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6468563|NCT00487448|Immunologic Factors|immunologic factors|mesh-ancestor
6468564|NCT00487448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468565|NCT00487448|Antiviral Agents|antiviral agents|mesh-ancestor
6468566|NCT00487448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6468567|NCT00487448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6468568|NCT00487448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5541959|NCT04163016|Immunologic Factors|immunologic factors|mesh-ancestor
5541960|NCT04163016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541961|NCT04163016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5541962|NCT04162743|Trazodone|trazodone|mesh-list
5541963|NCT04162743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5541964|NCT04162743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6468569|NCT00487448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6468570|NCT00487448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6468571|NCT00487591|Simvastatin|simvastatin|mesh-list
6468572|NCT00487591|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6468573|NCT00487591|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6468574|NCT00487591|Antimetabolites|antimetabolites|mesh-ancestor
6468575|NCT00487591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468576|NCT00487591|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6468577|NCT00487591|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6468578|NCT00487591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6468579|NCT00487682|Valacyclovir|valacyclovir|mesh-list
6468580|NCT00487682|Antiviral Agents|antiviral agents|mesh-ancestor
6468581|NCT00487682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6468582|NCT00487734|Methyltestosterone|methyltestosterone|mesh-list
6468583|NCT00487734|Testosterone|testosterone|mesh-list
6468584|NCT00487734|Testosterone undecanoate|testosterone undecanoate|mesh-list
6468585|NCT00487734|Testosterone enanthate|testosterone enanthate|mesh-list
6137896|NCT01280604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6137897|NCT01280604|Antimetabolites|antimetabolites|mesh-ancestor
6137898|NCT01280604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137899|NCT01280604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6137900|NCT01280617|Thymoglobulin|thymoglobulin|mesh-list
5541965|NCT04162743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5541966|NCT04162743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5541967|NCT04162743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5541968|NCT04162743|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5541969|NCT04162743|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5541970|NCT04162743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5541971|NCT04162743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541972|NCT04162743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5541973|NCT04162743|Serotonin Agents|serotonin agents|mesh-ancestor
5541974|NCT04162743|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5541975|NCT04162743|Antidepressive Agents|antidepressive agents|mesh-ancestor
5541976|NCT04162834|Papaverine|papaverine|mesh-list
5541977|NCT04162834|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5541978|NCT04162834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5541979|NCT04162834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541980|NCT04162834|Vasodilator Agents|vasodilator agents|mesh-ancestor
5541981|NCT04162834|Urological Agents|urological agents|mesh-ancestor
5541982|NCT04162873|Celecoxib|celecoxib|mesh-list
5541983|NCT04162873|Benzenesulfonamide|benzenesulfonamide|mesh-list
5541984|NCT04162873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5541985|NCT04162873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5541986|NCT04162873|Analgesics|analgesics|mesh-ancestor
5541987|NCT04162873|Sensory System Agents|sensory system agents|mesh-ancestor
5541988|NCT04162873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5541989|NCT04162873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137901|NCT01280617|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6137902|NCT01280617|Immunologic Factors|immunologic factors|mesh-ancestor
6137903|NCT01280617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137904|NCT01280617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6137905|NCT01280656|Interferons|interferons|mesh-list
6137906|NCT01280656|Ribavirin|ribavirin|mesh-list
6137907|NCT01280656|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6137908|NCT01280656|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6137909|NCT01280656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6137910|NCT01280656|Antiviral Agents|antiviral agents|mesh-ancestor
6468586|NCT00487734|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6137911|NCT01280656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6137912|NCT01280656|Antimetabolites|antimetabolites|mesh-ancestor
6137913|NCT01280656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137914|NCT01280695|Pioglitazone|pioglitazone|mesh-list
6137915|NCT01280695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6137916|NCT01280695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137917|NCT01280721|Tolvaptan|tolvaptan|mesh-list
6137918|NCT01280721|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6137919|NCT01280721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137920|NCT01280721|Natriuretic Agents|natriuretic agents|mesh-ancestor
6137921|NCT01280721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137922|NCT01280955|Plerixafor|plerixafor|mesh-list
6137923|NCT01280955|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6137924|NCT01280955|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6137925|NCT01280955|Antiviral Agents|antiviral agents|mesh-ancestor
6137926|NCT01280955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6137927|NCT01280968|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6137928|NCT01280968|Vaccines|vaccines|mesh-list
6468587|NCT00487734|Androgens|androgens|mesh-ancestor
6468588|NCT00487734|Hormones|hormones|mesh-ancestor
6468589|NCT00487734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6468590|NCT00487734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468591|NCT00487734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6468592|NCT00487734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6468593|NCT00487734|Anabolic Agents|anabolic agents|mesh-ancestor
6468594|NCT00487773|Cholecalciferol|cholecalciferol|mesh-list
6468595|NCT00487773|Budesonide|budesonide|mesh-list
6468596|NCT00487773|Albuterol|albuterol|mesh-list
6468597|NCT00487773|Montelukast|montelukast|mesh-list
6468598|NCT00487773|Vitamins|vitamins|mesh-ancestor
6468599|NCT00487773|Micronutrients|micronutrients|mesh-ancestor
6468600|NCT00487773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468601|NCT00487773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6468602|NCT00487773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6468603|NCT00487773|Autonomic Agents|autonomic agents|mesh-ancestor
6468604|NCT00487773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6468605|NCT00487773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6468606|NCT00487773|Respiratory System Agents|respiratory system agents|mesh-ancestor
6468607|NCT00487773|Glucocorticoids|glucocorticoids|mesh-ancestor
6468608|NCT00487773|Hormones|hormones|mesh-ancestor
6468609|NCT00487773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6468610|NCT00487773|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6468611|NCT00487773|Hormone Antagonists|hormone antagonists|mesh-ancestor
6468612|NCT00487773|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6468613|NCT00487773|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6468614|NCT00487773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468615|NCT00487773|Tocolytic Agents|tocolytic agents|mesh-ancestor
6468616|NCT00487773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6468617|NCT00487773|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6468618|NCT00487773|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6468619|NCT00487773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5541990|NCT04162873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5541991|NCT04162873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5541992|NCT04162873|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5541993|NCT04162873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5541994|NCT04162873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5541995|NCT04162873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5541996|NCT04162873|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5541997|NCT04162535|Lidocaine|lidocaine|mesh-list
5541998|NCT04162535|Propofol|propofol|mesh-list
5541999|NCT04162535|Sevoflurane|sevoflurane|mesh-list
5542000|NCT04162535|Anesthetics|anesthetics|mesh-list
5542001|NCT04162535|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
5542002|NCT04162535|Anesthetics, Local|anesthetics, local|mesh-ancestor
5542003|NCT04162535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5542004|NCT04162535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542005|NCT04162535|Sensory System Agents|sensory system agents|mesh-ancestor
5542006|NCT04162535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5542007|NCT04162535|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5542008|NCT04162535|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5542009|NCT04162535|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5542010|NCT04162535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5542011|NCT04162535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542012|NCT04162535|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6468620|NCT00487773|Adrenergic Agents|adrenergic agents|mesh-ancestor
6468621|NCT00487773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6468622|NCT00487773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5542013|NCT04162535|Anesthetics, General|anesthetics, general|mesh-ancestor
5542014|NCT04162535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6468623|NCT00487773|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6468624|NCT00487786|Docetaxel|docetaxel|mesh-list
6468625|NCT00487786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6468626|NCT00487786|Tubulin Modulators|tubulin modulators|mesh-ancestor
6468627|NCT00487786|Antimitotic Agents|antimitotic agents|mesh-ancestor
6137929|NCT01280968|Nicotine|nicotine|mesh-list
6137930|NCT01280968|Immunologic Factors|immunologic factors|mesh-ancestor
6137931|NCT01280968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468628|NCT00487786|Mitosis Modulators|mitosis modulators|mesh-ancestor
6468629|NCT00487786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468630|NCT00487799|Ularitide|ularitide|mesh-list
6468631|NCT00487799|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6468632|NCT00487799|Autonomic Agents|autonomic agents|mesh-ancestor
6468633|NCT00487799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6468634|NCT00487799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468635|NCT00487799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5542015|NCT04162535|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5602322|NCT04682860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5602323|NCT04682860|Mydriatics|mydriatics|mesh-ancestor
5602324|NCT04682860|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5602325|NCT04682860|Cholinergic Agents|cholinergic agents|mesh-ancestor
5602326|NCT04682860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6468636|NCT00487799|Respiratory System Agents|respiratory system agents|mesh-ancestor
6468637|NCT00487799|Diuretics|diuretics|mesh-ancestor
6468638|NCT00487799|Natriuretic Agents|natriuretic agents|mesh-ancestor
6488513|NCT00584610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6488514|NCT00584610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488515|NCT00584610|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6137932|NCT01280968|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6137933|NCT01280968|Autonomic Agents|autonomic agents|mesh-ancestor
6137934|NCT01280968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6137935|NCT01280968|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6137936|NCT01280968|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6137937|NCT01280968|Cholinergic Agents|cholinergic agents|mesh-ancestor
6137938|NCT01280968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6137939|NCT01280968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137940|NCT01280968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6137941|NCT01280968|Antacids|antacids|mesh-ancestor
6488516|NCT00584610|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5602327|NCT04682860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602328|NCT04682860|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5602329|NCT04682860|Parasympatholytics|parasympatholytics|mesh-ancestor
5602330|NCT04680936|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5602331|NCT04669041|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5602332|NCT04669041|Ezetimibe|ezetimibe|mesh-list
5602333|NCT04669041|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5602334|NCT04669041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5602335|NCT04669041|Antimetabolites|antimetabolites|mesh-ancestor
5602336|NCT04669041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602337|NCT04669041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5602338|NCT04669041|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5602339|NCT04669041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5602340|NCT04666636|Mirabegron|mirabegron|mesh-list
5602341|NCT04666636|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
5602342|NCT04666636|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5602343|NCT04666636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5602344|NCT04666636|Adrenergic Agents|adrenergic agents|mesh-ancestor
6488517|NCT00584610|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6137942|NCT01280968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6137943|NCT01280981|Tranexamic Acid|tranexamic acid|mesh-list
6137944|NCT01280981|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6137945|NCT01280981|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6137946|NCT01280981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137947|NCT01280981|Hemostatics|hemostatics|mesh-ancestor
6137948|NCT01280981|Coagulants|coagulants|mesh-ancestor
6137949|NCT01281007|Acyclovir|acyclovir|mesh-list
6137950|NCT01281007|Famciclovir|famciclovir|mesh-list
6137951|NCT01281007|Antiviral Agents|antiviral agents|mesh-ancestor
6137952|NCT01281007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6137953|NCT01281007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6137954|NCT01281007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6137955|NCT01281007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468639|NCT00487812|Dobutamine|dobutamine|mesh-list
6468640|NCT00487812|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6468641|NCT00487812|Sympathomimetics|sympathomimetics|mesh-ancestor
6468642|NCT00487812|Autonomic Agents|autonomic agents|mesh-ancestor
6468643|NCT00487812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6468644|NCT00487812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468645|NCT00487812|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6468646|NCT00487812|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6468647|NCT00487812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6468648|NCT00487812|Adrenergic Agents|adrenergic agents|mesh-ancestor
6468649|NCT00487812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6468650|NCT00487812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468651|NCT00487812|Protective Agents|protective agents|mesh-ancestor
6468652|NCT00487994|Atorvastatin|atorvastatin|mesh-list
6468653|NCT00487994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6468654|NCT00487994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6468655|NCT00487994|Antimetabolites|antimetabolites|mesh-ancestor
6468656|NCT00487994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468657|NCT00487994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6468658|NCT00487994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6468659|NCT00487994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6468660|NCT00488072|Mirtazapine|mirtazapine|mesh-list
6468661|NCT00488072|Antidepressive Agents|antidepressive agents|mesh-ancestor
6468662|NCT00488072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6468663|NCT00488072|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6468664|NCT00488072|Histamine Antagonists|histamine antagonists|mesh-ancestor
6468665|NCT00488072|Histamine Agents|histamine agents|mesh-ancestor
6468666|NCT00488072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6468667|NCT00488072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468668|NCT00488072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468669|NCT00488072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6468670|NCT00488072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6468671|NCT00488072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6468672|NCT00488072|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6468673|NCT00488072|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6468674|NCT00488072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6468675|NCT00488072|Adrenergic Agents|adrenergic agents|mesh-ancestor
6468676|NCT00488072|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6468677|NCT00488072|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6468678|NCT00488072|Serotonin Agents|serotonin agents|mesh-ancestor
6468679|NCT00488072|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6468680|NCT00488137|Prucalopride|prucalopride|mesh-list
6468681|NCT00488137|Laxatives|laxatives|mesh-ancestor
6468682|NCT00488137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6468683|NCT00488137|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
6468684|NCT00488137|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6468685|NCT00488137|Serotonin Agents|serotonin agents|mesh-ancestor
6468686|NCT00488137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6468687|NCT00488137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205293|NCT02083809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6205294|NCT02083809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207841|NCT02120950|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6207842|NCT02120950|Dermatologic Agents|dermatologic agents|mesh-ancestor
6207843|NCT02121002|Diclofenac|diclofenac|mesh-list
6207844|NCT02121002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6207845|NCT02121002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6207846|NCT02121002|Analgesics|analgesics|mesh-ancestor
6207847|NCT02121002|Sensory System Agents|sensory system agents|mesh-ancestor
6207848|NCT02121002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6207849|NCT02121002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542016|NCT04162522|Citalopram|citalopram|mesh-list
5542017|NCT04162522|Brexpiprazole|brexpiprazole|mesh-list
5542018|NCT04162522|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5542019|NCT04162522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5542020|NCT04162522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5542021|NCT04162522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542022|NCT04162522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5542023|NCT04162522|Serotonin Agents|serotonin agents|mesh-ancestor
5542024|NCT04162522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542025|NCT04162522|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5542026|NCT04162522|Antidepressive Agents|antidepressive agents|mesh-ancestor
5542027|NCT04162522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5542028|NCT04162522|Dopamine Agonists|dopamine agonists|mesh-ancestor
5542029|NCT04162522|Dopamine Agents|dopamine agents|mesh-ancestor
5542030|NCT04162028|Ketamine|ketamine|mesh-list
5542031|NCT04162028|Analgesics|analgesics|mesh-ancestor
6468688|NCT00488137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468689|NCT00488163|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6468690|NCT00488163|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6468691|NCT00488163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6468692|NCT00488163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6468693|NCT00488163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468694|NCT00488163|Adrenergic Agents|adrenergic agents|mesh-ancestor
6468695|NCT00488163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6468696|NCT00488163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468697|NCT00488176|Cetirizine|cetirizine|mesh-list
6468698|NCT00488176|Montelukast|montelukast|mesh-list
5542032|NCT04162028|Sensory System Agents|sensory system agents|mesh-ancestor
5542033|NCT04162028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5542034|NCT04162028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542035|NCT04162028|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5542036|NCT04162028|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5542037|NCT04162028|Anesthetics, General|anesthetics, general|mesh-ancestor
5542038|NCT04162028|Anesthetics|anesthetics|mesh-ancestor
5542039|NCT04162028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5542040|NCT04162028|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5542041|NCT04162028|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5542042|NCT04162028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5542043|NCT04162028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542044|NCT04161976|Insulin Lispro|insulin lispro|mesh-list
5542045|NCT04161976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5542046|NCT04161976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542047|NCT04161768|Norfloxacin|norfloxacin|mesh-list
5542048|NCT04161768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5542049|NCT04161768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5542050|NCT04161768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6468699|NCT00488176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6468700|NCT00488176|Respiratory System Agents|respiratory system agents|mesh-ancestor
6468701|NCT00488176|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6468702|NCT00488176|Hormone Antagonists|hormone antagonists|mesh-ancestor
6468703|NCT00488176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6468704|NCT00488176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468705|NCT00488176|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6468706|NCT00488176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6468707|NCT00488176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542051|NCT04161768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5542052|NCT04161768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5542053|NCT04161768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542054|NCT04161768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5542055|NCT04161768|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5542056|NCT04161768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6468708|NCT00488176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6468709|NCT00488176|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6468710|NCT00488176|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6468711|NCT00488176|Histamine Antagonists|histamine antagonists|mesh-ancestor
6468712|NCT00488176|Histamine Agents|histamine agents|mesh-ancestor
6468713|NCT00488176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6468714|NCT00488189|Tazobactam|tazobactam|mesh-list
6468715|NCT00488189|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
6468716|NCT00488189|Piperacillin|piperacillin|mesh-list
6468717|NCT00488189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6468718|NCT00488189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5542057|NCT04161690|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
5542058|NCT04161690|Ropivacaine|ropivacaine|mesh-list
5542059|NCT04161690|Anesthetics, Local|anesthetics, local|mesh-ancestor
5542060|NCT04161690|Anesthetics|anesthetics|mesh-ancestor
5542061|NCT04161690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5542062|NCT04161690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542063|NCT04161690|Sensory System Agents|sensory system agents|mesh-ancestor
5542064|NCT04161690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5542065|NCT04161690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5542066|NCT04161690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5542067|NCT04161690|Analgesics|analgesics|mesh-ancestor
5542068|NCT04161690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5542069|NCT04161690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5542070|NCT04161664|Paclitaxel|paclitaxel|mesh-list
5542071|NCT04161664|Carboplatin|carboplatin|mesh-list
5542072|NCT04161664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5542073|NCT04161664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5542074|NCT04161664|Tubulin Modulators|tubulin modulators|mesh-ancestor
5542075|NCT04161664|Antimitotic Agents|antimitotic agents|mesh-ancestor
5542076|NCT04161664|Mitosis Modulators|mitosis modulators|mesh-ancestor
5542077|NCT04161664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542078|NCT04161729|Magnesium Sulfate|magnesium sulfate|mesh-list
5542079|NCT04161729|Analgesics|analgesics|mesh-ancestor
5542080|NCT04161729|Sensory System Agents|sensory system agents|mesh-ancestor
5542081|NCT04161729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5542082|NCT04161729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542083|NCT04161729|Anesthetics|anesthetics|mesh-ancestor
5542084|NCT04161729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5542085|NCT04161729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5542086|NCT04161729|Anticonvulsants|anticonvulsants|mesh-ancestor
5542087|NCT04161729|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5542088|NCT04161729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5542089|NCT04161729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542090|NCT04161729|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5542091|NCT04161729|Tocolytic Agents|tocolytic agents|mesh-ancestor
5542092|NCT04161729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5542093|NCT04161599|Metronidazole|metronidazole|mesh-list
5542094|NCT04161599|Cefuroxime|cefuroxime|mesh-list
5542095|NCT04161599|Cefuroxime axetil|cefuroxime axetil|mesh-list
5542096|NCT04161599|Picosulfate sodium|picosulfate sodium|mesh-list
6666513|NCT01523054|Autonomic Agents|autonomic agents|mesh-ancestor
6666514|NCT01523054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6468719|NCT00488189|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6137956|NCT01281189|Pramipexole|pramipexole|mesh-list
6137957|NCT01281189|Antioxidants|antioxidants|mesh-ancestor
6137958|NCT01281189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468720|NCT00488189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6468721|NCT00488189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468722|NCT00488215|Prucalopride|prucalopride|mesh-list
6468723|NCT00488215|Laxatives|laxatives|mesh-ancestor
6468724|NCT00488215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6468725|NCT00488215|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
6468726|NCT00488215|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6468727|NCT00488215|Serotonin Agents|serotonin agents|mesh-ancestor
6468728|NCT00488215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6468729|NCT00488215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137959|NCT01281189|Protective Agents|protective agents|mesh-ancestor
6137960|NCT01281189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137961|NCT01281189|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6137962|NCT01281189|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6137963|NCT01281189|Dopamine Agonists|dopamine agonists|mesh-ancestor
6137964|NCT01281189|Dopamine Agents|dopamine agents|mesh-ancestor
6137965|NCT01281189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6137966|NCT01281202|Vigabatrin|vigabatrin|mesh-list
6137967|NCT01281202|Anticonvulsants|anticonvulsants|mesh-ancestor
6137968|NCT01281202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6137969|NCT01281202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137970|NCT01281202|GABA Agents|gaba agents|mesh-ancestor
6137971|NCT01281202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6137972|NCT01281202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137973|NCT01281306|Valsartan|valsartan|mesh-list
6137974|NCT01281306|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
6468730|NCT00488215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666515|NCT01523054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542097|NCT04161599|Magnesium Oxide|magnesium oxide|mesh-list
6468731|NCT00488306|Tigecycline|tigecycline|mesh-list
6468732|NCT00488306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6468733|NCT00488306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6468734|NCT00488306|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6468735|NCT00488306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6468736|NCT00488306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468737|NCT00488371|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6137975|NCT01281306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6137976|NCT01281306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6137977|NCT01281306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6137978|NCT01281306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137979|NCT01281475|Levodopa|levodopa|mesh-list
6137980|NCT01281475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6137981|NCT01281475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6137982|NCT01281475|Dopamine Agents|dopamine agents|mesh-ancestor
6137983|NCT01281475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6468738|NCT00488371|Immunologic Factors|immunologic factors|mesh-ancestor
6468739|NCT00488371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468740|NCT00488384|Acitretin|acitretin|mesh-list
6468741|NCT00488384|Keratolytic Agents|keratolytic agents|mesh-ancestor
6468742|NCT00488384|Dermatologic Agents|dermatologic agents|mesh-ancestor
6137984|NCT01281475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137985|NCT01281475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6137986|NCT01281501|Scopolamine|scopolamine|mesh-list
6137987|NCT01281501|Pantoprazole|pantoprazole|mesh-list
6137988|NCT01281501|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
6137989|NCT01281501|Antacids|antacids|mesh-list
6137990|NCT01281501|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
6137991|NCT01281501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6137992|NCT01281501|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6137993|NCT01281501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6137994|NCT01281501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6137995|NCT01281501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6137996|NCT01281501|Antiemetics|antiemetics|mesh-ancestor
6137997|NCT01281501|Autonomic Agents|autonomic agents|mesh-ancestor
6137998|NCT01281501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6137999|NCT01281501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138000|NCT01281501|Mydriatics|mydriatics|mesh-ancestor
6138001|NCT01281501|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6138002|NCT01281501|Cholinergic Agents|cholinergic agents|mesh-ancestor
6138003|NCT01281501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6138004|NCT01281501|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6138005|NCT01281501|Parasympatholytics|parasympatholytics|mesh-ancestor
6138006|NCT01281839|Ribavirin|ribavirin|mesh-list
6138007|NCT01281839|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6138008|NCT01281839|Simeprevir|simeprevir|mesh-list
6138009|NCT01281839|Antimetabolites|antimetabolites|mesh-ancestor
6138010|NCT01281839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138011|NCT01281839|Antiviral Agents|antiviral agents|mesh-ancestor
6138012|NCT01281839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6138013|NCT01281839|Protease Inhibitors|protease inhibitors|mesh-ancestor
6138014|NCT01281839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6138015|NCT01281865|Everolimus|everolimus|mesh-list
6138016|NCT01281865|Imatinib Mesylate|imatinib mesylate|mesh-list
6138017|NCT01281865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6138018|NCT01281865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6666516|NCT01523054|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6666517|NCT01523054|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6138019|NCT01281865|Immunologic Factors|immunologic factors|mesh-ancestor
6138020|NCT01281865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138021|NCT01281865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6138022|NCT01281865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6138023|NCT01281865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138024|NCT01281917|Sirolimus|sirolimus|mesh-list
6138025|NCT01281917|Bortezomib|bortezomib|mesh-list
6138026|NCT01281917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6138027|NCT01281917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6138028|NCT01281917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6138029|NCT01281917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6138030|NCT01281917|Antifungal Agents|antifungal agents|mesh-ancestor
6138031|NCT01281917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6138032|NCT01281917|Immunologic Factors|immunologic factors|mesh-ancestor
5542098|NCT04161599|Citric Acid|citric acid|mesh-list
6138033|NCT01281917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138034|NCT01281956|Naluzotan|naluzotan|mesh-list
6138035|NCT01281956|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6138036|NCT01281956|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6138037|NCT01281956|Serotonin Agents|serotonin agents|mesh-ancestor
6138038|NCT01281956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6138039|NCT01281956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468743|NCT00488436|Cyclosporine|cyclosporine|mesh-list
6468744|NCT00488436|Cyclosporins|cyclosporins|mesh-list
6468745|NCT00488436|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6468746|NCT00488436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6468747|NCT00488436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468748|NCT00488436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6468749|NCT00488436|Immunologic Factors|immunologic factors|mesh-ancestor
6468750|NCT00488436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468751|NCT00488436|Antifungal Agents|antifungal agents|mesh-ancestor
6666518|NCT01523054|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6666519|NCT01523054|Adrenergic Agents|adrenergic agents|mesh-ancestor
6666520|NCT01523054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6666521|NCT01523054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542099|NCT04161599|Sodium Citrate|sodium citrate|mesh-list
5542100|NCT04161599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5542101|NCT04161599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5542102|NCT04161599|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5542103|NCT04161599|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5542104|NCT04161599|Anticoagulants|anticoagulants|mesh-ancestor
5542105|NCT04161599|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5542106|NCT04161599|Chelating Agents|chelating agents|mesh-ancestor
6138040|NCT01281956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138041|NCT01281969|Immunoglobulins|immunoglobulins|mesh-list
6138042|NCT01281969|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6138043|NCT01281969|Antibodies|antibodies|mesh-list
6138044|NCT01281969|gamma-Globulins|gamma-globulins|mesh-list
6138045|NCT01281969|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6138046|NCT01281969|Immunologic Factors|immunologic factors|mesh-ancestor
6138047|NCT01281969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468752|NCT00488436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6468753|NCT00488436|Dermatologic Agents|dermatologic agents|mesh-ancestor
6468754|NCT00488436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6468755|NCT00488436|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6468756|NCT00488527|Insulin Glargine|insulin glargine|mesh-list
6468757|NCT00488527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6468758|NCT00488527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468759|NCT00488540|Acetaminophen|acetaminophen|mesh-list
6468760|NCT00488540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6468761|NCT00488540|Analgesics|analgesics|mesh-ancestor
6468762|NCT00488540|Sensory System Agents|sensory system agents|mesh-ancestor
6468763|NCT00488540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6468764|NCT00488540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468765|NCT00488540|Antipyretics|antipyretics|mesh-ancestor
6468766|NCT00488566|Lamotrigine|lamotrigine|mesh-list
6468767|NCT00488566|Anticonvulsants|anticonvulsants|mesh-ancestor
6468768|NCT00488566|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6468769|NCT00488566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6468770|NCT00488566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468771|NCT00488566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6468772|NCT00488566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468773|NCT00488566|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6468774|NCT00488566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6468775|NCT00488566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6468776|NCT00488566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6468777|NCT00488566|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6468778|NCT00488605|Leucovorin|leucovorin|mesh-list
6468779|NCT00488605|Prednisone|prednisone|mesh-list
6138048|NCT01282138|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
6138049|NCT01282138|Dextrans|dextrans|mesh-list
6138050|NCT01282138|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6468780|NCT00488605|Methotrexate|methotrexate|mesh-list
6468781|NCT00488605|Vinblastine|vinblastine|mesh-list
6138051|NCT01282138|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6138052|NCT01282138|Anticoagulants|anticoagulants|mesh-ancestor
6138053|NCT01282138|Plasma Substitutes|plasma substitutes|mesh-ancestor
6138054|NCT01282138|Blood Substitutes|blood substitutes|mesh-ancestor
6138055|NCT01282138|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5542107|NCT04161599|Sequestering Agents|sequestering agents|mesh-ancestor
5542108|NCT04161599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542109|NCT04161599|Cathartics|cathartics|mesh-ancestor
5542110|NCT04161599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5542111|NCT04161599|Antacids|antacids|mesh-ancestor
6138056|NCT01282138|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6138057|NCT01282138|Analgesics|analgesics|mesh-ancestor
6138058|NCT01282138|Sensory System Agents|sensory system agents|mesh-ancestor
6138059|NCT01282138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6138060|NCT01282138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666522|NCT01523067|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
6666523|NCT01523067|Vasodilator Agents|vasodilator agents|mesh-ancestor
5542112|NCT04161586|Prilocaine|prilocaine|mesh-list
5542113|NCT04161586|Anesthetics|anesthetics|mesh-ancestor
5542114|NCT04161586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5542115|NCT04161586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542116|NCT04161586|Anesthetics, Local|anesthetics, local|mesh-ancestor
5542117|NCT04161586|Sensory System Agents|sensory system agents|mesh-ancestor
5542118|NCT04161586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5542119|NCT04161508|Glycopyrrolate|glycopyrrolate|mesh-list
5542120|NCT04161508|Neostigmine|neostigmine|mesh-list
5542121|NCT04161508|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5542122|NCT04161508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5542123|NCT04161508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542124|NCT04161508|Cholinergic Agents|cholinergic agents|mesh-ancestor
6666524|NCT01523080|Acetaminophen|acetaminophen|mesh-list
6666525|NCT01523080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6666526|NCT01523080|Analgesics|analgesics|mesh-ancestor
6468782|NCT00488605|Levoleucovorin|levoleucovorin|mesh-list
6468783|NCT00488605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6468784|NCT00488605|Glucocorticoids|glucocorticoids|mesh-ancestor
6468785|NCT00488605|Hormones|hormones|mesh-ancestor
6468786|NCT00488605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6468787|NCT00488605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468788|NCT00488605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6468789|NCT00488605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6468790|NCT00488605|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6468791|NCT00488605|Abortifacient Agents|abortifacient agents|mesh-ancestor
6468792|NCT00488605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6468793|NCT00488605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6468794|NCT00488605|Antimetabolites|antimetabolites|mesh-ancestor
6468795|NCT00488605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666527|NCT01523080|Sensory System Agents|sensory system agents|mesh-ancestor
6666528|NCT01523080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6666529|NCT01523080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666530|NCT01523080|Antipyretics|antipyretics|mesh-ancestor
6666531|NCT01523093|Ondansetron|ondansetron|mesh-list
6666532|NCT01523093|Antiemetics|antiemetics|mesh-ancestor
5542125|NCT04161508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6138061|NCT01282138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6138062|NCT01282138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6138063|NCT01282138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6138064|NCT01282138|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6468796|NCT00488605|Dermatologic Agents|dermatologic agents|mesh-ancestor
6468797|NCT00488605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6468798|NCT00488605|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6468799|NCT00488605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6468800|NCT00488605|Immunologic Factors|immunologic factors|mesh-ancestor
6468801|NCT00488605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6468802|NCT00488605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6468803|NCT00488605|Antidotes|antidotes|mesh-ancestor
6138065|NCT01282138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6138066|NCT01282138|Histamine Antagonists|histamine antagonists|mesh-ancestor
6138067|NCT01282138|Histamine Agents|histamine agents|mesh-ancestor
6468804|NCT00488605|Protective Agents|protective agents|mesh-ancestor
6468805|NCT00488605|Vitamin B Complex|vitamin b complex|mesh-ancestor
6468806|NCT00488605|Vitamins|vitamins|mesh-ancestor
6468807|NCT00488605|Micronutrients|micronutrients|mesh-ancestor
6468808|NCT00488605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6666533|NCT01523093|Autonomic Agents|autonomic agents|mesh-ancestor
6666534|NCT01523093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5542126|NCT04161508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542127|NCT04161508|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5542128|NCT04161508|Autonomic Agents|autonomic agents|mesh-ancestor
5542129|NCT04161508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5542130|NCT04161508|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5542131|NCT04161508|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5542132|NCT04161508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5542133|NCT04161560|Cetuximab|cetuximab|mesh-list
5542134|NCT04161560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6138068|NCT01282138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6138069|NCT01282138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138070|NCT01282164|Insulin|insulin|mesh-list
6138071|NCT01282164|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6138072|NCT01282164|Glucagon|glucagon|mesh-list
6138073|NCT01282164|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6138074|NCT01282164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6138075|NCT01282164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138076|NCT01282164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6138077|NCT01282164|Hormones|hormones|mesh-ancestor
6138078|NCT01282164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6138079|NCT01282164|Incretins|incretins|mesh-ancestor
6138080|NCT01282242|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6138081|NCT01282242|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6138082|NCT01282242|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5542135|NCT04161560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5542136|NCT04161482|Furosemide|furosemide|mesh-list
5542137|NCT04161482|Diuretics|diuretics|mesh-ancestor
5542138|NCT04161482|Natriuretic Agents|natriuretic agents|mesh-ancestor
5542139|NCT04161482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138083|NCT01282242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138084|NCT01282424|Idelalisib|idelalisib|mesh-list
6138085|NCT01282424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6138086|NCT01282424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6138087|NCT01282424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138088|NCT01282463|Docetaxel|docetaxel|mesh-list
5542140|NCT04161482|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6138089|NCT01282463|Ramucirumab|ramucirumab|mesh-list
6138090|NCT01282463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6468809|NCT00488605|Tubulin Modulators|tubulin modulators|mesh-ancestor
6468810|NCT00488605|Antimitotic Agents|antimitotic agents|mesh-ancestor
6468811|NCT00488605|Mitosis Modulators|mitosis modulators|mesh-ancestor
6468812|NCT00488670|Citalopram|citalopram|mesh-list
6468813|NCT00488670|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6468814|NCT00488670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6468815|NCT00488670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6468816|NCT00488670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468817|NCT00488670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6468818|NCT00488670|Serotonin Agents|serotonin agents|mesh-ancestor
6468819|NCT00488670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468820|NCT00488670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6468821|NCT00488670|Antidepressive Agents|antidepressive agents|mesh-ancestor
6468822|NCT00488670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6468823|NCT00488709|Cytarabine|cytarabine|mesh-list
6468824|NCT00488709|Fludarabine|fludarabine|mesh-list
6468825|NCT00488709|Topotecan|topotecan|mesh-list
6468826|NCT00488709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6468827|NCT00488709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6138091|NCT01282463|Tubulin Modulators|tubulin modulators|mesh-ancestor
6138092|NCT01282463|Antimitotic Agents|antimitotic agents|mesh-ancestor
6138093|NCT01282463|Mitosis Modulators|mitosis modulators|mesh-ancestor
6138094|NCT01282463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138095|NCT01282476|Rituximab|rituximab|mesh-list
6138096|NCT01282476|Panobinostat|panobinostat|mesh-list
6138097|NCT01282476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6138098|NCT01282476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6138099|NCT01282476|Immunologic Factors|immunologic factors|mesh-ancestor
6138100|NCT01282476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138101|NCT01282476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6138102|NCT01282476|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6138103|NCT01282476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6138104|NCT01282476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138105|NCT01282801|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6138106|NCT01282801|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6138107|NCT01282801|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6138108|NCT01282801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6138109|NCT01282801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138110|NCT01282801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6138111|NCT01282801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138112|NCT01282801|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6138113|NCT01282801|Antidepressive Agents|antidepressive agents|mesh-ancestor
6468828|NCT00488709|Antimetabolites|antimetabolites|mesh-ancestor
6468829|NCT00488709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468830|NCT00488709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6468831|NCT00488709|Immunologic Factors|immunologic factors|mesh-ancestor
6468832|NCT00488709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468833|NCT00488709|Antiviral Agents|antiviral agents|mesh-ancestor
6468834|NCT00488709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6468835|NCT00488709|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6468836|NCT00488709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6468837|NCT00488709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6468838|NCT00488722|Goserelin|goserelin|mesh-list
6468839|NCT00488722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6468840|NCT00488722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6468841|NCT00488761|Tigecycline|tigecycline|mesh-list
6468842|NCT00488761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6468843|NCT00488761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6468844|NCT00488761|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6468845|NCT00488761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6468846|NCT00488761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468847|NCT00488787|Ketamine|ketamine|mesh-list
6468848|NCT00488787|Analgesics|analgesics|mesh-ancestor
6468849|NCT00488787|Sensory System Agents|sensory system agents|mesh-ancestor
6468850|NCT00488787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6468851|NCT00488787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468852|NCT00488787|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6468853|NCT00488787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5542141|NCT04161482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5542142|NCT04161482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542143|NCT04161339|Hydroxychloroquine|hydroxychloroquine|mesh-list
5542144|NCT04161339|Antimalarials|antimalarials|mesh-ancestor
5542145|NCT04161339|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5542146|NCT04161339|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5542147|NCT04161339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5542148|NCT04161339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5542149|NCT04161339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542150|NCT04161339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5542151|NCT04161274|Silver Nitrate|silver nitrate|mesh-list
5542152|NCT04161274|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5542153|NCT04161274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5542154|NCT04161430|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5542155|NCT04161430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6138114|NCT01282801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6138115|NCT01282814|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6138116|NCT01282814|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6138117|NCT01282814|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6138118|NCT01282814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6138119|NCT01282814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138120|NCT01282814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6138121|NCT01282814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138122|NCT01282814|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6138123|NCT01282814|Antidepressive Agents|antidepressive agents|mesh-ancestor
6468854|NCT00488787|Anesthetics, General|anesthetics, general|mesh-ancestor
6468855|NCT00488787|Anesthetics|anesthetics|mesh-ancestor
6488518|NCT00584610|Trace Elements|trace elements|mesh-ancestor
6138124|NCT01282814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6138125|NCT01283009|Methylprednisolone|methylprednisolone|mesh-list
6138126|NCT01283009|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6138127|NCT01283009|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6138128|NCT01283009|Prednisolone|prednisolone|mesh-list
6138129|NCT01283009|Prednisolone acetate|prednisolone acetate|mesh-list
6138130|NCT01283009|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6138131|NCT01283009|Prednisolone phosphate|prednisolone phosphate|mesh-list
6138132|NCT01283009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6138133|NCT01283009|Antiemetics|antiemetics|mesh-ancestor
6138134|NCT01283009|Autonomic Agents|autonomic agents|mesh-ancestor
6138135|NCT01283009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6138136|NCT01283009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138137|NCT01283009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6138138|NCT01283009|Glucocorticoids|glucocorticoids|mesh-ancestor
6138139|NCT01283009|Hormones|hormones|mesh-ancestor
6138140|NCT01283009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6138141|NCT01283009|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6138142|NCT01283009|Protective Agents|protective agents|mesh-ancestor
6138143|NCT01283009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6138144|NCT01283009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6138145|NCT01283139|Sifalimumab|sifalimumab|mesh-list
6138146|NCT01283139|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6138147|NCT01283139|Immunologic Factors|immunologic factors|mesh-ancestor
6138148|NCT01283139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138149|NCT01283152|Lactulose|lactulose|mesh-list
6138150|NCT01283152|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
6138151|NCT01283152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6138152|NCT01283152|Laxatives|laxatives|mesh-ancestor
6138153|NCT01283282|Clopidogrel|clopidogrel|mesh-list
6138154|NCT01283282|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6138155|NCT01283282|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6138156|NCT01283282|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6138157|NCT01283282|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5542156|NCT04161430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542157|NCT04161430|Incretins|incretins|mesh-ancestor
5542158|NCT04161430|Hormones|hormones|mesh-ancestor
5542159|NCT04161430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5542160|NCT04161430|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5542161|NCT04161430|Protease Inhibitors|protease inhibitors|mesh-ancestor
5542162|NCT04161430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5542163|NCT04161430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542164|NCT04161404|Metformin|metformin|mesh-list
5542165|NCT04161404|Andrographolide|andrographolide|mesh-list
5542166|NCT04161404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5542167|NCT04161404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542168|NCT04161404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5542169|NCT04161404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5542170|NCT04161404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5542171|NCT04161404|Analgesics|analgesics|mesh-ancestor
5542172|NCT04161404|Sensory System Agents|sensory system agents|mesh-ancestor
5542173|NCT04161404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5542174|NCT04161404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6138158|NCT01283282|Purinergic Agents|purinergic agents|mesh-ancestor
6138159|NCT01283282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6138160|NCT01283282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138161|NCT01283282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138162|NCT01283334|Carboplatin|carboplatin|mesh-list
6138163|NCT01283334|Cetuximab|cetuximab|mesh-list
6138164|NCT01283334|Everolimus|everolimus|mesh-list
6138165|NCT01283334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6138166|NCT01283334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6138167|NCT01283334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6138168|NCT01283334|Immunologic Factors|immunologic factors|mesh-ancestor
6138169|NCT01283334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138170|NCT01283386|Cyclophosphamide|cyclophosphamide|mesh-list
6138171|NCT01283386|Chlorambucil|chlorambucil|mesh-list
6138172|NCT01283386|Rituximab|rituximab|mesh-list
6138173|NCT01283386|Fludarabine|fludarabine|mesh-list
6138174|NCT01283386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6138175|NCT01283386|Immunologic Factors|immunologic factors|mesh-ancestor
6138176|NCT01283386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138177|NCT01283386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6138178|NCT01283386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6468856|NCT00488787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6138179|NCT01283386|Alkylating Agents|alkylating agents|mesh-ancestor
5542175|NCT04161404|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5542176|NCT04161404|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5542177|NCT04161404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5542178|NCT04161404|Antiviral Agents|antiviral agents|mesh-ancestor
5542179|NCT04161404|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5542180|NCT04161209|Citalopram|citalopram|mesh-list
5542181|NCT04161209|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5542182|NCT04161209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5542183|NCT04161209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5542184|NCT04161209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542185|NCT04161209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5542186|NCT04161209|Serotonin Agents|serotonin agents|mesh-ancestor
5542187|NCT04161209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542188|NCT04161209|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5542189|NCT04161209|Antidepressive Agents|antidepressive agents|mesh-ancestor
5542190|NCT04161209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5542191|NCT04161456|Apremilast|apremilast|mesh-list
5542192|NCT04161456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6138180|NCT01283386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138181|NCT01283386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6138182|NCT01283386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6138183|NCT01283386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6138184|NCT01283464|Vitamin A|vitamin a|mesh-list
6138185|NCT01283464|Tretinoin|tretinoin|mesh-list
6138186|NCT01283464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6138187|NCT01283464|Keratolytic Agents|keratolytic agents|mesh-ancestor
6468857|NCT00488787|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6468858|NCT00488787|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6468859|NCT00488787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6468860|NCT00488787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468861|NCT00488800|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6468862|NCT00488800|Immunologic Factors|immunologic factors|mesh-ancestor
6468863|NCT00488800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468864|NCT00488813|Cephalosporins|cephalosporins|mesh-list
6468865|NCT00488813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6468866|NCT00488813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6468867|NCT00488891|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6468868|NCT00488891|Antipsychotic Agents|antipsychotic agents|mesh-list
6468869|NCT00488891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6468870|NCT00488891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6468871|NCT00488891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468872|NCT00488891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6468873|NCT00488891|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6468874|NCT00488891|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6468875|NCT00488891|Serotonin Agents|serotonin agents|mesh-ancestor
6468876|NCT00488891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6468877|NCT00488891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468878|NCT00488891|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6468879|NCT00488891|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6468880|NCT00488891|Dopamine Agents|dopamine agents|mesh-ancestor
6468881|NCT00488969|Morphine|morphine|mesh-list
6468882|NCT00488969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6468883|NCT00488969|Narcotics|narcotics|mesh-ancestor
6468884|NCT00488969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6468885|NCT00488969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468886|NCT00488969|Analgesics|analgesics|mesh-ancestor
6468887|NCT00488969|Sensory System Agents|sensory system agents|mesh-ancestor
6468888|NCT00488969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6468889|NCT00488995|Tremelimumab|tremelimumab|mesh-list
6468890|NCT00488995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6468891|NCT00489073|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6468892|NCT00489073|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6468893|NCT00489073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6468894|NCT00489073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6468895|NCT00489073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468896|NCT00489073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6468897|NCT00489073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468898|NCT00489073|Analgesics|analgesics|mesh-ancestor
6468899|NCT00489073|Sensory System Agents|sensory system agents|mesh-ancestor
6468900|NCT00489073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6468901|NCT00489073|Antidepressive Agents|antidepressive agents|mesh-ancestor
6468902|NCT00489073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6468903|NCT00489073|Dopamine Agents|dopamine agents|mesh-ancestor
6468904|NCT00489099|Vaccines|vaccines|mesh-list
6468905|NCT00489099|Immunologic Factors|immunologic factors|mesh-ancestor
6468906|NCT00489099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138188|NCT01283464|Dermatologic Agents|dermatologic agents|mesh-ancestor
6138189|NCT01283464|Vitamins|vitamins|mesh-ancestor
6138190|NCT01283464|Micronutrients|micronutrients|mesh-ancestor
6138191|NCT01283464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138192|NCT01283516|Ceritinib|ceritinib|mesh-list
6138193|NCT01283516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6138194|NCT01283516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6138195|NCT01283516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6138196|NCT01283516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138197|NCT01283542|Pasireotide|pasireotide|mesh-list
6138198|NCT01283542|Hormones|hormones|mesh-ancestor
6138199|NCT01283542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6138200|NCT01283542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138201|NCT01283555|Tenofovir|tenofovir|mesh-list
6138202|NCT01283555|Antiviral Agents|antiviral agents|mesh-ancestor
6138203|NCT01283555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6138204|NCT01283555|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6138205|NCT01283555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6138206|NCT01283555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6468907|NCT00489138|Ertapenem|ertapenem|mesh-list
6468908|NCT00489138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6468909|NCT00489138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6468910|NCT00489151|Lamivudine|lamivudine|mesh-list
6468911|NCT00489151|Adefovir|adefovir|mesh-list
6468912|NCT00489151|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6468913|NCT00489151|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6468914|NCT00489151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6468915|NCT00489151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6468916|NCT00489151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468917|NCT00489151|Antiviral Agents|antiviral agents|mesh-ancestor
6468918|NCT00489151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6468919|NCT00489151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6468920|NCT00489151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6468921|NCT00489164|Sirolimus|sirolimus|mesh-list
6468922|NCT00489164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6468923|NCT00489164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6488519|NCT00584610|Micronutrients|micronutrients|mesh-ancestor
6666535|NCT01523093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666536|NCT01523093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6666537|NCT01523093|Antipruritics|antipruritics|mesh-ancestor
6666538|NCT01523093|Dermatologic Agents|dermatologic agents|mesh-ancestor
6666539|NCT01523093|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6666540|NCT01523093|Serotonin Agents|serotonin agents|mesh-ancestor
6666541|NCT01523093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6666542|NCT01523093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666543|NCT01523093|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6666544|NCT01523093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6666545|NCT01523093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6666546|NCT01523093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6666547|NCT01523093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6666548|NCT01523119|Ondansetron|ondansetron|mesh-list
6666549|NCT01523119|Antiemetics|antiemetics|mesh-ancestor
6666550|NCT01523119|Autonomic Agents|autonomic agents|mesh-ancestor
6666551|NCT01523119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6666552|NCT01523119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666553|NCT01523119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6666554|NCT01523119|Antipruritics|antipruritics|mesh-ancestor
6666555|NCT01523119|Dermatologic Agents|dermatologic agents|mesh-ancestor
6666556|NCT01523119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6666557|NCT01523119|Serotonin Agents|serotonin agents|mesh-ancestor
6468924|NCT00489164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6468925|NCT00489164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6468926|NCT00489164|Antifungal Agents|antifungal agents|mesh-ancestor
5542193|NCT04161456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5542194|NCT04161456|Analgesics|analgesics|mesh-ancestor
5542195|NCT04161456|Sensory System Agents|sensory system agents|mesh-ancestor
5542196|NCT04161456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5542197|NCT04161456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542198|NCT04161456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5542199|NCT04161456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5542200|NCT04161456|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5542201|NCT04161456|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5542202|NCT04161456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5542203|NCT04161456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542204|NCT04161014|Nintedanib|nintedanib|mesh-list
5542205|NCT04161014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6468927|NCT00489164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6468928|NCT00489164|Immunologic Factors|immunologic factors|mesh-ancestor
6468929|NCT00489164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468930|NCT00489190|Insulin glulisine|insulin glulisine|mesh-list
6138207|NCT01283555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138208|NCT01283555|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6138209|NCT01283555|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6138210|NCT01283581|Vancomycin|vancomycin|mesh-list
5542206|NCT04161014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5542207|NCT04161014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5542208|NCT04161014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542209|NCT04161053|Rifaximin|rifaximin|mesh-list
5542210|NCT04161053|Nitazoxanide|nitazoxanide|mesh-list
5542211|NCT04161053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5542212|NCT04161053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5542213|NCT04161053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5542214|NCT04161053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5542215|NCT04161001|Amlodipine|amlodipine|mesh-list
5542216|NCT04161001|Olmesartan|olmesartan|mesh-list
5542217|NCT04161001|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
5542218|NCT04161001|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
5542219|NCT04161001|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5542220|NCT04161001|Ezetimibe|ezetimibe|mesh-list
5542221|NCT04161001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5542222|NCT04161001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5542223|NCT04161001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5542224|NCT04161001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542225|NCT04161001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5542226|NCT04161001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542227|NCT04161001|Vasodilator Agents|vasodilator agents|mesh-ancestor
5542228|NCT04161001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5542229|NCT04161001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5542230|NCT04161001|Antimetabolites|antimetabolites|mesh-ancestor
6138211|NCT01283581|Linezolid|linezolid|mesh-list
6138212|NCT01283581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6138213|NCT01283581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6138214|NCT01283581|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6468931|NCT00489190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6468932|NCT00489190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468933|NCT00489229|Rosiglitazone|rosiglitazone|mesh-list
6468934|NCT00489229|Ramipril|ramipril|mesh-list
6468935|NCT00489229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6468936|NCT00489229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138215|NCT01283581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6138216|NCT01283581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138217|NCT01283971|Adalimumab|adalimumab|mesh-list
6138218|NCT01283971|Methotrexate|methotrexate|mesh-list
6138219|NCT01283971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6138220|NCT01283971|Abortifacient Agents|abortifacient agents|mesh-ancestor
6138221|NCT01283971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6138222|NCT01283971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138223|NCT01283971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6138224|NCT01283971|Antimetabolites|antimetabolites|mesh-ancestor
6138225|NCT01283971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666558|NCT01523119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6138226|NCT01283971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6138227|NCT01283971|Dermatologic Agents|dermatologic agents|mesh-ancestor
6138228|NCT01283971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5542231|NCT04161001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5542232|NCT04161001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5542233|NCT04161001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5542234|NCT04161001|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5542235|NCT04161001|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5542236|NCT04160936|Ropivacaine|ropivacaine|mesh-list
5542237|NCT04160936|Anesthetics, Local|anesthetics, local|mesh-ancestor
5542238|NCT04160936|Anesthetics|anesthetics|mesh-ancestor
5542239|NCT04160936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5542240|NCT04160936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542241|NCT04160936|Sensory System Agents|sensory system agents|mesh-ancestor
5542242|NCT04160936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5542243|NCT04161027|Pregabalin|pregabalin|mesh-list
5542244|NCT04161027|Analgesics|analgesics|mesh-ancestor
5542245|NCT04161027|Sensory System Agents|sensory system agents|mesh-ancestor
5542246|NCT04161027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5542247|NCT04161027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542248|NCT04161027|Anticonvulsants|anticonvulsants|mesh-ancestor
5542249|NCT04161027|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5542250|NCT04161027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5542251|NCT04161027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542252|NCT04161027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5542253|NCT04161027|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5542254|NCT04161027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5542255|NCT04161027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5542256|NCT04161027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5602345|NCT04666636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5602346|NCT04666636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602347|NCT04666636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602348|NCT04666636|Urological Agents|urological agents|mesh-ancestor
5602349|NCT04664946|Neuroprotective Agents|neuroprotective agents|mesh-list
5602350|NCT04664946|Protective Agents|protective agents|mesh-ancestor
5602351|NCT04664946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602352|NCT04664933|Neuroprotective Agents|neuroprotective agents|mesh-list
6138229|NCT01283971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6138230|NCT01283971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6138231|NCT01283971|Immunologic Factors|immunologic factors|mesh-ancestor
6138232|NCT01283971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6138233|NCT01283971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6468937|NCT00489229|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6468938|NCT00489229|Protease Inhibitors|protease inhibitors|mesh-ancestor
6468939|NCT00489229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6468940|NCT00489229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468941|NCT00489229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6468942|NCT00489372|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
6468943|NCT00489372|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6468944|NCT00489372|Protective Agents|protective agents|mesh-ancestor
6468945|NCT00489372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468946|NCT00489372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6468947|NCT00489385|Ribavirin|ribavirin|mesh-list
6468948|NCT00489385|Antimetabolites|antimetabolites|mesh-ancestor
6468949|NCT00489385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468950|NCT00489385|Antiviral Agents|antiviral agents|mesh-ancestor
6468951|NCT00489385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6468952|NCT00489398|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
6468953|NCT00489398|Epinastine|epinastine|mesh-list
6468954|NCT00489398|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5542257|NCT04160897|Tenofovir|tenofovir|mesh-list
5542258|NCT04160897|Entecavir|entecavir|mesh-list
5542259|NCT04160897|Antiviral Agents|antiviral agents|mesh-ancestor
5542260|NCT04160897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5542261|NCT04160897|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5542262|NCT04160897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5542263|NCT04160897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5542264|NCT04160897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542265|NCT04160897|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5542266|NCT04160897|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5542267|NCT04160598|Fentanyl|fentanyl|mesh-list
5542268|NCT04160598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5542269|NCT04160598|Narcotics|narcotics|mesh-ancestor
5542270|NCT04160598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5542271|NCT04160598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542272|NCT04160598|Analgesics|analgesics|mesh-ancestor
5542273|NCT04160598|Sensory System Agents|sensory system agents|mesh-ancestor
5542274|NCT04160598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5542275|NCT04160598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5542276|NCT04160598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5542277|NCT04160598|Anesthetics, General|anesthetics, general|mesh-ancestor
5542278|NCT04160598|Anesthetics|anesthetics|mesh-ancestor
5542279|NCT04160676|Ascorbic Acid|ascorbic acid|mesh-list
5542280|NCT04160676|Thiamine|thiamine|mesh-list
6468955|NCT00489398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6468956|NCT00489398|Analgesics|analgesics|mesh-ancestor
6468957|NCT00489398|Sensory System Agents|sensory system agents|mesh-ancestor
6468958|NCT00489398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6468959|NCT00489398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468960|NCT00489398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6468961|NCT00489398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5542281|NCT04160676|Hydrocortisone|hydrocortisone|mesh-list
5542282|NCT04160676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5542283|NCT04160676|Antioxidants|antioxidants|mesh-ancestor
5542284|NCT04160676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542285|NCT04160676|Protective Agents|protective agents|mesh-ancestor
5542286|NCT04160676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542287|NCT04160676|Vitamins|vitamins|mesh-ancestor
5542288|NCT04160676|Micronutrients|micronutrients|mesh-ancestor
5542289|NCT04160676|Vitamin B Complex|vitamin b complex|mesh-ancestor
5542290|NCT04160416|Capecitabine|capecitabine|mesh-list
5542291|NCT04160416|Oxaliplatin|oxaliplatin|mesh-list
5542292|NCT04160416|Irinotecan|irinotecan|mesh-list
5542293|NCT04160416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5542294|NCT04160416|Antimetabolites|antimetabolites|mesh-ancestor
5542295|NCT04160416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542296|NCT04160416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5542297|NCT04160416|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5542298|NCT04160416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5542299|NCT04160416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5542300|NCT04160494|Atezolizumab|atezolizumab|mesh-list
5542301|NCT04160494|Immunoconjugates|immunoconjugates|mesh-list
5542302|NCT04160494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5542303|NCT04160494|Immunologic Factors|immunologic factors|mesh-ancestor
5542304|NCT04160494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542305|NCT04160520|Morphine|morphine|mesh-list
6468962|NCT00489398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6138234|NCT01283971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6138235|NCT01284296|Lidocaine|lidocaine|mesh-list
6138236|NCT01284296|Anesthetics, Local|anesthetics, local|mesh-ancestor
6138237|NCT01284296|Anesthetics|anesthetics|mesh-ancestor
6138238|NCT01284296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6138239|NCT01284296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138240|NCT01284296|Sensory System Agents|sensory system agents|mesh-ancestor
6138241|NCT01284296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6138242|NCT01284296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6468963|NCT00489398|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6468964|NCT00489398|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6468965|NCT00489398|Histamine Antagonists|histamine antagonists|mesh-ancestor
6468966|NCT00489398|Histamine Agents|histamine agents|mesh-ancestor
6468967|NCT00489398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6468968|NCT00489398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542306|NCT04160520|Pramipexole|pramipexole|mesh-list
5542307|NCT04160520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5542308|NCT04160520|Narcotics|narcotics|mesh-ancestor
5542309|NCT04160520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6205295|NCT02083861|Oxymetazoline|oxymetazoline|mesh-list
5542310|NCT04160520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542311|NCT04160520|Analgesics|analgesics|mesh-ancestor
5542312|NCT04160520|Sensory System Agents|sensory system agents|mesh-ancestor
6468969|NCT00489437|Heparin|heparin|mesh-list
6468970|NCT00489437|Antibodies|antibodies|mesh-list
6468971|NCT00489437|Immunologic Factors|immunologic factors|mesh-ancestor
6468972|NCT00489437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666559|NCT01523119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666560|NCT01523119|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6666561|NCT01523119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6666562|NCT01523119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5542313|NCT04160520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5542314|NCT04160520|Antioxidants|antioxidants|mesh-ancestor
5542315|NCT04160520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542316|NCT04160520|Protective Agents|protective agents|mesh-ancestor
5542317|NCT04160520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6468973|NCT00489437|Anticoagulants|anticoagulants|mesh-ancestor
5542318|NCT04160520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5542319|NCT04160520|Dopamine Agonists|dopamine agonists|mesh-ancestor
5542320|NCT04160520|Dopamine Agents|dopamine agents|mesh-ancestor
5542321|NCT04160520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5542322|NCT04160377|Fluvoxamine|fluvoxamine|mesh-list
5542323|NCT04160377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5542324|NCT04160377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5542325|NCT04160377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5542326|NCT04160377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542327|NCT04160377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5542328|NCT04160377|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5542329|NCT04160377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5542330|NCT04160377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5542331|NCT04160377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542332|NCT04160377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5542333|NCT04160377|Serotonin Agents|serotonin agents|mesh-ancestor
5542334|NCT04160377|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5542335|NCT04160377|Antidepressive Agents|antidepressive agents|mesh-ancestor
5542336|NCT04160377|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5542337|NCT04160377|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5542338|NCT04160377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6468974|NCT00489437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6138243|NCT01284296|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6138244|NCT01284296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6138245|NCT01284296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6138246|NCT01284296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138247|NCT01284335|Gemcitabine|gemcitabine|mesh-list
6138248|NCT01284335|Docetaxel|docetaxel|mesh-list
6138249|NCT01284335|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6138250|NCT01284335|Temozolomide|temozolomide|mesh-list
6138251|NCT01284335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6138252|NCT01284335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6138253|NCT01284335|Antimetabolites|antimetabolites|mesh-ancestor
5542339|NCT04160377|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5542340|NCT04160611|Midazolam|midazolam|mesh-list
5542341|NCT04160611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5542342|NCT04160611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5542343|NCT04160611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5542344|NCT04160611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542345|NCT04160611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5542346|NCT04160611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5542347|NCT04160611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5542348|NCT04160611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5542349|NCT04160611|Anesthetics, General|anesthetics, general|mesh-ancestor
5542350|NCT04160611|Anesthetics|anesthetics|mesh-ancestor
5542351|NCT04160611|GABA Modulators|gaba modulators|mesh-ancestor
5542352|NCT04160611|GABA Agents|gaba agents|mesh-ancestor
5542353|NCT04160611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5542354|NCT04160611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205296|NCT02083861|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6468975|NCT00489437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6468976|NCT00489437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6468977|NCT00489528|Hormones|hormones|mesh-list
6468978|NCT00489528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6468979|NCT00489528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468980|NCT00489593|Olanzapine|olanzapine|mesh-list
5542355|NCT04160195|Cyclophosphamide|cyclophosphamide|mesh-list
5542356|NCT04160195|Fludarabine|fludarabine|mesh-list
5542357|NCT04160195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5542358|NCT04160195|Immunologic Factors|immunologic factors|mesh-ancestor
5542359|NCT04160195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542360|NCT04160195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5542361|NCT04160195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6138254|NCT01284335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138255|NCT01284335|Antiviral Agents|antiviral agents|mesh-ancestor
6138256|NCT01284335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6138257|NCT01284335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6138258|NCT01284335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6138259|NCT01284335|Immunologic Factors|immunologic factors|mesh-ancestor
6138260|NCT01284335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138261|NCT01284335|Tubulin Modulators|tubulin modulators|mesh-ancestor
6138262|NCT01284335|Antimitotic Agents|antimitotic agents|mesh-ancestor
6138263|NCT01284335|Mitosis Modulators|mitosis modulators|mesh-ancestor
6138264|NCT01284335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6138265|NCT01284335|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6138266|NCT01284335|Alkylating Agents|alkylating agents|mesh-ancestor
6138267|NCT01284517|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
6138268|NCT01284517|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6138269|NCT01284517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6138270|NCT01284517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6138271|NCT01284517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138272|NCT01284517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6138273|NCT01284517|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6138274|NCT01284517|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6138275|NCT01284517|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6138276|NCT01284517|Adrenergic Agents|adrenergic agents|mesh-ancestor
6138277|NCT01284517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6138278|NCT01284517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138279|NCT01284517|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6138280|NCT01284517|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6138281|NCT01284517|Serotonin Agents|serotonin agents|mesh-ancestor
6138282|NCT01284517|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6138283|NCT01284517|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6138284|NCT01284517|Dopamine Agents|dopamine agents|mesh-ancestor
5542362|NCT04160195|Alkylating Agents|alkylating agents|mesh-ancestor
5542363|NCT04160195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138285|NCT01284621|Empagliflozin|empagliflozin|mesh-list
6138286|NCT01284621|Ramipril|ramipril|mesh-list
6138287|NCT01284621|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6468981|NCT00489593|Fluoxetine|fluoxetine|mesh-list
6468982|NCT00489593|Antiemetics|antiemetics|mesh-ancestor
6468983|NCT00489593|Autonomic Agents|autonomic agents|mesh-ancestor
6468984|NCT00489593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5542364|NCT04160195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5542365|NCT04160195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5542366|NCT04160026|Pyrimethamine|pyrimethamine|mesh-list
5542367|NCT04160026|Piperaquine|piperaquine|mesh-list
5542368|NCT04160026|Sulfadoxine|sulfadoxine|mesh-list
5542369|NCT04160026|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
5542370|NCT04160026|Antimalarials|antimalarials|mesh-ancestor
6468985|NCT00489593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6468986|NCT00489593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6468987|NCT00489593|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6468988|NCT00489593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6468989|NCT00489593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6468990|NCT00489593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6468991|NCT00489593|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6468992|NCT00489593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6468993|NCT00489593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6468994|NCT00489593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542371|NCT04160026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5542372|NCT04160026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5542373|NCT04160026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5542374|NCT04160026|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5542375|NCT04160026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5542376|NCT04160026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542377|NCT04160026|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5542378|NCT04160026|Renal Agents|renal agents|mesh-ancestor
5542379|NCT04159870|Rifaximin|rifaximin|mesh-list
5542380|NCT04159870|Norfloxacin|norfloxacin|mesh-list
5542381|NCT04159870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5542382|NCT04159870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5542383|NCT04159870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5542384|NCT04159870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5542385|NCT04159870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6468995|NCT00489593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6468996|NCT00489593|Serotonin Agents|serotonin agents|mesh-ancestor
6468997|NCT00489593|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6468998|NCT00489593|Antidepressive Agents|antidepressive agents|mesh-ancestor
6468999|NCT00489593|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6469000|NCT00489593|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6469001|NCT00489593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6488520|NCT00584636|Budesonide|budesonide|mesh-list
6488521|NCT00584636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6488522|NCT00584636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6488523|NCT00584636|Autonomic Agents|autonomic agents|mesh-ancestor
6488524|NCT00584636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5542386|NCT04159870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5542387|NCT04159870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542388|NCT04159870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5542389|NCT04159870|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5542390|NCT04159870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5542391|NCT04160117|Colchicine|colchicine|mesh-list
5542392|NCT04160117|Gout Suppressants|gout suppressants|mesh-ancestor
5542393|NCT04160117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5542394|NCT04160117|Tubulin Modulators|tubulin modulators|mesh-ancestor
5542395|NCT04160117|Antimitotic Agents|antimitotic agents|mesh-ancestor
6488525|NCT00584636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488526|NCT00584636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6488527|NCT00584636|Respiratory System Agents|respiratory system agents|mesh-ancestor
6138288|NCT01284621|Protease Inhibitors|protease inhibitors|mesh-ancestor
6138289|NCT01284621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5542396|NCT04160117|Mitosis Modulators|mitosis modulators|mesh-ancestor
5542397|NCT04160117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542398|NCT04160117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5542399|NCT04159818|Doxorubicin|doxorubicin|mesh-list
5542400|NCT04159818|Nivolumab|nivolumab|mesh-list
5542401|NCT04159818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6138290|NCT01284621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138291|NCT01284621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6138292|NCT01284621|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6138293|NCT01284621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6138294|NCT01284621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138295|NCT01284634|Cannabidiol|cannabidiol|mesh-list
6138296|NCT01284634|Anticonvulsants|anticonvulsants|mesh-ancestor
6138297|NCT01284959|Risperidone|risperidone|mesh-list
6138298|NCT01284959|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6138299|NCT01284959|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6138300|NCT01284959|Serotonin Agents|serotonin agents|mesh-ancestor
6138301|NCT01284959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6138302|NCT01284959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138303|NCT01284959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138304|NCT01284959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6138305|NCT01284959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6138306|NCT01284959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6138307|NCT01284959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6138308|NCT01284959|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6138309|NCT01284959|Dopamine Agents|dopamine agents|mesh-ancestor
6138310|NCT01284959|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6138311|NCT01284959|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6488528|NCT00584636|Glucocorticoids|glucocorticoids|mesh-ancestor
6488529|NCT00584636|Hormones|hormones|mesh-ancestor
6488530|NCT00584636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5602353|NCT04664933|Protective Agents|protective agents|mesh-ancestor
5542402|NCT04159818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5542403|NCT04159818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5542404|NCT04159818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5542405|NCT04159818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5542406|NCT04159818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542407|NCT04159818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5542408|NCT04159818|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5542409|NCT04159896|Nivolumab|nivolumab|mesh-list
5542410|NCT04159896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5542411|NCT04159896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5542412|NCT04159896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6469002|NCT00489645|Pramlintide|pramlintide|mesh-list
6469003|NCT00489645|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
6469004|NCT00489645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6469005|NCT00489645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542413|NCT04159896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542414|NCT04159649|Letrozole|letrozole|mesh-list
5542415|NCT04159649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5542416|NCT04159649|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5542417|NCT04159649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5542418|NCT04159649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6138312|NCT01285050|Tenofovir|tenofovir|mesh-list
6138313|NCT01285050|Emtricitabine|emtricitabine|mesh-list
6138314|NCT01285050|Raltegravir Potassium|raltegravir potassium|mesh-list
6138315|NCT01285050|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6138316|NCT01285050|Antiviral Agents|antiviral agents|mesh-ancestor
6138317|NCT01285050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6138318|NCT01285050|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6138319|NCT01285050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6138320|NCT01285050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6138321|NCT01285050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138322|NCT01285050|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6138323|NCT01285050|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6138324|NCT01285050|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6138325|NCT01285310|Thalidomide|thalidomide|mesh-list
6138326|NCT01285310|Apremilast|apremilast|mesh-list
6138327|NCT01285310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6138328|NCT01285310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6138329|NCT01285310|Analgesics|analgesics|mesh-ancestor
6138330|NCT01285310|Sensory System Agents|sensory system agents|mesh-ancestor
6138331|NCT01285310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6138332|NCT01285310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138333|NCT01285310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6138334|NCT01285310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6138335|NCT01285310|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6138336|NCT01285310|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5542419|NCT04159649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542420|NCT04159649|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5542421|NCT04159649|Hormone Antagonists|hormone antagonists|mesh-ancestor
5542422|NCT04159649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5542423|NCT04159649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542424|NCT04160000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
5542425|NCT04159597|Upadacitinib|upadacitinib|mesh-list
5542426|NCT04159597|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
5542427|NCT04159597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5542428|NCT04159597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5542429|NCT04159597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542430|NCT04159597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5542431|NCT04159610|Glycopyrrolate|glycopyrrolate|mesh-list
5542432|NCT04159610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5542433|NCT04159610|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5542434|NCT04159610|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5542435|NCT04159610|Cholinergic Agents|cholinergic agents|mesh-ancestor
5542436|NCT04159610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5542437|NCT04159610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138337|NCT01285310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6138338|NCT01285310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138339|NCT01285310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6138340|NCT01285310|Immunologic Factors|immunologic factors|mesh-ancestor
6138341|NCT01285310|Leprostatic Agents|leprostatic agents|mesh-ancestor
6138342|NCT01285310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6138343|NCT01285310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6469006|NCT00489645|Appetite Depressants|appetite depressants|mesh-ancestor
6138344|NCT01285310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6138345|NCT01285310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6138346|NCT01285310|Growth Substances|growth substances|mesh-ancestor
6138347|NCT01285310|Growth Inhibitors|growth inhibitors|mesh-ancestor
6138348|NCT01285310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6138349|NCT01285323|Reslizumab|reslizumab|mesh-list
6138350|NCT01285323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6138351|NCT01285323|Respiratory System Agents|respiratory system agents|mesh-ancestor
6138352|NCT01285401|Interferons|interferons|mesh-list
6138353|NCT01285401|Interferon-beta|interferon-beta|mesh-list
6469007|NCT00489645|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6469008|NCT00489645|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
6469009|NCT00489645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469010|NCT00489658|Eflornithine|eflornithine|mesh-list
6469011|NCT00489658|Nifurtimox|nifurtimox|mesh-list
6469012|NCT00489658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6469013|NCT00489658|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6469014|NCT00489658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6469015|NCT00489658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6469016|NCT00489658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6469017|NCT00489658|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
6469018|NCT00489658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6469019|NCT00489658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469020|NCT00489710|Enzyme Inhibitors|enzyme inhibitors|mesh-list
6469021|NCT00489710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469022|NCT00489723|Tamsulosin|tamsulosin|mesh-list
5542438|NCT04159610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542439|NCT04159181|Lactulose|lactulose|mesh-list
5542440|NCT04159181|Picosulfate sodium|picosulfate sodium|mesh-list
5542441|NCT04159181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5542442|NCT04159181|Cathartics|cathartics|mesh-ancestor
5542443|NCT04159246|Sofosbuvir|sofosbuvir|mesh-list
5542444|NCT04159246|Antiviral Agents|antiviral agents|mesh-ancestor
6469023|NCT00489723|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6469024|NCT00489723|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6469025|NCT00489723|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6469026|NCT00489723|Adrenergic Agents|adrenergic agents|mesh-ancestor
6469027|NCT00489723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6469028|NCT00489723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469029|NCT00489723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542445|NCT04159246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5542446|NCT04159155|Paclitaxel|paclitaxel|mesh-list
5542447|NCT04159155|Carboplatin|carboplatin|mesh-list
5542448|NCT04159155|Niraparib|niraparib|mesh-list
5542449|NCT04159155|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6469030|NCT00489723|Urological Agents|urological agents|mesh-ancestor
6469031|NCT00489775|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6469032|NCT00489775|Paroxetine|paroxetine|mesh-list
6469033|NCT00489775|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6469034|NCT00489775|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6469035|NCT00489775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6469036|NCT00489775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469037|NCT00489775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6469038|NCT00489775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469039|NCT00489775|Analgesics|analgesics|mesh-ancestor
6469040|NCT00489775|Sensory System Agents|sensory system agents|mesh-ancestor
6469041|NCT00489775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6469042|NCT00489775|Antidepressive Agents|antidepressive agents|mesh-ancestor
6469043|NCT00489775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6469044|NCT00489775|Dopamine Agents|dopamine agents|mesh-ancestor
6469045|NCT00489775|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6469046|NCT00489775|Serotonin Agents|serotonin agents|mesh-ancestor
6469047|NCT00489775|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6469048|NCT00489775|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6469049|NCT00489775|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6469050|NCT00489775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6469051|NCT00489840|Hydrocortisone|hydrocortisone|mesh-list
6469052|NCT00489840|Anecortave|anecortave|mesh-list
6469053|NCT00489840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6469054|NCT00489840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6469055|NCT00489840|Growth Substances|growth substances|mesh-ancestor
6469056|NCT00489840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542450|NCT04159155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6138354|NCT01285401|Interferon beta-1a|interferon beta-1a|mesh-list
6138355|NCT01285401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5542451|NCT04159155|Tubulin Modulators|tubulin modulators|mesh-ancestor
5542452|NCT04159155|Antimitotic Agents|antimitotic agents|mesh-ancestor
5542453|NCT04159155|Mitosis Modulators|mitosis modulators|mesh-ancestor
5542454|NCT04159155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542455|NCT04159155|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5542456|NCT04159155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5542457|NCT04159142|Paclitaxel|paclitaxel|mesh-list
6469057|NCT00489840|Growth Inhibitors|growth inhibitors|mesh-ancestor
6469058|NCT00489840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6138356|NCT01285401|Antiviral Agents|antiviral agents|mesh-ancestor
6138357|NCT01285401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6138358|NCT01285401|Immunologic Factors|immunologic factors|mesh-ancestor
6138359|NCT01285401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138360|NCT01285401|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6138361|NCT01285492|Tiotropium Bromide|tiotropium bromide|mesh-list
6138362|NCT01285492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6138363|NCT01285492|Autonomic Agents|autonomic agents|mesh-ancestor
6138364|NCT01285492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6138365|NCT01285492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138366|NCT01285492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6138367|NCT01285492|Respiratory System Agents|respiratory system agents|mesh-ancestor
6138368|NCT01285492|Parasympatholytics|parasympatholytics|mesh-ancestor
6138369|NCT01285492|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6138370|NCT01285492|Cholinergic Agents|cholinergic agents|mesh-ancestor
6138371|NCT01285492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6138372|NCT01285492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138373|NCT01285609|Paclitaxel|paclitaxel|mesh-list
6138374|NCT01285609|Carboplatin|carboplatin|mesh-list
6138375|NCT01285609|Ipilimumab|ipilimumab|mesh-list
6138376|NCT01285609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6138377|NCT01285609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6469059|NCT00489840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6469060|NCT00489892|Modafinil|modafinil|mesh-list
6469061|NCT00489892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6469062|NCT00489892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469063|NCT00489892|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6469064|NCT00489892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6138378|NCT01285609|Tubulin Modulators|tubulin modulators|mesh-ancestor
6138379|NCT01285609|Antimitotic Agents|antimitotic agents|mesh-ancestor
6138380|NCT01285609|Mitosis Modulators|mitosis modulators|mesh-ancestor
6138381|NCT01285609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138382|NCT01285609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6138383|NCT01285609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6469065|NCT00489892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6469066|NCT00489892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469067|NCT00489905|Zoledronic Acid|zoledronic acid|mesh-list
6469068|NCT00489905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6469069|NCT00489905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542458|NCT04159142|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5542459|NCT04159142|Carboplatin|carboplatin|mesh-list
5542460|NCT04159142|Capecitabine|capecitabine|mesh-list
5542461|NCT04159142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5542462|NCT04159142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5542463|NCT04159142|Tubulin Modulators|tubulin modulators|mesh-ancestor
5542464|NCT04159142|Antimitotic Agents|antimitotic agents|mesh-ancestor
5542465|NCT04159142|Mitosis Modulators|mitosis modulators|mesh-ancestor
5542466|NCT04159142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542467|NCT04159142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5542468|NCT04159142|Antimetabolites|antimetabolites|mesh-ancestor
5602354|NCT04664933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469070|NCT00489944|Tamoxifen|tamoxifen|mesh-list
6469071|NCT00489944|Sunitinib|sunitinib|mesh-list
6469072|NCT00489944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6469073|NCT00489944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469074|NCT00489944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6469075|NCT00489944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6469076|NCT00489944|Growth Substances|growth substances|mesh-ancestor
6666563|NCT01523119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5602355|NCT04654052|Clopidogrel|clopidogrel|mesh-list
5602356|NCT04654052|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5602357|NCT04654052|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5602358|NCT04654052|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5602359|NCT04654052|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6469077|NCT00489944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469078|NCT00489944|Growth Inhibitors|growth inhibitors|mesh-ancestor
6469079|NCT00489944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6469080|NCT00489944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6469081|NCT00489944|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5542469|NCT04159077|Tamsulosin|tamsulosin|mesh-list
5542470|NCT04159077|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5542471|NCT04159077|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5542472|NCT04159077|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5542473|NCT04159077|Adrenergic Agents|adrenergic agents|mesh-ancestor
5542474|NCT04159077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5542475|NCT04159077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542476|NCT04159077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542477|NCT04159077|Urological Agents|urological agents|mesh-ancestor
6469082|NCT00489944|Hormone Antagonists|hormone antagonists|mesh-ancestor
6469083|NCT00489944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6469084|NCT00489944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6469085|NCT00489944|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6469086|NCT00489944|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6469087|NCT00489944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6469088|NCT00489983|Gemcitabine|gemcitabine|mesh-list
6469089|NCT00489983|Pemetrexed|pemetrexed|mesh-list
6469090|NCT00489983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6469091|NCT00489983|Antimetabolites|antimetabolites|mesh-ancestor
6469092|NCT00489983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469093|NCT00489983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6469094|NCT00489983|Antiviral Agents|antiviral agents|mesh-ancestor
6469095|NCT00489983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6469096|NCT00489983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6469097|NCT00489983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6469098|NCT00489983|Immunologic Factors|immunologic factors|mesh-ancestor
6469099|NCT00489983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469100|NCT00489983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6469101|NCT00489983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6469102|NCT00489996|Gemcitabine|gemcitabine|mesh-list
6469103|NCT00489996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6469104|NCT00489996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6469105|NCT00489996|Antimetabolites|antimetabolites|mesh-ancestor
6469106|NCT00489996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542478|NCT04158934|Factor VIII|factor viii|mesh-list
5542479|NCT04158934|BAX 855|bax 855|mesh-list
5542480|NCT04158934|Coagulants|coagulants|mesh-ancestor
5542481|NCT04158947|Trastuzumab|trastuzumab|mesh-list
5542482|NCT04158947|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
5542483|NCT04158947|Afatinib|afatinib|mesh-list
5542484|NCT04158947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5542485|NCT04158947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5542486|NCT04158947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5542487|NCT04158947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5542488|NCT04158947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542489|NCT04158947|Tubulin Modulators|tubulin modulators|mesh-ancestor
5542490|NCT04158947|Antimitotic Agents|antimitotic agents|mesh-ancestor
5542491|NCT04158947|Mitosis Modulators|mitosis modulators|mesh-ancestor
5542492|NCT04158739|Cytarabine|cytarabine|mesh-list
5542493|NCT04158739|Antibodies|antibodies|mesh-list
5542494|NCT04158739|Immunoglobulins|immunoglobulins|mesh-list
5542495|NCT04158739|Antibodies, Bispecific|antibodies, bispecific|mesh-list
5542496|NCT04158739|Immunologic Factors|immunologic factors|mesh-ancestor
5542497|NCT04158739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542498|NCT04158739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5542499|NCT04158739|Antimetabolites|antimetabolites|mesh-ancestor
5542500|NCT04158739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542501|NCT04158739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5542502|NCT04158739|Antiviral Agents|antiviral agents|mesh-ancestor
5542503|NCT04158739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5542504|NCT04158739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6138384|NCT01285635|Docetaxel|docetaxel|mesh-list
6138385|NCT01285635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6138386|NCT01285635|Tubulin Modulators|tubulin modulators|mesh-ancestor
6138387|NCT01285635|Antimitotic Agents|antimitotic agents|mesh-ancestor
6138388|NCT01285635|Mitosis Modulators|mitosis modulators|mesh-ancestor
6138389|NCT01285635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138390|NCT01285908|Norepinephrine|norepinephrine|mesh-list
6138391|NCT01285908|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6138392|NCT01285908|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5542505|NCT04158674|Simendan|simendan|mesh-list
5542506|NCT04158674|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5542507|NCT04158674|Vasodilator Agents|vasodilator agents|mesh-ancestor
6469107|NCT00489996|Antiviral Agents|antiviral agents|mesh-ancestor
6469108|NCT00489996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6469109|NCT00489996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6469110|NCT00489996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6469111|NCT00489996|Immunologic Factors|immunologic factors|mesh-ancestor
6469112|NCT00489996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469113|NCT00490087|Levonorgestrel|levonorgestrel|mesh-list
6469114|NCT00490087|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6469115|NCT00490087|Contraceptive Agents|contraceptive agents|mesh-ancestor
6469116|NCT00490087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6469117|NCT00490087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469118|NCT00490087|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6469119|NCT00490087|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6469120|NCT00490087|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6469121|NCT00490113|Pyridoxamine|pyridoxamine|mesh-list
6469122|NCT00490113|Vitamin B Complex|vitamin b complex|mesh-ancestor
6469123|NCT00490113|Vitamins|vitamins|mesh-ancestor
6469124|NCT00490113|Micronutrients|micronutrients|mesh-ancestor
6469125|NCT00490113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469126|NCT00490178|Metformin|metformin|mesh-list
6469127|NCT00490178|Fenofibrate|fenofibrate|mesh-list
6469128|NCT00490178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6469129|NCT00490178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469130|NCT00490178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6469131|NCT00490178|Antimetabolites|antimetabolites|mesh-ancestor
6469132|NCT00490178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469133|NCT00490178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6469134|NCT00490204|Cetirizine|cetirizine|mesh-list
6469135|NCT00490204|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6469136|NCT00490204|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6469137|NCT00490204|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6469138|NCT00490204|Histamine Antagonists|histamine antagonists|mesh-ancestor
6469139|NCT00490204|Histamine Agents|histamine agents|mesh-ancestor
6469140|NCT00490204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6469141|NCT00490204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469142|NCT00490204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469143|NCT00490243|Budesonide|budesonide|mesh-list
6469144|NCT00490243|Formoterol Fumarate|formoterol fumarate|mesh-list
5542508|NCT04158674|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5542509|NCT04158674|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5542510|NCT04158674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5542511|NCT04158674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542512|NCT04158674|Protective Agents|protective agents|mesh-ancestor
5542513|NCT04158674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542514|NCT04158778|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
5542515|NCT04158778|Hallucinogens|hallucinogens|mesh-ancestor
5542516|NCT04158778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542517|NCT04158778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5542518|NCT04158778|Serotonin Agents|serotonin agents|mesh-ancestor
5542519|NCT04158778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5542520|NCT04158778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542521|NCT04158778|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5542522|NCT04158778|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5542523|NCT04158778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5542524|NCT04158778|Adrenergic Agents|adrenergic agents|mesh-ancestor
5542525|NCT04158700|Pembrolizumab|pembrolizumab|mesh-list
5542526|NCT04158700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5542527|NCT04158700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5542528|NCT04158713|Piperaquine|piperaquine|mesh-list
5542529|NCT04158713|Artenimol|artenimol|mesh-list
5542530|NCT04158713|Antimalarials|antimalarials|mesh-ancestor
5542531|NCT04158713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5542532|NCT04158713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5542533|NCT04158713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6469145|NCT00490243|Montelukast|montelukast|mesh-list
6469146|NCT00490243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6138393|NCT01285908|Adrenergic Agents|adrenergic agents|mesh-ancestor
6469147|NCT00490243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6469148|NCT00490243|Autonomic Agents|autonomic agents|mesh-ancestor
6469149|NCT00490243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6469150|NCT00490243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666564|NCT01523119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6488531|NCT00584662|Phenylephrine|phenylephrine|mesh-list
6469151|NCT00490243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6469152|NCT00490243|Respiratory System Agents|respiratory system agents|mesh-ancestor
6469153|NCT00490243|Glucocorticoids|glucocorticoids|mesh-ancestor
6469154|NCT00490243|Hormones|hormones|mesh-ancestor
6469155|NCT00490243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6469156|NCT00490243|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6469157|NCT00490243|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6469158|NCT00490243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6469159|NCT00490243|Adrenergic Agents|adrenergic agents|mesh-ancestor
6469160|NCT00490243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6469161|NCT00490243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469162|NCT00490243|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6469163|NCT00490243|Hormone Antagonists|hormone antagonists|mesh-ancestor
6469164|NCT00490243|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6469165|NCT00490243|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6469166|NCT00490308|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6469167|NCT00490308|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5542534|NCT04158830|Aspirin|aspirin|mesh-list
5542535|NCT04158830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5542536|NCT04158830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5542537|NCT04158830|Analgesics|analgesics|mesh-ancestor
5542538|NCT04158830|Sensory System Agents|sensory system agents|mesh-ancestor
5542539|NCT04158830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5542540|NCT04158830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542541|NCT04158830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5542542|NCT04158830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5542543|NCT04158830|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5542544|NCT04158830|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5542545|NCT04158830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542546|NCT04158830|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5542547|NCT04158830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5542548|NCT04158830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5542549|NCT04158830|Antipyretics|antipyretics|mesh-ancestor
6469168|NCT00490308|Estradiol|estradiol|mesh-list
6469169|NCT00490308|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6469170|NCT00490308|Estrogens|estrogens|mesh-ancestor
6469171|NCT00490308|Hormones|hormones|mesh-ancestor
6469172|NCT00490308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6469173|NCT00490308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469174|NCT00490308|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6469175|NCT00490308|Contraceptive Agents|contraceptive agents|mesh-ancestor
6469176|NCT00490308|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6469177|NCT00490308|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6469178|NCT00490360|Gemcitabine|gemcitabine|mesh-list
6469179|NCT00490360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6469180|NCT00490360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5542550|NCT04158856|Trastuzumab|trastuzumab|mesh-list
5542551|NCT04158856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5542552|NCT04158856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5542553|NCT04158440|Paclitaxel|paclitaxel|mesh-list
5542554|NCT04158440|Docetaxel|docetaxel|mesh-list
5542555|NCT04158440|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5542556|NCT04158440|Cisplatin|cisplatin|mesh-list
5542557|NCT04158440|Carboplatin|carboplatin|mesh-list
5542558|NCT04158440|Pemetrexed|pemetrexed|mesh-list
5542559|NCT04158440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5542560|NCT04158440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5542561|NCT04158440|Tubulin Modulators|tubulin modulators|mesh-ancestor
6469181|NCT00490360|Antimetabolites|antimetabolites|mesh-ancestor
6469182|NCT00490360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469183|NCT00490360|Antiviral Agents|antiviral agents|mesh-ancestor
6469184|NCT00490360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6469185|NCT00490360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6469186|NCT00490360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6469187|NCT00490360|Immunologic Factors|immunologic factors|mesh-ancestor
6469188|NCT00490360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469189|NCT00490373|Pemetrexed|pemetrexed|mesh-list
6469190|NCT00490373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6138394|NCT01285908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6138395|NCT01285908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469191|NCT00490373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6469192|NCT00490373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469193|NCT00490373|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5542562|NCT04158440|Antimitotic Agents|antimitotic agents|mesh-ancestor
6469194|NCT00490373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6469195|NCT00490399|Gemcitabine|gemcitabine|mesh-list
6138396|NCT01285908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138397|NCT01285908|Sympathomimetics|sympathomimetics|mesh-ancestor
6138398|NCT01285908|Autonomic Agents|autonomic agents|mesh-ancestor
6138399|NCT01285908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6138400|NCT01285908|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6138401|NCT01286077|Bortezomib|bortezomib|mesh-list
6138402|NCT01286077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6138403|NCT01286168|Chlorhexidine|chlorhexidine|mesh-list
6138404|NCT01286168|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6138405|NCT01286168|Sodium Hypochlorite|sodium hypochlorite|mesh-list
6138406|NCT01286168|Eusol|eusol|mesh-list
6469196|NCT00490399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6469197|NCT00490399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6469198|NCT00490399|Antimetabolites|antimetabolites|mesh-ancestor
6469199|NCT00490399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469200|NCT00490399|Antiviral Agents|antiviral agents|mesh-ancestor
6469201|NCT00490399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6469202|NCT00490399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6469203|NCT00490399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6469204|NCT00490399|Immunologic Factors|immunologic factors|mesh-ancestor
6469205|NCT00490399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469206|NCT00490412|Vitamin D|vitamin d|mesh-list
6469207|NCT00490412|Vitamins|vitamins|mesh-ancestor
6469208|NCT00490412|Micronutrients|micronutrients|mesh-ancestor
6469209|NCT00490412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469210|NCT00490412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6469211|NCT00490464|Nicardipine|nicardipine|mesh-list
6469212|NCT00490464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6469213|NCT00490464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6469214|NCT00490464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6469215|NCT00490464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138407|NCT01286168|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6138408|NCT01286168|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6138409|NCT01286168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6138410|NCT01286168|Disinfectants|disinfectants|mesh-ancestor
6138411|NCT01286168|Dermatologic Agents|dermatologic agents|mesh-ancestor
6138412|NCT01286259|Disulfiram|disulfiram|mesh-list
6138413|NCT01286259|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6469216|NCT00490464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6469217|NCT00490464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469218|NCT00490464|Vasodilator Agents|vasodilator agents|mesh-ancestor
6469219|NCT00490620|Antiviral Agents|antiviral agents|mesh-list
6469220|NCT00490620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6469221|NCT00490633|Ethanol|ethanol|mesh-list
6469222|NCT00490633|Hand Sanitizers|hand sanitizers|mesh-list
6469223|NCT00490633|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6469224|NCT00490633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6469225|NCT00490633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6469226|NCT00490633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469227|NCT00490633|Disinfectants|disinfectants|mesh-ancestor
6469228|NCT00490659|Gemcitabine|gemcitabine|mesh-list
6469229|NCT00490659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6469230|NCT00490659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5542563|NCT04158440|Mitosis Modulators|mitosis modulators|mesh-ancestor
5542564|NCT04158440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542565|NCT04158440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5542566|NCT04158440|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5542567|NCT04158440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5542568|NCT04158076|Amlodipine|amlodipine|mesh-list
5542569|NCT04158076|Telmisartan|telmisartan|mesh-list
5542570|NCT04158076|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
5542571|NCT04158076|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5542572|NCT04158076|Ezetimibe|ezetimibe|mesh-list
5542573|NCT04158076|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6138414|NCT01286259|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
6138415|NCT01286259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6469231|NCT00490659|Antimetabolites|antimetabolites|mesh-ancestor
6469232|NCT00490659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469233|NCT00490659|Antiviral Agents|antiviral agents|mesh-ancestor
6469234|NCT00490659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6138416|NCT01286259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138417|NCT01286402|Bupropion|bupropion|mesh-list
6138418|NCT01286402|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6138419|NCT01286402|Antidepressive Agents|antidepressive agents|mesh-ancestor
6138420|NCT01286402|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6138421|NCT01286402|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6138422|NCT01286402|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6138423|NCT01286402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6138424|NCT01286402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138425|NCT01286402|Dopamine Agents|dopamine agents|mesh-ancestor
6138426|NCT01286402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6138427|NCT01286402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138428|NCT01286402|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6138429|NCT01286402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6469235|NCT00490659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6469236|NCT00490659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6469237|NCT00490659|Immunologic Factors|immunologic factors|mesh-ancestor
6469238|NCT00490659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469239|NCT00490685|Sorafenib|sorafenib|mesh-list
6469240|NCT00490685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6469241|NCT00490685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6469242|NCT00490685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6469243|NCT00490685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469244|NCT00490711|Gemcitabine|gemcitabine|mesh-list
6469245|NCT00490711|Paclitaxel|paclitaxel|mesh-list
6469246|NCT00490711|Carboplatin|carboplatin|mesh-list
6469247|NCT00490711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5542574|NCT04158076|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5542575|NCT04158076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5542576|NCT04158076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542577|NCT04158076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5542578|NCT04158076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542579|NCT04158076|Vasodilator Agents|vasodilator agents|mesh-ancestor
5542580|NCT04158076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5542581|NCT04158076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6469248|NCT00490711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6469249|NCT00490711|Tubulin Modulators|tubulin modulators|mesh-ancestor
6469250|NCT00490711|Antimitotic Agents|antimitotic agents|mesh-ancestor
6469251|NCT00490711|Mitosis Modulators|mitosis modulators|mesh-ancestor
6469252|NCT00490711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469253|NCT00490711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6469254|NCT00490711|Antimetabolites|antimetabolites|mesh-ancestor
6469255|NCT00490711|Antiviral Agents|antiviral agents|mesh-ancestor
6469256|NCT00490711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5542582|NCT04158076|Antimetabolites|antimetabolites|mesh-ancestor
5542583|NCT04158076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5542584|NCT04158076|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5542585|NCT04158076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5542586|NCT04158076|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5542587|NCT04158076|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5542588|NCT04158102|Bupivacaine|bupivacaine|mesh-list
5542589|NCT04158102|Anesthetics, Local|anesthetics, local|mesh-ancestor
6138430|NCT01286402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6138431|NCT01286454|Fesoterodine|fesoterodine|mesh-list
6138432|NCT01286454|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6138433|NCT01286454|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6138434|NCT01286454|Cholinergic Agents|cholinergic agents|mesh-ancestor
6138435|NCT01286454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6138436|NCT01286454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138437|NCT01286454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138438|NCT01286454|Urological Agents|urological agents|mesh-ancestor
6138439|NCT01286558|Amlodipine|amlodipine|mesh-list
6138440|NCT01286558|Telmisartan|telmisartan|mesh-list
6138441|NCT01286558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6138442|NCT01286558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6138443|NCT01286558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6469257|NCT00490711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6469258|NCT00490711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6469259|NCT00490711|Immunologic Factors|immunologic factors|mesh-ancestor
6469260|NCT00490711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469261|NCT00490737|Daptomycin|daptomycin|mesh-list
6469262|NCT00490737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6469263|NCT00490737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6469264|NCT00490789|Sirolimus|sirolimus|mesh-list
6469265|NCT00490789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6469266|NCT00490789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6469267|NCT00490789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6469268|NCT00490789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6469269|NCT00490789|Antifungal Agents|antifungal agents|mesh-ancestor
6469270|NCT00490789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6469271|NCT00490789|Immunologic Factors|immunologic factors|mesh-ancestor
6469272|NCT00490789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469273|NCT00490828|Hydrocortisone|hydrocortisone|mesh-list
6469274|NCT00490828|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6469275|NCT00490828|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6469276|NCT00490828|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6469277|NCT00490828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6469278|NCT00490854|Insulin|insulin|mesh-list
6469279|NCT00490854|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6469280|NCT00490854|Insulin, Isophane|insulin, isophane|mesh-list
6469281|NCT00490854|Isophane Insulin, Human|isophane insulin, human|mesh-list
5542590|NCT04158102|Anesthetics|anesthetics|mesh-ancestor
5542591|NCT04158102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5542592|NCT04158102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542593|NCT04158102|Sensory System Agents|sensory system agents|mesh-ancestor
5542594|NCT04158102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6469282|NCT00490854|Isophane insulin, beef|isophane insulin, beef|mesh-list
6469283|NCT00490854|Protamines|protamines|mesh-list
6666565|NCT01523236|Mometasone Furoate|mometasone furoate|mesh-list
6666566|NCT01523236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6666567|NCT01523236|Dermatologic Agents|dermatologic agents|mesh-ancestor
6666568|NCT01523236|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6666569|NCT01523314|Dexamethasone|dexamethasone|mesh-list
6666570|NCT01523314|Bevacizumab|bevacizumab|mesh-list
6469284|NCT00490854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6666571|NCT01523314|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6666572|NCT01523314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6666573|NCT01523314|Antiemetics|antiemetics|mesh-ancestor
6666574|NCT01523314|Autonomic Agents|autonomic agents|mesh-ancestor
6666575|NCT01523314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6666576|NCT01523314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666577|NCT01523314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6666578|NCT01523314|Glucocorticoids|glucocorticoids|mesh-ancestor
6666579|NCT01523314|Hormones|hormones|mesh-ancestor
6666580|NCT01523314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6666581|NCT01523314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5542595|NCT04158167|Oxytocin|oxytocin|mesh-list
5542596|NCT04158167|Oxytocics|oxytocics|mesh-ancestor
5542597|NCT04158167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5542598|NCT04158167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542599|NCT04158362|Paclitaxel|paclitaxel|mesh-list
5542600|NCT04158362|Capecitabine|capecitabine|mesh-list
5542601|NCT04158362|Letrozole|letrozole|mesh-list
5542602|NCT04158362|Fulvestrant|fulvestrant|mesh-list
5542603|NCT04158362|Anastrozole|anastrozole|mesh-list
5542604|NCT04158362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5542605|NCT04158362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5542606|NCT04158362|Tubulin Modulators|tubulin modulators|mesh-ancestor
5542607|NCT04158362|Antimitotic Agents|antimitotic agents|mesh-ancestor
5542608|NCT04158362|Mitosis Modulators|mitosis modulators|mesh-ancestor
5542609|NCT04158362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542610|NCT04158362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5542611|NCT04158362|Antimetabolites|antimetabolites|mesh-ancestor
5542612|NCT04158362|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5542613|NCT04158362|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5542614|NCT04158362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5542615|NCT04158362|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5542616|NCT04158362|Hormone Antagonists|hormone antagonists|mesh-ancestor
5542617|NCT04158362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5542618|NCT04158362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542619|NCT04158362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5542620|NCT04158362|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5542621|NCT04158050|Omalizumab|omalizumab|mesh-list
5542622|NCT04158050|Antibodies|antibodies|mesh-list
6469285|NCT00490854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469286|NCT00490854|Heparin Antagonists|heparin antagonists|mesh-ancestor
6469287|NCT00490854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469288|NCT00490854|Coagulants|coagulants|mesh-ancestor
6469289|NCT00490867|Thioctic Acid|thioctic acid|mesh-list
6469290|NCT00490867|Antioxidants|antioxidants|mesh-ancestor
6469291|NCT00490867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469292|NCT00490867|Protective Agents|protective agents|mesh-ancestor
6469293|NCT00490867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469294|NCT00490867|Vitamin B Complex|vitamin b complex|mesh-ancestor
6469295|NCT00490867|Vitamins|vitamins|mesh-ancestor
6469296|NCT00490867|Micronutrients|micronutrients|mesh-ancestor
6469297|NCT00490880|Gemcitabine|gemcitabine|mesh-list
6469298|NCT00490880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6469299|NCT00490880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6469300|NCT00490880|Antimetabolites|antimetabolites|mesh-ancestor
6469301|NCT00490880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469302|NCT00490880|Antiviral Agents|antiviral agents|mesh-ancestor
6469303|NCT00490880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5542623|NCT04158050|Immunologic Factors|immunologic factors|mesh-ancestor
5542624|NCT04158050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542625|NCT04158050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5542626|NCT04158050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5542627|NCT04158050|Respiratory System Agents|respiratory system agents|mesh-ancestor
5542628|NCT04158388|Tryptophan|tryptophan|mesh-list
5542629|NCT04158388|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5542630|NCT04158388|Antidepressive Agents|antidepressive agents|mesh-ancestor
5542631|NCT04158388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5542632|NCT04158349|Oxaliplatin|oxaliplatin|mesh-list
5542633|NCT04158349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5542634|NCT04157881|Rabeprazole|rabeprazole|mesh-list
5542635|NCT04157881|Dabigatran|dabigatran|mesh-list
5542636|NCT04157881|Antithrombins|antithrombins|mesh-ancestor
5542637|NCT04157881|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5542638|NCT04157881|Protease Inhibitors|protease inhibitors|mesh-ancestor
6469304|NCT00490880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6469305|NCT00490880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6469306|NCT00490880|Immunologic Factors|immunologic factors|mesh-ancestor
6469307|NCT00490880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469308|NCT00490893|Insulin Detemir|insulin detemir|mesh-list
6469309|NCT00490893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6469310|NCT00490893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469311|NCT00490906|Interferons|interferons|mesh-list
6469312|NCT00490906|Interferon-beta|interferon-beta|mesh-list
6469313|NCT00490906|Interferon beta-1a|interferon beta-1a|mesh-list
6469314|NCT00490906|Glatiramer Acetate|glatiramer acetate|mesh-list
6469315|NCT00490906|Interferon beta-1b|interferon beta-1b|mesh-list
6469316|NCT00490906|(T,G)-A-L|(t,g)-a-l|mesh-list
6469317|NCT00490906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6469318|NCT00490906|Antiviral Agents|antiviral agents|mesh-ancestor
6469319|NCT00490906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6469320|NCT00490906|Immunologic Factors|immunologic factors|mesh-ancestor
6469321|NCT00490906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469322|NCT00490906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6469323|NCT00490906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5542639|NCT04157881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5542640|NCT04157881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542641|NCT04157881|Anticoagulants|anticoagulants|mesh-ancestor
5542642|NCT04157881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5542643|NCT04157881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5542644|NCT04157881|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5542645|NCT04157803|Acetic Acid|acetic acid|mesh-list
6469324|NCT00490906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6469325|NCT00490958|Telmisartan|telmisartan|mesh-list
6469326|NCT00490958|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6469327|NCT00490958|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6469328|NCT00490958|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6469329|NCT00490958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469330|NCT00490997|Ketamine|ketamine|mesh-list
6469331|NCT00490997|Propofol|propofol|mesh-list
6469332|NCT00490997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6469333|NCT00490997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6469334|NCT00490997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469335|NCT00490997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6469336|NCT00490997|Anesthetics, General|anesthetics, general|mesh-ancestor
6469337|NCT00490997|Anesthetics|anesthetics|mesh-ancestor
5542646|NCT04157803|Retinol acetate|retinol acetate|mesh-list
5542647|NCT04157803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5542648|NCT04157803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6469338|NCT00490997|Analgesics|analgesics|mesh-ancestor
5542649|NCT04157803|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5542650|NCT04157803|Immunologic Factors|immunologic factors|mesh-ancestor
5542651|NCT04157803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542652|NCT04157803|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5542653|NCT04157803|Protective Agents|protective agents|mesh-ancestor
5542654|NCT04157803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5542655|NCT04157959|Febuxostat|febuxostat|mesh-list
5542656|NCT04157959|Gout Suppressants|gout suppressants|mesh-ancestor
5542657|NCT04157959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5542658|NCT04157751|Empagliflozin|empagliflozin|mesh-list
5542659|NCT04157751|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5542660|NCT04157751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542661|NCT04157751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5542662|NCT04157751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542663|NCT04157998|Metoclopramide|metoclopramide|mesh-list
5542664|NCT04157998|Antiemetics|antiemetics|mesh-ancestor
5542665|NCT04157998|Autonomic Agents|autonomic agents|mesh-ancestor
5542666|NCT04157998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5542667|NCT04157998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542668|NCT04157998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5542669|NCT04157998|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5542670|NCT04157998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5542671|NCT04157998|Dopamine Agents|dopamine agents|mesh-ancestor
5542672|NCT04157998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5542673|NCT04157998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542674|NCT04157491|Antibodies|antibodies|mesh-list
5542675|NCT04157491|Immunologic Factors|immunologic factors|mesh-ancestor
5542676|NCT04157491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542677|NCT04157478|Temozolomide|temozolomide|mesh-list
5542678|NCT04157478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5542679|NCT04157478|Alkylating Agents|alkylating agents|mesh-ancestor
5542680|NCT04157478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542681|NCT04157478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5602360|NCT04654052|Purinergic Agents|purinergic agents|mesh-ancestor
6469339|NCT00490997|Sensory System Agents|sensory system agents|mesh-ancestor
6469340|NCT00490997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6469341|NCT00490997|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6469342|NCT00490997|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6469343|NCT00490997|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5602361|NCT04654052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5602362|NCT04654052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602363|NCT04654052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602364|NCT04621500|Vitamin D|vitamin d|mesh-list
5602365|NCT04621500|Cholecalciferol|cholecalciferol|mesh-list
6469344|NCT00490997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6469345|NCT00490997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469346|NCT00491049|Levofloxacin|levofloxacin|mesh-list
6469347|NCT00491049|Ofloxacin|ofloxacin|mesh-list
6469348|NCT00491049|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6469349|NCT00491049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6469350|NCT00491049|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6469351|NCT00491049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6469352|NCT00491049|Renal Agents|renal agents|mesh-ancestor
6469353|NCT00491049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5602366|NCT04621500|Vitamins|vitamins|mesh-ancestor
5602367|NCT04621500|Micronutrients|micronutrients|mesh-ancestor
5602368|NCT04621500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602369|NCT04621500|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5602370|NCT04621500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5602371|NCT04613453|Midazolam|midazolam|mesh-list
5602372|NCT04613453|Ketamine|ketamine|mesh-list
5602373|NCT04613453|Analgesics|analgesics|mesh-ancestor
5602374|NCT04613453|Sensory System Agents|sensory system agents|mesh-ancestor
5602375|NCT04613453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5602376|NCT04613453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602377|NCT04613453|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6469354|NCT00491049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6469355|NCT00491049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6469356|NCT00491049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6469357|NCT00491049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469358|NCT00491049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5602378|NCT04613453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5602379|NCT04613453|Anesthetics, General|anesthetics, general|mesh-ancestor
5602380|NCT04613453|Anesthetics|anesthetics|mesh-ancestor
6138444|NCT01286558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138445|NCT01286558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6138446|NCT01286558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138447|NCT01286558|Vasodilator Agents|vasodilator agents|mesh-ancestor
6138448|NCT01286558|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6138449|NCT01286558|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5542682|NCT04157153|Sirolimus|sirolimus|mesh-list
5542683|NCT04157153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5542684|NCT04157153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5542685|NCT04157153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5542686|NCT04157153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5542687|NCT04157153|Antifungal Agents|antifungal agents|mesh-ancestor
5542688|NCT04157153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5542689|NCT04157153|Immunologic Factors|immunologic factors|mesh-ancestor
5542690|NCT04157153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542691|NCT04157699|Tenofovir|tenofovir|mesh-list
5542692|NCT04157699|Antiviral Agents|antiviral agents|mesh-ancestor
5542693|NCT04157699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5542694|NCT04157699|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5542695|NCT04157699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5542696|NCT04157699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5542697|NCT04157699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542698|NCT04157699|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5542699|NCT04157699|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5542700|NCT04157075|Bupivacaine|bupivacaine|mesh-list
5542701|NCT04157075|Anesthetics, Local|anesthetics, local|mesh-ancestor
5542702|NCT04157075|Anesthetics|anesthetics|mesh-ancestor
5542703|NCT04157075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6138450|NCT01286740|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
6138451|NCT01286740|Antiviral Agents|antiviral agents|mesh-ancestor
6138452|NCT01286740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6138453|NCT01286740|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6138454|NCT01286740|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6138455|NCT01286740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6138456|NCT01286740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138457|NCT01286740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6138458|NCT01286740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6138459|NCT01286753|Vemurafenib|vemurafenib|mesh-list
6138460|NCT01286753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6138461|NCT01286753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6138462|NCT01286753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6138463|NCT01286753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138464|NCT01286805|Bupivacaine|bupivacaine|mesh-list
6138465|NCT01286805|Anesthetics, Local|anesthetics, local|mesh-ancestor
6138466|NCT01286805|Anesthetics|anesthetics|mesh-ancestor
6138467|NCT01286805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6138468|NCT01286805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138469|NCT01286805|Sensory System Agents|sensory system agents|mesh-ancestor
6138470|NCT01286805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6138471|NCT01286818|Leucovorin|leucovorin|mesh-list
6138472|NCT01286818|Fluorouracil|fluorouracil|mesh-list
6138473|NCT01286818|Irinotecan|irinotecan|mesh-list
6138474|NCT01286818|Ramucirumab|ramucirumab|mesh-list
5542704|NCT04157075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542705|NCT04157075|Sensory System Agents|sensory system agents|mesh-ancestor
5542706|NCT04157075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5542707|NCT04157257|Tenofovir|tenofovir|mesh-list
5542708|NCT04157257|Entecavir|entecavir|mesh-list
5542709|NCT04157257|Antiviral Agents|antiviral agents|mesh-ancestor
6138475|NCT01286818|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6138476|NCT01286818|Levoleucovorin|levoleucovorin|mesh-list
6138477|NCT01286818|Antimetabolites|antimetabolites|mesh-ancestor
6138478|NCT01286818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138479|NCT01286818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6138480|NCT01286818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6138481|NCT01286818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6138482|NCT01286818|Immunologic Factors|immunologic factors|mesh-ancestor
6138483|NCT01286818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138484|NCT01286818|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6469359|NCT00491049|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6488532|NCT00584662|Oxymetazoline|oxymetazoline|mesh-list
5542710|NCT04157257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5542711|NCT04157257|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5542712|NCT04157257|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6469360|NCT00491049|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6469361|NCT00491114|Gemcitabine|gemcitabine|mesh-list
6469362|NCT00491114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6469363|NCT00491114|Antimetabolites|antimetabolites|mesh-ancestor
6469364|NCT00491114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469365|NCT00491114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6469366|NCT00491114|Antiviral Agents|antiviral agents|mesh-ancestor
6469367|NCT00491114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6469368|NCT00491114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6469369|NCT00491114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6469370|NCT00491114|Immunologic Factors|immunologic factors|mesh-ancestor
6469371|NCT00491114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469372|NCT00491127|Gemcitabine|gemcitabine|mesh-list
6469373|NCT00491127|Dexamethasone|dexamethasone|mesh-list
6469374|NCT00491127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5542713|NCT04157257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5542714|NCT04157257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542715|NCT04157257|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5542716|NCT04157257|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5542717|NCT04156984|Golimumab|golimumab|mesh-list
5542718|NCT04156984|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
5542719|NCT04156984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5542720|NCT04156984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5542721|NCT04156984|Immunologic Factors|immunologic factors|mesh-ancestor
5542722|NCT04156984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542723|NCT04157010|Methotrexate|methotrexate|mesh-list
6469375|NCT00491127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6469376|NCT00491127|Antiemetics|antiemetics|mesh-ancestor
6469377|NCT00491127|Autonomic Agents|autonomic agents|mesh-ancestor
6666582|NCT01523314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6666583|NCT01523314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6666584|NCT01523314|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5542724|NCT04157010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5542725|NCT04157010|Abortifacient Agents|abortifacient agents|mesh-ancestor
5542726|NCT04157010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5542727|NCT04157010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542728|NCT04157010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5542729|NCT04157010|Antimetabolites|antimetabolites|mesh-ancestor
5542730|NCT04157010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542731|NCT04157010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5542732|NCT04157010|Dermatologic Agents|dermatologic agents|mesh-ancestor
6666585|NCT01523314|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6666586|NCT01523314|Growth Substances|growth substances|mesh-ancestor
6666587|NCT01523314|Growth Inhibitors|growth inhibitors|mesh-ancestor
5542733|NCT04157010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6469378|NCT00491127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6469379|NCT00491127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469380|NCT00491127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6469381|NCT00491127|Glucocorticoids|glucocorticoids|mesh-ancestor
6469382|NCT00491127|Hormones|hormones|mesh-ancestor
6469383|NCT00491127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6469384|NCT00491127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6469385|NCT00491127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6469386|NCT00491127|Antimetabolites|antimetabolites|mesh-ancestor
6469387|NCT00491127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138485|NCT01286818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6138486|NCT01286818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6138487|NCT01286818|Antidotes|antidotes|mesh-ancestor
6138488|NCT01286818|Protective Agents|protective agents|mesh-ancestor
6138489|NCT01286818|Vitamin B Complex|vitamin b complex|mesh-ancestor
6138490|NCT01286818|Vitamins|vitamins|mesh-ancestor
6138491|NCT01286818|Micronutrients|micronutrients|mesh-ancestor
6138492|NCT01286987|Talazoparib|talazoparib|mesh-list
6138493|NCT01286987|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6138494|NCT01286987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6138495|NCT01286987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138496|NCT01286987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6138497|NCT01287039|Reslizumab|reslizumab|mesh-list
6138498|NCT01287039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6138499|NCT01287039|Respiratory System Agents|respiratory system agents|mesh-ancestor
6138500|NCT01287078|Cyclosporine|cyclosporine|mesh-list
6138501|NCT01287078|Cyclosporins|cyclosporins|mesh-list
6138502|NCT01287078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6138503|NCT01287078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469388|NCT00491127|Antiviral Agents|antiviral agents|mesh-ancestor
6469389|NCT00491127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6469390|NCT00491127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6469391|NCT00491127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6469392|NCT00491127|Immunologic Factors|immunologic factors|mesh-ancestor
6469393|NCT00491166|Bromfenac|bromfenac|mesh-list
6469394|NCT00491166|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6469395|NCT00491166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6469396|NCT00491166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6469397|NCT00491166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6469398|NCT00491166|Analgesics|analgesics|mesh-ancestor
6469399|NCT00491166|Sensory System Agents|sensory system agents|mesh-ancestor
6469400|NCT00491166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6469401|NCT00491166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469402|NCT00491166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6469403|NCT00491166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6469404|NCT00491192|Diclofenac|diclofenac|mesh-list
6469405|NCT00491192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6469406|NCT00491192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6469407|NCT00491192|Analgesics|analgesics|mesh-ancestor
6666588|NCT01523314|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6138504|NCT01287078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6138505|NCT01287078|Immunologic Factors|immunologic factors|mesh-ancestor
6138506|NCT01287078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138507|NCT01287078|Antifungal Agents|antifungal agents|mesh-ancestor
6138508|NCT01287078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5542734|NCT04157010|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5542735|NCT04157010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5542736|NCT04157010|Immunologic Factors|immunologic factors|mesh-ancestor
5542737|NCT04157010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5542738|NCT04157010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5542739|NCT04157036|Ibuprofen|ibuprofen|mesh-list
5542740|NCT04157036|Methylprednisolone|methylprednisolone|mesh-list
6138509|NCT01287078|Dermatologic Agents|dermatologic agents|mesh-ancestor
6138510|NCT01287078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6138511|NCT01287078|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6138512|NCT01287117|Omalizumab|omalizumab|mesh-list
6138513|NCT01287117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6138514|NCT01287117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6138515|NCT01287117|Respiratory System Agents|respiratory system agents|mesh-ancestor
6138516|NCT01287195|Omeprazole|omeprazole|mesh-list
6138517|NCT01287195|Muromonab-CD3|muromonab-cd3|mesh-list
5542741|NCT04157036|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5542742|NCT04157036|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5542743|NCT04157036|Prednisolone|prednisolone|mesh-list
6138518|NCT01287195|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6138519|NCT01287195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6138520|NCT01287195|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6138521|NCT01287195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6138522|NCT01287195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138523|NCT01287195|Immunologic Factors|immunologic factors|mesh-ancestor
6138524|NCT01287195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138525|NCT01287195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6138526|NCT01287221|Riboflavin|riboflavin|mesh-list
6138527|NCT01287221|Rifampin|rifampin|mesh-list
6138528|NCT01287221|Vitamins|vitamins|mesh-ancestor
6138529|NCT01287221|Micronutrients|micronutrients|mesh-ancestor
6138530|NCT01287221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542744|NCT04157036|Prednisolone acetate|prednisolone acetate|mesh-list
5542745|NCT04157036|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5542746|NCT04157036|Prednisolone phosphate|prednisolone phosphate|mesh-list
5542747|NCT04157036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6138531|NCT01287221|Vitamin B Complex|vitamin b complex|mesh-ancestor
6138532|NCT01287221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6138533|NCT01287221|Antitubercular Agents|antitubercular agents|mesh-ancestor
6138534|NCT01287221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6138535|NCT01287221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6138536|NCT01287221|Leprostatic Agents|leprostatic agents|mesh-ancestor
5542748|NCT04157036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5542749|NCT04157036|Analgesics|analgesics|mesh-ancestor
5542750|NCT04157036|Sensory System Agents|sensory system agents|mesh-ancestor
5542751|NCT04157036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5542752|NCT04157036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138537|NCT01287221|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6138538|NCT01287221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6469408|NCT00491192|Sensory System Agents|sensory system agents|mesh-ancestor
5542753|NCT04157036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6205297|NCT02083861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6666589|NCT01523327|Uric Acid|uric acid|mesh-list
6138539|NCT01287221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138540|NCT01287221|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6138541|NCT01287221|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6138542|NCT01287221|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6138543|NCT01287221|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6138544|NCT01287221|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5542754|NCT04157036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5542755|NCT04157036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5542756|NCT04157036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5542757|NCT04157036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542758|NCT04157036|Antiemetics|antiemetics|mesh-ancestor
5542759|NCT04157036|Autonomic Agents|autonomic agents|mesh-ancestor
5542760|NCT04157036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5542761|NCT04157036|Glucocorticoids|glucocorticoids|mesh-ancestor
5542762|NCT04157036|Hormones|hormones|mesh-ancestor
5542763|NCT04157036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5542764|NCT04157036|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5542765|NCT04157036|Protective Agents|protective agents|mesh-ancestor
5542766|NCT04157036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5542767|NCT04157036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5542768|NCT04156750|Metformin|metformin|mesh-list
5542769|NCT04156750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5542770|NCT04156750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542771|NCT04156555|Amoxicillin|amoxicillin|mesh-list
5542772|NCT04156555|Clavulanic Acid|clavulanic acid|mesh-list
5542773|NCT04156555|Clavulanic Acids|clavulanic acids|mesh-list
5542774|NCT04156555|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5542775|NCT04156555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5542776|NCT04156555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5542777|NCT04156555|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5542778|NCT04156555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5542779|NCT04156555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542780|NCT04156815|Isotretinoin|isotretinoin|mesh-list
5542781|NCT04156815|Dermatologic Agents|dermatologic agents|mesh-ancestor
5542782|NCT04156425|Golimumab|golimumab|mesh-list
5542783|NCT04156425|Dexetimide|dexetimide|mesh-list
5542784|NCT04156425|Citalopram|citalopram|mesh-list
5542785|NCT04156425|Calcium|calcium|mesh-list
5542786|NCT04156425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5542787|NCT04156425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542788|NCT04156425|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5542789|NCT04156425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5542790|NCT04156425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5542791|NCT04156425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542792|NCT04156425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5542793|NCT04156425|Serotonin Agents|serotonin agents|mesh-ancestor
6138545|NCT01287221|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6138546|NCT01287221|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6138547|NCT01287221|Dermatologic Agents|dermatologic agents|mesh-ancestor
6205298|NCT02083861|Adrenergic Agents|adrenergic agents|mesh-ancestor
6205299|NCT02083861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6205300|NCT02083861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205301|NCT02083861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205302|NCT02083861|Sympathomimetics|sympathomimetics|mesh-ancestor
6205303|NCT02083861|Autonomic Agents|autonomic agents|mesh-ancestor
6205304|NCT02083861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6205305|NCT02083861|Nasal Decongestants|nasal decongestants|mesh-ancestor
6205306|NCT02083861|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6205307|NCT02083861|Respiratory System Agents|respiratory system agents|mesh-ancestor
6205308|NCT02083926|Ketamine|ketamine|mesh-list
6205309|NCT02083926|Analgesics|analgesics|mesh-ancestor
6205310|NCT02083926|Sensory System Agents|sensory system agents|mesh-ancestor
6205311|NCT02083926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5542794|NCT04156425|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5542795|NCT04156425|Antidepressive Agents|antidepressive agents|mesh-ancestor
5542796|NCT04156425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5542797|NCT04156425|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5542798|NCT04156425|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5542799|NCT04156425|Parasympatholytics|parasympatholytics|mesh-ancestor
5542800|NCT04156425|Autonomic Agents|autonomic agents|mesh-ancestor
5542801|NCT04156425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5542802|NCT04156425|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5542803|NCT04156425|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5542804|NCT04156425|Cholinergic Agents|cholinergic agents|mesh-ancestor
6138548|NCT01287364|Mometasone Furoate|mometasone furoate|mesh-list
5542805|NCT04156425|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
5542806|NCT04156425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5542807|NCT04156425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6138549|NCT01287364|Ciclesonide|ciclesonide|mesh-list
6138550|NCT01287364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6138551|NCT01287364|Dermatologic Agents|dermatologic agents|mesh-ancestor
6138552|NCT01287364|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6469409|NCT00491192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6469410|NCT00491192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469411|NCT00491192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6469412|NCT00491192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6469413|NCT00491192|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6469414|NCT00491192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6138553|NCT01287364|Glucocorticoids|glucocorticoids|mesh-ancestor
6138554|NCT01287364|Hormones|hormones|mesh-ancestor
6138555|NCT01287364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6138556|NCT01287364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138557|NCT01287377|Nicotine|nicotine|mesh-list
6138558|NCT01287377|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6138559|NCT01287377|Autonomic Agents|autonomic agents|mesh-ancestor
6138560|NCT01287377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6138561|NCT01287377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138562|NCT01287377|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6138563|NCT01287377|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6138564|NCT01287377|Cholinergic Agents|cholinergic agents|mesh-ancestor
6138565|NCT01287377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6138566|NCT01287377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138567|NCT01287520|Carboplatin|carboplatin|mesh-list
6138568|NCT01287520|Pemetrexed|pemetrexed|mesh-list
6138569|NCT01287520|Ranitidine|ranitidine|mesh-list
6138570|NCT01287520|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
6138571|NCT01287520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6138572|NCT01287520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6469415|NCT00491192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469416|NCT00491348|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6469417|NCT00491348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6469418|NCT00491348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6469419|NCT00491348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6469420|NCT00491348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469421|NCT00491348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6469422|NCT00491348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469423|NCT00491348|Analgesics|analgesics|mesh-ancestor
6469424|NCT00491348|Sensory System Agents|sensory system agents|mesh-ancestor
6469425|NCT00491348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6469426|NCT00491348|Antidepressive Agents|antidepressive agents|mesh-ancestor
6469427|NCT00491348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6469428|NCT00491348|Dopamine Agents|dopamine agents|mesh-ancestor
6469429|NCT00491413|Epoetin Alfa|epoetin alfa|mesh-list
6469430|NCT00491413|Hematinics|hematinics|mesh-ancestor
6469431|NCT00491426|Metronidazole|metronidazole|mesh-list
6138573|NCT01287520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138574|NCT01287520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6138575|NCT01287520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5542808|NCT04156425|Immunologic Factors|immunologic factors|mesh-ancestor
5542809|NCT04156451|Furosemide|furosemide|mesh-list
5542810|NCT04156451|Diuretics|diuretics|mesh-ancestor
5542811|NCT04156451|Natriuretic Agents|natriuretic agents|mesh-ancestor
6666590|NCT01523327|Antioxidants|antioxidants|mesh-ancestor
5542812|NCT04156451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138576|NCT01287520|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5542813|NCT04156451|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5542814|NCT04156451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6138577|NCT01287520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6138578|NCT01287520|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6469432|NCT00491426|Tazobactam|tazobactam|mesh-list
6469433|NCT00491426|Piperacillin|piperacillin|mesh-list
5542815|NCT04156451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542816|NCT04156464|Lorazepam|lorazepam|mesh-list
5542817|NCT04156464|Phenobarbital|phenobarbital|mesh-list
5542818|NCT04156464|Anticonvulsants|anticonvulsants|mesh-ancestor
5542819|NCT04156464|Antiemetics|antiemetics|mesh-ancestor
5542820|NCT04156464|Autonomic Agents|autonomic agents|mesh-ancestor
5542821|NCT04156464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6138579|NCT01287520|Histamine Antagonists|histamine antagonists|mesh-ancestor
6469434|NCT00491426|Amphotericin B|amphotericin b|mesh-list
6469435|NCT00491426|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
5542822|NCT04156464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542823|NCT04156464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5542824|NCT04156464|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5542825|NCT04156464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5542826|NCT04156464|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6469436|NCT00491426|Acyclovir|acyclovir|mesh-list
6469437|NCT00491426|Ampicillin|ampicillin|mesh-list
6469438|NCT00491426|Caspofungin|caspofungin|mesh-list
6469439|NCT00491426|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
6469440|NCT00491426|Anidulafungin|anidulafungin|mesh-list
6469441|NCT00491426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6469442|NCT00491426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6469443|NCT00491426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6469444|NCT00491426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6469445|NCT00491426|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6469446|NCT00491426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6469447|NCT00491426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469448|NCT00491426|Amebicides|amebicides|mesh-ancestor
6469449|NCT00491426|Antifungal Agents|antifungal agents|mesh-ancestor
6469450|NCT00491426|Antiviral Agents|antiviral agents|mesh-ancestor
6488533|NCT00584662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6488534|NCT00584662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6488535|NCT00584662|Adrenergic Agents|adrenergic agents|mesh-ancestor
6488536|NCT00584662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6488537|NCT00584662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488538|NCT00584662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488539|NCT00584662|Sympathomimetics|sympathomimetics|mesh-ancestor
6488540|NCT00584662|Autonomic Agents|autonomic agents|mesh-ancestor
6488541|NCT00584662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6488542|NCT00584662|Nasal Decongestants|nasal decongestants|mesh-ancestor
6488543|NCT00584662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6488544|NCT00584662|Respiratory System Agents|respiratory system agents|mesh-ancestor
6666591|NCT01523327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666592|NCT01523327|Protective Agents|protective agents|mesh-ancestor
6666593|NCT01523327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488545|NCT00584662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6488546|NCT00584662|Mydriatics|mydriatics|mesh-ancestor
6488547|NCT00584662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6488548|NCT00584662|Protective Agents|protective agents|mesh-ancestor
6488549|NCT00584688|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6488550|NCT00584688|Antidepressive Agents|antidepressive agents|mesh-ancestor
6488551|NCT00584688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6488552|NCT00584688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6488553|NCT00584688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6488554|NCT00584688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6488555|NCT00584688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488556|NCT00584779|Gabapentin|gabapentin|mesh-list
6488557|NCT00584779|Analgesics|analgesics|mesh-ancestor
5725549|NCT03179839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725550|NCT03179839|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5725551|NCT03179839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5725552|NCT03179839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5725553|NCT03179839|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5725554|NCT03179839|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5725555|NCT03179839|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5725556|NCT03179839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5542827|NCT04156464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5542828|NCT04156464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5542829|NCT04156464|GABA Modulators|gaba modulators|mesh-ancestor
5542830|NCT04156464|GABA Agents|gaba agents|mesh-ancestor
5542831|NCT04156464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5542832|NCT04156464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542833|NCT04156464|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5542834|NCT04156464|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5542835|NCT04156464|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5542836|NCT04156464|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5542837|NCT04156464|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5542838|NCT04156204|Tacrolimus|tacrolimus|mesh-list
5542839|NCT04156204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5542840|NCT04156204|Immunologic Factors|immunologic factors|mesh-ancestor
5542841|NCT04156204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488558|NCT00584779|Sensory System Agents|sensory system agents|mesh-ancestor
6666594|NCT01523379|Parecoxib|parecoxib|mesh-list
5725557|NCT03179839|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5725558|NCT03179904|Paclitaxel|paclitaxel|mesh-list
5725559|NCT03179904|Trastuzumab|trastuzumab|mesh-list
5725560|NCT03179904|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5725561|NCT03179904|Letrozole|letrozole|mesh-list
5725562|NCT03179904|Fulvestrant|fulvestrant|mesh-list
5725563|NCT03179904|Anastrozole|anastrozole|mesh-list
5725564|NCT03179904|Exemestane|exemestane|mesh-list
5725565|NCT03179904|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
6469451|NCT00491478|Sertraline|sertraline|mesh-list
6469452|NCT00491478|Antidepressive Agents|antidepressive agents|mesh-ancestor
6469453|NCT00491478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6469454|NCT00491478|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6138580|NCT01287520|Histamine Agents|histamine agents|mesh-ancestor
6138581|NCT01287520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6138582|NCT01287520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138583|NCT01287754|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6138584|NCT01287754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6138585|NCT01287754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6138586|NCT01287754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6138587|NCT01287754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138588|NCT01287832|Vancomycin|vancomycin|mesh-list
6138589|NCT01287832|Daptomycin|daptomycin|mesh-list
6138590|NCT01287832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6138591|NCT01287832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6138592|NCT01288079|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6138593|NCT01288079|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6138594|NCT01288079|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6138595|NCT01288079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6138596|NCT01288079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138597|NCT01288079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6138598|NCT01288079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138599|NCT01288079|Analgesics|analgesics|mesh-ancestor
6138600|NCT01288079|Sensory System Agents|sensory system agents|mesh-ancestor
6138601|NCT01288079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6138602|NCT01288079|Antidepressive Agents|antidepressive agents|mesh-ancestor
6138603|NCT01288079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6138604|NCT01288079|Dopamine Agents|dopamine agents|mesh-ancestor
6138605|NCT01288209|Ribavirin|ribavirin|mesh-list
6138606|NCT01288209|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6138607|NCT01288209|Simeprevir|simeprevir|mesh-list
6138608|NCT01288209|Antimetabolites|antimetabolites|mesh-ancestor
6138609|NCT01288209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138610|NCT01288209|Antiviral Agents|antiviral agents|mesh-ancestor
5542842|NCT04156204|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5542843|NCT04156204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5542844|NCT04156204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542845|NCT04156347|Topotecan|topotecan|mesh-list
5542846|NCT04156347|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5542847|NCT04156347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5542848|NCT04156347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5542849|NCT04156347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542850|NCT04156347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5542851|NCT04156035|Lamotrigine|lamotrigine|mesh-list
5542852|NCT04156035|Ketamine|ketamine|mesh-list
5542853|NCT04156035|Analgesics|analgesics|mesh-ancestor
5542854|NCT04156035|Sensory System Agents|sensory system agents|mesh-ancestor
5542855|NCT04156035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5542856|NCT04156035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542857|NCT04156035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5542858|NCT04156035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5542859|NCT04156035|Anesthetics, General|anesthetics, general|mesh-ancestor
5542860|NCT04156035|Anesthetics|anesthetics|mesh-ancestor
5542861|NCT04156035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6138611|NCT01288209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6138612|NCT01288209|Protease Inhibitors|protease inhibitors|mesh-ancestor
5542862|NCT04156035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5542863|NCT04156035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5542864|NCT04156035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5542865|NCT04156035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542866|NCT04156035|Anticonvulsants|anticonvulsants|mesh-ancestor
5542867|NCT04156035|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5542868|NCT04156035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5725566|NCT03179904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5725567|NCT03179904|Antibodies|antibodies|mesh-list
6138613|NCT01288209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6138614|NCT01288443|Atorvastatin|atorvastatin|mesh-list
6138615|NCT01288443|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6138616|NCT01288443|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6138617|NCT01288443|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6138618|NCT01288443|Antimetabolites|antimetabolites|mesh-ancestor
6138619|NCT01288443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469455|NCT00491478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6469456|NCT00491478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6469457|NCT00491478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542869|NCT04156035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6469458|NCT00491478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6469459|NCT00491478|Serotonin Agents|serotonin agents|mesh-ancestor
6469460|NCT00491478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469461|NCT00491517|Sirolimus|sirolimus|mesh-list
6469462|NCT00491517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6469463|NCT00491517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6469464|NCT00491517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6469465|NCT00491517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6469466|NCT00491517|Antifungal Agents|antifungal agents|mesh-ancestor
6469467|NCT00491517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6469468|NCT00491517|Immunologic Factors|immunologic factors|mesh-ancestor
6469469|NCT00491517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469470|NCT00491582|Hormones|hormones|mesh-list
6469471|NCT00491582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6469472|NCT00491582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469473|NCT00491634|Treosulfan|treosulfan|mesh-list
6469474|NCT00491634|Busulfan|busulfan|mesh-list
6469475|NCT00491634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6469476|NCT00491634|Alkylating Agents|alkylating agents|mesh-ancestor
6469477|NCT00491634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469478|NCT00491634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6469479|NCT00491634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6469480|NCT00491634|Immunologic Factors|immunologic factors|mesh-ancestor
6138620|NCT01288443|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6138621|NCT01288443|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6138622|NCT01288443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6138623|NCT01288443|Immunologic Factors|immunologic factors|mesh-ancestor
6138624|NCT01288443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138625|NCT01288469|Atorvastatin|atorvastatin|mesh-list
6138626|NCT01288469|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6138627|NCT01288469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6138628|NCT01288469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6138629|NCT01288469|Antimetabolites|antimetabolites|mesh-ancestor
6469481|NCT00491634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469482|NCT00491634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6469483|NCT00491712|Triamcinolone|triamcinolone|mesh-list
6469484|NCT00491712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6469485|NCT00491712|Glucocorticoids|glucocorticoids|mesh-ancestor
6469486|NCT00491712|Hormones|hormones|mesh-ancestor
6469487|NCT00491712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6469488|NCT00491712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469489|NCT00491725|Metformin|metformin|mesh-list
6469490|NCT00491725|Repaglinide|repaglinide|mesh-list
6469491|NCT00491725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6469492|NCT00491725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469493|NCT00491790|Montelukast|montelukast|mesh-list
6469494|NCT00491790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6469495|NCT00491790|Respiratory System Agents|respiratory system agents|mesh-ancestor
6469496|NCT00491790|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5542870|NCT04156035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5542871|NCT04156035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5542872|NCT04156035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5542873|NCT04156035|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5542874|NCT04156074|Vitamin D|vitamin d|mesh-list
6469497|NCT00491790|Hormone Antagonists|hormone antagonists|mesh-ancestor
6469498|NCT00491790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5542875|NCT04156074|Ergocalciferols|ergocalciferols|mesh-list
5542876|NCT04156074|Vitamins|vitamins|mesh-list
5542877|NCT04156074|Micronutrients|micronutrients|mesh-ancestor
5542878|NCT04156074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542879|NCT04156074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5542880|NCT04156074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5542881|NCT04156152|Listerine|listerine|mesh-list
5542882|NCT04156152|Fluorides|fluorides|mesh-list
5542883|NCT04156152|Sodium Fluoride|sodium fluoride|mesh-list
5542884|NCT04156152|Cariostatic Agents|cariostatic agents|mesh-ancestor
5542885|NCT04156152|Protective Agents|protective agents|mesh-ancestor
5542886|NCT04156152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469499|NCT00491790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469500|NCT00491790|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6469501|NCT00491790|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6469502|NCT00491790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469503|NCT00491803|Sildenafil Citrate|sildenafil citrate|mesh-list
5542887|NCT04156152|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5542888|NCT04156152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5542889|NCT04156087|Gemcitabine|gemcitabine|mesh-list
5542890|NCT04156087|Durvalumab|durvalumab|mesh-list
5542891|NCT04156087|Tremelimumab|tremelimumab|mesh-list
5542892|NCT04156087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5542893|NCT04156087|Antimetabolites|antimetabolites|mesh-ancestor
6469504|NCT00491803|Vasodilator Agents|vasodilator agents|mesh-ancestor
6469505|NCT00491803|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6469506|NCT00491803|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6469507|NCT00491803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6469508|NCT00491803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542894|NCT04156087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542895|NCT04156087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5542896|NCT04156087|Antiviral Agents|antiviral agents|mesh-ancestor
5542897|NCT04156087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5542898|NCT04156087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5542899|NCT04156087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5542900|NCT04156087|Immunologic Factors|immunologic factors|mesh-ancestor
5542901|NCT04156087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542902|NCT04156087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5542903|NCT04155814|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6469509|NCT00491803|Urological Agents|urological agents|mesh-ancestor
6469510|NCT00491816|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6469511|NCT00491816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6469512|NCT00491816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6469513|NCT00491816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6469514|NCT00491816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469515|NCT00491855|Paclitaxel|paclitaxel|mesh-list
6469516|NCT00491855|Bevacizumab|bevacizumab|mesh-list
6469517|NCT00491855|Oxaliplatin|oxaliplatin|mesh-list
6469518|NCT00491855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6469519|NCT00491855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6469520|NCT00491855|Tubulin Modulators|tubulin modulators|mesh-ancestor
6469521|NCT00491855|Antimitotic Agents|antimitotic agents|mesh-ancestor
6469522|NCT00491855|Mitosis Modulators|mitosis modulators|mesh-ancestor
6469523|NCT00491855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469524|NCT00491855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6469525|NCT00491855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6469526|NCT00491855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6469527|NCT00491855|Growth Substances|growth substances|mesh-ancestor
6469528|NCT00491855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469529|NCT00491855|Growth Inhibitors|growth inhibitors|mesh-ancestor
6469530|NCT00491868|Epoetin Alfa|epoetin alfa|mesh-list
6469531|NCT00491868|Hematinics|hematinics|mesh-ancestor
6469532|NCT00491907|Folic Acid|folic acid|mesh-list
6469533|NCT00491907|Hematinics|hematinics|mesh-ancestor
6469534|NCT00491907|Vitamin B Complex|vitamin b complex|mesh-ancestor
6469535|NCT00491907|Vitamins|vitamins|mesh-ancestor
6469536|NCT00491907|Micronutrients|micronutrients|mesh-ancestor
6469537|NCT00491907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469538|NCT00491920|Vitamin D|vitamin d|mesh-list
6469539|NCT00491920|Cholecalciferol|cholecalciferol|mesh-list
6469540|NCT00491920|Vitamins|vitamins|mesh-ancestor
6469541|NCT00491920|Micronutrients|micronutrients|mesh-ancestor
5542904|NCT04155814|Hematinics|hematinics|mesh-ancestor
5542905|NCT04155879|Colchicine|colchicine|mesh-list
5542906|NCT04155879|Gout Suppressants|gout suppressants|mesh-ancestor
6469542|NCT00491920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469543|NCT00491920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6469544|NCT00491920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6469545|NCT00491946|Dactinomycin|dactinomycin|mesh-list
6469546|NCT00491946|Vincristine|vincristine|mesh-list
6469547|NCT00491946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6469548|NCT00491946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6469549|NCT00491946|Tubulin Modulators|tubulin modulators|mesh-ancestor
6469550|NCT00491946|Antimitotic Agents|antimitotic agents|mesh-ancestor
6469551|NCT00491946|Mitosis Modulators|mitosis modulators|mesh-ancestor
6469552|NCT00491946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469553|NCT00491946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6469554|NCT00491946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6469555|NCT00491946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6469556|NCT00491946|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6469557|NCT00491946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6469558|NCT00491946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6138630|NCT01288469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138631|NCT01288469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6138632|NCT01288469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6138633|NCT01288469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6138634|NCT01288469|Immunologic Factors|immunologic factors|mesh-ancestor
6469559|NCT00491985|Vaccines|vaccines|mesh-list
6469560|NCT00491985|Immunologic Factors|immunologic factors|mesh-ancestor
6469561|NCT00491985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469562|NCT00491998|Entacapone|entacapone|mesh-list
6469563|NCT00491998|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6469564|NCT00491998|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6469565|NCT00491998|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6469566|NCT00491998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6469567|NCT00491998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469568|NCT00492037|Conivaptan|conivaptan|mesh-list
6469569|NCT00492037|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6469570|NCT00492037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469571|NCT00492037|Natriuretic Agents|natriuretic agents|mesh-ancestor
6469572|NCT00492037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469573|NCT00492050|Valacyclovir|valacyclovir|mesh-list
5542907|NCT04155879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5542908|NCT04155879|Tubulin Modulators|tubulin modulators|mesh-ancestor
6469574|NCT00492050|Rituximab|rituximab|mesh-list
6469575|NCT00492050|Bortezomib|bortezomib|mesh-list
6469576|NCT00492050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6469577|NCT00492050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6469578|NCT00492050|Immunologic Factors|immunologic factors|mesh-ancestor
6469579|NCT00492050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469580|NCT00492050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6469581|NCT00492050|Antiviral Agents|antiviral agents|mesh-ancestor
6469582|NCT00492050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6469583|NCT00492102|Montelukast|montelukast|mesh-list
6469584|NCT00492102|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6469585|NCT00492102|Respiratory System Agents|respiratory system agents|mesh-ancestor
6469586|NCT00492102|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6469587|NCT00492102|Hormone Antagonists|hormone antagonists|mesh-ancestor
6469588|NCT00492102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6469589|NCT00492102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469590|NCT00492102|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5542909|NCT04155879|Antimitotic Agents|antimitotic agents|mesh-ancestor
5542910|NCT04155879|Mitosis Modulators|mitosis modulators|mesh-ancestor
5542911|NCT04155879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138635|NCT01288469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138636|NCT01288521|Ketoconazole|ketoconazole|mesh-list
5542912|NCT04155879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5542913|NCT04155983|Ropivacaine|ropivacaine|mesh-list
5542914|NCT04155983|Anesthetics, Local|anesthetics, local|mesh-ancestor
5542915|NCT04155983|Anesthetics|anesthetics|mesh-ancestor
5542916|NCT04155983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5542917|NCT04155983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138637|NCT01288521|Tacrolimus|tacrolimus|mesh-list
6138638|NCT01288521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6138639|NCT01288521|Immunologic Factors|immunologic factors|mesh-ancestor
6138640|NCT01288521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138641|NCT01288521|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6138642|NCT01288521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5542918|NCT04155983|Sensory System Agents|sensory system agents|mesh-ancestor
5542919|NCT04155983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5542920|NCT04155632|Acetylcysteine|acetylcysteine|mesh-list
5542921|NCT04155632|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5542922|NCT04155632|Antiviral Agents|antiviral agents|mesh-ancestor
6138643|NCT01288521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469591|NCT00492102|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6469592|NCT00492102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469593|NCT00492128|Losartan|losartan|mesh-list
6469594|NCT00492128|Amlodipine|amlodipine|mesh-list
6469595|NCT00492128|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6469596|NCT00492128|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6469597|NCT00492128|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6469598|NCT00492128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6469599|NCT00492128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469600|NCT00492128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6469601|NCT00492128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469602|NCT00492128|Vasodilator Agents|vasodilator agents|mesh-ancestor
6469603|NCT00492128|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6469604|NCT00492128|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6469605|NCT00492128|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6469606|NCT00492128|Diuretics|diuretics|mesh-ancestor
6469607|NCT00492128|Natriuretic Agents|natriuretic agents|mesh-ancestor
6469608|NCT00492128|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6469609|NCT00492141|Temozolomide|temozolomide|mesh-list
6469610|NCT00492141|Camptothecin|camptothecin|mesh-list
6469611|NCT00492141|Rubitecan|rubitecan|mesh-list
6469612|NCT00492141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6469613|NCT00492141|Alkylating Agents|alkylating agents|mesh-ancestor
6469614|NCT00492141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469615|NCT00492141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5542923|NCT04155632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5542924|NCT04155632|Expectorants|expectorants|mesh-ancestor
5542925|NCT04155632|Respiratory System Agents|respiratory system agents|mesh-ancestor
5542926|NCT04155632|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5542927|NCT04155632|Antioxidants|antioxidants|mesh-ancestor
5542928|NCT04155632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542929|NCT04155632|Protective Agents|protective agents|mesh-ancestor
5542930|NCT04155632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542931|NCT04155632|Antidotes|antidotes|mesh-ancestor
5542932|NCT04155658|Fluorides|fluorides|mesh-list
5542933|NCT04155658|Cariostatic Agents|cariostatic agents|mesh-ancestor
5542934|NCT04155658|Protective Agents|protective agents|mesh-ancestor
5542935|NCT04155658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542936|NCT04155918|Allopurinol|allopurinol|mesh-list
5542937|NCT04155918|Febuxostat|febuxostat|mesh-list
5542938|NCT04155918|Antimetabolites|antimetabolites|mesh-ancestor
5542939|NCT04155918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469616|NCT00492141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6469617|NCT00492141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6469618|NCT00492141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6469619|NCT00492141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6469620|NCT00492167|Antibodies|antibodies|mesh-list
6469621|NCT00492167|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6469622|NCT00492167|Immunologic Factors|immunologic factors|mesh-ancestor
6469623|NCT00492167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469624|NCT00492219|Cimetidine|cimetidine|mesh-list
6469625|NCT00492219|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6469626|NCT00492219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6469627|NCT00492219|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6469628|NCT00492219|Histamine Antagonists|histamine antagonists|mesh-ancestor
6469629|NCT00492219|Histamine Agents|histamine agents|mesh-ancestor
6469630|NCT00492219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6469631|NCT00492219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469632|NCT00492219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469633|NCT00492219|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6469634|NCT00492219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6469635|NCT00492219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6469636|NCT00492245|Mitomycins|mitomycins|mesh-list
6469637|NCT00492245|Mitomycin|mitomycin|mesh-list
6469638|NCT00492245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6469639|NCT00492245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6469640|NCT00492245|Alkylating Agents|alkylating agents|mesh-ancestor
5542940|NCT04155918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5542941|NCT04155918|Gout Suppressants|gout suppressants|mesh-ancestor
5542942|NCT04155918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5542943|NCT04155918|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5542944|NCT04155918|Antioxidants|antioxidants|mesh-ancestor
5542945|NCT04155918|Protective Agents|protective agents|mesh-ancestor
5542946|NCT04155918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542947|NCT04155840|Rituximab|rituximab|mesh-list
5542948|NCT04155840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5542949|NCT04155840|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5542950|NCT04155840|Antibodies|antibodies|mesh-list
5542951|NCT04155840|Immunoglobulins|immunoglobulins|mesh-list
5542952|NCT04155840|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5542953|NCT04155840|Immunologic Factors|immunologic factors|mesh-ancestor
5542954|NCT04155840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542955|NCT04155840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5542956|NCT04155840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6469641|NCT00492245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469642|NCT00492245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6469643|NCT00492245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6469644|NCT00492258|Sorafenib|sorafenib|mesh-list
6469645|NCT00492258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6469646|NCT00492258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6469647|NCT00492258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6469648|NCT00492258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469649|NCT00492388|Ketamine|ketamine|mesh-list
6469650|NCT00492388|Analgesics|analgesics|mesh-ancestor
6469651|NCT00492388|Sensory System Agents|sensory system agents|mesh-ancestor
6469652|NCT00492388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6469653|NCT00492388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469654|NCT00492388|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6469655|NCT00492388|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6469656|NCT00492388|Anesthetics, General|anesthetics, general|mesh-ancestor
6469657|NCT00492388|Anesthetics|anesthetics|mesh-ancestor
6469658|NCT00492388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6469659|NCT00492388|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6469660|NCT00492388|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6469661|NCT00492388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6469662|NCT00492388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469663|NCT00492414|Paroxetine|paroxetine|mesh-list
6469664|NCT00492414|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6469665|NCT00492414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6138644|NCT01288521|Antifungal Agents|antifungal agents|mesh-ancestor
6138645|NCT01288521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6138646|NCT01288521|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6138647|NCT01288521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6138648|NCT01288521|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6138649|NCT01288521|Hormone Antagonists|hormone antagonists|mesh-ancestor
6138650|NCT01288521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6138651|NCT01288521|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6469666|NCT00492414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6469667|NCT00492414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469668|NCT00492414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6469669|NCT00492414|Serotonin Agents|serotonin agents|mesh-ancestor
6469670|NCT00492414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138652|NCT01288781|Acetazolamide|acetazolamide|mesh-list
6138653|NCT01288781|Anticonvulsants|anticonvulsants|mesh-ancestor
6138654|NCT01288781|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6138655|NCT01288781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6138656|NCT01288781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138657|NCT01288781|Diuretics|diuretics|mesh-ancestor
6138658|NCT01288781|Natriuretic Agents|natriuretic agents|mesh-ancestor
6138659|NCT01288781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138660|NCT01288807|Milnacipran|milnacipran|mesh-list
6138661|NCT01288807|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5542957|NCT04155840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5542958|NCT04155840|Alkylating Agents|alkylating agents|mesh-ancestor
5542959|NCT04155840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542960|NCT04155697|Hand Sanitizers|hand sanitizers|mesh-list
5542961|NCT04155697|Ethanol|ethanol|mesh-list
5542962|NCT04155697|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5542963|NCT04155697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5542964|NCT04155697|Disinfectants|disinfectants|mesh-ancestor
5542965|NCT04155697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5542966|NCT04155697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602381|NCT04613453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5602382|NCT04613453|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6138662|NCT01288807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6138663|NCT01288807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6138664|NCT01288807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138665|NCT01288807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6138666|NCT01288807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138667|NCT01288807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6138668|NCT01288807|Analgesics|analgesics|mesh-ancestor
6138669|NCT01288807|Sensory System Agents|sensory system agents|mesh-ancestor
6138670|NCT01288807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6469671|NCT00492414|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6469672|NCT00492414|Antidepressive Agents|antidepressive agents|mesh-ancestor
6469673|NCT00492414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6469674|NCT00492414|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6469675|NCT00492414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6469676|NCT00492414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6469677|NCT00492427|Epoetin Alfa|epoetin alfa|mesh-list
6469678|NCT00492427|Hematinics|hematinics|mesh-ancestor
6469679|NCT00492466|Interferons|interferons|mesh-list
6469680|NCT00492466|Interferon-beta|interferon-beta|mesh-list
6469681|NCT00492466|Interferon beta-1a|interferon beta-1a|mesh-list
6469682|NCT00492466|Methylprednisolone|methylprednisolone|mesh-list
6469683|NCT00492466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6469684|NCT00492466|Antiviral Agents|antiviral agents|mesh-ancestor
6469685|NCT00492466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6138671|NCT01288859|Curcumin|curcumin|mesh-list
6138672|NCT01288859|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6138673|NCT01288859|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6469686|NCT00492466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6469687|NCT00492466|Antiemetics|antiemetics|mesh-ancestor
6469688|NCT00492466|Autonomic Agents|autonomic agents|mesh-ancestor
6469689|NCT00492466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6469690|NCT00492466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469691|NCT00492466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6469692|NCT00492466|Glucocorticoids|glucocorticoids|mesh-ancestor
6469693|NCT00492466|Hormones|hormones|mesh-ancestor
6469694|NCT00492466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5602383|NCT04613453|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5602384|NCT04613453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5602385|NCT04613453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602386|NCT04613453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5602387|NCT04613453|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5602388|NCT04613453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5602389|NCT04613453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6469695|NCT00492466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6469696|NCT00492466|Protective Agents|protective agents|mesh-ancestor
6469697|NCT00492466|Immunologic Factors|immunologic factors|mesh-ancestor
6469698|NCT00492466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6469699|NCT00492479|Kinetin|kinetin|mesh-list
6469700|NCT00492479|Plant Growth Regulators|plant growth regulators|mesh-ancestor
6469701|NCT00492479|Growth Substances|growth substances|mesh-ancestor
6469702|NCT00492479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469703|NCT00492505|Tamoxifen|tamoxifen|mesh-list
6469704|NCT00492505|Sorafenib|sorafenib|mesh-list
6469705|NCT00492505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6469706|NCT00492505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469707|NCT00492505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6469708|NCT00492505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6469709|NCT00492505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6469710|NCT00492505|Hormone Antagonists|hormone antagonists|mesh-ancestor
6469711|NCT00492505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6469712|NCT00492505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469713|NCT00492505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6469714|NCT00492505|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6138674|NCT01288859|Analgesics|analgesics|mesh-ancestor
6138675|NCT01288859|Sensory System Agents|sensory system agents|mesh-ancestor
6138676|NCT01288859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6138677|NCT01288859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138678|NCT01288859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6138679|NCT01288859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6469715|NCT00492505|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6138680|NCT01288859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5542967|NCT04155411|Dasatinib|dasatinib|mesh-list
5542968|NCT04155411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5542969|NCT04155411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5542970|NCT04155411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6138681|NCT01288859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6138682|NCT01288859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138683|NCT01288911|Bicalutamide|bicalutamide|mesh-list
6138684|NCT01288911|Androgen Antagonists|androgen antagonists|mesh-ancestor
6138685|NCT01288911|Hormone Antagonists|hormone antagonists|mesh-ancestor
6138686|NCT01288911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6138687|NCT01288911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469716|NCT00492505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5542971|NCT04155411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542972|NCT04155424|Eculizumab|eculizumab|mesh-list
5542973|NCT04155424|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5542974|NCT04155424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5542975|NCT04155424|Immunologic Factors|immunologic factors|mesh-ancestor
5542976|NCT04155424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5542977|NCT04155554|Tenofovir|tenofovir|mesh-list
5542978|NCT04155554|Lamivudine|lamivudine|mesh-list
5542979|NCT04155554|Emtricitabine|emtricitabine|mesh-list
5542980|NCT04155554|Abacavir|abacavir|mesh-list
5542981|NCT04155554|Dolutegravir|dolutegravir|mesh-list
5542982|NCT04155554|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
5542983|NCT04155554|Triumeq|triumeq|mesh-list
5542984|NCT04155554|Antiviral Agents|antiviral agents|mesh-ancestor
6469717|NCT00492518|Acetylcysteine|acetylcysteine|mesh-list
6469718|NCT00492518|Theophylline|theophylline|mesh-list
6469719|NCT00492518|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6469720|NCT00492518|Antiviral Agents|antiviral agents|mesh-ancestor
6469721|NCT00492518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5542985|NCT04155554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6138688|NCT01288911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6138689|NCT01288937|Milnacipran|milnacipran|mesh-list
6138690|NCT01288937|Levomilnacipran|levomilnacipran|mesh-list
6138691|NCT01288937|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6138692|NCT01288937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6138693|NCT01288937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6138694|NCT01288937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138695|NCT01288937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6138696|NCT01288937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138697|NCT01288937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6138698|NCT01288937|Analgesics|analgesics|mesh-ancestor
6138699|NCT01288937|Sensory System Agents|sensory system agents|mesh-ancestor
6138700|NCT01288937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6138701|NCT01288937|Antidepressive Agents|antidepressive agents|mesh-ancestor
6138702|NCT01288937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6138703|NCT01289067|Satraplatin|satraplatin|mesh-list
6138704|NCT01289067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6138705|NCT01289119|Metformin|metformin|mesh-list
6138706|NCT01289119|Pioglitazone|pioglitazone|mesh-list
6138707|NCT01289119|Alogliptin|alogliptin|mesh-list
6138708|NCT01289119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6469722|NCT00492518|Expectorants|expectorants|mesh-ancestor
5542986|NCT04155554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5542987|NCT04155554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5542988|NCT04155554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5542989|NCT04155554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542990|NCT04155554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5542991|NCT04155554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5542992|NCT04155554|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5542993|NCT04155554|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5542994|NCT04155515|Ribavirin|ribavirin|mesh-list
5542995|NCT04155515|Yimitasvir|yimitasvir|mesh-list
5542996|NCT04155515|Antimetabolites|antimetabolites|mesh-ancestor
5542997|NCT04155515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5542998|NCT04155515|Antiviral Agents|antiviral agents|mesh-ancestor
5542999|NCT04155515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5543000|NCT04155229|Acetaminophen|acetaminophen|mesh-list
5543001|NCT04155229|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
5543002|NCT04155229|Oxycodone|oxycodone|mesh-list
5543003|NCT04155229|Hydrocodone|hydrocodone|mesh-list
5543004|NCT04155229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5543005|NCT04155229|Analgesics|analgesics|mesh-ancestor
5543006|NCT04155229|Sensory System Agents|sensory system agents|mesh-ancestor
5543007|NCT04155229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6469723|NCT00492518|Respiratory System Agents|respiratory system agents|mesh-ancestor
6469724|NCT00492518|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6469725|NCT00492518|Antioxidants|antioxidants|mesh-ancestor
6469726|NCT00492518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469727|NCT00492518|Protective Agents|protective agents|mesh-ancestor
6469728|NCT00492518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469729|NCT00492518|Antidotes|antidotes|mesh-ancestor
6469730|NCT00492518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6469731|NCT00492518|Autonomic Agents|autonomic agents|mesh-ancestor
6138709|NCT01289119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138710|NCT01289119|Incretins|incretins|mesh-ancestor
6138711|NCT01289119|Hormones|hormones|mesh-ancestor
6138712|NCT01289119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6138713|NCT01289119|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6138714|NCT01289119|Protease Inhibitors|protease inhibitors|mesh-ancestor
6138715|NCT01289119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6138716|NCT01289119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138717|NCT01289275|Nicotine|nicotine|mesh-list
5543008|NCT04155229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543009|NCT04155229|Antipyretics|antipyretics|mesh-ancestor
5543010|NCT04155229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5543011|NCT04155229|Narcotics|narcotics|mesh-ancestor
5543012|NCT04155229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5543013|NCT04155229|Antitussive Agents|antitussive agents|mesh-ancestor
5543014|NCT04155229|Respiratory System Agents|respiratory system agents|mesh-ancestor
5543015|NCT04155229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5543016|NCT04155229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5543017|NCT04155229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5543018|NCT04155190|Veratrum Alkaloids|veratrum alkaloids|mesh-list
5543019|NCT04155190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5543020|NCT04155476|Nitroglycerin|nitroglycerin|mesh-list
5543021|NCT04155476|Vasodilator Agents|vasodilator agents|mesh-ancestor
6138718|NCT01289275|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6138719|NCT01289275|Autonomic Agents|autonomic agents|mesh-ancestor
6138720|NCT01289275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6138721|NCT01289275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138722|NCT01289275|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6138723|NCT01289275|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6469732|NCT00492518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6469733|NCT00492518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6469734|NCT00492518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6138724|NCT01289275|Cholinergic Agents|cholinergic agents|mesh-ancestor
6138725|NCT01289275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6138726|NCT01289275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138727|NCT01289353|Carboplatin|carboplatin|mesh-list
6138728|NCT01289353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6138729|NCT01289457|Cytarabine|cytarabine|mesh-list
6138730|NCT01289457|Fludarabine|fludarabine|mesh-list
6138731|NCT01289457|Idarubicin|idarubicin|mesh-list
6138732|NCT01289457|Clofarabine|clofarabine|mesh-list
6138733|NCT01289457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6138734|NCT01289457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6138735|NCT01289457|Antimetabolites|antimetabolites|mesh-ancestor
6138736|NCT01289457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138737|NCT01289457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6138738|NCT01289457|Immunologic Factors|immunologic factors|mesh-ancestor
6138739|NCT01289457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138740|NCT01289457|Antiviral Agents|antiviral agents|mesh-ancestor
6138741|NCT01289457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6138742|NCT01289457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6138743|NCT01289457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6138744|NCT01289457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6138745|NCT01289457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6138746|NCT01289522|Cetuximab|cetuximab|mesh-list
6138747|NCT01289522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6469735|NCT00492518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6469736|NCT00492518|Vasodilator Agents|vasodilator agents|mesh-ancestor
6138748|NCT01289522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6138749|NCT01289639|Pioglitazone|pioglitazone|mesh-list
6138750|NCT01289639|Fenofibrate|fenofibrate|mesh-list
6138751|NCT01289639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6138752|NCT01289639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138753|NCT01289639|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6138754|NCT01289639|Antimetabolites|antimetabolites|mesh-ancestor
6138755|NCT01289639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543022|NCT04154852|Folic Acid|folic acid|mesh-list
6138756|NCT01289639|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6138757|NCT01289678|Interleukin-2|interleukin-2|mesh-list
6138758|NCT01289678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6138759|NCT01289678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6138760|NCT01289678|Analgesics|analgesics|mesh-ancestor
6138761|NCT01289678|Sensory System Agents|sensory system agents|mesh-ancestor
6138762|NCT01289678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6138763|NCT01289678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138764|NCT01289782|Ribavirin|ribavirin|mesh-list
6138765|NCT01289782|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6138766|NCT01289782|Simeprevir|simeprevir|mesh-list
6138767|NCT01289782|Antimetabolites|antimetabolites|mesh-ancestor
6138768|NCT01289782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138769|NCT01289782|Antiviral Agents|antiviral agents|mesh-ancestor
6138770|NCT01289782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6138771|NCT01289782|Protease Inhibitors|protease inhibitors|mesh-ancestor
6138772|NCT01289782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6138773|NCT01289821|Leucovorin|leucovorin|mesh-list
6138774|NCT01289821|Folic Acid|folic acid|mesh-list
6138775|NCT01289821|Oxaliplatin|oxaliplatin|mesh-list
6138776|NCT01289821|Levoleucovorin|levoleucovorin|mesh-list
6138777|NCT01289821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6138778|NCT01289821|Antidotes|antidotes|mesh-ancestor
6138779|NCT01289821|Protective Agents|protective agents|mesh-ancestor
6138780|NCT01289821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138781|NCT01289821|Vitamin B Complex|vitamin b complex|mesh-ancestor
6138782|NCT01289821|Vitamins|vitamins|mesh-ancestor
6138783|NCT01289821|Micronutrients|micronutrients|mesh-ancestor
6138784|NCT01289821|Hematinics|hematinics|mesh-ancestor
6138785|NCT01289847|gamma-Globulins|gamma-globulins|mesh-list
6138786|NCT01289847|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6138787|NCT01289847|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6138788|NCT01289847|Immunologic Factors|immunologic factors|mesh-ancestor
6138789|NCT01289847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138790|NCT01289912|Everolimus|everolimus|mesh-list
6138791|NCT01289912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6138792|NCT01289912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6138793|NCT01289912|Immunologic Factors|immunologic factors|mesh-ancestor
6138794|NCT01289912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138795|NCT01289990|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6138796|NCT01289990|Empagliflozin|empagliflozin|mesh-list
6138797|NCT01289990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6138798|NCT01289990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138799|NCT01289990|Incretins|incretins|mesh-ancestor
6138800|NCT01289990|Hormones|hormones|mesh-ancestor
6138801|NCT01289990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6138802|NCT01289990|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6138803|NCT01289990|Protease Inhibitors|protease inhibitors|mesh-ancestor
6138804|NCT01289990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6138805|NCT01289990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138806|NCT01289990|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6138807|NCT01290029|Cinacalcet|cinacalcet|mesh-list
6205312|NCT02083926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469737|NCT00492518|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6469738|NCT00492518|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6469739|NCT00492518|Purinergic Agents|purinergic agents|mesh-ancestor
6469740|NCT00492518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6469741|NCT00492635|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6469742|NCT00492635|Vasodilator Agents|vasodilator agents|mesh-ancestor
6666595|NCT01523379|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6666596|NCT01523379|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6469743|NCT00492635|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6469744|NCT00492635|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6469745|NCT00492635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6469746|NCT00492635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469747|NCT00492635|Urological Agents|urological agents|mesh-ancestor
6469748|NCT00492661|Tacrolimus|tacrolimus|mesh-list
6469749|NCT00492661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6469750|NCT00492661|Immunologic Factors|immunologic factors|mesh-ancestor
6469751|NCT00492661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469752|NCT00492661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6469753|NCT00492661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6469754|NCT00492661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469755|NCT00492687|Tamoxifen|tamoxifen|mesh-list
6469756|NCT00492687|Carboplatin|carboplatin|mesh-list
6469757|NCT00492687|Temozolomide|temozolomide|mesh-list
6469758|NCT00492687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6469759|NCT00492687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138808|NCT01290029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6138809|NCT01290029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138810|NCT01290029|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6138811|NCT01290029|Hormone Antagonists|hormone antagonists|mesh-ancestor
6138812|NCT01290029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6138813|NCT01290094|Ibandronic Acid|ibandronic acid|mesh-list
6138814|NCT01290094|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6138815|NCT01290094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469760|NCT00492687|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6469761|NCT00492687|Alkylating Agents|alkylating agents|mesh-ancestor
5543023|NCT04154852|Adalimumab|adalimumab|mesh-list
5543024|NCT04154852|Methotrexate|methotrexate|mesh-list
5543025|NCT04154852|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5543026|NCT04154852|Abortifacient Agents|abortifacient agents|mesh-ancestor
5543027|NCT04154852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5543028|NCT04154852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543029|NCT04154852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5543030|NCT04154852|Antimetabolites|antimetabolites|mesh-ancestor
5543031|NCT04154852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543032|NCT04154852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5543033|NCT04154852|Dermatologic Agents|dermatologic agents|mesh-ancestor
5543034|NCT04154852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5543035|NCT04154852|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5543036|NCT04154852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5543037|NCT04154852|Immunologic Factors|immunologic factors|mesh-ancestor
6469762|NCT00492687|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6469763|NCT00492687|Hormone Antagonists|hormone antagonists|mesh-ancestor
6469764|NCT00492687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6469765|NCT00492687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469766|NCT00492687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6469767|NCT00492687|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6469768|NCT00492687|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6469769|NCT00492687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6469770|NCT00492700|Rosiglitazone|rosiglitazone|mesh-list
6469771|NCT00492700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6469772|NCT00492700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469773|NCT00492739|Vaccines|vaccines|mesh-list
6469774|NCT00492739|Immunologic Factors|immunologic factors|mesh-ancestor
6469775|NCT00492739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469776|NCT00492765|Interferons|interferons|mesh-list
6469777|NCT00492765|Interferon-beta|interferon-beta|mesh-list
6469778|NCT00492765|Interferon beta-1a|interferon beta-1a|mesh-list
6469779|NCT00492765|Simvastatin|simvastatin|mesh-list
6469780|NCT00492765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6469781|NCT00492765|Antiviral Agents|antiviral agents|mesh-ancestor
6469782|NCT00492765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6469783|NCT00492765|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6469784|NCT00492765|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6469785|NCT00492765|Antimetabolites|antimetabolites|mesh-ancestor
6469786|NCT00492765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469787|NCT00492765|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6469788|NCT00492765|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6469789|NCT00492765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6469790|NCT00492765|Immunologic Factors|immunologic factors|mesh-ancestor
6469791|NCT00492765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469792|NCT00492765|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6469793|NCT00492778|Cisplatin|cisplatin|mesh-list
6469794|NCT00492778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6469795|NCT00492830|Antibodies|antibodies|mesh-list
6469796|NCT00492830|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6469797|NCT00492830|Immunologic Factors|immunologic factors|mesh-ancestor
6469798|NCT00492830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469799|NCT00492843|Ibandronic Acid|ibandronic acid|mesh-list
6469800|NCT00492843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6469801|NCT00492843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469802|NCT00492934|Menotropins|menotropins|mesh-list
6469803|NCT00492934|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6469804|NCT00492934|Fertility Agents|fertility agents|mesh-ancestor
6469805|NCT00492934|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6666597|NCT01523379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6666598|NCT01523379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666599|NCT01523379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6666600|NCT01523379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6666601|NCT01523379|Analgesics|analgesics|mesh-ancestor
6666602|NCT01523379|Sensory System Agents|sensory system agents|mesh-ancestor
6666603|NCT01523379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6469806|NCT00492934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469807|NCT00492986|Sorafenib|sorafenib|mesh-list
6469808|NCT00492986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6469809|NCT00492986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6469810|NCT00492986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6469811|NCT00492986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138816|NCT01290237|Vancomycin|vancomycin|mesh-list
6138817|NCT01290237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6138818|NCT01290237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6138819|NCT01290263|Bevacizumab|bevacizumab|mesh-list
6138820|NCT01290263|Trebananib|trebananib|mesh-list
6138821|NCT01290263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6138822|NCT01290263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6138823|NCT01290263|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6138824|NCT01290263|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6138825|NCT01290263|Growth Substances|growth substances|mesh-ancestor
6138826|NCT01290263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138827|NCT01290263|Growth Inhibitors|growth inhibitors|mesh-ancestor
6469812|NCT00493077|Interferons|interferons|mesh-list
5543038|NCT04154852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5543039|NCT04154852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5543040|NCT04154852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5543041|NCT04154852|Hematinics|hematinics|mesh-ancestor
5543042|NCT04154852|Vitamin B Complex|vitamin b complex|mesh-ancestor
5543043|NCT04154852|Vitamins|vitamins|mesh-ancestor
5543044|NCT04154852|Micronutrients|micronutrients|mesh-ancestor
5543045|NCT04154813|Topiramate|topiramate|mesh-list
5543046|NCT04154813|Fluoxetine|fluoxetine|mesh-list
5543047|NCT04154813|Anticonvulsants|anticonvulsants|mesh-ancestor
5543048|NCT04154813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5543049|NCT04154813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543050|NCT04154813|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5543051|NCT04154813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5543052|NCT04154813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5543053|NCT04154813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469813|NCT00493077|Interferon-beta|interferon-beta|mesh-list
6469814|NCT00493077|Interferon beta-1a|interferon beta-1a|mesh-list
6469815|NCT00493077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6469816|NCT00493077|Antiviral Agents|antiviral agents|mesh-ancestor
6469817|NCT00493077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6469818|NCT00493077|Immunologic Factors|immunologic factors|mesh-ancestor
6469819|NCT00493077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469820|NCT00493077|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5543054|NCT04154813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5543055|NCT04154813|Serotonin Agents|serotonin agents|mesh-ancestor
5543056|NCT04154813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5543057|NCT04154813|Antidepressive Agents|antidepressive agents|mesh-ancestor
5543058|NCT04154813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5543059|NCT04154813|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5543060|NCT04154813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5543061|NCT04154813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5543062|NCT04154982|Acetylcysteine|acetylcysteine|mesh-list
5543063|NCT04154982|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5543064|NCT04154982|Antiviral Agents|antiviral agents|mesh-ancestor
5543065|NCT04154982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6469821|NCT00493116|Interferons|interferons|mesh-list
6469822|NCT00493116|Interferon-beta|interferon-beta|mesh-list
6469823|NCT00493116|Interferon beta-1a|interferon beta-1a|mesh-list
6138828|NCT01290315|Dextrans|dextrans|mesh-list
6469824|NCT00493116|Methylprednisolone|methylprednisolone|mesh-list
6469825|NCT00493116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6469826|NCT00493116|Antiviral Agents|antiviral agents|mesh-ancestor
6469827|NCT00493116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6469828|NCT00493116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6469829|NCT00493116|Antiemetics|antiemetics|mesh-ancestor
5543066|NCT04154982|Expectorants|expectorants|mesh-ancestor
5543067|NCT04154982|Respiratory System Agents|respiratory system agents|mesh-ancestor
5543068|NCT04154982|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5543069|NCT04154982|Antioxidants|antioxidants|mesh-ancestor
5543070|NCT04154982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543071|NCT04154982|Protective Agents|protective agents|mesh-ancestor
5543072|NCT04154982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469830|NCT00493116|Autonomic Agents|autonomic agents|mesh-ancestor
6469831|NCT00493116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6469832|NCT00493116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469833|NCT00493116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6469834|NCT00493116|Glucocorticoids|glucocorticoids|mesh-ancestor
5543073|NCT04154982|Antidotes|antidotes|mesh-ancestor
5543074|NCT04154748|Omeprazole|omeprazole|mesh-list
5543075|NCT04154748|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5543076|NCT04154748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5543077|NCT04154748|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5543078|NCT04154748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5543079|NCT04154748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543080|NCT04155008|Dexamethasone|dexamethasone|mesh-list
5543081|NCT04155008|Dronabinol|dronabinol|mesh-list
6469835|NCT00493116|Hormones|hormones|mesh-ancestor
6469836|NCT00493116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6469837|NCT00493116|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6469838|NCT00493116|Protective Agents|protective agents|mesh-ancestor
6469839|NCT00493116|Immunologic Factors|immunologic factors|mesh-ancestor
6469840|NCT00493116|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6469841|NCT00493129|Denileukin diftitox|denileukin diftitox|mesh-list
6469842|NCT00493129|Interleukin-2|interleukin-2|mesh-list
6469843|NCT00493129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5543082|NCT04155008|Mirtazapine|mirtazapine|mesh-list
5543083|NCT04155008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5543084|NCT04155008|Antiemetics|antiemetics|mesh-ancestor
6469844|NCT00493129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6469845|NCT00493129|Analgesics|analgesics|mesh-ancestor
6469846|NCT00493129|Sensory System Agents|sensory system agents|mesh-ancestor
6469847|NCT00493129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6469848|NCT00493129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469849|NCT00493194|Cyclosporine|cyclosporine|mesh-list
6469850|NCT00493194|Sirolimus|sirolimus|mesh-list
6138829|NCT01290315|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6138830|NCT01290315|Iron-Dextran Complex|iron-dextran complex|mesh-list
6138831|NCT01290315|Hematinics|hematinics|mesh-ancestor
6138832|NCT01290315|Anticoagulants|anticoagulants|mesh-ancestor
6138833|NCT01290315|Plasma Substitutes|plasma substitutes|mesh-ancestor
6138834|NCT01290315|Blood Substitutes|blood substitutes|mesh-ancestor
6138835|NCT01290341|Naftifine|naftifine|mesh-list
5543085|NCT04155008|Autonomic Agents|autonomic agents|mesh-ancestor
5543086|NCT04155008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5543087|NCT04155008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543088|NCT04155008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5543089|NCT04155008|Glucocorticoids|glucocorticoids|mesh-ancestor
5543090|NCT04155008|Hormones|hormones|mesh-ancestor
5543091|NCT04155008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5543092|NCT04155008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5543093|NCT04155008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5543094|NCT04155008|Antidepressive Agents|antidepressive agents|mesh-ancestor
5543095|NCT04155008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5543096|NCT04155008|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6138836|NCT01290341|Antifungal Agents|antifungal agents|mesh-ancestor
6138837|NCT01290341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6138838|NCT01290445|Varenicline|varenicline|mesh-list
6138839|NCT01290445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6138840|NCT01290445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6138841|NCT01290445|Cholinergic Agents|cholinergic agents|mesh-ancestor
6138842|NCT01290445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6138843|NCT01290445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469851|NCT00493194|Cyclosporins|cyclosporins|mesh-list
5543097|NCT04155008|Histamine Antagonists|histamine antagonists|mesh-ancestor
6138844|NCT01290445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138845|NCT01290484|Sildenafil Citrate|sildenafil citrate|mesh-list
6469852|NCT00493194|Daclizumab|daclizumab|mesh-list
6138846|NCT01290484|Vasodilator Agents|vasodilator agents|mesh-ancestor
6138847|NCT01290484|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6138848|NCT01290484|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6138849|NCT01290484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6138850|NCT01290484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138851|NCT01290484|Urological Agents|urological agents|mesh-ancestor
6138852|NCT01290601|Chloroquine|chloroquine|mesh-list
6138853|NCT01290601|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
6138854|NCT01290601|Primaquine|primaquine|mesh-list
6138855|NCT01290601|Tafenoquine|tafenoquine|mesh-list
6138856|NCT01290601|Amebicides|amebicides|mesh-ancestor
6138857|NCT01290601|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6138858|NCT01290601|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5543098|NCT04155008|Histamine Agents|histamine agents|mesh-ancestor
5543099|NCT04155008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5543100|NCT04155008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543101|NCT04155008|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5543102|NCT04155008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5543103|NCT04155008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5543104|NCT04155008|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5543105|NCT04155008|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5543106|NCT04155008|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5543107|NCT04155008|Adrenergic Agents|adrenergic agents|mesh-ancestor
5543108|NCT04155008|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5543109|NCT04155008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5543110|NCT04155008|Serotonin Agents|serotonin agents|mesh-ancestor
5543111|NCT04155008|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5543112|NCT04155008|Hallucinogens|hallucinogens|mesh-ancestor
5543113|NCT04155008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5543114|NCT04155008|Analgesics|analgesics|mesh-ancestor
5543115|NCT04155008|Sensory System Agents|sensory system agents|mesh-ancestor
5543116|NCT04155008|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5543117|NCT04155008|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5543118|NCT04154735|Rifaximin|rifaximin|mesh-list
5543119|NCT04154735|Cyclophosphamide|cyclophosphamide|mesh-list
5543120|NCT04154735|Fludarabine|fludarabine|mesh-list
5543121|NCT04154735|Alemtuzumab|alemtuzumab|mesh-list
5543122|NCT04154735|Tacrolimus|tacrolimus|mesh-list
5543123|NCT04154735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5543124|NCT04154735|Immunologic Factors|immunologic factors|mesh-ancestor
5543125|NCT04154735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543126|NCT04154735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5543127|NCT04154735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5543128|NCT04154735|Alkylating Agents|alkylating agents|mesh-ancestor
5543129|NCT04154735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138859|NCT01290601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6138860|NCT01290601|Antimalarials|antimalarials|mesh-ancestor
6138861|NCT01290601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6138862|NCT01290601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6138863|NCT01290601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6469853|NCT00493194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5543130|NCT04154735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6138864|NCT01290601|Analgesics|analgesics|mesh-ancestor
6138865|NCT01290601|Sensory System Agents|sensory system agents|mesh-ancestor
6138866|NCT01290601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6138867|NCT01290601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138868|NCT01290601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6138869|NCT01290601|Filaricides|filaricides|mesh-ancestor
6138870|NCT01290601|Antinematodal Agents|antinematodal agents|mesh-ancestor
6138871|NCT01290601|Anthelmintics|anthelmintics|mesh-ancestor
6138872|NCT01290679|Ribavirin|ribavirin|mesh-list
6138873|NCT01290679|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6138874|NCT01290679|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6469854|NCT00493194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469855|NCT00493194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6469856|NCT00493194|Immunologic Factors|immunologic factors|mesh-ancestor
6469857|NCT00493194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469858|NCT00493194|Antifungal Agents|antifungal agents|mesh-ancestor
6469859|NCT00493194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6469860|NCT00493194|Dermatologic Agents|dermatologic agents|mesh-ancestor
6469861|NCT00493194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6469862|NCT00493194|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6469863|NCT00493194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5543131|NCT04154735|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5543132|NCT04154735|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5543133|NCT04154735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5543134|NCT04154735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5543135|NCT04154735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5543136|NCT04154735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5543137|NCT04154735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6469864|NCT00493194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6469865|NCT00493194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6469866|NCT00493233|Olanzapine|olanzapine|mesh-list
6469867|NCT00493233|Risperidone|risperidone|mesh-list
6469868|NCT00493233|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6469869|NCT00493233|Antipsychotic Agents|antipsychotic agents|mesh-list
6469870|NCT00493233|Clozapine|clozapine|mesh-list
6469871|NCT00493233|Perphenazine|perphenazine|mesh-list
6469872|NCT00493233|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6138875|NCT01290679|Simeprevir|simeprevir|mesh-list
6138876|NCT01290679|Antimetabolites|antimetabolites|mesh-ancestor
6138877|NCT01290679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138878|NCT01290679|Antiviral Agents|antiviral agents|mesh-ancestor
6138879|NCT01290679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6138880|NCT01290679|Protease Inhibitors|protease inhibitors|mesh-ancestor
6138881|NCT01290679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6138882|NCT01290731|Interferons|interferons|mesh-list
6138883|NCT01290731|Ribavirin|ribavirin|mesh-list
6469873|NCT00493233|Serotonin Agents|serotonin agents|mesh-ancestor
6469874|NCT00493233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6469875|NCT00493233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469876|NCT00493233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469877|NCT00493233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6469878|NCT00493233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6469879|NCT00493233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6469880|NCT00493233|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6469881|NCT00493233|Dopamine Agents|dopamine agents|mesh-ancestor
6469882|NCT00493233|Antiemetics|antiemetics|mesh-ancestor
6469883|NCT00493233|Autonomic Agents|autonomic agents|mesh-ancestor
6469884|NCT00493233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6469885|NCT00493233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5543138|NCT04154722|Azithromycin|azithromycin|mesh-list
5543139|NCT04154722|Meropenem|meropenem|mesh-list
6138884|NCT01290731|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6469886|NCT00493233|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6469887|NCT00493233|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6469888|NCT00493233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6469889|NCT00493233|Antidepressive Agents|antidepressive agents|mesh-ancestor
6469890|NCT00493233|GABA Antagonists|gaba antagonists|mesh-ancestor
6138885|NCT01290731|Simeprevir|simeprevir|mesh-list
6138886|NCT01290731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6138887|NCT01290731|Antiviral Agents|antiviral agents|mesh-ancestor
6138888|NCT01290731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6138889|NCT01290731|Antimetabolites|antimetabolites|mesh-ancestor
6138890|NCT01290731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138891|NCT01290731|Protease Inhibitors|protease inhibitors|mesh-ancestor
6138892|NCT01290731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6138893|NCT01290757|Dabigatran|dabigatran|mesh-list
6469891|NCT00493233|GABA Agents|gaba agents|mesh-ancestor
6469892|NCT00493298|Natalizumab|natalizumab|mesh-list
6469893|NCT00493298|Immunologic Factors|immunologic factors|mesh-ancestor
6138894|NCT01290757|Antithrombins|antithrombins|mesh-ancestor
6138895|NCT01290757|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6138896|NCT01290757|Protease Inhibitors|protease inhibitors|mesh-ancestor
6138897|NCT01290757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6138898|NCT01290757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138899|NCT01290757|Anticoagulants|anticoagulants|mesh-ancestor
5543140|NCT04154722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5543141|NCT04154722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5543142|NCT04154449|Insulin|insulin|mesh-list
5543143|NCT04154449|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5543144|NCT04154449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543145|NCT04154319|Vaccines|vaccines|mesh-list
5543146|NCT04154319|Immunologic Factors|immunologic factors|mesh-ancestor
5543147|NCT04154319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543148|NCT04154150|Ketamine|ketamine|mesh-list
6138900|NCT01290874|Formoterol Fumarate|formoterol fumarate|mesh-list
6138901|NCT01290874|Tiotropium Bromide|tiotropium bromide|mesh-list
6138902|NCT01290874|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6138903|NCT01290874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6138904|NCT01290874|Autonomic Agents|autonomic agents|mesh-ancestor
6138905|NCT01290874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6138906|NCT01290874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138907|NCT01290874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6138908|NCT01290874|Respiratory System Agents|respiratory system agents|mesh-ancestor
6469894|NCT00493298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469895|NCT00493324|Alefacept|alefacept|mesh-list
6469896|NCT00493324|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6469897|NCT00493324|Immunologic Factors|immunologic factors|mesh-ancestor
6469898|NCT00493324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469899|NCT00493324|Dermatologic Agents|dermatologic agents|mesh-ancestor
6469900|NCT00493363|Artesunate|artesunate|mesh-list
6469901|NCT00493363|Mefloquine|mefloquine|mesh-list
6469902|NCT00493363|Antimalarials|antimalarials|mesh-ancestor
6138909|NCT01290874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6138910|NCT01290874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6138911|NCT01290874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6138912|NCT01290874|Adrenergic Agents|adrenergic agents|mesh-ancestor
6138913|NCT01290874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6138914|NCT01290874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543149|NCT04154150|Analgesics|analgesics|mesh-ancestor
5543150|NCT04154150|Sensory System Agents|sensory system agents|mesh-ancestor
5543151|NCT04154150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5543152|NCT04154150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543153|NCT04154150|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5543154|NCT04154150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5543155|NCT04154150|Anesthetics, General|anesthetics, general|mesh-ancestor
5543156|NCT04154150|Anesthetics|anesthetics|mesh-ancestor
5543157|NCT04154150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5543158|NCT04154150|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5543159|NCT04154150|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6138915|NCT01290874|Parasympatholytics|parasympatholytics|mesh-ancestor
6138916|NCT01290874|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6138917|NCT01290874|Cholinergic Agents|cholinergic agents|mesh-ancestor
6138918|NCT01290887|Reslizumab|reslizumab|mesh-list
6138919|NCT01290887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6138920|NCT01290887|Respiratory System Agents|respiratory system agents|mesh-ancestor
6138921|NCT01290913|Omalizumab|omalizumab|mesh-list
6138922|NCT01290913|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6138923|NCT01290913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6138924|NCT01290913|Respiratory System Agents|respiratory system agents|mesh-ancestor
6469903|NCT00493363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6469904|NCT00493363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6469905|NCT00493363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6469906|NCT00493363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6469907|NCT00493363|Antiviral Agents|antiviral agents|mesh-ancestor
6138925|NCT01291017|Palbociclib|palbociclib|mesh-list
6138926|NCT01291017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6138927|NCT01291017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6138928|NCT01291017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5543160|NCT04154150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5543161|NCT04154150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543162|NCT04154293|Isotretinoin|isotretinoin|mesh-list
6138929|NCT01291017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138930|NCT01291056|Clomiphene|clomiphene|mesh-list
5543163|NCT04154293|Dermatologic Agents|dermatologic agents|mesh-ancestor
6138931|NCT01291056|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6138932|NCT01291056|Hormone Antagonists|hormone antagonists|mesh-ancestor
6469908|NCT00493363|Schistosomicides|schistosomicides|mesh-ancestor
6138933|NCT01291056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6138934|NCT01291056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138935|NCT01291056|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6138936|NCT01291056|Fertility Agents|fertility agents|mesh-ancestor
6138937|NCT01291056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6138938|NCT01291056|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6138939|NCT01291056|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6138940|NCT01291108|Bimatoprost|bimatoprost|mesh-list
6138941|NCT01291108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6138942|NCT01291173|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6138943|NCT01291173|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6138944|NCT01291173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138945|NCT01291173|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6138946|NCT01291173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6138947|NCT01291173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6138948|NCT01291173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138949|NCT01291173|Dopamine Agents|dopamine agents|mesh-ancestor
6138950|NCT01291173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6138951|NCT01291784|Antibodies|antibodies|mesh-list
6138952|NCT01291784|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6138953|NCT01291784|Immunologic Factors|immunologic factors|mesh-ancestor
6138954|NCT01291784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138955|NCT01292005|Pentoxifylline|pentoxifylline|mesh-list
6138956|NCT01292005|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6138957|NCT01292005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6138958|NCT01292005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138959|NCT01292005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6138960|NCT01292005|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6138961|NCT01292005|Protective Agents|protective agents|mesh-ancestor
6138962|NCT01292005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138963|NCT01292005|Vasodilator Agents|vasodilator agents|mesh-ancestor
6138964|NCT01292005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6138965|NCT01292005|Antioxidants|antioxidants|mesh-ancestor
6138966|NCT01292057|Aripiprazole|aripiprazole|mesh-list
6138967|NCT01292057|Antidepressive Agents|antidepressive agents|mesh-ancestor
6138968|NCT01292057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5543164|NCT04153968|Retinol acetate|retinol acetate|mesh-list
5543165|NCT04153968|Protective Agents|protective agents|mesh-ancestor
5543166|NCT04153968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543167|NCT04153968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6138969|NCT01292057|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6138970|NCT01292057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6138971|NCT01292057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6138972|NCT01292057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138973|NCT01292057|Dopamine Agonists|dopamine agonists|mesh-ancestor
6138974|NCT01292057|Dopamine Agents|dopamine agents|mesh-ancestor
6666604|NCT01523379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543168|NCT04153968|Immunologic Factors|immunologic factors|mesh-ancestor
6469909|NCT00493363|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6469910|NCT00493363|Anthelmintics|anthelmintics|mesh-ancestor
6469911|NCT00493389|Hormones|hormones|mesh-list
6469912|NCT00493389|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6469913|NCT00493389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6469914|NCT00493389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469915|NCT00493402|Chlorotrianisene|chlorotrianisene|mesh-list
6469916|NCT00493402|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6469917|NCT00493402|Estrogens|estrogens|mesh-ancestor
6469918|NCT00493402|Hormones|hormones|mesh-ancestor
6469919|NCT00493402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6469920|NCT00493402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469921|NCT00493402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6469922|NCT00493402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6469923|NCT00493415|Nitroglycerin|nitroglycerin|mesh-list
6469924|NCT00493415|Vasodilator Agents|vasodilator agents|mesh-ancestor
6488559|NCT00584779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6488560|NCT00584779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488561|NCT00584779|Anticonvulsants|anticonvulsants|mesh-ancestor
6488562|NCT00584779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6138975|NCT01292057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6138976|NCT01292057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6138977|NCT01292057|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6138978|NCT01292057|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6138979|NCT01292057|Serotonin Agents|serotonin agents|mesh-ancestor
6138980|NCT01292057|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6138981|NCT01292057|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6138982|NCT01292057|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6138983|NCT01292057|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6138984|NCT01292187|Calcitonin|calcitonin|mesh-list
6138985|NCT01292187|Salmon calcitonin|salmon calcitonin|mesh-list
6138986|NCT01292187|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
6138987|NCT01292187|Katacalcin|katacalcin|mesh-list
6138988|NCT01292187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6138989|NCT01292187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138990|NCT01292187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6138991|NCT01292187|Vasodilator Agents|vasodilator agents|mesh-ancestor
6138992|NCT01292226|Cyclosporine|cyclosporine|mesh-list
6138993|NCT01292226|Mycophenolic Acid|mycophenolic acid|mesh-list
5543169|NCT04153968|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5543170|NCT04153968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5543171|NCT04153981|Insulin Glargine|insulin glargine|mesh-list
5543172|NCT04153981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5543173|NCT04153981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138994|NCT01292226|Antibodies|antibodies|mesh-list
6138995|NCT01292226|Cyclosporins|cyclosporins|mesh-list
6138996|NCT01292226|Immunologic Factors|immunologic factors|mesh-ancestor
6138997|NCT01292226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6138998|NCT01292226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6138999|NCT01292226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469925|NCT00493428|Baclofen|baclofen|mesh-list
6469926|NCT00493428|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6469927|NCT00493428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469928|NCT00493428|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6469929|NCT00493428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6469930|NCT00493428|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6666605|NCT01523379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6666606|NCT01523379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6666607|NCT01523418|Rivaroxaban|rivaroxaban|mesh-list
6469931|NCT00493428|GABA Agonists|gaba agonists|mesh-ancestor
6469932|NCT00493428|GABA Agents|gaba agents|mesh-ancestor
6469933|NCT00493428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6469934|NCT00493428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469935|NCT00493480|Propranolol|propranolol|mesh-list
6469936|NCT00493480|Carvedilol|carvedilol|mesh-list
6469937|NCT00493480|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6469938|NCT00493480|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6469939|NCT00493480|Adrenergic Agents|adrenergic agents|mesh-ancestor
6469940|NCT00493480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6469941|NCT00493480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469942|NCT00493480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469943|NCT00493480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6469944|NCT00493480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6469945|NCT00493480|Vasodilator Agents|vasodilator agents|mesh-ancestor
6469946|NCT00493480|Antioxidants|antioxidants|mesh-ancestor
6469947|NCT00493480|Protective Agents|protective agents|mesh-ancestor
6469948|NCT00493480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6469949|NCT00493480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6469950|NCT00493480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5543174|NCT04154033|Naltrexone|naltrexone|mesh-list
6139000|NCT01292226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6139001|NCT01292226|Antifungal Agents|antifungal agents|mesh-ancestor
5543175|NCT04154033|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5543176|NCT04154033|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5543177|NCT04154033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543178|NCT04154033|Sensory System Agents|sensory system agents|mesh-ancestor
5543179|NCT04154033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5602390|NCT04613453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5602391|NCT04613453|GABA Modulators|gaba modulators|mesh-ancestor
5602392|NCT04613453|GABA Agents|gaba agents|mesh-ancestor
5602393|NCT04610528|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
6139002|NCT01292226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6139003|NCT01292226|Dermatologic Agents|dermatologic agents|mesh-ancestor
6139004|NCT01292226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5602394|NCT04610528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5602395|NCT04610528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5602396|NCT04602507|Ivermectin|ivermectin|mesh-list
6666608|NCT01523418|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5602397|NCT04602507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5602398|NCT04602507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6139005|NCT01292226|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6139006|NCT01292226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6139007|NCT01292226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6139008|NCT01292226|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6139009|NCT01292226|Antitubercular Agents|antitubercular agents|mesh-ancestor
6139010|NCT01292226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6139011|NCT01292239|Ribavirin|ribavirin|mesh-list
6139012|NCT01292239|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6139013|NCT01292239|Simeprevir|simeprevir|mesh-list
6139014|NCT01292239|Antimetabolites|antimetabolites|mesh-ancestor
6139015|NCT01292239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139016|NCT01292239|Antiviral Agents|antiviral agents|mesh-ancestor
6139017|NCT01292239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6139018|NCT01292239|Protease Inhibitors|protease inhibitors|mesh-ancestor
6139019|NCT01292239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6139020|NCT01292252|Teriparatide|teriparatide|mesh-list
5543180|NCT04153682|Anti-Infective Agents|anti-infective agents|mesh-list
5543181|NCT04153682|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5543182|NCT04153708|Antibodies|antibodies|mesh-list
5543183|NCT04153708|Immunoglobulins|immunoglobulins|mesh-list
5543184|NCT04153708|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
5543185|NCT04153708|Immunologic Factors|immunologic factors|mesh-ancestor
5543186|NCT04153708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543187|NCT04153487|Ascorbic Acid|ascorbic acid|mesh-list
5543188|NCT04153487|Vitamins|vitamins|mesh-ancestor
5543189|NCT04153487|Micronutrients|micronutrients|mesh-ancestor
5543190|NCT04153487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543191|NCT04153487|Antioxidants|antioxidants|mesh-ancestor
5543192|NCT04153487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543193|NCT04153487|Protective Agents|protective agents|mesh-ancestor
5543194|NCT04153734|Paclitaxel|paclitaxel|mesh-list
5543195|NCT04153734|Carboplatin|carboplatin|mesh-list
5543196|NCT04153734|Pembrolizumab|pembrolizumab|mesh-list
5543197|NCT04153734|Pemetrexed|pemetrexed|mesh-list
5543198|NCT04153734|Cisplatin|cisplatin|mesh-list
5543199|NCT04153734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5543200|NCT04153734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5543201|NCT04153734|Tubulin Modulators|tubulin modulators|mesh-ancestor
6469951|NCT00493480|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6139021|NCT01292252|Parathyroid Hormone|parathyroid hormone|mesh-list
6469952|NCT00493480|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6469953|NCT00493532|Ibandronic Acid|ibandronic acid|mesh-list
6469954|NCT00493532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6469955|NCT00493532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469956|NCT00493545|Poly ICLC|poly iclc|mesh-list
5543202|NCT04153734|Antimitotic Agents|antimitotic agents|mesh-ancestor
5543203|NCT04153734|Mitosis Modulators|mitosis modulators|mesh-ancestor
5543204|NCT04153734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543205|NCT04153734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5543206|NCT04153734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5543207|NCT04153734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5543208|NCT04153734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5543209|NCT04153565|Pembrolizumab|pembrolizumab|mesh-list
6139022|NCT01292252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469957|NCT00493545|Interferon Inducers|interferon inducers|mesh-ancestor
6469958|NCT00493545|Immunologic Factors|immunologic factors|mesh-ancestor
6469959|NCT00493545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469960|NCT00493610|Acetylcysteine|acetylcysteine|mesh-list
6469961|NCT00493610|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6469962|NCT00493610|Antiviral Agents|antiviral agents|mesh-ancestor
6469963|NCT00493610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6469964|NCT00493610|Expectorants|expectorants|mesh-ancestor
6469965|NCT00493610|Respiratory System Agents|respiratory system agents|mesh-ancestor
6469966|NCT00493610|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5543210|NCT04153565|Pemetrexed|pemetrexed|mesh-list
5543211|NCT04153565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6469967|NCT00493610|Antioxidants|antioxidants|mesh-ancestor
6139023|NCT01292252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6139024|NCT01292252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6139025|NCT01292304|Tolvaptan|tolvaptan|mesh-list
6139026|NCT01292304|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6139027|NCT01292304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139028|NCT01292304|Natriuretic Agents|natriuretic agents|mesh-ancestor
6139029|NCT01292304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139030|NCT01292447|Lidocaine|lidocaine|mesh-list
6139031|NCT01292447|Anesthetics, Local|anesthetics, local|mesh-ancestor
6139032|NCT01292447|Anesthetics|anesthetics|mesh-ancestor
6139033|NCT01292447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6139034|NCT01292447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139035|NCT01292447|Sensory System Agents|sensory system agents|mesh-ancestor
6139036|NCT01292447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6139037|NCT01292447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6139038|NCT01292447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6139039|NCT01292447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6139040|NCT01292447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6139041|NCT01292447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139042|NCT01292473|Omalizumab|omalizumab|mesh-list
6139043|NCT01292473|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6139044|NCT01292473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6139045|NCT01292473|Respiratory System Agents|respiratory system agents|mesh-ancestor
6205313|NCT02083926|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6205314|NCT02083926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6205315|NCT02083926|Anesthetics, General|anesthetics, general|mesh-ancestor
6205316|NCT02083926|Anesthetics|anesthetics|mesh-ancestor
6205317|NCT02083926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6205318|NCT02083926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6205319|NCT02083926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6205320|NCT02083926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6205321|NCT02083926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205322|NCT02083965|Factor VIII|factor viii|mesh-list
6205323|NCT02083965|Coagulants|coagulants|mesh-ancestor
6205324|NCT02084056|Metformin|metformin|mesh-list
6205325|NCT02084056|Linagliptin|linagliptin|mesh-list
6205326|NCT02084056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6205327|NCT02084056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205328|NCT02084056|Incretins|incretins|mesh-ancestor
6205329|NCT02084056|Hormones|hormones|mesh-ancestor
6205330|NCT02084056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6205331|NCT02084056|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6205332|NCT02084056|Protease Inhibitors|protease inhibitors|mesh-ancestor
6205333|NCT02084056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6205334|NCT02084056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205335|NCT02084069|Atorvastatin|atorvastatin|mesh-list
6205336|NCT02084069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6205337|NCT02084069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6205338|NCT02084069|Antimetabolites|antimetabolites|mesh-ancestor
6205339|NCT02084069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205340|NCT02084069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6205341|NCT02084069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6205342|NCT02084069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6205343|NCT02084082|Metformin|metformin|mesh-list
6205344|NCT02084082|Linagliptin|linagliptin|mesh-list
6205345|NCT02084082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6205346|NCT02084082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205347|NCT02084082|Incretins|incretins|mesh-ancestor
6205348|NCT02084082|Hormones|hormones|mesh-ancestor
6205349|NCT02084082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6205350|NCT02084082|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6205351|NCT02084082|Protease Inhibitors|protease inhibitors|mesh-ancestor
6205352|NCT02084082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6205353|NCT02084082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205354|NCT02084134|Dexamethasone|dexamethasone|mesh-list
6205355|NCT02084134|Dexamethasone acetate|dexamethasone acetate|mesh-list
6205356|NCT02084134|Hydrocortisone|hydrocortisone|mesh-list
6205357|NCT02084134|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6205358|NCT02084134|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6205359|NCT02084134|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6205360|NCT02084134|BB 1101|bb 1101|mesh-list
6205361|NCT02084134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5543212|NCT04153565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5543213|NCT04153565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5543214|NCT04153565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543215|NCT04153565|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5543216|NCT04153565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5543217|NCT04153422|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5543218|NCT04153422|Immunologic Factors|immunologic factors|mesh-ancestor
6139046|NCT01292603|Cyclophosphamide|cyclophosphamide|mesh-list
6139047|NCT01292603|Rituximab|rituximab|mesh-list
6139048|NCT01292603|Fludarabine|fludarabine|mesh-list
6139049|NCT01292603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6139050|NCT01292603|Immunologic Factors|immunologic factors|mesh-ancestor
6139051|NCT01292603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139052|NCT01292603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6469968|NCT00493610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469969|NCT00493610|Protective Agents|protective agents|mesh-ancestor
6469970|NCT00493610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469971|NCT00493610|Antidotes|antidotes|mesh-ancestor
6469972|NCT00493623|Ibandronic Acid|ibandronic acid|mesh-list
6469973|NCT00493623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6469974|NCT00493623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469975|NCT00493662|Hyaluronic Acid|hyaluronic acid|mesh-list
6469976|NCT00493662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6469977|NCT00493662|Immunologic Factors|immunologic factors|mesh-ancestor
6469978|NCT00493662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469979|NCT00493662|Viscosupplements|viscosupplements|mesh-ancestor
6469980|NCT00493662|Protective Agents|protective agents|mesh-ancestor
6469981|NCT00493727|Acetylcysteine|acetylcysteine|mesh-list
6469982|NCT00493727|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6469983|NCT00493727|Antiviral Agents|antiviral agents|mesh-ancestor
6469984|NCT00493727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6469985|NCT00493727|Expectorants|expectorants|mesh-ancestor
6139053|NCT01292603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6139054|NCT01292603|Alkylating Agents|alkylating agents|mesh-ancestor
6139055|NCT01292603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139056|NCT01292603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6139057|NCT01292603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5543219|NCT04153422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543220|NCT04153201|Hydroxychloroquine|hydroxychloroquine|mesh-list
5543221|NCT04153201|Antimalarials|antimalarials|mesh-list
5543222|NCT04153201|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5543223|NCT04153201|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5543224|NCT04153201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5543225|NCT04153201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5543226|NCT04153201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543227|NCT04153201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5543228|NCT04153188|Phenylephrine|phenylephrine|mesh-list
5543229|NCT04153188|Oxymetazoline|oxymetazoline|mesh-list
6469986|NCT00493727|Respiratory System Agents|respiratory system agents|mesh-ancestor
6469987|NCT00493727|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6469988|NCT00493727|Antioxidants|antioxidants|mesh-ancestor
6469989|NCT00493727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469990|NCT00493727|Protective Agents|protective agents|mesh-ancestor
6469991|NCT00493727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6469992|NCT00493727|Antidotes|antidotes|mesh-ancestor
6469993|NCT00493766|Panobinostat|panobinostat|mesh-list
6469994|NCT00493766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6469995|NCT00493766|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6469996|NCT00493766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6469997|NCT00493766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6469998|NCT00493831|Nicotine|nicotine|mesh-list
6469999|NCT00493831|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6470000|NCT00493831|Autonomic Agents|autonomic agents|mesh-ancestor
6470001|NCT00493831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6470002|NCT00493831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470003|NCT00493831|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6470004|NCT00493831|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5543230|NCT04153188|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5543231|NCT04153188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5543232|NCT04153188|Adrenergic Agents|adrenergic agents|mesh-ancestor
6470005|NCT00493831|Cholinergic Agents|cholinergic agents|mesh-ancestor
6470006|NCT00493831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6470007|NCT00493831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6470008|NCT00493857|Nimotuzumab|nimotuzumab|mesh-list
6205362|NCT02084134|Antiemetics|antiemetics|mesh-ancestor
6470009|NCT00493857|Antibodies|antibodies|mesh-list
6470010|NCT00493857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6470011|NCT00493857|Immunologic Factors|immunologic factors|mesh-ancestor
5543233|NCT04153188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5543234|NCT04153188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543235|NCT04153188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543236|NCT04153188|Sympathomimetics|sympathomimetics|mesh-ancestor
5543237|NCT04153188|Autonomic Agents|autonomic agents|mesh-ancestor
5543238|NCT04153188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5543239|NCT04153188|Nasal Decongestants|nasal decongestants|mesh-ancestor
5543240|NCT04153188|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5543241|NCT04153188|Respiratory System Agents|respiratory system agents|mesh-ancestor
5543242|NCT04153188|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5543243|NCT04153188|Mydriatics|mydriatics|mesh-ancestor
5543244|NCT04153188|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5543245|NCT04153188|Protective Agents|protective agents|mesh-ancestor
6470012|NCT00493857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470013|NCT00493857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6470014|NCT00493857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6470015|NCT00493870|Cyclophosphamide|cyclophosphamide|mesh-list
6470016|NCT00493870|Docetaxel|docetaxel|mesh-list
6470017|NCT00493870|Doxorubicin|doxorubicin|mesh-list
6139058|NCT01292603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6139059|NCT01292642|Nicotine|nicotine|mesh-list
6139060|NCT01292642|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6470018|NCT00493870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6470019|NCT00493870|Immunologic Factors|immunologic factors|mesh-ancestor
6470020|NCT00493870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470021|NCT00493870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6470022|NCT00493870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6470023|NCT00493870|Alkylating Agents|alkylating agents|mesh-ancestor
6470024|NCT00493870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6470025|NCT00493870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6470026|NCT00493870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6470027|NCT00493870|Tubulin Modulators|tubulin modulators|mesh-ancestor
6470028|NCT00493870|Antimitotic Agents|antimitotic agents|mesh-ancestor
6470029|NCT00493870|Mitosis Modulators|mitosis modulators|mesh-ancestor
6470030|NCT00493870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6470031|NCT00493870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6470032|NCT00493870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6470033|NCT00493870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6470034|NCT00493896|Enoxaparin|enoxaparin|mesh-list
6470035|NCT00493896|PENTA|penta|mesh-list
6470036|NCT00493896|Fondaparinux|fondaparinux|mesh-list
6470037|NCT00493896|Anticoagulants|anticoagulants|mesh-ancestor
6470038|NCT00493896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6139061|NCT01292642|Autonomic Agents|autonomic agents|mesh-ancestor
6139062|NCT01292642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6139063|NCT01292642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139064|NCT01292642|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6139065|NCT01292642|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6139066|NCT01292642|Cholinergic Agents|cholinergic agents|mesh-ancestor
6139067|NCT01292642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6139068|NCT01292642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139069|NCT01292798|Ranibizumab|ranibizumab|mesh-list
6139070|NCT01292798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6139071|NCT01292798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6139072|NCT01292798|Growth Substances|growth substances|mesh-ancestor
5543246|NCT04153383|Milrinone|milrinone|mesh-list
5543247|NCT04153383|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5543248|NCT04153383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5543249|NCT04153383|Vasodilator Agents|vasodilator agents|mesh-ancestor
5543250|NCT04153383|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5543251|NCT04153383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5543252|NCT04153383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5543253|NCT04153383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543254|NCT04153383|Protective Agents|protective agents|mesh-ancestor
5543255|NCT04153383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543256|NCT04153253|Aflibercept|aflibercept|mesh-list
5543257|NCT04153253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5543258|NCT04153253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5543259|NCT04153253|Growth Substances|growth substances|mesh-ancestor
5543260|NCT04153253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543261|NCT04153253|Growth Inhibitors|growth inhibitors|mesh-ancestor
5543262|NCT04153253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6139073|NCT01292798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543263|NCT04153123|Epinephrine|epinephrine|mesh-list
5543264|NCT04153123|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6139074|NCT01292798|Growth Inhibitors|growth inhibitors|mesh-ancestor
6139075|NCT01292798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6139076|NCT01292837|Levetiracetam|levetiracetam|mesh-list
6139077|NCT01292837|Anticonvulsants|anticonvulsants|mesh-ancestor
6139078|NCT01292837|Nootropic Agents|nootropic agents|mesh-ancestor
6139079|NCT01293006|Suvorexant|suvorexant|mesh-list
6139080|NCT01293006|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5543265|NCT04153123|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5543266|NCT04153123|Adrenergic Agents|adrenergic agents|mesh-ancestor
5543267|NCT04153123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5543268|NCT04153123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543269|NCT04153123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543270|NCT04153123|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5543271|NCT04153123|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5543272|NCT04153123|Autonomic Agents|autonomic agents|mesh-ancestor
5543273|NCT04153123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5543274|NCT04153123|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5543275|NCT04153123|Respiratory System Agents|respiratory system agents|mesh-ancestor
5543276|NCT04153123|Mydriatics|mydriatics|mesh-ancestor
5543277|NCT04153123|Sympathomimetics|sympathomimetics|mesh-ancestor
5543278|NCT04153123|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6139081|NCT01293006|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6139082|NCT01293006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6139083|NCT01293006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543282|NCT04153084|Picosulfate sodium|picosulfate sodium|mesh-list
5543283|NCT04153084|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
5543284|NCT04153084|Cathartics|cathartics|mesh-ancestor
5543285|NCT04153084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5543286|NCT04153084|Laxatives|laxatives|mesh-ancestor
6139084|NCT01293006|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
6139085|NCT01293006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6139086|NCT01293006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6470039|NCT00493896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6470040|NCT00493896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6470041|NCT00493896|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6470042|NCT00493896|Antithrombins|antithrombins|mesh-ancestor
6470043|NCT00493896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6470044|NCT00493896|Protease Inhibitors|protease inhibitors|mesh-ancestor
6470045|NCT00493896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5543287|NCT04152655|Coenzyme Q10|coenzyme q10|mesh-list
5543288|NCT04152655|Idebenone|idebenone|mesh-list
5543289|NCT04152655|Micronutrients|micronutrients|mesh-ancestor
5543290|NCT04152655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543291|NCT04152655|Vitamins|vitamins|mesh-ancestor
5543292|NCT04152655|Antioxidants|antioxidants|mesh-ancestor
5543293|NCT04152655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543294|NCT04152655|Protective Agents|protective agents|mesh-ancestor
5543295|NCT04152694|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
5543296|NCT04152694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5543297|NCT04152694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5543298|NCT04152681|Apatinib|apatinib|mesh-list
5543299|NCT04152681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6470046|NCT00493961|Hormones|hormones|mesh-list
6470047|NCT00493961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6470048|NCT00493961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470049|NCT00493987|Methyltestosterone|methyltestosterone|mesh-list
5543300|NCT04152681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5543301|NCT04152681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5543302|NCT04152681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543303|NCT04152759|Golimumab|golimumab|mesh-list
5543304|NCT04152759|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
5543305|NCT04152759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5543306|NCT04152759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6470050|NCT00493987|Testosterone|testosterone|mesh-list
6470051|NCT00493987|Testosterone undecanoate|testosterone undecanoate|mesh-list
6470052|NCT00493987|Testosterone enanthate|testosterone enanthate|mesh-list
6470053|NCT00493987|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6470054|NCT00493987|Dutasteride|dutasteride|mesh-list
6470055|NCT00493987|Androgens|androgens|mesh-ancestor
6470056|NCT00493987|Hormones|hormones|mesh-ancestor
6470057|NCT00493987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6470058|NCT00493987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543307|NCT04152759|Immunologic Factors|immunologic factors|mesh-ancestor
5543308|NCT04152759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470059|NCT00493987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6470060|NCT00493987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6470061|NCT00493987|Anabolic Agents|anabolic agents|mesh-ancestor
6470062|NCT00493987|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
5543309|NCT04153032|Diltiazem|diltiazem|mesh-list
5543310|NCT04153032|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5543311|NCT04153032|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5543312|NCT04153032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5543313|NCT04153032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543314|NCT04153032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5543315|NCT04153032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470063|NCT00493987|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6470064|NCT00493987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6470065|NCT00493987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6470066|NCT00493987|Hormone Antagonists|hormone antagonists|mesh-ancestor
6470067|NCT00494078|Insulin Aspart|insulin aspart|mesh-list
6470068|NCT00494078|Insulin, Long-Acting|insulin, long-acting|mesh-list
6470069|NCT00494078|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6470070|NCT00494078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6470071|NCT00494078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470072|NCT00494104|Vitamin D|vitamin d|mesh-list
6139087|NCT01293032|Tamoxifen|tamoxifen|mesh-list
6139088|NCT01293032|Aromatase Inhibitors|aromatase inhibitors|mesh-list
6139089|NCT01293032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139090|NCT01293032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6139091|NCT01293032|Hormone Antagonists|hormone antagonists|mesh-ancestor
6139092|NCT01293032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5543316|NCT04153032|Vasodilator Agents|vasodilator agents|mesh-ancestor
5543317|NCT04152889|Docetaxel|docetaxel|mesh-list
5543318|NCT04152889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5543319|NCT04152889|Tubulin Modulators|tubulin modulators|mesh-ancestor
5543320|NCT04152889|Antimitotic Agents|antimitotic agents|mesh-ancestor
5543321|NCT04152889|Mitosis Modulators|mitosis modulators|mesh-ancestor
5543322|NCT04152889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543323|NCT04152980|Pentoxifylline|pentoxifylline|mesh-list
5543324|NCT04152980|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5543325|NCT04152980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5543326|NCT04152980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543327|NCT04152980|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5543328|NCT04152980|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5543329|NCT04152980|Protective Agents|protective agents|mesh-ancestor
5543330|NCT04152980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543331|NCT04152980|Vasodilator Agents|vasodilator agents|mesh-ancestor
5543332|NCT04152980|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6139093|NCT01293032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139094|NCT01293032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6139095|NCT01293032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6139096|NCT01293032|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6139097|NCT01293032|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6139098|NCT01293032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6139099|NCT01293032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6470073|NCT00494104|Vitamins|vitamins|mesh-ancestor
5543333|NCT04152980|Antioxidants|antioxidants|mesh-ancestor
5543334|NCT04152564|Bupivacaine|bupivacaine|mesh-list
5543335|NCT04152564|Levobupivacaine|levobupivacaine|mesh-list
5543336|NCT04152564|Anesthetics, Local|anesthetics, local|mesh-ancestor
5543337|NCT04152564|Anesthetics|anesthetics|mesh-ancestor
5543338|NCT04152564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5543339|NCT04152564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543340|NCT04152564|Sensory System Agents|sensory system agents|mesh-ancestor
5543341|NCT04152564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5543342|NCT04152551|Risedronic Acid|risedronic acid|mesh-list
5543343|NCT04152551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5543344|NCT04152551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5543345|NCT04152551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543346|NCT04152551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5543347|NCT04152551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543348|NCT04152551|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5543349|NCT04152434|Erenumab|erenumab|mesh-list
5543350|NCT04152434|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
5543351|NCT04152434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543352|NCT04152434|Analgesics|analgesics|mesh-ancestor
5543353|NCT04152434|Sensory System Agents|sensory system agents|mesh-ancestor
5543354|NCT04152434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6139100|NCT01293032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6139101|NCT01293396|Insulin|insulin|mesh-list
6139102|NCT01293396|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6139103|NCT01293396|Insulin Aspart|insulin aspart|mesh-list
6139104|NCT01293396|Insulin, Long-Acting|insulin, long-acting|mesh-list
6139105|NCT01293396|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6139106|NCT01293396|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6139107|NCT01293396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6139108|NCT01293396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139109|NCT01293539|Melphalan|melphalan|mesh-list
6139110|NCT01293539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6139111|NCT01293539|Alkylating Agents|alkylating agents|mesh-ancestor
6470074|NCT00494104|Micronutrients|micronutrients|mesh-ancestor
6470075|NCT00494104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470076|NCT00494104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6470077|NCT00494156|Aspirin|aspirin|mesh-list
6470078|NCT00494156|Heparin|heparin|mesh-list
6470079|NCT00494156|Clopidogrel|clopidogrel|mesh-list
6470080|NCT00494156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6470081|NCT00494156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6470082|NCT00494156|Analgesics|analgesics|mesh-ancestor
6139112|NCT01293539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139113|NCT01293539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6139114|NCT01293539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6139115|NCT01293539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5543355|NCT04152434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543356|NCT04152473|Proglumide|proglumide|mesh-list
5543357|NCT04152473|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5543358|NCT04152473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5543359|NCT04152629|Methylphenidate|methylphenidate|mesh-list
5543360|NCT04152629|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
5543361|NCT04152629|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5543362|NCT04152629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543363|NCT04152629|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5543364|NCT04152629|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5543365|NCT04152629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5543366|NCT04152629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543367|NCT04152629|Dopamine Agents|dopamine agents|mesh-ancestor
5543368|NCT04152629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5543369|NCT04152291|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
5543370|NCT04152291|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5543371|NCT04152291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5543372|NCT04152369|Anti-Infective Agents|anti-infective agents|mesh-list
5543373|NCT04152369|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5543374|NCT04152317|Misoprostol|misoprostol|mesh-list
5543375|NCT04152317|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5543376|NCT04152317|Abortifacient Agents|abortifacient agents|mesh-ancestor
5543377|NCT04152317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5543378|NCT04152317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543379|NCT04152317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5543380|NCT04152317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5543381|NCT04152317|Oxytocics|oxytocics|mesh-ancestor
5543382|NCT04152356|Sorafenib|sorafenib|mesh-list
5543383|NCT04152356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5543384|NCT04152356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5543385|NCT04152356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5543386|NCT04152356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602399|NCT04595045|Botulinum Toxins|botulinum toxins|mesh-list
5602400|NCT04595045|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5602401|NCT04595045|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5602402|NCT04595045|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5602403|NCT04595045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5602404|NCT04595045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602405|NCT04595045|Cholinergic Agents|cholinergic agents|mesh-ancestor
5602406|NCT04595045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5602407|NCT04595045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602408|NCT04595045|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5602409|NCT04595045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6139116|NCT01293539|Immunologic Factors|immunologic factors|mesh-ancestor
6470083|NCT00494156|Sensory System Agents|sensory system agents|mesh-ancestor
6139117|NCT01293539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139118|NCT01293682|Calcitriol|calcitriol|mesh-list
6139119|NCT01293682|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6139120|NCT01293682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139121|NCT01293682|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6139122|NCT01293682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6139123|NCT01293682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139124|NCT01293682|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5543387|NCT04152161|BCG Vaccine|bcg vaccine|mesh-list
5543388|NCT04152161|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5543389|NCT04152161|Immunologic Factors|immunologic factors|mesh-ancestor
6139125|NCT01293682|Vitamins|vitamins|mesh-ancestor
6139126|NCT01293682|Micronutrients|micronutrients|mesh-ancestor
6139127|NCT01293682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6139128|NCT01293695|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
6139129|NCT01293695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6139130|NCT01293695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139131|NCT01293825|Ziprasidone|ziprasidone|mesh-list
6139132|NCT01293825|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6139133|NCT01293825|Serotonin Agents|serotonin agents|mesh-ancestor
6139134|NCT01293825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6139135|NCT01293825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6470084|NCT00494156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6470085|NCT00494156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470086|NCT00494156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6470087|NCT00494156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6470088|NCT00494156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6470089|NCT00494156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6470090|NCT00494156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6470091|NCT00494156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6139136|NCT01293825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470092|NCT00494156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6470093|NCT00494156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6470094|NCT00494156|Antipyretics|antipyretics|mesh-ancestor
6470095|NCT00494156|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6470096|NCT00494156|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6470097|NCT00494156|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6470098|NCT00494156|Purinergic Agents|purinergic agents|mesh-ancestor
6470099|NCT00494156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6470100|NCT00494156|Anticoagulants|anticoagulants|mesh-ancestor
6470101|NCT00494182|Paclitaxel|paclitaxel|mesh-list
6470102|NCT00494182|Carboplatin|carboplatin|mesh-list
6470103|NCT00494182|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6470104|NCT00494182|Sorafenib|sorafenib|mesh-list
6470105|NCT00494182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6470106|NCT00494182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6470107|NCT00494182|Tubulin Modulators|tubulin modulators|mesh-ancestor
6470108|NCT00494182|Antimitotic Agents|antimitotic agents|mesh-ancestor
6470109|NCT00494182|Mitosis Modulators|mitosis modulators|mesh-ancestor
6470110|NCT00494182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139137|NCT01293825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6139138|NCT01293825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6139139|NCT01293825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6139140|NCT01293825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6139141|NCT01293825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6139142|NCT01293825|Dopamine Agents|dopamine agents|mesh-ancestor
6139143|NCT01293968|Diphenhydramine|diphenhydramine|mesh-list
6139144|NCT01293968|Promethazine|promethazine|mesh-list
6470111|NCT00494182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5543390|NCT04152161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543391|NCT04152057|Paclitaxel|paclitaxel|mesh-list
5543392|NCT04152057|Trastuzumab|trastuzumab|mesh-list
5543393|NCT04152057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5543394|NCT04152057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5543395|NCT04152057|Tubulin Modulators|tubulin modulators|mesh-ancestor
5543396|NCT04152057|Antimitotic Agents|antimitotic agents|mesh-ancestor
5543397|NCT04152057|Mitosis Modulators|mitosis modulators|mesh-ancestor
5543398|NCT04152057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6470112|NCT00494182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6470113|NCT00494208|Testosterone|testosterone|mesh-list
6470114|NCT00494208|Androgens|androgens|mesh-ancestor
6470115|NCT00494208|Hormones|hormones|mesh-ancestor
6470116|NCT00494208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6470117|NCT00494208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470118|NCT00494247|Antibodies|antibodies|mesh-list
6470119|NCT00494247|Immunologic Factors|immunologic factors|mesh-ancestor
6470120|NCT00494247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470121|NCT00494312|Pioglitazone|pioglitazone|mesh-list
6470122|NCT00494312|Glyburide|glyburide|mesh-list
6470123|NCT00494312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6470124|NCT00494312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543399|NCT04152057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5543400|NCT04151823|Vitamin D|vitamin d|mesh-list
5543401|NCT04151823|Cholecalciferol|cholecalciferol|mesh-list
5543402|NCT04151823|Vitamins|vitamins|mesh-ancestor
5543403|NCT04151823|Micronutrients|micronutrients|mesh-ancestor
5543404|NCT04151823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543405|NCT04151823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5543406|NCT04151823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5543407|NCT04151849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
5543408|NCT04151849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139145|NCT01293968|Ibuprofen|ibuprofen|mesh-list
6139146|NCT01293968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6139147|NCT01293968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6139148|NCT01293968|Analgesics|analgesics|mesh-ancestor
6139149|NCT01293968|Sensory System Agents|sensory system agents|mesh-ancestor
6139150|NCT01293968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6139151|NCT01293968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139152|NCT01293968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6139153|NCT01293968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6139154|NCT01293968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6139155|NCT01293968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6139156|NCT01293968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139157|NCT01293968|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6139158|NCT01293968|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6139159|NCT01293968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6139160|NCT01293968|Anesthetics, Local|anesthetics, local|mesh-ancestor
6139161|NCT01293968|Anesthetics|anesthetics|mesh-ancestor
6139162|NCT01293968|Antiemetics|antiemetics|mesh-ancestor
6139163|NCT01293968|Autonomic Agents|autonomic agents|mesh-ancestor
6139164|NCT01293968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6139165|NCT01293968|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6139166|NCT01293968|Histamine Antagonists|histamine antagonists|mesh-ancestor
6139167|NCT01293968|Histamine Agents|histamine agents|mesh-ancestor
6139168|NCT01293968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6139169|NCT01293968|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6139170|NCT01293968|Antipruritics|antipruritics|mesh-ancestor
6139171|NCT01293968|Dermatologic Agents|dermatologic agents|mesh-ancestor
6139172|NCT01294098|Bupivacaine|bupivacaine|mesh-list
6139173|NCT01294098|Anesthetics, Local|anesthetics, local|mesh-ancestor
6139174|NCT01294098|Anesthetics|anesthetics|mesh-ancestor
6139175|NCT01294098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6139176|NCT01294098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139177|NCT01294098|Sensory System Agents|sensory system agents|mesh-ancestor
6139178|NCT01294098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6139179|NCT01294163|Propofol|propofol|mesh-list
6139180|NCT01294163|Sevoflurane|sevoflurane|mesh-list
6139181|NCT01294163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6139182|NCT01294163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6139183|NCT01294163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139184|NCT01294163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6139185|NCT01294163|Anesthetics, General|anesthetics, general|mesh-ancestor
6139186|NCT01294163|Anesthetics|anesthetics|mesh-ancestor
6470125|NCT00494338|Docetaxel|docetaxel|mesh-list
6470126|NCT00494338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6470127|NCT00494338|Tubulin Modulators|tubulin modulators|mesh-ancestor
6470128|NCT00494338|Antimitotic Agents|antimitotic agents|mesh-ancestor
6470129|NCT00494338|Mitosis Modulators|mitosis modulators|mesh-ancestor
6470130|NCT00494338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139187|NCT01294163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6139188|NCT01294163|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6139189|NCT01294306|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6139190|NCT01294306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6139191|NCT01294306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6139192|NCT01294306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6139193|NCT01294306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139194|NCT01294319|Dexamethasone|dexamethasone|mesh-list
6139195|NCT01294319|Dexamethasone acetate|dexamethasone acetate|mesh-list
6139196|NCT01294319|Spironolactone|spironolactone|mesh-list
5543409|NCT04151849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5543410|NCT04151849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543411|NCT04151680|Rivaroxaban|rivaroxaban|mesh-list
5543412|NCT04151680|Apixaban|apixaban|mesh-list
5543413|NCT04151680|Edoxaban|edoxaban|mesh-list
5543414|NCT04151680|Dabigatran|dabigatran|mesh-list
5543415|NCT04151680|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5543416|NCT04151680|Antithrombins|antithrombins|mesh-ancestor
5543417|NCT04151680|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5543418|NCT04151680|Protease Inhibitors|protease inhibitors|mesh-ancestor
5543419|NCT04151680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5543420|NCT04151680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543421|NCT04151680|Anticoagulants|anticoagulants|mesh-ancestor
5543422|NCT04151706|Cyclophosphamide|cyclophosphamide|mesh-list
5543423|NCT04151706|Busulfan|busulfan|mesh-list
5543424|NCT04151706|Thiotepa|thiotepa|mesh-list
5543425|NCT04151706|Fludarabine|fludarabine|mesh-list
5543426|NCT04151706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6139197|NCT01294319|Mifepristone|mifepristone|mesh-list
6139198|NCT01294319|BB 1101|bb 1101|mesh-list
6139199|NCT01294319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6139200|NCT01294319|Antiemetics|antiemetics|mesh-ancestor
6139201|NCT01294319|Autonomic Agents|autonomic agents|mesh-ancestor
6139202|NCT01294319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6139203|NCT01294319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139204|NCT01294319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6139205|NCT01294319|Glucocorticoids|glucocorticoids|mesh-ancestor
6139206|NCT01294319|Hormones|hormones|mesh-ancestor
6139207|NCT01294319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6139208|NCT01294319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6139209|NCT01294319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6139210|NCT01294319|Protease Inhibitors|protease inhibitors|mesh-ancestor
6139211|NCT01294319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6139212|NCT01294319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139213|NCT01294319|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6139214|NCT01294319|Hormone Antagonists|hormone antagonists|mesh-ancestor
6139215|NCT01294319|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6139216|NCT01294319|Diuretics|diuretics|mesh-ancestor
6139217|NCT01294319|Natriuretic Agents|natriuretic agents|mesh-ancestor
6139218|NCT01294319|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6139219|NCT01294319|Abortifacient Agents|abortifacient agents|mesh-ancestor
6139220|NCT01294319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6139221|NCT01294319|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6139222|NCT01294319|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6470131|NCT00494377|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6470132|NCT00494377|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6470133|NCT00494377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6470134|NCT00494377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6470135|NCT00494377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6470136|NCT00494377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6470137|NCT00494377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139223|NCT01294319|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6139224|NCT01294319|Contraceptive Agents|contraceptive agents|mesh-ancestor
6470138|NCT00494377|Analgesics|analgesics|mesh-ancestor
6470139|NCT00494377|Sensory System Agents|sensory system agents|mesh-ancestor
6470140|NCT00494377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6470141|NCT00494377|Antidepressive Agents|antidepressive agents|mesh-ancestor
6470142|NCT00494377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5543427|NCT04151706|Immunologic Factors|immunologic factors|mesh-ancestor
5543428|NCT04151706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543429|NCT04151706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6470143|NCT00494377|Dopamine Agents|dopamine agents|mesh-ancestor
6470144|NCT00494429|Morphine|morphine|mesh-list
6470145|NCT00494429|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6470146|NCT00494429|Narcotics|narcotics|mesh-ancestor
6470147|NCT00494429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6139225|NCT01294319|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6139226|NCT01294319|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6139227|NCT01294319|Luteolytic Agents|luteolytic agents|mesh-ancestor
6139228|NCT01294319|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6139229|NCT01294319|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6470148|NCT00494429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470149|NCT00494429|Analgesics|analgesics|mesh-ancestor
6470150|NCT00494429|Sensory System Agents|sensory system agents|mesh-ancestor
6470151|NCT00494429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6470152|NCT00494468|Zolpidem|zolpidem|mesh-list
5543430|NCT04151706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5543431|NCT04151706|Alkylating Agents|alkylating agents|mesh-ancestor
6470153|NCT00494468|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6470154|NCT00494468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6470155|NCT00494468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5543432|NCT04151706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543433|NCT04151706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5543434|NCT04151706|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5543435|NCT04151472|Ubiquinone|ubiquinone|mesh-list
5543436|NCT04151472|Idebenone|idebenone|mesh-list
5543437|NCT04151472|Antioxidants|antioxidants|mesh-ancestor
5543438|NCT04151472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543439|NCT04151472|Protective Agents|protective agents|mesh-ancestor
5543440|NCT04151472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543441|NCT04151472|Micronutrients|micronutrients|mesh-ancestor
5543442|NCT04151563|Docetaxel|docetaxel|mesh-list
5543443|NCT04151563|Nivolumab|nivolumab|mesh-list
5543444|NCT04151563|Ipilimumab|ipilimumab|mesh-list
5543445|NCT04151563|Ramucirumab|ramucirumab|mesh-list
5543446|NCT04151563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5543447|NCT04151563|Tubulin Modulators|tubulin modulators|mesh-ancestor
5543448|NCT04151563|Antimitotic Agents|antimitotic agents|mesh-ancestor
5543449|NCT04151563|Mitosis Modulators|mitosis modulators|mesh-ancestor
5543450|NCT04151563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543451|NCT04151563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6470156|NCT00494468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470157|NCT00494468|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6470158|NCT00494468|GABA Agonists|gaba agonists|mesh-ancestor
6470159|NCT00494468|GABA Agents|gaba agents|mesh-ancestor
6470160|NCT00494468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6139230|NCT01294358|Gemcitabine|gemcitabine|mesh-list
6139231|NCT01294358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6139232|NCT01294358|Antimetabolites|antimetabolites|mesh-ancestor
6139233|NCT01294358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139234|NCT01294358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6139235|NCT01294358|Antiviral Agents|antiviral agents|mesh-ancestor
6139236|NCT01294358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6139237|NCT01294358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6139238|NCT01294358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6139239|NCT01294358|Immunologic Factors|immunologic factors|mesh-ancestor
6139240|NCT01294358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139241|NCT01294384|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6139242|NCT01294384|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6139243|NCT01294384|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6139244|NCT01294384|Laxatives|laxatives|mesh-ancestor
6139245|NCT01294384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6139246|NCT01294397|Denosumab|denosumab|mesh-list
6139247|NCT01294397|Etanercept|etanercept|mesh-list
5543452|NCT04151563|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5543453|NCT04151719|Bromides|bromides|mesh-list
6139248|NCT01294397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6470161|NCT00494468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139249|NCT01294397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6139250|NCT01294397|Analgesics|analgesics|mesh-ancestor
6139251|NCT01294397|Sensory System Agents|sensory system agents|mesh-ancestor
6139252|NCT01294397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6139253|NCT01294397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139254|NCT01294397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6139255|NCT01294397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6139256|NCT01294397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6139257|NCT01294397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6139258|NCT01294397|Immunologic Factors|immunologic factors|mesh-ancestor
6139259|NCT01294397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6139260|NCT01294423|Dapagliflozin|dapagliflozin|mesh-list
6139261|NCT01294423|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6139262|NCT01294423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139263|NCT01294423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5543454|NCT04151719|Methylnaltrexone|methylnaltrexone|mesh-list
5543455|NCT04151719|Anticonvulsants|anticonvulsants|mesh-ancestor
5543456|NCT04151719|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5543457|NCT04151719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543458|NCT04151719|Sensory System Agents|sensory system agents|mesh-ancestor
5543459|NCT04151719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5543460|NCT04151459|Metformin|metformin|mesh-list
5543461|NCT04151459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5543462|NCT04151459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543463|NCT04151355|Atorvastatin|atorvastatin|mesh-list
5543464|NCT04151355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6139264|NCT01294423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139265|NCT01294436|Dapagliflozin|dapagliflozin|mesh-list
6139266|NCT01294436|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6139267|NCT01294436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139268|NCT01294436|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6139269|NCT01294436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139270|NCT01294449|Cytarabine|cytarabine|mesh-list
6139271|NCT01294449|Dexamethasone|dexamethasone|mesh-list
6139272|NCT01294449|Methotrexate|methotrexate|mesh-list
6139273|NCT01294449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6139274|NCT01294449|Antimetabolites|antimetabolites|mesh-ancestor
6139275|NCT01294449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139276|NCT01294449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6139277|NCT01294449|Antiviral Agents|antiviral agents|mesh-ancestor
6139278|NCT01294449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6139279|NCT01294449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6139280|NCT01294449|Immunologic Factors|immunologic factors|mesh-ancestor
6139281|NCT01294449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139282|NCT01294449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5543465|NCT04151355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5543466|NCT04151355|Antimetabolites|antimetabolites|mesh-ancestor
5543467|NCT04151355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543468|NCT04151355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5543469|NCT04151355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5543470|NCT04151355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5543471|NCT04151381|Aminophylline|aminophylline|mesh-list
5543472|NCT04151381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5543473|NCT04151381|Autonomic Agents|autonomic agents|mesh-ancestor
5543474|NCT04151381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5543475|NCT04151381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543476|NCT04151381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5543477|NCT04151381|Respiratory System Agents|respiratory system agents|mesh-ancestor
5543478|NCT04151381|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5543479|NCT04151381|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5543480|NCT04151381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5543481|NCT04151381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543482|NCT04151381|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6139283|NCT01294449|Antiemetics|antiemetics|mesh-ancestor
6139284|NCT01294449|Autonomic Agents|autonomic agents|mesh-ancestor
6139285|NCT01294449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6139286|NCT01294449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6139287|NCT01294449|Glucocorticoids|glucocorticoids|mesh-ancestor
6139288|NCT01294449|Hormones|hormones|mesh-ancestor
6139289|NCT01294449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6139290|NCT01294449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6205363|NCT02084134|Autonomic Agents|autonomic agents|mesh-ancestor
5725568|NCT03179904|Immunoglobulins|immunoglobulins|mesh-list
5725569|NCT03179904|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5543483|NCT04151381|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5543484|NCT04151381|Purinergic Agents|purinergic agents|mesh-ancestor
5543485|NCT04151381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6139291|NCT01294449|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6139292|NCT01294449|Abortifacient Agents|abortifacient agents|mesh-ancestor
6139293|NCT01294449|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6139294|NCT01294449|Dermatologic Agents|dermatologic agents|mesh-ancestor
6139295|NCT01294449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6139296|NCT01294449|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6139297|NCT01294449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6139298|NCT01294449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6139299|NCT01294462|Aspirin|aspirin|mesh-list
6139300|NCT01294462|Clopidogrel|clopidogrel|mesh-list
6139301|NCT01294462|Ticagrelor|ticagrelor|mesh-list
6139302|NCT01294462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6470162|NCT00494533|Treprostinil|treprostinil|mesh-list
6470163|NCT00494533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6470164|NCT00494559|Pioglitazone|pioglitazone|mesh-list
6139303|NCT01294462|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6139304|NCT01294462|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6139305|NCT01294462|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6139306|NCT01294462|Purinergic Agents|purinergic agents|mesh-ancestor
6139307|NCT01294462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6139308|NCT01294462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139309|NCT01294462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139310|NCT01294462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6139311|NCT01294462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6139312|NCT01294462|Analgesics|analgesics|mesh-ancestor
6139313|NCT01294462|Sensory System Agents|sensory system agents|mesh-ancestor
6139314|NCT01294462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6139315|NCT01294462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6139316|NCT01294462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6139317|NCT01294462|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6139318|NCT01294462|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6139319|NCT01294462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6470165|NCT00494559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6470166|NCT00494559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470167|NCT00494572|Montelukast|montelukast|mesh-list
6470168|NCT00494572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6470169|NCT00494572|Respiratory System Agents|respiratory system agents|mesh-ancestor
6470170|NCT00494572|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6470171|NCT00494572|Hormone Antagonists|hormone antagonists|mesh-ancestor
6470172|NCT00494572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6470173|NCT00494572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470174|NCT00494572|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6470175|NCT00494572|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6470176|NCT00494572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6470177|NCT00494598|Sufentanil|sufentanil|mesh-list
6470178|NCT00494598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5543486|NCT04151381|Protective Agents|protective agents|mesh-ancestor
5543487|NCT04150900|Pembrolizumab|pembrolizumab|mesh-list
5543488|NCT04150900|Bavituximab|bavituximab|mesh-list
5543489|NCT04150900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5543490|NCT04150900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5543491|NCT04151017|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
5543492|NCT04151017|Hemostatics|hemostatics|mesh-ancestor
5543493|NCT04151017|Coagulants|coagulants|mesh-ancestor
5543494|NCT04151147|Mitogens|mitogens|mesh-list
6139320|NCT01294462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6139321|NCT01294462|Antipyretics|antipyretics|mesh-ancestor
6470179|NCT00494598|Narcotics|narcotics|mesh-ancestor
6470180|NCT00494598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6470181|NCT00494598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470182|NCT00494598|Analgesics|analgesics|mesh-ancestor
6470183|NCT00494598|Sensory System Agents|sensory system agents|mesh-ancestor
6470184|NCT00494598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6470185|NCT00494598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6470186|NCT00494598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6470187|NCT00494598|Anesthetics, General|anesthetics, general|mesh-ancestor
6470188|NCT00494598|Anesthetics|anesthetics|mesh-ancestor
6470189|NCT00494611|Cetuximab|cetuximab|mesh-list
6470190|NCT00494611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6470191|NCT00494611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6470192|NCT00494624|Prednisolone|prednisolone|mesh-list
6470193|NCT00494624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6470194|NCT00494624|Glucocorticoids|glucocorticoids|mesh-ancestor
6470195|NCT00494624|Hormones|hormones|mesh-ancestor
6470196|NCT00494624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6470197|NCT00494624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470198|NCT00494624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6470199|NCT00494624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6470200|NCT00494663|Ketoconazole|ketoconazole|mesh-list
6470201|NCT00494663|Antifungal Agents|antifungal agents|mesh-ancestor
6470202|NCT00494663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6470203|NCT00494663|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6470204|NCT00494663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6139322|NCT01294553|Metformin|metformin|mesh-list
6139323|NCT01294553|Rosiglitazone|rosiglitazone|mesh-list
6139324|NCT01294553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6139325|NCT01294553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139326|NCT01294579|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6139327|NCT01294579|Ofatumumab|ofatumumab|mesh-list
6139328|NCT01294579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6139329|NCT01294579|Alkylating Agents|alkylating agents|mesh-ancestor
6139330|NCT01294579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139331|NCT01294579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6139332|NCT01294592|Tamsulosin|tamsulosin|mesh-list
6139333|NCT01294592|Dutasteride|dutasteride|mesh-list
6139334|NCT01294592|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6139335|NCT01294592|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6139336|NCT01294592|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6139337|NCT01294592|Adrenergic Agents|adrenergic agents|mesh-ancestor
6139338|NCT01294592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6139339|NCT01294592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139340|NCT01294592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139341|NCT01294592|Urological Agents|urological agents|mesh-ancestor
6139342|NCT01294592|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6139343|NCT01294592|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6139344|NCT01294592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6139345|NCT01294592|Hormone Antagonists|hormone antagonists|mesh-ancestor
6139346|NCT01294592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6139347|NCT01294644|Deoxycholic Acid|deoxycholic acid|mesh-list
6139348|NCT01294644|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6139349|NCT01294644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6470205|NCT00494663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6470206|NCT00494663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6470207|NCT00494663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6470208|NCT00494663|Hormone Antagonists|hormone antagonists|mesh-ancestor
6470209|NCT00494663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6470210|NCT00494663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470211|NCT00494663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6470212|NCT00494715|Valsartan|valsartan|mesh-list
6470213|NCT00494715|Benazepril|benazepril|mesh-list
6470214|NCT00494715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6470215|NCT00494715|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6470216|NCT00494715|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5543495|NCT04151147|Mitosis Modulators|mitosis modulators|mesh-ancestor
5543496|NCT04151147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543497|NCT04151082|Prednisone|prednisone|mesh-list
5543498|NCT04151082|Methylprednisolone|methylprednisolone|mesh-list
5543499|NCT04151082|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5543500|NCT04151082|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5543501|NCT04151082|Prednisolone|prednisolone|mesh-list
5543502|NCT04151082|Prednisolone acetate|prednisolone acetate|mesh-list
5543503|NCT04151082|Cortisone|cortisone|mesh-list
5543504|NCT04151082|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5543505|NCT04151082|Prednisolone phosphate|prednisolone phosphate|mesh-list
5543506|NCT04151082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5543507|NCT04151082|Glucocorticoids|glucocorticoids|mesh-ancestor
5543508|NCT04151082|Hormones|hormones|mesh-ancestor
5543509|NCT04151082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5543510|NCT04151082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470217|NCT00494715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666609|NCT01523418|Antithrombins|antithrombins|mesh-ancestor
5543511|NCT04151082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5543512|NCT04151082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6139350|NCT01294683|Niacin|niacin|mesh-list
6139351|NCT01294683|Niacinamide|niacinamide|mesh-list
6139352|NCT01294683|Nicotinic Acids|nicotinic acids|mesh-list
6139353|NCT01294683|Simvastatin|simvastatin|mesh-list
6139354|NCT01294683|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6139355|NCT01294683|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6139356|NCT01294683|Antimetabolites|antimetabolites|mesh-ancestor
6139357|NCT01294683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139358|NCT01294683|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6139359|NCT01294683|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6139360|NCT01294683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6139361|NCT01294683|Vasodilator Agents|vasodilator agents|mesh-ancestor
6139362|NCT01294683|Vitamin B Complex|vitamin b complex|mesh-ancestor
6139363|NCT01294683|Vitamins|vitamins|mesh-ancestor
6139364|NCT01294683|Micronutrients|micronutrients|mesh-ancestor
6139365|NCT01294683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139366|NCT01294787|Glycopyrrolate|glycopyrrolate|mesh-list
6139367|NCT01294787|Bromides|bromides|mesh-list
6139368|NCT01294787|Tiotropium Bromide|tiotropium bromide|mesh-list
6139369|NCT01294787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6139370|NCT01294787|Autonomic Agents|autonomic agents|mesh-ancestor
6139371|NCT01294787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6139372|NCT01294787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139373|NCT01294787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5543513|NCT04151082|Antiemetics|antiemetics|mesh-ancestor
5543514|NCT04151082|Autonomic Agents|autonomic agents|mesh-ancestor
5543515|NCT04151082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5543516|NCT04151082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5543517|NCT04151082|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5543518|NCT04151082|Protective Agents|protective agents|mesh-ancestor
5543519|NCT04150965|Thalidomide|thalidomide|mesh-list
5543520|NCT04150965|Dexamethasone|dexamethasone|mesh-list
5543521|NCT04150965|Dexamethasone acetate|dexamethasone acetate|mesh-list
5543522|NCT04150965|Pomalidomide|pomalidomide|mesh-list
5543523|NCT04150965|Elotuzumab|elotuzumab|mesh-list
6139374|NCT01294787|Respiratory System Agents|respiratory system agents|mesh-ancestor
6139375|NCT01294787|Parasympatholytics|parasympatholytics|mesh-ancestor
6139376|NCT01294787|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6139377|NCT01294787|Cholinergic Agents|cholinergic agents|mesh-ancestor
6139378|NCT01294787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5543524|NCT04150965|BB 1101|bb 1101|mesh-list
5543525|NCT04150965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5543526|NCT04150965|Antiemetics|antiemetics|mesh-ancestor
5543527|NCT04150965|Autonomic Agents|autonomic agents|mesh-ancestor
6139379|NCT01294787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139380|NCT01294787|Anticonvulsants|anticonvulsants|mesh-ancestor
6139381|NCT01294787|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6139382|NCT01294787|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6139383|NCT01295034|Vitamin D|vitamin d|mesh-list
6139384|NCT01295034|Ergocalciferols|ergocalciferols|mesh-list
6139385|NCT01295034|Vitamins|vitamins|mesh-list
6470218|NCT00494715|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6470219|NCT00494715|Protease Inhibitors|protease inhibitors|mesh-ancestor
6470220|NCT00494715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6470221|NCT00494728|Nicotine|nicotine|mesh-list
6666610|NCT01523418|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6139386|NCT01295034|Micronutrients|micronutrients|mesh-ancestor
6139387|NCT01295034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139388|NCT01295034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6470222|NCT00494728|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6470223|NCT00494728|Autonomic Agents|autonomic agents|mesh-ancestor
6470224|NCT00494728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6470225|NCT00494728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470226|NCT00494728|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6470227|NCT00494728|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6470228|NCT00494728|Cholinergic Agents|cholinergic agents|mesh-ancestor
6470229|NCT00494728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6470230|NCT00494728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6470231|NCT00494741|Mycophenolic Acid|mycophenolic acid|mesh-list
6470232|NCT00494741|Azathioprine|azathioprine|mesh-list
6470233|NCT00494741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6139389|NCT01295034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6139390|NCT01295112|Dexamethasone|dexamethasone|mesh-list
6139391|NCT01295112|Dexamethasone acetate|dexamethasone acetate|mesh-list
6139392|NCT01295112|Bevacizumab|bevacizumab|mesh-list
6139393|NCT01295112|BB 1101|bb 1101|mesh-list
6139394|NCT01295112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6139395|NCT01295112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6139396|NCT01295112|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6139397|NCT01295112|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6139398|NCT01295112|Growth Substances|growth substances|mesh-ancestor
6139399|NCT01295112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139400|NCT01295112|Growth Inhibitors|growth inhibitors|mesh-ancestor
6139401|NCT01295112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6139402|NCT01295112|Antiemetics|antiemetics|mesh-ancestor
6139403|NCT01295112|Autonomic Agents|autonomic agents|mesh-ancestor
6139404|NCT01295112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6139405|NCT01295112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6139406|NCT01295112|Glucocorticoids|glucocorticoids|mesh-ancestor
6139407|NCT01295112|Hormones|hormones|mesh-ancestor
6139408|NCT01295112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6139409|NCT01295112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6139410|NCT01295112|Protease Inhibitors|protease inhibitors|mesh-ancestor
6139411|NCT01295112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6139412|NCT01295112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139413|NCT01295515|Interferons|interferons|mesh-list
6139414|NCT01295515|Interferon-alpha|interferon-alpha|mesh-list
6139415|NCT01295515|Interferon alpha-2|interferon alpha-2|mesh-list
6139416|NCT01295515|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6139417|NCT01295515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6139418|NCT01295515|Antiviral Agents|antiviral agents|mesh-ancestor
6139419|NCT01295515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6139420|NCT01295515|Immunologic Factors|immunologic factors|mesh-ancestor
6139421|NCT01295515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139422|NCT01295710|Immunoglobulins|immunoglobulins|mesh-list
6139423|NCT01295710|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6139424|NCT01295710|Immunologic Factors|immunologic factors|mesh-ancestor
6139425|NCT01295710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139426|NCT01295710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6139427|NCT01295814|Adalimumab|adalimumab|mesh-list
6139428|NCT01295814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6139429|NCT01295814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6139430|NCT01295827|Pembrolizumab|pembrolizumab|mesh-list
6139431|NCT01295827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6139432|NCT01295827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6139433|NCT01295879|Vitamin D|vitamin d|mesh-list
6139434|NCT01295879|Ergocalciferols|ergocalciferols|mesh-list
6139435|NCT01295879|Vitamins|vitamins|mesh-ancestor
5543528|NCT04150965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5543529|NCT04150965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543530|NCT04150965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5543531|NCT04150965|Glucocorticoids|glucocorticoids|mesh-ancestor
5543532|NCT04150965|Hormones|hormones|mesh-ancestor
5543533|NCT04150965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5543534|NCT04150965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5543535|NCT04150965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5543536|NCT04150965|Protease Inhibitors|protease inhibitors|mesh-ancestor
5543537|NCT04150965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5543538|NCT04150965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543539|NCT04150965|Immunologic Factors|immunologic factors|mesh-ancestor
6139436|NCT01295879|Micronutrients|micronutrients|mesh-ancestor
6139437|NCT01295879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139438|NCT01295879|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6139439|NCT01295879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6488563|NCT00584779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5543540|NCT04150965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5543541|NCT04150965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5543542|NCT04150965|Growth Substances|growth substances|mesh-ancestor
5543543|NCT04150965|Growth Inhibitors|growth inhibitors|mesh-ancestor
5543544|NCT04150965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6139440|NCT01296035|Panitumumab|panitumumab|mesh-list
6139441|NCT01296035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6139442|NCT01296035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6139443|NCT01296152|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6139444|NCT01296152|Medroxyprogesterone|medroxyprogesterone|mesh-list
6139445|NCT01296152|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6139446|NCT01296152|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6139447|NCT01296152|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6139448|NCT01296152|Contraceptive Agents|contraceptive agents|mesh-ancestor
6139449|NCT01296152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5543545|NCT04150965|Leprostatic Agents|leprostatic agents|mesh-ancestor
5543546|NCT04150965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5543547|NCT04150965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5543548|NCT04151277|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5543549|NCT04151277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5543550|NCT04150939|Immunologic Factors|immunologic factors|mesh-list
5543551|NCT04150939|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
5543552|NCT04150939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543553|NCT04150575|Paclitaxel|paclitaxel|mesh-list
5543554|NCT04150575|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5543555|NCT04150575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5543556|NCT04150575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5543557|NCT04150575|Tubulin Modulators|tubulin modulators|mesh-ancestor
5543558|NCT04150575|Antimitotic Agents|antimitotic agents|mesh-ancestor
5543559|NCT04150575|Mitosis Modulators|mitosis modulators|mesh-ancestor
5543560|NCT04150575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543561|NCT04150614|Dexamethasone|dexamethasone|mesh-list
5543562|NCT04150614|Ondansetron|ondansetron|mesh-list
6139450|NCT01296152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139451|NCT01296152|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6139452|NCT01296152|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6139453|NCT01296152|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6139454|NCT01296152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6139455|NCT01296152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6139456|NCT01296191|Moxifloxacin|moxifloxacin|mesh-list
6139457|NCT01296191|Besifloxacin|besifloxacin|mesh-list
6139458|NCT01296191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6139459|NCT01296191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6470234|NCT00494741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6470235|NCT00494741|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6470236|NCT00494741|Antitubercular Agents|antitubercular agents|mesh-ancestor
6470237|NCT00494741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6470238|NCT00494741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6470239|NCT00494741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6470240|NCT00494741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6470241|NCT00494741|Antimetabolites|antimetabolites|mesh-ancestor
6139460|NCT01296191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6139461|NCT01296191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6139462|NCT01296191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6139463|NCT01296191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139464|NCT01296191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6139465|NCT01296347|Ketamine|ketamine|mesh-list
6139466|NCT01296347|Analgesics|analgesics|mesh-ancestor
6139467|NCT01296347|Sensory System Agents|sensory system agents|mesh-ancestor
6139468|NCT01296347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6139469|NCT01296347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139470|NCT01296347|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6139471|NCT01296347|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6139472|NCT01296347|Anesthetics, General|anesthetics, general|mesh-ancestor
6139473|NCT01296347|Anesthetics|anesthetics|mesh-ancestor
6139474|NCT01296347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6139475|NCT01296347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6139476|NCT01296347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6139477|NCT01296347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6139478|NCT01296347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139479|NCT01296412|Metformin|metformin|mesh-list
6139480|NCT01296412|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6139481|NCT01296412|Liraglutide|liraglutide|mesh-list
6666611|NCT01523418|Protease Inhibitors|protease inhibitors|mesh-ancestor
5543563|NCT04150614|Granisetron|granisetron|mesh-list
6470242|NCT00494741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6470243|NCT00494741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6470244|NCT00494741|Immunologic Factors|immunologic factors|mesh-ancestor
5543564|NCT04150614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5543565|NCT04150614|Antiemetics|antiemetics|mesh-ancestor
5543566|NCT04150614|Autonomic Agents|autonomic agents|mesh-ancestor
5543567|NCT04150614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5543568|NCT04150614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543569|NCT04150614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5543570|NCT04150614|Glucocorticoids|glucocorticoids|mesh-ancestor
5543571|NCT04150614|Hormones|hormones|mesh-ancestor
5543572|NCT04150614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5543573|NCT04150614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5543574|NCT04150614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5543575|NCT04150614|Antipruritics|antipruritics|mesh-ancestor
5543576|NCT04150614|Dermatologic Agents|dermatologic agents|mesh-ancestor
5543577|NCT04150614|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5543578|NCT04150614|Serotonin Agents|serotonin agents|mesh-ancestor
5543579|NCT04150614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5543580|NCT04150614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543581|NCT04150614|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5543582|NCT04150614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5543583|NCT04150614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5543584|NCT04150614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5543585|NCT04150614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5543586|NCT04150458|Choline|choline|mesh-list
5543587|NCT04150458|Lipotropic Agents|lipotropic agents|mesh-ancestor
5543588|NCT04150458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5543589|NCT04150458|Antimetabolites|antimetabolites|mesh-ancestor
5543590|NCT04150458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543591|NCT04150458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5543592|NCT04150458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5543593|NCT04150458|Nootropic Agents|nootropic agents|mesh-ancestor
5543594|NCT04150640|Fluorouracil|fluorouracil|mesh-list
5543595|NCT04150640|Oxaliplatin|oxaliplatin|mesh-list
5543596|NCT04150640|Trastuzumab|trastuzumab|mesh-list
5543597|NCT04150640|Irinotecan|irinotecan|mesh-list
5543598|NCT04150640|Antimetabolites|antimetabolites|mesh-ancestor
6470245|NCT00494741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470246|NCT00494741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6470247|NCT00494832|Dexmedetomidine|dexmedetomidine|mesh-list
6470248|NCT00494832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6470249|NCT00494832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6470250|NCT00494832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470251|NCT00494832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6470252|NCT00494832|Analgesics|analgesics|mesh-ancestor
6470253|NCT00494832|Sensory System Agents|sensory system agents|mesh-ancestor
6470254|NCT00494832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6470255|NCT00494832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6470256|NCT00494832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6139482|NCT01296412|Glimepiride|glimepiride|mesh-list
6139483|NCT01296412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6139484|NCT01296412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139485|NCT01296412|Incretins|incretins|mesh-ancestor
6139486|NCT01296412|Hormones|hormones|mesh-ancestor
6139487|NCT01296412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6139488|NCT01296412|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6139489|NCT01296412|Protease Inhibitors|protease inhibitors|mesh-ancestor
6139490|NCT01296412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6139491|NCT01296412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139492|NCT01296412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6139493|NCT01296412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6139494|NCT01296412|Immunologic Factors|immunologic factors|mesh-ancestor
6139495|NCT01296542|Moxifloxacin|moxifloxacin|mesh-list
6139496|NCT01296542|Besifloxacin|besifloxacin|mesh-list
6139497|NCT01296542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6139498|NCT01296542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6139499|NCT01296542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6139500|NCT01296542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6139501|NCT01296542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6139502|NCT01296542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139503|NCT01296542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6139504|NCT01296568|Gemcitabine|gemcitabine|mesh-list
6139505|NCT01296568|Pemetrexed|pemetrexed|mesh-list
6139506|NCT01296568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6139507|NCT01296568|Antimetabolites|antimetabolites|mesh-ancestor
6139508|NCT01296568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139509|NCT01296568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6139510|NCT01296568|Antiviral Agents|antiviral agents|mesh-ancestor
6139511|NCT01296568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6139512|NCT01296568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6139513|NCT01296568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6139514|NCT01296568|Immunologic Factors|immunologic factors|mesh-ancestor
6139515|NCT01296568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139516|NCT01296568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6139517|NCT01296568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6139518|NCT01296646|Naltrexone|naltrexone|mesh-list
6139519|NCT01296646|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6139520|NCT01296646|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6139521|NCT01296646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139522|NCT01296646|Sensory System Agents|sensory system agents|mesh-ancestor
6139523|NCT01296646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6139524|NCT01296672|Finasteride|finasteride|mesh-list
6139525|NCT01296672|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6139526|NCT01296672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6139527|NCT01296672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6139528|NCT01296672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139529|NCT01296672|Hormone Antagonists|hormone antagonists|mesh-ancestor
6139530|NCT01296672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6139531|NCT01296672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139532|NCT01296672|Urological Agents|urological agents|mesh-ancestor
6139533|NCT01296698|Nicotine|nicotine|mesh-list
6139534|NCT01296698|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6139535|NCT01296698|Autonomic Agents|autonomic agents|mesh-ancestor
6139536|NCT01296698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6139537|NCT01296698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139538|NCT01296698|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6139539|NCT01296698|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6139540|NCT01296698|Cholinergic Agents|cholinergic agents|mesh-ancestor
6139541|NCT01296698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6139542|NCT01296698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139543|NCT01296763|Irinotecan|irinotecan|mesh-list
6139544|NCT01296763|Olaparib|olaparib|mesh-list
6139545|NCT01296763|Mitomycins|mitomycins|mesh-list
6139546|NCT01296763|Mitomycin|mitomycin|mesh-list
6139547|NCT01296763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6139548|NCT01296763|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6139549|NCT01296763|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6139550|NCT01296763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6139551|NCT01296763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139552|NCT01296763|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6139553|NCT01296763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6139554|NCT01296763|Alkylating Agents|alkylating agents|mesh-ancestor
6139555|NCT01296763|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6139556|NCT01296815|Bevacizumab|bevacizumab|mesh-list
6139557|NCT01296815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6139558|NCT01296815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6139559|NCT01296815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6470257|NCT00494832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5543599|NCT04150640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543600|NCT04150640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5543601|NCT04150640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5543602|NCT04150640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5543603|NCT04150640|Immunologic Factors|immunologic factors|mesh-ancestor
5543604|NCT04150640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139560|NCT01296815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6470258|NCT00494832|Adrenergic Agents|adrenergic agents|mesh-ancestor
6470259|NCT00494832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6470260|NCT00494832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6470261|NCT00494884|Vildagliptin|vildagliptin|mesh-list
6470262|NCT00494884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6470263|NCT00494884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470264|NCT00494884|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6470265|NCT00494884|Protease Inhibitors|protease inhibitors|mesh-ancestor
6470266|NCT00494884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6470267|NCT00494884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6470268|NCT00494897|Cytarabine|cytarabine|mesh-list
6470269|NCT00494897|Prednisone|prednisone|mesh-list
6470270|NCT00494897|Cyclophosphamide|cyclophosphamide|mesh-list
6470271|NCT00494897|Methotrexate|methotrexate|mesh-list
6470272|NCT00494897|Vincristine|vincristine|mesh-list
6470273|NCT00494897|Daunorubicin|daunorubicin|mesh-list
6666612|NCT01523418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6139561|NCT01296815|Growth Substances|growth substances|mesh-ancestor
6139562|NCT01296815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139563|NCT01296815|Growth Inhibitors|growth inhibitors|mesh-ancestor
6139564|NCT01296932|BI 836826|bi 836826|mesh-list
6139565|NCT01296932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6139566|NCT01296932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6139567|NCT01297062|Exenatide|exenatide|mesh-list
6139568|NCT01297062|Moxifloxacin|moxifloxacin|mesh-list
6139569|NCT01297062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6666613|NCT01523418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666614|NCT01523418|Anticoagulants|anticoagulants|mesh-ancestor
6666615|NCT01523431|Leucovorin|leucovorin|mesh-list
6666616|NCT01523431|Fluorouracil|fluorouracil|mesh-list
6139570|NCT01297062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6139571|NCT01297062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6666617|NCT01523431|Irinotecan|irinotecan|mesh-list
5543605|NCT04150640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5543606|NCT04150640|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5543607|NCT04150640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5543608|NCT04150640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5543609|NCT04150562|Avelumab|avelumab|mesh-list
5543610|NCT04150562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5543611|NCT04150562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5543612|NCT04150536|Lidocaine|lidocaine|mesh-list
5543613|NCT04150536|Anesthetics, Local|anesthetics, local|mesh-ancestor
5543614|NCT04150536|Anesthetics|anesthetics|mesh-ancestor
5543615|NCT04150536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5543616|NCT04150536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139572|NCT01297062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6666618|NCT01523431|Antimetabolites|antimetabolites|mesh-ancestor
6666619|NCT01523431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666620|NCT01523431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6666621|NCT01523431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6666622|NCT01523431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6666623|NCT01523431|Immunologic Factors|immunologic factors|mesh-ancestor
6666624|NCT01523431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139573|NCT01297062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6139574|NCT01297062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139575|NCT01297062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6139576|NCT01297062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139577|NCT01297062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6139578|NCT01297062|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6139579|NCT01297062|Incretins|incretins|mesh-ancestor
6139580|NCT01297062|Hormones|hormones|mesh-ancestor
6139581|NCT01297062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6139582|NCT01297335|Clonidine|clonidine|mesh-list
6139583|NCT01297335|Analgesics|analgesics|mesh-ancestor
6139584|NCT01297335|Sensory System Agents|sensory system agents|mesh-ancestor
6139585|NCT01297335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6139586|NCT01297335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470274|NCT00494897|Asparaginase|asparaginase|mesh-list
6470275|NCT00494897|Mercaptopurine|mercaptopurine|mesh-list
6139587|NCT01297335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5543617|NCT04150536|Sensory System Agents|sensory system agents|mesh-ancestor
5543618|NCT04150536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5543619|NCT04150536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5543620|NCT04150536|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5543621|NCT04150536|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5543622|NCT04150536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5543623|NCT04150536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602410|NCT04576000|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
5602411|NCT04576000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5602412|NCT04576000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5602413|NCT04576000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602414|NCT04552197|Tofacitinib|tofacitinib|mesh-list
5602415|NCT04552197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5602416|NCT04552197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5602417|NCT04552197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602418|NCT04538664|Carboplatin|carboplatin|mesh-list
5602419|NCT04538664|Pemetrexed|pemetrexed|mesh-list
5602420|NCT04538664|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
5602421|NCT04538664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5602422|NCT04538664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5602423|NCT04538664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602424|NCT04538664|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5602425|NCT04538664|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5602426|NCT04538664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5602427|NCT04537793|Ivacaftor|ivacaftor|mesh-list
5602428|NCT04537793|Elexacaftor|elexacaftor|mesh-list
5602429|NCT04537793|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
5602430|NCT04537793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5602431|NCT04537793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602432|NCT04533568|Ibuprofen|ibuprofen|mesh-list
5602433|NCT04533568|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
6139588|NCT01297335|Sympatholytics|sympatholytics|mesh-ancestor
6139589|NCT01297335|Autonomic Agents|autonomic agents|mesh-ancestor
6470276|NCT00494897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6470277|NCT00494897|Immunologic Factors|immunologic factors|mesh-ancestor
6470278|NCT00494897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470279|NCT00494897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6470280|NCT00494897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6470281|NCT00494897|Alkylating Agents|alkylating agents|mesh-ancestor
6470282|NCT00494897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6470283|NCT00494897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6470284|NCT00494897|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6470285|NCT00494897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6470286|NCT00494897|Glucocorticoids|glucocorticoids|mesh-ancestor
6470287|NCT00494897|Hormones|hormones|mesh-ancestor
6470288|NCT00494897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6470289|NCT00494897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6470290|NCT00494897|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6470291|NCT00494897|Abortifacient Agents|abortifacient agents|mesh-ancestor
6470292|NCT00494897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6470293|NCT00494897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6470294|NCT00494897|Antimetabolites|antimetabolites|mesh-ancestor
6470295|NCT00494897|Dermatologic Agents|dermatologic agents|mesh-ancestor
6470296|NCT00494897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6470297|NCT00494897|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6470298|NCT00494897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6470299|NCT00494897|Antiviral Agents|antiviral agents|mesh-ancestor
6470300|NCT00494897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6470301|NCT00494897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6470302|NCT00494897|Tubulin Modulators|tubulin modulators|mesh-ancestor
6470303|NCT00494897|Antimitotic Agents|antimitotic agents|mesh-ancestor
6470304|NCT00494897|Mitosis Modulators|mitosis modulators|mesh-ancestor
6470305|NCT00494897|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6470306|NCT00494897|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6470307|NCT00494897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6470308|NCT00494949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6470309|NCT00494988|Insulin|insulin|mesh-list
6470310|NCT00494988|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6470311|NCT00494988|Insulin Aspart|insulin aspart|mesh-list
6470312|NCT00494988|Isophane Insulin, Human|isophane insulin, human|mesh-list
6470313|NCT00494988|Insulin, Isophane|insulin, isophane|mesh-list
6470314|NCT00494988|Isophane insulin, beef|isophane insulin, beef|mesh-list
6470315|NCT00494988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6470316|NCT00494988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470317|NCT00495027|Vaccines|vaccines|mesh-list
6470318|NCT00495027|Immunologic Factors|immunologic factors|mesh-ancestor
6470319|NCT00495027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470320|NCT00495066|Ipilimumab|ipilimumab|mesh-list
6470321|NCT00495066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6470322|NCT00495066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6470323|NCT00495066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6470324|NCT00495066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6470325|NCT00495092|Biperiden|biperiden|mesh-list
6470326|NCT00495092|Caffeine|caffeine|mesh-list
6470327|NCT00495092|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6470328|NCT00495092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470329|NCT00495092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6470330|NCT00495092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5543624|NCT04150731|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5543625|NCT04150731|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5543626|NCT04150731|Estradiol|estradiol|mesh-list
5543627|NCT04150731|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5543628|NCT04150731|Estrogens|estrogens|mesh-ancestor
5543629|NCT04150731|Hormones|hormones|mesh-ancestor
5543630|NCT04150731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5543631|NCT04150731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543632|NCT04150731|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5543633|NCT04150731|Contraceptive Agents|contraceptive agents|mesh-ancestor
5543634|NCT04150731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5543635|NCT04150731|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6470331|NCT00495092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6470332|NCT00495092|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6470333|NCT00495092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6470334|NCT00495092|Purinergic Agents|purinergic agents|mesh-ancestor
6139590|NCT01297335|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6139591|NCT01297335|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6139592|NCT01297335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6139593|NCT01297335|Adrenergic Agents|adrenergic agents|mesh-ancestor
6139594|NCT01297335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6139595|NCT01297335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543636|NCT04150757|Ketamine|ketamine|mesh-list
5543637|NCT04150757|Analgesics|analgesics|mesh-ancestor
5543638|NCT04150757|Sensory System Agents|sensory system agents|mesh-ancestor
5543639|NCT04150757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5543640|NCT04150757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543641|NCT04150757|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6139596|NCT01297348|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6139597|NCT01297348|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6139598|NCT01297348|Levonorgestrel|levonorgestrel|mesh-list
6139599|NCT01297348|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6139600|NCT01297348|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
6139601|NCT01297348|Norinyl|norinyl|mesh-list
6139602|NCT01297348|Contraceptive Agents|contraceptive agents|mesh-list
5543642|NCT04150757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5543643|NCT04150757|Anesthetics, General|anesthetics, general|mesh-ancestor
5543644|NCT04150757|Anesthetics|anesthetics|mesh-ancestor
5543645|NCT04150757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5543646|NCT04150757|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5543647|NCT04150757|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5543648|NCT04150757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5543649|NCT04150757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543650|NCT04150289|Panobinostat|panobinostat|mesh-list
5543651|NCT04150289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5543652|NCT04150289|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5543653|NCT04150289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5543654|NCT04150289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543655|NCT04150367|Rifampin|rifampin|mesh-list
5543656|NCT04150367|Isoniazid|isoniazid|mesh-list
5543657|NCT04150367|Ethambutol|ethambutol|mesh-list
5543658|NCT04150367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5543659|NCT04150367|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5543660|NCT04150367|Antitubercular Agents|antitubercular agents|mesh-ancestor
5543661|NCT04150367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5543662|NCT04150367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5543663|NCT04150367|Leprostatic Agents|leprostatic agents|mesh-ancestor
5543664|NCT04150367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5543665|NCT04150367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5543666|NCT04150367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543667|NCT04150367|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5543668|NCT04150367|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5543669|NCT04150367|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5543670|NCT04150367|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5543671|NCT04150367|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5543672|NCT04150367|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5543673|NCT04150367|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5543674|NCT04150367|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5543675|NCT04150367|Antimetabolites|antimetabolites|mesh-ancestor
6139603|NCT01297348|Contraceptives, Oral|contraceptives, oral|mesh-list
6139604|NCT01297348|Estradiol|estradiol|mesh-list
6139605|NCT01297348|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6139606|NCT01297348|Estrogens|estrogens|mesh-ancestor
6139607|NCT01297348|Hormones|hormones|mesh-ancestor
6470335|NCT00495092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6470336|NCT00495092|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5543676|NCT04150367|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5543677|NCT04150172|Rebamipide|rebamipide|mesh-list
5543678|NCT04150172|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5543679|NCT04150172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5543680|NCT04150172|Antioxidants|antioxidants|mesh-ancestor
5543681|NCT04150172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543682|NCT04150172|Protective Agents|protective agents|mesh-ancestor
5543683|NCT04150172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543684|NCT04150172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5543685|NCT04149938|Lidocaine|lidocaine|mesh-list
5543686|NCT04149938|Anesthetics, Local|anesthetics, local|mesh-ancestor
5543687|NCT04149938|Anesthetics|anesthetics|mesh-ancestor
5543688|NCT04149938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5543689|NCT04149938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543690|NCT04149938|Sensory System Agents|sensory system agents|mesh-ancestor
5543691|NCT04149938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5543692|NCT04149938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5543693|NCT04149938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5543694|NCT04149938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5543695|NCT04149938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5606775|NCT03786783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6139608|NCT01297348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6470337|NCT00495092|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6470338|NCT00495092|Parasympatholytics|parasympatholytics|mesh-ancestor
6470339|NCT00495092|Autonomic Agents|autonomic agents|mesh-ancestor
6470340|NCT00495092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6470341|NCT00495092|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6470342|NCT00495092|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6470343|NCT00495092|Cholinergic Agents|cholinergic agents|mesh-ancestor
6139609|NCT01297348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139610|NCT01297348|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6139611|NCT01297348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6139612|NCT01297348|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6139613|NCT01297348|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6139614|NCT01297348|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6470344|NCT00495118|Risperidone|risperidone|mesh-list
6470345|NCT00495118|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6470346|NCT00495118|Serotonin Agents|serotonin agents|mesh-ancestor
6470347|NCT00495118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6470348|NCT00495118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6470349|NCT00495118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470350|NCT00495118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6666625|NCT01523431|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6139615|NCT01297348|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6139616|NCT01297348|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
6139617|NCT01297465|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6139618|NCT01297465|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6139619|NCT01297465|Hormones|hormones|mesh-ancestor
6139620|NCT01297465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6139621|NCT01297465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139622|NCT01297465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6139623|NCT01297517|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6139624|NCT01297517|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6666626|NCT01523431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6666627|NCT01523431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6666628|NCT01523431|Antidotes|antidotes|mesh-ancestor
6666629|NCT01523431|Protective Agents|protective agents|mesh-ancestor
6666630|NCT01523431|Vitamin B Complex|vitamin b complex|mesh-ancestor
6666631|NCT01523431|Vitamins|vitamins|mesh-ancestor
6666632|NCT01523431|Micronutrients|micronutrients|mesh-ancestor
5543696|NCT04149938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543697|NCT04150146|Rebamipide|rebamipide|mesh-list
5543698|NCT04150146|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5543699|NCT04150146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5543700|NCT04150146|Antioxidants|antioxidants|mesh-ancestor
5543701|NCT04150146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6470351|NCT00495118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6470352|NCT00495118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6470353|NCT00495118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6470354|NCT00495118|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5543702|NCT04150146|Protective Agents|protective agents|mesh-ancestor
5543703|NCT04150146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543704|NCT04150146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5543705|NCT04150107|Insulin|insulin|mesh-list
5543706|NCT04150107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5543707|NCT04150107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543708|NCT04149483|Atorvastatin|atorvastatin|mesh-list
5543709|NCT04149483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5543710|NCT04149483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5543711|NCT04149483|Antimetabolites|antimetabolites|mesh-ancestor
5543712|NCT04149483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543713|NCT04149483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5543714|NCT04149483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5543715|NCT04149483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5543716|NCT04149678|Cyclosporine|cyclosporine|mesh-list
5543717|NCT04149678|Cyclosporins|cyclosporins|mesh-list
5543718|NCT04149678|Ozanimod|ozanimod|mesh-list
5543719|NCT04149678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5543720|NCT04149678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543721|NCT04149678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5543722|NCT04149678|Immunologic Factors|immunologic factors|mesh-ancestor
5543723|NCT04149678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543724|NCT04149678|Antifungal Agents|antifungal agents|mesh-ancestor
5543725|NCT04149678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5543726|NCT04149678|Dermatologic Agents|dermatologic agents|mesh-ancestor
5543727|NCT04149678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5543728|NCT04149678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5543729|NCT04149678|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5543730|NCT04149626|Midazolam|midazolam|mesh-list
5543731|NCT04149626|Dexmedetomidine|dexmedetomidine|mesh-list
5543732|NCT04149626|Remifentanil|remifentanil|mesh-list
5543733|NCT04149626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5543734|NCT04149626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5543735|NCT04149626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543736|NCT04149626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5543737|NCT04149626|Analgesics|analgesics|mesh-ancestor
6470355|NCT00495118|Dopamine Agents|dopamine agents|mesh-ancestor
6488564|NCT00584779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6139625|NCT01297517|Brinzolamide|brinzolamide|mesh-list
6139626|NCT01297517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6139627|NCT01297517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6139628|NCT01297517|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6139629|NCT01297517|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6139630|NCT01297517|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6139631|NCT01297517|Adrenergic Agents|adrenergic agents|mesh-ancestor
6139632|NCT01297517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6139633|NCT01297517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543738|NCT04149626|Sensory System Agents|sensory system agents|mesh-ancestor
5543739|NCT04149626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5543740|NCT04149626|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6488565|NCT00584779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6488566|NCT00584779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6488567|NCT00584779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6488568|NCT00584779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6488569|NCT00584779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488570|NCT00584779|Antimanic Agents|antimanic agents|mesh-ancestor
6666633|NCT01523483|Progesterone|progesterone|mesh-list
5543741|NCT04149626|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6470356|NCT00495183|Biperiden|biperiden|mesh-list
6470357|NCT00495183|Caffeine|caffeine|mesh-list
6139634|NCT01297517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139635|NCT01297517|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6139636|NCT01297517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6139637|NCT01297595|Crizotinib|crizotinib|mesh-list
6139638|NCT01297595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6139639|NCT01297595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6139640|NCT01297595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6139641|NCT01297595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139642|NCT01297920|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6139643|NCT01297920|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6470358|NCT00495183|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6470359|NCT00495183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470360|NCT00495183|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6470361|NCT00495183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6470362|NCT00495183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6470363|NCT00495183|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6470364|NCT00495183|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6470365|NCT00495183|Purinergic Agents|purinergic agents|mesh-ancestor
6470366|NCT00495183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6470367|NCT00495183|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6470368|NCT00495183|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6470369|NCT00495183|Parasympatholytics|parasympatholytics|mesh-ancestor
6470370|NCT00495183|Autonomic Agents|autonomic agents|mesh-ancestor
6470371|NCT00495183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6470372|NCT00495183|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6470373|NCT00495183|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6470374|NCT00495183|Cholinergic Agents|cholinergic agents|mesh-ancestor
6470375|NCT00495287|Cytarabine|cytarabine|mesh-list
6470376|NCT00495287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6470377|NCT00495287|Antimetabolites|antimetabolites|mesh-ancestor
6139644|NCT01297920|Brinzolamide|brinzolamide|mesh-list
6139645|NCT01297920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6139646|NCT01297920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6139647|NCT01297920|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6139648|NCT01297920|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6139649|NCT01297920|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6139650|NCT01297920|Adrenergic Agents|adrenergic agents|mesh-ancestor
6139651|NCT01297920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6139652|NCT01297920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139653|NCT01297920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139654|NCT01297920|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6470378|NCT00495287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6470379|NCT00495287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6470380|NCT00495287|Antiviral Agents|antiviral agents|mesh-ancestor
6470381|NCT00495287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6470382|NCT00495287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6470383|NCT00495287|Immunologic Factors|immunologic factors|mesh-ancestor
6470384|NCT00495287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470385|NCT00495313|Metronidazole|metronidazole|mesh-list
6470386|NCT00495313|Doxycycline|doxycycline|mesh-list
6470387|NCT00495313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6470388|NCT00495313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6470389|NCT00495313|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6470390|NCT00495313|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6470391|NCT00495313|Antimalarials|antimalarials|mesh-ancestor
6470392|NCT00495326|Efavirenz|efavirenz|mesh-list
6470393|NCT00495326|Nevirapine|nevirapine|mesh-list
6470394|NCT00495326|Rifampin|rifampin|mesh-list
6470395|NCT00495326|Isoniazid|isoniazid|mesh-list
6470396|NCT00495326|Ethambutol|ethambutol|mesh-list
6470397|NCT00495326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6666634|NCT01523483|Progestins|progestins|mesh-ancestor
5543742|NCT04149626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6470398|NCT00495326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6470399|NCT00495326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6470400|NCT00495326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6470401|NCT00495326|Antiviral Agents|antiviral agents|mesh-ancestor
6470402|NCT00495326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6470403|NCT00495326|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6470404|NCT00495326|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6470405|NCT00495326|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5543743|NCT04149626|Adrenergic Agents|adrenergic agents|mesh-ancestor
5543744|NCT04149626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5543745|NCT04149626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543746|NCT04149626|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5543747|NCT04149626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5543748|NCT04149626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5543749|NCT04149626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5543750|NCT04149626|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5543751|NCT04149626|Anesthetics, General|anesthetics, general|mesh-ancestor
5543752|NCT04149626|Anesthetics|anesthetics|mesh-ancestor
5543753|NCT04149626|GABA Modulators|gaba modulators|mesh-ancestor
5543754|NCT04149626|GABA Agents|gaba agents|mesh-ancestor
5543755|NCT04149626|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5543756|NCT04149626|Narcotics|narcotics|mesh-ancestor
5543757|NCT04149470|Omeprazole|omeprazole|mesh-list
5543758|NCT04149470|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5543759|NCT04149470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5543760|NCT04149470|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5543761|NCT04149470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5543762|NCT04149470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543763|NCT04149444|Trifluridine|trifluridine|mesh-list
5543764|NCT04149444|Antimetabolites|antimetabolites|mesh-ancestor
5543765|NCT04149444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543766|NCT04149444|Antiviral Agents|antiviral agents|mesh-ancestor
5543767|NCT04149444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5543768|NCT04149210|Fluorometholone|fluorometholone|mesh-list
5543769|NCT04149210|Lubricant Eye Drops|lubricant eye drops|mesh-list
5543770|NCT04149210|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5543771|NCT04149210|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5543772|NCT04149210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5543773|NCT04149210|Glucocorticoids|glucocorticoids|mesh-ancestor
5543774|NCT04149210|Hormones|hormones|mesh-ancestor
5543775|NCT04149210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5543776|NCT04149210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543777|NCT04149210|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6470406|NCT00495326|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6470407|NCT00495326|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6470408|NCT00495326|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6470409|NCT00495326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6139655|NCT01297920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6139656|NCT01297959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6139657|NCT01298063|Afatinib|afatinib|mesh-list
6139658|NCT01298063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6139659|NCT01298063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6139660|NCT01298063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6139661|NCT01298063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139662|NCT01298128|NuvaRing|nuvaring|mesh-list
6139663|NCT01298128|Desogestrel|desogestrel|mesh-list
6139664|NCT01298128|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6139665|NCT01298128|Contraceptive Agents|contraceptive agents|mesh-ancestor
6666635|NCT01523483|Hormones|hormones|mesh-ancestor
6139666|NCT01298128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6139667|NCT01298128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139668|NCT01298128|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6139669|NCT01298128|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6139670|NCT01298128|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6139671|NCT01298128|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5543778|NCT04149262|Insulin Aspart|insulin aspart|mesh-list
5543779|NCT04149262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5543780|NCT04149262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543781|NCT04149275|Nivolumab|nivolumab|mesh-list
5543782|NCT04149275|Ipilimumab|ipilimumab|mesh-list
5543783|NCT04149275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5543784|NCT04149275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5543785|NCT04149275|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5543786|NCT04149275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666636|NCT01523483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5543787|NCT04148963|Loxapine|loxapine|mesh-list
5543788|NCT04148963|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5543789|NCT04148963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5543790|NCT04148963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5543791|NCT04148963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543792|NCT04148963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6666637|NCT01523483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666638|NCT01523548|Carbon Monoxide|carbon monoxide|mesh-list
6666639|NCT01523548|Antimetabolites|antimetabolites|mesh-ancestor
6666640|NCT01523548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139672|NCT01298128|Progestins|progestins|mesh-ancestor
6139673|NCT01298128|Hormones|hormones|mesh-ancestor
6139674|NCT01298128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5543793|NCT04148963|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5543794|NCT04148963|Dopamine Agents|dopamine agents|mesh-ancestor
5543795|NCT04148963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5543796|NCT04148963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543797|NCT04149327|Amoxicillin|amoxicillin|mesh-list
5543798|NCT04149327|Metronidazole|metronidazole|mesh-list
5543799|NCT04149327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5543800|NCT04149327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5543801|NCT04149327|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5543802|NCT04149327|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6139675|NCT01298193|Phenothiazine|phenothiazine|mesh-list
6139676|NCT01298193|Droperidol|droperidol|mesh-list
6470410|NCT00495326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6470411|NCT00495326|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6470412|NCT00495326|Antitubercular Agents|antitubercular agents|mesh-ancestor
6470413|NCT00495326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6470414|NCT00495326|Leprostatic Agents|leprostatic agents|mesh-ancestor
6470415|NCT00495326|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5543803|NCT04149067|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5543804|NCT04149067|Dapagliflozin|dapagliflozin|mesh-list
5543805|NCT04149067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5543806|NCT04149067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543807|NCT04149067|Incretins|incretins|mesh-ancestor
5543808|NCT04149067|Hormones|hormones|mesh-ancestor
5543809|NCT04149067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5543810|NCT04149067|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6139677|NCT01298193|Haloperidol|haloperidol|mesh-list
6139678|NCT01298193|Aprepitant|aprepitant|mesh-list
6139679|NCT01298193|Metoclopramide|metoclopramide|mesh-list
6139680|NCT01298193|Domperidone|domperidone|mesh-list
6139681|NCT01298193|Alizapride|alizapride|mesh-list
6139682|NCT01298193|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
6139683|NCT01298193|Antiemetics|antiemetics|mesh-ancestor
6139684|NCT01298193|Autonomic Agents|autonomic agents|mesh-ancestor
6139685|NCT01298193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6139686|NCT01298193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139687|NCT01298193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6139688|NCT01298193|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6139689|NCT01298193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6139690|NCT01298193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139691|NCT01298193|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6139692|NCT01298193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6139693|NCT01298193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6139694|NCT01298193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6139695|NCT01298193|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6139696|NCT01298193|Dopamine Agents|dopamine agents|mesh-ancestor
6139697|NCT01298193|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6139698|NCT01298193|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6139699|NCT01298193|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6139700|NCT01298193|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6139701|NCT01298193|Serotonin Agents|serotonin agents|mesh-ancestor
6139702|NCT01298193|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6139703|NCT01298193|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6470416|NCT00495326|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6470417|NCT00495326|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6139704|NCT01298193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6666641|NCT01523548|Gasotransmitters|gasotransmitters|mesh-ancestor
6666642|NCT01523548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6666643|NCT01523548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543811|NCT04149067|Protease Inhibitors|protease inhibitors|mesh-ancestor
5543812|NCT04149067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5543813|NCT04149067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543814|NCT04149067|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5543815|NCT04149106|Pyrimethamine|pyrimethamine|mesh-list
5543816|NCT04149106|Sulfadoxine|sulfadoxine|mesh-list
5543817|NCT04149106|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
5543818|NCT04149106|Amodiaquine|amodiaquine|mesh-list
5543819|NCT04149106|Artenimol|artenimol|mesh-list
5543820|NCT04149106|Antimalarials|antimalarials|mesh-ancestor
6666644|NCT01523574|Calcium, Dietary|calcium, dietary|mesh-list
6666645|NCT01523574|Vitamin E|vitamin e|mesh-list
6666646|NCT01523574|Oxaliplatin|oxaliplatin|mesh-list
6666647|NCT01523574|Magnesium Sulfate|magnesium sulfate|mesh-list
6470418|NCT00495326|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6470419|NCT00495326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6470420|NCT00495326|Antimetabolites|antimetabolites|mesh-ancestor
6470421|NCT00495326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6470422|NCT00495339|Levofloxacin|levofloxacin|mesh-list
6470423|NCT00495339|Ofloxacin|ofloxacin|mesh-list
6470424|NCT00495339|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6470425|NCT00495339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6470426|NCT00495339|Renal Agents|renal agents|mesh-ancestor
6470427|NCT00495339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6470428|NCT00495339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6470429|NCT00495339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5543821|NCT04149106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5543822|NCT04149106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5543823|NCT04149106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5543824|NCT04149106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5543825|NCT04149106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5543826|NCT04149106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543827|NCT04149106|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5543828|NCT04149106|Renal Agents|renal agents|mesh-ancestor
5543829|NCT04149015|Paclitaxel|paclitaxel|mesh-list
5543830|NCT04149015|Fluorouracil|fluorouracil|mesh-list
5543831|NCT04149015|Oxaliplatin|oxaliplatin|mesh-list
5543832|NCT04149015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5543833|NCT04149015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5543834|NCT04149015|Tubulin Modulators|tubulin modulators|mesh-ancestor
5543835|NCT04149015|Antimitotic Agents|antimitotic agents|mesh-ancestor
6470430|NCT00495339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6470431|NCT00495339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6470432|NCT00495339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6470433|NCT00495339|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5543836|NCT04149015|Mitosis Modulators|mitosis modulators|mesh-ancestor
5543837|NCT04149015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543838|NCT04149015|Antimetabolites|antimetabolites|mesh-ancestor
5543839|NCT04149015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5543840|NCT04149015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5543841|NCT04149015|Immunologic Factors|immunologic factors|mesh-ancestor
5543842|NCT04149015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543843|NCT04149171|Tranexamic Acid|tranexamic acid|mesh-list
5543844|NCT04149171|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6139705|NCT01298219|Lubiprostone|lubiprostone|mesh-list
6139706|NCT01298219|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6470434|NCT00495339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6139707|NCT01298219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6139708|NCT01298219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6470435|NCT00495352|Bupropion|bupropion|mesh-list
6470436|NCT00495352|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6470437|NCT00495352|Antidepressive Agents|antidepressive agents|mesh-ancestor
6470438|NCT00495352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6470439|NCT00495352|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6470440|NCT00495352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6488571|NCT00585000|Tremelimumab|tremelimumab|mesh-list
6666648|NCT01523574|Calcium|calcium|mesh-list
6666649|NCT01523574|Vitamins|vitamins|mesh-ancestor
6666650|NCT01523574|Micronutrients|micronutrients|mesh-ancestor
6666651|NCT01523574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543845|NCT04149171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5606776|NCT03786783|Alkylating Agents|alkylating agents|mesh-ancestor
6139709|NCT01298362|Aromatase Inhibitors|aromatase inhibitors|mesh-list
6139710|NCT01298362|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6139711|NCT01298362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6139712|NCT01298362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139713|NCT01298362|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6139714|NCT01298362|Hormone Antagonists|hormone antagonists|mesh-ancestor
5543846|NCT04149171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139715|NCT01298362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6139716|NCT01298362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139717|NCT01298531|Etanercept|etanercept|mesh-list
6139718|NCT01298531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6139719|NCT01298531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6139720|NCT01298531|Analgesics|analgesics|mesh-ancestor
6139721|NCT01298531|Sensory System Agents|sensory system agents|mesh-ancestor
6139722|NCT01298531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6139723|NCT01298531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139724|NCT01298531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6139725|NCT01298531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6139726|NCT01298531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6139727|NCT01298531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6139728|NCT01298531|Immunologic Factors|immunologic factors|mesh-ancestor
6139729|NCT01298570|Leucovorin|leucovorin|mesh-list
6139730|NCT01298570|Fluorouracil|fluorouracil|mesh-list
6139731|NCT01298570|Irinotecan|irinotecan|mesh-list
6139732|NCT01298570|Levoleucovorin|levoleucovorin|mesh-list
6139733|NCT01298570|Antimetabolites|antimetabolites|mesh-ancestor
6139734|NCT01298570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139735|NCT01298570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6470441|NCT00495352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6470442|NCT00495352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6470443|NCT00495352|Dopamine Agents|dopamine agents|mesh-ancestor
6470444|NCT00495352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6470445|NCT00495352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470446|NCT00495352|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6470447|NCT00495352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6470448|NCT00495352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6470449|NCT00495365|Epoetin Alfa|epoetin alfa|mesh-list
6470450|NCT00495365|Hematinics|hematinics|mesh-ancestor
6470451|NCT00495378|Epoetin Alfa|epoetin alfa|mesh-list
6470452|NCT00495378|Hematinics|hematinics|mesh-ancestor
6470453|NCT00495508|Lumefantrine|lumefantrine|mesh-list
6470454|NCT00495508|Artemether|artemether|mesh-list
6470455|NCT00495508|Quinine|quinine|mesh-list
6470456|NCT00495508|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6470457|NCT00495508|Antimalarials|antimalarials|mesh-ancestor
6470458|NCT00495508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6470459|NCT00495508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5543847|NCT04149171|Hemostatics|hemostatics|mesh-ancestor
5543848|NCT04149171|Coagulants|coagulants|mesh-ancestor
5543849|NCT04148937|Pembrolizumab|pembrolizumab|mesh-list
5543850|NCT04148937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5543851|NCT04148937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5543852|NCT04149132|Nitric Oxide|nitric oxide|mesh-list
5543853|NCT04149132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5543854|NCT04149132|Autonomic Agents|autonomic agents|mesh-ancestor
5543855|NCT04149132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6139736|NCT01298570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6470460|NCT00495508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6470461|NCT00495508|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6470462|NCT00495508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470463|NCT00495508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6470464|NCT00495508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6470465|NCT00495508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6470466|NCT00495508|Analgesics|analgesics|mesh-ancestor
6470467|NCT00495508|Sensory System Agents|sensory system agents|mesh-ancestor
6470468|NCT00495547|Azacitidine|azacitidine|mesh-list
6470469|NCT00495547|Epoetin Alfa|epoetin alfa|mesh-list
5543856|NCT04149132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543857|NCT04149132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5543858|NCT04149132|Respiratory System Agents|respiratory system agents|mesh-ancestor
5543859|NCT04149132|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5543860|NCT04149132|Antioxidants|antioxidants|mesh-ancestor
5543861|NCT04149132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543862|NCT04149132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5543863|NCT04149132|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5543864|NCT04149132|Vasodilator Agents|vasodilator agents|mesh-ancestor
5543865|NCT04149132|Gasotransmitters|gasotransmitters|mesh-ancestor
5543866|NCT04149132|Protective Agents|protective agents|mesh-ancestor
5543867|NCT04148898|Bevacizumab|bevacizumab|mesh-list
5543868|NCT04148898|Osimertinib|osimertinib|mesh-list
5543869|NCT04148898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5543870|NCT04148898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5543871|NCT04148898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5543872|NCT04148898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5543873|NCT04148898|Growth Substances|growth substances|mesh-ancestor
5543874|NCT04148898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543875|NCT04148898|Growth Inhibitors|growth inhibitors|mesh-ancestor
5543876|NCT04148898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5543877|NCT04148898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5543878|NCT04148898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543879|NCT04148885|Paclitaxel|paclitaxel|mesh-list
5543880|NCT04148885|Carboplatin|carboplatin|mesh-list
5543881|NCT04148885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5543882|NCT04148885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5543883|NCT04148885|Tubulin Modulators|tubulin modulators|mesh-ancestor
5543884|NCT04148885|Antimitotic Agents|antimitotic agents|mesh-ancestor
5543885|NCT04148885|Mitosis Modulators|mitosis modulators|mesh-ancestor
5543886|NCT04148885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543887|NCT04148820|Aspirin|aspirin|mesh-list
5543888|NCT04148820|Perindopril|perindopril|mesh-list
5543889|NCT04148820|Atorvastatin|atorvastatin|mesh-list
5543890|NCT04148820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6470470|NCT00495547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6470471|NCT00495547|Antimetabolites|antimetabolites|mesh-ancestor
6470472|NCT00495547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6470473|NCT00495547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6470474|NCT00495547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6470475|NCT00495547|Hematinics|hematinics|mesh-ancestor
6470476|NCT00495560|Misoprostol|misoprostol|mesh-list
6470477|NCT00495560|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6470478|NCT00495560|Abortifacient Agents|abortifacient agents|mesh-ancestor
6470479|NCT00495560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6470480|NCT00495560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470481|NCT00495560|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6470482|NCT00495560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6470483|NCT00495560|Oxytocics|oxytocics|mesh-ancestor
6470484|NCT00495573|Acyclovir|acyclovir|mesh-list
6470485|NCT00495573|Antiviral Agents|antiviral agents|mesh-ancestor
6470486|NCT00495573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6470487|NCT00495651|Isoniazid|isoniazid|mesh-list
6470488|NCT00495651|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6470489|NCT00495651|Antitubercular Agents|antitubercular agents|mesh-ancestor
6470490|NCT00495651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6139737|NCT01298570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6139738|NCT01298570|Immunologic Factors|immunologic factors|mesh-ancestor
6139739|NCT01298570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139740|NCT01298570|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6139741|NCT01298570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6139742|NCT01298570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6139743|NCT01298570|Antidotes|antidotes|mesh-ancestor
6139744|NCT01298570|Protective Agents|protective agents|mesh-ancestor
6139745|NCT01298570|Vitamin B Complex|vitamin b complex|mesh-ancestor
6139746|NCT01298570|Vitamins|vitamins|mesh-ancestor
6470491|NCT00495651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6139747|NCT01298570|Micronutrients|micronutrients|mesh-ancestor
6470492|NCT00495651|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6470493|NCT00495651|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6470494|NCT00495651|Antimetabolites|antimetabolites|mesh-ancestor
6470495|NCT00495651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6470496|NCT00495651|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6470497|NCT00495651|Antiviral Agents|antiviral agents|mesh-ancestor
6470498|NCT00495729|Simvastatin|simvastatin|mesh-list
6470499|NCT00495729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6470500|NCT00495729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6470501|NCT00495729|Antimetabolites|antimetabolites|mesh-ancestor
6470502|NCT00495729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6470503|NCT00495729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6470504|NCT00495729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6470505|NCT00495729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6470506|NCT00495781|Iron|iron|mesh-list
6139748|NCT01298700|Bimatoprost|bimatoprost|mesh-list
6139749|NCT01298700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5543891|NCT04148820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5543892|NCT04148820|Analgesics|analgesics|mesh-ancestor
5543893|NCT04148820|Sensory System Agents|sensory system agents|mesh-ancestor
5543894|NCT04148820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5543895|NCT04148820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543896|NCT04148820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5543897|NCT04148820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6139750|NCT01298700|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6470507|NCT00495781|Trace Elements|trace elements|mesh-ancestor
6470508|NCT00495781|Micronutrients|micronutrients|mesh-ancestor
6470509|NCT00495781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470510|NCT00495846|Octreotide|octreotide|mesh-list
6470511|NCT00495846|Lanreotide|lanreotide|mesh-list
6470512|NCT00495846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6470513|NCT00495846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6470514|NCT00495846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6470515|NCT00495872|Lenalidomide|lenalidomide|mesh-list
6470516|NCT00495872|Sunitinib|sunitinib|mesh-list
6470517|NCT00495872|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6470518|NCT00495872|Sorafenib|sorafenib|mesh-list
6470519|NCT00495872|Dasatinib|dasatinib|mesh-list
6470520|NCT00495872|Lapatinib|lapatinib|mesh-list
6470521|NCT00495872|Valproic Acid|valproic acid|mesh-list
6470522|NCT00495872|Immunologic Factors|immunologic factors|mesh-ancestor
6470523|NCT00495872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470524|NCT00495872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6470525|NCT00495872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6470526|NCT00495872|Growth Substances|growth substances|mesh-ancestor
6470527|NCT00495872|Growth Inhibitors|growth inhibitors|mesh-ancestor
5543898|NCT04148820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6139751|NCT01298700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5543899|NCT04148820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5543900|NCT04148820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543901|NCT04148820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5543902|NCT04148820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5543903|NCT04148820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5543904|NCT04148820|Antipyretics|antipyretics|mesh-ancestor
5543905|NCT04148820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5543906|NCT04148820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5543907|NCT04148820|Antimetabolites|antimetabolites|mesh-ancestor
6139752|NCT01298765|Buprenorphine|buprenorphine|mesh-list
6139753|NCT01298765|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6139754|NCT01298765|Narcotics|narcotics|mesh-ancestor
6470528|NCT00495872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6470529|NCT00495872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6470530|NCT00495872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6470531|NCT00495872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139755|NCT01298765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6470532|NCT00495872|Anticonvulsants|anticonvulsants|mesh-ancestor
6470533|NCT00495872|GABA Agents|gaba agents|mesh-ancestor
6470534|NCT00495872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6470535|NCT00495872|Antimanic Agents|antimanic agents|mesh-ancestor
6470536|NCT00495872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5543908|NCT04148820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5543909|NCT04148820|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5543910|NCT04148820|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5543911|NCT04148820|Protease Inhibitors|protease inhibitors|mesh-ancestor
5543912|NCT04148820|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5543913|NCT04148833|Paclitaxel|paclitaxel|mesh-list
6139756|NCT01298765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666652|NCT01523574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6666653|NCT01523574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6666654|NCT01523574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6666655|NCT01523574|Analgesics|analgesics|mesh-ancestor
5543914|NCT04148833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5543915|NCT04148833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5543916|NCT04148833|Tubulin Modulators|tubulin modulators|mesh-ancestor
5543917|NCT04148833|Antimitotic Agents|antimitotic agents|mesh-ancestor
5543918|NCT04148833|Mitosis Modulators|mitosis modulators|mesh-ancestor
5543919|NCT04148833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543920|NCT04148781|4-Aminopyridine|4-aminopyridine|mesh-list
5543921|NCT04148781|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5543922|NCT04148781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5543923|NCT04148781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543924|NCT04148495|Acetaminophen|acetaminophen|mesh-list
5543925|NCT04148495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5543926|NCT04148495|Analgesics|analgesics|mesh-ancestor
5543927|NCT04148495|Sensory System Agents|sensory system agents|mesh-ancestor
5543928|NCT04148495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5543929|NCT04148495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543930|NCT04148495|Antipyretics|antipyretics|mesh-ancestor
5602434|NCT04533568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5602435|NCT04533568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5602436|NCT04533568|Analgesics|analgesics|mesh-ancestor
5602437|NCT04533568|Sensory System Agents|sensory system agents|mesh-ancestor
5602438|NCT04533568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5602439|NCT04533568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602440|NCT04533568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5602441|NCT04533568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5602442|NCT04533568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5602443|NCT04533568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5602444|NCT04533568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666656|NCT01523574|Sensory System Agents|sensory system agents|mesh-ancestor
6666657|NCT01523574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6666658|NCT01523574|Anesthetics|anesthetics|mesh-ancestor
6666659|NCT01523574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6666660|NCT01523574|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6666661|NCT01523574|Anticonvulsants|anticonvulsants|mesh-ancestor
6666662|NCT01523574|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6666663|NCT01523574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5602445|NCT04511078|Panitumumab|panitumumab|mesh-list
5602446|NCT04511078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6470537|NCT00495872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5602447|NCT04511078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5602448|NCT04510636|Pembrolizumab|pembrolizumab|mesh-list
5602449|NCT04510636|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5602450|NCT04510636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5602451|NCT04510636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5602452|NCT04510636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5602453|NCT04510636|Alkylating Agents|alkylating agents|mesh-ancestor
5602454|NCT04510636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602455|NCT04508634|Metformin|metformin|mesh-list
5602456|NCT04508634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5602457|NCT04508634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602458|NCT04507373|Simvastatin|simvastatin|mesh-list
5602459|NCT04507373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5602460|NCT04507373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5602461|NCT04507373|Antimetabolites|antimetabolites|mesh-ancestor
5602462|NCT04507373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602463|NCT04507373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6139757|NCT01298765|Analgesics|analgesics|mesh-ancestor
6470538|NCT00495872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6470539|NCT00495898|Sirolimus|sirolimus|mesh-list
6470540|NCT00495898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6470541|NCT00495898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6470542|NCT00495898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6470543|NCT00495898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6470544|NCT00495898|Antifungal Agents|antifungal agents|mesh-ancestor
6470545|NCT00495898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6470546|NCT00495898|Immunologic Factors|immunologic factors|mesh-ancestor
6470547|NCT00495898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470548|NCT00496002|Adefovir|adefovir|mesh-list
6666664|NCT01523574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666665|NCT01523574|Tocolytic Agents|tocolytic agents|mesh-ancestor
6666666|NCT01523574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6666667|NCT01523574|Antioxidants|antioxidants|mesh-ancestor
6666668|NCT01523574|Protective Agents|protective agents|mesh-ancestor
6666669|NCT01523639|Metformin|metformin|mesh-list
6666670|NCT01523639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6666671|NCT01523639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666672|NCT01523678|Paclitaxel|paclitaxel|mesh-list
6666673|NCT01523678|Carboplatin|carboplatin|mesh-list
6139758|NCT01298765|Sensory System Agents|sensory system agents|mesh-ancestor
6139759|NCT01298765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6139760|NCT01298765|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6139761|NCT01298778|Acetaminophen|acetaminophen|mesh-list
6139762|NCT01298778|Morphine|morphine|mesh-list
6139763|NCT01298778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6139764|NCT01298778|Analgesics|analgesics|mesh-ancestor
6139765|NCT01298778|Sensory System Agents|sensory system agents|mesh-ancestor
6139766|NCT01298778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6470549|NCT00496002|Clevudine|clevudine|mesh-list
6470550|NCT00496002|Antiviral Agents|antiviral agents|mesh-ancestor
6139767|NCT01298778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139768|NCT01298778|Antipyretics|antipyretics|mesh-ancestor
6139769|NCT01298778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6139770|NCT01298778|Narcotics|narcotics|mesh-ancestor
6139771|NCT01298778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6139772|NCT01299038|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6139773|NCT01299038|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6139774|NCT01299038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6139775|NCT01299038|Antimetabolites|antimetabolites|mesh-ancestor
6139776|NCT01299038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139777|NCT01299038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6139778|NCT01299038|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6139779|NCT01299038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6139780|NCT01299116|Contraceptive Agents|contraceptive agents|mesh-list
6139781|NCT01299116|Etonogestrel|etonogestrel|mesh-list
6470551|NCT00496002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6470552|NCT00496002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6470553|NCT00496002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6470554|NCT00496002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6470555|NCT00496002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6470556|NCT00496028|Paclitaxel|paclitaxel|mesh-list
6470557|NCT00496028|Carboplatin|carboplatin|mesh-list
6470558|NCT00496028|Saracatinib|saracatinib|mesh-list
6470559|NCT00496028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6470560|NCT00496028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6470561|NCT00496028|Tubulin Modulators|tubulin modulators|mesh-ancestor
6470562|NCT00496028|Antimitotic Agents|antimitotic agents|mesh-ancestor
6470563|NCT00496028|Mitosis Modulators|mitosis modulators|mesh-ancestor
6470564|NCT00496028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6470565|NCT00496028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6470566|NCT00496093|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6470567|NCT00496093|Immunologic Factors|immunologic factors|mesh-ancestor
6470568|NCT00496093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470569|NCT00496158|Adefovir|adefovir|mesh-list
6470570|NCT00496158|Clevudine|clevudine|mesh-list
6470571|NCT00496158|Antiviral Agents|antiviral agents|mesh-ancestor
6470572|NCT00496158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6470573|NCT00496158|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6470574|NCT00496158|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6470575|NCT00496158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6139782|NCT01299116|Contraceptives, Oral|contraceptives, oral|mesh-list
6139783|NCT01299116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6139784|NCT01299116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139785|NCT01299116|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6139786|NCT01299116|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6139787|NCT01299272|Serotonin|serotonin|mesh-list
6666674|NCT01523678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6666675|NCT01523678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6139788|NCT01299272|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
6139789|NCT01299272|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6139790|NCT01299272|Serotonin Agents|serotonin agents|mesh-ancestor
6139791|NCT01299272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6139792|NCT01299272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139793|NCT01299272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470576|NCT00496158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6470577|NCT00496184|Nifedipine|nifedipine|mesh-list
6470578|NCT00496184|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6470579|NCT00496184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6470580|NCT00496184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6470581|NCT00496184|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6470582|NCT00496184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470583|NCT00496184|Vasodilator Agents|vasodilator agents|mesh-ancestor
6470584|NCT00496184|Tocolytic Agents|tocolytic agents|mesh-ancestor
6470585|NCT00496184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6470586|NCT00496223|Sunitinib|sunitinib|mesh-list
6470587|NCT00496223|Dacarbazine|dacarbazine|mesh-list
6470588|NCT00496223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6470589|NCT00496223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6470590|NCT00496223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6470591|NCT00496223|Growth Substances|growth substances|mesh-ancestor
6470592|NCT00496223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470593|NCT00496223|Growth Inhibitors|growth inhibitors|mesh-ancestor
6470594|NCT00496223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6470595|NCT00496223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6470596|NCT00496223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6470597|NCT00496223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6470598|NCT00496223|Alkylating Agents|alkylating agents|mesh-ancestor
6470599|NCT00496275|Gemcitabine|gemcitabine|mesh-list
6470600|NCT00496275|Cisplatin|cisplatin|mesh-list
6470601|NCT00496275|Vinorelbine|vinorelbine|mesh-list
6470602|NCT00496275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6470603|NCT00496275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6470604|NCT00496275|Antimetabolites|antimetabolites|mesh-ancestor
6470605|NCT00496275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6470606|NCT00496275|Antiviral Agents|antiviral agents|mesh-ancestor
6470607|NCT00496275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6470608|NCT00496275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6470609|NCT00496275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6470610|NCT00496275|Immunologic Factors|immunologic factors|mesh-ancestor
6470611|NCT00496275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470612|NCT00496275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6470613|NCT00496275|Tubulin Modulators|tubulin modulators|mesh-ancestor
6470614|NCT00496275|Antimitotic Agents|antimitotic agents|mesh-ancestor
6470615|NCT00496275|Mitosis Modulators|mitosis modulators|mesh-ancestor
6470616|NCT00496301|Gemcitabine|gemcitabine|mesh-list
6470617|NCT00496301|Capecitabine|capecitabine|mesh-list
6139794|NCT01299272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6139795|NCT01299272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6470618|NCT00496301|Sorafenib|sorafenib|mesh-list
6470619|NCT00496301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6470620|NCT00496301|Antimetabolites|antimetabolites|mesh-ancestor
6470621|NCT00496301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6470622|NCT00496301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6470623|NCT00496301|Antiviral Agents|antiviral agents|mesh-ancestor
6139796|NCT01299389|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6139797|NCT01299389|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6139798|NCT01299389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6139799|NCT01299389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6139800|NCT01299389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139801|NCT01299389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6139802|NCT01299389|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6470624|NCT00496301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6470625|NCT00496301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6139803|NCT01299389|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6139804|NCT01299389|Serotonin Agents|serotonin agents|mesh-ancestor
6139805|NCT01299389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6139806|NCT01299389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139807|NCT01299389|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6139808|NCT01299389|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6139809|NCT01299389|Dopamine Agents|dopamine agents|mesh-ancestor
6139810|NCT01299480|Vaccines|vaccines|mesh-list
6139811|NCT01299480|Immunologic Factors|immunologic factors|mesh-ancestor
6139812|NCT01299480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139813|NCT01299571|Dutasteride|dutasteride|mesh-list
6139814|NCT01299571|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6139815|NCT01299571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6139816|NCT01299571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6139817|NCT01299571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139818|NCT01299571|Hormone Antagonists|hormone antagonists|mesh-ancestor
6139819|NCT01299571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6139820|NCT01299571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139821|NCT01299584|Remifentanil|remifentanil|mesh-list
6139822|NCT01299584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6139823|NCT01299584|Narcotics|narcotics|mesh-ancestor
6139824|NCT01299584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6139825|NCT01299584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139826|NCT01299584|Analgesics|analgesics|mesh-ancestor
6139827|NCT01299584|Sensory System Agents|sensory system agents|mesh-ancestor
6139828|NCT01299584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6139829|NCT01299805|Vortioxetine|vortioxetine|mesh-list
6666676|NCT01523678|Tubulin Modulators|tubulin modulators|mesh-ancestor
6666677|NCT01523678|Antimitotic Agents|antimitotic agents|mesh-ancestor
6666678|NCT01523678|Mitosis Modulators|mitosis modulators|mesh-ancestor
6666679|NCT01523678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666680|NCT01523847|Doxorubicin|doxorubicin|mesh-list
6666681|NCT01523847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6666682|NCT01523847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6666683|NCT01523847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6666684|NCT01523847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6666685|NCT01523847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6666686|NCT01523847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666687|NCT01523860|Rituximab|rituximab|mesh-list
6666688|NCT01523860|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6666689|NCT01523860|Mitoxantrone|mitoxantrone|mesh-list
6666690|NCT01523860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6666691|NCT01523860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6666692|NCT01523860|Immunologic Factors|immunologic factors|mesh-ancestor
6666693|NCT01523860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666694|NCT01523860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6139830|NCT01299805|Antidepressive Agents|antidepressive agents|mesh-ancestor
6139831|NCT01299805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6139832|NCT01299805|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5543931|NCT04148599|Lidocaine|lidocaine|mesh-list
5543932|NCT04148599|Dexmedetomidine|dexmedetomidine|mesh-list
5543933|NCT04148599|Anesthetics, Local|anesthetics, local|mesh-ancestor
6139833|NCT01299805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6139834|NCT01299805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6139835|NCT01299805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139836|NCT01299805|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5543934|NCT04148599|Anesthetics|anesthetics|mesh-ancestor
5543935|NCT04148599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5543936|NCT04148599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543937|NCT04148599|Sensory System Agents|sensory system agents|mesh-ancestor
5543938|NCT04148599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5543939|NCT04148599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5543940|NCT04148599|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5543941|NCT04148599|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5543942|NCT04148599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5543943|NCT04148599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543944|NCT04148599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5543945|NCT04148599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5543946|NCT04148599|Analgesics|analgesics|mesh-ancestor
5543947|NCT04148599|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5543948|NCT04148599|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5543949|NCT04148599|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5543950|NCT04148599|Adrenergic Agents|adrenergic agents|mesh-ancestor
6470626|NCT00496301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6470627|NCT00496301|Immunologic Factors|immunologic factors|mesh-ancestor
6470628|NCT00496301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470629|NCT00496301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6470630|NCT00496392|Fentanyl|fentanyl|mesh-list
6470631|NCT00496392|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6470632|NCT00496392|Narcotics|narcotics|mesh-ancestor
6470633|NCT00496392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5543951|NCT04148599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5543952|NCT04148534|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-list
5543953|NCT04148534|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5543954|NCT04148534|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5543955|NCT04148534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5543956|NCT04148534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543957|NCT04148872|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5543958|NCT04148872|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5543959|NCT04148872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5543960|NCT04148872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543961|NCT04148872|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6470634|NCT00496392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470635|NCT00496392|Analgesics|analgesics|mesh-ancestor
6470636|NCT00496392|Sensory System Agents|sensory system agents|mesh-ancestor
6470637|NCT00496392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6470638|NCT00496392|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6470639|NCT00496392|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6470640|NCT00496392|Anesthetics, General|anesthetics, general|mesh-ancestor
6470641|NCT00496392|Anesthetics|anesthetics|mesh-ancestor
6470642|NCT00496405|Bevacizumab|bevacizumab|mesh-list
6470643|NCT00496405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6470644|NCT00496405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6470645|NCT00496405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6470646|NCT00496405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6470647|NCT00496405|Growth Substances|growth substances|mesh-ancestor
6470648|NCT00496405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470649|NCT00496405|Growth Inhibitors|growth inhibitors|mesh-ancestor
6470650|NCT00496444|Azacitidine|azacitidine|mesh-list
6470651|NCT00496444|Valproic Acid|valproic acid|mesh-list
6470652|NCT00496444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6470653|NCT00496444|Antimetabolites|antimetabolites|mesh-ancestor
6470654|NCT00496444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6470655|NCT00496444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6470656|NCT00496444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6470657|NCT00496444|Anticonvulsants|anticonvulsants|mesh-ancestor
5543962|NCT04148872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6139837|NCT01299805|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6139838|NCT01299805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6139839|NCT01299805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139840|NCT01299805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6139841|NCT01299805|Serotonin Agents|serotonin agents|mesh-ancestor
6139842|NCT01299805|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6139843|NCT01299805|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6139844|NCT01299805|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6139845|NCT01299805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6139846|NCT01299896|Bupropion|bupropion|mesh-list
6139847|NCT01299896|Nicotine|nicotine|mesh-list
6139848|NCT01299896|Varenicline|varenicline|mesh-list
6139849|NCT01299896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6139850|NCT01299896|Autonomic Agents|autonomic agents|mesh-ancestor
6139851|NCT01299896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6139852|NCT01299896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139853|NCT01299896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6139854|NCT01299896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6139855|NCT01299896|Cholinergic Agents|cholinergic agents|mesh-ancestor
6139856|NCT01299896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6139857|NCT01299896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139858|NCT01299896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6139859|NCT01299896|Antidepressive Agents|antidepressive agents|mesh-ancestor
6139860|NCT01299896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5543963|NCT04148872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543964|NCT04148872|Cholinergic Agents|cholinergic agents|mesh-ancestor
5543965|NCT04148872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6470658|NCT00496444|GABA Agents|gaba agents|mesh-ancestor
6470659|NCT00496444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6470660|NCT00496444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470661|NCT00496444|Antimanic Agents|antimanic agents|mesh-ancestor
6470662|NCT00496444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6139861|NCT01299896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6139862|NCT01299896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6139863|NCT01299896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6470663|NCT00496444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6470664|NCT00496444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6470665|NCT00496561|Immunologic Factors|immunologic factors|mesh-list
6470666|NCT00496561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470667|NCT00496600|Everolimus|everolimus|mesh-list
6470668|NCT00496600|Epothilone B|epothilone b|mesh-list
6139864|NCT01299896|Dopamine Agents|dopamine agents|mesh-ancestor
6139865|NCT01299896|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6139866|NCT01299896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6470669|NCT00496600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6470670|NCT00496600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6470671|NCT00496600|Immunologic Factors|immunologic factors|mesh-ancestor
6139867|NCT01299896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6139868|NCT01299961|Abatacept|abatacept|mesh-list
6139869|NCT01299961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6139870|NCT01299961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139871|NCT01299961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6139872|NCT01299961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6139873|NCT01299961|Immunologic Factors|immunologic factors|mesh-ancestor
6139874|NCT01299961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139875|NCT01299961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6139876|NCT01300234|Tenofovir|tenofovir|mesh-list
6139877|NCT01300234|Adefovir|adefovir|mesh-list
6139878|NCT01300234|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6139879|NCT01300234|Antiviral Agents|antiviral agents|mesh-ancestor
6139880|NCT01300234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6139881|NCT01300234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6139882|NCT01300234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6139883|NCT01300234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6139884|NCT01300234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139885|NCT01300234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6470672|NCT00496600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470673|NCT00496600|Tubulin Modulators|tubulin modulators|mesh-ancestor
6470674|NCT00496600|Antimitotic Agents|antimitotic agents|mesh-ancestor
6470675|NCT00496600|Mitosis Modulators|mitosis modulators|mesh-ancestor
6470676|NCT00496600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6470677|NCT00496652|Zalutumumab|zalutumumab|mesh-list
6470678|NCT00496652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6470679|NCT00496652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6470680|NCT00496665|Cyclophosphamide|cyclophosphamide|mesh-list
6470681|NCT00496665|Methotrexate|methotrexate|mesh-list
6470682|NCT00496665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6470683|NCT00496665|Immunologic Factors|immunologic factors|mesh-ancestor
6470684|NCT00496665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470685|NCT00496665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6470686|NCT00496665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6470687|NCT00496665|Alkylating Agents|alkylating agents|mesh-ancestor
6470688|NCT00496665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6470689|NCT00496665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5543966|NCT04148846|Dexamethasone|dexamethasone|mesh-list
5543967|NCT04148846|Ketoprofen|ketoprofen|mesh-list
5543968|NCT04148846|Theophylline|theophylline|mesh-list
5543969|NCT04148846|Gabapentin|gabapentin|mesh-list
5543970|NCT04148846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5543971|NCT04148846|Antiemetics|antiemetics|mesh-ancestor
5543972|NCT04148846|Autonomic Agents|autonomic agents|mesh-ancestor
5543973|NCT04148846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5543974|NCT04148846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5543975|NCT04148846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5543976|NCT04148846|Glucocorticoids|glucocorticoids|mesh-ancestor
5543977|NCT04148846|Hormones|hormones|mesh-ancestor
5543978|NCT04148846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5543979|NCT04148846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5543980|NCT04148846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5543981|NCT04148846|Analgesics|analgesics|mesh-ancestor
5543982|NCT04148846|Sensory System Agents|sensory system agents|mesh-ancestor
5543983|NCT04148846|Anticonvulsants|anticonvulsants|mesh-ancestor
5543984|NCT04148846|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5543985|NCT04148846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6470690|NCT00496665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6470691|NCT00496665|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6470692|NCT00496665|Abortifacient Agents|abortifacient agents|mesh-ancestor
6470693|NCT00496665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6470694|NCT00496665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6470695|NCT00496665|Antimetabolites|antimetabolites|mesh-ancestor
6470696|NCT00496665|Dermatologic Agents|dermatologic agents|mesh-ancestor
6470697|NCT00496665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6470698|NCT00496665|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6470699|NCT00496665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6470700|NCT00496704|Gemcitabine|gemcitabine|mesh-list
6470701|NCT00496704|Capecitabine|capecitabine|mesh-list
6470702|NCT00496704|Oxaliplatin|oxaliplatin|mesh-list
6470703|NCT00496704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6470704|NCT00496704|Antimetabolites|antimetabolites|mesh-ancestor
6470705|NCT00496704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139886|NCT01300234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6139887|NCT01300247|Cyclophosphamide|cyclophosphamide|mesh-list
6139888|NCT01300247|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5543986|NCT04148846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5543987|NCT04148846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5543988|NCT04148846|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5543989|NCT04148846|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5543990|NCT04148846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5543991|NCT04148846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5543992|NCT04148846|Antimanic Agents|antimanic agents|mesh-ancestor
5543993|NCT04148846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5543994|NCT04148846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5543995|NCT04148846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5543996|NCT04148846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5543997|NCT04148846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6139889|NCT01300247|Fludarabine|fludarabine|mesh-list
6139890|NCT01300247|Obinutuzumab|obinutuzumab|mesh-list
6139891|NCT01300247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6139892|NCT01300247|Immunologic Factors|immunologic factors|mesh-ancestor
6139893|NCT01300247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139894|NCT01300247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6139895|NCT01300247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6139896|NCT01300247|Alkylating Agents|alkylating agents|mesh-ancestor
6139897|NCT01300247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139898|NCT01300247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5543998|NCT04148846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5543999|NCT04148846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5544000|NCT04148846|Respiratory System Agents|respiratory system agents|mesh-ancestor
5544001|NCT04148846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5544002|NCT04148846|Vasodilator Agents|vasodilator agents|mesh-ancestor
5544003|NCT04148846|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5544004|NCT04148846|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5544005|NCT04148846|Purinergic Agents|purinergic agents|mesh-ancestor
5544006|NCT04148261|Hydrocortisone|hydrocortisone|mesh-list
5544007|NCT04148261|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
5544008|NCT04148261|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
5544009|NCT04148261|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6139899|NCT01300247|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6139900|NCT01300247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6139901|NCT01300260|Dulaglutide|dulaglutide|mesh-list
6139902|NCT01300260|Glucagon|glucagon|mesh-list
6139903|NCT01300260|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6139904|NCT01300260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6139905|NCT01300260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139906|NCT01300260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6139907|NCT01300260|Hormones|hormones|mesh-ancestor
6139908|NCT01300260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6139909|NCT01300260|Incretins|incretins|mesh-ancestor
6139910|NCT01300351|Fulvestrant|fulvestrant|mesh-list
6139911|NCT01300351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6139912|NCT01300351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6139913|NCT01300351|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6139914|NCT01300351|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6139915|NCT01300351|Hormone Antagonists|hormone antagonists|mesh-ancestor
6139916|NCT01300351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6139917|NCT01300351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139918|NCT01300455|Suvorexant|suvorexant|mesh-list
6139919|NCT01300455|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6139920|NCT01300455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6139921|NCT01300455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5544010|NCT04148261|Epinephrine|epinephrine|mesh-list
5544011|NCT04148261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5544012|NCT04148261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5544013|NCT04148261|Adrenergic Agents|adrenergic agents|mesh-ancestor
5544014|NCT04148261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5544015|NCT04148261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544016|NCT04148261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544017|NCT04148261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5544018|NCT04148261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5544019|NCT04148261|Autonomic Agents|autonomic agents|mesh-ancestor
5544020|NCT04148261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5544021|NCT04148261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6139922|NCT01300455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139923|NCT01300455|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
6139924|NCT01300455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6139925|NCT01300455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139926|NCT01300546|Naproxen|naproxen|mesh-list
5544022|NCT04148261|Respiratory System Agents|respiratory system agents|mesh-ancestor
5544023|NCT04148261|Mydriatics|mydriatics|mesh-ancestor
5544024|NCT04148261|Sympathomimetics|sympathomimetics|mesh-ancestor
5544025|NCT04148261|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5544026|NCT04148261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5544027|NCT04148183|Metformin|metformin|mesh-list
5544028|NCT04148183|Rosiglitazone|rosiglitazone|mesh-list
6470706|NCT00496704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5544029|NCT04148183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5544030|NCT04148183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544031|NCT04147572|Tiotropium Bromide|tiotropium bromide|mesh-list
5544032|NCT04147572|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5544033|NCT04147572|Autonomic Agents|autonomic agents|mesh-ancestor
5544034|NCT04147572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5544035|NCT04147572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544036|NCT04147572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5544037|NCT04147572|Respiratory System Agents|respiratory system agents|mesh-ancestor
5544038|NCT04147572|Parasympatholytics|parasympatholytics|mesh-ancestor
5544039|NCT04147572|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5544040|NCT04147572|Cholinergic Agents|cholinergic agents|mesh-ancestor
6470707|NCT00496704|Antiviral Agents|antiviral agents|mesh-ancestor
6470708|NCT00496704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6470709|NCT00496704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6470710|NCT00496704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5544041|NCT04147572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5544042|NCT04147572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544043|NCT04147806|Dexamethasone|dexamethasone|mesh-list
5544044|NCT04147806|Tamsulosin|tamsulosin|mesh-list
5544045|NCT04147806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5544046|NCT04147806|Antiemetics|antiemetics|mesh-ancestor
5544047|NCT04147806|Autonomic Agents|autonomic agents|mesh-ancestor
5544048|NCT04147806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5544049|NCT04147806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544050|NCT04147806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5544051|NCT04147806|Glucocorticoids|glucocorticoids|mesh-ancestor
5544052|NCT04147806|Hormones|hormones|mesh-ancestor
5544053|NCT04147806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5544054|NCT04147806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5544055|NCT04147806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5544056|NCT04147806|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5544057|NCT04147806|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5544058|NCT04147806|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5544059|NCT04147806|Adrenergic Agents|adrenergic agents|mesh-ancestor
5544060|NCT04147806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5544061|NCT04147806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544062|NCT04147806|Urological Agents|urological agents|mesh-ancestor
5544063|NCT04147754|Morphine|morphine|mesh-list
6470711|NCT00496704|Immunologic Factors|immunologic factors|mesh-ancestor
6470712|NCT00496704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470713|NCT00496795|Docetaxel|docetaxel|mesh-list
6470714|NCT00496795|Epirubicin|epirubicin|mesh-list
6470715|NCT00496795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6470716|NCT00496795|Tubulin Modulators|tubulin modulators|mesh-ancestor
6470717|NCT00496795|Antimitotic Agents|antimitotic agents|mesh-ancestor
6470718|NCT00496795|Mitosis Modulators|mitosis modulators|mesh-ancestor
6666695|NCT01523860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6470719|NCT00496795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6470720|NCT00496795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6470721|NCT00496795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6470722|NCT00496795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6470723|NCT00496795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6488572|NCT00585000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6488573|NCT00585091|Phenylephrine|phenylephrine|mesh-list
6488574|NCT00585091|Oxymetazoline|oxymetazoline|mesh-list
6488575|NCT00585091|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6488576|NCT00585091|Mydriatics|mydriatics|mesh-ancestor
6488577|NCT00585091|Autonomic Agents|autonomic agents|mesh-ancestor
5544064|NCT04147754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5544065|NCT04147754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139927|NCT01300546|Sumatriptan|sumatriptan|mesh-list
6139928|NCT01300546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6139929|NCT01300546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6139930|NCT01300546|Analgesics|analgesics|mesh-ancestor
6139931|NCT01300546|Sensory System Agents|sensory system agents|mesh-ancestor
6139932|NCT01300546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6139933|NCT01300546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139934|NCT01300546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6488578|NCT00585091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6488579|NCT00585091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488580|NCT00585091|Sympathomimetics|sympathomimetics|mesh-ancestor
6488581|NCT00585091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6488582|NCT00585091|Nasal Decongestants|nasal decongestants|mesh-ancestor
6488583|NCT00585091|Respiratory System Agents|respiratory system agents|mesh-ancestor
6488584|NCT00585091|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6139935|NCT01300546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6139936|NCT01300546|Gout Suppressants|gout suppressants|mesh-ancestor
6139937|NCT01300546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6139938|NCT01300546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6139939|NCT01300546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139940|NCT01300546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6139941|NCT01300546|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6139942|NCT01300546|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6139943|NCT01300546|Serotonin Agents|serotonin agents|mesh-ancestor
6139944|NCT01300546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6139945|NCT01300572|Cyclosporine|cyclosporine|mesh-list
6139946|NCT01300572|Mycophenolic Acid|mycophenolic acid|mesh-list
6139947|NCT01300572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6139948|NCT01300572|Fludarabine|fludarabine|mesh-list
6139949|NCT01300572|Fludarabine phosphate|fludarabine phosphate|mesh-list
6139950|NCT01300572|Antibodies|antibodies|mesh-list
6139951|NCT01300572|Immunoglobulins|immunoglobulins|mesh-list
6139952|NCT01300572|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6139953|NCT01300572|Cyclosporins|cyclosporins|mesh-list
6139954|NCT01300572|Immunologic Factors|immunologic factors|mesh-ancestor
6139955|NCT01300572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139956|NCT01300572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6139957|NCT01300572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6139958|NCT01300572|Antimetabolites|antimetabolites|mesh-ancestor
6139959|NCT01300572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139960|NCT01300572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6139961|NCT01300572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6139962|NCT01300572|Antifungal Agents|antifungal agents|mesh-ancestor
6139963|NCT01300572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6139964|NCT01300572|Dermatologic Agents|dermatologic agents|mesh-ancestor
6139965|NCT01300572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6139966|NCT01300572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6139967|NCT01300572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6139968|NCT01300572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6139969|NCT01300572|Antitubercular Agents|antitubercular agents|mesh-ancestor
6139970|NCT01300572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6488585|NCT00585091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6488586|NCT00585091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6139971|NCT01300650|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6139972|NCT01300650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6139973|NCT01300741|Contact Lens Solutions|contact lens solutions|mesh-list
6139974|NCT01300741|Disinfectants|disinfectants|mesh-ancestor
6139975|NCT01300741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6139976|NCT01300767|Contact Lens Solutions|contact lens solutions|mesh-list
6139977|NCT01300767|Disinfectants|disinfectants|mesh-ancestor
6139978|NCT01300767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6139979|NCT01300819|Rotigotine|rotigotine|mesh-list
6139980|NCT01300819|Dopamine Agonists|dopamine agonists|mesh-ancestor
6139981|NCT01300819|Dopamine Agents|dopamine agents|mesh-ancestor
6139982|NCT01300819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6139983|NCT01300819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6139984|NCT01300819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139985|NCT01300923|Acamprosate|acamprosate|mesh-list
6139986|NCT01300923|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6139987|NCT01301001|Gabapentin|gabapentin|mesh-list
6470724|NCT00497003|Metoprolol|metoprolol|mesh-list
6470725|NCT00497003|Carvedilol|carvedilol|mesh-list
6470726|NCT00497003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6470727|NCT00497003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6470728|NCT00497003|Sympatholytics|sympatholytics|mesh-ancestor
5544066|NCT04147754|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5544067|NCT04147754|Narcotics|narcotics|mesh-ancestor
5544068|NCT04147754|Analgesics|analgesics|mesh-ancestor
5544069|NCT04147754|Sensory System Agents|sensory system agents|mesh-ancestor
5544070|NCT04147754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5544071|NCT04147845|Triamcinolone|triamcinolone|mesh-list
5544072|NCT04147845|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5544073|NCT04147845|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5544074|NCT04147845|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5544075|NCT04147845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5544076|NCT04147845|Glucocorticoids|glucocorticoids|mesh-ancestor
5544077|NCT04147845|Hormones|hormones|mesh-ancestor
5544078|NCT04147845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5544079|NCT04147845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544080|NCT04147845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5544081|NCT04147845|Immunologic Factors|immunologic factors|mesh-ancestor
6470729|NCT00497003|Autonomic Agents|autonomic agents|mesh-ancestor
6470730|NCT00497003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6470731|NCT00497003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470732|NCT00497003|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6470733|NCT00497003|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6470734|NCT00497003|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6470735|NCT00497003|Adrenergic Agents|adrenergic agents|mesh-ancestor
6470736|NCT00497003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6470737|NCT00497003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544082|NCT04147845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5544083|NCT04147845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544084|NCT04147728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
6666696|NCT01523860|Alkylating Agents|alkylating agents|mesh-ancestor
6666697|NCT01523860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666698|NCT01523860|Analgesics|analgesics|mesh-ancestor
6666699|NCT01523860|Sensory System Agents|sensory system agents|mesh-ancestor
6666700|NCT01523860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6666701|NCT01523860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6666702|NCT01523860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6139988|NCT01301001|Analgesics|analgesics|mesh-ancestor
6139989|NCT01301001|Sensory System Agents|sensory system agents|mesh-ancestor
5544085|NCT04147728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5544086|NCT04147728|Growth Substances|growth substances|mesh-ancestor
5544087|NCT04147728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544088|NCT04147728|Growth Inhibitors|growth inhibitors|mesh-ancestor
5544089|NCT04147728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5544090|NCT04147286|Atorvastatin|atorvastatin|mesh-list
5544091|NCT04147286|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6139990|NCT01301001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6139991|NCT01301001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6139992|NCT01301001|Anticonvulsants|anticonvulsants|mesh-ancestor
6139993|NCT01301001|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6470738|NCT00497003|Antioxidants|antioxidants|mesh-ancestor
6470739|NCT00497003|Protective Agents|protective agents|mesh-ancestor
6666703|NCT01523860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5544092|NCT04147286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6139994|NCT01301001|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6470740|NCT00497003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6470741|NCT00497003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6470742|NCT00497003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6470743|NCT00497003|Vasodilator Agents|vasodilator agents|mesh-ancestor
6470744|NCT00497003|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6139995|NCT01301001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6139996|NCT01301001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6139997|NCT01301001|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6139998|NCT01301001|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6139999|NCT01301001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6140000|NCT01301001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140001|NCT01301001|Antimanic Agents|antimanic agents|mesh-ancestor
6140002|NCT01301027|Pioglitazone|pioglitazone|mesh-list
6140003|NCT01301027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6140004|NCT01301027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140005|NCT01301066|Pravastatin|pravastatin|mesh-list
6140006|NCT01301066|Pitavastatin|pitavastatin|mesh-list
6470745|NCT00497003|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6470746|NCT00497016|Atorvastatin|atorvastatin|mesh-list
6470747|NCT00497016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6470748|NCT00497016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6470749|NCT00497016|Antimetabolites|antimetabolites|mesh-ancestor
6470750|NCT00497016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6470751|NCT00497016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6470752|NCT00497016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6470753|NCT00497016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6470754|NCT00497029|Fluorides|fluorides|mesh-list
6470755|NCT00497029|Fluorides, Topical|fluorides, topical|mesh-list
6470756|NCT00497029|Cariostatic Agents|cariostatic agents|mesh-ancestor
6470757|NCT00497029|Protective Agents|protective agents|mesh-ancestor
6470758|NCT00497029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488587|NCT00585091|Adrenergic Agents|adrenergic agents|mesh-ancestor
6488588|NCT00585091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6488589|NCT00585091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488590|NCT00585091|Protective Agents|protective agents|mesh-ancestor
6140007|NCT01301066|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6140008|NCT01301066|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6140009|NCT01301066|Antimetabolites|antimetabolites|mesh-ancestor
6488591|NCT00585143|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5544093|NCT04147286|Antimetabolites|antimetabolites|mesh-ancestor
6140010|NCT01301066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140011|NCT01301066|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5544094|NCT04147286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544095|NCT04147286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6140012|NCT01301066|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6140013|NCT01301066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6140014|NCT01301079|Ketamine|ketamine|mesh-list
6140015|NCT01301079|Analgesics|analgesics|mesh-ancestor
6140016|NCT01301079|Sensory System Agents|sensory system agents|mesh-ancestor
6140017|NCT01301079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6140018|NCT01301079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140019|NCT01301079|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5544096|NCT04147286|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5544097|NCT04147286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5544098|NCT04147221|Imipenem|imipenem|mesh-list
5544099|NCT04147221|Relebactam|relebactam|mesh-list
5544100|NCT04147221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6140020|NCT01301079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6140021|NCT01301079|Anesthetics, General|anesthetics, general|mesh-ancestor
6140022|NCT01301079|Anesthetics|anesthetics|mesh-ancestor
6140023|NCT01301079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6140024|NCT01301079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6140025|NCT01301079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6140026|NCT01301079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6140027|NCT01301079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140028|NCT01301092|Dulaglutide|dulaglutide|mesh-list
6140029|NCT01301092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6140030|NCT01301092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140031|NCT01301183|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6140032|NCT01301183|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6140033|NCT01301183|Estradiol|estradiol|mesh-list
6470759|NCT00497107|Calcium, Dietary|calcium, dietary|mesh-list
6470760|NCT00497107|Leucovorin|leucovorin|mesh-list
6470761|NCT00497107|Calcium|calcium|mesh-list
6140034|NCT01301183|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6140035|NCT01301183|Mecasermin|mecasermin|mesh-list
6140036|NCT01301183|Estrogens|estrogens|mesh-ancestor
6140037|NCT01301183|Hormones|hormones|mesh-ancestor
6140038|NCT01301183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6470762|NCT00497107|Levoleucovorin|levoleucovorin|mesh-list
6470763|NCT00497107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6470764|NCT00497107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470765|NCT00497107|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6470766|NCT00497107|Antidotes|antidotes|mesh-ancestor
6470767|NCT00497107|Protective Agents|protective agents|mesh-ancestor
6470768|NCT00497107|Vitamin B Complex|vitamin b complex|mesh-ancestor
6470769|NCT00497107|Vitamins|vitamins|mesh-ancestor
6470770|NCT00497107|Micronutrients|micronutrients|mesh-ancestor
6470771|NCT00497120|Acetazolamide|acetazolamide|mesh-list
6470772|NCT00497120|Anticonvulsants|anticonvulsants|mesh-ancestor
6140039|NCT01301183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140040|NCT01301183|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6140041|NCT01301183|Contraceptive Agents|contraceptive agents|mesh-ancestor
6140042|NCT01301183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6140043|NCT01301183|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6140044|NCT01301183|Growth Substances|growth substances|mesh-ancestor
6140045|NCT01301391|Maleic acid|maleic acid|mesh-list
6470773|NCT00497120|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5544101|NCT04147221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5544102|NCT04147221|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5544103|NCT04147221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5544104|NCT04147221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544105|NCT04147208|Ritonavir|ritonavir|mesh-list
5544106|NCT04147208|Entecavir|entecavir|mesh-list
5544107|NCT04147208|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5544108|NCT04147208|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5544109|NCT04147208|Protease Inhibitors|protease inhibitors|mesh-ancestor
6470774|NCT00497120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6470775|NCT00497120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6470776|NCT00497120|Diuretics|diuretics|mesh-ancestor
6470777|NCT00497120|Natriuretic Agents|natriuretic agents|mesh-ancestor
5544110|NCT04147208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6140046|NCT01301391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6140047|NCT01301391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140048|NCT01301729|Paclitaxel|paclitaxel|mesh-list
6140049|NCT01301729|Docetaxel|docetaxel|mesh-list
6140050|NCT01301729|Trastuzumab|trastuzumab|mesh-list
6140051|NCT01301729|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6140052|NCT01301729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6470778|NCT00497120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470779|NCT00497172|Sirolimus|sirolimus|mesh-list
6140053|NCT01301729|Tubulin Modulators|tubulin modulators|mesh-ancestor
6140054|NCT01301729|Antimitotic Agents|antimitotic agents|mesh-ancestor
6140055|NCT01301729|Mitosis Modulators|mitosis modulators|mesh-ancestor
6140056|NCT01301729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140057|NCT01301729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6140058|NCT01301742|Empagliflozin|empagliflozin|mesh-list
6140059|NCT01301742|Gemfibrozil|gemfibrozil|mesh-list
6140060|NCT01301742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6140061|NCT01301742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140062|NCT01301742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6140063|NCT01301742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140064|NCT01301742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6140065|NCT01301742|Antimetabolites|antimetabolites|mesh-ancestor
6140066|NCT01301742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6140067|NCT01301742|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6140068|NCT01301742|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6140069|NCT01301742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6140070|NCT01301833|Biguanides|biguanides|mesh-list
6140071|NCT01301833|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
6140072|NCT01301833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6140073|NCT01301833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140074|NCT01301833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6140075|NCT01301833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140076|NCT01302054|Fesoterodine|fesoterodine|mesh-list
6140077|NCT01302054|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6140078|NCT01302054|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6140079|NCT01302054|Cholinergic Agents|cholinergic agents|mesh-ancestor
6140080|NCT01302054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6140081|NCT01302054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140082|NCT01302054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140083|NCT01302054|Urological Agents|urological agents|mesh-ancestor
6140084|NCT01302067|Fesoterodine|fesoterodine|mesh-list
6140085|NCT01302067|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5544111|NCT04147208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544112|NCT04147208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5544113|NCT04147208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5544114|NCT04147208|Antiviral Agents|antiviral agents|mesh-ancestor
5544115|NCT04147208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5544116|NCT04147208|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6140086|NCT01302067|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6470780|NCT00497172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6470781|NCT00497172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6470782|NCT00497172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6470783|NCT00497172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6470784|NCT00497172|Antifungal Agents|antifungal agents|mesh-ancestor
6470785|NCT00497172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6470786|NCT00497172|Immunologic Factors|immunologic factors|mesh-ancestor
6470787|NCT00497172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470788|NCT00497224|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6470789|NCT00497224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6470790|NCT00497224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6470791|NCT00497224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6470792|NCT00497224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544117|NCT04147208|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5544118|NCT04147481|Anesthetics|anesthetics|mesh-list
5544119|NCT04147481|Anesthetics, Local|anesthetics, local|mesh-list
5544120|NCT04147481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5544121|NCT04147481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544122|NCT04147481|Sensory System Agents|sensory system agents|mesh-ancestor
5544123|NCT04147481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5544124|NCT04147390|Mycophenolic Acid|mycophenolic acid|mesh-list
5544125|NCT04147390|Tacrolimus|tacrolimus|mesh-list
5544126|NCT04147390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5544127|NCT04147390|Immunologic Factors|immunologic factors|mesh-ancestor
5544128|NCT04147390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544129|NCT04147390|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5544130|NCT04147390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5544131|NCT04147390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140087|NCT01302067|Cholinergic Agents|cholinergic agents|mesh-ancestor
6140088|NCT01302067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6140089|NCT01302067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140090|NCT01302067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544132|NCT04147390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5544133|NCT04147390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5544134|NCT04147390|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5544135|NCT04147390|Antitubercular Agents|antitubercular agents|mesh-ancestor
5544136|NCT04147390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5544137|NCT04147390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5544138|NCT04147533|Imatinib Mesylate|imatinib mesylate|mesh-list
5544139|NCT04147533|Dasatinib|dasatinib|mesh-list
5544140|NCT04147533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5544141|NCT04147533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5544142|NCT04147533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5544143|NCT04147533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544144|NCT04147260|Ciprofloxacin|ciprofloxacin|mesh-list
5544145|NCT04147260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5544146|NCT04147260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5544147|NCT04147260|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5544148|NCT04147260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5544149|NCT04147260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5544150|NCT04147260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544151|NCT04147260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5544152|NCT04147260|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5544153|NCT04147260|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5544154|NCT04146883|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5544155|NCT04146883|Cephalexin|cephalexin|mesh-list
6140091|NCT01302067|Urological Agents|urological agents|mesh-ancestor
6140092|NCT01302080|Sertraline|sertraline|mesh-list
6470793|NCT00497237|Fluticasone|fluticasone|mesh-list
6470794|NCT00497237|Beclomethasone|beclomethasone|mesh-list
6470795|NCT00497237|Formoterol Fumarate|formoterol fumarate|mesh-list
6470796|NCT00497237|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5544156|NCT04146883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6140093|NCT01302080|Antidepressive Agents|antidepressive agents|mesh-ancestor
6140094|NCT01302080|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6140095|NCT01302080|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6140096|NCT01302080|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6140097|NCT01302080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6140098|NCT01302080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140099|NCT01302080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5544157|NCT04147416|Propofol|propofol|mesh-list
5544158|NCT04147416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5544159|NCT04147416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5544160|NCT04147416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544161|NCT04147416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5544162|NCT04147416|Anesthetics, General|anesthetics, general|mesh-ancestor
5544163|NCT04147416|Anesthetics|anesthetics|mesh-ancestor
5602464|NCT04507373|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5602465|NCT04507373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5602466|NCT04501653|Methylphenidate|methylphenidate|mesh-list
5602467|NCT04501653|Psilocybin|psilocybin|mesh-list
5602468|NCT04501653|Psilocin|psilocin|mesh-list
5602469|NCT04501653|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5602470|NCT04501653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602471|NCT04501653|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5602472|NCT04501653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5602473|NCT04501653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5602474|NCT04501653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602475|NCT04501653|Dopamine Agents|dopamine agents|mesh-ancestor
5602476|NCT04501653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5602477|NCT04501653|Hallucinogens|hallucinogens|mesh-ancestor
5602478|NCT04501653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5602479|NCT04481009|Gemcitabine|gemcitabine|mesh-list
5602480|NCT04481009|Paclitaxel|paclitaxel|mesh-list
5602481|NCT04481009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5602482|NCT04481009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5602483|NCT04481009|Tubulin Modulators|tubulin modulators|mesh-ancestor
5602484|NCT04481009|Antimitotic Agents|antimitotic agents|mesh-ancestor
5602485|NCT04481009|Mitosis Modulators|mitosis modulators|mesh-ancestor
5602486|NCT04481009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602487|NCT04481009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5602488|NCT04481009|Antimetabolites|antimetabolites|mesh-ancestor
5602489|NCT04481009|Antiviral Agents|antiviral agents|mesh-ancestor
5602490|NCT04481009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5602491|NCT04481009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6140100|NCT01302080|Serotonin Agents|serotonin agents|mesh-ancestor
6470797|NCT00497237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6140101|NCT01302080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140102|NCT01302119|Tavaborole|tavaborole|mesh-list
6140103|NCT01302119|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6140104|NCT01302119|Antifungal Agents|antifungal agents|mesh-ancestor
6140105|NCT01302119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6140106|NCT01302379|Metformin|metformin|mesh-list
6140107|NCT01302379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6140108|NCT01302379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140109|NCT01302483|Lidocaine|lidocaine|mesh-list
6140110|NCT01302483|Phenylephrine|phenylephrine|mesh-list
6140111|NCT01302483|Oxymetazoline|oxymetazoline|mesh-list
6140112|NCT01302483|Tetracaine|tetracaine|mesh-list
6140113|NCT01302483|Anesthetics, Local|anesthetics, local|mesh-ancestor
6140114|NCT01302483|Anesthetics|anesthetics|mesh-ancestor
6140115|NCT01302483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6140116|NCT01302483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140117|NCT01302483|Sensory System Agents|sensory system agents|mesh-ancestor
5544164|NCT04146922|Anti-Infective Agents|anti-infective agents|mesh-list
5544165|NCT04146922|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5544166|NCT04146610|Antibodies|antibodies|mesh-list
5544167|NCT04146610|Immunoconjugates|immunoconjugates|mesh-list
5544168|NCT04146610|Immunologic Factors|immunologic factors|mesh-ancestor
5544169|NCT04146610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544170|NCT04146220|Prednisolone|prednisolone|mesh-list
5544171|NCT04146220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5544172|NCT04146220|Glucocorticoids|glucocorticoids|mesh-ancestor
5544173|NCT04146220|Hormones|hormones|mesh-ancestor
5544174|NCT04146220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5544175|NCT04146220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544176|NCT04146220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5544177|NCT04146220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5544178|NCT04146376|Tranexamic Acid|tranexamic acid|mesh-list
5544179|NCT04146376|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5544180|NCT04146376|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5544181|NCT04146376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544182|NCT04146376|Hemostatics|hemostatics|mesh-ancestor
5544183|NCT04146376|Coagulants|coagulants|mesh-ancestor
5544184|NCT04146207|Prednisone|prednisone|mesh-list
5544185|NCT04146207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5544186|NCT04146207|Glucocorticoids|glucocorticoids|mesh-ancestor
5544187|NCT04146207|Hormones|hormones|mesh-ancestor
5544188|NCT04146207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5544189|NCT04146207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544190|NCT04146207|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5544191|NCT04146207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5544192|NCT04146571|Ensartinib|ensartinib|mesh-list
5544193|NCT04146571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5544194|NCT04146571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5544195|NCT04146571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5544196|NCT04146571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544197|NCT04146493|Heparin|heparin|mesh-list
5544198|NCT04146493|Anticoagulants|anticoagulants|mesh-ancestor
5544199|NCT04146493|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5544200|NCT04146493|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5544201|NCT04146493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544202|NCT04146532|Aspirin|aspirin|mesh-list
5544203|NCT04146532|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5544204|NCT04146532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6140118|NCT01302483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6140119|NCT01302483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6140120|NCT01302483|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6140121|NCT01302483|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6140122|NCT01302483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6140123|NCT01302483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140124|NCT01302483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6140125|NCT01302483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6140126|NCT01302483|Adrenergic Agents|adrenergic agents|mesh-ancestor
5544205|NCT04146532|Analgesics|analgesics|mesh-ancestor
5544206|NCT04146532|Sensory System Agents|sensory system agents|mesh-ancestor
5544207|NCT04146532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5544208|NCT04146532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544209|NCT04146532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5544210|NCT04146532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5544211|NCT04146532|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5544212|NCT04146532|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6140127|NCT01302483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5544213|NCT04146532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544214|NCT04146532|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5544215|NCT04146532|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6140128|NCT01302483|Sympathomimetics|sympathomimetics|mesh-ancestor
6140129|NCT01302483|Autonomic Agents|autonomic agents|mesh-ancestor
6140130|NCT01302483|Nasal Decongestants|nasal decongestants|mesh-ancestor
6140131|NCT01302483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6140132|NCT01302483|Respiratory System Agents|respiratory system agents|mesh-ancestor
6140133|NCT01302483|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6140134|NCT01302483|Mydriatics|mydriatics|mesh-ancestor
6140135|NCT01302483|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6140136|NCT01302483|Protective Agents|protective agents|mesh-ancestor
6140137|NCT01302691|Losartan|losartan|mesh-list
6140138|NCT01302691|Amlodipine|amlodipine|mesh-list
6470798|NCT00497237|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6470799|NCT00497237|Autonomic Agents|autonomic agents|mesh-ancestor
6470800|NCT00497237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6470801|NCT00497237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470802|NCT00497237|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6470803|NCT00497237|Respiratory System Agents|respiratory system agents|mesh-ancestor
6470804|NCT00497237|Dermatologic Agents|dermatologic agents|mesh-ancestor
6470805|NCT00497237|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6470806|NCT00497237|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5544216|NCT04146532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5544217|NCT04146532|Antipyretics|antipyretics|mesh-ancestor
5544218|NCT04146155|Liraglutide|liraglutide|mesh-list
5544219|NCT04146155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5544220|NCT04146155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544221|NCT04146155|Incretins|incretins|mesh-ancestor
5544222|NCT04146155|Hormones|hormones|mesh-ancestor
5544223|NCT04146155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5544224|NCT04146259|Alfacalcidol|alfacalcidol|mesh-list
5544225|NCT04146259|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
5544226|NCT04146259|Calcium Carbonate|calcium carbonate|mesh-list
5544227|NCT04146259|Calcium|calcium|mesh-list
6470807|NCT00497237|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6470808|NCT00497237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6470809|NCT00497237|Adrenergic Agents|adrenergic agents|mesh-ancestor
5544228|NCT04146259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5544229|NCT04146259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544230|NCT04146259|Antacids|antacids|mesh-ancestor
5544231|NCT04146259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544232|NCT04146259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5544233|NCT04146259|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5544234|NCT04146259|Vitamins|vitamins|mesh-ancestor
5544235|NCT04146259|Micronutrients|micronutrients|mesh-ancestor
5544236|NCT04145856|Simethicone|simethicone|mesh-list
5544237|NCT04145856|Alverine|alverine|mesh-list
5544238|NCT04145856|Antifoaming Agents|antifoaming agents|mesh-ancestor
5544239|NCT04145856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544240|NCT04145856|Emollients|emollients|mesh-ancestor
5544241|NCT04145856|Dermatologic Agents|dermatologic agents|mesh-ancestor
5544242|NCT04145856|Parasympatholytics|parasympatholytics|mesh-ancestor
5544243|NCT04145856|Autonomic Agents|autonomic agents|mesh-ancestor
5544244|NCT04145856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5544245|NCT04145856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470810|NCT00497237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6470811|NCT00497237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6470812|NCT00497237|Glucocorticoids|glucocorticoids|mesh-ancestor
6470813|NCT00497237|Hormones|hormones|mesh-ancestor
6470814|NCT00497237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6140139|NCT01302691|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6140140|NCT01302691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6140141|NCT01302691|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5544246|NCT04146038|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
5544247|NCT04146038|Sodium Salicylate|sodium salicylate|mesh-list
5544248|NCT04146038|Azacitidine|azacitidine|mesh-list
5544249|NCT04146038|Decitabine|decitabine|mesh-list
5544250|NCT04146038|Venetoclax|venetoclax|mesh-list
5544251|NCT04146038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5544252|NCT04146038|Antimetabolites|antimetabolites|mesh-ancestor
5544253|NCT04146038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544254|NCT04146038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5544255|NCT04146038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5544256|NCT04146038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6470815|NCT00497250|Gefitinib|gefitinib|mesh-list
6470816|NCT00497250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6470817|NCT00497250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6470818|NCT00497250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6470819|NCT00497250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6470820|NCT00497315|Pemetrexed|pemetrexed|mesh-list
6470821|NCT00497315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6470822|NCT00497315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6470823|NCT00497315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6470824|NCT00497315|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6470825|NCT00497315|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6470826|NCT00497328|Acetylcysteine|acetylcysteine|mesh-list
6470827|NCT00497328|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6470828|NCT00497328|Antiviral Agents|antiviral agents|mesh-ancestor
6470829|NCT00497328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6470830|NCT00497328|Expectorants|expectorants|mesh-ancestor
6470831|NCT00497328|Respiratory System Agents|respiratory system agents|mesh-ancestor
6470832|NCT00497328|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6470833|NCT00497328|Antioxidants|antioxidants|mesh-ancestor
6470834|NCT00497328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6470835|NCT00497328|Protective Agents|protective agents|mesh-ancestor
6470836|NCT00497328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470837|NCT00497328|Antidotes|antidotes|mesh-ancestor
6470838|NCT00497341|Cefuroxime|cefuroxime|mesh-list
6470839|NCT00497341|Cefuroxime axetil|cefuroxime axetil|mesh-list
6470840|NCT00497341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6470841|NCT00497341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6470842|NCT00497354|Anesthetics|anesthetics|mesh-list
6470843|NCT00497354|Anesthetics, Local|anesthetics, local|mesh-list
6470844|NCT00497354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6470845|NCT00497354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140142|NCT01302691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6140143|NCT01302691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140144|NCT01302691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6140145|NCT01302691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140146|NCT01302691|Vasodilator Agents|vasodilator agents|mesh-ancestor
6140147|NCT01302691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6140148|NCT01302691|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6470846|NCT00497354|Sensory System Agents|sensory system agents|mesh-ancestor
6470847|NCT00497354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6470848|NCT00497458|Testosterone|testosterone|mesh-list
6470849|NCT00497458|Androgens|androgens|mesh-ancestor
6470850|NCT00497458|Hormones|hormones|mesh-ancestor
6470851|NCT00497458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6470852|NCT00497458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470853|NCT00497471|Pyrimethamine|pyrimethamine|mesh-list
6470854|NCT00497471|Dapsone|dapsone|mesh-list
6470855|NCT00497471|Antimalarials|antimalarials|mesh-ancestor
6470856|NCT00497471|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6470857|NCT00497471|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6470858|NCT00497471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6470859|NCT00497471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6470860|NCT00497471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6470861|NCT00497471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6470862|NCT00497471|Leprostatic Agents|leprostatic agents|mesh-ancestor
6470863|NCT00497471|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6470864|NCT00497497|Bevacizumab|bevacizumab|mesh-list
6470865|NCT00497497|Cetuximab|cetuximab|mesh-list
6470866|NCT00497497|Irinotecan|irinotecan|mesh-list
6470867|NCT00497497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6470868|NCT00497497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5544257|NCT04146038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5544258|NCT04146038|Analgesics|analgesics|mesh-ancestor
5544259|NCT04146038|Sensory System Agents|sensory system agents|mesh-ancestor
5544260|NCT04146038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5544261|NCT04146038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544262|NCT04146038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5544263|NCT04146038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5544264|NCT04146038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5544265|NCT04146116|Povidone-Iodine|povidone-iodine|mesh-list
5544266|NCT04146116|Povidone|povidone|mesh-list
5544267|NCT04146116|Plasma Substitutes|plasma substitutes|mesh-ancestor
6470869|NCT00497497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6470870|NCT00497497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6470871|NCT00497497|Growth Substances|growth substances|mesh-ancestor
6470872|NCT00497497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470873|NCT00497497|Growth Inhibitors|growth inhibitors|mesh-ancestor
6470874|NCT00497497|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6470875|NCT00497497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6470876|NCT00497497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6470877|NCT00497497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6470878|NCT00497523|Beclomethasone|beclomethasone|mesh-list
6470879|NCT00497523|Albuterol|albuterol|mesh-list
6470880|NCT00497523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6470881|NCT00497523|Autonomic Agents|autonomic agents|mesh-ancestor
6470882|NCT00497523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6470883|NCT00497523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470884|NCT00497523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6470885|NCT00497523|Respiratory System Agents|respiratory system agents|mesh-ancestor
6470886|NCT00497523|Tocolytic Agents|tocolytic agents|mesh-ancestor
6470887|NCT00497523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6470888|NCT00497523|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6470889|NCT00497523|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6140149|NCT01302691|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6140150|NCT01302691|Diuretics|diuretics|mesh-ancestor
6140151|NCT01302691|Natriuretic Agents|natriuretic agents|mesh-ancestor
6140152|NCT01302691|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6140153|NCT01302743|Metformin|metformin|mesh-list
6140154|NCT01302743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6140155|NCT01302743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140156|NCT01302808|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6140157|NCT01302808|Romidepsin|romidepsin|mesh-list
6140158|NCT01302808|Antiemetics|antiemetics|mesh-list
6140159|NCT01302808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6140160|NCT01302808|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6140161|NCT01302808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6140162|NCT01302808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140163|NCT01302808|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6140164|NCT01302808|Autonomic Agents|autonomic agents|mesh-ancestor
6140165|NCT01302808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6140166|NCT01302808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140167|NCT01302808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6140168|NCT01302834|Cetuximab|cetuximab|mesh-list
6140169|NCT01302834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6140170|NCT01302834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5544268|NCT04146116|Blood Substitutes|blood substitutes|mesh-ancestor
5544269|NCT04146116|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5544270|NCT04146116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5544271|NCT04145804|Insulin|insulin|mesh-list
5544272|NCT04145804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5544273|NCT04145804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544274|NCT04145583|Voriconazole|voriconazole|mesh-list
5544275|NCT04145583|Antifungal Agents|antifungal agents|mesh-ancestor
5544276|NCT04145583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5544277|NCT04145583|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5544278|NCT04145583|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5544279|NCT04145583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5544280|NCT04145583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544281|NCT04145583|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5544282|NCT04145583|Hormone Antagonists|hormone antagonists|mesh-ancestor
5544283|NCT04145583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5544284|NCT04145583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140171|NCT01302899|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6140172|NCT01302899|Ramipril|ramipril|mesh-list
6470890|NCT00497523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6470891|NCT00497523|Adrenergic Agents|adrenergic agents|mesh-ancestor
6140173|NCT01302899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6140174|NCT01302899|Diuretics|diuretics|mesh-ancestor
6140175|NCT01302899|Natriuretic Agents|natriuretic agents|mesh-ancestor
6140176|NCT01302899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140177|NCT01302899|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6140178|NCT01302899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6470892|NCT00497523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6470893|NCT00497523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6470894|NCT00497523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6470895|NCT00497523|Glucocorticoids|glucocorticoids|mesh-ancestor
6140179|NCT01302899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140180|NCT01302899|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6140181|NCT01302899|Protease Inhibitors|protease inhibitors|mesh-ancestor
6140182|NCT01302899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6140183|NCT01302938|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6140184|NCT01302938|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6140185|NCT01302938|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6140186|NCT01302938|Cholinergic Agents|cholinergic agents|mesh-ancestor
6140187|NCT01302938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5544285|NCT04145583|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5544286|NCT04145570|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5544287|NCT04145570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5544288|NCT04145570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5544289|NCT04145570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5544290|NCT04145570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544291|NCT04145492|Vitamin D|vitamin d|mesh-list
5544292|NCT04145492|Cholecalciferol|cholecalciferol|mesh-list
5544293|NCT04145492|Vitamins|vitamins|mesh-list
5544294|NCT04145492|Vitamin K|vitamin k|mesh-list
5544295|NCT04145492|Vitamin K 2|vitamin k 2|mesh-list
5544296|NCT04145492|Micronutrients|micronutrients|mesh-ancestor
5544297|NCT04145492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544298|NCT04145492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5544299|NCT04145492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5544300|NCT04145492|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5544301|NCT04145492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5544302|NCT04145492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544303|NCT04145492|Hemostatics|hemostatics|mesh-ancestor
5544304|NCT04145492|Coagulants|coagulants|mesh-ancestor
5544305|NCT04145921|Tacrine|tacrine|mesh-list
5544306|NCT04145921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5544307|NCT04145921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5544308|NCT04145921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544309|NCT04145921|Cholinergic Agents|cholinergic agents|mesh-ancestor
6140188|NCT01302938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6470896|NCT00497523|Hormones|hormones|mesh-ancestor
6470897|NCT00497523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6470898|NCT00497536|Insulin|insulin|mesh-list
6470899|NCT00497536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6470900|NCT00497536|Insulin Aspart|insulin aspart|mesh-list
6470901|NCT00497536|Insulin, Long-Acting|insulin, long-acting|mesh-list
6470902|NCT00497536|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6470903|NCT00497536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6470904|NCT00497536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470905|NCT00497562|Tramadol|tramadol|mesh-list
6470906|NCT00497562|Amitriptyline|amitriptyline|mesh-list
5544310|NCT04145921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6140189|NCT01302938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140190|NCT01302938|Urological Agents|urological agents|mesh-ancestor
6140191|NCT01302964|Mirtazapine|mirtazapine|mesh-list
6140192|NCT01302964|Antidepressive Agents|antidepressive agents|mesh-ancestor
6140193|NCT01302964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5544311|NCT04145921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544312|NCT04145921|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5544313|NCT04145921|Autonomic Agents|autonomic agents|mesh-ancestor
5544314|NCT04145921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5544315|NCT04145921|Nootropic Agents|nootropic agents|mesh-ancestor
5544316|NCT04145687|Metformin|metformin|mesh-list
5544317|NCT04145687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5544318|NCT04145687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544319|NCT04145518|Naproxen|naproxen|mesh-list
5544320|NCT04145518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5544321|NCT04145518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6140194|NCT01302964|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6666704|NCT01524068|Rituximab|rituximab|mesh-list
5544322|NCT04145518|Analgesics|analgesics|mesh-ancestor
5544323|NCT04145518|Sensory System Agents|sensory system agents|mesh-ancestor
5544324|NCT04145518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5544325|NCT04145518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544326|NCT04145518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5544327|NCT04145518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5544328|NCT04145518|Gout Suppressants|gout suppressants|mesh-ancestor
5544329|NCT04145518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5544330|NCT04145518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5544331|NCT04145518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544332|NCT04145193|Leucovorin|leucovorin|mesh-list
5544333|NCT04145193|Fluorouracil|fluorouracil|mesh-list
5544334|NCT04145193|Oxaliplatin|oxaliplatin|mesh-list
5544335|NCT04145193|Durvalumab|durvalumab|mesh-list
5544336|NCT04145193|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5544337|NCT04145193|Antimetabolites|antimetabolites|mesh-ancestor
5544338|NCT04145193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544339|NCT04145193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5544340|NCT04145193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6140195|NCT01302964|Histamine Antagonists|histamine antagonists|mesh-ancestor
6140196|NCT01302964|Histamine Agents|histamine agents|mesh-ancestor
6140197|NCT01302964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6140198|NCT01302964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140199|NCT01302964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470907|NCT00497562|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6470908|NCT00497562|Fluoxetine|fluoxetine|mesh-list
6470909|NCT00497562|Hormones|hormones|mesh-list
6470910|NCT00497562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6470911|NCT00497562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470912|NCT00497562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6470913|NCT00497562|Narcotics|narcotics|mesh-ancestor
6140200|NCT01302964|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6140201|NCT01302964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6140202|NCT01302964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6140203|NCT01302964|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6140204|NCT01302964|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6140205|NCT01302964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6470914|NCT00497562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6470915|NCT00497562|Analgesics|analgesics|mesh-ancestor
6470916|NCT00497562|Sensory System Agents|sensory system agents|mesh-ancestor
6470917|NCT00497562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6470918|NCT00497562|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6470919|NCT00497562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6470920|NCT00497562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6470921|NCT00497562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6470922|NCT00497562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5544341|NCT04145193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6140206|NCT01302964|Adrenergic Agents|adrenergic agents|mesh-ancestor
6140207|NCT01302964|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6140208|NCT01302964|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6140209|NCT01302964|Serotonin Agents|serotonin agents|mesh-ancestor
6140210|NCT01302964|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6140211|NCT01303172|Gemcitabine|gemcitabine|mesh-list
5544342|NCT04145193|Immunologic Factors|immunologic factors|mesh-ancestor
5544343|NCT04145193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544344|NCT04145193|Antidotes|antidotes|mesh-ancestor
5544345|NCT04145193|Protective Agents|protective agents|mesh-ancestor
5544346|NCT04145193|Vitamin B Complex|vitamin b complex|mesh-ancestor
5544347|NCT04145193|Vitamins|vitamins|mesh-ancestor
5544348|NCT04145193|Micronutrients|micronutrients|mesh-ancestor
5544349|NCT04145193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5544350|NCT04145258|Aspirin|aspirin|mesh-list
5544351|NCT04145258|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5544352|NCT04145258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5544353|NCT04145258|Analgesics|analgesics|mesh-ancestor
5544354|NCT04145258|Sensory System Agents|sensory system agents|mesh-ancestor
5544355|NCT04145258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5544356|NCT04145258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544357|NCT04145258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5544358|NCT04145258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5544359|NCT04145258|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5544360|NCT04145258|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5544361|NCT04145258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544362|NCT04145258|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5544363|NCT04145258|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5544364|NCT04145258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5544365|NCT04145258|Antipyretics|antipyretics|mesh-ancestor
5544366|NCT04145076|Citalopram|citalopram|mesh-list
5544367|NCT04145076|Tianeptine|tianeptine|mesh-list
5544368|NCT04145076|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5544369|NCT04145076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5544370|NCT04145076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5544371|NCT04145076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544372|NCT04145076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6470923|NCT00497562|Serotonin Agents|serotonin agents|mesh-ancestor
6470924|NCT00497562|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6470925|NCT00497562|Antidepressive Agents|antidepressive agents|mesh-ancestor
6470926|NCT00497562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6470927|NCT00497562|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6140212|NCT01303172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6140213|NCT01303172|Antimetabolites|antimetabolites|mesh-ancestor
6140214|NCT01303172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140215|NCT01303172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6140216|NCT01303172|Antiviral Agents|antiviral agents|mesh-ancestor
5544373|NCT04145076|Serotonin Agents|serotonin agents|mesh-ancestor
5544374|NCT04145076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544375|NCT04145076|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5544376|NCT04145076|Antidepressive Agents|antidepressive agents|mesh-ancestor
5544377|NCT04145076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5544378|NCT04145076|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5544379|NCT04145440|Felzartamab|felzartamab|mesh-list
5544380|NCT04145440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5544381|NCT04145440|Immunologic Factors|immunologic factors|mesh-ancestor
5544382|NCT04145440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544383|NCT04145102|Propolis|propolis|mesh-list
5544384|NCT04145102|Fluorides|fluorides|mesh-list
5544385|NCT04145102|Cariostatic Agents|cariostatic agents|mesh-ancestor
5544386|NCT04145102|Protective Agents|protective agents|mesh-ancestor
5544387|NCT04145102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544388|NCT04145102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5602492|NCT04481009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5602493|NCT04481009|Immunologic Factors|immunologic factors|mesh-ancestor
6140217|NCT01303172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6140218|NCT01303172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6140219|NCT01303172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6140220|NCT01303172|Immunologic Factors|immunologic factors|mesh-ancestor
6140221|NCT01303172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140222|NCT01303406|Idebenone|idebenone|mesh-list
6140223|NCT01303406|Antioxidants|antioxidants|mesh-ancestor
6140224|NCT01303406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140225|NCT01303406|Protective Agents|protective agents|mesh-ancestor
6140226|NCT01303406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140227|NCT01303445|Omeprazole|omeprazole|mesh-list
5602494|NCT04481009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602495|NCT04475731|Ponatinib|ponatinib|mesh-list
5602496|NCT04475731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5602497|NCT04475731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5602498|NCT04475731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5602499|NCT04475731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602500|NCT04469491|Interferons|interferons|mesh-list
5602501|NCT04469491|Interferon Type I|interferon type i|mesh-list
6140228|NCT01303445|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
6140229|NCT01303445|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6140230|NCT01303445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6140231|NCT01303445|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6140232|NCT01303445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6140233|NCT01303445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140234|NCT01303445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6140235|NCT01303627|Remifentanil|remifentanil|mesh-list
5602502|NCT04469491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5602503|NCT04469491|Antiviral Agents|antiviral agents|mesh-ancestor
5602504|NCT04469491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5606777|NCT03786783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606778|NCT03786783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5606779|NCT03786783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5606780|NCT03786783|Vitamins|vitamins|mesh-ancestor
6140236|NCT01303627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5606781|NCT03786783|Micronutrients|micronutrients|mesh-ancestor
5544389|NCT04145297|Hydroxychloroquine|hydroxychloroquine|mesh-list
5544390|NCT04145297|Antimalarials|antimalarials|mesh-ancestor
5544391|NCT04145297|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5544392|NCT04145297|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5544393|NCT04145297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5544394|NCT04145297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5544395|NCT04145297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544396|NCT04145297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5544397|NCT04145336|Indomethacin|indomethacin|mesh-list
5544398|NCT04145336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5544399|NCT04145336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5544400|NCT04145336|Analgesics|analgesics|mesh-ancestor
6140237|NCT01303627|Narcotics|narcotics|mesh-ancestor
6140238|NCT01303627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6140239|NCT01303627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140240|NCT01303627|Analgesics|analgesics|mesh-ancestor
6140241|NCT01303627|Sensory System Agents|sensory system agents|mesh-ancestor
6140242|NCT01303627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6140243|NCT01303744|Flurbiprofen|flurbiprofen|mesh-list
6140244|NCT01303744|Analgesics|analgesics|mesh-ancestor
6140245|NCT01303744|Sensory System Agents|sensory system agents|mesh-ancestor
6140246|NCT01303744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6140247|NCT01303744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140248|NCT01303744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5544401|NCT04145336|Sensory System Agents|sensory system agents|mesh-ancestor
5544402|NCT04145336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5544403|NCT04145336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544404|NCT04145336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5544405|NCT04145336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5544406|NCT04145336|Gout Suppressants|gout suppressants|mesh-ancestor
5544407|NCT04145336|Tocolytic Agents|tocolytic agents|mesh-ancestor
5544408|NCT04145336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5544409|NCT04145336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5544410|NCT04145336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5544411|NCT04145336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544412|NCT04145232|Nivolumab|nivolumab|mesh-list
5544413|NCT04145232|Ipilimumab|ipilimumab|mesh-list
5544414|NCT04145232|Atezolizumab|atezolizumab|mesh-list
5544415|NCT04145232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5544416|NCT04145232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5544417|NCT04145232|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5544418|NCT04145232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140249|NCT01303744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6140250|NCT01303744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6140251|NCT01303744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6140252|NCT01303744|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6140253|NCT01303744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6140254|NCT01303744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544419|NCT04144920|Oxymetazoline|oxymetazoline|mesh-list
5544420|NCT04144920|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5544421|NCT04144920|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5544422|NCT04144920|Adrenergic Agents|adrenergic agents|mesh-ancestor
5544423|NCT04144920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5544424|NCT04144920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544425|NCT04144920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544426|NCT04144920|Sympathomimetics|sympathomimetics|mesh-ancestor
5544427|NCT04144920|Autonomic Agents|autonomic agents|mesh-ancestor
5544428|NCT04144920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5544429|NCT04144920|Nasal Decongestants|nasal decongestants|mesh-ancestor
6470928|NCT00497562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6470929|NCT00497562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6470930|NCT00497562|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6470931|NCT00497562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6470932|NCT00497562|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6470933|NCT00497562|Adrenergic Agents|adrenergic agents|mesh-ancestor
6470934|NCT00497562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6470935|NCT00497562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6470936|NCT00497601|Amphotericin B|amphotericin b|mesh-list
6470937|NCT00497601|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6470938|NCT00497601|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6470939|NCT00497601|Amebicides|amebicides|mesh-ancestor
6470940|NCT00497601|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5544430|NCT04144920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5544431|NCT04144920|Respiratory System Agents|respiratory system agents|mesh-ancestor
5544432|NCT04144712|Caffeine|caffeine|mesh-list
5544433|NCT04144712|Caffeine citrate|caffeine citrate|mesh-list
5544434|NCT04144712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544435|NCT04144712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5544436|NCT04144712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544437|NCT04144712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5544438|NCT04144712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5544439|NCT04144712|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5544440|NCT04144712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5544441|NCT04144712|Purinergic Agents|purinergic agents|mesh-ancestor
5544442|NCT04144712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5544443|NCT04144933|Acetaminophen|acetaminophen|mesh-list
5544444|NCT04144933|Dexamethasone|dexamethasone|mesh-list
5544445|NCT04144933|Lidocaine|lidocaine|mesh-list
5544446|NCT04144933|Magnesium Sulfate|magnesium sulfate|mesh-list
5544447|NCT04144933|Sufentanil|sufentanil|mesh-list
5544448|NCT04144933|Dexmedetomidine|dexmedetomidine|mesh-list
5544449|NCT04144933|Ketamine|ketamine|mesh-list
5544450|NCT04144933|Gabapentin|gabapentin|mesh-list
5544451|NCT04144933|Dsuvia|dsuvia|mesh-list
5544452|NCT04144933|Analgesics, Opioid|analgesics, opioid|mesh-list
5544453|NCT04144933|Ondansetron|ondansetron|mesh-list
5544454|NCT04144933|Sevoflurane|sevoflurane|mesh-list
5544455|NCT04144933|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6470941|NCT00497601|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6470942|NCT00497601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6470943|NCT00497601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6470944|NCT00497601|Antifungal Agents|antifungal agents|mesh-ancestor
6470945|NCT00497601|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6470946|NCT00497601|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6470947|NCT00497601|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5544456|NCT04144933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5544457|NCT04144933|Antiemetics|antiemetics|mesh-ancestor
5544458|NCT04144933|Autonomic Agents|autonomic agents|mesh-ancestor
6470948|NCT00497614|Adalimumab|adalimumab|mesh-list
6470949|NCT00497614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6470950|NCT00497614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6140255|NCT01303835|Naltrexone|naltrexone|mesh-list
6140256|NCT01303835|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6140257|NCT01303835|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6140258|NCT01303835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140259|NCT01303835|Sensory System Agents|sensory system agents|mesh-ancestor
6470951|NCT00497744|Cefepime|cefepime|mesh-list
6470952|NCT00497744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6470953|NCT00497744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6470954|NCT00497809|Lenograstim|lenograstim|mesh-list
6470955|NCT00497809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6470956|NCT00497809|Immunologic Factors|immunologic factors|mesh-ancestor
6470957|NCT00497809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470958|NCT00497900|Vitamin D|vitamin d|mesh-list
6470959|NCT00497900|Vitamins|vitamins|mesh-ancestor
6470960|NCT00497900|Micronutrients|micronutrients|mesh-ancestor
6470961|NCT00497900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470962|NCT00497900|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6470963|NCT00497913|Botulinum Toxins|botulinum toxins|mesh-list
6470964|NCT00497913|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6470965|NCT00497913|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6470966|NCT00497913|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6470967|NCT00497913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6470968|NCT00497913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6470969|NCT00497913|Cholinergic Agents|cholinergic agents|mesh-ancestor
6470970|NCT00497913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6470971|NCT00497913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470972|NCT00497913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5544459|NCT04144933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5544460|NCT04144933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544461|NCT04144933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6470973|NCT00497913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6470974|NCT00497939|Saw palmetto extract|saw palmetto extract|mesh-list
6470975|NCT00497939|Urological Agents|urological agents|mesh-ancestor
6470976|NCT00498004|Risperidone|risperidone|mesh-list
5544462|NCT04144933|Glucocorticoids|glucocorticoids|mesh-ancestor
5544463|NCT04144933|Hormones|hormones|mesh-ancestor
5544464|NCT04144933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5544465|NCT04144933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6470977|NCT00498004|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6470978|NCT00498004|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6470979|NCT00498004|Serotonin Agents|serotonin agents|mesh-ancestor
6470980|NCT00498004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6470981|NCT00498004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6470982|NCT00498004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544466|NCT04144933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5544467|NCT04144933|Anesthetics, Local|anesthetics, local|mesh-ancestor
5544468|NCT04144933|Anesthetics|anesthetics|mesh-ancestor
5544469|NCT04144933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5544470|NCT04144933|Sensory System Agents|sensory system agents|mesh-ancestor
5544471|NCT04144933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5544472|NCT04144933|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5544473|NCT04144933|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5544474|NCT04144933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5544475|NCT04144933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544476|NCT04144933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5544477|NCT04144933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5544478|NCT04144933|Analgesics|analgesics|mesh-ancestor
5544479|NCT04144933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5544480|NCT04144933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5544481|NCT04144933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5544482|NCT04144933|Adrenergic Agents|adrenergic agents|mesh-ancestor
5544483|NCT04144933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5544484|NCT04144933|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5544485|NCT04144933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5544486|NCT04144933|Anesthetics, General|anesthetics, general|mesh-ancestor
5544487|NCT04144933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5544488|NCT04144933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5544489|NCT04144933|Antipyretics|antipyretics|mesh-ancestor
5544490|NCT04144933|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6470983|NCT00498004|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6470984|NCT00498004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6470985|NCT00498004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6470986|NCT00498004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6470987|NCT00498004|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6470988|NCT00498004|Dopamine Agents|dopamine agents|mesh-ancestor
6470989|NCT00498004|Antidepressive Agents|antidepressive agents|mesh-ancestor
6470990|NCT00498108|Rotigotine|rotigotine|mesh-list
6470991|NCT00498108|Dopamine Agonists|dopamine agonists|mesh-ancestor
6470992|NCT00498108|Dopamine Agents|dopamine agents|mesh-ancestor
6470993|NCT00498108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6470994|NCT00498108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6470995|NCT00498108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6470996|NCT00498134|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
6470997|NCT00498134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6470998|NCT00498134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6470999|NCT00498134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471000|NCT00498134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5544491|NCT04144933|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6140260|NCT01303835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6140261|NCT01303861|Bupropion|bupropion|mesh-list
6140262|NCT01303861|Nicotine|nicotine|mesh-list
6140263|NCT01303861|Varenicline|varenicline|mesh-list
6140264|NCT01303861|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6140265|NCT01303861|Autonomic Agents|autonomic agents|mesh-ancestor
6140266|NCT01303861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6140267|NCT01303861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140268|NCT01303861|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5544492|NCT04144933|Anticonvulsants|anticonvulsants|mesh-ancestor
5544493|NCT04144933|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5544494|NCT04144933|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5544495|NCT04144933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5544496|NCT04144933|Antimanic Agents|antimanic agents|mesh-ancestor
5544497|NCT04144933|Narcotics|narcotics|mesh-ancestor
5544498|NCT04144933|Antipruritics|antipruritics|mesh-ancestor
5544499|NCT04144933|Dermatologic Agents|dermatologic agents|mesh-ancestor
5544500|NCT04144933|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6140269|NCT01303861|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6140270|NCT01303861|Cholinergic Agents|cholinergic agents|mesh-ancestor
5544501|NCT04144933|Serotonin Agents|serotonin agents|mesh-ancestor
5544502|NCT04144933|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5544503|NCT04144933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5544504|NCT04144933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5544505|NCT04144933|Tocolytic Agents|tocolytic agents|mesh-ancestor
5544506|NCT04144933|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5544507|NCT04144933|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5544508|NCT04144582|Docetaxel|docetaxel|mesh-list
5544509|NCT04144582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5544510|NCT04144582|Tubulin Modulators|tubulin modulators|mesh-ancestor
5544511|NCT04144582|Antimitotic Agents|antimitotic agents|mesh-ancestor
5544512|NCT04144582|Mitosis Modulators|mitosis modulators|mesh-ancestor
5544513|NCT04144582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544514|NCT04144439|Butyric Acid|butyric acid|mesh-list
6140271|NCT01303861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6140272|NCT01303861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140273|NCT01303861|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6666705|NCT01524068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6666706|NCT01524068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6666707|NCT01524068|Immunologic Factors|immunologic factors|mesh-ancestor
6666708|NCT01524068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666709|NCT01524068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6666710|NCT01524081|Amoxicillin|amoxicillin|mesh-list
6666711|NCT01524081|Metronidazole|metronidazole|mesh-list
6666712|NCT01524081|Clavulanic Acids|clavulanic acids|mesh-list
5544515|NCT04144439|Histamine Antagonists|histamine antagonists|mesh-ancestor
6140274|NCT01303861|Antidepressive Agents|antidepressive agents|mesh-ancestor
6140275|NCT01303861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6140276|NCT01303861|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6140277|NCT01303861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6140278|NCT01303861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6140279|NCT01303861|Dopamine Agents|dopamine agents|mesh-ancestor
6140280|NCT01303861|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6140281|NCT01303861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6140282|NCT01303861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6471001|NCT00498134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6471002|NCT00498134|Analgesics|analgesics|mesh-ancestor
6471003|NCT00498134|Sensory System Agents|sensory system agents|mesh-ancestor
6471004|NCT00498134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6471005|NCT00498134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471006|NCT00498134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6471007|NCT00498134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6471008|NCT00498225|Gemcitabine|gemcitabine|mesh-list
6471009|NCT00498225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6140283|NCT01303965|Sirolimus|sirolimus|mesh-list
6140284|NCT01303965|Lenalidomide|lenalidomide|mesh-list
6140285|NCT01303965|Tacrolimus|tacrolimus|mesh-list
6140286|NCT01303965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6140287|NCT01303965|Immunologic Factors|immunologic factors|mesh-ancestor
6140288|NCT01303965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471010|NCT00498225|Antimetabolites|antimetabolites|mesh-ancestor
5544516|NCT04144439|Histamine Agents|histamine agents|mesh-ancestor
5544517|NCT04144439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5544518|NCT04144439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544519|NCT04144439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544520|NCT04144218|Lacosamide|lacosamide|mesh-list
5544521|NCT04144218|Anticonvulsants|anticonvulsants|mesh-ancestor
5544522|NCT04144218|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5544523|NCT04144218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5544524|NCT04144218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5544525|NCT04144218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544526|NCT04144465|Phenylephrine|phenylephrine|mesh-list
5544527|NCT04144465|Oxymetazoline|oxymetazoline|mesh-list
5544528|NCT04144465|Norepinephrine|norepinephrine|mesh-list
5544529|NCT04144465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5544530|NCT04144465|Mydriatics|mydriatics|mesh-ancestor
5544531|NCT04144465|Autonomic Agents|autonomic agents|mesh-ancestor
5544532|NCT04144465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5544533|NCT04144465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544534|NCT04144465|Sympathomimetics|sympathomimetics|mesh-ancestor
5544535|NCT04144465|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5544536|NCT04144465|Nasal Decongestants|nasal decongestants|mesh-ancestor
5544537|NCT04144465|Respiratory System Agents|respiratory system agents|mesh-ancestor
5544538|NCT04144465|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6666713|NCT01524081|Clavulanic Acid|clavulanic acid|mesh-list
6666714|NCT01524081|Cefuroxime|cefuroxime|mesh-list
6140289|NCT01303965|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6140290|NCT01303965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6140291|NCT01303965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140292|NCT01303965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6140293|NCT01303965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6140294|NCT01303965|Growth Substances|growth substances|mesh-ancestor
6140295|NCT01303965|Growth Inhibitors|growth inhibitors|mesh-ancestor
6140296|NCT01303965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6140297|NCT01303965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6140298|NCT01303965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6140299|NCT01303965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6140300|NCT01303965|Antifungal Agents|antifungal agents|mesh-ancestor
6471011|NCT00498225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471012|NCT00498225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6471013|NCT00498225|Antiviral Agents|antiviral agents|mesh-ancestor
6140301|NCT01304082|Lidocaine|lidocaine|mesh-list
6140302|NCT01304082|Anesthetics, Local|anesthetics, local|mesh-ancestor
6140303|NCT01304082|Anesthetics|anesthetics|mesh-ancestor
6140304|NCT01304082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6140305|NCT01304082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140306|NCT01304082|Sensory System Agents|sensory system agents|mesh-ancestor
6140307|NCT01304082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6140308|NCT01304082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6140309|NCT01304082|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6140310|NCT01304082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6140311|NCT01304082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6140312|NCT01304082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140313|NCT01304147|Ketamine|ketamine|mesh-list
6140314|NCT01304147|Analgesics|analgesics|mesh-ancestor
6140315|NCT01304147|Sensory System Agents|sensory system agents|mesh-ancestor
6140316|NCT01304147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6140317|NCT01304147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140318|NCT01304147|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6140319|NCT01304147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6140320|NCT01304147|Anesthetics, General|anesthetics, general|mesh-ancestor
6140321|NCT01304147|Anesthetics|anesthetics|mesh-ancestor
6140322|NCT01304147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6140323|NCT01304147|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6140324|NCT01304147|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6140325|NCT01304147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6140326|NCT01304147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140327|NCT01304238|PENTA|penta|mesh-list
6140328|NCT01304238|Lepirudin|lepirudin|mesh-list
6140329|NCT01304238|Danaparoid|danaparoid|mesh-list
6140330|NCT01304238|Fondaparinux|fondaparinux|mesh-list
6140331|NCT01304238|Argatroban|argatroban|mesh-list
6140332|NCT01304238|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6140333|NCT01304238|Antithrombins|antithrombins|mesh-ancestor
6140334|NCT01304238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6471014|NCT00498225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6471015|NCT00498225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6471016|NCT00498225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6666715|NCT01524081|Cefuroxime axetil|cefuroxime axetil|mesh-list
6140335|NCT01304238|Protease Inhibitors|protease inhibitors|mesh-ancestor
6140336|NCT01304238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6140337|NCT01304238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544539|NCT04144465|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5544540|NCT04144465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5544541|NCT04144465|Adrenergic Agents|adrenergic agents|mesh-ancestor
5544542|NCT04144465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5544543|NCT04144465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140338|NCT01304238|Anticoagulants|anticoagulants|mesh-ancestor
6140339|NCT01304238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6140340|NCT01304238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6140341|NCT01304238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6140342|NCT01304329|Empagliflozin|empagliflozin|mesh-list
6140343|NCT01304329|Simvastatin|simvastatin|mesh-list
6140344|NCT01304329|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6140345|NCT01304329|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6140346|NCT01304329|Antimetabolites|antimetabolites|mesh-ancestor
6140347|NCT01304329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140348|NCT01304329|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6140349|NCT01304329|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6140350|NCT01304329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5544544|NCT04144465|Protective Agents|protective agents|mesh-ancestor
5544545|NCT04144153|Analgesics, Opioid|analgesics, opioid|mesh-list
5544546|NCT04144153|Anesthetics|anesthetics|mesh-list
5544547|NCT04144153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5544548|NCT04144153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140351|NCT01304329|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6140352|NCT01304329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6140353|NCT01304329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140354|NCT01304407|Calcium|calcium|mesh-list
6140355|NCT01304407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6140356|NCT01304407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140357|NCT01304498|Vaccines|vaccines|mesh-list
6140358|NCT01304498|Immunologic Factors|immunologic factors|mesh-ancestor
6140359|NCT01304498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140360|NCT01304589|Milnacipran|milnacipran|mesh-list
6140361|NCT01304589|Levomilnacipran|levomilnacipran|mesh-list
6471017|NCT00498225|Immunologic Factors|immunologic factors|mesh-ancestor
6666716|NCT01524081|Fluconazole|fluconazole|mesh-list
6666717|NCT01524081|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6666718|NCT01524081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6471018|NCT00498225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471019|NCT00498251|Albuterol|albuterol|mesh-list
6471020|NCT00498251|Ipratropium|ipratropium|mesh-list
6471021|NCT00498251|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6471022|NCT00498251|Autonomic Agents|autonomic agents|mesh-ancestor
6471023|NCT00498251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6471024|NCT00498251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471025|NCT00498251|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6471026|NCT00498251|Respiratory System Agents|respiratory system agents|mesh-ancestor
6471027|NCT00498251|Tocolytic Agents|tocolytic agents|mesh-ancestor
6666719|NCT01524081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6471028|NCT00498251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6471029|NCT00498251|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6471030|NCT00498251|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6471031|NCT00498251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6471032|NCT00498251|Adrenergic Agents|adrenergic agents|mesh-ancestor
6471033|NCT00498251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6471034|NCT00498251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471035|NCT00498251|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6471036|NCT00498251|Cholinergic Agents|cholinergic agents|mesh-ancestor
6471037|NCT00498316|Mycophenolic Acid|mycophenolic acid|mesh-list
6471038|NCT00498316|Cyclophosphamide|cyclophosphamide|mesh-list
6471039|NCT00498316|Melphalan|melphalan|mesh-list
6471040|NCT00498316|Busulfan|busulfan|mesh-list
6471041|NCT00498316|Rituximab|rituximab|mesh-list
6471042|NCT00498316|Fludarabine|fludarabine|mesh-list
6666720|NCT01524081|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5544549|NCT04144153|Narcotics|narcotics|mesh-ancestor
5544550|NCT04144153|Analgesics|analgesics|mesh-ancestor
5544551|NCT04144153|Sensory System Agents|sensory system agents|mesh-ancestor
5544552|NCT04144153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5544553|NCT04144101|Etoricoxib|etoricoxib|mesh-list
5544554|NCT04144101|Aceclofenac|aceclofenac|mesh-list
5544555|NCT04144101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5544556|NCT04144101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6140362|NCT01304589|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6471043|NCT00498316|Fludarabine phosphate|fludarabine phosphate|mesh-list
6471044|NCT00498316|Clofarabine|clofarabine|mesh-list
5544557|NCT04144101|Analgesics|analgesics|mesh-ancestor
5544558|NCT04144101|Sensory System Agents|sensory system agents|mesh-ancestor
5544559|NCT04144101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5544560|NCT04144101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544561|NCT04144101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6471045|NCT00498316|Tacrolimus|tacrolimus|mesh-list
6471046|NCT00498316|Thymoglobulin|thymoglobulin|mesh-list
6471047|NCT00498316|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6471048|NCT00498316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6140363|NCT01304589|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6140364|NCT01304589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6140365|NCT01304589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140366|NCT01304589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6140367|NCT01304589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140368|NCT01304589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6140369|NCT01304589|Analgesics|analgesics|mesh-ancestor
6140370|NCT01304589|Sensory System Agents|sensory system agents|mesh-ancestor
6140371|NCT01304589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6140372|NCT01304589|Antidepressive Agents|antidepressive agents|mesh-ancestor
6140373|NCT01304589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6140374|NCT01304641|Atorvastatin|atorvastatin|mesh-list
6140375|NCT01304641|Simvastatin|simvastatin|mesh-list
6140376|NCT01304641|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6140377|NCT01304641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6140378|NCT01304641|Antimetabolites|antimetabolites|mesh-ancestor
6140379|NCT01304641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140380|NCT01304641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6140381|NCT01304641|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6140382|NCT01304641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5544562|NCT04144101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5544563|NCT04144101|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5544564|NCT04144101|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5544565|NCT04144101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5544566|NCT04144101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471049|NCT00498316|Immunologic Factors|immunologic factors|mesh-ancestor
6471050|NCT00498316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471051|NCT00498316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6140383|NCT01304693|Ranibizumab|ranibizumab|mesh-list
6140384|NCT01304693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6140385|NCT01304693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6140386|NCT01304693|Growth Substances|growth substances|mesh-ancestor
6140387|NCT01304693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140388|NCT01304693|Growth Inhibitors|growth inhibitors|mesh-ancestor
6140389|NCT01304693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6140390|NCT01304706|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
6140391|NCT01304706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6140392|NCT01304706|Glucocorticoids|glucocorticoids|mesh-ancestor
6140393|NCT01304706|Hormones|hormones|mesh-ancestor
6471052|NCT00498316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6471053|NCT00498316|Alkylating Agents|alkylating agents|mesh-ancestor
6471054|NCT00498316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471055|NCT00498316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6471056|NCT00498316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6471057|NCT00498316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6471058|NCT00498316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6471059|NCT00498316|Antimetabolites|antimetabolites|mesh-ancestor
6471060|NCT00498316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6471061|NCT00498316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6140394|NCT01304706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6140395|NCT01304706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140396|NCT01305200|Calcium|calcium|mesh-list
6140397|NCT01305200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6140398|NCT01305200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140399|NCT01305213|Bevacizumab|bevacizumab|mesh-list
6140400|NCT01305213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6140401|NCT01305213|Fosbretabulin|fosbretabulin|mesh-list
6140402|NCT01305213|Endothelial Growth Factors|endothelial growth factors|mesh-list
6140403|NCT01305213|Antibodies|antibodies|mesh-list
6140404|NCT01305213|Immunoglobulins|immunoglobulins|mesh-list
6140405|NCT01305213|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6140406|NCT01305213|Immunoglobulin G|immunoglobulin g|mesh-list
6140407|NCT01305213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6140408|NCT01305213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5544567|NCT04143880|Progesterone|progesterone|mesh-list
5544568|NCT04143880|Progestins|progestins|mesh-ancestor
5544569|NCT04143880|Hormones|hormones|mesh-ancestor
5544570|NCT04143880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5544571|NCT04143880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544572|NCT04143906|Gemcitabine|gemcitabine|mesh-list
6140409|NCT01305213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6140410|NCT01305213|Growth Substances|growth substances|mesh-ancestor
6140411|NCT01305213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140412|NCT01305213|Growth Inhibitors|growth inhibitors|mesh-ancestor
6140413|NCT01305213|Immunologic Factors|immunologic factors|mesh-ancestor
6140414|NCT01305213|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6140415|NCT01305239|Exemestane|exemestane|mesh-list
6140416|NCT01305239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6471062|NCT00498316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6471063|NCT00498316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6471064|NCT00498316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6471065|NCT00498316|Antitubercular Agents|antitubercular agents|mesh-ancestor
6471066|NCT00498316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6471067|NCT00498342|Acetylcysteine|acetylcysteine|mesh-list
6471068|NCT00498342|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6471069|NCT00498342|Antiviral Agents|antiviral agents|mesh-ancestor
6471070|NCT00498342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6471071|NCT00498342|Expectorants|expectorants|mesh-ancestor
6471072|NCT00498342|Respiratory System Agents|respiratory system agents|mesh-ancestor
6471073|NCT00498342|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6471074|NCT00498342|Antioxidants|antioxidants|mesh-ancestor
6471075|NCT00498342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471076|NCT00498342|Protective Agents|protective agents|mesh-ancestor
6471077|NCT00498342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471078|NCT00498342|Antidotes|antidotes|mesh-ancestor
6471079|NCT00498537|Spironolactone|spironolactone|mesh-list
6471080|NCT00498537|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6471081|NCT00498537|Hormone Antagonists|hormone antagonists|mesh-ancestor
6471082|NCT00498537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5544573|NCT04143906|Carboplatin|carboplatin|mesh-list
5544574|NCT04143906|Vinorelbine|vinorelbine|mesh-list
5544575|NCT04143906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5544576|NCT04143906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5544577|NCT04143906|Antimetabolites|antimetabolites|mesh-ancestor
5544578|NCT04143906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544579|NCT04143906|Antiviral Agents|antiviral agents|mesh-ancestor
5544580|NCT04143906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5544581|NCT04143906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5544582|NCT04143906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5544583|NCT04143906|Immunologic Factors|immunologic factors|mesh-ancestor
6471083|NCT00498537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471084|NCT00498537|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6471085|NCT00498537|Diuretics|diuretics|mesh-ancestor
6471086|NCT00498537|Natriuretic Agents|natriuretic agents|mesh-ancestor
6488592|NCT00585143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6488593|NCT00585143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6488594|NCT00585143|Antimetabolites|antimetabolites|mesh-ancestor
5544584|NCT04143906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544585|NCT04143906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5544586|NCT04143906|Tubulin Modulators|tubulin modulators|mesh-ancestor
5544587|NCT04143906|Antimitotic Agents|antimitotic agents|mesh-ancestor
5544588|NCT04143906|Mitosis Modulators|mitosis modulators|mesh-ancestor
5544589|NCT04144192|Lidocaine|lidocaine|mesh-list
5544590|NCT04144192|Anesthetics, Local|anesthetics, local|mesh-ancestor
5544591|NCT04144192|Anesthetics|anesthetics|mesh-ancestor
5544592|NCT04144192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5544593|NCT04144192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544594|NCT04144192|Sensory System Agents|sensory system agents|mesh-ancestor
6140417|NCT01305239|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6140418|NCT01305239|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6140419|NCT01305239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6140420|NCT01305239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140421|NCT01305239|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6140422|NCT01305239|Hormone Antagonists|hormone antagonists|mesh-ancestor
6140423|NCT01305239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6488595|NCT00585143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488596|NCT00585143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6488597|NCT00585143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5544595|NCT04144192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6471087|NCT00498589|Methotrexate|methotrexate|mesh-list
6471088|NCT00498589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6471089|NCT00498589|Abortifacient Agents|abortifacient agents|mesh-ancestor
6471090|NCT00498589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6471091|NCT00498589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140424|NCT01305239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140425|NCT01305252|Treprostinil|treprostinil|mesh-list
6140426|NCT01305252|Tadalafil|tadalafil|mesh-list
6140427|NCT01305252|Vasodilator Agents|vasodilator agents|mesh-ancestor
6140428|NCT01305252|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6140429|NCT01305252|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6140430|NCT01305252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6140431|NCT01305252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140432|NCT01305252|Urological Agents|urological agents|mesh-ancestor
6140433|NCT01305252|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6140434|NCT01305408|Modafinil|modafinil|mesh-list
6140435|NCT01305408|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6140436|NCT01305408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140437|NCT01305408|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6140438|NCT01305408|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6140439|NCT01305408|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6140440|NCT01305408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544596|NCT04144192|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5544597|NCT04144192|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5544598|NCT04144192|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5544599|NCT04144192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5544600|NCT04144192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544601|NCT04143802|Dulaglutide|dulaglutide|mesh-list
5544602|NCT04143802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5544603|NCT04143802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544604|NCT04143685|Misoprostol|misoprostol|mesh-list
6140441|NCT01305577|Deoxycholic Acid|deoxycholic acid|mesh-list
6140442|NCT01305577|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6140443|NCT01305577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6140444|NCT01305772|Panitumumab|panitumumab|mesh-list
6140445|NCT01305772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6140446|NCT01305772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6140447|NCT01305941|Trastuzumab|trastuzumab|mesh-list
6140448|NCT01305941|Everolimus|everolimus|mesh-list
6140449|NCT01305941|Vinorelbine|vinorelbine|mesh-list
6140450|NCT01305941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6140451|NCT01305941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6140452|NCT01305941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6140453|NCT01305941|Immunologic Factors|immunologic factors|mesh-ancestor
6140454|NCT01305941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140455|NCT01305941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6140456|NCT01305941|Tubulin Modulators|tubulin modulators|mesh-ancestor
6140457|NCT01305941|Antimitotic Agents|antimitotic agents|mesh-ancestor
6140458|NCT01305941|Mitosis Modulators|mitosis modulators|mesh-ancestor
6140459|NCT01305941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140460|NCT01306032|Cyclophosphamide|cyclophosphamide|mesh-list
6140461|NCT01306032|Veliparib|veliparib|mesh-list
6140462|NCT01306032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6140463|NCT01306032|Immunologic Factors|immunologic factors|mesh-ancestor
6140464|NCT01306032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140465|NCT01306032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6140466|NCT01306032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6140467|NCT01306032|Alkylating Agents|alkylating agents|mesh-ancestor
6140468|NCT01306032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140469|NCT01306032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6140470|NCT01306032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6471092|NCT00498589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5544605|NCT04143685|Oxytocin|oxytocin|mesh-list
5544606|NCT04143685|Oxytocics|oxytocics|mesh-ancestor
5544607|NCT04143685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5544608|NCT04143685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544609|NCT04143685|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6140471|NCT01306032|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6140472|NCT01306032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6140473|NCT01306058|Sorafenib|sorafenib|mesh-list
6140474|NCT01306058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6140475|NCT01306058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5544610|NCT04143685|Abortifacient Agents|abortifacient agents|mesh-ancestor
5544611|NCT04143685|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6140476|NCT01306058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6140477|NCT01306058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140478|NCT01306162|Dronedarone|dronedarone|mesh-list
6140479|NCT01306162|Dabigatran|dabigatran|mesh-list
6471093|NCT00498589|Antimetabolites|antimetabolites|mesh-ancestor
6471094|NCT00498589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471095|NCT00498589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6471096|NCT00498589|Dermatologic Agents|dermatologic agents|mesh-ancestor
6140480|NCT01306162|Antithrombins|antithrombins|mesh-ancestor
6140481|NCT01306162|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6140482|NCT01306162|Protease Inhibitors|protease inhibitors|mesh-ancestor
6140483|NCT01306162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6140484|NCT01306162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140485|NCT01306162|Anticoagulants|anticoagulants|mesh-ancestor
6140486|NCT01306162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6140487|NCT01306175|Empagliflozin|empagliflozin|mesh-list
6140488|NCT01306175|Digoxin|digoxin|mesh-list
6140489|NCT01306175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6140490|NCT01306175|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6140491|NCT01306175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6140492|NCT01306175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140493|NCT01306175|Protective Agents|protective agents|mesh-ancestor
6140494|NCT01306175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140495|NCT01306175|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6140496|NCT01306175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6140497|NCT01306214|Empagliflozin|empagliflozin|mesh-list
6140498|NCT01306214|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6140499|NCT01306214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140500|NCT01306214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6140501|NCT01306214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140502|NCT01306331|Nonoxynol|nonoxynol|mesh-list
6140503|NCT01306331|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
6471097|NCT00498589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6471098|NCT00498589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6471099|NCT00498589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5544612|NCT04143685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5544613|NCT04143724|Luspatercept|luspatercept|mesh-list
5544614|NCT04143724|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
5544615|NCT04143724|Hematinics|hematinics|mesh-ancestor
5544616|NCT04143724|Immunologic Factors|immunologic factors|mesh-ancestor
5544617|NCT04143724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544618|NCT04143854|Botulinum Toxins|botulinum toxins|mesh-list
5544619|NCT04143854|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5544620|NCT04143854|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5544621|NCT04143854|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5544622|NCT04143854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5544623|NCT04143854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544624|NCT04143854|Cholinergic Agents|cholinergic agents|mesh-ancestor
5544625|NCT04143854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5544626|NCT04143854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544627|NCT04143854|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5544628|NCT04143854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5544629|NCT04143581|Empagliflozin|empagliflozin|mesh-list
5544630|NCT04143581|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5544631|NCT04143581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544632|NCT04143581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5544633|NCT04143581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544634|NCT04143607|Gefitinib|gefitinib|mesh-list
5544635|NCT04143607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5544636|NCT04143607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5544637|NCT04143607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5544638|NCT04143607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602505|NCT04398524|Cemiplimab|cemiplimab|mesh-list
5602506|NCT04398524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5602507|NCT04398524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5602508|NCT04397354|Dexamethasone|dexamethasone|mesh-list
5602509|NCT04397354|Dexamethasone acetate|dexamethasone acetate|mesh-list
5602510|NCT04397354|BB 1101|bb 1101|mesh-list
5602511|NCT04397354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5602512|NCT04397354|Antiemetics|antiemetics|mesh-ancestor
5602513|NCT04397354|Autonomic Agents|autonomic agents|mesh-ancestor
5602514|NCT04397354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6140504|NCT01306331|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
6471100|NCT00498589|Immunologic Factors|immunologic factors|mesh-ancestor
5544639|NCT04143451|Imiquimod|imiquimod|mesh-list
5544640|NCT04143451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5544641|NCT04143451|Immunologic Factors|immunologic factors|mesh-ancestor
5544642|NCT04143451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544643|NCT04143451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5544644|NCT04143451|Interferon Inducers|interferon inducers|mesh-ancestor
6140505|NCT01306331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471101|NCT00498589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6471102|NCT00498589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6471103|NCT00498680|Sildenafil Citrate|sildenafil citrate|mesh-list
6471104|NCT00498680|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6471105|NCT00498680|Vasodilator Agents|vasodilator agents|mesh-ancestor
6471106|NCT00498680|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6471107|NCT00498680|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6140506|NCT01306331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5544645|NCT04143815|Botulinum Toxins|botulinum toxins|mesh-list
5544646|NCT04143815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5544647|NCT04143815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5544648|NCT04143815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5544649|NCT04143815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6140507|NCT01306331|Contraceptive Agents|contraceptive agents|mesh-ancestor
6140508|NCT01306331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6140509|NCT01306331|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6140510|NCT01306617|Ritonavir|ritonavir|mesh-list
6140511|NCT01306617|Ribavirin|ribavirin|mesh-list
6471108|NCT00498680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6471109|NCT00498680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471110|NCT00498680|Urological Agents|urological agents|mesh-ancestor
6471111|NCT00498784|Levonorgestrel|levonorgestrel|mesh-list
6471112|NCT00498784|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6471113|NCT00498784|Contraceptive Agents|contraceptive agents|mesh-ancestor
6471114|NCT00498784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6471115|NCT00498784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471116|NCT00498784|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6471117|NCT00498784|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6471118|NCT00498784|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6471119|NCT00498888|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6471120|NCT00498888|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6471121|NCT00498888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6471122|NCT00498888|Cholinergic Agents|cholinergic agents|mesh-ancestor
6471123|NCT00498888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6471124|NCT00498888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471125|NCT00498888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471126|NCT00498888|Urological Agents|urological agents|mesh-ancestor
6471127|NCT00498901|Letrozole|letrozole|mesh-list
6471128|NCT00498901|Leuprolide|leuprolide|mesh-list
6471129|NCT00498901|Goserelin|goserelin|mesh-list
6471130|NCT00498901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6471131|NCT00498901|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6471132|NCT00498901|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6471133|NCT00498901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6471134|NCT00498901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471135|NCT00498901|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6471136|NCT00498901|Hormone Antagonists|hormone antagonists|mesh-ancestor
6471137|NCT00498901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6471138|NCT00498901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471139|NCT00498901|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6471140|NCT00498901|Fertility Agents|fertility agents|mesh-ancestor
6471141|NCT00498901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6471142|NCT00498901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6471143|NCT00498953|Carboplatin|carboplatin|mesh-list
6471144|NCT00498953|Docetaxel|docetaxel|mesh-list
6471145|NCT00498953|Fluorouracil|fluorouracil|mesh-list
6471146|NCT00498953|Lapatinib|lapatinib|mesh-list
6471147|NCT00498953|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6471148|NCT00498953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6471149|NCT00498953|Tubulin Modulators|tubulin modulators|mesh-ancestor
6471150|NCT00498953|Antimitotic Agents|antimitotic agents|mesh-ancestor
6471151|NCT00498953|Mitosis Modulators|mitosis modulators|mesh-ancestor
6471152|NCT00498953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471153|NCT00498953|Antimetabolites|antimetabolites|mesh-ancestor
6471154|NCT00498953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6471155|NCT00498953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6471156|NCT00498953|Immunologic Factors|immunologic factors|mesh-ancestor
6471157|NCT00498953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471158|NCT00498953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6471159|NCT00498953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6471160|NCT00498953|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6471161|NCT00498979|Interferons|interferons|mesh-list
6140512|NCT01306617|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6140513|NCT01306617|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6140514|NCT01306617|Protease Inhibitors|protease inhibitors|mesh-ancestor
6140515|NCT01306617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6140516|NCT01306617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140517|NCT01306617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6140518|NCT01306617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6140519|NCT01306617|Antiviral Agents|antiviral agents|mesh-ancestor
6140520|NCT01306617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6140521|NCT01306617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6140522|NCT01306617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6140523|NCT01306617|Antimetabolites|antimetabolites|mesh-ancestor
6140524|NCT01306643|Idelalisib|idelalisib|mesh-list
6140525|NCT01306643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6140526|NCT01306643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6140527|NCT01306643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140528|NCT01306656|Vitamin D|vitamin d|mesh-list
5544650|NCT04143815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544651|NCT04143815|Cholinergic Agents|cholinergic agents|mesh-ancestor
5544652|NCT04143815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5544653|NCT04143815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471162|NCT00498979|Interferon-alpha|interferon-alpha|mesh-list
6471163|NCT00498979|Interferon alpha-2|interferon alpha-2|mesh-list
6471164|NCT00498979|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
6471165|NCT00498979|Dacarbazine|dacarbazine|mesh-list
6471166|NCT00498979|Vinblastine|vinblastine|mesh-list
6471167|NCT00498979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6471168|NCT00498979|Antiviral Agents|antiviral agents|mesh-ancestor
6471169|NCT00498979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6471170|NCT00498979|Immunologic Factors|immunologic factors|mesh-ancestor
6471171|NCT00498979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471172|NCT00498979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5544654|NCT04143815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5544655|NCT04143815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5544656|NCT04143321|Empagliflozin|empagliflozin|mesh-list
5544657|NCT04143321|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5544658|NCT04143321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544659|NCT04143321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5544660|NCT04143321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544661|NCT04143165|Lidocaine|lidocaine|mesh-list
5544662|NCT04143165|Anesthetics, Local|anesthetics, local|mesh-ancestor
5544663|NCT04143165|Anesthetics|anesthetics|mesh-ancestor
5544664|NCT04143165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5544665|NCT04143165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544666|NCT04143165|Sensory System Agents|sensory system agents|mesh-ancestor
5544667|NCT04143165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5544668|NCT04143165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5544669|NCT04143165|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6471173|NCT00498979|Alkylating Agents|alkylating agents|mesh-ancestor
5544670|NCT04143165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5544671|NCT04143165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5544672|NCT04143165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544673|NCT04143256|Menthol|menthol|mesh-list
5544674|NCT04143256|Antipruritics|antipruritics|mesh-ancestor
5544675|NCT04143256|Dermatologic Agents|dermatologic agents|mesh-ancestor
5544676|NCT04143412|Ramipril|ramipril|mesh-list
5544677|NCT04143412|Eplerenone|eplerenone|mesh-list
5544678|NCT04143412|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5544679|NCT04143412|Protease Inhibitors|protease inhibitors|mesh-ancestor
5544680|NCT04143412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5544681|NCT04143412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140529|NCT01306656|Ergocalciferols|ergocalciferols|mesh-list
6140530|NCT01306656|Cholecalciferol|cholecalciferol|mesh-list
6140531|NCT01306656|Vitamins|vitamins|mesh-list
5544682|NCT04143412|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5544683|NCT04143412|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5544684|NCT04143412|Hormone Antagonists|hormone antagonists|mesh-ancestor
5544685|NCT04143412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5544686|NCT04143412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544687|NCT04143412|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5544688|NCT04143412|Diuretics|diuretics|mesh-ancestor
6140532|NCT01306656|Micronutrients|micronutrients|mesh-ancestor
6140533|NCT01306656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140534|NCT01306656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6140535|NCT01306656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6140536|NCT01306942|Paclitaxel|paclitaxel|mesh-list
6140537|NCT01306942|Trastuzumab|trastuzumab|mesh-list
6471174|NCT00498979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471175|NCT00498979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6471176|NCT00498979|Tubulin Modulators|tubulin modulators|mesh-ancestor
6471177|NCT00498979|Antimitotic Agents|antimitotic agents|mesh-ancestor
6471178|NCT00498979|Mitosis Modulators|mitosis modulators|mesh-ancestor
6471179|NCT00498979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5544689|NCT04143412|Natriuretic Agents|natriuretic agents|mesh-ancestor
5544690|NCT04143191|Sorafenib|sorafenib|mesh-list
5544691|NCT04143191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5544692|NCT04143191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5544693|NCT04143191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5544694|NCT04143191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544695|NCT04142931|Nivolumab|nivolumab|mesh-list
5544696|NCT04142931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5544697|NCT04142931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5544698|NCT04142931|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5544699|NCT04142931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544700|NCT04142892|Onapristone|onapristone|mesh-list
5544701|NCT04142892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5544702|NCT04142892|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5544703|NCT04142892|Fertility Agents|fertility agents|mesh-ancestor
5544704|NCT04142892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5544705|NCT04142892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544706|NCT04142892|Hormone Antagonists|hormone antagonists|mesh-ancestor
5544707|NCT04142892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5544708|NCT04142840|Dexmedetomidine|dexmedetomidine|mesh-list
5544709|NCT04142840|Propofol|propofol|mesh-list
5544710|NCT04142840|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5544711|NCT04142840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6471180|NCT00498979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6471181|NCT00498979|Schistosomicides|schistosomicides|mesh-ancestor
6471182|NCT00498979|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6471183|NCT00498979|Anthelmintics|anthelmintics|mesh-ancestor
6471184|NCT00498992|Vitamin E|vitamin e|mesh-list
6666721|NCT01524081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6666722|NCT01524081|Antifungal Agents|antifungal agents|mesh-ancestor
6666723|NCT01524081|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6666724|NCT01524081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6666725|NCT01524081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6666726|NCT01524081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666727|NCT01524081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6666728|NCT01524081|Hormone Antagonists|hormone antagonists|mesh-ancestor
6140538|NCT01306942|Dasatinib|dasatinib|mesh-list
6140539|NCT01306942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6140540|NCT01306942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6471185|NCT00498992|Lidocaine|lidocaine|mesh-list
5544712|NCT04142840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544713|NCT04142840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5544714|NCT04142840|Anesthetics, General|anesthetics, general|mesh-ancestor
5544715|NCT04142840|Anesthetics|anesthetics|mesh-ancestor
5544716|NCT04142840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5544717|NCT04142840|Analgesics|analgesics|mesh-ancestor
5544718|NCT04142840|Sensory System Agents|sensory system agents|mesh-ancestor
5544719|NCT04142840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5544720|NCT04142840|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5544721|NCT04142840|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5544722|NCT04142840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5544723|NCT04142840|Adrenergic Agents|adrenergic agents|mesh-ancestor
5544724|NCT04142840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5544725|NCT04142840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544726|NCT04142762|Itraconazole|itraconazole|mesh-list
5544727|NCT04142762|Rifampin|rifampin|mesh-list
5544728|NCT04142762|Midazolam|midazolam|mesh-list
5544729|NCT04142762|Esomeprazole|esomeprazole|mesh-list
5544730|NCT04142762|Levonorgestrel|levonorgestrel|mesh-list
5544731|NCT04142762|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5544732|NCT04142762|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
5544733|NCT04142762|Contraceptive Agents|contraceptive agents|mesh-list
5544734|NCT04142762|Contraceptives, Oral|contraceptives, oral|mesh-list
5544735|NCT04142762|Estradiol|estradiol|mesh-list
5544736|NCT04142762|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5544737|NCT04142762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5544738|NCT04142762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5544739|NCT04142762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544740|NCT04142762|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5544741|NCT04142762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5544742|NCT04142762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5544743|NCT04142762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5544744|NCT04142762|Anesthetics, General|anesthetics, general|mesh-ancestor
5544745|NCT04142762|Anesthetics|anesthetics|mesh-ancestor
5544746|NCT04142762|GABA Modulators|gaba modulators|mesh-ancestor
5544747|NCT04142762|GABA Agents|gaba agents|mesh-ancestor
5544748|NCT04142762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5544749|NCT04142762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544750|NCT04142762|Estrogens|estrogens|mesh-ancestor
6471186|NCT00498992|Vitamins|vitamins|mesh-ancestor
6471187|NCT00498992|Micronutrients|micronutrients|mesh-ancestor
6471188|NCT00498992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471189|NCT00498992|Anesthetics, Local|anesthetics, local|mesh-ancestor
6471190|NCT00498992|Anesthetics|anesthetics|mesh-ancestor
6471191|NCT00498992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6471192|NCT00498992|Sensory System Agents|sensory system agents|mesh-ancestor
6471193|NCT00498992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6471194|NCT00498992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6471195|NCT00498992|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6471196|NCT00498992|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6471197|NCT00498992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6471198|NCT00498992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471199|NCT00498992|Antioxidants|antioxidants|mesh-ancestor
6471200|NCT00498992|Protective Agents|protective agents|mesh-ancestor
6471201|NCT00499005|Carbetocin|carbetocin|mesh-list
6471202|NCT00499005|Oxytocin|oxytocin|mesh-list
6471203|NCT00499005|Oxytocics|oxytocics|mesh-ancestor
6471204|NCT00499005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6471205|NCT00499005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471206|NCT00499018|Cytarabine|cytarabine|mesh-list
6471207|NCT00499018|Prednisone|prednisone|mesh-list
6471208|NCT00499018|Rituximab|rituximab|mesh-list
6471209|NCT00499018|Mitoxantrone|mitoxantrone|mesh-list
6471210|NCT00499018|Cyclophosphamide|cyclophosphamide|mesh-list
6471211|NCT00499018|Vincristine|vincristine|mesh-list
5544751|NCT04142762|Hormones|hormones|mesh-ancestor
6140541|NCT01306942|Tubulin Modulators|tubulin modulators|mesh-ancestor
6471212|NCT00499018|Doxorubicin|doxorubicin|mesh-list
6471213|NCT00499018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6140542|NCT01306942|Antimitotic Agents|antimitotic agents|mesh-ancestor
6140543|NCT01306942|Mitosis Modulators|mitosis modulators|mesh-ancestor
6140544|NCT01306942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140545|NCT01306942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6140546|NCT01306942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6140547|NCT01306942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6140548|NCT01307007|Dextrans|dextrans|mesh-list
5544752|NCT04142762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5544753|NCT04142762|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5544754|NCT04142762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5544755|NCT04142762|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5544756|NCT04142762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5544757|NCT04142762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5544758|NCT04142762|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5544759|NCT04142762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5544760|NCT04142762|Antifungal Agents|antifungal agents|mesh-ancestor
5544761|NCT04142762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5544762|NCT04142762|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5544763|NCT04142762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5544764|NCT04142762|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5544765|NCT04142762|Hormone Antagonists|hormone antagonists|mesh-ancestor
5544766|NCT04142762|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5544767|NCT04142762|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6140549|NCT01307007|Iron-Dextran Complex|iron-dextran complex|mesh-list
6140550|NCT01307007|Anticoagulants|anticoagulants|mesh-ancestor
6140551|NCT01307007|Plasma Substitutes|plasma substitutes|mesh-ancestor
6140552|NCT01307007|Blood Substitutes|blood substitutes|mesh-ancestor
6140553|NCT01307007|Hematinics|hematinics|mesh-ancestor
6471214|NCT00499018|Lenograstim|lenograstim|mesh-list
6471215|NCT00499018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6471216|NCT00499018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6471217|NCT00499018|Immunologic Factors|immunologic factors|mesh-ancestor
6471218|NCT00499018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471219|NCT00499018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5544768|NCT04142762|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5544769|NCT04142762|Antitubercular Agents|antitubercular agents|mesh-ancestor
5544770|NCT04142762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5544771|NCT04142762|Leprostatic Agents|leprostatic agents|mesh-ancestor
5544772|NCT04142762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5544773|NCT04142762|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5544774|NCT04142762|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6471220|NCT00499018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6471221|NCT00499018|Glucocorticoids|glucocorticoids|mesh-ancestor
6471222|NCT00499018|Hormones|hormones|mesh-ancestor
6471223|NCT00499018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6471224|NCT00499018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6471225|NCT00499018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6471226|NCT00499018|Antimetabolites|antimetabolites|mesh-ancestor
6471227|NCT00499018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471228|NCT00499018|Antiviral Agents|antiviral agents|mesh-ancestor
5544775|NCT04142762|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5544776|NCT04142762|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5544777|NCT04142762|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6140554|NCT01307020|Ibuprofen|ibuprofen|mesh-list
5544778|NCT04142762|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5544779|NCT04142762|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5544780|NCT04142762|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5544781|NCT04142749|Oltipraz|oltipraz|mesh-list
5544782|NCT04142749|Antiviral Agents|antiviral agents|mesh-ancestor
5544783|NCT04142749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5544784|NCT04142749|Schistosomicides|schistosomicides|mesh-ancestor
5544785|NCT04142749|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5544786|NCT04142749|Anthelmintics|anthelmintics|mesh-ancestor
5544787|NCT04142749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5544788|NCT04142749|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6140555|NCT01307020|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
6140556|NCT01307020|Ketoprofen|ketoprofen|mesh-list
6140557|NCT01307020|Tramadol|tramadol|mesh-list
6140558|NCT01307020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6140559|NCT01307020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6140560|NCT01307020|Analgesics|analgesics|mesh-ancestor
6140561|NCT01307020|Sensory System Agents|sensory system agents|mesh-ancestor
6488598|NCT00585143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6471229|NCT00499018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6471230|NCT00499018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5544789|NCT04142749|Protective Agents|protective agents|mesh-ancestor
5544790|NCT04142749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544791|NCT04142749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5544792|NCT04142749|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5544793|NCT04142749|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5544794|NCT04142749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5544795|NCT04142749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544796|NCT04142151|Aspirin|aspirin|mesh-list
5544797|NCT04142151|Clopidogrel|clopidogrel|mesh-list
5544798|NCT04142151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5544799|NCT04142151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5544800|NCT04142151|Analgesics|analgesics|mesh-ancestor
5544801|NCT04142151|Sensory System Agents|sensory system agents|mesh-ancestor
5544802|NCT04142151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5544803|NCT04142151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544804|NCT04142151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5544805|NCT04142151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5544806|NCT04142151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5544807|NCT04142151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5544808|NCT04142151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544809|NCT04142151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5544810|NCT04142151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6471231|NCT00499018|Analgesics|analgesics|mesh-ancestor
6140562|NCT01307020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6140563|NCT01307020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140564|NCT01307020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6140565|NCT01307020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6140566|NCT01307020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6140567|NCT01307020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6140568|NCT01307020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140569|NCT01307020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5544811|NCT04142151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5544812|NCT04142151|Antipyretics|antipyretics|mesh-ancestor
5544813|NCT04142151|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5544814|NCT04142151|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5544815|NCT04142151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5544816|NCT04142151|Purinergic Agents|purinergic agents|mesh-ancestor
5544817|NCT04142151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5544818|NCT04142125|Aspirin|aspirin|mesh-list
5544819|NCT04142125|Rivaroxaban|rivaroxaban|mesh-list
5544820|NCT04142125|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5544821|NCT04142125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5544822|NCT04142125|Analgesics|analgesics|mesh-ancestor
5544823|NCT04142125|Sensory System Agents|sensory system agents|mesh-ancestor
6140570|NCT01307020|Narcotics|narcotics|mesh-ancestor
6140571|NCT01307020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6471232|NCT00499018|Sensory System Agents|sensory system agents|mesh-ancestor
6471233|NCT00499018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6471234|NCT00499018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6471235|NCT00499018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6471236|NCT00499018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6471237|NCT00499018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6471238|NCT00499018|Alkylating Agents|alkylating agents|mesh-ancestor
6471239|NCT00499018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6471240|NCT00499018|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6471241|NCT00499018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5544824|NCT04142125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6140572|NCT01307111|Misoprostol|misoprostol|mesh-list
6140573|NCT01307111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6140574|NCT01307111|Abortifacient Agents|abortifacient agents|mesh-ancestor
5544825|NCT04142125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544826|NCT04142125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5544827|NCT04142125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5544828|NCT04142125|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5544829|NCT04142125|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5544830|NCT04142125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544831|NCT04142125|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5544832|NCT04142125|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6140575|NCT01307111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6140576|NCT01307111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140577|NCT01307111|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6140578|NCT01307111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6140579|NCT01307111|Oxytocics|oxytocics|mesh-ancestor
6140580|NCT01307267|Rituximab|rituximab|mesh-list
6140581|NCT01307267|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6140582|NCT01307267|Immunoglobulin G|immunoglobulin g|mesh-list
6140583|NCT01307267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6140584|NCT01307267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6140585|NCT01307267|Immunologic Factors|immunologic factors|mesh-ancestor
6140586|NCT01307267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140587|NCT01307267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6140588|NCT01307319|Beclomethasone|beclomethasone|mesh-list
6140589|NCT01307319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6140590|NCT01307319|Glucocorticoids|glucocorticoids|mesh-ancestor
6140591|NCT01307319|Hormones|hormones|mesh-ancestor
6140592|NCT01307319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6140593|NCT01307319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140594|NCT01307319|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5544833|NCT04142125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5544834|NCT04142125|Antipyretics|antipyretics|mesh-ancestor
5544835|NCT04142125|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5544836|NCT04142125|Antithrombins|antithrombins|mesh-ancestor
5544837|NCT04142125|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5544838|NCT04142125|Protease Inhibitors|protease inhibitors|mesh-ancestor
6140595|NCT01307319|Respiratory System Agents|respiratory system agents|mesh-ancestor
6140596|NCT01307397|Vemurafenib|vemurafenib|mesh-list
6140597|NCT01307397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6140598|NCT01307397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6140599|NCT01307397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6140600|NCT01307397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140601|NCT01307423|Thalidomide|thalidomide|mesh-list
6140602|NCT01307423|Apremilast|apremilast|mesh-list
6140603|NCT01307423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6140604|NCT01307423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6140605|NCT01307423|Analgesics|analgesics|mesh-ancestor
6140606|NCT01307423|Sensory System Agents|sensory system agents|mesh-ancestor
6471242|NCT00499018|Tubulin Modulators|tubulin modulators|mesh-ancestor
6471243|NCT00499018|Antimitotic Agents|antimitotic agents|mesh-ancestor
6471244|NCT00499018|Mitosis Modulators|mitosis modulators|mesh-ancestor
6471245|NCT00499018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6471246|NCT00499135|Alovudine|alovudine|mesh-list
6140607|NCT01307423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6140608|NCT01307423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140609|NCT01307423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6140610|NCT01307423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6140611|NCT01307423|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6140612|NCT01307423|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6140613|NCT01307423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6140614|NCT01307423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140615|NCT01307423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5544839|NCT04142125|Anticoagulants|anticoagulants|mesh-ancestor
5544840|NCT04141995|Leucovorin|leucovorin|mesh-list
5544841|NCT04141995|Fluorouracil|fluorouracil|mesh-list
5544842|NCT04141995|Oxaliplatin|oxaliplatin|mesh-list
5544843|NCT04141995|Irinotecan|irinotecan|mesh-list
5544844|NCT04141995|Camptothecin|camptothecin|mesh-list
5544845|NCT04141995|Digoxin|digoxin|mesh-list
5544846|NCT04141995|Calcium|calcium|mesh-list
5544847|NCT04141995|Levoleucovorin|levoleucovorin|mesh-list
5544848|NCT04141995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6140616|NCT01307423|Immunologic Factors|immunologic factors|mesh-ancestor
6140617|NCT01307423|Leprostatic Agents|leprostatic agents|mesh-ancestor
6140618|NCT01307423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6140619|NCT01307423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6140620|NCT01307423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6140621|NCT01307423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6140622|NCT01307423|Growth Substances|growth substances|mesh-ancestor
6140623|NCT01307423|Growth Inhibitors|growth inhibitors|mesh-ancestor
6140624|NCT01307423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6140625|NCT01307449|Vaccines|vaccines|mesh-list
5544849|NCT04141995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544850|NCT04141995|Antimetabolites|antimetabolites|mesh-ancestor
5544851|NCT04141995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544852|NCT04141995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6471247|NCT00499135|Sunitinib|sunitinib|mesh-list
5544853|NCT04141995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5544854|NCT04141995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6471248|NCT00499135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5544855|NCT04141995|Immunologic Factors|immunologic factors|mesh-ancestor
5544856|NCT04141995|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5544857|NCT04141995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6140626|NCT01307449|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6140627|NCT01307449|Immunologic Factors|immunologic factors|mesh-ancestor
6140628|NCT01307449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140629|NCT01307462|Fluticasone|fluticasone|mesh-list
6140630|NCT01307462|Xhance|xhance|mesh-list
6140631|NCT01307462|Azithromycin|azithromycin|mesh-list
6140632|NCT01307462|Montelukast|montelukast|mesh-list
6140633|NCT01307462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6140634|NCT01307462|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6140635|NCT01307462|Autonomic Agents|autonomic agents|mesh-ancestor
6140636|NCT01307462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6140637|NCT01307462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471249|NCT00499135|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6471250|NCT00499135|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6471251|NCT00499135|Growth Substances|growth substances|mesh-ancestor
6471252|NCT00499135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471253|NCT00499135|Growth Inhibitors|growth inhibitors|mesh-ancestor
6471254|NCT00499135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6471255|NCT00499135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6471256|NCT00499135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471257|NCT00499135|Antiviral Agents|antiviral agents|mesh-ancestor
6471258|NCT00499135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6140638|NCT01307462|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6140639|NCT01307462|Respiratory System Agents|respiratory system agents|mesh-ancestor
6140640|NCT01307462|Dermatologic Agents|dermatologic agents|mesh-ancestor
6140641|NCT01307462|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6140642|NCT01307462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6140643|NCT01307462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6140644|NCT01307462|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6140645|NCT01307462|Hormone Antagonists|hormone antagonists|mesh-ancestor
5544858|NCT04141995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5544859|NCT04141995|Antidotes|antidotes|mesh-ancestor
5544860|NCT04141995|Protective Agents|protective agents|mesh-ancestor
5544861|NCT04141995|Vitamin B Complex|vitamin b complex|mesh-ancestor
5544862|NCT04141995|Vitamins|vitamins|mesh-ancestor
5544863|NCT04141995|Micronutrients|micronutrients|mesh-ancestor
5544864|NCT04141995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5544865|NCT04141995|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5544866|NCT04141995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5544867|NCT04142411|Insulin|insulin|mesh-list
5544868|NCT04142411|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5544869|NCT04142411|Hyaluronic Acid|hyaluronic acid|mesh-list
5544870|NCT04142411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5544871|NCT04142411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544872|NCT04142411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5544873|NCT04142411|Immunologic Factors|immunologic factors|mesh-ancestor
5544874|NCT04142411|Viscosupplements|viscosupplements|mesh-ancestor
5544875|NCT04142411|Protective Agents|protective agents|mesh-ancestor
5544876|NCT04141904|Tofacitinib|tofacitinib|mesh-list
5544877|NCT04141904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5544878|NCT04141904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5544879|NCT04141904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544880|NCT04141787|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5544881|NCT04141787|Cefazolin|cefazolin|mesh-list
5544882|NCT04141787|Ceftriaxone|ceftriaxone|mesh-list
5544883|NCT04141787|Daptomycin|daptomycin|mesh-list
5544884|NCT04141787|Cloxacillin|cloxacillin|mesh-list
5544885|NCT04141787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5544886|NCT04141410|Simendan|simendan|mesh-list
5544887|NCT04141410|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5544888|NCT04141410|Vasodilator Agents|vasodilator agents|mesh-ancestor
5544889|NCT04141410|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5544890|NCT04141410|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5544891|NCT04141410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6140646|NCT01307462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6140647|NCT01307462|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5544892|NCT04141410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544893|NCT04141410|Protective Agents|protective agents|mesh-ancestor
5544894|NCT04141410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602515|NCT04397354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602516|NCT04397354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5602517|NCT04397354|Glucocorticoids|glucocorticoids|mesh-ancestor
6140648|NCT01307462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5602518|NCT04397354|Hormones|hormones|mesh-ancestor
5544895|NCT04141501|Psilocybin|psilocybin|mesh-list
5544896|NCT04141501|Hallucinogens|hallucinogens|mesh-ancestor
6140649|NCT01307462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471259|NCT00499265|Gemcitabine|gemcitabine|mesh-list
6471260|NCT00499265|Protease Inhibitors|protease inhibitors|mesh-list
6471261|NCT00499265|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-list
6471262|NCT00499265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6471263|NCT00499265|Antimetabolites|antimetabolites|mesh-ancestor
6471264|NCT00499265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471265|NCT00499265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6471266|NCT00499265|Antiviral Agents|antiviral agents|mesh-ancestor
6471267|NCT00499265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6471268|NCT00499265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6471269|NCT00499265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6471270|NCT00499265|Immunologic Factors|immunologic factors|mesh-ancestor
6471271|NCT00499265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471272|NCT00499291|Paclitaxel|paclitaxel|mesh-list
6471273|NCT00499291|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6140650|NCT01307579|Fluconazole|fluconazole|mesh-list
6140651|NCT01307579|Caspofungin|caspofungin|mesh-list
6140652|NCT01307579|Antifungal Agents|antifungal agents|mesh-ancestor
6140653|NCT01307579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6140654|NCT01307579|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6140655|NCT01307579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6140656|NCT01307579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6140657|NCT01307579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140658|NCT01307579|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6140659|NCT01307579|Hormone Antagonists|hormone antagonists|mesh-ancestor
5544897|NCT04141501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544898|NCT04141501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5544899|NCT04141553|Diltiazem|diltiazem|mesh-list
5544900|NCT04141553|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5544901|NCT04141553|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5544902|NCT04141553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5544903|NCT04141553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544904|NCT04141553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5544905|NCT04141553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140660|NCT01307579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6140661|NCT01307579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140662|NCT01307579|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6140663|NCT01307579|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6140664|NCT01307618|Interleukin-12|interleukin-12|mesh-list
6140665|NCT01307618|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6140666|NCT01307618|Immunologic Factors|immunologic factors|mesh-ancestor
6471274|NCT00499291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6471275|NCT00499291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6471276|NCT00499291|Tubulin Modulators|tubulin modulators|mesh-ancestor
6471277|NCT00499291|Antimitotic Agents|antimitotic agents|mesh-ancestor
6471278|NCT00499291|Mitosis Modulators|mitosis modulators|mesh-ancestor
6471279|NCT00499291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471280|NCT00499525|Paclitaxel|paclitaxel|mesh-list
6471281|NCT00499525|Sorafenib|sorafenib|mesh-list
6471282|NCT00499525|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6471283|NCT00499525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6471284|NCT00499525|Tubulin Modulators|tubulin modulators|mesh-ancestor
6471285|NCT00499525|Antimitotic Agents|antimitotic agents|mesh-ancestor
6471286|NCT00499525|Mitosis Modulators|mitosis modulators|mesh-ancestor
6471287|NCT00499525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471288|NCT00499525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6471289|NCT00499525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6471290|NCT00499577|Vaccines|vaccines|mesh-list
6471291|NCT00499577|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6471292|NCT00499577|Immunologic Factors|immunologic factors|mesh-ancestor
5544906|NCT04141553|Vasodilator Agents|vasodilator agents|mesh-ancestor
6140667|NCT01307618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140668|NCT01307618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6140669|NCT01307618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6140670|NCT01307618|Growth Substances|growth substances|mesh-ancestor
6140671|NCT01307618|Growth Inhibitors|growth inhibitors|mesh-ancestor
6140672|NCT01307618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6140673|NCT01307891|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6140674|NCT01307891|Paclitaxel|paclitaxel|mesh-list
6471293|NCT00499577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544907|NCT04141319|Ketorolac|ketorolac|mesh-list
5544908|NCT04141319|Epinephrine|epinephrine|mesh-list
5544909|NCT04141319|Ropivacaine|ropivacaine|mesh-list
5544910|NCT04141319|Anesthetics, Local|anesthetics, local|mesh-ancestor
6471294|NCT00499642|Moxifloxacin|moxifloxacin|mesh-list
6471295|NCT00499642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6471296|NCT00499642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6471297|NCT00499642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6471298|NCT00499642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6471299|NCT00499642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6471300|NCT00499642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471301|NCT00499642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6471302|NCT00499668|Ondansetron|ondansetron|mesh-list
6471303|NCT00499668|Aprepitant|aprepitant|mesh-list
6471304|NCT00499668|Antiemetics|antiemetics|mesh-ancestor
6471305|NCT00499668|Autonomic Agents|autonomic agents|mesh-ancestor
6471306|NCT00499668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6471307|NCT00499668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471308|NCT00499668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6471309|NCT00499668|Antipruritics|antipruritics|mesh-ancestor
6471310|NCT00499668|Dermatologic Agents|dermatologic agents|mesh-ancestor
6471311|NCT00499668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6140675|NCT01307891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6140676|NCT01307891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6140677|NCT01307891|Tubulin Modulators|tubulin modulators|mesh-ancestor
6140678|NCT01307891|Antimitotic Agents|antimitotic agents|mesh-ancestor
6140679|NCT01307891|Mitosis Modulators|mitosis modulators|mesh-ancestor
6140680|NCT01307891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140681|NCT01307930|Anidulafungin|anidulafungin|mesh-list
6140682|NCT01307930|Antifungal Agents|antifungal agents|mesh-ancestor
6140683|NCT01307930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6140684|NCT01307956|Calcium, Dietary|calcium, dietary|mesh-list
6140685|NCT01307956|Leucovorin|leucovorin|mesh-list
6140686|NCT01307956|Folic Acid|folic acid|mesh-list
6471312|NCT00499668|Serotonin Agents|serotonin agents|mesh-ancestor
6471313|NCT00499668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6471314|NCT00499668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544911|NCT04141319|Anesthetics|anesthetics|mesh-ancestor
5544912|NCT04141319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6140687|NCT01307956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6140688|NCT01307956|Panitumumab|panitumumab|mesh-list
6140689|NCT01307956|Fluorouracil|fluorouracil|mesh-list
6140690|NCT01307956|Oxaliplatin|oxaliplatin|mesh-list
6140691|NCT01307956|Antibodies|antibodies|mesh-list
6140692|NCT01307956|Immunoglobulins|immunoglobulins|mesh-list
6140693|NCT01307956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6140694|NCT01307956|Calcium|calcium|mesh-list
6140695|NCT01307956|Levoleucovorin|levoleucovorin|mesh-list
6140696|NCT01307956|Immunologic Factors|immunologic factors|mesh-ancestor
5544913|NCT04141319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544914|NCT04141319|Sensory System Agents|sensory system agents|mesh-ancestor
6140697|NCT01307956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140698|NCT01307956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6140699|NCT01307956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6140700|NCT01307956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6140701|NCT01307956|Antimetabolites|antimetabolites|mesh-ancestor
6140702|NCT01307956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140703|NCT01307956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6140704|NCT01307956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6140705|NCT01307956|Antidotes|antidotes|mesh-ancestor
6140706|NCT01307956|Protective Agents|protective agents|mesh-ancestor
6140707|NCT01307956|Vitamin B Complex|vitamin b complex|mesh-ancestor
6140708|NCT01307956|Vitamins|vitamins|mesh-ancestor
6140709|NCT01307956|Micronutrients|micronutrients|mesh-ancestor
6140710|NCT01307956|Hematinics|hematinics|mesh-ancestor
6140711|NCT01308060|Botulinum Toxins|botulinum toxins|mesh-list
6140712|NCT01308060|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6140713|NCT01308060|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6140714|NCT01308060|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6140715|NCT01308060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6140716|NCT01308060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140717|NCT01308060|Cholinergic Agents|cholinergic agents|mesh-ancestor
6140718|NCT01308060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6140719|NCT01308060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140720|NCT01308060|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6140721|NCT01308060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6140722|NCT01308294|Vaccines|vaccines|mesh-list
6471315|NCT00499668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5544915|NCT04141319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5544916|NCT04141319|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5544917|NCT04141319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5544918|NCT04141319|Adrenergic Agents|adrenergic agents|mesh-ancestor
5544919|NCT04141319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5544920|NCT04141319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140723|NCT01308294|Immunologic Factors|immunologic factors|mesh-ancestor
6140724|NCT01308294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140725|NCT01308567|Prednisone|prednisone|mesh-list
6140726|NCT01308567|Docetaxel|docetaxel|mesh-list
6140727|NCT01308567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6140728|NCT01308567|Tubulin Modulators|tubulin modulators|mesh-ancestor
6140729|NCT01308567|Antimitotic Agents|antimitotic agents|mesh-ancestor
6140730|NCT01308567|Mitosis Modulators|mitosis modulators|mesh-ancestor
6140731|NCT01308567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140732|NCT01308567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6140733|NCT01308567|Glucocorticoids|glucocorticoids|mesh-ancestor
6140734|NCT01308567|Hormones|hormones|mesh-ancestor
6140735|NCT01308567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6140736|NCT01308567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140737|NCT01308567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6140738|NCT01308580|Prednisone|prednisone|mesh-list
6140739|NCT01308580|Prednisolone|prednisolone|mesh-list
5544921|NCT04141319|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5544922|NCT04141319|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5544923|NCT04141319|Autonomic Agents|autonomic agents|mesh-ancestor
5544924|NCT04141319|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5544925|NCT04141319|Respiratory System Agents|respiratory system agents|mesh-ancestor
5544926|NCT04141319|Mydriatics|mydriatics|mesh-ancestor
5544927|NCT04141319|Sympathomimetics|sympathomimetics|mesh-ancestor
6140740|NCT01308580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6140741|NCT01308580|Glucocorticoids|glucocorticoids|mesh-ancestor
6140742|NCT01308580|Hormones|hormones|mesh-ancestor
6140743|NCT01308580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6140744|NCT01308580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140745|NCT01308580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6140746|NCT01308580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6140747|NCT01308619|Doxycycline|doxycycline|mesh-list
6140748|NCT01308619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6140749|NCT01308619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6140750|NCT01308619|Antimalarials|antimalarials|mesh-ancestor
6140751|NCT01308619|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6140752|NCT01308619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6140753|NCT01308736|Varenicline|varenicline|mesh-list
5544928|NCT04141319|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5544929|NCT04141319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5544930|NCT04141319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5544931|NCT04141319|Analgesics|analgesics|mesh-ancestor
5544932|NCT04141319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5544933|NCT04141319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5544934|NCT04141319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5544935|NCT04141319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5544936|NCT04141163|Metformin|metformin|mesh-list
5544937|NCT04141163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5544938|NCT04141163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140754|NCT01308736|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6140755|NCT01308736|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6140756|NCT01308736|Cholinergic Agents|cholinergic agents|mesh-ancestor
6140757|NCT01308736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6140758|NCT01308736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140759|NCT01308736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140760|NCT01308749|Oxytocin|oxytocin|mesh-list
6140761|NCT01308749|Oxytocics|oxytocics|mesh-ancestor
6140762|NCT01308749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5544939|NCT04140786|Gentamicins|gentamicins|mesh-list
5544940|NCT04140786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5544941|NCT04140786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5544942|NCT04140786|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6140763|NCT01308749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140764|NCT01308814|Estradiol|estradiol|mesh-list
6471316|NCT00499668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6471317|NCT00499668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6471318|NCT00499668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6471319|NCT00499668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6488599|NCT00585156|Celecoxib|celecoxib|mesh-list
5544943|NCT04140786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6140765|NCT01308814|Estrogens|estrogens|mesh-ancestor
5544944|NCT04140786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544945|NCT04140968|Progesterone|progesterone|mesh-list
5544946|NCT04140968|Progestins|progestins|mesh-ancestor
5544947|NCT04140968|Hormones|hormones|mesh-ancestor
5544948|NCT04140968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5544949|NCT04140968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544950|NCT04140578|Ertapenem|ertapenem|mesh-list
5544951|NCT04140578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5544952|NCT04140578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6471320|NCT00499668|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6471321|NCT00499707|Metformin|metformin|mesh-list
6471322|NCT00499707|Rosiglitazone|rosiglitazone|mesh-list
6471323|NCT00499707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6471324|NCT00499707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471325|NCT00499720|Aztreonam|aztreonam|mesh-list
6471326|NCT00499720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6471327|NCT00499720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6471328|NCT00499733|Cyclophosphamide|cyclophosphamide|mesh-list
6471329|NCT00499733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6471330|NCT00499733|Immunologic Factors|immunologic factors|mesh-ancestor
6471331|NCT00499733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471332|NCT00499733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6471333|NCT00499733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6471334|NCT00499733|Alkylating Agents|alkylating agents|mesh-ancestor
6471335|NCT00499733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471336|NCT00499733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6471337|NCT00499733|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6471338|NCT00499811|Vorinostat|vorinostat|mesh-list
6471339|NCT00499811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6471340|NCT00499811|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6471341|NCT00499811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6471342|NCT00499811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471343|NCT00499837|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
6471344|NCT00499837|Protein C Inhibitor|protein c inhibitor|mesh-list
6471345|NCT00499837|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6471346|NCT00499837|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6471347|NCT00499837|Protease Inhibitors|protease inhibitors|mesh-ancestor
6471348|NCT00499837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6471349|NCT00499837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140766|NCT01308814|Hormones|hormones|mesh-ancestor
6140767|NCT01308814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6140768|NCT01308814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140769|NCT01308840|Gemcitabine|gemcitabine|mesh-list
6140770|NCT01308840|Oxaliplatin|oxaliplatin|mesh-list
6140771|NCT01308840|Panitumumab|panitumumab|mesh-list
6140772|NCT01308840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6140773|NCT01308840|Antimetabolites|antimetabolites|mesh-ancestor
6140774|NCT01308840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140775|NCT01308840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5544953|NCT04140487|Azacitidine|azacitidine|mesh-list
5544954|NCT04140487|Venetoclax|venetoclax|mesh-list
6140776|NCT01308840|Antiviral Agents|antiviral agents|mesh-ancestor
6140777|NCT01308840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6140778|NCT01308840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6140779|NCT01308840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5544955|NCT04140487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5544956|NCT04140487|Antimetabolites|antimetabolites|mesh-ancestor
5544957|NCT04140487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544958|NCT04140487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5544959|NCT04140487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5544960|NCT04140448|Ranibizumab|ranibizumab|mesh-list
5544961|NCT04140448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5544962|NCT04140448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5544963|NCT04140448|Growth Substances|growth substances|mesh-ancestor
5544964|NCT04140448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544965|NCT04140448|Growth Inhibitors|growth inhibitors|mesh-ancestor
5544966|NCT04140448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5544967|NCT04140513|Deoxyglucose|deoxyglucose|mesh-list
5544968|NCT04140513|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5544969|NCT04140513|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5544970|NCT04140513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140780|NCT01308840|Immunologic Factors|immunologic factors|mesh-ancestor
6140781|NCT01308840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140782|NCT01308840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6471350|NCT00499850|Leucovorin|leucovorin|mesh-list
5544971|NCT04140513|Antimetabolites|antimetabolites|mesh-ancestor
5544972|NCT04140513|Antiviral Agents|antiviral agents|mesh-ancestor
5544973|NCT04140513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5544974|NCT04140461|Amphotericin B|amphotericin b|mesh-list
5544975|NCT04140461|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
5544976|NCT04140461|Flucytosine|flucytosine|mesh-list
5544977|NCT04140461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6140783|NCT01309204|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6140784|NCT01309204|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6140785|NCT01309204|Brinzolamide|brinzolamide|mesh-list
6140786|NCT01309204|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6140787|NCT01309204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6140788|NCT01309204|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6471351|NCT00499850|Fluorouracil|fluorouracil|mesh-list
6471352|NCT00499850|Oxaliplatin|oxaliplatin|mesh-list
6471353|NCT00499850|Antimetabolites|antimetabolites|mesh-ancestor
6471354|NCT00499850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471355|NCT00499850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6471356|NCT00499850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6471357|NCT00499850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6471358|NCT00499850|Immunologic Factors|immunologic factors|mesh-ancestor
6471359|NCT00499850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471360|NCT00499850|Antidotes|antidotes|mesh-ancestor
6471361|NCT00499850|Protective Agents|protective agents|mesh-ancestor
6471362|NCT00499850|Vitamin B Complex|vitamin b complex|mesh-ancestor
6471363|NCT00499850|Vitamins|vitamins|mesh-ancestor
6471364|NCT00499850|Micronutrients|micronutrients|mesh-ancestor
6471365|NCT00499876|Mefloquine|mefloquine|mesh-list
6471366|NCT00499876|Antimalarials|antimalarials|mesh-ancestor
6471367|NCT00499876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6471368|NCT00499876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6471369|NCT00499876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6471370|NCT00499993|Lanreotide|lanreotide|mesh-list
5544978|NCT04140461|Amebicides|amebicides|mesh-ancestor
5544979|NCT04140461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5544980|NCT04140461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5544981|NCT04140461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6471371|NCT00499993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6471372|NCT00500006|Dasatinib|dasatinib|mesh-list
6471373|NCT00500006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6471374|NCT00500006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6471375|NCT00500006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6471376|NCT00500006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471377|NCT00500058|Rituximab|rituximab|mesh-list
6666729|NCT01524081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6666730|NCT01524081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666731|NCT01524081|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6666732|NCT01524081|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6666733|NCT01524081|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6666734|NCT01524094|Leucovorin|leucovorin|mesh-list
6666735|NCT01524094|Fluorouracil|fluorouracil|mesh-list
5544982|NCT04140461|Antifungal Agents|antifungal agents|mesh-ancestor
5544983|NCT04140461|Antimetabolites|antimetabolites|mesh-ancestor
5544984|NCT04140461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544985|NCT04140591|Propranolol|propranolol|mesh-list
5544986|NCT04140591|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
6140789|NCT01309204|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6140790|NCT01309204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6140791|NCT01309204|Adrenergic Agents|adrenergic agents|mesh-ancestor
6140792|NCT01309204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6140793|NCT01309204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140794|NCT01309204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140795|NCT01309204|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6140796|NCT01309204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6140797|NCT01309243|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6140798|NCT01309243|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6140799|NCT01309243|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6140800|NCT01309243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6140801|NCT01309243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140802|NCT01309243|Antiviral Agents|antiviral agents|mesh-ancestor
6140803|NCT01309243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6140804|NCT01309243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6471378|NCT00500058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5544987|NCT04140591|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6471379|NCT00500058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6140805|NCT01309243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6140806|NCT01309360|Midazolam|midazolam|mesh-list
6471380|NCT00500058|Immunologic Factors|immunologic factors|mesh-ancestor
6471381|NCT00500058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471382|NCT00500058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6471383|NCT00500123|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
6471384|NCT00500123|Protein C Inhibitor|protein c inhibitor|mesh-list
6471385|NCT00500123|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6471386|NCT00500123|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6471387|NCT00500123|Protease Inhibitors|protease inhibitors|mesh-ancestor
6471388|NCT00500123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6140807|NCT01309360|Prilocaine|prilocaine|mesh-list
6140808|NCT01309360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6140809|NCT01309360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6140810|NCT01309360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6140811|NCT01309360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140812|NCT01309360|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6140813|NCT01309360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6140814|NCT01309360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6140815|NCT01309360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6140816|NCT01309360|Anesthetics, General|anesthetics, general|mesh-ancestor
6666736|NCT01524094|Oxaliplatin|oxaliplatin|mesh-list
6666737|NCT01524094|Levoleucovorin|levoleucovorin|mesh-list
6666738|NCT01524094|Antimetabolites|antimetabolites|mesh-ancestor
6666739|NCT01524094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666740|NCT01524094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6666741|NCT01524094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6666742|NCT01524094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6666743|NCT01524094|Immunologic Factors|immunologic factors|mesh-ancestor
6666744|NCT01524094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544988|NCT04140591|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6140817|NCT01309360|Anesthetics|anesthetics|mesh-ancestor
6140818|NCT01309360|GABA Modulators|gaba modulators|mesh-ancestor
6140819|NCT01309360|GABA Agents|gaba agents|mesh-ancestor
6471389|NCT00500123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471390|NCT00500188|Imatinib Mesylate|imatinib mesylate|mesh-list
6471391|NCT00500188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6140820|NCT01309360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6140821|NCT01309360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140822|NCT01309360|Anesthetics, Local|anesthetics, local|mesh-ancestor
5544989|NCT04140591|Adrenergic Agents|adrenergic agents|mesh-ancestor
5544990|NCT04140591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5544991|NCT04140591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5544992|NCT04140591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5544993|NCT04140591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5544994|NCT04140591|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5544995|NCT04140591|Vasodilator Agents|vasodilator agents|mesh-ancestor
5544996|NCT04140591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5544997|NCT04140422|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6140823|NCT01309360|Sensory System Agents|sensory system agents|mesh-ancestor
6140824|NCT01309360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5544998|NCT04140422|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5544999|NCT04140409|Octreotide|octreotide|mesh-list
5545000|NCT04140409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5545001|NCT04140409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5545002|NCT04140409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5545003|NCT04140318|Paclitaxel|paclitaxel|mesh-list
5545004|NCT04140318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5545005|NCT04140318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5545006|NCT04140318|Tubulin Modulators|tubulin modulators|mesh-ancestor
5545007|NCT04140318|Antimitotic Agents|antimitotic agents|mesh-ancestor
5545008|NCT04140318|Mitosis Modulators|mitosis modulators|mesh-ancestor
5545009|NCT04140318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545010|NCT04140006|Alendronate|alendronate|mesh-list
5545011|NCT04140006|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5545012|NCT04140006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545013|NCT04139928|Magnesium citrate|magnesium citrate|mesh-list
5545014|NCT04139928|Magnesium Oxide|magnesium oxide|mesh-list
5545015|NCT04139928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545016|NCT04139928|Cathartics|cathartics|mesh-ancestor
5545017|NCT04139928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5545018|NCT04139928|Antacids|antacids|mesh-ancestor
5545019|NCT04140292|Vitamin D|vitamin d|mesh-list
6140825|NCT01309386|Morphine|morphine|mesh-list
6140826|NCT01309386|Tapentadol|tapentadol|mesh-list
6471392|NCT00500188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6666745|NCT01524094|Antidotes|antidotes|mesh-ancestor
6140827|NCT01309386|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6140828|NCT01309386|Narcotics|narcotics|mesh-ancestor
5545020|NCT04140292|Cholecalciferol|cholecalciferol|mesh-list
5545021|NCT04140292|Vitamins|vitamins|mesh-ancestor
5545022|NCT04140292|Micronutrients|micronutrients|mesh-ancestor
5545023|NCT04140292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545024|NCT04140292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5545025|NCT04140292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5545026|NCT04139915|Dactolisib|dactolisib|mesh-list
5545027|NCT04139915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5545028|NCT04139941|Antibodies|antibodies|mesh-list
5545029|NCT04139941|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
5545030|NCT04139941|Immunologic Factors|immunologic factors|mesh-ancestor
5545031|NCT04139941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545032|NCT04140058|Ondansetron|ondansetron|mesh-list
5545033|NCT04140058|Antiemetics|antiemetics|mesh-ancestor
5545034|NCT04140058|Autonomic Agents|autonomic agents|mesh-ancestor
5545035|NCT04140058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6140829|NCT01309386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6140830|NCT01309386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140831|NCT01309386|Analgesics|analgesics|mesh-ancestor
6140832|NCT01309386|Sensory System Agents|sensory system agents|mesh-ancestor
6140833|NCT01309386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6140834|NCT01309386|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6140835|NCT01309386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6140836|NCT01309386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6140837|NCT01309386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140838|NCT01309386|Adrenergic Agents|adrenergic agents|mesh-ancestor
6140839|NCT01309386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6140840|NCT01309451|Dexamethasone|dexamethasone|mesh-list
6140841|NCT01309451|Bevacizumab|bevacizumab|mesh-list
6140842|NCT01309451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6140843|NCT01309451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5545036|NCT04140058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545037|NCT04140058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6140844|NCT01309451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6140845|NCT01309451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6140846|NCT01309451|Growth Substances|growth substances|mesh-ancestor
6140847|NCT01309451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140848|NCT01309451|Growth Inhibitors|growth inhibitors|mesh-ancestor
6140849|NCT01309451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6140850|NCT01309451|Antiemetics|antiemetics|mesh-ancestor
6140851|NCT01309451|Autonomic Agents|autonomic agents|mesh-ancestor
6140852|NCT01309451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6140853|NCT01309451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6666746|NCT01524094|Protective Agents|protective agents|mesh-ancestor
6666747|NCT01524094|Vitamin B Complex|vitamin b complex|mesh-ancestor
6666748|NCT01524094|Vitamins|vitamins|mesh-ancestor
6471393|NCT00500188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6471394|NCT00500188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471395|NCT00500253|Nitric Oxide|nitric oxide|mesh-list
6140854|NCT01309451|Glucocorticoids|glucocorticoids|mesh-ancestor
6140855|NCT01309451|Hormones|hormones|mesh-ancestor
6140856|NCT01309451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6140857|NCT01309451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6140858|NCT01309659|Iron|iron|mesh-list
6140859|NCT01309659|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6140860|NCT01309659|Trace Elements|trace elements|mesh-ancestor
6140861|NCT01309659|Micronutrients|micronutrients|mesh-ancestor
6140862|NCT01309659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545038|NCT04140058|Antipruritics|antipruritics|mesh-ancestor
5545039|NCT04140058|Dermatologic Agents|dermatologic agents|mesh-ancestor
5545040|NCT04140058|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5545041|NCT04140058|Serotonin Agents|serotonin agents|mesh-ancestor
5545042|NCT04140058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5545043|NCT04140058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545044|NCT04140058|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5545045|NCT04140058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5545046|NCT04140058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5545047|NCT04140058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5545048|NCT04140058|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6471396|NCT00500253|Methacholine Chloride|methacholine chloride|mesh-list
5545049|NCT04140188|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
5545050|NCT04140188|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5545051|NCT04140188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545052|NCT04140136|Tocotrienols|tocotrienols|mesh-list
6471397|NCT00500253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6471398|NCT00500253|Autonomic Agents|autonomic agents|mesh-ancestor
6471399|NCT00500253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6471400|NCT00500253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471401|NCT00500253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6471402|NCT00500253|Respiratory System Agents|respiratory system agents|mesh-ancestor
6471403|NCT00500253|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6471404|NCT00500253|Antioxidants|antioxidants|mesh-ancestor
6471405|NCT00500253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471406|NCT00500253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6471407|NCT00500253|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6471408|NCT00500253|Vasodilator Agents|vasodilator agents|mesh-ancestor
5545053|NCT04140136|Vitamin E|vitamin e|mesh-list
5545054|NCT04140136|Tocopherols|tocopherols|mesh-list
5545055|NCT04140136|Antioxidants|antioxidants|mesh-ancestor
5545056|NCT04140136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545057|NCT04140136|Protective Agents|protective agents|mesh-ancestor
5545058|NCT04140136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545059|NCT04140136|Vitamins|vitamins|mesh-ancestor
5545060|NCT04140136|Micronutrients|micronutrients|mesh-ancestor
5545061|NCT04140201|Simvastatin|simvastatin|mesh-list
5545062|NCT04140201|Fenofibrate|fenofibrate|mesh-list
5545063|NCT04140201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5545064|NCT04140201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5545065|NCT04140201|Antimetabolites|antimetabolites|mesh-ancestor
5545066|NCT04140201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545067|NCT04140201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5545068|NCT04140201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5545069|NCT04140201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5545070|NCT04139824|Naproxen|naproxen|mesh-list
5545071|NCT04139824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
5545072|NCT04139824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
5545073|NCT04139824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5545074|NCT04139824|Analgesics|analgesics|mesh-ancestor
5545075|NCT04139824|Sensory System Agents|sensory system agents|mesh-ancestor
5545076|NCT04139824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5545077|NCT04139824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545078|NCT04139824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5545079|NCT04139824|Gout Suppressants|gout suppressants|mesh-ancestor
5545080|NCT04139824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5545081|NCT04139824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5545082|NCT04139824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602519|NCT04397354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6471409|NCT00500253|Gasotransmitters|gasotransmitters|mesh-ancestor
6471410|NCT00500253|Protective Agents|protective agents|mesh-ancestor
6471411|NCT00500253|Miotics|miotics|mesh-ancestor
6471412|NCT00500253|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6471413|NCT00500253|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
6471414|NCT00500253|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6471415|NCT00500253|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6471416|NCT00500253|Cholinergic Agents|cholinergic agents|mesh-ancestor
6471417|NCT00500279|Celecoxib|celecoxib|mesh-list
6140863|NCT01309659|Hematinics|hematinics|mesh-ancestor
6140864|NCT01309737|Tofacitinib|tofacitinib|mesh-list
6140865|NCT01309737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6140866|NCT01309737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6140867|NCT01309737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140868|NCT01309802|Botulinum Toxins|botulinum toxins|mesh-list
6140869|NCT01309802|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6140870|NCT01309802|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6140871|NCT01309802|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6140872|NCT01309802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6140873|NCT01309802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140874|NCT01309802|Cholinergic Agents|cholinergic agents|mesh-ancestor
6140875|NCT01309802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6140876|NCT01309802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140877|NCT01309802|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6140878|NCT01309802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6140879|NCT01309828|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6140880|NCT01309828|Olmesartan|olmesartan|mesh-list
6140881|NCT01309828|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6140882|NCT01309828|Chlorthalidone|chlorthalidone|mesh-list
6140883|NCT01309828|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
6140884|NCT01309828|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6471418|NCT00500279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5545083|NCT04139668|Naltrexone|naltrexone|mesh-list
6140885|NCT01309828|Diuretics|diuretics|mesh-ancestor
6140886|NCT01309828|Natriuretic Agents|natriuretic agents|mesh-ancestor
6140887|NCT01309828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140888|NCT01309828|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6140889|NCT01309828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6140890|NCT01309828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140891|NCT01309828|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6140892|NCT01309828|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6140893|NCT01309841|Naloxegol|naloxegol|mesh-list
6140894|NCT01309841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6140895|NCT01309841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140896|NCT01309841|Sensory System Agents|sensory system agents|mesh-ancestor
6140897|NCT01309841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6205364|NCT02084134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6205365|NCT02084134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205366|NCT02084134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6205367|NCT02084134|Glucocorticoids|glucocorticoids|mesh-ancestor
6205368|NCT02084134|Hormones|hormones|mesh-ancestor
6205369|NCT02084134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6205370|NCT02084134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6205371|NCT02084134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6205372|NCT02084134|Protease Inhibitors|protease inhibitors|mesh-ancestor
6471419|NCT00500279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6471420|NCT00500279|Analgesics|analgesics|mesh-ancestor
6471421|NCT00500279|Sensory System Agents|sensory system agents|mesh-ancestor
6471422|NCT00500279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6471423|NCT00500279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471424|NCT00500279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6471425|NCT00500279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6471426|NCT00500279|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6471427|NCT00500279|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6471428|NCT00500279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6471429|NCT00500279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471430|NCT00500344|Ranibizumab|ranibizumab|mesh-list
6471431|NCT00500344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6471432|NCT00500344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6471433|NCT00500344|Growth Substances|growth substances|mesh-ancestor
6471434|NCT00500344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545084|NCT04139668|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5545085|NCT04139668|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5545086|NCT04139668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545087|NCT04139668|Sensory System Agents|sensory system agents|mesh-ancestor
5545088|NCT04139668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6205373|NCT02084134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6205374|NCT02084134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205375|NCT02084238|Interleukin-2|interleukin-2|mesh-list
6205376|NCT02084238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6471435|NCT00500344|Growth Inhibitors|growth inhibitors|mesh-ancestor
6471436|NCT00500344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6471437|NCT00500409|Vitamin D|vitamin d|mesh-list
6471438|NCT00500409|Vitamins|vitamins|mesh-ancestor
6471439|NCT00500409|Micronutrients|micronutrients|mesh-ancestor
6471440|NCT00500409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471441|NCT00500409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6471442|NCT00500422|Gemcitabine|gemcitabine|mesh-list
6471443|NCT00500422|Doxorubicin|doxorubicin|mesh-list
6471444|NCT00500422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5545089|NCT04139525|Heparin|heparin|mesh-list
5545090|NCT04139525|Calcium heparin|calcium heparin|mesh-list
5545091|NCT04139525|Citric Acid|citric acid|mesh-list
5545092|NCT04139525|Sodium Citrate|sodium citrate|mesh-list
5545093|NCT04139525|Anticoagulants|anticoagulants|mesh-ancestor
5545094|NCT04139525|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5545095|NCT04139525|Chelating Agents|chelating agents|mesh-ancestor
5545096|NCT04139525|Sequestering Agents|sequestering agents|mesh-ancestor
5545097|NCT04139525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545098|NCT04139525|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5545099|NCT04139525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5545100|NCT04139850|Antiviral Agents|antiviral agents|mesh-list
5545101|NCT04139850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6471445|NCT00500422|Bortezomib|bortezomib|mesh-list
6471446|NCT00500422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6471447|NCT00500422|Antimetabolites|antimetabolites|mesh-ancestor
6666749|NCT01524094|Micronutrients|micronutrients|mesh-ancestor
5545102|NCT04139772|Docetaxel|docetaxel|mesh-list
6471448|NCT00500422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140898|NCT01309997|Rituximab|rituximab|mesh-list
6140899|NCT01309997|Imatinib Mesylate|imatinib mesylate|mesh-list
6140900|NCT01309997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6140901|NCT01309997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6666750|NCT01524237|Ketamine|ketamine|mesh-list
6666751|NCT01524237|Analgesics|analgesics|mesh-ancestor
6666752|NCT01524237|Sensory System Agents|sensory system agents|mesh-ancestor
5545103|NCT04139772|Abiraterone Acetate|abiraterone acetate|mesh-list
5545104|NCT04139772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5545105|NCT04139772|Tubulin Modulators|tubulin modulators|mesh-ancestor
5545106|NCT04139772|Antimitotic Agents|antimitotic agents|mesh-ancestor
5545107|NCT04139772|Mitosis Modulators|mitosis modulators|mesh-ancestor
5545108|NCT04139772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545109|NCT04139772|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5545110|NCT04139772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5545111|NCT04139772|Hormone Antagonists|hormone antagonists|mesh-ancestor
5545112|NCT04139772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5545113|NCT04139772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545114|NCT04139772|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5545115|NCT04139395|Citric Acid|citric acid|mesh-list
5545116|NCT04139395|Sodium Citrate|sodium citrate|mesh-list
5545117|NCT04139395|Gallium citrate|gallium citrate|mesh-list
5545118|NCT04139395|Anticoagulants|anticoagulants|mesh-ancestor
5545119|NCT04139395|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5545120|NCT04139395|Chelating Agents|chelating agents|mesh-ancestor
5545121|NCT04139395|Sequestering Agents|sequestering agents|mesh-ancestor
5545122|NCT04139395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471449|NCT00500422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6471450|NCT00500422|Antiviral Agents|antiviral agents|mesh-ancestor
6471451|NCT00500422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6471452|NCT00500422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6471453|NCT00500422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6471454|NCT00500422|Immunologic Factors|immunologic factors|mesh-ancestor
6471455|NCT00500422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471456|NCT00500422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6471457|NCT00500422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5545123|NCT04139395|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5545124|NCT04139629|Antibodies|antibodies|mesh-list
5545125|NCT04139629|Immunologic Factors|immunologic factors|mesh-ancestor
5545126|NCT04139629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545127|NCT04139681|Menthol|menthol|mesh-list
5545128|NCT04139681|Antipruritics|antipruritics|mesh-ancestor
5545129|NCT04139681|Dermatologic Agents|dermatologic agents|mesh-ancestor
5545130|NCT04139213|Naltrexone|naltrexone|mesh-list
5545131|NCT04139213|Buprenorphine|buprenorphine|mesh-list
6471458|NCT00500422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6471459|NCT00500552|Perhexiline|perhexiline|mesh-list
5545132|NCT04139213|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6140902|NCT01309997|Immunologic Factors|immunologic factors|mesh-ancestor
6140903|NCT01309997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140904|NCT01309997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6140905|NCT01309997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6140906|NCT01309997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6140907|NCT01309997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140908|NCT01310036|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6140909|NCT01310036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6140910|NCT01310036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6140911|NCT01310036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6140912|NCT01310036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140913|NCT01310127|Nepafenac|nepafenac|mesh-list
6140914|NCT01310127|Bromfenac|bromfenac|mesh-list
6140915|NCT01310127|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6140916|NCT01310127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6140917|NCT01310127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6140918|NCT01310127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6140919|NCT01310127|Analgesics|analgesics|mesh-ancestor
6140920|NCT01310127|Sensory System Agents|sensory system agents|mesh-ancestor
6140921|NCT01310127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6140922|NCT01310127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140923|NCT01310127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6140924|NCT01310127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6140925|NCT01310179|Fludarabine|fludarabine|mesh-list
6140926|NCT01310179|Fludarabine phosphate|fludarabine phosphate|mesh-list
6471460|NCT00500552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6666753|NCT01524237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5545133|NCT04139213|Naloxone|naloxone|mesh-list
5545134|NCT04139213|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5545135|NCT04139213|Narcotics|narcotics|mesh-ancestor
5545136|NCT04139213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5545137|NCT04139213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545138|NCT04139213|Analgesics|analgesics|mesh-ancestor
5545139|NCT04139213|Sensory System Agents|sensory system agents|mesh-ancestor
5545140|NCT04139213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5545141|NCT04139213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6140927|NCT01310179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6140928|NCT01310179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6140929|NCT01310179|Antimetabolites|antimetabolites|mesh-ancestor
6140930|NCT01310179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140931|NCT01310179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6140932|NCT01310179|Immunologic Factors|immunologic factors|mesh-ancestor
6140933|NCT01310179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140934|NCT01310231|Metformin|metformin|mesh-list
6140935|NCT01310231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6140936|NCT01310231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140937|NCT01310582|Sevoflurane|sevoflurane|mesh-list
6140938|NCT01310582|Desflurane|desflurane|mesh-list
6140939|NCT01310582|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6140940|NCT01310582|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6471461|NCT00500552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6471462|NCT00500552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471463|NCT00500552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6471464|NCT00500552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471465|NCT00500552|Vasodilator Agents|vasodilator agents|mesh-ancestor
6471466|NCT00500565|Bupivacaine|bupivacaine|mesh-list
6471467|NCT00500565|Anesthetics, Local|anesthetics, local|mesh-ancestor
6471468|NCT00500565|Anesthetics|anesthetics|mesh-ancestor
6471469|NCT00500565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6471470|NCT00500565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471471|NCT00500565|Sensory System Agents|sensory system agents|mesh-ancestor
6471472|NCT00500565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6488600|NCT00585156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6488601|NCT00585156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6488602|NCT00585156|Analgesics|analgesics|mesh-ancestor
6488603|NCT00585156|Sensory System Agents|sensory system agents|mesh-ancestor
6488604|NCT00585156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5545142|NCT04139213|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5545143|NCT04138979|Cyclophosphamide|cyclophosphamide|mesh-list
5545144|NCT04138979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5545145|NCT04138979|Immunologic Factors|immunologic factors|mesh-ancestor
5545146|NCT04138979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545147|NCT04138979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5545148|NCT04138979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5545149|NCT04138979|Alkylating Agents|alkylating agents|mesh-ancestor
6488605|NCT00585156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488606|NCT00585156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6488607|NCT00585156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6488608|NCT00585156|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6488609|NCT00585156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6488610|NCT00585156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6488611|NCT00585156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488612|NCT00585260|Mannitol|mannitol|mesh-list
6488613|NCT00585260|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6488614|NCT00585260|Diuretics|diuretics|mesh-ancestor
6488615|NCT00585260|Natriuretic Agents|natriuretic agents|mesh-ancestor
6488616|NCT00585260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488617|NCT00585442|Vitamin D|vitamin d|mesh-list
6488618|NCT00585442|Calcitriol|calcitriol|mesh-list
6488619|NCT00585442|Vitamins|vitamins|mesh-ancestor
6488620|NCT00585442|Micronutrients|micronutrients|mesh-ancestor
6488621|NCT00585442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545150|NCT04138979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545151|NCT04138979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6140941|NCT01310582|Anesthetics, General|anesthetics, general|mesh-ancestor
6140942|NCT01310582|Anesthetics|anesthetics|mesh-ancestor
6140943|NCT01310582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6140944|NCT01310582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140945|NCT01310777|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6140946|NCT01310777|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6140947|NCT01310777|Brinzolamide|brinzolamide|mesh-list
6140948|NCT01310777|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6140949|NCT01310777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6140950|NCT01310777|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6140951|NCT01310777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6140952|NCT01310777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6140953|NCT01310777|Adrenergic Agents|adrenergic agents|mesh-ancestor
6140954|NCT01310777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6140955|NCT01310777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140956|NCT01310777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140957|NCT01310777|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6140958|NCT01310777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6140959|NCT01310855|Gefitinib|gefitinib|mesh-list
6140960|NCT01310855|Cediranib|cediranib|mesh-list
6140961|NCT01310855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6140962|NCT01310855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140963|NCT01310855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6140964|NCT01310855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6140965|NCT01310868|Carmustine|carmustine|mesh-list
6140966|NCT01310868|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6140967|NCT01310868|Levulinic acid|levulinic acid|mesh-list
6140968|NCT01310868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6140969|NCT01310868|Alkylating Agents|alkylating agents|mesh-ancestor
6140970|NCT01310868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140971|NCT01310868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6140972|NCT01310868|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6140973|NCT01310868|Dermatologic Agents|dermatologic agents|mesh-ancestor
6140974|NCT01310868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6140975|NCT01311024|Vaccines|vaccines|mesh-list
6140976|NCT01311024|Immunologic Factors|immunologic factors|mesh-ancestor
6140977|NCT01311024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140978|NCT01311102|Lidocaine|lidocaine|mesh-list
6140979|NCT01311102|Anesthetics, Local|anesthetics, local|mesh-ancestor
6666754|NCT01524237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666755|NCT01524237|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5545152|NCT04138979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5545153|NCT04138992|Bevacizumab|bevacizumab|mesh-list
5545154|NCT04138992|Cisplatin|cisplatin|mesh-list
5545155|NCT04138992|Docetaxel|docetaxel|mesh-list
5545156|NCT04138992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5545157|NCT04138992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6666756|NCT01524237|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6666757|NCT01524237|Anesthetics, General|anesthetics, general|mesh-ancestor
6666758|NCT01524237|Anesthetics|anesthetics|mesh-ancestor
6666759|NCT01524237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6666760|NCT01524237|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6471473|NCT00500604|Valsartan|valsartan|mesh-list
6471474|NCT00500604|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6471475|NCT00500604|Irbesartan|irbesartan|mesh-list
6471476|NCT00500604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6471477|NCT00500604|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6471478|NCT00500604|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6471479|NCT00500604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471480|NCT00500604|Diuretics|diuretics|mesh-ancestor
6471481|NCT00500604|Natriuretic Agents|natriuretic agents|mesh-ancestor
6471482|NCT00500604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471483|NCT00500604|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6471484|NCT00500604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6471485|NCT00500669|Povidone-Iodine|povidone-iodine|mesh-list
6471486|NCT00500669|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6471487|NCT00500669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6471488|NCT00500721|Desipramine|desipramine|mesh-list
6471489|NCT00500721|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5545158|NCT04138992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5545159|NCT04138992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5545160|NCT04138992|Growth Substances|growth substances|mesh-ancestor
5545161|NCT04138992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545162|NCT04138992|Growth Inhibitors|growth inhibitors|mesh-ancestor
5545163|NCT04138992|Tubulin Modulators|tubulin modulators|mesh-ancestor
5545164|NCT04138992|Antimitotic Agents|antimitotic agents|mesh-ancestor
5545165|NCT04138992|Mitosis Modulators|mitosis modulators|mesh-ancestor
5545166|NCT04138992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545167|NCT04139070|Bleomycin|bleomycin|mesh-list
6471490|NCT00500721|Antidepressive Agents|antidepressive agents|mesh-ancestor
6471491|NCT00500721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6471492|NCT00500721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5545168|NCT04139070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5545169|NCT04139070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5545170|NCT04138901|Ropivacaine|ropivacaine|mesh-list
5545171|NCT04138901|Anesthetics, Local|anesthetics, local|mesh-ancestor
5545172|NCT04138901|Anesthetics|anesthetics|mesh-ancestor
5545173|NCT04138901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5545174|NCT04138901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545175|NCT04138901|Sensory System Agents|sensory system agents|mesh-ancestor
5545176|NCT04138901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5545177|NCT04138628|Atezolizumab|atezolizumab|mesh-list
5545178|NCT04138628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5545179|NCT04138420|Bevacizumab|bevacizumab|mesh-list
5545180|NCT04138420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5545181|NCT04138420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5545182|NCT04138420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5545183|NCT04138420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5545184|NCT04138420|Growth Substances|growth substances|mesh-ancestor
5545185|NCT04138420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545186|NCT04138420|Growth Inhibitors|growth inhibitors|mesh-ancestor
5545187|NCT04138381|Imatinib Mesylate|imatinib mesylate|mesh-list
5545188|NCT04138381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5545189|NCT04138381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5545190|NCT04138381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5545191|NCT04138381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545192|NCT04138888|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5545193|NCT04138888|Olmesartan|olmesartan|mesh-list
6471493|NCT00500721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471494|NCT00500721|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6471495|NCT00500721|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6471496|NCT00500721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6471497|NCT00500721|Adrenergic Agents|adrenergic agents|mesh-ancestor
6471498|NCT00500721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6471499|NCT00500721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471500|NCT00500864|Magnesium Sulfate|magnesium sulfate|mesh-list
6471501|NCT00500864|Analgesics|analgesics|mesh-ancestor
6471502|NCT00500864|Sensory System Agents|sensory system agents|mesh-ancestor
6471503|NCT00500864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6471504|NCT00500864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471505|NCT00500864|Anesthetics|anesthetics|mesh-ancestor
6471506|NCT00500864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5545194|NCT04138888|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
5545195|NCT04138888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5545196|NCT04138888|Diuretics|diuretics|mesh-ancestor
5545197|NCT04138888|Natriuretic Agents|natriuretic agents|mesh-ancestor
5545198|NCT04138888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545199|NCT04138888|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5545200|NCT04138888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5545201|NCT04138888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545202|NCT04138888|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5545203|NCT04138888|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5545204|NCT04138836|Itraconazole|itraconazole|mesh-list
5545205|NCT04138836|Midazolam|midazolam|mesh-list
5545206|NCT04138836|Esomeprazole|esomeprazole|mesh-list
5545207|NCT04138836|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5545208|NCT04138836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5545209|NCT04138836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5545210|NCT04138836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545211|NCT04138836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5545212|NCT04138836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5545213|NCT04138836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5545214|NCT04138836|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5545215|NCT04138836|Anesthetics, General|anesthetics, general|mesh-ancestor
5545216|NCT04138836|Anesthetics|anesthetics|mesh-ancestor
5545217|NCT04138836|GABA Modulators|gaba modulators|mesh-ancestor
5545218|NCT04138836|GABA Agents|gaba agents|mesh-ancestor
5545219|NCT04138836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6471507|NCT00500864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6471508|NCT00500864|Anticonvulsants|anticonvulsants|mesh-ancestor
6471509|NCT00500864|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6471510|NCT00500864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6471511|NCT00500864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471512|NCT00500864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6471513|NCT00500864|Tocolytic Agents|tocolytic agents|mesh-ancestor
6471514|NCT00500864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6471515|NCT00500955|Rosiglitazone|rosiglitazone|mesh-list
6471516|NCT00500955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6471517|NCT00500955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471518|NCT00501020|Rosiglitazone|rosiglitazone|mesh-list
6471519|NCT00501020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6471520|NCT00501020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471521|NCT00501098|Caspofungin|caspofungin|mesh-list
6471522|NCT00501098|Antifungal Agents|antifungal agents|mesh-ancestor
6471523|NCT00501098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6471524|NCT00501098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6140980|NCT01311102|Anesthetics|anesthetics|mesh-ancestor
6140981|NCT01311102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5545220|NCT04138836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545221|NCT04138836|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5545222|NCT04138836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5545223|NCT04138836|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5545224|NCT04138836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5545225|NCT04138836|Antifungal Agents|antifungal agents|mesh-ancestor
5545226|NCT04138836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5545227|NCT04138836|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5545228|NCT04138836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5545229|NCT04138836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5545230|NCT04138836|Hormone Antagonists|hormone antagonists|mesh-ancestor
5545231|NCT04138836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5545232|NCT04138836|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5545233|NCT04138719|Paclitaxel|paclitaxel|mesh-list
6140982|NCT01311102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6140983|NCT01311102|Sensory System Agents|sensory system agents|mesh-ancestor
6140984|NCT01311102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6140985|NCT01311102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6140986|NCT01311102|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6140987|NCT01311102|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6140988|NCT01311102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6140989|NCT01311102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6140990|NCT01311505|Rifampin|rifampin|mesh-list
6140991|NCT01311505|Isoniazid|isoniazid|mesh-list
6140992|NCT01311505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6140993|NCT01311505|Antitubercular Agents|antitubercular agents|mesh-ancestor
6140994|NCT01311505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6140995|NCT01311505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6140996|NCT01311505|Leprostatic Agents|leprostatic agents|mesh-ancestor
6140997|NCT01311505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5545234|NCT04138719|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5545235|NCT04138719|Carboplatin|carboplatin|mesh-list
5545236|NCT04138719|Epirubicin|epirubicin|mesh-list
5545237|NCT04138719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5545238|NCT04138719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5545239|NCT04138719|Tubulin Modulators|tubulin modulators|mesh-ancestor
5545240|NCT04138719|Antimitotic Agents|antimitotic agents|mesh-ancestor
5545241|NCT04138719|Mitosis Modulators|mitosis modulators|mesh-ancestor
5545242|NCT04138719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545243|NCT04138719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5545244|NCT04138719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5545245|NCT04138719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5545246|NCT04138719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5545247|NCT04138368|Psychotropic Drugs|psychotropic drugs|mesh-list
5545248|NCT04138277|Miglustat|miglustat|mesh-list
5545249|NCT04138277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5545250|NCT04138277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545251|NCT04138277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5545252|NCT04138277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5545253|NCT04138277|Antiviral Agents|antiviral agents|mesh-ancestor
5545254|NCT04138277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5545255|NCT04138277|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
5545256|NCT04138277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5545257|NCT04138277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545258|NCT04138290|Antidepressive Agents|antidepressive agents|mesh-list
5545259|NCT04138290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5545260|NCT04138472|Lidocaine|lidocaine|mesh-list
5545261|NCT04138472|Fentanyl|fentanyl|mesh-list
5545262|NCT04138472|Dexmedetomidine|dexmedetomidine|mesh-list
5545263|NCT04138472|Anesthetics, Local|anesthetics, local|mesh-ancestor
5545264|NCT04138472|Anesthetics|anesthetics|mesh-ancestor
5545265|NCT04138472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6140998|NCT01311505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6140999|NCT01311505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141000|NCT01311505|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6141001|NCT01311505|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6141002|NCT01311505|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6141003|NCT01311505|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6141004|NCT01311505|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6141005|NCT01311505|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6666761|NCT01524237|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6666762|NCT01524237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6141006|NCT01311505|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6141007|NCT01311505|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6141008|NCT01311505|Antimetabolites|antimetabolites|mesh-ancestor
6141009|NCT01311505|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5545266|NCT04138472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545267|NCT04138472|Sensory System Agents|sensory system agents|mesh-ancestor
5545268|NCT04138472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5545269|NCT04138472|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5545270|NCT04138472|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5545271|NCT04138472|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5545272|NCT04138472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5545273|NCT04138472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545274|NCT04138472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5545275|NCT04138472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5545276|NCT04138472|Analgesics|analgesics|mesh-ancestor
5545277|NCT04138472|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6141010|NCT01311648|Factor VIII|factor viii|mesh-list
6141011|NCT01311648|Coagulants|coagulants|mesh-ancestor
6141012|NCT01311661|Olodaterol|olodaterol|mesh-list
6141013|NCT01311661|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6141014|NCT01311661|Autonomic Agents|autonomic agents|mesh-ancestor
6141015|NCT01311661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6141016|NCT01311661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141017|NCT01311661|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6141018|NCT01311661|Respiratory System Agents|respiratory system agents|mesh-ancestor
6141019|NCT01311674|Vaccines|vaccines|mesh-list
6141020|NCT01311674|Immunologic Factors|immunologic factors|mesh-ancestor
6141021|NCT01311674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141022|NCT01311687|Dexamethasone|dexamethasone|mesh-list
6141023|NCT01311687|Pomalidomide|pomalidomide|mesh-list
6141024|NCT01311687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6141025|NCT01311687|Antiemetics|antiemetics|mesh-ancestor
6141026|NCT01311687|Autonomic Agents|autonomic agents|mesh-ancestor
6141027|NCT01311687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6141028|NCT01311687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141029|NCT01311687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6141030|NCT01311687|Glucocorticoids|glucocorticoids|mesh-ancestor
6141031|NCT01311687|Hormones|hormones|mesh-ancestor
6141032|NCT01311687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6141033|NCT01311687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6141034|NCT01311687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6141035|NCT01311687|Immunologic Factors|immunologic factors|mesh-ancestor
6141036|NCT01311687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6141037|NCT01311687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6141038|NCT01311687|Growth Substances|growth substances|mesh-ancestor
6141039|NCT01311687|Growth Inhibitors|growth inhibitors|mesh-ancestor
6141040|NCT01311895|Hydromorphone|hydromorphone|mesh-list
6141041|NCT01311895|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6141042|NCT01311895|Narcotics|narcotics|mesh-ancestor
5545278|NCT04138472|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5545279|NCT04138472|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5545280|NCT04138472|Adrenergic Agents|adrenergic agents|mesh-ancestor
5545281|NCT04138472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5545282|NCT04138472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6141043|NCT01311895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6141044|NCT01311895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141045|NCT01311895|Analgesics|analgesics|mesh-ancestor
6141046|NCT01311895|Sensory System Agents|sensory system agents|mesh-ancestor
6141047|NCT01311895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6141048|NCT01312038|Simethicone|simethicone|mesh-list
6141049|NCT01312038|Antifoaming Agents|antifoaming agents|mesh-ancestor
6141050|NCT01312038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141051|NCT01312038|Emollients|emollients|mesh-ancestor
6141052|NCT01312038|Dermatologic Agents|dermatologic agents|mesh-ancestor
6141053|NCT01312129|Sulfasalazine|sulfasalazine|mesh-list
5545283|NCT04138472|Narcotics|narcotics|mesh-ancestor
5545284|NCT04138472|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5545285|NCT04138472|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6141054|NCT01312129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6141055|NCT01312129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6141056|NCT01312129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6141057|NCT01312129|Analgesics|analgesics|mesh-ancestor
6141058|NCT01312129|Sensory System Agents|sensory system agents|mesh-ancestor
6141059|NCT01312129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6141060|NCT01312129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141061|NCT01312129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6141062|NCT01312129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6141063|NCT01312129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6141064|NCT01312272|Oxytocin|oxytocin|mesh-list
6141065|NCT01312272|Oxytocics|oxytocics|mesh-ancestor
6141066|NCT01312272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6141067|NCT01312272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141068|NCT01312389|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
6141069|NCT01312389|Antiviral Agents|antiviral agents|mesh-ancestor
6141070|NCT01312389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6141071|NCT01312467|Metformin|metformin|mesh-list
6141072|NCT01312467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6141073|NCT01312467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141074|NCT01312766|Menotropins|menotropins|mesh-list
6141075|NCT01312766|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6141076|NCT01312766|Fertility Agents|fertility agents|mesh-ancestor
6141077|NCT01312766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6141078|NCT01312766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141079|NCT01312818|Dexamethasone|dexamethasone|mesh-list
6141080|NCT01312818|Methotrexate|methotrexate|mesh-list
6141081|NCT01312818|Bortezomib|bortezomib|mesh-list
6141082|NCT01312818|Imatinib Mesylate|imatinib mesylate|mesh-list
6141083|NCT01312818|Vorinostat|vorinostat|mesh-list
6141084|NCT01312818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6141085|NCT01312818|Antiemetics|antiemetics|mesh-ancestor
5545286|NCT04138472|Anesthetics, General|anesthetics, general|mesh-ancestor
5545287|NCT04138264|Analgesics, Opioid|analgesics, opioid|mesh-list
5545288|NCT04138264|Narcotics|narcotics|mesh-ancestor
5545289|NCT04138264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5545290|NCT04138264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545291|NCT04138264|Analgesics|analgesics|mesh-ancestor
5545292|NCT04138264|Sensory System Agents|sensory system agents|mesh-ancestor
5545293|NCT04138264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5545294|NCT04138485|Immunoglobulins|immunoglobulins|mesh-list
5545295|NCT04138485|Immunologic Factors|immunologic factors|mesh-ancestor
5545296|NCT04138485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545297|NCT04138251|Empagliflozin|empagliflozin|mesh-list
5545298|NCT04138251|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5545299|NCT04138251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141086|NCT01312818|Autonomic Agents|autonomic agents|mesh-ancestor
6141087|NCT01312818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6141088|NCT01312818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141089|NCT01312818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6141090|NCT01312818|Glucocorticoids|glucocorticoids|mesh-ancestor
6141091|NCT01312818|Hormones|hormones|mesh-ancestor
6141092|NCT01312818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6141093|NCT01312818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6471525|NCT00501098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471526|NCT00501111|Donepezil|donepezil|mesh-list
6471527|NCT00501111|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6471528|NCT00501111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6471529|NCT00501111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471530|NCT00501111|Cholinergic Agents|cholinergic agents|mesh-ancestor
6471531|NCT00501111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6471532|NCT00501111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471533|NCT00501111|Nootropic Agents|nootropic agents|mesh-ancestor
6471534|NCT00501124|Clevudine|clevudine|mesh-list
6471535|NCT00501124|Antiviral Agents|antiviral agents|mesh-ancestor
6141094|NCT01312818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6141095|NCT01312818|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6141096|NCT01312818|Abortifacient Agents|abortifacient agents|mesh-ancestor
6141097|NCT01312818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5545300|NCT04138251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6141098|NCT01312818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6141099|NCT01312818|Antimetabolites|antimetabolites|mesh-ancestor
6141100|NCT01312818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141101|NCT01312818|Dermatologic Agents|dermatologic agents|mesh-ancestor
6141102|NCT01312818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5545301|NCT04138251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545302|NCT04137978|Potassium Citrate|potassium citrate|mesh-list
5545303|NCT04137978|Diuretics|diuretics|mesh-ancestor
5545304|NCT04137978|Natriuretic Agents|natriuretic agents|mesh-ancestor
5545305|NCT04137978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545306|NCT04137978|Expectorants|expectorants|mesh-ancestor
5545307|NCT04137978|Respiratory System Agents|respiratory system agents|mesh-ancestor
5602520|NCT04397354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5602521|NCT04397354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5602522|NCT04397354|Protease Inhibitors|protease inhibitors|mesh-ancestor
5602523|NCT04397354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5602524|NCT04397354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602525|NCT04394481|Dexamethasone|dexamethasone|mesh-list
5602526|NCT04394481|Dexmedetomidine|dexmedetomidine|mesh-list
5602527|NCT04394481|Ropivacaine|ropivacaine|mesh-list
5602528|NCT04394481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5602529|NCT04394481|Antiemetics|antiemetics|mesh-ancestor
5602530|NCT04394481|Autonomic Agents|autonomic agents|mesh-ancestor
5602531|NCT04394481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5602532|NCT04394481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602533|NCT04394481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5602534|NCT04394481|Glucocorticoids|glucocorticoids|mesh-ancestor
5602535|NCT04394481|Hormones|hormones|mesh-ancestor
5602536|NCT04394481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5602537|NCT04394481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5602538|NCT04394481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6141103|NCT01312818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6471536|NCT00501124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6471537|NCT00501137|Vaccines|vaccines|mesh-list
6471538|NCT00501137|Immunologic Factors|immunologic factors|mesh-ancestor
6471539|NCT00501137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471540|NCT00501150|Linezolid|linezolid|mesh-list
6471541|NCT00501150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6471542|NCT00501150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6471543|NCT00501150|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6141104|NCT01312818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6141105|NCT01312818|Immunologic Factors|immunologic factors|mesh-ancestor
6141106|NCT01312818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6141107|NCT01312818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6141108|NCT01312818|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6141109|NCT01312818|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6141110|NCT01312844|Scopolamine|scopolamine|mesh-list
6141111|NCT01312844|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
6141112|NCT01312844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6141113|NCT01312844|Antiemetics|antiemetics|mesh-ancestor
6141114|NCT01312844|Autonomic Agents|autonomic agents|mesh-ancestor
5602539|NCT04394481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5602540|NCT04394481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5602541|NCT04394481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5602542|NCT04394481|Analgesics|analgesics|mesh-ancestor
5602543|NCT04394481|Sensory System Agents|sensory system agents|mesh-ancestor
5602544|NCT04394481|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5602545|NCT04394481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5602546|NCT04394481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5602547|NCT04394481|Adrenergic Agents|adrenergic agents|mesh-ancestor
5602548|NCT04394481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5602549|NCT04394481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602550|NCT04394481|Anesthetics, Local|anesthetics, local|mesh-ancestor
5602551|NCT04394481|Anesthetics|anesthetics|mesh-ancestor
6141115|NCT01312844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6471544|NCT00501150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5602552|NCT04370847|Ephedrine|ephedrine|mesh-list
5602553|NCT04370847|Fentanyl|fentanyl|mesh-list
5602554|NCT04370847|Bupivacaine|bupivacaine|mesh-list
5602555|NCT04370847|Oxytocin|oxytocin|mesh-list
5602556|NCT04370847|Anesthetics, Local|anesthetics, local|mesh-ancestor
5602557|NCT04370847|Anesthetics|anesthetics|mesh-ancestor
5602558|NCT04370847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5602559|NCT04370847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602560|NCT04370847|Sensory System Agents|sensory system agents|mesh-ancestor
5602561|NCT04370847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5602562|NCT04370847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5602563|NCT04370847|Narcotics|narcotics|mesh-ancestor
5602564|NCT04370847|Analgesics|analgesics|mesh-ancestor
5602565|NCT04370847|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6141116|NCT01312844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141117|NCT01312844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6141118|NCT01312844|Mydriatics|mydriatics|mesh-ancestor
6141119|NCT01312844|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6141120|NCT01312844|Cholinergic Agents|cholinergic agents|mesh-ancestor
6141121|NCT01312844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6141122|NCT01312844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141123|NCT01312844|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6141124|NCT01312844|Parasympatholytics|parasympatholytics|mesh-ancestor
6471545|NCT00501150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471546|NCT00501215|Parathyroid Hormone|parathyroid hormone|mesh-list
6471547|NCT00501215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6471548|NCT00501215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471549|NCT00501241|ATI 7505|ati 7505|mesh-list
6471550|NCT00501241|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
6471551|NCT00501241|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6471552|NCT00501241|Serotonin Agents|serotonin agents|mesh-ancestor
6471553|NCT00501241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6471554|NCT00501241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471555|NCT00501241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545308|NCT04138004|Lubiprostone|lubiprostone|mesh-list
5545309|NCT04138004|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
5545310|NCT04138004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5545311|NCT04138004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545312|NCT04137887|Vaccines|vaccines|mesh-list
5545313|NCT04137887|Immunologic Factors|immunologic factors|mesh-ancestor
5545314|NCT04137887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545315|NCT04138238|Sirolimus|sirolimus|mesh-list
5545316|NCT04138238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5545317|NCT04138238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5545318|NCT04138238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5545319|NCT04138238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5545320|NCT04138238|Antifungal Agents|antifungal agents|mesh-ancestor
5545321|NCT04138238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5545322|NCT04138238|Immunologic Factors|immunologic factors|mesh-ancestor
6471556|NCT00501254|Aspirin|aspirin|mesh-list
6471557|NCT00501254|Salicylic Acid|salicylic acid|mesh-list
6471558|NCT00501254|Salicylates|salicylates|mesh-list
6471559|NCT00501254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6471560|NCT00501254|Antifungal Agents|antifungal agents|mesh-ancestor
6471561|NCT00501254|Keratolytic Agents|keratolytic agents|mesh-ancestor
6471562|NCT00501254|Dermatologic Agents|dermatologic agents|mesh-ancestor
6471563|NCT00501254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6471564|NCT00501254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6471565|NCT00501254|Analgesics|analgesics|mesh-ancestor
6141125|NCT01312909|Varenicline|varenicline|mesh-list
6141126|NCT01312909|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6141127|NCT01312909|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6666763|NCT01524237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666764|NCT01524315|Vitamins|vitamins|mesh-list
5545323|NCT04138238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545324|NCT04138212|Paclitaxel|paclitaxel|mesh-list
5545325|NCT04138212|Cisplatin|cisplatin|mesh-list
5545326|NCT04138212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6666765|NCT01524315|Thiamine|thiamine|mesh-list
6666766|NCT01524315|Vitamin B Complex|vitamin b complex|mesh-list
6666767|NCT01524315|Micronutrients|micronutrients|mesh-ancestor
6666768|NCT01524315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666769|NCT01524354|Anesthetics|anesthetics|mesh-list
6666770|NCT01524354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6666771|NCT01524354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666772|NCT01524367|Dexmedetomidine|dexmedetomidine|mesh-list
6666773|NCT01524367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6471566|NCT00501254|Sensory System Agents|sensory system agents|mesh-ancestor
6471567|NCT00501254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6471568|NCT00501254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471569|NCT00501254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6471570|NCT00501254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6471571|NCT00501254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6471572|NCT00501254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6471573|NCT00501254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471574|NCT00501254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5545327|NCT04138212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5545328|NCT04138212|Tubulin Modulators|tubulin modulators|mesh-ancestor
6141128|NCT01312909|Cholinergic Agents|cholinergic agents|mesh-ancestor
6471575|NCT00501254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6471576|NCT00501254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6471577|NCT00501254|Antipyretics|antipyretics|mesh-ancestor
6471578|NCT00501267|Oxybutynin|oxybutynin|mesh-list
6471579|NCT00501267|Solabegron|solabegron|mesh-list
6471580|NCT00501267|Parasympatholytics|parasympatholytics|mesh-ancestor
6141129|NCT01312909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5545329|NCT04138212|Antimitotic Agents|antimitotic agents|mesh-ancestor
5545330|NCT04138212|Mitosis Modulators|mitosis modulators|mesh-ancestor
5545331|NCT04138212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545332|NCT04137640|Cyclophosphamide|cyclophosphamide|mesh-list
5545333|NCT04137640|Docetaxel|docetaxel|mesh-list
5545334|NCT04137640|Letrozole|letrozole|mesh-list
5545335|NCT04137640|Epirubicin|epirubicin|mesh-list
5545336|NCT04137640|Palbociclib|palbociclib|mesh-list
6141130|NCT01312909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471581|NCT00501267|Autonomic Agents|autonomic agents|mesh-ancestor
6471582|NCT00501267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6471583|NCT00501267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471584|NCT00501267|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6141131|NCT01312909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141132|NCT01312961|Fluticasone|fluticasone|mesh-list
6141133|NCT01312961|Xhance|xhance|mesh-list
6141134|NCT01312961|Albuterol|albuterol|mesh-list
6141135|NCT01312961|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6141136|NCT01312961|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6141137|NCT01312961|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6141138|NCT01312961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6141139|NCT01312961|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6141140|NCT01312961|Autonomic Agents|autonomic agents|mesh-ancestor
6141141|NCT01312961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6141142|NCT01312961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141143|NCT01312961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6141144|NCT01312961|Respiratory System Agents|respiratory system agents|mesh-ancestor
6141145|NCT01312961|Dermatologic Agents|dermatologic agents|mesh-ancestor
6141146|NCT01312961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6141147|NCT01312961|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6141148|NCT01312961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6141149|NCT01312961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6141150|NCT01312961|Adrenergic Agents|adrenergic agents|mesh-ancestor
6141151|NCT01312961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6141152|NCT01312961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141153|NCT01312961|Tocolytic Agents|tocolytic agents|mesh-ancestor
6141154|NCT01312961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6141155|NCT01312961|Immunologic Factors|immunologic factors|mesh-ancestor
6141156|NCT01312961|Glucocorticoids|glucocorticoids|mesh-ancestor
6141157|NCT01312961|Hormones|hormones|mesh-ancestor
6141158|NCT01312961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6141159|NCT01312961|Sympathomimetics|sympathomimetics|mesh-ancestor
6141160|NCT01313078|Asparaginase|asparaginase|mesh-list
6141161|NCT01313078|Pegaspargase|pegaspargase|mesh-list
6141162|NCT01313078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6141163|NCT01313117|Thioctic Acid|thioctic acid|mesh-list
6141164|NCT01313117|Antioxidants|antioxidants|mesh-ancestor
6141165|NCT01313117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471585|NCT00501267|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6471586|NCT00501267|Cholinergic Agents|cholinergic agents|mesh-ancestor
6471587|NCT00501267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6471588|NCT00501267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471589|NCT00501267|Urological Agents|urological agents|mesh-ancestor
6471590|NCT00501267|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6471591|NCT00501267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6471592|NCT00501267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6471593|NCT00501267|Adrenergic Agents|adrenergic agents|mesh-ancestor
6471594|NCT00501384|Satavaptan|satavaptan|mesh-list
6471595|NCT00501384|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6471596|NCT00501384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471597|NCT00501384|Natriuretic Agents|natriuretic agents|mesh-ancestor
6471598|NCT00501384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471599|NCT00501397|Ketoconazole|ketoconazole|mesh-list
6471600|NCT00501397|Antifungal Agents|antifungal agents|mesh-ancestor
6471601|NCT00501397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6471602|NCT00501397|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5545337|NCT04137640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5545338|NCT04137640|Immunologic Factors|immunologic factors|mesh-ancestor
6141166|NCT01313117|Protective Agents|protective agents|mesh-ancestor
6141167|NCT01313117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545339|NCT04137640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545340|NCT04137640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5545341|NCT04137640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5545342|NCT04137640|Alkylating Agents|alkylating agents|mesh-ancestor
5545343|NCT04137640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545344|NCT04137640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5545345|NCT04137640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5545346|NCT04137640|Tubulin Modulators|tubulin modulators|mesh-ancestor
5545347|NCT04137640|Antimitotic Agents|antimitotic agents|mesh-ancestor
5545348|NCT04137640|Mitosis Modulators|mitosis modulators|mesh-ancestor
5545349|NCT04137640|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6141168|NCT01313117|Vitamin B Complex|vitamin b complex|mesh-ancestor
6141169|NCT01313117|Vitamins|vitamins|mesh-ancestor
6141170|NCT01313117|Micronutrients|micronutrients|mesh-ancestor
6141171|NCT01313182|Povidone-Iodine|povidone-iodine|mesh-list
6141172|NCT01313182|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
6141173|NCT01313182|Mupirocin|mupirocin|mesh-list
6141174|NCT01313182|Povidone|povidone|mesh-list
6141175|NCT01313182|Calcium|calcium|mesh-list
6141176|NCT01313182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6141177|NCT01313182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141178|NCT01313182|Plasma Substitutes|plasma substitutes|mesh-ancestor
6141179|NCT01313182|Blood Substitutes|blood substitutes|mesh-ancestor
6141180|NCT01313182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6141181|NCT01313182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6141182|NCT01313182|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6141183|NCT01313182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6141184|NCT01313182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141185|NCT01313208|Etanercept|etanercept|mesh-list
6141186|NCT01313208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6141187|NCT01313208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6141188|NCT01313208|Analgesics|analgesics|mesh-ancestor
6141189|NCT01313208|Sensory System Agents|sensory system agents|mesh-ancestor
6141190|NCT01313208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6141191|NCT01313208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141192|NCT01313208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6141193|NCT01313208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5545350|NCT04137640|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5545351|NCT04137640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5545352|NCT04137640|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5545353|NCT04137640|Hormone Antagonists|hormone antagonists|mesh-ancestor
5545354|NCT04137640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5545355|NCT04137640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5545356|NCT04137640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6141194|NCT01313208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6141195|NCT01313208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6141196|NCT01313208|Immunologic Factors|immunologic factors|mesh-ancestor
6141197|NCT01313221|Etanercept|etanercept|mesh-list
6141198|NCT01313221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6141199|NCT01313221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6141200|NCT01313221|Analgesics|analgesics|mesh-ancestor
6141201|NCT01313221|Sensory System Agents|sensory system agents|mesh-ancestor
6141202|NCT01313221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6141203|NCT01313221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141204|NCT01313221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6141205|NCT01313221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6141206|NCT01313221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6141207|NCT01313221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6141208|NCT01313221|Immunologic Factors|immunologic factors|mesh-ancestor
6471603|NCT00501397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6471604|NCT00501397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6471605|NCT00501397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141209|NCT01313286|Globalagliatin|globalagliatin|mesh-list
6141210|NCT01313286|Enzyme Activators|enzyme activators|mesh-ancestor
6141211|NCT01313286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141212|NCT01313299|Botulinum Toxins|botulinum toxins|mesh-list
6141213|NCT01313299|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6141214|NCT01313299|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5545357|NCT04137640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6141215|NCT01313299|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6141216|NCT01313299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6141217|NCT01313299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141218|NCT01313299|Cholinergic Agents|cholinergic agents|mesh-ancestor
6141219|NCT01313299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6141220|NCT01313299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141221|NCT01313299|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6141222|NCT01313299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6141223|NCT01313312|Botulinum Toxins|botulinum toxins|mesh-list
6141224|NCT01313312|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6141225|NCT01313312|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6141226|NCT01313312|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6141227|NCT01313312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6141228|NCT01313312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141229|NCT01313312|Cholinergic Agents|cholinergic agents|mesh-ancestor
6141230|NCT01313312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6141231|NCT01313312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141232|NCT01313312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6141233|NCT01313312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6141234|NCT01313494|Albuterol|albuterol|mesh-list
6141235|NCT01313494|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6141236|NCT01313494|Autonomic Agents|autonomic agents|mesh-ancestor
6141237|NCT01313494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6141238|NCT01313494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141239|NCT01313494|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5545358|NCT04137640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5545359|NCT04137536|Antibodies|antibodies|mesh-list
5545360|NCT04137536|Antibodies, Bispecific|antibodies, bispecific|mesh-list
5545361|NCT04137536|Immunologic Factors|immunologic factors|mesh-ancestor
5545362|NCT04137536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545363|NCT04137770|Ketorolac|ketorolac|mesh-list
5545364|NCT04137770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5545365|NCT04137770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5545366|NCT04137770|Analgesics|analgesics|mesh-ancestor
5545367|NCT04137770|Sensory System Agents|sensory system agents|mesh-ancestor
5545368|NCT04137770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5545369|NCT04137770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545370|NCT04137770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6141240|NCT01313494|Respiratory System Agents|respiratory system agents|mesh-ancestor
6141241|NCT01313494|Tocolytic Agents|tocolytic agents|mesh-ancestor
6141242|NCT01313494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6141243|NCT01313494|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6141244|NCT01313494|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6141245|NCT01313494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6141246|NCT01313494|Adrenergic Agents|adrenergic agents|mesh-ancestor
6141247|NCT01313494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6141248|NCT01313494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141249|NCT01313520|Infliximab|infliximab|mesh-list
6141250|NCT01313520|Dermatologic Agents|dermatologic agents|mesh-ancestor
6141251|NCT01313520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5545371|NCT04137770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5545372|NCT04137770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5545373|NCT04137770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5545374|NCT04137770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545375|NCT04137588|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5545376|NCT04137588|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
5545377|NCT04137588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545378|NCT04137588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5545379|NCT04137588|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5545380|NCT04137588|Growth Substances|growth substances|mesh-ancestor
6141252|NCT01313520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6141253|NCT01313559|Everolimus|everolimus|mesh-list
6141254|NCT01313559|Pasireotide|pasireotide|mesh-list
6141255|NCT01313559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6141256|NCT01313559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6141257|NCT01313559|Immunologic Factors|immunologic factors|mesh-ancestor
6141258|NCT01313559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141259|NCT01313559|Hormones|hormones|mesh-ancestor
6141260|NCT01313559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6141261|NCT01313637|Bromides|bromides|mesh-list
6141262|NCT01313637|Anticonvulsants|anticonvulsants|mesh-ancestor
6141263|NCT01313663|Pemetrexed|pemetrexed|mesh-list
6141264|NCT01313663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6141265|NCT01313663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6141266|NCT01313663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141267|NCT01313663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5545381|NCT04137588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141268|NCT01313663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6141269|NCT01313676|Fluticasone|fluticasone|mesh-list
6141270|NCT01313676|Xhance|xhance|mesh-list
6141271|NCT01313676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6141272|NCT01313676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6141273|NCT01313676|Autonomic Agents|autonomic agents|mesh-ancestor
6141274|NCT01313676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6141275|NCT01313676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141276|NCT01313676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6141277|NCT01313676|Respiratory System Agents|respiratory system agents|mesh-ancestor
6141278|NCT01313676|Dermatologic Agents|dermatologic agents|mesh-ancestor
6141279|NCT01313676|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6141280|NCT01313728|Dapsone|dapsone|mesh-list
6141281|NCT01313728|Tretinoin|tretinoin|mesh-list
5545382|NCT04137588|Growth Inhibitors|growth inhibitors|mesh-ancestor
5545383|NCT04137653|Paclitaxel|paclitaxel|mesh-list
5545384|NCT04137653|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5545385|NCT04137653|Carboplatin|carboplatin|mesh-list
5545386|NCT04137653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5545387|NCT04137653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5545388|NCT04137653|Tubulin Modulators|tubulin modulators|mesh-ancestor
5545389|NCT04137653|Antimitotic Agents|antimitotic agents|mesh-ancestor
6141282|NCT01313728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6141283|NCT01313728|Keratolytic Agents|keratolytic agents|mesh-ancestor
6141284|NCT01313728|Dermatologic Agents|dermatologic agents|mesh-ancestor
6141285|NCT01313728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6141286|NCT01313728|Antimalarials|antimalarials|mesh-ancestor
6141287|NCT01313728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6141288|NCT01313728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6141289|NCT01313728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6141290|NCT01313728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6141291|NCT01313728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141292|NCT01313728|Leprostatic Agents|leprostatic agents|mesh-ancestor
6141293|NCT01313728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6141294|NCT01313767|Botulinum Toxins|botulinum toxins|mesh-list
5545390|NCT04137653|Mitosis Modulators|mitosis modulators|mesh-ancestor
5545391|NCT04137653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545392|NCT04137432|Oxytocin|oxytocin|mesh-list
5545393|NCT04137432|Oxytocics|oxytocics|mesh-ancestor
5545394|NCT04137432|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5545395|NCT04137432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545396|NCT04137068|Benzocaine|benzocaine|mesh-list
5545397|NCT04137068|Anesthetics, Local|anesthetics, local|mesh-ancestor
5545398|NCT04137068|Anesthetics|anesthetics|mesh-ancestor
5545399|NCT04137068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6141295|NCT01313767|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6141296|NCT01313767|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6141297|NCT01313767|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6141298|NCT01313767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5545400|NCT04137068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545401|NCT04137068|Sensory System Agents|sensory system agents|mesh-ancestor
6141299|NCT01313767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141300|NCT01313767|Cholinergic Agents|cholinergic agents|mesh-ancestor
6141301|NCT01313767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6141302|NCT01313767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141303|NCT01313767|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6141304|NCT01313767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5545402|NCT04137068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6141305|NCT01313780|Oxycodone|oxycodone|mesh-list
6141306|NCT01313780|Naloxone|naloxone|mesh-list
6141307|NCT01313780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6471606|NCT00501397|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6471607|NCT00501397|Hormone Antagonists|hormone antagonists|mesh-ancestor
6471608|NCT00501397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6471609|NCT00501397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471610|NCT00501397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6471611|NCT00501410|Leucovorin|leucovorin|mesh-list
6471612|NCT00501410|Fluorouracil|fluorouracil|mesh-list
6471613|NCT00501410|Oxaliplatin|oxaliplatin|mesh-list
6471614|NCT00501410|Cetuximab|cetuximab|mesh-list
6471615|NCT00501410|Dasatinib|dasatinib|mesh-list
6666774|NCT01524367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6666775|NCT01524367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545403|NCT04137198|Sufentanil|sufentanil|mesh-list
5545404|NCT04137198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6141308|NCT01313780|Narcotics|narcotics|mesh-ancestor
6141309|NCT01313780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6471616|NCT00501410|Antimetabolites|antimetabolites|mesh-ancestor
6666776|NCT01524367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6666777|NCT01524367|Analgesics|analgesics|mesh-ancestor
6666778|NCT01524367|Sensory System Agents|sensory system agents|mesh-ancestor
6666779|NCT01524367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6666780|NCT01524367|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6666781|NCT01524367|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6666782|NCT01524367|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6666783|NCT01524367|Adrenergic Agents|adrenergic agents|mesh-ancestor
6666784|NCT01524367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6666785|NCT01524367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666786|NCT01524432|Clotrimazole|clotrimazole|mesh-list
6666787|NCT01524432|Miconazole|miconazole|mesh-list
6471617|NCT00501410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471618|NCT00501410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6471619|NCT00501410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5545405|NCT04137198|Narcotics|narcotics|mesh-ancestor
5545406|NCT04137198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5545407|NCT04137198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545408|NCT04137198|Analgesics|analgesics|mesh-ancestor
5545409|NCT04137198|Sensory System Agents|sensory system agents|mesh-ancestor
5545410|NCT04137198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5545411|NCT04137198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6471620|NCT00501410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6471621|NCT00501410|Immunologic Factors|immunologic factors|mesh-ancestor
6471622|NCT00501410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471623|NCT00501410|Antidotes|antidotes|mesh-ancestor
6471624|NCT00501410|Protective Agents|protective agents|mesh-ancestor
6471625|NCT00501410|Vitamin B Complex|vitamin b complex|mesh-ancestor
5545412|NCT04137198|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5545413|NCT04137198|Anesthetics, General|anesthetics, general|mesh-ancestor
5545414|NCT04137198|Anesthetics|anesthetics|mesh-ancestor
5545415|NCT04137185|Hormones|hormones|mesh-list
5545416|NCT04137185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5545417|NCT04137185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545418|NCT04137328|Liraglutide|liraglutide|mesh-list
5545419|NCT04137328|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5545420|NCT04137328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545421|NCT04137328|Incretins|incretins|mesh-ancestor
5545422|NCT04137328|Hormones|hormones|mesh-ancestor
5545423|NCT04137328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5545424|NCT04137276|Vitamins|vitamins|mesh-list
5545425|NCT04137276|Ascorbic Acid|ascorbic acid|mesh-list
5545426|NCT04137276|Thiamine|thiamine|mesh-list
5545427|NCT04137276|Vitamin B Complex|vitamin b complex|mesh-list
5545428|NCT04137276|Micronutrients|micronutrients|mesh-ancestor
5545429|NCT04137276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545430|NCT04137276|Antioxidants|antioxidants|mesh-ancestor
6471626|NCT00501410|Vitamins|vitamins|mesh-ancestor
6471627|NCT00501410|Micronutrients|micronutrients|mesh-ancestor
6471628|NCT00501410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6471629|NCT00501410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6471630|NCT00501410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6471631|NCT00501488|Rosiglitazone|rosiglitazone|mesh-list
6471632|NCT00501488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6471633|NCT00501488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471634|NCT00501514|Hormones|hormones|mesh-list
6471635|NCT00501514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6471636|NCT00501514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471637|NCT00501566|Satavaptan|satavaptan|mesh-list
6471638|NCT00501566|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6471639|NCT00501566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545431|NCT04137276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545432|NCT04137276|Protective Agents|protective agents|mesh-ancestor
5545433|NCT04137302|Hydrocortisone|hydrocortisone|mesh-list
5545434|NCT04137302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5545435|NCT04137380|Mirikizumab|mirikizumab|mesh-list
5545436|NCT04137380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6471640|NCT00501566|Natriuretic Agents|natriuretic agents|mesh-ancestor
6666788|NCT01524432|Antifungal Agents|antifungal agents|mesh-list
6666789|NCT01524432|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5545437|NCT04137380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5545438|NCT04137380|Analgesics|analgesics|mesh-ancestor
5545439|NCT04137380|Sensory System Agents|sensory system agents|mesh-ancestor
5545440|NCT04137380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5545441|NCT04137380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545442|NCT04137380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5545443|NCT04137380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6471641|NCT00501566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471642|NCT00501579|Prednisolone|prednisolone|mesh-list
6471643|NCT00501579|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6471644|NCT00501579|Methylprednisolone|methylprednisolone|mesh-list
6471645|NCT00501579|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6471646|NCT00501579|Prednisolone acetate|prednisolone acetate|mesh-list
5545444|NCT04137380|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5545445|NCT04137380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6471647|NCT00501579|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6141310|NCT01313780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141311|NCT01313780|Analgesics|analgesics|mesh-ancestor
6141312|NCT01313780|Sensory System Agents|sensory system agents|mesh-ancestor
6141313|NCT01313780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6141314|NCT01313780|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6141315|NCT01313858|Golimumab|golimumab|mesh-list
6141316|NCT01313858|Methotrexate|methotrexate|mesh-list
6141317|NCT01313858|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6141318|NCT01313858|Abortifacient Agents|abortifacient agents|mesh-ancestor
6141319|NCT01313858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6141320|NCT01313858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141321|NCT01313858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6141322|NCT01313858|Antimetabolites|antimetabolites|mesh-ancestor
6141323|NCT01313858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141324|NCT01313858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6141325|NCT01313858|Dermatologic Agents|dermatologic agents|mesh-ancestor
6141326|NCT01313858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6141327|NCT01313858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6141328|NCT01313858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6141329|NCT01313858|Immunologic Factors|immunologic factors|mesh-ancestor
6141330|NCT01313858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6141331|NCT01313858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6141332|NCT01313858|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6141333|NCT01313858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6141334|NCT01313884|Cyclophosphamide|cyclophosphamide|mesh-list
5545446|NCT04137029|Bromides|bromides|mesh-list
5545447|NCT04137029|Formoterol Fumarate|formoterol fumarate|mesh-list
5545448|NCT04137029|Tiotropium Bromide|tiotropium bromide|mesh-list
5545449|NCT04137029|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5545450|NCT04137029|Autonomic Agents|autonomic agents|mesh-ancestor
6141335|NCT01313884|Temozolomide|temozolomide|mesh-list
6141336|NCT01313884|Doxorubicin|doxorubicin|mesh-list
6141337|NCT01313884|Irinotecan|irinotecan|mesh-list
6141338|NCT01313884|Vincristine|vincristine|mesh-list
6141339|NCT01313884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6141340|NCT01313884|Immunologic Factors|immunologic factors|mesh-ancestor
6141341|NCT01313884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141342|NCT01313884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6141343|NCT01313884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6141344|NCT01313884|Alkylating Agents|alkylating agents|mesh-ancestor
6141345|NCT01313884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141346|NCT01313884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6141347|NCT01313884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6141348|NCT01313884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6141349|NCT01313884|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6141350|NCT01313884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6141351|NCT01313884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6141352|NCT01313884|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6141353|NCT01313884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6141354|NCT01313884|Tubulin Modulators|tubulin modulators|mesh-ancestor
6141355|NCT01313884|Antimitotic Agents|antimitotic agents|mesh-ancestor
6141356|NCT01313884|Mitosis Modulators|mitosis modulators|mesh-ancestor
6141357|NCT01313897|Bortezomib|bortezomib|mesh-list
6141358|NCT01313897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6141359|NCT01313936|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
6141360|NCT01313936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6141361|NCT01313936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6141362|NCT01313936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141363|NCT01313936|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5545451|NCT04137029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5545452|NCT04137029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545453|NCT04137029|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5545454|NCT04137029|Respiratory System Agents|respiratory system agents|mesh-ancestor
6141364|NCT01314001|Nicotine|nicotine|mesh-list
6141365|NCT01314001|Varenicline|varenicline|mesh-list
6141366|NCT01314001|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6141367|NCT01314001|Autonomic Agents|autonomic agents|mesh-ancestor
5545455|NCT04137029|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5545456|NCT04137029|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5545457|NCT04137029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5545458|NCT04137029|Adrenergic Agents|adrenergic agents|mesh-ancestor
5545459|NCT04137029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5545460|NCT04137029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545461|NCT04137029|Parasympatholytics|parasympatholytics|mesh-ancestor
5545462|NCT04137029|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5545463|NCT04137029|Cholinergic Agents|cholinergic agents|mesh-ancestor
5545464|NCT04137029|Anticonvulsants|anticonvulsants|mesh-ancestor
5545465|NCT04136886|Cisplatin|cisplatin|mesh-list
5545466|NCT04136886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5545467|NCT04136613|Copper|copper|mesh-list
6141368|NCT01314001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6141369|NCT01314001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141370|NCT01314001|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6141371|NCT01314001|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6141372|NCT01314001|Cholinergic Agents|cholinergic agents|mesh-ancestor
6141373|NCT01314001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6141374|NCT01314001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141375|NCT01314105|Carboplatin|carboplatin|mesh-list
5545468|NCT04136613|Trace Elements|trace elements|mesh-ancestor
5545469|NCT04136613|Micronutrients|micronutrients|mesh-ancestor
5545470|NCT04136613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545471|NCT04136743|Dexamethasone|dexamethasone|mesh-list
5545472|NCT04136743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5545473|NCT04136743|Antiemetics|antiemetics|mesh-ancestor
5545474|NCT04136743|Autonomic Agents|autonomic agents|mesh-ancestor
5545475|NCT04136743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5545476|NCT04136743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141376|NCT01314105|Nintedanib|nintedanib|mesh-list
6141377|NCT01314105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6141378|NCT01314105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6141379|NCT01314105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6141380|NCT01314105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141381|NCT01314261|Interferons|interferons|mesh-list
6141382|NCT01314261|Ribavirin|ribavirin|mesh-list
6141383|NCT01314261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6141384|NCT01314261|Antiviral Agents|antiviral agents|mesh-ancestor
6141385|NCT01314261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6141386|NCT01314261|Antimetabolites|antimetabolites|mesh-ancestor
6141387|NCT01314261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471648|NCT00501579|Prednisolone phosphate|prednisolone phosphate|mesh-list
6471649|NCT00501579|Difluprednate|difluprednate|mesh-list
6471650|NCT00501579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6471651|NCT00501579|Glucocorticoids|glucocorticoids|mesh-ancestor
6471652|NCT00501579|Hormones|hormones|mesh-ancestor
6471653|NCT00501579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6471654|NCT00501579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471655|NCT00501579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6471656|NCT00501579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6471657|NCT00501579|Antiemetics|antiemetics|mesh-ancestor
6141388|NCT01314417|Methotrexate|methotrexate|mesh-list
6141389|NCT01314417|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6141390|NCT01314417|Abortifacient Agents|abortifacient agents|mesh-ancestor
6141391|NCT01314417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6141392|NCT01314417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141393|NCT01314417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6141394|NCT01314417|Antimetabolites|antimetabolites|mesh-ancestor
6141395|NCT01314417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471658|NCT00501579|Autonomic Agents|autonomic agents|mesh-ancestor
6471659|NCT00501579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6471660|NCT00501579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6471661|NCT00501579|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6471662|NCT00501579|Protective Agents|protective agents|mesh-ancestor
6141396|NCT01314417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6141397|NCT01314417|Dermatologic Agents|dermatologic agents|mesh-ancestor
6141398|NCT01314417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6141399|NCT01314417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6141400|NCT01314417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6141401|NCT01314417|Immunologic Factors|immunologic factors|mesh-ancestor
6471663|NCT00501605|Cediranib|cediranib|mesh-list
6471664|NCT00501605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5545477|NCT04136743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6141402|NCT01314417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6141403|NCT01314417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6141404|NCT01314443|Vitamin E|vitamin e|mesh-list
6141405|NCT01314443|Tocopherols|tocopherols|mesh-list
6141406|NCT01314443|Tocotrienols|tocotrienols|mesh-list
6141407|NCT01314443|alpha-Tocopherol|alpha-tocopherol|mesh-list
6141408|NCT01314443|gamma-Tocopherol|gamma-tocopherol|mesh-list
6471665|NCT00501605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6471666|NCT00501605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6471667|NCT00501605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666790|NCT01524432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6666791|NCT01524432|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6666792|NCT01524432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6666793|NCT01524432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6471668|NCT00501618|Clozapine|clozapine|mesh-list
6471669|NCT00501618|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6471670|NCT00501618|Serotonin Agents|serotonin agents|mesh-ancestor
6471671|NCT00501618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6471672|NCT00501618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471673|NCT00501618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471674|NCT00501618|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6141409|NCT01314443|Nicotine|nicotine|mesh-list
6141410|NCT01314443|Vitamins|vitamins|mesh-ancestor
6141411|NCT01314443|Micronutrients|micronutrients|mesh-ancestor
6141412|NCT01314443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141413|NCT01314443|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6141414|NCT01314443|Autonomic Agents|autonomic agents|mesh-ancestor
6141415|NCT01314443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6141416|NCT01314443|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6141417|NCT01314443|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6141418|NCT01314443|Cholinergic Agents|cholinergic agents|mesh-ancestor
6141419|NCT01314443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6141420|NCT01314443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141421|NCT01314443|Antioxidants|antioxidants|mesh-ancestor
6141422|NCT01314443|Protective Agents|protective agents|mesh-ancestor
6141423|NCT01314872|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6141424|NCT01314872|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6141425|NCT01314872|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6141426|NCT01314872|Cholinergic Agents|cholinergic agents|mesh-ancestor
6141427|NCT01314872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6141428|NCT01314872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141429|NCT01314872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141430|NCT01314872|Urological Agents|urological agents|mesh-ancestor
6141431|NCT01314911|Oseltamivir|oseltamivir|mesh-list
6141432|NCT01314911|Antiviral Agents|antiviral agents|mesh-ancestor
6141433|NCT01314911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6141434|NCT01314911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6141435|NCT01314911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141436|NCT01315002|Nicotine|nicotine|mesh-list
6471675|NCT00501618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6471676|NCT00501618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6141437|NCT01315002|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6141438|NCT01315002|Autonomic Agents|autonomic agents|mesh-ancestor
6141439|NCT01315002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6141440|NCT01315002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141441|NCT01315002|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6141442|NCT01315002|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6141443|NCT01315002|Cholinergic Agents|cholinergic agents|mesh-ancestor
6141444|NCT01315002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6141445|NCT01315002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141446|NCT01315158|Fentanyl|fentanyl|mesh-list
6141447|NCT01315158|Midazolam|midazolam|mesh-list
6141448|NCT01315158|Analgesics, Opioid|analgesics, opioid|mesh-list
6141449|NCT01315158|Propofol|propofol|mesh-list
6141450|NCT01315158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6141451|NCT01315158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6141452|NCT01315158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141453|NCT01315158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6141454|NCT01315158|Anesthetics, General|anesthetics, general|mesh-ancestor
6141455|NCT01315158|Anesthetics|anesthetics|mesh-ancestor
6141456|NCT01315158|Narcotics|narcotics|mesh-ancestor
6141457|NCT01315158|Analgesics|analgesics|mesh-ancestor
6141458|NCT01315158|Sensory System Agents|sensory system agents|mesh-ancestor
5545478|NCT04136743|Glucocorticoids|glucocorticoids|mesh-ancestor
6141459|NCT01315158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6141460|NCT01315158|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6141461|NCT01315158|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5545479|NCT04136743|Hormones|hormones|mesh-ancestor
5545480|NCT04136743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5545481|NCT04136743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5545482|NCT04136743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5545483|NCT04136782|Paclitaxel|paclitaxel|mesh-list
5545484|NCT04136782|Docetaxel|docetaxel|mesh-list
5545485|NCT04136782|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5545486|NCT04136782|Carboplatin|carboplatin|mesh-list
5545487|NCT04136782|Epirubicin|epirubicin|mesh-list
5545488|NCT04136782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5545489|NCT04136782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5545490|NCT04136782|Tubulin Modulators|tubulin modulators|mesh-ancestor
5545491|NCT04136782|Antimitotic Agents|antimitotic agents|mesh-ancestor
5545492|NCT04136782|Mitosis Modulators|mitosis modulators|mesh-ancestor
5545493|NCT04136782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545494|NCT04136782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5545495|NCT04136782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5545496|NCT04136782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6141462|NCT01315158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6141463|NCT01315158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6141464|NCT01315158|GABA Modulators|gaba modulators|mesh-ancestor
6471677|NCT00501618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6471678|NCT00501618|GABA Antagonists|gaba antagonists|mesh-ancestor
6471679|NCT00501618|GABA Agents|gaba agents|mesh-ancestor
6471680|NCT00501657|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6471681|NCT00501657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6471682|NCT00501657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471683|NCT00501657|Incretins|incretins|mesh-ancestor
6471684|NCT00501657|Hormones|hormones|mesh-ancestor
6471685|NCT00501657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6471686|NCT00501657|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6471687|NCT00501657|Protease Inhibitors|protease inhibitors|mesh-ancestor
6471688|NCT00501657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6471689|NCT00501657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471690|NCT00501696|Naltrexone|naltrexone|mesh-list
6471691|NCT00501696|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6471692|NCT00501696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6471693|NCT00501696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471694|NCT00501696|Sensory System Agents|sensory system agents|mesh-ancestor
6471695|NCT00501696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6471696|NCT00501722|Satavaptan|satavaptan|mesh-list
5545497|NCT04136782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5545498|NCT04136535|Carboplatin|carboplatin|mesh-list
6471697|NCT00501722|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6471698|NCT00501722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471699|NCT00501722|Natriuretic Agents|natriuretic agents|mesh-ancestor
6471700|NCT00501722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471701|NCT00501748|Rituximab|rituximab|mesh-list
6471702|NCT00501748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6471703|NCT00501748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6471704|NCT00501748|Immunologic Factors|immunologic factors|mesh-ancestor
6471705|NCT00501748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471706|NCT00501748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6471707|NCT00501787|Metformin|metformin|mesh-list
6471708|NCT00501787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6471709|NCT00501787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471710|NCT00501839|Clomiphene|clomiphene|mesh-list
6471711|NCT00501839|Enclomiphene|enclomiphene|mesh-list
6471712|NCT00501839|Zuclomiphene|zuclomiphene|mesh-list
6471713|NCT00501839|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6471714|NCT00501839|Hormone Antagonists|hormone antagonists|mesh-ancestor
6471715|NCT00501839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6471716|NCT00501839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471717|NCT00501839|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6471718|NCT00501839|Fertility Agents|fertility agents|mesh-ancestor
6471719|NCT00501839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6471720|NCT00501839|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6471721|NCT00501839|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6471722|NCT00501878|Phenylephrine|phenylephrine|mesh-list
5545499|NCT04136535|Pemetrexed|pemetrexed|mesh-list
5545500|NCT04136535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5545501|NCT04136535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5545502|NCT04136535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141465|NCT01315158|GABA Agents|gaba agents|mesh-ancestor
6141466|NCT01315158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6471723|NCT00501878|Oxymetazoline|oxymetazoline|mesh-list
6141467|NCT01315158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141468|NCT01315236|Amikacin|amikacin|mesh-list
6141469|NCT01315236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6141470|NCT01315236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6141471|NCT01315249|Fluticasone|fluticasone|mesh-list
6141472|NCT01315249|Xhance|xhance|mesh-list
6141473|NCT01315249|Glycopyrrolate|glycopyrrolate|mesh-list
6141474|NCT01315249|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6141475|NCT01315249|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6141476|NCT01315249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6141477|NCT01315249|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6141478|NCT01315249|Autonomic Agents|autonomic agents|mesh-ancestor
6141479|NCT01315249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6141480|NCT01315249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141481|NCT01315249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6141482|NCT01315249|Respiratory System Agents|respiratory system agents|mesh-ancestor
6141483|NCT01315249|Dermatologic Agents|dermatologic agents|mesh-ancestor
6141484|NCT01315249|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6141485|NCT01315249|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6141486|NCT01315249|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6141487|NCT01315249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6141488|NCT01315249|Adrenergic Agents|adrenergic agents|mesh-ancestor
6141489|NCT01315249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6141490|NCT01315249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141491|NCT01315249|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6141492|NCT01315249|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6141493|NCT01315249|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6141494|NCT01315249|Cholinergic Agents|cholinergic agents|mesh-ancestor
6141495|NCT01315249|Glucocorticoids|glucocorticoids|mesh-ancestor
6141496|NCT01315249|Hormones|hormones|mesh-ancestor
6141497|NCT01315249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6471724|NCT00501878|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6471725|NCT00501878|Mydriatics|mydriatics|mesh-ancestor
6471726|NCT00501878|Autonomic Agents|autonomic agents|mesh-ancestor
6471727|NCT00501878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6471728|NCT00501878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471729|NCT00501878|Sympathomimetics|sympathomimetics|mesh-ancestor
6471730|NCT00501878|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6141498|NCT01315249|Sympathomimetics|sympathomimetics|mesh-ancestor
5545503|NCT04136535|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6141499|NCT01315574|Travoprost|travoprost|mesh-list
6141500|NCT01315574|Latanoprost|latanoprost|mesh-list
6141501|NCT01315574|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6141502|NCT01315574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6141503|NCT01315574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6141504|NCT01315665|Sulforaphane|sulforaphane|mesh-list
6141505|NCT01315665|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6141506|NCT01315665|Protective Agents|protective agents|mesh-ancestor
6141507|NCT01315665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141508|NCT01315665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6141509|NCT01315678|Tobramycin|tobramycin|mesh-list
6141510|NCT01315678|Amikacin|amikacin|mesh-list
6141511|NCT01315678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6141512|NCT01315678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6141513|NCT01316042|Metformin|metformin|mesh-list
6141514|NCT01316042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6141515|NCT01316042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141516|NCT01316055|4-Aminopyridine|4-aminopyridine|mesh-list
6141517|NCT01316055|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6141518|NCT01316055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5545504|NCT04136535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5545505|NCT04136639|Proanthocyanidin|proanthocyanidin|mesh-list
5545506|NCT04136639|Grape Seed Extract|grape seed extract|mesh-list
5545507|NCT04136639|Fluorides|fluorides|mesh-list
5545508|NCT04136639|Sodium Fluoride|sodium fluoride|mesh-list
6141519|NCT01316055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141520|NCT01316263|Olaratumab|olaratumab|mesh-list
6471731|NCT00501878|Nasal Decongestants|nasal decongestants|mesh-ancestor
6471732|NCT00501878|Respiratory System Agents|respiratory system agents|mesh-ancestor
6471733|NCT00501878|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6471734|NCT00501878|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6471735|NCT00501878|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6141521|NCT01316263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6205377|NCT02084238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6205378|NCT02084238|Analgesics|analgesics|mesh-ancestor
6205379|NCT02084238|Sensory System Agents|sensory system agents|mesh-ancestor
6205380|NCT02084238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6205381|NCT02084238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205382|NCT02084511|Celecoxib|celecoxib|mesh-list
5545509|NCT04136639|Cariostatic Agents|cariostatic agents|mesh-ancestor
5545510|NCT04136639|Protective Agents|protective agents|mesh-ancestor
5545511|NCT04136639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545512|NCT04136639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5545513|NCT04136639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5545514|NCT04136639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5545515|NCT04136639|Antioxidants|antioxidants|mesh-ancestor
5545516|NCT04136639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205383|NCT02084511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6205384|NCT02084511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6205385|NCT02084511|Analgesics|analgesics|mesh-ancestor
6205386|NCT02084511|Sensory System Agents|sensory system agents|mesh-ancestor
6205387|NCT02084511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6205388|NCT02084511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205389|NCT02084511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6205390|NCT02084511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6205391|NCT02084511|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6205392|NCT02084511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6205393|NCT02084511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6205394|NCT02084511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205395|NCT02084706|Triamcinolone|triamcinolone|mesh-list
6205396|NCT02084706|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6205397|NCT02084706|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6205398|NCT02084706|Lidocaine|lidocaine|mesh-list
6205399|NCT02084706|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6205400|NCT02084706|Anesthetics, Local|anesthetics, local|mesh-ancestor
6205401|NCT02084706|Anesthetics|anesthetics|mesh-ancestor
6205402|NCT02084706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6205403|NCT02084706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205404|NCT02084706|Sensory System Agents|sensory system agents|mesh-ancestor
6205405|NCT02084706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6205406|NCT02084706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6205407|NCT02084706|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6205408|NCT02084706|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6205409|NCT02084706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6205410|NCT02084706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205411|NCT02084706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6205412|NCT02084706|Glucocorticoids|glucocorticoids|mesh-ancestor
6205413|NCT02084706|Hormones|hormones|mesh-ancestor
6205414|NCT02084706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6205415|NCT02084706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6205416|NCT02084706|Immunologic Factors|immunologic factors|mesh-ancestor
6205417|NCT02084706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6205418|NCT02084797|Tolvaptan|tolvaptan|mesh-list
6205419|NCT02084797|Vasopressins|vasopressins|mesh-list
6205420|NCT02084797|Arginine Vasopressin|arginine vasopressin|mesh-list
6205421|NCT02084797|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6205422|NCT02084797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205423|NCT02084797|Natriuretic Agents|natriuretic agents|mesh-ancestor
6205424|NCT02084797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205425|NCT02084797|Hemostatics|hemostatics|mesh-ancestor
6205426|NCT02084797|Coagulants|coagulants|mesh-ancestor
6471736|NCT00501878|Adrenergic Agents|adrenergic agents|mesh-ancestor
6471737|NCT00501878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6205427|NCT02084797|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6205428|NCT02084797|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6205429|NCT02085070|Pembrolizumab|pembrolizumab|mesh-list
6205430|NCT02085070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6205431|NCT02085070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6205432|NCT02085161|Tiotropium Bromide|tiotropium bromide|mesh-list
6205433|NCT02085161|Olodaterol|olodaterol|mesh-list
6471738|NCT00501878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545517|NCT04136639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5545518|NCT04136639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5545519|NCT04136470|Nivolumab|nivolumab|mesh-list
5545520|NCT04136470|Ipilimumab|ipilimumab|mesh-list
5545521|NCT04136470|Atezolizumab|atezolizumab|mesh-list
5545522|NCT04136470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5545523|NCT04136470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5545524|NCT04136470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5545525|NCT04136470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545526|NCT04136600|Antibodies|antibodies|mesh-list
5545527|NCT04136600|Immunologic Factors|immunologic factors|mesh-ancestor
5545528|NCT04136600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471739|NCT00501878|Protective Agents|protective agents|mesh-ancestor
6471740|NCT00501904|Metformin|metformin|mesh-list
6471741|NCT00501904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5545529|NCT04136327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5602566|NCT04370847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5602567|NCT04370847|Anesthetics, General|anesthetics, general|mesh-ancestor
5602568|NCT04370847|Oxytocics|oxytocics|mesh-ancestor
5602569|NCT04370847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5602570|NCT04370847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5602571|NCT04370847|Sympathomimetics|sympathomimetics|mesh-ancestor
5602572|NCT04370847|Autonomic Agents|autonomic agents|mesh-ancestor
5602573|NCT04370847|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6471742|NCT00501904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471743|NCT00501917|Darbepoetin alfa|darbepoetin alfa|mesh-list
6471744|NCT00501917|Hematinics|hematinics|mesh-ancestor
6471745|NCT00501982|Poractant alfa|poractant alfa|mesh-list
6141522|NCT01316276|Amikacin|amikacin|mesh-list
6141523|NCT01316276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6141524|NCT01316276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6141525|NCT01316302|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6141526|NCT01316302|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6141527|NCT01316302|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6141528|NCT01316302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6141529|NCT01316302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141530|NCT01316302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6141531|NCT01316302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141532|NCT01316302|Antidepressive Agents|antidepressive agents|mesh-ancestor
6141533|NCT01316302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6141534|NCT01316341|Empagliflozin|empagliflozin|mesh-list
5602574|NCT04370847|Adrenergic Agents|adrenergic agents|mesh-ancestor
5602575|NCT04370847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5602576|NCT04370847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602577|NCT04356430|Prednisone|prednisone|mesh-list
5602578|NCT04356430|Goserelin|goserelin|mesh-list
5602579|NCT04356430|Abiraterone Acetate|abiraterone acetate|mesh-list
6141535|NCT01316341|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6141536|NCT01316341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141537|NCT01316341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6141538|NCT01316341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471746|NCT00501982|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
6471747|NCT00501982|Respiratory System Agents|respiratory system agents|mesh-ancestor
6471748|NCT00502034|Interferons|interferons|mesh-list
6471749|NCT00502034|Interferon-alpha|interferon-alpha|mesh-list
6471750|NCT00502034|Interferon alpha-2|interferon alpha-2|mesh-list
6471751|NCT00502034|Interleukin-2|interleukin-2|mesh-list
6471752|NCT00502034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6471753|NCT00502034|Antiviral Agents|antiviral agents|mesh-ancestor
5602580|NCT04356430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5602581|NCT04356430|Glucocorticoids|glucocorticoids|mesh-ancestor
5602582|NCT04356430|Hormones|hormones|mesh-ancestor
5602583|NCT04356430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5602584|NCT04356430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602585|NCT04356430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5602586|NCT04356430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5602587|NCT04356430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5602588|NCT04356430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5602589|NCT04356430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602590|NCT04356430|Hormone Antagonists|hormone antagonists|mesh-ancestor
5602591|NCT04356430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5602592|NCT04353271|Hydroxychloroquine|hydroxychloroquine|mesh-list
5602593|NCT04353271|Antimalarials|antimalarials|mesh-ancestor
5602594|NCT04353271|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6471754|NCT00502034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5545530|NCT04136262|Methotrexate|methotrexate|mesh-list
5545531|NCT04136262|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5545532|NCT04136262|Abortifacient Agents|abortifacient agents|mesh-ancestor
6141539|NCT01316380|Tiotropium Bromide|tiotropium bromide|mesh-list
6141540|NCT01316380|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6141541|NCT01316380|Autonomic Agents|autonomic agents|mesh-ancestor
6141542|NCT01316380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6141543|NCT01316380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141544|NCT01316380|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6141545|NCT01316380|Respiratory System Agents|respiratory system agents|mesh-ancestor
6141546|NCT01316380|Parasympatholytics|parasympatholytics|mesh-ancestor
6141547|NCT01316380|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6141548|NCT01316380|Cholinergic Agents|cholinergic agents|mesh-ancestor
6141549|NCT01316380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6141550|NCT01316380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141551|NCT01316419|Amlodipine|amlodipine|mesh-list
6141552|NCT01316419|Telmisartan|telmisartan|mesh-list
6141553|NCT01316419|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6141554|NCT01316419|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6141555|NCT01316419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6141556|NCT01316419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141557|NCT01316419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6141558|NCT01316419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141559|NCT01316419|Vasodilator Agents|vasodilator agents|mesh-ancestor
6141560|NCT01316419|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6141561|NCT01316419|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6141562|NCT01316770|Dexamethasone|dexamethasone|mesh-list
6141563|NCT01316770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6141564|NCT01316770|Antiemetics|antiemetics|mesh-ancestor
6141565|NCT01316770|Autonomic Agents|autonomic agents|mesh-ancestor
6141566|NCT01316770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6141567|NCT01316770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141568|NCT01316770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6141569|NCT01316770|Glucocorticoids|glucocorticoids|mesh-ancestor
6141570|NCT01316770|Hormones|hormones|mesh-ancestor
6471755|NCT00502034|Immunologic Factors|immunologic factors|mesh-ancestor
6471756|NCT00502034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471757|NCT00502034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6471758|NCT00502034|Analgesics|analgesics|mesh-ancestor
6471759|NCT00502034|Sensory System Agents|sensory system agents|mesh-ancestor
6471760|NCT00502034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5545533|NCT04136262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5545534|NCT04136262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545535|NCT04136262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5545536|NCT04136262|Antimetabolites|antimetabolites|mesh-ancestor
5545537|NCT04136262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545538|NCT04136262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6471761|NCT00502060|Cediranib|cediranib|mesh-list
6471762|NCT00502060|Gefitinib|gefitinib|mesh-list
6471763|NCT00502060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6471764|NCT00502060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6471765|NCT00502060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6471766|NCT00502060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471767|NCT00502073|Cyclosporine|cyclosporine|mesh-list
6471768|NCT00502073|Cyclosporins|cyclosporins|mesh-list
6471769|NCT00502073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6471770|NCT00502073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471771|NCT00502073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6471772|NCT00502073|Immunologic Factors|immunologic factors|mesh-ancestor
6471773|NCT00502073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471774|NCT00502073|Antifungal Agents|antifungal agents|mesh-ancestor
6471775|NCT00502073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6471776|NCT00502073|Dermatologic Agents|dermatologic agents|mesh-ancestor
6471777|NCT00502073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6471778|NCT00502073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5545539|NCT04136262|Dermatologic Agents|dermatologic agents|mesh-ancestor
5545540|NCT04136262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5545541|NCT04136262|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5545542|NCT04136262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5545543|NCT04136262|Immunologic Factors|immunologic factors|mesh-ancestor
5545544|NCT04136262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5545545|NCT04136262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5545546|NCT04136067|Insulin Glargine|insulin glargine|mesh-list
5545547|NCT04136067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6471779|NCT00502099|Interferons|interferons|mesh-list
6471780|NCT00502099|Ribavirin|ribavirin|mesh-list
6141571|NCT01316770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6141572|NCT01316770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6141573|NCT01316770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6141574|NCT01316900|Bromides|bromides|mesh-list
6141575|NCT01316900|Tiotropium Bromide|tiotropium bromide|mesh-list
6141576|NCT01316900|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6141577|NCT01316900|Autonomic Agents|autonomic agents|mesh-ancestor
5545548|NCT04136067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545549|NCT04135989|Everolimus|everolimus|mesh-list
6141578|NCT01316900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6141579|NCT01316900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141580|NCT01316900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6141581|NCT01316900|Respiratory System Agents|respiratory system agents|mesh-ancestor
6141582|NCT01316900|Parasympatholytics|parasympatholytics|mesh-ancestor
6141583|NCT01316900|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6141584|NCT01316900|Cholinergic Agents|cholinergic agents|mesh-ancestor
6141585|NCT01316900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6141586|NCT01316900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141587|NCT01316900|Anticonvulsants|anticonvulsants|mesh-ancestor
6141588|NCT01316913|Bromides|bromides|mesh-list
6141589|NCT01316913|Tiotropium Bromide|tiotropium bromide|mesh-list
6141590|NCT01316913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6141591|NCT01316913|Autonomic Agents|autonomic agents|mesh-ancestor
6141592|NCT01316913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6141593|NCT01316913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141594|NCT01316913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6141595|NCT01316913|Respiratory System Agents|respiratory system agents|mesh-ancestor
6141596|NCT01316913|Parasympatholytics|parasympatholytics|mesh-ancestor
6141597|NCT01316913|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6141598|NCT01316913|Cholinergic Agents|cholinergic agents|mesh-ancestor
6141599|NCT01316913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6141600|NCT01316913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141601|NCT01316913|Anticonvulsants|anticonvulsants|mesh-ancestor
6141602|NCT01317004|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6141603|NCT01317004|Interferon beta-1b|interferon beta-1b|mesh-list
6141604|NCT01317004|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6141605|NCT01317004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141606|NCT01317004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6141607|NCT01317004|Immunologic Factors|immunologic factors|mesh-ancestor
6141608|NCT01317004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141609|NCT01317004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6141610|NCT01317472|Dexlansoprazole|dexlansoprazole|mesh-list
6141611|NCT01317472|Lansoprazole|lansoprazole|mesh-list
6141612|NCT01317472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6141613|NCT01317472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6141614|NCT01317472|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6141615|NCT01317472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6141616|NCT01317472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545550|NCT04135989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5545551|NCT04135989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5545552|NCT04135989|Immunologic Factors|immunologic factors|mesh-ancestor
5545553|NCT04135989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141617|NCT01317550|Minocycline|minocycline|mesh-list
6141618|NCT01317550|Modafinil|modafinil|mesh-list
6141619|NCT01317550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6141620|NCT01317550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6471781|NCT00502099|Interferon-alpha|interferon-alpha|mesh-list
6471782|NCT00502099|Interferon alpha-2|interferon alpha-2|mesh-list
6471783|NCT00502099|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6471784|NCT00502099|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6141621|NCT01317550|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6141622|NCT01317550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141623|NCT01317550|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6141624|NCT01317550|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6141625|NCT01317550|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6141626|NCT01317550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141627|NCT01317615|Paclitaxel|paclitaxel|mesh-list
6141628|NCT01317615|Carboplatin|carboplatin|mesh-list
6141629|NCT01317615|Everolimus|everolimus|mesh-list
6141630|NCT01317615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6141631|NCT01317615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6141632|NCT01317615|Tubulin Modulators|tubulin modulators|mesh-ancestor
5545554|NCT04136028|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6141633|NCT01317615|Antimitotic Agents|antimitotic agents|mesh-ancestor
6141634|NCT01317615|Mitosis Modulators|mitosis modulators|mesh-ancestor
6141635|NCT01317615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141636|NCT01317615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6141637|NCT01317615|Immunologic Factors|immunologic factors|mesh-ancestor
6141638|NCT01317615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141639|NCT01317667|Vaccines|vaccines|mesh-list
6141640|NCT01317667|Immunologic Factors|immunologic factors|mesh-ancestor
6141641|NCT01317667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141642|NCT01317901|Rituximab|rituximab|mesh-list
6141643|NCT01317901|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6141644|NCT01317901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6141645|NCT01317901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6471785|NCT00502099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6471786|NCT00502099|Antiviral Agents|antiviral agents|mesh-ancestor
6471787|NCT00502099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6471788|NCT00502099|Antimetabolites|antimetabolites|mesh-ancestor
6471789|NCT00502099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471790|NCT00502099|Immunologic Factors|immunologic factors|mesh-ancestor
6471791|NCT00502099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471792|NCT00502112|Lenalidomide|lenalidomide|mesh-list
6471793|NCT00502112|Lintuzumab|lintuzumab|mesh-list
6471794|NCT00502112|Immunologic Factors|immunologic factors|mesh-ancestor
6141646|NCT01317901|Immunologic Factors|immunologic factors|mesh-ancestor
6141647|NCT01317901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545555|NCT04136028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5545556|NCT04135846|Doxazosin|doxazosin|mesh-list
5545557|NCT04135846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5545558|NCT04135846|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5545559|NCT04135846|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5545560|NCT04135846|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5545561|NCT04135846|Adrenergic Agents|adrenergic agents|mesh-ancestor
6141648|NCT01317901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6141649|NCT01317901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6141650|NCT01317901|Alkylating Agents|alkylating agents|mesh-ancestor
6141651|NCT01317901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141652|NCT01317940|Calcium, Dietary|calcium, dietary|mesh-list
6141653|NCT01317940|Vitamin D|vitamin d|mesh-list
6141654|NCT01317940|Calcitriol|calcitriol|mesh-list
6141655|NCT01317940|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
6471795|NCT00502112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471796|NCT00502112|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5545562|NCT04135846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5545563|NCT04135846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545564|NCT04135846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545565|NCT04136080|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
5545566|NCT04136015|Dasatinib|dasatinib|mesh-list
5545567|NCT04136015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5545568|NCT04136015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5545569|NCT04136015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5545570|NCT04136015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545571|NCT04135898|Bevacizumab|bevacizumab|mesh-list
6471797|NCT00502112|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6471798|NCT00502112|Growth Substances|growth substances|mesh-ancestor
6471799|NCT00502112|Growth Inhibitors|growth inhibitors|mesh-ancestor
6471800|NCT00502112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6471801|NCT00502112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6471802|NCT00502138|Pramlintide|pramlintide|mesh-list
6141656|NCT01317940|Calcium Carbonate|calcium carbonate|mesh-list
6141657|NCT01317940|Calcium|calcium|mesh-list
6141658|NCT01317940|Vitamins|vitamins|mesh-ancestor
6141659|NCT01317940|Micronutrients|micronutrients|mesh-ancestor
6141660|NCT01317940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141661|NCT01317940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6141662|NCT01317940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6141663|NCT01317940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141664|NCT01317940|Antacids|antacids|mesh-ancestor
6141665|NCT01317940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6141666|NCT01317940|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6141667|NCT01317940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6141668|NCT01317940|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6141669|NCT01318070|Pioglitazone|pioglitazone|mesh-list
6141670|NCT01318070|Alogliptin|alogliptin|mesh-list
6141671|NCT01318070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6141672|NCT01318070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141673|NCT01318070|Incretins|incretins|mesh-ancestor
5545572|NCT04135898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5545573|NCT04135898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5545574|NCT04135898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5545575|NCT04135898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5545576|NCT04135898|Growth Substances|growth substances|mesh-ancestor
5545577|NCT04135898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545578|NCT04135898|Growth Inhibitors|growth inhibitors|mesh-ancestor
5545579|NCT04135885|Folic Acid|folic acid|mesh-list
5545580|NCT04135885|Hematinics|hematinics|mesh-ancestor
5545581|NCT04135885|Vitamin B Complex|vitamin b complex|mesh-ancestor
5545582|NCT04135885|Vitamins|vitamins|mesh-ancestor
5545583|NCT04135885|Micronutrients|micronutrients|mesh-ancestor
5545584|NCT04135885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545585|NCT04135833|Itraconazole|itraconazole|mesh-list
5545586|NCT04135833|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
5545587|NCT04135833|Rifampin|rifampin|mesh-list
5545588|NCT04135833|Antifungal Agents|antifungal agents|mesh-ancestor
5545589|NCT04135833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6141674|NCT01318070|Hormones|hormones|mesh-ancestor
6141675|NCT01318070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6141676|NCT01318070|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6141677|NCT01318070|Protease Inhibitors|protease inhibitors|mesh-ancestor
6141678|NCT01318070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6471803|NCT00502138|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
6471804|NCT00502138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6471805|NCT00502138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545590|NCT04135833|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5545591|NCT04135833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5545592|NCT04135833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5545593|NCT04135833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545594|NCT04135833|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5545595|NCT04135833|Hormone Antagonists|hormone antagonists|mesh-ancestor
5545596|NCT04135833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5545597|NCT04135833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545598|NCT04135833|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5545599|NCT04135833|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5545600|NCT04135833|Antitubercular Agents|antitubercular agents|mesh-ancestor
5545601|NCT04135833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5545602|NCT04135833|Leprostatic Agents|leprostatic agents|mesh-ancestor
5545603|NCT04135833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5545604|NCT04135833|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5545605|NCT04135833|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5545606|NCT04135833|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5545607|NCT04135833|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5545608|NCT04135833|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5545609|NCT04135833|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5545610|NCT04135677|Rivaroxaban|rivaroxaban|mesh-list
5545611|NCT04135677|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5545612|NCT04135677|Antithrombins|antithrombins|mesh-ancestor
5545613|NCT04135677|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6141679|NCT01318070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141680|NCT01318083|Glimepiride|glimepiride|mesh-list
6141681|NCT01318083|Alogliptin|alogliptin|mesh-list
6141682|NCT01318083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6141683|NCT01318083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6666794|NCT01524432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666795|NCT01524432|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6666796|NCT01524432|Hormone Antagonists|hormone antagonists|mesh-ancestor
5545614|NCT04135677|Protease Inhibitors|protease inhibitors|mesh-ancestor
5545615|NCT04135677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5545616|NCT04135677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141684|NCT01318083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141685|NCT01318083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6471806|NCT00502138|Appetite Depressants|appetite depressants|mesh-ancestor
6471807|NCT00502138|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6471808|NCT00502138|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
6471809|NCT00502138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471810|NCT00502164|Cediranib|cediranib|mesh-list
6471811|NCT00502164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6471812|NCT00502164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6141686|NCT01318083|Immunologic Factors|immunologic factors|mesh-ancestor
6141687|NCT01318083|Incretins|incretins|mesh-ancestor
6141688|NCT01318083|Hormones|hormones|mesh-ancestor
6141689|NCT01318083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6141690|NCT01318083|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6141691|NCT01318083|Protease Inhibitors|protease inhibitors|mesh-ancestor
6141692|NCT01318083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6141693|NCT01318083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141694|NCT01318109|Metformin|metformin|mesh-list
6141695|NCT01318109|Alogliptin|alogliptin|mesh-list
6141696|NCT01318109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6141697|NCT01318109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141698|NCT01318109|Incretins|incretins|mesh-ancestor
6141699|NCT01318109|Hormones|hormones|mesh-ancestor
6141700|NCT01318109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6141701|NCT01318109|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6141702|NCT01318109|Protease Inhibitors|protease inhibitors|mesh-ancestor
6141703|NCT01318109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6141704|NCT01318109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141705|NCT01318122|Pioglitazone|pioglitazone|mesh-list
6141706|NCT01318122|Alogliptin|alogliptin|mesh-list
6141707|NCT01318122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6141708|NCT01318122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141709|NCT01318122|Incretins|incretins|mesh-ancestor
6141710|NCT01318122|Hormones|hormones|mesh-ancestor
6141711|NCT01318122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6141712|NCT01318122|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6141713|NCT01318122|Protease Inhibitors|protease inhibitors|mesh-ancestor
6141714|NCT01318122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6141715|NCT01318122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141716|NCT01318135|Metformin|metformin|mesh-list
6141717|NCT01318135|Glimepiride|glimepiride|mesh-list
6141718|NCT01318135|Alogliptin|alogliptin|mesh-list
6141719|NCT01318135|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6141720|NCT01318135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141721|NCT01318135|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6141722|NCT01318135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6141723|NCT01318135|Immunologic Factors|immunologic factors|mesh-ancestor
6141724|NCT01318135|Incretins|incretins|mesh-ancestor
6141725|NCT01318135|Hormones|hormones|mesh-ancestor
6141726|NCT01318135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6141727|NCT01318135|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6141728|NCT01318135|Protease Inhibitors|protease inhibitors|mesh-ancestor
6141729|NCT01318135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6141730|NCT01318135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141731|NCT01318278|Dopamine|dopamine|mesh-list
6141732|NCT01318278|Vasopressins|vasopressins|mesh-list
6141733|NCT01318278|Arginine Vasopressin|arginine vasopressin|mesh-list
5545617|NCT04135677|Anticoagulants|anticoagulants|mesh-ancestor
5545618|NCT04135781|Paclitaxel|paclitaxel|mesh-list
5545619|NCT04135781|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5545620|NCT04135781|Capecitabine|capecitabine|mesh-list
5545621|NCT04135781|Oxaliplatin|oxaliplatin|mesh-list
5545622|NCT04135781|Tegafur|tegafur|mesh-list
5545623|NCT04135781|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5545624|NCT04135781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5545625|NCT04135781|Tubulin Modulators|tubulin modulators|mesh-ancestor
6141734|NCT01318278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141735|NCT01318278|Hemostatics|hemostatics|mesh-ancestor
6141736|NCT01318278|Coagulants|coagulants|mesh-ancestor
6141737|NCT01318278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6141738|NCT01318278|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6141739|NCT01318278|Natriuretic Agents|natriuretic agents|mesh-ancestor
6141740|NCT01318278|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6141741|NCT01318278|Sympathomimetics|sympathomimetics|mesh-ancestor
6141742|NCT01318278|Autonomic Agents|autonomic agents|mesh-ancestor
6141743|NCT01318278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6141744|NCT01318278|Dopamine Agents|dopamine agents|mesh-ancestor
5545626|NCT04135781|Antimitotic Agents|antimitotic agents|mesh-ancestor
5545627|NCT04135781|Mitosis Modulators|mitosis modulators|mesh-ancestor
5545628|NCT04135781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545629|NCT04135781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6141745|NCT01318278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6141746|NCT01318278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141747|NCT01318278|Protective Agents|protective agents|mesh-ancestor
5545630|NCT04135781|Antimetabolites|antimetabolites|mesh-ancestor
6141748|NCT01318356|Doxycycline|doxycycline|mesh-list
5545631|NCT04135508|Adalimumab|adalimumab|mesh-list
6141749|NCT01318356|Tetracycline|tetracycline|mesh-list
6141750|NCT01318356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6471813|NCT00502164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6471814|NCT00502164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471815|NCT00502190|Silicon|silicon|mesh-list
6471816|NCT00502190|Trace Elements|trace elements|mesh-ancestor
6666797|NCT01524432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6666798|NCT01524432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666799|NCT01524432|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6666800|NCT01524432|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5545632|NCT04135508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5545633|NCT04135508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5545634|NCT04135313|Capecitabine|capecitabine|mesh-list
5545635|NCT04135313|Oxaliplatin|oxaliplatin|mesh-list
5545636|NCT04135313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5545637|NCT04135313|Antimetabolites|antimetabolites|mesh-ancestor
5545638|NCT04135313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545639|NCT04135313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5545640|NCT04135378|Ascorbic Acid|ascorbic acid|mesh-list
5545641|NCT04135378|Vitamins|vitamins|mesh-ancestor
5545642|NCT04135378|Micronutrients|micronutrients|mesh-ancestor
5545643|NCT04135378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545644|NCT04135378|Antioxidants|antioxidants|mesh-ancestor
5545645|NCT04135378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666801|NCT01524445|Bortezomib|bortezomib|mesh-list
6666802|NCT01524445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6666803|NCT01524497|Trazodone|trazodone|mesh-list
6666804|NCT01524497|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5545646|NCT04135378|Protective Agents|protective agents|mesh-ancestor
5545647|NCT04135690|Sorafenib|sorafenib|mesh-list
6471817|NCT00502190|Micronutrients|micronutrients|mesh-ancestor
6471818|NCT00502190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471819|NCT00502229|Metformin|metformin|mesh-list
6471820|NCT00502229|Clomiphene|clomiphene|mesh-list
6471821|NCT00502229|Enclomiphene|enclomiphene|mesh-list
6471822|NCT00502229|Zuclomiphene|zuclomiphene|mesh-list
6471823|NCT00502229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6471824|NCT00502229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471825|NCT00502229|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6471826|NCT00502229|Hormone Antagonists|hormone antagonists|mesh-ancestor
6471827|NCT00502229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6471828|NCT00502229|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5545648|NCT04135690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6141751|NCT01318356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6141752|NCT01318356|Antimalarials|antimalarials|mesh-ancestor
6141753|NCT01318356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6141754|NCT01318356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6141755|NCT01318356|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6141756|NCT01318356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6141757|NCT01318356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141758|NCT01318408|Levetiracetam|levetiracetam|mesh-list
6141759|NCT01318408|Anticonvulsants|anticonvulsants|mesh-ancestor
6141760|NCT01318408|Nootropic Agents|nootropic agents|mesh-ancestor
6141761|NCT01318499|Nepafenac|nepafenac|mesh-list
6141762|NCT01318499|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6141763|NCT01318499|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6141764|NCT01318499|Analgesics|analgesics|mesh-ancestor
6141765|NCT01318499|Sensory System Agents|sensory system agents|mesh-ancestor
6141766|NCT01318499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6141767|NCT01318499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141768|NCT01318499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6141769|NCT01318499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6141770|NCT01318577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6141771|NCT01318694|Ribavirin|ribavirin|mesh-list
6141772|NCT01318694|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6141773|NCT01318694|Antimetabolites|antimetabolites|mesh-ancestor
6141774|NCT01318694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141775|NCT01318694|Antiviral Agents|antiviral agents|mesh-ancestor
6141776|NCT01318694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6141777|NCT01318811|Heparin|heparin|mesh-list
6141778|NCT01318811|Calcium heparin|calcium heparin|mesh-list
6141779|NCT01318811|Anticoagulants|anticoagulants|mesh-ancestor
6141780|NCT01318811|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5545649|NCT04135690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6141781|NCT01318811|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6471829|NCT00502229|Fertility Agents|fertility agents|mesh-ancestor
6471830|NCT00502229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6141782|NCT01318811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141783|NCT01318902|Dexamethasone|dexamethasone|mesh-list
6141784|NCT01318902|Ixazomib|ixazomib|mesh-list
6141785|NCT01318902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6141786|NCT01318902|Antiemetics|antiemetics|mesh-ancestor
6141787|NCT01318902|Autonomic Agents|autonomic agents|mesh-ancestor
6141788|NCT01318902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6141789|NCT01318902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141790|NCT01318902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6141791|NCT01318902|Glucocorticoids|glucocorticoids|mesh-ancestor
6141792|NCT01318902|Hormones|hormones|mesh-ancestor
6141793|NCT01318902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6141794|NCT01318902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6141795|NCT01318902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6141796|NCT01318902|Protease Inhibitors|protease inhibitors|mesh-ancestor
6141797|NCT01318902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6141798|NCT01318902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141799|NCT01318915|Mycophenolic Acid|mycophenolic acid|mesh-list
6141800|NCT01318915|Sirolimus|sirolimus|mesh-list
6141801|NCT01318915|Rituximab|rituximab|mesh-list
6141802|NCT01318915|Tacrolimus|tacrolimus|mesh-list
6141803|NCT01318915|Thymoglobulin|thymoglobulin|mesh-list
6141804|NCT01318915|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6141805|NCT01318915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6141806|NCT01318915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6141807|NCT01318915|Immunologic Factors|immunologic factors|mesh-ancestor
6141808|NCT01318915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141809|NCT01318915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5545650|NCT04135690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5545651|NCT04135690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545652|NCT04135456|Mannitol|mannitol|mesh-list
5545653|NCT04135456|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5545654|NCT04135456|Diuretics|diuretics|mesh-ancestor
5545655|NCT04135456|Natriuretic Agents|natriuretic agents|mesh-ancestor
5545656|NCT04135456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545657|NCT04134884|Talazoparib|talazoparib|mesh-list
5545658|NCT04134884|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5545659|NCT04134884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5545660|NCT04134884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545661|NCT04134884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5545662|NCT04134923|Corticosterone|corticosterone|mesh-list
5545663|NCT04134923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5545664|NCT04134897|Capecitabine|capecitabine|mesh-list
6141810|NCT01318915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6141811|NCT01318915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6141812|NCT01318915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6141813|NCT01318915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141814|NCT01318915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6141815|NCT01318915|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6141816|NCT01318915|Antitubercular Agents|antitubercular agents|mesh-ancestor
6141817|NCT01318915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6141818|NCT01318915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6141819|NCT01318915|Antifungal Agents|antifungal agents|mesh-ancestor
6141820|NCT01318967|Furosemide|furosemide|mesh-list
6141821|NCT01318967|Diuretics|diuretics|mesh-ancestor
6141822|NCT01318967|Natriuretic Agents|natriuretic agents|mesh-ancestor
6141823|NCT01318967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141824|NCT01318967|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6141825|NCT01318967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6141826|NCT01318967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141827|NCT01319045|Iloprost|iloprost|mesh-list
6141828|NCT01319045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6141829|NCT01319045|Vasodilator Agents|vasodilator agents|mesh-ancestor
6141830|NCT01319110|Ubiquinone|ubiquinone|mesh-list
6141831|NCT01319110|Coenzyme Q10|coenzyme q10|mesh-list
6141832|NCT01319110|Micronutrients|micronutrients|mesh-ancestor
6141833|NCT01319110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141834|NCT01319110|Vitamins|vitamins|mesh-ancestor
6141835|NCT01319383|Vorinostat|vorinostat|mesh-list
6141836|NCT01319383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6141837|NCT01319383|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6141838|NCT01319383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6141839|NCT01319383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141840|NCT01319422|Pomalidomide|pomalidomide|mesh-list
6141841|NCT01319422|Immunologic Factors|immunologic factors|mesh-ancestor
6141842|NCT01319422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141843|NCT01319422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6141844|NCT01319422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6141845|NCT01319422|Growth Substances|growth substances|mesh-ancestor
6141846|NCT01319422|Growth Inhibitors|growth inhibitors|mesh-ancestor
6141847|NCT01319422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6141848|NCT01319721|Mitomycins|mitomycins|mesh-list
6141849|NCT01319721|Mitomycin|mitomycin|mesh-list
6141850|NCT01319721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6141851|NCT01319721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6141852|NCT01319721|Alkylating Agents|alkylating agents|mesh-ancestor
6141853|NCT01319721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141854|NCT01319721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6141855|NCT01319721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6141856|NCT01319773|Cyclosporine|cyclosporine|mesh-list
6141857|NCT01319773|Cyclosporins|cyclosporins|mesh-list
6141858|NCT01319773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6141859|NCT01319773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141860|NCT01319773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6141861|NCT01319773|Immunologic Factors|immunologic factors|mesh-ancestor
6141862|NCT01319773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141863|NCT01319773|Antifungal Agents|antifungal agents|mesh-ancestor
6141864|NCT01319773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6141865|NCT01319773|Dermatologic Agents|dermatologic agents|mesh-ancestor
6141866|NCT01319773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6141867|NCT01319773|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6141868|NCT01319851|Alefacept|alefacept|mesh-list
6141869|NCT01319851|Dermatologic Agents|dermatologic agents|mesh-ancestor
5545665|NCT04134897|Oxaliplatin|oxaliplatin|mesh-list
5545666|NCT04134897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5545667|NCT04134897|Antimetabolites|antimetabolites|mesh-ancestor
6141870|NCT01319851|Immunologic Factors|immunologic factors|mesh-ancestor
6141871|NCT01319851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141872|NCT01319994|Metformin|metformin|mesh-list
6141873|NCT01319994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6141874|NCT01319994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141875|NCT01320033|Doxycycline|doxycycline|mesh-list
6141876|NCT01320033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6141877|NCT01320033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6141878|NCT01320033|Antimalarials|antimalarials|mesh-ancestor
6141879|NCT01320033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6141880|NCT01320033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6141881|NCT01320202|Dialysis Solutions|dialysis solutions|mesh-list
6141882|NCT01320202|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6141883|NCT01320293|Adalimumab|adalimumab|mesh-list
6141884|NCT01320293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6141885|NCT01320293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6141886|NCT01320722|Vitamin D|vitamin d|mesh-list
6141887|NCT01320722|Ergocalciferols|ergocalciferols|mesh-list
6141888|NCT01320722|Vitamins|vitamins|mesh-list
6141889|NCT01320722|Allopurinol|allopurinol|mesh-list
6471831|NCT00502229|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6471832|NCT00502229|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6471833|NCT00502268|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
5545668|NCT04134897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545669|NCT04134897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5545670|NCT04134936|Lenalidomide|lenalidomide|mesh-list
5545671|NCT04134936|Immunologic Factors|immunologic factors|mesh-ancestor
6471834|NCT00502268|Ergocalciferols|ergocalciferols|mesh-list
6471835|NCT00502268|Vitamins|vitamins|mesh-ancestor
6471836|NCT00502268|Micronutrients|micronutrients|mesh-ancestor
6471837|NCT00502268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471838|NCT00502268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6471839|NCT00502268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6141890|NCT01320722|Probenecid|probenecid|mesh-list
6141891|NCT01320722|Micronutrients|micronutrients|mesh-ancestor
6141892|NCT01320722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141893|NCT01320722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6141894|NCT01320722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6141895|NCT01320722|Antimetabolites|antimetabolites|mesh-ancestor
6141896|NCT01320722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141897|NCT01320722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6141898|NCT01320722|Gout Suppressants|gout suppressants|mesh-ancestor
6141899|NCT01320722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6141900|NCT01320722|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6141901|NCT01320722|Antioxidants|antioxidants|mesh-ancestor
6141902|NCT01320722|Protective Agents|protective agents|mesh-ancestor
6141903|NCT01320722|Uricosuric Agents|uricosuric agents|mesh-ancestor
6141904|NCT01320722|Renal Agents|renal agents|mesh-ancestor
6141905|NCT01321073|Treprostinil|treprostinil|mesh-list
6141906|NCT01321073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6141907|NCT01321151|Resveratrol|resveratrol|mesh-list
6141908|NCT01321151|Antioxidants|antioxidants|mesh-ancestor
6141909|NCT01321151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141910|NCT01321151|Protective Agents|protective agents|mesh-ancestor
6141911|NCT01321151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141912|NCT01321151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6141913|NCT01321151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6141914|NCT01321437|Axitinib|axitinib|mesh-list
6141915|NCT01321437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6141916|NCT01321437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6141917|NCT01321437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6141918|NCT01321437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545672|NCT04134936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545673|NCT04134936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5545674|NCT04134936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5545675|NCT04134936|Growth Substances|growth substances|mesh-ancestor
5545676|NCT04134936|Growth Inhibitors|growth inhibitors|mesh-ancestor
5545677|NCT04134936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5545678|NCT04135014|Midazolam|midazolam|mesh-list
5545679|NCT04135014|Dexmedetomidine|dexmedetomidine|mesh-list
6141919|NCT01321541|Gemcitabine|gemcitabine|mesh-list
6141920|NCT01321541|Rituximab|rituximab|mesh-list
6141921|NCT01321541|Pixantrone|pixantrone|mesh-list
6141922|NCT01321541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6141923|NCT01321541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6471840|NCT00502294|Visilizumab|visilizumab|mesh-list
6471841|NCT00502294|Immunologic Factors|immunologic factors|mesh-ancestor
6471842|NCT00502294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488622|NCT00585442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6488623|NCT00585442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6488624|NCT00585442|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6488625|NCT00585442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6488626|NCT00585442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488627|NCT00585442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6488628|NCT00585455|Sertraline|sertraline|mesh-list
6488629|NCT00585455|Antidepressive Agents|antidepressive agents|mesh-ancestor
6488630|NCT00585455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6488631|NCT00585455|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6488632|NCT00585455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6488633|NCT00585455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6141924|NCT01321541|Immunologic Factors|immunologic factors|mesh-ancestor
6141925|NCT01321541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141926|NCT01321541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6141927|NCT01321541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6141928|NCT01321541|Antimetabolites|antimetabolites|mesh-ancestor
6141929|NCT01321541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141930|NCT01321541|Antiviral Agents|antiviral agents|mesh-ancestor
6141931|NCT01321541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6141932|NCT01321541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6141933|NCT01321541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6141934|NCT01321541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6141935|NCT01321541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6141936|NCT01321554|Lenvatinib|lenvatinib|mesh-list
6141937|NCT01321554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6141938|NCT01321554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6141939|NCT01321554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6141940|NCT01321554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141941|NCT01321710|Acetaminophen|acetaminophen|mesh-list
6141942|NCT01321710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6141943|NCT01321710|Analgesics|analgesics|mesh-ancestor
6141944|NCT01321710|Sensory System Agents|sensory system agents|mesh-ancestor
6141945|NCT01321710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6141946|NCT01321710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141947|NCT01321710|Antipyretics|antipyretics|mesh-ancestor
6141948|NCT01321723|Teriparatide|teriparatide|mesh-list
6141949|NCT01321723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6141950|NCT01321723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141951|NCT01321723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6141952|NCT01321879|Telavancin|telavancin|mesh-list
6141953|NCT01321879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6141954|NCT01321879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6141955|NCT01322009|Acetylcysteine|acetylcysteine|mesh-list
6141956|NCT01322009|Probenecid|probenecid|mesh-list
6141957|NCT01322009|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6141958|NCT01322009|Antiviral Agents|antiviral agents|mesh-ancestor
5545680|NCT04135014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5545681|NCT04135014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5545682|NCT04135014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545683|NCT04135014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5545684|NCT04135014|Analgesics|analgesics|mesh-ancestor
5545685|NCT04135014|Sensory System Agents|sensory system agents|mesh-ancestor
5545686|NCT04135014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5545687|NCT04135014|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6141959|NCT01322009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6141960|NCT01322009|Expectorants|expectorants|mesh-ancestor
6141961|NCT01322009|Respiratory System Agents|respiratory system agents|mesh-ancestor
6141962|NCT01322009|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6141963|NCT01322009|Antioxidants|antioxidants|mesh-ancestor
6141964|NCT01322009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141965|NCT01322009|Protective Agents|protective agents|mesh-ancestor
6141966|NCT01322009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141967|NCT01322009|Antidotes|antidotes|mesh-ancestor
6141968|NCT01322009|Uricosuric Agents|uricosuric agents|mesh-ancestor
6141969|NCT01322009|Gout Suppressants|gout suppressants|mesh-ancestor
6141970|NCT01322009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6141971|NCT01322009|Renal Agents|renal agents|mesh-ancestor
6141972|NCT01322048|Propranolol|propranolol|mesh-list
6141973|NCT01322048|Clonidine|clonidine|mesh-list
6141974|NCT01322048|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6141975|NCT01322048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6141976|NCT01322048|Adrenergic Agents|adrenergic agents|mesh-ancestor
6141977|NCT01322048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6141978|NCT01322048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6141979|NCT01322048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141980|NCT01322048|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6141981|NCT01322048|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6141982|NCT01322048|Vasodilator Agents|vasodilator agents|mesh-ancestor
6141983|NCT01322048|Analgesics|analgesics|mesh-ancestor
6141984|NCT01322048|Sensory System Agents|sensory system agents|mesh-ancestor
6141985|NCT01322048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6141986|NCT01322048|Sympatholytics|sympatholytics|mesh-ancestor
6141987|NCT01322048|Autonomic Agents|autonomic agents|mesh-ancestor
6141988|NCT01322048|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6141989|NCT01322048|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6141990|NCT01322048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6141991|NCT01322347|Dialysis Solutions|dialysis solutions|mesh-list
6141992|NCT01322347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6141993|NCT01322360|Morphine|morphine|mesh-list
6141994|NCT01322360|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6141995|NCT01322360|Narcotics|narcotics|mesh-ancestor
6141996|NCT01322360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6141997|NCT01322360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6141998|NCT01322360|Analgesics|analgesics|mesh-ancestor
6141999|NCT01322360|Sensory System Agents|sensory system agents|mesh-ancestor
5545688|NCT04135014|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5545689|NCT04135014|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5545690|NCT04135014|Adrenergic Agents|adrenergic agents|mesh-ancestor
5545691|NCT04135014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5545692|NCT04135014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545693|NCT04135014|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5545694|NCT04135014|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5545695|NCT04135014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5545696|NCT04135014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5545697|NCT04135014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5545698|NCT04135014|Anesthetics, General|anesthetics, general|mesh-ancestor
5545699|NCT04135014|Anesthetics|anesthetics|mesh-ancestor
5545700|NCT04135014|GABA Modulators|gaba modulators|mesh-ancestor
5545701|NCT04135014|GABA Agents|gaba agents|mesh-ancestor
6142000|NCT01322360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6142001|NCT01322386|Vancomycin|vancomycin|mesh-list
6142002|NCT01322386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6471843|NCT00502385|Cediranib|cediranib|mesh-list
6471844|NCT00502385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6471845|NCT00502385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6471846|NCT00502385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6471847|NCT00502385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666805|NCT01524497|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5545702|NCT04134611|Hyaluronic Acid|hyaluronic acid|mesh-list
6142003|NCT01322386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6142004|NCT01322490|Molgramostim|molgramostim|mesh-list
5545703|NCT04134611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5545704|NCT04134611|Immunologic Factors|immunologic factors|mesh-ancestor
5545705|NCT04134611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545706|NCT04134611|Viscosupplements|viscosupplements|mesh-ancestor
5545707|NCT04134611|Protective Agents|protective agents|mesh-ancestor
5545708|NCT04134650|Metformin|metformin|mesh-list
5545709|NCT04134650|Linagliptin|linagliptin|mesh-list
5545710|NCT04134650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5545711|NCT04134650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545712|NCT04134650|Incretins|incretins|mesh-ancestor
5545713|NCT04134650|Hormones|hormones|mesh-ancestor
5545714|NCT04134650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5545715|NCT04134650|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5545716|NCT04134650|Protease Inhibitors|protease inhibitors|mesh-ancestor
5545717|NCT04134650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5545718|NCT04134650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471848|NCT00502411|Doxorubicin|doxorubicin|mesh-list
5545719|NCT04134442|Bupivacaine|bupivacaine|mesh-list
5545720|NCT04134442|Anesthetics, Local|anesthetics, local|mesh-ancestor
5545721|NCT04134442|Anesthetics|anesthetics|mesh-ancestor
5545722|NCT04134442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5545723|NCT04134442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545724|NCT04134442|Sensory System Agents|sensory system agents|mesh-ancestor
5545725|NCT04134442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5602595|NCT04353271|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5602596|NCT04353271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5602597|NCT04353271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5602598|NCT04353271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602599|NCT04353271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5602600|NCT04335669|Paclitaxel|paclitaxel|mesh-list
5602601|NCT04335669|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5602602|NCT04335669|Cyclophosphamide|cyclophosphamide|mesh-list
6142005|NCT01322490|Sargramostim|sargramostim|mesh-list
6142006|NCT01322490|Immunologic Factors|immunologic factors|mesh-ancestor
6471849|NCT00502411|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6471850|NCT00502411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6471851|NCT00502411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6471852|NCT00502411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6471853|NCT00502411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6471854|NCT00502411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6471855|NCT00502411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471856|NCT00502437|Granisetron|granisetron|mesh-list
6666806|NCT01524497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6142007|NCT01322490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142008|NCT01322490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6205434|NCT02085161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6205435|NCT02085161|Autonomic Agents|autonomic agents|mesh-ancestor
6205436|NCT02085161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6205437|NCT02085161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205438|NCT02085161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6205439|NCT02085161|Respiratory System Agents|respiratory system agents|mesh-ancestor
6205440|NCT02085161|Parasympatholytics|parasympatholytics|mesh-ancestor
6205441|NCT02085161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6205442|NCT02085161|Cholinergic Agents|cholinergic agents|mesh-ancestor
6471857|NCT00502437|Antiemetics|antiemetics|mesh-ancestor
6666807|NCT01524497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666808|NCT01524497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6666809|NCT01524497|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5602603|NCT04335669|Carboplatin|carboplatin|mesh-list
5602604|NCT04335669|Capecitabine|capecitabine|mesh-list
5545726|NCT04134715|Contraceptive Agents|contraceptive agents|mesh-list
5545727|NCT04134715|Contraceptives, Oral|contraceptives, oral|mesh-list
5545728|NCT04134715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5545729|NCT04134715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545730|NCT04134715|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5545731|NCT04134468|Gemcitabine|gemcitabine|mesh-list
5545732|NCT04134468|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5545733|NCT04134468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5545734|NCT04134468|Antimetabolites|antimetabolites|mesh-ancestor
5545735|NCT04134468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142009|NCT01322815|Leucovorin|leucovorin|mesh-list
6142010|NCT01322815|Fluorouracil|fluorouracil|mesh-list
6142011|NCT01322815|Oxaliplatin|oxaliplatin|mesh-list
6142012|NCT01322815|Irinotecan|irinotecan|mesh-list
6142013|NCT01322815|Bevacizumab|bevacizumab|mesh-list
6142014|NCT01322815|Levoleucovorin|levoleucovorin|mesh-list
6471858|NCT00502437|Autonomic Agents|autonomic agents|mesh-ancestor
6471859|NCT00502437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6471860|NCT00502437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471861|NCT00502437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6471862|NCT00502437|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6471863|NCT00502437|Serotonin Agents|serotonin agents|mesh-ancestor
6471864|NCT00502437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6471865|NCT00502437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471866|NCT00502476|Chlorhexidine|chlorhexidine|mesh-list
6471867|NCT00502476|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6471868|NCT00502476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6471869|NCT00502476|Disinfectants|disinfectants|mesh-ancestor
6471870|NCT00502528|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
6471871|NCT00502528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6471872|NCT00502528|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6471873|NCT00502528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471874|NCT00502541|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
6471875|NCT00502541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5545736|NCT04134468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5545737|NCT04134468|Antiviral Agents|antiviral agents|mesh-ancestor
6142015|NCT01322815|Antimetabolites|antimetabolites|mesh-ancestor
6142016|NCT01322815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142017|NCT01322815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6142018|NCT01322815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6142019|NCT01322815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6142020|NCT01322815|Immunologic Factors|immunologic factors|mesh-ancestor
6142021|NCT01322815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142022|NCT01322815|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6142023|NCT01322815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6142024|NCT01322815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6142025|NCT01322815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5545738|NCT04134468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5545739|NCT04134468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5545740|NCT04134468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5545741|NCT04134468|Immunologic Factors|immunologic factors|mesh-ancestor
5545742|NCT04134468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545743|NCT04134559|Pembrolizumab|pembrolizumab|mesh-list
5545744|NCT04134559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5545745|NCT04134559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5545746|NCT04134416|Donepezil|donepezil|mesh-list
5545747|NCT04134416|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5545748|NCT04134416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5545749|NCT04134416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545750|NCT04134416|Cholinergic Agents|cholinergic agents|mesh-ancestor
5545751|NCT04134416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6142026|NCT01322815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6142027|NCT01322815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6142028|NCT01322815|Growth Substances|growth substances|mesh-ancestor
6142029|NCT01322815|Growth Inhibitors|growth inhibitors|mesh-ancestor
6142030|NCT01322815|Antidotes|antidotes|mesh-ancestor
6142031|NCT01322815|Protective Agents|protective agents|mesh-ancestor
6142032|NCT01322815|Vitamin B Complex|vitamin b complex|mesh-ancestor
6142033|NCT01322815|Vitamins|vitamins|mesh-ancestor
6142034|NCT01322815|Micronutrients|micronutrients|mesh-ancestor
6142035|NCT01323010|Albuterol|albuterol|mesh-list
6142036|NCT01323010|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6142037|NCT01323010|Autonomic Agents|autonomic agents|mesh-ancestor
6142038|NCT01323010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6142039|NCT01323010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142040|NCT01323010|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6142041|NCT01323010|Respiratory System Agents|respiratory system agents|mesh-ancestor
6142042|NCT01323010|Tocolytic Agents|tocolytic agents|mesh-ancestor
6471876|NCT00502541|Glucocorticoids|glucocorticoids|mesh-ancestor
6471877|NCT00502541|Hormones|hormones|mesh-ancestor
6471878|NCT00502541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6471879|NCT00502541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471880|NCT00502567|Leucovorin|leucovorin|mesh-list
6471881|NCT00502567|Docetaxel|docetaxel|mesh-list
6142043|NCT01323010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6142044|NCT01323010|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6142045|NCT01323010|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6142046|NCT01323010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6142047|NCT01323010|Adrenergic Agents|adrenergic agents|mesh-ancestor
6142048|NCT01323010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6142049|NCT01323010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142050|NCT01323140|Testosterone|testosterone|mesh-list
6142051|NCT01323140|Androgens|androgens|mesh-ancestor
6142052|NCT01323140|Hormones|hormones|mesh-ancestor
6142053|NCT01323140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6142054|NCT01323140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142055|NCT01323153|Dalcetrapib|dalcetrapib|mesh-list
6142056|NCT01323153|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6142057|NCT01323153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6142058|NCT01323153|Antimetabolites|antimetabolites|mesh-ancestor
6142059|NCT01323153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142060|NCT01323153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6142061|NCT01323478|Vortioxetine|vortioxetine|mesh-list
6142062|NCT01323478|Antidepressive Agents|antidepressive agents|mesh-ancestor
6142063|NCT01323478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6142064|NCT01323478|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6471882|NCT00502567|Fluorouracil|fluorouracil|mesh-list
6471883|NCT00502567|Oxaliplatin|oxaliplatin|mesh-list
6471884|NCT00502567|Irinotecan|irinotecan|mesh-list
6471885|NCT00502567|Pemetrexed|pemetrexed|mesh-list
6471886|NCT00502567|Cetuximab|cetuximab|mesh-list
6471887|NCT00502567|Cediranib|cediranib|mesh-list
6471888|NCT00502567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6471889|NCT00502567|Tubulin Modulators|tubulin modulators|mesh-ancestor
6471890|NCT00502567|Antimitotic Agents|antimitotic agents|mesh-ancestor
5545752|NCT04134416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545753|NCT04134416|Nootropic Agents|nootropic agents|mesh-ancestor
5545754|NCT04134182|Nivolumab|nivolumab|mesh-list
5545755|NCT04134182|Ipilimumab|ipilimumab|mesh-list
5545756|NCT04134182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5545757|NCT04134182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5545758|NCT04134182|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5545759|NCT04134182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545760|NCT04134130|Methyltestosterone|methyltestosterone|mesh-list
5545761|NCT04134130|Testosterone|testosterone|mesh-list
5545762|NCT04134130|Testosterone undecanoate|testosterone undecanoate|mesh-list
5545763|NCT04134130|Testosterone enanthate|testosterone enanthate|mesh-list
5545764|NCT04134130|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5545765|NCT04134130|Androgens|androgens|mesh-ancestor
5545766|NCT04134130|Hormones|hormones|mesh-ancestor
5545767|NCT04134130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5545768|NCT04134130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545769|NCT04134130|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5545770|NCT04134130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5545771|NCT04134130|Anabolic Agents|anabolic agents|mesh-ancestor
5545772|NCT04134273|Clindamycin|clindamycin|mesh-list
5545773|NCT04134273|Clindamycin palmitate|clindamycin palmitate|mesh-list
5545774|NCT04134273|Clindamycin phosphate|clindamycin phosphate|mesh-list
5545775|NCT04134273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5545776|NCT04134273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5545777|NCT04134273|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6471891|NCT00502567|Mitosis Modulators|mitosis modulators|mesh-ancestor
6471892|NCT00502567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471893|NCT00502567|Antimetabolites|antimetabolites|mesh-ancestor
6471894|NCT00502567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6471895|NCT00502567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6471896|NCT00502567|Immunologic Factors|immunologic factors|mesh-ancestor
6471897|NCT00502567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545778|NCT04134273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6142065|NCT01323478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6471898|NCT00502567|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6471899|NCT00502567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6471900|NCT00502567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6471901|NCT00502567|Antidotes|antidotes|mesh-ancestor
6471902|NCT00502567|Protective Agents|protective agents|mesh-ancestor
6471903|NCT00502567|Vitamin B Complex|vitamin b complex|mesh-ancestor
6471904|NCT00502567|Vitamins|vitamins|mesh-ancestor
6142066|NCT01323478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6142067|NCT01323478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142068|NCT01323478|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6142069|NCT01323478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6142070|NCT01323478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6142071|NCT01323478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142072|NCT01323478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6666810|NCT01524497|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6666811|NCT01524497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6666812|NCT01524497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666813|NCT01524497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6666814|NCT01524497|Serotonin Agents|serotonin agents|mesh-ancestor
5545779|NCT04134273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142073|NCT01323478|Serotonin Agents|serotonin agents|mesh-ancestor
6142074|NCT01323478|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6142075|NCT01323478|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6142076|NCT01323478|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6142077|NCT01323478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6142078|NCT01323517|Dactinomycin|dactinomycin|mesh-list
6142079|NCT01323517|Ipilimumab|ipilimumab|mesh-list
6142080|NCT01323517|Melphalan|melphalan|mesh-list
6142081|NCT01323517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6142082|NCT01323517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6142083|NCT01323517|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6142084|NCT01323517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142085|NCT01323517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6142086|NCT01323517|Alkylating Agents|alkylating agents|mesh-ancestor
6142087|NCT01323517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5545780|NCT04134598|Tamoxifen|tamoxifen|mesh-list
5545781|NCT04134598|Letrozole|letrozole|mesh-list
5545782|NCT04134598|Anastrozole|anastrozole|mesh-list
6142088|NCT01323517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6142089|NCT01323517|Immunologic Factors|immunologic factors|mesh-ancestor
6142090|NCT01323517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142091|NCT01323517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6142092|NCT01323517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6142093|NCT01323517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6142094|NCT01323517|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6471905|NCT00502567|Micronutrients|micronutrients|mesh-ancestor
6471906|NCT00502567|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6471907|NCT00502567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6471908|NCT00502567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5545783|NCT04134598|Exemestane|exemestane|mesh-list
5545784|NCT04134598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5545785|NCT04134598|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5545786|NCT04134598|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6142095|NCT01323517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6142096|NCT01323517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6142097|NCT01323530|Capecitabine|capecitabine|mesh-list
6142098|NCT01323530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6142099|NCT01323530|Antimetabolites|antimetabolites|mesh-ancestor
6142100|NCT01323530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545787|NCT04134598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5545788|NCT04134598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545789|NCT04134598|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5545790|NCT04134598|Hormone Antagonists|hormone antagonists|mesh-ancestor
5545791|NCT04134598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5545792|NCT04134598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545793|NCT04134598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5545794|NCT04134598|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5545795|NCT04134598|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5545796|NCT04134598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6142101|NCT01323530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6142102|NCT01323582|Azithromycin|azithromycin|mesh-list
6142103|NCT01323582|Erythromycin|erythromycin|mesh-list
6142104|NCT01323582|Erythromycin Estolate|erythromycin estolate|mesh-list
6142105|NCT01323582|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
5545797|NCT04134078|Nitric Oxide|nitric oxide|mesh-list
5545798|NCT04134078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5545799|NCT04134078|Autonomic Agents|autonomic agents|mesh-ancestor
5545800|NCT04134078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5545801|NCT04134078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545802|NCT04134078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5545803|NCT04134078|Respiratory System Agents|respiratory system agents|mesh-ancestor
5545804|NCT04134078|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6142106|NCT01323582|Erythromycin stearate|erythromycin stearate|mesh-list
6142107|NCT01323582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6142108|NCT01323582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6142109|NCT01323582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6142110|NCT01323582|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6142111|NCT01323582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6142112|NCT01323582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142113|NCT01323595|Celecoxib|celecoxib|mesh-list
6142114|NCT01323595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6142115|NCT01323595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5545805|NCT04134078|Antioxidants|antioxidants|mesh-ancestor
5545806|NCT04134078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545807|NCT04134078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5545808|NCT04134078|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5545809|NCT04134078|Vasodilator Agents|vasodilator agents|mesh-ancestor
5545810|NCT04134078|Gasotransmitters|gasotransmitters|mesh-ancestor
5545811|NCT04134078|Protective Agents|protective agents|mesh-ancestor
5545812|NCT04134065|Vitamin D|vitamin d|mesh-list
5545813|NCT04134065|Vitamins|vitamins|mesh-ancestor
5545814|NCT04134065|Micronutrients|micronutrients|mesh-ancestor
5545815|NCT04134065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545816|NCT04134065|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5545817|NCT04134052|Midazolam|midazolam|mesh-list
5545818|NCT04134052|Ketamine|ketamine|mesh-list
5545819|NCT04134052|Analgesics|analgesics|mesh-ancestor
5545820|NCT04134052|Sensory System Agents|sensory system agents|mesh-ancestor
5545821|NCT04134052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5545822|NCT04134052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545823|NCT04134052|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5545824|NCT04134052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5545825|NCT04134052|Anesthetics, General|anesthetics, general|mesh-ancestor
5545826|NCT04134052|Anesthetics|anesthetics|mesh-ancestor
5545827|NCT04134052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5545828|NCT04134052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5545829|NCT04134052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5545830|NCT04134052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5545831|NCT04134052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545832|NCT04134052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5545833|NCT04134052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5545834|NCT04134052|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5545835|NCT04134052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5545836|NCT04134052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5545837|NCT04134052|GABA Modulators|gaba modulators|mesh-ancestor
5545838|NCT04134052|GABA Agents|gaba agents|mesh-ancestor
5545839|NCT04133961|Phenylephrine|phenylephrine|mesh-list
5545840|NCT04133961|Oxymetazoline|oxymetazoline|mesh-list
6142116|NCT01323595|Analgesics|analgesics|mesh-ancestor
6142117|NCT01323595|Sensory System Agents|sensory system agents|mesh-ancestor
6142118|NCT01323595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6142119|NCT01323595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142120|NCT01323595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6142121|NCT01323595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5545841|NCT04133961|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5545842|NCT04133961|Mydriatics|mydriatics|mesh-ancestor
5545843|NCT04133961|Autonomic Agents|autonomic agents|mesh-ancestor
5545844|NCT04133961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5545845|NCT04133961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545846|NCT04133961|Sympathomimetics|sympathomimetics|mesh-ancestor
5545847|NCT04133961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5545848|NCT04133961|Nasal Decongestants|nasal decongestants|mesh-ancestor
5545849|NCT04133961|Respiratory System Agents|respiratory system agents|mesh-ancestor
5545850|NCT04133961|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6142122|NCT01323595|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6142123|NCT01323595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6142124|NCT01323595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6142125|NCT01323595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142126|NCT01323621|Fluticasone|fluticasone|mesh-list
6142127|NCT01323621|Xhance|xhance|mesh-list
6142128|NCT01323621|Albuterol|albuterol|mesh-list
6142129|NCT01323621|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6142130|NCT01323621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6142131|NCT01323621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6471909|NCT00502567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5545851|NCT04133961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5545852|NCT04133961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5545853|NCT04133961|Adrenergic Agents|adrenergic agents|mesh-ancestor
5545854|NCT04133961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5545855|NCT04133961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545856|NCT04133961|Protective Agents|protective agents|mesh-ancestor
5545857|NCT04133922|Insulin|insulin|mesh-list
5545858|NCT04133922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5545859|NCT04133922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545860|NCT04133948|Nivolumab|nivolumab|mesh-list
5545861|NCT04133948|Ipilimumab|ipilimumab|mesh-list
5545862|NCT04133948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5545863|NCT04133948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5545864|NCT04133948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5545865|NCT04133948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545866|NCT04134026|Epoetin Alfa|epoetin alfa|mesh-list
5545867|NCT04134026|Hematinics|hematinics|mesh-ancestor
5545868|NCT04133974|Methadone|methadone|mesh-list
5545869|NCT04133974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5545870|NCT04133974|Narcotics|narcotics|mesh-ancestor
5545871|NCT04133974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5545872|NCT04133974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545873|NCT04133974|Analgesics|analgesics|mesh-ancestor
5545874|NCT04133974|Sensory System Agents|sensory system agents|mesh-ancestor
5545875|NCT04133974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5545876|NCT04133974|Antitussive Agents|antitussive agents|mesh-ancestor
5545877|NCT04133974|Respiratory System Agents|respiratory system agents|mesh-ancestor
5545878|NCT04134637|Bupivacaine|bupivacaine|mesh-list
5545879|NCT04134637|Anesthetics, Local|anesthetics, local|mesh-ancestor
5545880|NCT04134637|Anesthetics|anesthetics|mesh-ancestor
5545881|NCT04134637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6471910|NCT00502658|Vitamins|vitamins|mesh-list
6471911|NCT00502658|Micronutrients|micronutrients|mesh-ancestor
6471912|NCT00502658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471913|NCT00502684|Etodolac|etodolac|mesh-list
6471914|NCT00502684|Propranolol|propranolol|mesh-list
6471915|NCT00502684|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6471916|NCT00502684|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6471917|NCT00502684|Adrenergic Agents|adrenergic agents|mesh-ancestor
6471918|NCT00502684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6471919|NCT00502684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471920|NCT00502684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471921|NCT00502684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5545882|NCT04134637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142132|NCT01323621|Autonomic Agents|autonomic agents|mesh-ancestor
6142133|NCT01323621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6142134|NCT01323621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142135|NCT01323621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6142136|NCT01323621|Respiratory System Agents|respiratory system agents|mesh-ancestor
6142137|NCT01323621|Dermatologic Agents|dermatologic agents|mesh-ancestor
6142138|NCT01323621|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6142139|NCT01323621|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6142140|NCT01323621|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6142141|NCT01323621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6142142|NCT01323621|Adrenergic Agents|adrenergic agents|mesh-ancestor
5545883|NCT04134637|Sensory System Agents|sensory system agents|mesh-ancestor
5545884|NCT04134637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5545885|NCT04133571|Lidocaine|lidocaine|mesh-list
5545886|NCT04133571|Anesthetics, Local|anesthetics, local|mesh-ancestor
5545887|NCT04133571|Anesthetics|anesthetics|mesh-ancestor
5545888|NCT04133571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6471922|NCT00502684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6471923|NCT00502684|Vasodilator Agents|vasodilator agents|mesh-ancestor
6471924|NCT00502684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6471925|NCT00502684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6471926|NCT00502684|Analgesics|analgesics|mesh-ancestor
6471927|NCT00502684|Sensory System Agents|sensory system agents|mesh-ancestor
6471928|NCT00502684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6471929|NCT00502684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5545889|NCT04133571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545890|NCT04133571|Sensory System Agents|sensory system agents|mesh-ancestor
5545891|NCT04133571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5545892|NCT04133571|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6142143|NCT01323621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6142144|NCT01323621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142145|NCT01323621|Tocolytic Agents|tocolytic agents|mesh-ancestor
6142146|NCT01323621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6142147|NCT01323634|Fluticasone|fluticasone|mesh-list
6142148|NCT01323634|Xhance|xhance|mesh-list
6142149|NCT01323634|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6142150|NCT01323634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6142151|NCT01323634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6142152|NCT01323634|Autonomic Agents|autonomic agents|mesh-ancestor
6142153|NCT01323634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6142154|NCT01323634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545893|NCT04133571|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5545894|NCT04133571|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5545895|NCT04133571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5545896|NCT04133571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545897|NCT04133792|Simvastatin|simvastatin|mesh-list
5545898|NCT04133792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5545899|NCT04133792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5545900|NCT04133792|Antimetabolites|antimetabolites|mesh-ancestor
5545901|NCT04133792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545902|NCT04133792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5545903|NCT04133792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5545904|NCT04133792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5545905|NCT04133428|Valsartan|valsartan|mesh-list
5545906|NCT04133428|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5545907|NCT04133428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5545908|NCT04133428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5545909|NCT04133428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5545910|NCT04133428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545911|NCT04133155|Gemcitabine|gemcitabine|mesh-list
5545912|NCT04133155|Paclitaxel|paclitaxel|mesh-list
5545913|NCT04133155|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5545914|NCT04133155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5545915|NCT04133155|Tubulin Modulators|tubulin modulators|mesh-ancestor
5545916|NCT04133155|Antimitotic Agents|antimitotic agents|mesh-ancestor
5545917|NCT04133155|Mitosis Modulators|mitosis modulators|mesh-ancestor
5545918|NCT04133155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545919|NCT04133155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5545920|NCT04133155|Antimetabolites|antimetabolites|mesh-ancestor
5545921|NCT04133155|Antiviral Agents|antiviral agents|mesh-ancestor
5545922|NCT04133155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5545923|NCT04133155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5545924|NCT04133155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5545925|NCT04133155|Immunologic Factors|immunologic factors|mesh-ancestor
5545926|NCT04133155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142155|NCT01323634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6142156|NCT01323634|Respiratory System Agents|respiratory system agents|mesh-ancestor
6142157|NCT01323634|Dermatologic Agents|dermatologic agents|mesh-ancestor
6142158|NCT01323634|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6142159|NCT01323634|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6142160|NCT01323634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6142161|NCT01323634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6142162|NCT01323634|Adrenergic Agents|adrenergic agents|mesh-ancestor
6471930|NCT00502684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6142163|NCT01323634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6142164|NCT01323634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142165|NCT01323673|Clobetasol|clobetasol|mesh-list
6142166|NCT01323673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6142167|NCT01323673|Glucocorticoids|glucocorticoids|mesh-ancestor
6142168|NCT01323673|Hormones|hormones|mesh-ancestor
6142169|NCT01323673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6142170|NCT01323673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666815|NCT01524497|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6666816|NCT01524497|Antidepressive Agents|antidepressive agents|mesh-ancestor
6666817|NCT01524575|Gemcitabine|gemcitabine|mesh-list
6666818|NCT01524575|Oxaliplatin|oxaliplatin|mesh-list
6666819|NCT01524575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6142171|NCT01323790|Naloxegol|naloxegol|mesh-list
6142172|NCT01323790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5545927|NCT04133311|Latanoprost|latanoprost|mesh-list
5545928|NCT04133311|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5545929|NCT04133311|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5545930|NCT04133337|Apatinib|apatinib|mesh-list
5545931|NCT04133337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5545932|NCT04133337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5545933|NCT04133337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5545934|NCT04133337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545935|NCT04133506|Aspirin|aspirin|mesh-list
5545936|NCT04133506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5545937|NCT04133506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5545938|NCT04133506|Analgesics|analgesics|mesh-ancestor
5545939|NCT04133506|Sensory System Agents|sensory system agents|mesh-ancestor
5545940|NCT04133506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5545941|NCT04133506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545942|NCT04133506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5545943|NCT04133506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5545944|NCT04133506|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5545945|NCT04133506|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5545946|NCT04133506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545947|NCT04133506|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5545948|NCT04133506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5545949|NCT04133506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5545950|NCT04133506|Antipyretics|antipyretics|mesh-ancestor
5545951|NCT04133194|Mesalamine|mesalamine|mesh-list
5545952|NCT04133194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6142173|NCT01323790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142174|NCT01323790|Sensory System Agents|sensory system agents|mesh-ancestor
6142175|NCT01323790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6142176|NCT01323920|Methotrexate|methotrexate|mesh-list
6471931|NCT00502684|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6471932|NCT00502684|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6471933|NCT00502684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6471934|NCT00502736|Ibandronic Acid|ibandronic acid|mesh-list
6471935|NCT00502736|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6471936|NCT00502736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471937|NCT00502762|Topotecan|topotecan|mesh-list
6471938|NCT00502762|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6471939|NCT00502762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6471940|NCT00502762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6142177|NCT01323920|Bortezomib|bortezomib|mesh-list
6142178|NCT01323920|Tacrolimus|tacrolimus|mesh-list
6142179|NCT01323920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6142180|NCT01323920|Abortifacient Agents|abortifacient agents|mesh-ancestor
6142181|NCT01323920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6142182|NCT01323920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142183|NCT01323920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6142184|NCT01323920|Antimetabolites|antimetabolites|mesh-ancestor
5545953|NCT04133194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5545954|NCT04133194|Analgesics|analgesics|mesh-ancestor
5545955|NCT04133194|Sensory System Agents|sensory system agents|mesh-ancestor
5545956|NCT04133194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5545957|NCT04133194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545958|NCT04133194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5545959|NCT04133194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5545960|NCT04133259|Tenofovir|tenofovir|mesh-list
5545961|NCT04133259|Entecavir|entecavir|mesh-list
5545962|NCT04133259|Antibodies|antibodies|mesh-list
5545963|NCT04133259|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6666820|NCT01524575|Antimetabolites|antimetabolites|mesh-ancestor
5545964|NCT04133259|Immunologic Factors|immunologic factors|mesh-ancestor
5545965|NCT04133259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545966|NCT04133259|Antiviral Agents|antiviral agents|mesh-ancestor
5545967|NCT04133259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5545968|NCT04133259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5545969|NCT04133259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5545970|NCT04133259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5545971|NCT04133259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545972|NCT04133259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5545973|NCT04133259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5545974|NCT04133480|Cannabidiol|cannabidiol|mesh-list
5545975|NCT04133480|Anticonvulsants|anticonvulsants|mesh-ancestor
5545976|NCT04132791|Aspirin|aspirin|mesh-list
5545977|NCT04132791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5545978|NCT04132791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5545979|NCT04132791|Analgesics|analgesics|mesh-ancestor
5545980|NCT04132791|Sensory System Agents|sensory system agents|mesh-ancestor
5545981|NCT04132791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5545982|NCT04132791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545983|NCT04132791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5545984|NCT04132791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5545985|NCT04132791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5545986|NCT04132791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5545987|NCT04132791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5545988|NCT04132791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5545989|NCT04132791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5545990|NCT04132791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5545991|NCT04132791|Antipyretics|antipyretics|mesh-ancestor
5545992|NCT04133051|Bupivacaine|bupivacaine|mesh-list
5545993|NCT04133051|Anesthetics, Local|anesthetics, local|mesh-ancestor
5545994|NCT04133051|Anesthetics|anesthetics|mesh-ancestor
5545995|NCT04133051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5545996|NCT04133051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5545997|NCT04133051|Sensory System Agents|sensory system agents|mesh-ancestor
5545998|NCT04133051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5602605|NCT04335669|Epirubicin|epirubicin|mesh-list
6142185|NCT01323920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142186|NCT01323920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6142187|NCT01323920|Dermatologic Agents|dermatologic agents|mesh-ancestor
6142188|NCT01323920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6142189|NCT01323920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6142190|NCT01323920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6142191|NCT01323920|Immunologic Factors|immunologic factors|mesh-ancestor
6471941|NCT00502762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471942|NCT00502762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6471943|NCT00502788|Ribavirin|ribavirin|mesh-list
6471944|NCT00502788|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6471945|NCT00502788|Antimetabolites|antimetabolites|mesh-ancestor
6471946|NCT00502788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471947|NCT00502788|Antiviral Agents|antiviral agents|mesh-ancestor
6471948|NCT00502788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6471949|NCT00502879|Etanercept|etanercept|mesh-list
6471950|NCT00502879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6471951|NCT00502879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6471952|NCT00502879|Analgesics|analgesics|mesh-ancestor
6471953|NCT00502879|Sensory System Agents|sensory system agents|mesh-ancestor
6471954|NCT00502879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6471955|NCT00502879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471956|NCT00502879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6142192|NCT01323920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6142193|NCT01323920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6142194|NCT01323920|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6142195|NCT01324024|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6142196|NCT01324024|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6142197|NCT01324024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142198|NCT01324024|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5602606|NCT04335669|Taxane|taxane|mesh-list
6142199|NCT01324024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6142200|NCT01324024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6142201|NCT01324024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142202|NCT01324024|Dopamine Agents|dopamine agents|mesh-ancestor
6142203|NCT01324024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6142204|NCT01324128|Iron|iron|mesh-list
6142205|NCT01324128|Sevelamer|sevelamer|mesh-list
5602607|NCT04335669|Antimetabolites|antimetabolites|mesh-list
6142206|NCT01324128|Trace Elements|trace elements|mesh-ancestor
6666821|NCT01524575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666822|NCT01524575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6666823|NCT01524575|Antiviral Agents|antiviral agents|mesh-ancestor
6666824|NCT01524575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6666825|NCT01524575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6666826|NCT01524575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6666827|NCT01524575|Immunologic Factors|immunologic factors|mesh-ancestor
5545999|NCT04132583|Diclofenac|diclofenac|mesh-list
6142207|NCT01324128|Micronutrients|micronutrients|mesh-ancestor
6142208|NCT01324128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471957|NCT00502879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6471958|NCT00502879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6471959|NCT00502879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6471960|NCT00502879|Immunologic Factors|immunologic factors|mesh-ancestor
6471961|NCT00502892|Carboplatin|carboplatin|mesh-list
6471962|NCT00502892|Topotecan|topotecan|mesh-list
6471963|NCT00502892|Ifosfamide|ifosfamide|mesh-list
6471964|NCT00502892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6471965|NCT00502892|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6471966|NCT00502892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6471967|NCT00502892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6471968|NCT00502892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471969|NCT00502892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6471970|NCT00502892|Alkylating Agents|alkylating agents|mesh-ancestor
6471971|NCT00502970|Interferons|interferons|mesh-list
6471972|NCT00502970|Ribavirin|ribavirin|mesh-list
6471973|NCT00502970|Iron-Dextran Complex|iron-dextran complex|mesh-list
6471974|NCT00502970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6471975|NCT00502970|Antiviral Agents|antiviral agents|mesh-ancestor
6471976|NCT00502970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6471977|NCT00502970|Antimetabolites|antimetabolites|mesh-ancestor
5546000|NCT04132583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5546001|NCT04132583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5546002|NCT04132583|Analgesics|analgesics|mesh-ancestor
5546003|NCT04132583|Sensory System Agents|sensory system agents|mesh-ancestor
5546004|NCT04132583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5546005|NCT04132583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546006|NCT04132583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5546007|NCT04132583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5546008|NCT04132583|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5546009|NCT04132583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6471978|NCT00502970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471979|NCT00502970|Hematinics|hematinics|mesh-ancestor
6471980|NCT00503035|Celecoxib|celecoxib|mesh-list
6471981|NCT00503035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6471982|NCT00503035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6471983|NCT00503035|Analgesics|analgesics|mesh-ancestor
6471984|NCT00503035|Sensory System Agents|sensory system agents|mesh-ancestor
6471985|NCT00503035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6471986|NCT00503035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6471987|NCT00503035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6471988|NCT00503035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6471989|NCT00503035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6471990|NCT00503035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6471991|NCT00503035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6471992|NCT00503035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471993|NCT00503126|Bivalirudin|bivalirudin|mesh-list
6471994|NCT00503126|Antithrombins|antithrombins|mesh-ancestor
5546010|NCT04132583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546011|NCT04132479|Amoxicillin|amoxicillin|mesh-list
5546012|NCT04132479|Clarithromycin|clarithromycin|mesh-list
5546013|NCT04132479|Tinidazole|tinidazole|mesh-list
5546014|NCT04132479|Rabeprazole|rabeprazole|mesh-list
5546015|NCT04132479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5546016|NCT04132479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5546017|NCT04132479|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5546018|NCT04132479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6471995|NCT00503126|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6666828|NCT01524575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546019|NCT04132479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546020|NCT04132479|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5546021|NCT04132479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6142209|NCT01324128|Chelating Agents|chelating agents|mesh-ancestor
6471996|NCT00503126|Protease Inhibitors|protease inhibitors|mesh-ancestor
6471997|NCT00503126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6471998|NCT00503126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6471999|NCT00503126|Anticoagulants|anticoagulants|mesh-ancestor
6472000|NCT00503152|Valsartan|valsartan|mesh-list
6472001|NCT00503152|Benazepril|benazepril|mesh-list
6472002|NCT00503152|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6472003|NCT00503152|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6472004|NCT00503152|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6472005|NCT00503152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472006|NCT00503152|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6142210|NCT01324128|Sequestering Agents|sequestering agents|mesh-ancestor
6142211|NCT01324128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142212|NCT01324141|Fluorouracil|fluorouracil|mesh-list
6142213|NCT01324141|Mitomycins|mitomycins|mesh-list
6142214|NCT01324141|Mitomycin|mitomycin|mesh-list
6142215|NCT01324141|Tempol|tempol|mesh-list
6142216|NCT01324141|Antimetabolites|antimetabolites|mesh-ancestor
6142217|NCT01324141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142218|NCT01324141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6142219|NCT01324141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6142220|NCT01324141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6472007|NCT00503152|Protease Inhibitors|protease inhibitors|mesh-ancestor
6472008|NCT00503152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6472009|NCT00503204|Cediranib|cediranib|mesh-list
6472010|NCT00503204|Lomustine|lomustine|mesh-list
6472011|NCT00503204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6142221|NCT01324141|Immunologic Factors|immunologic factors|mesh-ancestor
6142222|NCT01324141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142223|NCT01324141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6142224|NCT01324141|Alkylating Agents|alkylating agents|mesh-ancestor
6142225|NCT01324141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6142226|NCT01324141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6142227|NCT01324141|Antioxidants|antioxidants|mesh-ancestor
6142228|NCT01324141|Protective Agents|protective agents|mesh-ancestor
6142229|NCT01324141|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6142230|NCT01324141|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6142231|NCT01324141|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5546022|NCT04132479|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5546023|NCT04132479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5546024|NCT04132479|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5546025|NCT04132479|Alkylating Agents|alkylating agents|mesh-ancestor
6142232|NCT01324232|Quinidine|quinidine|mesh-list
6142233|NCT01324232|Dextromethorphan|dextromethorphan|mesh-list
6142234|NCT01324232|Antitussive Agents|antitussive agents|mesh-ancestor
6142235|NCT01324232|Respiratory System Agents|respiratory system agents|mesh-ancestor
6142236|NCT01324232|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6142237|NCT01324232|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6142238|NCT01324232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6142239|NCT01324232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142240|NCT01324232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142241|NCT01324232|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6142242|NCT01324232|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6142243|NCT01324232|Adrenergic Agents|adrenergic agents|mesh-ancestor
6142244|NCT01324232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6142245|NCT01324232|Antimalarials|antimalarials|mesh-ancestor
6142246|NCT01324232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6142247|NCT01324232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6142248|NCT01324232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6666829|NCT01524601|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6666830|NCT01524601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6666831|NCT01524601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6666832|NCT01524601|Antimetabolites|antimetabolites|mesh-ancestor
6666833|NCT01524601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142249|NCT01324232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6142250|NCT01324232|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6142251|NCT01324232|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6142252|NCT01324232|Cholinergic Agents|cholinergic agents|mesh-ancestor
6142253|NCT01324232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5546026|NCT04132479|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
5546027|NCT04132479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5546028|NCT04132479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6142254|NCT01324232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6142255|NCT01324232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6472012|NCT00503204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5546029|NCT04132674|Tenofovir|tenofovir|mesh-list
6142256|NCT01324232|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6142257|NCT01324232|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6142258|NCT01324310|Ketoconazole|ketoconazole|mesh-list
6142259|NCT01324310|Romidepsin|romidepsin|mesh-list
5546030|NCT04132674|Emtricitabine|emtricitabine|mesh-list
5546031|NCT04132674|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
5546032|NCT04132674|Antiviral Agents|antiviral agents|mesh-ancestor
5546033|NCT04132674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5546034|NCT04132674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5546035|NCT04132674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5546036|NCT04132674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5546037|NCT04132674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546038|NCT04132674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5546039|NCT04132674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5546040|NCT04132505|Hydroxychloroquine|hydroxychloroquine|mesh-list
5546041|NCT04132505|Antimalarials|antimalarials|mesh-ancestor
5546042|NCT04132505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5546043|NCT04132505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5546044|NCT04132505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5546045|NCT04132505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5546046|NCT04132505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546047|NCT04132505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6142260|NCT01324310|Antifungal Agents|antifungal agents|mesh-ancestor
6142261|NCT01324310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6142262|NCT01324310|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6142263|NCT01324310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6142264|NCT01324310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6142265|NCT01324310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546048|NCT04132661|Bisacodyl|bisacodyl|mesh-list
5546049|NCT04132661|Cathartics|cathartics|mesh-ancestor
5546050|NCT04132661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6142266|NCT01324310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6142267|NCT01324310|Hormone Antagonists|hormone antagonists|mesh-ancestor
6472013|NCT00503204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6472014|NCT00503204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472015|NCT00503204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6472016|NCT00503204|Alkylating Agents|alkylating agents|mesh-ancestor
6472017|NCT00503243|Mesalamine|mesalamine|mesh-list
6472018|NCT00503243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6472019|NCT00503243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6472020|NCT00503243|Analgesics|analgesics|mesh-ancestor
6472021|NCT00503243|Sensory System Agents|sensory system agents|mesh-ancestor
6472022|NCT00503243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6472023|NCT00503243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472024|NCT00503243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6472025|NCT00503243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6472026|NCT00503321|polysaccharide-K|polysaccharide-k|mesh-list
6472027|NCT00503321|Tegafur|tegafur|mesh-list
6472028|NCT00503321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6472029|NCT00503321|Antimetabolites|antimetabolites|mesh-ancestor
5546051|NCT04132661|Laxatives|laxatives|mesh-ancestor
5546052|NCT04132713|Capecitabine|capecitabine|mesh-list
5546053|NCT04132713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5546054|NCT04132713|Antimetabolites|antimetabolites|mesh-ancestor
5546055|NCT04132713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546056|NCT04132713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5546057|NCT04132635|Mitogens|mitogens|mesh-list
5546058|NCT04132635|Mitosis Modulators|mitosis modulators|mesh-ancestor
5546059|NCT04132635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472030|NCT00503321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472031|NCT00503321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6472032|NCT00503321|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6472033|NCT00503321|Immunologic Factors|immunologic factors|mesh-ancestor
6472034|NCT00503321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472035|NCT00503321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6472036|NCT00503321|Antiviral Agents|antiviral agents|mesh-ancestor
6472037|NCT00503321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6472038|NCT00503321|Interferon Inducers|interferon inducers|mesh-ancestor
6472039|NCT00503321|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6472040|NCT00503321|Protective Agents|protective agents|mesh-ancestor
6472041|NCT00503347|Bavituximab|bavituximab|mesh-list
6472042|NCT00503347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5546060|NCT04132648|Curcumin|curcumin|mesh-list
6205443|NCT02085161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5546061|NCT04132648|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5546062|NCT04132648|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6472043|NCT00503347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6472044|NCT00503386|Palonosetron|palonosetron|mesh-list
6472045|NCT00503386|Granisetron|granisetron|mesh-list
6472046|NCT00503386|Antiemetics|antiemetics|mesh-ancestor
6472047|NCT00503386|Autonomic Agents|autonomic agents|mesh-ancestor
6142268|NCT01324310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6142269|NCT01324310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142270|NCT01324310|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6142271|NCT01324310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6142272|NCT01324310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6142273|NCT01324323|Rifampin|rifampin|mesh-list
5546063|NCT04132648|Analgesics|analgesics|mesh-ancestor
5546064|NCT04132648|Sensory System Agents|sensory system agents|mesh-ancestor
5546065|NCT04132648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5546066|NCT04132648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546067|NCT04132648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5546068|NCT04132648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5546069|NCT04132648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5546070|NCT04132648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5546071|NCT04132648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546072|NCT04132570|Budesonide|budesonide|mesh-list
5546073|NCT04132570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5546074|NCT04132570|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5546075|NCT04132570|Autonomic Agents|autonomic agents|mesh-ancestor
5546076|NCT04132570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5546077|NCT04132570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142274|NCT01324323|Romidepsin|romidepsin|mesh-list
6142275|NCT01324323|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6142276|NCT01324323|Antitubercular Agents|antitubercular agents|mesh-ancestor
6142277|NCT01324323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6142278|NCT01324323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6142279|NCT01324323|Leprostatic Agents|leprostatic agents|mesh-ancestor
6142280|NCT01324323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6142281|NCT01324323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6142282|NCT01324323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142283|NCT01324323|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6142284|NCT01324323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6142285|NCT01324323|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6142286|NCT01324323|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6142287|NCT01324323|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6142288|NCT01324323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6142289|NCT01324323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6142290|NCT01324323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6142291|NCT01324349|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
5546078|NCT04132570|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5546079|NCT04132570|Respiratory System Agents|respiratory system agents|mesh-ancestor
5546080|NCT04132570|Glucocorticoids|glucocorticoids|mesh-ancestor
6142292|NCT01324349|Hemostatics|hemostatics|mesh-list
6142293|NCT01324349|Coagulants|coagulants|mesh-ancestor
6142294|NCT01324388|Dulaglutide|dulaglutide|mesh-list
6142295|NCT01324388|Metoprolol|metoprolol|mesh-list
6142296|NCT01324388|Lisinopril|lisinopril|mesh-list
6472048|NCT00503386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5546081|NCT04132570|Hormones|hormones|mesh-ancestor
5546082|NCT04132570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6472049|NCT00503386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472050|NCT00503386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6472051|NCT00503386|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5546083|NCT04132349|Ulipristal acetate|ulipristal acetate|mesh-list
5546084|NCT04132349|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5546085|NCT04132349|Contraceptive Agents|contraceptive agents|mesh-ancestor
5546086|NCT04132349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5546087|NCT04132349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546088|NCT04132349|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5546089|NCT04132557|Methylphenidate|methylphenidate|mesh-list
5546090|NCT04132557|Amphetamine|amphetamine|mesh-list
6472052|NCT00503386|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6472053|NCT00503386|Serotonin Agents|serotonin agents|mesh-ancestor
6472054|NCT00503386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6472055|NCT00503386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472056|NCT00503412|Cediranib|cediranib|mesh-list
6472057|NCT00503412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6472058|NCT00503412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5546091|NCT04132557|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
5546092|NCT04132557|Dextroamphetamine|dextroamphetamine|mesh-list
5546093|NCT04132557|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
5546094|NCT04132557|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5546095|NCT04132557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546096|NCT04132557|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5546097|NCT04132557|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6472059|NCT00503412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6472060|NCT00503412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472061|NCT00503451|Panobinostat|panobinostat|mesh-list
6472062|NCT00503451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6472063|NCT00503451|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6472064|NCT00503451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6472065|NCT00503451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666834|NCT01524601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6666835|NCT01524601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5546098|NCT04132557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6142297|NCT01324388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6142298|NCT01324388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6142299|NCT01324388|Sympatholytics|sympatholytics|mesh-ancestor
6142300|NCT01324388|Autonomic Agents|autonomic agents|mesh-ancestor
6472066|NCT00503477|Cediranib|cediranib|mesh-list
6472067|NCT00503477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6472068|NCT00503477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6472069|NCT00503477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6472070|NCT00503477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472071|NCT00503490|Levofloxacin|levofloxacin|mesh-list
6472072|NCT00503490|Ofloxacin|ofloxacin|mesh-list
6472073|NCT00503490|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6472074|NCT00503490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6472075|NCT00503490|Renal Agents|renal agents|mesh-ancestor
6472076|NCT00503490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6472077|NCT00503490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5546099|NCT04132557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546100|NCT04132557|Dopamine Agents|dopamine agents|mesh-ancestor
5546101|NCT04132557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5546102|NCT04132557|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5546103|NCT04132557|Adrenergic Agents|adrenergic agents|mesh-ancestor
5546104|NCT04132557|Sympathomimetics|sympathomimetics|mesh-ancestor
5546105|NCT04132557|Autonomic Agents|autonomic agents|mesh-ancestor
5546106|NCT04132557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5546107|NCT04132063|Levetiracetam|levetiracetam|mesh-list
5546108|NCT04132063|Anticonvulsants|anticonvulsants|mesh-ancestor
5546109|NCT04132063|Nootropic Agents|nootropic agents|mesh-ancestor
5546110|NCT04132115|Vancomycin|vancomycin|mesh-list
5546111|NCT04132115|Gentamicins|gentamicins|mesh-list
5546112|NCT04132115|Meropenem|meropenem|mesh-list
5546113|NCT04132115|Tazobactam|tazobactam|mesh-list
6472078|NCT00503490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6472079|NCT00503490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6666836|NCT01524601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5546114|NCT04132115|Linezolid|linezolid|mesh-list
5546115|NCT04132115|Piperacillin|piperacillin|mesh-list
5546116|NCT04132115|Daptomycin|daptomycin|mesh-list
5546117|NCT04132115|Amikacin|amikacin|mesh-list
6142301|NCT01324388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6142302|NCT01324388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142303|NCT01324388|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6142304|NCT01324388|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6142305|NCT01324388|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6142306|NCT01324388|Adrenergic Agents|adrenergic agents|mesh-ancestor
6472080|NCT00503490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142307|NCT01324388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6142308|NCT01324388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142309|NCT01324388|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6142310|NCT01324388|Protease Inhibitors|protease inhibitors|mesh-ancestor
6142311|NCT01324388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6142312|NCT01324388|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6142313|NCT01324388|Protective Agents|protective agents|mesh-ancestor
6142314|NCT01324388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5546118|NCT04132115|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
5546119|NCT04132115|Ceftobiprole|ceftobiprole|mesh-list
5546120|NCT04132115|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
5546121|NCT04132115|Acyclovir|acyclovir|mesh-list
5546122|NCT04132115|Ganciclovir|ganciclovir|mesh-list
5546123|NCT04132115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5546124|NCT04132115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5546125|NCT04132115|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6142315|NCT01324570|Buprenorphine|buprenorphine|mesh-list
6142316|NCT01324570|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6142317|NCT01324570|Narcotics|narcotics|mesh-ancestor
6142318|NCT01324570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6142319|NCT01324570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142320|NCT01324570|Analgesics|analgesics|mesh-ancestor
6142321|NCT01324570|Sensory System Agents|sensory system agents|mesh-ancestor
6142322|NCT01324570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6142323|NCT01324570|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6142324|NCT01324700|Dexetimide|dexetimide|mesh-list
6142325|NCT01324700|Citalopram|citalopram|mesh-list
6472081|NCT00503490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6472082|NCT00503490|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6472083|NCT00503490|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6472084|NCT00503503|Etanercept|etanercept|mesh-list
6472085|NCT00503503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6472086|NCT00503503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6472087|NCT00503503|Analgesics|analgesics|mesh-ancestor
6472088|NCT00503503|Sensory System Agents|sensory system agents|mesh-ancestor
6472089|NCT00503503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6472090|NCT00503503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472091|NCT00503503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5546126|NCT04132115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5546127|NCT04132115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546128|NCT04132115|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5546129|NCT04132115|Antiviral Agents|antiviral agents|mesh-ancestor
5546130|NCT04132011|Morphine|morphine|mesh-list
5546131|NCT04132011|Oxycodone|oxycodone|mesh-list
5546132|NCT04132011|Analgesics, Opioid|analgesics, opioid|mesh-list
5546133|NCT04132011|Hydromorphone|hydromorphone|mesh-list
5546134|NCT04132011|Narcotics|narcotics|mesh-ancestor
5546135|NCT04132011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5546136|NCT04132011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546137|NCT04132011|Analgesics|analgesics|mesh-ancestor
5546138|NCT04132011|Sensory System Agents|sensory system agents|mesh-ancestor
5546139|NCT04132011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6142326|NCT01324700|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
6472092|NCT00503503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6472093|NCT00503503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6472094|NCT00503503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6472095|NCT00503503|Immunologic Factors|immunologic factors|mesh-ancestor
6472096|NCT00503516|Megestrol|megestrol|mesh-list
6472097|NCT00503516|Megestrol Acetate|megestrol acetate|mesh-list
6472098|NCT00503516|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6472099|NCT00503516|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6472100|NCT00503516|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5546140|NCT04132232|Carbon Monoxide|carbon monoxide|mesh-list
6142327|NCT01324700|Serotonin|serotonin|mesh-list
6142328|NCT01324700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6142329|NCT01324700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6142330|NCT01324700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142331|NCT01324700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6142332|NCT01324700|Serotonin Agents|serotonin agents|mesh-ancestor
6142333|NCT01324700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142334|NCT01324700|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6142335|NCT01324700|Antidepressive Agents|antidepressive agents|mesh-ancestor
5546141|NCT04132232|Antimetabolites|antimetabolites|mesh-ancestor
6142336|NCT01324700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6472101|NCT00503516|Contraceptive Agents|contraceptive agents|mesh-ancestor
6142337|NCT01324700|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6142338|NCT01324700|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6142339|NCT01324700|Parasympatholytics|parasympatholytics|mesh-ancestor
6142340|NCT01324700|Autonomic Agents|autonomic agents|mesh-ancestor
6142341|NCT01324700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6472102|NCT00503516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6472103|NCT00503516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472104|NCT00503516|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6472105|NCT00503516|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6472106|NCT00503516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6472107|NCT00503516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6142342|NCT01324700|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5546142|NCT04132232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546143|NCT04132232|Gasotransmitters|gasotransmitters|mesh-ancestor
5546144|NCT04132232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5546145|NCT04132232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546146|NCT04132102|Afatinib|afatinib|mesh-list
5546147|NCT04132102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5546148|NCT04132102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5546149|NCT04132102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5546150|NCT04132102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546151|NCT04131829|Fluoxetine|fluoxetine|mesh-list
6142343|NCT01324700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6142344|NCT01324700|Cholinergic Agents|cholinergic agents|mesh-ancestor
6142345|NCT01324700|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6142346|NCT01324947|Pomalidomide|pomalidomide|mesh-list
6142347|NCT01324947|Immunologic Factors|immunologic factors|mesh-ancestor
6142348|NCT01324947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142349|NCT01324947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6472108|NCT00503516|Appetite Stimulants|appetite stimulants|mesh-ancestor
6472109|NCT00503516|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6472110|NCT00503542|Metronidazole|metronidazole|mesh-list
6472111|NCT00503542|Clindamycin|clindamycin|mesh-list
6472112|NCT00503542|Clindamycin palmitate|clindamycin palmitate|mesh-list
6472113|NCT00503542|Clindamycin phosphate|clindamycin phosphate|mesh-list
5546152|NCT04131829|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5546153|NCT04131829|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5546154|NCT04131829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5546155|NCT04131829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546156|NCT04131829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5546157|NCT04131829|Serotonin Agents|serotonin agents|mesh-ancestor
5546158|NCT04131829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546159|NCT04131829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6472114|NCT00503542|Fluconazole|fluconazole|mesh-list
6472115|NCT00503542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6472116|NCT00503542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6472117|NCT00503542|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6472118|NCT00503542|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6472119|NCT00503542|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6472120|NCT00503542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6472121|NCT00503542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472122|NCT00503542|Antifungal Agents|antifungal agents|mesh-ancestor
6472123|NCT00503542|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6472124|NCT00503542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6472125|NCT00503542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6472126|NCT00503542|Hormone Antagonists|hormone antagonists|mesh-ancestor
6472127|NCT00503542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6472128|NCT00503542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472129|NCT00503542|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6472130|NCT00503542|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5546160|NCT04131829|Antidepressive Agents|antidepressive agents|mesh-ancestor
5546161|NCT04131829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5546162|NCT04131829|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5546163|NCT04131829|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5546164|NCT04131829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5546165|NCT04131621|Nivolumab|nivolumab|mesh-list
5546166|NCT04131621|Ipilimumab|ipilimumab|mesh-list
5546167|NCT04131621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5546168|NCT04131621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5546169|NCT04131621|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5546170|NCT04131621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546171|NCT04131348|Botulinum Toxins|botulinum toxins|mesh-list
6472131|NCT00503568|Vaccines|vaccines|mesh-list
6142350|NCT01324947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5546172|NCT04131348|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5546173|NCT04131348|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5546174|NCT04131348|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5546175|NCT04131348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5546176|NCT04131348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546177|NCT04131348|Cholinergic Agents|cholinergic agents|mesh-ancestor
5546178|NCT04131348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5546179|NCT04131348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546180|NCT04131348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5546181|NCT04131348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5546182|NCT04131582|Metformin|metformin|mesh-list
5546183|NCT04131582|Empagliflozin|empagliflozin|mesh-list
5546184|NCT04131582|Linagliptin|linagliptin|mesh-list
5546185|NCT04131582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6142351|NCT01324947|Growth Substances|growth substances|mesh-ancestor
6142352|NCT01324947|Growth Inhibitors|growth inhibitors|mesh-ancestor
6142353|NCT01324947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6142354|NCT01324999|Tadalafil|tadalafil|mesh-list
6142355|NCT01324999|Vasodilator Agents|vasodilator agents|mesh-ancestor
6142356|NCT01324999|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6142357|NCT01324999|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6142358|NCT01324999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6472132|NCT00503568|Immunologic Factors|immunologic factors|mesh-ancestor
6472133|NCT00503568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472134|NCT00503594|Cytarabine|cytarabine|mesh-list
6472135|NCT00503594|Methotrexate|methotrexate|mesh-list
6472136|NCT00503594|Vincristine|vincristine|mesh-list
6472137|NCT00503594|Temozolomide|temozolomide|mesh-list
6472138|NCT00503594|Procarbazine|procarbazine|mesh-list
6472139|NCT00503594|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6472140|NCT00503594|Abortifacient Agents|abortifacient agents|mesh-ancestor
6472141|NCT00503594|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6472142|NCT00503594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472143|NCT00503594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6472144|NCT00503594|Antimetabolites|antimetabolites|mesh-ancestor
6142359|NCT01324999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142360|NCT01324999|Urological Agents|urological agents|mesh-ancestor
6142361|NCT01325181|Ranibizumab|ranibizumab|mesh-list
6142362|NCT01325181|Verteporfin|verteporfin|mesh-list
6142363|NCT01325181|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6142364|NCT01325181|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6142365|NCT01325181|Growth Substances|growth substances|mesh-ancestor
6142366|NCT01325181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472145|NCT00503594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472146|NCT00503594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6472147|NCT00503594|Dermatologic Agents|dermatologic agents|mesh-ancestor
6472148|NCT00503594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6472149|NCT00503594|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6472150|NCT00503594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6472151|NCT00503594|Immunologic Factors|immunologic factors|mesh-ancestor
6472152|NCT00503594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6472153|NCT00503594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6472154|NCT00503594|Antiviral Agents|antiviral agents|mesh-ancestor
5546186|NCT04131582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546187|NCT04131582|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5546188|NCT04131582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546189|NCT04131582|Incretins|incretins|mesh-ancestor
5546190|NCT04131582|Hormones|hormones|mesh-ancestor
5546191|NCT04131582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5546192|NCT04131582|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5546193|NCT04131582|Protease Inhibitors|protease inhibitors|mesh-ancestor
5546194|NCT04131582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5546195|NCT04131283|Epinephrine|epinephrine|mesh-list
5546196|NCT04131283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5546197|NCT04131283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6142367|NCT01325181|Growth Inhibitors|growth inhibitors|mesh-ancestor
6142368|NCT01325181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6142369|NCT01325181|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6142370|NCT01325181|Dermatologic Agents|dermatologic agents|mesh-ancestor
6142371|NCT01325207|Trastuzumab|trastuzumab|mesh-list
6142372|NCT01325207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6142373|NCT01325207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6142374|NCT01325311|Vitamin D|vitamin d|mesh-list
6142375|NCT01325311|Cholecalciferol|cholecalciferol|mesh-list
5546198|NCT04131283|Adrenergic Agents|adrenergic agents|mesh-ancestor
5546199|NCT04131283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5546200|NCT04131283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546201|NCT04131283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546202|NCT04131283|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5546203|NCT04131283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5546204|NCT04131283|Autonomic Agents|autonomic agents|mesh-ancestor
5546205|NCT04131283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5546206|NCT04131283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6142376|NCT01325311|Genistein|genistein|mesh-list
6142377|NCT01325311|Vitamins|vitamins|mesh-ancestor
6472155|NCT00503594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6472156|NCT00503594|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6472157|NCT00503594|Tubulin Modulators|tubulin modulators|mesh-ancestor
6472158|NCT00503594|Antimitotic Agents|antimitotic agents|mesh-ancestor
6472159|NCT00503594|Mitosis Modulators|mitosis modulators|mesh-ancestor
6472160|NCT00503594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6472161|NCT00503594|Alkylating Agents|alkylating agents|mesh-ancestor
6472162|NCT00503607|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
6472163|NCT00503607|Laxatives|laxatives|mesh-ancestor
6472164|NCT00503607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6472165|NCT00503620|Botulinum Toxins|botulinum toxins|mesh-list
6472166|NCT00503620|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6472167|NCT00503620|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6472168|NCT00503620|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6472169|NCT00503620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6472170|NCT00503620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472171|NCT00503620|Cholinergic Agents|cholinergic agents|mesh-ancestor
6666837|NCT01524653|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5546207|NCT04131283|Respiratory System Agents|respiratory system agents|mesh-ancestor
5546208|NCT04131283|Mydriatics|mydriatics|mesh-ancestor
5546209|NCT04131283|Sympathomimetics|sympathomimetics|mesh-ancestor
5546210|NCT04131283|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5546211|NCT04131309|Dexamethasone|dexamethasone|mesh-list
5546212|NCT04131309|Bortezomib|bortezomib|mesh-list
5546213|NCT04131309|Daratumumab|daratumumab|mesh-list
5546214|NCT04131309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5546215|NCT04131309|Antiemetics|antiemetics|mesh-ancestor
5546216|NCT04131309|Autonomic Agents|autonomic agents|mesh-ancestor
5546217|NCT04131309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5546218|NCT04131309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546219|NCT04131309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5546220|NCT04131309|Glucocorticoids|glucocorticoids|mesh-ancestor
5546221|NCT04131309|Hormones|hormones|mesh-ancestor
5546222|NCT04131309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5546223|NCT04131309|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5546224|NCT04131309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5546225|NCT04131231|Aldesleukin|aldesleukin|mesh-list
6142378|NCT01325311|Micronutrients|micronutrients|mesh-ancestor
6142379|NCT01325311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142380|NCT01325311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6142381|NCT01325311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6142382|NCT01325311|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6666838|NCT01524653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6666839|NCT01524653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6666840|NCT01524653|Antimetabolites|antimetabolites|mesh-ancestor
6666841|NCT01524653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666842|NCT01524653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6666843|NCT01524653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6666844|NCT01524653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6666845|NCT01524705|Insulin|insulin|mesh-list
6666846|NCT01524705|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6666847|NCT01524705|Metformin|metformin|mesh-list
6666848|NCT01524705|Insulin Glargine|insulin glargine|mesh-list
6472172|NCT00503620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6472173|NCT00503620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142383|NCT01325311|Protective Agents|protective agents|mesh-ancestor
6142384|NCT01325311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6142385|NCT01325311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6142386|NCT01325311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6142387|NCT01325311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142388|NCT01325311|Phytoestrogens|phytoestrogens|mesh-ancestor
6142389|NCT01325311|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6142390|NCT01325311|Estrogens|estrogens|mesh-ancestor
6142391|NCT01325311|Hormones|hormones|mesh-ancestor
6142392|NCT01325311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6142393|NCT01325337|Bimatoprost|bimatoprost|mesh-list
6142394|NCT01325337|Minoxidil|minoxidil|mesh-list
6142395|NCT01325337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6142396|NCT01325337|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6142397|NCT01325337|Vasodilator Agents|vasodilator agents|mesh-ancestor
6142398|NCT01325350|Bimatoprost|bimatoprost|mesh-list
6142399|NCT01325350|Minoxidil|minoxidil|mesh-list
6142400|NCT01325350|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6142401|NCT01325350|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6142402|NCT01325350|Vasodilator Agents|vasodilator agents|mesh-ancestor
6472174|NCT00503620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6472175|NCT00503620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6472176|NCT00503659|Methacholine Chloride|methacholine chloride|mesh-list
6472177|NCT00503659|Miotics|miotics|mesh-ancestor
6472178|NCT00503659|Autonomic Agents|autonomic agents|mesh-ancestor
6142403|NCT01325428|Vinorelbine|vinorelbine|mesh-list
6142404|NCT01325428|Afatinib|afatinib|mesh-list
6142405|NCT01325428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6142406|NCT01325428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6142407|NCT01325428|Tubulin Modulators|tubulin modulators|mesh-ancestor
6472179|NCT00503659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6472180|NCT00503659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546226|NCT04131231|Methotrexate|methotrexate|mesh-list
5546227|NCT04131231|Interleukin-2|interleukin-2|mesh-list
5546228|NCT04131231|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5546229|NCT04131231|Abortifacient Agents|abortifacient agents|mesh-ancestor
5546230|NCT04131231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5546231|NCT04131231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546232|NCT04131231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5546233|NCT04131231|Antimetabolites|antimetabolites|mesh-ancestor
5546234|NCT04131231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546235|NCT04131231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5546236|NCT04131231|Dermatologic Agents|dermatologic agents|mesh-ancestor
6472181|NCT00503659|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6472182|NCT00503659|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
6472183|NCT00503659|Respiratory System Agents|respiratory system agents|mesh-ancestor
6472184|NCT00503659|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6472185|NCT00503659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6472186|NCT00503659|Cholinergic Agents|cholinergic agents|mesh-ancestor
6472187|NCT00503659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6472188|NCT00503659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472189|NCT00503763|Simvastatin|simvastatin|mesh-list
6472190|NCT00503763|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6472191|NCT00503763|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6472192|NCT00503763|Antimetabolites|antimetabolites|mesh-ancestor
6142408|NCT01325428|Antimitotic Agents|antimitotic agents|mesh-ancestor
6142409|NCT01325428|Mitosis Modulators|mitosis modulators|mesh-ancestor
6142410|NCT01325428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142411|NCT01325428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6142412|NCT01325428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6142413|NCT01325493|Ketamine|ketamine|mesh-list
6142414|NCT01325493|Analgesics|analgesics|mesh-ancestor
6142415|NCT01325493|Sensory System Agents|sensory system agents|mesh-ancestor
5546237|NCT04131231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5546238|NCT04131231|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5546239|NCT04131231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5546240|NCT04131231|Immunologic Factors|immunologic factors|mesh-ancestor
5546241|NCT04131231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5546242|NCT04131231|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5546243|NCT04131231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5546244|NCT04131231|Analgesics|analgesics|mesh-ancestor
6142416|NCT01325493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6142417|NCT01325493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666849|NCT01524705|Exenatide|exenatide|mesh-list
6142418|NCT01325493|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6142419|NCT01325493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6472193|NCT00503763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472194|NCT00503763|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6472195|NCT00503763|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5546245|NCT04131231|Sensory System Agents|sensory system agents|mesh-ancestor
5546246|NCT04131231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5546247|NCT04131231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5546248|NCT04131231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5546249|NCT04131231|Antiviral Agents|antiviral agents|mesh-ancestor
5546250|NCT04131231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5546251|NCT04131322|Adalimumab|adalimumab|mesh-list
6472196|NCT00503763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6472197|NCT00503815|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
6472198|NCT00503815|Laxatives|laxatives|mesh-ancestor
6472199|NCT00503815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6142420|NCT01325493|Anesthetics, General|anesthetics, general|mesh-ancestor
6142421|NCT01325493|Anesthetics|anesthetics|mesh-ancestor
6142422|NCT01325493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6472200|NCT00503828|Naproxen|naproxen|mesh-list
6472201|NCT00503828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6666850|NCT01524705|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6666851|NCT01524705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6666852|NCT01524705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666853|NCT01524705|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6666854|NCT01524705|Incretins|incretins|mesh-ancestor
6666855|NCT01524705|Hormones|hormones|mesh-ancestor
6666856|NCT01524705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6666857|NCT01524731|Dexamethasone|dexamethasone|mesh-list
6666858|NCT01524731|Dexamethasone acetate|dexamethasone acetate|mesh-list
6666859|NCT01524731|BB 1101|bb 1101|mesh-list
6666860|NCT01524731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6666861|NCT01524731|Antiemetics|antiemetics|mesh-ancestor
6666862|NCT01524731|Autonomic Agents|autonomic agents|mesh-ancestor
6666863|NCT01524731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6666864|NCT01524731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472202|NCT00503828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6472203|NCT00503828|Analgesics|analgesics|mesh-ancestor
6666865|NCT01524731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5546252|NCT04131322|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5546253|NCT04131322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5546254|NCT04131322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5602608|NCT04335669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5602609|NCT04335669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5602610|NCT04335669|Tubulin Modulators|tubulin modulators|mesh-ancestor
5602611|NCT04335669|Antimitotic Agents|antimitotic agents|mesh-ancestor
5602612|NCT04335669|Mitosis Modulators|mitosis modulators|mesh-ancestor
5602613|NCT04335669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602614|NCT04335669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5602615|NCT04335669|Immunologic Factors|immunologic factors|mesh-ancestor
5602616|NCT04335669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602617|NCT04335669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5602618|NCT04335669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5602619|NCT04335669|Alkylating Agents|alkylating agents|mesh-ancestor
5602620|NCT04335669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5602621|NCT04335669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5602622|NCT04335669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5602623|NCT04335669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5602624|NCT04335669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5602625|NCT04335669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5602626|NCT04327999|Lubricant Eye Drops|lubricant eye drops|mesh-list
5602627|NCT04327999|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5602628|NCT04327999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5602629|NCT04323189|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5602630|NCT04323189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5602631|NCT04323189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602632|NCT04323189|Incretins|incretins|mesh-ancestor
5602633|NCT04323189|Hormones|hormones|mesh-ancestor
5602634|NCT04323189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5602635|NCT04323189|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5602636|NCT04323189|Protease Inhibitors|protease inhibitors|mesh-ancestor
5602637|NCT04323189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5602638|NCT04323189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602639|NCT04313153|Darbepoetin alfa|darbepoetin alfa|mesh-list
6666866|NCT01524731|Glucocorticoids|glucocorticoids|mesh-ancestor
6142423|NCT01325493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6142424|NCT01325493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6142425|NCT01325493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6142426|NCT01325493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142427|NCT01326026|Insulin|insulin|mesh-list
6142428|NCT01326026|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6142429|NCT01326026|Insulin, Long-Acting|insulin, long-acting|mesh-list
6142430|NCT01326026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6142431|NCT01326026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142432|NCT01326481|Capecitabine|capecitabine|mesh-list
6142433|NCT01326481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6472204|NCT00503828|Sensory System Agents|sensory system agents|mesh-ancestor
6472205|NCT00503828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6472206|NCT00503828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472207|NCT00503828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6472208|NCT00503828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6472209|NCT00503828|Gout Suppressants|gout suppressants|mesh-ancestor
6472210|NCT00503828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6472211|NCT00503828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6472212|NCT00503828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472213|NCT00503932|Capecitabine|capecitabine|mesh-list
6472214|NCT00503932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6472215|NCT00503932|Antimetabolites|antimetabolites|mesh-ancestor
6472216|NCT00503932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472217|NCT00503932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6472218|NCT00503971|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6472219|NCT00503971|Vorinostat|vorinostat|mesh-list
6472220|NCT00503971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6472221|NCT00503971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6472222|NCT00503971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6472223|NCT00503971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472224|NCT00503971|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6488634|NCT00585455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488635|NCT00585455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6488636|NCT00585455|Serotonin Agents|serotonin agents|mesh-ancestor
6488637|NCT00585455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488638|NCT00585507|Fulvestrant|fulvestrant|mesh-list
6488639|NCT00585507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6488640|NCT00585507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6488641|NCT00585507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6488642|NCT00585507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6488643|NCT00585507|Hormone Antagonists|hormone antagonists|mesh-ancestor
6488644|NCT00585507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6142434|NCT01326481|Antimetabolites|antimetabolites|mesh-ancestor
6142435|NCT01326481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142436|NCT01326481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6142437|NCT01326533|Hydroxychloroquine|hydroxychloroquine|mesh-list
6142438|NCT01326533|Antimalarials|antimalarials|mesh-ancestor
6142439|NCT01326533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6142440|NCT01326533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6142441|NCT01326533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6142442|NCT01326533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6142443|NCT01326533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142444|NCT01326533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6142445|NCT01326546|Entecavir|entecavir|mesh-list
6142446|NCT01326546|Antiviral Agents|antiviral agents|mesh-ancestor
6142447|NCT01326546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6142448|NCT01326702|Rituximab|rituximab|mesh-list
6488645|NCT00585507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546255|NCT04131335|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5546256|NCT04131335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5546257|NCT04131192|Gemcitabine|gemcitabine|mesh-list
5546258|NCT04131192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5546259|NCT04131192|Antimetabolites|antimetabolites|mesh-ancestor
5546260|NCT04131192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488646|NCT00585520|Progesterone|progesterone|mesh-list
6488647|NCT00585520|Progestins|progestins|mesh-ancestor
6488648|NCT00585520|Hormones|hormones|mesh-ancestor
6488649|NCT00585520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6488650|NCT00585520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546261|NCT04131192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6142449|NCT01326702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6142450|NCT01326702|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6142451|NCT01326702|Veliparib|veliparib|mesh-list
6142452|NCT01326702|Antibodies|antibodies|mesh-list
6142453|NCT01326702|Immunoglobulins|immunoglobulins|mesh-list
6472225|NCT00504062|Fluticasone|fluticasone|mesh-list
6472226|NCT00504062|Budesonide|budesonide|mesh-list
6472227|NCT00504062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6472228|NCT00504062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6472229|NCT00504062|Autonomic Agents|autonomic agents|mesh-ancestor
6472230|NCT00504062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6472231|NCT00504062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472232|NCT00504062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6472233|NCT00504062|Respiratory System Agents|respiratory system agents|mesh-ancestor
6472234|NCT00504062|Dermatologic Agents|dermatologic agents|mesh-ancestor
6472235|NCT00504062|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6472236|NCT00504062|Glucocorticoids|glucocorticoids|mesh-ancestor
6472237|NCT00504062|Hormones|hormones|mesh-ancestor
6472238|NCT00504062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6472239|NCT00504101|Bortezomib|bortezomib|mesh-list
6472240|NCT00504101|Melphalan|melphalan|mesh-list
6472241|NCT00504101|Arsenic Trioxide|arsenic trioxide|mesh-list
6472242|NCT00504101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6472243|NCT00504101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6472244|NCT00504101|Alkylating Agents|alkylating agents|mesh-ancestor
6472245|NCT00504101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472246|NCT00504101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6472247|NCT00504101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6472248|NCT00504101|Immunologic Factors|immunologic factors|mesh-ancestor
6472249|NCT00504101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472250|NCT00504127|Naproxen|naproxen|mesh-list
6472251|NCT00504127|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
6472252|NCT00504127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6472253|NCT00504127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6472254|NCT00504127|Analgesics|analgesics|mesh-ancestor
6472255|NCT00504127|Sensory System Agents|sensory system agents|mesh-ancestor
6472256|NCT00504127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6472257|NCT00504127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472258|NCT00504127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6472259|NCT00504127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6472260|NCT00504127|Gout Suppressants|gout suppressants|mesh-ancestor
6472261|NCT00504127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6472262|NCT00504127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6472263|NCT00504127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472264|NCT00504127|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6472265|NCT00504140|Interferons|interferons|mesh-list
6472266|NCT00504140|Interferon-alpha|interferon-alpha|mesh-list
6142454|NCT01326702|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6142455|NCT01326702|Immunologic Factors|immunologic factors|mesh-ancestor
6666867|NCT01524731|Hormones|hormones|mesh-ancestor
6672427|NCT01555970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142456|NCT01326702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142457|NCT01326702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6142458|NCT01326702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6142459|NCT01326702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6142460|NCT01326702|Alkylating Agents|alkylating agents|mesh-ancestor
6142461|NCT01326702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472267|NCT00504140|Etoposide|etoposide|mesh-list
6472268|NCT00504140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6472269|NCT00504140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6472270|NCT00504140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6472271|NCT00504140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6472272|NCT00504140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6472273|NCT00504140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472274|NCT00504140|Antiviral Agents|antiviral agents|mesh-ancestor
6472275|NCT00504140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6472276|NCT00504140|Immunologic Factors|immunologic factors|mesh-ancestor
6472277|NCT00504140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472278|NCT00504192|Gemcitabine|gemcitabine|mesh-list
6472279|NCT00504192|Oxaliplatin|oxaliplatin|mesh-list
6472280|NCT00504192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6472281|NCT00504192|Antimetabolites|antimetabolites|mesh-ancestor
6472282|NCT00504192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472283|NCT00504192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5546262|NCT04131192|Antiviral Agents|antiviral agents|mesh-ancestor
5546263|NCT04131192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6472284|NCT00504192|Antiviral Agents|antiviral agents|mesh-ancestor
6472285|NCT00504192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5546264|NCT04131192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5546265|NCT04131192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5546266|NCT04131192|Immunologic Factors|immunologic factors|mesh-ancestor
6472286|NCT00504192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6472287|NCT00504192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6472288|NCT00504192|Immunologic Factors|immunologic factors|mesh-ancestor
6472289|NCT00504192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472290|NCT00504244|Mycophenolic Acid|mycophenolic acid|mesh-list
6472291|NCT00504244|Azathioprine|azathioprine|mesh-list
6472292|NCT00504244|Antimetabolites|antimetabolites|mesh-ancestor
6472293|NCT00504244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472294|NCT00504244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6472295|NCT00504244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6142462|NCT01326702|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6142463|NCT01326702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6142464|NCT01327157|Salicylic Acid|salicylic acid|mesh-list
6142465|NCT01327157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6142466|NCT01327157|Antifungal Agents|antifungal agents|mesh-ancestor
6142467|NCT01327157|Keratolytic Agents|keratolytic agents|mesh-ancestor
6142468|NCT01327157|Dermatologic Agents|dermatologic agents|mesh-ancestor
6142469|NCT01327300|Mesalamine|mesalamine|mesh-list
6142470|NCT01327300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6142471|NCT01327300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6142472|NCT01327300|Analgesics|analgesics|mesh-ancestor
5546267|NCT04131192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546268|NCT04130698|Nicotine|nicotine|mesh-list
5546269|NCT04130698|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5546270|NCT04130698|Autonomic Agents|autonomic agents|mesh-ancestor
6142473|NCT01327300|Sensory System Agents|sensory system agents|mesh-ancestor
6142474|NCT01327300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6142475|NCT01327300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142476|NCT01327300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6142477|NCT01327300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6142478|NCT01327339|Ropinirole|ropinirole|mesh-list
6142479|NCT01327339|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6142480|NCT01327339|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6142481|NCT01327339|Dopamine Agonists|dopamine agonists|mesh-ancestor
6142482|NCT01327339|Dopamine Agents|dopamine agents|mesh-ancestor
6472296|NCT00504244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6472297|NCT00504244|Immunologic Factors|immunologic factors|mesh-ancestor
6472298|NCT00504244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472299|NCT00504244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6472300|NCT00504244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6472301|NCT00504244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6472302|NCT00504244|Antitubercular Agents|antitubercular agents|mesh-ancestor
5546271|NCT04130698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6142483|NCT01327339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6142484|NCT01327339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142485|NCT01327339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142486|NCT01327482|Raltegravir Potassium|raltegravir potassium|mesh-list
6142487|NCT01327482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6142488|NCT01327482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6142489|NCT01327482|Antiviral Agents|antiviral agents|mesh-ancestor
6142490|NCT01327482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6142491|NCT01327482|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6142492|NCT01327482|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6142493|NCT01327482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6142494|NCT01327482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142495|NCT01327495|Methyltestosterone|methyltestosterone|mesh-list
5546272|NCT04130698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546273|NCT04130698|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5546274|NCT04130698|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5546275|NCT04130698|Cholinergic Agents|cholinergic agents|mesh-ancestor
5546276|NCT04130698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5546277|NCT04130698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546278|NCT04130659|Omeprazole|omeprazole|mesh-list
5546279|NCT04130659|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6142496|NCT01327495|Testosterone|testosterone|mesh-list
6142497|NCT01327495|Testosterone undecanoate|testosterone undecanoate|mesh-list
6142498|NCT01327495|Testosterone enanthate|testosterone enanthate|mesh-list
6142499|NCT01327495|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6142500|NCT01327495|Acyline|acyline|mesh-list
6142501|NCT01327495|Androgens|androgens|mesh-ancestor
6142502|NCT01327495|Hormones|hormones|mesh-ancestor
6142503|NCT01327495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6142504|NCT01327495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546280|NCT04130659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5546281|NCT04130659|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5546282|NCT04130659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5546283|NCT04130659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546284|NCT04130815|Furosemide|furosemide|mesh-list
6142505|NCT01327495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6472303|NCT00504244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6472304|NCT00504244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6472305|NCT00504244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5546285|NCT04130815|Diuretics|diuretics|mesh-ancestor
5546286|NCT04130815|Natriuretic Agents|natriuretic agents|mesh-ancestor
5546287|NCT04130815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546288|NCT04130815|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5546289|NCT04130815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5546290|NCT04130815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546291|NCT04130672|Hemostatics|hemostatics|mesh-list
5546292|NCT04130672|Coagulants|coagulants|mesh-ancestor
5546293|NCT04130464|Ketorolac|ketorolac|mesh-list
5546294|NCT04130464|Ropivacaine|ropivacaine|mesh-list
5546295|NCT04130464|Anesthetics, Local|anesthetics, local|mesh-ancestor
5546296|NCT04130464|Anesthetics|anesthetics|mesh-ancestor
5546297|NCT04130464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5546298|NCT04130464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546299|NCT04130464|Sensory System Agents|sensory system agents|mesh-ancestor
5546300|NCT04130464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5546301|NCT04130464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5546302|NCT04130464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5546303|NCT04130464|Analgesics|analgesics|mesh-ancestor
5546304|NCT04130464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5546305|NCT04130464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6472306|NCT00504283|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6472307|NCT00504283|Morphine|morphine|mesh-list
6472308|NCT00504283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6472309|NCT00504283|Narcotics|narcotics|mesh-ancestor
6472310|NCT00504283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6472311|NCT00504283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472312|NCT00504283|Analgesics|analgesics|mesh-ancestor
6472313|NCT00504283|Sensory System Agents|sensory system agents|mesh-ancestor
6472314|NCT00504283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6472315|NCT00504283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6472316|NCT00504283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6472317|NCT00504283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6472318|NCT00504283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6472319|NCT00504283|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6472320|NCT00504283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6472321|NCT00504283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472322|NCT00504296|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
6472323|NCT00504296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6472324|NCT00504296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472325|NCT00504400|Ranibizumab|ranibizumab|mesh-list
6472326|NCT00504400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6472327|NCT00504400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6472328|NCT00504400|Growth Substances|growth substances|mesh-ancestor
6472329|NCT00504400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472330|NCT00504400|Growth Inhibitors|growth inhibitors|mesh-ancestor
6472331|NCT00504400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6472332|NCT00504413|Digoxin|digoxin|mesh-list
6472333|NCT00504413|Midazolam|midazolam|mesh-list
6472334|NCT00504413|Methadone|methadone|mesh-list
6472335|NCT00504413|Bupropion|bupropion|mesh-list
6472336|NCT00504413|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6472337|NCT00504413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6472338|NCT00504413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6472339|NCT00504413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472340|NCT00504413|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6472341|NCT00504413|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6472342|NCT00504413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5546306|NCT04130464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5546307|NCT04130464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5546308|NCT04130464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546309|NCT04130399|Folfirinox|folfirinox|mesh-list
5546310|NCT04130399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5546311|NCT04130438|Nebivolol|nebivolol|mesh-list
5546312|NCT04130438|Diltiazem|diltiazem|mesh-list
5546313|NCT04130438|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5546314|NCT04130438|Vasodilator Agents|vasodilator agents|mesh-ancestor
5546315|NCT04130438|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5546316|NCT04130438|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5546317|NCT04130438|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5546318|NCT04130438|Adrenergic Agents|adrenergic agents|mesh-ancestor
5546319|NCT04130438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5546320|NCT04130438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546321|NCT04130438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602640|NCT04313153|Hematinics|hematinics|mesh-ancestor
6142506|NCT01327495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6472343|NCT00504413|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6472344|NCT00504413|Anesthetics, General|anesthetics, general|mesh-ancestor
6472345|NCT00504413|Anesthetics|anesthetics|mesh-ancestor
6142507|NCT01327495|Anabolic Agents|anabolic agents|mesh-ancestor
6142508|NCT01327495|Hormone Antagonists|hormone antagonists|mesh-ancestor
6666868|NCT01524731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6666869|NCT01524731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6666870|NCT01524731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6666871|NCT01524731|Protease Inhibitors|protease inhibitors|mesh-ancestor
6666872|NCT01524731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6666873|NCT01524731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666874|NCT01524744|Pimecrolimus|pimecrolimus|mesh-list
6142509|NCT01327547|Maraviroc|maraviroc|mesh-list
6142510|NCT01327547|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6142511|NCT01327547|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6142512|NCT01327547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142513|NCT01327547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6142514|NCT01327547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6472346|NCT00504413|GABA Modulators|gaba modulators|mesh-ancestor
6472347|NCT00504413|GABA Agents|gaba agents|mesh-ancestor
6472348|NCT00504413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6472349|NCT00504413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472350|NCT00504413|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6472351|NCT00504413|Antidepressive Agents|antidepressive agents|mesh-ancestor
6472352|NCT00504413|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6472353|NCT00504413|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6472354|NCT00504413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6472355|NCT00504413|Dopamine Agents|dopamine agents|mesh-ancestor
6472356|NCT00504413|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6472357|NCT00504413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6472358|NCT00504413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6472359|NCT00504413|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6472360|NCT00504413|Narcotics|narcotics|mesh-ancestor
6472361|NCT00504413|Analgesics|analgesics|mesh-ancestor
6472362|NCT00504413|Sensory System Agents|sensory system agents|mesh-ancestor
6472363|NCT00504413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6472364|NCT00504413|Antitussive Agents|antitussive agents|mesh-ancestor
6472365|NCT00504413|Respiratory System Agents|respiratory system agents|mesh-ancestor
6472366|NCT00504413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6472367|NCT00504413|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6472368|NCT00504413|Protective Agents|protective agents|mesh-ancestor
6472369|NCT00504439|Simvastatin|simvastatin|mesh-list
6472370|NCT00504439|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6472371|NCT00504439|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6472372|NCT00504439|Antimetabolites|antimetabolites|mesh-ancestor
6472373|NCT00504439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472374|NCT00504439|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6472375|NCT00504439|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6472376|NCT00504439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6472377|NCT00504465|Dinoprostone|dinoprostone|mesh-list
6472378|NCT00504465|Oxytocics|oxytocics|mesh-ancestor
6472379|NCT00504465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6472380|NCT00504465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472381|NCT00504491|Rituximab|rituximab|mesh-list
6472382|NCT00504491|Alemtuzumab|alemtuzumab|mesh-list
6472383|NCT00504491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6472384|NCT00504491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6472385|NCT00504491|Immunologic Factors|immunologic factors|mesh-ancestor
6472386|NCT00504491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472387|NCT00504491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6472388|NCT00504543|Everolimus|everolimus|mesh-list
6472389|NCT00504543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6472390|NCT00504543|Immunologic Factors|immunologic factors|mesh-ancestor
6472391|NCT00504543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472392|NCT00504543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6472393|NCT00504634|Bortezomib|bortezomib|mesh-list
6472394|NCT00504634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6472395|NCT00504673|Insulin|insulin|mesh-list
6472396|NCT00504673|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6472397|NCT00504673|Insulin Aspart|insulin aspart|mesh-list
6472398|NCT00504673|Insulin Detemir|insulin detemir|mesh-list
6472399|NCT00504673|Isophane Insulin, Human|isophane insulin, human|mesh-list
6142515|NCT01327547|Antiviral Agents|antiviral agents|mesh-ancestor
6142516|NCT01327547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5546322|NCT04130438|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5546323|NCT04130438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5546324|NCT04130438|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5546325|NCT04130477|Nickel|nickel|mesh-list
5546326|NCT04130477|Trace Elements|trace elements|mesh-ancestor
5546327|NCT04130477|Micronutrients|micronutrients|mesh-ancestor
5546328|NCT04130477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546329|NCT04130230|Choline|choline|mesh-list
5546330|NCT04130230|Neostigmine|neostigmine|mesh-list
5546331|NCT04130230|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5546332|NCT04130230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6142517|NCT01327547|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6142518|NCT01327573|Eculizumab|eculizumab|mesh-list
6142519|NCT01327573|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6142520|NCT01327573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6142521|NCT01327573|Immunologic Factors|immunologic factors|mesh-ancestor
6142522|NCT01327573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142523|NCT01327599|Timolol|timolol|mesh-list
6142524|NCT01327599|Travoprost|travoprost|mesh-list
6142525|NCT01327599|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6142526|NCT01327599|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6142527|NCT01327599|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6142528|NCT01327599|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6666875|NCT01524744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6666876|NCT01524744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6666877|NCT01524744|Analgesics|analgesics|mesh-ancestor
6666878|NCT01524744|Sensory System Agents|sensory system agents|mesh-ancestor
6666879|NCT01524744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6666880|NCT01524744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666881|NCT01524744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6472400|NCT00504673|Insulin, Isophane|insulin, isophane|mesh-list
6472401|NCT00504673|Isophane insulin, beef|isophane insulin, beef|mesh-list
6472402|NCT00504673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6472403|NCT00504673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472404|NCT00504712|Testosterone|testosterone|mesh-list
6472405|NCT00504712|Androgens|androgens|mesh-ancestor
6472406|NCT00504712|Hormones|hormones|mesh-ancestor
6472407|NCT00504712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6472408|NCT00504712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472409|NCT00504764|Arsenic Trioxide|arsenic trioxide|mesh-list
6472410|NCT00504764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6472411|NCT00504816|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
6472412|NCT00504816|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6472413|NCT00504816|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6472414|NCT00504816|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6472415|NCT00504816|Contraceptive Agents|contraceptive agents|mesh-ancestor
6472416|NCT00504816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6472417|NCT00504816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472418|NCT00504816|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6472419|NCT00504816|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6472420|NCT00504816|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
6472421|NCT00504816|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6666882|NCT01524744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5602641|NCT04282811|Venetoclax|venetoclax|mesh-list
6142529|NCT01327599|Adrenergic Agents|adrenergic agents|mesh-ancestor
6142530|NCT01327599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6142531|NCT01327599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142532|NCT01327599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472422|NCT00504855|Calpastatin|calpastatin|mesh-list
6472423|NCT00504855|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
6472424|NCT00504855|Protease Inhibitors|protease inhibitors|mesh-ancestor
6472425|NCT00504855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6472426|NCT00504855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472427|NCT00504933|Cetirizine|cetirizine|mesh-list
6472428|NCT00504933|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6472429|NCT00504933|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6472430|NCT00504933|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6472431|NCT00504933|Histamine Antagonists|histamine antagonists|mesh-ancestor
6472432|NCT00504933|Histamine Agents|histamine agents|mesh-ancestor
6472433|NCT00504933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6472434|NCT00504933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472435|NCT00504933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472436|NCT00504946|Cholecalciferol|cholecalciferol|mesh-list
6472437|NCT00504946|Prednisone|prednisone|mesh-list
6472438|NCT00504946|Budesonide|budesonide|mesh-list
6472439|NCT00504946|Montelukast|montelukast|mesh-list
6472440|NCT00504946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6472441|NCT00504946|Glucocorticoids|glucocorticoids|mesh-ancestor
6472442|NCT00504946|Hormones|hormones|mesh-ancestor
6472443|NCT00504946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6472444|NCT00504946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472445|NCT00504946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6472446|NCT00504946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6472447|NCT00504946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6472448|NCT00504946|Respiratory System Agents|respiratory system agents|mesh-ancestor
6472449|NCT00504946|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6472450|NCT00504946|Hormone Antagonists|hormone antagonists|mesh-ancestor
6472451|NCT00504946|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6472452|NCT00504946|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6472453|NCT00504946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472454|NCT00504946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6472455|NCT00504946|Autonomic Agents|autonomic agents|mesh-ancestor
6472456|NCT00504946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5546333|NCT04130230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546334|NCT04130230|Cholinergic Agents|cholinergic agents|mesh-ancestor
5546335|NCT04130230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6472457|NCT00504946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6472458|NCT00504946|Vitamins|vitamins|mesh-ancestor
6472459|NCT00504946|Micronutrients|micronutrients|mesh-ancestor
6472460|NCT00504946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6472461|NCT00504959|Ranibizumab|ranibizumab|mesh-list
6472462|NCT00504959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6472463|NCT00504959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6472464|NCT00504959|Growth Substances|growth substances|mesh-ancestor
6472465|NCT00504959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472466|NCT00504959|Growth Inhibitors|growth inhibitors|mesh-ancestor
6472467|NCT00504959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6472468|NCT00505037|Sevelamer|sevelamer|mesh-list
6472469|NCT00505037|Chelating Agents|chelating agents|mesh-ancestor
5546336|NCT04130230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546337|NCT04130230|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5546338|NCT04130230|Autonomic Agents|autonomic agents|mesh-ancestor
5546339|NCT04130230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5546340|NCT04130230|Lipotropic Agents|lipotropic agents|mesh-ancestor
5546341|NCT04130230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5546342|NCT04130230|Antimetabolites|antimetabolites|mesh-ancestor
5546343|NCT04130230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5546344|NCT04130230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5546345|NCT04130230|Nootropic Agents|nootropic agents|mesh-ancestor
5546346|NCT04130152|Letrozole|letrozole|mesh-list
5546347|NCT04130152|Palbociclib|palbociclib|mesh-list
5546348|NCT04130152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5546349|NCT04130152|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5546350|NCT04130152|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6142533|NCT01327599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6142534|NCT01327599|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6142535|NCT01327612|Leucovorin|leucovorin|mesh-list
6142536|NCT01327612|Bevacizumab|bevacizumab|mesh-list
6142537|NCT01327612|Conatumumab|conatumumab|mesh-list
6142538|NCT01327612|Fluorouracil|fluorouracil|mesh-list
6142539|NCT01327612|Oxaliplatin|oxaliplatin|mesh-list
6142540|NCT01327612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6142541|NCT01327612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6142542|NCT01327612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6142543|NCT01327612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6142544|NCT01327612|Growth Substances|growth substances|mesh-ancestor
6142545|NCT01327612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142546|NCT01327612|Growth Inhibitors|growth inhibitors|mesh-ancestor
6142547|NCT01327612|Antimetabolites|antimetabolites|mesh-ancestor
6207850|NCT02121002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6472470|NCT00505037|Sequestering Agents|sequestering agents|mesh-ancestor
6472471|NCT00505037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472472|NCT00505063|Vaccines|vaccines|mesh-list
6472473|NCT00505063|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6472474|NCT00505063|Immunologic Factors|immunologic factors|mesh-ancestor
6472475|NCT00505063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472476|NCT00505089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6472477|NCT00505089|Immunologic Factors|immunologic factors|mesh-ancestor
6472478|NCT00505089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472479|NCT00505102|Everolimus|everolimus|mesh-list
6472480|NCT00505102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6472481|NCT00505102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6472482|NCT00505102|Immunologic Factors|immunologic factors|mesh-ancestor
6472483|NCT00505102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472484|NCT00505154|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6472485|NCT00505154|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6472486|NCT00505154|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6472487|NCT00505154|Antimetabolites|antimetabolites|mesh-ancestor
6472488|NCT00505154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472489|NCT00505154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6472490|NCT00505154|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6472491|NCT00505154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6472492|NCT00505167|Memantine|memantine|mesh-list
6142548|NCT01327612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142549|NCT01327612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6142550|NCT01327612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6142551|NCT01327612|Immunologic Factors|immunologic factors|mesh-ancestor
6142552|NCT01327612|Antidotes|antidotes|mesh-ancestor
6142553|NCT01327612|Protective Agents|protective agents|mesh-ancestor
6142554|NCT01327612|Vitamin B Complex|vitamin b complex|mesh-ancestor
6142555|NCT01327612|Vitamins|vitamins|mesh-ancestor
6472493|NCT00505167|Donepezil|donepezil|mesh-list
6472494|NCT00505167|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6472495|NCT00505167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5546351|NCT04130152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5546352|NCT04130152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142556|NCT01327612|Micronutrients|micronutrients|mesh-ancestor
6142557|NCT01327651|Tenofovir|tenofovir|mesh-list
6142558|NCT01327651|Emtricitabine|emtricitabine|mesh-list
5546353|NCT04130152|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5546354|NCT04130152|Hormone Antagonists|hormone antagonists|mesh-ancestor
5546355|NCT04130152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5546356|NCT04130152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546357|NCT04130152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5546358|NCT04130087|Selegiline|selegiline|mesh-list
5546359|NCT04130087|Antidepressive Agents|antidepressive agents|mesh-ancestor
5546360|NCT04130087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5546361|NCT04130087|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5546362|NCT04130087|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5546363|NCT04130087|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
5546364|NCT04130087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5546365|NCT04130087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546366|NCT04130087|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5546367|NCT04130087|Protective Agents|protective agents|mesh-ancestor
5546368|NCT04130087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546369|NCT04130100|Hyaluronic Acid|hyaluronic acid|mesh-list
5546370|NCT04130100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5546371|NCT04130100|Immunologic Factors|immunologic factors|mesh-ancestor
5546372|NCT04130100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546373|NCT04130100|Viscosupplements|viscosupplements|mesh-ancestor
5546374|NCT04130100|Protective Agents|protective agents|mesh-ancestor
5546375|NCT04129788|Bisacodyl|bisacodyl|mesh-list
5546376|NCT04129788|Cathartics|cathartics|mesh-ancestor
5546377|NCT04129788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5546378|NCT04129788|Laxatives|laxatives|mesh-ancestor
5546379|NCT04129697|Dexamethasone|dexamethasone|mesh-list
5546380|NCT04129697|Methylprednisolone|methylprednisolone|mesh-list
5546381|NCT04129697|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5546382|NCT04129697|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5546383|NCT04129697|Prednisolone|prednisolone|mesh-list
5546384|NCT04129697|Prednisolone acetate|prednisolone acetate|mesh-list
5546385|NCT04129697|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5546386|NCT04129697|Prednisolone phosphate|prednisolone phosphate|mesh-list
5546387|NCT04129697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5546388|NCT04129697|Antiemetics|antiemetics|mesh-ancestor
5546389|NCT04129697|Autonomic Agents|autonomic agents|mesh-ancestor
5546390|NCT04129697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6142559|NCT01327651|Antiviral Agents|antiviral agents|mesh-ancestor
6472496|NCT00505167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142560|NCT01327651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6142561|NCT01327651|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6142562|NCT01327651|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6142563|NCT01327651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6142564|NCT01327651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142565|NCT01327651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6142566|NCT01327651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6142567|NCT01327677|Fentanyl|fentanyl|mesh-list
6142568|NCT01327677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6142569|NCT01327677|Narcotics|narcotics|mesh-ancestor
6142570|NCT01327677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6142571|NCT01327677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142572|NCT01327677|Analgesics|analgesics|mesh-ancestor
6142573|NCT01327677|Sensory System Agents|sensory system agents|mesh-ancestor
6142574|NCT01327677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6142575|NCT01327677|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6142576|NCT01327677|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6142577|NCT01327677|Anesthetics, General|anesthetics, general|mesh-ancestor
6142578|NCT01327677|Anesthetics|anesthetics|mesh-ancestor
6142579|NCT01327703|Pancreatin|pancreatin|mesh-list
6142580|NCT01327703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6142581|NCT01327885|Dacarbazine|dacarbazine|mesh-list
6142582|NCT01327885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6142583|NCT01327885|Alkylating Agents|alkylating agents|mesh-ancestor
6142584|NCT01327885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142585|NCT01327885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6142586|NCT01328002|Milnacipran|milnacipran|mesh-list
6142587|NCT01328002|Levomilnacipran|levomilnacipran|mesh-list
6142588|NCT01328002|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6142589|NCT01328002|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6142590|NCT01328002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6142591|NCT01328002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142592|NCT01328002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6142593|NCT01328002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546391|NCT04129697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546392|NCT04129697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5546393|NCT04129697|Glucocorticoids|glucocorticoids|mesh-ancestor
5546394|NCT04129697|Hormones|hormones|mesh-ancestor
5546395|NCT04129697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5546396|NCT04129697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5546397|NCT04129697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5546398|NCT04129697|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5546399|NCT04129697|Protective Agents|protective agents|mesh-ancestor
5546400|NCT04129736|Teriflunomide|teriflunomide|mesh-list
5546401|NCT04129736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5546402|NCT04129736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5546403|NCT04129736|Analgesics|analgesics|mesh-ancestor
5546404|NCT04129736|Sensory System Agents|sensory system agents|mesh-ancestor
5546405|NCT04129736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5546406|NCT04129736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546407|NCT04129736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6142594|NCT01328002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6142595|NCT01328002|Analgesics|analgesics|mesh-ancestor
6142596|NCT01328002|Sensory System Agents|sensory system agents|mesh-ancestor
6142597|NCT01328002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6142598|NCT01328002|Antidepressive Agents|antidepressive agents|mesh-ancestor
6142599|NCT01328002|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6142600|NCT01328041|Dolutegravir|dolutegravir|mesh-list
6142601|NCT01328041|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6142602|NCT01328041|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6142603|NCT01328041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6142604|NCT01328041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142605|NCT01328041|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6142606|NCT01328041|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6142607|NCT01328041|Antiviral Agents|antiviral agents|mesh-ancestor
6142608|NCT01328041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6142609|NCT01328054|Lapatinib|lapatinib|mesh-list
6142610|NCT01328054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6472497|NCT00505167|Cholinergic Agents|cholinergic agents|mesh-ancestor
5546408|NCT04129736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5546409|NCT04129736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5546410|NCT04129736|Immunologic Factors|immunologic factors|mesh-ancestor
5546411|NCT04129710|Rituximab|rituximab|mesh-list
5546412|NCT04129710|Methotrexate|methotrexate|mesh-list
5546413|NCT04129710|Etoposide|etoposide|mesh-list
6142611|NCT01328054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6142612|NCT01328054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6142613|NCT01328054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142614|NCT01328184|Empagliflozin|empagliflozin|mesh-list
6142615|NCT01328184|Levonorgestrel|levonorgestrel|mesh-list
6472498|NCT00505167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6472499|NCT00505167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472500|NCT00505167|Nootropic Agents|nootropic agents|mesh-ancestor
6472501|NCT00505167|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6472502|NCT00505167|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6472503|NCT00505167|Dopamine Agents|dopamine agents|mesh-ancestor
6142616|NCT01328184|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6142617|NCT01328184|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
6142618|NCT01328184|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
6142619|NCT01328184|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6142620|NCT01328184|Contraceptive Agents|contraceptive agents|mesh-ancestor
6142621|NCT01328184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6142622|NCT01328184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142623|NCT01328184|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6142624|NCT01328184|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6142625|NCT01328184|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6142626|NCT01328184|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6142627|NCT01328184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142628|NCT01328184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6142629|NCT01328184|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6472504|NCT00505167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6472505|NCT00505167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6472506|NCT00505232|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6472507|NCT00505232|Immunologic Factors|immunologic factors|mesh-ancestor
6472508|NCT00505232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472509|NCT00505258|Ceftobiprole|ceftobiprole|mesh-list
6472510|NCT00505258|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
6472511|NCT00505258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6472512|NCT00505258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6472513|NCT00505336|Eplerenone|eplerenone|mesh-list
6472514|NCT00505336|Atorvastatin|atorvastatin|mesh-list
6472515|NCT00505336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6472516|NCT00505336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5546414|NCT04129710|Lenalidomide|lenalidomide|mesh-list
5546415|NCT04129710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6472517|NCT00505336|Antimetabolites|antimetabolites|mesh-ancestor
6472518|NCT00505336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546416|NCT04129710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5546417|NCT04129710|Immunologic Factors|immunologic factors|mesh-ancestor
5546418|NCT04129710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546419|NCT04129710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5546420|NCT04129710|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5546421|NCT04129710|Abortifacient Agents|abortifacient agents|mesh-ancestor
5546422|NCT04129710|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5546423|NCT04129710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5546424|NCT04129710|Antimetabolites|antimetabolites|mesh-ancestor
5546425|NCT04129710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546426|NCT04129710|Dermatologic Agents|dermatologic agents|mesh-ancestor
5546427|NCT04129710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5546428|NCT04129710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5546429|NCT04129710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5546430|NCT04129710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5546431|NCT04129710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5546432|NCT04129710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5546433|NCT04129710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5546434|NCT04129710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5546435|NCT04129710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5546436|NCT04129710|Growth Substances|growth substances|mesh-ancestor
5546437|NCT04129710|Growth Inhibitors|growth inhibitors|mesh-ancestor
5546438|NCT04129424|Insulin|insulin|mesh-list
5546439|NCT04129424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5546440|NCT04129424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546441|NCT04129255|Octreotide|octreotide|mesh-list
5546442|NCT04129255|Somatostatin|somatostatin|mesh-list
5546443|NCT04129255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5546444|NCT04129255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5546445|NCT04129255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5546446|NCT04129255|Hormones|hormones|mesh-ancestor
5602642|NCT04282811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6472519|NCT00505336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6472520|NCT00505336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6472521|NCT00505336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6472522|NCT00505336|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6472523|NCT00505336|Hormone Antagonists|hormone antagonists|mesh-ancestor
6472524|NCT00505336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6142630|NCT01328184|Estrogens|estrogens|mesh-ancestor
6142631|NCT01328184|Hormones|hormones|mesh-ancestor
5546447|NCT04129255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5546448|NCT04129255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602643|NCT04279197|Ascorbic Acid|ascorbic acid|mesh-list
5602644|NCT04279197|Vitamins|vitamins|mesh-ancestor
5602645|NCT04279197|Micronutrients|micronutrients|mesh-ancestor
5602646|NCT04279197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142632|NCT01328184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6142633|NCT01328184|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6142634|NCT01328184|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
6142635|NCT01328184|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6142636|NCT01328184|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6205444|NCT02085161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205445|NCT02085252|Bicalutamide|bicalutamide|mesh-list
6205446|NCT02085252|Leuprolide|leuprolide|mesh-list
6205447|NCT02085252|Androgen Antagonists|androgen antagonists|mesh-ancestor
6205448|NCT02085252|Hormone Antagonists|hormone antagonists|mesh-ancestor
6205449|NCT02085252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6205450|NCT02085252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205451|NCT02085252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6205452|NCT02085252|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6205453|NCT02085252|Fertility Agents|fertility agents|mesh-ancestor
6472525|NCT00505336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666883|NCT01524744|Dermatologic Agents|dermatologic agents|mesh-ancestor
6205454|NCT02085252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6205455|NCT02085252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6205456|NCT02085447|Haloperidol|haloperidol|mesh-list
6205457|NCT02085447|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6205458|NCT02085447|Haloperidol decanoate|haloperidol decanoate|mesh-list
6205459|NCT02085447|Antipsychotic Agents|antipsychotic agents|mesh-list
6205460|NCT02085447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6205461|NCT02085447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6205462|NCT02085447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205463|NCT02085447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6205464|NCT02085447|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6205465|NCT02085447|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6666884|NCT01524744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6666885|NCT01524744|Immunologic Factors|immunologic factors|mesh-ancestor
6666886|NCT01524744|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6205466|NCT02085447|Serotonin Agents|serotonin agents|mesh-ancestor
6205467|NCT02085447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6205468|NCT02085447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205469|NCT02085447|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6205470|NCT02085447|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6205471|NCT02085447|Dopamine Agents|dopamine agents|mesh-ancestor
6205472|NCT02085447|Antiemetics|antiemetics|mesh-ancestor
6205473|NCT02085447|Autonomic Agents|autonomic agents|mesh-ancestor
6205474|NCT02085447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6205475|NCT02085447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6205476|NCT02085447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6205477|NCT02085460|Rebamipide|rebamipide|mesh-list
6205478|NCT02085460|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6205479|NCT02085460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6205480|NCT02085460|Antioxidants|antioxidants|mesh-ancestor
6205481|NCT02085460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205482|NCT02085460|Protective Agents|protective agents|mesh-ancestor
6205483|NCT02085460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205484|NCT02085460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6205485|NCT02086175|Rituximab|rituximab|mesh-list
6205486|NCT02086175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6205487|NCT02086175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6205488|NCT02086175|Immunologic Factors|immunologic factors|mesh-ancestor
6205489|NCT02086175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205490|NCT02086175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6205491|NCT02086500|Tranexamic Acid|tranexamic acid|mesh-list
6472526|NCT00505336|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6472527|NCT00505336|Diuretics|diuretics|mesh-ancestor
6472528|NCT00505336|Natriuretic Agents|natriuretic agents|mesh-ancestor
6666887|NCT01524744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6666888|NCT01524744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666889|NCT01524757|Pantoprazole|pantoprazole|mesh-list
6666890|NCT01524757|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6666891|NCT01524757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6142637|NCT01328379|4-Aminopyridine|4-aminopyridine|mesh-list
6142638|NCT01328379|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6142639|NCT01328379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6142640|NCT01328379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142641|NCT01328535|Temozolomide|temozolomide|mesh-list
6142642|NCT01328535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6142643|NCT01328535|Alkylating Agents|alkylating agents|mesh-ancestor
6142644|NCT01328535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142645|NCT01328535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6142646|NCT01328548|Vaccines|vaccines|mesh-list
6142647|NCT01328548|Immunologic Factors|immunologic factors|mesh-ancestor
6142648|NCT01328548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142649|NCT01328756|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6142650|NCT01328756|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6142651|NCT01328756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142652|NCT01328756|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6142653|NCT01328756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6142654|NCT01328756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6666892|NCT01524757|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6666893|NCT01524757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5546449|NCT04129489|Cannabidiol|cannabidiol|mesh-list
5546450|NCT04129489|Anticonvulsants|anticonvulsants|mesh-ancestor
5546451|NCT04129515|Pembrolizumab|pembrolizumab|mesh-list
5546452|NCT04129515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5546453|NCT04129515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5546454|NCT04128891|Valsartan|valsartan|mesh-list
5546455|NCT04128891|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5546456|NCT04128891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5546457|NCT04128891|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5546458|NCT04128891|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6666894|NCT01524757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666895|NCT01524809|Insulin|insulin|mesh-list
6666896|NCT01524809|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6666897|NCT01524809|Insulin Aspart|insulin aspart|mesh-list
6666898|NCT01524809|Insulin, Long-Acting|insulin, long-acting|mesh-list
6666899|NCT01524809|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6666900|NCT01524809|Biphasic Insulins|biphasic insulins|mesh-list
6666901|NCT01524809|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6666902|NCT01524809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6666903|NCT01524809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666904|NCT01524861|Thioctic Acid|thioctic acid|mesh-list
6666905|NCT01524861|Acetylcarnitine|acetylcarnitine|mesh-list
6666906|NCT01524861|Antioxidants|antioxidants|mesh-ancestor
6666907|NCT01524861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666908|NCT01524861|Protective Agents|protective agents|mesh-ancestor
5546459|NCT04128891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142655|NCT01328756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142656|NCT01328756|Dopamine Agents|dopamine agents|mesh-ancestor
6142657|NCT01328756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6142658|NCT01328769|Febuxostat|febuxostat|mesh-list
6142659|NCT01328769|Gout Suppressants|gout suppressants|mesh-ancestor
6142660|NCT01328769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6142661|NCT01328782|Acetaminophen|acetaminophen|mesh-list
6142662|NCT01328782|Oxycodone|oxycodone|mesh-list
6142663|NCT01328782|Bupivacaine|bupivacaine|mesh-list
6142664|NCT01328782|Ropivacaine|ropivacaine|mesh-list
6142665|NCT01328782|Anesthetics, Local|anesthetics, local|mesh-ancestor
6142666|NCT01328782|Anesthetics|anesthetics|mesh-ancestor
6142667|NCT01328782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6472529|NCT00505336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6472530|NCT00505427|Thioctic Acid|thioctic acid|mesh-list
6472531|NCT00505427|Antioxidants|antioxidants|mesh-ancestor
6472532|NCT00505427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472533|NCT00505427|Protective Agents|protective agents|mesh-ancestor
6472534|NCT00505427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142668|NCT01328782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142669|NCT01328782|Sensory System Agents|sensory system agents|mesh-ancestor
6142670|NCT01328782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6142671|NCT01328782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6142672|NCT01328782|Analgesics|analgesics|mesh-ancestor
6142673|NCT01328782|Antipyretics|antipyretics|mesh-ancestor
6142674|NCT01328782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6142675|NCT01328782|Narcotics|narcotics|mesh-ancestor
6142676|NCT01328951|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6142677|NCT01328951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5546460|NCT04128787|Omeprazole|omeprazole|mesh-list
5546461|NCT04128787|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5546462|NCT04128787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5546463|NCT04128787|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5546464|NCT04128787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6142678|NCT01328951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6142679|NCT01328951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6142680|NCT01328951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472535|NCT00505427|Vitamin B Complex|vitamin b complex|mesh-ancestor
6472536|NCT00505427|Vitamins|vitamins|mesh-ancestor
6472537|NCT00505427|Micronutrients|micronutrients|mesh-ancestor
6472538|NCT00505492|Paclitaxel|paclitaxel|mesh-list
6472539|NCT00505492|Cisplatin|cisplatin|mesh-list
6472540|NCT00505492|Carboplatin|carboplatin|mesh-list
5546465|NCT04128787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546466|NCT04128800|Apatinib|apatinib|mesh-list
5546467|NCT04128800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5546468|NCT04128800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5546469|NCT04128800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5546470|NCT04128800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546471|NCT04129060|Cholinergic Agents|cholinergic agents|mesh-list
5546472|NCT04129060|Cholinergic Antagonists|cholinergic antagonists|mesh-list
5546473|NCT04129060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5546474|NCT04129060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546475|NCT04129060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546476|NCT04129008|Aspirin|aspirin|mesh-list
5546477|NCT04129008|Indobufen|indobufen|mesh-list
6472541|NCT00505492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6472542|NCT00505492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6472543|NCT00505492|Tubulin Modulators|tubulin modulators|mesh-ancestor
6472544|NCT00505492|Antimitotic Agents|antimitotic agents|mesh-ancestor
6472545|NCT00505492|Mitosis Modulators|mitosis modulators|mesh-ancestor
6472546|NCT00505492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472547|NCT00505505|Insulin|insulin|mesh-list
6472548|NCT00505505|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6472549|NCT00505505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6472550|NCT00505505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472551|NCT00505531|Diphenhydramine|diphenhydramine|mesh-list
6472552|NCT00505531|Tramadol|tramadol|mesh-list
6142681|NCT01328964|Fluticasone|fluticasone|mesh-list
6142682|NCT01328964|Xhance|xhance|mesh-list
6142683|NCT01328964|Budesonide|budesonide|mesh-list
5546478|NCT04129008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5546479|NCT04129008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5546480|NCT04129008|Analgesics|analgesics|mesh-ancestor
5546481|NCT04129008|Sensory System Agents|sensory system agents|mesh-ancestor
5546482|NCT04129008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6142684|NCT01328964|Montelukast|montelukast|mesh-list
6142685|NCT01328964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6472553|NCT00505531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6472554|NCT00505531|Narcotics|narcotics|mesh-ancestor
6472555|NCT00505531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6142686|NCT01328964|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6142687|NCT01328964|Autonomic Agents|autonomic agents|mesh-ancestor
6142688|NCT01328964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6472556|NCT00505531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472557|NCT00505531|Analgesics|analgesics|mesh-ancestor
6472558|NCT00505531|Sensory System Agents|sensory system agents|mesh-ancestor
6472559|NCT00505531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6472560|NCT00505531|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6472561|NCT00505531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6472562|NCT00505531|Anesthetics, Local|anesthetics, local|mesh-ancestor
5546483|NCT04129008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142689|NCT01328964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142690|NCT01328964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6472563|NCT00505531|Anesthetics|anesthetics|mesh-ancestor
6472564|NCT00505531|Antiemetics|antiemetics|mesh-ancestor
6472565|NCT00505531|Autonomic Agents|autonomic agents|mesh-ancestor
6472566|NCT00505531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6472567|NCT00505531|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6472568|NCT00505531|Histamine Antagonists|histamine antagonists|mesh-ancestor
6472569|NCT00505531|Histamine Agents|histamine agents|mesh-ancestor
6488651|NCT00585559|Acetaminophen|acetaminophen|mesh-list
5546484|NCT04129008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5546485|NCT04129008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5546486|NCT04129008|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5546487|NCT04129008|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5546488|NCT04129008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546489|NCT04129008|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5546490|NCT04129008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5546491|NCT04129008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5546492|NCT04129008|Antipyretics|antipyretics|mesh-ancestor
5546493|NCT04129086|Ketamine|ketamine|mesh-list
5546494|NCT04129086|Analgesics|analgesics|mesh-ancestor
5546495|NCT04129086|Sensory System Agents|sensory system agents|mesh-ancestor
5546496|NCT04129086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5546497|NCT04129086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546498|NCT04129086|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5546499|NCT04129086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5546500|NCT04129086|Anesthetics, General|anesthetics, general|mesh-ancestor
5546501|NCT04129086|Anesthetics|anesthetics|mesh-ancestor
5546502|NCT04129086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5546503|NCT04129086|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5546504|NCT04129086|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5546505|NCT04129086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5546506|NCT04129086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546507|NCT04129112|Propofol|propofol|mesh-list
5546508|NCT04129112|Anesthetics|anesthetics|mesh-ancestor
5546509|NCT04129112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5546510|NCT04129112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546511|NCT04129112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5546512|NCT04129112|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5546513|NCT04129112|Anesthetics, General|anesthetics, general|mesh-ancestor
6472570|NCT00505531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6142691|NCT01328964|Respiratory System Agents|respiratory system agents|mesh-ancestor
6142692|NCT01328964|Dermatologic Agents|dermatologic agents|mesh-ancestor
6472571|NCT00505531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472572|NCT00505531|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6472573|NCT00505700|Cytarabine|cytarabine|mesh-list
6472574|NCT00505700|Bortezomib|bortezomib|mesh-list
6142693|NCT01328964|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6142694|NCT01328964|Glucocorticoids|glucocorticoids|mesh-ancestor
6142695|NCT01328964|Hormones|hormones|mesh-ancestor
6142696|NCT01328964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6142697|NCT01328964|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6142698|NCT01328964|Hormone Antagonists|hormone antagonists|mesh-ancestor
6142699|NCT01328964|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6142700|NCT01328964|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6142701|NCT01328964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142702|NCT01329185|Valganciclovir|valganciclovir|mesh-list
6142703|NCT01329185|Antiviral Agents|antiviral agents|mesh-ancestor
6142704|NCT01329185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6142705|NCT01329263|Menthol|menthol|mesh-list
6142706|NCT01329263|Antipruritics|antipruritics|mesh-ancestor
6142707|NCT01329263|Dermatologic Agents|dermatologic agents|mesh-ancestor
6142708|NCT01329419|Adefovir|adefovir|mesh-list
6142709|NCT01329419|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6142710|NCT01329419|Antiviral Agents|antiviral agents|mesh-ancestor
6142711|NCT01329419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6142712|NCT01329419|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6472575|NCT00505700|Idarubicin|idarubicin|mesh-list
6472576|NCT00505700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6472577|NCT00505700|Antimetabolites|antimetabolites|mesh-ancestor
6472578|NCT00505700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472579|NCT00505700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6472580|NCT00505700|Antiviral Agents|antiviral agents|mesh-ancestor
6472581|NCT00505700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6472582|NCT00505700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6472583|NCT00505700|Immunologic Factors|immunologic factors|mesh-ancestor
6472584|NCT00505700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472585|NCT00505700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6472586|NCT00505700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6472587|NCT00505700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6472588|NCT00505700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6472589|NCT00505739|Mifepristone|mifepristone|mesh-list
6472590|NCT00505739|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6472591|NCT00505739|Abortifacient Agents|abortifacient agents|mesh-ancestor
6472592|NCT00505739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6472593|NCT00505739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472594|NCT00505739|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6472595|NCT00505739|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6472596|NCT00505739|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6472597|NCT00505739|Contraceptive Agents|contraceptive agents|mesh-ancestor
6472598|NCT00505739|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6472599|NCT00505739|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6472600|NCT00505739|Hormone Antagonists|hormone antagonists|mesh-ancestor
6472601|NCT00505739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6472602|NCT00505739|Luteolytic Agents|luteolytic agents|mesh-ancestor
6472603|NCT00505739|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6472604|NCT00505739|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6472605|NCT00505791|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6472606|NCT00505791|Natriuretic Agents|natriuretic agents|mesh-ancestor
6472607|NCT00505791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472608|NCT00505804|Dexmedetomidine|dexmedetomidine|mesh-list
6472609|NCT00505804|Haloperidol|haloperidol|mesh-list
6472610|NCT00505804|Haloperidol decanoate|haloperidol decanoate|mesh-list
6472611|NCT00505804|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6472612|NCT00505804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6472613|NCT00505804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472614|NCT00505804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6472615|NCT00505804|Analgesics|analgesics|mesh-ancestor
6472616|NCT00505804|Sensory System Agents|sensory system agents|mesh-ancestor
6472617|NCT00505804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6472618|NCT00505804|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6472619|NCT00505804|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6472620|NCT00505804|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6142713|NCT01329419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6472621|NCT00505804|Adrenergic Agents|adrenergic agents|mesh-ancestor
6472622|NCT00505804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6472623|NCT00505804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472624|NCT00505804|Antiemetics|antiemetics|mesh-ancestor
6472625|NCT00505804|Autonomic Agents|autonomic agents|mesh-ancestor
6472626|NCT00505804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6472627|NCT00505804|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6472628|NCT00505804|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6472629|NCT00505804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6472630|NCT00505804|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6472631|NCT00505804|Dopamine Agents|dopamine agents|mesh-ancestor
6472632|NCT00505804|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6472633|NCT00505817|Leuprolide|leuprolide|mesh-list
6472634|NCT00505817|Cetrorelix|cetrorelix|mesh-list
6666909|NCT01524861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666910|NCT01524861|Vitamin B Complex|vitamin b complex|mesh-ancestor
6142714|NCT01329419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6142715|NCT01329419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546514|NCT04128878|Sotalol|sotalol|mesh-list
5546515|NCT04128878|Dofetilide|dofetilide|mesh-list
5546516|NCT04128878|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5546517|NCT04128878|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5546518|NCT04128878|Adrenergic Agents|adrenergic agents|mesh-ancestor
5546519|NCT04128878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5546520|NCT04128878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546521|NCT04128878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546522|NCT04128878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5546523|NCT04128878|Sympatholytics|sympatholytics|mesh-ancestor
5546524|NCT04128878|Autonomic Agents|autonomic agents|mesh-ancestor
5546525|NCT04128878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6142716|NCT01329562|Naproxen|naproxen|mesh-list
6142717|NCT01329562|Sumatriptan|sumatriptan|mesh-list
6142718|NCT01329562|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6666911|NCT01524861|Vitamins|vitamins|mesh-ancestor
6666912|NCT01524861|Micronutrients|micronutrients|mesh-ancestor
5546526|NCT04128878|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5546527|NCT04128878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5546528|NCT04128722|Sirolimus|sirolimus|mesh-list
5546529|NCT04128722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5546530|NCT04128722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5546531|NCT04128722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5546532|NCT04128722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5546533|NCT04128722|Antifungal Agents|antifungal agents|mesh-ancestor
5546534|NCT04128722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5546535|NCT04128722|Immunologic Factors|immunologic factors|mesh-ancestor
5546536|NCT04128722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546537|NCT04128748|Cytarabine|cytarabine|mesh-list
5546538|NCT04128748|Daunorubicin|daunorubicin|mesh-list
5546539|NCT04128748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5546540|NCT04128748|Antimetabolites|antimetabolites|mesh-ancestor
5546541|NCT04128748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546542|NCT04128748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6666913|NCT01524861|Nootropic Agents|nootropic agents|mesh-ancestor
5546543|NCT04128748|Antiviral Agents|antiviral agents|mesh-ancestor
6142719|NCT01329562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6142720|NCT01329562|Analgesics|analgesics|mesh-ancestor
6142721|NCT01329562|Sensory System Agents|sensory system agents|mesh-ancestor
6142722|NCT01329562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6142723|NCT01329562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142724|NCT01329562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6142725|NCT01329562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6142726|NCT01329562|Gout Suppressants|gout suppressants|mesh-ancestor
6142727|NCT01329562|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6666914|NCT01524874|Vitamin D|vitamin d|mesh-list
6142728|NCT01329562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6142729|NCT01329562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142730|NCT01329562|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6142731|NCT01329562|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6142732|NCT01329562|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6142733|NCT01329562|Serotonin Agents|serotonin agents|mesh-ancestor
6142734|NCT01329562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6142735|NCT01329900|Etoposide|etoposide|mesh-list
6142736|NCT01329900|Ifosfamide|ifosfamide|mesh-list
6142737|NCT01329900|Ofatumumab|ofatumumab|mesh-list
6142738|NCT01329900|Lenograstim|lenograstim|mesh-list
6142739|NCT01329900|Sargramostim|sargramostim|mesh-list
6142740|NCT01329900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6142741|NCT01329900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6142742|NCT01329900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6142743|NCT01329900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6142744|NCT01329900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6142745|NCT01329900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142746|NCT01329900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6142747|NCT01329900|Immunologic Factors|immunologic factors|mesh-ancestor
6142748|NCT01329900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472635|NCT00505817|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6472636|NCT00505817|Fertility Agents|fertility agents|mesh-ancestor
6472637|NCT00505817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6472638|NCT00505817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472639|NCT00505817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6472640|NCT00505817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6472641|NCT00505817|Hormone Antagonists|hormone antagonists|mesh-ancestor
6472642|NCT00505817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6142749|NCT01329900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6142750|NCT01329900|Alkylating Agents|alkylating agents|mesh-ancestor
6142751|NCT01329939|Montelukast|montelukast|mesh-list
6142752|NCT01329939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6142753|NCT01329939|Respiratory System Agents|respiratory system agents|mesh-ancestor
6142754|NCT01329939|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6142755|NCT01329939|Hormone Antagonists|hormone antagonists|mesh-ancestor
6142756|NCT01329939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6142757|NCT01329939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142758|NCT01329939|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6142759|NCT01329939|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6142760|NCT01329939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142761|NCT01329978|Sofosbuvir|sofosbuvir|mesh-list
6142762|NCT01329978|Antiviral Agents|antiviral agents|mesh-ancestor
6142763|NCT01329978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6142764|NCT01330017|Loratadine|loratadine|mesh-list
6142765|NCT01330017|Phenylephrine|phenylephrine|mesh-list
6142766|NCT01330017|Oxymetazoline|oxymetazoline|mesh-list
6142767|NCT01330017|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6142768|NCT01330017|Mydriatics|mydriatics|mesh-ancestor
6142769|NCT01330017|Autonomic Agents|autonomic agents|mesh-ancestor
6142770|NCT01330017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6142771|NCT01330017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142772|NCT01330017|Sympathomimetics|sympathomimetics|mesh-ancestor
6142773|NCT01330017|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6142774|NCT01330017|Nasal Decongestants|nasal decongestants|mesh-ancestor
6142775|NCT01330017|Respiratory System Agents|respiratory system agents|mesh-ancestor
6142776|NCT01330017|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6142777|NCT01330017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6142778|NCT01330017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6142779|NCT01330017|Adrenergic Agents|adrenergic agents|mesh-ancestor
6207851|NCT02121002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6472643|NCT00505843|Levodopa|levodopa|mesh-list
6472644|NCT00505843|Carbidopa|carbidopa|mesh-list
6472645|NCT00505843|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6472646|NCT00505843|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6472647|NCT00505843|Dopamine Agents|dopamine agents|mesh-ancestor
6472648|NCT00505843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6472649|NCT00505843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472650|NCT00505843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472651|NCT00505843|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6472652|NCT00505843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6488652|NCT00585559|Acetylcysteine|acetylcysteine|mesh-list
6488653|NCT00585559|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6488654|NCT00585559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6488655|NCT00585559|Analgesics|analgesics|mesh-ancestor
6472653|NCT00505882|Pramlintide|pramlintide|mesh-list
6472654|NCT00505882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6472655|NCT00505882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472656|NCT00505947|Infliximab|infliximab|mesh-list
6472657|NCT00505947|Dermatologic Agents|dermatologic agents|mesh-ancestor
6472658|NCT00505947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6472659|NCT00505947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6472660|NCT00506051|Pemetrexed|pemetrexed|mesh-list
6472661|NCT00506051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6472662|NCT00506051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6472663|NCT00506051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472664|NCT00506051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6472665|NCT00506051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6472666|NCT00506168|Capecitabine|capecitabine|mesh-list
6472667|NCT00506168|Irinotecan|irinotecan|mesh-list
6472668|NCT00506168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6472669|NCT00506168|Antimetabolites|antimetabolites|mesh-ancestor
6472670|NCT00506168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472671|NCT00506168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6472672|NCT00506168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5546544|NCT04128748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5546545|NCT04128748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5546546|NCT04128748|Immunologic Factors|immunologic factors|mesh-ancestor
5546547|NCT04128748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546548|NCT04128748|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5546549|NCT04128748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5546550|NCT04128748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5546551|NCT04128748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5546552|NCT04128462|Phenylacetic acid|phenylacetic acid|mesh-list
5546553|NCT04128462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5546554|NCT04128462|Antimetabolites|antimetabolites|mesh-ancestor
5546555|NCT04128462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546556|NCT04128462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5546557|NCT04128436|Progesterone|progesterone|mesh-list
5546558|NCT04128436|Progestins|progestins|mesh-ancestor
5546559|NCT04128436|Hormones|hormones|mesh-ancestor
5546560|NCT04128436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5546561|NCT04128436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546562|NCT04128683|Bromocriptine|bromocriptine|mesh-list
5546563|NCT04128683|Amisulpride|amisulpride|mesh-list
5546564|NCT04128683|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5546565|NCT04128683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5546566|NCT04128683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5546567|NCT04128683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546568|NCT04128683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5546569|NCT04128683|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5546570|NCT04128683|Dopamine Agents|dopamine agents|mesh-ancestor
5546571|NCT04128683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5546572|NCT04128683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546573|NCT04128683|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5546574|NCT04128683|Antidepressive Agents|antidepressive agents|mesh-ancestor
5546575|NCT04128683|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6472673|NCT00506168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6472674|NCT00506168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6472675|NCT00506194|Gliclazide|gliclazide|mesh-list
6472676|NCT00506194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6472677|NCT00506194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546576|NCT04128683|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5546577|NCT04128683|Hormone Antagonists|hormone antagonists|mesh-ancestor
5546578|NCT04128683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5546579|NCT04128683|Dopamine Agonists|dopamine agonists|mesh-ancestor
5546580|NCT04128254|Apixaban|apixaban|mesh-list
5546581|NCT04128254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5546582|NCT04128254|Antithrombins|antithrombins|mesh-ancestor
5546583|NCT04128254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5546584|NCT04128254|Protease Inhibitors|protease inhibitors|mesh-ancestor
5546585|NCT04128254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5546586|NCT04128254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546587|NCT04128254|Anticoagulants|anticoagulants|mesh-ancestor
6472678|NCT00506207|Oxaliplatin|oxaliplatin|mesh-list
6472679|NCT00506207|Irinotecan|irinotecan|mesh-list
5546588|NCT04128540|Fentanyl|fentanyl|mesh-list
5546589|NCT04128540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6472680|NCT00506207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5546590|NCT04128540|Narcotics|narcotics|mesh-ancestor
6472681|NCT00506207|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6472682|NCT00506207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6142780|NCT01330017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6142781|NCT01330017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142782|NCT01330017|Protective Agents|protective agents|mesh-ancestor
6666915|NCT01524874|Ergocalciferols|ergocalciferols|mesh-list
6666916|NCT01524874|Cholecalciferol|cholecalciferol|mesh-list
6666917|NCT01524874|Calcitriol|calcitriol|mesh-list
6666918|NCT01524874|Vitamins|vitamins|mesh-list
5546591|NCT04128540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6472683|NCT00506207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6472684|NCT00506207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472685|NCT00506246|Propofol|propofol|mesh-list
6472686|NCT00506246|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6472687|NCT00506246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6472688|NCT00506246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472689|NCT00506246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6142783|NCT01330017|Antipruritics|antipruritics|mesh-ancestor
6142784|NCT01330017|Dermatologic Agents|dermatologic agents|mesh-ancestor
5546592|NCT04128540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546593|NCT04128540|Analgesics|analgesics|mesh-ancestor
5546594|NCT04128540|Sensory System Agents|sensory system agents|mesh-ancestor
5546595|NCT04128540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5546596|NCT04128540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5546597|NCT04128540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5546598|NCT04128540|Anesthetics, General|anesthetics, general|mesh-ancestor
5546599|NCT04128540|Anesthetics|anesthetics|mesh-ancestor
5546600|NCT04128501|Azacitidine|azacitidine|mesh-list
5546601|NCT04128501|Venetoclax|venetoclax|mesh-list
5546602|NCT04128501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5546603|NCT04128501|Antimetabolites|antimetabolites|mesh-ancestor
5546604|NCT04128501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546605|NCT04128501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5546606|NCT04128501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5546607|NCT04128176|Omalizumab|omalizumab|mesh-list
5546608|NCT04128176|Rituximab|rituximab|mesh-list
5546609|NCT04128176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5546610|NCT04128176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5546611|NCT04128176|Immunologic Factors|immunologic factors|mesh-ancestor
5546612|NCT04128176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546613|NCT04128176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5546614|NCT04128176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5546615|NCT04128176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5546616|NCT04128176|Respiratory System Agents|respiratory system agents|mesh-ancestor
5546617|NCT04128137|Fludrocortisone|fludrocortisone|mesh-list
5546618|NCT04128137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5546619|NCT04128072|Mogamulizumab|mogamulizumab|mesh-list
5546620|NCT04128072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5546621|NCT04127747|Rituximab|rituximab|mesh-list
6142785|NCT01330017|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6142786|NCT01330017|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6142787|NCT01330017|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5546622|NCT04127747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5546623|NCT04127747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5546624|NCT04127747|Immunologic Factors|immunologic factors|mesh-ancestor
5546625|NCT04127747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546626|NCT04127747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5546627|NCT04127851|Cyclosporine|cyclosporine|mesh-list
5546628|NCT04127851|Cyclosporins|cyclosporins|mesh-list
6142788|NCT01330017|Histamine Antagonists|histamine antagonists|mesh-ancestor
6142789|NCT01330017|Histamine Agents|histamine agents|mesh-ancestor
6142790|NCT01330030|Selegiline|selegiline|mesh-list
6142791|NCT01330030|Antidepressive Agents|antidepressive agents|mesh-ancestor
6142792|NCT01330030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6142793|NCT01330030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6142794|NCT01330030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6142795|NCT01330030|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6142796|NCT01330030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6142797|NCT01330030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142798|NCT01330030|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6142799|NCT01330030|Protective Agents|protective agents|mesh-ancestor
6142800|NCT01330030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142801|NCT01330043|Bupropion|bupropion|mesh-list
6142802|NCT01330043|Nicotine|nicotine|mesh-list
6142803|NCT01330043|Varenicline|varenicline|mesh-list
6472690|NCT00506246|Anesthetics, General|anesthetics, general|mesh-ancestor
6666919|NCT01524874|Micronutrients|micronutrients|mesh-ancestor
6142804|NCT01330043|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6672428|NCT01555970|Protective Agents|protective agents|mesh-ancestor
6142805|NCT01330043|Autonomic Agents|autonomic agents|mesh-ancestor
6142806|NCT01330043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6142807|NCT01330043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142808|NCT01330043|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6142809|NCT01330043|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6142810|NCT01330043|Cholinergic Agents|cholinergic agents|mesh-ancestor
6142811|NCT01330043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5546629|NCT04127851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5546630|NCT04127851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546631|NCT04127851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5546632|NCT04127851|Immunologic Factors|immunologic factors|mesh-ancestor
6142812|NCT01330043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142813|NCT01330043|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6142814|NCT01330043|Antidepressive Agents|antidepressive agents|mesh-ancestor
6142815|NCT01330043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6142816|NCT01330043|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6142817|NCT01330043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6142818|NCT01330043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6142819|NCT01330043|Dopamine Agents|dopamine agents|mesh-ancestor
6142820|NCT01330043|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6142821|NCT01330043|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6142822|NCT01330043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6142823|NCT01330108|Ambrisentan|ambrisentan|mesh-list
6142824|NCT01330108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6142825|NCT01330134|Lidocaine|lidocaine|mesh-list
5546633|NCT04127851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546634|NCT04127851|Antifungal Agents|antifungal agents|mesh-ancestor
5546635|NCT04127851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5546636|NCT04127851|Dermatologic Agents|dermatologic agents|mesh-ancestor
5546637|NCT04127851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5546638|NCT04127851|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5546639|NCT04127916|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5546640|NCT04127916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5546641|NCT04127916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5546642|NCT04127916|Alkylating Agents|alkylating agents|mesh-ancestor
5546643|NCT04127916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546644|NCT04128020|Nivolumab|nivolumab|mesh-list
5546645|NCT04128020|Azacitidine|azacitidine|mesh-list
5546646|NCT04128020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5546647|NCT04128020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5546648|NCT04128020|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5546649|NCT04128020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546650|NCT04128020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5546651|NCT04128020|Antimetabolites|antimetabolites|mesh-ancestor
5546652|NCT04128020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5546653|NCT04127721|Methotrexate|methotrexate|mesh-list
5546654|NCT04127721|Fludarabine|fludarabine|mesh-list
5546655|NCT04127721|Busulfan|busulfan|mesh-list
6142826|NCT01330134|Anesthetics, Local|anesthetics, local|mesh-ancestor
6142827|NCT01330134|Anesthetics|anesthetics|mesh-ancestor
6142828|NCT01330134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6142829|NCT01330134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142830|NCT01330134|Sensory System Agents|sensory system agents|mesh-ancestor
6142831|NCT01330134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6142832|NCT01330134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6142833|NCT01330134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6142834|NCT01330134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6142835|NCT01330134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6142836|NCT01330134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142837|NCT01330290|Rotigotine|rotigotine|mesh-list
5546656|NCT04127721|Tacrolimus|tacrolimus|mesh-list
5546657|NCT04127721|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5546658|NCT04127721|Abortifacient Agents|abortifacient agents|mesh-ancestor
5546659|NCT04127721|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5546660|NCT04127721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142838|NCT01330290|Dopamine Agonists|dopamine agonists|mesh-ancestor
6142839|NCT01330290|Dopamine Agents|dopamine agents|mesh-ancestor
6142840|NCT01330290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6142841|NCT01330290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142842|NCT01330290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142843|NCT01330355|Gatifloxacin|gatifloxacin|mesh-list
6142844|NCT01330355|Besifloxacin|besifloxacin|mesh-list
6472691|NCT00506246|Anesthetics|anesthetics|mesh-ancestor
5602647|NCT04279197|Antioxidants|antioxidants|mesh-ancestor
5546661|NCT04127721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5546662|NCT04127721|Antimetabolites|antimetabolites|mesh-ancestor
5546663|NCT04127721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546664|NCT04127721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5546665|NCT04127721|Dermatologic Agents|dermatologic agents|mesh-ancestor
5546666|NCT04127721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5546667|NCT04127721|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5546668|NCT04127721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5546669|NCT04127721|Immunologic Factors|immunologic factors|mesh-ancestor
5546670|NCT04127721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5546671|NCT04127721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5546672|NCT04127721|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5546673|NCT04127721|Alkylating Agents|alkylating agents|mesh-ancestor
5546674|NCT04127721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5546675|NCT04127721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6142845|NCT01330355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6142846|NCT01330355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6142847|NCT01330355|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6142848|NCT01330355|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6142849|NCT01330355|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6142850|NCT01330355|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6142851|NCT01330355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6142852|NCT01330355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142853|NCT01330355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6142854|NCT01330381|Prucalopride|prucalopride|mesh-list
6472692|NCT00506259|Melatonin|melatonin|mesh-list
6472693|NCT00506259|Antioxidants|antioxidants|mesh-ancestor
6472694|NCT00506259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472695|NCT00506259|Protective Agents|protective agents|mesh-ancestor
6472696|NCT00506259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472697|NCT00506259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6472698|NCT00506272|Insulin|insulin|mesh-list
6472699|NCT00506272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6472700|NCT00506272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472701|NCT00506298|Diflunisal|diflunisal|mesh-list
6472702|NCT00506298|Bezafibrate|bezafibrate|mesh-list
6472703|NCT00506298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6472704|NCT00506298|Antimetabolites|antimetabolites|mesh-ancestor
6472705|NCT00506298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142855|NCT01330381|Laxatives|laxatives|mesh-ancestor
6142856|NCT01330381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6142857|NCT01330381|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
6142858|NCT01330381|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6142859|NCT01330381|Serotonin Agents|serotonin agents|mesh-ancestor
6142860|NCT01330381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6142861|NCT01330381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142862|NCT01330381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142863|NCT01330459|Acetaminophen|acetaminophen|mesh-list
6142864|NCT01330459|Ibuprofen|ibuprofen|mesh-list
6142865|NCT01330459|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
6142866|NCT01330459|Lidocaine|lidocaine|mesh-list
6142867|NCT01330459|Hydrocodone|hydrocodone|mesh-list
6142868|NCT01330459|Lorazepam|lorazepam|mesh-list
6142869|NCT01330459|Anesthetics, Local|anesthetics, local|mesh-ancestor
6142870|NCT01330459|Anesthetics|anesthetics|mesh-ancestor
6142871|NCT01330459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6142872|NCT01330459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142873|NCT01330459|Sensory System Agents|sensory system agents|mesh-ancestor
6142874|NCT01330459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6142875|NCT01330459|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6142876|NCT01330459|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6142877|NCT01330459|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6142878|NCT01330459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6142879|NCT01330459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142880|NCT01330459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5602648|NCT04279197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602649|NCT04279197|Protective Agents|protective agents|mesh-ancestor
5602650|NCT04274426|Gemcitabine|gemcitabine|mesh-list
5602651|NCT04274426|Paclitaxel|paclitaxel|mesh-list
5602652|NCT04274426|Maytansine|maytansine|mesh-list
5602653|NCT04274426|Carboplatin|carboplatin|mesh-list
5602654|NCT04274426|Doxorubicin|doxorubicin|mesh-list
5602655|NCT04274426|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6142881|NCT01330459|Analgesics|analgesics|mesh-ancestor
6142882|NCT01330459|Antipyretics|antipyretics|mesh-ancestor
6142883|NCT01330459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6142884|NCT01330459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6142885|NCT01330459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6142886|NCT01330459|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6142887|NCT01330459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6142888|NCT01330459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6142889|NCT01330459|Narcotics|narcotics|mesh-ancestor
6142890|NCT01330459|Antitussive Agents|antitussive agents|mesh-ancestor
6142891|NCT01330459|Respiratory System Agents|respiratory system agents|mesh-ancestor
6142892|NCT01330459|Anticonvulsants|anticonvulsants|mesh-ancestor
6142893|NCT01330459|Antiemetics|antiemetics|mesh-ancestor
6142894|NCT01330459|Autonomic Agents|autonomic agents|mesh-ancestor
6142895|NCT01330459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6142896|NCT01330459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6142897|NCT01330459|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5546678|NCT04127396|Sorafenib|sorafenib|mesh-list
5546679|NCT04127396|Chlorotrianisene|chlorotrianisene|mesh-list
5546680|NCT04127396|Lenvatinib|lenvatinib|mesh-list
5546681|NCT04127396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5546682|NCT04127396|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5546683|NCT04127396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5546684|NCT04127396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546685|NCT04127396|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
5546686|NCT04127396|Estrogens|estrogens|mesh-ancestor
5546687|NCT04127396|Hormones|hormones|mesh-ancestor
5546688|NCT04127396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5546689|NCT04127396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546690|NCT04127396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5546691|NCT04127500|Dexmedetomidine|dexmedetomidine|mesh-list
5546692|NCT04127500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5546693|NCT04127500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5546694|NCT04127500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546695|NCT04127500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5546696|NCT04127500|Analgesics|analgesics|mesh-ancestor
5546697|NCT04127500|Sensory System Agents|sensory system agents|mesh-ancestor
5546698|NCT04127500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5546699|NCT04127500|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5546700|NCT04127500|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6142898|NCT01330459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6142899|NCT01330459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6142900|NCT01330459|GABA Modulators|gaba modulators|mesh-ancestor
6142901|NCT01330459|GABA Agents|gaba agents|mesh-ancestor
6142902|NCT01330459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6142903|NCT01331005|Nepafenac|nepafenac|mesh-list
6142904|NCT01331005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6142905|NCT01331005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6142906|NCT01331005|Analgesics|analgesics|mesh-ancestor
6142907|NCT01331005|Sensory System Agents|sensory system agents|mesh-ancestor
6142908|NCT01331005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6142909|NCT01331005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142910|NCT01331005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6142911|NCT01331005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6142912|NCT01331109|Milnacipran|milnacipran|mesh-list
6142913|NCT01331109|Levomilnacipran|levomilnacipran|mesh-list
6142914|NCT01331109|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6142915|NCT01331109|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6142916|NCT01331109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5546701|NCT04127500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5546702|NCT04127500|Adrenergic Agents|adrenergic agents|mesh-ancestor
5546703|NCT04127500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5546704|NCT04127500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546705|NCT04127357|Fluorides|fluorides|mesh-list
5546706|NCT04127357|Cariostatic Agents|cariostatic agents|mesh-ancestor
5546707|NCT04127357|Protective Agents|protective agents|mesh-ancestor
5546708|NCT04127357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546709|NCT04127084|Empagliflozin|empagliflozin|mesh-list
5546710|NCT04127084|Canagliflozin|canagliflozin|mesh-list
5546711|NCT04127084|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5546712|NCT04127084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546713|NCT04127084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5546714|NCT04127084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142917|NCT01331109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142918|NCT01331109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6472706|NCT00506298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6472707|NCT00506298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6472708|NCT00506298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6472709|NCT00506298|Analgesics|analgesics|mesh-ancestor
6472710|NCT00506298|Sensory System Agents|sensory system agents|mesh-ancestor
6472711|NCT00506298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6472712|NCT00506298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472713|NCT00506298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6472714|NCT00506298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5546715|NCT04126941|Calcium|calcium|mesh-list
5546716|NCT04126941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5546717|NCT04126941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546718|NCT04127058|Iloperidone|iloperidone|mesh-list
5546719|NCT04127058|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5546720|NCT04127058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5546721|NCT04127058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5546722|NCT04127058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546723|NCT04127058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5546724|NCT04127019|Paclitaxel|paclitaxel|mesh-list
5546725|NCT04127019|Docetaxel|docetaxel|mesh-list
5546726|NCT04127019|Cyclophosphamide|cyclophosphamide|mesh-list
5546727|NCT04127019|Fluorouracil|fluorouracil|mesh-list
5546728|NCT04127019|Epirubicin|epirubicin|mesh-list
5546729|NCT04127019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5546730|NCT04127019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5546731|NCT04127019|Tubulin Modulators|tubulin modulators|mesh-ancestor
5546732|NCT04127019|Antimitotic Agents|antimitotic agents|mesh-ancestor
5546733|NCT04127019|Mitosis Modulators|mitosis modulators|mesh-ancestor
5546734|NCT04127019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546735|NCT04127019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5546736|NCT04127019|Immunologic Factors|immunologic factors|mesh-ancestor
5546737|NCT04127019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546738|NCT04127019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5546739|NCT04127019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5546740|NCT04127019|Alkylating Agents|alkylating agents|mesh-ancestor
6472715|NCT00506298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6472716|NCT00506298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6472717|NCT00506311|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6472718|NCT00506311|Hemostatics|hemostatics|mesh-ancestor
6472719|NCT00506311|Coagulants|coagulants|mesh-ancestor
6472720|NCT00506506|Acetylcysteine|acetylcysteine|mesh-list
6472721|NCT00506506|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5546741|NCT04127019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5546742|NCT04127019|Antimetabolites|antimetabolites|mesh-ancestor
5546743|NCT04127019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5546744|NCT04127019|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5546745|NCT04127019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5546746|NCT04127019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5546747|NCT04127019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5546748|NCT04126993|Apatinib|apatinib|mesh-list
5546749|NCT04126993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5546750|NCT04126993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5546751|NCT04126993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6472722|NCT00506506|Antiviral Agents|antiviral agents|mesh-ancestor
6472723|NCT00506506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6472724|NCT00506506|Expectorants|expectorants|mesh-ancestor
6472725|NCT00506506|Respiratory System Agents|respiratory system agents|mesh-ancestor
6472726|NCT00506506|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6472727|NCT00506506|Antioxidants|antioxidants|mesh-ancestor
6142919|NCT01331109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142920|NCT01331109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6142921|NCT01331109|Analgesics|analgesics|mesh-ancestor
6142922|NCT01331109|Sensory System Agents|sensory system agents|mesh-ancestor
6142923|NCT01331109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6142924|NCT01331109|Antidepressive Agents|antidepressive agents|mesh-ancestor
6142925|NCT01331109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6142926|NCT01331161|Vaccines|vaccines|mesh-list
6142927|NCT01331161|Immunologic Factors|immunologic factors|mesh-ancestor
6142928|NCT01331161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142929|NCT01331213|Pregabalin|pregabalin|mesh-list
6142930|NCT01331213|Analgesics|analgesics|mesh-ancestor
6142931|NCT01331213|Sensory System Agents|sensory system agents|mesh-ancestor
6142932|NCT01331213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6142933|NCT01331213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142934|NCT01331213|Anticonvulsants|anticonvulsants|mesh-ancestor
6472728|NCT00506506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472729|NCT00506506|Protective Agents|protective agents|mesh-ancestor
6142935|NCT01331213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6142936|NCT01331213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6142937|NCT01331213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6142938|NCT01331213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6142939|NCT01331213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6142940|NCT01331213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6142941|NCT01331213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6142942|NCT01331213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6142943|NCT01331304|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6142944|NCT01331304|Antidepressive Agents|antidepressive agents|mesh-ancestor
6142945|NCT01331304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6142946|NCT01331304|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6142947|NCT01331304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6142948|NCT01331304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6142949|NCT01331304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666920|NCT01524874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666921|NCT01524874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6666922|NCT01524874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6666923|NCT01524874|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6666924|NCT01524874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6666925|NCT01524874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666926|NCT01524874|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6666927|NCT01524926|Crizotinib|crizotinib|mesh-list
6666928|NCT01524926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6666929|NCT01524926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6666930|NCT01524926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6666931|NCT01524926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666932|NCT01524939|Immunoglobulins|immunoglobulins|mesh-list
6666933|NCT01524939|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6472730|NCT00506506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472731|NCT00506506|Antidotes|antidotes|mesh-ancestor
6472732|NCT00506532|Pulmonary Surfactants|pulmonary surfactants|mesh-list
6472733|NCT00506532|Calfactant|calfactant|mesh-list
6472734|NCT00506532|Respiratory System Agents|respiratory system agents|mesh-ancestor
6142950|NCT01331681|Aflibercept|aflibercept|mesh-list
6142951|NCT01331681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6142952|NCT01331681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6142953|NCT01331681|Growth Substances|growth substances|mesh-ancestor
6142954|NCT01331681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142955|NCT01331681|Growth Inhibitors|growth inhibitors|mesh-ancestor
6142956|NCT01331681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6472735|NCT00506545|Rolapitant|rolapitant|mesh-list
6472736|NCT00506545|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6472737|NCT00506545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5546752|NCT04126993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546753|NCT04127227|Gemcitabine|gemcitabine|mesh-list
5546754|NCT04127227|Oxaliplatin|oxaliplatin|mesh-list
5546755|NCT04127227|Pegaspargase|pegaspargase|mesh-list
5546756|NCT04127227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5546757|NCT04127227|Antimetabolites|antimetabolites|mesh-ancestor
5546758|NCT04127227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546759|NCT04127227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5546760|NCT04127227|Antiviral Agents|antiviral agents|mesh-ancestor
5546761|NCT04127227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5546762|NCT04127227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6142957|NCT01331694|Fluticasone|fluticasone|mesh-list
6472738|NCT00506545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472739|NCT00506545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472740|NCT00506571|Oxaliplatin|oxaliplatin|mesh-list
6472741|NCT00506571|Irinotecan|irinotecan|mesh-list
6472742|NCT00506571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6472743|NCT00506571|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6472744|NCT00506571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6472745|NCT00506571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6472746|NCT00506571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472747|NCT00506623|Capecitabine|capecitabine|mesh-list
6472748|NCT00506623|Irinotecan|irinotecan|mesh-list
6472749|NCT00506623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6472750|NCT00506623|Antimetabolites|antimetabolites|mesh-ancestor
6472751|NCT00506623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472752|NCT00506623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6472753|NCT00506623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6142958|NCT01331694|Bromides|bromides|mesh-list
6142959|NCT01331694|Albuterol|albuterol|mesh-list
6142960|NCT01331694|Tiotropium Bromide|tiotropium bromide|mesh-list
6142961|NCT01331694|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6142962|NCT01331694|Ipratropium|ipratropium|mesh-list
6142963|NCT01331694|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6142964|NCT01331694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6142965|NCT01331694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6142966|NCT01331694|Autonomic Agents|autonomic agents|mesh-ancestor
6142967|NCT01331694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6142968|NCT01331694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142969|NCT01331694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6142970|NCT01331694|Respiratory System Agents|respiratory system agents|mesh-ancestor
6142971|NCT01331694|Dermatologic Agents|dermatologic agents|mesh-ancestor
6142972|NCT01331694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6142973|NCT01331694|Parasympatholytics|parasympatholytics|mesh-ancestor
6142974|NCT01331694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6142975|NCT01331694|Cholinergic Agents|cholinergic agents|mesh-ancestor
6142976|NCT01331694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6142977|NCT01331694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546763|NCT04127227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5546764|NCT04127227|Immunologic Factors|immunologic factors|mesh-ancestor
5546765|NCT04127227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546766|NCT04126811|Apatinib|apatinib|mesh-list
5546767|NCT04126811|Ifosfamide|ifosfamide|mesh-list
5546768|NCT04126811|Isophosphamide mustard|isophosphamide mustard|mesh-list
5546769|NCT04126811|Pirarubicin|pirarubicin|mesh-list
5546770|NCT04126811|Doxorubicin|doxorubicin|mesh-list
5546771|NCT04126811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5546772|NCT04126811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5546773|NCT04126811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6666934|NCT01524939|Antibodies|antibodies|mesh-list
6666935|NCT01524939|Immunoglobulin G|immunoglobulin g|mesh-list
6666936|NCT01524939|Immunologic Factors|immunologic factors|mesh-ancestor
6666937|NCT01524939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666938|NCT01525004|Vaccines|vaccines|mesh-list
6666939|NCT01525004|Immunologic Factors|immunologic factors|mesh-ancestor
6142978|NCT01331694|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6142979|NCT01331694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6142980|NCT01331694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6142981|NCT01331694|Adrenergic Agents|adrenergic agents|mesh-ancestor
6142982|NCT01331694|Anticonvulsants|anticonvulsants|mesh-ancestor
6142983|NCT01331694|Tocolytic Agents|tocolytic agents|mesh-ancestor
6142984|NCT01331694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6142985|NCT01331694|Glucocorticoids|glucocorticoids|mesh-ancestor
6142986|NCT01331694|Hormones|hormones|mesh-ancestor
6142987|NCT01331694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6142988|NCT01331694|Sympathomimetics|sympathomimetics|mesh-ancestor
6142989|NCT01331824|Amrubicin|amrubicin|mesh-list
6142990|NCT01331824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6142991|NCT01331837|Etanercept|etanercept|mesh-list
6142992|NCT01331837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6142993|NCT01331837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6142994|NCT01331837|Analgesics|analgesics|mesh-ancestor
6142995|NCT01331837|Sensory System Agents|sensory system agents|mesh-ancestor
6142996|NCT01331837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6142997|NCT01331837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6142998|NCT01331837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6142999|NCT01331837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6143000|NCT01331837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6143001|NCT01331837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6143002|NCT01331837|Immunologic Factors|immunologic factors|mesh-ancestor
6666940|NCT01525004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666941|NCT01525043|Naproxen|naproxen|mesh-list
6666942|NCT01525043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6666943|NCT01525043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6666944|NCT01525043|Analgesics|analgesics|mesh-ancestor
6666945|NCT01525043|Sensory System Agents|sensory system agents|mesh-ancestor
6666946|NCT01525043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6666947|NCT01525043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666948|NCT01525043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6666949|NCT01525043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6666950|NCT01525043|Gout Suppressants|gout suppressants|mesh-ancestor
6666951|NCT01525043|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6666952|NCT01525043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6666953|NCT01525043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666954|NCT01525069|Gemcitabine|gemcitabine|mesh-list
5602656|NCT04274426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6143003|NCT01332019|Interferons|interferons|mesh-list
6666955|NCT01525069|Dexamethasone|dexamethasone|mesh-list
6666956|NCT01525069|Oxaliplatin|oxaliplatin|mesh-list
6143004|NCT01332019|Interferon-beta|interferon-beta|mesh-list
6143005|NCT01332019|Interferon beta-1a|interferon beta-1a|mesh-list
6143006|NCT01332019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6143007|NCT01332019|Antiviral Agents|antiviral agents|mesh-ancestor
6143008|NCT01332019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6143009|NCT01332019|Immunologic Factors|immunologic factors|mesh-ancestor
6143010|NCT01332019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143011|NCT01332019|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6143012|NCT01332071|Metformin|metformin|mesh-list
6143013|NCT01332071|Rosiglitazone|rosiglitazone|mesh-list
6143014|NCT01332071|Maleic acid|maleic acid|mesh-list
6143015|NCT01332071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6143016|NCT01332071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143017|NCT01332071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6143018|NCT01332071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143019|NCT01332149|Pregabalin|pregabalin|mesh-list
6143020|NCT01332149|Analgesics|analgesics|mesh-ancestor
6143021|NCT01332149|Sensory System Agents|sensory system agents|mesh-ancestor
6143022|NCT01332149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6666957|NCT01525069|Floxuridine|floxuridine|mesh-list
6666958|NCT01525069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6666959|NCT01525069|Antiemetics|antiemetics|mesh-ancestor
6666960|NCT01525069|Autonomic Agents|autonomic agents|mesh-ancestor
6666961|NCT01525069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6666962|NCT01525069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6666963|NCT01525069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5546774|NCT04126811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546775|NCT04126811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5546776|NCT04126811|Alkylating Agents|alkylating agents|mesh-ancestor
5546777|NCT04126811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6143023|NCT01332149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143024|NCT01332149|Anticonvulsants|anticonvulsants|mesh-ancestor
6143025|NCT01332149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6143026|NCT01332149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6143027|NCT01332149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143028|NCT01332149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6666964|NCT01525069|Glucocorticoids|glucocorticoids|mesh-ancestor
6143029|NCT01332149|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6143030|NCT01332149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6143031|NCT01332149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6143032|NCT01332149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6143033|NCT01332188|Cetirizine|cetirizine|mesh-list
6143034|NCT01332188|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6143035|NCT01332188|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6143036|NCT01332188|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6143037|NCT01332188|Histamine Antagonists|histamine antagonists|mesh-ancestor
6143038|NCT01332188|Histamine Agents|histamine agents|mesh-ancestor
6143039|NCT01332188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6143040|NCT01332188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143041|NCT01332188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143042|NCT01332227|Ritonavir|ritonavir|mesh-list
6143043|NCT01332227|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6143044|NCT01332227|Tenofovir|tenofovir|mesh-list
6143045|NCT01332227|Emtricitabine|emtricitabine|mesh-list
6472754|NCT00506623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6472755|NCT00506623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6472756|NCT00506701|Tadalafil|tadalafil|mesh-list
6472757|NCT00506701|Vasodilator Agents|vasodilator agents|mesh-ancestor
6472758|NCT00506701|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6472759|NCT00506701|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6472760|NCT00506701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6488656|NCT00585559|Sensory System Agents|sensory system agents|mesh-ancestor
6666965|NCT01525069|Hormones|hormones|mesh-ancestor
5546778|NCT04126811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5546779|NCT04126811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5546780|NCT04126668|Vorolanib|vorolanib|mesh-list
6472761|NCT00506701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472762|NCT00506701|Urological Agents|urological agents|mesh-ancestor
6472763|NCT00506727|Amphetamine|amphetamine|mesh-list
6472764|NCT00506727|Adderall|adderall|mesh-list
6472765|NCT00506727|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6472766|NCT00506727|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6472767|NCT00506727|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6472768|NCT00506727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6472769|NCT00506727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472770|NCT00506727|Adrenergic Agents|adrenergic agents|mesh-ancestor
6472771|NCT00506727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6472772|NCT00506727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472773|NCT00506727|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6472774|NCT00506727|Sympathomimetics|sympathomimetics|mesh-ancestor
6472775|NCT00506727|Autonomic Agents|autonomic agents|mesh-ancestor
6472776|NCT00506727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6143046|NCT01332227|Raltegravir Potassium|raltegravir potassium|mesh-list
6143047|NCT01332227|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6143048|NCT01332227|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6143049|NCT01332227|Protease Inhibitors|protease inhibitors|mesh-ancestor
6143050|NCT01332227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6143051|NCT01332227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143052|NCT01332227|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6143053|NCT01332227|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6143054|NCT01332227|Antiviral Agents|antiviral agents|mesh-ancestor
6143055|NCT01332227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6143056|NCT01332227|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6143057|NCT01332227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6143058|NCT01332227|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6472777|NCT00506727|Dopamine Agents|dopamine agents|mesh-ancestor
6472778|NCT00506727|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6472779|NCT00506844|Capecitabine|capecitabine|mesh-list
6472780|NCT00506844|Irinotecan|irinotecan|mesh-list
6472781|NCT00506844|Cetuximab|cetuximab|mesh-list
6472782|NCT00506844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6472783|NCT00506844|Antimetabolites|antimetabolites|mesh-ancestor
6472784|NCT00506844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472785|NCT00506844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6472786|NCT00506844|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6672429|NCT01555970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546781|NCT04126668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5546782|NCT04126668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5546783|NCT04126668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546784|NCT04126681|Interferons|interferons|mesh-list
5546785|NCT04126681|Imatinib Mesylate|imatinib mesylate|mesh-list
5546786|NCT04126681|Dasatinib|dasatinib|mesh-list
5546787|NCT04126681|Hydroxyurea|hydroxyurea|mesh-list
5546788|NCT04126681|Homoharringtonine|homoharringtonine|mesh-list
5546789|NCT04126681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5546790|NCT04126681|Antiviral Agents|antiviral agents|mesh-ancestor
5546791|NCT04126681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5546792|NCT04126681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5546793|NCT04126681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5546794|NCT04126681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546795|NCT04126681|Antisickling Agents|antisickling agents|mesh-ancestor
5546796|NCT04126681|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5546797|NCT04126681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5546798|NCT04126681|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5546799|NCT04126330|Vitamin D|vitamin d|mesh-list
5546800|NCT04126330|Vitamins|vitamins|mesh-ancestor
5546801|NCT04126330|Micronutrients|micronutrients|mesh-ancestor
5546802|NCT04126330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546803|NCT04126330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5546804|NCT04126382|Pulmonary Surfactants|pulmonary surfactants|mesh-list
5546805|NCT04126382|Respiratory System Agents|respiratory system agents|mesh-ancestor
5546806|NCT04126720|Vitamin E|vitamin e|mesh-list
5546807|NCT04126720|Vitamins|vitamins|mesh-ancestor
5546808|NCT04126720|Micronutrients|micronutrients|mesh-ancestor
5546809|NCT04126720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546810|NCT04126720|Antioxidants|antioxidants|mesh-ancestor
5546811|NCT04126720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546812|NCT04126720|Protective Agents|protective agents|mesh-ancestor
5546813|NCT04126304|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5546814|NCT04126304|Azithromycin|azithromycin|mesh-list
5546815|NCT04126304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5546816|NCT04126252|Sildenafil Citrate|sildenafil citrate|mesh-list
5546817|NCT04126252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666966|NCT01525069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6666967|NCT01525069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6666968|NCT01525069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6666969|NCT01525069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6666970|NCT01525069|Antimetabolites|antimetabolites|mesh-ancestor
6143059|NCT01332227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6143060|NCT01332227|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6143061|NCT01332227|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6143062|NCT01332253|Ibuprofen|ibuprofen|mesh-list
6143063|NCT01332253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6143064|NCT01332253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6143065|NCT01332253|Analgesics|analgesics|mesh-ancestor
6143066|NCT01332253|Sensory System Agents|sensory system agents|mesh-ancestor
6472787|NCT00506844|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6472788|NCT00506844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6472789|NCT00506844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6472790|NCT00506935|Vigabatrin|vigabatrin|mesh-list
6472791|NCT00506935|Anticonvulsants|anticonvulsants|mesh-ancestor
6666971|NCT01525069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666972|NCT01525069|Antiviral Agents|antiviral agents|mesh-ancestor
6666973|NCT01525069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6666974|NCT01525069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6666975|NCT01525069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6666976|NCT01525069|Immunologic Factors|immunologic factors|mesh-ancestor
6143067|NCT01332253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6143068|NCT01332253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143069|NCT01332253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6143070|NCT01332253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6143071|NCT01332253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6143072|NCT01332253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6143073|NCT01332253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143074|NCT01332292|Fluticasone|fluticasone|mesh-list
6143075|NCT01332292|Xhance|xhance|mesh-list
6143076|NCT01332292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6143077|NCT01332292|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6143078|NCT01332292|Autonomic Agents|autonomic agents|mesh-ancestor
6472792|NCT00506935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6472793|NCT00506935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472794|NCT00506935|GABA Agents|gaba agents|mesh-ancestor
6472795|NCT00506935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6472796|NCT00506935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143079|NCT01332292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6143080|NCT01332292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143081|NCT01332292|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6143082|NCT01332292|Respiratory System Agents|respiratory system agents|mesh-ancestor
6143083|NCT01332292|Dermatologic Agents|dermatologic agents|mesh-ancestor
6143084|NCT01332292|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6143085|NCT01332318|Diphenhydramine|diphenhydramine|mesh-list
6143086|NCT01332318|Promethazine|promethazine|mesh-list
6143087|NCT01332318|Gabapentin|gabapentin|mesh-list
6143088|NCT01332318|Analgesics|analgesics|mesh-ancestor
6143089|NCT01332318|Sensory System Agents|sensory system agents|mesh-ancestor
6143090|NCT01332318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6143091|NCT01332318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143092|NCT01332318|Anticonvulsants|anticonvulsants|mesh-ancestor
6143093|NCT01332318|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6143094|NCT01332318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6472797|NCT00506961|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6472798|NCT00506961|Simvastatin|simvastatin|mesh-list
6472799|NCT00506961|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6472800|NCT00506961|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6472801|NCT00506961|Antimetabolites|antimetabolites|mesh-ancestor
6472802|NCT00506961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472803|NCT00506961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6472804|NCT00506961|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6472805|NCT00506961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6472806|NCT00506974|Sodium Oxybate|sodium oxybate|mesh-list
6472807|NCT00506974|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6666977|NCT01525290|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6143095|NCT01332318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5546818|NCT04126252|Vasodilator Agents|vasodilator agents|mesh-ancestor
5546819|NCT04126252|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5546820|NCT04126252|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5546821|NCT04126252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5546822|NCT04126252|Urological Agents|urological agents|mesh-ancestor
5546823|NCT04126044|Bevacizumab|bevacizumab|mesh-list
5546824|NCT04126044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5546825|NCT04126044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5546826|NCT04126044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5546827|NCT04126044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5546828|NCT04126044|Growth Substances|growth substances|mesh-ancestor
5546829|NCT04126044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546830|NCT04126044|Growth Inhibitors|growth inhibitors|mesh-ancestor
5546831|NCT04126070|Docetaxel|docetaxel|mesh-list
5546832|NCT04126070|Nivolumab|nivolumab|mesh-list
5546833|NCT04126070|Leuprolide|leuprolide|mesh-list
5546834|NCT04126070|Goserelin|goserelin|mesh-list
5546835|NCT04126070|Androgens|androgens|mesh-list
5546836|NCT04126070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5546837|NCT04126070|Tubulin Modulators|tubulin modulators|mesh-ancestor
5546838|NCT04126070|Antimitotic Agents|antimitotic agents|mesh-ancestor
5546839|NCT04126070|Mitosis Modulators|mitosis modulators|mesh-ancestor
5546840|NCT04126070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472808|NCT00506974|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6472809|NCT00506974|Anesthetics, General|anesthetics, general|mesh-ancestor
6472810|NCT00506974|Anesthetics|anesthetics|mesh-ancestor
6472811|NCT00506974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6472812|NCT00506974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472813|NCT00507000|Vitamin D|vitamin d|mesh-list
6472814|NCT00507000|Cholecalciferol|cholecalciferol|mesh-list
6472815|NCT00507000|Vitamins|vitamins|mesh-ancestor
6472816|NCT00507000|Micronutrients|micronutrients|mesh-ancestor
6472817|NCT00507000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472818|NCT00507000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6472819|NCT00507000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6472820|NCT00507052|Acetylcysteine|acetylcysteine|mesh-list
6472821|NCT00507052|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6472822|NCT00507052|Antiviral Agents|antiviral agents|mesh-ancestor
6472823|NCT00507052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5546841|NCT04126070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5546842|NCT04126070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5546843|NCT04126070|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5546844|NCT04126070|Fertility Agents|fertility agents|mesh-ancestor
5546845|NCT04126070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5546846|NCT04126070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546847|NCT04126070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5546848|NCT04126070|Hormones|hormones|mesh-ancestor
5546849|NCT04126070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5546850|NCT04125862|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5546851|NCT04125862|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5546852|NCT04125862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546853|NCT04125927|Cysteamine|cysteamine|mesh-list
5546854|NCT04125927|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
5546855|NCT04125927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602657|NCT04274426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5602658|NCT04274426|Tubulin Modulators|tubulin modulators|mesh-ancestor
5602659|NCT04274426|Antimitotic Agents|antimitotic agents|mesh-ancestor
5602660|NCT04274426|Mitosis Modulators|mitosis modulators|mesh-ancestor
5602661|NCT04274426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602662|NCT04274426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5602663|NCT04274426|Antimetabolites|antimetabolites|mesh-ancestor
5602664|NCT04274426|Antiviral Agents|antiviral agents|mesh-ancestor
5602665|NCT04274426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5602666|NCT04274426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6472824|NCT00507052|Expectorants|expectorants|mesh-ancestor
6143096|NCT01332318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6143097|NCT01332318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6143098|NCT01332318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6143099|NCT01332318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6143100|NCT01332318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472825|NCT00507052|Respiratory System Agents|respiratory system agents|mesh-ancestor
5602667|NCT04274426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5602668|NCT04274426|Immunologic Factors|immunologic factors|mesh-ancestor
5602669|NCT04274426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472826|NCT00507052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5546856|NCT04125719|Nivolumab|nivolumab|mesh-list
6472827|NCT00507052|Antioxidants|antioxidants|mesh-ancestor
6472828|NCT00507052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472829|NCT00507052|Protective Agents|protective agents|mesh-ancestor
6472830|NCT00507052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472831|NCT00507052|Antidotes|antidotes|mesh-ancestor
5546857|NCT04125719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5546858|NCT04125719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5546859|NCT04125719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6472832|NCT00507065|Amphetamine|amphetamine|mesh-list
6472833|NCT00507065|Adderall|adderall|mesh-list
6472834|NCT00507065|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6472835|NCT00507065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472836|NCT00507065|Sympathomimetics|sympathomimetics|mesh-ancestor
6472837|NCT00507065|Autonomic Agents|autonomic agents|mesh-ancestor
6472838|NCT00507065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6472839|NCT00507065|Dopamine Agents|dopamine agents|mesh-ancestor
6472840|NCT00507065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6472841|NCT00507065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472842|NCT00507065|Adrenergic Agents|adrenergic agents|mesh-ancestor
6472843|NCT00507065|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6472844|NCT00507065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6472845|NCT00507065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6472846|NCT00507065|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6472847|NCT00507091|Leucovorin|leucovorin|mesh-list
6472848|NCT00507091|Fluorouracil|fluorouracil|mesh-list
6472849|NCT00507091|Irinotecan|irinotecan|mesh-list
6666978|NCT01525290|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6666979|NCT01525290|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6666980|NCT01525290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546860|NCT04125719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546861|NCT04125550|Propofol|propofol|mesh-list
6143101|NCT01332318|Antimanic Agents|antimanic agents|mesh-ancestor
6143102|NCT01332318|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6143103|NCT01332318|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6143104|NCT01332318|Anesthetics, Local|anesthetics, local|mesh-ancestor
6143105|NCT01332318|Anesthetics|anesthetics|mesh-ancestor
6143106|NCT01332318|Antiemetics|antiemetics|mesh-ancestor
5546862|NCT04125550|Sevoflurane|sevoflurane|mesh-list
5546863|NCT04125550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5546864|NCT04125550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5546865|NCT04125550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546866|NCT04125550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5546867|NCT04125550|Anesthetics, General|anesthetics, general|mesh-ancestor
5546868|NCT04125550|Anesthetics|anesthetics|mesh-ancestor
5546869|NCT04125550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5546870|NCT04125550|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5546871|NCT04125563|Capsaicin|capsaicin|mesh-list
5546872|NCT04125563|Antipruritics|antipruritics|mesh-ancestor
5546873|NCT04125563|Dermatologic Agents|dermatologic agents|mesh-ancestor
5546874|NCT04125563|Sensory System Agents|sensory system agents|mesh-ancestor
5546875|NCT04125563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5546876|NCT04125563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143107|NCT01332318|Autonomic Agents|autonomic agents|mesh-ancestor
6143108|NCT01332318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6143109|NCT01332318|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6143110|NCT01332318|Histamine Antagonists|histamine antagonists|mesh-ancestor
6143111|NCT01332318|Histamine Agents|histamine agents|mesh-ancestor
6143112|NCT01332318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6143113|NCT01332318|Antipruritics|antipruritics|mesh-ancestor
6143114|NCT01332318|Dermatologic Agents|dermatologic agents|mesh-ancestor
6143115|NCT01332331|Ambrisentan|ambrisentan|mesh-list
6143116|NCT01332331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6143117|NCT01332357|Fluticasone|fluticasone|mesh-list
6143118|NCT01332357|Xhance|xhance|mesh-list
6143119|NCT01332357|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6143120|NCT01332357|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6143121|NCT01332357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6143122|NCT01332357|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6143123|NCT01332357|Autonomic Agents|autonomic agents|mesh-ancestor
6143124|NCT01332357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6143125|NCT01332357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143126|NCT01332357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6143127|NCT01332357|Respiratory System Agents|respiratory system agents|mesh-ancestor
6472850|NCT00507091|Antimetabolites|antimetabolites|mesh-ancestor
6143128|NCT01332357|Dermatologic Agents|dermatologic agents|mesh-ancestor
6143129|NCT01332357|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5546877|NCT04125706|Metronidazole|metronidazole|mesh-list
5546878|NCT04125706|Minocycline|minocycline|mesh-list
6143130|NCT01332357|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6143131|NCT01332357|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6143132|NCT01332357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6143133|NCT01332357|Adrenergic Agents|adrenergic agents|mesh-ancestor
6143134|NCT01332357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6143135|NCT01332357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143136|NCT01332357|Glucocorticoids|glucocorticoids|mesh-ancestor
6666981|NCT01525394|Moxifloxacin|moxifloxacin|mesh-list
6666982|NCT01525394|Lenvatinib|lenvatinib|mesh-list
6666983|NCT01525394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6666984|NCT01525394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6666985|NCT01525394|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6666986|NCT01525394|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6666987|NCT01525394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6666988|NCT01525394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6666989|NCT01525394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6666990|NCT01525394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6666991|NCT01525537|Sufentanil|sufentanil|mesh-list
6666992|NCT01525537|Dsuvia|dsuvia|mesh-list
6666993|NCT01525537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6666994|NCT01525537|Narcotics|narcotics|mesh-ancestor
6666995|NCT01525537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6666996|NCT01525537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546879|NCT04125706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5546880|NCT04125706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5546881|NCT04125706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5546882|NCT04125706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5546883|NCT04125394|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5546884|NCT04125394|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5546885|NCT04125082|Insulin|insulin|mesh-list
5546886|NCT04125082|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5546887|NCT04125082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5546888|NCT04125082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546889|NCT04124991|Durvalumab|durvalumab|mesh-list
5546890|NCT04124991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5546891|NCT04124991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5546892|NCT04125121|Propofol|propofol|mesh-list
5546893|NCT04125121|Sevoflurane|sevoflurane|mesh-list
5546894|NCT04125121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5546895|NCT04125121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5546896|NCT04125121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143137|NCT01332357|Hormones|hormones|mesh-ancestor
6143138|NCT01332357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6143139|NCT01332357|Sympathomimetics|sympathomimetics|mesh-ancestor
6143140|NCT01332461|Fluticasone|fluticasone|mesh-list
6143141|NCT01332461|Xhance|xhance|mesh-list
6143142|NCT01332461|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6143143|NCT01332461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6143144|NCT01332461|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6143145|NCT01332461|Autonomic Agents|autonomic agents|mesh-ancestor
6143146|NCT01332461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6143147|NCT01332461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143148|NCT01332461|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6143149|NCT01332461|Respiratory System Agents|respiratory system agents|mesh-ancestor
6143150|NCT01332461|Dermatologic Agents|dermatologic agents|mesh-ancestor
6143151|NCT01332461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6143152|NCT01332461|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6143153|NCT01332461|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6143154|NCT01332461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6143155|NCT01332461|Adrenergic Agents|adrenergic agents|mesh-ancestor
6143156|NCT01332461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6143157|NCT01332461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143158|NCT01332500|Naproxen|naproxen|mesh-list
6143159|NCT01332500|Sumatriptan|sumatriptan|mesh-list
6143160|NCT01332500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6143161|NCT01332500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6143162|NCT01332500|Analgesics|analgesics|mesh-ancestor
6143163|NCT01332500|Sensory System Agents|sensory system agents|mesh-ancestor
6143164|NCT01332500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6143165|NCT01332500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143166|NCT01332500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6666997|NCT01525537|Analgesics|analgesics|mesh-ancestor
6666998|NCT01525537|Sensory System Agents|sensory system agents|mesh-ancestor
6666999|NCT01525537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5546897|NCT04125121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6143167|NCT01332500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6143168|NCT01332500|Gout Suppressants|gout suppressants|mesh-ancestor
6143169|NCT01332500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6143170|NCT01332500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6143171|NCT01332500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143172|NCT01332500|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6143173|NCT01332500|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6143174|NCT01332500|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6143175|NCT01332500|Serotonin Agents|serotonin agents|mesh-ancestor
6143176|NCT01332500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6143177|NCT01332578|Acetaminophen|acetaminophen|mesh-list
6143178|NCT01332578|Ascorbic Acid|ascorbic acid|mesh-list
5546898|NCT04125121|Anesthetics, General|anesthetics, general|mesh-ancestor
5546899|NCT04125121|Anesthetics|anesthetics|mesh-ancestor
5546900|NCT04125121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5546901|NCT04125121|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5546902|NCT04124614|Sertraline|sertraline|mesh-list
5546903|NCT04124614|Brexpiprazole|brexpiprazole|mesh-list
5546904|NCT04124614|Antidepressive Agents|antidepressive agents|mesh-ancestor
5546905|NCT04124614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5546906|NCT04124614|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5546907|NCT04124614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5546908|NCT04124614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5546909|NCT04124614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546910|NCT04124614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5546911|NCT04124614|Serotonin Agents|serotonin agents|mesh-ancestor
5546912|NCT04124614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546913|NCT04124614|Dopamine Agonists|dopamine agonists|mesh-ancestor
5546914|NCT04124614|Dopamine Agents|dopamine agents|mesh-ancestor
5546915|NCT04124822|Prednisolone|prednisolone|mesh-list
5546916|NCT04124822|Piroxicam|piroxicam|mesh-list
5546917|NCT04124822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5546918|NCT04124822|Glucocorticoids|glucocorticoids|mesh-ancestor
5546919|NCT04124822|Hormones|hormones|mesh-ancestor
5546920|NCT04124822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5546921|NCT04124822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546922|NCT04124822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6143179|NCT01332578|Phenylephrine|phenylephrine|mesh-list
6143180|NCT01332578|Oxymetazoline|oxymetazoline|mesh-list
6143181|NCT01332578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6143182|NCT01332578|Analgesics|analgesics|mesh-ancestor
6143183|NCT01332578|Sensory System Agents|sensory system agents|mesh-ancestor
6143184|NCT01332578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6143185|NCT01332578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143186|NCT01332578|Antipyretics|antipyretics|mesh-ancestor
6143187|NCT01332578|Antioxidants|antioxidants|mesh-ancestor
6143188|NCT01332578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143189|NCT01332578|Protective Agents|protective agents|mesh-ancestor
6143190|NCT01332578|Vitamins|vitamins|mesh-ancestor
6143191|NCT01332578|Micronutrients|micronutrients|mesh-ancestor
6143192|NCT01332578|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6143193|NCT01332578|Mydriatics|mydriatics|mesh-ancestor
6143194|NCT01332578|Autonomic Agents|autonomic agents|mesh-ancestor
6143195|NCT01332578|Sympathomimetics|sympathomimetics|mesh-ancestor
6143196|NCT01332578|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6143197|NCT01332578|Nasal Decongestants|nasal decongestants|mesh-ancestor
6143198|NCT01332578|Respiratory System Agents|respiratory system agents|mesh-ancestor
6143199|NCT01332578|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6143200|NCT01332578|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6143201|NCT01332578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6143202|NCT01332578|Adrenergic Agents|adrenergic agents|mesh-ancestor
6143203|NCT01332578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6143204|NCT01332630|Diphenhydramine|diphenhydramine|mesh-list
6143205|NCT01332630|Dexamethasone|dexamethasone|mesh-list
6143206|NCT01332630|Ranitidine|ranitidine|mesh-list
6143207|NCT01332630|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
6143208|NCT01332630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6472851|NCT00507091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472852|NCT00507091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6472853|NCT00507091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6472854|NCT00507091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6472855|NCT00507091|Immunologic Factors|immunologic factors|mesh-ancestor
6472856|NCT00507091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472857|NCT00507091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6143209|NCT01332630|Antiemetics|antiemetics|mesh-ancestor
6143210|NCT01332630|Autonomic Agents|autonomic agents|mesh-ancestor
6143211|NCT01332630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6143212|NCT01332630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143213|NCT01332630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5546923|NCT04124822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5546924|NCT04124822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5546925|NCT04124822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5546926|NCT04124822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5546927|NCT04124822|Analgesics|analgesics|mesh-ancestor
5546928|NCT04124822|Sensory System Agents|sensory system agents|mesh-ancestor
5546929|NCT04124822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5546930|NCT04124822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5546931|NCT04124822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5546932|NCT04124822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546933|NCT04124887|Calcium, Dietary|calcium, dietary|mesh-list
5546934|NCT04124887|Listerine|listerine|mesh-list
5546935|NCT04124887|Calcium|calcium|mesh-list
6143214|NCT01332630|Glucocorticoids|glucocorticoids|mesh-ancestor
6143215|NCT01332630|Hormones|hormones|mesh-ancestor
6143216|NCT01332630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6143217|NCT01332630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6143218|NCT01332630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6143219|NCT01332630|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6143220|NCT01332630|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6143221|NCT01332630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6143222|NCT01332630|Anesthetics, Local|anesthetics, local|mesh-ancestor
6143223|NCT01332630|Anesthetics|anesthetics|mesh-ancestor
6143224|NCT01332630|Sensory System Agents|sensory system agents|mesh-ancestor
6143225|NCT01332630|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6143226|NCT01332630|Histamine Antagonists|histamine antagonists|mesh-ancestor
6143227|NCT01332630|Histamine Agents|histamine agents|mesh-ancestor
6143228|NCT01332630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6143229|NCT01332630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143230|NCT01332630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6143231|NCT01332630|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6143232|NCT01332630|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6472858|NCT00507091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6667000|NCT01525537|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6667001|NCT01525537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6667002|NCT01525537|Anesthetics, General|anesthetics, general|mesh-ancestor
6667003|NCT01525537|Anesthetics|anesthetics|mesh-ancestor
6667004|NCT01525680|Hydrocortisone|hydrocortisone|mesh-list
6667005|NCT01525680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6667006|NCT01525706|Ethanol|ethanol|mesh-list
6667007|NCT01525706|Paclitaxel|paclitaxel|mesh-list
6667008|NCT01525706|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6667009|NCT01525706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6667010|NCT01525706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6667011|NCT01525706|Tubulin Modulators|tubulin modulators|mesh-ancestor
5546936|NCT04124887|Fluorides|fluorides|mesh-list
5546937|NCT04124887|Sodium Fluoride|sodium fluoride|mesh-list
5546938|NCT04124887|Caseins|caseins|mesh-list
5546939|NCT04124887|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5546940|NCT04124887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546941|NCT04124887|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5546942|NCT04124887|Cariostatic Agents|cariostatic agents|mesh-ancestor
5546943|NCT04124887|Protective Agents|protective agents|mesh-ancestor
5546944|NCT04124887|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5546945|NCT04124887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5546946|NCT04124887|Chelating Agents|chelating agents|mesh-ancestor
5546947|NCT04124887|Sequestering Agents|sequestering agents|mesh-ancestor
6667012|NCT01525706|Antimitotic Agents|antimitotic agents|mesh-ancestor
6667013|NCT01525706|Mitosis Modulators|mitosis modulators|mesh-ancestor
6472859|NCT00507091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6472860|NCT00507091|Antidotes|antidotes|mesh-ancestor
6472861|NCT00507091|Protective Agents|protective agents|mesh-ancestor
6472862|NCT00507091|Vitamin B Complex|vitamin b complex|mesh-ancestor
6472863|NCT00507091|Vitamins|vitamins|mesh-ancestor
6472864|NCT00507091|Micronutrients|micronutrients|mesh-ancestor
6472865|NCT00507117|Eszopiclone|eszopiclone|mesh-list
6472866|NCT00507117|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6472867|NCT00507117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6472868|NCT00507117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472869|NCT00507143|Irinotecan|irinotecan|mesh-list
6472870|NCT00507143|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6472871|NCT00507143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6472872|NCT00507143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6667014|NCT01525706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667015|NCT01525706|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6472873|NCT00507143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472874|NCT00507143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6472875|NCT00507195|Midazolam|midazolam|mesh-list
6472876|NCT00507195|Propofol|propofol|mesh-list
6472877|NCT00507195|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
6472878|NCT00507195|Sevoflurane|sevoflurane|mesh-list
6472879|NCT00507195|Desflurane|desflurane|mesh-list
6472880|NCT00507195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6472881|NCT00507195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472882|NCT00507195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6472883|NCT00507195|Anesthetics, General|anesthetics, general|mesh-ancestor
6472884|NCT00507195|Anesthetics|anesthetics|mesh-ancestor
6472885|NCT00507195|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6472886|NCT00507195|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5546948|NCT04124887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546949|NCT04124939|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5546950|NCT04124939|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5546951|NCT04124939|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5546952|NCT04124939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5546953|NCT04124939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546954|NCT04124939|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5546955|NCT04124939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5546956|NCT04124939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546957|NCT04124939|Cholinergic Agents|cholinergic agents|mesh-ancestor
5546958|NCT04124939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5546959|NCT04124913|Progesterone|progesterone|mesh-list
5546960|NCT04124913|Dydrogesterone|dydrogesterone|mesh-list
5546961|NCT04124913|Progestins|progestins|mesh-ancestor
5546962|NCT04124913|Hormones|hormones|mesh-ancestor
6143233|NCT01332721|Bevacizumab|bevacizumab|mesh-list
6143234|NCT01332721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6143235|NCT01332721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6143236|NCT01332721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6143237|NCT01332721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6143238|NCT01332721|Growth Substances|growth substances|mesh-ancestor
6143239|NCT01332721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143240|NCT01332721|Growth Inhibitors|growth inhibitors|mesh-ancestor
6143241|NCT01332994|Rituximab|rituximab|mesh-list
6143242|NCT01332994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6143243|NCT01332994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6143244|NCT01332994|Immunologic Factors|immunologic factors|mesh-ancestor
6143245|NCT01332994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143246|NCT01332994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6143247|NCT01333033|Leucovorin|leucovorin|mesh-list
6143248|NCT01333033|Paclitaxel|paclitaxel|mesh-list
6143249|NCT01333033|Carboplatin|carboplatin|mesh-list
6143250|NCT01333033|Fluorouracil|fluorouracil|mesh-list
6143251|NCT01333033|Oxaliplatin|oxaliplatin|mesh-list
6143252|NCT01333033|Calcium|calcium|mesh-list
6143253|NCT01333033|Levoleucovorin|levoleucovorin|mesh-list
6143254|NCT01333033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6143255|NCT01333033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6472887|NCT00507195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6472888|NCT00507195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6472889|NCT00507195|GABA Modulators|gaba modulators|mesh-ancestor
6472890|NCT00507195|GABA Agents|gaba agents|mesh-ancestor
5546963|NCT04124913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5546964|NCT04124913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546965|NCT04124926|Lansoprazole|lansoprazole|mesh-list
5546966|NCT04124926|Dexlansoprazole|dexlansoprazole|mesh-list
5546967|NCT04124926|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5546968|NCT04124926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5546969|NCT04124926|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5546970|NCT04124926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5546971|NCT04124926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546972|NCT04124965|Rozanolixizumab|rozanolixizumab|mesh-list
6143256|NCT01333033|Tubulin Modulators|tubulin modulators|mesh-ancestor
6472891|NCT00507195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6472892|NCT00507195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472893|NCT00507195|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6472894|NCT00507195|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6472895|NCT00507221|Albendazole|albendazole|mesh-list
6472896|NCT00507221|Praziquantel|praziquantel|mesh-list
6472897|NCT00507221|Anthelmintics|anthelmintics|mesh-ancestor
6143257|NCT01333033|Antimitotic Agents|antimitotic agents|mesh-ancestor
6472898|NCT00507221|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6472899|NCT00507221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5546973|NCT04124965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5546974|NCT04124965|Immunologic Factors|immunologic factors|mesh-ancestor
5546975|NCT04124965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546976|NCT04124757|Rocuronium|rocuronium|mesh-list
5546977|NCT04124757|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5546978|NCT04124757|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5546979|NCT04124757|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5546980|NCT04124757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5546981|NCT04124757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5546982|NCT04124601|Nivolumab|nivolumab|mesh-list
5546983|NCT04124601|Ipilimumab|ipilimumab|mesh-list
5546984|NCT04124601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5546985|NCT04124601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5546986|NCT04124601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5546987|NCT04124601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5546988|NCT04124198|Nimorazole|nimorazole|mesh-list
5546989|NCT04124198|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
5546990|NCT04124198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5546991|NCT04124198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5546992|NCT04124198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5546993|NCT04124302|Insulin|insulin|mesh-list
5546994|NCT04124302|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6472900|NCT00507221|Anticestodal Agents|anticestodal agents|mesh-ancestor
6472901|NCT00507221|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6472902|NCT00507221|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6472903|NCT00507221|Tubulin Modulators|tubulin modulators|mesh-ancestor
6472904|NCT00507221|Antimitotic Agents|antimitotic agents|mesh-ancestor
6667016|NCT01525706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6667017|NCT01525706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6667018|NCT01525706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667019|NCT01525719|Everolimus|everolimus|mesh-list
6667020|NCT01525719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6143258|NCT01333033|Mitosis Modulators|mitosis modulators|mesh-ancestor
6143259|NCT01333033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143260|NCT01333033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6143261|NCT01333033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143262|NCT01333033|Antimetabolites|antimetabolites|mesh-ancestor
6143263|NCT01333033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6667021|NCT01525719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6667022|NCT01525719|Immunologic Factors|immunologic factors|mesh-ancestor
6667023|NCT01525719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667024|NCT01525771|Cisplatin|cisplatin|mesh-list
6667025|NCT01525771|Docetaxel|docetaxel|mesh-list
6667026|NCT01525771|Capecitabine|capecitabine|mesh-list
6667027|NCT01525771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6667028|NCT01525771|Tubulin Modulators|tubulin modulators|mesh-ancestor
5546995|NCT04124302|Insulin Aspart|insulin aspart|mesh-list
6472905|NCT00507221|Mitosis Modulators|mitosis modulators|mesh-ancestor
6472906|NCT00507221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472907|NCT00507221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6472908|NCT00507234|Formoterol Fumarate|formoterol fumarate|mesh-list
6472909|NCT00507234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6472910|NCT00507234|Autonomic Agents|autonomic agents|mesh-ancestor
6472911|NCT00507234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6472912|NCT00507234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472913|NCT00507234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6472914|NCT00507234|Respiratory System Agents|respiratory system agents|mesh-ancestor
6472915|NCT00507234|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6472916|NCT00507234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6472917|NCT00507234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5546996|NCT04124302|Insulin Lispro|insulin lispro|mesh-list
6667029|NCT01525771|Antimitotic Agents|antimitotic agents|mesh-ancestor
6667030|NCT01525771|Mitosis Modulators|mitosis modulators|mesh-ancestor
6667031|NCT01525771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667032|NCT01525771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6667033|NCT01525771|Antimetabolites|antimetabolites|mesh-ancestor
6667034|NCT01525823|Metformin|metformin|mesh-list
6667035|NCT01525823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6667036|NCT01525823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667037|NCT01525836|Rituximab|rituximab|mesh-list
6667038|NCT01525836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6667039|NCT01525836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6143264|NCT01333033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6472918|NCT00507234|Adrenergic Agents|adrenergic agents|mesh-ancestor
6667040|NCT01525836|Immunologic Factors|immunologic factors|mesh-ancestor
6472919|NCT00507234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6472920|NCT00507234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472921|NCT00507247|Daptomycin|daptomycin|mesh-list
6472922|NCT00507247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6472923|NCT00507247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5546997|NCT04124302|Insulin glulisine|insulin glulisine|mesh-list
5546998|NCT04124302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5546999|NCT04124302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547000|NCT04124367|Cerebrolysin|cerebrolysin|mesh-list
5547001|NCT04124367|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5547002|NCT04124367|Protective Agents|protective agents|mesh-ancestor
5547003|NCT04124367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547004|NCT04124367|Nootropic Agents|nootropic agents|mesh-ancestor
5547005|NCT04124432|Nicotine|nicotine|mesh-list
6472924|NCT00507286|Alprostadil|alprostadil|mesh-list
6472925|NCT00507286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6472926|NCT00507286|Vasodilator Agents|vasodilator agents|mesh-ancestor
6472927|NCT00507286|Urological Agents|urological agents|mesh-ancestor
6472928|NCT00507403|Infliximab|infliximab|mesh-list
6472929|NCT00507403|Dermatologic Agents|dermatologic agents|mesh-ancestor
6472930|NCT00507403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6472931|NCT00507403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6143265|NCT01333033|Immunologic Factors|immunologic factors|mesh-ancestor
5547006|NCT04124432|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5547007|NCT04124432|Autonomic Agents|autonomic agents|mesh-ancestor
5547008|NCT04124432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5547009|NCT04124432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472932|NCT00507494|Pioglitazone|pioglitazone|mesh-list
6472933|NCT00507494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6472934|NCT00507494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143266|NCT01333033|Antidotes|antidotes|mesh-ancestor
6143267|NCT01333033|Protective Agents|protective agents|mesh-ancestor
6143268|NCT01333033|Vitamin B Complex|vitamin b complex|mesh-ancestor
6143269|NCT01333033|Vitamins|vitamins|mesh-ancestor
6667041|NCT01525836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667042|NCT01525836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6667043|NCT01525888|Enzyme Inhibitors|enzyme inhibitors|mesh-list
6667044|NCT01525888|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6667045|NCT01525888|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
6667046|NCT01525888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547010|NCT04124432|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6143270|NCT01333033|Micronutrients|micronutrients|mesh-ancestor
6143271|NCT01333059|Fentanyl|fentanyl|mesh-list
6143272|NCT01333059|Midazolam|midazolam|mesh-list
6143273|NCT01333059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6143274|NCT01333059|Narcotics|narcotics|mesh-ancestor
6143275|NCT01333059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6143276|NCT01333059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143277|NCT01333059|Analgesics|analgesics|mesh-ancestor
6143278|NCT01333059|Sensory System Agents|sensory system agents|mesh-ancestor
6143279|NCT01333059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6143280|NCT01333059|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6472935|NCT00507585|Leucovorin|leucovorin|mesh-list
6472936|NCT00507585|Bevacizumab|bevacizumab|mesh-list
6472937|NCT00507585|Fluorouracil|fluorouracil|mesh-list
6472938|NCT00507585|Oxaliplatin|oxaliplatin|mesh-list
5547011|NCT04124432|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5547012|NCT04124432|Cholinergic Agents|cholinergic agents|mesh-ancestor
6143281|NCT01333059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6143282|NCT01333059|Anesthetics, General|anesthetics, general|mesh-ancestor
6143283|NCT01333059|Anesthetics|anesthetics|mesh-ancestor
6143284|NCT01333059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6143285|NCT01333059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6143286|NCT01333059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6143287|NCT01333059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6143288|NCT01333059|GABA Modulators|gaba modulators|mesh-ancestor
6143289|NCT01333059|GABA Agents|gaba agents|mesh-ancestor
6143290|NCT01333059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6143291|NCT01333059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143292|NCT01333072|Risperidone|risperidone|mesh-list
6143293|NCT01333072|Aripiprazole|aripiprazole|mesh-list
6143294|NCT01333072|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6472939|NCT00507585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5547013|NCT04124432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6143295|NCT01333072|Serotonin Agents|serotonin agents|mesh-ancestor
6143296|NCT01333072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6143297|NCT01333072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472940|NCT00507585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6472941|NCT00507585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6472942|NCT00507585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6472943|NCT00507585|Growth Substances|growth substances|mesh-ancestor
6472944|NCT00507585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472945|NCT00507585|Growth Inhibitors|growth inhibitors|mesh-ancestor
6472946|NCT00507585|Antimetabolites|antimetabolites|mesh-ancestor
6472947|NCT00507585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143298|NCT01333072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143299|NCT01333072|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6472948|NCT00507585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6472949|NCT00507585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6472950|NCT00507585|Immunologic Factors|immunologic factors|mesh-ancestor
6472951|NCT00507585|Antidotes|antidotes|mesh-ancestor
6472952|NCT00507585|Protective Agents|protective agents|mesh-ancestor
6472953|NCT00507585|Vitamin B Complex|vitamin b complex|mesh-ancestor
6472954|NCT00507585|Vitamins|vitamins|mesh-ancestor
6472955|NCT00507585|Micronutrients|micronutrients|mesh-ancestor
6472956|NCT00507637|Botulinum Toxins|botulinum toxins|mesh-list
5547014|NCT04124432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547015|NCT04124497|Dexamethasone|dexamethasone|mesh-list
5547016|NCT04124497|Daratumumab|daratumumab|mesh-list
5547017|NCT04124497|Pomalidomide|pomalidomide|mesh-list
5547018|NCT04124497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5547019|NCT04124497|Antiemetics|antiemetics|mesh-ancestor
5547020|NCT04124497|Autonomic Agents|autonomic agents|mesh-ancestor
5547021|NCT04124497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5547022|NCT04124497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547023|NCT04124497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5547024|NCT04124497|Glucocorticoids|glucocorticoids|mesh-ancestor
5547025|NCT04124497|Hormones|hormones|mesh-ancestor
5547026|NCT04124497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5547027|NCT04124497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5547028|NCT04124497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5547029|NCT04124497|Immunologic Factors|immunologic factors|mesh-ancestor
5547030|NCT04124497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5547031|NCT04124497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5547032|NCT04124497|Growth Substances|growth substances|mesh-ancestor
5547033|NCT04124497|Growth Inhibitors|growth inhibitors|mesh-ancestor
5547034|NCT04124003|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5547035|NCT04124003|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5547036|NCT04124003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5547037|NCT04124003|Antimetabolites|antimetabolites|mesh-ancestor
5547038|NCT04124003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472957|NCT00507637|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6472958|NCT00507637|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6472959|NCT00507637|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
6472960|NCT00507637|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6472961|NCT00507637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6472962|NCT00507637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472963|NCT00507637|Cholinergic Agents|cholinergic agents|mesh-ancestor
6472964|NCT00507637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5547039|NCT04124003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5547040|NCT04124003|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5547041|NCT04124003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5547042|NCT04124016|Grape Seed Extract|grape seed extract|mesh-list
5547043|NCT04124016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5547044|NCT04124016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5547045|NCT04124016|Antioxidants|antioxidants|mesh-ancestor
5547046|NCT04124016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547047|NCT04124016|Protective Agents|protective agents|mesh-ancestor
6143300|NCT01333072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6143301|NCT01333072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6472965|NCT00507637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143302|NCT01333072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6143303|NCT01333072|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6143304|NCT01333072|Dopamine Agents|dopamine agents|mesh-ancestor
6143305|NCT01333072|Antidepressive Agents|antidepressive agents|mesh-ancestor
6143306|NCT01333072|Dopamine Agonists|dopamine agonists|mesh-ancestor
6143307|NCT01333072|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6143308|NCT01333072|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6143309|NCT01333072|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6143310|NCT01333072|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6143311|NCT01333098|Mifepristone|mifepristone|mesh-list
6143312|NCT01333098|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6143313|NCT01333098|Abortifacient Agents|abortifacient agents|mesh-ancestor
5547048|NCT04124016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547049|NCT04124107|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5547050|NCT04124107|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5547051|NCT04124107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602670|NCT04274426|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5602671|NCT04274426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6143314|NCT01333098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6143315|NCT01333098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143316|NCT01333098|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6143317|NCT01333098|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6143318|NCT01333098|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6143319|NCT01333098|Contraceptive Agents|contraceptive agents|mesh-ancestor
6143320|NCT01333098|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6143321|NCT01333098|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6143322|NCT01333098|Hormone Antagonists|hormone antagonists|mesh-ancestor
6143323|NCT01333098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6143324|NCT01333098|Luteolytic Agents|luteolytic agents|mesh-ancestor
6472966|NCT00507637|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6472967|NCT00507637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6472968|NCT00507663|Atenolol|atenolol|mesh-list
6472969|NCT00507663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6472970|NCT00507663|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6143325|NCT01333098|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6143326|NCT01333098|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6143327|NCT01333397|Botulinum Toxins|botulinum toxins|mesh-list
6143328|NCT01333397|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6143329|NCT01333397|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6143330|NCT01333397|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6143331|NCT01333397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6143332|NCT01333397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143333|NCT01333397|Cholinergic Agents|cholinergic agents|mesh-ancestor
6143334|NCT01333397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6143335|NCT01333397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143336|NCT01333397|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6143337|NCT01333397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6143338|NCT01333488|Magnesium Sulfate|magnesium sulfate|mesh-list
6143339|NCT01333488|Analgesics|analgesics|mesh-ancestor
6143340|NCT01333488|Sensory System Agents|sensory system agents|mesh-ancestor
6143341|NCT01333488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6143342|NCT01333488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143343|NCT01333488|Anesthetics|anesthetics|mesh-ancestor
6143344|NCT01333488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6143345|NCT01333488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6143346|NCT01333488|Anticonvulsants|anticonvulsants|mesh-ancestor
6143347|NCT01333488|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6143348|NCT01333488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6143349|NCT01333488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143350|NCT01333488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6143351|NCT01333488|Tocolytic Agents|tocolytic agents|mesh-ancestor
6143352|NCT01333488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6143353|NCT01333501|Interferons|interferons|mesh-list
6143354|NCT01333501|Interferon-beta|interferon-beta|mesh-list
6143355|NCT01333501|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6143356|NCT01333501|Interferon beta-1b|interferon beta-1b|mesh-list
6143357|NCT01333501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6143358|NCT01333501|Antiviral Agents|antiviral agents|mesh-ancestor
6143359|NCT01333501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6143360|NCT01333501|Immunologic Factors|immunologic factors|mesh-ancestor
6143361|NCT01333501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143362|NCT01333501|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6143363|NCT01333501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143364|NCT01333501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6143365|NCT01333501|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6143366|NCT01333592|Mitiglinide|mitiglinide|mesh-list
6143367|NCT01333592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5602672|NCT04274426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5602673|NCT04256421|Carboplatin|carboplatin|mesh-list
6143368|NCT01333592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143369|NCT01333722|Acetaminophen|acetaminophen|mesh-list
6143370|NCT01333722|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
6143371|NCT01333722|Hydrocodone|hydrocodone|mesh-list
6143372|NCT01333722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6472971|NCT00507663|Sympatholytics|sympatholytics|mesh-ancestor
6143373|NCT01333722|Analgesics|analgesics|mesh-ancestor
6143374|NCT01333722|Sensory System Agents|sensory system agents|mesh-ancestor
5547052|NCT04124094|Fluticasone|fluticasone|mesh-list
5547053|NCT04124094|Xhance|xhance|mesh-list
5547054|NCT04124094|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5547055|NCT04124094|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
5547056|NCT04124094|Charcoal|charcoal|mesh-list
5547057|NCT04124094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5547058|NCT04124094|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5547059|NCT04124094|Autonomic Agents|autonomic agents|mesh-ancestor
5547060|NCT04124094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5547061|NCT04124094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547062|NCT04124094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5547063|NCT04124094|Respiratory System Agents|respiratory system agents|mesh-ancestor
5547064|NCT04124094|Dermatologic Agents|dermatologic agents|mesh-ancestor
5547065|NCT04124094|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5547066|NCT04124094|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5547067|NCT04124094|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5547068|NCT04124094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5547069|NCT04124094|Adrenergic Agents|adrenergic agents|mesh-ancestor
6143375|NCT01333722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6143376|NCT01333722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143377|NCT01333722|Antipyretics|antipyretics|mesh-ancestor
6143378|NCT01333722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6143379|NCT01333722|Narcotics|narcotics|mesh-ancestor
6143380|NCT01333722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6143381|NCT01333722|Antitussive Agents|antitussive agents|mesh-ancestor
6143382|NCT01333722|Respiratory System Agents|respiratory system agents|mesh-ancestor
6143383|NCT01333722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6143384|NCT01333722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6143385|NCT01333722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6143386|NCT01333865|Memantine|memantine|mesh-list
6143387|NCT01333865|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6143388|NCT01333865|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6143389|NCT01333865|Dopamine Agents|dopamine agents|mesh-ancestor
6143390|NCT01333865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6143391|NCT01333865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143392|NCT01333865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143393|NCT01333865|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6143394|NCT01333865|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6205492|NCT02086500|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6472972|NCT00507663|Autonomic Agents|autonomic agents|mesh-ancestor
6472973|NCT00507663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6472974|NCT00507663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472975|NCT00507663|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6472976|NCT00507663|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6472977|NCT00507663|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6205493|NCT02086500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6205494|NCT02086500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205495|NCT02086500|Hemostatics|hemostatics|mesh-ancestor
6205496|NCT02086500|Coagulants|coagulants|mesh-ancestor
6205497|NCT02086591|Doxycycline|doxycycline|mesh-list
6205498|NCT02086591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6205499|NCT02086591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6205500|NCT02086591|Antimalarials|antimalarials|mesh-ancestor
6205501|NCT02086591|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6205502|NCT02086591|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6205503|NCT02086786|Risperidone|risperidone|mesh-list
6205504|NCT02086786|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6205505|NCT02086786|Serotonin Agents|serotonin agents|mesh-ancestor
6205506|NCT02086786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6667047|NCT01525888|Protease Inhibitors|protease inhibitors|mesh-ancestor
5547070|NCT04124094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5547071|NCT04124094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547072|NCT04124094|Glucocorticoids|glucocorticoids|mesh-ancestor
5547073|NCT04124094|Hormones|hormones|mesh-ancestor
5547074|NCT04124094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5547075|NCT04124094|Sympathomimetics|sympathomimetics|mesh-ancestor
5547076|NCT04124094|Antidotes|antidotes|mesh-ancestor
5547077|NCT04124094|Protective Agents|protective agents|mesh-ancestor
5547078|NCT04124068|Hydrogen Peroxide|hydrogen peroxide|mesh-list
5547079|NCT04124068|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5547080|NCT04124068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5547081|NCT04124081|Entecavir|entecavir|mesh-list
5547082|NCT04124081|Antiviral Agents|antiviral agents|mesh-ancestor
5547083|NCT04124081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5547084|NCT04123873|Acetaminophen|acetaminophen|mesh-list
5547085|NCT04123873|Dexamethasone|dexamethasone|mesh-list
5547086|NCT04123873|Ibuprofen|ibuprofen|mesh-list
5547087|NCT04123873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5547088|NCT04123873|Antiemetics|antiemetics|mesh-ancestor
5547089|NCT04123873|Autonomic Agents|autonomic agents|mesh-ancestor
5547090|NCT04123873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5547091|NCT04123873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547092|NCT04123873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5547093|NCT04123873|Glucocorticoids|glucocorticoids|mesh-ancestor
5547094|NCT04123873|Hormones|hormones|mesh-ancestor
5547095|NCT04123873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5547096|NCT04123873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5547097|NCT04123873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5547098|NCT04123873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5547099|NCT04123873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5547100|NCT04123873|Analgesics|analgesics|mesh-ancestor
5547101|NCT04123873|Sensory System Agents|sensory system agents|mesh-ancestor
5547102|NCT04123873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5547103|NCT04123873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6472978|NCT00507663|Adrenergic Agents|adrenergic agents|mesh-ancestor
6472979|NCT00507663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6472980|NCT00507663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488657|NCT00585559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6488658|NCT00585559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488659|NCT00585559|Antipyretics|antipyretics|mesh-ancestor
6488660|NCT00585559|Antiviral Agents|antiviral agents|mesh-ancestor
6143395|NCT01333956|Pregabalin|pregabalin|mesh-list
6143396|NCT01333956|Analgesics|analgesics|mesh-ancestor
6667048|NCT01525901|Mitogens|mitogens|mesh-list
6667049|NCT01525901|Mecasermin|mecasermin|mesh-list
6667050|NCT01525901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547104|NCT04123873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6143397|NCT01333956|Sensory System Agents|sensory system agents|mesh-ancestor
6143398|NCT01333956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6143399|NCT01333956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143400|NCT01333956|Anticonvulsants|anticonvulsants|mesh-ancestor
6143401|NCT01333956|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6143402|NCT01333956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6143403|NCT01333956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143404|NCT01333956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6143405|NCT01333956|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6143406|NCT01333956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6143407|NCT01333956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6143408|NCT01333956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6143409|NCT01334086|Aprepitant|aprepitant|mesh-list
6143410|NCT01334086|Antiemetics|antiemetics|mesh-ancestor
6143411|NCT01334086|Autonomic Agents|autonomic agents|mesh-ancestor
6143412|NCT01334086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6143413|NCT01334086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143414|NCT01334086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6143415|NCT01334086|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6143416|NCT01334086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6143417|NCT01334086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143418|NCT01334125|Metformin|metformin|mesh-list
6143419|NCT01334125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6143420|NCT01334125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143421|NCT01334229|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6143422|NCT01334229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6143423|NCT01334229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143424|NCT01334229|Incretins|incretins|mesh-ancestor
6143425|NCT01334229|Hormones|hormones|mesh-ancestor
6667051|NCT01525901|Mitosis Modulators|mitosis modulators|mesh-ancestor
6667052|NCT01525901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667053|NCT01525901|Growth Substances|growth substances|mesh-ancestor
6667054|NCT01525914|Dutasteride|dutasteride|mesh-list
6667055|NCT01525914|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6667056|NCT01525914|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6667057|NCT01525914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6667058|NCT01525914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667059|NCT01525914|Hormone Antagonists|hormone antagonists|mesh-ancestor
6667060|NCT01525914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6488661|NCT00585559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5547105|NCT04123873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143426|NCT01334229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6667061|NCT01525914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667062|NCT01525966|Paclitaxel|paclitaxel|mesh-list
6472981|NCT00507793|Cyclosporine|cyclosporine|mesh-list
6472982|NCT00507793|Sirolimus|sirolimus|mesh-list
6143427|NCT01334229|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6143428|NCT01334229|Protease Inhibitors|protease inhibitors|mesh-ancestor
6143429|NCT01334229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6143430|NCT01334229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472983|NCT00507793|Cyclosporins|cyclosporins|mesh-list
6472984|NCT00507793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5547106|NCT04123873|Antipyretics|antipyretics|mesh-ancestor
5547107|NCT04123925|Nivolumab|nivolumab|mesh-list
5547108|NCT04123925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6472985|NCT00507793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6472986|NCT00507793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6472987|NCT00507793|Immunologic Factors|immunologic factors|mesh-ancestor
6472988|NCT00507793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6472989|NCT00507793|Antifungal Agents|antifungal agents|mesh-ancestor
6472990|NCT00507793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6472991|NCT00507793|Dermatologic Agents|dermatologic agents|mesh-ancestor
6472992|NCT00507793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6472993|NCT00507793|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6472994|NCT00507793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6472995|NCT00507793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6667063|NCT01525966|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6667064|NCT01525966|Carboplatin|carboplatin|mesh-list
6667065|NCT01525966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6472996|NCT00507793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6472997|NCT00507832|Hydrocortisone|hydrocortisone|mesh-list
6472998|NCT00507832|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6472999|NCT00507832|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6473000|NCT00507832|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6143431|NCT01334515|Isotretinoin|isotretinoin|mesh-list
6143432|NCT01334515|Sargramostim|sargramostim|mesh-list
6143433|NCT01334515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143434|NCT01334515|Immunologic Factors|immunologic factors|mesh-ancestor
6143435|NCT01334515|Dermatologic Agents|dermatologic agents|mesh-ancestor
6143436|NCT01334554|Sildenafil Citrate|sildenafil citrate|mesh-list
6143437|NCT01334554|Vasodilator Agents|vasodilator agents|mesh-ancestor
6143438|NCT01334554|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6143439|NCT01334554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6143440|NCT01334554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6143441|NCT01334554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143442|NCT01334554|Urological Agents|urological agents|mesh-ancestor
6143443|NCT01334710|Sorafenib|sorafenib|mesh-list
6143444|NCT01334710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6143445|NCT01334710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6143446|NCT01334710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6143447|NCT01334710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143448|NCT01334723|Finasteride|finasteride|mesh-list
6143449|NCT01334723|Dutasteride|dutasteride|mesh-list
6143450|NCT01334723|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
6143451|NCT01334723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6143452|NCT01334723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6143453|NCT01334723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143454|NCT01334723|Hormone Antagonists|hormone antagonists|mesh-ancestor
6143455|NCT01334723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6143456|NCT01334723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143457|NCT01334723|Urological Agents|urological agents|mesh-ancestor
6143458|NCT01334918|Regadenoson|regadenoson|mesh-list
6143459|NCT01334918|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
6143460|NCT01334918|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
5547109|NCT04123925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5547110|NCT04123925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5547111|NCT04123925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547112|NCT04123587|Hypoglycemic Agents|hypoglycemic agents|mesh-list
5547113|NCT04123587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547114|NCT04123717|Acetaminophen|acetaminophen|mesh-list
6143461|NCT01334918|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6473001|NCT00507832|Pimecrolimus|pimecrolimus|mesh-list
6473002|NCT00507832|Tacrolimus|tacrolimus|mesh-list
6667066|NCT01525966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6667067|NCT01525966|Tubulin Modulators|tubulin modulators|mesh-ancestor
6667068|NCT01525966|Antimitotic Agents|antimitotic agents|mesh-ancestor
6667069|NCT01525966|Mitosis Modulators|mitosis modulators|mesh-ancestor
6667070|NCT01525966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667071|NCT01526005|Nicotine|nicotine|mesh-list
6667072|NCT01526005|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6667073|NCT01526005|Autonomic Agents|autonomic agents|mesh-ancestor
6667074|NCT01526005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6667075|NCT01526005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667076|NCT01526005|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6667077|NCT01526005|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6667078|NCT01526005|Cholinergic Agents|cholinergic agents|mesh-ancestor
5547115|NCT04123717|Ibuprofen|ibuprofen|mesh-list
6473003|NCT00507832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6473004|NCT00507832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5547116|NCT04123717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5547117|NCT04123717|Analgesics|analgesics|mesh-ancestor
5547118|NCT04123717|Sensory System Agents|sensory system agents|mesh-ancestor
5547119|NCT04123717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5547120|NCT04123717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473005|NCT00507832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6473006|NCT00507832|Analgesics|analgesics|mesh-ancestor
6473007|NCT00507832|Sensory System Agents|sensory system agents|mesh-ancestor
6473008|NCT00507832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6473009|NCT00507832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547121|NCT04123717|Antipyretics|antipyretics|mesh-ancestor
5547122|NCT04123717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5547123|NCT04123717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5547124|NCT04123717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5602674|NCT04256421|Etoposide|etoposide|mesh-list
6143462|NCT01334918|Purinergic Agonists|purinergic agonists|mesh-ancestor
6143463|NCT01334918|Purinergic Agents|purinergic agents|mesh-ancestor
6143464|NCT01334918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6143465|NCT01334918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143466|NCT01334918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473010|NCT00507832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6473011|NCT00507832|Dermatologic Agents|dermatologic agents|mesh-ancestor
6667079|NCT01526005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6667080|NCT01526005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667081|NCT01526070|Aflibercept|aflibercept|mesh-list
6667082|NCT01526070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6667083|NCT01526070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6667084|NCT01526070|Growth Substances|growth substances|mesh-ancestor
6667085|NCT01526070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667086|NCT01526070|Growth Inhibitors|growth inhibitors|mesh-ancestor
6667087|NCT01526070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6667088|NCT01526083|Lacosamide|lacosamide|mesh-list
6667089|NCT01526083|Warfarin|warfarin|mesh-list
6667090|NCT01526083|Anticoagulants|anticoagulants|mesh-ancestor
6667091|NCT01526083|Anticonvulsants|anticonvulsants|mesh-ancestor
6667092|NCT01526083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6667093|NCT01526083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6143467|NCT01334918|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6143468|NCT01334944|Ibuprofen|ibuprofen|mesh-list
6143469|NCT01334944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6143470|NCT01334944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6143471|NCT01334944|Analgesics|analgesics|mesh-ancestor
6143472|NCT01334944|Sensory System Agents|sensory system agents|mesh-ancestor
6143473|NCT01334944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6143474|NCT01334944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667094|NCT01526083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6667095|NCT01526083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667096|NCT01526096|Plerixafor|plerixafor|mesh-list
6667097|NCT01526096|Melphalan|melphalan|mesh-list
6667098|NCT01526096|Basiliximab|basiliximab|mesh-list
6473012|NCT00507832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6473013|NCT00507832|Immunologic Factors|immunologic factors|mesh-ancestor
6473014|NCT00507832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6473015|NCT00507832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6473016|NCT00507832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473017|NCT00507845|Felodipine|felodipine|mesh-list
6473018|NCT00507845|Ramipril|ramipril|mesh-list
6473019|NCT00507845|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6473020|NCT00507845|Protease Inhibitors|protease inhibitors|mesh-ancestor
6473021|NCT00507845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6473022|NCT00507845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473023|NCT00507845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6473024|NCT00507845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6473025|NCT00507845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6473026|NCT00507845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6143475|NCT01334944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6143476|NCT01334944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6143477|NCT01334944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6143478|NCT01334944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6143479|NCT01334944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143480|NCT01334957|Ibuprofen|ibuprofen|mesh-list
6672430|NCT01555970|Antidotes|antidotes|mesh-ancestor
6143481|NCT01334957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6143482|NCT01334957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6143483|NCT01334957|Analgesics|analgesics|mesh-ancestor
6143484|NCT01334957|Sensory System Agents|sensory system agents|mesh-ancestor
5547125|NCT04123717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5547126|NCT04123717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5547127|NCT04123717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547128|NCT04123652|Lidocaine|lidocaine|mesh-list
5547129|NCT04123652|Ketamine|ketamine|mesh-list
5547130|NCT04123652|Anesthetics, Local|anesthetics, local|mesh-ancestor
5547131|NCT04123652|Anesthetics|anesthetics|mesh-ancestor
5547132|NCT04123652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5547133|NCT04123652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547134|NCT04123652|Sensory System Agents|sensory system agents|mesh-ancestor
5547135|NCT04123652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5547136|NCT04123652|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5547137|NCT04123652|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6473027|NCT00507845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6473028|NCT00507845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473029|NCT00507845|Vasodilator Agents|vasodilator agents|mesh-ancestor
6143485|NCT01334957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6143486|NCT01334957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143487|NCT01334957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6143488|NCT01334957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5547138|NCT04123652|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5547139|NCT04123652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6143489|NCT01334957|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6143490|NCT01334957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6143491|NCT01334957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143492|NCT01335009|Antibodies|antibodies|mesh-list
6143493|NCT01335009|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6143494|NCT01335009|Immunologic Factors|immunologic factors|mesh-ancestor
6143495|NCT01335009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143496|NCT01335204|Bavituximab|bavituximab|mesh-list
6143497|NCT01335204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6143498|NCT01335204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6143499|NCT01335464|Nintedanib|nintedanib|mesh-list
6143500|NCT01335464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6143501|NCT01335464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6143502|NCT01335464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6143503|NCT01335464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143504|NCT01335477|Nintedanib|nintedanib|mesh-list
6143505|NCT01335477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6143506|NCT01335477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6143507|NCT01335477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6143508|NCT01335477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143509|NCT01335620|Tenofovir|tenofovir|mesh-list
6143510|NCT01335620|Emtricitabine|emtricitabine|mesh-list
6143511|NCT01335620|Raltegravir Potassium|raltegravir potassium|mesh-list
6143512|NCT01335620|Antiviral Agents|antiviral agents|mesh-ancestor
6143513|NCT01335620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6143514|NCT01335620|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6143515|NCT01335620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6143516|NCT01335620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5602675|NCT04256421|Atezolizumab|atezolizumab|mesh-list
6143517|NCT01335620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143518|NCT01335620|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6143519|NCT01335620|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6143520|NCT01335620|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6143521|NCT01335620|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6143522|NCT01335698|Ritonavir|ritonavir|mesh-list
6143523|NCT01335698|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6143524|NCT01335698|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6143525|NCT01335698|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6143526|NCT01335698|Protease Inhibitors|protease inhibitors|mesh-ancestor
6143527|NCT01335698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6143528|NCT01335698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143529|NCT01335698|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6143530|NCT01335698|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6143531|NCT01335698|Antiviral Agents|antiviral agents|mesh-ancestor
6143532|NCT01335698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6143533|NCT01335698|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6143534|NCT01335698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6143535|NCT01335724|Diclofenac|diclofenac|mesh-list
6473030|NCT00507858|Dexamethasone|dexamethasone|mesh-list
6473031|NCT00507858|Pemetrexed|pemetrexed|mesh-list
6473032|NCT00507858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6473033|NCT00507858|Antiemetics|antiemetics|mesh-ancestor
6473034|NCT00507858|Autonomic Agents|autonomic agents|mesh-ancestor
5547140|NCT04123652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547141|NCT04123652|Analgesics|analgesics|mesh-ancestor
6143536|NCT01335724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6143537|NCT01335724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6143538|NCT01335724|Analgesics|analgesics|mesh-ancestor
6667099|NCT01526096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6667100|NCT01526096|Alkylating Agents|alkylating agents|mesh-ancestor
6667101|NCT01526096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667102|NCT01526096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6667103|NCT01526096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6667104|NCT01526096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6667105|NCT01526096|Immunologic Factors|immunologic factors|mesh-ancestor
6667106|NCT01526096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547142|NCT04123652|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6143539|NCT01335724|Sensory System Agents|sensory system agents|mesh-ancestor
6143540|NCT01335724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6143541|NCT01335724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143542|NCT01335724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6143543|NCT01335724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6143544|NCT01335724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6143545|NCT01335724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6143546|NCT01335724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143547|NCT01335750|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6143548|NCT01335789|Oxytocin|oxytocin|mesh-list
6143549|NCT01335789|Oxytocics|oxytocics|mesh-ancestor
6143550|NCT01335789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6143551|NCT01335789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143552|NCT01335867|Vigabatrin|vigabatrin|mesh-list
6143553|NCT01335867|Anticonvulsants|anticonvulsants|mesh-ancestor
6143554|NCT01335867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6473035|NCT00507858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6473036|NCT00507858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473037|NCT00507858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6473038|NCT00507858|Glucocorticoids|glucocorticoids|mesh-ancestor
6473039|NCT00507858|Hormones|hormones|mesh-ancestor
6473040|NCT00507858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6473041|NCT00507858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6473042|NCT00507858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6473043|NCT00507858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6473044|NCT00507858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547143|NCT04123652|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5547144|NCT04123652|Anesthetics, General|anesthetics, general|mesh-ancestor
5547145|NCT04123652|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5547146|NCT04123652|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5547147|NCT04123652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5547148|NCT04123743|Sunscreening Agents|sunscreening agents|mesh-list
5547149|NCT04123743|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6143555|NCT01335867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473045|NCT00507858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6473046|NCT00507858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6473047|NCT00507949|Megestrol|megestrol|mesh-list
6473048|NCT00507949|Megestrol Acetate|megestrol acetate|mesh-list
6473049|NCT00507949|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6473050|NCT00507949|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6473051|NCT00507949|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6473052|NCT00507949|Contraceptive Agents|contraceptive agents|mesh-ancestor
6473053|NCT00507949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6473054|NCT00507949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143556|NCT01335867|GABA Agents|gaba agents|mesh-ancestor
6143557|NCT01335867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6143558|NCT01335867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143559|NCT01335932|Ganciclovir|ganciclovir|mesh-list
6143560|NCT01335932|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6143561|NCT01335932|Antiviral Agents|antiviral agents|mesh-ancestor
6143562|NCT01335932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6143563|NCT01335932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6143564|NCT01335932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6143565|NCT01335932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143566|NCT01335971|Sulforaphane|sulforaphane|mesh-list
6143567|NCT01335971|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6143568|NCT01335971|Protective Agents|protective agents|mesh-ancestor
6143569|NCT01335971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488662|NCT00585559|Expectorants|expectorants|mesh-ancestor
5547150|NCT04123743|Protective Agents|protective agents|mesh-ancestor
5547151|NCT04123743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547152|NCT04123743|Dermatologic Agents|dermatologic agents|mesh-ancestor
5547153|NCT04123392|Cyclophosphamide|cyclophosphamide|mesh-list
5547154|NCT04123392|Busulfan|busulfan|mesh-list
5547155|NCT04123392|Decitabine|decitabine|mesh-list
5547156|NCT04123392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5547157|NCT04123392|Immunologic Factors|immunologic factors|mesh-ancestor
5547158|NCT04123392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547159|NCT04123392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5547160|NCT04123392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5547161|NCT04123392|Alkylating Agents|alkylating agents|mesh-ancestor
5547162|NCT04123392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547163|NCT04123392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5547164|NCT04123392|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5547165|NCT04123392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5547166|NCT04123392|Antimetabolites|antimetabolites|mesh-ancestor
5547167|NCT04123392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5547168|NCT04123470|Atezolizumab|atezolizumab|mesh-list
5547169|NCT04123470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6143570|NCT01335971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6143571|NCT01336023|Insulin|insulin|mesh-list
6143572|NCT01336023|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6143573|NCT01336023|Liraglutide|liraglutide|mesh-list
6143574|NCT01336023|Insulin, Long-Acting|insulin, long-acting|mesh-list
6143575|NCT01336023|Xultophy|xultophy|mesh-list
6143576|NCT01336023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6143577|NCT01336023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143578|NCT01336023|Incretins|incretins|mesh-ancestor
6143579|NCT01336023|Hormones|hormones|mesh-ancestor
6143580|NCT01336023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6143581|NCT01336140|Aminophylline|aminophylline|mesh-list
6143582|NCT01336140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6143583|NCT01336140|Autonomic Agents|autonomic agents|mesh-ancestor
6143584|NCT01336140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6143585|NCT01336140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143586|NCT01336140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6143587|NCT01336140|Respiratory System Agents|respiratory system agents|mesh-ancestor
6143588|NCT01336140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6143589|NCT01336140|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6143590|NCT01336140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6667107|NCT01526096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5547170|NCT04123288|ACT-709478|act-709478|mesh-list
6143591|NCT01336140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143592|NCT01336140|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6143593|NCT01336140|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6143594|NCT01336140|Purinergic Agents|purinergic agents|mesh-ancestor
6143595|NCT01336140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6143596|NCT01336140|Protective Agents|protective agents|mesh-ancestor
6143597|NCT01336205|Naloxegol|naloxegol|mesh-list
6143598|NCT01336205|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6143599|NCT01336205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143600|NCT01336205|Sensory System Agents|sensory system agents|mesh-ancestor
5547171|NCT04123288|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5547172|NCT04123288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5547173|NCT04123288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547174|NCT04123288|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5547175|NCT04123288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143601|NCT01336205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6143602|NCT01336296|Mycophenolic Acid|mycophenolic acid|mesh-list
6473055|NCT00507949|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5547176|NCT04123210|Vitamin A|vitamin a|mesh-list
5547177|NCT04123210|Vitamins|vitamins|mesh-ancestor
5547178|NCT04123210|Micronutrients|micronutrients|mesh-ancestor
5547179|NCT04123210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547180|NCT04123041|Nicotine|nicotine|mesh-list
5547181|NCT04123041|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5547182|NCT04123041|Autonomic Agents|autonomic agents|mesh-ancestor
5547183|NCT04123041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6473056|NCT00507949|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5547184|NCT04123041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473057|NCT00507949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6473058|NCT00507949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6473059|NCT00507949|Appetite Stimulants|appetite stimulants|mesh-ancestor
6473060|NCT00507949|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6473061|NCT00507962|Cisplatin|cisplatin|mesh-list
5547185|NCT04123041|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6143603|NCT01336296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6143604|NCT01336296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6143605|NCT01336296|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5547186|NCT04123041|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5547187|NCT04123041|Cholinergic Agents|cholinergic agents|mesh-ancestor
5547188|NCT04123041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5547189|NCT04123041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547190|NCT04123314|Psilocybin|psilocybin|mesh-list
5547191|NCT04123314|Hallucinogens|hallucinogens|mesh-ancestor
6143606|NCT01336296|Antitubercular Agents|antitubercular agents|mesh-ancestor
6143607|NCT01336296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6143608|NCT01336296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6143609|NCT01336296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5547192|NCT04123314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547193|NCT04123314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6143610|NCT01336296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143611|NCT01336569|Timolol|timolol|mesh-list
6143612|NCT01336569|Travoprost|travoprost|mesh-list
6143613|NCT01336569|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6143614|NCT01336569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6143615|NCT01336569|Adrenergic Agents|adrenergic agents|mesh-ancestor
6143616|NCT01336569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6143617|NCT01336569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143618|NCT01336569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143619|NCT01336569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6473062|NCT00507962|Doxorubicin|doxorubicin|mesh-list
6667108|NCT01526096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6667109|NCT01526096|Antiviral Agents|antiviral agents|mesh-ancestor
6667110|NCT01526096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6667111|NCT01526122|Aspirin|aspirin|mesh-list
6667112|NCT01526122|Clopidogrel|clopidogrel|mesh-list
6667113|NCT01526122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6667114|NCT01526122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6667115|NCT01526122|Analgesics|analgesics|mesh-ancestor
6667116|NCT01526122|Sensory System Agents|sensory system agents|mesh-ancestor
5547194|NCT04123249|Propofol|propofol|mesh-list
5547195|NCT04123249|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
5547196|NCT04123249|Sevoflurane|sevoflurane|mesh-list
5547197|NCT04123249|Anesthetics|anesthetics|mesh-list
5547198|NCT04123249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5547199|NCT04123249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5547200|NCT04123249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547201|NCT04123249|Anesthetics, General|anesthetics, general|mesh-ancestor
5547202|NCT04123249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5547203|NCT04123249|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5547204|NCT04122885|Oxaliplatin|oxaliplatin|mesh-list
5547205|NCT04122885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5547206|NCT04122911|Temozolomide|temozolomide|mesh-list
5547207|NCT04122911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5547208|NCT04122911|Alkylating Agents|alkylating agents|mesh-ancestor
5547209|NCT04122911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547210|NCT04122911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5547211|NCT04122599|Melatonin|melatonin|mesh-list
5547212|NCT04122599|Antioxidants|antioxidants|mesh-ancestor
5547213|NCT04122599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547214|NCT04122599|Protective Agents|protective agents|mesh-ancestor
5547215|NCT04122599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547216|NCT04122599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5547217|NCT04122716|Liraglutide|liraglutide|mesh-list
5547218|NCT04122716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5547219|NCT04122716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547220|NCT04122716|Incretins|incretins|mesh-ancestor
5547221|NCT04122716|Hormones|hormones|mesh-ancestor
5547222|NCT04122716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5547223|NCT04122560|Fluconazole|fluconazole|mesh-list
5547224|NCT04122560|Antifungal Agents|antifungal agents|mesh-ancestor
5547225|NCT04122560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5547226|NCT04122560|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5547227|NCT04122560|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6667117|NCT01526122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6667118|NCT01526122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547228|NCT04122560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5547229|NCT04122560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667119|NCT01526122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6143620|NCT01336569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6143621|NCT01336608|Fluticasone|fluticasone|mesh-list
6143622|NCT01336608|Xhance|xhance|mesh-list
6143623|NCT01336608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6143624|NCT01336608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6143625|NCT01336608|Autonomic Agents|autonomic agents|mesh-ancestor
6143626|NCT01336608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6143627|NCT01336608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143628|NCT01336608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6143629|NCT01336608|Respiratory System Agents|respiratory system agents|mesh-ancestor
6143630|NCT01336608|Dermatologic Agents|dermatologic agents|mesh-ancestor
6143631|NCT01336608|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6143632|NCT01336634|Trametinib|trametinib|mesh-list
6143633|NCT01336634|Dabrafenib|dabrafenib|mesh-list
6143634|NCT01336634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6143635|NCT01336634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6143636|NCT01336634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6143637|NCT01336634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143638|NCT01336738|Nicotinic Acids|nicotinic acids|mesh-list
6143639|NCT01336738|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6143640|NCT01336738|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
6143641|NCT01336738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6143642|NCT01336738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143643|NCT01336738|Incretins|incretins|mesh-ancestor
6143644|NCT01336738|Hormones|hormones|mesh-ancestor
6143645|NCT01336738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5547230|NCT04122560|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5547231|NCT04122560|Hormone Antagonists|hormone antagonists|mesh-ancestor
5547232|NCT04122560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5547233|NCT04122560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143646|NCT01336738|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6143647|NCT01336738|Protease Inhibitors|protease inhibitors|mesh-ancestor
6143648|NCT01336738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6143649|NCT01336738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143650|NCT01336738|Vitamin B Complex|vitamin b complex|mesh-ancestor
6143651|NCT01336738|Vitamins|vitamins|mesh-ancestor
6143652|NCT01336738|Micronutrients|micronutrients|mesh-ancestor
6143653|NCT01336803|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
6143654|NCT01336803|Hematinics|hematinics|mesh-ancestor
6143655|NCT01336803|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5547234|NCT04122560|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5547235|NCT04122560|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5602676|NCT04256421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5602677|NCT04256421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5602678|NCT04256421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5602679|NCT04256421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5602680|NCT04256421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5602681|NCT04256421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602682|NCT04251065|Daratumumab|daratumumab|mesh-list
5602683|NCT04251065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5602684|NCT04245085|Paclitaxel|paclitaxel|mesh-list
5602685|NCT04245085|Bevacizumab|bevacizumab|mesh-list
5602686|NCT04245085|Carboplatin|carboplatin|mesh-list
5602687|NCT04245085|Pemetrexed|pemetrexed|mesh-list
5602688|NCT04245085|Atezolizumab|atezolizumab|mesh-list
5602689|NCT04245085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5602690|NCT04245085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6143656|NCT01336803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6143657|NCT01336933|Prednisone|prednisone|mesh-list
6143658|NCT01336933|Cyclophosphamide|cyclophosphamide|mesh-list
6143659|NCT01336933|Etoposide|etoposide|mesh-list
6143660|NCT01336933|Vincristine|vincristine|mesh-list
6143661|NCT01336933|Etoposide phosphate|etoposide phosphate|mesh-list
5602691|NCT04245085|Tubulin Modulators|tubulin modulators|mesh-ancestor
6143662|NCT01336933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5547236|NCT04122066|Sofosbuvir|sofosbuvir|mesh-list
5547237|NCT04122066|Antiviral Agents|antiviral agents|mesh-ancestor
5547238|NCT04122066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5547239|NCT04122105|Sildenafil Citrate|sildenafil citrate|mesh-list
5547240|NCT04122105|Vasodilator Agents|vasodilator agents|mesh-ancestor
5547241|NCT04122105|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5547242|NCT04122105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5547243|NCT04122105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5547244|NCT04122105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143663|NCT01336933|Immunologic Factors|immunologic factors|mesh-ancestor
6143664|NCT01336933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143665|NCT01336933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6143666|NCT01336933|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6143667|NCT01336933|Alkylating Agents|alkylating agents|mesh-ancestor
6143668|NCT01336933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143669|NCT01336933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6143670|NCT01336933|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6143671|NCT01336933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6143672|NCT01336933|Glucocorticoids|glucocorticoids|mesh-ancestor
6143673|NCT01336933|Hormones|hormones|mesh-ancestor
6143674|NCT01336933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6143675|NCT01336933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6143676|NCT01336933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6143677|NCT01336933|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6473063|NCT00507962|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5547245|NCT04122105|Urological Agents|urological agents|mesh-ancestor
5547246|NCT04122222|Vaccines|vaccines|mesh-list
5547247|NCT04122222|Immunologic Factors|immunologic factors|mesh-ancestor
5547248|NCT04122222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547249|NCT04121975|Endostar protein|endostar protein|mesh-list
5547250|NCT04121975|Endostatins|endostatins|mesh-list
5547251|NCT04121975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5547252|NCT04121975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5547253|NCT04121975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5547254|NCT04121975|Growth Substances|growth substances|mesh-ancestor
5547255|NCT04121975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547256|NCT04121975|Growth Inhibitors|growth inhibitors|mesh-ancestor
5547257|NCT04122040|Roxithromycin|roxithromycin|mesh-list
5547258|NCT04122040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5547259|NCT04122040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5547260|NCT04121910|Itraconazole|itraconazole|mesh-list
5547261|NCT04121910|Antifungal Agents|antifungal agents|mesh-ancestor
5547262|NCT04121910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5547263|NCT04121910|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5547264|NCT04121910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6473064|NCT00507962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6473065|NCT00507962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6473066|NCT00507962|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6473067|NCT00507962|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5547265|NCT04121910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5547266|NCT04121910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547267|NCT04121910|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5547268|NCT04121910|Hormone Antagonists|hormone antagonists|mesh-ancestor
6473068|NCT00507962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6473069|NCT00507962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473070|NCT00507975|Nicotine|nicotine|mesh-list
6473071|NCT00507975|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5547269|NCT04121910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6473072|NCT00507975|Autonomic Agents|autonomic agents|mesh-ancestor
5547270|NCT04121910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547271|NCT04121910|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5547272|NCT04121767|Warfarin|warfarin|mesh-list
5547273|NCT04121767|Edoxaban|edoxaban|mesh-list
5547274|NCT04121767|Anticoagulants|anticoagulants|mesh-ancestor
5547275|NCT04121767|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5547276|NCT04121767|Antithrombins|antithrombins|mesh-ancestor
5547277|NCT04121767|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5547278|NCT04121767|Protease Inhibitors|protease inhibitors|mesh-ancestor
5547279|NCT04121767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5547280|NCT04121767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547281|NCT04121689|Caseins|caseins|mesh-list
5547282|NCT04121689|Chelating Agents|chelating agents|mesh-ancestor
6143678|NCT01336933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6143679|NCT01336933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6143680|NCT01336933|Tubulin Modulators|tubulin modulators|mesh-ancestor
6143681|NCT01336933|Antimitotic Agents|antimitotic agents|mesh-ancestor
6143682|NCT01336933|Mitosis Modulators|mitosis modulators|mesh-ancestor
6143683|NCT01336972|Tolvaptan|tolvaptan|mesh-list
6473073|NCT00507975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6473074|NCT00507975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473075|NCT00507975|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6473076|NCT00507975|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6473077|NCT00507975|Cholinergic Agents|cholinergic agents|mesh-ancestor
6473078|NCT00507975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6143684|NCT01336972|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6143685|NCT01336972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143686|NCT01336972|Natriuretic Agents|natriuretic agents|mesh-ancestor
6143687|NCT01336972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143688|NCT01337089|Nabiximols|nabiximols|mesh-list
6143689|NCT01337089|Analgesics|analgesics|mesh-ancestor
6143690|NCT01337089|Sensory System Agents|sensory system agents|mesh-ancestor
6143691|NCT01337089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6143692|NCT01337089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143693|NCT01337115|Ropivacaine|ropivacaine|mesh-list
6143694|NCT01337115|Anesthetics, Local|anesthetics, local|mesh-list
6143695|NCT01337115|Anesthetics|anesthetics|mesh-list
6143696|NCT01337115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6143697|NCT01337115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143698|NCT01337115|Sensory System Agents|sensory system agents|mesh-ancestor
6143699|NCT01337115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6143700|NCT01337167|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6143701|NCT01337167|Immunologic Factors|immunologic factors|mesh-ancestor
6143702|NCT01337167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143703|NCT01337336|Fluticasone|fluticasone|mesh-list
6143704|NCT01337336|Xhance|xhance|mesh-list
6667120|NCT01526122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6667121|NCT01526122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6667122|NCT01526122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6667123|NCT01526122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473079|NCT00507975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473080|NCT00508040|Interferons|interferons|mesh-list
6473081|NCT00508040|Interferon-alpha|interferon-alpha|mesh-list
6473082|NCT00508040|Interferon alpha-2|interferon alpha-2|mesh-list
6473083|NCT00508040|Prednisone|prednisone|mesh-list
6473084|NCT00508040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6473085|NCT00508040|Glucocorticoids|glucocorticoids|mesh-ancestor
6473086|NCT00508040|Hormones|hormones|mesh-ancestor
6473087|NCT00508040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6473088|NCT00508040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473089|NCT00508040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6473090|NCT00508040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6473091|NCT00508040|Antiviral Agents|antiviral agents|mesh-ancestor
6667124|NCT01526122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6667125|NCT01526122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5547283|NCT04121689|Sequestering Agents|sequestering agents|mesh-ancestor
6143705|NCT01337336|Tiotropium Bromide|tiotropium bromide|mesh-list
6143706|NCT01337336|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6143707|NCT01337336|Ipratropium|ipratropium|mesh-list
6143708|NCT01337336|Cholinergic Antagonists|cholinergic antagonists|mesh-list
6143709|NCT01337336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6143710|NCT01337336|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6143711|NCT01337336|Autonomic Agents|autonomic agents|mesh-ancestor
6143712|NCT01337336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6143713|NCT01337336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667126|NCT01526122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6473092|NCT00508040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6473093|NCT00508040|Immunologic Factors|immunologic factors|mesh-ancestor
6473094|NCT00508092|Anesthetics|anesthetics|mesh-list
5547284|NCT04121689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547285|NCT04121611|Aspirin|aspirin|mesh-list
5547286|NCT04121611|Heparin|heparin|mesh-list
5547287|NCT04121611|Calcium heparin|calcium heparin|mesh-list
5547288|NCT04121611|Anticoagulants|anticoagulants|mesh-ancestor
5547289|NCT04121611|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5547290|NCT04121611|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6473095|NCT00508092|Anesthetics, Local|anesthetics, local|mesh-list
6473096|NCT00508092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6473097|NCT00508092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473098|NCT00508092|Sensory System Agents|sensory system agents|mesh-ancestor
6473099|NCT00508092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6473100|NCT00508209|Bortezomib|bortezomib|mesh-list
6473101|NCT00508209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6473102|NCT00508222|Lopinavir|lopinavir|mesh-list
6473103|NCT00508222|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6473104|NCT00508222|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6473105|NCT00508222|Protease Inhibitors|protease inhibitors|mesh-ancestor
6143714|NCT01337336|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6143715|NCT01337336|Respiratory System Agents|respiratory system agents|mesh-ancestor
5547291|NCT04121611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547292|NCT04121611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5547293|NCT04121611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5547294|NCT04121611|Analgesics|analgesics|mesh-ancestor
5547295|NCT04121611|Sensory System Agents|sensory system agents|mesh-ancestor
5547296|NCT04121611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5547297|NCT04121611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547298|NCT04121611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5547299|NCT04121611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5547300|NCT04121611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5547301|NCT04121611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5547302|NCT04121611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5547303|NCT04121611|Antipyretics|antipyretics|mesh-ancestor
6143716|NCT01337336|Dermatologic Agents|dermatologic agents|mesh-ancestor
6143717|NCT01337336|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6143718|NCT01337336|Parasympatholytics|parasympatholytics|mesh-ancestor
6143719|NCT01337336|Cholinergic Agents|cholinergic agents|mesh-ancestor
6143720|NCT01337336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6143721|NCT01337336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143722|NCT01337336|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6473106|NCT00508222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6473107|NCT00508222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473108|NCT00508222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6473109|NCT00508222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6473110|NCT00508222|Antiviral Agents|antiviral agents|mesh-ancestor
6473111|NCT00508222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6473112|NCT00508222|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6473113|NCT00508222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6473114|NCT00508287|Exenatide|exenatide|mesh-list
6473115|NCT00508287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6473116|NCT00508287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473117|NCT00508287|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6473118|NCT00508287|Incretins|incretins|mesh-ancestor
6473119|NCT00508287|Hormones|hormones|mesh-ancestor
6473120|NCT00508287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6473121|NCT00508326|Paclitaxel|paclitaxel|mesh-list
6473122|NCT00508326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6473123|NCT00508326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6473124|NCT00508326|Tubulin Modulators|tubulin modulators|mesh-ancestor
6473125|NCT00508326|Antimitotic Agents|antimitotic agents|mesh-ancestor
6473126|NCT00508326|Mitosis Modulators|mitosis modulators|mesh-ancestor
6667127|NCT01526122|Antipyretics|antipyretics|mesh-ancestor
5547304|NCT04121819|Cytarabine|cytarabine|mesh-list
5602692|NCT04245085|Antimitotic Agents|antimitotic agents|mesh-ancestor
5547305|NCT04121819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6473127|NCT00508326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473128|NCT00508365|Carvedilol|carvedilol|mesh-list
6473129|NCT00508365|Lisinopril|lisinopril|mesh-list
6473130|NCT00508365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6473131|NCT00508365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6473132|NCT00508365|Adrenergic Agents|adrenergic agents|mesh-ancestor
6473133|NCT00508365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6473134|NCT00508365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547306|NCT04121819|Antimetabolites|antimetabolites|mesh-ancestor
5547307|NCT04121819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547308|NCT04121819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5547309|NCT04121819|Antiviral Agents|antiviral agents|mesh-ancestor
5547310|NCT04121819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5547311|NCT04121819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5547312|NCT04121819|Immunologic Factors|immunologic factors|mesh-ancestor
5547313|NCT04121819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547314|NCT04121780|Hormones|hormones|mesh-list
5547315|NCT04121780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5547316|NCT04121780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547317|NCT04121507|Cyclophosphamide|cyclophosphamide|mesh-list
5547318|NCT04121507|Thiotepa|thiotepa|mesh-list
5547319|NCT04121507|Fludarabine|fludarabine|mesh-list
5547320|NCT04121507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5547321|NCT04121507|Immunologic Factors|immunologic factors|mesh-ancestor
5547322|NCT04121507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547323|NCT04121507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5547324|NCT04121507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5547325|NCT04121507|Alkylating Agents|alkylating agents|mesh-ancestor
5547326|NCT04121507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547327|NCT04121507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5547328|NCT04121507|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5547329|NCT04121533|Vitamin D|vitamin d|mesh-list
5547330|NCT04121533|Cholecalciferol|cholecalciferol|mesh-list
5547331|NCT04121533|Vitamins|vitamins|mesh-ancestor
5547332|NCT04121533|Micronutrients|micronutrients|mesh-ancestor
5547333|NCT04121533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473135|NCT00508365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473136|NCT00508365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6473137|NCT00508365|Antioxidants|antioxidants|mesh-ancestor
6473138|NCT00508365|Protective Agents|protective agents|mesh-ancestor
6473139|NCT00508365|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6473140|NCT00508365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6473141|NCT00508365|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6473142|NCT00508365|Vasodilator Agents|vasodilator agents|mesh-ancestor
6473143|NCT00508365|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6473144|NCT00508365|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6473145|NCT00508365|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6473146|NCT00508365|Protease Inhibitors|protease inhibitors|mesh-ancestor
6473147|NCT00508365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6473148|NCT00508365|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6473149|NCT00508456|Temozolomide|temozolomide|mesh-list
6473150|NCT00508456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6473151|NCT00508456|Alkylating Agents|alkylating agents|mesh-ancestor
6473152|NCT00508456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473153|NCT00508456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6473154|NCT00508495|Acetaminophen|acetaminophen|mesh-list
6473155|NCT00508495|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6473156|NCT00508495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6473157|NCT00508495|Analgesics|analgesics|mesh-ancestor
6473158|NCT00508495|Sensory System Agents|sensory system agents|mesh-ancestor
6473159|NCT00508495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6473160|NCT00508495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473161|NCT00508495|Antipyretics|antipyretics|mesh-ancestor
6473162|NCT00508664|Docetaxel|docetaxel|mesh-list
6473163|NCT00508664|Fluorouracil|fluorouracil|mesh-list
5547334|NCT04121533|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5547335|NCT04121533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5547336|NCT04121468|Metformin|metformin|mesh-list
5547337|NCT04121468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5547338|NCT04121468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547339|NCT04121416|Sufentanil|sufentanil|mesh-list
5547340|NCT04121416|Oxycodone|oxycodone|mesh-list
5547341|NCT04121416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6473164|NCT00508664|Cetuximab|cetuximab|mesh-list
6473165|NCT00508664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6473166|NCT00508664|Tubulin Modulators|tubulin modulators|mesh-ancestor
6143723|NCT01337336|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6143724|NCT01337336|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6473167|NCT00508664|Antimitotic Agents|antimitotic agents|mesh-ancestor
6473168|NCT00508664|Mitosis Modulators|mitosis modulators|mesh-ancestor
6473169|NCT00508664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473170|NCT00508664|Antimetabolites|antimetabolites|mesh-ancestor
6473171|NCT00508664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6473172|NCT00508664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6473173|NCT00508664|Immunologic Factors|immunologic factors|mesh-ancestor
6473174|NCT00508664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473175|NCT00508664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6473176|NCT00508690|Metronidazole|metronidazole|mesh-list
6667128|NCT01526122|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6667129|NCT01526122|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6667130|NCT01526122|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6667131|NCT01526122|Purinergic Agents|purinergic agents|mesh-ancestor
6667132|NCT01526122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6667133|NCT01526161|Fluticasone|fluticasone|mesh-list
6667134|NCT01526161|Xhance|xhance|mesh-list
6667135|NCT01526161|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6667136|NCT01526161|Montelukast|montelukast|mesh-list
5547342|NCT04121416|Narcotics|narcotics|mesh-ancestor
5547343|NCT04121416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5547344|NCT04121416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547345|NCT04121416|Analgesics|analgesics|mesh-ancestor
5547346|NCT04121416|Sensory System Agents|sensory system agents|mesh-ancestor
5547347|NCT04121416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5547348|NCT04121416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5547349|NCT04121416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5547350|NCT04121416|Anesthetics, General|anesthetics, general|mesh-ancestor
5547351|NCT04121416|Anesthetics|anesthetics|mesh-ancestor
5547352|NCT04121039|Apatinib|apatinib|mesh-list
5547353|NCT04121039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5547354|NCT04121039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6667137|NCT01526161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6667138|NCT01526161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6667139|NCT01526161|Autonomic Agents|autonomic agents|mesh-ancestor
6667140|NCT01526161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6672431|NCT01556035|Lenalidomide|lenalidomide|mesh-list
5547355|NCT04121039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5547356|NCT04121039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547357|NCT04121338|Bupivacaine|bupivacaine|mesh-list
5547358|NCT04121338|Anesthetics, Local|anesthetics, local|mesh-ancestor
6143725|NCT01337336|Adrenergic Agents|adrenergic agents|mesh-ancestor
6143726|NCT01337635|Vitamin D|vitamin d|mesh-list
5547359|NCT04121338|Anesthetics|anesthetics|mesh-ancestor
5547360|NCT04121338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5547361|NCT04121338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547362|NCT04121338|Sensory System Agents|sensory system agents|mesh-ancestor
6143727|NCT01337635|Vitamins|vitamins|mesh-ancestor
6143728|NCT01337635|Micronutrients|micronutrients|mesh-ancestor
6143729|NCT01337635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143730|NCT01337635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6143731|NCT01337674|Metoprolol|metoprolol|mesh-list
6143732|NCT01337674|Amlodipine|amlodipine|mesh-list
6143733|NCT01337674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6143734|NCT01337674|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6143735|NCT01337674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6143736|NCT01337674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143737|NCT01337674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6143738|NCT01337674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143739|NCT01337674|Vasodilator Agents|vasodilator agents|mesh-ancestor
6143740|NCT01337674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6143741|NCT01337674|Sympatholytics|sympatholytics|mesh-ancestor
6143742|NCT01337674|Autonomic Agents|autonomic agents|mesh-ancestor
6143743|NCT01337674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6143744|NCT01337674|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6143745|NCT01337674|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6143746|NCT01337674|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6143747|NCT01337674|Adrenergic Agents|adrenergic agents|mesh-ancestor
6143748|NCT01337674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6143749|NCT01337687|Oxytocin|oxytocin|mesh-list
6143750|NCT01337687|Oxytocics|oxytocics|mesh-ancestor
5547363|NCT04121338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6473177|NCT00508690|Kanamycin|kanamycin|mesh-list
6473178|NCT00508690|Cefmetazole|cefmetazole|mesh-list
6473179|NCT00508690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6473180|NCT00508690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6473181|NCT00508690|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6473182|NCT00508690|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6473183|NCT00508690|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6473184|NCT00508690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6473185|NCT00508690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473186|NCT00508859|Sertraline|sertraline|mesh-list
6473187|NCT00508859|Antidepressive Agents|antidepressive agents|mesh-ancestor
6473188|NCT00508859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6473189|NCT00508859|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6473190|NCT00508859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6473191|NCT00508859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6473192|NCT00508859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473193|NCT00508859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6473194|NCT00508859|Serotonin Agents|serotonin agents|mesh-ancestor
6473195|NCT00508859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473196|NCT00508885|Niacinamide|niacinamide|mesh-list
6473197|NCT00508885|Niacin|niacin|mesh-list
6473198|NCT00508885|Nicotinic Acids|nicotinic acids|mesh-list
6473199|NCT00508885|Vitamin B Complex|vitamin b complex|mesh-ancestor
6473200|NCT00508885|Vitamins|vitamins|mesh-ancestor
6473201|NCT00508885|Micronutrients|micronutrients|mesh-ancestor
6473202|NCT00508885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473203|NCT00508885|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6473204|NCT00508885|Antimetabolites|antimetabolites|mesh-ancestor
6473205|NCT00508885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473206|NCT00508885|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6473207|NCT00508885|Vasodilator Agents|vasodilator agents|mesh-ancestor
6473208|NCT00508898|Calcitriol|calcitriol|mesh-list
6473209|NCT00508898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6473210|NCT00508898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473211|NCT00508898|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6473212|NCT00508898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6473213|NCT00508898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473214|NCT00508898|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6473215|NCT00508898|Vitamins|vitamins|mesh-ancestor
6473216|NCT00508898|Micronutrients|micronutrients|mesh-ancestor
6473217|NCT00508898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6473218|NCT00508911|Contraceptive Agents|contraceptive agents|mesh-list
6473219|NCT00508911|Contraceptives, Oral|contraceptives, oral|mesh-list
6473220|NCT00508911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6473221|NCT00508911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473222|NCT00508911|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6473223|NCT00508963|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
6473224|NCT00508963|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5547364|NCT04121403|Rituximab|rituximab|mesh-list
5547365|NCT04121403|Cladribine|cladribine|mesh-list
6143751|NCT01337687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6143752|NCT01337687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143753|NCT01337700|Milnacipran|milnacipran|mesh-list
6143754|NCT01337700|Levomilnacipran|levomilnacipran|mesh-list
6143755|NCT01337700|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6143756|NCT01337700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6143757|NCT01337700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6143758|NCT01337700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143759|NCT01337700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6143760|NCT01337700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143761|NCT01337700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6143762|NCT01337700|Analgesics|analgesics|mesh-ancestor
6143763|NCT01337700|Sensory System Agents|sensory system agents|mesh-ancestor
6143764|NCT01337700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6143765|NCT01337700|Antidepressive Agents|antidepressive agents|mesh-ancestor
6143766|NCT01337700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6143767|NCT01337986|4-Aminopyridine|4-aminopyridine|mesh-list
6143768|NCT01337986|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6143769|NCT01337986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6143770|NCT01337986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547366|NCT04121403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5547367|NCT04121403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5547368|NCT04121403|Immunologic Factors|immunologic factors|mesh-ancestor
5547369|NCT04121403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143771|NCT01338025|Lamivudine|lamivudine|mesh-list
6143772|NCT01338025|Emtricitabine|emtricitabine|mesh-list
6143773|NCT01338025|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6143774|NCT01338025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6143775|NCT01338025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6143776|NCT01338025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143777|NCT01338025|Antiviral Agents|antiviral agents|mesh-ancestor
5547370|NCT04121403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5547371|NCT04121403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5547372|NCT04120870|Ketamine|ketamine|mesh-list
5547373|NCT04120870|Etomidate|etomidate|mesh-list
5547374|NCT04120870|Analgesics|analgesics|mesh-ancestor
5547375|NCT04120870|Sensory System Agents|sensory system agents|mesh-ancestor
5547376|NCT04120870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5547377|NCT04120870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547378|NCT04120870|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5547379|NCT04120870|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5547380|NCT04120870|Anesthetics, General|anesthetics, general|mesh-ancestor
5547381|NCT04120870|Anesthetics|anesthetics|mesh-ancestor
5547382|NCT04120870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5547383|NCT04120870|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5547384|NCT04120870|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5547385|NCT04120870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5547386|NCT04120870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547387|NCT04120870|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5547388|NCT04121091|Pramipexole|pramipexole|mesh-list
5547389|NCT04121091|Antioxidants|antioxidants|mesh-ancestor
5547390|NCT04121091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547391|NCT04121091|Protective Agents|protective agents|mesh-ancestor
5547392|NCT04121091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547393|NCT04121091|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5547394|NCT04121091|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5547395|NCT04121091|Dopamine Agonists|dopamine agonists|mesh-ancestor
5547396|NCT04121091|Dopamine Agents|dopamine agents|mesh-ancestor
5547397|NCT04121091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5547398|NCT04120883|Hydroxychloroquine|hydroxychloroquine|mesh-list
5547399|NCT04120883|Antimalarials|antimalarials|mesh-ancestor
6143778|NCT01338025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6143779|NCT01338025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6143780|NCT01338025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6143781|NCT01338298|Aripiprazole|aripiprazole|mesh-list
6143782|NCT01338298|Antidepressive Agents|antidepressive agents|mesh-ancestor
6143783|NCT01338298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6143784|NCT01338298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6143785|NCT01338298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6143786|NCT01338298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6143787|NCT01338298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143788|NCT01338298|Dopamine Agonists|dopamine agonists|mesh-ancestor
6143789|NCT01338298|Dopamine Agents|dopamine agents|mesh-ancestor
6143790|NCT01338298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6143791|NCT01338298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143792|NCT01338298|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6667141|NCT01526161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547400|NCT04120883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5547401|NCT04120883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5547402|NCT04120883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5547403|NCT04120883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5547404|NCT04120883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547405|NCT04120883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5547406|NCT04120779|Sulfamethazine|sulfamethazine|mesh-list
5547407|NCT04120779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5547408|NCT04120987|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5547409|NCT04120987|Lifitegrast|lifitegrast|mesh-list
5547410|NCT04120987|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5547411|NCT04120753|Amlodipine|amlodipine|mesh-list
5547412|NCT04120753|Olmesartan|olmesartan|mesh-list
5547413|NCT04120753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5547414|NCT04120753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5547415|NCT04120753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5547416|NCT04120753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547417|NCT04120753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5547418|NCT04120753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547419|NCT04120753|Vasodilator Agents|vasodilator agents|mesh-ancestor
5547420|NCT04120753|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5602693|NCT04245085|Mitosis Modulators|mitosis modulators|mesh-ancestor
6143793|NCT01338298|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5547421|NCT04120753|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5547422|NCT04120974|Insulin|insulin|mesh-list
5547423|NCT04120974|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5547424|NCT04120974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547425|NCT04120805|Hemostatics|hemostatics|mesh-list
5547426|NCT04120805|Coagulants|coagulants|mesh-ancestor
5547427|NCT04120922|Calcium Carbonate|calcium carbonate|mesh-list
5547428|NCT04120922|Calcium|calcium|mesh-list
5547429|NCT04120922|Sevelamer|sevelamer|mesh-list
5547430|NCT04120922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5547431|NCT04120922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547432|NCT04120922|Antacids|antacids|mesh-ancestor
5547433|NCT04120922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547434|NCT04120922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6143794|NCT01338298|Serotonin Agents|serotonin agents|mesh-ancestor
6143795|NCT01338298|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6143796|NCT01338298|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6143797|NCT01338298|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5547435|NCT04120922|Chelating Agents|chelating agents|mesh-ancestor
5547436|NCT04120922|Sequestering Agents|sequestering agents|mesh-ancestor
5547437|NCT04120831|Abatacept|abatacept|mesh-list
6143798|NCT01338298|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6143799|NCT01338415|Bosentan|bosentan|mesh-list
6143800|NCT01338415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6143801|NCT01338415|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6143802|NCT01338415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143803|NCT01338610|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6143804|NCT01338610|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6143805|NCT01338792|Oxaliplatin|oxaliplatin|mesh-list
6143806|NCT01338792|Pemetrexed|pemetrexed|mesh-list
6143807|NCT01338792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6143808|NCT01338792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6143809|NCT01338792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143810|NCT01338792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6143811|NCT01338792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6143812|NCT01338818|Methylphenidate|methylphenidate|mesh-list
5547438|NCT04120831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5547439|NCT04120831|Immunologic Factors|immunologic factors|mesh-ancestor
5547440|NCT04120831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547441|NCT04120831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5547442|NCT04120831|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5547443|NCT04120831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547444|NCT04120831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5547445|NCT04120961|Hirudins|hirudins|mesh-list
5547446|NCT04120961|Bivalirudin|bivalirudin|mesh-list
5547447|NCT04120961|Antithrombins|antithrombins|mesh-ancestor
5547448|NCT04120961|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5547449|NCT04120961|Protease Inhibitors|protease inhibitors|mesh-ancestor
5547450|NCT04120961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5547451|NCT04120961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547452|NCT04120961|Anticoagulants|anticoagulants|mesh-ancestor
5547453|NCT04120961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5547454|NCT04120961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5547455|NCT04120636|Celecoxib|celecoxib|mesh-list
5547456|NCT04120636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5547457|NCT04120636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5547458|NCT04120636|Analgesics|analgesics|mesh-ancestor
5547459|NCT04120636|Sensory System Agents|sensory system agents|mesh-ancestor
5547460|NCT04120636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5547461|NCT04120636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547462|NCT04120636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5547463|NCT04120636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6143813|NCT01338818|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6143814|NCT01338818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143815|NCT01338818|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6143816|NCT01338818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6143817|NCT01338818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6143818|NCT01338818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473225|NCT00508963|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6473226|NCT00508963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6473227|NCT00508963|Schistosomicides|schistosomicides|mesh-ancestor
5547464|NCT04120636|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5547465|NCT04120636|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6473228|NCT00508963|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6143819|NCT01338818|Dopamine Agents|dopamine agents|mesh-ancestor
6143820|NCT01338818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6143821|NCT01338857|Sorafenib|sorafenib|mesh-list
6143822|NCT01338857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6143823|NCT01338857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5547466|NCT04120636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5547467|NCT04120636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547468|NCT04120623|Insulin Aspart|insulin aspart|mesh-list
5547469|NCT04120623|Dapagliflozin|dapagliflozin|mesh-list
5547470|NCT04120623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6143824|NCT01338857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6143825|NCT01338857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143826|NCT01338870|Nicotinic Acids|nicotinic acids|mesh-list
6143827|NCT01338870|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6143828|NCT01338870|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
6143829|NCT01338870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6143830|NCT01338870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143831|NCT01338870|Incretins|incretins|mesh-ancestor
6143832|NCT01338870|Hormones|hormones|mesh-ancestor
6143833|NCT01338870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6143834|NCT01338870|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6143835|NCT01338870|Protease Inhibitors|protease inhibitors|mesh-ancestor
6143836|NCT01338870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6143837|NCT01338870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143838|NCT01338870|Vitamin B Complex|vitamin b complex|mesh-ancestor
6143839|NCT01338870|Vitamins|vitamins|mesh-ancestor
6473229|NCT00508963|Anthelmintics|anthelmintics|mesh-ancestor
6473230|NCT00508976|Lidocaine|lidocaine|mesh-list
6473231|NCT00508976|Bupivacaine|bupivacaine|mesh-list
5547471|NCT04120623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547472|NCT04120623|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5547473|NCT04120623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547474|NCT04120363|Methyltestosterone|methyltestosterone|mesh-list
5547475|NCT04120363|Testosterone|testosterone|mesh-list
5547476|NCT04120363|Testosterone undecanoate|testosterone undecanoate|mesh-list
5547477|NCT04120363|Testosterone enanthate|testosterone enanthate|mesh-list
5547478|NCT04120363|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5547479|NCT04120363|Androgens|androgens|mesh-ancestor
5547480|NCT04120363|Hormones|hormones|mesh-ancestor
5547481|NCT04120363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5547482|NCT04120363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547483|NCT04120363|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5547484|NCT04120363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5547485|NCT04120363|Anabolic Agents|anabolic agents|mesh-ancestor
5547486|NCT04120311|Dexamethasone|dexamethasone|mesh-list
5547487|NCT04120311|Dexamethasone acetate|dexamethasone acetate|mesh-list
5547488|NCT04120311|BB 1101|bb 1101|mesh-list
5547489|NCT04120311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5547490|NCT04120311|Antiemetics|antiemetics|mesh-ancestor
6473232|NCT00508976|Anesthetics, Local|anesthetics, local|mesh-ancestor
6473233|NCT00508976|Anesthetics|anesthetics|mesh-ancestor
6473234|NCT00508976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6473235|NCT00508976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473236|NCT00508976|Sensory System Agents|sensory system agents|mesh-ancestor
6473237|NCT00508976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6473238|NCT00508976|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6473239|NCT00508976|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6473240|NCT00508976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6473241|NCT00508976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6473242|NCT00508976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667142|NCT01526161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5547491|NCT04120311|Autonomic Agents|autonomic agents|mesh-ancestor
6143840|NCT01338870|Micronutrients|micronutrients|mesh-ancestor
6143841|NCT01338987|Alovudine|alovudine|mesh-list
6143842|NCT01338987|Cyclophosphamide|cyclophosphamide|mesh-list
6143843|NCT01338987|Busulfan|busulfan|mesh-list
6143844|NCT01338987|Methotrexate|methotrexate|mesh-list
6143845|NCT01338987|Fludarabine|fludarabine|mesh-list
6143846|NCT01338987|Leuprolide|leuprolide|mesh-list
6143847|NCT01338987|Tacrolimus|tacrolimus|mesh-list
6143848|NCT01338987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6143849|NCT01338987|Immunologic Factors|immunologic factors|mesh-ancestor
6143850|NCT01338987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143851|NCT01338987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6143852|NCT01338987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6473243|NCT00509015|Artesunate|artesunate|mesh-list
5547492|NCT04120311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5547493|NCT04120311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547494|NCT04120311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5547495|NCT04120311|Glucocorticoids|glucocorticoids|mesh-ancestor
5547496|NCT04120311|Hormones|hormones|mesh-ancestor
5547497|NCT04120311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5547498|NCT04120311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5547499|NCT04120311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5547500|NCT04120311|Protease Inhibitors|protease inhibitors|mesh-ancestor
5547501|NCT04120311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5547502|NCT04120311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602694|NCT04245085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602695|NCT04245085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5602696|NCT04245085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5602697|NCT04245085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5602698|NCT04245085|Growth Substances|growth substances|mesh-ancestor
5602699|NCT04245085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602700|NCT04245085|Growth Inhibitors|growth inhibitors|mesh-ancestor
5602701|NCT04245085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5602702|NCT04245085|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5602703|NCT04245085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5602704|NCT04235855|Liver Extracts|liver extracts|mesh-list
5602705|NCT04235855|Hematinics|hematinics|mesh-ancestor
5602706|NCT04234945|Doxycycline|doxycycline|mesh-list
5602707|NCT04234945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5602708|NCT04234945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6143853|NCT01338987|Alkylating Agents|alkylating agents|mesh-ancestor
6143854|NCT01338987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143855|NCT01338987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6143856|NCT01338987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6143857|NCT01338987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6143858|NCT01338987|Abortifacient Agents|abortifacient agents|mesh-ancestor
5602709|NCT04234945|Antimalarials|antimalarials|mesh-ancestor
5602710|NCT04234945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5602711|NCT04234945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5602712|NCT04234906|Magnesium Sulfate|magnesium sulfate|mesh-list
5602713|NCT04234906|Amiodarone|amiodarone|mesh-list
5602714|NCT04234906|Procainamide|procainamide|mesh-list
5602715|NCT04234906|Dexmedetomidine|dexmedetomidine|mesh-list
5602716|NCT04234906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5602717|NCT04234906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5602718|NCT04234906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602719|NCT04234906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5602720|NCT04234906|Analgesics|analgesics|mesh-ancestor
5602721|NCT04234906|Sensory System Agents|sensory system agents|mesh-ancestor
5602722|NCT04234906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5602723|NCT04234906|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5602724|NCT04234906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5602725|NCT04234906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6143859|NCT01338987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6143860|NCT01338987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6143861|NCT01338987|Antimetabolites|antimetabolites|mesh-ancestor
6143862|NCT01338987|Dermatologic Agents|dermatologic agents|mesh-ancestor
6143863|NCT01338987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6143864|NCT01338987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6143865|NCT01338987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6143866|NCT01338987|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6143867|NCT01338987|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6143868|NCT01338987|Fertility Agents|fertility agents|mesh-ancestor
6143869|NCT01338987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6143870|NCT01338987|Antiviral Agents|antiviral agents|mesh-ancestor
6143871|NCT01338987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6143872|NCT01339000|Vaccines|vaccines|mesh-list
6143873|NCT01339000|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6143874|NCT01339000|Immunologic Factors|immunologic factors|mesh-ancestor
6143875|NCT01339000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143876|NCT01339013|Anesthetics|anesthetics|mesh-list
6143877|NCT01339013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6143878|NCT01339013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143879|NCT01339091|Vancomycin|vancomycin|mesh-list
6143880|NCT01339091|Linezolid|linezolid|mesh-list
6143881|NCT01339091|Dalbavancin|dalbavancin|mesh-list
6143882|NCT01339091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5602726|NCT04234906|Adrenergic Agents|adrenergic agents|mesh-ancestor
6143883|NCT01339091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6143884|NCT01339091|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5547503|NCT04120259|Metformin|metformin|mesh-list
5547504|NCT04120259|Acetic Acid|acetic acid|mesh-list
5547505|NCT04120259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5547506|NCT04120259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547507|NCT04120259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5547508|NCT04120259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5547509|NCT04120350|Rituximab|rituximab|mesh-list
5547510|NCT04120350|Methotrexate|methotrexate|mesh-list
6143885|NCT01339091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6143886|NCT01339091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143887|NCT01339247|Halofantrine|halofantrine|mesh-list
6143888|NCT01339247|Paroxetine|paroxetine|mesh-list
6143889|NCT01339247|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6143890|NCT01339247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5547511|NCT04120350|Lenalidomide|lenalidomide|mesh-list
5547512|NCT04120350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5547513|NCT04120350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5547514|NCT04120350|Immunologic Factors|immunologic factors|mesh-ancestor
5547515|NCT04120350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547516|NCT04120350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6143891|NCT01339247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6143892|NCT01339247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143893|NCT01339247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6143894|NCT01339247|Serotonin Agents|serotonin agents|mesh-ancestor
6143895|NCT01339247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143896|NCT01339247|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6143897|NCT01339247|Antidepressive Agents|antidepressive agents|mesh-ancestor
6143898|NCT01339247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6143899|NCT01339247|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6143900|NCT01339247|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6143901|NCT01339247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6473244|NCT00509015|Pyrimethamine|pyrimethamine|mesh-list
6473245|NCT00509015|Primaquine|primaquine|mesh-list
6473246|NCT00509015|Sulfadoxine|sulfadoxine|mesh-list
6473247|NCT00509015|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6473248|NCT00509015|Antimalarials|antimalarials|mesh-ancestor
6473249|NCT00509015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6473250|NCT00509015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6473251|NCT00509015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6473252|NCT00509015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6473253|NCT00509015|Antiviral Agents|antiviral agents|mesh-ancestor
6473254|NCT00509015|Schistosomicides|schistosomicides|mesh-ancestor
6473255|NCT00509015|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6473256|NCT00509015|Anthelmintics|anthelmintics|mesh-ancestor
6473257|NCT00509015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6473258|NCT00509015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6473259|NCT00509015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473260|NCT00509015|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6473261|NCT00509015|Renal Agents|renal agents|mesh-ancestor
6143902|NCT01339247|Antimalarials|antimalarials|mesh-ancestor
6143903|NCT01339247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6143904|NCT01339247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6143905|NCT01339247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6143906|NCT01339260|Dexamethasone|dexamethasone|mesh-list
6143907|NCT01339260|Palonosetron|palonosetron|mesh-list
6143908|NCT01339260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6143909|NCT01339260|Antiemetics|antiemetics|mesh-ancestor
6143910|NCT01339260|Autonomic Agents|autonomic agents|mesh-ancestor
6143911|NCT01339260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5547517|NCT04120350|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5547518|NCT04120350|Abortifacient Agents|abortifacient agents|mesh-ancestor
5547519|NCT04120350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5547520|NCT04120350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5547521|NCT04120350|Antimetabolites|antimetabolites|mesh-ancestor
5547522|NCT04120350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547523|NCT04120350|Dermatologic Agents|dermatologic agents|mesh-ancestor
5547524|NCT04120350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5547525|NCT04120350|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5547526|NCT04120350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5547527|NCT04120350|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5547528|NCT04120350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6473262|NCT00509158|Aluminum Hydroxide|aluminum hydroxide|mesh-list
5547529|NCT04120350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6473263|NCT00509158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6143912|NCT01339260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143913|NCT01339260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6143914|NCT01339260|Glucocorticoids|glucocorticoids|mesh-ancestor
6143915|NCT01339260|Hormones|hormones|mesh-ancestor
6143916|NCT01339260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6143917|NCT01339260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6143918|NCT01339260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6143919|NCT01339260|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6143920|NCT01339260|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6143921|NCT01339260|Serotonin Agents|serotonin agents|mesh-ancestor
6143922|NCT01339260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6143923|NCT01339260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143924|NCT01339273|Anesthetics|anesthetics|mesh-list
6143925|NCT01339273|Anesthetics, Local|anesthetics, local|mesh-list
6143926|NCT01339273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6143927|NCT01339273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143928|NCT01339273|Sensory System Agents|sensory system agents|mesh-ancestor
6143929|NCT01339273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6143930|NCT01339299|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6143931|NCT01339299|Hormones|hormones|mesh-list
6143932|NCT01339299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6143933|NCT01339299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143934|NCT01339299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6143935|NCT01339559|Brivaracetam|brivaracetam|mesh-list
6143936|NCT01339559|Anticonvulsants|anticonvulsants|mesh-ancestor
6143937|NCT01339858|Acetylcysteine|acetylcysteine|mesh-list
6143938|NCT01339858|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6143939|NCT01339858|Antiviral Agents|antiviral agents|mesh-ancestor
6143940|NCT01339858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6143941|NCT01339858|Expectorants|expectorants|mesh-ancestor
6143942|NCT01339858|Respiratory System Agents|respiratory system agents|mesh-ancestor
6473264|NCT00509158|Immunologic Factors|immunologic factors|mesh-ancestor
6473265|NCT00509158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473266|NCT00509158|Antacids|antacids|mesh-ancestor
6473267|NCT00509158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473268|NCT00509158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6473269|NCT00509184|Rituximab|rituximab|mesh-list
6473270|NCT00509184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6473271|NCT00509184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6473272|NCT00509184|Immunologic Factors|immunologic factors|mesh-ancestor
6473273|NCT00509184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473274|NCT00509184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6473275|NCT00509327|Bisacodyl|bisacodyl|mesh-list
6473276|NCT00509327|Cathartics|cathartics|mesh-ancestor
6473277|NCT00509327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6473278|NCT00509327|Laxatives|laxatives|mesh-ancestor
6473279|NCT00509353|Irinotecan|irinotecan|mesh-list
6473280|NCT00509353|Vincristine|vincristine|mesh-list
6473281|NCT00509353|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
6473282|NCT00509353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6473283|NCT00509353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6473284|NCT00509353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6473285|NCT00509353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473286|NCT00509353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6473287|NCT00509353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6473288|NCT00509353|Tubulin Modulators|tubulin modulators|mesh-ancestor
6473289|NCT00509353|Antimitotic Agents|antimitotic agents|mesh-ancestor
6473290|NCT00509353|Mitosis Modulators|mitosis modulators|mesh-ancestor
6473291|NCT00509353|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6473292|NCT00509379|Rituximab|rituximab|mesh-list
6473293|NCT00509379|Bortezomib|bortezomib|mesh-list
6473294|NCT00509379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6473295|NCT00509379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6473296|NCT00509379|Immunologic Factors|immunologic factors|mesh-ancestor
6473297|NCT00509379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473298|NCT00509379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6473299|NCT00509405|Potassium Citrate|potassium citrate|mesh-list
6473300|NCT00509405|Diuretics|diuretics|mesh-ancestor
6473301|NCT00509405|Natriuretic Agents|natriuretic agents|mesh-ancestor
6473302|NCT00509405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473303|NCT00509405|Expectorants|expectorants|mesh-ancestor
6473304|NCT00509405|Respiratory System Agents|respiratory system agents|mesh-ancestor
6473305|NCT00509431|Sirolimus|sirolimus|mesh-list
6473306|NCT00509431|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6473307|NCT00509431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6473308|NCT00509431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6473309|NCT00509431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6473310|NCT00509431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473311|NCT00509431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6473312|NCT00509431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6473313|NCT00509431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6143943|NCT01339858|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6473314|NCT00509431|Antifungal Agents|antifungal agents|mesh-ancestor
6473315|NCT00509431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6473316|NCT00509431|Immunologic Factors|immunologic factors|mesh-ancestor
6473317|NCT00509431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473318|NCT00509470|Amlodipine|amlodipine|mesh-list
6473319|NCT00509470|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6473320|NCT00509470|Telmisartan|telmisartan|mesh-list
6473321|NCT00509470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6473322|NCT00509470|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6473323|NCT00509470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6473324|NCT00509470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473325|NCT00509470|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6473326|NCT00509470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473327|NCT00509470|Vasodilator Agents|vasodilator agents|mesh-ancestor
6473328|NCT00509470|Diuretics|diuretics|mesh-ancestor
6473329|NCT00509470|Natriuretic Agents|natriuretic agents|mesh-ancestor
6473330|NCT00509470|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6667143|NCT01526161|Respiratory System Agents|respiratory system agents|mesh-ancestor
6667144|NCT01526161|Dermatologic Agents|dermatologic agents|mesh-ancestor
6667145|NCT01526161|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6667146|NCT01526161|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6667147|NCT01526161|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6667148|NCT01526161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6667149|NCT01526161|Adrenergic Agents|adrenergic agents|mesh-ancestor
6143944|NCT01339858|Antioxidants|antioxidants|mesh-ancestor
6143945|NCT01339858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143946|NCT01339858|Protective Agents|protective agents|mesh-ancestor
6667150|NCT01526161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6667151|NCT01526161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667152|NCT01526161|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6143947|NCT01339858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143948|NCT01339858|Antidotes|antidotes|mesh-ancestor
6143949|NCT01339910|Vidarabine|vidarabine|mesh-list
6143950|NCT01339910|Cyclophosphamide|cyclophosphamide|mesh-list
6143951|NCT01339910|Melphalan|melphalan|mesh-list
6143952|NCT01339910|Busulfan|busulfan|mesh-list
6143953|NCT01339910|Fludarabine|fludarabine|mesh-list
6143954|NCT01339910|Fludarabine phosphate|fludarabine phosphate|mesh-list
6143955|NCT01339910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6143956|NCT01339910|Immunologic Factors|immunologic factors|mesh-ancestor
6143957|NCT01339910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143958|NCT01339910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6143959|NCT01339910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6143960|NCT01339910|Alkylating Agents|alkylating agents|mesh-ancestor
6143961|NCT01339910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667153|NCT01526161|Hormone Antagonists|hormone antagonists|mesh-ancestor
6143962|NCT01339910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6143963|NCT01339910|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6143964|NCT01339910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6143965|NCT01339910|Antimetabolites|antimetabolites|mesh-ancestor
6143966|NCT01339910|Antiviral Agents|antiviral agents|mesh-ancestor
6143967|NCT01339910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6143968|NCT01339923|Vaccines|vaccines|mesh-list
6143969|NCT01339923|Immunologic Factors|immunologic factors|mesh-ancestor
6143970|NCT01339923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143971|NCT01339936|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6143972|NCT01339936|Glycerol|glycerol|mesh-list
6143973|NCT01339936|Laxatives|laxatives|mesh-ancestor
6473331|NCT00509470|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6473332|NCT00509470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6473333|NCT00509561|Capecitabine|capecitabine|mesh-list
6473334|NCT00509561|Cetuximab|cetuximab|mesh-list
6473335|NCT00509561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5547530|NCT04120350|Growth Substances|growth substances|mesh-ancestor
5547531|NCT04120350|Growth Inhibitors|growth inhibitors|mesh-ancestor
5547532|NCT04120519|Thalidomide|thalidomide|mesh-list
5547533|NCT04120519|Dexamethasone|dexamethasone|mesh-list
5547534|NCT04120519|Cyclophosphamide|cyclophosphamide|mesh-list
5547535|NCT04120519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5547536|NCT04120519|Immunologic Factors|immunologic factors|mesh-ancestor
5547537|NCT04120519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547538|NCT04120519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5547539|NCT04120519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5547540|NCT04120519|Alkylating Agents|alkylating agents|mesh-ancestor
5547541|NCT04120519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547542|NCT04120519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5547543|NCT04120519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5547544|NCT04120519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5547545|NCT04120519|Antiemetics|antiemetics|mesh-ancestor
5547546|NCT04120519|Autonomic Agents|autonomic agents|mesh-ancestor
5547547|NCT04120519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5547548|NCT04120519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5547549|NCT04120519|Glucocorticoids|glucocorticoids|mesh-ancestor
5547550|NCT04120519|Hormones|hormones|mesh-ancestor
6473336|NCT00509561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6473337|NCT00509561|Antimetabolites|antimetabolites|mesh-ancestor
6473338|NCT00509561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143974|NCT01339936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6143975|NCT01339936|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6143976|NCT01339936|Protective Agents|protective agents|mesh-ancestor
6143977|NCT01339936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143978|NCT01340014|Timolol|timolol|mesh-list
6143979|NCT01340014|Dorzolamide|dorzolamide|mesh-list
6143980|NCT01340014|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6143981|NCT01340014|Brinzolamide|brinzolamide|mesh-list
6143982|NCT01340014|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6143983|NCT01340014|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6143984|NCT01340014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6143985|NCT01340014|Adrenergic Agents|adrenergic agents|mesh-ancestor
6143986|NCT01340014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6143987|NCT01340014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6143988|NCT01340014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6143989|NCT01340014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6143990|NCT01340014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6143991|NCT01340014|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6143992|NCT01340014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6143993|NCT01340027|Solifenacin Succinate|solifenacin succinate|mesh-list
6143994|NCT01340027|Mirabegron|mirabegron|mesh-list
6143995|NCT01340027|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6143996|NCT01340027|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6143997|NCT01340027|Cholinergic Agents|cholinergic agents|mesh-ancestor
6143998|NCT01340027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6143999|NCT01340027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144000|NCT01340027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144001|NCT01340027|Urological Agents|urological agents|mesh-ancestor
6144002|NCT01340027|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6144003|NCT01340027|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6473339|NCT00509561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6473340|NCT00509613|Sirolimus|sirolimus|mesh-list
5547551|NCT04120519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6144004|NCT01340027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6144005|NCT01340027|Adrenergic Agents|adrenergic agents|mesh-ancestor
6144006|NCT01340196|Tenofovir|tenofovir|mesh-list
6144007|NCT01340196|Antiviral Agents|antiviral agents|mesh-ancestor
6144008|NCT01340196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6144009|NCT01340196|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6144010|NCT01340196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6144011|NCT01340196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5547552|NCT04120519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5547553|NCT04120519|Leprostatic Agents|leprostatic agents|mesh-ancestor
5547554|NCT04120519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5547555|NCT04120519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5547556|NCT04120519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5547557|NCT04120519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5547558|NCT04120519|Growth Substances|growth substances|mesh-ancestor
5547559|NCT04120519|Growth Inhibitors|growth inhibitors|mesh-ancestor
5547560|NCT04120415|Vedolizumab|vedolizumab|mesh-list
5547561|NCT04120415|Vaccines|vaccines|mesh-list
5547562|NCT04120415|Immunologic Factors|immunologic factors|mesh-ancestor
5547563|NCT04120415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547564|NCT04120415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5547565|NCT04120337|Lidocaine|lidocaine|mesh-list
5547566|NCT04120337|Anesthetics, Local|anesthetics, local|mesh-ancestor
5547567|NCT04120337|Anesthetics|anesthetics|mesh-ancestor
5547568|NCT04120337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5547569|NCT04120337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547570|NCT04120337|Sensory System Agents|sensory system agents|mesh-ancestor
5547571|NCT04120337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5547572|NCT04120337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5547573|NCT04120337|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6144012|NCT01340196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144013|NCT01340196|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6144014|NCT01340196|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6144015|NCT01340209|Tiotropium Bromide|tiotropium bromide|mesh-list
6144016|NCT01340209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6144017|NCT01340209|Autonomic Agents|autonomic agents|mesh-ancestor
6144018|NCT01340209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6144019|NCT01340209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144020|NCT01340209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6144021|NCT01340209|Respiratory System Agents|respiratory system agents|mesh-ancestor
6144022|NCT01340209|Parasympatholytics|parasympatholytics|mesh-ancestor
6144023|NCT01340209|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6144024|NCT01340209|Cholinergic Agents|cholinergic agents|mesh-ancestor
6144025|NCT01340209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6144026|NCT01340209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144027|NCT01340300|Metformin|metformin|mesh-list
6144028|NCT01340300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6144029|NCT01340300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144030|NCT01340586|Apixaban|apixaban|mesh-list
6144031|NCT01340586|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6144032|NCT01340586|Antithrombins|antithrombins|mesh-ancestor
6144033|NCT01340586|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6144034|NCT01340586|Protease Inhibitors|protease inhibitors|mesh-ancestor
6144035|NCT01340586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6144036|NCT01340586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144037|NCT01340586|Anticoagulants|anticoagulants|mesh-ancestor
6144038|NCT01340625|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6144039|NCT01340625|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6144040|NCT01340625|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6144041|NCT01340625|Norethindrone|norethindrone|mesh-list
6144042|NCT01340625|Norethindrone Acetate|norethindrone acetate|mesh-list
6144043|NCT01340625|Estradiol|estradiol|mesh-list
6144044|NCT01340625|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6144045|NCT01340625|Estrogens|estrogens|mesh-ancestor
5547574|NCT04120337|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5547575|NCT04120337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5547576|NCT04120337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547577|NCT04119921|Ketorolac|ketorolac|mesh-list
5547578|NCT04119921|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
5547579|NCT04119921|Lubricant Eye Drops|lubricant eye drops|mesh-list
5547580|NCT04119921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5547581|NCT04119921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5547582|NCT04119921|Analgesics|analgesics|mesh-ancestor
5547583|NCT04119921|Sensory System Agents|sensory system agents|mesh-ancestor
6144046|NCT01340625|Hormones|hormones|mesh-ancestor
6144047|NCT01340625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6144048|NCT01340625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473341|NCT00509613|Sorafenib|sorafenib|mesh-list
5547584|NCT04119921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5547585|NCT04119921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547586|NCT04119921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5547587|NCT04119921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5547588|NCT04119921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5547589|NCT04119921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5547590|NCT04119921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547591|NCT04119921|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5547592|NCT04119921|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5547593|NCT04120064|Cholecalciferol|cholecalciferol|mesh-list
5547594|NCT04120064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5547595|NCT04120064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547596|NCT04120064|Vitamins|vitamins|mesh-ancestor
5547597|NCT04120064|Micronutrients|micronutrients|mesh-ancestor
5547598|NCT04120064|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6144049|NCT01340625|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6144050|NCT01340625|Contraceptive Agents|contraceptive agents|mesh-ancestor
6144051|NCT01340625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6144052|NCT01340625|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6144053|NCT01340625|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6144054|NCT01340625|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5547599|NCT04119752|Curcumin|curcumin|mesh-list
5547600|NCT04119752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5547601|NCT04119752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5547602|NCT04119752|Analgesics|analgesics|mesh-ancestor
5547603|NCT04119752|Sensory System Agents|sensory system agents|mesh-ancestor
5547604|NCT04119752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5547605|NCT04119752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144055|NCT01340625|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6144056|NCT01340664|Metformin|metformin|mesh-list
6144057|NCT01340664|Canagliflozin|canagliflozin|mesh-list
6144058|NCT01340664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6144059|NCT01340664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144060|NCT01340664|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6144061|NCT01340664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144062|NCT01340768|Metformin|metformin|mesh-list
6144063|NCT01340768|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6144064|NCT01340768|Glimepiride|glimepiride|mesh-list
6144065|NCT01340768|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5547606|NCT04119752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5547607|NCT04119752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5547608|NCT04119752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5547609|NCT04119752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5547610|NCT04119752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547611|NCT04119622|Capecitabine|capecitabine|mesh-list
5547612|NCT04119622|Oxaliplatin|oxaliplatin|mesh-list
6144066|NCT01340768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144067|NCT01340768|Incretins|incretins|mesh-ancestor
6144068|NCT01340768|Hormones|hormones|mesh-ancestor
6144069|NCT01340768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6144070|NCT01340768|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6144071|NCT01340768|Protease Inhibitors|protease inhibitors|mesh-ancestor
6144072|NCT01340768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5547613|NCT04119622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5547614|NCT04119622|Antimetabolites|antimetabolites|mesh-ancestor
5547615|NCT04119622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547616|NCT04119622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5547617|NCT04119674|Temozolomide|temozolomide|mesh-list
5547618|NCT04119674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5547619|NCT04119674|Alkylating Agents|alkylating agents|mesh-ancestor
5547620|NCT04119674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547621|NCT04119674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5547622|NCT04119297|Heparinoids|heparinoids|mesh-list
5547623|NCT04119297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5547624|NCT04119297|Anticoagulants|anticoagulants|mesh-ancestor
5547625|NCT04119739|Ibuprofen|ibuprofen|mesh-list
5547626|NCT04119739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5547627|NCT04119739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5547628|NCT04119739|Analgesics|analgesics|mesh-ancestor
5547629|NCT04119739|Sensory System Agents|sensory system agents|mesh-ancestor
5547630|NCT04119739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5547631|NCT04119739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547632|NCT04119739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5547633|NCT04119739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5547634|NCT04119739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5547635|NCT04119739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5547636|NCT04119739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144073|NCT01340768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144074|NCT01340768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6144075|NCT01340768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6144076|NCT01340768|Immunologic Factors|immunologic factors|mesh-ancestor
6144077|NCT01340872|Ferric maltol|ferric maltol|mesh-list
6473342|NCT00509613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6473343|NCT00509613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6473344|NCT00509613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6473345|NCT00509613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473346|NCT00509613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6473347|NCT00509613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6473348|NCT00509613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6473349|NCT00509613|Antifungal Agents|antifungal agents|mesh-ancestor
6473350|NCT00509613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6473351|NCT00509613|Immunologic Factors|immunologic factors|mesh-ancestor
6473352|NCT00509613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473353|NCT00509639|Metronidazole|metronidazole|mesh-list
6473354|NCT00509639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6144078|NCT01340872|Hematinics|hematinics|mesh-ancestor
6144079|NCT01340937|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6144080|NCT01340937|Immunologic Factors|immunologic factors|mesh-ancestor
6144081|NCT01340937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473355|NCT00509639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6473356|NCT00509639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6144082|NCT01341301|Mycophenolic Acid|mycophenolic acid|mesh-list
6144083|NCT01341301|Cyclophosphamide|cyclophosphamide|mesh-list
6144084|NCT01341301|Tacrolimus|tacrolimus|mesh-list
6144085|NCT01341301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6144086|NCT01341301|Immunologic Factors|immunologic factors|mesh-ancestor
6144087|NCT01341301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144088|NCT01341301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6144089|NCT01341301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6144090|NCT01341301|Alkylating Agents|alkylating agents|mesh-ancestor
6144091|NCT01341301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473357|NCT00509639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6473358|NCT00509678|Rituximab|rituximab|mesh-list
6473359|NCT00509678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6473360|NCT00509678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6473361|NCT00509678|Immunologic Factors|immunologic factors|mesh-ancestor
6473362|NCT00509678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473363|NCT00509678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6488663|NCT00585559|Respiratory System Agents|respiratory system agents|mesh-ancestor
6488664|NCT00585559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6667154|NCT01526161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6667155|NCT01526161|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6667156|NCT01526161|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6667157|NCT01526174|Golimumab|golimumab|mesh-list
6667158|NCT01526174|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6488665|NCT00585559|Antioxidants|antioxidants|mesh-ancestor
6488666|NCT00585559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488667|NCT00585559|Protective Agents|protective agents|mesh-ancestor
6667159|NCT01526174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6667160|NCT01526174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5547637|NCT04119284|Terephthalic acid|terephthalic acid|mesh-list
5547638|NCT04119284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5547639|NCT04119284|Antioxidants|antioxidants|mesh-ancestor
5547640|NCT04119284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547641|NCT04119284|Protective Agents|protective agents|mesh-ancestor
6667161|NCT01526174|Immunologic Factors|immunologic factors|mesh-ancestor
6667162|NCT01526174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547642|NCT04119284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547643|NCT04119180|Midazolam|midazolam|mesh-list
5547644|NCT04119180|Ketamine|ketamine|mesh-list
5547645|NCT04119180|Analgesics|analgesics|mesh-ancestor
5547646|NCT04119180|Sensory System Agents|sensory system agents|mesh-ancestor
5547647|NCT04119180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5547648|NCT04119180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547649|NCT04119180|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6488668|NCT00585559|Antidotes|antidotes|mesh-ancestor
6488669|NCT00585741|Alovudine|alovudine|mesh-list
6488670|NCT00585741|Antiviral Agents|antiviral agents|mesh-ancestor
6144092|NCT01341301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6144093|NCT01341301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6144094|NCT01341301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6144095|NCT01341301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6144096|NCT01341301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6144097|NCT01341301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6144098|NCT01341301|Antitubercular Agents|antitubercular agents|mesh-ancestor
6144099|NCT01341301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5547650|NCT04119180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5547651|NCT04119180|Anesthetics, General|anesthetics, general|mesh-ancestor
5547652|NCT04119180|Anesthetics|anesthetics|mesh-ancestor
5547653|NCT04119180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5547654|NCT04119180|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5547655|NCT04119180|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6144100|NCT01341301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6144101|NCT01341457|Gemcitabine|gemcitabine|mesh-list
6144102|NCT01341457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6144103|NCT01341457|Antimetabolites|antimetabolites|mesh-ancestor
6144104|NCT01341457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144105|NCT01341457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6144106|NCT01341457|Antiviral Agents|antiviral agents|mesh-ancestor
6144107|NCT01341457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6144108|NCT01341457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6144109|NCT01341457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6144110|NCT01341457|Immunologic Factors|immunologic factors|mesh-ancestor
6144111|NCT01341457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144112|NCT01341639|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6144113|NCT01341639|Immunologic Factors|immunologic factors|mesh-ancestor
6144114|NCT01341639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144115|NCT01341652|Molgramostim|molgramostim|mesh-list
6144116|NCT01341652|Sargramostim|sargramostim|mesh-list
6144117|NCT01341652|Immunologic Factors|immunologic factors|mesh-ancestor
6144118|NCT01341652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144119|NCT01341652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6144120|NCT01341730|Pioglitazone|pioglitazone|mesh-list
6144121|NCT01341730|Atorvastatin|atorvastatin|mesh-list
6144122|NCT01341730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6144123|NCT01341730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6144124|NCT01341730|Antimetabolites|antimetabolites|mesh-ancestor
6144125|NCT01341730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144126|NCT01341730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6144127|NCT01341730|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6144128|NCT01341730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6144129|NCT01341730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6144130|NCT01341730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144131|NCT01341782|Ergocalciferols|ergocalciferols|mesh-list
6144132|NCT01341782|Calcitriol|calcitriol|mesh-list
6144133|NCT01341782|Maxacalcitol|maxacalcitol|mesh-list
6144134|NCT01341782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6144135|NCT01341782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144136|NCT01341782|Vitamins|vitamins|mesh-ancestor
6473364|NCT00509743|Diclofenac|diclofenac|mesh-list
6473365|NCT00509743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6473366|NCT00509743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6473367|NCT00509743|Analgesics|analgesics|mesh-ancestor
6473368|NCT00509743|Sensory System Agents|sensory system agents|mesh-ancestor
6473369|NCT00509743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6473370|NCT00509743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473371|NCT00509743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6473372|NCT00509743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6473373|NCT00509743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6473374|NCT00509743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6473375|NCT00509743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473376|NCT00509834|Lactoferrin|lactoferrin|mesh-list
6473377|NCT00509834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6473378|NCT00509847|Lactoferrin|lactoferrin|mesh-list
6473379|NCT00509847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6473380|NCT00509860|Irinotecan|irinotecan|mesh-list
6473381|NCT00509860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6473382|NCT00509860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6473383|NCT00509860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6473384|NCT00509860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473385|NCT00509860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6144137|NCT01341782|Micronutrients|micronutrients|mesh-ancestor
6144138|NCT01341782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5547656|NCT04119180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5547657|NCT04119180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547658|NCT04119180|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5547659|NCT04119180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5547660|NCT04119180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5547661|NCT04119180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5547662|NCT04119180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5547663|NCT04119180|GABA Modulators|gaba modulators|mesh-ancestor
5547664|NCT04119180|GABA Agents|gaba agents|mesh-ancestor
6144139|NCT01341782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6144140|NCT01341782|Dermatologic Agents|dermatologic agents|mesh-ancestor
6144141|NCT01341782|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6144142|NCT01341782|Protective Agents|protective agents|mesh-ancestor
6144143|NCT01341782|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6144144|NCT01341782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6144145|NCT01341782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144146|NCT01341782|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6144147|NCT01341977|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6144148|NCT01341990|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6144149|NCT01342029|Ranolazine|ranolazine|mesh-list
6144150|NCT01342029|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6144151|NCT01342029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6144152|NCT01342029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144153|NCT01342081|Timolol|timolol|mesh-list
6144154|NCT01342081|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6473386|NCT00509938|Lactoferrin|lactoferrin|mesh-list
6473387|NCT00509938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6473388|NCT00509964|Irinotecan|irinotecan|mesh-list
6473389|NCT00509964|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6473390|NCT00509964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6473391|NCT00509964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6473392|NCT00509964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725570|NCT03179904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5725571|NCT03179904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5725572|NCT03179904|Tubulin Modulators|tubulin modulators|mesh-ancestor
5725573|NCT03179904|Antimitotic Agents|antimitotic agents|mesh-ancestor
5725574|NCT03179904|Mitosis Modulators|mitosis modulators|mesh-ancestor
5725575|NCT03179904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725576|NCT03179904|Immunologic Factors|immunologic factors|mesh-ancestor
5725577|NCT03179904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725578|NCT03179904|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6473393|NCT00509964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6473394|NCT00509990|Pimecrolimus|pimecrolimus|mesh-list
6473395|NCT00509990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5725579|NCT03179904|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5547665|NCT04118920|Insulin|insulin|mesh-list
5547666|NCT04118920|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5547667|NCT04118920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5547668|NCT04118920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547669|NCT04119336|Dexamethasone|dexamethasone|mesh-list
5547670|NCT04119336|Cyclophosphamide|cyclophosphamide|mesh-list
5547671|NCT04119336|Nivolumab|nivolumab|mesh-list
5547672|NCT04119336|Ixazomib|ixazomib|mesh-list
5547673|NCT04119336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5547674|NCT04119336|Immunologic Factors|immunologic factors|mesh-ancestor
5547675|NCT04119336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547676|NCT04119336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5547677|NCT04119336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5547678|NCT04119336|Alkylating Agents|alkylating agents|mesh-ancestor
5547679|NCT04119336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725580|NCT03179904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5725581|NCT03179904|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5547680|NCT04119336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5547681|NCT04119336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5547682|NCT04119336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5547683|NCT04119336|Antiemetics|antiemetics|mesh-ancestor
5547684|NCT04119336|Autonomic Agents|autonomic agents|mesh-ancestor
5725582|NCT03179904|Hormone Antagonists|hormone antagonists|mesh-ancestor
5725713|NCT03178591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144155|NCT01342081|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6144156|NCT01342081|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6144157|NCT01342081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5547685|NCT04119336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5547686|NCT04119336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5547687|NCT04119336|Glucocorticoids|glucocorticoids|mesh-ancestor
5547688|NCT04119336|Hormones|hormones|mesh-ancestor
5547689|NCT04119336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5547690|NCT04119336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5547691|NCT04119336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5547692|NCT04119336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5547693|NCT04119336|Protease Inhibitors|protease inhibitors|mesh-ancestor
5547694|NCT04119336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5547695|NCT04119037|Morphine|morphine|mesh-list
5547696|NCT04119037|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5547697|NCT04119037|Narcotics|narcotics|mesh-ancestor
5547698|NCT04119037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5547699|NCT04119037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547700|NCT04119037|Analgesics|analgesics|mesh-ancestor
6144158|NCT01342081|Adrenergic Agents|adrenergic agents|mesh-ancestor
6144159|NCT01342081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6144160|NCT01342081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144161|NCT01342081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144162|NCT01342081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6144163|NCT01342081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6144164|NCT01342094|Timolol|timolol|mesh-list
6144165|NCT01342094|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6144166|NCT01342094|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6144167|NCT01342094|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6144168|NCT01342094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5547701|NCT04119037|Sensory System Agents|sensory system agents|mesh-ancestor
5547702|NCT04119037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5547703|NCT04118855|Axitinib|axitinib|mesh-list
5547704|NCT04118855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5547705|NCT04118855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5547706|NCT04118855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6144169|NCT01342094|Adrenergic Agents|adrenergic agents|mesh-ancestor
5547707|NCT04118855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144170|NCT01342094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6144171|NCT01342094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144172|NCT01342094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144173|NCT01342094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6144174|NCT01342094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6144175|NCT01342107|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6144176|NCT01342172|Lenalidomide|lenalidomide|mesh-list
6144177|NCT01342172|Immunologic Factors|immunologic factors|mesh-ancestor
6144178|NCT01342172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144179|NCT01342172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6144180|NCT01342172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6144181|NCT01342172|Growth Substances|growth substances|mesh-ancestor
6473396|NCT00509990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6473397|NCT00509990|Analgesics|analgesics|mesh-ancestor
6473398|NCT00509990|Sensory System Agents|sensory system agents|mesh-ancestor
6473399|NCT00509990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6473400|NCT00509990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473401|NCT00509990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6473402|NCT00509990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6473403|NCT00509990|Dermatologic Agents|dermatologic agents|mesh-ancestor
6473404|NCT00509990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6473405|NCT00509990|Immunologic Factors|immunologic factors|mesh-ancestor
6473406|NCT00509990|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6473407|NCT00509990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6473408|NCT00509990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473409|NCT00510003|Pimecrolimus|pimecrolimus|mesh-list
6473410|NCT00510003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6473411|NCT00510003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6473412|NCT00510003|Analgesics|analgesics|mesh-ancestor
6473413|NCT00510003|Sensory System Agents|sensory system agents|mesh-ancestor
6473414|NCT00510003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6473415|NCT00510003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473416|NCT00510003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6473417|NCT00510003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6473418|NCT00510003|Dermatologic Agents|dermatologic agents|mesh-ancestor
6473419|NCT00510003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6473420|NCT00510003|Immunologic Factors|immunologic factors|mesh-ancestor
6473421|NCT00510003|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5547708|NCT04118842|Rifampin|rifampin|mesh-list
5547709|NCT04118842|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5547710|NCT04118842|Antitubercular Agents|antitubercular agents|mesh-ancestor
5547711|NCT04118842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5547712|NCT04118842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5547713|NCT04118842|Leprostatic Agents|leprostatic agents|mesh-ancestor
5547714|NCT04118842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5547715|NCT04118842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5547716|NCT04118842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547717|NCT04118842|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6473422|NCT00510003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6473423|NCT00510003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473424|NCT00510016|Clonidine|clonidine|mesh-list
6473425|NCT00510016|Analgesics|analgesics|mesh-ancestor
6473426|NCT00510016|Sensory System Agents|sensory system agents|mesh-ancestor
6473427|NCT00510016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6473428|NCT00510016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473429|NCT00510016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6473430|NCT00510016|Sympatholytics|sympatholytics|mesh-ancestor
6473431|NCT00510016|Autonomic Agents|autonomic agents|mesh-ancestor
6473432|NCT00510016|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6473433|NCT00510016|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5547718|NCT04118842|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5547719|NCT04118842|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5547720|NCT04118842|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5547721|NCT04118842|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5547722|NCT04118842|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5547723|NCT04118868|Pembrolizumab|pembrolizumab|mesh-list
5547724|NCT04118868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6473434|NCT00510016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6473435|NCT00510016|Adrenergic Agents|adrenergic agents|mesh-ancestor
6473436|NCT00510016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6473437|NCT00510016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473438|NCT00510081|Calcium|calcium|mesh-list
6473439|NCT00510081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6473440|NCT00510081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473441|NCT00510107|Oxaliplatin|oxaliplatin|mesh-list
6473442|NCT00510107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6144182|NCT01342172|Growth Inhibitors|growth inhibitors|mesh-ancestor
6144183|NCT01342172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6144184|NCT01342211|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
6144185|NCT01342211|Bococizumab|bococizumab|mesh-list
6144186|NCT01342211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6144187|NCT01342211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6144188|NCT01342211|Antimetabolites|antimetabolites|mesh-ancestor
6144189|NCT01342211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144190|NCT01342211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6144191|NCT01342211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6144192|NCT01342341|Chlorzoxazone|chlorzoxazone|mesh-list
6144193|NCT01342341|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6144194|NCT01342341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144195|NCT01342341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6144196|NCT01342341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6144197|NCT01342367|Bicalutamide|bicalutamide|mesh-list
5547725|NCT04118868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5547726|NCT04118556|Sirolimus|sirolimus|mesh-list
5547727|NCT04118556|Etanercept|etanercept|mesh-list
5547728|NCT04118556|Everolimus|everolimus|mesh-list
5547729|NCT04118556|Infliximab|infliximab|mesh-list
5547730|NCT04118556|Vedolizumab|vedolizumab|mesh-list
5547731|NCT04118556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5547732|NCT04118556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5547733|NCT04118556|Immunologic Factors|immunologic factors|mesh-ancestor
5547734|NCT04118556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547735|NCT04118556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5547736|NCT04118556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5547737|NCT04118556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5547738|NCT04118556|Antifungal Agents|antifungal agents|mesh-ancestor
6144198|NCT01342367|Finasteride|finasteride|mesh-list
6144199|NCT01342367|Dutasteride|dutasteride|mesh-list
6144200|NCT01342367|Androgen Antagonists|androgen antagonists|mesh-ancestor
6144201|NCT01342367|Hormone Antagonists|hormone antagonists|mesh-ancestor
6144202|NCT01342367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6144203|NCT01342367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144204|NCT01342367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6144205|NCT01342367|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6144206|NCT01342367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6144207|NCT01342367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6144208|NCT01342367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144209|NCT01342367|Urological Agents|urological agents|mesh-ancestor
6144210|NCT01342445|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6144211|NCT01342445|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6144212|NCT01342445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144213|NCT01342445|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6144214|NCT01342445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6144215|NCT01342445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6144216|NCT01342445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144217|NCT01342445|Dopamine Agents|dopamine agents|mesh-ancestor
6144218|NCT01342445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6144219|NCT01342484|Linagliptin|linagliptin|mesh-list
6144220|NCT01342484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6144221|NCT01342484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144222|NCT01342484|Incretins|incretins|mesh-ancestor
6144223|NCT01342484|Hormones|hormones|mesh-ancestor
6144224|NCT01342484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6144225|NCT01342484|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6144226|NCT01342484|Protease Inhibitors|protease inhibitors|mesh-ancestor
6144227|NCT01342484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6144228|NCT01342484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547739|NCT04118556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5547740|NCT04118556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5547741|NCT04118556|Analgesics|analgesics|mesh-ancestor
5547742|NCT04118556|Sensory System Agents|sensory system agents|mesh-ancestor
5547743|NCT04118556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5547744|NCT04118556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5547745|NCT04118556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6473443|NCT00510159|Artesunate|artesunate|mesh-list
6473444|NCT00510159|Sulfalene|sulfalene|mesh-list
5547746|NCT04118556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5547747|NCT04118556|Dermatologic Agents|dermatologic agents|mesh-ancestor
6144229|NCT01342510|Lidocaine|lidocaine|mesh-list
6144230|NCT01342510|Magnesium Sulfate|magnesium sulfate|mesh-list
6144231|NCT01342510|Anesthetics, Local|anesthetics, local|mesh-ancestor
6144232|NCT01342510|Anesthetics|anesthetics|mesh-ancestor
6144233|NCT01342510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6144234|NCT01342510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144235|NCT01342510|Sensory System Agents|sensory system agents|mesh-ancestor
6144236|NCT01342510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6473445|NCT00510159|Praziquantel|praziquantel|mesh-list
6473446|NCT00510159|Antimalarials|antimalarials|mesh-ancestor
6473447|NCT00510159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6473448|NCT00510159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6473449|NCT00510159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6473450|NCT00510159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6473451|NCT00510159|Antiviral Agents|antiviral agents|mesh-ancestor
6473452|NCT00510159|Schistosomicides|schistosomicides|mesh-ancestor
6473453|NCT00510159|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6473454|NCT00510159|Anthelmintics|anthelmintics|mesh-ancestor
6473455|NCT00510159|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6473456|NCT00510159|Renal Agents|renal agents|mesh-ancestor
6473457|NCT00510172|Epoprostenol|epoprostenol|mesh-list
6473458|NCT00510172|Tezosentan|tezosentan|mesh-list
6473459|NCT00510172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6473460|NCT00510172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6473461|NCT00510172|Vasodilator Agents|vasodilator agents|mesh-ancestor
5547748|NCT04118699|Rifaximin|rifaximin|mesh-list
5547749|NCT04118699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5547750|NCT04118699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5547751|NCT04118699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5547752|NCT04118777|Ropivacaine|ropivacaine|mesh-list
5547753|NCT04118777|Anesthetics, Local|anesthetics, local|mesh-ancestor
5547754|NCT04118777|Anesthetics|anesthetics|mesh-ancestor
6473462|NCT00510211|Olanzapine|olanzapine|mesh-list
6473463|NCT00510211|Antiemetics|antiemetics|mesh-ancestor
6473464|NCT00510211|Autonomic Agents|autonomic agents|mesh-ancestor
6473465|NCT00510211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6473466|NCT00510211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473467|NCT00510211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6473468|NCT00510211|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6473469|NCT00510211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5547755|NCT04118777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5547756|NCT04118777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547757|NCT04118777|Sensory System Agents|sensory system agents|mesh-ancestor
5547758|NCT04118777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5547759|NCT04118153|Abatacept|abatacept|mesh-list
5547760|NCT04118153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5547761|NCT04118153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547762|NCT04118153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5547763|NCT04118153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5547764|NCT04118153|Immunologic Factors|immunologic factors|mesh-ancestor
5547765|NCT04118153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547766|NCT04118153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5547767|NCT04118010|Vitamin D|vitamin d|mesh-list
5547768|NCT04118010|Ergocalciferols|ergocalciferols|mesh-list
5547769|NCT04118010|Cholecalciferol|cholecalciferol|mesh-list
5547770|NCT04118010|Vitamins|vitamins|mesh-list
6473470|NCT00510211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6473471|NCT00510211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6473472|NCT00510211|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5547771|NCT04118010|Micronutrients|micronutrients|mesh-ancestor
6144237|NCT01342510|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6144238|NCT01342510|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5547772|NCT04118010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547773|NCT04118010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5547774|NCT04118010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5547775|NCT04117932|Ustekinumab|ustekinumab|mesh-list
5547776|NCT04117932|Dermatologic Agents|dermatologic agents|mesh-ancestor
5547777|NCT04117919|Triamcinolone|triamcinolone|mesh-list
5547778|NCT04117919|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5547779|NCT04117919|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5547780|NCT04117919|Hydrocortisone|hydrocortisone|mesh-list
5547781|NCT04117919|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
5547782|NCT04117919|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
5547783|NCT04117919|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
5547784|NCT04117919|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5547785|NCT04117919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6144239|NCT01342510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6667163|NCT01526278|Alendronate|alendronate|mesh-list
5547786|NCT04117919|Glucocorticoids|glucocorticoids|mesh-ancestor
5547787|NCT04117919|Hormones|hormones|mesh-ancestor
5547788|NCT04117919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5547789|NCT04117919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547790|NCT04117919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5547791|NCT04117919|Immunologic Factors|immunologic factors|mesh-ancestor
5547792|NCT04117919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5547793|NCT04117919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547794|NCT04117893|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6144240|NCT01342510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6144241|NCT01342510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144242|NCT01342510|Analgesics|analgesics|mesh-ancestor
6144243|NCT01342510|Anticonvulsants|anticonvulsants|mesh-ancestor
6144244|NCT01342510|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6144245|NCT01342510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6144246|NCT01342510|Tocolytic Agents|tocolytic agents|mesh-ancestor
6667164|NCT01526278|Calcitriol|calcitriol|mesh-list
5547795|NCT04117893|Hyaluronic Acid|hyaluronic acid|mesh-list
6144247|NCT01342510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6144248|NCT01342523|Nicotine|nicotine|mesh-list
6144249|NCT01342523|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6473473|NCT00510211|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6473474|NCT00510211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6473475|NCT00510211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473476|NCT00510211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6473477|NCT00510211|Serotonin Agents|serotonin agents|mesh-ancestor
6473478|NCT00510250|Sorafenib|sorafenib|mesh-list
6473479|NCT00510250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6473480|NCT00510250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6473481|NCT00510250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6473482|NCT00510250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473483|NCT00510263|Valacyclovir|valacyclovir|mesh-list
6473484|NCT00510263|Prednisolone|prednisolone|mesh-list
6473485|NCT00510263|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6473486|NCT00510263|Methylprednisolone|methylprednisolone|mesh-list
6473487|NCT00510263|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6473488|NCT00510263|Prednisolone acetate|prednisolone acetate|mesh-list
6473489|NCT00510263|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6667165|NCT01526278|Maxmarvil|maxmarvil|mesh-list
6144250|NCT01342523|Autonomic Agents|autonomic agents|mesh-ancestor
6144251|NCT01342523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6144252|NCT01342523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144253|NCT01342523|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6144254|NCT01342523|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6144255|NCT01342523|Cholinergic Agents|cholinergic agents|mesh-ancestor
6144256|NCT01342523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6144257|NCT01342523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144258|NCT01342549|Naltrexone|naltrexone|mesh-list
6144259|NCT01342549|Valproic Acid|valproic acid|mesh-list
6144260|NCT01342549|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6144261|NCT01342549|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6144262|NCT01342549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547796|NCT04117893|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5547797|NCT04117893|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5547798|NCT04117893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5547799|NCT04117893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547800|NCT04117893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5547801|NCT04117893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547802|NCT04117893|Analgesics|analgesics|mesh-ancestor
5547803|NCT04117893|Sensory System Agents|sensory system agents|mesh-ancestor
5547804|NCT04117893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5547805|NCT04117893|Antidepressive Agents|antidepressive agents|mesh-ancestor
5547806|NCT04117893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5547807|NCT04117893|Dopamine Agents|dopamine agents|mesh-ancestor
6144263|NCT01342549|Sensory System Agents|sensory system agents|mesh-ancestor
6144264|NCT01342549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6144265|NCT01342549|Anticonvulsants|anticonvulsants|mesh-ancestor
6144266|NCT01342549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6144267|NCT01342549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144268|NCT01342549|GABA Agents|gaba agents|mesh-ancestor
6144269|NCT01342549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6144270|NCT01342549|Antimanic Agents|antimanic agents|mesh-ancestor
6144271|NCT01342549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6667166|NCT01526278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5547808|NCT04117893|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5547809|NCT04117893|Immunologic Factors|immunologic factors|mesh-ancestor
5547810|NCT04117893|Viscosupplements|viscosupplements|mesh-ancestor
6144272|NCT01342549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6144273|NCT01342549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6144274|NCT01342640|Epoetin Alfa|epoetin alfa|mesh-list
6144275|NCT01342640|Hematinics|hematinics|mesh-ancestor
6144276|NCT01342757|Temozolomide|temozolomide|mesh-list
6144277|NCT01342757|Vorinostat|vorinostat|mesh-list
6144278|NCT01342757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6144279|NCT01342757|Alkylating Agents|alkylating agents|mesh-ancestor
6144280|NCT01342757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144281|NCT01342757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6144282|NCT01342757|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6144283|NCT01342757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6144284|NCT01342770|Pioglitazone|pioglitazone|mesh-list
6144285|NCT01342770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6144286|NCT01342770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144287|NCT01342796|Vaccines|vaccines|mesh-list
6144288|NCT01342796|Immunologic Factors|immunologic factors|mesh-ancestor
6144289|NCT01342796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144290|NCT01342887|Cyclosporine|cyclosporine|mesh-list
6144291|NCT01342887|Etoposide|etoposide|mesh-list
6144292|NCT01342887|Mitoxantrone|mitoxantrone|mesh-list
6144293|NCT01342887|Etoposide phosphate|etoposide phosphate|mesh-list
6144294|NCT01342887|Pravastatin|pravastatin|mesh-list
6144295|NCT01342887|Cyclosporins|cyclosporins|mesh-list
6144296|NCT01342887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6144297|NCT01342887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6144298|NCT01342887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5547811|NCT04117893|Protective Agents|protective agents|mesh-ancestor
5547812|NCT04117776|Chlorhexidine|chlorhexidine|mesh-list
5547813|NCT04117776|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5547814|NCT04117776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5547815|NCT04117776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5547816|NCT04117776|Disinfectants|disinfectants|mesh-ancestor
5547817|NCT04117776|Dermatologic Agents|dermatologic agents|mesh-ancestor
5547818|NCT04117672|Antisecretory factor|antisecretory factor|mesh-list
5547819|NCT04117672|Antidiarrheals|antidiarrheals|mesh-ancestor
5547820|NCT04117672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6144299|NCT01342887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6144300|NCT01342887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6144301|NCT01342887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144302|NCT01342887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6144303|NCT01342887|Immunologic Factors|immunologic factors|mesh-ancestor
6144304|NCT01342887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144305|NCT01342887|Antifungal Agents|antifungal agents|mesh-ancestor
6144306|NCT01342887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6144307|NCT01342887|Dermatologic Agents|dermatologic agents|mesh-ancestor
6144308|NCT01342887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6144309|NCT01342887|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6144310|NCT01342887|Analgesics|analgesics|mesh-ancestor
6144311|NCT01342887|Sensory System Agents|sensory system agents|mesh-ancestor
6144312|NCT01342887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6144313|NCT01342887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6144314|NCT01342887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6144315|NCT01342887|Antimetabolites|antimetabolites|mesh-ancestor
6144316|NCT01342887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6144317|NCT01342887|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6144318|NCT01342913|Fluticasone|fluticasone|mesh-list
6144319|NCT01342913|Xhance|xhance|mesh-list
6144320|NCT01342913|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6144321|NCT01342913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6473490|NCT00510263|Prednisolone phosphate|prednisolone phosphate|mesh-list
6473491|NCT00510263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6473492|NCT00510263|Glucocorticoids|glucocorticoids|mesh-ancestor
6473493|NCT00510263|Hormones|hormones|mesh-ancestor
5547821|NCT04117750|Cholecalciferol|cholecalciferol|mesh-list
5547822|NCT04117750|Calcium Carbonate|calcium carbonate|mesh-list
5547823|NCT04117750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5547824|NCT04117750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547825|NCT04117750|Vitamins|vitamins|mesh-ancestor
5547826|NCT04117750|Micronutrients|micronutrients|mesh-ancestor
5547827|NCT04117750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6473494|NCT00510263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6144322|NCT01342913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6144323|NCT01342913|Autonomic Agents|autonomic agents|mesh-ancestor
6144324|NCT01342913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6473495|NCT00510263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473496|NCT00510263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5547828|NCT04117750|Antacids|antacids|mesh-ancestor
5547829|NCT04117750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547830|NCT04117750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5547831|NCT04117698|Ethambutol|ethambutol|mesh-list
5547832|NCT04117698|Antitubercular Agents|antitubercular agents|mesh-ancestor
5547833|NCT04117698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5547834|NCT04117698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5547835|NCT04118322|Peppermint oil|peppermint oil|mesh-list
5547836|NCT04118322|Antiemetics|antiemetics|mesh-ancestor
5547837|NCT04118322|Autonomic Agents|autonomic agents|mesh-ancestor
5547838|NCT04118322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5547839|NCT04118322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547840|NCT04118322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5547841|NCT04118322|Parasympatholytics|parasympatholytics|mesh-ancestor
5547842|NCT04117659|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
5547843|NCT04117659|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5547844|NCT04117659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5547845|NCT04117659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547846|NCT04117451|Propolis|propolis|mesh-list
5547847|NCT04117451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5547848|NCT04117139|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5547849|NCT04117139|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5547850|NCT04117139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547851|NCT04117178|Memantine|memantine|mesh-list
6473497|NCT00510263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6473498|NCT00510263|Antiemetics|antiemetics|mesh-ancestor
6473499|NCT00510263|Autonomic Agents|autonomic agents|mesh-ancestor
6473500|NCT00510263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6473501|NCT00510263|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6473502|NCT00510263|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6473503|NCT00510263|Protective Agents|protective agents|mesh-ancestor
6473504|NCT00510263|Antiviral Agents|antiviral agents|mesh-ancestor
6473505|NCT00510263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6473506|NCT00510354|Imatinib Mesylate|imatinib mesylate|mesh-list
6473507|NCT00510354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6473508|NCT00510354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6473509|NCT00510354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6473510|NCT00510354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473511|NCT00510367|Cyclophosphamide|cyclophosphamide|mesh-list
6473512|NCT00510367|Doxorubicin|doxorubicin|mesh-list
6473513|NCT00510367|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6473514|NCT00510367|Fluorouracil|fluorouracil|mesh-list
6473515|NCT00510367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5547852|NCT04117178|Donepezil|donepezil|mesh-list
5547853|NCT04117178|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5547854|NCT04117178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5547855|NCT04117178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547856|NCT04117178|Cholinergic Agents|cholinergic agents|mesh-ancestor
5547857|NCT04117178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5547858|NCT04117178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547859|NCT04117178|Nootropic Agents|nootropic agents|mesh-ancestor
5547860|NCT04117178|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5547861|NCT04117178|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5547862|NCT04117178|Dopamine Agents|dopamine agents|mesh-ancestor
5547863|NCT04117178|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5547864|NCT04117178|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5547865|NCT04117009|Remifentanil|remifentanil|mesh-list
5547866|NCT04117009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5547867|NCT04117009|Narcotics|narcotics|mesh-ancestor
6144325|NCT01342913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144326|NCT01342913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6144327|NCT01342913|Respiratory System Agents|respiratory system agents|mesh-ancestor
6144328|NCT01342913|Dermatologic Agents|dermatologic agents|mesh-ancestor
6144329|NCT01342913|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6144330|NCT01342913|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6144331|NCT01342913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6144332|NCT01342913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6144333|NCT01342913|Adrenergic Agents|adrenergic agents|mesh-ancestor
6144334|NCT01342913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6144335|NCT01342913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473516|NCT00510367|Immunologic Factors|immunologic factors|mesh-ancestor
5547868|NCT04117009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5547869|NCT04117009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144336|NCT01342965|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6144337|NCT01342965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6144338|NCT01342965|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6144339|NCT01342965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6144340|NCT01342965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144341|NCT01343004|Teriparatide|teriparatide|mesh-list
6144342|NCT01343004|Abaloparatide|abaloparatide|mesh-list
6144343|NCT01343004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6144344|NCT01343004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547870|NCT04117009|Analgesics|analgesics|mesh-ancestor
5547871|NCT04117009|Sensory System Agents|sensory system agents|mesh-ancestor
5547872|NCT04117009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5547873|NCT04117243|Misoprostol|misoprostol|mesh-list
5547874|NCT04117243|Tranexamic Acid|tranexamic acid|mesh-list
5547875|NCT04117243|Oxytocin|oxytocin|mesh-list
5547876|NCT04117243|Oxytocics|oxytocics|mesh-ancestor
6144345|NCT01343004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6144346|NCT01343043|Cyclophosphamide|cyclophosphamide|mesh-list
6144347|NCT01343043|Fludarabine|fludarabine|mesh-list
6144348|NCT01343043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6144349|NCT01343043|Immunologic Factors|immunologic factors|mesh-ancestor
6144350|NCT01343043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144351|NCT01343043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6144352|NCT01343043|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6144353|NCT01343043|Alkylating Agents|alkylating agents|mesh-ancestor
6144354|NCT01343043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144355|NCT01343043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6144356|NCT01343043|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6144357|NCT01343082|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6144358|NCT01343082|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6144359|NCT01343277|Dacarbazine|dacarbazine|mesh-list
6144360|NCT01343277|Trabectedin|trabectedin|mesh-list
6144361|NCT01343277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6144362|NCT01343277|Alkylating Agents|alkylating agents|mesh-ancestor
6144363|NCT01343277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144364|NCT01343277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6473517|NCT00510367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473518|NCT00510367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6473519|NCT00510367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6473520|NCT00510367|Alkylating Agents|alkylating agents|mesh-ancestor
6473521|NCT00510367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473522|NCT00510367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6473523|NCT00510367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6473524|NCT00510367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6473525|NCT00510367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6473526|NCT00510367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6473527|NCT00510367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6473528|NCT00510367|Antimetabolites|antimetabolites|mesh-ancestor
6473529|NCT00510367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6473530|NCT00510393|Everolimus|everolimus|mesh-list
6473531|NCT00510393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6473532|NCT00510393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6473533|NCT00510393|Immunologic Factors|immunologic factors|mesh-ancestor
6473534|NCT00510393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473535|NCT00510406|Tamsulosin|tamsulosin|mesh-list
6473536|NCT00510406|Solifenacin Succinate|solifenacin succinate|mesh-list
6473537|NCT00510406|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6144365|NCT01343368|Leuprolide|leuprolide|mesh-list
6144366|NCT01343368|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6144367|NCT01343368|Fertility Agents|fertility agents|mesh-ancestor
6144368|NCT01343368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6144369|NCT01343368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473538|NCT00510406|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6473539|NCT00510406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6473540|NCT00510406|Adrenergic Agents|adrenergic agents|mesh-ancestor
6473541|NCT00510406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6473542|NCT00510406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473543|NCT00510406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473544|NCT00510406|Urological Agents|urological agents|mesh-ancestor
6473545|NCT00510406|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6473546|NCT00510406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6473547|NCT00510406|Cholinergic Agents|cholinergic agents|mesh-ancestor
5547877|NCT04117243|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5547878|NCT04117243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473548|NCT00510419|Sumatriptan|sumatriptan|mesh-list
6473549|NCT00510419|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6473550|NCT00510419|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6473551|NCT00510419|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5547879|NCT04117243|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5547880|NCT04117243|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5547881|NCT04117243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547882|NCT04117243|Hemostatics|hemostatics|mesh-ancestor
5547883|NCT04117243|Coagulants|coagulants|mesh-ancestor
5547884|NCT04117243|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5547885|NCT04117243|Abortifacient Agents|abortifacient agents|mesh-ancestor
6473552|NCT00510419|Serotonin Agents|serotonin agents|mesh-ancestor
6473553|NCT00510419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6473554|NCT00510419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473555|NCT00510419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473556|NCT00510445|Imetelstat|imetelstat|mesh-list
6473557|NCT00510445|Motesanib diphosphate|motesanib diphosphate|mesh-list
6473558|NCT00510445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6473559|NCT00510445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144370|NCT01343368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6144371|NCT01343368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6144372|NCT01343823|Ecallantide|ecallantide|mesh-list
6144373|NCT01343823|Analgesics|analgesics|mesh-ancestor
6144374|NCT01343823|Sensory System Agents|sensory system agents|mesh-ancestor
5547886|NCT04117243|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5547887|NCT04117243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5547888|NCT04117074|Bupivacaine|bupivacaine|mesh-list
5547889|NCT04117074|Anesthetics, Local|anesthetics, local|mesh-ancestor
5547890|NCT04117074|Anesthetics|anesthetics|mesh-ancestor
5547891|NCT04117074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5547892|NCT04117074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547893|NCT04117074|Sensory System Agents|sensory system agents|mesh-ancestor
6144375|NCT01343823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6144376|NCT01343823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144377|NCT01343823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6144378|NCT01343823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6144379|NCT01343823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6144380|NCT01343823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6144381|NCT01343901|Bevacizumab|bevacizumab|mesh-list
6144382|NCT01343901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6144383|NCT01343901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6144384|NCT01343901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6144385|NCT01343901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6144386|NCT01343901|Growth Substances|growth substances|mesh-ancestor
6144387|NCT01343901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144388|NCT01343901|Growth Inhibitors|growth inhibitors|mesh-ancestor
6144389|NCT01344161|Vitamin D|vitamin d|mesh-list
6144390|NCT01344161|Cholecalciferol|cholecalciferol|mesh-list
6144391|NCT01344161|Vitamins|vitamins|mesh-ancestor
6144392|NCT01344161|Micronutrients|micronutrients|mesh-ancestor
6144393|NCT01344161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144394|NCT01344161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6144395|NCT01344161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6144396|NCT01344226|Loteprednol Etabonate|loteprednol etabonate|mesh-list
6144397|NCT01344226|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6144398|NCT01344226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6144399|NCT01344226|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6144400|NCT01344369|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6473560|NCT00510445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5547894|NCT04117074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5547895|NCT04117191|Tryptophan|tryptophan|mesh-list
5547896|NCT04117191|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5547897|NCT04117191|Antidepressive Agents|antidepressive agents|mesh-ancestor
5547898|NCT04117191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5547899|NCT04117087|Nivolumab|nivolumab|mesh-list
5547900|NCT04117087|Ipilimumab|ipilimumab|mesh-list
5547901|NCT04117087|Poly ICLC|poly iclc|mesh-list
5547902|NCT04117087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5547903|NCT04117087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5547904|NCT04117087|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5547905|NCT04117087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547906|NCT04117087|Interferon Inducers|interferon inducers|mesh-ancestor
5547907|NCT04117087|Immunologic Factors|immunologic factors|mesh-ancestor
5547908|NCT04117087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547909|NCT04116775|Pembrolizumab|pembrolizumab|mesh-list
5547910|NCT04116775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5547911|NCT04116775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5602727|NCT04234906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5602728|NCT04234906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602729|NCT04234906|Anesthetics|anesthetics|mesh-ancestor
5602730|NCT04234906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5602731|NCT04234906|Anticonvulsants|anticonvulsants|mesh-ancestor
5602732|NCT04234906|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5602733|NCT04234906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6473561|NCT00510471|Immunoglobulins|immunoglobulins|mesh-list
6473562|NCT00510471|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6473563|NCT00510471|Antibodies|antibodies|mesh-list
6473564|NCT00510471|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
6473565|NCT00510471|Immunologic Factors|immunologic factors|mesh-ancestor
6473566|NCT00510471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473567|NCT00510536|Acetaminophen|acetaminophen|mesh-list
6473568|NCT00510536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6473569|NCT00510536|Analgesics|analgesics|mesh-ancestor
6144401|NCT01344369|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6144402|NCT01344369|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6144403|NCT01344369|Norethindrone|norethindrone|mesh-list
6144404|NCT01344369|Norethindrone Acetate|norethindrone acetate|mesh-list
6144405|NCT01344369|Estradiol|estradiol|mesh-list
6144406|NCT01344369|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6144407|NCT01344369|Estrogens|estrogens|mesh-ancestor
6144408|NCT01344369|Hormones|hormones|mesh-ancestor
6667167|NCT01526278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602734|NCT04234906|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5602735|NCT04234906|Tocolytic Agents|tocolytic agents|mesh-ancestor
5602736|NCT04234906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5602737|NCT04234906|Vasodilator Agents|vasodilator agents|mesh-ancestor
5602738|NCT04234906|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5602739|NCT04234906|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5602740|NCT04234906|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5602741|NCT04234906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5602742|NCT04234906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5602743|NCT04234906|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5602744|NCT04234906|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5602745|NCT04234906|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5602746|NCT04234906|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6667168|NCT01526278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6667169|NCT01526278|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6667170|NCT01526278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6667171|NCT01526278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667172|NCT01526278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6667173|NCT01526278|Vitamins|vitamins|mesh-ancestor
6667174|NCT01526278|Micronutrients|micronutrients|mesh-ancestor
6667175|NCT01526317|Metformin|metformin|mesh-list
6667176|NCT01526317|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6667177|NCT01526317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6667178|NCT01526317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667179|NCT01526317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6667180|NCT01526317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6667181|NCT01526317|Antimetabolites|antimetabolites|mesh-ancestor
6667182|NCT01526317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667183|NCT01526317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6473570|NCT00510536|Sensory System Agents|sensory system agents|mesh-ancestor
6473571|NCT00510536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5602747|NCT04209543|Progesterone|progesterone|mesh-list
6144409|NCT01344369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6473572|NCT00510536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473573|NCT00510536|Antipyretics|antipyretics|mesh-ancestor
6144410|NCT01344369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144411|NCT01344369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6144412|NCT01344369|Contraceptive Agents|contraceptive agents|mesh-ancestor
6144413|NCT01344369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6144414|NCT01344369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6144415|NCT01344369|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6144416|NCT01344369|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6144417|NCT01344369|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6144418|NCT01344629|Telmisartan|telmisartan|mesh-list
6144419|NCT01344629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6473574|NCT00510588|Metformin|metformin|mesh-list
6473575|NCT00510588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6473576|NCT00510588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473577|NCT00510614|Tinidazole|tinidazole|mesh-list
6473578|NCT00510614|Alkylating Agents|alkylating agents|mesh-ancestor
6473579|NCT00510614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473580|NCT00510614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6473581|NCT00510614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6144420|NCT01344629|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6144421|NCT01344629|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6144422|NCT01344629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144423|NCT01344759|Dexmedetomidine|dexmedetomidine|mesh-list
6144424|NCT01344759|Propofol|propofol|mesh-list
6144425|NCT01344759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6144426|NCT01344759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6144427|NCT01344759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144428|NCT01344759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6144429|NCT01344759|Anesthetics, General|anesthetics, general|mesh-ancestor
6144430|NCT01344759|Anesthetics|anesthetics|mesh-ancestor
6144431|NCT01344759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6144432|NCT01344759|Analgesics|analgesics|mesh-ancestor
6144433|NCT01344759|Sensory System Agents|sensory system agents|mesh-ancestor
6144434|NCT01344759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6144435|NCT01344759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6144436|NCT01344759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6473582|NCT00510614|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
6473583|NCT00510614|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6473584|NCT00510614|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6473585|NCT00510627|Oxaliplatin|oxaliplatin|mesh-list
6473586|NCT00510627|Irinotecan|irinotecan|mesh-list
6473587|NCT00510627|Cetuximab|cetuximab|mesh-list
6667184|NCT01526317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6667185|NCT01526317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6667186|NCT01526369|Paclitaxel|paclitaxel|mesh-list
6667187|NCT01526369|Trastuzumab|trastuzumab|mesh-list
6144437|NCT01344759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6144438|NCT01344759|Adrenergic Agents|adrenergic agents|mesh-ancestor
6144439|NCT01344759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6144440|NCT01344759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473588|NCT00510627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6473589|NCT00510627|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6473590|NCT00510627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6473591|NCT00510627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6473592|NCT00510627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473593|NCT00510627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6473594|NCT00510640|Sunitinib|sunitinib|mesh-list
6473595|NCT00510640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6473596|NCT00510640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6473597|NCT00510640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6473598|NCT00510640|Growth Substances|growth substances|mesh-ancestor
6473599|NCT00510640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473600|NCT00510640|Growth Inhibitors|growth inhibitors|mesh-ancestor
6473601|NCT00510640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6473602|NCT00510640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6473603|NCT00510640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473604|NCT00510666|Tramadol|tramadol|mesh-list
6473605|NCT00510666|Butorphanol|butorphanol|mesh-list
6473606|NCT00510666|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6144441|NCT01344824|Bevacizumab|bevacizumab|mesh-list
6144442|NCT01344824|Carboplatin|carboplatin|mesh-list
6144443|NCT01344824|Pemetrexed|pemetrexed|mesh-list
6473607|NCT00510666|Narcotics|narcotics|mesh-ancestor
6473608|NCT00510666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6667188|NCT01526369|Lapatinib|lapatinib|mesh-list
5547912|NCT04116931|Clopidogrel|clopidogrel|mesh-list
5547913|NCT04116931|Ticagrelor|ticagrelor|mesh-list
5547914|NCT04116931|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5547915|NCT04116931|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5547916|NCT04116931|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5547917|NCT04116931|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5547918|NCT04116931|Purinergic Agents|purinergic agents|mesh-ancestor
5547919|NCT04116931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5547920|NCT04116931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547921|NCT04116931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547922|NCT04116554|Bupivacaine|bupivacaine|mesh-list
5547923|NCT04116554|Anesthetics, Local|anesthetics, local|mesh-ancestor
5547924|NCT04116554|Anesthetics|anesthetics|mesh-ancestor
5547925|NCT04116554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5547926|NCT04116554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547927|NCT04116554|Sensory System Agents|sensory system agents|mesh-ancestor
5547928|NCT04116554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5547929|NCT04116437|Zanubrutinib|zanubrutinib|mesh-list
5547930|NCT04116437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6144444|NCT01344824|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6144445|NCT01344824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6144446|NCT01344824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6144447|NCT01344824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6144448|NCT01344824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6144449|NCT01344824|Growth Substances|growth substances|mesh-ancestor
6144450|NCT01344824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144451|NCT01344824|Growth Inhibitors|growth inhibitors|mesh-ancestor
6144452|NCT01344824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6144453|NCT01344824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144454|NCT01344824|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6473609|NCT00510666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473610|NCT00510666|Analgesics|analgesics|mesh-ancestor
6473611|NCT00510666|Sensory System Agents|sensory system agents|mesh-ancestor
6473612|NCT00510666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6473613|NCT00510666|Antitussive Agents|antitussive agents|mesh-ancestor
6667189|NCT01526369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6144455|NCT01344824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6144456|NCT01344824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6144457|NCT01345019|Zoledronic Acid|zoledronic acid|mesh-list
6144458|NCT01345019|Denosumab|denosumab|mesh-list
6144459|NCT01345019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6144460|NCT01345019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144461|NCT01345058|Lacosamide|lacosamide|mesh-list
6144462|NCT01345058|Levetiracetam|levetiracetam|mesh-list
6144463|NCT01345058|Anticonvulsants|anticonvulsants|mesh-ancestor
6144464|NCT01345058|Nootropic Agents|nootropic agents|mesh-ancestor
6144465|NCT01345058|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6144466|NCT01345058|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5547931|NCT04116437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5547932|NCT04116437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5547933|NCT04116437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547934|NCT04116398|Dexamethasone|dexamethasone|mesh-list
5547935|NCT04116398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5547936|NCT04116398|Antiemetics|antiemetics|mesh-ancestor
5547937|NCT04116398|Autonomic Agents|autonomic agents|mesh-ancestor
5547938|NCT04116398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5547939|NCT04116398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547940|NCT04116398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5547941|NCT04116398|Glucocorticoids|glucocorticoids|mesh-ancestor
5547942|NCT04116398|Hormones|hormones|mesh-ancestor
5547943|NCT04116398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5547944|NCT04116398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5547945|NCT04116398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5547946|NCT04116528|Ketamine|ketamine|mesh-list
5547947|NCT04116528|Buprenorphine|buprenorphine|mesh-list
5547948|NCT04116528|Analgesics|analgesics|mesh-ancestor
5602748|NCT04209543|Progestins|progestins|mesh-ancestor
6144467|NCT01345058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6144468|NCT01345058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473614|NCT00510666|Respiratory System Agents|respiratory system agents|mesh-ancestor
6473615|NCT00510666|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6473616|NCT00510705|Metformin|metformin|mesh-list
6473617|NCT00510705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6473618|NCT00510705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547949|NCT04116528|Sensory System Agents|sensory system agents|mesh-ancestor
5547950|NCT04116528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5547951|NCT04116528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547952|NCT04116528|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5547953|NCT04116528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5547954|NCT04116528|Anesthetics, General|anesthetics, general|mesh-ancestor
5547955|NCT04116528|Anesthetics|anesthetics|mesh-ancestor
5547956|NCT04116528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5547957|NCT04116528|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5547958|NCT04116528|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5547959|NCT04116528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5547960|NCT04116528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547961|NCT04116528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5547962|NCT04116528|Narcotics|narcotics|mesh-ancestor
5547963|NCT04116528|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5547964|NCT04116827|Tamoxifen|tamoxifen|mesh-list
5547965|NCT04116827|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5547966|NCT04116827|Hormone Antagonists|hormone antagonists|mesh-ancestor
5547967|NCT04116827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5547968|NCT04116827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5547969|NCT04116827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5547970|NCT04116827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5547971|NCT04116827|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5547972|NCT04116827|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5547973|NCT04116827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5547974|NCT04116411|Valganciclovir|valganciclovir|mesh-list
5547975|NCT04116411|Temozolomide|temozolomide|mesh-list
5547976|NCT04116411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5547977|NCT04116411|Alkylating Agents|alkylating agents|mesh-ancestor
5547978|NCT04116411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547979|NCT04116411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5547980|NCT04116411|Antiviral Agents|antiviral agents|mesh-ancestor
5547981|NCT04116411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5547982|NCT04116359|Cisplatin|cisplatin|mesh-list
5547983|NCT04116359|Etoposide|etoposide|mesh-list
6144469|NCT01345162|Ketorolac|ketorolac|mesh-list
6144470|NCT01345162|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6144471|NCT01345162|Tramadol|tramadol|mesh-list
6144472|NCT01345162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6144473|NCT01345162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6144474|NCT01345162|Analgesics|analgesics|mesh-ancestor
6144475|NCT01345162|Sensory System Agents|sensory system agents|mesh-ancestor
6144476|NCT01345162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6144477|NCT01345162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144478|NCT01345162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6144479|NCT01345162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6144480|NCT01345162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6144481|NCT01345162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6144482|NCT01345162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144483|NCT01345162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5547984|NCT04116359|Etoposide phosphate|etoposide phosphate|mesh-list
5547985|NCT04116359|Podophyllotoxin|podophyllotoxin|mesh-list
5547986|NCT04116359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5547987|NCT04116359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5547988|NCT04116359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5547989|NCT04116359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5547990|NCT04116359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5547991|NCT04116359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5547992|NCT04116359|Keratolytic Agents|keratolytic agents|mesh-ancestor
5547993|NCT04116359|Dermatologic Agents|dermatologic agents|mesh-ancestor
5547994|NCT04116359|Tubulin Modulators|tubulin modulators|mesh-ancestor
5547995|NCT04116359|Antimitotic Agents|antimitotic agents|mesh-ancestor
5547996|NCT04116359|Mitosis Modulators|mitosis modulators|mesh-ancestor
5547997|NCT04115982|Cholecalciferol|cholecalciferol|mesh-list
5547998|NCT04115982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5547999|NCT04115982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548000|NCT04115982|Vitamins|vitamins|mesh-ancestor
5548001|NCT04115982|Micronutrients|micronutrients|mesh-ancestor
5548002|NCT04115982|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5548003|NCT04116255|Salicylic Acid|salicylic acid|mesh-list
5548004|NCT04116255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5548005|NCT04116255|Antifungal Agents|antifungal agents|mesh-ancestor
5548006|NCT04116255|Keratolytic Agents|keratolytic agents|mesh-ancestor
5548007|NCT04116255|Dermatologic Agents|dermatologic agents|mesh-ancestor
6144484|NCT01345162|Narcotics|narcotics|mesh-ancestor
6144485|NCT01345162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6144486|NCT01345188|Ranolazine|ranolazine|mesh-list
6144487|NCT01345188|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6144488|NCT01345188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6144489|NCT01345188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5548008|NCT04115904|Ibuprofen|ibuprofen|mesh-list
5548009|NCT04115904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5548010|NCT04115904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6144490|NCT01345253|Belimumab|belimumab|mesh-list
6144491|NCT01345253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6144492|NCT01345253|Immunologic Factors|immunologic factors|mesh-ancestor
6144493|NCT01345253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144494|NCT01345292|Listerine|listerine|mesh-list
6144495|NCT01345292|Fluorides|fluorides|mesh-list
6144496|NCT01345292|Sodium Fluoride|sodium fluoride|mesh-list
6144497|NCT01345292|Cariostatic Agents|cariostatic agents|mesh-ancestor
6144498|NCT01345292|Protective Agents|protective agents|mesh-ancestor
6144499|NCT01345292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144500|NCT01345292|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6144501|NCT01345292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6144502|NCT01345630|Ritonavir|ritonavir|mesh-list
6144503|NCT01345630|Darunavir|darunavir|mesh-list
6144504|NCT01345630|Tenofovir|tenofovir|mesh-list
6144505|NCT01345630|Emtricitabine|emtricitabine|mesh-list
6144506|NCT01345630|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6144507|NCT01345630|Maraviroc|maraviroc|mesh-list
6144508|NCT01345630|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6144509|NCT01345630|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6144510|NCT01345630|Protease Inhibitors|protease inhibitors|mesh-ancestor
6144511|NCT01345630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6144512|NCT01345630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473619|NCT00510913|Tacrolimus|tacrolimus|mesh-list
6473620|NCT00510913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6473621|NCT00510913|Immunologic Factors|immunologic factors|mesh-ancestor
6144513|NCT01345630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6144514|NCT01345630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6144515|NCT01345630|Antiviral Agents|antiviral agents|mesh-ancestor
6144516|NCT01345630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6144517|NCT01345630|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6144518|NCT01345630|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6144519|NCT01345630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6144520|NCT01345630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6144521|NCT01345630|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6144522|NCT01345630|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6144523|NCT01345630|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6144524|NCT01345669|Afatinib|afatinib|mesh-list
6144525|NCT01345669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6144526|NCT01345669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6144527|NCT01345669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6473622|NCT00510913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473623|NCT00510913|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6473624|NCT00510913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6473625|NCT00510913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473626|NCT00510926|Imatinib Mesylate|imatinib mesylate|mesh-list
6473627|NCT00510926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6473628|NCT00510926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6473629|NCT00510926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6473630|NCT00510926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473631|NCT00510939|Bortezomib|bortezomib|mesh-list
6473632|NCT00510939|Tipifarnib|tipifarnib|mesh-list
6473633|NCT00510939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6473634|NCT00510965|Ranibizumab|ranibizumab|mesh-list
6473635|NCT00510965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6473636|NCT00510965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6473637|NCT00510965|Growth Substances|growth substances|mesh-ancestor
6473638|NCT00510965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473639|NCT00510965|Growth Inhibitors|growth inhibitors|mesh-ancestor
6473640|NCT00510965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6473641|NCT00511017|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
6473642|NCT00511017|Vitamins|vitamins|mesh-ancestor
6473643|NCT00511017|Micronutrients|micronutrients|mesh-ancestor
6473644|NCT00511017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473645|NCT00511017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5548011|NCT04115904|Analgesics|analgesics|mesh-ancestor
5548012|NCT04115904|Sensory System Agents|sensory system agents|mesh-ancestor
5548013|NCT04115904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5548014|NCT04115904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548015|NCT04115904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5548016|NCT04115904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5548017|NCT04115904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5548018|NCT04115904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5548019|NCT04115904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5548020|NCT04116320|Imiquimod|imiquimod|mesh-list
5548021|NCT04116320|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6473646|NCT00511069|Bortezomib|bortezomib|mesh-list
6473647|NCT00511069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6473648|NCT00511121|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6473649|NCT00511121|Imatinib Mesylate|imatinib mesylate|mesh-list
6667190|NCT01526369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6667191|NCT01526369|Tubulin Modulators|tubulin modulators|mesh-ancestor
6667192|NCT01526369|Antimitotic Agents|antimitotic agents|mesh-ancestor
6667193|NCT01526369|Mitosis Modulators|mitosis modulators|mesh-ancestor
6667194|NCT01526369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667195|NCT01526369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6667196|NCT01526369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6667197|NCT01526369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6667198|NCT01526395|Propofol|propofol|mesh-list
5548022|NCT04116320|Immunologic Factors|immunologic factors|mesh-ancestor
5548023|NCT04116320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548024|NCT04116320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5548025|NCT04116320|Interferon Inducers|interferon inducers|mesh-ancestor
5548026|NCT04116138|Antisecretory factor|antisecretory factor|mesh-list
5548027|NCT04116138|Antidiarrheals|antidiarrheals|mesh-ancestor
5548028|NCT04116138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5548029|NCT04116073|Antibodies|antibodies|mesh-list
5548030|NCT04116073|Immunologic Factors|immunologic factors|mesh-ancestor
6667199|NCT01526395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6667200|NCT01526395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6667201|NCT01526395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667202|NCT01526395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6667203|NCT01526395|Anesthetics, General|anesthetics, general|mesh-ancestor
6667204|NCT01526395|Anesthetics|anesthetics|mesh-ancestor
6672432|NCT01556035|Immunologic Factors|immunologic factors|mesh-ancestor
5548031|NCT04116073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144528|NCT01345669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144529|NCT01345682|Methotrexate|methotrexate|mesh-list
6144530|NCT01345682|Afatinib|afatinib|mesh-list
6144531|NCT01345682|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6144532|NCT01345682|Abortifacient Agents|abortifacient agents|mesh-ancestor
6144533|NCT01345682|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6473650|NCT00511121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6473651|NCT00511121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6473652|NCT00511121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6473653|NCT00511121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473654|NCT00511121|Antiviral Agents|antiviral agents|mesh-ancestor
6473655|NCT00511121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6473656|NCT00511212|Immunoglobulins|immunoglobulins|mesh-list
6473657|NCT00511212|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6473658|NCT00511212|Antibodies|antibodies|mesh-list
6473659|NCT00511212|gamma-Globulins|gamma-globulins|mesh-list
6473660|NCT00511212|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6473661|NCT00511212|Immunologic Factors|immunologic factors|mesh-ancestor
6473662|NCT00511212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144534|NCT01345682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144535|NCT01345682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6144536|NCT01345682|Antimetabolites|antimetabolites|mesh-ancestor
6144537|NCT01345682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144538|NCT01345682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6144539|NCT01345682|Dermatologic Agents|dermatologic agents|mesh-ancestor
6144540|NCT01345682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6144541|NCT01345682|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6144542|NCT01345682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6144543|NCT01345682|Immunologic Factors|immunologic factors|mesh-ancestor
6144544|NCT01345682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6144545|NCT01345682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6144546|NCT01345682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6144547|NCT01345929|Levofloxacin|levofloxacin|mesh-list
6144548|NCT01345929|Ofloxacin|ofloxacin|mesh-list
6144549|NCT01345929|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6144550|NCT01345929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6144551|NCT01345929|Renal Agents|renal agents|mesh-ancestor
6144552|NCT01345929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6144553|NCT01345929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6144554|NCT01345929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6144555|NCT01345929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6144556|NCT01345929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473663|NCT00511225|Cholecalciferol|cholecalciferol|mesh-list
6473664|NCT00511225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6473665|NCT00511225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473666|NCT00511225|Vitamins|vitamins|mesh-ancestor
5548032|NCT04116203|Metformin|metformin|mesh-list
5548033|NCT04116203|Hypoglycemic Agents|hypoglycemic agents|mesh-list
5548034|NCT04116203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548035|NCT04115878|Oxybutynin|oxybutynin|mesh-list
5548036|NCT04115878|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
5548037|NCT04115878|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6473667|NCT00511225|Micronutrients|micronutrients|mesh-ancestor
6473668|NCT00511225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6473669|NCT00511277|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6473670|NCT00511277|Antidepressive Agents|antidepressive agents|mesh-ancestor
6473671|NCT00511277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6473672|NCT00511277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6473673|NCT00511277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6473674|NCT00511277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6473675|NCT00511277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473676|NCT00511303|Imatinib Mesylate|imatinib mesylate|mesh-list
6473677|NCT00511303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6473678|NCT00511303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6473679|NCT00511303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6473680|NCT00511303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473681|NCT00511316|Montelukast|montelukast|mesh-list
6144557|NCT01345929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6144558|NCT01345929|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6144559|NCT01345929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6144560|NCT01346059|Vancomycin|vancomycin|mesh-list
6144561|NCT01346059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6144562|NCT01346059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6144563|NCT01346072|Tolvaptan|tolvaptan|mesh-list
6144564|NCT01346072|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6144565|NCT01346072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144566|NCT01346072|Natriuretic Agents|natriuretic agents|mesh-ancestor
6144567|NCT01346072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144568|NCT01346085|Thymoglobulin|thymoglobulin|mesh-list
6144569|NCT01346085|Immunologic Factors|immunologic factors|mesh-ancestor
6144570|NCT01346085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144571|NCT01346085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6205507|NCT02086786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205508|NCT02086786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205509|NCT02086786|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6205510|NCT02086786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6205511|NCT02086786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6205512|NCT02086786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6205513|NCT02086786|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6205514|NCT02086786|Dopamine Agents|dopamine agents|mesh-ancestor
6205515|NCT02087085|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6205516|NCT02087085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5548038|NCT04115878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6473682|NCT00511316|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6473683|NCT00511316|Respiratory System Agents|respiratory system agents|mesh-ancestor
6473684|NCT00511316|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6473685|NCT00511316|Hormone Antagonists|hormone antagonists|mesh-ancestor
6667205|NCT01526460|Atorvastatin|atorvastatin|mesh-list
5548039|NCT04115878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6144572|NCT01346371|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6144573|NCT01346371|Lubricant Eye Drops|lubricant eye drops|mesh-list
6144574|NCT01346371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6144575|NCT01346397|Cyclosporine|cyclosporine|mesh-list
6144576|NCT01346397|Tacrolimus|tacrolimus|mesh-list
6144577|NCT01346397|Cyclosporins|cyclosporins|mesh-list
6144578|NCT01346397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6144579|NCT01346397|Immunologic Factors|immunologic factors|mesh-ancestor
6144580|NCT01346397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144581|NCT01346397|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6144582|NCT01346397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6144583|NCT01346397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144584|NCT01346397|Antifungal Agents|antifungal agents|mesh-ancestor
6144585|NCT01346397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6144586|NCT01346397|Dermatologic Agents|dermatologic agents|mesh-ancestor
6144587|NCT01346397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6144588|NCT01346475|Valacyclovir|valacyclovir|mesh-list
6144589|NCT01346475|Antiviral Agents|antiviral agents|mesh-ancestor
6144590|NCT01346475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6144591|NCT01346540|Nintedanib|nintedanib|mesh-list
6144592|NCT01346540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6144593|NCT01346540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6144594|NCT01346540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6144595|NCT01346540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144596|NCT01346592|Vaccines|vaccines|mesh-list
6144597|NCT01346592|Immunologic Factors|immunologic factors|mesh-ancestor
6144598|NCT01346592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144599|NCT01347008|Sildenafil Citrate|sildenafil citrate|mesh-list
6144600|NCT01347008|Citric Acid|citric acid|mesh-list
6144601|NCT01347008|Sodium Citrate|sodium citrate|mesh-list
6144602|NCT01347008|Anticoagulants|anticoagulants|mesh-ancestor
6144603|NCT01347008|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6144604|NCT01347008|Chelating Agents|chelating agents|mesh-ancestor
6144605|NCT01347008|Sequestering Agents|sequestering agents|mesh-ancestor
6144606|NCT01347008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144607|NCT01347008|Vasodilator Agents|vasodilator agents|mesh-ancestor
6144608|NCT01347008|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6144609|NCT01347008|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6144610|NCT01347008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6144611|NCT01347008|Urological Agents|urological agents|mesh-ancestor
6144612|NCT01347060|Fluticasone|fluticasone|mesh-list
5548040|NCT04115878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5548041|NCT04115878|Adrenergic Agents|adrenergic agents|mesh-ancestor
5548042|NCT04115878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5548043|NCT04115878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548044|NCT04115878|Parasympatholytics|parasympatholytics|mesh-ancestor
5548045|NCT04115878|Autonomic Agents|autonomic agents|mesh-ancestor
5548046|NCT04115878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5548047|NCT04115878|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5548048|NCT04115878|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5548049|NCT04115878|Cholinergic Agents|cholinergic agents|mesh-ancestor
5548050|NCT04115878|Urological Agents|urological agents|mesh-ancestor
5548051|NCT04115748|Adalimumab|adalimumab|mesh-list
5548052|NCT04115748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5548053|NCT04115748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5548054|NCT04115644|Triamcinolone|triamcinolone|mesh-list
5548055|NCT04115644|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6144613|NCT01347060|Xhance|xhance|mesh-list
6144614|NCT01347060|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6144615|NCT01347060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5548056|NCT04115644|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5548057|NCT04115644|Ketorolac|ketorolac|mesh-list
5548058|NCT04115644|Bupivacaine|bupivacaine|mesh-list
5548059|NCT04115644|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5548060|NCT04115644|Anesthetics, Local|anesthetics, local|mesh-ancestor
5548061|NCT04115644|Anesthetics|anesthetics|mesh-ancestor
5548062|NCT04115644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5602749|NCT04209543|Hormones|hormones|mesh-ancestor
6144616|NCT01347060|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6144617|NCT01347060|Autonomic Agents|autonomic agents|mesh-ancestor
6144618|NCT01347060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6144619|NCT01347060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667206|NCT01526460|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6144620|NCT01347060|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6144621|NCT01347060|Respiratory System Agents|respiratory system agents|mesh-ancestor
6144622|NCT01347060|Dermatologic Agents|dermatologic agents|mesh-ancestor
6144623|NCT01347060|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6144624|NCT01347060|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6144625|NCT01347060|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6144626|NCT01347060|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6144627|NCT01347060|Adrenergic Agents|adrenergic agents|mesh-ancestor
6144628|NCT01347060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6144629|NCT01347060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144630|NCT01347073|Glycerol|glycerol|mesh-list
6144631|NCT01347073|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6144632|NCT01347073|Protective Agents|protective agents|mesh-ancestor
6667207|NCT01526460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6667208|NCT01526460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6667209|NCT01526460|Antimetabolites|antimetabolites|mesh-ancestor
6144633|NCT01347073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144634|NCT01347112|Varenicline|varenicline|mesh-list
6473686|NCT00511316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6473687|NCT00511316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473688|NCT00511316|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6473689|NCT00511316|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6473690|NCT00511316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473691|NCT00511446|Docetaxel|docetaxel|mesh-list
6473692|NCT00511446|Capecitabine|capecitabine|mesh-list
6473693|NCT00511446|Oxaliplatin|oxaliplatin|mesh-list
6473694|NCT00511446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6473695|NCT00511446|Tubulin Modulators|tubulin modulators|mesh-ancestor
6473696|NCT00511446|Antimitotic Agents|antimitotic agents|mesh-ancestor
6473697|NCT00511446|Mitosis Modulators|mitosis modulators|mesh-ancestor
6473698|NCT00511446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473699|NCT00511446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6473700|NCT00511446|Antimetabolites|antimetabolites|mesh-ancestor
6473701|NCT00511498|Sildenafil Citrate|sildenafil citrate|mesh-list
6473702|NCT00511498|Vasodilator Agents|vasodilator agents|mesh-ancestor
6473703|NCT00511498|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6473704|NCT00511498|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6473705|NCT00511498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6473706|NCT00511498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473707|NCT00511498|Urological Agents|urological agents|mesh-ancestor
6473708|NCT00511576|Docetaxel|docetaxel|mesh-list
6473709|NCT00511576|Mocetinostat|mocetinostat|mesh-list
6473710|NCT00511576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6473711|NCT00511576|Tubulin Modulators|tubulin modulators|mesh-ancestor
6473712|NCT00511576|Antimitotic Agents|antimitotic agents|mesh-ancestor
6473713|NCT00511576|Mitosis Modulators|mitosis modulators|mesh-ancestor
5548063|NCT04115644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548064|NCT04115644|Sensory System Agents|sensory system agents|mesh-ancestor
5548065|NCT04115644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5548066|NCT04115644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5548067|NCT04115644|Glucocorticoids|glucocorticoids|mesh-ancestor
5548068|NCT04115644|Hormones|hormones|mesh-ancestor
5548069|NCT04115644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5548070|NCT04115644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5548071|NCT04115644|Immunologic Factors|immunologic factors|mesh-ancestor
5548072|NCT04115644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5548073|NCT04115644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5548074|NCT04115644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5548075|NCT04115644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5548076|NCT04115644|Analgesics|analgesics|mesh-ancestor
5548077|NCT04115644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5548078|NCT04115644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5548079|NCT04115800|Sirolimus|sirolimus|mesh-list
5548080|NCT04115800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5548081|NCT04115800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5548082|NCT04115800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5548083|NCT04115800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5548084|NCT04115800|Antifungal Agents|antifungal agents|mesh-ancestor
5548085|NCT04115800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5548086|NCT04115800|Immunologic Factors|immunologic factors|mesh-ancestor
5548087|NCT04115800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548088|NCT04115423|Adalimumab|adalimumab|mesh-list
6144635|NCT01347112|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6144636|NCT01347112|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6473714|NCT00511576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473715|NCT00511576|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6473716|NCT00511576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6488671|NCT00585741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6488672|NCT00585754|Guanfacine|guanfacine|mesh-list
6488673|NCT00585754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6488674|NCT00585754|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6488675|NCT00585754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6488676|NCT00585754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6488677|NCT00585754|Adrenergic Agents|adrenergic agents|mesh-ancestor
6488678|NCT00585754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6488679|NCT00585754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488680|NCT00585754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488681|NCT00585793|Lopinavir|lopinavir|mesh-list
6144637|NCT01347112|Cholinergic Agents|cholinergic agents|mesh-ancestor
6144638|NCT01347112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6144639|NCT01347112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144640|NCT01347112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144641|NCT01347255|Betamethasone|betamethasone|mesh-list
6144642|NCT01347255|Betamethasone Valerate|betamethasone valerate|mesh-list
6144643|NCT01347255|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
6144644|NCT01347255|Betamethasone benzoate|betamethasone benzoate|mesh-list
6144645|NCT01347255|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
6144646|NCT01347255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6667210|NCT01526460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667211|NCT01526460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5548089|NCT04115423|Etanercept|etanercept|mesh-list
5548090|NCT04115423|Golimumab|golimumab|mesh-list
5548091|NCT04115423|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
5548092|NCT04115423|Infliximab|infliximab|mesh-list
5548093|NCT04115423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5548094|NCT04115423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6667212|NCT01526460|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6667213|NCT01526460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6667214|NCT01526499|Cyclophosphamide|cyclophosphamide|mesh-list
6667215|NCT01526499|Docetaxel|docetaxel|mesh-list
6667216|NCT01526499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5548095|NCT04115423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6144647|NCT01347255|Glucocorticoids|glucocorticoids|mesh-ancestor
6144648|NCT01347255|Hormones|hormones|mesh-ancestor
6144649|NCT01347255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6144650|NCT01347255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144651|NCT01347255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6144652|NCT01347255|Respiratory System Agents|respiratory system agents|mesh-ancestor
6144653|NCT01347554|Everolimus|everolimus|mesh-list
6144654|NCT01347554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6144655|NCT01347554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6144656|NCT01347554|Immunologic Factors|immunologic factors|mesh-ancestor
6144657|NCT01347554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144658|NCT01347580|Ticagrelor|ticagrelor|mesh-list
6144659|NCT01347580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6144660|NCT01347580|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6144661|NCT01347580|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5548096|NCT04115423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5548097|NCT04115423|Analgesics|analgesics|mesh-ancestor
5548098|NCT04115423|Sensory System Agents|sensory system agents|mesh-ancestor
5548099|NCT04115423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6144662|NCT01347580|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6144663|NCT01347580|Purinergic Agents|purinergic agents|mesh-ancestor
6144664|NCT01347580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6144665|NCT01347580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5548100|NCT04115423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548101|NCT04115423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5548102|NCT04115423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5548103|NCT04115423|Immunologic Factors|immunologic factors|mesh-ancestor
5548104|NCT04115423|Dermatologic Agents|dermatologic agents|mesh-ancestor
5548105|NCT04115631|Cytarabine|cytarabine|mesh-list
5548106|NCT04115631|Rituximab|rituximab|mesh-list
5548107|NCT04115631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5548108|NCT04115631|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5548109|NCT04115631|Acalabrutinib|acalabrutinib|mesh-list
6144666|NCT01347580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144667|NCT01347710|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
5548110|NCT04115631|Antibodies|antibodies|mesh-list
5548111|NCT04115631|Immunoglobulins|immunoglobulins|mesh-list
5548112|NCT04115631|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5548113|NCT04115631|Immunologic Factors|immunologic factors|mesh-ancestor
5548114|NCT04115631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144668|NCT01347710|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
6144669|NCT01347710|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6144670|NCT01347710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144671|NCT01347762|Nabilone|nabilone|mesh-list
6144672|NCT01347762|Antiemetics|antiemetics|mesh-ancestor
6144673|NCT01347762|Autonomic Agents|autonomic agents|mesh-ancestor
6144674|NCT01347762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6144675|NCT01347762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144676|NCT01347762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6144677|NCT01347762|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5548115|NCT04115631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5548116|NCT04115631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5548117|NCT04115631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5548118|NCT04115631|Antimetabolites|antimetabolites|mesh-ancestor
5548119|NCT04115631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5548120|NCT04115631|Antiviral Agents|antiviral agents|mesh-ancestor
5548121|NCT04115631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5548122|NCT04115631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5548123|NCT04115631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5548124|NCT04115631|Alkylating Agents|alkylating agents|mesh-ancestor
5548125|NCT04115449|Dexmedetomidine|dexmedetomidine|mesh-list
5548126|NCT04115449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5548127|NCT04115449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5548128|NCT04115449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548129|NCT04115449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5548130|NCT04115449|Analgesics|analgesics|mesh-ancestor
6144678|NCT01347762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6144679|NCT01347762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6144680|NCT01347762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6144681|NCT01347866|Irinotecan|irinotecan|mesh-list
6144682|NCT01347866|Gedatolisib|gedatolisib|mesh-list
6144683|NCT01347866|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6144684|NCT01347866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6144685|NCT01347866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5548131|NCT04115449|Sensory System Agents|sensory system agents|mesh-ancestor
5548132|NCT04115449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5548133|NCT04115449|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5548134|NCT04115449|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5548135|NCT04115449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5548136|NCT04115449|Adrenergic Agents|adrenergic agents|mesh-ancestor
5548137|NCT04115449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5548138|NCT04115449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5548139|NCT04115410|Gemcitabine|gemcitabine|mesh-list
5548140|NCT04115410|Cisplatin|cisplatin|mesh-list
5548141|NCT04115410|Carboplatin|carboplatin|mesh-list
5548142|NCT04115410|Docetaxel|docetaxel|mesh-list
5548143|NCT04115410|Pemetrexed|pemetrexed|mesh-list
5548144|NCT04115410|Vinorelbine|vinorelbine|mesh-list
5548145|NCT04115410|Gefitinib|gefitinib|mesh-list
5548146|NCT04115410|Mitomycins|mitomycins|mesh-list
6144686|NCT01347866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144687|NCT01347866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6144688|NCT01347866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6144689|NCT01348100|Iloperidone|iloperidone|mesh-list
6144690|NCT01348100|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6144691|NCT01348100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5548147|NCT04115410|Mitomycin|mitomycin|mesh-list
5548148|NCT04115410|Vinblastine|vinblastine|mesh-list
5548149|NCT04115410|Afatinib|afatinib|mesh-list
5548150|NCT04115410|Osimertinib|osimertinib|mesh-list
5548151|NCT04115410|Crizotinib|crizotinib|mesh-list
5548152|NCT04115410|Ceritinib|ceritinib|mesh-list
6144692|NCT01348100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6144693|NCT01348100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144694|NCT01348100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6144695|NCT01348139|AZD-3199|azd-3199|mesh-list
6144696|NCT01348139|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6144697|NCT01348139|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5548153|NCT04115410|Antineoplastic Agents|antineoplastic agents|mesh-list
5548154|NCT04115410|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5548155|NCT04115410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5548156|NCT04115410|Antimetabolites|antimetabolites|mesh-ancestor
5548157|NCT04115410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5548158|NCT04115410|Antiviral Agents|antiviral agents|mesh-ancestor
5548159|NCT04115410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5548160|NCT04115410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6144698|NCT01348139|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6144699|NCT01348139|Adrenergic Agents|adrenergic agents|mesh-ancestor
6144700|NCT01348139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6144701|NCT01348139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144702|NCT01348139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144703|NCT01348542|Trazodone|trazodone|mesh-list
6144704|NCT01348542|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6144705|NCT01348542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6144706|NCT01348542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6144707|NCT01348542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144708|NCT01348542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6144709|NCT01348542|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6144710|NCT01348542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6144711|NCT01348542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6144712|NCT01348542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144713|NCT01348542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6144714|NCT01348542|Serotonin Agents|serotonin agents|mesh-ancestor
6144715|NCT01348542|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6144716|NCT01348542|Antidepressive Agents|antidepressive agents|mesh-ancestor
6144717|NCT01348607|Methylphenidate|methylphenidate|mesh-list
6144718|NCT01348607|Modafinil|modafinil|mesh-list
6144719|NCT01348607|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6144720|NCT01348607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144721|NCT01348607|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6144722|NCT01348607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6144723|NCT01348607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6144724|NCT01348607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144725|NCT01348607|Dopamine Agents|dopamine agents|mesh-ancestor
6144726|NCT01348607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6144727|NCT01348607|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6144728|NCT01348607|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6144729|NCT01348607|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6144730|NCT01348763|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6144731|NCT01348763|Maraviroc|maraviroc|mesh-list
6144732|NCT01348763|Darunavir|darunavir|mesh-list
6144733|NCT01348763|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6144734|NCT01348763|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6144735|NCT01348763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6144736|NCT01348763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144737|NCT01348763|Antiviral Agents|antiviral agents|mesh-ancestor
6144738|NCT01348763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6144739|NCT01348763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6144740|NCT01348763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6144741|NCT01348763|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6144742|NCT01348763|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6144743|NCT01348763|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6144744|NCT01348763|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6144745|NCT01348763|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6144746|NCT01348763|Protease Inhibitors|protease inhibitors|mesh-ancestor
6144747|NCT01349192|Chlorhexidine|chlorhexidine|mesh-list
6144748|NCT01349192|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6667217|NCT01526499|Immunologic Factors|immunologic factors|mesh-ancestor
6667218|NCT01526499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667219|NCT01526499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6667220|NCT01526499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6667221|NCT01526499|Alkylating Agents|alkylating agents|mesh-ancestor
6672433|NCT01556035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548161|NCT04115410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5548162|NCT04115410|Immunologic Factors|immunologic factors|mesh-ancestor
5548163|NCT04115410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548164|NCT04115410|Tubulin Modulators|tubulin modulators|mesh-ancestor
5548165|NCT04115410|Antimitotic Agents|antimitotic agents|mesh-ancestor
5548166|NCT04115410|Mitosis Modulators|mitosis modulators|mesh-ancestor
5548167|NCT04115410|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5548168|NCT04115410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5548169|NCT04115410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5548170|NCT04115410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5548171|NCT04115410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5548172|NCT04115410|Alkylating Agents|alkylating agents|mesh-ancestor
6144749|NCT01349192|Minocycline|minocycline|mesh-list
6144750|NCT01349192|Rifampin|rifampin|mesh-list
6144751|NCT01349192|Trimethoprim|trimethoprim|mesh-list
6144752|NCT01349192|Sulfamethoxazole|sulfamethoxazole|mesh-list
6144753|NCT01349192|Mupirocin|mupirocin|mesh-list
6144754|NCT01349192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6144755|NCT01349192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6144756|NCT01349192|Disinfectants|disinfectants|mesh-ancestor
6144757|NCT01349192|Dermatologic Agents|dermatologic agents|mesh-ancestor
6144758|NCT01349192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6144759|NCT01349192|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6144760|NCT01349192|Antitubercular Agents|antitubercular agents|mesh-ancestor
6144761|NCT01349192|Leprostatic Agents|leprostatic agents|mesh-ancestor
6144762|NCT01349192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6144763|NCT01349192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6144764|NCT01349192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144765|NCT01349192|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6144766|NCT01349192|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6144767|NCT01349192|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6144768|NCT01349192|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6144769|NCT01349192|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6144770|NCT01349192|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6144771|NCT01349192|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6144772|NCT01349192|Renal Agents|renal agents|mesh-ancestor
6144773|NCT01349192|Antimalarials|antimalarials|mesh-ancestor
6144774|NCT01349192|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6144775|NCT01349192|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6144776|NCT01349192|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6144777|NCT01349192|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6144778|NCT01349192|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6144779|NCT01349192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6144780|NCT01349192|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6144781|NCT01349231|Ketamine|ketamine|mesh-list
6144782|NCT01349231|Analgesics|analgesics|mesh-ancestor
6144783|NCT01349231|Sensory System Agents|sensory system agents|mesh-ancestor
6144784|NCT01349231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6144785|NCT01349231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144786|NCT01349231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6144787|NCT01349231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6144788|NCT01349231|Anesthetics, General|anesthetics, general|mesh-ancestor
6144789|NCT01349231|Anesthetics|anesthetics|mesh-ancestor
6144790|NCT01349231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6144791|NCT01349231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6144792|NCT01349231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6144793|NCT01349231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6144794|NCT01349231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144795|NCT01349491|Ranolazine|ranolazine|mesh-list
6144796|NCT01349491|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6144797|NCT01349491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6144798|NCT01349491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144799|NCT01349569|Lenalidomide|lenalidomide|mesh-list
6144800|NCT01349569|Vaccines|vaccines|mesh-list
6144801|NCT01349569|Immunologic Factors|immunologic factors|mesh-ancestor
6144802|NCT01349569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144803|NCT01349569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6144804|NCT01349569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6144805|NCT01349569|Growth Substances|growth substances|mesh-ancestor
6144806|NCT01349569|Growth Inhibitors|growth inhibitors|mesh-ancestor
6144807|NCT01349569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6144808|NCT01349660|Bevacizumab|bevacizumab|mesh-list
6144809|NCT01349660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6144810|NCT01349660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5548173|NCT04115462|Morphine|morphine|mesh-list
5548174|NCT04115462|Histamine|histamine|mesh-list
6144811|NCT01349660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6144812|NCT01349660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6144813|NCT01349660|Growth Substances|growth substances|mesh-ancestor
6144814|NCT01349660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144815|NCT01349660|Growth Inhibitors|growth inhibitors|mesh-ancestor
6144816|NCT01349673|Budesonide|budesonide|mesh-list
6667222|NCT01526499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667223|NCT01526499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5548175|NCT04115462|Histamine phosphate|histamine phosphate|mesh-list
5548176|NCT04115462|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5548177|NCT04115462|Narcotics|narcotics|mesh-ancestor
5548178|NCT04115462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5548179|NCT04115462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548180|NCT04115462|Analgesics|analgesics|mesh-ancestor
5548181|NCT04115462|Sensory System Agents|sensory system agents|mesh-ancestor
5548182|NCT04115462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6667224|NCT01526499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6667225|NCT01526499|Tubulin Modulators|tubulin modulators|mesh-ancestor
6144817|NCT01349673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6144818|NCT01349673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6144819|NCT01349673|Autonomic Agents|autonomic agents|mesh-ancestor
6144820|NCT01349673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6144821|NCT01349673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144822|NCT01349673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6144823|NCT01349673|Respiratory System Agents|respiratory system agents|mesh-ancestor
6144824|NCT01349673|Glucocorticoids|glucocorticoids|mesh-ancestor
6144825|NCT01349673|Hormones|hormones|mesh-ancestor
6144826|NCT01349673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6144827|NCT01349803|Formoterol Fumarate|formoterol fumarate|mesh-list
6144828|NCT01349803|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6144829|NCT01349803|Autonomic Agents|autonomic agents|mesh-ancestor
6144830|NCT01349803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6144831|NCT01349803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144832|NCT01349803|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6144833|NCT01349803|Respiratory System Agents|respiratory system agents|mesh-ancestor
6144834|NCT01349803|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6144835|NCT01349803|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6144836|NCT01349803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6144837|NCT01349803|Adrenergic Agents|adrenergic agents|mesh-ancestor
6144838|NCT01349803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6144839|NCT01349803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144840|NCT01349920|Infliximab|infliximab|mesh-list
6144841|NCT01349920|Dermatologic Agents|dermatologic agents|mesh-ancestor
6144842|NCT01349920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6144843|NCT01349920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6144844|NCT01349972|Cytarabine|cytarabine|mesh-list
6473717|NCT00511602|Insulin|insulin|mesh-list
6473718|NCT00511602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6144845|NCT01349972|Daunorubicin|daunorubicin|mesh-list
6144846|NCT01349972|Mitoxantrone|mitoxantrone|mesh-list
6144847|NCT01349972|Alvocidib|alvocidib|mesh-list
6144848|NCT01349972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6144849|NCT01349972|Antimetabolites|antimetabolites|mesh-ancestor
6144850|NCT01349972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144851|NCT01349972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6144852|NCT01349972|Antiviral Agents|antiviral agents|mesh-ancestor
6144853|NCT01349972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6144854|NCT01349972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6144855|NCT01349972|Immunologic Factors|immunologic factors|mesh-ancestor
6144856|NCT01349972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144857|NCT01349972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6144858|NCT01349972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5548183|NCT04115462|Histamine Agonists|histamine agonists|mesh-ancestor
6144859|NCT01349972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6144860|NCT01349972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6144861|NCT01349972|Analgesics|analgesics|mesh-ancestor
6144862|NCT01349972|Sensory System Agents|sensory system agents|mesh-ancestor
6144863|NCT01349972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6144864|NCT01349972|Growth Inhibitors|growth inhibitors|mesh-ancestor
6144865|NCT01349972|Growth Substances|growth substances|mesh-ancestor
6144866|NCT01349972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6144867|NCT01350102|Ascorbic Acid|ascorbic acid|mesh-list
6144868|NCT01350102|Bacitracin|bacitracin|mesh-list
6144869|NCT01350102|Vitamins|vitamins|mesh-ancestor
6144870|NCT01350102|Micronutrients|micronutrients|mesh-ancestor
6144871|NCT01350102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144872|NCT01350102|Antioxidants|antioxidants|mesh-ancestor
6144873|NCT01350102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144874|NCT01350102|Protective Agents|protective agents|mesh-ancestor
6144875|NCT01350102|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6144876|NCT01350102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6144877|NCT01350102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6144878|NCT01350128|Bromides|bromides|mesh-list
6144879|NCT01350128|Ipratropium|ipratropium|mesh-list
6144880|NCT01350128|Anticonvulsants|anticonvulsants|mesh-ancestor
6144881|NCT01350128|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6144882|NCT01350128|Autonomic Agents|autonomic agents|mesh-ancestor
6144883|NCT01350128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6144884|NCT01350128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144885|NCT01350128|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6144886|NCT01350128|Respiratory System Agents|respiratory system agents|mesh-ancestor
6144887|NCT01350128|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6144888|NCT01350128|Cholinergic Agents|cholinergic agents|mesh-ancestor
6144889|NCT01350128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6667226|NCT01526499|Antimitotic Agents|antimitotic agents|mesh-ancestor
5548184|NCT04115462|Histamine Agents|histamine agents|mesh-ancestor
5548185|NCT04115462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5548186|NCT04115462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5548187|NCT04115397|Zoledronic Acid|zoledronic acid|mesh-list
6667227|NCT01526499|Mitosis Modulators|mitosis modulators|mesh-ancestor
5548188|NCT04115397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6473719|NCT00511602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473720|NCT00511628|Risperidone|risperidone|mesh-list
6473721|NCT00511628|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6473722|NCT00511628|Serotonin Agents|serotonin agents|mesh-ancestor
6473723|NCT00511628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6144890|NCT01350128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144891|NCT01350141|Bococizumab|bococizumab|mesh-list
6144892|NCT01350141|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6144893|NCT01350141|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6144894|NCT01350141|Antimetabolites|antimetabolites|mesh-ancestor
6144895|NCT01350141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144896|NCT01350141|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6144897|NCT01350245|Mycophenolic Acid|mycophenolic acid|mesh-list
6144898|NCT01350245|Cyclophosphamide|cyclophosphamide|mesh-list
6144899|NCT01350245|Tacrolimus|tacrolimus|mesh-list
6144900|NCT01350245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6144901|NCT01350245|Immunologic Factors|immunologic factors|mesh-ancestor
6144902|NCT01350245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144903|NCT01350245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6144904|NCT01350245|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6144905|NCT01350245|Alkylating Agents|alkylating agents|mesh-ancestor
6144906|NCT01350245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144907|NCT01350245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6144908|NCT01350245|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6144909|NCT01350245|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6144910|NCT01350245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6473724|NCT00511628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473725|NCT00511628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473726|NCT00511628|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6473727|NCT00511628|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6667228|NCT01526525|Acetaminophen|acetaminophen|mesh-list
5548189|NCT04115397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548190|NCT04116112|Hydralazine|hydralazine|mesh-list
5548191|NCT04116112|Labetalol|labetalol|mesh-list
5548192|NCT04116112|Nicardipine|nicardipine|mesh-list
5548193|NCT04116112|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5548194|NCT04116112|Vasodilator Agents|vasodilator agents|mesh-ancestor
5548195|NCT04116112|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5548196|NCT04116112|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5548197|NCT04116112|Adrenergic Agents|adrenergic agents|mesh-ancestor
5548198|NCT04116112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5548199|NCT04116112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5548200|NCT04116112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548201|NCT04116112|Sympathomimetics|sympathomimetics|mesh-ancestor
5548202|NCT04116112|Autonomic Agents|autonomic agents|mesh-ancestor
5548203|NCT04116112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5548204|NCT04116112|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5725714|NCT03178591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6667229|NCT01526525|Parecoxib|parecoxib|mesh-list
6473728|NCT00511628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6473729|NCT00511628|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6473730|NCT00511628|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6473731|NCT00511628|Dopamine Agents|dopamine agents|mesh-ancestor
6144911|NCT01350245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6144912|NCT01350245|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6144913|NCT01350245|Antitubercular Agents|antitubercular agents|mesh-ancestor
6144914|NCT01350245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6144915|NCT01350245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6144916|NCT01350271|Mebendazole|mebendazole|mesh-list
6144917|NCT01350271|Piperazine|piperazine|mesh-list
6144918|NCT01350271|Piperazine citrate|piperazine citrate|mesh-list
6144919|NCT01350271|DMP 777|dmp 777|mesh-list
6144920|NCT01350271|Antinematodal Agents|antinematodal agents|mesh-ancestor
6144921|NCT01350271|Anthelmintics|anthelmintics|mesh-ancestor
6144922|NCT01350271|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6144923|NCT01350271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6144924|NCT01350271|Tubulin Modulators|tubulin modulators|mesh-ancestor
6144925|NCT01350271|Antimitotic Agents|antimitotic agents|mesh-ancestor
6144926|NCT01350271|Mitosis Modulators|mitosis modulators|mesh-ancestor
6144927|NCT01350271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144928|NCT01350271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6144929|NCT01350271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6144930|NCT01350388|Febuxostat|febuxostat|mesh-list
6144931|NCT01350388|Gout Suppressants|gout suppressants|mesh-ancestor
6144932|NCT01350388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6144933|NCT01350804|Abatacept|abatacept|mesh-list
6144934|NCT01350804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6144935|NCT01350804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144936|NCT01350804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6144937|NCT01350804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6144938|NCT01350804|Immunologic Factors|immunologic factors|mesh-ancestor
6144939|NCT01350804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144940|NCT01350804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6144941|NCT01350947|Azacitidine|azacitidine|mesh-list
6144942|NCT01350947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6144943|NCT01350947|Antimetabolites|antimetabolites|mesh-ancestor
6144944|NCT01350947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144945|NCT01350947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6144946|NCT01350947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6144947|NCT01351025|Atorvastatin|atorvastatin|mesh-list
6144948|NCT01351025|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6144949|NCT01351025|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6144950|NCT01351025|Antimetabolites|antimetabolites|mesh-ancestor
6144951|NCT01351025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144952|NCT01351025|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6144953|NCT01351025|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5548205|NCT04116112|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5548206|NCT04116112|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5548207|NCT04116112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5548208|NCT04116112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5548209|NCT04115189|Sunitinib|sunitinib|mesh-list
5548210|NCT04115189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5548211|NCT04115189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5548212|NCT04115189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5548213|NCT04115189|Growth Substances|growth substances|mesh-ancestor
5548214|NCT04115189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548215|NCT04115189|Growth Inhibitors|growth inhibitors|mesh-ancestor
5548216|NCT04115189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5548217|NCT04115189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5548218|NCT04115189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5548219|NCT04115111|Durvalumab|durvalumab|mesh-list
5548220|NCT04115111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5548221|NCT04115111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5602750|NCT04209543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6144954|NCT01351025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6144955|NCT01351090|Ketorolac|ketorolac|mesh-list
6144956|NCT01351090|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6144957|NCT01351090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6144958|NCT01351090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6144959|NCT01351090|Analgesics|analgesics|mesh-ancestor
6144960|NCT01351090|Sensory System Agents|sensory system agents|mesh-ancestor
6144961|NCT01351090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6473732|NCT00511654|Midazolam|midazolam|mesh-list
6473733|NCT00511654|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5548222|NCT04115163|Gemcitabine|gemcitabine|mesh-list
5548223|NCT04115163|Paclitaxel|paclitaxel|mesh-list
6144962|NCT01351090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144963|NCT01351090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6144964|NCT01351090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6144965|NCT01351090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6144966|NCT01351090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6144967|NCT01351090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144968|NCT01351350|Paclitaxel|paclitaxel|mesh-list
6144969|NCT01351350|Trastuzumab|trastuzumab|mesh-list
6144970|NCT01351350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6144971|NCT01351350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6144972|NCT01351350|Tubulin Modulators|tubulin modulators|mesh-ancestor
5548224|NCT04115163|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5548225|NCT04115163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5548226|NCT04115163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5548227|NCT04115163|Tubulin Modulators|tubulin modulators|mesh-ancestor
5548228|NCT04115163|Antimitotic Agents|antimitotic agents|mesh-ancestor
5548229|NCT04115163|Mitosis Modulators|mitosis modulators|mesh-ancestor
5548230|NCT04115163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5548231|NCT04115163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5548232|NCT04115163|Antimetabolites|antimetabolites|mesh-ancestor
5548233|NCT04115163|Antiviral Agents|antiviral agents|mesh-ancestor
5548234|NCT04115163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5548235|NCT04115163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5548236|NCT04115163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5548237|NCT04115163|Immunologic Factors|immunologic factors|mesh-ancestor
6144973|NCT01351350|Antimitotic Agents|antimitotic agents|mesh-ancestor
6144974|NCT01351350|Mitosis Modulators|mitosis modulators|mesh-ancestor
6144975|NCT01351350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144976|NCT01351350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6144977|NCT01351415|Bevacizumab|bevacizumab|mesh-list
6144978|NCT01351415|Docetaxel|docetaxel|mesh-list
6144979|NCT01351415|Pemetrexed|pemetrexed|mesh-list
6144980|NCT01351415|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6144981|NCT01351415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6144982|NCT01351415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6144983|NCT01351415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6144984|NCT01351415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6144985|NCT01351415|Growth Substances|growth substances|mesh-ancestor
6144986|NCT01351415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6144987|NCT01351415|Growth Inhibitors|growth inhibitors|mesh-ancestor
6144988|NCT01351415|Tubulin Modulators|tubulin modulators|mesh-ancestor
6144989|NCT01351415|Antimitotic Agents|antimitotic agents|mesh-ancestor
6667230|NCT01526525|Morphine|morphine|mesh-list
5548238|NCT04115163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548239|NCT04115267|Antineoplastic Agents|antineoplastic agents|mesh-list
5548240|NCT04115020|Naltrexone|naltrexone|mesh-list
5548241|NCT04115020|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5548242|NCT04115020|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5548243|NCT04115020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548244|NCT04115020|Sensory System Agents|sensory system agents|mesh-ancestor
5548245|NCT04115020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5548246|NCT04115072|Praziquantel|praziquantel|mesh-list
5548247|NCT04115072|Anthelmintics|anthelmintics|mesh-ancestor
5548248|NCT04115072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5548249|NCT04115072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5548250|NCT04114890|Tenofovir|tenofovir|mesh-list
5548251|NCT04114890|Antiviral Agents|antiviral agents|mesh-ancestor
5548252|NCT04114890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5548253|NCT04114890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6667231|NCT01526525|Tramadol|tramadol|mesh-list
6667232|NCT01526525|Ketamine|ketamine|mesh-list
6667233|NCT01526525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6667234|NCT01526525|Narcotics|narcotics|mesh-ancestor
6667235|NCT01526525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5548254|NCT04114890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6144990|NCT01351415|Mitosis Modulators|mitosis modulators|mesh-ancestor
6144991|NCT01351415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144992|NCT01351415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6144993|NCT01351415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6144994|NCT01351415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6144995|NCT01351415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6144996|NCT01351480|Abatacept|abatacept|mesh-list
6667236|NCT01526525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667237|NCT01526525|Analgesics|analgesics|mesh-ancestor
6667238|NCT01526525|Sensory System Agents|sensory system agents|mesh-ancestor
6667239|NCT01526525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6667240|NCT01526525|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6667241|NCT01526525|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6667242|NCT01526525|Anesthetics, General|anesthetics, general|mesh-ancestor
6667243|NCT01526525|Anesthetics|anesthetics|mesh-ancestor
6667244|NCT01526525|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6667245|NCT01526525|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6667246|NCT01526525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6667247|NCT01526525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667248|NCT01526525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6667249|NCT01526525|Antipyretics|antipyretics|mesh-ancestor
6667250|NCT01526525|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6667251|NCT01526525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6667252|NCT01526525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6667253|NCT01526525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6667254|NCT01526525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6667255|NCT01526525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6473734|NCT00511654|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6473735|NCT00511654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6473736|NCT00511654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473737|NCT00511654|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6473738|NCT00511654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5548255|NCT04114890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5548256|NCT04114890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5548257|NCT04114890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5548258|NCT04114890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5548259|NCT04114643|Thrombin|thrombin|mesh-list
5548260|NCT04114643|Hemostatics|hemostatics|mesh-ancestor
5548261|NCT04114643|Coagulants|coagulants|mesh-ancestor
5548262|NCT04114630|Erenumab|erenumab|mesh-list
5548263|NCT04114630|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
5548264|NCT04114630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667256|NCT01526564|Acetylcarnitine|acetylcarnitine|mesh-list
6667257|NCT01526564|Vitamin B Complex|vitamin b complex|mesh-ancestor
6667258|NCT01526564|Vitamins|vitamins|mesh-ancestor
6667259|NCT01526564|Micronutrients|micronutrients|mesh-ancestor
6667260|NCT01526564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667261|NCT01526564|Nootropic Agents|nootropic agents|mesh-ancestor
6667262|NCT01526603|Carboplatin|carboplatin|mesh-list
5548265|NCT04114630|Analgesics|analgesics|mesh-ancestor
5548266|NCT04114630|Sensory System Agents|sensory system agents|mesh-ancestor
5548267|NCT04114630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5548268|NCT04114630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548269|NCT04114383|Deuterium Oxide|deuterium oxide|mesh-list
5548270|NCT04114383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5548271|NCT04114383|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5548272|NCT04114383|Protective Agents|protective agents|mesh-ancestor
5548273|NCT04114383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548274|NCT04114526|Nicotine|nicotine|mesh-list
6144997|NCT01351480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6667263|NCT01526603|Etoposide|etoposide|mesh-list
6667264|NCT01526603|Melphalan|melphalan|mesh-list
6667265|NCT01526603|Tretinoin|tretinoin|mesh-list
6667266|NCT01526603|Isotretinoin|isotretinoin|mesh-list
6667267|NCT01526603|Sargramostim|sargramostim|mesh-list
6667268|NCT01526603|Lenograstim|lenograstim|mesh-list
6667269|NCT01526603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6144998|NCT01351480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6144999|NCT01351480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6145000|NCT01351480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6145001|NCT01351480|Immunologic Factors|immunologic factors|mesh-ancestor
6145002|NCT01351480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145003|NCT01351480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6145004|NCT01351740|Ritonavir|ritonavir|mesh-list
6145005|NCT01351740|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6145006|NCT01351740|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6473739|NCT00511654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6473740|NCT00511654|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6473741|NCT00511654|Anesthetics, General|anesthetics, general|mesh-ancestor
6473742|NCT00511654|Anesthetics|anesthetics|mesh-ancestor
6473743|NCT00511654|GABA Modulators|gaba modulators|mesh-ancestor
6473744|NCT00511654|GABA Agents|gaba agents|mesh-ancestor
6473745|NCT00511654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6667270|NCT01526603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6667271|NCT01526603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6667272|NCT01526603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6145007|NCT01351740|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6145008|NCT01351740|Protease Inhibitors|protease inhibitors|mesh-ancestor
6145009|NCT01351740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6145010|NCT01351740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145011|NCT01351740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6145012|NCT01351740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6145013|NCT01351740|Antiviral Agents|antiviral agents|mesh-ancestor
6145014|NCT01351740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6145015|NCT01351740|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6145016|NCT01351740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6205517|NCT02087085|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6205518|NCT02087085|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6205519|NCT02087085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6205520|NCT02087085|Adrenergic Agents|adrenergic agents|mesh-ancestor
6205521|NCT02087085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5548275|NCT04114526|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5548276|NCT04114526|Autonomic Agents|autonomic agents|mesh-ancestor
5548277|NCT04114526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6205522|NCT02087085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205523|NCT02087085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205524|NCT02087176|Antimitotic Agents|antimitotic agents|mesh-list
6205525|NCT02087176|Adavosertib|adavosertib|mesh-list
6205526|NCT02087176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6205527|NCT02087176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205528|NCT02087176|Mitosis Modulators|mitosis modulators|mesh-ancestor
6205529|NCT02087176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6205530|NCT02087241|Carboplatin|carboplatin|mesh-list
6205531|NCT02087241|Pemetrexed|pemetrexed|mesh-list
6205532|NCT02087241|Adavosertib|adavosertib|mesh-list
6205533|NCT02087241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6205534|NCT02087241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6205535|NCT02087241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205536|NCT02087241|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6205537|NCT02087241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6205538|NCT02087306|Brincidofovir|brincidofovir|mesh-list
6205539|NCT02087306|Antiviral Agents|antiviral agents|mesh-ancestor
6205540|NCT02087306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5548278|NCT04114526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548279|NCT04114526|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5548280|NCT04114526|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5548281|NCT04114526|Cholinergic Agents|cholinergic agents|mesh-ancestor
5548282|NCT04114526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5548283|NCT04114526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5548284|NCT04114461|Tofacitinib|tofacitinib|mesh-list
5548285|NCT04114461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5548286|NCT04114461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5548287|NCT04114461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5548288|NCT04114396|Antibodies|antibodies|mesh-list
5548289|NCT04114396|Immunologic Factors|immunologic factors|mesh-ancestor
5548290|NCT04114396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548291|NCT04114188|Prednisolone|prednisolone|mesh-list
5548292|NCT04114188|Infliximab|infliximab|mesh-list
6205541|NCT02087423|Durvalumab|durvalumab|mesh-list
6205542|NCT02087423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6205543|NCT02087423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6473746|NCT00511654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473747|NCT00511719|Insulin|insulin|mesh-list
6473748|NCT00511719|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6473749|NCT00511719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6473750|NCT00511719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473751|NCT00511732|Insulin|insulin|mesh-list
6473752|NCT00511732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6473753|NCT00511732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473754|NCT00511771|Tegaserod|tegaserod|mesh-list
6473755|NCT00511771|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6473756|NCT00511771|Serotonin Agents|serotonin agents|mesh-ancestor
6473757|NCT00511771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6205544|NCT02087748|Diclofenac|diclofenac|mesh-list
6205545|NCT02087748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6205546|NCT02087748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6205547|NCT02087748|Analgesics|analgesics|mesh-ancestor
6205548|NCT02087748|Sensory System Agents|sensory system agents|mesh-ancestor
6205549|NCT02087748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6667273|NCT01526603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5548293|NCT04114188|Tacrolimus|tacrolimus|mesh-list
5548294|NCT04114188|Thymoglobulin|thymoglobulin|mesh-list
6145017|NCT01351753|Metformin|metformin|mesh-list
6145018|NCT01351753|Topiramate|topiramate|mesh-list
6145019|NCT01351753|Orlistat|orlistat|mesh-list
6145020|NCT01351753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6145021|NCT01351753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145022|NCT01351753|Anticonvulsants|anticonvulsants|mesh-ancestor
6145023|NCT01351753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6145024|NCT01351753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145025|NCT01351753|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6145026|NCT01351753|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6145027|NCT01351766|Nicotine|nicotine|mesh-list
6145028|NCT01351766|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6145029|NCT01351766|Autonomic Agents|autonomic agents|mesh-ancestor
6145030|NCT01351766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6145031|NCT01351766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145032|NCT01351766|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6145033|NCT01351766|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6145034|NCT01351766|Cholinergic Agents|cholinergic agents|mesh-ancestor
6145035|NCT01351766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6145036|NCT01351766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145037|NCT01351805|Vitamin D|vitamin d|mesh-list
6145038|NCT01351805|Ergocalciferols|ergocalciferols|mesh-list
6145039|NCT01351805|Cholecalciferol|cholecalciferol|mesh-list
6145040|NCT01351805|Vitamins|vitamins|mesh-list
6145041|NCT01351805|Micronutrients|micronutrients|mesh-ancestor
6145042|NCT01351805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145043|NCT01351805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6145044|NCT01351805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6145045|NCT01352117|Tenofovir|tenofovir|mesh-list
6145046|NCT01352117|Emtricitabine|emtricitabine|mesh-list
6145047|NCT01352117|Efavirenz|efavirenz|mesh-list
6145048|NCT01352117|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6145049|NCT01352117|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6145050|NCT01352117|Etoposide|etoposide|mesh-list
6145051|NCT01352117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6473758|NCT00511771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473759|NCT00511771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145052|NCT01352117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6145053|NCT01352117|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6145054|NCT01352117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6145055|NCT01352117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6145056|NCT01352117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145057|NCT01352117|Antiviral Agents|antiviral agents|mesh-ancestor
6145058|NCT01352117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6145059|NCT01352117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6145060|NCT01352117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6145061|NCT01352117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6145062|NCT01352117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6145063|NCT01352117|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6145064|NCT01352117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6145065|NCT01352117|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6145066|NCT01352117|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6473760|NCT00511823|Rosiglitazone|rosiglitazone|mesh-list
6473761|NCT00511823|Granisetron|granisetron|mesh-list
6473762|NCT00511823|Casopitant|casopitant|mesh-list
6473763|NCT00511823|Dolasetron|dolasetron|mesh-list
6473764|NCT00511823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6473765|NCT00511823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473766|NCT00511823|Antiemetics|antiemetics|mesh-ancestor
5548295|NCT04114188|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6145067|NCT01352117|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6145068|NCT01352117|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6145069|NCT01352182|Pioglitazone|pioglitazone|mesh-list
6145070|NCT01352182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6145071|NCT01352182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145072|NCT01352221|Ferric maltol|ferric maltol|mesh-list
6145073|NCT01352221|Hematinics|hematinics|mesh-ancestor
5548296|NCT04114188|Immunoglobulins|immunoglobulins|mesh-list
5548297|NCT04114188|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5548298|NCT04114188|Antibodies|antibodies|mesh-list
5548299|NCT04114188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5548300|NCT04114188|Immunologic Factors|immunologic factors|mesh-ancestor
5548301|NCT04114188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548302|NCT04114188|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5548303|NCT04114188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5548304|NCT04114188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5548305|NCT04114188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5548306|NCT04114188|Glucocorticoids|glucocorticoids|mesh-ancestor
5548307|NCT04114188|Hormones|hormones|mesh-ancestor
5548308|NCT04114188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5548309|NCT04114188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5548310|NCT04114188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5548311|NCT04114188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5548312|NCT04114188|Dermatologic Agents|dermatologic agents|mesh-ancestor
5548313|NCT04114188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5548314|NCT04114136|Metformin|metformin|mesh-list
5548315|NCT04114136|Rosiglitazone|rosiglitazone|mesh-list
5548316|NCT04114136|Pembrolizumab|pembrolizumab|mesh-list
5548317|NCT04114136|Nivolumab|nivolumab|mesh-list
6145074|NCT01352507|Sildenafil Citrate|sildenafil citrate|mesh-list
6145075|NCT01352507|Tadalafil|tadalafil|mesh-list
6145076|NCT01352507|Vasodilator Agents|vasodilator agents|mesh-ancestor
6145077|NCT01352507|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6145078|NCT01352507|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6145079|NCT01352507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6145080|NCT01352507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145081|NCT01352507|Urological Agents|urological agents|mesh-ancestor
6145082|NCT01352585|Anagrelide|anagrelide|mesh-list
6145083|NCT01352585|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6145084|NCT01352585|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6145085|NCT01352585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145086|NCT01352585|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6145087|NCT01352637|Cycloserine|cycloserine|mesh-list
6145088|NCT01352637|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6145089|NCT01352637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6145090|NCT01352637|Renal Agents|renal agents|mesh-ancestor
6145091|NCT01352637|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6145092|NCT01352637|Antitubercular Agents|antitubercular agents|mesh-ancestor
6145093|NCT01352637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6145094|NCT01352637|Antimetabolites|antimetabolites|mesh-ancestor
6145095|NCT01352637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145096|NCT01352715|Ritonavir|ritonavir|mesh-list
6145097|NCT01352715|Lopinavir|lopinavir|mesh-list
6145098|NCT01352715|Tenofovir|tenofovir|mesh-list
6145099|NCT01352715|Lamivudine|lamivudine|mesh-list
6145100|NCT01352715|Zidovudine|zidovudine|mesh-list
6145101|NCT01352715|Emtricitabine|emtricitabine|mesh-list
6145102|NCT01352715|Raltegravir Potassium|raltegravir potassium|mesh-list
6145103|NCT01352715|Abacavir|abacavir|mesh-list
6145104|NCT01352715|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6145105|NCT01352715|Dideoxynucleosides|dideoxynucleosides|mesh-list
6145106|NCT01352715|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6145107|NCT01352715|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6145108|NCT01352715|Protease Inhibitors|protease inhibitors|mesh-ancestor
6145109|NCT01352715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6145110|NCT01352715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5548318|NCT04114136|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5548319|NCT04114136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145111|NCT01352715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6473767|NCT00511823|Autonomic Agents|autonomic agents|mesh-ancestor
6473768|NCT00511823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6145112|NCT01352715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6145113|NCT01352715|Antiviral Agents|antiviral agents|mesh-ancestor
5548320|NCT04114136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5548321|NCT04114136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5548322|NCT04114136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5548323|NCT04114136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5548324|NCT04114149|Analgesics, Opioid|analgesics, opioid|mesh-list
5548325|NCT04114149|Narcotics|narcotics|mesh-ancestor
5548326|NCT04114149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5548327|NCT04114149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548328|NCT04114149|Analgesics|analgesics|mesh-ancestor
5548329|NCT04114149|Sensory System Agents|sensory system agents|mesh-ancestor
5548330|NCT04114149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5548331|NCT04113772|Nitisinone|nitisinone|mesh-list
5548332|NCT04113772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6145114|NCT01352715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6145115|NCT01352715|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6473769|NCT00511823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6473770|NCT00511823|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6473771|NCT00511823|Serotonin Agents|serotonin agents|mesh-ancestor
6473772|NCT00511823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6473773|NCT00511823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473774|NCT00511823|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6473775|NCT00511849|Paclitaxel|paclitaxel|mesh-list
6473776|NCT00511849|Carboplatin|carboplatin|mesh-list
5548333|NCT04113772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5548334|NCT04113863|Anastrozole|anastrozole|mesh-list
5548335|NCT04113863|Tretinoin|tretinoin|mesh-list
5548336|NCT04113863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5548337|NCT04113863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5548338|NCT04113863|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5548339|NCT04113863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5548340|NCT04113863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5548341|NCT04113863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5548342|NCT04113863|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5548343|NCT04113863|Hormone Antagonists|hormone antagonists|mesh-ancestor
5548344|NCT04113863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5548345|NCT04113863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548346|NCT04113863|Keratolytic Agents|keratolytic agents|mesh-ancestor
5548347|NCT04113863|Dermatologic Agents|dermatologic agents|mesh-ancestor
5548348|NCT04113954|Prilocaine|prilocaine|mesh-list
5548349|NCT04113954|Mepivacaine|mepivacaine|mesh-list
5548350|NCT04113954|Anesthetics, Local|anesthetics, local|mesh-ancestor
5548351|NCT04113954|Anesthetics|anesthetics|mesh-ancestor
5548352|NCT04113954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5548353|NCT04113954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548354|NCT04113954|Sensory System Agents|sensory system agents|mesh-ancestor
6145116|NCT01352715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6145117|NCT01352715|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6145118|NCT01352715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6145119|NCT01352715|Antimetabolites|antimetabolites|mesh-ancestor
6145120|NCT01352715|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6145121|NCT01352715|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6145122|NCT01352741|Pregabalin|pregabalin|mesh-list
6145123|NCT01352741|Tapentadol|tapentadol|mesh-list
6145124|NCT01352741|Analgesics|analgesics|mesh-ancestor
6145125|NCT01352741|Sensory System Agents|sensory system agents|mesh-ancestor
6145126|NCT01352741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6145127|NCT01352741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667274|NCT01526603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667275|NCT01526603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6667276|NCT01526603|Alkylating Agents|alkylating agents|mesh-ancestor
6145128|NCT01352741|Anticonvulsants|anticonvulsants|mesh-ancestor
6145129|NCT01352741|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6145130|NCT01352741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6145131|NCT01352741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145132|NCT01352741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6145133|NCT01352741|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6145134|NCT01352741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6145135|NCT01352741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6145136|NCT01352741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6145137|NCT01352741|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6145138|NCT01352741|Narcotics|narcotics|mesh-ancestor
6473777|NCT00511849|Sunitinib|sunitinib|mesh-list
6145139|NCT01352741|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6145140|NCT01352741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6145141|NCT01352741|Adrenergic Agents|adrenergic agents|mesh-ancestor
6145142|NCT01352741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6145143|NCT01353144|Aspirin|aspirin|mesh-list
6145144|NCT01353144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6145145|NCT01353144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6145146|NCT01353144|Analgesics|analgesics|mesh-ancestor
6473778|NCT00511849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6473779|NCT00511849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6473780|NCT00511849|Tubulin Modulators|tubulin modulators|mesh-ancestor
6473781|NCT00511849|Antimitotic Agents|antimitotic agents|mesh-ancestor
6473782|NCT00511849|Mitosis Modulators|mitosis modulators|mesh-ancestor
6473783|NCT00511849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473784|NCT00511849|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6145147|NCT01353144|Sensory System Agents|sensory system agents|mesh-ancestor
6145148|NCT01353144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6145149|NCT01353144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145150|NCT01353144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6145151|NCT01353144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6145152|NCT01353144|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6145153|NCT01353144|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6145154|NCT01353144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145155|NCT01353144|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6145156|NCT01353144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6145157|NCT01353144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6145158|NCT01353144|Antipyretics|antipyretics|mesh-ancestor
6145159|NCT01353508|Valsartan|valsartan|mesh-list
6473785|NCT00511849|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6473786|NCT00511849|Growth Substances|growth substances|mesh-ancestor
6145160|NCT01353508|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
6145161|NCT01353508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6145162|NCT01353508|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6145163|NCT01353508|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5548355|NCT04113954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5548356|NCT04113915|Cyclosporine|cyclosporine|mesh-list
5548357|NCT04113915|Dexamethasone|dexamethasone|mesh-list
5548358|NCT04113915|Cyclosporins|cyclosporins|mesh-list
5548359|NCT04113915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5548360|NCT04113915|Antiemetics|antiemetics|mesh-ancestor
5548361|NCT04113915|Autonomic Agents|autonomic agents|mesh-ancestor
5548362|NCT04113915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6145164|NCT01353508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145165|NCT01353664|Romidepsin|romidepsin|mesh-list
6145166|NCT01353664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6145167|NCT01353664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6145168|NCT01353859|Methotrexate|methotrexate|mesh-list
6145169|NCT01353859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6145170|NCT01353859|Abortifacient Agents|abortifacient agents|mesh-ancestor
6145171|NCT01353859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6145172|NCT01353859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145173|NCT01353859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6145174|NCT01353859|Antimetabolites|antimetabolites|mesh-ancestor
6145175|NCT01353859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145176|NCT01353859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6145177|NCT01353859|Dermatologic Agents|dermatologic agents|mesh-ancestor
6145178|NCT01353859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6145179|NCT01353859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6145180|NCT01353859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6145181|NCT01353859|Immunologic Factors|immunologic factors|mesh-ancestor
6145182|NCT01353859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6145183|NCT01353859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6145184|NCT01353911|Interferons|interferons|mesh-list
6145185|NCT01353911|Ribavirin|ribavirin|mesh-list
6145186|NCT01353911|Interferon-alpha|interferon-alpha|mesh-list
6145187|NCT01353911|Interferon alpha-2|interferon alpha-2|mesh-list
6667277|NCT01526603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5548363|NCT04113915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548364|NCT04113915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5548365|NCT04113915|Glucocorticoids|glucocorticoids|mesh-ancestor
5548366|NCT04113915|Hormones|hormones|mesh-ancestor
5548367|NCT04113915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5548368|NCT04113915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6667278|NCT01526603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5548369|NCT04113915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5548370|NCT04113915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5548371|NCT04113915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5548372|NCT04113915|Immunologic Factors|immunologic factors|mesh-ancestor
5548373|NCT04113915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5548374|NCT04113915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5548375|NCT04113915|Antifungal Agents|antifungal agents|mesh-ancestor
5548376|NCT04113915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5548377|NCT04113915|Dermatologic Agents|dermatologic agents|mesh-ancestor
5548378|NCT04113915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5548379|NCT04113889|Acetylcarnitine|acetylcarnitine|mesh-list
5548380|NCT04113889|Metformin|metformin|mesh-list
5548381|NCT04113889|Pioglitazone|pioglitazone|mesh-list
6667279|NCT01526603|Immunologic Factors|immunologic factors|mesh-ancestor
6667280|NCT01526603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667281|NCT01526603|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6473787|NCT00511849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473788|NCT00511849|Growth Inhibitors|growth inhibitors|mesh-ancestor
6473789|NCT00511849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6473790|NCT00511849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6473791|NCT00511940|Acamprosate|acamprosate|mesh-list
6473792|NCT00511940|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6473793|NCT00511953|Gabapentin|gabapentin|mesh-list
6473794|NCT00511953|Analgesics|analgesics|mesh-ancestor
6473795|NCT00511953|Sensory System Agents|sensory system agents|mesh-ancestor
6473796|NCT00511953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6667282|NCT01526603|Keratolytic Agents|keratolytic agents|mesh-ancestor
6145188|NCT01353911|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6145189|NCT01353911|Grazoprevir|grazoprevir|mesh-list
6145190|NCT01353911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6145191|NCT01353911|Antiviral Agents|antiviral agents|mesh-ancestor
6667283|NCT01526603|Dermatologic Agents|dermatologic agents|mesh-ancestor
6667284|NCT01526616|Metformin|metformin|mesh-list
6667285|NCT01526616|Spironolactone|spironolactone|mesh-list
6667286|NCT01526616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6667287|NCT01526616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667288|NCT01526616|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6667289|NCT01526616|Hormone Antagonists|hormone antagonists|mesh-ancestor
6667290|NCT01526616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6667291|NCT01526616|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6667292|NCT01526616|Diuretics|diuretics|mesh-ancestor
6667293|NCT01526616|Natriuretic Agents|natriuretic agents|mesh-ancestor
6667294|NCT01526694|Thalidomide|thalidomide|mesh-list
6145192|NCT01353911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6145193|NCT01353911|Antimetabolites|antimetabolites|mesh-ancestor
6145194|NCT01353911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145195|NCT01353911|Immunologic Factors|immunologic factors|mesh-ancestor
6145196|NCT01353911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145197|NCT01353963|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6145198|NCT01353963|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6145199|NCT01353963|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6145200|NCT01353963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6145201|NCT01353963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145202|NCT01353963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6145203|NCT01353963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145204|NCT01353963|Antidepressive Agents|antidepressive agents|mesh-ancestor
6145205|NCT01353963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6145206|NCT01353976|Econazole|econazole|mesh-list
6145207|NCT01353976|Antifungal Agents|antifungal agents|mesh-ancestor
6145208|NCT01353976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6145209|NCT01353976|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6145210|NCT01353976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6145211|NCT01353976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6145212|NCT01353976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145213|NCT01353976|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6145214|NCT01353976|Hormone Antagonists|hormone antagonists|mesh-ancestor
6145215|NCT01353976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6145216|NCT01353976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145217|NCT01354132|Acetylcysteine|acetylcysteine|mesh-list
6145218|NCT01354132|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6145219|NCT01354132|Antiviral Agents|antiviral agents|mesh-ancestor
6145220|NCT01354132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6473797|NCT00511953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667295|NCT01526694|Dexamethasone|dexamethasone|mesh-list
5548382|NCT04113889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5548383|NCT04113889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548384|NCT04113889|Vitamin B Complex|vitamin b complex|mesh-ancestor
5548385|NCT04113889|Vitamins|vitamins|mesh-ancestor
5548386|NCT04113889|Micronutrients|micronutrients|mesh-ancestor
5548387|NCT04113889|Nootropic Agents|nootropic agents|mesh-ancestor
5548388|NCT04113928|Mechlorethamine|mechlorethamine|mesh-list
5548389|NCT04113928|Alkylating Agents|alkylating agents|mesh-ancestor
5548390|NCT04113928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5548391|NCT04113928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6145221|NCT01354132|Expectorants|expectorants|mesh-ancestor
6145222|NCT01354132|Respiratory System Agents|respiratory system agents|mesh-ancestor
6145223|NCT01354132|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6145224|NCT01354132|Antioxidants|antioxidants|mesh-ancestor
6145225|NCT01354132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145226|NCT01354132|Protective Agents|protective agents|mesh-ancestor
6145227|NCT01354132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145228|NCT01354132|Antidotes|antidotes|mesh-ancestor
6145229|NCT01354145|Celecoxib|celecoxib|mesh-list
6145230|NCT01354145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6145231|NCT01354145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6145232|NCT01354145|Analgesics|analgesics|mesh-ancestor
6145233|NCT01354145|Sensory System Agents|sensory system agents|mesh-ancestor
6145234|NCT01354145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6145235|NCT01354145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145236|NCT01354145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6145237|NCT01354145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6145238|NCT01354145|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6145239|NCT01354145|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6145240|NCT01354145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6145241|NCT01354145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145242|NCT01354314|Fluconazole|fluconazole|mesh-list
6145243|NCT01354314|Paroxetine|paroxetine|mesh-list
6145244|NCT01354314|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6145245|NCT01354314|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6145246|NCT01354314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6145247|NCT01354314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145248|NCT01354314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5548392|NCT04113928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5548393|NCT04114097|Betamethasone|betamethasone|mesh-list
5548394|NCT04114097|Betamethasone Valerate|betamethasone valerate|mesh-list
6473798|NCT00511953|Anticonvulsants|anticonvulsants|mesh-ancestor
5548395|NCT04114097|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5548396|NCT04114097|Betamethasone benzoate|betamethasone benzoate|mesh-list
5548397|NCT04114097|Tacrolimus|tacrolimus|mesh-list
5548398|NCT04114097|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
5548399|NCT04114097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6473799|NCT00511953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6473800|NCT00511953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6473801|NCT00511953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5548400|NCT04114097|Immunologic Factors|immunologic factors|mesh-ancestor
5548401|NCT04114097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548402|NCT04114097|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5548403|NCT04114097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5548404|NCT04114097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5548405|NCT04114097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5548406|NCT04114097|Glucocorticoids|glucocorticoids|mesh-ancestor
5548407|NCT04114097|Hormones|hormones|mesh-ancestor
5548408|NCT04114097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5548409|NCT04114097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5548410|NCT04114097|Respiratory System Agents|respiratory system agents|mesh-ancestor
5548411|NCT04113941|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6473802|NCT00511953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6473803|NCT00511953|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6473804|NCT00511953|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6473805|NCT00511953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6473806|NCT00511953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473807|NCT00511953|Antimanic Agents|antimanic agents|mesh-ancestor
6145249|NCT01354314|Serotonin Agents|serotonin agents|mesh-ancestor
6145250|NCT01354314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145251|NCT01354314|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6145252|NCT01354314|Antidepressive Agents|antidepressive agents|mesh-ancestor
6145253|NCT01354314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6473808|NCT00511966|Rabeprazole|rabeprazole|mesh-list
6473809|NCT00511966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5548412|NCT04113941|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5548413|NCT04113941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5548414|NCT04113941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548415|NCT04113941|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5548416|NCT04113941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5548417|NCT04113941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5548418|NCT04113941|Cholinergic Agents|cholinergic agents|mesh-ancestor
5548419|NCT04113941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5548420|NCT04113993|Bazedoxifene|bazedoxifene|mesh-list
5548421|NCT04113993|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5548422|NCT04113993|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5548423|NCT04113993|Hormone Antagonists|hormone antagonists|mesh-ancestor
5548424|NCT04113993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5548425|NCT04113993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548426|NCT04113993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5548427|NCT04113668|Diflunisal|diflunisal|mesh-list
5548428|NCT04113668|BMS-986165|bms-986165|mesh-list
5548429|NCT04113668|Dermatologic Agents|dermatologic agents|mesh-ancestor
5548430|NCT04113668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5548431|NCT04113668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5548432|NCT04113668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5548433|NCT04113668|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5548434|NCT04113668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5548435|NCT04113668|Analgesics|analgesics|mesh-ancestor
5548436|NCT04113668|Sensory System Agents|sensory system agents|mesh-ancestor
5548437|NCT04113668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5548438|NCT04113668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548439|NCT04113668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5548440|NCT04113668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5548441|NCT04113668|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5548442|NCT04113551|Guanfacine|guanfacine|mesh-list
5548443|NCT04113551|Methylphenidate|methylphenidate|mesh-list
5548444|NCT04113551|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
5548445|NCT04113551|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5548446|NCT04113551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5548447|NCT04113551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5548448|NCT04113551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5548449|NCT04113551|Adrenergic Agents|adrenergic agents|mesh-ancestor
5548450|NCT04113551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5548451|NCT04113551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548452|NCT04113551|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5548453|NCT04113551|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5548454|NCT04113551|Dopamine Agents|dopamine agents|mesh-ancestor
5548455|NCT04113551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5548456|NCT04113551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5548457|NCT04113551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6473810|NCT00511966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6473811|NCT00511966|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6473812|NCT00511966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6473813|NCT00511966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473814|NCT00511979|Insulin|insulin|mesh-list
6145254|NCT01354314|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6145255|NCT01354314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6145256|NCT01354314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5548458|NCT04113551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5602751|NCT04209543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602752|NCT04192370|Cannabidiol|cannabidiol|mesh-list
5602753|NCT04192370|Anticonvulsants|anticonvulsants|mesh-ancestor
5602754|NCT04188028|Dextromethorphan|dextromethorphan|mesh-list
5602755|NCT04188028|Paroxetine|paroxetine|mesh-list
5602756|NCT04188028|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5602757|NCT04188028|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6145257|NCT01354314|Antifungal Agents|antifungal agents|mesh-ancestor
6145258|NCT01354314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6145259|NCT01354314|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6145260|NCT01354314|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6145261|NCT01354314|Hormone Antagonists|hormone antagonists|mesh-ancestor
6145262|NCT01354314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6145263|NCT01354314|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6145264|NCT01354314|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6145265|NCT01354353|Aripiprazole|aripiprazole|mesh-list
5548459|NCT04113317|Lenograstim|lenograstim|mesh-list
5548460|NCT04113317|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5548461|NCT04113317|Immunologic Factors|immunologic factors|mesh-ancestor
5548462|NCT04113317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548463|NCT04113538|Aflibercept|aflibercept|mesh-list
5548464|NCT04113538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5548465|NCT04113538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5548466|NCT04113538|Growth Substances|growth substances|mesh-ancestor
5548467|NCT04113538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548468|NCT04113538|Growth Inhibitors|growth inhibitors|mesh-ancestor
5548469|NCT04113538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6145266|NCT01354353|Antidepressive Agents|antidepressive agents|mesh-ancestor
6145267|NCT01354353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6145268|NCT01354353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6145269|NCT01354353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6145270|NCT01354353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6145271|NCT01354353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145272|NCT01354353|Dopamine Agonists|dopamine agonists|mesh-ancestor
6145273|NCT01354353|Dopamine Agents|dopamine agents|mesh-ancestor
6145274|NCT01354353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5548470|NCT04113226|Rituximab|rituximab|mesh-list
5548471|NCT04113226|Lenalidomide|lenalidomide|mesh-list
5548472|NCT04113226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6145275|NCT01354353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145276|NCT01354353|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6145277|NCT01354353|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6145278|NCT01354353|Serotonin Agents|serotonin agents|mesh-ancestor
6145279|NCT01354353|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6145280|NCT01354353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6145281|NCT01354353|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6145282|NCT01354353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6145283|NCT01354431|Nivolumab|nivolumab|mesh-list
6145284|NCT01354431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6473815|NCT00511979|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6473816|NCT00511979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6473817|NCT00511979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548473|NCT04113226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5548474|NCT04113226|Immunologic Factors|immunologic factors|mesh-ancestor
5548475|NCT04113226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548476|NCT04113226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5548477|NCT04113226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5548478|NCT04113226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5548479|NCT04113226|Growth Substances|growth substances|mesh-ancestor
5548480|NCT04113226|Growth Inhibitors|growth inhibitors|mesh-ancestor
5548481|NCT04113109|Icatibant|icatibant|mesh-list
5548482|NCT04113109|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5548483|NCT04113109|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5548484|NCT04113109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5548485|NCT04113109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5548486|NCT04113109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5548487|NCT04113109|Analgesics|analgesics|mesh-ancestor
5548488|NCT04113109|Sensory System Agents|sensory system agents|mesh-ancestor
5548489|NCT04113109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5548490|NCT04113109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548491|NCT04113109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5548492|NCT04113109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5548493|NCT04113109|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
5548494|NCT04113109|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
5548495|NCT04113109|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5548496|NCT04113109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5548497|NCT04113109|Immunologic Factors|immunologic factors|mesh-ancestor
5548498|NCT04113005|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
5548499|NCT04113005|Hemostatics|hemostatics|mesh-ancestor
5548500|NCT04113005|Coagulants|coagulants|mesh-ancestor
5548501|NCT04113005|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5548502|NCT04113005|Natriuretic Agents|natriuretic agents|mesh-ancestor
5548503|NCT04113005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548504|NCT04113018|Dexamethasone|dexamethasone|mesh-list
5548505|NCT04113018|Lenalidomide|lenalidomide|mesh-list
6473818|NCT00512044|Anesthetics|anesthetics|mesh-list
6473819|NCT00512044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6473820|NCT00512044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473821|NCT00512057|Allopurinol|allopurinol|mesh-list
6473822|NCT00512057|Antimetabolites|antimetabolites|mesh-ancestor
5548506|NCT04113018|Daratumumab|daratumumab|mesh-list
6473823|NCT00512057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473824|NCT00512057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6473825|NCT00512057|Gout Suppressants|gout suppressants|mesh-ancestor
6473826|NCT00512057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6473827|NCT00512057|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6473828|NCT00512057|Antioxidants|antioxidants|mesh-ancestor
6473829|NCT00512057|Protective Agents|protective agents|mesh-ancestor
6473830|NCT00512057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473831|NCT00512070|Olanzapine|olanzapine|mesh-list
6473832|NCT00512070|Melatonin|melatonin|mesh-list
6473833|NCT00512070|Antioxidants|antioxidants|mesh-ancestor
6473834|NCT00512070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473835|NCT00512070|Protective Agents|protective agents|mesh-ancestor
6473836|NCT00512070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473837|NCT00512070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6473838|NCT00512070|Antiemetics|antiemetics|mesh-ancestor
6473839|NCT00512070|Autonomic Agents|autonomic agents|mesh-ancestor
6473840|NCT00512070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6473841|NCT00512070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6473842|NCT00512070|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6473843|NCT00512070|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6473844|NCT00512070|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6473845|NCT00512070|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6473846|NCT00512070|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6473847|NCT00512070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6473848|NCT00512070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5548507|NCT04113018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5548508|NCT04113018|Antiemetics|antiemetics|mesh-ancestor
5548509|NCT04113018|Autonomic Agents|autonomic agents|mesh-ancestor
5548510|NCT04113018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6473849|NCT00512070|Serotonin Agents|serotonin agents|mesh-ancestor
6473850|NCT00512265|Acetylcysteine|acetylcysteine|mesh-list
6473851|NCT00512265|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6145285|NCT01354431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6145286|NCT01354431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6145287|NCT01354431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145288|NCT01354444|Carvedilol|carvedilol|mesh-list
6145289|NCT01354444|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6145290|NCT01354444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6145291|NCT01354444|Adrenergic Agents|adrenergic agents|mesh-ancestor
6145292|NCT01354444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6145293|NCT01354444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145294|NCT01354444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145295|NCT01354444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6145296|NCT01354444|Antioxidants|antioxidants|mesh-ancestor
6145297|NCT01354444|Protective Agents|protective agents|mesh-ancestor
6145298|NCT01354444|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6145299|NCT01354444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6145300|NCT01354444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6145301|NCT01354444|Vasodilator Agents|vasodilator agents|mesh-ancestor
6145302|NCT01354444|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6145303|NCT01354444|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6145304|NCT01354652|Lamivudine|lamivudine|mesh-list
6145305|NCT01354652|Entecavir|entecavir|mesh-list
6145306|NCT01354652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6145307|NCT01354652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6473852|NCT00512265|Antiviral Agents|antiviral agents|mesh-ancestor
5548511|NCT04113018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548512|NCT04113018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5548513|NCT04113018|Glucocorticoids|glucocorticoids|mesh-ancestor
5548514|NCT04113018|Hormones|hormones|mesh-ancestor
5548515|NCT04113018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5548516|NCT04113018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5548517|NCT04113018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5548518|NCT04113018|Immunologic Factors|immunologic factors|mesh-ancestor
5548519|NCT04113018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5548520|NCT04113018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5548521|NCT04113018|Growth Substances|growth substances|mesh-ancestor
5548522|NCT04113018|Growth Inhibitors|growth inhibitors|mesh-ancestor
5548523|NCT04112823|Dexamethasone|dexamethasone|mesh-list
5548524|NCT04112823|Dexamethasone acetate|dexamethasone acetate|mesh-list
5548525|NCT04112823|BB 1101|bb 1101|mesh-list
5548526|NCT04112823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5548527|NCT04112823|Antiemetics|antiemetics|mesh-ancestor
5548528|NCT04112823|Autonomic Agents|autonomic agents|mesh-ancestor
6145308|NCT01354652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6145309|NCT01354652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145310|NCT01354652|Antiviral Agents|antiviral agents|mesh-ancestor
6145311|NCT01354652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6145312|NCT01354652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6145313|NCT01354652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6145314|NCT01354938|Clarithromycin|clarithromycin|mesh-list
6145315|NCT01354938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6145316|NCT01354938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6145317|NCT01354938|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6145318|NCT01354938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6145319|NCT01354938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145320|NCT01354938|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6145321|NCT01354938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6145322|NCT01354964|Vitamin D|vitamin d|mesh-list
6145323|NCT01354964|Ergocalciferols|ergocalciferols|mesh-list
6145324|NCT01354964|Cholecalciferol|cholecalciferol|mesh-list
6145325|NCT01354964|Vitamins|vitamins|mesh-list
6145326|NCT01354964|Micronutrients|micronutrients|mesh-ancestor
6145327|NCT01354964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145328|NCT01354964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6145329|NCT01354964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6145330|NCT01354990|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6145331|NCT01354990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6145332|NCT01354990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145333|NCT01354990|Incretins|incretins|mesh-ancestor
6145334|NCT01354990|Hormones|hormones|mesh-ancestor
6145335|NCT01354990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6145336|NCT01354990|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6145337|NCT01354990|Protease Inhibitors|protease inhibitors|mesh-ancestor
6145338|NCT01354990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6145339|NCT01354990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145340|NCT01355068|Phenytoin|phenytoin|mesh-list
6145341|NCT01355068|Anticonvulsants|anticonvulsants|mesh-ancestor
6145342|NCT01355068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6145343|NCT01355068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6145344|NCT01355068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6145345|NCT01355068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145346|NCT01355068|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6145347|NCT01355068|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6145348|NCT01355081|Vortioxetine|vortioxetine|mesh-list
6145349|NCT01355081|Antidepressive Agents|antidepressive agents|mesh-ancestor
6145350|NCT01355081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5548529|NCT04112823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5548530|NCT04112823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548531|NCT04112823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5548532|NCT04112823|Glucocorticoids|glucocorticoids|mesh-ancestor
5548533|NCT04112823|Hormones|hormones|mesh-ancestor
6145351|NCT01355081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6145352|NCT01355081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6473853|NCT00512265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6473854|NCT00512265|Expectorants|expectorants|mesh-ancestor
6473855|NCT00512265|Respiratory System Agents|respiratory system agents|mesh-ancestor
6473856|NCT00512265|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6473857|NCT00512265|Antioxidants|antioxidants|mesh-ancestor
6473858|NCT00512265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473859|NCT00512265|Protective Agents|protective agents|mesh-ancestor
6473860|NCT00512265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473861|NCT00512265|Antidotes|antidotes|mesh-ancestor
5602758|NCT04188028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6145353|NCT01355081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6145354|NCT01355081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145355|NCT01355081|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6145356|NCT01355081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6145357|NCT01355081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6145358|NCT01355081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145359|NCT01355081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6145360|NCT01355081|Serotonin Agents|serotonin agents|mesh-ancestor
6145361|NCT01355081|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6145362|NCT01355081|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6145363|NCT01355081|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6145364|NCT01355081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6473862|NCT00512291|Olanzapine|olanzapine|mesh-list
6473863|NCT00512291|Fluoxetine|fluoxetine|mesh-list
6473864|NCT00512291|Antiemetics|antiemetics|mesh-ancestor
6473865|NCT00512291|Autonomic Agents|autonomic agents|mesh-ancestor
6473866|NCT00512291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6473867|NCT00512291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145365|NCT01355159|Folic Acid|folic acid|mesh-list
6145366|NCT01355159|Hematinics|hematinics|mesh-ancestor
6145367|NCT01355159|Vitamin B Complex|vitamin b complex|mesh-ancestor
6145368|NCT01355159|Vitamins|vitamins|mesh-ancestor
6145369|NCT01355159|Micronutrients|micronutrients|mesh-ancestor
6145370|NCT01355159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145371|NCT01355289|Interferons|interferons|mesh-list
6145372|NCT01355289|Ribavirin|ribavirin|mesh-list
6145373|NCT01355289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6145374|NCT01355289|Antiviral Agents|antiviral agents|mesh-ancestor
6145375|NCT01355289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6145376|NCT01355289|Antimetabolites|antimetabolites|mesh-ancestor
6145377|NCT01355289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145378|NCT01355302|Capecitabine|capecitabine|mesh-list
6145379|NCT01355302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6145380|NCT01355302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6145381|NCT01355302|Antimetabolites|antimetabolites|mesh-ancestor
6145382|NCT01355302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145383|NCT01355523|Melatonin|melatonin|mesh-list
6145384|NCT01355523|Antioxidants|antioxidants|mesh-ancestor
6145385|NCT01355523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145386|NCT01355523|Protective Agents|protective agents|mesh-ancestor
6145387|NCT01355523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145388|NCT01355523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6145389|NCT01355575|Rifaximin|rifaximin|mesh-list
6145390|NCT01355575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6145391|NCT01355575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6145392|NCT01355575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6145393|NCT01355588|Ketorolac|ketorolac|mesh-list
6145394|NCT01355588|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6145395|NCT01355588|Lidocaine|lidocaine|mesh-list
6145396|NCT01355588|Anesthetics, Local|anesthetics, local|mesh-ancestor
6145397|NCT01355588|Anesthetics|anesthetics|mesh-ancestor
6145398|NCT01355588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6145399|NCT01355588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145400|NCT01355588|Sensory System Agents|sensory system agents|mesh-ancestor
6145401|NCT01355588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6145402|NCT01355588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6145403|NCT01355588|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6145404|NCT01355588|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6145405|NCT01355588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6145406|NCT01355588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145407|NCT01355588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6145408|NCT01355588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6145409|NCT01355588|Analgesics|analgesics|mesh-ancestor
6145410|NCT01355588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6145411|NCT01355588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6145412|NCT01355588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6145413|NCT01355588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6145414|NCT01355705|Aspirin|aspirin|mesh-list
6145415|NCT01355705|Dexamethasone|dexamethasone|mesh-list
6145416|NCT01355705|Dexamethasone acetate|dexamethasone acetate|mesh-list
6473868|NCT00512291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6473869|NCT00512291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6473870|NCT00512291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6473871|NCT00512291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6473872|NCT00512291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6473873|NCT00512291|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6473874|NCT00512291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6473875|NCT00512291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6473876|NCT00512291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473877|NCT00512291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6473878|NCT00512291|Serotonin Agents|serotonin agents|mesh-ancestor
6473879|NCT00512291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6473880|NCT00512291|Antidepressive Agents|antidepressive agents|mesh-ancestor
6473881|NCT00512291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6473882|NCT00512291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6145417|NCT01355705|Lenalidomide|lenalidomide|mesh-list
6145418|NCT01355705|Amrubicin|amrubicin|mesh-list
6145419|NCT01355705|BB 1101|bb 1101|mesh-list
5548534|NCT04112823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5548535|NCT04112823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5548536|NCT04112823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5548537|NCT04112823|Protease Inhibitors|protease inhibitors|mesh-ancestor
5548538|NCT04112823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6473883|NCT00512291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6473884|NCT00512395|Fentanyl|fentanyl|mesh-list
6473885|NCT00512395|Ropivacaine|ropivacaine|mesh-list
6473886|NCT00512395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6473887|NCT00512395|Narcotics|narcotics|mesh-ancestor
5548539|NCT04112823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5548540|NCT04112589|Cytarabine|cytarabine|mesh-list
6145420|NCT01355705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6145421|NCT01355705|Antiemetics|antiemetics|mesh-ancestor
6145422|NCT01355705|Autonomic Agents|autonomic agents|mesh-ancestor
6145423|NCT01355705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6145424|NCT01355705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145425|NCT01355705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6145426|NCT01355705|Glucocorticoids|glucocorticoids|mesh-ancestor
5548541|NCT04112589|Fludarabine|fludarabine|mesh-list
5548542|NCT04112589|Idarubicin|idarubicin|mesh-list
5548543|NCT04112589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5548544|NCT04112589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5548545|NCT04112589|Antimetabolites|antimetabolites|mesh-ancestor
5548546|NCT04112589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5548547|NCT04112589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5548548|NCT04112589|Immunologic Factors|immunologic factors|mesh-ancestor
5548549|NCT04112589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548550|NCT04112589|Antiviral Agents|antiviral agents|mesh-ancestor
5548551|NCT04112589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5548552|NCT04112589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5548553|NCT04112589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6145427|NCT01355705|Hormones|hormones|mesh-ancestor
6145428|NCT01355705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6145429|NCT01355705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6145430|NCT01355705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6145431|NCT01355705|Protease Inhibitors|protease inhibitors|mesh-ancestor
6145432|NCT01355705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6145433|NCT01355705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145434|NCT01355705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6145435|NCT01355705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6145436|NCT01355705|Analgesics|analgesics|mesh-ancestor
6145437|NCT01355705|Sensory System Agents|sensory system agents|mesh-ancestor
6145438|NCT01355705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6145439|NCT01355705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6145440|NCT01355705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6145441|NCT01355705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6145442|NCT01355705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6145443|NCT01355705|Antipyretics|antipyretics|mesh-ancestor
6145444|NCT01355705|Immunologic Factors|immunologic factors|mesh-ancestor
6145445|NCT01355705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6145446|NCT01355705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6145447|NCT01355705|Growth Substances|growth substances|mesh-ancestor
6145448|NCT01355705|Growth Inhibitors|growth inhibitors|mesh-ancestor
6145449|NCT01356407|Picosulfate sodium|picosulfate sodium|mesh-list
6145450|NCT01356407|Cathartics|cathartics|mesh-ancestor
6145451|NCT01356407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6145452|NCT01356602|Triamcinolone|triamcinolone|mesh-list
6145453|NCT01356602|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6145454|NCT01356602|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6145455|NCT01356602|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6145456|NCT01356602|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6145457|NCT01356602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6145458|NCT01356602|Glucocorticoids|glucocorticoids|mesh-ancestor
6145459|NCT01356602|Hormones|hormones|mesh-ancestor
6145460|NCT01356602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6145461|NCT01356602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145462|NCT01356602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6145463|NCT01356602|Immunologic Factors|immunologic factors|mesh-ancestor
6145464|NCT01356602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6145465|NCT01356602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145466|NCT01356628|Palbociclib|palbociclib|mesh-list
6145467|NCT01356628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6473888|NCT00512395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6145468|NCT01356628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6145469|NCT01356628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6145470|NCT01356628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145471|NCT01356940|4-Aminopyridine|4-aminopyridine|mesh-list
6145472|NCT01356940|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6145473|NCT01356940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6145474|NCT01356940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145475|NCT01356966|Folic Acid|folic acid|mesh-list
6145476|NCT01356966|Hematinics|hematinics|mesh-ancestor
6145477|NCT01356966|Vitamin B Complex|vitamin b complex|mesh-ancestor
6145478|NCT01356966|Vitamins|vitamins|mesh-ancestor
6145479|NCT01356966|Micronutrients|micronutrients|mesh-ancestor
6145480|NCT01356966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145481|NCT01357135|Metformin|metformin|mesh-list
6145482|NCT01357135|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6145483|NCT01357135|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6145484|NCT01357135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145485|NCT01357135|Incretins|incretins|mesh-ancestor
6145486|NCT01357135|Hormones|hormones|mesh-ancestor
6145487|NCT01357135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6145488|NCT01357135|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6145489|NCT01357135|Protease Inhibitors|protease inhibitors|mesh-ancestor
6145490|NCT01357135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6473889|NCT00512395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473890|NCT00512395|Analgesics|analgesics|mesh-ancestor
6473891|NCT00512395|Sensory System Agents|sensory system agents|mesh-ancestor
6473892|NCT00512395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6145491|NCT01357135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145492|NCT01357148|Metformin|metformin|mesh-list
6145493|NCT01357148|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6145494|NCT01357148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6145495|NCT01357148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145496|NCT01357148|Incretins|incretins|mesh-ancestor
6145497|NCT01357148|Hormones|hormones|mesh-ancestor
6145498|NCT01357148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6145499|NCT01357148|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6145500|NCT01357148|Protease Inhibitors|protease inhibitors|mesh-ancestor
6145501|NCT01357148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6145502|NCT01357148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145503|NCT01357161|Paclitaxel|paclitaxel|mesh-list
6145504|NCT01357161|Carboplatin|carboplatin|mesh-list
6145505|NCT01357161|Adavosertib|adavosertib|mesh-list
6145506|NCT01357161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6145507|NCT01357161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6145508|NCT01357161|Tubulin Modulators|tubulin modulators|mesh-ancestor
6145509|NCT01357161|Antimitotic Agents|antimitotic agents|mesh-ancestor
6145510|NCT01357161|Mitosis Modulators|mitosis modulators|mesh-ancestor
6145511|NCT01357161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145512|NCT01357161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6145513|NCT01357616|Timolol|timolol|mesh-list
6145514|NCT01357616|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6145515|NCT01357616|Brinzolamide|brinzolamide|mesh-list
6145516|NCT01357616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6145517|NCT01357616|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6145518|NCT01357616|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6145519|NCT01357616|Adrenergic Agents|adrenergic agents|mesh-ancestor
6145520|NCT01357616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6145521|NCT01357616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145522|NCT01357616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145523|NCT01357616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6145524|NCT01357616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6145525|NCT01357616|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6145526|NCT01357616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6145527|NCT01357655|Dasatinib|dasatinib|mesh-list
6145528|NCT01357655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6145529|NCT01357655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6145530|NCT01357655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6145531|NCT01357655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145532|NCT01357889|rGLP-1 protein|rglp-1 protein|mesh-list
6145533|NCT01357889|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6145534|NCT01357889|Incretins|incretins|mesh-ancestor
6145535|NCT01357889|Hormones|hormones|mesh-ancestor
6145536|NCT01357889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6145537|NCT01357889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145538|NCT01357980|Botulinum Toxins|botulinum toxins|mesh-list
6145539|NCT01357980|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6145540|NCT01357980|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6145541|NCT01357980|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6145542|NCT01357980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5548554|NCT04112589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5548555|NCT04112589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5548556|NCT04112550|Acetaminophen|acetaminophen|mesh-list
5548557|NCT04112550|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
5548558|NCT04112550|Oxycodone|oxycodone|mesh-list
5548559|NCT04112550|Methadone|methadone|mesh-list
5548560|NCT04112550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5548561|NCT04112550|Analgesics|analgesics|mesh-ancestor
5548562|NCT04112550|Sensory System Agents|sensory system agents|mesh-ancestor
5548563|NCT04112550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5548564|NCT04112550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548565|NCT04112550|Antipyretics|antipyretics|mesh-ancestor
5548566|NCT04112550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5548567|NCT04112550|Narcotics|narcotics|mesh-ancestor
5548568|NCT04112550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5548569|NCT04112550|Antitussive Agents|antitussive agents|mesh-ancestor
5548570|NCT04112550|Respiratory System Agents|respiratory system agents|mesh-ancestor
5548571|NCT04112550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5548572|NCT04112550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5548573|NCT04112550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5548574|NCT04112212|Vedolizumab|vedolizumab|mesh-list
5548575|NCT04112212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5548576|NCT04112368|Estradiol|estradiol|mesh-list
5548577|NCT04112368|Progesterone|progesterone|mesh-list
5548578|NCT04112368|Estrogens|estrogens|mesh-ancestor
5548579|NCT04112368|Hormones|hormones|mesh-ancestor
5548580|NCT04112368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5548581|NCT04112368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548582|NCT04112368|Progestins|progestins|mesh-ancestor
5548583|NCT04112407|Benzoyl Peroxide|benzoyl peroxide|mesh-list
5548584|NCT04112407|Dermatologic Agents|dermatologic agents|mesh-ancestor
6145543|NCT01357980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145544|NCT01357980|Cholinergic Agents|cholinergic agents|mesh-ancestor
6145545|NCT01357980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6145546|NCT01357980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145547|NCT01357980|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6145548|NCT01357980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6145549|NCT01358175|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6145550|NCT01358175|Immunologic Factors|immunologic factors|mesh-ancestor
6145551|NCT01358175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548594|NCT04112147|Ubiquinone|ubiquinone|mesh-list
5548595|NCT04112147|Micronutrients|micronutrients|mesh-ancestor
5548596|NCT04112147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548597|NCT04112043|Niacinamide|niacinamide|mesh-list
5548598|NCT04112043|Niacin|niacin|mesh-list
5548599|NCT04112043|Nicotinic Acids|nicotinic acids|mesh-list
5548600|NCT04112043|Vitamin B Complex|vitamin b complex|mesh-ancestor
5548601|NCT04112043|Vitamins|vitamins|mesh-ancestor
5548602|NCT04112043|Micronutrients|micronutrients|mesh-ancestor
5548603|NCT04112043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548604|NCT04112043|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5548605|NCT04112043|Antimetabolites|antimetabolites|mesh-ancestor
5548606|NCT04112043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145552|NCT01358266|Sirolimus|sirolimus|mesh-list
6145553|NCT01358266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6145554|NCT01358266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6145555|NCT01358266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6145556|NCT01358266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6145557|NCT01358266|Antifungal Agents|antifungal agents|mesh-ancestor
6145558|NCT01358266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6145559|NCT01358266|Immunologic Factors|immunologic factors|mesh-ancestor
6145560|NCT01358266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145561|NCT01358357|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
6145562|NCT01358357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6145563|NCT01358357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6145564|NCT01358357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6145565|NCT01358357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145566|NCT01358357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6145567|NCT01358357|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6145568|NCT01358357|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5548607|NCT04112043|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6473893|NCT00512395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5548608|NCT04112043|Vasodilator Agents|vasodilator agents|mesh-ancestor
5548609|NCT04112498|Nivolumab|nivolumab|mesh-list
5548610|NCT04112498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5548611|NCT04112498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5548612|NCT04112498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5548613|NCT04112498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145569|NCT01358357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6145570|NCT01358357|Adrenergic Agents|adrenergic agents|mesh-ancestor
6145571|NCT01358357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6145572|NCT01358357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145573|NCT01358357|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6145574|NCT01358357|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6145575|NCT01358357|Serotonin Agents|serotonin agents|mesh-ancestor
6145576|NCT01358357|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6145577|NCT01358357|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6145578|NCT01358357|Dopamine Agents|dopamine agents|mesh-ancestor
6205550|NCT02087748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548614|NCT04112303|Sofosbuvir|sofosbuvir|mesh-list
5548615|NCT04112303|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
5548616|NCT04112303|Antiviral Agents|antiviral agents|mesh-ancestor
5548617|NCT04112303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5548618|NCT04112394|Anesthetics|anesthetics|mesh-list
5548619|NCT04112394|Anesthetics, Local|anesthetics, local|mesh-list
5548620|NCT04112394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5548621|NCT04112394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548622|NCT04112394|Sensory System Agents|sensory system agents|mesh-ancestor
5548623|NCT04112394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5548624|NCT04111926|Dexmedetomidine|dexmedetomidine|mesh-list
5548625|NCT04111926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5548626|NCT04111926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5548627|NCT04111926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548628|NCT04111926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5548629|NCT04111926|Analgesics|analgesics|mesh-ancestor
5548630|NCT04111926|Sensory System Agents|sensory system agents|mesh-ancestor
5548631|NCT04111926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5548632|NCT04111926|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5548633|NCT04111926|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5548634|NCT04111926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5548635|NCT04111926|Adrenergic Agents|adrenergic agents|mesh-ancestor
5548636|NCT04111926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5548637|NCT04111926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5548638|NCT04111822|Tranexamic Acid|tranexamic acid|mesh-list
5548639|NCT04111822|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5548640|NCT04111822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5548641|NCT04111822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5548642|NCT04111822|Hemostatics|hemostatics|mesh-ancestor
5548643|NCT04111822|Coagulants|coagulants|mesh-ancestor
5548644|NCT04111614|Tofacitinib|tofacitinib|mesh-list
5548645|NCT04111614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5548646|NCT04111614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5548647|NCT04111614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602759|NCT04188028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602760|NCT04188028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6205551|NCT02087748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6205552|NCT02087748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6205553|NCT02087748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6205554|NCT02087748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6205555|NCT02087748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205556|NCT02087943|Thalidomide|thalidomide|mesh-list
6205557|NCT02087943|Apremilast|apremilast|mesh-list
6205558|NCT02087943|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6205559|NCT02087943|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6205560|NCT02087943|Analgesics|analgesics|mesh-ancestor
6205561|NCT02087943|Sensory System Agents|sensory system agents|mesh-ancestor
6205562|NCT02087943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6205563|NCT02087943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205564|NCT02087943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6205565|NCT02087943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6205566|NCT02087943|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6205567|NCT02087943|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6205568|NCT02087943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6145579|NCT01358526|Oxycodone|oxycodone|mesh-list
6145580|NCT01358526|Naloxone|naloxone|mesh-list
6145581|NCT01358526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6145582|NCT01358526|Narcotics|narcotics|mesh-ancestor
6473894|NCT00512395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6473895|NCT00512395|Anesthetics, General|anesthetics, general|mesh-ancestor
6473896|NCT00512395|Anesthetics|anesthetics|mesh-ancestor
6473897|NCT00512395|Anesthetics, Local|anesthetics, local|mesh-ancestor
6473898|NCT00512408|Testosterone|testosterone|mesh-list
6473899|NCT00512408|Androgens|androgens|mesh-ancestor
6473900|NCT00512408|Hormones|hormones|mesh-ancestor
6473901|NCT00512408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6473902|NCT00512408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473903|NCT00512473|Hormones|hormones|mesh-list
6145583|NCT01358526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6145584|NCT01358526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145585|NCT01358526|Analgesics|analgesics|mesh-ancestor
6145586|NCT01358526|Sensory System Agents|sensory system agents|mesh-ancestor
6145587|NCT01358526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6145588|NCT01358526|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6145589|NCT01358578|Etanercept|etanercept|mesh-list
6145590|NCT01358578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6145591|NCT01358578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6145592|NCT01358578|Analgesics|analgesics|mesh-ancestor
6145593|NCT01358578|Sensory System Agents|sensory system agents|mesh-ancestor
6145594|NCT01358578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6145595|NCT01358578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145596|NCT01358578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6145597|NCT01358578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6145598|NCT01358578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6145599|NCT01358578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6145600|NCT01358578|Immunologic Factors|immunologic factors|mesh-ancestor
6145601|NCT01358721|Nivolumab|nivolumab|mesh-list
6145602|NCT01358721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6145603|NCT01358721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6473904|NCT00512473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6473905|NCT00512473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473906|NCT00512486|Benralizumab|benralizumab|mesh-list
6473907|NCT00512486|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6473908|NCT00512486|Respiratory System Agents|respiratory system agents|mesh-ancestor
6473909|NCT00512616|Ceftriaxone|ceftriaxone|mesh-list
6473910|NCT00512616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6473911|NCT00512616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6473912|NCT00512629|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6473913|NCT00512629|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6473914|NCT00512629|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6473915|NCT00512629|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6473916|NCT00512668|Sirolimus|sirolimus|mesh-list
6473917|NCT00512668|Leuprolide|leuprolide|mesh-list
6473918|NCT00512668|Goserelin|goserelin|mesh-list
6473919|NCT00512668|Flutamide|flutamide|mesh-list
6473920|NCT00512668|Bicalutamide|bicalutamide|mesh-list
6473921|NCT00512668|Nilutamide|nilutamide|mesh-list
6473922|NCT00512668|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6473923|NCT00512668|Fertility Agents|fertility agents|mesh-ancestor
6473924|NCT00512668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6473925|NCT00512668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548648|NCT04111484|Adrenomedullin|adrenomedullin|mesh-list
6145604|NCT01358721|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6145605|NCT01358721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145606|NCT01358734|Lenalidomide|lenalidomide|mesh-list
6145607|NCT01358734|Azacitidine|azacitidine|mesh-list
6145608|NCT01358734|Immunologic Factors|immunologic factors|mesh-ancestor
6145609|NCT01358734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145610|NCT01358734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6145611|NCT01358734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6145612|NCT01358734|Growth Substances|growth substances|mesh-ancestor
6473926|NCT00512668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6473927|NCT00512668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5548649|NCT04111484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5548650|NCT04111484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5548651|NCT04111484|Autonomic Agents|autonomic agents|mesh-ancestor
5548652|NCT04111484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5548653|NCT04111484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145613|NCT01358734|Growth Inhibitors|growth inhibitors|mesh-ancestor
6145614|NCT01358734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6145615|NCT01358734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6145616|NCT01358734|Antimetabolites|antimetabolites|mesh-ancestor
6145617|NCT01358734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145618|NCT01358734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6145619|NCT01358760|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
6145620|NCT01358760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6145621|NCT01358760|Immunologic Factors|immunologic factors|mesh-ancestor
6145622|NCT01358760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145623|NCT01358864|Interferons|interferons|mesh-list
6145624|NCT01358864|Ribavirin|ribavirin|mesh-list
6145625|NCT01358864|Interferon-alpha|interferon-alpha|mesh-list
6145626|NCT01358864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6145627|NCT01358864|Antiviral Agents|antiviral agents|mesh-ancestor
6145628|NCT01358864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6145629|NCT01358864|Antimetabolites|antimetabolites|mesh-ancestor
6145630|NCT01358864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145631|NCT01358864|Immunologic Factors|immunologic factors|mesh-ancestor
6145632|NCT01358864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145633|NCT01358877|Paclitaxel|paclitaxel|mesh-list
5548654|NCT04111484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5548655|NCT04111484|Respiratory System Agents|respiratory system agents|mesh-ancestor
5548656|NCT04111484|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5548657|NCT04111484|Vasodilator Agents|vasodilator agents|mesh-ancestor
5548658|NCT04111484|Protective Agents|protective agents|mesh-ancestor
5548659|NCT04111432|Vaccines|vaccines|mesh-list
5548660|NCT04111432|Immunologic Factors|immunologic factors|mesh-ancestor
6145634|NCT01358877|Docetaxel|docetaxel|mesh-list
6145635|NCT01358877|Cyclophosphamide|cyclophosphamide|mesh-list
6145636|NCT01358877|Carboplatin|carboplatin|mesh-list
6145637|NCT01358877|Doxorubicin|doxorubicin|mesh-list
6145638|NCT01358877|Fluorouracil|fluorouracil|mesh-list
6145639|NCT01358877|Trastuzumab|trastuzumab|mesh-list
6145640|NCT01358877|Epirubicin|epirubicin|mesh-list
6145641|NCT01358877|Pertuzumab|pertuzumab|mesh-list
6145642|NCT01358877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6145643|NCT01358877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6145644|NCT01358877|Tubulin Modulators|tubulin modulators|mesh-ancestor
6145645|NCT01358877|Antimitotic Agents|antimitotic agents|mesh-ancestor
6145646|NCT01358877|Mitosis Modulators|mitosis modulators|mesh-ancestor
5548661|NCT04111432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548662|NCT04111328|Sufentanil|sufentanil|mesh-list
5548663|NCT04111328|Dexmedetomidine|dexmedetomidine|mesh-list
5548664|NCT04111328|Dsuvia|dsuvia|mesh-list
5548665|NCT04111328|Hydromorphone|hydromorphone|mesh-list
5548666|NCT04111328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5548667|NCT04111328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5548668|NCT04111328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548669|NCT04111328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5548670|NCT04111328|Analgesics|analgesics|mesh-ancestor
5548671|NCT04111328|Sensory System Agents|sensory system agents|mesh-ancestor
5548672|NCT04111328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6207852|NCT02121002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6667296|NCT01526694|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6667297|NCT01526694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6667298|NCT01526694|Antiemetics|antiemetics|mesh-ancestor
6667299|NCT01526694|Autonomic Agents|autonomic agents|mesh-ancestor
6667300|NCT01526694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6667301|NCT01526694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667302|NCT01526694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6667303|NCT01526694|Glucocorticoids|glucocorticoids|mesh-ancestor
6667304|NCT01526694|Hormones|hormones|mesh-ancestor
6667305|NCT01526694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6667306|NCT01526694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6667307|NCT01526694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6667308|NCT01526694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6667309|NCT01526694|Alkylating Agents|alkylating agents|mesh-ancestor
6145647|NCT01358877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145648|NCT01358877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6145649|NCT01358877|Immunologic Factors|immunologic factors|mesh-ancestor
6145650|NCT01358877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145651|NCT01358877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6145652|NCT01358877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6473928|NCT00512668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6473929|NCT00512668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6473930|NCT00512668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6473931|NCT00512668|Antifungal Agents|antifungal agents|mesh-ancestor
6145653|NCT01358877|Alkylating Agents|alkylating agents|mesh-ancestor
6145654|NCT01358877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6145655|NCT01358877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6145656|NCT01358877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6145657|NCT01358877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6145658|NCT01358877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6145659|NCT01358877|Antimetabolites|antimetabolites|mesh-ancestor
6145660|NCT01358877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6145661|NCT01358877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6145662|NCT01358968|Gemcitabine|gemcitabine|mesh-list
6145663|NCT01358968|Pemetrexed|pemetrexed|mesh-list
6145664|NCT01358968|Desipramine|desipramine|mesh-list
6145665|NCT01358968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6145666|NCT01358968|Antimetabolites|antimetabolites|mesh-ancestor
6145667|NCT01358968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145668|NCT01358968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6145669|NCT01358968|Antiviral Agents|antiviral agents|mesh-ancestor
6145670|NCT01358968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6145671|NCT01358968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6145672|NCT01358968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6145673|NCT01358968|Immunologic Factors|immunologic factors|mesh-ancestor
6145674|NCT01358968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145675|NCT01358968|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6145676|NCT01358968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6473932|NCT00512668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6473933|NCT00512668|Immunologic Factors|immunologic factors|mesh-ancestor
6473934|NCT00512668|Androgen Antagonists|androgen antagonists|mesh-ancestor
6473935|NCT00512668|Hormone Antagonists|hormone antagonists|mesh-ancestor
6473936|NCT00512668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6473937|NCT00512681|Oxaliplatin|oxaliplatin|mesh-list
6473938|NCT00512681|Irinotecan|irinotecan|mesh-list
6473939|NCT00512681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6473940|NCT00512681|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6473941|NCT00512681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6473942|NCT00512681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6473943|NCT00512681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473944|NCT00512759|Nitroglycerin|nitroglycerin|mesh-list
6473945|NCT00512759|Vasodilator Agents|vasodilator agents|mesh-ancestor
6473946|NCT00512811|Furosemide|furosemide|mesh-list
6473947|NCT00512811|Diuretics|diuretics|mesh-ancestor
6473948|NCT00512811|Natriuretic Agents|natriuretic agents|mesh-ancestor
5548673|NCT04111328|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6667310|NCT01526694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667311|NCT01526694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6667312|NCT01526694|Immunologic Factors|immunologic factors|mesh-ancestor
6667313|NCT01526694|Leprostatic Agents|leprostatic agents|mesh-ancestor
6145677|NCT01358968|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6145678|NCT01358968|Antidepressive Agents|antidepressive agents|mesh-ancestor
6145679|NCT01358968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6145680|NCT01358968|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6145681|NCT01358968|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6145682|NCT01358968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6145683|NCT01358968|Adrenergic Agents|adrenergic agents|mesh-ancestor
6473949|NCT00512811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488682|NCT00585793|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5548674|NCT04111328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5548675|NCT04111328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5548676|NCT04111328|Adrenergic Agents|adrenergic agents|mesh-ancestor
5548677|NCT04111328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5548678|NCT04111328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5548679|NCT04111328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5548680|NCT04111328|Narcotics|narcotics|mesh-ancestor
5548681|NCT04111328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5548682|NCT04111328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5548683|NCT04111328|Anesthetics, General|anesthetics, general|mesh-ancestor
5548684|NCT04111328|Anesthetics|anesthetics|mesh-ancestor
5548685|NCT04111159|Propofol|propofol|mesh-list
5548686|NCT04111159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5548687|NCT04111159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5548688|NCT04111159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548689|NCT04111159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5548690|NCT04111159|Anesthetics, General|anesthetics, general|mesh-ancestor
5548691|NCT04111159|Anesthetics|anesthetics|mesh-ancestor
5548692|NCT04111315|Dipyrone|dipyrone|mesh-list
5548693|NCT04111315|Ibuprofen|ibuprofen|mesh-list
5548694|NCT04111315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6145684|NCT01358968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6145685|NCT01359007|Leucovorin|leucovorin|mesh-list
6145686|NCT01359007|Oxaliplatin|oxaliplatin|mesh-list
6145687|NCT01359007|Irinotecan|irinotecan|mesh-list
6145688|NCT01359007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6145689|NCT01359007|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6145690|NCT01359007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5548695|NCT04111315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5548696|NCT04111315|Analgesics|analgesics|mesh-ancestor
5548697|NCT04111315|Sensory System Agents|sensory system agents|mesh-ancestor
5548698|NCT04111315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5548699|NCT04111315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548700|NCT04111315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5548701|NCT04111315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5548702|NCT04111315|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5548703|NCT04111315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5548704|NCT04111315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5548705|NCT04111315|Antipyretics|antipyretics|mesh-ancestor
5548706|NCT04111302|Dezocine|dezocine|mesh-list
5548707|NCT04111302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6145691|NCT01359007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6473950|NCT00512811|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6473951|NCT00512811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6473952|NCT00512811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473953|NCT00512824|Calcium Carbonate|calcium carbonate|mesh-list
6473954|NCT00512824|Calcium|calcium|mesh-list
6145692|NCT01359007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145693|NCT01359007|Antidotes|antidotes|mesh-ancestor
6145694|NCT01359007|Protective Agents|protective agents|mesh-ancestor
6145695|NCT01359007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145696|NCT01359007|Vitamin B Complex|vitamin b complex|mesh-ancestor
6145697|NCT01359007|Vitamins|vitamins|mesh-ancestor
6145698|NCT01359007|Micronutrients|micronutrients|mesh-ancestor
6145699|NCT01359150|Tofacitinib|tofacitinib|mesh-list
6145700|NCT01359150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6145701|NCT01359150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6145702|NCT01359150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145703|NCT01359592|Prednisone|prednisone|mesh-list
6145704|NCT01359592|Cyclophosphamide|cyclophosphamide|mesh-list
6145705|NCT01359592|Rituximab|rituximab|mesh-list
5548708|NCT04111302|Narcotics|narcotics|mesh-ancestor
5548709|NCT04111302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6145706|NCT01359592|Doxorubicin|doxorubicin|mesh-list
6145707|NCT01359592|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6145708|NCT01359592|Vincristine|vincristine|mesh-list
6145709|NCT01359592|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6145710|NCT01359592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6145711|NCT01359592|Immunologic Factors|immunologic factors|mesh-ancestor
6145712|NCT01359592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145713|NCT01359592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6145714|NCT01359592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6145715|NCT01359592|Alkylating Agents|alkylating agents|mesh-ancestor
6145716|NCT01359592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145717|NCT01359592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6145718|NCT01359592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6145719|NCT01359592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6145720|NCT01359592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6145721|NCT01359592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6145722|NCT01359592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6145723|NCT01359592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6145724|NCT01359592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6145725|NCT01359592|Glucocorticoids|glucocorticoids|mesh-ancestor
6145726|NCT01359592|Hormones|hormones|mesh-ancestor
6145727|NCT01359592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6145728|NCT01359592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6145729|NCT01359592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6145730|NCT01359592|Tubulin Modulators|tubulin modulators|mesh-ancestor
6145731|NCT01359592|Antimitotic Agents|antimitotic agents|mesh-ancestor
6145732|NCT01359592|Mitosis Modulators|mitosis modulators|mesh-ancestor
6145733|NCT01359592|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6145734|NCT01359644|Ribavirin|ribavirin|mesh-list
6145735|NCT01359644|Sofosbuvir|sofosbuvir|mesh-list
6145736|NCT01359644|Antimetabolites|antimetabolites|mesh-ancestor
6145737|NCT01359644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145738|NCT01359644|Antiviral Agents|antiviral agents|mesh-ancestor
6145739|NCT01359644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6145740|NCT01359735|Bacitracin|bacitracin|mesh-list
6145741|NCT01359735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6145742|NCT01359735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6145743|NCT01359735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6145744|NCT01359904|Dialysis Solutions|dialysis solutions|mesh-list
6145745|NCT01359904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6145746|NCT01359956|Interferons|interferons|mesh-list
6145747|NCT01359956|Interferon-alpha|interferon-alpha|mesh-list
6145748|NCT01359956|Interferon alpha-2|interferon alpha-2|mesh-list
6145749|NCT01359956|Dacarbazine|dacarbazine|mesh-list
6145750|NCT01359956|Fotemustine|fotemustine|mesh-list
6145751|NCT01359956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6145752|NCT01359956|Antiviral Agents|antiviral agents|mesh-ancestor
6145753|NCT01359956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6145754|NCT01359956|Immunologic Factors|immunologic factors|mesh-ancestor
5548710|NCT04111302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548711|NCT04111302|Analgesics|analgesics|mesh-ancestor
5548712|NCT04111302|Sensory System Agents|sensory system agents|mesh-ancestor
5548713|NCT04111302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5548714|NCT04111133|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
5548715|NCT04111133|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5548716|NCT04111133|Adrenergic Agents|adrenergic agents|mesh-ancestor
6145755|NCT01359956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145756|NCT01359956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6145757|NCT01359956|Alkylating Agents|alkylating agents|mesh-ancestor
6145758|NCT01359956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145759|NCT01360021|Budesonide|budesonide|mesh-list
6145760|NCT01360021|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6145761|NCT01360021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6145762|NCT01360021|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6145763|NCT01360021|Autonomic Agents|autonomic agents|mesh-ancestor
6145764|NCT01360021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6145765|NCT01360021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145766|NCT01360021|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6145767|NCT01360021|Respiratory System Agents|respiratory system agents|mesh-ancestor
6145768|NCT01360021|Glucocorticoids|glucocorticoids|mesh-ancestor
6145769|NCT01360021|Hormones|hormones|mesh-ancestor
6145770|NCT01360021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6145771|NCT01360450|Clonidine|clonidine|mesh-list
6145772|NCT01360450|Analgesics|analgesics|mesh-ancestor
6145773|NCT01360450|Sensory System Agents|sensory system agents|mesh-ancestor
6145774|NCT01360450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6145775|NCT01360450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145776|NCT01360450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6145777|NCT01360450|Sympatholytics|sympatholytics|mesh-ancestor
5548717|NCT04111133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5548718|NCT04111133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5548719|NCT04111133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548720|NCT04111848|Ketamine|ketamine|mesh-list
5548721|NCT04111848|Analgesics|analgesics|mesh-ancestor
5548722|NCT04111848|Sensory System Agents|sensory system agents|mesh-ancestor
5548723|NCT04111848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5548724|NCT04111848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548725|NCT04111848|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5548726|NCT04111848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5548727|NCT04111848|Anesthetics, General|anesthetics, general|mesh-ancestor
5548728|NCT04111848|Anesthetics|anesthetics|mesh-ancestor
5548729|NCT04111848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5548730|NCT04111848|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5548731|NCT04111848|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5548732|NCT04111848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5548733|NCT04111848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5548734|NCT04111367|Sofosbuvir|sofosbuvir|mesh-list
5548735|NCT04111367|Antiviral Agents|antiviral agents|mesh-ancestor
5548736|NCT04111367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5548737|NCT04111003|Anesthetics|anesthetics|mesh-list
5548738|NCT04111003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5548739|NCT04111003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145778|NCT01360450|Autonomic Agents|autonomic agents|mesh-ancestor
6145779|NCT01360450|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6145780|NCT01360450|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6145781|NCT01360450|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6145782|NCT01360450|Adrenergic Agents|adrenergic agents|mesh-ancestor
6145783|NCT01360450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6145784|NCT01360450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145785|NCT01360554|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6145786|NCT01360554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6145787|NCT01360554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6145788|NCT01360554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6145789|NCT01360554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145790|NCT01360762|Pentamidine|pentamidine|mesh-list
6145791|NCT01360762|Antifungal Agents|antifungal agents|mesh-ancestor
6145792|NCT01360762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5548740|NCT04110665|Acetaminophen|acetaminophen|mesh-list
5548741|NCT04110665|Morphine|morphine|mesh-list
5548742|NCT04110665|Oxycodone|oxycodone|mesh-list
5548743|NCT04110665|Tramadol|tramadol|mesh-list
5548744|NCT04110665|Nefopam|nefopam|mesh-list
5548745|NCT04110665|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5548746|NCT04110665|Narcotics|narcotics|mesh-ancestor
5548747|NCT04110665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5548748|NCT04110665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548749|NCT04110665|Analgesics|analgesics|mesh-ancestor
5548750|NCT04110665|Sensory System Agents|sensory system agents|mesh-ancestor
5548751|NCT04110665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5548752|NCT04110665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5548753|NCT04110665|Antipyretics|antipyretics|mesh-ancestor
5548754|NCT04110873|Ubiquinone|ubiquinone|mesh-list
5548755|NCT04110873|Micronutrients|micronutrients|mesh-ancestor
6145793|NCT01360762|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6145794|NCT01360762|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6145795|NCT01360762|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6145796|NCT01360866|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6145797|NCT01360866|Citalopram|citalopram|mesh-list
6145798|NCT01360866|Fluoxetine|fluoxetine|mesh-list
6145799|NCT01360866|Paroxetine|paroxetine|mesh-list
6145800|NCT01360866|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6145801|NCT01360866|Sertraline|sertraline|mesh-list
6145802|NCT01360866|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6145803|NCT01360866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6145804|NCT01360866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6667314|NCT01526694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6667315|NCT01526694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6667316|NCT01526694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6667317|NCT01526694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6667318|NCT01526694|Growth Substances|growth substances|mesh-ancestor
6145805|NCT01360866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5548756|NCT04110873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145806|NCT01360866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6145807|NCT01360866|Serotonin Agents|serotonin agents|mesh-ancestor
6145808|NCT01360866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145809|NCT01360866|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6145810|NCT01360866|Antidepressive Agents|antidepressive agents|mesh-ancestor
6145811|NCT01360866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6145812|NCT01360866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6145813|NCT01360866|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5548757|NCT04110834|Itraconazole|itraconazole|mesh-list
5548758|NCT04110834|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
5548759|NCT04110834|Antifungal Agents|antifungal agents|mesh-ancestor
5548760|NCT04110834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5548761|NCT04110834|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5548762|NCT04110834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5548763|NCT04110834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5548764|NCT04110834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5548765|NCT04110834|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5548766|NCT04110834|Hormone Antagonists|hormone antagonists|mesh-ancestor
5548767|NCT04110834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5548768|NCT04110834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548769|NCT04110834|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5548770|NCT04110860|Voriconazole|voriconazole|mesh-list
5548771|NCT04110860|Antifungal Agents|antifungal agents|mesh-ancestor
5548772|NCT04110860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5548773|NCT04110860|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5548774|NCT04110860|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5548775|NCT04110860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5548776|NCT04110860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145814|NCT01360866|Analgesics|analgesics|mesh-ancestor
6145815|NCT01360866|Sensory System Agents|sensory system agents|mesh-ancestor
6145816|NCT01360866|Dopamine Agents|dopamine agents|mesh-ancestor
6145817|NCT01360866|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6145818|NCT01360866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6145819|NCT01360866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6145820|NCT01360996|Contraceptive Agents|contraceptive agents|mesh-list
6145821|NCT01360996|Contraceptives, Oral|contraceptives, oral|mesh-list
6145822|NCT01360996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6145823|NCT01360996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145824|NCT01360996|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6145825|NCT01361009|Pramipexole|pramipexole|mesh-list
6145826|NCT01361009|Antioxidants|antioxidants|mesh-ancestor
6145827|NCT01361009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145828|NCT01361009|Protective Agents|protective agents|mesh-ancestor
6145829|NCT01361009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473955|NCT00512824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6473956|NCT00512824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473957|NCT00512824|Antacids|antacids|mesh-ancestor
6473958|NCT00512824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145830|NCT01361009|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6145831|NCT01361009|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6145832|NCT01361009|Dopamine Agonists|dopamine agonists|mesh-ancestor
6145833|NCT01361009|Dopamine Agents|dopamine agents|mesh-ancestor
6145834|NCT01361009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6145835|NCT01361048|Metronidazole|metronidazole|mesh-list
6145836|NCT01361048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6145837|NCT01361048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6145838|NCT01361048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6145839|NCT01361048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6145840|NCT01361217|Midazolam|midazolam|mesh-list
6145841|NCT01361217|Dextromethorphan|dextromethorphan|mesh-list
6145842|NCT01361217|Caffeine|caffeine|mesh-list
6145843|NCT01361217|Fluoxetine|fluoxetine|mesh-list
6145844|NCT01361217|Omeprazole|omeprazole|mesh-list
6145845|NCT01361217|Lovastatin|lovastatin|mesh-list
6145846|NCT01361217|L 647318|l 647318|mesh-list
6145847|NCT01361217|Dihydromevinolin|dihydromevinolin|mesh-list
6145848|NCT01361217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6145849|NCT01361217|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6145850|NCT01361217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6145851|NCT01361217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145852|NCT01361217|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6145853|NCT01361217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6145854|NCT01361217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6145855|NCT01361217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6145856|NCT01361217|Anesthetics, General|anesthetics, general|mesh-ancestor
6145857|NCT01361217|Anesthetics|anesthetics|mesh-ancestor
6145858|NCT01361217|GABA Modulators|gaba modulators|mesh-ancestor
6473959|NCT00512824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6473960|NCT00512850|Folic Acid|folic acid|mesh-list
5548777|NCT04110860|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5548778|NCT04110860|Hormone Antagonists|hormone antagonists|mesh-ancestor
5548779|NCT04110860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5548780|NCT04110860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548781|NCT04110860|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5548782|NCT04110808|Phentolamine|phentolamine|mesh-list
5548783|NCT04110808|Antihypertensive Agents|antihypertensive agents|mesh-list
5548784|NCT04110808|Nitroglycerin|nitroglycerin|mesh-list
5548785|NCT04110808|Anesthetics|anesthetics|mesh-list
5548786|NCT04110808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5548787|NCT04110808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473961|NCT00512850|Hematinics|hematinics|mesh-ancestor
6473962|NCT00512850|Vitamin B Complex|vitamin b complex|mesh-ancestor
6473963|NCT00512850|Vitamins|vitamins|mesh-ancestor
6145859|NCT01361217|GABA Agents|gaba agents|mesh-ancestor
6145860|NCT01361217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6145861|NCT01361217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145862|NCT01361217|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5548788|NCT04110808|Vasodilator Agents|vasodilator agents|mesh-ancestor
5548789|NCT04110808|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5548790|NCT04110808|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5548791|NCT04110808|Adrenergic Agents|adrenergic agents|mesh-ancestor
5548792|NCT04110808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5548793|NCT04110808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5548794|NCT04111380|Paclitaxel|paclitaxel|mesh-list
5548795|NCT04111380|Cisplatin|cisplatin|mesh-list
5548796|NCT04111380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5548797|NCT04111380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5548798|NCT04111380|Tubulin Modulators|tubulin modulators|mesh-ancestor
5548799|NCT04111380|Antimitotic Agents|antimitotic agents|mesh-ancestor
5548800|NCT04111380|Mitosis Modulators|mitosis modulators|mesh-ancestor
5548801|NCT04111380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5548802|NCT04111289|Tirofiban|tirofiban|mesh-list
5548803|NCT04111289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5548804|NCT04111289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5548805|NCT04111289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145863|NCT01361217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6145864|NCT01361217|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6145865|NCT01361217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6145866|NCT01361217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6145867|NCT01361217|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6145868|NCT01361217|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6145869|NCT01361217|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6145870|NCT01361217|Purinergic Agents|purinergic agents|mesh-ancestor
6145871|NCT01361217|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6145872|NCT01361217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6145873|NCT01361217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6145874|NCT01361217|Serotonin Agents|serotonin agents|mesh-ancestor
6145875|NCT01361217|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6145876|NCT01361217|Antidepressive Agents|antidepressive agents|mesh-ancestor
6145877|NCT01361217|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6145878|NCT01361217|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6145879|NCT01361217|Antitussive Agents|antitussive agents|mesh-ancestor
6145880|NCT01361217|Respiratory System Agents|respiratory system agents|mesh-ancestor
6145881|NCT01361217|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6145882|NCT01361217|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6145883|NCT01361217|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6145884|NCT01361217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6473964|NCT00512850|Micronutrients|micronutrients|mesh-ancestor
6473965|NCT00512850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473966|NCT00512863|Adalimumab|adalimumab|mesh-list
6473967|NCT00512863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6473968|NCT00512863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6473969|NCT00512928|Vitamin K 2|vitamin k 2|mesh-list
6473970|NCT00512928|Vitamin K|vitamin k|mesh-list
6473971|NCT00512928|Acenocoumarol|acenocoumarol|mesh-list
6473972|NCT00512928|Vitamin MK 7|vitamin mk 7|mesh-list
6473973|NCT00512928|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6473974|NCT00512928|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6473975|NCT00512928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473976|NCT00512928|Hemostatics|hemostatics|mesh-ancestor
6473977|NCT00512928|Coagulants|coagulants|mesh-ancestor
6473978|NCT00512928|Vitamins|vitamins|mesh-ancestor
6473979|NCT00512928|Micronutrients|micronutrients|mesh-ancestor
6473980|NCT00512928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548806|NCT04111289|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5548807|NCT04110535|Midazolam|midazolam|mesh-list
6473981|NCT00512928|Anticoagulants|anticoagulants|mesh-ancestor
6473982|NCT00512980|Gemcitabine|gemcitabine|mesh-list
6473983|NCT00512980|Prednisone|prednisone|mesh-list
6145885|NCT01361217|Antimetabolites|antimetabolites|mesh-ancestor
6145886|NCT01361217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6145887|NCT01361217|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6145888|NCT01361308|Paroxetine|paroxetine|mesh-list
6145889|NCT01361308|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6145890|NCT01361308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6145891|NCT01361308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6145892|NCT01361308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145893|NCT01361308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6145894|NCT01361308|Serotonin Agents|serotonin agents|mesh-ancestor
5548808|NCT04110535|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5548809|NCT04110535|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5548810|NCT04110535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5548811|NCT04110535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548812|NCT04110535|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5548813|NCT04110535|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5548814|NCT04110535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5548815|NCT04110535|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6145895|NCT01361308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145896|NCT01361308|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6145897|NCT01361308|Antidepressive Agents|antidepressive agents|mesh-ancestor
6145898|NCT01361308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6145899|NCT01361308|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6145900|NCT01361308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6145901|NCT01361308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6145902|NCT01361464|Tipifarnib|tipifarnib|mesh-list
6145903|NCT01361464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6145904|NCT01361594|Insulin|insulin|mesh-list
6145905|NCT01361594|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6667319|NCT01526694|Growth Inhibitors|growth inhibitors|mesh-ancestor
6667320|NCT01526837|Bevacizumab|bevacizumab|mesh-list
6667321|NCT01526837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6667322|NCT01526837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6667323|NCT01526837|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6145906|NCT01361594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6145907|NCT01361594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473984|NCT00512980|Doxorubicin|doxorubicin|mesh-list
6473985|NCT00512980|Vinblastine|vinblastine|mesh-list
6473986|NCT00512980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6473987|NCT00512980|Antimetabolites|antimetabolites|mesh-ancestor
6473988|NCT00512980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6473989|NCT00512980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6473990|NCT00512980|Antiviral Agents|antiviral agents|mesh-ancestor
6473991|NCT00512980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6473992|NCT00512980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6473993|NCT00512980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6473994|NCT00512980|Immunologic Factors|immunologic factors|mesh-ancestor
6473995|NCT00512980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6473996|NCT00512980|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6145908|NCT01361607|Nabiximols|nabiximols|mesh-list
6145909|NCT01361607|Analgesics|analgesics|mesh-ancestor
5548816|NCT04110535|Anesthetics, General|anesthetics, general|mesh-ancestor
5548817|NCT04110535|Anesthetics|anesthetics|mesh-ancestor
5548818|NCT04110535|GABA Modulators|gaba modulators|mesh-ancestor
5548819|NCT04110535|GABA Agents|gaba agents|mesh-ancestor
6145910|NCT01361607|Sensory System Agents|sensory system agents|mesh-ancestor
6145911|NCT01361607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6145912|NCT01361607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145913|NCT01361620|Aspirin|aspirin|mesh-list
6145914|NCT01361620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6145915|NCT01361620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6145916|NCT01361620|Analgesics|analgesics|mesh-ancestor
6145917|NCT01361620|Sensory System Agents|sensory system agents|mesh-ancestor
6145918|NCT01361620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6145919|NCT01361620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145920|NCT01361620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6145921|NCT01361620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6145922|NCT01361620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6145923|NCT01361620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6473997|NCT00512980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6473998|NCT00512980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6473999|NCT00512980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6474000|NCT00512980|Glucocorticoids|glucocorticoids|mesh-ancestor
6474001|NCT00512980|Hormones|hormones|mesh-ancestor
6474002|NCT00512980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6474003|NCT00512980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6474004|NCT00512980|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6667324|NCT01526837|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6667325|NCT01526837|Growth Substances|growth substances|mesh-ancestor
6667326|NCT01526837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145924|NCT01361620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145925|NCT01361620|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6145926|NCT01361620|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6145927|NCT01361620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6145928|NCT01361620|Antipyretics|antipyretics|mesh-ancestor
6145929|NCT01361633|Cycloserine|cycloserine|mesh-list
6145930|NCT01361633|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6145931|NCT01361633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6145932|NCT01361633|Renal Agents|renal agents|mesh-ancestor
6145933|NCT01361633|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6145934|NCT01361633|Antitubercular Agents|antitubercular agents|mesh-ancestor
6145935|NCT01361633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6667327|NCT01526837|Growth Inhibitors|growth inhibitors|mesh-ancestor
6667328|NCT01526850|Cyclosporine|cyclosporine|mesh-list
6667329|NCT01526850|Cyclosporins|cyclosporins|mesh-list
6474005|NCT00512980|Tubulin Modulators|tubulin modulators|mesh-ancestor
6474006|NCT00512980|Antimitotic Agents|antimitotic agents|mesh-ancestor
5548820|NCT04110535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5548821|NCT04110535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5548822|NCT04110418|Terlipressin|terlipressin|mesh-list
5548823|NCT04110418|Methylene Blue|methylene blue|mesh-list
5548824|NCT04110418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6474007|NCT00512980|Mitosis Modulators|mitosis modulators|mesh-ancestor
6474008|NCT00512993|Zoledronic Acid|zoledronic acid|mesh-list
6474009|NCT00512993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6474010|NCT00512993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474011|NCT00513032|Methylene Blue|methylene blue|mesh-list
6474012|NCT00513032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6474013|NCT00513032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474014|NCT00513058|Vinorelbine|vinorelbine|mesh-list
6474015|NCT00513058|Lapatinib|lapatinib|mesh-list
6474016|NCT00513058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6474017|NCT00513058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6474018|NCT00513058|Tubulin Modulators|tubulin modulators|mesh-ancestor
6474019|NCT00513058|Antimitotic Agents|antimitotic agents|mesh-ancestor
6474020|NCT00513058|Mitosis Modulators|mitosis modulators|mesh-ancestor
6474021|NCT00513058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474022|NCT00513058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6474023|NCT00513058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6474024|NCT00513110|Caffeine|caffeine|mesh-list
6474025|NCT00513110|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6474026|NCT00513110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474027|NCT00513110|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6667330|NCT01526850|Glucocorticoids|glucocorticoids|mesh-list
5602761|NCT04188028|Serotonin Agents|serotonin agents|mesh-ancestor
6474028|NCT00513110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6474029|NCT00513110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474030|NCT00513110|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6474031|NCT00513110|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6474032|NCT00513110|Purinergic Agents|purinergic agents|mesh-ancestor
6474033|NCT00513110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6667331|NCT01526850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6667332|NCT01526850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145936|NCT01361633|Antimetabolites|antimetabolites|mesh-ancestor
6145937|NCT01361633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145938|NCT01361711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6145939|NCT01361711|Alemtuzumab|alemtuzumab|mesh-list
6145940|NCT01361711|Ofatumumab|ofatumumab|mesh-list
6145941|NCT01361711|Antibodies|antibodies|mesh-list
6145942|NCT01361711|Immunoglobulins|immunoglobulins|mesh-list
6145943|NCT01361711|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6145944|NCT01361711|Immunologic Factors|immunologic factors|mesh-ancestor
6145945|NCT01361711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145946|NCT01361711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6145947|NCT01362127|Cisplatin|cisplatin|mesh-list
6145948|NCT01362127|Carboplatin|carboplatin|mesh-list
6145949|NCT01362127|Oxaliplatin|oxaliplatin|mesh-list
6145950|NCT01362127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6145951|NCT01362140|Darbepoetin alfa|darbepoetin alfa|mesh-list
6145952|NCT01362140|Hematinics|hematinics|mesh-ancestor
6145953|NCT01362192|Chlorhexidine|chlorhexidine|mesh-list
5548825|NCT04110418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5548826|NCT04110418|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5548827|NCT04110418|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5548828|NCT04110444|Sildenafil Citrate|sildenafil citrate|mesh-list
5548829|NCT04110444|Vasodilator Agents|vasodilator agents|mesh-ancestor
5548830|NCT04110444|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5548831|NCT04110444|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5548832|NCT04110444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5548833|NCT04110444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5548834|NCT04110444|Urological Agents|urological agents|mesh-ancestor
5548835|NCT04110314|Vaccines|vaccines|mesh-list
5548836|NCT04110314|Immunologic Factors|immunologic factors|mesh-ancestor
5548837|NCT04110314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548838|NCT04110587|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5548839|NCT04110587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
5548840|NCT04110587|Analgesics|analgesics|mesh-list
5548841|NCT04110587|Hyaluronic Acid|hyaluronic acid|mesh-list
5548842|NCT04110587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5548843|NCT04110587|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5548844|NCT04110587|Immunologic Factors|immunologic factors|mesh-ancestor
5548845|NCT04110587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548846|NCT04110587|Viscosupplements|viscosupplements|mesh-ancestor
5548847|NCT04110587|Protective Agents|protective agents|mesh-ancestor
5548848|NCT04110587|Sensory System Agents|sensory system agents|mesh-ancestor
5548849|NCT04110587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5548850|NCT04110132|Bupivacaine|bupivacaine|mesh-list
6145954|NCT01362192|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6145955|NCT01362192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6145956|NCT01362192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6145957|NCT01362192|Disinfectants|disinfectants|mesh-ancestor
6145958|NCT01362192|Dermatologic Agents|dermatologic agents|mesh-ancestor
6145959|NCT01362205|Dexmedetomidine|dexmedetomidine|mesh-list
6145960|NCT01362205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6145961|NCT01362205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6145962|NCT01362205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145963|NCT01362205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6145964|NCT01362205|Analgesics|analgesics|mesh-ancestor
6145965|NCT01362205|Sensory System Agents|sensory system agents|mesh-ancestor
6145966|NCT01362205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6145967|NCT01362205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6145968|NCT01362205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6145969|NCT01362205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6145970|NCT01362205|Adrenergic Agents|adrenergic agents|mesh-ancestor
6145971|NCT01362205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6145972|NCT01362205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145973|NCT01362296|Docetaxel|docetaxel|mesh-list
6145974|NCT01362296|Trametinib|trametinib|mesh-list
6145975|NCT01362296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6145976|NCT01362296|Tubulin Modulators|tubulin modulators|mesh-ancestor
6145977|NCT01362296|Antimitotic Agents|antimitotic agents|mesh-ancestor
6145978|NCT01362296|Mitosis Modulators|mitosis modulators|mesh-ancestor
6145979|NCT01362296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474034|NCT00513149|Clopidogrel|clopidogrel|mesh-list
6474035|NCT00513149|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6474036|NCT00513149|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6474037|NCT00513149|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6474038|NCT00513149|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6474039|NCT00513149|Purinergic Agents|purinergic agents|mesh-ancestor
6474040|NCT00513149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6145980|NCT01362296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6145981|NCT01362296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6145982|NCT01362348|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6145983|NCT01362348|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6145984|NCT01362439|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6145985|NCT01362439|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5548851|NCT04110132|Anesthetics, Local|anesthetics, local|mesh-ancestor
5548852|NCT04110132|Anesthetics|anesthetics|mesh-ancestor
5548853|NCT04110132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5548854|NCT04110132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548855|NCT04110132|Sensory System Agents|sensory system agents|mesh-ancestor
5548856|NCT04110132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5548857|NCT04110028|Niacinamide|niacinamide|mesh-list
5548858|NCT04110028|Niacin|niacin|mesh-list
5548859|NCT04110028|Nicotinic Acids|nicotinic acids|mesh-list
5548860|NCT04110028|Vitamin B Complex|vitamin b complex|mesh-ancestor
5548861|NCT04110028|Vitamins|vitamins|mesh-ancestor
5548862|NCT04110028|Micronutrients|micronutrients|mesh-ancestor
6145986|NCT01362439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6145987|NCT01362439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6145988|NCT01362439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6145989|NCT01362439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6145990|NCT01362439|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6145991|NCT01362439|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6145992|NCT01362439|Serotonin Agents|serotonin agents|mesh-ancestor
6145993|NCT01362439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6145994|NCT01362439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6145995|NCT01362439|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6145996|NCT01362439|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6145997|NCT01362439|Dopamine Agents|dopamine agents|mesh-ancestor
6145998|NCT01362491|Ibuprofen|ibuprofen|mesh-list
6145999|NCT01362491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6146000|NCT01362491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6474041|NCT00513149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474042|NCT00513149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474043|NCT00513162|Etoposide|etoposide|mesh-list
6474044|NCT00513162|Valproic Acid|valproic acid|mesh-list
6474045|NCT00513162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6474046|NCT00513162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6474047|NCT00513162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6474048|NCT00513162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6474049|NCT00513162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6474050|NCT00513162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474051|NCT00513162|Anticonvulsants|anticonvulsants|mesh-ancestor
6474052|NCT00513162|GABA Agents|gaba agents|mesh-ancestor
6474053|NCT00513162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6474054|NCT00513162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474055|NCT00513162|Antimanic Agents|antimanic agents|mesh-ancestor
6474056|NCT00513162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6474057|NCT00513162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6474058|NCT00513162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6474059|NCT00513188|Leucovorin|leucovorin|mesh-list
6474060|NCT00513188|Cytarabine|cytarabine|mesh-list
6474061|NCT00513188|Prednisone|prednisone|mesh-list
6146001|NCT01362491|Analgesics|analgesics|mesh-ancestor
6146002|NCT01362491|Sensory System Agents|sensory system agents|mesh-ancestor
6146003|NCT01362491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6146004|NCT01362491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146005|NCT01362491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6474062|NCT00513188|Cyclophosphamide|cyclophosphamide|mesh-list
6146006|NCT01362491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6146007|NCT01362491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6146008|NCT01362491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5548863|NCT04110028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548864|NCT04110028|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6474063|NCT00513188|Doxorubicin|doxorubicin|mesh-list
6146009|NCT01362491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6146010|NCT01362530|Ondansetron|ondansetron|mesh-list
6146011|NCT01362530|Aprepitant|aprepitant|mesh-list
6146012|NCT01362530|Fosaprepitant|fosaprepitant|mesh-list
6146013|NCT01362530|Antiemetics|antiemetics|mesh-ancestor
6146014|NCT01362530|Autonomic Agents|autonomic agents|mesh-ancestor
6146015|NCT01362530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6146016|NCT01362530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146017|NCT01362530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6146018|NCT01362530|Antipruritics|antipruritics|mesh-ancestor
6146019|NCT01362530|Dermatologic Agents|dermatologic agents|mesh-ancestor
6474064|NCT00513188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6474065|NCT00513188|Methotrexate|methotrexate|mesh-list
6474066|NCT00513188|Vincristine|vincristine|mesh-list
6474067|NCT00513188|Denileukin diftitox|denileukin diftitox|mesh-list
6474068|NCT00513188|Levoleucovorin|levoleucovorin|mesh-list
6474069|NCT00513188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6474070|NCT00513188|Immunologic Factors|immunologic factors|mesh-ancestor
6474071|NCT00513188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474072|NCT00513188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6474073|NCT00513188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6474074|NCT00513188|Alkylating Agents|alkylating agents|mesh-ancestor
6474075|NCT00513188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474076|NCT00513188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6474077|NCT00513188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5548865|NCT04110028|Antimetabolites|antimetabolites|mesh-ancestor
5548866|NCT04110028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5548867|NCT04110028|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5548868|NCT04110028|Vasodilator Agents|vasodilator agents|mesh-ancestor
5548869|NCT04110080|Anesthetics|anesthetics|mesh-list
5548870|NCT04110080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5548871|NCT04110080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548872|NCT04110210|Morphine|morphine|mesh-list
5548873|NCT04110210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5548874|NCT04110210|Narcotics|narcotics|mesh-ancestor
5548875|NCT04110210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5548876|NCT04110210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548877|NCT04110210|Analgesics|analgesics|mesh-ancestor
5548878|NCT04110210|Sensory System Agents|sensory system agents|mesh-ancestor
5548879|NCT04110210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5548880|NCT04110301|Lenalidomide|lenalidomide|mesh-list
5548881|NCT04110301|Antibodies|antibodies|mesh-list
5548882|NCT04110301|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5548883|NCT04110301|Immunologic Factors|immunologic factors|mesh-ancestor
5548884|NCT04110301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548885|NCT04110301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5548886|NCT04110301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5548887|NCT04110301|Growth Substances|growth substances|mesh-ancestor
5548888|NCT04110301|Growth Inhibitors|growth inhibitors|mesh-ancestor
5548889|NCT04110301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5548890|NCT04110288|Paclitaxel|paclitaxel|mesh-list
5548891|NCT04110288|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5548892|NCT04110288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6474078|NCT00513188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6474079|NCT00513188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6474080|NCT00513188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6474081|NCT00513188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6474082|NCT00513188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6474083|NCT00513188|Glucocorticoids|glucocorticoids|mesh-ancestor
6474084|NCT00513188|Hormones|hormones|mesh-ancestor
6474085|NCT00513188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6474086|NCT00513188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6474087|NCT00513188|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6474088|NCT00513188|Abortifacient Agents|abortifacient agents|mesh-ancestor
6474089|NCT00513188|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6474090|NCT00513188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6474091|NCT00513188|Antimetabolites|antimetabolites|mesh-ancestor
6474092|NCT00513188|Dermatologic Agents|dermatologic agents|mesh-ancestor
6474093|NCT00513188|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6474094|NCT00513188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6474095|NCT00513188|Antiviral Agents|antiviral agents|mesh-ancestor
6474096|NCT00513188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6474097|NCT00513188|Antidotes|antidotes|mesh-ancestor
6474098|NCT00513188|Protective Agents|protective agents|mesh-ancestor
5548893|NCT04110288|Tubulin Modulators|tubulin modulators|mesh-ancestor
6474099|NCT00513188|Vitamin B Complex|vitamin b complex|mesh-ancestor
6474100|NCT00513188|Vitamins|vitamins|mesh-ancestor
6474101|NCT00513188|Micronutrients|micronutrients|mesh-ancestor
6146020|NCT01362530|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6146021|NCT01362530|Serotonin Agents|serotonin agents|mesh-ancestor
6146022|NCT01362530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5548894|NCT04110288|Antimitotic Agents|antimitotic agents|mesh-ancestor
5548895|NCT04110288|Mitosis Modulators|mitosis modulators|mesh-ancestor
5548896|NCT04110288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5548897|NCT04110340|Ciprofloxacin|ciprofloxacin|mesh-list
5548898|NCT04110340|Streptomycin|streptomycin|mesh-list
5548899|NCT04110340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5548900|NCT04110340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5548901|NCT04110340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5548902|NCT04110340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5548903|NCT04110340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6146023|NCT01362530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6146024|NCT01362530|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6146025|NCT01362530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6146026|NCT01362530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6146027|NCT01362530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6146028|NCT01362530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6146029|NCT01362530|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6146030|NCT01362608|Triamcinolone|triamcinolone|mesh-list
6474102|NCT00513188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6474103|NCT00513188|Tubulin Modulators|tubulin modulators|mesh-ancestor
6474104|NCT00513188|Antimitotic Agents|antimitotic agents|mesh-ancestor
6474105|NCT00513188|Mitosis Modulators|mitosis modulators|mesh-ancestor
6488683|NCT00585793|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5548904|NCT04110340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5548905|NCT04110340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5548906|NCT04110340|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5548907|NCT04110340|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5548908|NCT04110340|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5548909|NCT04110275|Plasminogen|plasminogen|mesh-list
5548910|NCT04110275|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5548911|NCT04110275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5548912|NCT04110275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5548913|NCT04110275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5548914|NCT04110145|Linaclotide|linaclotide|mesh-list
5548915|NCT04110145|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
6488684|NCT00585793|Protease Inhibitors|protease inhibitors|mesh-ancestor
6488685|NCT00585793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6488686|NCT00585793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488687|NCT00585793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6488688|NCT00585793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6488689|NCT00585793|Antiviral Agents|antiviral agents|mesh-ancestor
6488690|NCT00585793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6488691|NCT00585793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6474106|NCT00513201|Insulin|insulin|mesh-list
6474107|NCT00513201|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6474108|NCT00513201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6474109|NCT00513201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474110|NCT00513253|Lapatinib|lapatinib|mesh-list
6474111|NCT00513253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6474112|NCT00513253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6474113|NCT00513253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6474114|NCT00513253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474115|NCT00513266|Leucovorin|leucovorin|mesh-list
6474116|NCT00513266|Bevacizumab|bevacizumab|mesh-list
6474117|NCT00513266|Cetuximab|cetuximab|mesh-list
6474118|NCT00513266|Fluorouracil|fluorouracil|mesh-list
6474119|NCT00513266|Oxaliplatin|oxaliplatin|mesh-list
6474120|NCT00513266|Irinotecan|irinotecan|mesh-list
6146031|NCT01362608|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6146032|NCT01362608|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6146033|NCT01362608|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6146034|NCT01362608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6146035|NCT01362608|Glucocorticoids|glucocorticoids|mesh-ancestor
6146036|NCT01362608|Hormones|hormones|mesh-ancestor
6146037|NCT01362608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6146038|NCT01362608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548916|NCT04110145|Enzyme Activators|enzyme activators|mesh-ancestor
5548917|NCT04110145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5548918|NCT04110145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5548919|NCT04110093|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5548920|NCT04110093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5548921|NCT04110093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5548922|NCT04110119|Diclofenac|diclofenac|mesh-list
5548923|NCT04110119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5548924|NCT04110119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5548925|NCT04110119|Analgesics|analgesics|mesh-ancestor
5548926|NCT04110119|Sensory System Agents|sensory system agents|mesh-ancestor
6146039|NCT01362608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6146040|NCT01362608|Immunologic Factors|immunologic factors|mesh-ancestor
6146041|NCT01362608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6146042|NCT01362608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6146043|NCT01362686|Rivastigmine|rivastigmine|mesh-list
6146044|NCT01362686|Donepezil|donepezil|mesh-list
6146045|NCT01362686|Galantamine|galantamine|mesh-list
6146046|NCT01362686|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6146047|NCT01362686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6146048|NCT01362686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6146049|NCT01362686|Cholinergic Agents|cholinergic agents|mesh-ancestor
6146050|NCT01362686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6146051|NCT01362686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146052|NCT01362686|Nootropic Agents|nootropic agents|mesh-ancestor
6146053|NCT01362686|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6146054|NCT01362686|Autonomic Agents|autonomic agents|mesh-ancestor
6146055|NCT01362686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6146056|NCT01362686|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6146057|NCT01362686|Protective Agents|protective agents|mesh-ancestor
6146058|NCT01362790|Cyclophosphamide|cyclophosphamide|mesh-list
5548927|NCT04110119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5548928|NCT04110119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548929|NCT04110119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5548930|NCT04110119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5548931|NCT04110119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5548932|NCT04110119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5548933|NCT04110119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5548934|NCT04109872|Lenalidomide|lenalidomide|mesh-list
5548935|NCT04109872|Immunologic Factors|immunologic factors|mesh-ancestor
5548936|NCT04109872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548937|NCT04109872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6146059|NCT01362790|Pentostatin|pentostatin|mesh-list
6474121|NCT00513266|Calcium|calcium|mesh-list
6474122|NCT00513266|Levoleucovorin|levoleucovorin|mesh-list
6146060|NCT01362790|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6146061|NCT01362790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6146062|NCT01362790|Immunologic Factors|immunologic factors|mesh-ancestor
6146063|NCT01362790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146064|NCT01362790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6146065|NCT01362790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6146066|NCT01362790|Alkylating Agents|alkylating agents|mesh-ancestor
6146067|NCT01362790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5548938|NCT04109872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5548939|NCT04109872|Growth Substances|growth substances|mesh-ancestor
5548940|NCT04109872|Growth Inhibitors|growth inhibitors|mesh-ancestor
5548941|NCT04109872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5548942|NCT04109742|Curcumin|curcumin|mesh-list
5548943|NCT04109742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5548944|NCT04109742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6146068|NCT01362790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6146069|NCT01362790|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6146070|NCT01362790|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
6146071|NCT01362790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6146072|NCT01362959|Nicotine|nicotine|mesh-list
6146073|NCT01362959|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6146074|NCT01362959|Autonomic Agents|autonomic agents|mesh-ancestor
6146075|NCT01362959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6146076|NCT01362959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548945|NCT04109742|Analgesics|analgesics|mesh-ancestor
5548946|NCT04109742|Sensory System Agents|sensory system agents|mesh-ancestor
5548947|NCT04109742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5548948|NCT04109742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548949|NCT04109742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5548950|NCT04109742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5548951|NCT04109742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5548952|NCT04109742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5548953|NCT04109742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5548954|NCT04109729|Nivolumab|nivolumab|mesh-list
5548955|NCT04109729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5548956|NCT04109729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6146077|NCT01362959|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6146078|NCT01362959|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6146079|NCT01362959|Cholinergic Agents|cholinergic agents|mesh-ancestor
6146080|NCT01362959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6146081|NCT01362959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6146082|NCT01363011|Darunavir|darunavir|mesh-list
6146083|NCT01363011|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6146084|NCT01363011|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6146085|NCT01363011|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6146086|NCT01363011|Protease Inhibitors|protease inhibitors|mesh-ancestor
6146087|NCT01363011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6146088|NCT01363011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5548957|NCT04109729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5548958|NCT04109729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602762|NCT04188028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602763|NCT04188028|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5602764|NCT04188028|Antidepressive Agents|antidepressive agents|mesh-ancestor
5602765|NCT04188028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5602766|NCT04188028|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5602767|NCT04188028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5602768|NCT04188028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6146089|NCT01363011|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6146090|NCT01363011|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6146091|NCT01363011|Antiviral Agents|antiviral agents|mesh-ancestor
6146092|NCT01363011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6146093|NCT01363050|Ketorolac|ketorolac|mesh-list
6146094|NCT01363050|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6146095|NCT01363050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6146096|NCT01363050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6146097|NCT01363050|Analgesics|analgesics|mesh-ancestor
6146098|NCT01363050|Sensory System Agents|sensory system agents|mesh-ancestor
6146099|NCT01363050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6146100|NCT01363050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146101|NCT01363050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6146102|NCT01363050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6146103|NCT01363050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6146104|NCT01363050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6146105|NCT01363050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6146106|NCT01363076|Ketorolac|ketorolac|mesh-list
6146107|NCT01363076|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6146108|NCT01363076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5548959|NCT04109859|Methylene Blue|methylene blue|mesh-list
5548960|NCT04109859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5548961|NCT04109859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5548962|NCT04109924|Trifluridine|trifluridine|mesh-list
6146109|NCT01363076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6146110|NCT01363076|Analgesics|analgesics|mesh-ancestor
6146111|NCT01363076|Sensory System Agents|sensory system agents|mesh-ancestor
6146112|NCT01363076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6146113|NCT01363076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146114|NCT01363076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6146115|NCT01363076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6146116|NCT01363076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6146117|NCT01363076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6146118|NCT01363076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6146119|NCT01363128|Cytarabine|cytarabine|mesh-list
6146120|NCT01363128|Dexamethasone|dexamethasone|mesh-list
6146121|NCT01363128|Dexamethasone acetate|dexamethasone acetate|mesh-list
6146122|NCT01363128|Cyclophosphamide|cyclophosphamide|mesh-list
6146123|NCT01363128|Doxorubicin|doxorubicin|mesh-list
6146124|NCT01363128|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6146125|NCT01363128|Methotrexate|methotrexate|mesh-list
6146126|NCT01363128|Vincristine|vincristine|mesh-list
6146127|NCT01363128|Ofatumumab|ofatumumab|mesh-list
6146128|NCT01363128|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6146129|NCT01363128|BB 1101|bb 1101|mesh-list
6474123|NCT00513266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6474124|NCT00513266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6474125|NCT00513266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6474126|NCT00513266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6474127|NCT00513266|Growth Substances|growth substances|mesh-ancestor
6146130|NCT01363128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6146131|NCT01363128|Immunologic Factors|immunologic factors|mesh-ancestor
6146132|NCT01363128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146133|NCT01363128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5548963|NCT04109924|Bevacizumab|bevacizumab|mesh-list
5548964|NCT04109924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5548965|NCT04109924|Irinotecan|irinotecan|mesh-list
5548966|NCT04109924|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
5548967|NCT04109924|Antibodies|antibodies|mesh-list
5548968|NCT04109924|Immunoglobulins|immunoglobulins|mesh-list
5548969|NCT04109924|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5548970|NCT04109924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5548971|NCT04109924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5548972|NCT04109924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5548973|NCT04109924|Growth Substances|growth substances|mesh-ancestor
5548974|NCT04109924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548975|NCT04109924|Growth Inhibitors|growth inhibitors|mesh-ancestor
5548976|NCT04109924|Immunologic Factors|immunologic factors|mesh-ancestor
5548977|NCT04109924|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6146134|NCT01363128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6146135|NCT01363128|Alkylating Agents|alkylating agents|mesh-ancestor
6146136|NCT01363128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474128|NCT00513266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474129|NCT00513266|Growth Inhibitors|growth inhibitors|mesh-ancestor
6474130|NCT00513266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6146137|NCT01363128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6146138|NCT01363128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6146139|NCT01363128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6146140|NCT01363128|Antiemetics|antiemetics|mesh-ancestor
6146141|NCT01363128|Autonomic Agents|autonomic agents|mesh-ancestor
6146142|NCT01363128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6146143|NCT01363128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6146144|NCT01363128|Glucocorticoids|glucocorticoids|mesh-ancestor
6146145|NCT01363128|Hormones|hormones|mesh-ancestor
6146146|NCT01363128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6146147|NCT01363128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6146148|NCT01363128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6146149|NCT01363128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6146150|NCT01363128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6146151|NCT01363128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6146152|NCT01363128|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6146153|NCT01363128|Abortifacient Agents|abortifacient agents|mesh-ancestor
6146154|NCT01363128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6146155|NCT01363128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6146156|NCT01363128|Antimetabolites|antimetabolites|mesh-ancestor
6474131|NCT00513266|Antimetabolites|antimetabolites|mesh-ancestor
6474132|NCT00513266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474133|NCT00513266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6146157|NCT01363128|Dermatologic Agents|dermatologic agents|mesh-ancestor
6146158|NCT01363128|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6146159|NCT01363128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6146160|NCT01363128|Antiviral Agents|antiviral agents|mesh-ancestor
6146161|NCT01363128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6146162|NCT01363128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6146163|NCT01363128|Tubulin Modulators|tubulin modulators|mesh-ancestor
6146164|NCT01363128|Antimitotic Agents|antimitotic agents|mesh-ancestor
6146165|NCT01363128|Mitosis Modulators|mitosis modulators|mesh-ancestor
6146166|NCT01363128|Protease Inhibitors|protease inhibitors|mesh-ancestor
6146167|NCT01363297|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
6146168|NCT01363297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6667333|NCT01526850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6667334|NCT01526850|Immunologic Factors|immunologic factors|mesh-ancestor
6667335|NCT01526850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667336|NCT01526850|Antifungal Agents|antifungal agents|mesh-ancestor
6667337|NCT01526850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6667338|NCT01526850|Dermatologic Agents|dermatologic agents|mesh-ancestor
6667339|NCT01526850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6667340|NCT01526850|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6474134|NCT00513266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6474135|NCT00513266|Immunologic Factors|immunologic factors|mesh-ancestor
6474136|NCT00513266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6474137|NCT00513266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6474138|NCT00513266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6474139|NCT00513266|Antidotes|antidotes|mesh-ancestor
6474140|NCT00513266|Protective Agents|protective agents|mesh-ancestor
6474141|NCT00513266|Vitamin B Complex|vitamin b complex|mesh-ancestor
6667341|NCT01526850|Hormones|hormones|mesh-ancestor
6146169|NCT01363297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6146170|NCT01363297|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6146171|NCT01363349|Risperidone|risperidone|mesh-list
6146172|NCT01363349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6146173|NCT01363349|Serotonin Agents|serotonin agents|mesh-ancestor
6146174|NCT01363349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6146175|NCT01363349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6146176|NCT01363349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146177|NCT01363349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6146178|NCT01363349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6146179|NCT01363349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6146180|NCT01363349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6146181|NCT01363349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6146182|NCT01363349|Dopamine Agents|dopamine agents|mesh-ancestor
6146183|NCT01363440|Aflibercept|aflibercept|mesh-list
6146184|NCT01363440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6146185|NCT01363440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6146186|NCT01363440|Growth Substances|growth substances|mesh-ancestor
6146187|NCT01363440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146188|NCT01363440|Growth Inhibitors|growth inhibitors|mesh-ancestor
6146189|NCT01363440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6146190|NCT01363479|Dexamethasone|dexamethasone|mesh-list
6146191|NCT01363479|Palonosetron|palonosetron|mesh-list
6146192|NCT01363479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6146193|NCT01363479|Antiemetics|antiemetics|mesh-ancestor
6672434|NCT01556035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6146194|NCT01363479|Autonomic Agents|autonomic agents|mesh-ancestor
6146195|NCT01363479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6146196|NCT01363479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146197|NCT01363479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6146198|NCT01363479|Glucocorticoids|glucocorticoids|mesh-ancestor
6146199|NCT01363479|Hormones|hormones|mesh-ancestor
6146200|NCT01363479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6146201|NCT01363479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6146202|NCT01363479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6146203|NCT01363479|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6146204|NCT01363479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6146205|NCT01363479|Serotonin Agents|serotonin agents|mesh-ancestor
6146206|NCT01363479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6146207|NCT01363479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6146208|NCT01363661|Molsidomine|molsidomine|mesh-list
6146209|NCT01363661|Vasodilator Agents|vasodilator agents|mesh-ancestor
6146210|NCT01363661|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6146211|NCT01363661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6146212|NCT01363700|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
6146213|NCT01363700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6146214|NCT01363700|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6146215|NCT01363700|Epinastine|epinastine|mesh-list
6146216|NCT01363700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6146217|NCT01363700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6146218|NCT01363700|Analgesics|analgesics|mesh-ancestor
6146219|NCT01363700|Sensory System Agents|sensory system agents|mesh-ancestor
6146220|NCT01363700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6146221|NCT01363700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146222|NCT01363700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6146223|NCT01363700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6146224|NCT01363700|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6146225|NCT01363700|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6146226|NCT01363700|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6146227|NCT01363700|Histamine Antagonists|histamine antagonists|mesh-ancestor
6146228|NCT01363700|Histamine Agents|histamine agents|mesh-ancestor
6146229|NCT01363700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6146230|NCT01363700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6146231|NCT01363713|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6146232|NCT01363713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6146233|NCT01363843|Leucovorin|leucovorin|mesh-list
5548978|NCT04109924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5548979|NCT04109924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5548980|NCT04109924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5548981|NCT04109924|Antimetabolites|antimetabolites|mesh-ancestor
5548982|NCT04109924|Antiviral Agents|antiviral agents|mesh-ancestor
5548983|NCT04109924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5548984|NCT04109924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5548985|NCT04109833|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6146234|NCT01363843|Oxaliplatin|oxaliplatin|mesh-list
6146235|NCT01363843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6146236|NCT01363843|Antidotes|antidotes|mesh-ancestor
6146237|NCT01363843|Protective Agents|protective agents|mesh-ancestor
6146238|NCT01363843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5548986|NCT04109833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5548987|NCT04109755|Pembrolizumab|pembrolizumab|mesh-list
5548988|NCT04109755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5548989|NCT04109755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5548990|NCT04109261|Palbociclib|palbociclib|mesh-list
5548991|NCT04109261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5548992|NCT04109261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5548993|NCT04109261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5548994|NCT04109261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6146239|NCT01363843|Vitamin B Complex|vitamin b complex|mesh-ancestor
6146240|NCT01363843|Vitamins|vitamins|mesh-ancestor
5548995|NCT04109339|Oxytocin|oxytocin|mesh-list
6146241|NCT01363843|Micronutrients|micronutrients|mesh-ancestor
6146242|NCT01363986|Trastuzumab|trastuzumab|mesh-list
6146243|NCT01363986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6146244|NCT01363986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6146245|NCT01363999|Atorvastatin|atorvastatin|mesh-list
6146246|NCT01363999|Dalcetrapib|dalcetrapib|mesh-list
6146247|NCT01363999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6146248|NCT01363999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6146249|NCT01363999|Antimetabolites|antimetabolites|mesh-ancestor
6146250|NCT01363999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6146251|NCT01363999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6146252|NCT01363999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6146253|NCT01363999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6146254|NCT01364090|Interferons|interferons|mesh-list
6146255|NCT01364090|Ribavirin|ribavirin|mesh-list
6146256|NCT01364090|Interferon-alpha|interferon-alpha|mesh-list
6146257|NCT01364090|Interferon alpha-2|interferon alpha-2|mesh-list
6146258|NCT01364090|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6146259|NCT01364090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6146260|NCT01364090|Antiviral Agents|antiviral agents|mesh-ancestor
6146261|NCT01364090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6146262|NCT01364090|Antimetabolites|antimetabolites|mesh-ancestor
6146263|NCT01364090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6146264|NCT01364090|Immunologic Factors|immunologic factors|mesh-ancestor
6146265|NCT01364090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146266|NCT01364259|Amifostine|amifostine|mesh-list
6146267|NCT01364259|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6146268|NCT01364259|Protective Agents|protective agents|mesh-ancestor
6146269|NCT01364259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146270|NCT01364298|Pregabalin|pregabalin|mesh-list
6146271|NCT01364298|Gabapentin|gabapentin|mesh-list
6146272|NCT01364298|Analgesics|analgesics|mesh-ancestor
6146273|NCT01364298|Sensory System Agents|sensory system agents|mesh-ancestor
6146274|NCT01364298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6146275|NCT01364298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146276|NCT01364298|Anticonvulsants|anticonvulsants|mesh-ancestor
6146277|NCT01364298|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6146278|NCT01364298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6146279|NCT01364298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6146280|NCT01364298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6146281|NCT01364298|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6146282|NCT01364298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6146283|NCT01364298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6146284|NCT01364298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6146285|NCT01364298|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6146286|NCT01364298|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6146287|NCT01364298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6146288|NCT01364298|Antimanic Agents|antimanic agents|mesh-ancestor
6205569|NCT02087943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205570|NCT02087943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5548996|NCT04109339|Oxytocics|oxytocics|mesh-ancestor
5548997|NCT04109339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5548998|NCT04109339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474142|NCT00513266|Vitamins|vitamins|mesh-ancestor
6474143|NCT00513266|Micronutrients|micronutrients|mesh-ancestor
6474144|NCT00513383|Paclitaxel|paclitaxel|mesh-list
6474145|NCT00513383|Docetaxel|docetaxel|mesh-list
6205571|NCT02087943|Immunologic Factors|immunologic factors|mesh-ancestor
6205572|NCT02087943|Leprostatic Agents|leprostatic agents|mesh-ancestor
6205573|NCT02087943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6205574|NCT02087943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6205575|NCT02087943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6205576|NCT02087943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6474146|NCT00513383|Carboplatin|carboplatin|mesh-list
6474147|NCT00513383|Fluorouracil|fluorouracil|mesh-list
6474148|NCT00513383|Panitumumab|panitumumab|mesh-list
5548999|NCT04109482|Cyclophosphamide|cyclophosphamide|mesh-list
5549000|NCT04109482|Fludarabine|fludarabine|mesh-list
5549001|NCT04109482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5549002|NCT04109482|Immunologic Factors|immunologic factors|mesh-ancestor
6474149|NCT00513383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6474150|NCT00513383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6474151|NCT00513383|Tubulin Modulators|tubulin modulators|mesh-ancestor
6474152|NCT00513383|Antimitotic Agents|antimitotic agents|mesh-ancestor
5549003|NCT04109482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205577|NCT02087943|Growth Substances|growth substances|mesh-ancestor
6474153|NCT00513383|Mitosis Modulators|mitosis modulators|mesh-ancestor
6474154|NCT00513383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474155|NCT00513383|Antimetabolites|antimetabolites|mesh-ancestor
6474156|NCT00513383|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6474157|NCT00513383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6474158|NCT00513383|Immunologic Factors|immunologic factors|mesh-ancestor
6474159|NCT00513383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474160|NCT00513383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6146289|NCT01364389|Prednisone|prednisone|mesh-list
6146290|NCT01364389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6146291|NCT01364389|Glucocorticoids|glucocorticoids|mesh-ancestor
6146292|NCT01364389|Hormones|hormones|mesh-ancestor
6146293|NCT01364389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6146294|NCT01364389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549004|NCT04109482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5549005|NCT04109482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5549006|NCT04109482|Alkylating Agents|alkylating agents|mesh-ancestor
6146295|NCT01364389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6146296|NCT01364389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6146297|NCT01364428|Insulin|insulin|mesh-list
6146298|NCT01364428|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6146299|NCT01364428|Insulin, Long-Acting|insulin, long-acting|mesh-list
6146300|NCT01364428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6146301|NCT01364428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146302|NCT01364467|Phenylpropanolamine|phenylpropanolamine|mesh-list
6146303|NCT01364467|Guaifenesin|guaifenesin|mesh-list
6146304|NCT01364467|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
6146305|NCT01364467|Expectorants|expectorants|mesh-ancestor
6146306|NCT01364467|Respiratory System Agents|respiratory system agents|mesh-ancestor
6146307|NCT01364467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6146308|NCT01364467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6146309|NCT01364467|Adrenergic Agents|adrenergic agents|mesh-ancestor
6146310|NCT01364467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6146311|NCT01364467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6146312|NCT01364467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146313|NCT01364467|Appetite Depressants|appetite depressants|mesh-ancestor
6146314|NCT01364467|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6146315|NCT01364467|Sympathomimetics|sympathomimetics|mesh-ancestor
6146316|NCT01364467|Autonomic Agents|autonomic agents|mesh-ancestor
6146317|NCT01364467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6146318|NCT01364467|Nasal Decongestants|nasal decongestants|mesh-ancestor
6146319|NCT01364467|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6146320|NCT01364558|Diazepam|diazepam|mesh-list
6146321|NCT01364558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6146322|NCT01364558|Anticonvulsants|anticonvulsants|mesh-ancestor
6146323|NCT01364558|Antiemetics|antiemetics|mesh-ancestor
6146324|NCT01364558|Autonomic Agents|autonomic agents|mesh-ancestor
6146325|NCT01364558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6146326|NCT01364558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146327|NCT01364558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6146328|NCT01364558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6146329|NCT01364558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6146330|NCT01364558|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6146331|NCT01364558|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6146332|NCT01364558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6146333|NCT01364558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6146334|NCT01364558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6146335|NCT01364558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6474161|NCT00513396|Isoniazid|isoniazid|mesh-list
6474162|NCT00513396|Antitubercular Agents|antitubercular agents|mesh-ancestor
6474163|NCT00513396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6474164|NCT00513396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6474165|NCT00513396|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6474166|NCT00513396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6474167|NCT00513396|Antimetabolites|antimetabolites|mesh-ancestor
6474168|NCT00513396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474169|NCT00513396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6474170|NCT00513487|Fluticasone|fluticasone|mesh-list
6474171|NCT00513487|Methacholine Chloride|methacholine chloride|mesh-list
6474172|NCT00513487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6474173|NCT00513487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6474174|NCT00513487|Autonomic Agents|autonomic agents|mesh-ancestor
6474175|NCT00513487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6474176|NCT00513487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549007|NCT04109482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474177|NCT00513487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6474178|NCT00513487|Respiratory System Agents|respiratory system agents|mesh-ancestor
6474179|NCT00513487|Dermatologic Agents|dermatologic agents|mesh-ancestor
6474180|NCT00513487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6474181|NCT00513487|Miotics|miotics|mesh-ancestor
6474182|NCT00513487|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6474183|NCT00513487|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
6146336|NCT01364558|Anesthetics, General|anesthetics, general|mesh-ancestor
6146337|NCT01364558|Anesthetics|anesthetics|mesh-ancestor
6146338|NCT01364558|GABA Modulators|gaba modulators|mesh-ancestor
6146339|NCT01364558|GABA Agents|gaba agents|mesh-ancestor
6146340|NCT01364558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6146341|NCT01364558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6146342|NCT01364584|Exenatide|exenatide|mesh-list
6146343|NCT01364584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6146344|NCT01364584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146345|NCT01364584|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6146346|NCT01364584|Incretins|incretins|mesh-ancestor
6146347|NCT01364584|Hormones|hormones|mesh-ancestor
6474184|NCT00513487|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6474185|NCT00513487|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6474186|NCT00513487|Cholinergic Agents|cholinergic agents|mesh-ancestor
6474187|NCT00513487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6474188|NCT00513487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474189|NCT00513513|Ritonavir|ritonavir|mesh-list
5549008|NCT04109482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5549009|NCT04109482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5549010|NCT04109534|Methacholine Chloride|methacholine chloride|mesh-list
5549011|NCT04109534|Miotics|miotics|mesh-ancestor
6146348|NCT01364584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6146349|NCT01364623|Methyltestosterone|methyltestosterone|mesh-list
6146350|NCT01364623|Testosterone|testosterone|mesh-list
6474190|NCT00513513|Darunavir|darunavir|mesh-list
6474191|NCT00513513|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6474192|NCT00513513|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6474193|NCT00513513|Protease Inhibitors|protease inhibitors|mesh-ancestor
6474194|NCT00513513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6474195|NCT00513513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474196|NCT00513513|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6474197|NCT00513513|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6474198|NCT00513513|Antiviral Agents|antiviral agents|mesh-ancestor
6474199|NCT00513513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6474200|NCT00513513|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6474201|NCT00513513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6474202|NCT00513539|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
6474203|NCT00513539|Trioxsalen|trioxsalen|mesh-list
6474204|NCT00513539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6474205|NCT00513539|Dermatologic Agents|dermatologic agents|mesh-ancestor
6474206|NCT00513539|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6474207|NCT00513552|Clarithromycin|clarithromycin|mesh-list
6474208|NCT00513552|Rifabutin|rifabutin|mesh-list
6474209|NCT00513552|Clofazimine|clofazimine|mesh-list
6474210|NCT00513552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6667342|NCT01526850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6667343|NCT01526876|Clevidipine|clevidipine|mesh-list
6667344|NCT01526876|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6667345|NCT01526876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6672435|NCT01556035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5549012|NCT04109534|Autonomic Agents|autonomic agents|mesh-ancestor
5549013|NCT04109534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5549014|NCT04109534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549015|NCT04109534|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5549016|NCT04109534|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
5549017|NCT04109534|Respiratory System Agents|respiratory system agents|mesh-ancestor
5549018|NCT04109534|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
5549019|NCT04109534|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6146351|NCT01364623|Testosterone undecanoate|testosterone undecanoate|mesh-list
6146352|NCT01364623|Testosterone enanthate|testosterone enanthate|mesh-list
6146353|NCT01364623|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6146354|NCT01364623|Androgens|androgens|mesh-ancestor
6146355|NCT01364623|Hormones|hormones|mesh-ancestor
6146356|NCT01364623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6146357|NCT01364623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146358|NCT01364623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6146359|NCT01364623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6146360|NCT01364623|Anabolic Agents|anabolic agents|mesh-ancestor
6146361|NCT01364649|Vortioxetine|vortioxetine|mesh-list
6146362|NCT01364649|Citalopram|citalopram|mesh-list
6146363|NCT01364649|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6146364|NCT01364649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6146365|NCT01364649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6146366|NCT01364649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6146367|NCT01364649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6146368|NCT01364649|Serotonin Agents|serotonin agents|mesh-ancestor
6146369|NCT01364649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146370|NCT01364649|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6146371|NCT01364649|Antidepressive Agents|antidepressive agents|mesh-ancestor
6146372|NCT01364649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6146373|NCT01364649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6146374|NCT01364649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6146375|NCT01364649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6146376|NCT01364649|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6146377|NCT01364649|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6146378|NCT01364649|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6146379|NCT01364649|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6146380|NCT01364727|Amrubicin|amrubicin|mesh-list
6146381|NCT01364727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6146382|NCT01364922|Acetaminophen|acetaminophen|mesh-list
6146383|NCT01364922|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
6146384|NCT01364922|Hydrocodone|hydrocodone|mesh-list
6146385|NCT01364922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6146386|NCT01364922|Analgesics|analgesics|mesh-ancestor
6146387|NCT01364922|Sensory System Agents|sensory system agents|mesh-ancestor
6146388|NCT01364922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6146389|NCT01364922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146390|NCT01364922|Antipyretics|antipyretics|mesh-ancestor
6146391|NCT01364922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6146392|NCT01364922|Narcotics|narcotics|mesh-ancestor
6146393|NCT01364922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6146394|NCT01364922|Antitussive Agents|antitussive agents|mesh-ancestor
6146395|NCT01364922|Respiratory System Agents|respiratory system agents|mesh-ancestor
6146396|NCT01364922|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6146397|NCT01364922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5549020|NCT04109534|Cholinergic Agents|cholinergic agents|mesh-ancestor
5549021|NCT04109534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5549022|NCT04109534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549023|NCT04108897|Doxycycline|doxycycline|mesh-list
5549024|NCT04108897|Ivermectin|ivermectin|mesh-list
5549025|NCT04108897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5549026|NCT04108897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6146398|NCT01364922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6146399|NCT01365052|Naproxen|naproxen|mesh-list
6146400|NCT01365052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6146401|NCT01365052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6146402|NCT01365052|Analgesics|analgesics|mesh-ancestor
6146403|NCT01365052|Sensory System Agents|sensory system agents|mesh-ancestor
6146404|NCT01365052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6146405|NCT01365052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146406|NCT01365052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6146407|NCT01365052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6146408|NCT01365052|Gout Suppressants|gout suppressants|mesh-ancestor
6146409|NCT01365052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6146410|NCT01365052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6146411|NCT01365052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6146412|NCT01365091|Metformin|metformin|mesh-list
6146413|NCT01365091|Saxagliptin|saxagliptin|mesh-list
6146414|NCT01365091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6146415|NCT01365091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146416|NCT01365091|Incretins|incretins|mesh-ancestor
6146417|NCT01365091|Hormones|hormones|mesh-ancestor
6146418|NCT01365091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6146419|NCT01365091|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6146420|NCT01365091|Protease Inhibitors|protease inhibitors|mesh-ancestor
6146421|NCT01365091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6146422|NCT01365091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6146423|NCT01365455|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6474211|NCT00513552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6474212|NCT00513552|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6474213|NCT00513552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6474214|NCT00513552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474215|NCT00513552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6474216|NCT00513552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6474217|NCT00513552|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6474218|NCT00513552|Antitubercular Agents|antitubercular agents|mesh-ancestor
6474219|NCT00513552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6474220|NCT00513552|Leprostatic Agents|leprostatic agents|mesh-ancestor
6474221|NCT00513578|Sargramostim|sargramostim|mesh-list
6146424|NCT01365455|Immunologic Factors|immunologic factors|mesh-ancestor
6146425|NCT01365455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146426|NCT01365468|Everolimus|everolimus|mesh-list
6146427|NCT01365468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6146428|NCT01365468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6146429|NCT01365468|Immunologic Factors|immunologic factors|mesh-ancestor
6146430|NCT01365468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146431|NCT01365481|Amlodipine|amlodipine|mesh-list
6146432|NCT01365481|Valsartan|valsartan|mesh-list
6146433|NCT01365481|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6146434|NCT01365481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6146435|NCT01365481|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6146436|NCT01365481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6146437|NCT01365481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6146438|NCT01365481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6146439|NCT01365481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146440|NCT01365481|Vasodilator Agents|vasodilator agents|mesh-ancestor
6146441|NCT01365481|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6146442|NCT01365481|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6146443|NCT01365481|Diuretics|diuretics|mesh-ancestor
6146444|NCT01365481|Natriuretic Agents|natriuretic agents|mesh-ancestor
6146445|NCT01365481|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6146446|NCT01365507|Insulin|insulin|mesh-list
6146447|NCT01365507|Insulin Aspart|insulin aspart|mesh-list
6146448|NCT01365507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6146449|NCT01365507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146450|NCT01365585|Sildenafil Citrate|sildenafil citrate|mesh-list
6146451|NCT01365585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6146452|NCT01365585|Vasodilator Agents|vasodilator agents|mesh-ancestor
6146453|NCT01365585|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6146454|NCT01365585|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6146455|NCT01365585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6146456|NCT01365585|Urological Agents|urological agents|mesh-ancestor
6146457|NCT01365611|Fluticasone|fluticasone|mesh-list
6146458|NCT01365611|Xhance|xhance|mesh-list
6146459|NCT01365611|Ketorolac|ketorolac|mesh-list
6146460|NCT01365611|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6146461|NCT01365611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5549027|NCT04108897|Antimalarials|antimalarials|mesh-ancestor
6146462|NCT01365611|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6146463|NCT01365611|Autonomic Agents|autonomic agents|mesh-ancestor
6146464|NCT01365611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6667346|NCT01526876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667347|NCT01526876|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5549028|NCT04108897|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5549029|NCT04108897|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5549030|NCT04108845|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5549031|NCT04108845|Immunologic Factors|immunologic factors|mesh-ancestor
5549032|NCT04108845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549033|NCT04108468|Golimumab|golimumab|mesh-list
5549034|NCT04108468|Methotrexate|methotrexate|mesh-list
6146465|NCT01365611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146466|NCT01365611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6146467|NCT01365611|Respiratory System Agents|respiratory system agents|mesh-ancestor
6146468|NCT01365611|Dermatologic Agents|dermatologic agents|mesh-ancestor
6146469|NCT01365611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6146470|NCT01365611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6146471|NCT01365611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6146472|NCT01365611|Analgesics|analgesics|mesh-ancestor
6146473|NCT01365611|Sensory System Agents|sensory system agents|mesh-ancestor
6146474|NCT01365611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6146475|NCT01365611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6146476|NCT01365611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6146477|NCT01365611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6146478|NCT01365624|Ketorolac|ketorolac|mesh-list
6146479|NCT01365624|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6146480|NCT01365624|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6146481|NCT01365624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6146482|NCT01365624|Analgesics|analgesics|mesh-ancestor
6146483|NCT01365624|Sensory System Agents|sensory system agents|mesh-ancestor
6146484|NCT01365624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6146485|NCT01365624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146486|NCT01365624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6146487|NCT01365624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6146488|NCT01365624|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6146489|NCT01365624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6146490|NCT01365624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6146491|NCT01365650|Fluticasone|fluticasone|mesh-list
6146492|NCT01365650|Xhance|xhance|mesh-list
6146493|NCT01365650|Ketorolac|ketorolac|mesh-list
6146494|NCT01365650|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6146495|NCT01365650|Phenylephrine|phenylephrine|mesh-list
6146496|NCT01365650|Oxymetazoline|oxymetazoline|mesh-list
6146497|NCT01365650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6146498|NCT01365650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6146499|NCT01365650|Autonomic Agents|autonomic agents|mesh-ancestor
6146500|NCT01365650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6146501|NCT01365650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146502|NCT01365650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6146503|NCT01365650|Respiratory System Agents|respiratory system agents|mesh-ancestor
6146504|NCT01365650|Dermatologic Agents|dermatologic agents|mesh-ancestor
6146505|NCT01365650|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6146506|NCT01365650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6146507|NCT01365650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6146508|NCT01365650|Analgesics|analgesics|mesh-ancestor
6146509|NCT01365650|Sensory System Agents|sensory system agents|mesh-ancestor
6146510|NCT01365650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6146511|NCT01365650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6146512|NCT01365650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6474222|NCT00513578|Freund's Adjuvant|freund's adjuvant|mesh-list
6474223|NCT00513578|Immunologic Factors|immunologic factors|mesh-ancestor
6474224|NCT00513578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549035|NCT04108468|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5549036|NCT04108468|Abortifacient Agents|abortifacient agents|mesh-ancestor
5549037|NCT04108468|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6146513|NCT01365650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474225|NCT00513578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6474226|NCT00513630|Metformin|metformin|mesh-list
6474227|NCT00513630|Glipizide|glipizide|mesh-list
6474228|NCT00513630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6474229|NCT00513630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474230|NCT00513643|Insulin|insulin|mesh-list
6474231|NCT00513643|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6474232|NCT00513643|Insulin Aspart|insulin aspart|mesh-list
6474233|NCT00513643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6474234|NCT00513643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474235|NCT00513656|Oxycodone|oxycodone|mesh-list
6474236|NCT00513656|Naloxone|naloxone|mesh-list
6474237|NCT00513656|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6474238|NCT00513656|Narcotics|narcotics|mesh-ancestor
6474239|NCT00513656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6474240|NCT00513656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474241|NCT00513656|Analgesics|analgesics|mesh-ancestor
6474242|NCT00513656|Sensory System Agents|sensory system agents|mesh-ancestor
6474243|NCT00513656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6474244|NCT00513656|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6474245|NCT00513786|Paclitaxel|paclitaxel|mesh-list
6146514|NCT01365650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6146515|NCT01365650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6146516|NCT01365650|Adrenergic Agents|adrenergic agents|mesh-ancestor
6146517|NCT01365650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6146518|NCT01365650|Sympathomimetics|sympathomimetics|mesh-ancestor
6146519|NCT01365650|Nasal Decongestants|nasal decongestants|mesh-ancestor
6146520|NCT01365650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6146521|NCT01365650|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6146522|NCT01365650|Mydriatics|mydriatics|mesh-ancestor
6146523|NCT01365650|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6146524|NCT01365650|Protective Agents|protective agents|mesh-ancestor
6146525|NCT01365819|Varenicline|varenicline|mesh-list
6146526|NCT01365819|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6146527|NCT01365819|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6146528|NCT01365819|Cholinergic Agents|cholinergic agents|mesh-ancestor
6146529|NCT01365819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6146530|NCT01365819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6146531|NCT01365819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146532|NCT01366196|Pregabalin|pregabalin|mesh-list
6146533|NCT01366196|Analgesics|analgesics|mesh-ancestor
6146534|NCT01366196|Sensory System Agents|sensory system agents|mesh-ancestor
6146535|NCT01366196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6146536|NCT01366196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146537|NCT01366196|Anticonvulsants|anticonvulsants|mesh-ancestor
6146538|NCT01366196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6146539|NCT01366196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6146540|NCT01366196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667348|NCT01526876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549038|NCT04108468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549039|NCT04108468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5549040|NCT04108468|Antimetabolites|antimetabolites|mesh-ancestor
5549041|NCT04108468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549042|NCT04108468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5549043|NCT04108468|Dermatologic Agents|dermatologic agents|mesh-ancestor
5549044|NCT04108468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5549045|NCT04108468|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5549046|NCT04108468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5549047|NCT04108468|Immunologic Factors|immunologic factors|mesh-ancestor
5549048|NCT04108468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5549049|NCT04108468|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5549050|NCT04108468|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
5549051|NCT04108468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5549052|NCT04108676|Omeprazole|omeprazole|mesh-list
5549053|NCT04108676|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5549054|NCT04108676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6146541|NCT01366196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6474246|NCT00513786|Bevacizumab|bevacizumab|mesh-list
6474247|NCT00513786|Carboplatin|carboplatin|mesh-list
6667349|NCT01526941|Insulin|insulin|mesh-list
6667350|NCT01526941|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6667351|NCT01526941|Insulin Aspart|insulin aspart|mesh-list
6667352|NCT01526941|Insulin, Long-Acting|insulin, long-acting|mesh-list
6667353|NCT01526941|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6667354|NCT01526941|Biphasic Insulins|biphasic insulins|mesh-list
6672436|NCT01556035|Growth Substances|growth substances|mesh-ancestor
6146542|NCT01366196|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5549055|NCT04108676|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5549056|NCT04108676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5549057|NCT04108676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549058|NCT04108637|Penicillins|penicillins|mesh-list
5549059|NCT04108637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5549060|NCT04108637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5549061|NCT04108234|Ketamine|ketamine|mesh-list
5549062|NCT04108234|Analgesics|analgesics|mesh-ancestor
5549063|NCT04108234|Sensory System Agents|sensory system agents|mesh-ancestor
5549064|NCT04108234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5549065|NCT04108234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549066|NCT04108234|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5549067|NCT04108234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5549068|NCT04108234|Anesthetics, General|anesthetics, general|mesh-ancestor
5549069|NCT04108234|Anesthetics|anesthetics|mesh-ancestor
5549070|NCT04108234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5549071|NCT04108234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5549072|NCT04108234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5549073|NCT04108234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5549074|NCT04108234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549075|NCT04108039|Cetrorelix|cetrorelix|mesh-list
5549076|NCT04108039|Progesterone|progesterone|mesh-list
5549077|NCT04108039|Ganirelix|ganirelix|mesh-list
5549078|NCT04108039|Progestins|progestins|mesh-ancestor
6146543|NCT01366196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6146544|NCT01366196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6146545|NCT01366196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6146546|NCT01366209|Pirfenidone|pirfenidone|mesh-list
6146547|NCT01366209|Analgesics|analgesics|mesh-ancestor
5549079|NCT04108039|Hormones|hormones|mesh-ancestor
5549080|NCT04108039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5549081|NCT04108039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549082|NCT04108039|Hormone Antagonists|hormone antagonists|mesh-ancestor
5549083|NCT04108039|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5549084|NCT04108039|Fertility Agents|fertility agents|mesh-ancestor
5549085|NCT04108039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5549086|NCT04108013|Paclitaxel|paclitaxel|mesh-list
5549087|NCT04108013|Carboplatin|carboplatin|mesh-list
5549088|NCT04108013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5549089|NCT04108013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6146548|NCT01366209|Sensory System Agents|sensory system agents|mesh-ancestor
6146549|NCT01366209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6146550|NCT01366209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146551|NCT01366209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6146552|NCT01366209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6146553|NCT01366209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6146554|NCT01366209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6146555|NCT01366209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6146556|NCT01366534|Vaccines|vaccines|mesh-list
6146557|NCT01366534|Immunologic Factors|immunologic factors|mesh-ancestor
6146558|NCT01366534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146559|NCT01366638|Ribavirin|ribavirin|mesh-list
6146560|NCT01366638|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6146561|NCT01366638|Simeprevir|simeprevir|mesh-list
6146562|NCT01366638|Antimetabolites|antimetabolites|mesh-ancestor
6146563|NCT01366638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6146564|NCT01366638|Antiviral Agents|antiviral agents|mesh-ancestor
6146565|NCT01366638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6146566|NCT01366638|Protease Inhibitors|protease inhibitors|mesh-ancestor
5549090|NCT04108013|Tubulin Modulators|tubulin modulators|mesh-ancestor
5549091|NCT04108013|Antimitotic Agents|antimitotic agents|mesh-ancestor
5549092|NCT04108013|Mitosis Modulators|mitosis modulators|mesh-ancestor
5549093|NCT04108013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602769|NCT04188028|Antitussive Agents|antitussive agents|mesh-ancestor
5602770|NCT04188028|Respiratory System Agents|respiratory system agents|mesh-ancestor
5602771|NCT04188028|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5602772|NCT04188028|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5602773|NCT04174612|Cytarabine|cytarabine|mesh-list
5602774|NCT04174612|Daunorubicin|daunorubicin|mesh-list
5549094|NCT04108104|Cyproheptadine|cyproheptadine|mesh-list
5549095|NCT04108104|Prazosin|prazosin|mesh-list
5549096|NCT04108104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6146567|NCT01366638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6146568|NCT01366885|Vitamin D|vitamin d|mesh-list
5549097|NCT04108104|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5549098|NCT04108104|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5549099|NCT04108104|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5549100|NCT04108104|Adrenergic Agents|adrenergic agents|mesh-ancestor
5549101|NCT04108104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5549102|NCT04108104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549103|NCT04108104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146569|NCT01366885|Cholecalciferol|cholecalciferol|mesh-list
6146570|NCT01366885|Vitamins|vitamins|mesh-ancestor
6146571|NCT01366885|Micronutrients|micronutrients|mesh-ancestor
6146572|NCT01366885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146573|NCT01366885|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6146574|NCT01366885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6146575|NCT01366976|Acetaminophen|acetaminophen|mesh-list
6146576|NCT01366976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6146577|NCT01366976|Analgesics|analgesics|mesh-ancestor
6146578|NCT01366976|Sensory System Agents|sensory system agents|mesh-ancestor
6146579|NCT01366976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6146580|NCT01366976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146581|NCT01366976|Antipyretics|antipyretics|mesh-ancestor
6146582|NCT01367119|Ketamine|ketamine|mesh-list
6146583|NCT01367119|Methohexital|methohexital|mesh-list
6146584|NCT01367119|Analgesics|analgesics|mesh-ancestor
6146585|NCT01367119|Sensory System Agents|sensory system agents|mesh-ancestor
5549104|NCT04108104|Antipruritics|antipruritics|mesh-ancestor
5549105|NCT04108104|Dermatologic Agents|dermatologic agents|mesh-ancestor
5549106|NCT04108104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5549107|NCT04108104|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5549108|NCT04108104|Histamine Antagonists|histamine antagonists|mesh-ancestor
5549109|NCT04108104|Histamine Agents|histamine agents|mesh-ancestor
5549110|NCT04108104|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5549111|NCT04108104|Serotonin Agents|serotonin agents|mesh-ancestor
5549112|NCT04108104|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5549113|NCT04107896|Tamsulosin|tamsulosin|mesh-list
5549114|NCT04107896|Silodosin|silodosin|mesh-list
5549115|NCT04107896|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5549116|NCT04107896|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5549117|NCT04107896|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5549118|NCT04107896|Adrenergic Agents|adrenergic agents|mesh-ancestor
5549119|NCT04107896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5549120|NCT04107896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549121|NCT04107896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549122|NCT04107896|Urological Agents|urological agents|mesh-ancestor
5549123|NCT04108026|Durvalumab|durvalumab|mesh-list
5549124|NCT04108026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5549125|NCT04108026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5549126|NCT04107805|Midazolam|midazolam|mesh-list
6667355|NCT01526941|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6667356|NCT01526941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5549127|NCT04107805|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5549128|NCT04107805|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5549129|NCT04107805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6146586|NCT01367119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6146587|NCT01367119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146588|NCT01367119|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6474248|NCT00513786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6474249|NCT00513786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6474250|NCT00513786|Tubulin Modulators|tubulin modulators|mesh-ancestor
6474251|NCT00513786|Antimitotic Agents|antimitotic agents|mesh-ancestor
6474252|NCT00513786|Mitosis Modulators|mitosis modulators|mesh-ancestor
6474253|NCT00513786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6146589|NCT01367119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6146590|NCT01367119|Anesthetics, General|anesthetics, general|mesh-ancestor
6146591|NCT01367119|Anesthetics|anesthetics|mesh-ancestor
6146592|NCT01367119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6146593|NCT01367119|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6146594|NCT01367119|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6146595|NCT01367119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6474254|NCT00513786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6474255|NCT00513786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6474256|NCT00513786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6474257|NCT00513786|Growth Substances|growth substances|mesh-ancestor
6474258|NCT00513786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474259|NCT00513786|Growth Inhibitors|growth inhibitors|mesh-ancestor
6474260|NCT00513864|Morphine|morphine|mesh-list
6474261|NCT00513864|Codeine|codeine|mesh-list
6474262|NCT00513864|Dextromethorphan|dextromethorphan|mesh-list
6474263|NCT00513864|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6474264|NCT00513864|Narcotics|narcotics|mesh-ancestor
6474265|NCT00513864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6474266|NCT00513864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474267|NCT00513864|Analgesics|analgesics|mesh-ancestor
6474268|NCT00513864|Sensory System Agents|sensory system agents|mesh-ancestor
6474269|NCT00513864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6146596|NCT01367119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6146597|NCT01367158|Vaccines|vaccines|mesh-list
6146598|NCT01367158|Immunologic Factors|immunologic factors|mesh-ancestor
6146599|NCT01367158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146600|NCT01367249|Bromfenac|bromfenac|mesh-list
6146601|NCT01367249|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6146602|NCT01367249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6146603|NCT01367249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6146604|NCT01367249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6146605|NCT01367249|Analgesics|analgesics|mesh-ancestor
5549130|NCT04107805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549131|NCT04107805|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5549132|NCT04107805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5549133|NCT04107805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6146606|NCT01367249|Sensory System Agents|sensory system agents|mesh-ancestor
6146607|NCT01367249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6146608|NCT01367249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146609|NCT01367249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6146610|NCT01367249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6146611|NCT01367275|Irinotecan|irinotecan|mesh-list
6146612|NCT01367275|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6146613|NCT01367275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6146614|NCT01367275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6146615|NCT01367275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6146616|NCT01367275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6146617|NCT01367457|Sirolimus|sirolimus|mesh-list
6146618|NCT01367457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6146619|NCT01367457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6146620|NCT01367457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5549134|NCT04107805|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5549135|NCT04107805|Anesthetics, General|anesthetics, general|mesh-ancestor
5549136|NCT04107805|Anesthetics|anesthetics|mesh-ancestor
5549137|NCT04107805|GABA Modulators|gaba modulators|mesh-ancestor
5549138|NCT04107805|GABA Agents|gaba agents|mesh-ancestor
6146621|NCT01367457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6146622|NCT01367457|Antifungal Agents|antifungal agents|mesh-ancestor
6146623|NCT01367457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6146624|NCT01367457|Immunologic Factors|immunologic factors|mesh-ancestor
6146625|NCT01367457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146626|NCT01367834|Hormones|hormones|mesh-list
6146627|NCT01367834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6146628|NCT01367834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146629|NCT01367886|Fesoterodine|fesoterodine|mesh-list
5549139|NCT04107805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5549140|NCT04107805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549141|NCT04107740|TA 0910|ta 0910|mesh-list
5549142|NCT04107740|Nootropic Agents|nootropic agents|mesh-ancestor
5549143|NCT04107428|Somatostatin|somatostatin|mesh-list
5549144|NCT04107428|Hormones|hormones|mesh-ancestor
6146630|NCT01367886|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6146631|NCT01367886|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6146632|NCT01367886|Cholinergic Agents|cholinergic agents|mesh-ancestor
6146633|NCT01367886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6146634|NCT01367886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6146635|NCT01367886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146636|NCT01367886|Urological Agents|urological agents|mesh-ancestor
6146637|NCT01368081|Metformin|metformin|mesh-list
6146638|NCT01368081|Empagliflozin|empagliflozin|mesh-list
6146639|NCT01368081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5549145|NCT04107428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6474270|NCT00513864|Antitussive Agents|antitussive agents|mesh-ancestor
6474271|NCT00513864|Respiratory System Agents|respiratory system agents|mesh-ancestor
6146640|NCT01368081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146641|NCT01368081|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6146642|NCT01368081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6146643|NCT01368263|Letrozole|letrozole|mesh-list
6146644|NCT01368263|Anastrozole|anastrozole|mesh-list
6146645|NCT01368263|Goserelin|goserelin|mesh-list
6146646|NCT01368263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6146647|NCT01368263|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6146648|NCT01368263|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6146649|NCT01368263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6146650|NCT01368263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6146651|NCT01368263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6146652|NCT01368263|Hormone Antagonists|hormone antagonists|mesh-ancestor
6146653|NCT01368263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6146654|NCT01368263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146655|NCT01368263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6146656|NCT01368276|Molgramostim|molgramostim|mesh-list
6146657|NCT01368276|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
6146658|NCT01368276|Sargramostim|sargramostim|mesh-list
6146659|NCT01368276|Immunologic Factors|immunologic factors|mesh-ancestor
6146660|NCT01368276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146661|NCT01368276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6146662|NCT01368276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6146663|NCT01368432|Citalopram|citalopram|mesh-list
6146664|NCT01368432|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6146665|NCT01368432|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6146666|NCT01368432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6146667|NCT01368432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6146668|NCT01368432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6146669|NCT01368432|Serotonin Agents|serotonin agents|mesh-ancestor
6146670|NCT01368432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146671|NCT01368432|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6146672|NCT01368432|Antidepressive Agents|antidepressive agents|mesh-ancestor
6146673|NCT01368432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6146674|NCT01368497|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6146675|NCT01368497|Entecavir|entecavir|mesh-list
6146676|NCT01368497|Antiviral Agents|antiviral agents|mesh-ancestor
6146677|NCT01368497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6146678|NCT01368536|Amlodipine|amlodipine|mesh-list
6146679|NCT01368536|Chlorthalidone|chlorthalidone|mesh-list
6146680|NCT01368536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6146681|NCT01368536|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6146682|NCT01368536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6146683|NCT01368536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6146684|NCT01368536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6146685|NCT01368536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146686|NCT01368536|Vasodilator Agents|vasodilator agents|mesh-ancestor
6146687|NCT01368536|Diuretics|diuretics|mesh-ancestor
6146688|NCT01368536|Natriuretic Agents|natriuretic agents|mesh-ancestor
6146689|NCT01368536|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6146690|NCT01368562|Methylnaltrexone|methylnaltrexone|mesh-list
6146691|NCT01368562|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6146692|NCT01368562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146693|NCT01368562|Sensory System Agents|sensory system agents|mesh-ancestor
6146694|NCT01368562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6146695|NCT01368653|Nicotine|nicotine|mesh-list
6146696|NCT01368653|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6146697|NCT01368653|Autonomic Agents|autonomic agents|mesh-ancestor
6146698|NCT01368653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6146699|NCT01368653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146700|NCT01368653|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6146701|NCT01368653|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6146702|NCT01368653|Cholinergic Agents|cholinergic agents|mesh-ancestor
6146703|NCT01368653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6146704|NCT01368653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6146705|NCT01368809|Fentanyl|fentanyl|mesh-list
6146706|NCT01368809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6146707|NCT01368809|Narcotics|narcotics|mesh-ancestor
6146708|NCT01368809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6146709|NCT01368809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146710|NCT01368809|Analgesics|analgesics|mesh-ancestor
6146711|NCT01368809|Sensory System Agents|sensory system agents|mesh-ancestor
6146712|NCT01368809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6205578|NCT02087943|Growth Inhibitors|growth inhibitors|mesh-ancestor
6146713|NCT01368809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6474272|NCT00513864|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6474273|NCT00513864|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6474274|NCT00513864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6474275|NCT00513864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474276|NCT00513877|Bortezomib|bortezomib|mesh-list
6474277|NCT00513877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6474278|NCT00513929|Zinc Sulfate|zinc sulfate|mesh-list
6474279|NCT00513929|Astringents|astringents|mesh-ancestor
6474280|NCT00513929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474281|NCT00513929|Dermatologic Agents|dermatologic agents|mesh-ancestor
6474282|NCT00513955|Prednisolone|prednisolone|mesh-list
6474283|NCT00513955|Cyclophosphamide|cyclophosphamide|mesh-list
6146714|NCT01368809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6146715|NCT01368809|Anesthetics, General|anesthetics, general|mesh-ancestor
6146716|NCT01368809|Anesthetics|anesthetics|mesh-ancestor
6146717|NCT01369069|Insulin|insulin|mesh-list
6146718|NCT01369069|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6146719|NCT01369069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6146720|NCT01369069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146721|NCT01369199|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6146722|NCT01369199|Entecavir|entecavir|mesh-list
6146723|NCT01369199|Antiviral Agents|antiviral agents|mesh-ancestor
6146724|NCT01369199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6146725|NCT01369329|Ustekinumab|ustekinumab|mesh-list
5549146|NCT04107428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549147|NCT04107779|Menthol|menthol|mesh-list
6146726|NCT01369329|Dermatologic Agents|dermatologic agents|mesh-ancestor
6146727|NCT01369342|Ustekinumab|ustekinumab|mesh-list
6146728|NCT01369342|Dermatologic Agents|dermatologic agents|mesh-ancestor
6146729|NCT01369355|Ustekinumab|ustekinumab|mesh-list
6474284|NCT00513955|Doxorubicin|doxorubicin|mesh-list
6474285|NCT00513955|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6146730|NCT01369355|Dermatologic Agents|dermatologic agents|mesh-ancestor
6146731|NCT01369433|Sirolimus|sirolimus|mesh-list
6146732|NCT01369433|Paclitaxel|paclitaxel|mesh-list
6146733|NCT01369433|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6146734|NCT01369433|Capecitabine|capecitabine|mesh-list
6146735|NCT01369433|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6146736|NCT01369433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6146737|NCT01369433|Tubulin Modulators|tubulin modulators|mesh-ancestor
6146738|NCT01369433|Antimitotic Agents|antimitotic agents|mesh-ancestor
6146739|NCT01369433|Mitosis Modulators|mitosis modulators|mesh-ancestor
6146740|NCT01369433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6146741|NCT01369433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6146742|NCT01369433|Antimetabolites|antimetabolites|mesh-ancestor
6146743|NCT01369433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6146744|NCT01369433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6146745|NCT01369433|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6146746|NCT01369433|Antifungal Agents|antifungal agents|mesh-ancestor
6146747|NCT01369433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6146748|NCT01369433|Immunologic Factors|immunologic factors|mesh-ancestor
6146749|NCT01369433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146750|NCT01369485|Caffeine|caffeine|mesh-list
6146751|NCT01369485|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6146752|NCT01369485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146753|NCT01369485|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6146754|NCT01369485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6146755|NCT01369485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6146756|NCT01369485|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6146757|NCT01369485|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6146758|NCT01369485|Purinergic Agents|purinergic agents|mesh-ancestor
6146759|NCT01369485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6146760|NCT01369615|Oxycodone|oxycodone|mesh-list
6146761|NCT01369615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6146762|NCT01369615|Narcotics|narcotics|mesh-ancestor
6474286|NCT00513955|Vincristine|vincristine|mesh-list
6474287|NCT00513955|Bortezomib|bortezomib|mesh-list
6474288|NCT00513955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6474289|NCT00513955|Immunologic Factors|immunologic factors|mesh-ancestor
6474290|NCT00513955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474291|NCT00513955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6672437|NCT01556035|Growth Inhibitors|growth inhibitors|mesh-ancestor
5549148|NCT04107779|Nicotine|nicotine|mesh-list
6146763|NCT01369615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6146764|NCT01369615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146765|NCT01369615|Analgesics|analgesics|mesh-ancestor
6146766|NCT01369615|Sensory System Agents|sensory system agents|mesh-ancestor
6207853|NCT02121002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5549149|NCT04107779|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5549150|NCT04107779|Autonomic Agents|autonomic agents|mesh-ancestor
5549151|NCT04107779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5549152|NCT04107779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549153|NCT04107779|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5549154|NCT04107779|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6474292|NCT00513955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6474293|NCT00513955|Alkylating Agents|alkylating agents|mesh-ancestor
6474294|NCT00513955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474295|NCT00513955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6474296|NCT00513955|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6474297|NCT00513955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6474298|NCT00513955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6474299|NCT00513955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6474300|NCT00513955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6474301|NCT00513955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6474302|NCT00513955|Tubulin Modulators|tubulin modulators|mesh-ancestor
6474303|NCT00513955|Antimitotic Agents|antimitotic agents|mesh-ancestor
6474304|NCT00513955|Mitosis Modulators|mitosis modulators|mesh-ancestor
6474305|NCT00513955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6474306|NCT00513955|Glucocorticoids|glucocorticoids|mesh-ancestor
6474307|NCT00513955|Hormones|hormones|mesh-ancestor
6474308|NCT00513955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6474309|NCT00513955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6474310|NCT00513968|Adefovir|adefovir|mesh-list
6474311|NCT00513968|Antiviral Agents|antiviral agents|mesh-ancestor
6474312|NCT00513968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6474313|NCT00513968|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6474314|NCT00513968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6474315|NCT00513968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6474316|NCT00513968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474317|NCT00513981|Leucovorin|leucovorin|mesh-list
6474318|NCT00513981|Methotrexate|methotrexate|mesh-list
6474319|NCT00513981|Calcium|calcium|mesh-list
6474320|NCT00513981|Levoleucovorin|levoleucovorin|mesh-list
6474321|NCT00513981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6474322|NCT00513981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474323|NCT00513981|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6474324|NCT00513981|Abortifacient Agents|abortifacient agents|mesh-ancestor
6474325|NCT00513981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6474326|NCT00513981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6474327|NCT00513981|Antimetabolites|antimetabolites|mesh-ancestor
6474328|NCT00513981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474329|NCT00513981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6474330|NCT00513981|Dermatologic Agents|dermatologic agents|mesh-ancestor
6474331|NCT00513981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6474332|NCT00513981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6474333|NCT00513981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6474334|NCT00513981|Immunologic Factors|immunologic factors|mesh-ancestor
6474335|NCT00513981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6474336|NCT00513981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6474337|NCT00513981|Antidotes|antidotes|mesh-ancestor
5549155|NCT04107779|Cholinergic Agents|cholinergic agents|mesh-ancestor
5549156|NCT04107779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5549157|NCT04107779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549158|NCT04107779|Antipruritics|antipruritics|mesh-ancestor
5549159|NCT04107779|Dermatologic Agents|dermatologic agents|mesh-ancestor
5549160|NCT04107675|Cyclosporine|cyclosporine|mesh-list
5549161|NCT04107675|Cyclosporins|cyclosporins|mesh-list
5549162|NCT04107675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5549163|NCT04107675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549164|NCT04107675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5549165|NCT04107675|Immunologic Factors|immunologic factors|mesh-ancestor
5549166|NCT04107675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549167|NCT04107675|Antifungal Agents|antifungal agents|mesh-ancestor
5549168|NCT04107675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5549169|NCT04107675|Dermatologic Agents|dermatologic agents|mesh-ancestor
6474338|NCT00513981|Protective Agents|protective agents|mesh-ancestor
6474339|NCT00513981|Vitamin B Complex|vitamin b complex|mesh-ancestor
6474340|NCT00513981|Vitamins|vitamins|mesh-ancestor
6474341|NCT00513981|Micronutrients|micronutrients|mesh-ancestor
5549170|NCT04107675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5549171|NCT04107675|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6474342|NCT00513994|Nitroglycerin|nitroglycerin|mesh-list
6474343|NCT00513994|Vasodilator Agents|vasodilator agents|mesh-ancestor
5549172|NCT04107480|Dopamine|dopamine|mesh-list
5549173|NCT04107480|Dopamine Agonists|dopamine agonists|mesh-list
5549174|NCT04107480|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5549175|NCT04107480|Sympathomimetics|sympathomimetics|mesh-ancestor
6474344|NCT00514072|Vaccines|vaccines|mesh-list
6474345|NCT00514072|BCG Vaccine|bcg vaccine|mesh-list
6474346|NCT00514072|Immunologic Factors|immunologic factors|mesh-ancestor
6474347|NCT00514072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474348|NCT00514072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6474349|NCT00514111|Interferons|interferons|mesh-list
6474350|NCT00514111|Ribavirin|ribavirin|mesh-list
6474351|NCT00514111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6474352|NCT00514111|Antiviral Agents|antiviral agents|mesh-ancestor
5549176|NCT04107480|Autonomic Agents|autonomic agents|mesh-ancestor
5549177|NCT04107480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5549178|NCT04107480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474353|NCT00514111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6474354|NCT00514111|Antimetabolites|antimetabolites|mesh-ancestor
6474355|NCT00514111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474356|NCT00514163|Gemcitabine|gemcitabine|mesh-list
6146767|NCT01369615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6146768|NCT01369680|Ketamine|ketamine|mesh-list
6146769|NCT01369680|Analgesics|analgesics|mesh-ancestor
6146770|NCT01369680|Sensory System Agents|sensory system agents|mesh-ancestor
6146771|NCT01369680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6146772|NCT01369680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146773|NCT01369680|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6146774|NCT01369680|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6146775|NCT01369680|Anesthetics, General|anesthetics, general|mesh-ancestor
6146776|NCT01369680|Anesthetics|anesthetics|mesh-ancestor
6146777|NCT01369680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6146778|NCT01369680|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6146779|NCT01369680|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6474357|NCT00514163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6474358|NCT00514163|Antimetabolites|antimetabolites|mesh-ancestor
6474359|NCT00514163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474360|NCT00514163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6474361|NCT00514163|Antiviral Agents|antiviral agents|mesh-ancestor
6474362|NCT00514163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6474363|NCT00514163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6474364|NCT00514163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6474365|NCT00514163|Immunologic Factors|immunologic factors|mesh-ancestor
6474366|NCT00514163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474367|NCT00514202|Dextroamphetamine|dextroamphetamine|mesh-list
6474368|NCT00514202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6474369|NCT00514202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474370|NCT00514202|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6474371|NCT00514202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5549179|NCT04107480|Dopamine Agents|dopamine agents|mesh-ancestor
5549180|NCT04107480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5549181|NCT04107480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549182|NCT04107480|Protective Agents|protective agents|mesh-ancestor
5549183|NCT04106999|Dexmedetomidine|dexmedetomidine|mesh-list
5549184|NCT04106999|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5549185|NCT04106999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5549186|NCT04106999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549187|NCT04106999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5549188|NCT04106999|Analgesics|analgesics|mesh-ancestor
5549189|NCT04106999|Sensory System Agents|sensory system agents|mesh-ancestor
5549190|NCT04106999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5549191|NCT04106999|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5549192|NCT04106999|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5549193|NCT04106999|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5549194|NCT04106999|Adrenergic Agents|adrenergic agents|mesh-ancestor
5549195|NCT04106999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5549196|NCT04106999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549197|NCT04107194|Amoxicillin|amoxicillin|mesh-list
5549198|NCT04107194|Metronidazole|metronidazole|mesh-list
5549199|NCT04107194|Clarithromycin|clarithromycin|mesh-list
5549200|NCT04107194|Levofloxacin|levofloxacin|mesh-list
5549201|NCT04107194|Tetracycline|tetracycline|mesh-list
6474372|NCT00514202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6474373|NCT00514202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474374|NCT00514202|Dopamine Agents|dopamine agents|mesh-ancestor
5549202|NCT04107194|Rifabutin|rifabutin|mesh-list
5549203|NCT04107194|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
6474375|NCT00514202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6474376|NCT00514228|Sunitinib|sunitinib|mesh-list
6474377|NCT00514228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6474378|NCT00514228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6474379|NCT00514228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6474380|NCT00514228|Growth Substances|growth substances|mesh-ancestor
6474381|NCT00514228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474382|NCT00514228|Growth Inhibitors|growth inhibitors|mesh-ancestor
6474383|NCT00514228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6474384|NCT00514228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6474385|NCT00514228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474386|NCT00514293|Carboplatin|carboplatin|mesh-list
6474387|NCT00514293|Docetaxel|docetaxel|mesh-list
6474388|NCT00514293|Capecitabine|capecitabine|mesh-list
6474389|NCT00514293|Tretinoin|tretinoin|mesh-list
6474390|NCT00514293|Bexarotene|bexarotene|mesh-list
6474391|NCT00514293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6474392|NCT00514293|Tubulin Modulators|tubulin modulators|mesh-ancestor
6474393|NCT00514293|Antimitotic Agents|antimitotic agents|mesh-ancestor
6474394|NCT00514293|Mitosis Modulators|mitosis modulators|mesh-ancestor
6474395|NCT00514293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474396|NCT00514293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6474397|NCT00514293|Antimetabolites|antimetabolites|mesh-ancestor
6474398|NCT00514293|Keratolytic Agents|keratolytic agents|mesh-ancestor
6474399|NCT00514293|Dermatologic Agents|dermatologic agents|mesh-ancestor
6474400|NCT00514397|Temozolomide|temozolomide|mesh-list
6474401|NCT00514397|Motexafin gadolinium|motexafin gadolinium|mesh-list
6474402|NCT00514397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6474403|NCT00514397|Alkylating Agents|alkylating agents|mesh-ancestor
6474404|NCT00514397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474405|NCT00514397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6474406|NCT00514397|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6474407|NCT00514397|Dermatologic Agents|dermatologic agents|mesh-ancestor
6474408|NCT00514410|Folic Acid|folic acid|mesh-list
6474409|NCT00514410|Hematinics|hematinics|mesh-ancestor
6474410|NCT00514410|Vitamin B Complex|vitamin b complex|mesh-ancestor
6474411|NCT00514410|Vitamins|vitamins|mesh-ancestor
6474412|NCT00514410|Micronutrients|micronutrients|mesh-ancestor
6474413|NCT00514410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474414|NCT00514475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6474415|NCT00514475|Immunologic Factors|immunologic factors|mesh-ancestor
6474416|NCT00514475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474417|NCT00514488|Imatinib Mesylate|imatinib mesylate|mesh-list
6474418|NCT00514488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6474419|NCT00514488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6474420|NCT00514488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6474421|NCT00514488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474422|NCT00514527|Oritavancin|oritavancin|mesh-list
6474423|NCT00514527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6146780|NCT01369680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6146781|NCT01369680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6146782|NCT01369732|Epoetin Alfa|epoetin alfa|mesh-list
6146783|NCT01369732|Hematinics|hematinics|mesh-ancestor
6146784|NCT01369745|Prednisone|prednisone|mesh-list
6146785|NCT01369745|Prednisolone|prednisolone|mesh-list
6146786|NCT01369745|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6146787|NCT01369745|Methylprednisolone|methylprednisolone|mesh-list
6146788|NCT01369745|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6146789|NCT01369745|Prednisolone acetate|prednisolone acetate|mesh-list
6146790|NCT01369745|Dipyridamole|dipyridamole|mesh-list
6146791|NCT01369745|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6146792|NCT01369745|Prednisolone phosphate|prednisolone phosphate|mesh-list
6146793|NCT01369745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6146794|NCT01369745|Glucocorticoids|glucocorticoids|mesh-ancestor
6146795|NCT01369745|Hormones|hormones|mesh-ancestor
6146796|NCT01369745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6146797|NCT01369745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146798|NCT01369745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6146799|NCT01369745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6146800|NCT01369745|Antiemetics|antiemetics|mesh-ancestor
6146801|NCT01369745|Autonomic Agents|autonomic agents|mesh-ancestor
6146802|NCT01369745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6146803|NCT01369745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6146804|NCT01369745|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6474424|NCT00514527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6474425|NCT00514605|Antibodies|antibodies|mesh-list
6474426|NCT00514605|Immunoglobulins|immunoglobulins|mesh-list
6474427|NCT00514605|Immunologic Factors|immunologic factors|mesh-ancestor
6146805|NCT01369745|Protective Agents|protective agents|mesh-ancestor
6146806|NCT01369745|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6146807|NCT01369745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6146808|NCT01369745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6146809|NCT01369745|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6146810|NCT01369745|Vasodilator Agents|vasodilator agents|mesh-ancestor
6146811|NCT01369849|Rituximab|rituximab|mesh-list
6146812|NCT01369849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6146813|NCT01369849|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6146814|NCT01369849|Antibodies|antibodies|mesh-list
6474428|NCT00514605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474429|NCT00514618|Misoprostol|misoprostol|mesh-list
6474430|NCT00514618|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6146815|NCT01369849|Immunoglobulins|immunoglobulins|mesh-list
6146816|NCT01369849|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6146817|NCT01369849|Immunologic Factors|immunologic factors|mesh-ancestor
6146818|NCT01369849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146819|NCT01369849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5549204|NCT04107194|Pantoprazole|pantoprazole|mesh-list
5549205|NCT04107194|Bismuth|bismuth|mesh-list
5549206|NCT04107194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5549207|NCT04107194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5549208|NCT04107194|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5549209|NCT04107194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5549210|NCT04107194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5549211|NCT04107194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5549212|NCT04107194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549213|NCT04107194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5549214|NCT04107194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5549215|NCT04107194|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5549216|NCT04107194|Renal Agents|renal agents|mesh-ancestor
5549217|NCT04107194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5549218|NCT04107194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5549219|NCT04107194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5549220|NCT04107194|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6146820|NCT01369849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6146821|NCT01369849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6146822|NCT01369849|Alkylating Agents|alkylating agents|mesh-ancestor
6146823|NCT01369849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6146824|NCT01369875|Aldesleukin|aldesleukin|mesh-list
6146825|NCT01369875|Cyclophosphamide|cyclophosphamide|mesh-list
6146826|NCT01369875|Fludarabine|fludarabine|mesh-list
6146827|NCT01369875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6146828|NCT01369875|Immunologic Factors|immunologic factors|mesh-ancestor
6146829|NCT01369875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146830|NCT01369875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6146831|NCT01369875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6146832|NCT01369875|Alkylating Agents|alkylating agents|mesh-ancestor
6146833|NCT01369875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6146834|NCT01369875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6146835|NCT01369875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6146836|NCT01369875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6146837|NCT01369875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6146838|NCT01369875|Antiviral Agents|antiviral agents|mesh-ancestor
6146839|NCT01369875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6146840|NCT01369888|Cyclophosphamide|cyclophosphamide|mesh-list
6146841|NCT01369888|Fludarabine|fludarabine|mesh-list
6146842|NCT01369888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6146843|NCT01369888|Immunologic Factors|immunologic factors|mesh-ancestor
6146844|NCT01369888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146845|NCT01369888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6146846|NCT01369888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6146847|NCT01369888|Alkylating Agents|alkylating agents|mesh-ancestor
6146848|NCT01369888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6146849|NCT01369888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6146850|NCT01369888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6474431|NCT00514618|Abortifacient Agents|abortifacient agents|mesh-ancestor
6474432|NCT00514618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6474433|NCT00514618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474434|NCT00514618|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6474435|NCT00514618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6474436|NCT00514618|Oxytocics|oxytocics|mesh-ancestor
6474437|NCT00514657|Mitogens|mitogens|mesh-list
6474438|NCT00514657|Mitosis Modulators|mitosis modulators|mesh-ancestor
5549221|NCT04107194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5549222|NCT04107194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5549223|NCT04107194|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5549224|NCT04107194|Antacids|antacids|mesh-ancestor
5549225|NCT04107194|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5549226|NCT04107194|Antitubercular Agents|antitubercular agents|mesh-ancestor
5549227|NCT04107220|Valsartan|valsartan|mesh-list
5549228|NCT04107220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5549229|NCT04107220|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5549230|NCT04107220|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5549231|NCT04107220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549232|NCT04107103|Nivolumab|nivolumab|mesh-list
5549233|NCT04107103|Pemetrexed|pemetrexed|mesh-list
6146851|NCT01370005|Empagliflozin|empagliflozin|mesh-list
6146852|NCT01370005|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6146853|NCT01370005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6146854|NCT01370005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6146855|NCT01370005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146856|NCT01370018|Protease Inhibitors|protease inhibitors|mesh-list
6146857|NCT01370018|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
6146858|NCT01370018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6146859|NCT01370018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6146860|NCT01370018|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6146861|NCT01370018|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6205579|NCT02087943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6205580|NCT02088034|Metformin|metformin|mesh-list
6205581|NCT02088034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6205582|NCT02088034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205583|NCT02088177|Naltrexone|naltrexone|mesh-list
6205584|NCT02088177|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6205585|NCT02088177|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6205586|NCT02088177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205587|NCT02088177|Sensory System Agents|sensory system agents|mesh-ancestor
6205588|NCT02088177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6205589|NCT02088216|Acetylcysteine|acetylcysteine|mesh-list
6205590|NCT02088216|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6205591|NCT02088216|Antiviral Agents|antiviral agents|mesh-ancestor
6205592|NCT02088216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6205593|NCT02088216|Expectorants|expectorants|mesh-ancestor
6205594|NCT02088216|Respiratory System Agents|respiratory system agents|mesh-ancestor
6205595|NCT02088216|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6205596|NCT02088216|Antioxidants|antioxidants|mesh-ancestor
6205597|NCT02088216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205598|NCT02088216|Protective Agents|protective agents|mesh-ancestor
6205599|NCT02088216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205600|NCT02088216|Antidotes|antidotes|mesh-ancestor
6205601|NCT02088541|Cytarabine|cytarabine|mesh-list
6205602|NCT02088541|Hydroxyurea|hydroxyurea|mesh-list
6205603|NCT02088541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6205604|NCT02088541|Antimetabolites|antimetabolites|mesh-ancestor
6205605|NCT02088541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549234|NCT04107103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5549235|NCT04107103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5549236|NCT04107103|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5549237|NCT04107103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549238|NCT04107103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5549239|NCT04107103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5549240|NCT04107103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6205606|NCT02088541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6474439|NCT00514657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474440|NCT00514670|Hand Sanitizers|hand sanitizers|mesh-list
6474441|NCT00514670|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6474442|NCT00514670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5549241|NCT04106856|Losartan|losartan|mesh-list
5549242|NCT04106856|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5549243|NCT04106856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5549244|NCT04106856|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5549245|NCT04106856|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5549246|NCT04106856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474443|NCT00514670|Disinfectants|disinfectants|mesh-ancestor
6205607|NCT02088541|Antiviral Agents|antiviral agents|mesh-ancestor
6205608|NCT02088541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6205609|NCT02088541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6205610|NCT02088541|Immunologic Factors|immunologic factors|mesh-ancestor
6146862|NCT01370213|Interleukin-2|interleukin-2|mesh-list
6146863|NCT01370213|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5549247|NCT04106830|Mycophenolic Acid|mycophenolic acid|mesh-list
5549248|NCT04106830|Azathioprine|azathioprine|mesh-list
5549249|NCT04106830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5549250|NCT04106830|Immunologic Factors|immunologic factors|mesh-ancestor
5549251|NCT04106830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549252|NCT04106830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5549253|NCT04106830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5549254|NCT04106830|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5549255|NCT04106830|Antitubercular Agents|antitubercular agents|mesh-ancestor
5549256|NCT04106830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5549257|NCT04106830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5549258|NCT04106830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5549259|NCT04106830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549260|NCT04106830|Antimetabolites|antimetabolites|mesh-ancestor
5549261|NCT04106830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5549262|NCT04106830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5549263|NCT04106752|Caffeine|caffeine|mesh-list
6146864|NCT01370213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6146865|NCT01370213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6146866|NCT01370213|Analgesics|analgesics|mesh-ancestor
6146867|NCT01370213|Sensory System Agents|sensory system agents|mesh-ancestor
6146868|NCT01370213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6146869|NCT01370213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146870|NCT01370213|Immunologic Factors|immunologic factors|mesh-ancestor
6146871|NCT01370213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6146872|NCT01370265|Adenosine|adenosine|mesh-list
5549264|NCT04106752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5549265|NCT04106752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549266|NCT04106752|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5549267|NCT04106752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5549268|NCT04106752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549269|NCT04106752|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5549270|NCT04106752|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5549271|NCT04106752|Purinergic Agents|purinergic agents|mesh-ancestor
5549272|NCT04106752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5549273|NCT04106700|Apixaban|apixaban|mesh-list
5549274|NCT04106700|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5549275|NCT04106700|Antithrombins|antithrombins|mesh-ancestor
5549276|NCT04106700|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5549277|NCT04106700|Protease Inhibitors|protease inhibitors|mesh-ancestor
5549278|NCT04106700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6146873|NCT01370265|Regadenoson|regadenoson|mesh-list
6146874|NCT01370265|Analgesics|analgesics|mesh-ancestor
6146875|NCT01370265|Sensory System Agents|sensory system agents|mesh-ancestor
6146876|NCT01370265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5549279|NCT04106700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549280|NCT04106700|Anticoagulants|anticoagulants|mesh-ancestor
5549281|NCT04106804|Abatacept|abatacept|mesh-list
5549282|NCT04106804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5549283|NCT04106804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549284|NCT04106804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5549285|NCT04106804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5549286|NCT04106804|Immunologic Factors|immunologic factors|mesh-ancestor
5549287|NCT04106804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146877|NCT01370265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146878|NCT01370265|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6146879|NCT01370265|Vasodilator Agents|vasodilator agents|mesh-ancestor
6146880|NCT01370265|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6146881|NCT01370265|Purinergic Agonists|purinergic agonists|mesh-ancestor
6146882|NCT01370265|Purinergic Agents|purinergic agents|mesh-ancestor
6146883|NCT01370265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6146884|NCT01370265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474444|NCT00514748|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
6474445|NCT00514748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6474446|NCT00514748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6474447|NCT00514748|Analgesics|analgesics|mesh-ancestor
6474448|NCT00514748|Sensory System Agents|sensory system agents|mesh-ancestor
6474449|NCT00514748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5549288|NCT04106804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5549289|NCT04106791|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
5549290|NCT04106557|Gaboxadol|gaboxadol|mesh-list
6146885|NCT01370265|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
6146886|NCT01370356|Varenicline|varenicline|mesh-list
6474450|NCT00514748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474451|NCT00514748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6474452|NCT00514748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6474453|NCT00514761|Capecitabine|capecitabine|mesh-list
6474454|NCT00514761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6474455|NCT00514761|Antimetabolites|antimetabolites|mesh-ancestor
6474456|NCT00514761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474457|NCT00514761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6474458|NCT00514774|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
6474459|NCT00514774|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6474460|NCT00514774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6474461|NCT00514891|Vitamin A|vitamin a|mesh-list
6474462|NCT00514891|Vitamins|vitamins|mesh-ancestor
6474463|NCT00514891|Micronutrients|micronutrients|mesh-ancestor
6474464|NCT00514891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474465|NCT00514969|Imatinib Mesylate|imatinib mesylate|mesh-list
6474466|NCT00514969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6474467|NCT00514969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6474468|NCT00514969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6474469|NCT00514969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474470|NCT00514982|Adalimumab|adalimumab|mesh-list
6474471|NCT00514982|Mesalamine|mesalamine|mesh-list
6474472|NCT00514982|Mercaptopurine|mercaptopurine|mesh-list
6474473|NCT00514982|Infliximab|infliximab|mesh-list
6474474|NCT00514982|Tacrolimus|tacrolimus|mesh-list
6474475|NCT00514982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5549291|NCT04106557|Analgesics|analgesics|mesh-ancestor
6146887|NCT01370356|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6146888|NCT01370356|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6146889|NCT01370356|Cholinergic Agents|cholinergic agents|mesh-ancestor
6146890|NCT01370356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6146891|NCT01370356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6146892|NCT01370356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146893|NCT01370369|Testosterone|testosterone|mesh-list
6146894|NCT01370369|Androgens|androgens|mesh-ancestor
6146895|NCT01370369|Hormones|hormones|mesh-ancestor
6146896|NCT01370369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6146897|NCT01370369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146898|NCT01370408|Dexamethasone|dexamethasone|mesh-list
6146899|NCT01370408|Ondansetron|ondansetron|mesh-list
6146900|NCT01370408|Palonosetron|palonosetron|mesh-list
6146901|NCT01370408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6146902|NCT01370408|Antiemetics|antiemetics|mesh-ancestor
6146903|NCT01370408|Autonomic Agents|autonomic agents|mesh-ancestor
6146904|NCT01370408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6146905|NCT01370408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146906|NCT01370408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6146907|NCT01370408|Glucocorticoids|glucocorticoids|mesh-ancestor
6146908|NCT01370408|Hormones|hormones|mesh-ancestor
6146909|NCT01370408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6146910|NCT01370408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6146911|NCT01370408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6146912|NCT01370408|Antipruritics|antipruritics|mesh-ancestor
6146913|NCT01370408|Dermatologic Agents|dermatologic agents|mesh-ancestor
6146914|NCT01370408|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6146915|NCT01370408|Serotonin Agents|serotonin agents|mesh-ancestor
6146916|NCT01370408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6146917|NCT01370408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6146918|NCT01370408|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6146919|NCT01370408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6146920|NCT01370408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6146921|NCT01370408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6146922|NCT01370408|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6146923|NCT01370408|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6146924|NCT01370460|Tranexamic Acid|tranexamic acid|mesh-list
6146925|NCT01370460|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6146926|NCT01370460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6146927|NCT01370460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6146928|NCT01370460|Hemostatics|hemostatics|mesh-ancestor
6146929|NCT01370460|Coagulants|coagulants|mesh-ancestor
6146930|NCT01370499|Serotonin|serotonin|mesh-list
6146931|NCT01370499|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
6146932|NCT01370499|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5549292|NCT04106557|Sensory System Agents|sensory system agents|mesh-ancestor
5549293|NCT04106557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6146933|NCT01370499|Serotonin Agents|serotonin agents|mesh-ancestor
6474476|NCT00514982|Immunologic Factors|immunologic factors|mesh-ancestor
6146934|NCT01370499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6146935|NCT01370499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6146936|NCT01370499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146937|NCT01370499|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6146938|NCT01370499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6146939|NCT01370525|Esomeprazole|esomeprazole|mesh-list
6146940|NCT01370525|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6146941|NCT01370525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6146942|NCT01370525|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6146943|NCT01370525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6146944|NCT01370525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6146945|NCT01370538|Esomeprazole|esomeprazole|mesh-list
6146946|NCT01370538|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6146947|NCT01370538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6146948|NCT01370538|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6146949|NCT01370538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6146950|NCT01370538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6146951|NCT01370564|Diuretics|diuretics|mesh-list
6146952|NCT01370564|Natriuretic Agents|natriuretic agents|mesh-ancestor
6146953|NCT01370564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549294|NCT04106557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549295|NCT04106557|Anticonvulsants|anticonvulsants|mesh-ancestor
5549296|NCT04106557|GABA Agonists|gaba agonists|mesh-ancestor
5549297|NCT04106557|GABA Agents|gaba agents|mesh-ancestor
5549298|NCT04106557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6146954|NCT01370616|Amoxicillin|amoxicillin|mesh-list
6146955|NCT01370616|Tazobactam|tazobactam|mesh-list
6146956|NCT01370616|Piperacillin|piperacillin|mesh-list
5549299|NCT04106557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549300|NCT04106726|Ivermectin|ivermectin|mesh-list
5549301|NCT04106726|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5549302|NCT04106726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5549303|NCT04106843|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
5549304|NCT04106843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549305|NCT04106843|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5549306|NCT04106401|Carbon Monoxide|carbon monoxide|mesh-list
5549307|NCT04106401|Antimetabolites|antimetabolites|mesh-ancestor
5549308|NCT04106401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549309|NCT04106401|Gasotransmitters|gasotransmitters|mesh-ancestor
5549310|NCT04106401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5549311|NCT04106401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602775|NCT04174612|Midostaurin|midostaurin|mesh-list
5602776|NCT04174612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5602777|NCT04174612|Antimetabolites|antimetabolites|mesh-ancestor
5602778|NCT04174612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602779|NCT04174612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6146957|NCT01370616|Ertapenem|ertapenem|mesh-list
6146958|NCT01370616|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
6146959|NCT01370616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6146960|NCT01370616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6146961|NCT01370616|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6146962|NCT01370616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6146963|NCT01370616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6146964|NCT01370642|Ribavirin|ribavirin|mesh-list
6146965|NCT01370642|Antimetabolites|antimetabolites|mesh-ancestor
6146966|NCT01370642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6146967|NCT01370642|Antiviral Agents|antiviral agents|mesh-ancestor
6146968|NCT01370642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6146969|NCT01370655|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6146970|NCT01370655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6667357|NCT01526941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146971|NCT01370655|Diuretics|diuretics|mesh-ancestor
6146972|NCT01370655|Natriuretic Agents|natriuretic agents|mesh-ancestor
6146973|NCT01370655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146974|NCT01370655|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6146975|NCT01370655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6146976|NCT01370655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6146977|NCT01370694|Prednisolone|prednisolone|mesh-list
6146978|NCT01370694|Cyclophosphamide|cyclophosphamide|mesh-list
6146979|NCT01370694|Vincristine|vincristine|mesh-list
6146980|NCT01370694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6146981|NCT01370694|Immunologic Factors|immunologic factors|mesh-ancestor
6146982|NCT01370694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6146983|NCT01370694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6146984|NCT01370694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6474477|NCT00514982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549312|NCT04106362|Cisplatin|cisplatin|mesh-list
5549313|NCT04106362|Cetuximab|cetuximab|mesh-list
6474478|NCT00514982|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6474479|NCT00514982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6474480|NCT00514982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474481|NCT00514982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6474482|NCT00514982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6474483|NCT00514982|Dermatologic Agents|dermatologic agents|mesh-ancestor
6474484|NCT00514982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6146985|NCT01370694|Alkylating Agents|alkylating agents|mesh-ancestor
6146986|NCT01370694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6146987|NCT01370694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6146988|NCT01370694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6146989|NCT01370694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6146990|NCT01370694|Tubulin Modulators|tubulin modulators|mesh-ancestor
6146991|NCT01370694|Antimitotic Agents|antimitotic agents|mesh-ancestor
6146992|NCT01370694|Mitosis Modulators|mitosis modulators|mesh-ancestor
6146993|NCT01370694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6146994|NCT01370694|Glucocorticoids|glucocorticoids|mesh-ancestor
6146995|NCT01370694|Hormones|hormones|mesh-ancestor
5549314|NCT04106362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5549315|NCT04106362|Antibodies|antibodies|mesh-list
5549316|NCT04106362|Immunoglobulins|immunoglobulins|mesh-list
6146996|NCT01370694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6146997|NCT01370694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6146998|NCT01371110|Midazolam|midazolam|mesh-list
5549317|NCT04106362|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5549318|NCT04106362|Immunologic Factors|immunologic factors|mesh-ancestor
5549319|NCT04106362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549320|NCT04106362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6146999|NCT01371110|Ketamine|ketamine|mesh-list
6147000|NCT01371110|Analgesics|analgesics|mesh-ancestor
6147001|NCT01371110|Sensory System Agents|sensory system agents|mesh-ancestor
6147002|NCT01371110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6147003|NCT01371110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147004|NCT01371110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6147005|NCT01371110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6147006|NCT01371110|Anesthetics, General|anesthetics, general|mesh-ancestor
6147007|NCT01371110|Anesthetics|anesthetics|mesh-ancestor
6474485|NCT00514982|Antimetabolites|antimetabolites|mesh-ancestor
6474486|NCT00514982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6474487|NCT00514982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6474488|NCT00514982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6474489|NCT00514982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6474490|NCT00514982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6474491|NCT00514982|Analgesics|analgesics|mesh-ancestor
6474492|NCT00514982|Sensory System Agents|sensory system agents|mesh-ancestor
6474493|NCT00514982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6474494|NCT00514995|Sodium Oxybate|sodium oxybate|mesh-list
6474495|NCT00514995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6474496|NCT00514995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6474497|NCT00514995|Anesthetics, General|anesthetics, general|mesh-ancestor
6474498|NCT00514995|Anesthetics|anesthetics|mesh-ancestor
6474499|NCT00514995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5549321|NCT04105985|Oxymetazoline|oxymetazoline|mesh-list
6147008|NCT01371110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6147009|NCT01371110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6147010|NCT01371110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6147011|NCT01371110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6147012|NCT01371110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6147013|NCT01371110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6147014|NCT01371110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6147015|NCT01371110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6147016|NCT01371110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6147017|NCT01371110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6147018|NCT01371110|GABA Modulators|gaba modulators|mesh-ancestor
6147019|NCT01371110|GABA Agents|gaba agents|mesh-ancestor
6147020|NCT01371565|Mifepristone|mifepristone|mesh-list
6147021|NCT01371565|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6147022|NCT01371565|Abortifacient Agents|abortifacient agents|mesh-ancestor
6147023|NCT01371565|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6147024|NCT01371565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474500|NCT00514995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474501|NCT00515138|Rituximab|rituximab|mesh-list
6147025|NCT01371565|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6147026|NCT01371565|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6147027|NCT01371565|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6147028|NCT01371565|Contraceptive Agents|contraceptive agents|mesh-ancestor
6147029|NCT01371565|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6147030|NCT01371565|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6147031|NCT01371565|Hormone Antagonists|hormone antagonists|mesh-ancestor
6147032|NCT01371565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6147033|NCT01371565|Luteolytic Agents|luteolytic agents|mesh-ancestor
6147034|NCT01371565|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6147035|NCT01371565|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6474502|NCT00515138|Carboplatin|carboplatin|mesh-list
6474503|NCT00515138|Etoposide|etoposide|mesh-list
6474504|NCT00515138|Bortezomib|bortezomib|mesh-list
6474505|NCT00515138|Ifosfamide|ifosfamide|mesh-list
6474506|NCT00515138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6474507|NCT00515138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6474508|NCT00515138|Immunologic Factors|immunologic factors|mesh-ancestor
6474509|NCT00515138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474510|NCT00515138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6474511|NCT00515138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5549322|NCT04105985|Tetracaine|tetracaine|mesh-list
5549323|NCT04105985|Carticaine|carticaine|mesh-list
5549324|NCT04105985|Anesthetics, Local|anesthetics, local|mesh-ancestor
5549325|NCT04105985|Anesthetics|anesthetics|mesh-ancestor
5549326|NCT04105985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5549327|NCT04105985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549328|NCT04105985|Sensory System Agents|sensory system agents|mesh-ancestor
5549329|NCT04105985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5549330|NCT04105985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6474512|NCT00515138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6474513|NCT00515138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6474514|NCT00515138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6474515|NCT00515138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474516|NCT00515138|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5549331|NCT04105985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5549332|NCT04105985|Adrenergic Agents|adrenergic agents|mesh-ancestor
5549333|NCT04105985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5549334|NCT04105985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549335|NCT04105985|Sympathomimetics|sympathomimetics|mesh-ancestor
5549336|NCT04105985|Autonomic Agents|autonomic agents|mesh-ancestor
5549337|NCT04105985|Nasal Decongestants|nasal decongestants|mesh-ancestor
5549338|NCT04105985|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5549339|NCT04105985|Respiratory System Agents|respiratory system agents|mesh-ancestor
5549340|NCT04106011|Gabapentin|gabapentin|mesh-list
5549341|NCT04106011|Analgesics|analgesics|mesh-ancestor
5549342|NCT04106011|Sensory System Agents|sensory system agents|mesh-ancestor
5549343|NCT04106011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5549344|NCT04106011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549345|NCT04106011|Anticonvulsants|anticonvulsants|mesh-ancestor
6147036|NCT01371643|Octreotide|octreotide|mesh-list
6147037|NCT01371643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6147038|NCT01371643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6147039|NCT01371643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6147040|NCT01371656|Levofloxacin|levofloxacin|mesh-list
6147041|NCT01371656|Ofloxacin|ofloxacin|mesh-list
6147042|NCT01371656|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6147043|NCT01371656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6147044|NCT01371656|Renal Agents|renal agents|mesh-ancestor
6147045|NCT01371656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6474517|NCT00515138|Alkylating Agents|alkylating agents|mesh-ancestor
6474518|NCT00515151|Ethanol|ethanol|mesh-list
5549346|NCT04106011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5549347|NCT04106011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5549348|NCT04106011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5549349|NCT04106011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5549350|NCT04106011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5549351|NCT04106011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5549352|NCT04106011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5549353|NCT04106011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549354|NCT04106011|Antimanic Agents|antimanic agents|mesh-ancestor
5549355|NCT04106050|Lidocaine|lidocaine|mesh-list
5549356|NCT04106050|Anesthetics, Local|anesthetics, local|mesh-ancestor
5549357|NCT04106050|Anesthetics|anesthetics|mesh-ancestor
5549358|NCT04106050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6147046|NCT01371656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6147047|NCT01371656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6474519|NCT00515151|Octenidine|octenidine|mesh-list
6474520|NCT00515151|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6474521|NCT00515151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6474522|NCT00515151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6474523|NCT00515151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474524|NCT00515190|Oxaliplatin|oxaliplatin|mesh-list
6474525|NCT00515190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6488692|NCT00585793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6488693|NCT00585871|Metoprolol|metoprolol|mesh-list
6488694|NCT00585871|Clonidine|clonidine|mesh-list
6488695|NCT00585871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6147048|NCT01371656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6147049|NCT01371656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6147050|NCT01371656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6147051|NCT01371656|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6147052|NCT01371656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5549359|NCT04106050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549360|NCT04106050|Sensory System Agents|sensory system agents|mesh-ancestor
5549361|NCT04106050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5549362|NCT04106050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5549363|NCT04106050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5549364|NCT04106050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5549365|NCT04106050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5549366|NCT04106050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549367|NCT04105946|Dexmedetomidine|dexmedetomidine|mesh-list
5549368|NCT04105946|Remifentanil|remifentanil|mesh-list
5549369|NCT04105946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5549370|NCT04105946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6147053|NCT01371734|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6147054|NCT01371734|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6147055|NCT01371734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6147056|NCT01371734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6147057|NCT01371734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6147058|NCT01371734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6147059|NCT01371734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147060|NCT01371734|Antidepressive Agents|antidepressive agents|mesh-ancestor
6147061|NCT01371734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6147062|NCT01371747|Losartan|losartan|mesh-list
6147063|NCT01371747|Spironolactone|spironolactone|mesh-list
6147064|NCT01371747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6147065|NCT01371747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6147066|NCT01371747|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6147067|NCT01371747|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6488696|NCT00585871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5549371|NCT04105946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549372|NCT04105946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5549373|NCT04105946|Analgesics|analgesics|mesh-ancestor
5549374|NCT04105946|Sensory System Agents|sensory system agents|mesh-ancestor
5549375|NCT04105946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5549376|NCT04105946|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5602780|NCT04174612|Antiviral Agents|antiviral agents|mesh-ancestor
6147068|NCT01371747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6147069|NCT01371747|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6488697|NCT00585871|Sympatholytics|sympatholytics|mesh-ancestor
6488698|NCT00585871|Autonomic Agents|autonomic agents|mesh-ancestor
6488699|NCT00585871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6488700|NCT00585871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488701|NCT00585871|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6147070|NCT01371747|Hormone Antagonists|hormone antagonists|mesh-ancestor
6147071|NCT01371747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6147072|NCT01371747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147073|NCT01371747|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6147074|NCT01371747|Diuretics|diuretics|mesh-ancestor
6147075|NCT01371747|Natriuretic Agents|natriuretic agents|mesh-ancestor
6147076|NCT01371786|Mometasone Furoate|mometasone furoate|mesh-list
6147077|NCT01371786|Ciclesonide|ciclesonide|mesh-list
6147078|NCT01371786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6147079|NCT01371786|Dermatologic Agents|dermatologic agents|mesh-ancestor
6488702|NCT00585871|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6147080|NCT01371786|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6147081|NCT01371786|Glucocorticoids|glucocorticoids|mesh-ancestor
6147082|NCT01371786|Hormones|hormones|mesh-ancestor
6147083|NCT01371786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6147084|NCT01371786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147085|NCT01371838|Ceftriaxone|ceftriaxone|mesh-list
6474526|NCT00515229|Amitriptyline|amitriptyline|mesh-list
5549377|NCT04105946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6147086|NCT01371838|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
6147087|NCT01371838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6147088|NCT01371838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5549378|NCT04105946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5549379|NCT04105946|Adrenergic Agents|adrenergic agents|mesh-ancestor
5549380|NCT04105946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5549381|NCT04105946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549382|NCT04105946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5549383|NCT04105946|Narcotics|narcotics|mesh-ancestor
5549384|NCT04106297|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5549385|NCT04105920|Hyaluronic Acid|hyaluronic acid|mesh-list
5549386|NCT04105920|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5549387|NCT04105920|Immunologic Factors|immunologic factors|mesh-ancestor
5549388|NCT04105920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549389|NCT04105920|Viscosupplements|viscosupplements|mesh-ancestor
5549390|NCT04105920|Protective Agents|protective agents|mesh-ancestor
5549391|NCT04105764|Bromides|bromides|mesh-list
5549392|NCT04105764|Rocuronium|rocuronium|mesh-list
6147089|NCT01371851|Doxazosin|doxazosin|mesh-list
6147090|NCT01371851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6147091|NCT01371851|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6147092|NCT01371851|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6147093|NCT01371851|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6147094|NCT01371851|Adrenergic Agents|adrenergic agents|mesh-ancestor
6147095|NCT01371851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6147096|NCT01371851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6147097|NCT01371851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549393|NCT04105764|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
5549394|NCT04105764|Anticonvulsants|anticonvulsants|mesh-ancestor
5549395|NCT04105764|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5549396|NCT04105764|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5549397|NCT04105764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5549398|NCT04105764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549399|NCT04105374|Flucytosine|flucytosine|mesh-list
5549400|NCT04105374|Temozolomide|temozolomide|mesh-list
5549401|NCT04105374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5549402|NCT04105374|Alkylating Agents|alkylating agents|mesh-ancestor
5549403|NCT04105374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549404|NCT04105374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5549405|NCT04105374|Antifungal Agents|antifungal agents|mesh-ancestor
5549406|NCT04105374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5549407|NCT04105374|Antimetabolites|antimetabolites|mesh-ancestor
6147098|NCT01371877|Vitamin D|vitamin d|mesh-list
6147099|NCT01371877|Ergocalciferols|ergocalciferols|mesh-list
6147100|NCT01371877|Cholecalciferol|cholecalciferol|mesh-list
5549408|NCT04105426|Antioxidants|antioxidants|mesh-list
5549409|NCT04105426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549410|NCT04105426|Protective Agents|protective agents|mesh-ancestor
5549411|NCT04105426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549412|NCT04105140|Oxytocin|oxytocin|mesh-list
5549413|NCT04105140|Oxytocics|oxytocics|mesh-ancestor
5549414|NCT04105140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5549415|NCT04105140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147101|NCT01371877|Vitamins|vitamins|mesh-list
6147102|NCT01371877|Micronutrients|micronutrients|mesh-ancestor
6147103|NCT01371877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147104|NCT01371877|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6147105|NCT01371877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6147106|NCT01371994|Solifenacin Succinate|solifenacin succinate|mesh-list
6147107|NCT01371994|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6147108|NCT01371994|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6147109|NCT01371994|Cholinergic Agents|cholinergic agents|mesh-ancestor
6147110|NCT01371994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6147111|NCT01371994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6147112|NCT01371994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147113|NCT01371994|Urological Agents|urological agents|mesh-ancestor
6147114|NCT01372150|Fluoxetine|fluoxetine|mesh-list
6147115|NCT01372150|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6474527|NCT00515229|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6474528|NCT00515229|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6474529|NCT00515229|Antidepressive Agents|antidepressive agents|mesh-ancestor
6474530|NCT00515229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6667358|NCT01526980|Insulin|insulin|mesh-list
6147116|NCT01372150|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6147117|NCT01372150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6147118|NCT01372150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6147119|NCT01372150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6147120|NCT01372150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6147121|NCT01372150|Serotonin Agents|serotonin agents|mesh-ancestor
6147122|NCT01372150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667359|NCT01526980|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6667360|NCT01526980|Insulin Aspart|insulin aspart|mesh-list
5549416|NCT04105231|Cannabidiol|cannabidiol|mesh-list
5549417|NCT04105231|Risperidone|risperidone|mesh-list
5549418|NCT04105231|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5549419|NCT04105231|Serotonin Agents|serotonin agents|mesh-ancestor
5549420|NCT04105231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5549421|NCT04105231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667361|NCT01526980|Insulin, Long-Acting|insulin, long-acting|mesh-list
5549422|NCT04105231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147123|NCT01372150|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6147124|NCT01372150|Antidepressive Agents|antidepressive agents|mesh-ancestor
6147125|NCT01372150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6147126|NCT01372150|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6147127|NCT01372150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6147128|NCT01372150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6147129|NCT01372150|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6147130|NCT01372202|Paclitaxel|paclitaxel|mesh-list
6147131|NCT01372202|Fluorouracil|fluorouracil|mesh-list
6147132|NCT01372202|Oxaliplatin|oxaliplatin|mesh-list
6147133|NCT01372202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6147134|NCT01372202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5549423|NCT04105231|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5549424|NCT04105231|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6147135|NCT01372202|Tubulin Modulators|tubulin modulators|mesh-ancestor
6147136|NCT01372202|Antimitotic Agents|antimitotic agents|mesh-ancestor
6147137|NCT01372202|Mitosis Modulators|mitosis modulators|mesh-ancestor
6147138|NCT01372202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6147139|NCT01372202|Antimetabolites|antimetabolites|mesh-ancestor
6147140|NCT01372202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6147141|NCT01372202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6147142|NCT01372202|Immunologic Factors|immunologic factors|mesh-ancestor
6147143|NCT01372202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147144|NCT01372254|Nicotine|nicotine|mesh-list
6147145|NCT01372254|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6147146|NCT01372254|Autonomic Agents|autonomic agents|mesh-ancestor
6147147|NCT01372254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6147148|NCT01372254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147149|NCT01372254|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6147150|NCT01372254|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6147151|NCT01372254|Cholinergic Agents|cholinergic agents|mesh-ancestor
6147152|NCT01372254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6147153|NCT01372254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6147154|NCT01372384|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6147155|NCT01372384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6147156|NCT01372384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6147157|NCT01372384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6147158|NCT01372384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6147159|NCT01372410|Tiotropium Bromide|tiotropium bromide|mesh-list
6147160|NCT01372410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6147161|NCT01372410|Autonomic Agents|autonomic agents|mesh-ancestor
6147162|NCT01372410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6147163|NCT01372410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147164|NCT01372410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6147165|NCT01372410|Respiratory System Agents|respiratory system agents|mesh-ancestor
6147166|NCT01372410|Parasympatholytics|parasympatholytics|mesh-ancestor
6147167|NCT01372410|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6474531|NCT00515229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6474532|NCT00515229|Analgesics|analgesics|mesh-ancestor
6474533|NCT00515229|Sensory System Agents|sensory system agents|mesh-ancestor
6474534|NCT00515229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6474535|NCT00515229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474536|NCT00515229|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6474537|NCT00515229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6474538|NCT00515229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6474539|NCT00515229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474540|NCT00515229|Adrenergic Agents|adrenergic agents|mesh-ancestor
6474541|NCT00515229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6474542|NCT00515229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6474543|NCT00515229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6474544|NCT00515229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6474545|NCT00515255|Minocycline|minocycline|mesh-list
6474546|NCT00515255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6474547|NCT00515255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6474548|NCT00515268|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
6474549|NCT00515268|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6474550|NCT00515268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6474551|NCT00515268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6474552|NCT00515268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474553|NCT00515281|Nitric Oxide|nitric oxide|mesh-list
6474554|NCT00515281|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6474555|NCT00515281|Autonomic Agents|autonomic agents|mesh-ancestor
6474556|NCT00515281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6147168|NCT01372410|Cholinergic Agents|cholinergic agents|mesh-ancestor
6147169|NCT01372410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6147170|NCT01372410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6147171|NCT01372995|Vitamin D|vitamin d|mesh-list
6147172|NCT01372995|Ergocalciferols|ergocalciferols|mesh-list
6147173|NCT01372995|Cholecalciferol|cholecalciferol|mesh-list
6147174|NCT01372995|Vitamins|vitamins|mesh-list
6147175|NCT01372995|Micronutrients|micronutrients|mesh-ancestor
6147176|NCT01372995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147177|NCT01372995|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6147178|NCT01372995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6147179|NCT01373164|Gemcitabine|gemcitabine|mesh-list
6474557|NCT00515281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474558|NCT00515281|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6474559|NCT00515281|Respiratory System Agents|respiratory system agents|mesh-ancestor
6474560|NCT00515281|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6474561|NCT00515281|Antioxidants|antioxidants|mesh-ancestor
6474562|NCT00515281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474563|NCT00515281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6474564|NCT00515281|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6667362|NCT01526980|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
5549425|NCT04105231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5549426|NCT04105231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5549427|NCT04105231|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5549428|NCT04105231|Dopamine Agents|dopamine agents|mesh-ancestor
5549429|NCT04105231|Anticonvulsants|anticonvulsants|mesh-ancestor
5549430|NCT04105205|Apramycin|apramycin|mesh-list
6667363|NCT01526980|Biphasic Insulins|biphasic insulins|mesh-list
6667364|NCT01526980|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6147180|NCT01373164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6147181|NCT01373164|Antimetabolites|antimetabolites|mesh-ancestor
6147182|NCT01373164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549431|NCT04105205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5549432|NCT04105205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6147183|NCT01373164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6147184|NCT01373164|Antiviral Agents|antiviral agents|mesh-ancestor
6147185|NCT01373164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6147186|NCT01373164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6147187|NCT01373164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6147188|NCT01373164|Immunologic Factors|immunologic factors|mesh-ancestor
6147189|NCT01373164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147190|NCT01373229|Plerixafor|plerixafor|mesh-list
6147191|NCT01373229|Rituximab|rituximab|mesh-list
6147192|NCT01373229|Lenalidomide|lenalidomide|mesh-list
6147193|NCT01373229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6147194|NCT01373229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6147195|NCT01373229|Immunologic Factors|immunologic factors|mesh-ancestor
6147196|NCT01373229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147197|NCT01373229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6147198|NCT01373229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6147199|NCT01373229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6147200|NCT01373229|Growth Substances|growth substances|mesh-ancestor
6147201|NCT01373229|Growth Inhibitors|growth inhibitors|mesh-ancestor
6147202|NCT01373229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6147203|NCT01373229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5549433|NCT04105283|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
5549434|NCT04105283|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5549435|NCT04105283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549436|NCT04105023|Genistein|genistein|mesh-list
5549437|NCT04105023|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5549438|NCT04105023|Protective Agents|protective agents|mesh-ancestor
5549439|NCT04105023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549440|NCT04105023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5549441|NCT04105023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6147204|NCT01373229|Antiviral Agents|antiviral agents|mesh-ancestor
6147205|NCT01373229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6147206|NCT01373281|Vaccines|vaccines|mesh-list
6147207|NCT01373281|Immunologic Factors|immunologic factors|mesh-ancestor
6147208|NCT01373281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147209|NCT01373294|Lenalidomide|lenalidomide|mesh-list
6147210|NCT01373294|BCG Vaccine|bcg vaccine|mesh-list
6147211|NCT01373294|Immunologic Factors|immunologic factors|mesh-ancestor
6474565|NCT00515281|Vasodilator Agents|vasodilator agents|mesh-ancestor
6474566|NCT00515281|Gasotransmitters|gasotransmitters|mesh-ancestor
6474567|NCT00515281|Protective Agents|protective agents|mesh-ancestor
6474568|NCT00515320|Fluoxetine|fluoxetine|mesh-list
6474569|NCT00515320|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6474570|NCT00515320|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6474571|NCT00515320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5549442|NCT04105023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5549443|NCT04105023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549444|NCT04105023|Phytoestrogens|phytoestrogens|mesh-ancestor
5549445|NCT04105023|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
5549446|NCT04105023|Estrogens|estrogens|mesh-ancestor
5549447|NCT04105023|Hormones|hormones|mesh-ancestor
5549448|NCT04105023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5549449|NCT04105114|Buspirone|buspirone|mesh-list
5549450|NCT04105114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5549451|NCT04105114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5549452|NCT04105114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5549453|NCT04105114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549454|NCT04105114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5549455|NCT04105114|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5549456|NCT04105114|Serotonin Agents|serotonin agents|mesh-ancestor
6474572|NCT00515320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474573|NCT00515320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6474574|NCT00515320|Serotonin Agents|serotonin agents|mesh-ancestor
6474575|NCT00515320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474576|NCT00515320|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6147212|NCT01373294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147213|NCT01373294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6147214|NCT01373294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6147215|NCT01373294|Growth Substances|growth substances|mesh-ancestor
6147216|NCT01373294|Growth Inhibitors|growth inhibitors|mesh-ancestor
6147217|NCT01373294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6147218|NCT01373294|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6147219|NCT01373450|Liraglutide|liraglutide|mesh-list
6147220|NCT01373450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6147221|NCT01373450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147222|NCT01373450|Incretins|incretins|mesh-ancestor
6147223|NCT01373450|Hormones|hormones|mesh-ancestor
6147224|NCT01373450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6147225|NCT01373918|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6147226|NCT01373918|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6147227|NCT01373918|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6147228|NCT01373918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6147229|NCT01373931|Moxifloxacin|moxifloxacin|mesh-list
6147230|NCT01373931|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6147231|NCT01373931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6147232|NCT01373931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6147233|NCT01373931|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6147234|NCT01373931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6147235|NCT01373931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6147236|NCT01373931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6147237|NCT01373931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6147238|NCT01373931|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6147239|NCT01373931|Contraceptive Agents|contraceptive agents|mesh-ancestor
6147240|NCT01373931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6147241|NCT01373931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147242|NCT01373931|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6147243|NCT01373931|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6147244|NCT01373931|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6147245|NCT01374087|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6147246|NCT01374087|Luteolytic Agents|luteolytic agents|mesh-ancestor
6147247|NCT01374087|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6147248|NCT01374087|Contraceptive Agents|contraceptive agents|mesh-ancestor
6147249|NCT01374087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6147250|NCT01374087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667365|NCT01526980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6667366|NCT01526980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667367|NCT01527019|Cephalosporins|cephalosporins|mesh-list
6667368|NCT01527019|Norfloxacin|norfloxacin|mesh-list
6147251|NCT01374087|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6147252|NCT01374087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6147253|NCT01374087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6147254|NCT01374178|Insulin Glargine|insulin glargine|mesh-list
6147255|NCT01374178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6147256|NCT01374178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147257|NCT01374217|Clarithromycin|clarithromycin|mesh-list
6147258|NCT01374217|Dexamethasone|dexamethasone|mesh-list
6147259|NCT01374217|Lenalidomide|lenalidomide|mesh-list
6147260|NCT01374217|Tadalafil|tadalafil|mesh-list
6147261|NCT01374217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6147262|NCT01374217|Antiemetics|antiemetics|mesh-ancestor
6147263|NCT01374217|Autonomic Agents|autonomic agents|mesh-ancestor
6147264|NCT01374217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6147265|NCT01374217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147266|NCT01374217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6147267|NCT01374217|Glucocorticoids|glucocorticoids|mesh-ancestor
6147268|NCT01374217|Hormones|hormones|mesh-ancestor
6147269|NCT01374217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6474577|NCT00515320|Antidepressive Agents|antidepressive agents|mesh-ancestor
6474578|NCT00515320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6474579|NCT00515320|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6474580|NCT00515320|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6474581|NCT00515320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6474582|NCT00515359|Propofol|propofol|mesh-list
6474583|NCT00515359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6667369|NCT01527019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6147270|NCT01374217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6147271|NCT01374217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6147272|NCT01374217|Immunologic Factors|immunologic factors|mesh-ancestor
6147273|NCT01374217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6147274|NCT01374217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6147275|NCT01374217|Growth Substances|growth substances|mesh-ancestor
6147276|NCT01374217|Growth Inhibitors|growth inhibitors|mesh-ancestor
6147277|NCT01374217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6147278|NCT01374217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6147279|NCT01374217|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6147280|NCT01374217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6147281|NCT01374217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6147282|NCT01374217|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6147283|NCT01374217|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6667370|NCT01527019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6474584|NCT00515359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6474585|NCT00515359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474586|NCT00515359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6474587|NCT00515359|Anesthetics, General|anesthetics, general|mesh-ancestor
6474588|NCT00515359|Anesthetics|anesthetics|mesh-ancestor
6474589|NCT00515450|Immunoglobulins|immunoglobulins|mesh-list
6147284|NCT01374217|Vasodilator Agents|vasodilator agents|mesh-ancestor
6147285|NCT01374217|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6147286|NCT01374217|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6147287|NCT01374217|Urological Agents|urological agents|mesh-ancestor
6147288|NCT01374269|Acetaminophen|acetaminophen|mesh-list
5549457|NCT04105114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5549458|NCT04105114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549459|NCT04104893|Pembrolizumab|pembrolizumab|mesh-list
6147289|NCT01374269|Celecoxib|celecoxib|mesh-list
6147290|NCT01374269|Naproxen|naproxen|mesh-list
6147291|NCT01374269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
6147292|NCT01374269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
6147293|NCT01374269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6147294|NCT01374269|Analgesics|analgesics|mesh-ancestor
6147295|NCT01374269|Sensory System Agents|sensory system agents|mesh-ancestor
6147296|NCT01374269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6147297|NCT01374269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474590|NCT00515450|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6474591|NCT00515450|Antibodies|antibodies|mesh-list
6474592|NCT00515450|gamma-Globulins|gamma-globulins|mesh-list
6474593|NCT00515450|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6474594|NCT00515450|Immunologic Factors|immunologic factors|mesh-ancestor
6474595|NCT00515450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474596|NCT00515489|Risperidone|risperidone|mesh-list
6474597|NCT00515489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6474598|NCT00515489|Serotonin Agents|serotonin agents|mesh-ancestor
6474599|NCT00515489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6474600|NCT00515489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474601|NCT00515489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667371|NCT01527019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6667372|NCT01527019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6667373|NCT01527019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6667374|NCT01527019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667375|NCT01527019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6667376|NCT01527019|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5549460|NCT04104893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5549461|NCT04104893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5549462|NCT04104867|Domperidone|domperidone|mesh-list
6147298|NCT01374269|Antipyretics|antipyretics|mesh-ancestor
6667377|NCT01527019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6667378|NCT01527032|Thalidomide|thalidomide|mesh-list
6667379|NCT01527032|Dexamethasone|dexamethasone|mesh-list
6667380|NCT01527032|Melphalan|melphalan|mesh-list
6667381|NCT01527032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6667382|NCT01527032|Antiemetics|antiemetics|mesh-ancestor
6667383|NCT01527032|Autonomic Agents|autonomic agents|mesh-ancestor
6667384|NCT01527032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6147299|NCT01374269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6147300|NCT01374269|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6147301|NCT01374269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6147302|NCT01374269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6147303|NCT01374269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6147304|NCT01374269|Gout Suppressants|gout suppressants|mesh-ancestor
6147305|NCT01374425|Leucovorin|leucovorin|mesh-list
6147306|NCT01374425|Bevacizumab|bevacizumab|mesh-list
6147307|NCT01374425|Fluorouracil|fluorouracil|mesh-list
6147308|NCT01374425|Capecitabine|capecitabine|mesh-list
6147309|NCT01374425|Oxaliplatin|oxaliplatin|mesh-list
6147310|NCT01374425|Irinotecan|irinotecan|mesh-list
6147311|NCT01374425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6147312|NCT01374425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6147313|NCT01374425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6147314|NCT01374425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6147315|NCT01374425|Growth Substances|growth substances|mesh-ancestor
6147316|NCT01374425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147317|NCT01374425|Growth Inhibitors|growth inhibitors|mesh-ancestor
6147318|NCT01374425|Antimetabolites|antimetabolites|mesh-ancestor
6147319|NCT01374425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6147320|NCT01374425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6147321|NCT01374425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6147322|NCT01374425|Immunologic Factors|immunologic factors|mesh-ancestor
6147323|NCT01374425|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6147324|NCT01374425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6147325|NCT01374425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6147326|NCT01374425|Antidotes|antidotes|mesh-ancestor
6147327|NCT01374425|Protective Agents|protective agents|mesh-ancestor
6147328|NCT01374425|Vitamin B Complex|vitamin b complex|mesh-ancestor
6147329|NCT01374425|Vitamins|vitamins|mesh-ancestor
5549463|NCT04104867|Antiemetics|antiemetics|mesh-ancestor
5549464|NCT04104867|Autonomic Agents|autonomic agents|mesh-ancestor
5549465|NCT04104867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5549466|NCT04104867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147330|NCT01374425|Micronutrients|micronutrients|mesh-ancestor
6147331|NCT01374451|Everolimus|everolimus|mesh-list
6147332|NCT01374451|Pasireotide|pasireotide|mesh-list
6147333|NCT01374451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6147334|NCT01374451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6147335|NCT01374451|Immunologic Factors|immunologic factors|mesh-ancestor
6147336|NCT01374451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147337|NCT01374451|Hormones|hormones|mesh-ancestor
6147338|NCT01374451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6147339|NCT01374516|Vaccines|vaccines|mesh-list
6147340|NCT01374516|Immunologic Factors|immunologic factors|mesh-ancestor
6147341|NCT01374516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474602|NCT00515489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6474603|NCT00515489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6474604|NCT00515489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6474605|NCT00515489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6474606|NCT00515489|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6474607|NCT00515489|Dopamine Agents|dopamine agents|mesh-ancestor
6474608|NCT00515554|Rituximab|rituximab|mesh-list
6474609|NCT00515554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6474610|NCT00515554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6474611|NCT00515554|Immunologic Factors|immunologic factors|mesh-ancestor
6474612|NCT00515554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474613|NCT00515554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6474614|NCT00515593|Hormones|hormones|mesh-list
6474615|NCT00515593|Parathyroid Hormone|parathyroid hormone|mesh-list
6474616|NCT00515593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6474617|NCT00515593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474618|NCT00515593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6147342|NCT01374568|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6147343|NCT01374568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6147344|NCT01374568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147345|NCT01374568|Incretins|incretins|mesh-ancestor
6474619|NCT00515684|Bevacizumab|bevacizumab|mesh-list
6474620|NCT00515684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6474621|NCT00515684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6474622|NCT00515684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6474623|NCT00515684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5549467|NCT04104867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5549468|NCT04104867|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5549469|NCT04104867|Dopamine Agents|dopamine agents|mesh-ancestor
5549470|NCT04104867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6147346|NCT01374568|Hormones|hormones|mesh-ancestor
6474624|NCT00515684|Growth Substances|growth substances|mesh-ancestor
6147347|NCT01374568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6474625|NCT00515684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474626|NCT00515684|Growth Inhibitors|growth inhibitors|mesh-ancestor
6474627|NCT00515736|Vitamins|vitamins|mesh-list
6474628|NCT00515736|Vitamin E|vitamin e|mesh-list
6474629|NCT00515736|Thiamine|thiamine|mesh-list
6474630|NCT00515736|Zinc|zinc|mesh-list
6474631|NCT00515736|Selenium|selenium|mesh-list
6474632|NCT00515736|Micronutrients|micronutrients|mesh-ancestor
6147348|NCT01374568|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6147349|NCT01374568|Protease Inhibitors|protease inhibitors|mesh-ancestor
6147350|NCT01374568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6147351|NCT01374568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6147352|NCT01374802|Ritonavir|ritonavir|mesh-list
6147353|NCT01374802|Darunavir|darunavir|mesh-list
5549471|NCT04104867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549472|NCT04104984|Tocolytic Agents|tocolytic agents|mesh-list
5549473|NCT04104984|Progesterone|progesterone|mesh-list
5549474|NCT04104984|Progestins|progestins|mesh-ancestor
5549475|NCT04104984|Hormones|hormones|mesh-ancestor
5549476|NCT04104984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6474633|NCT00515736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474634|NCT00515736|Trace Elements|trace elements|mesh-ancestor
6474635|NCT00515736|Antioxidants|antioxidants|mesh-ancestor
6474636|NCT00515736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474637|NCT00515736|Protective Agents|protective agents|mesh-ancestor
6474638|NCT00515736|Vitamin B Complex|vitamin b complex|mesh-ancestor
6474639|NCT00515788|Cytarabine|cytarabine|mesh-list
6474640|NCT00515788|Temozolomide|temozolomide|mesh-list
6474641|NCT00515788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6474642|NCT00515788|Antimetabolites|antimetabolites|mesh-ancestor
6474643|NCT00515788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474644|NCT00515788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6474645|NCT00515788|Antiviral Agents|antiviral agents|mesh-ancestor
6474646|NCT00515788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6474647|NCT00515788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6474648|NCT00515788|Immunologic Factors|immunologic factors|mesh-ancestor
6474649|NCT00515788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474650|NCT00515788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6147354|NCT01374802|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6147355|NCT01374802|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6147356|NCT01374802|Protease Inhibitors|protease inhibitors|mesh-ancestor
6667385|NCT01527032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667386|NCT01527032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6667387|NCT01527032|Glucocorticoids|glucocorticoids|mesh-ancestor
6667388|NCT01527032|Hormones|hormones|mesh-ancestor
6667389|NCT01527032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6147357|NCT01374802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6147358|NCT01374802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6147359|NCT01374802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6147360|NCT01374802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6147361|NCT01374802|Antiviral Agents|antiviral agents|mesh-ancestor
6147362|NCT01374802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6147363|NCT01374802|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6147364|NCT01374802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6147365|NCT01374906|Pasireotide|pasireotide|mesh-list
6147366|NCT01374906|Hormones|hormones|mesh-ancestor
6147367|NCT01374906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6147368|NCT01374906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147369|NCT01374919|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
6147370|NCT01374919|Hematinics|hematinics|mesh-ancestor
6147371|NCT01374919|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6147372|NCT01374919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6147373|NCT01374971|Certolizumab Pegol|certolizumab pegol|mesh-list
6147374|NCT01374971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5549477|NCT04104984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147375|NCT01374971|Immunologic Factors|immunologic factors|mesh-ancestor
6147376|NCT01374971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147377|NCT01374971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6147378|NCT01375010|Vitamin D|vitamin d|mesh-list
6147379|NCT01375010|Cholecalciferol|cholecalciferol|mesh-list
6147380|NCT01375010|Vitamins|vitamins|mesh-list
6147381|NCT01375010|Micronutrients|micronutrients|mesh-ancestor
6147382|NCT01375010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147383|NCT01375010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6474651|NCT00515788|Alkylating Agents|alkylating agents|mesh-ancestor
6474652|NCT00515801|Glyburide|glyburide|mesh-list
6474653|NCT00515801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6147384|NCT01375010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6147385|NCT01375049|Aztreonam|aztreonam|mesh-list
6147386|NCT01375049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6147387|NCT01375049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6147388|NCT01375075|Atorvastatin|atorvastatin|mesh-list
6147389|NCT01375075|Evacetrapib|evacetrapib|mesh-list
6147390|NCT01375075|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6147391|NCT01375075|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6147392|NCT01375075|Antimetabolites|antimetabolites|mesh-ancestor
6147393|NCT01375075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6147394|NCT01375075|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6147395|NCT01375075|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6147396|NCT01375075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6147397|NCT01375127|Tofacitinib|tofacitinib|mesh-list
5549478|NCT04104984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6474654|NCT00515801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474655|NCT00515866|Gemcitabine|gemcitabine|mesh-list
6147398|NCT01375127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6147399|NCT01375127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6147400|NCT01375127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6147401|NCT01375140|Prednisone|prednisone|mesh-list
6147402|NCT01375140|Lenalidomide|lenalidomide|mesh-list
6147403|NCT01375140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6147404|NCT01375140|Glucocorticoids|glucocorticoids|mesh-ancestor
6474656|NCT00515866|Olaparib|olaparib|mesh-list
6474657|NCT00515866|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
6474658|NCT00515866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6474659|NCT00515866|Antimetabolites|antimetabolites|mesh-ancestor
6474660|NCT00515866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474661|NCT00515866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6474662|NCT00515866|Antiviral Agents|antiviral agents|mesh-ancestor
6474663|NCT00515866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6474664|NCT00515866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6474665|NCT00515866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6474666|NCT00515866|Immunologic Factors|immunologic factors|mesh-ancestor
6474667|NCT00515866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474668|NCT00515892|Immunotoxin HA22|immunotoxin ha22|mesh-list
6474669|NCT00515892|Antibodies|antibodies|mesh-list
6474670|NCT00515892|Immunoglobulins|immunoglobulins|mesh-list
6147405|NCT01375140|Hormones|hormones|mesh-ancestor
6147406|NCT01375140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6147407|NCT01375140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474671|NCT00515892|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6474672|NCT00515892|Immunotoxins|immunotoxins|mesh-list
6474673|NCT00515892|Immunologic Factors|immunologic factors|mesh-ancestor
6474674|NCT00515892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474675|NCT00515892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5549479|NCT04104646|Morphine|morphine|mesh-list
5549480|NCT04104646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6147408|NCT01375140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6474676|NCT00515905|Propofol|propofol|mesh-list
6474677|NCT00515905|Sevoflurane|sevoflurane|mesh-list
6667390|NCT01527032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6667391|NCT01527032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6667392|NCT01527032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6667393|NCT01527032|Alkylating Agents|alkylating agents|mesh-ancestor
6667394|NCT01527032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667395|NCT01527032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6667396|NCT01527032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6667397|NCT01527032|Immunologic Factors|immunologic factors|mesh-ancestor
6667398|NCT01527032|Leprostatic Agents|leprostatic agents|mesh-ancestor
6667399|NCT01527032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6667400|NCT01527032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6667401|NCT01527032|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6667402|NCT01527032|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6667403|NCT01527032|Growth Substances|growth substances|mesh-ancestor
5549481|NCT04104646|Narcotics|narcotics|mesh-ancestor
5549482|NCT04104646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6147409|NCT01375140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5549483|NCT04104646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549484|NCT04104646|Analgesics|analgesics|mesh-ancestor
5549485|NCT04104646|Sensory System Agents|sensory system agents|mesh-ancestor
5549486|NCT04104646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5602781|NCT04174612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5602782|NCT04174612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5602783|NCT04174612|Immunologic Factors|immunologic factors|mesh-ancestor
5602784|NCT04174612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602785|NCT04174612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5602786|NCT04174612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5602787|NCT04174612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5602788|NCT04174612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6147410|NCT01375140|Immunologic Factors|immunologic factors|mesh-ancestor
6147411|NCT01375140|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6147412|NCT01375140|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6147413|NCT01375140|Growth Substances|growth substances|mesh-ancestor
5602789|NCT04174612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5602790|NCT04168502|Gemtuzumab|gemtuzumab|mesh-list
5602791|NCT04168502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5602792|NCT04168502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5602793|NCT04154800|Itraconazole|itraconazole|mesh-list
6147414|NCT01375140|Growth Inhibitors|growth inhibitors|mesh-ancestor
6147415|NCT01375374|Lacosamide|lacosamide|mesh-list
6147416|NCT01375374|Levetiracetam|levetiracetam|mesh-list
6147417|NCT01375374|Anticonvulsants|anticonvulsants|mesh-ancestor
6147418|NCT01375374|Nootropic Agents|nootropic agents|mesh-ancestor
6147419|NCT01375374|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6147420|NCT01375374|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6147421|NCT01375374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6147422|NCT01375374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6147423|NCT01375491|Doxycycline|doxycycline|mesh-list
6147424|NCT01375491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6147425|NCT01375491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6147426|NCT01375491|Antimalarials|antimalarials|mesh-ancestor
6147427|NCT01375491|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6147428|NCT01375491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6147429|NCT01375608|Decitabine|decitabine|mesh-list
6147430|NCT01375608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6147431|NCT01375608|Antimetabolites|antimetabolites|mesh-ancestor
6147432|NCT01375608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6147433|NCT01375608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6147434|NCT01375608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6147435|NCT01375660|Vitamin D|vitamin d|mesh-list
6147436|NCT01375660|Ergocalciferols|ergocalciferols|mesh-list
6147437|NCT01375660|Vitamins|vitamins|mesh-ancestor
5602794|NCT04154800|Diltiazem|diltiazem|mesh-list
5602795|NCT04154800|Antifungal Agents|antifungal agents|mesh-ancestor
5602796|NCT04154800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5602797|NCT04154800|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5602798|NCT04154800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5602799|NCT04154800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5602800|NCT04154800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602801|NCT04154800|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5602802|NCT04154800|Hormone Antagonists|hormone antagonists|mesh-ancestor
5602803|NCT04154800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6147438|NCT01375660|Micronutrients|micronutrients|mesh-ancestor
6147439|NCT01375660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474678|NCT00515905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6474679|NCT00515905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6474680|NCT00515905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474681|NCT00515905|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6474682|NCT00515905|Anesthetics, General|anesthetics, general|mesh-ancestor
6147440|NCT01375660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6147441|NCT01375660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6147442|NCT01375751|Evolocumab|evolocumab|mesh-list
6147443|NCT01375751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6147444|NCT01375751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6474683|NCT00515905|Anesthetics|anesthetics|mesh-ancestor
6474684|NCT00515905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6474685|NCT00515905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6147445|NCT01375751|Antimetabolites|antimetabolites|mesh-ancestor
6147446|NCT01375751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474686|NCT00515944|Botulinum Toxins|botulinum toxins|mesh-list
6474687|NCT00515944|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6474688|NCT00515944|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6474689|NCT00515944|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6474690|NCT00515944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6474691|NCT00515944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474692|NCT00515944|Cholinergic Agents|cholinergic agents|mesh-ancestor
6474693|NCT00515944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6474694|NCT00515944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474695|NCT00515944|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6474696|NCT00515944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6474697|NCT00515957|Antibodies|antibodies|mesh-list
6474698|NCT00515957|Immunologic Factors|immunologic factors|mesh-ancestor
6474699|NCT00515957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474700|NCT00516009|Dexamethasone|dexamethasone|mesh-list
6474701|NCT00516009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6474702|NCT00516009|Antiemetics|antiemetics|mesh-ancestor
6474703|NCT00516009|Autonomic Agents|autonomic agents|mesh-ancestor
6474704|NCT00516009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6474705|NCT00516009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474706|NCT00516009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6474707|NCT00516009|Glucocorticoids|glucocorticoids|mesh-ancestor
6474708|NCT00516009|Hormones|hormones|mesh-ancestor
6474709|NCT00516009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6474710|NCT00516009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6474711|NCT00516009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6474712|NCT00516100|Pemetrexed|pemetrexed|mesh-list
6474713|NCT00516100|Bortezomib|bortezomib|mesh-list
6474714|NCT00516100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6474715|NCT00516100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6474716|NCT00516100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474717|NCT00516100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6474718|NCT00516100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6474719|NCT00516113|Paroxetine|paroxetine|mesh-list
6474720|NCT00516113|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6147447|NCT01375751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6147448|NCT01375764|Ezetimibe|ezetimibe|mesh-list
6147449|NCT01375764|Evolocumab|evolocumab|mesh-list
6147450|NCT01375764|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6147451|NCT01375764|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6147452|NCT01375764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6147453|NCT01375764|Antimetabolites|antimetabolites|mesh-ancestor
6147454|NCT01375764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6147455|NCT01375764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6147456|NCT01375764|Immunologic Factors|immunologic factors|mesh-ancestor
6147457|NCT01375764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147458|NCT01375777|Ezetimibe|ezetimibe|mesh-list
6147459|NCT01375777|Evolocumab|evolocumab|mesh-list
6147460|NCT01375777|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6147461|NCT01375777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6147462|NCT01375777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6147463|NCT01375777|Antimetabolites|antimetabolites|mesh-ancestor
6147464|NCT01375777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6147465|NCT01375777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6147466|NCT01375777|Immunologic Factors|immunologic factors|mesh-ancestor
6147467|NCT01375777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147468|NCT01375946|Contraceptive Agents|contraceptive agents|mesh-list
6147469|NCT01375946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6147470|NCT01375946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147471|NCT01376167|Chloroquine|chloroquine|mesh-list
6147472|NCT01376167|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
6147473|NCT01376167|Primaquine|primaquine|mesh-list
6147474|NCT01376167|Tafenoquine|tafenoquine|mesh-list
6147475|NCT01376167|Amebicides|amebicides|mesh-ancestor
6147476|NCT01376167|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6147477|NCT01376167|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6147478|NCT01376167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6147479|NCT01376167|Antimalarials|antimalarials|mesh-ancestor
6147480|NCT01376167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6147481|NCT01376167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5549487|NCT04104789|Oxymetazoline|oxymetazoline|mesh-list
6147482|NCT01376167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6147483|NCT01376167|Analgesics|analgesics|mesh-ancestor
6147484|NCT01376167|Sensory System Agents|sensory system agents|mesh-ancestor
5549488|NCT04104789|Tetracaine|tetracaine|mesh-list
5549489|NCT04104789|Carticaine|carticaine|mesh-list
5549490|NCT04104789|Anesthetics, Local|anesthetics, local|mesh-ancestor
5549491|NCT04104789|Anesthetics|anesthetics|mesh-ancestor
5549492|NCT04104789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5549493|NCT04104789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549494|NCT04104789|Sensory System Agents|sensory system agents|mesh-ancestor
5549495|NCT04104789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5549496|NCT04104789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5549497|NCT04104789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5549498|NCT04104789|Adrenergic Agents|adrenergic agents|mesh-ancestor
5549499|NCT04104789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5549500|NCT04104789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549501|NCT04104789|Sympathomimetics|sympathomimetics|mesh-ancestor
5549502|NCT04104789|Autonomic Agents|autonomic agents|mesh-ancestor
5549503|NCT04104789|Nasal Decongestants|nasal decongestants|mesh-ancestor
5549504|NCT04104789|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5549505|NCT04104789|Respiratory System Agents|respiratory system agents|mesh-ancestor
5549506|NCT04104204|Morphine|morphine|mesh-list
5549507|NCT04104204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5549508|NCT04104204|Narcotics|narcotics|mesh-ancestor
5549509|NCT04104204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5549510|NCT04104204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549511|NCT04104204|Analgesics|analgesics|mesh-ancestor
5549512|NCT04104204|Sensory System Agents|sensory system agents|mesh-ancestor
5549513|NCT04104204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5549514|NCT04104438|Everolimus|everolimus|mesh-list
5549515|NCT04104438|Basiliximab|basiliximab|mesh-list
5549516|NCT04104438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5549517|NCT04104438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5549518|NCT04104438|Immunologic Factors|immunologic factors|mesh-ancestor
5549519|NCT04104438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549520|NCT04104334|Remifentanil|remifentanil|mesh-list
5549521|NCT04104334|Desflurane|desflurane|mesh-list
6147485|NCT01376167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6147486|NCT01376167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147487|NCT01376167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6147488|NCT01376167|Filaricides|filaricides|mesh-ancestor
6147489|NCT01376167|Antinematodal Agents|antinematodal agents|mesh-ancestor
6147490|NCT01376167|Anthelmintics|anthelmintics|mesh-ancestor
6147491|NCT01376245|Fluticasone|fluticasone|mesh-list
6474721|NCT00516113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6474722|NCT00516113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6474723|NCT00516113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474724|NCT00516113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6474725|NCT00516113|Serotonin Agents|serotonin agents|mesh-ancestor
6474726|NCT00516113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474727|NCT00516113|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5549522|NCT04104334|Anesthetics|anesthetics|mesh-ancestor
5549523|NCT04104334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5549524|NCT04104334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147492|NCT01376245|Xhance|xhance|mesh-list
5549525|NCT04104334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5549526|NCT04104334|Narcotics|narcotics|mesh-ancestor
5549527|NCT04104334|Analgesics|analgesics|mesh-ancestor
6474728|NCT00516113|Antidepressive Agents|antidepressive agents|mesh-ancestor
6474729|NCT00516113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5549528|NCT04104334|Sensory System Agents|sensory system agents|mesh-ancestor
5549529|NCT04104334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5549530|NCT04104334|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5549531|NCT04104334|Anesthetics, General|anesthetics, general|mesh-ancestor
5549532|NCT04103684|Dexamethasone|dexamethasone|mesh-list
5549533|NCT04103684|Methylprednisolone|methylprednisolone|mesh-list
5549534|NCT04103684|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5549535|NCT04103684|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5549536|NCT04103684|Prednisolone|prednisolone|mesh-list
5549537|NCT04103684|Prednisolone acetate|prednisolone acetate|mesh-list
5549538|NCT04103684|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5549539|NCT04103684|Prednisolone phosphate|prednisolone phosphate|mesh-list
5549540|NCT04103684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5549541|NCT04103684|Antiemetics|antiemetics|mesh-ancestor
5549542|NCT04103684|Autonomic Agents|autonomic agents|mesh-ancestor
6474730|NCT00516113|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6474731|NCT00516113|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6474732|NCT00516113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6474733|NCT00516152|Methotrexate|methotrexate|mesh-list
6474734|NCT00516152|Fludarabine phosphate|fludarabine phosphate|mesh-list
6474735|NCT00516152|Fludarabine|fludarabine|mesh-list
6474736|NCT00516152|Busulfan|busulfan|mesh-list
6474737|NCT00516152|Tacrolimus|tacrolimus|mesh-list
6474738|NCT00516152|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6474739|NCT00516152|Abortifacient Agents|abortifacient agents|mesh-ancestor
6474740|NCT00516152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6474741|NCT00516152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147493|NCT01376245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6147494|NCT01376245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6147495|NCT01376245|Autonomic Agents|autonomic agents|mesh-ancestor
6147496|NCT01376245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6147497|NCT01376245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147498|NCT01376245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6147499|NCT01376245|Respiratory System Agents|respiratory system agents|mesh-ancestor
6147500|NCT01376245|Dermatologic Agents|dermatologic agents|mesh-ancestor
6147501|NCT01376245|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6147502|NCT01376297|Dexamethasone|dexamethasone|mesh-list
6147503|NCT01376297|Aprepitant|aprepitant|mesh-list
6147504|NCT01376297|Palonosetron|palonosetron|mesh-list
6147505|NCT01376297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5549543|NCT04103684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5549544|NCT04103684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549545|NCT04103684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5549546|NCT04103684|Glucocorticoids|glucocorticoids|mesh-ancestor
5549547|NCT04103684|Hormones|hormones|mesh-ancestor
5549548|NCT04103684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5549549|NCT04103684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5549550|NCT04103684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5549551|NCT04103684|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5549552|NCT04103684|Protective Agents|protective agents|mesh-ancestor
5549553|NCT04103905|Antibodies|antibodies|mesh-list
5549554|NCT04103905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5549555|NCT04103905|Immunologic Factors|immunologic factors|mesh-ancestor
5549556|NCT04103905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549557|NCT04103697|Capecitabine|capecitabine|mesh-list
5549558|NCT04103697|Oxaliplatin|oxaliplatin|mesh-list
6147506|NCT01376297|Antiemetics|antiemetics|mesh-ancestor
6147507|NCT01376297|Autonomic Agents|autonomic agents|mesh-ancestor
6147508|NCT01376297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6147509|NCT01376297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147510|NCT01376297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6147511|NCT01376297|Glucocorticoids|glucocorticoids|mesh-ancestor
6147512|NCT01376297|Hormones|hormones|mesh-ancestor
6147513|NCT01376297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6474742|NCT00516152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6147514|NCT01376297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6147515|NCT01376297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6147516|NCT01376297|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6147517|NCT01376297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6147518|NCT01376297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474743|NCT00516152|Antimetabolites|antimetabolites|mesh-ancestor
6474744|NCT00516152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474745|NCT00516152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6147519|NCT01376297|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6147520|NCT01376297|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6147521|NCT01376297|Serotonin Agents|serotonin agents|mesh-ancestor
6205611|NCT02088541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205612|NCT02088541|Antisickling Agents|antisickling agents|mesh-ancestor
6205613|NCT02088541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6205614|NCT02088541|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5549559|NCT04103697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5549560|NCT04103697|Antimetabolites|antimetabolites|mesh-ancestor
5549561|NCT04103697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549562|NCT04103697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5549563|NCT04103489|Eculizumab|eculizumab|mesh-list
5549564|NCT04103489|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5549565|NCT04103489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5549566|NCT04103489|Immunologic Factors|immunologic factors|mesh-ancestor
5549567|NCT04103489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205615|NCT02089113|Dexamethasone|dexamethasone|mesh-list
6205616|NCT02089113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6205617|NCT02089113|Antiemetics|antiemetics|mesh-ancestor
6205618|NCT02089113|Autonomic Agents|autonomic agents|mesh-ancestor
6205619|NCT02089113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6474746|NCT00516152|Dermatologic Agents|dermatologic agents|mesh-ancestor
6474747|NCT00516152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6474748|NCT00516152|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6474749|NCT00516152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6474750|NCT00516152|Immunologic Factors|immunologic factors|mesh-ancestor
6474751|NCT00516152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6474752|NCT00516152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6205620|NCT02089113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205621|NCT02089113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6205622|NCT02089113|Glucocorticoids|glucocorticoids|mesh-ancestor
6205623|NCT02089113|Hormones|hormones|mesh-ancestor
6205624|NCT02089113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6205625|NCT02089113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6205626|NCT02089113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6205627|NCT02089347|Vaccines|vaccines|mesh-list
6205628|NCT02089347|Immunologic Factors|immunologic factors|mesh-ancestor
6205629|NCT02089347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205630|NCT02089737|Panitumumab|panitumumab|mesh-list
6205631|NCT02089737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6205632|NCT02089737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6205633|NCT02089997|Risedronic Acid|risedronic acid|mesh-list
6205634|NCT02089997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6205635|NCT02089997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6474753|NCT00516152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6474754|NCT00516152|Alkylating Agents|alkylating agents|mesh-ancestor
6474755|NCT00516152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6474756|NCT00516152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6474757|NCT00516191|Doxorubicin|doxorubicin|mesh-list
6474758|NCT00516191|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6474759|NCT00516191|Bortezomib|bortezomib|mesh-list
6474760|NCT00516191|Melphalan|melphalan|mesh-list
6205636|NCT02089997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205637|NCT02089997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6205638|NCT02089997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205639|NCT02089997|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6205640|NCT02090075|Warfarin|warfarin|mesh-list
6205641|NCT02090075|Apixaban|apixaban|mesh-list
6205642|NCT02090075|Anticoagulants|anticoagulants|mesh-ancestor
6205643|NCT02090075|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6474761|NCT00516191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6474762|NCT00516191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6474763|NCT00516191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6474764|NCT00516191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6474765|NCT00516191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6488703|NCT00585871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6474766|NCT00516191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474767|NCT00516191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6474768|NCT00516191|Alkylating Agents|alkylating agents|mesh-ancestor
6147522|NCT01376310|Gemcitabine|gemcitabine|mesh-list
6147523|NCT01376310|Paclitaxel|paclitaxel|mesh-list
6147524|NCT01376310|Docetaxel|docetaxel|mesh-list
6147525|NCT01376310|Carboplatin|carboplatin|mesh-list
6147526|NCT01376310|Pemetrexed|pemetrexed|mesh-list
6147527|NCT01376310|Everolimus|everolimus|mesh-list
6147528|NCT01376310|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6147529|NCT01376310|Trametinib|trametinib|mesh-list
6147530|NCT01376310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6147531|NCT01376310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6147532|NCT01376310|Tubulin Modulators|tubulin modulators|mesh-ancestor
6147533|NCT01376310|Antimitotic Agents|antimitotic agents|mesh-ancestor
6147534|NCT01376310|Mitosis Modulators|mitosis modulators|mesh-ancestor
5549568|NCT04103476|Bazedoxifene|bazedoxifene|mesh-list
5549569|NCT04103476|Estrogens|estrogens|mesh-list
5549570|NCT04103476|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
5549571|NCT04103476|Hormones|hormones|mesh-ancestor
5549572|NCT04103476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5549573|NCT04103476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549574|NCT04103476|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5549575|NCT04103476|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5549576|NCT04103476|Hormone Antagonists|hormone antagonists|mesh-ancestor
5549577|NCT04103476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5549578|NCT04103216|Nitazoxanide|nitazoxanide|mesh-list
5549579|NCT04103216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5549580|NCT04103216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5549581|NCT04103385|Risedronic Acid|risedronic acid|mesh-list
5549582|NCT04103385|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6147535|NCT01376310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6147536|NCT01376310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6147537|NCT01376310|Antimetabolites|antimetabolites|mesh-ancestor
6147538|NCT01376310|Antiviral Agents|antiviral agents|mesh-ancestor
6147539|NCT01376310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6147540|NCT01376310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6147541|NCT01376310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6147542|NCT01376310|Immunologic Factors|immunologic factors|mesh-ancestor
6147543|NCT01376310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147544|NCT01376310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6205644|NCT02090075|Antithrombins|antithrombins|mesh-ancestor
6474769|NCT00516191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6474770|NCT00516191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6474771|NCT00516191|Immunologic Factors|immunologic factors|mesh-ancestor
6474772|NCT00516191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474773|NCT00516243|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
6474774|NCT00516243|Antioxidants|antioxidants|mesh-ancestor
6474775|NCT00516243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474776|NCT00516243|Protective Agents|protective agents|mesh-ancestor
6474777|NCT00516243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474778|NCT00516243|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
6474779|NCT00516243|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6474780|NCT00516243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6474781|NCT00516243|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6474782|NCT00516282|Temozolomide|temozolomide|mesh-list
6474783|NCT00516282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6474784|NCT00516282|Alkylating Agents|alkylating agents|mesh-ancestor
6474785|NCT00516282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474786|NCT00516282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6474787|NCT00516360|Chlorhexidine|chlorhexidine|mesh-list
6474788|NCT00516360|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
6474789|NCT00516360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6474790|NCT00516360|Disinfectants|disinfectants|mesh-ancestor
6474791|NCT00516399|Povidone-Iodine|povidone-iodine|mesh-list
6474792|NCT00516399|Natamycin|natamycin|mesh-list
6474793|NCT00516399|Povidone|povidone|mesh-list
6474794|NCT00516399|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6474795|NCT00516399|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5549583|NCT04103385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5549584|NCT04103385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549585|NCT04103385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5549586|NCT04103385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549587|NCT04103385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5549588|NCT04103398|Sorafenib|sorafenib|mesh-list
5549589|NCT04103398|Chlorotrianisene|chlorotrianisene|mesh-list
5549590|NCT04103398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5549591|NCT04103398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5549592|NCT04103398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5549593|NCT04103398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549594|NCT04103398|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
5549595|NCT04103398|Estrogens|estrogens|mesh-ancestor
5549596|NCT04103398|Hormones|hormones|mesh-ancestor
5549597|NCT04103398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5549598|NCT04103398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474796|NCT00516399|Plasma Substitutes|plasma substitutes|mesh-ancestor
6474797|NCT00516399|Blood Substitutes|blood substitutes|mesh-ancestor
6474798|NCT00516399|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6474799|NCT00516399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6474800|NCT00516399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6474801|NCT00516399|Antifungal Agents|antifungal agents|mesh-ancestor
6474802|NCT00516412|Everolimus|everolimus|mesh-list
6474803|NCT00516412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6474804|NCT00516412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6474805|NCT00516412|Immunologic Factors|immunologic factors|mesh-ancestor
6474806|NCT00516412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474807|NCT00516425|Cyclophosphamide|cyclophosphamide|mesh-list
6474808|NCT00516425|Doxorubicin|doxorubicin|mesh-list
6474809|NCT00516425|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6474810|NCT00516425|Epirubicin|epirubicin|mesh-list
6474811|NCT00516425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6474812|NCT00516425|Immunologic Factors|immunologic factors|mesh-ancestor
6474813|NCT00516425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474814|NCT00516425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5549599|NCT04103398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5549600|NCT04103125|Hyaluronic Acid|hyaluronic acid|mesh-list
5549601|NCT04103125|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5549602|NCT04103125|Immunologic Factors|immunologic factors|mesh-ancestor
5549603|NCT04103125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549604|NCT04103125|Viscosupplements|viscosupplements|mesh-ancestor
5549605|NCT04103125|Protective Agents|protective agents|mesh-ancestor
5549606|NCT04103034|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
5549607|NCT04103034|Hemostatics|hemostatics|mesh-ancestor
5549608|NCT04103034|Coagulants|coagulants|mesh-ancestor
5549609|NCT04103034|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5549610|NCT04103034|Natriuretic Agents|natriuretic agents|mesh-ancestor
5549611|NCT04103034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549612|NCT04102995|Pregnanolone|pregnanolone|mesh-list
5549613|NCT04102995|Anesthetics|anesthetics|mesh-ancestor
5549614|NCT04102995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5549615|NCT04102995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549616|NCT04102878|Anesthetics|anesthetics|mesh-list
5549617|NCT04102878|Anesthetics, Local|anesthetics, local|mesh-list
5549618|NCT04102878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5549619|NCT04102878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549620|NCT04102878|Sensory System Agents|sensory system agents|mesh-ancestor
5549621|NCT04102878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5549622|NCT04102670|Hyaluronic Acid|hyaluronic acid|mesh-list
5549623|NCT04102670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474815|NCT00516425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6474816|NCT00516425|Alkylating Agents|alkylating agents|mesh-ancestor
6474817|NCT00516425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474818|NCT00516425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6474819|NCT00516425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6474820|NCT00516425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6147545|NCT01376310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6147546|NCT01376310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6147547|NCT01376349|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
6147548|NCT01376349|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6147549|NCT01376349|Immunologic Factors|immunologic factors|mesh-ancestor
6147550|NCT01376349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474821|NCT00516425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6147551|NCT01376362|Interferons|interferons|mesh-list
6488704|NCT00585871|Adrenergic Agents|adrenergic agents|mesh-ancestor
6474822|NCT00516425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6474823|NCT00516425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6474824|NCT00516438|Topotecan|topotecan|mesh-list
6474825|NCT00516438|Olaparib|olaparib|mesh-list
6474826|NCT00516438|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
6474827|NCT00516438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6474828|NCT00516438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6474829|NCT00516438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6474830|NCT00516438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474831|NCT00516438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6474832|NCT00516464|Ranibizumab|ranibizumab|mesh-list
6474833|NCT00516464|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6474834|NCT00516464|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6474835|NCT00516464|Growth Substances|growth substances|mesh-ancestor
6474836|NCT00516464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474837|NCT00516464|Growth Inhibitors|growth inhibitors|mesh-ancestor
6474838|NCT00516464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6474839|NCT00516490|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6474840|NCT00516490|Luteolytic Agents|luteolytic agents|mesh-ancestor
6474841|NCT00516490|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6474842|NCT00516490|Contraceptive Agents|contraceptive agents|mesh-ancestor
6474843|NCT00516490|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6474844|NCT00516490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474845|NCT00516490|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6474846|NCT00516490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6474847|NCT00516490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6147552|NCT01376362|Interferon-gamma|interferon-gamma|mesh-list
6147553|NCT01376362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6147554|NCT01376362|Antiviral Agents|antiviral agents|mesh-ancestor
6147555|NCT01376362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6147556|NCT01376557|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
6147557|NCT01376557|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6147558|NCT01376557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6147559|NCT01376557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6147560|NCT01376557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147561|NCT01376700|Factor VIII|factor viii|mesh-list
6147562|NCT01376700|Coagulants|coagulants|mesh-ancestor
6147563|NCT01376804|Valganciclovir|valganciclovir|mesh-list
6147564|NCT01376804|Antiviral Agents|antiviral agents|mesh-ancestor
6147565|NCT01376804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6147566|NCT01377194|Milnacipran|milnacipran|mesh-list
6147567|NCT01377194|Levomilnacipran|levomilnacipran|mesh-list
6474848|NCT00516542|Letrozole|letrozole|mesh-list
6474849|NCT00516542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5549624|NCT04102670|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5549625|NCT04102670|Immunologic Factors|immunologic factors|mesh-ancestor
5549626|NCT04102670|Viscosupplements|viscosupplements|mesh-ancestor
5549627|NCT04102670|Protective Agents|protective agents|mesh-ancestor
5549628|NCT04102800|Benralizumab|benralizumab|mesh-list
5549629|NCT04102800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5549630|NCT04102800|Respiratory System Agents|respiratory system agents|mesh-ancestor
5549631|NCT04102943|Tacrolimus|tacrolimus|mesh-list
5549632|NCT04102943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5549633|NCT04102943|Immunologic Factors|immunologic factors|mesh-ancestor
5549634|NCT04102943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549635|NCT04102943|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5549636|NCT04102943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5549637|NCT04102943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602804|NCT04154800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602805|NCT04154800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5602806|NCT04154800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5602807|NCT04154800|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5602808|NCT04154800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5602809|NCT04154800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6474850|NCT00516542|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6474851|NCT00516542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6474852|NCT00516542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6474853|NCT00516542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474854|NCT00516542|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6147568|NCT01377194|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6147569|NCT01377194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6147570|NCT01377194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5602810|NCT04154800|Vasodilator Agents|vasodilator agents|mesh-ancestor
6147571|NCT01377194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6147572|NCT01377194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6147573|NCT01377194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147574|NCT01377194|Antidepressive Agents|antidepressive agents|mesh-ancestor
6147575|NCT01377194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6147576|NCT01377194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6147577|NCT01377194|Analgesics|analgesics|mesh-ancestor
6147578|NCT01377194|Sensory System Agents|sensory system agents|mesh-ancestor
6147579|NCT01377194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6147580|NCT01377389|Ipilimumab|ipilimumab|mesh-list
6147581|NCT01377389|Leuprolide|leuprolide|mesh-list
6147582|NCT01377389|Goserelin|goserelin|mesh-list
6147583|NCT01377389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6147584|NCT01377389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6147585|NCT01377389|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6147586|NCT01377389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6147587|NCT01377389|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5549638|NCT04102592|Permethrin|permethrin|mesh-list
5549639|NCT04102592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5549640|NCT04102592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549641|NCT04102371|Plasma-lyte 148|plasma-lyte 148|mesh-list
5549642|NCT04102371|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5549643|NCT04102371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5549644|NCT04102267|Epinephrine|epinephrine|mesh-list
5549645|NCT04102267|Bupivacaine|bupivacaine|mesh-list
5549646|NCT04102267|Anesthetics, Local|anesthetics, local|mesh-ancestor
5549647|NCT04102267|Anesthetics|anesthetics|mesh-ancestor
5549648|NCT04102267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5549649|NCT04102267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549650|NCT04102267|Sensory System Agents|sensory system agents|mesh-ancestor
5549651|NCT04102267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5549652|NCT04102267|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5549653|NCT04102267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5549654|NCT04102267|Adrenergic Agents|adrenergic agents|mesh-ancestor
5549655|NCT04102267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5549656|NCT04102267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549657|NCT04102267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5549658|NCT04102267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5549659|NCT04102267|Autonomic Agents|autonomic agents|mesh-ancestor
5549660|NCT04102267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5549661|NCT04102267|Respiratory System Agents|respiratory system agents|mesh-ancestor
6147588|NCT01377389|Fertility Agents|fertility agents|mesh-ancestor
6147589|NCT01377389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6147590|NCT01377389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147591|NCT01377389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6147592|NCT01377467|Denosumab|denosumab|mesh-list
6147593|NCT01377467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6147594|NCT01377467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147595|NCT01377480|Posaconazole|posaconazole|mesh-list
6147596|NCT01377480|Benzonidazole|benzonidazole|mesh-list
6147597|NCT01377480|Antifungal Agents|antifungal agents|mesh-ancestor
6474855|NCT00516542|Hormone Antagonists|hormone antagonists|mesh-ancestor
6474856|NCT00516542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6474857|NCT00516542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474858|NCT00516607|Temozolomide|temozolomide|mesh-list
6474859|NCT00516607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6474860|NCT00516607|Alkylating Agents|alkylating agents|mesh-ancestor
6147598|NCT01377480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6147599|NCT01377480|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6147600|NCT01377480|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6147601|NCT01377480|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6147602|NCT01377480|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6147603|NCT01377480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6474861|NCT00516607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474862|NCT00516607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6474863|NCT00516672|Lapatinib|lapatinib|mesh-list
6474864|NCT00516672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6474865|NCT00516672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6474866|NCT00516672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6474867|NCT00516672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474868|NCT00516711|Sevoflurane|sevoflurane|mesh-list
6474869|NCT00516711|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6474870|NCT00516711|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6147604|NCT01377480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6147605|NCT01377480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6147606|NCT01377480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6147607|NCT01377480|Hormone Antagonists|hormone antagonists|mesh-ancestor
6147608|NCT01377480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6147609|NCT01377480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147610|NCT01377480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6147611|NCT01377480|Immunologic Factors|immunologic factors|mesh-ancestor
6147612|NCT01377623|Dexmedetomidine|dexmedetomidine|mesh-list
6147613|NCT01377623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6147614|NCT01377623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6474871|NCT00516711|Anesthetics, General|anesthetics, general|mesh-ancestor
6474872|NCT00516711|Anesthetics|anesthetics|mesh-ancestor
6474873|NCT00516711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6474874|NCT00516711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474875|NCT00516750|Doxorubicin|doxorubicin|mesh-list
6474876|NCT00516750|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6474877|NCT00516750|Methotrexate|methotrexate|mesh-list
6147615|NCT01377623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147616|NCT01377623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5549662|NCT04102267|Mydriatics|mydriatics|mesh-ancestor
5549663|NCT04102267|Sympathomimetics|sympathomimetics|mesh-ancestor
5549664|NCT04102267|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5549665|NCT04102449|Apremilast|apremilast|mesh-list
5549666|NCT04102449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5549667|NCT04102449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5549668|NCT04102449|Analgesics|analgesics|mesh-ancestor
5549669|NCT04102449|Sensory System Agents|sensory system agents|mesh-ancestor
5549670|NCT04102449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5549671|NCT04102449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549672|NCT04102449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5549673|NCT04102449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5549674|NCT04102449|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5549675|NCT04102449|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5549676|NCT04102449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5549677|NCT04102449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549678|NCT04102566|Ibuprofen|ibuprofen|mesh-list
6147617|NCT01377623|Analgesics|analgesics|mesh-ancestor
6147618|NCT01377623|Sensory System Agents|sensory system agents|mesh-ancestor
6147619|NCT01377623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6667404|NCT01527032|Growth Inhibitors|growth inhibitors|mesh-ancestor
6667405|NCT01527097|Atorvastatin|atorvastatin|mesh-list
6667406|NCT01527097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6667407|NCT01527097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6667408|NCT01527097|Antimetabolites|antimetabolites|mesh-ancestor
6667409|NCT01527097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667410|NCT01527097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6667411|NCT01527097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6667412|NCT01527097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6667413|NCT01527279|Antazoline|antazoline|mesh-list
6667414|NCT01527279|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6667415|NCT01527279|Histamine Antagonists|histamine antagonists|mesh-ancestor
6667416|NCT01527279|Histamine Agents|histamine agents|mesh-ancestor
6667417|NCT01527279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6667418|NCT01527279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667419|NCT01527279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667420|NCT01527279|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6667421|NCT01527305|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6667422|NCT01527305|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6667423|NCT01527305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6667424|NCT01527305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6667425|NCT01527305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667426|NCT01527305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6667427|NCT01527305|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6147620|NCT01377623|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5549679|NCT04102566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5549680|NCT04102566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5549681|NCT04102566|Analgesics|analgesics|mesh-ancestor
5549682|NCT04102566|Sensory System Agents|sensory system agents|mesh-ancestor
6147621|NCT01377623|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6147622|NCT01377623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6147623|NCT01377623|Adrenergic Agents|adrenergic agents|mesh-ancestor
6147624|NCT01377623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6474878|NCT00516750|Vinblastine|vinblastine|mesh-list
6474879|NCT00516750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5549683|NCT04102566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5549684|NCT04102566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549685|NCT04102566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5549686|NCT04102566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5549687|NCT04102566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5549688|NCT04102566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5549689|NCT04102566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474880|NCT00516750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6474881|NCT00516750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6474882|NCT00516750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6474883|NCT00516750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6474884|NCT00516750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474885|NCT00516750|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6474886|NCT00516750|Abortifacient Agents|abortifacient agents|mesh-ancestor
6474887|NCT00516750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6474888|NCT00516750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474889|NCT00516750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6147625|NCT01377623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6147626|NCT01377636|Isoproterenol|isoproterenol|mesh-list
6147627|NCT01377636|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6667428|NCT01527305|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6667429|NCT01527305|Serotonin Agents|serotonin agents|mesh-ancestor
6667430|NCT01527305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5549690|NCT04102176|Tin Fluorides|tin fluorides|mesh-list
5549691|NCT04102176|Cariostatic Agents|cariostatic agents|mesh-ancestor
5549692|NCT04102176|Protective Agents|protective agents|mesh-ancestor
5549693|NCT04102176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549694|NCT04101877|Bevacizumab|bevacizumab|mesh-list
5549695|NCT04101877|Aflibercept|aflibercept|mesh-list
6667431|NCT01527305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667432|NCT01527305|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6667433|NCT01527305|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6667434|NCT01527305|Dopamine Agents|dopamine agents|mesh-ancestor
6667435|NCT01527318|Clofibric Acid|clofibric acid|mesh-list
6667436|NCT01527318|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6667437|NCT01527318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6667438|NCT01527318|Antimetabolites|antimetabolites|mesh-ancestor
6667439|NCT01527318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667440|NCT01527318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6667441|NCT01527422|Prednisone|prednisone|mesh-list
6667442|NCT01527422|Cyclophosphamide|cyclophosphamide|mesh-list
6667443|NCT01527422|Doxorubicin|doxorubicin|mesh-list
6667444|NCT01527422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6667445|NCT01527422|Vincristine|vincristine|mesh-list
6667446|NCT01527422|Sargramostim|sargramostim|mesh-list
6667447|NCT01527422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6667448|NCT01527422|Immunologic Factors|immunologic factors|mesh-ancestor
6667449|NCT01527422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667450|NCT01527422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6667451|NCT01527422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6474890|NCT00516750|Antimetabolites|antimetabolites|mesh-ancestor
6474891|NCT00516750|Dermatologic Agents|dermatologic agents|mesh-ancestor
5549696|NCT04101877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5549697|NCT04101877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5602811|NCT04141696|Midazolam|midazolam|mesh-list
6474892|NCT00516750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6474893|NCT00516750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6474894|NCT00516750|Immunologic Factors|immunologic factors|mesh-ancestor
6474895|NCT00516750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6667452|NCT01527422|Alkylating Agents|alkylating agents|mesh-ancestor
6667453|NCT01527422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667454|NCT01527422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6667455|NCT01527422|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5549698|NCT04101877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6147628|NCT01377636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6147629|NCT01377636|Adrenergic Agents|adrenergic agents|mesh-ancestor
6147630|NCT01377636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6147631|NCT01377636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6147632|NCT01377636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147633|NCT01377636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6147634|NCT01377636|Autonomic Agents|autonomic agents|mesh-ancestor
6147635|NCT01377636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6147636|NCT01377636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6147637|NCT01377636|Respiratory System Agents|respiratory system agents|mesh-ancestor
5549699|NCT04101877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5549700|NCT04101877|Growth Substances|growth substances|mesh-ancestor
5549701|NCT04101877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549702|NCT04101877|Growth Inhibitors|growth inhibitors|mesh-ancestor
5549703|NCT04101929|Irinotecan|irinotecan|mesh-list
5549704|NCT04101929|Apatinib|apatinib|mesh-list
5549705|NCT04101929|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5549706|NCT04101929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5549707|NCT04101929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5549708|NCT04101929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549709|NCT04101929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5549710|NCT04101929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5549711|NCT04102072|Dobutamine|dobutamine|mesh-list
5549712|NCT04102072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5549713|NCT04102072|Sympathomimetics|sympathomimetics|mesh-ancestor
5549714|NCT04102072|Autonomic Agents|autonomic agents|mesh-ancestor
5549715|NCT04102072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5549716|NCT04102072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549717|NCT04102072|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5549718|NCT04102072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5549719|NCT04102072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5549720|NCT04102072|Adrenergic Agents|adrenergic agents|mesh-ancestor
5549721|NCT04102072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5549722|NCT04102072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549723|NCT04102072|Protective Agents|protective agents|mesh-ancestor
5549724|NCT04101838|Vaccines|vaccines|mesh-list
5549725|NCT04101838|Immunologic Factors|immunologic factors|mesh-ancestor
5549726|NCT04101838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549727|NCT04101812|Doxorubicin|doxorubicin|mesh-list
5549728|NCT04101812|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6147638|NCT01377636|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6147639|NCT01377636|Sympathomimetics|sympathomimetics|mesh-ancestor
6147640|NCT01377636|Protective Agents|protective agents|mesh-ancestor
6667456|NCT01527422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6667457|NCT01527422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6667458|NCT01527422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6667459|NCT01527422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6667460|NCT01527422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6667461|NCT01527422|Glucocorticoids|glucocorticoids|mesh-ancestor
6667462|NCT01527422|Hormones|hormones|mesh-ancestor
6667463|NCT01527422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6667464|NCT01527422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6667465|NCT01527422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5549729|NCT04101812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6147641|NCT01377844|Bexagliflozin|bexagliflozin|mesh-list
6147642|NCT01377844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6147643|NCT01377844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147644|NCT01377922|Amifampridine|amifampridine|mesh-list
6147645|NCT01377922|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6147646|NCT01377922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6147647|NCT01377922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147648|NCT01377922|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6147649|NCT01377922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6147650|NCT01377922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6147651|NCT01377987|Acetazolamide|acetazolamide|mesh-list
6147652|NCT01377987|Anticonvulsants|anticonvulsants|mesh-ancestor
6147653|NCT01377987|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6147654|NCT01377987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6147655|NCT01377987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6147656|NCT01377987|Diuretics|diuretics|mesh-ancestor
6147657|NCT01377987|Natriuretic Agents|natriuretic agents|mesh-ancestor
6147658|NCT01377987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147659|NCT01378104|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6147660|NCT01378104|Interferon-alpha|interferon-alpha|mesh-list
6147661|NCT01378104|Antiviral Agents|antiviral agents|mesh-ancestor
6147662|NCT01378104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6147663|NCT01378104|Immunologic Factors|immunologic factors|mesh-ancestor
6147664|NCT01378104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147665|NCT01378117|Insulin Glargine|insulin glargine|mesh-list
6147666|NCT01378117|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6147667|NCT01378117|Insulin Lispro|insulin lispro|mesh-list
6147668|NCT01378117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6147669|NCT01378117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147670|NCT01378117|Incretins|incretins|mesh-ancestor
6147671|NCT01378117|Hormones|hormones|mesh-ancestor
6147672|NCT01378117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6147673|NCT01378117|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6147674|NCT01378117|Protease Inhibitors|protease inhibitors|mesh-ancestor
6147675|NCT01378117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6147676|NCT01378117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6147677|NCT01378273|Epoetin Alfa|epoetin alfa|mesh-list
6147678|NCT01378273|Hematinics|hematinics|mesh-ancestor
5549730|NCT04101812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5549731|NCT04101812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5549732|NCT04101812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5549733|NCT04101812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5549734|NCT04101812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549735|NCT04101500|Aminophylline|aminophylline|mesh-list
5549736|NCT04101500|Bromides|bromides|mesh-list
5549737|NCT04101500|Ipratropium|ipratropium|mesh-list
5549738|NCT04101500|Anticonvulsants|anticonvulsants|mesh-ancestor
5549739|NCT04101500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5549740|NCT04101500|Autonomic Agents|autonomic agents|mesh-ancestor
5549741|NCT04101500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5549742|NCT04101500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549743|NCT04101500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5549744|NCT04101500|Respiratory System Agents|respiratory system agents|mesh-ancestor
5549745|NCT04101500|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5549746|NCT04101500|Cholinergic Agents|cholinergic agents|mesh-ancestor
5549747|NCT04101500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5549748|NCT04101500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549749|NCT04101500|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5549750|NCT04101500|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5549751|NCT04101500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5549752|NCT04101500|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5549753|NCT04101500|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5549754|NCT04101500|Purinergic Agents|purinergic agents|mesh-ancestor
5549755|NCT04101500|Protective Agents|protective agents|mesh-ancestor
6147679|NCT01378299|Methyltestosterone|methyltestosterone|mesh-list
6147680|NCT01378299|Testosterone|testosterone|mesh-list
6147681|NCT01378299|Testosterone undecanoate|testosterone undecanoate|mesh-list
5549756|NCT04101474|Ketamine|ketamine|mesh-list
5549757|NCT04101474|Analgesics|analgesics|mesh-ancestor
5549758|NCT04101474|Sensory System Agents|sensory system agents|mesh-ancestor
5549759|NCT04101474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5549760|NCT04101474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549761|NCT04101474|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6147682|NCT01378299|Testosterone enanthate|testosterone enanthate|mesh-list
6147683|NCT01378299|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6147684|NCT01378299|Androgens|androgens|mesh-ancestor
6147685|NCT01378299|Hormones|hormones|mesh-ancestor
6667466|NCT01527422|Tubulin Modulators|tubulin modulators|mesh-ancestor
6147686|NCT01378299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6147687|NCT01378299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147688|NCT01378299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6147689|NCT01378299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6147690|NCT01378299|Anabolic Agents|anabolic agents|mesh-ancestor
6147691|NCT01378325|Phenylephrine|phenylephrine|mesh-list
6147692|NCT01378325|Oxymetazoline|oxymetazoline|mesh-list
6147693|NCT01378325|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6474896|NCT00516750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6474897|NCT00516750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6147694|NCT01378325|Mydriatics|mydriatics|mesh-ancestor
6147695|NCT01378325|Autonomic Agents|autonomic agents|mesh-ancestor
6147696|NCT01378325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6147697|NCT01378325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147698|NCT01378325|Sympathomimetics|sympathomimetics|mesh-ancestor
6147699|NCT01378325|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6147700|NCT01378325|Nasal Decongestants|nasal decongestants|mesh-ancestor
6147701|NCT01378325|Respiratory System Agents|respiratory system agents|mesh-ancestor
6147702|NCT01378325|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6147703|NCT01378325|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6147704|NCT01378325|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6474898|NCT00516750|Tubulin Modulators|tubulin modulators|mesh-ancestor
6474899|NCT00516750|Antimitotic Agents|antimitotic agents|mesh-ancestor
6474900|NCT00516750|Mitosis Modulators|mitosis modulators|mesh-ancestor
6474901|NCT00516802|Olaparib|olaparib|mesh-list
6474902|NCT00516802|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
6474903|NCT00516802|Dacarbazine|dacarbazine|mesh-list
6474904|NCT00516802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5549762|NCT04101474|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5549763|NCT04101474|Anesthetics, General|anesthetics, general|mesh-ancestor
5549764|NCT04101474|Anesthetics|anesthetics|mesh-ancestor
5549765|NCT04101474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5549766|NCT04101474|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5549767|NCT04101474|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5549768|NCT04101474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5549769|NCT04101474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549770|NCT04101682|Bupivacaine|bupivacaine|mesh-list
5549771|NCT04101682|Anesthetics, Local|anesthetics, local|mesh-ancestor
5549772|NCT04101682|Anesthetics|anesthetics|mesh-ancestor
5549773|NCT04101682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5549774|NCT04101682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549775|NCT04101682|Sensory System Agents|sensory system agents|mesh-ancestor
5549776|NCT04101682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5549777|NCT04101578|Cyclosporine|cyclosporine|mesh-list
5549778|NCT04101578|Mycophenolic Acid|mycophenolic acid|mesh-list
5549779|NCT04101578|Prednisone|prednisone|mesh-list
5549780|NCT04101578|Methylprednisolone|methylprednisolone|mesh-list
5549781|NCT04101578|Cyclophosphamide|cyclophosphamide|mesh-list
5549782|NCT04101578|Methotrexate|methotrexate|mesh-list
6474905|NCT00516802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474906|NCT00516802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6474907|NCT00516802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6474908|NCT00516802|Alkylating Agents|alkylating agents|mesh-ancestor
6474909|NCT00516828|Cytarabine|cytarabine|mesh-list
6147705|NCT01378325|Adrenergic Agents|adrenergic agents|mesh-ancestor
6147706|NCT01378325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6147707|NCT01378325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549783|NCT04101578|Azathioprine|azathioprine|mesh-list
5549784|NCT04101578|Bromides|bromides|mesh-list
5549785|NCT04101578|Tacrolimus|tacrolimus|mesh-list
5549786|NCT04101578|Cyclosporins|cyclosporins|mesh-list
5549787|NCT04101578|Immunosuppressive Agents|immunosuppressive agents|mesh-list
5549788|NCT04101578|Immunoglobulins|immunoglobulins|mesh-list
5549789|NCT04101578|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6147708|NCT01378325|Protective Agents|protective agents|mesh-ancestor
6147709|NCT01378377|Niacinamide|niacinamide|mesh-list
6147710|NCT01378377|Sirolimus|sirolimus|mesh-list
6147711|NCT01378377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6147712|NCT01378377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6147713|NCT01378377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5549790|NCT04101578|Antibodies|antibodies|mesh-list
5549791|NCT04101578|gamma-Globulins|gamma-globulins|mesh-list
5549792|NCT04101578|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5549793|NCT04101578|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
5549794|NCT04101578|Immunologic Factors|immunologic factors|mesh-ancestor
5549795|NCT04101578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147714|NCT01378377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6147715|NCT01378377|Antifungal Agents|antifungal agents|mesh-ancestor
6147716|NCT01378377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6147717|NCT01378377|Immunologic Factors|immunologic factors|mesh-ancestor
6147718|NCT01378377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147719|NCT01378377|Vitamin B Complex|vitamin b complex|mesh-ancestor
6474910|NCT00516828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6474911|NCT00516828|Antimetabolites|antimetabolites|mesh-ancestor
6474912|NCT00516828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474913|NCT00516828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6474914|NCT00516828|Antiviral Agents|antiviral agents|mesh-ancestor
6474915|NCT00516828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6474916|NCT00516828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6474917|NCT00516828|Immunologic Factors|immunologic factors|mesh-ancestor
6474918|NCT00516828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147720|NCT01378377|Vitamins|vitamins|mesh-ancestor
6147721|NCT01378377|Micronutrients|micronutrients|mesh-ancestor
6147722|NCT01378416|Decitabine|decitabine|mesh-list
6147723|NCT01378416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6147724|NCT01378416|Antimetabolites|antimetabolites|mesh-ancestor
6147725|NCT01378416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6147726|NCT01378416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6474919|NCT00516841|Volociximab|volociximab|mesh-list
6147727|NCT01378416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6147728|NCT01378429|Ciclesonide|ciclesonide|mesh-list
6147729|NCT01378429|Glucocorticoids|glucocorticoids|mesh-ancestor
6147730|NCT01378429|Hormones|hormones|mesh-ancestor
6147731|NCT01378429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6474920|NCT00516841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6474921|NCT00516841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6474922|NCT00516841|Growth Substances|growth substances|mesh-ancestor
6474923|NCT00516841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474924|NCT00516841|Growth Inhibitors|growth inhibitors|mesh-ancestor
6474925|NCT00516841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6474926|NCT00516854|Chlordiazepoxide|chlordiazepoxide|mesh-list
6474927|NCT00516854|Clidinium|clidinium|mesh-list
6474928|NCT00516854|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6474929|NCT00516854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6474930|NCT00516854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6474931|NCT00516854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474932|NCT00516854|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6474933|NCT00516854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6474934|NCT00516854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6474935|NCT00516854|GABA Modulators|gaba modulators|mesh-ancestor
6474936|NCT00516854|GABA Agents|gaba agents|mesh-ancestor
6474937|NCT00516854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6474938|NCT00516854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474939|NCT00516854|Parasympatholytics|parasympatholytics|mesh-ancestor
6474940|NCT00516854|Autonomic Agents|autonomic agents|mesh-ancestor
6474941|NCT00516854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6474942|NCT00516880|Rosiglitazone|rosiglitazone|mesh-list
6474943|NCT00516880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6474944|NCT00516880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474945|NCT00516945|Lamivudine|lamivudine|mesh-list
6474946|NCT00516945|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6474947|NCT00516945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6474948|NCT00516945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6474949|NCT00516945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474950|NCT00516945|Antiviral Agents|antiviral agents|mesh-ancestor
6147732|NCT01378429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474951|NCT00516945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6474952|NCT00516945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6474953|NCT00516945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6474954|NCT00516958|Levofloxacin|levofloxacin|mesh-list
6474955|NCT00516958|Ofloxacin|ofloxacin|mesh-list
6474956|NCT00516958|Sodium Hypochlorite|sodium hypochlorite|mesh-list
6474957|NCT00516958|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6474958|NCT00516958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6474959|NCT00516958|Renal Agents|renal agents|mesh-ancestor
6474960|NCT00516958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6147733|NCT01378429|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6147734|NCT01378520|Ketoconazole|ketoconazole|mesh-list
6147735|NCT01378520|Antifungal Agents|antifungal agents|mesh-ancestor
6147736|NCT01378520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6147737|NCT01378520|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6147738|NCT01378520|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6147739|NCT01378520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6147740|NCT01378520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6147741|NCT01378520|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6147742|NCT01378520|Hormone Antagonists|hormone antagonists|mesh-ancestor
6147743|NCT01378520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6147744|NCT01378520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147745|NCT01378520|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6147746|NCT01378858|Varenicline|varenicline|mesh-list
6147747|NCT01378858|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6147748|NCT01378858|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6147749|NCT01378858|Cholinergic Agents|cholinergic agents|mesh-ancestor
6147750|NCT01378858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6147751|NCT01378858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6147752|NCT01378858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147753|NCT01378962|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6147754|NCT01378962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6147755|NCT01378962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6147756|NCT01378962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6147757|NCT01378962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6147758|NCT01378975|Vemurafenib|vemurafenib|mesh-list
6147759|NCT01378975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6147760|NCT01378975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6147761|NCT01378975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6147762|NCT01378975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6147763|NCT01378988|Dexmedetomidine|dexmedetomidine|mesh-list
6147764|NCT01378988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6147765|NCT01378988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6147766|NCT01378988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147767|NCT01378988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6474961|NCT00516958|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5549796|NCT04101578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5549797|NCT04101578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5549798|NCT04101578|Alkylating Agents|alkylating agents|mesh-ancestor
5549799|NCT04101578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549800|NCT04101578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5549801|NCT04101578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5549802|NCT04101578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5549803|NCT04101578|Glucocorticoids|glucocorticoids|mesh-ancestor
5549804|NCT04101578|Hormones|hormones|mesh-ancestor
5549805|NCT04101578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5549806|NCT04101578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5549807|NCT04101578|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5549808|NCT04101578|Abortifacient Agents|abortifacient agents|mesh-ancestor
5549809|NCT04101578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5549810|NCT04101578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5549811|NCT04101578|Antimetabolites|antimetabolites|mesh-ancestor
5549812|NCT04101578|Dermatologic Agents|dermatologic agents|mesh-ancestor
5549813|NCT04101578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5549814|NCT04101578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5549815|NCT04101578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5549816|NCT04101578|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5549817|NCT04101578|Antifungal Agents|antifungal agents|mesh-ancestor
5549818|NCT04101578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5549819|NCT04101578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5549820|NCT04101578|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5549821|NCT04101578|Antitubercular Agents|antitubercular agents|mesh-ancestor
5549822|NCT04101578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5549823|NCT04101578|Antiemetics|antiemetics|mesh-ancestor
5549824|NCT04101578|Autonomic Agents|autonomic agents|mesh-ancestor
5549825|NCT04101578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5549826|NCT04101578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5549827|NCT04101578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5549828|NCT04101578|Protective Agents|protective agents|mesh-ancestor
6474962|NCT00516958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6147768|NCT01378988|Analgesics|analgesics|mesh-ancestor
5549829|NCT04101578|Anticonvulsants|anticonvulsants|mesh-ancestor
5549830|NCT04101578|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5549831|NCT04101578|Cholinergic Agents|cholinergic agents|mesh-ancestor
5549832|NCT04101578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5549833|NCT04101708|Amoxicillin|amoxicillin|mesh-list
5549834|NCT04101708|Clarithromycin|clarithromycin|mesh-list
5549835|NCT04101708|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
5549836|NCT04101708|Lansoprazole|lansoprazole|mesh-list
5549837|NCT04101708|Dexlansoprazole|dexlansoprazole|mesh-list
5549838|NCT04101708|Bismuth|bismuth|mesh-list
5549839|NCT04101708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5549840|NCT04101708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5549841|NCT04101708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5549842|NCT04101708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5549843|NCT04101708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549844|NCT04101708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5549845|NCT04101708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5549846|NCT04101708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6474963|NCT00516958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6474964|NCT00516958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474965|NCT00516958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6147769|NCT01378988|Sensory System Agents|sensory system agents|mesh-ancestor
6147770|NCT01378988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6147771|NCT01378988|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5549847|NCT04101708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5549848|NCT04101708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5549849|NCT04101708|Antacids|antacids|mesh-ancestor
5549850|NCT04101760|Sargramostim|sargramostim|mesh-list
5549851|NCT04101760|Lenograstim|lenograstim|mesh-list
5549852|NCT04101760|Immunologic Factors|immunologic factors|mesh-ancestor
5549853|NCT04101760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549854|NCT04101760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5549855|NCT04101370|Bosentan|bosentan|mesh-list
5549856|NCT04101370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6147772|NCT01378988|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6147773|NCT01378988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6147774|NCT01378988|Adrenergic Agents|adrenergic agents|mesh-ancestor
6147775|NCT01378988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6147776|NCT01378988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6147777|NCT01379183|Erythromycin|erythromycin|mesh-list
6667467|NCT01527422|Antimitotic Agents|antimitotic agents|mesh-ancestor
6667468|NCT01527422|Mitosis Modulators|mitosis modulators|mesh-ancestor
6667469|NCT01527448|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6667470|NCT01527448|Antidepressive Agents|antidepressive agents|mesh-ancestor
6667471|NCT01527448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6667472|NCT01527448|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6667473|NCT01527448|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6667474|NCT01527448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6667475|NCT01527448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147778|NCT01379183|Erythromycin Estolate|erythromycin estolate|mesh-list
6147779|NCT01379183|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
6147780|NCT01379183|Erythromycin stearate|erythromycin stearate|mesh-list
6147781|NCT01379183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6147782|NCT01379183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6147783|NCT01379183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6147784|NCT01379183|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6147785|NCT01379183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6474966|NCT00516958|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6474967|NCT00516958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6474968|NCT00516958|Disinfectants|disinfectants|mesh-ancestor
6474969|NCT00516971|Esomeprazole|esomeprazole|mesh-list
6474970|NCT00516971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6474971|NCT00516971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6474972|NCT00516971|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6474973|NCT00516971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6474974|NCT00516971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488705|NCT00585871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6488706|NCT00585871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488707|NCT00585871|Analgesics|analgesics|mesh-ancestor
6488708|NCT00585871|Sensory System Agents|sensory system agents|mesh-ancestor
6488709|NCT00585871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6488710|NCT00585871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6488711|NCT00585871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6667476|NCT01527474|Citalopram|citalopram|mesh-list
5549857|NCT04101370|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5602812|NCT04141696|Ketamine|ketamine|mesh-list
6474975|NCT00517062|Hormones|hormones|mesh-list
6474976|NCT00517062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6474977|NCT00517062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474978|NCT00517114|Rabeprazole|rabeprazole|mesh-list
6474979|NCT00517114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5549858|NCT04101370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549859|NCT04101357|Carboplatin|carboplatin|mesh-list
5549860|NCT04101357|Etoposide|etoposide|mesh-list
5549861|NCT04101357|Atezolizumab|atezolizumab|mesh-list
5549862|NCT04101357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5549863|NCT04101357|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5549864|NCT04101357|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5549865|NCT04101357|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5549866|NCT04101357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5549867|NCT04101357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549868|NCT04101227|Ondansetron|ondansetron|mesh-list
5549869|NCT04101227|Antiemetics|antiemetics|mesh-ancestor
5549870|NCT04101227|Autonomic Agents|autonomic agents|mesh-ancestor
5549871|NCT04101227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5549872|NCT04101227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549873|NCT04101227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5549874|NCT04101227|Antipruritics|antipruritics|mesh-ancestor
5549875|NCT04101227|Dermatologic Agents|dermatologic agents|mesh-ancestor
5549876|NCT04101227|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5549877|NCT04101227|Serotonin Agents|serotonin agents|mesh-ancestor
5549878|NCT04101227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5549879|NCT04101227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549880|NCT04101227|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5549881|NCT04101227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5549882|NCT04101227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5549883|NCT04101227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5549884|NCT04101227|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5549885|NCT04101136|Atorvastatin|atorvastatin|mesh-list
5549886|NCT04101136|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5549887|NCT04101136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5549888|NCT04101136|Antimetabolites|antimetabolites|mesh-ancestor
6474980|NCT00517114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6474981|NCT00517114|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6474982|NCT00517114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6474983|NCT00517114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474984|NCT00517179|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6474985|NCT00517179|Vasodilator Agents|vasodilator agents|mesh-ancestor
6474986|NCT00517179|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6474987|NCT00517179|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6474988|NCT00517179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6488712|NCT00586092|Bevacizumab|bevacizumab|mesh-list
5549889|NCT04101136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549890|NCT04101136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5549891|NCT04101136|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5549892|NCT04101136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5549893|NCT04101019|Lidocaine|lidocaine|mesh-list
5549894|NCT04101019|Anesthetics, Local|anesthetics, local|mesh-ancestor
5549895|NCT04101019|Anesthetics|anesthetics|mesh-ancestor
5549896|NCT04101019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5549897|NCT04101019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549898|NCT04101019|Sensory System Agents|sensory system agents|mesh-ancestor
5549899|NCT04101019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5549900|NCT04101019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5549901|NCT04101019|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5549902|NCT04101019|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5549903|NCT04101019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5549904|NCT04101019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549905|NCT04100759|Sildenafil Citrate|sildenafil citrate|mesh-list
5549906|NCT04100759|Vasodilator Agents|vasodilator agents|mesh-ancestor
5549907|NCT04100759|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5549908|NCT04100759|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5549909|NCT04100759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5549910|NCT04100759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549911|NCT04100759|Urological Agents|urological agents|mesh-ancestor
5602813|NCT04141696|Analgesics|analgesics|mesh-ancestor
5602814|NCT04141696|Sensory System Agents|sensory system agents|mesh-ancestor
5602815|NCT04141696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5602816|NCT04141696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6474989|NCT00517179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474990|NCT00517179|Urological Agents|urological agents|mesh-ancestor
6474991|NCT00517218|Oblimersen|oblimersen|mesh-list
6474992|NCT00517218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6474993|NCT00517257|Atorvastatin|atorvastatin|mesh-list
6474994|NCT00517257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6474995|NCT00517257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6474996|NCT00517257|Antimetabolites|antimetabolites|mesh-ancestor
6474997|NCT00517257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6474998|NCT00517257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6474999|NCT00517257|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6475000|NCT00517257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6475001|NCT00517270|Rabeprazole|rabeprazole|mesh-list
5549912|NCT04100772|Vaccines|vaccines|mesh-list
5549913|NCT04100772|Immunologic Factors|immunologic factors|mesh-ancestor
5549914|NCT04100772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475002|NCT00517270|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6475003|NCT00517270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6475004|NCT00517270|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6475005|NCT00517270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6475006|NCT00517270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6147786|NCT01379183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549915|NCT04100655|Molgramostim|molgramostim|mesh-list
5549916|NCT04100655|Estradiol|estradiol|mesh-list
5549917|NCT04100655|Sargramostim|sargramostim|mesh-list
5549918|NCT04100655|Estrogens|estrogens|mesh-ancestor
5549919|NCT04100655|Hormones|hormones|mesh-ancestor
5549920|NCT04100655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5549921|NCT04100655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147787|NCT01379508|Tenofovir|tenofovir|mesh-list
6147788|NCT01379508|Telbivudine|telbivudine|mesh-list
6475007|NCT00517283|Exenatide|exenatide|mesh-list
6475008|NCT00517283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6475009|NCT00517283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475010|NCT00517283|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6475011|NCT00517283|Incretins|incretins|mesh-ancestor
6475012|NCT00517283|Hormones|hormones|mesh-ancestor
6475013|NCT00517283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6475014|NCT00517309|Vaccines|vaccines|mesh-list
6475015|NCT00517309|Immunologic Factors|immunologic factors|mesh-ancestor
6475016|NCT00517309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475017|NCT00517322|Ramipril|ramipril|mesh-list
6147789|NCT01379508|Antiviral Agents|antiviral agents|mesh-ancestor
6147790|NCT01379508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6147791|NCT01379508|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6147792|NCT01379508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6147793|NCT01379508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6147794|NCT01379508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6147795|NCT01379508|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6147796|NCT01379508|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6147797|NCT01379521|Everolimus|everolimus|mesh-list
6147798|NCT01379521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6147799|NCT01379521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6147800|NCT01379521|Immunologic Factors|immunologic factors|mesh-ancestor
6147801|NCT01379521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475018|NCT00517322|Irbesartan|irbesartan|mesh-list
6475019|NCT00517322|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6475020|NCT00517322|Protease Inhibitors|protease inhibitors|mesh-ancestor
5549922|NCT04100655|Immunologic Factors|immunologic factors|mesh-ancestor
5549923|NCT04100655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5549924|NCT04101383|Insulin|insulin|mesh-list
5549925|NCT04101383|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5549926|NCT04101383|Insulin Glargine|insulin glargine|mesh-list
5549927|NCT04101383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5549928|NCT04101383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549929|NCT04100824|Nimodipine|nimodipine|mesh-list
5549930|NCT04100824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6147802|NCT01379573|Hydroxychloroquine|hydroxychloroquine|mesh-list
5549931|NCT04100824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5549932|NCT04100824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6475021|NCT00517322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6475022|NCT00517322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475023|NCT00517322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6475024|NCT00517322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6147803|NCT01379573|Antimalarials|antimalarials|mesh-ancestor
6147804|NCT01379573|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6147805|NCT01379573|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6147806|NCT01379573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6147807|NCT01379573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6147808|NCT01379573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6147809|NCT01379573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6147810|NCT01379664|Sevoflurane|sevoflurane|mesh-list
6147811|NCT01379664|Isoflurane|isoflurane|mesh-list
5549933|NCT04100824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549934|NCT04100824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5549935|NCT04100824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549936|NCT04100824|Vasodilator Agents|vasodilator agents|mesh-ancestor
5549937|NCT04100330|Cytarabine|cytarabine|mesh-list
5549938|NCT04100330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5549939|NCT04100330|Antimetabolites|antimetabolites|mesh-ancestor
5549940|NCT04100330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549941|NCT04100330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5549942|NCT04100330|Antiviral Agents|antiviral agents|mesh-ancestor
5549943|NCT04100330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5549944|NCT04100330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5549945|NCT04100330|Immunologic Factors|immunologic factors|mesh-ancestor
5549946|NCT04100330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549947|NCT04100473|Insulin|insulin|mesh-list
5549948|NCT04100473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5549949|NCT04100473|Insulin Lispro|insulin lispro|mesh-list
5549950|NCT04100473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5549951|NCT04100473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549952|NCT04100226|Vitamin D|vitamin d|mesh-list
5549953|NCT04100226|Cholecalciferol|cholecalciferol|mesh-list
5549954|NCT04100226|Calcium Carbonate|calcium carbonate|mesh-list
5549955|NCT04100226|Vitamins|vitamins|mesh-ancestor
5549956|NCT04100226|Micronutrients|micronutrients|mesh-ancestor
5549957|NCT04100226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475025|NCT00517322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6475026|NCT00517387|Quetiapine Fumarate|quetiapine fumarate|mesh-list
5549958|NCT04100226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5549959|NCT04100226|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6475027|NCT00517387|Antidepressive Agents|antidepressive agents|mesh-ancestor
6475028|NCT00517387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6475029|NCT00517387|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6475030|NCT00517387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6475031|NCT00517387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6475032|NCT00517387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475033|NCT00517426|Acetazolamide|acetazolamide|mesh-list
6475034|NCT00517426|Anticonvulsants|anticonvulsants|mesh-ancestor
6475035|NCT00517426|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6475036|NCT00517426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6475037|NCT00517426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475038|NCT00517426|Diuretics|diuretics|mesh-ancestor
6475039|NCT00517426|Natriuretic Agents|natriuretic agents|mesh-ancestor
6475040|NCT00517426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475041|NCT00517491|Lanreotide|lanreotide|mesh-list
6475042|NCT00517491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6475043|NCT00517504|Methylphenidate|methylphenidate|mesh-list
6147812|NCT01379664|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6147813|NCT01379664|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6147814|NCT01379664|Anesthetics, General|anesthetics, general|mesh-ancestor
6147815|NCT01379664|Anesthetics|anesthetics|mesh-ancestor
6147816|NCT01379664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6147817|NCT01379664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147818|NCT01379937|Vaccines|vaccines|mesh-list
6147819|NCT01379937|Immunologic Factors|immunologic factors|mesh-ancestor
6147820|NCT01379937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147821|NCT01380080|Efavirenz|efavirenz|mesh-list
6147822|NCT01380080|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6147823|NCT01380080|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6147824|NCT01380080|Rifampin|rifampin|mesh-list
6147825|NCT01380080|Isoniazid|isoniazid|mesh-list
6147826|NCT01380080|Pyrazinamide|pyrazinamide|mesh-list
6147827|NCT01380080|Ethambutol|ethambutol|mesh-list
6475044|NCT00517504|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6475045|NCT00517504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475046|NCT00517504|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6475047|NCT00517504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6475048|NCT00517504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6147828|NCT01380080|Isoniazid, pyrazinamide, rifampin drug combination|isoniazid, pyrazinamide, rifampin drug combination|mesh-list
6147829|NCT01380080|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6147830|NCT01380080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6147831|NCT01380080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6147832|NCT01380080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6147833|NCT01380080|Antiviral Agents|antiviral agents|mesh-ancestor
6667477|NCT01527474|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6667478|NCT01527474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6667479|NCT01527474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6147834|NCT01380080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6672438|NCT01556035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5549960|NCT04100226|Antacids|antacids|mesh-ancestor
5549961|NCT04100226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549962|NCT04100226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5549963|NCT04100447|Tranexamic Acid|tranexamic acid|mesh-list
5549964|NCT04100447|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5549965|NCT04100447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5549966|NCT04100447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549967|NCT04100447|Hemostatics|hemostatics|mesh-ancestor
5549968|NCT04100447|Coagulants|coagulants|mesh-ancestor
5549969|NCT04100434|Evolocumab|evolocumab|mesh-list
5549970|NCT04100434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5549971|NCT04100434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6147835|NCT01380080|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6147836|NCT01380080|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6147837|NCT01380080|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6147838|NCT01380080|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6147839|NCT01380080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6147840|NCT01380080|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6147841|NCT01380080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6147842|NCT01380080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6147843|NCT01380080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6147844|NCT01380080|Antitubercular Agents|antitubercular agents|mesh-ancestor
6147845|NCT01380080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6147846|NCT01380080|Leprostatic Agents|leprostatic agents|mesh-ancestor
6147847|NCT01380080|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6147848|NCT01380080|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6147849|NCT01380080|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6147850|NCT01380080|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6475049|NCT00517504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475050|NCT00517504|Dopamine Agents|dopamine agents|mesh-ancestor
6475051|NCT00517504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6147851|NCT01380080|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6147852|NCT01380080|Antimetabolites|antimetabolites|mesh-ancestor
6147853|NCT01380080|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6147854|NCT01380093|Naltrexone|naltrexone|mesh-list
6147855|NCT01380093|Morphine|morphine|mesh-list
6475052|NCT00517517|Hemagglutinins|hemagglutinins|mesh-list
6475053|NCT00517517|Agglutinins|agglutinins|mesh-ancestor
6475054|NCT00517517|Immunologic Factors|immunologic factors|mesh-ancestor
6475055|NCT00517517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475056|NCT00517582|Icatibant|icatibant|mesh-list
6475057|NCT00517582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6475058|NCT00517582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6475059|NCT00517582|Analgesics|analgesics|mesh-ancestor
6475060|NCT00517582|Sensory System Agents|sensory system agents|mesh-ancestor
6475061|NCT00517582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6147856|NCT01380093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6147857|NCT01380093|Narcotics|narcotics|mesh-ancestor
6147858|NCT01380093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6147859|NCT01380093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147860|NCT01380093|Analgesics|analgesics|mesh-ancestor
6147861|NCT01380093|Sensory System Agents|sensory system agents|mesh-ancestor
6147862|NCT01380093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6147863|NCT01380093|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6147864|NCT01380093|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6147865|NCT01380106|Lenalidomide|lenalidomide|mesh-list
6147866|NCT01380106|Immunologic Factors|immunologic factors|mesh-ancestor
6147867|NCT01380106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147868|NCT01380106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6147869|NCT01380106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6147870|NCT01380106|Growth Substances|growth substances|mesh-ancestor
6147871|NCT01380106|Growth Inhibitors|growth inhibitors|mesh-ancestor
6147872|NCT01380106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6147873|NCT01380184|Sirolimus|sirolimus|mesh-list
6147874|NCT01380184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6147875|NCT01380184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6147876|NCT01380184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6147877|NCT01380184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5549972|NCT04100434|Antimetabolites|antimetabolites|mesh-ancestor
5549973|NCT04100434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549974|NCT04100434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6475062|NCT00517582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475063|NCT00517582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6147878|NCT01380184|Antifungal Agents|antifungal agents|mesh-ancestor
6147879|NCT01380184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6147880|NCT01380184|Immunologic Factors|immunologic factors|mesh-ancestor
6147881|NCT01380184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147882|NCT01380197|Morphine|morphine|mesh-list
6147883|NCT01380197|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6147884|NCT01380197|Narcotics|narcotics|mesh-ancestor
6147885|NCT01380197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6147886|NCT01380197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147887|NCT01380197|Analgesics|analgesics|mesh-ancestor
6147888|NCT01380197|Sensory System Agents|sensory system agents|mesh-ancestor
6147889|NCT01380197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6147890|NCT01380327|Immunologic Factors|immunologic factors|mesh-list
6147891|NCT01380327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147892|NCT01380366|Hormones|hormones|mesh-list
6475064|NCT00517582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6475065|NCT00517582|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
6475066|NCT00517582|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
6475067|NCT00517582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475068|NCT00517582|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6475069|NCT00517582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6475070|NCT00517582|Immunologic Factors|immunologic factors|mesh-ancestor
6475071|NCT00517621|Paclitaxel|paclitaxel|mesh-list
6475072|NCT00517621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6475073|NCT00517621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6475074|NCT00517621|Tubulin Modulators|tubulin modulators|mesh-ancestor
6475075|NCT00517621|Antimitotic Agents|antimitotic agents|mesh-ancestor
6475076|NCT00517621|Mitosis Modulators|mitosis modulators|mesh-ancestor
6475077|NCT00517621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475078|NCT00517712|Arsenic Trioxide|arsenic trioxide|mesh-list
6475079|NCT00517712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6475080|NCT00517725|Carvedilol|carvedilol|mesh-list
6475081|NCT00517725|Nebivolol|nebivolol|mesh-list
6475082|NCT00517725|Bisoprolol|bisoprolol|mesh-list
5549975|NCT04099901|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5549976|NCT04099901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5549977|NCT04100135|Clopidogrel|clopidogrel|mesh-list
5549978|NCT04100135|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
5549979|NCT04100135|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5549980|NCT04100135|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6475083|NCT00517725|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6475084|NCT00517725|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6475085|NCT00517725|Adrenergic Agents|adrenergic agents|mesh-ancestor
6475086|NCT00517725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6475087|NCT00517725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475088|NCT00517725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475089|NCT00517725|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6475090|NCT00517725|Antioxidants|antioxidants|mesh-ancestor
6475091|NCT00517725|Protective Agents|protective agents|mesh-ancestor
6475092|NCT00517725|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6475093|NCT00517725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6475094|NCT00517725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6475095|NCT00517725|Vasodilator Agents|vasodilator agents|mesh-ancestor
6475096|NCT00517725|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6475097|NCT00517725|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6475098|NCT00517725|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6475099|NCT00517725|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6667480|NCT01527474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667481|NCT01527474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6667482|NCT01527474|Serotonin Agents|serotonin agents|mesh-ancestor
6667483|NCT01527474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549981|NCT04100135|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5549982|NCT04100135|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5549983|NCT04100135|Purinergic Agents|purinergic agents|mesh-ancestor
5549984|NCT04100135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5549985|NCT04100135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5549986|NCT04100135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549987|NCT04100083|Spironolactone|spironolactone|mesh-list
5549988|NCT04100083|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5549989|NCT04100083|Hormone Antagonists|hormone antagonists|mesh-ancestor
5549990|NCT04100083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5549991|NCT04100083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549992|NCT04100083|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5549993|NCT04100083|Diuretics|diuretics|mesh-ancestor
5549994|NCT04100083|Natriuretic Agents|natriuretic agents|mesh-ancestor
5549995|NCT04099849|Zinc|zinc|mesh-list
5549996|NCT04099849|Trace Elements|trace elements|mesh-ancestor
5549997|NCT04099849|Micronutrients|micronutrients|mesh-ancestor
5549998|NCT04099849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5549999|NCT04099771|Ketamine|ketamine|mesh-list
5550000|NCT04099771|Analgesics|analgesics|mesh-ancestor
5550001|NCT04099771|Sensory System Agents|sensory system agents|mesh-ancestor
5550002|NCT04099771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5550003|NCT04099771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550004|NCT04099771|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6205645|NCT02090075|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6475100|NCT00517725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6475101|NCT00517725|Sympatholytics|sympatholytics|mesh-ancestor
6475102|NCT00517725|Autonomic Agents|autonomic agents|mesh-ancestor
6475103|NCT00517725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6475104|NCT00517725|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6475105|NCT00517764|Citalopram|citalopram|mesh-list
6475106|NCT00517764|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6475107|NCT00517764|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6475108|NCT00517764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6475109|NCT00517764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475110|NCT00517764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6475111|NCT00517764|Serotonin Agents|serotonin agents|mesh-ancestor
6475112|NCT00517764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475113|NCT00517764|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6475114|NCT00517764|Antidepressive Agents|antidepressive agents|mesh-ancestor
6475115|NCT00517764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6475116|NCT00517803|Micronutrients|micronutrients|mesh-list
6475117|NCT00517803|Trace Elements|trace elements|mesh-list
6475118|NCT00517803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475119|NCT00517946|Cetirizine|cetirizine|mesh-list
6475120|NCT00517946|Pseudoephedrine|pseudoephedrine|mesh-list
6475121|NCT00517946|Ephedrine|ephedrine|mesh-list
6475122|NCT00517946|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6475123|NCT00517946|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6475124|NCT00517946|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6475125|NCT00517946|Histamine Antagonists|histamine antagonists|mesh-ancestor
6475126|NCT00517946|Histamine Agents|histamine agents|mesh-ancestor
6475127|NCT00517946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6475128|NCT00517946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475129|NCT00517946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475130|NCT00517946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6475131|NCT00517946|Autonomic Agents|autonomic agents|mesh-ancestor
6475132|NCT00517946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6475133|NCT00517946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6475134|NCT00517946|Respiratory System Agents|respiratory system agents|mesh-ancestor
6475135|NCT00517946|Nasal Decongestants|nasal decongestants|mesh-ancestor
6475136|NCT00517946|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6475137|NCT00517946|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6475138|NCT00517946|Sympathomimetics|sympathomimetics|mesh-ancestor
6475139|NCT00517946|Adrenergic Agents|adrenergic agents|mesh-ancestor
6475140|NCT00517985|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6475141|NCT00517985|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6475142|NCT00517985|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6475143|NCT00517985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6475144|NCT00517985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475145|NCT00517985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6475146|NCT00517985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475147|NCT00517985|Analgesics|analgesics|mesh-ancestor
6475148|NCT00517985|Sensory System Agents|sensory system agents|mesh-ancestor
6475149|NCT00517985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6475150|NCT00517985|Antidepressive Agents|antidepressive agents|mesh-ancestor
6475151|NCT00517985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6475152|NCT00517985|Dopamine Agents|dopamine agents|mesh-ancestor
6475153|NCT00518102|Becaplermin|becaplermin|mesh-list
6475154|NCT00518102|Anticoagulants|anticoagulants|mesh-ancestor
6475155|NCT00518102|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
6475156|NCT00518102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6475157|NCT00518102|Growth Substances|growth substances|mesh-ancestor
6475158|NCT00518102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475159|NCT00518141|Aspirin|aspirin|mesh-list
6475160|NCT00518141|Salicylic Acid|salicylic acid|mesh-list
6475161|NCT00518141|Salicylates|salicylates|mesh-list
6475162|NCT00518141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6475163|NCT00518141|Antifungal Agents|antifungal agents|mesh-ancestor
5550005|NCT04099771|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5550006|NCT04099771|Anesthetics, General|anesthetics, general|mesh-ancestor
5550007|NCT04099771|Anesthetics|anesthetics|mesh-ancestor
5550008|NCT04099771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5550009|NCT04099771|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5550010|NCT04099771|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5550011|NCT04099771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5550012|NCT04099771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550013|NCT04099563|Abrocitinib|abrocitinib|mesh-list
5550014|NCT04099563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5550015|NCT04099563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5550016|NCT04099563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550017|NCT04099641|Pembrolizumab|pembrolizumab|mesh-list
5550018|NCT04099641|Bavituximab|bavituximab|mesh-list
5550019|NCT04099641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5550020|NCT04099641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5550021|NCT04099732|Dabigatran|dabigatran|mesh-list
6475164|NCT00518141|Keratolytic Agents|keratolytic agents|mesh-ancestor
6475165|NCT00518141|Dermatologic Agents|dermatologic agents|mesh-ancestor
6475166|NCT00518141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6475167|NCT00518141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6475168|NCT00518141|Analgesics|analgesics|mesh-ancestor
6475169|NCT00518141|Sensory System Agents|sensory system agents|mesh-ancestor
6475170|NCT00518141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6475171|NCT00518141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475172|NCT00518141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6475173|NCT00518141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6475174|NCT00518141|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6475175|NCT00518141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6475176|NCT00518141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475177|NCT00518141|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6475178|NCT00518141|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6475179|NCT00518141|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6475180|NCT00518141|Antipyretics|antipyretics|mesh-ancestor
6475181|NCT00518193|Cetuximab|cetuximab|mesh-list
6475182|NCT00518193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6475183|NCT00518193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6475184|NCT00518232|Methylphenidate|methylphenidate|mesh-list
6475185|NCT00518232|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6475186|NCT00518232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475187|NCT00518232|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6475188|NCT00518232|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6147893|NCT01380366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6147894|NCT01380366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147895|NCT01380535|Methoxsalen|methoxsalen|mesh-list
6147896|NCT01380535|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6475189|NCT00518232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6475190|NCT00518232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475191|NCT00518232|Dopamine Agents|dopamine agents|mesh-ancestor
6475192|NCT00518232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6475193|NCT00518245|Enoxaparin|enoxaparin|mesh-list
6475194|NCT00518245|Anticoagulants|anticoagulants|mesh-ancestor
6475195|NCT00518245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6475196|NCT00518245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6475197|NCT00518245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475198|NCT00518271|Sirolimus|sirolimus|mesh-list
6475199|NCT00518271|Tacrolimus|tacrolimus|mesh-list
6475200|NCT00518271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6475201|NCT00518271|Immunologic Factors|immunologic factors|mesh-ancestor
5550022|NCT04099732|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5550023|NCT04099732|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5550024|NCT04099732|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5550025|NCT04099732|Antimetabolites|antimetabolites|mesh-ancestor
5550026|NCT04099732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475202|NCT00518271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475203|NCT00518271|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6475204|NCT00518271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6475205|NCT00518271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475206|NCT00518271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6475207|NCT00518271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6475208|NCT00518271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6475209|NCT00518271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6475210|NCT00518271|Antifungal Agents|antifungal agents|mesh-ancestor
6475211|NCT00518297|Raltegravir Potassium|raltegravir potassium|mesh-list
6475212|NCT00518297|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6475213|NCT00518297|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6475214|NCT00518297|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6475215|NCT00518297|Antiviral Agents|antiviral agents|mesh-ancestor
6147897|NCT01380535|Dermatologic Agents|dermatologic agents|mesh-ancestor
6147898|NCT01380691|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
6147899|NCT01380691|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6147900|NCT01380691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6147901|NCT01380691|Disinfectants|disinfectants|mesh-ancestor
6147902|NCT01380730|Evolocumab|evolocumab|mesh-list
6147903|NCT01380730|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6147904|NCT01380730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6147905|NCT01380730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6147906|NCT01380730|Antimetabolites|antimetabolites|mesh-ancestor
6147907|NCT01380730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6147908|NCT01380730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6147909|NCT01380730|Immunologic Factors|immunologic factors|mesh-ancestor
6147910|NCT01380730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147911|NCT01380743|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
6147912|NCT01380743|Antiviral Agents|antiviral agents|mesh-ancestor
6147913|NCT01380743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6475216|NCT00518297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6475217|NCT00518297|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6475218|NCT00518297|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6475219|NCT00518297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6475220|NCT00518297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475221|NCT00518297|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6475222|NCT00518297|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6475223|NCT00518297|Protease Inhibitors|protease inhibitors|mesh-ancestor
6475224|NCT00518375|Cyclosporine|cyclosporine|mesh-list
6475225|NCT00518375|Sirolimus|sirolimus|mesh-list
6475226|NCT00518375|Cyclosporins|cyclosporins|mesh-list
6475227|NCT00518375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6475228|NCT00518375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475229|NCT00518375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6475230|NCT00518375|Immunologic Factors|immunologic factors|mesh-ancestor
6475231|NCT00518375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475232|NCT00518375|Antifungal Agents|antifungal agents|mesh-ancestor
5550027|NCT04099732|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5550028|NCT04099732|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5550029|NCT04099732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5550030|NCT04099732|Antithrombins|antithrombins|mesh-ancestor
5550031|NCT04099732|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5550032|NCT04099732|Protease Inhibitors|protease inhibitors|mesh-ancestor
5550033|NCT04099732|Anticoagulants|anticoagulants|mesh-ancestor
6475233|NCT00518375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6475234|NCT00518375|Dermatologic Agents|dermatologic agents|mesh-ancestor
6147914|NCT01380743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6205646|NCT02090075|Protease Inhibitors|protease inhibitors|mesh-ancestor
6475235|NCT00518375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6475236|NCT00518375|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5550034|NCT04099667|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
6147915|NCT01380743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6147916|NCT01380782|Nintedanib|nintedanib|mesh-list
6147917|NCT01380782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6147918|NCT01380782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5550035|NCT04099667|Botulinum Toxins|botulinum toxins|mesh-list
5550036|NCT04099667|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5550037|NCT04099667|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5550038|NCT04099667|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5550039|NCT04099667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6147919|NCT01380782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6147920|NCT01380782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6147921|NCT01380990|Busulfan|busulfan|mesh-list
6475237|NCT00518375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6475238|NCT00518375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6475239|NCT00518375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6475240|NCT00518427|Insulin Glargine|insulin glargine|mesh-list
6475241|NCT00518427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6147922|NCT01380990|Alkylating Agents|alkylating agents|mesh-ancestor
6147923|NCT01380990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6147924|NCT01380990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6147925|NCT01380990|Immunologic Factors|immunologic factors|mesh-ancestor
6147926|NCT01380990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475242|NCT00518427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475243|NCT00518466|Topiramate|topiramate|mesh-list
6475244|NCT00518466|Phentermine|phentermine|mesh-list
6475245|NCT00518466|Anticonvulsants|anticonvulsants|mesh-ancestor
6475246|NCT00518466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6475247|NCT00518466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475248|NCT00518466|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6475249|NCT00518466|Appetite Depressants|appetite depressants|mesh-ancestor
6475250|NCT00518466|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6475251|NCT00518466|Sympathomimetics|sympathomimetics|mesh-ancestor
6475252|NCT00518466|Autonomic Agents|autonomic agents|mesh-ancestor
6475253|NCT00518466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6475254|NCT00518466|Adrenergic Agents|adrenergic agents|mesh-ancestor
6475255|NCT00518466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6475256|NCT00518466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475257|NCT00518479|Amlodipine|amlodipine|mesh-list
6475258|NCT00518479|Valsartan|valsartan|mesh-list
6475259|NCT00518479|Moxonidine|moxonidine|mesh-list
6475260|NCT00518479|Bendroflumethiazide|bendroflumethiazide|mesh-list
6147927|NCT01380990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6147928|NCT01380990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5550040|NCT04099667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550041|NCT04099667|Cholinergic Agents|cholinergic agents|mesh-ancestor
5550042|NCT04099667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5550043|NCT04099667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550044|NCT04099667|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5550045|NCT04099667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5550046|NCT04099667|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5550047|NCT04099407|Pirfenidone|pirfenidone|mesh-list
5550048|NCT04099407|Analgesics|analgesics|mesh-ancestor
5550049|NCT04099407|Sensory System Agents|sensory system agents|mesh-ancestor
5550050|NCT04099407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5550051|NCT04099407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550052|NCT04099407|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5550053|NCT04099407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5550054|NCT04099407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5550055|NCT04099407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5550056|NCT04099407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6147929|NCT01380990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6147930|NCT01381016|Hormones|hormones|mesh-list
6147931|NCT01381016|Estradiol|estradiol|mesh-list
6147932|NCT01381016|Progesterone|progesterone|mesh-list
6147933|NCT01381016|Estrogens|estrogens|mesh-list
6147934|NCT01381016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5550057|NCT04099238|Warfarin|warfarin|mesh-list
5550058|NCT04099238|Rivaroxaban|rivaroxaban|mesh-list
5550059|NCT04099238|Dabigatran|dabigatran|mesh-list
5550060|NCT04099238|Apixaban|apixaban|mesh-list
5550061|NCT04099238|Edoxaban|edoxaban|mesh-list
5550062|NCT04099238|Anticoagulants|anticoagulants|mesh-list
6475261|NCT00518479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5550063|NCT04099238|Acenocoumarol|acenocoumarol|mesh-list
5550064|NCT04099238|Phenindione|phenindione|mesh-list
5550065|NCT04099238|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5550066|NCT04099238|Antithrombins|antithrombins|mesh-ancestor
5550067|NCT04099238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5550068|NCT04099238|Protease Inhibitors|protease inhibitors|mesh-ancestor
5550069|NCT04099238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5550070|NCT04099238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550071|NCT04099069|Anesthetics|anesthetics|mesh-list
5550072|NCT04099069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6147935|NCT01381016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147936|NCT01381016|Progestins|progestins|mesh-ancestor
6147937|NCT01381120|Acetaminophen|acetaminophen|mesh-list
6147938|NCT01381120|Oxycodone|oxycodone|mesh-list
6147939|NCT01381120|Solifenacin Succinate|solifenacin succinate|mesh-list
6147940|NCT01381120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6147941|NCT01381120|Analgesics|analgesics|mesh-ancestor
6147942|NCT01381120|Sensory System Agents|sensory system agents|mesh-ancestor
6147943|NCT01381120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6147944|NCT01381120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147945|NCT01381120|Antipyretics|antipyretics|mesh-ancestor
6147946|NCT01381120|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6147947|NCT01381120|Narcotics|narcotics|mesh-ancestor
6147948|NCT01381120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6475262|NCT00518479|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6475263|NCT00518479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6475264|NCT00518479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475265|NCT00518479|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6475266|NCT00518479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475267|NCT00518479|Vasodilator Agents|vasodilator agents|mesh-ancestor
6475268|NCT00518479|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6475269|NCT00518479|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6475270|NCT00518479|Diuretics|diuretics|mesh-ancestor
6475271|NCT00518479|Natriuretic Agents|natriuretic agents|mesh-ancestor
6475272|NCT00518479|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6475273|NCT00518570|Levetiracetam|levetiracetam|mesh-list
5550073|NCT04099069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602817|NCT04141696|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5602818|NCT04141696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5602819|NCT04141696|Anesthetics, General|anesthetics, general|mesh-ancestor
5602820|NCT04141696|Anesthetics|anesthetics|mesh-ancestor
5602821|NCT04141696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5602822|NCT04141696|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5602823|NCT04141696|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5602824|NCT04141696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5602825|NCT04141696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602826|NCT04141696|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5602827|NCT04141696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5602828|NCT04141696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5602829|NCT04141696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5602830|NCT04141696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5602831|NCT04141696|GABA Modulators|gaba modulators|mesh-ancestor
5602832|NCT04141696|GABA Agents|gaba agents|mesh-ancestor
5602833|NCT04127968|Vitamin A|vitamin a|mesh-list
5602834|NCT04127968|Vitamins|vitamins|mesh-ancestor
5602835|NCT04127968|Micronutrients|micronutrients|mesh-ancestor
5602836|NCT04127968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602837|NCT04071626|Ertugliflozin|ertugliflozin|mesh-list
5602838|NCT04071626|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5602839|NCT04071626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602840|NCT04071626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5602841|NCT04071626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602842|NCT04056962|Tacrolimus|tacrolimus|mesh-list
5602843|NCT04056962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5602844|NCT04056962|Immunologic Factors|immunologic factors|mesh-ancestor
5602845|NCT04056962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602846|NCT04056962|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5602847|NCT04056962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5602848|NCT04056962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602849|NCT04051268|Vaccines|vaccines|mesh-list
5602850|NCT04051268|Immunologic Factors|immunologic factors|mesh-ancestor
5602851|NCT04051268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475274|NCT00518570|Anticonvulsants|anticonvulsants|mesh-ancestor
6147949|NCT01381120|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5602852|NCT04038515|Menthol|menthol|mesh-list
5602853|NCT04038515|Nicotine|nicotine|mesh-list
6475275|NCT00518570|Nootropic Agents|nootropic agents|mesh-ancestor
6475276|NCT00518583|Paclitaxel|paclitaxel|mesh-list
6475277|NCT00518583|Doxorubicin|doxorubicin|mesh-list
6475278|NCT00518583|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6475279|NCT00518583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6475280|NCT00518583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6475281|NCT00518583|Tubulin Modulators|tubulin modulators|mesh-ancestor
6147950|NCT01381120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6147951|NCT01381120|Cholinergic Agents|cholinergic agents|mesh-ancestor
6147952|NCT01381120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6147953|NCT01381120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6147954|NCT01381120|Urological Agents|urological agents|mesh-ancestor
6475282|NCT00518583|Antimitotic Agents|antimitotic agents|mesh-ancestor
6475283|NCT00518583|Mitosis Modulators|mitosis modulators|mesh-ancestor
6475284|NCT00518583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550074|NCT04099303|Vaccines|vaccines|mesh-list
5550075|NCT04099303|Immunologic Factors|immunologic factors|mesh-ancestor
5550076|NCT04099303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550077|NCT04098861|Timolol|timolol|mesh-list
5550078|NCT04098861|Latanoprost|latanoprost|mesh-list
5550079|NCT04098861|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6475285|NCT00518583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6475286|NCT00518583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6475287|NCT00518583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6475288|NCT00518583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5550080|NCT04098861|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5550081|NCT04098861|Adrenergic Agents|adrenergic agents|mesh-ancestor
5550082|NCT04098861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5550083|NCT04098861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550084|NCT04098861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550085|NCT04098861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5550086|NCT04098861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5550087|NCT04098861|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5550088|NCT04098861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5550089|NCT04098653|Cyclophosphamide|cyclophosphamide|mesh-list
5550090|NCT04098653|Busulfan|busulfan|mesh-list
5550091|NCT04098653|Decitabine|decitabine|mesh-list
5550092|NCT04098653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5550093|NCT04098653|Immunologic Factors|immunologic factors|mesh-ancestor
6147955|NCT01381406|Tiotropium Bromide|tiotropium bromide|mesh-list
6147956|NCT01381406|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6147957|NCT01381406|Autonomic Agents|autonomic agents|mesh-ancestor
6147958|NCT01381406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6147959|NCT01381406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147960|NCT01381406|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6147961|NCT01381406|Respiratory System Agents|respiratory system agents|mesh-ancestor
6475289|NCT00518635|Insulin|insulin|mesh-list
6475290|NCT00518635|Hormones|hormones|mesh-list
6475291|NCT00518635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6475292|NCT00518635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475293|NCT00518635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6488713|NCT00586092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6488714|NCT00586092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6488715|NCT00586092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6488716|NCT00586092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6488717|NCT00586092|Growth Substances|growth substances|mesh-ancestor
6488718|NCT00586092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488719|NCT00586092|Growth Inhibitors|growth inhibitors|mesh-ancestor
6488720|NCT00586118|Propofol|propofol|mesh-list
6488721|NCT00586118|Sevoflurane|sevoflurane|mesh-list
6488722|NCT00586118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6488723|NCT00586118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6488724|NCT00586118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488725|NCT00586118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6488726|NCT00586118|Anesthetics, General|anesthetics, general|mesh-ancestor
6488727|NCT00586118|Anesthetics|anesthetics|mesh-ancestor
6488728|NCT00586118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6475294|NCT00518895|Dacarbazine|dacarbazine|mesh-list
6475295|NCT00518895|Oblimersen|oblimersen|mesh-list
6475296|NCT00518895|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6475297|NCT00518895|Alkylating Agents|alkylating agents|mesh-ancestor
6475298|NCT00518895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475299|NCT00518895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6475300|NCT00518908|Sevoflurane|sevoflurane|mesh-list
6475301|NCT00518908|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6475302|NCT00518908|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6475303|NCT00518908|Anesthetics, General|anesthetics, general|mesh-ancestor
6475304|NCT00518908|Anesthetics|anesthetics|mesh-ancestor
6475305|NCT00518908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6475306|NCT00518908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475307|NCT00518947|Verapamil|verapamil|mesh-list
6475308|NCT00518947|Lithium Carbonate|lithium carbonate|mesh-list
6475309|NCT00518947|Antidepressive Agents|antidepressive agents|mesh-ancestor
6475310|NCT00518947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6475311|NCT00518947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6475312|NCT00518947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475313|NCT00518947|Antimanic Agents|antimanic agents|mesh-ancestor
6475314|NCT00518947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6475315|NCT00518947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6475316|NCT00518947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475317|NCT00518947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6475318|NCT00518947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6475319|NCT00518947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6475320|NCT00518947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6475321|NCT00518947|Vasodilator Agents|vasodilator agents|mesh-ancestor
6475322|NCT00519012|Sertraline|sertraline|mesh-list
6475323|NCT00519012|Paroxetine|paroxetine|mesh-list
6475324|NCT00519012|Antidepressive Agents|antidepressive agents|mesh-ancestor
6475325|NCT00519012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6475326|NCT00519012|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6475327|NCT00519012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6475328|NCT00519012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6475329|NCT00519012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475330|NCT00519012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6475331|NCT00519012|Serotonin Agents|serotonin agents|mesh-ancestor
6475332|NCT00519012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475333|NCT00519012|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6475334|NCT00519012|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6475335|NCT00519012|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6475336|NCT00519012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6475337|NCT00519051|Fluoxetine|fluoxetine|mesh-list
6475338|NCT00519051|Antidepressive Agents|antidepressive agents|mesh-list
6475339|NCT00519051|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6475340|NCT00519051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6147962|NCT01381406|Parasympatholytics|parasympatholytics|mesh-ancestor
6147963|NCT01381406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6147964|NCT01381406|Cholinergic Agents|cholinergic agents|mesh-ancestor
6147965|NCT01381406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6475341|NCT00519051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6147966|NCT01381406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6147967|NCT01381471|Fluticasone|fluticasone|mesh-list
6147968|NCT01381471|Xhance|xhance|mesh-list
6147969|NCT01381471|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6147970|NCT01381471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6147971|NCT01381471|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6147972|NCT01381471|Autonomic Agents|autonomic agents|mesh-ancestor
6147973|NCT01381471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6147974|NCT01381471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6147975|NCT01381471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6147976|NCT01381471|Respiratory System Agents|respiratory system agents|mesh-ancestor
6147977|NCT01381471|Dermatologic Agents|dermatologic agents|mesh-ancestor
6147978|NCT01381471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6147979|NCT01381471|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6147980|NCT01381471|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6147981|NCT01381471|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6147982|NCT01381471|Adrenergic Agents|adrenergic agents|mesh-ancestor
6147983|NCT01381471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6147984|NCT01381471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6147985|NCT01381549|Imipenem|imipenem|mesh-list
6147986|NCT01381549|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
6147987|NCT01381549|Cilastatin|cilastatin|mesh-list
6147988|NCT01381549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6147989|NCT01381549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6147990|NCT01381549|Protease Inhibitors|protease inhibitors|mesh-ancestor
6147991|NCT01381549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6147992|NCT01381549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6147993|NCT01381562|Meropenem|meropenem|mesh-list
6147994|NCT01381562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6147995|NCT01381562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6147996|NCT01381692|Sirolimus|sirolimus|mesh-list
5550094|NCT04098653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550095|NCT04098653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5550096|NCT04098653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6147997|NCT01381692|Dexamethasone|dexamethasone|mesh-list
6147998|NCT01381692|Dexamethasone acetate|dexamethasone acetate|mesh-list
6147999|NCT01381692|Rituximab|rituximab|mesh-list
6148000|NCT01381692|Bortezomib|bortezomib|mesh-list
6148001|NCT01381692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6148002|NCT01381692|Antibodies|antibodies|mesh-list
5550097|NCT04098653|Alkylating Agents|alkylating agents|mesh-ancestor
5550098|NCT04098653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550099|NCT04098653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5550100|NCT04098653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5550101|NCT04098653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5550102|NCT04098653|Antimetabolites|antimetabolites|mesh-ancestor
6148003|NCT01381692|Immunoglobulins|immunoglobulins|mesh-list
6148004|NCT01381692|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6148005|NCT01381692|BB 1101|bb 1101|mesh-list
6148006|NCT01381692|Immunologic Factors|immunologic factors|mesh-ancestor
6148007|NCT01381692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148008|NCT01381692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6148009|NCT01381692|Antiemetics|antiemetics|mesh-ancestor
6148010|NCT01381692|Autonomic Agents|autonomic agents|mesh-ancestor
6148011|NCT01381692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6148012|NCT01381692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6148013|NCT01381692|Glucocorticoids|glucocorticoids|mesh-ancestor
6148014|NCT01381692|Hormones|hormones|mesh-ancestor
6148015|NCT01381692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5550103|NCT04098653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5550104|NCT04098874|Bupropion|bupropion|mesh-list
5550105|NCT04098874|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5550106|NCT04098874|Antidepressive Agents|antidepressive agents|mesh-ancestor
5550107|NCT04098874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5550108|NCT04098874|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5550109|NCT04098874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6475342|NCT00519051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475343|NCT00519051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6475344|NCT00519051|Serotonin Agents|serotonin agents|mesh-ancestor
6475345|NCT00519051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475346|NCT00519051|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6475347|NCT00519051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6475348|NCT00519051|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6475349|NCT00519051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6475350|NCT00519051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6475351|NCT00519116|Sirolimus|sirolimus|mesh-list
6667484|NCT01527474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6667485|NCT01527474|Antidepressive Agents|antidepressive agents|mesh-ancestor
6667486|NCT01527474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6667487|NCT01527539|Insulin Aspart|insulin aspart|mesh-list
6667488|NCT01527539|Biphasic Insulins|biphasic insulins|mesh-list
6667489|NCT01527539|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6667490|NCT01527539|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6667491|NCT01527539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667492|NCT01527552|Insulin Aspart|insulin aspart|mesh-list
6667493|NCT01527552|Biphasic Insulins|biphasic insulins|mesh-list
6667494|NCT01527552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6667495|NCT01527552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667496|NCT01527565|Insulin Aspart|insulin aspart|mesh-list
6667497|NCT01527565|Biphasic Insulins|biphasic insulins|mesh-list
6667498|NCT01527565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6667499|NCT01527565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667500|NCT01527591|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6148016|NCT01381692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6148017|NCT01381692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6148018|NCT01381692|Protease Inhibitors|protease inhibitors|mesh-ancestor
6148019|NCT01381692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6667501|NCT01527591|Immunologic Factors|immunologic factors|mesh-ancestor
6667502|NCT01527591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667503|NCT01527630|Insulin Aspart|insulin aspart|mesh-list
6667504|NCT01527630|Biphasic Insulins|biphasic insulins|mesh-list
6667505|NCT01527630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6667506|NCT01527630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550110|NCT04098874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6148020|NCT01381692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6148021|NCT01381692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6148022|NCT01381692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6148023|NCT01381692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6148024|NCT01381692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5550111|NCT04098874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550112|NCT04098874|Dopamine Agents|dopamine agents|mesh-ancestor
5550113|NCT04098874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5550114|NCT04098874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550115|NCT04098874|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5550116|NCT04098874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5550117|NCT04098874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5550118|NCT04098718|Prednisolone|prednisolone|mesh-list
5550119|NCT04098718|Benralizumab|benralizumab|mesh-list
6148025|NCT01381692|Antifungal Agents|antifungal agents|mesh-ancestor
6148026|NCT01381692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6148027|NCT01381718|Modafinil|modafinil|mesh-list
6148028|NCT01381718|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6148029|NCT01381718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148030|NCT01381718|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6148031|NCT01381718|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6148032|NCT01381718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6148033|NCT01381718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6148034|NCT01381861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5550120|NCT04098718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5550121|NCT04098718|Glucocorticoids|glucocorticoids|mesh-ancestor
5550122|NCT04098718|Hormones|hormones|mesh-ancestor
6475352|NCT00519116|Tacrolimus|tacrolimus|mesh-list
6475353|NCT00519116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6475354|NCT00519116|Immunologic Factors|immunologic factors|mesh-ancestor
6475355|NCT00519116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475356|NCT00519116|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6475357|NCT00519116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6475358|NCT00519116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475359|NCT00519116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6475360|NCT00519116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5550123|NCT04098718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6148035|NCT01381861|Immunologic Factors|immunologic factors|mesh-ancestor
6148036|NCT01381861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148037|NCT01381874|Prednisone|prednisone|mesh-list
6148038|NCT01381874|Prednisolone|prednisolone|mesh-list
6148039|NCT01381874|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6148040|NCT01381874|Methylprednisolone|methylprednisolone|mesh-list
5550124|NCT04098718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550125|NCT04098718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5550126|NCT04098718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5550127|NCT04098718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5550128|NCT04098718|Respiratory System Agents|respiratory system agents|mesh-ancestor
5550129|NCT04098796|Antibodies|antibodies|mesh-list
5550130|NCT04098796|Immunologic Factors|immunologic factors|mesh-ancestor
5550131|NCT04098796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550132|NCT04098432|Nivolumab|nivolumab|mesh-list
5550133|NCT04098432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5550134|NCT04098432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5550135|NCT04098432|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5602854|NCT04038515|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6148041|NCT01381874|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6148042|NCT01381874|Prednisolone acetate|prednisolone acetate|mesh-list
6148043|NCT01381874|Exemestane|exemestane|mesh-list
6148044|NCT01381874|Abiraterone Acetate|abiraterone acetate|mesh-list
6148045|NCT01381874|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6148046|NCT01381874|Prednisolone phosphate|prednisolone phosphate|mesh-list
6148047|NCT01381874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6148048|NCT01381874|Glucocorticoids|glucocorticoids|mesh-ancestor
6148049|NCT01381874|Hormones|hormones|mesh-ancestor
6148050|NCT01381874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6667507|NCT01527643|Insulin Aspart|insulin aspart|mesh-list
6148051|NCT01381874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148052|NCT01381874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6148053|NCT01381874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6148054|NCT01381874|Antiemetics|antiemetics|mesh-ancestor
6148055|NCT01381874|Autonomic Agents|autonomic agents|mesh-ancestor
6148056|NCT01381874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6148057|NCT01381874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6148058|NCT01381874|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6148059|NCT01381874|Protective Agents|protective agents|mesh-ancestor
6148060|NCT01381874|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6148061|NCT01381874|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6148062|NCT01381874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6148063|NCT01381874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6148064|NCT01381874|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6148065|NCT01381874|Hormone Antagonists|hormone antagonists|mesh-ancestor
6148066|NCT01381874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6148067|NCT01381900|Metformin|metformin|mesh-list
6148068|NCT01381900|Canagliflozin|canagliflozin|mesh-list
6148069|NCT01381900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6148070|NCT01381900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148071|NCT01381900|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6148072|NCT01381900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6148073|NCT01381926|Exenatide|exenatide|mesh-list
6148074|NCT01381926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6148075|NCT01381926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148076|NCT01381926|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6148077|NCT01381926|Incretins|incretins|mesh-ancestor
6148078|NCT01381926|Hormones|hormones|mesh-ancestor
6148079|NCT01381926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6148080|NCT01382225|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6148081|NCT01382225|Hyaluronic Acid|hyaluronic acid|mesh-list
6148082|NCT01382225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6148083|NCT01382225|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6148084|NCT01382225|Immunologic Factors|immunologic factors|mesh-ancestor
6148085|NCT01382225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148086|NCT01382225|Viscosupplements|viscosupplements|mesh-ancestor
6148087|NCT01382225|Protective Agents|protective agents|mesh-ancestor
6148088|NCT01382303|Pentoxifylline|pentoxifylline|mesh-list
6148089|NCT01382303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6148090|NCT01382303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6148091|NCT01382303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6148092|NCT01382303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5550136|NCT04098432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550137|NCT04098250|Erenumab|erenumab|mesh-list
5550138|NCT04098250|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
5550139|NCT04098250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550140|NCT04098250|Analgesics|analgesics|mesh-ancestor
5550141|NCT04098250|Sensory System Agents|sensory system agents|mesh-ancestor
5550142|NCT04098250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5550143|NCT04098250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550144|NCT04098302|Dutasteride|dutasteride|mesh-list
5550145|NCT04098302|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
5550146|NCT04098302|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5550147|NCT04098302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5550148|NCT04098302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550149|NCT04098302|Hormone Antagonists|hormone antagonists|mesh-ancestor
5550150|NCT04098302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5550151|NCT04098302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550152|NCT04098081|Gemcitabine|gemcitabine|mesh-list
5550153|NCT04098081|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
5550154|NCT04098081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5550155|NCT04098081|Antimetabolites|antimetabolites|mesh-ancestor
5550156|NCT04098081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550157|NCT04098081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5550158|NCT04098081|Antiviral Agents|antiviral agents|mesh-ancestor
5550159|NCT04098081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5550160|NCT04098081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5550161|NCT04098081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5550162|NCT04098081|Immunologic Factors|immunologic factors|mesh-ancestor
5550163|NCT04098081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550164|NCT04098068|Pembrolizumab|pembrolizumab|mesh-list
6148093|NCT01382303|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6148094|NCT01382303|Protective Agents|protective agents|mesh-ancestor
6148095|NCT01382303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148096|NCT01382303|Vasodilator Agents|vasodilator agents|mesh-ancestor
6148097|NCT01382303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6148098|NCT01382303|Antioxidants|antioxidants|mesh-ancestor
6148099|NCT01382446|Chlorhexidine|chlorhexidine|mesh-list
6148100|NCT01382446|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6148101|NCT01382446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6148102|NCT01382446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6148103|NCT01382446|Disinfectants|disinfectants|mesh-ancestor
6148104|NCT01382446|Dermatologic Agents|dermatologic agents|mesh-ancestor
6148105|NCT01382940|Acetaminophen|acetaminophen|mesh-list
6148106|NCT01382940|Methylprednisolone|methylprednisolone|mesh-list
6148107|NCT01382940|Rituximab|rituximab|mesh-list
5550165|NCT04098068|Antibodies|antibodies|mesh-list
5550166|NCT04098068|Immunologic Factors|immunologic factors|mesh-ancestor
5550167|NCT04098068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550168|NCT04098068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5550169|NCT04098068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5550170|NCT04098003|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5550171|NCT04098003|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5550172|NCT04098003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5550173|NCT04098003|Antimetabolites|antimetabolites|mesh-ancestor
5550174|NCT04098003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6148108|NCT01382940|Methotrexate|methotrexate|mesh-list
6148109|NCT01382940|Histamine Antagonists|histamine antagonists|mesh-list
6148110|NCT01382940|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
6148111|NCT01382940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6148112|NCT01382940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6475361|NCT00519116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6475362|NCT00519116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6475363|NCT00519116|Antifungal Agents|antifungal agents|mesh-ancestor
6475364|NCT00519181|Valproic Acid|valproic acid|mesh-list
6475365|NCT00519181|Anticonvulsants|anticonvulsants|mesh-ancestor
6475366|NCT00519181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6475367|NCT00519181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475368|NCT00519181|GABA Agents|gaba agents|mesh-ancestor
6475369|NCT00519181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6475370|NCT00519181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475371|NCT00519181|Antimanic Agents|antimanic agents|mesh-ancestor
6475372|NCT00519181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6475373|NCT00519181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6475374|NCT00519181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6475375|NCT00519207|Lidocaine|lidocaine|mesh-list
6475376|NCT00519207|Anesthetics, Local|anesthetics, local|mesh-ancestor
6475377|NCT00519207|Anesthetics|anesthetics|mesh-ancestor
6475378|NCT00519207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6475379|NCT00519207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475380|NCT00519207|Sensory System Agents|sensory system agents|mesh-ancestor
6475381|NCT00519207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6475382|NCT00519207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6148113|NCT01382940|Immunologic Factors|immunologic factors|mesh-ancestor
6148114|NCT01382940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148115|NCT01382940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6205647|NCT02090075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6475383|NCT00519207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6475384|NCT00519207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6148116|NCT01382940|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6148117|NCT01382940|Abortifacient Agents|abortifacient agents|mesh-ancestor
6148118|NCT01382940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6148119|NCT01382940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6148120|NCT01382940|Antimetabolites|antimetabolites|mesh-ancestor
6148121|NCT01382940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6148122|NCT01382940|Dermatologic Agents|dermatologic agents|mesh-ancestor
6148123|NCT01382940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6148124|NCT01382940|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6148125|NCT01382940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6148126|NCT01382940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6148127|NCT01382940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6148128|NCT01382940|Analgesics|analgesics|mesh-ancestor
6148129|NCT01382940|Sensory System Agents|sensory system agents|mesh-ancestor
6148130|NCT01382940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6148131|NCT01382940|Antipyretics|antipyretics|mesh-ancestor
6148132|NCT01382940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6148133|NCT01382940|Antiemetics|antiemetics|mesh-ancestor
6148134|NCT01382940|Autonomic Agents|autonomic agents|mesh-ancestor
6148135|NCT01382940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6148136|NCT01382940|Glucocorticoids|glucocorticoids|mesh-ancestor
6148137|NCT01382940|Hormones|hormones|mesh-ancestor
6148138|NCT01382940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6148139|NCT01382940|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6148140|NCT01382940|Protective Agents|protective agents|mesh-ancestor
6148141|NCT01382940|Histamine Agents|histamine agents|mesh-ancestor
6148142|NCT01382940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6205648|NCT02090075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205649|NCT02090374|Vitamin D|vitamin d|mesh-list
6205650|NCT02090374|Poly ICLC|poly iclc|mesh-list
6205651|NCT02090374|Vitamins|vitamins|mesh-ancestor
6205652|NCT02090374|Micronutrients|micronutrients|mesh-ancestor
6205653|NCT02090374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205654|NCT02090374|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6205655|NCT02090374|Interferon Inducers|interferon inducers|mesh-ancestor
6205656|NCT02090374|Immunologic Factors|immunologic factors|mesh-ancestor
5550175|NCT04098003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5550176|NCT04098003|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5550177|NCT04098003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5550178|NCT04097847|Clodronic Acid|clodronic acid|mesh-list
5550179|NCT04097847|Tocopherols|tocopherols|mesh-list
5550180|NCT04097847|Vitamin E|vitamin e|mesh-list
5550181|NCT04097847|Tocotrienols|tocotrienols|mesh-list
5550182|NCT04097847|alpha-Tocopherol|alpha-tocopherol|mesh-list
5550183|NCT04097847|Pentoxifylline|pentoxifylline|mesh-list
5550184|NCT04097847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5550185|NCT04097847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5550186|NCT04097847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205657|NCT02090413|Aspirin|aspirin|mesh-list
6205658|NCT02090413|Dimethyl Fumarate|dimethyl fumarate|mesh-list
5550187|NCT04097847|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5602855|NCT04038515|Autonomic Agents|autonomic agents|mesh-ancestor
6148143|NCT01383096|Artefenomel|artefenomel|mesh-list
6148144|NCT01383096|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6148145|NCT01383096|Antimalarials|antimalarials|mesh-ancestor
6148146|NCT01383096|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6148147|NCT01383096|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6148148|NCT01383096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6148149|NCT01383161|Curcumin|curcumin|mesh-list
6148150|NCT01383161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6148151|NCT01383161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6148152|NCT01383161|Analgesics|analgesics|mesh-ancestor
6475385|NCT00519207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6475386|NCT00519207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475387|NCT00519246|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
6475388|NCT00519246|Analgesics, Opioid|analgesics, opioid|mesh-list
6475389|NCT00519246|Narcotics|narcotics|mesh-ancestor
6475390|NCT00519246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6475391|NCT00519246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475392|NCT00519246|Analgesics|analgesics|mesh-ancestor
6475393|NCT00519246|Sensory System Agents|sensory system agents|mesh-ancestor
6475394|NCT00519246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6475395|NCT00519246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6475396|NCT00519246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6475397|NCT00519246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6475398|NCT00519259|Lobeline|lobeline|mesh-list
6475399|NCT00519259|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6475400|NCT00519259|Autonomic Agents|autonomic agents|mesh-ancestor
6475401|NCT00519259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6475402|NCT00519259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475403|NCT00519259|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5550188|NCT04097847|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5550189|NCT04097847|Protective Agents|protective agents|mesh-ancestor
5550190|NCT04097847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550191|NCT04097847|Vasodilator Agents|vasodilator agents|mesh-ancestor
5550192|NCT04097847|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5550193|NCT04097847|Antioxidants|antioxidants|mesh-ancestor
6475404|NCT00519259|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6475405|NCT00519259|Cholinergic Agents|cholinergic agents|mesh-ancestor
6475406|NCT00519259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6488729|NCT00586118|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5550194|NCT04097847|Vitamins|vitamins|mesh-ancestor
5550195|NCT04097847|Micronutrients|micronutrients|mesh-ancestor
5550196|NCT04097847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5550197|NCT04097899|Anti-Infective Agents|anti-infective agents|mesh-list
5550198|NCT04097899|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5550199|NCT04097925|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
5550200|NCT04097925|Antiviral Agents|antiviral agents|mesh-ancestor
5550201|NCT04097925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6148153|NCT01383161|Sensory System Agents|sensory system agents|mesh-ancestor
6148154|NCT01383161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6148155|NCT01383161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148156|NCT01383161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6148157|NCT01383161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5550202|NCT04097925|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5550203|NCT04097925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5550204|NCT04097925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5550205|NCT04097925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550206|NCT04097925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5550207|NCT04097925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5550208|NCT04097613|Povidone-Iodine|povidone-iodine|mesh-list
5550209|NCT04097613|Budesonide|budesonide|mesh-list
5550210|NCT04097613|Povidone|povidone|mesh-list
5550211|NCT04097613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5550212|NCT04097613|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5550213|NCT04097613|Autonomic Agents|autonomic agents|mesh-ancestor
5550214|NCT04097613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6148158|NCT01383161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6148159|NCT01383161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6148160|NCT01383161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6148161|NCT01383200|Lidocaine|lidocaine|mesh-list
6148162|NCT01383200|Tetracaine|tetracaine|mesh-list
6148163|NCT01383200|Anesthetics, Local|anesthetics, local|mesh-ancestor
6148164|NCT01383200|Anesthetics|anesthetics|mesh-ancestor
6148165|NCT01383200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6148166|NCT01383200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148167|NCT01383200|Sensory System Agents|sensory system agents|mesh-ancestor
6148168|NCT01383200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6148169|NCT01383200|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6148170|NCT01383200|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6148171|NCT01383200|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6148172|NCT01383200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6475407|NCT00519259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475408|NCT00519259|Respiratory System Agents|respiratory system agents|mesh-ancestor
6475409|NCT00519298|Donepezil|donepezil|mesh-list
6475410|NCT00519298|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6475411|NCT00519298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6475412|NCT00519298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475413|NCT00519298|Cholinergic Agents|cholinergic agents|mesh-ancestor
6475414|NCT00519298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6475415|NCT00519298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475416|NCT00519298|Nootropic Agents|nootropic agents|mesh-ancestor
6475417|NCT00519324|Everolimus|everolimus|mesh-list
5550215|NCT04097613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550216|NCT04097613|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5550217|NCT04097613|Respiratory System Agents|respiratory system agents|mesh-ancestor
6475418|NCT00519324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6475419|NCT00519324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6475420|NCT00519324|Immunologic Factors|immunologic factors|mesh-ancestor
6475421|NCT00519324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667508|NCT01527643|Biphasic Insulins|biphasic insulins|mesh-list
6667509|NCT01527643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6667510|NCT01527643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148173|NCT01383200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6148174|NCT01383356|Metformin|metformin|mesh-list
6148175|NCT01383356|Linagliptin|linagliptin|mesh-list
6148176|NCT01383356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6148177|NCT01383356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148178|NCT01383356|Incretins|incretins|mesh-ancestor
6148179|NCT01383356|Hormones|hormones|mesh-ancestor
6148180|NCT01383356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6148181|NCT01383356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6148182|NCT01383356|Protease Inhibitors|protease inhibitors|mesh-ancestor
6148183|NCT01383356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6475422|NCT00519337|Ascorbic Acid|ascorbic acid|mesh-list
6475423|NCT00519337|Vitamins|vitamins|mesh-ancestor
6475424|NCT00519337|Micronutrients|micronutrients|mesh-ancestor
6475425|NCT00519337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475426|NCT00519337|Antioxidants|antioxidants|mesh-ancestor
6475427|NCT00519337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475428|NCT00519337|Protective Agents|protective agents|mesh-ancestor
6475429|NCT00519363|Atorvastatin|atorvastatin|mesh-list
6475430|NCT00519363|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6475431|NCT00519363|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6475432|NCT00519363|Antimetabolites|antimetabolites|mesh-ancestor
6475433|NCT00519363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475434|NCT00519363|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6475435|NCT00519363|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6475436|NCT00519363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6475437|NCT00519467|Artesunate|artesunate|mesh-list
6475438|NCT00519467|Dapsone|dapsone|mesh-list
6475439|NCT00519467|Chlorproguanil|chlorproguanil|mesh-list
6475440|NCT00519467|Antimalarials|antimalarials|mesh-ancestor
6475441|NCT00519467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6475442|NCT00519467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6475443|NCT00519467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6475444|NCT00519467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6475445|NCT00519467|Antiviral Agents|antiviral agents|mesh-ancestor
6475446|NCT00519467|Schistosomicides|schistosomicides|mesh-ancestor
6475447|NCT00519467|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6475448|NCT00519467|Anthelmintics|anthelmintics|mesh-ancestor
6475449|NCT00519467|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6475450|NCT00519467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5550218|NCT04097613|Glucocorticoids|glucocorticoids|mesh-ancestor
6475451|NCT00519467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475452|NCT00519467|Leprostatic Agents|leprostatic agents|mesh-ancestor
6475453|NCT00519467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6475454|NCT00519480|Metformin|metformin|mesh-list
6475455|NCT00519480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6475456|NCT00519480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475457|NCT00519519|Omeprazole|omeprazole|mesh-list
6667511|NCT01527656|Insulin Aspart|insulin aspart|mesh-list
5550219|NCT04097613|Hormones|hormones|mesh-ancestor
6475458|NCT00519519|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6667512|NCT01527656|Biphasic Insulins|biphasic insulins|mesh-list
6475459|NCT00519519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6475460|NCT00519519|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6475461|NCT00519519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6475462|NCT00519519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475463|NCT00519675|Alitretinoin|alitretinoin|mesh-list
6475464|NCT00519675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6475465|NCT00519675|Dermatologic Agents|dermatologic agents|mesh-ancestor
6475466|NCT00519688|Thalidomide|thalidomide|mesh-list
5550220|NCT04097613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5550221|NCT04097613|Plasma Substitutes|plasma substitutes|mesh-ancestor
5550222|NCT04097613|Blood Substitutes|blood substitutes|mesh-ancestor
5550223|NCT04097613|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5550224|NCT04097613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5550225|NCT04097574|Menthol|menthol|mesh-list
5550226|NCT04097574|Antipruritics|antipruritics|mesh-ancestor
5550227|NCT04097574|Dermatologic Agents|dermatologic agents|mesh-ancestor
5550228|NCT04097444|Leucovorin|leucovorin|mesh-list
5550229|NCT04097444|Bevacizumab|bevacizumab|mesh-list
5550230|NCT04097444|Fluorouracil|fluorouracil|mesh-list
5550231|NCT04097444|Capecitabine|capecitabine|mesh-list
5550232|NCT04097444|Oxaliplatin|oxaliplatin|mesh-list
5550233|NCT04097444|Irinotecan|irinotecan|mesh-list
5550234|NCT04097444|Calcium|calcium|mesh-list
6667513|NCT01527656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6667514|NCT01527656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667515|NCT01527669|Lovastatin|lovastatin|mesh-list
6667516|NCT01527669|L 647318|l 647318|mesh-list
6148184|NCT01383356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6148185|NCT01383486|Naproxen|naproxen|mesh-list
6667517|NCT01527669|Dihydromevinolin|dihydromevinolin|mesh-list
6667518|NCT01527669|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6667519|NCT01527669|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6667520|NCT01527669|Antimetabolites|antimetabolites|mesh-ancestor
6667521|NCT01527669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667522|NCT01527669|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6667523|NCT01527669|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6667524|NCT01527669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6667525|NCT01527734|Tetrodotoxin|tetrodotoxin|mesh-list
6667526|NCT01527734|Anesthetics, Local|anesthetics, local|mesh-ancestor
6667527|NCT01527734|Anesthetics|anesthetics|mesh-ancestor
6667528|NCT01527734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6667529|NCT01527734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667530|NCT01527734|Sensory System Agents|sensory system agents|mesh-ancestor
6667531|NCT01527734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6667532|NCT01527734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6667533|NCT01527734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6667534|NCT01527734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550235|NCT04097444|Levoleucovorin|levoleucovorin|mesh-list
5550236|NCT04097444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5550237|NCT04097444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5550238|NCT04097444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5550239|NCT04097444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5550240|NCT04097444|Growth Substances|growth substances|mesh-ancestor
6148186|NCT01383486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6148187|NCT01383486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5550241|NCT04097444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550242|NCT04097444|Growth Inhibitors|growth inhibitors|mesh-ancestor
5550243|NCT04097444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5550244|NCT04097444|Antimetabolites|antimetabolites|mesh-ancestor
5550245|NCT04097444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550246|NCT04097444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6148188|NCT01383486|Analgesics|analgesics|mesh-ancestor
6148189|NCT01383486|Sensory System Agents|sensory system agents|mesh-ancestor
6148190|NCT01383486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6148191|NCT01383486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148192|NCT01383486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6148193|NCT01383486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6148194|NCT01383486|Gout Suppressants|gout suppressants|mesh-ancestor
6148195|NCT01383486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6148196|NCT01383486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6148197|NCT01383486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6148198|NCT01383499|Bromides|bromides|mesh-list
6148199|NCT01383499|Tiotropium Bromide|tiotropium bromide|mesh-list
5550247|NCT04097444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6475467|NCT00519688|Tegafur|tegafur|mesh-list
5550248|NCT04097444|Immunologic Factors|immunologic factors|mesh-ancestor
5550249|NCT04097444|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5550250|NCT04097444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5550251|NCT04097444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5550252|NCT04097444|Antidotes|antidotes|mesh-ancestor
6475468|NCT00519688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6475469|NCT00519688|Immunologic Factors|immunologic factors|mesh-ancestor
6475470|NCT00519688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475471|NCT00519688|Leprostatic Agents|leprostatic agents|mesh-ancestor
6475472|NCT00519688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6475473|NCT00519688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6475474|NCT00519688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6475475|NCT00519688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6475476|NCT00519688|Growth Substances|growth substances|mesh-ancestor
6475477|NCT00519688|Growth Inhibitors|growth inhibitors|mesh-ancestor
6475478|NCT00519688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6475479|NCT00519688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6475480|NCT00519688|Antimetabolites|antimetabolites|mesh-ancestor
6475481|NCT00519688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475482|NCT00519701|Hydroxyurea|hydroxyurea|mesh-list
6475483|NCT00519701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6475484|NCT00519701|Antisickling Agents|antisickling agents|mesh-ancestor
6475485|NCT00519701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6475486|NCT00519701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475487|NCT00519701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6475488|NCT00519753|Timolol|timolol|mesh-list
6148200|NCT01383499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6148201|NCT01383499|Autonomic Agents|autonomic agents|mesh-ancestor
6148202|NCT01383499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6148203|NCT01383499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148204|NCT01383499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6148205|NCT01383499|Respiratory System Agents|respiratory system agents|mesh-ancestor
6148206|NCT01383499|Parasympatholytics|parasympatholytics|mesh-ancestor
6148207|NCT01383499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6148208|NCT01383499|Cholinergic Agents|cholinergic agents|mesh-ancestor
6148209|NCT01383499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6148210|NCT01383499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6148211|NCT01383499|Anticonvulsants|anticonvulsants|mesh-ancestor
6148212|NCT01383707|Leucovorin|leucovorin|mesh-list
6148213|NCT01383707|Bevacizumab|bevacizumab|mesh-list
6148214|NCT01383707|Fluorouracil|fluorouracil|mesh-list
6148215|NCT01383707|Oxaliplatin|oxaliplatin|mesh-list
6148216|NCT01383707|Levoleucovorin|levoleucovorin|mesh-list
6148217|NCT01383707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6148218|NCT01383707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6148219|NCT01383707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6475489|NCT00519753|Travoprost|travoprost|mesh-list
5550253|NCT04097444|Protective Agents|protective agents|mesh-ancestor
6148220|NCT01383707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6148221|NCT01383707|Growth Substances|growth substances|mesh-ancestor
6148222|NCT01383707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148223|NCT01383707|Growth Inhibitors|growth inhibitors|mesh-ancestor
6148224|NCT01383707|Antimetabolites|antimetabolites|mesh-ancestor
6148225|NCT01383707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6148226|NCT01383707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6148227|NCT01383707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6148228|NCT01383707|Immunologic Factors|immunologic factors|mesh-ancestor
6148229|NCT01383707|Antidotes|antidotes|mesh-ancestor
6148230|NCT01383707|Protective Agents|protective agents|mesh-ancestor
6148231|NCT01383707|Vitamin B Complex|vitamin b complex|mesh-ancestor
6148232|NCT01383707|Vitamins|vitamins|mesh-ancestor
6148233|NCT01383707|Micronutrients|micronutrients|mesh-ancestor
6148234|NCT01383759|Dexamethasone|dexamethasone|mesh-list
6148235|NCT01383759|Dexamethasone acetate|dexamethasone acetate|mesh-list
6148236|NCT01383759|Bortezomib|bortezomib|mesh-list
6148237|NCT01383759|BB 1101|bb 1101|mesh-list
6148238|NCT01383759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6148239|NCT01383759|Antiemetics|antiemetics|mesh-ancestor
6148240|NCT01383759|Autonomic Agents|autonomic agents|mesh-ancestor
6148241|NCT01383759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6148242|NCT01383759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148243|NCT01383759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6148244|NCT01383759|Glucocorticoids|glucocorticoids|mesh-ancestor
6148245|NCT01383759|Hormones|hormones|mesh-ancestor
6148246|NCT01383759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5550254|NCT04097444|Vitamin B Complex|vitamin b complex|mesh-ancestor
6148247|NCT01383759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5550255|NCT04097444|Vitamins|vitamins|mesh-ancestor
5550256|NCT04097444|Micronutrients|micronutrients|mesh-ancestor
5550257|NCT04097288|Dexetimide|dexetimide|mesh-list
5550258|NCT04097288|Citalopram|citalopram|mesh-list
5550259|NCT04097288|Reboxetine|reboxetine|mesh-list
5550260|NCT04097288|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5550261|NCT04097288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6148248|NCT01383759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6148249|NCT01383759|Protease Inhibitors|protease inhibitors|mesh-ancestor
6148250|NCT01383759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6148251|NCT01383759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6148252|NCT01383928|Dexamethasone|dexamethasone|mesh-list
5550262|NCT04097288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5550263|NCT04097288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550264|NCT04097288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6148253|NCT01383928|Lenalidomide|lenalidomide|mesh-list
6148254|NCT01383928|Ixazomib|ixazomib|mesh-list
6148255|NCT01383928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6148256|NCT01383928|Antiemetics|antiemetics|mesh-ancestor
6148257|NCT01383928|Autonomic Agents|autonomic agents|mesh-ancestor
6148258|NCT01383928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6148259|NCT01383928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148260|NCT01383928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6148261|NCT01383928|Glucocorticoids|glucocorticoids|mesh-ancestor
6148262|NCT01383928|Hormones|hormones|mesh-ancestor
6148263|NCT01383928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6148264|NCT01383928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6148265|NCT01383928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6148266|NCT01383928|Immunologic Factors|immunologic factors|mesh-ancestor
6148267|NCT01383928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6148268|NCT01383928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6148269|NCT01383928|Growth Substances|growth substances|mesh-ancestor
6148270|NCT01383928|Growth Inhibitors|growth inhibitors|mesh-ancestor
6148271|NCT01383928|Protease Inhibitors|protease inhibitors|mesh-ancestor
6148272|NCT01383928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6148273|NCT01383928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6148274|NCT01383954|Diclofenac|diclofenac|mesh-list
6148275|NCT01383954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6148276|NCT01383954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6148277|NCT01383954|Analgesics|analgesics|mesh-ancestor
6475490|NCT00519753|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6475491|NCT00519753|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6475492|NCT00519753|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6475493|NCT00519753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5550265|NCT04097288|Serotonin Agents|serotonin agents|mesh-ancestor
5550266|NCT04097288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550267|NCT04097288|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5550268|NCT04097288|Antidepressive Agents|antidepressive agents|mesh-ancestor
5550269|NCT04097288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5550270|NCT04097288|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5550271|NCT04097288|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5550272|NCT04097288|Parasympatholytics|parasympatholytics|mesh-ancestor
5550273|NCT04097288|Autonomic Agents|autonomic agents|mesh-ancestor
5550274|NCT04097288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5550275|NCT04097288|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6475494|NCT00519753|Adrenergic Agents|adrenergic agents|mesh-ancestor
6475495|NCT00519753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6475496|NCT00519753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475497|NCT00519753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475498|NCT00519753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6475499|NCT00519753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6475500|NCT00519805|Dalteparin|dalteparin|mesh-list
6475501|NCT00519805|Tinzaparin|tinzaparin|mesh-list
5550276|NCT04097288|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5550277|NCT04097288|Cholinergic Agents|cholinergic agents|mesh-ancestor
5550278|NCT04097288|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5550279|NCT04097288|Adrenergic Agents|adrenergic agents|mesh-ancestor
5602856|NCT04038515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5602857|NCT04038515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602858|NCT04038515|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5602859|NCT04038515|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6475502|NCT00519805|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6475503|NCT00519805|Anticoagulants|anticoagulants|mesh-ancestor
6475504|NCT00519805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6475505|NCT00519805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5602860|NCT04038515|Cholinergic Agents|cholinergic agents|mesh-ancestor
6475506|NCT00519805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475507|NCT00519870|Losartan|losartan|mesh-list
6475508|NCT00519870|Nifedipine|nifedipine|mesh-list
6475509|NCT00519870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6475510|NCT00519870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6475511|NCT00519870|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6475512|NCT00519870|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6475513|NCT00519870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550280|NCT04096768|Dexmedetomidine|dexmedetomidine|mesh-list
5550281|NCT04096768|Ketamine|ketamine|mesh-list
5550282|NCT04096768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6475514|NCT00519870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6475515|NCT00519870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6148278|NCT01383954|Sensory System Agents|sensory system agents|mesh-ancestor
6148279|NCT01383954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6148280|NCT01383954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148281|NCT01383954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5550283|NCT04096768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5550284|NCT04096768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550285|NCT04096768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5550286|NCT04096768|Analgesics|analgesics|mesh-ancestor
5550287|NCT04096768|Sensory System Agents|sensory system agents|mesh-ancestor
5550288|NCT04096768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5550289|NCT04096768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5550290|NCT04096768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5550291|NCT04096768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5550292|NCT04096768|Adrenergic Agents|adrenergic agents|mesh-ancestor
5550293|NCT04096768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5550294|NCT04096768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6148282|NCT01383954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6475516|NCT00519870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6475517|NCT00519870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475518|NCT00519870|Vasodilator Agents|vasodilator agents|mesh-ancestor
6475519|NCT00519870|Tocolytic Agents|tocolytic agents|mesh-ancestor
6475520|NCT00519870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6148283|NCT01383954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6148284|NCT01383954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6475521|NCT00519909|Calcium|calcium|mesh-list
6475522|NCT00519909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6475523|NCT00519909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475524|NCT00519987|Ketamine|ketamine|mesh-list
6475525|NCT00519987|Analgesics|analgesics|mesh-ancestor
6475526|NCT00519987|Sensory System Agents|sensory system agents|mesh-ancestor
6475527|NCT00519987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6475528|NCT00519987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475529|NCT00519987|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6475530|NCT00519987|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6475531|NCT00519987|Anesthetics, General|anesthetics, general|mesh-ancestor
6475532|NCT00519987|Anesthetics|anesthetics|mesh-ancestor
6475533|NCT00519987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6475534|NCT00519987|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6475535|NCT00519987|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5550295|NCT04096768|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5550296|NCT04096768|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5550297|NCT04096768|Anesthetics, General|anesthetics, general|mesh-ancestor
5550298|NCT04096768|Anesthetics|anesthetics|mesh-ancestor
6475536|NCT00519987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6488730|NCT00586131|Citric Acid|citric acid|mesh-list
6475537|NCT00519987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475538|NCT00520000|Carboplatin|carboplatin|mesh-list
6475539|NCT00520000|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6475540|NCT00520000|Paclitaxel|paclitaxel|mesh-list
6475541|NCT00520000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6148285|NCT01383954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6148286|NCT01383993|Voriconazole|voriconazole|mesh-list
6148287|NCT01383993|Antifungal Agents|antifungal agents|mesh-ancestor
6148288|NCT01383993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6148289|NCT01383993|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6148290|NCT01383993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6148291|NCT01383993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6148292|NCT01383993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6148293|NCT01383993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6148294|NCT01383993|Hormone Antagonists|hormone antagonists|mesh-ancestor
6148295|NCT01383993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6148296|NCT01383993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148297|NCT01383993|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6148298|NCT01384292|Naloxegol|naloxegol|mesh-list
6148299|NCT01384292|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6148300|NCT01384292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148301|NCT01384292|Sensory System Agents|sensory system agents|mesh-ancestor
6475542|NCT00520000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6475543|NCT00520000|Tubulin Modulators|tubulin modulators|mesh-ancestor
6475544|NCT00520000|Antimitotic Agents|antimitotic agents|mesh-ancestor
6475545|NCT00520000|Mitosis Modulators|mitosis modulators|mesh-ancestor
6475546|NCT00520000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475547|NCT00520026|Lithium Carbonate|lithium carbonate|mesh-list
6148302|NCT01384292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6148303|NCT01384539|Cholecalciferol|cholecalciferol|mesh-list
6148304|NCT01384539|Calcitriol|calcitriol|mesh-list
6148305|NCT01384539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6148306|NCT01384539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148307|NCT01384539|Vitamins|vitamins|mesh-ancestor
6667535|NCT01527747|Saxagliptin|saxagliptin|mesh-list
6667536|NCT01527747|Incretins|incretins|mesh-ancestor
6667537|NCT01527747|Hormones|hormones|mesh-ancestor
6667538|NCT01527747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6667539|NCT01527747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667540|NCT01527747|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5550299|NCT04096768|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5550300|NCT04096768|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5550301|NCT04097028|Trifluridine|trifluridine|mesh-list
5550302|NCT04097028|Oxaliplatin|oxaliplatin|mesh-list
5550303|NCT04097028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6667541|NCT01527747|Protease Inhibitors|protease inhibitors|mesh-ancestor
6667542|NCT01527747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6667543|NCT01527747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667544|NCT01527747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6667545|NCT01527786|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6667546|NCT01527786|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6667547|NCT01527786|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6667548|NCT01527786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6667549|NCT01527786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667550|NCT01527786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6667551|NCT01527786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667552|NCT01527786|Antidepressive Agents|antidepressive agents|mesh-ancestor
6667553|NCT01527786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6667554|NCT01527864|Paclitaxel|paclitaxel|mesh-list
6667555|NCT01527864|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6667556|NCT01527864|Carboplatin|carboplatin|mesh-list
6475548|NCT00520026|Antidepressive Agents|antidepressive agents|mesh-ancestor
6475549|NCT00520026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6475550|NCT00520026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6475551|NCT00520026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475552|NCT00520026|Antimanic Agents|antimanic agents|mesh-ancestor
6148308|NCT01384539|Micronutrients|micronutrients|mesh-ancestor
6148309|NCT01384539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6148310|NCT01384539|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
5550304|NCT04097028|Antimetabolites|antimetabolites|mesh-ancestor
5550305|NCT04097028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550306|NCT04097028|Antiviral Agents|antiviral agents|mesh-ancestor
6148311|NCT01384539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6148312|NCT01384539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475553|NCT00520026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6475554|NCT00520026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5550307|NCT04097028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5550308|NCT04096599|Fluorides|fluorides|mesh-list
5550309|NCT04096599|Cariostatic Agents|cariostatic agents|mesh-ancestor
5550310|NCT04096599|Protective Agents|protective agents|mesh-ancestor
5550311|NCT04096599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550312|NCT04096742|Tretinoin|tretinoin|mesh-list
5550313|NCT04096742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5550314|NCT04096742|Keratolytic Agents|keratolytic agents|mesh-ancestor
5550315|NCT04096742|Dermatologic Agents|dermatologic agents|mesh-ancestor
5550316|NCT04096638|Atezolizumab|atezolizumab|mesh-list
5550317|NCT04096638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6475555|NCT00520026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475556|NCT00520052|Zoledronic Acid|zoledronic acid|mesh-list
6475557|NCT00520052|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6475558|NCT00520052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475559|NCT00520091|Celecoxib|celecoxib|mesh-list
6148313|NCT01384539|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6148314|NCT01384591|Acetylcysteine|acetylcysteine|mesh-list
6475560|NCT00520091|Irinotecan|irinotecan|mesh-list
6475561|NCT00520091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5550318|NCT04096690|Pegaspargase|pegaspargase|mesh-list
5550319|NCT04096690|Antibodies|antibodies|mesh-list
5550320|NCT04096690|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5550321|NCT04096690|Immunologic Factors|immunologic factors|mesh-ancestor
5550322|NCT04096690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550323|NCT04096690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5550324|NCT04096547|Rivaroxaban|rivaroxaban|mesh-list
5550325|NCT04096547|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5550326|NCT04096547|Antithrombins|antithrombins|mesh-ancestor
5550327|NCT04096547|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5550328|NCT04096547|Protease Inhibitors|protease inhibitors|mesh-ancestor
5550329|NCT04096547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5550330|NCT04096547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550331|NCT04096547|Anticoagulants|anticoagulants|mesh-ancestor
5550332|NCT04096391|Analgesics|analgesics|mesh-list
5550333|NCT04096391|Sensory System Agents|sensory system agents|mesh-ancestor
5550334|NCT04096391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6475562|NCT00520091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6475563|NCT00520091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6475564|NCT00520091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6475565|NCT00520091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475566|NCT00520091|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6475567|NCT00520091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6475568|NCT00520091|Analgesics|analgesics|mesh-ancestor
6475569|NCT00520091|Sensory System Agents|sensory system agents|mesh-ancestor
6475570|NCT00520091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6475571|NCT00520091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475572|NCT00520091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6475573|NCT00520091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6475574|NCT00520091|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6475575|NCT00520091|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6475576|NCT00520104|Ketamine|ketamine|mesh-list
6475577|NCT00520104|Analgesics|analgesics|mesh-ancestor
6475578|NCT00520104|Sensory System Agents|sensory system agents|mesh-ancestor
6475579|NCT00520104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6475580|NCT00520104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475581|NCT00520104|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6475582|NCT00520104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6475583|NCT00520104|Anesthetics, General|anesthetics, general|mesh-ancestor
6475584|NCT00520104|Anesthetics|anesthetics|mesh-ancestor
6475585|NCT00520104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6475586|NCT00520104|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6475587|NCT00520104|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6148315|NCT01384591|Losartan|losartan|mesh-list
6148316|NCT01384591|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6148317|NCT01384591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6148318|NCT01384591|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6148319|NCT01384591|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6148320|NCT01384591|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5550335|NCT04096391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550336|NCT04096066|Dexamethasone|dexamethasone|mesh-list
5550337|NCT04096066|Lenalidomide|lenalidomide|mesh-list
6148321|NCT01384591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6148322|NCT01384591|Antiviral Agents|antiviral agents|mesh-ancestor
6148323|NCT01384591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6148324|NCT01384591|Expectorants|expectorants|mesh-ancestor
6148325|NCT01384591|Respiratory System Agents|respiratory system agents|mesh-ancestor
6148326|NCT01384591|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6148327|NCT01384591|Antioxidants|antioxidants|mesh-ancestor
6148328|NCT01384591|Protective Agents|protective agents|mesh-ancestor
6148329|NCT01384591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148330|NCT01384591|Antidotes|antidotes|mesh-ancestor
6148331|NCT01384734|Ritonavir|ritonavir|mesh-list
6148332|NCT01384734|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6148333|NCT01384734|Tenofovir|tenofovir|mesh-list
6148334|NCT01384734|Raltegravir Potassium|raltegravir potassium|mesh-list
6475588|NCT00520104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6475589|NCT00520104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475590|NCT00520169|Ketamine|ketamine|mesh-list
6475591|NCT00520169|Analgesics|analgesics|mesh-ancestor
6475592|NCT00520169|Sensory System Agents|sensory system agents|mesh-ancestor
6475593|NCT00520169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6475594|NCT00520169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148335|NCT01384734|Fostemsavir|fostemsavir|mesh-list
6148336|NCT01384734|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6148337|NCT01384734|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6148338|NCT01384734|Protease Inhibitors|protease inhibitors|mesh-ancestor
6148339|NCT01384734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6148340|NCT01384734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6148341|NCT01384734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6148342|NCT01384734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6148343|NCT01384734|Antiviral Agents|antiviral agents|mesh-ancestor
6148344|NCT01384734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6475595|NCT00520169|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6475596|NCT00520169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6475597|NCT00520169|Anesthetics, General|anesthetics, general|mesh-ancestor
6475598|NCT00520169|Anesthetics|anesthetics|mesh-ancestor
6475599|NCT00520169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6475600|NCT00520169|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6475601|NCT00520169|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6475602|NCT00520169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6475603|NCT00520169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475604|NCT00520247|Folic Acid|folic acid|mesh-list
6475605|NCT00520247|Enalapril|enalapril|mesh-list
6475606|NCT00520247|Hematinics|hematinics|mesh-ancestor
6475607|NCT00520247|Vitamin B Complex|vitamin b complex|mesh-ancestor
6475608|NCT00520247|Vitamins|vitamins|mesh-ancestor
6475609|NCT00520247|Micronutrients|micronutrients|mesh-ancestor
6475610|NCT00520247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475611|NCT00520247|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6475612|NCT00520247|Protease Inhibitors|protease inhibitors|mesh-ancestor
6475613|NCT00520247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6475614|NCT00520247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475615|NCT00520247|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6475616|NCT00520260|Ketorolac|ketorolac|mesh-list
6475617|NCT00520260|Bromfenac|bromfenac|mesh-list
6475618|NCT00520260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6475619|NCT00520260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6475620|NCT00520260|Analgesics|analgesics|mesh-ancestor
6475621|NCT00520260|Sensory System Agents|sensory system agents|mesh-ancestor
6475622|NCT00520260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6475623|NCT00520260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475624|NCT00520260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6475625|NCT00520260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6475626|NCT00520260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6475627|NCT00520260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6475628|NCT00520260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550338|NCT04096066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5550339|NCT04096066|Antiemetics|antiemetics|mesh-ancestor
5550340|NCT04096066|Autonomic Agents|autonomic agents|mesh-ancestor
5550341|NCT04096066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5550342|NCT04096066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550343|NCT04096066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5550344|NCT04096066|Glucocorticoids|glucocorticoids|mesh-ancestor
6148345|NCT01384734|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6475629|NCT00520325|Lectins|lectins|mesh-list
6475630|NCT00520325|Agglutinins|agglutinins|mesh-ancestor
6475631|NCT00520325|Immunologic Factors|immunologic factors|mesh-ancestor
6475632|NCT00520325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475633|NCT00520325|Coagulants|coagulants|mesh-ancestor
6475634|NCT00520338|Celecoxib|celecoxib|mesh-list
6475635|NCT00520338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6475636|NCT00520338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6475637|NCT00520338|Analgesics|analgesics|mesh-ancestor
6475638|NCT00520338|Sensory System Agents|sensory system agents|mesh-ancestor
6475639|NCT00520338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6475640|NCT00520338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475641|NCT00520338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6475642|NCT00520338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6475643|NCT00520338|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6475644|NCT00520338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6475645|NCT00520338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6475646|NCT00520338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475647|NCT00520442|Ibuprofen|ibuprofen|mesh-list
6475648|NCT00520442|Codeine|codeine|mesh-list
6475649|NCT00520442|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6475650|NCT00520442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6475651|NCT00520442|Analgesics|analgesics|mesh-ancestor
6475652|NCT00520442|Sensory System Agents|sensory system agents|mesh-ancestor
6475653|NCT00520442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6475654|NCT00520442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475655|NCT00520442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6475656|NCT00520442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6475657|NCT00520442|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6475658|NCT00520442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6475659|NCT00520442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475660|NCT00520442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6148346|NCT01384734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6148347|NCT01384734|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6148348|NCT01384734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6148349|NCT01384734|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6148350|NCT01384734|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6148351|NCT01384734|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6148352|NCT01384734|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6148353|NCT01384877|Lidocaine|lidocaine|mesh-list
6148354|NCT01384877|Anesthetics, Local|anesthetics, local|mesh-ancestor
6148355|NCT01384877|Anesthetics|anesthetics|mesh-ancestor
6148356|NCT01384877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6148357|NCT01384877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148358|NCT01384877|Sensory System Agents|sensory system agents|mesh-ancestor
6148359|NCT01384877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6148360|NCT01384877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6148361|NCT01384877|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6475661|NCT00520442|Narcotics|narcotics|mesh-ancestor
6475662|NCT00520442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6475663|NCT00520442|Antitussive Agents|antitussive agents|mesh-ancestor
6475664|NCT00520442|Respiratory System Agents|respiratory system agents|mesh-ancestor
6475665|NCT00520455|Levonorgestrel|levonorgestrel|mesh-list
6475666|NCT00520455|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6475667|NCT00520455|Contraceptive Agents|contraceptive agents|mesh-ancestor
6475668|NCT00520455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6475669|NCT00520455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475670|NCT00520455|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6148362|NCT01384877|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6148363|NCT01384877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6148364|NCT01384877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6148365|NCT01385098|Calcium, Dietary|calcium, dietary|mesh-list
6148366|NCT01385098|Vitamin D|vitamin d|mesh-list
5550345|NCT04096066|Hormones|hormones|mesh-ancestor
5550346|NCT04096066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5550347|NCT04096066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5550348|NCT04096066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5550349|NCT04096066|Immunologic Factors|immunologic factors|mesh-ancestor
5550350|NCT04096066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5550351|NCT04096066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5550352|NCT04096066|Growth Substances|growth substances|mesh-ancestor
5550353|NCT04096066|Growth Inhibitors|growth inhibitors|mesh-ancestor
5550354|NCT04096157|Isavuconazole|isavuconazole|mesh-list
5550355|NCT04096157|Antifungal Agents|antifungal agents|mesh-ancestor
5550356|NCT04096157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5550357|NCT04096144|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
6148367|NCT01385098|Ergocalciferols|ergocalciferols|mesh-list
6148368|NCT01385098|Cholecalciferol|cholecalciferol|mesh-list
6148369|NCT01385098|Vitamins|vitamins|mesh-list
6148370|NCT01385098|Calcium|calcium|mesh-list
6148371|NCT01385098|Micronutrients|micronutrients|mesh-ancestor
6148372|NCT01385098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148373|NCT01385098|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6148374|NCT01385098|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6148375|NCT01385189|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6667557|NCT01527864|Endostatins|endostatins|mesh-list
6667558|NCT01527864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6667559|NCT01527864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6667560|NCT01527864|Tubulin Modulators|tubulin modulators|mesh-ancestor
6667561|NCT01527864|Antimitotic Agents|antimitotic agents|mesh-ancestor
6667562|NCT01527864|Mitosis Modulators|mitosis modulators|mesh-ancestor
6667563|NCT01527864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6148376|NCT01385189|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6148377|NCT01385189|Immunologic Factors|immunologic factors|mesh-ancestor
6148378|NCT01385189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148379|NCT01385189|Antacids|antacids|mesh-ancestor
6475671|NCT00520455|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6475672|NCT00520455|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6475673|NCT00520507|Olanzapine|olanzapine|mesh-list
6475674|NCT00520507|Antiemetics|antiemetics|mesh-ancestor
6475675|NCT00520507|Autonomic Agents|autonomic agents|mesh-ancestor
6475676|NCT00520507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6475677|NCT00520507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475678|NCT00520507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6475679|NCT00520507|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6475680|NCT00520507|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6475681|NCT00520507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6475682|NCT00520507|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6475683|NCT00520507|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6475684|NCT00520507|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6475685|NCT00520507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6475686|NCT00520507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475687|NCT00520507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6475688|NCT00520507|Serotonin Agents|serotonin agents|mesh-ancestor
5550358|NCT04096144|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5550359|NCT04096144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5550360|NCT04096144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550361|NCT04096170|Lidocaine|lidocaine|mesh-list
6488731|NCT00586131|Sodium Citrate|sodium citrate|mesh-list
6488732|NCT00586131|Anticoagulants|anticoagulants|mesh-ancestor
6488733|NCT00586131|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6488734|NCT00586131|Chelating Agents|chelating agents|mesh-ancestor
6488735|NCT00586131|Sequestering Agents|sequestering agents|mesh-ancestor
6488736|NCT00586131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488737|NCT00586274|Fludarabine|fludarabine|mesh-list
6488738|NCT00586274|Alemtuzumab|alemtuzumab|mesh-list
6148380|NCT01385189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6148381|NCT01385189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6148382|NCT01385566|Vaccines|vaccines|mesh-list
6148383|NCT01385566|Immunoglobulins|immunoglobulins|mesh-list
6148384|NCT01385566|Immunologic Factors|immunologic factors|mesh-ancestor
6148385|NCT01385566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148386|NCT01385748|Clonidine|clonidine|mesh-list
6148387|NCT01385748|Analgesics|analgesics|mesh-ancestor
6148388|NCT01385748|Sensory System Agents|sensory system agents|mesh-ancestor
6148389|NCT01385748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6148390|NCT01385748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148391|NCT01385748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6148392|NCT01385748|Sympatholytics|sympatholytics|mesh-ancestor
6148393|NCT01385748|Autonomic Agents|autonomic agents|mesh-ancestor
6148394|NCT01385748|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6148395|NCT01385748|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6148396|NCT01385748|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6148397|NCT01385748|Adrenergic Agents|adrenergic agents|mesh-ancestor
6148398|NCT01385748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6148399|NCT01385748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6148400|NCT01386554|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6148401|NCT01386554|Hormones|hormones|mesh-ancestor
6148402|NCT01386554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6148403|NCT01386554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488739|NCT00586274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5550362|NCT04096170|Anesthetics, Local|anesthetics, local|mesh-ancestor
5550363|NCT04096170|Anesthetics|anesthetics|mesh-ancestor
5550364|NCT04096170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5550365|NCT04096170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550366|NCT04096170|Sensory System Agents|sensory system agents|mesh-ancestor
5550367|NCT04096170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6148404|NCT01386606|Methyltestosterone|methyltestosterone|mesh-list
6148405|NCT01386606|Enclomiphene|enclomiphene|mesh-list
6148406|NCT01386606|Clomiphene|clomiphene|mesh-list
6148407|NCT01386606|Zuclomiphene|zuclomiphene|mesh-list
6148408|NCT01386606|Testosterone|testosterone|mesh-list
6148409|NCT01386606|Testosterone undecanoate|testosterone undecanoate|mesh-list
6148410|NCT01386606|Testosterone enanthate|testosterone enanthate|mesh-list
5550368|NCT04096170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5550369|NCT04096170|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5550370|NCT04096170|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5550371|NCT04096170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5550372|NCT04096170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550373|NCT04095754|Dexmedetomidine|dexmedetomidine|mesh-list
6148411|NCT01386606|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6148412|NCT01386606|Androgens|androgens|mesh-ancestor
6148413|NCT01386606|Hormones|hormones|mesh-ancestor
6148414|NCT01386606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6148415|NCT01386606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148416|NCT01386606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6148417|NCT01386606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6148418|NCT01386606|Anabolic Agents|anabolic agents|mesh-ancestor
6148419|NCT01386606|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6148420|NCT01386606|Hormone Antagonists|hormone antagonists|mesh-ancestor
6148421|NCT01386606|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6148422|NCT01386606|Fertility Agents|fertility agents|mesh-ancestor
6148423|NCT01386606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5550374|NCT04095754|Anesthetics|anesthetics|mesh-list
5550375|NCT04095754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5550376|NCT04095754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550377|NCT04095754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5550378|NCT04095754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5550379|NCT04095754|Analgesics|analgesics|mesh-ancestor
5550380|NCT04095754|Sensory System Agents|sensory system agents|mesh-ancestor
5550381|NCT04095754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5550382|NCT04095754|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6148424|NCT01386606|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6148425|NCT01386606|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6148426|NCT01386645|Acetylcysteine|acetylcysteine|mesh-list
6148427|NCT01386645|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6148428|NCT01386645|Antiviral Agents|antiviral agents|mesh-ancestor
6148429|NCT01386645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6148430|NCT01386645|Expectorants|expectorants|mesh-ancestor
6148431|NCT01386645|Respiratory System Agents|respiratory system agents|mesh-ancestor
6148432|NCT01386645|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6148433|NCT01386645|Antioxidants|antioxidants|mesh-ancestor
6148434|NCT01386645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6148435|NCT01386645|Protective Agents|protective agents|mesh-ancestor
6148436|NCT01386645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148437|NCT01386645|Antidotes|antidotes|mesh-ancestor
6148438|NCT01386970|Lamivudine|lamivudine|mesh-list
6148439|NCT01386970|Zidovudine|zidovudine|mesh-list
6148440|NCT01386970|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6148441|NCT01386970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6148442|NCT01386970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6148443|NCT01386970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6148444|NCT01386970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6148445|NCT01386970|Antiviral Agents|antiviral agents|mesh-ancestor
6148446|NCT01386970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6148447|NCT01386970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6148448|NCT01386970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6148449|NCT01386970|Antimetabolites|antimetabolites|mesh-ancestor
6148450|NCT01386983|Finasteride|finasteride|mesh-list
6148451|NCT01386983|Dutasteride|dutasteride|mesh-list
6148452|NCT01386983|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6148453|NCT01386983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6148454|NCT01386983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6148455|NCT01386983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6148456|NCT01386983|Hormone Antagonists|hormone antagonists|mesh-ancestor
6205659|NCT02090413|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6148457|NCT01386983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6148458|NCT01386983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475689|NCT00520585|Atorvastatin|atorvastatin|mesh-list
6475690|NCT00520585|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6475691|NCT00520585|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6475692|NCT00520585|Antimetabolites|antimetabolites|mesh-ancestor
6475693|NCT00520585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475694|NCT00520585|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6475695|NCT00520585|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6475696|NCT00520585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6475697|NCT00520650|Aripiprazole|aripiprazole|mesh-list
5550383|NCT04095754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6148459|NCT01386983|Urological Agents|urological agents|mesh-ancestor
6148460|NCT01387022|Tenofovir|tenofovir|mesh-list
6148461|NCT01387022|Lamivudine|lamivudine|mesh-list
6148462|NCT01387022|Efavirenz|efavirenz|mesh-list
6148463|NCT01387022|Antiviral Agents|antiviral agents|mesh-ancestor
6148464|NCT01387022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6148465|NCT01387022|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6148466|NCT01387022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6148467|NCT01387022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6148468|NCT01387022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475698|NCT00520650|Antidepressive Agents|antidepressive agents|mesh-ancestor
6475699|NCT00520650|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6475700|NCT00520650|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6475701|NCT00520650|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6475702|NCT00520650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6475703|NCT00520650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475704|NCT00520650|Dopamine Agonists|dopamine agonists|mesh-ancestor
6475705|NCT00520650|Dopamine Agents|dopamine agents|mesh-ancestor
6475706|NCT00520650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6475707|NCT00520650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475708|NCT00520650|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6475709|NCT00520650|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6475710|NCT00520650|Serotonin Agents|serotonin agents|mesh-ancestor
6475711|NCT00520650|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6475712|NCT00520650|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6475713|NCT00520650|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6667564|NCT01527864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6667565|NCT01527864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6667566|NCT01527864|Growth Substances|growth substances|mesh-ancestor
6667567|NCT01527864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667568|NCT01527864|Growth Inhibitors|growth inhibitors|mesh-ancestor
6667569|NCT01527890|Fentanyl|fentanyl|mesh-list
6667570|NCT01527890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6667571|NCT01527890|Narcotics|narcotics|mesh-ancestor
6667572|NCT01527890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6667573|NCT01527890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667574|NCT01527890|Analgesics|analgesics|mesh-ancestor
6667575|NCT01527890|Sensory System Agents|sensory system agents|mesh-ancestor
6667576|NCT01527890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6667577|NCT01527890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6667578|NCT01527890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6667579|NCT01527890|Anesthetics, General|anesthetics, general|mesh-ancestor
6667580|NCT01527890|Anesthetics|anesthetics|mesh-ancestor
6667581|NCT01527903|Midazolam|midazolam|mesh-list
6667582|NCT01527903|Propofol|propofol|mesh-list
5550384|NCT04095754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5550385|NCT04095754|Adrenergic Agents|adrenergic agents|mesh-ancestor
5550386|NCT04095754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5550387|NCT04095754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550388|NCT04095715|Hemostatics|hemostatics|mesh-list
5550389|NCT04095715|Coagulants|coagulants|mesh-ancestor
5550390|NCT04096027|Cabergoline|cabergoline|mesh-list
6475714|NCT00520650|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6475715|NCT00520754|Levocetirizine|levocetirizine|mesh-list
6475716|NCT00520754|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6475717|NCT00520754|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6475718|NCT00520754|Histamine Antagonists|histamine antagonists|mesh-ancestor
6475719|NCT00520754|Histamine Agents|histamine agents|mesh-ancestor
6475720|NCT00520754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6475721|NCT00520754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475722|NCT00520754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475723|NCT00520806|Methocarbamol|methocarbamol|mesh-list
6475724|NCT00520806|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6475725|NCT00520806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475726|NCT00520806|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6475727|NCT00520806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6475728|NCT00520819|Antioxidants|antioxidants|mesh-list
6475729|NCT00520819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475730|NCT00520819|Protective Agents|protective agents|mesh-ancestor
5550391|NCT04096027|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5550392|NCT04096027|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5550393|NCT04096027|Dopamine Agonists|dopamine agonists|mesh-ancestor
6475731|NCT00520819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475732|NCT00520897|Raltegravir Potassium|raltegravir potassium|mesh-list
6475733|NCT00520897|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6475734|NCT00520897|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6475735|NCT00520897|Antiviral Agents|antiviral agents|mesh-ancestor
6475736|NCT00520897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6475737|NCT00520897|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6475738|NCT00520897|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6475739|NCT00520897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6475740|NCT00520897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6148469|NCT01387022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6148470|NCT01387022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6148471|NCT01387022|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6148472|NCT01387022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5550394|NCT04096027|Dopamine Agents|dopamine agents|mesh-ancestor
5550395|NCT04096027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5550396|NCT04096027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550397|NCT04096027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550398|NCT04095832|Anesthetics|anesthetics|mesh-list
5550399|NCT04095832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5550400|NCT04095832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550401|NCT04095624|Analgesics, Opioid|analgesics, opioid|mesh-list
5550402|NCT04095624|Narcotics|narcotics|mesh-ancestor
5550403|NCT04095624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5550404|NCT04095624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550405|NCT04095624|Analgesics|analgesics|mesh-ancestor
5550406|NCT04095624|Sensory System Agents|sensory system agents|mesh-ancestor
5550407|NCT04095624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5550408|NCT04095312|Pancrelipase|pancrelipase|mesh-list
5550409|NCT04095312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5550410|NCT04095390|Capecitabine|capecitabine|mesh-list
5550411|NCT04095390|Letrozole|letrozole|mesh-list
6148473|NCT01387022|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6148474|NCT01387022|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6148475|NCT01387022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6148476|NCT01387022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6148477|NCT01387074|Botulinum Toxins|botulinum toxins|mesh-list
6148478|NCT01387074|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6148479|NCT01387074|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6475741|NCT00520949|Amoxicillin|amoxicillin|mesh-list
6488740|NCT00586274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6148480|NCT01387074|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6148481|NCT01387074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6148482|NCT01387074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6148483|NCT01387074|Cholinergic Agents|cholinergic agents|mesh-ancestor
6148484|NCT01387074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6148485|NCT01387074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148486|NCT01387074|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6148487|NCT01387074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6148488|NCT01387139|Ketamine|ketamine|mesh-list
6148489|NCT01387139|Propofol|propofol|mesh-list
6148490|NCT01387139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6148491|NCT01387139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6148492|NCT01387139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148493|NCT01387139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6148494|NCT01387139|Anesthetics, General|anesthetics, general|mesh-ancestor
6148495|NCT01387139|Anesthetics|anesthetics|mesh-ancestor
6148496|NCT01387139|Analgesics|analgesics|mesh-ancestor
6148497|NCT01387139|Sensory System Agents|sensory system agents|mesh-ancestor
6148498|NCT01387139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6148499|NCT01387139|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6475742|NCT00520949|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6475743|NCT00520949|Furazolidone|furazolidone|mesh-list
6475744|NCT00520949|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
6475745|NCT00520949|Esomeprazole|esomeprazole|mesh-list
6475746|NCT00520949|Bismuth|bismuth|mesh-list
6475747|NCT00520949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6475748|NCT00520949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6475749|NCT00520949|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5550412|NCT04095390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5550413|NCT04095390|Antimetabolites|antimetabolites|mesh-ancestor
5550414|NCT04095390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550415|NCT04095390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5550416|NCT04095390|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5550417|NCT04095390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5550418|NCT04095390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5550419|NCT04095390|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5550420|NCT04095390|Hormone Antagonists|hormone antagonists|mesh-ancestor
5550421|NCT04095390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5550422|NCT04095390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602861|NCT04038515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6148500|NCT01387139|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6475750|NCT00520949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6475751|NCT00520949|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6475752|NCT00520949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6475753|NCT00520949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475754|NCT00520949|Antacids|antacids|mesh-ancestor
6475755|NCT00520949|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6475756|NCT00520949|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6475757|NCT00520949|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6475758|NCT00520949|Renal Agents|renal agents|mesh-ancestor
6475759|NCT00520949|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
6475760|NCT00520949|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6475761|NCT00520949|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6475762|NCT00520949|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6475763|NCT00521040|Levocetirizine|levocetirizine|mesh-list
6475764|NCT00521040|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6475765|NCT00521040|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6475766|NCT00521040|Histamine Antagonists|histamine antagonists|mesh-ancestor
6148501|NCT01387139|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6148502|NCT01387139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6148503|NCT01387139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6148504|NCT01387178|Fluticasone|fluticasone|mesh-list
6148505|NCT01387178|Xhance|xhance|mesh-list
6148506|NCT01387178|Bromides|bromides|mesh-list
6148507|NCT01387178|Tiotropium Bromide|tiotropium bromide|mesh-list
6148508|NCT01387178|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6148509|NCT01387178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6148510|NCT01387178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6148511|NCT01387178|Autonomic Agents|autonomic agents|mesh-ancestor
6148512|NCT01387178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6148513|NCT01387178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148514|NCT01387178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6148515|NCT01387178|Respiratory System Agents|respiratory system agents|mesh-ancestor
6148516|NCT01387178|Dermatologic Agents|dermatologic agents|mesh-ancestor
6148517|NCT01387178|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6148518|NCT01387178|Parasympatholytics|parasympatholytics|mesh-ancestor
6148519|NCT01387178|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6148520|NCT01387178|Cholinergic Agents|cholinergic agents|mesh-ancestor
6148521|NCT01387178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6475767|NCT00521040|Histamine Agents|histamine agents|mesh-ancestor
6148522|NCT01387178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475768|NCT00521040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6475769|NCT00521040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475770|NCT00521040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475771|NCT00521092|Sunitinib|sunitinib|mesh-list
5550423|NCT04095442|Benzocaine|benzocaine|mesh-list
5550424|NCT04095442|Anesthetics, Local|anesthetics, local|mesh-ancestor
5550425|NCT04095442|Anesthetics|anesthetics|mesh-ancestor
5550426|NCT04095442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5550427|NCT04095442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550428|NCT04095442|Sensory System Agents|sensory system agents|mesh-ancestor
5550429|NCT04095442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5550430|NCT04095455|Ketamine|ketamine|mesh-list
5550431|NCT04095455|Analgesics|analgesics|mesh-ancestor
5550432|NCT04095455|Sensory System Agents|sensory system agents|mesh-ancestor
5550433|NCT04095455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5550434|NCT04095455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550435|NCT04095455|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5550436|NCT04095455|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5550437|NCT04095455|Anesthetics, General|anesthetics, general|mesh-ancestor
5550438|NCT04095455|Anesthetics|anesthetics|mesh-ancestor
5550439|NCT04095455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5550440|NCT04095455|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5550441|NCT04095455|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5550442|NCT04095455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5550443|NCT04095455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550444|NCT04095182|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
5550445|NCT04095182|Anticonvulsants|anticonvulsants|mesh-ancestor
5550446|NCT04095182|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5550447|NCT04095182|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5550448|NCT04095182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5550449|NCT04095182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550450|NCT04095299|Capecitabine|capecitabine|mesh-list
5550451|NCT04095299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5550452|NCT04095299|Antimetabolites|antimetabolites|mesh-ancestor
5550453|NCT04095299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550454|NCT04095299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5550455|NCT04095169|Complement System Proteins|complement system proteins|mesh-list
5550456|NCT04095169|Complement C3|complement c3|mesh-list
6475772|NCT00521092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6475773|NCT00521092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6475774|NCT00521092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6475775|NCT00521092|Growth Substances|growth substances|mesh-ancestor
6475776|NCT00521092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475777|NCT00521092|Growth Inhibitors|growth inhibitors|mesh-ancestor
6475778|NCT00521092|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6148523|NCT01387178|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6148524|NCT01387178|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6148525|NCT01387178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6148526|NCT01387178|Adrenergic Agents|adrenergic agents|mesh-ancestor
6148527|NCT01387178|Anticonvulsants|anticonvulsants|mesh-ancestor
6148528|NCT01387347|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6148529|NCT01387347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6148530|NCT01387464|Bromfenac|bromfenac|mesh-list
6148531|NCT01387464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6148532|NCT01387464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6148533|NCT01387464|Analgesics|analgesics|mesh-ancestor
5550457|NCT04095169|Complement C3d|complement c3d|mesh-list
5550458|NCT04095169|Immunologic Factors|immunologic factors|mesh-ancestor
5550459|NCT04095169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550460|NCT04094948|Clenbuterol|clenbuterol|mesh-list
5550461|NCT04094948|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5550462|NCT04094948|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5550463|NCT04094948|Adrenergic Agents|adrenergic agents|mesh-ancestor
5550464|NCT04094948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5550465|NCT04094948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550466|NCT04094948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148534|NCT01387464|Sensory System Agents|sensory system agents|mesh-ancestor
6475779|NCT00521092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5550467|NCT04094948|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5550468|NCT04094948|Autonomic Agents|autonomic agents|mesh-ancestor
5550469|NCT04094948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5550470|NCT04094948|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5550471|NCT04094948|Respiratory System Agents|respiratory system agents|mesh-ancestor
5550472|NCT04094948|Sympathomimetics|sympathomimetics|mesh-ancestor
5550473|NCT04094961|Dexamethasone|dexamethasone|mesh-list
5550474|NCT04094961|Dexamethasone acetate|dexamethasone acetate|mesh-list
5550475|NCT04094961|Pomalidomide|pomalidomide|mesh-list
5550476|NCT04094961|Ixazomib|ixazomib|mesh-list
6148535|NCT01387464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6148536|NCT01387464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475780|NCT00521092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475781|NCT00521131|Levocetirizine|levocetirizine|mesh-list
6475782|NCT00521131|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6475783|NCT00521131|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6475784|NCT00521131|Histamine Antagonists|histamine antagonists|mesh-ancestor
6475785|NCT00521131|Histamine Agents|histamine agents|mesh-ancestor
6475786|NCT00521131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6475787|NCT00521131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475788|NCT00521131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475789|NCT00521157|Naltrexone|naltrexone|mesh-list
6475790|NCT00521157|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6475791|NCT00521157|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6475792|NCT00521157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475793|NCT00521157|Sensory System Agents|sensory system agents|mesh-ancestor
6475794|NCT00521157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6475795|NCT00521170|Levocetirizine|levocetirizine|mesh-list
6475796|NCT00521170|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6475797|NCT00521170|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6475798|NCT00521170|Histamine Antagonists|histamine antagonists|mesh-ancestor
6475799|NCT00521170|Histamine Agents|histamine agents|mesh-ancestor
6475800|NCT00521170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6475801|NCT00521170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475802|NCT00521170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475803|NCT00521183|Tetrahydrouridine|tetrahydrouridine|mesh-list
6475804|NCT00521183|Antimetabolites|antimetabolites|mesh-ancestor
6475805|NCT00521183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475806|NCT00521222|Fluticasone|fluticasone|mesh-list
6475807|NCT00521222|Xhance|xhance|mesh-list
6475808|NCT00521222|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6475809|NCT00521222|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6475810|NCT00521222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6475811|NCT00521222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5550477|NCT04094961|BB 1101|bb 1101|mesh-list
5550478|NCT04094961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5550479|NCT04094961|Antiemetics|antiemetics|mesh-ancestor
6475812|NCT00521222|Autonomic Agents|autonomic agents|mesh-ancestor
6475813|NCT00521222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6475814|NCT00521222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475815|NCT00521222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6475816|NCT00521222|Respiratory System Agents|respiratory system agents|mesh-ancestor
6148537|NCT01387464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6148538|NCT01387464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6148539|NCT01387516|Nicotine|nicotine|mesh-list
6148540|NCT01387516|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6148541|NCT01387516|Autonomic Agents|autonomic agents|mesh-ancestor
6148542|NCT01387516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6148543|NCT01387516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148544|NCT01387516|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6148545|NCT01387516|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6148546|NCT01387516|Cholinergic Agents|cholinergic agents|mesh-ancestor
6148547|NCT01387516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6148548|NCT01387516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6148549|NCT01387542|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6148550|NCT01387542|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6148551|NCT01387542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6148552|NCT01387542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6148553|NCT01387542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148554|NCT01387542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6148555|NCT01387542|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6148556|NCT01387542|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6148557|NCT01387542|Serotonin Agents|serotonin agents|mesh-ancestor
6148558|NCT01387542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6148559|NCT01387542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475817|NCT00521222|Dermatologic Agents|dermatologic agents|mesh-ancestor
6475818|NCT00521222|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6475819|NCT00521222|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5550480|NCT04094961|Autonomic Agents|autonomic agents|mesh-ancestor
5550481|NCT04094961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5550482|NCT04094961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550483|NCT04094961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5550484|NCT04094961|Glucocorticoids|glucocorticoids|mesh-ancestor
5550485|NCT04094961|Hormones|hormones|mesh-ancestor
5550486|NCT04094961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5550487|NCT04094961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5550488|NCT04094961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5550489|NCT04094961|Protease Inhibitors|protease inhibitors|mesh-ancestor
5550490|NCT04094961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5550491|NCT04094961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550492|NCT04094961|Immunologic Factors|immunologic factors|mesh-ancestor
5550493|NCT04094961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5550494|NCT04094961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5550495|NCT04094961|Growth Substances|growth substances|mesh-ancestor
5550496|NCT04094961|Growth Inhibitors|growth inhibitors|mesh-ancestor
5550497|NCT04095104|Topiramate|topiramate|mesh-list
5550498|NCT04095104|Phentermine|phentermine|mesh-list
5550499|NCT04095104|Anticonvulsants|anticonvulsants|mesh-ancestor
5550500|NCT04095104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5550501|NCT04095104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550502|NCT04095104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5550503|NCT04095104|Appetite Depressants|appetite depressants|mesh-ancestor
5550504|NCT04095104|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5550505|NCT04095104|Sympathomimetics|sympathomimetics|mesh-ancestor
5550506|NCT04095104|Autonomic Agents|autonomic agents|mesh-ancestor
5550507|NCT04095104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5550508|NCT04095104|Adrenergic Agents|adrenergic agents|mesh-ancestor
5550509|NCT04095104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5550510|NCT04095104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550511|NCT04095013|Fentanyl|fentanyl|mesh-list
5550512|NCT04095013|Dexmedetomidine|dexmedetomidine|mesh-list
6475820|NCT00521222|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6475821|NCT00521222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6475822|NCT00521222|Adrenergic Agents|adrenergic agents|mesh-ancestor
6475823|NCT00521222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6475824|NCT00521222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475825|NCT00521222|Glucocorticoids|glucocorticoids|mesh-ancestor
6475826|NCT00521222|Hormones|hormones|mesh-ancestor
6148560|NCT01387542|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6148561|NCT01387542|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6148562|NCT01387542|Dopamine Agents|dopamine agents|mesh-ancestor
6475827|NCT00521222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6475828|NCT00521222|Sympathomimetics|sympathomimetics|mesh-ancestor
6475829|NCT00521248|Morphine|morphine|mesh-list
6475830|NCT00521248|Buprenorphine|buprenorphine|mesh-list
6475831|NCT00521248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6475832|NCT00521248|Narcotics|narcotics|mesh-ancestor
6475833|NCT00521248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5550513|NCT04095013|Bupivacaine|bupivacaine|mesh-list
5550514|NCT04095013|Anesthetics, Local|anesthetics, local|mesh-ancestor
5550515|NCT04095013|Anesthetics|anesthetics|mesh-ancestor
5550516|NCT04095013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5550517|NCT04095013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550518|NCT04095013|Sensory System Agents|sensory system agents|mesh-ancestor
5550519|NCT04095013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5550520|NCT04095013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5550521|NCT04095013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6475834|NCT00521248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475835|NCT00521248|Analgesics|analgesics|mesh-ancestor
6475836|NCT00521248|Sensory System Agents|sensory system agents|mesh-ancestor
6475837|NCT00521248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6475838|NCT00521248|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6475839|NCT00521261|Antibodies|antibodies|mesh-list
6475840|NCT00521261|Antibodies, Bispecific|antibodies, bispecific|mesh-list
6475841|NCT00521261|Immunologic Factors|immunologic factors|mesh-ancestor
6475842|NCT00521261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475843|NCT00521274|Docetaxel|docetaxel|mesh-list
6475844|NCT00521274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6475845|NCT00521274|Tubulin Modulators|tubulin modulators|mesh-ancestor
5550522|NCT04095013|Analgesics|analgesics|mesh-ancestor
5550523|NCT04095013|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6148563|NCT01387607|Pregabalin|pregabalin|mesh-list
6148564|NCT01387607|Analgesics|analgesics|mesh-ancestor
6667583|NCT01527903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5550524|NCT04095013|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6475846|NCT00521274|Antimitotic Agents|antimitotic agents|mesh-ancestor
6475847|NCT00521274|Mitosis Modulators|mitosis modulators|mesh-ancestor
5550525|NCT04095013|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5550526|NCT04095013|Adrenergic Agents|adrenergic agents|mesh-ancestor
5550527|NCT04095013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5550528|NCT04095013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6148565|NCT01387607|Sensory System Agents|sensory system agents|mesh-ancestor
6148566|NCT01387607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6148567|NCT01387607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148568|NCT01387607|Anticonvulsants|anticonvulsants|mesh-ancestor
6148569|NCT01387607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6148570|NCT01387607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6148571|NCT01387607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6148572|NCT01387607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6148573|NCT01387607|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6148574|NCT01387607|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6148575|NCT01387607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6475848|NCT00521274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475849|NCT00521300|Octreotide|octreotide|mesh-list
6475850|NCT00521300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6475851|NCT00521300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6475852|NCT00521300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6475853|NCT00521430|Cyclosporine|cyclosporine|mesh-list
6475854|NCT00521430|Methylprednisolone|methylprednisolone|mesh-list
6475855|NCT00521430|Methotrexate|methotrexate|mesh-list
6475856|NCT00521430|Fludarabine phosphate|fludarabine phosphate|mesh-list
6475857|NCT00521430|Fludarabine|fludarabine|mesh-list
6475858|NCT00521430|Busulfan|busulfan|mesh-list
6475859|NCT00521430|Cyclosporins|cyclosporins|mesh-list
6475860|NCT00521430|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6475861|NCT00521430|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6475862|NCT00521430|Abortifacient Agents|abortifacient agents|mesh-ancestor
6475863|NCT00521430|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5550529|NCT04095013|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5550530|NCT04095013|Narcotics|narcotics|mesh-ancestor
5550531|NCT04095013|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5550532|NCT04095013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5550533|NCT04095013|Anesthetics, General|anesthetics, general|mesh-ancestor
5550534|NCT04094805|Calcitriol|calcitriol|mesh-list
5550535|NCT04094805|Dexamethasone|dexamethasone|mesh-list
5550536|NCT04094805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5550537|NCT04094805|Antiemetics|antiemetics|mesh-ancestor
5550538|NCT04094805|Autonomic Agents|autonomic agents|mesh-ancestor
5550539|NCT04094805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5550540|NCT04094805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550541|NCT04094805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6475864|NCT00521430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475865|NCT00521430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6475866|NCT00521430|Antimetabolites|antimetabolites|mesh-ancestor
6475867|NCT00521430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475868|NCT00521430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6475869|NCT00521430|Dermatologic Agents|dermatologic agents|mesh-ancestor
6475870|NCT00521430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6148576|NCT01387607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6148577|NCT01387672|Nitroglycerin|nitroglycerin|mesh-list
6148578|NCT01387672|Vasodilator Agents|vasodilator agents|mesh-ancestor
6148579|NCT01387815|Adalimumab|adalimumab|mesh-list
6148580|NCT01387815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6148581|NCT01387815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6148582|NCT01387932|Doxorubicin|doxorubicin|mesh-list
6148583|NCT01387932|Ethiodized Oil|ethiodized oil|mesh-list
6148584|NCT01387932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6148585|NCT01387932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6148586|NCT01387932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6148587|NCT01387932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6148588|NCT01387932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6148589|NCT01387932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6148590|NCT01388335|Warfarin|warfarin|mesh-list
6148591|NCT01388335|Anticoagulants|anticoagulants|mesh-ancestor
6148592|NCT01388361|Insulin|insulin|mesh-list
6148593|NCT01388361|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6148594|NCT01388361|Insulin Aspart|insulin aspart|mesh-list
6148595|NCT01388361|Liraglutide|liraglutide|mesh-list
6148596|NCT01388361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6148597|NCT01388361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148598|NCT01388361|Incretins|incretins|mesh-ancestor
6475871|NCT00521430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6475872|NCT00521430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5550542|NCT04094805|Glucocorticoids|glucocorticoids|mesh-ancestor
5550543|NCT04094805|Hormones|hormones|mesh-ancestor
5550544|NCT04094805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5550545|NCT04094805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5550546|NCT04094805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5550547|NCT04094805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5550548|NCT04094805|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
5550549|NCT04094805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5550550|NCT04094805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550551|NCT04094805|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5550552|NCT04094805|Vitamins|vitamins|mesh-ancestor
5550553|NCT04094805|Micronutrients|micronutrients|mesh-ancestor
5550554|NCT04094805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5550555|NCT04094909|Paclitaxel|paclitaxel|mesh-list
6148599|NCT01388361|Hormones|hormones|mesh-ancestor
6148600|NCT01388361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6148601|NCT01388478|Pramipexole|pramipexole|mesh-list
6148602|NCT01388478|Antioxidants|antioxidants|mesh-ancestor
6148603|NCT01388478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6148604|NCT01388478|Protective Agents|protective agents|mesh-ancestor
6148605|NCT01388478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550556|NCT04094909|Cisplatin|cisplatin|mesh-list
5550557|NCT04094909|Carboplatin|carboplatin|mesh-list
5550558|NCT04094909|Pembrolizumab|pembrolizumab|mesh-list
5550559|NCT04094909|Pemetrexed|pemetrexed|mesh-list
5550560|NCT04094909|Endostatins|endostatins|mesh-list
5550561|NCT04094909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5550562|NCT04094909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5550563|NCT04094909|Tubulin Modulators|tubulin modulators|mesh-ancestor
5550564|NCT04094909|Antimitotic Agents|antimitotic agents|mesh-ancestor
5550565|NCT04094909|Mitosis Modulators|mitosis modulators|mesh-ancestor
5550566|NCT04094909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550567|NCT04094909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5550568|NCT04094909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6148606|NCT01388478|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6148607|NCT01388478|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6148608|NCT01388478|Dopamine Agonists|dopamine agonists|mesh-ancestor
6148609|NCT01388478|Dopamine Agents|dopamine agents|mesh-ancestor
6148610|NCT01388478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6148611|NCT01388543|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6148612|NCT01388543|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6148613|NCT01388543|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6148614|NCT01388543|Protease Inhibitors|protease inhibitors|mesh-ancestor
6148615|NCT01388543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6148616|NCT01388543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6148617|NCT01388543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6148618|NCT01388543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6148619|NCT01388543|Antiviral Agents|antiviral agents|mesh-ancestor
6148620|NCT01388543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6148621|NCT01388647|Carboplatin|carboplatin|mesh-list
6148622|NCT01388647|Trastuzumab|trastuzumab|mesh-list
6148623|NCT01388647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6148624|NCT01388647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6148625|NCT01388790|Cetuximab|cetuximab|mesh-list
6148626|NCT01388790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6148627|NCT01388790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6148628|NCT01388946|Ropivacaine|ropivacaine|mesh-list
6148629|NCT01388946|Anesthetics, Local|anesthetics, local|mesh-ancestor
6148630|NCT01388946|Anesthetics|anesthetics|mesh-ancestor
6148631|NCT01388946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6148632|NCT01388946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550569|NCT04094909|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5550570|NCT04094909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5550571|NCT04094909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5550572|NCT04094909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5550573|NCT04094909|Growth Substances|growth substances|mesh-ancestor
6148633|NCT01388946|Sensory System Agents|sensory system agents|mesh-ancestor
6148634|NCT01388946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6148635|NCT01388985|Vaccines|vaccines|mesh-list
5550574|NCT04094909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550575|NCT04094909|Growth Inhibitors|growth inhibitors|mesh-ancestor
5550576|NCT04094727|Lumefantrine|lumefantrine|mesh-list
5550577|NCT04094727|Artemether|artemether|mesh-list
5550578|NCT04094727|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
5550579|NCT04094727|Antimalarials|antimalarials|mesh-ancestor
5550580|NCT04094727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6148636|NCT01388985|Immunologic Factors|immunologic factors|mesh-ancestor
6475873|NCT00521430|Immunologic Factors|immunologic factors|mesh-ancestor
5550581|NCT04094727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6148637|NCT01388985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475874|NCT00521430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6475875|NCT00521430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6475876|NCT00521430|Antifungal Agents|antifungal agents|mesh-ancestor
6475877|NCT00521430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6475878|NCT00521430|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6475879|NCT00521430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5550582|NCT04094727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5550583|NCT04094584|Naltrexone|naltrexone|mesh-list
5550584|NCT04094584|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5550585|NCT04094584|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5550586|NCT04094584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550587|NCT04094584|Sensory System Agents|sensory system agents|mesh-ancestor
5550588|NCT04094584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5550589|NCT04094597|Lactoferrin|lactoferrin|mesh-list
5550590|NCT04094597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5550591|NCT04094532|Bupivacaine|bupivacaine|mesh-list
5550592|NCT04094532|Anesthetics, Local|anesthetics, local|mesh-ancestor
5550593|NCT04094532|Anesthetics|anesthetics|mesh-ancestor
5550594|NCT04094532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5550595|NCT04094532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550596|NCT04094532|Sensory System Agents|sensory system agents|mesh-ancestor
5550597|NCT04094532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5550598|NCT04094467|Leuprolide|leuprolide|mesh-list
5550599|NCT04094467|Cetrorelix|cetrorelix|mesh-list
5550600|NCT04094467|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6475880|NCT00521430|Antiemetics|antiemetics|mesh-ancestor
6475881|NCT00521430|Autonomic Agents|autonomic agents|mesh-ancestor
6475882|NCT00521430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6475883|NCT00521430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6475884|NCT00521430|Glucocorticoids|glucocorticoids|mesh-ancestor
6148638|NCT01389076|Methotrexate|methotrexate|mesh-list
6148639|NCT01389076|Tositumomab I-131|tositumomab i-131|mesh-list
6475885|NCT00521430|Hormones|hormones|mesh-ancestor
6475886|NCT00521430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6475887|NCT00521430|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6148640|NCT01389076|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6148641|NCT01389076|Abortifacient Agents|abortifacient agents|mesh-ancestor
6148642|NCT01389076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6148643|NCT01389076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148644|NCT01389076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6148645|NCT01389076|Antimetabolites|antimetabolites|mesh-ancestor
6148646|NCT01389076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6148647|NCT01389076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6148648|NCT01389076|Dermatologic Agents|dermatologic agents|mesh-ancestor
6148649|NCT01389076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6148650|NCT01389076|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6148651|NCT01389076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6148652|NCT01389076|Immunologic Factors|immunologic factors|mesh-ancestor
6148653|NCT01389076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6148654|NCT01389076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6148655|NCT01389102|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6148656|NCT01389102|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6148657|NCT01389102|Estradiol|estradiol|mesh-list
6148658|NCT01389102|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6148659|NCT01389102|Estrogens|estrogens|mesh-ancestor
6148660|NCT01389102|Hormones|hormones|mesh-ancestor
6148661|NCT01389102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6148662|NCT01389102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148663|NCT01389102|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6148664|NCT01389102|Contraceptive Agents|contraceptive agents|mesh-ancestor
6148665|NCT01389102|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6148666|NCT01389102|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6148667|NCT01389284|Naproxen|naproxen|mesh-list
6148668|NCT01389284|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6148669|NCT01389284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6148670|NCT01389284|Analgesics|analgesics|mesh-ancestor
6148671|NCT01389284|Sensory System Agents|sensory system agents|mesh-ancestor
6148672|NCT01389284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6148673|NCT01389284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148674|NCT01389284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6148675|NCT01389284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6148676|NCT01389284|Gout Suppressants|gout suppressants|mesh-ancestor
6148677|NCT01389284|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5550601|NCT04094467|Fertility Agents|fertility agents|mesh-ancestor
6148678|NCT01389284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6148679|NCT01389284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6148680|NCT01389323|Interferons|interferons|mesh-list
6148681|NCT01389323|Ribavirin|ribavirin|mesh-list
6148682|NCT01389323|Interferon-alpha|interferon-alpha|mesh-list
6148683|NCT01389323|Interferon alpha-2|interferon alpha-2|mesh-list
6148684|NCT01389323|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6148685|NCT01389323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6148686|NCT01389323|Antiviral Agents|antiviral agents|mesh-ancestor
6148687|NCT01389323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6148688|NCT01389323|Antimetabolites|antimetabolites|mesh-ancestor
6148689|NCT01389323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6148690|NCT01389323|Immunologic Factors|immunologic factors|mesh-ancestor
6148691|NCT01389323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148692|NCT01389596|Pregabalin|pregabalin|mesh-list
6148693|NCT01389596|Analgesics|analgesics|mesh-ancestor
6148694|NCT01389596|Sensory System Agents|sensory system agents|mesh-ancestor
6148695|NCT01389596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6148696|NCT01389596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148697|NCT01389596|Anticonvulsants|anticonvulsants|mesh-ancestor
6148698|NCT01389596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6148699|NCT01389596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6148700|NCT01389596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6148701|NCT01389596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6148702|NCT01389596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6148703|NCT01389596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5550602|NCT04094467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5550603|NCT04094467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550604|NCT04094467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5550605|NCT04094467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5550606|NCT04094467|Hormone Antagonists|hormone antagonists|mesh-ancestor
5550607|NCT04094467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5550608|NCT04094701|Analgesics, Opioid|analgesics, opioid|mesh-list
5550609|NCT04094701|Narcotics|narcotics|mesh-ancestor
5550610|NCT04094701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5550611|NCT04094701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550612|NCT04094701|Analgesics|analgesics|mesh-ancestor
5550613|NCT04094701|Sensory System Agents|sensory system agents|mesh-ancestor
5550614|NCT04094701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5550615|NCT04094090|Riboflavin|riboflavin|mesh-list
5550616|NCT04094090|Vitamin B Complex|vitamin b complex|mesh-ancestor
5550617|NCT04094090|Vitamins|vitamins|mesh-ancestor
5550618|NCT04094090|Micronutrients|micronutrients|mesh-ancestor
5550619|NCT04094090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550620|NCT04094090|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6148704|NCT01389596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6148705|NCT01389596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6148706|NCT01389752|Charcoal|charcoal|mesh-list
6148707|NCT01389752|Antidotes|antidotes|mesh-ancestor
6148708|NCT01389752|Protective Agents|protective agents|mesh-ancestor
6148709|NCT01389752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148710|NCT01389856|Bosentan|bosentan|mesh-list
6148711|NCT01389856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6475888|NCT00521430|Protective Agents|protective agents|mesh-ancestor
6475889|NCT00521430|Alkylating Agents|alkylating agents|mesh-ancestor
6475890|NCT00521430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6475891|NCT00521430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6475892|NCT00521482|Thalidomide|thalidomide|mesh-list
6475893|NCT00521482|Temozolomide|temozolomide|mesh-list
6475894|NCT00521482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6475895|NCT00521482|Alkylating Agents|alkylating agents|mesh-ancestor
6475896|NCT00521482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475897|NCT00521482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6475898|NCT00521482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6475899|NCT00521482|Immunologic Factors|immunologic factors|mesh-ancestor
6475900|NCT00521482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475901|NCT00521482|Leprostatic Agents|leprostatic agents|mesh-ancestor
6475902|NCT00521482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6475903|NCT00521482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6475904|NCT00521482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6475905|NCT00521482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6475906|NCT00521482|Growth Substances|growth substances|mesh-ancestor
5550621|NCT04094090|Dermatologic Agents|dermatologic agents|mesh-ancestor
6148712|NCT01389856|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6148713|NCT01389856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6148714|NCT01389973|Ustekinumab|ustekinumab|mesh-list
6148715|NCT01389973|Dermatologic Agents|dermatologic agents|mesh-ancestor
6148716|NCT01390064|Vaccines|vaccines|mesh-list
6148717|NCT01390064|Immunologic Factors|immunologic factors|mesh-ancestor
6148718|NCT01390064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148719|NCT01390077|Nitisinone|nitisinone|mesh-list
6148720|NCT01390077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6148721|NCT01390077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550622|NCT04094142|Lenalidomide|lenalidomide|mesh-list
5550623|NCT04094142|Acalabrutinib|acalabrutinib|mesh-list
5550624|NCT04094142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5550625|NCT04094142|Immunologic Factors|immunologic factors|mesh-ancestor
5550626|NCT04094142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550627|NCT04094142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5550628|NCT04094142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5550629|NCT04094142|Growth Substances|growth substances|mesh-ancestor
5550630|NCT04094142|Growth Inhibitors|growth inhibitors|mesh-ancestor
5550631|NCT04093895|Taurolidine|taurolidine|mesh-list
5550632|NCT04093895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5550633|NCT04093895|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5550634|NCT04093895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5550635|NCT04093765|Antimalarials|antimalarials|mesh-list
5550636|NCT04093765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5550637|NCT04093765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5550638|NCT04093765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5550639|NCT04093518|Estradiol|estradiol|mesh-list
5550640|NCT04093518|Estrogens|estrogens|mesh-ancestor
5550641|NCT04093518|Hormones|hormones|mesh-ancestor
5550642|NCT04093518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5550643|NCT04093518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550644|NCT04093505|Gemtuzumab|gemtuzumab|mesh-list
5550645|NCT04093505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5550646|NCT04093505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6148722|NCT01390220|Midazolam|midazolam|mesh-list
6148723|NCT01390220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6475907|NCT00521482|Growth Inhibitors|growth inhibitors|mesh-ancestor
5550647|NCT04093531|Ustekinumab|ustekinumab|mesh-list
5550648|NCT04093531|Dermatologic Agents|dermatologic agents|mesh-ancestor
5550649|NCT04093713|Nordefrin|nordefrin|mesh-list
5550650|NCT04093713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6475908|NCT00521521|Docetaxel|docetaxel|mesh-list
6475909|NCT00521521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6475910|NCT00521521|Tubulin Modulators|tubulin modulators|mesh-ancestor
6475911|NCT00521521|Antimitotic Agents|antimitotic agents|mesh-ancestor
6475912|NCT00521521|Mitosis Modulators|mitosis modulators|mesh-ancestor
6475913|NCT00521521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475914|NCT00521612|Sevoflurane|sevoflurane|mesh-list
6475915|NCT00521612|Isoflurane|isoflurane|mesh-list
6475916|NCT00521612|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6475917|NCT00521612|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6148724|NCT01390220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6148725|NCT01390220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6148726|NCT01390220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148727|NCT01390220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6148728|NCT01390220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6148729|NCT01390220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6148730|NCT01390220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6148731|NCT01390220|Anesthetics, General|anesthetics, general|mesh-ancestor
6667584|NCT01527903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6667585|NCT01527903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667586|NCT01527903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6667587|NCT01527903|Anesthetics, General|anesthetics, general|mesh-ancestor
6667588|NCT01527903|Anesthetics|anesthetics|mesh-ancestor
6667589|NCT01527903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6667590|NCT01527903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6667591|NCT01527903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6667592|NCT01527903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5550651|NCT04093648|Cyclophosphamide|cyclophosphamide|mesh-list
5550652|NCT04093648|Fludarabine|fludarabine|mesh-list
5550653|NCT04093648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5550654|NCT04093648|Immunologic Factors|immunologic factors|mesh-ancestor
5550655|NCT04093648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550656|NCT04093648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5550657|NCT04093648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5550658|NCT04093648|Alkylating Agents|alkylating agents|mesh-ancestor
6148732|NCT01390220|Anesthetics|anesthetics|mesh-ancestor
6148733|NCT01390220|GABA Modulators|gaba modulators|mesh-ancestor
6475918|NCT00521612|Anesthetics, General|anesthetics, general|mesh-ancestor
6667593|NCT01527903|GABA Modulators|gaba modulators|mesh-ancestor
6667594|NCT01527903|GABA Agents|gaba agents|mesh-ancestor
6148734|NCT01390220|GABA Agents|gaba agents|mesh-ancestor
6148735|NCT01390220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6148736|NCT01390220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6148737|NCT01390233|Dinoprostone|dinoprostone|mesh-list
5550659|NCT04093648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550660|NCT04093648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6148738|NCT01390233|Oxytocics|oxytocics|mesh-ancestor
6148739|NCT01390233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6148740|NCT01390233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148741|NCT01390246|Bupropion|bupropion|mesh-list
6148742|NCT01390246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6148743|NCT01390246|Antidepressive Agents|antidepressive agents|mesh-ancestor
6148744|NCT01390246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6148745|NCT01390246|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6148746|NCT01390246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6148747|NCT01390246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6148748|NCT01390246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6148749|NCT01390246|Dopamine Agents|dopamine agents|mesh-ancestor
6148750|NCT01390246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6148751|NCT01390246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148752|NCT01390246|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6148753|NCT01390246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6148754|NCT01390246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6205660|NCT02090413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6205661|NCT02090413|Analgesics|analgesics|mesh-ancestor
6205662|NCT02090413|Sensory System Agents|sensory system agents|mesh-ancestor
6205663|NCT02090413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6205664|NCT02090413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205665|NCT02090413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6205666|NCT02090413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6205667|NCT02090413|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6205668|NCT02090413|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6205669|NCT02090413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205670|NCT02090413|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6205671|NCT02090413|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6205672|NCT02090413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5550661|NCT04093648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5602862|NCT04038515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602863|NCT04038515|Antipruritics|antipruritics|mesh-ancestor
5602864|NCT04038515|Dermatologic Agents|dermatologic agents|mesh-ancestor
5602865|NCT04031508|SMOFlipid|smoflipid|mesh-list
5602866|NCT04031508|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
5602867|NCT04031508|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5602868|NCT04031508|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5606782|NCT03786783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5606783|NCT03786783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5606784|NCT03786783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5606785|NCT03786783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5606786|NCT03786783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5606787|NCT03786783|Tubulin Modulators|tubulin modulators|mesh-ancestor
5606788|NCT03786783|Antimitotic Agents|antimitotic agents|mesh-ancestor
5606789|NCT03786783|Mitosis Modulators|mitosis modulators|mesh-ancestor
5606790|NCT03786783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6205673|NCT02090413|Antipyretics|antipyretics|mesh-ancestor
6205674|NCT02090413|Dermatologic Agents|dermatologic agents|mesh-ancestor
6205675|NCT02090413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6205676|NCT02090413|Immunologic Factors|immunologic factors|mesh-ancestor
6205677|NCT02091206|Cannabidiol|cannabidiol|mesh-list
6205678|NCT02091206|Anticonvulsants|anticonvulsants|mesh-ancestor
6205679|NCT02091362|Metformin|metformin|mesh-list
6205680|NCT02091362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6205681|NCT02091362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205682|NCT02091375|Cannabidiol|cannabidiol|mesh-list
6205683|NCT02091375|Anticonvulsants|anticonvulsants|mesh-ancestor
6205684|NCT02091414|Cyclosporine|cyclosporine|mesh-list
6205685|NCT02091414|Mycophenolic Acid|mycophenolic acid|mesh-list
5550662|NCT04093206|Vitamins|vitamins|mesh-list
5550663|NCT04093206|Ascorbic Acid|ascorbic acid|mesh-list
5550664|NCT04093206|Micronutrients|micronutrients|mesh-ancestor
5550665|NCT04093206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550666|NCT04093206|Antioxidants|antioxidants|mesh-ancestor
5550667|NCT04093206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550668|NCT04093206|Protective Agents|protective agents|mesh-ancestor
6148755|NCT01390389|Ubiquinone|ubiquinone|mesh-list
6148756|NCT01390389|Coenzyme Q10|coenzyme q10|mesh-list
6148757|NCT01390389|Micronutrients|micronutrients|mesh-ancestor
6148758|NCT01390389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148759|NCT01390389|Vitamins|vitamins|mesh-ancestor
6148760|NCT01390402|Aldesleukin|aldesleukin|mesh-list
6148761|NCT01390402|Methotrexate|methotrexate|mesh-list
6148762|NCT01390402|Fludarabine phosphate|fludarabine phosphate|mesh-list
6148763|NCT01390402|Fludarabine|fludarabine|mesh-list
6148764|NCT01390402|Busulfan|busulfan|mesh-list
6148765|NCT01390402|Interleukin-2|interleukin-2|mesh-list
6148766|NCT01390402|Tacrolimus|tacrolimus|mesh-list
6148767|NCT01390402|Thymoglobulin|thymoglobulin|mesh-list
6148768|NCT01390402|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6148769|NCT01390402|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6148770|NCT01390402|Abortifacient Agents|abortifacient agents|mesh-ancestor
6148771|NCT01390402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6148772|NCT01390402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148773|NCT01390402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6148774|NCT01390402|Antimetabolites|antimetabolites|mesh-ancestor
6148775|NCT01390402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6148776|NCT01390402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6148777|NCT01390402|Dermatologic Agents|dermatologic agents|mesh-ancestor
6148778|NCT01390402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6148779|NCT01390402|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6667595|NCT01527903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6667596|NCT01527903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550669|NCT04093219|Acetaminophen|acetaminophen|mesh-list
5550670|NCT04093219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5550671|NCT04093219|Analgesics|analgesics|mesh-ancestor
5550672|NCT04093219|Sensory System Agents|sensory system agents|mesh-ancestor
5550673|NCT04093219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5550674|NCT04093219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550675|NCT04093219|Antipyretics|antipyretics|mesh-ancestor
5550676|NCT04093271|Diphenhydramine|diphenhydramine|mesh-list
5550677|NCT04093271|Promethazine|promethazine|mesh-list
5550678|NCT04093271|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5550679|NCT04093271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5550680|NCT04093271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5550681|NCT04093271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550682|NCT04093271|Anesthetics, Local|anesthetics, local|mesh-ancestor
6667597|NCT01527968|Tranexamic Acid|tranexamic acid|mesh-list
6667598|NCT01527968|Aminocaproic Acid|aminocaproic acid|mesh-list
6667599|NCT01527968|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6667600|NCT01527968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6667601|NCT01527968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667602|NCT01527968|Hemostatics|hemostatics|mesh-ancestor
6667603|NCT01527968|Coagulants|coagulants|mesh-ancestor
6667604|NCT01527994|Aprepitant|aprepitant|mesh-list
6667605|NCT01527994|Antiemetics|antiemetics|mesh-ancestor
6667606|NCT01527994|Autonomic Agents|autonomic agents|mesh-ancestor
6667607|NCT01527994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6667608|NCT01527994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667609|NCT01527994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5550683|NCT04093271|Anesthetics|anesthetics|mesh-ancestor
5550684|NCT04093271|Sensory System Agents|sensory system agents|mesh-ancestor
6148780|NCT01390402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6148781|NCT01390402|Immunologic Factors|immunologic factors|mesh-ancestor
6148782|NCT01390402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6667610|NCT01527994|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5550685|NCT04093271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5550686|NCT04093271|Antiemetics|antiemetics|mesh-ancestor
5550687|NCT04093271|Autonomic Agents|autonomic agents|mesh-ancestor
5550688|NCT04093271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5550689|NCT04093271|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5550690|NCT04093271|Histamine Antagonists|histamine antagonists|mesh-ancestor
5550691|NCT04093271|Histamine Agents|histamine agents|mesh-ancestor
5550692|NCT04093271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5550693|NCT04093271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550694|NCT04093271|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5550695|NCT04093271|Antipruritics|antipruritics|mesh-ancestor
5550696|NCT04093271|Dermatologic Agents|dermatologic agents|mesh-ancestor
5550697|NCT04093050|Vasopressins|vasopressins|mesh-list
5550698|NCT04093050|Hemostatics|hemostatics|mesh-ancestor
5550699|NCT04093050|Coagulants|coagulants|mesh-ancestor
6667611|NCT01527994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6667612|NCT01527994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667613|NCT01528007|Naltrexone|naltrexone|mesh-list
5550700|NCT04093050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5550701|NCT04093050|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5550702|NCT04093050|Natriuretic Agents|natriuretic agents|mesh-ancestor
5550703|NCT04093050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550704|NCT04092751|Ibrexafungerp|ibrexafungerp|mesh-list
5550705|NCT04092751|Antifungal Agents|antifungal agents|mesh-ancestor
5550706|NCT04092751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5550707|NCT04092725|Ibrexafungerp|ibrexafungerp|mesh-list
6148783|NCT01390402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6148784|NCT01390402|Antiviral Agents|antiviral agents|mesh-ancestor
6148785|NCT01390402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6148786|NCT01390402|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6475919|NCT00521612|Anesthetics|anesthetics|mesh-ancestor
6475920|NCT00521612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6475921|NCT00521612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475922|NCT00521690|Insulin Detemir|insulin detemir|mesh-list
6475923|NCT00521690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6475924|NCT00521690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475925|NCT00521703|Lidocaine|lidocaine|mesh-list
6148787|NCT01390402|Alkylating Agents|alkylating agents|mesh-ancestor
6148788|NCT01390402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6148789|NCT01390402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6148790|NCT01390402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6148791|NCT01390402|Analgesics|analgesics|mesh-ancestor
6148792|NCT01390402|Sensory System Agents|sensory system agents|mesh-ancestor
6148793|NCT01390402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6148794|NCT01390402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6148795|NCT01390402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6148796|NCT01390428|Grazoprevir|grazoprevir|mesh-list
6148797|NCT01390428|Antiviral Agents|antiviral agents|mesh-ancestor
6148798|NCT01390428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6148799|NCT01390441|Acetaminophen|acetaminophen|mesh-list
6148800|NCT01390441|Loratadine|loratadine|mesh-list
6148801|NCT01390441|Methylprednisolone|methylprednisolone|mesh-list
6148802|NCT01390441|Rituximab|rituximab|mesh-list
6148803|NCT01390441|Methotrexate|methotrexate|mesh-list
6148804|NCT01390441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6148805|NCT01390441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6148806|NCT01390441|Immunologic Factors|immunologic factors|mesh-ancestor
6148807|NCT01390441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148808|NCT01390441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6148809|NCT01390441|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6148810|NCT01390441|Abortifacient Agents|abortifacient agents|mesh-ancestor
6148811|NCT01390441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6148812|NCT01390441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6148813|NCT01390441|Antimetabolites|antimetabolites|mesh-ancestor
6475926|NCT00521703|Anesthetics, Local|anesthetics, local|mesh-ancestor
6475927|NCT00521703|Anesthetics|anesthetics|mesh-ancestor
6475928|NCT00521703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6475929|NCT00521703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475930|NCT00521703|Sensory System Agents|sensory system agents|mesh-ancestor
6475931|NCT00521703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6475932|NCT00521703|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6475933|NCT00521703|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6475934|NCT00521703|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6475935|NCT00521703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6475936|NCT00521703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550708|NCT04092725|Antifungal Agents|antifungal agents|mesh-ancestor
6205686|NCT02091414|Cyclosporins|cyclosporins|mesh-list
5550709|NCT04092725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6475937|NCT00521742|Pioglitazone|pioglitazone|mesh-list
6475938|NCT00521742|Glyburide|glyburide|mesh-list
6475939|NCT00521742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6475940|NCT00521742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475941|NCT00521781|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6475942|NCT00521781|Leuprolide|leuprolide|mesh-list
6475943|NCT00521781|Bicalutamide|bicalutamide|mesh-list
6475944|NCT00521781|Androgen Antagonists|androgen antagonists|mesh-list
6475945|NCT00521781|Androgens|androgens|mesh-list
6475946|NCT00521781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6475947|NCT00521781|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6475948|NCT00521781|Fertility Agents|fertility agents|mesh-ancestor
6475949|NCT00521781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6475950|NCT00521781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475951|NCT00521781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6475952|NCT00521781|Hormone Antagonists|hormone antagonists|mesh-ancestor
6475953|NCT00521781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6148814|NCT01390441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6148815|NCT01390441|Dermatologic Agents|dermatologic agents|mesh-ancestor
6148816|NCT01390441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6148817|NCT01390441|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6148818|NCT01390441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6148819|NCT01390441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6148820|NCT01390441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6148821|NCT01390441|Analgesics|analgesics|mesh-ancestor
6148822|NCT01390441|Sensory System Agents|sensory system agents|mesh-ancestor
6148823|NCT01390441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6148824|NCT01390441|Antipyretics|antipyretics|mesh-ancestor
6148825|NCT01390441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6148826|NCT01390441|Antiemetics|antiemetics|mesh-ancestor
6148827|NCT01390441|Autonomic Agents|autonomic agents|mesh-ancestor
6148828|NCT01390441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6148829|NCT01390441|Glucocorticoids|glucocorticoids|mesh-ancestor
6148830|NCT01390441|Hormones|hormones|mesh-ancestor
6148831|NCT01390441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6475954|NCT00521781|Hormones|hormones|mesh-ancestor
6475955|NCT00521820|Pioglitazone|pioglitazone|mesh-list
6475956|NCT00521820|Glyburide|glyburide|mesh-list
6475957|NCT00521820|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6475958|NCT00521820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475959|NCT00521859|Vidarabine|vidarabine|mesh-list
6475960|NCT00521859|Fludarabine|fludarabine|mesh-list
6475961|NCT00521859|Fludarabine phosphate|fludarabine phosphate|mesh-list
6148832|NCT01390441|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5550710|NCT04092868|Protamines|protamines|mesh-list
5550711|NCT04092868|Heparin Antagonists|heparin antagonists|mesh-ancestor
5550712|NCT04092868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550713|NCT04092868|Coagulants|coagulants|mesh-ancestor
5550714|NCT04092621|Amiodarone|amiodarone|mesh-list
5550715|NCT04092621|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5550716|NCT04092621|Vasodilator Agents|vasodilator agents|mesh-ancestor
5550717|NCT04092621|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5550718|NCT04092621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6148833|NCT01390441|Protective Agents|protective agents|mesh-ancestor
6148834|NCT01390441|Antipruritics|antipruritics|mesh-ancestor
6148835|NCT01390441|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6148836|NCT01390441|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6475962|NCT00521859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6475963|NCT00521859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6475964|NCT00521859|Antimetabolites|antimetabolites|mesh-ancestor
6475965|NCT00521859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475966|NCT00521859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6475967|NCT00521859|Immunologic Factors|immunologic factors|mesh-ancestor
6148837|NCT01390441|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6148838|NCT01390441|Histamine Antagonists|histamine antagonists|mesh-ancestor
6148839|NCT01390441|Histamine Agents|histamine agents|mesh-ancestor
6148840|NCT01390441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6148841|NCT01390584|Prednisone|prednisone|mesh-list
6148842|NCT01390584|Cyclophosphamide|cyclophosphamide|mesh-list
6148843|NCT01390584|Dacarbazine|dacarbazine|mesh-list
6148844|NCT01390584|Doxorubicin|doxorubicin|mesh-list
6148845|NCT01390584|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6148846|NCT01390584|Etoposide|etoposide|mesh-list
6148847|NCT01390584|Vincristine|vincristine|mesh-list
6667614|NCT01528007|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6148848|NCT01390584|Etoposide phosphate|etoposide phosphate|mesh-list
6148849|NCT01390584|Bleomycin|bleomycin|mesh-list
6475968|NCT00521859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148850|NCT01390584|Vinblastine|vinblastine|mesh-list
6148851|NCT01390584|Podophyllotoxin|podophyllotoxin|mesh-list
6148852|NCT01390584|Procarbazine|procarbazine|mesh-list
6148853|NCT01390584|Imidazole|imidazole|mesh-list
6148854|NCT01390584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6148855|NCT01390584|Immunologic Factors|immunologic factors|mesh-ancestor
6148856|NCT01390584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148857|NCT01390584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6148858|NCT01390584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6148859|NCT01390584|Alkylating Agents|alkylating agents|mesh-ancestor
6148860|NCT01390584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6148861|NCT01390584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6148862|NCT01390584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6475969|NCT00521859|Antiviral Agents|antiviral agents|mesh-ancestor
6148863|NCT01390584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6475970|NCT00521859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6475971|NCT00521950|Mercaptopurine|mercaptopurine|mesh-list
6475972|NCT00521950|Azathioprine|azathioprine|mesh-list
6475973|NCT00521950|Antimetabolites|antimetabolites|mesh-ancestor
6475974|NCT00521950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475975|NCT00521950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6475976|NCT00521950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6475977|NCT00521950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6475978|NCT00521950|Immunologic Factors|immunologic factors|mesh-ancestor
6475979|NCT00521950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475980|NCT00521950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6475981|NCT00521950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6475982|NCT00521950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6475983|NCT00521963|Infliximab|infliximab|mesh-list
6475984|NCT00521963|Dermatologic Agents|dermatologic agents|mesh-ancestor
6475985|NCT00521963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6475986|NCT00521963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6475987|NCT00522015|Rivastigmine|rivastigmine|mesh-list
6475988|NCT00522015|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6475989|NCT00522015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6475990|NCT00522015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6475991|NCT00522015|Cholinergic Agents|cholinergic agents|mesh-ancestor
6475992|NCT00522015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6475993|NCT00522015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475994|NCT00522015|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6475995|NCT00522015|Protective Agents|protective agents|mesh-ancestor
6475996|NCT00522132|Artesunate|artesunate|mesh-list
6148864|NCT01390584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6148865|NCT01390584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6148866|NCT01390584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6148867|NCT01390584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6148868|NCT01390584|Glucocorticoids|glucocorticoids|mesh-ancestor
6148869|NCT01390584|Hormones|hormones|mesh-ancestor
6148870|NCT01390584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6667615|NCT01528007|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6667616|NCT01528007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667617|NCT01528007|Sensory System Agents|sensory system agents|mesh-ancestor
6667618|NCT01528007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6667619|NCT01528137|Lactoferrin|lactoferrin|mesh-list
6667620|NCT01528137|Talactoferrin alfa|talactoferrin alfa|mesh-list
6667621|NCT01528137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6667622|NCT01528137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6672439|NCT01556191|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6672440|NCT01556191|Fulvestrant|fulvestrant|mesh-list
6672441|NCT01556191|Gefitinib|gefitinib|mesh-list
6672442|NCT01556191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6672443|NCT01556191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6672444|NCT01556191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6672445|NCT01556191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672446|NCT01556191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6672447|NCT01556191|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6672448|NCT01556191|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6475997|NCT00522132|Antimalarials|antimalarials|mesh-ancestor
6475998|NCT00522132|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5550719|NCT04092621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667623|NCT01528163|Methotrexate|methotrexate|mesh-list
6667624|NCT01528163|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6667625|NCT01528163|Abortifacient Agents|abortifacient agents|mesh-ancestor
6667626|NCT01528163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6667627|NCT01528163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667628|NCT01528163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6667629|NCT01528163|Antimetabolites|antimetabolites|mesh-ancestor
6667630|NCT01528163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6148871|NCT01390584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6148872|NCT01390584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6148873|NCT01390584|Tubulin Modulators|tubulin modulators|mesh-ancestor
6148874|NCT01390584|Antimitotic Agents|antimitotic agents|mesh-ancestor
6148875|NCT01390584|Mitosis Modulators|mitosis modulators|mesh-ancestor
6148876|NCT01390584|Keratolytic Agents|keratolytic agents|mesh-ancestor
6148877|NCT01390584|Dermatologic Agents|dermatologic agents|mesh-ancestor
6148878|NCT01390649|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6148879|NCT01390649|Immunologic Factors|immunologic factors|mesh-ancestor
6148880|NCT01390649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6475999|NCT00522132|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6476000|NCT00522132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6476001|NCT00522132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6476002|NCT00522132|Antiviral Agents|antiviral agents|mesh-ancestor
6476003|NCT00522132|Schistosomicides|schistosomicides|mesh-ancestor
6476004|NCT00522132|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6476005|NCT00522132|Anthelmintics|anthelmintics|mesh-ancestor
6476006|NCT00522158|Atorvastatin|atorvastatin|mesh-list
6476007|NCT00522158|Simvastatin|simvastatin|mesh-list
6476008|NCT00522158|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6476009|NCT00522158|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6476010|NCT00522158|Antimetabolites|antimetabolites|mesh-ancestor
6476011|NCT00522158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476012|NCT00522158|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6476013|NCT00522158|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6476014|NCT00522158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6148881|NCT01390818|Niacinamide|niacinamide|mesh-list
6148882|NCT01390818|Sirolimus|sirolimus|mesh-list
6148883|NCT01390818|Elafin|elafin|mesh-list
6148884|NCT01390818|Protease Inhibitors|protease inhibitors|mesh-ancestor
6148885|NCT01390818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6148886|NCT01390818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6148887|NCT01390818|Vitamin B Complex|vitamin b complex|mesh-ancestor
6148888|NCT01390818|Vitamins|vitamins|mesh-ancestor
6148889|NCT01390818|Micronutrients|micronutrients|mesh-ancestor
6148890|NCT01390818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148891|NCT01390818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6148892|NCT01390818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6148893|NCT01390818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6148894|NCT01390818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6148895|NCT01390818|Antifungal Agents|antifungal agents|mesh-ancestor
6148896|NCT01390818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6148897|NCT01390818|Immunologic Factors|immunologic factors|mesh-ancestor
6148898|NCT01390844|Ribavirin|ribavirin|mesh-list
6148899|NCT01390844|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6148900|NCT01390844|Antimetabolites|antimetabolites|mesh-ancestor
6148901|NCT01390844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476015|NCT00522184|Etanercept|etanercept|mesh-list
6476016|NCT00522184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6476017|NCT00522184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6476018|NCT00522184|Analgesics|analgesics|mesh-ancestor
6148902|NCT01390844|Antiviral Agents|antiviral agents|mesh-ancestor
6148903|NCT01390844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6148904|NCT01390857|Valacyclovir|valacyclovir|mesh-list
6148905|NCT01390857|Antiviral Agents|antiviral agents|mesh-ancestor
6148906|NCT01390857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6148907|NCT01390870|Alfuzosin|alfuzosin|mesh-list
6476019|NCT00522184|Sensory System Agents|sensory system agents|mesh-ancestor
6476020|NCT00522184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6476021|NCT00522184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476022|NCT00522184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6476023|NCT00522184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6476024|NCT00522184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6476025|NCT00522184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6148908|NCT01390870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6148909|NCT01390870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476026|NCT00522184|Immunologic Factors|immunologic factors|mesh-ancestor
5550720|NCT04092621|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5550721|NCT04092621|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5550722|NCT04092621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5550723|NCT04092621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5550724|NCT04092621|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5550725|NCT04092621|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5550726|NCT04092621|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5550727|NCT04092595|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5550728|NCT04092595|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5550729|NCT04092595|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5550730|NCT04092595|Antimetabolites|antimetabolites|mesh-ancestor
5550731|NCT04092595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550732|NCT04092595|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5550733|NCT04092595|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5550734|NCT04092595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5550735|NCT04092387|Nicotine|nicotine|mesh-list
5550736|NCT04092387|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5550737|NCT04092387|Autonomic Agents|autonomic agents|mesh-ancestor
5550738|NCT04092387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5550739|NCT04092387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550740|NCT04092387|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5550741|NCT04092387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5550742|NCT04092387|Cholinergic Agents|cholinergic agents|mesh-ancestor
5550743|NCT04092387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5550744|NCT04092387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476027|NCT00522210|Insulin|insulin|mesh-list
6476028|NCT00522210|Isophane Insulin, Human|isophane insulin, human|mesh-list
6476029|NCT00522210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6476030|NCT00522210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476031|NCT00522249|Interferons|interferons|mesh-list
6476032|NCT00522249|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6476033|NCT00522249|Interferon-alpha|interferon-alpha|mesh-list
6476034|NCT00522249|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
5550745|NCT04092478|Anesthetics|anesthetics|mesh-list
5550746|NCT04092478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5550747|NCT04092478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550748|NCT04092205|N,N'-Bis(2-mercaptoethyl)isophthalamide|n,n'-bis(2-mercaptoethyl)isophthalamide|mesh-list
5550749|NCT04092205|Chelating Agents|chelating agents|mesh-ancestor
5550750|NCT04092205|Sequestering Agents|sequestering agents|mesh-ancestor
5550751|NCT04092205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550752|NCT04092309|Valsartan|valsartan|mesh-list
6476035|NCT00522249|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6476036|NCT00522249|Sunitinib|sunitinib|mesh-list
6476037|NCT00522249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6476038|NCT00522249|Antiviral Agents|antiviral agents|mesh-ancestor
6476039|NCT00522249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6148910|NCT01390870|Urological Agents|urological agents|mesh-ancestor
6148911|NCT01390870|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5550753|NCT04092309|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5550754|NCT04092309|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
5550755|NCT04092309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5550756|NCT04092309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5550757|NCT04092309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5550758|NCT04092309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550759|NCT04092309|Protease Inhibitors|protease inhibitors|mesh-ancestor
5550760|NCT04092309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5550761|NCT04091971|Ketamine|ketamine|mesh-list
5550762|NCT04091971|Analgesics|analgesics|mesh-ancestor
5550763|NCT04091971|Sensory System Agents|sensory system agents|mesh-ancestor
5550764|NCT04091971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5550765|NCT04091971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550766|NCT04091971|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6148912|NCT01390870|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6148913|NCT01390870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6148914|NCT01390870|Adrenergic Agents|adrenergic agents|mesh-ancestor
6148915|NCT01390870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6148916|NCT01390909|Oxcarbazepine|oxcarbazepine|mesh-list
6476040|NCT00522249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5550767|NCT04091971|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5550768|NCT04091971|Anesthetics, General|anesthetics, general|mesh-ancestor
5550769|NCT04091971|Anesthetics|anesthetics|mesh-ancestor
5602869|NCT04017832|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6476041|NCT00522249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6148917|NCT01390909|Anticonvulsants|anticonvulsants|mesh-list
6148918|NCT01390909|Lactitol|lactitol|mesh-list
6667631|NCT01528163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6667632|NCT01528163|Dermatologic Agents|dermatologic agents|mesh-ancestor
6667633|NCT01528163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6667634|NCT01528163|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6667635|NCT01528163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6667636|NCT01528163|Immunologic Factors|immunologic factors|mesh-ancestor
6667637|NCT01528163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6476042|NCT00522249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476043|NCT00522249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6476044|NCT00522249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6476045|NCT00522249|Growth Substances|growth substances|mesh-ancestor
6476046|NCT00522249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148919|NCT01390909|Cathartics|cathartics|mesh-ancestor
6148920|NCT01390909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6148921|NCT01390909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6148922|NCT01390909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6148923|NCT01390909|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6148924|NCT01390909|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6148925|NCT01390909|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6148926|NCT01390909|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6148927|NCT01390948|Bevacizumab|bevacizumab|mesh-list
6148928|NCT01390948|Temozolomide|temozolomide|mesh-list
6148929|NCT01390948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6148930|NCT01390948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6148931|NCT01390948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6148932|NCT01390948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6148933|NCT01390948|Growth Substances|growth substances|mesh-ancestor
6148934|NCT01390948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148935|NCT01390948|Growth Inhibitors|growth inhibitors|mesh-ancestor
6148936|NCT01390948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6148937|NCT01390948|Alkylating Agents|alkylating agents|mesh-ancestor
6148938|NCT01390948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476047|NCT00522249|Growth Inhibitors|growth inhibitors|mesh-ancestor
6476048|NCT00522249|Immunologic Factors|immunologic factors|mesh-ancestor
6488741|NCT00586287|Phenprocoumon|phenprocoumon|mesh-list
6488742|NCT00586287|Anticoagulants|anticoagulants|mesh-ancestor
6488743|NCT00586365|Naproxen|naproxen|mesh-list
6488744|NCT00586365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6488745|NCT00586365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6488746|NCT00586365|Analgesics|analgesics|mesh-ancestor
6488747|NCT00586365|Sensory System Agents|sensory system agents|mesh-ancestor
6488748|NCT00586365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6488749|NCT00586365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488750|NCT00586365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6488751|NCT00586365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6488752|NCT00586365|Gout Suppressants|gout suppressants|mesh-ancestor
6488753|NCT00586365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6488754|NCT00586365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6488755|NCT00586365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488756|NCT00586430|Lorazepam|lorazepam|mesh-list
6148939|NCT01391013|Ritonavir|ritonavir|mesh-list
6148940|NCT01391013|Darunavir|darunavir|mesh-list
6148941|NCT01391013|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
6488757|NCT00586430|Anticonvulsants|anticonvulsants|mesh-ancestor
6488758|NCT00586430|Antiemetics|antiemetics|mesh-ancestor
6488759|NCT00586430|Autonomic Agents|autonomic agents|mesh-ancestor
6488760|NCT00586430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6488761|NCT00586430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488762|NCT00586430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6488763|NCT00586430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6488764|NCT00586430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6488765|NCT00586430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6488766|NCT00586430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6488767|NCT00586430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6488768|NCT00586430|GABA Modulators|gaba modulators|mesh-ancestor
6488769|NCT00586430|GABA Agents|gaba agents|mesh-ancestor
6488770|NCT00586430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6488771|NCT00586430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488772|NCT00586443|Bevacizumab|bevacizumab|mesh-list
6488773|NCT00586443|Panitumumab|panitumumab|mesh-list
6488774|NCT00586443|Everolimus|everolimus|mesh-list
6667638|NCT01528163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6488775|NCT00586443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6148942|NCT01391013|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6148943|NCT01391013|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6148944|NCT01391013|Protease Inhibitors|protease inhibitors|mesh-ancestor
6148945|NCT01391013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6148946|NCT01391013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6148947|NCT01391013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6148948|NCT01391013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6667639|NCT01528176|Cholecalciferol|cholecalciferol|mesh-list
6667640|NCT01528176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6667641|NCT01528176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667642|NCT01528176|Vitamins|vitamins|mesh-ancestor
6667643|NCT01528176|Micronutrients|micronutrients|mesh-ancestor
6667644|NCT01528176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6667645|NCT01528280|Vaccines|vaccines|mesh-list
6667646|NCT01528280|Immunologic Factors|immunologic factors|mesh-ancestor
6667647|NCT01528280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667648|NCT01528371|Midazolam|midazolam|mesh-list
6667649|NCT01528371|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6667650|NCT01528371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6667651|NCT01528371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6667652|NCT01528371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667653|NCT01528371|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6667654|NCT01528371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6667655|NCT01528371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6476049|NCT00522444|Magnesium Sulfate|magnesium sulfate|mesh-list
6476050|NCT00522444|Analgesics|analgesics|mesh-ancestor
6476051|NCT00522444|Sensory System Agents|sensory system agents|mesh-ancestor
6476052|NCT00522444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6476053|NCT00522444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476054|NCT00522444|Anesthetics|anesthetics|mesh-ancestor
6476055|NCT00522444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6476056|NCT00522444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6476057|NCT00522444|Anticonvulsants|anticonvulsants|mesh-ancestor
6476058|NCT00522444|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6148949|NCT01391013|Antiviral Agents|antiviral agents|mesh-ancestor
6148950|NCT01391013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6148951|NCT01391013|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6148952|NCT01391013|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6476059|NCT00522444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5550770|NCT04091971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5550771|NCT04091971|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5550772|NCT04091971|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5550773|NCT04091971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5550774|NCT04091971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550775|NCT04092101|Nicotine|nicotine|mesh-list
5550776|NCT04092101|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5550777|NCT04092101|Autonomic Agents|autonomic agents|mesh-ancestor
5550778|NCT04092101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5550779|NCT04092101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550780|NCT04092101|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5550781|NCT04092101|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5550782|NCT04092101|Cholinergic Agents|cholinergic agents|mesh-ancestor
5550783|NCT04092101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5550784|NCT04092101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550785|NCT04091880|Vaccines|vaccines|mesh-list
5550786|NCT04091880|Immunologic Factors|immunologic factors|mesh-ancestor
6476060|NCT00522444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476061|NCT00522444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5550787|NCT04091880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550788|NCT04091815|Anesthetics|anesthetics|mesh-list
5550789|NCT04091815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5550790|NCT04091815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550791|NCT04091698|Coenzyme Q10|coenzyme q10|mesh-list
5550792|NCT04091698|Ubiquinone|ubiquinone|mesh-list
5550793|NCT04091698|Vitamins|vitamins|mesh-ancestor
5550794|NCT04091698|Micronutrients|micronutrients|mesh-ancestor
5550795|NCT04091698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476062|NCT00522444|Tocolytic Agents|tocolytic agents|mesh-ancestor
6476063|NCT00522444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6476064|NCT00522470|Rosiglitazone|rosiglitazone|mesh-list
6476065|NCT00522470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6476066|NCT00522470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667656|NCT01528371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6667657|NCT01528371|Anesthetics, General|anesthetics, general|mesh-ancestor
6667658|NCT01528371|Anesthetics|anesthetics|mesh-ancestor
6476067|NCT00522509|Floxuridine|floxuridine|mesh-list
6476068|NCT00522509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6476069|NCT00522509|Antimetabolites|antimetabolites|mesh-ancestor
6476070|NCT00522509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476071|NCT00522509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6476072|NCT00522587|Remifentanil|remifentanil|mesh-list
6476073|NCT00522587|Sevoflurane|sevoflurane|mesh-list
6476074|NCT00522587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6476075|NCT00522587|Narcotics|narcotics|mesh-ancestor
6476076|NCT00522587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6476077|NCT00522587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550796|NCT04091932|Pembrolizumab|pembrolizumab|mesh-list
5550797|NCT04091932|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5550798|NCT04091932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5550799|NCT04091932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5550800|NCT04091932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550801|NCT04091763|Polidocanol|polidocanol|mesh-list
5550802|NCT04091763|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
5550803|NCT04091763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6476078|NCT00522587|Analgesics|analgesics|mesh-ancestor
6476079|NCT00522587|Sensory System Agents|sensory system agents|mesh-ancestor
6476080|NCT00522587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6476081|NCT00522587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5550804|NCT04091503|Temozolomide|temozolomide|mesh-list
6148953|NCT01391013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6148954|NCT01391130|Sunitinib|sunitinib|mesh-list
6148955|NCT01391130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6148956|NCT01391130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6148957|NCT01391130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6148958|NCT01391130|Growth Substances|growth substances|mesh-ancestor
6148959|NCT01391130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148960|NCT01391130|Growth Inhibitors|growth inhibitors|mesh-ancestor
6148961|NCT01391130|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6148962|NCT01391130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6148963|NCT01391130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6148964|NCT01391273|Bimatoprost|bimatoprost|mesh-list
6148965|NCT01391273|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6148966|NCT01391273|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6148967|NCT01391286|Bimatoprost|bimatoprost|mesh-list
5550805|NCT04091503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5550806|NCT04091503|Alkylating Agents|alkylating agents|mesh-ancestor
5550807|NCT04091503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550808|NCT04091503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6148968|NCT01391286|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6148969|NCT01391286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6148970|NCT01391299|Botulinum Toxins|botulinum toxins|mesh-list
6148971|NCT01391299|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6148972|NCT01391299|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6148973|NCT01391299|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6148974|NCT01391299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6148975|NCT01391299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6148976|NCT01391299|Cholinergic Agents|cholinergic agents|mesh-ancestor
6148977|NCT01391299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6148978|NCT01391299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148979|NCT01391299|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6148980|NCT01391299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6148981|NCT01391312|Botulinum Toxins|botulinum toxins|mesh-list
6148982|NCT01391312|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6148983|NCT01391312|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6148984|NCT01391312|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6148985|NCT01391312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6148986|NCT01391312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6148987|NCT01391312|Cholinergic Agents|cholinergic agents|mesh-ancestor
6148988|NCT01391312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6148989|NCT01391312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6148990|NCT01391312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6148991|NCT01391312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6148992|NCT01391325|Allopurinol|allopurinol|mesh-list
6476082|NCT00522587|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5602870|NCT04017832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5602871|NCT04017832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602872|NCT04017832|Incretins|incretins|mesh-ancestor
5602873|NCT04017832|Hormones|hormones|mesh-ancestor
5606791|NCT03786783|Protective Agents|protective agents|mesh-ancestor
5550809|NCT04091490|Nivolumab|nivolumab|mesh-list
5550810|NCT04091490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6148993|NCT01391325|Antimetabolites|antimetabolites|mesh-ancestor
6148994|NCT01391325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6148995|NCT01391325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6148996|NCT01391325|Gout Suppressants|gout suppressants|mesh-ancestor
6148997|NCT01391325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6148998|NCT01391325|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6148999|NCT01391325|Antioxidants|antioxidants|mesh-ancestor
6149000|NCT01391325|Protective Agents|protective agents|mesh-ancestor
6476083|NCT00522587|Anesthetics, General|anesthetics, general|mesh-ancestor
6476084|NCT00522587|Anesthetics|anesthetics|mesh-ancestor
6476085|NCT00522639|Deoxyglucose|deoxyglucose|mesh-list
6476086|NCT00522639|Antimetabolites|antimetabolites|mesh-ancestor
6476087|NCT00522639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476088|NCT00522639|Antiviral Agents|antiviral agents|mesh-ancestor
6476089|NCT00522639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6476090|NCT00522665|Irinotecan|irinotecan|mesh-list
6476091|NCT00522665|Cetuximab|cetuximab|mesh-list
6476092|NCT00522665|Everolimus|everolimus|mesh-list
6476093|NCT00522665|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6476094|NCT00522665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6476095|NCT00522665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6476096|NCT00522665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476097|NCT00522665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6476098|NCT00522665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6476099|NCT00522665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5550811|NCT04091490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5550812|NCT04091490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5550813|NCT04091490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550814|NCT04091412|3-n-butylphthalide|3-n-butylphthalide|mesh-list
5550815|NCT04091412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5550816|NCT04091412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5550817|NCT04091412|Protective Agents|protective agents|mesh-ancestor
5550818|NCT04091412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550819|NCT04091204|Olaparib|olaparib|mesh-list
5550820|NCT04091204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5550821|NCT04091204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5550822|NCT04091204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550823|NCT04091204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5550824|NCT04091074|Clopidogrel|clopidogrel|mesh-list
5550825|NCT04091074|Ticagrelor|ticagrelor|mesh-list
5550826|NCT04091074|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5550827|NCT04091074|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5550828|NCT04091074|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5550829|NCT04091074|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5550830|NCT04091074|Purinergic Agents|purinergic agents|mesh-ancestor
5550831|NCT04091074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5550832|NCT04091074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550833|NCT04091074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550834|NCT04091178|Vitamin D|vitamin d|mesh-list
5550835|NCT04091178|Vitamins|vitamins|mesh-ancestor
5550836|NCT04091178|Micronutrients|micronutrients|mesh-ancestor
5550837|NCT04091178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550838|NCT04091178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6149001|NCT01391325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149002|NCT01391364|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6149003|NCT01391559|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6149004|NCT01391559|Formoterol Fumarate|formoterol fumarate|mesh-list
6149005|NCT01391559|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6149006|NCT01391559|Autonomic Agents|autonomic agents|mesh-ancestor
6149007|NCT01391559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6149008|NCT01391559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149009|NCT01391559|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6149010|NCT01391559|Respiratory System Agents|respiratory system agents|mesh-ancestor
6149011|NCT01391559|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6149012|NCT01391559|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6149013|NCT01391559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6149014|NCT01391559|Adrenergic Agents|adrenergic agents|mesh-ancestor
6149015|NCT01391559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6149016|NCT01391559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149017|NCT01391663|Alogliptin|alogliptin|mesh-list
6476100|NCT00522665|Immunologic Factors|immunologic factors|mesh-ancestor
6476101|NCT00522665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476102|NCT00522743|Hormones|hormones|mesh-list
6149018|NCT01391663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6149019|NCT01391663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149020|NCT01391663|Incretins|incretins|mesh-ancestor
6149021|NCT01391663|Hormones|hormones|mesh-ancestor
6149022|NCT01391663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6149023|NCT01391663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6149024|NCT01391663|Protease Inhibitors|protease inhibitors|mesh-ancestor
6149025|NCT01391663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6149026|NCT01391663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149027|NCT01391793|Dexamethasone|dexamethasone|mesh-list
6149028|NCT01391793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6149029|NCT01391793|Antiemetics|antiemetics|mesh-ancestor
6149030|NCT01391793|Autonomic Agents|autonomic agents|mesh-ancestor
6149031|NCT01391793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6149032|NCT01391793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149033|NCT01391793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6149034|NCT01391793|Glucocorticoids|glucocorticoids|mesh-ancestor
6149035|NCT01391793|Hormones|hormones|mesh-ancestor
6149036|NCT01391793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6149037|NCT01391793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6149038|NCT01391793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6149039|NCT01391858|Pregabalin|pregabalin|mesh-list
6149040|NCT01391858|Analgesics|analgesics|mesh-ancestor
6149041|NCT01391858|Sensory System Agents|sensory system agents|mesh-ancestor
6149042|NCT01391858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6149043|NCT01391858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149044|NCT01391858|Anticonvulsants|anticonvulsants|mesh-ancestor
6149045|NCT01391858|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6149046|NCT01391858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6149047|NCT01391858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149048|NCT01391858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6149049|NCT01391858|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6476103|NCT00522743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6476104|NCT00522743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476105|NCT00522782|Budesonide|budesonide|mesh-list
6476106|NCT00522782|Nitric Oxide|nitric oxide|mesh-list
6667659|NCT01528371|GABA Modulators|gaba modulators|mesh-ancestor
6667660|NCT01528371|GABA Agents|gaba agents|mesh-ancestor
6667661|NCT01528371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6667662|NCT01528371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667663|NCT01528501|Panobinostat|panobinostat|mesh-list
6667664|NCT01528501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6667665|NCT01528501|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6476107|NCT00522782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6476108|NCT00522782|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6476109|NCT00522782|Autonomic Agents|autonomic agents|mesh-ancestor
6476110|NCT00522782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6476111|NCT00522782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476112|NCT00522782|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6476113|NCT00522782|Respiratory System Agents|respiratory system agents|mesh-ancestor
6476114|NCT00522782|Glucocorticoids|glucocorticoids|mesh-ancestor
6476115|NCT00522782|Hormones|hormones|mesh-ancestor
6476116|NCT00522782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6476117|NCT00522782|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6476118|NCT00522782|Antioxidants|antioxidants|mesh-ancestor
6476119|NCT00522782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476120|NCT00522782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6476121|NCT00522782|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6476122|NCT00522782|Vasodilator Agents|vasodilator agents|mesh-ancestor
6476123|NCT00522782|Gasotransmitters|gasotransmitters|mesh-ancestor
6476124|NCT00522782|Protective Agents|protective agents|mesh-ancestor
6476125|NCT00522821|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5550839|NCT04091009|Buprenorphine|buprenorphine|mesh-list
5550840|NCT04091009|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
5550841|NCT04091009|Naloxone|naloxone|mesh-list
5550842|NCT04091009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5550843|NCT04091009|Narcotics|narcotics|mesh-ancestor
5550844|NCT04091009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5550845|NCT04091009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550846|NCT04091009|Analgesics|analgesics|mesh-ancestor
5550847|NCT04091009|Sensory System Agents|sensory system agents|mesh-ancestor
5550848|NCT04091009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5550849|NCT04091009|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5550850|NCT04090879|Nicotine|nicotine|mesh-list
5550851|NCT04090879|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5550852|NCT04090879|Autonomic Agents|autonomic agents|mesh-ancestor
5550853|NCT04090879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5550854|NCT04090879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550855|NCT04090879|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5550856|NCT04090879|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5550857|NCT04090879|Cholinergic Agents|cholinergic agents|mesh-ancestor
5550858|NCT04090879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5550859|NCT04090879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550860|NCT04090697|Oxandrolone|oxandrolone|mesh-list
5550861|NCT04090697|Androgens|androgens|mesh-ancestor
5550862|NCT04090697|Hormones|hormones|mesh-ancestor
5550863|NCT04090697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5550864|NCT04090697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550865|NCT04090697|Anabolic Agents|anabolic agents|mesh-ancestor
5550866|NCT04090736|Azacitidine|azacitidine|mesh-list
5550867|NCT04090736|Pevonedistat|pevonedistat|mesh-list
5550868|NCT04090736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5550869|NCT04090736|Antimetabolites|antimetabolites|mesh-ancestor
5550870|NCT04090736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550871|NCT04090736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5550872|NCT04090736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6476126|NCT00522821|Immunoglobulins|immunoglobulins|mesh-list
6476127|NCT00522821|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6476128|NCT00522821|Antibodies|antibodies|mesh-list
6476129|NCT00522821|gamma-Globulins|gamma-globulins|mesh-list
6476130|NCT00522821|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6476131|NCT00522821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6476132|NCT00522821|Immunologic Factors|immunologic factors|mesh-ancestor
6476133|NCT00522821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476134|NCT00522886|Cetuximab|cetuximab|mesh-list
5550873|NCT04090801|Ethanol|ethanol|mesh-list
5550874|NCT04090801|Minoxidil|minoxidil|mesh-list
5550875|NCT04090801|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5550876|NCT04090801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5550877|NCT04090801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5550878|NCT04090801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550879|NCT04090801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5550880|NCT04090801|Vasodilator Agents|vasodilator agents|mesh-ancestor
5550881|NCT04090528|Pembrolizumab|pembrolizumab|mesh-list
5550882|NCT04090528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5550883|NCT04090528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6476135|NCT00522886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6476136|NCT00522886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6476137|NCT00522938|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6476138|NCT00522938|Tosedostat|tosedostat|mesh-list
6476139|NCT00522938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6476140|NCT00522938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6476141|NCT00522938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6476142|NCT00522938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476143|NCT00523055|Lidocaine|lidocaine|mesh-list
6476144|NCT00523055|Anesthetics, Local|anesthetics, local|mesh-ancestor
6476145|NCT00523055|Anesthetics|anesthetics|mesh-ancestor
6476146|NCT00523055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6476147|NCT00523055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476148|NCT00523055|Sensory System Agents|sensory system agents|mesh-ancestor
6476149|NCT00523055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6476150|NCT00523055|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6149050|NCT01391858|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6149051|NCT01391858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6149052|NCT01391858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6149053|NCT01392183|Diphenhydramine|diphenhydramine|mesh-list
6149054|NCT01392183|Sirolimus|sirolimus|mesh-list
6149055|NCT01392183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6149056|NCT01392183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6476151|NCT00523055|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5550884|NCT04090190|Solifenacin Succinate|solifenacin succinate|mesh-list
6149057|NCT01392183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6149058|NCT01392183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6149059|NCT01392183|Antifungal Agents|antifungal agents|mesh-ancestor
6149060|NCT01392183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6149061|NCT01392183|Immunologic Factors|immunologic factors|mesh-ancestor
6149062|NCT01392183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149063|NCT01392183|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6149064|NCT01392183|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5550885|NCT04090190|Tolterodine Tartrate|tolterodine tartrate|mesh-list
5550886|NCT04090190|Oxybutynin|oxybutynin|mesh-list
5550887|NCT04090190|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5550888|NCT04090190|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5550889|NCT04090190|Cholinergic Agents|cholinergic agents|mesh-ancestor
5550890|NCT04090190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5550891|NCT04090190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550892|NCT04090190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550893|NCT04090190|Urological Agents|urological agents|mesh-ancestor
5550894|NCT04090190|Parasympatholytics|parasympatholytics|mesh-ancestor
5550895|NCT04090190|Autonomic Agents|autonomic agents|mesh-ancestor
5550896|NCT04090190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5550897|NCT04090112|Lidocaine|lidocaine|mesh-list
5550898|NCT04090112|Anesthetics, Local|anesthetics, local|mesh-ancestor
6149065|NCT01392183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6149066|NCT01392183|Anesthetics, Local|anesthetics, local|mesh-ancestor
6476152|NCT00523055|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5550899|NCT04090112|Anesthetics|anesthetics|mesh-ancestor
5550900|NCT04090112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5550901|NCT04090112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476153|NCT00523055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6476154|NCT00523055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476155|NCT00523068|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6476156|NCT00523068|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6476157|NCT00523068|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6476158|NCT00523068|Cholinergic Agents|cholinergic agents|mesh-ancestor
6476159|NCT00523068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6476160|NCT00523068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476161|NCT00523068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476162|NCT00523068|Urological Agents|urological agents|mesh-ancestor
6476163|NCT00523120|Diclofenac|diclofenac|mesh-list
6476164|NCT00523120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6476165|NCT00523120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6476166|NCT00523120|Analgesics|analgesics|mesh-ancestor
6476167|NCT00523120|Sensory System Agents|sensory system agents|mesh-ancestor
6476168|NCT00523120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6476169|NCT00523120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476170|NCT00523120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6476171|NCT00523120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6476172|NCT00523120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6476173|NCT00523120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6149067|NCT01392183|Anesthetics|anesthetics|mesh-ancestor
6149068|NCT01392183|Sensory System Agents|sensory system agents|mesh-ancestor
6149069|NCT01392183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6476174|NCT00523120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476175|NCT00523133|Naltrexone|naltrexone|mesh-list
6476176|NCT00523133|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6476177|NCT00523133|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6476178|NCT00523133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476179|NCT00523133|Sensory System Agents|sensory system agents|mesh-ancestor
6476180|NCT00523133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6476181|NCT00523159|Sargramostim|sargramostim|mesh-list
6476182|NCT00523159|Immunologic Factors|immunologic factors|mesh-ancestor
6149070|NCT01392183|Antiemetics|antiemetics|mesh-ancestor
5550902|NCT04090112|Sensory System Agents|sensory system agents|mesh-ancestor
5550903|NCT04090112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5550904|NCT04090112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5550905|NCT04090112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5550906|NCT04090112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5606792|NCT03786783|Keratolytic Agents|keratolytic agents|mesh-ancestor
6149071|NCT01392183|Autonomic Agents|autonomic agents|mesh-ancestor
6149072|NCT01392183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6149073|NCT01392183|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6476183|NCT00523159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476184|NCT00523185|Diazepam|diazepam|mesh-list
6476185|NCT00523185|Lorazepam|lorazepam|mesh-list
6476186|NCT00523185|Anticonvulsants|anticonvulsants|mesh-ancestor
6476187|NCT00523185|Antiemetics|antiemetics|mesh-ancestor
6476188|NCT00523185|Autonomic Agents|autonomic agents|mesh-ancestor
6476189|NCT00523185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6476190|NCT00523185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476191|NCT00523185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6476192|NCT00523185|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5550907|NCT04090112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5550908|NCT04090112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550909|NCT04090047|Itraconazole|itraconazole|mesh-list
5550910|NCT04090047|PF-06700841|pf-06700841|mesh-list
5550911|NCT04090047|Antifungal Agents|antifungal agents|mesh-ancestor
5550912|NCT04090047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5550913|NCT04090047|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5550914|NCT04090047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5550915|NCT04090047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5550916|NCT04090047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550917|NCT04090047|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5550918|NCT04090047|Hormone Antagonists|hormone antagonists|mesh-ancestor
5550919|NCT04090047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5550920|NCT04090047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550921|NCT04090047|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5550922|NCT04090047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5550923|NCT04090021|Amoxicillin|amoxicillin|mesh-list
5550924|NCT04090021|Metronidazole|metronidazole|mesh-list
6476193|NCT00523185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6476194|NCT00523185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6476195|NCT00523185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6476196|NCT00523185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6476197|NCT00523185|GABA Modulators|gaba modulators|mesh-ancestor
6476198|NCT00523185|GABA Agents|gaba agents|mesh-ancestor
5550925|NCT04090021|Clarithromycin|clarithromycin|mesh-list
5550926|NCT04090021|Levofloxacin|levofloxacin|mesh-list
5550927|NCT04090021|Ofloxacin|ofloxacin|mesh-list
5550928|NCT04090021|Rifabutin|rifabutin|mesh-list
5550929|NCT04090021|Esomeprazole|esomeprazole|mesh-list
5550930|NCT04090021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5550931|NCT04090021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5550932|NCT04090021|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6476199|NCT00523185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6476200|NCT00523185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476201|NCT00523185|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6476202|NCT00523185|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6476203|NCT00523185|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6476204|NCT00523185|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6476205|NCT00523185|Anesthetics, General|anesthetics, general|mesh-ancestor
6476206|NCT00523185|Anesthetics|anesthetics|mesh-ancestor
6476207|NCT00523263|Heparin|heparin|mesh-list
6149074|NCT01392183|Histamine Antagonists|histamine antagonists|mesh-ancestor
6149075|NCT01392183|Histamine Agents|histamine agents|mesh-ancestor
6149076|NCT01392183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6476208|NCT00523263|Anticoagulants|anticoagulants|mesh-ancestor
6476209|NCT00523263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5550933|NCT04090021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5550934|NCT04090021|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6476210|NCT00523263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6476211|NCT00523263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476212|NCT00523289|Bupivacaine|bupivacaine|mesh-list
6476213|NCT00523289|Ropivacaine|ropivacaine|mesh-list
6476214|NCT00523289|Anesthetics, Local|anesthetics, local|mesh-ancestor
6476215|NCT00523289|Anesthetics|anesthetics|mesh-ancestor
6476216|NCT00523289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6476217|NCT00523289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476218|NCT00523289|Sensory System Agents|sensory system agents|mesh-ancestor
6476219|NCT00523289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6476220|NCT00523354|Infliximab|infliximab|mesh-list
6476221|NCT00523354|Dermatologic Agents|dermatologic agents|mesh-ancestor
6476222|NCT00523354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6476223|NCT00523354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6476224|NCT00523380|Doxorubicin|doxorubicin|mesh-list
6476225|NCT00523380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6476226|NCT00523380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6476227|NCT00523380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6476228|NCT00523380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6476229|NCT00523380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6476230|NCT00523380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6476231|NCT00523380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149077|NCT01392183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149078|NCT01392183|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6149079|NCT01392300|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
6149080|NCT01392300|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6149081|NCT01392300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6149082|NCT01392300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149083|NCT01392300|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6149084|NCT01392300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6149085|NCT01392300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149086|NCT01392300|Cholinergic Agents|cholinergic agents|mesh-ancestor
6149087|NCT01392300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6149088|NCT01392326|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6149089|NCT01392326|Immunologic Factors|immunologic factors|mesh-ancestor
6149090|NCT01392326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149091|NCT01392378|Acetaminophen|acetaminophen|mesh-list
6149092|NCT01392378|Ibuprofen|ibuprofen|mesh-list
6149093|NCT01392378|Vaccines|vaccines|mesh-list
6149094|NCT01392378|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6149095|NCT01392378|Immunologic Factors|immunologic factors|mesh-ancestor
6149096|NCT01392378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149097|NCT01392378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6149098|NCT01392378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6149099|NCT01392378|Analgesics|analgesics|mesh-ancestor
6149100|NCT01392378|Sensory System Agents|sensory system agents|mesh-ancestor
6149101|NCT01392378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6149102|NCT01392378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6149103|NCT01392378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6149104|NCT01392378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6149105|NCT01392378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6149106|NCT01392378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149107|NCT01392378|Antipyretics|antipyretics|mesh-ancestor
6149108|NCT01392469|Imatinib Mesylate|imatinib mesylate|mesh-list
6149109|NCT01392469|Bosentan|bosentan|mesh-list
6149110|NCT01392469|Sildenafil Citrate|sildenafil citrate|mesh-list
6149111|NCT01392469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6476232|NCT00523393|Insulin|insulin|mesh-list
6476233|NCT00523393|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6476234|NCT00523393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6476235|NCT00523393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476236|NCT00523406|Triamcinolone|triamcinolone|mesh-list
6476237|NCT00523406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6476238|NCT00523406|Glucocorticoids|glucocorticoids|mesh-ancestor
6476239|NCT00523406|Hormones|hormones|mesh-ancestor
6476240|NCT00523406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6476241|NCT00523406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476242|NCT00523432|Sirolimus|sirolimus|mesh-list
5550935|NCT04090021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5550936|NCT04090021|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5550937|NCT04090021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5550938|NCT04090021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550939|NCT04090021|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5550940|NCT04090021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5550941|NCT04090021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5550942|NCT04090021|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5550943|NCT04090021|Renal Agents|renal agents|mesh-ancestor
5550944|NCT04090021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5550945|NCT04090021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5550946|NCT04090021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5550947|NCT04090021|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5550948|NCT04090021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6476243|NCT00523432|Topotecan|topotecan|mesh-list
6149112|NCT01392469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6149113|NCT01392469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6149114|NCT01392469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149115|NCT01392469|Vasodilator Agents|vasodilator agents|mesh-ancestor
6149116|NCT01392469|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6149117|NCT01392469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6149118|NCT01392469|Urological Agents|urological agents|mesh-ancestor
6149119|NCT01392469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6149120|NCT01392469|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6149121|NCT01392495|Imatinib Mesylate|imatinib mesylate|mesh-list
6149122|NCT01392495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6149123|NCT01392495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6149124|NCT01392495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6149125|NCT01392495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149126|NCT01392560|Empagliflozin|empagliflozin|mesh-list
6149127|NCT01392560|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6149128|NCT01392560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149129|NCT01392560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6149130|NCT01392560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149131|NCT01392573|Insulin|insulin|mesh-list
6149132|NCT01392573|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6149133|NCT01392573|Liraglutide|liraglutide|mesh-list
6149134|NCT01392573|Insulin, Long-Acting|insulin, long-acting|mesh-list
6149135|NCT01392573|Xultophy|xultophy|mesh-list
6149136|NCT01392573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6149137|NCT01392573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149138|NCT01392573|Incretins|incretins|mesh-ancestor
6149139|NCT01392573|Hormones|hormones|mesh-ancestor
6149140|NCT01392573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6667666|NCT01528501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6149141|NCT01392677|Dapagliflozin|dapagliflozin|mesh-list
6149142|NCT01392677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6149143|NCT01392677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149144|NCT01392677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6149145|NCT01392677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149146|NCT01392703|Dasatinib|dasatinib|mesh-list
6149147|NCT01392703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6149148|NCT01392703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6149149|NCT01392703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6149150|NCT01392703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149151|NCT01392859|Levocetirizine|levocetirizine|mesh-list
6149152|NCT01392859|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6149153|NCT01392859|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6149154|NCT01392859|Histamine Antagonists|histamine antagonists|mesh-ancestor
6149155|NCT01392859|Histamine Agents|histamine agents|mesh-ancestor
6149156|NCT01392859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6149157|NCT01392859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149158|NCT01392859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149159|NCT01392963|Botulinum Toxins|botulinum toxins|mesh-list
6149160|NCT01392963|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6149161|NCT01392963|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6149162|NCT01392963|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6149163|NCT01392963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6149164|NCT01392963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149165|NCT01392963|Cholinergic Agents|cholinergic agents|mesh-ancestor
6149166|NCT01392963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6149167|NCT01392963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149168|NCT01392963|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6149169|NCT01392963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6149170|NCT01392989|Cyclosporine|cyclosporine|mesh-list
6149171|NCT01392989|Mycophenolic Acid|mycophenolic acid|mesh-list
6149172|NCT01392989|Cyclosporins|cyclosporins|mesh-list
6149173|NCT01392989|Thymoglobulin|thymoglobulin|mesh-list
6149174|NCT01392989|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6149175|NCT01392989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6149176|NCT01392989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149177|NCT01392989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6149178|NCT01392989|Immunologic Factors|immunologic factors|mesh-ancestor
6149179|NCT01392989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550949|NCT04090021|Antitubercular Agents|antitubercular agents|mesh-ancestor
5550950|NCT04089657|Apatinib|apatinib|mesh-list
5550951|NCT04089657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5550952|NCT04089657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5550953|NCT04089657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5550954|NCT04089657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550955|NCT04089722|Deoxycholic Acid|deoxycholic acid|mesh-list
6149180|NCT01392989|Antifungal Agents|antifungal agents|mesh-ancestor
6149181|NCT01392989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6149182|NCT01392989|Dermatologic Agents|dermatologic agents|mesh-ancestor
6149183|NCT01392989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6149184|NCT01392989|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6149185|NCT01392989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6149186|NCT01392989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6149187|NCT01392989|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6149188|NCT01392989|Antitubercular Agents|antitubercular agents|mesh-ancestor
6149189|NCT01392989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6149190|NCT01393106|Idelalisib|idelalisib|mesh-list
5550956|NCT04089722|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5550957|NCT04089722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5550958|NCT04089813|Metformin|metformin|mesh-list
5550959|NCT04089813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5550960|NCT04089813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550961|NCT04089865|Tranexamic Acid|tranexamic acid|mesh-list
5550962|NCT04089865|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5550963|NCT04089865|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5550964|NCT04089865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550965|NCT04089865|Hemostatics|hemostatics|mesh-ancestor
5550966|NCT04089865|Coagulants|coagulants|mesh-ancestor
5550967|NCT04089852|Nitrous Oxide|nitrous oxide|mesh-list
6149191|NCT01393106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6149192|NCT01393106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6149193|NCT01393106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149194|NCT01393132|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6149195|NCT01393132|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6149196|NCT01393158|Apremilast|apremilast|mesh-list
5550968|NCT04089852|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5550969|NCT04089852|Anesthetics, General|anesthetics, general|mesh-ancestor
5550970|NCT04089852|Anesthetics|anesthetics|mesh-ancestor
5550971|NCT04089852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5550972|NCT04089852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550973|NCT04089852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5550974|NCT04089852|Analgesics|analgesics|mesh-ancestor
5550975|NCT04089852|Sensory System Agents|sensory system agents|mesh-ancestor
6667667|NCT01528501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667668|NCT01528540|Pregabalin|pregabalin|mesh-list
6667669|NCT01528540|Antioxidants|antioxidants|mesh-list
5550976|NCT04089852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5550977|NCT04089904|Pembrolizumab|pembrolizumab|mesh-list
5550978|NCT04089904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5550979|NCT04089904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5550980|NCT04089631|Capecitabine|capecitabine|mesh-list
5550981|NCT04089631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5550982|NCT04089631|Antimetabolites|antimetabolites|mesh-ancestor
5550983|NCT04089631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5550984|NCT04089631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5602874|NCT04017832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5602875|NCT04017832|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5602876|NCT04017832|Protease Inhibitors|protease inhibitors|mesh-ancestor
5602877|NCT04017832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5602878|NCT04017832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602879|NCT04006522|Atezolizumab|atezolizumab|mesh-list
5602880|NCT04006522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5602881|NCT04002947|Rituximab|rituximab|mesh-list
5602882|NCT04002947|Acalabrutinib|acalabrutinib|mesh-list
5602883|NCT04002947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5602884|NCT04002947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5602885|NCT04002947|Immunologic Factors|immunologic factors|mesh-ancestor
5602886|NCT04002947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602887|NCT04002947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5602888|NCT03965091|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5602889|NCT03965091|Immunologic Factors|immunologic factors|mesh-ancestor
5602890|NCT03965091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602891|NCT03945825|Vaccines|vaccines|mesh-list
5602892|NCT03945825|Immunologic Factors|immunologic factors|mesh-ancestor
5602893|NCT03945825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602894|NCT03942419|Atropine|atropine|mesh-list
5602895|NCT03942419|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5602896|NCT03942419|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5602897|NCT03942419|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5602898|NCT03942419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5602899|NCT03942419|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5602900|NCT03942419|Autonomic Agents|autonomic agents|mesh-ancestor
5602901|NCT03942419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5602902|NCT03942419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602903|NCT03942419|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5602904|NCT03942419|Respiratory System Agents|respiratory system agents|mesh-ancestor
5602905|NCT03942419|Mydriatics|mydriatics|mesh-ancestor
5602906|NCT03942419|Parasympatholytics|parasympatholytics|mesh-ancestor
5602907|NCT03942419|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5602908|NCT03942419|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5602909|NCT03942419|Cholinergic Agents|cholinergic agents|mesh-ancestor
5602910|NCT03942419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5602911|NCT03942419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602912|NCT03889418|Analgesics, Opioid|analgesics, opioid|mesh-list
5602913|NCT03889418|Narcotics|narcotics|mesh-ancestor
5602914|NCT03889418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5602915|NCT03889418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602916|NCT03889418|Analgesics|analgesics|mesh-ancestor
5602917|NCT03889418|Sensory System Agents|sensory system agents|mesh-ancestor
6149197|NCT01393158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6667670|NCT01528540|Analgesics|analgesics|mesh-ancestor
6667671|NCT01528540|Sensory System Agents|sensory system agents|mesh-ancestor
6149198|NCT01393158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6149199|NCT01393158|Analgesics|analgesics|mesh-ancestor
6149200|NCT01393158|Sensory System Agents|sensory system agents|mesh-ancestor
6149201|NCT01393158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6149202|NCT01393158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149203|NCT01393158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6149204|NCT01393158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6667672|NCT01528540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5550985|NCT04089605|Dexamethasone|dexamethasone|mesh-list
5550986|NCT04089605|Dexamethasone acetate|dexamethasone acetate|mesh-list
5550987|NCT04089605|Ranibizumab|ranibizumab|mesh-list
5550988|NCT04089605|BB 1101|bb 1101|mesh-list
5550989|NCT04089605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5550990|NCT04089605|Antiemetics|antiemetics|mesh-ancestor
5550991|NCT04089605|Autonomic Agents|autonomic agents|mesh-ancestor
5550992|NCT04089605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5550993|NCT04089605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5550994|NCT04089605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5550995|NCT04089605|Glucocorticoids|glucocorticoids|mesh-ancestor
5550996|NCT04089605|Hormones|hormones|mesh-ancestor
5550997|NCT04089605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6149205|NCT01393158|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6149206|NCT01393158|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6149207|NCT01393158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6149208|NCT01393158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149209|NCT01393392|Methadone|methadone|mesh-list
6149210|NCT01393392|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6149211|NCT01393392|Narcotics|narcotics|mesh-ancestor
6149212|NCT01393392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5550998|NCT04089605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5550999|NCT04089605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5551000|NCT04089605|Protease Inhibitors|protease inhibitors|mesh-ancestor
5551001|NCT04089605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5551002|NCT04089605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5551003|NCT04089605|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5551004|NCT04089605|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5551005|NCT04089605|Growth Substances|growth substances|mesh-ancestor
5551006|NCT04089605|Growth Inhibitors|growth inhibitors|mesh-ancestor
5551007|NCT04089592|Fentanyl|fentanyl|mesh-list
5551008|NCT04089592|Dexmedetomidine|dexmedetomidine|mesh-list
5551009|NCT04089592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5551010|NCT04089592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5551011|NCT04089592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551012|NCT04089592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5551013|NCT04089592|Analgesics|analgesics|mesh-ancestor
5551014|NCT04089592|Sensory System Agents|sensory system agents|mesh-ancestor
5551015|NCT04089592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5551016|NCT04089592|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6149213|NCT01393392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149214|NCT01393392|Analgesics|analgesics|mesh-ancestor
6149215|NCT01393392|Sensory System Agents|sensory system agents|mesh-ancestor
6149216|NCT01393392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6149217|NCT01393392|Antitussive Agents|antitussive agents|mesh-ancestor
6149218|NCT01393392|Respiratory System Agents|respiratory system agents|mesh-ancestor
6149219|NCT01393405|Methotrexate|methotrexate|mesh-list
6149220|NCT01393405|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6149221|NCT01393405|Abortifacient Agents|abortifacient agents|mesh-ancestor
6149222|NCT01393405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6149223|NCT01393405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149224|NCT01393405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6149225|NCT01393405|Antimetabolites|antimetabolites|mesh-ancestor
6149226|NCT01393405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149227|NCT01393405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6149228|NCT01393405|Dermatologic Agents|dermatologic agents|mesh-ancestor
6149229|NCT01393405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6149230|NCT01393405|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6149231|NCT01393405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6149232|NCT01393405|Immunologic Factors|immunologic factors|mesh-ancestor
6149233|NCT01393405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6149234|NCT01393405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6149235|NCT01393457|Levodopa|levodopa|mesh-list
6149236|NCT01393457|Carbidopa|carbidopa|mesh-list
6149237|NCT01393457|Ropinirole|ropinirole|mesh-list
6149238|NCT01393457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6476244|NCT00523432|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6476245|NCT00523432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6476246|NCT00523432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6476247|NCT00523432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476248|NCT00523432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6476249|NCT00523432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6476250|NCT00523432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6476251|NCT00523432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5551017|NCT04089592|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5551018|NCT04089592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5551019|NCT04089592|Adrenergic Agents|adrenergic agents|mesh-ancestor
5551020|NCT04089592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5551021|NCT04089592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5551022|NCT04089592|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5551023|NCT04089592|Narcotics|narcotics|mesh-ancestor
5551024|NCT04089592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5551025|NCT04089592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5551026|NCT04089592|Anesthetics, General|anesthetics, general|mesh-ancestor
5551027|NCT04089592|Anesthetics|anesthetics|mesh-ancestor
5551028|NCT04089345|Ustekinumab|ustekinumab|mesh-list
5551029|NCT04089345|Dermatologic Agents|dermatologic agents|mesh-ancestor
5551030|NCT04089163|Flucytosine|flucytosine|mesh-list
5551031|NCT04089163|Antifungal Agents|antifungal agents|mesh-ancestor
6476252|NCT00523432|Antifungal Agents|antifungal agents|mesh-ancestor
6667673|NCT01528540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667674|NCT01528540|Anticonvulsants|anticonvulsants|mesh-ancestor
6667675|NCT01528540|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6667676|NCT01528540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6667677|NCT01528540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667678|NCT01528540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5551032|NCT04089163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6149239|NCT01393457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6149240|NCT01393457|Dopamine Agents|dopamine agents|mesh-ancestor
5551033|NCT04089163|Antimetabolites|antimetabolites|mesh-ancestor
5551034|NCT04089163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5551035|NCT04089072|Phenylephrine|phenylephrine|mesh-list
6149241|NCT01393457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6149242|NCT01393457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149243|NCT01393457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149244|NCT01393457|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6149245|NCT01393457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6149246|NCT01393457|Dopamine Agonists|dopamine agonists|mesh-ancestor
6149247|NCT01393600|Tetrabenazine|tetrabenazine|mesh-list
6149248|NCT01393600|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6476253|NCT00523432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5551036|NCT04089072|Oxymetazoline|oxymetazoline|mesh-list
5551037|NCT04089072|Methylene Blue|methylene blue|mesh-list
5551038|NCT04089072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5551039|NCT04089072|Mydriatics|mydriatics|mesh-ancestor
5551040|NCT04089072|Autonomic Agents|autonomic agents|mesh-ancestor
5551041|NCT04089072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5551042|NCT04089072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551043|NCT04089072|Sympathomimetics|sympathomimetics|mesh-ancestor
5551044|NCT04089072|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5551045|NCT04089072|Nasal Decongestants|nasal decongestants|mesh-ancestor
5551046|NCT04089072|Respiratory System Agents|respiratory system agents|mesh-ancestor
5551047|NCT04089072|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5551048|NCT04089072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5551049|NCT04089072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5551050|NCT04089072|Adrenergic Agents|adrenergic agents|mesh-ancestor
6476254|NCT00523432|Immunologic Factors|immunologic factors|mesh-ancestor
6476255|NCT00523432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476256|NCT00523445|Varenicline|varenicline|mesh-list
5551051|NCT04089072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5551052|NCT04089072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5551053|NCT04089072|Protective Agents|protective agents|mesh-ancestor
5551054|NCT04089072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5551055|NCT04089176|Oxytocin|oxytocin|mesh-list
5551056|NCT04089176|Carbetocin|carbetocin|mesh-list
5551057|NCT04089176|Oxytocics|oxytocics|mesh-ancestor
5551058|NCT04089176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5551059|NCT04089176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476257|NCT00523445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6476258|NCT00523445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6476259|NCT00523445|Cholinergic Agents|cholinergic agents|mesh-ancestor
6476260|NCT00523445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6476261|NCT00523445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476262|NCT00523445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149249|NCT01393600|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6149250|NCT01393600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6149251|NCT01393600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476263|NCT00523458|Efavirenz|efavirenz|mesh-list
6476264|NCT00523458|Nevirapine|nevirapine|mesh-list
5551060|NCT04088864|Cyclophosphamide|cyclophosphamide|mesh-list
5551061|NCT04088864|Fludarabine|fludarabine|mesh-list
5551062|NCT04088864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5551063|NCT04088864|Immunologic Factors|immunologic factors|mesh-ancestor
5551064|NCT04088864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551065|NCT04088864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6476265|NCT00523458|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6476266|NCT00523458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6476267|NCT00523458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6476268|NCT00523458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476269|NCT00523458|Antiviral Agents|antiviral agents|mesh-ancestor
6476270|NCT00523458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6476271|NCT00523458|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6476272|NCT00523458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6476273|NCT00523458|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6476274|NCT00523458|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6476275|NCT00523458|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6476276|NCT00523458|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6476277|NCT00523458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6476278|NCT00523458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6149252|NCT01393600|Adrenergic Agents|adrenergic agents|mesh-ancestor
6149253|NCT01393600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6149254|NCT01393600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149255|NCT01393626|Tofacitinib|tofacitinib|mesh-list
5551066|NCT04088864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5551067|NCT04088864|Alkylating Agents|alkylating agents|mesh-ancestor
5551068|NCT04088864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476279|NCT00523666|Galantamine|galantamine|mesh-list
6476280|NCT00523666|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6476281|NCT00523666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6476282|NCT00523666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476283|NCT00523666|Cholinergic Agents|cholinergic agents|mesh-ancestor
6476284|NCT00523666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6476285|NCT00523666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551069|NCT04088864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5551070|NCT04088864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5551071|NCT04088851|Metformin|metformin|mesh-list
5551072|NCT04088851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6149256|NCT01393626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6149257|NCT01393626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6149258|NCT01393626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149259|NCT01393704|Vasopressins|vasopressins|mesh-list
6149260|NCT01393704|Arginine Vasopressin|arginine vasopressin|mesh-list
6149261|NCT01393704|Hemostatics|hemostatics|mesh-ancestor
6149262|NCT01393704|Coagulants|coagulants|mesh-ancestor
6149263|NCT01393704|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5551073|NCT04088851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551074|NCT04088630|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
5551075|NCT04088630|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5551076|NCT04088630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5551077|NCT04088630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5551078|NCT04088630|Immunologic Factors|immunologic factors|mesh-ancestor
5551079|NCT04088630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551080|NCT04088903|Daratumumab|daratumumab|mesh-list
5551081|NCT04088903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5551082|NCT04088604|Fluorouracil|fluorouracil|mesh-list
5551083|NCT04088604|Irinotecan|irinotecan|mesh-list
5551084|NCT04088604|Antimetabolites|antimetabolites|mesh-ancestor
5551085|NCT04088604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5551086|NCT04088604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5551087|NCT04088604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5551088|NCT04088604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5551089|NCT04088604|Immunologic Factors|immunologic factors|mesh-ancestor
5551090|NCT04088604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551091|NCT04088604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5551092|NCT04088604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5551093|NCT04088604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5551094|NCT04088513|Aspirin|aspirin|mesh-list
5551095|NCT04088513|Clopidogrel|clopidogrel|mesh-list
5551096|NCT04088513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5551097|NCT04088513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5551098|NCT04088513|Analgesics|analgesics|mesh-ancestor
5551099|NCT04088513|Sensory System Agents|sensory system agents|mesh-ancestor
5606793|NCT03786783|Dermatologic Agents|dermatologic agents|mesh-ancestor
6149264|NCT01393704|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6149265|NCT01393704|Natriuretic Agents|natriuretic agents|mesh-ancestor
6149266|NCT01393704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149267|NCT01393717|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6476286|NCT00523666|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6476287|NCT00523666|Autonomic Agents|autonomic agents|mesh-ancestor
6476288|NCT00523666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6476289|NCT00523666|Nootropic Agents|nootropic agents|mesh-ancestor
6476290|NCT00523692|Etanercept|etanercept|mesh-list
6149268|NCT01393717|Antibodies|antibodies|mesh-list
6149269|NCT01393717|Immunoglobulins|immunoglobulins|mesh-list
6149270|NCT01393717|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6149271|NCT01393717|Immunoconjugates|immunoconjugates|mesh-list
6149272|NCT01393717|Immunologic Factors|immunologic factors|mesh-ancestor
6149273|NCT01393717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149274|NCT01393717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6149275|NCT01393717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6149276|NCT01393730|Prednisone|prednisone|mesh-list
6149277|NCT01393730|Abiraterone Acetate|abiraterone acetate|mesh-list
6149278|NCT01393730|Dutasteride|dutasteride|mesh-list
6149279|NCT01393730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6149280|NCT01393730|Glucocorticoids|glucocorticoids|mesh-ancestor
6149281|NCT01393730|Hormones|hormones|mesh-ancestor
6149282|NCT01393730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6149283|NCT01393730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149284|NCT01393730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6149285|NCT01393730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6476291|NCT00523692|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6476292|NCT00523692|Methotrexate|methotrexate|mesh-list
6476293|NCT00523692|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6476294|NCT00523692|Abortifacient Agents|abortifacient agents|mesh-ancestor
6476295|NCT00523692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6476296|NCT00523692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476297|NCT00523692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6476298|NCT00523692|Antimetabolites|antimetabolites|mesh-ancestor
6476299|NCT00523692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476300|NCT00523692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6476301|NCT00523692|Dermatologic Agents|dermatologic agents|mesh-ancestor
6476302|NCT00523692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6476303|NCT00523692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6476304|NCT00523692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6476305|NCT00523692|Immunologic Factors|immunologic factors|mesh-ancestor
6476306|NCT00523692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6476307|NCT00523692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6476308|NCT00523692|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5551100|NCT04088513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6149286|NCT01393730|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6149287|NCT01393730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6149288|NCT01393730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149289|NCT01393730|Hormone Antagonists|hormone antagonists|mesh-ancestor
6149290|NCT01393730|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6149291|NCT01393730|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
5551101|NCT04088513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551102|NCT04088513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5551103|NCT04088513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5551104|NCT04088513|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5551105|NCT04088513|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5551106|NCT04088513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5551107|NCT04088513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5551108|NCT04088513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5551109|NCT04088513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6149292|NCT01393899|Tofacitinib|tofacitinib|mesh-list
6149293|NCT01393899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5551110|NCT04088513|Antipyretics|antipyretics|mesh-ancestor
5551111|NCT04088513|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5551112|NCT04088513|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6149294|NCT01393899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6149295|NCT01393899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149296|NCT01393964|Dexamethasone|dexamethasone|mesh-list
6149297|NCT01393964|Dexamethasone acetate|dexamethasone acetate|mesh-list
6149298|NCT01393964|Lenalidomide|lenalidomide|mesh-list
6149299|NCT01393964|Elotuzumab|elotuzumab|mesh-list
6149300|NCT01393964|BB 1101|bb 1101|mesh-list
6149301|NCT01393964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6476309|NCT00523692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6476310|NCT00523692|Analgesics|analgesics|mesh-ancestor
5551113|NCT04088513|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5551114|NCT04088513|Purinergic Agents|purinergic agents|mesh-ancestor
5551115|NCT04088513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5551116|NCT04088500|Nivolumab|nivolumab|mesh-list
5551117|NCT04088500|Ipilimumab|ipilimumab|mesh-list
5551118|NCT04088500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6476311|NCT00523692|Sensory System Agents|sensory system agents|mesh-ancestor
6149302|NCT01393964|Antiemetics|antiemetics|mesh-ancestor
6149303|NCT01393964|Autonomic Agents|autonomic agents|mesh-ancestor
6149304|NCT01393964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6149305|NCT01393964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149306|NCT01393964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6149307|NCT01393964|Glucocorticoids|glucocorticoids|mesh-ancestor
6149308|NCT01393964|Hormones|hormones|mesh-ancestor
6149309|NCT01393964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6476312|NCT00523692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6476313|NCT00523692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6476314|NCT00523692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6476315|NCT00523757|Spironolactone|spironolactone|mesh-list
6476316|NCT00523757|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6476317|NCT00523757|Hormone Antagonists|hormone antagonists|mesh-ancestor
6476318|NCT00523757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6476319|NCT00523757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476320|NCT00523757|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6476321|NCT00523757|Diuretics|diuretics|mesh-ancestor
6476322|NCT00523757|Natriuretic Agents|natriuretic agents|mesh-ancestor
6476323|NCT00523887|Fentanyl|fentanyl|mesh-list
5551119|NCT04088500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5551120|NCT04088500|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5551121|NCT04088500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5551122|NCT04088461|Metformin|metformin|mesh-list
5551123|NCT04088461|Linagliptin|linagliptin|mesh-list
5551124|NCT04088461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5551125|NCT04088461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551126|NCT04088461|Incretins|incretins|mesh-ancestor
5551127|NCT04088461|Hormones|hormones|mesh-ancestor
5551128|NCT04088461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5551129|NCT04088461|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5551130|NCT04088461|Protease Inhibitors|protease inhibitors|mesh-ancestor
5551131|NCT04088461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5551132|NCT04088461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5551133|NCT04088448|Metformin|metformin|mesh-list
5551134|NCT04088448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5551135|NCT04088448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551136|NCT04088292|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5551137|NCT04088292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5551138|NCT04088292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5551139|NCT04088292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5551140|NCT04088266|Buprenorphine|buprenorphine|mesh-list
5551141|NCT04088266|Naloxone|naloxone|mesh-list
5551142|NCT04088266|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5551143|NCT04088266|Narcotics|narcotics|mesh-ancestor
5551144|NCT04088266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5551145|NCT04088266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551146|NCT04088266|Analgesics|analgesics|mesh-ancestor
5551147|NCT04088266|Sensory System Agents|sensory system agents|mesh-ancestor
5551148|NCT04088266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5551149|NCT04088266|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5551150|NCT04088032|Durvalumab|durvalumab|mesh-list
5551151|NCT04088032|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5551152|NCT04088032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5551153|NCT04088032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5551154|NCT04088032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5551155|NCT04088032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5551156|NCT04088032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5551157|NCT04088032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5551158|NCT04088032|Hormone Antagonists|hormone antagonists|mesh-ancestor
5551159|NCT04088032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5551160|NCT04088032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551161|NCT04088175|Menthol|menthol|mesh-list
5551162|NCT04088175|Nicotine|nicotine|mesh-list
5551163|NCT04088175|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6476324|NCT00523887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6149310|NCT01393964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6149311|NCT01393964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6149312|NCT01393964|Protease Inhibitors|protease inhibitors|mesh-ancestor
6149313|NCT01393964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6149314|NCT01393964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149315|NCT01393964|Immunologic Factors|immunologic factors|mesh-ancestor
6149316|NCT01393964|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6149317|NCT01393964|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6149318|NCT01393964|Growth Substances|growth substances|mesh-ancestor
6149319|NCT01393964|Growth Inhibitors|growth inhibitors|mesh-ancestor
6149320|NCT01393990|Tamoxifen|tamoxifen|mesh-list
6149321|NCT01393990|Midazolam|midazolam|mesh-list
6149322|NCT01393990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6149323|NCT01393990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6149324|NCT01393990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6149325|NCT01393990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149326|NCT01393990|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6149327|NCT01393990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6149328|NCT01393990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6149329|NCT01393990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6149330|NCT01393990|Anesthetics, General|anesthetics, general|mesh-ancestor
6149331|NCT01393990|Anesthetics|anesthetics|mesh-ancestor
6149332|NCT01393990|GABA Modulators|gaba modulators|mesh-ancestor
6149333|NCT01393990|GABA Agents|gaba agents|mesh-ancestor
6476325|NCT00523887|Narcotics|narcotics|mesh-ancestor
6476326|NCT00523887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6476327|NCT00523887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476328|NCT00523887|Analgesics|analgesics|mesh-ancestor
6476329|NCT00523887|Sensory System Agents|sensory system agents|mesh-ancestor
6476330|NCT00523887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6476331|NCT00523887|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6476332|NCT00523887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6476333|NCT00523887|Anesthetics, General|anesthetics, general|mesh-ancestor
6476334|NCT00523887|Anesthetics|anesthetics|mesh-ancestor
5551164|NCT04088175|Autonomic Agents|autonomic agents|mesh-ancestor
6149334|NCT01393990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6149335|NCT01393990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149336|NCT01393990|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6149337|NCT01393990|Hormone Antagonists|hormone antagonists|mesh-ancestor
6149338|NCT01393990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6149339|NCT01393990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5551165|NCT04088175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5551166|NCT04088175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551167|NCT04088175|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5551168|NCT04088175|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5551169|NCT04088175|Cholinergic Agents|cholinergic agents|mesh-ancestor
5551170|NCT04088175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5551171|NCT04088175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5551172|NCT04088175|Antipruritics|antipruritics|mesh-ancestor
5551173|NCT04088175|Dermatologic Agents|dermatologic agents|mesh-ancestor
5551174|NCT04087915|Evolocumab|evolocumab|mesh-list
5551175|NCT04087915|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5551176|NCT04087915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5551177|NCT04087915|Antimetabolites|antimetabolites|mesh-ancestor
5551178|NCT04087915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5551179|NCT04087915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5551180|NCT04088084|Palmidrol|palmidrol|mesh-list
5551181|NCT04088084|Analgesics|analgesics|mesh-ancestor
5551182|NCT04088084|Sensory System Agents|sensory system agents|mesh-ancestor
5551183|NCT04088084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5551184|NCT04088084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149340|NCT01393990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6149341|NCT01393990|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6149342|NCT01393990|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6149343|NCT01393990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6149344|NCT01394185|Dronabinol|dronabinol|mesh-list
6149345|NCT01394185|Hallucinogens|hallucinogens|mesh-ancestor
6149346|NCT01394185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149347|NCT01394185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6149348|NCT01394185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6149349|NCT01394185|Analgesics|analgesics|mesh-ancestor
6149350|NCT01394185|Sensory System Agents|sensory system agents|mesh-ancestor
5551185|NCT04088084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6149351|NCT01394185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6476335|NCT00523913|Rosiglitazone|rosiglitazone|mesh-list
6149352|NCT01394185|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6149353|NCT01394185|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6149354|NCT01394185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6149355|NCT01394185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149356|NCT01394185|Hormones|hormones|mesh-ancestor
6149357|NCT01394185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6149358|NCT01394250|Lidocaine|lidocaine|mesh-list
6149359|NCT01394250|Anesthetics, Local|anesthetics, local|mesh-ancestor
6149360|NCT01394250|Anesthetics|anesthetics|mesh-ancestor
6149361|NCT01394250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6149362|NCT01394250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149363|NCT01394250|Sensory System Agents|sensory system agents|mesh-ancestor
6149364|NCT01394250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6149365|NCT01394250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6149366|NCT01394250|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6149367|NCT01394250|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6149368|NCT01394250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6149369|NCT01394250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476336|NCT00523913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6476337|NCT00523913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476338|NCT00523926|Bedaquiline|bedaquiline|mesh-list
6476339|NCT00523926|Antitubercular Agents|antitubercular agents|mesh-ancestor
6476340|NCT00523926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6476341|NCT00523926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6476342|NCT00523952|Tacrolimus|tacrolimus|mesh-list
6476343|NCT00523952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6476344|NCT00523952|Immunologic Factors|immunologic factors|mesh-ancestor
6476345|NCT00523952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476346|NCT00523952|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6476347|NCT00523952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6476348|NCT00523952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476349|NCT00523965|Amphotericin B|amphotericin b|mesh-list
6476350|NCT00523965|Paromomycin|paromomycin|mesh-list
6476351|NCT00523965|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6476352|NCT00523965|Miltefosine|miltefosine|mesh-list
6476353|NCT00523965|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
6476354|NCT00523965|Deoxycholic Acid|deoxycholic acid|mesh-list
6476355|NCT00523965|Amebicides|amebicides|mesh-ancestor
6476356|NCT00523965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6476357|NCT00523965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6476358|NCT00523965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6476359|NCT00523965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6476360|NCT00523965|Antifungal Agents|antifungal agents|mesh-ancestor
6149370|NCT01394510|Acetylcysteine|acetylcysteine|mesh-list
6149371|NCT01394510|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6149372|NCT01394510|Antiviral Agents|antiviral agents|mesh-ancestor
6149373|NCT01394510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6149374|NCT01394510|Expectorants|expectorants|mesh-ancestor
6149375|NCT01394510|Respiratory System Agents|respiratory system agents|mesh-ancestor
6149376|NCT01394510|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6149377|NCT01394510|Antioxidants|antioxidants|mesh-ancestor
6149378|NCT01394510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149379|NCT01394510|Protective Agents|protective agents|mesh-ancestor
6149380|NCT01394510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149381|NCT01394510|Antidotes|antidotes|mesh-ancestor
6149382|NCT01394523|Bupivacaine|bupivacaine|mesh-list
6149383|NCT01394523|Anesthetics, Local|anesthetics, local|mesh-ancestor
6149384|NCT01394523|Anesthetics|anesthetics|mesh-ancestor
6149385|NCT01394523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6149386|NCT01394523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476361|NCT00523965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6476362|NCT00523965|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5551186|NCT04088084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5551187|NCT04088084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5551188|NCT04088084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6149387|NCT01394523|Sensory System Agents|sensory system agents|mesh-ancestor
6149388|NCT01394523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6149389|NCT01394614|Vaccines|vaccines|mesh-list
6149390|NCT01394614|Immunologic Factors|immunologic factors|mesh-ancestor
6149391|NCT01394614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149392|NCT01394627|Eplerenone|eplerenone|mesh-list
6149393|NCT01394627|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6149394|NCT01394627|Hormone Antagonists|hormone antagonists|mesh-ancestor
6149395|NCT01394627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6149396|NCT01394627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476363|NCT00523965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6476364|NCT00524004|Immunoglobulin G|immunoglobulin g|mesh-list
6476365|NCT00524004|Immunologic Factors|immunologic factors|mesh-ancestor
6476366|NCT00524004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476367|NCT00524069|Gemcitabine|gemcitabine|mesh-list
6476368|NCT00524069|Bevacizumab|bevacizumab|mesh-list
5551189|NCT04088084|Antiviral Agents|antiviral agents|mesh-ancestor
5551190|NCT04088084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5551191|NCT04088084|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5551192|NCT04088084|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6476369|NCT00524069|Capecitabine|capecitabine|mesh-list
6476370|NCT00524069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6476371|NCT00524069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6667679|NCT01528540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6149397|NCT01394627|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6149398|NCT01394627|Diuretics|diuretics|mesh-ancestor
6149399|NCT01394627|Natriuretic Agents|natriuretic agents|mesh-ancestor
6149400|NCT01394627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6149401|NCT01394718|Acetaminophen|acetaminophen|mesh-list
6149402|NCT01394718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6149403|NCT01394718|Analgesics|analgesics|mesh-ancestor
6149404|NCT01394718|Sensory System Agents|sensory system agents|mesh-ancestor
6149405|NCT01394718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6149406|NCT01394718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149407|NCT01394718|Antipyretics|antipyretics|mesh-ancestor
6149408|NCT01394939|Irinotecan|irinotecan|mesh-list
6149409|NCT01394939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6149410|NCT01394939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6667680|NCT01528540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6667681|NCT01528540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6667682|NCT01528540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5551193|NCT04088084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5551194|NCT04088084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5551195|NCT04088084|Hormones|hormones|mesh-ancestor
5551196|NCT04088084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5551197|NCT04088110|Trastuzumab|trastuzumab|mesh-list
5551198|NCT04088110|Letrozole|letrozole|mesh-list
5551199|NCT04088110|Anastrozole|anastrozole|mesh-list
5551200|NCT04088110|Exemestane|exemestane|mesh-list
5551201|NCT04088110|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5551202|NCT04088110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5551203|NCT04088110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5551204|NCT04088110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5551205|NCT04088110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5551206|NCT04088110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5551207|NCT04088110|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5551208|NCT04088110|Hormone Antagonists|hormone antagonists|mesh-ancestor
5551209|NCT04088110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5551210|NCT04088110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551211|NCT04088110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5551212|NCT04087746|Ranibizumab|ranibizumab|mesh-list
5551213|NCT04087746|Aflibercept|aflibercept|mesh-list
5551214|NCT04087746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5551215|NCT04087746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5551216|NCT04087746|Growth Substances|growth substances|mesh-ancestor
5551217|NCT04087746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551218|NCT04087746|Growth Inhibitors|growth inhibitors|mesh-ancestor
5551219|NCT04087746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5551220|NCT04088006|Hyaluronic Acid|hyaluronic acid|mesh-list
6149411|NCT01394939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6476372|NCT00524069|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6667683|NCT01528540|Protective Agents|protective agents|mesh-ancestor
6667684|NCT01528618|Gemcitabine|gemcitabine|mesh-list
6667685|NCT01528618|Cisplatin|cisplatin|mesh-list
6667686|NCT01528618|Fluorouracil|fluorouracil|mesh-list
6667687|NCT01528618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6667688|NCT01528618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6149412|NCT01394939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149413|NCT01394939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6149414|NCT01394952|Dulaglutide|dulaglutide|mesh-list
6149415|NCT01394952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6149416|NCT01394952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149417|NCT01394991|Epoetin Alfa|epoetin alfa|mesh-list
6149418|NCT01394991|Hematinics|hematinics|mesh-ancestor
6149419|NCT01395017|Dasatinib|dasatinib|mesh-list
6149420|NCT01395017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6149421|NCT01395017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6149422|NCT01395017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6149423|NCT01395017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149424|NCT01395030|Choline|choline|mesh-list
6149425|NCT01395030|Lipotropic Agents|lipotropic agents|mesh-ancestor
6149426|NCT01395030|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6149427|NCT01395030|Antimetabolites|antimetabolites|mesh-ancestor
6149428|NCT01395030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149429|NCT01395030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6149430|NCT01395030|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6149431|NCT01395030|Nootropic Agents|nootropic agents|mesh-ancestor
6149432|NCT01395043|Epinephrine|epinephrine|mesh-list
6149433|NCT01395043|Bupivacaine|bupivacaine|mesh-list
6149434|NCT01395043|Anesthetics, Local|anesthetics, local|mesh-ancestor
6149435|NCT01395043|Anesthetics|anesthetics|mesh-ancestor
6149436|NCT01395043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6149437|NCT01395043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149438|NCT01395043|Sensory System Agents|sensory system agents|mesh-ancestor
6149439|NCT01395043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6149440|NCT01395043|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6149441|NCT01395043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6149442|NCT01395043|Adrenergic Agents|adrenergic agents|mesh-ancestor
6149443|NCT01395043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6149444|NCT01395043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149445|NCT01395043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6149446|NCT01395043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6149447|NCT01395043|Autonomic Agents|autonomic agents|mesh-ancestor
6149448|NCT01395043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6149449|NCT01395043|Respiratory System Agents|respiratory system agents|mesh-ancestor
6149450|NCT01395043|Mydriatics|mydriatics|mesh-ancestor
6149451|NCT01395043|Sympathomimetics|sympathomimetics|mesh-ancestor
6149452|NCT01395043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6149453|NCT01395316|Alemtuzumab|alemtuzumab|mesh-list
6149454|NCT01395316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6149455|NCT01395316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5551221|NCT04088006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5551222|NCT04088006|Immunologic Factors|immunologic factors|mesh-ancestor
5551223|NCT04088006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149456|NCT01395329|Metoprolol|metoprolol|mesh-list
6149457|NCT01395329|Nebivolol|nebivolol|mesh-list
6149458|NCT01395329|Nitroprusside|nitroprusside|mesh-list
6149459|NCT01395329|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
6149460|NCT01395329|BQ 788|bq 788|mesh-list
6149461|NCT01395329|Acetylcholine|acetylcholine|mesh-list
6149462|NCT01395329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6149463|NCT01395329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6149464|NCT01395329|Sympatholytics|sympatholytics|mesh-ancestor
6149465|NCT01395329|Autonomic Agents|autonomic agents|mesh-ancestor
6149466|NCT01395329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6149467|NCT01395329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149468|NCT01395329|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5551224|NCT04088006|Viscosupplements|viscosupplements|mesh-ancestor
5551225|NCT04088006|Protective Agents|protective agents|mesh-ancestor
5551226|NCT04087967|Cytarabine|cytarabine|mesh-list
6149469|NCT01395329|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6149470|NCT01395329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6149471|NCT01395329|Adrenergic Agents|adrenergic agents|mesh-ancestor
6149472|NCT01395329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6149473|NCT01395329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149474|NCT01395329|Vasodilator Agents|vasodilator agents|mesh-ancestor
6149475|NCT01395329|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6149476|NCT01395329|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6149477|NCT01395329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6149478|NCT01395329|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6149479|NCT01395329|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6149480|NCT01395329|Cholinergic Agents|cholinergic agents|mesh-ancestor
6149481|NCT01395329|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6149482|NCT01395329|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
6149483|NCT01395524|Naloxegol|naloxegol|mesh-list
6476373|NCT00524069|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6476374|NCT00524069|Growth Substances|growth substances|mesh-ancestor
6476375|NCT00524069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476376|NCT00524069|Growth Inhibitors|growth inhibitors|mesh-ancestor
6476377|NCT00524069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6476378|NCT00524069|Antimetabolites|antimetabolites|mesh-ancestor
6476379|NCT00524069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476380|NCT00524069|Antiviral Agents|antiviral agents|mesh-ancestor
6476381|NCT00524069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6476382|NCT00524069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5551227|NCT04087967|Decitabine|decitabine|mesh-list
5551228|NCT04087967|Idarubicin|idarubicin|mesh-list
5551229|NCT04087967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5551230|NCT04087967|Antimetabolites|antimetabolites|mesh-ancestor
5551231|NCT04087967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5551232|NCT04087967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5551233|NCT04087967|Antiviral Agents|antiviral agents|mesh-ancestor
5551234|NCT04087967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5551235|NCT04087967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5551236|NCT04087967|Immunologic Factors|immunologic factors|mesh-ancestor
5551237|NCT04087967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551238|NCT04087967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5551239|NCT04087967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6476383|NCT00524069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6476384|NCT00524069|Immunologic Factors|immunologic factors|mesh-ancestor
6476385|NCT00524095|Fluticasone|fluticasone|mesh-list
6476386|NCT00524095|Xhance|xhance|mesh-list
6476387|NCT00524095|Azithromycin|azithromycin|mesh-list
6476388|NCT00524095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6476389|NCT00524095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6476390|NCT00524095|Autonomic Agents|autonomic agents|mesh-ancestor
6476391|NCT00524095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6476392|NCT00524095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476393|NCT00524095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6476394|NCT00524095|Respiratory System Agents|respiratory system agents|mesh-ancestor
6476395|NCT00524095|Dermatologic Agents|dermatologic agents|mesh-ancestor
6149484|NCT01395524|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6149485|NCT01395524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149486|NCT01395524|Sensory System Agents|sensory system agents|mesh-ancestor
6149487|NCT01395524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6149488|NCT01395537|Paclitaxel|paclitaxel|mesh-list
6149489|NCT01395537|Carboplatin|carboplatin|mesh-list
6149490|NCT01395537|Lapatinib|lapatinib|mesh-list
6149491|NCT01395537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6149492|NCT01395537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6149493|NCT01395537|Tubulin Modulators|tubulin modulators|mesh-ancestor
6149494|NCT01395537|Antimitotic Agents|antimitotic agents|mesh-ancestor
6149495|NCT01395537|Mitosis Modulators|mitosis modulators|mesh-ancestor
6149496|NCT01395537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149497|NCT01395537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6149498|NCT01395537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6149499|NCT01395758|Gemcitabine|gemcitabine|mesh-list
6149500|NCT01395758|Docetaxel|docetaxel|mesh-list
6149501|NCT01395758|Pemetrexed|pemetrexed|mesh-list
6149502|NCT01395758|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6149503|NCT01395758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6476396|NCT00524095|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6149504|NCT01395758|Antimetabolites|antimetabolites|mesh-ancestor
6149505|NCT01395758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149506|NCT01395758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6149507|NCT01395758|Antiviral Agents|antiviral agents|mesh-ancestor
6149508|NCT01395758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6149509|NCT01395758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6149510|NCT01395758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6476397|NCT00524095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6476398|NCT00524095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6488776|NCT00586443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6488777|NCT00586443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6488778|NCT00586443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6488779|NCT00586443|Growth Substances|growth substances|mesh-ancestor
6488780|NCT00586443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488781|NCT00586443|Growth Inhibitors|growth inhibitors|mesh-ancestor
6488782|NCT00586443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6488783|NCT00586443|Immunologic Factors|immunologic factors|mesh-ancestor
6488784|NCT00586560|Cyclophosphamide|cyclophosphamide|mesh-list
6488785|NCT00586560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6488786|NCT00586560|Immunologic Factors|immunologic factors|mesh-ancestor
6488787|NCT00586560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488788|NCT00586560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6488789|NCT00586560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6488790|NCT00586560|Alkylating Agents|alkylating agents|mesh-ancestor
6488791|NCT00586560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488792|NCT00586560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5551240|NCT04087967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5551241|NCT04087967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5551242|NCT04087590|Glycopyrrolate|glycopyrrolate|mesh-list
5551243|NCT04087590|Formoterol Fumarate|formoterol fumarate|mesh-list
5551244|NCT04087590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5551245|NCT04087590|Autonomic Agents|autonomic agents|mesh-ancestor
5551246|NCT04087590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5551247|NCT04087590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551248|NCT04087590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5551249|NCT04087590|Respiratory System Agents|respiratory system agents|mesh-ancestor
5551250|NCT04087590|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5551251|NCT04087590|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5551252|NCT04087590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5551253|NCT04087590|Adrenergic Agents|adrenergic agents|mesh-ancestor
5551254|NCT04087590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5551255|NCT04087590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5551256|NCT04087590|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6149511|NCT01395758|Immunologic Factors|immunologic factors|mesh-ancestor
6149512|NCT01395758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149513|NCT01395758|Tubulin Modulators|tubulin modulators|mesh-ancestor
5551257|NCT04087590|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5551258|NCT04087590|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5551259|NCT04087590|Cholinergic Agents|cholinergic agents|mesh-ancestor
5602918|NCT03889418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5602919|NCT03877354|Anesthetics|anesthetics|mesh-list
5602920|NCT03877354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5606794|NCT03786783|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6149514|NCT01395758|Antimitotic Agents|antimitotic agents|mesh-ancestor
6149515|NCT01395758|Mitosis Modulators|mitosis modulators|mesh-ancestor
6149516|NCT01395758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6149517|NCT01395758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6149518|NCT01395758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6476399|NCT00524160|Fentanyl|fentanyl|mesh-list
6149519|NCT01395784|Pioglitazone|pioglitazone|mesh-list
6149520|NCT01395784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6149521|NCT01395784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205687|NCT02091414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6205688|NCT02091414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205689|NCT02091414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6205690|NCT02091414|Immunologic Factors|immunologic factors|mesh-ancestor
6205691|NCT02091414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551260|NCT04087460|Vaccines|vaccines|mesh-list
5551261|NCT04087460|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5551262|NCT04087460|Immunologic Factors|immunologic factors|mesh-ancestor
5551263|NCT04087460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551264|NCT04087668|Anesthetics|anesthetics|mesh-list
5551265|NCT04087668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5551266|NCT04087668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205692|NCT02091414|Antifungal Agents|antifungal agents|mesh-ancestor
6205693|NCT02091414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6205694|NCT02091414|Dermatologic Agents|dermatologic agents|mesh-ancestor
6205695|NCT02091414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6205696|NCT02091414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6205697|NCT02091414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6205698|NCT02091414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6205699|NCT02091414|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6205700|NCT02091414|Antitubercular Agents|antitubercular agents|mesh-ancestor
6205701|NCT02091414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6205702|NCT02091739|Botulinum Toxins|botulinum toxins|mesh-list
6205703|NCT02091739|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6205704|NCT02091739|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6205705|NCT02091739|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
6205706|NCT02091739|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6205707|NCT02091739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6205708|NCT02091739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205709|NCT02091739|Cholinergic Agents|cholinergic agents|mesh-ancestor
6205710|NCT02091739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6476400|NCT00524160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6476401|NCT00524160|Narcotics|narcotics|mesh-ancestor
6476402|NCT00524160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6476403|NCT00524160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476404|NCT00524160|Analgesics|analgesics|mesh-ancestor
6476405|NCT00524160|Sensory System Agents|sensory system agents|mesh-ancestor
6476406|NCT00524160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6476407|NCT00524160|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6476408|NCT00524160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6476409|NCT00524160|Anesthetics, General|anesthetics, general|mesh-ancestor
6476410|NCT00524160|Anesthetics|anesthetics|mesh-ancestor
6476411|NCT00524186|Leucovorin|leucovorin|mesh-list
6476412|NCT00524186|Fluorouracil|fluorouracil|mesh-list
6476413|NCT00524186|Irinotecan|irinotecan|mesh-list
6476414|NCT00524186|Sunitinib|sunitinib|mesh-list
5551267|NCT04087759|Bedaquiline|bedaquiline|mesh-list
5551268|NCT04087759|Diarylquinolines|diarylquinolines|mesh-list
5551269|NCT04087759|Antitubercular Agents|antitubercular agents|mesh-ancestor
5551270|NCT04087759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5551271|NCT04087759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5551272|NCT04087408|Hormones|hormones|mesh-list
6476415|NCT00524186|Calcium|calcium|mesh-list
6476416|NCT00524186|Levoleucovorin|levoleucovorin|mesh-list
6476417|NCT00524186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6476418|NCT00524186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476419|NCT00524186|Antimetabolites|antimetabolites|mesh-ancestor
6476420|NCT00524186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476421|NCT00524186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6476422|NCT00524186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6476423|NCT00524186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6476424|NCT00524186|Immunologic Factors|immunologic factors|mesh-ancestor
5551273|NCT04087408|Progesterone|progesterone|mesh-list
6205711|NCT02091739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476425|NCT00524186|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6476426|NCT00524186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6476427|NCT00524186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6476428|NCT00524186|Antidotes|antidotes|mesh-ancestor
5551274|NCT04087408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5551275|NCT04087408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551276|NCT04087408|Progestins|progestins|mesh-ancestor
5551277|NCT04087421|Glycerol|glycerol|mesh-list
5551278|NCT04087421|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
5551279|NCT04087421|Protective Agents|protective agents|mesh-ancestor
5551280|NCT04087421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551281|NCT04087239|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
5551282|NCT04087239|Antiviral Agents|antiviral agents|mesh-ancestor
5551283|NCT04087239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5551284|NCT04086940|Esmolol|esmolol|mesh-list
5551285|NCT04086940|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5551286|NCT04086940|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5551287|NCT04086940|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5551288|NCT04086940|Adrenergic Agents|adrenergic agents|mesh-ancestor
5551289|NCT04086940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5551290|NCT04086940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5551291|NCT04086940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551292|NCT04087317|Acetaminophen|acetaminophen|mesh-list
5551293|NCT04087317|Ibuprofen|ibuprofen|mesh-list
5551294|NCT04087317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5551295|NCT04087317|Analgesics|analgesics|mesh-ancestor
5551296|NCT04087317|Sensory System Agents|sensory system agents|mesh-ancestor
5551297|NCT04087317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5551298|NCT04087317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551299|NCT04087317|Antipyretics|antipyretics|mesh-ancestor
5551300|NCT04087317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5551301|NCT04087317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5551302|NCT04087317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5551303|NCT04087317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5551304|NCT04087317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5551305|NCT04087317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5551306|NCT04087096|Zoledronic Acid|zoledronic acid|mesh-list
5551307|NCT04087096|Denosumab|denosumab|mesh-list
6476429|NCT00524186|Protective Agents|protective agents|mesh-ancestor
6476430|NCT00524186|Vitamin B Complex|vitamin b complex|mesh-ancestor
6476431|NCT00524186|Vitamins|vitamins|mesh-ancestor
6476432|NCT00524186|Micronutrients|micronutrients|mesh-ancestor
6476433|NCT00524186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6476434|NCT00524186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6476435|NCT00524186|Growth Substances|growth substances|mesh-ancestor
5551308|NCT04087096|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5551309|NCT04087096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551310|NCT04086537|Hepcidins|hepcidins|mesh-list
5551311|NCT04086537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5551312|NCT04086719|Pyrimethamine|pyrimethamine|mesh-list
5551313|NCT04086719|BMS-986165|bms-986165|mesh-list
5551314|NCT04086719|Antimalarials|antimalarials|mesh-ancestor
5551315|NCT04086719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5551316|NCT04086719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5551317|NCT04086719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5551318|NCT04086719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5551319|NCT04086719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5551320|NCT04086719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5551321|NCT04086719|Dermatologic Agents|dermatologic agents|mesh-ancestor
5551322|NCT04086719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5551323|NCT04086108|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
5551324|NCT04086108|GABA Agents|gaba agents|mesh-ancestor
5551325|NCT04086108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5551326|NCT04086108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5551327|NCT04086108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551328|NCT04086290|Androgens|androgens|mesh-list
5551329|NCT04086290|Hormones|hormones|mesh-ancestor
5551330|NCT04086290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6476436|NCT00524186|Growth Inhibitors|growth inhibitors|mesh-ancestor
6476437|NCT00524186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6476438|NCT00524199|Mesna|mesna|mesh-list
6476439|NCT00524199|Protective Agents|protective agents|mesh-ancestor
6476440|NCT00524199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476441|NCT00524251|Esomeprazole|esomeprazole|mesh-list
6476442|NCT00524251|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6476443|NCT00524251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6476444|NCT00524251|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6476445|NCT00524251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6476446|NCT00524251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476447|NCT00524381|Etanercept|etanercept|mesh-list
6149522|NCT01395797|Pioglitazone|pioglitazone|mesh-list
6149523|NCT01395797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6149524|NCT01395797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149525|NCT01395823|Vitamin D|vitamin d|mesh-list
6149526|NCT01395823|Ergocalciferols|ergocalciferols|mesh-list
6476448|NCT00524381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5551331|NCT04086290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551332|NCT04086264|Azacitidine|azacitidine|mesh-list
5551333|NCT04086264|Decitabine|decitabine|mesh-list
5551334|NCT04086264|Venetoclax|venetoclax|mesh-list
5551335|NCT04086264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5551336|NCT04086264|Antimetabolites|antimetabolites|mesh-ancestor
5551337|NCT04086264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5551338|NCT04086264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5551339|NCT04086264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5551340|NCT04086212|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5551341|NCT04086212|Icodextrin|icodextrin|mesh-list
5551342|NCT04086212|Dialysis Solutions|dialysis solutions|mesh-list
5551343|NCT04086186|Bupivacaine|bupivacaine|mesh-list
5551344|NCT04086186|Anesthetics, Local|anesthetics, local|mesh-ancestor
5551345|NCT04086186|Anesthetics|anesthetics|mesh-ancestor
5551346|NCT04086186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5551347|NCT04086186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551348|NCT04086186|Sensory System Agents|sensory system agents|mesh-ancestor
5551349|NCT04086186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5551350|NCT04086238|Decitabine|decitabine|mesh-list
5551351|NCT04086238|Tetrahydrouridine|tetrahydrouridine|mesh-list
6476449|NCT00524381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6476450|NCT00524381|Analgesics|analgesics|mesh-ancestor
6476451|NCT00524381|Sensory System Agents|sensory system agents|mesh-ancestor
6476452|NCT00524381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6476453|NCT00524381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476454|NCT00524381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6476455|NCT00524381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6476456|NCT00524381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6476457|NCT00524381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6476458|NCT00524381|Immunologic Factors|immunologic factors|mesh-ancestor
6476459|NCT00524407|Epoetin Alfa|epoetin alfa|mesh-list
6476460|NCT00524407|Hematinics|hematinics|mesh-ancestor
6476461|NCT00524433|Tezosentan|tezosentan|mesh-list
6476462|NCT00524433|Vasodilator Agents|vasodilator agents|mesh-ancestor
6476463|NCT00524498|Cisplatin|cisplatin|mesh-list
6476464|NCT00524498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6476465|NCT00524524|Beta-lapachone|beta-lapachone|mesh-list
6476466|NCT00524524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6476467|NCT00524524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6476468|NCT00524524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6476469|NCT00524524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6476470|NCT00524524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476471|NCT00524524|Antiviral Agents|antiviral agents|mesh-ancestor
6476472|NCT00524615|Spironolactone|spironolactone|mesh-list
6149527|NCT01395823|Vitamins|vitamins|mesh-ancestor
6149528|NCT01395823|Micronutrients|micronutrients|mesh-ancestor
6149529|NCT01395823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149530|NCT01395823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6149531|NCT01395823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6476473|NCT00524615|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6476474|NCT00524615|Hormone Antagonists|hormone antagonists|mesh-ancestor
6476475|NCT00524615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5551352|NCT04086238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5551353|NCT04086238|Antimetabolites|antimetabolites|mesh-ancestor
6149532|NCT01395888|Fluticasone|fluticasone|mesh-list
6149533|NCT01395888|Xhance|xhance|mesh-list
6149534|NCT01395888|Tiotropium Bromide|tiotropium bromide|mesh-list
6149535|NCT01395888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6149536|NCT01395888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6149537|NCT01395888|Autonomic Agents|autonomic agents|mesh-ancestor
6149538|NCT01395888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6149539|NCT01395888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149540|NCT01395888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6149541|NCT01395888|Respiratory System Agents|respiratory system agents|mesh-ancestor
6149542|NCT01395888|Dermatologic Agents|dermatologic agents|mesh-ancestor
6149543|NCT01395888|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6149544|NCT01395888|Parasympatholytics|parasympatholytics|mesh-ancestor
6476476|NCT00524615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476477|NCT00524615|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6476478|NCT00524615|Diuretics|diuretics|mesh-ancestor
5551354|NCT04086238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5551355|NCT04086238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5551356|NCT04086238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5602921|NCT03877354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149545|NCT01395888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5602922|NCT03759184|Obinutuzumab|obinutuzumab|mesh-list
5602923|NCT03759184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5602924|NCT03759184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5602925|NCT03733925|Golimumab|golimumab|mesh-list
5602926|NCT03733925|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
5602927|NCT03733925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5602928|NCT03733925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5602929|NCT03733925|Immunologic Factors|immunologic factors|mesh-ancestor
5602930|NCT03733925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602931|NCT03670355|Tenofovir|tenofovir|mesh-list
5602932|NCT03670355|Antiviral Agents|antiviral agents|mesh-ancestor
6149546|NCT01395888|Cholinergic Agents|cholinergic agents|mesh-ancestor
6149547|NCT01395888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6149548|NCT01395888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149549|NCT01395901|Ondansetron|ondansetron|mesh-list
6149550|NCT01395901|Palonosetron|palonosetron|mesh-list
6149551|NCT01395901|Antiemetics|antiemetics|mesh-ancestor
6149552|NCT01395901|Autonomic Agents|autonomic agents|mesh-ancestor
6149553|NCT01395901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6149554|NCT01395901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149555|NCT01395901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6149556|NCT01395901|Antipruritics|antipruritics|mesh-ancestor
6149557|NCT01395901|Dermatologic Agents|dermatologic agents|mesh-ancestor
6149558|NCT01395901|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6149559|NCT01395901|Serotonin Agents|serotonin agents|mesh-ancestor
6149560|NCT01395901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6149561|NCT01395901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149562|NCT01395901|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6149563|NCT01395901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6149564|NCT01395901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6149565|NCT01395901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6149566|NCT01395901|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6149567|NCT01395901|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6149568|NCT01396005|Buprenorphine|buprenorphine|mesh-list
6149569|NCT01396005|Methadone|methadone|mesh-list
6149570|NCT01396005|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6149571|NCT01396005|Naloxone|naloxone|mesh-list
6149572|NCT01396005|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6149573|NCT01396005|Narcotics|narcotics|mesh-ancestor
6149574|NCT01396005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6149575|NCT01396005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149576|NCT01396005|Analgesics|analgesics|mesh-ancestor
6149577|NCT01396005|Sensory System Agents|sensory system agents|mesh-ancestor
6149578|NCT01396005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6149579|NCT01396005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6149580|NCT01396005|Antitussive Agents|antitussive agents|mesh-ancestor
5602933|NCT03670355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5602934|NCT03670355|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5602935|NCT03670355|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6149581|NCT01396005|Respiratory System Agents|respiratory system agents|mesh-ancestor
6476479|NCT00524615|Natriuretic Agents|natriuretic agents|mesh-ancestor
6476480|NCT00524667|Fludarabine|fludarabine|mesh-list
6476481|NCT00524667|Valproic Acid|valproic acid|mesh-list
6476482|NCT00524667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6476483|NCT00524667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476484|NCT00524667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476485|NCT00524667|Anticonvulsants|anticonvulsants|mesh-ancestor
6476486|NCT00524667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6476487|NCT00524667|GABA Agents|gaba agents|mesh-ancestor
6476488|NCT00524667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6476489|NCT00524667|Antimanic Agents|antimanic agents|mesh-ancestor
6476490|NCT00524667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6476491|NCT00524667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6476492|NCT00524667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6476493|NCT00524693|Montelukast|montelukast|mesh-list
6476494|NCT00524693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6149582|NCT01396057|Dexamethasone|dexamethasone|mesh-list
6149583|NCT01396057|Ranibizumab|ranibizumab|mesh-list
5551357|NCT04085913|Lidocaine|lidocaine|mesh-list
5551358|NCT04085913|Epinephrine|epinephrine|mesh-list
5551359|NCT04085913|Racepinephrine|racepinephrine|mesh-list
5551360|NCT04085913|Bupivacaine|bupivacaine|mesh-list
5551361|NCT04085913|Epinephryl borate|epinephryl borate|mesh-list
5551362|NCT04085913|Anesthetics, Local|anesthetics, local|mesh-ancestor
5551363|NCT04085913|Anesthetics|anesthetics|mesh-ancestor
6149584|NCT01396057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6149585|NCT01396057|Antiemetics|antiemetics|mesh-ancestor
6149586|NCT01396057|Autonomic Agents|autonomic agents|mesh-ancestor
6149587|NCT01396057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6149588|NCT01396057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149589|NCT01396057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6149590|NCT01396057|Glucocorticoids|glucocorticoids|mesh-ancestor
6149591|NCT01396057|Hormones|hormones|mesh-ancestor
6149592|NCT01396057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6149593|NCT01396057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6149594|NCT01396057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6149595|NCT01396057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6149596|NCT01396057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6149597|NCT01396057|Growth Substances|growth substances|mesh-ancestor
6149598|NCT01396057|Growth Inhibitors|growth inhibitors|mesh-ancestor
6149599|NCT01396070|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5551364|NCT04085913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5551365|NCT04085913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551366|NCT04085913|Sensory System Agents|sensory system agents|mesh-ancestor
5551367|NCT04085913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5551368|NCT04085913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5551369|NCT04085913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5551370|NCT04085913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5551371|NCT04085913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5551372|NCT04085913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5551373|NCT04085913|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5551374|NCT04085913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5551375|NCT04085913|Adrenergic Agents|adrenergic agents|mesh-ancestor
5551376|NCT04085913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5551377|NCT04085913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5551378|NCT04085913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5551379|NCT04085913|Autonomic Agents|autonomic agents|mesh-ancestor
6149600|NCT01396070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6149601|NCT01396070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5551380|NCT04085913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5551381|NCT04085913|Respiratory System Agents|respiratory system agents|mesh-ancestor
6149602|NCT01396083|Dexamethasone|dexamethasone|mesh-list
6149603|NCT01396083|Ranibizumab|ranibizumab|mesh-list
6149604|NCT01396083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6149605|NCT01396083|Antiemetics|antiemetics|mesh-ancestor
6149606|NCT01396083|Autonomic Agents|autonomic agents|mesh-ancestor
6205712|NCT02091739|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6476495|NCT00524693|Respiratory System Agents|respiratory system agents|mesh-ancestor
6476496|NCT00524693|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6476497|NCT00524693|Hormone Antagonists|hormone antagonists|mesh-ancestor
6476498|NCT00524693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6476499|NCT00524693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476500|NCT00524693|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6149607|NCT01396083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6149608|NCT01396083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149609|NCT01396083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6149610|NCT01396083|Glucocorticoids|glucocorticoids|mesh-ancestor
6149611|NCT01396083|Hormones|hormones|mesh-ancestor
6149612|NCT01396083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6149613|NCT01396083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6476501|NCT00524693|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6476502|NCT00524693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476503|NCT00524706|Leucovorin|leucovorin|mesh-list
6476504|NCT00524706|Oxaliplatin|oxaliplatin|mesh-list
6476505|NCT00524706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6476506|NCT00524706|Antidotes|antidotes|mesh-ancestor
6476507|NCT00524706|Protective Agents|protective agents|mesh-ancestor
6476508|NCT00524706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476509|NCT00524706|Vitamin B Complex|vitamin b complex|mesh-ancestor
6476510|NCT00524706|Vitamins|vitamins|mesh-ancestor
6476511|NCT00524706|Micronutrients|micronutrients|mesh-ancestor
6476512|NCT00524810|Docetaxel|docetaxel|mesh-list
6476513|NCT00524810|Doxorubicin|doxorubicin|mesh-list
6476514|NCT00524810|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6476515|NCT00524810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6476516|NCT00524810|Tubulin Modulators|tubulin modulators|mesh-ancestor
6476517|NCT00524810|Antimitotic Agents|antimitotic agents|mesh-ancestor
6476518|NCT00524810|Mitosis Modulators|mitosis modulators|mesh-ancestor
6476519|NCT00524810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476520|NCT00524810|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6476521|NCT00524810|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6476522|NCT00524810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6476523|NCT00524810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6476524|NCT00524836|Levocetirizine|levocetirizine|mesh-list
6476525|NCT00524836|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6476526|NCT00524836|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6476527|NCT00524836|Histamine Antagonists|histamine antagonists|mesh-ancestor
6476528|NCT00524836|Histamine Agents|histamine agents|mesh-ancestor
6667689|NCT01528618|Antimetabolites|antimetabolites|mesh-ancestor
6667690|NCT01528618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667691|NCT01528618|Antiviral Agents|antiviral agents|mesh-ancestor
5551382|NCT04085913|Mydriatics|mydriatics|mesh-ancestor
6476529|NCT00524836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5551383|NCT04085913|Sympathomimetics|sympathomimetics|mesh-ancestor
5551384|NCT04085913|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5551385|NCT04085562|Amlodipine|amlodipine|mesh-list
5551386|NCT04085562|Bisoprolol|bisoprolol|mesh-list
5551387|NCT04085562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5551388|NCT04085562|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6476530|NCT00524836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476531|NCT00524836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149614|NCT01396083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6149615|NCT01396083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6149616|NCT01396083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6149617|NCT01396083|Growth Substances|growth substances|mesh-ancestor
6149618|NCT01396083|Growth Inhibitors|growth inhibitors|mesh-ancestor
6149619|NCT01396148|Sunitinib|sunitinib|mesh-list
6149620|NCT01396148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6149621|NCT01396148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6149622|NCT01396148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6149623|NCT01396148|Growth Substances|growth substances|mesh-ancestor
6149624|NCT01396148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149625|NCT01396148|Growth Inhibitors|growth inhibitors|mesh-ancestor
6149626|NCT01396148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6149627|NCT01396148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6149628|NCT01396148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149629|NCT01396265|Rifampin|rifampin|mesh-list
6149630|NCT01396265|Afatinib|afatinib|mesh-list
6149631|NCT01396265|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6149632|NCT01396265|Antitubercular Agents|antitubercular agents|mesh-ancestor
6149633|NCT01396265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6667692|NCT01528618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6476532|NCT00524849|Zoledronic Acid|zoledronic acid|mesh-list
6476533|NCT00524849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6476534|NCT00524849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476535|NCT00524875|Bevacizumab|bevacizumab|mesh-list
6476536|NCT00524875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6476537|NCT00524875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6149634|NCT01396265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6149635|NCT01396265|Leprostatic Agents|leprostatic agents|mesh-ancestor
6149636|NCT01396265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6149637|NCT01396265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6149638|NCT01396265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149639|NCT01396265|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6149640|NCT01396265|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6149641|NCT01396265|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6149642|NCT01396265|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6149643|NCT01396265|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6149644|NCT01396265|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6149645|NCT01396265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6149646|NCT01396265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6149647|NCT01396395|Nicorandil|nicorandil|mesh-list
6149648|NCT01396395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6149649|NCT01396395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6149650|NCT01396395|Vasodilator Agents|vasodilator agents|mesh-ancestor
6149651|NCT01396395|Vitamin B Complex|vitamin b complex|mesh-ancestor
6149652|NCT01396395|Vitamins|vitamins|mesh-ancestor
6476538|NCT00524875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6476539|NCT00524875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6476540|NCT00524875|Growth Substances|growth substances|mesh-ancestor
6667693|NCT01528618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6149653|NCT01396395|Micronutrients|micronutrients|mesh-ancestor
6149654|NCT01396395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149655|NCT01396421|Brexpiprazole|brexpiprazole|mesh-list
6149656|NCT01396421|Serotonin Agents|serotonin agents|mesh-ancestor
6149657|NCT01396421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6149658|NCT01396421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149659|NCT01396421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149660|NCT01396421|Dopamine Agonists|dopamine agonists|mesh-ancestor
6149661|NCT01396421|Dopamine Agents|dopamine agents|mesh-ancestor
6149662|NCT01396434|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6149663|NCT01396434|Immunologic Factors|immunologic factors|mesh-ancestor
6149664|NCT01396434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149665|NCT01396447|Cariprazine|cariprazine|mesh-list
6149666|NCT01396447|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5551389|NCT04085562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5551390|NCT04085562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5551391|NCT04085562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5551392|NCT04085562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551393|NCT04085562|Vasodilator Agents|vasodilator agents|mesh-ancestor
5551394|NCT04085562|Sympatholytics|sympatholytics|mesh-ancestor
5551395|NCT04085562|Autonomic Agents|autonomic agents|mesh-ancestor
5551396|NCT04085562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5551397|NCT04085562|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5551398|NCT04085562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5551399|NCT04085562|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5551400|NCT04085562|Adrenergic Agents|adrenergic agents|mesh-ancestor
5551401|NCT04085562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5551402|NCT04085744|Mometasone Furoate|mometasone furoate|mesh-list
5551403|NCT04085744|Lidocaine|lidocaine|mesh-list
5551404|NCT04085744|Anesthetics, Local|anesthetics, local|mesh-ancestor
5551405|NCT04085744|Anesthetics|anesthetics|mesh-ancestor
5551406|NCT04085744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5551407|NCT04085744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551408|NCT04085744|Sensory System Agents|sensory system agents|mesh-ancestor
5551409|NCT04085744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5551410|NCT04085744|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5551411|NCT04085744|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5551412|NCT04085744|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5551413|NCT04085744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6149667|NCT01396447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6149668|NCT01396447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6149669|NCT01396447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149670|NCT01396447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6149671|NCT01396486|Inositol|inositol|mesh-list
6149672|NCT01396486|Vitamin B Complex|vitamin b complex|mesh-ancestor
6149673|NCT01396486|Vitamins|vitamins|mesh-ancestor
6149674|NCT01396486|Micronutrients|micronutrients|mesh-ancestor
6149675|NCT01396486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149676|NCT01396512|Vaccines|vaccines|mesh-list
6149677|NCT01396512|Immunologic Factors|immunologic factors|mesh-ancestor
6149678|NCT01396512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149679|NCT01397084|Esomeprazole|esomeprazole|mesh-list
6149680|NCT01397084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5551414|NCT04085744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5551415|NCT04085744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5551416|NCT04085744|Dermatologic Agents|dermatologic agents|mesh-ancestor
5551417|NCT04085744|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5551418|NCT04085484|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-list
5551419|NCT04085484|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5551420|NCT04085770|Alfacalcidol|alfacalcidol|mesh-list
5551421|NCT04085770|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
5551422|NCT04085770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5551423|NCT04085770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551424|NCT04085770|Vitamins|vitamins|mesh-ancestor
5551425|NCT04085770|Micronutrients|micronutrients|mesh-ancestor
5551426|NCT04085757|Dinoprostone|dinoprostone|mesh-list
5551427|NCT04085757|Oxytocics|oxytocics|mesh-ancestor
5551428|NCT04085757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5551429|NCT04085757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551430|NCT04085575|Tranexamic Acid|tranexamic acid|mesh-list
5551431|NCT04085575|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6149681|NCT01397084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6149682|NCT01397084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6149683|NCT01397084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6149684|NCT01397084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149685|NCT01397409|Ranibizumab|ranibizumab|mesh-list
6149686|NCT01397409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6149687|NCT01397409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6476541|NCT00524875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476542|NCT00524875|Growth Inhibitors|growth inhibitors|mesh-ancestor
6476543|NCT00524901|Epoetin Alfa|epoetin alfa|mesh-list
6476544|NCT00524901|Hematinics|hematinics|mesh-ancestor
6476545|NCT00524914|Apomorphine|apomorphine|mesh-list
6476546|NCT00524914|Emetics|emetics|mesh-ancestor
6476547|NCT00524914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149688|NCT01397409|Growth Substances|growth substances|mesh-ancestor
6149689|NCT01397409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149690|NCT01397409|Growth Inhibitors|growth inhibitors|mesh-ancestor
6149691|NCT01397409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6149692|NCT01397422|Amantadine|amantadine|mesh-list
6149693|NCT01397422|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6149694|NCT01397422|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6149695|NCT01397422|Antiviral Agents|antiviral agents|mesh-ancestor
6149696|NCT01397422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6149697|NCT01397422|Dopamine Agents|dopamine agents|mesh-ancestor
6149698|NCT01397422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6149699|NCT01397422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149700|NCT01397422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149701|NCT01397422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6149702|NCT01397422|Analgesics|analgesics|mesh-ancestor
6149703|NCT01397422|Sensory System Agents|sensory system agents|mesh-ancestor
6149704|NCT01397422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6149705|NCT01397448|Rabeprazole|rabeprazole|mesh-list
6149706|NCT01397448|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6149707|NCT01397448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6149708|NCT01397448|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6149709|NCT01397448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6667694|NCT01528618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6667695|NCT01528618|Immunologic Factors|immunologic factors|mesh-ancestor
6667696|NCT01528618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667697|NCT01528644|Calcium, Dietary|calcium, dietary|mesh-list
5551432|NCT04085575|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6149710|NCT01397448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149711|NCT01397461|Retapamulin|retapamulin|mesh-list
6149712|NCT01397461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6149713|NCT01397461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6149714|NCT01397591|Bortezomib|bortezomib|mesh-list
6149715|NCT01397591|Ofatumumab|ofatumumab|mesh-list
6149716|NCT01397591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6476548|NCT00524914|Autonomic Agents|autonomic agents|mesh-ancestor
6149717|NCT01397825|Rituximab|rituximab|mesh-list
6476549|NCT00524914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6149718|NCT01397825|Vincristine|vincristine|mesh-list
6149719|NCT01397825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6149720|NCT01397825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6149721|NCT01397825|Immunologic Factors|immunologic factors|mesh-ancestor
6149722|NCT01397825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149723|NCT01397825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6149724|NCT01397825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6149725|NCT01397825|Tubulin Modulators|tubulin modulators|mesh-ancestor
6149726|NCT01397825|Antimitotic Agents|antimitotic agents|mesh-ancestor
6149727|NCT01397825|Mitosis Modulators|mitosis modulators|mesh-ancestor
6149728|NCT01397825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149729|NCT01397890|Budesonide|budesonide|mesh-list
6149730|NCT01397890|Formoterol Fumarate|formoterol fumarate|mesh-list
6149731|NCT01397890|Tiotropium Bromide|tiotropium bromide|mesh-list
5551433|NCT04085575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5551434|NCT04085575|Hemostatics|hemostatics|mesh-ancestor
5551435|NCT04085575|Coagulants|coagulants|mesh-ancestor
5551436|NCT04085627|Amlodipine|amlodipine|mesh-list
5551437|NCT04085627|Valsartan|valsartan|mesh-list
5551438|NCT04085627|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
5551439|NCT04085627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5551440|NCT04085627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6149732|NCT01397890|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6149733|NCT01397890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6149734|NCT01397890|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6149735|NCT01397890|Autonomic Agents|autonomic agents|mesh-ancestor
6149736|NCT01397890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6149737|NCT01397890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149738|NCT01397890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6149739|NCT01397890|Respiratory System Agents|respiratory system agents|mesh-ancestor
6149740|NCT01397890|Glucocorticoids|glucocorticoids|mesh-ancestor
6149741|NCT01397890|Hormones|hormones|mesh-ancestor
6149742|NCT01397890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6149743|NCT01397890|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6149744|NCT01397890|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6149745|NCT01397890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6149746|NCT01397890|Adrenergic Agents|adrenergic agents|mesh-ancestor
6149747|NCT01397890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6149748|NCT01397890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149749|NCT01397890|Parasympatholytics|parasympatholytics|mesh-ancestor
6476550|NCT00524914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6476551|NCT00524914|Dopamine Agonists|dopamine agonists|mesh-ancestor
6476552|NCT00524914|Dopamine Agents|dopamine agents|mesh-ancestor
6476553|NCT00524914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6476554|NCT00524914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476555|NCT00524927|Methoxyflurane|methoxyflurane|mesh-list
6476556|NCT00524927|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6476557|NCT00524927|Anesthetics, General|anesthetics, general|mesh-ancestor
6476558|NCT00524927|Anesthetics|anesthetics|mesh-ancestor
6476559|NCT00524927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6476560|NCT00524927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476561|NCT00524966|Hemostatics|hemostatics|mesh-list
6476562|NCT00524966|Coagulants|coagulants|mesh-ancestor
6476563|NCT00525005|Docetaxel|docetaxel|mesh-list
5551441|NCT04085627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5551442|NCT04085627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5551443|NCT04085627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5551444|NCT04085627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551445|NCT04085627|Vasodilator Agents|vasodilator agents|mesh-ancestor
5551446|NCT04085627|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5551447|NCT04085627|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5551448|NCT04085393|Granisetron|granisetron|mesh-list
5551449|NCT04085393|Antiemetics|antiemetics|mesh-ancestor
5551450|NCT04085393|Autonomic Agents|autonomic agents|mesh-ancestor
5551451|NCT04085393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6667698|NCT01528644|Iron|iron|mesh-list
6667699|NCT01528644|Ferrous gluconate|ferrous gluconate|mesh-list
6667700|NCT01528644|Calcium|calcium|mesh-list
6667701|NCT01528644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6476564|NCT00525005|Oxaliplatin|oxaliplatin|mesh-list
6476565|NCT00525005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6476566|NCT00525005|Tubulin Modulators|tubulin modulators|mesh-ancestor
6476567|NCT00525005|Antimitotic Agents|antimitotic agents|mesh-ancestor
6476568|NCT00525005|Mitosis Modulators|mitosis modulators|mesh-ancestor
6667702|NCT01528644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476569|NCT00525005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476570|NCT00525096|Celecoxib|celecoxib|mesh-list
6476571|NCT00525096|Exemestane|exemestane|mesh-list
6476572|NCT00525096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6476573|NCT00525096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6476574|NCT00525096|Analgesics|analgesics|mesh-ancestor
6476575|NCT00525096|Sensory System Agents|sensory system agents|mesh-ancestor
6476576|NCT00525096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6476577|NCT00525096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149750|NCT01397890|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6149751|NCT01397890|Cholinergic Agents|cholinergic agents|mesh-ancestor
6149752|NCT01398280|Aminocaproic Acid|aminocaproic acid|mesh-list
6476578|NCT00525096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6476579|NCT00525096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6667703|NCT01528644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6667704|NCT01528644|Trace Elements|trace elements|mesh-ancestor
6667705|NCT01528644|Micronutrients|micronutrients|mesh-ancestor
6667706|NCT01528644|Hematinics|hematinics|mesh-ancestor
6667707|NCT01528722|Bupivacaine|bupivacaine|mesh-list
6667708|NCT01528722|Anesthetics, Local|anesthetics, local|mesh-ancestor
6667709|NCT01528722|Anesthetics|anesthetics|mesh-ancestor
5551452|NCT04085393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476580|NCT00525096|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6476581|NCT00525096|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6476582|NCT00525096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6149753|NCT01398280|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6149754|NCT01398280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6149755|NCT01398280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149756|NCT01398280|Hemostatics|hemostatics|mesh-ancestor
6149757|NCT01398280|Coagulants|coagulants|mesh-ancestor
6149758|NCT01398410|Rabeprazole|rabeprazole|mesh-list
6149759|NCT01398410|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6149760|NCT01398410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6149761|NCT01398410|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6149762|NCT01398410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6149763|NCT01398410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476583|NCT00525096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476584|NCT00525096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6476585|NCT00525096|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5551453|NCT04085393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5551454|NCT04085393|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5551455|NCT04085393|Serotonin Agents|serotonin agents|mesh-ancestor
5551456|NCT04085393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5551457|NCT04085393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5551458|NCT04085640|Ropivacaine|ropivacaine|mesh-list
5551459|NCT04085640|Anesthetics, Local|anesthetics, local|mesh-ancestor
5551460|NCT04085640|Anesthetics|anesthetics|mesh-ancestor
5551461|NCT04085640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5551462|NCT04085640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551463|NCT04085640|Sensory System Agents|sensory system agents|mesh-ancestor
5551464|NCT04085640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5551465|NCT04085094|Pilocarpine|pilocarpine|mesh-list
5551466|NCT04085094|Miotics|miotics|mesh-ancestor
5551467|NCT04085094|Autonomic Agents|autonomic agents|mesh-ancestor
5551468|NCT04085094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5602936|NCT03670355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6476586|NCT00525096|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6476587|NCT00525096|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6476588|NCT00525096|Hormone Antagonists|hormone antagonists|mesh-ancestor
6476589|NCT00525096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6476590|NCT00525200|Docetaxel|docetaxel|mesh-list
6476591|NCT00525200|Cisplatin|cisplatin|mesh-list
6476592|NCT00525200|Fluorouracil|fluorouracil|mesh-list
6149764|NCT01398514|Citalopram|citalopram|mesh-list
6149765|NCT01398514|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6149766|NCT01398514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6149767|NCT01398514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6149768|NCT01398514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149769|NCT01398514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6149770|NCT01398514|Serotonin Agents|serotonin agents|mesh-ancestor
6149771|NCT01398514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149772|NCT01398514|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6149773|NCT01398514|Antidepressive Agents|antidepressive agents|mesh-ancestor
6149774|NCT01398514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6667710|NCT01528722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6149775|NCT01398943|Antioxidants|antioxidants|mesh-list
6149776|NCT01398943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149777|NCT01398943|Protective Agents|protective agents|mesh-ancestor
6149778|NCT01398943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149779|NCT01398956|Levetiracetam|levetiracetam|mesh-list
6149780|NCT01398956|Anticonvulsants|anticonvulsants|mesh-ancestor
6149781|NCT01398956|Nootropic Agents|nootropic agents|mesh-ancestor
6149782|NCT01398982|Bupivacaine|bupivacaine|mesh-list
6149783|NCT01398982|Anesthetics, Local|anesthetics, local|mesh-ancestor
6149784|NCT01398982|Anesthetics|anesthetics|mesh-ancestor
6149785|NCT01398982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6149786|NCT01398982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149787|NCT01398982|Sensory System Agents|sensory system agents|mesh-ancestor
6149788|NCT01398982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6149789|NCT01399008|Colchicine|colchicine|mesh-list
6149790|NCT01399008|Allopurinol|allopurinol|mesh-list
6149791|NCT01399008|Gout Suppressants|gout suppressants|mesh-ancestor
6149792|NCT01399008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6149793|NCT01399008|Tubulin Modulators|tubulin modulators|mesh-ancestor
6149794|NCT01399008|Antimitotic Agents|antimitotic agents|mesh-ancestor
6149795|NCT01399008|Mitosis Modulators|mitosis modulators|mesh-ancestor
6149796|NCT01399008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149797|NCT01399008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6149798|NCT01399008|Antimetabolites|antimetabolites|mesh-ancestor
6149799|NCT01399008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6149800|NCT01399008|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6149801|NCT01399008|Antioxidants|antioxidants|mesh-ancestor
6149802|NCT01399008|Protective Agents|protective agents|mesh-ancestor
5551469|NCT04085094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551470|NCT04085094|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
5551471|NCT04085094|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5551472|NCT04085094|Cholinergic Agents|cholinergic agents|mesh-ancestor
5551473|NCT04085094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5551474|NCT04085094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5551475|NCT04085354|Vitamins|vitamins|mesh-list
5551476|NCT04085354|Folic Acid|folic acid|mesh-list
5551477|NCT04085354|Vitamin B 12|vitamin b 12|mesh-list
5551478|NCT04085354|Hydroxocobalamin|hydroxocobalamin|mesh-list
5551479|NCT04085354|Micronutrients|micronutrients|mesh-ancestor
5551480|NCT04085354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551481|NCT04085354|Hematinics|hematinics|mesh-ancestor
5551482|NCT04085354|Vitamin B Complex|vitamin b complex|mesh-ancestor
5551483|NCT04085172|Guanfacine|guanfacine|mesh-list
5551484|NCT04085172|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
5551485|NCT04085172|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5551486|NCT04085172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5551487|NCT04085172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5551488|NCT04085172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5551489|NCT04085172|Adrenergic Agents|adrenergic agents|mesh-ancestor
5551490|NCT04085172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5551491|NCT04085172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551492|NCT04085172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6149803|NCT01399008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476593|NCT00525200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5551493|NCT04085172|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5551494|NCT04085172|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5551495|NCT04085172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5551496|NCT04085120|Dexamethasone|dexamethasone|mesh-list
5551497|NCT04085120|Dexamethasone acetate|dexamethasone acetate|mesh-list
5551498|NCT04085120|Lidocaine|lidocaine|mesh-list
5551499|NCT04085120|Ropivacaine|ropivacaine|mesh-list
5551500|NCT04085120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5551501|NCT04085120|Antiemetics|antiemetics|mesh-ancestor
5551502|NCT04085120|Autonomic Agents|autonomic agents|mesh-ancestor
5551503|NCT04085120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5551504|NCT04085120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551505|NCT04085120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5551506|NCT04085120|Glucocorticoids|glucocorticoids|mesh-ancestor
5551507|NCT04085120|Hormones|hormones|mesh-ancestor
5551508|NCT04085120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5551509|NCT04085120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5551510|NCT04085120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5551511|NCT04085120|Anesthetics, Local|anesthetics, local|mesh-ancestor
6149804|NCT01399047|Mycophenolic Acid|mycophenolic acid|mesh-list
6149805|NCT01399047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6149806|NCT01399047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6149807|NCT01399047|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6149808|NCT01399047|Antitubercular Agents|antitubercular agents|mesh-ancestor
6149809|NCT01399047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6149810|NCT01399047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6149811|NCT01399047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6149812|NCT01399047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149813|NCT01399125|Rivastigmine|rivastigmine|mesh-list
6149814|NCT01399125|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6149815|NCT01399125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6149816|NCT01399125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149817|NCT01399125|Cholinergic Agents|cholinergic agents|mesh-ancestor
6149818|NCT01399125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6149819|NCT01399125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149820|NCT01399125|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6149821|NCT01399125|Protective Agents|protective agents|mesh-ancestor
6149822|NCT01399190|Bevacizumab|bevacizumab|mesh-list
6476594|NCT00525200|Tubulin Modulators|tubulin modulators|mesh-ancestor
6476595|NCT00525200|Antimitotic Agents|antimitotic agents|mesh-ancestor
6476596|NCT00525200|Mitosis Modulators|mitosis modulators|mesh-ancestor
6476597|NCT00525200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476598|NCT00525200|Antimetabolites|antimetabolites|mesh-ancestor
6476599|NCT00525200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6667711|NCT01528722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667712|NCT01528722|Sensory System Agents|sensory system agents|mesh-ancestor
6149823|NCT01399190|Capecitabine|capecitabine|mesh-list
6149824|NCT01399190|Oxaliplatin|oxaliplatin|mesh-list
6149825|NCT01399190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6149826|NCT01399190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6476600|NCT00525200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6476601|NCT00525200|Immunologic Factors|immunologic factors|mesh-ancestor
5551512|NCT04085120|Anesthetics|anesthetics|mesh-ancestor
5551513|NCT04085120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5551514|NCT04085120|Sensory System Agents|sensory system agents|mesh-ancestor
5551515|NCT04085120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5551516|NCT04085120|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6476602|NCT00525200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476603|NCT00525239|Ritonavir|ritonavir|mesh-list
5551517|NCT04085120|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5551518|NCT04085120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5551519|NCT04085120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5551520|NCT04085276|Paclitaxel|paclitaxel|mesh-list
5551521|NCT04085276|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5551522|NCT04085276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5551523|NCT04085276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5551524|NCT04085276|Tubulin Modulators|tubulin modulators|mesh-ancestor
5551525|NCT04085276|Antimitotic Agents|antimitotic agents|mesh-ancestor
5551526|NCT04085276|Mitosis Modulators|mitosis modulators|mesh-ancestor
5551527|NCT04085276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5551528|NCT04085250|Nivolumab|nivolumab|mesh-list
5551529|NCT04085250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6476604|NCT00525239|Lopinavir|lopinavir|mesh-list
6476605|NCT00525239|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6476606|NCT00525239|Efavirenz|efavirenz|mesh-list
6476607|NCT00525239|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6476608|NCT00525239|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6476609|NCT00525239|Protease Inhibitors|protease inhibitors|mesh-ancestor
6476610|NCT00525239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6476611|NCT00525239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476612|NCT00525239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6149827|NCT01399190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6149828|NCT01399190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6149829|NCT01399190|Growth Substances|growth substances|mesh-ancestor
6149830|NCT01399190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149831|NCT01399190|Growth Inhibitors|growth inhibitors|mesh-ancestor
6149832|NCT01399190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6149833|NCT01399190|Antimetabolites|antimetabolites|mesh-ancestor
6476613|NCT00525239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6667713|NCT01528722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6667714|NCT01528800|Vitamin K|vitamin k|mesh-list
6667715|NCT01528800|Vitamin K 1|vitamin k 1|mesh-list
6667716|NCT01528800|Vitamins|vitamins|mesh-ancestor
5551530|NCT04085250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5551531|NCT04085250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5551532|NCT04085250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667717|NCT01528800|Micronutrients|micronutrients|mesh-ancestor
6476614|NCT00525239|Antiviral Agents|antiviral agents|mesh-ancestor
6476615|NCT00525239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6476616|NCT00525239|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6476617|NCT00525239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6476618|NCT00525239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6476619|NCT00525239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6476620|NCT00525239|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6476621|NCT00525239|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6476622|NCT00525239|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6476623|NCT00525239|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5551533|NCT04085315|Osimertinib|osimertinib|mesh-list
5551534|NCT04085315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5551535|NCT04085315|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5551536|NCT04085315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5551537|NCT04085315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5551538|NCT04085419|Zoledronic Acid|zoledronic acid|mesh-list
5551539|NCT04085419|Denosumab|denosumab|mesh-list
5551540|NCT04085419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5551541|NCT04085419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551542|NCT04085237|Ropivacaine|ropivacaine|mesh-list
5551543|NCT04085237|Anesthetics, Local|anesthetics, local|mesh-ancestor
5551544|NCT04085237|Anesthetics|anesthetics|mesh-ancestor
5551545|NCT04085237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5551546|NCT04085237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551547|NCT04085237|Sensory System Agents|sensory system agents|mesh-ancestor
5551548|NCT04085237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5551549|NCT04084977|Antibodies|antibodies|mesh-list
5551550|NCT04084977|Immunologic Factors|immunologic factors|mesh-ancestor
5551551|NCT04084977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551552|NCT04084860|Ketamine|ketamine|mesh-list
5551553|NCT04084860|Analgesics|analgesics|mesh-ancestor
5551554|NCT04084860|Sensory System Agents|sensory system agents|mesh-ancestor
5551555|NCT04084860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5551556|NCT04084860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551557|NCT04084860|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5551558|NCT04084860|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5551559|NCT04084860|Anesthetics, General|anesthetics, general|mesh-ancestor
5551560|NCT04084860|Anesthetics|anesthetics|mesh-ancestor
6667718|NCT01528800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667719|NCT01528800|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6667720|NCT01528800|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5551561|NCT04084860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5551562|NCT04084860|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5551563|NCT04084860|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5551564|NCT04084860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5551565|NCT04084860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667721|NCT01528800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667722|NCT01528800|Hemostatics|hemostatics|mesh-ancestor
6667723|NCT01528800|Coagulants|coagulants|mesh-ancestor
6667724|NCT01528813|Amorolfine|amorolfine|mesh-list
6667725|NCT01528813|Antifungal Agents|antifungal agents|mesh-ancestor
6667726|NCT01528813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6667727|NCT01528826|Oxaliplatin|oxaliplatin|mesh-list
6667728|NCT01528826|Vinorelbine|vinorelbine|mesh-list
6667729|NCT01528826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6667730|NCT01528826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6667731|NCT01528826|Tubulin Modulators|tubulin modulators|mesh-ancestor
6667732|NCT01528826|Antimitotic Agents|antimitotic agents|mesh-ancestor
5551566|NCT04084912|Dexamethasone|dexamethasone|mesh-list
5551567|NCT04084912|Dexamethasone acetate|dexamethasone acetate|mesh-list
5551568|NCT04084912|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
5551569|NCT04084912|BB 1101|bb 1101|mesh-list
6149834|NCT01399190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149835|NCT01399268|Hydrocortisone|hydrocortisone|mesh-list
6149836|NCT01399268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6149837|NCT01399372|Cytarabine|cytarabine|mesh-list
6476624|NCT00525239|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6476625|NCT00525252|Baclofen|baclofen|mesh-list
6476626|NCT00525252|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6476627|NCT00525252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551570|NCT04084912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5551571|NCT04084912|Antiemetics|antiemetics|mesh-ancestor
5551572|NCT04084912|Autonomic Agents|autonomic agents|mesh-ancestor
5551573|NCT04084912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5551574|NCT04084912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551575|NCT04084912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5551576|NCT04084912|Glucocorticoids|glucocorticoids|mesh-ancestor
5551577|NCT04084912|Hormones|hormones|mesh-ancestor
5551578|NCT04084912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5551579|NCT04084912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5551580|NCT04084912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5551581|NCT04084912|Protease Inhibitors|protease inhibitors|mesh-ancestor
5551582|NCT04084912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5551583|NCT04084912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5551584|NCT04084548|Lidocaine|lidocaine|mesh-list
5551585|NCT04084548|Ketamine|ketamine|mesh-list
5551586|NCT04084548|Anesthetics, Local|anesthetics, local|mesh-ancestor
5551587|NCT04084548|Anesthetics|anesthetics|mesh-ancestor
5551588|NCT04084548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5551589|NCT04084548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476628|NCT00525252|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6476629|NCT00525252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6476630|NCT00525252|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6476631|NCT00525252|GABA Agonists|gaba agonists|mesh-ancestor
6476632|NCT00525252|GABA Agents|gaba agents|mesh-ancestor
6476633|NCT00525252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6476634|NCT00525252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476635|NCT00525278|Levocetirizine|levocetirizine|mesh-list
6476636|NCT00525278|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6476637|NCT00525278|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6476638|NCT00525278|Histamine Antagonists|histamine antagonists|mesh-ancestor
6476639|NCT00525278|Histamine Agents|histamine agents|mesh-ancestor
6476640|NCT00525278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6476641|NCT00525278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476642|NCT00525278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476643|NCT00525382|Levocetirizine|levocetirizine|mesh-list
6476644|NCT00525382|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6476645|NCT00525382|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6476646|NCT00525382|Histamine Antagonists|histamine antagonists|mesh-ancestor
6476647|NCT00525382|Histamine Agents|histamine agents|mesh-ancestor
6476648|NCT00525382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6476649|NCT00525382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476650|NCT00525382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476651|NCT00525408|Docetaxel|docetaxel|mesh-list
6476652|NCT00525408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6476653|NCT00525408|Tubulin Modulators|tubulin modulators|mesh-ancestor
5551590|NCT04084548|Sensory System Agents|sensory system agents|mesh-ancestor
5551591|NCT04084548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5551592|NCT04084548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5551593|NCT04084548|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5551594|NCT04084548|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5551595|NCT04084548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5606795|NCT03770130|Dexmedetomidine|dexmedetomidine|mesh-list
5551596|NCT04084548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5551597|NCT04084548|Analgesics|analgesics|mesh-ancestor
5551598|NCT04084548|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5551599|NCT04084548|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5551600|NCT04084548|Anesthetics, General|anesthetics, general|mesh-ancestor
5551601|NCT04084548|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5551602|NCT04084548|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5551603|NCT04084548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5551604|NCT04084496|Folfirinox|folfirinox|mesh-list
5551605|NCT04084496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5551606|NCT04084158|Paclitaxel|paclitaxel|mesh-list
5551607|NCT04084158|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5551608|NCT04084158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6476654|NCT00525408|Antimitotic Agents|antimitotic agents|mesh-ancestor
6476655|NCT00525408|Mitosis Modulators|mitosis modulators|mesh-ancestor
6476656|NCT00525408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476657|NCT00525447|Dexamethasone|dexamethasone|mesh-list
6476658|NCT00525447|Lenalidomide|lenalidomide|mesh-list
6476659|NCT00525447|Dacetuzumab|dacetuzumab|mesh-list
6476660|NCT00525447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6476661|NCT00525447|Antiemetics|antiemetics|mesh-ancestor
5551609|NCT04084158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6476662|NCT00525447|Autonomic Agents|autonomic agents|mesh-ancestor
6476663|NCT00525447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6476664|NCT00525447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476665|NCT00525447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6476666|NCT00525447|Glucocorticoids|glucocorticoids|mesh-ancestor
6476667|NCT00525447|Hormones|hormones|mesh-ancestor
6476668|NCT00525447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6476669|NCT00525447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6476670|NCT00525447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6476671|NCT00525447|Immunologic Factors|immunologic factors|mesh-ancestor
6476672|NCT00525447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6476673|NCT00525447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6476674|NCT00525447|Growth Substances|growth substances|mesh-ancestor
6476675|NCT00525447|Growth Inhibitors|growth inhibitors|mesh-ancestor
6476676|NCT00525447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6476677|NCT00525473|Azathioprine|azathioprine|mesh-list
6476678|NCT00525473|Antimetabolites|antimetabolites|mesh-ancestor
6476679|NCT00525473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476680|NCT00525473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6476681|NCT00525473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6476682|NCT00525473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6476683|NCT00525473|Immunologic Factors|immunologic factors|mesh-ancestor
6476684|NCT00525473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551610|NCT04084158|Tubulin Modulators|tubulin modulators|mesh-ancestor
5551611|NCT04084158|Antimitotic Agents|antimitotic agents|mesh-ancestor
5551612|NCT04084158|Mitosis Modulators|mitosis modulators|mesh-ancestor
5551613|NCT04084158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476685|NCT00525473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6476686|NCT00525486|Nifedipine|nifedipine|mesh-list
6476687|NCT00525486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6476688|NCT00525486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6476689|NCT00525486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476690|NCT00525486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6476691|NCT00525486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476692|NCT00525486|Vasodilator Agents|vasodilator agents|mesh-ancestor
6476693|NCT00525486|Tocolytic Agents|tocolytic agents|mesh-ancestor
6476694|NCT00525486|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6476695|NCT00525551|Acetylcysteine|acetylcysteine|mesh-list
6476696|NCT00525551|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6476697|NCT00525551|Antiviral Agents|antiviral agents|mesh-ancestor
6476698|NCT00525551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6476699|NCT00525551|Expectorants|expectorants|mesh-ancestor
6476700|NCT00525551|Respiratory System Agents|respiratory system agents|mesh-ancestor
6476701|NCT00525551|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6476702|NCT00525551|Antioxidants|antioxidants|mesh-ancestor
6476703|NCT00525551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476704|NCT00525551|Protective Agents|protective agents|mesh-ancestor
6476705|NCT00525551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476706|NCT00525551|Antidotes|antidotes|mesh-ancestor
6476707|NCT00525564|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6476708|NCT00525564|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6476709|NCT00525564|Autonomic Agents|autonomic agents|mesh-ancestor
6667733|NCT01528826|Mitosis Modulators|mitosis modulators|mesh-ancestor
6476710|NCT00525564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6476711|NCT00525564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476712|NCT00525564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6476713|NCT00525564|Respiratory System Agents|respiratory system agents|mesh-ancestor
6476714|NCT00525564|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6476715|NCT00525564|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6476716|NCT00525564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6476717|NCT00525564|Adrenergic Agents|adrenergic agents|mesh-ancestor
6476718|NCT00525564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6476719|NCT00525564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476720|NCT00525577|Probucol|probucol|mesh-list
6476721|NCT00525577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6149838|NCT01399372|Rituximab|rituximab|mesh-list
6149839|NCT01399372|Methotrexate|methotrexate|mesh-list
6149840|NCT01399372|Vincristine|vincristine|mesh-list
6149841|NCT01399372|Procarbazine|procarbazine|mesh-list
6149842|NCT01399372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5551614|NCT04084106|Amoxicillin|amoxicillin|mesh-list
5551615|NCT04084106|Clavulanic Acids|clavulanic acids|mesh-list
5551616|NCT04084106|Clavulanic Acid|clavulanic acid|mesh-list
5551617|NCT04084106|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5551618|NCT04084106|Penicillin V|penicillin v|mesh-list
5551619|NCT04084106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5551620|NCT04084106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5551621|NCT04084106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5551622|NCT04084106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5551623|NCT04084106|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5551624|NCT04084171|Insulin|insulin|mesh-list
5551625|NCT04084171|Pancrelipase|pancrelipase|mesh-list
5551626|NCT04084171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5551627|NCT04084171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551628|NCT04084171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6149843|NCT01399372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6149844|NCT01399372|Immunologic Factors|immunologic factors|mesh-ancestor
6149845|NCT01399372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476722|NCT00525577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6476723|NCT00525577|Antimetabolites|antimetabolites|mesh-ancestor
6149846|NCT01399372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6149847|NCT01399372|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6149848|NCT01399372|Abortifacient Agents|abortifacient agents|mesh-ancestor
5602937|NCT03670355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602938|NCT03670355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5602939|NCT03670355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5602940|NCT03668392|Asparaginase|asparaginase|mesh-list
5602941|NCT03668392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5602942|NCT03659578|Thymalfasin|thymalfasin|mesh-list
5602943|NCT03659578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5602944|NCT03659578|Immunologic Factors|immunologic factors|mesh-ancestor
5602945|NCT03659578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149849|NCT01399372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5602946|NCT03629873|Cytarabine|cytarabine|mesh-list
5602947|NCT03629873|Cyclophosphamide|cyclophosphamide|mesh-list
5602948|NCT03629873|Carmustine|carmustine|mesh-list
5551629|NCT04084093|Pulmonary Surfactants|pulmonary surfactants|mesh-list
5551630|NCT04084093|Respiratory System Agents|respiratory system agents|mesh-ancestor
6476724|NCT00525577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476725|NCT00525577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6476726|NCT00525577|Antioxidants|antioxidants|mesh-ancestor
6149850|NCT01399372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6149851|NCT01399372|Antimetabolites|antimetabolites|mesh-ancestor
6149852|NCT01399372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149853|NCT01399372|Dermatologic Agents|dermatologic agents|mesh-ancestor
6149854|NCT01399372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6149855|NCT01399372|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6149856|NCT01399372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6149857|NCT01399372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6149858|NCT01399372|Antiviral Agents|antiviral agents|mesh-ancestor
6149859|NCT01399372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6476727|NCT00525577|Protective Agents|protective agents|mesh-ancestor
6476728|NCT00525577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476729|NCT00525616|Rituximab|rituximab|mesh-list
6476730|NCT00525616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5551631|NCT04084210|Nicotine|nicotine|mesh-list
5551632|NCT04084210|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6476731|NCT00525616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6476732|NCT00525616|Immunologic Factors|immunologic factors|mesh-ancestor
6476733|NCT00525616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476734|NCT00525616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6476735|NCT00525642|Cyclophosphamide|cyclophosphamide|mesh-list
5551633|NCT04084210|Autonomic Agents|autonomic agents|mesh-ancestor
5551634|NCT04084210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5551635|NCT04084210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551636|NCT04084210|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5551637|NCT04084210|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5551638|NCT04084210|Cholinergic Agents|cholinergic agents|mesh-ancestor
6476736|NCT00525642|Docetaxel|docetaxel|mesh-list
6476737|NCT00525642|Doxorubicin|doxorubicin|mesh-list
6476738|NCT00525642|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6476739|NCT00525642|Epirubicin|epirubicin|mesh-list
6476740|NCT00525642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6476741|NCT00525642|Immunologic Factors|immunologic factors|mesh-ancestor
6476742|NCT00525642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476743|NCT00525642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6476744|NCT00525642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6476745|NCT00525642|Alkylating Agents|alkylating agents|mesh-ancestor
5551639|NCT04084210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5551640|NCT04084210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5551641|NCT04083898|Prednisone|prednisone|mesh-list
5551642|NCT04083898|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5551643|NCT04083898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5551644|NCT04083898|Glucocorticoids|glucocorticoids|mesh-ancestor
5551645|NCT04083898|Hormones|hormones|mesh-ancestor
5551646|NCT04083898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5551647|NCT04083898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551648|NCT04083898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5551649|NCT04083898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5551650|NCT04083898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5551651|NCT04083898|Alkylating Agents|alkylating agents|mesh-ancestor
6476746|NCT00525642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476747|NCT00525642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6476748|NCT00525642|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6476749|NCT00525642|Tubulin Modulators|tubulin modulators|mesh-ancestor
6476750|NCT00525642|Antimitotic Agents|antimitotic agents|mesh-ancestor
6476751|NCT00525642|Mitosis Modulators|mitosis modulators|mesh-ancestor
6476752|NCT00525642|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6476753|NCT00525642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6476754|NCT00525642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5551652|NCT04083898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5551653|NCT04083911|Cytarabine|cytarabine|mesh-list
5551654|NCT04083911|Decitabine|decitabine|mesh-list
5551655|NCT04083911|Homoharringtonine|homoharringtonine|mesh-list
5551656|NCT04083911|Aclarubicin|aclarubicin|mesh-list
5551657|NCT04083911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5551658|NCT04083911|Antimetabolites|antimetabolites|mesh-ancestor
5551659|NCT04083911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5551660|NCT04083911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5551661|NCT04083911|Antiviral Agents|antiviral agents|mesh-ancestor
5551662|NCT04083911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5551663|NCT04083911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5551664|NCT04083911|Immunologic Factors|immunologic factors|mesh-ancestor
5551665|NCT04083911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551666|NCT04083911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5551667|NCT04083911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6476755|NCT00525642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6476756|NCT00525668|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
6476757|NCT00525668|Antioxidants|antioxidants|mesh-ancestor
6476758|NCT00525668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476759|NCT00525668|Protective Agents|protective agents|mesh-ancestor
6476760|NCT00525668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149860|NCT01399372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6149861|NCT01399372|Tubulin Modulators|tubulin modulators|mesh-ancestor
6149862|NCT01399372|Antimitotic Agents|antimitotic agents|mesh-ancestor
6149863|NCT01399372|Mitosis Modulators|mitosis modulators|mesh-ancestor
6149864|NCT01399593|Eculizumab|eculizumab|mesh-list
6149865|NCT01399593|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6149866|NCT01399593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6149867|NCT01399593|Immunologic Factors|immunologic factors|mesh-ancestor
6149868|NCT01399593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149869|NCT01399697|Methotrexate|methotrexate|mesh-list
6149870|NCT01399697|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6149871|NCT01399697|Abortifacient Agents|abortifacient agents|mesh-ancestor
6149872|NCT01399697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6149873|NCT01399697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149874|NCT01399697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6149875|NCT01399697|Antimetabolites|antimetabolites|mesh-ancestor
6149876|NCT01399697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149877|NCT01399697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6149878|NCT01399697|Dermatologic Agents|dermatologic agents|mesh-ancestor
6149879|NCT01399697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6149880|NCT01399697|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6149881|NCT01399697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6149882|NCT01399697|Immunologic Factors|immunologic factors|mesh-ancestor
6149883|NCT01399697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6149884|NCT01399697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6149885|NCT01399723|Amoxicillin|amoxicillin|mesh-list
6149886|NCT01399723|Penicillins|penicillins|mesh-list
6149887|NCT01399723|Penicillin G|penicillin g|mesh-list
6149888|NCT01399723|Penicillin G Benzathine|penicillin g benzathine|mesh-list
6149889|NCT01399723|Penicillin G Procaine|penicillin g procaine|mesh-list
6149890|NCT01399723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6149891|NCT01399723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6149892|NCT01399827|Methylphenidate|methylphenidate|mesh-list
6149893|NCT01399827|Amphetamine|amphetamine|mesh-list
6149894|NCT01399827|Adderall|adderall|mesh-list
6149895|NCT01399827|Dextroamphetamine|dextroamphetamine|mesh-list
6476761|NCT00525668|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
6476762|NCT00525668|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6476763|NCT00525668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6476764|NCT00525668|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6476765|NCT00525681|Cyclosporine|cyclosporine|mesh-list
6476766|NCT00525681|Tacrolimus|tacrolimus|mesh-list
6476767|NCT00525681|Cyclosporins|cyclosporins|mesh-list
6476768|NCT00525681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6476769|NCT00525681|Immunologic Factors|immunologic factors|mesh-ancestor
6476770|NCT00525681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476771|NCT00525681|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6476772|NCT00525681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6476773|NCT00525681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476774|NCT00525681|Antifungal Agents|antifungal agents|mesh-ancestor
6476775|NCT00525681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6476776|NCT00525681|Dermatologic Agents|dermatologic agents|mesh-ancestor
6149896|NCT01399827|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
6476777|NCT00525681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6476778|NCT00525694|Cocaine|cocaine|mesh-list
6476779|NCT00525694|Anesthetics, Local|anesthetics, local|mesh-ancestor
6149897|NCT01399827|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6149898|NCT01399827|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6149899|NCT01399827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149900|NCT01399827|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6149901|NCT01399827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6149902|NCT01399827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6149903|NCT01399827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149904|NCT01399827|Dopamine Agents|dopamine agents|mesh-ancestor
5551668|NCT04083911|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5551669|NCT04083911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5551670|NCT04083911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5551671|NCT04083911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5551672|NCT04083807|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
5551673|NCT04083807|Thrombin|thrombin|mesh-list
5551674|NCT04083807|Hemostatics|hemostatics|mesh-ancestor
5551675|NCT04083807|Coagulants|coagulants|mesh-ancestor
5551676|NCT04083833|Tetrodotoxin|tetrodotoxin|mesh-list
5551677|NCT04083833|Anesthetics, Local|anesthetics, local|mesh-ancestor
5551678|NCT04083833|Anesthetics|anesthetics|mesh-ancestor
5551679|NCT04083833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5551680|NCT04083833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551681|NCT04083833|Sensory System Agents|sensory system agents|mesh-ancestor
5551682|NCT04083833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5551683|NCT04083833|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5551684|NCT04083833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5551685|NCT04083833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5551686|NCT04083755|Ferric Compounds|ferric compounds|mesh-list
5551687|NCT04083755|Hematinics|hematinics|mesh-ancestor
5551688|NCT04083599|Gemcitabine|gemcitabine|mesh-list
5551689|NCT04083599|Paclitaxel|paclitaxel|mesh-list
5551690|NCT04083599|Carboplatin|carboplatin|mesh-list
5551691|NCT04083599|Pembrolizumab|pembrolizumab|mesh-list
5551692|NCT04083599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5551693|NCT04083599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5551694|NCT04083599|Tubulin Modulators|tubulin modulators|mesh-ancestor
5551695|NCT04083599|Antimitotic Agents|antimitotic agents|mesh-ancestor
5551696|NCT04083599|Mitosis Modulators|mitosis modulators|mesh-ancestor
5551697|NCT04083599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5551698|NCT04083599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5551699|NCT04083599|Antimetabolites|antimetabolites|mesh-ancestor
5551700|NCT04083599|Antiviral Agents|antiviral agents|mesh-ancestor
5551701|NCT04083599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5551702|NCT04083599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5551703|NCT04083599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5551704|NCT04083599|Immunologic Factors|immunologic factors|mesh-ancestor
6149905|NCT01399827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6149906|NCT01399827|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6149907|NCT01399827|Adrenergic Agents|adrenergic agents|mesh-ancestor
6149908|NCT01399827|Sympathomimetics|sympathomimetics|mesh-ancestor
6149909|NCT01399827|Autonomic Agents|autonomic agents|mesh-ancestor
6149910|NCT01399827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6149911|NCT01399866|Cycloserine|cycloserine|mesh-list
6149912|NCT01399866|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5551705|NCT04083599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551706|NCT04083599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5551707|NCT04083651|Bromides|bromides|mesh-list
5551708|NCT04083651|Methylnaltrexone|methylnaltrexone|mesh-list
5551709|NCT04083651|Anticonvulsants|anticonvulsants|mesh-ancestor
6149913|NCT01399866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6149914|NCT01399866|Renal Agents|renal agents|mesh-ancestor
6476780|NCT00525694|Anesthetics|anesthetics|mesh-ancestor
6476781|NCT00525694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6476782|NCT00525694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551710|NCT04083651|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5551711|NCT04083651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551712|NCT04083651|Sensory System Agents|sensory system agents|mesh-ancestor
5551713|NCT04083651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5551714|NCT04083417|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5551715|NCT04083417|Penicillins|penicillins|mesh-list
6476783|NCT00525694|Sensory System Agents|sensory system agents|mesh-ancestor
5551716|NCT04083417|Penicillin V|penicillin v|mesh-list
5551717|NCT04083417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5551718|NCT04083664|Hepcidins|hepcidins|mesh-list
5551719|NCT04083664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6476784|NCT00525694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6476785|NCT00525694|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6476786|NCT00525694|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6476787|NCT00525694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6476788|NCT00525694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6476789|NCT00525694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476790|NCT00525694|Dopamine Agents|dopamine agents|mesh-ancestor
6476791|NCT00525694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6476792|NCT00525707|Tezosentan|tezosentan|mesh-list
6476793|NCT00525707|Vasodilator Agents|vasodilator agents|mesh-ancestor
6476794|NCT00525759|Zoledronic Acid|zoledronic acid|mesh-list
6476795|NCT00525759|Cyclophosphamide|cyclophosphamide|mesh-list
6476796|NCT00525759|Docetaxel|docetaxel|mesh-list
6476797|NCT00525759|Fluorouracil|fluorouracil|mesh-list
6149915|NCT01399866|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6149916|NCT01399866|Antitubercular Agents|antitubercular agents|mesh-ancestor
6149917|NCT01399866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5551720|NCT04083625|Carbetocin|carbetocin|mesh-list
5551721|NCT04083625|Oxytocics|oxytocics|mesh-ancestor
5551722|NCT04083625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5551723|NCT04083625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149918|NCT01399866|Antimetabolites|antimetabolites|mesh-ancestor
6149919|NCT01399866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149920|NCT01399905|Carbidopa|carbidopa|mesh-list
6149921|NCT01399905|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6476798|NCT00525759|Epirubicin|epirubicin|mesh-list
6476799|NCT00525759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6476800|NCT00525759|Immunologic Factors|immunologic factors|mesh-ancestor
6476801|NCT00525759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476802|NCT00525759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6149922|NCT01399905|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6149923|NCT01399905|Dopamine Agents|dopamine agents|mesh-ancestor
6149924|NCT01399905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6476803|NCT00525759|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6476804|NCT00525759|Alkylating Agents|alkylating agents|mesh-ancestor
6476805|NCT00525759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149925|NCT01399905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149926|NCT01399905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149927|NCT01399905|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6149928|NCT01399905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6149929|NCT01400113|Asenapine|asenapine|mesh-list
6149930|NCT01400113|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6149931|NCT01400113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6149932|NCT01400113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6149933|NCT01400113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149934|NCT01400113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6149935|NCT01400139|Hydrocodone|hydrocodone|mesh-list
5551724|NCT04083144|Varenicline|varenicline|mesh-list
5551725|NCT04083144|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5551726|NCT04083144|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5551727|NCT04083144|Cholinergic Agents|cholinergic agents|mesh-ancestor
5551728|NCT04083144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5551729|NCT04083144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5551730|NCT04083144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551731|NCT04083105|Midazolam|midazolam|mesh-list
5551732|NCT04083105|Nitrous Oxide|nitrous oxide|mesh-list
5551733|NCT04083105|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5551734|NCT04083105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5551735|NCT04083105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5551736|NCT04083105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551737|NCT04083105|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5551738|NCT04083105|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5551739|NCT04083105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5551740|NCT04083105|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5551741|NCT04083105|Anesthetics, General|anesthetics, general|mesh-ancestor
6149936|NCT01400139|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6149937|NCT01400139|Narcotics|narcotics|mesh-ancestor
6476806|NCT00525759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6476807|NCT00525759|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6476808|NCT00525759|Tubulin Modulators|tubulin modulators|mesh-ancestor
6476809|NCT00525759|Antimitotic Agents|antimitotic agents|mesh-ancestor
6476810|NCT00525759|Mitosis Modulators|mitosis modulators|mesh-ancestor
6476811|NCT00525759|Antimetabolites|antimetabolites|mesh-ancestor
6476812|NCT00525759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6476813|NCT00525759|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5551742|NCT04083105|Anesthetics|anesthetics|mesh-ancestor
6476814|NCT00525759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6476815|NCT00525759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6476816|NCT00525759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6476817|NCT00525759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6476818|NCT00525772|Ciclesonide|ciclesonide|mesh-list
6476819|NCT00525772|Glucocorticoids|glucocorticoids|mesh-ancestor
6476820|NCT00525772|Hormones|hormones|mesh-ancestor
6476821|NCT00525772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6476822|NCT00525772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476823|NCT00525772|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6476824|NCT00525889|Sirolimus|sirolimus|mesh-list
6476825|NCT00525889|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6476826|NCT00525889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6476827|NCT00525889|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6476828|NCT00525889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6476829|NCT00525889|Antifungal Agents|antifungal agents|mesh-ancestor
6476830|NCT00525889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6476831|NCT00525889|Immunologic Factors|immunologic factors|mesh-ancestor
6476832|NCT00525889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476833|NCT00525928|Varenicline|varenicline|mesh-list
6149938|NCT01400139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6149939|NCT01400139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149940|NCT01400139|Analgesics|analgesics|mesh-ancestor
6149941|NCT01400139|Sensory System Agents|sensory system agents|mesh-ancestor
5551743|NCT04083105|GABA Modulators|gaba modulators|mesh-ancestor
5551744|NCT04083105|GABA Agents|gaba agents|mesh-ancestor
5551745|NCT04083105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5551746|NCT04083105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5551747|NCT04083105|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5551748|NCT04083105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5551749|NCT04083105|Analgesics|analgesics|mesh-ancestor
5551750|NCT04083105|Sensory System Agents|sensory system agents|mesh-ancestor
6149942|NCT01400139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6149943|NCT01400139|Antitussive Agents|antitussive agents|mesh-ancestor
6476834|NCT00525928|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6476835|NCT00525928|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6476836|NCT00525928|Cholinergic Agents|cholinergic agents|mesh-ancestor
6476837|NCT00525928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6476838|NCT00525928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476839|NCT00525928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551751|NCT04083105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5551752|NCT04083157|Imiquimod|imiquimod|mesh-list
5551753|NCT04083157|Vaccines|vaccines|mesh-list
5551754|NCT04083157|Immunologic Factors|immunologic factors|mesh-ancestor
5551755|NCT04083157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551756|NCT04083157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5551757|NCT04083157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5551758|NCT04083157|Interferon Inducers|interferon inducers|mesh-ancestor
6476840|NCT00525967|Acetaminophen|acetaminophen|mesh-list
6476841|NCT00525967|Methadone|methadone|mesh-list
6476842|NCT00525967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6476843|NCT00525967|Analgesics|analgesics|mesh-ancestor
6476844|NCT00525967|Sensory System Agents|sensory system agents|mesh-ancestor
5551759|NCT04083209|Analgesics, Opioid|analgesics, opioid|mesh-list
5551760|NCT04083209|Narcotics|narcotics|mesh-ancestor
5551761|NCT04083209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5551762|NCT04083209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551763|NCT04083209|Analgesics|analgesics|mesh-ancestor
5551764|NCT04083209|Sensory System Agents|sensory system agents|mesh-ancestor
5551765|NCT04083209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5551766|NCT04083560|Hydroxocobalamin|hydroxocobalamin|mesh-list
5551767|NCT04083560|Vitamin B 12|vitamin b 12|mesh-list
5551768|NCT04083560|Hematinics|hematinics|mesh-ancestor
5551769|NCT04083560|Vitamin B Complex|vitamin b complex|mesh-ancestor
5551770|NCT04083560|Vitamins|vitamins|mesh-ancestor
5551771|NCT04083560|Micronutrients|micronutrients|mesh-ancestor
5551772|NCT04083560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551773|NCT04083066|Cytarabine|cytarabine|mesh-list
5551774|NCT04083066|Dexamethasone|dexamethasone|mesh-list
5551775|NCT04083066|Rituximab|rituximab|mesh-list
5551776|NCT04083066|Methotrexate|methotrexate|mesh-list
5551777|NCT04083066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5551778|NCT04083066|Antiemetics|antiemetics|mesh-ancestor
6476845|NCT00525967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5551779|NCT04083066|Autonomic Agents|autonomic agents|mesh-ancestor
5551780|NCT04083066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5551781|NCT04083066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551782|NCT04083066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6476846|NCT00525967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149944|NCT01400139|Respiratory System Agents|respiratory system agents|mesh-ancestor
6149945|NCT01400243|Nicotine|nicotine|mesh-list
6149946|NCT01400243|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6149947|NCT01400243|Autonomic Agents|autonomic agents|mesh-ancestor
6149948|NCT01400243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6149949|NCT01400243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149950|NCT01400243|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6149951|NCT01400243|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5551783|NCT04083066|Glucocorticoids|glucocorticoids|mesh-ancestor
5551784|NCT04083066|Hormones|hormones|mesh-ancestor
5551785|NCT04083066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5551786|NCT04083066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5551787|NCT04083066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6149952|NCT01400243|Cholinergic Agents|cholinergic agents|mesh-ancestor
6149953|NCT01400243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6149954|NCT01400243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149955|NCT01400412|Ritonavir|ritonavir|mesh-list
6149956|NCT01400412|Darunavir|darunavir|mesh-list
6149957|NCT01400412|Tenofovir|tenofovir|mesh-list
6149958|NCT01400412|Emtricitabine|emtricitabine|mesh-list
6149959|NCT01400412|Maraviroc|maraviroc|mesh-list
6149960|NCT01400412|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6149961|NCT01400412|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6149962|NCT01400412|Protease Inhibitors|protease inhibitors|mesh-ancestor
6149963|NCT01400412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6149964|NCT01400412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149965|NCT01400412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6149966|NCT01400412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6149967|NCT01400412|Antiviral Agents|antiviral agents|mesh-ancestor
6149968|NCT01400412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6149969|NCT01400412|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6149970|NCT01400412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6149971|NCT01400412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6149972|NCT01400412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6149973|NCT01400412|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6149974|NCT01400412|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6149975|NCT01400412|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6149976|NCT01400451|Ipilimumab|ipilimumab|mesh-list
6149977|NCT01400451|Vemurafenib|vemurafenib|mesh-list
6149978|NCT01400451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6149979|NCT01400451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6149980|NCT01400451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6149981|NCT01400451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6149982|NCT01400451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6149983|NCT01400451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6149984|NCT01400503|Siltuximab|siltuximab|mesh-list
6149985|NCT01400503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6149986|NCT01400516|Vitamin D|vitamin d|mesh-list
6149987|NCT01400516|Teriparatide|teriparatide|mesh-list
6149988|NCT01400516|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
6149989|NCT01400516|Calcium|calcium|mesh-list
6149990|NCT01400516|Vitamins|vitamins|mesh-ancestor
6149991|NCT01400516|Micronutrients|micronutrients|mesh-ancestor
6149992|NCT01400516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6149993|NCT01400516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6149994|NCT01400516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6149995|NCT01400516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6149996|NCT01400906|Fluticasone|fluticasone|mesh-list
6149997|NCT01400906|Xhance|xhance|mesh-list
6149998|NCT01400906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6149999|NCT01400906|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6150000|NCT01400906|Autonomic Agents|autonomic agents|mesh-ancestor
5551788|NCT04083066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5551789|NCT04083066|Immunologic Factors|immunologic factors|mesh-ancestor
5551790|NCT04083066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5551791|NCT04083066|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5551792|NCT04083066|Abortifacient Agents|abortifacient agents|mesh-ancestor
5551793|NCT04083066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5551794|NCT04083066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6150001|NCT01400906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6150002|NCT01400906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476847|NCT00525967|Antipyretics|antipyretics|mesh-ancestor
6150003|NCT01400906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6150004|NCT01400906|Respiratory System Agents|respiratory system agents|mesh-ancestor
6150005|NCT01400906|Dermatologic Agents|dermatologic agents|mesh-ancestor
6150006|NCT01400906|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6150007|NCT01400932|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6150008|NCT01400932|Dermatologic Agents|dermatologic agents|mesh-ancestor
6150009|NCT01400958|Modafinil|modafinil|mesh-list
6150010|NCT01400958|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6150011|NCT01400958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150012|NCT01400958|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6150013|NCT01400958|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6150014|NCT01400958|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6150015|NCT01400958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6150016|NCT01401010|Doripenem|doripenem|mesh-list
6150017|NCT01401010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6150018|NCT01401010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6150019|NCT01401023|Tigecycline|tigecycline|mesh-list
6150020|NCT01401023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6150021|NCT01401023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6150022|NCT01401023|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6150023|NCT01401023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6150024|NCT01401023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6150025|NCT01401166|Trastuzumab|trastuzumab|mesh-list
6150026|NCT01401166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6150027|NCT01401166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6205713|NCT02091739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6207854|NCT02121002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207855|NCT02121041|Losartan|losartan|mesh-list
6476848|NCT00525967|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6476849|NCT00525967|Narcotics|narcotics|mesh-ancestor
6476850|NCT00525967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6476851|NCT00525967|Antitussive Agents|antitussive agents|mesh-ancestor
6476852|NCT00525967|Respiratory System Agents|respiratory system agents|mesh-ancestor
6476853|NCT00525993|Etoricoxib|etoricoxib|mesh-list
6476854|NCT00525993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6207856|NCT02121041|Amlodipine|amlodipine|mesh-list
6207857|NCT02121041|Chlorthalidone|chlorthalidone|mesh-list
6207858|NCT02121041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6207859|NCT02121041|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6207860|NCT02121041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5551795|NCT04083066|Antimetabolites|antimetabolites|mesh-ancestor
5551796|NCT04083066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5551797|NCT04083066|Dermatologic Agents|dermatologic agents|mesh-ancestor
5551798|NCT04083066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5551799|NCT04083066|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5551800|NCT04083066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5551801|NCT04083066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5551802|NCT04083066|Antiviral Agents|antiviral agents|mesh-ancestor
5551803|NCT04083066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5551804|NCT04083118|Listerine|listerine|mesh-list
5551805|NCT04083118|Fluorides|fluorides|mesh-list
5551806|NCT04083118|Sodium Fluoride|sodium fluoride|mesh-list
5551807|NCT04083118|Cariostatic Agents|cariostatic agents|mesh-ancestor
5551808|NCT04083118|Protective Agents|protective agents|mesh-ancestor
5551809|NCT04083118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551810|NCT04083118|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5551811|NCT04083118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5551812|NCT04083235|Leucovorin|leucovorin|mesh-list
5551813|NCT04083235|Gemcitabine|gemcitabine|mesh-list
5551814|NCT04083235|Paclitaxel|paclitaxel|mesh-list
6207861|NCT02121041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207862|NCT02121041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6207863|NCT02121041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207864|NCT02121041|Vasodilator Agents|vasodilator agents|mesh-ancestor
6207865|NCT02121041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6207866|NCT02121041|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6207867|NCT02121041|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6207868|NCT02121041|Diuretics|diuretics|mesh-ancestor
6207869|NCT02121041|Natriuretic Agents|natriuretic agents|mesh-ancestor
6207870|NCT02121041|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6207871|NCT02121067|Levonorgestrel|levonorgestrel|mesh-list
6207872|NCT02121067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6207873|NCT02121067|Contraceptive Agents|contraceptive agents|mesh-ancestor
6207874|NCT02121067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6207875|NCT02121067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667734|NCT01528826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5551815|NCT04083235|Fluorouracil|fluorouracil|mesh-list
5551816|NCT04083235|Oxaliplatin|oxaliplatin|mesh-list
6150028|NCT01401322|Lenalidomide|lenalidomide|mesh-list
6150029|NCT01401322|Immunologic Factors|immunologic factors|mesh-ancestor
6150030|NCT01401322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150031|NCT01401322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6150032|NCT01401322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6150033|NCT01401322|Growth Substances|growth substances|mesh-ancestor
6150034|NCT01401322|Growth Inhibitors|growth inhibitors|mesh-ancestor
6150035|NCT01401322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6150036|NCT01401465|Mometasone Furoate|mometasone furoate|mesh-list
6150037|NCT01401465|Ciclesonide|ciclesonide|mesh-list
6150038|NCT01401465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5551817|NCT04083235|Irinotecan|irinotecan|mesh-list
5551818|NCT04083235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6150039|NCT01401465|Dermatologic Agents|dermatologic agents|mesh-ancestor
6150040|NCT01401465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6150041|NCT01401465|Glucocorticoids|glucocorticoids|mesh-ancestor
6150042|NCT01401465|Hormones|hormones|mesh-ancestor
6150043|NCT01401465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6476855|NCT00525993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6476856|NCT00525993|Analgesics|analgesics|mesh-ancestor
6476857|NCT00525993|Sensory System Agents|sensory system agents|mesh-ancestor
6476858|NCT00525993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6476859|NCT00525993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476860|NCT00525993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6476861|NCT00525993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6476862|NCT00525993|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6150044|NCT01401465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150045|NCT01401530|Denileukin diftitox|denileukin diftitox|mesh-list
6150046|NCT01401530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6150047|NCT01401543|Tadalafil|tadalafil|mesh-list
6150048|NCT01401543|Vasodilator Agents|vasodilator agents|mesh-ancestor
6150049|NCT01401543|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5551819|NCT04083235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5551820|NCT04083235|Tubulin Modulators|tubulin modulators|mesh-ancestor
5551821|NCT04083235|Antimitotic Agents|antimitotic agents|mesh-ancestor
5551822|NCT04083235|Mitosis Modulators|mitosis modulators|mesh-ancestor
5551823|NCT04083235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5551824|NCT04083235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5551825|NCT04083235|Antimetabolites|antimetabolites|mesh-ancestor
5551826|NCT04083235|Antiviral Agents|antiviral agents|mesh-ancestor
6150050|NCT01401543|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6150051|NCT01401543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6150052|NCT01401543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6150053|NCT01401543|Urological Agents|urological agents|mesh-ancestor
6150054|NCT01401595|Dexetimide|dexetimide|mesh-list
6150055|NCT01401595|Citalopram|citalopram|mesh-list
6150056|NCT01401595|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6150057|NCT01401595|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6150058|NCT01401595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6476863|NCT00525993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6476864|NCT00525993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6476865|NCT00525993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476866|NCT00526006|Esomeprazole|esomeprazole|mesh-list
6476867|NCT00526006|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6476868|NCT00526006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6476869|NCT00526006|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6476870|NCT00526006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6476871|NCT00526006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667735|NCT01528852|Chlorhexidine|chlorhexidine|mesh-list
6667736|NCT01528852|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6667737|NCT01528852|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6150059|NCT01401595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6150060|NCT01401595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6150061|NCT01401595|Serotonin Agents|serotonin agents|mesh-ancestor
6150062|NCT01401595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150063|NCT01401595|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6150064|NCT01401595|Antidepressive Agents|antidepressive agents|mesh-ancestor
6150065|NCT01401595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6150066|NCT01401595|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6150067|NCT01401595|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6488793|NCT00586560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6488794|NCT00586794|Sildenafil Citrate|sildenafil citrate|mesh-list
6488795|NCT00586794|Vasodilator Agents|vasodilator agents|mesh-ancestor
6667738|NCT01528852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6150068|NCT01401595|Parasympatholytics|parasympatholytics|mesh-ancestor
6476872|NCT00526175|Cytarabine|cytarabine|mesh-list
5551827|NCT04083235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5551828|NCT04083235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5551829|NCT04083235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5551830|NCT04083235|Immunologic Factors|immunologic factors|mesh-ancestor
5551831|NCT04083235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551832|NCT04083235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5551833|NCT04083235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5551834|NCT04083235|Antidotes|antidotes|mesh-ancestor
5551835|NCT04083235|Protective Agents|protective agents|mesh-ancestor
5551836|NCT04083235|Vitamin B Complex|vitamin b complex|mesh-ancestor
5551837|NCT04083235|Vitamins|vitamins|mesh-ancestor
5551838|NCT04083235|Micronutrients|micronutrients|mesh-ancestor
5551839|NCT04083183|Mycophenolic Acid|mycophenolic acid|mesh-list
5551840|NCT04083183|Sirolimus|sirolimus|mesh-list
5551841|NCT04083183|Vidarabine|vidarabine|mesh-list
5551842|NCT04083183|Cyclophosphamide|cyclophosphamide|mesh-list
5551843|NCT04083183|Fludarabine|fludarabine|mesh-list
5551844|NCT04083183|Fludarabine phosphate|fludarabine phosphate|mesh-list
5551845|NCT04083183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5551846|NCT04083183|Thymoglobulin|thymoglobulin|mesh-list
5551847|NCT04083183|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5551848|NCT04083183|Antibodies|antibodies|mesh-list
5551849|NCT04083183|Immunoglobulins|immunoglobulins|mesh-list
5551850|NCT04083183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6150069|NCT01401595|Autonomic Agents|autonomic agents|mesh-ancestor
6150070|NCT01401595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6150071|NCT01401595|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6150072|NCT01401595|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6150073|NCT01401595|Cholinergic Agents|cholinergic agents|mesh-ancestor
5551851|NCT04083183|gamma-Globulins|gamma-globulins|mesh-list
5551852|NCT04083183|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5551853|NCT04083183|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6150074|NCT01401647|Lidocaine|lidocaine|mesh-list
6150075|NCT01401647|Amiodarone|amiodarone|mesh-list
6150076|NCT01401647|Anesthetics, Local|anesthetics, local|mesh-ancestor
6150077|NCT01401647|Anesthetics|anesthetics|mesh-ancestor
6150078|NCT01401647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6150079|NCT01401647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150080|NCT01401647|Sensory System Agents|sensory system agents|mesh-ancestor
6150081|NCT01401647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6150082|NCT01401647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6150083|NCT01401647|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6150084|NCT01401647|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6150085|NCT01401647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6150086|NCT01401647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6150087|NCT01401647|Vasodilator Agents|vasodilator agents|mesh-ancestor
6150088|NCT01401647|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6150089|NCT01401647|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6150090|NCT01401647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6150091|NCT01401647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6150092|NCT01401647|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6150093|NCT01401647|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6150094|NCT01401647|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6150095|NCT01401959|Trastuzumab|trastuzumab|mesh-list
6150096|NCT01401959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5551854|NCT04083183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5551855|NCT04083183|Immunologic Factors|immunologic factors|mesh-ancestor
5551856|NCT04083183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551857|NCT04083183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5551858|NCT04083183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5551859|NCT04083183|Alkylating Agents|alkylating agents|mesh-ancestor
5551860|NCT04083183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5551861|NCT04083183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5551862|NCT04083183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6150097|NCT01401959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6150098|NCT01402011|Lidocaine|lidocaine|mesh-list
6150099|NCT01402011|Anesthetics, Local|anesthetics, local|mesh-ancestor
6150100|NCT01402011|Anesthetics|anesthetics|mesh-ancestor
6150101|NCT01402011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6150102|NCT01402011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150103|NCT01402011|Sensory System Agents|sensory system agents|mesh-ancestor
5551863|NCT04083183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5551864|NCT04083183|Antimetabolites|antimetabolites|mesh-ancestor
5551865|NCT04083183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5551866|NCT04083183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5551867|NCT04083183|Antitubercular Agents|antitubercular agents|mesh-ancestor
5551868|NCT04083183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5551869|NCT04083183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5551870|NCT04083183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6150104|NCT01402011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6150105|NCT01402011|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6150106|NCT01402011|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6150107|NCT01402011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6150108|NCT01402011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5551871|NCT04083183|Antifungal Agents|antifungal agents|mesh-ancestor
5551872|NCT04083183|Antiviral Agents|antiviral agents|mesh-ancestor
5551873|NCT04082949|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
5551874|NCT04082949|Hemostatics|hemostatics|mesh-ancestor
5551875|NCT04082949|Coagulants|coagulants|mesh-ancestor
5551876|NCT04082962|Dexamethasone|dexamethasone|mesh-list
5551877|NCT04082962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5551878|NCT04082962|Antiemetics|antiemetics|mesh-ancestor
6150109|NCT01402011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6150110|NCT01402050|Dinoprostone|dinoprostone|mesh-list
6150111|NCT01402050|Oxytocics|oxytocics|mesh-ancestor
6150112|NCT01402050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6150113|NCT01402050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150114|NCT01402063|Temozolomide|temozolomide|mesh-list
6150115|NCT01402063|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
6150116|NCT01402063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6150117|NCT01402063|Alkylating Agents|alkylating agents|mesh-ancestor
6150118|NCT01402063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6150119|NCT01402063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6150120|NCT01402284|Dexamethasone|dexamethasone|mesh-list
6150121|NCT01402284|Lenalidomide|lenalidomide|mesh-list
6150122|NCT01402284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6150123|NCT01402284|Antiemetics|antiemetics|mesh-ancestor
5551879|NCT04082962|Autonomic Agents|autonomic agents|mesh-ancestor
5551880|NCT04082962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5551881|NCT04082962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551882|NCT04082962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5551883|NCT04082962|Glucocorticoids|glucocorticoids|mesh-ancestor
5551884|NCT04082962|Hormones|hormones|mesh-ancestor
5551885|NCT04082962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5551886|NCT04082962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5551887|NCT04082962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5551888|NCT04082988|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5551889|NCT04082988|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5551890|NCT04082988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5551891|NCT04082897|Atezolizumab|atezolizumab|mesh-list
6150124|NCT01402284|Autonomic Agents|autonomic agents|mesh-ancestor
6150125|NCT01402284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6150126|NCT01402284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150127|NCT01402284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6150128|NCT01402284|Glucocorticoids|glucocorticoids|mesh-ancestor
6150129|NCT01402284|Hormones|hormones|mesh-ancestor
6150130|NCT01402284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6150131|NCT01402284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6150132|NCT01402284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6150133|NCT01402284|Immunologic Factors|immunologic factors|mesh-ancestor
6150134|NCT01402284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6150135|NCT01402284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6150136|NCT01402284|Growth Substances|growth substances|mesh-ancestor
6150137|NCT01402284|Growth Inhibitors|growth inhibitors|mesh-ancestor
6150138|NCT01402375|Acetaminophen|acetaminophen|mesh-list
5551892|NCT04082897|Venetoclax|venetoclax|mesh-list
5551893|NCT04082897|Obinutuzumab|obinutuzumab|mesh-list
5551894|NCT04082897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5551895|NCT04082897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5551896|NCT04082650|Vitamin D|vitamin d|mesh-list
5551897|NCT04082650|Vitamins|vitamins|mesh-ancestor
6150139|NCT01402375|Oxycodone|oxycodone|mesh-list
6150140|NCT01402375|Hydrocodone|hydrocodone|mesh-list
6150141|NCT01402375|Codeine|codeine|mesh-list
6150142|NCT01402375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6150143|NCT01402375|Analgesics|analgesics|mesh-ancestor
6150144|NCT01402375|Sensory System Agents|sensory system agents|mesh-ancestor
6150145|NCT01402375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5551898|NCT04082650|Micronutrients|micronutrients|mesh-ancestor
5551899|NCT04082650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150146|NCT01402375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150147|NCT01402375|Antipyretics|antipyretics|mesh-ancestor
6150148|NCT01402375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6150149|NCT01402375|Narcotics|narcotics|mesh-ancestor
6150150|NCT01402375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6150151|NCT01402375|Antitussive Agents|antitussive agents|mesh-ancestor
6150152|NCT01402375|Respiratory System Agents|respiratory system agents|mesh-ancestor
6150153|NCT01402427|Verapamil|verapamil|mesh-list
6150154|NCT01402427|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6150155|NCT01402427|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6150156|NCT01402427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6150157|NCT01402427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6150158|NCT01402427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6150159|NCT01402427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150160|NCT01402427|Vasodilator Agents|vasodilator agents|mesh-ancestor
6150161|NCT01402492|Naltrexone|naltrexone|mesh-list
6150162|NCT01402492|Buprenorphine|buprenorphine|mesh-list
6150163|NCT01402492|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6150164|NCT01402492|Naloxone|naloxone|mesh-list
6150165|NCT01402492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5551900|NCT04082650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5551901|NCT04082715|Celecoxib|celecoxib|mesh-list
5551902|NCT04082715|Levodopa|levodopa|mesh-list
5551903|NCT04082715|Carbidopa|carbidopa|mesh-list
5551904|NCT04082715|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
5551905|NCT04082715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5551906|NCT04082715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5551907|NCT04082715|Analgesics|analgesics|mesh-ancestor
5551908|NCT04082715|Sensory System Agents|sensory system agents|mesh-ancestor
5551909|NCT04082715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5551910|NCT04082715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551911|NCT04082715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5551912|NCT04082715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5551913|NCT04082715|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5551914|NCT04082715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5551915|NCT04082715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5551916|NCT04082715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6150166|NCT01402492|Narcotics|narcotics|mesh-ancestor
6150167|NCT01402492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6150168|NCT01402492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150169|NCT01402492|Analgesics|analgesics|mesh-ancestor
6150170|NCT01402492|Sensory System Agents|sensory system agents|mesh-ancestor
6150171|NCT01402492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6150172|NCT01402492|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6150173|NCT01402492|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6150174|NCT01402544|Ranibizumab|ranibizumab|mesh-list
6150175|NCT01402544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6150176|NCT01402544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6150177|NCT01402544|Growth Substances|growth substances|mesh-ancestor
6150178|NCT01402544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150179|NCT01402544|Growth Inhibitors|growth inhibitors|mesh-ancestor
6150180|NCT01402544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6150181|NCT01402817|Sunitinib|sunitinib|mesh-list
6150182|NCT01402817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6150183|NCT01402817|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6150184|NCT01402817|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6150185|NCT01402817|Growth Substances|growth substances|mesh-ancestor
6150186|NCT01402817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150187|NCT01402817|Growth Inhibitors|growth inhibitors|mesh-ancestor
5551917|NCT04082715|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5551918|NCT04082715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5551919|NCT04082715|Dopamine Agents|dopamine agents|mesh-ancestor
5551920|NCT04082715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5551921|NCT04082715|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5551922|NCT04082715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5551923|NCT04082715|Immunologic Factors|immunologic factors|mesh-ancestor
5551924|NCT04082715|Dopamine Agonists|dopamine agonists|mesh-ancestor
5551925|NCT04082858|Midazolam|midazolam|mesh-list
5551926|NCT04082858|Ketamine|ketamine|mesh-list
5551927|NCT04082858|Analgesics|analgesics|mesh-ancestor
5551928|NCT04082858|Sensory System Agents|sensory system agents|mesh-ancestor
5551929|NCT04082858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5551930|NCT04082858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551931|NCT04082858|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5551932|NCT04082858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6150188|NCT01402817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5551933|NCT04082858|Anesthetics, General|anesthetics, general|mesh-ancestor
6150189|NCT01402817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5551934|NCT04082858|Anesthetics|anesthetics|mesh-ancestor
5551935|NCT04082858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5551936|NCT04082858|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5551937|NCT04082858|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5551938|NCT04082858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5551939|NCT04082858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5551940|NCT04082858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5551941|NCT04082858|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5551942|NCT04082858|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6150190|NCT01402817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6150191|NCT01402869|Lidocaine|lidocaine|mesh-list
6150192|NCT01402869|Epinephrine|epinephrine|mesh-list
6476873|NCT00526175|Prednisone|prednisone|mesh-list
6476874|NCT00526175|Cyclophosphamide|cyclophosphamide|mesh-list
6476875|NCT00526175|Methotrexate|methotrexate|mesh-list
6476876|NCT00526175|Vincristine|vincristine|mesh-list
5551943|NCT04082858|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5551944|NCT04082858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5551945|NCT04082858|GABA Modulators|gaba modulators|mesh-ancestor
5551946|NCT04082858|GABA Agents|gaba agents|mesh-ancestor
5551947|NCT04082793|Diclofenac|diclofenac|mesh-list
5551948|NCT04082793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5551949|NCT04082793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5551950|NCT04082793|Analgesics|analgesics|mesh-ancestor
5551951|NCT04082793|Sensory System Agents|sensory system agents|mesh-ancestor
5551952|NCT04082793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6150193|NCT01402869|Prilocaine|prilocaine|mesh-list
6150194|NCT01402869|Anesthetics, Local|anesthetics, local|mesh-ancestor
6150195|NCT01402869|Anesthetics|anesthetics|mesh-ancestor
6150196|NCT01402869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6150197|NCT01402869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150198|NCT01402869|Sensory System Agents|sensory system agents|mesh-ancestor
6150199|NCT01402869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6150200|NCT01402869|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6150201|NCT01402869|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6150202|NCT01402869|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6150203|NCT01402869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6150204|NCT01402869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6150205|NCT01402869|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6150206|NCT01402869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6150207|NCT01402869|Adrenergic Agents|adrenergic agents|mesh-ancestor
6150208|NCT01402869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6150209|NCT01402869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6150210|NCT01402869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5551953|NCT04082793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551954|NCT04082793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5551955|NCT04082793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5551956|NCT04082793|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6150211|NCT01402869|Autonomic Agents|autonomic agents|mesh-ancestor
6150212|NCT01402869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6150213|NCT01402869|Respiratory System Agents|respiratory system agents|mesh-ancestor
6150214|NCT01402869|Mydriatics|mydriatics|mesh-ancestor
6150215|NCT01402869|Sympathomimetics|sympathomimetics|mesh-ancestor
6150216|NCT01402869|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6150217|NCT01402947|Ciprofloxacin|ciprofloxacin|mesh-list
6150218|NCT01402947|Mesalamine|mesalamine|mesh-list
6150219|NCT01402947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6150220|NCT01402947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6150221|NCT01402947|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6150222|NCT01402947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6150223|NCT01402947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6150224|NCT01402947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6150225|NCT01402947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6150226|NCT01402947|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6150227|NCT01402947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6150228|NCT01402947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6150229|NCT01402947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6150230|NCT01402947|Analgesics|analgesics|mesh-ancestor
6150231|NCT01402947|Sensory System Agents|sensory system agents|mesh-ancestor
6150232|NCT01402947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6150233|NCT01402947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150234|NCT01402947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6150235|NCT01402947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6150236|NCT01402986|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6476877|NCT00526175|Daunorubicin|daunorubicin|mesh-list
5551957|NCT04082793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5551958|NCT04082793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5551959|NCT04082754|Antibodies|antibodies|mesh-list
5551960|NCT04082754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5551961|NCT04082754|Immunologic Factors|immunologic factors|mesh-ancestor
5551962|NCT04082754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551963|NCT04082936|Immunoglobulin M|immunoglobulin m|mesh-list
5551964|NCT04082936|Immunologic Factors|immunologic factors|mesh-ancestor
5551965|NCT04082936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551966|NCT04082572|Pembrolizumab|pembrolizumab|mesh-list
5551967|NCT04082572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5551968|NCT04082572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5551969|NCT04082910|Metoprolol|metoprolol|mesh-list
5551970|NCT04082910|Antibodies|antibodies|mesh-list
5551971|NCT04082910|Immunologic Factors|immunologic factors|mesh-ancestor
5551972|NCT04082910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5551973|NCT04082910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5551974|NCT04082910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5551975|NCT04082910|Sympatholytics|sympatholytics|mesh-ancestor
5551976|NCT04082910|Autonomic Agents|autonomic agents|mesh-ancestor
5551977|NCT04082910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5551978|NCT04082910|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5551979|NCT04082910|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5551980|NCT04082910|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5551981|NCT04082910|Adrenergic Agents|adrenergic agents|mesh-ancestor
5551982|NCT04082910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5551983|NCT04082910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476878|NCT00526175|Asparaginase|asparaginase|mesh-list
6476879|NCT00526175|Mercaptopurine|mercaptopurine|mesh-list
6476880|NCT00526175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6476881|NCT00526175|Immunologic Factors|immunologic factors|mesh-ancestor
6476882|NCT00526175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476883|NCT00526175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6476884|NCT00526175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6476885|NCT00526175|Alkylating Agents|alkylating agents|mesh-ancestor
6476886|NCT00526175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476887|NCT00526175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6476888|NCT00526175|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6476889|NCT00526175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6476890|NCT00526175|Glucocorticoids|glucocorticoids|mesh-ancestor
6476891|NCT00526175|Hormones|hormones|mesh-ancestor
6476892|NCT00526175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6476893|NCT00526175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6476894|NCT00526175|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6150237|NCT01402986|Immunologic Factors|immunologic factors|mesh-ancestor
5551984|NCT04082806|Trazodone|trazodone|mesh-list
5551985|NCT04082806|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5551986|NCT04082806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5551987|NCT04082806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6150238|NCT01402986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150239|NCT01403051|Calcium, Dietary|calcium, dietary|mesh-list
6150240|NCT01403051|Vitamin D|vitamin d|mesh-list
6150241|NCT01403051|Ergocalciferols|ergocalciferols|mesh-list
6150242|NCT01403051|Cholecalciferol|cholecalciferol|mesh-list
6150243|NCT01403051|Vitamins|vitamins|mesh-list
6150244|NCT01403051|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6150245|NCT01403051|Calcium Carbonate|calcium carbonate|mesh-list
6150246|NCT01403051|Calcium|calcium|mesh-list
6150247|NCT01403051|Micronutrients|micronutrients|mesh-ancestor
6150248|NCT01403051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150249|NCT01403051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6150250|NCT01403051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6150251|NCT01403051|Antacids|antacids|mesh-ancestor
6205714|NCT02091882|Aripiprazole|aripiprazole|mesh-list
6476895|NCT00526175|Abortifacient Agents|abortifacient agents|mesh-ancestor
6476896|NCT00526175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6476897|NCT00526175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6476898|NCT00526175|Antimetabolites|antimetabolites|mesh-ancestor
6476899|NCT00526175|Dermatologic Agents|dermatologic agents|mesh-ancestor
6476900|NCT00526175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6476901|NCT00526175|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6476902|NCT00526175|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6476903|NCT00526175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5551988|NCT04082806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476904|NCT00526175|Tubulin Modulators|tubulin modulators|mesh-ancestor
6476905|NCT00526175|Antimitotic Agents|antimitotic agents|mesh-ancestor
6476906|NCT00526175|Mitosis Modulators|mitosis modulators|mesh-ancestor
6476907|NCT00526175|Antiviral Agents|antiviral agents|mesh-ancestor
6476908|NCT00526175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6476909|NCT00526175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6476910|NCT00526175|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6476911|NCT00526175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6476912|NCT00526214|Celecoxib|celecoxib|mesh-list
6476913|NCT00526214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6476914|NCT00526214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6476915|NCT00526214|Analgesics|analgesics|mesh-ancestor
6476916|NCT00526214|Sensory System Agents|sensory system agents|mesh-ancestor
6476917|NCT00526214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6476918|NCT00526214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476919|NCT00526214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6476920|NCT00526214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6476921|NCT00526214|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6476922|NCT00526214|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6476923|NCT00526214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6476924|NCT00526214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476925|NCT00526305|Cytarabine|cytarabine|mesh-list
6150252|NCT01403051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6150253|NCT01403051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6150254|NCT01403051|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6150255|NCT01403051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6150256|NCT01403051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6150257|NCT01403051|Antiviral Agents|antiviral agents|mesh-ancestor
6150258|NCT01403051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6150259|NCT01403051|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6150260|NCT01403051|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6150261|NCT01403116|Methyltestosterone|methyltestosterone|mesh-list
6150262|NCT01403116|Testosterone|testosterone|mesh-list
5551989|NCT04082806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6150263|NCT01403116|Testosterone undecanoate|testosterone undecanoate|mesh-list
6150264|NCT01403116|Testosterone enanthate|testosterone enanthate|mesh-list
6150265|NCT01403116|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6150266|NCT01403116|Androgens|androgens|mesh-ancestor
6150267|NCT01403116|Hormones|hormones|mesh-ancestor
6150268|NCT01403116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6150269|NCT01403116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150270|NCT01403116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6150271|NCT01403116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6150272|NCT01403116|Anabolic Agents|anabolic agents|mesh-ancestor
6150273|NCT01403246|Lenalidomide|lenalidomide|mesh-list
6150274|NCT01403246|Chlorambucil|chlorambucil|mesh-list
6150275|NCT01403246|Immunologic Factors|immunologic factors|mesh-ancestor
6150276|NCT01403246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150277|NCT01403246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6150278|NCT01403246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6150279|NCT01403246|Growth Substances|growth substances|mesh-ancestor
6476926|NCT00526305|Dexamethasone|dexamethasone|mesh-list
5551990|NCT04082806|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5551991|NCT04082806|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5551992|NCT04082806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5551993|NCT04082806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5551994|NCT04082806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5551995|NCT04082806|Serotonin Agents|serotonin agents|mesh-ancestor
6150280|NCT01403246|Growth Inhibitors|growth inhibitors|mesh-ancestor
6476927|NCT00526305|Prednisone|prednisone|mesh-list
6476928|NCT00526305|Hydrocortisone|hydrocortisone|mesh-list
5551996|NCT04082806|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5551997|NCT04082806|Antidepressive Agents|antidepressive agents|mesh-ancestor
5551998|NCT04082767|Midazolam|midazolam|mesh-list
5551999|NCT04082767|Dexmedetomidine|dexmedetomidine|mesh-list
5552000|NCT04082767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5552001|NCT04082767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6150281|NCT01403246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6150282|NCT01403246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6150283|NCT01403246|Alkylating Agents|alkylating agents|mesh-ancestor
6150284|NCT01403246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6150285|NCT01403376|Interferons|interferons|mesh-list
6150286|NCT01403376|Interferon-beta|interferon-beta|mesh-list
6150287|NCT01403376|Teriflunomide|teriflunomide|mesh-list
6150288|NCT01403376|Interferon beta-1b|interferon beta-1b|mesh-list
6150289|NCT01403376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6150290|NCT01403376|Antiviral Agents|antiviral agents|mesh-ancestor
6150291|NCT01403376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6150292|NCT01403376|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6150293|NCT01403376|Immunologic Factors|immunologic factors|mesh-ancestor
6150294|NCT01403376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150295|NCT01403376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6150296|NCT01403376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6150297|NCT01403376|Analgesics|analgesics|mesh-ancestor
6150298|NCT01403376|Sensory System Agents|sensory system agents|mesh-ancestor
6150299|NCT01403376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6150300|NCT01403376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6150301|NCT01403376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6150302|NCT01403376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6150303|NCT01403610|Bevacizumab|bevacizumab|mesh-list
6150304|NCT01403610|Phosphoramide Mustards|phosphoramide mustards|mesh-list
6150305|NCT01403610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6150306|NCT01403610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6150307|NCT01403610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6150308|NCT01403610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6150309|NCT01403610|Growth Substances|growth substances|mesh-ancestor
6150310|NCT01403610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150311|NCT01403610|Growth Inhibitors|growth inhibitors|mesh-ancestor
6150312|NCT01403610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6150313|NCT01403610|Alkylating Agents|alkylating agents|mesh-ancestor
6150314|NCT01403610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6150315|NCT01403805|Vaccines|vaccines|mesh-list
6150316|NCT01403805|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6150317|NCT01403805|Immunologic Factors|immunologic factors|mesh-ancestor
6150318|NCT01403805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150319|NCT01404208|Cycloserine|cycloserine|mesh-list
6150320|NCT01404208|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6150321|NCT01404208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6150322|NCT01404208|Renal Agents|renal agents|mesh-ancestor
6150323|NCT01404208|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6150324|NCT01404208|Antitubercular Agents|antitubercular agents|mesh-ancestor
6150325|NCT01404208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6150326|NCT01404208|Antimetabolites|antimetabolites|mesh-ancestor
6150327|NCT01404208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6150328|NCT01404260|Gemcitabine|gemcitabine|mesh-list
6150329|NCT01404260|Carboplatin|carboplatin|mesh-list
6150330|NCT01404260|Gefitinib|gefitinib|mesh-list
6150331|NCT01404260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6150332|NCT01404260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6150333|NCT01404260|Antimetabolites|antimetabolites|mesh-ancestor
6150334|NCT01404260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6150335|NCT01404260|Antiviral Agents|antiviral agents|mesh-ancestor
6150336|NCT01404260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6150337|NCT01404260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6150338|NCT01404260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6150339|NCT01404260|Immunologic Factors|immunologic factors|mesh-ancestor
6150340|NCT01404260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150341|NCT01404260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6150342|NCT01404325|Everolimus|everolimus|mesh-list
6150343|NCT01404325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6150344|NCT01404325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6150345|NCT01404325|Immunologic Factors|immunologic factors|mesh-ancestor
6150346|NCT01404325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476929|NCT00526305|Cyclophosphamide|cyclophosphamide|mesh-list
6476930|NCT00526305|Vincristine|vincristine|mesh-list
5552002|NCT04082767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150347|NCT01404429|Methotrexate|methotrexate|mesh-list
6150348|NCT01404429|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6150349|NCT01404429|Abortifacient Agents|abortifacient agents|mesh-ancestor
6150350|NCT01404429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6150351|NCT01404429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150352|NCT01404429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6150353|NCT01404429|Antimetabolites|antimetabolites|mesh-ancestor
5552003|NCT04082767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5552004|NCT04082767|Analgesics|analgesics|mesh-ancestor
5552005|NCT04082767|Sensory System Agents|sensory system agents|mesh-ancestor
5552006|NCT04082767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5552007|NCT04082767|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5552008|NCT04082767|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5552009|NCT04082767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6150354|NCT01404429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6150355|NCT01404429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6150356|NCT01404429|Dermatologic Agents|dermatologic agents|mesh-ancestor
6150357|NCT01404429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6150358|NCT01404429|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6150359|NCT01404429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6150360|NCT01404429|Immunologic Factors|immunologic factors|mesh-ancestor
6150361|NCT01404429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6150362|NCT01404429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6150363|NCT01404572|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6150364|NCT01404572|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6150365|NCT01404572|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6150366|NCT01404572|Protease Inhibitors|protease inhibitors|mesh-ancestor
6150367|NCT01404572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6150368|NCT01404572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6150369|NCT01404572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6150370|NCT01404572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6150371|NCT01404572|Antiviral Agents|antiviral agents|mesh-ancestor
6150372|NCT01404572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6150373|NCT01404832|Lansoprazole|lansoprazole|mesh-list
6150374|NCT01404832|Dexlansoprazole|dexlansoprazole|mesh-list
6150375|NCT01404832|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6150376|NCT01404832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6150377|NCT01404832|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6150378|NCT01404832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6150379|NCT01404832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6150380|NCT01404923|Mebeverine|mebeverine|mesh-list
6150381|NCT01404923|Alverine|alverine|mesh-list
6150382|NCT01404923|Parasympatholytics|parasympatholytics|mesh-list
6150383|NCT01404923|Autonomic Agents|autonomic agents|mesh-ancestor
6150384|NCT01404923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6150385|NCT01404923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150386|NCT01404923|Anticonvulsants|anticonvulsants|mesh-ancestor
6150387|NCT01404936|Interferons|interferons|mesh-list
6150388|NCT01404936|Interferon-alpha|interferon-alpha|mesh-list
5552010|NCT04082767|Adrenergic Agents|adrenergic agents|mesh-ancestor
5552011|NCT04082767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5552012|NCT04082767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5552013|NCT04082767|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5552014|NCT04082767|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5552015|NCT04082767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5552016|NCT04082767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5552017|NCT04082767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5552018|NCT04082767|Anesthetics, General|anesthetics, general|mesh-ancestor
5552019|NCT04082767|Anesthetics|anesthetics|mesh-ancestor
5552020|NCT04082767|GABA Modulators|gaba modulators|mesh-ancestor
6150389|NCT01404936|Interferon alpha-2|interferon alpha-2|mesh-list
6150390|NCT01404936|Doxorubicin|doxorubicin|mesh-list
6150391|NCT01404936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6150392|NCT01404936|Bleomycin|bleomycin|mesh-list
6150393|NCT01404936|Dacarbazine|dacarbazine|mesh-list
6150394|NCT01404936|Vinblastine|vinblastine|mesh-list
6150395|NCT01404936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6476931|NCT00526305|Daunorubicin|daunorubicin|mesh-list
6476932|NCT00526305|Asparaginase|asparaginase|mesh-list
5552021|NCT04082767|GABA Agents|gaba agents|mesh-ancestor
6150396|NCT01404936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6150397|NCT01404936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6150398|NCT01404936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6150399|NCT01404936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5552022|NCT04082598|Amoxicillin|amoxicillin|mesh-list
5552023|NCT04082598|Clavulanic Acid|clavulanic acid|mesh-list
6150400|NCT01404936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476933|NCT00526305|Mercaptopurine|mercaptopurine|mesh-list
6150401|NCT01404936|Antiviral Agents|antiviral agents|mesh-ancestor
6150402|NCT01404936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6150403|NCT01404936|Immunologic Factors|immunologic factors|mesh-ancestor
6150404|NCT01404936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150405|NCT01404936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6150406|NCT01404936|Alkylating Agents|alkylating agents|mesh-ancestor
6150407|NCT01404936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6150408|NCT01404936|Tubulin Modulators|tubulin modulators|mesh-ancestor
6150409|NCT01404936|Antimitotic Agents|antimitotic agents|mesh-ancestor
6150410|NCT01404936|Mitosis Modulators|mitosis modulators|mesh-ancestor
6150411|NCT01404949|Arsenic Trioxide|arsenic trioxide|mesh-list
6150412|NCT01404949|Tretinoin|tretinoin|mesh-list
6150413|NCT01404949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6150414|NCT01404949|Keratolytic Agents|keratolytic agents|mesh-ancestor
6150415|NCT01404949|Dermatologic Agents|dermatologic agents|mesh-ancestor
6150416|NCT01405027|Interferons|interferons|mesh-list
6150417|NCT01405027|Ribavirin|ribavirin|mesh-list
6150418|NCT01405027|Interferon-alpha|interferon-alpha|mesh-list
6150419|NCT01405027|Interferon alpha-2|interferon alpha-2|mesh-list
6150420|NCT01405027|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6150421|NCT01405027|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6150422|NCT01405027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6150423|NCT01405027|Antiviral Agents|antiviral agents|mesh-ancestor
6150424|NCT01405027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5552024|NCT04082598|Clavulanic Acids|clavulanic acids|mesh-list
5552025|NCT04082598|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6476934|NCT00526305|Mitoxantrone|mitoxantrone|mesh-list
6476935|NCT00526305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6476936|NCT00526305|Immunologic Factors|immunologic factors|mesh-ancestor
6476937|NCT00526305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476938|NCT00526305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6476939|NCT00526305|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6476940|NCT00526305|Alkylating Agents|alkylating agents|mesh-ancestor
6476941|NCT00526305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476942|NCT00526305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6476943|NCT00526305|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6150425|NCT01405027|Antimetabolites|antimetabolites|mesh-ancestor
6150426|NCT01405027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476944|NCT00526305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6476945|NCT00526305|Antiemetics|antiemetics|mesh-ancestor
6476946|NCT00526305|Autonomic Agents|autonomic agents|mesh-ancestor
6476947|NCT00526305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6150427|NCT01405027|Immunologic Factors|immunologic factors|mesh-ancestor
6150428|NCT01405027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150429|NCT01405053|Rufinamide|rufinamide|mesh-list
6150430|NCT01405053|Anticonvulsants|anticonvulsants|mesh-list
6150431|NCT01405053|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6150432|NCT01405053|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6150433|NCT01405053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6150434|NCT01405053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6150435|NCT01405456|Eplerenone|eplerenone|mesh-list
6150436|NCT01405456|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6150437|NCT01405456|Hormone Antagonists|hormone antagonists|mesh-ancestor
6150438|NCT01405456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6150439|NCT01405456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150440|NCT01405456|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6150441|NCT01405456|Diuretics|diuretics|mesh-ancestor
6150442|NCT01405456|Natriuretic Agents|natriuretic agents|mesh-ancestor
6150443|NCT01405456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6150444|NCT01405508|Brivaracetam|brivaracetam|mesh-list
6150445|NCT01405508|Anticonvulsants|anticonvulsants|mesh-ancestor
6150446|NCT01405560|Ribavirin|ribavirin|mesh-list
6150447|NCT01405560|Antimetabolites|antimetabolites|mesh-ancestor
5552026|NCT04082598|Lactoferrin|lactoferrin|mesh-list
5552027|NCT04082598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5552028|NCT04082598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5552029|NCT04082598|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5552030|NCT04082598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5552031|NCT04082598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5552032|NCT04082559|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5552033|NCT04082559|Metronidazole|metronidazole|mesh-list
5552034|NCT04082559|Doxycycline|doxycycline|mesh-list
5552035|NCT04082559|Ciprofloxacin|ciprofloxacin|mesh-list
5552036|NCT04082559|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5552037|NCT04082559|Complement Factor H|complement factor h|mesh-list
6150448|NCT01405560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5552038|NCT04082559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5552039|NCT04082559|Antitubercular Agents|antitubercular agents|mesh-ancestor
5552040|NCT04082559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5552041|NCT04082559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5552042|NCT04082559|Antimalarials|antimalarials|mesh-ancestor
5552043|NCT04082559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5552044|NCT04082559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5552045|NCT04082559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5552046|NCT04082559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5552047|NCT04082559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5552048|NCT04082559|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5552049|NCT04082559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5552050|NCT04082559|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5552051|NCT04082559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5552052|NCT04082559|Immunologic Factors|immunologic factors|mesh-ancestor
5552053|NCT04082559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552054|NCT04082286|Antibodies|antibodies|mesh-list
5552055|NCT04082286|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5552056|NCT04082286|Immunologic Factors|immunologic factors|mesh-ancestor
5552057|NCT04082286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602949|NCT03629873|Etoposide|etoposide|mesh-list
5602950|NCT03629873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5602951|NCT03629873|Immunologic Factors|immunologic factors|mesh-ancestor
5602952|NCT03629873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602953|NCT03629873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6150449|NCT01405560|Antiviral Agents|antiviral agents|mesh-ancestor
6150450|NCT01405560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5602954|NCT03629873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5602955|NCT03629873|Alkylating Agents|alkylating agents|mesh-ancestor
5602956|NCT03629873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602957|NCT03629873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5602958|NCT03629873|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5602959|NCT03629873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6150451|NCT01405742|Factor VIII|factor viii|mesh-list
6150452|NCT01405742|Coagulants|coagulants|mesh-ancestor
5602960|NCT03629873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5602961|NCT03629873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5602962|NCT03629873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5602963|NCT03629873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5602964|NCT03629873|Antimetabolites|antimetabolites|mesh-ancestor
5602965|NCT03629873|Antiviral Agents|antiviral agents|mesh-ancestor
5602966|NCT03629873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5602967|NCT03610438|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
5602968|NCT03610438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5602969|NCT03610438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5602970|NCT03610438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5602971|NCT03608865|Durvalumab|durvalumab|mesh-list
6150453|NCT01405768|Lidocaine|lidocaine|mesh-list
6150454|NCT01405768|Anesthetics, Local|anesthetics, local|mesh-ancestor
5602972|NCT03608865|Tremelimumab|tremelimumab|mesh-list
5602973|NCT03608865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5602974|NCT03608865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5602975|NCT03602235|Ascorbic Acid|ascorbic acid|mesh-list
5602976|NCT03602235|Melphalan|melphalan|mesh-list
5602977|NCT03602235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5602978|NCT03602235|Alkylating Agents|alkylating agents|mesh-ancestor
5602979|NCT03602235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5602980|NCT03602235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5602981|NCT03602235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5602982|NCT03602235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5602983|NCT03602235|Immunologic Factors|immunologic factors|mesh-ancestor
5602984|NCT03602235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602985|NCT03602235|Antioxidants|antioxidants|mesh-ancestor
5602986|NCT03602235|Protective Agents|protective agents|mesh-ancestor
5602987|NCT03602235|Vitamins|vitamins|mesh-ancestor
5602988|NCT03602235|Micronutrients|micronutrients|mesh-ancestor
5602989|NCT03560193|Chlorhexidine|chlorhexidine|mesh-list
5602990|NCT03560193|Ethanol|ethanol|mesh-list
5602991|NCT03560193|Povidone-Iodine|povidone-iodine|mesh-list
5602992|NCT03560193|Povidone|povidone|mesh-list
5602993|NCT03560193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6150455|NCT01405768|Anesthetics|anesthetics|mesh-ancestor
6150456|NCT01405768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5602994|NCT03560193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5602995|NCT03560193|Disinfectants|disinfectants|mesh-ancestor
6150457|NCT01405768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150458|NCT01405768|Sensory System Agents|sensory system agents|mesh-ancestor
5552058|NCT04082260|Alemtuzumab|alemtuzumab|mesh-list
5552059|NCT04082260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5552060|NCT04082260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5552061|NCT04082182|Vaccines|vaccines|mesh-list
5552062|NCT04082182|Immunologic Factors|immunologic factors|mesh-ancestor
5552063|NCT04082182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552064|NCT04081792|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5552065|NCT04081792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5552066|NCT04081909|Fentanyl|fentanyl|mesh-list
5552067|NCT04081909|Dexmedetomidine|dexmedetomidine|mesh-list
5552068|NCT04081909|Ketamine|ketamine|mesh-list
5552069|NCT04081909|Remifentanil|remifentanil|mesh-list
5552070|NCT04081909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5552071|NCT04081909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5552072|NCT04081909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552073|NCT04081909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5552074|NCT04081909|Analgesics|analgesics|mesh-ancestor
5552075|NCT04081909|Sensory System Agents|sensory system agents|mesh-ancestor
5552076|NCT04081909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5552077|NCT04081909|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5552078|NCT04081909|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6150459|NCT01405768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6150460|NCT01405768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6150461|NCT01405768|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6150462|NCT01405768|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6150463|NCT01405768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6150464|NCT01405768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6150465|NCT01405820|Natalizumab|natalizumab|mesh-list
6150466|NCT01405820|Immunologic Factors|immunologic factors|mesh-ancestor
6476948|NCT00526305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6476949|NCT00526305|Glucocorticoids|glucocorticoids|mesh-ancestor
6476950|NCT00526305|Hormones|hormones|mesh-ancestor
5552079|NCT04081909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5552080|NCT04081909|Adrenergic Agents|adrenergic agents|mesh-ancestor
5552081|NCT04081909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5552082|NCT04081909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5552083|NCT04081909|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5552084|NCT04081909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6476951|NCT00526305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6476952|NCT00526305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6476953|NCT00526305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6476954|NCT00526305|Tubulin Modulators|tubulin modulators|mesh-ancestor
6476955|NCT00526305|Antimitotic Agents|antimitotic agents|mesh-ancestor
6476956|NCT00526305|Mitosis Modulators|mitosis modulators|mesh-ancestor
6476957|NCT00526305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6476958|NCT00526305|Antimetabolites|antimetabolites|mesh-ancestor
6476959|NCT00526305|Antiviral Agents|antiviral agents|mesh-ancestor
6476960|NCT00526305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6476961|NCT00526305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6667739|NCT01528852|Disinfectants|disinfectants|mesh-ancestor
5552085|NCT04081909|Anesthetics, General|anesthetics, general|mesh-ancestor
6150467|NCT01405820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150468|NCT01405911|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6150469|NCT01405911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6150470|NCT01405911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150471|NCT01405911|Incretins|incretins|mesh-ancestor
6150472|NCT01405911|Hormones|hormones|mesh-ancestor
6150473|NCT01405911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6150474|NCT01405911|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6150475|NCT01405911|Protease Inhibitors|protease inhibitors|mesh-ancestor
6150476|NCT01405911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6150477|NCT01405911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6150478|NCT01405924|Dexamethasone|dexamethasone|mesh-list
6150479|NCT01405924|Fosaprepitant|fosaprepitant|mesh-list
6150480|NCT01405924|Aprepitant|aprepitant|mesh-list
6150481|NCT01405924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6476962|NCT00526305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6476963|NCT00526305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6476964|NCT00526305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6150482|NCT01405924|Antiemetics|antiemetics|mesh-ancestor
6150483|NCT01405924|Autonomic Agents|autonomic agents|mesh-ancestor
6150484|NCT01405924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6150485|NCT01405924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150486|NCT01405924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6150487|NCT01405924|Glucocorticoids|glucocorticoids|mesh-ancestor
6150488|NCT01405924|Hormones|hormones|mesh-ancestor
6150489|NCT01405924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6150490|NCT01405924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6150491|NCT01405924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6476965|NCT00526305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6476966|NCT00526305|Analgesics|analgesics|mesh-ancestor
6476967|NCT00526305|Sensory System Agents|sensory system agents|mesh-ancestor
6476968|NCT00526318|Cyclophosphamide|cyclophosphamide|mesh-list
6476969|NCT00526318|Melphalan|melphalan|mesh-list
6476970|NCT00526318|Ifosfamide|ifosfamide|mesh-list
6476971|NCT00526318|Dacarbazine|dacarbazine|mesh-list
6476972|NCT00526318|Carboplatin|carboplatin|mesh-list
6476973|NCT00526318|Doxorubicin|doxorubicin|mesh-list
6476974|NCT00526318|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6476975|NCT00526318|Etoposide|etoposide|mesh-list
6476976|NCT00526318|Vincristine|vincristine|mesh-list
6476977|NCT00526318|Topotecan|topotecan|mesh-list
6476978|NCT00526318|Etoposide phosphate|etoposide phosphate|mesh-list
6476979|NCT00526318|Vindesine|vindesine|mesh-list
6476980|NCT00526318|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
6476981|NCT00526318|Isotretinoin|isotretinoin|mesh-list
6476982|NCT00526318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6150492|NCT01405924|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5552086|NCT04081909|Anesthetics|anesthetics|mesh-ancestor
5552087|NCT04081909|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5552088|NCT04081909|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5552089|NCT04081909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5552090|NCT04081909|Narcotics|narcotics|mesh-ancestor
5552091|NCT04081909|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5552092|NCT04081831|Aspirin|aspirin|mesh-list
5552093|NCT04081831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5552094|NCT04081831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5552095|NCT04081831|Analgesics|analgesics|mesh-ancestor
5552096|NCT04081831|Sensory System Agents|sensory system agents|mesh-ancestor
5552097|NCT04081831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5552098|NCT04081831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552099|NCT04081831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5552100|NCT04081831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5552101|NCT04081831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6150493|NCT01405924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6150494|NCT01405924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6150495|NCT01405937|Ribavirin|ribavirin|mesh-list
6150496|NCT01405937|Antimetabolites|antimetabolites|mesh-ancestor
6150497|NCT01405937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5552102|NCT04081831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6476983|NCT00526318|Immunologic Factors|immunologic factors|mesh-ancestor
6476984|NCT00526318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6476985|NCT00526318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6476986|NCT00526318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6150498|NCT01405937|Antiviral Agents|antiviral agents|mesh-ancestor
6150499|NCT01405937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6150500|NCT01405950|Clonidine|clonidine|mesh-list
5552103|NCT04081831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5552104|NCT04081831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5552105|NCT04081831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5552106|NCT04081831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5552107|NCT04081831|Antipyretics|antipyretics|mesh-ancestor
5552108|NCT04081545|Analgesics, Opioid|analgesics, opioid|mesh-list
5552109|NCT04081545|Analgesics|analgesics|mesh-list
5552110|NCT04081545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
5552111|NCT04081545|Anesthetics|anesthetics|mesh-list
5552112|NCT04081545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5552113|NCT04081545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552114|NCT04081545|Narcotics|narcotics|mesh-ancestor
5552115|NCT04081545|Sensory System Agents|sensory system agents|mesh-ancestor
5552116|NCT04081545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5552117|NCT04081805|Estradiol|estradiol|mesh-list
5552118|NCT04081805|Estrogens|estrogens|mesh-ancestor
5552119|NCT04081805|Hormones|hormones|mesh-ancestor
5552120|NCT04081805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5552121|NCT04081805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552122|NCT04081688|Atezolizumab|atezolizumab|mesh-list
5552123|NCT04081688|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5552124|NCT04081688|Immunoglobulins|immunoglobulins|mesh-list
5552125|NCT04081688|Immunoglobulin G|immunoglobulin g|mesh-list
6150501|NCT01405950|Tizanidine|tizanidine|mesh-list
6150502|NCT01405950|Analgesics|analgesics|mesh-ancestor
6150503|NCT01405950|Sensory System Agents|sensory system agents|mesh-ancestor
6150504|NCT01405950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6150505|NCT01405950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150506|NCT01405950|Anticonvulsants|anticonvulsants|mesh-ancestor
6150507|NCT01405950|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6150508|NCT01405950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6150509|NCT01405950|Parasympatholytics|parasympatholytics|mesh-ancestor
6150510|NCT01405950|Autonomic Agents|autonomic agents|mesh-ancestor
6150511|NCT01405950|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6150512|NCT01405950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6150513|NCT01405950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6150514|NCT01405950|Adrenergic Agents|adrenergic agents|mesh-ancestor
6150515|NCT01405950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6150516|NCT01405950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6150517|NCT01405950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6150518|NCT01405950|Sympatholytics|sympatholytics|mesh-ancestor
6150519|NCT01406015|Spironolactone|spironolactone|mesh-list
6150520|NCT01406015|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6150521|NCT01406015|Hormone Antagonists|hormone antagonists|mesh-ancestor
6150522|NCT01406015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6150523|NCT01406015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150524|NCT01406015|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6150525|NCT01406015|Diuretics|diuretics|mesh-ancestor
6150526|NCT01406015|Natriuretic Agents|natriuretic agents|mesh-ancestor
6150527|NCT01406223|Bupropion|bupropion|mesh-list
6150528|NCT01406223|Nicotine|nicotine|mesh-list
6150529|NCT01406223|Varenicline|varenicline|mesh-list
6150530|NCT01406223|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6150531|NCT01406223|Autonomic Agents|autonomic agents|mesh-ancestor
5552126|NCT04081688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5552127|NCT04081688|Immunologic Factors|immunologic factors|mesh-ancestor
5552128|NCT04081688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552129|NCT04081389|Interferons|interferons|mesh-list
5552130|NCT04081389|Interferon-alpha|interferon-alpha|mesh-list
6150532|NCT01406223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6150533|NCT01406223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150534|NCT01406223|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6150535|NCT01406223|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6150536|NCT01406223|Cholinergic Agents|cholinergic agents|mesh-ancestor
6150537|NCT01406223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6150538|NCT01406223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6150539|NCT01406223|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6150540|NCT01406223|Antidepressive Agents|antidepressive agents|mesh-ancestor
6150541|NCT01406223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6150542|NCT01406223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6150543|NCT01406223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5552131|NCT04081389|Interferon alpha-2|interferon alpha-2|mesh-list
5552132|NCT04081389|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
6150544|NCT01406223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6150545|NCT01406223|Dopamine Agents|dopamine agents|mesh-ancestor
6150546|NCT01406223|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6150547|NCT01406223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6150548|NCT01406223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6150549|NCT01406444|Risedronic Acid|risedronic acid|mesh-list
6150550|NCT01406444|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6150551|NCT01406444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6150552|NCT01406444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6150553|NCT01406444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6150554|NCT01406444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150555|NCT01406444|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6150556|NCT01406795|Heparin|heparin|mesh-list
5552133|NCT04081389|Celecoxib|celecoxib|mesh-list
5552134|NCT04081389|Paclitaxel|paclitaxel|mesh-list
5552135|NCT04081389|Cyclophosphamide|cyclophosphamide|mesh-list
5552136|NCT04081389|Doxorubicin|doxorubicin|mesh-list
5552137|NCT04081389|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5552138|NCT04081389|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5552139|NCT04081389|Daunorubicin|daunorubicin|mesh-list
5552140|NCT04081389|Benzenesulfonamide|benzenesulfonamide|mesh-list
5552141|NCT04081389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5552142|NCT04081389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5552143|NCT04081389|Tubulin Modulators|tubulin modulators|mesh-ancestor
5552144|NCT04081389|Antimitotic Agents|antimitotic agents|mesh-ancestor
5552145|NCT04081389|Mitosis Modulators|mitosis modulators|mesh-ancestor
5552146|NCT04081389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5552147|NCT04081389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5552148|NCT04081389|Immunologic Factors|immunologic factors|mesh-ancestor
5552149|NCT04081389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552150|NCT04081389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5552151|NCT04081389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5552152|NCT04081389|Alkylating Agents|alkylating agents|mesh-ancestor
6150557|NCT01406795|Anticoagulants|anticoagulants|mesh-ancestor
6150558|NCT01406795|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6150559|NCT01406795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5552153|NCT04081389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5552154|NCT04081389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5552155|NCT04081389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5552156|NCT04081389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5552157|NCT04081389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6150560|NCT01406795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6150561|NCT01406873|Mexiletine|mexiletine|mesh-list
6150562|NCT01406873|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6150563|NCT01406873|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6150564|NCT01406873|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6150565|NCT01406873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6150566|NCT01406873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6150567|NCT01406938|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6150568|NCT01406938|Immunologic Factors|immunologic factors|mesh-ancestor
6150569|NCT01406938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150570|NCT01407094|Sertraline|sertraline|mesh-list
6150571|NCT01407094|Antidepressive Agents|antidepressive agents|mesh-ancestor
6150572|NCT01407094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6150573|NCT01407094|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6150574|NCT01407094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6476987|NCT00526318|Alkylating Agents|alkylating agents|mesh-ancestor
5552158|NCT04081389|Antiviral Agents|antiviral agents|mesh-ancestor
5552159|NCT04081389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5552160|NCT04081389|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5552161|NCT04081389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5552162|NCT04081389|Analgesics|analgesics|mesh-ancestor
5552163|NCT04081389|Sensory System Agents|sensory system agents|mesh-ancestor
5552164|NCT04081389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5552165|NCT04081389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5552166|NCT04081389|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5552167|NCT04081389|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5552168|NCT04081389|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5552169|NCT04081376|Hydromorphone|hydromorphone|mesh-list
5552170|NCT04081376|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5552171|NCT04081376|Narcotics|narcotics|mesh-ancestor
5552172|NCT04081376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5552173|NCT04081376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552174|NCT04081376|Analgesics|analgesics|mesh-ancestor
5552175|NCT04081376|Sensory System Agents|sensory system agents|mesh-ancestor
5552176|NCT04081376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6150575|NCT01407094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6150576|NCT01407094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6150577|NCT01407094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5552177|NCT04081480|Valacyclovir|valacyclovir|mesh-list
5552178|NCT04081480|Antiviral Agents|antiviral agents|mesh-ancestor
5552179|NCT04081480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5552180|NCT04081012|Acetylcysteine|acetylcysteine|mesh-list
5552181|NCT04081012|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5552182|NCT04081012|Antiviral Agents|antiviral agents|mesh-ancestor
5552183|NCT04081012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5552184|NCT04081012|Expectorants|expectorants|mesh-ancestor
5552185|NCT04081012|Respiratory System Agents|respiratory system agents|mesh-ancestor
5552186|NCT04081012|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5552187|NCT04081012|Antioxidants|antioxidants|mesh-ancestor
5552188|NCT04081012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5552189|NCT04081012|Protective Agents|protective agents|mesh-ancestor
5552190|NCT04081012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552191|NCT04081012|Antidotes|antidotes|mesh-ancestor
5552192|NCT04081077|Moxifloxacin|moxifloxacin|mesh-list
5552193|NCT04081077|Linezolid|linezolid|mesh-list
5552194|NCT04081077|Bedaquiline|bedaquiline|mesh-list
5552195|NCT04081077|Clofazimine|clofazimine|mesh-list
5552196|NCT04081077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5552197|NCT04081077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5552198|NCT04081077|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5552199|NCT04081077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5552200|NCT04081077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5552201|NCT04081077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5552202|NCT04081077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5552203|NCT04081077|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5552204|NCT04081077|Antitubercular Agents|antitubercular agents|mesh-ancestor
5552205|NCT04081077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5552206|NCT04081077|Leprostatic Agents|leprostatic agents|mesh-ancestor
5552207|NCT04080895|Lumefantrine|lumefantrine|mesh-list
5552208|NCT04080895|Artemether|artemether|mesh-list
5552209|NCT04080895|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
5552210|NCT04080895|Amodiaquine|amodiaquine|mesh-list
5552211|NCT04080895|Antimalarials|antimalarials|mesh-ancestor
5552212|NCT04080895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5552213|NCT04080895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5552214|NCT04080895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5552215|NCT04080908|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
5552216|NCT04080908|Hematinics|hematinics|mesh-ancestor
6150578|NCT01407094|Serotonin Agents|serotonin agents|mesh-ancestor
6150579|NCT01407094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150580|NCT01407107|Nitroglycerin|nitroglycerin|mesh-list
6150581|NCT01407107|Vasodilator Agents|vasodilator agents|mesh-ancestor
6150582|NCT01407523|Levetiracetam|levetiracetam|mesh-list
6150583|NCT01407523|Anticonvulsants|anticonvulsants|mesh-ancestor
6150584|NCT01407523|Nootropic Agents|nootropic agents|mesh-ancestor
5552217|NCT04080908|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5552218|NCT04080908|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5552219|NCT04080518|Dapagliflozin|dapagliflozin|mesh-list
6150585|NCT01407575|Buprenorphine|buprenorphine|mesh-list
5552220|NCT04080518|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5552221|NCT04080518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5552222|NCT04080518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5552223|NCT04080518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552224|NCT04080726|Esomeprazole|esomeprazole|mesh-list
6150586|NCT01407575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6150587|NCT01407575|Narcotics|narcotics|mesh-ancestor
6150588|NCT01407575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6150589|NCT01407575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150590|NCT01407575|Analgesics|analgesics|mesh-ancestor
6150591|NCT01407575|Sensory System Agents|sensory system agents|mesh-ancestor
6150592|NCT01407575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6150593|NCT01407575|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6150594|NCT01408030|Bevacizumab|bevacizumab|mesh-list
6150595|NCT01408030|Tranexamic Acid|tranexamic acid|mesh-list
6150596|NCT01408030|Endothelial Growth Factors|endothelial growth factors|mesh-list
5552225|NCT04080726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5552226|NCT04080726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6150597|NCT01408030|Estrogens|estrogens|mesh-list
6150598|NCT01408030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6150599|NCT01408030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6150600|NCT01408030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6150601|NCT01408030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6150602|NCT01408030|Growth Substances|growth substances|mesh-ancestor
6150603|NCT01408030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150604|NCT01408030|Growth Inhibitors|growth inhibitors|mesh-ancestor
6150605|NCT01408030|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6476988|NCT00526318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6476989|NCT00526318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6476990|NCT00526318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5552227|NCT04080726|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5552228|NCT04080726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5552229|NCT04080726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5552230|NCT04080739|Ropivacaine|ropivacaine|mesh-list
5552231|NCT04080739|Anesthetics, Local|anesthetics, local|mesh-ancestor
5552232|NCT04080739|Anesthetics|anesthetics|mesh-ancestor
5552233|NCT04080739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5552234|NCT04080739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552235|NCT04080739|Sensory System Agents|sensory system agents|mesh-ancestor
5552236|NCT04080739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5602996|NCT03560193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5602997|NCT03560193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5602998|NCT03560193|Plasma Substitutes|plasma substitutes|mesh-ancestor
5602999|NCT03560193|Blood Substitutes|blood substitutes|mesh-ancestor
5603000|NCT03557281|GSK656|gsk656|mesh-list
5603001|NCT03557281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5603002|NCT03557281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5603003|NCT03557242|Aspirin|aspirin|mesh-list
5603004|NCT03557242|Warfarin|warfarin|mesh-list
5603005|NCT03557242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5603006|NCT03557242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5603007|NCT03557242|Analgesics|analgesics|mesh-ancestor
5603008|NCT03557242|Sensory System Agents|sensory system agents|mesh-ancestor
5603009|NCT03557242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5603010|NCT03557242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603011|NCT03557242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5603012|NCT03557242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5603013|NCT03557242|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5603014|NCT03557242|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5603015|NCT03557242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603016|NCT03557242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5603017|NCT03557242|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5603018|NCT03557242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5603019|NCT03557242|Antipyretics|antipyretics|mesh-ancestor
5603020|NCT03557242|Anticoagulants|anticoagulants|mesh-ancestor
5603021|NCT03540420|Atezolizumab|atezolizumab|mesh-list
6150606|NCT01408030|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6476991|NCT00526318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6476992|NCT00526318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6476993|NCT00526318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6476994|NCT00526318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6150607|NCT01408030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6150608|NCT01408030|Hemostatics|hemostatics|mesh-ancestor
6150609|NCT01408030|Coagulants|coagulants|mesh-ancestor
6150610|NCT01408030|Hormones|hormones|mesh-ancestor
6150611|NCT01408030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6150612|NCT01408043|Plerixafor|plerixafor|mesh-list
6150613|NCT01408043|Etoposide|etoposide|mesh-list
6150614|NCT01408043|Etoposide phosphate|etoposide phosphate|mesh-list
6150615|NCT01408043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6476995|NCT00526318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6150616|NCT01408043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6150617|NCT01408043|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6150618|NCT01408043|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6150619|NCT01408043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6150620|NCT01408043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6150621|NCT01408043|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6150622|NCT01408043|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6150623|NCT01408043|Antiviral Agents|antiviral agents|mesh-ancestor
6150624|NCT01408043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6205715|NCT02091882|Antidepressive Agents|antidepressive agents|mesh-ancestor
6205716|NCT02091882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6205717|NCT02091882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6476996|NCT00526318|Tubulin Modulators|tubulin modulators|mesh-ancestor
6476997|NCT00526318|Antimitotic Agents|antimitotic agents|mesh-ancestor
6476998|NCT00526318|Mitosis Modulators|mitosis modulators|mesh-ancestor
6476999|NCT00526318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6477000|NCT00526318|Dermatologic Agents|dermatologic agents|mesh-ancestor
6477001|NCT00526318|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6477002|NCT00526383|Antidepressive Agents|antidepressive agents|mesh-list
6477003|NCT00526383|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
6477004|NCT00526383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6477005|NCT00526396|Cisplatin|cisplatin|mesh-list
6477006|NCT00526396|Etoposide|etoposide|mesh-list
6477007|NCT00526396|Etoposide phosphate|etoposide phosphate|mesh-list
6477008|NCT00526396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6477009|NCT00526396|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5552237|NCT04080375|Dinoprostone|dinoprostone|mesh-list
5552238|NCT04080375|Oxytocics|oxytocics|mesh-ancestor
5552239|NCT04080375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5552240|NCT04080375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552241|NCT04080388|Diuretics|diuretics|mesh-list
5552242|NCT04080388|Natriuretic Agents|natriuretic agents|mesh-ancestor
5552243|NCT04080388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552244|NCT04080713|Budesonide|budesonide|mesh-list
5552245|NCT04080713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5552246|NCT04080713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6477010|NCT00526396|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6477011|NCT00526396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6477012|NCT00526396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6477013|NCT00526396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477014|NCT00526409|Cytarabine|cytarabine|mesh-list
6477015|NCT00526409|Prednisolone|prednisolone|mesh-list
6477016|NCT00526409|Cyclophosphamide|cyclophosphamide|mesh-list
6477017|NCT00526409|Methotrexate|methotrexate|mesh-list
6477018|NCT00526409|Vincristine|vincristine|mesh-list
6477019|NCT00526409|Daunorubicin|daunorubicin|mesh-list
6477020|NCT00526409|Asparaginase|asparaginase|mesh-list
6477021|NCT00526409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6477022|NCT00526409|Immunologic Factors|immunologic factors|mesh-ancestor
6477023|NCT00526409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477024|NCT00526409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6477025|NCT00526409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6477026|NCT00526409|Alkylating Agents|alkylating agents|mesh-ancestor
6477027|NCT00526409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477028|NCT00526409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6477029|NCT00526409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6477030|NCT00526409|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6477031|NCT00526409|Abortifacient Agents|abortifacient agents|mesh-ancestor
6477032|NCT00526409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6477033|NCT00526409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5552247|NCT04080713|Autonomic Agents|autonomic agents|mesh-ancestor
6205718|NCT02091882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6205719|NCT02091882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5552248|NCT04080713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5552249|NCT04080713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552250|NCT04080713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5552251|NCT04080713|Respiratory System Agents|respiratory system agents|mesh-ancestor
5552252|NCT04080713|Glucocorticoids|glucocorticoids|mesh-ancestor
5552253|NCT04080713|Hormones|hormones|mesh-ancestor
5552254|NCT04080713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5552255|NCT04080284|Niraparib|niraparib|mesh-list
5552256|NCT04080284|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6205720|NCT02091882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205721|NCT02091882|Dopamine Agonists|dopamine agonists|mesh-ancestor
6477034|NCT00526409|Antimetabolites|antimetabolites|mesh-ancestor
5552257|NCT04080284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5552258|NCT04080284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5552259|NCT04080284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5552260|NCT04080622|Selenium|selenium|mesh-list
5552261|NCT04080622|Antioxidants|antioxidants|mesh-ancestor
5552262|NCT04080622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5552263|NCT04080622|Protective Agents|protective agents|mesh-ancestor
5552264|NCT04080622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552265|NCT04080622|Trace Elements|trace elements|mesh-ancestor
5552266|NCT04080622|Micronutrients|micronutrients|mesh-ancestor
6150625|NCT01408563|Fludarabine|fludarabine|mesh-list
6150626|NCT01408563|Melphalan|melphalan|mesh-list
6150627|NCT01408563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6150628|NCT01408563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6150629|NCT01408563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6150630|NCT01408563|Immunologic Factors|immunologic factors|mesh-ancestor
6150631|NCT01408563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150632|NCT01408563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6150633|NCT01408563|Alkylating Agents|alkylating agents|mesh-ancestor
6150634|NCT01408563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6150635|NCT01408576|Epratuzumab|epratuzumab|mesh-list
6150636|NCT01408576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6150637|NCT01408576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6150638|NCT01408628|Insulin|insulin|mesh-list
6150639|NCT01408628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6150640|NCT01408628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150641|NCT01408732|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
6150642|NCT01408732|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
5552267|NCT04080349|Misoprostol|misoprostol|mesh-list
5552268|NCT04080349|Dinoprostone|dinoprostone|mesh-list
5552269|NCT04080349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5552270|NCT04080349|Abortifacient Agents|abortifacient agents|mesh-ancestor
5552271|NCT04080349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5552272|NCT04080349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552273|NCT04080349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5552274|NCT04080349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5552275|NCT04080349|Oxytocics|oxytocics|mesh-ancestor
5552276|NCT04080323|Dinoprostone|dinoprostone|mesh-list
5552277|NCT04080323|Oxytocics|oxytocics|mesh-ancestor
5552278|NCT04080323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5552279|NCT04080323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552280|NCT04080336|Misoprostol|misoprostol|mesh-list
5552281|NCT04080336|Dinoprostone|dinoprostone|mesh-list
5552282|NCT04080336|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5552283|NCT04080336|Abortifacient Agents|abortifacient agents|mesh-ancestor
5552284|NCT04080336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5552285|NCT04080336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552286|NCT04080336|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5552287|NCT04080336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5552288|NCT04080336|Oxytocics|oxytocics|mesh-ancestor
5552289|NCT04080310|Ezetimibe|ezetimibe|mesh-list
5552290|NCT04080310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
5552291|NCT04080310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5552292|NCT04080310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5552293|NCT04080310|Antimetabolites|antimetabolites|mesh-ancestor
5552294|NCT04080310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5552295|NCT04080310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5552296|NCT04080310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6150643|NCT01408732|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6150644|NCT01408888|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6150645|NCT01408888|Dulaglutide|dulaglutide|mesh-list
6150646|NCT01408888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6150647|NCT01408888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150648|NCT01408888|Incretins|incretins|mesh-ancestor
6150649|NCT01408888|Hormones|hormones|mesh-ancestor
6150650|NCT01408888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6150651|NCT01408888|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6150652|NCT01408888|Protease Inhibitors|protease inhibitors|mesh-ancestor
6150653|NCT01408888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6150654|NCT01408888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6150655|NCT01408901|Molgramostim|molgramostim|mesh-list
6150656|NCT01408901|Sargramostim|sargramostim|mesh-list
6150657|NCT01408901|Immunologic Factors|immunologic factors|mesh-ancestor
5552297|NCT04080427|Dronabinol|dronabinol|mesh-list
5552298|NCT04080427|Hallucinogens|hallucinogens|mesh-ancestor
6150658|NCT01408901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150659|NCT01408901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6150660|NCT01408914|Rifampin|rifampin|mesh-list
6150661|NCT01408914|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6150662|NCT01408914|Antitubercular Agents|antitubercular agents|mesh-ancestor
6150663|NCT01408914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6150664|NCT01408914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6150665|NCT01408914|Leprostatic Agents|leprostatic agents|mesh-ancestor
6150666|NCT01408914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6150667|NCT01408914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6150668|NCT01408914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5552299|NCT04080427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552300|NCT04080427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5552301|NCT04080427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5552302|NCT04080427|Analgesics|analgesics|mesh-ancestor
5552303|NCT04080427|Sensory System Agents|sensory system agents|mesh-ancestor
5552304|NCT04080427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5552305|NCT04080427|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5552306|NCT04080427|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5552307|NCT04080427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5552308|NCT04080427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5552309|NCT04080427|Hormones|hormones|mesh-ancestor
5552310|NCT04080427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5552311|NCT04080869|Vitamin A|vitamin a|mesh-list
5552312|NCT04080869|Tretinoin|tretinoin|mesh-list
5552313|NCT04080869|Retinol palmitate|retinol palmitate|mesh-list
5552314|NCT04080869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5552315|NCT04080869|Keratolytic Agents|keratolytic agents|mesh-ancestor
5552316|NCT04080869|Dermatologic Agents|dermatologic agents|mesh-ancestor
5552317|NCT04080869|Antioxidants|antioxidants|mesh-ancestor
5552318|NCT04080869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5552319|NCT04080869|Protective Agents|protective agents|mesh-ancestor
5552320|NCT04080869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552321|NCT04080869|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5552322|NCT04080869|Vitamins|vitamins|mesh-ancestor
5552323|NCT04080869|Micronutrients|micronutrients|mesh-ancestor
5552324|NCT04079933|Nicotine|nicotine|mesh-list
5552325|NCT04079933|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5552326|NCT04079933|Autonomic Agents|autonomic agents|mesh-ancestor
5552327|NCT04079933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5552328|NCT04079933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552329|NCT04079933|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5552330|NCT04079933|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5552331|NCT04079933|Cholinergic Agents|cholinergic agents|mesh-ancestor
5552332|NCT04079933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5552333|NCT04079933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5552334|NCT04080076|Tacrolimus|tacrolimus|mesh-list
5552335|NCT04080076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5552336|NCT04080076|Immunologic Factors|immunologic factors|mesh-ancestor
5552337|NCT04080076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552338|NCT04080076|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6150669|NCT01408914|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6150670|NCT01408914|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6150671|NCT01408914|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6150672|NCT01408914|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6150673|NCT01408914|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6150674|NCT01408914|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6150675|NCT01409239|Insulin|insulin|mesh-list
6150676|NCT01409239|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6150677|NCT01409239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6150678|NCT01409239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150679|NCT01409564|Cilostazol|cilostazol|mesh-list
6150680|NCT01409564|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5552339|NCT04080076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5552340|NCT04080076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5552341|NCT04079881|Insulin|insulin|mesh-list
5552342|NCT04079881|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5552343|NCT04079881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5552344|NCT04079881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552345|NCT04079517|Tamoxifen|tamoxifen|mesh-list
5552346|NCT04079517|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6150681|NCT01409564|Autonomic Agents|autonomic agents|mesh-ancestor
6150682|NCT01409564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6150683|NCT01409564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150684|NCT01409564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6150685|NCT01409564|Respiratory System Agents|respiratory system agents|mesh-ancestor
6150686|NCT01409564|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6150687|NCT01409564|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6150688|NCT01409564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6150689|NCT01409564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5552347|NCT04079517|Hormone Antagonists|hormone antagonists|mesh-ancestor
5552348|NCT04079517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5552349|NCT04079517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552350|NCT04079517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5552351|NCT04079517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5552352|NCT04079517|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5552353|NCT04079517|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5552354|NCT04079517|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6150690|NCT01409564|Vasodilator Agents|vasodilator agents|mesh-ancestor
6150691|NCT01409564|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6150692|NCT01409564|Protective Agents|protective agents|mesh-ancestor
6150693|NCT01409564|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6150694|NCT01409564|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6150695|NCT01409564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6150696|NCT01409811|Zoledronic Acid|zoledronic acid|mesh-list
6150697|NCT01409811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5552355|NCT04079686|Cefazolin|cefazolin|mesh-list
5552356|NCT04079686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5552357|NCT04079686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5552358|NCT04079582|Dialysis Solutions|dialysis solutions|mesh-list
5552359|NCT04079582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5552360|NCT04079725|Mitomycins|mitomycins|mesh-list
5552361|NCT04079725|Mitomycin|mitomycin|mesh-list
5552362|NCT04079725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6150698|NCT01409811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150699|NCT01409837|Lisinopril|lisinopril|mesh-list
6150700|NCT01409837|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6150701|NCT01409837|Protease Inhibitors|protease inhibitors|mesh-ancestor
6150702|NCT01409837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6150703|NCT01409837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6150704|NCT01409837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6150705|NCT01409837|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6150706|NCT01409837|Protective Agents|protective agents|mesh-ancestor
6150707|NCT01409837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150708|NCT01409915|Molgramostim|molgramostim|mesh-list
6150709|NCT01409915|Sargramostim|sargramostim|mesh-list
6477035|NCT00526409|Dermatologic Agents|dermatologic agents|mesh-ancestor
5552363|NCT04079725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5552364|NCT04079725|Alkylating Agents|alkylating agents|mesh-ancestor
5552365|NCT04079725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5552366|NCT04079725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5552367|NCT04079725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5552368|NCT04079738|Ixazomib|ixazomib|mesh-list
5552369|NCT04079738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5552370|NCT04079738|Protease Inhibitors|protease inhibitors|mesh-ancestor
5552371|NCT04079738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5552372|NCT04079738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5552373|NCT04079452|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
5552374|NCT04079452|Antiviral Agents|antiviral agents|mesh-ancestor
5552375|NCT04079452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5552376|NCT04079452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5552377|NCT04079452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5552378|NCT04079452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5552379|NCT04079452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5552380|NCT04079452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5552381|NCT04079452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5552382|NCT04079413|Insulin|insulin|mesh-list
5552383|NCT04079413|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5552384|NCT04079413|Insulin Aspart|insulin aspart|mesh-list
5552385|NCT04079413|Insulin, Long-Acting|insulin, long-acting|mesh-list
5552386|NCT04079413|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
5552387|NCT04079413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5552388|NCT04079413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552389|NCT04079192|Umirolimus|umirolimus|mesh-list
5552390|NCT04079192|Paclitaxel|paclitaxel|mesh-list
5552391|NCT04079192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5552392|NCT04079192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5552393|NCT04079192|Tubulin Modulators|tubulin modulators|mesh-ancestor
5552394|NCT04079192|Antimitotic Agents|antimitotic agents|mesh-ancestor
6150710|NCT01409915|Immunologic Factors|immunologic factors|mesh-ancestor
5552395|NCT04079192|Mitosis Modulators|mitosis modulators|mesh-ancestor
5552396|NCT04079192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5552397|NCT04079192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5552398|NCT04079192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5552399|NCT04079192|Immunologic Factors|immunologic factors|mesh-ancestor
5552400|NCT04079192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477036|NCT00526409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6477037|NCT00526409|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6477038|NCT00526409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6477039|NCT00526409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6477040|NCT00526409|Tubulin Modulators|tubulin modulators|mesh-ancestor
6477041|NCT00526409|Antimitotic Agents|antimitotic agents|mesh-ancestor
6477042|NCT00526409|Mitosis Modulators|mitosis modulators|mesh-ancestor
6477043|NCT00526409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5552401|NCT04079231|Aflibercept|aflibercept|mesh-list
5552402|NCT04079231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6477044|NCT00526409|Glucocorticoids|glucocorticoids|mesh-ancestor
6477045|NCT00526409|Hormones|hormones|mesh-ancestor
6477046|NCT00526409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6477047|NCT00526409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6477048|NCT00526409|Antiviral Agents|antiviral agents|mesh-ancestor
6477049|NCT00526409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6477050|NCT00526409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6477051|NCT00526409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6477052|NCT00526409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6477053|NCT00526448|Ribavirin|ribavirin|mesh-list
6477054|NCT00526448|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6477055|NCT00526448|Antimetabolites|antimetabolites|mesh-ancestor
6477056|NCT00526448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477057|NCT00526448|Antiviral Agents|antiviral agents|mesh-ancestor
6477058|NCT00526448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6477059|NCT00526513|Insulin glulisine|insulin glulisine|mesh-list
6477060|NCT00526513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6477061|NCT00526513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477062|NCT00526617|Temozolomide|temozolomide|mesh-list
6477063|NCT00526617|Veliparib|veliparib|mesh-list
6477064|NCT00526617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6477065|NCT00526617|Alkylating Agents|alkylating agents|mesh-ancestor
6477066|NCT00526617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477067|NCT00526617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6477068|NCT00526617|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6477069|NCT00526617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6477070|NCT00526643|Gemcitabine|gemcitabine|mesh-list
6477071|NCT00526643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6477072|NCT00526643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6477073|NCT00526643|Antimetabolites|antimetabolites|mesh-ancestor
6477074|NCT00526643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477075|NCT00526643|Antiviral Agents|antiviral agents|mesh-ancestor
6150711|NCT01409915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150712|NCT01409915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6150713|NCT01409993|Sildenafil Citrate|sildenafil citrate|mesh-list
6150714|NCT01409993|Vasodilator Agents|vasodilator agents|mesh-ancestor
6150715|NCT01409993|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6150716|NCT01409993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6150717|NCT01409993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6150718|NCT01409993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6150719|NCT01409993|Urological Agents|urological agents|mesh-ancestor
6150720|NCT01410058|Efavirenz|efavirenz|mesh-list
6150721|NCT01410058|Nevirapine|nevirapine|mesh-list
6150722|NCT01410058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6150723|NCT01410058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6150724|NCT01410058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6477076|NCT00526643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5552403|NCT04079231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6150725|NCT01410058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6150726|NCT01410058|Antiviral Agents|antiviral agents|mesh-ancestor
6150727|NCT01410058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6150728|NCT01410058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6150729|NCT01410058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6150730|NCT01410058|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6150731|NCT01410058|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6150732|NCT01410058|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6150733|NCT01410058|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6150734|NCT01410058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6150735|NCT01410058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6150736|NCT01410084|Vitamin D|vitamin d|mesh-list
6150737|NCT01410084|Cholecalciferol|cholecalciferol|mesh-list
5552404|NCT04079231|Growth Substances|growth substances|mesh-ancestor
5552405|NCT04079231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552406|NCT04079231|Growth Inhibitors|growth inhibitors|mesh-ancestor
5552407|NCT04079231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5552408|NCT04079374|Etanercept|etanercept|mesh-list
5552409|NCT04079374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5552410|NCT04079374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5552411|NCT04079374|Analgesics|analgesics|mesh-ancestor
5552412|NCT04079374|Sensory System Agents|sensory system agents|mesh-ancestor
5552413|NCT04079374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5552414|NCT04079374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150738|NCT01410084|Vitamins|vitamins|mesh-list
6150739|NCT01410084|Vitamin E|vitamin e|mesh-list
6150740|NCT01410084|Micronutrients|micronutrients|mesh-ancestor
6150741|NCT01410084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150742|NCT01410084|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6150743|NCT01410084|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6150744|NCT01410084|Antioxidants|antioxidants|mesh-ancestor
6150745|NCT01410084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6150746|NCT01410084|Protective Agents|protective agents|mesh-ancestor
6150747|NCT01410227|Factor VIII|factor viii|mesh-list
6150748|NCT01410227|Coagulants|coagulants|mesh-ancestor
6150749|NCT01410240|Hemostatics|hemostatics|mesh-list
5552415|NCT04079374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5552416|NCT04079374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5552417|NCT04079374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5552418|NCT04079374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5552419|NCT04079374|Immunologic Factors|immunologic factors|mesh-ancestor
5552420|NCT04079257|Eculizumab|eculizumab|mesh-list
5552421|NCT04079257|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5552422|NCT04079257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5552423|NCT04079257|Immunologic Factors|immunologic factors|mesh-ancestor
5552424|NCT04079257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552425|NCT04079088|Interferons|interferons|mesh-list
6150750|NCT01410240|Coagulants|coagulants|mesh-ancestor
6150751|NCT01410344|Vidarabine|vidarabine|mesh-list
6150752|NCT01410344|Cyclophosphamide|cyclophosphamide|mesh-list
6150753|NCT01410344|Melphalan|melphalan|mesh-list
6150754|NCT01410344|Busulfan|busulfan|mesh-list
5552426|NCT04079088|Interferon-beta|interferon-beta|mesh-list
5552427|NCT04079088|Glatiramer Acetate|glatiramer acetate|mesh-list
5552428|NCT04079088|(T,G)-A-L|(t,g)-a-l|mesh-list
5552429|NCT04079088|Interferon beta-1b|interferon beta-1b|mesh-list
5552430|NCT04079088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5552431|NCT04079088|Antiviral Agents|antiviral agents|mesh-ancestor
6150755|NCT01410344|Fludarabine|fludarabine|mesh-list
6150756|NCT01410344|Fludarabine phosphate|fludarabine phosphate|mesh-list
6150757|NCT01410344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5552432|NCT04079088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5552433|NCT04079088|Immunologic Factors|immunologic factors|mesh-ancestor
5552434|NCT04079088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552435|NCT04079088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5552436|NCT04079088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5552437|NCT04079088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6150758|NCT01410344|Immunologic Factors|immunologic factors|mesh-ancestor
6150759|NCT01410344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552438|NCT04079140|Dinoprostone|dinoprostone|mesh-list
5552439|NCT04079140|Oxytocics|oxytocics|mesh-ancestor
5552440|NCT04079140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5552441|NCT04079140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150760|NCT01410344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6150761|NCT01410344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5552442|NCT04078724|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
5552443|NCT04078724|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6150762|NCT01410344|Alkylating Agents|alkylating agents|mesh-ancestor
6150763|NCT01410344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6150764|NCT01410344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6150765|NCT01410344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6150766|NCT01410344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6150767|NCT01410344|Antimetabolites|antimetabolites|mesh-ancestor
5552444|NCT04078724|Antidepressive Agents|antidepressive agents|mesh-ancestor
5552445|NCT04078724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5603022|NCT03540420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5603023|NCT03516279|Pembrolizumab|pembrolizumab|mesh-list
5603024|NCT03516279|Imatinib Mesylate|imatinib mesylate|mesh-list
5603025|NCT03516279|Dasatinib|dasatinib|mesh-list
5603026|NCT03516279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5603027|NCT03516279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5603028|NCT03516279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6150768|NCT01410344|Antiviral Agents|antiviral agents|mesh-ancestor
6150769|NCT01410344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6150770|NCT01410409|Acetaminophen|acetaminophen|mesh-list
6150771|NCT01410409|Pantoprazole|pantoprazole|mesh-list
6150772|NCT01410409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6150773|NCT01410409|Analgesics|analgesics|mesh-ancestor
6150774|NCT01410409|Sensory System Agents|sensory system agents|mesh-ancestor
6150775|NCT01410409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6150776|NCT01410409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150777|NCT01410409|Antipyretics|antipyretics|mesh-ancestor
6150778|NCT01410409|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6150779|NCT01410409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6150780|NCT01410409|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6150781|NCT01410409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6150782|NCT01410409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6150783|NCT01410448|Cyclosporine|cyclosporine|mesh-list
6150784|NCT01410448|Mycophenolic Acid|mycophenolic acid|mesh-list
6150785|NCT01410448|Everolimus|everolimus|mesh-list
6150786|NCT01410448|Cyclosporins|cyclosporins|mesh-list
6150787|NCT01410448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6150788|NCT01410448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6150789|NCT01410448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6150790|NCT01410448|Immunologic Factors|immunologic factors|mesh-ancestor
6150791|NCT01410448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150792|NCT01410448|Antifungal Agents|antifungal agents|mesh-ancestor
6150793|NCT01410448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6150794|NCT01410448|Dermatologic Agents|dermatologic agents|mesh-ancestor
6150795|NCT01410448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6150796|NCT01410448|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6150797|NCT01410448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6150798|NCT01410448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6150799|NCT01410448|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6150800|NCT01410448|Antitubercular Agents|antitubercular agents|mesh-ancestor
6150801|NCT01410448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6150802|NCT01410565|Apaziquone|apaziquone|mesh-list
6150803|NCT01410565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6150804|NCT01410604|Metformin|metformin|mesh-list
6150805|NCT01410604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6150806|NCT01410604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150807|NCT01411085|Risperidone|risperidone|mesh-list
6150808|NCT01411085|Desipramine|desipramine|mesh-list
6150809|NCT01411085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6150810|NCT01411085|Serotonin Agents|serotonin agents|mesh-ancestor
6150811|NCT01411085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5603029|NCT03516279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5603030|NCT03516279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603031|NCT03509012|Paclitaxel|paclitaxel|mesh-list
5603032|NCT03509012|Etoposide|etoposide|mesh-list
5603033|NCT03509012|Cisplatin|cisplatin|mesh-list
6150812|NCT01411085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6150813|NCT01411085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150814|NCT01411085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6150815|NCT01411085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6150816|NCT01411085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6150817|NCT01411085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6150818|NCT01411085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6150819|NCT01411085|Dopamine Agents|dopamine agents|mesh-ancestor
6150820|NCT01411085|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6150821|NCT01411085|Antidepressive Agents|antidepressive agents|mesh-ancestor
6150822|NCT01411085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6150823|NCT01411085|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6150824|NCT01411085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6150825|NCT01411085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5603034|NCT03509012|Carboplatin|carboplatin|mesh-list
6150826|NCT01411085|Adrenergic Agents|adrenergic agents|mesh-ancestor
6150827|NCT01411137|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
6150828|NCT01411137|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6150829|NCT01411137|Immunologic Factors|immunologic factors|mesh-ancestor
6150830|NCT01411137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150831|NCT01411137|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6150832|NCT01411137|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6150833|NCT01411137|Dopamine Agonists|dopamine agonists|mesh-ancestor
6150834|NCT01411137|Dopamine Agents|dopamine agents|mesh-ancestor
6150835|NCT01411137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6150836|NCT01411137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6150837|NCT01411215|Etanercept|etanercept|mesh-list
6150838|NCT01411215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5552446|NCT04078711|Losartan|losartan|mesh-list
5552447|NCT04078711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5552448|NCT04078711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5552449|NCT04078711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5552450|NCT04078711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5552451|NCT04078711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5552452|NCT04078659|Lidocaine|lidocaine|mesh-list
5552453|NCT04078659|Magnesium Sulfate|magnesium sulfate|mesh-list
5552454|NCT04078659|Fentanyl|fentanyl|mesh-list
5552455|NCT04078659|Propofol|propofol|mesh-list
5552456|NCT04078659|Atracurium|atracurium|mesh-list
5552457|NCT04078659|Anesthetics, Local|anesthetics, local|mesh-ancestor
5552458|NCT04078659|Anesthetics|anesthetics|mesh-ancestor
5552459|NCT04078659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5552460|NCT04078659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552461|NCT04078659|Sensory System Agents|sensory system agents|mesh-ancestor
5552462|NCT04078659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5552463|NCT04078659|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5552464|NCT04078659|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5552465|NCT04078659|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5552466|NCT04078659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5552467|NCT04078659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5552468|NCT04078659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5552469|NCT04078659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5552470|NCT04078659|Anesthetics, General|anesthetics, general|mesh-ancestor
5552471|NCT04078659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5552472|NCT04078659|Narcotics|narcotics|mesh-ancestor
5552473|NCT04078659|Analgesics|analgesics|mesh-ancestor
5552474|NCT04078659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6150839|NCT01411215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6150840|NCT01411215|Analgesics|analgesics|mesh-ancestor
6150841|NCT01411215|Sensory System Agents|sensory system agents|mesh-ancestor
6150842|NCT01411215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6150843|NCT01411215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150844|NCT01411215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6150845|NCT01411215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6150846|NCT01411215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6150847|NCT01411215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6150848|NCT01411215|Immunologic Factors|immunologic factors|mesh-ancestor
6150849|NCT01411241|Vaccines|vaccines|mesh-list
6477077|NCT00526643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5552475|NCT04078659|Anticonvulsants|anticonvulsants|mesh-ancestor
5552476|NCT04078659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5552477|NCT04078659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5552478|NCT04078659|Tocolytic Agents|tocolytic agents|mesh-ancestor
5552479|NCT04078659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5552480|NCT04078659|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5552481|NCT04078659|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5552482|NCT04078659|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5552483|NCT04078659|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
5552484|NCT04078659|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5552485|NCT04078659|Cholinergic Agents|cholinergic agents|mesh-ancestor
5552486|NCT04078659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5552487|NCT04078880|Ascorbic Acid|ascorbic acid|mesh-list
5552488|NCT04078880|Antioxidants|antioxidants|mesh-ancestor
5552489|NCT04078880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5552490|NCT04078880|Protective Agents|protective agents|mesh-ancestor
5552491|NCT04078880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552492|NCT04078880|Vitamins|vitamins|mesh-ancestor
5552493|NCT04078880|Micronutrients|micronutrients|mesh-ancestor
5552494|NCT04078399|Interferons|interferons|mesh-list
5552495|NCT04078399|Azacitidine|azacitidine|mesh-list
5552496|NCT04078399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6150850|NCT01411241|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6150851|NCT01411241|Immunologic Factors|immunologic factors|mesh-ancestor
6150852|NCT01411241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150853|NCT01411267|Cytarabine|cytarabine|mesh-list
6150854|NCT01411267|Methotrexate|methotrexate|mesh-list
6150855|NCT01411267|Etoposide|etoposide|mesh-list
6150856|NCT01411267|Etoposide phosphate|etoposide phosphate|mesh-list
5552497|NCT04078399|Antiviral Agents|antiviral agents|mesh-ancestor
5552498|NCT04078399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5552499|NCT04078399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5552500|NCT04078399|Antimetabolites|antimetabolites|mesh-ancestor
5552501|NCT04078399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5552502|NCT04078399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5552503|NCT04078425|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
5552504|NCT04078425|Hormone Antagonists|hormone antagonists|mesh-ancestor
5552505|NCT04078425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5552506|NCT04078425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552507|NCT04078425|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5552508|NCT04078425|Diuretics|diuretics|mesh-ancestor
5552509|NCT04078425|Natriuretic Agents|natriuretic agents|mesh-ancestor
5552510|NCT04078295|Nivolumab|nivolumab|mesh-list
5552511|NCT04078295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5552512|NCT04078295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5552513|NCT04078295|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5552514|NCT04078295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5552515|NCT04078269|Vaccines|vaccines|mesh-list
5552516|NCT04078269|Immunologic Factors|immunologic factors|mesh-ancestor
5552517|NCT04078269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552518|NCT04078204|3-n-butylphthalide|3-n-butylphthalide|mesh-list
5552519|NCT04078204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5552520|NCT04078204|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5552521|NCT04078204|Protective Agents|protective agents|mesh-ancestor
5552522|NCT04078204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552523|NCT04078048|Vitamins|vitamins|mesh-list
5552524|NCT04078048|Ascorbic Acid|ascorbic acid|mesh-list
6150857|NCT01411267|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6150858|NCT01411267|Abortifacient Agents|abortifacient agents|mesh-ancestor
6150859|NCT01411267|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6150860|NCT01411267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150861|NCT01411267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6150862|NCT01411267|Antimetabolites|antimetabolites|mesh-ancestor
6150863|NCT01411267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5552525|NCT04078048|Vitamin E|vitamin e|mesh-list
5552526|NCT04078048|Antioxidants|antioxidants|mesh-list
5552527|NCT04078048|Micronutrients|micronutrients|mesh-ancestor
5552528|NCT04078048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552529|NCT04078048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6150864|NCT01411267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6150865|NCT01411267|Dermatologic Agents|dermatologic agents|mesh-ancestor
6150866|NCT01411267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5552530|NCT04078048|Protective Agents|protective agents|mesh-ancestor
5552531|NCT04077853|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
5552532|NCT04077853|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
5552533|NCT04077853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5552534|NCT04077853|Hormone Antagonists|hormone antagonists|mesh-ancestor
6150867|NCT01411267|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6150868|NCT01411267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6150869|NCT01411267|Immunologic Factors|immunologic factors|mesh-ancestor
6150870|NCT01411267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6150871|NCT01411267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6150872|NCT01411267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6150873|NCT01411267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6150874|NCT01411267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6150875|NCT01411267|Antiviral Agents|antiviral agents|mesh-ancestor
6150876|NCT01411267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6150877|NCT01411501|Mosapride|mosapride|mesh-list
6150878|NCT01411501|Citric Acid|citric acid|mesh-list
6150879|NCT01411501|Sodium Citrate|sodium citrate|mesh-list
6150880|NCT01411501|Anticoagulants|anticoagulants|mesh-ancestor
6150881|NCT01411501|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6150882|NCT01411501|Chelating Agents|chelating agents|mesh-ancestor
6150883|NCT01411501|Sequestering Agents|sequestering agents|mesh-ancestor
5552535|NCT04077853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6150884|NCT01411501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6150885|NCT01411501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6150886|NCT01411501|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6150887|NCT01411501|Serotonin Agents|serotonin agents|mesh-ancestor
6150888|NCT01411501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6150889|NCT01411501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150890|NCT01411696|Dexamethasone|dexamethasone|mesh-list
6150891|NCT01411696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6150892|NCT01411696|Antiemetics|antiemetics|mesh-ancestor
6150893|NCT01411696|Autonomic Agents|autonomic agents|mesh-ancestor
6150894|NCT01411696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6150895|NCT01411696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150896|NCT01411696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6150897|NCT01411696|Glucocorticoids|glucocorticoids|mesh-ancestor
6150898|NCT01411696|Hormones|hormones|mesh-ancestor
6150899|NCT01411696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6150900|NCT01411696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6150901|NCT01411696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6150902|NCT01411774|Cycloserine|cycloserine|mesh-list
6150903|NCT01411774|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6150904|NCT01411774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6150905|NCT01411774|Renal Agents|renal agents|mesh-ancestor
6150906|NCT01411774|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6150907|NCT01411774|Antitubercular Agents|antitubercular agents|mesh-ancestor
6150908|NCT01411774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6150909|NCT01411774|Antimetabolites|antimetabolites|mesh-ancestor
6150910|NCT01411774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6150911|NCT01411891|Chlorhexidine|chlorhexidine|mesh-list
6150912|NCT01411891|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6150913|NCT01411891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6150914|NCT01411891|Disinfectants|disinfectants|mesh-ancestor
6150915|NCT01411995|Lidocaine|lidocaine|mesh-list
6150916|NCT01411995|Anesthetics, Local|anesthetics, local|mesh-ancestor
6150917|NCT01411995|Anesthetics|anesthetics|mesh-ancestor
6150918|NCT01411995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6477078|NCT00526643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6477079|NCT00526643|Immunologic Factors|immunologic factors|mesh-ancestor
6150919|NCT01411995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150920|NCT01411995|Sensory System Agents|sensory system agents|mesh-ancestor
6150921|NCT01411995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6150922|NCT01411995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6150923|NCT01411995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6150924|NCT01411995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6150925|NCT01411995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6150926|NCT01411995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6150927|NCT01412060|Cariprazine|cariprazine|mesh-list
6150928|NCT01412060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6150929|NCT01412060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6150930|NCT01412060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6150931|NCT01412060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150932|NCT01412060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6150933|NCT01412164|Sirolimus|sirolimus|mesh-list
6150934|NCT01412164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6150935|NCT01412164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6150936|NCT01412164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6150937|NCT01412164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6150938|NCT01412164|Antifungal Agents|antifungal agents|mesh-ancestor
6150939|NCT01412164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6150940|NCT01412164|Immunologic Factors|immunologic factors|mesh-ancestor
6150941|NCT01412164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150942|NCT01412229|Paclitaxel|paclitaxel|mesh-list
6150943|NCT01412229|Carboplatin|carboplatin|mesh-list
6150944|NCT01412229|Cetuximab|cetuximab|mesh-list
6150945|NCT01412229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6150946|NCT01412229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6150947|NCT01412229|Tubulin Modulators|tubulin modulators|mesh-ancestor
6150948|NCT01412229|Antimitotic Agents|antimitotic agents|mesh-ancestor
6150949|NCT01412229|Mitosis Modulators|mitosis modulators|mesh-ancestor
6150950|NCT01412229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6150951|NCT01412229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6150952|NCT01412281|Vaccines|vaccines|mesh-list
6150953|NCT01412281|Immunologic Factors|immunologic factors|mesh-ancestor
6150954|NCT01412281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150955|NCT01412372|Mesalamine|mesalamine|mesh-list
6150956|NCT01412372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6150957|NCT01412372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5552536|NCT04077853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552537|NCT04077853|Progestins|progestins|mesh-ancestor
5552538|NCT04077853|Hormones|hormones|mesh-ancestor
5552539|NCT04077827|Propofol|propofol|mesh-list
5552540|NCT04077827|Desflurane|desflurane|mesh-list
5552541|NCT04077827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5552542|NCT04077827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5552543|NCT04077827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552544|NCT04077827|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5552545|NCT04077827|Anesthetics, General|anesthetics, general|mesh-ancestor
5552546|NCT04077827|Anesthetics|anesthetics|mesh-ancestor
5552547|NCT04077827|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5552548|NCT04078126|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
5552549|NCT04078126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5552550|NCT04078126|Respiratory System Agents|respiratory system agents|mesh-ancestor
5552551|NCT04077957|Hydroxychloroquine|hydroxychloroquine|mesh-list
6150958|NCT01412372|Analgesics|analgesics|mesh-ancestor
6150959|NCT01412372|Sensory System Agents|sensory system agents|mesh-ancestor
6150960|NCT01412372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6150961|NCT01412372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150962|NCT01412372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6150963|NCT01412372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6150964|NCT01412424|Octreotide|octreotide|mesh-list
6150965|NCT01412424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5552552|NCT04077957|Sulfasalazine|sulfasalazine|mesh-list
5552553|NCT04077957|Etanercept|etanercept|mesh-list
5552554|NCT04077957|Methotrexate|methotrexate|mesh-list
5552555|NCT04077957|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5552556|NCT04077957|Abortifacient Agents|abortifacient agents|mesh-ancestor
5552557|NCT04077957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5552558|NCT04077957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552559|NCT04077957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5552560|NCT04077957|Antimetabolites|antimetabolites|mesh-ancestor
5552561|NCT04077957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5552562|NCT04077957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5552563|NCT04077957|Dermatologic Agents|dermatologic agents|mesh-ancestor
5552564|NCT04077957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5552565|NCT04077957|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5552566|NCT04077957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5552567|NCT04077957|Immunologic Factors|immunologic factors|mesh-ancestor
5552568|NCT04077957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5552569|NCT04077957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5552570|NCT04077957|Antimalarials|antimalarials|mesh-ancestor
5552571|NCT04077957|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5552572|NCT04077957|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5552573|NCT04077957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5552574|NCT04077957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5552575|NCT04077957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5552576|NCT04077957|Analgesics|analgesics|mesh-ancestor
5552577|NCT04077957|Sensory System Agents|sensory system agents|mesh-ancestor
5552578|NCT04077957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6150966|NCT01412424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5725583|NCT03179904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5725584|NCT03179904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6150967|NCT01412424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6150968|NCT01412710|Vitamin D|vitamin d|mesh-list
6150969|NCT01412710|Cholecalciferol|cholecalciferol|mesh-list
6150970|NCT01412710|Vitamins|vitamins|mesh-ancestor
6150971|NCT01412710|Micronutrients|micronutrients|mesh-ancestor
6150972|NCT01412710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150973|NCT01412710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6150974|NCT01412710|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6150975|NCT01412879|Leucovorin|leucovorin|mesh-list
6150976|NCT01412879|Cytarabine|cytarabine|mesh-list
6150977|NCT01412879|Dexamethasone|dexamethasone|mesh-list
6150978|NCT01412879|Cyclophosphamide|cyclophosphamide|mesh-list
6150979|NCT01412879|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6150980|NCT01412879|Rituximab|rituximab|mesh-list
5552579|NCT04077957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5552580|NCT04077957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5552581|NCT04077892|Budesonide|budesonide|mesh-list
6150981|NCT01412879|Doxorubicin|doxorubicin|mesh-list
6150982|NCT01412879|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6150983|NCT01412879|Methotrexate|methotrexate|mesh-list
6150984|NCT01412879|Vincristine|vincristine|mesh-list
5552582|NCT04077892|Montelukast|montelukast|mesh-list
5552583|NCT04077892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6150985|NCT01412879|Levoleucovorin|levoleucovorin|mesh-list
5552584|NCT04077892|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5552585|NCT04077892|Autonomic Agents|autonomic agents|mesh-ancestor
5552586|NCT04077892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5552587|NCT04077892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552588|NCT04077892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5552589|NCT04077892|Respiratory System Agents|respiratory system agents|mesh-ancestor
5552590|NCT04077892|Glucocorticoids|glucocorticoids|mesh-ancestor
5552591|NCT04077892|Hormones|hormones|mesh-ancestor
5552592|NCT04077892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5552593|NCT04077892|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5552594|NCT04077892|Hormone Antagonists|hormone antagonists|mesh-ancestor
5552595|NCT04077892|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5552596|NCT04077892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5552597|NCT04077892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5552598|NCT04077866|Temozolomide|temozolomide|mesh-list
5552599|NCT04077866|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6150986|NCT01412879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6150987|NCT01412879|Immunologic Factors|immunologic factors|mesh-ancestor
6150988|NCT01412879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6150989|NCT01412879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6150990|NCT01412879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6150991|NCT01412879|Alkylating Agents|alkylating agents|mesh-ancestor
6150992|NCT01412879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6150993|NCT01412879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6150994|NCT01412879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6150995|NCT01412879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6150996|NCT01412879|Antiemetics|antiemetics|mesh-ancestor
6667740|NCT01528852|Dermatologic Agents|dermatologic agents|mesh-ancestor
6667741|NCT01528865|Tenofovir|tenofovir|mesh-list
6667742|NCT01528865|Lamivudine|lamivudine|mesh-list
6667743|NCT01528865|Antiviral Agents|antiviral agents|mesh-ancestor
6667744|NCT01528865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6667745|NCT01528865|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6667746|NCT01528865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6667747|NCT01528865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6667748|NCT01528865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667749|NCT01528865|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6667750|NCT01528865|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5552600|NCT04077866|Alkylating Agents|alkylating agents|mesh-ancestor
5552601|NCT04077866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5552602|NCT04077866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5552603|NCT04077983|Gemcitabine|gemcitabine|mesh-list
5552604|NCT04077983|Paclitaxel|paclitaxel|mesh-list
5552605|NCT04077983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5552606|NCT04077983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5552607|NCT04077983|Tubulin Modulators|tubulin modulators|mesh-ancestor
5552608|NCT04077983|Antimitotic Agents|antimitotic agents|mesh-ancestor
5552609|NCT04077983|Mitosis Modulators|mitosis modulators|mesh-ancestor
5552610|NCT04077983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5552611|NCT04077983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5552612|NCT04077983|Antimetabolites|antimetabolites|mesh-ancestor
5552613|NCT04077983|Antiviral Agents|antiviral agents|mesh-ancestor
5552614|NCT04077983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5552615|NCT04077983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5552616|NCT04077983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5552617|NCT04077983|Immunologic Factors|immunologic factors|mesh-ancestor
5552618|NCT04077983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552619|NCT04077905|Methylprednisolone|methylprednisolone|mesh-list
5552620|NCT04077905|Doxorubicin|doxorubicin|mesh-list
5552621|NCT04077905|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5552622|NCT04077905|Etoposide|etoposide|mesh-list
5552623|NCT04077905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5552624|NCT04077905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5552625|NCT04077905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5552626|NCT04077905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5552627|NCT04077905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5552628|NCT04077905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667751|NCT01528930|Amikacin|amikacin|mesh-list
6150997|NCT01412879|Autonomic Agents|autonomic agents|mesh-ancestor
6150998|NCT01412879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6150999|NCT01412879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6151000|NCT01412879|Glucocorticoids|glucocorticoids|mesh-ancestor
6151001|NCT01412879|Hormones|hormones|mesh-ancestor
6205722|NCT02091882|Dopamine Agents|dopamine agents|mesh-ancestor
6667752|NCT01528930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5552629|NCT04077905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5552630|NCT04077905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5552631|NCT04077905|Antiemetics|antiemetics|mesh-ancestor
5552632|NCT04077905|Autonomic Agents|autonomic agents|mesh-ancestor
5552633|NCT04077905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6151002|NCT01412879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6151003|NCT01412879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6151004|NCT01412879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6151005|NCT01412879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6151006|NCT01412879|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6151007|NCT01412879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6151008|NCT01412879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6151009|NCT01412879|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6151010|NCT01412879|Abortifacient Agents|abortifacient agents|mesh-ancestor
6151011|NCT01412879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6151012|NCT01412879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6151013|NCT01412879|Antimetabolites|antimetabolites|mesh-ancestor
6151014|NCT01412879|Dermatologic Agents|dermatologic agents|mesh-ancestor
6151015|NCT01412879|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6151016|NCT01412879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6151017|NCT01412879|Antiviral Agents|antiviral agents|mesh-ancestor
6151018|NCT01412879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6151019|NCT01412879|Antidotes|antidotes|mesh-ancestor
6151020|NCT01412879|Protective Agents|protective agents|mesh-ancestor
6151021|NCT01412879|Vitamin B Complex|vitamin b complex|mesh-ancestor
6151022|NCT01412879|Vitamins|vitamins|mesh-ancestor
5552634|NCT04077905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552635|NCT04077905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5552636|NCT04077905|Glucocorticoids|glucocorticoids|mesh-ancestor
5552637|NCT04077905|Hormones|hormones|mesh-ancestor
5552638|NCT04077905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5552639|NCT04077905|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5552640|NCT04077905|Protective Agents|protective agents|mesh-ancestor
5552641|NCT04077736|Aldesleukin|aldesleukin|mesh-list
5552642|NCT04077736|Interleukin-2|interleukin-2|mesh-list
5552643|NCT04077736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5552644|NCT04077736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5552645|NCT04077736|Analgesics|analgesics|mesh-ancestor
5552646|NCT04077736|Sensory System Agents|sensory system agents|mesh-ancestor
5552647|NCT04077736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5552648|NCT04077736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552649|NCT04077736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5552650|NCT04077736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5552651|NCT04077736|Antiviral Agents|antiviral agents|mesh-ancestor
5552652|NCT04077736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5552653|NCT04077944|Trace Elements|trace elements|mesh-list
5552654|NCT04077944|Micronutrients|micronutrients|mesh-list
5552655|NCT04077944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552656|NCT04077333|Pulmonary Surfactants|pulmonary surfactants|mesh-list
5552657|NCT04077333|Respiratory System Agents|respiratory system agents|mesh-ancestor
5552658|NCT04077346|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
5552659|NCT04077346|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5552660|NCT04077346|Immunologic Factors|immunologic factors|mesh-ancestor
5552661|NCT04077346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552662|NCT04077515|Sirolimus|sirolimus|mesh-list
5552663|NCT04077515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5552664|NCT04077515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5552665|NCT04077515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5552666|NCT04077515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5552667|NCT04077515|Antifungal Agents|antifungal agents|mesh-ancestor
5552668|NCT04077515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5552669|NCT04077515|Immunologic Factors|immunologic factors|mesh-ancestor
5552670|NCT04077515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552671|NCT04077580|Methenamine|methenamine|mesh-list
5552672|NCT04077580|Methenamine hippurate|methenamine hippurate|mesh-list
5552673|NCT04077580|Methenamine mandelate|methenamine mandelate|mesh-list
5552674|NCT04077580|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6151023|NCT01412879|Micronutrients|micronutrients|mesh-ancestor
6151024|NCT01412879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6151025|NCT01412879|Tubulin Modulators|tubulin modulators|mesh-ancestor
6151026|NCT01412879|Antimitotic Agents|antimitotic agents|mesh-ancestor
6151027|NCT01412879|Mitosis Modulators|mitosis modulators|mesh-ancestor
6151028|NCT01412944|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6477080|NCT00526643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552675|NCT04077580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5552676|NCT04077580|Renal Agents|renal agents|mesh-ancestor
5552677|NCT04077580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5552678|NCT04077684|Interleukin-2|interleukin-2|mesh-list
5552679|NCT04077684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5552680|NCT04077684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6151029|NCT01412944|Immunologic Factors|immunologic factors|mesh-ancestor
6151030|NCT01412944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151031|NCT01412957|Panitumumab|panitumumab|mesh-list
6151032|NCT01412957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6151033|NCT01412957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6151034|NCT01413178|Melphalan|melphalan|mesh-list
6151035|NCT01413178|Busulfan|busulfan|mesh-list
6151036|NCT01413178|Immunologic Factors|immunologic factors|mesh-ancestor
6151037|NCT01413178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151038|NCT01413178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6151039|NCT01413178|Alkylating Agents|alkylating agents|mesh-ancestor
6151040|NCT01413178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6151041|NCT01413178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6151042|NCT01413178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6151043|NCT01413178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6151044|NCT01413191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6151045|NCT01413191|Immunologic Factors|immunologic factors|mesh-ancestor
6151046|NCT01413191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151047|NCT01413360|Vitamins|vitamins|mesh-list
6151048|NCT01413360|Ascorbic Acid|ascorbic acid|mesh-list
6151049|NCT01413360|Micronutrients|micronutrients|mesh-ancestor
6151050|NCT01413360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151051|NCT01413360|Antioxidants|antioxidants|mesh-ancestor
6151052|NCT01413360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477081|NCT00526695|Sevoflurane|sevoflurane|mesh-list
6477082|NCT00526695|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6477083|NCT00526695|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5552681|NCT04077684|Analgesics|analgesics|mesh-ancestor
5552682|NCT04077684|Sensory System Agents|sensory system agents|mesh-ancestor
5552683|NCT04077684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5552684|NCT04077684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552685|NCT04077398|Ropivacaine|ropivacaine|mesh-list
5552686|NCT04077398|Anesthetics, Local|anesthetics, local|mesh-ancestor
6151053|NCT01413360|Protective Agents|protective agents|mesh-ancestor
6151054|NCT01413503|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
6151055|NCT01413503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6151056|NCT01413503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6151057|NCT01413503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6151058|NCT01413503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6151059|NCT01413516|Varenicline|varenicline|mesh-list
6151060|NCT01413516|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6151061|NCT01413516|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6151062|NCT01413516|Cholinergic Agents|cholinergic agents|mesh-ancestor
6151063|NCT01413516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6151064|NCT01413516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6151065|NCT01413516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151066|NCT01413542|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6151067|NCT01413542|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
5552687|NCT04077398|Anesthetics|anesthetics|mesh-ancestor
5552688|NCT04077398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5552689|NCT04077398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552690|NCT04077398|Sensory System Agents|sensory system agents|mesh-ancestor
5552691|NCT04077398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5552692|NCT04076930|Enzyme Inhibitors|enzyme inhibitors|mesh-list
5552693|NCT04076930|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6151068|NCT01413542|Enalaprilat|enalaprilat|mesh-list
6151069|NCT01413542|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6151070|NCT01413542|Bradykinin|bradykinin|mesh-list
6151071|NCT01413542|Glucagon|glucagon|mesh-list
6151072|NCT01413542|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6151073|NCT01413542|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6151074|NCT01413542|Substance P|substance p|mesh-list
6151075|NCT01413542|Neurokinin A|neurokinin a|mesh-list
6151076|NCT01413542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6151077|NCT01413542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151078|NCT01413542|Incretins|incretins|mesh-ancestor
5552694|NCT04076930|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
5552695|NCT04076930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5552696|NCT04076930|Protease Inhibitors|protease inhibitors|mesh-ancestor
6151079|NCT01413542|Hormones|hormones|mesh-ancestor
6205723|NCT02091882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6477084|NCT00526695|Anesthetics, General|anesthetics, general|mesh-ancestor
6151080|NCT01413542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6151081|NCT01413542|Protease Inhibitors|protease inhibitors|mesh-ancestor
6151082|NCT01413542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6151083|NCT01413542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6151084|NCT01413542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6151085|NCT01413542|Natriuretic Agents|natriuretic agents|mesh-ancestor
6477085|NCT00526695|Anesthetics|anesthetics|mesh-ancestor
6477086|NCT00526695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6477087|NCT00526695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477088|NCT00526734|Melphalan|melphalan|mesh-list
6477089|NCT00526734|Immunologic Factors|immunologic factors|mesh-ancestor
6477090|NCT00526734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552697|NCT04077190|Cortisone|cortisone|mesh-list
6151086|NCT01413542|Vasodilator Agents|vasodilator agents|mesh-ancestor
6151087|NCT01413542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6151088|NCT01413542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6151089|NCT01413750|Paclitaxel|paclitaxel|mesh-list
6151090|NCT01413750|Carboplatin|carboplatin|mesh-list
6151091|NCT01413750|Vorinostat|vorinostat|mesh-list
6151092|NCT01413750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6151093|NCT01413750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6151094|NCT01413750|Tubulin Modulators|tubulin modulators|mesh-ancestor
6151095|NCT01413750|Antimitotic Agents|antimitotic agents|mesh-ancestor
6151096|NCT01413750|Mitosis Modulators|mitosis modulators|mesh-ancestor
6151097|NCT01413750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6151098|NCT01413750|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6151099|NCT01413750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6151100|NCT01413958|Loratadine|loratadine|mesh-list
6151101|NCT01413958|Phenylephrine|phenylephrine|mesh-list
6151102|NCT01413958|Oxymetazoline|oxymetazoline|mesh-list
6151103|NCT01413958|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6151104|NCT01413958|Mydriatics|mydriatics|mesh-ancestor
6151105|NCT01413958|Autonomic Agents|autonomic agents|mesh-ancestor
6151106|NCT01413958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6151107|NCT01413958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151108|NCT01413958|Sympathomimetics|sympathomimetics|mesh-ancestor
6151109|NCT01413958|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5552698|NCT04077190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5552699|NCT04076865|Lidocaine|lidocaine|mesh-list
5552700|NCT04076865|Histamine|histamine|mesh-list
5552701|NCT04076865|Anesthetics, Local|anesthetics, local|mesh-ancestor
5552702|NCT04076865|Anesthetics|anesthetics|mesh-ancestor
5552703|NCT04076865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6151110|NCT01413958|Nasal Decongestants|nasal decongestants|mesh-ancestor
6151111|NCT01413958|Respiratory System Agents|respiratory system agents|mesh-ancestor
6151112|NCT01413958|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6151113|NCT01413958|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6151114|NCT01413958|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6151115|NCT01413958|Adrenergic Agents|adrenergic agents|mesh-ancestor
6151116|NCT01413958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6151117|NCT01413958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6151118|NCT01413958|Protective Agents|protective agents|mesh-ancestor
6151119|NCT01413958|Antipruritics|antipruritics|mesh-ancestor
6151120|NCT01413958|Dermatologic Agents|dermatologic agents|mesh-ancestor
6151121|NCT01413958|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6151122|NCT01413958|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6151123|NCT01413958|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6151124|NCT01413958|Histamine Antagonists|histamine antagonists|mesh-ancestor
6151125|NCT01413958|Histamine Agents|histamine agents|mesh-ancestor
6151126|NCT01414010|Amoxicillin|amoxicillin|mesh-list
6151127|NCT01414010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6151128|NCT01414010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6151129|NCT01414075|Iron|iron|mesh-list
6151130|NCT01414075|Trace Elements|trace elements|mesh-ancestor
6151131|NCT01414075|Micronutrients|micronutrients|mesh-ancestor
6151132|NCT01414075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151133|NCT01414153|Bevacizumab|bevacizumab|mesh-list
6151134|NCT01414153|Ranibizumab|ranibizumab|mesh-list
6151135|NCT01414153|Aflibercept|aflibercept|mesh-list
6151136|NCT01414153|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6151137|NCT01414153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6151138|NCT01414153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6151139|NCT01414153|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6151140|NCT01414153|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6667753|NCT01528930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5552704|NCT04076865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151141|NCT01414153|Growth Substances|growth substances|mesh-ancestor
6667754|NCT01528943|Epoprostenol|epoprostenol|mesh-list
6151142|NCT01414153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151143|NCT01414153|Growth Inhibitors|growth inhibitors|mesh-ancestor
6151144|NCT01414153|Immunologic Factors|immunologic factors|mesh-ancestor
6205724|NCT02091882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205725|NCT02091882|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6205726|NCT02091882|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6205727|NCT02091882|Serotonin Agents|serotonin agents|mesh-ancestor
6205728|NCT02091882|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6205729|NCT02091882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6205730|NCT02091882|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6205731|NCT02091882|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6205732|NCT02091921|Ticagrelor|ticagrelor|mesh-list
6205733|NCT02091921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6205734|NCT02091921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6205735|NCT02091921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6205736|NCT02091921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6205737|NCT02091921|Purinergic Agents|purinergic agents|mesh-ancestor
6205738|NCT02091921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6205739|NCT02091921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205740|NCT02091921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205741|NCT02091986|Budesonide|budesonide|mesh-list
6477091|NCT00526734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6477092|NCT00526734|Alkylating Agents|alkylating agents|mesh-ancestor
6477093|NCT00526734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477094|NCT00526734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6477095|NCT00526734|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6477096|NCT00526734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6477097|NCT00526760|Dexmedetomidine|dexmedetomidine|mesh-list
6667755|NCT01528943|Tezosentan|tezosentan|mesh-list
6667756|NCT01528943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6205742|NCT02091986|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6205743|NCT02091986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6205744|NCT02091986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6205745|NCT02091986|Autonomic Agents|autonomic agents|mesh-ancestor
6205746|NCT02091986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6205747|NCT02091986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205748|NCT02091986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6205749|NCT02091986|Respiratory System Agents|respiratory system agents|mesh-ancestor
6205750|NCT02091986|Glucocorticoids|glucocorticoids|mesh-ancestor
6205751|NCT02091986|Hormones|hormones|mesh-ancestor
6477098|NCT00526760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6477099|NCT00526760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6477100|NCT00526760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477101|NCT00526760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6477102|NCT00526760|Analgesics|analgesics|mesh-ancestor
6477103|NCT00526760|Sensory System Agents|sensory system agents|mesh-ancestor
6477104|NCT00526760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6667757|NCT01528943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6205752|NCT02091986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6205753|NCT02092025|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
6205754|NCT02092025|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6205755|NCT02092025|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6205756|NCT02092025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205757|NCT02092116|Romidepsin|romidepsin|mesh-list
6205758|NCT02092116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6205759|NCT02092116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6205760|NCT02092168|Opicapone|opicapone|mesh-list
6205761|NCT02092168|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6205762|NCT02092168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6205763|NCT02092168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205764|NCT02092168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6205765|NCT02092168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6205766|NCT02092181|Mirabegron|mirabegron|mesh-list
6205767|NCT02092181|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6205768|NCT02092181|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6205769|NCT02092181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6205770|NCT02092181|Adrenergic Agents|adrenergic agents|mesh-ancestor
6205771|NCT02092181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6205772|NCT02092181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205773|NCT02092181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205774|NCT02092181|Urological Agents|urological agents|mesh-ancestor
6151145|NCT01414205|Obinutuzumab|obinutuzumab|mesh-list
6151146|NCT01414205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6151147|NCT01414205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6151148|NCT01414257|Methotrexate|methotrexate|mesh-list
5725585|NCT03179904|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5725586|NCT03179813|Hydrocortisone|hydrocortisone|mesh-list
5725587|NCT03179813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5725715|NCT03178591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725716|NCT03178591|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5725717|NCT03178591|Protease Inhibitors|protease inhibitors|mesh-ancestor
6151149|NCT01414257|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6151150|NCT01414257|Abortifacient Agents|abortifacient agents|mesh-ancestor
6151151|NCT01414257|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6151152|NCT01414257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151153|NCT01414257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6151154|NCT01414257|Antimetabolites|antimetabolites|mesh-ancestor
6477105|NCT00526760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6477106|NCT00526760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6477107|NCT00526760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6477108|NCT00526760|Adrenergic Agents|adrenergic agents|mesh-ancestor
6477109|NCT00526760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6477110|NCT00526760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477111|NCT00526877|Risperidone|risperidone|mesh-list
6477112|NCT00526877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6151155|NCT01414257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5552705|NCT04076865|Sensory System Agents|sensory system agents|mesh-ancestor
5552706|NCT04076865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5552707|NCT04076865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5552708|NCT04076865|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5552709|NCT04076865|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5552710|NCT04076865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5552711|NCT04076865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5552712|NCT04076865|Histamine Agonists|histamine agonists|mesh-ancestor
5552713|NCT04076865|Histamine Agents|histamine agents|mesh-ancestor
6477113|NCT00526877|Serotonin Agents|serotonin agents|mesh-ancestor
6477114|NCT00526877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6477115|NCT00526877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477116|NCT00526877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552714|NCT04076865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5552715|NCT04077255|Paclitaxel|paclitaxel|mesh-list
5552716|NCT04077255|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5552717|NCT04077255|Antibodies|antibodies|mesh-list
5552718|NCT04077255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5552719|NCT04077255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5552720|NCT04077255|Tubulin Modulators|tubulin modulators|mesh-ancestor
5552721|NCT04077255|Antimitotic Agents|antimitotic agents|mesh-ancestor
6151156|NCT01414257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6151157|NCT01414257|Dermatologic Agents|dermatologic agents|mesh-ancestor
6151158|NCT01414257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6151159|NCT01414257|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5552722|NCT04077255|Mitosis Modulators|mitosis modulators|mesh-ancestor
5552723|NCT04077255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5552724|NCT04077255|Immunologic Factors|immunologic factors|mesh-ancestor
5552725|NCT04077255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552726|NCT04077125|Rifaximin|rifaximin|mesh-list
5552727|NCT04077125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5552728|NCT04077125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5552729|NCT04077125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5552730|NCT04076436|Fosfomycin|fosfomycin|mesh-list
5552731|NCT04076436|Lactams|lactams|mesh-list
5552732|NCT04076436|beta-Lactams|beta-lactams|mesh-list
5552733|NCT04076436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5552734|NCT04076436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6151160|NCT01414257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6151161|NCT01414257|Immunologic Factors|immunologic factors|mesh-ancestor
6151162|NCT01414257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6151163|NCT01414257|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6151164|NCT01414855|Prednisone|prednisone|mesh-list
6151165|NCT01414855|Cyclophosphamide|cyclophosphamide|mesh-list
6151166|NCT01414855|Doxorubicin|doxorubicin|mesh-list
6151167|NCT01414855|Vincristine|vincristine|mesh-list
6151168|NCT01414855|Obinutuzumab|obinutuzumab|mesh-list
6151169|NCT01414855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6151170|NCT01414855|Immunologic Factors|immunologic factors|mesh-ancestor
6151171|NCT01414855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151172|NCT01414855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6151173|NCT01414855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6151174|NCT01414855|Alkylating Agents|alkylating agents|mesh-ancestor
6151175|NCT01414855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6151176|NCT01414855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5552735|NCT04076709|Anesthetics|anesthetics|mesh-list
5552736|NCT04076709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5552737|NCT04076709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552738|NCT04076826|Midazolam|midazolam|mesh-list
5552739|NCT04076826|Dexmedetomidine|dexmedetomidine|mesh-list
5552740|NCT04076826|Propofol|propofol|mesh-list
6151177|NCT01414855|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6151178|NCT01414855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6151179|NCT01414855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6151180|NCT01414855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6151181|NCT01414855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6151182|NCT01414855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6151183|NCT01414855|Glucocorticoids|glucocorticoids|mesh-ancestor
6151184|NCT01414855|Hormones|hormones|mesh-ancestor
6151185|NCT01414855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6151186|NCT01414855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6151187|NCT01414855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6151188|NCT01414855|Tubulin Modulators|tubulin modulators|mesh-ancestor
6151189|NCT01414855|Antimitotic Agents|antimitotic agents|mesh-ancestor
6151190|NCT01414855|Mitosis Modulators|mitosis modulators|mesh-ancestor
6151191|NCT01414855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6151192|NCT01415349|Omeprazole|omeprazole|mesh-list
6151193|NCT01415349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6151194|NCT01415349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6151195|NCT01415349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6151196|NCT01415349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6151197|NCT01415349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6151198|NCT01415401|Timolol|timolol|mesh-list
6151199|NCT01415401|Brinzolamide|brinzolamide|mesh-list
6151200|NCT01415401|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6151201|NCT01415401|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6151202|NCT01415401|Adrenergic Agents|adrenergic agents|mesh-ancestor
6477117|NCT00526877|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6477118|NCT00526877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6477119|NCT00526877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6667758|NCT01528943|Vasodilator Agents|vasodilator agents|mesh-ancestor
6667759|NCT01529073|Nitazoxanide|nitazoxanide|mesh-list
6667760|NCT01529073|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6667761|NCT01529073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6667762|NCT01529125|Lamivudine|lamivudine|mesh-list
6477120|NCT00526877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6477121|NCT00526877|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6477122|NCT00526877|Dopamine Agents|dopamine agents|mesh-ancestor
6477123|NCT00526929|Darbepoetin alfa|darbepoetin alfa|mesh-list
6477124|NCT00526929|Hematinics|hematinics|mesh-ancestor
6477125|NCT00527020|Nicotine|nicotine|mesh-list
6477126|NCT00527020|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6477127|NCT00527020|Autonomic Agents|autonomic agents|mesh-ancestor
6477128|NCT00527020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6477129|NCT00527020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477130|NCT00527020|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6477131|NCT00527020|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6667763|NCT01529125|Zidovudine|zidovudine|mesh-list
6151203|NCT01415401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6151204|NCT01415401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6151205|NCT01415401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151206|NCT01415401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6477132|NCT00527020|Cholinergic Agents|cholinergic agents|mesh-ancestor
6667764|NCT01529125|Nevirapine|nevirapine|mesh-list
5552741|NCT04076826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6667765|NCT01529125|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6151207|NCT01415401|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6151208|NCT01415401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6151209|NCT01415401|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6151210|NCT01415440|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6151211|NCT01415440|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6151212|NCT01415440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151213|NCT01415440|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6151214|NCT01415440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6151215|NCT01415440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6151216|NCT01415440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6151217|NCT01415440|Dopamine Agents|dopamine agents|mesh-ancestor
6151218|NCT01415440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6151219|NCT01415518|Budesonide|budesonide|mesh-list
6151220|NCT01415518|Theophylline|theophylline|mesh-list
6151221|NCT01415518|Formoterol Fumarate|formoterol fumarate|mesh-list
6151222|NCT01415518|Ipratropium|ipratropium|mesh-list
6151223|NCT01415518|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6151224|NCT01415518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6151225|NCT01415518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6151226|NCT01415518|Autonomic Agents|autonomic agents|mesh-ancestor
6151227|NCT01415518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6151228|NCT01415518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151229|NCT01415518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6151230|NCT01415518|Respiratory System Agents|respiratory system agents|mesh-ancestor
6667766|NCT01529125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6667767|NCT01529125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6667768|NCT01529125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5552742|NCT04076826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5552743|NCT04076826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552744|NCT04076826|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5552745|NCT04076826|Anesthetics, General|anesthetics, general|mesh-ancestor
6667769|NCT01529125|Antiviral Agents|antiviral agents|mesh-ancestor
6667770|NCT01529125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6667771|NCT01529125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6667772|NCT01529125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6667773|NCT01529125|Antimetabolites|antimetabolites|mesh-ancestor
6667774|NCT01529125|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6667775|NCT01529125|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6667776|NCT01529138|Sirolimus|sirolimus|mesh-list
6667777|NCT01529138|Axitinib|axitinib|mesh-list
5552746|NCT04076826|Anesthetics|anesthetics|mesh-ancestor
6151231|NCT01415518|Glucocorticoids|glucocorticoids|mesh-ancestor
6151232|NCT01415518|Hormones|hormones|mesh-ancestor
6151233|NCT01415518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6151234|NCT01415518|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5552747|NCT04076826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5552748|NCT04076826|Analgesics|analgesics|mesh-ancestor
5552749|NCT04076826|Sensory System Agents|sensory system agents|mesh-ancestor
5552750|NCT04076826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5552751|NCT04076826|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5552752|NCT04076826|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5552753|NCT04076826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5552754|NCT04076826|Adrenergic Agents|adrenergic agents|mesh-ancestor
5552755|NCT04076826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5552756|NCT04076826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5552757|NCT04076826|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5552758|NCT04076826|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5552759|NCT04076826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6151235|NCT01415518|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6151236|NCT01415518|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6151237|NCT01415518|Adrenergic Agents|adrenergic agents|mesh-ancestor
6151238|NCT01415518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6151239|NCT01415518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5552760|NCT04076826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5552761|NCT04076826|GABA Modulators|gaba modulators|mesh-ancestor
5552762|NCT04076826|GABA Agents|gaba agents|mesh-ancestor
5552763|NCT04076527|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
5552764|NCT04076527|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5552765|NCT04076527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6151240|NCT01415518|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6151241|NCT01415518|Cholinergic Agents|cholinergic agents|mesh-ancestor
6151242|NCT01415518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6667778|NCT01529138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5552766|NCT04076371|Olanzapine|olanzapine|mesh-list
6151243|NCT01415518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6151244|NCT01415518|Vasodilator Agents|vasodilator agents|mesh-ancestor
6151245|NCT01415518|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6151246|NCT01415518|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6151247|NCT01415518|Purinergic Agents|purinergic agents|mesh-ancestor
6151248|NCT01415531|Nebivolol|nebivolol|mesh-list
5552767|NCT04076371|Risperidone|risperidone|mesh-list
5552768|NCT04076371|Paliperidone Palmitate|paliperidone palmitate|mesh-list
5552769|NCT04076371|Ziprasidone|ziprasidone|mesh-list
5552770|NCT04076371|Sertraline|sertraline|mesh-list
5552771|NCT04076371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5552772|NCT04076371|Serotonin Agents|serotonin agents|mesh-ancestor
5552773|NCT04076371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5552774|NCT04076371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5552775|NCT04076371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552776|NCT04076371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5552777|NCT04076371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5552778|NCT04076371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6151249|NCT01415531|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6151250|NCT01415531|Vasodilator Agents|vasodilator agents|mesh-ancestor
6151251|NCT01415531|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6151252|NCT01415531|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6151253|NCT01415531|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6151254|NCT01415531|Adrenergic Agents|adrenergic agents|mesh-ancestor
6151255|NCT01415531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6151256|NCT01415531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6151257|NCT01415531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151258|NCT01415583|Dexamethasone|dexamethasone|mesh-list
6151259|NCT01415583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6151260|NCT01415583|Antiemetics|antiemetics|mesh-ancestor
6151261|NCT01415583|Autonomic Agents|autonomic agents|mesh-ancestor
6151262|NCT01415583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6151263|NCT01415583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151264|NCT01415583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6151265|NCT01415583|Glucocorticoids|glucocorticoids|mesh-ancestor
6151266|NCT01415583|Hormones|hormones|mesh-ancestor
6151267|NCT01415583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6151268|NCT01415583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6151269|NCT01415583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6151270|NCT01415921|Bromides|bromides|mesh-list
6151271|NCT01415921|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
6151272|NCT01415921|Anticonvulsants|anticonvulsants|mesh-ancestor
6151273|NCT01415921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6151274|NCT01415921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6151275|NCT01415921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6151276|NCT01415921|Cholinergic Agents|cholinergic agents|mesh-ancestor
6151277|NCT01415921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6151278|NCT01415921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151279|NCT01415960|Leuprolide|leuprolide|mesh-list
6151280|NCT01415960|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6151281|NCT01415960|Fertility Agents|fertility agents|mesh-ancestor
6151282|NCT01415960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6151283|NCT01415960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151284|NCT01415960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6151285|NCT01415960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5552779|NCT04076371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5552780|NCT04076371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5552781|NCT04076371|Dopamine Agents|dopamine agents|mesh-ancestor
5552782|NCT04076371|Antiemetics|antiemetics|mesh-ancestor
5552783|NCT04076371|Autonomic Agents|autonomic agents|mesh-ancestor
5552784|NCT04076371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5552785|NCT04076371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5552786|NCT04076371|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5552787|NCT04076371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5552788|NCT04076371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5552789|NCT04076371|Antidepressive Agents|antidepressive agents|mesh-ancestor
5552790|NCT04076371|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6151286|NCT01416155|Natalizumab|natalizumab|mesh-list
6151287|NCT01416155|Immunologic Factors|immunologic factors|mesh-ancestor
6151288|NCT01416155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151289|NCT01416181|Natalizumab|natalizumab|mesh-list
6151290|NCT01416181|Immunologic Factors|immunologic factors|mesh-ancestor
6151291|NCT01416181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151292|NCT01416194|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
6151293|NCT01416194|Bazedoxifene|bazedoxifene|mesh-list
6672449|NCT01556191|Hormone Antagonists|hormone antagonists|mesh-ancestor
6151294|NCT01416194|Diphosphonates|diphosphonates|mesh-list
6477133|NCT00527020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6477134|NCT00527020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477135|NCT00527033|Mirabegron|mirabegron|mesh-list
6477136|NCT00527033|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6477137|NCT00527033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6477138|NCT00527033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6151295|NCT01416194|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6151296|NCT01416194|Hormone Antagonists|hormone antagonists|mesh-ancestor
6151297|NCT01416194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6151298|NCT01416194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151299|NCT01416194|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6151300|NCT01416194|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6151301|NCT01416194|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6151302|NCT01416389|Lenograstim|lenograstim|mesh-list
6151303|NCT01416389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6151304|NCT01416389|Immunologic Factors|immunologic factors|mesh-ancestor
5552791|NCT04076371|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5552792|NCT04076098|Minocycline|minocycline|mesh-list
5552793|NCT04076098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5552794|NCT04076098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5552795|NCT04076137|Decitabine|decitabine|mesh-list
5552796|NCT04076137|Antibodies|antibodies|mesh-list
5552797|NCT04076137|Antibodies, Bispecific|antibodies, bispecific|mesh-list
5552798|NCT04076137|Immunologic Factors|immunologic factors|mesh-ancestor
5552799|NCT04076137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151305|NCT01416389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151306|NCT01416441|Aripiprazole|aripiprazole|mesh-list
6151307|NCT01416441|Antidepressive Agents|antidepressive agents|mesh-ancestor
6151308|NCT01416441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6151309|NCT01416441|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6477139|NCT00527033|Adrenergic Agents|adrenergic agents|mesh-ancestor
6477140|NCT00527033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6477141|NCT00527033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5552800|NCT04076137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5552801|NCT04076137|Antimetabolites|antimetabolites|mesh-ancestor
5552802|NCT04076137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5552803|NCT04076137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5552804|NCT04076137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5552805|NCT04076228|Pembrolizumab|pembrolizumab|mesh-list
5552806|NCT04076228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5552807|NCT04076228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5552808|NCT04075955|Olanzapine|olanzapine|mesh-list
5552809|NCT04075955|Aprepitant|aprepitant|mesh-list
5552810|NCT04075955|Antiemetics|antiemetics|mesh-ancestor
5552811|NCT04075955|Autonomic Agents|autonomic agents|mesh-ancestor
5552812|NCT04075955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6477142|NCT00527033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477143|NCT00527033|Urological Agents|urological agents|mesh-ancestor
6477144|NCT00527059|Simendan|simendan|mesh-list
6477145|NCT00527059|Spironolactone|spironolactone|mesh-list
6477146|NCT00527059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
6477147|NCT00527059|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6477148|NCT00527059|Hormone Antagonists|hormone antagonists|mesh-ancestor
6477149|NCT00527059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6477150|NCT00527059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477151|NCT00527059|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6477152|NCT00527059|Diuretics|diuretics|mesh-ancestor
6477153|NCT00527059|Natriuretic Agents|natriuretic agents|mesh-ancestor
6477154|NCT00527059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6477155|NCT00527059|Adrenergic Agents|adrenergic agents|mesh-ancestor
6477156|NCT00527059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6477157|NCT00527059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477158|NCT00527059|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6477159|NCT00527059|Vasodilator Agents|vasodilator agents|mesh-ancestor
6477160|NCT00527059|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6477161|NCT00527059|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6477162|NCT00527059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6477163|NCT00527059|Protective Agents|protective agents|mesh-ancestor
6477164|NCT00527085|Cinacalcet|cinacalcet|mesh-list
6477165|NCT00527085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5552813|NCT04075955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552814|NCT04075955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5552815|NCT04075955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5552816|NCT04075955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5552817|NCT04075955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5552818|NCT04075955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5552819|NCT04075955|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5552820|NCT04075955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5552821|NCT04075955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5552822|NCT04075955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5552823|NCT04075955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5552824|NCT04075955|Serotonin Agents|serotonin agents|mesh-ancestor
5552825|NCT04075955|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5552826|NCT04075721|Dexamethasone|dexamethasone|mesh-list
5552827|NCT04075721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5552828|NCT04075721|Antiemetics|antiemetics|mesh-ancestor
5552829|NCT04075721|Autonomic Agents|autonomic agents|mesh-ancestor
5552830|NCT04075721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5552831|NCT04075721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552832|NCT04075721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5552833|NCT04075721|Glucocorticoids|glucocorticoids|mesh-ancestor
5552834|NCT04075721|Hormones|hormones|mesh-ancestor
5552835|NCT04075721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5552836|NCT04075721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5552837|NCT04075721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5552838|NCT04075760|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
5552839|NCT04075760|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5552840|NCT04075760|Adrenergic Agents|adrenergic agents|mesh-ancestor
5552841|NCT04075760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5552842|NCT04075760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5552843|NCT04075760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552844|NCT04075747|Venetoclax|venetoclax|mesh-list
5552845|NCT04075747|Midostaurin|midostaurin|mesh-list
5552846|NCT04075747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5552847|NCT04075747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5552848|NCT04075747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5552849|NCT04075747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5552850|NCT04075513|Insulin|insulin|mesh-list
5552851|NCT04075513|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5552852|NCT04075513|Insulin Glargine|insulin glargine|mesh-list
5552853|NCT04075513|Insulin, Short-Acting|insulin, short-acting|mesh-list
5552854|NCT04075513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5552855|NCT04075513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552856|NCT04075578|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5552857|NCT04075578|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5552858|NCT04075578|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5552859|NCT04075578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5552860|NCT04075578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477166|NCT00527085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477167|NCT00527085|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6477168|NCT00527085|Hormone Antagonists|hormone antagonists|mesh-ancestor
6477169|NCT00527085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6477170|NCT00527137|Darbepoetin alfa|darbepoetin alfa|mesh-list
6477171|NCT00527137|Hematinics|hematinics|mesh-ancestor
6477172|NCT00527150|Varenicline|varenicline|mesh-list
6477173|NCT00527150|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6477174|NCT00527150|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6477175|NCT00527150|Cholinergic Agents|cholinergic agents|mesh-ancestor
6477176|NCT00527150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6151310|NCT01416441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6151311|NCT01416441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6151312|NCT01416441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151313|NCT01416441|Dopamine Agonists|dopamine agonists|mesh-ancestor
6151314|NCT01416441|Dopamine Agents|dopamine agents|mesh-ancestor
6151315|NCT01416441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6151316|NCT01416441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6151317|NCT01416441|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6151318|NCT01416441|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6151319|NCT01416441|Serotonin Agents|serotonin agents|mesh-ancestor
6151320|NCT01416441|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6477177|NCT00527150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477178|NCT00527150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477179|NCT00527202|Botulinum Toxins|botulinum toxins|mesh-list
6477180|NCT00527202|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6477181|NCT00527202|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6477182|NCT00527202|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6477183|NCT00527202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6477184|NCT00527202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477185|NCT00527202|Cholinergic Agents|cholinergic agents|mesh-ancestor
6477186|NCT00527202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5552861|NCT04075578|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5552862|NCT04075578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5552863|NCT04075578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5552864|NCT04075578|Cholinergic Agents|cholinergic agents|mesh-ancestor
5552865|NCT04075578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6477187|NCT00527202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477188|NCT00527202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6477189|NCT00527202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6477190|NCT00527215|Darbepoetin alfa|darbepoetin alfa|mesh-list
6477191|NCT00527215|Hematinics|hematinics|mesh-ancestor
6477192|NCT00527228|Deflazacort|deflazacort|mesh-list
6477193|NCT00527228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6477194|NCT00527228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6477195|NCT00527228|Immunologic Factors|immunologic factors|mesh-ancestor
6477196|NCT00527228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477197|NCT00527267|Cinacalcet|cinacalcet|mesh-list
6477198|NCT00527267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6477199|NCT00527267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151321|NCT01416441|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6151322|NCT01416441|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5603035|NCT03509012|Etoposide phosphate|etoposide phosphate|mesh-list
5603036|NCT03509012|Pemetrexed|pemetrexed|mesh-list
5603037|NCT03509012|Durvalumab|durvalumab|mesh-list
5603038|NCT03509012|Tremelimumab|tremelimumab|mesh-list
5603039|NCT03509012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5603040|NCT03509012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5603041|NCT03509012|Tubulin Modulators|tubulin modulators|mesh-ancestor
5603042|NCT03509012|Antimitotic Agents|antimitotic agents|mesh-ancestor
5603043|NCT03509012|Mitosis Modulators|mitosis modulators|mesh-ancestor
5603044|NCT03509012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603045|NCT03509012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6151323|NCT01416441|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6151324|NCT01416584|Methadone|methadone|mesh-list
6151325|NCT01416584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6151326|NCT01416584|Narcotics|narcotics|mesh-ancestor
6151327|NCT01416584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6151328|NCT01416584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151329|NCT01416584|Analgesics|analgesics|mesh-ancestor
6151330|NCT01416584|Sensory System Agents|sensory system agents|mesh-ancestor
6151331|NCT01416584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6151332|NCT01416584|Antitussive Agents|antitussive agents|mesh-ancestor
6151333|NCT01416584|Respiratory System Agents|respiratory system agents|mesh-ancestor
6151334|NCT01416636|Treprostinil|treprostinil|mesh-list
6151335|NCT01416636|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6151336|NCT01417000|Cyclophosphamide|cyclophosphamide|mesh-list
6151337|NCT01417000|Pancrelipase|pancrelipase|mesh-list
6151338|NCT01417000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6151339|NCT01417000|Immunologic Factors|immunologic factors|mesh-ancestor
6151340|NCT01417000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151341|NCT01417000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6477200|NCT00527267|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6151342|NCT01417000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6151343|NCT01417000|Alkylating Agents|alkylating agents|mesh-ancestor
6151344|NCT01417000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6151345|NCT01417000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6151346|NCT01417000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6477201|NCT00527267|Hormone Antagonists|hormone antagonists|mesh-ancestor
6477202|NCT00527267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6477203|NCT00527449|Carboplatin|carboplatin|mesh-list
6151347|NCT01417000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6151348|NCT01417026|Oxytocin|oxytocin|mesh-list
6151349|NCT01417026|Oxytocics|oxytocics|mesh-ancestor
6151350|NCT01417026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6151351|NCT01417026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151352|NCT01417078|Diazepam|diazepam|mesh-list
6151353|NCT01417078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6151354|NCT01417078|Anticonvulsants|anticonvulsants|mesh-ancestor
6667779|NCT01529138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6667780|NCT01529138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6667781|NCT01529138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6151355|NCT01417078|Antiemetics|antiemetics|mesh-ancestor
6151356|NCT01417078|Autonomic Agents|autonomic agents|mesh-ancestor
6151357|NCT01417078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6151358|NCT01417078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151359|NCT01417078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6151360|NCT01417078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6151361|NCT01417078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6151362|NCT01417078|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6151363|NCT01417078|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6151364|NCT01417078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6151365|NCT01417078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6151366|NCT01417078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5552866|NCT04075474|Listerine|listerine|mesh-list
5552867|NCT04075474|Fluorides|fluorides|mesh-list
5552868|NCT04075474|Sodium Fluoride|sodium fluoride|mesh-list
5552869|NCT04075474|Cariostatic Agents|cariostatic agents|mesh-ancestor
5552870|NCT04075474|Protective Agents|protective agents|mesh-ancestor
5552871|NCT04075474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552872|NCT04075474|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5552873|NCT04075474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5552874|NCT04075227|Loteprednol Etabonate|loteprednol etabonate|mesh-list
5552875|NCT04075227|Dexamethasone|dexamethasone|mesh-list
6151367|NCT01417078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6151368|NCT01417078|Anesthetics, General|anesthetics, general|mesh-ancestor
6151369|NCT01417078|Anesthetics|anesthetics|mesh-ancestor
6151370|NCT01417078|GABA Modulators|gaba modulators|mesh-ancestor
6151371|NCT01417078|GABA Agents|gaba agents|mesh-ancestor
6151372|NCT01417078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6151373|NCT01417078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6151374|NCT01417156|Nintedanib|nintedanib|mesh-list
6151375|NCT01417156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6151376|NCT01417156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5552876|NCT04075227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5552877|NCT04075227|Antiemetics|antiemetics|mesh-ancestor
5552878|NCT04075227|Autonomic Agents|autonomic agents|mesh-ancestor
5552879|NCT04075227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5552880|NCT04075227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552881|NCT04075227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5552882|NCT04075227|Glucocorticoids|glucocorticoids|mesh-ancestor
5552883|NCT04075227|Hormones|hormones|mesh-ancestor
5552884|NCT04075227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5552885|NCT04075227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5552886|NCT04075227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5552887|NCT04075227|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6151377|NCT01417156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6151378|NCT01417156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6151379|NCT01417195|Menotropins|menotropins|mesh-list
6151380|NCT01417195|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6151381|NCT01417195|Hormones|hormones|mesh-ancestor
6477204|NCT00527449|Docetaxel|docetaxel|mesh-list
6477205|NCT00527449|Epirubicin|epirubicin|mesh-list
6477206|NCT00527449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6477207|NCT00527449|Tubulin Modulators|tubulin modulators|mesh-ancestor
6477208|NCT00527449|Antimitotic Agents|antimitotic agents|mesh-ancestor
6477209|NCT00527449|Mitosis Modulators|mitosis modulators|mesh-ancestor
6667782|NCT01529138|Antifungal Agents|antifungal agents|mesh-ancestor
6151382|NCT01417195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6205775|NCT02092220|Pancrelipase|pancrelipase|mesh-list
6151383|NCT01417195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151384|NCT01417195|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6151385|NCT01417195|Fertility Agents|fertility agents|mesh-ancestor
6151386|NCT01417195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6151387|NCT01417481|Glycine|glycine|mesh-list
6151388|NCT01417481|Glycine Agents|glycine agents|mesh-ancestor
6477210|NCT00527449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477211|NCT00527449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6477212|NCT00527449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6477213|NCT00527449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6477214|NCT00527449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6477215|NCT00527501|Travoprost|travoprost|mesh-list
6477216|NCT00527501|Brinzolamide|brinzolamide|mesh-list
6477217|NCT00527501|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6477218|NCT00527501|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6477219|NCT00527501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6477220|NCT00527501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477221|NCT00527540|Interferons|interferons|mesh-list
6477222|NCT00527540|Ribavirin|ribavirin|mesh-list
6477223|NCT00527540|Interferon-alpha|interferon-alpha|mesh-list
6477224|NCT00527540|Interferon alpha-2|interferon alpha-2|mesh-list
6477225|NCT00527540|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6477226|NCT00527540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6477227|NCT00527540|Antiviral Agents|antiviral agents|mesh-ancestor
6477228|NCT00527540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6477229|NCT00527540|Antimetabolites|antimetabolites|mesh-ancestor
6477230|NCT00527540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477231|NCT00527540|Immunologic Factors|immunologic factors|mesh-ancestor
6477232|NCT00527540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477233|NCT00527657|Thalidomide|thalidomide|mesh-list
6477234|NCT00527657|Temozolomide|temozolomide|mesh-list
6477235|NCT00527657|Lomustine|lomustine|mesh-list
6477236|NCT00527657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6477237|NCT00527657|Alkylating Agents|alkylating agents|mesh-ancestor
6477238|NCT00527657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477239|NCT00527657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6477240|NCT00527657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6477241|NCT00527657|Immunologic Factors|immunologic factors|mesh-ancestor
6477242|NCT00527657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477243|NCT00527657|Leprostatic Agents|leprostatic agents|mesh-ancestor
6477244|NCT00527657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6477245|NCT00527657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6477246|NCT00527657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6477247|NCT00527657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6477248|NCT00527657|Growth Substances|growth substances|mesh-ancestor
6477249|NCT00527657|Growth Inhibitors|growth inhibitors|mesh-ancestor
6477250|NCT00527683|Vigabatrin|vigabatrin|mesh-list
6477251|NCT00527683|Anticonvulsants|anticonvulsants|mesh-ancestor
6151389|NCT01417481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6151390|NCT01417481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6151391|NCT01417481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151392|NCT01418001|Gemcitabine|gemcitabine|mesh-list
6667783|NCT01529138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6667784|NCT01529138|Immunologic Factors|immunologic factors|mesh-ancestor
6667785|NCT01529138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667786|NCT01529138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6667787|NCT01529138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6667788|NCT01529138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667789|NCT01529164|Leucovorin|leucovorin|mesh-list
6667790|NCT01529164|Fluorouracil|fluorouracil|mesh-list
6667791|NCT01529164|Oxaliplatin|oxaliplatin|mesh-list
6667792|NCT01529164|Endostar protein|endostar protein|mesh-list
6667793|NCT01529164|Endostatins|endostatins|mesh-list
6667794|NCT01529164|Antimetabolites|antimetabolites|mesh-ancestor
6667795|NCT01529164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6151393|NCT01418001|Docetaxel|docetaxel|mesh-list
6151394|NCT01418001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6477252|NCT00527683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6477253|NCT00527683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477254|NCT00527683|GABA Agents|gaba agents|mesh-ancestor
6477255|NCT00527683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6477256|NCT00527683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477257|NCT00527761|Cisplatin|cisplatin|mesh-list
6477258|NCT00527761|Docetaxel|docetaxel|mesh-list
6477259|NCT00527761|Temozolomide|temozolomide|mesh-list
6477260|NCT00527761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6667796|NCT01529164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6477261|NCT00527761|Tubulin Modulators|tubulin modulators|mesh-ancestor
6477262|NCT00527761|Antimitotic Agents|antimitotic agents|mesh-ancestor
6477263|NCT00527761|Mitosis Modulators|mitosis modulators|mesh-ancestor
6477264|NCT00527761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477265|NCT00527761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6477266|NCT00527761|Alkylating Agents|alkylating agents|mesh-ancestor
6477267|NCT00527800|Lumefantrine|lumefantrine|mesh-list
6477268|NCT00527800|Artemether|artemether|mesh-list
6477269|NCT00527800|Piperaquine|piperaquine|mesh-list
6477270|NCT00527800|Trimethoprim|trimethoprim|mesh-list
6477271|NCT00527800|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6477272|NCT00527800|Artenimol|artenimol|mesh-list
6477273|NCT00527800|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
5552888|NCT04075526|Vancomycin|vancomycin|mesh-list
5552889|NCT04075526|Povidone-Iodine|povidone-iodine|mesh-list
5552890|NCT04075526|Povidone|povidone|mesh-list
5552891|NCT04075526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5552892|NCT04075526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5552893|NCT04075526|Plasma Substitutes|plasma substitutes|mesh-ancestor
5552894|NCT04075526|Blood Substitutes|blood substitutes|mesh-ancestor
5552895|NCT04075526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5552896|NCT04075006|Ketamine|ketamine|mesh-list
5552897|NCT04075006|Analgesics|analgesics|mesh-ancestor
5552898|NCT04075006|Sensory System Agents|sensory system agents|mesh-ancestor
5552899|NCT04075006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5552900|NCT04075006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552901|NCT04075006|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5552902|NCT04075006|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6477274|NCT00527800|Sulfamethoxazole|sulfamethoxazole|mesh-list
6477275|NCT00527800|Antimalarials|antimalarials|mesh-ancestor
6477276|NCT00527800|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6477277|NCT00527800|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5552903|NCT04075006|Anesthetics, General|anesthetics, general|mesh-ancestor
5552904|NCT04075006|Anesthetics|anesthetics|mesh-ancestor
5552905|NCT04075006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6477278|NCT00527800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6477279|NCT00527800|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6477280|NCT00527800|Renal Agents|renal agents|mesh-ancestor
6477281|NCT00527800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6477282|NCT00527800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6477283|NCT00527800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477284|NCT00527800|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6477285|NCT00527800|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6477286|NCT00527800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6477287|NCT00527800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6477288|NCT00527930|Oxaliplatin|oxaliplatin|mesh-list
6477289|NCT00527930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6488796|NCT00586794|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6488797|NCT00586794|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6488798|NCT00586794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6488799|NCT00586794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488800|NCT00586794|Urological Agents|urological agents|mesh-ancestor
6488801|NCT00586833|Neurotransmitter Agents|neurotransmitter agents|mesh-list
6488802|NCT00586833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6151395|NCT01418001|Antimetabolites|antimetabolites|mesh-ancestor
6151396|NCT01418001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6151397|NCT01418001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6488803|NCT00586833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552906|NCT04075006|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5552907|NCT04075006|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5552908|NCT04075006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5552909|NCT04075006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5552910|NCT04075149|Spironolactone|spironolactone|mesh-list
5552911|NCT04075149|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6488804|NCT00586911|Betaine|betaine|mesh-list
6488805|NCT00586911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6488806|NCT00586911|Lipotropic Agents|lipotropic agents|mesh-ancestor
6488807|NCT00586911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6488808|NCT00586911|Antimetabolites|antimetabolites|mesh-ancestor
6488809|NCT00586911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488810|NCT00586911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6488811|NCT00586924|Immunotoxin HA22|immunotoxin ha22|mesh-list
6488812|NCT00586924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6488813|NCT00586976|Ropivacaine|ropivacaine|mesh-list
5552912|NCT04075149|Hormone Antagonists|hormone antagonists|mesh-ancestor
6477290|NCT00527995|Sildenafil Citrate|sildenafil citrate|mesh-list
6151398|NCT01418001|Antiviral Agents|antiviral agents|mesh-ancestor
6151399|NCT01418001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5552913|NCT04075149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5552914|NCT04075149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552915|NCT04075149|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5552916|NCT04075149|Diuretics|diuretics|mesh-ancestor
5552917|NCT04075149|Natriuretic Agents|natriuretic agents|mesh-ancestor
5552918|NCT04075240|Aspirin|aspirin|mesh-list
5552919|NCT04075240|Rivaroxaban|rivaroxaban|mesh-list
5552920|NCT04075240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5552921|NCT04075240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6151400|NCT01418001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6477291|NCT00527995|Vasodilator Agents|vasodilator agents|mesh-ancestor
6477292|NCT00527995|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6477293|NCT00527995|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6477294|NCT00527995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6477295|NCT00527995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477296|NCT00527995|Urological Agents|urological agents|mesh-ancestor
6477297|NCT00528008|Chlorhexidine|chlorhexidine|mesh-list
6477298|NCT00528008|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6477299|NCT00528008|Povidone-Iodine|povidone-iodine|mesh-list
5552922|NCT04075240|Analgesics|analgesics|mesh-ancestor
5552923|NCT04075240|Sensory System Agents|sensory system agents|mesh-ancestor
5552924|NCT04075240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5552925|NCT04075240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552926|NCT04075240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5552927|NCT04075240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5552928|NCT04075240|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5552929|NCT04075240|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5552930|NCT04075240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5552931|NCT04075240|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5552932|NCT04075240|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5552933|NCT04075240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5552934|NCT04075240|Antipyretics|antipyretics|mesh-ancestor
5552935|NCT04075240|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5552936|NCT04075240|Antithrombins|antithrombins|mesh-ancestor
5552937|NCT04075240|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6477300|NCT00528008|Povidone|povidone|mesh-list
6477301|NCT00528008|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6477302|NCT00528008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6477303|NCT00528008|Disinfectants|disinfectants|mesh-ancestor
6477304|NCT00528008|Dermatologic Agents|dermatologic agents|mesh-ancestor
6477305|NCT00528008|Plasma Substitutes|plasma substitutes|mesh-ancestor
6477306|NCT00528008|Blood Substitutes|blood substitutes|mesh-ancestor
6477307|NCT00528060|Ritonavir|ritonavir|mesh-list
6477308|NCT00528060|Atazanavir Sulfate|atazanavir sulfate|mesh-list
5552938|NCT04075240|Protease Inhibitors|protease inhibitors|mesh-ancestor
5552939|NCT04075240|Anticoagulants|anticoagulants|mesh-ancestor
5552940|NCT04074915|Chlorhexidine|chlorhexidine|mesh-list
5552941|NCT04074915|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5552942|NCT04074915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5552943|NCT04074915|Disinfectants|disinfectants|mesh-ancestor
5552944|NCT04075188|Aflibercept|aflibercept|mesh-list
5552945|NCT04075188|Verteporfin|verteporfin|mesh-list
5552946|NCT04075188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5552947|NCT04075188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5552948|NCT04075188|Growth Substances|growth substances|mesh-ancestor
5552949|NCT04075188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552950|NCT04075188|Growth Inhibitors|growth inhibitors|mesh-ancestor
5552951|NCT04075188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5552952|NCT04075188|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5552953|NCT04075188|Dermatologic Agents|dermatologic agents|mesh-ancestor
5552954|NCT04075604|Nivolumab|nivolumab|mesh-list
5552955|NCT04075604|Palbociclib|palbociclib|mesh-list
5552956|NCT04075604|Anastrozole|anastrozole|mesh-list
5552957|NCT04075604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5552958|NCT04075604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5552959|NCT04075604|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5552960|NCT04075604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5552961|NCT04075604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5552962|NCT04075604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5552963|NCT04075604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5552964|NCT04075604|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5552965|NCT04075604|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6477309|NCT00528060|Tenofovir|tenofovir|mesh-list
5552966|NCT04075604|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6477310|NCT00528060|Emtricitabine|emtricitabine|mesh-list
6477311|NCT00528060|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6477312|NCT00528060|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6477313|NCT00528060|Protease Inhibitors|protease inhibitors|mesh-ancestor
6477314|NCT00528060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6477315|NCT00528060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477316|NCT00528060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6477317|NCT00528060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6477318|NCT00528060|Antiviral Agents|antiviral agents|mesh-ancestor
6477319|NCT00528060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6477320|NCT00528060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6477321|NCT00528060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6477322|NCT00528060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6477323|NCT00528060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6151401|NCT01418001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6151402|NCT01418001|Immunologic Factors|immunologic factors|mesh-ancestor
6151403|NCT01418001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151404|NCT01418001|Tubulin Modulators|tubulin modulators|mesh-ancestor
6151405|NCT01418001|Antimitotic Agents|antimitotic agents|mesh-ancestor
6151406|NCT01418001|Mitosis Modulators|mitosis modulators|mesh-ancestor
5552967|NCT04075604|Hormone Antagonists|hormone antagonists|mesh-ancestor
5552968|NCT04075604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5552969|NCT04075604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477324|NCT00528073|Rifaximin|rifaximin|mesh-list
6477325|NCT00528073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6477326|NCT00528073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6477327|NCT00528073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6477328|NCT00528151|Curcumin|curcumin|mesh-list
6477329|NCT00528151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6477330|NCT00528151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6477331|NCT00528151|Analgesics|analgesics|mesh-ancestor
6151407|NCT01418209|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6151408|NCT01418209|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6151409|NCT01418209|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6151410|NCT01418209|Estradiol|estradiol|mesh-list
6151411|NCT01418209|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6151412|NCT01418209|Progesterone|progesterone|mesh-list
6151413|NCT01418209|Estrogens|estrogens|mesh-ancestor
6151414|NCT01418209|Hormones|hormones|mesh-ancestor
6151415|NCT01418209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6151416|NCT01418209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151417|NCT01418209|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6477332|NCT00528151|Sensory System Agents|sensory system agents|mesh-ancestor
5552970|NCT04075201|Vaccines|vaccines|mesh-list
5552971|NCT04075201|Immunologic Factors|immunologic factors|mesh-ancestor
5552972|NCT04075201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552973|NCT04074746|Vidarabine|vidarabine|mesh-list
5552974|NCT04074746|Cyclophosphamide|cyclophosphamide|mesh-list
5552975|NCT04074746|Fludarabine|fludarabine|mesh-list
6477333|NCT00528151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6477334|NCT00528151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477335|NCT00528151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5552976|NCT04074746|Fludarabine phosphate|fludarabine phosphate|mesh-list
5552977|NCT04074746|Antibodies|antibodies|mesh-list
5552978|NCT04074746|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5552979|NCT04074746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5552980|NCT04074746|Immunologic Factors|immunologic factors|mesh-ancestor
5552981|NCT04074746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552982|NCT04074746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5552983|NCT04074746|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5552984|NCT04074746|Alkylating Agents|alkylating agents|mesh-ancestor
5552985|NCT04074746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5552986|NCT04074746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5552987|NCT04074746|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6151418|NCT01418209|Contraceptive Agents|contraceptive agents|mesh-ancestor
6151419|NCT01418209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6151420|NCT01418209|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6151421|NCT01418209|Progestins|progestins|mesh-ancestor
6151422|NCT01418209|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6151423|NCT01418209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6151424|NCT01418209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6151425|NCT01418209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6151426|NCT01418209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6477336|NCT00528151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6151427|NCT01418209|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6151428|NCT01418209|Antidepressive Agents|antidepressive agents|mesh-ancestor
6151429|NCT01418209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6151430|NCT01418339|Aripiprazole|aripiprazole|mesh-list
6151431|NCT01418339|Antidepressive Agents|antidepressive agents|mesh-ancestor
6151432|NCT01418339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6477337|NCT00528151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6477338|NCT00528151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6477339|NCT00528151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477340|NCT00528177|Morphine|morphine|mesh-list
6477341|NCT00528177|Oxycodone|oxycodone|mesh-list
6151433|NCT01418339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6151434|NCT01418339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6151435|NCT01418339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6151436|NCT01418339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151437|NCT01418339|Dopamine Agonists|dopamine agonists|mesh-ancestor
6151438|NCT01418339|Dopamine Agents|dopamine agents|mesh-ancestor
5552988|NCT04074746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5552989|NCT04074746|Antimetabolites|antimetabolites|mesh-ancestor
5552990|NCT04074746|Antiviral Agents|antiviral agents|mesh-ancestor
5552991|NCT04074746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5552992|NCT04074473|Propranolol|propranolol|mesh-list
5552993|NCT04074473|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5552994|NCT04074473|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5552995|NCT04074473|Adrenergic Agents|adrenergic agents|mesh-ancestor
5552996|NCT04074473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5552997|NCT04074473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5552998|NCT04074473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5552999|NCT04074473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5553000|NCT04074473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5553001|NCT04074473|Vasodilator Agents|vasodilator agents|mesh-ancestor
6477342|NCT00528177|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6477343|NCT00528177|Narcotics|narcotics|mesh-ancestor
6477344|NCT00528177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6151439|NCT01418339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6151440|NCT01418339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6151441|NCT01418339|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6151442|NCT01418339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6151443|NCT01418339|Serotonin Agents|serotonin agents|mesh-ancestor
6151444|NCT01418339|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6477345|NCT00528177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477346|NCT00528177|Analgesics|analgesics|mesh-ancestor
5553002|NCT04074603|Insulin|insulin|mesh-list
5553003|NCT04074603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5553004|NCT04074603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553005|NCT04074564|Apatinib|apatinib|mesh-list
5553006|NCT04074564|Antibodies|antibodies|mesh-list
5553007|NCT04074564|Immunologic Factors|immunologic factors|mesh-ancestor
5553008|NCT04074564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151445|NCT01418339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6477347|NCT00528177|Sensory System Agents|sensory system agents|mesh-ancestor
6477348|NCT00528177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6477349|NCT00528216|Capsaicin|capsaicin|mesh-list
6477350|NCT00528216|Antipruritics|antipruritics|mesh-ancestor
6477351|NCT00528216|Dermatologic Agents|dermatologic agents|mesh-ancestor
6477352|NCT00528216|Sensory System Agents|sensory system agents|mesh-ancestor
6477353|NCT00528216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6477354|NCT00528216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477355|NCT00528255|Misoprostol|misoprostol|mesh-list
6477356|NCT00528255|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6151446|NCT01418339|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6151447|NCT01418339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6151448|NCT01418352|Aripiprazole|aripiprazole|mesh-list
6151449|NCT01418352|Antidepressive Agents|antidepressive agents|mesh-ancestor
6151450|NCT01418352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6151451|NCT01418352|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6477357|NCT00528255|Abortifacient Agents|abortifacient agents|mesh-ancestor
6477358|NCT00528255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6477359|NCT00528255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477360|NCT00528255|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6477361|NCT00528255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6477362|NCT00528255|Oxytocics|oxytocics|mesh-ancestor
6477363|NCT00528281|Pemetrexed|pemetrexed|mesh-list
6477364|NCT00528281|Lapatinib|lapatinib|mesh-list
6151452|NCT01418352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6477365|NCT00528281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6477366|NCT00528281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6477367|NCT00528281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477368|NCT00528281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6477369|NCT00528281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6477370|NCT00528281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6477371|NCT00528359|Olanzapine|olanzapine|mesh-list
6477372|NCT00528359|Risperidone|risperidone|mesh-list
6477373|NCT00528359|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6477374|NCT00528359|Aripiprazole|aripiprazole|mesh-list
6477375|NCT00528359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6477376|NCT00528359|Serotonin Agents|serotonin agents|mesh-ancestor
6477377|NCT00528359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5553009|NCT04074564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5553010|NCT04074564|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5553011|NCT04074564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5553012|NCT04074564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553013|NCT04074460|Propofol|propofol|mesh-list
5553014|NCT04074460|Sevoflurane|sevoflurane|mesh-list
5553015|NCT04074460|Desflurane|desflurane|mesh-list
5553016|NCT04074460|Isoflurane|isoflurane|mesh-list
5553017|NCT04074460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5553018|NCT04074460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5553019|NCT04074460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553020|NCT04074460|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6477378|NCT00528359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477379|NCT00528359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553021|NCT04074460|Anesthetics, General|anesthetics, general|mesh-ancestor
5553022|NCT04074460|Anesthetics|anesthetics|mesh-ancestor
5553023|NCT04074460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5553024|NCT04074460|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5553025|NCT04074551|Losartan|losartan|mesh-list
5553026|NCT04074551|Amlodipine|amlodipine|mesh-list
5553027|NCT04074551|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5553028|NCT04074551|Ezetimibe|ezetimibe|mesh-list
5553029|NCT04074551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5553030|NCT04074551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5553031|NCT04074551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5553032|NCT04074551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553033|NCT04074551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5553034|NCT04074551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553035|NCT04074551|Vasodilator Agents|vasodilator agents|mesh-ancestor
5553036|NCT04074551|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5553037|NCT04074551|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5553038|NCT04074551|Antimetabolites|antimetabolites|mesh-ancestor
5553039|NCT04074551|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5553040|NCT04074551|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5553041|NCT04074551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5553042|NCT04074551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5553043|NCT04074551|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5553044|NCT04074551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5553045|NCT04074512|Copper|copper|mesh-list
5553046|NCT04074512|Trace Elements|trace elements|mesh-ancestor
5553047|NCT04074512|Micronutrients|micronutrients|mesh-ancestor
5553048|NCT04074512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553049|NCT04074421|Rifaximin|rifaximin|mesh-list
5553050|NCT04074421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5553051|NCT04074421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5553052|NCT04074421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5553053|NCT04074187|Methylprednisolone|methylprednisolone|mesh-list
5553054|NCT04074187|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5553055|NCT04074187|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5553056|NCT04074187|Prednisolone|prednisolone|mesh-list
5553057|NCT04074187|Prednisolone acetate|prednisolone acetate|mesh-list
5553058|NCT04074187|Rituximab|rituximab|mesh-list
5553059|NCT04074187|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5553060|NCT04074187|Prednisolone phosphate|prednisolone phosphate|mesh-list
6477380|NCT00528359|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6477381|NCT00528359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6477382|NCT00528359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6477383|NCT00528359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5553061|NCT04074187|Immunosuppressive Agents|immunosuppressive agents|mesh-list
5553062|NCT04074187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5553063|NCT04074187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5553064|NCT04074187|Immunologic Factors|immunologic factors|mesh-ancestor
5553065|NCT04074187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553066|NCT04074187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5553067|NCT04074187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6477384|NCT00528359|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6477385|NCT00528359|Dopamine Agents|dopamine agents|mesh-ancestor
6477386|NCT00528359|Antiemetics|antiemetics|mesh-ancestor
6477387|NCT00528359|Autonomic Agents|autonomic agents|mesh-ancestor
6477388|NCT00528359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6477389|NCT00528359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6477390|NCT00528359|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5553068|NCT04074187|Antiemetics|antiemetics|mesh-ancestor
5553069|NCT04074187|Autonomic Agents|autonomic agents|mesh-ancestor
5553070|NCT04074187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5553071|NCT04074187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5553072|NCT04074187|Glucocorticoids|glucocorticoids|mesh-ancestor
5553073|NCT04074187|Hormones|hormones|mesh-ancestor
5553074|NCT04074187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5553075|NCT04074187|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5553076|NCT04074187|Protective Agents|protective agents|mesh-ancestor
5553077|NCT04074187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5553078|NCT04074213|Clozapine|clozapine|mesh-list
5553079|NCT04074213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5553080|NCT04074213|Serotonin Agents|serotonin agents|mesh-ancestor
5553081|NCT04074213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5553082|NCT04074213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553083|NCT04074213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553084|NCT04074213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5553085|NCT04074213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5553086|NCT04074213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5553087|NCT04074213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5553088|NCT04074213|GABA Antagonists|gaba antagonists|mesh-ancestor
5553089|NCT04074213|GABA Agents|gaba agents|mesh-ancestor
5553090|NCT04073953|Primaquine|primaquine|mesh-list
6151453|NCT01418352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6151454|NCT01418352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151455|NCT01418352|Dopamine Agonists|dopamine agonists|mesh-ancestor
6151456|NCT01418352|Dopamine Agents|dopamine agents|mesh-ancestor
6151457|NCT01418352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6151458|NCT01418352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553091|NCT04073953|Antimalarials|antimalarials|mesh-ancestor
5553092|NCT04073953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6667797|NCT01529164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6667798|NCT01529164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6477391|NCT00528359|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6477392|NCT00528359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6477393|NCT00528359|Antidepressive Agents|antidepressive agents|mesh-ancestor
6477394|NCT00528359|Dopamine Agonists|dopamine agonists|mesh-ancestor
6477395|NCT00528359|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6477396|NCT00528359|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6151459|NCT01418352|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6151460|NCT01418352|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6151461|NCT01418352|Serotonin Agents|serotonin agents|mesh-ancestor
6151462|NCT01418352|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6151463|NCT01418352|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6151464|NCT01418352|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6151465|NCT01418352|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6151466|NCT01418365|Metronidazole|metronidazole|mesh-list
6477397|NCT00528359|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6477398|NCT00528359|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6151467|NCT01418365|Mesalamine|mesalamine|mesh-list
6151468|NCT01418365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6151469|NCT01418365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6151470|NCT01418365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6151471|NCT01418365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6477399|NCT00528385|Spironolactone|spironolactone|mesh-list
6477400|NCT00528385|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6477401|NCT00528385|Hormone Antagonists|hormone antagonists|mesh-ancestor
6477402|NCT00528385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6477403|NCT00528385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477404|NCT00528385|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6477405|NCT00528385|Diuretics|diuretics|mesh-ancestor
6477406|NCT00528385|Natriuretic Agents|natriuretic agents|mesh-ancestor
6477407|NCT00528502|Lidocaine|lidocaine|mesh-list
6477408|NCT00528502|Anesthetics, Local|anesthetics, local|mesh-ancestor
5553093|NCT04073953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6151472|NCT01418365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6151473|NCT01418365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6151474|NCT01418365|Analgesics|analgesics|mesh-ancestor
6151475|NCT01418365|Sensory System Agents|sensory system agents|mesh-ancestor
6151476|NCT01418365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6151477|NCT01418365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151478|NCT01418365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6151479|NCT01418365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6151480|NCT01419184|Vancomycin|vancomycin|mesh-list
6151481|NCT01419184|Daptomycin|daptomycin|mesh-list
6151482|NCT01419184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6667799|NCT01529164|Immunologic Factors|immunologic factors|mesh-ancestor
6667800|NCT01529164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667801|NCT01529164|Antidotes|antidotes|mesh-ancestor
6667802|NCT01529164|Protective Agents|protective agents|mesh-ancestor
6667803|NCT01529164|Vitamin B Complex|vitamin b complex|mesh-ancestor
5553094|NCT04073953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5553095|NCT04074317|Insulin|insulin|mesh-list
5553096|NCT04074317|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5553097|NCT04074317|Pramlintide|pramlintide|mesh-list
5553098|NCT04074317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5553099|NCT04074317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553100|NCT04074343|Irinotecan|irinotecan|mesh-list
5553101|NCT04074343|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6477409|NCT00528502|Anesthetics|anesthetics|mesh-ancestor
6477410|NCT00528502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6477411|NCT00528502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477412|NCT00528502|Sensory System Agents|sensory system agents|mesh-ancestor
6477413|NCT00528502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6477414|NCT00528502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6477415|NCT00528502|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6477416|NCT00528502|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6667804|NCT01529164|Vitamins|vitamins|mesh-ancestor
5553102|NCT04074343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5553103|NCT04074343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5553104|NCT04074343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553105|NCT04074343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5553106|NCT04073849|Epoetin Alfa|epoetin alfa|mesh-list
5553107|NCT04073849|Hematinics|hematinics|mesh-ancestor
6667805|NCT01529164|Micronutrients|micronutrients|mesh-ancestor
6667806|NCT01529164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6667807|NCT01529164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6667808|NCT01529164|Growth Substances|growth substances|mesh-ancestor
6667809|NCT01529164|Growth Inhibitors|growth inhibitors|mesh-ancestor
6667810|NCT01529177|Metformin|metformin|mesh-list
6667811|NCT01529177|Citric Acid|citric acid|mesh-list
6667812|NCT01529177|Sodium Citrate|sodium citrate|mesh-list
6667813|NCT01529177|Clomiphene|clomiphene|mesh-list
6667814|NCT01529177|Enclomiphene|enclomiphene|mesh-list
6667815|NCT01529177|Zuclomiphene|zuclomiphene|mesh-list
5553108|NCT04073758|Dexmedetomidine|dexmedetomidine|mesh-list
5553109|NCT04073758|Remifentanil|remifentanil|mesh-list
5553110|NCT04073758|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5553111|NCT04073758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5553112|NCT04073758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553113|NCT04073758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5553114|NCT04073758|Analgesics|analgesics|mesh-ancestor
5553115|NCT04073758|Sensory System Agents|sensory system agents|mesh-ancestor
5553116|NCT04073758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5553117|NCT04073758|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5553118|NCT04073758|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5553119|NCT04073758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5553120|NCT04073758|Adrenergic Agents|adrenergic agents|mesh-ancestor
5553121|NCT04073758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6667816|NCT01529177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6667817|NCT01529177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667818|NCT01529177|Anticoagulants|anticoagulants|mesh-ancestor
6667819|NCT01529177|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6667820|NCT01529177|Chelating Agents|chelating agents|mesh-ancestor
6667821|NCT01529177|Sequestering Agents|sequestering agents|mesh-ancestor
6667822|NCT01529177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667823|NCT01529177|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5553122|NCT04073758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553123|NCT04073758|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5553124|NCT04073758|Narcotics|narcotics|mesh-ancestor
5553125|NCT04073784|Gemcitabine|gemcitabine|mesh-list
5725588|NCT03179735|Cetylpyridinium|cetylpyridinium|mesh-list
6151483|NCT01419184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6151484|NCT01419197|Trastuzumab|trastuzumab|mesh-list
6667824|NCT01529177|Hormone Antagonists|hormone antagonists|mesh-ancestor
6667825|NCT01529177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6151485|NCT01419197|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
6151486|NCT01419197|Maytansine|maytansine|mesh-list
5553126|NCT04073784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5553127|NCT04073784|Antimetabolites|antimetabolites|mesh-ancestor
5553128|NCT04073784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553129|NCT04073784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5553130|NCT04073784|Antiviral Agents|antiviral agents|mesh-ancestor
5553131|NCT04073784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5553132|NCT04073784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5553133|NCT04073784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5553134|NCT04073784|Immunologic Factors|immunologic factors|mesh-ancestor
5553135|NCT04073784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553136|NCT04073797|Evolocumab|evolocumab|mesh-list
5553137|NCT04073797|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5553138|NCT04073797|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5553139|NCT04073797|Antimetabolites|antimetabolites|mesh-ancestor
5553140|NCT04073797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477417|NCT00528502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6477418|NCT00528502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477419|NCT00528515|Propofol|propofol|mesh-list
6477420|NCT00528515|Desflurane|desflurane|mesh-list
6477421|NCT00528515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6477422|NCT00528515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6477423|NCT00528515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477424|NCT00528515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6477425|NCT00528515|Anesthetics, General|anesthetics, general|mesh-ancestor
5553141|NCT04073797|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5553142|NCT04073615|Trifluridine|trifluridine|mesh-list
6151487|NCT01419197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6151488|NCT01419197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6151489|NCT01419197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6151490|NCT01419197|Tubulin Modulators|tubulin modulators|mesh-ancestor
6151491|NCT01419197|Antimitotic Agents|antimitotic agents|mesh-ancestor
6151492|NCT01419197|Mitosis Modulators|mitosis modulators|mesh-ancestor
6151493|NCT01419197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6151494|NCT01419236|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5553143|NCT04073615|Apatinib|apatinib|mesh-list
5553144|NCT04073615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5553145|NCT04073615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5553146|NCT04073615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6151495|NCT01419236|Testosterone|testosterone|mesh-list
6151496|NCT01419236|Androgens|androgens|mesh-ancestor
6151497|NCT01419236|Hormones|hormones|mesh-ancestor
6151498|NCT01419236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6151499|NCT01419236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151500|NCT01419275|Xenon|xenon|mesh-list
6151501|NCT01419275|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6151502|NCT01419275|Anesthetics, General|anesthetics, general|mesh-ancestor
6151503|NCT01419275|Anesthetics|anesthetics|mesh-ancestor
6151504|NCT01419275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6151505|NCT01419275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553147|NCT04073615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553148|NCT04073615|Antimetabolites|antimetabolites|mesh-ancestor
5553149|NCT04073615|Antiviral Agents|antiviral agents|mesh-ancestor
5553150|NCT04073615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5553151|NCT04073550|Topotecan|topotecan|mesh-list
5553152|NCT04073550|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5553153|NCT04073550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5553154|NCT04073550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5553155|NCT04073550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553156|NCT04073550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5553157|NCT04073537|Paclitaxel|paclitaxel|mesh-list
5553158|NCT04073537|Carboplatin|carboplatin|mesh-list
5553159|NCT04073537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5553160|NCT04073537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5553161|NCT04073537|Tubulin Modulators|tubulin modulators|mesh-ancestor
5553162|NCT04073537|Antimitotic Agents|antimitotic agents|mesh-ancestor
5553163|NCT04073537|Mitosis Modulators|mitosis modulators|mesh-ancestor
5553164|NCT04073537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553165|NCT04073719|Acetic Acid|acetic acid|mesh-list
5553166|NCT04073719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5553167|NCT04073719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6477426|NCT00528515|Anesthetics|anesthetics|mesh-ancestor
6477427|NCT00528515|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5553168|NCT04073602|Trastuzumab|trastuzumab|mesh-list
6151506|NCT01419535|Mifepristone|mifepristone|mesh-list
6151507|NCT01419535|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6151508|NCT01419535|Abortifacient Agents|abortifacient agents|mesh-ancestor
6151509|NCT01419535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6151510|NCT01419535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151511|NCT01419535|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6151512|NCT01419535|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6151513|NCT01419535|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6151514|NCT01419535|Contraceptive Agents|contraceptive agents|mesh-ancestor
6151515|NCT01419535|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6151516|NCT01419535|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6151517|NCT01419535|Hormone Antagonists|hormone antagonists|mesh-ancestor
6151518|NCT01419535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6151519|NCT01419535|Luteolytic Agents|luteolytic agents|mesh-ancestor
6477428|NCT00528593|Epoetin Alfa|epoetin alfa|mesh-list
6477429|NCT00528593|Hematinics|hematinics|mesh-ancestor
6477430|NCT00528619|Carboplatin|carboplatin|mesh-list
6477431|NCT00528619|Pemetrexed|pemetrexed|mesh-list
6477432|NCT00528619|Sunitinib|sunitinib|mesh-list
6477433|NCT00528619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6477434|NCT00528619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6477435|NCT00528619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477436|NCT00528619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6151520|NCT01419535|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6151521|NCT01419535|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6151522|NCT01419639|Everolimus|everolimus|mesh-list
6151523|NCT01419639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6151524|NCT01419639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6151525|NCT01419639|Immunologic Factors|immunologic factors|mesh-ancestor
6151526|NCT01419639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151527|NCT01419665|Rituximab|rituximab|mesh-list
6151528|NCT01419665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6151529|NCT01419665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6151530|NCT01419665|Immunologic Factors|immunologic factors|mesh-ancestor
6151531|NCT01419665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151532|NCT01419665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6151533|NCT01419717|Denosumab|denosumab|mesh-list
6151534|NCT01419717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6151535|NCT01419717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151536|NCT01419795|Rituximab|rituximab|mesh-list
6151537|NCT01419795|Lenalidomide|lenalidomide|mesh-list
6151538|NCT01419795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6151539|NCT01419795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6151540|NCT01419795|Immunologic Factors|immunologic factors|mesh-ancestor
6151541|NCT01419795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151542|NCT01419795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6151543|NCT01419795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6151544|NCT01419795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6151545|NCT01419795|Growth Substances|growth substances|mesh-ancestor
6151546|NCT01419795|Growth Inhibitors|growth inhibitors|mesh-ancestor
6151547|NCT01419977|Dalteparin|dalteparin|mesh-list
6151548|NCT01419977|Tinzaparin|tinzaparin|mesh-list
5553169|NCT04073602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5553170|NCT04073602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5603046|NCT03509012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6151549|NCT01419977|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6151550|NCT01419977|Anticoagulants|anticoagulants|mesh-ancestor
6151551|NCT01419977|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6151552|NCT01419977|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6151553|NCT01419977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6151554|NCT01420081|Gedatolisib|gedatolisib|mesh-list
6151555|NCT01420081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6151556|NCT01420081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6151557|NCT01420081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6151558|NCT01420146|Trastuzumab|trastuzumab|mesh-list
6151559|NCT01420146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6477437|NCT00528619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5553171|NCT04073680|Canagliflozin|canagliflozin|mesh-list
5553172|NCT04073680|Serabelisib|serabelisib|mesh-list
5553173|NCT04073680|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5553174|NCT04073680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553175|NCT04073680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5553176|NCT04073680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553177|NCT04073680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5553178|NCT04073173|Analgesics, Opioid|analgesics, opioid|mesh-list
6667826|NCT01529177|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6667827|NCT01529177|Fertility Agents|fertility agents|mesh-ancestor
6667828|NCT01529177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6667829|NCT01529177|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6667830|NCT01529177|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6667831|NCT01529190|Pregabalin|pregabalin|mesh-list
6667832|NCT01529190|Analgesics|analgesics|mesh-ancestor
6667833|NCT01529190|Sensory System Agents|sensory system agents|mesh-ancestor
6477438|NCT00528619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6477439|NCT00528619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6477440|NCT00528619|Growth Substances|growth substances|mesh-ancestor
5553179|NCT04073173|Analgesics|analgesics|mesh-list
5553180|NCT04073173|Narcotics|narcotics|mesh-ancestor
5553181|NCT04073173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6151560|NCT01420146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6151561|NCT01420536|Salicylic Acid|salicylic acid|mesh-list
6151562|NCT01420536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6151563|NCT01420536|Antifungal Agents|antifungal agents|mesh-ancestor
6151564|NCT01420536|Keratolytic Agents|keratolytic agents|mesh-ancestor
6151565|NCT01420536|Dermatologic Agents|dermatologic agents|mesh-ancestor
6151566|NCT01420549|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6151567|NCT01420549|Simvastatin|simvastatin|mesh-list
6151568|NCT01420549|Ezetimibe|ezetimibe|mesh-list
6151569|NCT01420549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6151570|NCT01420549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6151571|NCT01420549|Antimetabolites|antimetabolites|mesh-ancestor
6151572|NCT01420549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6151573|NCT01420549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5553182|NCT04073173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553183|NCT04073173|Sensory System Agents|sensory system agents|mesh-ancestor
5553184|NCT04073173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5553185|NCT04074265|Ketorolac|ketorolac|mesh-list
5553186|NCT04074265|Epinephrine|epinephrine|mesh-list
5553187|NCT04074265|Ropivacaine|ropivacaine|mesh-list
5553188|NCT04074265|Anesthetics, Local|anesthetics, local|mesh-ancestor
5553189|NCT04074265|Anesthetics|anesthetics|mesh-ancestor
5603047|NCT03509012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6151574|NCT01420549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6151575|NCT01420549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6151576|NCT01420653|Acetaminophen|acetaminophen|mesh-list
6151577|NCT01420653|Ibuprofen|ibuprofen|mesh-list
6477441|NCT00528619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477442|NCT00528619|Growth Inhibitors|growth inhibitors|mesh-ancestor
6477443|NCT00528619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6151578|NCT01420653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6151579|NCT01420653|Analgesics|analgesics|mesh-ancestor
6151580|NCT01420653|Sensory System Agents|sensory system agents|mesh-ancestor
6151581|NCT01420653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6151582|NCT01420653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151583|NCT01420653|Antipyretics|antipyretics|mesh-ancestor
6477444|NCT00528658|Acetaminophen|acetaminophen|mesh-list
6477445|NCT00528658|Ibuprofen|ibuprofen|mesh-list
6488814|NCT00586976|Anesthetics, Local|anesthetics, local|mesh-ancestor
6667834|NCT01529190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5553190|NCT04074265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5553191|NCT04074265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553192|NCT04074265|Sensory System Agents|sensory system agents|mesh-ancestor
5553193|NCT04074265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5553194|NCT04074265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5553195|NCT04074265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5553196|NCT04074265|Adrenergic Agents|adrenergic agents|mesh-ancestor
5553197|NCT04074265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5553198|NCT04074265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553199|NCT04074265|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5553200|NCT04074265|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5553201|NCT04074265|Autonomic Agents|autonomic agents|mesh-ancestor
5553202|NCT04074265|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5553203|NCT04074265|Respiratory System Agents|respiratory system agents|mesh-ancestor
5553204|NCT04074265|Mydriatics|mydriatics|mesh-ancestor
5553205|NCT04074265|Sympathomimetics|sympathomimetics|mesh-ancestor
5553206|NCT04074265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5553207|NCT04074265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5553208|NCT04074265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5553209|NCT04074265|Analgesics|analgesics|mesh-ancestor
6151584|NCT01420653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6151585|NCT01420653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6151586|NCT01420653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6151587|NCT01420653|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6151588|NCT01420653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6151589|NCT01420653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6151590|NCT01420679|10-deazaaminopterin|10-deazaaminopterin|mesh-list
6151591|NCT01420679|Aminopterin|aminopterin|mesh-list
6151592|NCT01420679|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6151593|NCT01420679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6151594|NCT01420679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6151595|NCT01420679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6151596|NCT01420926|Bortezomib|bortezomib|mesh-list
6477446|NCT00528658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6477447|NCT00528658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6477448|NCT00528658|Analgesics|analgesics|mesh-ancestor
6477449|NCT00528658|Sensory System Agents|sensory system agents|mesh-ancestor
6477450|NCT00528658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6477451|NCT00528658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477452|NCT00528658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6477453|NCT00528658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6477454|NCT00528658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6477455|NCT00528658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6667835|NCT01529190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667836|NCT01529190|Anticonvulsants|anticonvulsants|mesh-ancestor
6151597|NCT01420926|Decitabine|decitabine|mesh-list
6151598|NCT01420926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6151599|NCT01420926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6151600|NCT01420926|Antimetabolites|antimetabolites|mesh-ancestor
6151601|NCT01420926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6151602|NCT01420926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6151603|NCT01421017|Cyclophosphamide|cyclophosphamide|mesh-list
6151604|NCT01421017|Imiquimod|imiquimod|mesh-list
6151605|NCT01421017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6151606|NCT01421017|Immunologic Factors|immunologic factors|mesh-ancestor
6151607|NCT01421017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151608|NCT01421017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6151609|NCT01421017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6667837|NCT01529190|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6667838|NCT01529190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6667839|NCT01529190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667840|NCT01529190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6667841|NCT01529190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6667842|NCT01529190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6667843|NCT01529190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5553210|NCT04074265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5553211|NCT04074265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5553212|NCT04074265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5553213|NCT04074265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5553214|NCT04073160|Durvalumab|durvalumab|mesh-list
5553215|NCT04073160|Tremelimumab|tremelimumab|mesh-list
5553216|NCT04073160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6151610|NCT01421017|Alkylating Agents|alkylating agents|mesh-ancestor
5553217|NCT04073160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6151611|NCT01421017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6151612|NCT01421017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6151613|NCT01421017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6151614|NCT01421017|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6151615|NCT01421017|Interferon Inducers|interferon inducers|mesh-ancestor
6151616|NCT01421134|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
5553218|NCT04073134|Evolocumab|evolocumab|mesh-list
5553219|NCT04073134|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5553220|NCT04073134|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5553221|NCT04073134|Antimetabolites|antimetabolites|mesh-ancestor
5553222|NCT04073134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553223|NCT04073134|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6151617|NCT01421134|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6151618|NCT01421134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6151619|NCT01421134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6151620|NCT01421134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151621|NCT01421134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6151622|NCT01421134|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6151623|NCT01421134|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6151624|NCT01421134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6151625|NCT01421134|Adrenergic Agents|adrenergic agents|mesh-ancestor
6151626|NCT01421134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6151627|NCT01421134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667844|NCT01529190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5553224|NCT04074122|Adenosine|adenosine|mesh-list
5553225|NCT04074122|Isoproterenol|isoproterenol|mesh-list
5553226|NCT04074122|Epinephrine|epinephrine|mesh-list
5553227|NCT04074122|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5553228|NCT04074122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5553229|NCT04074122|Adrenergic Agents|adrenergic agents|mesh-ancestor
5553230|NCT04074122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5553231|NCT04074122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553232|NCT04074122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553233|NCT04074122|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5553234|NCT04074122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5553235|NCT04074122|Autonomic Agents|autonomic agents|mesh-ancestor
6151628|NCT01421134|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6151629|NCT01421134|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6151630|NCT01421134|Serotonin Agents|serotonin agents|mesh-ancestor
6151631|NCT01421134|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6151632|NCT01421134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6151633|NCT01421134|Dopamine Agents|dopamine agents|mesh-ancestor
6151634|NCT01421147|Insulin Lispro|insulin lispro|mesh-list
6151635|NCT01421147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6151636|NCT01421147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151637|NCT01421186|Dexamethasone|dexamethasone|mesh-list
6151638|NCT01421186|Lenalidomide|lenalidomide|mesh-list
6477456|NCT00528658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553236|NCT04074122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5553237|NCT04074122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5553238|NCT04074122|Respiratory System Agents|respiratory system agents|mesh-ancestor
5553239|NCT04074122|Mydriatics|mydriatics|mesh-ancestor
5553240|NCT04074122|Sympathomimetics|sympathomimetics|mesh-ancestor
5553241|NCT04074122|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5553242|NCT04074122|Analgesics|analgesics|mesh-ancestor
5553243|NCT04074122|Sensory System Agents|sensory system agents|mesh-ancestor
5553244|NCT04074122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5553245|NCT04074122|Vasodilator Agents|vasodilator agents|mesh-ancestor
5553246|NCT04074122|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5553247|NCT04074122|Purinergic Agonists|purinergic agonists|mesh-ancestor
5553248|NCT04074122|Purinergic Agents|purinergic agents|mesh-ancestor
5553249|NCT04074122|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5553250|NCT04074122|Protective Agents|protective agents|mesh-ancestor
5553251|NCT04073927|Butyric Acid|butyric acid|mesh-list
5553252|NCT04073927|Histamine Antagonists|histamine antagonists|mesh-ancestor
5553253|NCT04073927|Histamine Agents|histamine agents|mesh-ancestor
6477457|NCT00528658|Antipyretics|antipyretics|mesh-ancestor
6477458|NCT00528671|Phenprocoumon|phenprocoumon|mesh-list
5553254|NCT04073927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5553255|NCT04073927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553256|NCT04073927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553257|NCT04073316|Warfarin|warfarin|mesh-list
5553258|NCT04073316|Rivaroxaban|rivaroxaban|mesh-list
5553259|NCT04073316|Anticoagulants|anticoagulants|mesh-ancestor
5553260|NCT04073316|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5553261|NCT04073316|Antithrombins|antithrombins|mesh-ancestor
5553262|NCT04073316|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5553263|NCT04073316|Protease Inhibitors|protease inhibitors|mesh-ancestor
5553264|NCT04073316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5553265|NCT04073316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553266|NCT04073303|Botulinum Toxins|botulinum toxins|mesh-list
5553267|NCT04073303|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5553268|NCT04073303|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5553269|NCT04073303|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5553270|NCT04073303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5553271|NCT04073303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477459|NCT00528671|Anticoagulants|anticoagulants|mesh-ancestor
6477460|NCT00528723|Albuterol|albuterol|mesh-list
6477461|NCT00528723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6477462|NCT00528723|Autonomic Agents|autonomic agents|mesh-ancestor
6477463|NCT00528723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6477464|NCT00528723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477465|NCT00528723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6477466|NCT00528723|Respiratory System Agents|respiratory system agents|mesh-ancestor
6477467|NCT00528723|Tocolytic Agents|tocolytic agents|mesh-ancestor
6477468|NCT00528723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6477469|NCT00528723|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6477470|NCT00528723|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6477471|NCT00528723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6151639|NCT01421186|Pomalidomide|pomalidomide|mesh-list
6151640|NCT01421186|Felzartamab|felzartamab|mesh-list
6151641|NCT01421186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6151642|NCT01421186|Antiemetics|antiemetics|mesh-ancestor
6151643|NCT01421186|Autonomic Agents|autonomic agents|mesh-ancestor
6477472|NCT00528723|Adrenergic Agents|adrenergic agents|mesh-ancestor
6477473|NCT00528723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6477474|NCT00528723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477475|NCT00528814|Hand Sanitizers|hand sanitizers|mesh-list
6477476|NCT00528814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6477477|NCT00528814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6477478|NCT00528814|Disinfectants|disinfectants|mesh-ancestor
6477479|NCT00528827|Nicardipine|nicardipine|mesh-list
6477480|NCT00528827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6477481|NCT00528827|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6477482|NCT00528827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6477483|NCT00528827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477484|NCT00528827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5553272|NCT04073303|Cholinergic Agents|cholinergic agents|mesh-ancestor
5553273|NCT04073303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5553274|NCT04073303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553275|NCT04073303|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5553276|NCT04073303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5553277|NCT04073056|Bupivacaine|bupivacaine|mesh-list
5553278|NCT04073056|Anesthetics, Local|anesthetics, local|mesh-ancestor
5553279|NCT04073056|Anesthetics|anesthetics|mesh-ancestor
5553280|NCT04073056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5553281|NCT04073056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553282|NCT04073056|Sensory System Agents|sensory system agents|mesh-ancestor
5553283|NCT04073056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5553284|NCT04072822|Prednisone|prednisone|mesh-list
5553285|NCT04072822|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5553286|NCT04072822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5553287|NCT04072822|Glucocorticoids|glucocorticoids|mesh-ancestor
5553288|NCT04072822|Hormones|hormones|mesh-ancestor
5553289|NCT04072822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6151644|NCT01421186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6151645|NCT01421186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151646|NCT01421186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6151647|NCT01421186|Glucocorticoids|glucocorticoids|mesh-ancestor
6151648|NCT01421186|Hormones|hormones|mesh-ancestor
5553290|NCT04072822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553291|NCT04072822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5553292|NCT04072822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5553293|NCT04072822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5553294|NCT04072640|Voriconazole|voriconazole|mesh-list
5553295|NCT04072640|Amphotericin B|amphotericin b|mesh-list
5553296|NCT04072640|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
5553297|NCT04072640|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
6205776|NCT02092220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6151649|NCT01421186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6151650|NCT01421186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6151651|NCT01421186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6151652|NCT01421186|Immunologic Factors|immunologic factors|mesh-ancestor
6151653|NCT01421186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6151654|NCT01421186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6151655|NCT01421186|Growth Substances|growth substances|mesh-ancestor
6151656|NCT01421186|Growth Inhibitors|growth inhibitors|mesh-ancestor
6151657|NCT01421225|Insulin|insulin|mesh-list
6151658|NCT01421225|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6151659|NCT01421225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6151660|NCT01421225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477485|NCT00528827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477486|NCT00528827|Vasodilator Agents|vasodilator agents|mesh-ancestor
6477487|NCT00528892|Raltegravir Potassium|raltegravir potassium|mesh-list
6477488|NCT00528892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6477489|NCT00528892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6151661|NCT01421303|Etanercept|etanercept|mesh-list
6151662|NCT01421303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6151663|NCT01421303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6477490|NCT00528892|Antiviral Agents|antiviral agents|mesh-ancestor
6477491|NCT00528892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6477492|NCT00528892|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6477493|NCT00528892|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6477494|NCT00528892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6477495|NCT00528892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477496|NCT00528918|Insulin glulisine|insulin glulisine|mesh-list
6477497|NCT00528918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6477498|NCT00528918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477499|NCT00528983|Azacitidine|azacitidine|mesh-list
6477500|NCT00528983|Cc-486|cc-486|mesh-list
6477501|NCT00528983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6477502|NCT00528983|Antimetabolites|antimetabolites|mesh-ancestor
6477503|NCT00528983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477504|NCT00528983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6477505|NCT00528983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6477506|NCT00529022|Carboplatin|carboplatin|mesh-list
6477507|NCT00529022|Azacitidine|azacitidine|mesh-list
6477508|NCT00529022|Valproic Acid|valproic acid|mesh-list
6477509|NCT00529022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6477510|NCT00529022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6477511|NCT00529022|Antimetabolites|antimetabolites|mesh-ancestor
6477512|NCT00529022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477513|NCT00529022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6477514|NCT00529022|Anticonvulsants|anticonvulsants|mesh-ancestor
6477515|NCT00529022|GABA Agents|gaba agents|mesh-ancestor
6477516|NCT00529022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6477517|NCT00529022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477518|NCT00529022|Antimanic Agents|antimanic agents|mesh-ancestor
6477519|NCT00529022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6477520|NCT00529022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6477521|NCT00529022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6477522|NCT00529269|Mycophenolic Acid|mycophenolic acid|mesh-list
6477523|NCT00529269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6477524|NCT00529269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6477525|NCT00529269|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6151664|NCT01421303|Analgesics|analgesics|mesh-ancestor
6151665|NCT01421303|Sensory System Agents|sensory system agents|mesh-ancestor
6151666|NCT01421303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6151667|NCT01421303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151668|NCT01421303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6151669|NCT01421303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6477526|NCT00529269|Antitubercular Agents|antitubercular agents|mesh-ancestor
6477527|NCT00529269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6477528|NCT00529269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6477529|NCT00529269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6477530|NCT00529269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477531|NCT00529295|Misoprostol|misoprostol|mesh-list
6477532|NCT00529295|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6477533|NCT00529295|Abortifacient Agents|abortifacient agents|mesh-ancestor
6667845|NCT01529229|Prednisolone|prednisolone|mesh-list
5553298|NCT04072640|Deoxycholic Acid|deoxycholic acid|mesh-list
5553299|NCT04072640|Antifungal Agents|antifungal agents|mesh-ancestor
5553300|NCT04072640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6151670|NCT01421303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6151671|NCT01421303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5553301|NCT04072640|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5553302|NCT04072640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5553303|NCT04072640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5553304|NCT04072640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553305|NCT04072640|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5553306|NCT04072640|Hormone Antagonists|hormone antagonists|mesh-ancestor
5553307|NCT04072640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5553308|NCT04072640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553309|NCT04072640|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5553310|NCT04072640|Amebicides|amebicides|mesh-ancestor
5553311|NCT04072640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5553312|NCT04072640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5553313|NCT04072640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5553314|NCT04072640|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5553315|NCT04072640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5553316|NCT04072770|Caseins|caseins|mesh-list
5553317|NCT04072770|Chelating Agents|chelating agents|mesh-ancestor
5553318|NCT04072770|Sequestering Agents|sequestering agents|mesh-ancestor
5553319|NCT04072770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477534|NCT00529295|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6477535|NCT00529295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477536|NCT00529295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6477537|NCT00529295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6477538|NCT00529295|Oxytocics|oxytocics|mesh-ancestor
6477539|NCT00529360|Clofarabine|clofarabine|mesh-list
6477540|NCT00529360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6477541|NCT00529360|Antimetabolites|antimetabolites|mesh-ancestor
6477542|NCT00529360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477543|NCT00529360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6477544|NCT00529425|Ropivacaine|ropivacaine|mesh-list
6477545|NCT00529425|Anesthetics, Local|anesthetics, local|mesh-ancestor
6477546|NCT00529425|Anesthetics|anesthetics|mesh-ancestor
6477547|NCT00529425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6151672|NCT01421303|Immunologic Factors|immunologic factors|mesh-ancestor
6151673|NCT01421342|Aripiprazole|aripiprazole|mesh-list
6151674|NCT01421342|Bupropion|bupropion|mesh-list
6151675|NCT01421342|Antidepressive Agents|antidepressive agents|mesh-list
6477548|NCT00529425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477549|NCT00529425|Sensory System Agents|sensory system agents|mesh-ancestor
6477550|NCT00529425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6477551|NCT00529594|Etoricoxib|etoricoxib|mesh-list
6477552|NCT00529594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6477553|NCT00529594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6477554|NCT00529594|Analgesics|analgesics|mesh-ancestor
6477555|NCT00529594|Sensory System Agents|sensory system agents|mesh-ancestor
5553320|NCT04072900|Imiquimod|imiquimod|mesh-list
5553321|NCT04072900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5553322|NCT04072900|Immunologic Factors|immunologic factors|mesh-ancestor
5553323|NCT04072900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553324|NCT04072900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5553325|NCT04072900|Interferon Inducers|interferon inducers|mesh-ancestor
5553326|NCT04072601|Atorvastatin|atorvastatin|mesh-list
5553327|NCT04072601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5553328|NCT04072601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5553329|NCT04072601|Antimetabolites|antimetabolites|mesh-ancestor
5553330|NCT04072601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553331|NCT04072601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5553332|NCT04072601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5553333|NCT04072601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5553334|NCT04072341|Propolis|propolis|mesh-list
5553335|NCT04072341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5553336|NCT04072497|Vaccines|vaccines|mesh-list
5553337|NCT04072497|Immunologic Factors|immunologic factors|mesh-ancestor
5553338|NCT04072497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553339|NCT04072263|Interferons|interferons|mesh-list
5553340|NCT04072263|Interferon-alpha|interferon-alpha|mesh-list
6477556|NCT00529594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6477557|NCT00529594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477558|NCT00529594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6477559|NCT00529594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6477560|NCT00529594|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5553341|NCT04072263|Interferon alpha-2|interferon alpha-2|mesh-list
5553342|NCT04072263|Paclitaxel|paclitaxel|mesh-list
5553343|NCT04072263|Carboplatin|carboplatin|mesh-list
6151676|NCT01421342|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6477561|NCT00529594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6477562|NCT00529594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6477563|NCT00529594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477564|NCT00529620|Pyrimethamine|pyrimethamine|mesh-list
6477565|NCT00529620|Piperaquine|piperaquine|mesh-list
6477566|NCT00529620|Sulfadoxine|sulfadoxine|mesh-list
6477567|NCT00529620|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6477568|NCT00529620|Amodiaquine|amodiaquine|mesh-list
6151677|NCT01421342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6151678|NCT01421342|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6151679|NCT01421342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6151680|NCT01421342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6151681|NCT01421342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6151682|NCT01421342|Dopamine Agents|dopamine agents|mesh-ancestor
6151683|NCT01421342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6151684|NCT01421342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151685|NCT01421342|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6151686|NCT01421342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6151687|NCT01421342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6151688|NCT01421342|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6151689|NCT01421342|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6151690|NCT01421342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6151691|NCT01421342|Dopamine Agonists|dopamine agonists|mesh-ancestor
6151692|NCT01421342|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6151693|NCT01421342|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6151694|NCT01421342|Serotonin Agents|serotonin agents|mesh-ancestor
6151695|NCT01421342|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6151696|NCT01421342|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6151697|NCT01421342|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6151698|NCT01421342|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6151699|NCT01421355|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6151700|NCT01421355|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6151701|NCT01421355|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6151702|NCT01421355|Protease Inhibitors|protease inhibitors|mesh-ancestor
6151703|NCT01421355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6151704|NCT01421355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6151705|NCT01421355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6151706|NCT01421355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6151707|NCT01421355|Antiviral Agents|antiviral agents|mesh-ancestor
6151708|NCT01421355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6151709|NCT01421459|Insulin Glargine|insulin glargine|mesh-list
6151710|NCT01421459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6151711|NCT01421459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151712|NCT01421472|Paclitaxel|paclitaxel|mesh-list
6151713|NCT01421472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6151714|NCT01421472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6151715|NCT01421472|Tubulin Modulators|tubulin modulators|mesh-ancestor
6151716|NCT01421472|Antimitotic Agents|antimitotic agents|mesh-ancestor
6151717|NCT01421472|Mitosis Modulators|mitosis modulators|mesh-ancestor
6151718|NCT01421472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6151719|NCT01421498|Lifitegrast|lifitegrast|mesh-list
6151720|NCT01421498|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6151721|NCT01421498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6151722|NCT01421511|Linezolid|linezolid|mesh-list
6151723|NCT01421511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6151724|NCT01421511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6151725|NCT01421511|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6151726|NCT01421511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6151727|NCT01421511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6151728|NCT01421589|Hormones|hormones|mesh-list
6151729|NCT01421589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6151730|NCT01421589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205777|NCT02092285|Golimumab|golimumab|mesh-list
6205778|NCT02092285|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6205779|NCT02092285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6205780|NCT02092285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6477569|NCT00529620|Artenimol|artenimol|mesh-list
5553344|NCT04072263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5553345|NCT04072263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5553346|NCT04072263|Tubulin Modulators|tubulin modulators|mesh-ancestor
5553347|NCT04072263|Antimitotic Agents|antimitotic agents|mesh-ancestor
5553348|NCT04072263|Mitosis Modulators|mitosis modulators|mesh-ancestor
5603048|NCT03509012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6477570|NCT00529620|Sulfalene|sulfalene|mesh-list
6151731|NCT01421641|Lidocaine|lidocaine|mesh-list
6151732|NCT01421641|Anesthetics, Local|anesthetics, local|mesh-ancestor
6151733|NCT01421641|Anesthetics|anesthetics|mesh-ancestor
6151734|NCT01421641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6477571|NCT00529620|Antimalarials|antimalarials|mesh-ancestor
6477572|NCT00529620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6477573|NCT00529620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6477574|NCT00529620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6477575|NCT00529620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5553349|NCT04072263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553350|NCT04072263|Antiviral Agents|antiviral agents|mesh-ancestor
5553351|NCT04072263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6477576|NCT00529620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6477577|NCT00529620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477578|NCT00529620|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6151735|NCT01421641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151736|NCT01421641|Sensory System Agents|sensory system agents|mesh-ancestor
6151737|NCT01421641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6151738|NCT01421641|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6151739|NCT01421641|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6151740|NCT01421641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6151741|NCT01421641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6151742|NCT01421641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6151743|NCT01421667|Rituximab|rituximab|mesh-list
6151744|NCT01421667|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6151745|NCT01421667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6151746|NCT01421667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6151747|NCT01421667|Immunologic Factors|immunologic factors|mesh-ancestor
6151748|NCT01421667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151749|NCT01421667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6151750|NCT01421719|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6151751|NCT01421719|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6151752|NCT01421719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6151753|NCT01421719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477579|NCT00529620|Renal Agents|renal agents|mesh-ancestor
6477580|NCT00529646|APD791|apd791|mesh-list
5553352|NCT04072263|Immunologic Factors|immunologic factors|mesh-ancestor
5553353|NCT04072263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553354|NCT04072471|Lesinurad|lesinurad|mesh-list
5553355|NCT04072471|Gout Suppressants|gout suppressants|mesh-ancestor
5553356|NCT04072471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5553357|NCT04072471|Uricosuric Agents|uricosuric agents|mesh-ancestor
5553358|NCT04072471|Renal Agents|renal agents|mesh-ancestor
5553359|NCT04072445|Trifluridine|trifluridine|mesh-list
5553360|NCT04072445|Irinotecan|irinotecan|mesh-list
5553361|NCT04072445|Camptothecin|camptothecin|mesh-list
5553362|NCT04072445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5553363|NCT04072445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5553364|NCT04072445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5553365|NCT04072445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553366|NCT04072445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5553367|NCT04072445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5553368|NCT04072445|Antimetabolites|antimetabolites|mesh-ancestor
6667846|NCT01529229|Betamethasone|betamethasone|mesh-list
6667847|NCT01529229|Desloratadine|desloratadine|mesh-list
6667848|NCT01529229|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
6667849|NCT01529229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6667850|NCT01529229|Glucocorticoids|glucocorticoids|mesh-ancestor
6667851|NCT01529229|Hormones|hormones|mesh-ancestor
6667852|NCT01529229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6667853|NCT01529229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667854|NCT01529229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6667855|NCT01529229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6667856|NCT01529229|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6667857|NCT01529229|Respiratory System Agents|respiratory system agents|mesh-ancestor
6667858|NCT01529229|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6667859|NCT01529229|Cholinergic Agents|cholinergic agents|mesh-ancestor
6667860|NCT01529229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6667861|NCT01529229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667862|NCT01529229|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6667863|NCT01529229|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6667864|NCT01529229|Histamine Antagonists|histamine antagonists|mesh-ancestor
6477581|NCT00529646|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6477582|NCT00529646|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6477583|NCT00529646|Serotonin Agents|serotonin agents|mesh-ancestor
6477584|NCT00529646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6477585|NCT00529646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477586|NCT00529646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477587|NCT00529750|Atenolol|atenolol|mesh-list
6477588|NCT00529750|Irbesartan|irbesartan|mesh-list
6477589|NCT00529750|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6477590|NCT00529750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6477591|NCT00529750|Sympatholytics|sympatholytics|mesh-ancestor
6477592|NCT00529750|Autonomic Agents|autonomic agents|mesh-ancestor
6477593|NCT00529750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6477594|NCT00529750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477595|NCT00529750|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6477596|NCT00529750|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6151754|NCT01421719|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6151755|NCT01421719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6151756|NCT01421719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6151757|NCT01421719|Cholinergic Agents|cholinergic agents|mesh-ancestor
6151758|NCT01421719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6151759|NCT01422135|Contraceptive Agents|contraceptive agents|mesh-list
6151760|NCT01422135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6151761|NCT01422135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151762|NCT01422161|Botulinum Toxins|botulinum toxins|mesh-list
6151763|NCT01422161|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6151764|NCT01422161|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6151765|NCT01422161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6151766|NCT01422161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6151767|NCT01422161|Cholinergic Agents|cholinergic agents|mesh-ancestor
6151768|NCT01422161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6151769|NCT01422161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553369|NCT04072445|Antiviral Agents|antiviral agents|mesh-ancestor
5553370|NCT04072445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6151770|NCT01422161|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6151771|NCT01422161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6151772|NCT01422200|Vaccines|vaccines|mesh-list
6151773|NCT01422200|Immunologic Factors|immunologic factors|mesh-ancestor
6151774|NCT01422200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151775|NCT01422213|Vortioxetine|vortioxetine|mesh-list
6151776|NCT01422213|Antidepressive Agents|antidepressive agents|mesh-ancestor
6151777|NCT01422213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6151778|NCT01422213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6151779|NCT01422213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6151780|NCT01422213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6151781|NCT01422213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151782|NCT01422213|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6151783|NCT01422213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6151784|NCT01422213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6151785|NCT01422213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6151786|NCT01422213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6151787|NCT01422213|Serotonin Agents|serotonin agents|mesh-ancestor
6151788|NCT01422213|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6151789|NCT01422213|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6151790|NCT01422213|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5553371|NCT04072146|Varenicline|varenicline|mesh-list
5553372|NCT04072146|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5553373|NCT04072146|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5553374|NCT04072146|Cholinergic Agents|cholinergic agents|mesh-ancestor
5553375|NCT04072146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5553376|NCT04072146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553377|NCT04072146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553378|NCT04072068|Edoxaban|edoxaban|mesh-list
5553379|NCT04072068|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5553380|NCT04072068|Antithrombins|antithrombins|mesh-ancestor
5553381|NCT04072068|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5553382|NCT04072068|Protease Inhibitors|protease inhibitors|mesh-ancestor
5553383|NCT04072068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5553384|NCT04072068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553385|NCT04072068|Anticoagulants|anticoagulants|mesh-ancestor
5553386|NCT04072198|Leucovorin|leucovorin|mesh-list
5553387|NCT04072198|Bevacizumab|bevacizumab|mesh-list
5553388|NCT04072198|Nivolumab|nivolumab|mesh-list
5553389|NCT04072198|Oxaliplatin|oxaliplatin|mesh-list
5553390|NCT04072198|Irinotecan|irinotecan|mesh-list
5553391|NCT04072198|Fluorouracil|fluorouracil|mesh-list
6151791|NCT01422213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6151792|NCT01422226|Alprostadil|alprostadil|mesh-list
6151793|NCT01422226|Misoprostol|misoprostol|mesh-list
6151794|NCT01422226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6151795|NCT01422226|Abortifacient Agents|abortifacient agents|mesh-ancestor
6151796|NCT01422226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5553392|NCT04072198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5553393|NCT04072198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5553394|NCT04072198|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5553395|NCT04072198|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5553396|NCT04072198|Growth Substances|growth substances|mesh-ancestor
5553397|NCT04072198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553398|NCT04072198|Growth Inhibitors|growth inhibitors|mesh-ancestor
6151797|NCT01422226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151798|NCT01422226|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6151799|NCT01422226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6667865|NCT01529229|Histamine Agents|histamine agents|mesh-ancestor
6667866|NCT01529242|Prednisolone|prednisolone|mesh-list
6667867|NCT01529242|Betamethasone|betamethasone|mesh-list
6667868|NCT01529242|Desloratadine|desloratadine|mesh-list
6667869|NCT01529242|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
6667870|NCT01529242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6667871|NCT01529242|Glucocorticoids|glucocorticoids|mesh-ancestor
6667872|NCT01529242|Hormones|hormones|mesh-ancestor
6151800|NCT01422226|Oxytocics|oxytocics|mesh-ancestor
6151801|NCT01422226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6151802|NCT01422226|Vasodilator Agents|vasodilator agents|mesh-ancestor
6667873|NCT01529242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6667874|NCT01529242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667875|NCT01529242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6667876|NCT01529242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6667877|NCT01529242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6667878|NCT01529242|Respiratory System Agents|respiratory system agents|mesh-ancestor
6667879|NCT01529242|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6667880|NCT01529242|Cholinergic Agents|cholinergic agents|mesh-ancestor
6667881|NCT01529242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6667882|NCT01529242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667883|NCT01529242|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6667884|NCT01529242|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6667885|NCT01529242|Histamine Antagonists|histamine antagonists|mesh-ancestor
6667886|NCT01529242|Histamine Agents|histamine agents|mesh-ancestor
6667887|NCT01529255|Telbivudine|telbivudine|mesh-list
6667888|NCT01529255|Antiviral Agents|antiviral agents|mesh-ancestor
5553399|NCT04072198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6151803|NCT01422226|Urological Agents|urological agents|mesh-ancestor
6151804|NCT01422304|Atropine|atropine|mesh-list
6151805|NCT01422304|Glycopyrrolate|glycopyrrolate|mesh-list
6151806|NCT01422304|Neostigmine|neostigmine|mesh-list
6151807|NCT01422304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6151808|NCT01422304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6151809|NCT01422304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6151810|NCT01422304|Autonomic Agents|autonomic agents|mesh-ancestor
6151811|NCT01422304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6151812|NCT01422304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151813|NCT01422304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6151814|NCT01422304|Respiratory System Agents|respiratory system agents|mesh-ancestor
6151815|NCT01422304|Mydriatics|mydriatics|mesh-ancestor
6151816|NCT01422304|Parasympatholytics|parasympatholytics|mesh-ancestor
6151817|NCT01422304|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6151818|NCT01422304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6151819|NCT01422304|Cholinergic Agents|cholinergic agents|mesh-ancestor
6151820|NCT01422304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6151821|NCT01422304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6151822|NCT01422304|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6151823|NCT01422304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6151824|NCT01422304|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6151825|NCT01422369|Ritonavir|ritonavir|mesh-list
5603049|NCT03509012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6151826|NCT01422369|Darunavir|darunavir|mesh-list
6151827|NCT01422369|Pitavastatin|pitavastatin|mesh-list
6151828|NCT01422369|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6151829|NCT01422369|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6151830|NCT01422369|Protease Inhibitors|protease inhibitors|mesh-ancestor
6151831|NCT01422369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6151832|NCT01422369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6151833|NCT01422369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6151834|NCT01422369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6151835|NCT01422369|Antiviral Agents|antiviral agents|mesh-ancestor
6151836|NCT01422369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6151837|NCT01422369|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6151838|NCT01422369|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6151839|NCT01422369|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6151840|NCT01422369|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6151841|NCT01422369|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6151842|NCT01422369|Antimetabolites|antimetabolites|mesh-ancestor
6151843|NCT01422369|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6151844|NCT01422382|Diltiazem|diltiazem|mesh-list
6151845|NCT01422382|Pitavastatin|pitavastatin|mesh-list
6151846|NCT01422382|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6151847|NCT01422382|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6151848|NCT01422382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6151849|NCT01422382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553400|NCT04072198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553401|NCT04072198|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5553402|NCT04072198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5553403|NCT04072198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5553404|NCT04072198|Antidotes|antidotes|mesh-ancestor
5553405|NCT04072198|Protective Agents|protective agents|mesh-ancestor
5553406|NCT04072198|Vitamin B Complex|vitamin b complex|mesh-ancestor
5553407|NCT04072198|Vitamins|vitamins|mesh-ancestor
5553408|NCT04072198|Micronutrients|micronutrients|mesh-ancestor
5553409|NCT04072198|Antimetabolites|antimetabolites|mesh-ancestor
5553410|NCT04072198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5553411|NCT04072198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5553412|NCT04072198|Immunologic Factors|immunologic factors|mesh-ancestor
6151850|NCT01422382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6151851|NCT01422382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151852|NCT01422382|Vasodilator Agents|vasodilator agents|mesh-ancestor
6151853|NCT01422382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6151854|NCT01422382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6151855|NCT01422382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6151856|NCT01422382|Antimetabolites|antimetabolites|mesh-ancestor
6151857|NCT01422382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6151858|NCT01422382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6151859|NCT01422408|Fluocinonide|fluocinonide|mesh-list
5553413|NCT04072107|Capecitabine|capecitabine|mesh-list
5553414|NCT04072107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5553415|NCT04072107|Antimetabolites|antimetabolites|mesh-ancestor
5553416|NCT04072107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553417|NCT04072107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5553418|NCT04072042|Apatinib|apatinib|mesh-list
5553419|NCT04072042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6151860|NCT01422408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6151861|NCT01422408|Glucocorticoids|glucocorticoids|mesh-ancestor
6151862|NCT01422408|Hormones|hormones|mesh-ancestor
6151863|NCT01422408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6151864|NCT01422408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151865|NCT01422408|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6151866|NCT01422434|Calcitriol|calcitriol|mesh-list
6151867|NCT01422434|Betamethasone|betamethasone|mesh-list
6151868|NCT01422434|Betamethasone Valerate|betamethasone valerate|mesh-list
6151869|NCT01422434|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5553420|NCT04072042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6151870|NCT01422434|Betamethasone benzoate|betamethasone benzoate|mesh-list
5553421|NCT04072042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6151871|NCT01422434|Calcipotriene|calcipotriene|mesh-list
5553422|NCT04072042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553423|NCT04071977|Antioxidants|antioxidants|mesh-list
5553424|NCT04071977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553425|NCT04071977|Protective Agents|protective agents|mesh-ancestor
5553426|NCT04071977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553427|NCT04071756|Tazarotene|tazarotene|mesh-list
5553428|NCT04071756|Dermatologic Agents|dermatologic agents|mesh-ancestor
5553429|NCT04071756|Keratolytic Agents|keratolytic agents|mesh-ancestor
5553430|NCT04072328|Midazolam|midazolam|mesh-list
5553431|NCT04072328|Propofol|propofol|mesh-list
5553432|NCT04072328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5553433|NCT04072328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5553434|NCT04072328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553435|NCT04072328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5553436|NCT04072328|Anesthetics, General|anesthetics, general|mesh-ancestor
6151872|NCT01422434|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
6151873|NCT01422434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6151874|NCT01422434|Glucocorticoids|glucocorticoids|mesh-ancestor
6151875|NCT01422434|Hormones|hormones|mesh-ancestor
6151876|NCT01422434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6151877|NCT01422434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151878|NCT01422434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6151879|NCT01422434|Respiratory System Agents|respiratory system agents|mesh-ancestor
6151880|NCT01422434|Dermatologic Agents|dermatologic agents|mesh-ancestor
6151881|NCT01422434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6151882|NCT01422434|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6151883|NCT01422434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6151884|NCT01422434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6151885|NCT01422434|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6151886|NCT01422434|Vitamins|vitamins|mesh-ancestor
6151887|NCT01422434|Micronutrients|micronutrients|mesh-ancestor
6151888|NCT01422434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6151889|NCT01422538|Mannitol|mannitol|mesh-list
6151890|NCT01422538|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6151891|NCT01422538|Diuretics|diuretics|mesh-ancestor
5553437|NCT04072328|Anesthetics|anesthetics|mesh-ancestor
5553438|NCT04072328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5553439|NCT04072328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5553440|NCT04072328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5553441|NCT04072328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5553442|NCT04072328|GABA Modulators|gaba modulators|mesh-ancestor
5553443|NCT04072328|GABA Agents|gaba agents|mesh-ancestor
5553444|NCT04072328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5553445|NCT04072328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603050|NCT03509012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5603051|NCT03508739|Valsartan|valsartan|mesh-list
5603052|NCT03508739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5603053|NCT03508739|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5603054|NCT03508739|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6151892|NCT01422538|Natriuretic Agents|natriuretic agents|mesh-ancestor
6151893|NCT01422538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151894|NCT01422720|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
6151895|NCT01422720|Anticonvulsants|anticonvulsants|mesh-ancestor
6477597|NCT00529750|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6477598|NCT00529750|Adrenergic Agents|adrenergic agents|mesh-ancestor
6477599|NCT00529750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6477600|NCT00529750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477601|NCT00529750|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6477602|NCT00529750|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6477603|NCT00529841|Hydrocortisone|hydrocortisone|mesh-list
5603055|NCT03508739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603056|NCT03484819|Nivolumab|nivolumab|mesh-list
5603057|NCT03484819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5603058|NCT03484819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5603059|NCT03484819|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5603060|NCT03484819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603061|NCT03473561|Racecadotril|racecadotril|mesh-list
5603062|NCT03473561|Antidiarrheals|antidiarrheals|mesh-ancestor
5603063|NCT03473561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5603064|NCT03473561|Protease Inhibitors|protease inhibitors|mesh-ancestor
5603065|NCT03473561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6477604|NCT00529841|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
5603066|NCT03473561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553446|NCT04071769|Xenon|xenon|mesh-list
5553447|NCT04071769|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5553448|NCT04071769|Anesthetics, General|anesthetics, general|mesh-ancestor
5553449|NCT04071769|Anesthetics|anesthetics|mesh-ancestor
5553450|NCT04071769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6477605|NCT00529841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6477606|NCT00529867|Lumefantrine|lumefantrine|mesh-list
6477607|NCT00529867|Artemether|artemether|mesh-list
6477608|NCT00529867|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6477609|NCT00529867|Antimalarials|antimalarials|mesh-ancestor
6477610|NCT00529867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6477611|NCT00529867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6667889|NCT01529255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6151896|NCT01422720|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6151897|NCT01422720|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6151898|NCT01422720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6151899|NCT01422720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6151900|NCT01422876|Linagliptin|linagliptin|mesh-list
6151901|NCT01422876|Empagliflozin|empagliflozin|mesh-list
6151902|NCT01422876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6151903|NCT01422876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151904|NCT01422876|Incretins|incretins|mesh-ancestor
6151905|NCT01422876|Hormones|hormones|mesh-ancestor
6151906|NCT01422876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6151907|NCT01422876|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6151908|NCT01422876|Protease Inhibitors|protease inhibitors|mesh-ancestor
6151909|NCT01422876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6151910|NCT01422876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6151911|NCT01422876|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6667890|NCT01529255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6667891|NCT01529255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6667892|NCT01529255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667893|NCT01529294|Iloperidone|iloperidone|mesh-list
6667894|NCT01529294|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6667895|NCT01529294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6667896|NCT01529294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6667897|NCT01529294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667898|NCT01529294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6667899|NCT01529320|Methylprednisolone|methylprednisolone|mesh-list
6667900|NCT01529320|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6667901|NCT01529320|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6667902|NCT01529320|Prednisolone|prednisolone|mesh-list
6667903|NCT01529320|Prednisolone acetate|prednisolone acetate|mesh-list
6667904|NCT01529320|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
6151912|NCT01422915|Colestipol|colestipol|mesh-list
6151913|NCT01422915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5553451|NCT04071769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553452|NCT04071821|Cetirizine|cetirizine|mesh-list
5553453|NCT04071821|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5553454|NCT04071821|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5553455|NCT04071821|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5553456|NCT04071821|Histamine Antagonists|histamine antagonists|mesh-ancestor
5553457|NCT04071821|Histamine Agents|histamine agents|mesh-ancestor
6151914|NCT01422915|Antimetabolites|antimetabolites|mesh-ancestor
6477612|NCT00529867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5553458|NCT04071821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6477613|NCT00529880|Cytarabine|cytarabine|mesh-list
6477614|NCT00529880|Fludarabine|fludarabine|mesh-list
6477615|NCT00529880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6477616|NCT00529880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5553459|NCT04071821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6151915|NCT01422915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6151916|NCT01422915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6151917|NCT01422915|Sequestering Agents|sequestering agents|mesh-ancestor
6151918|NCT01423162|Ascorbic Acid|ascorbic acid|mesh-list
6151919|NCT01423162|Antioxidants|antioxidants|mesh-ancestor
6151920|NCT01423162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6151921|NCT01423162|Protective Agents|protective agents|mesh-ancestor
6151922|NCT01423162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667905|NCT01529320|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6667906|NCT01529320|Prednisolone phosphate|prednisolone phosphate|mesh-list
5553460|NCT04071821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553461|NCT04071639|Ubiquinone|ubiquinone|mesh-list
5553462|NCT04071639|Haloperidol|haloperidol|mesh-list
5553463|NCT04071639|Risperidone|risperidone|mesh-list
5553464|NCT04071639|Haloperidol decanoate|haloperidol decanoate|mesh-list
5553465|NCT04071639|Sertraline|sertraline|mesh-list
5553466|NCT04071639|Tetrabenazine|tetrabenazine|mesh-list
5553467|NCT04071639|Idebenone|idebenone|mesh-list
5553468|NCT04071639|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5553469|NCT04071639|Serotonin Agents|serotonin agents|mesh-ancestor
5553470|NCT04071639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5553471|NCT04071639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553472|NCT04071639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553473|NCT04071639|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5553474|NCT04071639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5553475|NCT04071639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5553476|NCT04071639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5553477|NCT04071639|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5553478|NCT04071639|Dopamine Agents|dopamine agents|mesh-ancestor
5553479|NCT04071639|Antidepressive Agents|antidepressive agents|mesh-ancestor
5553480|NCT04071639|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5553481|NCT04071639|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5553482|NCT04071639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5553483|NCT04071639|Antiemetics|antiemetics|mesh-ancestor
6151923|NCT01423162|Vitamins|vitamins|mesh-ancestor
6151924|NCT01423162|Micronutrients|micronutrients|mesh-ancestor
6151925|NCT01423253|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
6151926|NCT01423253|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6151927|NCT01423253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6151928|NCT01423253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6477617|NCT00529880|Antimetabolites|antimetabolites|mesh-ancestor
6477618|NCT00529880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477619|NCT00529880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6477620|NCT00529880|Immunologic Factors|immunologic factors|mesh-ancestor
6477621|NCT00529880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477622|NCT00529880|Antiviral Agents|antiviral agents|mesh-ancestor
6477623|NCT00529880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6477624|NCT00530101|Doxorubicin|doxorubicin|mesh-list
6477625|NCT00530101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6477626|NCT00530101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6477627|NCT00530101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6477628|NCT00530101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6477629|NCT00530101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6477630|NCT00530101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477631|NCT00530127|Deferiprone|deferiprone|mesh-list
6477632|NCT00530127|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6477633|NCT00530127|Chelating Agents|chelating agents|mesh-ancestor
6477634|NCT00530127|Sequestering Agents|sequestering agents|mesh-ancestor
6477635|NCT00530127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488815|NCT00586976|Anesthetics|anesthetics|mesh-ancestor
6488816|NCT00586976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6488817|NCT00586976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488818|NCT00586976|Sensory System Agents|sensory system agents|mesh-ancestor
6477636|NCT00530140|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
6477637|NCT00530140|Immunologic Factors|immunologic factors|mesh-ancestor
6477638|NCT00530140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151929|NCT01423253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151930|NCT01423253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6151931|NCT01423253|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6151932|NCT01423253|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6151933|NCT01423253|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6151934|NCT01423253|Adrenergic Agents|adrenergic agents|mesh-ancestor
6151935|NCT01423253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6151936|NCT01423253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6151937|NCT01423253|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6151938|NCT01423253|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6151939|NCT01423253|Serotonin Agents|serotonin agents|mesh-ancestor
6151940|NCT01423253|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6151941|NCT01423253|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6151942|NCT01423253|Dopamine Agents|dopamine agents|mesh-ancestor
6151943|NCT01423604|Capecitabine|capecitabine|mesh-list
6151944|NCT01423604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6151945|NCT01423604|Antimetabolites|antimetabolites|mesh-ancestor
6151946|NCT01423604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6151947|NCT01423604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6151948|NCT01423812|Ritonavir|ritonavir|mesh-list
6151949|NCT01423812|Darunavir|darunavir|mesh-list
5553484|NCT04071639|Autonomic Agents|autonomic agents|mesh-ancestor
5553485|NCT04071639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5553486|NCT04071639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6151950|NCT01423812|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6151951|NCT01423812|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6151952|NCT01423812|Protease Inhibitors|protease inhibitors|mesh-ancestor
6151953|NCT01423812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6151954|NCT01423812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6151955|NCT01423812|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6151956|NCT01423812|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6151957|NCT01423812|Antiviral Agents|antiviral agents|mesh-ancestor
6151958|NCT01423812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6151959|NCT01423812|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6151960|NCT01423812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6151961|NCT01423916|Moxifloxacin|moxifloxacin|mesh-list
6151962|NCT01423916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6151963|NCT01423916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6151964|NCT01423916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6151965|NCT01423916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6151966|NCT01423916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6151967|NCT01423916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6151968|NCT01423916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6151969|NCT01424033|Acetylcysteine|acetylcysteine|mesh-list
5553487|NCT04071639|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5553488|NCT04071639|Antioxidants|antioxidants|mesh-ancestor
5553489|NCT04071639|Protective Agents|protective agents|mesh-ancestor
5553490|NCT04071639|Micronutrients|micronutrients|mesh-ancestor
5553491|NCT04071639|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5553492|NCT04071639|Adrenergic Agents|adrenergic agents|mesh-ancestor
5553493|NCT04071574|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5553494|NCT04071574|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5553495|NCT04071574|Cetrorelix|cetrorelix|mesh-list
5553496|NCT04071574|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
5553497|NCT04071574|Hormones|hormones|mesh-ancestor
5553498|NCT04071574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5553499|NCT04071574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553500|NCT04071574|Luteolytic Agents|luteolytic agents|mesh-ancestor
5553501|NCT04071574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5553502|NCT04071574|Contraceptive Agents|contraceptive agents|mesh-ancestor
6151970|NCT01424033|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6151971|NCT01424033|Antiviral Agents|antiviral agents|mesh-ancestor
6151972|NCT01424033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6151973|NCT01424033|Expectorants|expectorants|mesh-ancestor
6151974|NCT01424033|Respiratory System Agents|respiratory system agents|mesh-ancestor
5553503|NCT04071574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5553504|NCT04071574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5553505|NCT04071574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5553506|NCT04071574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6151975|NCT01424033|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5553507|NCT04071574|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5553508|NCT04071574|Fertility Agents|fertility agents|mesh-ancestor
5553509|NCT04071574|Hormone Antagonists|hormone antagonists|mesh-ancestor
5553510|NCT04071262|Prednisolone|prednisolone|mesh-list
5553511|NCT04071262|Abiraterone Acetate|abiraterone acetate|mesh-list
5553512|NCT04071262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5553513|NCT04071262|Glucocorticoids|glucocorticoids|mesh-ancestor
5553514|NCT04071262|Hormones|hormones|mesh-ancestor
5553515|NCT04071262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6151976|NCT01424033|Antioxidants|antioxidants|mesh-ancestor
6477639|NCT00530361|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6477640|NCT00530361|Natriuretic Agents|natriuretic agents|mesh-ancestor
6477641|NCT00530361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151977|NCT01424033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6151978|NCT01424033|Protective Agents|protective agents|mesh-ancestor
6151979|NCT01424033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151980|NCT01424033|Antidotes|antidotes|mesh-ancestor
6151981|NCT01424228|Prucalopride|prucalopride|mesh-list
6151982|NCT01424228|Laxatives|laxatives|mesh-ancestor
6477642|NCT00530387|Ibuprofen|ibuprofen|mesh-list
6477643|NCT00530387|Diclofenac|diclofenac|mesh-list
6477644|NCT00530387|Ketoprofen|ketoprofen|mesh-list
6477645|NCT00530387|Piroxicam|piroxicam|mesh-list
6477646|NCT00530387|Salicylates|salicylates|mesh-list
6477647|NCT00530387|Etofenamate|etofenamate|mesh-list
6477648|NCT00530387|Sunscreening Agents|sunscreening agents|mesh-list
6477649|NCT00530387|Homosalate|homosalate|mesh-list
6477650|NCT00530387|Octylmethoxycinnamate|octylmethoxycinnamate|mesh-list
6477651|NCT00530387|Benzophenone|benzophenone|mesh-list
6477652|NCT00530387|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6477653|NCT00530387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6477654|NCT00530387|Analgesics|analgesics|mesh-ancestor
6477655|NCT00530387|Sensory System Agents|sensory system agents|mesh-ancestor
6477656|NCT00530387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6477657|NCT00530387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477658|NCT00530387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6151983|NCT01424228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6151984|NCT01424228|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
6151985|NCT01424228|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6151986|NCT01424228|Serotonin Agents|serotonin agents|mesh-ancestor
6151987|NCT01424228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6151988|NCT01424228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6151989|NCT01424228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151990|NCT01424566|Nabiximols|nabiximols|mesh-list
6151991|NCT01424566|Analgesics|analgesics|mesh-ancestor
6151992|NCT01424566|Sensory System Agents|sensory system agents|mesh-ancestor
6151993|NCT01424566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6151994|NCT01424566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151995|NCT01424644|Vaccines|vaccines|mesh-list
6151996|NCT01424644|Immunologic Factors|immunologic factors|mesh-ancestor
6151997|NCT01424644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6151998|NCT01424813|Albuterol|albuterol|mesh-list
6151999|NCT01424813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6152000|NCT01424813|Autonomic Agents|autonomic agents|mesh-ancestor
6152001|NCT01424813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6152002|NCT01424813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152003|NCT01424813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6152004|NCT01424813|Respiratory System Agents|respiratory system agents|mesh-ancestor
6152005|NCT01424813|Tocolytic Agents|tocolytic agents|mesh-ancestor
6152006|NCT01424813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6152007|NCT01424813|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6477659|NCT00530387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6477660|NCT00530387|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6477661|NCT00530387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6477662|NCT00530387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477663|NCT00530387|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6152008|NCT01424813|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6152009|NCT01424813|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6477664|NCT00530387|Protective Agents|protective agents|mesh-ancestor
5553516|NCT04071262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553517|NCT04071262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5553518|NCT04071262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5553519|NCT04071262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5553520|NCT04071262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5553521|NCT04071262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553522|NCT04071262|Hormone Antagonists|hormone antagonists|mesh-ancestor
6477665|NCT00530387|Dermatologic Agents|dermatologic agents|mesh-ancestor
6152010|NCT01424813|Adrenergic Agents|adrenergic agents|mesh-ancestor
6152011|NCT01424813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6152012|NCT01424813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152013|NCT01424930|Prednisone|prednisone|mesh-list
6152014|NCT01424930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6152015|NCT01424930|Glucocorticoids|glucocorticoids|mesh-ancestor
6152016|NCT01424930|Hormones|hormones|mesh-ancestor
6152017|NCT01424930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6152018|NCT01424930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152019|NCT01424930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6152020|NCT01424930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6152021|NCT01425203|Ribavirin|ribavirin|mesh-list
6152022|NCT01425203|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6152023|NCT01425203|Antimetabolites|antimetabolites|mesh-ancestor
6152024|NCT01425203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152025|NCT01425203|Antiviral Agents|antiviral agents|mesh-ancestor
6152026|NCT01425203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6152027|NCT01425229|Bosentan|bosentan|mesh-list
6152028|NCT01425229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5553523|NCT04071262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5553524|NCT04071353|Interferons|interferons|mesh-list
5553525|NCT04071353|Ribavirin|ribavirin|mesh-list
6152029|NCT01425229|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6152030|NCT01425229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152031|NCT01425281|Everolimus|everolimus|mesh-list
6152032|NCT01425281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6152033|NCT01425281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6152034|NCT01425281|Immunologic Factors|immunologic factors|mesh-ancestor
6152035|NCT01425281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152036|NCT01425307|Hydroxyurea|hydroxyurea|mesh-list
6152037|NCT01425307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6152038|NCT01425307|Antisickling Agents|antisickling agents|mesh-ancestor
6152039|NCT01425307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6152040|NCT01425307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152041|NCT01425307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6152042|NCT01425359|Ranolazine|ranolazine|mesh-list
6152043|NCT01425359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6152044|NCT01425359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6152045|NCT01425359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152046|NCT01425463|Glycine|glycine|mesh-list
6152047|NCT01425463|Glycine Agents|glycine agents|mesh-ancestor
6152048|NCT01425463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6152049|NCT01425463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152050|NCT01425463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152051|NCT01425632|Bepotastine besilate|bepotastine besilate|mesh-list
6152052|NCT01425632|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6152053|NCT01425801|Albuterol|albuterol|mesh-list
6152054|NCT01425801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6152055|NCT01425801|Autonomic Agents|autonomic agents|mesh-ancestor
6152056|NCT01425801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6152057|NCT01425801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152058|NCT01425801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6152059|NCT01425801|Respiratory System Agents|respiratory system agents|mesh-ancestor
6152060|NCT01425801|Tocolytic Agents|tocolytic agents|mesh-ancestor
6152061|NCT01425801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6152062|NCT01425801|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6152063|NCT01425801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6152064|NCT01425801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6152065|NCT01425801|Adrenergic Agents|adrenergic agents|mesh-ancestor
6152066|NCT01425801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6152067|NCT01425801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152068|NCT01425853|Celecoxib|celecoxib|mesh-list
6152069|NCT01425853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6152070|NCT01425853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6152071|NCT01425853|Analgesics|analgesics|mesh-ancestor
6152072|NCT01425853|Sensory System Agents|sensory system agents|mesh-ancestor
6152073|NCT01425853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5553526|NCT04071353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5553527|NCT04071353|Antiviral Agents|antiviral agents|mesh-ancestor
5553528|NCT04071353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5553529|NCT04071353|Antimetabolites|antimetabolites|mesh-ancestor
5553530|NCT04071353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553531|NCT04071119|Oxytocin|oxytocin|mesh-list
5553532|NCT04071119|Oxytocics|oxytocics|mesh-ancestor
5553533|NCT04071119|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5553534|NCT04071119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553535|NCT04071106|Betamethasone|betamethasone|mesh-list
6152074|NCT01425853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152075|NCT01425853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6152076|NCT01425853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6152077|NCT01425853|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6152078|NCT01425853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6152079|NCT01425853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6152080|NCT01425853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152081|NCT01426009|Bromides|bromides|mesh-list
6152082|NCT01426009|Tiotropium Bromide|tiotropium bromide|mesh-list
6152083|NCT01426009|Ipratropium|ipratropium|mesh-list
6152084|NCT01426009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6152085|NCT01426009|Autonomic Agents|autonomic agents|mesh-ancestor
6152086|NCT01426009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6152087|NCT01426009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152088|NCT01426009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6152089|NCT01426009|Respiratory System Agents|respiratory system agents|mesh-ancestor
6152090|NCT01426009|Parasympatholytics|parasympatholytics|mesh-ancestor
5553536|NCT04071106|Calcipotriene|calcipotriene|mesh-list
5553537|NCT04071106|Petrolatum|petrolatum|mesh-list
5553538|NCT04071106|Turmeric extract|turmeric extract|mesh-list
5553539|NCT04071106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5553540|NCT04071106|Glucocorticoids|glucocorticoids|mesh-ancestor
5553541|NCT04071106|Hormones|hormones|mesh-ancestor
5553542|NCT04071106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5553543|NCT04071106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553544|NCT04071106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5553545|NCT04071106|Respiratory System Agents|respiratory system agents|mesh-ancestor
5553546|NCT04071106|Dermatologic Agents|dermatologic agents|mesh-ancestor
6152091|NCT01426009|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6152092|NCT01426009|Cholinergic Agents|cholinergic agents|mesh-ancestor
6152093|NCT01426009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6152094|NCT01426009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152095|NCT01426009|Anticonvulsants|anticonvulsants|mesh-ancestor
6152096|NCT01426269|Metronidazole|metronidazole|mesh-list
6152097|NCT01426269|Doxycycline|doxycycline|mesh-list
6152098|NCT01426269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6152099|NCT01426269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6152100|NCT01426269|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6152101|NCT01426269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6152102|NCT01426269|Antimalarials|antimalarials|mesh-ancestor
6152103|NCT01426347|Vitamin D|vitamin d|mesh-list
6152104|NCT01426347|Ergocalciferols|ergocalciferols|mesh-list
6152105|NCT01426347|Vitamins|vitamins|mesh-ancestor
6152106|NCT01426347|Micronutrients|micronutrients|mesh-ancestor
6152107|NCT01426347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152108|NCT01426347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6152109|NCT01426347|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6152110|NCT01426373|Deoxycholic Acid|deoxycholic acid|mesh-list
6152111|NCT01426373|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5553547|NCT04071106|Antioxidants|antioxidants|mesh-ancestor
5553548|NCT04071106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152112|NCT01426373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6152113|NCT01426412|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6152114|NCT01426412|Immunologic Factors|immunologic factors|mesh-ancestor
6152115|NCT01426412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152116|NCT01426438|Aspirin|aspirin|mesh-list
6152117|NCT01426438|Niacin|niacin|mesh-list
6152118|NCT01426438|Fenofibrate|fenofibrate|mesh-list
6152119|NCT01426438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6152120|NCT01426438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6152121|NCT01426438|Analgesics|analgesics|mesh-ancestor
6477666|NCT00530387|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6477667|NCT00530400|Cefuroxime|cefuroxime|mesh-list
6477668|NCT00530400|Cefuroxime axetil|cefuroxime axetil|mesh-list
6152122|NCT01426438|Sensory System Agents|sensory system agents|mesh-ancestor
6152123|NCT01426438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6152124|NCT01426438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152125|NCT01426438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6152126|NCT01426438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6152127|NCT01426438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5553549|NCT04071106|Protective Agents|protective agents|mesh-ancestor
6152128|NCT01426438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6152129|NCT01426438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477669|NCT00530400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5553550|NCT04071106|Emollients|emollients|mesh-ancestor
5553551|NCT04070742|Minocycline|minocycline|mesh-list
5553552|NCT04070742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5553553|NCT04070742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5553554|NCT04070755|Minocycline|minocycline|mesh-list
5553555|NCT04070755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5553556|NCT04070755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5553557|NCT04070794|Metformin|metformin|mesh-list
5553558|NCT04070794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5553559|NCT04070794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553560|NCT04070833|Vitamin D|vitamin d|mesh-list
5553561|NCT04070833|Ergocalciferols|ergocalciferols|mesh-list
5553562|NCT04070833|Vitamins|vitamins|mesh-list
5553563|NCT04070833|Micronutrients|micronutrients|mesh-ancestor
5553564|NCT04070833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553565|NCT04070833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5553566|NCT04070833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5553567|NCT04070690|Dialysis Solutions|dialysis solutions|mesh-list
5553568|NCT04070690|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6152130|NCT01426438|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6152131|NCT01426438|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6152132|NCT01426438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6152133|NCT01426438|Antipyretics|antipyretics|mesh-ancestor
6152134|NCT01426438|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6152135|NCT01426438|Antimetabolites|antimetabolites|mesh-ancestor
6152136|NCT01426438|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6152137|NCT01426438|Vasodilator Agents|vasodilator agents|mesh-ancestor
6152138|NCT01426438|Vitamin B Complex|vitamin b complex|mesh-ancestor
6152139|NCT01426438|Vitamins|vitamins|mesh-ancestor
6152140|NCT01426438|Micronutrients|micronutrients|mesh-ancestor
6152141|NCT01426763|Complement C1s|complement c1s|mesh-list
6667907|NCT01529320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6667908|NCT01529320|Antiemetics|antiemetics|mesh-ancestor
6667909|NCT01529320|Autonomic Agents|autonomic agents|mesh-ancestor
6667910|NCT01529320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6667911|NCT01529320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667912|NCT01529320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6667913|NCT01529320|Glucocorticoids|glucocorticoids|mesh-ancestor
6667914|NCT01529320|Hormones|hormones|mesh-ancestor
5553569|NCT04070729|Hyaluronic Acid|hyaluronic acid|mesh-list
5553570|NCT04070729|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5553571|NCT04070729|Immunologic Factors|immunologic factors|mesh-ancestor
5553572|NCT04070729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553573|NCT04070729|Viscosupplements|viscosupplements|mesh-ancestor
5553574|NCT04070729|Protective Agents|protective agents|mesh-ancestor
6667915|NCT01529320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6667916|NCT01529320|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6152142|NCT01426763|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
6152143|NCT01426763|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
6152144|NCT01426763|Immunologic Factors|immunologic factors|mesh-ancestor
6152145|NCT01426763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152146|NCT01426763|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6152147|NCT01426763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6152148|NCT01426854|Nepafenac|nepafenac|mesh-list
6152149|NCT01426854|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6152150|NCT01426854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6152151|NCT01426854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6152152|NCT01426854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6152153|NCT01426854|Analgesics|analgesics|mesh-ancestor
6152154|NCT01426854|Sensory System Agents|sensory system agents|mesh-ancestor
6152155|NCT01426854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6152156|NCT01426854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152157|NCT01426854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6152158|NCT01426854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6152159|NCT01426867|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6152160|NCT01426867|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6152161|NCT01426867|Brinzolamide|brinzolamide|mesh-list
6152162|NCT01426867|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6152163|NCT01426867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6152164|NCT01426867|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6152165|NCT01426867|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6152166|NCT01426867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6152167|NCT01426867|Adrenergic Agents|adrenergic agents|mesh-ancestor
6152168|NCT01426867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6667917|NCT01529320|Protective Agents|protective agents|mesh-ancestor
5553575|NCT04070495|Clarithromycin|clarithromycin|mesh-list
6205781|NCT02092285|Immunologic Factors|immunologic factors|mesh-ancestor
5553576|NCT04070495|Rifampin|rifampin|mesh-list
6152169|NCT01426867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152170|NCT01426867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152171|NCT01426867|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6152172|NCT01426867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6477670|NCT00530400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5553577|NCT04070495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5553578|NCT04070495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5553579|NCT04070495|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5553580|NCT04070495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5553581|NCT04070495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152173|NCT01426958|Ritonavir|ritonavir|mesh-list
6152174|NCT01426958|Afatinib|afatinib|mesh-list
6152175|NCT01426958|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6152176|NCT01426958|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6152177|NCT01426958|Protease Inhibitors|protease inhibitors|mesh-ancestor
6152178|NCT01426958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6152179|NCT01426958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152180|NCT01426958|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6152181|NCT01426958|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6152182|NCT01426958|Antiviral Agents|antiviral agents|mesh-ancestor
6152183|NCT01426958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6152184|NCT01426958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5553582|NCT04070495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5553583|NCT04070495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5553584|NCT04070495|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5553585|NCT04070495|Antitubercular Agents|antitubercular agents|mesh-ancestor
5553586|NCT04070495|Leprostatic Agents|leprostatic agents|mesh-ancestor
5553587|NCT04070495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5553588|NCT04070495|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5553589|NCT04070495|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5553590|NCT04070495|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5553591|NCT04070495|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5553592|NCT04070495|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5553593|NCT04070495|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5553594|NCT04070469|Amoxicillin|amoxicillin|mesh-list
5553595|NCT04070469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5553596|NCT04070469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5553597|NCT04070391|Vitamin B 6|vitamin b 6|mesh-list
5553598|NCT04070391|Pyridoxal|pyridoxal|mesh-list
5553599|NCT04070391|Pyridoxine|pyridoxine|mesh-list
6152185|NCT01426958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6152186|NCT01426958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6152187|NCT01426958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6152188|NCT01427309|Vaccines|vaccines|mesh-list
6152189|NCT01427309|Immunologic Factors|immunologic factors|mesh-ancestor
6152190|NCT01427309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152191|NCT01427504|Etravirine|etravirine|mesh-list
6152192|NCT01427504|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6152193|NCT01427504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5553600|NCT04070391|Vitamins|vitamins|mesh-ancestor
5553601|NCT04070391|Micronutrients|micronutrients|mesh-ancestor
5553602|NCT04070391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553603|NCT04070391|Vitamin B Complex|vitamin b complex|mesh-ancestor
5553604|NCT04070482|Tenofovir|tenofovir|mesh-list
5553605|NCT04070482|Antiviral Agents|antiviral agents|mesh-ancestor
5553606|NCT04070482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5553607|NCT04070482|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5553608|NCT04070482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5553609|NCT04070482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5553610|NCT04070482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553611|NCT04070482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6152194|NCT01427504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6152195|NCT01427504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152196|NCT01427504|Antiviral Agents|antiviral agents|mesh-ancestor
6152197|NCT01427504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6152198|NCT01427517|Acetylcysteine|acetylcysteine|mesh-list
6152199|NCT01427517|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6152200|NCT01427517|Antiviral Agents|antiviral agents|mesh-ancestor
6152201|NCT01427517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6152202|NCT01427517|Expectorants|expectorants|mesh-ancestor
6152203|NCT01427517|Respiratory System Agents|respiratory system agents|mesh-ancestor
6152204|NCT01427517|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6152205|NCT01427517|Antioxidants|antioxidants|mesh-ancestor
6477671|NCT00530413|Phenobarbital|phenobarbital|mesh-list
6477672|NCT00530413|Anticonvulsants|anticonvulsants|mesh-ancestor
6477673|NCT00530413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6477674|NCT00530413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6477675|NCT00530413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477676|NCT00530413|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6477677|NCT00530413|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6152206|NCT01427517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152207|NCT01427517|Protective Agents|protective agents|mesh-ancestor
6152208|NCT01427517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152209|NCT01427517|Antidotes|antidotes|mesh-ancestor
6152210|NCT01427595|Metformin|metformin|mesh-list
6152211|NCT01427595|Progesterone|progesterone|mesh-list
6152212|NCT01427595|Estradiol|estradiol|mesh-list
6152213|NCT01427595|Estrogens|estrogens|mesh-list
6152214|NCT01427595|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6152215|NCT01427595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152216|NCT01427595|Progestins|progestins|mesh-ancestor
6152217|NCT01427595|Hormones|hormones|mesh-ancestor
6152218|NCT01427595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6152219|NCT01427608|Olanzapine|olanzapine|mesh-list
6152220|NCT01427608|Sertraline|sertraline|mesh-list
6477678|NCT00530413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6477679|NCT00530413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477680|NCT00530413|GABA Modulators|gaba modulators|mesh-ancestor
6477681|NCT00530413|GABA Agents|gaba agents|mesh-ancestor
6477682|NCT00530413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6477683|NCT00530413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6477684|NCT00530413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6477685|NCT00530478|Donepezil|donepezil|mesh-list
6477686|NCT00530478|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6477687|NCT00530478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6477688|NCT00530478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477689|NCT00530478|Cholinergic Agents|cholinergic agents|mesh-ancestor
6477690|NCT00530478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6477691|NCT00530478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477692|NCT00530478|Nootropic Agents|nootropic agents|mesh-ancestor
6477693|NCT00530517|Sumatriptan|sumatriptan|mesh-list
6477694|NCT00530517|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6477695|NCT00530517|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6477696|NCT00530517|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6477697|NCT00530517|Serotonin Agents|serotonin agents|mesh-ancestor
5553612|NCT04070482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6152221|NCT01427608|Antiemetics|antiemetics|mesh-ancestor
6152222|NCT01427608|Autonomic Agents|autonomic agents|mesh-ancestor
6152223|NCT01427608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6152224|NCT01427608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152225|NCT01427608|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6152226|NCT01427608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6152227|NCT01427608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6152228|NCT01427608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6152229|NCT01427608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6152230|NCT01427608|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6152231|NCT01427608|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6152232|NCT01427608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5553613|NCT04070079|Tenofovir|tenofovir|mesh-list
5553614|NCT04070079|Antiviral Agents|antiviral agents|mesh-ancestor
5553615|NCT04070079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5553616|NCT04070079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5553617|NCT04070079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5553618|NCT04070079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6152233|NCT01427608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152234|NCT01427608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6152235|NCT01427608|Serotonin Agents|serotonin agents|mesh-ancestor
6152236|NCT01427608|Antidepressive Agents|antidepressive agents|mesh-ancestor
6152237|NCT01427738|Nystatin|nystatin|mesh-list
6152238|NCT01427738|Gentian Violet|gentian violet|mesh-list
6152239|NCT01427738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6152240|NCT01427738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6152241|NCT01427738|Antifungal Agents|antifungal agents|mesh-ancestor
6152242|NCT01427738|Ionophores|ionophores|mesh-ancestor
6152243|NCT01427738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6152244|NCT01427738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553619|NCT04070079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152245|NCT01427738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6152246|NCT01427751|Dexamethasone|dexamethasone|mesh-list
6152247|NCT01427751|Ranibizumab|ranibizumab|mesh-list
6152248|NCT01427751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6152249|NCT01427751|Antiemetics|antiemetics|mesh-ancestor
6152250|NCT01427751|Autonomic Agents|autonomic agents|mesh-ancestor
6152251|NCT01427751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6152252|NCT01427751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152253|NCT01427751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6152254|NCT01427751|Glucocorticoids|glucocorticoids|mesh-ancestor
6152255|NCT01427751|Hormones|hormones|mesh-ancestor
6152256|NCT01427751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6152257|NCT01427751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6152258|NCT01427751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6152259|NCT01427751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6152260|NCT01427751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6152261|NCT01427751|Growth Substances|growth substances|mesh-ancestor
6152262|NCT01427751|Growth Inhibitors|growth inhibitors|mesh-ancestor
6152263|NCT01427803|Naproxen|naproxen|mesh-list
6152264|NCT01427803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6152265|NCT01427803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6152266|NCT01427803|Analgesics|analgesics|mesh-ancestor
6152267|NCT01427803|Sensory System Agents|sensory system agents|mesh-ancestor
6152268|NCT01427803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6152269|NCT01427803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152270|NCT01427803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6152271|NCT01427803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6152272|NCT01427803|Gout Suppressants|gout suppressants|mesh-ancestor
6152273|NCT01427803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6152274|NCT01427803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6152275|NCT01427803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477698|NCT00530517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6477699|NCT00530517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477700|NCT00530517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477701|NCT00530556|Zolpidem|zolpidem|mesh-list
6477702|NCT00530556|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6477703|NCT00530556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6477704|NCT00530556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6477705|NCT00530556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477706|NCT00530556|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6477707|NCT00530556|GABA Agonists|gaba agonists|mesh-ancestor
6477708|NCT00530556|GABA Agents|gaba agents|mesh-ancestor
6477709|NCT00530556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6477710|NCT00530556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477711|NCT00530582|Progesterone|progesterone|mesh-list
6477712|NCT00530582|Progestins|progestins|mesh-ancestor
6477713|NCT00530582|Hormones|hormones|mesh-ancestor
6477714|NCT00530582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6477715|NCT00530582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477716|NCT00530595|Losartan|losartan|mesh-list
6477717|NCT00530595|Valsartan|valsartan|mesh-list
6477718|NCT00530595|Candesartan|candesartan|mesh-list
6477719|NCT00530595|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6152276|NCT01427881|Cyclosporine|cyclosporine|mesh-list
6152277|NCT01427881|Cyclophosphamide|cyclophosphamide|mesh-list
6152278|NCT01427881|Busulfan|busulfan|mesh-list
5553620|NCT04070079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6152279|NCT01427881|Fludarabine|fludarabine|mesh-list
6152280|NCT01427881|Fludarabine phosphate|fludarabine phosphate|mesh-list
6152281|NCT01427881|Cyclosporins|cyclosporins|mesh-list
6152282|NCT01427881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6152283|NCT01427881|Immunologic Factors|immunologic factors|mesh-ancestor
6477720|NCT00530595|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6477721|NCT00530595|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6477722|NCT00530595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477723|NCT00530595|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6477724|NCT00530868|Bevacizumab|bevacizumab|mesh-list
6477725|NCT00530868|Letrozole|letrozole|mesh-list
6477726|NCT00530868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6477727|NCT00530868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6477728|NCT00530868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6477729|NCT00530868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6477730|NCT00530868|Growth Substances|growth substances|mesh-ancestor
6477731|NCT00530868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477732|NCT00530868|Growth Inhibitors|growth inhibitors|mesh-ancestor
6152284|NCT01427881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477733|NCT00530868|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6477734|NCT00530868|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6477735|NCT00530868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6477736|NCT00530868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477737|NCT00530868|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6477738|NCT00530868|Hormone Antagonists|hormone antagonists|mesh-ancestor
6477739|NCT00530868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5553621|NCT04070079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5553622|NCT04070352|Fidaxomicin|fidaxomicin|mesh-list
5553623|NCT04070352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5553624|NCT04070352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5553625|NCT04070157|Lofexidine|lofexidine|mesh-list
5553626|NCT04070157|Clonidine|clonidine|mesh-list
5553627|NCT04070157|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5553628|NCT04070157|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5553629|NCT04070157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553630|NCT04070157|Sensory System Agents|sensory system agents|mesh-ancestor
5553631|NCT04070157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5553632|NCT04070157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5553633|NCT04070157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5553634|NCT04070157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5553635|NCT04070157|Adrenergic Agents|adrenergic agents|mesh-ancestor
5553636|NCT04070157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5553637|NCT04070157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553638|NCT04070157|Analgesics|analgesics|mesh-ancestor
5553639|NCT04070157|Sympatholytics|sympatholytics|mesh-ancestor
5553640|NCT04070157|Autonomic Agents|autonomic agents|mesh-ancestor
5553641|NCT04070001|Ibuprofen|ibuprofen|mesh-list
5553642|NCT04070001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5553643|NCT04070001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5553644|NCT04070001|Analgesics|analgesics|mesh-ancestor
5553645|NCT04070001|Sensory System Agents|sensory system agents|mesh-ancestor
5553646|NCT04070001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5553647|NCT04070001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553648|NCT04070001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5553649|NCT04070001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5553650|NCT04070001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5553651|NCT04070001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6477740|NCT00530907|Bevacizumab|bevacizumab|mesh-list
6477741|NCT00530907|Valproic Acid|valproic acid|mesh-list
5553652|NCT04070001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152285|NCT01427881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6152286|NCT01427881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6152287|NCT01427881|Alkylating Agents|alkylating agents|mesh-ancestor
6152288|NCT01427881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152289|NCT01427881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6152290|NCT01427881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6152291|NCT01427881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6152292|NCT01427881|Antimetabolites|antimetabolites|mesh-ancestor
6152293|NCT01427881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6152294|NCT01427881|Antifungal Agents|antifungal agents|mesh-ancestor
6152295|NCT01427881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6152296|NCT01427881|Dermatologic Agents|dermatologic agents|mesh-ancestor
6152297|NCT01427881|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6152298|NCT01427907|Calcium|calcium|mesh-list
6152299|NCT01427907|Sevelamer|sevelamer|mesh-list
6152300|NCT01427907|Calcium acetate|calcium acetate|mesh-list
6152301|NCT01427907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6152302|NCT01427907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152303|NCT01427907|Chelating Agents|chelating agents|mesh-ancestor
6152304|NCT01427907|Sequestering Agents|sequestering agents|mesh-ancestor
6152305|NCT01427907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152306|NCT01427920|Insulin Aspart|insulin aspart|mesh-list
6152307|NCT01427920|Biphasic Insulins|biphasic insulins|mesh-list
6152308|NCT01427920|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6152309|NCT01427920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6152310|NCT01427920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152311|NCT01427933|Ramucirumab|ramucirumab|mesh-list
6152312|NCT01427933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6152313|NCT01427972|Eplerenone|eplerenone|mesh-list
5553653|NCT04069949|Sorafenib|sorafenib|mesh-list
5553654|NCT04069949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5553655|NCT04069949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5553656|NCT04069949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5553657|NCT04069949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553658|NCT04069936|Nivolumab|nivolumab|mesh-list
5553659|NCT04069936|Tadalafil|tadalafil|mesh-list
5553660|NCT04069936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5553661|NCT04069936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5553662|NCT04069936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5553663|NCT04069936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553664|NCT04069936|Vasodilator Agents|vasodilator agents|mesh-ancestor
5553665|NCT04069936|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5553666|NCT04069936|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6152314|NCT01427972|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6152315|NCT01427972|Hormone Antagonists|hormone antagonists|mesh-ancestor
6152316|NCT01427972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6152317|NCT01427972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152318|NCT01427972|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6152319|NCT01427972|Diuretics|diuretics|mesh-ancestor
6152320|NCT01427972|Natriuretic Agents|natriuretic agents|mesh-ancestor
6152321|NCT01427972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6205782|NCT02092285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205783|NCT02092298|Sodium thiosulfate|sodium thiosulfate|mesh-list
6205784|NCT02092298|Cisplatin|cisplatin|mesh-list
6205785|NCT02092298|Mitomycins|mitomycins|mesh-list
6205786|NCT02092298|Mitomycin|mitomycin|mesh-list
6205787|NCT02092298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6205788|NCT02092298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6205789|NCT02092298|Alkylating Agents|alkylating agents|mesh-ancestor
6205790|NCT02092298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205791|NCT02092298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6205792|NCT02092298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6205793|NCT02092298|Antidotes|antidotes|mesh-ancestor
6477742|NCT00530907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6477743|NCT00530907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6477744|NCT00530907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6477745|NCT00530907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6477746|NCT00530907|Growth Substances|growth substances|mesh-ancestor
6477747|NCT00530907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477748|NCT00530907|Growth Inhibitors|growth inhibitors|mesh-ancestor
6477749|NCT00530907|Anticonvulsants|anticonvulsants|mesh-ancestor
6477750|NCT00530907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6477751|NCT00530907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477752|NCT00530907|GABA Agents|gaba agents|mesh-ancestor
5553667|NCT04069936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6205794|NCT02092298|Protective Agents|protective agents|mesh-ancestor
6205795|NCT02092298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205796|NCT02092298|Antioxidants|antioxidants|mesh-ancestor
6205797|NCT02092298|Antitubercular Agents|antitubercular agents|mesh-ancestor
6205798|NCT02092298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6205799|NCT02092298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6205800|NCT02092298|Chelating Agents|chelating agents|mesh-ancestor
6205801|NCT02092298|Sequestering Agents|sequestering agents|mesh-ancestor
5553668|NCT04069936|Urological Agents|urological agents|mesh-ancestor
5553669|NCT04069845|Doxorubicin|doxorubicin|mesh-list
5553670|NCT04069845|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5553671|NCT04069845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5553672|NCT04069845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5553673|NCT04069845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5553674|NCT04069845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5553675|NCT04069845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6205802|NCT02092350|Grazoprevir|grazoprevir|mesh-list
6205803|NCT02092350|Antiviral Agents|antiviral agents|mesh-ancestor
6205804|NCT02092350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6205805|NCT02092467|Adalimumab|adalimumab|mesh-list
6205806|NCT02092467|Etanercept|etanercept|mesh-list
6205807|NCT02092467|Tofacitinib|tofacitinib|mesh-list
6205808|NCT02092467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6205809|NCT02092467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6205810|NCT02092467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6205811|NCT02092467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6205812|NCT02092467|Analgesics|analgesics|mesh-ancestor
6205813|NCT02092467|Sensory System Agents|sensory system agents|mesh-ancestor
6205814|NCT02092467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6205815|NCT02092467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205816|NCT02092467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6205817|NCT02092467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5553676|NCT04069845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553677|NCT04069858|Entecavir|entecavir|mesh-list
6205818|NCT02092467|Immunologic Factors|immunologic factors|mesh-ancestor
5553678|NCT04069858|Antiviral Agents|antiviral agents|mesh-ancestor
5553679|NCT04069858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5553680|NCT04069234|Clopidogrel|clopidogrel|mesh-list
5553681|NCT04069234|Ticagrelor|ticagrelor|mesh-list
5553682|NCT04069234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5553683|NCT04069234|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5553684|NCT04069234|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5553685|NCT04069234|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5553686|NCT04069234|Purinergic Agents|purinergic agents|mesh-ancestor
5553687|NCT04069234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5553688|NCT04069234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553689|NCT04069234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553690|NCT04069169|Lidocaine|lidocaine|mesh-list
5553691|NCT04069169|Anesthetics, Local|anesthetics, local|mesh-ancestor
6152322|NCT01428024|Hyaluronic Acid|hyaluronic acid|mesh-list
6152323|NCT01428024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6152324|NCT01428024|Immunologic Factors|immunologic factors|mesh-ancestor
6152325|NCT01428024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152326|NCT01428024|Viscosupplements|viscosupplements|mesh-ancestor
6152327|NCT01428024|Protective Agents|protective agents|mesh-ancestor
6152328|NCT01428063|Interferons|interferons|mesh-list
6152329|NCT01428063|Ribavirin|ribavirin|mesh-list
6152330|NCT01428063|Interferon-alpha|interferon-alpha|mesh-list
6152331|NCT01428063|Interferon alpha-2|interferon alpha-2|mesh-list
6152332|NCT01428063|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6152333|NCT01428063|Asunaprevir|asunaprevir|mesh-list
6152334|NCT01428063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6152335|NCT01428063|Antiviral Agents|antiviral agents|mesh-ancestor
6152336|NCT01428063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6152337|NCT01428063|Antimetabolites|antimetabolites|mesh-ancestor
6152338|NCT01428063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152339|NCT01428063|Immunologic Factors|immunologic factors|mesh-ancestor
6152340|NCT01428063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152341|NCT01428063|Protease Inhibitors|protease inhibitors|mesh-ancestor
6152342|NCT01428063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6152343|NCT01428076|Polidocanol|polidocanol|mesh-list
6152344|NCT01428076|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
6152345|NCT01428076|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6152346|NCT01428128|Arsenic Trioxide|arsenic trioxide|mesh-list
6152347|NCT01428128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6152348|NCT01428193|Flutamide|flutamide|mesh-list
5553692|NCT04069169|Anesthetics|anesthetics|mesh-ancestor
5553693|NCT04069169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5553694|NCT04069169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553695|NCT04069169|Sensory System Agents|sensory system agents|mesh-ancestor
5553696|NCT04069169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5553697|NCT04069169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5553698|NCT04069169|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5553699|NCT04069169|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5553700|NCT04069169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5553701|NCT04069169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553702|NCT04069117|Letrozole|letrozole|mesh-list
5553703|NCT04069117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5553704|NCT04069117|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5553705|NCT04069117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5553706|NCT04069117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5553707|NCT04069117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553708|NCT04069117|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5553709|NCT04069117|Hormone Antagonists|hormone antagonists|mesh-ancestor
5553710|NCT04069117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5553711|NCT04069117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553712|NCT04069208|Cytarabine|cytarabine|mesh-list
5553713|NCT04069208|Idarubicin|idarubicin|mesh-list
5553714|NCT04069208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5553715|NCT04069208|Antimetabolites|antimetabolites|mesh-ancestor
5603067|NCT03455517|Rituximab|rituximab|mesh-list
6152349|NCT01428193|Estradiol|estradiol|mesh-list
6152350|NCT01428193|Progesterone|progesterone|mesh-list
6152351|NCT01428193|Estrogens|estrogens|mesh-ancestor
6152352|NCT01428193|Hormones|hormones|mesh-ancestor
6152353|NCT01428193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6152354|NCT01428193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152355|NCT01428193|Progestins|progestins|mesh-ancestor
6152356|NCT01428193|Androgen Antagonists|androgen antagonists|mesh-ancestor
6152357|NCT01428193|Hormone Antagonists|hormone antagonists|mesh-ancestor
6152358|NCT01428193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5553716|NCT04069208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553717|NCT04069208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5553718|NCT04069208|Antiviral Agents|antiviral agents|mesh-ancestor
5553719|NCT04069208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5553720|NCT04069208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5553721|NCT04069208|Immunologic Factors|immunologic factors|mesh-ancestor
5553722|NCT04069208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553723|NCT04069208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5553724|NCT04069208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5553725|NCT04069208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5553726|NCT04069208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5553727|NCT04069325|Febuxostat|febuxostat|mesh-list
5553728|NCT04069325|Gout Suppressants|gout suppressants|mesh-ancestor
5553729|NCT04069325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5553730|NCT04069429|Heparin|heparin|mesh-list
5553731|NCT04069429|Anticoagulants|anticoagulants|mesh-ancestor
5553732|NCT04069429|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6477753|NCT00530907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6477754|NCT00530907|Antimanic Agents|antimanic agents|mesh-ancestor
6477755|NCT00530907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6477756|NCT00530907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6477757|NCT00530907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6477758|NCT00530972|Ribavirin|ribavirin|mesh-list
6477759|NCT00530972|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6477760|NCT00530972|Antimetabolites|antimetabolites|mesh-ancestor
6477761|NCT00530972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477762|NCT00530972|Antiviral Agents|antiviral agents|mesh-ancestor
6477763|NCT00530972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6477764|NCT00531024|Bevacizumab|bevacizumab|mesh-list
6477765|NCT00531024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6477766|NCT00531024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6477767|NCT00531024|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6477768|NCT00531024|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6477769|NCT00531024|Growth Substances|growth substances|mesh-ancestor
6477770|NCT00531024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477771|NCT00531024|Growth Inhibitors|growth inhibitors|mesh-ancestor
6477772|NCT00531063|Everolimus|everolimus|mesh-list
6477773|NCT00531063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6477774|NCT00531063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6477775|NCT00531063|Immunologic Factors|immunologic factors|mesh-ancestor
6477776|NCT00531063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477777|NCT00531076|Bevacizumab|bevacizumab|mesh-list
6477778|NCT00531076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6477779|NCT00531076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6477780|NCT00531076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6477781|NCT00531076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6477782|NCT00531076|Growth Substances|growth substances|mesh-ancestor
6477783|NCT00531076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152359|NCT01428193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6152360|NCT01428245|Estradiol|estradiol|mesh-list
6152361|NCT01428245|Estrogens|estrogens|mesh-list
6152362|NCT01428245|Progesterone|progesterone|mesh-list
6152363|NCT01428245|Hormones|hormones|mesh-ancestor
6152364|NCT01428245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6152365|NCT01428245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152366|NCT01428245|Progestins|progestins|mesh-ancestor
6152367|NCT01428258|Coal Tar|coal tar|mesh-list
6152368|NCT01428258|Keratolytic Agents|keratolytic agents|mesh-ancestor
6152369|NCT01428258|Dermatologic Agents|dermatologic agents|mesh-ancestor
6152370|NCT01428336|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6152371|NCT01428336|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
6152372|NCT01428336|Cosyntropin|cosyntropin|mesh-list
6152373|NCT01428336|beta-Endorphin|beta-endorphin|mesh-list
6152374|NCT01428336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152375|NCT01428336|Hormones|hormones|mesh-ancestor
6152376|NCT01428336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6152377|NCT01428336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6152378|NCT01428336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152379|NCT01428583|Naltrexone|naltrexone|mesh-list
6152380|NCT01428583|Oxycodone|oxycodone|mesh-list
6152381|NCT01428583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6152382|NCT01428583|Narcotics|narcotics|mesh-ancestor
6152383|NCT01428583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6152384|NCT01428583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477784|NCT00531076|Growth Inhibitors|growth inhibitors|mesh-ancestor
5553733|NCT04069429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6152385|NCT01428583|Analgesics|analgesics|mesh-ancestor
6152386|NCT01428583|Sensory System Agents|sensory system agents|mesh-ancestor
6152387|NCT01428583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6152388|NCT01428583|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6152389|NCT01428583|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6152390|NCT01428713|Tranexamic Acid|tranexamic acid|mesh-list
6152391|NCT01428713|Contraceptive Agents|contraceptive agents|mesh-list
6152392|NCT01428713|Contraceptives, Oral|contraceptives, oral|mesh-list
6152393|NCT01428713|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
6152394|NCT01428713|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6152395|NCT01428713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6152396|NCT01428713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152397|NCT01428713|Hemostatics|hemostatics|mesh-ancestor
6152398|NCT01428713|Coagulants|coagulants|mesh-ancestor
6152399|NCT01428713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6152400|NCT01428713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152401|NCT01428713|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6152402|NCT01428882|Midazolam|midazolam|mesh-list
6152403|NCT01428882|Propofol|propofol|mesh-list
6152404|NCT01428882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6152405|NCT01428882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6152406|NCT01428882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152407|NCT01428882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6152408|NCT01428882|Anesthetics, General|anesthetics, general|mesh-ancestor
6152409|NCT01428882|Anesthetics|anesthetics|mesh-ancestor
6152410|NCT01428882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5553734|NCT04069429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553735|NCT04069286|Amoxicillin|amoxicillin|mesh-list
5553736|NCT04069286|Omeprazole|omeprazole|mesh-list
5553737|NCT04069286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5553738|NCT04069286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5553739|NCT04069286|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5553740|NCT04069286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5553741|NCT04069286|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5553742|NCT04069286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5553743|NCT04069286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553744|NCT04069078|Scopolamine|scopolamine|mesh-list
5553745|NCT04069078|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
5553746|NCT04069078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5553747|NCT04069078|Antiemetics|antiemetics|mesh-ancestor
5553748|NCT04069078|Autonomic Agents|autonomic agents|mesh-ancestor
5553749|NCT04069078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5553750|NCT04069078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553751|NCT04069078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5553752|NCT04069078|Mydriatics|mydriatics|mesh-ancestor
5553753|NCT04069078|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5553754|NCT04069078|Cholinergic Agents|cholinergic agents|mesh-ancestor
5553755|NCT04069078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5553756|NCT04069078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152411|NCT01428882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6152412|NCT01428882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6152413|NCT01428882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6152414|NCT01428882|GABA Modulators|gaba modulators|mesh-ancestor
6152415|NCT01428882|GABA Agents|gaba agents|mesh-ancestor
6152416|NCT01428882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6477785|NCT00531089|Rituximab|rituximab|mesh-list
6477786|NCT00531089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6477787|NCT00531089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6477788|NCT00531089|Immunologic Factors|immunologic factors|mesh-ancestor
6477789|NCT00531089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477790|NCT00531089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6477791|NCT00531115|Cetuximab|cetuximab|mesh-list
6477792|NCT00531115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6477793|NCT00531115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6477794|NCT00531128|Gamma-sitosterol|gamma-sitosterol|mesh-list
6477795|NCT00531128|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6477796|NCT00531128|Antimetabolites|antimetabolites|mesh-ancestor
6477797|NCT00531128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477798|NCT00531128|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6477799|NCT00531167|Lamivudine|lamivudine|mesh-list
6477800|NCT00531167|Adefovir|adefovir|mesh-list
6477801|NCT00531167|Entecavir|entecavir|mesh-list
5553757|NCT04069078|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5553758|NCT04069078|Parasympatholytics|parasympatholytics|mesh-ancestor
5553759|NCT04069065|Tacrolimus|tacrolimus|mesh-list
6205819|NCT02092467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6477802|NCT00531167|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5553760|NCT04069065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6477803|NCT00531167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6477804|NCT00531167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6477805|NCT00531167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477806|NCT00531167|Antiviral Agents|antiviral agents|mesh-ancestor
6477807|NCT00531167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6477808|NCT00531167|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5553761|NCT04069065|Immunologic Factors|immunologic factors|mesh-ancestor
5553762|NCT04069065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553763|NCT04069065|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6477809|NCT00531167|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6477810|NCT00531193|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
6477811|NCT00531193|SCH 442416|sch 442416|mesh-list
6477812|NCT00531193|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
6477813|NCT00531193|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6477814|NCT00531193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6477815|NCT00531193|Purinergic Agents|purinergic agents|mesh-ancestor
5553764|NCT04069065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5553765|NCT04069065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553766|NCT04069052|Nitric Oxide|nitric oxide|mesh-list
5553767|NCT04069052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5553768|NCT04069052|Autonomic Agents|autonomic agents|mesh-ancestor
5553769|NCT04069052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5553770|NCT04069052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553771|NCT04069052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6477816|NCT00531193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6477817|NCT00531193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553772|NCT04069052|Respiratory System Agents|respiratory system agents|mesh-ancestor
5553773|NCT04069052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5553774|NCT04069052|Antioxidants|antioxidants|mesh-ancestor
5553775|NCT04069052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553776|NCT04069052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5553777|NCT04069052|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5553778|NCT04069052|Vasodilator Agents|vasodilator agents|mesh-ancestor
5553779|NCT04069052|Gasotransmitters|gasotransmitters|mesh-ancestor
5553780|NCT04069052|Protective Agents|protective agents|mesh-ancestor
6477818|NCT00531193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477819|NCT00531245|Oxaliplatin|oxaliplatin|mesh-list
6477820|NCT00531245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6477821|NCT00531271|Docetaxel|docetaxel|mesh-list
6477822|NCT00531271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6477823|NCT00531271|Tubulin Modulators|tubulin modulators|mesh-ancestor
6152417|NCT01428882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152418|NCT01429051|Fentanyl|fentanyl|mesh-list
6477824|NCT00531271|Antimitotic Agents|antimitotic agents|mesh-ancestor
6477825|NCT00531271|Mitosis Modulators|mitosis modulators|mesh-ancestor
6477826|NCT00531271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477827|NCT00531310|Fludarabine|fludarabine|mesh-list
5553781|NCT04068766|Bupivacaine|bupivacaine|mesh-list
5553782|NCT04068766|Anesthetics, Local|anesthetics, local|mesh-ancestor
5553783|NCT04068766|Anesthetics|anesthetics|mesh-ancestor
5553784|NCT04068766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5553785|NCT04068766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553786|NCT04068766|Sensory System Agents|sensory system agents|mesh-ancestor
5553787|NCT04068766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5553788|NCT04068974|Apatinib|apatinib|mesh-list
5553789|NCT04068974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5553790|NCT04068974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5553791|NCT04068974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5553792|NCT04068974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553793|NCT04068870|Contraceptive Agents|contraceptive agents|mesh-list
5553794|NCT04068870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5553795|NCT04068870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553796|NCT04068948|Midazolam|midazolam|mesh-list
5553797|NCT04068948|Meperidine|meperidine|mesh-list
5553798|NCT04068948|Hydroxyzine|hydroxyzine|mesh-list
6477828|NCT00531310|Busulfan|busulfan|mesh-list
6477829|NCT00531310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6477830|NCT00531310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553799|NCT04068948|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5553800|NCT04068948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5553801|NCT04068948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5553802|NCT04068948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553803|NCT04068948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5553804|NCT04068948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5553805|NCT04068948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5553806|NCT04068948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5553807|NCT04068948|Anesthetics, General|anesthetics, general|mesh-ancestor
5553808|NCT04068948|Anesthetics|anesthetics|mesh-ancestor
5553809|NCT04068948|GABA Modulators|gaba modulators|mesh-ancestor
5553810|NCT04068948|GABA Agents|gaba agents|mesh-ancestor
5553811|NCT04068948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5553812|NCT04068948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553813|NCT04068948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5553814|NCT04068948|Narcotics|narcotics|mesh-ancestor
5553815|NCT04068948|Analgesics|analgesics|mesh-ancestor
5553816|NCT04068948|Sensory System Agents|sensory system agents|mesh-ancestor
5553817|NCT04068948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5553818|NCT04068948|Antipruritics|antipruritics|mesh-ancestor
5553819|NCT04068948|Dermatologic Agents|dermatologic agents|mesh-ancestor
5553820|NCT04068948|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5553821|NCT04068948|Histamine Antagonists|histamine antagonists|mesh-ancestor
5553822|NCT04068948|Histamine Agents|histamine agents|mesh-ancestor
5553823|NCT04068610|Leucovorin|leucovorin|mesh-list
5553824|NCT04068610|Bevacizumab|bevacizumab|mesh-list
5553825|NCT04068610|Durvalumab|durvalumab|mesh-list
5553826|NCT04068610|Fluorouracil|fluorouracil|mesh-list
5553827|NCT04068610|Oxaliplatin|oxaliplatin|mesh-list
5553828|NCT04068610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6477831|NCT00531310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6477832|NCT00531310|Immunologic Factors|immunologic factors|mesh-ancestor
6477833|NCT00531310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477834|NCT00531310|Alkylating Agents|alkylating agents|mesh-ancestor
6477835|NCT00531310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6152419|NCT01429051|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6152420|NCT01429051|Narcotics|narcotics|mesh-ancestor
6152421|NCT01429051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6152422|NCT01429051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152423|NCT01429051|Analgesics|analgesics|mesh-ancestor
6152424|NCT01429051|Sensory System Agents|sensory system agents|mesh-ancestor
6152425|NCT01429051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6152426|NCT01429051|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6152427|NCT01429051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6152428|NCT01429051|Anesthetics, General|anesthetics, general|mesh-ancestor
6152429|NCT01429051|Anesthetics|anesthetics|mesh-ancestor
6152430|NCT01429077|Levodopa|levodopa|mesh-list
6152431|NCT01429077|Carbidopa|carbidopa|mesh-list
6152432|NCT01429077|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6152433|NCT01429077|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6152434|NCT01429077|Dopamine Agents|dopamine agents|mesh-ancestor
6152435|NCT01429077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6152436|NCT01429077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152437|NCT01429077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152438|NCT01429077|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6152439|NCT01429077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6152440|NCT01429259|Meropenem|meropenem|mesh-list
6152441|NCT01429259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6152442|NCT01429259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6152443|NCT01429272|Aspirin|aspirin|mesh-list
6152444|NCT01429272|Minocycline|minocycline|mesh-list
6152445|NCT01429272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6152446|NCT01429272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6152447|NCT01429272|Analgesics|analgesics|mesh-ancestor
6152448|NCT01429272|Sensory System Agents|sensory system agents|mesh-ancestor
6152449|NCT01429272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6152450|NCT01429272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152451|NCT01429272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6152452|NCT01429272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6152453|NCT01429272|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6152454|NCT01429272|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6152455|NCT01429272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152456|NCT01429272|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6152457|NCT01429272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6152458|NCT01429272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6152459|NCT01429272|Antipyretics|antipyretics|mesh-ancestor
6152460|NCT01429272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6152461|NCT01429272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5553829|NCT04068610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5553830|NCT04068610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6477836|NCT00531310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6152462|NCT01429285|Hydromorphone|hydromorphone|mesh-list
6152463|NCT01429285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6152464|NCT01429285|Narcotics|narcotics|mesh-ancestor
6152465|NCT01429285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6152466|NCT01429285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152467|NCT01429285|Analgesics|analgesics|mesh-ancestor
6152468|NCT01429285|Sensory System Agents|sensory system agents|mesh-ancestor
6152469|NCT01429285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6152470|NCT01429298|Hydromorphone|hydromorphone|mesh-list
6152471|NCT01429298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6152472|NCT01429298|Narcotics|narcotics|mesh-ancestor
6152473|NCT01429298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6152474|NCT01429298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152475|NCT01429298|Analgesics|analgesics|mesh-ancestor
6152476|NCT01429298|Sensory System Agents|sensory system agents|mesh-ancestor
6152477|NCT01429298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6152478|NCT01429350|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6152479|NCT01429350|Plasminogen|plasminogen|mesh-list
6152480|NCT01429350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6152481|NCT01429350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6152482|NCT01429350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152483|NCT01429584|Bupivacaine|bupivacaine|mesh-list
6152484|NCT01429584|Anesthetics, Local|anesthetics, local|mesh-ancestor
6152485|NCT01429584|Anesthetics|anesthetics|mesh-ancestor
6152486|NCT01429584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6152487|NCT01429584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152488|NCT01429584|Sensory System Agents|sensory system agents|mesh-ancestor
6152489|NCT01429584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6152490|NCT01429792|Ribavirin|ribavirin|mesh-list
6152491|NCT01429792|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6152492|NCT01429792|Antimetabolites|antimetabolites|mesh-ancestor
6152493|NCT01429792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152494|NCT01429792|Antiviral Agents|antiviral agents|mesh-ancestor
6152495|NCT01429792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6152496|NCT01429987|Plecanatide|plecanatide|mesh-list
6152497|NCT01429987|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
6152498|NCT01429987|Enzyme Activators|enzyme activators|mesh-ancestor
5553831|NCT04068610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5553832|NCT04068610|Growth Substances|growth substances|mesh-ancestor
5553833|NCT04068610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553834|NCT04068610|Growth Inhibitors|growth inhibitors|mesh-ancestor
5553835|NCT04068610|Antimetabolites|antimetabolites|mesh-ancestor
5553836|NCT04068610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553837|NCT04068610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5553838|NCT04068610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5553839|NCT04068610|Immunologic Factors|immunologic factors|mesh-ancestor
5553840|NCT04068610|Antidotes|antidotes|mesh-ancestor
5553841|NCT04068610|Protective Agents|protective agents|mesh-ancestor
5553842|NCT04068610|Vitamin B Complex|vitamin b complex|mesh-ancestor
5553843|NCT04068610|Vitamins|vitamins|mesh-ancestor
5553844|NCT04068610|Micronutrients|micronutrients|mesh-ancestor
5553845|NCT04068506|Gabapentin|gabapentin|mesh-list
5553846|NCT04068506|Analgesics|analgesics|mesh-ancestor
5553847|NCT04068506|Sensory System Agents|sensory system agents|mesh-ancestor
5553848|NCT04068506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5553849|NCT04068506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553850|NCT04068506|Anticonvulsants|anticonvulsants|mesh-ancestor
5553851|NCT04068506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5553852|NCT04068506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5553853|NCT04068506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5553854|NCT04068506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5553855|NCT04068506|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5553856|NCT04068506|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5553857|NCT04068506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5553858|NCT04068506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553859|NCT04068506|Antimanic Agents|antimanic agents|mesh-ancestor
5553860|NCT04068272|Bosentan|bosentan|mesh-list
5553861|NCT04068272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5553862|NCT04068272|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5553863|NCT04068272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553864|NCT04068207|Minocycline|minocycline|mesh-list
5553865|NCT04068207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5553866|NCT04068207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5603068|NCT03455517|Venetoclax|venetoclax|mesh-list
6152499|NCT01429987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152500|NCT01429987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6152501|NCT01430091|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6152502|NCT01430091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6152503|NCT01430104|Teriparatide|teriparatide|mesh-list
6152504|NCT01430104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5553867|NCT04068246|Metformin|metformin|mesh-list
5553868|NCT04068246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5553869|NCT04068246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553870|NCT04067986|Apatinib|apatinib|mesh-list
5553871|NCT04067986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5553872|NCT04067986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5553873|NCT04067986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5553874|NCT04067986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553875|NCT04067791|Melatonin|melatonin|mesh-list
5553876|NCT04067791|Antioxidants|antioxidants|mesh-ancestor
5553877|NCT04067791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553878|NCT04067791|Protective Agents|protective agents|mesh-ancestor
5553879|NCT04067791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152505|NCT01430104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152506|NCT01430104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6152507|NCT01430182|Morphine|morphine|mesh-list
6152508|NCT01430182|Methadone|methadone|mesh-list
6152509|NCT01430182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6152510|NCT01430182|Narcotics|narcotics|mesh-ancestor
6152511|NCT01430182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6152512|NCT01430182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152513|NCT01430182|Analgesics|analgesics|mesh-ancestor
6152514|NCT01430182|Sensory System Agents|sensory system agents|mesh-ancestor
6152515|NCT01430182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6152516|NCT01430182|Antitussive Agents|antitussive agents|mesh-ancestor
6152517|NCT01430182|Respiratory System Agents|respiratory system agents|mesh-ancestor
6152518|NCT01430403|Fluticasone|fluticasone|mesh-list
6152519|NCT01430403|Xhance|xhance|mesh-list
6152520|NCT01430403|Omalizumab|omalizumab|mesh-list
6152521|NCT01430403|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6152522|NCT01430403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6152523|NCT01430403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6152524|NCT01430403|Autonomic Agents|autonomic agents|mesh-ancestor
6152525|NCT01430403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6152526|NCT01430403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152527|NCT01430403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6152528|NCT01430403|Respiratory System Agents|respiratory system agents|mesh-ancestor
6152529|NCT01430403|Dermatologic Agents|dermatologic agents|mesh-ancestor
6152530|NCT01430403|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6152531|NCT01430403|Immunologic Factors|immunologic factors|mesh-ancestor
6152532|NCT01430442|Sumatriptan|sumatriptan|mesh-list
6152533|NCT01430442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6152534|NCT01430442|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6152535|NCT01430442|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6152536|NCT01430442|Serotonin Agents|serotonin agents|mesh-ancestor
6152537|NCT01430442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6152538|NCT01430442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152539|NCT01430442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152540|NCT01430455|Tranylcypromine|tranylcypromine|mesh-list
6152541|NCT01430455|Antidepressive Agents|antidepressive agents|mesh-ancestor
6152542|NCT01430455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6152543|NCT01430455|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6152544|NCT01430455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6152545|NCT01430455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152546|NCT01430455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6152547|NCT01430455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6152548|NCT01430455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6152549|NCT01430455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152550|NCT01430559|Meloxicam|meloxicam|mesh-list
6152551|NCT01430559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6152552|NCT01430559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6152553|NCT01430559|Analgesics|analgesics|mesh-ancestor
6152554|NCT01430559|Sensory System Agents|sensory system agents|mesh-ancestor
6152555|NCT01430559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6152556|NCT01430559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152557|NCT01430559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6152558|NCT01430559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6152559|NCT01430559|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6152560|NCT01430559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6152561|NCT01430559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6205820|NCT02092467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5553880|NCT04067791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6152562|NCT01430559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152563|NCT01430585|Letrozole|letrozole|mesh-list
6152564|NCT01430585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6152565|NCT01430585|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6152566|NCT01430585|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6152567|NCT01430585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6152568|NCT01430585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152569|NCT01430585|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6152570|NCT01430585|Hormone Antagonists|hormone antagonists|mesh-ancestor
6152571|NCT01430585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6477837|NCT00531323|Etravirine|etravirine|mesh-list
6477838|NCT00531323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6477839|NCT00531323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6477840|NCT00531323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6477841|NCT00531323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477842|NCT00531323|Antiviral Agents|antiviral agents|mesh-ancestor
6477843|NCT00531323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6477844|NCT00531336|Bevacizumab|bevacizumab|mesh-list
6152572|NCT01430585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152573|NCT01430611|Vaccines|vaccines|mesh-list
6152574|NCT01430611|Immunologic Factors|immunologic factors|mesh-ancestor
6152575|NCT01430611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152576|NCT01430819|Vaccines|vaccines|mesh-list
6152577|NCT01430819|Immunologic Factors|immunologic factors|mesh-ancestor
6152578|NCT01430819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553881|NCT04067817|Phenylephrine|phenylephrine|mesh-list
5553882|NCT04067817|Oxymetazoline|oxymetazoline|mesh-list
5553883|NCT04067817|Norepinephrine|norepinephrine|mesh-list
5553884|NCT04067817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
5553885|NCT04067817|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5553886|NCT04067817|Mydriatics|mydriatics|mesh-ancestor
5553887|NCT04067817|Autonomic Agents|autonomic agents|mesh-ancestor
5553888|NCT04067817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5553889|NCT04067817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553890|NCT04067817|Sympathomimetics|sympathomimetics|mesh-ancestor
5553891|NCT04067817|Nasal Decongestants|nasal decongestants|mesh-ancestor
5553892|NCT04067817|Respiratory System Agents|respiratory system agents|mesh-ancestor
5553893|NCT04067817|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5553894|NCT04067817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5553895|NCT04067817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5553896|NCT04067817|Adrenergic Agents|adrenergic agents|mesh-ancestor
5553897|NCT04067817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5553898|NCT04067817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553899|NCT04067817|Protective Agents|protective agents|mesh-ancestor
5553900|NCT04067726|Vitamin D|vitamin d|mesh-list
5553901|NCT04067726|Cholecalciferol|cholecalciferol|mesh-list
5553902|NCT04067726|Denosumab|denosumab|mesh-list
5553903|NCT04067726|Calcium|calcium|mesh-list
5553904|NCT04067726|Vitamins|vitamins|mesh-ancestor
5553905|NCT04067726|Micronutrients|micronutrients|mesh-ancestor
5553906|NCT04067726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553907|NCT04067726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5553908|NCT04067726|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5553909|NCT04067648|Sufentanil|sufentanil|mesh-list
5553910|NCT04067648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6152579|NCT01431014|Dexamethasone|dexamethasone|mesh-list
6152580|NCT01431014|Dexamethasone acetate|dexamethasone acetate|mesh-list
6152581|NCT01431014|BB 1101|bb 1101|mesh-list
6152582|NCT01431014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6152583|NCT01431014|Antiemetics|antiemetics|mesh-ancestor
6152584|NCT01431014|Autonomic Agents|autonomic agents|mesh-ancestor
6152585|NCT01431014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6152586|NCT01431014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152587|NCT01431014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6152588|NCT01431014|Glucocorticoids|glucocorticoids|mesh-ancestor
6152589|NCT01431014|Hormones|hormones|mesh-ancestor
6152590|NCT01431014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6152591|NCT01431014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6152592|NCT01431014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6152593|NCT01431014|Protease Inhibitors|protease inhibitors|mesh-ancestor
6152594|NCT01431014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6152595|NCT01431014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152596|NCT01431105|Atorvastatin|atorvastatin|mesh-list
6477845|NCT00531336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5553911|NCT04067648|Narcotics|narcotics|mesh-ancestor
5725718|NCT03178591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6152597|NCT01431105|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6152598|NCT01431105|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6152599|NCT01431105|Antimetabolites|antimetabolites|mesh-ancestor
6477846|NCT00531336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6477847|NCT00531336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6477848|NCT00531336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6477849|NCT00531336|Growth Substances|growth substances|mesh-ancestor
6477850|NCT00531336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477851|NCT00531336|Growth Inhibitors|growth inhibitors|mesh-ancestor
6477852|NCT00531349|Propofol|propofol|mesh-list
6477853|NCT00531349|Sevoflurane|sevoflurane|mesh-list
6477854|NCT00531349|Anesthetics|anesthetics|mesh-ancestor
6477855|NCT00531349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6477856|NCT00531349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477857|NCT00531349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6477858|NCT00531349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6477859|NCT00531349|Anesthetics, General|anesthetics, general|mesh-ancestor
6477860|NCT00531349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6152600|NCT01431105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152601|NCT01431105|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6152602|NCT01431105|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6152603|NCT01431105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6152604|NCT01431170|Trimethoprim|trimethoprim|mesh-list
6152605|NCT01431170|Polymyxins|polymyxins|mesh-list
6152606|NCT01431170|Polymyxin B|polymyxin b|mesh-list
6152607|NCT01431170|Besifloxacin|besifloxacin|mesh-list
6152608|NCT01431170|Fluoroquinolones|fluoroquinolones|mesh-list
6152609|NCT01431170|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6152610|NCT01431170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6152611|NCT01431170|Renal Agents|renal agents|mesh-ancestor
6152612|NCT01431170|Antimalarials|antimalarials|mesh-ancestor
6152613|NCT01431170|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6152614|NCT01431170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6152615|NCT01431170|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6152616|NCT01431170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6152617|NCT01431170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152618|NCT01431170|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6152619|NCT01431170|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6152620|NCT01431170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6152621|NCT01431170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6152622|NCT01431170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6152623|NCT01431170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6152624|NCT01431170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6152625|NCT01431170|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6152626|NCT01431274|Tiotropium Bromide|tiotropium bromide|mesh-list
6152627|NCT01431274|Olodaterol|olodaterol|mesh-list
6152628|NCT01431274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6152629|NCT01431274|Autonomic Agents|autonomic agents|mesh-ancestor
6152630|NCT01431274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6152631|NCT01431274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152632|NCT01431274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6152633|NCT01431274|Respiratory System Agents|respiratory system agents|mesh-ancestor
6152634|NCT01431274|Parasympatholytics|parasympatholytics|mesh-ancestor
6152635|NCT01431274|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6152636|NCT01431274|Cholinergic Agents|cholinergic agents|mesh-ancestor
6152637|NCT01431274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6152638|NCT01431274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152639|NCT01431287|Tiotropium Bromide|tiotropium bromide|mesh-list
6477861|NCT00531349|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6477862|NCT00531362|Aspirin|aspirin|mesh-list
6477863|NCT00531362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6152640|NCT01431287|Olodaterol|olodaterol|mesh-list
6152641|NCT01431287|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5553912|NCT04067648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5553913|NCT04067648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553914|NCT04067648|Analgesics|analgesics|mesh-ancestor
5553915|NCT04067648|Sensory System Agents|sensory system agents|mesh-ancestor
5553916|NCT04067648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5553917|NCT04067648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5553918|NCT04067648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5553919|NCT04067648|Anesthetics, General|anesthetics, general|mesh-ancestor
5553920|NCT04067648|Anesthetics|anesthetics|mesh-ancestor
5553921|NCT04067856|Dexamethasone|dexamethasone|mesh-list
5553922|NCT04067856|Bevacizumab|bevacizumab|mesh-list
6152642|NCT01431287|Autonomic Agents|autonomic agents|mesh-ancestor
6152643|NCT01431287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6152644|NCT01431287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152645|NCT01431287|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6152646|NCT01431287|Respiratory System Agents|respiratory system agents|mesh-ancestor
6152647|NCT01431287|Parasympatholytics|parasympatholytics|mesh-ancestor
6152648|NCT01431287|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6152649|NCT01431287|Cholinergic Agents|cholinergic agents|mesh-ancestor
6152650|NCT01431287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6152651|NCT01431287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152652|NCT01431339|Vancomycin|vancomycin|mesh-list
6152653|NCT01431339|Linezolid|linezolid|mesh-list
6152654|NCT01431339|Dalbavancin|dalbavancin|mesh-list
6152655|NCT01431339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6152656|NCT01431339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6152657|NCT01431339|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5553923|NCT04067856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5553924|NCT04067856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5553925|NCT04067856|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5553926|NCT04067856|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5553927|NCT04067856|Growth Substances|growth substances|mesh-ancestor
5553928|NCT04067856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553929|NCT04067856|Growth Inhibitors|growth inhibitors|mesh-ancestor
5553930|NCT04067856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6152658|NCT01431339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6152659|NCT01431339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477864|NCT00531362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6477865|NCT00531362|Analgesics|analgesics|mesh-ancestor
6477866|NCT00531362|Sensory System Agents|sensory system agents|mesh-ancestor
6152660|NCT01431391|Leuprolide|leuprolide|mesh-list
5553931|NCT04067856|Antiemetics|antiemetics|mesh-ancestor
5553932|NCT04067856|Autonomic Agents|autonomic agents|mesh-ancestor
5553933|NCT04067856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5553934|NCT04067856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5553935|NCT04067856|Glucocorticoids|glucocorticoids|mesh-ancestor
5553936|NCT04067856|Hormones|hormones|mesh-ancestor
5553937|NCT04067856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5553938|NCT04067856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5553939|NCT04067752|Dialysis Solutions|dialysis solutions|mesh-list
5553940|NCT04067752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5553941|NCT04067531|Clindamycin|clindamycin|mesh-list
5553942|NCT04067531|Clindamycin palmitate|clindamycin palmitate|mesh-list
6152661|NCT01431391|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6152662|NCT01431391|Fertility Agents|fertility agents|mesh-ancestor
6152663|NCT01431391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6152664|NCT01431391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152665|NCT01431391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6152666|NCT01431391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6152667|NCT01431521|Pioglitazone|pioglitazone|mesh-list
6152668|NCT01431521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6152669|NCT01431521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152670|NCT01431573|Lithium Carbonate|lithium carbonate|mesh-list
6152671|NCT01431573|Antidepressive Agents|antidepressive agents|mesh-ancestor
6152672|NCT01431573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6152673|NCT01431573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6152674|NCT01431573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152675|NCT01431573|Antimanic Agents|antimanic agents|mesh-ancestor
6152676|NCT01431573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5553943|NCT04067531|Clindamycin phosphate|clindamycin phosphate|mesh-list
5553944|NCT04067531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6152677|NCT01431573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6152678|NCT01431573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152679|NCT01431716|Epoprostenol|epoprostenol|mesh-list
6152680|NCT01431716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6152681|NCT01431716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6477867|NCT00531362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6477868|NCT00531362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477869|NCT00531362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6477870|NCT00531362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6477871|NCT00531362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6477872|NCT00531362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6477873|NCT00531362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477874|NCT00531362|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6477875|NCT00531362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6477876|NCT00531362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6477877|NCT00531362|Antipyretics|antipyretics|mesh-ancestor
6152682|NCT01431755|Lidocaine|lidocaine|mesh-list
6152683|NCT01431755|Hyaluronic Acid|hyaluronic acid|mesh-list
6152684|NCT01431755|Anesthetics, Local|anesthetics, local|mesh-ancestor
6152685|NCT01431755|Anesthetics|anesthetics|mesh-ancestor
6152686|NCT01431755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6152687|NCT01431755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553945|NCT04067531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5553946|NCT04067531|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5553947|NCT04067531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5553948|NCT04067531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553949|NCT04067518|Pegaspargase|pegaspargase|mesh-list
5553950|NCT04067518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5553951|NCT04067115|Alovudine|alovudine|mesh-list
5553952|NCT04067115|Irinotecan|irinotecan|mesh-list
5553953|NCT04067115|Trabectedin|trabectedin|mesh-list
5553954|NCT04067115|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5553955|NCT04067115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5553956|NCT04067115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5553957|NCT04067115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553958|NCT04067115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5553959|NCT04067115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5553960|NCT04067115|Alkylating Agents|alkylating agents|mesh-ancestor
5553961|NCT04067115|Antiviral Agents|antiviral agents|mesh-ancestor
5553962|NCT04067115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5553963|NCT04067505|Nadroparin|nadroparin|mesh-list
5553964|NCT04067505|Warfarin|warfarin|mesh-list
5553965|NCT04067505|Rivaroxaban|rivaroxaban|mesh-list
5553966|NCT04067505|Anticoagulants|anticoagulants|mesh-ancestor
5553967|NCT04067505|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5553968|NCT04067505|Antithrombins|antithrombins|mesh-ancestor
5553969|NCT04067505|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5553970|NCT04067505|Protease Inhibitors|protease inhibitors|mesh-ancestor
5553971|NCT04067505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5553972|NCT04067505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553973|NCT04067505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5553974|NCT04067505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5553975|NCT04067492|Diclofenac|diclofenac|mesh-list
5553976|NCT04067492|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5553977|NCT04067492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5553978|NCT04067492|Analgesics|analgesics|mesh-ancestor
5553979|NCT04067492|Sensory System Agents|sensory system agents|mesh-ancestor
5553980|NCT04067492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5553981|NCT04067492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553982|NCT04067492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5553983|NCT04067492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5553984|NCT04067492|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5553985|NCT04067492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5553986|NCT04067492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5553987|NCT04067024|Anesthetics|anesthetics|mesh-list
5553988|NCT04067024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6152688|NCT01431755|Sensory System Agents|sensory system agents|mesh-ancestor
6152689|NCT01431755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6152690|NCT01431755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6152691|NCT01431755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6152692|NCT01431755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6152693|NCT01431755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6152694|NCT01431755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152695|NCT01431755|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6152696|NCT01431755|Immunologic Factors|immunologic factors|mesh-ancestor
6152697|NCT01431755|Viscosupplements|viscosupplements|mesh-ancestor
6152698|NCT01431755|Protective Agents|protective agents|mesh-ancestor
5553989|NCT04067024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5553990|NCT04067102|Paclitaxel|paclitaxel|mesh-list
5553991|NCT04067102|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5553992|NCT04067102|Cyclophosphamide|cyclophosphamide|mesh-list
5553993|NCT04067102|Carboplatin|carboplatin|mesh-list
5553994|NCT04067102|Epirubicin|epirubicin|mesh-list
5553995|NCT04067102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5553996|NCT04067102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5553997|NCT04067102|Tubulin Modulators|tubulin modulators|mesh-ancestor
5553998|NCT04067102|Antimitotic Agents|antimitotic agents|mesh-ancestor
5553999|NCT04067102|Mitosis Modulators|mitosis modulators|mesh-ancestor
5554000|NCT04067102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554001|NCT04067102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5554002|NCT04067102|Immunologic Factors|immunologic factors|mesh-ancestor
5554003|NCT04067102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554004|NCT04067102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5554005|NCT04067102|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5554006|NCT04067102|Alkylating Agents|alkylating agents|mesh-ancestor
5554007|NCT04067102|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5554008|NCT04067102|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6152699|NCT01431794|Gemcitabine|gemcitabine|mesh-list
6152700|NCT01431794|Paclitaxel|paclitaxel|mesh-list
6152701|NCT01431794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6152702|NCT01431794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6152703|NCT01431794|Tubulin Modulators|tubulin modulators|mesh-ancestor
6152704|NCT01431794|Antimitotic Agents|antimitotic agents|mesh-ancestor
6152705|NCT01431794|Mitosis Modulators|mitosis modulators|mesh-ancestor
5554009|NCT04067102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5554010|NCT04067102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5554011|NCT04067102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5554012|NCT04067037|Vincristine|vincristine|mesh-list
5554013|NCT04067037|Epirubicin|epirubicin|mesh-list
5554014|NCT04067037|Dacarbazine|dacarbazine|mesh-list
5554015|NCT04067037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6152706|NCT01431794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152707|NCT01431794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6152708|NCT01431794|Antimetabolites|antimetabolites|mesh-ancestor
6152709|NCT01431794|Antiviral Agents|antiviral agents|mesh-ancestor
6152710|NCT01431794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6152711|NCT01431794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6152712|NCT01431794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6152713|NCT01431794|Immunologic Factors|immunologic factors|mesh-ancestor
6152714|NCT01431794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152715|NCT01431950|Fluticasone|fluticasone|mesh-list
6152716|NCT01431950|Xhance|xhance|mesh-list
6152717|NCT01431950|Albuterol|albuterol|mesh-list
6152718|NCT01431950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6152719|NCT01431950|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6152720|NCT01431950|Autonomic Agents|autonomic agents|mesh-ancestor
6152721|NCT01431950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6152722|NCT01431950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152723|NCT01431950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6152724|NCT01431950|Respiratory System Agents|respiratory system agents|mesh-ancestor
6152725|NCT01431950|Dermatologic Agents|dermatologic agents|mesh-ancestor
6152726|NCT01431950|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6152727|NCT01431950|Tocolytic Agents|tocolytic agents|mesh-ancestor
6152728|NCT01431950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6152729|NCT01431950|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6152730|NCT01431950|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6152731|NCT01431950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6152732|NCT01431950|Adrenergic Agents|adrenergic agents|mesh-ancestor
6152733|NCT01431950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6152734|NCT01431950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152735|NCT01431963|Lamotrigine|lamotrigine|mesh-list
6152736|NCT01431963|Anticonvulsants|anticonvulsants|mesh-ancestor
6152737|NCT01431963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6152738|NCT01431963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6207876|NCT02121067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5554016|NCT04067037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5554017|NCT04067037|Tubulin Modulators|tubulin modulators|mesh-ancestor
5554018|NCT04067037|Antimitotic Agents|antimitotic agents|mesh-ancestor
6152739|NCT01431963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152740|NCT01431963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6152741|NCT01431963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152742|NCT01431963|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6152743|NCT01431963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6152744|NCT01431963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6152745|NCT01431963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6152746|NCT01431963|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6152747|NCT01431976|Lamotrigine|lamotrigine|mesh-list
6152748|NCT01431976|Anticonvulsants|anticonvulsants|mesh-ancestor
6152749|NCT01431976|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6152750|NCT01431976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6152751|NCT01431976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152752|NCT01431976|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6152753|NCT01431976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152754|NCT01431976|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6152755|NCT01431976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6152756|NCT01431976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5554019|NCT04067037|Mitosis Modulators|mitosis modulators|mesh-ancestor
5554020|NCT04067037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554021|NCT04067037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5554022|NCT04067037|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5554023|NCT04067037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5554024|NCT04067037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5554025|NCT04067037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5554026|NCT04067037|Alkylating Agents|alkylating agents|mesh-ancestor
5554027|NCT04066803|Folic Acid|folic acid|mesh-list
6152757|NCT01431976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6152758|NCT01431976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6152759|NCT01431989|Amoxicillin|amoxicillin|mesh-list
6152760|NCT01431989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6152761|NCT01431989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6152762|NCT01432015|Aprepitant|aprepitant|mesh-list
5554028|NCT04066803|Hematinics|hematinics|mesh-ancestor
5554029|NCT04066803|Vitamin B Complex|vitamin b complex|mesh-ancestor
5554030|NCT04066803|Vitamins|vitamins|mesh-ancestor
5554031|NCT04066803|Micronutrients|micronutrients|mesh-ancestor
5554032|NCT04066803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554033|NCT04066790|Paclitaxel|paclitaxel|mesh-list
5554034|NCT04066790|Trastuzumab|trastuzumab|mesh-list
5554035|NCT04066790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5554036|NCT04066790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6152763|NCT01432015|Fosaprepitant|fosaprepitant|mesh-list
6152764|NCT01432015|Antiemetics|antiemetics|mesh-ancestor
6152765|NCT01432015|Autonomic Agents|autonomic agents|mesh-ancestor
6152766|NCT01432015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6152767|NCT01432015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152768|NCT01432015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6152769|NCT01432015|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6152770|NCT01432015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6152771|NCT01432015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152772|NCT01432145|Methotrexate|methotrexate|mesh-list
6152773|NCT01432145|Mercaptopurine|mercaptopurine|mesh-list
6477878|NCT00531401|Farnesylthiosalicylic acid|farnesylthiosalicylic acid|mesh-list
6477879|NCT00531401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6477880|NCT00531401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6477881|NCT00531401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477882|NCT00531440|Everolimus|everolimus|mesh-list
6477883|NCT00531440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6477884|NCT00531440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6477885|NCT00531440|Immunologic Factors|immunologic factors|mesh-ancestor
6477886|NCT00531440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477887|NCT00531466|Tolperisone|tolperisone|mesh-list
6477888|NCT00531466|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5554037|NCT04066790|Tubulin Modulators|tubulin modulators|mesh-ancestor
6152774|NCT01432145|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6152775|NCT01432145|Abortifacient Agents|abortifacient agents|mesh-ancestor
6152776|NCT01432145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6152777|NCT01432145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152778|NCT01432145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6152779|NCT01432145|Antimetabolites|antimetabolites|mesh-ancestor
5554038|NCT04066790|Antimitotic Agents|antimitotic agents|mesh-ancestor
6152780|NCT01432145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152781|NCT01432145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6152782|NCT01432145|Dermatologic Agents|dermatologic agents|mesh-ancestor
6152783|NCT01432145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6152784|NCT01432145|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6152785|NCT01432145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6152786|NCT01432145|Immunologic Factors|immunologic factors|mesh-ancestor
6152787|NCT01432145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6152788|NCT01432145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6152789|NCT01432171|Lacosamide|lacosamide|mesh-list
6152790|NCT01432171|Anticonvulsants|anticonvulsants|mesh-ancestor
6152791|NCT01432171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6152792|NCT01432171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6152793|NCT01432171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5554039|NCT04066790|Mitosis Modulators|mitosis modulators|mesh-ancestor
5554040|NCT04066790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554041|NCT04066790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5554042|NCT04066764|Nadroparin|nadroparin|mesh-list
5554043|NCT04066764|Warfarin|warfarin|mesh-list
5554044|NCT04066764|Rivaroxaban|rivaroxaban|mesh-list
5554045|NCT04066764|Anticoagulants|anticoagulants|mesh-ancestor
5554046|NCT04066764|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5554047|NCT04066764|Antithrombins|antithrombins|mesh-ancestor
5554048|NCT04066764|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5554049|NCT04066764|Protease Inhibitors|protease inhibitors|mesh-ancestor
5554050|NCT04066764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5554051|NCT04066764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554052|NCT04066764|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5554053|NCT04066764|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5554054|NCT04066894|Neurotransmitter Agents|neurotransmitter agents|mesh-list
5554055|NCT04066894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152794|NCT01432171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152795|NCT01432236|Pregabalin|pregabalin|mesh-list
6152796|NCT01432236|Analgesics|analgesics|mesh-ancestor
6152797|NCT01432236|Sensory System Agents|sensory system agents|mesh-ancestor
6152798|NCT01432236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6152799|NCT01432236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152800|NCT01432236|Anticonvulsants|anticonvulsants|mesh-ancestor
6152801|NCT01432236|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6152802|NCT01432236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6152803|NCT01432236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152804|NCT01432236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6152805|NCT01432236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6152806|NCT01432236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6152807|NCT01432236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6152808|NCT01432236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6152809|NCT01432262|Vaccines|vaccines|mesh-list
6152810|NCT01432262|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6152811|NCT01432262|Immunologic Factors|immunologic factors|mesh-ancestor
6152812|NCT01432262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152813|NCT01432275|Insulin|insulin|mesh-list
6152814|NCT01432275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6152815|NCT01432275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152816|NCT01432379|Botulinum Toxins|botulinum toxins|mesh-list
6152817|NCT01432379|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6152818|NCT01432379|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6152819|NCT01432379|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6152820|NCT01432379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6152821|NCT01432379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152822|NCT01432379|Cholinergic Agents|cholinergic agents|mesh-ancestor
5554056|NCT04066894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554057|NCT04066881|Vaccines|vaccines|mesh-list
5554058|NCT04066881|Immunologic Factors|immunologic factors|mesh-ancestor
5554059|NCT04066881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554060|NCT04066621|Ceftriaxone|ceftriaxone|mesh-list
5554061|NCT04066621|Sulbactam|sulbactam|mesh-list
5554062|NCT04066621|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5554063|NCT04066621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5554064|NCT04066621|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5554065|NCT04066621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5554066|NCT04066621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554067|NCT04066478|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
6152823|NCT01432379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6152824|NCT01432379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152825|NCT01432379|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6152826|NCT01432379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6152827|NCT01432405|Pioglitazone|pioglitazone|mesh-list
6152828|NCT01432405|Exenatide|exenatide|mesh-list
6152829|NCT01432405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6152830|NCT01432405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152831|NCT01432405|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6152832|NCT01432405|Incretins|incretins|mesh-ancestor
6152833|NCT01432405|Hormones|hormones|mesh-ancestor
6152834|NCT01432405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6152835|NCT01432444|Aripiprazole|aripiprazole|mesh-list
6152836|NCT01432444|Antidepressive Agents|antidepressive agents|mesh-ancestor
6152837|NCT01432444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6152838|NCT01432444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6152839|NCT01432444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6152840|NCT01432444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6152841|NCT01432444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152842|NCT01432444|Dopamine Agonists|dopamine agonists|mesh-ancestor
6152843|NCT01432444|Dopamine Agents|dopamine agents|mesh-ancestor
6152844|NCT01432444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6152845|NCT01432444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152846|NCT01432444|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6152847|NCT01432444|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6152848|NCT01432444|Serotonin Agents|serotonin agents|mesh-ancestor
5554068|NCT04066478|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5554069|NCT04066478|Immunologic Factors|immunologic factors|mesh-ancestor
5554070|NCT04066478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603069|NCT03455517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5603070|NCT03455517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5603071|NCT03455517|Immunologic Factors|immunologic factors|mesh-ancestor
5603072|NCT03455517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603073|NCT03455517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5606796|NCT03770130|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5606797|NCT03770130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6152849|NCT01432444|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6152850|NCT01432444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6152851|NCT01432444|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6152852|NCT01432444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6152853|NCT01432457|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6152854|NCT01432457|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6152855|NCT01432457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6152856|NCT01432457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6152857|NCT01432457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152858|NCT01432457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6152859|NCT01432457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152860|NCT01432457|Antidepressive Agents|antidepressive agents|mesh-ancestor
6152861|NCT01432457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6152862|NCT01432535|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6152863|NCT01432535|Antiviral Agents|antiviral agents|mesh-ancestor
6152864|NCT01432535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6152865|NCT01432561|Cysteamine|cysteamine|mesh-list
6152866|NCT01432561|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
6152867|NCT01432561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152868|NCT01432574|Vaccines|vaccines|mesh-list
6152869|NCT01432574|Immunologic Factors|immunologic factors|mesh-ancestor
6152870|NCT01432574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152871|NCT01432600|Dexamethasone|dexamethasone|mesh-list
6152872|NCT01432600|Cyclophosphamide|cyclophosphamide|mesh-list
6152873|NCT01432600|Pomalidomide|pomalidomide|mesh-list
6152874|NCT01432600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6152875|NCT01432600|Immunologic Factors|immunologic factors|mesh-ancestor
6152876|NCT01432600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152877|NCT01432600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6152878|NCT01432600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6152879|NCT01432600|Alkylating Agents|alkylating agents|mesh-ancestor
6152880|NCT01432600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477889|NCT00531466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477890|NCT00531466|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6477891|NCT00531466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6477892|NCT00531544|Sunitinib|sunitinib|mesh-list
6477893|NCT00531544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6477894|NCT00531544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5554071|NCT04066452|Immunoglobulins|immunoglobulins|mesh-list
5554072|NCT04066452|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5554073|NCT04066452|Antibodies|antibodies|mesh-list
5554074|NCT04066452|Immunologic Factors|immunologic factors|mesh-ancestor
5554075|NCT04066452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554076|NCT04066179|Prednisolone|prednisolone|mesh-list
5554077|NCT04066179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5554078|NCT04066179|Glucocorticoids|glucocorticoids|mesh-ancestor
6477895|NCT00531544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6477896|NCT00531544|Growth Substances|growth substances|mesh-ancestor
6477897|NCT00531544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477898|NCT00531544|Growth Inhibitors|growth inhibitors|mesh-ancestor
6477899|NCT00531544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6477900|NCT00531544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6477901|NCT00531544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477902|NCT00531557|Ritonavir|ritonavir|mesh-list
5554079|NCT04066179|Hormones|hormones|mesh-ancestor
5554080|NCT04066179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5554081|NCT04066179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554082|NCT04066179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5554083|NCT04066179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5554084|NCT04066296|Bupivacaine|bupivacaine|mesh-list
5554085|NCT04066296|Anesthetics, Local|anesthetics, local|mesh-list
5554086|NCT04066296|Anesthetics|anesthetics|mesh-list
5554087|NCT04066296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6477903|NCT00531557|Darunavir|darunavir|mesh-list
6477904|NCT00531557|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6477905|NCT00531557|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6477906|NCT00531557|Protease Inhibitors|protease inhibitors|mesh-ancestor
6477907|NCT00531557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6477908|NCT00531557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477909|NCT00531557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6477910|NCT00531557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6477911|NCT00531557|Antiviral Agents|antiviral agents|mesh-ancestor
6477912|NCT00531557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6152881|NCT01432600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6152882|NCT01432600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6152883|NCT01432600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6152884|NCT01432600|Antiemetics|antiemetics|mesh-ancestor
6152885|NCT01432600|Autonomic Agents|autonomic agents|mesh-ancestor
6152886|NCT01432600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6152887|NCT01432600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6152888|NCT01432600|Glucocorticoids|glucocorticoids|mesh-ancestor
6152889|NCT01432600|Hormones|hormones|mesh-ancestor
6152890|NCT01432600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6152891|NCT01432600|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6152892|NCT01432600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6152893|NCT01432600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6152894|NCT01432600|Growth Substances|growth substances|mesh-ancestor
6152895|NCT01432600|Growth Inhibitors|growth inhibitors|mesh-ancestor
6152896|NCT01432626|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
6152897|NCT01432626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6152898|NCT01432626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6152899|NCT01432626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152900|NCT01432626|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6152901|NCT01432938|Dulaglutide|dulaglutide|mesh-list
6152902|NCT01432938|Warfarin|warfarin|mesh-list
6152903|NCT01432938|Anticoagulants|anticoagulants|mesh-ancestor
6477913|NCT00531557|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6477914|NCT00531557|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6477915|NCT00531596|Selegiline|selegiline|mesh-list
6477916|NCT00531596|Antidepressive Agents|antidepressive agents|mesh-ancestor
6477917|NCT00531596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5554088|NCT04066296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554089|NCT04066296|Sensory System Agents|sensory system agents|mesh-ancestor
5554090|NCT04066296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5554091|NCT04066257|Metronidazole|metronidazole|mesh-list
5554092|NCT04066257|Tetracycline|tetracycline|mesh-list
5554093|NCT04066257|Bismuth|bismuth|mesh-list
5554094|NCT04066257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5554095|NCT04066257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5554096|NCT04066257|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5554097|NCT04066257|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6477918|NCT00531596|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6477919|NCT00531596|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5554098|NCT04066257|Antacids|antacids|mesh-ancestor
6152904|NCT01432938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6477920|NCT00531596|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6477921|NCT00531596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6477922|NCT00531596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477923|NCT00531596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6477924|NCT00531596|Protective Agents|protective agents|mesh-ancestor
5554099|NCT04066257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554100|NCT04066257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5554101|NCT04066257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5554102|NCT04066257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5554103|NCT04066231|Erythromycin|erythromycin|mesh-list
5554104|NCT04066231|Erythromycin Estolate|erythromycin estolate|mesh-list
5554105|NCT04066231|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
5554106|NCT04066231|Erythromycin stearate|erythromycin stearate|mesh-list
5554107|NCT04066231|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
5554108|NCT04066231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5554109|NCT04066231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5554110|NCT04066231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5554111|NCT04066231|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6152905|NCT01432938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152906|NCT01433055|Minocycline|minocycline|mesh-list
6152907|NCT01433055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6152908|NCT01433055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6205821|NCT02092467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205822|NCT02092961|Adalimumab|adalimumab|mesh-list
6205823|NCT02092961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6205824|NCT02092961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6205825|NCT02093026|Folic Acid|folic acid|mesh-list
6205826|NCT02093026|Methylprednisolone|methylprednisolone|mesh-list
5554112|NCT04066231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5554113|NCT04066231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554114|NCT04066114|Mycophenolic Acid|mycophenolic acid|mesh-list
5554115|NCT04066114|Prednisone|prednisone|mesh-list
5554116|NCT04066114|Methylprednisolone|methylprednisolone|mesh-list
5554117|NCT04066114|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5554118|NCT04066114|Everolimus|everolimus|mesh-list
5554119|NCT04066114|Abatacept|abatacept|mesh-list
5554120|NCT04066114|Thymoglobulin|thymoglobulin|mesh-list
5554121|NCT04066114|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5554122|NCT04066114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5554123|NCT04066114|Glucocorticoids|glucocorticoids|mesh-ancestor
5554124|NCT04066114|Hormones|hormones|mesh-ancestor
5554125|NCT04066114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6205827|NCT02093026|Rituximab|rituximab|mesh-list
6205828|NCT02093026|Methotrexate|methotrexate|mesh-list
6205829|NCT02093026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6205830|NCT02093026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6205831|NCT02093026|Immunologic Factors|immunologic factors|mesh-ancestor
6205832|NCT02093026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205833|NCT02093026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6205834|NCT02093026|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5554126|NCT04066114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554127|NCT04066114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5554128|NCT04066114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5554129|NCT04066114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6205835|NCT02093026|Abortifacient Agents|abortifacient agents|mesh-ancestor
6205836|NCT02093026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6205837|NCT02093026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6205838|NCT02093026|Antimetabolites|antimetabolites|mesh-ancestor
6205839|NCT02093026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205840|NCT02093026|Dermatologic Agents|dermatologic agents|mesh-ancestor
6205841|NCT02093026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6205842|NCT02093026|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6205843|NCT02093026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6205844|NCT02093026|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6205845|NCT02093026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6205846|NCT02093026|Antiemetics|antiemetics|mesh-ancestor
6205847|NCT02093026|Autonomic Agents|autonomic agents|mesh-ancestor
6205848|NCT02093026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6205849|NCT02093026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6205850|NCT02093026|Glucocorticoids|glucocorticoids|mesh-ancestor
6205851|NCT02093026|Hormones|hormones|mesh-ancestor
6205852|NCT02093026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6205853|NCT02093026|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6205854|NCT02093026|Protective Agents|protective agents|mesh-ancestor
6205855|NCT02093026|Hematinics|hematinics|mesh-ancestor
6152909|NCT01433081|Magnesium Sulfate|magnesium sulfate|mesh-list
6152910|NCT01433081|Analgesics|analgesics|mesh-ancestor
6152911|NCT01433081|Sensory System Agents|sensory system agents|mesh-ancestor
6152912|NCT01433081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6152913|NCT01433081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152914|NCT01433081|Anesthetics|anesthetics|mesh-ancestor
6152915|NCT01433081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6152916|NCT01433081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6152917|NCT01433081|Anticonvulsants|anticonvulsants|mesh-ancestor
6152918|NCT01433081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6152919|NCT01433081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6477925|NCT00531596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477926|NCT00531635|Mycophenolic Acid|mycophenolic acid|mesh-list
6477927|NCT00531635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5554130|NCT04066114|Immunologic Factors|immunologic factors|mesh-ancestor
5554131|NCT04066114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5554132|NCT04066114|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5554133|NCT04066114|Antitubercular Agents|antitubercular agents|mesh-ancestor
5554134|NCT04066114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6477928|NCT00531635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6477929|NCT00531635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6477930|NCT00531635|Antitubercular Agents|antitubercular agents|mesh-ancestor
6477931|NCT00531635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6477932|NCT00531635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6477933|NCT00531635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6477934|NCT00531635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477935|NCT00531674|Tocopherols|tocopherols|mesh-list
6477936|NCT00531674|Antioxidants|antioxidants|mesh-ancestor
6477937|NCT00531674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477938|NCT00531674|Protective Agents|protective agents|mesh-ancestor
6477939|NCT00531674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477940|NCT00531674|Vitamins|vitamins|mesh-ancestor
6477941|NCT00531674|Micronutrients|micronutrients|mesh-ancestor
6152920|NCT01433081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152921|NCT01433081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6152922|NCT01433081|Tocolytic Agents|tocolytic agents|mesh-ancestor
6477942|NCT00531687|Gemcitabine|gemcitabine|mesh-list
6477943|NCT00531687|Paclitaxel|paclitaxel|mesh-list
6477944|NCT00531687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6152923|NCT01433081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6152924|NCT01433107|Terbinafine|terbinafine|mesh-list
6152925|NCT01433107|Antifungal Agents|antifungal agents|mesh-ancestor
6152926|NCT01433107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6152927|NCT01433107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6152928|NCT01433107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152929|NCT01433172|Vaccines|vaccines|mesh-list
6152930|NCT01433172|Immunologic Factors|immunologic factors|mesh-ancestor
6152931|NCT01433172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152932|NCT01433250|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6152933|NCT01433250|Immunologic Factors|immunologic factors|mesh-ancestor
6152934|NCT01433250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152935|NCT01433913|Metformin|metformin|mesh-list
6152936|NCT01433913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6152937|NCT01433913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152938|NCT01433978|Maleic acid|maleic acid|mesh-list
6152939|NCT01433978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6152940|NCT01433978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152941|NCT01433991|Lenvatinib|lenvatinib|mesh-list
6152942|NCT01433991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6152943|NCT01433991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6152944|NCT01433991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6477945|NCT00531687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6477946|NCT00531687|Tubulin Modulators|tubulin modulators|mesh-ancestor
6477947|NCT00531687|Antimitotic Agents|antimitotic agents|mesh-ancestor
6477948|NCT00531687|Mitosis Modulators|mitosis modulators|mesh-ancestor
6477949|NCT00531687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477950|NCT00531687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5554135|NCT04066114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5554136|NCT04066114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5554137|NCT04066114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554138|NCT04066114|Antiemetics|antiemetics|mesh-ancestor
5554139|NCT04066114|Autonomic Agents|autonomic agents|mesh-ancestor
5554140|NCT04066114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5554141|NCT04066114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6477951|NCT00531687|Antimetabolites|antimetabolites|mesh-ancestor
5554142|NCT04066114|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5554143|NCT04066114|Protective Agents|protective agents|mesh-ancestor
6477952|NCT00531687|Antiviral Agents|antiviral agents|mesh-ancestor
6477953|NCT00531687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6477954|NCT00531687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6477955|NCT00531687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6477956|NCT00531687|Immunologic Factors|immunologic factors|mesh-ancestor
6477957|NCT00531687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152945|NCT01433991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152946|NCT01434121|Ascorbic Acid|ascorbic acid|mesh-list
6152947|NCT01434121|Vitamins|vitamins|mesh-ancestor
6152948|NCT01434121|Micronutrients|micronutrients|mesh-ancestor
6152949|NCT01434121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152950|NCT01434121|Antioxidants|antioxidants|mesh-ancestor
6152951|NCT01434121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152952|NCT01434121|Protective Agents|protective agents|mesh-ancestor
6152953|NCT01434186|Metformin|metformin|mesh-list
6477958|NCT00531791|Prednisone|prednisone|mesh-list
6477959|NCT00531791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6477960|NCT00531791|Glucocorticoids|glucocorticoids|mesh-ancestor
6477961|NCT00531791|Hormones|hormones|mesh-ancestor
6477962|NCT00531791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6477963|NCT00531791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477964|NCT00531791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6477965|NCT00531791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6477966|NCT00531856|Carbon Monoxide|carbon monoxide|mesh-list
6477967|NCT00531856|Antimetabolites|antimetabolites|mesh-ancestor
6477968|NCT00531856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477969|NCT00531856|Gasotransmitters|gasotransmitters|mesh-ancestor
6477970|NCT00531856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6477971|NCT00531856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554144|NCT04066114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5554145|NCT04066114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5554146|NCT04066192|Brexpiprazole|brexpiprazole|mesh-list
5554147|NCT04066192|Serotonin Agents|serotonin agents|mesh-ancestor
5554148|NCT04066192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5554149|NCT04066192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477972|NCT00531895|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6477973|NCT00531895|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6477974|NCT00531895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6477975|NCT00531895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6477976|NCT00531895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477977|NCT00531895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6477978|NCT00531895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554150|NCT04066192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554151|NCT04066192|Dopamine Agonists|dopamine agonists|mesh-ancestor
5554152|NCT04066192|Dopamine Agents|dopamine agents|mesh-ancestor
5554153|NCT04066660|Fucoidan|fucoidan|mesh-list
5554154|NCT04066660|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5554155|NCT04066660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5554156|NCT04066660|Anticoagulants|anticoagulants|mesh-ancestor
5554157|NCT04066660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5554158|NCT04066088|Guanfacine|guanfacine|mesh-list
5554159|NCT04066088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5554160|NCT04066088|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5554161|NCT04066088|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6152954|NCT01434186|Saxagliptin|saxagliptin|mesh-list
6152955|NCT01434186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6152956|NCT01434186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152957|NCT01434186|Incretins|incretins|mesh-ancestor
6152958|NCT01434186|Hormones|hormones|mesh-ancestor
6152959|NCT01434186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6152960|NCT01434186|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6152961|NCT01434186|Protease Inhibitors|protease inhibitors|mesh-ancestor
5554162|NCT04066088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5554163|NCT04066088|Adrenergic Agents|adrenergic agents|mesh-ancestor
5554164|NCT04066088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5554165|NCT04066088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554166|NCT04066088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554167|NCT04065906|Methylphenidate|methylphenidate|mesh-list
5554168|NCT04065906|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
5554169|NCT04065906|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6152962|NCT01434186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5554170|NCT04065906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152963|NCT01434186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152964|NCT01434342|Nicotine|nicotine|mesh-list
6152965|NCT01434342|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6152966|NCT01434342|Autonomic Agents|autonomic agents|mesh-ancestor
6152967|NCT01434342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6152968|NCT01434342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6152969|NCT01434342|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6477979|NCT00531895|Analgesics|analgesics|mesh-ancestor
6477980|NCT00531895|Sensory System Agents|sensory system agents|mesh-ancestor
6477981|NCT00531895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6477982|NCT00531895|Antidepressive Agents|antidepressive agents|mesh-ancestor
6477983|NCT00531895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6152970|NCT01434342|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6152971|NCT01434342|Cholinergic Agents|cholinergic agents|mesh-ancestor
6152972|NCT01434342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6152973|NCT01434342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152974|NCT01434472|Vidarabine|vidarabine|mesh-list
6152975|NCT01434472|Cyclosporine|cyclosporine|mesh-list
6152976|NCT01434472|Mycophenolic Acid|mycophenolic acid|mesh-list
6152977|NCT01434472|Rituximab|rituximab|mesh-list
6152978|NCT01434472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6152979|NCT01434472|Fludarabine|fludarabine|mesh-list
6152980|NCT01434472|Fludarabine phosphate|fludarabine phosphate|mesh-list
6152981|NCT01434472|Antibodies|antibodies|mesh-list
6152982|NCT01434472|Immunoglobulins|immunoglobulins|mesh-list
6152983|NCT01434472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6152984|NCT01434472|Cyclosporins|cyclosporins|mesh-list
6152985|NCT01434472|Immunologic Factors|immunologic factors|mesh-ancestor
6152986|NCT01434472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554171|NCT04065906|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5554172|NCT04065906|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5554173|NCT04065906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5554174|NCT04065906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6152987|NCT01434472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6152988|NCT01434472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6152989|NCT01434472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6477984|NCT00531895|Dopamine Agents|dopamine agents|mesh-ancestor
6477985|NCT00531908|Furosemide|furosemide|mesh-list
6477986|NCT00531908|Diuretics|diuretics|mesh-ancestor
6477987|NCT00531908|Natriuretic Agents|natriuretic agents|mesh-ancestor
6477988|NCT00531908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6477989|NCT00531908|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5554175|NCT04065906|Dopamine Agents|dopamine agents|mesh-ancestor
5554176|NCT04065906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6152990|NCT01434472|Antimetabolites|antimetabolites|mesh-ancestor
6152991|NCT01434472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477990|NCT00531908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6477991|NCT00531908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6477992|NCT00531973|Doxorubicin|doxorubicin|mesh-list
6477993|NCT00531973|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6477994|NCT00531973|Epirubicin|epirubicin|mesh-list
6477995|NCT00531973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6477996|NCT00531973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6477997|NCT00531973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6477998|NCT00531973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6477999|NCT00531973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6152992|NCT01434472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6152993|NCT01434472|Antiviral Agents|antiviral agents|mesh-ancestor
6152994|NCT01434472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6152995|NCT01434472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5554177|NCT04065906|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5554178|NCT04065906|Adrenergic Agents|adrenergic agents|mesh-ancestor
5554179|NCT04066023|Zolmitriptan|zolmitriptan|mesh-list
5554180|NCT04066023|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5554181|NCT04066023|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5554182|NCT04066023|Serotonin Agents|serotonin agents|mesh-ancestor
5554183|NCT04066023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5554184|NCT04066023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554185|NCT04066023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554186|NCT04065919|Epinephrine|epinephrine|mesh-list
5554187|NCT04065919|Bupivacaine|bupivacaine|mesh-list
5554188|NCT04065919|Anesthetics, Local|anesthetics, local|mesh-ancestor
5554189|NCT04065919|Anesthetics|anesthetics|mesh-ancestor
5554190|NCT04065919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5554191|NCT04065919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554192|NCT04065919|Sensory System Agents|sensory system agents|mesh-ancestor
5554193|NCT04065919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5554194|NCT04065919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5554195|NCT04065919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5554196|NCT04065919|Adrenergic Agents|adrenergic agents|mesh-ancestor
5554197|NCT04065919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5554198|NCT04065919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554199|NCT04065919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5554200|NCT04065919|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5554201|NCT04065919|Autonomic Agents|autonomic agents|mesh-ancestor
5554202|NCT04065919|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5554203|NCT04065919|Respiratory System Agents|respiratory system agents|mesh-ancestor
5554204|NCT04065919|Mydriatics|mydriatics|mesh-ancestor
6152996|NCT01434472|Antifungal Agents|antifungal agents|mesh-ancestor
6152997|NCT01434472|Dermatologic Agents|dermatologic agents|mesh-ancestor
6152998|NCT01434472|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6152999|NCT01434472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6153000|NCT01434472|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6153001|NCT01434472|Antitubercular Agents|antitubercular agents|mesh-ancestor
6153002|NCT01434472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6153003|NCT01435018|Tenofovir|tenofovir|mesh-list
6153004|NCT01435018|Emtricitabine|emtricitabine|mesh-list
6153005|NCT01435018|Efavirenz|efavirenz|mesh-list
6153006|NCT01435018|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6153007|NCT01435018|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6153008|NCT01435018|Paclitaxel|paclitaxel|mesh-list
6478000|NCT00531973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478001|NCT00531986|Lopinavir|lopinavir|mesh-list
6478002|NCT00531986|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6478003|NCT00531986|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6478004|NCT00531986|Protease Inhibitors|protease inhibitors|mesh-ancestor
6153009|NCT01435018|Etoposide|etoposide|mesh-list
6153010|NCT01435018|Vincristine|vincristine|mesh-list
6153011|NCT01435018|Bleomycin|bleomycin|mesh-list
6153012|NCT01435018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6153013|NCT01435018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6153014|NCT01435018|Tubulin Modulators|tubulin modulators|mesh-ancestor
6153015|NCT01435018|Antimitotic Agents|antimitotic agents|mesh-ancestor
6153016|NCT01435018|Mitosis Modulators|mitosis modulators|mesh-ancestor
6153017|NCT01435018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153018|NCT01435018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6153019|NCT01435018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6153020|NCT01435018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6478005|NCT00531986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6488819|NCT00586976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5554205|NCT04065919|Sympathomimetics|sympathomimetics|mesh-ancestor
6153021|NCT01435018|Antiviral Agents|antiviral agents|mesh-ancestor
6153022|NCT01435018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6153023|NCT01435018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6153024|NCT01435018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6153025|NCT01435018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6153026|NCT01435018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6153027|NCT01435018|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6478006|NCT00531986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478007|NCT00531986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6478008|NCT00531986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6478009|NCT00531986|Antiviral Agents|antiviral agents|mesh-ancestor
6478010|NCT00531986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6478011|NCT00531986|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6478012|NCT00531986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6478013|NCT00531999|Ritonavir|ritonavir|mesh-list
6478014|NCT00531999|Lopinavir|lopinavir|mesh-list
5554206|NCT04065919|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5554207|NCT04065932|BMS-986165|bms-986165|mesh-list
6153028|NCT01435018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6153029|NCT01435018|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6153030|NCT01435018|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6153031|NCT01435018|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6153032|NCT01435018|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6153033|NCT01435018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6153034|NCT01435122|Axitinib|axitinib|mesh-list
6153035|NCT01435122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6153036|NCT01435122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6153037|NCT01435122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6153038|NCT01435122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153039|NCT01435174|Ranolazine|ranolazine|mesh-list
6153040|NCT01435174|Dialysis Solutions|dialysis solutions|mesh-list
6153041|NCT01435174|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6153042|NCT01435174|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6153043|NCT01435174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6153044|NCT01435174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153045|NCT01435382|Bococizumab|bococizumab|mesh-list
6153046|NCT01435382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6153047|NCT01435382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6153048|NCT01435382|Antimetabolites|antimetabolites|mesh-ancestor
6153049|NCT01435382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153050|NCT01435382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6153051|NCT01435460|Loteprednol Etabonate|loteprednol etabonate|mesh-list
6153052|NCT01435460|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
6153053|NCT01435460|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6153054|NCT01435460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6153055|NCT01435460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6153056|NCT01435460|Analgesics|analgesics|mesh-ancestor
6153057|NCT01435460|Sensory System Agents|sensory system agents|mesh-ancestor
6153058|NCT01435460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6153059|NCT01435460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153060|NCT01435460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6153061|NCT01435460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6153062|NCT01435460|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6153063|NCT01435460|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6153064|NCT01435460|Histamine Antagonists|histamine antagonists|mesh-ancestor
6153065|NCT01435460|Histamine Agents|histamine agents|mesh-ancestor
6153066|NCT01435460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6153067|NCT01435460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153068|NCT01435577|Tapentadol|tapentadol|mesh-list
6153069|NCT01435577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6153070|NCT01435577|Narcotics|narcotics|mesh-ancestor
6153071|NCT01435577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6153072|NCT01435577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153073|NCT01435577|Analgesics|analgesics|mesh-ancestor
6153074|NCT01435577|Sensory System Agents|sensory system agents|mesh-ancestor
6153075|NCT01435577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6153076|NCT01435577|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6205856|NCT02093026|Vitamin B Complex|vitamin b complex|mesh-ancestor
5554208|NCT04065932|Famotidine|famotidine|mesh-list
5554209|NCT04065932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5554210|NCT04065932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5554211|NCT04065932|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5554212|NCT04065932|Histamine Antagonists|histamine antagonists|mesh-ancestor
6478015|NCT00531999|Raltegravir Potassium|raltegravir potassium|mesh-list
5554213|NCT04065932|Histamine Agents|histamine agents|mesh-ancestor
5554214|NCT04065932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5554215|NCT04065932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554216|NCT04065932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554217|NCT04065932|Dermatologic Agents|dermatologic agents|mesh-ancestor
5554218|NCT04065932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5554219|NCT04065932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5554220|NCT04065529|Zinc|zinc|mesh-list
5554221|NCT04065529|Trace Elements|trace elements|mesh-ancestor
5554222|NCT04065529|Micronutrients|micronutrients|mesh-ancestor
5554223|NCT04065529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554224|NCT04065451|Epinephrine|epinephrine|mesh-list
5554225|NCT04065451|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5554226|NCT04065451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5554227|NCT04065451|Adrenergic Agents|adrenergic agents|mesh-ancestor
5554228|NCT04065451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6153077|NCT01435577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6153078|NCT01435577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6153079|NCT01435577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153080|NCT01435577|Adrenergic Agents|adrenergic agents|mesh-ancestor
6153081|NCT01435577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6153082|NCT01435616|Insulin Glargine|insulin glargine|mesh-list
6478016|NCT00531999|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5554229|NCT04065451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554230|NCT04065451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554231|NCT04065451|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5554232|NCT04065451|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5554233|NCT04065451|Autonomic Agents|autonomic agents|mesh-ancestor
5554234|NCT04065451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5554235|NCT04065451|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5554236|NCT04065451|Respiratory System Agents|respiratory system agents|mesh-ancestor
5554237|NCT04065451|Mydriatics|mydriatics|mesh-ancestor
5554238|NCT04065451|Sympathomimetics|sympathomimetics|mesh-ancestor
5554239|NCT04065451|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5554240|NCT04065581|Metformin|metformin|mesh-list
5554241|NCT04065581|Acarbose|acarbose|mesh-list
5554242|NCT04065581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5554243|NCT04065581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554244|NCT04065581|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
5554245|NCT04065581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5554246|NCT04065581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554247|NCT04065555|Cetuximab|cetuximab|mesh-list
6478017|NCT00531999|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6478018|NCT00531999|Protease Inhibitors|protease inhibitors|mesh-ancestor
6478019|NCT00531999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6478020|NCT00531999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478021|NCT00531999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6478022|NCT00531999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6478023|NCT00531999|Antiviral Agents|antiviral agents|mesh-ancestor
6478024|NCT00531999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6478025|NCT00531999|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6478026|NCT00531999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5554248|NCT04065555|Avelumab|avelumab|mesh-list
5554249|NCT04065555|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5554250|NCT04065555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6478027|NCT00531999|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5554251|NCT04065555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6153083|NCT01435616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6153084|NCT01435616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153085|NCT01435759|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6153086|NCT01435759|Antidepressive Agents|antidepressive agents|mesh-list
6153087|NCT01435759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6153088|NCT01435759|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6153089|NCT01435759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153090|NCT01435759|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6153091|NCT01435759|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6153092|NCT01435759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6153093|NCT01435759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153094|NCT01435759|Dopamine Agents|dopamine agents|mesh-ancestor
6153095|NCT01435759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6153096|NCT01435798|Dextromethorphan|dextromethorphan|mesh-list
6153097|NCT01435798|Antitussive Agents|antitussive agents|mesh-ancestor
6205857|NCT02093026|Vitamins|vitamins|mesh-ancestor
6478028|NCT00531999|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5554252|NCT04065555|Immunologic Factors|immunologic factors|mesh-ancestor
5554253|NCT04065555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554254|NCT04065230|Tenofovir|tenofovir|mesh-list
5554255|NCT04065230|Antiviral Agents|antiviral agents|mesh-ancestor
5554256|NCT04065230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5554257|NCT04065230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5554258|NCT04065230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5554259|NCT04065230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5554260|NCT04065230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554261|NCT04065230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5554262|NCT04065230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6153098|NCT01435798|Respiratory System Agents|respiratory system agents|mesh-ancestor
6153099|NCT01435798|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6478029|NCT00532025|Sorafenib|sorafenib|mesh-list
6478030|NCT00532025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6478031|NCT00532025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6153100|NCT01435798|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6153101|NCT01435798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6153102|NCT01435798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153103|NCT01435798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153104|NCT01435824|Amoxicillin|amoxicillin|mesh-list
6153105|NCT01435824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6153106|NCT01435824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6153107|NCT01435928|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
6153108|NCT01435928|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6153109|NCT01435928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6153110|NCT01435928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6153111|NCT01435928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153112|NCT01435928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6153113|NCT01435928|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6153114|NCT01435928|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6153115|NCT01435928|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6153116|NCT01435928|Adrenergic Agents|adrenergic agents|mesh-ancestor
6153117|NCT01435928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6153118|NCT01435928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153119|NCT01435928|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6153120|NCT01435928|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6153121|NCT01435928|Serotonin Agents|serotonin agents|mesh-ancestor
6153122|NCT01435928|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6153123|NCT01435928|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6153124|NCT01435928|Dopamine Agents|dopamine agents|mesh-ancestor
6153125|NCT01436045|Insulin glulisine|insulin glulisine|mesh-list
6153126|NCT01436045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6153127|NCT01436045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153128|NCT01436071|Fluticasone|fluticasone|mesh-list
6153129|NCT01436071|Xhance|xhance|mesh-list
6153130|NCT01436071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6153131|NCT01436071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6153132|NCT01436071|Autonomic Agents|autonomic agents|mesh-ancestor
6153133|NCT01436071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6153134|NCT01436071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153135|NCT01436071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5554263|NCT04065399|Cobicistat|cobicistat|mesh-list
5554264|NCT04065399|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5554265|NCT04065399|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5554266|NCT04065399|Antiviral Agents|antiviral agents|mesh-ancestor
5554267|NCT04065399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5554268|NCT04065399|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5554269|NCT04065399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5554270|NCT04065399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5554271|NCT04065399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554272|NCT04065165|Lanreotide|lanreotide|mesh-list
5554273|NCT04065165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5554274|NCT04065308|Daratumumab|daratumumab|mesh-list
5554275|NCT04065308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5554276|NCT04065282|Capecitabine|capecitabine|mesh-list
5554277|NCT04065282|Oxaliplatin|oxaliplatin|mesh-list
5554278|NCT04065282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6153136|NCT01436071|Respiratory System Agents|respiratory system agents|mesh-ancestor
6153137|NCT01436071|Dermatologic Agents|dermatologic agents|mesh-ancestor
6153138|NCT01436071|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6153139|NCT01436110|Fluticasone|fluticasone|mesh-list
6153140|NCT01436110|Xhance|xhance|mesh-list
6153141|NCT01436110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5554279|NCT04065282|Antimetabolites|antimetabolites|mesh-ancestor
6153142|NCT01436110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6153143|NCT01436110|Autonomic Agents|autonomic agents|mesh-ancestor
6153144|NCT01436110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6667918|NCT01529320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6667919|NCT01529320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6667920|NCT01529437|Immunologic Factors|immunologic factors|mesh-list
6667921|NCT01529437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667922|NCT01529476|Levofloxacin|levofloxacin|mesh-list
6153145|NCT01436110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153146|NCT01436110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6153147|NCT01436110|Respiratory System Agents|respiratory system agents|mesh-ancestor
6153148|NCT01436110|Dermatologic Agents|dermatologic agents|mesh-ancestor
6153149|NCT01436110|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6153150|NCT01436149|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6153151|NCT01436149|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6153152|NCT01436149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153153|NCT01436149|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6153154|NCT01436149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6153155|NCT01436149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6153156|NCT01436149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153157|NCT01436149|Dopamine Agents|dopamine agents|mesh-ancestor
6153158|NCT01436149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6153159|NCT01436162|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6153160|NCT01436162|Antidepressive Agents|antidepressive agents|mesh-list
5554280|NCT04065282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554281|NCT04065282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5554282|NCT04064918|Timolol|timolol|mesh-list
5554283|NCT04064918|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5554284|NCT04064918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5554285|NCT04064918|Adrenergic Agents|adrenergic agents|mesh-ancestor
5554286|NCT04064918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5554287|NCT04064918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153161|NCT01436162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6153162|NCT01436162|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6153163|NCT01436162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153164|NCT01436162|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6153165|NCT01436162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6153166|NCT01436162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6153167|NCT01436162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153168|NCT01436162|Dopamine Agents|dopamine agents|mesh-ancestor
6153169|NCT01436162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6153170|NCT01436175|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6153171|NCT01436175|Antidepressive Agents|antidepressive agents|mesh-list
6153172|NCT01436175|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6153173|NCT01436175|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6153174|NCT01436175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153175|NCT01436175|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6153176|NCT01436175|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6153177|NCT01436175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5554288|NCT04064918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554289|NCT04064918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5554290|NCT04064918|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5554291|NCT04065152|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
5554292|NCT04065152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5554293|NCT04065152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5554294|NCT04065269|Olaparib|olaparib|mesh-list
5554295|NCT04065269|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6153178|NCT01436175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153179|NCT01436175|Dopamine Agents|dopamine agents|mesh-ancestor
6153180|NCT01436175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6153181|NCT01436201|Dulaglutide|dulaglutide|mesh-list
6153182|NCT01436201|Digoxin|digoxin|mesh-list
6153183|NCT01436201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6153184|NCT01436201|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6153185|NCT01436201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6153186|NCT01436201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153187|NCT01436201|Protective Agents|protective agents|mesh-ancestor
6153188|NCT01436201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153189|NCT01436201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6153190|NCT01436266|Folic Acid|folic acid|mesh-list
6153191|NCT01436266|Misoprostol|misoprostol|mesh-list
6153192|NCT01436266|Vitamins|vitamins|mesh-ancestor
6153193|NCT01436266|Micronutrients|micronutrients|mesh-ancestor
6153194|NCT01436266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153195|NCT01436266|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6153196|NCT01436266|Abortifacient Agents|abortifacient agents|mesh-ancestor
6153197|NCT01436266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6153198|NCT01436266|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6153199|NCT01436266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6153200|NCT01436266|Oxytocics|oxytocics|mesh-ancestor
6153201|NCT01436266|Hematinics|hematinics|mesh-ancestor
6478032|NCT00532025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6478033|NCT00532025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478034|NCT00532090|R04929097|r04929097|mesh-list
6478035|NCT00532090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6478036|NCT00532090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478037|NCT00532116|Selegiline|selegiline|mesh-list
6153202|NCT01436266|Vitamin B Complex|vitamin b complex|mesh-ancestor
6153203|NCT01436279|Mifepristone|mifepristone|mesh-list
6153204|NCT01436279|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6153205|NCT01436279|Abortifacient Agents|abortifacient agents|mesh-ancestor
6153206|NCT01436279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6153207|NCT01436279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153208|NCT01436279|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6153209|NCT01436279|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6153210|NCT01436279|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6153211|NCT01436279|Contraceptive Agents|contraceptive agents|mesh-ancestor
6153212|NCT01436279|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6153213|NCT01436279|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6153214|NCT01436279|Hormone Antagonists|hormone antagonists|mesh-ancestor
5554296|NCT04065269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5554297|NCT04065269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554298|NCT04065269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5554299|NCT04065035|Sunscreening Agents|sunscreening agents|mesh-list
5554300|NCT04065035|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5554301|NCT04065035|Protective Agents|protective agents|mesh-ancestor
5554302|NCT04065035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554303|NCT04065035|Dermatologic Agents|dermatologic agents|mesh-ancestor
5554304|NCT04065009|Ropivacaine|ropivacaine|mesh-list
5554305|NCT04065009|Anesthetics, Local|anesthetics, local|mesh-ancestor
5554306|NCT04065009|Anesthetics|anesthetics|mesh-ancestor
5554307|NCT04065009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5554308|NCT04065009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554309|NCT04065009|Sensory System Agents|sensory system agents|mesh-ancestor
5554310|NCT04065009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5554311|NCT04065113|Ethanol|ethanol|mesh-list
5554312|NCT04065113|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5554313|NCT04065113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5554314|NCT04065113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5554315|NCT04065113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554316|NCT04064840|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5554317|NCT04064840|Luteolytic Agents|luteolytic agents|mesh-ancestor
5554318|NCT04064840|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5554319|NCT04064840|Contraceptive Agents|contraceptive agents|mesh-ancestor
5554320|NCT04064840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5554321|NCT04064840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554322|NCT04064840|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5554323|NCT04064840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6153215|NCT01436279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6153216|NCT01436279|Luteolytic Agents|luteolytic agents|mesh-ancestor
6478038|NCT00532116|Antidepressive Agents|antidepressive agents|mesh-ancestor
6478039|NCT00532116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6478040|NCT00532116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6478041|NCT00532116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6478042|NCT00532116|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6478043|NCT00532116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6478044|NCT00532116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478045|NCT00532116|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6478046|NCT00532116|Protective Agents|protective agents|mesh-ancestor
6478047|NCT00532116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153217|NCT01436279|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6153218|NCT01436279|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6153219|NCT01436305|Mycophenolic Acid|mycophenolic acid|mesh-list
6153220|NCT01436305|Methylprednisolone|methylprednisolone|mesh-list
6153221|NCT01436305|Alemtuzumab|alemtuzumab|mesh-list
6478048|NCT00532142|Triamcinolone|triamcinolone|mesh-list
5554324|NCT04064840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5554325|NCT04064619|Solifenacin Succinate|solifenacin succinate|mesh-list
5554326|NCT04064619|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5554327|NCT04064619|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5554328|NCT04064619|Cholinergic Agents|cholinergic agents|mesh-ancestor
6153222|NCT01436305|Abatacept|abatacept|mesh-list
6153223|NCT01436305|Tacrolimus|tacrolimus|mesh-list
6153224|NCT01436305|Basiliximab|basiliximab|mesh-list
6153225|NCT01436305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6153226|NCT01436305|Immunologic Factors|immunologic factors|mesh-ancestor
6153227|NCT01436305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153228|NCT01436305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5554329|NCT04064619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5554330|NCT04064619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554331|NCT04064619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554332|NCT04064619|Urological Agents|urological agents|mesh-ancestor
5554333|NCT04064632|Darunavir|darunavir|mesh-list
5554334|NCT04064632|Cobicistat|cobicistat|mesh-list
5554335|NCT04064632|Rilpivirine|rilpivirine|mesh-list
6153229|NCT01436305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6153230|NCT01436305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153231|NCT01436305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6153232|NCT01436305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6153233|NCT01436305|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6153234|NCT01436305|Antitubercular Agents|antitubercular agents|mesh-ancestor
6153235|NCT01436305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6153236|NCT01436305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6153237|NCT01436305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6153238|NCT01436305|Antiemetics|antiemetics|mesh-ancestor
6153239|NCT01436305|Autonomic Agents|autonomic agents|mesh-ancestor
6153240|NCT01436305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6153241|NCT01436305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6153242|NCT01436305|Glucocorticoids|glucocorticoids|mesh-ancestor
6153243|NCT01436305|Hormones|hormones|mesh-ancestor
6153244|NCT01436305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6153245|NCT01436305|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6153246|NCT01436305|Protective Agents|protective agents|mesh-ancestor
6153247|NCT01436305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6153248|NCT01436305|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6153249|NCT01436305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6153250|NCT01436370|Vaccines|vaccines|mesh-list
6153251|NCT01436370|Immunologic Factors|immunologic factors|mesh-ancestor
6153252|NCT01436370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153253|NCT01436396|Vaccines|vaccines|mesh-list
6153254|NCT01436396|Immunologic Factors|immunologic factors|mesh-ancestor
6478049|NCT00532142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6478050|NCT00532142|Glucocorticoids|glucocorticoids|mesh-ancestor
6478051|NCT00532142|Hormones|hormones|mesh-ancestor
6478052|NCT00532142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6478053|NCT00532142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554336|NCT04064632|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5554337|NCT04064632|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6478054|NCT00532168|Ritonavir|ritonavir|mesh-list
6478055|NCT00532168|Lopinavir|lopinavir|mesh-list
6478056|NCT00532168|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6478057|NCT00532168|Tenofovir|tenofovir|mesh-list
6478058|NCT00532168|Emtricitabine|emtricitabine|mesh-list
6478059|NCT00532168|Efavirenz|efavirenz|mesh-list
6478060|NCT00532168|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6478061|NCT00532168|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6478062|NCT00532168|Protease Inhibitors|protease inhibitors|mesh-ancestor
5554338|NCT04064632|Protease Inhibitors|protease inhibitors|mesh-ancestor
5554339|NCT04064632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5554340|NCT04064632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554341|NCT04064632|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5554342|NCT04064632|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5554343|NCT04064632|Antiviral Agents|antiviral agents|mesh-ancestor
6153255|NCT01436396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153256|NCT01436500|Ifetroban|ifetroban|mesh-list
6478063|NCT00532168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6478064|NCT00532168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153257|NCT01436500|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6153258|NCT01436526|Rivaroxaban|rivaroxaban|mesh-list
6153259|NCT01436526|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6153260|NCT01436526|Antithrombins|antithrombins|mesh-ancestor
6153261|NCT01436526|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6153262|NCT01436526|Protease Inhibitors|protease inhibitors|mesh-ancestor
6153263|NCT01436526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6153264|NCT01436526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153265|NCT01436526|Anticoagulants|anticoagulants|mesh-ancestor
6153266|NCT01436643|Fluoxetine|fluoxetine|mesh-list
6153267|NCT01436643|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6153268|NCT01436643|Citalopram|citalopram|mesh-list
6153269|NCT01436643|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6153270|NCT01436643|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6153271|NCT01436643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6153272|NCT01436643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6153273|NCT01436643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153274|NCT01436643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6478065|NCT00532168|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6478066|NCT00532168|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6478067|NCT00532168|Antiviral Agents|antiviral agents|mesh-ancestor
6478068|NCT00532168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6478069|NCT00532168|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6478070|NCT00532168|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6478071|NCT00532168|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6478072|NCT00532168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6478073|NCT00532168|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6478074|NCT00532168|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6478075|NCT00532168|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5554344|NCT04064632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5554345|NCT04064632|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5554346|NCT04064632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5554347|NCT04064632|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5554348|NCT04064632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5603074|NCT03419234|Ascorbic Acid|ascorbic acid|mesh-list
5603075|NCT03419234|Prednisone|prednisone|mesh-list
5603076|NCT03419234|Cortisone|cortisone|mesh-list
6153275|NCT01436643|Serotonin Agents|serotonin agents|mesh-ancestor
6153276|NCT01436643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153277|NCT01436643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6153278|NCT01436643|Antidepressive Agents|antidepressive agents|mesh-ancestor
6153279|NCT01436643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6205858|NCT02093026|Micronutrients|micronutrients|mesh-ancestor
6478076|NCT00532168|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6478077|NCT00532168|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6478078|NCT00532194|Cediranib|cediranib|mesh-list
6478079|NCT00532194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6478080|NCT00532194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6478081|NCT00532194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6478082|NCT00532194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478083|NCT00532207|Teriparatide|teriparatide|mesh-list
6153280|NCT01436643|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6153281|NCT01436643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6153282|NCT01436643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6153283|NCT01436643|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6153284|NCT01436643|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6153285|NCT01436643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6153286|NCT01436643|Immunologic Factors|immunologic factors|mesh-ancestor
6153287|NCT01436799|Alfentanil|alfentanil|mesh-list
6153288|NCT01436799|Propofol|propofol|mesh-list
6153289|NCT01436799|Desflurane|desflurane|mesh-list
6153290|NCT01436799|Rocuronium|rocuronium|mesh-list
6153291|NCT01436799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6153292|NCT01436799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6153293|NCT01436799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153294|NCT01436799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6153295|NCT01436799|Anesthetics, General|anesthetics, general|mesh-ancestor
6153296|NCT01436799|Anesthetics|anesthetics|mesh-ancestor
6153297|NCT01436799|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6153298|NCT01436799|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6153299|NCT01436799|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6153300|NCT01436799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6153301|NCT01436799|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6153302|NCT01436799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6153303|NCT01436799|Narcotics|narcotics|mesh-ancestor
6153304|NCT01436799|Analgesics|analgesics|mesh-ancestor
6153305|NCT01436799|Sensory System Agents|sensory system agents|mesh-ancestor
6153306|NCT01437267|Vaccines|vaccines|mesh-list
6153307|NCT01437267|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6153308|NCT01437267|Immunologic Factors|immunologic factors|mesh-ancestor
6153309|NCT01437267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478084|NCT00532207|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6478085|NCT00532207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478086|NCT00532207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6478087|NCT00532220|Ibandronic Acid|ibandronic acid|mesh-list
6478088|NCT00532220|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6478089|NCT00532220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478090|NCT00532246|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
6478091|NCT00532246|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6478092|NCT00532246|Hormone Antagonists|hormone antagonists|mesh-ancestor
6478093|NCT00532246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6478094|NCT00532246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478095|NCT00532246|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6478096|NCT00532246|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6478097|NCT00532246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6478098|NCT00532272|Letrozole|letrozole|mesh-list
6478099|NCT00532272|Goserelin|goserelin|mesh-list
6478100|NCT00532272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6478101|NCT00532272|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6478102|NCT00532272|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5554349|NCT04064697|Valganciclovir|valganciclovir|mesh-list
5554350|NCT04064697|Antiviral Agents|antiviral agents|mesh-ancestor
5554351|NCT04064697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5554352|NCT04064554|Vaccines|vaccines|mesh-list
5554353|NCT04064554|Immunologic Factors|immunologic factors|mesh-ancestor
5554354|NCT04064554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554355|NCT04064190|Durvalumab|durvalumab|mesh-list
5554356|NCT04064190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6478103|NCT00532272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5554357|NCT04064190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5554358|NCT04064125|Minocycline|minocycline|mesh-list
5554359|NCT04064125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6153310|NCT01437397|Bromides|bromides|mesh-list
6153311|NCT01437397|Formoterol Fumarate|formoterol fumarate|mesh-list
5554360|NCT04064125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5554361|NCT04063839|Sofosbuvir|sofosbuvir|mesh-list
5554362|NCT04063839|Grazoprevir|grazoprevir|mesh-list
5554363|NCT04063839|Ledipasvir|ledipasvir|mesh-list
5554364|NCT04063839|Antiviral Agents|antiviral agents|mesh-ancestor
5554365|NCT04063839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5554366|NCT04064138|Anesthetics|anesthetics|mesh-list
5554367|NCT04064138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5554368|NCT04064138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153312|NCT01437397|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6153313|NCT01437397|Autonomic Agents|autonomic agents|mesh-ancestor
6153314|NCT01437397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5554369|NCT04064073|Metformin|metformin|mesh-list
5554370|NCT04064073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5554371|NCT04064073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554372|NCT04064931|Niacin|niacin|mesh-list
5554373|NCT04064931|Vitamins|vitamins|mesh-ancestor
6153315|NCT01437397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153316|NCT01437397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6153317|NCT01437397|Respiratory System Agents|respiratory system agents|mesh-ancestor
6153318|NCT01437397|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6153319|NCT01437397|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6153320|NCT01437397|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6153321|NCT01437397|Adrenergic Agents|adrenergic agents|mesh-ancestor
6153322|NCT01437397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6153323|NCT01437397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153324|NCT01437397|Anticonvulsants|anticonvulsants|mesh-ancestor
6153325|NCT01437449|Carboplatin|carboplatin|mesh-list
6153326|NCT01437449|Docetaxel|docetaxel|mesh-list
6153327|NCT01437449|Cetuximab|cetuximab|mesh-list
6153328|NCT01437449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6153329|NCT01437449|Tubulin Modulators|tubulin modulators|mesh-ancestor
6153330|NCT01437449|Antimitotic Agents|antimitotic agents|mesh-ancestor
6153331|NCT01437449|Mitosis Modulators|mitosis modulators|mesh-ancestor
6153332|NCT01437449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153333|NCT01437449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6153334|NCT01437540|Bromides|bromides|mesh-list
6153335|NCT01437540|Formoterol Fumarate|formoterol fumarate|mesh-list
6478104|NCT00532272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478105|NCT00532272|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6478106|NCT00532272|Hormone Antagonists|hormone antagonists|mesh-ancestor
6478107|NCT00532272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6478108|NCT00532272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478109|NCT00532272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6478110|NCT00532285|Gemcitabine|gemcitabine|mesh-list
5554374|NCT04064931|Micronutrients|micronutrients|mesh-ancestor
5554375|NCT04064931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478111|NCT00532285|Paclitaxel|paclitaxel|mesh-list
6478112|NCT00532285|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6478113|NCT00532285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6478114|NCT00532285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6478115|NCT00532285|Tubulin Modulators|tubulin modulators|mesh-ancestor
6478116|NCT00532285|Antimitotic Agents|antimitotic agents|mesh-ancestor
6478117|NCT00532285|Mitosis Modulators|mitosis modulators|mesh-ancestor
6478118|NCT00532285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478119|NCT00532285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6478120|NCT00532285|Antimetabolites|antimetabolites|mesh-ancestor
6478121|NCT00532285|Antiviral Agents|antiviral agents|mesh-ancestor
6478122|NCT00532285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6478123|NCT00532285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6153336|NCT01437540|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6153337|NCT01437540|Autonomic Agents|autonomic agents|mesh-ancestor
6153338|NCT01437540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6153339|NCT01437540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153340|NCT01437540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6153341|NCT01437540|Respiratory System Agents|respiratory system agents|mesh-ancestor
6153342|NCT01437540|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6153343|NCT01437540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6153344|NCT01437540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6153345|NCT01437540|Adrenergic Agents|adrenergic agents|mesh-ancestor
6153346|NCT01437540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6153347|NCT01437540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153348|NCT01437540|Anticonvulsants|anticonvulsants|mesh-ancestor
6153349|NCT01437605|Poly I-C|poly i-c|mesh-list
6153350|NCT01437605|Interferon Inducers|interferon inducers|mesh-ancestor
6478124|NCT00532285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6478125|NCT00532285|Immunologic Factors|immunologic factors|mesh-ancestor
6478126|NCT00532285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554376|NCT04064931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6153351|NCT01437605|Immunologic Factors|immunologic factors|mesh-ancestor
6153352|NCT01437605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153353|NCT01437605|Antiviral Agents|antiviral agents|mesh-ancestor
5554377|NCT04064931|Antimetabolites|antimetabolites|mesh-ancestor
5554378|NCT04064931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153354|NCT01437605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6153355|NCT01437878|Iloprost|iloprost|mesh-list
6153356|NCT01437878|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6153357|NCT01437878|Vasodilator Agents|vasodilator agents|mesh-ancestor
6153358|NCT01437995|Fluticasone|fluticasone|mesh-list
6153359|NCT01437995|Xhance|xhance|mesh-list
6153360|NCT01437995|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6153361|NCT01437995|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6153362|NCT01437995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6153363|NCT01437995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6153364|NCT01437995|Autonomic Agents|autonomic agents|mesh-ancestor
6153365|NCT01437995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6153366|NCT01437995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153367|NCT01437995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6153368|NCT01437995|Respiratory System Agents|respiratory system agents|mesh-ancestor
6153369|NCT01437995|Dermatologic Agents|dermatologic agents|mesh-ancestor
6153370|NCT01437995|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6153371|NCT01437995|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6153372|NCT01437995|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6153373|NCT01437995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6153374|NCT01437995|Adrenergic Agents|adrenergic agents|mesh-ancestor
6153375|NCT01437995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6153376|NCT01437995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153377|NCT01437995|Glucocorticoids|glucocorticoids|mesh-ancestor
6153378|NCT01437995|Hormones|hormones|mesh-ancestor
6478127|NCT00532324|Chlorhexidine|chlorhexidine|mesh-list
6478128|NCT00532324|Mupirocin|mupirocin|mesh-list
6478129|NCT00532324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6478130|NCT00532324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6478131|NCT00532324|Disinfectants|disinfectants|mesh-ancestor
6478132|NCT00532324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6478133|NCT00532324|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6478134|NCT00532324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6478135|NCT00532324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478136|NCT00532350|Tiotropium Bromide|tiotropium bromide|mesh-list
6478137|NCT00532350|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6478138|NCT00532350|Autonomic Agents|autonomic agents|mesh-ancestor
6478139|NCT00532350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6478140|NCT00532350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478141|NCT00532350|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6478142|NCT00532350|Respiratory System Agents|respiratory system agents|mesh-ancestor
6667923|NCT01529476|Ofloxacin|ofloxacin|mesh-list
6667924|NCT01529476|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6667925|NCT01529476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6667926|NCT01529476|Renal Agents|renal agents|mesh-ancestor
6667927|NCT01529476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6667928|NCT01529476|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6667929|NCT01529476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6667930|NCT01529476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6667931|NCT01529476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667932|NCT01529476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6667933|NCT01529476|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5554379|NCT04064931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5554380|NCT04064931|Vasodilator Agents|vasodilator agents|mesh-ancestor
6667934|NCT01529476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6667935|NCT01529528|Anagliptin|anagliptin|mesh-list
6667936|NCT01529528|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6667937|NCT01529528|Protease Inhibitors|protease inhibitors|mesh-ancestor
6153379|NCT01437995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6153380|NCT01437995|Sympathomimetics|sympathomimetics|mesh-ancestor
6153381|NCT01438060|Aripiprazole|aripiprazole|mesh-list
6153382|NCT01438060|Antidepressive Agents|antidepressive agents|mesh-ancestor
6153383|NCT01438060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6153384|NCT01438060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5554381|NCT04064931|Vitamin B Complex|vitamin b complex|mesh-ancestor
5554382|NCT04063904|Misoprostol|misoprostol|mesh-list
5554383|NCT04063904|Mifepristone|mifepristone|mesh-list
5554384|NCT04063904|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5554385|NCT04063904|Abortifacient Agents|abortifacient agents|mesh-ancestor
5554386|NCT04063904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5554387|NCT04063904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554388|NCT04063904|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5554389|NCT04063904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5554390|NCT04063904|Oxytocics|oxytocics|mesh-ancestor
5554391|NCT04063904|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5554392|NCT04063904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5554393|NCT04063904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6153385|NCT01438060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6478143|NCT00532350|Parasympatholytics|parasympatholytics|mesh-ancestor
5554394|NCT04063904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5554395|NCT04063904|Contraceptive Agents|contraceptive agents|mesh-ancestor
5554396|NCT04063904|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5554397|NCT04063904|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5554398|NCT04063904|Hormone Antagonists|hormone antagonists|mesh-ancestor
5554399|NCT04063904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5554400|NCT04063904|Luteolytic Agents|luteolytic agents|mesh-ancestor
5554401|NCT04063904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5554402|NCT04063904|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5554403|NCT04064060|Luspatercept|luspatercept|mesh-list
5554404|NCT04064060|Hematinics|hematinics|mesh-ancestor
5554405|NCT04063865|Everolimus|everolimus|mesh-list
5554406|NCT04063865|Tacrolimus|tacrolimus|mesh-list
5554407|NCT04063865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5554408|NCT04063865|Immunologic Factors|immunologic factors|mesh-ancestor
5554409|NCT04063865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554410|NCT04063865|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5554411|NCT04063865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5554412|NCT04063865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554413|NCT04063865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5554414|NCT04063683|Paclitaxel|paclitaxel|mesh-list
5554415|NCT04063683|Cisplatin|cisplatin|mesh-list
5554416|NCT04063683|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5554417|NCT04063683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6153386|NCT01438060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6153387|NCT01438060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153388|NCT01438060|Dopamine Agonists|dopamine agonists|mesh-ancestor
6153389|NCT01438060|Dopamine Agents|dopamine agents|mesh-ancestor
6153390|NCT01438060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6153391|NCT01438060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153392|NCT01438060|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6153393|NCT01438060|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6153394|NCT01438060|Serotonin Agents|serotonin agents|mesh-ancestor
6153395|NCT01438060|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6153396|NCT01438060|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5554418|NCT04063683|Tubulin Modulators|tubulin modulators|mesh-ancestor
5554419|NCT04063683|Antimitotic Agents|antimitotic agents|mesh-ancestor
5554420|NCT04063683|Mitosis Modulators|mitosis modulators|mesh-ancestor
5554421|NCT04063683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554422|NCT04063527|Paclitaxel|paclitaxel|mesh-list
5554423|NCT04063527|Carboplatin|carboplatin|mesh-list
5554424|NCT04063527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5554425|NCT04063527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5554426|NCT04063527|Tubulin Modulators|tubulin modulators|mesh-ancestor
5554427|NCT04063527|Antimitotic Agents|antimitotic agents|mesh-ancestor
5554428|NCT04063527|Mitosis Modulators|mitosis modulators|mesh-ancestor
5554429|NCT04063527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554430|NCT04063540|Amiloride|amiloride|mesh-list
5554431|NCT04063540|Diuretics|diuretics|mesh-ancestor
5554432|NCT04063540|Natriuretic Agents|natriuretic agents|mesh-ancestor
5554433|NCT04063540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554434|NCT04063540|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
5554435|NCT04063540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5554436|NCT04063540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5603077|NCT03419234|Methyltestosterone|methyltestosterone|mesh-list
6153397|NCT01438060|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6153398|NCT01438060|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6153399|NCT01438151|Infliximab|infliximab|mesh-list
6153400|NCT01438151|Dermatologic Agents|dermatologic agents|mesh-ancestor
6153401|NCT01438151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6153402|NCT01438151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6153403|NCT01438177|Chloroquine|chloroquine|mesh-list
6153404|NCT01438177|Cyclophosphamide|cyclophosphamide|mesh-list
6153405|NCT01438177|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6153406|NCT01438177|Bortezomib|bortezomib|mesh-list
6153407|NCT01438177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6153408|NCT01438177|Immunologic Factors|immunologic factors|mesh-ancestor
6153409|NCT01438177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153410|NCT01438177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6153411|NCT01438177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6153412|NCT01438177|Alkylating Agents|alkylating agents|mesh-ancestor
6153413|NCT01438177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153414|NCT01438177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6153415|NCT01438177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6153416|NCT01438177|Amebicides|amebicides|mesh-ancestor
6153417|NCT01438177|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6153418|NCT01438177|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6478144|NCT00532350|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6478145|NCT00532350|Cholinergic Agents|cholinergic agents|mesh-ancestor
5554437|NCT04063540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554438|NCT04063540|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
5554439|NCT04063540|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5554440|NCT04063267|Nicotine|nicotine|mesh-list
5554441|NCT04063267|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5554442|NCT04063267|Autonomic Agents|autonomic agents|mesh-ancestor
5554443|NCT04063267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5554444|NCT04063267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554445|NCT04063267|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5554446|NCT04063267|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5554447|NCT04063267|Cholinergic Agents|cholinergic agents|mesh-ancestor
5554448|NCT04063267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6478146|NCT00532350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6478147|NCT00532350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478148|NCT00532389|Panobinostat|panobinostat|mesh-list
6478149|NCT00532389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6478150|NCT00532389|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6478151|NCT00532389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6478152|NCT00532389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478153|NCT00532415|Triamcinolone|triamcinolone|mesh-list
6478154|NCT00532415|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6478155|NCT00532415|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6478156|NCT00532415|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6478157|NCT00532415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6478158|NCT00532415|Glucocorticoids|glucocorticoids|mesh-ancestor
6478159|NCT00532415|Hormones|hormones|mesh-ancestor
6478160|NCT00532415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6478161|NCT00532415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478162|NCT00532415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6478163|NCT00532415|Immunologic Factors|immunologic factors|mesh-ancestor
6478164|NCT00532415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5554449|NCT04063267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554450|NCT04063449|Endostar protein|endostar protein|mesh-list
5554451|NCT04063449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5554452|NCT04063449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5554453|NCT04063449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5554454|NCT04063449|Growth Substances|growth substances|mesh-ancestor
5554455|NCT04063449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554456|NCT04063449|Growth Inhibitors|growth inhibitors|mesh-ancestor
5554457|NCT04063449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5554458|NCT04063449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554459|NCT04063358|Ranibizumab|ranibizumab|mesh-list
5554460|NCT04063358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5554461|NCT04063358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5554462|NCT04063358|Growth Substances|growth substances|mesh-ancestor
5554463|NCT04063358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554464|NCT04063358|Growth Inhibitors|growth inhibitors|mesh-ancestor
6153419|NCT01438177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6478165|NCT00532415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478166|NCT00532428|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
5554465|NCT04063358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5554466|NCT04063189|Clarithromycin|clarithromycin|mesh-list
5554467|NCT04063189|Dexamethasone|dexamethasone|mesh-list
6478167|NCT00532428|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6478168|NCT00532428|Hormone Antagonists|hormone antagonists|mesh-ancestor
6478169|NCT00532428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6478170|NCT00532428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478171|NCT00532428|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6478172|NCT00532428|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6478173|NCT00532428|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6478174|NCT00532454|Tamoxifen|tamoxifen|mesh-list
6478175|NCT00532454|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6478176|NCT00532454|Hormone Antagonists|hormone antagonists|mesh-ancestor
6478177|NCT00532454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6478178|NCT00532454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478179|NCT00532454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6478180|NCT00532454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6478181|NCT00532454|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6478182|NCT00532454|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6153420|NCT01438177|Antimalarials|antimalarials|mesh-ancestor
6153421|NCT01438411|Cholic Acids|cholic acids|mesh-list
6153422|NCT01438411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6153423|NCT01438424|Lamivudine|lamivudine|mesh-list
6153424|NCT01438424|Entecavir|entecavir|mesh-list
6153425|NCT01438424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6153426|NCT01438424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6153427|NCT01438424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6153428|NCT01438424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153429|NCT01438424|Antiviral Agents|antiviral agents|mesh-ancestor
6153430|NCT01438424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6153431|NCT01438424|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6153432|NCT01438424|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5554468|NCT04063189|Lenalidomide|lenalidomide|mesh-list
5554469|NCT04063189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5554470|NCT04063189|Antiemetics|antiemetics|mesh-ancestor
5554471|NCT04063189|Autonomic Agents|autonomic agents|mesh-ancestor
5554472|NCT04063189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5554473|NCT04063189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554474|NCT04063189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5554475|NCT04063189|Glucocorticoids|glucocorticoids|mesh-ancestor
5554476|NCT04063189|Hormones|hormones|mesh-ancestor
5554477|NCT04063189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5554478|NCT04063189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6153433|NCT01438489|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6153434|NCT01438489|Immunologic Factors|immunologic factors|mesh-ancestor
6153435|NCT01438489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153436|NCT01438710|Tacrolimus|tacrolimus|mesh-list
6153437|NCT01438710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6153438|NCT01438710|Immunologic Factors|immunologic factors|mesh-ancestor
6153439|NCT01438710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153440|NCT01438710|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6153441|NCT01438710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6153442|NCT01438710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153443|NCT01438814|Metformin|metformin|mesh-list
6153444|NCT01438814|Linagliptin|linagliptin|mesh-list
6153445|NCT01438814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6153446|NCT01438814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153447|NCT01438814|Incretins|incretins|mesh-ancestor
6153448|NCT01438814|Hormones|hormones|mesh-ancestor
6153449|NCT01438814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6153450|NCT01438814|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5554479|NCT04063189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6153451|NCT01438814|Protease Inhibitors|protease inhibitors|mesh-ancestor
6153452|NCT01438814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6153453|NCT01438814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153454|NCT01438840|Maleic acid|maleic acid|mesh-list
6153455|NCT01438840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6153456|NCT01438840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153457|NCT01438957|Dexmedetomidine|dexmedetomidine|mesh-list
6153458|NCT01438957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6153459|NCT01438957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6153460|NCT01438957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153461|NCT01438957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6478183|NCT00532454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6478184|NCT00532519|Citalopram|citalopram|mesh-list
6478185|NCT00532519|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6478186|NCT00532519|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6478187|NCT00532519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6478188|NCT00532519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478189|NCT00532519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6478190|NCT00532519|Serotonin Agents|serotonin agents|mesh-ancestor
6153462|NCT01438957|Analgesics|analgesics|mesh-ancestor
6153463|NCT01438957|Sensory System Agents|sensory system agents|mesh-ancestor
6153464|NCT01438957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6153465|NCT01438957|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6153466|NCT01438957|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6153467|NCT01438957|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6153468|NCT01438957|Adrenergic Agents|adrenergic agents|mesh-ancestor
6153469|NCT01438957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6478191|NCT00532519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554480|NCT04063189|Immunologic Factors|immunologic factors|mesh-ancestor
5554481|NCT04063189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5554482|NCT04063189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5554483|NCT04063189|Growth Substances|growth substances|mesh-ancestor
5554484|NCT04063189|Growth Inhibitors|growth inhibitors|mesh-ancestor
5554485|NCT04063189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5554486|NCT04063189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5554487|NCT04063189|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5554488|NCT04063189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5554489|NCT04063189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554490|NCT04063189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5554491|NCT04063189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5554492|NCT04063163|Carboplatin|carboplatin|mesh-list
5554493|NCT04063163|Etoposide|etoposide|mesh-list
6153470|NCT01438957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153471|NCT01439009|Tolvaptan|tolvaptan|mesh-list
6153472|NCT01439009|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6153473|NCT01439009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153474|NCT01439009|Natriuretic Agents|natriuretic agents|mesh-ancestor
6153475|NCT01439009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153476|NCT01439074|Sulfadiazine|sulfadiazine|mesh-list
6153477|NCT01439074|Silver Sulfadiazine|silver sulfadiazine|mesh-list
6153478|NCT01439074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6153479|NCT01439074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6478192|NCT00532519|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6478193|NCT00532519|Antidepressive Agents|antidepressive agents|mesh-ancestor
6478194|NCT00532519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6478195|NCT00532532|Tolperisone|tolperisone|mesh-list
6478196|NCT00532532|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6478197|NCT00532532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478198|NCT00532532|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5554494|NCT04063163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5554495|NCT04063163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5554496|NCT04063163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5554497|NCT04063163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5554498|NCT04063163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5554499|NCT04063163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603078|NCT03419234|Abiraterone Acetate|abiraterone acetate|mesh-list
5603079|NCT03419234|Hormones|hormones|mesh-list
5603080|NCT03419234|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
5603081|NCT03419234|Androgens|androgens|mesh-list
6153480|NCT01439074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6153481|NCT01439074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6153482|NCT01439074|Coccidiostats|coccidiostats|mesh-ancestor
6488820|NCT00587015|Immunotoxin HA22|immunotoxin ha22|mesh-list
6153483|NCT01439074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6153484|NCT01439126|Clonidine|clonidine|mesh-list
6153485|NCT01439126|Analgesics|analgesics|mesh-ancestor
5554500|NCT04063046|Anesthetics|anesthetics|mesh-list
5554501|NCT04063046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5554502|NCT04063046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554503|NCT04063124|Dasatinib|dasatinib|mesh-list
5554504|NCT04063124|Quercetin|quercetin|mesh-list
5554505|NCT04063124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5554506|NCT04063124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5554507|NCT04063124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5554508|NCT04063124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554509|NCT04063124|Antioxidants|antioxidants|mesh-ancestor
5554510|NCT04063124|Protective Agents|protective agents|mesh-ancestor
6153486|NCT01439126|Sensory System Agents|sensory system agents|mesh-ancestor
6153487|NCT01439126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6153488|NCT01439126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153489|NCT01439126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6153490|NCT01439126|Sympatholytics|sympatholytics|mesh-ancestor
6153491|NCT01439126|Autonomic Agents|autonomic agents|mesh-ancestor
6153492|NCT01439126|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6153493|NCT01439126|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6153494|NCT01439126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6153495|NCT01439126|Adrenergic Agents|adrenergic agents|mesh-ancestor
6667938|NCT01529528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6667939|NCT01529528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667940|NCT01529528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6667941|NCT01529528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667942|NCT01529541|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5554511|NCT04063124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554512|NCT04062760|Diuretics|diuretics|mesh-list
5554513|NCT04062760|Natriuretic Agents|natriuretic agents|mesh-ancestor
5554514|NCT04062760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554515|NCT04062890|Vigabatrin|vigabatrin|mesh-list
5554516|NCT04062890|Anticonvulsants|anticonvulsants|mesh-ancestor
5554517|NCT04062890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5603082|NCT03419234|Androgen Antagonists|androgen antagonists|mesh-list
6153496|NCT01439126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6153497|NCT01439126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205859|NCT02093221|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
6205860|NCT02093221|Protein C Inhibitor|protein c inhibitor|mesh-list
6205861|NCT02093221|Protease Inhibitors|protease inhibitors|mesh-list
6205862|NCT02093221|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6205863|NCT02093221|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6205864|NCT02093221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6205865|NCT02093221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205866|NCT02093351|Tamoxifen|tamoxifen|mesh-list
6205867|NCT02093351|Letrozole|letrozole|mesh-list
6205868|NCT02093351|Olaparib|olaparib|mesh-list
6205869|NCT02093351|Anastrozole|anastrozole|mesh-list
6205870|NCT02093351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6205871|NCT02093351|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6205872|NCT02093351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6478199|NCT00532532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6478200|NCT00532545|Teriparatide|teriparatide|mesh-list
6478201|NCT00532545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6478202|NCT00532545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478203|NCT00532545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6478204|NCT00532571|Coenzyme Q10|coenzyme q10|mesh-list
6478205|NCT00532571|Vitamins|vitamins|mesh-ancestor
6478206|NCT00532571|Micronutrients|micronutrients|mesh-ancestor
6478207|NCT00532571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478208|NCT00532584|Beclomethasone|beclomethasone|mesh-list
6478209|NCT00532584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6478210|NCT00532584|Glucocorticoids|glucocorticoids|mesh-ancestor
6478211|NCT00532584|Hormones|hormones|mesh-ancestor
6478212|NCT00532584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6478213|NCT00532584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478214|NCT00532584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6478215|NCT00532584|Respiratory System Agents|respiratory system agents|mesh-ancestor
6478216|NCT00532623|Gemcitabine|gemcitabine|mesh-list
6478217|NCT00532623|Vinorelbine|vinorelbine|mesh-list
6478218|NCT00532623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6478219|NCT00532623|Antimetabolites|antimetabolites|mesh-ancestor
6478220|NCT00532623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478221|NCT00532623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5554518|NCT04062890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554519|NCT04062890|GABA Agents|gaba agents|mesh-ancestor
5554520|NCT04062890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5554521|NCT04062890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554522|NCT04063033|Ferric gluconate|ferric gluconate|mesh-list
6153498|NCT01439204|Abatacept|abatacept|mesh-list
6478222|NCT00532623|Antiviral Agents|antiviral agents|mesh-ancestor
6478223|NCT00532623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6478224|NCT00532623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6478225|NCT00532623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6478226|NCT00532623|Immunologic Factors|immunologic factors|mesh-ancestor
6478227|NCT00532623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478228|NCT00532623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6478229|NCT00532623|Tubulin Modulators|tubulin modulators|mesh-ancestor
6478230|NCT00532623|Antimitotic Agents|antimitotic agents|mesh-ancestor
6478231|NCT00532623|Mitosis Modulators|mitosis modulators|mesh-ancestor
6478232|NCT00532662|Ketamine|ketamine|mesh-list
6478233|NCT00532662|Analgesics|analgesics|mesh-ancestor
6478234|NCT00532662|Sensory System Agents|sensory system agents|mesh-ancestor
6478235|NCT00532662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6478236|NCT00532662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478237|NCT00532662|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6478238|NCT00532662|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6478239|NCT00532662|Anesthetics, General|anesthetics, general|mesh-ancestor
6153499|NCT01439204|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6153500|NCT01439204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153501|NCT01439204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6153502|NCT01439204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5554523|NCT04063033|Hematinics|hematinics|mesh-ancestor
5554524|NCT04062695|Tofacitinib|tofacitinib|mesh-list
5554525|NCT04062695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5554526|NCT04062695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6153503|NCT01439204|Immunologic Factors|immunologic factors|mesh-ancestor
6153504|NCT01439204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153505|NCT01439204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6153506|NCT01439282|Capecitabine|capecitabine|mesh-list
6153507|NCT01439282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6153508|NCT01439282|Antimetabolites|antimetabolites|mesh-ancestor
6153509|NCT01439282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153510|NCT01439282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6153511|NCT01439360|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6153512|NCT01439360|Immunologic Factors|immunologic factors|mesh-ancestor
6153513|NCT01439360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153514|NCT01439373|Interferons|interferons|mesh-list
6153515|NCT01439373|Ribavirin|ribavirin|mesh-list
6153516|NCT01439373|Interferon-alpha|interferon-alpha|mesh-list
6153517|NCT01439373|Interferon alpha-2|interferon alpha-2|mesh-list
6153518|NCT01439373|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6478240|NCT00532662|Anesthetics|anesthetics|mesh-ancestor
6478241|NCT00532662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6478242|NCT00532662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6478243|NCT00532662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6478244|NCT00532662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6478245|NCT00532662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153519|NCT01439373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6153520|NCT01439373|Antiviral Agents|antiviral agents|mesh-ancestor
6153521|NCT01439373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6153522|NCT01439373|Antimetabolites|antimetabolites|mesh-ancestor
6153523|NCT01439373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153524|NCT01439373|Immunologic Factors|immunologic factors|mesh-ancestor
6153525|NCT01439373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153526|NCT01439555|Simvastatin|simvastatin|mesh-list
6478246|NCT00532675|Lenalidomide|lenalidomide|mesh-list
5554527|NCT04062695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554528|NCT04062656|Leucovorin|leucovorin|mesh-list
5554529|NCT04062656|Folic Acid|folic acid|mesh-list
5554530|NCT04062656|Docetaxel|docetaxel|mesh-list
5554531|NCT04062656|Fluorouracil|fluorouracil|mesh-list
5554532|NCT04062656|Oxaliplatin|oxaliplatin|mesh-list
5554533|NCT04062656|Nivolumab|nivolumab|mesh-list
5554534|NCT04062656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5554535|NCT04062656|Tubulin Modulators|tubulin modulators|mesh-ancestor
6478247|NCT00532675|Panobinostat|panobinostat|mesh-list
6478248|NCT00532675|Immunologic Factors|immunologic factors|mesh-ancestor
6478249|NCT00532675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478250|NCT00532675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6478251|NCT00532675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6478252|NCT00532675|Growth Substances|growth substances|mesh-ancestor
6478253|NCT00532675|Growth Inhibitors|growth inhibitors|mesh-ancestor
6478254|NCT00532675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6478255|NCT00532675|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6478256|NCT00532675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6478257|NCT00532675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478258|NCT00532688|Acetylcysteine|acetylcysteine|mesh-list
6478259|NCT00532688|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6478260|NCT00532688|Antiviral Agents|antiviral agents|mesh-ancestor
6478261|NCT00532688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6478262|NCT00532688|Expectorants|expectorants|mesh-ancestor
6478263|NCT00532688|Respiratory System Agents|respiratory system agents|mesh-ancestor
5554536|NCT04062656|Antimitotic Agents|antimitotic agents|mesh-ancestor
5554537|NCT04062656|Mitosis Modulators|mitosis modulators|mesh-ancestor
5554538|NCT04062656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153527|NCT01439555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6153528|NCT01439555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6153529|NCT01439555|Antimetabolites|antimetabolites|mesh-ancestor
6153530|NCT01439555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153531|NCT01439555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6153532|NCT01439555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5554539|NCT04062656|Antimetabolites|antimetabolites|mesh-ancestor
5554540|NCT04062656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5554541|NCT04062656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5554542|NCT04062656|Immunologic Factors|immunologic factors|mesh-ancestor
5554543|NCT04062656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554544|NCT04062656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5554545|NCT04062656|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6153533|NCT01439555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6153534|NCT01439568|Carboplatin|carboplatin|mesh-list
6153535|NCT01439568|Etoposide|etoposide|mesh-list
6153536|NCT01439568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6478264|NCT00532688|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5554546|NCT04062656|Antidotes|antidotes|mesh-ancestor
5554547|NCT04062656|Protective Agents|protective agents|mesh-ancestor
6153537|NCT01439568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6153538|NCT01439568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6153539|NCT01439568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6153540|NCT01439568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6153541|NCT01439568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153542|NCT01439672|Insulin|insulin|mesh-list
6153543|NCT01439672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6153544|NCT01439672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153545|NCT01439711|Letrozole|letrozole|mesh-list
6153546|NCT01439711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6153547|NCT01439711|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6153548|NCT01439711|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6153549|NCT01439711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6153550|NCT01439711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153551|NCT01439711|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6153552|NCT01439711|Hormone Antagonists|hormone antagonists|mesh-ancestor
6153553|NCT01439711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6153554|NCT01439711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153555|NCT01439815|Fluticasone|fluticasone|mesh-list
6153556|NCT01439815|Xhance|xhance|mesh-list
6153557|NCT01439815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6153558|NCT01439815|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6153559|NCT01439815|Autonomic Agents|autonomic agents|mesh-ancestor
6153560|NCT01439815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6667943|NCT01529541|Anagliptin|anagliptin|mesh-list
6667944|NCT01529541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6667945|NCT01529541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153561|NCT01439815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153562|NCT01439815|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6153563|NCT01439815|Respiratory System Agents|respiratory system agents|mesh-ancestor
6153564|NCT01439815|Dermatologic Agents|dermatologic agents|mesh-ancestor
6153565|NCT01439815|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6153566|NCT01439854|Dapagliflozin|dapagliflozin|mesh-list
6153567|NCT01439854|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6153568|NCT01439854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153569|NCT01439854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6153570|NCT01439854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153571|NCT01439867|Cinacalcet|cinacalcet|mesh-list
6153572|NCT01439867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6153573|NCT01439867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153574|NCT01439867|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6153575|NCT01439867|Hormone Antagonists|hormone antagonists|mesh-ancestor
6153576|NCT01439867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6153577|NCT01439880|Evolocumab|evolocumab|mesh-list
6153578|NCT01439880|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6153579|NCT01439880|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6153580|NCT01439880|Antimetabolites|antimetabolites|mesh-ancestor
6478265|NCT00532688|Antioxidants|antioxidants|mesh-ancestor
6478266|NCT00532688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478267|NCT00532688|Protective Agents|protective agents|mesh-ancestor
6478268|NCT00532688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478269|NCT00532688|Antidotes|antidotes|mesh-ancestor
6478270|NCT00532701|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6478271|NCT00532701|Interferon-alpha|interferon-alpha|mesh-list
6478272|NCT00532701|Ribavirin|ribavirin|mesh-list
6478273|NCT00532701|Antiviral Agents|antiviral agents|mesh-ancestor
6478274|NCT00532701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6478275|NCT00532701|Immunologic Factors|immunologic factors|mesh-ancestor
6478276|NCT00532701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667946|NCT01529541|Incretins|incretins|mesh-ancestor
6478277|NCT00532701|Antimetabolites|antimetabolites|mesh-ancestor
6478278|NCT00532701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478279|NCT00532714|Capecitabine|capecitabine|mesh-list
6478280|NCT00532714|Irinotecan|irinotecan|mesh-list
6478281|NCT00532714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6478282|NCT00532714|Antimetabolites|antimetabolites|mesh-ancestor
6478283|NCT00532714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478284|NCT00532714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6478285|NCT00532714|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6478286|NCT00532714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6478287|NCT00532714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6478288|NCT00532727|Carboplatin|carboplatin|mesh-list
6478289|NCT00532727|Docetaxel|docetaxel|mesh-list
6478290|NCT00532727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6478291|NCT00532727|Tubulin Modulators|tubulin modulators|mesh-ancestor
6478292|NCT00532727|Antimitotic Agents|antimitotic agents|mesh-ancestor
6478293|NCT00532727|Mitosis Modulators|mitosis modulators|mesh-ancestor
6478294|NCT00532727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478295|NCT00532818|Hydralazine|hydralazine|mesh-list
6478296|NCT00532818|Valproic Acid|valproic acid|mesh-list
6478297|NCT00532818|Anticonvulsants|anticonvulsants|mesh-ancestor
6478298|NCT00532818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6478299|NCT00532818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478300|NCT00532818|GABA Agents|gaba agents|mesh-ancestor
6478301|NCT00532818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6478302|NCT00532818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478303|NCT00532818|Antimanic Agents|antimanic agents|mesh-ancestor
6478304|NCT00532818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6478305|NCT00532818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6478306|NCT00532818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6478307|NCT00532818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6478308|NCT00532818|Vasodilator Agents|vasodilator agents|mesh-ancestor
6478309|NCT00532857|Gemcitabine|gemcitabine|mesh-list
6478310|NCT00532857|Paclitaxel|paclitaxel|mesh-list
6478311|NCT00532857|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6478312|NCT00532857|Trastuzumab|trastuzumab|mesh-list
6478313|NCT00532857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6478314|NCT00532857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6478315|NCT00532857|Tubulin Modulators|tubulin modulators|mesh-ancestor
6478316|NCT00532857|Antimitotic Agents|antimitotic agents|mesh-ancestor
6478317|NCT00532857|Mitosis Modulators|mitosis modulators|mesh-ancestor
6478318|NCT00532857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478319|NCT00532857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6478320|NCT00532857|Antimetabolites|antimetabolites|mesh-ancestor
6478321|NCT00532857|Antiviral Agents|antiviral agents|mesh-ancestor
6478322|NCT00532857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6478323|NCT00532857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6153581|NCT01439880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153582|NCT01439880|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6153583|NCT01439945|Magnesium Oxide|magnesium oxide|mesh-list
6153584|NCT01439945|Antacids|antacids|mesh-ancestor
5554548|NCT04062656|Vitamin B Complex|vitamin b complex|mesh-ancestor
5554549|NCT04062656|Vitamins|vitamins|mesh-ancestor
5554550|NCT04062656|Micronutrients|micronutrients|mesh-ancestor
5554551|NCT04062656|Hematinics|hematinics|mesh-ancestor
5554552|NCT04062669|Vaccines|vaccines|mesh-list
5554553|NCT04062669|Immunologic Factors|immunologic factors|mesh-ancestor
5554554|NCT04062669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554555|NCT04062175|Azithromycin|azithromycin|mesh-list
5554556|NCT04062175|Cephalosporins|cephalosporins|mesh-list
5554557|NCT04062175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5554558|NCT04062175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5554559|NCT04062123|Fentanyl|fentanyl|mesh-list
5554560|NCT04062123|Dexmedetomidine|dexmedetomidine|mesh-list
6153585|NCT01439945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153586|NCT01439945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6153587|NCT01440101|Natalizumab|natalizumab|mesh-list
6153588|NCT01440101|Immunologic Factors|immunologic factors|mesh-ancestor
6153589|NCT01440101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554561|NCT04062123|Propofol|propofol|mesh-list
5554562|NCT04062123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5554563|NCT04062123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6153590|NCT01440569|Darunavir|darunavir|mesh-list
6153591|NCT01440569|Cobicistat|cobicistat|mesh-list
6478324|NCT00532857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6478325|NCT00532857|Immunologic Factors|immunologic factors|mesh-ancestor
5554564|NCT04062123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554565|NCT04062123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6153592|NCT01440569|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6153593|NCT01440569|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6153594|NCT01440569|Protease Inhibitors|protease inhibitors|mesh-ancestor
6153595|NCT01440569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6153596|NCT01440569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153597|NCT01440569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6153598|NCT01440569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6153599|NCT01440569|Antiviral Agents|antiviral agents|mesh-ancestor
6153600|NCT01440569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5554566|NCT04062123|Anesthetics, General|anesthetics, general|mesh-ancestor
5554567|NCT04062123|Anesthetics|anesthetics|mesh-ancestor
5554568|NCT04062123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5554569|NCT04062123|Analgesics|analgesics|mesh-ancestor
5554570|NCT04062123|Sensory System Agents|sensory system agents|mesh-ancestor
5554571|NCT04062123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5554572|NCT04062123|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6153601|NCT01440569|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6153602|NCT01440569|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6153603|NCT01440764|Furosemide|furosemide|mesh-list
6153604|NCT01440764|Diuretics|diuretics|mesh-ancestor
6478326|NCT00532857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478327|NCT00532857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6478328|NCT00532909|Bevacizumab|bevacizumab|mesh-list
6478329|NCT00532909|Capecitabine|capecitabine|mesh-list
6478330|NCT00532909|Oxaliplatin|oxaliplatin|mesh-list
6478331|NCT00532909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6478332|NCT00532909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6478333|NCT00532909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6478334|NCT00532909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6478335|NCT00532909|Growth Substances|growth substances|mesh-ancestor
6478336|NCT00532909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478337|NCT00532909|Growth Inhibitors|growth inhibitors|mesh-ancestor
6478338|NCT00532909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6478339|NCT00532909|Antimetabolites|antimetabolites|mesh-ancestor
6478340|NCT00532909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478341|NCT00532961|Loteprednol Etabonate|loteprednol etabonate|mesh-list
6478342|NCT00532961|Tobramycin|tobramycin|mesh-list
6478343|NCT00532961|Dexamethasone|dexamethasone|mesh-list
6478344|NCT00532961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6478345|NCT00532961|Antiemetics|antiemetics|mesh-ancestor
6478346|NCT00532961|Autonomic Agents|autonomic agents|mesh-ancestor
6478347|NCT00532961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6478348|NCT00532961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478349|NCT00532961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6478350|NCT00532961|Glucocorticoids|glucocorticoids|mesh-ancestor
6478351|NCT00532961|Hormones|hormones|mesh-ancestor
6478352|NCT00532961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6478353|NCT00532961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6478354|NCT00532961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6478355|NCT00532961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6478356|NCT00532961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6478357|NCT00532961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6478358|NCT00533026|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6478359|NCT00533026|Warfarin|warfarin|mesh-list
6478360|NCT00533026|Anticoagulants|anticoagulants|mesh-ancestor
6478361|NCT00533026|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6478362|NCT00533026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6478363|NCT00533026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6478364|NCT00533026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478365|NCT00533026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6478366|NCT00533026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478367|NCT00533026|Analgesics|analgesics|mesh-ancestor
6478368|NCT00533026|Sensory System Agents|sensory system agents|mesh-ancestor
6478369|NCT00533026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6478370|NCT00533026|Antidepressive Agents|antidepressive agents|mesh-ancestor
6478371|NCT00533026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6478372|NCT00533026|Dopamine Agents|dopamine agents|mesh-ancestor
6478373|NCT00533039|Varespladib methyl|varespladib methyl|mesh-list
6478374|NCT00533039|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
6478375|NCT00533039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6478376|NCT00533039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478377|NCT00533065|Donepezil|donepezil|mesh-list
6478378|NCT00533065|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5554573|NCT04062123|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5554574|NCT04062123|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5554575|NCT04062123|Adrenergic Agents|adrenergic agents|mesh-ancestor
5554576|NCT04062123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5554577|NCT04062123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153605|NCT01440764|Natriuretic Agents|natriuretic agents|mesh-ancestor
6153606|NCT01440764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153607|NCT01440764|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6153608|NCT01440764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6478379|NCT00533065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6478380|NCT00533065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478381|NCT00533065|Cholinergic Agents|cholinergic agents|mesh-ancestor
6478382|NCT00533065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6478383|NCT00533065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478384|NCT00533065|Nootropic Agents|nootropic agents|mesh-ancestor
6478385|NCT00533091|Sifalimumab|sifalimumab|mesh-list
6478386|NCT00533091|Immunologic Factors|immunologic factors|mesh-ancestor
6478387|NCT00533091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478388|NCT00533169|Tretinoin|tretinoin|mesh-list
6478389|NCT00533169|Isotretinoin|isotretinoin|mesh-list
6478390|NCT00533169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6478391|NCT00533169|Keratolytic Agents|keratolytic agents|mesh-ancestor
6478392|NCT00533169|Dermatologic Agents|dermatologic agents|mesh-ancestor
6478393|NCT00533195|5-Methoxypsoralen|5-methoxypsoralen|mesh-list
6478394|NCT00533195|Methoxsalen|methoxsalen|mesh-list
6478395|NCT00533195|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6478396|NCT00533195|Dermatologic Agents|dermatologic agents|mesh-ancestor
6478397|NCT00533195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6478398|NCT00533247|Celecoxib|celecoxib|mesh-list
6478399|NCT00533247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6478400|NCT00533247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6478401|NCT00533247|Analgesics|analgesics|mesh-ancestor
6478402|NCT00533247|Sensory System Agents|sensory system agents|mesh-ancestor
6153609|NCT01440764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153610|NCT01440803|Teriparatide|teriparatide|mesh-list
6153611|NCT01440803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6153612|NCT01440803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153613|NCT01440803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6153614|NCT01440816|Interleukin-12|interleukin-12|mesh-list
6153615|NCT01440816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6153616|NCT01440816|Immunologic Factors|immunologic factors|mesh-ancestor
6153617|NCT01440816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153618|NCT01440816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6153619|NCT01440816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6153620|NCT01440816|Growth Substances|growth substances|mesh-ancestor
6153621|NCT01440816|Growth Inhibitors|growth inhibitors|mesh-ancestor
6153622|NCT01440816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5554578|NCT04062123|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5554579|NCT04062123|Narcotics|narcotics|mesh-ancestor
5554580|NCT04062123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5554581|NCT04062591|Piroxicam|piroxicam|mesh-list
6153623|NCT01440881|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6153624|NCT01440881|Natriuretic Agents|natriuretic agents|mesh-ancestor
6153625|NCT01440881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554582|NCT04062591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5554583|NCT04062591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5554584|NCT04062591|Analgesics|analgesics|mesh-ancestor
5554585|NCT04062591|Sensory System Agents|sensory system agents|mesh-ancestor
5554586|NCT04062591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5554587|NCT04062591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153626|NCT01441037|Danazol|danazol|mesh-list
6153627|NCT01441037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6153628|NCT01441037|Hormone Antagonists|hormone antagonists|mesh-ancestor
6153629|NCT01441037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6153630|NCT01441037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153631|NCT01441063|Zidovudine|zidovudine|mesh-list
6153632|NCT01441063|Valganciclovir|valganciclovir|mesh-list
6153633|NCT01441063|Antimetabolites|antimetabolites|mesh-ancestor
6153634|NCT01441063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153635|NCT01441063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6153636|NCT01441063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6153637|NCT01441063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6478403|NCT00533247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6478404|NCT00533247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725719|NCT03178292|Levofloxacin|levofloxacin|mesh-list
6153638|NCT01441063|Antiviral Agents|antiviral agents|mesh-ancestor
6153639|NCT01441063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6153640|NCT01441063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6153641|NCT01441063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6153642|NCT01441076|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6153643|NCT01441076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6153644|NCT01441102|Dextromethorphan|dextromethorphan|mesh-list
6153645|NCT01441102|Antitussive Agents|antitussive agents|mesh-ancestor
6478405|NCT00533247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6478406|NCT00533247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6478407|NCT00533247|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6478408|NCT00533247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6478409|NCT00533247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6478410|NCT00533247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478411|NCT00533299|Hydralazine|hydralazine|mesh-list
6478412|NCT00533299|Valproic Acid|valproic acid|mesh-list
6478413|NCT00533299|Anticonvulsants|anticonvulsants|mesh-ancestor
6478414|NCT00533299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6153646|NCT01441102|Respiratory System Agents|respiratory system agents|mesh-ancestor
6153647|NCT01441102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6153648|NCT01441102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5554588|NCT04062591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6153649|NCT01441102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6153650|NCT01441102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153651|NCT01441102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153652|NCT01441180|Sofosbuvir|sofosbuvir|mesh-list
6153653|NCT01441180|Ribavirin|ribavirin|mesh-list
6153654|NCT01441180|Antiviral Agents|antiviral agents|mesh-ancestor
6153655|NCT01441180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6153656|NCT01441180|Antimetabolites|antimetabolites|mesh-ancestor
6153657|NCT01441180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153658|NCT01441245|Furosemide|furosemide|mesh-list
6153659|NCT01441245|Diuretics|diuretics|mesh-ancestor
5554589|NCT04062591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5554590|NCT04062591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5554591|NCT04062591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5554592|NCT04062591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554593|NCT04062565|Treprostinil|treprostinil|mesh-list
5554594|NCT04062565|Riociguat|riociguat|mesh-list
5554595|NCT04062565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6153660|NCT01441245|Natriuretic Agents|natriuretic agents|mesh-ancestor
6153661|NCT01441245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153662|NCT01441245|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6153663|NCT01441245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6153664|NCT01441245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153665|NCT01441401|Gabapentin|gabapentin|mesh-list
6153666|NCT01441401|Analgesics|analgesics|mesh-ancestor
6153667|NCT01441401|Sensory System Agents|sensory system agents|mesh-ancestor
6153668|NCT01441401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6153669|NCT01441401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153670|NCT01441401|Anticonvulsants|anticonvulsants|mesh-ancestor
6153671|NCT01441401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6153672|NCT01441401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6153673|NCT01441401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6153674|NCT01441401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6153675|NCT01441401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6153676|NCT01441401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6153677|NCT01441401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6153678|NCT01441401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153679|NCT01441401|Antimanic Agents|antimanic agents|mesh-ancestor
6153680|NCT01441414|Axitinib|axitinib|mesh-list
6153681|NCT01441414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5554596|NCT04062565|Enzyme Activators|enzyme activators|mesh-ancestor
5554597|NCT04062565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554598|NCT04062201|Levofloxacin|levofloxacin|mesh-list
5554599|NCT04062201|Ofloxacin|ofloxacin|mesh-list
5554600|NCT04062201|Isoniazid|isoniazid|mesh-list
5554601|NCT04062201|Linezolid|linezolid|mesh-list
5554602|NCT04062201|Pyrazinamide|pyrazinamide|mesh-list
5554603|NCT04062201|Ethambutol|ethambutol|mesh-list
5554604|NCT04062201|Bedaquiline|bedaquiline|mesh-list
5554605|NCT04062201|Clofazimine|clofazimine|mesh-list
6153682|NCT01441414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6153683|NCT01441414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6153684|NCT01441414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153685|NCT01441440|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6153686|NCT01441440|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6153687|NCT01441440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6153688|NCT01441440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6153689|NCT01441440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153690|NCT01441440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6153691|NCT01441440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153692|NCT01441440|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6153693|NCT01441440|Antidepressive Agents|antidepressive agents|mesh-ancestor
6153694|NCT01441440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6478415|NCT00533299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478416|NCT00533299|GABA Agents|gaba agents|mesh-ancestor
6478417|NCT00533299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6478418|NCT00533299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478419|NCT00533299|Antimanic Agents|antimanic agents|mesh-ancestor
6478420|NCT00533299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6153695|NCT01441570|Metoprolol|metoprolol|mesh-list
6153696|NCT01441570|Nebivolol|nebivolol|mesh-list
6153697|NCT01441570|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6153698|NCT01441570|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6153699|NCT01441570|Sympatholytics|sympatholytics|mesh-ancestor
6153700|NCT01441570|Autonomic Agents|autonomic agents|mesh-ancestor
6153701|NCT01441570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6153702|NCT01441570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153703|NCT01441570|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6153704|NCT01441570|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6153705|NCT01441570|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6153706|NCT01441570|Adrenergic Agents|adrenergic agents|mesh-ancestor
6153707|NCT01441570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6153708|NCT01441570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153709|NCT01441570|Vasodilator Agents|vasodilator agents|mesh-ancestor
6153710|NCT01441570|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6153711|NCT01441570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6153712|NCT01441570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6153713|NCT01441596|Vinorelbine|vinorelbine|mesh-list
6153714|NCT01441596|Afatinib|afatinib|mesh-list
5554606|NCT04062201|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5554607|NCT04062201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5554608|NCT04062201|Renal Agents|renal agents|mesh-ancestor
6153715|NCT01441596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6153716|NCT01441596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6153717|NCT01441596|Tubulin Modulators|tubulin modulators|mesh-ancestor
5554609|NCT04062201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5554610|NCT04062201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5554611|NCT04062201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5554612|NCT04062201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5554613|NCT04062201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554614|NCT04062201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5554615|NCT04062201|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6153718|NCT01441596|Antimitotic Agents|antimitotic agents|mesh-ancestor
6153719|NCT01441596|Mitosis Modulators|mitosis modulators|mesh-ancestor
6153720|NCT01441596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153721|NCT01441596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6153722|NCT01441596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6153723|NCT01441635|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6153724|NCT01441635|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6153725|NCT01441635|Norethindrone|norethindrone|mesh-list
6153726|NCT01441635|Norethindrone Acetate|norethindrone acetate|mesh-list
6478421|NCT00533299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5554616|NCT04062201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5554617|NCT04062201|Antitubercular Agents|antitubercular agents|mesh-ancestor
6153727|NCT01441635|Estradiol|estradiol|mesh-list
6153728|NCT01441635|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6153729|NCT01441635|Progesterone|progesterone|mesh-list
6153730|NCT01441635|Estrogens|estrogens|mesh-ancestor
6153731|NCT01441635|Hormones|hormones|mesh-ancestor
6153732|NCT01441635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6153733|NCT01441635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153734|NCT01441635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6153735|NCT01441635|Contraceptive Agents|contraceptive agents|mesh-ancestor
6153736|NCT01441635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6153737|NCT01441635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6153738|NCT01441635|Progestins|progestins|mesh-ancestor
6153739|NCT01441635|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6153740|NCT01441635|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6153741|NCT01441635|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6153742|NCT01441765|Pidilizumab|pidilizumab|mesh-list
6153743|NCT01441765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6153744|NCT01441765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6153745|NCT01441843|Lorazepam|lorazepam|mesh-list
6153746|NCT01441843|Anticonvulsants|anticonvulsants|mesh-ancestor
6153747|NCT01441843|Antiemetics|antiemetics|mesh-ancestor
6153748|NCT01441843|Autonomic Agents|autonomic agents|mesh-ancestor
6153749|NCT01441843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6153750|NCT01441843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153751|NCT01441843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5554618|NCT04062201|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5554619|NCT04062201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5554620|NCT04062201|Antimetabolites|antimetabolites|mesh-ancestor
5554621|NCT04062201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5554622|NCT04062201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5554623|NCT04062201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6153752|NCT01441843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6153753|NCT01441843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6153754|NCT01441843|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6153755|NCT01441843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6153756|NCT01441843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6153757|NCT01441843|GABA Modulators|gaba modulators|mesh-ancestor
6478422|NCT00533299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6478423|NCT00533299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6478424|NCT00533299|Vasodilator Agents|vasodilator agents|mesh-ancestor
6478425|NCT00533312|Niacin|niacin|mesh-list
6478426|NCT00533312|Niacinamide|niacinamide|mesh-list
6478427|NCT00533312|Nicotinic Acids|nicotinic acids|mesh-list
6478428|NCT00533312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6153758|NCT01441843|GABA Agents|gaba agents|mesh-ancestor
6153759|NCT01441843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6153760|NCT01441843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153761|NCT01441882|Dasatinib|dasatinib|mesh-list
6153762|NCT01441882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6153763|NCT01441882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6667947|NCT01529541|Hormones|hormones|mesh-ancestor
6667948|NCT01529541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6667949|NCT01529541|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6667950|NCT01529541|Protease Inhibitors|protease inhibitors|mesh-ancestor
6153764|NCT01441882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6153765|NCT01441882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153766|NCT01441960|Rocuronium|rocuronium|mesh-list
6153767|NCT01441960|Succinylcholine|succinylcholine|mesh-list
6153768|NCT01441960|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6153769|NCT01441960|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6153770|NCT01441960|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6153771|NCT01441960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6153772|NCT01441960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153773|NCT01441960|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
6153774|NCT01441973|Elotuzumab|elotuzumab|mesh-list
6153775|NCT01441973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6153776|NCT01442038|Ranolazine|ranolazine|mesh-list
6153777|NCT01442038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6153778|NCT01442038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6153779|NCT01442038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153780|NCT01442064|Ranibizumab|ranibizumab|mesh-list
6153781|NCT01442064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6153782|NCT01442064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6478429|NCT00533312|Antimetabolites|antimetabolites|mesh-ancestor
6478430|NCT00533312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153783|NCT01442064|Growth Substances|growth substances|mesh-ancestor
6153784|NCT01442064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153785|NCT01442064|Growth Inhibitors|growth inhibitors|mesh-ancestor
5554624|NCT04062201|Leprostatic Agents|leprostatic agents|mesh-ancestor
5554625|NCT04062370|Ranibizumab|ranibizumab|mesh-list
5554626|NCT04062370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5554627|NCT04062370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5554628|NCT04062370|Growth Substances|growth substances|mesh-ancestor
5554629|NCT04062370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554630|NCT04062370|Growth Inhibitors|growth inhibitors|mesh-ancestor
5554631|NCT04062370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5554632|NCT04062357|Lidocaine|lidocaine|mesh-list
5554633|NCT04062357|Anesthetics, Local|anesthetics, local|mesh-ancestor
5554634|NCT04062357|Anesthetics|anesthetics|mesh-ancestor
5554635|NCT04062357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5554636|NCT04062357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153786|NCT01442064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6153787|NCT01442155|Capecitabine|capecitabine|mesh-list
6153788|NCT01442155|Oxaliplatin|oxaliplatin|mesh-list
6153789|NCT01442155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6153790|NCT01442155|Antimetabolites|antimetabolites|mesh-ancestor
6153791|NCT01442155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153792|NCT01442155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5554637|NCT04062357|Sensory System Agents|sensory system agents|mesh-ancestor
5554638|NCT04062357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5554639|NCT04062357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5554640|NCT04062357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5554641|NCT04062357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5554642|NCT04062357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5554643|NCT04062357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554644|NCT04062097|Vitamin K|vitamin k|mesh-list
5554645|NCT04062097|Dabigatran|dabigatran|mesh-list
5554646|NCT04062097|Vitamins|vitamins|mesh-ancestor
5554647|NCT04062097|Micronutrients|micronutrients|mesh-ancestor
5554648|NCT04062097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554649|NCT04062097|Antithrombins|antithrombins|mesh-ancestor
5554650|NCT04062097|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5554651|NCT04062097|Protease Inhibitors|protease inhibitors|mesh-ancestor
5554652|NCT04062097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5554653|NCT04062097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554654|NCT04062097|Anticoagulants|anticoagulants|mesh-ancestor
5554655|NCT04062097|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5554656|NCT04062097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5554657|NCT04062097|Hemostatics|hemostatics|mesh-ancestor
5554658|NCT04062097|Coagulants|coagulants|mesh-ancestor
5554659|NCT04061824|Olmesartan|olmesartan|mesh-list
5554660|NCT04061824|Angiotensin II|angiotensin ii|mesh-list
5554661|NCT04061824|Giapreza|giapreza|mesh-list
5554662|NCT04061824|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5554663|NCT04061824|Angiotensinogen|angiotensinogen|mesh-list
5554664|NCT04061824|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
5554665|NCT04061824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5554666|NCT04061824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5554667|NCT04061824|Antimetabolites|antimetabolites|mesh-ancestor
5554668|NCT04061824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554669|NCT04061824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5554670|NCT04061824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5554671|NCT04061824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5554672|NCT04061824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5554673|NCT04061824|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5554674|NCT04061824|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5554675|NCT04061824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6153793|NCT01442376|Ondansetron|ondansetron|mesh-list
6153794|NCT01442376|Palonosetron|palonosetron|mesh-list
6153795|NCT01442376|Antiemetics|antiemetics|mesh-ancestor
6153796|NCT01442376|Autonomic Agents|autonomic agents|mesh-ancestor
6153797|NCT01442376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6153798|NCT01442376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153799|NCT01442376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6153800|NCT01442376|Antipruritics|antipruritics|mesh-ancestor
6153801|NCT01442376|Dermatologic Agents|dermatologic agents|mesh-ancestor
6153802|NCT01442376|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6153803|NCT01442376|Serotonin Agents|serotonin agents|mesh-ancestor
6153804|NCT01442376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5554676|NCT04061824|Protease Inhibitors|protease inhibitors|mesh-ancestor
6153805|NCT01442376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153806|NCT01442376|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6153807|NCT01442376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5554677|NCT04061772|Prednisone|prednisone|mesh-list
5554678|NCT04061772|Cyclophosphamide|cyclophosphamide|mesh-list
5554679|NCT04061772|Etoposide|etoposide|mesh-list
5554680|NCT04061772|Bortezomib|bortezomib|mesh-list
5554681|NCT04061772|Epirubicin|epirubicin|mesh-list
5554682|NCT04061772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5554683|NCT04061772|Immunologic Factors|immunologic factors|mesh-ancestor
6153808|NCT01442376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6153809|NCT01442376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6478431|NCT00533312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6478432|NCT00533312|Vasodilator Agents|vasodilator agents|mesh-ancestor
6478433|NCT00533312|Vitamin B Complex|vitamin b complex|mesh-ancestor
6478434|NCT00533312|Vitamins|vitamins|mesh-ancestor
6478435|NCT00533312|Micronutrients|micronutrients|mesh-ancestor
6478436|NCT00533312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478437|NCT00533390|Efavirenz|efavirenz|mesh-list
6478438|NCT00533390|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6478439|NCT00533390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6478440|NCT00533390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6478441|NCT00533390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478442|NCT00533390|Antiviral Agents|antiviral agents|mesh-ancestor
6478443|NCT00533390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6153810|NCT01442376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6153811|NCT01442376|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6153812|NCT01442493|Methadone|methadone|mesh-list
6153813|NCT01442493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6153814|NCT01442493|Narcotics|narcotics|mesh-ancestor
6153815|NCT01442493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6153816|NCT01442493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153817|NCT01442493|Analgesics|analgesics|mesh-ancestor
6153818|NCT01442493|Sensory System Agents|sensory system agents|mesh-ancestor
6153819|NCT01442493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6153820|NCT01442493|Antitussive Agents|antitussive agents|mesh-ancestor
6153821|NCT01442493|Respiratory System Agents|respiratory system agents|mesh-ancestor
6153822|NCT01442688|Amoxicillin|amoxicillin|mesh-list
5554684|NCT04061772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554685|NCT04061772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6153823|NCT01442688|Mesalamine|mesalamine|mesh-list
6153824|NCT01442688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6153825|NCT01442688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6153826|NCT01442688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6153827|NCT01442688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6153828|NCT01442688|Analgesics|analgesics|mesh-ancestor
6153829|NCT01442688|Sensory System Agents|sensory system agents|mesh-ancestor
6153830|NCT01442688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6153831|NCT01442688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478444|NCT00533390|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6478445|NCT00533390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6478446|NCT00533390|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6478447|NCT00533390|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6478448|NCT00533390|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6153832|NCT01442688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6153833|NCT01442688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6153834|NCT01442714|Lenalidomide|lenalidomide|mesh-list
6153835|NCT01442714|Azacitidine|azacitidine|mesh-list
6153836|NCT01442714|Immunologic Factors|immunologic factors|mesh-ancestor
6478449|NCT00533390|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6478450|NCT00533416|ON 01910|on 01910|mesh-list
6478451|NCT00533416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6478452|NCT00533416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6478453|NCT00533416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6478454|NCT00533416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478455|NCT00533455|Gabapentin|gabapentin|mesh-list
6478456|NCT00533455|Analgesics|analgesics|mesh-ancestor
6478457|NCT00533455|Sensory System Agents|sensory system agents|mesh-ancestor
6478458|NCT00533455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6478459|NCT00533455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478460|NCT00533455|Anticonvulsants|anticonvulsants|mesh-ancestor
6478461|NCT00533455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6478462|NCT00533455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6478463|NCT00533455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5554686|NCT04061772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6153837|NCT01442714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153838|NCT01442714|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5554687|NCT04061772|Alkylating Agents|alkylating agents|mesh-ancestor
5554688|NCT04061772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554689|NCT04061772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5554690|NCT04061772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5554691|NCT04061772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5554692|NCT04061772|Glucocorticoids|glucocorticoids|mesh-ancestor
6478464|NCT00533455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6478465|NCT00533455|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6478466|NCT00533455|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6153839|NCT01442714|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6153840|NCT01442714|Growth Substances|growth substances|mesh-ancestor
6153841|NCT01442714|Growth Inhibitors|growth inhibitors|mesh-ancestor
6153842|NCT01442714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6153843|NCT01442714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6153844|NCT01442714|Antimetabolites|antimetabolites|mesh-ancestor
6153845|NCT01442714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153846|NCT01442714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6153847|NCT01442779|Interferons|interferons|mesh-list
6153848|NCT01442779|Interferon-alpha|interferon-alpha|mesh-list
6153849|NCT01442779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6153850|NCT01442779|Antiviral Agents|antiviral agents|mesh-ancestor
6153851|NCT01442779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6153852|NCT01442779|Immunologic Factors|immunologic factors|mesh-ancestor
6153853|NCT01442779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153854|NCT01443026|Lycopene|lycopene|mesh-list
6478467|NCT00533455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6478468|NCT00533455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478469|NCT00533455|Antimanic Agents|antimanic agents|mesh-ancestor
6478470|NCT00533468|Lidocaine|lidocaine|mesh-list
6153855|NCT01443026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6153856|NCT01443026|Antioxidants|antioxidants|mesh-ancestor
6153857|NCT01443026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153858|NCT01443026|Protective Agents|protective agents|mesh-ancestor
6153859|NCT01443026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153860|NCT01443026|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6153861|NCT01443026|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6153862|NCT01443026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6478471|NCT00533468|Anesthetics, Local|anesthetics, local|mesh-ancestor
6478472|NCT00533468|Anesthetics|anesthetics|mesh-ancestor
6478473|NCT00533468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6478474|NCT00533468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554693|NCT04061772|Hormones|hormones|mesh-ancestor
5554694|NCT04061772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5554695|NCT04061772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5554696|NCT04061772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5554697|NCT04061772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5554698|NCT04061772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5554699|NCT04061772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5554700|NCT04061772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5554701|NCT04062019|Aldesleukin|aldesleukin|mesh-list
5554702|NCT04062019|Interleukin-2|interleukin-2|mesh-list
5554703|NCT04062019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5554704|NCT04062019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5554705|NCT04062019|Analgesics|analgesics|mesh-ancestor
5554706|NCT04062019|Sensory System Agents|sensory system agents|mesh-ancestor
5554707|NCT04062019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5554708|NCT04062019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554709|NCT04062019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5554710|NCT04062019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5554711|NCT04062019|Antiviral Agents|antiviral agents|mesh-ancestor
5554712|NCT04062019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5554713|NCT04062045|Ropivacaine|ropivacaine|mesh-list
5554714|NCT04062045|Anesthetics, Local|anesthetics, local|mesh-ancestor
5554715|NCT04062045|Anesthetics|anesthetics|mesh-ancestor
5554716|NCT04062045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5554717|NCT04062045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554718|NCT04062045|Sensory System Agents|sensory system agents|mesh-ancestor
5554719|NCT04062045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5554720|NCT04061798|Heparin|heparin|mesh-list
5554721|NCT04061798|Anticoagulants|anticoagulants|mesh-ancestor
5554722|NCT04061798|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5554723|NCT04061798|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5554724|NCT04061798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554725|NCT04061863|Nivolumab|nivolumab|mesh-list
5554726|NCT04061863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5554727|NCT04061863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5554728|NCT04061863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5554729|NCT04061863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554730|NCT04062006|Aldesleukin|aldesleukin|mesh-list
5554731|NCT04062006|Interleukin-2|interleukin-2|mesh-list
5554732|NCT04062006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5554733|NCT04062006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5554734|NCT04062006|Analgesics|analgesics|mesh-ancestor
5554735|NCT04062006|Sensory System Agents|sensory system agents|mesh-ancestor
5554736|NCT04062006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5554737|NCT04062006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554738|NCT04062006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6478475|NCT00533468|Sensory System Agents|sensory system agents|mesh-ancestor
6478476|NCT00533468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5554739|NCT04062006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5554740|NCT04062006|Antiviral Agents|antiviral agents|mesh-ancestor
5554741|NCT04062006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5554742|NCT04061512|Dexamethasone|dexamethasone|mesh-list
5554743|NCT04061512|Cyclophosphamide|cyclophosphamide|mesh-list
5554744|NCT04061512|Rituximab|rituximab|mesh-list
5554745|NCT04061512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5554746|NCT04061512|Immunologic Factors|immunologic factors|mesh-ancestor
5554747|NCT04061512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554748|NCT04061512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5554749|NCT04061512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5554750|NCT04061512|Alkylating Agents|alkylating agents|mesh-ancestor
5554751|NCT04061512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554752|NCT04061512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5554753|NCT04061512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5554754|NCT04061512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5554755|NCT04061512|Antiemetics|antiemetics|mesh-ancestor
5554756|NCT04061512|Autonomic Agents|autonomic agents|mesh-ancestor
5554757|NCT04061512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5554758|NCT04061512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5554759|NCT04061512|Glucocorticoids|glucocorticoids|mesh-ancestor
5554760|NCT04061512|Hormones|hormones|mesh-ancestor
5554761|NCT04061512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5554762|NCT04061512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5554763|NCT04061512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5554764|NCT04061655|Iron|iron|mesh-list
5554765|NCT04061655|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
5554766|NCT04061655|Trace Elements|trace elements|mesh-ancestor
5554767|NCT04061655|Micronutrients|micronutrients|mesh-ancestor
5554768|NCT04061655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153863|NCT01443078|Gemcitabine|gemcitabine|mesh-list
6153864|NCT01443078|Carboplatin|carboplatin|mesh-list
6153865|NCT01443078|Docetaxel|docetaxel|mesh-list
6153866|NCT01443078|Pemetrexed|pemetrexed|mesh-list
6153867|NCT01443078|Vinorelbine|vinorelbine|mesh-list
6153868|NCT01443078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6153869|NCT01443078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6153870|NCT01443078|Antimetabolites|antimetabolites|mesh-ancestor
6153871|NCT01443078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153872|NCT01443078|Antiviral Agents|antiviral agents|mesh-ancestor
6153873|NCT01443078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6153874|NCT01443078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6153875|NCT01443078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5554769|NCT04061655|Hematinics|hematinics|mesh-ancestor
5554770|NCT04061447|Clarithromycin|clarithromycin|mesh-list
5554771|NCT04061447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5554772|NCT04061447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5725720|NCT03178292|Ofloxacin|ofloxacin|mesh-list
6153876|NCT01443078|Immunologic Factors|immunologic factors|mesh-ancestor
6153877|NCT01443078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153878|NCT01443078|Tubulin Modulators|tubulin modulators|mesh-ancestor
6153879|NCT01443078|Antimitotic Agents|antimitotic agents|mesh-ancestor
6153880|NCT01443078|Mitosis Modulators|mitosis modulators|mesh-ancestor
6153881|NCT01443078|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6153882|NCT01443078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6153883|NCT01443078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6153884|NCT01443130|Chloroquine|chloroquine|mesh-list
6153885|NCT01443130|Pyrimethamine|pyrimethamine|mesh-list
6153886|NCT01443130|Sulfadoxine|sulfadoxine|mesh-list
6153887|NCT01443130|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6153888|NCT01443130|Amebicides|amebicides|mesh-ancestor
6153889|NCT01443130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6153890|NCT01443130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6478477|NCT00533468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6478478|NCT00533468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6478479|NCT00533468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6478480|NCT00533468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6478481|NCT00533468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478482|NCT00533520|Ranibizumab|ranibizumab|mesh-list
6478483|NCT00533520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6478484|NCT00533520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6478485|NCT00533520|Growth Substances|growth substances|mesh-ancestor
6153891|NCT01443130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5725589|NCT03179735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5725590|NCT03179735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5725591|NCT03179930|Pembrolizumab|pembrolizumab|mesh-list
5725592|NCT03179930|Entinostat|entinostat|mesh-list
6153892|NCT01443130|Antimalarials|antimalarials|mesh-ancestor
6153893|NCT01443130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5554773|NCT04061447|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5554774|NCT04061447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5554775|NCT04061447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554776|NCT04061447|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5554777|NCT04061447|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5554778|NCT04061265|Lidocaine|lidocaine|mesh-list
5554779|NCT04061265|Epinephrine|epinephrine|mesh-list
6153894|NCT01443130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6153895|NCT01443130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6153896|NCT01443130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153897|NCT01443130|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6153898|NCT01443130|Renal Agents|renal agents|mesh-ancestor
6153899|NCT01443364|Certolizumab Pegol|certolizumab pegol|mesh-list
6153900|NCT01443364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6153901|NCT01443364|Immunologic Factors|immunologic factors|mesh-ancestor
5554780|NCT04061265|Carticaine|carticaine|mesh-list
5554781|NCT04061265|Anesthetics, Local|anesthetics, local|mesh-ancestor
5554782|NCT04061265|Anesthetics|anesthetics|mesh-ancestor
5554783|NCT04061265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5554784|NCT04061265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554785|NCT04061265|Sensory System Agents|sensory system agents|mesh-ancestor
5554786|NCT04061265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5554787|NCT04061265|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5554788|NCT04061265|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5554789|NCT04061265|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5554790|NCT04061265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5554791|NCT04061265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554792|NCT04061265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5554793|NCT04061265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5554794|NCT04061265|Adrenergic Agents|adrenergic agents|mesh-ancestor
5554795|NCT04061265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5554796|NCT04061265|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5554797|NCT04061265|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5554798|NCT04061265|Autonomic Agents|autonomic agents|mesh-ancestor
5554799|NCT04061265|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5554800|NCT04061265|Respiratory System Agents|respiratory system agents|mesh-ancestor
5554801|NCT04061265|Mydriatics|mydriatics|mesh-ancestor
5554802|NCT04061265|Sympathomimetics|sympathomimetics|mesh-ancestor
5554803|NCT04061265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5554804|NCT04061252|Brodalumab|brodalumab|mesh-list
5554805|NCT04061252|Dermatologic Agents|dermatologic agents|mesh-ancestor
5554806|NCT04061538|Zinc|zinc|mesh-list
5554807|NCT04061538|Zinc Sulfate|zinc sulfate|mesh-list
5554808|NCT04061538|Trace Elements|trace elements|mesh-ancestor
5554809|NCT04061538|Micronutrients|micronutrients|mesh-ancestor
5554810|NCT04061538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554811|NCT04061538|Astringents|astringents|mesh-ancestor
5554812|NCT04061538|Dermatologic Agents|dermatologic agents|mesh-ancestor
5603083|NCT03419234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5603084|NCT03419234|Glucocorticoids|glucocorticoids|mesh-ancestor
5603085|NCT03419234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5603086|NCT03419234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603087|NCT03419234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6478486|NCT00533520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478487|NCT00533520|Growth Inhibitors|growth inhibitors|mesh-ancestor
6478488|NCT00533520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6478489|NCT00533533|Docetaxel|docetaxel|mesh-list
6478490|NCT00533533|Oxaliplatin|oxaliplatin|mesh-list
6478491|NCT00533533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5554813|NCT04061590|Cisplatin|cisplatin|mesh-list
5554814|NCT04061590|Pembrolizumab|pembrolizumab|mesh-list
5554815|NCT04061590|Pemetrexed|pemetrexed|mesh-list
5554816|NCT04061590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5554817|NCT04061590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5554818|NCT04061590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5554819|NCT04061590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554820|NCT04061590|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5554821|NCT04061590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5554822|NCT04061473|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5554823|NCT04061473|Empagliflozin|empagliflozin|mesh-list
5554824|NCT04061473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5554825|NCT04061473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554826|NCT04061473|Incretins|incretins|mesh-ancestor
6153902|NCT01443364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153903|NCT01443364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6153904|NCT01443442|Loteprednol Etabonate|loteprednol etabonate|mesh-list
6153905|NCT01443442|Bepotastine besilate|bepotastine besilate|mesh-list
6153906|NCT01443442|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6153907|NCT01443546|Leuprolide|leuprolide|mesh-list
6153908|NCT01443546|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6153909|NCT01443546|Fertility Agents|fertility agents|mesh-ancestor
6478492|NCT00533533|Tubulin Modulators|tubulin modulators|mesh-ancestor
6478493|NCT00533533|Antimitotic Agents|antimitotic agents|mesh-ancestor
6478494|NCT00533533|Mitosis Modulators|mitosis modulators|mesh-ancestor
6478495|NCT00533533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478496|NCT00533559|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
6478497|NCT00533559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6153910|NCT01443546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6153911|NCT01443546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554827|NCT04061473|Hormones|hormones|mesh-ancestor
5554828|NCT04061473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5554829|NCT04061473|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5554830|NCT04061473|Protease Inhibitors|protease inhibitors|mesh-ancestor
5554831|NCT04061473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5554832|NCT04061473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554833|NCT04061473|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5554834|NCT04061200|Empagliflozin|empagliflozin|mesh-list
5554835|NCT04061200|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5554836|NCT04061200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554837|NCT04061200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5554838|NCT04061200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554839|NCT04061161|Bromides|bromides|mesh-list
5554840|NCT04061161|Tiotropium Bromide|tiotropium bromide|mesh-list
6153912|NCT01443546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6153913|NCT01443546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6153914|NCT01443858|Meclizine|meclizine|mesh-list
6153915|NCT01443858|Nicotine|nicotine|mesh-list
6153916|NCT01443858|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6153917|NCT01443858|Autonomic Agents|autonomic agents|mesh-ancestor
6153918|NCT01443858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6153919|NCT01443858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153920|NCT01443858|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6153921|NCT01443858|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6153922|NCT01443858|Cholinergic Agents|cholinergic agents|mesh-ancestor
6205873|NCT02093351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6478498|NCT00533585|Paclitaxel|paclitaxel|mesh-list
6478499|NCT00533585|Bevacizumab|bevacizumab|mesh-list
6478500|NCT00533585|Carboplatin|carboplatin|mesh-list
5554841|NCT04061161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5554842|NCT04061161|Autonomic Agents|autonomic agents|mesh-ancestor
5554843|NCT04061161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5554844|NCT04061161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554845|NCT04061161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5554846|NCT04061161|Respiratory System Agents|respiratory system agents|mesh-ancestor
5554847|NCT04061161|Parasympatholytics|parasympatholytics|mesh-ancestor
5554848|NCT04061161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5554849|NCT04061161|Cholinergic Agents|cholinergic agents|mesh-ancestor
5554850|NCT04061161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5554851|NCT04061161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478501|NCT00533585|Sorafenib|sorafenib|mesh-list
6153923|NCT01443858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6153924|NCT01443858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153925|NCT01443858|Antiemetics|antiemetics|mesh-ancestor
6153926|NCT01443858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6153927|NCT01443858|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6153928|NCT01443858|Histamine Antagonists|histamine antagonists|mesh-ancestor
6153929|NCT01443858|Histamine Agents|histamine agents|mesh-ancestor
6153930|NCT01443858|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6153931|NCT01444300|4-Aminopyridine|4-aminopyridine|mesh-list
6153932|NCT01444300|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6153933|NCT01444300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6153934|NCT01444300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153935|NCT01444430|Budesonide|budesonide|mesh-list
6153936|NCT01444430|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6153937|NCT01444430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6153938|NCT01444430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6153939|NCT01444430|Autonomic Agents|autonomic agents|mesh-ancestor
6153940|NCT01444430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6153941|NCT01444430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153942|NCT01444430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6153943|NCT01444430|Respiratory System Agents|respiratory system agents|mesh-ancestor
6153944|NCT01444430|Glucocorticoids|glucocorticoids|mesh-ancestor
5554852|NCT04061161|Anticonvulsants|anticonvulsants|mesh-ancestor
5554853|NCT04060888|Ustekinumab|ustekinumab|mesh-list
5554854|NCT04060888|Dermatologic Agents|dermatologic agents|mesh-ancestor
5554855|NCT04061057|Lidocaine|lidocaine|mesh-list
5554856|NCT04061057|Anesthetics, Local|anesthetics, local|mesh-ancestor
5554857|NCT04061057|Anesthetics|anesthetics|mesh-ancestor
5554858|NCT04061057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5554859|NCT04061057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153945|NCT01444430|Hormones|hormones|mesh-ancestor
6153946|NCT01444430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6153947|NCT01444651|Tadalafil|tadalafil|mesh-list
6153948|NCT01444651|Vasodilator Agents|vasodilator agents|mesh-ancestor
6153949|NCT01444651|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6153950|NCT01444651|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6153951|NCT01444651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6153952|NCT01444651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153953|NCT01444651|Urological Agents|urological agents|mesh-ancestor
6153954|NCT01444716|Ofatumumab|ofatumumab|mesh-list
6153955|NCT01444716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6153956|NCT01444716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5554860|NCT04061057|Sensory System Agents|sensory system agents|mesh-ancestor
5554861|NCT04061057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5554862|NCT04061057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5554863|NCT04061057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5554864|NCT04061057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5554865|NCT04061057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5554866|NCT04061057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554867|NCT04061239|Cytarabine|cytarabine|mesh-list
5554868|NCT04061239|Azacitidine|azacitidine|mesh-list
5554869|NCT04061239|Daunorubicin|daunorubicin|mesh-list
5554870|NCT04061239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5554871|NCT04061239|Antimetabolites|antimetabolites|mesh-ancestor
5554872|NCT04061239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554873|NCT04061239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5554874|NCT04061239|Antiviral Agents|antiviral agents|mesh-ancestor
5554875|NCT04061239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5554876|NCT04061239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5554877|NCT04061239|Immunologic Factors|immunologic factors|mesh-ancestor
6153957|NCT01444716|Immunologic Factors|immunologic factors|mesh-ancestor
6478502|NCT00533585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6153958|NCT01444716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153959|NCT01444742|Cytarabine|cytarabine|mesh-list
6153960|NCT01444742|Clofarabine|clofarabine|mesh-list
6153961|NCT01444742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6153962|NCT01444742|Antimetabolites|antimetabolites|mesh-ancestor
6153963|NCT01444742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153964|NCT01444742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6153965|NCT01444742|Antiviral Agents|antiviral agents|mesh-ancestor
6153966|NCT01444742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6153967|NCT01444742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6153968|NCT01444742|Immunologic Factors|immunologic factors|mesh-ancestor
6153969|NCT01444742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153970|NCT01444781|Vaccines|vaccines|mesh-list
6153971|NCT01444781|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6153972|NCT01444781|Immunologic Factors|immunologic factors|mesh-ancestor
6153973|NCT01444781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153974|NCT01444898|Exenatide|exenatide|mesh-list
6153975|NCT01444898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6153976|NCT01444898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153977|NCT01444898|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6153978|NCT01444898|Incretins|incretins|mesh-ancestor
6153979|NCT01444898|Hormones|hormones|mesh-ancestor
6153980|NCT01444898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6153981|NCT01444924|Bupivacaine|bupivacaine|mesh-list
6153982|NCT01444924|Anesthetics, Local|anesthetics, local|mesh-ancestor
6153983|NCT01444924|Anesthetics|anesthetics|mesh-ancestor
6153984|NCT01444924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6153985|NCT01444924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6153986|NCT01444924|Sensory System Agents|sensory system agents|mesh-ancestor
6153987|NCT01444924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6153988|NCT01445028|Isotretinoin|isotretinoin|mesh-list
6153989|NCT01445028|Dermatologic Agents|dermatologic agents|mesh-ancestor
6153990|NCT01445080|Sorafenib|sorafenib|mesh-list
6153991|NCT01445080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6478503|NCT00533585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6478504|NCT00533585|Tubulin Modulators|tubulin modulators|mesh-ancestor
6478505|NCT00533585|Antimitotic Agents|antimitotic agents|mesh-ancestor
6478506|NCT00533585|Mitosis Modulators|mitosis modulators|mesh-ancestor
6478507|NCT00533585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478508|NCT00533585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6478509|NCT00533585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6478510|NCT00533585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6478511|NCT00533585|Growth Substances|growth substances|mesh-ancestor
6478512|NCT00533585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478513|NCT00533585|Growth Inhibitors|growth inhibitors|mesh-ancestor
6478514|NCT00533585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6478515|NCT00533585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5554878|NCT04061239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554879|NCT04061239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5554880|NCT04061239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5554881|NCT04061239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5554882|NCT04061239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5554883|NCT04060914|Clopidogrel|clopidogrel|mesh-list
5554884|NCT04060914|Ticagrelor|ticagrelor|mesh-list
5554885|NCT04060914|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5554886|NCT04060914|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5554887|NCT04060914|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5554888|NCT04060914|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5554889|NCT04060914|Purinergic Agents|purinergic agents|mesh-ancestor
5554890|NCT04060914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5554891|NCT04060914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554892|NCT04060914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554893|NCT04060849|Ethanol|ethanol|mesh-list
5554894|NCT04060849|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5554895|NCT04060849|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5554896|NCT04060849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5554897|NCT04060849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5554898|NCT04060849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554899|NCT04060771|Dexamethasone|dexamethasone|mesh-list
5554900|NCT04060771|Palonosetron|palonosetron|mesh-list
5554901|NCT04060771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5554902|NCT04060771|Antiemetics|antiemetics|mesh-ancestor
5554903|NCT04060771|Autonomic Agents|autonomic agents|mesh-ancestor
5554904|NCT04060771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6478516|NCT00533611|Niacin|niacin|mesh-list
5554905|NCT04060771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554906|NCT04060771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5554907|NCT04060771|Glucocorticoids|glucocorticoids|mesh-ancestor
5554908|NCT04060771|Hormones|hormones|mesh-ancestor
5554909|NCT04060771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5554910|NCT04060771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5554911|NCT04060771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5554912|NCT04060771|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5554913|NCT04060771|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6478517|NCT00533611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478518|NCT00533611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478519|NCT00533611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6478520|NCT00533611|Antimetabolites|antimetabolites|mesh-ancestor
6478521|NCT00533611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6478522|NCT00533611|Vasodilator Agents|vasodilator agents|mesh-ancestor
6478523|NCT00533611|Vitamin B Complex|vitamin b complex|mesh-ancestor
6478524|NCT00533611|Vitamins|vitamins|mesh-ancestor
6478525|NCT00533611|Micronutrients|micronutrients|mesh-ancestor
6478526|NCT00533624|Mycophenolic Acid|mycophenolic acid|mesh-list
6478527|NCT00533624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6478528|NCT00533624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6478529|NCT00533624|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6478530|NCT00533624|Antitubercular Agents|antitubercular agents|mesh-ancestor
5554914|NCT04060771|Serotonin Agents|serotonin agents|mesh-ancestor
5554915|NCT04060771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5554916|NCT04060771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554917|NCT04061213|Technetium Tc 99m 1,1-diphosphonopropane-2,3-dicarboxylic acid|technetium tc 99m 1,1-diphosphonopropane-2,3-dicarboxylic acid|mesh-list
5554918|NCT04061213|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5554919|NCT04061213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554920|NCT04060979|Nitric Oxide|nitric oxide|mesh-list
5554921|NCT04060979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5554922|NCT04060979|Autonomic Agents|autonomic agents|mesh-ancestor
5554923|NCT04060979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5554924|NCT04060979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478531|NCT00533624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6478532|NCT00533624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6478533|NCT00533624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6153992|NCT01445080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6153993|NCT01445080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6207877|NCT02121067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6478534|NCT00533624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554925|NCT04060979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5554926|NCT04060979|Respiratory System Agents|respiratory system agents|mesh-ancestor
5554927|NCT04060979|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5554928|NCT04060979|Antioxidants|antioxidants|mesh-ancestor
5554929|NCT04060979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554930|NCT04060979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5554931|NCT04060979|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5554932|NCT04060979|Vasodilator Agents|vasodilator agents|mesh-ancestor
5554933|NCT04060979|Gasotransmitters|gasotransmitters|mesh-ancestor
5554934|NCT04060979|Protective Agents|protective agents|mesh-ancestor
5554935|NCT04060836|Factor VIII|factor viii|mesh-list
5554936|NCT04060836|Coagulants|coagulants|mesh-ancestor
5554937|NCT04060862|Fulvestrant|fulvestrant|mesh-list
5554938|NCT04060862|Palbociclib|palbociclib|mesh-list
5554939|NCT04060862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5554940|NCT04060862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5554941|NCT04060862|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5554942|NCT04060862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5554943|NCT04060862|Hormone Antagonists|hormone antagonists|mesh-ancestor
5554944|NCT04060862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5554945|NCT04060862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5554946|NCT04060862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5554947|NCT04060862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5554948|NCT04060862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554949|NCT04060719|Rifampin|rifampin|mesh-list
5554950|NCT04060719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5554951|NCT04060719|Antitubercular Agents|antitubercular agents|mesh-ancestor
5554952|NCT04060719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5554953|NCT04060719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5554954|NCT04060719|Leprostatic Agents|leprostatic agents|mesh-ancestor
6153994|NCT01445080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6153995|NCT01445535|Prednisone|prednisone|mesh-list
6153996|NCT01445535|Cyclophosphamide|cyclophosphamide|mesh-list
6153997|NCT01445535|Rituximab|rituximab|mesh-list
6153998|NCT01445535|Doxorubicin|doxorubicin|mesh-list
6153999|NCT01445535|Etoposide|etoposide|mesh-list
6154000|NCT01445535|Vincristine|vincristine|mesh-list
6154001|NCT01445535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6154002|NCT01445535|Immunologic Factors|immunologic factors|mesh-ancestor
6154003|NCT01445535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154004|NCT01445535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6154005|NCT01445535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6154006|NCT01445535|Alkylating Agents|alkylating agents|mesh-ancestor
6154007|NCT01445535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154008|NCT01445535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6154009|NCT01445535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6154010|NCT01445535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6154011|NCT01445535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6154012|NCT01445535|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6154013|NCT01445535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6154014|NCT01445535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6154015|NCT01445535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6154016|NCT01445535|Glucocorticoids|glucocorticoids|mesh-ancestor
6667951|NCT01529541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6667952|NCT01529541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667953|NCT01529554|Everolimus|everolimus|mesh-list
6667954|NCT01529554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6667955|NCT01529554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6154017|NCT01445535|Hormones|hormones|mesh-ancestor
6154018|NCT01445535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6154019|NCT01445535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6154020|NCT01445535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6154021|NCT01445535|Tubulin Modulators|tubulin modulators|mesh-ancestor
6154022|NCT01445535|Antimitotic Agents|antimitotic agents|mesh-ancestor
5725593|NCT03179930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6154023|NCT01445535|Mitosis Modulators|mitosis modulators|mesh-ancestor
6207878|NCT02121067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5554955|NCT04060719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5554956|NCT04060719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5554957|NCT04060719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554958|NCT04060719|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5554959|NCT04060719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5554960|NCT04060719|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5554961|NCT04060719|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5554962|NCT04060719|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6154024|NCT01445548|Sirolimus|sirolimus|mesh-list
6154025|NCT01445548|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6478535|NCT00533637|Cetirizine|cetirizine|mesh-list
6478536|NCT00533637|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6478537|NCT00533637|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6478538|NCT00533637|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6478539|NCT00533637|Histamine Antagonists|histamine antagonists|mesh-ancestor
6478540|NCT00533637|Histamine Agents|histamine agents|mesh-ancestor
6478541|NCT00533637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5554963|NCT04060719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5554964|NCT04060628|Docetaxel|docetaxel|mesh-list
5554965|NCT04060628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5554966|NCT04060628|Tubulin Modulators|tubulin modulators|mesh-ancestor
5554967|NCT04060628|Antimitotic Agents|antimitotic agents|mesh-ancestor
5554968|NCT04060628|Mitosis Modulators|mitosis modulators|mesh-ancestor
5554969|NCT04060628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554970|NCT04060381|Ibuprofen|ibuprofen|mesh-list
5554971|NCT04060381|Dopamine|dopamine|mesh-list
5554972|NCT04060381|Epinephrine|epinephrine|mesh-list
5554973|NCT04060381|Norepinephrine|norepinephrine|mesh-list
5554974|NCT04060381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5554975|NCT04060381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5554976|NCT04060381|Analgesics|analgesics|mesh-ancestor
5554977|NCT04060381|Sensory System Agents|sensory system agents|mesh-ancestor
5554978|NCT04060381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5554979|NCT04060381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478542|NCT00533637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478543|NCT00533637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488821|NCT00587015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6154026|NCT01445548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6154027|NCT01445548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6154028|NCT01445548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6154029|NCT01445548|Antifungal Agents|antifungal agents|mesh-ancestor
6154030|NCT01445548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6154031|NCT01445548|Immunologic Factors|immunologic factors|mesh-ancestor
6154032|NCT01445548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154033|NCT01445626|Dexamethasone|dexamethasone|mesh-list
6154034|NCT01445626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6154035|NCT01445626|Antiemetics|antiemetics|mesh-ancestor
6154036|NCT01445626|Autonomic Agents|autonomic agents|mesh-ancestor
6154037|NCT01445626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6154038|NCT01445626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154039|NCT01445626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6154040|NCT01445626|Glucocorticoids|glucocorticoids|mesh-ancestor
6154041|NCT01445626|Hormones|hormones|mesh-ancestor
6154042|NCT01445626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6154043|NCT01445626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6154044|NCT01445626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5554980|NCT04060381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5554981|NCT04060381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5554982|NCT04060381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5554983|NCT04060381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5554984|NCT04060381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5554985|NCT04060381|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5554986|NCT04060381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5554987|NCT04060381|Adrenergic Agents|adrenergic agents|mesh-ancestor
5554988|NCT04060381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5554989|NCT04060381|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5554990|NCT04060381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5554991|NCT04060381|Autonomic Agents|autonomic agents|mesh-ancestor
5554992|NCT04060381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5554993|NCT04060381|Respiratory System Agents|respiratory system agents|mesh-ancestor
6154045|NCT01445678|Metronidazole|metronidazole|mesh-list
6488822|NCT00587119|Budesonide|budesonide|mesh-list
5554994|NCT04060381|Mydriatics|mydriatics|mesh-ancestor
6154046|NCT01445678|Meropenem|meropenem|mesh-list
6154047|NCT01445678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6154048|NCT01445678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6154049|NCT01445678|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6154050|NCT01445678|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5554995|NCT04060381|Sympathomimetics|sympathomimetics|mesh-ancestor
5554996|NCT04060381|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5554997|NCT04060381|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5554998|NCT04060381|Dopamine Agents|dopamine agents|mesh-ancestor
6154051|NCT01445821|Methylprednisolone|methylprednisolone|mesh-list
5554999|NCT04060381|Protective Agents|protective agents|mesh-ancestor
6207879|NCT02121262|Dexamethasone|dexamethasone|mesh-list
5555000|NCT04060472|Paclitaxel|paclitaxel|mesh-list
5555001|NCT04060472|Oxaliplatin|oxaliplatin|mesh-list
5555002|NCT04060472|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5555003|NCT04060472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5555004|NCT04060472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5555005|NCT04060472|Tubulin Modulators|tubulin modulators|mesh-ancestor
6154052|NCT01445821|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5555006|NCT04060472|Antimitotic Agents|antimitotic agents|mesh-ancestor
5555007|NCT04060472|Mitosis Modulators|mitosis modulators|mesh-ancestor
5555008|NCT04060472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555009|NCT04060459|Paclitaxel|paclitaxel|mesh-list
5555010|NCT04060459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5555011|NCT04060459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5555012|NCT04060459|Tubulin Modulators|tubulin modulators|mesh-ancestor
5555013|NCT04060459|Antimitotic Agents|antimitotic agents|mesh-ancestor
5555014|NCT04060459|Mitosis Modulators|mitosis modulators|mesh-ancestor
5555015|NCT04060459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555016|NCT04060407|Nivolumab|nivolumab|mesh-list
5555017|NCT04060407|Ipilimumab|ipilimumab|mesh-list
5555018|NCT04060407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5555019|NCT04060407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5555020|NCT04060407|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5555021|NCT04060407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555022|NCT04060277|Acetic Acid|acetic acid|mesh-list
5555023|NCT04060277|Letermovir|letermovir|mesh-list
5555024|NCT04060277|Vaccines|vaccines|mesh-list
5555025|NCT04060277|Immunologic Factors|immunologic factors|mesh-ancestor
5555026|NCT04060277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555027|NCT04060277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5555028|NCT04060277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5555029|NCT04060277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5555030|NCT04060277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555031|NCT04060277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5555032|NCT04060277|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5555033|NCT04060277|Antiviral Agents|antiviral agents|mesh-ancestor
5555034|NCT04060264|Eculizumab|eculizumab|mesh-list
5555035|NCT04060264|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5555036|NCT04060264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5555037|NCT04060264|Immunologic Factors|immunologic factors|mesh-ancestor
6154053|NCT01445821|Cyclophosphamide|cyclophosphamide|mesh-list
6154054|NCT01445821|Fludarabine|fludarabine|mesh-list
6154055|NCT01445821|Thymoglobulin|thymoglobulin|mesh-list
6154056|NCT01445821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6154057|NCT01445821|Immunologic Factors|immunologic factors|mesh-ancestor
6154058|NCT01445821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154059|NCT01445821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6154060|NCT01445821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6154061|NCT01445821|Alkylating Agents|alkylating agents|mesh-ancestor
6154062|NCT01445821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154063|NCT01445821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6154064|NCT01445821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6154065|NCT01445821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6154066|NCT01445821|Antiemetics|antiemetics|mesh-ancestor
6154067|NCT01445821|Autonomic Agents|autonomic agents|mesh-ancestor
6154068|NCT01445821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6154069|NCT01445821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5555038|NCT04060264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555039|NCT04060550|Omalizumab|omalizumab|mesh-list
5555040|NCT04060550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5555041|NCT04060550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6667956|NCT01529554|Immunologic Factors|immunologic factors|mesh-ancestor
6667957|NCT01529554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478544|NCT00533676|Oxymetazoline|oxymetazoline|mesh-list
6478545|NCT00533676|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6478546|NCT00533676|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6478547|NCT00533676|Adrenergic Agents|adrenergic agents|mesh-ancestor
6478548|NCT00533676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6478549|NCT00533676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478550|NCT00533676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478551|NCT00533676|Sympathomimetics|sympathomimetics|mesh-ancestor
6478552|NCT00533676|Autonomic Agents|autonomic agents|mesh-ancestor
6478553|NCT00533676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6478554|NCT00533676|Nasal Decongestants|nasal decongestants|mesh-ancestor
6478555|NCT00533676|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6478556|NCT00533676|Respiratory System Agents|respiratory system agents|mesh-ancestor
6478557|NCT00533741|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6478558|NCT00533741|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6478559|NCT00533741|Immunologic Factors|immunologic factors|mesh-ancestor
6478560|NCT00533741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667958|NCT01529619|Rivastigmine|rivastigmine|mesh-list
6154070|NCT01445821|Glucocorticoids|glucocorticoids|mesh-ancestor
6154071|NCT01445821|Hormones|hormones|mesh-ancestor
6154072|NCT01445821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5555042|NCT04060550|Respiratory System Agents|respiratory system agents|mesh-ancestor
5555043|NCT04059770|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
5555044|NCT04059770|Amphotericin B|amphotericin b|mesh-list
5555045|NCT04059770|Antifungal Agents|antifungal agents|mesh-ancestor
6154073|NCT01445821|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6154074|NCT01445821|Protective Agents|protective agents|mesh-ancestor
6667959|NCT01529619|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6667960|NCT01529619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6667961|NCT01529619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667962|NCT01529619|Cholinergic Agents|cholinergic agents|mesh-ancestor
6667963|NCT01529619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6667964|NCT01529619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667965|NCT01529619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6667966|NCT01529619|Protective Agents|protective agents|mesh-ancestor
6667967|NCT01529710|Praziquantel|praziquantel|mesh-list
6667968|NCT01529710|Anthelmintics|anthelmintics|mesh-ancestor
6667969|NCT01529710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6667970|NCT01529710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6154075|NCT01445821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6154076|NCT01445847|Lidocaine|lidocaine|mesh-list
6154077|NCT01445847|Anesthetics, Local|anesthetics, local|mesh-ancestor
6154078|NCT01445847|Anesthetics|anesthetics|mesh-ancestor
6154079|NCT01445847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6154080|NCT01445847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154081|NCT01445847|Sensory System Agents|sensory system agents|mesh-ancestor
6154082|NCT01445847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6154083|NCT01445847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6154084|NCT01445847|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6154085|NCT01445847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6154086|NCT01445847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6154087|NCT01445847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154088|NCT01445873|Sitaxsentan|sitaxsentan|mesh-list
6478561|NCT00533741|Antacids|antacids|mesh-ancestor
6478562|NCT00533741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478563|NCT00533741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6478564|NCT00533858|Losartan|losartan|mesh-list
6478565|NCT00533858|Lacidipine|lacidipine|mesh-list
6478566|NCT00533858|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6478567|NCT00533858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6478568|NCT00533858|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6478569|NCT00533858|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6478570|NCT00533858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478571|NCT00533858|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6478572|NCT00533858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6478573|NCT00533858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6478574|NCT00533858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478575|NCT00533923|Cyclosporine|cyclosporine|mesh-list
6478576|NCT00533923|Cyclophosphamide|cyclophosphamide|mesh-list
6478577|NCT00533923|Fludarabine|fludarabine|mesh-list
6478578|NCT00533923|Alemtuzumab|alemtuzumab|mesh-list
6478579|NCT00533923|Cyclosporins|cyclosporins|mesh-list
6478580|NCT00533923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6478581|NCT00533923|Immunologic Factors|immunologic factors|mesh-ancestor
6478582|NCT00533923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478583|NCT00533923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6667971|NCT01529788|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6667972|NCT01529788|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5555046|NCT04059770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5555047|NCT04059770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5555048|NCT04059770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5555049|NCT04059770|Amebicides|amebicides|mesh-ancestor
5555050|NCT04059770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5555051|NCT04060043|Goserelin|goserelin|mesh-list
5555052|NCT04060043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5555053|NCT04060043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5555054|NCT04060095|Anesthetics|anesthetics|mesh-list
5555055|NCT04060095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5555056|NCT04060095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555057|NCT04060017|Calcium, Dietary|calcium, dietary|mesh-list
5555058|NCT04060017|Leucovorin|leucovorin|mesh-list
6478584|NCT00533923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6478585|NCT00533923|Alkylating Agents|alkylating agents|mesh-ancestor
6478586|NCT00533923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478587|NCT00533923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6478588|NCT00533923|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6478589|NCT00533923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6478590|NCT00533923|Antifungal Agents|antifungal agents|mesh-ancestor
6478591|NCT00533923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6478592|NCT00533923|Dermatologic Agents|dermatologic agents|mesh-ancestor
6478593|NCT00533923|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6478594|NCT00533923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6478595|NCT00533936|Paclitaxel|paclitaxel|mesh-list
6478596|NCT00533936|Cyclophosphamide|cyclophosphamide|mesh-list
6154089|NCT01445873|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6154090|NCT01445873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154091|NCT01445886|Calcitriol|calcitriol|mesh-list
6154092|NCT01445886|Calcipotriene|calcipotriene|mesh-list
6154093|NCT01445886|Dermatologic Agents|dermatologic agents|mesh-ancestor
6154094|NCT01445886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6154095|NCT01445886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154096|NCT01445886|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
5555059|NCT04060017|Calcium|calcium|mesh-list
5555060|NCT04060017|Levoleucovorin|levoleucovorin|mesh-list
5555061|NCT04060017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5555062|NCT04060017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154097|NCT01445886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6154098|NCT01445886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154099|NCT01445886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6154100|NCT01445886|Vitamins|vitamins|mesh-ancestor
6154101|NCT01445886|Micronutrients|micronutrients|mesh-ancestor
6154102|NCT01445886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6154103|NCT01445951|Insulin|insulin|mesh-list
6154104|NCT01445951|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6154105|NCT01445951|Insulin Aspart|insulin aspart|mesh-list
6154106|NCT01445951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6154107|NCT01445951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154108|NCT01446042|Methyltestosterone|methyltestosterone|mesh-list
6154109|NCT01446042|Testosterone|testosterone|mesh-list
6154110|NCT01446042|Testosterone undecanoate|testosterone undecanoate|mesh-list
6154111|NCT01446042|Testosterone enanthate|testosterone enanthate|mesh-list
6154112|NCT01446042|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6154113|NCT01446042|Androgens|androgens|mesh-ancestor
6154114|NCT01446042|Hormones|hormones|mesh-ancestor
6154115|NCT01446042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6154116|NCT01446042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154117|NCT01446042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6478597|NCT00533936|Doxorubicin|doxorubicin|mesh-list
6478598|NCT00533936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6478599|NCT00533936|Fluorouracil|fluorouracil|mesh-list
6478600|NCT00533936|Trastuzumab|trastuzumab|mesh-list
6478601|NCT00533936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6478602|NCT00533936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6478603|NCT00533936|Tubulin Modulators|tubulin modulators|mesh-ancestor
6478604|NCT00533936|Antimitotic Agents|antimitotic agents|mesh-ancestor
6154118|NCT01446042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6154119|NCT01446042|Anabolic Agents|anabolic agents|mesh-ancestor
6154120|NCT01446159|Aromatase Inhibitors|aromatase inhibitors|mesh-list
6154121|NCT01446159|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6154122|NCT01446159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6154123|NCT01446159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154124|NCT01446159|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6154125|NCT01446159|Hormone Antagonists|hormone antagonists|mesh-ancestor
6154126|NCT01446159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6154127|NCT01446159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154128|NCT01446237|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6154129|NCT01446237|Dermatologic Agents|dermatologic agents|mesh-ancestor
6154130|NCT01446809|Doxorubicin|doxorubicin|mesh-list
6154131|NCT01446809|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6154132|NCT01446809|Ifosfamide|ifosfamide|mesh-list
6667973|NCT01529788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6667974|NCT01529788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6667975|NCT01529788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667976|NCT01529788|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6667977|NCT01529788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6154133|NCT01446809|Isophosphamide mustard|isophosphamide mustard|mesh-list
6154134|NCT01446809|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6154135|NCT01446809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6154136|NCT01446809|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6154137|NCT01446809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6154138|NCT01446809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6154139|NCT01446809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154140|NCT01446809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6154141|NCT01446809|Alkylating Agents|alkylating agents|mesh-ancestor
6154142|NCT01446874|Chlorhexidine|chlorhexidine|mesh-list
6154143|NCT01446874|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6154144|NCT01446874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6154145|NCT01446874|Disinfectants|disinfectants|mesh-ancestor
6154146|NCT01447017|Carbamide Peroxide|carbamide peroxide|mesh-list
6154147|NCT01447017|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6154148|NCT01447017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6154149|NCT01447225|Gemcitabine|gemcitabine|mesh-list
6154150|NCT01447225|Carboplatin|carboplatin|mesh-list
6154151|NCT01447225|Pemetrexed|pemetrexed|mesh-list
6154152|NCT01447225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5555063|NCT04060017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5555064|NCT04060017|Antidotes|antidotes|mesh-ancestor
5555065|NCT04060017|Protective Agents|protective agents|mesh-ancestor
5555066|NCT04060017|Vitamin B Complex|vitamin b complex|mesh-ancestor
5555067|NCT04060017|Vitamins|vitamins|mesh-ancestor
5555068|NCT04060017|Micronutrients|micronutrients|mesh-ancestor
5555069|NCT04059887|Atezolizumab|atezolizumab|mesh-list
5555070|NCT04059887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5555071|NCT04059978|Remifentanil|remifentanil|mesh-list
5555072|NCT04059978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5555073|NCT04059978|Narcotics|narcotics|mesh-ancestor
5555074|NCT04059978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5555075|NCT04059978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555076|NCT04059978|Analgesics|analgesics|mesh-ancestor
5555077|NCT04059978|Sensory System Agents|sensory system agents|mesh-ancestor
5555078|NCT04059978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6154153|NCT01447225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6154154|NCT01447225|Antimetabolites|antimetabolites|mesh-ancestor
6154155|NCT01447225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154156|NCT01447225|Antiviral Agents|antiviral agents|mesh-ancestor
6154157|NCT01447225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6154158|NCT01447225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6154159|NCT01447225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6154160|NCT01447225|Immunologic Factors|immunologic factors|mesh-ancestor
6154161|NCT01447225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478605|NCT00533936|Mitosis Modulators|mitosis modulators|mesh-ancestor
6478606|NCT00533936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478607|NCT00533936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6478608|NCT00533936|Immunologic Factors|immunologic factors|mesh-ancestor
6478609|NCT00533936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555079|NCT04060030|Calcium, Dietary|calcium, dietary|mesh-list
6154162|NCT01447225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5555080|NCT04060030|Leucovorin|leucovorin|mesh-list
5555081|NCT04060030|Calcium|calcium|mesh-list
6478610|NCT00533936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6154163|NCT01447225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6154164|NCT01447407|Vaccines|vaccines|mesh-list
6154165|NCT01447407|Aluminum sulfate|aluminum sulfate|mesh-list
6154166|NCT01447407|Immunologic Factors|immunologic factors|mesh-ancestor
6154167|NCT01447407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154168|NCT01447407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5555082|NCT04060030|Levoleucovorin|levoleucovorin|mesh-list
5555083|NCT04060030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5555084|NCT04060030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555085|NCT04060030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5555086|NCT04060030|Antidotes|antidotes|mesh-ancestor
5555087|NCT04060030|Protective Agents|protective agents|mesh-ancestor
5555088|NCT04060030|Vitamin B Complex|vitamin b complex|mesh-ancestor
5555089|NCT04060030|Vitamins|vitamins|mesh-ancestor
5555090|NCT04060030|Micronutrients|micronutrients|mesh-ancestor
5555091|NCT04059679|Aspirin|aspirin|mesh-list
5555092|NCT04059679|Rivaroxaban|rivaroxaban|mesh-list
5555093|NCT04059679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5555094|NCT04059679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5555095|NCT04059679|Analgesics|analgesics|mesh-ancestor
5555096|NCT04059679|Sensory System Agents|sensory system agents|mesh-ancestor
5555097|NCT04059679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5555098|NCT04059679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555099|NCT04059679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6154169|NCT01447420|Ribavirin|ribavirin|mesh-list
6154170|NCT01447420|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6154171|NCT01447420|Antimetabolites|antimetabolites|mesh-ancestor
6154172|NCT01447420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154173|NCT01447420|Antiviral Agents|antiviral agents|mesh-ancestor
6154174|NCT01447420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6154175|NCT01447433|Calcium Carbonate|calcium carbonate|mesh-list
6154176|NCT01447433|Calcium|calcium|mesh-list
6154177|NCT01447433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6154178|NCT01447433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154179|NCT01447433|Antacids|antacids|mesh-ancestor
5555100|NCT04059679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5555101|NCT04059679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5555102|NCT04059679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5555103|NCT04059679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555104|NCT04059679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5555105|NCT04059679|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5555106|NCT04059679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5555107|NCT04059679|Antipyretics|antipyretics|mesh-ancestor
5555108|NCT04059679|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5555109|NCT04059679|Antithrombins|antithrombins|mesh-ancestor
5555110|NCT04059679|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5555111|NCT04059679|Protease Inhibitors|protease inhibitors|mesh-ancestor
5555112|NCT04059679|Anticoagulants|anticoagulants|mesh-ancestor
5555113|NCT04059445|Calcium, Dietary|calcium, dietary|mesh-list
5555114|NCT04059445|Calcium|calcium|mesh-list
5555115|NCT04059445|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5555116|NCT04059445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154180|NCT01447433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154181|NCT01447433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6154182|NCT01447446|Ribavirin|ribavirin|mesh-list
6154183|NCT01447446|Interferon-alpha|interferon-alpha|mesh-list
6154184|NCT01447446|Interferon alpha-2|interferon alpha-2|mesh-list
6154185|NCT01447446|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
6154186|NCT01447446|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6154187|NCT01447446|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
5555117|NCT04059445|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5603088|NCT03419234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5603089|NCT03419234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5603090|NCT03419234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5603091|NCT03419234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603092|NCT03419234|Hormone Antagonists|hormone antagonists|mesh-ancestor
5603093|NCT03419234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5603094|NCT03419234|Antioxidants|antioxidants|mesh-ancestor
5603095|NCT03419234|Protective Agents|protective agents|mesh-ancestor
5603096|NCT03419234|Vitamins|vitamins|mesh-ancestor
5603097|NCT03419234|Micronutrients|micronutrients|mesh-ancestor
5603098|NCT03419234|Estrogens|estrogens|mesh-ancestor
6154188|NCT01447446|Antimetabolites|antimetabolites|mesh-ancestor
5603099|NCT03419234|Anabolic Agents|anabolic agents|mesh-ancestor
5603100|NCT03383679|Capecitabine|capecitabine|mesh-list
5603101|NCT03383679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5555118|NCT04059536|Aspirin|aspirin|mesh-list
5555119|NCT04059536|Heparin|heparin|mesh-list
5555120|NCT04059536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5555121|NCT04059536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6154189|NCT01447446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154190|NCT01447446|Antiviral Agents|antiviral agents|mesh-ancestor
6154191|NCT01447446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6154192|NCT01447446|Immunologic Factors|immunologic factors|mesh-ancestor
6154193|NCT01447446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154194|NCT01447446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5555122|NCT04059536|Analgesics|analgesics|mesh-ancestor
5555123|NCT04059536|Sensory System Agents|sensory system agents|mesh-ancestor
5555124|NCT04059536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6154195|NCT01447511|Rifampin|rifampin|mesh-list
6154196|NCT01447511|Fluconazole|fluconazole|mesh-list
6154197|NCT01447511|Warfarin|warfarin|mesh-list
6154198|NCT01447511|Anticoagulants|anticoagulants|mesh-ancestor
6154199|NCT01447511|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6154200|NCT01447511|Antitubercular Agents|antitubercular agents|mesh-ancestor
6154201|NCT01447511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6154202|NCT01447511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6154203|NCT01447511|Leprostatic Agents|leprostatic agents|mesh-ancestor
6154204|NCT01447511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6478611|NCT00533936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6478612|NCT00533936|Alkylating Agents|alkylating agents|mesh-ancestor
6478613|NCT00533936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6478614|NCT00533936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6478615|NCT00533936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6478616|NCT00533936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6478617|NCT00533936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6478618|NCT00533936|Antimetabolites|antimetabolites|mesh-ancestor
6478619|NCT00533936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6478620|NCT00533936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6478621|NCT00533962|Anecortave|anecortave|mesh-list
6478622|NCT00533962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6478623|NCT00533962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6478624|NCT00533962|Growth Substances|growth substances|mesh-ancestor
6478625|NCT00533962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478626|NCT00533962|Growth Inhibitors|growth inhibitors|mesh-ancestor
6478627|NCT00533962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6478628|NCT00533988|Anti-Infective Agents|anti-infective agents|mesh-list
6478629|NCT00533988|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6478630|NCT00534014|Ascorbic Acid|ascorbic acid|mesh-list
6478631|NCT00534014|Vitamins|vitamins|mesh-ancestor
6478632|NCT00534014|Micronutrients|micronutrients|mesh-ancestor
6478633|NCT00534014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478634|NCT00534014|Antioxidants|antioxidants|mesh-ancestor
6478635|NCT00534014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555125|NCT04059536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478636|NCT00534014|Protective Agents|protective agents|mesh-ancestor
5555126|NCT04059536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5555127|NCT04059536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5555128|NCT04059536|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5555129|NCT04059536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5555130|NCT04059536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555131|NCT04059536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5555132|NCT04059536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5555133|NCT04059536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5555134|NCT04059536|Antipyretics|antipyretics|mesh-ancestor
5555135|NCT04059536|Anticoagulants|anticoagulants|mesh-ancestor
5555136|NCT04059458|Calcium, Dietary|calcium, dietary|mesh-list
5555137|NCT04059458|Calcium|calcium|mesh-list
5555138|NCT04059458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5555139|NCT04059458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555140|NCT04059458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5555141|NCT04059523|Tretinoin|tretinoin|mesh-list
5555142|NCT04059523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5555143|NCT04059523|Keratolytic Agents|keratolytic agents|mesh-ancestor
5555144|NCT04059523|Dermatologic Agents|dermatologic agents|mesh-ancestor
5555145|NCT04059224|Trametinib|trametinib|mesh-list
5555146|NCT04059224|Dabrafenib|dabrafenib|mesh-list
5555147|NCT04059224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5555148|NCT04059224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5555149|NCT04059224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5555150|NCT04059224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478637|NCT00534144|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6154205|NCT01447511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6154206|NCT01447511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154207|NCT01447511|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6154208|NCT01447511|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6154209|NCT01447511|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6154210|NCT01447511|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6154211|NCT01447511|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6478638|NCT00534144|Ferric gluconate|ferric gluconate|mesh-list
6478639|NCT00534144|Hematinics|hematinics|mesh-ancestor
6478640|NCT00534183|Haloperidol|haloperidol|mesh-list
6478641|NCT00534183|Olanzapine|olanzapine|mesh-list
6478642|NCT00534183|Risperidone|risperidone|mesh-list
6478643|NCT00534183|Haloperidol decanoate|haloperidol decanoate|mesh-list
6478644|NCT00534183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6478645|NCT00534183|Serotonin Agents|serotonin agents|mesh-ancestor
5555151|NCT04059081|Obinutuzumab|obinutuzumab|mesh-list
5555152|NCT04059081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5555153|NCT04059081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5555154|NCT04059198|Tenofovir|tenofovir|mesh-list
5555155|NCT04059198|Antiviral Agents|antiviral agents|mesh-ancestor
5555156|NCT04059198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5555157|NCT04059198|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5555158|NCT04059198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5555159|NCT04059198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5555160|NCT04059198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555161|NCT04059198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5555162|NCT04059198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5555163|NCT04058899|Dexmedetomidine|dexmedetomidine|mesh-list
5555164|NCT04058899|Nalbuphine|nalbuphine|mesh-list
5555165|NCT04058899|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6478646|NCT00534183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6478647|NCT00534183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478648|NCT00534183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154212|NCT01447511|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6154213|NCT01447511|Antifungal Agents|antifungal agents|mesh-ancestor
6154214|NCT01447511|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6154215|NCT01447511|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6154216|NCT01447511|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6154217|NCT01447511|Hormone Antagonists|hormone antagonists|mesh-ancestor
6154218|NCT01447511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6154219|NCT01447511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154220|NCT01447511|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6154221|NCT01447511|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6154222|NCT01447576|Antidepressive Agents|antidepressive agents|mesh-list
6154223|NCT01447576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6154224|NCT01447706|Paclitaxel|paclitaxel|mesh-list
6154225|NCT01447706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6154226|NCT01447706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6154227|NCT01447706|Tubulin Modulators|tubulin modulators|mesh-ancestor
6154228|NCT01447706|Antimitotic Agents|antimitotic agents|mesh-ancestor
6154229|NCT01447706|Mitosis Modulators|mitosis modulators|mesh-ancestor
6154230|NCT01447706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154231|NCT01447849|Lubiprostone|lubiprostone|mesh-list
6154232|NCT01447849|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6154233|NCT01447849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6154234|NCT01447849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154235|NCT01447888|Morphine|morphine|mesh-list
6154236|NCT01447888|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6154237|NCT01447888|Narcotics|narcotics|mesh-ancestor
6154238|NCT01447888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6154239|NCT01447888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154240|NCT01447888|Analgesics|analgesics|mesh-ancestor
6478649|NCT00534183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5555166|NCT04058899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5555167|NCT04058899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555168|NCT04058899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5555169|NCT04058899|Analgesics|analgesics|mesh-ancestor
5555170|NCT04058899|Sensory System Agents|sensory system agents|mesh-ancestor
5555171|NCT04058899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5555172|NCT04058899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5555173|NCT04058899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5555174|NCT04058899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5555175|NCT04058899|Adrenergic Agents|adrenergic agents|mesh-ancestor
5555176|NCT04058899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5555177|NCT04058899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154241|NCT01447888|Sensory System Agents|sensory system agents|mesh-ancestor
6154242|NCT01447888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6154243|NCT01447927|Metformin|metformin|mesh-list
6154244|NCT01447927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6154245|NCT01447927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154246|NCT01448044|Interferons|interferons|mesh-list
6154247|NCT01448044|Ribavirin|ribavirin|mesh-list
6154248|NCT01448044|Interferon-alpha|interferon-alpha|mesh-list
6154249|NCT01448044|Interferon alpha-2|interferon alpha-2|mesh-list
6154250|NCT01448044|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6478650|NCT00534183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6478651|NCT00534183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6478652|NCT00534183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6478653|NCT00534183|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6478654|NCT00534183|Dopamine Agents|dopamine agents|mesh-ancestor
6478655|NCT00534183|Antiemetics|antiemetics|mesh-ancestor
6478656|NCT00534183|Autonomic Agents|autonomic agents|mesh-ancestor
6478657|NCT00534183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6478658|NCT00534183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6478659|NCT00534183|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6478660|NCT00534183|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6478661|NCT00534183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6478662|NCT00534183|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6478663|NCT00534261|Interferons|interferons|mesh-list
6478664|NCT00534261|Interferon-beta|interferon-beta|mesh-list
6478665|NCT00534261|Interferon beta-1a|interferon beta-1a|mesh-list
6478666|NCT00534261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6478667|NCT00534261|Antiviral Agents|antiviral agents|mesh-ancestor
6478668|NCT00534261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6478669|NCT00534261|Immunologic Factors|immunologic factors|mesh-ancestor
6478670|NCT00534261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478671|NCT00534261|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6478672|NCT00534287|Moxifloxacin|moxifloxacin|mesh-list
6478673|NCT00534287|Meropenem|meropenem|mesh-list
6478674|NCT00534287|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
5555178|NCT04058899|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5555179|NCT04058899|Narcotics|narcotics|mesh-ancestor
5555180|NCT04058964|Pembrolizumab|pembrolizumab|mesh-list
5555181|NCT04058964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5555182|NCT04058964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5555183|NCT04059172|Ibuprofen|ibuprofen|mesh-list
5555184|NCT04059172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5555185|NCT04059172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5555186|NCT04059172|Analgesics|analgesics|mesh-ancestor
5555187|NCT04059172|Sensory System Agents|sensory system agents|mesh-ancestor
5555188|NCT04059172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5555189|NCT04059172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555190|NCT04059172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5555191|NCT04059172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5555192|NCT04059172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5555193|NCT04059172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5555194|NCT04059172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555195|NCT04058522|Triamcinolone|triamcinolone|mesh-list
5555196|NCT04058522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5555197|NCT04058522|Glucocorticoids|glucocorticoids|mesh-ancestor
5555198|NCT04058522|Hormones|hormones|mesh-ancestor
5555199|NCT04058522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5555200|NCT04058522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555201|NCT04058678|Danazol|danazol|mesh-list
5555202|NCT04058678|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5555203|NCT04058678|Hormone Antagonists|hormone antagonists|mesh-ancestor
5555204|NCT04058678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5555205|NCT04058678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555206|NCT04058717|Nicotine|nicotine|mesh-list
5555207|NCT04058717|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6478675|NCT00534287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6478676|NCT00534287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6478677|NCT00534287|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6478678|NCT00534287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6478679|NCT00534287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6478680|NCT00534287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555208|NCT04058717|Autonomic Agents|autonomic agents|mesh-ancestor
6154251|NCT01448044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6154252|NCT01448044|Antiviral Agents|antiviral agents|mesh-ancestor
6478681|NCT00534287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6478682|NCT00534287|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6478683|NCT00534287|Contraceptive Agents|contraceptive agents|mesh-ancestor
6478684|NCT00534287|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6478685|NCT00534287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478686|NCT00534287|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6478687|NCT00534287|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6478688|NCT00534287|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6478689|NCT00534378|Midazolam|midazolam|mesh-list
6478690|NCT00534378|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6478691|NCT00534378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6478692|NCT00534378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6478693|NCT00534378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478694|NCT00534378|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6478695|NCT00534378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6478696|NCT00534378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6478697|NCT00534378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6154253|NCT01448044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6154254|NCT01448044|Antimetabolites|antimetabolites|mesh-ancestor
6154255|NCT01448044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154256|NCT01448044|Immunologic Factors|immunologic factors|mesh-ancestor
6154257|NCT01448044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154258|NCT01448057|Acetaminophen|acetaminophen|mesh-list
6478698|NCT00534378|Anesthetics, General|anesthetics, general|mesh-ancestor
6478699|NCT00534378|Anesthetics|anesthetics|mesh-ancestor
6478700|NCT00534378|GABA Modulators|gaba modulators|mesh-ancestor
6478701|NCT00534378|GABA Agents|gaba agents|mesh-ancestor
6478702|NCT00534378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6478703|NCT00534378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478704|NCT00534391|Polymyxins|polymyxins|mesh-list
6478705|NCT00534391|Neomycin|neomycin|mesh-list
6478706|NCT00534391|Polymyxin B|polymyxin b|mesh-list
6478707|NCT00534391|Gramicidin|gramicidin|mesh-list
6478708|NCT00534391|Lubricant Eye Drops|lubricant eye drops|mesh-list
6478709|NCT00534391|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6478710|NCT00534391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6478711|NCT00534391|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6478712|NCT00534391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6478713|NCT00534391|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6478714|NCT00534391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6478715|NCT00534391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478716|NCT00534391|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6478717|NCT00534456|Darbepoetin alfa|darbepoetin alfa|mesh-list
6478718|NCT00534456|Hematinics|hematinics|mesh-ancestor
6154259|NCT01448057|Dimethindene|dimethindene|mesh-list
6154260|NCT01448057|Phenylephrine|phenylephrine|mesh-list
6154261|NCT01448057|Oxymetazoline|oxymetazoline|mesh-list
6154262|NCT01448057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6154263|NCT01448057|Analgesics|analgesics|mesh-ancestor
6154264|NCT01448057|Sensory System Agents|sensory system agents|mesh-ancestor
6154265|NCT01448057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6154266|NCT01448057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154267|NCT01448057|Antipyretics|antipyretics|mesh-ancestor
6154268|NCT01448057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154269|NCT01448057|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6154270|NCT01448057|Mydriatics|mydriatics|mesh-ancestor
6154271|NCT01448057|Autonomic Agents|autonomic agents|mesh-ancestor
6154272|NCT01448057|Sympathomimetics|sympathomimetics|mesh-ancestor
6154273|NCT01448057|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6154274|NCT01448057|Nasal Decongestants|nasal decongestants|mesh-ancestor
6154275|NCT01448057|Respiratory System Agents|respiratory system agents|mesh-ancestor
6154276|NCT01448057|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6478719|NCT00534508|Tacrolimus|tacrolimus|mesh-list
6478720|NCT00534508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6478721|NCT00534508|Immunologic Factors|immunologic factors|mesh-ancestor
6478722|NCT00534508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478723|NCT00534508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6478724|NCT00534508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6478725|NCT00534508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478726|NCT00534573|Amisulpride|amisulpride|mesh-list
6154277|NCT01448057|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6154278|NCT01448057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6154279|NCT01448057|Adrenergic Agents|adrenergic agents|mesh-ancestor
6154280|NCT01448057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6154281|NCT01448057|Protective Agents|protective agents|mesh-ancestor
6154282|NCT01448057|Antipruritics|antipruritics|mesh-ancestor
6154283|NCT01448057|Dermatologic Agents|dermatologic agents|mesh-ancestor
6154284|NCT01448057|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6154285|NCT01448057|Histamine Antagonists|histamine antagonists|mesh-ancestor
6154286|NCT01448057|Histamine Agents|histamine agents|mesh-ancestor
6154287|NCT01448057|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6154288|NCT01448213|Fluorometholone|fluorometholone|mesh-list
5555209|NCT04058717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5555210|NCT04058717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555211|NCT04058717|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5555212|NCT04058717|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5555213|NCT04058717|Cholinergic Agents|cholinergic agents|mesh-ancestor
5555214|NCT04058717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5555215|NCT04058717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555216|NCT04058743|Cobalt|cobalt|mesh-list
5555217|NCT04058743|Chromium|chromium|mesh-list
5555218|NCT04058743|Nickel|nickel|mesh-list
5555219|NCT04058743|Trace Elements|trace elements|mesh-ancestor
5555220|NCT04058743|Micronutrients|micronutrients|mesh-ancestor
5555221|NCT04058743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555222|NCT04058470|Prednisone|prednisone|mesh-list
5555223|NCT04058470|Cyclophosphamide|cyclophosphamide|mesh-list
5555224|NCT04058470|Doxorubicin|doxorubicin|mesh-list
5555225|NCT04058470|Vincristine|vincristine|mesh-list
5555226|NCT04058470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5555227|NCT04058470|Immunologic Factors|immunologic factors|mesh-ancestor
5555228|NCT04058470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555229|NCT04058470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6154289|NCT01448213|Prednisolone|prednisolone|mesh-list
6154290|NCT01448213|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6154291|NCT01448213|Methylprednisolone|methylprednisolone|mesh-list
6154292|NCT01448213|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6478727|NCT00534573|Moclobemide|moclobemide|mesh-list
6478728|NCT00534573|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6478729|NCT00534573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6478730|NCT00534573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6478731|NCT00534573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478732|NCT00534573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6478733|NCT00534573|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5555230|NCT04058470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6154293|NCT01448213|Prednisolone acetate|prednisolone acetate|mesh-list
6154294|NCT01448213|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6154295|NCT01448213|Prednisolone phosphate|prednisolone phosphate|mesh-list
6154296|NCT01448213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6154297|NCT01448213|Glucocorticoids|glucocorticoids|mesh-ancestor
6154298|NCT01448213|Hormones|hormones|mesh-ancestor
6154299|NCT01448213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6154300|NCT01448213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154301|NCT01448213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6154302|NCT01448213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6154303|NCT01448213|Antiemetics|antiemetics|mesh-ancestor
6154304|NCT01448213|Autonomic Agents|autonomic agents|mesh-ancestor
6154305|NCT01448213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6154306|NCT01448213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5555231|NCT04058470|Alkylating Agents|alkylating agents|mesh-ancestor
5555232|NCT04058470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555233|NCT04058470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5555234|NCT04058470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5555235|NCT04058470|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5555236|NCT04058470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5555237|NCT04058470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5555238|NCT04058470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5555239|NCT04058470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5555240|NCT04058470|Glucocorticoids|glucocorticoids|mesh-ancestor
5555241|NCT04058470|Hormones|hormones|mesh-ancestor
6154307|NCT01448213|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6154308|NCT01448213|Protective Agents|protective agents|mesh-ancestor
5555242|NCT04058470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6154309|NCT01448213|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6154310|NCT01448486|Raltegravir Potassium|raltegravir potassium|mesh-list
5603102|NCT03383679|Antimetabolites|antimetabolites|mesh-ancestor
6154311|NCT01448486|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6478734|NCT00534573|Dopamine Agents|dopamine agents|mesh-ancestor
6154312|NCT01448486|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6154313|NCT01448486|Antiviral Agents|antiviral agents|mesh-ancestor
6154314|NCT01448486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6154315|NCT01448486|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6154316|NCT01448486|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6154317|NCT01448486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6154318|NCT01448486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154319|NCT01448525|Bimatoprost|bimatoprost|mesh-list
6154320|NCT01448525|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6154321|NCT01448525|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6154322|NCT01448525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6154323|NCT01448616|Tenofovir|tenofovir|mesh-list
6154324|NCT01448616|Antiviral Agents|antiviral agents|mesh-ancestor
5555243|NCT04058470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5555244|NCT04058470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6478735|NCT00534573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6478736|NCT00534573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478737|NCT00534573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6478738|NCT00534573|Antidepressive Agents|antidepressive agents|mesh-ancestor
6478739|NCT00534573|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6478740|NCT00534573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6478741|NCT00534586|Ketamine|ketamine|mesh-list
6478742|NCT00534586|Remifentanil|remifentanil|mesh-list
6478743|NCT00534586|Propofol|propofol|mesh-list
6478744|NCT00534586|Sevoflurane|sevoflurane|mesh-list
6667978|NCT01529788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667979|NCT01529788|Cholinergic Agents|cholinergic agents|mesh-ancestor
6667980|NCT01529788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6667981|NCT01529892|Methamphetamine|methamphetamine|mesh-list
6667982|NCT01529892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6154325|NCT01448616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6154326|NCT01448616|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6478745|NCT00534586|Esketamine|esketamine|mesh-list
6478746|NCT00534586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6478747|NCT00534586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6478748|NCT00534586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478749|NCT00534586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6478750|NCT00534586|Anesthetics, General|anesthetics, general|mesh-ancestor
6478751|NCT00534586|Anesthetics|anesthetics|mesh-ancestor
6478752|NCT00534586|Analgesics|analgesics|mesh-ancestor
5555245|NCT04058470|Tubulin Modulators|tubulin modulators|mesh-ancestor
6154327|NCT01448616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6154328|NCT01448616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6154329|NCT01448616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154330|NCT01448616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6154331|NCT01448616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6154332|NCT01448707|Ritonavir|ritonavir|mesh-list
6154333|NCT01448707|Darunavir|darunavir|mesh-list
6154334|NCT01448707|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6154335|NCT01448707|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6154336|NCT01448707|Protease Inhibitors|protease inhibitors|mesh-ancestor
6154337|NCT01448707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6154338|NCT01448707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154339|NCT01448707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6154340|NCT01448707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6154341|NCT01448707|Antiviral Agents|antiviral agents|mesh-ancestor
6154342|NCT01448707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6154343|NCT01448707|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6154344|NCT01448707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6154345|NCT01448824|Ketoconazole|ketoconazole|mesh-list
6154346|NCT01448824|Evacetrapib|evacetrapib|mesh-list
6154347|NCT01448824|Antifungal Agents|antifungal agents|mesh-ancestor
6154348|NCT01448824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6154349|NCT01448824|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6154350|NCT01448824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6154351|NCT01448824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6154352|NCT01448824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154353|NCT01448824|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6154354|NCT01448824|Hormone Antagonists|hormone antagonists|mesh-ancestor
6154355|NCT01448824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6154356|NCT01448824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154357|NCT01448824|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6154358|NCT01448824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6478753|NCT00534586|Sensory System Agents|sensory system agents|mesh-ancestor
5555246|NCT04058470|Antimitotic Agents|antimitotic agents|mesh-ancestor
5555247|NCT04058470|Mitosis Modulators|mitosis modulators|mesh-ancestor
5555248|NCT04058236|Polygeline|polygeline|mesh-list
5555249|NCT04058236|Plasma Substitutes|plasma substitutes|mesh-ancestor
5555250|NCT04058236|Blood Substitutes|blood substitutes|mesh-ancestor
5555251|NCT04058145|Plerixafor|plerixafor|mesh-list
5555252|NCT04058145|Pembrolizumab|pembrolizumab|mesh-list
5555253|NCT04058145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5555254|NCT04058145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5555255|NCT04058145|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5555256|NCT04058145|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5555257|NCT04058145|Antiviral Agents|antiviral agents|mesh-ancestor
5555258|NCT04058145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5555259|NCT04058210|Ivacaftor|ivacaftor|mesh-list
5555260|NCT04058210|Elexacaftor|elexacaftor|mesh-list
5555261|NCT04058210|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
5555262|NCT04058210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5555263|NCT04058210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555264|NCT04058132|Sildenafil Citrate|sildenafil citrate|mesh-list
5555265|NCT04058132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555266|NCT04058132|Vasodilator Agents|vasodilator agents|mesh-ancestor
5555267|NCT04058132|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5555268|NCT04058132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6154359|NCT01448824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6154360|NCT01448824|Antimetabolites|antimetabolites|mesh-ancestor
5555269|NCT04058132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5555270|NCT04058132|Urological Agents|urological agents|mesh-ancestor
5555271|NCT04057755|Botulinum Toxins|botulinum toxins|mesh-list
5555272|NCT04057755|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5555273|NCT04057755|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5555274|NCT04057755|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5555275|NCT04057755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5555276|NCT04057755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555277|NCT04057755|Cholinergic Agents|cholinergic agents|mesh-ancestor
5555278|NCT04057755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5555279|NCT04057755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555280|NCT04057755|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5555281|NCT04057755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5603103|NCT03383679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603104|NCT03383679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5603105|NCT03367299|Blinatumomab|blinatumomab|mesh-list
5603106|NCT03367299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5603107|NCT03341806|Avelumab|avelumab|mesh-list
5603108|NCT03341806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5603109|NCT03341806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5603110|NCT03316872|Pembrolizumab|pembrolizumab|mesh-list
6154361|NCT01448824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6154362|NCT01449006|Maraviroc|maraviroc|mesh-list
6154363|NCT01449006|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6154364|NCT01449006|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6154365|NCT01449006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154366|NCT01449006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6154367|NCT01449006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6154368|NCT01449006|Antiviral Agents|antiviral agents|mesh-ancestor
6154369|NCT01449006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6154370|NCT01449006|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6154371|NCT01449266|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
6154372|NCT01449266|Chelating Agents|chelating agents|mesh-ancestor
6154373|NCT01449266|Sequestering Agents|sequestering agents|mesh-ancestor
6154374|NCT01449266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667983|NCT01529892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667984|NCT01529892|Sympathomimetics|sympathomimetics|mesh-ancestor
6667985|NCT01529892|Autonomic Agents|autonomic agents|mesh-ancestor
6667986|NCT01529892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6667987|NCT01529892|Dopamine Agents|dopamine agents|mesh-ancestor
6154375|NCT01449279|Ipilimumab|ipilimumab|mesh-list
6154376|NCT01449279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6154377|NCT01449279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6154378|NCT01449279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6154379|NCT01449279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154380|NCT01449370|Serabelisib|serabelisib|mesh-list
5603111|NCT03316872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5603112|NCT03316872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5603113|NCT03271047|Nivolumab|nivolumab|mesh-list
5603114|NCT03271047|Ipilimumab|ipilimumab|mesh-list
6154381|NCT01449370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5555282|NCT04058054|Histamine|histamine|mesh-list
5555283|NCT04058054|Histamine Agonists|histamine agonists|mesh-ancestor
5555284|NCT04058054|Histamine Agents|histamine agents|mesh-ancestor
5555285|NCT04058054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5555286|NCT04058054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555287|NCT04058054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555288|NCT04057989|Ketamine|ketamine|mesh-list
5555289|NCT04057989|Analgesics|analgesics|mesh-ancestor
6154382|NCT01449370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154383|NCT01449630|Celecoxib|celecoxib|mesh-list
6154384|NCT01449630|LY3031207|ly3031207|mesh-list
6154385|NCT01449630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6154386|NCT01449630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6154387|NCT01449630|Analgesics|analgesics|mesh-ancestor
6154388|NCT01449630|Sensory System Agents|sensory system agents|mesh-ancestor
6154389|NCT01449630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6154390|NCT01449630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154391|NCT01449630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6154392|NCT01449630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6154393|NCT01449630|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6154394|NCT01449630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6154395|NCT01449630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6154396|NCT01449630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154397|NCT01449630|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
6154398|NCT01449630|Hormone Antagonists|hormone antagonists|mesh-ancestor
5555290|NCT04057989|Sensory System Agents|sensory system agents|mesh-ancestor
5555291|NCT04057989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5555292|NCT04057989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555293|NCT04057989|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5555294|NCT04057989|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5555295|NCT04057989|Anesthetics, General|anesthetics, general|mesh-ancestor
5555296|NCT04057989|Anesthetics|anesthetics|mesh-ancestor
5555297|NCT04057989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5555298|NCT04057989|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5555299|NCT04057989|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5555300|NCT04057989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6154399|NCT01449630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6154400|NCT01449682|Dexamethasone|dexamethasone|mesh-list
6154401|NCT01449682|Dexamethasone acetate|dexamethasone acetate|mesh-list
6154402|NCT01449682|BB 1101|bb 1101|mesh-list
6154403|NCT01449682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6154404|NCT01449682|Antiemetics|antiemetics|mesh-ancestor
6154405|NCT01449682|Autonomic Agents|autonomic agents|mesh-ancestor
6154406|NCT01449682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6154407|NCT01449682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154408|NCT01449682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6154409|NCT01449682|Glucocorticoids|glucocorticoids|mesh-ancestor
6154410|NCT01449682|Hormones|hormones|mesh-ancestor
6154411|NCT01449682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6154412|NCT01449682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6154413|NCT01449682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6154414|NCT01449682|Protease Inhibitors|protease inhibitors|mesh-ancestor
6154415|NCT01449682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6154416|NCT01449682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154417|NCT01449747|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6154418|NCT01449747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6154419|NCT01449747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154420|NCT01449747|Incretins|incretins|mesh-ancestor
6154421|NCT01449747|Hormones|hormones|mesh-ancestor
6154422|NCT01449747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6154423|NCT01449747|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6478754|NCT00534586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6667988|NCT01529892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6667989|NCT01529892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6667990|NCT01529892|Adrenergic Agents|adrenergic agents|mesh-ancestor
5555301|NCT04057989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555302|NCT04057365|Nivolumab|nivolumab|mesh-list
5555303|NCT04057365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5555304|NCT04057365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5555305|NCT04057365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5555306|NCT04057365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555307|NCT04057456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
5555308|NCT04057456|Nabilone|nabilone|mesh-list
5555309|NCT04057456|Antiemetics|antiemetics|mesh-ancestor
6478755|NCT00534586|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6478756|NCT00534586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6478757|NCT00534586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6478758|NCT00534586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6478759|NCT00534586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555310|NCT04057456|Autonomic Agents|autonomic agents|mesh-ancestor
5555311|NCT04057456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5555312|NCT04057456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555313|NCT04057456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5555314|NCT04057456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5555315|NCT04057456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5555316|NCT04057456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5555317|NCT04057456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5555318|NCT04057261|Liraglutide|liraglutide|mesh-list
5555319|NCT04057261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5555320|NCT04057261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555321|NCT04057261|Incretins|incretins|mesh-ancestor
5555322|NCT04057261|Hormones|hormones|mesh-ancestor
5555323|NCT04057261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5555324|NCT04057300|Aspirin|aspirin|mesh-list
5555325|NCT04057300|Clopidogrel|clopidogrel|mesh-list
5555326|NCT04057300|Ticagrelor|ticagrelor|mesh-list
5555327|NCT04057300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5555328|NCT04057300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5555329|NCT04057300|Analgesics|analgesics|mesh-ancestor
5555330|NCT04057300|Sensory System Agents|sensory system agents|mesh-ancestor
5555331|NCT04057300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5555332|NCT04057300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555333|NCT04057300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5555334|NCT04057300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5555335|NCT04057300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5555336|NCT04057300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5555337|NCT04057300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555338|NCT04057300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5555339|NCT04057300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5555340|NCT04057300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5555341|NCT04057300|Antipyretics|antipyretics|mesh-ancestor
5555342|NCT04057300|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5555343|NCT04057300|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5555344|NCT04057300|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5555345|NCT04057300|Purinergic Agents|purinergic agents|mesh-ancestor
5555346|NCT04057300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5555347|NCT04057326|Pancreatin|pancreatin|mesh-list
5555348|NCT04057326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5555349|NCT04057131|Icatibant|icatibant|mesh-list
5555350|NCT04057131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5555351|NCT04057131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5555352|NCT04057131|Analgesics|analgesics|mesh-ancestor
6478760|NCT00534586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6478761|NCT00534586|Narcotics|narcotics|mesh-ancestor
6478762|NCT00534586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6478763|NCT00534586|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6478764|NCT00534586|Antidepressive Agents|antidepressive agents|mesh-ancestor
6478765|NCT00534586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6478766|NCT00534625|Zileuton|zileuton|mesh-list
5555353|NCT04057131|Sensory System Agents|sensory system agents|mesh-ancestor
5555354|NCT04057131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5555355|NCT04057131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555356|NCT04057131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5555357|NCT04057131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5555358|NCT04057131|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
6478767|NCT00534625|Hydroxyurea|hydroxyurea|mesh-list
6478768|NCT00534625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6154424|NCT01449747|Protease Inhibitors|protease inhibitors|mesh-ancestor
6154425|NCT01449747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6154426|NCT01449747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555359|NCT04057131|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
5555360|NCT04057131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154427|NCT01449929|Ritonavir|ritonavir|mesh-list
5555361|NCT04057131|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5555362|NCT04057131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5555363|NCT04057131|Immunologic Factors|immunologic factors|mesh-ancestor
6154428|NCT01449929|Darunavir|darunavir|mesh-list
6154429|NCT01449929|Dolutegravir|dolutegravir|mesh-list
6154430|NCT01449929|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6154431|NCT01449929|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6154432|NCT01449929|Protease Inhibitors|protease inhibitors|mesh-ancestor
6154433|NCT01449929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6154434|NCT01449929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154435|NCT01449929|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6154436|NCT01449929|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6154437|NCT01449929|Antiviral Agents|antiviral agents|mesh-ancestor
6154438|NCT01449929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6154439|NCT01449929|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6154440|NCT01449929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6154441|NCT01449929|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6154442|NCT01449929|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6154443|NCT01449955|Sirolimus|sirolimus|mesh-list
6154444|NCT01449955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6478769|NCT00534625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6478770|NCT00534625|Analgesics|analgesics|mesh-ancestor
6478771|NCT00534625|Sensory System Agents|sensory system agents|mesh-ancestor
6478772|NCT00534625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6478773|NCT00534625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478774|NCT00534625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6478775|NCT00534625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6478776|NCT00534625|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6478777|NCT00534625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6478778|NCT00534625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478779|NCT00534625|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6478780|NCT00534625|Hormone Antagonists|hormone antagonists|mesh-ancestor
6478781|NCT00534625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6478782|NCT00534625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6154445|NCT01449955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6154446|NCT01449955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6154447|NCT01449955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6154448|NCT01449955|Antifungal Agents|antifungal agents|mesh-ancestor
6154449|NCT01449955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5555364|NCT04057482|Dequalinium|dequalinium|mesh-list
5555365|NCT04057482|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5555366|NCT04057482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5555367|NCT04056923|Methylene Blue|methylene blue|mesh-list
5555368|NCT04056923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5555369|NCT04056923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555370|NCT04056949|Paclitaxel|paclitaxel|mesh-list
5555371|NCT04056949|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6154450|NCT01449955|Immunologic Factors|immunologic factors|mesh-ancestor
6154451|NCT01449955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154452|NCT01450007|Dexamethasone|dexamethasone|mesh-list
6154453|NCT01450007|Dexamethasone acetate|dexamethasone acetate|mesh-list
6154454|NCT01450007|Ropivacaine|ropivacaine|mesh-list
6478783|NCT00534625|Antisickling Agents|antisickling agents|mesh-ancestor
6478784|NCT00534625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6478785|NCT00534651|Acetaminophen|acetaminophen|mesh-list
6478786|NCT00534651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6478787|NCT00534651|Analgesics|analgesics|mesh-ancestor
6478788|NCT00534651|Sensory System Agents|sensory system agents|mesh-ancestor
6478789|NCT00534651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6478790|NCT00534651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6667991|NCT01529892|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6667992|NCT01529892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6667993|NCT01529892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6667994|NCT01529892|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5555372|NCT04056949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6154455|NCT01450007|BB 1101|bb 1101|mesh-list
6154456|NCT01450007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6154457|NCT01450007|Antiemetics|antiemetics|mesh-ancestor
6154458|NCT01450007|Autonomic Agents|autonomic agents|mesh-ancestor
6154459|NCT01450007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6154460|NCT01450007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555373|NCT04056949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5555374|NCT04056949|Tubulin Modulators|tubulin modulators|mesh-ancestor
5555375|NCT04056949|Antimitotic Agents|antimitotic agents|mesh-ancestor
6154461|NCT01450007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6154462|NCT01450007|Glucocorticoids|glucocorticoids|mesh-ancestor
6154463|NCT01450007|Hormones|hormones|mesh-ancestor
5555376|NCT04056949|Mitosis Modulators|mitosis modulators|mesh-ancestor
5555377|NCT04056949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555378|NCT04056897|Teriflunomide|teriflunomide|mesh-list
5555379|NCT04056897|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6154464|NCT01450007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6154465|NCT01450007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6154466|NCT01450007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6154467|NCT01450007|Protease Inhibitors|protease inhibitors|mesh-ancestor
6478791|NCT00534651|Antipyretics|antipyretics|mesh-ancestor
6478792|NCT00534677|Octreotide|octreotide|mesh-list
6478793|NCT00534677|Terlipressin|terlipressin|mesh-list
6478794|NCT00534677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6478795|NCT00534677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6478796|NCT00534677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6478797|NCT00534677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5555380|NCT04056897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5555381|NCT04056897|Analgesics|analgesics|mesh-ancestor
5555382|NCT04056897|Sensory System Agents|sensory system agents|mesh-ancestor
5555383|NCT04056897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5555384|NCT04056897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555385|NCT04056897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5555386|NCT04056897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5555387|NCT04056897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5555388|NCT04056897|Immunologic Factors|immunologic factors|mesh-ancestor
5555389|NCT04057014|Amoxicillin|amoxicillin|mesh-list
5555390|NCT04057014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5555391|NCT04057014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5555392|NCT04057053|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5555393|NCT04057053|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5555394|NCT04056975|Antibodies|antibodies|mesh-list
5555395|NCT04056975|Immunologic Factors|immunologic factors|mesh-ancestor
5555396|NCT04056975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555397|NCT04056806|Ceftriaxone|ceftriaxone|mesh-list
5555398|NCT04056806|Terlipressin|terlipressin|mesh-list
5555399|NCT04056806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5555400|NCT04056806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5555401|NCT04056806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5555402|NCT04056806|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5555403|NCT04056910|Nivolumab|nivolumab|mesh-list
5555404|NCT04056910|Ivosidenib|ivosidenib|mesh-list
5555405|NCT04056910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5555406|NCT04056910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5555407|NCT04056910|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5555408|NCT04056910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478798|NCT00534677|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6478799|NCT00534729|Carboplatin|carboplatin|mesh-list
6478800|NCT00534729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6478801|NCT00534807|Rifampin|rifampin|mesh-list
6478802|NCT00534807|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5555409|NCT04056910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5555410|NCT04056845|Acetaminophen|acetaminophen|mesh-list
5555411|NCT04056845|Diclofenac|diclofenac|mesh-list
5555412|NCT04056845|Analgesics|analgesics|mesh-list
5555413|NCT04056845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5555414|NCT04056845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5555415|NCT04056845|Sensory System Agents|sensory system agents|mesh-ancestor
5555416|NCT04056845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5555417|NCT04056845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555418|NCT04056845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5555419|NCT04056845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5555420|NCT04056845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5555421|NCT04056845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5555422|NCT04056845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555423|NCT04056845|Antipyretics|antipyretics|mesh-ancestor
5555424|NCT04056650|Caffeine|caffeine|mesh-list
5555425|NCT04056650|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6478803|NCT00534807|Antitubercular Agents|antitubercular agents|mesh-ancestor
6478804|NCT00534807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6478805|NCT00534807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6154468|NCT01450007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6154469|NCT01450007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154470|NCT01450007|Anesthetics, Local|anesthetics, local|mesh-ancestor
6154471|NCT01450007|Anesthetics|anesthetics|mesh-ancestor
6667995|NCT01530009|Amoxicillin|amoxicillin|mesh-list
6667996|NCT01530009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5555426|NCT04056650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555427|NCT04056650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5555428|NCT04056650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5555429|NCT04056650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555430|NCT04056650|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5555431|NCT04056650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5555432|NCT04056650|Purinergic Agents|purinergic agents|mesh-ancestor
5555433|NCT04056650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5555434|NCT04056754|Prednisone|prednisone|mesh-list
5555435|NCT04056754|Abiraterone Acetate|abiraterone acetate|mesh-list
5555436|NCT04056754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5555437|NCT04056754|Glucocorticoids|glucocorticoids|mesh-ancestor
5555438|NCT04056754|Hormones|hormones|mesh-ancestor
5555439|NCT04056754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5555440|NCT04056754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555441|NCT04056754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5555442|NCT04056754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5555443|NCT04056754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5555444|NCT04056754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5555445|NCT04056754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555446|NCT04056754|Hormone Antagonists|hormone antagonists|mesh-ancestor
5555447|NCT04056754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5555448|NCT04056442|Cannabidiol|cannabidiol|mesh-list
5555449|NCT04056442|Anticonvulsants|anticonvulsants|mesh-ancestor
5555450|NCT04056624|Carotenoids|carotenoids|mesh-list
5555451|NCT04056624|Antioxidants|antioxidants|mesh-ancestor
5555452|NCT04056624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555453|NCT04056624|Protective Agents|protective agents|mesh-ancestor
5555454|NCT04056624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555455|NCT04056325|Ivermectin|ivermectin|mesh-list
5555456|NCT04056325|Moxidectin|moxidectin|mesh-list
5555457|NCT04056325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5555458|NCT04056325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5555459|NCT04056325|Anthelmintics|anthelmintics|mesh-ancestor
5555460|NCT04056325|Antinematodal Agents|antinematodal agents|mesh-ancestor
5555461|NCT04056702|Ivacaftor|ivacaftor|mesh-list
5555462|NCT04056702|Elexacaftor|elexacaftor|mesh-list
5555463|NCT04056702|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
5555464|NCT04056702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5555465|NCT04056702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555466|NCT04056741|Pulmonary Surfactants|pulmonary surfactants|mesh-list
5555467|NCT04056741|Respiratory System Agents|respiratory system agents|mesh-ancestor
5603115|NCT03271047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5603116|NCT03271047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5603117|NCT03271047|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5603118|NCT03271047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154472|NCT01450007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6154473|NCT01450007|Sensory System Agents|sensory system agents|mesh-ancestor
6154474|NCT01450098|Evacetrapib|evacetrapib|mesh-list
6154475|NCT01450098|Propyl Gallate|propyl gallate|mesh-list
6154476|NCT01450098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6154477|NCT01450098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6154478|NCT01450098|Antimetabolites|antimetabolites|mesh-ancestor
6154479|NCT01450098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154480|NCT01450098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6154481|NCT01450098|Antioxidants|antioxidants|mesh-ancestor
6154482|NCT01450098|Protective Agents|protective agents|mesh-ancestor
6154483|NCT01450098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603122|NCT03171480|Isosorbide|isosorbide|mesh-list
5603123|NCT03171480|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
5603124|NCT03171480|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
5603125|NCT03171480|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5603126|NCT03171480|Diuretics|diuretics|mesh-ancestor
5603127|NCT03171480|Natriuretic Agents|natriuretic agents|mesh-ancestor
5603128|NCT03171480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603129|NCT03171480|Vasodilator Agents|vasodilator agents|mesh-ancestor
5603130|NCT03171480|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5603131|NCT03171480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603132|NCT03164655|Leucovorin|leucovorin|mesh-list
5603133|NCT03164655|Bevacizumab|bevacizumab|mesh-list
5603134|NCT03164655|Cetuximab|cetuximab|mesh-list
5603135|NCT03164655|Panitumumab|panitumumab|mesh-list
5603136|NCT03164655|Fluorouracil|fluorouracil|mesh-list
5603137|NCT03164655|Oxaliplatin|oxaliplatin|mesh-list
5603138|NCT03164655|Irinotecan|irinotecan|mesh-list
5603139|NCT03164655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5603140|NCT03164655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6154484|NCT01450137|Glucocorticoids|glucocorticoids|mesh-list
6154485|NCT01450137|Hormones|hormones|mesh-ancestor
6154486|NCT01450137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6154487|NCT01450137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154488|NCT01450189|Tenofovir|tenofovir|mesh-list
6154489|NCT01450189|Emtricitabine|emtricitabine|mesh-list
6154490|NCT01450189|Raltegravir Potassium|raltegravir potassium|mesh-list
6154491|NCT01450189|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6154492|NCT01450189|Antiviral Agents|antiviral agents|mesh-ancestor
6154493|NCT01450189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6154494|NCT01450189|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6478806|NCT00534807|Leprostatic Agents|leprostatic agents|mesh-ancestor
6478807|NCT00534807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6478808|NCT00534807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6478809|NCT00534807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478810|NCT00534807|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6478811|NCT00534807|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6478812|NCT00534807|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6478813|NCT00534807|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6478814|NCT00534807|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6478815|NCT00534807|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6478816|NCT00534846|Toremifene|toremifene|mesh-list
6478817|NCT00534846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6154495|NCT01450189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6154496|NCT01450189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6154497|NCT01450189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154498|NCT01450189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6154499|NCT01450189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6154500|NCT01450189|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6154501|NCT01450189|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6154502|NCT01450306|Cycloserine|cycloserine|mesh-list
6478818|NCT00534846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6478819|NCT00534846|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6478820|NCT00534846|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6478821|NCT00534846|Hormone Antagonists|hormone antagonists|mesh-ancestor
6478822|NCT00534846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5555468|NCT04056039|Colchicine|colchicine|mesh-list
5555469|NCT04056039|Atorvastatin|atorvastatin|mesh-list
6154503|NCT01450306|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5555470|NCT04056039|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5555471|NCT04056039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5555472|NCT04056039|Antimetabolites|antimetabolites|mesh-ancestor
5555473|NCT04056039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555474|NCT04056039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5555475|NCT04056039|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5555476|NCT04056039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5555477|NCT04056039|Gout Suppressants|gout suppressants|mesh-ancestor
5555478|NCT04056039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5555479|NCT04056039|Tubulin Modulators|tubulin modulators|mesh-ancestor
5555480|NCT04056039|Antimitotic Agents|antimitotic agents|mesh-ancestor
5555481|NCT04056039|Mitosis Modulators|mitosis modulators|mesh-ancestor
5555482|NCT04056039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5555483|NCT04055909|Nangibotide|nangibotide|mesh-list
5555484|NCT04055909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5555485|NCT04055818|Niacinamide|niacinamide|mesh-list
5555486|NCT04055818|Niacin|niacin|mesh-list
5555487|NCT04055818|Nicotinic Acids|nicotinic acids|mesh-list
5555488|NCT04055818|Decitabine|decitabine|mesh-list
5555489|NCT04055818|Tetrahydrouridine|tetrahydrouridine|mesh-list
5555490|NCT04055818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5555491|NCT04055818|Antimetabolites|antimetabolites|mesh-ancestor
5555492|NCT04055818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555493|NCT04055818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5555494|NCT04055818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5555495|NCT04055818|Vitamin B Complex|vitamin b complex|mesh-ancestor
5555496|NCT04055818|Vitamins|vitamins|mesh-ancestor
5555497|NCT04055818|Micronutrients|micronutrients|mesh-ancestor
6154504|NCT01450306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6154505|NCT01450306|Renal Agents|renal agents|mesh-ancestor
6154506|NCT01450306|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6154507|NCT01450306|Antitubercular Agents|antitubercular agents|mesh-ancestor
6154508|NCT01450306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6154509|NCT01450306|Antimetabolites|antimetabolites|mesh-ancestor
6207880|NCT02121262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6478823|NCT00534846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478824|NCT00534846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6478825|NCT00534898|Fenretinide|fenretinide|mesh-list
6478826|NCT00534898|Bexarotene|bexarotene|mesh-list
6478827|NCT00534898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6478828|NCT00534898|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6478829|NCT00534898|Protective Agents|protective agents|mesh-ancestor
6478830|NCT00534898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478831|NCT00535080|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
6478832|NCT00535080|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6478833|NCT00535080|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6478834|NCT00535080|Dermatologic Agents|dermatologic agents|mesh-ancestor
6478835|NCT00535119|Paclitaxel|paclitaxel|mesh-list
6478836|NCT00535119|Carboplatin|carboplatin|mesh-list
6478837|NCT00535119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6478838|NCT00535119|Veliparib|veliparib|mesh-list
6478839|NCT00535119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6478840|NCT00535119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6478841|NCT00535119|Tubulin Modulators|tubulin modulators|mesh-ancestor
6478842|NCT00535119|Antimitotic Agents|antimitotic agents|mesh-ancestor
6478843|NCT00535119|Mitosis Modulators|mitosis modulators|mesh-ancestor
6478844|NCT00535119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478845|NCT00535119|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5555498|NCT04055818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555499|NCT04055818|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6478846|NCT00535119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6478847|NCT00535158|Vitamin D|vitamin d|mesh-list
6478848|NCT00535158|Ergocalciferols|ergocalciferols|mesh-list
6478849|NCT00535158|Vitamins|vitamins|mesh-ancestor
6478850|NCT00535158|Micronutrients|micronutrients|mesh-ancestor
6478851|NCT00535158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478852|NCT00535158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6478853|NCT00535158|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6478854|NCT00535340|Amibegron|amibegron|mesh-list
6478855|NCT00535340|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6478856|NCT00535340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6478857|NCT00535340|Adrenergic Agents|adrenergic agents|mesh-ancestor
6478858|NCT00535340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6478859|NCT00535340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478860|NCT00535340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478861|NCT00535353|Irinotecan|irinotecan|mesh-list
6667997|NCT01530009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6478862|NCT00535353|Olaparib|olaparib|mesh-list
6478863|NCT00535353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6478864|NCT00535353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6478865|NCT00535353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6478866|NCT00535353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478867|NCT00535353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6478868|NCT00535353|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6154510|NCT01450306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154511|NCT01450319|Cetuximab|cetuximab|mesh-list
6154512|NCT01450319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6154513|NCT01450319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6154514|NCT01450683|Itraconazole|itraconazole|mesh-list
6154515|NCT01450683|Antifungal Agents|antifungal agents|mesh-ancestor
6154516|NCT01450683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6154517|NCT01450683|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6154518|NCT01450683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6154519|NCT01450683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6207881|NCT02121262|Antiemetics|antiemetics|mesh-ancestor
6478869|NCT00535379|Sunitinib|sunitinib|mesh-list
6478870|NCT00535379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6478871|NCT00535379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6478872|NCT00535379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6478873|NCT00535379|Growth Substances|growth substances|mesh-ancestor
6478874|NCT00535379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478875|NCT00535379|Growth Inhibitors|growth inhibitors|mesh-ancestor
5555500|NCT04055818|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5555501|NCT04055818|Vasodilator Agents|vasodilator agents|mesh-ancestor
5555502|NCT04056143|Rivaroxaban|rivaroxaban|mesh-list
5555503|NCT04056143|Apixaban|apixaban|mesh-list
5555504|NCT04056143|Edoxaban|edoxaban|mesh-list
5555505|NCT04056143|Dabigatran|dabigatran|mesh-list
5555506|NCT04056143|Thromboplastin|thromboplastin|mesh-list
5555507|NCT04056143|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5555508|NCT04056143|Antithrombins|antithrombins|mesh-ancestor
5555509|NCT04056143|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5555510|NCT04056143|Protease Inhibitors|protease inhibitors|mesh-ancestor
5555511|NCT04056143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5555512|NCT04056143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555513|NCT04056143|Anticoagulants|anticoagulants|mesh-ancestor
5555514|NCT04056143|Hemostatics|hemostatics|mesh-ancestor
5555515|NCT04056143|Coagulants|coagulants|mesh-ancestor
5555516|NCT04056169|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5555517|NCT04056169|Ezetimibe|ezetimibe|mesh-list
5555518|NCT04056169|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5555519|NCT04056169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5555520|NCT04056169|Antimetabolites|antimetabolites|mesh-ancestor
5555521|NCT04056169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555522|NCT04056169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6478876|NCT00535379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5555523|NCT04056169|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5555524|NCT04056169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5555525|NCT04056000|Caffeine|caffeine|mesh-list
5555526|NCT04056000|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5555527|NCT04056000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555528|NCT04056000|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5555529|NCT04056000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5555530|NCT04056000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555531|NCT04056000|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5555532|NCT04056000|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5555533|NCT04056000|Purinergic Agents|purinergic agents|mesh-ancestor
5555534|NCT04056000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5555535|NCT04055389|Antithrombins|antithrombins|mesh-list
5555536|NCT04055389|Antithrombin III|antithrombin iii|mesh-list
5555537|NCT04055389|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5555538|NCT04055389|Protease Inhibitors|protease inhibitors|mesh-ancestor
5555539|NCT04055389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5555540|NCT04055389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555541|NCT04055389|Anticoagulants|anticoagulants|mesh-ancestor
5555542|NCT04055480|Insulin|insulin|mesh-list
5555543|NCT04055480|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5555544|NCT04055480|Insulin Aspart|insulin aspart|mesh-list
6478877|NCT00535379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6478878|NCT00535379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478879|NCT00535418|Letrozole|letrozole|mesh-list
6478880|NCT00535418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6154520|NCT01450683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154521|NCT01450683|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6154522|NCT01450683|Hormone Antagonists|hormone antagonists|mesh-ancestor
6154523|NCT01450683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6478881|NCT00535418|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6478882|NCT00535418|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6478883|NCT00535418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6478884|NCT00535418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478885|NCT00535418|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6478886|NCT00535418|Hormone Antagonists|hormone antagonists|mesh-ancestor
6478887|NCT00535418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6478888|NCT00535418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478889|NCT00535470|Mechlorethamine|mechlorethamine|mesh-list
6154524|NCT01450683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154525|NCT01450683|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6154526|NCT01450696|Capecitabine|capecitabine|mesh-list
5555545|NCT04055480|Insulin, Short-Acting|insulin, short-acting|mesh-list
5555546|NCT04055480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5555547|NCT04055480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555548|NCT04055506|Ritonavir|ritonavir|mesh-list
5555549|NCT04055506|BMS-986165|bms-986165|mesh-list
5555550|NCT04055506|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5555551|NCT04055506|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5555552|NCT04055506|Protease Inhibitors|protease inhibitors|mesh-ancestor
5555553|NCT04055506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5555554|NCT04055506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555555|NCT04055506|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5555556|NCT04055506|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5555557|NCT04055506|Antiviral Agents|antiviral agents|mesh-ancestor
5555558|NCT04055506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5555559|NCT04055506|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5555560|NCT04055506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5555561|NCT04055506|Dermatologic Agents|dermatologic agents|mesh-ancestor
5555562|NCT04055506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5555563|NCT04055623|Aldesleukin|aldesleukin|mesh-list
5555564|NCT04055623|Interleukin-2|interleukin-2|mesh-list
5555565|NCT04055623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5555566|NCT04055623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5555567|NCT04055623|Analgesics|analgesics|mesh-ancestor
5555568|NCT04055623|Sensory System Agents|sensory system agents|mesh-ancestor
5555569|NCT04055623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5555570|NCT04055623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555571|NCT04055623|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5555572|NCT04055623|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5555573|NCT04055623|Antiviral Agents|antiviral agents|mesh-ancestor
5555574|NCT04055623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5555575|NCT04055649|Paclitaxel|paclitaxel|mesh-list
5555576|NCT04055649|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6154527|NCT01450696|Trastuzumab|trastuzumab|mesh-list
6154528|NCT01450696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6154529|NCT01450696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6478890|NCT00535470|Alkylating Agents|alkylating agents|mesh-ancestor
6478891|NCT00535470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478892|NCT00535470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6478893|NCT00535470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6488823|NCT00587119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6154530|NCT01450696|Antimetabolites|antimetabolites|mesh-ancestor
6154531|NCT01450696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154532|NCT01450696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6154533|NCT01450761|Carboplatin|carboplatin|mesh-list
6154534|NCT01450761|Etoposide|etoposide|mesh-list
6154535|NCT01450761|Ipilimumab|ipilimumab|mesh-list
6154536|NCT01450761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6154537|NCT01450761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6154538|NCT01450761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6154539|NCT01450761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6154540|NCT01450761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6154541|NCT01450761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154542|NCT01450761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6154543|NCT01450761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6154544|NCT01450800|Nitrofurantoin|nitrofurantoin|mesh-list
6154545|NCT01450800|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6154546|NCT01450800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6154547|NCT01450800|Renal Agents|renal agents|mesh-ancestor
6154548|NCT01450800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6154549|NCT01450813|Bromides|bromides|mesh-list
6154550|NCT01450813|Rocuronium|rocuronium|mesh-list
6154551|NCT01450813|Anticonvulsants|anticonvulsants|mesh-ancestor
6154552|NCT01450813|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5555577|NCT04055649|TIC10 compound|tic10 compound|mesh-list
5555578|NCT04055649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5555579|NCT04055649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5555580|NCT04055649|Tubulin Modulators|tubulin modulators|mesh-ancestor
5555581|NCT04055649|Antimitotic Agents|antimitotic agents|mesh-ancestor
5555582|NCT04055649|Mitosis Modulators|mitosis modulators|mesh-ancestor
6154553|NCT01450813|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6154554|NCT01450813|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6154555|NCT01450813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6154556|NCT01450813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154557|NCT01450826|Ondansetron|ondansetron|mesh-list
6154558|NCT01450826|Aprepitant|aprepitant|mesh-list
6154559|NCT01450826|Antiemetics|antiemetics|mesh-ancestor
6154560|NCT01450826|Autonomic Agents|autonomic agents|mesh-ancestor
6154561|NCT01450826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6154562|NCT01450826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154563|NCT01450826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6154564|NCT01450826|Antipruritics|antipruritics|mesh-ancestor
6154565|NCT01450826|Dermatologic Agents|dermatologic agents|mesh-ancestor
6154566|NCT01450826|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5555583|NCT04055649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555584|NCT04055415|Bronchodilator Agents|bronchodilator agents|mesh-list
5555585|NCT04055415|Expectorants|expectorants|mesh-list
5555586|NCT04055415|Autonomic Agents|autonomic agents|mesh-ancestor
5555587|NCT04055415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5555588|NCT04055415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555589|NCT04055415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5555590|NCT04055415|Respiratory System Agents|respiratory system agents|mesh-ancestor
5555591|NCT04054960|Levodopa|levodopa|mesh-list
5555592|NCT04054960|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5555593|NCT04054960|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5555594|NCT04054960|Dopamine Agents|dopamine agents|mesh-ancestor
5555595|NCT04054960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5555596|NCT04054960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488824|NCT00587119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6488825|NCT00587119|Autonomic Agents|autonomic agents|mesh-ancestor
6488826|NCT00587119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6488827|NCT00587119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488828|NCT00587119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6488829|NCT00587119|Respiratory System Agents|respiratory system agents|mesh-ancestor
6488830|NCT00587119|Glucocorticoids|glucocorticoids|mesh-ancestor
6488831|NCT00587119|Hormones|hormones|mesh-ancestor
6154567|NCT01450826|Serotonin Agents|serotonin agents|mesh-ancestor
6154568|NCT01450826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5555597|NCT04054960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555598|NCT04055194|Tranexamic Acid|tranexamic acid|mesh-list
5555599|NCT04055194|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5555600|NCT04055194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5555601|NCT04055194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555602|NCT04055194|Hemostatics|hemostatics|mesh-ancestor
6667998|NCT01530022|Lacosamide|lacosamide|mesh-list
6667999|NCT01530022|Carbamazepine|carbamazepine|mesh-list
6668000|NCT01530022|Anticonvulsants|anticonvulsants|mesh-ancestor
6668001|NCT01530022|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6478894|NCT00535509|Cisplatin|cisplatin|mesh-list
6478895|NCT00535509|Docetaxel|docetaxel|mesh-list
6478896|NCT00535509|Trastuzumab|trastuzumab|mesh-list
6478897|NCT00535509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6478898|NCT00535509|Tubulin Modulators|tubulin modulators|mesh-ancestor
6478899|NCT00535509|Antimitotic Agents|antimitotic agents|mesh-ancestor
6478900|NCT00535509|Mitosis Modulators|mitosis modulators|mesh-ancestor
6478901|NCT00535509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478902|NCT00535509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6478903|NCT00535574|Bexarotene|bexarotene|mesh-list
6478904|NCT00535574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6154569|NCT01450826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154570|NCT01450826|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6154571|NCT01450826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6154572|NCT01450826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6154573|NCT01450826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6154574|NCT01450826|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6154575|NCT01450826|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6154576|NCT01451203|Methotrexate|methotrexate|mesh-list
6154577|NCT01451203|Certolizumab Pegol|certolizumab pegol|mesh-list
6154578|NCT01451203|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6478905|NCT00535665|Vaccines|vaccines|mesh-list
5555603|NCT04055194|Coagulants|coagulants|mesh-ancestor
5555604|NCT04055142|Cidofovir|cidofovir|mesh-list
5555605|NCT04055142|Antiviral Agents|antiviral agents|mesh-ancestor
6478906|NCT00535665|Immunologic Factors|immunologic factors|mesh-ancestor
6478907|NCT00535665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478908|NCT00535691|Tacrolimus|tacrolimus|mesh-list
6154579|NCT01451203|Abortifacient Agents|abortifacient agents|mesh-ancestor
6154580|NCT01451203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6478909|NCT00535691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6668002|NCT01530022|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6668003|NCT01530022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6668004|NCT01530022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668005|NCT01530022|Antimanic Agents|antimanic agents|mesh-ancestor
6668006|NCT01530022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6668007|NCT01530022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6668008|NCT01530022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668009|NCT01530022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6668010|NCT01530022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6668011|NCT01530022|Analgesics|analgesics|mesh-ancestor
6668012|NCT01530022|Sensory System Agents|sensory system agents|mesh-ancestor
6668013|NCT01530022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6668014|NCT01530022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6668015|NCT01530022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6668016|NCT01530048|Insulin Aspart|insulin aspart|mesh-list
6668017|NCT01530048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6668018|NCT01530048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555606|NCT04055142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5555607|NCT04055142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5555608|NCT04055142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555609|NCT04055233|Biguanides|biguanides|mesh-list
5555610|NCT04055233|Polihexanide|polihexanide|mesh-list
5555611|NCT04055233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5555612|NCT04055233|Disinfectants|disinfectants|mesh-ancestor
5555613|NCT04055233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5555614|NCT04055233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555615|NCT04054830|Diclofenac|diclofenac|mesh-list
5555616|NCT04054830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5555617|NCT04054830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5555618|NCT04054830|Analgesics|analgesics|mesh-ancestor
5555619|NCT04054830|Sensory System Agents|sensory system agents|mesh-ancestor
5555620|NCT04054830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5555621|NCT04054830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668019|NCT01530126|Becaplermin|becaplermin|mesh-list
5555622|NCT04054830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6668020|NCT01530126|Anticoagulants|anticoagulants|mesh-ancestor
6668021|NCT01530126|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
6668022|NCT01530126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6668023|NCT01530126|Growth Substances|growth substances|mesh-ancestor
6668024|NCT01530126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668025|NCT01530152|Lidocaine|lidocaine|mesh-list
6154581|NCT01451203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154582|NCT01451203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6154583|NCT01451203|Antimetabolites|antimetabolites|mesh-ancestor
6154584|NCT01451203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154585|NCT01451203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6154586|NCT01451203|Dermatologic Agents|dermatologic agents|mesh-ancestor
6154587|NCT01451203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6154588|NCT01451203|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6154589|NCT01451203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6478910|NCT00535691|Immunologic Factors|immunologic factors|mesh-ancestor
6478911|NCT00535691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478912|NCT00535691|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6478913|NCT00535691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6478914|NCT00535691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478915|NCT00535808|Nitroprusside|nitroprusside|mesh-list
6668026|NCT01530152|Anesthetics, Local|anesthetics, local|mesh-ancestor
6668027|NCT01530152|Anesthetics|anesthetics|mesh-ancestor
6668028|NCT01530152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6668029|NCT01530152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668030|NCT01530152|Sensory System Agents|sensory system agents|mesh-ancestor
6668031|NCT01530152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6668032|NCT01530152|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5555623|NCT04054830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6154590|NCT01451203|Immunologic Factors|immunologic factors|mesh-ancestor
6154591|NCT01451203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6154592|NCT01451203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6154593|NCT01451398|Insulin|insulin|mesh-list
6154594|NCT01451398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6154595|NCT01451398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154596|NCT01451411|Conivaptan|conivaptan|mesh-list
6154597|NCT01451411|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6154598|NCT01451411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154599|NCT01451411|Natriuretic Agents|natriuretic agents|mesh-ancestor
6154600|NCT01451411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154601|NCT01451541|Ciclesonide|ciclesonide|mesh-list
6154602|NCT01451541|Glucocorticoids|glucocorticoids|mesh-ancestor
6154603|NCT01451541|Hormones|hormones|mesh-ancestor
6154604|NCT01451541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6154605|NCT01451541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154606|NCT01451541|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6154607|NCT01451606|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5555624|NCT04054830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5555625|NCT04054830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5555626|NCT04054830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555627|NCT04054674|Salicylic Acid|salicylic acid|mesh-list
5555628|NCT04054674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5555629|NCT04054674|Antifungal Agents|antifungal agents|mesh-ancestor
5555630|NCT04054674|Keratolytic Agents|keratolytic agents|mesh-ancestor
6154608|NCT01451606|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6154609|NCT01451606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6154610|NCT01451606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6154611|NCT01451606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154612|NCT01451606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6154613|NCT01451606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154614|NCT01451606|Analgesics|analgesics|mesh-ancestor
6154615|NCT01451606|Sensory System Agents|sensory system agents|mesh-ancestor
6154616|NCT01451606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6154617|NCT01451606|Antidepressive Agents|antidepressive agents|mesh-ancestor
6478916|NCT00535808|Nitroglycerin|nitroglycerin|mesh-list
6478917|NCT00535808|Sevoflurane|sevoflurane|mesh-list
6478918|NCT00535808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6478919|NCT00535808|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6478920|NCT00535808|Anesthetics, General|anesthetics, general|mesh-ancestor
6478921|NCT00535808|Anesthetics|anesthetics|mesh-ancestor
6478922|NCT00535808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5555631|NCT04054674|Dermatologic Agents|dermatologic agents|mesh-ancestor
6668033|NCT01530152|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6154618|NCT01451606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6154619|NCT01451606|Dopamine Agents|dopamine agents|mesh-ancestor
6205874|NCT02093351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555632|NCT04054648|Antihypertensive Agents|antihypertensive agents|mesh-list
5555633|NCT04054531|Paclitaxel|paclitaxel|mesh-list
5555634|NCT04054531|Carboplatin|carboplatin|mesh-list
5555635|NCT04054531|Pemetrexed|pemetrexed|mesh-list
5555636|NCT04054531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5555637|NCT04054531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5555638|NCT04054531|Tubulin Modulators|tubulin modulators|mesh-ancestor
5555639|NCT04054531|Antimitotic Agents|antimitotic agents|mesh-ancestor
5555640|NCT04054531|Mitosis Modulators|mitosis modulators|mesh-ancestor
5555641|NCT04054531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555642|NCT04054531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5555643|NCT04054531|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5555644|NCT04054531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5555645|NCT04054687|Tranexamic Acid|tranexamic acid|mesh-list
5555646|NCT04054687|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5555647|NCT04054687|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5555648|NCT04054687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555649|NCT04054687|Hemostatics|hemostatics|mesh-ancestor
5555650|NCT04054687|Coagulants|coagulants|mesh-ancestor
5555651|NCT04054635|Fluorides|fluorides|mesh-list
6205875|NCT02093351|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6205876|NCT02093351|Hormone Antagonists|hormone antagonists|mesh-ancestor
6205877|NCT02093351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6205878|NCT02093351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205879|NCT02093351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6205880|NCT02093351|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6478923|NCT00535808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478924|NCT00535808|Vasodilator Agents|vasodilator agents|mesh-ancestor
6478925|NCT00535808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5555652|NCT04054635|Cariostatic Agents|cariostatic agents|mesh-ancestor
5555653|NCT04054635|Protective Agents|protective agents|mesh-ancestor
5555654|NCT04054635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603141|NCT03164655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5603142|NCT03164655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5603143|NCT03164655|Growth Substances|growth substances|mesh-ancestor
6478926|NCT00535808|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6478927|NCT00535808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478928|NCT00535860|Teriparatide|teriparatide|mesh-list
6478929|NCT00535860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6478930|NCT00535860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478931|NCT00535860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6478932|NCT00535951|Panobinostat|panobinostat|mesh-list
6478933|NCT00535951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6478934|NCT00535951|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5603144|NCT03164655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603145|NCT03164655|Growth Inhibitors|growth inhibitors|mesh-ancestor
5603146|NCT03164655|Antimetabolites|antimetabolites|mesh-ancestor
6478935|NCT00535951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6478936|NCT00535951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478937|NCT00536003|Progesterone|progesterone|mesh-list
6478938|NCT00536003|Progestins|progestins|mesh-ancestor
6478939|NCT00536003|Hormones|hormones|mesh-ancestor
6478940|NCT00536003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6478941|NCT00536003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478942|NCT00536042|Minocycline|minocycline|mesh-list
6478943|NCT00536042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6478944|NCT00536042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6478945|NCT00536068|Acetaminophen|acetaminophen|mesh-list
6478946|NCT00536068|Aspirin|aspirin|mesh-list
6478947|NCT00536068|Diclofenac|diclofenac|mesh-list
6478948|NCT00536068|Naproxen|naproxen|mesh-list
6478949|NCT00536068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5603147|NCT03164655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603148|NCT03164655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5603149|NCT03164655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5603150|NCT03164655|Immunologic Factors|immunologic factors|mesh-ancestor
5603151|NCT03164655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5603152|NCT03164655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5603153|NCT03164655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5603154|NCT03164655|Antidotes|antidotes|mesh-ancestor
5603155|NCT03164655|Protective Agents|protective agents|mesh-ancestor
5603156|NCT03164655|Vitamin B Complex|vitamin b complex|mesh-ancestor
5555655|NCT04054518|Durvalumab|durvalumab|mesh-list
5555656|NCT04054518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5555657|NCT04054518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5555658|NCT04054362|Gemcitabine|gemcitabine|mesh-list
5555659|NCT04054362|Paclitaxel|paclitaxel|mesh-list
5555660|NCT04054362|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5555661|NCT04054362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5555662|NCT04054362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5555663|NCT04054362|Tubulin Modulators|tubulin modulators|mesh-ancestor
5555664|NCT04054362|Antimitotic Agents|antimitotic agents|mesh-ancestor
5555665|NCT04054362|Mitosis Modulators|mitosis modulators|mesh-ancestor
5555666|NCT04054362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555667|NCT04054362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5555668|NCT04054362|Antimetabolites|antimetabolites|mesh-ancestor
5555669|NCT04054362|Antiviral Agents|antiviral agents|mesh-ancestor
5555670|NCT04054362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5555671|NCT04054362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5555672|NCT04054362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5555673|NCT04054362|Immunologic Factors|immunologic factors|mesh-ancestor
5555674|NCT04054362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478950|NCT00536068|Analgesics|analgesics|mesh-ancestor
6478951|NCT00536068|Sensory System Agents|sensory system agents|mesh-ancestor
6478952|NCT00536068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6478953|NCT00536068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478954|NCT00536068|Antipyretics|antipyretics|mesh-ancestor
6478955|NCT00536068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6478956|NCT00536068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6478957|NCT00536068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6478958|NCT00536068|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6478959|NCT00536068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6154620|NCT01451632|Irinotecan|irinotecan|mesh-list
6154621|NCT01451632|Cetuximab|cetuximab|mesh-list
6154622|NCT01451632|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6154623|NCT01451632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6154624|NCT01451632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6154625|NCT01451632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478960|NCT00536068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478961|NCT00536068|Gout Suppressants|gout suppressants|mesh-ancestor
6478962|NCT00536068|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6478963|NCT00536068|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6478964|NCT00536068|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6478965|NCT00536211|Metformin|metformin|mesh-list
6478966|NCT00536211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6478967|NCT00536211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478968|NCT00536237|Niacin|niacin|mesh-list
6478969|NCT00536237|Niacinamide|niacinamide|mesh-list
6478970|NCT00536237|Nicotinic Acids|nicotinic acids|mesh-list
6478971|NCT00536237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478972|NCT00536237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478973|NCT00536237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6478974|NCT00536237|Antimetabolites|antimetabolites|mesh-ancestor
6478975|NCT00536237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6478976|NCT00536237|Vasodilator Agents|vasodilator agents|mesh-ancestor
6478977|NCT00536237|Vitamin B Complex|vitamin b complex|mesh-ancestor
6478978|NCT00536237|Vitamins|vitamins|mesh-ancestor
6478979|NCT00536237|Micronutrients|micronutrients|mesh-ancestor
6478980|NCT00536276|Vitamin D|vitamin d|mesh-list
6478981|NCT00536276|Ergocalciferols|ergocalciferols|mesh-list
6478982|NCT00536276|Cholecalciferol|cholecalciferol|mesh-list
6478983|NCT00536276|Vitamins|vitamins|mesh-list
6478984|NCT00536276|Micronutrients|micronutrients|mesh-ancestor
6478985|NCT00536276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478986|NCT00536276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5555675|NCT04054284|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6154626|NCT01451632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6154627|NCT01451632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6154628|NCT01451645|Colchicine|colchicine|mesh-list
6154629|NCT01451645|Allopurinol|allopurinol|mesh-list
6154630|NCT01451645|Gout Suppressants|gout suppressants|mesh-ancestor
6154631|NCT01451645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6154632|NCT01451645|Tubulin Modulators|tubulin modulators|mesh-ancestor
6154633|NCT01451645|Antimitotic Agents|antimitotic agents|mesh-ancestor
6154634|NCT01451645|Mitosis Modulators|mitosis modulators|mesh-ancestor
6478987|NCT00536276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6478988|NCT00536393|Doxorubicin|doxorubicin|mesh-list
5603157|NCT03164655|Vitamins|vitamins|mesh-ancestor
6154635|NCT01451645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478989|NCT00536393|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6154636|NCT01451645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6154637|NCT01451645|Antimetabolites|antimetabolites|mesh-ancestor
6154638|NCT01451645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6154639|NCT01451645|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6478990|NCT00536393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6478991|NCT00536393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6478992|NCT00536393|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6478993|NCT00536393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6478994|NCT00536393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6478995|NCT00536393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6478996|NCT00536419|Methylphenidate|methylphenidate|mesh-list
6478997|NCT00536419|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6478998|NCT00536419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6478999|NCT00536419|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6479000|NCT00536419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6479001|NCT00536419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6479002|NCT00536419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479003|NCT00536419|Dopamine Agents|dopamine agents|mesh-ancestor
6479004|NCT00536419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6479005|NCT00536614|Cetuximab|cetuximab|mesh-list
6479006|NCT00536614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6479007|NCT00536614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6479008|NCT00536640|Gemcitabine|gemcitabine|mesh-list
6479009|NCT00536640|Bevacizumab|bevacizumab|mesh-list
6479010|NCT00536640|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6479011|NCT00536640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6479012|NCT00536640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6479013|NCT00536640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6479014|NCT00536640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6479015|NCT00536640|Growth Substances|growth substances|mesh-ancestor
6479016|NCT00536640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479017|NCT00536640|Growth Inhibitors|growth inhibitors|mesh-ancestor
6479018|NCT00536640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6479019|NCT00536640|Antimetabolites|antimetabolites|mesh-ancestor
6479020|NCT00536640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479021|NCT00536640|Antiviral Agents|antiviral agents|mesh-ancestor
6154640|NCT01451645|Antioxidants|antioxidants|mesh-ancestor
6154641|NCT01451645|Protective Agents|protective agents|mesh-ancestor
6154642|NCT01451645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154643|NCT01451749|Donepezil|donepezil|mesh-list
6154644|NCT01451749|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6154645|NCT01451749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6479022|NCT00536640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6479023|NCT00536640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6479024|NCT00536640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6479025|NCT00536640|Immunologic Factors|immunologic factors|mesh-ancestor
6479026|NCT00536640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5555676|NCT04054284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555677|NCT04054206|Ibudilast|ibudilast|mesh-list
5555678|NCT04054206|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5555679|NCT04054206|Autonomic Agents|autonomic agents|mesh-ancestor
5555680|NCT04054206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5555681|NCT04054206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555682|NCT04054206|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5555683|NCT04054206|Respiratory System Agents|respiratory system agents|mesh-ancestor
5555684|NCT04054206|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5555685|NCT04054206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5555686|NCT04054206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555687|NCT04054206|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5555688|NCT04054206|Vasodilator Agents|vasodilator agents|mesh-ancestor
6154646|NCT01451749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479027|NCT00536653|Calcium, Dietary|calcium, dietary|mesh-list
6479028|NCT00536653|Vitamin D|vitamin d|mesh-list
6479029|NCT00536653|Ergocalciferols|ergocalciferols|mesh-list
6479030|NCT00536653|Vitamins|vitamins|mesh-list
6479031|NCT00536653|Goserelin|goserelin|mesh-list
6479032|NCT00536653|Bicalutamide|bicalutamide|mesh-list
6479033|NCT00536653|Calcium|calcium|mesh-list
6479034|NCT00536653|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
6479035|NCT00536653|Micronutrients|micronutrients|mesh-ancestor
6479036|NCT00536653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479037|NCT00536653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5555689|NCT04054024|Erenumab|erenumab|mesh-list
6154647|NCT01451749|Cholinergic Agents|cholinergic agents|mesh-ancestor
6479038|NCT00536653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6479039|NCT00536653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6479040|NCT00536653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6479041|NCT00536653|Androgen Antagonists|androgen antagonists|mesh-ancestor
6479042|NCT00536653|Hormone Antagonists|hormone antagonists|mesh-ancestor
6479043|NCT00536653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5555690|NCT04054024|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
5555691|NCT04054024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555692|NCT04054024|Analgesics|analgesics|mesh-ancestor
5555693|NCT04054024|Sensory System Agents|sensory system agents|mesh-ancestor
6479044|NCT00536653|Hormones|hormones|mesh-ancestor
6154648|NCT01451749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6154649|NCT01451749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154650|NCT01451749|Nootropic Agents|nootropic agents|mesh-ancestor
6668034|NCT01530152|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6668035|NCT01530152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6668036|NCT01530152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668037|NCT01530217|Ibuprofen|ibuprofen|mesh-list
6668038|NCT01530217|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6668039|NCT01530217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6668040|NCT01530217|Analgesics|analgesics|mesh-ancestor
6668041|NCT01530217|Sensory System Agents|sensory system agents|mesh-ancestor
6668042|NCT01530217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6154651|NCT01451762|Diphenhydramine|diphenhydramine|mesh-list
6154652|NCT01451762|Promethazine|promethazine|mesh-list
6154653|NCT01451762|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6154654|NCT01451762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6154655|NCT01451762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6154656|NCT01451762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154657|NCT01451762|Anesthetics, Local|anesthetics, local|mesh-ancestor
6154658|NCT01451762|Anesthetics|anesthetics|mesh-ancestor
6154659|NCT01451762|Sensory System Agents|sensory system agents|mesh-ancestor
5555694|NCT04054024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5555695|NCT04054024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555696|NCT04054089|Tenofovir|tenofovir|mesh-list
6154660|NCT01451762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6154661|NCT01451762|Antiemetics|antiemetics|mesh-ancestor
6154662|NCT01451762|Autonomic Agents|autonomic agents|mesh-ancestor
6154663|NCT01451762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6479045|NCT00536692|Mecamylamine|mecamylamine|mesh-list
6479046|NCT00536692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6479047|NCT00536692|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
6479048|NCT00536692|Autonomic Agents|autonomic agents|mesh-ancestor
6479049|NCT00536692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6479050|NCT00536692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479051|NCT00536692|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
6479052|NCT00536692|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6479053|NCT00536692|Cholinergic Agents|cholinergic agents|mesh-ancestor
5555697|NCT04054089|Lamivudine|lamivudine|mesh-list
5555698|NCT04054089|Emtricitabine|emtricitabine|mesh-list
5555699|NCT04054089|Dolutegravir|dolutegravir|mesh-list
5555700|NCT04054089|Antiviral Agents|antiviral agents|mesh-ancestor
5555701|NCT04054089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5555702|NCT04054089|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5555703|NCT04054089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5555704|NCT04054089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5555705|NCT04054089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555706|NCT04054089|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5555707|NCT04054089|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5555708|NCT04054089|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5555709|NCT04054089|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5555710|NCT04054063|Etomidate|etomidate|mesh-list
5555711|NCT04054063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5555712|NCT04054063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5555713|NCT04054063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555714|NCT04054063|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5555715|NCT04054063|Anesthetics, General|anesthetics, general|mesh-ancestor
5555716|NCT04054063|Anesthetics|anesthetics|mesh-ancestor
5555717|NCT04053959|Insulin|insulin|mesh-list
5555718|NCT04053959|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6479054|NCT00536692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5555719|NCT04053959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5555720|NCT04053959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555721|NCT04053972|Lenvatinib|lenvatinib|mesh-list
5555722|NCT04053972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6154664|NCT01451762|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5555723|NCT04053972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5555724|NCT04053972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5555725|NCT04053972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555726|NCT04054115|Alprostadil|alprostadil|mesh-list
5555727|NCT04054115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5555728|NCT04054115|Vasodilator Agents|vasodilator agents|mesh-ancestor
5555729|NCT04054115|Urological Agents|urological agents|mesh-ancestor
5555730|NCT04054128|Heparin|heparin|mesh-list
5555731|NCT04054128|Calcium heparin|calcium heparin|mesh-list
5555732|NCT04054128|Anticoagulants|anticoagulants|mesh-ancestor
5555733|NCT04054128|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5555734|NCT04054128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5555735|NCT04054128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555736|NCT04053985|Lenvatinib|lenvatinib|mesh-list
6479055|NCT00536692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479056|NCT00536705|Montelukast|montelukast|mesh-list
6479057|NCT00536705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6479058|NCT00536705|Respiratory System Agents|respiratory system agents|mesh-ancestor
6479059|NCT00536705|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6479060|NCT00536705|Hormone Antagonists|hormone antagonists|mesh-ancestor
6479061|NCT00536705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6479062|NCT00536705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154665|NCT01451762|Histamine Antagonists|histamine antagonists|mesh-ancestor
6154666|NCT01451762|Histamine Agents|histamine agents|mesh-ancestor
6154667|NCT01451762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6154668|NCT01451762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154669|NCT01451762|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6154670|NCT01451762|Antipruritics|antipruritics|mesh-ancestor
6154671|NCT01451762|Dermatologic Agents|dermatologic agents|mesh-ancestor
6154672|NCT01451775|Empagliflozin|empagliflozin|mesh-list
6154673|NCT01451775|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6154674|NCT01451775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154675|NCT01451775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6154676|NCT01451775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154677|NCT01451814|Nicotine|nicotine|mesh-list
6154678|NCT01451814|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6154679|NCT01451814|Autonomic Agents|autonomic agents|mesh-ancestor
6154680|NCT01451814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6154681|NCT01451814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154682|NCT01451814|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6154683|NCT01451814|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6154684|NCT01451814|Cholinergic Agents|cholinergic agents|mesh-ancestor
6154685|NCT01451814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6479063|NCT00536705|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6479064|NCT00536705|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6668043|NCT01530217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555737|NCT04053985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6154686|NCT01451814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154687|NCT01451827|Tolvaptan|tolvaptan|mesh-list
6154688|NCT01451827|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6154689|NCT01451827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154690|NCT01451827|Natriuretic Agents|natriuretic agents|mesh-ancestor
6154691|NCT01451827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154692|NCT01451996|Loratadine|loratadine|mesh-list
6154693|NCT01451996|Antipruritics|antipruritics|mesh-ancestor
6154694|NCT01451996|Dermatologic Agents|dermatologic agents|mesh-ancestor
6154695|NCT01451996|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6154696|NCT01451996|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6154697|NCT01451996|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6154698|NCT01451996|Histamine Antagonists|histamine antagonists|mesh-ancestor
6154699|NCT01451996|Histamine Agents|histamine agents|mesh-ancestor
6154700|NCT01451996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6154701|NCT01451996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154702|NCT01451996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154703|NCT01452126|Ropivacaine|ropivacaine|mesh-list
6154704|NCT01452126|Anesthetics, Local|anesthetics, local|mesh-ancestor
6154705|NCT01452126|Anesthetics|anesthetics|mesh-ancestor
6154706|NCT01452126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6154707|NCT01452126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154708|NCT01452126|Sensory System Agents|sensory system agents|mesh-ancestor
6154709|NCT01452126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6154710|NCT01452152|Clopidogrel|clopidogrel|mesh-list
5555738|NCT04053985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5555739|NCT04053985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5555740|NCT04053985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555741|NCT04053712|Glucagon|glucagon|mesh-list
5555742|NCT04053712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5555743|NCT04053712|Hormones|hormones|mesh-ancestor
5555744|NCT04053712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5555745|NCT04053712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555746|NCT04053699|Factor VIII|factor viii|mesh-list
5555747|NCT04053699|Coagulants|coagulants|mesh-ancestor
5555748|NCT04053621|Thiamine|thiamine|mesh-list
5555749|NCT04053621|Thiamine Pyrophosphate|thiamine pyrophosphate|mesh-list
5555750|NCT04053621|Metformin|metformin|mesh-list
5555751|NCT04053621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5555752|NCT04053621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154711|NCT01452152|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6154712|NCT01452152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6154713|NCT01452152|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6154714|NCT01452152|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6154715|NCT01452152|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6154716|NCT01452152|Purinergic Agents|purinergic agents|mesh-ancestor
6154717|NCT01452152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6154718|NCT01452152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154719|NCT01452152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154720|NCT01452347|Warfarin|warfarin|mesh-list
6154721|NCT01452347|Dabigatran|dabigatran|mesh-list
6154722|NCT01452347|Anticoagulants|anticoagulants|mesh-ancestor
6154723|NCT01452347|Antithrombins|antithrombins|mesh-ancestor
6154724|NCT01452347|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6154725|NCT01452347|Protease Inhibitors|protease inhibitors|mesh-ancestor
6154726|NCT01452347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6154727|NCT01452347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154728|NCT01452529|Hydrocodone|hydrocodone|mesh-list
6154729|NCT01452529|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6154730|NCT01452529|Narcotics|narcotics|mesh-ancestor
6154731|NCT01452529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6154732|NCT01452529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154733|NCT01452529|Analgesics|analgesics|mesh-ancestor
6479065|NCT00536705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479066|NCT00536770|Calcitriol|calcitriol|mesh-list
6479067|NCT00536770|Gemcitabine|gemcitabine|mesh-list
6479068|NCT00536770|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6479069|NCT00536770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6479070|NCT00536770|Antimetabolites|antimetabolites|mesh-ancestor
6479071|NCT00536770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154734|NCT01452529|Sensory System Agents|sensory system agents|mesh-ancestor
6154735|NCT01452529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6154736|NCT01452529|Antitussive Agents|antitussive agents|mesh-ancestor
6154737|NCT01452529|Respiratory System Agents|respiratory system agents|mesh-ancestor
6154738|NCT01452789|Morphine|morphine|mesh-list
6154739|NCT01452789|Buprenorphine|buprenorphine|mesh-list
5555753|NCT04053621|Vitamin B Complex|vitamin b complex|mesh-ancestor
5555754|NCT04053621|Vitamins|vitamins|mesh-ancestor
5555755|NCT04053621|Micronutrients|micronutrients|mesh-ancestor
5555756|NCT04053543|CXA-10|cxa-10|mesh-list
5555757|NCT04053543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5555758|NCT04053478|Phenylephrine|phenylephrine|mesh-list
5555759|NCT04053478|Oxymetazoline|oxymetazoline|mesh-list
6154740|NCT01452789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6154741|NCT01452789|Narcotics|narcotics|mesh-ancestor
6154742|NCT01452789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6154743|NCT01452789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154744|NCT01452789|Analgesics|analgesics|mesh-ancestor
6154745|NCT01452789|Sensory System Agents|sensory system agents|mesh-ancestor
6154746|NCT01452789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6154747|NCT01452789|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6154748|NCT01453023|Fluticasone|fluticasone|mesh-list
6154749|NCT01453023|Xhance|xhance|mesh-list
6154750|NCT01453023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6154751|NCT01453023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6154752|NCT01453023|Autonomic Agents|autonomic agents|mesh-ancestor
6154753|NCT01453023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6154754|NCT01453023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154755|NCT01453023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6154756|NCT01453023|Respiratory System Agents|respiratory system agents|mesh-ancestor
5555760|NCT04053478|Norepinephrine|norepinephrine|mesh-list
5555761|NCT04053478|Ephedrine|ephedrine|mesh-list
5555762|NCT04053478|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6154757|NCT01453023|Dermatologic Agents|dermatologic agents|mesh-ancestor
6154758|NCT01453023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6479072|NCT00536770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6479073|NCT00536770|Antiviral Agents|antiviral agents|mesh-ancestor
6479074|NCT00536770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5555763|NCT04053478|Mydriatics|mydriatics|mesh-ancestor
5555764|NCT04053478|Autonomic Agents|autonomic agents|mesh-ancestor
5555765|NCT04053478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5555766|NCT04053478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555767|NCT04053478|Sympathomimetics|sympathomimetics|mesh-ancestor
5555768|NCT04053478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5555769|NCT04053478|Nasal Decongestants|nasal decongestants|mesh-ancestor
5555770|NCT04053478|Respiratory System Agents|respiratory system agents|mesh-ancestor
5555771|NCT04053478|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5555772|NCT04053478|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5555773|NCT04053478|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5555774|NCT04053478|Adrenergic Agents|adrenergic agents|mesh-ancestor
5555775|NCT04053478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5555776|NCT04053478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555777|NCT04053478|Protective Agents|protective agents|mesh-ancestor
5555778|NCT04053478|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6479075|NCT00536770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6479076|NCT00536770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6479077|NCT00536770|Immunologic Factors|immunologic factors|mesh-ancestor
6479078|NCT00536770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479079|NCT00536770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6479080|NCT00536770|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6479081|NCT00536770|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6479082|NCT00536770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6479083|NCT00536770|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6479084|NCT00536770|Vitamins|vitamins|mesh-ancestor
6479085|NCT00536770|Micronutrients|micronutrients|mesh-ancestor
6479086|NCT00536770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6479087|NCT00536783|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6479088|NCT00536783|Antidepressive Agents|antidepressive agents|mesh-ancestor
6479089|NCT00536783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6479090|NCT00536783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6479091|NCT00536783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6479092|NCT00536783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6479093|NCT00536783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479094|NCT00536848|Metronidazole|metronidazole|mesh-list
6479095|NCT00536848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6479096|NCT00536848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6479097|NCT00536848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6479098|NCT00536848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6479099|NCT00536861|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6479100|NCT00536861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5555779|NCT04053400|Ketamine|ketamine|mesh-list
5555780|NCT04053400|Analgesics|analgesics|mesh-ancestor
5555781|NCT04053400|Sensory System Agents|sensory system agents|mesh-ancestor
5555782|NCT04053400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5555783|NCT04053400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555784|NCT04053400|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5555785|NCT04053400|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5555786|NCT04053400|Anesthetics, General|anesthetics, general|mesh-ancestor
5555787|NCT04053400|Anesthetics|anesthetics|mesh-ancestor
5555788|NCT04053400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5555789|NCT04053400|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5555790|NCT04053400|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5555791|NCT04053400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5555792|NCT04053400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154759|NCT01453049|Glimepiride|glimepiride|mesh-list
6154760|NCT01453049|Rosiglitazone|rosiglitazone|mesh-list
6479101|NCT00536861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6479102|NCT00536861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6479103|NCT00536861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479104|NCT00536887|Atorvastatin|atorvastatin|mesh-list
6479105|NCT00536887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6479106|NCT00536887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6479107|NCT00536887|Antimetabolites|antimetabolites|mesh-ancestor
6479108|NCT00536887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479109|NCT00536887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6479110|NCT00536887|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6154761|NCT01453049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6154762|NCT01453049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5555793|NCT04053491|Anesthetics|anesthetics|mesh-list
5555794|NCT04053491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5555795|NCT04053491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555796|NCT04053140|Penicillins|penicillins|mesh-list
5555797|NCT04053140|Penicillin G|penicillin g|mesh-list
5555798|NCT04053140|Penicillin G Benzathine|penicillin g benzathine|mesh-list
5555799|NCT04053140|Penicillin G Procaine|penicillin g procaine|mesh-list
5555800|NCT04053140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5555801|NCT04053140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5555802|NCT04052932|Allopurinol|allopurinol|mesh-list
5555803|NCT04052932|Antimetabolites|antimetabolites|mesh-ancestor
6668044|NCT01530217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6668045|NCT01530217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6668046|NCT01530217|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6154763|NCT01453049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154764|NCT01453049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6154765|NCT01453049|Immunologic Factors|immunologic factors|mesh-ancestor
6154766|NCT01453075|Valacyclovir|valacyclovir|mesh-list
6154767|NCT01453075|Antiviral Agents|antiviral agents|mesh-ancestor
6154768|NCT01453075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6154769|NCT01453153|Gemcitabine|gemcitabine|mesh-list
6154770|NCT01453153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6154771|NCT01453153|Antimetabolites|antimetabolites|mesh-ancestor
6154772|NCT01453153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154773|NCT01453153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6154774|NCT01453153|Antiviral Agents|antiviral agents|mesh-ancestor
6154775|NCT01453153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6154776|NCT01453153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6154777|NCT01453153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6154778|NCT01453153|Immunologic Factors|immunologic factors|mesh-ancestor
6154779|NCT01453153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154780|NCT01453205|Rituximab|rituximab|mesh-list
6154781|NCT01453205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6154782|NCT01453205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6154783|NCT01453205|Immunologic Factors|immunologic factors|mesh-ancestor
6154784|NCT01453205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154785|NCT01453205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6154786|NCT01453348|Vaccines|vaccines|mesh-list
6154787|NCT01453348|Immunologic Factors|immunologic factors|mesh-ancestor
6154788|NCT01453348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154789|NCT01453374|Naltrexone|naltrexone|mesh-list
6154790|NCT01453374|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6154791|NCT01453374|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6154792|NCT01453374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154793|NCT01453374|Sensory System Agents|sensory system agents|mesh-ancestor
6154794|NCT01453374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6154795|NCT01453595|Dactolisib|dactolisib|mesh-list
6154796|NCT01453595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6154797|NCT01453725|Golimumab|golimumab|mesh-list
6154798|NCT01453725|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6154799|NCT01453725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6154800|NCT01453725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6154801|NCT01453725|Immunologic Factors|immunologic factors|mesh-ancestor
6154802|NCT01453725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154803|NCT01453855|Travoprost|travoprost|mesh-list
6154804|NCT01453855|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6154805|NCT01453855|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6154806|NCT01453855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6668047|NCT01530217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6668048|NCT01530217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154807|NCT01453998|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6154808|NCT01453998|Immunologic Factors|immunologic factors|mesh-ancestor
6154809|NCT01453998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154810|NCT01454076|Clarithromycin|clarithromycin|mesh-list
6154811|NCT01454076|Rifampin|rifampin|mesh-list
6154812|NCT01454076|Ketoconazole|ketoconazole|mesh-list
6154813|NCT01454076|Ixazomib|ixazomib|mesh-list
6154814|NCT01454076|Glycine|glycine|mesh-list
6154815|NCT01454076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6154816|NCT01454076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6154817|NCT01454076|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6154818|NCT01454076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6668049|NCT01530230|Oxytocin|oxytocin|mesh-list
5555804|NCT04052932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154819|NCT01454076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154820|NCT01454076|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6154821|NCT01454076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6154822|NCT01454076|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6154823|NCT01454076|Antitubercular Agents|antitubercular agents|mesh-ancestor
6154824|NCT01454076|Leprostatic Agents|leprostatic agents|mesh-ancestor
6154825|NCT01454076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6154826|NCT01454076|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6154827|NCT01454076|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6154828|NCT01454076|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6154829|NCT01454076|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5555805|NCT04052932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5555806|NCT04052932|Gout Suppressants|gout suppressants|mesh-ancestor
5555807|NCT04052932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5555808|NCT04052932|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5555809|NCT04052932|Antioxidants|antioxidants|mesh-ancestor
5555810|NCT04052932|Protective Agents|protective agents|mesh-ancestor
5555811|NCT04052932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555812|NCT04052711|Minocycline|minocycline|mesh-list
5555813|NCT04052711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5555814|NCT04052711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5555815|NCT04052854|Zanubrutinib|zanubrutinib|mesh-list
5555816|NCT04052854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5555817|NCT04052854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5555818|NCT04052854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5555819|NCT04052854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555820|NCT04052867|Lidocaine|lidocaine|mesh-list
5555821|NCT04052867|Anesthetics, Local|anesthetics, local|mesh-ancestor
5555822|NCT04052867|Anesthetics|anesthetics|mesh-ancestor
5555823|NCT04052867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5555824|NCT04052867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555825|NCT04052867|Sensory System Agents|sensory system agents|mesh-ancestor
5555826|NCT04052867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5555827|NCT04052867|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5555828|NCT04052867|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5555829|NCT04052867|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5555830|NCT04052867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5555831|NCT04052867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555832|NCT04053205|Paclitaxel|paclitaxel|mesh-list
5555833|NCT04053205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5555834|NCT04053205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5555835|NCT04053205|Tubulin Modulators|tubulin modulators|mesh-ancestor
5555836|NCT04053205|Antimitotic Agents|antimitotic agents|mesh-ancestor
5555837|NCT04053205|Mitosis Modulators|mitosis modulators|mesh-ancestor
5555838|NCT04053205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555839|NCT04052776|Levodopa|levodopa|mesh-list
5555840|NCT04052776|Carbidopa|carbidopa|mesh-list
5555841|NCT04052776|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
5555842|NCT04052776|Buspirone|buspirone|mesh-list
5555843|NCT04052776|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5555844|NCT04052776|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5555845|NCT04052776|Dopamine Agents|dopamine agents|mesh-ancestor
5555846|NCT04052776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5555847|NCT04052776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555848|NCT04052776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555849|NCT04052776|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5555850|NCT04052776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5555851|NCT04052776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5555852|NCT04052776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5555853|NCT04052776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5555854|NCT04052776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5555855|NCT04052776|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5555856|NCT04052776|Serotonin Agents|serotonin agents|mesh-ancestor
5555857|NCT04052776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6154830|NCT01454076|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6154831|NCT01454076|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6154832|NCT01454076|Antifungal Agents|antifungal agents|mesh-ancestor
6154833|NCT01454076|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6154834|NCT01454076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6479111|NCT00536887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6479112|NCT00537121|Leucovorin|leucovorin|mesh-list
6479113|NCT00537121|Fluorouracil|fluorouracil|mesh-list
6479114|NCT00537121|Irinotecan|irinotecan|mesh-list
6154835|NCT01454076|Hormone Antagonists|hormone antagonists|mesh-ancestor
6154836|NCT01454076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6154837|NCT01454076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154838|NCT01454076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6154839|NCT01454076|Protease Inhibitors|protease inhibitors|mesh-ancestor
6154840|NCT01454076|Glycine Agents|glycine agents|mesh-ancestor
6154841|NCT01454076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6154842|NCT01454102|Gemcitabine|gemcitabine|mesh-list
6154843|NCT01454102|Paclitaxel|paclitaxel|mesh-list
6154844|NCT01454102|Bevacizumab|bevacizumab|mesh-list
6154845|NCT01454102|Carboplatin|carboplatin|mesh-list
6154846|NCT01454102|Nivolumab|nivolumab|mesh-list
6154847|NCT01454102|Pemetrexed|pemetrexed|mesh-list
6154848|NCT01454102|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6154849|NCT01454102|Ipilimumab|ipilimumab|mesh-list
6154850|NCT01454102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6154851|NCT01454102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6154852|NCT01454102|Tubulin Modulators|tubulin modulators|mesh-ancestor
6154853|NCT01454102|Antimitotic Agents|antimitotic agents|mesh-ancestor
6154854|NCT01454102|Mitosis Modulators|mitosis modulators|mesh-ancestor
6154855|NCT01454102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154856|NCT01454102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6154857|NCT01454102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6154858|NCT01454102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6154859|NCT01454102|Growth Substances|growth substances|mesh-ancestor
6154860|NCT01454102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154861|NCT01454102|Growth Inhibitors|growth inhibitors|mesh-ancestor
6154862|NCT01454102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6154863|NCT01454102|Antimetabolites|antimetabolites|mesh-ancestor
6154864|NCT01454102|Antiviral Agents|antiviral agents|mesh-ancestor
6154865|NCT01454102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6154866|NCT01454102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6154867|NCT01454102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6154868|NCT01454102|Immunologic Factors|immunologic factors|mesh-ancestor
6154869|NCT01454102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5555858|NCT04052776|Immunologic Factors|immunologic factors|mesh-ancestor
5555859|NCT04052776|Dopamine Agonists|dopamine agonists|mesh-ancestor
5603158|NCT03164655|Micronutrients|micronutrients|mesh-ancestor
5603159|NCT03162627|Olaparib|olaparib|mesh-list
5603160|NCT03162627|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5603161|NCT03162627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5603162|NCT03162627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603163|NCT03162627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5603164|NCT03115424|Liraglutide|liraglutide|mesh-list
5603165|NCT03115424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5603166|NCT03115424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603167|NCT03115424|Incretins|incretins|mesh-ancestor
5603168|NCT03115424|Hormones|hormones|mesh-ancestor
5603169|NCT03115424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5603170|NCT03094052|Trastuzumab|trastuzumab|mesh-list
5603171|NCT03094052|Atropine|atropine|mesh-list
5603172|NCT03094052|Diphenoxylate|diphenoxylate|mesh-list
5603173|NCT03094052|Loperamide|loperamide|mesh-list
5603174|NCT03094052|Antidiarrheals|antidiarrheals|mesh-list
5603175|NCT03094052|Atropine sulfate-diphenoxylate hydrochloride drug combination|atropine sulfate-diphenoxylate hydrochloride drug combination|mesh-list
5603176|NCT03094052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5603177|NCT03094052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5603178|NCT03094052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5603179|NCT03094052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5603180|NCT03094052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5603181|NCT03094052|Autonomic Agents|autonomic agents|mesh-ancestor
5603182|NCT03094052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5603183|NCT03094052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603184|NCT03094052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5603185|NCT03094052|Respiratory System Agents|respiratory system agents|mesh-ancestor
5603186|NCT03094052|Mydriatics|mydriatics|mesh-ancestor
5603187|NCT03094052|Parasympatholytics|parasympatholytics|mesh-ancestor
6479115|NCT00537121|Vorinostat|vorinostat|mesh-list
6479116|NCT00537121|Calcium|calcium|mesh-list
6479117|NCT00537121|Levoleucovorin|levoleucovorin|mesh-list
6479118|NCT00537121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6479119|NCT00537121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479120|NCT00537121|Antimetabolites|antimetabolites|mesh-ancestor
6479121|NCT00537121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479122|NCT00537121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6154870|NCT01454102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6154871|NCT01454102|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5603188|NCT03094052|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6154872|NCT01454102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5603189|NCT03094052|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6154873|NCT01454284|Insulin Lispro|insulin lispro|mesh-list
6154874|NCT01454284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6154875|NCT01454284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154876|NCT01454362|Nicotine|nicotine|mesh-list
6479123|NCT00537121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6479124|NCT00537121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6479125|NCT00537121|Immunologic Factors|immunologic factors|mesh-ancestor
6479126|NCT00537121|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6479127|NCT00537121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6479128|NCT00537121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6479129|NCT00537121|Antidotes|antidotes|mesh-ancestor
6479130|NCT00537121|Protective Agents|protective agents|mesh-ancestor
6479131|NCT00537121|Vitamin B Complex|vitamin b complex|mesh-ancestor
6479132|NCT00537121|Vitamins|vitamins|mesh-ancestor
6479133|NCT00537121|Micronutrients|micronutrients|mesh-ancestor
6479134|NCT00537121|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6479135|NCT00537173|Paclitaxel|paclitaxel|mesh-list
6479136|NCT00537173|Bevacizumab|bevacizumab|mesh-list
6479137|NCT00537173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6479138|NCT00537173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6154877|NCT01454362|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6154878|NCT01454362|Autonomic Agents|autonomic agents|mesh-ancestor
6154879|NCT01454362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6154880|NCT01454362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154881|NCT01454362|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6479139|NCT00537173|Tubulin Modulators|tubulin modulators|mesh-ancestor
6479140|NCT00537173|Antimitotic Agents|antimitotic agents|mesh-ancestor
6479141|NCT00537173|Mitosis Modulators|mitosis modulators|mesh-ancestor
6479142|NCT00537173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479143|NCT00537173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6479144|NCT00537173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6479145|NCT00537173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6479146|NCT00537173|Growth Substances|growth substances|mesh-ancestor
6479147|NCT00537173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479148|NCT00537173|Growth Inhibitors|growth inhibitors|mesh-ancestor
6479149|NCT00537251|Insulin Glargine|insulin glargine|mesh-list
6479150|NCT00537251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6479151|NCT00537251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479152|NCT00537355|Histamine|histamine|mesh-list
6479153|NCT00537355|Histamine Agonists|histamine agonists|mesh-ancestor
6479154|NCT00537355|Histamine Agents|histamine agents|mesh-ancestor
6479155|NCT00537355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6479156|NCT00537355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479157|NCT00537355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479158|NCT00537420|Sibutramine|sibutramine|mesh-list
6479159|NCT00537420|Antidepressive Agents|antidepressive agents|mesh-ancestor
6479160|NCT00537420|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6479161|NCT00537420|Appetite Depressants|appetite depressants|mesh-ancestor
6479162|NCT00537420|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6479163|NCT00537472|Bupivacaine|bupivacaine|mesh-list
6479164|NCT00537472|Anesthetics|anesthetics|mesh-list
6479165|NCT00537472|Anesthetics, Local|anesthetics, local|mesh-ancestor
6479166|NCT00537472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6479167|NCT00537472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479168|NCT00537472|Sensory System Agents|sensory system agents|mesh-ancestor
6479169|NCT00537472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6488832|NCT00587119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6488833|NCT00587145|Docetaxel|docetaxel|mesh-list
6488834|NCT00587145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6488835|NCT00587145|Tubulin Modulators|tubulin modulators|mesh-ancestor
6488836|NCT00587145|Antimitotic Agents|antimitotic agents|mesh-ancestor
6488837|NCT00587145|Mitosis Modulators|mitosis modulators|mesh-ancestor
6488838|NCT00587145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488839|NCT00587249|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6488840|NCT00587249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6488841|NCT00587249|Immunologic Factors|immunologic factors|mesh-ancestor
6488842|NCT00587249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488843|NCT00587249|Antacids|antacids|mesh-ancestor
6488844|NCT00587249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488845|NCT00587249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6488846|NCT00587327|Atosiban|atosiban|mesh-list
6488847|NCT00587327|Hormone Antagonists|hormone antagonists|mesh-ancestor
6488848|NCT00587327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6488849|NCT00587327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488850|NCT00587327|Tocolytic Agents|tocolytic agents|mesh-ancestor
6479170|NCT00537524|Vaccines|vaccines|mesh-list
6479171|NCT00537524|Immunologic Factors|immunologic factors|mesh-ancestor
6479172|NCT00537524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479173|NCT00537537|Telbivudine|telbivudine|mesh-list
6479174|NCT00537537|Antiviral Agents|antiviral agents|mesh-ancestor
6479175|NCT00537537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6479176|NCT00537537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6479177|NCT00537537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6479178|NCT00537537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479179|NCT00537550|Methotrexate|methotrexate|mesh-list
6479180|NCT00537550|Vincristine|vincristine|mesh-list
6479181|NCT00537550|Asparaginase|asparaginase|mesh-list
6479182|NCT00537550|Daunorubicin|daunorubicin|mesh-list
6479183|NCT00537550|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6479184|NCT00537550|Abortifacient Agents|abortifacient agents|mesh-ancestor
6479185|NCT00537550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6479186|NCT00537550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479187|NCT00537550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6479188|NCT00537550|Antimetabolites|antimetabolites|mesh-ancestor
6479189|NCT00537550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479190|NCT00537550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6479191|NCT00537550|Dermatologic Agents|dermatologic agents|mesh-ancestor
6479192|NCT00537550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6479193|NCT00537550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6479194|NCT00537550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6479195|NCT00537550|Immunologic Factors|immunologic factors|mesh-ancestor
6479196|NCT00537550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6479197|NCT00537550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6479198|NCT00537550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6479199|NCT00537550|Tubulin Modulators|tubulin modulators|mesh-ancestor
6479200|NCT00537550|Antimitotic Agents|antimitotic agents|mesh-ancestor
6479201|NCT00537550|Mitosis Modulators|mitosis modulators|mesh-ancestor
6479202|NCT00537550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6479203|NCT00537550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6479204|NCT00537550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6479205|NCT00537563|Telithromycin|telithromycin|mesh-list
6479206|NCT00537563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6479207|NCT00537563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6479208|NCT00537602|Miglustat|miglustat|mesh-list
6479209|NCT00537602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6154882|NCT01454362|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6154883|NCT01454362|Cholinergic Agents|cholinergic agents|mesh-ancestor
6154884|NCT01454362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6154885|NCT01454362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154886|NCT01454414|Permethrin|permethrin|mesh-list
6154887|NCT01454414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6154888|NCT01454414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154889|NCT01454596|Aldesleukin|aldesleukin|mesh-list
6154890|NCT01454596|Cyclophosphamide|cyclophosphamide|mesh-list
6479210|NCT00537602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479211|NCT00537602|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6479212|NCT00537602|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6479213|NCT00537602|Antiviral Agents|antiviral agents|mesh-ancestor
5555860|NCT04052659|Azacitidine|azacitidine|mesh-list
5555861|NCT04052659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5555862|NCT04052659|Antimetabolites|antimetabolites|mesh-ancestor
5555863|NCT04052659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555864|NCT04052659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5555865|NCT04052659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5555866|NCT04052620|Diclofenac|diclofenac|mesh-list
5555867|NCT04052620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5555868|NCT04052620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6479214|NCT00537602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6479215|NCT00537602|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6479216|NCT00537602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5555869|NCT04052620|Analgesics|analgesics|mesh-ancestor
5555870|NCT04052620|Sensory System Agents|sensory system agents|mesh-ancestor
5555871|NCT04052620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5555872|NCT04052620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555873|NCT04052620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5555874|NCT04052620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5555875|NCT04052620|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5555876|NCT04052620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5603190|NCT03094052|Cholinergic Agents|cholinergic agents|mesh-ancestor
6479217|NCT00537602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555877|NCT04052620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555878|NCT04052490|Salicylic Acid|salicylic acid|mesh-list
5555879|NCT04052490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5555880|NCT04052490|Antifungal Agents|antifungal agents|mesh-ancestor
6479218|NCT00537667|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6479219|NCT00537667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6479220|NCT00537732|Omeprazole|omeprazole|mesh-list
6479221|NCT00537732|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6479222|NCT00537732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6479223|NCT00537732|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6479224|NCT00537732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6479225|NCT00537732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479226|NCT00537836|Estradiol|estradiol|mesh-list
6479227|NCT00537836|Estrogens|estrogens|mesh-ancestor
6479228|NCT00537836|Hormones|hormones|mesh-ancestor
6479229|NCT00537836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6479230|NCT00537836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479231|NCT00537862|Mycophenolic Acid|mycophenolic acid|mesh-list
6479232|NCT00537862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6479233|NCT00537862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6479234|NCT00537862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6479235|NCT00537862|Antitubercular Agents|antitubercular agents|mesh-ancestor
5555881|NCT04052490|Keratolytic Agents|keratolytic agents|mesh-ancestor
5555882|NCT04052490|Dermatologic Agents|dermatologic agents|mesh-ancestor
5555883|NCT04052269|Sildenafil Citrate|sildenafil citrate|mesh-list
5555884|NCT04052269|Tadalafil|tadalafil|mesh-list
5555885|NCT04052269|Vasodilator Agents|vasodilator agents|mesh-ancestor
5555886|NCT04052269|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5555887|NCT04052269|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5555888|NCT04052269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5555889|NCT04052269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555890|NCT04052269|Urological Agents|urological agents|mesh-ancestor
5555891|NCT04052178|Capsaicin|capsaicin|mesh-list
5555892|NCT04052178|Antipruritics|antipruritics|mesh-ancestor
6479236|NCT00537862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6479237|NCT00537862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6479238|NCT00537862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6479239|NCT00537862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479240|NCT00537888|Fluconazole|fluconazole|mesh-list
6479241|NCT00537888|Antifungal Agents|antifungal agents|mesh-ancestor
6479242|NCT00537888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6479243|NCT00537888|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6479244|NCT00537888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6479245|NCT00537888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6479246|NCT00537888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479247|NCT00537888|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6154891|NCT01454596|Fludarabine|fludarabine|mesh-list
6154892|NCT01454596|Mitogens|mitogens|mesh-list
6154893|NCT01454596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6154894|NCT01454596|Immunologic Factors|immunologic factors|mesh-ancestor
6154895|NCT01454596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154896|NCT01454596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6479248|NCT00537888|Hormone Antagonists|hormone antagonists|mesh-ancestor
6479249|NCT00537888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6479250|NCT00537888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479251|NCT00537888|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6479252|NCT00537888|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6479253|NCT00537901|Bevacizumab|bevacizumab|mesh-list
6479254|NCT00537901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6479255|NCT00537901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5555893|NCT04052178|Dermatologic Agents|dermatologic agents|mesh-ancestor
5555894|NCT04052178|Sensory System Agents|sensory system agents|mesh-ancestor
5555895|NCT04052178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5555896|NCT04052178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555897|NCT04051723|Dexamethasone|dexamethasone|mesh-list
5555898|NCT04051723|Ropivacaine|ropivacaine|mesh-list
6154897|NCT01454596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6154898|NCT01454596|Alkylating Agents|alkylating agents|mesh-ancestor
6479256|NCT00537901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6479257|NCT00537901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6479258|NCT00537901|Growth Substances|growth substances|mesh-ancestor
6479259|NCT00537901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479260|NCT00537901|Growth Inhibitors|growth inhibitors|mesh-ancestor
5555899|NCT04051723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5555900|NCT04051723|Antiemetics|antiemetics|mesh-ancestor
5555901|NCT04051723|Autonomic Agents|autonomic agents|mesh-ancestor
5555902|NCT04051723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5555903|NCT04051723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555904|NCT04051723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6154899|NCT01454596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154900|NCT01454596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6154901|NCT01454596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5555905|NCT04051723|Glucocorticoids|glucocorticoids|mesh-ancestor
5555906|NCT04051723|Hormones|hormones|mesh-ancestor
5555907|NCT04051723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5555908|NCT04051723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5555909|NCT04051723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6154902|NCT01454596|Mitosis Modulators|mitosis modulators|mesh-ancestor
6154903|NCT01454596|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6154904|NCT01454596|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6154905|NCT01454596|Antiviral Agents|antiviral agents|mesh-ancestor
6154906|NCT01454596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6154907|NCT01454739|Factor VIII|factor viii|mesh-list
6154908|NCT01454739|Coagulants|coagulants|mesh-ancestor
6154909|NCT01454778|Paclitaxel|paclitaxel|mesh-list
6154910|NCT01454778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6154911|NCT01454778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6154912|NCT01454778|Tubulin Modulators|tubulin modulators|mesh-ancestor
6154913|NCT01454778|Antimitotic Agents|antimitotic agents|mesh-ancestor
6154914|NCT01454778|Mitosis Modulators|mitosis modulators|mesh-ancestor
6154915|NCT01454778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154916|NCT01454791|Diclofenac|diclofenac|mesh-list
6154917|NCT01454791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6154918|NCT01454791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6154919|NCT01454791|Analgesics|analgesics|mesh-ancestor
6154920|NCT01454791|Sensory System Agents|sensory system agents|mesh-ancestor
6154921|NCT01454791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6154922|NCT01454791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154923|NCT01454791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6154924|NCT01454791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5555910|NCT04051723|Anesthetics, Local|anesthetics, local|mesh-ancestor
5555911|NCT04051723|Anesthetics|anesthetics|mesh-ancestor
5555912|NCT04051723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5555913|NCT04051723|Sensory System Agents|sensory system agents|mesh-ancestor
5555914|NCT04051853|Sorafenib|sorafenib|mesh-list
5555915|NCT04051853|Midazolam|midazolam|mesh-list
5555916|NCT04051853|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5555917|NCT04051853|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5555918|NCT04051853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5555919|NCT04051853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555920|NCT04051853|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5555921|NCT04051853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5555922|NCT04051853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5555923|NCT04051853|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5555924|NCT04051853|Anesthetics, General|anesthetics, general|mesh-ancestor
5555925|NCT04051853|Anesthetics|anesthetics|mesh-ancestor
5555926|NCT04051853|GABA Modulators|gaba modulators|mesh-ancestor
5555927|NCT04051853|GABA Agents|gaba agents|mesh-ancestor
5555928|NCT04051853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5555929|NCT04051853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555930|NCT04051853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5555931|NCT04051853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5555932|NCT04051853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5555933|NCT04051827|Midazolam|midazolam|mesh-list
5555934|NCT04051827|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5555935|NCT04051827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5555936|NCT04051827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5555937|NCT04051827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555938|NCT04051827|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5555939|NCT04051827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5555940|NCT04051827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5555941|NCT04051827|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5555942|NCT04051827|Anesthetics, General|anesthetics, general|mesh-ancestor
5555943|NCT04051827|Anesthetics|anesthetics|mesh-ancestor
5555944|NCT04051827|GABA Modulators|gaba modulators|mesh-ancestor
5555945|NCT04051827|GABA Agents|gaba agents|mesh-ancestor
5555946|NCT04051827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5555947|NCT04051827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555948|NCT04051970|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
5555949|NCT04051970|Antiviral Agents|antiviral agents|mesh-ancestor
6207882|NCT02121262|Autonomic Agents|autonomic agents|mesh-ancestor
5555950|NCT04051970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5555951|NCT04051632|Insulin|insulin|mesh-list
5555952|NCT04051632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5555953|NCT04051632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555954|NCT04051580|Plasma-lyte 148|plasma-lyte 148|mesh-list
5555955|NCT04051580|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6154925|NCT01454791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6154926|NCT01454791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6154927|NCT01454791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154928|NCT01454934|Gemcitabine|gemcitabine|mesh-list
6154929|NCT01454934|Docetaxel|docetaxel|mesh-list
6154930|NCT01454934|Pemetrexed|pemetrexed|mesh-list
6154931|NCT01454934|Vinorelbine|vinorelbine|mesh-list
6154932|NCT01454934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6154933|NCT01454934|Antimetabolites|antimetabolites|mesh-ancestor
6154934|NCT01454934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154935|NCT01454934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6154936|NCT01454934|Antiviral Agents|antiviral agents|mesh-ancestor
6154937|NCT01454934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6154938|NCT01454934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6154939|NCT01454934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6154940|NCT01454934|Immunologic Factors|immunologic factors|mesh-ancestor
6154941|NCT01454934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154942|NCT01454934|Tubulin Modulators|tubulin modulators|mesh-ancestor
6154943|NCT01454934|Antimitotic Agents|antimitotic agents|mesh-ancestor
6154944|NCT01454934|Mitosis Modulators|mitosis modulators|mesh-ancestor
6154945|NCT01454934|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6154946|NCT01454934|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6154947|NCT01454934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6154948|NCT01455012|Rotigotine|rotigotine|mesh-list
6154949|NCT01455012|Dopamine Agonists|dopamine agonists|mesh-ancestor
6154950|NCT01455012|Dopamine Agents|dopamine agents|mesh-ancestor
6154951|NCT01455012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6154952|NCT01455012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154953|NCT01455012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154954|NCT01455194|Ciclesonide|ciclesonide|mesh-list
6154955|NCT01455194|Glucocorticoids|glucocorticoids|mesh-ancestor
6479261|NCT00537953|Miltefosine|miltefosine|mesh-list
6479262|NCT00537953|Meglumine Antimoniate|meglumine antimoniate|mesh-list
6479263|NCT00537953|Antifungal Agents|antifungal agents|mesh-ancestor
6479264|NCT00537953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6479265|NCT00537953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6479266|NCT00537953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6479267|NCT00537953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6479268|NCT00537966|Ritonavir|ritonavir|mesh-list
6479269|NCT00537966|Darunavir|darunavir|mesh-list
6479270|NCT00537966|Tenofovir|tenofovir|mesh-list
6479271|NCT00537966|Lamivudine|lamivudine|mesh-list
6479272|NCT00537966|Emtricitabine|emtricitabine|mesh-list
6479273|NCT00537966|Raltegravir Potassium|raltegravir potassium|mesh-list
6479274|NCT00537966|Abacavir|abacavir|mesh-list
6479275|NCT00537966|Dolutegravir|dolutegravir|mesh-list
6479276|NCT00537966|Cobicistat|cobicistat|mesh-list
6479277|NCT00537966|Rilpivirine|rilpivirine|mesh-list
6154956|NCT01455194|Hormones|hormones|mesh-ancestor
6154957|NCT01455194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6154958|NCT01455194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154959|NCT01455194|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6154960|NCT01455220|Natalizumab|natalizumab|mesh-list
6154961|NCT01455220|Immunologic Factors|immunologic factors|mesh-ancestor
6479278|NCT00537966|Elvitegravir|elvitegravir|mesh-list
6154962|NCT01455220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154963|NCT01455415|Pregabalin|pregabalin|mesh-list
6154964|NCT01455415|Analgesics|analgesics|mesh-ancestor
6479279|NCT00537966|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6479280|NCT00537966|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6479281|NCT00537966|Protease Inhibitors|protease inhibitors|mesh-ancestor
6479282|NCT00537966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5555956|NCT04051580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5555957|NCT04051567|Aspirin|aspirin|mesh-list
5555958|NCT04051567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5555959|NCT04051567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5555960|NCT04051567|Analgesics|analgesics|mesh-ancestor
5555961|NCT04051567|Sensory System Agents|sensory system agents|mesh-ancestor
5555962|NCT04051567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5555963|NCT04051567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555964|NCT04051567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5555965|NCT04051567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5555966|NCT04051567|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5555967|NCT04051567|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5555968|NCT04051567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5555969|NCT04051567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6154965|NCT01455415|Sensory System Agents|sensory system agents|mesh-ancestor
6154966|NCT01455415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5555970|NCT04051567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5555971|NCT04051567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5555972|NCT04051567|Antipyretics|antipyretics|mesh-ancestor
5555973|NCT04051203|Methylprednisolone|methylprednisolone|mesh-list
5555974|NCT04051203|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5555975|NCT04051203|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6154967|NCT01455415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154968|NCT01455415|Anticonvulsants|anticonvulsants|mesh-ancestor
6154969|NCT01455415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6154970|NCT01455415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6154971|NCT01455415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154972|NCT01455415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6154973|NCT01455415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6154974|NCT01455415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6154975|NCT01455415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6154976|NCT01455415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6154977|NCT01455428|Pregabalin|pregabalin|mesh-list
5555976|NCT04051203|Prednisolone|prednisolone|mesh-list
5555977|NCT04051203|Prednisolone acetate|prednisolone acetate|mesh-list
5555978|NCT04051203|Lidocaine|lidocaine|mesh-list
5555979|NCT04051203|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5555980|NCT04051203|Prednisolone phosphate|prednisolone phosphate|mesh-list
5555981|NCT04051203|Anesthetics, Local|anesthetics, local|mesh-ancestor
5555982|NCT04051203|Anesthetics|anesthetics|mesh-ancestor
6154978|NCT01455428|Analgesics|analgesics|mesh-ancestor
6154979|NCT01455428|Sensory System Agents|sensory system agents|mesh-ancestor
6154980|NCT01455428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6154981|NCT01455428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154982|NCT01455428|Anticonvulsants|anticonvulsants|mesh-ancestor
6154983|NCT01455428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6154984|NCT01455428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6154985|NCT01455428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6154986|NCT01455428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6154987|NCT01455428|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6154988|NCT01455428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6154989|NCT01455428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5555983|NCT04051203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6154990|NCT01455428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6154991|NCT01455519|Hydromorphone|hydromorphone|mesh-list
6154992|NCT01455519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6154993|NCT01455519|Narcotics|narcotics|mesh-ancestor
6154994|NCT01455519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6154995|NCT01455519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6154996|NCT01455519|Analgesics|analgesics|mesh-ancestor
6154997|NCT01455519|Sensory System Agents|sensory system agents|mesh-ancestor
6154998|NCT01455519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6154999|NCT01456039|Romidepsin|romidepsin|mesh-list
6155000|NCT01456039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6155001|NCT01456039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6155002|NCT01456130|Alogliptin|alogliptin|mesh-list
6155003|NCT01456130|Insulin, Short-Acting|insulin, short-acting|mesh-list
6155004|NCT01456130|Secretagogues|secretagogues|mesh-list
6155005|NCT01456130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6155006|NCT01456130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155007|NCT01456130|Incretins|incretins|mesh-ancestor
6155008|NCT01456130|Hormones|hormones|mesh-ancestor
6155009|NCT01456130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6155010|NCT01456130|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6155011|NCT01456130|Protease Inhibitors|protease inhibitors|mesh-ancestor
6155012|NCT01456130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5555984|NCT04051203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5555985|NCT04051203|Sensory System Agents|sensory system agents|mesh-ancestor
5555986|NCT04051203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5555987|NCT04051203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5555988|NCT04051203|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5555989|NCT04051203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6155013|NCT01456130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155014|NCT01456143|Proflavine|proflavine|mesh-list
6155015|NCT01456143|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6155016|NCT01456143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6155017|NCT01456169|Chlorthalidone|chlorthalidone|mesh-list
6155018|NCT01456169|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
6155019|NCT01456169|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6479283|NCT00537966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479284|NCT00537966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6479285|NCT00537966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6479286|NCT00537966|Antiviral Agents|antiviral agents|mesh-ancestor
6479287|NCT00537966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6479288|NCT00537966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6479289|NCT00537966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6479290|NCT00537966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5555990|NCT04051203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5555991|NCT04051203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479291|NCT00537966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6479292|NCT00537966|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6479293|NCT00537966|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6479294|NCT00538005|Bevacizumab|bevacizumab|mesh-list
6479295|NCT00538005|Oxaliplatin|oxaliplatin|mesh-list
6479296|NCT00538005|Sorafenib|sorafenib|mesh-list
6479297|NCT00538005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6479298|NCT00538005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6479299|NCT00538005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6479300|NCT00538005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6479301|NCT00538005|Growth Substances|growth substances|mesh-ancestor
6479302|NCT00538005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479303|NCT00538005|Growth Inhibitors|growth inhibitors|mesh-ancestor
6155020|NCT01456169|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6155021|NCT01456169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155022|NCT01456169|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6155023|NCT01456169|Diuretics|diuretics|mesh-ancestor
6155024|NCT01456169|Natriuretic Agents|natriuretic agents|mesh-ancestor
6668050|NCT01530230|Oxytocics|oxytocics|mesh-ancestor
6668051|NCT01530230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6668052|NCT01530230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668053|NCT01530295|Docetaxel|docetaxel|mesh-list
5555992|NCT04051203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6155025|NCT01456169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155026|NCT01456169|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6155027|NCT01456169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6155028|NCT01456299|Remifentanil|remifentanil|mesh-list
6155029|NCT01456299|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6479304|NCT00538005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5555993|NCT04051203|Antiemetics|antiemetics|mesh-ancestor
5555994|NCT04051203|Autonomic Agents|autonomic agents|mesh-ancestor
5555995|NCT04051203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5555996|NCT04051203|Glucocorticoids|glucocorticoids|mesh-ancestor
5555997|NCT04051203|Hormones|hormones|mesh-ancestor
5555998|NCT04051203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5555999|NCT04051203|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6668054|NCT01530295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5556000|NCT04051203|Protective Agents|protective agents|mesh-ancestor
6479305|NCT00538005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5556001|NCT04051203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5556002|NCT04051203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5556003|NCT04051255|Metronidazole|metronidazole|mesh-list
5556004|NCT04051255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5556005|NCT04051255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5556006|NCT04051255|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5556007|NCT04051255|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5556008|NCT04051320|Leuprolide|leuprolide|mesh-list
5556009|NCT04051320|Estradiol|estradiol|mesh-list
5556010|NCT04051320|Progesterone|progesterone|mesh-list
5556011|NCT04051320|Estrogens|estrogens|mesh-ancestor
5556012|NCT04051320|Hormones|hormones|mesh-ancestor
5556013|NCT04051320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5556014|NCT04051320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556015|NCT04051320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5556016|NCT04051320|Progestins|progestins|mesh-ancestor
5556017|NCT04051320|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5556018|NCT04051320|Fertility Agents|fertility agents|mesh-ancestor
5556019|NCT04051320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5556020|NCT04051320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5556021|NCT04051047|Gemcitabine|gemcitabine|mesh-list
5556022|NCT04051047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5556023|NCT04051047|Antimetabolites|antimetabolites|mesh-ancestor
5556024|NCT04051047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556025|NCT04051047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5556026|NCT04051047|Antiviral Agents|antiviral agents|mesh-ancestor
5556027|NCT04051047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5556028|NCT04051047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6155030|NCT01456299|Narcotics|narcotics|mesh-ancestor
5556029|NCT04051047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6155031|NCT01456299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6155032|NCT01456299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155033|NCT01456299|Analgesics|analgesics|mesh-ancestor
6155034|NCT01456299|Sensory System Agents|sensory system agents|mesh-ancestor
6155035|NCT01456299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6155036|NCT01456780|Loteprednol Etabonate|loteprednol etabonate|mesh-list
6155037|NCT01456780|Tobramycin|tobramycin|mesh-list
6155038|NCT01456780|Lubricant Eye Drops|lubricant eye drops|mesh-list
6155039|NCT01456780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6155040|NCT01456780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6155041|NCT01456780|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6155042|NCT01456780|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6155043|NCT01456780|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6155044|NCT01456936|Bupropion|bupropion|mesh-list
6155045|NCT01456936|Nicotine|nicotine|mesh-list
6155046|NCT01456936|Varenicline|varenicline|mesh-list
6155047|NCT01456936|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6155048|NCT01456936|Autonomic Agents|autonomic agents|mesh-ancestor
6155049|NCT01456936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6155050|NCT01456936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155051|NCT01456936|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6155052|NCT01456936|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6155053|NCT01456936|Cholinergic Agents|cholinergic agents|mesh-ancestor
6155054|NCT01456936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6155055|NCT01456936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155056|NCT01456936|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6155057|NCT01456936|Antidepressive Agents|antidepressive agents|mesh-ancestor
6155058|NCT01456936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6155059|NCT01456936|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6155060|NCT01456936|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6155061|NCT01456936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6155062|NCT01456936|Dopamine Agents|dopamine agents|mesh-ancestor
6155063|NCT01456936|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6155064|NCT01456936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6155065|NCT01456936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6155066|NCT01457118|Etirinotecan pegol|etirinotecan pegol|mesh-list
6155067|NCT01457118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6155068|NCT01457118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6155069|NCT01457118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6155070|NCT01457118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6155071|NCT01457118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155072|NCT01457339|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6155073|NCT01457339|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6155074|NCT01457339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155075|NCT01457339|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6155076|NCT01457339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6155077|NCT01457339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6155078|NCT01457339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155079|NCT01457339|Dopamine Agents|dopamine agents|mesh-ancestor
6155080|NCT01457339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6479306|NCT00538005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479307|NCT00538018|Telithromycin|telithromycin|mesh-list
6479308|NCT00538018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6479309|NCT00538018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6479310|NCT00538031|Celecoxib|celecoxib|mesh-list
6479311|NCT00538031|Cyclophosphamide|cyclophosphamide|mesh-list
5556030|NCT04051047|Immunologic Factors|immunologic factors|mesh-ancestor
5556031|NCT04051047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556032|NCT04051099|Dexmedetomidine|dexmedetomidine|mesh-list
5556033|NCT04051099|Bupivacaine|bupivacaine|mesh-list
5556034|NCT04051099|Propofol|propofol|mesh-list
5556035|NCT04051099|Anesthetics, Local|anesthetics, local|mesh-ancestor
5556036|NCT04051099|Anesthetics|anesthetics|mesh-ancestor
5556037|NCT04051099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5556038|NCT04051099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556039|NCT04051099|Sensory System Agents|sensory system agents|mesh-ancestor
5556040|NCT04051099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6155081|NCT01457430|Icatibant|icatibant|mesh-list
6155082|NCT01457430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6155083|NCT01457430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6155084|NCT01457430|Analgesics|analgesics|mesh-ancestor
6155085|NCT01457430|Sensory System Agents|sensory system agents|mesh-ancestor
6155086|NCT01457430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5556041|NCT04051099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5556042|NCT04051099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5556043|NCT04051099|Anesthetics, General|anesthetics, general|mesh-ancestor
5556044|NCT04051099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5556045|NCT04051099|Analgesics|analgesics|mesh-ancestor
5556046|NCT04051099|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5556047|NCT04051099|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5556048|NCT04051099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5556049|NCT04051099|Adrenergic Agents|adrenergic agents|mesh-ancestor
6155087|NCT01457430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155088|NCT01457430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6155089|NCT01457430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6155090|NCT01457430|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
6155091|NCT01457430|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
6155092|NCT01457430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155093|NCT01457430|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6155094|NCT01457430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6155095|NCT01457430|Immunologic Factors|immunologic factors|mesh-ancestor
6155096|NCT01457521|Ibuprofen|ibuprofen|mesh-list
6155097|NCT01457521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6155098|NCT01457521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6155099|NCT01457521|Analgesics|analgesics|mesh-ancestor
6155100|NCT01457521|Sensory System Agents|sensory system agents|mesh-ancestor
6155101|NCT01457521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6155102|NCT01457521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155103|NCT01457521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5556050|NCT04051099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5556051|NCT04051099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155104|NCT01457521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6155105|NCT01457521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6155106|NCT01457521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6155107|NCT01457521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155108|NCT01457573|Tamsulosin|tamsulosin|mesh-list
6155109|NCT01457573|Solifenacin Succinate|solifenacin succinate|mesh-list
6155110|NCT01457573|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6155111|NCT01457573|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6155112|NCT01457573|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6155113|NCT01457573|Adrenergic Agents|adrenergic agents|mesh-ancestor
6155114|NCT01457573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6155115|NCT01457573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155116|NCT01457573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155117|NCT01457573|Urological Agents|urological agents|mesh-ancestor
5556052|NCT04050592|Estradiol|estradiol|mesh-list
5556053|NCT04050592|Estrogens|estrogens|mesh-ancestor
5556054|NCT04050592|Hormones|hormones|mesh-ancestor
5556055|NCT04050592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5556056|NCT04050592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603191|NCT03094052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5603192|NCT03094052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479312|NCT00538031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5603193|NCT03094052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5603194|NCT03094052|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5603195|NCT03094052|Narcotics|narcotics|mesh-ancestor
5603196|NCT03094052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5603197|NCT03094052|Analgesics|analgesics|mesh-ancestor
5603198|NCT03094052|Sensory System Agents|sensory system agents|mesh-ancestor
5603199|NCT03074240|Anesthetics|anesthetics|mesh-list
5603200|NCT03074240|Anesthetics, General|anesthetics, general|mesh-list
5603201|NCT03074240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5603202|NCT03074240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603203|NCT03060473|Amoxicillin|amoxicillin|mesh-list
5603204|NCT03060473|Azithromycin|azithromycin|mesh-list
5603205|NCT03060473|Erythromycin|erythromycin|mesh-list
6479313|NCT00538031|Immunologic Factors|immunologic factors|mesh-ancestor
6479314|NCT00538031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479315|NCT00538031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6479316|NCT00538031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6479317|NCT00538031|Alkylating Agents|alkylating agents|mesh-ancestor
6479318|NCT00538031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479319|NCT00538031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6155118|NCT01457573|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6155119|NCT01457573|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6155120|NCT01457573|Cholinergic Agents|cholinergic agents|mesh-ancestor
6155121|NCT01457703|Letrozole|letrozole|mesh-list
6155122|NCT01457703|Cetrorelix|cetrorelix|mesh-list
6155123|NCT01457703|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
6155124|NCT01457703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6155125|NCT01457703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6155126|NCT01457703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6155127|NCT01457703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6479320|NCT00538031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6479321|NCT00538031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6479322|NCT00538031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6479323|NCT00538031|Analgesics|analgesics|mesh-ancestor
6479324|NCT00538031|Sensory System Agents|sensory system agents|mesh-ancestor
6479325|NCT00538031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6479326|NCT00538031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6479327|NCT00538031|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6479328|NCT00538031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6479329|NCT00538031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6479330|NCT00538044|Simvastatin|simvastatin|mesh-list
6479331|NCT00538044|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6479332|NCT00538044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5603206|NCT03060473|Erythromycin Estolate|erythromycin estolate|mesh-list
5603207|NCT03060473|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
5603208|NCT03060473|Erythromycin stearate|erythromycin stearate|mesh-list
5603209|NCT03060473|Ampicillin|ampicillin|mesh-list
5603210|NCT03060473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5603211|NCT03060473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5603212|NCT03060473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5603213|NCT03060473|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5603214|NCT03060473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5603215|NCT03060473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603216|NCT03051217|Certolizumab Pegol|certolizumab pegol|mesh-list
5603217|NCT03051217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5603218|NCT03051217|Immunologic Factors|immunologic factors|mesh-ancestor
5603219|NCT03051217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603220|NCT03051217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6155128|NCT01457703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155129|NCT01457703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6155130|NCT01457703|Hormone Antagonists|hormone antagonists|mesh-ancestor
6155131|NCT01457703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6155132|NCT01457703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155133|NCT01457703|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6479333|NCT00538044|Antimetabolites|antimetabolites|mesh-ancestor
6479334|NCT00538044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479335|NCT00538044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6479336|NCT00538044|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6479337|NCT00538044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6479338|NCT00538070|Glycine|glycine|mesh-list
6479339|NCT00538070|Glycine Agents|glycine agents|mesh-ancestor
6479340|NCT00538070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6479341|NCT00538070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479342|NCT00538070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479343|NCT00538096|Blinatumomab|blinatumomab|mesh-list
6479344|NCT00538096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6479345|NCT00538109|Imatinib Mesylate|imatinib mesylate|mesh-list
6479346|NCT00538109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6155134|NCT01457703|Fertility Agents|fertility agents|mesh-ancestor
6155135|NCT01457703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6155136|NCT01457703|Hormones|hormones|mesh-ancestor
6155137|NCT01457846|Paclitaxel|paclitaxel|mesh-list
6155138|NCT01457846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6479347|NCT00538109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6479348|NCT00538109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6479349|NCT00538109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479350|NCT00538148|Telithromycin|telithromycin|mesh-list
6479351|NCT00538148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6479352|NCT00538148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6479353|NCT00538174|Dapagliflozin|dapagliflozin|mesh-list
6479354|NCT00538174|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6479355|NCT00538174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479356|NCT00538174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6479357|NCT00538174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479358|NCT00538187|Bortezomib|bortezomib|mesh-list
6479359|NCT00538187|Obatoclax|obatoclax|mesh-list
6479360|NCT00538187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6479361|NCT00538187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6668055|NCT01530295|Tubulin Modulators|tubulin modulators|mesh-ancestor
6668056|NCT01530295|Antimitotic Agents|antimitotic agents|mesh-ancestor
6668057|NCT01530295|Mitosis Modulators|mitosis modulators|mesh-ancestor
6668058|NCT01530295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668059|NCT01530308|Dopamine|dopamine|mesh-list
6668060|NCT01530308|Haloperidol|haloperidol|mesh-list
6668061|NCT01530308|Haloperidol decanoate|haloperidol decanoate|mesh-list
6668062|NCT01530308|Antipsychotic Agents|antipsychotic agents|mesh-list
6668063|NCT01530308|Dopamine Antagonists|dopamine antagonists|mesh-list
6668064|NCT01530308|Antiemetics|antiemetics|mesh-ancestor
6668065|NCT01530308|Autonomic Agents|autonomic agents|mesh-ancestor
6668066|NCT01530308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6668067|NCT01530308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155139|NCT01457846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6155140|NCT01457846|Tubulin Modulators|tubulin modulators|mesh-ancestor
6479362|NCT00538187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479363|NCT00538239|Sirolimus|sirolimus|mesh-list
6479364|NCT00538239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6479365|NCT00538239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6479366|NCT00538239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6479367|NCT00538239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6155141|NCT01457846|Antimitotic Agents|antimitotic agents|mesh-ancestor
6155142|NCT01457846|Mitosis Modulators|mitosis modulators|mesh-ancestor
6155143|NCT01457846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155144|NCT01457885|Busulfan|busulfan|mesh-list
6155145|NCT01457885|Clofarabine|clofarabine|mesh-list
6155146|NCT01457885|Alkylating Agents|alkylating agents|mesh-ancestor
6155147|NCT01457885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155148|NCT01457885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6155149|NCT01457885|Immunologic Factors|immunologic factors|mesh-ancestor
6155150|NCT01457885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155151|NCT01457885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6155152|NCT01457885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6155153|NCT01457885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6155154|NCT01457885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6155155|NCT01457885|Antimetabolites|antimetabolites|mesh-ancestor
6155156|NCT01457924|Ofatumumab|ofatumumab|mesh-list
6155157|NCT01457924|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6155158|NCT01457924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6155159|NCT01457924|Immunologic Factors|immunologic factors|mesh-ancestor
6155160|NCT01457924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479368|NCT00538239|Antifungal Agents|antifungal agents|mesh-ancestor
6668068|NCT01530308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6668069|NCT01530308|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5556057|NCT04050670|Tirzepatide|tirzepatide|mesh-list
5556058|NCT04050670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5556059|NCT04050670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556060|NCT04050670|Incretins|incretins|mesh-ancestor
5556061|NCT04050670|Hormones|hormones|mesh-ancestor
5556062|NCT04050670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5556063|NCT04050826|Lidocaine|lidocaine|mesh-list
5556064|NCT04050826|Prilocaine|prilocaine|mesh-list
6479369|NCT00538239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6479370|NCT00538239|Immunologic Factors|immunologic factors|mesh-ancestor
6479371|NCT00538239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479372|NCT00538265|Mycophenolic Acid|mycophenolic acid|mesh-list
6479373|NCT00538265|Tacrolimus|tacrolimus|mesh-list
6479374|NCT00538265|Thymoglobulin|thymoglobulin|mesh-list
6479375|NCT00538265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6479376|NCT00538265|Immunologic Factors|immunologic factors|mesh-ancestor
6479377|NCT00538265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479378|NCT00538265|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6479379|NCT00538265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6479380|NCT00538265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479381|NCT00538265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6479382|NCT00538265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6479383|NCT00538265|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6479384|NCT00538265|Antitubercular Agents|antitubercular agents|mesh-ancestor
6479385|NCT00538265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6479386|NCT00538265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5556065|NCT04050826|Anesthetics, Local|anesthetics, local|mesh-ancestor
6155161|NCT01457950|Denosumab|denosumab|mesh-list
6155162|NCT01457950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6155163|NCT01457950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155164|NCT01458106|Factor VIII|factor viii|mesh-list
6155165|NCT01458106|Coagulants|coagulants|mesh-ancestor
6205881|NCT02093351|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6205882|NCT02093351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6205883|NCT02093351|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6205884|NCT02093390|Fluconazole|fluconazole|mesh-list
6205885|NCT02093390|Atorvastatin|atorvastatin|mesh-list
6205886|NCT02093390|Relugolix|relugolix|mesh-list
6205887|NCT02093390|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6205888|NCT02093390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6205889|NCT02093390|Antimetabolites|antimetabolites|mesh-ancestor
6205890|NCT02093390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205891|NCT02093390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5556066|NCT04050826|Anesthetics|anesthetics|mesh-ancestor
5556067|NCT04050826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5556068|NCT04050826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556069|NCT04050826|Sensory System Agents|sensory system agents|mesh-ancestor
5556070|NCT04050826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6205892|NCT02093390|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6205893|NCT02093390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6205894|NCT02093390|Antifungal Agents|antifungal agents|mesh-ancestor
5556071|NCT04050826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5556072|NCT04050826|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5556073|NCT04050826|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6205895|NCT02093390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6205896|NCT02093390|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6205897|NCT02093390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6205898|NCT02093390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6205899|NCT02093390|Hormone Antagonists|hormone antagonists|mesh-ancestor
6205900|NCT02093390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6205901|NCT02093390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205902|NCT02093390|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6205903|NCT02093390|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6205904|NCT02093390|Androgen Antagonists|androgen antagonists|mesh-ancestor
6205905|NCT02093663|Mesalamine|mesalamine|mesh-list
6205906|NCT02093663|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5556074|NCT04050826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5603221|NCT03008382|Metoprolol|metoprolol|mesh-list
6205907|NCT02093663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6205908|NCT02093663|Analgesics|analgesics|mesh-ancestor
6205909|NCT02093663|Sensory System Agents|sensory system agents|mesh-ancestor
6205910|NCT02093663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6205911|NCT02093663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479387|NCT00538317|Tirofiban|tirofiban|mesh-list
6155166|NCT01458171|Immunoglobulins|immunoglobulins|mesh-list
6155167|NCT01458171|Antibodies|antibodies|mesh-list
6155168|NCT01458171|gamma-Globulins|gamma-globulins|mesh-list
6155169|NCT01458171|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6155170|NCT01458171|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6155171|NCT01458171|Immunologic Factors|immunologic factors|mesh-ancestor
6155172|NCT01458171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155173|NCT01458210|Dulaglutide|dulaglutide|mesh-list
6155174|NCT01458210|Moxifloxacin|moxifloxacin|mesh-list
6155175|NCT01458210|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6155176|NCT01458210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6155177|NCT01458210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155178|NCT01458210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6155179|NCT01458210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6155180|NCT01458210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6155181|NCT01458210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6155182|NCT01458210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6155183|NCT01458210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155184|NCT01458210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6155185|NCT01458210|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6155186|NCT01458210|Contraceptive Agents|contraceptive agents|mesh-ancestor
6155187|NCT01458210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6155188|NCT01458210|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6155189|NCT01458210|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6155190|NCT01458210|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6155191|NCT01458275|Ciclesonide|ciclesonide|mesh-list
6155192|NCT01458275|Glucocorticoids|glucocorticoids|mesh-ancestor
6155193|NCT01458275|Hormones|hormones|mesh-ancestor
6155194|NCT01458275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6155195|NCT01458275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155196|NCT01458275|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6155197|NCT01458366|Carboplatin|carboplatin|mesh-list
6155198|NCT01458366|Etoposide|etoposide|mesh-list
6155199|NCT01458366|Etoposide phosphate|etoposide phosphate|mesh-list
6155200|NCT01458366|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5556075|NCT04050826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556076|NCT04050488|Zinc Sulfate|zinc sulfate|mesh-list
5556077|NCT04050488|Astringents|astringents|mesh-ancestor
5556078|NCT04050488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155201|NCT01458366|Ofatumumab|ofatumumab|mesh-list
6155202|NCT01458366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6155203|NCT01458366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6155204|NCT01458366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6479388|NCT00538317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6479389|NCT00538317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6479390|NCT00538317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479391|NCT00538317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6479392|NCT00538330|Tamoxifen|tamoxifen|mesh-list
6155205|NCT01458366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6155206|NCT01458366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6155207|NCT01458366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155208|NCT01458366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6155209|NCT01458366|Alkylating Agents|alkylating agents|mesh-ancestor
6155210|NCT01458418|Montelukast|montelukast|mesh-list
6155211|NCT01458418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6155212|NCT01458418|Respiratory System Agents|respiratory system agents|mesh-ancestor
6155213|NCT01458418|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6155214|NCT01458418|Hormone Antagonists|hormone antagonists|mesh-ancestor
6155215|NCT01458418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6155216|NCT01458418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155217|NCT01458418|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6155218|NCT01458418|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6205912|NCT02093663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6479393|NCT00538330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6479394|NCT00538330|Hormone Antagonists|hormone antagonists|mesh-ancestor
6479395|NCT00538330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6479396|NCT00538330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479397|NCT00538330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6479398|NCT00538330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6479399|NCT00538330|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6479400|NCT00538330|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6479401|NCT00538330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6668070|NCT01530308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6155219|NCT01458418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556079|NCT04050488|Dermatologic Agents|dermatologic agents|mesh-ancestor
6155220|NCT01458522|Lacosamide|lacosamide|mesh-list
6155221|NCT01458522|Fosphenytoin|fosphenytoin|mesh-list
6155222|NCT01458522|Anticonvulsants|anticonvulsants|mesh-ancestor
6155223|NCT01458522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6155224|NCT01458522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6155225|NCT01458522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5556086|NCT04050761|Nivolumab|nivolumab|mesh-list
5556087|NCT04050761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6155226|NCT01458522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155227|NCT01458535|Ritonavir|ritonavir|mesh-list
6155228|NCT01458535|Ribavirin|ribavirin|mesh-list
6155229|NCT01458535|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6155230|NCT01458535|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6155231|NCT01458535|Protease Inhibitors|protease inhibitors|mesh-ancestor
6155232|NCT01458535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6155233|NCT01458535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155234|NCT01458535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6155235|NCT01458535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6155236|NCT01458535|Antiviral Agents|antiviral agents|mesh-ancestor
6668071|NCT01530308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6668072|NCT01530308|Dopamine Agents|dopamine agents|mesh-ancestor
6668073|NCT01530308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6668074|NCT01530308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668075|NCT01530308|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6668076|NCT01530308|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6668077|NCT01530308|Sympathomimetics|sympathomimetics|mesh-ancestor
6668078|NCT01530308|Protective Agents|protective agents|mesh-ancestor
6668079|NCT01530373|Clonidine|clonidine|mesh-list
6668080|NCT01530373|Solifenacin Succinate|solifenacin succinate|mesh-list
6668081|NCT01530373|Analgesics|analgesics|mesh-ancestor
6155237|NCT01458535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6155238|NCT01458535|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6155239|NCT01458535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6155240|NCT01458535|Antimetabolites|antimetabolites|mesh-ancestor
6155241|NCT01458561|Thrombin|thrombin|mesh-list
6155242|NCT01458561|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
6155243|NCT01458561|Hemostatics|hemostatics|mesh-ancestor
6155244|NCT01458561|Coagulants|coagulants|mesh-ancestor
6479402|NCT00538382|Artesunate|artesunate|mesh-list
6479403|NCT00538382|Antimalarials|antimalarials|mesh-ancestor
6479404|NCT00538382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6479405|NCT00538382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6479406|NCT00538382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6479407|NCT00538382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6479408|NCT00538382|Antiviral Agents|antiviral agents|mesh-ancestor
6479409|NCT00538382|Schistosomicides|schistosomicides|mesh-ancestor
6479410|NCT00538382|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6479411|NCT00538382|Anthelmintics|anthelmintics|mesh-ancestor
6479412|NCT00538395|Cyclophosphamide|cyclophosphamide|mesh-list
6479413|NCT00538395|Doxorubicin|doxorubicin|mesh-list
6479414|NCT00538395|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6479415|NCT00538395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5556088|NCT04050761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5556089|NCT04050761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5556090|NCT04050761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556091|NCT04050735|Ethanol|ethanol|mesh-list
5556092|NCT04050735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5556093|NCT04050735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5556094|NCT04050735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5556095|NCT04050735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556096|NCT04050280|Cytarabine|cytarabine|mesh-list
5556097|NCT04050280|Cladribine|cladribine|mesh-list
5556098|NCT04050280|Gemtuzumab|gemtuzumab|mesh-list
5556099|NCT04050280|Sargramostim|sargramostim|mesh-list
5556100|NCT04050280|Lenograstim|lenograstim|mesh-list
5556101|NCT04050280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5556102|NCT04050280|Antimetabolites|antimetabolites|mesh-ancestor
6479416|NCT00538395|Immunologic Factors|immunologic factors|mesh-ancestor
6668082|NCT01530373|Sensory System Agents|sensory system agents|mesh-ancestor
5556103|NCT04050280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155245|NCT01458574|Tofacitinib|tofacitinib|mesh-list
5556104|NCT04050280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6479417|NCT00538395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479418|NCT00538395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6668083|NCT01530373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5556105|NCT04050280|Antiviral Agents|antiviral agents|mesh-ancestor
5556106|NCT04050280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6155246|NCT01458574|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6155247|NCT01458574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6155248|NCT01458574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556107|NCT04050280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5556108|NCT04050280|Immunologic Factors|immunologic factors|mesh-ancestor
5556109|NCT04050280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556110|NCT04050280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5556111|NCT04050280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5556112|NCT04050215|Edetic Acid|edetic acid|mesh-list
5556113|NCT04050215|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5556114|NCT04050215|Chelating Agents|chelating agents|mesh-ancestor
5556115|NCT04050215|Sequestering Agents|sequestering agents|mesh-ancestor
5556116|NCT04050215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556117|NCT04050215|Anticoagulants|anticoagulants|mesh-ancestor
5556118|NCT04050215|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5556119|NCT04050215|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5556120|NCT04050267|Nitrous Oxide|nitrous oxide|mesh-list
5556121|NCT04050267|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5556122|NCT04050267|Anesthetics, General|anesthetics, general|mesh-ancestor
5556123|NCT04050267|Anesthetics|anesthetics|mesh-ancestor
5556124|NCT04050267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5556125|NCT04050267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556126|NCT04050267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5556127|NCT04050267|Analgesics|analgesics|mesh-ancestor
5556128|NCT04050267|Sensory System Agents|sensory system agents|mesh-ancestor
5556129|NCT04050267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5556130|NCT04050176|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
5556131|NCT04050176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5556132|NCT04050176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556133|NCT04049864|Lenalidomide|lenalidomide|mesh-list
5556134|NCT04049864|Vaccines|vaccines|mesh-list
5556135|NCT04049864|Immunologic Factors|immunologic factors|mesh-ancestor
5556136|NCT04049864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556137|NCT04049864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5556138|NCT04049864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5556139|NCT04049864|Growth Substances|growth substances|mesh-ancestor
5556140|NCT04049864|Growth Inhibitors|growth inhibitors|mesh-ancestor
5556141|NCT04049864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5556142|NCT04050059|Lidocaine|lidocaine|mesh-list
5556143|NCT04050059|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
5556144|NCT04050059|Anesthetics, Local|anesthetics, local|mesh-ancestor
5556145|NCT04050059|Anesthetics|anesthetics|mesh-ancestor
5556146|NCT04050059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5556147|NCT04050059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556148|NCT04050059|Sensory System Agents|sensory system agents|mesh-ancestor
5556149|NCT04050059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6155249|NCT01458587|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6155250|NCT01458587|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6155251|NCT01458587|Dermatologic Agents|dermatologic agents|mesh-ancestor
6155252|NCT01458639|Xenon|xenon|mesh-list
6155253|NCT01458639|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6155254|NCT01458639|Anesthetics, General|anesthetics, general|mesh-ancestor
6155255|NCT01458639|Anesthetics|anesthetics|mesh-ancestor
6155256|NCT01458639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6155257|NCT01458639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155258|NCT01458951|Tofacitinib|tofacitinib|mesh-list
6155259|NCT01458951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6155260|NCT01458951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6155261|NCT01458951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155262|NCT01458990|Omeprazole|omeprazole|mesh-list
6155263|NCT01458990|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6155264|NCT01458990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6155265|NCT01458990|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6155266|NCT01458990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6155267|NCT01458990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155268|NCT01459588|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6155269|NCT01459588|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6155270|NCT01459588|Lubricant Eye Drops|lubricant eye drops|mesh-list
6155271|NCT01459588|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6155272|NCT01459588|Laxatives|laxatives|mesh-ancestor
6155273|NCT01459588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6155274|NCT01459614|Gemcitabine|gemcitabine|mesh-list
5556150|NCT04050059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6155275|NCT01459614|Docetaxel|docetaxel|mesh-list
6155276|NCT01459614|Capecitabine|capecitabine|mesh-list
6155277|NCT01459614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6155278|NCT01459614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6155279|NCT01459614|Antimetabolites|antimetabolites|mesh-ancestor
6155280|NCT01459614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155281|NCT01459614|Antiviral Agents|antiviral agents|mesh-ancestor
6155282|NCT01459614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6155283|NCT01459614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6155284|NCT01459614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6155285|NCT01459614|Immunologic Factors|immunologic factors|mesh-ancestor
6155286|NCT01459614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155287|NCT01459614|Tubulin Modulators|tubulin modulators|mesh-ancestor
6155288|NCT01459614|Antimitotic Agents|antimitotic agents|mesh-ancestor
6155289|NCT01459614|Mitosis Modulators|mitosis modulators|mesh-ancestor
6155290|NCT01459718|Deferasirox|deferasirox|mesh-list
6155291|NCT01459718|Deferoxamine|deferoxamine|mesh-list
6155292|NCT01459718|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6155293|NCT01459718|Chelating Agents|chelating agents|mesh-ancestor
6155294|NCT01459718|Sequestering Agents|sequestering agents|mesh-ancestor
6155295|NCT01459718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155296|NCT01459718|Siderophores|siderophores|mesh-ancestor
6155297|NCT01459796|Rilonacept|rilonacept|mesh-list
6479419|NCT00538395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6479420|NCT00538395|Alkylating Agents|alkylating agents|mesh-ancestor
6479421|NCT00538395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479422|NCT00538395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6479423|NCT00538395|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6479424|NCT00538395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6479425|NCT00538395|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6479426|NCT00538395|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6668084|NCT01530373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668085|NCT01530373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6668086|NCT01530373|Sympatholytics|sympatholytics|mesh-ancestor
6668087|NCT01530373|Autonomic Agents|autonomic agents|mesh-ancestor
6668088|NCT01530373|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6668089|NCT01530373|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6668090|NCT01530373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6668091|NCT01530373|Adrenergic Agents|adrenergic agents|mesh-ancestor
6155298|NCT01459796|Allopurinol|allopurinol|mesh-list
6155299|NCT01459796|Antimetabolites|antimetabolites|mesh-ancestor
6155300|NCT01459796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155301|NCT01459796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6155302|NCT01459796|Gout Suppressants|gout suppressants|mesh-ancestor
6155303|NCT01459796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6155304|NCT01459796|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6155305|NCT01459796|Antioxidants|antioxidants|mesh-ancestor
6155306|NCT01459796|Protective Agents|protective agents|mesh-ancestor
6155307|NCT01459796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155308|NCT01459796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6155309|NCT01459913|Interferons|interferons|mesh-list
6155310|NCT01459913|Ribavirin|ribavirin|mesh-list
6155311|NCT01459913|Interferon-alpha|interferon-alpha|mesh-list
6155312|NCT01459913|Interferon alpha-2|interferon alpha-2|mesh-list
6155313|NCT01459913|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6155314|NCT01459913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6155315|NCT01459913|Antiviral Agents|antiviral agents|mesh-ancestor
6155316|NCT01459913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6155317|NCT01459913|Antimetabolites|antimetabolites|mesh-ancestor
6155318|NCT01459913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155319|NCT01459913|Immunologic Factors|immunologic factors|mesh-ancestor
6155320|NCT01459913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155321|NCT01460225|Lubiprostone|lubiprostone|mesh-list
6155322|NCT01460225|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6155323|NCT01460225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6155324|NCT01460225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155325|NCT01460290|Asenapine|asenapine|mesh-list
6155326|NCT01460290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6155327|NCT01460290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6155328|NCT01460290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6155329|NCT01460290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155330|NCT01460290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6155331|NCT01460342|Tadalafil|tadalafil|mesh-list
5556151|NCT04050059|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5556152|NCT04050059|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6155332|NCT01460342|Vasodilator Agents|vasodilator agents|mesh-ancestor
6155333|NCT01460342|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6155334|NCT01460342|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6155335|NCT01460342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6155336|NCT01460342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155337|NCT01460342|Urological Agents|urological agents|mesh-ancestor
6155338|NCT01460368|Moxifloxacin|moxifloxacin|mesh-list
6155339|NCT01460368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6479427|NCT00538395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6479428|NCT00538421|Propofol|propofol|mesh-list
6479429|NCT00538421|Sevoflurane|sevoflurane|mesh-list
6479430|NCT00538421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6479431|NCT00538421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6155340|NCT01460368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6155341|NCT01460368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6155342|NCT01460368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6155343|NCT01460368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6155344|NCT01460368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155345|NCT01460368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6155346|NCT01460381|Quinidine|quinidine|mesh-list
6155347|NCT01460381|Quinidine gluconate|quinidine gluconate|mesh-list
6155348|NCT01460381|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6155349|NCT01460381|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5556153|NCT04050059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5556154|NCT04050059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556155|NCT04050059|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
5556156|NCT04049916|Artesunate|artesunate|mesh-list
5556157|NCT04049916|Piperaquine|piperaquine|mesh-list
5556158|NCT04049916|Primaquine|primaquine|mesh-list
5556159|NCT04049916|Artenimol|artenimol|mesh-list
5556160|NCT04049916|Pyronaridine|pyronaridine|mesh-list
5556161|NCT04049916|Antimalarials|antimalarials|mesh-ancestor
5556162|NCT04049916|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6155350|NCT01460381|Adrenergic Agents|adrenergic agents|mesh-ancestor
6155351|NCT01460381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6155352|NCT01460381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155353|NCT01460381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155354|NCT01460381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6668092|NCT01530373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6668093|NCT01530373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668094|NCT01530373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6155355|NCT01460381|Antimalarials|antimalarials|mesh-ancestor
6155356|NCT01460381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6155357|NCT01460381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6155358|NCT01460381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6155359|NCT01460381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6155360|NCT01460381|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6155361|NCT01460381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6155362|NCT01460381|Cholinergic Agents|cholinergic agents|mesh-ancestor
6155363|NCT01460381|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6155364|NCT01460381|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6155365|NCT01460381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6155366|NCT01460381|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6155367|NCT01460381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6155368|NCT01460407|Clarithromycin|clarithromycin|mesh-list
6155369|NCT01460407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6155370|NCT01460407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6155371|NCT01460407|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6155372|NCT01460407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6479432|NCT00538421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556163|NCT04049916|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5556164|NCT04049916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5556165|NCT04049916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5556166|NCT04049916|Antiviral Agents|antiviral agents|mesh-ancestor
5556167|NCT04049916|Schistosomicides|schistosomicides|mesh-ancestor
5556168|NCT04049916|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5556169|NCT04049916|Anthelmintics|anthelmintics|mesh-ancestor
5556170|NCT04050098|Metformin|metformin|mesh-list
5556171|NCT04050098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5556172|NCT04050098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155373|NCT01460407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155374|NCT01460407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6155375|NCT01460407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6155376|NCT01460628|Modafinil|modafinil|mesh-list
6155377|NCT01460628|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6155378|NCT01460628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155379|NCT01460628|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6155380|NCT01460628|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6155381|NCT01460628|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6155382|NCT01460628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155383|NCT01460719|Vaccines|vaccines|mesh-list
6155384|NCT01460719|Immunologic Factors|immunologic factors|mesh-ancestor
6155385|NCT01460719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155386|NCT01460875|Interferons|interferons|mesh-list
6155387|NCT01460875|Interferon-alpha|interferon-alpha|mesh-list
6155388|NCT01460875|Interferon alpha-2|interferon alpha-2|mesh-list
6155389|NCT01460875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6155390|NCT01460875|Antiviral Agents|antiviral agents|mesh-ancestor
6155391|NCT01460875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6155392|NCT01460875|Immunologic Factors|immunologic factors|mesh-ancestor
6155393|NCT01460875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155394|NCT01460940|Lenalidomide|lenalidomide|mesh-list
6155395|NCT01460940|Panobinostat|panobinostat|mesh-list
6155396|NCT01460940|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
6155397|NCT01460940|Immunologic Factors|immunologic factors|mesh-ancestor
6155398|NCT01460940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155399|NCT01460940|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6155400|NCT01460940|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6155401|NCT01460940|Growth Substances|growth substances|mesh-ancestor
6155402|NCT01460940|Growth Inhibitors|growth inhibitors|mesh-ancestor
6155403|NCT01460940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6155404|NCT01460940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6155405|NCT01460940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155406|NCT01461057|Capecitabine|capecitabine|mesh-list
6155407|NCT01461057|Trastuzumab|trastuzumab|mesh-list
6155408|NCT01461057|Pertuzumab|pertuzumab|mesh-list
6155409|NCT01461057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6155410|NCT01461057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6155411|NCT01461057|Antimetabolites|antimetabolites|mesh-ancestor
6155412|NCT01461057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155413|NCT01461057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6155414|NCT01461096|Vaccines|vaccines|mesh-list
6155415|NCT01461096|Immunologic Factors|immunologic factors|mesh-ancestor
6155416|NCT01461096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155417|NCT01461369|Diclofenac|diclofenac|mesh-list
6155418|NCT01461369|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6155419|NCT01461369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6155420|NCT01461369|Analgesics|analgesics|mesh-ancestor
6155421|NCT01461369|Sensory System Agents|sensory system agents|mesh-ancestor
6155422|NCT01461369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6155423|NCT01461369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155424|NCT01461369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6155425|NCT01461369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6155426|NCT01461369|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6155427|NCT01461369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6155428|NCT01461369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155429|NCT01461499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
6205913|NCT02093663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6668095|NCT01530373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6668096|NCT01530373|Cholinergic Agents|cholinergic agents|mesh-ancestor
6668097|NCT01530373|Urological Agents|urological agents|mesh-ancestor
6668098|NCT01530386|Lacosamide|lacosamide|mesh-list
6668099|NCT01530386|Anticonvulsants|anticonvulsants|mesh-ancestor
6668100|NCT01530386|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6668101|NCT01530386|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6668102|NCT01530386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5556173|NCT04049747|Bicalutamide|bicalutamide|mesh-list
5556174|NCT04049747|Finasteride|finasteride|mesh-list
5556175|NCT04049747|Androgen Antagonists|androgen antagonists|mesh-ancestor
5556176|NCT04049747|Hormone Antagonists|hormone antagonists|mesh-ancestor
5556177|NCT04049747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5556178|NCT04049747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556179|NCT04049747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5556180|NCT04049747|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
5556181|NCT04049747|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5556182|NCT04049747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5556183|NCT04049747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556184|NCT04049747|Urological Agents|urological agents|mesh-ancestor
5556185|NCT04049799|Analgesics, Opioid|analgesics, opioid|mesh-list
5556186|NCT04049799|Narcotics|narcotics|mesh-ancestor
5556187|NCT04049799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6155430|NCT01461499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155431|NCT01461538|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6155432|NCT01461538|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6155433|NCT01461538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6155434|NCT01461538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6155435|NCT01461538|Immunologic Factors|immunologic factors|mesh-ancestor
6155436|NCT01461538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155437|NCT01461551|Propofol|propofol|mesh-list
6155438|NCT01461551|Sevoflurane|sevoflurane|mesh-list
6155439|NCT01461551|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6155440|NCT01461551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6155441|NCT01461551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155442|NCT01461551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6155443|NCT01461551|Anesthetics, General|anesthetics, general|mesh-ancestor
6155444|NCT01461551|Anesthetics|anesthetics|mesh-ancestor
6155445|NCT01461551|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6155446|NCT01461551|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6155447|NCT01461668|Retapamulin|retapamulin|mesh-list
5556188|NCT04049799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556189|NCT04049799|Analgesics|analgesics|mesh-ancestor
5556190|NCT04049799|Sensory System Agents|sensory system agents|mesh-ancestor
5556191|NCT04049799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5556192|NCT04049669|Cyclophosphamide|cyclophosphamide|mesh-list
5556193|NCT04049669|Temozolomide|temozolomide|mesh-list
5556194|NCT04049669|Lomustine|lomustine|mesh-list
5556195|NCT04049669|Etoposide|etoposide|mesh-list
5556196|NCT04049669|Tryptophan|tryptophan|mesh-list
5556197|NCT04049669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5556198|NCT04049669|Immunologic Factors|immunologic factors|mesh-ancestor
5556199|NCT04049669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556200|NCT04049669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5556201|NCT04049669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5556202|NCT04049669|Alkylating Agents|alkylating agents|mesh-ancestor
5556203|NCT04049669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556204|NCT04049669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5556205|NCT04049669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5556206|NCT04049669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5556207|NCT04049669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5556208|NCT04049669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5556209|NCT04049669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5556210|NCT04049669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5556211|NCT04049669|Antidepressive Agents|antidepressive agents|mesh-ancestor
5556212|NCT04049669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5556213|NCT04049409|Trastuzumab|trastuzumab|mesh-list
6155448|NCT01461668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6155449|NCT01461668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6155450|NCT01461733|Amiodarone|amiodarone|mesh-list
6155451|NCT01461733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6155452|NCT01461733|Vasodilator Agents|vasodilator agents|mesh-ancestor
6155453|NCT01461733|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6155454|NCT01461733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6155455|NCT01461733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155456|NCT01461733|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6155457|NCT01461733|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6155458|NCT01461733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6155459|NCT01461733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6155460|NCT01461733|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5556214|NCT04049409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5556215|NCT04049409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5556216|NCT04049539|Cytarabine|cytarabine|mesh-list
5556217|NCT04049539|Daunorubicin|daunorubicin|mesh-list
6155461|NCT01461733|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6155462|NCT01461733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6155463|NCT01461824|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6155464|NCT01461824|Medroxyprogesterone|medroxyprogesterone|mesh-list
6155465|NCT01461824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6155466|NCT01461824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6155467|NCT01461824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6155468|NCT01461824|Contraceptive Agents|contraceptive agents|mesh-ancestor
6155469|NCT01461824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6155470|NCT01461824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155471|NCT01461824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6155472|NCT01461824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6155473|NCT01461824|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6155474|NCT01461824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6155475|NCT01461824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6155476|NCT01461928|Rituximab|rituximab|mesh-list
6155477|NCT01461928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6155478|NCT01461928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6155479|NCT01461928|Immunologic Factors|immunologic factors|mesh-ancestor
6155480|NCT01461928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155481|NCT01461928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6155482|NCT01462227|Naltrexone|naltrexone|mesh-list
6155483|NCT01462227|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6155484|NCT01462227|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6155485|NCT01462227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155486|NCT01462227|Sensory System Agents|sensory system agents|mesh-ancestor
6155487|NCT01462227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6155488|NCT01462253|Cyclophosphamide|cyclophosphamide|mesh-list
6155489|NCT01462253|Clofarabine|clofarabine|mesh-list
6155490|NCT01462253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6155491|NCT01462253|Immunologic Factors|immunologic factors|mesh-ancestor
6155492|NCT01462253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556218|NCT04049539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5556219|NCT04049539|Antimetabolites|antimetabolites|mesh-ancestor
5556220|NCT04049539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556221|NCT04049539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5556222|NCT04049539|Antiviral Agents|antiviral agents|mesh-ancestor
5556223|NCT04049539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5556224|NCT04049539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5556225|NCT04049539|Immunologic Factors|immunologic factors|mesh-ancestor
5556226|NCT04049539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155493|NCT01462253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6155494|NCT01462253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6155495|NCT01462253|Alkylating Agents|alkylating agents|mesh-ancestor
6155496|NCT01462253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155497|NCT01462253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6155498|NCT01462253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6155499|NCT01462253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6155500|NCT01462253|Antimetabolites|antimetabolites|mesh-ancestor
6155501|NCT01462266|Metformin|metformin|mesh-list
6155502|NCT01462266|Insulin Glargine|insulin glargine|mesh-list
6479433|NCT00538421|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6479434|NCT00538421|Anesthetics, General|anesthetics, general|mesh-ancestor
6479435|NCT00538421|Anesthetics|anesthetics|mesh-ancestor
6479436|NCT00538421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6479437|NCT00538421|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6479438|NCT00538486|Metformin|metformin|mesh-list
6479439|NCT00538486|Amlodipine|amlodipine|mesh-list
6479440|NCT00538486|Telmisartan|telmisartan|mesh-list
6479441|NCT00538486|Candesartan|candesartan|mesh-list
6479442|NCT00538486|Candesartan cilexetil|candesartan cilexetil|mesh-list
6479443|NCT00538486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6479444|NCT00538486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479445|NCT00538486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6479446|NCT00538486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6479447|NCT00538486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6479448|NCT00538486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479449|NCT00538486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6479450|NCT00538486|Vasodilator Agents|vasodilator agents|mesh-ancestor
6479451|NCT00538486|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6479452|NCT00538486|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6479453|NCT00538499|Fentanyl|fentanyl|mesh-list
6479454|NCT00538499|Bupivacaine|bupivacaine|mesh-list
6479455|NCT00538499|Anesthetics, Local|anesthetics, local|mesh-ancestor
5556227|NCT04049539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6155503|NCT01462266|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6155504|NCT01462266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6155505|NCT01462266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155506|NCT01462266|Incretins|incretins|mesh-ancestor
6155507|NCT01462266|Hormones|hormones|mesh-ancestor
6155508|NCT01462266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6155509|NCT01462266|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6155510|NCT01462266|Protease Inhibitors|protease inhibitors|mesh-ancestor
6155511|NCT01462266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6155512|NCT01462266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155513|NCT01462279|Thiamine|thiamine|mesh-list
6155514|NCT01462279|Vitamin B Complex|vitamin b complex|mesh-ancestor
6155515|NCT01462279|Vitamins|vitamins|mesh-ancestor
6155516|NCT01462279|Micronutrients|micronutrients|mesh-ancestor
6155517|NCT01462279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155518|NCT01462318|Vitamin K|vitamin k|mesh-list
6155519|NCT01462318|Midazolam|midazolam|mesh-list
6155520|NCT01462318|Dextromethorphan|dextromethorphan|mesh-list
5556228|NCT04049539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5556229|NCT04049539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5556230|NCT04049539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5556231|NCT04049513|Cyclophosphamide|cyclophosphamide|mesh-list
5556232|NCT04049513|Fludarabine|fludarabine|mesh-list
5556233|NCT04049513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5556234|NCT04049513|Immunologic Factors|immunologic factors|mesh-ancestor
5556235|NCT04049513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556236|NCT04049513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5556237|NCT04049513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5556238|NCT04049513|Alkylating Agents|alkylating agents|mesh-ancestor
5556239|NCT04049513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556240|NCT04049513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6155521|NCT01462318|Caffeine|caffeine|mesh-list
6155522|NCT01462318|Omeprazole|omeprazole|mesh-list
6155523|NCT01462318|Warfarin|warfarin|mesh-list
6155524|NCT01462318|Daclizumab|daclizumab|mesh-list
6155525|NCT01462318|Vitamins|vitamins|mesh-ancestor
6155526|NCT01462318|Micronutrients|micronutrients|mesh-ancestor
6155527|NCT01462318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155528|NCT01462318|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6155529|NCT01462318|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6155530|NCT01462318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6155531|NCT01462318|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6155532|NCT01462318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6155533|NCT01462318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6155534|NCT01462318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6155535|NCT01462318|Anesthetics, General|anesthetics, general|mesh-ancestor
6155536|NCT01462318|Anesthetics|anesthetics|mesh-ancestor
6155537|NCT01462318|GABA Modulators|gaba modulators|mesh-ancestor
6155538|NCT01462318|GABA Agents|gaba agents|mesh-ancestor
6155539|NCT01462318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6155540|NCT01462318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155541|NCT01462318|Anticoagulants|anticoagulants|mesh-ancestor
6668103|NCT01530386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155542|NCT01462318|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6155543|NCT01462318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6155544|NCT01462318|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6155545|NCT01462318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6155546|NCT01462318|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6155547|NCT01462318|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6155548|NCT01462318|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6155549|NCT01462318|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6155550|NCT01462318|Purinergic Agents|purinergic agents|mesh-ancestor
6155551|NCT01462318|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6155552|NCT01462318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6155553|NCT01462318|Hemostatics|hemostatics|mesh-ancestor
6155554|NCT01462318|Coagulants|coagulants|mesh-ancestor
6155555|NCT01462318|Antitussive Agents|antitussive agents|mesh-ancestor
6479456|NCT00538499|Anesthetics|anesthetics|mesh-ancestor
6155556|NCT01462318|Respiratory System Agents|respiratory system agents|mesh-ancestor
6205914|NCT02093897|Factor VIII|factor viii|mesh-list
6479457|NCT00538499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6479458|NCT00538499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479459|NCT00538499|Sensory System Agents|sensory system agents|mesh-ancestor
6479460|NCT00538499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6479461|NCT00538499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6479462|NCT00538499|Narcotics|narcotics|mesh-ancestor
6479463|NCT00538499|Analgesics|analgesics|mesh-ancestor
6479464|NCT00538499|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5556241|NCT04049513|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5556242|NCT04049266|Aflibercept|aflibercept|mesh-list
5556243|NCT04049266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5556244|NCT04049266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5556245|NCT04049266|Growth Substances|growth substances|mesh-ancestor
6479465|NCT00538499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6479466|NCT00538499|Anesthetics, General|anesthetics, general|mesh-ancestor
6479467|NCT00538525|Docetaxel|docetaxel|mesh-list
6479468|NCT00538525|Doxorubicin|doxorubicin|mesh-list
6479469|NCT00538525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6479470|NCT00538525|Tubulin Modulators|tubulin modulators|mesh-ancestor
6479471|NCT00538525|Antimitotic Agents|antimitotic agents|mesh-ancestor
6479472|NCT00538525|Mitosis Modulators|mitosis modulators|mesh-ancestor
5556246|NCT04049266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556247|NCT04049266|Growth Inhibitors|growth inhibitors|mesh-ancestor
5556248|NCT04049266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5556249|NCT04049344|Oxaliplatin|oxaliplatin|mesh-list
5556250|NCT04049344|Decitabine|decitabine|mesh-list
5556251|NCT04049344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5556252|NCT04049344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6479473|NCT00538525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479474|NCT00538525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6479475|NCT00538525|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6479476|NCT00538525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6479477|NCT00538525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6479478|NCT00538538|Ranibizumab|ranibizumab|mesh-list
6479479|NCT00538538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6479480|NCT00538538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6479481|NCT00538538|Growth Substances|growth substances|mesh-ancestor
6479482|NCT00538538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479483|NCT00538538|Growth Inhibitors|growth inhibitors|mesh-ancestor
6479484|NCT00538538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6479485|NCT00538564|Tadalafil|tadalafil|mesh-list
6479486|NCT00538564|Vasodilator Agents|vasodilator agents|mesh-ancestor
6479487|NCT00538564|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6479488|NCT00538564|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6479489|NCT00538564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6479490|NCT00538564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479491|NCT00538564|Urological Agents|urological agents|mesh-ancestor
6479492|NCT00538603|Paclitaxel|paclitaxel|mesh-list
6479493|NCT00538603|Carboplatin|carboplatin|mesh-list
6479494|NCT00538603|Doxorubicin|doxorubicin|mesh-list
6479495|NCT00538603|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6479496|NCT00538603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6155557|NCT01462318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6155558|NCT01462318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6155559|NCT01462318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6155560|NCT01462318|Immunologic Factors|immunologic factors|mesh-ancestor
6155561|NCT01462344|Fluticasone|fluticasone|mesh-list
6155562|NCT01462344|Xhance|xhance|mesh-list
6155563|NCT01462344|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6155564|NCT01462344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6479497|NCT00538603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6479498|NCT00538603|Tubulin Modulators|tubulin modulators|mesh-ancestor
6479499|NCT00538603|Antimitotic Agents|antimitotic agents|mesh-ancestor
6479500|NCT00538603|Mitosis Modulators|mitosis modulators|mesh-ancestor
6479501|NCT00538603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479502|NCT00538603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6479503|NCT00538603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6479504|NCT00538603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6155565|NCT01462344|Autonomic Agents|autonomic agents|mesh-ancestor
6155566|NCT01462344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6155567|NCT01462344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155568|NCT01462344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6155569|NCT01462344|Respiratory System Agents|respiratory system agents|mesh-ancestor
6155570|NCT01462344|Glucocorticoids|glucocorticoids|mesh-ancestor
6155571|NCT01462344|Hormones|hormones|mesh-ancestor
6155572|NCT01462344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6155573|NCT01462344|Sympathomimetics|sympathomimetics|mesh-ancestor
6155574|NCT01462344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6155575|NCT01462344|Dermatologic Agents|dermatologic agents|mesh-ancestor
6155576|NCT01462344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6479505|NCT00538603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6479506|NCT00538655|Modafinil|modafinil|mesh-list
5556253|NCT04049344|Antimetabolites|antimetabolites|mesh-ancestor
6155577|NCT01462435|Celecoxib|celecoxib|mesh-list
6155578|NCT01462435|Diclofenac|diclofenac|mesh-list
6155579|NCT01462435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6155580|NCT01462435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6155581|NCT01462435|Analgesics|analgesics|mesh-ancestor
6155582|NCT01462435|Sensory System Agents|sensory system agents|mesh-ancestor
6155583|NCT01462435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6155584|NCT01462435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155585|NCT01462435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6155586|NCT01462435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6155587|NCT01462435|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6155588|NCT01462435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6155589|NCT01462435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6668104|NCT01530438|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6668105|NCT01530438|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6668106|NCT01530438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668107|NCT01530451|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
6668108|NCT01530451|Hemostatics|hemostatics|mesh-ancestor
6479507|NCT00538655|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6479508|NCT00538655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479509|NCT00538655|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6479510|NCT00538655|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6479511|NCT00538655|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6479512|NCT00538655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479513|NCT00538694|Daptomycin|daptomycin|mesh-list
6479514|NCT00538694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6479515|NCT00538694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6479516|NCT00538720|Vitamin D|vitamin d|mesh-list
6479517|NCT00538720|Ergocalciferols|ergocalciferols|mesh-list
6479518|NCT00538720|Vitamins|vitamins|mesh-ancestor
6479519|NCT00538720|Micronutrients|micronutrients|mesh-ancestor
6479520|NCT00538720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479521|NCT00538720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6479522|NCT00538720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6479523|NCT00538811|Interferons|interferons|mesh-list
6479524|NCT00538811|Ribavirin|ribavirin|mesh-list
5556254|NCT04049344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556255|NCT04049344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5556256|NCT04049201|Midazolam|midazolam|mesh-list
6155590|NCT01462435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155591|NCT01462565|Epoprostenol|epoprostenol|mesh-list
6155592|NCT01462565|Tezosentan|tezosentan|mesh-list
6155593|NCT01462565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6155594|NCT01462565|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6155595|NCT01462565|Vasodilator Agents|vasodilator agents|mesh-ancestor
6155596|NCT01462695|Sunitinib|sunitinib|mesh-list
6155597|NCT01462695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6155598|NCT01462695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6155599|NCT01462695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6155600|NCT01462695|Growth Substances|growth substances|mesh-ancestor
6155601|NCT01462695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155602|NCT01462695|Growth Inhibitors|growth inhibitors|mesh-ancestor
5556257|NCT04049201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5556258|NCT04049201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5556259|NCT04049201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5556260|NCT04049201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556261|NCT04049201|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5556262|NCT04049201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5556263|NCT04049201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5556264|NCT04049201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5556265|NCT04049201|Anesthetics, General|anesthetics, general|mesh-ancestor
5556266|NCT04049201|Anesthetics|anesthetics|mesh-ancestor
5556267|NCT04049201|GABA Modulators|gaba modulators|mesh-ancestor
5556268|NCT04049201|GABA Agents|gaba agents|mesh-ancestor
5556269|NCT04049201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6155603|NCT01462695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6155604|NCT01462695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6155605|NCT01462695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155606|NCT01462773|Interferons|interferons|mesh-list
6155607|NCT01462773|Interferon-alpha|interferon-alpha|mesh-list
6155608|NCT01462773|Interferon alpha-2|interferon alpha-2|mesh-list
6155609|NCT01462773|Bortezomib|bortezomib|mesh-list
6155610|NCT01462773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6155611|NCT01462773|Antiviral Agents|antiviral agents|mesh-ancestor
6155612|NCT01462773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6155613|NCT01462773|Immunologic Factors|immunologic factors|mesh-ancestor
6479525|NCT00538811|Interferon-alpha|interferon-alpha|mesh-list
6479526|NCT00538811|Interferon alpha-2|interferon alpha-2|mesh-list
6479527|NCT00538811|Interferon-gamma|interferon-gamma|mesh-list
6155614|NCT01462773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155615|NCT01462812|Sumatriptan|sumatriptan|mesh-list
6155616|NCT01462812|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6155617|NCT01462812|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6155618|NCT01462812|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6155619|NCT01462812|Serotonin Agents|serotonin agents|mesh-ancestor
6155620|NCT01462812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6155621|NCT01462812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155622|NCT01462812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155623|NCT01462877|Fenofibrate|fenofibrate|mesh-list
6155624|NCT01462877|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6155625|NCT01462877|Antimetabolites|antimetabolites|mesh-ancestor
6155626|NCT01462877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155627|NCT01462877|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6155628|NCT01462929|Bromides|bromides|mesh-list
6155629|NCT01462929|Tiotropium Bromide|tiotropium bromide|mesh-list
6155630|NCT01462929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6155631|NCT01462929|Autonomic Agents|autonomic agents|mesh-ancestor
6155632|NCT01462929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6155633|NCT01462929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155634|NCT01462929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6155635|NCT01462929|Respiratory System Agents|respiratory system agents|mesh-ancestor
6155636|NCT01462929|Parasympatholytics|parasympatholytics|mesh-ancestor
6155637|NCT01462929|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6155638|NCT01462929|Cholinergic Agents|cholinergic agents|mesh-ancestor
6155639|NCT01462929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6155640|NCT01462929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155641|NCT01462929|Anticonvulsants|anticonvulsants|mesh-ancestor
6479528|NCT00538811|Amantadine|amantadine|mesh-list
6479529|NCT00538811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6479530|NCT00538811|Antiviral Agents|antiviral agents|mesh-ancestor
6479531|NCT00538811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6479532|NCT00538811|Antimetabolites|antimetabolites|mesh-ancestor
6479533|NCT00538811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479534|NCT00538811|Immunologic Factors|immunologic factors|mesh-ancestor
6479535|NCT00538811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479536|NCT00538811|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6479537|NCT00538811|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6479538|NCT00538811|Dopamine Agents|dopamine agents|mesh-ancestor
6479539|NCT00538811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6479540|NCT00538811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6479541|NCT00538811|Analgesics|analgesics|mesh-ancestor
6479542|NCT00538811|Sensory System Agents|sensory system agents|mesh-ancestor
6479543|NCT00538811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6479544|NCT00538876|Decitabine|decitabine|mesh-list
6479545|NCT00538876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6479546|NCT00538876|Antimetabolites|antimetabolites|mesh-ancestor
6479547|NCT00538876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479548|NCT00538876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5556270|NCT04049201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556271|NCT04049253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5556272|NCT04048889|Ropivacaine|ropivacaine|mesh-list
6155642|NCT01462942|Bromides|bromides|mesh-list
6155643|NCT01462942|Formoterol Fumarate|formoterol fumarate|mesh-list
5556273|NCT04048889|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5556274|NCT04048889|Anesthetics, Local|anesthetics, local|mesh-ancestor
5556275|NCT04048889|Anesthetics|anesthetics|mesh-ancestor
5556276|NCT04048889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5556277|NCT04048889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556278|NCT04048889|Sensory System Agents|sensory system agents|mesh-ancestor
5556279|NCT04048889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5603222|NCT03008382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5603223|NCT03008382|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5603224|NCT03008382|Sympatholytics|sympatholytics|mesh-ancestor
5603225|NCT03008382|Autonomic Agents|autonomic agents|mesh-ancestor
5603226|NCT03008382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5603227|NCT03008382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155644|NCT01462942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6155645|NCT01462942|Autonomic Agents|autonomic agents|mesh-ancestor
6155646|NCT01462942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6155647|NCT01462942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479549|NCT00538876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6155648|NCT01462942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6155649|NCT01462942|Respiratory System Agents|respiratory system agents|mesh-ancestor
6155650|NCT01462942|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6155651|NCT01462942|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6155652|NCT01462942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6155653|NCT01462942|Adrenergic Agents|adrenergic agents|mesh-ancestor
6155654|NCT01462942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6155655|NCT01462942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155656|NCT01462942|Anticonvulsants|anticonvulsants|mesh-ancestor
6155657|NCT01463033|Levetiracetam|levetiracetam|mesh-list
6155658|NCT01463033|Anticonvulsants|anticonvulsants|mesh-ancestor
6155659|NCT01463033|Nootropic Agents|nootropic agents|mesh-ancestor
6155660|NCT01463098|Zolpidem|zolpidem|mesh-list
6155661|NCT01463098|Lemborexant|lemborexant|mesh-list
6155662|NCT01463098|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6155663|NCT01463098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6155664|NCT01463098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6155665|NCT01463098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155666|NCT01463098|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6155667|NCT01463098|GABA Agonists|gaba agonists|mesh-ancestor
6155668|NCT01463098|GABA Agents|gaba agents|mesh-ancestor
6155669|NCT01463098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6155670|NCT01463098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155671|NCT01463098|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
6155672|NCT01463111|Lamotrigine|lamotrigine|mesh-list
6155673|NCT01463111|Valproic Acid|valproic acid|mesh-list
6155674|NCT01463111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6155675|NCT01463111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6155676|NCT01463111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155677|NCT01463111|Antimanic Agents|antimanic agents|mesh-ancestor
6155678|NCT01463111|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6155679|NCT01463111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6155680|NCT01463111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155681|NCT01463111|Anticonvulsants|anticonvulsants|mesh-ancestor
6155682|NCT01463111|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6155683|NCT01463111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6155684|NCT01463111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6155685|NCT01463111|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6155686|NCT01463111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6155687|NCT01463111|GABA Agents|gaba agents|mesh-ancestor
6155688|NCT01463111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6155689|NCT01463202|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6155690|NCT01463202|Medroxyprogesterone|medroxyprogesterone|mesh-list
6155691|NCT01463202|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6155692|NCT01463202|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6155693|NCT01463202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6155694|NCT01463202|Contraceptive Agents|contraceptive agents|mesh-ancestor
6155695|NCT01463202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6155696|NCT01463202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155697|NCT01463202|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6155698|NCT01463202|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6155699|NCT01463202|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6155700|NCT01463202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6155701|NCT01463202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6155702|NCT01463306|Pregabalin|pregabalin|mesh-list
6155703|NCT01463306|Analgesics|analgesics|mesh-ancestor
6155704|NCT01463306|Sensory System Agents|sensory system agents|mesh-ancestor
6155705|NCT01463306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6155706|NCT01463306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155707|NCT01463306|Anticonvulsants|anticonvulsants|mesh-ancestor
6155708|NCT01463306|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6155709|NCT01463306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6155710|NCT01463306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155711|NCT01463306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6155712|NCT01463306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6155713|NCT01463306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6155714|NCT01463306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6668109|NCT01530451|Coagulants|coagulants|mesh-ancestor
6668110|NCT01530451|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6668111|NCT01530451|Natriuretic Agents|natriuretic agents|mesh-ancestor
6668112|NCT01530451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668113|NCT01530490|Cabergoline|cabergoline|mesh-list
6668114|NCT01530490|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
6668115|NCT01530490|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6668116|NCT01530490|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6668117|NCT01530490|Dopamine Agonists|dopamine agonists|mesh-ancestor
6668118|NCT01530490|Dopamine Agents|dopamine agents|mesh-ancestor
6668119|NCT01530490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6668120|NCT01530490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668121|NCT01530490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155715|NCT01463306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6155716|NCT01463384|Minocycline|minocycline|mesh-list
6155717|NCT01463384|Tetracycline|tetracycline|mesh-list
6155718|NCT01463384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6479550|NCT00538889|Citalopram|citalopram|mesh-list
6479551|NCT00538889|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6479552|NCT00538889|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6479553|NCT00538889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6479554|NCT00538889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479555|NCT00538889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6479556|NCT00538889|Serotonin Agents|serotonin agents|mesh-ancestor
6479557|NCT00538889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479558|NCT00538889|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6479559|NCT00538889|Antidepressive Agents|antidepressive agents|mesh-ancestor
6479560|NCT00538889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6479561|NCT00538954|Magnesium Oxide|magnesium oxide|mesh-list
6479562|NCT00538954|Antacids|antacids|mesh-ancestor
6479563|NCT00538954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479564|NCT00538954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6479565|NCT00538967|Doxycycline|doxycycline|mesh-list
6479566|NCT00538967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6479567|NCT00538967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6479568|NCT00538967|Antimalarials|antimalarials|mesh-ancestor
6479569|NCT00538967|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6479570|NCT00538967|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6479571|NCT00539071|Risperidone|risperidone|mesh-list
6479572|NCT00539071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6479573|NCT00539071|Serotonin Agents|serotonin agents|mesh-ancestor
6479574|NCT00539071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5556280|NCT04049110|Dapagliflozin|dapagliflozin|mesh-list
5556281|NCT04049110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6155719|NCT01463384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6155720|NCT01463384|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6155721|NCT01463384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6155722|NCT01463384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155723|NCT01463982|Capecitabine|capecitabine|mesh-list
6155724|NCT01463982|Irinotecan|irinotecan|mesh-list
6155725|NCT01463982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6155726|NCT01463982|Antimetabolites|antimetabolites|mesh-ancestor
6155727|NCT01463982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155728|NCT01463982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6155729|NCT01463982|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6155730|NCT01463982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6155731|NCT01463982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6155732|NCT01464190|Sevelamer|sevelamer|mesh-list
6155733|NCT01464190|Chelating Agents|chelating agents|mesh-ancestor
6155734|NCT01464190|Sequestering Agents|sequestering agents|mesh-ancestor
6155735|NCT01464190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205915|NCT02093897|Coagulants|coagulants|mesh-ancestor
6205916|NCT02093962|Pemetrexed|pemetrexed|mesh-list
6205917|NCT02093962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6205918|NCT02093962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6205919|NCT02093962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205920|NCT02093962|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6205921|NCT02093962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6205922|NCT02094443|Ribavirin|ribavirin|mesh-list
6205923|NCT02094443|Antimetabolites|antimetabolites|mesh-ancestor
6668122|NCT01530490|Plasma Substitutes|plasma substitutes|mesh-ancestor
5556282|NCT04049110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556283|NCT04049110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5556284|NCT04049110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556285|NCT04049227|Letrozole|letrozole|mesh-list
5556286|NCT04049227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5556287|NCT04049227|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5556288|NCT04049227|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5556289|NCT04049227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5556290|NCT04049227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205924|NCT02094443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556291|NCT04049227|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6155736|NCT01464229|Iloperidone|iloperidone|mesh-list
6155737|NCT01464229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6155738|NCT01464229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6155739|NCT01464229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6155740|NCT01464229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155741|NCT01464229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6479575|NCT00539071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479576|NCT00539071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479577|NCT00539071|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6479578|NCT00539071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6479579|NCT00539071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6479580|NCT00539071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6479581|NCT00539071|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6479582|NCT00539071|Dopamine Agents|dopamine agents|mesh-ancestor
6479583|NCT00539123|Buprenorphine|buprenorphine|mesh-list
6479584|NCT00539123|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6479585|NCT00539123|Narcotics|narcotics|mesh-ancestor
6479586|NCT00539123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6479587|NCT00539123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479588|NCT00539123|Analgesics|analgesics|mesh-ancestor
6479589|NCT00539123|Sensory System Agents|sensory system agents|mesh-ancestor
6479590|NCT00539123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6479591|NCT00539123|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6479592|NCT00539149|Amoxicillin|amoxicillin|mesh-list
6479593|NCT00539149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6479594|NCT00539149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6479595|NCT00539331|Paclitaxel|paclitaxel|mesh-list
6479596|NCT00539331|Carboplatin|carboplatin|mesh-list
6479597|NCT00539331|Cediranib|cediranib|mesh-list
6479598|NCT00539331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6155742|NCT01464307|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
6155743|NCT01464307|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6155744|NCT01464307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6155745|NCT01464307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155746|NCT01464307|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6155747|NCT01464307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6155748|NCT01464307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155749|NCT01464307|Cholinergic Agents|cholinergic agents|mesh-ancestor
6155750|NCT01464307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6155751|NCT01464359|Cyclophosphamide|cyclophosphamide|mesh-list
6155752|NCT01464359|Busulfan|busulfan|mesh-list
6155753|NCT01464359|Fludarabine|fludarabine|mesh-list
6155754|NCT01464359|Interleukin-2|interleukin-2|mesh-list
6155755|NCT01464359|Allopurinol|allopurinol|mesh-list
6155756|NCT01464359|Levetiracetam|levetiracetam|mesh-list
6155757|NCT01464359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6155758|NCT01464359|Immunologic Factors|immunologic factors|mesh-ancestor
5556292|NCT04049227|Hormone Antagonists|hormone antagonists|mesh-ancestor
5556293|NCT04049227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5556294|NCT04049227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556295|NCT04049045|Empagliflozin|empagliflozin|mesh-list
6155759|NCT01464359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155760|NCT01464359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6155761|NCT01464359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6155762|NCT01464359|Alkylating Agents|alkylating agents|mesh-ancestor
6155763|NCT01464359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155764|NCT01464359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6155765|NCT01464359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6155766|NCT01464359|Antimetabolites|antimetabolites|mesh-ancestor
6155767|NCT01464359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6155768|NCT01464359|Analgesics|analgesics|mesh-ancestor
6155769|NCT01464359|Sensory System Agents|sensory system agents|mesh-ancestor
6155770|NCT01464359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6155771|NCT01464359|Anticonvulsants|anticonvulsants|mesh-ancestor
6155772|NCT01464359|Nootropic Agents|nootropic agents|mesh-ancestor
6155773|NCT01464359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6155774|NCT01464359|Gout Suppressants|gout suppressants|mesh-ancestor
6155775|NCT01464359|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6155776|NCT01464359|Antioxidants|antioxidants|mesh-ancestor
6155777|NCT01464359|Protective Agents|protective agents|mesh-ancestor
6155778|NCT01464424|Bimatoprost|bimatoprost|mesh-list
6479599|NCT00539331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6479600|NCT00539331|Tubulin Modulators|tubulin modulators|mesh-ancestor
6155779|NCT01464424|Travoprost|travoprost|mesh-list
6155780|NCT01464424|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6479601|NCT00539331|Antimitotic Agents|antimitotic agents|mesh-ancestor
6479602|NCT00539331|Mitosis Modulators|mitosis modulators|mesh-ancestor
6155781|NCT01464424|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6155782|NCT01464424|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6155783|NCT01464697|Progesterone|progesterone|mesh-list
6155784|NCT01464697|Progestins|progestins|mesh-ancestor
6155785|NCT01464697|Hormones|hormones|mesh-ancestor
6155786|NCT01464697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6155787|NCT01464697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155788|NCT01464788|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6155789|NCT01464788|Argatroban|argatroban|mesh-list
6155790|NCT01464788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6155791|NCT01464788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6155792|NCT01464788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155793|NCT01464788|Antithrombins|antithrombins|mesh-ancestor
6155794|NCT01464788|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6155795|NCT01464788|Protease Inhibitors|protease inhibitors|mesh-ancestor
6155796|NCT01464788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6155797|NCT01464788|Anticoagulants|anticoagulants|mesh-ancestor
6155798|NCT01464788|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6155799|NCT01464827|Ritonavir|ritonavir|mesh-list
6155800|NCT01464827|Ribavirin|ribavirin|mesh-list
6155801|NCT01464827|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6155802|NCT01464827|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6155803|NCT01464827|Protease Inhibitors|protease inhibitors|mesh-ancestor
6155804|NCT01464827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6155805|NCT01464827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155806|NCT01464827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6155807|NCT01464827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6155808|NCT01464827|Antiviral Agents|antiviral agents|mesh-ancestor
6155809|NCT01464827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6155810|NCT01464827|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6155811|NCT01464827|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6155812|NCT01464827|Antimetabolites|antimetabolites|mesh-ancestor
6155813|NCT01464840|Azithromycin|azithromycin|mesh-list
6155814|NCT01464840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6155815|NCT01464840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6155816|NCT01464879|Testosterone|testosterone|mesh-list
6155817|NCT01464879|Androgens|androgens|mesh-ancestor
6155818|NCT01464879|Hormones|hormones|mesh-ancestor
6155819|NCT01464879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6155820|NCT01464879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155821|NCT01464931|Denosumab|denosumab|mesh-list
6155822|NCT01464931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6155823|NCT01464931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155824|NCT01465022|Estrogens|estrogens|mesh-list
6155825|NCT01465022|Progestins|progestins|mesh-list
6155826|NCT01465022|Hormones|hormones|mesh-ancestor
6155827|NCT01465022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5556296|NCT04049045|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5556297|NCT04049045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556298|NCT04049045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5556299|NCT04049045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556300|NCT04048863|Imidacloprid|imidacloprid|mesh-list
5556301|NCT04048863|Cholinergic Agents|cholinergic agents|mesh-ancestor
5556302|NCT04048863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5556303|NCT04048863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556304|NCT04048863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556305|NCT04048811|Propofol|propofol|mesh-list
5556306|NCT04048811|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5556307|NCT04048811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5556308|NCT04048811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556309|NCT04048811|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5556310|NCT04048811|Anesthetics, General|anesthetics, general|mesh-ancestor
5556311|NCT04048811|Anesthetics|anesthetics|mesh-ancestor
5556312|NCT04048850|Grazoprevir|grazoprevir|mesh-list
5556313|NCT04048850|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
5556314|NCT04048850|Antiviral Agents|antiviral agents|mesh-ancestor
5556315|NCT04048850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5556316|NCT04048577|Natalizumab|natalizumab|mesh-list
6155828|NCT01465022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155829|NCT01465178|Cholecalciferol|cholecalciferol|mesh-list
6155830|NCT01465178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6155831|NCT01465178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155832|NCT01465178|Vitamins|vitamins|mesh-ancestor
6155833|NCT01465178|Micronutrients|micronutrients|mesh-ancestor
6155834|NCT01465178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6479603|NCT00539331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556317|NCT04048577|Immunologic Factors|immunologic factors|mesh-ancestor
6155835|NCT01465191|Morphine|morphine|mesh-list
6479604|NCT00539331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6479605|NCT00539331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6488851|NCT00587327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6488852|NCT00587379|Atorvastatin|atorvastatin|mesh-list
6155836|NCT01465191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6155837|NCT01465191|Narcotics|narcotics|mesh-ancestor
6155838|NCT01465191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6155839|NCT01465191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155840|NCT01465191|Analgesics|analgesics|mesh-ancestor
6155841|NCT01465191|Sensory System Agents|sensory system agents|mesh-ancestor
6155842|NCT01465191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6155843|NCT01465334|Methylprednisolone|methylprednisolone|mesh-list
6155844|NCT01465334|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6155845|NCT01465334|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6155846|NCT01465334|Prednisolone|prednisolone|mesh-list
6155847|NCT01465334|Prednisolone acetate|prednisolone acetate|mesh-list
6155848|NCT01465334|Alemtuzumab|alemtuzumab|mesh-list
6155849|NCT01465334|Ofatumumab|ofatumumab|mesh-list
6155850|NCT01465334|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6155851|NCT01465334|Prednisolone phosphate|prednisolone phosphate|mesh-list
6155852|NCT01465334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6155853|NCT01465334|Antiemetics|antiemetics|mesh-ancestor
6155854|NCT01465334|Autonomic Agents|autonomic agents|mesh-ancestor
6155855|NCT01465334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6155856|NCT01465334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155857|NCT01465334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6155858|NCT01465334|Glucocorticoids|glucocorticoids|mesh-ancestor
6155859|NCT01465334|Hormones|hormones|mesh-ancestor
6155860|NCT01465334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6155861|NCT01465334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6155862|NCT01465334|Protective Agents|protective agents|mesh-ancestor
6155863|NCT01465334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6155864|NCT01465334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6155865|NCT01465334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6155866|NCT01465347|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
6155867|NCT01465347|Antioxidants|antioxidants|mesh-ancestor
6155868|NCT01465347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155869|NCT01465347|Protective Agents|protective agents|mesh-ancestor
6155870|NCT01465347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155871|NCT01465347|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6155872|NCT01465347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6155873|NCT01465386|Bortezomib|bortezomib|mesh-list
6155874|NCT01465386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5556318|NCT04048577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556319|NCT04048655|Neostigmine|neostigmine|mesh-list
6155875|NCT01465412|Adenosine|adenosine|mesh-list
6155876|NCT01465412|Analgesics|analgesics|mesh-ancestor
6155877|NCT01465412|Sensory System Agents|sensory system agents|mesh-ancestor
6155878|NCT01465412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6155879|NCT01465412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155880|NCT01465412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6155881|NCT01465412|Vasodilator Agents|vasodilator agents|mesh-ancestor
6155882|NCT01465412|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6155883|NCT01465412|Purinergic Agonists|purinergic agonists|mesh-ancestor
6155884|NCT01465412|Purinergic Agents|purinergic agents|mesh-ancestor
6155885|NCT01465412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6155886|NCT01465412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155887|NCT01465464|Orantinib|orantinib|mesh-list
6155888|NCT01465464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6155889|NCT01465464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6155890|NCT01465464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155891|NCT01465659|Temozolomide|temozolomide|mesh-list
6155892|NCT01465659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6155893|NCT01465659|Alkylating Agents|alkylating agents|mesh-ancestor
6155894|NCT01465659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155895|NCT01465659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6155896|NCT01465763|Tofacitinib|tofacitinib|mesh-list
6155897|NCT01465763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6155898|NCT01465763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6155899|NCT01465763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155900|NCT01465802|Doxycycline|doxycycline|mesh-list
6155901|NCT01465802|Alclometasone dipropionate|alclometasone dipropionate|mesh-list
6155902|NCT01465802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6155903|NCT01465802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6155904|NCT01465802|Antimalarials|antimalarials|mesh-ancestor
6155905|NCT01465802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6155906|NCT01465802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6155907|NCT01465802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6155908|NCT01465802|Glucocorticoids|glucocorticoids|mesh-ancestor
6155909|NCT01465802|Hormones|hormones|mesh-ancestor
6155910|NCT01465802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6155911|NCT01465802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155912|NCT01465958|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6155913|NCT01465958|gamma-Globulins|gamma-globulins|mesh-list
6155914|NCT01465958|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6155915|NCT01465958|Immunoglobulin G|immunoglobulin g|mesh-list
6155916|NCT01465958|Immunologic Factors|immunologic factors|mesh-ancestor
6155917|NCT01465958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155918|NCT01465997|Lacosamide|lacosamide|mesh-list
6155919|NCT01465997|Carbamazepine|carbamazepine|mesh-list
6155920|NCT01465997|Anticonvulsants|anticonvulsants|mesh-ancestor
6155921|NCT01465997|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6155922|NCT01465997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6155923|NCT01465997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6155924|NCT01465997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155925|NCT01465997|Antimanic Agents|antimanic agents|mesh-ancestor
6155926|NCT01465997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6668123|NCT01530490|Blood Substitutes|blood substitutes|mesh-ancestor
6668124|NCT01530503|Capecitabine|capecitabine|mesh-list
6668125|NCT01530503|Mitomycins|mitomycins|mesh-list
6668126|NCT01530503|Mitomycin|mitomycin|mesh-list
6668127|NCT01530503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6668128|NCT01530503|Antimetabolites|antimetabolites|mesh-ancestor
5556320|NCT04048655|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5556321|NCT04048655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5556322|NCT04048655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556323|NCT04048655|Cholinergic Agents|cholinergic agents|mesh-ancestor
5556324|NCT04048655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5556325|NCT04048655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556326|NCT04048655|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5556327|NCT04048655|Autonomic Agents|autonomic agents|mesh-ancestor
5556328|NCT04048655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5556329|NCT04048707|Octreotide|octreotide|mesh-list
5556330|NCT04048707|Midodrine|midodrine|mesh-list
5556331|NCT04048707|Angiotensin II|angiotensin ii|mesh-list
5556332|NCT04048707|Giapreza|giapreza|mesh-list
5556333|NCT04048707|Angiotensinogen|angiotensinogen|mesh-list
5556334|NCT04048707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5556335|NCT04048707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5556336|NCT04048707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5556337|NCT04048707|Sympathomimetics|sympathomimetics|mesh-ancestor
5556338|NCT04048707|Autonomic Agents|autonomic agents|mesh-ancestor
5556339|NCT04048707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5556340|NCT04048707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556341|NCT04048707|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5556342|NCT04048707|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5556343|NCT04048707|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5556344|NCT04048707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6155927|NCT01465997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6155928|NCT01465997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155929|NCT01465997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6155930|NCT01465997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6155931|NCT01465997|Analgesics|analgesics|mesh-ancestor
6155932|NCT01465997|Sensory System Agents|sensory system agents|mesh-ancestor
6155933|NCT01465997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6155934|NCT01465997|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6155935|NCT01465997|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6155936|NCT01466062|Palivizumab|palivizumab|mesh-list
5556345|NCT04048707|Adrenergic Agents|adrenergic agents|mesh-ancestor
5556346|NCT04048707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5556347|NCT04048707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556348|NCT04048707|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5556349|NCT04048707|Protease Inhibitors|protease inhibitors|mesh-ancestor
5556350|NCT04048707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5556351|NCT04048343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5556352|NCT04048343|Immunologic Factors|immunologic factors|mesh-ancestor
5556353|NCT04048343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155937|NCT01466062|Antiviral Agents|antiviral agents|mesh-ancestor
6155938|NCT01466062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6155939|NCT01466127|Oxytocin|oxytocin|mesh-list
6479606|NCT00539396|Insulin|insulin|mesh-list
6479607|NCT00539396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6479608|NCT00539396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479609|NCT00539409|Insulin|insulin|mesh-list
6479610|NCT00539409|Insulin Aspart|insulin aspart|mesh-list
6479611|NCT00539409|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6479612|NCT00539409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6479613|NCT00539409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479614|NCT00539435|Insulin|insulin|mesh-list
6479615|NCT00539435|Insulin Aspart|insulin aspart|mesh-list
6479616|NCT00539435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6479617|NCT00539435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479618|NCT00539448|Insulin|insulin|mesh-list
6479619|NCT00539448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6479620|NCT00539448|Insulin Glargine|insulin glargine|mesh-list
6479621|NCT00539448|Insulin glulisine|insulin glulisine|mesh-list
6479622|NCT00539448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6479623|NCT00539448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556354|NCT04048317|Doxorubicin|doxorubicin|mesh-list
5556355|NCT04048317|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5556356|NCT04048317|Ethiodized Oil|ethiodized oil|mesh-list
5556357|NCT04048317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5556358|NCT04048317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5556359|NCT04048317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5556360|NCT04048317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5556361|NCT04048317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5556362|NCT04048317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155940|NCT01466127|Oxytocics|oxytocics|mesh-ancestor
6479624|NCT00539565|Prednisolone|prednisolone|mesh-list
6479625|NCT00539565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6479626|NCT00539565|Glucocorticoids|glucocorticoids|mesh-ancestor
6479627|NCT00539565|Hormones|hormones|mesh-ancestor
6479628|NCT00539565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6479629|NCT00539565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479630|NCT00539565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6155941|NCT01466127|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6155942|NCT01466127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155943|NCT01466153|Rituximab|rituximab|mesh-list
6155944|NCT01466153|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6479631|NCT00539565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6479632|NCT00539630|Docetaxel|docetaxel|mesh-list
6479633|NCT00539630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6479634|NCT00539630|Tubulin Modulators|tubulin modulators|mesh-ancestor
6479635|NCT00539630|Antimitotic Agents|antimitotic agents|mesh-ancestor
6479636|NCT00539630|Mitosis Modulators|mitosis modulators|mesh-ancestor
6479637|NCT00539630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556363|NCT04048226|Dexmedetomidine|dexmedetomidine|mesh-list
5556364|NCT04048226|Ketamine|ketamine|mesh-list
5556365|NCT04048226|Anesthetics|anesthetics|mesh-ancestor
5556366|NCT04048226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6479638|NCT00539669|Docetaxel|docetaxel|mesh-list
6479639|NCT00539669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6479640|NCT00539669|Tubulin Modulators|tubulin modulators|mesh-ancestor
6479641|NCT00539669|Antimitotic Agents|antimitotic agents|mesh-ancestor
6479642|NCT00539669|Mitosis Modulators|mitosis modulators|mesh-ancestor
6479643|NCT00539669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479644|NCT00539773|Interferons|interferons|mesh-list
6479645|NCT00539773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6479646|NCT00539773|Antiviral Agents|antiviral agents|mesh-ancestor
6155945|NCT01466153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6155946|NCT01466153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6155947|NCT01466153|Immunologic Factors|immunologic factors|mesh-ancestor
6155948|NCT01466153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155949|NCT01466153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6479647|NCT00539773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6479648|NCT00539786|Rabeprazole|rabeprazole|mesh-list
6479649|NCT00539786|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
6479650|NCT00539786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6479651|NCT00539786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6479652|NCT00539786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6479653|NCT00539786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479654|NCT00539799|Prednisolone|prednisolone|mesh-list
6479655|NCT00539799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6479656|NCT00539799|Glucocorticoids|glucocorticoids|mesh-ancestor
6479657|NCT00539799|Hormones|hormones|mesh-ancestor
6479658|NCT00539799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6479659|NCT00539799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479660|NCT00539799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6479661|NCT00539799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6479662|NCT00539877|Irinotecan|irinotecan|mesh-list
6479663|NCT00539877|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5556367|NCT04048226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556368|NCT04048226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5556369|NCT04048226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5556370|NCT04048226|Analgesics|analgesics|mesh-ancestor
5556371|NCT04048226|Sensory System Agents|sensory system agents|mesh-ancestor
5556372|NCT04048226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5556373|NCT04048226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5556374|NCT04048226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5556375|NCT04048226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6155950|NCT01466153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6155951|NCT01466153|Alkylating Agents|alkylating agents|mesh-ancestor
6155952|NCT01466153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155953|NCT01466179|Blinatumomab|blinatumomab|mesh-list
6155954|NCT01466179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6479664|NCT00539877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6479665|NCT00539877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6155955|NCT01466192|Ribavirin|ribavirin|mesh-list
6155956|NCT01466192|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6155957|NCT01466192|Antimetabolites|antimetabolites|mesh-ancestor
6155958|NCT01466192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155959|NCT01466192|Antiviral Agents|antiviral agents|mesh-ancestor
6155960|NCT01466192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6155961|NCT01466270|Donepezil|donepezil|mesh-list
6155962|NCT01466270|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6155963|NCT01466270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6155964|NCT01466270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155965|NCT01466270|Cholinergic Agents|cholinergic agents|mesh-ancestor
6155966|NCT01466270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6155967|NCT01466270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155968|NCT01466270|Nootropic Agents|nootropic agents|mesh-ancestor
6155969|NCT01466348|Acetaminophen|acetaminophen|mesh-list
6155970|NCT01466348|Caffeine|caffeine|mesh-list
6155971|NCT01466348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6155972|NCT01466348|Analgesics|analgesics|mesh-ancestor
6155973|NCT01466348|Sensory System Agents|sensory system agents|mesh-ancestor
6155974|NCT01466348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6155975|NCT01466348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155976|NCT01466348|Antipyretics|antipyretics|mesh-ancestor
6155977|NCT01466348|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6155978|NCT01466348|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6155979|NCT01466348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6155980|NCT01466348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155981|NCT01466348|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6155982|NCT01466348|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6155983|NCT01466348|Purinergic Agents|purinergic agents|mesh-ancestor
6155984|NCT01466348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6155985|NCT01466361|Nicotine|nicotine|mesh-list
6155986|NCT01466361|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6155987|NCT01466361|Autonomic Agents|autonomic agents|mesh-ancestor
6155988|NCT01466361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6155989|NCT01466361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155990|NCT01466361|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6155991|NCT01466361|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6155992|NCT01466361|Cholinergic Agents|cholinergic agents|mesh-ancestor
6155993|NCT01466361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5556376|NCT04048226|Adrenergic Agents|adrenergic agents|mesh-ancestor
5556377|NCT04048226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5556378|NCT04048226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556379|NCT04048226|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5556380|NCT04048226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5556381|NCT04048226|Anesthetics, General|anesthetics, general|mesh-ancestor
5556382|NCT04048226|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5556383|NCT04048226|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5556384|NCT04048304|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5556385|NCT04048304|Vancomycin|vancomycin|mesh-list
5556386|NCT04048304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5556387|NCT04048200|Fentanyl|fentanyl|mesh-list
5556388|NCT04048200|Dexmedetomidine|dexmedetomidine|mesh-list
5556389|NCT04048200|Ketamine|ketamine|mesh-list
5556390|NCT04048200|Analgesics, Opioid|analgesics, opioid|mesh-list
5556391|NCT04048200|Anesthetics|anesthetics|mesh-ancestor
5556392|NCT04048200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5556393|NCT04048200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556394|NCT04048200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5556395|NCT04048200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5556396|NCT04048200|Analgesics|analgesics|mesh-ancestor
5556397|NCT04048200|Sensory System Agents|sensory system agents|mesh-ancestor
5556398|NCT04048200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5556399|NCT04048200|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5556400|NCT04048200|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5556401|NCT04048200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5556402|NCT04048200|Adrenergic Agents|adrenergic agents|mesh-ancestor
5556403|NCT04048200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6155994|NCT01466361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6155995|NCT01466387|Vaccines|vaccines|mesh-list
6155996|NCT01466387|Immunologic Factors|immunologic factors|mesh-ancestor
6155997|NCT01466387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6155998|NCT01466491|Lidocaine|lidocaine|mesh-list
6155999|NCT01466491|Anesthetics, Local|anesthetics, local|mesh-ancestor
6156000|NCT01466491|Anesthetics|anesthetics|mesh-ancestor
6156001|NCT01466491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6156002|NCT01466491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156003|NCT01466491|Sensory System Agents|sensory system agents|mesh-ancestor
6156004|NCT01466491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6156005|NCT01466491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6156006|NCT01466491|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6156007|NCT01466491|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6156008|NCT01466491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6156009|NCT01466491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156010|NCT01466595|Rifaximin|rifaximin|mesh-list
6156011|NCT01466595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6156012|NCT01466595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5556404|NCT04048200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556405|NCT04048200|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5556406|NCT04048200|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5556407|NCT04048200|Anesthetics, General|anesthetics, general|mesh-ancestor
5556408|NCT04048200|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5556409|NCT04048200|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5556410|NCT04048200|Narcotics|narcotics|mesh-ancestor
5556411|NCT04048200|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5556412|NCT04048070|Flurbiprofen|flurbiprofen|mesh-list
5556413|NCT04048070|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
5556414|NCT04048070|Sufentanil|sufentanil|mesh-list
5556415|NCT04048070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5556416|NCT04048070|Narcotics|narcotics|mesh-ancestor
5556417|NCT04048070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5556418|NCT04048070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556419|NCT04048070|Analgesics|analgesics|mesh-ancestor
5556420|NCT04048070|Sensory System Agents|sensory system agents|mesh-ancestor
5556421|NCT04048070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5556422|NCT04048070|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5556423|NCT04048070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5556424|NCT04048070|Anesthetics, General|anesthetics, general|mesh-ancestor
5556425|NCT04048070|Anesthetics|anesthetics|mesh-ancestor
5556426|NCT04048070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5556427|NCT04048070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5556428|NCT04048070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5556429|NCT04048070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5556430|NCT04048070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5556431|NCT04048070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5556432|NCT04048070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556433|NCT04048161|Mycophenolic Acid|mycophenolic acid|mesh-list
5556434|NCT04048161|Tacrolimus|tacrolimus|mesh-list
5556435|NCT04048161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5556436|NCT04048161|Immunologic Factors|immunologic factors|mesh-ancestor
5556437|NCT04048161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556438|NCT04048161|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5556439|NCT04048161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5556440|NCT04048161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556441|NCT04048161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5556442|NCT04048161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5556443|NCT04048161|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6479666|NCT00539877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479667|NCT00539877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6479668|NCT00539890|Insulin|insulin|mesh-list
6479669|NCT00539890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6156013|NCT01466595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6156014|NCT01466660|Gefitinib|gefitinib|mesh-list
6156015|NCT01466660|Afatinib|afatinib|mesh-list
6156016|NCT01466660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6156017|NCT01466660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6156018|NCT01466660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6156019|NCT01466660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156020|NCT01466673|Moxifloxacin|moxifloxacin|mesh-list
6479670|NCT00539890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479671|NCT00539968|Docetaxel|docetaxel|mesh-list
5556444|NCT04048161|Antitubercular Agents|antitubercular agents|mesh-ancestor
5556445|NCT04048161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5556446|NCT04048161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5556447|NCT04048278|Lidocaine|lidocaine|mesh-list
5556448|NCT04048278|Anesthetics, Local|anesthetics, local|mesh-ancestor
5556449|NCT04048278|Anesthetics|anesthetics|mesh-ancestor
6479672|NCT00539968|Lonafarnib|lonafarnib|mesh-list
6479673|NCT00539968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6479674|NCT00539968|Tubulin Modulators|tubulin modulators|mesh-ancestor
6479675|NCT00539968|Antimitotic Agents|antimitotic agents|mesh-ancestor
6479676|NCT00539968|Mitosis Modulators|mitosis modulators|mesh-ancestor
6479677|NCT00539968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479678|NCT00539968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6479679|NCT00540072|Daptomycin|daptomycin|mesh-list
6479680|NCT00540072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6479681|NCT00540072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6479682|NCT00540085|Rocuronium|rocuronium|mesh-list
6479683|NCT00540085|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6479684|NCT00540085|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6479685|NCT00540085|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6479686|NCT00540085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6479687|NCT00540085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479688|NCT00540098|Paroxetine|paroxetine|mesh-list
6479689|NCT00540098|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6479690|NCT00540098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6479691|NCT00540098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6479692|NCT00540098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479693|NCT00540098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6479694|NCT00540098|Serotonin Agents|serotonin agents|mesh-ancestor
6479695|NCT00540098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479696|NCT00540098|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6479697|NCT00540098|Antidepressive Agents|antidepressive agents|mesh-ancestor
6479698|NCT00540098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6479699|NCT00540098|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6479700|NCT00540098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6479701|NCT00540098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6479702|NCT00540137|Ritonavir|ritonavir|mesh-list
6479703|NCT00540137|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6479704|NCT00540137|Nevirapine|nevirapine|mesh-list
6479705|NCT00540137|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6668129|NCT01530503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668130|NCT01530503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6668131|NCT01530503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5556450|NCT04048278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6156021|NCT01466673|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6156022|NCT01466673|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6156023|NCT01466673|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6156024|NCT01466673|Desogestrel|desogestrel|mesh-list
6156025|NCT01466673|Norgestimate|norgestimate|mesh-list
5556451|NCT04048278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156026|NCT01466673|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6156027|NCT01466673|Estradiol|estradiol|mesh-list
6156028|NCT01466673|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6156029|NCT01466673|Estrogens|estrogens|mesh-ancestor
6156030|NCT01466673|Hormones|hormones|mesh-ancestor
6156031|NCT01466673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6479706|NCT00540137|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5556452|NCT04048278|Sensory System Agents|sensory system agents|mesh-ancestor
5556453|NCT04048278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5556454|NCT04048278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5556455|NCT04048278|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5556456|NCT04048278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5556457|NCT04048278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5556458|NCT04048278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556459|NCT04047654|Anticoagulants|anticoagulants|mesh-list
5556460|NCT04047706|Nivolumab|nivolumab|mesh-list
5556461|NCT04047706|Temozolomide|temozolomide|mesh-list
5556462|NCT04047706|Linrodostat|linrodostat|mesh-list
5556463|NCT04047706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6479707|NCT00540137|Protease Inhibitors|protease inhibitors|mesh-ancestor
6479708|NCT00540137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6668132|NCT01530503|Alkylating Agents|alkylating agents|mesh-ancestor
6668133|NCT01530503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6668134|NCT01530503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6668135|NCT01530542|Oxycodone|oxycodone|mesh-list
6668136|NCT01530542|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6668137|NCT01530542|Narcotics|narcotics|mesh-ancestor
6156032|NCT01466673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156033|NCT01466673|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6668138|NCT01530542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5556464|NCT04047706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5556465|NCT04047706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5556466|NCT04047706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556467|NCT04047706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5556468|NCT04047706|Alkylating Agents|alkylating agents|mesh-ancestor
5556469|NCT04047706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5556470|NCT04047940|Metformin|metformin|mesh-list
5556471|NCT04047940|Valsartan|valsartan|mesh-list
5556472|NCT04047940|Atorvastatin|atorvastatin|mesh-list
5556473|NCT04047940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5556474|NCT04047940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556475|NCT04047940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5556476|NCT04047940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5556477|NCT04047940|Antimetabolites|antimetabolites|mesh-ancestor
5556478|NCT04047940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556479|NCT04047940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5556480|NCT04047940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6156034|NCT01466673|Contraceptive Agents|contraceptive agents|mesh-ancestor
6156035|NCT01466673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6156036|NCT01466673|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6156037|NCT01466673|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6156038|NCT01466673|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6156039|NCT01466673|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6156040|NCT01466673|Progestins|progestins|mesh-ancestor
6156041|NCT01466673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6156042|NCT01466673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6156043|NCT01466673|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6156044|NCT01466673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6156045|NCT01466673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6156046|NCT01466673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156047|NCT01466673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6156048|NCT01466673|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6205925|NCT02094443|Antiviral Agents|antiviral agents|mesh-ancestor
6479709|NCT00540137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479710|NCT00540137|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6479711|NCT00540137|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6479712|NCT00540137|Antiviral Agents|antiviral agents|mesh-ancestor
6479713|NCT00540137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6479714|NCT00540137|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6479715|NCT00540137|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6479716|NCT00540137|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6156049|NCT01466764|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6156050|NCT01466764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6156051|NCT01466790|Ribavirin|ribavirin|mesh-list
6156052|NCT01466790|Sofosbuvir|sofosbuvir|mesh-list
6156053|NCT01466790|Simeprevir|simeprevir|mesh-list
6156054|NCT01466790|Antimetabolites|antimetabolites|mesh-ancestor
6156055|NCT01466790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156056|NCT01466790|Antiviral Agents|antiviral agents|mesh-ancestor
6156057|NCT01466790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6156058|NCT01466790|Protease Inhibitors|protease inhibitors|mesh-ancestor
6156059|NCT01466790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6479717|NCT00540137|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6479718|NCT00540137|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6479719|NCT00540137|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6479720|NCT00540202|Lumefantrine|lumefantrine|mesh-list
6479721|NCT00540202|Artemether|artemether|mesh-list
6479722|NCT00540202|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6479723|NCT00540202|Quinine|quinine|mesh-list
6479724|NCT00540202|Antimalarials|antimalarials|mesh-ancestor
6479725|NCT00540202|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6479726|NCT00540202|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6479727|NCT00540202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6479728|NCT00540202|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6479729|NCT00540202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479730|NCT00540202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5556481|NCT04047940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5556482|NCT04047940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5556483|NCT04047940|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6479731|NCT00540202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5556484|NCT04047940|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5556485|NCT04047758|Letrozole|letrozole|mesh-list
5556486|NCT04047758|Palbociclib|palbociclib|mesh-list
5556487|NCT04047758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5556488|NCT04047758|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5556489|NCT04047758|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5556490|NCT04047758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5556491|NCT04047758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556492|NCT04047758|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5556493|NCT04047758|Hormone Antagonists|hormone antagonists|mesh-ancestor
5556494|NCT04047758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5556495|NCT04047758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479732|NCT00540202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6479733|NCT00540202|Analgesics|analgesics|mesh-ancestor
6479734|NCT00540202|Sensory System Agents|sensory system agents|mesh-ancestor
6479735|NCT00540241|Pemetrexed|pemetrexed|mesh-list
6479736|NCT00540241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6479737|NCT00540241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6479738|NCT00540241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479739|NCT00540241|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6479740|NCT00540241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6479741|NCT00540280|Gemcitabine|gemcitabine|mesh-list
6479742|NCT00540280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6479743|NCT00540280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6479744|NCT00540280|Antimetabolites|antimetabolites|mesh-ancestor
6479745|NCT00540280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479746|NCT00540280|Antiviral Agents|antiviral agents|mesh-ancestor
6479747|NCT00540280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6479748|NCT00540280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6479749|NCT00540280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6479750|NCT00540280|Immunologic Factors|immunologic factors|mesh-ancestor
6479751|NCT00540280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479752|NCT00540345|Interferons|interferons|mesh-list
6479753|NCT00540345|Ribavirin|ribavirin|mesh-list
6479754|NCT00540345|Interferon-alpha|interferon-alpha|mesh-list
5556496|NCT04047758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5556497|NCT04047641|Cytarabine|cytarabine|mesh-list
5556498|NCT04047641|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
5556499|NCT04047641|Idarubicin|idarubicin|mesh-list
5556500|NCT04047641|Cladribine|cladribine|mesh-list
5556501|NCT04047641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5556502|NCT04047641|Antimetabolites|antimetabolites|mesh-ancestor
5556503|NCT04047641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556504|NCT04047641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6479755|NCT00540345|Interferon alpha-2|interferon alpha-2|mesh-list
6156060|NCT01467076|Alprostadil|alprostadil|mesh-list
6156061|NCT01467076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5556505|NCT04047641|Antiviral Agents|antiviral agents|mesh-ancestor
6479756|NCT00540345|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6479757|NCT00540345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6479758|NCT00540345|Antiviral Agents|antiviral agents|mesh-ancestor
6479759|NCT00540345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6479760|NCT00540345|Antimetabolites|antimetabolites|mesh-ancestor
6479761|NCT00540345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479762|NCT00540345|Immunologic Factors|immunologic factors|mesh-ancestor
6479763|NCT00540345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479764|NCT00540384|Darbepoetin alfa|darbepoetin alfa|mesh-list
5556506|NCT04047641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5556507|NCT04047641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5556508|NCT04047641|Immunologic Factors|immunologic factors|mesh-ancestor
5556509|NCT04047641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556510|NCT04047641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5556511|NCT04047641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5556512|NCT04047641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5556513|NCT04047641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5556514|NCT04047849|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5556515|NCT04047849|Amoxicillin|amoxicillin|mesh-list
5556516|NCT04047849|Azithromycin|azithromycin|mesh-list
5556517|NCT04047849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5556518|NCT04047914|Mupirocin|mupirocin|mesh-list
5556519|NCT04047914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5556520|NCT04047914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5556521|NCT04047914|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5556522|NCT04047914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5556523|NCT04047914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556524|NCT04047875|Norethindrone|norethindrone|mesh-list
5556525|NCT04047875|Norethindrone Acetate|norethindrone acetate|mesh-list
5556526|NCT04047875|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5556527|NCT04047875|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5556528|NCT04047875|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6479765|NCT00540384|Hematinics|hematinics|mesh-ancestor
6156062|NCT01467076|Vasodilator Agents|vasodilator agents|mesh-ancestor
6156063|NCT01467076|Urological Agents|urological agents|mesh-ancestor
6156064|NCT01467466|Acetylcysteine|acetylcysteine|mesh-list
6156065|NCT01467466|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6156066|NCT01467466|Antiviral Agents|antiviral agents|mesh-ancestor
6156067|NCT01467466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6156068|NCT01467466|Expectorants|expectorants|mesh-ancestor
6156069|NCT01467466|Respiratory System Agents|respiratory system agents|mesh-ancestor
6156070|NCT01467466|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6156071|NCT01467466|Antioxidants|antioxidants|mesh-ancestor
6156072|NCT01467466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156073|NCT01467466|Protective Agents|protective agents|mesh-ancestor
6156074|NCT01467466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156075|NCT01467466|Antidotes|antidotes|mesh-ancestor
6156076|NCT01467479|Interferons|interferons|mesh-list
6156077|NCT01467479|Ribavirin|ribavirin|mesh-list
6156078|NCT01467479|Interferon-alpha|interferon-alpha|mesh-list
6156079|NCT01467479|Interferon alpha-2|interferon alpha-2|mesh-list
6479766|NCT00540410|Artesunate|artesunate|mesh-list
5556529|NCT04047875|Contraceptive Agents|contraceptive agents|mesh-ancestor
5556530|NCT04047875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5556531|NCT04047875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556532|NCT04047875|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5556533|NCT04047875|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5556534|NCT04047745|Bupivacaine|bupivacaine|mesh-list
5556535|NCT04047745|Ropivacaine|ropivacaine|mesh-list
5556536|NCT04047745|Anesthetics, Local|anesthetics, local|mesh-ancestor
5556537|NCT04047745|Anesthetics|anesthetics|mesh-ancestor
5556538|NCT04047745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5556539|NCT04047745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556540|NCT04047745|Sensory System Agents|sensory system agents|mesh-ancestor
5556541|NCT04047745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5556542|NCT04047680|Ritonavir|ritonavir|mesh-list
5556543|NCT04047680|Sofosbuvir|sofosbuvir|mesh-list
5556544|NCT04047680|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
5556545|NCT04047680|Grazoprevir|grazoprevir|mesh-list
5556546|NCT04047680|Ledipasvir|ledipasvir|mesh-list
5556547|NCT04047680|Velpatasvir|velpatasvir|mesh-list
5556548|NCT04047680|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5556549|NCT04047680|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5556550|NCT04047680|Protease Inhibitors|protease inhibitors|mesh-ancestor
5556551|NCT04047680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5606798|NCT03770130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156080|NCT01467479|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6479767|NCT00540410|Lumefantrine|lumefantrine|mesh-list
6156081|NCT01467479|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6156082|NCT01467479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6156083|NCT01467479|Antiviral Agents|antiviral agents|mesh-ancestor
5556552|NCT04047680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556553|NCT04047680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5556554|NCT04047680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5556555|NCT04047680|Antiviral Agents|antiviral agents|mesh-ancestor
5556556|NCT04047680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5556557|NCT04047680|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5556558|NCT04047680|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5556559|NCT04047576|Sirolimus|sirolimus|mesh-list
5556560|NCT04047576|Prednisone|prednisone|mesh-list
5556561|NCT04047576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5556562|NCT04047576|Glucocorticoids|glucocorticoids|mesh-ancestor
5556563|NCT04047576|Hormones|hormones|mesh-ancestor
5556564|NCT04047576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5556565|NCT04047576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156084|NCT01467479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6156085|NCT01467479|Antimetabolites|antimetabolites|mesh-ancestor
5556566|NCT04047576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5556567|NCT04047576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5556568|NCT04047576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5556569|NCT04047576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5556570|NCT04047576|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5556571|NCT04047576|Antifungal Agents|antifungal agents|mesh-ancestor
5556572|NCT04047576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5556573|NCT04047576|Immunologic Factors|immunologic factors|mesh-ancestor
5556574|NCT04047797|Rituximab|rituximab|mesh-list
5556575|NCT04047797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5556576|NCT04047797|Ixazomib|ixazomib|mesh-list
5556577|NCT04047797|Antibodies|antibodies|mesh-list
5556578|NCT04047797|Immunoglobulins|immunoglobulins|mesh-list
5556579|NCT04047797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5556580|NCT04047797|Glycine|glycine|mesh-list
5556581|NCT04047797|Immunologic Factors|immunologic factors|mesh-ancestor
5556582|NCT04047797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556583|NCT04047797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6156086|NCT01467479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156087|NCT01467479|Immunologic Factors|immunologic factors|mesh-ancestor
6156088|NCT01467479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156089|NCT01467492|Interferons|interferons|mesh-list
6156090|NCT01467492|Ribavirin|ribavirin|mesh-list
6156091|NCT01467492|Interferon-alpha|interferon-alpha|mesh-list
6156092|NCT01467492|Interferon alpha-2|interferon alpha-2|mesh-list
6156093|NCT01467492|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6156094|NCT01467492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6156095|NCT01467492|Antiviral Agents|antiviral agents|mesh-ancestor
6156096|NCT01467492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6156097|NCT01467492|Antimetabolites|antimetabolites|mesh-ancestor
6156098|NCT01467492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156099|NCT01467492|Immunologic Factors|immunologic factors|mesh-ancestor
6156100|NCT01467492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156101|NCT01467505|Interferons|interferons|mesh-list
6156102|NCT01467505|Ribavirin|ribavirin|mesh-list
6156103|NCT01467505|Interferon-alpha|interferon-alpha|mesh-list
6156104|NCT01467505|Interferon alpha-2|interferon alpha-2|mesh-list
5556584|NCT04047797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6156105|NCT01467505|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6156106|NCT01467505|Immunosuppressive Agents|immunosuppressive agents|mesh-list
6156107|NCT01467505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6156108|NCT01467505|Antiviral Agents|antiviral agents|mesh-ancestor
6156109|NCT01467505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6156110|NCT01467505|Antimetabolites|antimetabolites|mesh-ancestor
5556585|NCT04047797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156111|NCT01467505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556586|NCT04047797|Protease Inhibitors|protease inhibitors|mesh-ancestor
6156112|NCT01467505|Immunologic Factors|immunologic factors|mesh-ancestor
6479768|NCT00540410|Amodiaquine|amodiaquine|mesh-list
6156113|NCT01467505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156114|NCT01467583|PENTA|penta|mesh-list
6156115|NCT01467583|Fondaparinux|fondaparinux|mesh-list
6156116|NCT01467583|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6156117|NCT01467583|Antithrombins|antithrombins|mesh-ancestor
6156118|NCT01467583|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6479769|NCT00540410|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6479770|NCT00540410|Antimalarials|antimalarials|mesh-ancestor
6479771|NCT00540410|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6479772|NCT00540410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6479773|NCT00540410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6479774|NCT00540410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6479775|NCT00540410|Antiviral Agents|antiviral agents|mesh-ancestor
6479776|NCT00540410|Schistosomicides|schistosomicides|mesh-ancestor
6479777|NCT00540410|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6479778|NCT00540410|Anthelmintics|anthelmintics|mesh-ancestor
6479779|NCT00540501|Oseltamivir|oseltamivir|mesh-list
6479780|NCT00540501|Zanamivir|zanamivir|mesh-list
6479781|NCT00540501|Antiviral Agents|antiviral agents|mesh-ancestor
6156119|NCT01467583|Protease Inhibitors|protease inhibitors|mesh-ancestor
6156120|NCT01467583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6156121|NCT01467583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156122|NCT01467583|Anticoagulants|anticoagulants|mesh-ancestor
6156123|NCT01467583|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6156124|NCT01467583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6156125|NCT01467661|Anagrelide|anagrelide|mesh-list
6156126|NCT01467661|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6156127|NCT01467661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6156128|NCT01467661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156129|NCT01467661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6156130|NCT01467882|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6156131|NCT01467882|Luteolytic Agents|luteolytic agents|mesh-ancestor
6156132|NCT01467882|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6156133|NCT01467882|Contraceptive Agents|contraceptive agents|mesh-ancestor
6156134|NCT01467882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6156135|NCT01467882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156136|NCT01467882|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6156137|NCT01467882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6479782|NCT00540501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6479783|NCT00540501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6479784|NCT00540501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479785|NCT00540527|Plasminogen|plasminogen|mesh-list
5556587|NCT04047797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5556588|NCT04047797|Glycine Agents|glycine agents|mesh-ancestor
5556589|NCT04047797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5556590|NCT04047836|Nicotine|nicotine|mesh-list
5556591|NCT04047836|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5556592|NCT04047836|Autonomic Agents|autonomic agents|mesh-ancestor
5556593|NCT04047836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5556594|NCT04047836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556595|NCT04047836|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6156138|NCT01467882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6479786|NCT00540527|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6479787|NCT00540527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6479788|NCT00540527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6479789|NCT00540527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479790|NCT00540605|Tenofovir|tenofovir|mesh-list
6479791|NCT00540605|Antiviral Agents|antiviral agents|mesh-ancestor
6479792|NCT00540605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6479793|NCT00540605|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6479794|NCT00540605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6479795|NCT00540605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6479796|NCT00540605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479797|NCT00540605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6479798|NCT00540605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6479799|NCT00540696|Darbepoetin alfa|darbepoetin alfa|mesh-list
6479800|NCT00540696|Hematinics|hematinics|mesh-ancestor
6479801|NCT00540709|Insulin Glargine|insulin glargine|mesh-list
6479802|NCT00540709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6479803|NCT00540709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479804|NCT00540748|Oxytocin|oxytocin|mesh-list
6479805|NCT00540748|Oxytocics|oxytocics|mesh-ancestor
6668139|NCT01530542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156139|NCT01467947|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
6156140|NCT01467947|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
6156141|NCT01467947|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6156142|NCT01467947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6156143|NCT01467947|Immunologic Factors|immunologic factors|mesh-ancestor
6156144|NCT01467947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156145|NCT01467999|Guanfacine|guanfacine|mesh-list
6156146|NCT01467999|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6668140|NCT01530542|Analgesics|analgesics|mesh-ancestor
6668141|NCT01530542|Sensory System Agents|sensory system agents|mesh-ancestor
6668142|NCT01530542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6668143|NCT01530555|Thymoglobulin|thymoglobulin|mesh-list
6668144|NCT01530555|Immunologic Factors|immunologic factors|mesh-ancestor
6668145|NCT01530555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668146|NCT01530555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6668147|NCT01530594|Lenalidomide|lenalidomide|mesh-list
6668148|NCT01530594|Bortezomib|bortezomib|mesh-list
6668149|NCT01530594|Immunologic Factors|immunologic factors|mesh-ancestor
6668150|NCT01530594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156147|NCT01467999|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6156148|NCT01467999|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6156149|NCT01467999|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6156150|NCT01467999|Adrenergic Agents|adrenergic agents|mesh-ancestor
6156151|NCT01467999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6156152|NCT01467999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156153|NCT01467999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156154|NCT01468012|Levodopa|levodopa|mesh-list
6156155|NCT01468012|Carbidopa|carbidopa|mesh-list
6156156|NCT01468012|Entacapone|entacapone|mesh-list
6156157|NCT01468012|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
6156158|NCT01468012|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6156159|NCT01468012|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6156160|NCT01468012|Dopamine Agents|dopamine agents|mesh-ancestor
6156161|NCT01468012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6156162|NCT01468012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156163|NCT01468012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556596|NCT04047836|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5556597|NCT04047836|Cholinergic Agents|cholinergic agents|mesh-ancestor
5556598|NCT04047836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5606799|NCT03770130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6156164|NCT01468012|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6156165|NCT01468012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6156166|NCT01468012|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6156167|NCT01468012|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6156168|NCT01468012|Immunologic Factors|immunologic factors|mesh-ancestor
6156169|NCT01468012|Dopamine Agonists|dopamine agonists|mesh-ancestor
6156170|NCT01468181|Dulaglutide|dulaglutide|mesh-list
6156171|NCT01468181|Biguanides|biguanides|mesh-list
6156172|NCT01468181|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
6668151|NCT01530594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6156173|NCT01468181|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
6156174|NCT01468181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6156175|NCT01468181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156176|NCT01468181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6156177|NCT01468181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156178|NCT01468207|Adalimumab|adalimumab|mesh-list
6156179|NCT01468207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5556599|NCT04047836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556600|NCT04047329|Anesthetics|anesthetics|mesh-list
5556601|NCT04047329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5556602|NCT04047329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156180|NCT01468207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6156181|NCT01468233|Adalimumab|adalimumab|mesh-list
6156182|NCT01468233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6156183|NCT01468233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6156184|NCT01468311|Daclizumab|daclizumab|mesh-list
6156185|NCT01468311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6156186|NCT01468311|Immunologic Factors|immunologic factors|mesh-ancestor
6156187|NCT01468311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156188|NCT01468337|Interferons|interferons|mesh-list
6479806|NCT00540748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6479807|NCT00540748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479808|NCT00540787|Quinidine|quinidine|mesh-list
6479809|NCT00540787|Amiodarone|amiodarone|mesh-list
6479810|NCT00540787|Sotalol|sotalol|mesh-list
6479811|NCT00540787|Flecainide|flecainide|mesh-list
5556603|NCT04047394|Rasburicase|rasburicase|mesh-list
5556604|NCT04047394|Gout Suppressants|gout suppressants|mesh-ancestor
5556605|NCT04047394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5556606|NCT04047355|Propranolol|propranolol|mesh-list
5556607|NCT04047355|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5556608|NCT04047355|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5556609|NCT04047355|Adrenergic Agents|adrenergic agents|mesh-ancestor
5556610|NCT04047355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5556611|NCT04047355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556612|NCT04047355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556613|NCT04047355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5556614|NCT04047355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5556615|NCT04047355|Vasodilator Agents|vasodilator agents|mesh-ancestor
5556616|NCT04047446|Dexamethasone|dexamethasone|mesh-list
5556617|NCT04047446|Bupivacaine|bupivacaine|mesh-list
5556618|NCT04047446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5556619|NCT04047446|Antiemetics|antiemetics|mesh-ancestor
5556620|NCT04047446|Autonomic Agents|autonomic agents|mesh-ancestor
5556621|NCT04047446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5556622|NCT04047446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556623|NCT04047446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5556624|NCT04047446|Glucocorticoids|glucocorticoids|mesh-ancestor
5556625|NCT04047446|Hormones|hormones|mesh-ancestor
5556626|NCT04047446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5556627|NCT04047446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5556628|NCT04047446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5556629|NCT04047446|Anesthetics, Local|anesthetics, local|mesh-ancestor
6479812|NCT00540787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
6479813|NCT00540787|Propafenone|propafenone|mesh-list
6479814|NCT00540787|Dofetilide|dofetilide|mesh-list
6479815|NCT00540787|Cifenline|cifenline|mesh-list
5556630|NCT04047446|Anesthetics|anesthetics|mesh-ancestor
5556631|NCT04047446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5556632|NCT04047446|Sensory System Agents|sensory system agents|mesh-ancestor
5603228|NCT03008382|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6156189|NCT01468337|Interferon-gamma|interferon-gamma|mesh-list
6156190|NCT01468337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6156191|NCT01468337|Antiviral Agents|antiviral agents|mesh-ancestor
6479816|NCT00540787|Calcium Channel Blockers|calcium channel blockers|mesh-list
6488853|NCT00587379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5556633|NCT04046887|Gemcitabine|gemcitabine|mesh-list
5556634|NCT04046887|Paclitaxel|paclitaxel|mesh-list
5556635|NCT04046887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5556636|NCT04046887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6479817|NCT00540787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6479818|NCT00540787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479819|NCT00540787|Vasodilator Agents|vasodilator agents|mesh-ancestor
6479820|NCT00540787|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6479821|NCT00540787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6479822|NCT00540787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156192|NCT01468337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6156193|NCT01468350|4-Aminopyridine|4-aminopyridine|mesh-list
6156194|NCT01468350|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6156195|NCT01468350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6156196|NCT01468350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156197|NCT01468532|Prednisone|prednisone|mesh-list
6156198|NCT01468532|Docetaxel|docetaxel|mesh-list
6479823|NCT00540787|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6479824|NCT00540787|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6479825|NCT00540787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6479826|NCT00540787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6479827|NCT00540787|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5556637|NCT04046887|Tubulin Modulators|tubulin modulators|mesh-ancestor
5556638|NCT04046887|Antimitotic Agents|antimitotic agents|mesh-ancestor
5556639|NCT04046887|Mitosis Modulators|mitosis modulators|mesh-ancestor
5556640|NCT04046887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556641|NCT04046887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5556642|NCT04046887|Antimetabolites|antimetabolites|mesh-ancestor
5556643|NCT04046887|Antiviral Agents|antiviral agents|mesh-ancestor
5556644|NCT04046887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5556645|NCT04046887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6479828|NCT00540787|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6479829|NCT00540787|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6479830|NCT00540787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6479831|NCT00540787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5556646|NCT04046887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5556647|NCT04046887|Immunologic Factors|immunologic factors|mesh-ancestor
5556648|NCT04046887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556649|NCT04047017|Apatinib|apatinib|mesh-list
5556650|NCT04047017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5556651|NCT04047017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5556652|NCT04047017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5556653|NCT04047017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556654|NCT04046874|Analgesics|analgesics|mesh-list
5556655|NCT04046874|Sensory System Agents|sensory system agents|mesh-ancestor
6479832|NCT00540787|Adrenergic Agents|adrenergic agents|mesh-ancestor
6479833|NCT00540787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6479834|NCT00540787|Sympatholytics|sympatholytics|mesh-ancestor
6479835|NCT00540787|Autonomic Agents|autonomic agents|mesh-ancestor
6479836|NCT00540787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6479837|NCT00540787|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6479838|NCT00540787|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6479839|NCT00540787|Antimalarials|antimalarials|mesh-ancestor
6479840|NCT00540787|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6479841|NCT00540787|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6479842|NCT00540787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6479843|NCT00540787|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6479844|NCT00540787|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6479845|NCT00540787|Cholinergic Agents|cholinergic agents|mesh-ancestor
6479846|NCT00540800|Docetaxel|docetaxel|mesh-list
6479847|NCT00540800|Capecitabine|capecitabine|mesh-list
6156199|NCT01468532|Pasireotide|pasireotide|mesh-list
6156200|NCT01468532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6156201|NCT01468532|Tubulin Modulators|tubulin modulators|mesh-ancestor
6156202|NCT01468532|Antimitotic Agents|antimitotic agents|mesh-ancestor
6156203|NCT01468532|Mitosis Modulators|mitosis modulators|mesh-ancestor
6156204|NCT01468532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156205|NCT01468532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6156206|NCT01468532|Glucocorticoids|glucocorticoids|mesh-ancestor
6156207|NCT01468532|Hormones|hormones|mesh-ancestor
6156208|NCT01468532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6156209|NCT01468532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156210|NCT01468532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6668152|NCT01530594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6668153|NCT01530594|Growth Substances|growth substances|mesh-ancestor
6668154|NCT01530594|Growth Inhibitors|growth inhibitors|mesh-ancestor
6668155|NCT01530594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6668156|NCT01530607|Cyclophosphamide|cyclophosphamide|mesh-list
6668157|NCT01530607|Goserelin|goserelin|mesh-list
6668158|NCT01530607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6668159|NCT01530607|Immunologic Factors|immunologic factors|mesh-ancestor
6668160|NCT01530607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668161|NCT01530607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6668162|NCT01530607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6668163|NCT01530607|Alkylating Agents|alkylating agents|mesh-ancestor
6668164|NCT01530607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668165|NCT01530607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6668166|NCT01530607|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6668167|NCT01530607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6156211|NCT01468558|Ketoconazole|ketoconazole|mesh-list
6156212|NCT01468558|Antifungal Agents|antifungal agents|mesh-ancestor
6156213|NCT01468558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6156214|NCT01468558|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6156215|NCT01468558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6156216|NCT01468558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6156217|NCT01468558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156218|NCT01468558|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6156219|NCT01468558|Hormone Antagonists|hormone antagonists|mesh-ancestor
6156220|NCT01468558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6156221|NCT01468558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156222|NCT01468558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6156223|NCT01468584|Ribavirin|ribavirin|mesh-list
6156224|NCT01468584|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6156225|NCT01468584|Antimetabolites|antimetabolites|mesh-ancestor
6156226|NCT01468584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156227|NCT01468584|Antiviral Agents|antiviral agents|mesh-ancestor
6156228|NCT01468584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6156229|NCT01468818|Cyclophosphamide|cyclophosphamide|mesh-list
6156230|NCT01468818|Fludarabine|fludarabine|mesh-list
6479848|NCT00540800|Epirubicin|epirubicin|mesh-list
6479849|NCT00540800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6479850|NCT00540800|Tubulin Modulators|tubulin modulators|mesh-ancestor
6479851|NCT00540800|Antimitotic Agents|antimitotic agents|mesh-ancestor
6479852|NCT00540800|Mitosis Modulators|mitosis modulators|mesh-ancestor
6479853|NCT00540800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479854|NCT00540800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6479855|NCT00540800|Antimetabolites|antimetabolites|mesh-ancestor
6479856|NCT00540800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6479857|NCT00540800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6479858|NCT00540800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6479859|NCT00540800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6479860|NCT00540826|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6479861|NCT00540826|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6479862|NCT00540826|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6479863|NCT00540826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6479864|NCT00540826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479865|NCT00540826|Adrenergic Agents|adrenergic agents|mesh-ancestor
6479866|NCT00540826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6156231|NCT01468818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6156232|NCT01468818|Immunologic Factors|immunologic factors|mesh-ancestor
6156233|NCT01468818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156234|NCT01468818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6156235|NCT01468818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6156236|NCT01468818|Alkylating Agents|alkylating agents|mesh-ancestor
6479867|NCT00540826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479868|NCT00540891|Alfuzosin|alfuzosin|mesh-list
6479869|NCT00540891|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6479870|NCT00540891|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6479871|NCT00540891|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6479872|NCT00540891|Adrenergic Agents|adrenergic agents|mesh-ancestor
6479873|NCT00540891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6479874|NCT00540891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479875|NCT00540891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156237|NCT01468818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156238|NCT01468818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6156239|NCT01468818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6156240|NCT01468844|Minocycline|minocycline|mesh-list
6156241|NCT01468844|Bevacizumab|bevacizumab|mesh-list
6156242|NCT01468844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6156243|NCT01468844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6156244|NCT01468844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6156245|NCT01468844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6156246|NCT01468844|Growth Substances|growth substances|mesh-ancestor
6156247|NCT01468844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156248|NCT01468844|Growth Inhibitors|growth inhibitors|mesh-ancestor
6156249|NCT01468844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6156250|NCT01468844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6156251|NCT01468896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6156252|NCT01468896|Cetuximab|cetuximab|mesh-list
6156253|NCT01468896|Interleukin-12|interleukin-12|mesh-list
6156254|NCT01468896|Antibodies|antibodies|mesh-list
6156255|NCT01468896|Immunoglobulins|immunoglobulins|mesh-list
5556656|NCT04046874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5556657|NCT04046874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556658|NCT04046744|Lidocaine|lidocaine|mesh-list
6156256|NCT01468896|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6156257|NCT01468896|Immunologic Factors|immunologic factors|mesh-ancestor
6156258|NCT01468896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156259|NCT01468896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6156260|NCT01468896|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6156261|NCT01468896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6156262|NCT01468896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6156263|NCT01468896|Growth Substances|growth substances|mesh-ancestor
6156264|NCT01468896|Growth Inhibitors|growth inhibitors|mesh-ancestor
6156265|NCT01468909|Paclitaxel|paclitaxel|mesh-list
6156266|NCT01468909|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6156267|NCT01468909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6156268|NCT01468909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6156269|NCT01468909|Tubulin Modulators|tubulin modulators|mesh-ancestor
6156270|NCT01468909|Antimitotic Agents|antimitotic agents|mesh-ancestor
6156271|NCT01468909|Mitosis Modulators|mitosis modulators|mesh-ancestor
6156272|NCT01468909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156273|NCT01468987|Insulin|insulin|mesh-list
6156274|NCT01468987|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6156275|NCT01468987|Insulin Glargine|insulin glargine|mesh-list
6156276|NCT01468987|Insulin Lispro|insulin lispro|mesh-list
6156277|NCT01468987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6156278|NCT01468987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156279|NCT01469000|Pemetrexed|pemetrexed|mesh-list
6156280|NCT01469000|Gefitinib|gefitinib|mesh-list
6156281|NCT01469000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6156282|NCT01469000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6156283|NCT01469000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156284|NCT01469000|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6156285|NCT01469000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6156286|NCT01469000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6156287|NCT01469013|Methotrexate|methotrexate|mesh-list
6156288|NCT01469013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6156289|NCT01469013|Abortifacient Agents|abortifacient agents|mesh-ancestor
6156290|NCT01469013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6156291|NCT01469013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156292|NCT01469013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6156293|NCT01469013|Antimetabolites|antimetabolites|mesh-ancestor
6156294|NCT01469013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156295|NCT01469013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6156296|NCT01469013|Dermatologic Agents|dermatologic agents|mesh-ancestor
6156297|NCT01469013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6156298|NCT01469013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6156299|NCT01469013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6156300|NCT01469013|Immunologic Factors|immunologic factors|mesh-ancestor
6156301|NCT01469013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6156302|NCT01469013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6156303|NCT01469052|Axitinib|axitinib|mesh-list
6156304|NCT01469052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6156305|NCT01469052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6156306|NCT01469052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6156307|NCT01469052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156308|NCT01469065|Nicotinic Acids|nicotinic acids|mesh-list
6156309|NCT01469065|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
6156310|NCT01469065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6156311|NCT01469065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156312|NCT01469065|Vitamin B Complex|vitamin b complex|mesh-ancestor
6156313|NCT01469065|Vitamins|vitamins|mesh-ancestor
6156314|NCT01469065|Micronutrients|micronutrients|mesh-ancestor
6156315|NCT01469065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156316|NCT01469221|Apaziquone|apaziquone|mesh-list
6156317|NCT01469221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6205926|NCT02094443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6205927|NCT02094534|Insulin|insulin|mesh-list
6205928|NCT02094534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6205929|NCT02094534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205930|NCT02094716|Permethrin|permethrin|mesh-list
6205931|NCT02094716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6205932|NCT02094716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205933|NCT02094885|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6205934|NCT02094885|Hemostatics|hemostatics|mesh-ancestor
6205935|NCT02094885|Coagulants|coagulants|mesh-ancestor
6205936|NCT02094898|Ketamine|ketamine|mesh-list
6205937|NCT02094898|Analgesics|analgesics|mesh-ancestor
6205938|NCT02094898|Sensory System Agents|sensory system agents|mesh-ancestor
6205939|NCT02094898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6205940|NCT02094898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205941|NCT02094898|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6205942|NCT02094898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6479876|NCT00540891|Urological Agents|urological agents|mesh-ancestor
6479877|NCT00540930|Ranibizumab|ranibizumab|mesh-list
6479878|NCT00540930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6479879|NCT00540930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6479880|NCT00540930|Growth Substances|growth substances|mesh-ancestor
6479881|NCT00540930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479882|NCT00540930|Growth Inhibitors|growth inhibitors|mesh-ancestor
6479883|NCT00540930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6479884|NCT00540943|Irinotecan|irinotecan|mesh-list
6479885|NCT00540943|Cetuximab|cetuximab|mesh-list
6479886|NCT00540943|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6479887|NCT00540943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6479888|NCT00540943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6479889|NCT00540943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479890|NCT00540943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5556659|NCT04046744|Analgesics|analgesics|mesh-list
5556660|NCT04046744|Ropivacaine|ropivacaine|mesh-list
5556661|NCT04046744|Anesthetics, Local|anesthetics, local|mesh-list
5556662|NCT04046744|Anesthetics|anesthetics|mesh-list
5556663|NCT04046744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5556664|NCT04046744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556665|NCT04046744|Sensory System Agents|sensory system agents|mesh-ancestor
6205943|NCT02094898|Anesthetics, General|anesthetics, general|mesh-ancestor
6205944|NCT02094898|Anesthetics|anesthetics|mesh-ancestor
6479891|NCT00540943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5556666|NCT04046744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6205945|NCT02094898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6205946|NCT02094898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6205947|NCT02094898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6205948|NCT02094898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6205949|NCT02094898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205950|NCT02094937|Fluticasone|fluticasone|mesh-list
6205951|NCT02094937|Xhance|xhance|mesh-list
6205952|NCT02094937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5556667|NCT04046744|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6156318|NCT01469234|Loratadine|loratadine|mesh-list
6156319|NCT01469234|Fexofenadine|fexofenadine|mesh-list
6156320|NCT01469234|Terfenadine|terfenadine|mesh-list
6156321|NCT01469234|Antipruritics|antipruritics|mesh-ancestor
6479892|NCT00540956|Cytarabine|cytarabine|mesh-list
6479893|NCT00540956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6479894|NCT00540956|Antimetabolites|antimetabolites|mesh-ancestor
6479895|NCT00540956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479896|NCT00540956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6479897|NCT00540956|Antiviral Agents|antiviral agents|mesh-ancestor
6479898|NCT00540956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6479899|NCT00540956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6479900|NCT00540956|Immunologic Factors|immunologic factors|mesh-ancestor
6479901|NCT00540956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479902|NCT00541008|Sunitinib|sunitinib|mesh-list
6479903|NCT00541008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5556668|NCT04046744|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5556669|NCT04046744|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5556670|NCT04046744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5556671|NCT04046744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556672|NCT04047186|Nivolumab|nivolumab|mesh-list
5556673|NCT04047186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5556674|NCT04047186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5556675|NCT04047186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5556676|NCT04047186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556677|NCT04047004|Doxorubicin|doxorubicin|mesh-list
5556678|NCT04047004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5556679|NCT04047004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5556680|NCT04047004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5556681|NCT04047004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5556682|NCT04047004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5556683|NCT04047004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556684|NCT04046861|Ascorbic Acid|ascorbic acid|mesh-list
5556685|NCT04046861|Vitamins|vitamins|mesh-ancestor
5556686|NCT04046861|Micronutrients|micronutrients|mesh-ancestor
6479904|NCT00541008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6479905|NCT00541008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6479906|NCT00541008|Growth Substances|growth substances|mesh-ancestor
6479907|NCT00541008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479908|NCT00541008|Growth Inhibitors|growth inhibitors|mesh-ancestor
6479909|NCT00541008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6479910|NCT00541008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6479911|NCT00541008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479912|NCT00541021|Gemcitabine|gemcitabine|mesh-list
6479913|NCT00541021|Sorafenib|sorafenib|mesh-list
6479914|NCT00541021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6479915|NCT00541021|Antimetabolites|antimetabolites|mesh-ancestor
6479916|NCT00541021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479917|NCT00541021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6156322|NCT01469234|Dermatologic Agents|dermatologic agents|mesh-ancestor
6156323|NCT01469234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6156324|NCT01469234|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6156325|NCT01469234|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6156326|NCT01469234|Histamine Antagonists|histamine antagonists|mesh-ancestor
6156327|NCT01469234|Histamine Agents|histamine agents|mesh-ancestor
6156328|NCT01469234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6156329|NCT01469234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156330|NCT01469234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156331|NCT01469364|Aztreonam|aztreonam|mesh-list
6156332|NCT01469364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6156333|NCT01469364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6479918|NCT00541021|Antiviral Agents|antiviral agents|mesh-ancestor
6479919|NCT00541021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6479920|NCT00541021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6479921|NCT00541021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6479922|NCT00541021|Immunologic Factors|immunologic factors|mesh-ancestor
6479923|NCT00541021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479924|NCT00541021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6479925|NCT00541047|Leuprolide|leuprolide|mesh-list
6479926|NCT00541047|Goserelin|goserelin|mesh-list
6479927|NCT00541047|Bicalutamide|bicalutamide|mesh-list
6479928|NCT00541047|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6479929|NCT00541047|Fertility Agents|fertility agents|mesh-ancestor
6156334|NCT01469377|Cariprazine|cariprazine|mesh-list
6156335|NCT01469377|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6479930|NCT00541047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6479931|NCT00541047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479932|NCT00541047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6479933|NCT00541047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6479934|NCT00541047|Androgen Antagonists|androgen antagonists|mesh-ancestor
6156336|NCT01469377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6156337|NCT01469377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6156338|NCT01469377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156339|NCT01469377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6156340|NCT01469546|Axitinib|axitinib|mesh-list
6156341|NCT01469546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6479935|NCT00541047|Hormone Antagonists|hormone antagonists|mesh-ancestor
6479936|NCT00541047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6479937|NCT00541073|Vitamin B 12|vitamin b 12|mesh-list
6479938|NCT00541073|Hydroxocobalamin|hydroxocobalamin|mesh-list
6479939|NCT00541073|Pemetrexed|pemetrexed|mesh-list
6479940|NCT00541073|Vitamins|vitamins|mesh-ancestor
6479941|NCT00541073|Micronutrients|micronutrients|mesh-ancestor
6479942|NCT00541073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479943|NCT00541073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6479944|NCT00541073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6479945|NCT00541073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479946|NCT00541073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6479947|NCT00541073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6479948|NCT00541073|Vitamin B Complex|vitamin b complex|mesh-ancestor
6479949|NCT00541073|Hematinics|hematinics|mesh-ancestor
6479950|NCT00541086|Tamoxifen|tamoxifen|mesh-list
6156342|NCT01469546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6156343|NCT01469546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6156344|NCT01469546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156345|NCT01469585|Doxycycline|doxycycline|mesh-list
6156346|NCT01469585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6156347|NCT01469585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6156348|NCT01469585|Antimalarials|antimalarials|mesh-ancestor
6156349|NCT01469585|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6156350|NCT01469585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6156351|NCT01469637|Sulfamethoxazole|sulfamethoxazole|mesh-list
6156352|NCT01469637|Mesalamine|mesalamine|mesh-list
6156353|NCT01469637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6156354|NCT01469637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6156355|NCT01469637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6156356|NCT01469637|Analgesics|analgesics|mesh-ancestor
6156357|NCT01469637|Sensory System Agents|sensory system agents|mesh-ancestor
6156358|NCT01469637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6156359|NCT01469637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725594|NCT03179930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5725595|NCT03179930|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6479951|NCT00541086|Letrozole|letrozole|mesh-list
6479952|NCT00541086|Anastrozole|anastrozole|mesh-list
6479953|NCT00541086|Exemestane|exemestane|mesh-list
6479954|NCT00541086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479955|NCT00541086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6479956|NCT00541086|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6479957|NCT00541086|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5725596|NCT03179930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5725597|NCT03179930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725598|NCT03179618|Vasodilator Agents|vasodilator agents|mesh-list
6156360|NCT01469637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6156361|NCT01469637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6156362|NCT01469767|Fluocinonide|fluocinonide|mesh-list
6479958|NCT00541086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6479959|NCT00541086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6156363|NCT01469767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6479960|NCT00541086|Hormone Antagonists|hormone antagonists|mesh-ancestor
5556687|NCT04046861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556688|NCT04046861|Antioxidants|antioxidants|mesh-ancestor
6156364|NCT01469767|Glucocorticoids|glucocorticoids|mesh-ancestor
6156365|NCT01469767|Hormones|hormones|mesh-ancestor
6156366|NCT01469767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6156367|NCT01469767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156368|NCT01469767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6156369|NCT01469819|Lubiprostone|lubiprostone|mesh-list
6156370|NCT01469819|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6156371|NCT01469819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6156372|NCT01469819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156373|NCT01470001|Solifenacin Succinate|solifenacin succinate|mesh-list
6156374|NCT01470001|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6156375|NCT01470001|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6156376|NCT01470001|Cholinergic Agents|cholinergic agents|mesh-ancestor
6156377|NCT01470001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6156378|NCT01470001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156379|NCT01470001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156380|NCT01470001|Urological Agents|urological agents|mesh-ancestor
6156381|NCT01470027|Acetylcysteine|acetylcysteine|mesh-list
6156382|NCT01470027|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6156383|NCT01470027|Antiviral Agents|antiviral agents|mesh-ancestor
6156384|NCT01470027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6156385|NCT01470027|Expectorants|expectorants|mesh-ancestor
5556689|NCT04046861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556690|NCT04046861|Protective Agents|protective agents|mesh-ancestor
5556691|NCT04046822|Liraglutide|liraglutide|mesh-list
5556692|NCT04046822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5556693|NCT04046822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556694|NCT04046822|Incretins|incretins|mesh-ancestor
5556695|NCT04046822|Hormones|hormones|mesh-ancestor
5556696|NCT04046822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5556697|NCT04046510|Oxytocin|oxytocin|mesh-list
5556698|NCT04046510|Oxytocics|oxytocics|mesh-ancestor
5556699|NCT04046510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5556700|NCT04046510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556701|NCT04046653|Sulforaphane|sulforaphane|mesh-list
5556702|NCT04046653|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5556703|NCT04046653|Protective Agents|protective agents|mesh-ancestor
5556704|NCT04046653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556705|NCT04046653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5556706|NCT04046679|Bleomycin|bleomycin|mesh-list
5556707|NCT04046679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5556708|NCT04046679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6156386|NCT01470027|Respiratory System Agents|respiratory system agents|mesh-ancestor
6156387|NCT01470027|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6156388|NCT01470027|Antioxidants|antioxidants|mesh-ancestor
6479961|NCT00541086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6479962|NCT00541086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479963|NCT00541086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6479964|NCT00541086|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6479965|NCT00541086|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6156389|NCT01470027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156390|NCT01470027|Protective Agents|protective agents|mesh-ancestor
5556709|NCT04046029|Heparin|heparin|mesh-list
5556710|NCT04046029|Bivalirudin|bivalirudin|mesh-list
5556711|NCT04046029|Anticoagulants|anticoagulants|mesh-ancestor
5556712|NCT04046029|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5556713|NCT04046029|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5603229|NCT03008382|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6156391|NCT01470027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156392|NCT01470027|Antidotes|antidotes|mesh-ancestor
6156393|NCT01470118|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
6156394|NCT01470118|Dextrans|dextrans|mesh-list
6156395|NCT01470118|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6156396|NCT01470118|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6156397|NCT01470118|Lubricant Eye Drops|lubricant eye drops|mesh-list
6156398|NCT01470118|Alcaftadine|alcaftadine|mesh-list
6156399|NCT01470118|Anticoagulants|anticoagulants|mesh-ancestor
6156400|NCT01470118|Plasma Substitutes|plasma substitutes|mesh-ancestor
6156401|NCT01470118|Blood Substitutes|blood substitutes|mesh-ancestor
6156402|NCT01470118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6156403|NCT01470118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6156404|NCT01470118|Analgesics|analgesics|mesh-ancestor
6156405|NCT01470118|Sensory System Agents|sensory system agents|mesh-ancestor
6156406|NCT01470118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6156407|NCT01470118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156408|NCT01470118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6156409|NCT01470118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6156410|NCT01470118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6156411|NCT01470118|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6156412|NCT01470118|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6156413|NCT01470118|Histamine Antagonists|histamine antagonists|mesh-ancestor
6156414|NCT01470118|Histamine Agents|histamine agents|mesh-ancestor
6156415|NCT01470118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6156416|NCT01470118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156417|NCT01470144|Epoprostenol|epoprostenol|mesh-list
6156418|NCT01470144|Tezosentan|tezosentan|mesh-list
6156419|NCT01470144|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6156420|NCT01470144|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6156421|NCT01470144|Vasodilator Agents|vasodilator agents|mesh-ancestor
6156422|NCT01470170|Alfentanil|alfentanil|mesh-list
6156423|NCT01470170|Propofol|propofol|mesh-list
6156424|NCT01470170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6156425|NCT01470170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6156426|NCT01470170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156427|NCT01470170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6156428|NCT01470170|Anesthetics, General|anesthetics, general|mesh-ancestor
6156429|NCT01470170|Anesthetics|anesthetics|mesh-ancestor
6156430|NCT01470170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6156431|NCT01470170|Narcotics|narcotics|mesh-ancestor
6156432|NCT01470170|Analgesics|analgesics|mesh-ancestor
6156433|NCT01470170|Sensory System Agents|sensory system agents|mesh-ancestor
6156434|NCT01470170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6156435|NCT01470196|Dexamethasone|dexamethasone|mesh-list
6156436|NCT01470196|Rituximab|rituximab|mesh-list
6156437|NCT01470196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6156438|NCT01470196|Antiemetics|antiemetics|mesh-ancestor
6156439|NCT01470196|Autonomic Agents|autonomic agents|mesh-ancestor
6479966|NCT00541086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6156440|NCT01470196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6156441|NCT01470196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156442|NCT01470196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6156443|NCT01470196|Glucocorticoids|glucocorticoids|mesh-ancestor
6156444|NCT01470196|Hormones|hormones|mesh-ancestor
6156445|NCT01470196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6156446|NCT01470196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6156447|NCT01470196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6156448|NCT01470196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6156449|NCT01470196|Immunologic Factors|immunologic factors|mesh-ancestor
6156450|NCT01470196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6156451|NCT01470248|Arsenic Trioxide|arsenic trioxide|mesh-list
6156452|NCT01470248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6156453|NCT01470417|Gemcitabine|gemcitabine|mesh-list
6156454|NCT01470417|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6156455|NCT01470417|Paclitaxel|paclitaxel|mesh-list
6156456|NCT01470417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6156457|NCT01470417|Antimetabolites|antimetabolites|mesh-ancestor
6156458|NCT01470417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156459|NCT01470417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6156460|NCT01470417|Antiviral Agents|antiviral agents|mesh-ancestor
6156461|NCT01470417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6156462|NCT01470417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6156463|NCT01470417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6156464|NCT01470417|Immunologic Factors|immunologic factors|mesh-ancestor
6156465|NCT01470417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156466|NCT01470417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6156467|NCT01470417|Tubulin Modulators|tubulin modulators|mesh-ancestor
6156468|NCT01470417|Antimitotic Agents|antimitotic agents|mesh-ancestor
6156469|NCT01470417|Mitosis Modulators|mitosis modulators|mesh-ancestor
5556714|NCT04046029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556715|NCT04046029|Antithrombins|antithrombins|mesh-ancestor
5556716|NCT04046029|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5556717|NCT04046029|Protease Inhibitors|protease inhibitors|mesh-ancestor
5556718|NCT04046029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5556719|NCT04046016|Paclitaxel|paclitaxel|mesh-list
5556720|NCT04046016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6156470|NCT01470469|Guanfacine|guanfacine|mesh-list
6156471|NCT01470469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6156472|NCT01470469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6156473|NCT01470469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6156474|NCT01470469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6156475|NCT01470469|Adrenergic Agents|adrenergic agents|mesh-ancestor
6156476|NCT01470469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6156477|NCT01470469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156478|NCT01470469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156479|NCT01470599|Tofacitinib|tofacitinib|mesh-list
6156480|NCT01470599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6156481|NCT01470599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6156482|NCT01470599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156483|NCT01470612|Tofacitinib|tofacitinib|mesh-list
6156484|NCT01470612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6156485|NCT01470612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6156486|NCT01470612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156487|NCT01470651|Modafinil|modafinil|mesh-list
6156488|NCT01470651|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6156489|NCT01470651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156490|NCT01470651|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6156491|NCT01470651|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6156492|NCT01470651|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6156493|NCT01470651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156494|NCT01470859|Levodopa|levodopa|mesh-list
6156495|NCT01470859|Carbidopa|carbidopa|mesh-list
6156496|NCT01470859|Pramipexole|pramipexole|mesh-list
6156497|NCT01470859|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
6156498|NCT01470859|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6156499|NCT01470859|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6156500|NCT01470859|Dopamine Agents|dopamine agents|mesh-ancestor
6156501|NCT01470859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6156502|NCT01470859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156503|NCT01470859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156504|NCT01470859|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6156505|NCT01470859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5556721|NCT04046016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5556722|NCT04046016|Tubulin Modulators|tubulin modulators|mesh-ancestor
5556723|NCT04046016|Antimitotic Agents|antimitotic agents|mesh-ancestor
5556724|NCT04046016|Mitosis Modulators|mitosis modulators|mesh-ancestor
5556725|NCT04046016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556726|NCT04046094|Ascorbic Acid|ascorbic acid|mesh-list
5556727|NCT04046094|Vitamins|vitamins|mesh-ancestor
5556728|NCT04046094|Micronutrients|micronutrients|mesh-ancestor
5556729|NCT04046094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556730|NCT04046094|Antioxidants|antioxidants|mesh-ancestor
6156506|NCT01470859|Antioxidants|antioxidants|mesh-ancestor
6156507|NCT01470859|Protective Agents|protective agents|mesh-ancestor
6156508|NCT01470859|Dopamine Agonists|dopamine agonists|mesh-ancestor
6156509|NCT01470859|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6156510|NCT01470859|Immunologic Factors|immunologic factors|mesh-ancestor
6156511|NCT01470989|Triamcinolone|triamcinolone|mesh-list
6156512|NCT01470989|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6156513|NCT01470989|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6156514|NCT01470989|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6156515|NCT01470989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6156516|NCT01470989|Glucocorticoids|glucocorticoids|mesh-ancestor
6156517|NCT01470989|Hormones|hormones|mesh-ancestor
6156518|NCT01470989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6156519|NCT01470989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156520|NCT01470989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6156521|NCT01470989|Immunologic Factors|immunologic factors|mesh-ancestor
6156522|NCT01470989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6156523|NCT01470989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156524|NCT01471015|Darbepoetin alfa|darbepoetin alfa|mesh-list
6156525|NCT01471015|Hematinics|hematinics|mesh-ancestor
6156526|NCT01471054|Dexamethasone|dexamethasone|mesh-list
6156527|NCT01471054|Bevacizumab|bevacizumab|mesh-list
6156528|NCT01471054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6156529|NCT01471054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6156530|NCT01471054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6156531|NCT01471054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6156532|NCT01471054|Growth Substances|growth substances|mesh-ancestor
6156533|NCT01471054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156534|NCT01471054|Growth Inhibitors|growth inhibitors|mesh-ancestor
6156535|NCT01471054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6156536|NCT01471054|Antiemetics|antiemetics|mesh-ancestor
5556731|NCT04046094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556732|NCT04046094|Protective Agents|protective agents|mesh-ancestor
5556733|NCT04046289|Calcium, Dietary|calcium, dietary|mesh-list
6156537|NCT01471054|Autonomic Agents|autonomic agents|mesh-ancestor
6156538|NCT01471054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6156539|NCT01471054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6156540|NCT01471054|Glucocorticoids|glucocorticoids|mesh-ancestor
6156541|NCT01471054|Hormones|hormones|mesh-ancestor
6156542|NCT01471054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6156543|NCT01471054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6156544|NCT01471093|Rebamipide|rebamipide|mesh-list
6156545|NCT01471093|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6156546|NCT01471093|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6156547|NCT01471093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6156548|NCT01471093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6156549|NCT01471093|Antioxidants|antioxidants|mesh-ancestor
6156550|NCT01471093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156551|NCT01471093|Protective Agents|protective agents|mesh-ancestor
6156552|NCT01471093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156553|NCT01471093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5556734|NCT04046289|Calcium Carbonate|calcium carbonate|mesh-list
5556735|NCT04046289|Calcium|calcium|mesh-list
5556736|NCT04046289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6479967|NCT00541112|Leucovorin|leucovorin|mesh-list
6479968|NCT00541112|Fluorouracil|fluorouracil|mesh-list
5556737|NCT04046289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479969|NCT00541112|Capecitabine|capecitabine|mesh-list
6479970|NCT00541112|Oxaliplatin|oxaliplatin|mesh-list
6479971|NCT00541112|Cetuximab|cetuximab|mesh-list
6479972|NCT00541112|Calcium|calcium|mesh-list
6479973|NCT00541112|Levoleucovorin|levoleucovorin|mesh-list
6156554|NCT01471171|Bromides|bromides|mesh-list
6156555|NCT01471171|Anticonvulsants|anticonvulsants|mesh-ancestor
6156556|NCT01471197|Pemetrexed|pemetrexed|mesh-list
5556738|NCT04046289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5556739|NCT04046289|Antacids|antacids|mesh-ancestor
5556740|NCT04046289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156557|NCT01471197|Ipilimumab|ipilimumab|mesh-list
6156558|NCT01471197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6156559|NCT01471197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6479974|NCT00541112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6479975|NCT00541112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6479976|NCT00541112|Antimetabolites|antimetabolites|mesh-ancestor
6479977|NCT00541112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6479978|NCT00541112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6479979|NCT00541112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6156560|NCT01471197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156561|NCT01471197|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6156562|NCT01471197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6156563|NCT01471197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6156564|NCT01471197|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6156565|NCT01471353|Capecitabine|capecitabine|mesh-list
6156566|NCT01471353|Sorafenib|sorafenib|mesh-list
6156567|NCT01471353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6156568|NCT01471353|Antimetabolites|antimetabolites|mesh-ancestor
6156569|NCT01471353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156570|NCT01471353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6156571|NCT01471353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6156572|NCT01471353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6156573|NCT01471379|Milnacipran|milnacipran|mesh-list
6156574|NCT01471379|Levomilnacipran|levomilnacipran|mesh-list
6156575|NCT01471379|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6156576|NCT01471379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6156577|NCT01471379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6156578|NCT01471379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156579|NCT01471379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6156580|NCT01471379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156581|NCT01471379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6156582|NCT01471379|Analgesics|analgesics|mesh-ancestor
6156583|NCT01471379|Sensory System Agents|sensory system agents|mesh-ancestor
6156584|NCT01471379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6156585|NCT01471379|Antidepressive Agents|antidepressive agents|mesh-ancestor
6156586|NCT01471379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6156587|NCT01471574|Interferons|interferons|mesh-list
6156588|NCT01471574|Ribavirin|ribavirin|mesh-list
6156589|NCT01471574|Interferon-alpha|interferon-alpha|mesh-list
6156590|NCT01471574|Interferon alpha-2|interferon alpha-2|mesh-list
6156591|NCT01471574|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6156592|NCT01471574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6156593|NCT01471574|Antiviral Agents|antiviral agents|mesh-ancestor
6156594|NCT01471574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6156595|NCT01471574|Antimetabolites|antimetabolites|mesh-ancestor
6156596|NCT01471574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156597|NCT01471574|Immunologic Factors|immunologic factors|mesh-ancestor
6156598|NCT01471574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156599|NCT01471639|Ketorolac|ketorolac|mesh-list
6156600|NCT01471639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6156601|NCT01471639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6156602|NCT01471639|Analgesics|analgesics|mesh-ancestor
6156603|NCT01471639|Sensory System Agents|sensory system agents|mesh-ancestor
6479980|NCT00541112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6156604|NCT01471639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6156605|NCT01471639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156606|NCT01471639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6156607|NCT01471639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6156608|NCT01471639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6156609|NCT01471639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6156610|NCT01471639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156611|NCT01471691|Ranibizumab|ranibizumab|mesh-list
5556741|NCT04046289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5556742|NCT04046133|Pembrolizumab|pembrolizumab|mesh-list
5556743|NCT04046133|Capecitabine|capecitabine|mesh-list
5556744|NCT04046133|Mitomycins|mitomycins|mesh-list
5556745|NCT04046133|Mitomycin|mitomycin|mesh-list
5556746|NCT04046133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5556747|NCT04046133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5556748|NCT04046133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5556749|NCT04046133|Antimetabolites|antimetabolites|mesh-ancestor
5556750|NCT04046133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556751|NCT04046133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5556752|NCT04046133|Alkylating Agents|alkylating agents|mesh-ancestor
5556753|NCT04046133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5556754|NCT04046133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5556755|NCT04046302|Dinoprostone|dinoprostone|mesh-list
5556756|NCT04046302|Oxytocics|oxytocics|mesh-ancestor
6156612|NCT01471691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6156613|NCT01471691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6156614|NCT01471691|Growth Substances|growth substances|mesh-ancestor
6156615|NCT01471691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156616|NCT01471691|Growth Inhibitors|growth inhibitors|mesh-ancestor
6156617|NCT01471691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6156618|NCT01471782|Blinatumomab|blinatumomab|mesh-list
6156619|NCT01471782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6156620|NCT01472185|Ranolazine|ranolazine|mesh-list
6156621|NCT01472185|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6156622|NCT01472185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6156623|NCT01472185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156624|NCT01472380|Efavirenz|efavirenz|mesh-list
6156625|NCT01472380|Fenofibric acid|fenofibric acid|mesh-list
6156626|NCT01472380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6156627|NCT01472380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6156628|NCT01472380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6156629|NCT01472380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668168|NCT01530620|Propiverine|propiverine|mesh-list
5556757|NCT04046302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5556758|NCT04046302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556759|NCT04045678|Rotigotine|rotigotine|mesh-list
5556760|NCT04045678|Dopamine Agonists|dopamine agonists|mesh-ancestor
5556761|NCT04045678|Dopamine Agents|dopamine agents|mesh-ancestor
5556762|NCT04045678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5556763|NCT04045678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556764|NCT04045678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556765|NCT04045769|Moxifloxacin|moxifloxacin|mesh-list
5556766|NCT04045769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5556767|NCT04045769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5556768|NCT04045769|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5556769|NCT04045769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6668169|NCT01530620|Parasympatholytics|parasympatholytics|mesh-ancestor
6668170|NCT01530620|Autonomic Agents|autonomic agents|mesh-ancestor
6668171|NCT01530620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6668172|NCT01530620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668173|NCT01530620|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6668174|NCT01530620|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6668175|NCT01530620|Cholinergic Agents|cholinergic agents|mesh-ancestor
6668176|NCT01530620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6668177|NCT01530620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668178|NCT01530620|Urological Agents|urological agents|mesh-ancestor
6668179|NCT01530698|Vaccines|vaccines|mesh-list
6668180|NCT01530698|Immunologic Factors|immunologic factors|mesh-ancestor
6668181|NCT01530698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668182|NCT01530711|Terlipressin|terlipressin|mesh-list
6668183|NCT01530711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6668184|NCT01530711|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6668185|NCT01530737|Antithrombins|antithrombins|mesh-list
6668186|NCT01530737|Antithrombin III|antithrombin iii|mesh-list
6668187|NCT01530737|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6668188|NCT01530737|Protease Inhibitors|protease inhibitors|mesh-ancestor
6668189|NCT01530737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6668190|NCT01530737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668191|NCT01530737|Anticoagulants|anticoagulants|mesh-ancestor
6668192|NCT01530763|Amoxicillin|amoxicillin|mesh-list
6668193|NCT01530763|Ceftriaxone|ceftriaxone|mesh-list
6668194|NCT01530763|Clavulanic Acid|clavulanic acid|mesh-list
6668195|NCT01530763|Clavulanic Acids|clavulanic acids|mesh-list
6668196|NCT01530763|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
6668197|NCT01530763|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6668198|NCT01530763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6668199|NCT01530763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5556770|NCT04045769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5556771|NCT04045769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556772|NCT04045769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5556773|NCT04045730|Gemcitabine|gemcitabine|mesh-list
5556774|NCT04045730|Paclitaxel|paclitaxel|mesh-list
5556775|NCT04045730|Pembrolizumab|pembrolizumab|mesh-list
5556776|NCT04045730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5556777|NCT04045730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5556778|NCT04045730|Tubulin Modulators|tubulin modulators|mesh-ancestor
5556779|NCT04045730|Antimitotic Agents|antimitotic agents|mesh-ancestor
5556780|NCT04045730|Mitosis Modulators|mitosis modulators|mesh-ancestor
6156630|NCT01472380|Antiviral Agents|antiviral agents|mesh-ancestor
6156631|NCT01472380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6156632|NCT01472380|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6156633|NCT01472380|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6156634|NCT01472380|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6156635|NCT01472380|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6156636|NCT01472380|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6156637|NCT01472380|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6156638|NCT01472380|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6156639|NCT01472380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6156640|NCT01472380|Antimetabolites|antimetabolites|mesh-ancestor
6156641|NCT01472380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6156642|NCT01472432|Vildagliptin|vildagliptin|mesh-list
6156643|NCT01472432|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6156644|NCT01472432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156645|NCT01472432|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6156646|NCT01472432|Protease Inhibitors|protease inhibitors|mesh-ancestor
6156647|NCT01472432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6156648|NCT01472432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156649|NCT01472445|Vitamin D|vitamin d|mesh-list
6156650|NCT01472445|Cholecalciferol|cholecalciferol|mesh-list
6156651|NCT01472445|Vitamins|vitamins|mesh-ancestor
6156652|NCT01472445|Micronutrients|micronutrients|mesh-ancestor
6156653|NCT01472445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156654|NCT01472445|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6156655|NCT01472445|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6156656|NCT01472549|Ethanol|ethanol|mesh-list
6156657|NCT01472549|Chlorhexidine|chlorhexidine|mesh-list
6156658|NCT01472549|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6156659|NCT01472549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6156660|NCT01472549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6156661|NCT01472549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156662|NCT01472549|Disinfectants|disinfectants|mesh-ancestor
6156663|NCT01472562|Rituximab|rituximab|mesh-list
6156664|NCT01472562|Lenalidomide|lenalidomide|mesh-list
6156665|NCT01472562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6156666|NCT01472562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6156667|NCT01472562|Immunologic Factors|immunologic factors|mesh-ancestor
6668200|NCT01530763|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6668201|NCT01530763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5603230|NCT03008382|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5556781|NCT04045730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556782|NCT04045730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5556783|NCT04045730|Antimetabolites|antimetabolites|mesh-ancestor
5556784|NCT04045730|Antiviral Agents|antiviral agents|mesh-ancestor
5556785|NCT04045730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5556786|NCT04045730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5556787|NCT04045730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5556788|NCT04045730|Immunologic Factors|immunologic factors|mesh-ancestor
5556789|NCT04045730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556790|NCT04045730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5556791|NCT04045821|Plerixafor|plerixafor|mesh-list
5556792|NCT04045821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5556793|NCT04045821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5556794|NCT04045821|Antiviral Agents|antiviral agents|mesh-ancestor
5556795|NCT04045821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5556796|NCT04045548|Dinoprostone|dinoprostone|mesh-list
6156668|NCT01472562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156669|NCT01472562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6156670|NCT01472562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6156671|NCT01472562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6156672|NCT01472562|Growth Substances|growth substances|mesh-ancestor
6156673|NCT01472562|Growth Inhibitors|growth inhibitors|mesh-ancestor
6156674|NCT01472835|Fentanyl|fentanyl|mesh-list
6156675|NCT01472835|Midazolam|midazolam|mesh-list
6156676|NCT01472835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6156677|NCT01472835|Narcotics|narcotics|mesh-ancestor
6156678|NCT01472835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6156679|NCT01472835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156680|NCT01472835|Analgesics|analgesics|mesh-ancestor
6156681|NCT01472835|Sensory System Agents|sensory system agents|mesh-ancestor
6156682|NCT01472835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6156683|NCT01472835|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6156684|NCT01472835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6156685|NCT01472835|Anesthetics, General|anesthetics, general|mesh-ancestor
6156686|NCT01472835|Anesthetics|anesthetics|mesh-ancestor
6156687|NCT01472835|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6156688|NCT01472835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6156689|NCT01472835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6156690|NCT01472835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6156691|NCT01472835|GABA Modulators|gaba modulators|mesh-ancestor
6156692|NCT01472835|GABA Agents|gaba agents|mesh-ancestor
6156693|NCT01472835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6156694|NCT01472835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156695|NCT01472874|Trientine|trientine|mesh-list
6479981|NCT00541112|Immunologic Factors|immunologic factors|mesh-ancestor
6479982|NCT00541112|Antidotes|antidotes|mesh-ancestor
5556797|NCT04045548|Oxytocics|oxytocics|mesh-ancestor
5556798|NCT04045548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5556799|NCT04045548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556800|NCT04045522|Zoledronic Acid|zoledronic acid|mesh-list
5556801|NCT04045522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5556802|NCT04045522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556803|NCT04046185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5556804|NCT04046185|Progesterone|progesterone|mesh-list
5556805|NCT04046185|Progestins|progestins|mesh-ancestor
5556806|NCT04046185|Hormones|hormones|mesh-ancestor
5556807|NCT04046185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5556808|NCT04046185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556809|NCT04046185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556810|NCT04046185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5556811|NCT04046159|Tamoxifen|tamoxifen|mesh-list
5556812|NCT04046159|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5556813|NCT04046159|Hormone Antagonists|hormone antagonists|mesh-ancestor
5556814|NCT04046159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5556815|NCT04046159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556816|NCT04046159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5556817|NCT04046159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5556818|NCT04046159|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6156696|NCT01472874|Chelating Agents|chelating agents|mesh-ancestor
6156697|NCT01472874|Sequestering Agents|sequestering agents|mesh-ancestor
6156698|NCT01472874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156699|NCT01472965|Ethanol|ethanol|mesh-list
6156700|NCT01472965|Heparin|heparin|mesh-list
6156701|NCT01472965|Calcium heparin|calcium heparin|mesh-list
6156702|NCT01472965|Anticoagulants|anticoagulants|mesh-ancestor
6156703|NCT01472965|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5556819|NCT04046159|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5556820|NCT04046159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5603231|NCT03008382|Adrenergic Agents|adrenergic agents|mesh-ancestor
6156704|NCT01472965|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6156705|NCT01472965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156706|NCT01472965|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6156707|NCT01472965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5603232|NCT03008382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5603233|NCT03008382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603234|NCT02988401|Insulin|insulin|mesh-list
5603235|NCT02988401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5603236|NCT02988401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603237|NCT02987530|Tenofovir|tenofovir|mesh-list
5603238|NCT02987530|Emtricitabine|emtricitabine|mesh-list
5603239|NCT02987530|Darunavir|darunavir|mesh-list
5603240|NCT02987530|Dolutegravir|dolutegravir|mesh-list
5603241|NCT02987530|Cobicistat|cobicistat|mesh-list
6156708|NCT01472965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6156709|NCT01472965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156710|NCT01473368|Amoxicillin|amoxicillin|mesh-list
6479983|NCT00541112|Protective Agents|protective agents|mesh-ancestor
6479984|NCT00541112|Vitamin B Complex|vitamin b complex|mesh-ancestor
6479985|NCT00541112|Vitamins|vitamins|mesh-ancestor
6479986|NCT00541112|Micronutrients|micronutrients|mesh-ancestor
6156711|NCT01473368|Clavulanic Acid|clavulanic acid|mesh-list
6156712|NCT01473368|Clavulanic Acids|clavulanic acids|mesh-list
6156713|NCT01473368|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6156714|NCT01473368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6156715|NCT01473368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5603242|NCT02987530|Antiviral Agents|antiviral agents|mesh-ancestor
5603243|NCT02987530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6156716|NCT01473368|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6156717|NCT01473368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6156718|NCT01473368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156719|NCT01473381|Dexetimide|dexetimide|mesh-list
6156720|NCT01473381|Citalopram|citalopram|mesh-list
6156721|NCT01473381|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
6156722|NCT01473381|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6156723|NCT01473381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6156724|NCT01473381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6156725|NCT01473381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156726|NCT01473381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6156727|NCT01473381|Serotonin Agents|serotonin agents|mesh-ancestor
6156728|NCT01473381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668202|NCT01530763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603244|NCT02987530|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5603245|NCT02987530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5603246|NCT02987530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5603247|NCT02987530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603248|NCT02987530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5603249|NCT02987530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6156729|NCT01473381|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6156730|NCT01473381|Antidepressive Agents|antidepressive agents|mesh-ancestor
6156731|NCT01473381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6156732|NCT01473381|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6156733|NCT01473381|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6479987|NCT00541112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6479988|NCT00541125|Leucovorin|leucovorin|mesh-list
5603250|NCT02987530|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5603251|NCT02987530|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5603252|NCT02987530|Protease Inhibitors|protease inhibitors|mesh-ancestor
5603253|NCT02987530|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5603254|NCT02987530|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5603255|NCT02987530|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5603256|NCT02987530|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5603257|NCT02965690|Cimetidine|cimetidine|mesh-list
5603258|NCT02965690|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6479989|NCT00541125|Bevacizumab|bevacizumab|mesh-list
6479990|NCT00541125|Fluorouracil|fluorouracil|mesh-list
5603259|NCT02965690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6479991|NCT00541125|Irinotecan|irinotecan|mesh-list
6479992|NCT00541125|Calcium|calcium|mesh-list
6479993|NCT00541125|Levoleucovorin|levoleucovorin|mesh-list
6479994|NCT00541125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6479995|NCT00541125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5556821|NCT04045431|Hylan|hylan|mesh-list
5556822|NCT04045431|Viscosupplements|viscosupplements|mesh-ancestor
5556823|NCT04045431|Protective Agents|protective agents|mesh-ancestor
5556824|NCT04045431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556825|NCT04045093|Warfarin|warfarin|mesh-list
5556826|NCT04045093|Dabigatran|dabigatran|mesh-list
5556827|NCT04045093|Anticoagulants|anticoagulants|mesh-ancestor
5556828|NCT04045093|Antithrombins|antithrombins|mesh-ancestor
5556829|NCT04045093|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5556830|NCT04045093|Protease Inhibitors|protease inhibitors|mesh-ancestor
5556831|NCT04045093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5556832|NCT04045093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556833|NCT04044976|Caffeine|caffeine|mesh-list
5556834|NCT04044976|Caffeine citrate|caffeine citrate|mesh-list
5556835|NCT04044976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556836|NCT04044976|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5556837|NCT04044976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556838|NCT04044976|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5556839|NCT04044976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5556840|NCT04044976|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5556841|NCT04044976|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5556842|NCT04044976|Purinergic Agents|purinergic agents|mesh-ancestor
5556843|NCT04044976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5556844|NCT04044690|Immunoglobulins|immunoglobulins|mesh-list
5556845|NCT04044690|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5556846|NCT04044690|Antibodies|antibodies|mesh-list
5556847|NCT04044690|Immunoglobulin G|immunoglobulin g|mesh-list
5556848|NCT04044690|Immunologic Factors|immunologic factors|mesh-ancestor
5556849|NCT04044690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556850|NCT04044729|Cannabidiol|cannabidiol|mesh-list
5556851|NCT04044729|Anticonvulsants|anticonvulsants|mesh-ancestor
5556852|NCT04045015|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
5556853|NCT04045015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5556854|NCT04044651|Nivolumab|nivolumab|mesh-list
5556855|NCT04044651|Lenvatinib|lenvatinib|mesh-list
5556856|NCT04044651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6156734|NCT01473381|Parasympatholytics|parasympatholytics|mesh-ancestor
6156735|NCT01473381|Autonomic Agents|autonomic agents|mesh-ancestor
6156736|NCT01473381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6156737|NCT01473381|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6156738|NCT01473381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6156739|NCT01473381|Cholinergic Agents|cholinergic agents|mesh-ancestor
5556857|NCT04044651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5556858|NCT04044651|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5556859|NCT04044651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556860|NCT04044651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5556861|NCT04044651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5556862|NCT04044703|Vancomycin|vancomycin|mesh-list
5556863|NCT04044703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5556864|NCT04044703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5556865|NCT04044378|Ifosfamide|ifosfamide|mesh-list
5556866|NCT04044378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5556867|NCT04044378|Alkylating Agents|alkylating agents|mesh-ancestor
5556868|NCT04044378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156740|NCT01473381|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6156741|NCT01473381|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6156742|NCT01473394|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
6156743|NCT01473394|Antidepressive Agents|antidepressive agents|mesh-ancestor
6156744|NCT01473394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6156745|NCT01473394|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6156746|NCT01473394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6156747|NCT01473394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6156748|NCT01473394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156749|NCT01473394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6156750|NCT01473394|Serotonin Agents|serotonin agents|mesh-ancestor
6156751|NCT01473394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156752|NCT01473394|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6156753|NCT01473394|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6156754|NCT01473407|Epoetin Alfa|epoetin alfa|mesh-list
6156755|NCT01473407|Hematinics|hematinics|mesh-ancestor
6156756|NCT01473420|Epoetin Alfa|epoetin alfa|mesh-list
6156757|NCT01473420|Hematinics|hematinics|mesh-ancestor
6156758|NCT01473524|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
6156759|NCT01473524|Cathartics|cathartics|mesh-ancestor
6479996|NCT00541125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5556869|NCT04044378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5556870|NCT04044430|Nivolumab|nivolumab|mesh-list
5556871|NCT04044430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5556872|NCT04044430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5556873|NCT04044430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5556874|NCT04044430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556875|NCT04044417|Curcumin|curcumin|mesh-list
5556876|NCT04044417|Simvastatin|simvastatin|mesh-list
5556877|NCT04044417|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5556878|NCT04044417|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5556879|NCT04044417|Antimetabolites|antimetabolites|mesh-ancestor
5556880|NCT04044417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556881|NCT04044417|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5556882|NCT04044417|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5556883|NCT04044417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5556884|NCT04044417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5556885|NCT04044417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5556886|NCT04044417|Analgesics|analgesics|mesh-ancestor
5556887|NCT04044417|Sensory System Agents|sensory system agents|mesh-ancestor
5556888|NCT04044417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5556889|NCT04044417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556890|NCT04044417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5556891|NCT04044417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5556892|NCT04044417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5556893|NCT04044534|Insulin|insulin|mesh-list
5556894|NCT04044534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5556895|NCT04044534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556896|NCT04044547|Rotigotine|rotigotine|mesh-list
6156760|NCT01473524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6156761|NCT01473563|Pemetrexed|pemetrexed|mesh-list
6156762|NCT01473563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6156763|NCT01473563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6156764|NCT01473563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156765|NCT01473563|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6156766|NCT01473563|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6156767|NCT01473589|Vitamin D|vitamin d|mesh-list
6156768|NCT01473589|Teriparatide|teriparatide|mesh-list
6479997|NCT00541125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6479998|NCT00541125|Growth Substances|growth substances|mesh-ancestor
6479999|NCT00541125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480000|NCT00541125|Growth Inhibitors|growth inhibitors|mesh-ancestor
6156769|NCT01473589|Calcium|calcium|mesh-list
6156770|NCT01473589|Vitamins|vitamins|mesh-ancestor
6156771|NCT01473589|Micronutrients|micronutrients|mesh-ancestor
6156772|NCT01473589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156773|NCT01473589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6156774|NCT01473589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6156775|NCT01473602|Vitamin D|vitamin d|mesh-list
6156776|NCT01473602|Teriparatide|teriparatide|mesh-list
6156777|NCT01473602|Calcium|calcium|mesh-list
6156778|NCT01473602|Vitamins|vitamins|mesh-ancestor
6156779|NCT01473602|Micronutrients|micronutrients|mesh-ancestor
6156780|NCT01473602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156781|NCT01473602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6156782|NCT01473602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6156783|NCT01473745|Daminozide|daminozide|mesh-list
6156784|NCT01473745|Plant Growth Regulators|plant growth regulators|mesh-ancestor
6156785|NCT01473745|Growth Substances|growth substances|mesh-ancestor
6156786|NCT01473745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556897|NCT04044547|Dopamine Agonists|dopamine agonists|mesh-ancestor
5556898|NCT04044547|Dopamine Agents|dopamine agents|mesh-ancestor
5556899|NCT04044547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5556900|NCT04044547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556901|NCT04044547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556902|NCT04044313|Lenvatinib|lenvatinib|mesh-list
5556903|NCT04044313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5556904|NCT04044313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5556905|NCT04044313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5556906|NCT04044313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556907|NCT04044287|Misoprostol|misoprostol|mesh-list
5556908|NCT04044287|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5556909|NCT04044287|Abortifacient Agents|abortifacient agents|mesh-ancestor
5556910|NCT04044287|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5556911|NCT04044287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556912|NCT04044287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6156787|NCT01473836|Metronidazole|metronidazole|mesh-list
6156788|NCT01473836|Ceftriaxone|ceftriaxone|mesh-list
5556913|NCT04044287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5556914|NCT04044287|Oxytocics|oxytocics|mesh-ancestor
5556915|NCT04043897|Rifaximin|rifaximin|mesh-list
6156789|NCT01473836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6156790|NCT01473836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6156791|NCT01473836|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5556916|NCT04043897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5556917|NCT04043897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5556918|NCT04043897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5556919|NCT04043858|Midodrine|midodrine|mesh-list
5556920|NCT04043858|Sympathomimetics|sympathomimetics|mesh-ancestor
5556921|NCT04043858|Autonomic Agents|autonomic agents|mesh-ancestor
5556922|NCT04043858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5556923|NCT04043858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556924|NCT04043858|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5556925|NCT04043858|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5556926|NCT04043858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5556927|NCT04043858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5556928|NCT04043858|Adrenergic Agents|adrenergic agents|mesh-ancestor
6156792|NCT01473836|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6156793|NCT01473940|Gemcitabine|gemcitabine|mesh-list
6156794|NCT01473940|Ipilimumab|ipilimumab|mesh-list
6156795|NCT01473940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6156796|NCT01473940|Antibodies|antibodies|mesh-list
6156797|NCT01473940|Immunoglobulins|immunoglobulins|mesh-list
6156798|NCT01473940|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6156799|NCT01473940|Immunologic Factors|immunologic factors|mesh-ancestor
6156800|NCT01473940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156801|NCT01473940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6156802|NCT01473940|Antimetabolites|antimetabolites|mesh-ancestor
6156803|NCT01473940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156804|NCT01473940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6156805|NCT01473940|Antiviral Agents|antiviral agents|mesh-ancestor
5556929|NCT04043858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5556930|NCT04043858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556931|NCT04044131|Sorbitol|sorbitol|mesh-list
5556932|NCT04044131|Cathartics|cathartics|mesh-ancestor
5556933|NCT04044131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6156806|NCT01473940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6156807|NCT01473940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6156808|NCT01473940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6156809|NCT01473940|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6156810|NCT01473953|Liraglutide|liraglutide|mesh-list
6156811|NCT01473953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6156812|NCT01473953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156813|NCT01473953|Incretins|incretins|mesh-ancestor
6156814|NCT01473953|Hormones|hormones|mesh-ancestor
6156815|NCT01473953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6156816|NCT01474018|Bromocriptine|bromocriptine|mesh-list
6156817|NCT01474018|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6156818|NCT01474018|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6156819|NCT01474018|Hormone Antagonists|hormone antagonists|mesh-ancestor
6156820|NCT01474018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6156821|NCT01474018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156822|NCT01474018|Dopamine Agonists|dopamine agonists|mesh-ancestor
6156823|NCT01474018|Dopamine Agents|dopamine agents|mesh-ancestor
6156824|NCT01474018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6156825|NCT01474018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156826|NCT01474109|Macitentan|macitentan|mesh-list
6156827|NCT01474109|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
6156828|NCT01474109|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6156829|NCT01474109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156830|NCT01474109|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
6156831|NCT01474122|Macitentan|macitentan|mesh-list
6156832|NCT01474122|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
6156833|NCT01474122|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6156834|NCT01474122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156835|NCT01474122|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
6156836|NCT01474200|Furosemide|furosemide|mesh-list
6156837|NCT01474200|Diuretics|diuretics|mesh-list
6156838|NCT01474200|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
6156839|NCT01474200|Natriuretic Agents|natriuretic agents|mesh-ancestor
6156840|NCT01474200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556934|NCT04044079|Misoprostol|misoprostol|mesh-list
5556935|NCT04044079|Dinoprostone|dinoprostone|mesh-list
5556936|NCT04044079|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5556937|NCT04044079|Abortifacient Agents|abortifacient agents|mesh-ancestor
5556938|NCT04044079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5556939|NCT04044079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556940|NCT04044079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5556941|NCT04044079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5556942|NCT04044079|Oxytocics|oxytocics|mesh-ancestor
5556943|NCT04044222|Carboplatin|carboplatin|mesh-list
5556944|NCT04044222|Etoposide|etoposide|mesh-list
5556945|NCT04044222|Etoposide phosphate|etoposide phosphate|mesh-list
6668203|NCT01530815|Bupivacaine|bupivacaine|mesh-list
6668204|NCT01530815|Anesthetics, Local|anesthetics, local|mesh-ancestor
6668205|NCT01530815|Anesthetics|anesthetics|mesh-ancestor
5556946|NCT04044222|Ifosfamide|ifosfamide|mesh-list
5556947|NCT04044222|Isophosphamide mustard|isophosphamide mustard|mesh-list
5556948|NCT04044222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5556949|NCT04044222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5556950|NCT04044222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5556951|NCT04044222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5556952|NCT04044222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5556953|NCT04044222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488854|NCT00587379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5606800|NCT03770130|Analgesics|analgesics|mesh-ancestor
6668206|NCT01530815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5556954|NCT04044222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5556955|NCT04044222|Alkylating Agents|alkylating agents|mesh-ancestor
5556956|NCT04043676|Ponatinib|ponatinib|mesh-list
5556957|NCT04043676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5556958|NCT04043676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5556959|NCT04043676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5556960|NCT04043676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556961|NCT04043520|Estradiol|estradiol|mesh-list
5556962|NCT04043520|Estrogens|estrogens|mesh-list
5556963|NCT04043520|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
5556964|NCT04043520|Hormones|hormones|mesh-ancestor
6488855|NCT00587379|Antimetabolites|antimetabolites|mesh-ancestor
6156841|NCT01474200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6156842|NCT01474200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156843|NCT01474213|Dexmedetomidine|dexmedetomidine|mesh-list
6156844|NCT01474213|Remifentanil|remifentanil|mesh-list
5556965|NCT04043520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5556966|NCT04043520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556967|NCT04043806|Ivacaftor|ivacaftor|mesh-list
5556968|NCT04043806|Elexacaftor|elexacaftor|mesh-list
5556969|NCT04043806|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
5556970|NCT04043806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5556971|NCT04043806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603260|NCT02965690|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5603261|NCT02965690|Histamine Antagonists|histamine antagonists|mesh-ancestor
5603262|NCT02965690|Histamine Agents|histamine agents|mesh-ancestor
5603263|NCT02965690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5603264|NCT02965690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156845|NCT01474213|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6156846|NCT01474213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6156847|NCT01474213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156848|NCT01474213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6156849|NCT01474213|Analgesics|analgesics|mesh-ancestor
6156850|NCT01474213|Sensory System Agents|sensory system agents|mesh-ancestor
6156851|NCT01474213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6156852|NCT01474213|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6156853|NCT01474213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6156854|NCT01474213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6156855|NCT01474213|Adrenergic Agents|adrenergic agents|mesh-ancestor
6156856|NCT01474213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6156857|NCT01474213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156858|NCT01474213|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6156859|NCT01474213|Narcotics|narcotics|mesh-ancestor
6156860|NCT01474239|Bevacizumab|bevacizumab|mesh-list
6156861|NCT01474239|Fotemustine|fotemustine|mesh-list
6156862|NCT01474239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6156863|NCT01474239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6156864|NCT01474239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6156865|NCT01474239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6156866|NCT01474239|Growth Substances|growth substances|mesh-ancestor
6156867|NCT01474239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156868|NCT01474239|Growth Inhibitors|growth inhibitors|mesh-ancestor
6156869|NCT01474486|Ergocalciferols|ergocalciferols|mesh-list
6156870|NCT01474486|Thiamine|thiamine|mesh-list
6156871|NCT01474486|Micronutrients|micronutrients|mesh-list
6156872|NCT01474486|Trace Elements|trace elements|mesh-list
6156873|NCT01474486|Vitamins|vitamins|mesh-ancestor
6156874|NCT01474486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156875|NCT01474486|Vitamin B Complex|vitamin b complex|mesh-ancestor
6156876|NCT01474486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6156877|NCT01474486|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6156878|NCT01474512|Ixekizumab|ixekizumab|mesh-list
6156879|NCT01474512|Dermatologic Agents|dermatologic agents|mesh-ancestor
6156880|NCT01474538|Insulin|insulin|mesh-list
6156881|NCT01474538|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6156882|NCT01474538|Insulin Aspart|insulin aspart|mesh-list
6156883|NCT01474538|Insulin Lispro|insulin lispro|mesh-list
6156884|NCT01474538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6156885|NCT01474538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156886|NCT01474551|Vemurafenib|vemurafenib|mesh-list
6480001|NCT00541125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6480002|NCT00541125|Antimetabolites|antimetabolites|mesh-ancestor
6480003|NCT00541125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480004|NCT00541125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6480005|NCT00541125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6480006|NCT00541125|Immunologic Factors|immunologic factors|mesh-ancestor
6480007|NCT00541125|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6480008|NCT00541125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6480009|NCT00541125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6480010|NCT00541125|Antidotes|antidotes|mesh-ancestor
6480011|NCT00541125|Protective Agents|protective agents|mesh-ancestor
6480012|NCT00541125|Vitamin B Complex|vitamin b complex|mesh-ancestor
6480013|NCT00541125|Vitamins|vitamins|mesh-ancestor
6480014|NCT00541125|Micronutrients|micronutrients|mesh-ancestor
6480015|NCT00541138|Tamoxifen|tamoxifen|mesh-list
6480016|NCT00541138|Carboplatin|carboplatin|mesh-list
6480017|NCT00541138|Topotecan|topotecan|mesh-list
6480018|NCT00541138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6480019|NCT00541138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480020|NCT00541138|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6480021|NCT00541138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6480022|NCT00541138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6480023|NCT00541138|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6668207|NCT01530815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668208|NCT01530815|Sensory System Agents|sensory system agents|mesh-ancestor
6668209|NCT01530815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6668210|NCT01530984|Ipilimumab|ipilimumab|mesh-list
6668211|NCT01530984|Sargramostim|sargramostim|mesh-list
6668212|NCT01530984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6668213|NCT01530984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6668214|NCT01530984|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6668215|NCT01530984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668216|NCT01530984|Immunologic Factors|immunologic factors|mesh-ancestor
5556972|NCT04043702|Topiramate|topiramate|mesh-list
5556973|NCT04043702|Anticonvulsants|anticonvulsants|mesh-ancestor
5556974|NCT04043702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5556975|NCT04043702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556976|NCT04043624|Lidocaine|lidocaine|mesh-list
5556977|NCT04043624|Anesthetics, Local|anesthetics, local|mesh-ancestor
5556978|NCT04043624|Anesthetics|anesthetics|mesh-ancestor
5556979|NCT04043624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5556980|NCT04043624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5556981|NCT04043624|Sensory System Agents|sensory system agents|mesh-ancestor
5556982|NCT04043624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5556983|NCT04043624|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5556984|NCT04043624|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5556985|NCT04043624|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5556986|NCT04043624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5556987|NCT04043624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5556988|NCT04043494|Cytarabine|cytarabine|mesh-list
5556989|NCT04043494|Dexamethasone|dexamethasone|mesh-list
5556990|NCT04043494|Prednisone|prednisone|mesh-list
5556991|NCT04043494|Prednisolone|prednisolone|mesh-list
5556992|NCT04043494|Cyclophosphamide|cyclophosphamide|mesh-list
5556993|NCT04043494|Ifosfamide|ifosfamide|mesh-list
5556994|NCT04043494|Doxorubicin|doxorubicin|mesh-list
5556995|NCT04043494|Methotrexate|methotrexate|mesh-list
5556996|NCT04043494|Vincristine|vincristine|mesh-list
5556997|NCT04043494|Daunorubicin|daunorubicin|mesh-list
5556998|NCT04043494|Asparaginase|asparaginase|mesh-list
6156887|NCT01474551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6480024|NCT00541138|Hormone Antagonists|hormone antagonists|mesh-ancestor
6668217|NCT01530984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668218|NCT01531049|Nicotine|nicotine|mesh-list
6480025|NCT00541138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5556999|NCT04043494|Mercaptopurine|mercaptopurine|mesh-list
5557000|NCT04043494|Thioguanine|thioguanine|mesh-list
5557001|NCT04043494|Pegaspargase|pegaspargase|mesh-list
5557002|NCT04043494|Vindesine|vindesine|mesh-list
5557003|NCT04043494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6156888|NCT01474551|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6156889|NCT01474551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6156890|NCT01474551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156891|NCT01474590|Doxycycline|doxycycline|mesh-list
6156892|NCT01474590|Isotretinoin|isotretinoin|mesh-list
6156893|NCT01474590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6156894|NCT01474590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6156895|NCT01474590|Antimalarials|antimalarials|mesh-ancestor
6156896|NCT01474590|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6156897|NCT01474590|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6156898|NCT01474590|Dermatologic Agents|dermatologic agents|mesh-ancestor
6156899|NCT01474746|Sertraline|sertraline|mesh-list
6156900|NCT01474746|Antidepressive Agents|antidepressive agents|mesh-ancestor
6156901|NCT01474746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6480026|NCT00541138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480027|NCT00541138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6156902|NCT01474746|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6156903|NCT01474746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6156904|NCT01474746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6156905|NCT01474746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156906|NCT01474746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6156907|NCT01474746|Serotonin Agents|serotonin agents|mesh-ancestor
6156908|NCT01474746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156909|NCT01474772|Pregabalin|pregabalin|mesh-list
6156910|NCT01474772|Analgesics|analgesics|mesh-ancestor
5557004|NCT04043494|Immunologic Factors|immunologic factors|mesh-ancestor
5557005|NCT04043494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557006|NCT04043494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5557007|NCT04043494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5557008|NCT04043494|Alkylating Agents|alkylating agents|mesh-ancestor
5557009|NCT04043494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557010|NCT04043494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5557011|NCT04043494|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5557012|NCT04043494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5557013|NCT04043494|Antiemetics|antiemetics|mesh-ancestor
5557014|NCT04043494|Autonomic Agents|autonomic agents|mesh-ancestor
5557015|NCT04043494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5557016|NCT04043494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5557017|NCT04043494|Glucocorticoids|glucocorticoids|mesh-ancestor
5557018|NCT04043494|Hormones|hormones|mesh-ancestor
5557019|NCT04043494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5557020|NCT04043494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6156911|NCT01474772|Sensory System Agents|sensory system agents|mesh-ancestor
6156912|NCT01474772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6156913|NCT01474772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156914|NCT01474772|Anticonvulsants|anticonvulsants|mesh-ancestor
6156915|NCT01474772|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6156916|NCT01474772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6156917|NCT01474772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156918|NCT01474772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6156919|NCT01474772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6156920|NCT01474772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5557021|NCT04043494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5557022|NCT04043494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5557023|NCT04043494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5557024|NCT04043494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6156921|NCT01474772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6156922|NCT01474772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6156923|NCT01474915|Promethazine|promethazine|mesh-list
6156924|NCT01474915|Diphenhydramine|diphenhydramine|mesh-list
6156925|NCT01474915|Dexamethasone|dexamethasone|mesh-list
6156926|NCT01474915|Ondansetron|ondansetron|mesh-list
6156927|NCT01474915|Aprepitant|aprepitant|mesh-list
6156928|NCT01474915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6156929|NCT01474915|Antiemetics|antiemetics|mesh-ancestor
6156930|NCT01474915|Autonomic Agents|autonomic agents|mesh-ancestor
6156931|NCT01474915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6156932|NCT01474915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156933|NCT01474915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6156934|NCT01474915|Glucocorticoids|glucocorticoids|mesh-ancestor
6156935|NCT01474915|Hormones|hormones|mesh-ancestor
6156936|NCT01474915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6156937|NCT01474915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6156938|NCT01474915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6156939|NCT01474915|Antipruritics|antipruritics|mesh-ancestor
6156940|NCT01474915|Dermatologic Agents|dermatologic agents|mesh-ancestor
6156941|NCT01474915|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6156942|NCT01474915|Serotonin Agents|serotonin agents|mesh-ancestor
6156943|NCT01474915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6156944|NCT01474915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557025|NCT04043494|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5557026|NCT04043494|Abortifacient Agents|abortifacient agents|mesh-ancestor
5557027|NCT04043494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5557028|NCT04043494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5557029|NCT04043494|Antimetabolites|antimetabolites|mesh-ancestor
5557030|NCT04043494|Dermatologic Agents|dermatologic agents|mesh-ancestor
5557031|NCT04043494|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5557032|NCT04043494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5557033|NCT04043494|Antiviral Agents|antiviral agents|mesh-ancestor
5557034|NCT04043494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5557035|NCT04043494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5557036|NCT04043494|Tubulin Modulators|tubulin modulators|mesh-ancestor
5557037|NCT04043494|Antimitotic Agents|antimitotic agents|mesh-ancestor
5557038|NCT04043494|Mitosis Modulators|mitosis modulators|mesh-ancestor
5557039|NCT04043741|Sulfamethazine|sulfamethazine|mesh-list
6156945|NCT01474915|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6156946|NCT01474915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6156947|NCT01474915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6156948|NCT01474915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6156949|NCT01474915|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6156950|NCT01474915|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6156951|NCT01474915|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6156952|NCT01474915|Histamine Antagonists|histamine antagonists|mesh-ancestor
6156953|NCT01474915|Histamine Agents|histamine agents|mesh-ancestor
6480028|NCT00541138|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6480029|NCT00541138|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5557040|NCT04043741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5557041|NCT04043325|Antibodies|antibodies|mesh-list
5557042|NCT04043325|Immunologic Factors|immunologic factors|mesh-ancestor
5557043|NCT04043325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557044|NCT04042948|Acetaminophen|acetaminophen|mesh-list
5557045|NCT04042948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5557046|NCT04042948|Analgesics|analgesics|mesh-ancestor
5557047|NCT04042948|Sensory System Agents|sensory system agents|mesh-ancestor
5557048|NCT04042948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6480030|NCT00541138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6488856|NCT00587379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488857|NCT00587379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6668219|NCT01531049|Varenicline|varenicline|mesh-list
6156954|NCT01474915|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6156955|NCT01474915|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6156956|NCT01474915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6156957|NCT01474915|Anesthetics, Local|anesthetics, local|mesh-ancestor
6156958|NCT01474915|Anesthetics|anesthetics|mesh-ancestor
5557049|NCT04042948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557050|NCT04042948|Antipyretics|antipyretics|mesh-ancestor
5557051|NCT04043195|Oxaliplatin|oxaliplatin|mesh-list
5557052|NCT04043195|Nivolumab|nivolumab|mesh-list
5557053|NCT04043195|Ipilimumab|ipilimumab|mesh-list
5557054|NCT04043195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5557055|NCT04043195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6156959|NCT01474915|Sensory System Agents|sensory system agents|mesh-ancestor
6156960|NCT01474993|Sulforaphane|sulforaphane|mesh-list
6156961|NCT01474993|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6156962|NCT01474993|Protective Agents|protective agents|mesh-ancestor
6156963|NCT01474993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156964|NCT01474993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6156965|NCT01475071|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
6156966|NCT01475071|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6156967|NCT01475071|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6156968|NCT01475071|Dermatologic Agents|dermatologic agents|mesh-ancestor
6156969|NCT01475253|Lidocaine|lidocaine|mesh-list
6156970|NCT01475253|Anesthetics, Local|anesthetics, local|mesh-ancestor
6156971|NCT01475253|Anesthetics|anesthetics|mesh-ancestor
6156972|NCT01475253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6156973|NCT01475253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156974|NCT01475253|Sensory System Agents|sensory system agents|mesh-ancestor
6156975|NCT01475253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6156976|NCT01475253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6156977|NCT01475253|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6156978|NCT01475253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6156979|NCT01475253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6156980|NCT01475253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205953|NCT02094937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6205954|NCT02094937|Autonomic Agents|autonomic agents|mesh-ancestor
6205955|NCT02094937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6205956|NCT02094937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205957|NCT02094937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6480031|NCT00541164|Ubiquinone|ubiquinone|mesh-list
6480032|NCT00541164|Coenzyme Q10|coenzyme q10|mesh-list
6480033|NCT00541164|Micronutrients|micronutrients|mesh-ancestor
6480034|NCT00541164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480035|NCT00541164|Vitamins|vitamins|mesh-ancestor
6480036|NCT00541177|Atropine|atropine|mesh-list
6480037|NCT00541177|Tropicamide|tropicamide|mesh-list
6480038|NCT00541177|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6480039|NCT00541177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6480040|NCT00541177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5557056|NCT04043195|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5557057|NCT04043195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557058|NCT04042974|Dinoprostone|dinoprostone|mesh-list
5557059|NCT04042974|Oxytocics|oxytocics|mesh-ancestor
5557060|NCT04042974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6205958|NCT02094937|Respiratory System Agents|respiratory system agents|mesh-ancestor
6205959|NCT02094937|Dermatologic Agents|dermatologic agents|mesh-ancestor
6205960|NCT02094937|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6205961|NCT02095106|Calpastatin|calpastatin|mesh-list
6205962|NCT02095106|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
6205963|NCT02095106|Protease Inhibitors|protease inhibitors|mesh-ancestor
6205964|NCT02095106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6205965|NCT02095106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205966|NCT02095158|Phenylephrine|phenylephrine|mesh-list
6205967|NCT02095158|Oxymetazoline|oxymetazoline|mesh-list
6205968|NCT02095158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6205969|NCT02095158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6205970|NCT02095158|Adrenergic Agents|adrenergic agents|mesh-ancestor
6205971|NCT02095158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6205972|NCT02095158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205973|NCT02095158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205974|NCT02095158|Sympathomimetics|sympathomimetics|mesh-ancestor
6205975|NCT02095158|Autonomic Agents|autonomic agents|mesh-ancestor
6205976|NCT02095158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6205977|NCT02095158|Nasal Decongestants|nasal decongestants|mesh-ancestor
6205978|NCT02095158|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6205979|NCT02095158|Respiratory System Agents|respiratory system agents|mesh-ancestor
6205980|NCT02095158|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6480041|NCT00541177|Autonomic Agents|autonomic agents|mesh-ancestor
6480042|NCT00541177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5557061|NCT04042974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557062|NCT04043065|Anti-Infective Agents|anti-infective agents|mesh-list
5557063|NCT04043065|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5557064|NCT04042805|Lenvatinib|lenvatinib|mesh-list
5557065|NCT04042805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5557066|NCT04042805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5557067|NCT04042805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5557068|NCT04042805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557069|NCT04042727|Dexmedetomidine|dexmedetomidine|mesh-list
5557070|NCT04042727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5557071|NCT04042727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5557072|NCT04042727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557073|NCT04042727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5557074|NCT04042727|Analgesics|analgesics|mesh-ancestor
5557075|NCT04042727|Sensory System Agents|sensory system agents|mesh-ancestor
5557076|NCT04042727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5557077|NCT04042727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5557078|NCT04042727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5557079|NCT04042727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5557080|NCT04042727|Adrenergic Agents|adrenergic agents|mesh-ancestor
5557081|NCT04042727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5557082|NCT04042727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557083|NCT04042506|Nivolumab|nivolumab|mesh-list
6156981|NCT01475331|Ethanol|ethanol|mesh-list
6156982|NCT01475331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6156983|NCT01475331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6156984|NCT01475331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6156985|NCT01475331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6156986|NCT01475461|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6156987|NCT01475461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6480043|NCT00541177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480044|NCT00541177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6480045|NCT00541177|Respiratory System Agents|respiratory system agents|mesh-ancestor
6480046|NCT00541177|Mydriatics|mydriatics|mesh-ancestor
6480047|NCT00541177|Parasympatholytics|parasympatholytics|mesh-ancestor
6480048|NCT00541177|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6480049|NCT00541177|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6480050|NCT00541177|Cholinergic Agents|cholinergic agents|mesh-ancestor
6480051|NCT00541177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6480052|NCT00541177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557084|NCT04042506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5557085|NCT04042506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5557086|NCT04042506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6156988|NCT01475461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480053|NCT00541216|Ephedrine|ephedrine|mesh-list
6480054|NCT00541216|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6480055|NCT00541216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480056|NCT00541216|Sympathomimetics|sympathomimetics|mesh-ancestor
6156989|NCT01475461|Incretins|incretins|mesh-ancestor
6156990|NCT01475461|Hormones|hormones|mesh-ancestor
6480057|NCT00541216|Autonomic Agents|autonomic agents|mesh-ancestor
6480058|NCT00541216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6480059|NCT00541216|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6480060|NCT00541216|Adrenergic Agents|adrenergic agents|mesh-ancestor
6480061|NCT00541216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6480062|NCT00541216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480063|NCT00541281|Prednisone|prednisone|mesh-list
6480064|NCT00541281|Docetaxel|docetaxel|mesh-list
6156991|NCT01475461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6480065|NCT00541281|Estramustine|estramustine|mesh-list
6480066|NCT00541281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6480067|NCT00541281|Tubulin Modulators|tubulin modulators|mesh-ancestor
6480068|NCT00541281|Antimitotic Agents|antimitotic agents|mesh-ancestor
6480069|NCT00541281|Mitosis Modulators|mitosis modulators|mesh-ancestor
6480070|NCT00541281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557087|NCT04042506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557088|NCT04042441|Insulin|insulin|mesh-list
5557089|NCT04042441|Insulin Aspart|insulin aspart|mesh-list
5557090|NCT04042441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5557091|NCT04042441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557092|NCT04042688|Tranexamic Acid|tranexamic acid|mesh-list
5557093|NCT04042688|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6156992|NCT01475461|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6156993|NCT01475461|Protease Inhibitors|protease inhibitors|mesh-ancestor
6156994|NCT01475461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6156995|NCT01475461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6156996|NCT01475513|Moxifloxacin|moxifloxacin|mesh-list
6156997|NCT01475513|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6156998|NCT01475513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6156999|NCT01475513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6157000|NCT01475513|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6157001|NCT01475513|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6157002|NCT01475513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6157003|NCT01475513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557094|NCT04042688|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5557095|NCT04042688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157004|NCT01475513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6157005|NCT01475513|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6157006|NCT01475513|Contraceptive Agents|contraceptive agents|mesh-ancestor
6157007|NCT01475513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6157008|NCT01475513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157009|NCT01475513|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6157010|NCT01475513|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6157011|NCT01475513|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6157012|NCT01475643|Loteprednol Etabonate|loteprednol etabonate|mesh-list
6157013|NCT01475643|Prednisolone|prednisolone|mesh-list
6157014|NCT01475643|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6157015|NCT01475643|Methylprednisolone|methylprednisolone|mesh-list
6157016|NCT01475643|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6157017|NCT01475643|Prednisolone acetate|prednisolone acetate|mesh-list
6157018|NCT01475643|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6157019|NCT01475643|Prednisolone phosphate|prednisolone phosphate|mesh-list
6157020|NCT01475643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5557096|NCT04042688|Hemostatics|hemostatics|mesh-ancestor
5557097|NCT04042688|Coagulants|coagulants|mesh-ancestor
5557098|NCT04042558|Bevacizumab|bevacizumab|mesh-list
5557099|NCT04042558|Carboplatin|carboplatin|mesh-list
5557100|NCT04042558|Pemetrexed|pemetrexed|mesh-list
5557101|NCT04042558|Atezolizumab|atezolizumab|mesh-list
5557102|NCT04042558|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5557103|NCT04042558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5557104|NCT04042558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5557105|NCT04042558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5557106|NCT04042558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5557107|NCT04042558|Growth Substances|growth substances|mesh-ancestor
5557108|NCT04042558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557109|NCT04042558|Growth Inhibitors|growth inhibitors|mesh-ancestor
5557110|NCT04042558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5557111|NCT04042558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157021|NCT01475643|Glucocorticoids|glucocorticoids|mesh-ancestor
6157022|NCT01475643|Hormones|hormones|mesh-ancestor
6157023|NCT01475643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6157024|NCT01475643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157025|NCT01475643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6157026|NCT01475643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6157027|NCT01475643|Antiemetics|antiemetics|mesh-ancestor
6157028|NCT01475643|Autonomic Agents|autonomic agents|mesh-ancestor
6157029|NCT01475643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5557112|NCT04042558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5557113|NCT04042558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5557114|NCT04042558|Immunologic Factors|immunologic factors|mesh-ancestor
5557115|NCT04042714|Trifluridine|trifluridine|mesh-list
5557116|NCT04042714|Antimetabolites|antimetabolites|mesh-ancestor
5557117|NCT04042714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557118|NCT04042714|Antiviral Agents|antiviral agents|mesh-ancestor
5557119|NCT04042714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6157030|NCT01475643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6157031|NCT01475643|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6157032|NCT01475643|Protective Agents|protective agents|mesh-ancestor
6157033|NCT01475643|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6157034|NCT01475721|Fluticasone|fluticasone|mesh-list
6157035|NCT01475721|Xhance|xhance|mesh-list
6157036|NCT01475721|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6157037|NCT01475721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6157038|NCT01475721|Autonomic Agents|autonomic agents|mesh-ancestor
6157039|NCT01475721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6157040|NCT01475721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557120|NCT04042753|Nivolumab|nivolumab|mesh-list
5557121|NCT04042753|Ipilimumab|ipilimumab|mesh-list
5557122|NCT04042753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5557123|NCT04042753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5557124|NCT04042753|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5557125|NCT04042753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557126|NCT04042155|Rivaroxaban|rivaroxaban|mesh-list
5557127|NCT04042155|Apixaban|apixaban|mesh-list
5557128|NCT04042155|Edoxaban|edoxaban|mesh-list
5557129|NCT04042155|Dabigatran|dabigatran|mesh-list
5557130|NCT04042155|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5557131|NCT04042155|Antithrombins|antithrombins|mesh-ancestor
5557132|NCT04042155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5557133|NCT04042155|Protease Inhibitors|protease inhibitors|mesh-ancestor
5557134|NCT04042155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5557135|NCT04042155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557136|NCT04042155|Anticoagulants|anticoagulants|mesh-ancestor
5557137|NCT04042233|Vancomycin|vancomycin|mesh-list
5557138|NCT04042233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5557139|NCT04042233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5557140|NCT04041934|Tryptophan|tryptophan|mesh-list
5557141|NCT04041934|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5557142|NCT04041934|Antidepressive Agents|antidepressive agents|mesh-ancestor
5557143|NCT04041934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6157041|NCT01475721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6668220|NCT01531049|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6668221|NCT01531049|Autonomic Agents|autonomic agents|mesh-ancestor
6668222|NCT01531049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6668223|NCT01531049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668224|NCT01531049|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6668225|NCT01531049|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5557144|NCT04042051|Trastuzumab|trastuzumab|mesh-list
6157042|NCT01475721|Respiratory System Agents|respiratory system agents|mesh-ancestor
6157043|NCT01475721|Glucocorticoids|glucocorticoids|mesh-ancestor
6157044|NCT01475721|Hormones|hormones|mesh-ancestor
6157045|NCT01475721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6157046|NCT01475721|Sympathomimetics|sympathomimetics|mesh-ancestor
6157047|NCT01475721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6157048|NCT01475721|Dermatologic Agents|dermatologic agents|mesh-ancestor
6157049|NCT01475721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6157050|NCT01475734|rGLP-1 protein|rglp-1 protein|mesh-list
6157051|NCT01475734|Incretins|incretins|mesh-ancestor
6157052|NCT01475734|Hormones|hormones|mesh-ancestor
6157053|NCT01475734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6480071|NCT00541281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6480072|NCT00541281|Glucocorticoids|glucocorticoids|mesh-ancestor
6480073|NCT00541281|Hormones|hormones|mesh-ancestor
6480074|NCT00541281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6157054|NCT01475734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157055|NCT01475825|Mipomersen|mipomersen|mesh-list
6157056|NCT01475825|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6480075|NCT00541281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480076|NCT00541281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6480077|NCT00541281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6480078|NCT00541281|Alkylating Agents|alkylating agents|mesh-ancestor
5557145|NCT04042051|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
5557146|NCT04042051|Maytansine|maytansine|mesh-list
6157057|NCT01475825|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6157058|NCT01475825|Antimetabolites|antimetabolites|mesh-ancestor
6480079|NCT00541320|2-(5-chlorothien-2-yl)-N-(1-(1-methyl-2-(morpholin-4-yl)-2-oxoethyl)-2-oxopyrrolidin-3-yl)ethenesulfonamide|2-(5-chlorothien-2-yl)-n-(1-(1-methyl-2-(morpholin-4-yl)-2-oxoethyl)-2-oxopyrrolidin-3-yl)ethenesulfonamide|mesh-list
6480080|NCT00541320|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6480081|NCT00541320|Antithrombins|antithrombins|mesh-ancestor
6480082|NCT00541320|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5557147|NCT04042051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6157059|NCT01475825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157060|NCT01475825|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6157061|NCT01475838|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6157062|NCT01475838|Antiviral Agents|antiviral agents|mesh-ancestor
6157063|NCT01475838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6157064|NCT01475838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5557148|NCT04042051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5557149|NCT04042051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5557150|NCT04042051|Tubulin Modulators|tubulin modulators|mesh-ancestor
5557151|NCT04042051|Antimitotic Agents|antimitotic agents|mesh-ancestor
6157065|NCT01475838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6157066|NCT01475955|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6157067|NCT01475955|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6157068|NCT01475955|Dermatologic Agents|dermatologic agents|mesh-ancestor
6157069|NCT01476202|Nicotine|nicotine|mesh-list
6157070|NCT01476202|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6157071|NCT01476202|Autonomic Agents|autonomic agents|mesh-ancestor
6157072|NCT01476202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6157073|NCT01476202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157074|NCT01476202|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6157075|NCT01476202|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6157076|NCT01476202|Cholinergic Agents|cholinergic agents|mesh-ancestor
6157077|NCT01476202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6157078|NCT01476202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157079|NCT01476267|Dalcetrapib|dalcetrapib|mesh-list
6157080|NCT01476267|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6157081|NCT01476267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6157082|NCT01476267|Antimetabolites|antimetabolites|mesh-ancestor
6157083|NCT01476267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157084|NCT01476267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6157085|NCT01476345|Insulin Glargine|insulin glargine|mesh-list
6157086|NCT01476345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6157087|NCT01476345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157088|NCT01476449|Ranibizumab|ranibizumab|mesh-list
6157089|NCT01476449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6157090|NCT01476449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6157091|NCT01476449|Growth Substances|growth substances|mesh-ancestor
6157092|NCT01476449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157093|NCT01476449|Growth Inhibitors|growth inhibitors|mesh-ancestor
6157094|NCT01476449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6157095|NCT01476475|Insulin|insulin|mesh-list
6157096|NCT01476475|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6157097|NCT01476475|Metformin|metformin|mesh-list
6157098|NCT01476475|Insulin Glargine|insulin glargine|mesh-list
6157099|NCT01476475|Lixisenatide|lixisenatide|mesh-list
6157100|NCT01476475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6157101|NCT01476475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157102|NCT01476696|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6157103|NCT01476696|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6157104|NCT01477320|Pantoprazole|pantoprazole|mesh-list
6157105|NCT01477320|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6157106|NCT01477320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6157107|NCT01477320|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6157108|NCT01477320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6157109|NCT01477320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157110|NCT01477333|Treprostinil|treprostinil|mesh-list
6157111|NCT01477333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6157112|NCT01477463|Vitamin D|vitamin d|mesh-list
6157113|NCT01477463|Ergocalciferols|ergocalciferols|mesh-list
6157114|NCT01477463|Cholecalciferol|cholecalciferol|mesh-list
6157115|NCT01477463|Vitamins|vitamins|mesh-list
6157116|NCT01477463|Micronutrients|micronutrients|mesh-ancestor
6157117|NCT01477463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157118|NCT01477463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6157119|NCT01477463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6157120|NCT01477762|Dexamethasone|dexamethasone|mesh-list
6157121|NCT01477762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6157122|NCT01477762|Antiemetics|antiemetics|mesh-ancestor
6157123|NCT01477762|Autonomic Agents|autonomic agents|mesh-ancestor
6157124|NCT01477762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6157125|NCT01477762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157126|NCT01477762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6157127|NCT01477762|Glucocorticoids|glucocorticoids|mesh-ancestor
6157128|NCT01477762|Hormones|hormones|mesh-ancestor
6157129|NCT01477762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6157130|NCT01477762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6157131|NCT01477762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6157132|NCT01477853|Metformin|metformin|mesh-list
6157133|NCT01477853|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6157134|NCT01477853|Glimepiride|glimepiride|mesh-list
6157135|NCT01477853|Atorvastatin|atorvastatin|mesh-list
6157136|NCT01477853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6157137|NCT01477853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157138|NCT01477853|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6157139|NCT01477853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5557152|NCT04042051|Mitosis Modulators|mitosis modulators|mesh-ancestor
5557153|NCT04042051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557154|NCT04042220|Glucocorticoids|glucocorticoids|mesh-list
5557155|NCT04042220|Hormones|hormones|mesh-ancestor
5557156|NCT04042220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5557157|NCT04042220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603265|NCT02965690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603266|NCT02965690|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6157140|NCT01477853|Antimetabolites|antimetabolites|mesh-ancestor
6157141|NCT01477853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157142|NCT01477853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6157143|NCT01477853|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6157144|NCT01477853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6157145|NCT01477853|Incretins|incretins|mesh-ancestor
6157146|NCT01477853|Hormones|hormones|mesh-ancestor
6480083|NCT00541320|Protease Inhibitors|protease inhibitors|mesh-ancestor
6480084|NCT00541320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6480085|NCT00541320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480086|NCT00541320|Anticoagulants|anticoagulants|mesh-ancestor
6480087|NCT00541333|Glatiramer Acetate|glatiramer acetate|mesh-list
6157147|NCT01477853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6157148|NCT01477853|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6157149|NCT01477853|Protease Inhibitors|protease inhibitors|mesh-ancestor
6157150|NCT01477853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6157151|NCT01477853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6157152|NCT01477853|Immunologic Factors|immunologic factors|mesh-ancestor
6157153|NCT01477892|Remifentanil|remifentanil|mesh-list
6157154|NCT01477892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6157155|NCT01477892|Narcotics|narcotics|mesh-ancestor
6157156|NCT01477892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6157157|NCT01477892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157158|NCT01477892|Analgesics|analgesics|mesh-ancestor
6157159|NCT01477892|Sensory System Agents|sensory system agents|mesh-ancestor
6157160|NCT01477892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6157161|NCT01478048|Dexamethasone|dexamethasone|mesh-list
6157162|NCT01478048|Dexamethasone acetate|dexamethasone acetate|mesh-list
6157163|NCT01478048|Bortezomib|bortezomib|mesh-list
6157164|NCT01478048|Elotuzumab|elotuzumab|mesh-list
6157165|NCT01478048|BB 1101|bb 1101|mesh-list
6157166|NCT01478048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6157167|NCT01478048|Antiemetics|antiemetics|mesh-ancestor
6157168|NCT01478048|Autonomic Agents|autonomic agents|mesh-ancestor
6480088|NCT00541333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6480089|NCT00541333|Immunologic Factors|immunologic factors|mesh-ancestor
6480090|NCT00541333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480091|NCT00541333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6480092|NCT00541333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6480093|NCT00541359|Bortezomib|bortezomib|mesh-list
6480094|NCT00541359|Topotecan|topotecan|mesh-list
6480095|NCT00541359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6480096|NCT00541359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6480097|NCT00541359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6480098|NCT00541359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6480099|NCT00541359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480100|NCT00541372|Insulin|insulin|mesh-list
6480101|NCT00541372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6480102|NCT00541372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157169|NCT01478048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6205981|NCT02095158|Mydriatics|mydriatics|mesh-ancestor
6480103|NCT00541411|Dactinomycin|dactinomycin|mesh-list
5557158|NCT04041856|Povidone-Iodine|povidone-iodine|mesh-list
5557159|NCT04041856|Povidone|povidone|mesh-list
5557160|NCT04041856|Plasma Substitutes|plasma substitutes|mesh-ancestor
6157170|NCT01478048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157171|NCT01478048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6157172|NCT01478048|Glucocorticoids|glucocorticoids|mesh-ancestor
6157173|NCT01478048|Hormones|hormones|mesh-ancestor
6157174|NCT01478048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6157175|NCT01478048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6157176|NCT01478048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6157177|NCT01478048|Protease Inhibitors|protease inhibitors|mesh-ancestor
6157178|NCT01478048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6157179|NCT01478048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557161|NCT04041856|Blood Substitutes|blood substitutes|mesh-ancestor
5557162|NCT04041856|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5557163|NCT04041856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5557164|NCT04041973|Lumefantrine|lumefantrine|mesh-list
5557165|NCT04041973|Artemether|artemether|mesh-list
5557166|NCT04041973|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
5557167|NCT04041973|Antimalarials|antimalarials|mesh-ancestor
5557168|NCT04041973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5557169|NCT04041973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5557170|NCT04041973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5557171|NCT04042142|Glucagon|glucagon|mesh-list
5557172|NCT04042142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5557173|NCT04042142|Hormones|hormones|mesh-ancestor
5557174|NCT04042142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5557175|NCT04042142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557176|NCT04041843|Apixaban|apixaban|mesh-list
6157180|NCT01478256|Erythromycin|erythromycin|mesh-list
6157181|NCT01478256|Erythromycin Estolate|erythromycin estolate|mesh-list
6157182|NCT01478256|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
6157183|NCT01478256|Erythromycin stearate|erythromycin stearate|mesh-list
6157184|NCT01478256|Besifloxacin|besifloxacin|mesh-list
6480104|NCT00541411|Vincristine|vincristine|mesh-list
6480105|NCT00541411|Ifosfamide|ifosfamide|mesh-list
6480106|NCT00541411|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6480107|NCT00541411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6480108|NCT00541411|Tubulin Modulators|tubulin modulators|mesh-ancestor
6480109|NCT00541411|Antimitotic Agents|antimitotic agents|mesh-ancestor
6480110|NCT00541411|Mitosis Modulators|mitosis modulators|mesh-ancestor
6480111|NCT00541411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480112|NCT00541411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6480113|NCT00541411|Alkylating Agents|alkylating agents|mesh-ancestor
6480114|NCT00541411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6480115|NCT00541411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6480116|NCT00541411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6480117|NCT00541411|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6480118|NCT00541411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6480119|NCT00541411|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6480120|NCT00541463|Nelfinavir|nelfinavir|mesh-list
6480121|NCT00541463|Indinavir|indinavir|mesh-list
6480122|NCT00541463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480123|NCT00541463|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6480124|NCT00541463|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6480125|NCT00541463|Protease Inhibitors|protease inhibitors|mesh-ancestor
6480126|NCT00541463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6480127|NCT00541463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6480128|NCT00541463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6480129|NCT00541463|Antiviral Agents|antiviral agents|mesh-ancestor
6480130|NCT00541463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6480131|NCT00541489|Naproxen|naproxen|mesh-list
6480132|NCT00541489|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
6480133|NCT00541489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6480134|NCT00541489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6480135|NCT00541489|Analgesics|analgesics|mesh-ancestor
6480136|NCT00541489|Sensory System Agents|sensory system agents|mesh-ancestor
6480137|NCT00541489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6480138|NCT00541489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480139|NCT00541489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6480140|NCT00541489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6480141|NCT00541489|Gout Suppressants|gout suppressants|mesh-ancestor
6480142|NCT00541489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5557177|NCT04041843|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5557178|NCT04041843|Antithrombins|antithrombins|mesh-ancestor
6480143|NCT00541489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6668226|NCT01531049|Cholinergic Agents|cholinergic agents|mesh-ancestor
6480144|NCT00541489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480145|NCT00541489|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6480146|NCT00541515|Insulin|insulin|mesh-list
6480147|NCT00541515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6480148|NCT00541515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480149|NCT00541554|Aripiprazole|aripiprazole|mesh-list
6480150|NCT00541554|Antidepressive Agents|antidepressive agents|mesh-ancestor
6480151|NCT00541554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6480152|NCT00541554|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6480153|NCT00541554|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6480154|NCT00541554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6480155|NCT00541554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480156|NCT00541554|Dopamine Agonists|dopamine agonists|mesh-ancestor
6480157|NCT00541554|Dopamine Agents|dopamine agents|mesh-ancestor
6480158|NCT00541554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5557179|NCT04041843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5557180|NCT04041843|Protease Inhibitors|protease inhibitors|mesh-ancestor
5557181|NCT04041843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5557182|NCT04041843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557183|NCT04041843|Anticoagulants|anticoagulants|mesh-ancestor
5557184|NCT04041492|Vitamin D|vitamin d|mesh-list
5557185|NCT04041492|Cholecalciferol|cholecalciferol|mesh-list
5557186|NCT04041492|Vitamins|vitamins|mesh-ancestor
5557187|NCT04041492|Micronutrients|micronutrients|mesh-ancestor
6480159|NCT00541554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480160|NCT00541554|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6480161|NCT00541554|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6480162|NCT00541554|Serotonin Agents|serotonin agents|mesh-ancestor
6480163|NCT00541554|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6480164|NCT00541554|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5557188|NCT04041492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557189|NCT04041492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5557190|NCT04041492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5557191|NCT04041791|Amoxicillin|amoxicillin|mesh-list
5557192|NCT04041791|Gentamicins|gentamicins|mesh-list
5557193|NCT04041791|Ceftriaxone|ceftriaxone|mesh-list
5557194|NCT04041791|Clavulanic Acid|clavulanic acid|mesh-list
5557195|NCT04041791|Clavulanic Acids|clavulanic acids|mesh-list
5557196|NCT04041791|Penicillins|penicillins|mesh-list
5557197|NCT04041791|Ampicillin|ampicillin|mesh-list
6480165|NCT00541554|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6157185|NCT01478256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6157186|NCT01478256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6157187|NCT01478256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6157188|NCT01478256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6157189|NCT01478256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6157190|NCT01478256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157191|NCT01478256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6157192|NCT01478256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5557198|NCT04041791|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5557199|NCT04041791|Penicillin G|penicillin g|mesh-list
5557200|NCT04041791|Penicillin G Benzathine|penicillin g benzathine|mesh-list
5557201|NCT04041791|Penicillin G Procaine|penicillin g procaine|mesh-list
5557202|NCT04041791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5557203|NCT04041791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5557204|NCT04041791|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5557205|NCT04041791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5557206|NCT04041791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557207|NCT04041791|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5557208|NCT04041362|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
5557209|NCT04041362|UB-421|ub-421|mesh-list
6157193|NCT01478256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6157194|NCT01478321|Bevacizumab|bevacizumab|mesh-list
6157195|NCT01478321|Temozolomide|temozolomide|mesh-list
6157196|NCT01478321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6157197|NCT01478321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6157198|NCT01478321|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6157199|NCT01478321|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6157200|NCT01478321|Growth Substances|growth substances|mesh-ancestor
6157201|NCT01478321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157202|NCT01478321|Growth Inhibitors|growth inhibitors|mesh-ancestor
6157203|NCT01478321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6157204|NCT01478321|Alkylating Agents|alkylating agents|mesh-ancestor
6157205|NCT01478321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557210|NCT04041362|Antiviral Agents|antiviral agents|mesh-ancestor
6480166|NCT00541554|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6480167|NCT00541567|Ibipinabant|ibipinabant|mesh-list
6480168|NCT00541567|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
6480169|NCT00541567|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6157206|NCT01478581|Dexamethasone|dexamethasone|mesh-list
6157207|NCT01478581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6157208|NCT01478581|Antiemetics|antiemetics|mesh-ancestor
5557211|NCT04041362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5557212|NCT04041349|Mitogens|mitogens|mesh-list
5557213|NCT04041349|Mitosis Modulators|mitosis modulators|mesh-ancestor
5557214|NCT04041349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557215|NCT04041427|Albendazole|albendazole|mesh-list
5557216|NCT04041427|Anthelmintics|anthelmintics|mesh-ancestor
5557217|NCT04041427|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5557218|NCT04041427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5557219|NCT04041427|Anticestodal Agents|anticestodal agents|mesh-ancestor
5557220|NCT04041427|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5557221|NCT04041427|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5557222|NCT04041427|Tubulin Modulators|tubulin modulators|mesh-ancestor
5557223|NCT04041427|Antimitotic Agents|antimitotic agents|mesh-ancestor
5557224|NCT04041427|Mitosis Modulators|mitosis modulators|mesh-ancestor
5557225|NCT04041427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557226|NCT04041427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5557227|NCT04041167|Thioctic Acid|thioctic acid|mesh-list
5557228|NCT04041167|Antioxidants|antioxidants|mesh-ancestor
5557229|NCT04041167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557230|NCT04041167|Protective Agents|protective agents|mesh-ancestor
5557231|NCT04041167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557232|NCT04041167|Vitamin B Complex|vitamin b complex|mesh-ancestor
5557233|NCT04041167|Vitamins|vitamins|mesh-ancestor
5557234|NCT04041167|Micronutrients|micronutrients|mesh-ancestor
5557235|NCT04041128|Olaparib|olaparib|mesh-list
5557236|NCT04041128|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5557237|NCT04041128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5557238|NCT04041128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157209|NCT01478581|Autonomic Agents|autonomic agents|mesh-ancestor
6157210|NCT01478581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6157211|NCT01478581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157212|NCT01478581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6157213|NCT01478581|Glucocorticoids|glucocorticoids|mesh-ancestor
6157214|NCT01478581|Hormones|hormones|mesh-ancestor
6157215|NCT01478581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6157216|NCT01478581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5557239|NCT04041128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5557240|NCT04040946|Choline|choline|mesh-list
5557241|NCT04040946|Lipotropic Agents|lipotropic agents|mesh-ancestor
5557242|NCT04040946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5557243|NCT04040946|Antimetabolites|antimetabolites|mesh-ancestor
5557244|NCT04040946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557245|NCT04040946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5557246|NCT04040946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5557247|NCT04040946|Nootropic Agents|nootropic agents|mesh-ancestor
5557248|NCT04041648|Treprostinil|treprostinil|mesh-list
5557249|NCT04041648|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6157217|NCT01478581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5557250|NCT04041648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6480170|NCT00541567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6480171|NCT00541567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480172|NCT00541567|Hormones|hormones|mesh-ancestor
6668227|NCT01531049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6668228|NCT01531049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668229|NCT01531114|Ticagrelor|ticagrelor|mesh-list
6668230|NCT01531114|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6668231|NCT01531114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6668232|NCT01531114|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6668233|NCT01531114|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6668234|NCT01531114|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6668235|NCT01531114|Purinergic Agents|purinergic agents|mesh-ancestor
6480173|NCT00541567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6480174|NCT00541567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480175|NCT00541710|Genistein|genistein|mesh-list
6480176|NCT00541710|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6480177|NCT00541710|Protective Agents|protective agents|mesh-ancestor
6480178|NCT00541710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480179|NCT00541710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6157218|NCT01478594|Bevacizumab|bevacizumab|mesh-list
6157219|NCT01478594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6157220|NCT01478594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6157221|NCT01478594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6157222|NCT01478594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6157223|NCT01478594|Growth Substances|growth substances|mesh-ancestor
6157224|NCT01478594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157225|NCT01478594|Growth Inhibitors|growth inhibitors|mesh-ancestor
6157226|NCT01478828|Lovastatin|lovastatin|mesh-list
6157227|NCT01478828|L 647318|l 647318|mesh-list
6157228|NCT01478828|Dihydromevinolin|dihydromevinolin|mesh-list
6157229|NCT01478828|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6157230|NCT01478828|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6157231|NCT01478828|Antimetabolites|antimetabolites|mesh-ancestor
6157232|NCT01478828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157233|NCT01478828|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6157234|NCT01478828|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6157235|NCT01478828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6480180|NCT00541710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6480181|NCT00541710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6480182|NCT00541710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480183|NCT00541710|Phytoestrogens|phytoestrogens|mesh-ancestor
6480184|NCT00541710|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6480185|NCT00541710|Estrogens|estrogens|mesh-ancestor
6480186|NCT00541710|Hormones|hormones|mesh-ancestor
6480187|NCT00541710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6480188|NCT00541723|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
6480189|NCT00541723|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6480190|NCT00541723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6480191|NCT00541723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480192|NCT00541723|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6480193|NCT00541723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6480194|NCT00541723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480195|NCT00541723|Cholinergic Agents|cholinergic agents|mesh-ancestor
6480196|NCT00541723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6480197|NCT00541736|Nitroglycerin|nitroglycerin|mesh-list
6480198|NCT00541736|Vasodilator Agents|vasodilator agents|mesh-ancestor
6480199|NCT00541814|Cyclosporine|cyclosporine|mesh-list
6480200|NCT00541814|Cyclosporins|cyclosporins|mesh-list
6480201|NCT00541814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6480202|NCT00541814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480203|NCT00541814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6480204|NCT00541814|Immunologic Factors|immunologic factors|mesh-ancestor
6480205|NCT00541814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480206|NCT00541814|Antifungal Agents|antifungal agents|mesh-ancestor
6480207|NCT00541814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6480208|NCT00541814|Dermatologic Agents|dermatologic agents|mesh-ancestor
6480209|NCT00541814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6480210|NCT00541814|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6480211|NCT00541840|Sorafenib|sorafenib|mesh-list
6480212|NCT00541840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6480213|NCT00541840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6480214|NCT00541840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6157236|NCT01478971|Epoetin Alfa|epoetin alfa|mesh-list
5557251|NCT04040491|Gemcitabine|gemcitabine|mesh-list
5557252|NCT04040491|Lenalidomide|lenalidomide|mesh-list
5557253|NCT04040491|Antibodies|antibodies|mesh-list
5557254|NCT04040491|Antibodies, Blocking|antibodies, blocking|mesh-list
5557255|NCT04040491|Immunologic Factors|immunologic factors|mesh-ancestor
5557256|NCT04040491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557257|NCT04040491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5557258|NCT04040491|Antimetabolites|antimetabolites|mesh-ancestor
5557259|NCT04040491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557260|NCT04040491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5557261|NCT04040491|Antiviral Agents|antiviral agents|mesh-ancestor
5557262|NCT04040491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5557263|NCT04040491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5557264|NCT04040491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5557265|NCT04040491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5557266|NCT04040491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5557267|NCT04040491|Growth Substances|growth substances|mesh-ancestor
5557268|NCT04040491|Growth Inhibitors|growth inhibitors|mesh-ancestor
5557269|NCT04040322|Iloprost|iloprost|mesh-list
5557270|NCT04040322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5557271|NCT04040322|Vasodilator Agents|vasodilator agents|mesh-ancestor
5557272|NCT04040361|Pembrolizumab|pembrolizumab|mesh-list
5557273|NCT04040361|Ramucirumab|ramucirumab|mesh-list
6480215|NCT00541840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480216|NCT00541853|Candesartan|candesartan|mesh-list
6480217|NCT00541853|Candesartan cilexetil|candesartan cilexetil|mesh-list
6157237|NCT01478971|Hematinics|hematinics|mesh-ancestor
6157238|NCT01479127|Silicon|silicon|mesh-list
6157239|NCT01479127|Levodopa|levodopa|mesh-list
6157240|NCT01479127|Carbidopa|carbidopa|mesh-list
6157241|NCT01479127|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6157242|NCT01479127|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6157243|NCT01479127|Dopamine Agents|dopamine agents|mesh-ancestor
6157244|NCT01479127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6157245|NCT01479127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157246|NCT01479127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157247|NCT01479127|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6157248|NCT01479127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6157249|NCT01479127|Trace Elements|trace elements|mesh-ancestor
6157250|NCT01479127|Micronutrients|micronutrients|mesh-ancestor
6668236|NCT01531114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6668237|NCT01531114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668238|NCT01531114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668239|NCT01531140|Bisacodyl|bisacodyl|mesh-list
6668240|NCT01531140|Senna Extract|senna extract|mesh-list
6668241|NCT01531140|Sennosides|sennosides|mesh-list
6668242|NCT01531140|Cathartics|cathartics|mesh-ancestor
6668243|NCT01531140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6668244|NCT01531140|Laxatives|laxatives|mesh-ancestor
6480218|NCT00541853|Cilnidipine|cilnidipine|mesh-list
6480219|NCT00541853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6480220|NCT00541853|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6480221|NCT00541853|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6480222|NCT00541853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480223|NCT00541853|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6480224|NCT00541853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6480225|NCT00541853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6480226|NCT00541853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480227|NCT00541905|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
6480228|NCT00541905|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6480229|NCT00541905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6480230|NCT00541905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480231|NCT00541905|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6480232|NCT00541905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6480233|NCT00541905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480234|NCT00541905|Cholinergic Agents|cholinergic agents|mesh-ancestor
6480235|NCT00541905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6480236|NCT00541918|Propofol|propofol|mesh-list
6480237|NCT00541918|Sevoflurane|sevoflurane|mesh-list
6480238|NCT00541918|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6480239|NCT00541918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6480240|NCT00541918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668245|NCT01531166|Interferons|interferons|mesh-list
5557274|NCT04040361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6157251|NCT01479270|Epinephrine|epinephrine|mesh-list
6157252|NCT01479270|Ropivacaine|ropivacaine|mesh-list
6480241|NCT00541918|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6480242|NCT00541918|Anesthetics, General|anesthetics, general|mesh-ancestor
6480243|NCT00541918|Anesthetics|anesthetics|mesh-ancestor
5557275|NCT04040361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5557276|NCT04040465|Aspirin|aspirin|mesh-list
5557277|NCT04040465|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5557278|NCT04040465|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5557279|NCT04040465|Analgesics|analgesics|mesh-ancestor
5557280|NCT04040465|Sensory System Agents|sensory system agents|mesh-ancestor
5557281|NCT04040465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5557282|NCT04040465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557283|NCT04040465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5557284|NCT04040465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5557285|NCT04040465|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5557286|NCT04040465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5557287|NCT04040465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557288|NCT04040465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5557289|NCT04040465|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5557290|NCT04040465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5557291|NCT04040465|Antipyretics|antipyretics|mesh-ancestor
5557292|NCT04040452|Ketorolac|ketorolac|mesh-list
5557293|NCT04040452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5557294|NCT04040452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6157253|NCT01479270|Anesthetics, Local|anesthetics, local|mesh-ancestor
6157254|NCT01479270|Anesthetics|anesthetics|mesh-ancestor
6480244|NCT00541918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6480245|NCT00541918|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6480246|NCT00542022|Oxymetazoline|oxymetazoline|mesh-list
6480247|NCT00542022|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6480248|NCT00542022|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6480249|NCT00542022|Adrenergic Agents|adrenergic agents|mesh-ancestor
6480250|NCT00542022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6480251|NCT00542022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480252|NCT00542022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480253|NCT00542022|Sympathomimetics|sympathomimetics|mesh-ancestor
6480254|NCT00542022|Autonomic Agents|autonomic agents|mesh-ancestor
6480255|NCT00542022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6480256|NCT00542022|Nasal Decongestants|nasal decongestants|mesh-ancestor
6480257|NCT00542022|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6480258|NCT00542022|Respiratory System Agents|respiratory system agents|mesh-ancestor
6480259|NCT00542074|Ethanol|ethanol|mesh-list
6480260|NCT00542074|Emollients|emollients|mesh-list
6480261|NCT00542074|Dermatologic Agents|dermatologic agents|mesh-ancestor
6480262|NCT00542074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6480263|NCT00542074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6480264|NCT00542074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6480265|NCT00542074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480266|NCT00542126|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6480267|NCT00542126|Luteolytic Agents|luteolytic agents|mesh-ancestor
6480268|NCT00542126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6480269|NCT00542126|Contraceptive Agents|contraceptive agents|mesh-ancestor
6480270|NCT00542126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6480271|NCT00542126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480272|NCT00542126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6480273|NCT00542126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6480274|NCT00542126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6480275|NCT00542139|Betamethasone|betamethasone|mesh-list
6480276|NCT00542139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6480277|NCT00542139|Glucocorticoids|glucocorticoids|mesh-ancestor
6480278|NCT00542139|Hormones|hormones|mesh-ancestor
6480279|NCT00542139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6480280|NCT00542139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557295|NCT04040452|Analgesics|analgesics|mesh-ancestor
5557296|NCT04040452|Sensory System Agents|sensory system agents|mesh-ancestor
5557297|NCT04040452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5557298|NCT04040452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557299|NCT04040452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5557300|NCT04040452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5557301|NCT04040452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5557302|NCT04040452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5557303|NCT04040452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557304|NCT04040309|Lidocaine|lidocaine|mesh-list
5557305|NCT04040309|Anesthetics, Local|anesthetics, local|mesh-ancestor
6480281|NCT00542139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5557306|NCT04040309|Anesthetics|anesthetics|mesh-ancestor
5557307|NCT04040309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5557308|NCT04040309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557309|NCT04040309|Sensory System Agents|sensory system agents|mesh-ancestor
5557310|NCT04040309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5557311|NCT04040309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5557312|NCT04040309|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5557313|NCT04040309|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5557314|NCT04040309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5557315|NCT04040309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480282|NCT00542139|Respiratory System Agents|respiratory system agents|mesh-ancestor
6480283|NCT00542152|Cyclosporine|cyclosporine|mesh-list
6480284|NCT00542152|Infliximab|infliximab|mesh-list
6480285|NCT00542152|Cyclosporins|cyclosporins|mesh-list
6480286|NCT00542152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6480287|NCT00542152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480288|NCT00542152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6480289|NCT00542152|Immunologic Factors|immunologic factors|mesh-ancestor
6480290|NCT00542152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480291|NCT00542152|Antifungal Agents|antifungal agents|mesh-ancestor
6480292|NCT00542152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6480293|NCT00542152|Dermatologic Agents|dermatologic agents|mesh-ancestor
6480294|NCT00542152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6480295|NCT00542152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6480296|NCT00542152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6480297|NCT00542165|Alfuzosin|alfuzosin|mesh-list
6480298|NCT00542165|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6480299|NCT00542165|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6480300|NCT00542165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6480301|NCT00542165|Adrenergic Agents|adrenergic agents|mesh-ancestor
6480302|NCT00542165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6480303|NCT00542165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480304|NCT00542165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668246|NCT01531166|Interferon-alpha|interferon-alpha|mesh-list
6668247|NCT01531166|Interferon alpha-2|interferon alpha-2|mesh-list
6668248|NCT01531166|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5557316|NCT04040088|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
5557317|NCT04040088|Chelating Agents|chelating agents|mesh-ancestor
5557318|NCT04040088|Sequestering Agents|sequestering agents|mesh-ancestor
5557319|NCT04040088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557320|NCT04039854|Propofol|propofol|mesh-list
5557321|NCT04039854|Sevoflurane|sevoflurane|mesh-list
5557322|NCT04039854|Desflurane|desflurane|mesh-list
5557323|NCT04039854|Isoflurane|isoflurane|mesh-list
5557324|NCT04039854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5557325|NCT04039854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5557326|NCT04039854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557327|NCT04039854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5557328|NCT04039854|Anesthetics, General|anesthetics, general|mesh-ancestor
6668249|NCT01531166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6668250|NCT01531166|Antiviral Agents|antiviral agents|mesh-ancestor
6668251|NCT01531166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6157255|NCT01479270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6157256|NCT01479270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157257|NCT01479270|Sensory System Agents|sensory system agents|mesh-ancestor
6157258|NCT01479270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6157259|NCT01479270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6157260|NCT01479270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6157261|NCT01479270|Adrenergic Agents|adrenergic agents|mesh-ancestor
6157262|NCT01479270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6157263|NCT01479270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157264|NCT01479270|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6157265|NCT01479270|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6157266|NCT01479270|Autonomic Agents|autonomic agents|mesh-ancestor
6157267|NCT01479270|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6157268|NCT01479270|Respiratory System Agents|respiratory system agents|mesh-ancestor
6157269|NCT01479270|Mydriatics|mydriatics|mesh-ancestor
6157270|NCT01479270|Sympathomimetics|sympathomimetics|mesh-ancestor
6157271|NCT01479270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6157272|NCT01479348|Tetrahydrouridine|tetrahydrouridine|mesh-list
6157273|NCT01479348|Antimetabolites|antimetabolites|mesh-ancestor
6157274|NCT01479348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157275|NCT01479374|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
6668252|NCT01531166|Immunologic Factors|immunologic factors|mesh-ancestor
5557329|NCT04039854|Anesthetics|anesthetics|mesh-ancestor
5557330|NCT04039854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5557331|NCT04039854|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6157276|NCT01479374|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6157277|NCT01479374|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6157278|NCT01479374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6157279|NCT01479374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6157280|NCT01479374|Analgesics|analgesics|mesh-ancestor
6157281|NCT01479374|Sensory System Agents|sensory system agents|mesh-ancestor
6157282|NCT01479374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6157283|NCT01479374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157284|NCT01479374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6157285|NCT01479374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6157286|NCT01479374|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6157287|NCT01479374|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5557332|NCT04039828|Zinc|zinc|mesh-list
5557333|NCT04039828|Zinc Sulfate|zinc sulfate|mesh-list
5557334|NCT04039828|Trace Elements|trace elements|mesh-ancestor
5557335|NCT04039828|Micronutrients|micronutrients|mesh-ancestor
6157288|NCT01479374|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6157289|NCT01479374|Histamine Antagonists|histamine antagonists|mesh-ancestor
6157290|NCT01479374|Histamine Agents|histamine agents|mesh-ancestor
6157291|NCT01479374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6157292|NCT01479374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157293|NCT01479439|Losartan|losartan|mesh-list
6157294|NCT01479439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6157295|NCT01479439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6157296|NCT01479439|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6157297|NCT01479439|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6157298|NCT01479439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157299|NCT01479465|Leucovorin|leucovorin|mesh-list
6157300|NCT01479465|Fluorouracil|fluorouracil|mesh-list
6157301|NCT01479465|Irinotecan|irinotecan|mesh-list
6480305|NCT00542165|Urological Agents|urological agents|mesh-ancestor
6480306|NCT00542243|Finasteride|finasteride|mesh-list
5557336|NCT04039828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557337|NCT04039828|Astringents|astringents|mesh-ancestor
5557338|NCT04039828|Dermatologic Agents|dermatologic agents|mesh-ancestor
5603267|NCT02965690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5603268|NCT02965690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5603269|NCT02964182|Nicotine|nicotine|mesh-list
5603270|NCT02964182|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5603271|NCT02964182|Autonomic Agents|autonomic agents|mesh-ancestor
5603272|NCT02964182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5603273|NCT02964182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603274|NCT02964182|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5603275|NCT02964182|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5603276|NCT02964182|Cholinergic Agents|cholinergic agents|mesh-ancestor
6480307|NCT00542243|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6480308|NCT00542243|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6480309|NCT00542243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6480310|NCT00542243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480311|NCT00542243|Hormone Antagonists|hormone antagonists|mesh-ancestor
6480312|NCT00542243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6157302|NCT01479465|Antimetabolites|antimetabolites|mesh-ancestor
6157303|NCT01479465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157304|NCT01479465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6157305|NCT01479465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6157306|NCT01479465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6157307|NCT01479465|Immunologic Factors|immunologic factors|mesh-ancestor
6157308|NCT01479465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157309|NCT01479465|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6157310|NCT01479465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6157311|NCT01479465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6157312|NCT01479465|Antidotes|antidotes|mesh-ancestor
6157313|NCT01479465|Protective Agents|protective agents|mesh-ancestor
6157314|NCT01479465|Vitamin B Complex|vitamin b complex|mesh-ancestor
6157315|NCT01479465|Vitamins|vitamins|mesh-ancestor
6157316|NCT01479465|Micronutrients|micronutrients|mesh-ancestor
6157317|NCT01479517|Tetracaine|tetracaine|mesh-list
6157318|NCT01479517|Anesthetics, Local|anesthetics, local|mesh-ancestor
6157319|NCT01479517|Anesthetics|anesthetics|mesh-ancestor
6157320|NCT01479517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6157321|NCT01479517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157322|NCT01479517|Sensory System Agents|sensory system agents|mesh-ancestor
5603277|NCT02964182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6157323|NCT01479517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6157324|NCT01479530|Rasagiline|rasagiline|mesh-list
6157325|NCT01479530|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6157326|NCT01479530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6157327|NCT01479530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157328|NCT01479530|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6157329|NCT01479530|Protective Agents|protective agents|mesh-ancestor
6157330|NCT01479530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157331|NCT01479621|Fluticasone|fluticasone|mesh-list
6157332|NCT01479621|Xhance|xhance|mesh-list
6157333|NCT01479621|Albuterol|albuterol|mesh-list
6157334|NCT01479621|Adrenergic Agonists|adrenergic agonists|mesh-list
6157335|NCT01479621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6157336|NCT01479621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6157337|NCT01479621|Autonomic Agents|autonomic agents|mesh-ancestor
6157338|NCT01479621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6157339|NCT01479621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157340|NCT01479621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6157341|NCT01479621|Respiratory System Agents|respiratory system agents|mesh-ancestor
6157342|NCT01479621|Dermatologic Agents|dermatologic agents|mesh-ancestor
6157343|NCT01479621|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6157344|NCT01479621|Tocolytic Agents|tocolytic agents|mesh-ancestor
6157345|NCT01479621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6157346|NCT01479621|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6157347|NCT01479621|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6157348|NCT01479621|Adrenergic Agents|adrenergic agents|mesh-ancestor
6157349|NCT01479621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6157350|NCT01479621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157351|NCT01479764|Glycopyrrolate|glycopyrrolate|mesh-list
6157352|NCT01479764|Neostigmine|neostigmine|mesh-list
6157353|NCT01479764|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6157354|NCT01479764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6157355|NCT01479764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157356|NCT01479764|Cholinergic Agents|cholinergic agents|mesh-ancestor
6157357|NCT01479764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6157358|NCT01479764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157359|NCT01479764|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6157360|NCT01479764|Autonomic Agents|autonomic agents|mesh-ancestor
6157361|NCT01479764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6157362|NCT01479764|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6157363|NCT01479764|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6157364|NCT01479764|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6157365|NCT01479868|Interferons|interferons|mesh-list
6157366|NCT01479868|Ribavirin|ribavirin|mesh-list
6157367|NCT01479868|Interferon-alpha|interferon-alpha|mesh-list
6157368|NCT01479868|Interferon alpha-2|interferon alpha-2|mesh-list
6480313|NCT00542243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480314|NCT00542243|Urological Agents|urological agents|mesh-ancestor
6480315|NCT00542295|Mebeverine|mebeverine|mesh-list
6480316|NCT00542295|Alverine|alverine|mesh-list
6480317|NCT00542295|Parasympatholytics|parasympatholytics|mesh-ancestor
6480318|NCT00542295|Autonomic Agents|autonomic agents|mesh-ancestor
6480319|NCT00542295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6157369|NCT01479868|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6157370|NCT01479868|Simeprevir|simeprevir|mesh-list
6157371|NCT01479868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6157372|NCT01479868|Antiviral Agents|antiviral agents|mesh-ancestor
6157373|NCT01479868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6157374|NCT01479868|Antimetabolites|antimetabolites|mesh-ancestor
6157375|NCT01479868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157376|NCT01479868|Immunologic Factors|immunologic factors|mesh-ancestor
6157377|NCT01479868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157378|NCT01479868|Protease Inhibitors|protease inhibitors|mesh-ancestor
6157379|NCT01479868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6157380|NCT01480076|4-Aminopyridine|4-aminopyridine|mesh-list
6157381|NCT01480076|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6157382|NCT01480076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6480320|NCT00542295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157383|NCT01480076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157384|NCT01480089|Ropivacaine|ropivacaine|mesh-list
6480321|NCT00542295|Anticonvulsants|anticonvulsants|mesh-ancestor
6480322|NCT00542347|Esomeprazole|esomeprazole|mesh-list
6480323|NCT00542347|Omeprazole|omeprazole|mesh-list
6480324|NCT00542347|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6480325|NCT00542347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6480326|NCT00542347|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6480327|NCT00542347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6480328|NCT00542347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480329|NCT00542399|Insulin Detemir|insulin detemir|mesh-list
6480330|NCT00542399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6480331|NCT00542399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480332|NCT00542412|Riluzole|riluzole|mesh-list
6480333|NCT00542412|Anticonvulsants|anticonvulsants|mesh-ancestor
6480334|NCT00542412|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6480335|NCT00542412|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6480336|NCT00542412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6480337|NCT00542412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157385|NCT01480089|Anesthetics, Local|anesthetics, local|mesh-ancestor
6157386|NCT01480089|Anesthetics|anesthetics|mesh-ancestor
6157387|NCT01480089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6157388|NCT01480089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157389|NCT01480089|Sensory System Agents|sensory system agents|mesh-ancestor
6157390|NCT01480089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6157391|NCT01480219|Voriconazole|voriconazole|mesh-list
6157392|NCT01480219|Antifungal Agents|antifungal agents|mesh-ancestor
6157393|NCT01480219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6157394|NCT01480219|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6157395|NCT01480219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6157396|NCT01480219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6157397|NCT01480219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157398|NCT01480219|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6157399|NCT01480219|Hormone Antagonists|hormone antagonists|mesh-ancestor
6157400|NCT01480219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6157401|NCT01480219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157402|NCT01480219|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6157403|NCT01480232|Nicotine|nicotine|mesh-list
6157404|NCT01480232|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6157405|NCT01480232|Autonomic Agents|autonomic agents|mesh-ancestor
6157406|NCT01480232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6157407|NCT01480232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157408|NCT01480232|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6157409|NCT01480232|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6157410|NCT01480232|Cholinergic Agents|cholinergic agents|mesh-ancestor
6157411|NCT01480232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6157412|NCT01480232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157413|NCT01480258|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6157414|NCT01480258|Immunologic Factors|immunologic factors|mesh-ancestor
6157415|NCT01480258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157416|NCT01480297|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
6157417|NCT01480297|Sodium Salicylate|sodium salicylate|mesh-list
6157418|NCT01480297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6157419|NCT01480297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6157420|NCT01480297|Analgesics|analgesics|mesh-ancestor
6157421|NCT01480297|Sensory System Agents|sensory system agents|mesh-ancestor
6157422|NCT01480297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6157423|NCT01480297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157424|NCT01480297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6157425|NCT01480297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6157426|NCT01480297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6157427|NCT01480297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6157428|NCT01480297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157429|NCT01480596|Belimumab|belimumab|mesh-list
6157430|NCT01480596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6157431|NCT01480596|Immunologic Factors|immunologic factors|mesh-ancestor
6157432|NCT01480596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157433|NCT01480674|Trastuzumab|trastuzumab|mesh-list
6480338|NCT00542412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480339|NCT00542412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6480340|NCT00542412|Protective Agents|protective agents|mesh-ancestor
6480341|NCT00542451|Paclitaxel|paclitaxel|mesh-list
6480342|NCT00542451|Trastuzumab|trastuzumab|mesh-list
6480343|NCT00542451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6480344|NCT00542451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6480345|NCT00542451|Tubulin Modulators|tubulin modulators|mesh-ancestor
5557339|NCT04039880|Olorofim|olorofim|mesh-list
5557340|NCT04039880|Antifungal Agents|antifungal agents|mesh-ancestor
5557341|NCT04039880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6480346|NCT00542451|Antimitotic Agents|antimitotic agents|mesh-ancestor
6480347|NCT00542451|Mitosis Modulators|mitosis modulators|mesh-ancestor
6480348|NCT00542451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480349|NCT00542451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6480350|NCT00542555|Naproxen|naproxen|mesh-list
6480351|NCT00542555|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
6480352|NCT00542555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6480353|NCT00542555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5557342|NCT04040023|Vitamins|vitamins|mesh-list
5557343|NCT04040023|Micronutrients|micronutrients|mesh-ancestor
5557344|NCT04040023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480354|NCT00542555|Analgesics|analgesics|mesh-ancestor
6480355|NCT00542555|Sensory System Agents|sensory system agents|mesh-ancestor
6668253|NCT01531166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668254|NCT01531192|Nystatin|nystatin|mesh-list
6668255|NCT01531192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6668256|NCT01531192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6668257|NCT01531192|Antifungal Agents|antifungal agents|mesh-ancestor
6668258|NCT01531192|Ionophores|ionophores|mesh-ancestor
6668259|NCT01531192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5557345|NCT04039815|Ascorbic Acid|ascorbic acid|mesh-list
5557346|NCT04039815|Thiamine|thiamine|mesh-list
5557347|NCT04039815|Hydrocortisone|hydrocortisone|mesh-list
6668260|NCT01531192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668261|NCT01531218|Azithromycin|azithromycin|mesh-list
6668262|NCT01531218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6668263|NCT01531218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6668264|NCT01531244|Dactinomycin|dactinomycin|mesh-list
5557348|NCT04039815|Vitamins|vitamins|mesh-ancestor
5557349|NCT04039815|Micronutrients|micronutrients|mesh-ancestor
5557350|NCT04039815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557351|NCT04039815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5557352|NCT04039815|Vitamin B Complex|vitamin b complex|mesh-ancestor
5557353|NCT04039815|Antioxidants|antioxidants|mesh-ancestor
6668265|NCT01531244|Cactinomycin|cactinomycin|mesh-list
6157434|NCT01480674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6480356|NCT00542555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6480357|NCT00542555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480358|NCT00542555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6480359|NCT00542555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6480360|NCT00542555|Gout Suppressants|gout suppressants|mesh-ancestor
6480361|NCT00542555|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6480362|NCT00542555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6480363|NCT00542555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480364|NCT00542555|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6480365|NCT00542568|Epoetin Alfa|epoetin alfa|mesh-list
6668266|NCT01531244|Melphalan|melphalan|mesh-list
6668267|NCT01531244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5557354|NCT04039815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557355|NCT04039815|Protective Agents|protective agents|mesh-ancestor
5557356|NCT04039698|Sofosbuvir|sofosbuvir|mesh-list
6480366|NCT00542568|Hematinics|hematinics|mesh-ancestor
6157435|NCT01480674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6157436|NCT01480843|Insulin Glargine|insulin glargine|mesh-list
6157437|NCT01480843|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6157438|NCT01480843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157439|NCT01481116|Glimepiride|glimepiride|mesh-list
6480367|NCT00542607|Levocetirizine|levocetirizine|mesh-list
6480368|NCT00542607|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5557357|NCT04039698|Velpatasvir|velpatasvir|mesh-list
5557358|NCT04039698|Antiviral Agents|antiviral agents|mesh-ancestor
5557359|NCT04039698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5557360|NCT04039958|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
5557361|NCT04039958|Antiviral Agents|antiviral agents|mesh-ancestor
5557362|NCT04039958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5557363|NCT04039373|Mycophenolic Acid|mycophenolic acid|mesh-list
5557364|NCT04039373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5557365|NCT04039373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5557366|NCT04039373|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5557367|NCT04039373|Antitubercular Agents|antitubercular agents|mesh-ancestor
5557368|NCT04039373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5557369|NCT04039373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5557370|NCT04039373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5557371|NCT04039373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557372|NCT04039516|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
5557373|NCT04039516|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5557374|NCT04039516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557375|NCT04039347|Cyclosporine|cyclosporine|mesh-list
6480369|NCT00542607|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6480370|NCT00542607|Histamine Antagonists|histamine antagonists|mesh-ancestor
6480371|NCT00542607|Histamine Agents|histamine agents|mesh-ancestor
6480372|NCT00542607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6480373|NCT00542607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480374|NCT00542607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480375|NCT00542711|Curcumin|curcumin|mesh-list
6480376|NCT00542711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6480377|NCT00542711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6480378|NCT00542711|Analgesics|analgesics|mesh-ancestor
6480379|NCT00542711|Sensory System Agents|sensory system agents|mesh-ancestor
6480380|NCT00542711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6157440|NCT01481116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6157441|NCT01481116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6157442|NCT01481116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157443|NCT01481116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6157444|NCT01481116|Immunologic Factors|immunologic factors|mesh-ancestor
6157445|NCT01481545|Leucovorin|leucovorin|mesh-list
6157446|NCT01481545|Bevacizumab|bevacizumab|mesh-list
6157447|NCT01481545|Fluorouracil|fluorouracil|mesh-list
6157448|NCT01481545|Oxaliplatin|oxaliplatin|mesh-list
6157449|NCT01481545|Raltitrexed|raltitrexed|mesh-list
6157450|NCT01481545|Levoleucovorin|levoleucovorin|mesh-list
6157451|NCT01481545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6157452|NCT01481545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6157453|NCT01481545|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6157454|NCT01481545|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6157455|NCT01481545|Growth Substances|growth substances|mesh-ancestor
6157456|NCT01481545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157457|NCT01481545|Growth Inhibitors|growth inhibitors|mesh-ancestor
6157458|NCT01481545|Antimetabolites|antimetabolites|mesh-ancestor
6157459|NCT01481545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157460|NCT01481545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6157461|NCT01481545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6157462|NCT01481545|Immunologic Factors|immunologic factors|mesh-ancestor
6157463|NCT01481545|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6157464|NCT01481545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6157465|NCT01481545|Antidotes|antidotes|mesh-ancestor
6157466|NCT01481545|Protective Agents|protective agents|mesh-ancestor
6157467|NCT01481545|Vitamin B Complex|vitamin b complex|mesh-ancestor
6157468|NCT01481545|Vitamins|vitamins|mesh-ancestor
6157469|NCT01481545|Micronutrients|micronutrients|mesh-ancestor
6157470|NCT01481740|Phenylephrine|phenylephrine|mesh-list
6157471|NCT01481740|Oxymetazoline|oxymetazoline|mesh-list
6157472|NCT01481740|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6480381|NCT00542711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557376|NCT04039347|Cyclosporins|cyclosporins|mesh-list
6157473|NCT01481740|Mydriatics|mydriatics|mesh-ancestor
6157474|NCT01481740|Autonomic Agents|autonomic agents|mesh-ancestor
6157475|NCT01481740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6480382|NCT00542711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6480383|NCT00542711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6480384|NCT00542711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6480385|NCT00542711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6480386|NCT00542711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480387|NCT00542763|Mycophenolic Acid|mycophenolic acid|mesh-list
6480388|NCT00542763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6480389|NCT00542763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6157476|NCT01481740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157477|NCT01481740|Sympathomimetics|sympathomimetics|mesh-ancestor
6157478|NCT01481740|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6157479|NCT01481740|Nasal Decongestants|nasal decongestants|mesh-ancestor
6157480|NCT01481740|Respiratory System Agents|respiratory system agents|mesh-ancestor
6157481|NCT01481740|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6157482|NCT01481740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5557377|NCT04039347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5557378|NCT04039347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557379|NCT04039347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5557380|NCT04039347|Immunologic Factors|immunologic factors|mesh-ancestor
5557381|NCT04039347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557382|NCT04039347|Antifungal Agents|antifungal agents|mesh-ancestor
5557383|NCT04039347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6157483|NCT01481740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6157484|NCT01481740|Adrenergic Agents|adrenergic agents|mesh-ancestor
6157485|NCT01481740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6157486|NCT01481740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157487|NCT01481740|Protective Agents|protective agents|mesh-ancestor
6157488|NCT01481779|Insulin Lispro|insulin lispro|mesh-list
6157489|NCT01481779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6157490|NCT01481779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157491|NCT01482091|Fentanyl|fentanyl|mesh-list
6157492|NCT01482091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6157493|NCT01482091|Narcotics|narcotics|mesh-ancestor
6157494|NCT01482091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6157495|NCT01482091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157496|NCT01482091|Analgesics|analgesics|mesh-ancestor
6157497|NCT01482091|Sensory System Agents|sensory system agents|mesh-ancestor
5557384|NCT04039347|Dermatologic Agents|dermatologic agents|mesh-ancestor
5557385|NCT04039347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5557386|NCT04039347|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5557387|NCT04039126|Iodine|iodine|mesh-list
5557388|NCT04039126|Cadexomer iodine|cadexomer iodine|mesh-list
5557389|NCT04039126|Povidone-Iodine|povidone-iodine|mesh-list
5557390|NCT04039126|Tetracycline|tetracycline|mesh-list
6157498|NCT01482091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6157499|NCT01482091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6157500|NCT01482091|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6157501|NCT01482091|Anesthetics, General|anesthetics, general|mesh-ancestor
6157502|NCT01482091|Anesthetics|anesthetics|mesh-ancestor
6157503|NCT01482169|Adenosine|adenosine|mesh-list
6157504|NCT01482169|Regadenoson|regadenoson|mesh-list
6157505|NCT01482169|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
6157506|NCT01482169|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6157507|NCT01482169|Purinergic Agonists|purinergic agonists|mesh-ancestor
6157508|NCT01482169|Purinergic Agents|purinergic agents|mesh-ancestor
5557391|NCT04039126|Povidone|povidone|mesh-list
5557392|NCT04039126|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5557393|NCT04039126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5557394|NCT04039126|Trace Elements|trace elements|mesh-ancestor
5557395|NCT04039126|Micronutrients|micronutrients|mesh-ancestor
5557396|NCT04039126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557397|NCT04039126|Plasma Substitutes|plasma substitutes|mesh-ancestor
5557398|NCT04039126|Blood Substitutes|blood substitutes|mesh-ancestor
5557399|NCT04039126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5557400|NCT04039126|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5557401|NCT04039126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5557402|NCT04039126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557403|NCT04039087|Sildenafil Citrate|sildenafil citrate|mesh-list
5557404|NCT04039087|Vasodilator Agents|vasodilator agents|mesh-ancestor
5557405|NCT04039087|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5557406|NCT04039087|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5557407|NCT04039087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6157509|NCT01482169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5557408|NCT04039087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157510|NCT01482169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157511|NCT01482169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157512|NCT01482169|Analgesics|analgesics|mesh-ancestor
6157513|NCT01482169|Sensory System Agents|sensory system agents|mesh-ancestor
6157514|NCT01482169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6157515|NCT01482169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6157516|NCT01482169|Vasodilator Agents|vasodilator agents|mesh-ancestor
6157517|NCT01482715|Rucaparib|rucaparib|mesh-list
6157518|NCT01482715|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6157519|NCT01482715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6157520|NCT01482715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157521|NCT01482715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6157522|NCT01482767|Interferons|interferons|mesh-list
5557409|NCT04039087|Urological Agents|urological agents|mesh-ancestor
5557410|NCT04039152|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5557411|NCT04039152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5557412|NCT04038970|Methotrexate|methotrexate|mesh-list
5557413|NCT04038970|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5557414|NCT04038970|Abortifacient Agents|abortifacient agents|mesh-ancestor
5557415|NCT04038970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5557416|NCT04038970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557417|NCT04038970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5557418|NCT04038970|Antimetabolites|antimetabolites|mesh-ancestor
5557419|NCT04038970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557420|NCT04038970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5557421|NCT04038970|Dermatologic Agents|dermatologic agents|mesh-ancestor
5557422|NCT04038970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5557423|NCT04038970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5557424|NCT04038970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5557425|NCT04038970|Immunologic Factors|immunologic factors|mesh-ancestor
5557426|NCT04038970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6157523|NCT01482767|Ribavirin|ribavirin|mesh-list
6157524|NCT01482767|Interferon-alpha|interferon-alpha|mesh-list
6157525|NCT01482767|Interferon alpha-2|interferon alpha-2|mesh-list
6157526|NCT01482767|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6157527|NCT01482767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6157528|NCT01482767|Antiviral Agents|antiviral agents|mesh-ancestor
6157529|NCT01482767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6157530|NCT01482767|Antimetabolites|antimetabolites|mesh-ancestor
6157531|NCT01482767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157532|NCT01482767|Immunologic Factors|immunologic factors|mesh-ancestor
6157533|NCT01482767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157534|NCT01482910|Aflibercept|aflibercept|mesh-list
6157535|NCT01482910|Verteporfin|verteporfin|mesh-list
6157536|NCT01482910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6157537|NCT01482910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6157538|NCT01482910|Growth Substances|growth substances|mesh-ancestor
6157539|NCT01482910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157540|NCT01482910|Growth Inhibitors|growth inhibitors|mesh-ancestor
5557427|NCT04038970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5557428|NCT04038853|Vitamin D|vitamin d|mesh-list
5557429|NCT04038853|Cholecalciferol|cholecalciferol|mesh-list
5557430|NCT04038853|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
5557431|NCT04038853|Vitamins|vitamins|mesh-ancestor
5557432|NCT04038853|Micronutrients|micronutrients|mesh-ancestor
5557433|NCT04038853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557434|NCT04038853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5557435|NCT04038853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5557436|NCT04038749|Cabergoline|cabergoline|mesh-list
5557437|NCT04038749|Bromocriptine|bromocriptine|mesh-list
5557438|NCT04038749|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5557439|NCT04038749|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5557440|NCT04038749|Dopamine Agonists|dopamine agonists|mesh-ancestor
5557441|NCT04038749|Dopamine Agents|dopamine agents|mesh-ancestor
5557442|NCT04038749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5557443|NCT04038749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557444|NCT04038749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557445|NCT04038749|Hormone Antagonists|hormone antagonists|mesh-ancestor
5557446|NCT04038749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5557447|NCT04038411|Etoposide|etoposide|mesh-list
5557448|NCT04038411|Lenalidomide|lenalidomide|mesh-list
6157541|NCT01482910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6157542|NCT01482910|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6157543|NCT01482910|Dermatologic Agents|dermatologic agents|mesh-ancestor
6157544|NCT01482962|Gemcitabine|gemcitabine|mesh-list
5557449|NCT04038411|Antibodies|antibodies|mesh-list
6157545|NCT01482962|Romidepsin|romidepsin|mesh-list
6157546|NCT01482962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5557450|NCT04038411|Immunologic Factors|immunologic factors|mesh-ancestor
5557451|NCT04038411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157547|NCT01482962|Antimetabolites|antimetabolites|mesh-ancestor
6157548|NCT01482962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157549|NCT01482962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6157550|NCT01482962|Antiviral Agents|antiviral agents|mesh-ancestor
6157551|NCT01482962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6157552|NCT01482962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6157553|NCT01482962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6157554|NCT01482962|Immunologic Factors|immunologic factors|mesh-ancestor
6480390|NCT00542763|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6480391|NCT00542763|Antitubercular Agents|antitubercular agents|mesh-ancestor
6480392|NCT00542763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6480393|NCT00542763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6480394|NCT00542763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6480395|NCT00542763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480396|NCT00542802|Carbamazepine|carbamazepine|mesh-list
6480397|NCT00542802|Levetiracetam|levetiracetam|mesh-list
6480398|NCT00542802|Anticonvulsants|anticonvulsants|mesh-ancestor
6480399|NCT00542802|Nootropic Agents|nootropic agents|mesh-ancestor
6480400|NCT00542802|Antimanic Agents|antimanic agents|mesh-ancestor
6668268|NCT01531244|Alkylating Agents|alkylating agents|mesh-ancestor
6157555|NCT01482962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157556|NCT01482962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6157557|NCT01483144|Eflornithine|eflornithine|mesh-list
6157558|NCT01483144|Sulindac|sulindac|mesh-list
6157559|NCT01483144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6157560|NCT01483144|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6157561|NCT01483144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6157562|NCT01483144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6157563|NCT01483144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6157564|NCT01483144|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
6157565|NCT01483144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6157566|NCT01483144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157567|NCT01483144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6157568|NCT01483144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6668269|NCT01531244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668270|NCT01531244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6668271|NCT01531244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6668272|NCT01531244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6668273|NCT01531244|Immunologic Factors|immunologic factors|mesh-ancestor
6668274|NCT01531244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668275|NCT01531244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5557452|NCT04038411|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5557453|NCT04038411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5557454|NCT04038411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5557455|NCT04038411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5557456|NCT04038411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5557457|NCT04038411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557458|NCT04038411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5557459|NCT04038411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5557460|NCT04038411|Growth Substances|growth substances|mesh-ancestor
5557461|NCT04038411|Growth Inhibitors|growth inhibitors|mesh-ancestor
5557462|NCT04038437|Venetoclax|venetoclax|mesh-list
5557463|NCT04038437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5557464|NCT04038502|Carboplatin|carboplatin|mesh-list
5557465|NCT04038502|Olaparib|olaparib|mesh-list
5557466|NCT04038502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5557467|NCT04038502|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5557468|NCT04038502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5557469|NCT04038502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557470|NCT04038619|Loperamide|loperamide|mesh-list
5557471|NCT04038619|Antidiarrheals|antidiarrheals|mesh-list
5557472|NCT04038619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5557473|NCT04038320|Sofosbuvir|sofosbuvir|mesh-list
5557474|NCT04038320|Ledipasvir|ledipasvir|mesh-list
5557475|NCT04038320|Antiviral Agents|antiviral agents|mesh-ancestor
5557476|NCT04038320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5557477|NCT04038671|Anti-Infective Agents|anti-infective agents|mesh-list
5557478|NCT04038671|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5557479|NCT04038671|Charcoal|charcoal|mesh-list
5557480|NCT04038671|Antidotes|antidotes|mesh-ancestor
6668276|NCT01531244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5557481|NCT04038671|Protective Agents|protective agents|mesh-ancestor
6157569|NCT01483144|Analgesics|analgesics|mesh-ancestor
6480401|NCT00542802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6668277|NCT01531244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5557482|NCT04038671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157570|NCT01483144|Sensory System Agents|sensory system agents|mesh-ancestor
6157571|NCT01483144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6157572|NCT01483144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157573|NCT01483144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6157574|NCT01483144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6157575|NCT01483144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6205982|NCT02095158|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6205983|NCT02095158|Protective Agents|protective agents|mesh-ancestor
5557483|NCT04038307|Acetaminophen|acetaminophen|mesh-list
5557484|NCT04038307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5557485|NCT04038307|Analgesics|analgesics|mesh-ancestor
5557486|NCT04038307|Sensory System Agents|sensory system agents|mesh-ancestor
6205984|NCT02095197|Triamcinolone|triamcinolone|mesh-list
5557487|NCT04038307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5557488|NCT04038307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557489|NCT04038307|Antipyretics|antipyretics|mesh-ancestor
6205985|NCT02095197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6205986|NCT02095197|Glucocorticoids|glucocorticoids|mesh-ancestor
6205987|NCT02095197|Hormones|hormones|mesh-ancestor
6205988|NCT02095197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5603278|NCT02964182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603279|NCT02889809|Fluticasone|fluticasone|mesh-list
5603280|NCT02889809|Xhance|xhance|mesh-list
5603281|NCT02889809|Montelukast|montelukast|mesh-list
5603282|NCT02889809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5603283|NCT02889809|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5603284|NCT02889809|Autonomic Agents|autonomic agents|mesh-ancestor
5603285|NCT02889809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5603286|NCT02889809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603287|NCT02889809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5603288|NCT02889809|Respiratory System Agents|respiratory system agents|mesh-ancestor
5603289|NCT02889809|Dermatologic Agents|dermatologic agents|mesh-ancestor
5603290|NCT02889809|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5603291|NCT02889809|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5603292|NCT02889809|Hormone Antagonists|hormone antagonists|mesh-ancestor
5603293|NCT02889809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5603294|NCT02889809|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5603295|NCT02889809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5603296|NCT02889809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603297|NCT02884648|Bevacizumab|bevacizumab|mesh-list
5603298|NCT02884648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5603299|NCT02884648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5603300|NCT02884648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5603301|NCT02884648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5603302|NCT02884648|Growth Substances|growth substances|mesh-ancestor
5603303|NCT02884648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603304|NCT02884648|Growth Inhibitors|growth inhibitors|mesh-ancestor
5603305|NCT02818023|Pembrolizumab|pembrolizumab|mesh-list
5603306|NCT02818023|Vemurafenib|vemurafenib|mesh-list
5603307|NCT02818023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5603308|NCT02818023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5603309|NCT02818023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5603310|NCT02818023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5603311|NCT02818023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603312|NCT02815540|Cannabidiol|cannabidiol|mesh-list
5603313|NCT02815540|Anticonvulsants|anticonvulsants|mesh-ancestor
5603314|NCT02808572|Mitogens|mitogens|mesh-list
5603315|NCT02808572|Mitosis Modulators|mitosis modulators|mesh-ancestor
5603316|NCT02808572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205989|NCT02095197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6205990|NCT02095535|Chlorhexidine|chlorhexidine|mesh-list
6205991|NCT02095535|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6205992|NCT02095535|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6205993|NCT02095535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6205994|NCT02095535|Disinfectants|disinfectants|mesh-ancestor
6205995|NCT02095535|Dermatologic Agents|dermatologic agents|mesh-ancestor
6205996|NCT02095873|Resveratrol|resveratrol|mesh-list
6205997|NCT02095873|Antioxidants|antioxidants|mesh-ancestor
6205998|NCT02095873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6205999|NCT02095873|Protective Agents|protective agents|mesh-ancestor
6206000|NCT02095873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206001|NCT02095873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6157576|NCT01483560|Metformin|metformin|mesh-list
6157577|NCT01483560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6157578|NCT01483560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157579|NCT01483599|Adalimumab|adalimumab|mesh-list
6157580|NCT01483599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6157581|NCT01483599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6157582|NCT01483625|Tiotropium Bromide|tiotropium bromide|mesh-list
6157583|NCT01483625|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6157584|NCT01483625|Autonomic Agents|autonomic agents|mesh-ancestor
6157585|NCT01483625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6157586|NCT01483625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157587|NCT01483625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6157588|NCT01483625|Respiratory System Agents|respiratory system agents|mesh-ancestor
6157589|NCT01483625|Parasympatholytics|parasympatholytics|mesh-ancestor
5557490|NCT04038008|Fluconazole|fluconazole|mesh-list
5557491|NCT04038008|Antifungal Agents|antifungal agents|mesh-ancestor
5557492|NCT04038008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5557493|NCT04038008|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5557494|NCT04038008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5557495|NCT04038008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5557496|NCT04038008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557497|NCT04038008|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6157590|NCT01483625|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6157591|NCT01483625|Cholinergic Agents|cholinergic agents|mesh-ancestor
6157592|NCT01483625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6157593|NCT01483625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157594|NCT01483651|Insulin|insulin|mesh-list
6157595|NCT01483651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6157596|NCT01483651|Glucagon|glucagon|mesh-list
6157597|NCT01483651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6157598|NCT01483651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157599|NCT01483651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6157600|NCT01483651|Hormones|hormones|mesh-ancestor
6157601|NCT01483651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6157602|NCT01483690|Dexamethasone|dexamethasone|mesh-list
6157603|NCT01483690|Dexamethasone acetate|dexamethasone acetate|mesh-list
6157604|NCT01483690|Methotrexate|methotrexate|mesh-list
6157605|NCT01483690|Vincristine|vincristine|mesh-list
6157606|NCT01483690|Decitabine|decitabine|mesh-list
6157607|NCT01483690|Asparaginase|asparaginase|mesh-list
6157608|NCT01483690|Mitoxantrone|mitoxantrone|mesh-list
6157609|NCT01483690|Vorinostat|vorinostat|mesh-list
5557498|NCT04038008|Hormone Antagonists|hormone antagonists|mesh-ancestor
5557499|NCT04038008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5557500|NCT04038008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557501|NCT04038008|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5557502|NCT04038008|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5557503|NCT04038034|Coenzyme Q10|coenzyme q10|mesh-list
5557504|NCT04038034|Vitamins|vitamins|mesh-ancestor
5557505|NCT04038034|Micronutrients|micronutrients|mesh-ancestor
5557506|NCT04038034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557507|NCT04037878|Tramadol|tramadol|mesh-list
5557508|NCT04037878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5557509|NCT04037878|Narcotics|narcotics|mesh-ancestor
5557510|NCT04037878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5557511|NCT04037878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557512|NCT04037878|Analgesics|analgesics|mesh-ancestor
5557513|NCT04037878|Sensory System Agents|sensory system agents|mesh-ancestor
5557514|NCT04037878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5557515|NCT04038125|Dexamethasone|dexamethasone|mesh-list
5557516|NCT04038125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5557517|NCT04038125|Antiemetics|antiemetics|mesh-ancestor
5557518|NCT04038125|Autonomic Agents|autonomic agents|mesh-ancestor
5557519|NCT04038125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6157610|NCT01483690|Pegaspargase|pegaspargase|mesh-list
6157611|NCT01483690|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
6157612|NCT01483690|BB 1101|bb 1101|mesh-list
6157613|NCT01483690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6157614|NCT01483690|Antiemetics|antiemetics|mesh-ancestor
6157615|NCT01483690|Autonomic Agents|autonomic agents|mesh-ancestor
6157616|NCT01483690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6157617|NCT01483690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557520|NCT04038125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557521|NCT04038125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6157618|NCT01483690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6157619|NCT01483690|Glucocorticoids|glucocorticoids|mesh-ancestor
6157620|NCT01483690|Hormones|hormones|mesh-ancestor
6206002|NCT02095873|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6157621|NCT01483690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6157622|NCT01483690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6157623|NCT01483690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6157624|NCT01483690|Protease Inhibitors|protease inhibitors|mesh-ancestor
6480402|NCT00542802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6480403|NCT00542802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480404|NCT00542802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6480405|NCT00542802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6480406|NCT00542802|Analgesics|analgesics|mesh-ancestor
6157625|NCT01483690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6157626|NCT01483690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157627|NCT01483690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6157628|NCT01483690|Abortifacient Agents|abortifacient agents|mesh-ancestor
6157629|NCT01483690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6157630|NCT01483690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6157631|NCT01483690|Antimetabolites|antimetabolites|mesh-ancestor
6157632|NCT01483690|Dermatologic Agents|dermatologic agents|mesh-ancestor
6157633|NCT01483690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6157634|NCT01483690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6157635|NCT01483690|Immunologic Factors|immunologic factors|mesh-ancestor
6157636|NCT01483690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6157637|NCT01483690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6157638|NCT01483690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6157639|NCT01483690|Tubulin Modulators|tubulin modulators|mesh-ancestor
5557522|NCT04038125|Glucocorticoids|glucocorticoids|mesh-ancestor
5557523|NCT04038125|Hormones|hormones|mesh-ancestor
5557524|NCT04038125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5557525|NCT04038125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5557526|NCT04038125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5557527|NCT04038086|Insulin|insulin|mesh-list
5557528|NCT04038086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5557529|NCT04038086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557530|NCT04038073|Antibodies|antibodies|mesh-list
5557531|NCT04038073|Antistreptolysin|antistreptolysin|mesh-list
5557532|NCT04038073|Immunologic Factors|immunologic factors|mesh-ancestor
5557533|NCT04038073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557534|NCT04038255|Nicotine|nicotine|mesh-list
5557535|NCT04038255|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5557536|NCT04038255|Autonomic Agents|autonomic agents|mesh-ancestor
5557537|NCT04038255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6157640|NCT01483690|Antimitotic Agents|antimitotic agents|mesh-ancestor
6157641|NCT01483690|Mitosis Modulators|mitosis modulators|mesh-ancestor
6157642|NCT01483690|Analgesics|analgesics|mesh-ancestor
6157643|NCT01483690|Sensory System Agents|sensory system agents|mesh-ancestor
6157644|NCT01483690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6157645|NCT01483690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6157646|NCT01483690|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6157647|NCT01484041|Aromatase Inhibitors|aromatase inhibitors|mesh-list
6157648|NCT01484041|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6157649|NCT01484041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6157650|NCT01484041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157651|NCT01484041|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6157652|NCT01484041|Hormone Antagonists|hormone antagonists|mesh-ancestor
6157653|NCT01484041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6157654|NCT01484041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157655|NCT01484197|Maleic acid|maleic acid|mesh-list
6157656|NCT01484197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6157657|NCT01484197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157658|NCT01484275|Siltuximab|siltuximab|mesh-list
6157659|NCT01484275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6157660|NCT01484340|Nicotine|nicotine|mesh-list
6157661|NCT01484340|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6157662|NCT01484340|Autonomic Agents|autonomic agents|mesh-ancestor
6157663|NCT01484340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6157664|NCT01484340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157665|NCT01484340|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6157666|NCT01484340|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6157667|NCT01484340|Cholinergic Agents|cholinergic agents|mesh-ancestor
6157668|NCT01484340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6157669|NCT01484340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557538|NCT04038255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557539|NCT04038255|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5557540|NCT04038255|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6157670|NCT01484431|Tadalafil|tadalafil|mesh-list
6157671|NCT01484431|Vasodilator Agents|vasodilator agents|mesh-ancestor
6157672|NCT01484431|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6157673|NCT01484431|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6157674|NCT01484431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6157675|NCT01484431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157676|NCT01484431|Urological Agents|urological agents|mesh-ancestor
6157677|NCT01484496|Belimumab|belimumab|mesh-list
6157678|NCT01484496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6157679|NCT01484496|Immunologic Factors|immunologic factors|mesh-ancestor
6157680|NCT01484496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157681|NCT01484561|Tofacitinib|tofacitinib|mesh-list
6157682|NCT01484561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6157683|NCT01484561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6157684|NCT01484561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157685|NCT01484626|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6157686|NCT01484626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6157687|NCT01484626|Alkylating Agents|alkylating agents|mesh-ancestor
5557541|NCT04038255|Cholinergic Agents|cholinergic agents|mesh-ancestor
5557542|NCT04038255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5557543|NCT04038255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557544|NCT04037774|Dexmedetomidine|dexmedetomidine|mesh-list
5557545|NCT04037774|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6157688|NCT01484626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157689|NCT01484626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6157690|NCT01484873|Exenatide|exenatide|mesh-list
6157691|NCT01484873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6157692|NCT01484873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157693|NCT01484873|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6157694|NCT01484873|Incretins|incretins|mesh-ancestor
6157695|NCT01484873|Hormones|hormones|mesh-ancestor
6157696|NCT01484873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6157697|NCT01484951|Timolol|timolol|mesh-list
6157698|NCT01484951|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6157699|NCT01484951|Brinzolamide|brinzolamide|mesh-list
6157700|NCT01484951|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6157701|NCT01484951|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6157702|NCT01484951|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6157703|NCT01484951|Adrenergic Agents|adrenergic agents|mesh-ancestor
6157704|NCT01484951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6157705|NCT01484951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157706|NCT01484951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157707|NCT01484951|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6157708|NCT01484951|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6157709|NCT01484951|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6157710|NCT01484951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6157711|NCT01484977|Lacosamide|lacosamide|mesh-list
6157712|NCT01484977|Anticonvulsants|anticonvulsants|mesh-ancestor
6157713|NCT01484977|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6480407|NCT00542802|Sensory System Agents|sensory system agents|mesh-ancestor
6480408|NCT00542802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6480409|NCT00542802|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6480410|NCT00542802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6480411|NCT00542802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480412|NCT00542802|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6480413|NCT00542802|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6480414|NCT00542841|Hydrocortisone|hydrocortisone|mesh-list
6480415|NCT00542841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6480416|NCT00542893|Dacarbazine|dacarbazine|mesh-list
6480417|NCT00542893|Oblimersen|oblimersen|mesh-list
6480418|NCT00542893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6480419|NCT00542893|Alkylating Agents|alkylating agents|mesh-ancestor
6480420|NCT00542893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557546|NCT04037774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5603317|NCT02785224|Vasopressins|vasopressins|mesh-list
5557547|NCT04037774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557548|NCT04037774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5557549|NCT04037774|Analgesics|analgesics|mesh-ancestor
5557550|NCT04037774|Sensory System Agents|sensory system agents|mesh-ancestor
5557551|NCT04037774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5557552|NCT04037774|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5557553|NCT04037774|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5557554|NCT04037774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5557555|NCT04037774|Adrenergic Agents|adrenergic agents|mesh-ancestor
5557556|NCT04037774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5557557|NCT04037774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557558|NCT04037527|Gemcitabine|gemcitabine|mesh-list
5557559|NCT04037527|Docetaxel|docetaxel|mesh-list
5557560|NCT04037527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5557561|NCT04037527|Antimetabolites|antimetabolites|mesh-ancestor
6157714|NCT01484977|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6157715|NCT01484977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6157716|NCT01484977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157717|NCT01485055|Infliximab|infliximab|mesh-list
6157718|NCT01485055|Basiliximab|basiliximab|mesh-list
6157719|NCT01485055|Dermatologic Agents|dermatologic agents|mesh-ancestor
6157720|NCT01485055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6157721|NCT01485055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6157722|NCT01485055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6157723|NCT01485055|Immunologic Factors|immunologic factors|mesh-ancestor
6480421|NCT00542893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6480422|NCT00542984|Teriparatide|teriparatide|mesh-list
6480423|NCT00542984|Calcitonin|calcitonin|mesh-list
6480424|NCT00542984|Salmon calcitonin|salmon calcitonin|mesh-list
6480425|NCT00542984|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
6157724|NCT01485055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557562|NCT04037527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557563|NCT04037527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5557564|NCT04037527|Antiviral Agents|antiviral agents|mesh-ancestor
5557565|NCT04037527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5557566|NCT04037527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5557567|NCT04037527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5557568|NCT04037527|Immunologic Factors|immunologic factors|mesh-ancestor
5557569|NCT04037527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557570|NCT04037527|Tubulin Modulators|tubulin modulators|mesh-ancestor
5557571|NCT04037527|Antimitotic Agents|antimitotic agents|mesh-ancestor
5557572|NCT04037527|Mitosis Modulators|mitosis modulators|mesh-ancestor
5557573|NCT04037566|Cyclophosphamide|cyclophosphamide|mesh-list
5557574|NCT04037566|Fludarabine|fludarabine|mesh-list
5557575|NCT04037566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5557576|NCT04037566|Immunologic Factors|immunologic factors|mesh-ancestor
5557577|NCT04037566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557578|NCT04037566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5557579|NCT04037566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5557580|NCT04037566|Alkylating Agents|alkylating agents|mesh-ancestor
5557581|NCT04037566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557582|NCT04037566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5557583|NCT04037566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5557584|NCT04037657|Propofol|propofol|mesh-list
5557585|NCT04037657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5557586|NCT04037657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5557587|NCT04037657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557588|NCT04037657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5557589|NCT04037657|Anesthetics, General|anesthetics, general|mesh-ancestor
5557590|NCT04037657|Anesthetics|anesthetics|mesh-ancestor
5557591|NCT04037072|Mitomycins|mitomycins|mesh-list
5557592|NCT04037072|Mitomycin|mitomycin|mesh-list
5557593|NCT04037072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5557594|NCT04037072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5557595|NCT04037072|Alkylating Agents|alkylating agents|mesh-ancestor
5557596|NCT04037072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557597|NCT04037072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5557598|NCT04037072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5557599|NCT04037176|Omalizumab|omalizumab|mesh-list
5557600|NCT04037176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5557601|NCT04037176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5557602|NCT04037176|Respiratory System Agents|respiratory system agents|mesh-ancestor
5557603|NCT04037514|Acetaminophen|acetaminophen|mesh-list
5557604|NCT04037514|Ibuprofen|ibuprofen|mesh-list
6157725|NCT01485094|Pregabalin|pregabalin|mesh-list
6157726|NCT01485094|Analgesics|analgesics|mesh-ancestor
6480426|NCT00542984|Katacalcin|katacalcin|mesh-list
6157727|NCT01485094|Sensory System Agents|sensory system agents|mesh-ancestor
6157728|NCT01485094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6157729|NCT01485094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157730|NCT01485094|Anticonvulsants|anticonvulsants|mesh-ancestor
6157731|NCT01485094|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6157732|NCT01485094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6157733|NCT01485094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157734|NCT01485094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6157735|NCT01485094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6157736|NCT01485094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6157737|NCT01485094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6157738|NCT01485094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6157739|NCT01485172|Ropinirole|ropinirole|mesh-list
6157740|NCT01485172|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6157741|NCT01485172|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6157742|NCT01485172|Dopamine Agonists|dopamine agonists|mesh-ancestor
6157743|NCT01485172|Dopamine Agents|dopamine agents|mesh-ancestor
6157744|NCT01485172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6157745|NCT01485172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157746|NCT01485172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157747|NCT01485380|Dexmedetomidine|dexmedetomidine|mesh-list
6157748|NCT01485380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6157749|NCT01485380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6157750|NCT01485380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157751|NCT01485380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6157752|NCT01485380|Analgesics|analgesics|mesh-ancestor
6157753|NCT01485380|Sensory System Agents|sensory system agents|mesh-ancestor
6157754|NCT01485380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6157755|NCT01485380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6157756|NCT01485380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6157757|NCT01485380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6157758|NCT01485380|Adrenergic Agents|adrenergic agents|mesh-ancestor
6157759|NCT01485380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6157760|NCT01485380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157761|NCT01485393|Dexmedetomidine|dexmedetomidine|mesh-list
6157762|NCT01485393|Zolpidem|zolpidem|mesh-list
6157763|NCT01485393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6157764|NCT01485393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6480427|NCT00542984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6480428|NCT00542984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480429|NCT00542984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6480430|NCT00542984|Vasodilator Agents|vasodilator agents|mesh-ancestor
6488858|NCT00587379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6488859|NCT00587379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6488860|NCT00587444|Heparin|heparin|mesh-list
6488861|NCT00587444|Calcium heparin|calcium heparin|mesh-list
6488862|NCT00587444|Anticoagulants|anticoagulants|mesh-ancestor
6488863|NCT00587444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6488864|NCT00587444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6488865|NCT00587444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488866|NCT00587470|Candesartan|candesartan|mesh-list
6488867|NCT00587470|Candesartan cilexetil|candesartan cilexetil|mesh-list
6488868|NCT00587470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6488869|NCT00587470|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6488870|NCT00587470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6488871|NCT00587470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488872|NCT00587496|Aspirin|aspirin|mesh-list
6488873|NCT00587496|Valacyclovir|valacyclovir|mesh-list
6488874|NCT00587496|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5557605|NCT04037514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5557606|NCT04037514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5557607|NCT04037514|Analgesics|analgesics|mesh-ancestor
5557608|NCT04037514|Sensory System Agents|sensory system agents|mesh-ancestor
5557609|NCT04037514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5557610|NCT04037514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603318|NCT02785224|Arginine Vasopressin|arginine vasopressin|mesh-list
6480431|NCT00543023|Teriparatide|teriparatide|mesh-list
6480432|NCT00543023|Calcitonin|calcitonin|mesh-list
6480433|NCT00543023|Salmon calcitonin|salmon calcitonin|mesh-list
6480434|NCT00543023|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
6480435|NCT00543023|Katacalcin|katacalcin|mesh-list
6480436|NCT00543023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6480437|NCT00543023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157765|NCT01485393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157766|NCT01485393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6157767|NCT01485393|Analgesics|analgesics|mesh-ancestor
6157768|NCT01485393|Sensory System Agents|sensory system agents|mesh-ancestor
6157769|NCT01485393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6157770|NCT01485393|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6157771|NCT01485393|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6480438|NCT00543023|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6480439|NCT00543023|Vasodilator Agents|vasodilator agents|mesh-ancestor
6480440|NCT00543049|Sunitinib|sunitinib|mesh-list
6480441|NCT00543049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6480442|NCT00543049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6480443|NCT00543049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6480444|NCT00543049|Growth Substances|growth substances|mesh-ancestor
6480445|NCT00543049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480446|NCT00543049|Growth Inhibitors|growth inhibitors|mesh-ancestor
6157772|NCT01485393|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6157773|NCT01485393|Adrenergic Agents|adrenergic agents|mesh-ancestor
6157774|NCT01485393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6157775|NCT01485393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157776|NCT01485393|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6157777|NCT01485393|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6157778|NCT01485393|GABA Agonists|gaba agonists|mesh-ancestor
6157779|NCT01485393|GABA Agents|gaba agents|mesh-ancestor
6157780|NCT01485588|Immunoconjugates|immunoconjugates|mesh-list
6157781|NCT01485588|Immunologic Factors|immunologic factors|mesh-ancestor
6157782|NCT01485588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157783|NCT01485614|Metformin|metformin|mesh-list
6157784|NCT01485614|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6157785|NCT01485614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6480447|NCT00543049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6157786|NCT01485614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157787|NCT01485614|Incretins|incretins|mesh-ancestor
6157788|NCT01485614|Hormones|hormones|mesh-ancestor
6157789|NCT01485614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6157790|NCT01485614|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6157791|NCT01485614|Protease Inhibitors|protease inhibitors|mesh-ancestor
6157792|NCT01485614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6157793|NCT01485614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157794|NCT01485640|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
6157795|NCT01485640|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6157796|NCT01485640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6480448|NCT00543049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6157797|NCT01485640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6157798|NCT01485640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157799|NCT01485640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6157800|NCT01485640|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6157801|NCT01485640|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6157802|NCT01485640|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6157803|NCT01485640|Adrenergic Agents|adrenergic agents|mesh-ancestor
6157804|NCT01485640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6157805|NCT01485640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157806|NCT01485640|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6157807|NCT01485640|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6157808|NCT01485640|Serotonin Agents|serotonin agents|mesh-ancestor
6157809|NCT01485640|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6157810|NCT01485640|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6157811|NCT01485640|Dopamine Agents|dopamine agents|mesh-ancestor
6157812|NCT01485796|Immunoglobulins|immunoglobulins|mesh-list
6157813|NCT01485796|Antibodies|antibodies|mesh-list
6157814|NCT01485796|gamma-Globulins|gamma-globulins|mesh-list
6157815|NCT01485796|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6157816|NCT01485796|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6157817|NCT01485796|Immunologic Factors|immunologic factors|mesh-ancestor
6480449|NCT00543049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480450|NCT00543075|Oblimersen|oblimersen|mesh-list
6480451|NCT00543075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6480452|NCT00543114|Rituximab|rituximab|mesh-list
6480453|NCT00543114|Fludarabine|fludarabine|mesh-list
6480454|NCT00543114|Lenalidomide|lenalidomide|mesh-list
6480455|NCT00543114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6480456|NCT00543114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6480457|NCT00543114|Immunologic Factors|immunologic factors|mesh-ancestor
6157818|NCT01485796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157819|NCT01485887|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6157820|NCT01485887|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6157821|NCT01485887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5557611|NCT04037514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5557612|NCT04037514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5557613|NCT04037514|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5557614|NCT04037514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5557615|NCT04037514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157822|NCT01485887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6157823|NCT01485887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157824|NCT01485887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6157825|NCT01485887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157826|NCT01485887|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6157827|NCT01485887|Antidepressive Agents|antidepressive agents|mesh-ancestor
6157828|NCT01485887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6157829|NCT01485991|Simeprevir|simeprevir|mesh-list
6157830|NCT01485991|Antiviral Agents|antiviral agents|mesh-ancestor
6157831|NCT01485991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6157832|NCT01485991|Protease Inhibitors|protease inhibitors|mesh-ancestor
6480458|NCT00543114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557616|NCT04037514|Antipyretics|antipyretics|mesh-ancestor
5557617|NCT04037085|Ketamine|ketamine|mesh-list
5557618|NCT04037085|Analgesics|analgesics|mesh-ancestor
5557619|NCT04037085|Sensory System Agents|sensory system agents|mesh-ancestor
5557620|NCT04037085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5557621|NCT04037085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557622|NCT04037085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5557623|NCT04037085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5557624|NCT04037085|Anesthetics, General|anesthetics, general|mesh-ancestor
5557625|NCT04037085|Anesthetics|anesthetics|mesh-ancestor
5557626|NCT04037085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5557627|NCT04037085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5557628|NCT04037085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5557629|NCT04037085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6157833|NCT01485991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6157834|NCT01485991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157835|NCT01486043|Metformin|metformin|mesh-list
6157836|NCT01486043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6157837|NCT01486043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157838|NCT01486264|Botulinum Toxins|botulinum toxins|mesh-list
6157839|NCT01486264|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6157840|NCT01486264|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6157841|NCT01486264|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6157842|NCT01486264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6157843|NCT01486264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157844|NCT01486264|Cholinergic Agents|cholinergic agents|mesh-ancestor
6157845|NCT01486264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6157846|NCT01486264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668278|NCT01531244|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6668279|NCT01531244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6668280|NCT01531244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6668281|NCT01531309|S 20098|s 20098|mesh-list
5557630|NCT04037085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557631|NCT04037397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
5557632|NCT04037241|Leucovorin|leucovorin|mesh-list
5557633|NCT04037241|Gemcitabine|gemcitabine|mesh-list
5557634|NCT04037241|Paclitaxel|paclitaxel|mesh-list
5557635|NCT04037241|Capecitabine|capecitabine|mesh-list
5557636|NCT04037241|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5557637|NCT04037241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6157847|NCT01486264|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6157848|NCT01486264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6157849|NCT01486615|Melatonin|melatonin|mesh-list
6157850|NCT01486615|Alprazolam|alprazolam|mesh-list
6157851|NCT01486615|Azaperone|azaperone|mesh-list
6157852|NCT01486615|Antioxidants|antioxidants|mesh-ancestor
6157853|NCT01486615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157854|NCT01486615|Protective Agents|protective agents|mesh-ancestor
6157855|NCT01486615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157856|NCT01486615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6157857|NCT01486615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6157858|NCT01486615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6157859|NCT01486615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6157860|NCT01486615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6157861|NCT01486615|GABA Modulators|gaba modulators|mesh-ancestor
6157862|NCT01486615|GABA Agents|gaba agents|mesh-ancestor
6157863|NCT01486615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6157864|NCT01486615|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6157865|NCT01486615|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6157866|NCT01486615|Dopamine Agents|dopamine agents|mesh-ancestor
6157867|NCT01486758|Azithromycin|azithromycin|mesh-list
6480459|NCT00543114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6480460|NCT00543114|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6480461|NCT00543114|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6480462|NCT00543114|Growth Substances|growth substances|mesh-ancestor
6480463|NCT00543114|Growth Inhibitors|growth inhibitors|mesh-ancestor
6157868|NCT01486758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6157869|NCT01486758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6157870|NCT01486810|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6157871|NCT01486810|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6157872|NCT01486810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157873|NCT01486810|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6157874|NCT01486810|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6157875|NCT01486810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6157876|NCT01486810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157877|NCT01486810|Dopamine Agents|dopamine agents|mesh-ancestor
6157878|NCT01486810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6157879|NCT01486927|Factor VIII|factor viii|mesh-list
5557638|NCT04037241|Tubulin Modulators|tubulin modulators|mesh-ancestor
6157880|NCT01486927|Coagulants|coagulants|mesh-ancestor
6157881|NCT01486966|Insulin|insulin|mesh-list
6157882|NCT01486966|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6157883|NCT01486966|Metformin|metformin|mesh-list
6480464|NCT00543166|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
6480465|NCT00543166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6480466|NCT00543166|Immunologic Factors|immunologic factors|mesh-ancestor
6480467|NCT00543166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480468|NCT00543179|Lanreotide|lanreotide|mesh-list
6480469|NCT00543179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6480470|NCT00543205|Oblimersen|oblimersen|mesh-list
6480471|NCT00543205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6480472|NCT00543218|Teriparatide|teriparatide|mesh-list
6480473|NCT00543218|Calcitonin|calcitonin|mesh-list
6157884|NCT01486966|Insulin Aspart|insulin aspart|mesh-list
6157885|NCT01486966|Insulin Detemir|insulin detemir|mesh-list
6157886|NCT01486966|Isophane Insulin, Human|isophane insulin, human|mesh-list
6157887|NCT01486966|Insulin, Isophane|insulin, isophane|mesh-list
6157888|NCT01486966|Isophane insulin, beef|isophane insulin, beef|mesh-list
6157889|NCT01486966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6157890|NCT01486966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157891|NCT01487161|Triamcinolone|triamcinolone|mesh-list
6157892|NCT01487161|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6157893|NCT01487161|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6157894|NCT01487161|FX006|fx006|mesh-list
6157895|NCT01487161|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6157896|NCT01487161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5557639|NCT04037241|Antimitotic Agents|antimitotic agents|mesh-ancestor
5557640|NCT04037241|Mitosis Modulators|mitosis modulators|mesh-ancestor
5557641|NCT04037241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557642|NCT04037241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5557643|NCT04037241|Antimetabolites|antimetabolites|mesh-ancestor
5557644|NCT04037241|Antiviral Agents|antiviral agents|mesh-ancestor
5557645|NCT04037241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5557646|NCT04037241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5557647|NCT04037241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5557648|NCT04037241|Immunologic Factors|immunologic factors|mesh-ancestor
5557649|NCT04037241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557650|NCT04037241|Antidotes|antidotes|mesh-ancestor
5557651|NCT04037241|Protective Agents|protective agents|mesh-ancestor
5557652|NCT04037241|Vitamin B Complex|vitamin b complex|mesh-ancestor
5557653|NCT04037241|Vitamins|vitamins|mesh-ancestor
5557654|NCT04037241|Micronutrients|micronutrients|mesh-ancestor
5557655|NCT04036721|Prednisone|prednisone|mesh-list
5557656|NCT04036721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6157897|NCT01487161|Glucocorticoids|glucocorticoids|mesh-ancestor
6157898|NCT01487161|Hormones|hormones|mesh-ancestor
6480474|NCT00543218|Salmon calcitonin|salmon calcitonin|mesh-list
6480475|NCT00543218|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
5557657|NCT04036721|Glucocorticoids|glucocorticoids|mesh-ancestor
5557658|NCT04036721|Hormones|hormones|mesh-ancestor
5557659|NCT04036721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5557660|NCT04036721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557661|NCT04036721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5557662|NCT04036721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5557663|NCT04036890|Minocycline|minocycline|mesh-list
5557664|NCT04036890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5557665|NCT04036890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5557666|NCT04036981|Botulinum Toxins|botulinum toxins|mesh-list
5557667|NCT04036981|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5557668|NCT04036981|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5557669|NCT04036981|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5557670|NCT04036981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5557671|NCT04036981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557672|NCT04036981|Cholinergic Agents|cholinergic agents|mesh-ancestor
5557673|NCT04036981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5557674|NCT04036981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557675|NCT04036981|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5557676|NCT04036981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5603319|NCT02785224|Epinephrine|epinephrine|mesh-list
5603320|NCT02785224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6480476|NCT00543218|Katacalcin|katacalcin|mesh-list
5603321|NCT02785224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5603322|NCT02785224|Adrenergic Agents|adrenergic agents|mesh-ancestor
6157899|NCT01487161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6480477|NCT00543218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6157900|NCT01487161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157901|NCT01487161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6157902|NCT01487161|Immunologic Factors|immunologic factors|mesh-ancestor
6157903|NCT01487161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6157904|NCT01487161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157905|NCT01487200|Triamcinolone|triamcinolone|mesh-list
6157906|NCT01487200|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6157907|NCT01487200|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6157908|NCT01487200|FX006|fx006|mesh-list
6157909|NCT01487200|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6157910|NCT01487200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6157911|NCT01487200|Glucocorticoids|glucocorticoids|mesh-ancestor
6157912|NCT01487200|Hormones|hormones|mesh-ancestor
6157913|NCT01487200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6157914|NCT01487200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157915|NCT01487200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6157916|NCT01487200|Immunologic Factors|immunologic factors|mesh-ancestor
6480478|NCT00543218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480479|NCT00543218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6480480|NCT00543218|Vasodilator Agents|vasodilator agents|mesh-ancestor
6480481|NCT00543231|Oblimersen|oblimersen|mesh-list
6480482|NCT00543231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6480483|NCT00543244|Interferons|interferons|mesh-list
6480484|NCT00543244|Ribavirin|ribavirin|mesh-list
6480485|NCT00543244|Interferon-alpha|interferon-alpha|mesh-list
6480486|NCT00543244|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6480487|NCT00543244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6480488|NCT00543244|Antiviral Agents|antiviral agents|mesh-ancestor
6480489|NCT00543244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6480490|NCT00543244|Antimetabolites|antimetabolites|mesh-ancestor
6480491|NCT00543244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480492|NCT00543244|Immunologic Factors|immunologic factors|mesh-ancestor
6480493|NCT00543244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480494|NCT00543335|Sorafenib|sorafenib|mesh-list
6480495|NCT00543335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6668282|NCT01531309|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6668283|NCT01531309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6668284|NCT01531309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557677|NCT04036487|Propofol|propofol|mesh-list
5557678|NCT04036487|Desflurane|desflurane|mesh-list
5557679|NCT04036487|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5557680|NCT04036487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5557681|NCT04036487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557682|NCT04036487|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5557683|NCT04036487|Anesthetics, General|anesthetics, general|mesh-ancestor
5557684|NCT04036487|Anesthetics|anesthetics|mesh-ancestor
5557685|NCT04036487|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5557686|NCT04036500|Estradiol|estradiol|mesh-list
5557687|NCT04036500|Estrogens|estrogens|mesh-ancestor
5557688|NCT04036500|Hormones|hormones|mesh-ancestor
5557689|NCT04036500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5557690|NCT04036500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557691|NCT04036448|Lenalidomide|lenalidomide|mesh-list
5557692|NCT04036448|Immunologic Factors|immunologic factors|mesh-ancestor
5557693|NCT04036448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557694|NCT04036448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5557695|NCT04036448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5557696|NCT04036448|Growth Substances|growth substances|mesh-ancestor
6668285|NCT01531322|Vaccines|vaccines|mesh-list
6668286|NCT01531322|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6668287|NCT01531322|Immunologic Factors|immunologic factors|mesh-ancestor
5557697|NCT04036448|Growth Inhibitors|growth inhibitors|mesh-ancestor
6157917|NCT01487200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6157918|NCT01487200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157919|NCT01487265|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6157920|NCT01487265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6157921|NCT01487265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6157922|NCT01487265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6157923|NCT01487265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157924|NCT01487577|Mycophenolic Acid|mycophenolic acid|mesh-list
6157925|NCT01487577|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5557698|NCT04036448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5557699|NCT04036526|Vaccines|vaccines|mesh-list
6157926|NCT01487577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6480496|NCT00543335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6480497|NCT00543335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6157927|NCT01487577|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6157928|NCT01487577|Antitubercular Agents|antitubercular agents|mesh-ancestor
6157929|NCT01487577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6157930|NCT01487577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6157931|NCT01487577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6157932|NCT01487577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157933|NCT01487863|Abiraterone Acetate|abiraterone acetate|mesh-list
6157934|NCT01487863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6157935|NCT01487863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6157936|NCT01487863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6157937|NCT01487863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157938|NCT01487863|Hormone Antagonists|hormone antagonists|mesh-ancestor
6157939|NCT01487863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6157940|NCT01487863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157941|NCT01487863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5557700|NCT04036526|Immunologic Factors|immunologic factors|mesh-ancestor
5557701|NCT04036526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557702|NCT04036305|Lidocaine|lidocaine|mesh-list
5557703|NCT04036305|Bupivacaine|bupivacaine|mesh-list
5557704|NCT04036305|Anesthetics, Local|anesthetics, local|mesh-ancestor
5557705|NCT04036305|Anesthetics|anesthetics|mesh-ancestor
5557706|NCT04036305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5557707|NCT04036305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557708|NCT04036305|Sensory System Agents|sensory system agents|mesh-ancestor
6157942|NCT01488019|Formoterol Fumarate|formoterol fumarate|mesh-list
6157943|NCT01488019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6157944|NCT01488019|Autonomic Agents|autonomic agents|mesh-ancestor
6157945|NCT01488019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6157946|NCT01488019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157947|NCT01488019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6157948|NCT01488019|Respiratory System Agents|respiratory system agents|mesh-ancestor
6157949|NCT01488019|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6157950|NCT01488019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6157951|NCT01488019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6157952|NCT01488019|Adrenergic Agents|adrenergic agents|mesh-ancestor
6157953|NCT01488019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6157954|NCT01488019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157955|NCT01488071|Vortioxetine|vortioxetine|mesh-list
6157956|NCT01488071|S 20098|s 20098|mesh-list
6157957|NCT01488071|Antidepressive Agents|antidepressive agents|mesh-ancestor
6157958|NCT01488071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6157959|NCT01488071|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6157960|NCT01488071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6157961|NCT01488071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6157962|NCT01488071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157963|NCT01488071|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6157964|NCT01488071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6157965|NCT01488071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6480498|NCT00543335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480499|NCT00543361|Metformin|metformin|mesh-list
6480500|NCT00543361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6480501|NCT00543361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480502|NCT00543413|Enalapril|enalapril|mesh-list
6480503|NCT00543413|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6480504|NCT00543413|Protease Inhibitors|protease inhibitors|mesh-ancestor
6480505|NCT00543413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6480506|NCT00543413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480507|NCT00543413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6480508|NCT00543504|Bevacizumab|bevacizumab|mesh-list
6480509|NCT00543504|Trastuzumab|trastuzumab|mesh-list
6480510|NCT00543504|Cetuximab|cetuximab|mesh-list
6480511|NCT00543504|Sunitinib|sunitinib|mesh-list
6480512|NCT00543504|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6157966|NCT01488071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157967|NCT01488071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6157968|NCT01488071|Serotonin Agents|serotonin agents|mesh-ancestor
6157969|NCT01488071|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6480513|NCT00543504|Sorafenib|sorafenib|mesh-list
5557709|NCT04036305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5557710|NCT04036305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5557711|NCT04036305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5557712|NCT04036305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5557713|NCT04036305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6157970|NCT01488071|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6157971|NCT01488071|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6157972|NCT01488071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6157973|NCT01488071|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6157974|NCT01488188|Vaccines|vaccines|mesh-list
6157975|NCT01488188|Immunologic Factors|immunologic factors|mesh-ancestor
6157976|NCT01488188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157977|NCT01488279|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6157978|NCT01488279|Dexamethasone|dexamethasone|mesh-list
6157979|NCT01488279|Dexamethasone acetate|dexamethasone acetate|mesh-list
6157980|NCT01488279|BB 1101|bb 1101|mesh-list
6157981|NCT01488279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6157982|NCT01488279|Antiemetics|antiemetics|mesh-ancestor
6157983|NCT01488279|Autonomic Agents|autonomic agents|mesh-ancestor
5557714|NCT04036305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557715|NCT04036201|Bupivacaine|bupivacaine|mesh-list
5557716|NCT04036201|Hyaluronic Acid|hyaluronic acid|mesh-list
5557717|NCT04036201|Anesthetics, Local|anesthetics, local|mesh-ancestor
5557718|NCT04036201|Anesthetics|anesthetics|mesh-ancestor
5557719|NCT04036201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5557720|NCT04036201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557721|NCT04036201|Sensory System Agents|sensory system agents|mesh-ancestor
5557722|NCT04036201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5557723|NCT04036201|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5557724|NCT04036201|Immunologic Factors|immunologic factors|mesh-ancestor
5557725|NCT04036201|Viscosupplements|viscosupplements|mesh-ancestor
5557726|NCT04036201|Protective Agents|protective agents|mesh-ancestor
5557727|NCT04036188|Vitamin D|vitamin d|mesh-list
6157984|NCT01488279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6157985|NCT01488279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6157986|NCT01488279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6157987|NCT01488279|Glucocorticoids|glucocorticoids|mesh-ancestor
6157988|NCT01488279|Hormones|hormones|mesh-ancestor
6157989|NCT01488279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6157990|NCT01488279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6157991|NCT01488279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6157992|NCT01488279|Protease Inhibitors|protease inhibitors|mesh-ancestor
6157993|NCT01488279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6157994|NCT01488279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6157995|NCT01488279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6157996|NCT01488279|Incretins|incretins|mesh-ancestor
6157997|NCT01488279|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6157998|NCT01488318|Cetuximab|cetuximab|mesh-list
6157999|NCT01488318|Dasatinib|dasatinib|mesh-list
6158000|NCT01488318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6158001|NCT01488318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6158002|NCT01488318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6158003|NCT01488318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6158004|NCT01488318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158005|NCT01488409|Acipimox|acipimox|mesh-list
6158006|NCT01488409|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6158007|NCT01488409|Antimetabolites|antimetabolites|mesh-ancestor
6158008|NCT01488409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158009|NCT01488409|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6480514|NCT00543504|Lapatinib|lapatinib|mesh-list
6480515|NCT00543504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6480516|NCT00543504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6480517|NCT00543504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6480518|NCT00543504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6480519|NCT00543504|Growth Substances|growth substances|mesh-ancestor
6158010|NCT01488487|Everolimus|everolimus|mesh-list
5557728|NCT04036188|Cholecalciferol|cholecalciferol|mesh-list
5557729|NCT04036188|Triamcinolone|triamcinolone|mesh-list
5557730|NCT04036188|Vitamins|vitamins|mesh-ancestor
5557731|NCT04036188|Micronutrients|micronutrients|mesh-ancestor
5557732|NCT04036188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557733|NCT04036188|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5557734|NCT04036188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5557735|NCT04036188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5557736|NCT04036188|Glucocorticoids|glucocorticoids|mesh-ancestor
5557737|NCT04036188|Hormones|hormones|mesh-ancestor
5557738|NCT04036188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5557739|NCT04036253|Epoetin Alfa|epoetin alfa|mesh-list
5557740|NCT04036253|Hematinics|hematinics|mesh-ancestor
5557741|NCT04035850|Vortioxetine|vortioxetine|mesh-list
6158011|NCT01488487|Pasireotide|pasireotide|mesh-list
6158012|NCT01488487|Somatostatin|somatostatin|mesh-list
6158013|NCT01488487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6158014|NCT01488487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6158015|NCT01488487|Immunologic Factors|immunologic factors|mesh-ancestor
6158016|NCT01488487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158017|NCT01488487|Hormones|hormones|mesh-ancestor
6158018|NCT01488487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6158019|NCT01488578|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6158020|NCT01488578|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6158021|NCT01488578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6158022|NCT01488578|Cholinergic Agents|cholinergic agents|mesh-ancestor
6158023|NCT01488578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6158024|NCT01488578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557742|NCT04035850|Antidepressive Agents|antidepressive agents|mesh-ancestor
5557743|NCT04035850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5557744|NCT04035850|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5557745|NCT04035850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5557746|NCT04035850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5557747|NCT04035850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557748|NCT04035850|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5557749|NCT04035850|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5557750|NCT04035850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5557751|NCT04035850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557752|NCT04035850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5557753|NCT04035850|Serotonin Agents|serotonin agents|mesh-ancestor
6158025|NCT01488578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158026|NCT01488578|Urological Agents|urological agents|mesh-ancestor
6158027|NCT01488877|Spironolactone|spironolactone|mesh-list
6158028|NCT01488877|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6158029|NCT01488877|Hormone Antagonists|hormone antagonists|mesh-ancestor
6158030|NCT01488877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6158031|NCT01488877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158032|NCT01488877|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6158033|NCT01488877|Diuretics|diuretics|mesh-ancestor
6158034|NCT01488877|Natriuretic Agents|natriuretic agents|mesh-ancestor
6158035|NCT01488890|Vaccines|vaccines|mesh-list
6158036|NCT01488890|Immunologic Factors|immunologic factors|mesh-ancestor
6158037|NCT01488890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158038|NCT01489020|Vaccines|vaccines|mesh-list
6158039|NCT01489020|Immunologic Factors|immunologic factors|mesh-ancestor
6158040|NCT01489020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158041|NCT01489189|Ranibizumab|ranibizumab|mesh-list
6158042|NCT01489189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6158043|NCT01489189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6158044|NCT01489189|Growth Substances|growth substances|mesh-ancestor
6158045|NCT01489189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158046|NCT01489189|Growth Inhibitors|growth inhibitors|mesh-ancestor
6158047|NCT01489189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6158048|NCT01489254|Glatiramer Acetate|glatiramer acetate|mesh-list
6158049|NCT01489254|(T,G)-A-L|(t,g)-a-l|mesh-list
6158050|NCT01489254|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6480520|NCT00543504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480521|NCT00543504|Growth Inhibitors|growth inhibitors|mesh-ancestor
6480522|NCT00543504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6480523|NCT00543504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6158051|NCT01489254|Immunologic Factors|immunologic factors|mesh-ancestor
6158052|NCT01489254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158053|NCT01489254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6158054|NCT01489254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6158055|NCT01489670|Bimatoprost|bimatoprost|mesh-list
6488875|NCT00587496|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6158056|NCT01489670|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6158057|NCT01489670|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6158058|NCT01489670|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6158059|NCT01489826|HU 211|hu 211|mesh-list
6480524|NCT00543504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480525|NCT00543608|Vancomycin|vancomycin|mesh-list
6480526|NCT00543608|Iclaprim|iclaprim|mesh-list
5557754|NCT04035850|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5557755|NCT04035850|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5557756|NCT04035850|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5557757|NCT04035850|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5557758|NCT04035876|Apatinib|apatinib|mesh-list
5557759|NCT04035876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5557760|NCT04035876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5557761|NCT04035876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5557762|NCT04035876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557763|NCT04035889|Melatonin|melatonin|mesh-list
6480527|NCT00543608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6480528|NCT00543608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6480529|NCT00543608|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6480530|NCT00543608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6480531|NCT00543608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480532|NCT00543634|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6480533|NCT00543634|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6480534|NCT00543634|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6480535|NCT00543634|Contraceptive Agents|contraceptive agents|mesh-ancestor
6158060|NCT01489826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6158061|NCT01489826|Antiemetics|antiemetics|mesh-ancestor
6158062|NCT01489826|Autonomic Agents|autonomic agents|mesh-ancestor
5557764|NCT04035889|Antioxidants|antioxidants|mesh-ancestor
6158063|NCT01489826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6158064|NCT01489826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158065|NCT01489826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6158066|NCT01489826|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6158067|NCT01489826|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6158068|NCT01489826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6158069|NCT01489826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158070|NCT01489826|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6158071|NCT01489826|Protective Agents|protective agents|mesh-ancestor
6158072|NCT01489891|Lidocaine|lidocaine|mesh-list
6480536|NCT00543634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6480537|NCT00543634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480538|NCT00543634|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6480539|NCT00543634|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6480540|NCT00543634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6480541|NCT00543634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6480542|NCT00543634|Estrogens|estrogens|mesh-ancestor
6480543|NCT00543634|Hormones|hormones|mesh-ancestor
6480544|NCT00543634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6480545|NCT00543647|Fenofibrate|fenofibrate|mesh-list
6480546|NCT00543647|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6480547|NCT00543647|Antimetabolites|antimetabolites|mesh-ancestor
6480548|NCT00543647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158073|NCT01489891|Anesthetics, Local|anesthetics, local|mesh-ancestor
6158074|NCT01489891|Anesthetics|anesthetics|mesh-ancestor
6158075|NCT01489891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6158076|NCT01489891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158077|NCT01489891|Sensory System Agents|sensory system agents|mesh-ancestor
6158078|NCT01489891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6158079|NCT01489891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6158080|NCT01489891|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6158081|NCT01489891|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6158082|NCT01489891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6158083|NCT01489891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158084|NCT01489956|Freund's Adjuvant|freund's adjuvant|mesh-list
6158085|NCT01489956|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
6158086|NCT01489956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6158087|NCT01489956|Immunologic Factors|immunologic factors|mesh-ancestor
6158088|NCT01489956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158089|NCT01489969|Melatonin|melatonin|mesh-list
6158090|NCT01489969|Antioxidants|antioxidants|mesh-ancestor
6158091|NCT01489969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158092|NCT01489969|Protective Agents|protective agents|mesh-ancestor
6158093|NCT01489969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158094|NCT01489969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6158095|NCT01490060|Dexamethasone|dexamethasone|mesh-list
6158096|NCT01490060|Dexamethasone acetate|dexamethasone acetate|mesh-list
6158097|NCT01490060|Doxorubicin|doxorubicin|mesh-list
6158098|NCT01490060|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6158099|NCT01490060|Vincristine|vincristine|mesh-list
5557765|NCT04035889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557766|NCT04035889|Protective Agents|protective agents|mesh-ancestor
5557767|NCT04035889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557768|NCT04035889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5557769|NCT04035993|Hypoglycemic Agents|hypoglycemic agents|mesh-list
5557770|NCT04035993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557771|NCT04035785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
5557772|NCT04035798|Memantine|memantine|mesh-list
5557773|NCT04035798|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5557774|NCT04035798|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5557775|NCT04035798|Dopamine Agents|dopamine agents|mesh-ancestor
5557776|NCT04035798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5557777|NCT04035798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557778|NCT04035798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557779|NCT04035798|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5557780|NCT04035798|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5557781|NCT04035707|Rocuronium|rocuronium|mesh-list
5557782|NCT04035707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557783|NCT04035707|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5557784|NCT04035707|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5557785|NCT04035707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6158100|NCT01490060|Ifosfamide|ifosfamide|mesh-list
6158101|NCT01490060|Isophosphamide mustard|isophosphamide mustard|mesh-list
6158102|NCT01490060|Fosaprepitant|fosaprepitant|mesh-list
6158103|NCT01490060|Aprepitant|aprepitant|mesh-list
6158104|NCT01490060|BB 1101|bb 1101|mesh-list
6158105|NCT01490060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6158106|NCT01490060|Antiemetics|antiemetics|mesh-ancestor
6158107|NCT01490060|Autonomic Agents|autonomic agents|mesh-ancestor
6158108|NCT01490060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6158109|NCT01490060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158110|NCT01490060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6158111|NCT01490060|Glucocorticoids|glucocorticoids|mesh-ancestor
6158112|NCT01490060|Hormones|hormones|mesh-ancestor
6158113|NCT01490060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6158114|NCT01490060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6158115|NCT01490060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6158116|NCT01490060|Protease Inhibitors|protease inhibitors|mesh-ancestor
6158117|NCT01490060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6158118|NCT01490060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158119|NCT01490060|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6158120|NCT01490060|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6158121|NCT01490060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6158122|NCT01490060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6158123|NCT01490060|Tubulin Modulators|tubulin modulators|mesh-ancestor
6158124|NCT01490060|Antimitotic Agents|antimitotic agents|mesh-ancestor
6158125|NCT01490060|Mitosis Modulators|mitosis modulators|mesh-ancestor
6158126|NCT01490060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6158127|NCT01490060|Alkylating Agents|alkylating agents|mesh-ancestor
6158128|NCT01490060|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6158129|NCT01490060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6158130|NCT01490073|Nitroglycerin|nitroglycerin|mesh-list
6158131|NCT01490073|Vasodilator Agents|vasodilator agents|mesh-ancestor
6158132|NCT01490086|Aripiprazole|aripiprazole|mesh-list
6480549|NCT00543647|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5557786|NCT04035707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5557787|NCT04035603|Cycloserine|cycloserine|mesh-list
5557788|NCT04035603|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5557789|NCT04035603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5557790|NCT04035603|Renal Agents|renal agents|mesh-ancestor
5557791|NCT04035603|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5557792|NCT04035603|Antitubercular Agents|antitubercular agents|mesh-ancestor
5557793|NCT04035603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5557794|NCT04035603|Antimetabolites|antimetabolites|mesh-ancestor
6480550|NCT00543686|Fluticasone|fluticasone|mesh-list
6480551|NCT00543686|Montelukast|montelukast|mesh-list
6480552|NCT00543686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6480553|NCT00543686|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6480554|NCT00543686|Autonomic Agents|autonomic agents|mesh-ancestor
6480555|NCT00543686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6480556|NCT00543686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158133|NCT01490086|RP5063|rp5063|mesh-list
6158134|NCT01490086|Antidepressive Agents|antidepressive agents|mesh-ancestor
6158135|NCT01490086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6158136|NCT01490086|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6158137|NCT01490086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6158138|NCT01490086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6158139|NCT01490086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158140|NCT01490086|Dopamine Agonists|dopamine agonists|mesh-ancestor
6158141|NCT01490086|Dopamine Agents|dopamine agents|mesh-ancestor
6158142|NCT01490086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6158143|NCT01490086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158144|NCT01490086|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6158145|NCT01490086|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5557795|NCT04035603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557796|NCT04035473|Paclitaxel|paclitaxel|mesh-list
5557797|NCT04035473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5557798|NCT04035473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5557799|NCT04035473|Tubulin Modulators|tubulin modulators|mesh-ancestor
5557800|NCT04035473|Antimitotic Agents|antimitotic agents|mesh-ancestor
6158146|NCT01490086|Serotonin Agents|serotonin agents|mesh-ancestor
6480557|NCT00543686|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6158147|NCT01490086|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6158148|NCT01490086|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6158149|NCT01490086|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6158150|NCT01490086|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6158151|NCT01490125|Glycopyrrolate|glycopyrrolate|mesh-list
6480558|NCT00543686|Respiratory System Agents|respiratory system agents|mesh-ancestor
6480559|NCT00543686|Dermatologic Agents|dermatologic agents|mesh-ancestor
6480560|NCT00543686|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6480561|NCT00543686|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6480562|NCT00543686|Hormone Antagonists|hormone antagonists|mesh-ancestor
6480563|NCT00543686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6480564|NCT00543686|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6480565|NCT00543686|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6480566|NCT00543686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480567|NCT00543829|Tamoxifen|tamoxifen|mesh-list
6480568|NCT00543829|Docetaxel|docetaxel|mesh-list
6480569|NCT00543829|Doxorubicin|doxorubicin|mesh-list
6480570|NCT00543829|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6480571|NCT00543829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6480572|NCT00543829|Tubulin Modulators|tubulin modulators|mesh-ancestor
6480573|NCT00543829|Antimitotic Agents|antimitotic agents|mesh-ancestor
6480574|NCT00543829|Mitosis Modulators|mitosis modulators|mesh-ancestor
6480575|NCT00543829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158152|NCT01490125|Albuterol|albuterol|mesh-list
6158153|NCT01490125|Tiotropium Bromide|tiotropium bromide|mesh-list
6158154|NCT01490125|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5557801|NCT04035473|Mitosis Modulators|mitosis modulators|mesh-ancestor
5557802|NCT04035473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158155|NCT01490125|Autonomic Agents|autonomic agents|mesh-ancestor
6158156|NCT01490125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6158157|NCT01490125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158158|NCT01490125|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6158159|NCT01490125|Respiratory System Agents|respiratory system agents|mesh-ancestor
6158160|NCT01490125|Parasympatholytics|parasympatholytics|mesh-ancestor
6158161|NCT01490125|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6158162|NCT01490125|Cholinergic Agents|cholinergic agents|mesh-ancestor
6158163|NCT01490125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6158164|NCT01490125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158165|NCT01490125|Tocolytic Agents|tocolytic agents|mesh-ancestor
6158166|NCT01490125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6158167|NCT01490125|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6158168|NCT01490125|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6158169|NCT01490125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6158170|NCT01490125|Adrenergic Agents|adrenergic agents|mesh-ancestor
6158171|NCT01490125|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6158172|NCT01490125|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6206003|NCT02095951|Ethanol|ethanol|mesh-list
6206004|NCT02095951|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6206005|NCT02095951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6206006|NCT02095951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6206007|NCT02095951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206008|NCT02096003|Morphine|morphine|mesh-list
6206009|NCT02096003|Hydromorphone|hydromorphone|mesh-list
6206010|NCT02096003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6206011|NCT02096003|Narcotics|narcotics|mesh-ancestor
6206012|NCT02096003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6206013|NCT02096003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206014|NCT02096003|Analgesics|analgesics|mesh-ancestor
6206015|NCT02096003|Sensory System Agents|sensory system agents|mesh-ancestor
5557803|NCT04035525|Coenzyme Q10|coenzyme q10|mesh-list
5557804|NCT04035525|Ubiquinone|ubiquinone|mesh-list
5557805|NCT04035525|Vitamins|vitamins|mesh-ancestor
5557806|NCT04035525|Micronutrients|micronutrients|mesh-ancestor
5557807|NCT04035525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557808|NCT04035135|Immunoglobulins|immunoglobulins|mesh-list
5557809|NCT04035135|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6206016|NCT02096003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6206017|NCT02096029|Nicotine|nicotine|mesh-list
6206018|NCT02096029|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6206019|NCT02096029|Autonomic Agents|autonomic agents|mesh-ancestor
6206020|NCT02096029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6206021|NCT02096029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206022|NCT02096029|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6206023|NCT02096029|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5557810|NCT04035135|Antibodies|antibodies|mesh-list
6206024|NCT02096029|Cholinergic Agents|cholinergic agents|mesh-ancestor
6158173|NCT01490580|Atropine|atropine|mesh-list
6158174|NCT01490580|Sufentanil|sufentanil|mesh-list
6158175|NCT01490580|Propofol|propofol|mesh-list
6158176|NCT01490580|Atracurium|atracurium|mesh-list
6158177|NCT01490580|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6158178|NCT01490580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6158179|NCT01490580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158180|NCT01490580|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6158181|NCT01490580|Anesthetics, General|anesthetics, general|mesh-ancestor
6158182|NCT01490580|Anesthetics|anesthetics|mesh-ancestor
6158183|NCT01490580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5557811|NCT04035135|gamma-Globulins|gamma-globulins|mesh-list
5557812|NCT04035135|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5557813|NCT04035135|Immunologic Factors|immunologic factors|mesh-ancestor
5557814|NCT04035135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557815|NCT04035187|Itraconazole|itraconazole|mesh-list
5557816|NCT04035187|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
5557817|NCT04035187|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5557818|NCT04035187|Antifungal Agents|antifungal agents|mesh-ancestor
5557819|NCT04035187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5557820|NCT04035187|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5557821|NCT04035187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5557822|NCT04035187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5557823|NCT04035187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557824|NCT04035187|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5557825|NCT04035187|Hormone Antagonists|hormone antagonists|mesh-ancestor
5557826|NCT04035187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5557827|NCT04035187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557828|NCT04035187|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5557829|NCT04035330|Etidronic Acid|etidronic acid|mesh-list
6158184|NCT01490580|Narcotics|narcotics|mesh-ancestor
6158185|NCT01490580|Analgesics|analgesics|mesh-ancestor
6158186|NCT01490580|Sensory System Agents|sensory system agents|mesh-ancestor
6158187|NCT01490580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6158188|NCT01490580|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6158189|NCT01490580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6158190|NCT01490580|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6480576|NCT00543829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6480577|NCT00543829|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6480578|NCT00543829|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6480579|NCT00543829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6480580|NCT00543829|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6480581|NCT00543829|Hormone Antagonists|hormone antagonists|mesh-ancestor
6480582|NCT00543829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6480583|NCT00543829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480584|NCT00543829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6480585|NCT00543829|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5557830|NCT04035330|Sodium Hypochlorite|sodium hypochlorite|mesh-list
5557831|NCT04035330|Eusol|eusol|mesh-list
5557832|NCT04035330|Disinfectants|disinfectants|mesh-ancestor
5557833|NCT04035330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5557834|NCT04035330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5557835|NCT04035330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557836|NCT04035096|Ascorbic Acid|ascorbic acid|mesh-list
6480586|NCT00543829|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6480587|NCT00543829|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6480588|NCT00543842|Bevacizumab|bevacizumab|mesh-list
6480589|NCT00543842|Capecitabine|capecitabine|mesh-list
5557837|NCT04035096|Antioxidants|antioxidants|mesh-ancestor
5557838|NCT04035096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557839|NCT04035096|Protective Agents|protective agents|mesh-ancestor
6480590|NCT00543842|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6480591|NCT00543842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5557840|NCT04035096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158191|NCT01490580|Autonomic Agents|autonomic agents|mesh-ancestor
6480592|NCT00543842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6480593|NCT00543842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6480594|NCT00543842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6480595|NCT00543842|Growth Substances|growth substances|mesh-ancestor
6480596|NCT00543842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480597|NCT00543842|Growth Inhibitors|growth inhibitors|mesh-ancestor
6480598|NCT00543842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6480599|NCT00543842|Antimetabolites|antimetabolites|mesh-ancestor
6480600|NCT00543842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480601|NCT00543842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5557841|NCT04035096|Vitamins|vitamins|mesh-ancestor
5557842|NCT04035096|Micronutrients|micronutrients|mesh-ancestor
5557843|NCT04035382|Misoprostol|misoprostol|mesh-list
5557844|NCT04035382|Oxytocin|oxytocin|mesh-list
5557845|NCT04035382|Oxytocics|oxytocics|mesh-ancestor
5557846|NCT04035382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5557847|NCT04035382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557848|NCT04035382|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5557849|NCT04035382|Abortifacient Agents|abortifacient agents|mesh-ancestor
5557850|NCT04035382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5557851|NCT04035382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5557852|NCT04035109|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5557853|NCT04035109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5557854|NCT04035005|Ocrelizumab|ocrelizumab|mesh-list
5557855|NCT04035005|Immunologic Factors|immunologic factors|mesh-ancestor
5557856|NCT04035005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557857|NCT04034823|Docetaxel|docetaxel|mesh-list
5557858|NCT04034823|Trastuzumab|trastuzumab|mesh-list
5557859|NCT04034823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5557860|NCT04034823|Tubulin Modulators|tubulin modulators|mesh-ancestor
5557861|NCT04034823|Antimitotic Agents|antimitotic agents|mesh-ancestor
5557862|NCT04034823|Mitosis Modulators|mitosis modulators|mesh-ancestor
6480602|NCT00543842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6480603|NCT00543933|Nitric Oxide|nitric oxide|mesh-list
6480604|NCT00543933|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6480605|NCT00543933|Autonomic Agents|autonomic agents|mesh-ancestor
6480606|NCT00543933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5557863|NCT04034823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557864|NCT04034823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5557865|NCT04035070|Clindamycin|clindamycin|mesh-list
5557866|NCT04035070|Clindamycin palmitate|clindamycin palmitate|mesh-list
5557867|NCT04035070|Clindamycin phosphate|clindamycin phosphate|mesh-list
5557868|NCT04035070|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5557869|NCT04035070|Sodium Hypochlorite|sodium hypochlorite|mesh-list
5557870|NCT04035070|Eusol|eusol|mesh-list
5557871|NCT04035070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5557872|NCT04035070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5557873|NCT04035070|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5557874|NCT04035070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5557875|NCT04035070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557876|NCT04035070|Disinfectants|disinfectants|mesh-ancestor
5557877|NCT04035070|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5557878|NCT04034771|Propofol|propofol|mesh-list
5557879|NCT04034771|Melatonin|melatonin|mesh-list
5557880|NCT04034771|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5557881|NCT04034771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5557882|NCT04034771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557883|NCT04034771|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5557884|NCT04034771|Anesthetics, General|anesthetics, general|mesh-ancestor
5557885|NCT04034771|Anesthetics|anesthetics|mesh-ancestor
5557886|NCT04034771|Antioxidants|antioxidants|mesh-ancestor
5557887|NCT04034771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557888|NCT04034771|Protective Agents|protective agents|mesh-ancestor
5603323|NCT02785224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5603324|NCT02785224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603325|NCT02785224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603326|NCT02785224|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6480607|NCT00543933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480608|NCT00543933|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6480609|NCT00543933|Respiratory System Agents|respiratory system agents|mesh-ancestor
6480610|NCT00543933|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6480611|NCT00543933|Antioxidants|antioxidants|mesh-ancestor
5557889|NCT04034862|Lamivudine|lamivudine|mesh-list
5557890|NCT04034862|Dolutegravir|dolutegravir|mesh-list
5557891|NCT04034862|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5557892|NCT04034862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5557893|NCT04034862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5557894|NCT04034862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480612|NCT00543933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480613|NCT00543933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6480614|NCT00543933|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6480615|NCT00543933|Vasodilator Agents|vasodilator agents|mesh-ancestor
6480616|NCT00543933|Gasotransmitters|gasotransmitters|mesh-ancestor
6480617|NCT00543933|Protective Agents|protective agents|mesh-ancestor
6480618|NCT00543959|Pioglitazone|pioglitazone|mesh-list
6480619|NCT00543959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6480620|NCT00543959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480621|NCT00544011|Bevacizumab|bevacizumab|mesh-list
6480622|NCT00544011|Fluorouracil|fluorouracil|mesh-list
5557895|NCT04034862|Antiviral Agents|antiviral agents|mesh-ancestor
5557896|NCT04034862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5557897|NCT04034862|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5557898|NCT04034862|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5557899|NCT04034862|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5557900|NCT04034862|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5557901|NCT04034836|Parecoxib|parecoxib|mesh-list
5557902|NCT04034836|Ropivacaine|ropivacaine|mesh-list
5557903|NCT04034836|Anesthetics, Local|anesthetics, local|mesh-ancestor
5557904|NCT04034836|Anesthetics|anesthetics|mesh-ancestor
6480623|NCT00544011|Capecitabine|capecitabine|mesh-list
6480624|NCT00544011|Irinotecan|irinotecan|mesh-list
6158192|NCT01490580|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6158193|NCT01490580|Respiratory System Agents|respiratory system agents|mesh-ancestor
6158194|NCT01490580|Mydriatics|mydriatics|mesh-ancestor
6158195|NCT01490580|Parasympatholytics|parasympatholytics|mesh-ancestor
6158196|NCT01490580|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6158197|NCT01490580|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6158198|NCT01490580|Cholinergic Agents|cholinergic agents|mesh-ancestor
6158199|NCT01490580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6158200|NCT01490580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158201|NCT01490580|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6158202|NCT01490580|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6158203|NCT01490580|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6158204|NCT01490580|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
6158205|NCT01490697|Cycloserine|cycloserine|mesh-list
6158206|NCT01490697|Mifepristone|mifepristone|mesh-list
6158207|NCT01490697|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6668288|NCT01531322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668289|NCT01531361|Sorafenib|sorafenib|mesh-list
6668290|NCT01531361|Vemurafenib|vemurafenib|mesh-list
6668291|NCT01531361|Crizotinib|crizotinib|mesh-list
6668292|NCT01531361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6668293|NCT01531361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6668294|NCT01531361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6668295|NCT01531361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668296|NCT01531452|Oxaliplatin|oxaliplatin|mesh-list
6668297|NCT01531452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6672450|NCT01556191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6672451|NCT01556191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672452|NCT01556321|Caffeine|caffeine|mesh-list
6672453|NCT01556321|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6672454|NCT01556321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672455|NCT01556321|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6672456|NCT01556321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6158208|NCT01490697|Abortifacient Agents|abortifacient agents|mesh-ancestor
6158209|NCT01490697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6158210|NCT01490697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158211|NCT01490697|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6158212|NCT01490697|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6158213|NCT01490697|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5557905|NCT04034836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6158214|NCT01490697|Contraceptive Agents|contraceptive agents|mesh-ancestor
6158215|NCT01490697|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6158216|NCT01490697|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6158217|NCT01490697|Hormone Antagonists|hormone antagonists|mesh-ancestor
6158218|NCT01490697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6158219|NCT01490697|Luteolytic Agents|luteolytic agents|mesh-ancestor
6158220|NCT01490697|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6158221|NCT01490697|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6158222|NCT01490697|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6158223|NCT01490697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6158224|NCT01490697|Renal Agents|renal agents|mesh-ancestor
6158225|NCT01490697|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6158226|NCT01490697|Antitubercular Agents|antitubercular agents|mesh-ancestor
6158227|NCT01490697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6158228|NCT01490697|Antimetabolites|antimetabolites|mesh-ancestor
6158229|NCT01490697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158230|NCT01490723|Mycophenolic Acid|mycophenolic acid|mesh-list
5557906|NCT04034836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557907|NCT04034836|Sensory System Agents|sensory system agents|mesh-ancestor
6158231|NCT01490723|Rituximab|rituximab|mesh-list
6158232|NCT01490723|Methotrexate|methotrexate|mesh-list
6158233|NCT01490723|Fludarabine|fludarabine|mesh-list
6158234|NCT01490723|Fludarabine phosphate|fludarabine phosphate|mesh-list
6158235|NCT01490723|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6158236|NCT01490723|Tacrolimus|tacrolimus|mesh-list
6158237|NCT01490723|Thymoglobulin|thymoglobulin|mesh-list
6158238|NCT01490723|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6158239|NCT01490723|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6158240|NCT01490723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6158241|NCT01490723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6158242|NCT01490723|Immunologic Factors|immunologic factors|mesh-ancestor
6158243|NCT01490723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158244|NCT01490723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6158245|NCT01490723|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6158246|NCT01490723|Abortifacient Agents|abortifacient agents|mesh-ancestor
6158247|NCT01490723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6158248|NCT01490723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6158249|NCT01490723|Antimetabolites|antimetabolites|mesh-ancestor
6158250|NCT01490723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158251|NCT01490723|Dermatologic Agents|dermatologic agents|mesh-ancestor
6158252|NCT01490723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6158253|NCT01490723|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6158254|NCT01490723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6158255|NCT01490723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6158256|NCT01490723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5557908|NCT04034836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5557909|NCT04034836|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5557910|NCT04034836|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5557911|NCT04034836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5557912|NCT04034836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557913|NCT04034836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5557914|NCT04034836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5557915|NCT04034836|Analgesics|analgesics|mesh-ancestor
5557916|NCT04034836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5557917|NCT04034836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5557918|NCT04035031|Dapagliflozin|dapagliflozin|mesh-list
5557919|NCT04035031|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5557920|NCT04035031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557921|NCT04035031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5557922|NCT04035031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557923|NCT04034524|Insulin|insulin|mesh-list
5557924|NCT04034524|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5557925|NCT04034524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5557926|NCT04034524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557927|NCT04034589|Fulvestrant|fulvestrant|mesh-list
5557928|NCT04034589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5557929|NCT04034589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5557930|NCT04034589|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5557931|NCT04034589|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5557932|NCT04034589|Hormone Antagonists|hormone antagonists|mesh-ancestor
5557933|NCT04034589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5557934|NCT04034589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557935|NCT04034485|Evolocumab|evolocumab|mesh-list
6158257|NCT01490723|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6158258|NCT01490723|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6158259|NCT01490723|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6158260|NCT01490723|Antitubercular Agents|antitubercular agents|mesh-ancestor
6158261|NCT01490723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6158262|NCT01490723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6158263|NCT01490723|Alkylating Agents|alkylating agents|mesh-ancestor
6158264|NCT01490788|Amitriptyline|amitriptyline|mesh-list
6158265|NCT01490788|Cyclobenzaprine|cyclobenzaprine|mesh-list
5557936|NCT04034485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5557937|NCT04034485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5557938|NCT04034485|Antimetabolites|antimetabolites|mesh-ancestor
5557939|NCT04034485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557940|NCT04034485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5557941|NCT04034368|Tenofovir|tenofovir|mesh-list
5557942|NCT04034368|Antiviral Agents|antiviral agents|mesh-ancestor
5557943|NCT04034368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6158266|NCT01490788|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6158267|NCT01490788|Antidepressive Agents|antidepressive agents|mesh-ancestor
6158268|NCT01490788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6158269|NCT01490788|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6158270|NCT01490788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158271|NCT01490788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6158272|NCT01490788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6158273|NCT01490788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6158274|NCT01490788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6158275|NCT01490788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6158276|NCT01490788|Analgesics|analgesics|mesh-ancestor
6158277|NCT01490788|Sensory System Agents|sensory system agents|mesh-ancestor
6158278|NCT01490788|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6158279|NCT01490788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6158280|NCT01490788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6158281|NCT01490788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158282|NCT01490788|Adrenergic Agents|adrenergic agents|mesh-ancestor
6158283|NCT01490788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6158284|NCT01490866|Leucovorin|leucovorin|mesh-list
6158285|NCT01490866|Bevacizumab|bevacizumab|mesh-list
6158286|NCT01490866|Fluorouracil|fluorouracil|mesh-list
6158287|NCT01490866|Oxaliplatin|oxaliplatin|mesh-list
6158288|NCT01490866|Axitinib|axitinib|mesh-list
6158289|NCT01490866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6158290|NCT01490866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6158291|NCT01490866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6158292|NCT01490866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6158293|NCT01490866|Growth Substances|growth substances|mesh-ancestor
6668298|NCT01531517|Pantothenic Acid|pantothenic acid|mesh-list
6668299|NCT01531517|Propolis|propolis|mesh-list
6668300|NCT01531517|Vitamin B Complex|vitamin b complex|mesh-ancestor
6158294|NCT01490866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158295|NCT01490866|Growth Inhibitors|growth inhibitors|mesh-ancestor
6158296|NCT01490866|Antimetabolites|antimetabolites|mesh-ancestor
6158297|NCT01490866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158298|NCT01490866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6158299|NCT01490866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5557944|NCT04034368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5557945|NCT04034368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5557946|NCT04034368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5557947|NCT04034368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557948|NCT04034368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5557949|NCT04034368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5557950|NCT04034251|Paclitaxel|paclitaxel|mesh-list
5557951|NCT04034251|Capecitabine|capecitabine|mesh-list
5557952|NCT04034251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5557953|NCT04034251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5557954|NCT04034251|Tubulin Modulators|tubulin modulators|mesh-ancestor
5557955|NCT04034251|Antimitotic Agents|antimitotic agents|mesh-ancestor
5557956|NCT04034251|Mitosis Modulators|mitosis modulators|mesh-ancestor
5557957|NCT04034251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557958|NCT04034251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5557959|NCT04034251|Antimetabolites|antimetabolites|mesh-ancestor
6158300|NCT01490866|Immunologic Factors|immunologic factors|mesh-ancestor
6158301|NCT01490866|Antidotes|antidotes|mesh-ancestor
6158302|NCT01490866|Protective Agents|protective agents|mesh-ancestor
6158303|NCT01490866|Vitamin B Complex|vitamin b complex|mesh-ancestor
6158304|NCT01490866|Vitamins|vitamins|mesh-ancestor
5557960|NCT04034173|Leucovorin|leucovorin|mesh-list
6668301|NCT01531517|Vitamins|vitamins|mesh-ancestor
6158305|NCT01490866|Micronutrients|micronutrients|mesh-ancestor
6158306|NCT01490866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6158307|NCT01490866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6158308|NCT01490918|Metformin|metformin|mesh-list
6158309|NCT01490918|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6158310|NCT01490918|Acarbose|acarbose|mesh-list
6158311|NCT01490918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6158312|NCT01490918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158313|NCT01490918|Incretins|incretins|mesh-ancestor
6158314|NCT01490918|Hormones|hormones|mesh-ancestor
6158315|NCT01490918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6158316|NCT01490918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6158317|NCT01490918|Protease Inhibitors|protease inhibitors|mesh-ancestor
6158318|NCT01490918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6158319|NCT01490918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158320|NCT01490918|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6158321|NCT01490931|Ketorolac|ketorolac|mesh-list
6158322|NCT01490931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6158323|NCT01490931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6158324|NCT01490931|Analgesics|analgesics|mesh-ancestor
6158325|NCT01490931|Sensory System Agents|sensory system agents|mesh-ancestor
6158326|NCT01490931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6158327|NCT01490931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158328|NCT01490931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6158329|NCT01490931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6158330|NCT01490931|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5557961|NCT04034173|Folic Acid|folic acid|mesh-list
5557962|NCT04034173|Irinotecan|irinotecan|mesh-list
5557963|NCT04034173|Panitumumab|panitumumab|mesh-list
5557964|NCT04034173|Levoleucovorin|levoleucovorin|mesh-list
5557965|NCT04034173|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5557966|NCT04034173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5557967|NCT04034173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6158331|NCT01490931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6158332|NCT01490931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158333|NCT01491022|4-Aminopyridine|4-aminopyridine|mesh-list
6158334|NCT01491022|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6158335|NCT01491022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6158336|NCT01491022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158337|NCT01491035|Vortioxetine|vortioxetine|mesh-list
6158338|NCT01491035|Antidepressive Agents|antidepressive agents|mesh-ancestor
6158339|NCT01491035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6158340|NCT01491035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6158341|NCT01491035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6158342|NCT01491035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6158343|NCT01491035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158344|NCT01491035|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6158345|NCT01491035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6158346|NCT01491035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6158347|NCT01491035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158348|NCT01491035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6158349|NCT01491035|Serotonin Agents|serotonin agents|mesh-ancestor
6158350|NCT01491035|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6158351|NCT01491035|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6158352|NCT01491035|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6158353|NCT01491035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6158354|NCT01491113|Levetiracetam|levetiracetam|mesh-list
6158355|NCT01491113|Anticonvulsants|anticonvulsants|mesh-ancestor
6158356|NCT01491113|Nootropic Agents|nootropic agents|mesh-ancestor
6158357|NCT01491607|Vaccines|vaccines|mesh-list
6158358|NCT01491607|Immunologic Factors|immunologic factors|mesh-ancestor
6158359|NCT01491607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158360|NCT01491633|Dasatinib|dasatinib|mesh-list
6158361|NCT01491633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6158362|NCT01491633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6158363|NCT01491633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6158364|NCT01491633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158365|NCT01491672|Everolimus|everolimus|mesh-list
6158366|NCT01491672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6488876|NCT00587496|Analgesics|analgesics|mesh-ancestor
5557968|NCT04034173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5557969|NCT04034173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5557970|NCT04034173|Antidotes|antidotes|mesh-ancestor
5557971|NCT04034173|Protective Agents|protective agents|mesh-ancestor
5557972|NCT04034173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557973|NCT04034173|Vitamin B Complex|vitamin b complex|mesh-ancestor
5557974|NCT04034173|Vitamins|vitamins|mesh-ancestor
5557975|NCT04034173|Micronutrients|micronutrients|mesh-ancestor
6158367|NCT01491672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5557976|NCT04034173|Hematinics|hematinics|mesh-ancestor
5557977|NCT04034173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5557978|NCT04034225|Pembrolizumab|pembrolizumab|mesh-list
5557979|NCT04034225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5557980|NCT04034225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5557981|NCT04034199|Zoledronic Acid|zoledronic acid|mesh-list
5557982|NCT04034199|Denosumab|denosumab|mesh-list
5557983|NCT04034199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5557984|NCT04034199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158368|NCT01491672|Immunologic Factors|immunologic factors|mesh-ancestor
6158369|NCT01491672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158370|NCT01491737|Trastuzumab|trastuzumab|mesh-list
6158371|NCT01491737|Pertuzumab|pertuzumab|mesh-list
6158372|NCT01491737|Aromatase Inhibitors|aromatase inhibitors|mesh-list
6158373|NCT01491737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6158374|NCT01491737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5557985|NCT04033939|Propofol|propofol|mesh-list
5557986|NCT04033939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5557987|NCT04033939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5557988|NCT04033939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557989|NCT04033939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5557990|NCT04033939|Anesthetics, General|anesthetics, general|mesh-ancestor
5557991|NCT04033939|Anesthetics|anesthetics|mesh-ancestor
5557992|NCT04033575|Listerine|listerine|mesh-list
5557993|NCT04033575|Fluorides|fluorides|mesh-list
5557994|NCT04033575|Sodium Fluoride|sodium fluoride|mesh-list
5557995|NCT04033575|Tin Fluorides|tin fluorides|mesh-list
5557996|NCT04033575|Cariostatic Agents|cariostatic agents|mesh-ancestor
5557997|NCT04033575|Protective Agents|protective agents|mesh-ancestor
5557998|NCT04033575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5557999|NCT04033575|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6158375|NCT01491737|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6158376|NCT01491737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6158377|NCT01491737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158378|NCT01491737|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6158379|NCT01491737|Hormone Antagonists|hormone antagonists|mesh-ancestor
5558000|NCT04033575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5558001|NCT04033562|Lidocaine|lidocaine|mesh-list
5558002|NCT04033562|Bupivacaine|bupivacaine|mesh-list
5558003|NCT04033562|Anesthetics, Local|anesthetics, local|mesh-ancestor
5558004|NCT04033562|Anesthetics|anesthetics|mesh-ancestor
5558005|NCT04033562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5558006|NCT04033562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558007|NCT04033562|Sensory System Agents|sensory system agents|mesh-ancestor
5558008|NCT04033562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5558009|NCT04033562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6668302|NCT01531517|Micronutrients|micronutrients|mesh-ancestor
5558010|NCT04033562|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5558011|NCT04033562|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5558012|NCT04033562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5558013|NCT04033562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558014|NCT04033471|Midazolam|midazolam|mesh-list
5558015|NCT04033471|Morphine|morphine|mesh-list
5558016|NCT04033471|Bupivacaine|bupivacaine|mesh-list
5558017|NCT04033471|Anesthetics, Local|anesthetics, local|mesh-ancestor
5558018|NCT04033471|Anesthetics|anesthetics|mesh-ancestor
5558019|NCT04033471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5558020|NCT04033471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558021|NCT04033471|Sensory System Agents|sensory system agents|mesh-ancestor
5558022|NCT04033471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5558023|NCT04033471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5558024|NCT04033471|Narcotics|narcotics|mesh-ancestor
5558025|NCT04033471|Analgesics|analgesics|mesh-ancestor
5558026|NCT04033471|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5558027|NCT04033471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5558028|NCT04033471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5558029|NCT04033471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5558030|NCT04033471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5558031|NCT04033471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5558032|NCT04033471|Anesthetics, General|anesthetics, general|mesh-ancestor
5558033|NCT04033471|GABA Modulators|gaba modulators|mesh-ancestor
5558034|NCT04033471|GABA Agents|gaba agents|mesh-ancestor
5558035|NCT04033471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5558036|NCT04033471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558037|NCT04033354|Paclitaxel|paclitaxel|mesh-list
5558038|NCT04033354|Carboplatin|carboplatin|mesh-list
5558039|NCT04033354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5558040|NCT04033354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5558041|NCT04033354|Tubulin Modulators|tubulin modulators|mesh-ancestor
5558042|NCT04033354|Antimitotic Agents|antimitotic agents|mesh-ancestor
5558043|NCT04033354|Mitosis Modulators|mitosis modulators|mesh-ancestor
5558044|NCT04033354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158380|NCT01491737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6158381|NCT01491737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158382|NCT01491841|Rituximab|rituximab|mesh-list
6158383|NCT01491841|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6158384|NCT01491841|Pixantrone|pixantrone|mesh-list
6158385|NCT01491841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5558045|NCT04033250|Bisacodyl|bisacodyl|mesh-list
6158386|NCT01491841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6158387|NCT01491841|Immunologic Factors|immunologic factors|mesh-ancestor
6158388|NCT01491841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158389|NCT01491841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6158390|NCT01491841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6158391|NCT01491841|Alkylating Agents|alkylating agents|mesh-ancestor
6158392|NCT01491841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158393|NCT01491841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6158394|NCT01491841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6158395|NCT01491841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6158396|NCT01491919|Lisinopril|lisinopril|mesh-list
6158397|NCT01491919|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6158398|NCT01491919|Protease Inhibitors|protease inhibitors|mesh-ancestor
6158399|NCT01491919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5558046|NCT04033250|Picosulfate sodium|picosulfate sodium|mesh-list
5558047|NCT04033250|Magnesium Oxide|magnesium oxide|mesh-list
5558048|NCT04033250|Sodium Citrate|sodium citrate|mesh-list
5558049|NCT04033250|Citric Acid|citric acid|mesh-list
5558050|NCT04033250|Cathartics|cathartics|mesh-ancestor
5558051|NCT04033250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5558052|NCT04033250|Laxatives|laxatives|mesh-ancestor
5558053|NCT04033250|Anticoagulants|anticoagulants|mesh-ancestor
5558054|NCT04033250|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5558055|NCT04033250|Chelating Agents|chelating agents|mesh-ancestor
6158400|NCT01491919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158401|NCT01491919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6158402|NCT01491919|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6158403|NCT01491919|Protective Agents|protective agents|mesh-ancestor
6158404|NCT01491919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158405|NCT01491958|Methotrexate|methotrexate|mesh-list
6158406|NCT01491958|Atorvastatin|atorvastatin|mesh-list
6158407|NCT01491958|Tacrolimus|tacrolimus|mesh-list
6158408|NCT01491958|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6158409|NCT01491958|Abortifacient Agents|abortifacient agents|mesh-ancestor
6158410|NCT01491958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6158411|NCT01491958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158412|NCT01491958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6158413|NCT01491958|Antimetabolites|antimetabolites|mesh-ancestor
6158414|NCT01491958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158415|NCT01491958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6158416|NCT01491958|Dermatologic Agents|dermatologic agents|mesh-ancestor
6158417|NCT01491958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6158418|NCT01491958|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6158419|NCT01491958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6158420|NCT01491958|Immunologic Factors|immunologic factors|mesh-ancestor
6158421|NCT01491958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6158422|NCT01491958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6158423|NCT01491958|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6158424|NCT01491958|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6158425|NCT01491958|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6668303|NCT01531517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558056|NCT04033250|Sequestering Agents|sequestering agents|mesh-ancestor
6158426|NCT01491958|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6158427|NCT01491958|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6158428|NCT01492088|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6158429|NCT01492088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6158430|NCT01492088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6158431|NCT01492101|Etirinotecan pegol|etirinotecan pegol|mesh-list
6158432|NCT01492101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6158433|NCT01492101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6158434|NCT01492101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6158435|NCT01492101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6158436|NCT01492101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158437|NCT01492400|Dexamethasone|dexamethasone|mesh-list
5558057|NCT04033250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558058|NCT04033250|Antacids|antacids|mesh-ancestor
5558059|NCT04033172|Fulvestrant|fulvestrant|mesh-list
5558060|NCT04033172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5558061|NCT04033172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5558062|NCT04033172|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5558063|NCT04033172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5558064|NCT04033172|Hormone Antagonists|hormone antagonists|mesh-ancestor
5558065|NCT04033172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5558066|NCT04033172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558067|NCT04033237|Nicotine|nicotine|mesh-list
5558068|NCT04033237|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5558069|NCT04033237|Autonomic Agents|autonomic agents|mesh-ancestor
5558070|NCT04033237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5558071|NCT04033237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558072|NCT04033237|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5558073|NCT04033237|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5558074|NCT04033237|Cholinergic Agents|cholinergic agents|mesh-ancestor
5558075|NCT04033237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5558076|NCT04033237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558077|NCT04033029|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5558078|NCT04033029|Tazobactam|tazobactam|mesh-list
5558079|NCT04033029|Piperacillin|piperacillin|mesh-list
5558080|NCT04033029|Daptomycin|daptomycin|mesh-list
5558081|NCT04033029|Ceftazidime|ceftazidime|mesh-list
5558082|NCT04033029|Cefepime|cefepime|mesh-list
5558083|NCT04033029|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
5558084|NCT04033029|Ceftolozane|ceftolozane|mesh-list
6158438|NCT01492400|Ranibizumab|ranibizumab|mesh-list
6158439|NCT01492400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6158440|NCT01492400|Antiemetics|antiemetics|mesh-ancestor
6158441|NCT01492400|Autonomic Agents|autonomic agents|mesh-ancestor
6158442|NCT01492400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6158443|NCT01492400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158444|NCT01492400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6158445|NCT01492400|Glucocorticoids|glucocorticoids|mesh-ancestor
6158446|NCT01492400|Hormones|hormones|mesh-ancestor
6158447|NCT01492400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6158448|NCT01492400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6158449|NCT01492400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6158450|NCT01492400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6158451|NCT01492400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5558085|NCT04033029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5558086|NCT04033029|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5558087|NCT04033029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5558088|NCT04033029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558089|NCT04033055|Ropivacaine|ropivacaine|mesh-list
5558090|NCT04033055|Anesthetics, Local|anesthetics, local|mesh-ancestor
5558091|NCT04033055|Anesthetics|anesthetics|mesh-ancestor
6158452|NCT01492400|Growth Substances|growth substances|mesh-ancestor
6158453|NCT01492400|Growth Inhibitors|growth inhibitors|mesh-ancestor
6158454|NCT01492426|Ribavirin|ribavirin|mesh-list
6158455|NCT01492426|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6158456|NCT01492426|Antimetabolites|antimetabolites|mesh-ancestor
6158457|NCT01492426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158458|NCT01492426|Antiviral Agents|antiviral agents|mesh-ancestor
6158459|NCT01492426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6158460|NCT01492582|Vaccines|vaccines|mesh-list
6158461|NCT01492582|Immunologic Factors|immunologic factors|mesh-ancestor
6158462|NCT01492582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158463|NCT01492673|Cyclophosphamide|cyclophosphamide|mesh-list
6158464|NCT01492673|Bevacizumab|bevacizumab|mesh-list
5558092|NCT04033055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6158465|NCT01492673|Topotecan|topotecan|mesh-list
5558093|NCT04033055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558094|NCT04033055|Sensory System Agents|sensory system agents|mesh-ancestor
5558095|NCT04033055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5558096|NCT04033094|Morphine|morphine|mesh-list
5558097|NCT04033094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5558098|NCT04033094|Narcotics|narcotics|mesh-ancestor
5558099|NCT04033094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5558100|NCT04033094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558101|NCT04033094|Analgesics|analgesics|mesh-ancestor
5558102|NCT04033094|Sensory System Agents|sensory system agents|mesh-ancestor
5558103|NCT04033094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5603327|NCT02785224|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5603328|NCT02785224|Autonomic Agents|autonomic agents|mesh-ancestor
5603329|NCT02785224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5603330|NCT02785224|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6158466|NCT01492673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6158467|NCT01492673|Immunologic Factors|immunologic factors|mesh-ancestor
6158468|NCT01492673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158469|NCT01492673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6158470|NCT01492673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6158471|NCT01492673|Alkylating Agents|alkylating agents|mesh-ancestor
6158472|NCT01492673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158473|NCT01492673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6158474|NCT01492673|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6158475|NCT01492673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6158476|NCT01492673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6158477|NCT01492673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6158478|NCT01492673|Growth Substances|growth substances|mesh-ancestor
6158479|NCT01492673|Growth Inhibitors|growth inhibitors|mesh-ancestor
6158480|NCT01492673|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5603331|NCT02785224|Respiratory System Agents|respiratory system agents|mesh-ancestor
5603332|NCT02785224|Mydriatics|mydriatics|mesh-ancestor
5603333|NCT02785224|Sympathomimetics|sympathomimetics|mesh-ancestor
5603334|NCT02785224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5603335|NCT02785224|Hemostatics|hemostatics|mesh-ancestor
5603336|NCT02785224|Coagulants|coagulants|mesh-ancestor
5603337|NCT02785224|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5603338|NCT02785224|Natriuretic Agents|natriuretic agents|mesh-ancestor
6158481|NCT01492673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6158482|NCT01492673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6158483|NCT01492686|Edaravone|edaravone|mesh-list
6158484|NCT01492686|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6158485|NCT01492686|Antioxidants|antioxidants|mesh-ancestor
5603339|NCT02781883|Decitabine|decitabine|mesh-list
5603340|NCT02781883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5603341|NCT02781883|Antimetabolites|antimetabolites|mesh-ancestor
5603342|NCT02781883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603343|NCT02781883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6158486|NCT01492686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158487|NCT01492686|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6158488|NCT01492686|Protective Agents|protective agents|mesh-ancestor
6158489|NCT01492686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480625|NCT00544011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6480626|NCT00544011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6480627|NCT00544011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6480628|NCT00544011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6480629|NCT00544011|Growth Substances|growth substances|mesh-ancestor
6480630|NCT00544011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480631|NCT00544011|Growth Inhibitors|growth inhibitors|mesh-ancestor
6480632|NCT00544011|Antimetabolites|antimetabolites|mesh-ancestor
6480633|NCT00544011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480634|NCT00544011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6480635|NCT00544011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6480636|NCT00544011|Immunologic Factors|immunologic factors|mesh-ancestor
6480637|NCT00544011|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6480638|NCT00544011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6480639|NCT00544011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6480640|NCT00544037|Interferons|interferons|mesh-list
6480641|NCT00544037|Interferon-beta|interferon-beta|mesh-list
6480642|NCT00544037|Interferon beta-1b|interferon beta-1b|mesh-list
6480643|NCT00544037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5603344|NCT02781883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5603345|NCT02780583|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5603346|NCT02780583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5558104|NCT04033263|Fluorides|fluorides|mesh-list
5558105|NCT04033263|Cariostatic Agents|cariostatic agents|mesh-ancestor
5558106|NCT04033263|Protective Agents|protective agents|mesh-ancestor
5558107|NCT04033263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558108|NCT04033419|Memantine|memantine|mesh-list
5558109|NCT04033419|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5558110|NCT04033419|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5558111|NCT04033419|Dopamine Agents|dopamine agents|mesh-ancestor
6480644|NCT00544037|Antiviral Agents|antiviral agents|mesh-ancestor
6480645|NCT00544037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6480646|NCT00544037|Immunologic Factors|immunologic factors|mesh-ancestor
6480647|NCT00544037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480648|NCT00544037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6480649|NCT00544050|Levetiracetam|levetiracetam|mesh-list
6480650|NCT00544050|Anticonvulsants|anticonvulsants|mesh-ancestor
6158490|NCT01493089|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
6158491|NCT01493089|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6158492|NCT01493089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6158493|NCT01493089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158494|NCT01493180|Rebamipide|rebamipide|mesh-list
6158495|NCT01493180|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6158496|NCT01493180|Hyaluronic Acid|hyaluronic acid|mesh-list
6158497|NCT01493180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6158498|NCT01493180|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6158499|NCT01493180|Immunologic Factors|immunologic factors|mesh-ancestor
5558112|NCT04033419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5558113|NCT04033419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558114|NCT04033419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558115|NCT04033419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5558116|NCT04033419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5558117|NCT04033276|Rituximab|rituximab|mesh-list
6158500|NCT01493180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158501|NCT01493180|Viscosupplements|viscosupplements|mesh-ancestor
5558118|NCT04033276|Immunoglobulins|immunoglobulins|mesh-list
5558119|NCT04033276|Antibodies|antibodies|mesh-list
5558120|NCT04033276|gamma-Globulins|gamma-globulins|mesh-list
5558121|NCT04033276|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6158502|NCT01493180|Protective Agents|protective agents|mesh-ancestor
6158503|NCT01493180|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6158504|NCT01493180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6158505|NCT01493180|Antioxidants|antioxidants|mesh-ancestor
6158506|NCT01493180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158507|NCT01493180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6158508|NCT01493427|Travoprost|travoprost|mesh-list
6158509|NCT01493427|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6158510|NCT01493531|Allopurinol|allopurinol|mesh-list
6158511|NCT01493531|Lesinurad|lesinurad|mesh-list
6158512|NCT01493531|Antimetabolites|antimetabolites|mesh-ancestor
6158513|NCT01493531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668304|NCT01531517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6668305|NCT01531569|Secoisolariciresinol|secoisolariciresinol|mesh-list
6668306|NCT01531569|Phytoestrogens|phytoestrogens|mesh-ancestor
6668307|NCT01531569|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6668308|NCT01531569|Estrogens|estrogens|mesh-ancestor
6668309|NCT01531569|Hormones|hormones|mesh-ancestor
6668310|NCT01531569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6668311|NCT01531569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668312|NCT01531582|Minocycline|minocycline|mesh-list
6158514|NCT01493531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6158515|NCT01493531|Gout Suppressants|gout suppressants|mesh-ancestor
6158516|NCT01493531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6158517|NCT01493531|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6158518|NCT01493531|Antioxidants|antioxidants|mesh-ancestor
6158519|NCT01493531|Protective Agents|protective agents|mesh-ancestor
6158520|NCT01493531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158521|NCT01493531|Uricosuric Agents|uricosuric agents|mesh-ancestor
6158522|NCT01493531|Renal Agents|renal agents|mesh-ancestor
6158523|NCT01493557|Pantoprazole|pantoprazole|mesh-list
6158524|NCT01493557|Dabigatran|dabigatran|mesh-list
6158525|NCT01493557|Antithrombins|antithrombins|mesh-ancestor
6158526|NCT01493557|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6158527|NCT01493557|Protease Inhibitors|protease inhibitors|mesh-ancestor
6158528|NCT01493557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5558122|NCT04033276|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5603347|NCT02778204|Maraviroc|maraviroc|mesh-list
6158529|NCT01493557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480651|NCT00544050|Nootropic Agents|nootropic agents|mesh-ancestor
6480652|NCT00544063|Oxaliplatin|oxaliplatin|mesh-list
6668313|NCT01531582|Tetracycline|tetracycline|mesh-list
5558123|NCT04033276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5558124|NCT04033276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5558125|NCT04033276|Immunologic Factors|immunologic factors|mesh-ancestor
5558126|NCT04033276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558127|NCT04033276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5558128|NCT04032990|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
5558129|NCT04032990|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5558130|NCT04032990|Immunologic Factors|immunologic factors|mesh-ancestor
5558131|NCT04032990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558132|NCT04032964|Doxorubicin|doxorubicin|mesh-list
6158530|NCT01493557|Anticoagulants|anticoagulants|mesh-ancestor
6158531|NCT01493557|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6158532|NCT01493557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6158533|NCT01493557|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6158534|NCT01493687|Azelaic acid|azelaic acid|mesh-list
6158535|NCT01493687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6158536|NCT01493687|Dermatologic Agents|dermatologic agents|mesh-ancestor
6158537|NCT01493947|Metronidazole|metronidazole|mesh-list
6158538|NCT01493947|Ivermectin|ivermectin|mesh-list
6158539|NCT01493947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6158540|NCT01493947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6158541|NCT01493947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6158542|NCT01493947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6158543|NCT01494038|Isoniazid|isoniazid|mesh-list
6158544|NCT01494038|Antitubercular Agents|antitubercular agents|mesh-ancestor
6158545|NCT01494038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6158546|NCT01494038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6158547|NCT01494038|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5558133|NCT04032964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5558134|NCT04032964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5558135|NCT04032964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5558136|NCT04032964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5558137|NCT04032964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5558138|NCT04032964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558139|NCT04032626|Lenalidomide|lenalidomide|mesh-list
5558140|NCT04032626|Immunologic Factors|immunologic factors|mesh-ancestor
5558141|NCT04032626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558142|NCT04032626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5558143|NCT04032626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5558144|NCT04032626|Growth Substances|growth substances|mesh-ancestor
5558145|NCT04032626|Growth Inhibitors|growth inhibitors|mesh-ancestor
5558146|NCT04032626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5558147|NCT04032691|Clonidine|clonidine|mesh-list
5558148|NCT04032691|Analgesics|analgesics|mesh-ancestor
6158548|NCT01494038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6158549|NCT01494038|Antimetabolites|antimetabolites|mesh-ancestor
6158550|NCT01494038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158551|NCT01494038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6158552|NCT01494350|Gentamicins|gentamicins|mesh-list
6158553|NCT01494350|Paromomycin|paromomycin|mesh-list
6158554|NCT01494350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6158555|NCT01494350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6158556|NCT01494350|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6158557|NCT01494350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6158558|NCT01494350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158559|NCT01494350|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6158560|NCT01494350|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6158561|NCT01494467|Azelaic acid|azelaic acid|mesh-list
6158562|NCT01494467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6158563|NCT01494467|Dermatologic Agents|dermatologic agents|mesh-ancestor
6158564|NCT01494506|Leucovorin|leucovorin|mesh-list
6158565|NCT01494506|Fluorouracil|fluorouracil|mesh-list
6158566|NCT01494506|Antimetabolites|antimetabolites|mesh-ancestor
6158567|NCT01494506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558149|NCT04032691|Sensory System Agents|sensory system agents|mesh-ancestor
6158568|NCT01494506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6158569|NCT01494506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6158570|NCT01494506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6158571|NCT01494506|Immunologic Factors|immunologic factors|mesh-ancestor
6158572|NCT01494506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158573|NCT01494506|Antidotes|antidotes|mesh-ancestor
6158574|NCT01494506|Protective Agents|protective agents|mesh-ancestor
6158575|NCT01494506|Vitamin B Complex|vitamin b complex|mesh-ancestor
6158576|NCT01494506|Vitamins|vitamins|mesh-ancestor
6158577|NCT01494506|Micronutrients|micronutrients|mesh-ancestor
6158578|NCT01494532|Ropinirole|ropinirole|mesh-list
6158579|NCT01494532|Levodopa|levodopa|mesh-list
6158580|NCT01494532|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
6158581|NCT01494532|Dopamine Agents|dopamine agents|mesh-ancestor
6158582|NCT01494532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6158583|NCT01494532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158584|NCT01494532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158585|NCT01494532|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6158586|NCT01494532|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6158587|NCT01494532|Dopamine Agonists|dopamine agonists|mesh-ancestor
6158588|NCT01494584|Ezogabine|ezogabine|mesh-list
6158589|NCT01494584|Anticonvulsants|anticonvulsants|mesh-ancestor
6158590|NCT01494584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6158591|NCT01494584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558150|NCT04032691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5558151|NCT04032691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558152|NCT04032691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5558153|NCT04032691|Sympatholytics|sympatholytics|mesh-ancestor
5558154|NCT04032691|Autonomic Agents|autonomic agents|mesh-ancestor
5558155|NCT04032691|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5558156|NCT04032691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5558157|NCT04032691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5558158|NCT04032691|Adrenergic Agents|adrenergic agents|mesh-ancestor
5558159|NCT04032691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5558160|NCT04032691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558161|NCT04032860|Tenofovir|tenofovir|mesh-list
5558162|NCT04032860|Entecavir|entecavir|mesh-list
5558163|NCT04032860|Antiviral Agents|antiviral agents|mesh-ancestor
5558164|NCT04032860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5558165|NCT04032860|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5558166|NCT04032860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5558167|NCT04032860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5558168|NCT04032860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558169|NCT04032860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5558170|NCT04032860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5558171|NCT04032665|Rivaroxaban|rivaroxaban|mesh-list
5558172|NCT04032665|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5558173|NCT04032665|Antithrombins|antithrombins|mesh-ancestor
5558174|NCT04032665|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5558175|NCT04032665|Protease Inhibitors|protease inhibitors|mesh-ancestor
5558176|NCT04032665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5558177|NCT04032665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558178|NCT04032665|Anticoagulants|anticoagulants|mesh-ancestor
5558179|NCT04032847|Pembrolizumab|pembrolizumab|mesh-list
5558180|NCT04032847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5558181|NCT04032847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5558182|NCT04032834|Budesonide|budesonide|mesh-list
5558183|NCT04032834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5558184|NCT04032834|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5558185|NCT04032834|Autonomic Agents|autonomic agents|mesh-ancestor
5558186|NCT04032834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5558187|NCT04032834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558188|NCT04032834|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5558189|NCT04032834|Respiratory System Agents|respiratory system agents|mesh-ancestor
5558190|NCT04032834|Glucocorticoids|glucocorticoids|mesh-ancestor
6158592|NCT01494610|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6158593|NCT01494610|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6480653|NCT00544063|Irinotecan|irinotecan|mesh-list
6480654|NCT00544063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5558191|NCT04032834|Hormones|hormones|mesh-ancestor
6480655|NCT00544063|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6480656|NCT00544063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6480657|NCT00544063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6480658|NCT00544063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480659|NCT00544115|Cyclosporine|cyclosporine|mesh-list
5558192|NCT04032834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5558193|NCT04032548|Chlorhexidine|chlorhexidine|mesh-list
5558194|NCT04032548|Propolis|propolis|mesh-list
5558195|NCT04032548|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5558196|NCT04032548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5558197|NCT04032548|Disinfectants|disinfectants|mesh-ancestor
5558198|NCT04032418|Pembrolizumab|pembrolizumab|mesh-list
5558199|NCT04032418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5558200|NCT04032418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5558201|NCT04032236|Caffeine|caffeine|mesh-list
5558202|NCT04032236|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5558203|NCT04032236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558204|NCT04032236|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6158594|NCT01494610|Autonomic Agents|autonomic agents|mesh-ancestor
5558205|NCT04032236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5558206|NCT04032236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158595|NCT01494610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6158596|NCT01494610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158597|NCT01494610|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6158598|NCT01494610|Respiratory System Agents|respiratory system agents|mesh-ancestor
6158599|NCT01494610|Glucocorticoids|glucocorticoids|mesh-ancestor
6158600|NCT01494610|Hormones|hormones|mesh-ancestor
6158601|NCT01494610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6158602|NCT01494610|Sympathomimetics|sympathomimetics|mesh-ancestor
6158603|NCT01494818|Hydrogen Peroxide|hydrogen peroxide|mesh-list
6158604|NCT01494818|Contact Lens Solutions|contact lens solutions|mesh-list
6158605|NCT01494818|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6158606|NCT01494818|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5558207|NCT04032236|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5558208|NCT04032236|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5558209|NCT04032236|Purinergic Agents|purinergic agents|mesh-ancestor
6158607|NCT01494818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6158608|NCT01494818|Disinfectants|disinfectants|mesh-ancestor
6158609|NCT01494987|Glimepiride|glimepiride|mesh-list
6158610|NCT01494987|Ranolazine|ranolazine|mesh-list
6158611|NCT01494987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6158612|NCT01494987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6158613|NCT01494987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158614|NCT01494987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6158615|NCT01494987|Immunologic Factors|immunologic factors|mesh-ancestor
6158616|NCT01494987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6158617|NCT01494987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6158618|NCT01494987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158619|NCT01495000|Denosumab|denosumab|mesh-list
6158620|NCT01495000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6158621|NCT01495000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158622|NCT01495481|Adenosine|adenosine|mesh-list
6158623|NCT01495481|Dexmedetomidine|dexmedetomidine|mesh-list
6158624|NCT01495481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6158625|NCT01495481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6158626|NCT01495481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158627|NCT01495481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6480660|NCT00544115|Sirolimus|sirolimus|mesh-list
5558210|NCT04032236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5558211|NCT04032366|Nitric Oxide|nitric oxide|mesh-list
5558212|NCT04032366|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5558213|NCT04032366|Autonomic Agents|autonomic agents|mesh-ancestor
5558214|NCT04032366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5558215|NCT04032366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558216|NCT04032366|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5558217|NCT04032366|Respiratory System Agents|respiratory system agents|mesh-ancestor
5558218|NCT04032366|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5558219|NCT04032366|Antioxidants|antioxidants|mesh-ancestor
5558220|NCT04032366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558221|NCT04032366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5558222|NCT04032366|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5558223|NCT04032366|Vasodilator Agents|vasodilator agents|mesh-ancestor
5558224|NCT04032366|Gasotransmitters|gasotransmitters|mesh-ancestor
5558225|NCT04032366|Protective Agents|protective agents|mesh-ancestor
5558226|NCT04032067|Finasteride|finasteride|mesh-list
5558227|NCT04032067|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6158628|NCT01495481|Analgesics|analgesics|mesh-ancestor
6158629|NCT01495481|Sensory System Agents|sensory system agents|mesh-ancestor
6158630|NCT01495481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6158631|NCT01495481|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6158632|NCT01495481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6158633|NCT01495481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6158634|NCT01495481|Adrenergic Agents|adrenergic agents|mesh-ancestor
6158635|NCT01495481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6158636|NCT01495481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158637|NCT01495481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6158638|NCT01495481|Vasodilator Agents|vasodilator agents|mesh-ancestor
6158639|NCT01495481|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6158640|NCT01495481|Purinergic Agonists|purinergic agonists|mesh-ancestor
6158641|NCT01495481|Purinergic Agents|purinergic agents|mesh-ancestor
6158642|NCT01495572|Aldesleukin|aldesleukin|mesh-list
6158643|NCT01495572|Cyclophosphamide|cyclophosphamide|mesh-list
6158644|NCT01495572|Fludarabine|fludarabine|mesh-list
6158645|NCT01495572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6158646|NCT01495572|Immunologic Factors|immunologic factors|mesh-ancestor
6158647|NCT01495572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158648|NCT01495572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6158649|NCT01495572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6158650|NCT01495572|Alkylating Agents|alkylating agents|mesh-ancestor
6158651|NCT01495572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158652|NCT01495572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6158653|NCT01495572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6158654|NCT01495572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5558228|NCT04032067|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5558229|NCT04032067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5558230|NCT04032067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558231|NCT04032067|Hormone Antagonists|hormone antagonists|mesh-ancestor
5558232|NCT04032067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5558233|NCT04032067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558234|NCT04032067|Urological Agents|urological agents|mesh-ancestor
5558235|NCT04032132|Curcumin|curcumin|mesh-list
6158655|NCT01495572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6158656|NCT01495572|Antiviral Agents|antiviral agents|mesh-ancestor
6158657|NCT01495572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6480661|NCT00544115|Mycophenolic Acid|mycophenolic acid|mesh-list
6480662|NCT00544115|Cyclophosphamide|cyclophosphamide|mesh-list
6480663|NCT00544115|Melphalan|melphalan|mesh-list
6480664|NCT00544115|Busulfan|busulfan|mesh-list
6480665|NCT00544115|Methotrexate|methotrexate|mesh-list
6480666|NCT00544115|Fludarabine|fludarabine|mesh-list
6480667|NCT00544115|Fludarabine phosphate|fludarabine phosphate|mesh-list
6480668|NCT00544115|Etoposide|etoposide|mesh-list
6480669|NCT00544115|Tacrolimus|tacrolimus|mesh-list
6480670|NCT00544115|Cyclosporins|cyclosporins|mesh-list
6480671|NCT00544115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6480672|NCT00544115|Immunologic Factors|immunologic factors|mesh-ancestor
6480673|NCT00544115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480674|NCT00544115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6158658|NCT01495585|Lonafarnib|lonafarnib|mesh-list
6158659|NCT01495585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6480675|NCT00544115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6480676|NCT00544115|Alkylating Agents|alkylating agents|mesh-ancestor
6480677|NCT00544115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558236|NCT04032132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6158660|NCT01495585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158661|NCT01495702|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6158662|NCT01495702|Antiviral Agents|antiviral agents|mesh-ancestor
6158663|NCT01495702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6158664|NCT01495702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6158665|NCT01495702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6158666|NCT01495793|Rotigotine|rotigotine|mesh-list
6158667|NCT01495793|Dopamine Agonists|dopamine agonists|mesh-ancestor
6158668|NCT01495793|Dopamine Agents|dopamine agents|mesh-ancestor
6158669|NCT01495793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6158670|NCT01495793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158671|NCT01495793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158672|NCT01495819|Nicotine|nicotine|mesh-list
6158673|NCT01495819|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6158674|NCT01495819|Autonomic Agents|autonomic agents|mesh-ancestor
6158675|NCT01495819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6158676|NCT01495819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158677|NCT01495819|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6158678|NCT01495819|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6158679|NCT01495819|Cholinergic Agents|cholinergic agents|mesh-ancestor
6158680|NCT01495819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6158681|NCT01495819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158682|NCT01495858|Naproxen|naproxen|mesh-list
6158683|NCT01495858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6158684|NCT01495858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6158685|NCT01495858|Analgesics|analgesics|mesh-ancestor
6158686|NCT01495858|Sensory System Agents|sensory system agents|mesh-ancestor
6158687|NCT01495858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6158688|NCT01495858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158689|NCT01495858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6158690|NCT01495858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6158691|NCT01495858|Gout Suppressants|gout suppressants|mesh-ancestor
5558237|NCT04032132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5558238|NCT04032132|Analgesics|analgesics|mesh-ancestor
5558239|NCT04032132|Sensory System Agents|sensory system agents|mesh-ancestor
5558240|NCT04032132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5558241|NCT04032132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558242|NCT04032132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5558243|NCT04032132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5558244|NCT04032132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5558245|NCT04032132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5558246|NCT04032132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558247|NCT04032184|Chlorhexidine|chlorhexidine|mesh-list
5558248|NCT04032184|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5558249|NCT04032184|Fluorides|fluorides|mesh-list
5558250|NCT04032184|Cariostatic Agents|cariostatic agents|mesh-ancestor
5558251|NCT04032184|Protective Agents|protective agents|mesh-ancestor
5558252|NCT04032184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558253|NCT04032184|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5558254|NCT04032184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5558255|NCT04032184|Disinfectants|disinfectants|mesh-ancestor
5558256|NCT04032184|Dermatologic Agents|dermatologic agents|mesh-ancestor
5558257|NCT04032119|Epinephrine|epinephrine|mesh-list
5558258|NCT04032119|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5558259|NCT04032119|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5558260|NCT04032119|Adrenergic Agents|adrenergic agents|mesh-ancestor
5558261|NCT04032119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5558262|NCT04032119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158692|NCT01495858|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6158693|NCT01495858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5558263|NCT04032119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558264|NCT04032119|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5558265|NCT04032119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5558266|NCT04032119|Autonomic Agents|autonomic agents|mesh-ancestor
5558267|NCT04032119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5558268|NCT04032119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5558269|NCT04032119|Respiratory System Agents|respiratory system agents|mesh-ancestor
5558270|NCT04032119|Mydriatics|mydriatics|mesh-ancestor
5558271|NCT04032119|Sympathomimetics|sympathomimetics|mesh-ancestor
5558272|NCT04032119|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5558273|NCT04032210|Zinc|zinc|mesh-list
5558274|NCT04032210|Fluorides|fluorides|mesh-list
5558275|NCT04032210|Cariostatic Agents|cariostatic agents|mesh-ancestor
5558276|NCT04032210|Protective Agents|protective agents|mesh-ancestor
5558277|NCT04032210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558278|NCT04032210|Trace Elements|trace elements|mesh-ancestor
6158694|NCT01495858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158695|NCT01495923|Gabapentin|gabapentin|mesh-list
6158696|NCT01495923|Analgesics|analgesics|mesh-ancestor
6158697|NCT01495923|Sensory System Agents|sensory system agents|mesh-ancestor
6158698|NCT01495923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6158699|NCT01495923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158700|NCT01495923|Anticonvulsants|anticonvulsants|mesh-ancestor
6158701|NCT01495923|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6158702|NCT01495923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6158703|NCT01495923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6158704|NCT01495923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6158705|NCT01495923|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6158706|NCT01495923|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6158707|NCT01495923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6158708|NCT01495923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158709|NCT01495923|Antimanic Agents|antimanic agents|mesh-ancestor
6158710|NCT01496131|Cyclophosphamide|cyclophosphamide|mesh-list
5558279|NCT04032210|Micronutrients|micronutrients|mesh-ancestor
5558280|NCT04031859|Aspirin|aspirin|mesh-list
6158711|NCT01496131|Goserelin|goserelin|mesh-list
6158712|NCT01496131|Immunologic Factors|immunologic factors|mesh-ancestor
6158713|NCT01496131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158714|NCT01496131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6158715|NCT01496131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6158716|NCT01496131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6158717|NCT01496131|Alkylating Agents|alkylating agents|mesh-ancestor
6158718|NCT01496131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158719|NCT01496131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6158720|NCT01496131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6158721|NCT01496131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6158722|NCT01496183|Olanzapine|olanzapine|mesh-list
6158723|NCT01496183|Antiemetics|antiemetics|mesh-ancestor
6158724|NCT01496183|Autonomic Agents|autonomic agents|mesh-ancestor
5558281|NCT04031859|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5558282|NCT04031859|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5558283|NCT04031859|Analgesics|analgesics|mesh-ancestor
5558284|NCT04031859|Sensory System Agents|sensory system agents|mesh-ancestor
5558285|NCT04031859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6158725|NCT01496183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6158726|NCT01496183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158727|NCT01496183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6158728|NCT01496183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6158729|NCT01496183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6158730|NCT01496183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6158731|NCT01496183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6158732|NCT01496183|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6158733|NCT01496183|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6158734|NCT01496183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6158735|NCT01496183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158736|NCT01496183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6158737|NCT01496183|Serotonin Agents|serotonin agents|mesh-ancestor
6480678|NCT00544115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6480679|NCT00544115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6480680|NCT00544115|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6480681|NCT00544115|Abortifacient Agents|abortifacient agents|mesh-ancestor
6158738|NCT01496365|Pregabalin|pregabalin|mesh-list
6158739|NCT01496365|Analgesics|analgesics|mesh-ancestor
6158740|NCT01496365|Sensory System Agents|sensory system agents|mesh-ancestor
6158741|NCT01496365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5558286|NCT04031859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558287|NCT04031859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5558288|NCT04031859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5558289|NCT04031859|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5558290|NCT04031859|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5558291|NCT04031859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558292|NCT04031859|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5558293|NCT04031859|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5558294|NCT04031859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5558295|NCT04031859|Antipyretics|antipyretics|mesh-ancestor
5558296|NCT04031833|Amphotericin B|amphotericin b|mesh-list
5558297|NCT04031833|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
5558298|NCT04031833|Amebicides|amebicides|mesh-ancestor
5558299|NCT04031833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5558300|NCT04031833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5558301|NCT04031833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5558302|NCT04031833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5558303|NCT04031833|Antifungal Agents|antifungal agents|mesh-ancestor
5558304|NCT04031872|Capecitabine|capecitabine|mesh-list
5558305|NCT04031872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5558306|NCT04031872|Antimetabolites|antimetabolites|mesh-ancestor
5558307|NCT04031872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558308|NCT04031872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6158742|NCT01496365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158743|NCT01496365|Anticonvulsants|anticonvulsants|mesh-ancestor
6158744|NCT01496365|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6158745|NCT01496365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6158746|NCT01496365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158747|NCT01496365|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6158748|NCT01496365|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6158749|NCT01496365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6158750|NCT01496365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6158751|NCT01496365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6158752|NCT01496430|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
6158753|NCT01496430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6158754|NCT01496430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6158755|NCT01496430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158756|NCT01496469|Febuxostat|febuxostat|mesh-list
6158757|NCT01496469|Gout Suppressants|gout suppressants|mesh-ancestor
6158758|NCT01496469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6158759|NCT01496612|Buspirone|buspirone|mesh-list
6158760|NCT01496612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6158761|NCT01496612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6158762|NCT01496612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6158763|NCT01496612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158764|NCT01496612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6158765|NCT01496612|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6480682|NCT00544115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6480683|NCT00544115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6480684|NCT00544115|Antimetabolites|antimetabolites|mesh-ancestor
6480685|NCT00544115|Dermatologic Agents|dermatologic agents|mesh-ancestor
6480686|NCT00544115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6480687|NCT00544115|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6480688|NCT00544115|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6480689|NCT00544115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6480690|NCT00544115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6158766|NCT01496612|Serotonin Agents|serotonin agents|mesh-ancestor
6158767|NCT01496612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6158768|NCT01496612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158769|NCT01496807|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6158770|NCT01496807|Ipilimumab|ipilimumab|mesh-list
6158771|NCT01496807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6158772|NCT01496807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6158773|NCT01496807|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6158774|NCT01496807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158775|NCT01496807|Antiviral Agents|antiviral agents|mesh-ancestor
6158776|NCT01496807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6158777|NCT01496846|Lidocaine|lidocaine|mesh-list
6158778|NCT01496846|Carticaine|carticaine|mesh-list
6158779|NCT01496846|Anesthetics, Local|anesthetics, local|mesh-ancestor
6158780|NCT01496846|Anesthetics|anesthetics|mesh-ancestor
6158781|NCT01496846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6158782|NCT01496846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158783|NCT01496846|Sensory System Agents|sensory system agents|mesh-ancestor
6158784|NCT01496846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6158785|NCT01496846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6158786|NCT01496846|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6158787|NCT01496846|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6158788|NCT01496846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6158789|NCT01496846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206025|NCT02096029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6206026|NCT02096029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206027|NCT02096081|Botulinum Toxins|botulinum toxins|mesh-list
6206028|NCT02096081|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6206029|NCT02096081|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6206030|NCT02096081|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
6206031|NCT02096081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6206032|NCT02096081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6206033|NCT02096081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206034|NCT02096081|Cholinergic Agents|cholinergic agents|mesh-ancestor
6206035|NCT02096081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6158790|NCT01497197|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6158791|NCT01497197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6158792|NCT01497197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158793|NCT01497262|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6158794|NCT01497262|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6158795|NCT01497262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158796|NCT01497262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6158797|NCT01497262|Immunologic Factors|immunologic factors|mesh-ancestor
6158798|NCT01497262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158799|NCT01497275|Rituximab|rituximab|mesh-list
6158800|NCT01497275|Bortezomib|bortezomib|mesh-list
6158801|NCT01497275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6158802|NCT01497275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6158803|NCT01497275|Immunologic Factors|immunologic factors|mesh-ancestor
6158804|NCT01497275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158805|NCT01497275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6158806|NCT01497366|Sofosbuvir|sofosbuvir|mesh-list
6158807|NCT01497366|Antiviral Agents|antiviral agents|mesh-ancestor
6158808|NCT01497366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6158809|NCT01497496|Methylprednisolone|methylprednisolone|mesh-list
6158810|NCT01497496|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6158811|NCT01497496|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6158812|NCT01497496|Prednisolone|prednisolone|mesh-list
6158813|NCT01497496|Prednisolone acetate|prednisolone acetate|mesh-list
6158814|NCT01497496|Lenalidomide|lenalidomide|mesh-list
6158815|NCT01497496|Ofatumumab|ofatumumab|mesh-list
6158816|NCT01497496|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6158817|NCT01497496|Prednisolone phosphate|prednisolone phosphate|mesh-list
6158818|NCT01497496|Immunologic Factors|immunologic factors|mesh-ancestor
6158819|NCT01497496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158820|NCT01497496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6158821|NCT01497496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6158822|NCT01497496|Growth Substances|growth substances|mesh-ancestor
6158823|NCT01497496|Growth Inhibitors|growth inhibitors|mesh-ancestor
6480691|NCT00544115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6480692|NCT00544115|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6480693|NCT00544115|Antifungal Agents|antifungal agents|mesh-ancestor
6480694|NCT00544115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6480695|NCT00544115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6480696|NCT00544115|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6480697|NCT00544115|Antitubercular Agents|antitubercular agents|mesh-ancestor
6480698|NCT00544115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6480699|NCT00544128|Ritonavir|ritonavir|mesh-list
6480700|NCT00544128|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6480701|NCT00544128|Tenofovir|tenofovir|mesh-list
6480702|NCT00544128|Lamivudine|lamivudine|mesh-list
6480703|NCT00544128|Emtricitabine|emtricitabine|mesh-list
6480704|NCT00544128|Abacavir|abacavir|mesh-list
6158824|NCT01497496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6480705|NCT00544128|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6480706|NCT00544128|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6480707|NCT00544128|Protease Inhibitors|protease inhibitors|mesh-ancestor
6480708|NCT00544128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5558325|NCT04031755|Minocycline|minocycline|mesh-list
5558326|NCT04031755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5558327|NCT04031755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6668314|NCT01531582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6668315|NCT01531582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6668316|NCT01531582|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6668317|NCT01531582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6668318|NCT01531582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668319|NCT01531595|Bevacizumab|bevacizumab|mesh-list
6668320|NCT01531595|Oxaliplatin|oxaliplatin|mesh-list
6668321|NCT01531595|Irinotecan|irinotecan|mesh-list
6668322|NCT01531595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6480709|NCT00544128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480710|NCT00544128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6480711|NCT00544128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6480712|NCT00544128|Antiviral Agents|antiviral agents|mesh-ancestor
6480713|NCT00544128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6480714|NCT00544128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6480715|NCT00544128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6480716|NCT00544128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6480717|NCT00544128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6480718|NCT00544154|Certolizumab Pegol|certolizumab pegol|mesh-list
6480719|NCT00544154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6480720|NCT00544154|Immunologic Factors|immunologic factors|mesh-ancestor
6480721|NCT00544154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480722|NCT00544154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6480723|NCT00544180|Risedronic Acid|risedronic acid|mesh-list
6480724|NCT00544180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6480725|NCT00544180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6480726|NCT00544180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480727|NCT00544180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6480728|NCT00544180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480729|NCT00544180|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6480730|NCT00544193|Gemcitabine|gemcitabine|mesh-list
6480731|NCT00544193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6158825|NCT01497496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6158826|NCT01497496|Antiemetics|antiemetics|mesh-ancestor
6158827|NCT01497496|Autonomic Agents|autonomic agents|mesh-ancestor
6158828|NCT01497496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5558328|NCT04031703|Paclitaxel|paclitaxel|mesh-list
6158829|NCT01497496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6158830|NCT01497496|Glucocorticoids|glucocorticoids|mesh-ancestor
6158831|NCT01497496|Hormones|hormones|mesh-ancestor
6158832|NCT01497496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6158833|NCT01497496|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6158834|NCT01497496|Protective Agents|protective agents|mesh-ancestor
6158835|NCT01497496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6158836|NCT01497808|Ipilimumab|ipilimumab|mesh-list
6158837|NCT01497808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6158838|NCT01497808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6158839|NCT01497808|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6158840|NCT01497808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158841|NCT01497860|Vinorelbine|vinorelbine|mesh-list
6158842|NCT01497860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6158843|NCT01497860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6158844|NCT01497860|Tubulin Modulators|tubulin modulators|mesh-ancestor
6158845|NCT01497860|Antimitotic Agents|antimitotic agents|mesh-ancestor
6158846|NCT01497860|Mitosis Modulators|mitosis modulators|mesh-ancestor
6158847|NCT01497860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158848|NCT01497899|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6158849|NCT01497899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6158850|NCT01497899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6158851|NCT01497899|Antiviral Agents|antiviral agents|mesh-ancestor
6158852|NCT01497899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6158853|NCT01497938|Insulin|insulin|mesh-list
6158854|NCT01497938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6158855|NCT01497938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158856|NCT01498068|Interferons|interferons|mesh-list
6158857|NCT01498068|Ribavirin|ribavirin|mesh-list
6158858|NCT01498068|Interferon-alpha|interferon-alpha|mesh-list
6158859|NCT01498068|Interferon alpha-2|interferon alpha-2|mesh-list
6158860|NCT01498068|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6158861|NCT01498068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6158862|NCT01498068|Antiviral Agents|antiviral agents|mesh-ancestor
6158863|NCT01498068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6158864|NCT01498068|Antimetabolites|antimetabolites|mesh-ancestor
6158865|NCT01498068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158866|NCT01498068|Immunologic Factors|immunologic factors|mesh-ancestor
6158867|NCT01498068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158868|NCT01498120|Rotigotine|rotigotine|mesh-list
6158869|NCT01498120|Dopamine Agonists|dopamine agonists|mesh-ancestor
6158870|NCT01498120|Dopamine Agents|dopamine agents|mesh-ancestor
6158871|NCT01498120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6158872|NCT01498120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558329|NCT04031703|Docetaxel|docetaxel|mesh-list
5558330|NCT04031703|Cyclophosphamide|cyclophosphamide|mesh-list
5558331|NCT04031703|Carboplatin|carboplatin|mesh-list
5558332|NCT04031703|Fluorouracil|fluorouracil|mesh-list
5558333|NCT04031703|Epirubicin|epirubicin|mesh-list
5558334|NCT04031703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5558335|NCT04031703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5558336|NCT04031703|Tubulin Modulators|tubulin modulators|mesh-ancestor
5558337|NCT04031703|Antimitotic Agents|antimitotic agents|mesh-ancestor
5558338|NCT04031703|Mitosis Modulators|mitosis modulators|mesh-ancestor
5558339|NCT04031703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558340|NCT04031703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5558341|NCT04031703|Immunologic Factors|immunologic factors|mesh-ancestor
5558342|NCT04031703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558343|NCT04031703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5558344|NCT04031703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5558345|NCT04031703|Alkylating Agents|alkylating agents|mesh-ancestor
5558346|NCT04031703|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5558347|NCT04031703|Antimetabolites|antimetabolites|mesh-ancestor
5558348|NCT04031703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5558349|NCT04031703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5558350|NCT04031703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6158873|NCT01498120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158874|NCT01498185|Dapagliflozin|dapagliflozin|mesh-list
6158875|NCT01498185|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6158876|NCT01498185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158877|NCT01498185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6158878|NCT01498185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158879|NCT01498289|Leucovorin|leucovorin|mesh-list
6158880|NCT01498289|Docetaxel|docetaxel|mesh-list
6158881|NCT01498289|Fluorouracil|fluorouracil|mesh-list
6158882|NCT01498289|Oxaliplatin|oxaliplatin|mesh-list
6158883|NCT01498289|Irinotecan|irinotecan|mesh-list
6158884|NCT01498289|Calcium|calcium|mesh-list
6158885|NCT01498289|Levoleucovorin|levoleucovorin|mesh-list
6158886|NCT01498289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6158887|NCT01498289|Tubulin Modulators|tubulin modulators|mesh-ancestor
6158888|NCT01498289|Antimitotic Agents|antimitotic agents|mesh-ancestor
6158889|NCT01498289|Mitosis Modulators|mitosis modulators|mesh-ancestor
6158890|NCT01498289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158891|NCT01498289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6158892|NCT01498289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158893|NCT01498289|Antimetabolites|antimetabolites|mesh-ancestor
6158894|NCT01498289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5558351|NCT04031703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5558352|NCT04031703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6158895|NCT01498289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6158896|NCT01498289|Immunologic Factors|immunologic factors|mesh-ancestor
6158897|NCT01498289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6158898|NCT01498289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6158899|NCT01498289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6158900|NCT01498289|Antidotes|antidotes|mesh-ancestor
6158901|NCT01498289|Protective Agents|protective agents|mesh-ancestor
6158902|NCT01498289|Vitamin B Complex|vitamin b complex|mesh-ancestor
6158903|NCT01498289|Vitamins|vitamins|mesh-ancestor
6158904|NCT01498289|Micronutrients|micronutrients|mesh-ancestor
6158905|NCT01498419|Moxifloxacin|moxifloxacin|mesh-list
6158906|NCT01498419|Pyrazinamide|pyrazinamide|mesh-list
6158907|NCT01498419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6158908|NCT01498419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6158909|NCT01498419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6158910|NCT01498419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6158911|NCT01498419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6480732|NCT00544193|Antimetabolites|antimetabolites|mesh-ancestor
5558353|NCT04031157|Antidepressive Agents|antidepressive agents|mesh-list
5558354|NCT04031157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5603348|NCT02778204|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5603349|NCT02778204|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5603350|NCT02778204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603351|NCT02778204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5603352|NCT02778204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5603353|NCT02778204|Antiviral Agents|antiviral agents|mesh-ancestor
5603354|NCT02778204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5603355|NCT02778204|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
5603356|NCT02743364|Simvastatin|simvastatin|mesh-list
5603357|NCT02743364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5603358|NCT02743364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5603359|NCT02743364|Antimetabolites|antimetabolites|mesh-ancestor
5603360|NCT02743364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603361|NCT02743364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5603362|NCT02743364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5603363|NCT02743364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5603364|NCT02670044|Venetoclax|venetoclax|mesh-list
5603365|NCT02670044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5603366|NCT02648997|Nivolumab|nivolumab|mesh-list
5603367|NCT02648997|Ipilimumab|ipilimumab|mesh-list
5603368|NCT02648997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5603369|NCT02648997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5603370|NCT02648997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5603371|NCT02648997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603372|NCT02625441|Trastuzumab|trastuzumab|mesh-list
6480733|NCT00544193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480734|NCT00544193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6480735|NCT00544193|Antiviral Agents|antiviral agents|mesh-ancestor
6480736|NCT00544193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6480737|NCT00544193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6480738|NCT00544193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6480739|NCT00544193|Immunologic Factors|immunologic factors|mesh-ancestor
6480740|NCT00544193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480741|NCT00544219|Prednisone|prednisone|mesh-list
6480742|NCT00544219|Cyclophosphamide|cyclophosphamide|mesh-list
6668323|NCT01531595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6668324|NCT01531595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6668325|NCT01531595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6668326|NCT01531595|Growth Substances|growth substances|mesh-ancestor
6668327|NCT01531595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668328|NCT01531595|Growth Inhibitors|growth inhibitors|mesh-ancestor
6668329|NCT01531595|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6668330|NCT01531595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6668331|NCT01531595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6668332|NCT01531595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668333|NCT01531647|Ritonavir|ritonavir|mesh-list
6668334|NCT01531647|Raltegravir Potassium|raltegravir potassium|mesh-list
6668335|NCT01531647|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6668336|NCT01531647|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6668337|NCT01531647|Protease Inhibitors|protease inhibitors|mesh-ancestor
6668338|NCT01531647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6668339|NCT01531647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668340|NCT01531647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6668341|NCT01531647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6668342|NCT01531647|Antiviral Agents|antiviral agents|mesh-ancestor
6668343|NCT01531647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6668344|NCT01531647|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6668345|NCT01531647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6668346|NCT01531647|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6480743|NCT00544219|Rituximab|rituximab|mesh-list
6480744|NCT00544219|Doxorubicin|doxorubicin|mesh-list
6480745|NCT00544219|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6480746|NCT00544219|Vincristine|vincristine|mesh-list
6480747|NCT00544219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6480748|NCT00544219|Immunologic Factors|immunologic factors|mesh-ancestor
6480749|NCT00544219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480750|NCT00544219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6480751|NCT00544219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6480752|NCT00544219|Alkylating Agents|alkylating agents|mesh-ancestor
6480753|NCT00544219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480754|NCT00544219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6480755|NCT00544219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6480756|NCT00544219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6480757|NCT00544219|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6480758|NCT00544219|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6480759|NCT00544219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6480760|NCT00544219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6480761|NCT00544219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6480762|NCT00544219|Glucocorticoids|glucocorticoids|mesh-ancestor
6480763|NCT00544219|Hormones|hormones|mesh-ancestor
6480764|NCT00544219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6480765|NCT00544219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5558355|NCT04031027|Apremilast|apremilast|mesh-list
5558356|NCT04031027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6158912|NCT01498419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158913|NCT01498419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6158914|NCT01498419|Antitubercular Agents|antitubercular agents|mesh-ancestor
6158915|NCT01498445|Decitabine|decitabine|mesh-list
5558357|NCT04031027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5558358|NCT04031027|Analgesics|analgesics|mesh-ancestor
5558359|NCT04031027|Sensory System Agents|sensory system agents|mesh-ancestor
5558360|NCT04031027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5558361|NCT04031027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558362|NCT04031027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5558363|NCT04031027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5558364|NCT04031027|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5558365|NCT04031027|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5558366|NCT04031027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5558367|NCT04031027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558368|NCT04030663|Nitroglycerin|nitroglycerin|mesh-list
5558369|NCT04030663|Papaverine|papaverine|mesh-list
5558370|NCT04030663|Vasodilator Agents|vasodilator agents|mesh-ancestor
5558371|NCT04030663|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5558372|NCT04030663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5558373|NCT04030663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558374|NCT04030663|Urological Agents|urological agents|mesh-ancestor
5558375|NCT04030988|Dexamethasone|dexamethasone|mesh-list
5558376|NCT04030988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5558377|NCT04030988|Antiemetics|antiemetics|mesh-ancestor
5558378|NCT04030988|Autonomic Agents|autonomic agents|mesh-ancestor
5558379|NCT04030988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5558380|NCT04030988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558381|NCT04030988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5558382|NCT04030988|Glucocorticoids|glucocorticoids|mesh-ancestor
5558383|NCT04030988|Hormones|hormones|mesh-ancestor
6158916|NCT01498445|Dasatinib|dasatinib|mesh-list
6158917|NCT01498445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6158918|NCT01498445|Antimetabolites|antimetabolites|mesh-ancestor
6668347|NCT01531647|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6668348|NCT01531712|Gemcitabine|gemcitabine|mesh-list
6668349|NCT01531712|Oxaliplatin|oxaliplatin|mesh-list
5558384|NCT04030988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5558385|NCT04030988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5558386|NCT04030988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5558387|NCT04030715|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5558388|NCT04030715|Bismuth|bismuth|mesh-list
5558389|NCT04030715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5558390|NCT04030715|Antacids|antacids|mesh-ancestor
6158919|NCT01498445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158920|NCT01498445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6158921|NCT01498445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6158922|NCT01498445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5558391|NCT04030715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558392|NCT04030715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5558393|NCT04030741|Metronidazole|metronidazole|mesh-list
5558394|NCT04030741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5558395|NCT04030741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5558396|NCT04030741|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5558397|NCT04030741|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5558398|NCT04030442|Morphine|morphine|mesh-list
5558399|NCT04030442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5558400|NCT04030442|Narcotics|narcotics|mesh-ancestor
5558401|NCT04030442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5558402|NCT04030442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558403|NCT04030442|Analgesics|analgesics|mesh-ancestor
5558404|NCT04030442|Sensory System Agents|sensory system agents|mesh-ancestor
5558405|NCT04030442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5558406|NCT04030533|Ustekinumab|ustekinumab|mesh-list
6158923|NCT01498458|Capecitabine|capecitabine|mesh-list
6158924|NCT01498458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6158925|NCT01498458|Antimetabolites|antimetabolites|mesh-ancestor
6158926|NCT01498458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158927|NCT01498458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6158928|NCT01498549|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6158929|NCT01498549|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6158930|NCT01498549|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6158931|NCT01498549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6158932|NCT01498549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158933|NCT01498549|Adrenergic Agents|adrenergic agents|mesh-ancestor
6158934|NCT01498549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6158935|NCT01498549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158936|NCT01498588|Cyclophosphamide|cyclophosphamide|mesh-list
6158937|NCT01498588|Doxorubicin|doxorubicin|mesh-list
6158938|NCT01498588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6158939|NCT01498588|Immunologic Factors|immunologic factors|mesh-ancestor
6158940|NCT01498588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158941|NCT01498588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6158942|NCT01498588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5558407|NCT04030533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5558408|NCT04030533|Dermatologic Agents|dermatologic agents|mesh-ancestor
5558409|NCT04030533|Immunologic Factors|immunologic factors|mesh-ancestor
5558410|NCT04030533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558411|NCT04030572|Clonidine|clonidine|mesh-list
5558412|NCT04030572|Analgesics|analgesics|mesh-ancestor
5558413|NCT04030572|Sensory System Agents|sensory system agents|mesh-ancestor
5558414|NCT04030572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5558415|NCT04030572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558416|NCT04030572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5558417|NCT04030572|Sympatholytics|sympatholytics|mesh-ancestor
5558418|NCT04030572|Autonomic Agents|autonomic agents|mesh-ancestor
5558419|NCT04030572|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5558420|NCT04030572|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5558421|NCT04030572|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5558422|NCT04030572|Adrenergic Agents|adrenergic agents|mesh-ancestor
5558423|NCT04030572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5558424|NCT04030572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158943|NCT01498588|Alkylating Agents|alkylating agents|mesh-ancestor
6158944|NCT01498588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158945|NCT01498588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6158946|NCT01498588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6158947|NCT01498588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6158948|NCT01498588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6158949|NCT01498588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6158950|NCT01498588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6158951|NCT01498679|Fluticasone|fluticasone|mesh-list
6158952|NCT01498679|Xhance|xhance|mesh-list
6158953|NCT01498679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6158954|NCT01498679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6158955|NCT01498679|Autonomic Agents|autonomic agents|mesh-ancestor
6158956|NCT01498679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6158957|NCT01498679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158958|NCT01498679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6158959|NCT01498679|Respiratory System Agents|respiratory system agents|mesh-ancestor
6158960|NCT01498679|Dermatologic Agents|dermatologic agents|mesh-ancestor
6158961|NCT01498679|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6158962|NCT01498744|Clindamycin|clindamycin|mesh-list
6158963|NCT01498744|Clindamycin palmitate|clindamycin palmitate|mesh-list
6158964|NCT01498744|Clindamycin phosphate|clindamycin phosphate|mesh-list
6158965|NCT01498744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6158966|NCT01498744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6158967|NCT01498744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6158968|NCT01498744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6158969|NCT01498744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158970|NCT01498822|Oxcarbazepine|oxcarbazepine|mesh-list
6158971|NCT01498822|Levetiracetam|levetiracetam|mesh-list
6158972|NCT01498822|Anticonvulsants|anticonvulsants|mesh-ancestor
6158973|NCT01498822|Nootropic Agents|nootropic agents|mesh-ancestor
6158974|NCT01498822|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6158975|NCT01498822|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6158976|NCT01498822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6668350|NCT01531712|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6668351|NCT01531712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6668352|NCT01531712|Antimetabolites|antimetabolites|mesh-ancestor
6668353|NCT01531712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668354|NCT01531712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5558425|NCT04030481|Anesthetics|anesthetics|mesh-list
5558426|NCT04030481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5558427|NCT04030481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558428|NCT04030260|Nivolumab|nivolumab|mesh-list
5558429|NCT04030260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5558430|NCT04030260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5558431|NCT04030260|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5558432|NCT04030260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558433|NCT04030195|Cyclophosphamide|cyclophosphamide|mesh-list
5558434|NCT04030195|Fludarabine|fludarabine|mesh-list
6158977|NCT01498822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158978|NCT01498822|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6158979|NCT01498822|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6158980|NCT01498887|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6158981|NCT01498887|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6158982|NCT01498887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158983|NCT01498887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6158984|NCT01498887|Immunologic Factors|immunologic factors|mesh-ancestor
6158985|NCT01498887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158986|NCT01498952|Sorafenib|sorafenib|mesh-list
6158987|NCT01498952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6158988|NCT01498952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6158989|NCT01498952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6158990|NCT01498952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6158991|NCT01498978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6158992|NCT01498978|Ipilimumab|ipilimumab|mesh-list
6668355|NCT01531712|Antiviral Agents|antiviral agents|mesh-ancestor
6668356|NCT01531712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6668357|NCT01531712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6668358|NCT01531712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6668359|NCT01531712|Immunologic Factors|immunologic factors|mesh-ancestor
6668360|NCT01531712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158993|NCT01498978|Antibodies|antibodies|mesh-list
6158994|NCT01498978|Immunoglobulins|immunoglobulins|mesh-list
6158995|NCT01498978|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6158996|NCT01498978|Immunologic Factors|immunologic factors|mesh-ancestor
6158997|NCT01498978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6158998|NCT01498978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6158999|NCT01498978|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6159000|NCT01498978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159001|NCT01499082|Insulin|insulin|mesh-list
6159002|NCT01499082|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6159003|NCT01499082|Insulin Glargine|insulin glargine|mesh-list
6159004|NCT01499082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6480766|NCT00544219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6668361|NCT01531712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6668362|NCT01531764|Vinorelbine|vinorelbine|mesh-list
6668363|NCT01531764|Afatinib|afatinib|mesh-list
6668364|NCT01531764|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6668365|NCT01531764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6668366|NCT01531764|Tubulin Modulators|tubulin modulators|mesh-ancestor
6668367|NCT01531764|Antimitotic Agents|antimitotic agents|mesh-ancestor
6480767|NCT00544219|Tubulin Modulators|tubulin modulators|mesh-ancestor
5558435|NCT04030195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5558436|NCT04030195|Immunologic Factors|immunologic factors|mesh-ancestor
5558437|NCT04030195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558438|NCT04030195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5558439|NCT04030195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5558440|NCT04030195|Alkylating Agents|alkylating agents|mesh-ancestor
5558441|NCT04030195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558442|NCT04030195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5558443|NCT04030195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5558444|NCT04030039|Interferons|interferons|mesh-list
5558445|NCT04030039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6480768|NCT00544219|Antimitotic Agents|antimitotic agents|mesh-ancestor
6480769|NCT00544219|Mitosis Modulators|mitosis modulators|mesh-ancestor
6480770|NCT00544232|Paclitaxel|paclitaxel|mesh-list
6480771|NCT00544232|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6480772|NCT00544232|Cyclophosphamide|cyclophosphamide|mesh-list
6480773|NCT00544232|Methotrexate|methotrexate|mesh-list
6668368|NCT01531764|Mitosis Modulators|mitosis modulators|mesh-ancestor
5558446|NCT04030039|Antiviral Agents|antiviral agents|mesh-ancestor
5558447|NCT04030039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5558448|NCT04030429|Crizotinib|crizotinib|mesh-list
6480774|NCT00544232|Epirubicin|epirubicin|mesh-list
6480775|NCT00544232|Darbepoetin alfa|darbepoetin alfa|mesh-list
6159005|NCT01499082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159006|NCT01499095|Insulin|insulin|mesh-list
6159007|NCT01499095|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6159008|NCT01499095|Insulin Glargine|insulin glargine|mesh-list
6159009|NCT01499095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6159010|NCT01499095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159011|NCT01499134|Metoprolol|metoprolol|mesh-list
6159012|NCT01499134|Nebivolol|nebivolol|mesh-list
6159013|NCT01499134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6159014|NCT01499134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6159015|NCT01499134|Sympatholytics|sympatholytics|mesh-ancestor
6159016|NCT01499134|Autonomic Agents|autonomic agents|mesh-ancestor
6159017|NCT01499134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6159018|NCT01499134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159019|NCT01499134|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6159020|NCT01499134|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6159021|NCT01499134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6159022|NCT01499134|Adrenergic Agents|adrenergic agents|mesh-ancestor
6159023|NCT01499134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6159024|NCT01499134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159025|NCT01499134|Vasodilator Agents|vasodilator agents|mesh-ancestor
6159026|NCT01499134|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6159027|NCT01499134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5558449|NCT04030429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5558450|NCT04030429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5558451|NCT04030429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5558452|NCT04030429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558453|NCT04030455|Cisplatin|cisplatin|mesh-list
5558454|NCT04030455|Carboplatin|carboplatin|mesh-list
5558455|NCT04030455|Docetaxel|docetaxel|mesh-list
5558456|NCT04030455|Pembrolizumab|pembrolizumab|mesh-list
5558457|NCT04030455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5558458|NCT04030455|Tubulin Modulators|tubulin modulators|mesh-ancestor
6159028|NCT01499134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6159029|NCT01499147|Vidarabine|vidarabine|mesh-list
6159030|NCT01499147|Fludarabine|fludarabine|mesh-list
6159031|NCT01499147|Fludarabine phosphate|fludarabine phosphate|mesh-list
6159032|NCT01499147|Melphalan|melphalan|mesh-list
6159033|NCT01499147|Busulfan|busulfan|mesh-list
6159034|NCT01499147|Thymoglobulin|thymoglobulin|mesh-list
6159035|NCT01499147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6159036|NCT01499147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6159037|NCT01499147|Antimetabolites|antimetabolites|mesh-ancestor
6159038|NCT01499147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159039|NCT01499147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6159040|NCT01499147|Immunologic Factors|immunologic factors|mesh-ancestor
6159041|NCT01499147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159042|NCT01499147|Antiviral Agents|antiviral agents|mesh-ancestor
6159043|NCT01499147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6159044|NCT01499147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6159045|NCT01499147|Alkylating Agents|alkylating agents|mesh-ancestor
6159046|NCT01499147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6159047|NCT01499199|Dolutegravir|dolutegravir|mesh-list
6159048|NCT01499199|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6159049|NCT01499199|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6159050|NCT01499199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6159051|NCT01499199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159052|NCT01499199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6159053|NCT01499199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6159054|NCT01499199|Antiviral Agents|antiviral agents|mesh-ancestor
6159055|NCT01499199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6159056|NCT01499277|Vancomycin|vancomycin|mesh-list
6159057|NCT01499277|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
6159058|NCT01499277|Aztreonam|aztreonam|mesh-list
6159059|NCT01499277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6159060|NCT01499277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6159061|NCT01499290|Metronidazole|metronidazole|mesh-list
6159062|NCT01499290|Meropenem|meropenem|mesh-list
6159063|NCT01499290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6159064|NCT01499290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6159065|NCT01499290|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6159066|NCT01499290|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6159067|NCT01499355|Mycophenolic Acid|mycophenolic acid|mesh-list
6159068|NCT01499355|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6159069|NCT01499355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6159070|NCT01499355|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6159071|NCT01499355|Antitubercular Agents|antitubercular agents|mesh-ancestor
5558459|NCT04030455|Antimitotic Agents|antimitotic agents|mesh-ancestor
5558460|NCT04030455|Mitosis Modulators|mitosis modulators|mesh-ancestor
5558461|NCT04030455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558462|NCT04030455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5558463|NCT04030091|Insulin|insulin|mesh-list
5558464|NCT04030091|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5558465|NCT04030091|Insulin, Isophane|insulin, isophane|mesh-list
5558466|NCT04030091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5558467|NCT04030091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558468|NCT04029831|Ketamine|ketamine|mesh-list
5558469|NCT04029831|Propofol|propofol|mesh-list
5558470|NCT04029831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6159072|NCT01499355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6159073|NCT01499355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6159074|NCT01499355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5558471|NCT04029831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5558472|NCT04029831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558473|NCT04029831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5558474|NCT04029831|Anesthetics, General|anesthetics, general|mesh-ancestor
5558475|NCT04029831|Anesthetics|anesthetics|mesh-ancestor
6159075|NCT01499355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159076|NCT01499368|Omeprazole|omeprazole|mesh-list
6159077|NCT01499368|Famotidine|famotidine|mesh-list
6159078|NCT01499368|Lafutidine|lafutidine|mesh-list
6159079|NCT01499368|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6159080|NCT01499368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6159081|NCT01499368|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6159082|NCT01499368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6159083|NCT01499368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159084|NCT01499368|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6159085|NCT01499368|Histamine Antagonists|histamine antagonists|mesh-ancestor
6159086|NCT01499368|Histamine Agents|histamine agents|mesh-ancestor
6159087|NCT01499368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6159088|NCT01499368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159089|NCT01499498|Sildenafil Citrate|sildenafil citrate|mesh-list
6159090|NCT01499498|Vasodilator Agents|vasodilator agents|mesh-ancestor
6159091|NCT01499498|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6159092|NCT01499498|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6480776|NCT00544232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6480777|NCT00544232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6480778|NCT00544232|Tubulin Modulators|tubulin modulators|mesh-ancestor
6480779|NCT00544232|Antimitotic Agents|antimitotic agents|mesh-ancestor
6480780|NCT00544232|Mitosis Modulators|mitosis modulators|mesh-ancestor
6480781|NCT00544232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480782|NCT00544232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6159093|NCT01499498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6159094|NCT01499498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159095|NCT01499498|Urological Agents|urological agents|mesh-ancestor
6159096|NCT01499576|Acetic Acid|acetic acid|mesh-list
6159097|NCT01499576|Retinol acetate|retinol acetate|mesh-list
6159098|NCT01499576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5558476|NCT04029831|Analgesics|analgesics|mesh-ancestor
6159099|NCT01499576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6159100|NCT01499576|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6159101|NCT01499576|Immunologic Factors|immunologic factors|mesh-ancestor
6159102|NCT01499576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159103|NCT01499576|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6159104|NCT01499576|Protective Agents|protective agents|mesh-ancestor
6159105|NCT01499576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6159106|NCT01499654|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
6159107|NCT01499654|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6159108|NCT01499654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159109|NCT01499667|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6159110|NCT01499667|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6159111|NCT01499667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159112|NCT01499667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6159113|NCT01499667|Immunologic Factors|immunologic factors|mesh-ancestor
6159114|NCT01499667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159115|NCT01499849|Dexamethasone|dexamethasone|mesh-list
6159116|NCT01499849|Granisetron|granisetron|mesh-list
6159117|NCT01499849|Rolapitant|rolapitant|mesh-list
6159118|NCT01499849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6159119|NCT01499849|Antiemetics|antiemetics|mesh-ancestor
6159120|NCT01499849|Autonomic Agents|autonomic agents|mesh-ancestor
5558477|NCT04029831|Sensory System Agents|sensory system agents|mesh-ancestor
6159121|NCT01499849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6159122|NCT01499849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159123|NCT01499849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6159124|NCT01499849|Glucocorticoids|glucocorticoids|mesh-ancestor
6159125|NCT01499849|Hormones|hormones|mesh-ancestor
6159126|NCT01499849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6159127|NCT01499849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6159128|NCT01499849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6480783|NCT00544232|Immunologic Factors|immunologic factors|mesh-ancestor
5558478|NCT04029831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5558479|NCT04029831|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5558480|NCT04029831|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5558481|NCT04029831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5558482|NCT04029831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5558483|NCT04029831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558484|NCT04029610|Lidocaine|lidocaine|mesh-list
5558485|NCT04029610|Epinephrine|epinephrine|mesh-list
5558486|NCT04029610|Racepinephrine|racepinephrine|mesh-list
5558487|NCT04029610|Epinephryl borate|epinephryl borate|mesh-list
5558488|NCT04029610|Anesthetics, Local|anesthetics, local|mesh-ancestor
5558489|NCT04029610|Anesthetics|anesthetics|mesh-ancestor
5558490|NCT04029610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5558491|NCT04029610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558492|NCT04029610|Sensory System Agents|sensory system agents|mesh-ancestor
5558493|NCT04029610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5558494|NCT04029610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5558495|NCT04029610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5558496|NCT04029610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5558497|NCT04029610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5558498|NCT04029610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558499|NCT04029610|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5558500|NCT04029610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5558501|NCT04029610|Adrenergic Agents|adrenergic agents|mesh-ancestor
5558502|NCT04029610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5558503|NCT04029610|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5558504|NCT04029610|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5558505|NCT04029610|Autonomic Agents|autonomic agents|mesh-ancestor
5558506|NCT04029610|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5558507|NCT04029610|Respiratory System Agents|respiratory system agents|mesh-ancestor
5558508|NCT04029610|Mydriatics|mydriatics|mesh-ancestor
5558509|NCT04029610|Sympathomimetics|sympathomimetics|mesh-ancestor
5558510|NCT04029610|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5558511|NCT04029675|Ascorbic Acid|ascorbic acid|mesh-list
5558512|NCT04029675|Vitamins|vitamins|mesh-ancestor
5558513|NCT04029675|Micronutrients|micronutrients|mesh-ancestor
6159129|NCT01499849|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6159130|NCT01499849|Serotonin Agents|serotonin agents|mesh-ancestor
6159131|NCT01499849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6159132|NCT01499849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159133|NCT01499849|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6159134|NCT01499940|Vitamin D|vitamin d|mesh-list
6159135|NCT01499940|Cholecalciferol|cholecalciferol|mesh-list
6159136|NCT01499940|Vitamins|vitamins|mesh-ancestor
6159137|NCT01499940|Micronutrients|micronutrients|mesh-ancestor
6159138|NCT01499940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159139|NCT01499940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6159140|NCT01499940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6159141|NCT01500083|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6159142|NCT01500083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5558514|NCT04029675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558515|NCT04029675|Antioxidants|antioxidants|mesh-ancestor
5558516|NCT04029675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558517|NCT04029675|Protective Agents|protective agents|mesh-ancestor
5558518|NCT04029636|Xenon|xenon|mesh-list
6159143|NCT01500083|Alkylating Agents|alkylating agents|mesh-ancestor
6159144|NCT01500083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159145|NCT01500083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6159146|NCT01500213|Dexamethasone|dexamethasone|mesh-list
6159147|NCT01500213|Granisetron|granisetron|mesh-list
6159148|NCT01500213|Rolapitant|rolapitant|mesh-list
6159149|NCT01500213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6159150|NCT01500213|Antiemetics|antiemetics|mesh-ancestor
6159151|NCT01500213|Autonomic Agents|autonomic agents|mesh-ancestor
6159152|NCT01500213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6159153|NCT01500213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159154|NCT01500213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6159155|NCT01500213|Glucocorticoids|glucocorticoids|mesh-ancestor
6159156|NCT01500213|Hormones|hormones|mesh-ancestor
6159157|NCT01500213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6159158|NCT01500213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6159159|NCT01500213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6159160|NCT01500213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5558519|NCT04029636|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5558520|NCT04029636|Anesthetics, General|anesthetics, general|mesh-ancestor
5558521|NCT04029636|Anesthetics|anesthetics|mesh-ancestor
5558522|NCT04029636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5558523|NCT04029636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558524|NCT04029428|Octreotide|octreotide|mesh-list
5558525|NCT04029428|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
5558526|NCT04029428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5558527|NCT04029428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558528|NCT04029428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5558529|NCT04029428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5558530|NCT04029428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5603373|NCT02625441|Pertuzumab|pertuzumab|mesh-list
5603374|NCT02625441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6159161|NCT01500213|Serotonin Agents|serotonin agents|mesh-ancestor
6159162|NCT01500213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6159163|NCT01500213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159164|NCT01500213|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6159165|NCT01500226|Dexamethasone|dexamethasone|mesh-list
6159166|NCT01500226|Granisetron|granisetron|mesh-list
6159167|NCT01500226|Rolapitant|rolapitant|mesh-list
6159168|NCT01500226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6159169|NCT01500226|Antiemetics|antiemetics|mesh-ancestor
6159170|NCT01500226|Autonomic Agents|autonomic agents|mesh-ancestor
6159171|NCT01500226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6159172|NCT01500226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603375|NCT02625441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5603376|NCT02564380|Pembrolizumab|pembrolizumab|mesh-list
5603377|NCT02564380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5603378|NCT02564380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5603379|NCT02560298|Paclitaxel|paclitaxel|mesh-list
5603380|NCT02560298|Cisplatin|cisplatin|mesh-list
5603381|NCT02560298|Carboplatin|carboplatin|mesh-list
5603382|NCT02560298|Fluorouracil|fluorouracil|mesh-list
5603383|NCT02560298|Capecitabine|capecitabine|mesh-list
5603384|NCT02560298|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6159173|NCT01500226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6159174|NCT01500226|Glucocorticoids|glucocorticoids|mesh-ancestor
6159175|NCT01500226|Hormones|hormones|mesh-ancestor
6159176|NCT01500226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6159177|NCT01500226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6159178|NCT01500226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6159179|NCT01500226|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6159180|NCT01500226|Serotonin Agents|serotonin agents|mesh-ancestor
6159181|NCT01500226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6159182|NCT01500226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159183|NCT01500226|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6159184|NCT01500278|Adalimumab|adalimumab|mesh-list
6159185|NCT01500278|Methotrexate|methotrexate|mesh-list
6480784|NCT00544232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603385|NCT02560298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5603386|NCT02560298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6159186|NCT01500278|Certolizumab Pegol|certolizumab pegol|mesh-list
5558531|NCT04029454|Vaccines|vaccines|mesh-list
5558532|NCT04029454|Immunologic Factors|immunologic factors|mesh-ancestor
5558533|NCT04029454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558534|NCT04029350|Osimertinib|osimertinib|mesh-list
5558535|NCT04029350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5558536|NCT04029350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5558537|NCT04029350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5558538|NCT04029350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558539|NCT04029467|Dexmedetomidine|dexmedetomidine|mesh-list
5558540|NCT04029467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5558541|NCT04029467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5558542|NCT04029467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558543|NCT04029467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6159187|NCT01500278|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6159188|NCT01500278|Abortifacient Agents|abortifacient agents|mesh-ancestor
6159189|NCT01500278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6159190|NCT01500278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159191|NCT01500278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6159192|NCT01500278|Antimetabolites|antimetabolites|mesh-ancestor
5558544|NCT04029467|Analgesics|analgesics|mesh-ancestor
5558545|NCT04029467|Sensory System Agents|sensory system agents|mesh-ancestor
5558546|NCT04029467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5558547|NCT04029467|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5558548|NCT04029467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5558549|NCT04029467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5558550|NCT04029467|Adrenergic Agents|adrenergic agents|mesh-ancestor
5558551|NCT04029467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5558552|NCT04029467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558553|NCT04029090|Edaravone|edaravone|mesh-list
5558554|NCT04029090|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5558555|NCT04029090|Antioxidants|antioxidants|mesh-ancestor
5558556|NCT04029090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558557|NCT04029090|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5558558|NCT04029090|Protective Agents|protective agents|mesh-ancestor
5558559|NCT04029090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558560|NCT04029116|Fluconazole|fluconazole|mesh-list
5558561|NCT04029116|Ibrexafungerp|ibrexafungerp|mesh-list
5558562|NCT04029116|Antifungal Agents|antifungal agents|mesh-ancestor
5558563|NCT04029116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6159193|NCT01500278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159194|NCT01500278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6159195|NCT01500278|Dermatologic Agents|dermatologic agents|mesh-ancestor
6159196|NCT01500278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6159197|NCT01500278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6159198|NCT01500278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6159199|NCT01500278|Immunologic Factors|immunologic factors|mesh-ancestor
6159200|NCT01500278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6159201|NCT01500278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6480785|NCT00544232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6480786|NCT00544232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5558564|NCT04029116|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5558565|NCT04029116|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5558566|NCT04029116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5558567|NCT04029116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558568|NCT04029116|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5558569|NCT04029116|Hormone Antagonists|hormone antagonists|mesh-ancestor
5558570|NCT04029116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5558571|NCT04029116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558572|NCT04029116|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5558573|NCT04029116|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5558574|NCT04029272|Metformin|metformin|mesh-list
5558575|NCT04029272|Exenatide|exenatide|mesh-list
5558576|NCT04029272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5558577|NCT04029272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159202|NCT01500278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6480787|NCT00544232|Alkylating Agents|alkylating agents|mesh-ancestor
6480788|NCT00544232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6480789|NCT00544232|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6480790|NCT00544232|Abortifacient Agents|abortifacient agents|mesh-ancestor
6480791|NCT00544232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6159203|NCT01500317|Oxycodone|oxycodone|mesh-list
6159204|NCT01500317|Tapentadol|tapentadol|mesh-list
6159205|NCT01500317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6159206|NCT01500317|Narcotics|narcotics|mesh-ancestor
6159207|NCT01500317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6159208|NCT01500317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558578|NCT04029272|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5558579|NCT04029272|Incretins|incretins|mesh-ancestor
5558580|NCT04029272|Hormones|hormones|mesh-ancestor
5558581|NCT04029272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5558582|NCT04028986|Ulipristal acetate|ulipristal acetate|mesh-list
5558583|NCT04028986|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5558584|NCT04028986|Contraceptive Agents|contraceptive agents|mesh-ancestor
5558585|NCT04028986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5558586|NCT04028986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558587|NCT04028986|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5558588|NCT04028778|Gefitinib|gefitinib|mesh-list
5558589|NCT04028778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5558590|NCT04028778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5558591|NCT04028778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5558592|NCT04028778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558593|NCT04028856|Interferons|interferons|mesh-list
5558594|NCT04028856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5558595|NCT04028856|Antiviral Agents|antiviral agents|mesh-ancestor
5558596|NCT04028856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5558597|NCT04028830|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6159209|NCT01500317|Analgesics|analgesics|mesh-ancestor
6159210|NCT01500317|Sensory System Agents|sensory system agents|mesh-ancestor
6159211|NCT01500317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6159212|NCT01500317|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6159213|NCT01500317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6159214|NCT01500317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6159215|NCT01500317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159216|NCT01500317|Adrenergic Agents|adrenergic agents|mesh-ancestor
6159217|NCT01500317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6159218|NCT01500382|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6159219|NCT01500382|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6159220|NCT01500382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6159221|NCT01500382|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6159222|NCT01500382|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6159223|NCT01500382|Cholinergic Agents|cholinergic agents|mesh-ancestor
6159224|NCT01500382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6159225|NCT01500382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159226|NCT01500382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159227|NCT01500382|Urological Agents|urological agents|mesh-ancestor
6159228|NCT01500434|Aspirin|aspirin|mesh-list
6159229|NCT01500434|Ticlopidine|ticlopidine|mesh-list
6159230|NCT01500434|Clopidogrel|clopidogrel|mesh-list
6159231|NCT01500434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6159232|NCT01500434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6159233|NCT01500434|Analgesics|analgesics|mesh-ancestor
6159234|NCT01500434|Sensory System Agents|sensory system agents|mesh-ancestor
6159235|NCT01500434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6159236|NCT01500434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159237|NCT01500434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6668369|NCT01531764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558598|NCT04028830|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6159238|NCT01500434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6159239|NCT01500434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6159240|NCT01500434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6159241|NCT01500434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159242|NCT01500434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5558599|NCT04028830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5558600|NCT04028830|Antitubercular Agents|antitubercular agents|mesh-ancestor
5558601|NCT04028765|Misoprostol|misoprostol|mesh-list
6480792|NCT00544232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6480793|NCT00544232|Antimetabolites|antimetabolites|mesh-ancestor
6480794|NCT00544232|Dermatologic Agents|dermatologic agents|mesh-ancestor
6159243|NCT01500434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6480795|NCT00544232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6480796|NCT00544232|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6480797|NCT00544232|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6480798|NCT00544232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6480799|NCT00544232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6480800|NCT00544232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6480801|NCT00544232|Hematinics|hematinics|mesh-ancestor
6480802|NCT00544284|Bortezomib|bortezomib|mesh-list
6159244|NCT01500434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6159245|NCT01500434|Antipyretics|antipyretics|mesh-ancestor
6159246|NCT01500434|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6159247|NCT01500434|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6159248|NCT01500434|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6159249|NCT01500434|Purinergic Agents|purinergic agents|mesh-ancestor
6159250|NCT01500434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6159251|NCT01500434|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6159252|NCT01500434|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6159253|NCT01500694|Guanfacine|guanfacine|mesh-list
6159254|NCT01500694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6159255|NCT01500694|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6159256|NCT01500694|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6159257|NCT01500694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6159258|NCT01500694|Adrenergic Agents|adrenergic agents|mesh-ancestor
6480803|NCT00544284|Temozolomide|temozolomide|mesh-list
6480804|NCT00544284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6480805|NCT00544284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6480806|NCT00544284|Alkylating Agents|alkylating agents|mesh-ancestor
6480807|NCT00544284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558602|NCT04028765|Oxytocin|oxytocin|mesh-list
5558603|NCT04028765|Oxytocics|oxytocics|mesh-ancestor
5558604|NCT04028765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5558605|NCT04028765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558606|NCT04028765|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5558607|NCT04028765|Abortifacient Agents|abortifacient agents|mesh-ancestor
5558608|NCT04028765|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5558609|NCT04028765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5558610|NCT04028804|Deoxyglucose|deoxyglucose|mesh-list
5558611|NCT04028804|Fluorides|fluorides|mesh-list
5558612|NCT04028804|Cariostatic Agents|cariostatic agents|mesh-ancestor
5558613|NCT04028804|Protective Agents|protective agents|mesh-ancestor
6159259|NCT01500694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6159260|NCT01500694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159261|NCT01500694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159262|NCT01500720|Topotecan|topotecan|mesh-list
6159263|NCT01500720|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6159264|NCT01500720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6159265|NCT01500720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6159266|NCT01500720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159267|NCT01500720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6159268|NCT01501110|Acetylcysteine|acetylcysteine|mesh-list
5558614|NCT04028804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558615|NCT04028804|Antimetabolites|antimetabolites|mesh-ancestor
5558616|NCT04028804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558617|NCT04028804|Antiviral Agents|antiviral agents|mesh-ancestor
5558618|NCT04028804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5558619|NCT04028739|Curcumin|curcumin|mesh-list
5558620|NCT04028739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5558621|NCT04028739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5558622|NCT04028739|Analgesics|analgesics|mesh-ancestor
5558623|NCT04028739|Sensory System Agents|sensory system agents|mesh-ancestor
5558624|NCT04028739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5558625|NCT04028739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558626|NCT04028739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6159269|NCT01501110|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6159270|NCT01501110|Antiviral Agents|antiviral agents|mesh-ancestor
6159271|NCT01501110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6159272|NCT01501110|Expectorants|expectorants|mesh-ancestor
6159273|NCT01501110|Respiratory System Agents|respiratory system agents|mesh-ancestor
6159274|NCT01501110|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6159275|NCT01501110|Antioxidants|antioxidants|mesh-ancestor
6159276|NCT01501110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159277|NCT01501110|Protective Agents|protective agents|mesh-ancestor
6159278|NCT01501110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159279|NCT01501110|Antidotes|antidotes|mesh-ancestor
6159280|NCT01501162|Ethanol|ethanol|mesh-list
6159281|NCT01501162|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6159282|NCT01501162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6159283|NCT01501162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6159284|NCT01501162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159285|NCT01501929|Metoprolol|metoprolol|mesh-list
6159286|NCT01501929|Nebivolol|nebivolol|mesh-list
6159287|NCT01501929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6159288|NCT01501929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6668370|NCT01531764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6668371|NCT01531764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6668372|NCT01531777|Apatinib|apatinib|mesh-list
6159289|NCT01501929|Sympatholytics|sympatholytics|mesh-ancestor
6159290|NCT01501929|Autonomic Agents|autonomic agents|mesh-ancestor
6159291|NCT01501929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6159292|NCT01501929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159293|NCT01501929|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6159294|NCT01501929|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6480808|NCT00544349|Leucovorin|leucovorin|mesh-list
6480809|NCT00544349|Fluorouracil|fluorouracil|mesh-list
6480810|NCT00544349|Oxaliplatin|oxaliplatin|mesh-list
6480811|NCT00544349|Cetuximab|cetuximab|mesh-list
5558627|NCT04028739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5558628|NCT04028739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5558629|NCT04028739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5558630|NCT04028739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159295|NCT01501929|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6159296|NCT01501929|Adrenergic Agents|adrenergic agents|mesh-ancestor
6159297|NCT01501929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6159298|NCT01501929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159299|NCT01501929|Vasodilator Agents|vasodilator agents|mesh-ancestor
6159300|NCT01501929|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6159301|NCT01501929|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6159302|NCT01501929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6159303|NCT01502072|Ribavirin|ribavirin|mesh-list
6159304|NCT01502072|Antimetabolites|antimetabolites|mesh-ancestor
6159305|NCT01502072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159306|NCT01502072|Antiviral Agents|antiviral agents|mesh-ancestor
6159307|NCT01502072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6159308|NCT01502228|Sunitinib|sunitinib|mesh-list
6159309|NCT01502228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6159310|NCT01502228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5558631|NCT04028869|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
5558632|NCT04028869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5558633|NCT04029038|Cyclophosphamide|cyclophosphamide|mesh-list
5558634|NCT04029038|Fludarabine|fludarabine|mesh-list
5558635|NCT04029038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5558636|NCT04029038|Immunologic Factors|immunologic factors|mesh-ancestor
5558637|NCT04029038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558638|NCT04029038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5558639|NCT04029038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5558640|NCT04029038|Alkylating Agents|alkylating agents|mesh-ancestor
5558641|NCT04029038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558642|NCT04029038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5558643|NCT04029038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6159311|NCT01502228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6159312|NCT01502228|Growth Substances|growth substances|mesh-ancestor
6159313|NCT01502228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159314|NCT01502228|Growth Inhibitors|growth inhibitors|mesh-ancestor
6159315|NCT01502228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6159316|NCT01502228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6159317|NCT01502228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159318|NCT01502293|Interleukin-12|interleukin-12|mesh-list
6159319|NCT01502293|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6159320|NCT01502293|Immunologic Factors|immunologic factors|mesh-ancestor
6159321|NCT01502293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159322|NCT01502293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5558644|NCT04028622|Anesthetics|anesthetics|mesh-list
5558645|NCT04028622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5558646|NCT04028622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558647|NCT04028596|Acetaminophen|acetaminophen|mesh-list
5558648|NCT04028596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5558649|NCT04028596|Analgesics|analgesics|mesh-ancestor
6159323|NCT01502293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6159324|NCT01502293|Growth Substances|growth substances|mesh-ancestor
6159325|NCT01502293|Growth Inhibitors|growth inhibitors|mesh-ancestor
6159326|NCT01502293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6159327|NCT01502306|Nicotine|nicotine|mesh-list
6480812|NCT00544349|Calcium|calcium|mesh-list
6480813|NCT00544349|Levoleucovorin|levoleucovorin|mesh-list
6480814|NCT00544349|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6480815|NCT00544349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480816|NCT00544349|Antimetabolites|antimetabolites|mesh-ancestor
6480817|NCT00544349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159328|NCT01502306|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6159329|NCT01502306|Autonomic Agents|autonomic agents|mesh-ancestor
6159330|NCT01502306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6159331|NCT01502306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159332|NCT01502306|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6159333|NCT01502306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6159334|NCT01502306|Cholinergic Agents|cholinergic agents|mesh-ancestor
5558650|NCT04028596|Sensory System Agents|sensory system agents|mesh-ancestor
5558651|NCT04028596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5558652|NCT04028596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558653|NCT04028596|Antipyretics|antipyretics|mesh-ancestor
5558654|NCT04028505|Terlipressin|terlipressin|mesh-list
5558655|NCT04028505|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5558656|NCT04028505|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5558657|NCT04028518|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5558658|NCT04028518|Plasminogen|plasminogen|mesh-list
6159335|NCT01502306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6159336|NCT01502306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159337|NCT01502410|Sorafenib|sorafenib|mesh-list
6159338|NCT01502410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6159339|NCT01502410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6159340|NCT01502410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6159341|NCT01502410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159342|NCT01502423|Adalimumab|adalimumab|mesh-list
5558659|NCT04028518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5558660|NCT04028518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5558661|NCT04028518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558662|NCT04028245|Spartalizumab|spartalizumab|mesh-list
5558663|NCT04028245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5558664|NCT04028245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558665|NCT04028245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5558666|NCT04028323|Octreotide|octreotide|mesh-list
5558667|NCT04028323|Terlipressin|terlipressin|mesh-list
5558668|NCT04028323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5558669|NCT04028323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5558670|NCT04028323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5558671|NCT04028323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5558672|NCT04028323|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5558673|NCT04028466|Omeprazole|omeprazole|mesh-list
5558674|NCT04028466|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5558675|NCT04028466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5558676|NCT04028466|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5558677|NCT04028466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5558678|NCT04028466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558679|NCT04028141|Ketamine|ketamine|mesh-list
5558680|NCT04028141|Propofol|propofol|mesh-list
5558681|NCT04028141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5558682|NCT04028141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5558683|NCT04028141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558684|NCT04028141|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5558685|NCT04028141|Anesthetics, General|anesthetics, general|mesh-ancestor
5558686|NCT04028141|Anesthetics|anesthetics|mesh-ancestor
5558687|NCT04028141|Analgesics|analgesics|mesh-ancestor
5558688|NCT04028141|Sensory System Agents|sensory system agents|mesh-ancestor
5558689|NCT04028141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6159343|NCT01502423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6159344|NCT01502423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6159345|NCT01502644|Morphine|morphine|mesh-list
6159346|NCT01502644|Oxycodone|oxycodone|mesh-list
5558690|NCT04028141|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5558691|NCT04028141|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5558692|NCT04028141|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5558693|NCT04028141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6159347|NCT01502644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6159348|NCT01502644|Narcotics|narcotics|mesh-ancestor
6159349|NCT01502644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6480818|NCT00544349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6480819|NCT00544349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6480820|NCT00544349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6480821|NCT00544349|Immunologic Factors|immunologic factors|mesh-ancestor
5558694|NCT04028141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159350|NCT01502644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159351|NCT01502644|Analgesics|analgesics|mesh-ancestor
5558695|NCT04027972|Glycopyrrolate|glycopyrrolate|mesh-list
6159352|NCT01502644|Sensory System Agents|sensory system agents|mesh-ancestor
6480822|NCT00544349|Antidotes|antidotes|mesh-ancestor
5558696|NCT04027972|Neostigmine|neostigmine|mesh-list
5558697|NCT04027972|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5558698|NCT04027972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5558699|NCT04027972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558700|NCT04027972|Cholinergic Agents|cholinergic agents|mesh-ancestor
6159353|NCT01502644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6159354|NCT01502761|Magnesium Sulfate|magnesium sulfate|mesh-list
6159355|NCT01502761|Analgesics|analgesics|mesh-ancestor
5558701|NCT04027972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5558702|NCT04027972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558703|NCT04027972|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5558704|NCT04027972|Autonomic Agents|autonomic agents|mesh-ancestor
5558705|NCT04027972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5558706|NCT04027972|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5558707|NCT04027972|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5558708|NCT04027972|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5558709|NCT04027829|Dexmedetomidine|dexmedetomidine|mesh-list
5558710|NCT04027829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6159356|NCT01502761|Sensory System Agents|sensory system agents|mesh-ancestor
6159357|NCT01502761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6159358|NCT01502761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159359|NCT01502761|Anesthetics|anesthetics|mesh-ancestor
6159360|NCT01502761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6159361|NCT01502761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6159362|NCT01502761|Anticonvulsants|anticonvulsants|mesh-ancestor
6159363|NCT01502761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6159364|NCT01502761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5558711|NCT04027829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5558712|NCT04027829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558713|NCT04027829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5558714|NCT04027829|Analgesics|analgesics|mesh-ancestor
5558715|NCT04027829|Sensory System Agents|sensory system agents|mesh-ancestor
5558716|NCT04027829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5558717|NCT04027829|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5558718|NCT04027829|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5558719|NCT04027829|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5558720|NCT04027829|Adrenergic Agents|adrenergic agents|mesh-ancestor
5558721|NCT04027829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5558722|NCT04027829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558723|NCT04027764|Paclitaxel|paclitaxel|mesh-list
5558724|NCT04027764|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5558725|NCT04027764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5558726|NCT04027764|Tubulin Modulators|tubulin modulators|mesh-ancestor
5558727|NCT04027764|Antimitotic Agents|antimitotic agents|mesh-ancestor
5558728|NCT04027764|Mitosis Modulators|mitosis modulators|mesh-ancestor
5558729|NCT04027764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558730|NCT04027751|Tropisetron|tropisetron|mesh-list
5558731|NCT04027751|Antiemetics|antiemetics|mesh-ancestor
5558732|NCT04027751|Autonomic Agents|autonomic agents|mesh-ancestor
6159365|NCT01502761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159366|NCT01502761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6159367|NCT01502761|Tocolytic Agents|tocolytic agents|mesh-ancestor
6159368|NCT01502761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6159369|NCT01502787|Metoprolol|metoprolol|mesh-list
6159370|NCT01502787|Nebivolol|nebivolol|mesh-list
6159371|NCT01502787|Angiotensin II|angiotensin ii|mesh-list
6159372|NCT01502787|Giapreza|giapreza|mesh-list
6159373|NCT01502787|Angiotensinogen|angiotensinogen|mesh-list
6159374|NCT01502787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6159375|NCT01502787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6159376|NCT01502787|Sympatholytics|sympatholytics|mesh-ancestor
6159377|NCT01502787|Autonomic Agents|autonomic agents|mesh-ancestor
6159378|NCT01502787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6159379|NCT01502787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159380|NCT01502787|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6159381|NCT01502787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6159382|NCT01502787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6159383|NCT01502787|Adrenergic Agents|adrenergic agents|mesh-ancestor
6159384|NCT01502787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6159385|NCT01502787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159386|NCT01502787|Vasodilator Agents|vasodilator agents|mesh-ancestor
6159387|NCT01502787|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6159388|NCT01502787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5558733|NCT04027751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5558734|NCT04027751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558735|NCT04027751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5558736|NCT04027751|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5558737|NCT04027751|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5558738|NCT04027751|Serotonin Agents|serotonin agents|mesh-ancestor
5558739|NCT04027751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5558740|NCT04027751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558741|NCT04028024|Urinastatin|urinastatin|mesh-list
5558742|NCT04028024|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5558743|NCT04028024|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6159389|NCT01502787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6159390|NCT01502787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6159391|NCT01502787|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6159392|NCT01502787|Protease Inhibitors|protease inhibitors|mesh-ancestor
6159393|NCT01502787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6159394|NCT01502813|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
6159395|NCT01502813|Nootropic Agents|nootropic agents|mesh-ancestor
6159396|NCT01502956|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6159397|NCT01502956|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6159398|NCT01502956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6480823|NCT00544349|Protective Agents|protective agents|mesh-ancestor
6480824|NCT00544349|Vitamin B Complex|vitamin b complex|mesh-ancestor
6480825|NCT00544349|Vitamins|vitamins|mesh-ancestor
5558744|NCT04028024|Protease Inhibitors|protease inhibitors|mesh-ancestor
5558745|NCT04028024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5558746|NCT04028024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558747|NCT04027959|Vitamin B 12|vitamin b 12|mesh-list
5558748|NCT04027959|Hydroxocobalamin|hydroxocobalamin|mesh-list
5558749|NCT04027959|Vitamins|vitamins|mesh-ancestor
5558750|NCT04027959|Micronutrients|micronutrients|mesh-ancestor
5558751|NCT04027959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558752|NCT04027959|Vitamin B Complex|vitamin b complex|mesh-ancestor
5558753|NCT04027959|Hematinics|hematinics|mesh-ancestor
5603387|NCT02560298|Tubulin Modulators|tubulin modulators|mesh-ancestor
6480826|NCT00544349|Micronutrients|micronutrients|mesh-ancestor
6480827|NCT00544349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6480828|NCT00544362|Fluorouracil|fluorouracil|mesh-list
6480829|NCT00544362|Cetuximab|cetuximab|mesh-list
6480830|NCT00544362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6480831|NCT00544362|Antimetabolites|antimetabolites|mesh-ancestor
6480832|NCT00544362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480833|NCT00544362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6480834|NCT00544362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6480835|NCT00544362|Immunologic Factors|immunologic factors|mesh-ancestor
6480836|NCT00544362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480837|NCT00544362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6480838|NCT00544388|Levocetirizine|levocetirizine|mesh-list
6159399|NCT01502956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159400|NCT01502956|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6159401|NCT01502956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6159402|NCT01502956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159403|NCT01502956|Cholinergic Agents|cholinergic agents|mesh-ancestor
6159404|NCT01502956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6159405|NCT01503229|Prednisone|prednisone|mesh-list
6159406|NCT01503229|Cortisone|cortisone|mesh-list
6480839|NCT00544388|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6480840|NCT00544388|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6480841|NCT00544388|Histamine Antagonists|histamine antagonists|mesh-ancestor
6480842|NCT00544388|Histamine Agents|histamine agents|mesh-ancestor
6480843|NCT00544388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6480844|NCT00544388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480845|NCT00544388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480846|NCT00544466|Fludarabine|fludarabine|mesh-list
6480847|NCT00544466|Fludarabine phosphate|fludarabine phosphate|mesh-list
6480848|NCT00544466|Melphalan|melphalan|mesh-list
6480849|NCT00544466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6480850|NCT00544466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6480851|NCT00544466|Antimetabolites|antimetabolites|mesh-ancestor
6480852|NCT00544466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480853|NCT00544466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6480854|NCT00544466|Immunologic Factors|immunologic factors|mesh-ancestor
6480855|NCT00544466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480856|NCT00544466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6480857|NCT00544466|Alkylating Agents|alkylating agents|mesh-ancestor
6480858|NCT00544466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5558754|NCT04027517|Darbepoetin alfa|darbepoetin alfa|mesh-list
5558755|NCT04027517|Hematinics|hematinics|mesh-ancestor
5558756|NCT04027530|Ertugliflozin|ertugliflozin|mesh-list
6159407|NCT01503229|Abiraterone Acetate|abiraterone acetate|mesh-list
6159408|NCT01503229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6159409|NCT01503229|Glucocorticoids|glucocorticoids|mesh-ancestor
6668373|NCT01531777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6668374|NCT01531777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6480859|NCT00544505|Cyclophosphamide|cyclophosphamide|mesh-list
6480860|NCT00544505|Fluorouracil|fluorouracil|mesh-list
6480861|NCT00544505|Epirubicin|epirubicin|mesh-list
6480862|NCT00544505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6480863|NCT00544505|Immunologic Factors|immunologic factors|mesh-ancestor
6480864|NCT00544505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159410|NCT01503229|Hormones|hormones|mesh-ancestor
6159411|NCT01503229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6159412|NCT01503229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159413|NCT01503229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6159414|NCT01503229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6159415|NCT01503229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6159416|NCT01503229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6480865|NCT00544505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5558757|NCT04027530|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5558758|NCT04027530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558759|NCT04027530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5558760|NCT04027530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558761|NCT04027894|Rifamycins|rifamycins|mesh-list
5558762|NCT04027894|Rifamycin SV|rifamycin sv|mesh-list
5558763|NCT04027894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5558764|NCT04027894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5558765|NCT04027894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5558766|NCT04027322|Dexamethasone|dexamethasone|mesh-list
5558767|NCT04027322|Budesonide|budesonide|mesh-list
5558768|NCT04027322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5558769|NCT04027322|Antiemetics|antiemetics|mesh-ancestor
5558770|NCT04027322|Autonomic Agents|autonomic agents|mesh-ancestor
5558771|NCT04027322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5558772|NCT04027322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558773|NCT04027322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6480866|NCT00544505|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5558774|NCT04027322|Glucocorticoids|glucocorticoids|mesh-ancestor
6159417|NCT01503229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159418|NCT01503229|Hormone Antagonists|hormone antagonists|mesh-ancestor
6159419|NCT01503229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6159420|NCT01503749|Lenograstim|lenograstim|mesh-list
6159421|NCT01503749|Sargramostim|sargramostim|mesh-list
5558775|NCT04027322|Hormones|hormones|mesh-ancestor
5558776|NCT04027322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5558777|NCT04027322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5558778|NCT04027322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5558779|NCT04027322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5558780|NCT04027322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5558781|NCT04027322|Respiratory System Agents|respiratory system agents|mesh-ancestor
5558782|NCT04027309|Midostaurin|midostaurin|mesh-list
5558783|NCT04027309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5558784|NCT04027309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5558785|NCT04027309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5558786|NCT04027309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558787|NCT04027192|Midazolam|midazolam|mesh-list
5558788|NCT04027192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5558789|NCT04027192|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5558790|NCT04027192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5558791|NCT04027192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159422|NCT01503749|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6159423|NCT01503749|Immunologic Factors|immunologic factors|mesh-ancestor
6159424|NCT01503749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159425|NCT01504204|Adapalene|adapalene|mesh-list
6159426|NCT01504204|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
6159427|NCT01504204|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6159428|NCT01504204|Dermatologic Agents|dermatologic agents|mesh-ancestor
6159429|NCT01504204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5558792|NCT04027192|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6480867|NCT00544505|Alkylating Agents|alkylating agents|mesh-ancestor
5558793|NCT04027192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5558794|NCT04027192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5558795|NCT04027192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5558796|NCT04027192|Anesthetics, General|anesthetics, general|mesh-ancestor
5558797|NCT04027192|Anesthetics|anesthetics|mesh-ancestor
5558798|NCT04027192|GABA Modulators|gaba modulators|mesh-ancestor
5558799|NCT04027192|GABA Agents|gaba agents|mesh-ancestor
5558800|NCT04027192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5558801|NCT04027192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558802|NCT04027179|Chlorhexidine|chlorhexidine|mesh-list
5558803|NCT04027179|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5558804|NCT04027179|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5558805|NCT04027179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5558806|NCT04027179|Disinfectants|disinfectants|mesh-ancestor
5558807|NCT04027179|Dermatologic Agents|dermatologic agents|mesh-ancestor
5558808|NCT04026984|Rifamycins|rifamycins|mesh-list
5558809|NCT04026984|Rifamycin SV|rifamycin sv|mesh-list
5558810|NCT04026984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5558811|NCT04026984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5558812|NCT04026984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5558813|NCT04026958|Clarithromycin|clarithromycin|mesh-list
5558814|NCT04026958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5558815|NCT04026958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5558816|NCT04026958|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5558817|NCT04026958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5558818|NCT04026958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558819|NCT04026958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5558820|NCT04026958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6159430|NCT01504204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6159431|NCT01504204|Analgesics|analgesics|mesh-ancestor
6159432|NCT01504204|Sensory System Agents|sensory system agents|mesh-ancestor
6159433|NCT01504204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6159434|NCT01504204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159435|NCT01504204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6159436|NCT01504204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6159437|NCT01504412|Pregabalin|pregabalin|mesh-list
6159438|NCT01504412|Analgesics|analgesics|mesh-ancestor
6159439|NCT01504412|Sensory System Agents|sensory system agents|mesh-ancestor
6159440|NCT01504412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6159441|NCT01504412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159442|NCT01504412|Anticonvulsants|anticonvulsants|mesh-ancestor
6159443|NCT01504412|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6159444|NCT01504412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6159445|NCT01504412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159446|NCT01504412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6159447|NCT01504412|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6668375|NCT01531777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5558821|NCT04027166|Methadone|methadone|mesh-list
5558822|NCT04027166|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5558823|NCT04027166|Narcotics|narcotics|mesh-ancestor
5558824|NCT04027166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5558825|NCT04027166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558826|NCT04027166|Analgesics|analgesics|mesh-ancestor
5558827|NCT04027166|Sensory System Agents|sensory system agents|mesh-ancestor
5558828|NCT04027166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5558829|NCT04027166|Antitussive Agents|antitussive agents|mesh-ancestor
6159448|NCT01504412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6159449|NCT01504412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6159450|NCT01504412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6159451|NCT01504477|Bortezomib|bortezomib|mesh-list
6159452|NCT01504477|Panitumumab|panitumumab|mesh-list
6159453|NCT01504477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6159454|NCT01504477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6206036|NCT02096081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558830|NCT04027166|Respiratory System Agents|respiratory system agents|mesh-ancestor
5558831|NCT04026880|Methyltestosterone|methyltestosterone|mesh-list
5558832|NCT04026880|Testosterone|testosterone|mesh-list
5558833|NCT04026880|Testosterone undecanoate|testosterone undecanoate|mesh-list
5558834|NCT04026880|Testosterone enanthate|testosterone enanthate|mesh-list
5558835|NCT04026880|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5558836|NCT04026880|Androgens|androgens|mesh-ancestor
5558837|NCT04026880|Hormones|hormones|mesh-ancestor
5558838|NCT04026880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5558839|NCT04026880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558840|NCT04026880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5558841|NCT04026880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5558842|NCT04026880|Anabolic Agents|anabolic agents|mesh-ancestor
5558843|NCT04027283|Erythritol|erythritol|mesh-list
5558844|NCT04027283|Vasodilator Agents|vasodilator agents|mesh-ancestor
5558845|NCT04026841|Antibodies|antibodies|mesh-list
5558846|NCT04026841|Immunologic Factors|immunologic factors|mesh-ancestor
6159455|NCT01504711|Fosaprepitant|fosaprepitant|mesh-list
6159456|NCT01504711|Aprepitant|aprepitant|mesh-list
6159457|NCT01504711|Antiemetics|antiemetics|mesh-ancestor
6159458|NCT01504711|Autonomic Agents|autonomic agents|mesh-ancestor
6159459|NCT01504711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6159460|NCT01504711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159461|NCT01504711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6159462|NCT01504711|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6159463|NCT01504711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6159464|NCT01504711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159465|NCT01504841|Etravirine|etravirine|mesh-list
6159466|NCT01504841|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6159467|NCT01504841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6159468|NCT01504841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6159469|NCT01504841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159470|NCT01504841|Antiviral Agents|antiviral agents|mesh-ancestor
6159471|NCT01504841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6480868|NCT00544505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480869|NCT00544505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6480870|NCT00544505|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6480871|NCT00544505|Antimetabolites|antimetabolites|mesh-ancestor
6480872|NCT00544505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6480873|NCT00544505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6480874|NCT00544505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6480875|NCT00544505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6480876|NCT00544505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6480877|NCT00544518|Metformin|metformin|mesh-list
6480878|NCT00544518|Benfluorex|benfluorex|mesh-list
6480879|NCT00544518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6480880|NCT00544518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480881|NCT00544518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6480882|NCT00544518|Antimetabolites|antimetabolites|mesh-ancestor
6480883|NCT00544518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480884|NCT00544518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6480885|NCT00544518|Appetite Depressants|appetite depressants|mesh-ancestor
6480886|NCT00544518|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6480887|NCT00544570|Cyclophosphamide|cyclophosphamide|mesh-list
6480888|NCT00544570|Melphalan|melphalan|mesh-list
6480889|NCT00544570|Carmustine|carmustine|mesh-list
6480890|NCT00544570|Etoposide|etoposide|mesh-list
6480891|NCT00544570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6480892|NCT00544570|Immunologic Factors|immunologic factors|mesh-ancestor
6480893|NCT00544570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480894|NCT00544570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6480895|NCT00544570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6480896|NCT00544570|Alkylating Agents|alkylating agents|mesh-ancestor
6480897|NCT00544570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480898|NCT00544570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6480899|NCT00544570|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6480900|NCT00544570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6480901|NCT00544570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6480902|NCT00544570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6480903|NCT00544570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6480904|NCT00544596|Acetic Acid|acetic acid|mesh-list
5558847|NCT04026841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558848|NCT04026568|4-Aminopyridine|4-aminopyridine|mesh-list
5558849|NCT04026568|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6480905|NCT00544596|Etoposide|etoposide|mesh-list
6159472|NCT01504854|Resveratrol|resveratrol|mesh-list
6480906|NCT00544596|Etoposide phosphate|etoposide phosphate|mesh-list
6480907|NCT00544596|Retinol acetate|retinol acetate|mesh-list
6480908|NCT00544596|Gossypol acetic acid|gossypol acetic acid|mesh-list
6480909|NCT00544596|Gossypol|gossypol|mesh-list
6480910|NCT00544596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6480911|NCT00544596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6480912|NCT00544596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6480913|NCT00544596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6480914|NCT00544596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6480915|NCT00544596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480916|NCT00544596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5558850|NCT04026568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5558851|NCT04026568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558852|NCT04026776|Allopurinol|allopurinol|mesh-list
6159473|NCT01504854|Antioxidants|antioxidants|mesh-ancestor
6159474|NCT01504854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159475|NCT01504854|Protective Agents|protective agents|mesh-ancestor
6159476|NCT01504854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159477|NCT01504854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6159478|NCT01504854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6159479|NCT01504867|Aspirin|aspirin|mesh-list
6159480|NCT01504867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6159481|NCT01504867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6159482|NCT01504867|Analgesics|analgesics|mesh-ancestor
6159483|NCT01504867|Sensory System Agents|sensory system agents|mesh-ancestor
6480917|NCT00544596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6480918|NCT00544596|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6480919|NCT00544596|Immunologic Factors|immunologic factors|mesh-ancestor
6480920|NCT00544596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480921|NCT00544596|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6480922|NCT00544596|Protective Agents|protective agents|mesh-ancestor
6480923|NCT00544596|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6480924|NCT00544596|Contraceptive Agents|contraceptive agents|mesh-ancestor
6480925|NCT00544596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6480926|NCT00544596|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5558853|NCT04026776|Antimetabolites|antimetabolites|mesh-ancestor
5558854|NCT04026776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558855|NCT04026776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5558856|NCT04026776|Gout Suppressants|gout suppressants|mesh-ancestor
5558857|NCT04026776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5558858|NCT04026776|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5558859|NCT04026776|Antioxidants|antioxidants|mesh-ancestor
5558860|NCT04026776|Protective Agents|protective agents|mesh-ancestor
5558861|NCT04026776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558862|NCT04026685|Phenylephrine|phenylephrine|mesh-list
5558863|NCT04026685|Oxymetazoline|oxymetazoline|mesh-list
5558864|NCT04026685|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6480927|NCT00544596|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
6480928|NCT00544596|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
6480929|NCT00544609|Sorafenib|sorafenib|mesh-list
6480930|NCT00544609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6480931|NCT00544609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6480932|NCT00544609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6480933|NCT00544609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480934|NCT00544687|Mometasone Furoate|mometasone furoate|mesh-list
6480935|NCT00544687|Nortriptyline|nortriptyline|mesh-list
6480936|NCT00544687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6480937|NCT00544687|Dermatologic Agents|dermatologic agents|mesh-ancestor
5558865|NCT04026685|Mydriatics|mydriatics|mesh-ancestor
5558866|NCT04026685|Autonomic Agents|autonomic agents|mesh-ancestor
5558867|NCT04026685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5558868|NCT04026685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558869|NCT04026685|Sympathomimetics|sympathomimetics|mesh-ancestor
5558870|NCT04026685|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6480938|NCT00544687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6480939|NCT00544687|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6159484|NCT01504867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5558871|NCT04026685|Nasal Decongestants|nasal decongestants|mesh-ancestor
5558872|NCT04026685|Respiratory System Agents|respiratory system agents|mesh-ancestor
5558873|NCT04026685|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5558874|NCT04026685|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5558875|NCT04026685|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6206037|NCT02096081|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6480940|NCT00544687|Antidepressive Agents|antidepressive agents|mesh-ancestor
6480941|NCT00544687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6159485|NCT01504867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159486|NCT01504867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6159487|NCT01504867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6159488|NCT01504867|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6159489|NCT01504867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5558876|NCT04026685|Adrenergic Agents|adrenergic agents|mesh-ancestor
5558877|NCT04026685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5558878|NCT04026685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558879|NCT04026685|Protective Agents|protective agents|mesh-ancestor
5558880|NCT04026451|Propofol|propofol|mesh-list
5558881|NCT04026451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5558882|NCT04026451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5558883|NCT04026451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558884|NCT04026451|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5558885|NCT04026451|Anesthetics, General|anesthetics, general|mesh-ancestor
5558886|NCT04026451|Anesthetics|anesthetics|mesh-ancestor
5558887|NCT04026464|Acetaminophen|acetaminophen|mesh-list
5558888|NCT04026464|Ibuprofen|ibuprofen|mesh-list
5558889|NCT04026464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5558890|NCT04026464|Analgesics|analgesics|mesh-ancestor
5558891|NCT04026464|Sensory System Agents|sensory system agents|mesh-ancestor
5558892|NCT04026464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5558893|NCT04026464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558894|NCT04026464|Antipyretics|antipyretics|mesh-ancestor
5558895|NCT04026464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5558896|NCT04026464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5558897|NCT04026464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5558898|NCT04026464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5558899|NCT04026464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5558900|NCT04026464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558901|NCT04026074|Clonidine|clonidine|mesh-list
5558902|NCT04026074|Fentanyl|fentanyl|mesh-list
5558903|NCT04026074|Remifentanil|remifentanil|mesh-list
5558904|NCT04026074|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
5558905|NCT04026074|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6159490|NCT01504867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159491|NCT01504867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6159492|NCT01504867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6159493|NCT01504867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6159494|NCT01504867|Antipyretics|antipyretics|mesh-ancestor
6159495|NCT01504971|Rabeprazole|rabeprazole|mesh-list
5558906|NCT04026074|Narcotics|narcotics|mesh-ancestor
5558907|NCT04026074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5558908|NCT04026074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558909|NCT04026074|Analgesics|analgesics|mesh-ancestor
5558910|NCT04026074|Sensory System Agents|sensory system agents|mesh-ancestor
5558911|NCT04026074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5558912|NCT04026074|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5558913|NCT04026074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5558914|NCT04026074|Anesthetics, General|anesthetics, general|mesh-ancestor
5558915|NCT04026074|Anesthetics|anesthetics|mesh-ancestor
5558916|NCT04026074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5558917|NCT04026074|Sympatholytics|sympatholytics|mesh-ancestor
5558918|NCT04026074|Autonomic Agents|autonomic agents|mesh-ancestor
5558919|NCT04026074|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6159496|NCT01504971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6159497|NCT01504971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6159498|NCT01504971|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6159499|NCT01504971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6159500|NCT01504971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159501|NCT01505114|Tenofovir|tenofovir|mesh-list
6159502|NCT01505114|Emtricitabine|emtricitabine|mesh-list
6159503|NCT01505114|Maraviroc|maraviroc|mesh-list
6159504|NCT01505114|Antiviral Agents|antiviral agents|mesh-ancestor
6159505|NCT01505114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6159506|NCT01505114|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6159507|NCT01505114|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6159508|NCT01505114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6159509|NCT01505114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159510|NCT01505114|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6159511|NCT01505114|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6159512|NCT01505114|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6159513|NCT01505114|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5558920|NCT04026074|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5558921|NCT04026074|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5558922|NCT04026074|Adrenergic Agents|adrenergic agents|mesh-ancestor
6159514|NCT01505114|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6159515|NCT01505179|Ranolazine|ranolazine|mesh-list
6159516|NCT01505179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6480942|NCT00544687|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6480943|NCT00544687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6480944|NCT00544687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6480945|NCT00544687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480946|NCT00544687|Adrenergic Agents|adrenergic agents|mesh-ancestor
6480947|NCT00544687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6159517|NCT01505179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6159518|NCT01505179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159519|NCT01505465|Melatonin|melatonin|mesh-list
6159520|NCT01505465|Antioxidants|antioxidants|mesh-ancestor
6159521|NCT01505465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159522|NCT01505465|Protective Agents|protective agents|mesh-ancestor
6159523|NCT01505465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159524|NCT01505465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6159525|NCT01505491|Adalimumab|adalimumab|mesh-list
6159526|NCT01505491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6159527|NCT01505491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6159528|NCT01505608|Irinotecan|irinotecan|mesh-list
6159529|NCT01505608|Temozolomide|temozolomide|mesh-list
6159530|NCT01505608|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6159531|NCT01505608|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6159532|NCT01505608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6159533|NCT01505608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159534|NCT01505608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6159535|NCT01505608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6159536|NCT01505608|Alkylating Agents|alkylating agents|mesh-ancestor
6159537|NCT01505634|Ciprofloxacin|ciprofloxacin|mesh-list
6159538|NCT01505634|Imipenem|imipenem|mesh-list
6159539|NCT01505634|Relebactam|relebactam|mesh-list
6159540|NCT01505634|Cilastatin|cilastatin|mesh-list
6159541|NCT01505634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6159542|NCT01505634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6159543|NCT01505634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6159544|NCT01505634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6159545|NCT01505634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6159546|NCT01505634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159547|NCT01505634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6159548|NCT01505634|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6159549|NCT01505634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6159550|NCT01505634|Protease Inhibitors|protease inhibitors|mesh-ancestor
6159551|NCT01505634|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6159552|NCT01505647|Vaccines|vaccines|mesh-list
6159553|NCT01505647|Immunologic Factors|immunologic factors|mesh-ancestor
6159554|NCT01505647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159555|NCT01505673|Liraglutide|liraglutide|mesh-list
6159556|NCT01505673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6159557|NCT01505673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159558|NCT01505673|Incretins|incretins|mesh-ancestor
6159559|NCT01505673|Hormones|hormones|mesh-ancestor
6159560|NCT01505673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5558923|NCT04026074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5558924|NCT04026074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558925|NCT04026074|Anesthetics, Local|anesthetics, local|mesh-ancestor
5558926|NCT04026074|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
6159561|NCT01505868|Carboplatin|carboplatin|mesh-list
6480948|NCT00544687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480949|NCT00544700|Bevacizumab|bevacizumab|mesh-list
6480950|NCT00544700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6480951|NCT00544700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6480952|NCT00544700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6480953|NCT00544700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6480954|NCT00544700|Growth Substances|growth substances|mesh-ancestor
6480955|NCT00544700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480956|NCT00544700|Growth Inhibitors|growth inhibitors|mesh-ancestor
6488877|NCT00587496|Sensory System Agents|sensory system agents|mesh-ancestor
6488878|NCT00587496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6488879|NCT00587496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488880|NCT00587496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6488881|NCT00587496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6488882|NCT00587496|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6159562|NCT01505868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5558927|NCT04026022|Fentanyl|fentanyl|mesh-list
6480957|NCT00544791|Melatonin|melatonin|mesh-list
6480958|NCT00544791|Antioxidants|antioxidants|mesh-ancestor
6480959|NCT00544791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480960|NCT00544791|Protective Agents|protective agents|mesh-ancestor
6480961|NCT00544791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480962|NCT00544791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6480963|NCT00544804|Lapatinib|lapatinib|mesh-list
6480964|NCT00544804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6480965|NCT00544804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5558928|NCT04026022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5558929|NCT04026022|Narcotics|narcotics|mesh-ancestor
5558930|NCT04026022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5558931|NCT04026022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480966|NCT00544804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6480967|NCT00544804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480968|NCT00544830|Leuprolide|leuprolide|mesh-list
6480969|NCT00544830|Goserelin|goserelin|mesh-list
6480970|NCT00544830|Bicalutamide|bicalutamide|mesh-list
6480971|NCT00544830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6480972|NCT00544830|Fertility Agents|fertility agents|mesh-ancestor
6480973|NCT00544830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6480974|NCT00544830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159563|NCT01505881|Warfarin|warfarin|mesh-list
6159564|NCT01505881|Dabigatran|dabigatran|mesh-list
6159565|NCT01505881|Anticoagulants|anticoagulants|mesh-ancestor
6159566|NCT01505881|Antithrombins|antithrombins|mesh-ancestor
6159567|NCT01505881|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6159568|NCT01505881|Protease Inhibitors|protease inhibitors|mesh-ancestor
6159569|NCT01505881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6159570|NCT01505881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159571|NCT01505933|Dexmedetomidine|dexmedetomidine|mesh-list
6159572|NCT01505933|Propofol|propofol|mesh-list
6159573|NCT01505933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6159574|NCT01505933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6159575|NCT01505933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159576|NCT01505933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6159577|NCT01505933|Anesthetics, General|anesthetics, general|mesh-ancestor
6159578|NCT01505933|Anesthetics|anesthetics|mesh-ancestor
6159579|NCT01505933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6159580|NCT01505933|Analgesics|analgesics|mesh-ancestor
6159581|NCT01505933|Sensory System Agents|sensory system agents|mesh-ancestor
6159582|NCT01505933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6159583|NCT01505933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6159584|NCT01505933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6159585|NCT01505933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6159586|NCT01505933|Adrenergic Agents|adrenergic agents|mesh-ancestor
6159587|NCT01505933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6159588|NCT01505933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159589|NCT01506193|Vaccines|vaccines|mesh-list
6480975|NCT00544830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6480976|NCT00544830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6480977|NCT00544830|Androgen Antagonists|androgen antagonists|mesh-ancestor
5558932|NCT04026022|Analgesics|analgesics|mesh-ancestor
5558933|NCT04026022|Sensory System Agents|sensory system agents|mesh-ancestor
5558934|NCT04026022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5558935|NCT04026022|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5558936|NCT04026022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5558937|NCT04026022|Anesthetics, General|anesthetics, general|mesh-ancestor
5558938|NCT04026022|Anesthetics|anesthetics|mesh-ancestor
5558939|NCT04026282|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
5558940|NCT04026282|Hormones|hormones|mesh-ancestor
5558941|NCT04026282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5558942|NCT04026282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558943|NCT04026256|Denosumab|denosumab|mesh-list
5558944|NCT04026256|Teriparatide|teriparatide|mesh-list
5558945|NCT04026256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5558946|NCT04026256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558947|NCT04026256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6480978|NCT00544830|Hormone Antagonists|hormone antagonists|mesh-ancestor
6480979|NCT00544830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6480980|NCT00544986|Anastrozole|anastrozole|mesh-list
6480981|NCT00544986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5558948|NCT04026230|Atorvastatin|atorvastatin|mesh-list
6480982|NCT00544986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5558949|NCT04026230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5558950|NCT04026230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5558951|NCT04026230|Antimetabolites|antimetabolites|mesh-ancestor
5558952|NCT04026230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558953|NCT04026230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5558954|NCT04026230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5558955|NCT04026230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5558956|NCT04025736|Tranexamic Acid|tranexamic acid|mesh-list
5558957|NCT04025736|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5558958|NCT04025736|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5558959|NCT04025736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5558960|NCT04025736|Hemostatics|hemostatics|mesh-ancestor
5558961|NCT04025736|Coagulants|coagulants|mesh-ancestor
6480983|NCT00544986|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6480984|NCT00544986|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6480985|NCT00544986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6480986|NCT00544986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480987|NCT00544986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6480988|NCT00544986|Hormone Antagonists|hormone antagonists|mesh-ancestor
6480989|NCT00544986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6480990|NCT00544986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6480991|NCT00544999|Cytarabine|cytarabine|mesh-list
5603388|NCT02560298|Antimitotic Agents|antimitotic agents|mesh-ancestor
5603389|NCT02560298|Mitosis Modulators|mitosis modulators|mesh-ancestor
5603390|NCT02560298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480992|NCT00544999|Everolimus|everolimus|mesh-list
6480993|NCT00544999|Daunorubicin|daunorubicin|mesh-list
6480994|NCT00544999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6480995|NCT00544999|Antimetabolites|antimetabolites|mesh-ancestor
6480996|NCT00544999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6480997|NCT00544999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6480998|NCT00544999|Antiviral Agents|antiviral agents|mesh-ancestor
6159590|NCT01506193|Immunologic Factors|immunologic factors|mesh-ancestor
6159591|NCT01506193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159592|NCT01506271|Imipenem|imipenem|mesh-list
6159593|NCT01506271|Relebactam|relebactam|mesh-list
6159594|NCT01506271|Cilastatin|cilastatin|mesh-list
6159595|NCT01506271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6159596|NCT01506271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6159597|NCT01506271|Protease Inhibitors|protease inhibitors|mesh-ancestor
6159598|NCT01506271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6159599|NCT01506271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159600|NCT01506271|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6159601|NCT01506453|Gabapentin|gabapentin|mesh-list
6159602|NCT01506453|Analgesics|analgesics|mesh-ancestor
6159603|NCT01506453|Sensory System Agents|sensory system agents|mesh-ancestor
6159604|NCT01506453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6159605|NCT01506453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159606|NCT01506453|Anticonvulsants|anticonvulsants|mesh-ancestor
6159607|NCT01506453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6159608|NCT01506453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5603391|NCT02560298|Antimetabolites|antimetabolites|mesh-ancestor
5603392|NCT02560298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5603393|NCT02560298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5603394|NCT02560298|Immunologic Factors|immunologic factors|mesh-ancestor
5603395|NCT02560298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603396|NCT02551991|Leucovorin|leucovorin|mesh-list
5603397|NCT02551991|Fluorouracil|fluorouracil|mesh-list
5603398|NCT02551991|Oxaliplatin|oxaliplatin|mesh-list
5603399|NCT02551991|Antimetabolites|antimetabolites|mesh-ancestor
5603400|NCT02551991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603401|NCT02551991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5603402|NCT02551991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6159609|NCT01506453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6159610|NCT01506453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6159611|NCT01506453|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6159612|NCT01506453|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6159613|NCT01506453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6159614|NCT01506453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159615|NCT01506453|Antimanic Agents|antimanic agents|mesh-ancestor
6159616|NCT01506609|Paclitaxel|paclitaxel|mesh-list
6159617|NCT01506609|Carboplatin|carboplatin|mesh-list
6480999|NCT00544999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6481000|NCT00544999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6159618|NCT01506609|Temozolomide|temozolomide|mesh-list
6159619|NCT01506609|Veliparib|veliparib|mesh-list
6159620|NCT01506609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6159621|NCT01506609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6159622|NCT01506609|Tubulin Modulators|tubulin modulators|mesh-ancestor
6481001|NCT00544999|Immunologic Factors|immunologic factors|mesh-ancestor
6481002|NCT00544999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481003|NCT00544999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6481004|NCT00544999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6481005|NCT00544999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6481006|NCT00544999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6481007|NCT00545012|Levetiracetam|levetiracetam|mesh-list
6481008|NCT00545012|Anticonvulsants|anticonvulsants|mesh-ancestor
6481009|NCT00545012|Nootropic Agents|nootropic agents|mesh-ancestor
6481010|NCT00545090|Ibandronic Acid|ibandronic acid|mesh-list
6481011|NCT00545090|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6481012|NCT00545090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481013|NCT00545129|Tanezumab|tanezumab|mesh-list
6481014|NCT00545129|Analgesics|analgesics|mesh-ancestor
6481015|NCT00545129|Sensory System Agents|sensory system agents|mesh-ancestor
6481016|NCT00545129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6481017|NCT00545129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481018|NCT00545142|Valproic Acid|valproic acid|mesh-list
6481019|NCT00545142|Aripiprazole|aripiprazole|mesh-list
6481020|NCT00545142|Antidepressive Agents|antidepressive agents|mesh-ancestor
6481021|NCT00545142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6481022|NCT00545142|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6481023|NCT00545142|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6481024|NCT00545142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6481025|NCT00545142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159623|NCT01506609|Antimitotic Agents|antimitotic agents|mesh-ancestor
6159624|NCT01506609|Mitosis Modulators|mitosis modulators|mesh-ancestor
6159625|NCT01506609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159626|NCT01506609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6159627|NCT01506609|Alkylating Agents|alkylating agents|mesh-ancestor
6159628|NCT01506609|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6481026|NCT00545142|Dopamine Agonists|dopamine agonists|mesh-ancestor
6481027|NCT00545142|Dopamine Agents|dopamine agents|mesh-ancestor
6159629|NCT01506609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6159630|NCT01506726|Salicylic Acid|salicylic acid|mesh-list
6159631|NCT01506726|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
6159632|NCT01506726|Salicylates|salicylates|mesh-list
6159633|NCT01506726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6159634|NCT01506726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6159635|NCT01506726|Analgesics|analgesics|mesh-ancestor
6159636|NCT01506726|Sensory System Agents|sensory system agents|mesh-ancestor
6159637|NCT01506726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6159638|NCT01506726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159639|NCT01506726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6159640|NCT01506726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6159641|NCT01506726|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6159642|NCT01506726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6159643|NCT01506726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481028|NCT00545142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6481029|NCT00545142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481030|NCT00545142|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5558962|NCT04025671|Naloxone|naloxone|mesh-list
5558963|NCT04025671|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5558964|NCT04025671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558965|NCT04025671|Sensory System Agents|sensory system agents|mesh-ancestor
5558966|NCT04025671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5558967|NCT04025775|Insulin|insulin|mesh-list
6159644|NCT01506726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6159645|NCT01506726|Antifungal Agents|antifungal agents|mesh-ancestor
6159646|NCT01506726|Keratolytic Agents|keratolytic agents|mesh-ancestor
6159647|NCT01506726|Dermatologic Agents|dermatologic agents|mesh-ancestor
6159648|NCT01506882|Levetiracetam|levetiracetam|mesh-list
6159649|NCT01506882|Anticonvulsants|anticonvulsants|mesh-ancestor
6159650|NCT01506882|Nootropic Agents|nootropic agents|mesh-ancestor
6159651|NCT01506908|Nicotine|nicotine|mesh-list
6159652|NCT01506908|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6159653|NCT01506908|Autonomic Agents|autonomic agents|mesh-ancestor
6159654|NCT01506908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6159655|NCT01506908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159656|NCT01506908|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6159657|NCT01506908|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6159658|NCT01506908|Cholinergic Agents|cholinergic agents|mesh-ancestor
6159659|NCT01506908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6159660|NCT01506908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159661|NCT01506947|Darbepoetin alfa|darbepoetin alfa|mesh-list
6159662|NCT01506947|Hematinics|hematinics|mesh-ancestor
6159663|NCT01507051|Vitamin K|vitamin k|mesh-list
6159664|NCT01507051|Vitamin K 1|vitamin k 1|mesh-list
6159665|NCT01507051|Warfarin|warfarin|mesh-list
6159666|NCT01507051|Rivaroxaban|rivaroxaban|mesh-list
6159667|NCT01507051|Vitamins|vitamins|mesh-ancestor
6159668|NCT01507051|Micronutrients|micronutrients|mesh-ancestor
6481031|NCT00545142|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6481032|NCT00545142|Serotonin Agents|serotonin agents|mesh-ancestor
6481033|NCT00545142|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6481034|NCT00545142|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6481035|NCT00545142|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6481036|NCT00545142|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6481037|NCT00545142|Anticonvulsants|anticonvulsants|mesh-ancestor
6481038|NCT00545142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6481039|NCT00545142|GABA Agents|gaba agents|mesh-ancestor
6481040|NCT00545142|Antimanic Agents|antimanic agents|mesh-ancestor
6481041|NCT00545194|Dinoprostone|dinoprostone|mesh-list
6481042|NCT00545194|Oxytocics|oxytocics|mesh-ancestor
6159669|NCT01507051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159670|NCT01507051|Anticoagulants|anticoagulants|mesh-ancestor
6159671|NCT01507051|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6159672|NCT01507051|Antithrombins|antithrombins|mesh-ancestor
6159673|NCT01507051|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6159674|NCT01507051|Protease Inhibitors|protease inhibitors|mesh-ancestor
6159675|NCT01507051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6159676|NCT01507051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159677|NCT01507051|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6159678|NCT01507051|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6159679|NCT01507051|Hemostatics|hemostatics|mesh-ancestor
6159680|NCT01507051|Coagulants|coagulants|mesh-ancestor
6159681|NCT01507103|Cyclophosphamide|cyclophosphamide|mesh-list
6159682|NCT01507103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6481043|NCT00545194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6481044|NCT00545194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481045|NCT00545207|Ibandronic Acid|ibandronic acid|mesh-list
6481046|NCT00545207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6481047|NCT00545207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481048|NCT00545246|Docetaxel|docetaxel|mesh-list
6481049|NCT00545246|Aflibercept|aflibercept|mesh-list
6481050|NCT00545246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6481051|NCT00545246|Tubulin Modulators|tubulin modulators|mesh-ancestor
6481052|NCT00545246|Antimitotic Agents|antimitotic agents|mesh-ancestor
6481053|NCT00545246|Mitosis Modulators|mitosis modulators|mesh-ancestor
6481054|NCT00545246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481055|NCT00545246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6481056|NCT00545246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6481057|NCT00545246|Growth Substances|growth substances|mesh-ancestor
6481058|NCT00545246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481059|NCT00545246|Growth Inhibitors|growth inhibitors|mesh-ancestor
6481060|NCT00545311|Glycopyrrolate|glycopyrrolate|mesh-list
6159683|NCT01507103|Immunologic Factors|immunologic factors|mesh-ancestor
6159684|NCT01507103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481061|NCT00545311|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6159685|NCT01507103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6481062|NCT00545311|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6481063|NCT00545311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6481064|NCT00545311|Cholinergic Agents|cholinergic agents|mesh-ancestor
6481065|NCT00545311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6481066|NCT00545311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481067|NCT00545311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481068|NCT00545389|Mesalamine|mesalamine|mesh-list
6481069|NCT00545389|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6481070|NCT00545389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6481071|NCT00545389|Analgesics|analgesics|mesh-ancestor
6481072|NCT00545389|Sensory System Agents|sensory system agents|mesh-ancestor
6481073|NCT00545389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6481074|NCT00545389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481075|NCT00545389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6481076|NCT00545389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6481077|NCT00545467|Aripiprazole|aripiprazole|mesh-list
6481078|NCT00545467|Antidepressive Agents|antidepressive agents|mesh-ancestor
6159686|NCT01507103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5558968|NCT04025775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5558969|NCT04025775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558970|NCT04025840|Dexamethasone|dexamethasone|mesh-list
5558971|NCT04025840|Glucocorticoids|glucocorticoids|mesh-list
5558972|NCT04025840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5558973|NCT04025840|Antiemetics|antiemetics|mesh-ancestor
5558974|NCT04025840|Autonomic Agents|autonomic agents|mesh-ancestor
5558975|NCT04025840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5558976|NCT04025840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558977|NCT04025840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5558978|NCT04025840|Hormones|hormones|mesh-ancestor
5558979|NCT04025840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5558980|NCT04025840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5558981|NCT04025840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5558982|NCT04025918|Phenylephrine|phenylephrine|mesh-list
5558983|NCT04025918|Oxymetazoline|oxymetazoline|mesh-list
5558984|NCT04025918|Ephedrine|ephedrine|mesh-list
5558985|NCT04025918|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
5558986|NCT04025918|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5558987|NCT04025918|Mydriatics|mydriatics|mesh-ancestor
5558988|NCT04025918|Autonomic Agents|autonomic agents|mesh-ancestor
5558989|NCT04025918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5558990|NCT04025918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5558991|NCT04025918|Sympathomimetics|sympathomimetics|mesh-ancestor
6159687|NCT01507103|Alkylating Agents|alkylating agents|mesh-ancestor
6159688|NCT01507103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159689|NCT01507103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6159690|NCT01507103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6159691|NCT01507181|Midazolam|midazolam|mesh-list
6159692|NCT01507181|Ketamine|ketamine|mesh-list
6159693|NCT01507181|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-list
6159694|NCT01507181|N-Methylaspartate|n-methylaspartate|mesh-list
6159695|NCT01507181|Analgesics|analgesics|mesh-ancestor
6159696|NCT01507181|Sensory System Agents|sensory system agents|mesh-ancestor
6159697|NCT01507181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6159698|NCT01507181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159699|NCT01507181|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6159700|NCT01507181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6159701|NCT01507181|Anesthetics, General|anesthetics, general|mesh-ancestor
5558992|NCT04025918|Nasal Decongestants|nasal decongestants|mesh-ancestor
5558993|NCT04025918|Respiratory System Agents|respiratory system agents|mesh-ancestor
5558994|NCT04025918|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5558995|NCT04025918|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5558996|NCT04025918|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5558997|NCT04025918|Adrenergic Agents|adrenergic agents|mesh-ancestor
5558998|NCT04025918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5558999|NCT04025918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559000|NCT04025918|Protective Agents|protective agents|mesh-ancestor
5559001|NCT04025918|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5559002|NCT04025567|Vancomycin|vancomycin|mesh-list
5559003|NCT04025567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5559004|NCT04025567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5559005|NCT04025593|Prednisone|prednisone|mesh-list
5559006|NCT04025593|Cyclophosphamide|cyclophosphamide|mesh-list
5559007|NCT04025593|Rituximab|rituximab|mesh-list
5559008|NCT04025593|Doxorubicin|doxorubicin|mesh-list
5559009|NCT04025593|Vincristine|vincristine|mesh-list
5559010|NCT04025593|Lenalidomide|lenalidomide|mesh-list
5559011|NCT04025593|Decitabine|decitabine|mesh-list
6159702|NCT01507181|Anesthetics|anesthetics|mesh-ancestor
6159703|NCT01507181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6159704|NCT01507181|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6159705|NCT01507181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6159706|NCT01507181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159707|NCT01507181|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6159708|NCT01507181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6159709|NCT01507181|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6159710|NCT01507181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6159711|NCT01507181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5559012|NCT04025593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5559013|NCT04025593|Immunologic Factors|immunologic factors|mesh-ancestor
5559014|NCT04025593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559015|NCT04025593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5559016|NCT04025593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6159712|NCT01507181|GABA Modulators|gaba modulators|mesh-ancestor
6159713|NCT01507181|GABA Agents|gaba agents|mesh-ancestor
6159714|NCT01507181|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
6159715|NCT01507220|Morphine|morphine|mesh-list
6159716|NCT01507220|Bupivacaine|bupivacaine|mesh-list
6159717|NCT01507220|Anesthetics, Local|anesthetics, local|mesh-ancestor
6159718|NCT01507220|Anesthetics|anesthetics|mesh-ancestor
6159719|NCT01507220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6159720|NCT01507220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159721|NCT01507220|Sensory System Agents|sensory system agents|mesh-ancestor
6159722|NCT01507220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6159723|NCT01507220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6159724|NCT01507220|Narcotics|narcotics|mesh-ancestor
6159725|NCT01507220|Analgesics|analgesics|mesh-ancestor
6159726|NCT01507246|Morphine|morphine|mesh-list
6159727|NCT01507246|Bupivacaine|bupivacaine|mesh-list
6159728|NCT01507246|Anesthetics, Local|anesthetics, local|mesh-ancestor
6159729|NCT01507246|Anesthetics|anesthetics|mesh-ancestor
6159730|NCT01507246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6159731|NCT01507246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159732|NCT01507246|Sensory System Agents|sensory system agents|mesh-ancestor
6159733|NCT01507246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6159734|NCT01507246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6159735|NCT01507246|Narcotics|narcotics|mesh-ancestor
5559017|NCT04025593|Alkylating Agents|alkylating agents|mesh-ancestor
5559018|NCT04025593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559019|NCT04025593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5559020|NCT04025593|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5559021|NCT04025593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5559022|NCT04025593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5559023|NCT04025593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5559024|NCT04025593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5559025|NCT04025593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5559026|NCT04025593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5559027|NCT04025593|Glucocorticoids|glucocorticoids|mesh-ancestor
5559028|NCT04025593|Hormones|hormones|mesh-ancestor
5559029|NCT04025593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5559030|NCT04025593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5559031|NCT04025593|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5559032|NCT04025593|Tubulin Modulators|tubulin modulators|mesh-ancestor
5559033|NCT04025593|Antimitotic Agents|antimitotic agents|mesh-ancestor
5559034|NCT04025593|Mitosis Modulators|mitosis modulators|mesh-ancestor
5559035|NCT04025593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5559036|NCT04025593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5559037|NCT04025593|Growth Substances|growth substances|mesh-ancestor
5559038|NCT04025593|Growth Inhibitors|growth inhibitors|mesh-ancestor
5559039|NCT04025593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5559040|NCT04025593|Antimetabolites|antimetabolites|mesh-ancestor
5559041|NCT04025372|Bicalutamide|bicalutamide|mesh-list
5559042|NCT04025372|Androgen Antagonists|androgen antagonists|mesh-ancestor
5559043|NCT04025372|Hormone Antagonists|hormone antagonists|mesh-ancestor
5559044|NCT04025372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5559045|NCT04025372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559046|NCT04025372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6159736|NCT01507246|Analgesics|analgesics|mesh-ancestor
6159737|NCT01507779|Vaccines|vaccines|mesh-list
6159738|NCT01507779|Immunologic Factors|immunologic factors|mesh-ancestor
6159739|NCT01507779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159740|NCT01507831|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6159741|NCT01507831|Immunologic Factors|immunologic factors|mesh-ancestor
5559047|NCT04025203|Ibuprofen|ibuprofen|mesh-list
5559048|NCT04025203|Ibuprofen arginine|ibuprofen arginine|mesh-list
5559049|NCT04025203|Gabapentin|gabapentin|mesh-list
5559050|NCT04025203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5559051|NCT04025203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5559052|NCT04025203|Analgesics|analgesics|mesh-ancestor
5559053|NCT04025203|Sensory System Agents|sensory system agents|mesh-ancestor
5559054|NCT04025203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5559055|NCT04025203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159742|NCT01507831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159743|NCT01508117|Axitinib|axitinib|mesh-list
6668376|NCT01531777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668377|NCT01531790|Carboplatin|carboplatin|mesh-list
6668378|NCT01531790|Pemetrexed|pemetrexed|mesh-list
6668379|NCT01531790|Endostar protein|endostar protein|mesh-list
6668380|NCT01531790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6668381|NCT01531790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6668382|NCT01531790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668383|NCT01531790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6668384|NCT01531790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6668385|NCT01531790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6668386|NCT01531790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6668387|NCT01531790|Growth Substances|growth substances|mesh-ancestor
6668388|NCT01531790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159744|NCT01508117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6159745|NCT01508117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6159746|NCT01508117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6481079|NCT00545467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6481080|NCT00545467|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6481081|NCT00545467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6481082|NCT00545467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5559056|NCT04025203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5559057|NCT04025203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5559058|NCT04025203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6481083|NCT00545467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481084|NCT00545467|Dopamine Agonists|dopamine agonists|mesh-ancestor
6481085|NCT00545467|Dopamine Agents|dopamine agents|mesh-ancestor
6481086|NCT00545467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6481087|NCT00545467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481088|NCT00545467|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6481089|NCT00545467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6159747|NCT01508117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159748|NCT01508325|Metoprolol|metoprolol|mesh-list
6159749|NCT01508325|Bisoprolol|bisoprolol|mesh-list
6159750|NCT01508325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6159751|NCT01508325|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6159752|NCT01508325|Sympatholytics|sympatholytics|mesh-ancestor
6159753|NCT01508325|Autonomic Agents|autonomic agents|mesh-ancestor
6159754|NCT01508325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6159755|NCT01508325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159756|NCT01508325|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6159757|NCT01508325|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6159758|NCT01508325|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5559059|NCT04025203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5559060|NCT04025203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559061|NCT04025203|Anticonvulsants|anticonvulsants|mesh-ancestor
5559062|NCT04025203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6159759|NCT01508325|Adrenergic Agents|adrenergic agents|mesh-ancestor
6668389|NCT01531790|Growth Inhibitors|growth inhibitors|mesh-ancestor
6668390|NCT01531829|Heparin|heparin|mesh-list
6668391|NCT01531829|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6668392|NCT01531829|Tinzaparin|tinzaparin|mesh-list
5559063|NCT04025203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5559064|NCT04025203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5559065|NCT04025203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5559066|NCT04025203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6159760|NCT01508325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6159761|NCT01508325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159762|NCT01508455|Fentanyl|fentanyl|mesh-list
6159763|NCT01508455|Midazolam|midazolam|mesh-list
6159764|NCT01508455|Dexmedetomidine|dexmedetomidine|mesh-list
6159765|NCT01508455|Morphine|morphine|mesh-list
6159766|NCT01508455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6159767|NCT01508455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6668393|NCT01531829|Dalteparin|dalteparin|mesh-list
6668394|NCT01531829|Plasminogen|plasminogen|mesh-list
6668395|NCT01531829|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6668396|NCT01531829|Nadroparin|nadroparin|mesh-list
6668397|NCT01531829|Anticoagulants|anticoagulants|mesh-ancestor
6668398|NCT01531829|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6668399|NCT01531829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6668400|NCT01531829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668401|NCT01531842|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6668402|NCT01531842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6668403|NCT01531855|Insulin|insulin|mesh-list
6668404|NCT01531855|Insulin Lispro|insulin lispro|mesh-list
6668405|NCT01531855|Insulin, Short-Acting|insulin, short-acting|mesh-list
6668406|NCT01531855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5559067|NCT04025203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5559068|NCT04025203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5559069|NCT04025203|Antimanic Agents|antimanic agents|mesh-ancestor
5559070|NCT04025177|Indomethacin|indomethacin|mesh-list
5559071|NCT04025177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5559072|NCT04025177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5559073|NCT04025177|Analgesics|analgesics|mesh-ancestor
5559074|NCT04025177|Sensory System Agents|sensory system agents|mesh-ancestor
5559075|NCT04025177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5559076|NCT04025177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559077|NCT04025177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5559078|NCT04025177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5559079|NCT04025177|Gout Suppressants|gout suppressants|mesh-ancestor
5559080|NCT04025177|Tocolytic Agents|tocolytic agents|mesh-ancestor
5559081|NCT04025177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5559082|NCT04025177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5559083|NCT04025177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5559084|NCT04025177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559085|NCT04025489|Vitamin D|vitamin d|mesh-list
5559086|NCT04025489|Vitamins|vitamins|mesh-ancestor
5559087|NCT04025489|Micronutrients|micronutrients|mesh-ancestor
5559088|NCT04025489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559089|NCT04025489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5559090|NCT04025060|Caffeine|caffeine|mesh-list
5559091|NCT04025060|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5559092|NCT04025060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559093|NCT04025060|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5559094|NCT04025060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5559095|NCT04025060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559096|NCT04025060|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5559097|NCT04025060|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5559098|NCT04025060|Purinergic Agents|purinergic agents|mesh-ancestor
5559099|NCT04025060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5559100|NCT04024683|Ropivacaine|ropivacaine|mesh-list
5559101|NCT04024683|Anesthetics, Local|anesthetics, local|mesh-ancestor
5559102|NCT04024683|Anesthetics|anesthetics|mesh-ancestor
5559103|NCT04024683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5559104|NCT04024683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559105|NCT04024683|Sensory System Agents|sensory system agents|mesh-ancestor
5559106|NCT04024683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6481090|NCT00545467|Serotonin Agents|serotonin agents|mesh-ancestor
6481091|NCT00545467|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6481092|NCT00545467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6481093|NCT00545467|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6481094|NCT00545467|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6481095|NCT00545480|Ibandronic Acid|ibandronic acid|mesh-list
6481096|NCT00545480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6481097|NCT00545480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481098|NCT00545493|Tacrolimus|tacrolimus|mesh-list
6481099|NCT00545493|Immunoglobulins|immunoglobulins|mesh-list
6481100|NCT00545493|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6481101|NCT00545493|Antibodies|antibodies|mesh-list
6481102|NCT00545493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5559107|NCT04024800|Pembrolizumab|pembrolizumab|mesh-list
5559108|NCT04024800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5559109|NCT04024800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5559110|NCT04024696|Abexinostat|abexinostat|mesh-list
5559111|NCT04024696|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5559112|NCT04024696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5559113|NCT04024696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559114|NCT04024865|Domperidone|domperidone|mesh-list
5559115|NCT04024865|Antiemetics|antiemetics|mesh-ancestor
5559116|NCT04024865|Autonomic Agents|autonomic agents|mesh-ancestor
5559117|NCT04024865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5559118|NCT04024865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559119|NCT04024865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5559120|NCT04024865|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5559121|NCT04024865|Dopamine Agents|dopamine agents|mesh-ancestor
5559122|NCT04024865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5559123|NCT04024865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559124|NCT04024813|Seladelpar|seladelpar|mesh-list
5559125|NCT04024813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5559126|NCT04024813|Antimetabolites|antimetabolites|mesh-ancestor
5559127|NCT04024813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559128|NCT04024813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5559129|NCT04024527|Amoxicillin|amoxicillin|mesh-list
5559130|NCT04024527|Metronidazole|metronidazole|mesh-list
5559131|NCT04024527|Esomeprazole|esomeprazole|mesh-list
5559132|NCT04024527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5559133|NCT04024527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5559134|NCT04024527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5559135|NCT04024527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5559136|NCT04024527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5559137|NCT04024527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5559138|NCT04024527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5559139|NCT04024527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5559140|NCT04024527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559141|NCT04024878|Nivolumab|nivolumab|mesh-list
5559142|NCT04024878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5559143|NCT04024878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5559144|NCT04024878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5559145|NCT04024878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559146|NCT04024891|Phentolamine|phentolamine|mesh-list
5559147|NCT04024891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5559148|NCT04024891|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5559149|NCT04024891|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5559150|NCT04024891|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5559151|NCT04024891|Adrenergic Agents|adrenergic agents|mesh-ancestor
5559152|NCT04024891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5559153|NCT04024891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559154|NCT04024891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559155|NCT04024891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5559156|NCT04024254|Folic Acid|folic acid|mesh-list
5559157|NCT04024254|Hematinics|hematinics|mesh-ancestor
5559158|NCT04024254|Vitamin B Complex|vitamin b complex|mesh-ancestor
5559159|NCT04024254|Vitamins|vitamins|mesh-ancestor
5559160|NCT04024254|Micronutrients|micronutrients|mesh-ancestor
5559161|NCT04024254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559162|NCT04024384|Daratumumab|daratumumab|mesh-list
5559163|NCT04024384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6668407|NCT01531855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668408|NCT01531920|Ethanol|ethanol|mesh-list
6668409|NCT01531920|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6668410|NCT01531920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6668411|NCT01531920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5559164|NCT04024241|Cytarabine|cytarabine|mesh-list
5559165|NCT04024241|Mitoxantrone|mitoxantrone|mesh-list
5559166|NCT04024241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5559167|NCT04024241|Antimetabolites|antimetabolites|mesh-ancestor
5559168|NCT04024241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559169|NCT04024241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5559170|NCT04024241|Antiviral Agents|antiviral agents|mesh-ancestor
5559171|NCT04024241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5559172|NCT04024241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5559173|NCT04024241|Immunologic Factors|immunologic factors|mesh-ancestor
5559174|NCT04024241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668412|NCT01531920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668413|NCT01532011|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5559175|NCT04024241|Analgesics|analgesics|mesh-ancestor
5559176|NCT04024241|Sensory System Agents|sensory system agents|mesh-ancestor
5559177|NCT04024241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5559178|NCT04024241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5559179|NCT04024241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5559180|NCT04024241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5559181|NCT04024163|Benzonidazole|benzonidazole|mesh-list
5559182|NCT04024163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5559183|NCT04024163|Immunologic Factors|immunologic factors|mesh-ancestor
5559184|NCT04024163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559185|NCT04024163|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5559186|NCT04024163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5559187|NCT04024163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5559188|NCT04024163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5559189|NCT04024072|Brinzolamide|brinzolamide|mesh-list
5559190|NCT04024072|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5559191|NCT04024072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5559192|NCT04024072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603403|NCT02551991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6668414|NCT01532011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6668415|NCT01532011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6668416|NCT01532011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6668417|NCT01532011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668418|NCT01532076|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
5603404|NCT02551991|Immunologic Factors|immunologic factors|mesh-ancestor
5603405|NCT02551991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603406|NCT02551991|Antidotes|antidotes|mesh-ancestor
5603407|NCT02551991|Protective Agents|protective agents|mesh-ancestor
5603408|NCT02551991|Vitamin B Complex|vitamin b complex|mesh-ancestor
5603409|NCT02551991|Vitamins|vitamins|mesh-ancestor
6159768|NCT01508455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159769|NCT01508455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6159770|NCT01508455|Analgesics|analgesics|mesh-ancestor
6159771|NCT01508455|Sensory System Agents|sensory system agents|mesh-ancestor
6159772|NCT01508455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6159773|NCT01508455|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6159774|NCT01508455|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6159775|NCT01508455|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6159776|NCT01508455|Adrenergic Agents|adrenergic agents|mesh-ancestor
6159777|NCT01508455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6159778|NCT01508455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159779|NCT01508455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6159780|NCT01508455|Narcotics|narcotics|mesh-ancestor
6159781|NCT01508455|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6159782|NCT01508455|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6159783|NCT01508455|Anesthetics, General|anesthetics, general|mesh-ancestor
6159784|NCT01508455|Anesthetics|anesthetics|mesh-ancestor
6159785|NCT01508455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6159786|NCT01508455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6159787|NCT01508455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6159788|NCT01508455|GABA Modulators|gaba modulators|mesh-ancestor
6159789|NCT01508455|GABA Agents|gaba agents|mesh-ancestor
6159790|NCT01508676|Diclofenac|diclofenac|mesh-list
6159791|NCT01508676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
6159792|NCT01508676|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6159793|NCT01508676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6159794|NCT01508676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6159795|NCT01508676|Analgesics|analgesics|mesh-ancestor
6159796|NCT01508676|Sensory System Agents|sensory system agents|mesh-ancestor
6159797|NCT01508676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6159798|NCT01508676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159799|NCT01508676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6159800|NCT01508676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6159801|NCT01508676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6159802|NCT01508676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159803|NCT01508702|Lesinurad|lesinurad|mesh-list
6159804|NCT01508702|Gout Suppressants|gout suppressants|mesh-ancestor
6481103|NCT00545493|Immunologic Factors|immunologic factors|mesh-ancestor
6481104|NCT00545493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481105|NCT00545493|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6481106|NCT00545493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6481107|NCT00545493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481108|NCT00545519|Thymoglobulin|thymoglobulin|mesh-list
6481109|NCT00545519|Immunologic Factors|immunologic factors|mesh-ancestor
6481110|NCT00545519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481111|NCT00545519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6481112|NCT00545558|Tenofovir|tenofovir|mesh-list
6481113|NCT00545558|Emtricitabine|emtricitabine|mesh-list
6481114|NCT00545558|Efavirenz|efavirenz|mesh-list
6481115|NCT00545558|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6159805|NCT01508702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6159806|NCT01508702|Uricosuric Agents|uricosuric agents|mesh-ancestor
6159807|NCT01508702|Renal Agents|renal agents|mesh-ancestor
6159808|NCT01508832|Lidocaine|lidocaine|mesh-list
6159809|NCT01508832|Bupivacaine|bupivacaine|mesh-list
6159810|NCT01508832|Anesthetics, Local|anesthetics, local|mesh-ancestor
6159811|NCT01508832|Anesthetics|anesthetics|mesh-ancestor
6159812|NCT01508832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6159813|NCT01508832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159814|NCT01508832|Sensory System Agents|sensory system agents|mesh-ancestor
6159815|NCT01508832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6159816|NCT01508832|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5559193|NCT04023760|Apixaban|apixaban|mesh-list
5559194|NCT04023760|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5559195|NCT04023760|Antithrombins|antithrombins|mesh-ancestor
5559196|NCT04023760|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5559197|NCT04023760|Protease Inhibitors|protease inhibitors|mesh-ancestor
5559198|NCT04023760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5559199|NCT04023760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559200|NCT04023760|Anticoagulants|anticoagulants|mesh-ancestor
5559201|NCT04023669|Gemcitabine|gemcitabine|mesh-list
5559202|NCT04023669|Cyclophosphamide|cyclophosphamide|mesh-list
5559203|NCT04023669|Lenograstim|lenograstim|mesh-list
5559204|NCT04023669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5559205|NCT04023669|Immunologic Factors|immunologic factors|mesh-ancestor
5559206|NCT04023669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559207|NCT04023669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5559208|NCT04023669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5559209|NCT04023669|Alkylating Agents|alkylating agents|mesh-ancestor
5559210|NCT04023669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559211|NCT04023669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5559212|NCT04023669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5559213|NCT04023669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5559214|NCT04023669|Antimetabolites|antimetabolites|mesh-ancestor
5559215|NCT04023669|Antiviral Agents|antiviral agents|mesh-ancestor
5559216|NCT04023669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5559217|NCT04023669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5559218|NCT04023669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5559219|NCT04023565|Perindopril|perindopril|mesh-list
6159817|NCT01508832|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6159818|NCT01508832|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6159819|NCT01508832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6159820|NCT01508832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159821|NCT01508936|Reslizumab|reslizumab|mesh-list
6159822|NCT01508936|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6159823|NCT01508936|Respiratory System Agents|respiratory system agents|mesh-ancestor
6159824|NCT01509079|Vitamin D|vitamin d|mesh-list
6159825|NCT01509079|Ergocalciferols|ergocalciferols|mesh-list
6159826|NCT01509079|Cholecalciferol|cholecalciferol|mesh-list
6159827|NCT01509079|Vitamins|vitamins|mesh-list
6159828|NCT01509079|Micronutrients|micronutrients|mesh-ancestor
6159829|NCT01509079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559220|NCT04023565|Moxonidine|moxonidine|mesh-list
5559221|NCT04023565|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5559222|NCT04023565|Protease Inhibitors|protease inhibitors|mesh-ancestor
5559223|NCT04023565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5559224|NCT04023565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559225|NCT04023565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5559226|NCT04023617|Docetaxel|docetaxel|mesh-list
5559227|NCT04023617|Nivolumab|nivolumab|mesh-list
5559228|NCT04023617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6159830|NCT01509079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6159831|NCT01509079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6159832|NCT01509105|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6481116|NCT00545558|Antiviral Agents|antiviral agents|mesh-ancestor
6481117|NCT00545558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5559229|NCT04023617|Tubulin Modulators|tubulin modulators|mesh-ancestor
5559230|NCT04023617|Antimitotic Agents|antimitotic agents|mesh-ancestor
5559231|NCT04023617|Mitosis Modulators|mitosis modulators|mesh-ancestor
5559232|NCT04023617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159833|NCT01509105|Immunologic Factors|immunologic factors|mesh-ancestor
6159834|NCT01509105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481118|NCT00545558|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6481119|NCT00545558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6668419|NCT01532076|Hemostatics|hemostatics|mesh-ancestor
6159835|NCT01509404|Valganciclovir|valganciclovir|mesh-list
5559233|NCT04023617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5559234|NCT04023617|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5559235|NCT04023630|Rivaroxaban|rivaroxaban|mesh-list
5559236|NCT04023630|Clopidogrel|clopidogrel|mesh-list
5559237|NCT04023630|Ticagrelor|ticagrelor|mesh-list
5559238|NCT04023630|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5559239|NCT04023630|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5559240|NCT04023630|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5559241|NCT04023630|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5559242|NCT04023630|Purinergic Agents|purinergic agents|mesh-ancestor
5559243|NCT04023630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6159836|NCT01509404|Antiviral Agents|antiviral agents|mesh-ancestor
6159837|NCT01509404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6159838|NCT01509547|Varenicline|varenicline|mesh-list
6159839|NCT01509547|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6159840|NCT01509547|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6159841|NCT01509547|Cholinergic Agents|cholinergic agents|mesh-ancestor
6159842|NCT01509547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6159843|NCT01509547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668420|NCT01532076|Coagulants|coagulants|mesh-ancestor
6668421|NCT01532102|Antiviral Agents|antiviral agents|mesh-list
6668422|NCT01532102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6668423|NCT01532115|Moxifloxacin|moxifloxacin|mesh-list
6668424|NCT01532115|Opicapone|opicapone|mesh-list
5559244|NCT04023630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559245|NCT04023630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559246|NCT04023630|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5559247|NCT04023630|Antithrombins|antithrombins|mesh-ancestor
5559248|NCT04023630|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5559249|NCT04023630|Protease Inhibitors|protease inhibitors|mesh-ancestor
5559250|NCT04023630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6159844|NCT01509547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159845|NCT01509586|Lobeline|lobeline|mesh-list
6159846|NCT01509586|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6159847|NCT01509586|Autonomic Agents|autonomic agents|mesh-ancestor
6159848|NCT01509586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6159849|NCT01509586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159850|NCT01509586|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6159851|NCT01509586|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6159852|NCT01509586|Cholinergic Agents|cholinergic agents|mesh-ancestor
6159853|NCT01509586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6159854|NCT01509586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159855|NCT01509586|Respiratory System Agents|respiratory system agents|mesh-ancestor
6159856|NCT01509625|Fulvestrant|fulvestrant|mesh-list
5559251|NCT04023630|Anticoagulants|anticoagulants|mesh-ancestor
6159857|NCT01509625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6159858|NCT01509625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6159859|NCT01509625|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6159860|NCT01509625|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6159861|NCT01509625|Hormone Antagonists|hormone antagonists|mesh-ancestor
6159862|NCT01509625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6159863|NCT01509625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159864|NCT01509638|Bupivacaine|bupivacaine|mesh-list
6159865|NCT01509638|Anesthetics, Local|anesthetics, local|mesh-ancestor
6159866|NCT01509638|Anesthetics|anesthetics|mesh-ancestor
6159867|NCT01509638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6159868|NCT01509638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159869|NCT01509638|Sensory System Agents|sensory system agents|mesh-ancestor
6159870|NCT01509638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6159871|NCT01509807|Morphine|morphine|mesh-list
6159872|NCT01509807|Bupivacaine|bupivacaine|mesh-list
6159873|NCT01509807|Anesthetics, Local|anesthetics, local|mesh-ancestor
6481120|NCT00545558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6481121|NCT00545558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481122|NCT00545558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6481123|NCT00545558|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6481124|NCT00545558|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6481125|NCT00545558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6481126|NCT00545558|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6481127|NCT00545558|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5559252|NCT04023149|Aldesleukin|aldesleukin|mesh-list
5559253|NCT04023149|Interleukin-2|interleukin-2|mesh-list
5559254|NCT04023149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5559255|NCT04023149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5559256|NCT04023149|Analgesics|analgesics|mesh-ancestor
5559257|NCT04023149|Sensory System Agents|sensory system agents|mesh-ancestor
5559258|NCT04023149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5559259|NCT04023149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559260|NCT04023149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5559261|NCT04023149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5559262|NCT04023149|Antiviral Agents|antiviral agents|mesh-ancestor
5559263|NCT04023149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5559264|NCT04023331|Copper|copper|mesh-list
6159874|NCT01509807|Anesthetics|anesthetics|mesh-ancestor
6159875|NCT01509807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6159876|NCT01509807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159877|NCT01509807|Sensory System Agents|sensory system agents|mesh-ancestor
6159878|NCT01509807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6159879|NCT01509807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6159880|NCT01509807|Narcotics|narcotics|mesh-ancestor
6481128|NCT00545558|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6481129|NCT00545558|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6481130|NCT00545675|Valproic Acid|valproic acid|mesh-list
6481131|NCT00545675|Aripiprazole|aripiprazole|mesh-list
5559265|NCT04023331|Trace Elements|trace elements|mesh-ancestor
5559266|NCT04023331|Micronutrients|micronutrients|mesh-ancestor
5559267|NCT04023331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559268|NCT04023344|Insulin Lispro|insulin lispro|mesh-list
5559269|NCT04023344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5559270|NCT04023344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559271|NCT04023266|Acetylcysteine|acetylcysteine|mesh-list
5559272|NCT04023266|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5559273|NCT04023266|Antiviral Agents|antiviral agents|mesh-ancestor
5559274|NCT04023266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5559275|NCT04023266|Expectorants|expectorants|mesh-ancestor
5559276|NCT04023266|Respiratory System Agents|respiratory system agents|mesh-ancestor
5559277|NCT04023266|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5559278|NCT04023266|Antioxidants|antioxidants|mesh-ancestor
5559279|NCT04023266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481132|NCT00545675|Antidepressive Agents|antidepressive agents|mesh-ancestor
6481133|NCT00545675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6481134|NCT00545675|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6481135|NCT00545675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6481136|NCT00545675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6481137|NCT00545675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559280|NCT04023266|Protective Agents|protective agents|mesh-ancestor
5559281|NCT04023266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559282|NCT04023266|Antidotes|antidotes|mesh-ancestor
5559283|NCT04023292|Tamoxifen|tamoxifen|mesh-list
5559284|NCT04023292|Letrozole|letrozole|mesh-list
5559285|NCT04023292|Exemestane|exemestane|mesh-list
5559286|NCT04023292|Anastrozole|anastrozole|mesh-list
5559287|NCT04023292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5559288|NCT04023292|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5559289|NCT04023292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5559290|NCT04023292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6481138|NCT00545675|Dopamine Agonists|dopamine agonists|mesh-ancestor
6481139|NCT00545675|Dopamine Agents|dopamine agents|mesh-ancestor
6481140|NCT00545675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5559291|NCT04023292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159881|NCT01509807|Analgesics|analgesics|mesh-ancestor
6159882|NCT01509846|Vaccines|vaccines|mesh-list
6159883|NCT01509846|Immunologic Factors|immunologic factors|mesh-ancestor
6159884|NCT01509846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159885|NCT01510145|Travoprost|travoprost|mesh-list
6159886|NCT01510145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6159887|NCT01510158|Allopurinol|allopurinol|mesh-list
6159888|NCT01510158|Lesinurad|lesinurad|mesh-list
6159889|NCT01510158|Antimetabolites|antimetabolites|mesh-ancestor
6159890|NCT01510158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159891|NCT01510158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6159892|NCT01510158|Gout Suppressants|gout suppressants|mesh-ancestor
5559292|NCT04023292|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5559293|NCT04023292|Hormone Antagonists|hormone antagonists|mesh-ancestor
6159893|NCT01510158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5559294|NCT04023292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6159894|NCT01510158|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6159895|NCT01510158|Antioxidants|antioxidants|mesh-ancestor
6488883|NCT00587496|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5559295|NCT04023292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559296|NCT04023292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5559297|NCT04023292|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5559298|NCT04023292|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5559299|NCT04023292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5559300|NCT04023305|Sevoflurane|sevoflurane|mesh-list
5559301|NCT04023305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5559302|NCT04023305|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5559303|NCT04023305|Anesthetics, General|anesthetics, general|mesh-ancestor
5559304|NCT04023305|Anesthetics|anesthetics|mesh-ancestor
5559305|NCT04023305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5559306|NCT04023305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159896|NCT01510158|Protective Agents|protective agents|mesh-ancestor
6159897|NCT01510158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159898|NCT01510158|Uricosuric Agents|uricosuric agents|mesh-ancestor
6159899|NCT01510158|Renal Agents|renal agents|mesh-ancestor
6159900|NCT01510327|Aspirin|aspirin|mesh-list
6159901|NCT01510327|Everolimus|everolimus|mesh-list
6159902|NCT01510327|Ticlopidine|ticlopidine|mesh-list
6159903|NCT01510327|Clopidogrel|clopidogrel|mesh-list
6159904|NCT01510327|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5559307|NCT04023110|Carvedilol|carvedilol|mesh-list
5559308|NCT04023110|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6159905|NCT01510327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6159906|NCT01510327|Analgesics|analgesics|mesh-ancestor
6159907|NCT01510327|Sensory System Agents|sensory system agents|mesh-ancestor
6159908|NCT01510327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6159909|NCT01510327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159910|NCT01510327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6159911|NCT01510327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6159912|NCT01510327|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6159913|NCT01510327|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6159914|NCT01510327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159915|NCT01510327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6159916|NCT01510327|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6159917|NCT01510327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6159918|NCT01510327|Antipyretics|antipyretics|mesh-ancestor
6159919|NCT01510327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6159920|NCT01510327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6159921|NCT01510327|Immunologic Factors|immunologic factors|mesh-ancestor
6159922|NCT01510327|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5559309|NCT04023110|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5559310|NCT04023110|Adrenergic Agents|adrenergic agents|mesh-ancestor
5559311|NCT04023110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5559312|NCT04023110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559313|NCT04023110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559314|NCT04023110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5559315|NCT04023110|Antioxidants|antioxidants|mesh-ancestor
6159923|NCT01510327|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6159924|NCT01510327|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6159925|NCT01510327|Purinergic Agents|purinergic agents|mesh-ancestor
6159926|NCT01510327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6159927|NCT01510327|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6159928|NCT01510327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6481141|NCT00545675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559316|NCT04023110|Protective Agents|protective agents|mesh-ancestor
6159929|NCT01510379|Promethazine|promethazine|mesh-list
6159930|NCT01510379|Diphenhydramine|diphenhydramine|mesh-list
6159931|NCT01510379|Ondansetron|ondansetron|mesh-list
6159932|NCT01510379|Antiemetics|antiemetics|mesh-ancestor
6159933|NCT01510379|Autonomic Agents|autonomic agents|mesh-ancestor
6159934|NCT01510379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6159935|NCT01510379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159936|NCT01510379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6159937|NCT01510379|Antipruritics|antipruritics|mesh-ancestor
6159938|NCT01510379|Dermatologic Agents|dermatologic agents|mesh-ancestor
6159939|NCT01510379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6159940|NCT01510379|Serotonin Agents|serotonin agents|mesh-ancestor
6159941|NCT01510379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5559317|NCT04023110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5559318|NCT04023110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5559319|NCT04023110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5559320|NCT04023110|Vasodilator Agents|vasodilator agents|mesh-ancestor
6159942|NCT01510379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159943|NCT01510379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6159944|NCT01510379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6159945|NCT01510379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6159946|NCT01510379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6481142|NCT00545675|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6481143|NCT00545675|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5559321|NCT04023110|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5559322|NCT04023110|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5559323|NCT04022837|Pantoprazole|pantoprazole|mesh-list
5559324|NCT04022837|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5559325|NCT04022837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5559326|NCT04022837|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5559327|NCT04022837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5559328|NCT04022837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559329|NCT04023019|Thrombin|thrombin|mesh-list
5559330|NCT04023019|Hemostatics|hemostatics|mesh-ancestor
5559331|NCT04023019|Coagulants|coagulants|mesh-ancestor
5559332|NCT04022811|Tobramycin|tobramycin|mesh-list
5559333|NCT04022811|Dexamethasone|dexamethasone|mesh-list
5559334|NCT04022811|Bromfenac|bromfenac|mesh-list
5559335|NCT04022811|Hyaluronic Acid|hyaluronic acid|mesh-list
5559336|NCT04022811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5559337|NCT04022811|Antiemetics|antiemetics|mesh-ancestor
5559338|NCT04022811|Autonomic Agents|autonomic agents|mesh-ancestor
6481144|NCT00545675|Serotonin Agents|serotonin agents|mesh-ancestor
6481145|NCT00545675|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6481146|NCT00545675|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6481147|NCT00545675|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6481148|NCT00545675|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6481149|NCT00545675|Anticonvulsants|anticonvulsants|mesh-ancestor
6481150|NCT00545675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6481151|NCT00545675|GABA Agents|gaba agents|mesh-ancestor
6481152|NCT00545675|Antimanic Agents|antimanic agents|mesh-ancestor
6481153|NCT00545831|Taurolidine|taurolidine|mesh-list
6481154|NCT00545831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6481155|NCT00545831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6481156|NCT00545831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6481157|NCT00545857|Pioglitazone|pioglitazone|mesh-list
6481158|NCT00545857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6481159|NCT00545857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481160|NCT00545870|Bevacizumab|bevacizumab|mesh-list
5559339|NCT04022811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5559340|NCT04022811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559341|NCT04022811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5559342|NCT04022811|Glucocorticoids|glucocorticoids|mesh-ancestor
5559343|NCT04022811|Hormones|hormones|mesh-ancestor
5559344|NCT04022811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5559345|NCT04022811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5559346|NCT04022811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5559347|NCT04022811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5559348|NCT04022811|Immunologic Factors|immunologic factors|mesh-ancestor
5559349|NCT04022811|Viscosupplements|viscosupplements|mesh-ancestor
5559350|NCT04022811|Protective Agents|protective agents|mesh-ancestor
5559351|NCT04022811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5559352|NCT04022811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5559353|NCT04022811|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5559354|NCT04022811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5559355|NCT04022811|Analgesics|analgesics|mesh-ancestor
5559356|NCT04022811|Sensory System Agents|sensory system agents|mesh-ancestor
5559357|NCT04022811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5559358|NCT04022941|Sodium Benzoate|sodium benzoate|mesh-list
5559359|NCT04022941|Antifungal Agents|antifungal agents|mesh-ancestor
5559360|NCT04022941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5559361|NCT04022876|Carboplatin|carboplatin|mesh-list
5559362|NCT04022876|Pemetrexed|pemetrexed|mesh-list
5559363|NCT04022876|Topotecan|topotecan|mesh-list
5559364|NCT04022876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5559365|NCT04022876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5559366|NCT04022876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559367|NCT04022876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5559368|NCT04022876|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5559369|NCT04022876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5559370|NCT04022876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5559371|NCT04022785|Azacitidine|azacitidine|mesh-list
5559372|NCT04022785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6481161|NCT00545870|Ranibizumab|ranibizumab|mesh-list
5559373|NCT04022785|Antimetabolites|antimetabolites|mesh-ancestor
5603410|NCT02551991|Micronutrients|micronutrients|mesh-ancestor
6481162|NCT00545870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6481163|NCT00545870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6481164|NCT00545870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6159947|NCT01510379|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6159948|NCT01510379|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6159949|NCT01510379|Histamine Antagonists|histamine antagonists|mesh-ancestor
6159950|NCT01510379|Histamine Agents|histamine agents|mesh-ancestor
6159951|NCT01510379|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6159952|NCT01510379|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6159953|NCT01510379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6159954|NCT01510379|Anesthetics, Local|anesthetics, local|mesh-ancestor
6159955|NCT01510379|Anesthetics|anesthetics|mesh-ancestor
6159956|NCT01510379|Sensory System Agents|sensory system agents|mesh-ancestor
6159957|NCT01510457|Milnacipran|milnacipran|mesh-list
6159958|NCT01510457|Levomilnacipran|levomilnacipran|mesh-list
6159959|NCT01510457|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6159960|NCT01510457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6159961|NCT01510457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6159962|NCT01510457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6159963|NCT01510457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6159964|NCT01510457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159965|NCT01510457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6159966|NCT01510457|Analgesics|analgesics|mesh-ancestor
6159967|NCT01510457|Sensory System Agents|sensory system agents|mesh-ancestor
6159968|NCT01510457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6159969|NCT01510457|Antidepressive Agents|antidepressive agents|mesh-ancestor
6159970|NCT01510457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6159971|NCT01510769|Febuxostat|febuxostat|mesh-list
6159972|NCT01510769|Lesinurad|lesinurad|mesh-list
6159973|NCT01510769|Gout Suppressants|gout suppressants|mesh-ancestor
6159974|NCT01510769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6159975|NCT01510769|Uricosuric Agents|uricosuric agents|mesh-ancestor
6159976|NCT01510769|Renal Agents|renal agents|mesh-ancestor
6159977|NCT01510912|Diclofenac|diclofenac|mesh-list
6159978|NCT01510912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6159979|NCT01510912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6159980|NCT01510912|Analgesics|analgesics|mesh-ancestor
6159981|NCT01510912|Sensory System Agents|sensory system agents|mesh-ancestor
6159982|NCT01510912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6159983|NCT01510912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159984|NCT01510912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6159985|NCT01510912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6159986|NCT01510912|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6159987|NCT01510912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6159988|NCT01510912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481165|NCT00545870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6481166|NCT00545870|Growth Substances|growth substances|mesh-ancestor
6481167|NCT00545870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481168|NCT00545870|Growth Inhibitors|growth inhibitors|mesh-ancestor
6481169|NCT00545909|Ibandronic Acid|ibandronic acid|mesh-list
6481170|NCT00545909|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6159989|NCT01511068|Sargramostim|sargramostim|mesh-list
6159990|NCT01511068|Immunologic Factors|immunologic factors|mesh-ancestor
6159991|NCT01511068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6159992|NCT01511107|Amoxicillin|amoxicillin|mesh-list
6159993|NCT01511107|Clavulanic Acid|clavulanic acid|mesh-list
6159994|NCT01511107|Clavulanic Acids|clavulanic acids|mesh-list
6159995|NCT01511107|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6159996|NCT01511107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6159997|NCT01511107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6159998|NCT01511107|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6159999|NCT01511107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6160000|NCT01511107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206038|NCT02096081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6206039|NCT02096107|Everolimus|everolimus|mesh-list
6206040|NCT02096107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6206041|NCT02096107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6206042|NCT02096107|Immunologic Factors|immunologic factors|mesh-ancestor
6206043|NCT02096107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481171|NCT00545909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559374|NCT04022785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559375|NCT04022785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6481172|NCT00545935|Artesunate|artesunate|mesh-list
6481173|NCT00545935|Amodiaquine|amodiaquine|mesh-list
6481174|NCT00545935|Antimalarials|antimalarials|mesh-ancestor
6481175|NCT00545935|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6481176|NCT00545935|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6481177|NCT00545935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6160001|NCT01511315|Ustekinumab|ustekinumab|mesh-list
6160002|NCT01511315|Dermatologic Agents|dermatologic agents|mesh-ancestor
6160003|NCT01511445|Silicon|silicon|mesh-list
6160004|NCT01511445|Trace Elements|trace elements|mesh-ancestor
6160005|NCT01511445|Micronutrients|micronutrients|mesh-ancestor
6160006|NCT01511445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160007|NCT01511536|Prednisone|prednisone|mesh-list
6160008|NCT01511536|Abiraterone Acetate|abiraterone acetate|mesh-list
6160009|NCT01511536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6160010|NCT01511536|Glucocorticoids|glucocorticoids|mesh-ancestor
6160011|NCT01511536|Hormones|hormones|mesh-ancestor
6160012|NCT01511536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6160013|NCT01511536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160014|NCT01511536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6160015|NCT01511536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6160016|NCT01511536|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6160017|NCT01511536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5559376|NCT04022785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5559377|NCT04022993|Insulin Glargine|insulin glargine|mesh-list
5559378|NCT04022993|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5559379|NCT04022993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5559380|NCT04022993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559381|NCT04022304|Isophane Insulin, Human|isophane insulin, human|mesh-list
5559382|NCT04022304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5559383|NCT04022304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559384|NCT04022473|Dimethyl Fumarate|dimethyl fumarate|mesh-list
5559385|NCT04022473|Dermatologic Agents|dermatologic agents|mesh-ancestor
5559386|NCT04022473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5559387|NCT04022473|Immunologic Factors|immunologic factors|mesh-ancestor
5559388|NCT04022473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559389|NCT04022525|Leflunomide|leflunomide|mesh-list
5559390|NCT04022525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5559391|NCT04022525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559392|NCT04022525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5559393|NCT04022525|Immunologic Factors|immunologic factors|mesh-ancestor
5559394|NCT04022525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559395|NCT04022161|Nitric Oxide|nitric oxide|mesh-list
5559396|NCT04022161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5559397|NCT04022161|Autonomic Agents|autonomic agents|mesh-ancestor
5559398|NCT04022161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5559399|NCT04022161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559400|NCT04022161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6160018|NCT01511536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160019|NCT01511536|Hormone Antagonists|hormone antagonists|mesh-ancestor
6160020|NCT01511536|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6160021|NCT01511640|Pregabalin|pregabalin|mesh-list
6160022|NCT01511640|Analgesics|analgesics|mesh-ancestor
6160023|NCT01511640|Sensory System Agents|sensory system agents|mesh-ancestor
6160024|NCT01511640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6160025|NCT01511640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160026|NCT01511640|Anticonvulsants|anticonvulsants|mesh-ancestor
6160027|NCT01511640|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6160028|NCT01511640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6160029|NCT01511640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160030|NCT01511640|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6160031|NCT01511640|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6160032|NCT01511640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6160033|NCT01511640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6160034|NCT01511640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6160035|NCT01511809|Ritonavir|ritonavir|mesh-list
6160036|NCT01511809|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6160037|NCT01511809|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6160038|NCT01511809|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6160039|NCT01511809|Protease Inhibitors|protease inhibitors|mesh-ancestor
6160040|NCT01511809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6160041|NCT01511809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160042|NCT01511809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6160043|NCT01511809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6160044|NCT01511809|Antiviral Agents|antiviral agents|mesh-ancestor
6160045|NCT01511809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6481178|NCT00545935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5559401|NCT04022161|Respiratory System Agents|respiratory system agents|mesh-ancestor
6160046|NCT01511809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6160047|NCT01511809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6160048|NCT01511939|Diclofenac|diclofenac|mesh-list
6160049|NCT01511939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
6160050|NCT01511939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
6160051|NCT01511939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6160052|NCT01511939|Analgesics|analgesics|mesh-ancestor
6160053|NCT01511939|Sensory System Agents|sensory system agents|mesh-ancestor
6160054|NCT01511939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6160055|NCT01511939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160056|NCT01511939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6160057|NCT01511939|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6160058|NCT01511939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6160059|NCT01511939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160060|NCT01511978|Amifampridine|amifampridine|mesh-list
6160061|NCT01511978|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6160062|NCT01511978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6160063|NCT01511978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160064|NCT01511978|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6160065|NCT01511978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6160066|NCT01511978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160067|NCT01512108|Liraglutide|liraglutide|mesh-list
6481179|NCT00545935|Antiviral Agents|antiviral agents|mesh-ancestor
6481180|NCT00545935|Schistosomicides|schistosomicides|mesh-ancestor
6481181|NCT00545935|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6481182|NCT00545935|Anthelmintics|anthelmintics|mesh-ancestor
5559402|NCT04022161|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6160068|NCT01512108|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6160069|NCT01512108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160070|NCT01512108|Incretins|incretins|mesh-ancestor
6160071|NCT01512108|Hormones|hormones|mesh-ancestor
6160072|NCT01512108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5559403|NCT04022161|Antioxidants|antioxidants|mesh-ancestor
5559404|NCT04022161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559405|NCT04022161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5559406|NCT04022161|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5559407|NCT04022161|Vasodilator Agents|vasodilator agents|mesh-ancestor
5559408|NCT04022161|Gasotransmitters|gasotransmitters|mesh-ancestor
5559409|NCT04022161|Protective Agents|protective agents|mesh-ancestor
5603411|NCT02547493|Abatacept|abatacept|mesh-list
5603412|NCT02547493|Vaccines|vaccines|mesh-list
5603413|NCT02547493|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6160073|NCT01512160|Ibuprofen|ibuprofen|mesh-list
6160074|NCT01512160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6160075|NCT01512160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6160076|NCT01512160|Analgesics|analgesics|mesh-ancestor
6160077|NCT01512160|Sensory System Agents|sensory system agents|mesh-ancestor
6160078|NCT01512160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6160079|NCT01512160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160080|NCT01512160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6160081|NCT01512160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6160082|NCT01512160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6160083|NCT01512160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6160084|NCT01512160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160085|NCT01512225|Domperidone|domperidone|mesh-list
6160086|NCT01512225|Maleic acid|maleic acid|mesh-list
6160087|NCT01512225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6160088|NCT01512225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160089|NCT01512225|Antiemetics|antiemetics|mesh-ancestor
6160090|NCT01512225|Autonomic Agents|autonomic agents|mesh-ancestor
6160091|NCT01512225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6160092|NCT01512225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160093|NCT01512225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6160094|NCT01512225|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6160095|NCT01512225|Dopamine Agents|dopamine agents|mesh-ancestor
6160096|NCT01512225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6160097|NCT01512251|Vemurafenib|vemurafenib|mesh-list
6160098|NCT01512251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6160099|NCT01512251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6160100|NCT01512251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6160101|NCT01512251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160102|NCT01512446|Alendronate|alendronate|mesh-list
6481183|NCT00545961|Amoxicillin|amoxicillin|mesh-list
6481184|NCT00545961|Clavulanic Acid|clavulanic acid|mesh-list
6160103|NCT01512446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6160104|NCT01512446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559410|NCT04022421|Hydroxychloroquine|hydroxychloroquine|mesh-list
5559411|NCT04022421|Antimalarials|antimalarials|mesh-ancestor
5559412|NCT04022421|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5559413|NCT04022421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5559414|NCT04022421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5559415|NCT04022421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5559416|NCT04022421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559417|NCT04022421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5559418|NCT04022096|Lansoprazole|lansoprazole|mesh-list
5559419|NCT04022096|Dexlansoprazole|dexlansoprazole|mesh-list
5559420|NCT04022096|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5559421|NCT04022096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5559422|NCT04022096|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5559423|NCT04022096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6160105|NCT01512745|Apatinib|apatinib|mesh-list
6160106|NCT01512745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6160107|NCT01512745|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6160108|NCT01512745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6160109|NCT01512745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160110|NCT01512797|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6160111|NCT01512797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5559424|NCT04022096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559425|NCT04022291|Insulin|insulin|mesh-list
5559426|NCT04022291|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5559427|NCT04022291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5559428|NCT04022291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559429|NCT04022317|Insulin|insulin|mesh-list
5559430|NCT04022317|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5559431|NCT04022317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5559432|NCT04022317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559433|NCT04022200|Paclitaxel|paclitaxel|mesh-list
5559434|NCT04022200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5559435|NCT04022200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5559436|NCT04022200|Tubulin Modulators|tubulin modulators|mesh-ancestor
5559437|NCT04022200|Antimitotic Agents|antimitotic agents|mesh-ancestor
5559438|NCT04022200|Mitosis Modulators|mitosis modulators|mesh-ancestor
5559439|NCT04022200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559440|NCT04022226|Ketamine|ketamine|mesh-list
6160112|NCT01512797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160113|NCT01512797|Incretins|incretins|mesh-ancestor
6160114|NCT01512797|Hormones|hormones|mesh-ancestor
6160115|NCT01512797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6160116|NCT01512797|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6160117|NCT01512797|Protease Inhibitors|protease inhibitors|mesh-ancestor
6160118|NCT01512797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6160119|NCT01512797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160120|NCT01512979|Metformin|metformin|mesh-list
6160121|NCT01512979|Linagliptin|linagliptin|mesh-list
6160122|NCT01512979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6160123|NCT01512979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160124|NCT01512979|Incretins|incretins|mesh-ancestor
6160125|NCT01512979|Hormones|hormones|mesh-ancestor
6160126|NCT01512979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6160127|NCT01512979|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6160128|NCT01512979|Protease Inhibitors|protease inhibitors|mesh-ancestor
6160129|NCT01512979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6160130|NCT01512979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160131|NCT01513122|Ritonavir|ritonavir|mesh-list
6160132|NCT01513122|Lopinavir|lopinavir|mesh-list
6160133|NCT01513122|Raltegravir Potassium|raltegravir potassium|mesh-list
6160134|NCT01513122|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6160135|NCT01513122|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6160136|NCT01513122|Protease Inhibitors|protease inhibitors|mesh-ancestor
6160137|NCT01513122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6160138|NCT01513122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160139|NCT01513122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6160140|NCT01513122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6160141|NCT01513122|Antiviral Agents|antiviral agents|mesh-ancestor
6160142|NCT01513122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6160143|NCT01513122|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6160144|NCT01513122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6481185|NCT00545961|Clavulanic Acids|clavulanic acids|mesh-list
5559441|NCT04022226|Methohexital|methohexital|mesh-list
5559442|NCT04022226|Analgesics|analgesics|mesh-ancestor
6160145|NCT01513122|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6160146|NCT01513122|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6160147|NCT01513317|Siltuximab|siltuximab|mesh-list
6160148|NCT01513317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6481186|NCT00545961|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6481187|NCT00545961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6481188|NCT00545961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6481189|NCT00545961|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6481190|NCT00545961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6481191|NCT00545961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481192|NCT00546039|Genistein|genistein|mesh-list
6481193|NCT00546039|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6481194|NCT00546039|Protective Agents|protective agents|mesh-ancestor
6481195|NCT00546039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481196|NCT00546039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6481197|NCT00546039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6481198|NCT00546039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6481199|NCT00546039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559443|NCT04022226|Sensory System Agents|sensory system agents|mesh-ancestor
5559444|NCT04022226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5559445|NCT04022226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559446|NCT04022226|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5559447|NCT04022226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5559448|NCT04022226|Anesthetics, General|anesthetics, general|mesh-ancestor
5559449|NCT04022226|Anesthetics|anesthetics|mesh-ancestor
5559450|NCT04022226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5559451|NCT04022226|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5559452|NCT04022226|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5559453|NCT04022226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5559454|NCT04022226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481200|NCT00546039|Phytoestrogens|phytoestrogens|mesh-ancestor
6481201|NCT00546039|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6481202|NCT00546039|Estrogens|estrogens|mesh-ancestor
6160149|NCT01513460|Glycopyrrolate|glycopyrrolate|mesh-list
6160150|NCT01513460|Tiotropium Bromide|tiotropium bromide|mesh-list
6160151|NCT01513460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6160152|NCT01513460|Autonomic Agents|autonomic agents|mesh-ancestor
6160153|NCT01513460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6160154|NCT01513460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160155|NCT01513460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6160156|NCT01513460|Respiratory System Agents|respiratory system agents|mesh-ancestor
6160157|NCT01513460|Parasympatholytics|parasympatholytics|mesh-ancestor
6160158|NCT01513460|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6160159|NCT01513460|Cholinergic Agents|cholinergic agents|mesh-ancestor
6160160|NCT01513460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6160161|NCT01513460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160162|NCT01513460|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6160163|NCT01513460|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6160164|NCT01513473|Insulin|insulin|mesh-list
6160165|NCT01513473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6160166|NCT01513473|Insulin Aspart|insulin aspart|mesh-list
6160167|NCT01513473|Insulin Detemir|insulin detemir|mesh-list
6160168|NCT01513473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6160169|NCT01513473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160170|NCT01513551|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5559455|NCT04022135|Folic Acid|folic acid|mesh-list
5559456|NCT04022135|Hematinics|hematinics|mesh-ancestor
5559457|NCT04022135|Vitamin B Complex|vitamin b complex|mesh-ancestor
5559458|NCT04022135|Vitamins|vitamins|mesh-ancestor
5559459|NCT04022135|Micronutrients|micronutrients|mesh-ancestor
6160171|NCT01513551|Immunologic Factors|immunologic factors|mesh-ancestor
6160172|NCT01513551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160173|NCT01513590|Insulin|insulin|mesh-list
6160174|NCT01513590|Insulin Aspart|insulin aspart|mesh-list
6160175|NCT01513590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6160176|NCT01513590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160177|NCT01513759|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6160178|NCT01513759|Plasminogen|plasminogen|mesh-list
6160179|NCT01513759|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6160180|NCT01513759|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6160181|NCT01513759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160182|NCT01513902|Tofacitinib|tofacitinib|mesh-list
5559460|NCT04022135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160183|NCT01513902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5559461|NCT04021992|Gemcitabine|gemcitabine|mesh-list
5559462|NCT04021992|Rituximab|rituximab|mesh-list
5559463|NCT04021992|Doxorubicin|doxorubicin|mesh-list
6160184|NCT01513902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6160185|NCT01513902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160186|NCT01514149|Metformin|metformin|mesh-list
6160187|NCT01514149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6160188|NCT01514149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559464|NCT04021992|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5559465|NCT04021992|Vinorelbine|vinorelbine|mesh-list
5559466|NCT04021992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5559467|NCT04021992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5559468|NCT04021992|Immunologic Factors|immunologic factors|mesh-ancestor
5559469|NCT04021992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559470|NCT04021992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5559471|NCT04021992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5559472|NCT04021992|Antimetabolites|antimetabolites|mesh-ancestor
5559473|NCT04021992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160189|NCT01514201|Temozolomide|temozolomide|mesh-list
6160190|NCT01514201|Veliparib|veliparib|mesh-list
6160191|NCT01514201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6160192|NCT01514201|Alkylating Agents|alkylating agents|mesh-ancestor
6160193|NCT01514201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160194|NCT01514201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6481203|NCT00546039|Hormones|hormones|mesh-ancestor
6481204|NCT00546039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6481205|NCT00546065|Esomeprazole|esomeprazole|mesh-list
6481206|NCT00546065|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6481207|NCT00546065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6481208|NCT00546065|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6481209|NCT00546065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6481210|NCT00546065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481211|NCT00546130|polysaccharide-K|polysaccharide-k|mesh-list
6481212|NCT00546130|Cisplatin|cisplatin|mesh-list
6481213|NCT00546130|Irinotecan|irinotecan|mesh-list
6481214|NCT00546130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6481215|NCT00546130|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6481216|NCT00546130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6481217|NCT00546130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6481218|NCT00546130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481219|NCT00546130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6481220|NCT00546130|Immunologic Factors|immunologic factors|mesh-ancestor
6481221|NCT00546130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481222|NCT00546130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6481223|NCT00546130|Antiviral Agents|antiviral agents|mesh-ancestor
6481224|NCT00546130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6160195|NCT01514201|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6160196|NCT01514201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6160197|NCT01514240|Mesalamine|mesalamine|mesh-list
6160198|NCT01514240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6160199|NCT01514240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6160200|NCT01514240|Analgesics|analgesics|mesh-ancestor
6160201|NCT01514240|Sensory System Agents|sensory system agents|mesh-ancestor
6160202|NCT01514240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6160203|NCT01514240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160204|NCT01514240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6160205|NCT01514240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6160206|NCT01514357|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6160207|NCT01514357|Natriuretic Agents|natriuretic agents|mesh-ancestor
6160208|NCT01514357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160209|NCT01514370|Interferons|interferons|mesh-list
6160210|NCT01514370|Interferon-beta|interferon-beta|mesh-list
6160211|NCT01514370|Interferon beta-1a|interferon beta-1a|mesh-list
6160212|NCT01514370|Curcumin|curcumin|mesh-list
6160213|NCT01514370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6160214|NCT01514370|Antiviral Agents|antiviral agents|mesh-ancestor
6160215|NCT01514370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6160216|NCT01514370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6160217|NCT01514370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6160218|NCT01514370|Analgesics|analgesics|mesh-ancestor
6160219|NCT01514370|Sensory System Agents|sensory system agents|mesh-ancestor
6160220|NCT01514370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6481225|NCT00546130|Interferon Inducers|interferon inducers|mesh-ancestor
6481226|NCT00546130|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6481227|NCT00546130|Protective Agents|protective agents|mesh-ancestor
6481228|NCT00546143|Omalizumab|omalizumab|mesh-list
6481229|NCT00546143|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6160221|NCT01514370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160222|NCT01514370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6160223|NCT01514370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6160224|NCT01514370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6160225|NCT01514370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160226|NCT01514370|Immunologic Factors|immunologic factors|mesh-ancestor
6160227|NCT01514370|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6160228|NCT01514422|Minocycline|minocycline|mesh-list
6481230|NCT00546143|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6481231|NCT00546143|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6481232|NCT00546143|Respiratory System Agents|respiratory system agents|mesh-ancestor
6481233|NCT00546143|Immunologic Factors|immunologic factors|mesh-ancestor
6481234|NCT00546143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481235|NCT00546169|Thrombin|thrombin|mesh-list
6481236|NCT00546169|Hemostatics|hemostatics|mesh-ancestor
6481237|NCT00546169|Coagulants|coagulants|mesh-ancestor
6160229|NCT01514422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6160230|NCT01514422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6160231|NCT01514448|Everolimus|everolimus|mesh-list
6160232|NCT01514448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6160233|NCT01514448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6160234|NCT01514448|Immunologic Factors|immunologic factors|mesh-ancestor
6160235|NCT01514448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160236|NCT01514513|Permethrin|permethrin|mesh-list
6160237|NCT01514513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6160238|NCT01514513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160239|NCT01514682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
6160240|NCT01514734|Timolol|timolol|mesh-list
6160241|NCT01514734|Brinzolamide|brinzolamide|mesh-list
6160242|NCT01514734|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6160243|NCT01514734|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6160244|NCT01514734|Adrenergic Agents|adrenergic agents|mesh-ancestor
6160245|NCT01514734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6668425|NCT01532115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6668426|NCT01532115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6668427|NCT01532115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6668428|NCT01532115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6668429|NCT01532115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6668430|NCT01532115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160246|NCT01514734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160247|NCT01514734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160248|NCT01514734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6160249|NCT01514734|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6160250|NCT01514734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6160251|NCT01514734|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6160252|NCT01514864|Dasatinib|dasatinib|mesh-list
6160253|NCT01514864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6160254|NCT01514864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6160255|NCT01514864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6160256|NCT01514864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160257|NCT01515046|Ascorbic Acid|ascorbic acid|mesh-list
6160258|NCT01515046|Gemcitabine|gemcitabine|mesh-list
6160259|NCT01515046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6160260|NCT01515046|Antimetabolites|antimetabolites|mesh-ancestor
6160261|NCT01515046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160262|NCT01515046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6160263|NCT01515046|Antiviral Agents|antiviral agents|mesh-ancestor
6160264|NCT01515046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6160265|NCT01515046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6160266|NCT01515046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6160267|NCT01515046|Immunologic Factors|immunologic factors|mesh-ancestor
6160268|NCT01515046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160269|NCT01515046|Antioxidants|antioxidants|mesh-ancestor
6160270|NCT01515046|Protective Agents|protective agents|mesh-ancestor
6160271|NCT01515046|Vitamins|vitamins|mesh-ancestor
6160272|NCT01515046|Micronutrients|micronutrients|mesh-ancestor
6160273|NCT01515176|Ofatumumab|ofatumumab|mesh-list
6481238|NCT00546234|Tiotropium Bromide|tiotropium bromide|mesh-list
6160274|NCT01515176|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6160275|NCT01515176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6160276|NCT01515176|Immunologic Factors|immunologic factors|mesh-ancestor
6160277|NCT01515176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160278|NCT01515189|Ipilimumab|ipilimumab|mesh-list
6160279|NCT01515189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6160280|NCT01515189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6160281|NCT01515189|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6160282|NCT01515189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160283|NCT01515306|Paclitaxel|paclitaxel|mesh-list
6160284|NCT01515306|Ramucirumab|ramucirumab|mesh-list
6160285|NCT01515306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6160286|NCT01515306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6160287|NCT01515306|Tubulin Modulators|tubulin modulators|mesh-ancestor
6160288|NCT01515306|Antimitotic Agents|antimitotic agents|mesh-ancestor
6160289|NCT01515306|Mitosis Modulators|mitosis modulators|mesh-ancestor
6160290|NCT01515306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160291|NCT01515345|Clopidogrel|clopidogrel|mesh-list
6160292|NCT01515345|Ticagrelor|ticagrelor|mesh-list
6160293|NCT01515345|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6160294|NCT01515345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6160295|NCT01515345|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6160296|NCT01515345|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6160297|NCT01515345|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6160298|NCT01515345|Purinergic Agents|purinergic agents|mesh-ancestor
6160299|NCT01515345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6481239|NCT00546234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6481240|NCT00546234|Autonomic Agents|autonomic agents|mesh-ancestor
6481241|NCT00546234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6481242|NCT00546234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481243|NCT00546234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6481244|NCT00546234|Respiratory System Agents|respiratory system agents|mesh-ancestor
6160300|NCT01515345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559474|NCT04021992|Antiviral Agents|antiviral agents|mesh-ancestor
5559475|NCT04021992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5559476|NCT04021992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5559477|NCT04021992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5559478|NCT04021992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5559479|NCT04021992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5559480|NCT04021992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5559481|NCT04021992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6160301|NCT01515345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160302|NCT01515410|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
6160303|NCT01515410|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6160304|NCT01515410|Immunologic Factors|immunologic factors|mesh-ancestor
6160305|NCT01515410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160306|NCT01515410|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6160307|NCT01515410|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6160308|NCT01515410|Dopamine Agonists|dopamine agonists|mesh-ancestor
6160309|NCT01515410|Dopamine Agents|dopamine agents|mesh-ancestor
6160310|NCT01515410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6160311|NCT01515410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160312|NCT01515423|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6160313|NCT01515423|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6160314|NCT01515423|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6160315|NCT01515423|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6160316|NCT01515540|Lidocaine|lidocaine|mesh-list
6160317|NCT01515540|Anesthetics, Local|anesthetics, local|mesh-ancestor
6160318|NCT01515540|Anesthetics|anesthetics|mesh-ancestor
6160319|NCT01515540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5559482|NCT04021992|Tubulin Modulators|tubulin modulators|mesh-ancestor
5559483|NCT04021992|Antimitotic Agents|antimitotic agents|mesh-ancestor
5559484|NCT04021992|Mitosis Modulators|mitosis modulators|mesh-ancestor
5559485|NCT04022005|Gemcitabine|gemcitabine|mesh-list
5559486|NCT04022005|Rituximab|rituximab|mesh-list
5559487|NCT04022005|Oxaliplatin|oxaliplatin|mesh-list
6160320|NCT01515540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160321|NCT01515540|Sensory System Agents|sensory system agents|mesh-ancestor
6160322|NCT01515540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6160323|NCT01515540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6160324|NCT01515540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6160325|NCT01515540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5559488|NCT04022005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6160326|NCT01515540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6160327|NCT01515540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160328|NCT01515566|Fentanyl|fentanyl|mesh-list
6160329|NCT01515566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6160330|NCT01515566|Narcotics|narcotics|mesh-ancestor
6160331|NCT01515566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6160332|NCT01515566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160333|NCT01515566|Analgesics|analgesics|mesh-ancestor
6160334|NCT01515566|Sensory System Agents|sensory system agents|mesh-ancestor
6160335|NCT01515566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6160336|NCT01515566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6160337|NCT01515566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6160338|NCT01515566|Anesthetics, General|anesthetics, general|mesh-ancestor
6481245|NCT00546234|Parasympatholytics|parasympatholytics|mesh-ancestor
6481246|NCT00546234|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6481247|NCT00546234|Cholinergic Agents|cholinergic agents|mesh-ancestor
6481248|NCT00546234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6481249|NCT00546234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481250|NCT00546286|Timolol|timolol|mesh-list
6481251|NCT00546286|Dorzolamide|dorzolamide|mesh-list
6481252|NCT00546286|Maleic acid|maleic acid|mesh-list
6481253|NCT00546286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6481254|NCT00546286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6481255|NCT00546286|Adrenergic Agents|adrenergic agents|mesh-ancestor
6481256|NCT00546286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6481257|NCT00546286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481258|NCT00546286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481259|NCT00546286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6481260|NCT00546286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6481261|NCT00546286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6481262|NCT00546286|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6481263|NCT00546325|Rimonabant|rimonabant|mesh-list
6481264|NCT00546325|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6481265|NCT00546325|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
6481266|NCT00546325|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6481267|NCT00546325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6481268|NCT00546325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481269|NCT00546325|Hormones|hormones|mesh-ancestor
6481270|NCT00546325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6481271|NCT00546325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481272|NCT00546403|Modafinil|modafinil|mesh-list
6481273|NCT00546403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5559489|NCT04022005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5559490|NCT04022005|Immunologic Factors|immunologic factors|mesh-ancestor
5559491|NCT04022005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559492|NCT04022005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5559493|NCT04022005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5559494|NCT04022005|Antimetabolites|antimetabolites|mesh-ancestor
5559495|NCT04022005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559496|NCT04022005|Antiviral Agents|antiviral agents|mesh-ancestor
5559497|NCT04022005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5559498|NCT04022005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5559499|NCT04022005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5559500|NCT04022057|Ropivacaine|ropivacaine|mesh-list
5559501|NCT04022057|Anesthetics, Local|anesthetics, local|mesh-ancestor
6481274|NCT00546403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481275|NCT00546403|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6481276|NCT00546403|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6481277|NCT00546403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6481278|NCT00546403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481279|NCT00546442|Metformin|metformin|mesh-list
6481280|NCT00546442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5559502|NCT04022057|Anesthetics|anesthetics|mesh-ancestor
5559503|NCT04022057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5559504|NCT04022057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160339|NCT01515566|Anesthetics|anesthetics|mesh-ancestor
6160340|NCT01515657|Aspirin|aspirin|mesh-list
6160341|NCT01515657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5559505|NCT04022057|Sensory System Agents|sensory system agents|mesh-ancestor
5559506|NCT04022057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5559507|NCT04021498|Simvastatin|simvastatin|mesh-list
5559508|NCT04021498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6160342|NCT01515657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6160343|NCT01515657|Analgesics|analgesics|mesh-ancestor
6160344|NCT01515657|Sensory System Agents|sensory system agents|mesh-ancestor
6160345|NCT01515657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6160346|NCT01515657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160347|NCT01515657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6160348|NCT01515657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6160349|NCT01515657|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6160350|NCT01515657|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6160351|NCT01515657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160352|NCT01515657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6160353|NCT01515657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6160354|NCT01515657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6160355|NCT01515657|Antipyretics|antipyretics|mesh-ancestor
6160356|NCT01515748|Docetaxel|docetaxel|mesh-list
6160357|NCT01515748|Fluorouracil|fluorouracil|mesh-list
6160358|NCT01515748|Oxaliplatin|oxaliplatin|mesh-list
6160359|NCT01515748|Tegafur|tegafur|mesh-list
6160360|NCT01515748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6160361|NCT01515748|Tubulin Modulators|tubulin modulators|mesh-ancestor
6160362|NCT01515748|Antimitotic Agents|antimitotic agents|mesh-ancestor
6160363|NCT01515748|Mitosis Modulators|mitosis modulators|mesh-ancestor
6160364|NCT01515748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160365|NCT01515748|Antimetabolites|antimetabolites|mesh-ancestor
6160366|NCT01515748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6160367|NCT01515748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6160368|NCT01515748|Immunologic Factors|immunologic factors|mesh-ancestor
6160369|NCT01515748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160370|NCT01515865|Midodrine|midodrine|mesh-list
6481281|NCT00546442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481282|NCT00546494|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6481283|NCT00546494|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6481284|NCT00546494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6481285|NCT00546494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5559509|NCT04021498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5559510|NCT04021498|Antimetabolites|antimetabolites|mesh-ancestor
5559511|NCT04021498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559512|NCT04021498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5559513|NCT04021498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5559514|NCT04021498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5559515|NCT04021524|Chlorhexidine|chlorhexidine|mesh-list
5559516|NCT04021524|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5559517|NCT04021524|Benzoyl Peroxide|benzoyl peroxide|mesh-list
5559518|NCT04021524|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5559519|NCT04021524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5559520|NCT04021524|Disinfectants|disinfectants|mesh-ancestor
5559521|NCT04021524|Dermatologic Agents|dermatologic agents|mesh-ancestor
5559522|NCT04021550|Thioctic Acid|thioctic acid|mesh-list
5559523|NCT04021550|Telmisartan|telmisartan|mesh-list
5559524|NCT04021550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5559525|NCT04021550|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6481286|NCT00546494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481287|NCT00546494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6481288|NCT00546494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481289|NCT00546494|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6481290|NCT00546494|Antidepressive Agents|antidepressive agents|mesh-ancestor
6160371|NCT01515865|Sympathomimetics|sympathomimetics|mesh-ancestor
6160372|NCT01515865|Autonomic Agents|autonomic agents|mesh-ancestor
6160373|NCT01515865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6668431|NCT01532115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6668432|NCT01532115|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6668433|NCT01532115|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6668434|NCT01532115|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6160374|NCT01515865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160375|NCT01515865|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6481291|NCT00546494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6481292|NCT00546507|Celecoxib|celecoxib|mesh-list
6481293|NCT00546507|Diclofenac|diclofenac|mesh-list
6481294|NCT00546507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6481295|NCT00546507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6481296|NCT00546507|Analgesics|analgesics|mesh-ancestor
6481297|NCT00546507|Sensory System Agents|sensory system agents|mesh-ancestor
6481298|NCT00546507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5559526|NCT04021550|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6481299|NCT00546507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559527|NCT04021550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559528|NCT04021550|Antioxidants|antioxidants|mesh-ancestor
5559529|NCT04021550|Protective Agents|protective agents|mesh-ancestor
5559530|NCT04021550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559531|NCT04021550|Vitamin B Complex|vitamin b complex|mesh-ancestor
5559532|NCT04021550|Vitamins|vitamins|mesh-ancestor
5559533|NCT04021550|Micronutrients|micronutrients|mesh-ancestor
5559534|NCT04021433|Ketamine|ketamine|mesh-list
5559535|NCT04021433|Analgesics|analgesics|mesh-ancestor
5559536|NCT04021433|Sensory System Agents|sensory system agents|mesh-ancestor
5559537|NCT04021433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5559538|NCT04021433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559539|NCT04021433|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5559540|NCT04021433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5559541|NCT04021433|Anesthetics, General|anesthetics, general|mesh-ancestor
5559542|NCT04021433|Anesthetics|anesthetics|mesh-ancestor
5559543|NCT04021433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5559544|NCT04021433|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5559545|NCT04021433|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6481300|NCT00546507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6481301|NCT00546507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6481302|NCT00546507|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6481303|NCT00546507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6481304|NCT00546507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6481305|NCT00546507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481306|NCT00546520|Ciclesonide|ciclesonide|mesh-list
6481307|NCT00546520|Glucocorticoids|glucocorticoids|mesh-ancestor
6481308|NCT00546520|Hormones|hormones|mesh-ancestor
6160376|NCT01515865|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6160377|NCT01515865|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6160378|NCT01515865|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6160379|NCT01515865|Adrenergic Agents|adrenergic agents|mesh-ancestor
6160380|NCT01515865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6160381|NCT01515865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160382|NCT01515891|Opicapone|opicapone|mesh-list
6160383|NCT01515891|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6160384|NCT01515891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6160385|NCT01515891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160386|NCT01515891|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6160387|NCT01515891|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6160388|NCT01515995|Magnesium Sulfate|magnesium sulfate|mesh-list
6160389|NCT01515995|Analgesics|analgesics|mesh-ancestor
6160390|NCT01515995|Sensory System Agents|sensory system agents|mesh-ancestor
6160391|NCT01515995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6481309|NCT00546520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6481310|NCT00546520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481311|NCT00546520|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6481312|NCT00546533|Etanercept|etanercept|mesh-list
6481313|NCT00546533|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6481314|NCT00546533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6481315|NCT00546533|Analgesics|analgesics|mesh-ancestor
6481316|NCT00546533|Sensory System Agents|sensory system agents|mesh-ancestor
6481317|NCT00546533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6481318|NCT00546533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481319|NCT00546533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6481320|NCT00546533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6481321|NCT00546533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6481322|NCT00546533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6481323|NCT00546533|Immunologic Factors|immunologic factors|mesh-ancestor
6481324|NCT00546546|Methotrexate|methotrexate|mesh-list
6481325|NCT00546546|Azathioprine|azathioprine|mesh-list
6481326|NCT00546546|Immunosuppressive Agents|immunosuppressive agents|mesh-list
5559546|NCT04021433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6160392|NCT01515995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160393|NCT01515995|Anesthetics|anesthetics|mesh-ancestor
6160394|NCT01515995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6160395|NCT01515995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6160396|NCT01515995|Anticonvulsants|anticonvulsants|mesh-ancestor
6160397|NCT01515995|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6160398|NCT01515995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6160399|NCT01515995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160400|NCT01515995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6481327|NCT00546546|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6481328|NCT00546546|Abortifacient Agents|abortifacient agents|mesh-ancestor
6160401|NCT01515995|Tocolytic Agents|tocolytic agents|mesh-ancestor
5559547|NCT04021433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559548|NCT04021420|Nivolumab|nivolumab|mesh-list
5559549|NCT04021420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5559550|NCT04021420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5559551|NCT04021420|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5559552|NCT04021420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559553|NCT04021225|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5559554|NCT04021225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5559555|NCT04021264|Sufentanil|sufentanil|mesh-list
5559556|NCT04021264|Ropivacaine|ropivacaine|mesh-list
5559557|NCT04021264|Anesthetics, Local|anesthetics, local|mesh-ancestor
5559558|NCT04021264|Anesthetics|anesthetics|mesh-ancestor
5559559|NCT04021264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5559560|NCT04021264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559561|NCT04021264|Sensory System Agents|sensory system agents|mesh-ancestor
5559562|NCT04021264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5559563|NCT04021264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5559564|NCT04021264|Narcotics|narcotics|mesh-ancestor
5559565|NCT04021264|Analgesics|analgesics|mesh-ancestor
5559566|NCT04021264|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5559567|NCT04021264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5559568|NCT04021264|Anesthetics, General|anesthetics, general|mesh-ancestor
5559569|NCT04021108|Nivolumab|nivolumab|mesh-list
5559570|NCT04021108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6160402|NCT01515995|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6160403|NCT01516008|Tapentadol|tapentadol|mesh-list
6160404|NCT01516008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6481329|NCT00546546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6481330|NCT00546546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481331|NCT00546546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6481332|NCT00546546|Antimetabolites|antimetabolites|mesh-ancestor
5559571|NCT04021108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5559572|NCT04021108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5559573|NCT04021108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559574|NCT04020913|Hormones|hormones|mesh-list
5559575|NCT04020913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5559576|NCT04020913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559577|NCT04021121|Linezolid|linezolid|mesh-list
6481333|NCT00546546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481334|NCT00546546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6481335|NCT00546546|Dermatologic Agents|dermatologic agents|mesh-ancestor
6481336|NCT00546546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6481337|NCT00546546|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6481338|NCT00546546|Immunologic Factors|immunologic factors|mesh-ancestor
6481339|NCT00546546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6481340|NCT00546546|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6481341|NCT00546559|Simvastatin|simvastatin|mesh-list
6481342|NCT00546559|Pravastatin|pravastatin|mesh-list
6481343|NCT00546559|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6160405|NCT01516008|Narcotics|narcotics|mesh-ancestor
6160406|NCT01516008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6160407|NCT01516008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160408|NCT01516008|Analgesics|analgesics|mesh-ancestor
6160409|NCT01516008|Sensory System Agents|sensory system agents|mesh-ancestor
6481344|NCT00546559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6481345|NCT00546559|Antimetabolites|antimetabolites|mesh-ancestor
6481346|NCT00546559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481347|NCT00546559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6668435|NCT01532154|4-Aminopyridine|4-aminopyridine|mesh-list
5559578|NCT04021121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6160410|NCT01516008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6160411|NCT01516008|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6160412|NCT01516008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6160413|NCT01516008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6160414|NCT01516008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160415|NCT01516008|Adrenergic Agents|adrenergic agents|mesh-ancestor
6160416|NCT01516008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6160417|NCT01516268|Sufentanil|sufentanil|mesh-list
6160418|NCT01516268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6160419|NCT01516268|Narcotics|narcotics|mesh-ancestor
6160420|NCT01516268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6160421|NCT01516268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160422|NCT01516268|Analgesics|analgesics|mesh-ancestor
6481348|NCT00546559|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6481349|NCT00546559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6481350|NCT00546650|Sumatriptan|sumatriptan|mesh-list
6481351|NCT00546650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6481352|NCT00546650|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6481353|NCT00546650|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6481354|NCT00546650|Serotonin Agents|serotonin agents|mesh-ancestor
6481355|NCT00546650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6481356|NCT00546650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481357|NCT00546650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481358|NCT00546676|Telithromycin|telithromycin|mesh-list
6481359|NCT00546676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6481360|NCT00546676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6160423|NCT01516268|Sensory System Agents|sensory system agents|mesh-ancestor
6160424|NCT01516268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6160425|NCT01516268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6160426|NCT01516268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6160427|NCT01516268|Anesthetics, General|anesthetics, general|mesh-ancestor
6160428|NCT01516268|Anesthetics|anesthetics|mesh-ancestor
6481361|NCT00546741|Metformin|metformin|mesh-list
6481362|NCT00546741|Dapagliflozin|dapagliflozin|mesh-list
6481363|NCT00546741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6481364|NCT00546741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481365|NCT00546741|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6481366|NCT00546741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481367|NCT00546832|Celecoxib|celecoxib|mesh-list
6481368|NCT00546832|Diclofenac|diclofenac|mesh-list
6160429|NCT01516424|Risperidone|risperidone|mesh-list
6160430|NCT01516424|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6160431|NCT01516424|Serotonin Agents|serotonin agents|mesh-ancestor
6160432|NCT01516424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6481369|NCT00546832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6481370|NCT00546832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6481371|NCT00546832|Analgesics|analgesics|mesh-ancestor
6160433|NCT01516424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160434|NCT01516424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160435|NCT01516424|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6160436|NCT01516424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6160437|NCT01516424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6160438|NCT01516424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6160439|NCT01516424|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6160440|NCT01516424|Dopamine Agents|dopamine agents|mesh-ancestor
6160441|NCT01516684|Lidocaine|lidocaine|mesh-list
6160442|NCT01516684|Fentanyl|fentanyl|mesh-list
6160443|NCT01516684|Anesthetics, Local|anesthetics, local|mesh-list
6160444|NCT01516684|Prilocaine|prilocaine|mesh-list
6160445|NCT01516684|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
6160446|NCT01516684|Propofol|propofol|mesh-list
6160447|NCT01516684|Anesthetics|anesthetics|mesh-list
6160448|NCT01516684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6160449|NCT01516684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160450|NCT01516684|Sensory System Agents|sensory system agents|mesh-ancestor
6160451|NCT01516684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6160452|NCT01516684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6160453|NCT01516684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6160454|NCT01516684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6160455|NCT01516684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6160456|NCT01516684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160457|NCT01516684|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6160458|NCT01516684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6160459|NCT01516684|Anesthetics, General|anesthetics, general|mesh-ancestor
6160460|NCT01516684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6160461|NCT01516684|Narcotics|narcotics|mesh-ancestor
6160462|NCT01516684|Analgesics|analgesics|mesh-ancestor
6160463|NCT01516684|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6160464|NCT01516684|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
6160465|NCT01516749|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6160466|NCT01516749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6160467|NCT01516879|Atorvastatin|atorvastatin|mesh-list
6160468|NCT01516879|Ezetimibe|ezetimibe|mesh-list
6160469|NCT01516879|Evolocumab|evolocumab|mesh-list
6160470|NCT01516879|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6160471|NCT01516879|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6160472|NCT01516879|Antimetabolites|antimetabolites|mesh-ancestor
6160473|NCT01516879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481372|NCT00546832|Sensory System Agents|sensory system agents|mesh-ancestor
6160474|NCT01516879|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6160475|NCT01516879|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6160476|NCT01516879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6160477|NCT01516892|Botulinum Toxins|botulinum toxins|mesh-list
6160478|NCT01516892|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6160479|NCT01516892|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6160480|NCT01516892|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6160481|NCT01516892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6160482|NCT01516892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160483|NCT01516892|Cholinergic Agents|cholinergic agents|mesh-ancestor
6160484|NCT01516892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6160485|NCT01516892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160486|NCT01516892|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6160487|NCT01516892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6160488|NCT01516957|Brodalumab|brodalumab|mesh-list
6160489|NCT01516957|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6160490|NCT01516957|Dermatologic Agents|dermatologic agents|mesh-ancestor
6160491|NCT01516957|Immunologic Factors|immunologic factors|mesh-ancestor
5559579|NCT04021121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5559580|NCT04021121|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5559581|NCT04021121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6160492|NCT01516957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481373|NCT00546832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6481374|NCT00546832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481375|NCT00546832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6160493|NCT01516970|Ritonavir|ritonavir|mesh-list
6160494|NCT01516970|Lopinavir|lopinavir|mesh-list
6160495|NCT01516970|Darunavir|darunavir|mesh-list
6160496|NCT01516970|Zidovudine|zidovudine|mesh-list
6160497|NCT01516970|Efavirenz|efavirenz|mesh-list
6160498|NCT01516970|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6160499|NCT01516970|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6160500|NCT01516970|Protease Inhibitors|protease inhibitors|mesh-ancestor
6160501|NCT01516970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6160502|NCT01516970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160503|NCT01516970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6160504|NCT01516970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6160505|NCT01516970|Antiviral Agents|antiviral agents|mesh-ancestor
6160506|NCT01516970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6160507|NCT01516970|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6160508|NCT01516970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6160509|NCT01516970|Antimetabolites|antimetabolites|mesh-ancestor
6160510|NCT01516970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6160511|NCT01516970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6160512|NCT01516970|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6160513|NCT01516970|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6160514|NCT01516970|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6160515|NCT01516970|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6160516|NCT01516970|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6160517|NCT01517074|Sirolimus|sirolimus|mesh-list
6160518|NCT01517074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6160519|NCT01517074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6160520|NCT01517074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6160521|NCT01517074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6160522|NCT01517074|Antifungal Agents|antifungal agents|mesh-ancestor
6160523|NCT01517074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6160524|NCT01517074|Immunologic Factors|immunologic factors|mesh-ancestor
6160525|NCT01517074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160526|NCT01517295|Hydrocodone|hydrocodone|mesh-list
6160527|NCT01517295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6160528|NCT01517295|Narcotics|narcotics|mesh-ancestor
6160529|NCT01517295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6160530|NCT01517295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160531|NCT01517295|Analgesics|analgesics|mesh-ancestor
6160532|NCT01517295|Sensory System Agents|sensory system agents|mesh-ancestor
6481376|NCT00546832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6481377|NCT00546832|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6481378|NCT00546832|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6481379|NCT00546832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6481380|NCT00546832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481381|NCT00546923|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6481382|NCT00546923|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5559582|NCT04021121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481383|NCT00546923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6481384|NCT00546923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6481385|NCT00546923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160533|NCT01517295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6160534|NCT01517295|Antitussive Agents|antitussive agents|mesh-ancestor
6160535|NCT01517295|Respiratory System Agents|respiratory system agents|mesh-ancestor
6160536|NCT01517373|Glimepiride|glimepiride|mesh-list
6160537|NCT01517373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6668436|NCT01532154|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6668437|NCT01532154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5559583|NCT04021017|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5559584|NCT04021017|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5559585|NCT04021017|Estradiol|estradiol|mesh-list
5559586|NCT04021017|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5559587|NCT04021017|Estrogens|estrogens|mesh-ancestor
5559588|NCT04021017|Hormones|hormones|mesh-ancestor
5559589|NCT04021017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5559590|NCT04021017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559591|NCT04021017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5559592|NCT04021017|Contraceptive Agents|contraceptive agents|mesh-ancestor
5559593|NCT04021017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5559594|NCT04021017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5559595|NCT04021173|Fibrinolysin|fibrinolysin|mesh-list
5559596|NCT04021173|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5559597|NCT04021173|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5559598|NCT04021173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559599|NCT04020718|Nicotine|nicotine|mesh-list
5559600|NCT04020718|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5559601|NCT04020718|Autonomic Agents|autonomic agents|mesh-ancestor
5559602|NCT04020718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5559603|NCT04020718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559604|NCT04020718|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5559605|NCT04020718|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5559606|NCT04020718|Cholinergic Agents|cholinergic agents|mesh-ancestor
5559607|NCT04020718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6160538|NCT01517373|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6160539|NCT01517373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160540|NCT01517373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6160541|NCT01517373|Immunologic Factors|immunologic factors|mesh-ancestor
6160542|NCT01517412|Metformin|metformin|mesh-list
6160543|NCT01517412|Lixisenatide|lixisenatide|mesh-list
6160544|NCT01517412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6160545|NCT01517412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160546|NCT01517750|Immunoconjugates|immunoconjugates|mesh-list
6160547|NCT01517750|Immunologic Factors|immunologic factors|mesh-ancestor
6160548|NCT01517750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206044|NCT02096263|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6206045|NCT02096263|Immunologic Factors|immunologic factors|mesh-ancestor
6206046|NCT02096263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206047|NCT02096458|Dexlansoprazole|dexlansoprazole|mesh-list
6206048|NCT02096458|Lansoprazole|lansoprazole|mesh-list
6206049|NCT02096458|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6206050|NCT02096458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6206051|NCT02096458|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6206052|NCT02096458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6206053|NCT02096458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206054|NCT02096575|Nitrous Oxide|nitrous oxide|mesh-list
6206055|NCT02096575|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6206056|NCT02096575|Anesthetics, General|anesthetics, general|mesh-ancestor
5559608|NCT04020718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559609|NCT04020666|Kallikreins|kallikreins|mesh-list
6206057|NCT02096575|Anesthetics|anesthetics|mesh-ancestor
6481386|NCT00546923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6481387|NCT00546923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481388|NCT00546923|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6481389|NCT00546923|Antidepressive Agents|antidepressive agents|mesh-ancestor
6481390|NCT00546923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6481391|NCT00546936|Ranibizumab|ranibizumab|mesh-list
6481392|NCT00546936|Verteporfin|verteporfin|mesh-list
6481393|NCT00546936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6481394|NCT00546936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6481395|NCT00546936|Growth Substances|growth substances|mesh-ancestor
6481396|NCT00546936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481397|NCT00546936|Growth Inhibitors|growth inhibitors|mesh-ancestor
5559610|NCT04020666|Coagulants|coagulants|mesh-ancestor
5559611|NCT04020666|Fertility Agents, Male|fertility agents, male|mesh-ancestor
5559612|NCT04020666|Fertility Agents|fertility agents|mesh-ancestor
5559613|NCT04020666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5559614|NCT04020666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559615|NCT04020653|Ferrous citrate|ferrous citrate|mesh-list
5559616|NCT04020653|Lumefantrine|lumefantrine|mesh-list
5559617|NCT04020653|Artemether|artemether|mesh-list
5559618|NCT04020653|Artemisinins|artemisinins|mesh-list
5559619|NCT04020653|Artemisinin|artemisinin|mesh-list
5559620|NCT04020653|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5559621|NCT04020653|Citric Acid|citric acid|mesh-list
5559622|NCT04020653|Sodium Citrate|sodium citrate|mesh-list
5559623|NCT04020653|Anticoagulants|anticoagulants|mesh-ancestor
5559624|NCT04020653|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5559625|NCT04020653|Chelating Agents|chelating agents|mesh-ancestor
5559626|NCT04020653|Sequestering Agents|sequestering agents|mesh-ancestor
6160549|NCT01517893|Simvastatin|simvastatin|mesh-list
6160550|NCT01517893|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5559627|NCT04020653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559628|NCT04020653|Antimalarials|antimalarials|mesh-ancestor
5559629|NCT04020653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5559630|NCT04020653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5559631|NCT04020653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5559632|NCT04020653|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5559633|NCT04020653|Dermatologic Agents|dermatologic agents|mesh-ancestor
5559634|NCT04020653|Trace Elements|trace elements|mesh-ancestor
5559635|NCT04020653|Micronutrients|micronutrients|mesh-ancestor
5559636|NCT04020653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559637|NCT04021043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5559638|NCT04021043|Nivolumab|nivolumab|mesh-list
5559639|NCT04021043|Ipilimumab|ipilimumab|mesh-list
5559640|NCT04021043|Antibodies|antibodies|mesh-list
5559641|NCT04021043|Immunoglobulins|immunoglobulins|mesh-list
5559642|NCT04021043|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5559643|NCT04021043|Immunologic Factors|immunologic factors|mesh-ancestor
5559644|NCT04021043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559645|NCT04021043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5559646|NCT04021043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5559647|NCT04021043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603414|NCT02547493|Immunologic Factors|immunologic factors|mesh-ancestor
5603415|NCT02547493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603416|NCT02547493|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5603417|NCT02547493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603418|NCT02547493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5603419|NCT02547493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5603420|NCT02547493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5603421|NCT02537613|Obinutuzumab|obinutuzumab|mesh-list
5603422|NCT02537613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5603423|NCT02537613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5603424|NCT02496611|Exenatide|exenatide|mesh-list
5603425|NCT02496611|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5603426|NCT02496611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160551|NCT01517893|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6160552|NCT01517893|Antimetabolites|antimetabolites|mesh-ancestor
6160553|NCT01517893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160554|NCT01517893|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6160555|NCT01517893|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6160556|NCT01517893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6160557|NCT01517984|Mycophenolic Acid|mycophenolic acid|mesh-list
6160558|NCT01517984|Prednisone|prednisone|mesh-list
6160559|NCT01517984|Tacrolimus|tacrolimus|mesh-list
6160560|NCT01517984|Thymoglobulin|thymoglobulin|mesh-list
6160561|NCT01517984|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6160562|NCT01517984|Immunosuppressive Agents|immunosuppressive agents|mesh-list
6160563|NCT01517984|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
6160564|NCT01517984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6160565|NCT01517984|Glucocorticoids|glucocorticoids|mesh-ancestor
6160566|NCT01517984|Hormones|hormones|mesh-ancestor
6160567|NCT01517984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6160568|NCT01517984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160569|NCT01517984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6160570|NCT01517984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5603427|NCT02496611|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5603428|NCT02496611|Incretins|incretins|mesh-ancestor
5603429|NCT02496611|Hormones|hormones|mesh-ancestor
5603430|NCT02496611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6160571|NCT01517984|Immunologic Factors|immunologic factors|mesh-ancestor
6160572|NCT01517984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6160573|NCT01517984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160574|NCT01517984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6481398|NCT00546936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6481399|NCT00546936|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6481400|NCT00546936|Dermatologic Agents|dermatologic agents|mesh-ancestor
6481401|NCT00547001|Estradiol|estradiol|mesh-list
6481402|NCT00547001|Estrogens|estrogens|mesh-ancestor
6481403|NCT00547001|Hormones|hormones|mesh-ancestor
6481404|NCT00547001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6481405|NCT00547001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488884|NCT00587496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488885|NCT00587496|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6488886|NCT00587496|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6488887|NCT00587496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6488888|NCT00587496|Antipyretics|antipyretics|mesh-ancestor
6488889|NCT00587496|Antiviral Agents|antiviral agents|mesh-ancestor
6488890|NCT00587496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6488891|NCT00587548|Diethylenetriamine|diethylenetriamine|mesh-list
6488892|NCT00587548|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6488893|NCT00587548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488894|NCT00587665|Ketamine|ketamine|mesh-list
6488895|NCT00587665|Analgesics|analgesics|mesh-ancestor
5559648|NCT04020601|Ropivacaine|ropivacaine|mesh-list
5559649|NCT04020601|Anesthetics, Local|anesthetics, local|mesh-ancestor
6160575|NCT01517984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6160576|NCT01517984|Antitubercular Agents|antitubercular agents|mesh-ancestor
6160577|NCT01517984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6160578|NCT01517984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6160579|NCT01518153|Vidarabine|vidarabine|mesh-list
6160580|NCT01518153|Methotrexate|methotrexate|mesh-list
6160581|NCT01518153|Fludarabine phosphate|fludarabine phosphate|mesh-list
6160582|NCT01518153|Fludarabine|fludarabine|mesh-list
6160583|NCT01518153|Melphalan|melphalan|mesh-list
6160584|NCT01518153|Alemtuzumab|alemtuzumab|mesh-list
6160585|NCT01518153|Tacrolimus|tacrolimus|mesh-list
6160586|NCT01518153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6160587|NCT01518153|Abortifacient Agents|abortifacient agents|mesh-ancestor
6160588|NCT01518153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6160589|NCT01518153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160590|NCT01518153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6160591|NCT01518153|Antimetabolites|antimetabolites|mesh-ancestor
6160592|NCT01518153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160593|NCT01518153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6160594|NCT01518153|Dermatologic Agents|dermatologic agents|mesh-ancestor
6160595|NCT01518153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6160596|NCT01518153|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6160597|NCT01518153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6160598|NCT01518153|Immunologic Factors|immunologic factors|mesh-ancestor
5559650|NCT04020601|Anesthetics|anesthetics|mesh-ancestor
5559651|NCT04020601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5559652|NCT04020601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559653|NCT04020601|Sensory System Agents|sensory system agents|mesh-ancestor
5559654|NCT04020601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5559655|NCT04020848|Melatonin|melatonin|mesh-list
5559656|NCT04020848|Antioxidants|antioxidants|mesh-ancestor
5559657|NCT04020848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559658|NCT04020848|Protective Agents|protective agents|mesh-ancestor
5559659|NCT04020848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559660|NCT04020848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5559661|NCT04020588|Minocycline|minocycline|mesh-list
5559662|NCT04020588|Celecoxib|celecoxib|mesh-list
5559663|NCT04020588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5559664|NCT04020588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5559665|NCT04020588|Analgesics|analgesics|mesh-ancestor
5559666|NCT04020588|Sensory System Agents|sensory system agents|mesh-ancestor
5559667|NCT04020588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5559668|NCT04020588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559669|NCT04020588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5559670|NCT04020588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5559671|NCT04020588|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5603431|NCT02476097|Esomeprazole|esomeprazole|mesh-list
6160599|NCT01518153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6160600|NCT01518153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6488896|NCT00587665|Sensory System Agents|sensory system agents|mesh-ancestor
5559672|NCT04020588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5559673|NCT04020588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5559674|NCT04020588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559675|NCT04020588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5559676|NCT04020588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5559677|NCT04020705|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
5559678|NCT04020705|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5559679|NCT04020705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5559680|NCT04020705|Nootropic Agents|nootropic agents|mesh-ancestor
5559681|NCT04020536|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5559682|NCT04020536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5559683|NCT04020380|Azithromycin|azithromycin|mesh-list
5559684|NCT04020380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5559685|NCT04020380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5559686|NCT04020406|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5559687|NCT04020406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5559688|NCT04020445|Insulin|insulin|mesh-list
5559689|NCT04020445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5559690|NCT04020445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559691|NCT04020328|Prednisone|prednisone|mesh-list
5559692|NCT04020328|Leflunomide|leflunomide|mesh-list
5559693|NCT04020328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5559694|NCT04020328|Glucocorticoids|glucocorticoids|mesh-ancestor
5559695|NCT04020328|Hormones|hormones|mesh-ancestor
5559696|NCT04020328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5559697|NCT04020328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160601|NCT01518153|Antiviral Agents|antiviral agents|mesh-ancestor
6160602|NCT01518153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6160603|NCT01518153|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6160604|NCT01518153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6160605|NCT01518153|Alkylating Agents|alkylating agents|mesh-ancestor
6160606|NCT01518153|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6160607|NCT01518153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6160608|NCT01518192|Doxycycline|doxycycline|mesh-list
6160609|NCT01518192|Cefuroxime|cefuroxime|mesh-list
6160610|NCT01518192|Cefuroxime axetil|cefuroxime axetil|mesh-list
6160611|NCT01518192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6160612|NCT01518192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6160613|NCT01518192|Antimalarials|antimalarials|mesh-ancestor
6160614|NCT01518192|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6160615|NCT01518192|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6160616|NCT01518244|Timolol|timolol|mesh-list
6160617|NCT01518244|Brinzolamide|brinzolamide|mesh-list
6160618|NCT01518244|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6160619|NCT01518244|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6160620|NCT01518244|Adrenergic Agents|adrenergic agents|mesh-ancestor
6160621|NCT01518244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6160622|NCT01518244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160623|NCT01518244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160624|NCT01518244|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6160625|NCT01518244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6160626|NCT01518244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5559698|NCT04020328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5559699|NCT04020328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5559700|NCT04020328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5559701|NCT04020328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559702|NCT04020328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5559703|NCT04020328|Immunologic Factors|immunologic factors|mesh-ancestor
5559704|NCT04020341|Nitrofurantoin|nitrofurantoin|mesh-list
5559705|NCT04020341|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5559706|NCT04020341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5559707|NCT04020341|Renal Agents|renal agents|mesh-ancestor
5559708|NCT04020341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5559709|NCT04020263|Simendan|simendan|mesh-list
6160627|NCT01518244|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6160628|NCT01518257|Botulinum Toxins|botulinum toxins|mesh-list
6160629|NCT01518257|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6160630|NCT01518257|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6160631|NCT01518257|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6160632|NCT01518257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6160633|NCT01518257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160634|NCT01518257|Cholinergic Agents|cholinergic agents|mesh-ancestor
6160635|NCT01518257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5559710|NCT04020263|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5559711|NCT04020263|Vasodilator Agents|vasodilator agents|mesh-ancestor
5603432|NCT02476097|Omeprazole|omeprazole|mesh-list
6160636|NCT01518257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160637|NCT01518257|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6160638|NCT01518257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6160639|NCT01518309|Pimavanserin|pimavanserin|mesh-list
6160640|NCT01518309|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6160641|NCT01518309|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6160642|NCT01518309|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6160643|NCT01518309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6160644|NCT01518309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6160645|NCT01518309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160646|NCT01518309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6160647|NCT01518309|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6160648|NCT01518309|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6160649|NCT01518309|Serotonin Agents|serotonin agents|mesh-ancestor
6160650|NCT01518309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6160651|NCT01518309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160652|NCT01518699|Moxifloxacin|moxifloxacin|mesh-list
6160653|NCT01518699|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6160654|NCT01518699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5559712|NCT04020263|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5559713|NCT04020263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5559714|NCT04020263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5559715|NCT04020263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559716|NCT04020263|Protective Agents|protective agents|mesh-ancestor
5559717|NCT04020263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559718|NCT04020094|Atezolizumab|atezolizumab|mesh-list
5559719|NCT04020094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5559720|NCT04020016|Nalbuphine|nalbuphine|mesh-list
5559721|NCT04020016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5559722|NCT04020016|Narcotics|narcotics|mesh-ancestor
5559723|NCT04020016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6160655|NCT01518699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6160656|NCT01518699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6160657|NCT01518699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6160658|NCT01518699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6160659|NCT01518699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160660|NCT01518699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6160661|NCT01518699|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6160662|NCT01518699|Contraceptive Agents|contraceptive agents|mesh-ancestor
6160663|NCT01518699|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6160664|NCT01518699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160665|NCT01518699|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6160666|NCT01518699|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6160667|NCT01518699|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6160668|NCT01518946|Midodrine|midodrine|mesh-list
6160669|NCT01518946|Sympathomimetics|sympathomimetics|mesh-ancestor
6481406|NCT00547053|Amiloride|amiloride|mesh-list
6481407|NCT00547053|Diuretics|diuretics|mesh-ancestor
6481408|NCT00547053|Natriuretic Agents|natriuretic agents|mesh-ancestor
6481409|NCT00547053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481410|NCT00547053|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
5559724|NCT04020016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559725|NCT04020016|Analgesics|analgesics|mesh-ancestor
5559726|NCT04020016|Sensory System Agents|sensory system agents|mesh-ancestor
5559727|NCT04020016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5559728|NCT04020003|Simendan|simendan|mesh-list
5559729|NCT04020003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5559730|NCT04020003|Vasodilator Agents|vasodilator agents|mesh-ancestor
5559731|NCT04020003|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5559732|NCT04020003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5559733|NCT04020003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5559734|NCT04020003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559735|NCT04020003|Protective Agents|protective agents|mesh-ancestor
5559736|NCT04020003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559737|NCT04020172|Dobutamine|dobutamine|mesh-list
6481411|NCT00547053|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6481412|NCT00547053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6481413|NCT00547053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481414|NCT00547053|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
6481415|NCT00547053|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6481416|NCT00547092|Sildenafil Citrate|sildenafil citrate|mesh-list
6160670|NCT01518946|Autonomic Agents|autonomic agents|mesh-ancestor
6481417|NCT00547092|Tadalafil|tadalafil|mesh-list
5559738|NCT04020172|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6160671|NCT01518946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6160672|NCT01518946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160673|NCT01518946|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6160674|NCT01518946|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6160675|NCT01518946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6160676|NCT01518946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5559739|NCT04020172|Sympathomimetics|sympathomimetics|mesh-ancestor
5559740|NCT04020172|Autonomic Agents|autonomic agents|mesh-ancestor
5559741|NCT04020172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5559742|NCT04020172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559743|NCT04020172|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5559744|NCT04020172|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5559745|NCT04020172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5559746|NCT04020172|Adrenergic Agents|adrenergic agents|mesh-ancestor
5559747|NCT04020172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5559748|NCT04020172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559749|NCT04020172|Protective Agents|protective agents|mesh-ancestor
5559750|NCT04020185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5559751|NCT04020185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559752|NCT04020185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5559753|NCT04020133|Epinephrine|epinephrine|mesh-list
5559754|NCT04020133|Bupivacaine|bupivacaine|mesh-list
5559755|NCT04020133|Anesthetics, Local|anesthetics, local|mesh-ancestor
5559756|NCT04020133|Anesthetics|anesthetics|mesh-ancestor
6160677|NCT01518946|Adrenergic Agents|adrenergic agents|mesh-ancestor
6160678|NCT01518946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6160679|NCT01518946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160680|NCT01518972|Prazosin|prazosin|mesh-list
6160681|NCT01518972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6481418|NCT00547092|Vasodilator Agents|vasodilator agents|mesh-ancestor
6481419|NCT00547092|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6160682|NCT01518972|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6160683|NCT01518972|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6160684|NCT01518972|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6160685|NCT01518972|Adrenergic Agents|adrenergic agents|mesh-ancestor
5559757|NCT04020133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5559758|NCT04020133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559759|NCT04020133|Sensory System Agents|sensory system agents|mesh-ancestor
5559760|NCT04020133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5559761|NCT04020133|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5559762|NCT04020133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5559763|NCT04020133|Adrenergic Agents|adrenergic agents|mesh-ancestor
5559764|NCT04020133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5559765|NCT04020133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559766|NCT04020133|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5559767|NCT04020133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5559768|NCT04020133|Autonomic Agents|autonomic agents|mesh-ancestor
5559769|NCT04020133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5559770|NCT04020133|Respiratory System Agents|respiratory system agents|mesh-ancestor
6160686|NCT01518972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6160687|NCT01518972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559771|NCT04020133|Mydriatics|mydriatics|mesh-ancestor
5559772|NCT04020133|Sympathomimetics|sympathomimetics|mesh-ancestor
5559773|NCT04020133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5559774|NCT04019873|Lamivudine|lamivudine|mesh-list
5559775|NCT04019873|Rilpivirine|rilpivirine|mesh-list
5559776|NCT04019873|Dolutegravir|dolutegravir|mesh-list
5559777|NCT04019873|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5559778|NCT04019873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5559779|NCT04019873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5559780|NCT04019873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559781|NCT04019873|Antiviral Agents|antiviral agents|mesh-ancestor
5559782|NCT04019873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5559783|NCT04019873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5559784|NCT04019873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5559785|NCT04019873|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5559786|NCT04019873|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5559787|NCT04019964|Nivolumab|nivolumab|mesh-list
6160688|NCT01518972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160689|NCT01519063|Naltrexone|naltrexone|mesh-list
6160690|NCT01519063|Memantine|memantine|mesh-list
6160691|NCT01519063|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6160692|NCT01519063|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6160693|NCT01519063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160694|NCT01519063|Sensory System Agents|sensory system agents|mesh-ancestor
6160695|NCT01519063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6160696|NCT01519063|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5559788|NCT04019964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5559789|NCT04019964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5559790|NCT04019964|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5559791|NCT04019964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559792|NCT04019782|Hylan|hylan|mesh-list
5559793|NCT04019782|Viscosupplements|viscosupplements|mesh-ancestor
5559794|NCT04019782|Protective Agents|protective agents|mesh-ancestor
5559795|NCT04019782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559796|NCT04019496|Calcitonin|calcitonin|mesh-list
5559797|NCT04019496|Salmon calcitonin|salmon calcitonin|mesh-list
5559798|NCT04019496|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
6160697|NCT01519063|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6160698|NCT01519063|Dopamine Agents|dopamine agents|mesh-ancestor
6160699|NCT01519063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6160700|NCT01519063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160701|NCT01519063|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6160702|NCT01519063|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5559799|NCT04019496|Antibodies|antibodies|mesh-list
5559800|NCT04019496|Katacalcin|katacalcin|mesh-list
5559801|NCT04019496|Immunologic Factors|immunologic factors|mesh-ancestor
5559802|NCT04019496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559803|NCT04019496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5559804|NCT04019496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5559805|NCT04019496|Vasodilator Agents|vasodilator agents|mesh-ancestor
5559806|NCT04019548|Cisplatin|cisplatin|mesh-list
6160703|NCT01519089|Tofacitinib|tofacitinib|mesh-list
6160704|NCT01519089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6481420|NCT00547092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6481421|NCT00547092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6481422|NCT00547092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481423|NCT00547092|Urological Agents|urological agents|mesh-ancestor
6481424|NCT00547131|Temozolomide|temozolomide|mesh-list
6481425|NCT00547131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6481426|NCT00547131|Alkylating Agents|alkylating agents|mesh-ancestor
6481427|NCT00547131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481428|NCT00547131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6481429|NCT00547144|Gemcitabine|gemcitabine|mesh-list
6481430|NCT00547144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6481431|NCT00547144|Antimetabolites|antimetabolites|mesh-ancestor
6481432|NCT00547144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481433|NCT00547144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6481434|NCT00547144|Antiviral Agents|antiviral agents|mesh-ancestor
6481435|NCT00547144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6481436|NCT00547144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6481437|NCT00547144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6481438|NCT00547144|Immunologic Factors|immunologic factors|mesh-ancestor
6481439|NCT00547144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481440|NCT00547170|Doxycycline|doxycycline|mesh-list
6481441|NCT00547170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6160705|NCT01519089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6160706|NCT01519089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160707|NCT01519167|Fentanyl|fentanyl|mesh-list
6160708|NCT01519167|Midazolam|midazolam|mesh-list
6160709|NCT01519167|Dexmedetomidine|dexmedetomidine|mesh-list
6160710|NCT01519167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6160711|NCT01519167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6160712|NCT01519167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160713|NCT01519167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6160714|NCT01519167|Analgesics|analgesics|mesh-ancestor
6160715|NCT01519167|Sensory System Agents|sensory system agents|mesh-ancestor
6160716|NCT01519167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6160717|NCT01519167|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6481442|NCT00547170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6481443|NCT00547170|Antimalarials|antimalarials|mesh-ancestor
6160718|NCT01519167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6160719|NCT01519167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6160720|NCT01519167|Adrenergic Agents|adrenergic agents|mesh-ancestor
6160721|NCT01519167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6160722|NCT01519167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559807|NCT04019548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5559808|NCT04019379|Calcium, Dietary|calcium, dietary|mesh-list
5559809|NCT04019379|Calcium|calcium|mesh-list
6160723|NCT01519167|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6160724|NCT01519167|Narcotics|narcotics|mesh-ancestor
6160725|NCT01519167|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6160726|NCT01519167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6160727|NCT01519167|Anesthetics, General|anesthetics, general|mesh-ancestor
6160728|NCT01519167|Anesthetics|anesthetics|mesh-ancestor
6160729|NCT01519167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6160730|NCT01519167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6160731|NCT01519167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5559810|NCT04019379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5559811|NCT04019379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559812|NCT04019379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5559813|NCT04019600|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
5559814|NCT04019600|Natriuretic Agents|natriuretic agents|mesh-ancestor
5559815|NCT04019600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559816|NCT04019574|Moxifloxacin|moxifloxacin|mesh-list
5559817|NCT04019574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5559818|NCT04019574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5559819|NCT04019574|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5559820|NCT04019574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6160732|NCT01519167|GABA Modulators|gaba modulators|mesh-ancestor
6160733|NCT01519167|GABA Agents|gaba agents|mesh-ancestor
6160734|NCT01519245|Tranexamic Acid|tranexamic acid|mesh-list
5559821|NCT04019574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5559822|NCT04019574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559823|NCT04019574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5559824|NCT04019652|Moxifloxacin|moxifloxacin|mesh-list
5559825|NCT04019652|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
5559826|NCT04019652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5559827|NCT04019652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5559828|NCT04019652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6160735|NCT01519245|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6160736|NCT01519245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6160737|NCT01519245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160738|NCT01519245|Hemostatics|hemostatics|mesh-ancestor
6160739|NCT01519245|Coagulants|coagulants|mesh-ancestor
6160740|NCT01519271|Rivastigmine|rivastigmine|mesh-list
6160741|NCT01519271|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6160742|NCT01519271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6160743|NCT01519271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559829|NCT04019652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5559830|NCT04019652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5559831|NCT04019652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559832|NCT04019652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5559833|NCT04019652|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5559834|NCT04019652|Contraceptive Agents|contraceptive agents|mesh-ancestor
5559835|NCT04019652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6160744|NCT01519271|Cholinergic Agents|cholinergic agents|mesh-ancestor
6160745|NCT01519271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6160746|NCT01519271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160747|NCT01519271|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6160748|NCT01519271|Protective Agents|protective agents|mesh-ancestor
6160749|NCT01519284|Levodopa|levodopa|mesh-list
6160750|NCT01519284|Carbidopa|carbidopa|mesh-list
6160751|NCT01519284|Opicapone|opicapone|mesh-list
6160752|NCT01519284|Entacapone|entacapone|mesh-list
6160753|NCT01519284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6160754|NCT01519284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6160755|NCT01519284|Dopamine Agents|dopamine agents|mesh-ancestor
6160756|NCT01519284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6160757|NCT01519284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160758|NCT01519284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160759|NCT01519284|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6160760|NCT01519284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6160761|NCT01519284|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6160762|NCT01519323|Vemurafenib|vemurafenib|mesh-list
6160763|NCT01519323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6160764|NCT01519323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6160765|NCT01519323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6160766|NCT01519323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559836|NCT04019652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559837|NCT04019652|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5559838|NCT04019652|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5559839|NCT04019652|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5559840|NCT04018937|Fludarabine|fludarabine|mesh-list
5559841|NCT04018937|Melphalan|melphalan|mesh-list
5559842|NCT04018937|Alemtuzumab|alemtuzumab|mesh-list
5559843|NCT04018937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5559844|NCT04018937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559845|NCT04018937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5559846|NCT04018937|Immunologic Factors|immunologic factors|mesh-ancestor
5559847|NCT04018937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559848|NCT04018937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5559849|NCT04018937|Alkylating Agents|alkylating agents|mesh-ancestor
5559850|NCT04018937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5559851|NCT04018937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6160767|NCT01519518|Heparin|heparin|mesh-list
6160768|NCT01519518|Calcium heparin|calcium heparin|mesh-list
6160769|NCT01519518|Bivalirudin|bivalirudin|mesh-list
6160770|NCT01519518|Anticoagulants|anticoagulants|mesh-ancestor
6160771|NCT01519518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6160772|NCT01519518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6160773|NCT01519518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160774|NCT01519518|Antithrombins|antithrombins|mesh-ancestor
6160775|NCT01519518|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6160776|NCT01519518|Protease Inhibitors|protease inhibitors|mesh-ancestor
6160777|NCT01519518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6160778|NCT01519635|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6160779|NCT01519635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6160780|NCT01519635|Diuretics|diuretics|mesh-ancestor
6160781|NCT01519635|Natriuretic Agents|natriuretic agents|mesh-ancestor
6160782|NCT01519635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160783|NCT01519635|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6160784|NCT01519635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6160785|NCT01519635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160786|NCT01519674|Insulin|insulin|mesh-list
6160787|NCT01519674|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6160788|NCT01519674|Metformin|metformin|mesh-list
6160789|NCT01519674|Insulin Aspart|insulin aspart|mesh-list
6160790|NCT01519674|Insulin, Long-Acting|insulin, long-acting|mesh-list
6160791|NCT01519674|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6160792|NCT01519674|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6160793|NCT01519674|Biphasic Insulins|biphasic insulins|mesh-list
6160794|NCT01519674|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6160795|NCT01519674|Insulin, Isophane|insulin, isophane|mesh-list
6160796|NCT01519674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6160797|NCT01519674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160798|NCT01519674|Incretins|incretins|mesh-ancestor
6160799|NCT01519674|Hormones|hormones|mesh-ancestor
6160800|NCT01519674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6160801|NCT01519674|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6160802|NCT01519674|Protease Inhibitors|protease inhibitors|mesh-ancestor
6481444|NCT00547170|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6481445|NCT00547170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6481446|NCT00547183|Tadalafil|tadalafil|mesh-list
6481447|NCT00547183|Vasodilator Agents|vasodilator agents|mesh-ancestor
6481448|NCT00547183|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6481449|NCT00547183|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6481450|NCT00547183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6481451|NCT00547183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481452|NCT00547183|Urological Agents|urological agents|mesh-ancestor
6481453|NCT00547196|Cyclosporine|cyclosporine|mesh-list
6481454|NCT00547196|Mycophenolic Acid|mycophenolic acid|mesh-list
6481455|NCT00547196|Cyclophosphamide|cyclophosphamide|mesh-list
6481456|NCT00547196|Melphalan|melphalan|mesh-list
6481457|NCT00547196|Busulfan|busulfan|mesh-list
6481458|NCT00547196|Fludarabine|fludarabine|mesh-list
6481459|NCT00547196|Fludarabine phosphate|fludarabine phosphate|mesh-list
6481460|NCT00547196|Cyclosporins|cyclosporins|mesh-list
6481461|NCT00547196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6481462|NCT00547196|Immunologic Factors|immunologic factors|mesh-ancestor
6481463|NCT00547196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481464|NCT00547196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6481465|NCT00547196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6481466|NCT00547196|Alkylating Agents|alkylating agents|mesh-ancestor
6481467|NCT00547196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481468|NCT00547196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5559852|NCT04019015|Thrombin|thrombin|mesh-list
5559853|NCT04019015|Hemostatics|hemostatics|mesh-ancestor
5559854|NCT04019015|Coagulants|coagulants|mesh-ancestor
6160803|NCT01519674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6160804|NCT01519674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160805|NCT01519700|Lenograstim|lenograstim|mesh-list
6160806|NCT01519700|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6160807|NCT01519700|Immunologic Factors|immunologic factors|mesh-ancestor
6160808|NCT01519700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160809|NCT01519765|Misoprostol|misoprostol|mesh-list
6160810|NCT01519765|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6160811|NCT01519765|Abortifacient Agents|abortifacient agents|mesh-ancestor
6160812|NCT01519765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6160813|NCT01519765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160814|NCT01519765|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6160815|NCT01519765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6160816|NCT01519765|Oxytocics|oxytocics|mesh-ancestor
6160817|NCT01519778|Tedizolid|tedizolid|mesh-list
6160818|NCT01519778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6160819|NCT01519778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6160820|NCT01519791|Methotrexate|methotrexate|mesh-list
6160821|NCT01519791|Certolizumab Pegol|certolizumab pegol|mesh-list
6160822|NCT01519791|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6160823|NCT01519791|Abortifacient Agents|abortifacient agents|mesh-ancestor
6160824|NCT01519791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6160825|NCT01519791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160826|NCT01519791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6160827|NCT01519791|Antimetabolites|antimetabolites|mesh-ancestor
6160828|NCT01519791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160829|NCT01519791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6160830|NCT01519791|Dermatologic Agents|dermatologic agents|mesh-ancestor
6160831|NCT01519791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6160832|NCT01519791|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6160833|NCT01519791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6160834|NCT01519791|Immunologic Factors|immunologic factors|mesh-ancestor
6160835|NCT01519791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6160836|NCT01519791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6160837|NCT01519817|Vaccines|vaccines|mesh-list
6160838|NCT01519817|Immunologic Factors|immunologic factors|mesh-ancestor
6160839|NCT01519817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481469|NCT00547196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6481470|NCT00547196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6668438|NCT01532154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481471|NCT00547196|Antimetabolites|antimetabolites|mesh-ancestor
6481472|NCT00547196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6481473|NCT00547196|Antifungal Agents|antifungal agents|mesh-ancestor
6481474|NCT00547196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6481475|NCT00547196|Dermatologic Agents|dermatologic agents|mesh-ancestor
6481476|NCT00547196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6481477|NCT00547196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6481478|NCT00547196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6481479|NCT00547196|Antitubercular Agents|antitubercular agents|mesh-ancestor
6481480|NCT00547196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6481481|NCT00547209|Nitrous Oxide|nitrous oxide|mesh-list
6481482|NCT00547209|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6481483|NCT00547209|Anesthetics, General|anesthetics, general|mesh-ancestor
5559855|NCT04019093|Ethanol|ethanol|mesh-list
5559856|NCT04019093|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5559857|NCT04019093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5559858|NCT04019093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5559859|NCT04019093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559860|NCT04019106|Budesonide|budesonide|mesh-list
5559861|NCT04019106|Pulmonary Surfactants|pulmonary surfactants|mesh-list
5559862|NCT04019106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5559863|NCT04019106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5559864|NCT04019106|Autonomic Agents|autonomic agents|mesh-ancestor
5559865|NCT04019106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5559866|NCT04019106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559867|NCT04019106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5559868|NCT04019106|Respiratory System Agents|respiratory system agents|mesh-ancestor
5559869|NCT04019106|Glucocorticoids|glucocorticoids|mesh-ancestor
5559870|NCT04019106|Hormones|hormones|mesh-ancestor
5559871|NCT04019106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5559872|NCT04018833|Ranibizumab|ranibizumab|mesh-list
5559873|NCT04018833|Aflibercept|aflibercept|mesh-list
5559874|NCT04018833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6481484|NCT00547209|Anesthetics|anesthetics|mesh-ancestor
6481485|NCT00547209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6481486|NCT00547209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481487|NCT00547209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6481488|NCT00547209|Analgesics|analgesics|mesh-ancestor
6481489|NCT00547209|Sensory System Agents|sensory system agents|mesh-ancestor
6481490|NCT00547209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6481491|NCT00547287|Sildenafil Citrate|sildenafil citrate|mesh-list
6481492|NCT00547287|Tadalafil|tadalafil|mesh-list
6481493|NCT00547287|Vasodilator Agents|vasodilator agents|mesh-ancestor
6481494|NCT00547287|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6668439|NCT01532232|Varenicline|varenicline|mesh-list
6668440|NCT01532232|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6668441|NCT01532232|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6668442|NCT01532232|Cholinergic Agents|cholinergic agents|mesh-ancestor
6481495|NCT00547287|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6481496|NCT00547287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6668443|NCT01532232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6160840|NCT01519882|Rotigotine|rotigotine|mesh-list
6160841|NCT01519882|Dopamine Agonists|dopamine agonists|mesh-ancestor
6160842|NCT01519882|Dopamine Agents|dopamine agents|mesh-ancestor
6160843|NCT01519882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6160844|NCT01519882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160845|NCT01519882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160846|NCT01519921|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6160847|NCT01519921|Antiviral Agents|antiviral agents|mesh-ancestor
6160848|NCT01519921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6160849|NCT01519947|Epoetin Alfa|epoetin alfa|mesh-list
6160850|NCT01519947|Hematinics|hematinics|mesh-ancestor
6160851|NCT01520207|Mannitol|mannitol|mesh-list
6160852|NCT01520207|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6160853|NCT01520207|Diuretics|diuretics|mesh-ancestor
6160854|NCT01520207|Natriuretic Agents|natriuretic agents|mesh-ancestor
6160855|NCT01520207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160856|NCT01520363|Dextromethorphan|dextromethorphan|mesh-list
6160857|NCT01520363|Antitussive Agents|antitussive agents|mesh-ancestor
6160858|NCT01520363|Respiratory System Agents|respiratory system agents|mesh-ancestor
6160859|NCT01520363|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6160860|NCT01520363|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6160861|NCT01520363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5559875|NCT04018833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6481497|NCT00547287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559876|NCT04018833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5559877|NCT04018833|Growth Substances|growth substances|mesh-ancestor
5559878|NCT04018833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559879|NCT04018833|Growth Inhibitors|growth inhibitors|mesh-ancestor
5559880|NCT04018833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5559881|NCT04018482|Povidone-Iodine|povidone-iodine|mesh-list
5559882|NCT04018482|Povidone|povidone|mesh-list
5559883|NCT04018482|Plasma Substitutes|plasma substitutes|mesh-ancestor
5559884|NCT04018482|Blood Substitutes|blood substitutes|mesh-ancestor
5559885|NCT04018482|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5559886|NCT04018482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6160862|NCT01520363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160863|NCT01520363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160864|NCT01520402|Warfarin|warfarin|mesh-list
6160865|NCT01520402|Anticoagulants|anticoagulants|mesh-list
6160866|NCT01520454|Heparin|heparin|mesh-list
6160867|NCT01520454|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6160868|NCT01520454|Anticoagulants|anticoagulants|mesh-ancestor
6160869|NCT01520454|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6160870|NCT01520454|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6160871|NCT01520454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160872|NCT01520454|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
5559887|NCT04018612|Acetaminophen|acetaminophen|mesh-list
5559888|NCT04018612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5559889|NCT04018612|Analgesics|analgesics|mesh-ancestor
5559890|NCT04018612|Sensory System Agents|sensory system agents|mesh-ancestor
5559891|NCT04018612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5559892|NCT04018612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559893|NCT04018612|Antipyretics|antipyretics|mesh-ancestor
5559894|NCT04018703|Midazolam|midazolam|mesh-list
6160873|NCT01520454|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6160874|NCT01520454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6160875|NCT01520519|Rituximab|rituximab|mesh-list
6160876|NCT01520519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6160877|NCT01520519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5559895|NCT04018703|Dexmedetomidine|dexmedetomidine|mesh-list
5559896|NCT04018703|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5559897|NCT04018703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6160878|NCT01520519|Immunologic Factors|immunologic factors|mesh-ancestor
6160879|NCT01520519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160880|NCT01520519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6160881|NCT01520688|Fluticasone|fluticasone|mesh-list
6160882|NCT01520688|Xhance|xhance|mesh-list
6160883|NCT01520688|Budesonide|budesonide|mesh-list
6160884|NCT01520688|Beclomethasone|beclomethasone|mesh-list
6160885|NCT01520688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6160886|NCT01520688|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6160887|NCT01520688|Autonomic Agents|autonomic agents|mesh-ancestor
6160888|NCT01520688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6160889|NCT01520688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160890|NCT01520688|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6160891|NCT01520688|Respiratory System Agents|respiratory system agents|mesh-ancestor
6160892|NCT01520688|Dermatologic Agents|dermatologic agents|mesh-ancestor
6160893|NCT01520688|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6160894|NCT01520688|Glucocorticoids|glucocorticoids|mesh-ancestor
6160895|NCT01520688|Hormones|hormones|mesh-ancestor
6160896|NCT01520688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6160897|NCT01520727|Opicapone|opicapone|mesh-list
6160898|NCT01520727|Entacapone|entacapone|mesh-list
6160899|NCT01520727|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6160900|NCT01520727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6160901|NCT01520727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160902|NCT01520727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6160903|NCT01520727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6160904|NCT01520922|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6160905|NCT01520922|Ofatumumab|ofatumumab|mesh-list
6160906|NCT01520922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6160907|NCT01520922|Alkylating Agents|alkylating agents|mesh-ancestor
6160908|NCT01520922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160909|NCT01520922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5559898|NCT04018703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559899|NCT04018703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5559900|NCT04018703|Analgesics|analgesics|mesh-ancestor
6160910|NCT01520987|Opicapone|opicapone|mesh-list
6160911|NCT01520987|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6160912|NCT01520987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5559901|NCT04018703|Sensory System Agents|sensory system agents|mesh-ancestor
6160913|NCT01520987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160914|NCT01520987|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6160915|NCT01520987|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6160916|NCT01521117|Donepezil|donepezil|mesh-list
6160917|NCT01521117|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6160918|NCT01521117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6160919|NCT01521117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160920|NCT01521117|Cholinergic Agents|cholinergic agents|mesh-ancestor
6160921|NCT01521117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6160922|NCT01521117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160923|NCT01521117|Nootropic Agents|nootropic agents|mesh-ancestor
6160924|NCT01521260|Chlorhexidine|chlorhexidine|mesh-list
6160925|NCT01521260|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6160926|NCT01521260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6160927|NCT01521260|Disinfectants|disinfectants|mesh-ancestor
6160928|NCT01521364|Clarithromycin|clarithromycin|mesh-list
6160929|NCT01521364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6160930|NCT01521364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6160931|NCT01521364|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6160932|NCT01521364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6160933|NCT01521364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160934|NCT01521364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6160935|NCT01521364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6160936|NCT01521546|Eplerenone|eplerenone|mesh-list
6160937|NCT01521546|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6160938|NCT01521546|Hormone Antagonists|hormone antagonists|mesh-ancestor
6160939|NCT01521546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5559902|NCT04018703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5559903|NCT04018703|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5559904|NCT04018703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5559905|NCT04018703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5559906|NCT04018703|Adrenergic Agents|adrenergic agents|mesh-ancestor
5559907|NCT04018703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5559908|NCT04018703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559909|NCT04018703|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5559910|NCT04018703|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5559911|NCT04018703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5559912|NCT04018703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5559913|NCT04018703|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5559914|NCT04018703|Anesthetics, General|anesthetics, general|mesh-ancestor
5559915|NCT04018703|Anesthetics|anesthetics|mesh-ancestor
5559916|NCT04018703|GABA Modulators|gaba modulators|mesh-ancestor
5559917|NCT04018703|GABA Agents|gaba agents|mesh-ancestor
5559918|NCT04018690|Triamcinolone|triamcinolone|mesh-list
5559919|NCT04018690|Ropivacaine|ropivacaine|mesh-list
5559920|NCT04018690|Anesthetics, Local|anesthetics, local|mesh-ancestor
6160940|NCT01521546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160941|NCT01521546|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6160942|NCT01521546|Diuretics|diuretics|mesh-ancestor
6160943|NCT01521546|Natriuretic Agents|natriuretic agents|mesh-ancestor
6160944|NCT01521546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6160945|NCT01521559|Aflibercept|aflibercept|mesh-list
6160946|NCT01521559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6160947|NCT01521559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6160948|NCT01521559|Growth Substances|growth substances|mesh-ancestor
6160949|NCT01521559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160950|NCT01521559|Growth Inhibitors|growth inhibitors|mesh-ancestor
6160951|NCT01521559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6160952|NCT01521897|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6160953|NCT01521897|Immunologic Factors|immunologic factors|mesh-ancestor
6160954|NCT01521897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160955|NCT01521923|Methotrexate|methotrexate|mesh-list
6160956|NCT01521923|Certolizumab Pegol|certolizumab pegol|mesh-list
6160957|NCT01521923|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6160958|NCT01521923|Abortifacient Agents|abortifacient agents|mesh-ancestor
6160959|NCT01521923|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6160960|NCT01521923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160961|NCT01521923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6160962|NCT01521923|Antimetabolites|antimetabolites|mesh-ancestor
6160963|NCT01521923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160964|NCT01521923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6160965|NCT01521923|Dermatologic Agents|dermatologic agents|mesh-ancestor
5559921|NCT04018690|Anesthetics|anesthetics|mesh-ancestor
5603433|NCT02476097|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5559922|NCT04018690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5559923|NCT04018690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559924|NCT04018690|Sensory System Agents|sensory system agents|mesh-ancestor
5559925|NCT04018690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5559926|NCT04018690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5559927|NCT04018690|Glucocorticoids|glucocorticoids|mesh-ancestor
5559928|NCT04018690|Hormones|hormones|mesh-ancestor
5559929|NCT04018690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5559930|NCT04018417|Amphotericin B|amphotericin b|mesh-list
5559931|NCT04018417|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
5559932|NCT04018417|Amebicides|amebicides|mesh-ancestor
5559933|NCT04018417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6160966|NCT01521923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6160967|NCT01521923|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6160968|NCT01521923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6160969|NCT01521923|Immunologic Factors|immunologic factors|mesh-ancestor
6160970|NCT01521923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6160971|NCT01521923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6160972|NCT01522235|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6160973|NCT01522235|gamma-Globulins|gamma-globulins|mesh-list
6160974|NCT01522235|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6160975|NCT01522235|Immunologic Factors|immunologic factors|mesh-ancestor
6160976|NCT01522235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160977|NCT01522404|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6160978|NCT01522404|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6160979|NCT01522404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5559934|NCT04018417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5559935|NCT04018417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5559936|NCT04018417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5559937|NCT04018417|Antifungal Agents|antifungal agents|mesh-ancestor
5559938|NCT04018365|Empagliflozin|empagliflozin|mesh-list
5559939|NCT04018365|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5559940|NCT04018365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559941|NCT04018365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5559942|NCT04018365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559943|NCT04018768|Acetaminophen|acetaminophen|mesh-list
5559944|NCT04018768|Ibuprofen|ibuprofen|mesh-list
6160980|NCT01522404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6160981|NCT01522404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160982|NCT01522404|Adrenergic Agents|adrenergic agents|mesh-ancestor
6160983|NCT01522404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6481498|NCT00547287|Urological Agents|urological agents|mesh-ancestor
6481499|NCT00547352|Sildenafil Citrate|sildenafil citrate|mesh-list
6481500|NCT00547352|Tadalafil|tadalafil|mesh-list
6481501|NCT00547352|Vasodilator Agents|vasodilator agents|mesh-ancestor
6481502|NCT00547352|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6481503|NCT00547352|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6481504|NCT00547352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6481505|NCT00547352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481506|NCT00547352|Urological Agents|urological agents|mesh-ancestor
6481507|NCT00547417|Tadalafil|tadalafil|mesh-list
6481508|NCT00547417|Vasodilator Agents|vasodilator agents|mesh-ancestor
6481509|NCT00547417|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5559945|NCT04018768|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
5559946|NCT04018768|Oxycodone|oxycodone|mesh-list
5559947|NCT04018768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5559948|NCT04018768|Analgesics|analgesics|mesh-ancestor
5559949|NCT04018768|Sensory System Agents|sensory system agents|mesh-ancestor
5559950|NCT04018768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5559951|NCT04018768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559952|NCT04018768|Antipyretics|antipyretics|mesh-ancestor
6481510|NCT00547417|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6481511|NCT00547417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6481512|NCT00547417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481513|NCT00547417|Urological Agents|urological agents|mesh-ancestor
6481514|NCT00547443|Paclitaxel|paclitaxel|mesh-list
6481515|NCT00547443|Carboplatin|carboplatin|mesh-list
6481516|NCT00547443|Sorafenib|sorafenib|mesh-list
5559953|NCT04018768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5559954|NCT04018768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5559955|NCT04018768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5559956|NCT04018768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5559957|NCT04018768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6481517|NCT00547443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6481518|NCT00547443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5559958|NCT04018768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559959|NCT04018768|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5559960|NCT04018768|Narcotics|narcotics|mesh-ancestor
6481519|NCT00547443|Tubulin Modulators|tubulin modulators|mesh-ancestor
6481520|NCT00547443|Antimitotic Agents|antimitotic agents|mesh-ancestor
6481521|NCT00547443|Mitosis Modulators|mitosis modulators|mesh-ancestor
6481522|NCT00547443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481523|NCT00547443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6481524|NCT00547443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6481525|NCT00547495|Tadalafil|tadalafil|mesh-list
6481526|NCT00547495|Vasodilator Agents|vasodilator agents|mesh-ancestor
6481527|NCT00547495|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5559961|NCT04018768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5559962|NCT04018378|Varenicline|varenicline|mesh-list
5559963|NCT04018378|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5559964|NCT04018378|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6160984|NCT01522404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160985|NCT01522417|Tirofiban|tirofiban|mesh-list
6160986|NCT01522417|Eptifibatide|eptifibatide|mesh-list
6160987|NCT01522417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6160988|NCT01522417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6160989|NCT01522417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6160990|NCT01522417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6160991|NCT01522443|Prednisone|prednisone|mesh-list
6160992|NCT01522443|Mitoxantrone|mitoxantrone|mesh-list
6160993|NCT01522443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6160994|NCT01522443|Glucocorticoids|glucocorticoids|mesh-ancestor
6160995|NCT01522443|Hormones|hormones|mesh-ancestor
5559965|NCT04018378|Cholinergic Agents|cholinergic agents|mesh-ancestor
5559966|NCT04018378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5559967|NCT04018378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559968|NCT04018378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559969|NCT04018157|Dexmedetomidine|dexmedetomidine|mesh-list
5559970|NCT04018157|Ketamine|ketamine|mesh-list
5559971|NCT04018157|Propofol|propofol|mesh-list
5559972|NCT04018157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5559973|NCT04018157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5559974|NCT04018157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559975|NCT04018157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5559976|NCT04018157|Anesthetics, General|anesthetics, general|mesh-ancestor
5559977|NCT04018157|Anesthetics|anesthetics|mesh-ancestor
5559978|NCT04018157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5559979|NCT04018157|Analgesics|analgesics|mesh-ancestor
5559980|NCT04018157|Sensory System Agents|sensory system agents|mesh-ancestor
5559981|NCT04018157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5559982|NCT04018157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5559983|NCT04018157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5559984|NCT04018157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5559985|NCT04018157|Adrenergic Agents|adrenergic agents|mesh-ancestor
5559986|NCT04018157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5559987|NCT04018157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5559988|NCT04018157|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5559989|NCT04018157|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5559990|NCT04018157|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5559991|NCT04018313|Omalizumab|omalizumab|mesh-list
5559992|NCT04018313|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5559993|NCT04018313|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5559994|NCT04018313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5559995|NCT04018313|Respiratory System Agents|respiratory system agents|mesh-ancestor
5559996|NCT04018313|Immunologic Factors|immunologic factors|mesh-ancestor
5559997|NCT04018313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5559998|NCT04018274|Levonorgestrel|levonorgestrel|mesh-list
5559999|NCT04018274|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5560000|NCT04018274|Contraceptive Agents|contraceptive agents|mesh-list
5560001|NCT04018274|Contraceptives, Oral|contraceptives, oral|mesh-list
5560002|NCT04018274|Estradiol|estradiol|mesh-list
5560003|NCT04018274|Estrogens|estrogens|mesh-ancestor
6160996|NCT01522443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6160997|NCT01522443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6160998|NCT01522443|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6160999|NCT01522443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6161000|NCT01522443|Analgesics|analgesics|mesh-ancestor
6161001|NCT01522443|Sensory System Agents|sensory system agents|mesh-ancestor
6481528|NCT00547495|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6481529|NCT00547495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5560004|NCT04018274|Hormones|hormones|mesh-ancestor
5560005|NCT04018274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5560006|NCT04018274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560007|NCT04018274|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5560008|NCT04018274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5560009|NCT04018274|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5560010|NCT04018274|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5560011|NCT04018274|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5560012|NCT04017897|Pembrolizumab|pembrolizumab|mesh-list
5560013|NCT04017897|Nivolumab|nivolumab|mesh-list
5560014|NCT04017897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5560015|NCT04017897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5560016|NCT04017897|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5560017|NCT04017897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560018|NCT04018105|Metformin|metformin|mesh-list
5560019|NCT04018105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5560020|NCT04018105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560021|NCT04017741|Methylprednisolone|methylprednisolone|mesh-list
5560022|NCT04017741|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5560023|NCT04017741|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5560024|NCT04017741|Prednisolone|prednisolone|mesh-list
5560025|NCT04017741|Prednisolone acetate|prednisolone acetate|mesh-list
5560026|NCT04017741|Lidocaine|lidocaine|mesh-list
5560027|NCT04017741|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5560028|NCT04017741|Prednisolone phosphate|prednisolone phosphate|mesh-list
5560029|NCT04017741|Anesthetics, Local|anesthetics, local|mesh-ancestor
5560030|NCT04017741|Anesthetics|anesthetics|mesh-ancestor
5560031|NCT04017741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5560032|NCT04017741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560033|NCT04017741|Sensory System Agents|sensory system agents|mesh-ancestor
5560034|NCT04017741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5560035|NCT04017741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5560036|NCT04017741|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5560037|NCT04017741|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5560038|NCT04017741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6161002|NCT01522443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6161003|NCT01522443|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6161004|NCT01522443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5560039|NCT04017741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560040|NCT04017741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5560041|NCT04017741|Antiemetics|antiemetics|mesh-ancestor
5560042|NCT04017741|Autonomic Agents|autonomic agents|mesh-ancestor
5560043|NCT04017741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6161005|NCT01522443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6161006|NCT01522443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161007|NCT01522456|Tretinoin|tretinoin|mesh-list
6161008|NCT01522456|Dermatologic Agents|dermatologic agents|mesh-ancestor
6161009|NCT01522456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6161010|NCT01522456|Keratolytic Agents|keratolytic agents|mesh-ancestor
6161011|NCT01522651|Dronedarone|dronedarone|mesh-list
6161012|NCT01522651|Ranolazine|ranolazine|mesh-list
6161013|NCT01522651|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5560044|NCT04017741|Glucocorticoids|glucocorticoids|mesh-ancestor
5560045|NCT04017741|Hormones|hormones|mesh-ancestor
5560046|NCT04017741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5560047|NCT04017741|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5560048|NCT04017741|Protective Agents|protective agents|mesh-ancestor
5560049|NCT04017741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5560050|NCT04017741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5560051|NCT04018131|Cimetidine|cimetidine|mesh-list
5560052|NCT04018131|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5560053|NCT04018131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5560054|NCT04018131|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6161014|NCT01522651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6161015|NCT01522651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161016|NCT01522651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6161017|NCT01522950|Atenolol|atenolol|mesh-list
6161018|NCT01522950|Nebivolol|nebivolol|mesh-list
6161019|NCT01522950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6161020|NCT01522950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6161021|NCT01522950|Sympatholytics|sympatholytics|mesh-ancestor
6161022|NCT01522950|Autonomic Agents|autonomic agents|mesh-ancestor
6161023|NCT01522950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6161024|NCT01522950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161025|NCT01522950|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5560055|NCT04018131|Histamine Antagonists|histamine antagonists|mesh-ancestor
5560056|NCT04018131|Histamine Agents|histamine agents|mesh-ancestor
6161026|NCT01522950|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6161027|NCT01522950|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6161028|NCT01522950|Adrenergic Agents|adrenergic agents|mesh-ancestor
6161029|NCT01522950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6161030|NCT01522950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161031|NCT01522950|Vasodilator Agents|vasodilator agents|mesh-ancestor
6161032|NCT01522950|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6161033|NCT01522950|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6161034|NCT01522950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6161035|NCT01522963|Nicotine|nicotine|mesh-list
6161036|NCT01522963|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6161037|NCT01522963|Autonomic Agents|autonomic agents|mesh-ancestor
6161038|NCT01522963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6161039|NCT01522963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161040|NCT01522963|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6161041|NCT01522963|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6161042|NCT01522963|Cholinergic Agents|cholinergic agents|mesh-ancestor
6161043|NCT01522963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6161044|NCT01522963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161045|NCT01523275|Mitomycins|mitomycins|mesh-list
6161046|NCT01523275|Mitomycin|mitomycin|mesh-list
6161047|NCT01523275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6161048|NCT01523275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6161049|NCT01523275|Alkylating Agents|alkylating agents|mesh-ancestor
6161050|NCT01523275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161051|NCT01523275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6161052|NCT01523275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6481530|NCT00547495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481531|NCT00547495|Urological Agents|urological agents|mesh-ancestor
6481532|NCT00547508|Tadalafil|tadalafil|mesh-list
6481533|NCT00547508|Vasodilator Agents|vasodilator agents|mesh-ancestor
6481534|NCT00547508|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6668444|NCT01532232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668445|NCT01532232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668446|NCT01532297|Dialysis Solutions|dialysis solutions|mesh-list
6668447|NCT01532297|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6668448|NCT01532336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6481535|NCT00547508|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6481536|NCT00547508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6481537|NCT00547508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481538|NCT00547508|Urological Agents|urological agents|mesh-ancestor
6481539|NCT00547547|Selenium|selenium|mesh-list
6481540|NCT00547547|Capecitabine|capecitabine|mesh-list
6481541|NCT00547547|Irinotecan|irinotecan|mesh-list
6481542|NCT00547547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6481543|NCT00547547|Antimetabolites|antimetabolites|mesh-ancestor
6481544|NCT00547547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481545|NCT00547547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6481546|NCT00547547|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6481547|NCT00547547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6481548|NCT00547547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6481549|NCT00547547|Antioxidants|antioxidants|mesh-ancestor
6481550|NCT00547547|Protective Agents|protective agents|mesh-ancestor
6481551|NCT00547547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481552|NCT00547547|Trace Elements|trace elements|mesh-ancestor
6481553|NCT00547547|Micronutrients|micronutrients|mesh-ancestor
6481554|NCT00547573|Tadalafil|tadalafil|mesh-list
6481555|NCT00547573|Vasodilator Agents|vasodilator agents|mesh-ancestor
6481556|NCT00547573|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6481557|NCT00547573|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6481558|NCT00547573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6481559|NCT00547573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560057|NCT04018131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5560058|NCT04018131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560059|NCT04018131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560060|NCT04018131|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5560061|NCT04018131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5560062|NCT04018131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5560063|NCT04017845|Tribenoside|tribenoside|mesh-list
5560064|NCT04017845|Lidocaine|lidocaine|mesh-list
5560065|NCT04017845|Diltiazem|diltiazem|mesh-list
5560066|NCT04017845|Calcium Channel Blockers|calcium channel blockers|mesh-list
5560067|NCT04017845|Nitroglycerin|nitroglycerin|mesh-list
5560068|NCT04017845|Bisacodyl|bisacodyl|mesh-list
5560069|NCT04017845|Anesthetics, Local|anesthetics, local|mesh-ancestor
5560070|NCT04017845|Anesthetics|anesthetics|mesh-ancestor
5560071|NCT04017845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5560072|NCT04017845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560073|NCT04017845|Sensory System Agents|sensory system agents|mesh-ancestor
5560074|NCT04017845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5560075|NCT04017845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5560076|NCT04017845|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5560077|NCT04017845|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5560078|NCT04017845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5560079|NCT04017845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560080|NCT04017845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5560081|NCT04017845|Vasodilator Agents|vasodilator agents|mesh-ancestor
5560082|NCT04017845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5560083|NCT04017845|Cathartics|cathartics|mesh-ancestor
5560084|NCT04017845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6481560|NCT00547573|Urological Agents|urological agents|mesh-ancestor
6481561|NCT00547599|Tadalafil|tadalafil|mesh-list
6481562|NCT00547599|Vasodilator Agents|vasodilator agents|mesh-ancestor
5560085|NCT04017845|Laxatives|laxatives|mesh-ancestor
5560086|NCT04017845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5560087|NCT04017845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5560088|NCT04017845|Analgesics|analgesics|mesh-ancestor
5560089|NCT04017845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5560090|NCT04017845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6161053|NCT01523301|Rotigotine|rotigotine|mesh-list
6481563|NCT00547599|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6481564|NCT00547599|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6481565|NCT00547599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6481566|NCT00547599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481567|NCT00547599|Urological Agents|urological agents|mesh-ancestor
6481568|NCT00547612|Substance P|substance p|mesh-list
6481569|NCT00547612|Neurokinin A|neurokinin a|mesh-list
6481570|NCT00547612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6481571|NCT00547612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481572|NCT00547612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481573|NCT00547625|Tadalafil|tadalafil|mesh-list
6481574|NCT00547625|Vasodilator Agents|vasodilator agents|mesh-ancestor
6161054|NCT01523301|Dopamine Agonists|dopamine agonists|mesh-ancestor
6161055|NCT01523301|Dopamine Agents|dopamine agents|mesh-ancestor
6161056|NCT01523301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6161057|NCT01523301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161058|NCT01523301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161059|NCT01523366|Clopidogrel|clopidogrel|mesh-list
6161060|NCT01523366|Ticagrelor|ticagrelor|mesh-list
6161061|NCT01523366|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6161062|NCT01523366|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6161063|NCT01523366|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6161064|NCT01523366|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6161065|NCT01523366|Purinergic Agents|purinergic agents|mesh-ancestor
6161066|NCT01523366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6161067|NCT01523366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161068|NCT01523366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161069|NCT01523392|Clopidogrel|clopidogrel|mesh-list
6161070|NCT01523392|Ticagrelor|ticagrelor|mesh-list
6161071|NCT01523392|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6161072|NCT01523392|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6161073|NCT01523392|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6161074|NCT01523392|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6161075|NCT01523392|Purinergic Agents|purinergic agents|mesh-ancestor
6161076|NCT01523392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5560091|NCT04017988|Ethanol|ethanol|mesh-list
6161077|NCT01523392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161078|NCT01523392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481575|NCT00547625|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6481576|NCT00547625|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6481577|NCT00547625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6481578|NCT00547625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481579|NCT00547625|Urological Agents|urological agents|mesh-ancestor
6481580|NCT00547664|Morphine|morphine|mesh-list
6481581|NCT00547664|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6481582|NCT00547664|Narcotics|narcotics|mesh-ancestor
6481583|NCT00547664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6161079|NCT01523457|Folfirinox|folfirinox|mesh-list
6161080|NCT01523457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6161081|NCT01523496|Vitamin D|vitamin d|mesh-list
6161082|NCT01523496|Ergocalciferols|ergocalciferols|mesh-list
6161083|NCT01523496|Calcifediol|calcifediol|mesh-list
6161084|NCT01523496|Vitamins|vitamins|mesh-list
6161085|NCT01523496|Micronutrients|micronutrients|mesh-ancestor
6161086|NCT01523496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161087|NCT01523496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6161088|NCT01523496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6161089|NCT01523587|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5560092|NCT04017988|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5560093|NCT04017988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5560094|NCT04017988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5560095|NCT04017988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560096|NCT04017650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5560097|NCT04017650|Nivolumab|nivolumab|mesh-list
5560098|NCT04017650|Cetuximab|cetuximab|mesh-list
5560099|NCT04017650|Antibodies|antibodies|mesh-list
5560100|NCT04017650|Immunoglobulins|immunoglobulins|mesh-list
5560101|NCT04017650|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5560102|NCT04017650|Immunologic Factors|immunologic factors|mesh-ancestor
5560103|NCT04017650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560104|NCT04017650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5560105|NCT04017650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5560106|NCT04017650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560107|NCT04017624|Nicotine|nicotine|mesh-list
5560108|NCT04017624|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5560109|NCT04017624|Autonomic Agents|autonomic agents|mesh-ancestor
5560110|NCT04017624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5560111|NCT04017624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161090|NCT01523587|Afatinib|afatinib|mesh-list
6161091|NCT01523587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6161092|NCT01523587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6161093|NCT01523587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6161094|NCT01523587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206058|NCT02096575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6206059|NCT02096575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206060|NCT02096575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6206061|NCT02096575|Analgesics|analgesics|mesh-ancestor
6206062|NCT02096575|Sensory System Agents|sensory system agents|mesh-ancestor
5560112|NCT04017624|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5560113|NCT04017624|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5560114|NCT04017624|Cholinergic Agents|cholinergic agents|mesh-ancestor
5560115|NCT04017624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5560116|NCT04017624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560117|NCT04017377|Paclitaxel|paclitaxel|mesh-list
5560118|NCT04017377|Cisplatin|cisplatin|mesh-list
5560119|NCT04017377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6206063|NCT02096575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6206064|NCT02096588|Cyclophosphamide|cyclophosphamide|mesh-list
5560120|NCT04017377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5560121|NCT04017377|Tubulin Modulators|tubulin modulators|mesh-ancestor
5560122|NCT04017377|Antimitotic Agents|antimitotic agents|mesh-ancestor
5560123|NCT04017377|Mitosis Modulators|mitosis modulators|mesh-ancestor
5560124|NCT04017377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560125|NCT04017247|Oxytocin|oxytocin|mesh-list
5560126|NCT04017247|Oxytocics|oxytocics|mesh-ancestor
5560127|NCT04017247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5560128|NCT04017247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206065|NCT02096588|Doxorubicin|doxorubicin|mesh-list
6206066|NCT02096588|Simvastatin|simvastatin|mesh-list
6206067|NCT02096588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5560129|NCT04017598|Iron|iron|mesh-list
5560130|NCT04017598|Trace Elements|trace elements|mesh-ancestor
5560131|NCT04017598|Micronutrients|micronutrients|mesh-ancestor
5560132|NCT04017598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560133|NCT04017455|Bevacizumab|bevacizumab|mesh-list
5560134|NCT04017455|Atezolizumab|atezolizumab|mesh-list
5560135|NCT04017455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5560136|NCT04017455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6161095|NCT01523821|Protease Inhibitors|protease inhibitors|mesh-list
6161096|NCT01523821|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
6161097|NCT01523821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6161098|NCT01523821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161099|NCT01523821|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6161100|NCT01523821|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6161101|NCT01523834|Panobinostat|panobinostat|mesh-list
6161102|NCT01523834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6161103|NCT01523834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6161104|NCT01523834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6161105|NCT01523834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161106|NCT01523886|Rocuronium|rocuronium|mesh-list
6161107|NCT01523886|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6481584|NCT00547664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481585|NCT00547664|Analgesics|analgesics|mesh-ancestor
6481586|NCT00547664|Sensory System Agents|sensory system agents|mesh-ancestor
6481587|NCT00547664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6481588|NCT00547768|Fexofenadine|fexofenadine|mesh-list
6481589|NCT00547768|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6481590|NCT00547768|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6481591|NCT00547768|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6481592|NCT00547768|Histamine Antagonists|histamine antagonists|mesh-ancestor
6481593|NCT00547768|Histamine Agents|histamine agents|mesh-ancestor
6481594|NCT00547768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6481595|NCT00547768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481596|NCT00547768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481597|NCT00547885|Dihydrocodeine|dihydrocodeine|mesh-list
6481598|NCT00547885|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5560137|NCT04017455|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5560138|NCT04017455|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5560139|NCT04017455|Growth Substances|growth substances|mesh-ancestor
5560140|NCT04017455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481599|NCT00547885|Narcotics|narcotics|mesh-ancestor
6481600|NCT00547885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5560141|NCT04017455|Growth Inhibitors|growth inhibitors|mesh-ancestor
5560142|NCT04017546|Venetoclax|venetoclax|mesh-list
5560143|NCT04017546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5603434|NCT02476097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5603435|NCT02476097|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5603436|NCT02476097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5603437|NCT02476097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603438|NCT02459392|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5603439|NCT02459392|Methylprednisolone|methylprednisolone|mesh-list
5603440|NCT02459392|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5603441|NCT02459392|Prednisolone|prednisolone|mesh-list
5603442|NCT02459392|Prednisolone acetate|prednisolone acetate|mesh-list
5603443|NCT02459392|Hyaluronic Acid|hyaluronic acid|mesh-list
5603444|NCT02459392|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6481601|NCT00547885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481602|NCT00547885|Analgesics|analgesics|mesh-ancestor
6481603|NCT00547885|Sensory System Agents|sensory system agents|mesh-ancestor
6481604|NCT00547885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6481605|NCT00547989|Bupivacaine|bupivacaine|mesh-list
6481606|NCT00547989|Ropivacaine|ropivacaine|mesh-list
6481607|NCT00547989|Anesthetics, Local|anesthetics, local|mesh-ancestor
6481608|NCT00547989|Anesthetics|anesthetics|mesh-ancestor
5603445|NCT02459392|Prednisolone phosphate|prednisolone phosphate|mesh-list
5603446|NCT02459392|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5603447|NCT02459392|Immunologic Factors|immunologic factors|mesh-ancestor
6161108|NCT01523886|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6161109|NCT01523886|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6161110|NCT01523886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6161111|NCT01523886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161112|NCT01524133|Sertraline|sertraline|mesh-list
5603448|NCT02459392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603449|NCT02459392|Viscosupplements|viscosupplements|mesh-ancestor
5603450|NCT02459392|Protective Agents|protective agents|mesh-ancestor
6161113|NCT01524133|Antidepressive Agents|antidepressive agents|mesh-ancestor
6481609|NCT00547989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6668449|NCT01532466|Rocuronium|rocuronium|mesh-list
6161114|NCT01524133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6161115|NCT01524133|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6161116|NCT01524133|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6161117|NCT01524133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6161118|NCT01524133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161119|NCT01524133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6161120|NCT01524133|Serotonin Agents|serotonin agents|mesh-ancestor
6161121|NCT01524133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161122|NCT01524198|Budesonide|budesonide|mesh-list
6161123|NCT01524198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5560144|NCT04017338|Ezetimibe|ezetimibe|mesh-list
5560145|NCT04017338|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5560146|NCT04017338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5560147|NCT04017338|Antimetabolites|antimetabolites|mesh-ancestor
5560148|NCT04017338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560149|NCT04017338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5560150|NCT04017221|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
5560151|NCT04017221|Protease Inhibitors|protease inhibitors|mesh-ancestor
5560152|NCT04017221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5560153|NCT04017221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560154|NCT04017221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5560155|NCT04017221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560156|NCT04017013|Lidocaine|lidocaine|mesh-list
6161124|NCT01524198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6161125|NCT01524198|Autonomic Agents|autonomic agents|mesh-ancestor
6161126|NCT01524198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6161127|NCT01524198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161128|NCT01524198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6161129|NCT01524198|Respiratory System Agents|respiratory system agents|mesh-ancestor
6161130|NCT01524198|Glucocorticoids|glucocorticoids|mesh-ancestor
6161131|NCT01524198|Hormones|hormones|mesh-ancestor
6161132|NCT01524198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6161133|NCT01524289|Anacetrapib|anacetrapib|mesh-list
6161134|NCT01524289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6161135|NCT01524289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6161136|NCT01524289|Antimetabolites|antimetabolites|mesh-ancestor
6161137|NCT01524289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161138|NCT01524289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6161139|NCT01524302|Levofloxacin|levofloxacin|mesh-list
6161140|NCT01524302|Ofloxacin|ofloxacin|mesh-list
6161141|NCT01524302|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
6161142|NCT01524302|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6161143|NCT01524302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6161144|NCT01524302|Renal Agents|renal agents|mesh-ancestor
6161145|NCT01524302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6161146|NCT01524302|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6161147|NCT01524302|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6161148|NCT01524302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6161149|NCT01524302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161150|NCT01524302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6161151|NCT01524302|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6161152|NCT01524302|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6161153|NCT01524627|Varenicline|varenicline|mesh-list
6161154|NCT01524627|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6161155|NCT01524627|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6161156|NCT01524627|Cholinergic Agents|cholinergic agents|mesh-ancestor
6161157|NCT01524627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6161158|NCT01524627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161159|NCT01524627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161160|NCT01524679|Interferons|interferons|mesh-list
6161161|NCT01524679|Interferon-alpha|interferon-alpha|mesh-list
6161162|NCT01524679|Interferon alpha-2|interferon alpha-2|mesh-list
6161163|NCT01524679|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6161164|NCT01524679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6161165|NCT01524679|Antiviral Agents|antiviral agents|mesh-ancestor
6161166|NCT01524679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6161167|NCT01524679|Immunologic Factors|immunologic factors|mesh-ancestor
6161168|NCT01524679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161169|NCT01524770|Dulaglutide|dulaglutide|mesh-list
6161170|NCT01524770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5560157|NCT04017013|Anesthetics, Local|anesthetics, local|mesh-ancestor
6161171|NCT01524770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161172|NCT01524783|Everolimus|everolimus|mesh-list
6161173|NCT01524783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6161174|NCT01524783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6161175|NCT01524783|Immunologic Factors|immunologic factors|mesh-ancestor
6161176|NCT01524783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161177|NCT01524796|Pregabalin|pregabalin|mesh-list
6161178|NCT01524796|Analgesics|analgesics|mesh-ancestor
5560158|NCT04017013|Anesthetics|anesthetics|mesh-ancestor
5560159|NCT04017013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5560160|NCT04017013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560161|NCT04017013|Sensory System Agents|sensory system agents|mesh-ancestor
5560162|NCT04017013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5560163|NCT04017013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5560164|NCT04017013|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5560165|NCT04017013|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5560166|NCT04017013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5560167|NCT04017013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560168|NCT04016922|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
5560169|NCT04016922|Hematinics|hematinics|mesh-ancestor
6161179|NCT01524796|Sensory System Agents|sensory system agents|mesh-ancestor
6161180|NCT01524796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6161181|NCT01524796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161182|NCT01524796|Anticonvulsants|anticonvulsants|mesh-ancestor
6161183|NCT01524796|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6161184|NCT01524796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6161185|NCT01524796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161186|NCT01524796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6161187|NCT01524796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6161188|NCT01524796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6161189|NCT01524796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5560170|NCT04017104|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5560171|NCT04017104|Edotreotide|edotreotide|mesh-list
5560172|NCT04017104|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5560173|NCT04017104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560174|NCT04016753|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
5560175|NCT04016753|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5560176|NCT04016753|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5560177|NCT04016753|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5560178|NCT04016753|Contraceptive Agents|contraceptive agents|mesh-ancestor
5560179|NCT04016753|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5560180|NCT04016753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560181|NCT04016753|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5560182|NCT04016753|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5560183|NCT04016753|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
5560184|NCT04016753|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5560185|NCT04016389|Paclitaxel|paclitaxel|mesh-list
5560186|NCT04016389|Carboplatin|carboplatin|mesh-list
5560187|NCT04016389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5560188|NCT04016389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5560189|NCT04016389|Tubulin Modulators|tubulin modulators|mesh-ancestor
5560190|NCT04016389|Antimitotic Agents|antimitotic agents|mesh-ancestor
5560191|NCT04016389|Mitosis Modulators|mitosis modulators|mesh-ancestor
5560192|NCT04016389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560193|NCT04016740|Dexmedetomidine|dexmedetomidine|mesh-list
5560194|NCT04016740|Ketamine|ketamine|mesh-list
5560195|NCT04016740|Remifentanil|remifentanil|mesh-list
5560196|NCT04016740|Propofol|propofol|mesh-list
5560197|NCT04016740|Ropivacaine|ropivacaine|mesh-list
5560198|NCT04016740|Sevoflurane|sevoflurane|mesh-list
5560199|NCT04016740|Rocuronium|rocuronium|mesh-list
5560200|NCT04016740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5560201|NCT04016740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5560202|NCT04016740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560203|NCT04016740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5560204|NCT04016740|Anesthetics, General|anesthetics, general|mesh-ancestor
5560205|NCT04016740|Anesthetics|anesthetics|mesh-ancestor
5560206|NCT04016740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5560207|NCT04016740|Analgesics|analgesics|mesh-ancestor
5560208|NCT04016740|Sensory System Agents|sensory system agents|mesh-ancestor
5560209|NCT04016740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5560210|NCT04016740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5560211|NCT04016740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5560212|NCT04016740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5560213|NCT04016740|Adrenergic Agents|adrenergic agents|mesh-ancestor
5560214|NCT04016740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5560215|NCT04016740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161190|NCT01524796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6161191|NCT01524887|Immunoglobulins|immunoglobulins|mesh-list
6161192|NCT01524887|Antibodies|antibodies|mesh-list
6161193|NCT01524887|gamma-Globulins|gamma-globulins|mesh-list
6481610|NCT00547989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481611|NCT00547989|Sensory System Agents|sensory system agents|mesh-ancestor
6481612|NCT00547989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6481613|NCT00548002|Levofloxacin|levofloxacin|mesh-list
6481614|NCT00548002|Ofloxacin|ofloxacin|mesh-list
6481615|NCT00548002|Trovafloxacin|trovafloxacin|mesh-list
6481616|NCT00548002|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6481617|NCT00548002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6481618|NCT00548002|Renal Agents|renal agents|mesh-ancestor
5560216|NCT04016740|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5560217|NCT04016740|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5560218|NCT04016740|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5560219|NCT04016740|Anesthetics, Local|anesthetics, local|mesh-ancestor
5560220|NCT04016740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5560221|NCT04016740|Narcotics|narcotics|mesh-ancestor
6481619|NCT00548002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6481620|NCT00548002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6481621|NCT00548002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6481622|NCT00548002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6481623|NCT00548002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481624|NCT00548002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6161194|NCT01524887|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6161195|NCT01524887|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6161196|NCT01524887|Immunologic Factors|immunologic factors|mesh-ancestor
6161197|NCT01524887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161198|NCT01524913|Hyaluronic Acid|hyaluronic acid|mesh-list
6481625|NCT00548002|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6481626|NCT00548002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6481627|NCT00548067|Amlodipine|amlodipine|mesh-list
6481628|NCT00548067|Valsartan|valsartan|mesh-list
6481629|NCT00548067|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6481630|NCT00548067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6161199|NCT01524913|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5560222|NCT04016740|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5560223|NCT04016740|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5560224|NCT04016740|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5560225|NCT04016740|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6161200|NCT01524913|Immunologic Factors|immunologic factors|mesh-ancestor
6161201|NCT01524913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161202|NCT01524913|Viscosupplements|viscosupplements|mesh-ancestor
6161203|NCT01524913|Protective Agents|protective agents|mesh-ancestor
6161204|NCT01524978|Cetuximab|cetuximab|mesh-list
6161205|NCT01524978|Vemurafenib|vemurafenib|mesh-list
6161206|NCT01524978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6161207|NCT01524978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6161208|NCT01524978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6161209|NCT01524978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6161210|NCT01524978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161211|NCT01524991|Gemcitabine|gemcitabine|mesh-list
6161212|NCT01524991|Ipilimumab|ipilimumab|mesh-list
6161213|NCT01524991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6161214|NCT01524991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6161215|NCT01524991|Antimetabolites|antimetabolites|mesh-ancestor
6161216|NCT01524991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161217|NCT01524991|Antiviral Agents|antiviral agents|mesh-ancestor
6161218|NCT01524991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6161219|NCT01524991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6161220|NCT01524991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6161221|NCT01524991|Immunologic Factors|immunologic factors|mesh-ancestor
6161222|NCT01524991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161223|NCT01524991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6161224|NCT01524991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6161225|NCT01525082|Bevacizumab|bevacizumab|mesh-list
6161226|NCT01525082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6161227|NCT01525082|Capecitabine|capecitabine|mesh-list
6161228|NCT01525082|Temozolomide|temozolomide|mesh-list
6161229|NCT01525082|Antibodies|antibodies|mesh-list
6161230|NCT01525082|Immunoglobulins|immunoglobulins|mesh-list
6161231|NCT01525082|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6161232|NCT01525082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6161233|NCT01525082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6161234|NCT01525082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6161235|NCT01525082|Growth Substances|growth substances|mesh-ancestor
6161236|NCT01525082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161237|NCT01525082|Growth Inhibitors|growth inhibitors|mesh-ancestor
6161238|NCT01525082|Immunologic Factors|immunologic factors|mesh-ancestor
5560226|NCT04016740|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5560227|NCT04016246|Propofol|propofol|mesh-list
5560228|NCT04016246|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5560229|NCT04016246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5560230|NCT04016246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560231|NCT04016246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6161239|NCT01525082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6161240|NCT01525082|Antimetabolites|antimetabolites|mesh-ancestor
6161241|NCT01525082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560232|NCT04016246|Anesthetics, General|anesthetics, general|mesh-ancestor
5560233|NCT04016246|Anesthetics|anesthetics|mesh-ancestor
5560234|NCT04016233|Tenofovir|tenofovir|mesh-list
6161242|NCT01525082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6161243|NCT01525082|Alkylating Agents|alkylating agents|mesh-ancestor
6161244|NCT01525173|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6161245|NCT01525173|Bimatoprost|bimatoprost|mesh-list
6161246|NCT01525173|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5560235|NCT04016233|Antiviral Agents|antiviral agents|mesh-ancestor
5560236|NCT04016233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5560237|NCT04016233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5560238|NCT04016233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5560239|NCT04016233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5560240|NCT04016233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560241|NCT04016233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5560242|NCT04016233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5560243|NCT04016051|Clarithromycin|clarithromycin|mesh-list
5560244|NCT04016051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6161247|NCT01525173|Latanoprost|latanoprost|mesh-list
6161248|NCT01525173|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6161249|NCT01525173|Lubricant Eye Drops|lubricant eye drops|mesh-list
6161250|NCT01525173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6161251|NCT01525173|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6161252|NCT01525173|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6161253|NCT01525173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6161254|NCT01525173|Adrenergic Agents|adrenergic agents|mesh-ancestor
6161255|NCT01525173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5560245|NCT04016051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5560246|NCT04016051|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5560247|NCT04016051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5560248|NCT04016051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560249|NCT04016051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5560250|NCT04016051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5560251|NCT04016116|Pembrolizumab|pembrolizumab|mesh-list
5560252|NCT04016116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5560253|NCT04016116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5560254|NCT04016142|Paclitaxel|paclitaxel|mesh-list
5560255|NCT04016142|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5560256|NCT04016142|Carboplatin|carboplatin|mesh-list
5560257|NCT04016142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5560258|NCT04016142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5560259|NCT04016142|Tubulin Modulators|tubulin modulators|mesh-ancestor
5560260|NCT04016142|Antimitotic Agents|antimitotic agents|mesh-ancestor
6161256|NCT01525173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161257|NCT01525173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161258|NCT01525225|Metformin|metformin|mesh-list
6161259|NCT01525225|Saxagliptin|saxagliptin|mesh-list
6161260|NCT01525225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6161261|NCT01525225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161262|NCT01525225|Incretins|incretins|mesh-ancestor
6161263|NCT01525225|Hormones|hormones|mesh-ancestor
6161264|NCT01525225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6161265|NCT01525225|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6161266|NCT01525225|Protease Inhibitors|protease inhibitors|mesh-ancestor
6161267|NCT01525225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6161268|NCT01525225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161269|NCT01525238|Dapagliflozin|dapagliflozin|mesh-list
5560261|NCT04016142|Mitosis Modulators|mitosis modulators|mesh-ancestor
5560262|NCT04016142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161270|NCT01525238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6206068|NCT02096588|Immunologic Factors|immunologic factors|mesh-ancestor
6161271|NCT01525238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161272|NCT01525238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6161273|NCT01525238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161274|NCT01525329|Fluorouracil|fluorouracil|mesh-list
6161275|NCT01525329|Antimetabolites|antimetabolites|mesh-ancestor
6161276|NCT01525329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161277|NCT01525329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6161278|NCT01525329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6161279|NCT01525329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6161280|NCT01525329|Immunologic Factors|immunologic factors|mesh-ancestor
6161281|NCT01525329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161282|NCT01525407|Atorvastatin|atorvastatin|mesh-list
6161283|NCT01525407|Calcium|calcium|mesh-list
6161284|NCT01525407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5560263|NCT04016090|Folic Acid|folic acid|mesh-list
5560264|NCT04016090|Hematinics|hematinics|mesh-ancestor
5560265|NCT04016090|Vitamin B Complex|vitamin b complex|mesh-ancestor
5560266|NCT04016090|Vitamins|vitamins|mesh-ancestor
5560267|NCT04016090|Micronutrients|micronutrients|mesh-ancestor
5560268|NCT04016090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560269|NCT04016220|Budesonide|budesonide|mesh-list
5560270|NCT04016220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5560271|NCT04016220|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5560272|NCT04016220|Autonomic Agents|autonomic agents|mesh-ancestor
5560273|NCT04016220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5560274|NCT04016220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560275|NCT04016220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5560276|NCT04016220|Respiratory System Agents|respiratory system agents|mesh-ancestor
5560277|NCT04016220|Glucocorticoids|glucocorticoids|mesh-ancestor
5560278|NCT04016220|Hormones|hormones|mesh-ancestor
5560279|NCT04016220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5560280|NCT04015908|Acetaminophen|acetaminophen|mesh-list
6161285|NCT01525407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161286|NCT01525407|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6161287|NCT01525407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6161288|NCT01525407|Antimetabolites|antimetabolites|mesh-ancestor
6161289|NCT01525407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161290|NCT01525407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6161291|NCT01525407|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6161292|NCT01525407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6161293|NCT01525550|Sunitinib|sunitinib|mesh-list
6161294|NCT01525550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6161295|NCT01525550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6161296|NCT01525550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6161297|NCT01525550|Growth Substances|growth substances|mesh-ancestor
6161298|NCT01525550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161299|NCT01525550|Growth Inhibitors|growth inhibitors|mesh-ancestor
6161300|NCT01525550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6161301|NCT01525550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6161302|NCT01525550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161303|NCT01525602|Paclitaxel|paclitaxel|mesh-list
5560281|NCT04015908|Celecoxib|celecoxib|mesh-list
5560282|NCT04015908|Pregabalin|pregabalin|mesh-list
5560283|NCT04015908|Oxycodone|oxycodone|mesh-list
5560284|NCT04015908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5560285|NCT04015908|Analgesics|analgesics|mesh-ancestor
5560286|NCT04015908|Sensory System Agents|sensory system agents|mesh-ancestor
5560287|NCT04015908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5560288|NCT04015908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560289|NCT04015908|Antipyretics|antipyretics|mesh-ancestor
5560290|NCT04015908|Anticonvulsants|anticonvulsants|mesh-ancestor
5560291|NCT04015908|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5560292|NCT04015908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5560293|NCT04015908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560294|NCT04015908|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5560295|NCT04015908|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5560296|NCT04015908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5560297|NCT04015908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5560298|NCT04015908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5560299|NCT04015908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5560300|NCT04015908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6161304|NCT01525602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6161305|NCT01525602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5560301|NCT04015908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5560302|NCT04015908|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5560303|NCT04015908|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5560304|NCT04015908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6161306|NCT01525602|Tubulin Modulators|tubulin modulators|mesh-ancestor
6161307|NCT01525602|Antimitotic Agents|antimitotic agents|mesh-ancestor
6161308|NCT01525602|Mitosis Modulators|mitosis modulators|mesh-ancestor
6161309|NCT01525602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161310|NCT01525615|Tiotropium Bromide|tiotropium bromide|mesh-list
6161311|NCT01525615|Olodaterol|olodaterol|mesh-list
6161312|NCT01525615|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6161313|NCT01525615|Autonomic Agents|autonomic agents|mesh-ancestor
6161314|NCT01525615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6161315|NCT01525615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161316|NCT01525615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6161317|NCT01525615|Respiratory System Agents|respiratory system agents|mesh-ancestor
6161318|NCT01525615|Parasympatholytics|parasympatholytics|mesh-ancestor
6161319|NCT01525615|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6161320|NCT01525615|Cholinergic Agents|cholinergic agents|mesh-ancestor
6161321|NCT01525615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6161322|NCT01525615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161323|NCT01525628|Tolbutamide|tolbutamide|mesh-list
6161324|NCT01525628|Interferons|interferons|mesh-list
6161325|NCT01525628|Tenofovir|tenofovir|mesh-list
6161326|NCT01525628|Ribavirin|ribavirin|mesh-list
6161327|NCT01525628|Midazolam|midazolam|mesh-list
6161328|NCT01525628|Caffeine|caffeine|mesh-list
6161329|NCT01525628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6161330|NCT01525628|Antiviral Agents|antiviral agents|mesh-ancestor
6161331|NCT01525628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6161332|NCT01525628|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6161333|NCT01525628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6161334|NCT01525628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6161335|NCT01525628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161336|NCT01525628|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6161337|NCT01525628|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6161338|NCT01525628|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6161339|NCT01525628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6161340|NCT01525628|Anesthetics, General|anesthetics, general|mesh-ancestor
6161341|NCT01525628|Anesthetics|anesthetics|mesh-ancestor
6161342|NCT01525628|GABA Modulators|gaba modulators|mesh-ancestor
6161343|NCT01525628|GABA Agents|gaba agents|mesh-ancestor
6161344|NCT01525628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6161345|NCT01525628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161346|NCT01525628|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6161347|NCT01525628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6161348|NCT01525628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6161349|NCT01525628|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6161350|NCT01525628|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6161351|NCT01525628|Antimetabolites|antimetabolites|mesh-ancestor
6161352|NCT01525628|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6161353|NCT01525628|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6161354|NCT01525628|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6161355|NCT01525628|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6161356|NCT01525628|Purinergic Agents|purinergic agents|mesh-ancestor
6161357|NCT01525628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6161358|NCT01525641|Pramipexole|pramipexole|mesh-list
6161359|NCT01525641|Antioxidants|antioxidants|mesh-ancestor
6161360|NCT01525641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161361|NCT01525641|Protective Agents|protective agents|mesh-ancestor
6161362|NCT01525641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161363|NCT01525641|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6161364|NCT01525641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6161365|NCT01525641|Dopamine Agonists|dopamine agonists|mesh-ancestor
6161366|NCT01525641|Dopamine Agents|dopamine agents|mesh-ancestor
6161367|NCT01525641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6161368|NCT01525875|Magnesium Oxide|magnesium oxide|mesh-list
6161369|NCT01525875|Antacids|antacids|mesh-ancestor
6161370|NCT01525875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161371|NCT01525875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6161372|NCT01526057|Rituximab|rituximab|mesh-list
6161373|NCT01526057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6161374|NCT01526057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6161375|NCT01526057|Immunologic Factors|immunologic factors|mesh-ancestor
6161376|NCT01526057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161377|NCT01526057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6161378|NCT01526148|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6161379|NCT01526148|Lithium Carbonate|lithium carbonate|mesh-list
6161380|NCT01526148|Antidepressive Agents|antidepressive agents|mesh-ancestor
5560305|NCT04015908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5560306|NCT04015908|Narcotics|narcotics|mesh-ancestor
5560307|NCT04016207|Guanfacine|guanfacine|mesh-list
5560308|NCT04016207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5560309|NCT04016207|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5560310|NCT04016207|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5560311|NCT04016207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5560312|NCT04016207|Adrenergic Agents|adrenergic agents|mesh-ancestor
5560313|NCT04016207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5560314|NCT04016207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560315|NCT04016207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161381|NCT01526148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6161382|NCT01526148|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6161383|NCT01526148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6161384|NCT01526148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6161385|NCT01526148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161386|NCT01526148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6161387|NCT01526148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161388|NCT01526148|Antimanic Agents|antimanic agents|mesh-ancestor
6668450|NCT01532466|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6668451|NCT01532466|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6668452|NCT01532466|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6668453|NCT01532466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6161389|NCT01526213|Fexofenadine|fexofenadine|mesh-list
6161390|NCT01526213|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6161391|NCT01526213|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6161392|NCT01526213|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6161393|NCT01526213|Histamine Antagonists|histamine antagonists|mesh-ancestor
6161394|NCT01526213|Histamine Agents|histamine agents|mesh-ancestor
6161395|NCT01526213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6161396|NCT01526213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161397|NCT01526213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161398|NCT01526356|Sirolimus|sirolimus|mesh-list
6161399|NCT01526356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6161400|NCT01526356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6161401|NCT01526356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6161402|NCT01526356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6161403|NCT01526356|Antifungal Agents|antifungal agents|mesh-ancestor
6161404|NCT01526356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6161405|NCT01526356|Immunologic Factors|immunologic factors|mesh-ancestor
6161406|NCT01526356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668454|NCT01532466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668455|NCT01532518|MEN 11420|men 11420|mesh-list
5560316|NCT04015869|Pregnanolone|pregnanolone|mesh-list
6161407|NCT01526538|Cycloserine|cycloserine|mesh-list
6161408|NCT01526538|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6161409|NCT01526538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6161410|NCT01526538|Renal Agents|renal agents|mesh-ancestor
6161411|NCT01526538|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6161412|NCT01526538|Antitubercular Agents|antitubercular agents|mesh-ancestor
6161413|NCT01526538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6161414|NCT01526538|Antimetabolites|antimetabolites|mesh-ancestor
6161415|NCT01526538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161416|NCT01526551|Vaccines|vaccines|mesh-list
6161417|NCT01526551|Immunologic Factors|immunologic factors|mesh-ancestor
6161418|NCT01526551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161419|NCT01526577|Ticagrelor|ticagrelor|mesh-list
6161420|NCT01526577|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
6161421|NCT01526577|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6161422|NCT01526577|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6161423|NCT01526577|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6161424|NCT01526577|Purinergic Agents|purinergic agents|mesh-ancestor
6161425|NCT01526577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6161426|NCT01526577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161427|NCT01526577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161428|NCT01526733|Insulin|insulin|mesh-list
6161429|NCT01526733|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6161430|NCT01526733|Insulin Aspart|insulin aspart|mesh-list
6161431|NCT01526733|Insulin Lispro|insulin lispro|mesh-list
6161432|NCT01526733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6161433|NCT01526733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161434|NCT01527045|Calcium, Dietary|calcium, dietary|mesh-list
6161435|NCT01527045|Cyclosporine|cyclosporine|mesh-list
6161436|NCT01527045|Mycophenolic Acid|mycophenolic acid|mesh-list
6161437|NCT01527045|Fludarabine|fludarabine|mesh-list
6161438|NCT01527045|Fludarabine phosphate|fludarabine phosphate|mesh-list
6161439|NCT01527045|Atorvastatin|atorvastatin|mesh-list
6161440|NCT01527045|Calcium|calcium|mesh-list
5560317|NCT04015869|Anesthetics|anesthetics|mesh-ancestor
5560318|NCT04015869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5560319|NCT04015869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560320|NCT04015596|Naproxen|naproxen|mesh-list
6161441|NCT01527045|Cyclosporins|cyclosporins|mesh-list
6161442|NCT01527045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6161443|NCT01527045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161444|NCT01527045|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6161445|NCT01527045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6161446|NCT01527045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6161447|NCT01527045|Antimetabolites|antimetabolites|mesh-ancestor
6161448|NCT01527045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161449|NCT01527045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6161450|NCT01527045|Immunologic Factors|immunologic factors|mesh-ancestor
6161451|NCT01527045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6161452|NCT01527045|Antifungal Agents|antifungal agents|mesh-ancestor
6161453|NCT01527045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6161454|NCT01527045|Dermatologic Agents|dermatologic agents|mesh-ancestor
6161455|NCT01527045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6161456|NCT01527045|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5560321|NCT04015596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5560322|NCT04015596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5560323|NCT04015596|Analgesics|analgesics|mesh-ancestor
5560324|NCT04015596|Sensory System Agents|sensory system agents|mesh-ancestor
5560325|NCT04015596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5560326|NCT04015596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560327|NCT04015596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5560328|NCT04015596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5560329|NCT04015596|Gout Suppressants|gout suppressants|mesh-ancestor
5560330|NCT04015596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5560331|NCT04015596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6161457|NCT01527045|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6161458|NCT01527045|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6161459|NCT01527045|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6161460|NCT01527045|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6161461|NCT01527045|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6161462|NCT01527045|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6161463|NCT01527045|Antitubercular Agents|antitubercular agents|mesh-ancestor
6161464|NCT01527045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6161465|NCT01527110|Zanamivir|zanamivir|mesh-list
6161466|NCT01527110|Antiviral Agents|antiviral agents|mesh-ancestor
6161467|NCT01527110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6161468|NCT01527110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6161469|NCT01527110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161470|NCT01527149|Cytarabine|cytarabine|mesh-list
6161471|NCT01527149|Dexamethasone|dexamethasone|mesh-list
6161472|NCT01527149|Dexamethasone acetate|dexamethasone acetate|mesh-list
6161473|NCT01527149|Cyclophosphamide|cyclophosphamide|mesh-list
6161474|NCT01527149|Doxorubicin|doxorubicin|mesh-list
6161475|NCT01527149|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6161476|NCT01527149|Methotrexate|methotrexate|mesh-list
6161477|NCT01527149|Vincristine|vincristine|mesh-list
6161478|NCT01527149|Ofatumumab|ofatumumab|mesh-list
6161479|NCT01527149|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6161480|NCT01527149|BB 1101|bb 1101|mesh-list
6161481|NCT01527149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6161482|NCT01527149|Immunologic Factors|immunologic factors|mesh-ancestor
6161483|NCT01527149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161484|NCT01527149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6161485|NCT01527149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6161486|NCT01527149|Alkylating Agents|alkylating agents|mesh-ancestor
6161487|NCT01527149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161488|NCT01527149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6161489|NCT01527149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6161490|NCT01527149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6161491|NCT01527149|Antiemetics|antiemetics|mesh-ancestor
6161492|NCT01527149|Autonomic Agents|autonomic agents|mesh-ancestor
6161493|NCT01527149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6161494|NCT01527149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6161495|NCT01527149|Glucocorticoids|glucocorticoids|mesh-ancestor
6161496|NCT01527149|Hormones|hormones|mesh-ancestor
6161497|NCT01527149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6161498|NCT01527149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6161499|NCT01527149|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6161500|NCT01527149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6161501|NCT01527149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6161502|NCT01527149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6161503|NCT01527149|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6161504|NCT01527149|Abortifacient Agents|abortifacient agents|mesh-ancestor
6161505|NCT01527149|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6161506|NCT01527149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6161507|NCT01527149|Antimetabolites|antimetabolites|mesh-ancestor
6161508|NCT01527149|Dermatologic Agents|dermatologic agents|mesh-ancestor
6161509|NCT01527149|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6161510|NCT01527149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6161511|NCT01527149|Antiviral Agents|antiviral agents|mesh-ancestor
6161512|NCT01527149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6161513|NCT01527149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6161514|NCT01527149|Tubulin Modulators|tubulin modulators|mesh-ancestor
6161515|NCT01527149|Antimitotic Agents|antimitotic agents|mesh-ancestor
6161516|NCT01527149|Mitosis Modulators|mitosis modulators|mesh-ancestor
5560332|NCT04015596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560333|NCT04015414|Varenicline|varenicline|mesh-list
5560334|NCT04015414|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5560335|NCT04015414|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5560336|NCT04015414|Cholinergic Agents|cholinergic agents|mesh-ancestor
5560337|NCT04015414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5560338|NCT04015414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560339|NCT04015414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560340|NCT04015700|Coal Tar|coal tar|mesh-list
5560341|NCT04015700|Vaccines|vaccines|mesh-list
6161517|NCT01527149|Protease Inhibitors|protease inhibitors|mesh-ancestor
6161518|NCT01527357|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6161519|NCT01527357|Fibrin Foam|fibrin foam|mesh-list
6161520|NCT01527357|Hemostatics|hemostatics|mesh-ancestor
6161521|NCT01527357|Coagulants|coagulants|mesh-ancestor
6161522|NCT01527383|Vaccines|vaccines|mesh-list
6161523|NCT01527383|Immunologic Factors|immunologic factors|mesh-ancestor
6161524|NCT01527383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161525|NCT01527487|Cyclophosphamide|cyclophosphamide|mesh-list
6161526|NCT01527487|Docetaxel|docetaxel|mesh-list
6161527|NCT01527487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6161528|NCT01527487|Immunologic Factors|immunologic factors|mesh-ancestor
6161529|NCT01527487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161530|NCT01527487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6161531|NCT01527487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6161532|NCT01527487|Alkylating Agents|alkylating agents|mesh-ancestor
5560342|NCT04015700|Immunologic Factors|immunologic factors|mesh-ancestor
6161533|NCT01527487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161534|NCT01527487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6161535|NCT01527487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6161536|NCT01527487|Tubulin Modulators|tubulin modulators|mesh-ancestor
6161537|NCT01527487|Antimitotic Agents|antimitotic agents|mesh-ancestor
6161538|NCT01527487|Mitosis Modulators|mitosis modulators|mesh-ancestor
5560343|NCT04015700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560344|NCT04015700|Keratolytic Agents|keratolytic agents|mesh-ancestor
5560345|NCT04015700|Dermatologic Agents|dermatologic agents|mesh-ancestor
5560346|NCT04015557|Acetaminophen|acetaminophen|mesh-list
5560347|NCT04015557|Acetylcysteine|acetylcysteine|mesh-list
5560348|NCT04015557|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5560349|NCT04015557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5560350|NCT04015557|Analgesics|analgesics|mesh-ancestor
5560351|NCT04015557|Sensory System Agents|sensory system agents|mesh-ancestor
5560352|NCT04015557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5560353|NCT04015557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560354|NCT04015557|Antipyretics|antipyretics|mesh-ancestor
5560355|NCT04015557|Antiviral Agents|antiviral agents|mesh-ancestor
5560356|NCT04015557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5560357|NCT04015557|Expectorants|expectorants|mesh-ancestor
5560358|NCT04015557|Respiratory System Agents|respiratory system agents|mesh-ancestor
6161539|NCT01527513|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
6161540|NCT01527513|Anticonvulsants|anticonvulsants|mesh-ancestor
6161541|NCT01527513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6161542|NCT01527513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6161543|NCT01527513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6161544|NCT01527513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161545|NCT01527682|Dorzolamide|dorzolamide|mesh-list
6161546|NCT01527682|Latanoprost|latanoprost|mesh-list
6161547|NCT01527682|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6161548|NCT01527682|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6161549|NCT01527682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6161550|NCT01527682|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6161551|NCT01527682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6161552|NCT01527682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161553|NCT01528254|Metformin|metformin|mesh-list
6161554|NCT01528254|Vildagliptin|vildagliptin|mesh-list
6161555|NCT01528254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6161556|NCT01528254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161557|NCT01528254|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6161558|NCT01528254|Protease Inhibitors|protease inhibitors|mesh-ancestor
6161559|NCT01528254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6161560|NCT01528254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161561|NCT01528345|Fulvestrant|fulvestrant|mesh-list
6161562|NCT01528345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6161563|NCT01528345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6161564|NCT01528345|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6161565|NCT01528345|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6161566|NCT01528345|Hormone Antagonists|hormone antagonists|mesh-ancestor
6161567|NCT01528345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6161568|NCT01528345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161569|NCT01528592|Levodopa|levodopa|mesh-list
6161570|NCT01528592|Carbidopa|carbidopa|mesh-list
6161571|NCT01528592|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
6161572|NCT01528592|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6161573|NCT01528592|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6161574|NCT01528592|Dopamine Agents|dopamine agents|mesh-ancestor
6161575|NCT01528592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6161576|NCT01528592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161577|NCT01528592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668456|NCT01532518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6668457|NCT01532518|Autonomic Agents|autonomic agents|mesh-ancestor
6668458|NCT01532518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6668459|NCT01532518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668460|NCT01532518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6668461|NCT01532518|Respiratory System Agents|respiratory system agents|mesh-ancestor
6668462|NCT01532544|Heparin|heparin|mesh-list
6668463|NCT01532544|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6668464|NCT01532544|Tinzaparin|tinzaparin|mesh-list
6668465|NCT01532544|Dalteparin|dalteparin|mesh-list
6668466|NCT01532544|Eptifibatide|eptifibatide|mesh-list
6668467|NCT01532544|Anticoagulants|anticoagulants|mesh-ancestor
6668468|NCT01532544|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5560359|NCT04015557|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6668469|NCT01532544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5560360|NCT04015557|Antioxidants|antioxidants|mesh-ancestor
6161578|NCT01528592|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6161579|NCT01528592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6161580|NCT01528592|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6161581|NCT01528592|Immunologic Factors|immunologic factors|mesh-ancestor
6161582|NCT01528592|Dopamine Agonists|dopamine agonists|mesh-ancestor
5560361|NCT04015557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560362|NCT04015557|Protective Agents|protective agents|mesh-ancestor
5560363|NCT04015557|Antidotes|antidotes|mesh-ancestor
5603451|NCT02459392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5603452|NCT02459392|Antiemetics|antiemetics|mesh-ancestor
5603453|NCT02459392|Autonomic Agents|autonomic agents|mesh-ancestor
5603454|NCT02459392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5603455|NCT02459392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5603456|NCT02459392|Glucocorticoids|glucocorticoids|mesh-ancestor
5603457|NCT02459392|Hormones|hormones|mesh-ancestor
6161583|NCT01528709|Atorvastatin|atorvastatin|mesh-list
6161584|NCT01528709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6161585|NCT01528709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6161586|NCT01528709|Antimetabolites|antimetabolites|mesh-ancestor
6161587|NCT01528709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161588|NCT01528709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6161589|NCT01528709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6161590|NCT01528709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6161591|NCT01528735|Ribavirin|ribavirin|mesh-list
6161592|NCT01528735|Antimetabolites|antimetabolites|mesh-ancestor
6161593|NCT01528735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161594|NCT01528735|Antiviral Agents|antiviral agents|mesh-ancestor
6161595|NCT01528735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6161596|NCT01528787|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6161597|NCT01528787|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6161598|NCT01528891|Dexmedetomidine|dexmedetomidine|mesh-list
6161599|NCT01528891|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6161600|NCT01528891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6161601|NCT01528891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161602|NCT01528891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5603458|NCT02459392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5603459|NCT02459392|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6161603|NCT01528891|Analgesics|analgesics|mesh-ancestor
6161604|NCT01528891|Sensory System Agents|sensory system agents|mesh-ancestor
6161605|NCT01528891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6161606|NCT01528891|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6161607|NCT01528891|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6161608|NCT01528891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6161609|NCT01528891|Adrenergic Agents|adrenergic agents|mesh-ancestor
6161610|NCT01528891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6161611|NCT01528891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161612|NCT01528969|Sorbitol|sorbitol|mesh-list
6161613|NCT01528969|Cathartics|cathartics|mesh-ancestor
6161614|NCT01528969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6161615|NCT01529060|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
6161616|NCT01529060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6161617|NCT01529112|Lenvatinib|lenvatinib|mesh-list
6161618|NCT01529112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6161619|NCT01529112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6161620|NCT01529112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6161621|NCT01529112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161622|NCT01529203|Botulinum Toxins|botulinum toxins|mesh-list
6161623|NCT01529203|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6161624|NCT01529203|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6161625|NCT01529203|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6161626|NCT01529203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5603460|NCT02459392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5603461|NCT02459392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5603462|NCT02413736|Imatinib Mesylate|imatinib mesylate|mesh-list
5603463|NCT02413736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6161627|NCT01529203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161628|NCT01529203|Cholinergic Agents|cholinergic agents|mesh-ancestor
6161629|NCT01529203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6161630|NCT01529203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603464|NCT02413736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5603465|NCT02413736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5603466|NCT02413736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603467|NCT02361125|Methylphenidate|methylphenidate|mesh-list
6161631|NCT01529203|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5560364|NCT04015492|Factor VIII|factor viii|mesh-list
5560365|NCT04015492|BAX 855|bax 855|mesh-list
5560366|NCT04015492|Coagulants|coagulants|mesh-ancestor
5560367|NCT04015687|Lamotrigine|lamotrigine|mesh-list
5560368|NCT04015687|Anticonvulsants|anticonvulsants|mesh-ancestor
5560369|NCT04015687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5560370|NCT04015687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5560371|NCT04015687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560372|NCT04015687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5560373|NCT04015687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560374|NCT04015687|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5560375|NCT04015687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5560376|NCT04015687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5560377|NCT04015687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5560378|NCT04015687|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5560379|NCT04015778|Paclitaxel|paclitaxel|mesh-list
5560380|NCT04015778|Carboplatin|carboplatin|mesh-list
5560381|NCT04015778|Nivolumab|nivolumab|mesh-list
5560382|NCT04015778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5560383|NCT04015778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5560384|NCT04015778|Tubulin Modulators|tubulin modulators|mesh-ancestor
5560385|NCT04015778|Antimitotic Agents|antimitotic agents|mesh-ancestor
5560386|NCT04015778|Mitosis Modulators|mitosis modulators|mesh-ancestor
5560387|NCT04015778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560388|NCT04015778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5560389|NCT04015778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5560390|NCT04015661|Paclitaxel|paclitaxel|mesh-list
5560391|NCT04015661|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5560392|NCT04015661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5560393|NCT04015661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5560394|NCT04015661|Tubulin Modulators|tubulin modulators|mesh-ancestor
5560395|NCT04015661|Antimitotic Agents|antimitotic agents|mesh-ancestor
5560396|NCT04015661|Mitosis Modulators|mitosis modulators|mesh-ancestor
5560397|NCT04015661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560398|NCT04015375|Dapsone|dapsone|mesh-list
5560399|NCT04015375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5560400|NCT04015375|Antimalarials|antimalarials|mesh-ancestor
5560401|NCT04015375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5560402|NCT04015375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5560403|NCT04015375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5560404|NCT04015375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5560405|NCT04015375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560406|NCT04015375|Leprostatic Agents|leprostatic agents|mesh-ancestor
5560407|NCT04015375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6161632|NCT01529203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6161633|NCT01529268|Cysteamine|cysteamine|mesh-list
6161634|NCT01529268|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
6161635|NCT01529268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161636|NCT01529346|Ibuprofen|ibuprofen|mesh-list
6161637|NCT01529346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6161638|NCT01529346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6161639|NCT01529346|Analgesics|analgesics|mesh-ancestor
6161640|NCT01529346|Sensory System Agents|sensory system agents|mesh-ancestor
6161641|NCT01529346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6161642|NCT01529346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161643|NCT01529346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6161644|NCT01529346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6161645|NCT01529346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6161646|NCT01529346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6161647|NCT01529346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161648|NCT01529502|Nitric Oxide|nitric oxide|mesh-list
6161649|NCT01529502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6161650|NCT01529502|Autonomic Agents|autonomic agents|mesh-ancestor
6161651|NCT01529502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6161652|NCT01529502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161653|NCT01529502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6161654|NCT01529502|Respiratory System Agents|respiratory system agents|mesh-ancestor
6161655|NCT01529502|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6161656|NCT01529502|Antioxidants|antioxidants|mesh-ancestor
6161657|NCT01529502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161658|NCT01529502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6161659|NCT01529502|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5560408|NCT04015219|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5560409|NCT04015219|Lifitegrast|lifitegrast|mesh-list
5560410|NCT04015219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6161660|NCT01529502|Vasodilator Agents|vasodilator agents|mesh-ancestor
6161661|NCT01529502|Gasotransmitters|gasotransmitters|mesh-ancestor
6161662|NCT01529502|Protective Agents|protective agents|mesh-ancestor
6161663|NCT01529515|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6161664|NCT01529515|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6161665|NCT01529515|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6161666|NCT01529515|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6206069|NCT02096588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206070|NCT02096588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6206071|NCT02096588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6206072|NCT02096588|Alkylating Agents|alkylating agents|mesh-ancestor
6206073|NCT02096588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206074|NCT02096588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6206075|NCT02096588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6206076|NCT02096588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6206077|NCT02096588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6206078|NCT02096588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6206079|NCT02096588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6206080|NCT02096588|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6206081|NCT02096588|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6206082|NCT02096588|Antimetabolites|antimetabolites|mesh-ancestor
6206083|NCT02096588|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6206084|NCT02096588|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6206085|NCT02096679|Osimertinib|osimertinib|mesh-list
6206086|NCT02096679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6206087|NCT02096679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6206088|NCT02096679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6206089|NCT02096679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206090|NCT02096705|Dapagliflozin|dapagliflozin|mesh-list
6206091|NCT02096705|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6206092|NCT02096705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206093|NCT02096705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6206094|NCT02096705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206095|NCT02096718|Afatinib|afatinib|mesh-list
6206096|NCT02096718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6206097|NCT02096718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6206098|NCT02096718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6206099|NCT02096718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206100|NCT02096744|Clonidine|clonidine|mesh-list
5560411|NCT04014634|Methylprednisolone|methylprednisolone|mesh-list
5560412|NCT04014634|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5560413|NCT04014634|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5560414|NCT04014634|Prednisolone|prednisolone|mesh-list
5560415|NCT04014634|Prednisolone acetate|prednisolone acetate|mesh-list
5560416|NCT04014634|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5560417|NCT04014634|Prednisolone phosphate|prednisolone phosphate|mesh-list
5560418|NCT04014634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5560419|NCT04014634|Antiemetics|antiemetics|mesh-ancestor
5560420|NCT04014634|Autonomic Agents|autonomic agents|mesh-ancestor
5560421|NCT04014634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5560422|NCT04014634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560423|NCT04014634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5560424|NCT04014634|Glucocorticoids|glucocorticoids|mesh-ancestor
5560425|NCT04014634|Hormones|hormones|mesh-ancestor
5560426|NCT04014634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5560427|NCT04014634|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5560428|NCT04014634|Protective Agents|protective agents|mesh-ancestor
5560429|NCT04014634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5560430|NCT04014634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5560431|NCT04014530|Pembrolizumab|pembrolizumab|mesh-list
5560432|NCT04014530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5560433|NCT04014530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5560434|NCT04014790|KRN 7000|krn 7000|mesh-list
5560435|NCT04014790|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5560436|NCT04014790|Immunologic Factors|immunologic factors|mesh-ancestor
5560437|NCT04014790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560438|NCT04014790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5560439|NCT04014855|Lactoferrin|lactoferrin|mesh-list
5560440|NCT04014855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5560441|NCT04014556|Aflibercept|aflibercept|mesh-list
5560442|NCT04014556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5560443|NCT04014556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5560444|NCT04014556|Growth Substances|growth substances|mesh-ancestor
5560445|NCT04014556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560446|NCT04014556|Growth Inhibitors|growth inhibitors|mesh-ancestor
5560447|NCT04014556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5560448|NCT04014192|Dapagliflozin|dapagliflozin|mesh-list
5560449|NCT04014192|Empagliflozin|empagliflozin|mesh-list
5560450|NCT04014192|Canagliflozin|canagliflozin|mesh-list
5560451|NCT04014192|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5560452|NCT04014192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560453|NCT04014192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5560454|NCT04014192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560455|NCT04014387|Zolpidem|zolpidem|mesh-list
5560456|NCT04014387|Suvorexant|suvorexant|mesh-list
5560457|NCT04014387|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5560458|NCT04014387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5560459|NCT04014387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5560460|NCT04014387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560461|NCT04014387|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
5560462|NCT04014387|GABA Agonists|gaba agonists|mesh-ancestor
5560463|NCT04014387|GABA Agents|gaba agents|mesh-ancestor
6161667|NCT01529632|Glycopyrrolate|glycopyrrolate|mesh-list
6161668|NCT01529632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6161669|NCT01529632|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6161670|NCT01529632|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6161671|NCT01529632|Cholinergic Agents|cholinergic agents|mesh-ancestor
6161672|NCT01529632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6161673|NCT01529632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161674|NCT01529632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161675|NCT01529645|Vaccines|vaccines|mesh-list
6161676|NCT01529645|Immunologic Factors|immunologic factors|mesh-ancestor
6161677|NCT01529645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161678|NCT01529749|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6161679|NCT01529749|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6161680|NCT01529749|Raltegravir Potassium|raltegravir potassium|mesh-list
6161681|NCT01529749|Losartan|losartan|mesh-list
6161682|NCT01529749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6161683|NCT01529749|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6161684|NCT01529749|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6161685|NCT01529749|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6161686|NCT01529749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161687|NCT01529749|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6161688|NCT01529749|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6161689|NCT01529749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6161690|NCT01529749|Antiviral Agents|antiviral agents|mesh-ancestor
5560464|NCT04014387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5560465|NCT04014387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560466|NCT04014387|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
5560467|NCT04014101|Apatinib|apatinib|mesh-list
5560468|NCT04014101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5560469|NCT04014101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5560470|NCT04014101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5560471|NCT04014101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161691|NCT01529749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6161692|NCT01529749|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6161693|NCT01529749|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6161694|NCT01529749|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6161695|NCT01529749|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6161696|NCT01529827|Mycophenolic Acid|mycophenolic acid|mesh-list
6161697|NCT01529827|Methotrexate|methotrexate|mesh-list
6161698|NCT01529827|Fludarabine phosphate|fludarabine phosphate|mesh-list
6161699|NCT01529827|Fludarabine|fludarabine|mesh-list
6161700|NCT01529827|Melphalan|melphalan|mesh-list
6161701|NCT01529827|Tacrolimus|tacrolimus|mesh-list
6161702|NCT01529827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6161703|NCT01529827|Abortifacient Agents|abortifacient agents|mesh-ancestor
6161704|NCT01529827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5560472|NCT04014244|Triamcinolone|triamcinolone|mesh-list
5560473|NCT04014244|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6161705|NCT01529827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161706|NCT01529827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6161707|NCT01529827|Antimetabolites|antimetabolites|mesh-ancestor
6161708|NCT01529827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161709|NCT01529827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6161710|NCT01529827|Dermatologic Agents|dermatologic agents|mesh-ancestor
6161711|NCT01529827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6668470|NCT01532544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668471|NCT01532544|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6161712|NCT01529827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6161713|NCT01529827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6161714|NCT01529827|Immunologic Factors|immunologic factors|mesh-ancestor
6161715|NCT01529827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6161716|NCT01529827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6161717|NCT01529827|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6161718|NCT01529827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6161719|NCT01529827|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6161720|NCT01529827|Antitubercular Agents|antitubercular agents|mesh-ancestor
6161721|NCT01529827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6161722|NCT01529827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6161723|NCT01529827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6161724|NCT01529827|Alkylating Agents|alkylating agents|mesh-ancestor
6161725|NCT01529827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6161726|NCT01530178|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6161727|NCT01530178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6161728|NCT01530178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161729|NCT01530178|Incretins|incretins|mesh-ancestor
6161730|NCT01530178|Hormones|hormones|mesh-ancestor
6161731|NCT01530178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6161732|NCT01530178|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6161733|NCT01530178|Protease Inhibitors|protease inhibitors|mesh-ancestor
6161734|NCT01530178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6161735|NCT01530178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161736|NCT01530243|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6161737|NCT01530243|Terazosin|terazosin|mesh-list
6161738|NCT01530243|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6161739|NCT01530243|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6161740|NCT01530243|Cholinergic Agents|cholinergic agents|mesh-ancestor
6161741|NCT01530243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6161742|NCT01530243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161743|NCT01530243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161744|NCT01530243|Urological Agents|urological agents|mesh-ancestor
6161745|NCT01530243|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6161746|NCT01530243|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6161747|NCT01530243|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6161748|NCT01530243|Adrenergic Agents|adrenergic agents|mesh-ancestor
6161749|NCT01530334|Gefitinib|gefitinib|mesh-list
6161750|NCT01530334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6161751|NCT01530334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6161752|NCT01530334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6161753|NCT01530334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161754|NCT01530399|Tranexamic Acid|tranexamic acid|mesh-list
6161755|NCT01530399|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6161756|NCT01530399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6161757|NCT01530399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161758|NCT01530399|Hemostatics|hemostatics|mesh-ancestor
5560474|NCT04014244|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5560475|NCT04014244|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5560476|NCT04014244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5560477|NCT04014244|Glucocorticoids|glucocorticoids|mesh-ancestor
5560478|NCT04014244|Hormones|hormones|mesh-ancestor
5560479|NCT04014244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5560480|NCT04014244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161759|NCT01530399|Coagulants|coagulants|mesh-ancestor
6161760|NCT01530464|Ambrisentan|ambrisentan|mesh-list
6161761|NCT01530464|Aminophylline|aminophylline|mesh-list
6161762|NCT01530464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6161763|NCT01530464|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6161764|NCT01530464|Autonomic Agents|autonomic agents|mesh-ancestor
6161765|NCT01530464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6161766|NCT01530464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161767|NCT01530464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6161768|NCT01530464|Respiratory System Agents|respiratory system agents|mesh-ancestor
6161769|NCT01530464|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6161770|NCT01530464|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6161771|NCT01530464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6161772|NCT01530464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161773|NCT01530464|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6161774|NCT01530464|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6161775|NCT01530464|Purinergic Agents|purinergic agents|mesh-ancestor
6161776|NCT01530464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6161777|NCT01530464|Protective Agents|protective agents|mesh-ancestor
5560481|NCT04014244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5560482|NCT04014244|Immunologic Factors|immunologic factors|mesh-ancestor
5560483|NCT04014244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6161778|NCT01531153|Galantamine|galantamine|mesh-list
6161779|NCT01531153|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6161780|NCT01531153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6161781|NCT01531153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161782|NCT01531153|Cholinergic Agents|cholinergic agents|mesh-ancestor
6161783|NCT01531153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6161784|NCT01531153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161785|NCT01531153|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6161786|NCT01531153|Autonomic Agents|autonomic agents|mesh-ancestor
6161787|NCT01531153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6161788|NCT01531153|Nootropic Agents|nootropic agents|mesh-ancestor
6161789|NCT01531205|Leuprolide|leuprolide|mesh-list
6161790|NCT01531205|Goserelin|goserelin|mesh-list
6161791|NCT01531205|Bicalutamide|bicalutamide|mesh-list
6161792|NCT01531205|Androgens|androgens|mesh-list
6161793|NCT01531205|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6161794|NCT01531205|Fertility Agents|fertility agents|mesh-ancestor
6161795|NCT01531205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6161796|NCT01531205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161797|NCT01531205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6161798|NCT01531205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6161799|NCT01531205|Androgen Antagonists|androgen antagonists|mesh-ancestor
6161800|NCT01531205|Hormone Antagonists|hormone antagonists|mesh-ancestor
6161801|NCT01531205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6161802|NCT01531205|Hormones|hormones|mesh-ancestor
6161803|NCT01531439|Naloxone|naloxone|mesh-list
6161804|NCT01531439|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6161805|NCT01531439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161806|NCT01531439|Sensory System Agents|sensory system agents|mesh-ancestor
6161807|NCT01531439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6161808|NCT01531673|Ivacaftor|ivacaftor|mesh-list
6161809|NCT01531673|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6161810|NCT01531673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6161811|NCT01531673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161812|NCT01531803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6161813|NCT01531959|Midodrine|midodrine|mesh-list
6161814|NCT01531959|Sympathomimetics|sympathomimetics|mesh-ancestor
6161815|NCT01531959|Autonomic Agents|autonomic agents|mesh-ancestor
6161816|NCT01531959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6161817|NCT01531959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161818|NCT01531959|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6161819|NCT01531959|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6161820|NCT01531959|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6161821|NCT01531959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6161822|NCT01531959|Adrenergic Agents|adrenergic agents|mesh-ancestor
6161823|NCT01531959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5560484|NCT04014244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560485|NCT04014361|Itraconazole|itraconazole|mesh-list
5560486|NCT04014361|Antifungal Agents|antifungal agents|mesh-ancestor
5560487|NCT04014361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5560488|NCT04014361|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6161824|NCT01531959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161825|NCT01531998|Dexamethasone|dexamethasone|mesh-list
6161826|NCT01531998|Lenalidomide|lenalidomide|mesh-list
6161827|NCT01531998|Bortezomib|bortezomib|mesh-list
6161828|NCT01531998|Siltuximab|siltuximab|mesh-list
6161829|NCT01531998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6161830|NCT01531998|Antiemetics|antiemetics|mesh-ancestor
6161831|NCT01531998|Autonomic Agents|autonomic agents|mesh-ancestor
6161832|NCT01531998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6161833|NCT01531998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560489|NCT04014361|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5560490|NCT04014361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5560491|NCT04014361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560492|NCT04014361|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5560493|NCT04014361|Hormone Antagonists|hormone antagonists|mesh-ancestor
5560494|NCT04014361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6161834|NCT01531998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6481631|NCT00548067|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6481632|NCT00548067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6481633|NCT00548067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481634|NCT00548067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6481635|NCT00548067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481636|NCT00548067|Vasodilator Agents|vasodilator agents|mesh-ancestor
6481637|NCT00548067|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6161835|NCT01531998|Glucocorticoids|glucocorticoids|mesh-ancestor
6161836|NCT01531998|Hormones|hormones|mesh-ancestor
6161837|NCT01531998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6161838|NCT01531998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6161839|NCT01531998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6161840|NCT01531998|Immunologic Factors|immunologic factors|mesh-ancestor
6161841|NCT01531998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6161842|NCT01531998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6161843|NCT01531998|Growth Substances|growth substances|mesh-ancestor
6161844|NCT01531998|Growth Inhibitors|growth inhibitors|mesh-ancestor
6161845|NCT01532089|Bevacizumab|bevacizumab|mesh-list
6161846|NCT01532089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6161847|NCT01532089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6161848|NCT01532089|Endothelial Growth Factors|endothelial growth factors|mesh-list
6161849|NCT01532089|Antibodies|antibodies|mesh-list
6161850|NCT01532089|Immunoglobulins|immunoglobulins|mesh-list
6161851|NCT01532089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6161852|NCT01532089|Immunoglobulin G|immunoglobulin g|mesh-list
6161853|NCT01532089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6668472|NCT01532674|Anti-Infective Agents|anti-infective agents|mesh-list
6668473|NCT01532674|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6668474|NCT01532726|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
6668475|NCT01532726|Anticonvulsants|anticonvulsants|mesh-ancestor
6668476|NCT01532726|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6668477|NCT01532726|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6668478|NCT01532726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5560495|NCT04014361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560496|NCT04014361|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5560497|NCT04014283|Selenium|selenium|mesh-list
5560498|NCT04014283|Antioxidants|antioxidants|mesh-ancestor
5560499|NCT04014283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560500|NCT04014283|Protective Agents|protective agents|mesh-ancestor
5560501|NCT04014283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560502|NCT04014283|Trace Elements|trace elements|mesh-ancestor
5560503|NCT04014283|Micronutrients|micronutrients|mesh-ancestor
5560504|NCT04013815|Ropivacaine|ropivacaine|mesh-list
6161854|NCT01532089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6161855|NCT01532089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6161856|NCT01532089|Growth Substances|growth substances|mesh-ancestor
6161857|NCT01532089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161858|NCT01532089|Growth Inhibitors|growth inhibitors|mesh-ancestor
6161859|NCT01532089|Immunologic Factors|immunologic factors|mesh-ancestor
6161860|NCT01532089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6161861|NCT01532089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6161862|NCT01532089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668479|NCT01532726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560505|NCT04013815|Anesthetics, Local|anesthetics, local|mesh-ancestor
5560506|NCT04013815|Anesthetics|anesthetics|mesh-ancestor
5560507|NCT04013815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5560508|NCT04013815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560509|NCT04013815|Sensory System Agents|sensory system agents|mesh-ancestor
5560510|NCT04013815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5603468|NCT02361125|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5603469|NCT02361125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603470|NCT02361125|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5603471|NCT02361125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5603472|NCT02361125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5603473|NCT02361125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603474|NCT02361125|Dopamine Agents|dopamine agents|mesh-ancestor
5603475|NCT02361125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5603476|NCT02338921|Metformin|metformin|mesh-list
5603477|NCT02338921|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5603478|NCT02338921|Dapagliflozin|dapagliflozin|mesh-list
5603479|NCT02338921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5603480|NCT02338921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560511|NCT04013581|Empagliflozin|empagliflozin|mesh-list
5560512|NCT04013581|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5560513|NCT04013581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560514|NCT04013581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5560515|NCT04013581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560516|NCT04013919|Insulin|insulin|mesh-list
5560517|NCT04013919|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5560518|NCT04013919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5560519|NCT04013919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161863|NCT01532128|Opicapone|opicapone|mesh-list
6161864|NCT01532128|Rasagiline|rasagiline|mesh-list
6161865|NCT01532128|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6161866|NCT01532128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6161867|NCT01532128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161868|NCT01532128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6161869|NCT01532128|Protective Agents|protective agents|mesh-ancestor
6161870|NCT01532128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161871|NCT01532128|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6161872|NCT01532128|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6161873|NCT01532128|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6161874|NCT01532141|Opicapone|opicapone|mesh-list
6161875|NCT01532141|Rasagiline|rasagiline|mesh-list
6161876|NCT01532141|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6161877|NCT01532141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6161878|NCT01532141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161879|NCT01532141|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5560520|NCT04013646|Epoetin Alfa|epoetin alfa|mesh-list
5560521|NCT04013646|Hematinics|hematinics|mesh-ancestor
5560522|NCT04013659|Hydrogen Peroxide|hydrogen peroxide|mesh-list
5560523|NCT04013659|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5560524|NCT04013659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5560525|NCT04013620|Abatacept|abatacept|mesh-list
5560526|NCT04013620|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6161880|NCT01532141|Protective Agents|protective agents|mesh-ancestor
6161881|NCT01532141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161882|NCT01532141|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6161883|NCT01532141|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6161884|NCT01532141|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6161885|NCT01532349|Cholecalciferol|cholecalciferol|mesh-list
6161886|NCT01532349|Vitamins|vitamins|mesh-ancestor
6161887|NCT01532349|Micronutrients|micronutrients|mesh-ancestor
6161888|NCT01532349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161889|NCT01532349|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6481638|NCT00548067|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6481639|NCT00548067|Diuretics|diuretics|mesh-ancestor
6481640|NCT00548067|Natriuretic Agents|natriuretic agents|mesh-ancestor
6481641|NCT00548067|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6481642|NCT00548080|Caspofungin|caspofungin|mesh-list
6481643|NCT00548080|Antifungal Agents|antifungal agents|mesh-ancestor
6481644|NCT00548080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5560527|NCT04013620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560528|NCT04013620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5560529|NCT04013620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5560530|NCT04013620|Immunologic Factors|immunologic factors|mesh-ancestor
5560531|NCT04013620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560532|NCT04013620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5560533|NCT04013958|Ketamine|ketamine|mesh-list
5560534|NCT04013958|Analgesics|analgesics|mesh-ancestor
5560535|NCT04013958|Sensory System Agents|sensory system agents|mesh-ancestor
5560536|NCT04013958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5560537|NCT04013958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560538|NCT04013958|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5560539|NCT04013958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6161890|NCT01532349|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6161891|NCT01532414|Enclomiphene|enclomiphene|mesh-list
6161892|NCT01532414|Clomiphene|clomiphene|mesh-list
6161893|NCT01532414|Zuclomiphene|zuclomiphene|mesh-list
6161894|NCT01532414|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6161895|NCT01532414|Hormone Antagonists|hormone antagonists|mesh-ancestor
6161896|NCT01532414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6161897|NCT01532414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161898|NCT01532414|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6161899|NCT01532414|Fertility Agents|fertility agents|mesh-ancestor
6481645|NCT00548080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5560540|NCT04013958|Anesthetics, General|anesthetics, general|mesh-ancestor
5560541|NCT04013958|Anesthetics|anesthetics|mesh-ancestor
6161900|NCT01532414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6481646|NCT00548080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481647|NCT00548288|Pamidronate|pamidronate|mesh-list
6481648|NCT00548288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5560542|NCT04013958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5560543|NCT04013958|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5560544|NCT04013958|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5560545|NCT04013958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5560546|NCT04013958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560547|NCT04013672|Pembrolizumab|pembrolizumab|mesh-list
5560548|NCT04013672|Sargramostim|sargramostim|mesh-list
5560549|NCT04013672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5560550|NCT04013672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5560551|NCT04013672|Immunologic Factors|immunologic factors|mesh-ancestor
5560552|NCT04013672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560553|NCT04013880|Decitabine|decitabine|mesh-list
5560554|NCT04013880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5560555|NCT04013880|Antimetabolites|antimetabolites|mesh-ancestor
5560556|NCT04013880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560557|NCT04013880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5560558|NCT04013880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5560559|NCT04013854|Nivolumab|nivolumab|mesh-list
5560560|NCT04013854|Ipilimumab|ipilimumab|mesh-list
5560561|NCT04013854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5560562|NCT04013854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5560563|NCT04013854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5560564|NCT04013854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560565|NCT04013542|Nivolumab|nivolumab|mesh-list
5560566|NCT04013542|Ipilimumab|ipilimumab|mesh-list
5560567|NCT04013542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5560568|NCT04013542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5560569|NCT04013542|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5560570|NCT04013542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560571|NCT04013386|Dexamethasone|dexamethasone|mesh-list
5560572|NCT04013386|Dexamethasone acetate|dexamethasone acetate|mesh-list
6161901|NCT01532414|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6161902|NCT01532414|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6161903|NCT01532648|Budesonide|budesonide|mesh-list
6161904|NCT01532648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5560573|NCT04013386|Aprepitant|aprepitant|mesh-list
6161905|NCT01532648|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6161906|NCT01532648|Autonomic Agents|autonomic agents|mesh-ancestor
6161907|NCT01532648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6161908|NCT01532648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161909|NCT01532648|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6161910|NCT01532648|Respiratory System Agents|respiratory system agents|mesh-ancestor
6161911|NCT01532648|Glucocorticoids|glucocorticoids|mesh-ancestor
6161912|NCT01532648|Hormones|hormones|mesh-ancestor
6161913|NCT01532648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6161914|NCT01532687|Gemcitabine|gemcitabine|mesh-list
6161915|NCT01532687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6161916|NCT01532687|Antimetabolites|antimetabolites|mesh-ancestor
6161917|NCT01532687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161918|NCT01532687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6161919|NCT01532687|Antiviral Agents|antiviral agents|mesh-ancestor
6161920|NCT01532687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6161921|NCT01532687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6161922|NCT01532687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6161923|NCT01532687|Immunologic Factors|immunologic factors|mesh-ancestor
6206101|NCT02096744|Analgesics|analgesics|mesh-ancestor
6481649|NCT00548288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481650|NCT00548301|Cyclosporine|cyclosporine|mesh-list
6481651|NCT00548301|Cyclosporins|cyclosporins|mesh-list
6481652|NCT00548301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6481653|NCT00548301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481654|NCT00548301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6481655|NCT00548301|Immunologic Factors|immunologic factors|mesh-ancestor
6481656|NCT00548301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481657|NCT00548301|Antifungal Agents|antifungal agents|mesh-ancestor
6481658|NCT00548301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6481659|NCT00548301|Dermatologic Agents|dermatologic agents|mesh-ancestor
6481660|NCT00548301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6481661|NCT00548301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6481662|NCT00548379|Vitamin D|vitamin d|mesh-list
5560574|NCT04013386|Mirtazapine|mirtazapine|mesh-list
5560575|NCT04013386|BB 1101|bb 1101|mesh-list
5560576|NCT04013386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5560577|NCT04013386|Antiemetics|antiemetics|mesh-ancestor
5560578|NCT04013386|Autonomic Agents|autonomic agents|mesh-ancestor
5560579|NCT04013386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5560580|NCT04013386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560581|NCT04013386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5560582|NCT04013386|Glucocorticoids|glucocorticoids|mesh-ancestor
5560583|NCT04013386|Hormones|hormones|mesh-ancestor
6161924|NCT01532687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161925|NCT01532700|Ofatumumab|ofatumumab|mesh-list
6161926|NCT01532700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6161927|NCT01532908|Sofosbuvir|sofosbuvir|mesh-list
6161928|NCT01532908|Antiviral Agents|antiviral agents|mesh-ancestor
6161929|NCT01532908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6161930|NCT01533077|Levodopa|levodopa|mesh-list
6161931|NCT01533077|Carbidopa|carbidopa|mesh-list
6668480|NCT01532804|Bevacizumab|bevacizumab|mesh-list
5560584|NCT04013386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5560585|NCT04013386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6161932|NCT01533077|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
6161933|NCT01533077|Opicapone|opicapone|mesh-list
6161934|NCT01533077|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6161935|NCT01533077|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6161936|NCT01533077|Dopamine Agents|dopamine agents|mesh-ancestor
5560586|NCT04013386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5560587|NCT04013386|Protease Inhibitors|protease inhibitors|mesh-ancestor
5560588|NCT04013386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5560589|NCT04013386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560590|NCT04013386|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5560591|NCT04013386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5560592|NCT04013386|Antidepressive Agents|antidepressive agents|mesh-ancestor
5560593|NCT04013386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5560594|NCT04013386|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5560595|NCT04013386|Histamine Antagonists|histamine antagonists|mesh-ancestor
5560596|NCT04013386|Histamine Agents|histamine agents|mesh-ancestor
5560597|NCT04013386|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5560598|NCT04013386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6161937|NCT01533077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6161938|NCT01533077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161939|NCT01533077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161940|NCT01533077|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6161941|NCT01533077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6161942|NCT01533077|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6161943|NCT01533077|Immunologic Factors|immunologic factors|mesh-ancestor
5560599|NCT04013386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5560600|NCT04013386|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6161944|NCT01533077|Dopamine Agonists|dopamine agonists|mesh-ancestor
6161945|NCT01533077|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6481663|NCT00548379|Vitamins|vitamins|mesh-ancestor
6481664|NCT00548379|Micronutrients|micronutrients|mesh-ancestor
6481665|NCT00548379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481666|NCT00548379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6481667|NCT00548483|Dexamethasone|dexamethasone|mesh-list
6481668|NCT00548483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5560601|NCT04013386|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5560602|NCT04013386|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5560603|NCT04013386|Adrenergic Agents|adrenergic agents|mesh-ancestor
5560604|NCT04013386|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5560605|NCT04013386|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5560606|NCT04013386|Serotonin Agents|serotonin agents|mesh-ancestor
5560607|NCT04013386|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5560608|NCT04013334|Nivolumab|nivolumab|mesh-list
5560609|NCT04013334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5560610|NCT04013334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6161946|NCT01533116|Levodopa|levodopa|mesh-list
6161947|NCT01533116|Carbidopa|carbidopa|mesh-list
6161948|NCT01533116|Opicapone|opicapone|mesh-list
6161949|NCT01533116|Benserazide|benserazide|mesh-list
6161950|NCT01533116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6161951|NCT01533116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6161952|NCT01533116|Dopamine Agents|dopamine agents|mesh-ancestor
6161953|NCT01533116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6161954|NCT01533116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161955|NCT01533116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668481|NCT01532804|Oxaliplatin|oxaliplatin|mesh-list
6668482|NCT01532804|Raltitrexed|raltitrexed|mesh-list
6161956|NCT01533116|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6161957|NCT01533116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6161958|NCT01533116|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6161959|NCT01533181|Topotecan|topotecan|mesh-list
6161960|NCT01533181|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6161961|NCT01533181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5560611|NCT04013334|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5560612|NCT04013334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560613|NCT04013438|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5560614|NCT04013438|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6161962|NCT01533181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6481669|NCT00548483|Antiemetics|antiemetics|mesh-ancestor
6481670|NCT00548483|Autonomic Agents|autonomic agents|mesh-ancestor
6481671|NCT00548483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6161963|NCT01533181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161964|NCT01533181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5560615|NCT04013438|Saw palmetto extract|saw palmetto extract|mesh-list
5560616|NCT04013438|Estradiol|estradiol|mesh-list
5560617|NCT04013438|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5560618|NCT04013438|Estrogens|estrogens|mesh-ancestor
5560619|NCT04013438|Hormones|hormones|mesh-ancestor
5560620|NCT04013438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5560621|NCT04013438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560622|NCT04013438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5560623|NCT04013438|Contraceptive Agents|contraceptive agents|mesh-ancestor
5560624|NCT04013438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5560625|NCT04013438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5560626|NCT04013438|Urological Agents|urological agents|mesh-ancestor
5560627|NCT04013477|Donepezil|donepezil|mesh-list
5560628|NCT04013477|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5560629|NCT04013477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5560630|NCT04013477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560631|NCT04013477|Cholinergic Agents|cholinergic agents|mesh-ancestor
5560632|NCT04013477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5560633|NCT04013477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560634|NCT04013477|Nootropic Agents|nootropic agents|mesh-ancestor
5560635|NCT04013243|Magnesium Sulfate|magnesium sulfate|mesh-list
5560636|NCT04013243|Analgesics|analgesics|mesh-ancestor
5560637|NCT04013243|Sensory System Agents|sensory system agents|mesh-ancestor
6161965|NCT01533207|Gemcitabine|gemcitabine|mesh-list
6161966|NCT01533207|Docetaxel|docetaxel|mesh-list
6161967|NCT01533207|Doxorubicin|doxorubicin|mesh-list
6161968|NCT01533207|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6161969|NCT01533207|Lenograstim|lenograstim|mesh-list
6161970|NCT01533207|Sargramostim|sargramostim|mesh-list
6161971|NCT01533207|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6161972|NCT01533207|Antimetabolites|antimetabolites|mesh-ancestor
6161973|NCT01533207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6161974|NCT01533207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6161975|NCT01533207|Antiviral Agents|antiviral agents|mesh-ancestor
6161976|NCT01533207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6161977|NCT01533207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6161978|NCT01533207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6161979|NCT01533207|Immunologic Factors|immunologic factors|mesh-ancestor
6161980|NCT01533207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161981|NCT01533207|Tubulin Modulators|tubulin modulators|mesh-ancestor
6161982|NCT01533207|Antimitotic Agents|antimitotic agents|mesh-ancestor
6161983|NCT01533207|Mitosis Modulators|mitosis modulators|mesh-ancestor
6161984|NCT01533207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5560638|NCT04013243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5560639|NCT04013243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560640|NCT04013243|Anesthetics|anesthetics|mesh-ancestor
6161985|NCT01533207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6481672|NCT00548483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560641|NCT04013243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6161986|NCT01533207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6161987|NCT01533207|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6481673|NCT00548483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6481674|NCT00548483|Glucocorticoids|glucocorticoids|mesh-ancestor
6481675|NCT00548483|Hormones|hormones|mesh-ancestor
6481676|NCT00548483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6481677|NCT00548483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6481678|NCT00548483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5560642|NCT04013243|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5560643|NCT04013243|Anticonvulsants|anticonvulsants|mesh-ancestor
5560644|NCT04013243|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5560645|NCT04013243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5560646|NCT04013243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560647|NCT04013243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5560648|NCT04013243|Tocolytic Agents|tocolytic agents|mesh-ancestor
6161988|NCT01533259|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6161989|NCT01533259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6161990|NCT01533259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6161991|NCT01533259|Antiviral Agents|antiviral agents|mesh-ancestor
6161992|NCT01533259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6161993|NCT01533428|Capsaicin|capsaicin|mesh-list
6161994|NCT01533428|Antipruritics|antipruritics|mesh-ancestor
5560649|NCT04013243|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5560650|NCT04013464|Citalopram|citalopram|mesh-list
5560651|NCT04013464|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5560652|NCT04013464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5560653|NCT04013464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5560654|NCT04013464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560655|NCT04013464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5560656|NCT04013464|Serotonin Agents|serotonin agents|mesh-ancestor
5603481|NCT02338921|Incretins|incretins|mesh-ancestor
6161995|NCT01533428|Dermatologic Agents|dermatologic agents|mesh-ancestor
6161996|NCT01533428|Sensory System Agents|sensory system agents|mesh-ancestor
6161997|NCT01533428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6161998|NCT01533428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6161999|NCT01533493|Memantine|memantine|mesh-list
6162000|NCT01533493|Methylphenidate|methylphenidate|mesh-list
6162001|NCT01533493|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6162002|NCT01533493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162003|NCT01533493|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6162004|NCT01533493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6162005|NCT01533493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6162006|NCT01533493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162007|NCT01533493|Dopamine Agents|dopamine agents|mesh-ancestor
6162008|NCT01533493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6162009|NCT01533493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6162010|NCT01533493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6162011|NCT01533493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6162012|NCT01533493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6162013|NCT01533597|Tamsulosin|tamsulosin|mesh-list
6481679|NCT00548509|Vitamin K|vitamin k|mesh-list
6481680|NCT00548509|Vitamin K 2|vitamin k 2|mesh-list
6481681|NCT00548509|Menatetrenone|menatetrenone|mesh-list
6481682|NCT00548509|Vitamins|vitamins|mesh-ancestor
6481683|NCT00548509|Micronutrients|micronutrients|mesh-ancestor
6481684|NCT00548509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481685|NCT00548509|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6481686|NCT00548509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6481687|NCT00548509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481688|NCT00548509|Hemostatics|hemostatics|mesh-ancestor
6481689|NCT00548509|Coagulants|coagulants|mesh-ancestor
6481690|NCT00548561|Dexrazoxane|dexrazoxane|mesh-list
6481691|NCT00548561|Razoxane|razoxane|mesh-list
6668483|NCT01532804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6162014|NCT01533597|Solifenacin Succinate|solifenacin succinate|mesh-list
6481692|NCT00548561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6481693|NCT00548561|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6481694|NCT00548561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6481695|NCT00548561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6668484|NCT01532804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6668485|NCT01532804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6668486|NCT01532804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6668487|NCT01532804|Growth Substances|growth substances|mesh-ancestor
6668488|NCT01532804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668489|NCT01532804|Growth Inhibitors|growth inhibitors|mesh-ancestor
6481696|NCT00548561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6481697|NCT00548561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481698|NCT00548561|Protective Agents|protective agents|mesh-ancestor
6481699|NCT00548561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481700|NCT00548561|Antimitotic Agents|antimitotic agents|mesh-ancestor
6668490|NCT01532804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6481701|NCT00548561|Mitosis Modulators|mitosis modulators|mesh-ancestor
6162015|NCT01533597|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6162016|NCT01533597|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6162017|NCT01533597|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6162018|NCT01533597|Adrenergic Agents|adrenergic agents|mesh-ancestor
6162019|NCT01533597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6162020|NCT01533597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162021|NCT01533597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162022|NCT01533597|Urological Agents|urological agents|mesh-ancestor
6162023|NCT01533597|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6162024|NCT01533597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6162025|NCT01533597|Cholinergic Agents|cholinergic agents|mesh-ancestor
6162026|NCT01533688|Bisacodyl|bisacodyl|mesh-list
6162027|NCT01533688|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6162028|NCT01533688|Cathartics|cathartics|mesh-ancestor
6162029|NCT01533688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6162030|NCT01533688|Laxatives|laxatives|mesh-ancestor
6162031|NCT01533922|Tiotropium Bromide|tiotropium bromide|mesh-list
6162032|NCT01533922|Olodaterol|olodaterol|mesh-list
6162033|NCT01533922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6162034|NCT01533922|Autonomic Agents|autonomic agents|mesh-ancestor
6162035|NCT01533922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6162036|NCT01533922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481702|NCT00548574|Mesalamine|mesalamine|mesh-list
5560657|NCT04013464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560658|NCT04013464|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5560659|NCT04013464|Antidepressive Agents|antidepressive agents|mesh-ancestor
5560660|NCT04013464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5560661|NCT04012918|Capecitabine|capecitabine|mesh-list
5560662|NCT04012918|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5560663|NCT04012918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5560664|NCT04012918|Antimetabolites|antimetabolites|mesh-ancestor
5560665|NCT04012918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560666|NCT04012918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5560667|NCT04012918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5560668|NCT04012918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5560669|NCT04012918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5560670|NCT04012918|Hormone Antagonists|hormone antagonists|mesh-ancestor
5560671|NCT04012918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5560672|NCT04012918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560673|NCT04012541|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
5560674|NCT04012619|Cisplatin|cisplatin|mesh-list
5560675|NCT04012619|Carboplatin|carboplatin|mesh-list
5560676|NCT04012619|Pemetrexed|pemetrexed|mesh-list
5560677|NCT04012619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5560678|NCT04012619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5560679|NCT04012619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560680|NCT04012619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5560681|NCT04012619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5560682|NCT04012775|Insulin|insulin|mesh-list
5560683|NCT04012775|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5560684|NCT04012775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5560685|NCT04012775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560686|NCT04012606|Carboplatin|carboplatin|mesh-list
5560687|NCT04012606|Etoposide|etoposide|mesh-list
5560688|NCT04012606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5560689|NCT04012606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5560690|NCT04012606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5560691|NCT04012606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5560692|NCT04012606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5560693|NCT04012606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560694|NCT04012450|Anesthetics|anesthetics|mesh-list
5560695|NCT04012450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5560696|NCT04012450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560697|NCT04012424|Curcumin|curcumin|mesh-list
5560698|NCT04012424|Analgesics|analgesics|mesh-list
5603482|NCT02338921|Hormones|hormones|mesh-ancestor
6162037|NCT01533922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6162038|NCT01533922|Respiratory System Agents|respiratory system agents|mesh-ancestor
6162039|NCT01533922|Parasympatholytics|parasympatholytics|mesh-ancestor
6162040|NCT01533922|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6162041|NCT01533922|Cholinergic Agents|cholinergic agents|mesh-ancestor
6162042|NCT01533922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6162043|NCT01533922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162044|NCT01533935|Tiotropium Bromide|tiotropium bromide|mesh-list
6162045|NCT01533935|Olodaterol|olodaterol|mesh-list
6481703|NCT00548574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6481704|NCT00548574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5560699|NCT04012424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5560700|NCT04012424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5560701|NCT04012424|Sensory System Agents|sensory system agents|mesh-ancestor
5560702|NCT04012424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5560703|NCT04012424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560704|NCT04012424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5560705|NCT04012424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5560706|NCT04012424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5560707|NCT04012424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5560708|NCT04012424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560709|NCT04012307|Candesartan|candesartan|mesh-list
5560710|NCT04012307|Candesartan cilexetil|candesartan cilexetil|mesh-list
5560711|NCT04012307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5560712|NCT04012307|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5560713|NCT04012307|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5560714|NCT04012307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560715|NCT04012073|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
5560716|NCT04012073|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5560717|NCT04012073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5560718|NCT04012073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603483|NCT02338921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5603484|NCT02338921|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5603485|NCT02338921|Protease Inhibitors|protease inhibitors|mesh-ancestor
5603486|NCT02338921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5603487|NCT02338921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603488|NCT02338921|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5603489|NCT02245308|Bupropion|bupropion|mesh-list
5603490|NCT02245308|Nicotine|nicotine|mesh-list
5603491|NCT02245308|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5603492|NCT02245308|Autonomic Agents|autonomic agents|mesh-ancestor
5603493|NCT02245308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5603494|NCT02245308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603495|NCT02245308|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5603496|NCT02245308|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5603497|NCT02245308|Cholinergic Agents|cholinergic agents|mesh-ancestor
5603498|NCT02245308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5603499|NCT02245308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603500|NCT02245308|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5603501|NCT02245308|Antidepressive Agents|antidepressive agents|mesh-ancestor
5603502|NCT02245308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5603503|NCT02245308|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5603504|NCT02245308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6162046|NCT01533935|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6481705|NCT00548574|Analgesics|analgesics|mesh-ancestor
6481706|NCT00548574|Sensory System Agents|sensory system agents|mesh-ancestor
6481707|NCT00548574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6481708|NCT00548574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481709|NCT00548574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6481710|NCT00548574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6481711|NCT00548678|Aspirin|aspirin|mesh-list
6481712|NCT00548678|Diclofenac|diclofenac|mesh-list
6481713|NCT00548678|Ketorolac|ketorolac|mesh-list
6162047|NCT01533935|Autonomic Agents|autonomic agents|mesh-ancestor
6162048|NCT01533935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6162049|NCT01533935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162050|NCT01533935|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6162051|NCT01533935|Respiratory System Agents|respiratory system agents|mesh-ancestor
6162052|NCT01533935|Parasympatholytics|parasympatholytics|mesh-ancestor
6162053|NCT01533935|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6162054|NCT01533935|Cholinergic Agents|cholinergic agents|mesh-ancestor
6162055|NCT01533935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6162056|NCT01533935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162057|NCT01533948|Axitinib|axitinib|mesh-list
6162058|NCT01533948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6162059|NCT01533948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6162060|NCT01533948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6162061|NCT01533948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162062|NCT01534013|Insulin|insulin|mesh-list
6162063|NCT01534013|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6488897|NCT00587665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6162064|NCT01534013|Pancrelipase|pancrelipase|mesh-list
6162065|NCT01534013|Pancreatin|pancreatin|mesh-list
6162066|NCT01534013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6162067|NCT01534013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162068|NCT01534013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6162069|NCT01534078|Doxorubicin|doxorubicin|mesh-list
6162070|NCT01534078|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6162071|NCT01534078|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6162072|NCT01534078|Dacarbazine|dacarbazine|mesh-list
6162073|NCT01534078|Vinblastine|vinblastine|mesh-list
6162074|NCT01534078|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6162075|NCT01534078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5560719|NCT04012268|Aspirin|aspirin|mesh-list
5560720|NCT04012268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5560721|NCT04012268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5560722|NCT04012268|Analgesics|analgesics|mesh-ancestor
5560723|NCT04012268|Sensory System Agents|sensory system agents|mesh-ancestor
5560724|NCT04012268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5560725|NCT04012268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560726|NCT04012268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5560727|NCT04012268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5560728|NCT04012268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5560729|NCT04012268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5560730|NCT04012268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560731|NCT04012268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5560732|NCT04012268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5560733|NCT04012268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5560734|NCT04012268|Antipyretics|antipyretics|mesh-ancestor
5560735|NCT04012047|Cromakalim|cromakalim|mesh-list
5560736|NCT04012047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5560737|NCT04012047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5560738|NCT04012047|Autonomic Agents|autonomic agents|mesh-ancestor
5560739|NCT04012047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5560740|NCT04012047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162076|NCT01534078|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6162077|NCT01534078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6162078|NCT01534078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6162079|NCT01534078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162080|NCT01534078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6162081|NCT01534078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6162082|NCT01534078|Alkylating Agents|alkylating agents|mesh-ancestor
6668491|NCT01532804|Antimetabolites|antimetabolites|mesh-ancestor
6668492|NCT01532804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668493|NCT01532804|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6668494|NCT01532804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6668495|NCT01532843|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6668496|NCT01532843|Antiviral Agents|antiviral agents|mesh-ancestor
6668497|NCT01532843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6668498|NCT01532856|Thalidomide|thalidomide|mesh-list
6668499|NCT01532856|Dexamethasone|dexamethasone|mesh-list
6668500|NCT01532856|Dexamethasone acetate|dexamethasone acetate|mesh-list
6668501|NCT01532856|Prednisone|prednisone|mesh-list
6668502|NCT01532856|Cyclophosphamide|cyclophosphamide|mesh-list
6668503|NCT01532856|Melphalan|melphalan|mesh-list
6668504|NCT01532856|BB 1101|bb 1101|mesh-list
6668505|NCT01532856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6668506|NCT01532856|Immunologic Factors|immunologic factors|mesh-ancestor
6668507|NCT01532856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668508|NCT01532856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6668509|NCT01532856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6668510|NCT01532856|Alkylating Agents|alkylating agents|mesh-ancestor
6668511|NCT01532856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668512|NCT01532856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6668513|NCT01532856|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6668514|NCT01532856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6668515|NCT01532856|Antiemetics|antiemetics|mesh-ancestor
6162083|NCT01534078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6162084|NCT01534078|Tubulin Modulators|tubulin modulators|mesh-ancestor
6162085|NCT01534078|Antimitotic Agents|antimitotic agents|mesh-ancestor
6162086|NCT01534078|Mitosis Modulators|mitosis modulators|mesh-ancestor
6162087|NCT01534182|Interferons|interferons|mesh-list
6162088|NCT01534182|Interferon-beta|interferon-beta|mesh-list
6162089|NCT01534182|Glatiramer Acetate|glatiramer acetate|mesh-list
6162090|NCT01534182|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6162091|NCT01534182|(T,G)-A-L|(t,g)-a-l|mesh-list
6162092|NCT01534182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6162093|NCT01534182|Antiviral Agents|antiviral agents|mesh-ancestor
6162094|NCT01534182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6162095|NCT01534182|Immunologic Factors|immunologic factors|mesh-ancestor
6162096|NCT01534182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162097|NCT01534182|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5560741|NCT04012047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5560742|NCT04012047|Respiratory System Agents|respiratory system agents|mesh-ancestor
5560743|NCT04012047|Parasympatholytics|parasympatholytics|mesh-ancestor
5560744|NCT04012047|Vasodilator Agents|vasodilator agents|mesh-ancestor
5560745|NCT04012294|Allopurinol|allopurinol|mesh-list
5560746|NCT04012294|Antimetabolites|antimetabolites|mesh-ancestor
5560747|NCT04012294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560748|NCT04012294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5560749|NCT04012294|Gout Suppressants|gout suppressants|mesh-ancestor
5560750|NCT04012294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5560751|NCT04012294|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6162098|NCT01534182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162099|NCT01534182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6162100|NCT01534182|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6162101|NCT01534182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6162102|NCT01534195|Prednisolone|prednisolone|mesh-list
6162103|NCT01534195|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6668516|NCT01532856|Autonomic Agents|autonomic agents|mesh-ancestor
6668517|NCT01532856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6668518|NCT01532856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6668519|NCT01532856|Glucocorticoids|glucocorticoids|mesh-ancestor
6668520|NCT01532856|Hormones|hormones|mesh-ancestor
6668521|NCT01532856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6668522|NCT01532856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6668523|NCT01532856|Protease Inhibitors|protease inhibitors|mesh-ancestor
6668524|NCT01532856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5560752|NCT04012294|Antioxidants|antioxidants|mesh-ancestor
6162104|NCT01534195|Methylprednisolone|methylprednisolone|mesh-list
6162105|NCT01534195|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6162106|NCT01534195|Prednisolone acetate|prednisolone acetate|mesh-list
6162107|NCT01534195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6162108|NCT01534195|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6162109|NCT01534195|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6162110|NCT01534195|Prednisolone phosphate|prednisolone phosphate|mesh-list
6162111|NCT01534195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6162112|NCT01534195|Glucocorticoids|glucocorticoids|mesh-ancestor
6162113|NCT01534195|Hormones|hormones|mesh-ancestor
6162114|NCT01534195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6162115|NCT01534195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162116|NCT01534195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6162117|NCT01534195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6162118|NCT01534195|Antiemetics|antiemetics|mesh-ancestor
6162119|NCT01534195|Autonomic Agents|autonomic agents|mesh-ancestor
6162120|NCT01534195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6162121|NCT01534195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6162122|NCT01534195|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6481714|NCT00548678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6481715|NCT00548678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6481716|NCT00548678|Analgesics|analgesics|mesh-ancestor
6481717|NCT00548678|Sensory System Agents|sensory system agents|mesh-ancestor
6162123|NCT01534195|Protective Agents|protective agents|mesh-ancestor
6162124|NCT01534208|Enclomiphene|enclomiphene|mesh-list
6162125|NCT01534208|Clomiphene|clomiphene|mesh-list
6162126|NCT01534208|Zuclomiphene|zuclomiphene|mesh-list
6162127|NCT01534208|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6162128|NCT01534208|Hormone Antagonists|hormone antagonists|mesh-ancestor
6162129|NCT01534208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5560753|NCT04012294|Protective Agents|protective agents|mesh-ancestor
5560754|NCT04012294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162130|NCT01534208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668525|NCT01532856|Leprostatic Agents|leprostatic agents|mesh-ancestor
6162131|NCT01534208|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6162132|NCT01534208|Fertility Agents|fertility agents|mesh-ancestor
6162133|NCT01534208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6162134|NCT01534208|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6162135|NCT01534208|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6162136|NCT01534260|Bortezomib|bortezomib|mesh-list
6162137|NCT01534260|Sorafenib|sorafenib|mesh-list
6162138|NCT01534260|Vorinostat|vorinostat|mesh-list
6162139|NCT01534260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6162140|NCT01534260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6162141|NCT01534260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6162142|NCT01534260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162143|NCT01534260|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6162144|NCT01534351|Tamsulosin|tamsulosin|mesh-list
6162145|NCT01534351|Finasteride|finasteride|mesh-list
6162146|NCT01534351|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6162147|NCT01534351|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6162148|NCT01534351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6162149|NCT01534351|Adrenergic Agents|adrenergic agents|mesh-ancestor
6162150|NCT01534351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6162151|NCT01534351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162152|NCT01534351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162153|NCT01534351|Urological Agents|urological agents|mesh-ancestor
6162154|NCT01534351|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6162155|NCT01534351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6162156|NCT01534351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6162157|NCT01534351|Hormone Antagonists|hormone antagonists|mesh-ancestor
6162158|NCT01534351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6162159|NCT01534416|Bupivacaine|bupivacaine|mesh-list
6162160|NCT01534416|Anesthetics, Local|anesthetics, local|mesh-ancestor
6162161|NCT01534416|Anesthetics|anesthetics|mesh-ancestor
6162162|NCT01534416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6162163|NCT01534416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162164|NCT01534416|Sensory System Agents|sensory system agents|mesh-ancestor
6162165|NCT01534416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6162166|NCT01534520|Lidocaine|lidocaine|mesh-list
6162167|NCT01534520|Anesthetics, Local|anesthetics, local|mesh-ancestor
6162168|NCT01534520|Anesthetics|anesthetics|mesh-ancestor
6162169|NCT01534520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6162170|NCT01534520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560755|NCT04011930|Vitamin D|vitamin d|mesh-list
5560756|NCT04011930|Cholecalciferol|cholecalciferol|mesh-list
5560757|NCT04011930|Calcitriol|calcitriol|mesh-list
5560758|NCT04011930|Vitamins|vitamins|mesh-ancestor
5560759|NCT04011930|Micronutrients|micronutrients|mesh-ancestor
5560760|NCT04011930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560761|NCT04011930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5560762|NCT04011930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5560763|NCT04011930|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
5560764|NCT04011930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5560765|NCT04011930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560766|NCT04011930|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6162171|NCT01534520|Sensory System Agents|sensory system agents|mesh-ancestor
6162172|NCT01534520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6162173|NCT01534520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6162174|NCT01534520|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6162175|NCT01534520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6162176|NCT01534520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6162177|NCT01534520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162178|NCT01534637|Gemcitabine|gemcitabine|mesh-list
5560767|NCT04011813|Antioxidants|antioxidants|mesh-list
5560768|NCT04011813|Hypotaurine|hypotaurine|mesh-list
5560769|NCT04011813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560770|NCT04011813|Protective Agents|protective agents|mesh-ancestor
5560771|NCT04011813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560772|NCT04011670|Caffeine|caffeine|mesh-list
6162179|NCT01534637|Fluorouracil|fluorouracil|mesh-list
6162180|NCT01534637|Capecitabine|capecitabine|mesh-list
6162181|NCT01534637|Aprepitant|aprepitant|mesh-list
6162182|NCT01534637|Antiemetics|antiemetics|mesh-list
5560773|NCT04011670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5560774|NCT04011670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162183|NCT01534637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6162184|NCT01534637|Antimetabolites|antimetabolites|mesh-ancestor
6162185|NCT01534637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162186|NCT01534637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6162187|NCT01534637|Antiviral Agents|antiviral agents|mesh-ancestor
6162188|NCT01534637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6162189|NCT01534637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6162190|NCT01534637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6162191|NCT01534637|Immunologic Factors|immunologic factors|mesh-ancestor
6162192|NCT01534637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162193|NCT01534637|Autonomic Agents|autonomic agents|mesh-ancestor
6162194|NCT01534637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5560775|NCT04011670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5560776|NCT04011670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5560777|NCT04011670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560778|NCT04011670|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5560779|NCT04011670|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5560780|NCT04011670|Purinergic Agents|purinergic agents|mesh-ancestor
5560781|NCT04011670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5560782|NCT04011748|Minoxidil|minoxidil|mesh-list
5560783|NCT04011748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5560784|NCT04011748|Vasodilator Agents|vasodilator agents|mesh-ancestor
6162195|NCT01534637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6162196|NCT01534637|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6162197|NCT01534637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6162198|NCT01534897|Dabrafenib|dabrafenib|mesh-list
6162199|NCT01534897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6162200|NCT01534897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6162201|NCT01534897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6162202|NCT01534897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162203|NCT01534962|Ranolazine|ranolazine|mesh-list
6162204|NCT01534962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6162205|NCT01534962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6162206|NCT01534962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162207|NCT01535001|Acetaminophen|acetaminophen|mesh-list
6162208|NCT01535001|Pantoprazole|pantoprazole|mesh-list
6162209|NCT01535001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6162210|NCT01535001|Analgesics|analgesics|mesh-ancestor
6162211|NCT01535001|Sensory System Agents|sensory system agents|mesh-ancestor
6162212|NCT01535001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6162213|NCT01535001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162214|NCT01535001|Antipyretics|antipyretics|mesh-ancestor
6162215|NCT01535001|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6162216|NCT01535001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6162217|NCT01535001|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6162218|NCT01535001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6162219|NCT01535001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668526|NCT01532856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6668527|NCT01532856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6668528|NCT01532856|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6668529|NCT01532856|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6668530|NCT01532856|Growth Substances|growth substances|mesh-ancestor
6668531|NCT01532856|Growth Inhibitors|growth inhibitors|mesh-ancestor
6668532|NCT01532895|Hydromorphone|hydromorphone|mesh-list
6668533|NCT01532895|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6668534|NCT01532895|Narcotics|narcotics|mesh-ancestor
6668535|NCT01532895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6668536|NCT01532895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668537|NCT01532895|Analgesics|analgesics|mesh-ancestor
6668538|NCT01532895|Sensory System Agents|sensory system agents|mesh-ancestor
6668539|NCT01532895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5560785|NCT04011878|Mitomycins|mitomycins|mesh-list
5560786|NCT04011878|Mitomycin|mitomycin|mesh-list
6162220|NCT01535040|Memantine|memantine|mesh-list
6162221|NCT01535040|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6162222|NCT01535040|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6162223|NCT01535040|Dopamine Agents|dopamine agents|mesh-ancestor
6162224|NCT01535040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6162225|NCT01535040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560787|NCT04011878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5560788|NCT04011878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5560789|NCT04011878|Alkylating Agents|alkylating agents|mesh-ancestor
5560790|NCT04011878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560791|NCT04011878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5560792|NCT04011878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5560793|NCT04011475|Tiotropium Bromide|tiotropium bromide|mesh-list
5560794|NCT04011475|Olodaterol|olodaterol|mesh-list
6162226|NCT01535040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162227|NCT01535040|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6162228|NCT01535040|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5560795|NCT04011475|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5560796|NCT04011475|Autonomic Agents|autonomic agents|mesh-ancestor
5560797|NCT04011475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6481718|NCT00548678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6481719|NCT00548678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560798|NCT04011475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560799|NCT04011475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5560800|NCT04011475|Respiratory System Agents|respiratory system agents|mesh-ancestor
6162229|NCT01535053|Calcium, Dietary|calcium, dietary|mesh-list
6162230|NCT01535053|Leucovorin|leucovorin|mesh-list
6162231|NCT01535053|Folic Acid|folic acid|mesh-list
6162232|NCT01535053|Dactinomycin|dactinomycin|mesh-list
6162233|NCT01535053|Methotrexate|methotrexate|mesh-list
6162234|NCT01535053|Calcium|calcium|mesh-list
6162235|NCT01535053|Levoleucovorin|levoleucovorin|mesh-list
6162236|NCT01535053|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6162237|NCT01535053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162238|NCT01535053|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5560801|NCT04011475|Parasympatholytics|parasympatholytics|mesh-ancestor
5560802|NCT04011475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5560803|NCT04011475|Cholinergic Agents|cholinergic agents|mesh-ancestor
5560804|NCT04011475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6162239|NCT01535053|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6162240|NCT01535053|Abortifacient Agents|abortifacient agents|mesh-ancestor
6162241|NCT01535053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6162242|NCT01535053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6162243|NCT01535053|Antimetabolites|antimetabolites|mesh-ancestor
6162244|NCT01535053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162245|NCT01535053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6162246|NCT01535053|Dermatologic Agents|dermatologic agents|mesh-ancestor
6162247|NCT01535053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6162248|NCT01535053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6162249|NCT01535053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6162250|NCT01535053|Immunologic Factors|immunologic factors|mesh-ancestor
6162251|NCT01535053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6162252|NCT01535053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6162253|NCT01535053|Antidotes|antidotes|mesh-ancestor
6162254|NCT01535053|Protective Agents|protective agents|mesh-ancestor
6162255|NCT01535053|Vitamin B Complex|vitamin b complex|mesh-ancestor
6162256|NCT01535053|Vitamins|vitamins|mesh-ancestor
6162257|NCT01535053|Micronutrients|micronutrients|mesh-ancestor
6162258|NCT01535053|Hematinics|hematinics|mesh-ancestor
6162259|NCT01535053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6162260|NCT01535053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6162261|NCT01535053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6162262|NCT01535053|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6162263|NCT01535235|Lisinopril|lisinopril|mesh-list
6162264|NCT01535235|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6162265|NCT01535235|Protease Inhibitors|protease inhibitors|mesh-ancestor
6162266|NCT01535235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6481720|NCT00548678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6481721|NCT00548678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6481722|NCT00548678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6481723|NCT00548678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6481724|NCT00548678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162267|NCT01535235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162268|NCT01535235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6162269|NCT01535235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6162270|NCT01535235|Protective Agents|protective agents|mesh-ancestor
6162271|NCT01535235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162272|NCT01535261|Ranibizumab|ranibizumab|mesh-list
6162273|NCT01535261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6162274|NCT01535261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6162275|NCT01535261|Growth Substances|growth substances|mesh-ancestor
5560805|NCT04011475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560806|NCT04011345|Folic Acid|folic acid|mesh-list
5560807|NCT04011345|Hematinics|hematinics|mesh-ancestor
5560808|NCT04011345|Vitamin B Complex|vitamin b complex|mesh-ancestor
5560809|NCT04011345|Vitamins|vitamins|mesh-ancestor
5560810|NCT04011345|Micronutrients|micronutrients|mesh-ancestor
5560811|NCT04011345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560812|NCT04011280|Varenicline|varenicline|mesh-list
5560813|NCT04011280|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6162276|NCT01535261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162277|NCT01535261|Growth Inhibitors|growth inhibitors|mesh-ancestor
6162278|NCT01535261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6162279|NCT01535287|Dexmedetomidine|dexmedetomidine|mesh-list
6162280|NCT01535287|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6162281|NCT01535287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6162282|NCT01535287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560814|NCT04011280|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5560815|NCT04011280|Cholinergic Agents|cholinergic agents|mesh-ancestor
5560816|NCT04011280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5560817|NCT04011280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560818|NCT04011280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560819|NCT04011124|Rifampin|rifampin|mesh-list
5560820|NCT04011124|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5560821|NCT04011124|Antitubercular Agents|antitubercular agents|mesh-ancestor
6162283|NCT01535287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6162284|NCT01535287|Analgesics|analgesics|mesh-ancestor
6162285|NCT01535287|Sensory System Agents|sensory system agents|mesh-ancestor
6162286|NCT01535287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6162287|NCT01535287|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6162288|NCT01535287|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6162289|NCT01535287|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6162290|NCT01535287|Adrenergic Agents|adrenergic agents|mesh-ancestor
6162291|NCT01535287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6162292|NCT01535287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481725|NCT00548678|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6481726|NCT00548678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6481727|NCT00548678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6481728|NCT00548678|Antipyretics|antipyretics|mesh-ancestor
6481729|NCT00548704|Dexrazoxane|dexrazoxane|mesh-list
6162293|NCT01535443|Bromfenac|bromfenac|mesh-list
6162294|NCT01535443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6162295|NCT01535443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6162296|NCT01535443|Analgesics|analgesics|mesh-ancestor
6162297|NCT01535443|Sensory System Agents|sensory system agents|mesh-ancestor
6162298|NCT01535443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6162299|NCT01535443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162300|NCT01535443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6162301|NCT01535443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6162302|NCT01535573|Dexetimide|dexetimide|mesh-list
6162303|NCT01535573|Citalopram|citalopram|mesh-list
6162304|NCT01535573|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6162305|NCT01535573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6162306|NCT01535573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6162307|NCT01535573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560822|NCT04011124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5560823|NCT04011124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5560824|NCT04011124|Leprostatic Agents|leprostatic agents|mesh-ancestor
5560825|NCT04011124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5560826|NCT04011124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5560827|NCT04011124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560828|NCT04011124|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5560829|NCT04011124|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5560830|NCT04011124|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5560831|NCT04011124|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5560832|NCT04011124|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5560833|NCT04011124|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5560834|NCT04010955|Edoxaban|edoxaban|mesh-list
5560835|NCT04010955|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5560836|NCT04010955|Antithrombins|antithrombins|mesh-ancestor
5560837|NCT04010955|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5560838|NCT04010955|Protease Inhibitors|protease inhibitors|mesh-ancestor
5560839|NCT04010955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5560840|NCT04010955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560841|NCT04010955|Anticoagulants|anticoagulants|mesh-ancestor
5560842|NCT04011410|Hydroxychloroquine|hydroxychloroquine|mesh-list
5560843|NCT04011410|Antimalarials|antimalarials|mesh-ancestor
6162308|NCT01535573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6162309|NCT01535573|Serotonin Agents|serotonin agents|mesh-ancestor
6162310|NCT01535573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162311|NCT01535573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6162312|NCT01535573|Antidepressive Agents|antidepressive agents|mesh-ancestor
6162313|NCT01535573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6162314|NCT01535573|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5560844|NCT04011410|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5560845|NCT04011410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5560846|NCT04011410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5560847|NCT04011410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5560848|NCT04011410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560849|NCT04011410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5560850|NCT04011241|Itraconazole|itraconazole|mesh-list
5560851|NCT04011241|Antifungal Agents|antifungal agents|mesh-ancestor
5560852|NCT04011241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5560853|NCT04011241|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5560854|NCT04011241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5560855|NCT04011241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5560856|NCT04011241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560857|NCT04011241|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5560858|NCT04011241|Hormone Antagonists|hormone antagonists|mesh-ancestor
5560859|NCT04011241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5560860|NCT04011241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560861|NCT04011241|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5560862|NCT04011098|Fentanyl|fentanyl|mesh-list
6162315|NCT01535573|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6162316|NCT01535573|Parasympatholytics|parasympatholytics|mesh-ancestor
6162317|NCT01535573|Autonomic Agents|autonomic agents|mesh-ancestor
6162318|NCT01535573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6162319|NCT01535573|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6162320|NCT01535573|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6162321|NCT01535573|Cholinergic Agents|cholinergic agents|mesh-ancestor
6162322|NCT01535664|4-Aminopyridine|4-aminopyridine|mesh-list
6162323|NCT01535664|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6162324|NCT01535664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6162325|NCT01535664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162326|NCT01535924|Gemcitabine|gemcitabine|mesh-list
6162327|NCT01535924|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6162328|NCT01535924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6162329|NCT01535924|Antimetabolites|antimetabolites|mesh-ancestor
6162330|NCT01535924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162331|NCT01535924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6162332|NCT01535924|Antiviral Agents|antiviral agents|mesh-ancestor
6162333|NCT01535924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6162334|NCT01535924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6162335|NCT01535924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6162336|NCT01535924|Immunologic Factors|immunologic factors|mesh-ancestor
6162337|NCT01535924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162338|NCT01535924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6162339|NCT01535924|Alkylating Agents|alkylating agents|mesh-ancestor
6162340|NCT01535937|Midazolam|midazolam|mesh-list
6162341|NCT01535937|Ketamine|ketamine|mesh-list
6162342|NCT01535937|Analgesics|analgesics|mesh-ancestor
6162343|NCT01535937|Sensory System Agents|sensory system agents|mesh-ancestor
6162344|NCT01535937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5560863|NCT04011098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5560864|NCT04011098|Narcotics|narcotics|mesh-ancestor
5560865|NCT04011098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6481730|NCT00548704|Razoxane|razoxane|mesh-list
6481731|NCT00548704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6481732|NCT00548704|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6481733|NCT00548704|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6481734|NCT00548704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6481735|NCT00548704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6162345|NCT01535937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162346|NCT01535937|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6162347|NCT01535937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6162348|NCT01535937|Anesthetics, General|anesthetics, general|mesh-ancestor
6481736|NCT00548704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481737|NCT00548704|Protective Agents|protective agents|mesh-ancestor
6481738|NCT00548704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481739|NCT00548704|Antimitotic Agents|antimitotic agents|mesh-ancestor
6481740|NCT00548704|Mitosis Modulators|mitosis modulators|mesh-ancestor
6481741|NCT00548821|Cisplatin|cisplatin|mesh-list
6481742|NCT00548821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6481743|NCT00548834|Certolizumab Pegol|certolizumab pegol|mesh-list
6481744|NCT00548834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6481745|NCT00548834|Immunologic Factors|immunologic factors|mesh-ancestor
6481746|NCT00548834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481747|NCT00548834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6481748|NCT00548899|Sorafenib|sorafenib|mesh-list
6481749|NCT00548899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6481750|NCT00548899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6668540|NCT01532960|Poly ICLC|poly iclc|mesh-list
6668541|NCT01532960|Interferon Inducers|interferon inducers|mesh-ancestor
6668542|NCT01532960|Immunologic Factors|immunologic factors|mesh-ancestor
6668543|NCT01532960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668544|NCT01533090|Bisacodyl|bisacodyl|mesh-list
6162349|NCT01535937|Anesthetics|anesthetics|mesh-ancestor
6162350|NCT01535937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6162351|NCT01535937|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6162352|NCT01535937|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6162353|NCT01535937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6162354|NCT01535937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162355|NCT01535937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6162356|NCT01535937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6162357|NCT01535937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6162358|NCT01535937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6162359|NCT01535937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6162360|NCT01535937|GABA Modulators|gaba modulators|mesh-ancestor
6162361|NCT01535937|GABA Agents|gaba agents|mesh-ancestor
6162362|NCT01535976|Ketamine|ketamine|mesh-list
6162363|NCT01535976|Analgesics|analgesics|mesh-ancestor
6162364|NCT01535976|Sensory System Agents|sensory system agents|mesh-ancestor
6162365|NCT01535976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6162366|NCT01535976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162367|NCT01535976|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6162368|NCT01535976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6162369|NCT01535976|Anesthetics, General|anesthetics, general|mesh-ancestor
6162370|NCT01535976|Anesthetics|anesthetics|mesh-ancestor
6162371|NCT01535976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6162372|NCT01535976|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6162373|NCT01535976|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6162374|NCT01535976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6162375|NCT01535976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162376|NCT01536067|Bortezomib|bortezomib|mesh-list
6162377|NCT01536067|Ofatumumab|ofatumumab|mesh-list
6162378|NCT01536067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6206102|NCT02096744|Sensory System Agents|sensory system agents|mesh-ancestor
6206103|NCT02096744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6206104|NCT02096744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206105|NCT02096744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6206106|NCT02096744|Sympatholytics|sympatholytics|mesh-ancestor
6481751|NCT00548899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6481752|NCT00548899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668545|NCT01533090|Cathartics|cathartics|mesh-ancestor
6481753|NCT00548938|Temozolomide|temozolomide|mesh-list
6481754|NCT00548938|Carmustine|carmustine|mesh-list
6481755|NCT00548938|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6481756|NCT00548938|Alkylating Agents|alkylating agents|mesh-ancestor
6481757|NCT00548938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481758|NCT00548938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5560866|NCT04011098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560867|NCT04011098|Analgesics|analgesics|mesh-ancestor
5560868|NCT04011098|Sensory System Agents|sensory system agents|mesh-ancestor
5560869|NCT04011098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5560870|NCT04011098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5560871|NCT04011098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5560872|NCT04011098|Anesthetics, General|anesthetics, general|mesh-ancestor
5560873|NCT04011098|Anesthetics|anesthetics|mesh-ancestor
6162379|NCT01536262|Tiotropium Bromide|tiotropium bromide|mesh-list
6162380|NCT01536262|Olodaterol|olodaterol|mesh-list
6162381|NCT01536262|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6162382|NCT01536262|Autonomic Agents|autonomic agents|mesh-ancestor
6162383|NCT01536262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6162384|NCT01536262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162385|NCT01536262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6162386|NCT01536262|Respiratory System Agents|respiratory system agents|mesh-ancestor
6162387|NCT01536262|Parasympatholytics|parasympatholytics|mesh-ancestor
6162388|NCT01536262|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6162389|NCT01536262|Cholinergic Agents|cholinergic agents|mesh-ancestor
6162390|NCT01536262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6162391|NCT01536262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162392|NCT01536366|Repaglinide|repaglinide|mesh-list
6162393|NCT01536366|Opicapone|opicapone|mesh-list
6162394|NCT01536366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6162395|NCT01536366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162396|NCT01536366|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6162397|NCT01536366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6162398|NCT01536366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162399|NCT01536366|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6162400|NCT01536366|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6162401|NCT01536379|Belimumab|belimumab|mesh-list
6162402|NCT01536379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6162403|NCT01536379|Immunologic Factors|immunologic factors|mesh-ancestor
6162404|NCT01536379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162405|NCT01536392|Ondansetron|ondansetron|mesh-list
6162406|NCT01536392|Granisetron|granisetron|mesh-list
6162407|NCT01536392|Antiemetics|antiemetics|mesh-ancestor
6162408|NCT01536392|Autonomic Agents|autonomic agents|mesh-ancestor
6162409|NCT01536392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6162410|NCT01536392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162411|NCT01536392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5560874|NCT04010968|Venetoclax|venetoclax|mesh-list
5560875|NCT04010968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5560876|NCT04011150|Fentanyl|fentanyl|mesh-list
5560877|NCT04011150|Ropivacaine|ropivacaine|mesh-list
5560878|NCT04011150|Anesthetics, Local|anesthetics, local|mesh-list
6162412|NCT01536392|Antipruritics|antipruritics|mesh-ancestor
6162413|NCT01536392|Dermatologic Agents|dermatologic agents|mesh-ancestor
6162414|NCT01536392|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6162415|NCT01536392|Serotonin Agents|serotonin agents|mesh-ancestor
6162416|NCT01536392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6162417|NCT01536392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481759|NCT00548964|Ketamine|ketamine|mesh-list
6481760|NCT00548964|Lithium Carbonate|lithium carbonate|mesh-list
6481761|NCT00548964|Analgesics|analgesics|mesh-ancestor
6481762|NCT00548964|Sensory System Agents|sensory system agents|mesh-ancestor
6481763|NCT00548964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6481764|NCT00548964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481765|NCT00548964|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6481766|NCT00548964|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6481767|NCT00548964|Anesthetics, General|anesthetics, general|mesh-ancestor
6481768|NCT00548964|Anesthetics|anesthetics|mesh-ancestor
6481769|NCT00548964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6481770|NCT00548964|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6481771|NCT00548964|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6481772|NCT00548964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6488898|NCT00587665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560879|NCT04011150|Anesthetics|anesthetics|mesh-list
5560880|NCT04011150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6162418|NCT01536392|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6162419|NCT01536392|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5560881|NCT04011150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560882|NCT04011150|Sensory System Agents|sensory system agents|mesh-ancestor
5560883|NCT04011150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5560884|NCT04011150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5560885|NCT04011150|Narcotics|narcotics|mesh-ancestor
6481773|NCT00548964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481774|NCT00548964|Antidepressive Agents|antidepressive agents|mesh-ancestor
6481775|NCT00548964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6481776|NCT00548964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6481777|NCT00548964|Antimanic Agents|antimanic agents|mesh-ancestor
6481778|NCT00548964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6488899|NCT00587665|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6488900|NCT00587665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6488901|NCT00587665|Anesthetics, General|anesthetics, general|mesh-ancestor
6488902|NCT00587665|Anesthetics|anesthetics|mesh-ancestor
6488903|NCT00587665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6488904|NCT00587665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6488905|NCT00587665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6488906|NCT00587665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6488907|NCT00587665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488908|NCT00587717|Simvastatin|simvastatin|mesh-list
6488909|NCT00587717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6162420|NCT01536392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6162421|NCT01536392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6162422|NCT01536392|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6162423|NCT01536535|Prednisone|prednisone|mesh-list
6162424|NCT01536535|Mesalamine|mesalamine|mesh-list
6162425|NCT01536535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6162426|NCT01536535|Glucocorticoids|glucocorticoids|mesh-ancestor
6162427|NCT01536535|Hormones|hormones|mesh-ancestor
6162428|NCT01536535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6162429|NCT01536535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162430|NCT01536535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6162431|NCT01536535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6162432|NCT01536535|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6162433|NCT01536535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6162434|NCT01536535|Analgesics|analgesics|mesh-ancestor
6162435|NCT01536535|Sensory System Agents|sensory system agents|mesh-ancestor
6162436|NCT01536535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6162437|NCT01536535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6162438|NCT01536561|Tositumomab I-131|tositumomab i-131|mesh-list
6162439|NCT01536561|Antibodies|antibodies|mesh-list
6162440|NCT01536561|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6162441|NCT01536561|Antibodies, Anti-Idiotypic|antibodies, anti-idiotypic|mesh-list
5560886|NCT04011150|Analgesics|analgesics|mesh-ancestor
5560887|NCT04011150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5560888|NCT04011150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5560889|NCT04011150|Anesthetics, General|anesthetics, general|mesh-ancestor
5560890|NCT04011163|Morphine|morphine|mesh-list
5560891|NCT04011163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5560892|NCT04011163|Narcotics|narcotics|mesh-ancestor
5560893|NCT04011163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5560894|NCT04011163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560895|NCT04011163|Analgesics|analgesics|mesh-ancestor
5560896|NCT04011163|Sensory System Agents|sensory system agents|mesh-ancestor
5560897|NCT04011163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5560898|NCT04011033|Cyclophosphamide|cyclophosphamide|mesh-list
5560899|NCT04011033|Interleukin-2|interleukin-2|mesh-list
5560900|NCT04011033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6162442|NCT01536561|Immunologic Factors|immunologic factors|mesh-ancestor
6162443|NCT01536561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162444|NCT01536561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5560901|NCT04011033|Immunologic Factors|immunologic factors|mesh-ancestor
5560902|NCT04011033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560903|NCT04011033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5560904|NCT04011033|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5560905|NCT04011033|Alkylating Agents|alkylating agents|mesh-ancestor
5560906|NCT04011033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560907|NCT04011033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5560908|NCT04011033|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5560909|NCT04011033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5560910|NCT04011033|Analgesics|analgesics|mesh-ancestor
6162445|NCT01536574|Ropinirole|ropinirole|mesh-list
5560911|NCT04011033|Sensory System Agents|sensory system agents|mesh-ancestor
5560912|NCT04011033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6488910|NCT00587717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5560913|NCT04010929|Pemetrexed|pemetrexed|mesh-list
5560914|NCT04010929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5560915|NCT04010929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5560916|NCT04010929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560917|NCT04010929|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5560918|NCT04010929|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5560919|NCT04010942|Metformin|metformin|mesh-list
5560920|NCT04010942|Clomiphene|clomiphene|mesh-list
5560921|NCT04010942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5560922|NCT04010942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560923|NCT04010942|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5560924|NCT04010942|Hormone Antagonists|hormone antagonists|mesh-ancestor
5560925|NCT04010942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5560926|NCT04010942|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5560927|NCT04010942|Fertility Agents|fertility agents|mesh-ancestor
5560928|NCT04010942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5560929|NCT04010942|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5560930|NCT04010942|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5560931|NCT04010903|Insulin|insulin|mesh-list
5560932|NCT04010903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5560933|NCT04010903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560934|NCT04010669|Somatostatin|somatostatin|mesh-list
5560935|NCT04010669|Hormones|hormones|mesh-ancestor
6162446|NCT01536574|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6162447|NCT01536574|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6162448|NCT01536574|Dopamine Agonists|dopamine agonists|mesh-ancestor
6162449|NCT01536574|Dopamine Agents|dopamine agents|mesh-ancestor
6162450|NCT01536574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6162451|NCT01536574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162452|NCT01536574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162453|NCT01536587|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6162454|NCT01536587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6162455|NCT01536587|Autonomic Agents|autonomic agents|mesh-ancestor
6162456|NCT01536587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6162457|NCT01536587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162458|NCT01536587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6162459|NCT01536587|Respiratory System Agents|respiratory system agents|mesh-ancestor
5560936|NCT04010669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5560937|NCT04010669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603505|NCT02245308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5603506|NCT02245308|Dopamine Agents|dopamine agents|mesh-ancestor
5603507|NCT02245308|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5603508|NCT02245308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5603509|NCT02245308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5603510|NCT02227199|Carboplatin|carboplatin|mesh-list
5603511|NCT02227199|Etoposide|etoposide|mesh-list
6162460|NCT01536587|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6162461|NCT01536587|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6162462|NCT01536587|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6162463|NCT01536587|Adrenergic Agents|adrenergic agents|mesh-ancestor
6162464|NCT01536587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6162465|NCT01536587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162466|NCT01536704|Nicotine|nicotine|mesh-list
6162467|NCT01536704|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6162468|NCT01536704|Autonomic Agents|autonomic agents|mesh-ancestor
6162469|NCT01536704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6162470|NCT01536704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162471|NCT01536704|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6481779|NCT00549068|Risedronic Acid|risedronic acid|mesh-list
6481780|NCT00549068|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6481781|NCT00549068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6481782|NCT00549068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481783|NCT00549068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6481784|NCT00549068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481785|NCT00549068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6481786|NCT00549107|Simendan|simendan|mesh-list
6481787|NCT00549107|Milrinone|milrinone|mesh-list
6481788|NCT00549107|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6481789|NCT00549107|Vasodilator Agents|vasodilator agents|mesh-ancestor
6481790|NCT00549107|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6481791|NCT00549107|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6481792|NCT00549107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6668546|NCT01533090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5560938|NCT04010578|Vitamin D|vitamin d|mesh-list
5560939|NCT04010578|Cholecalciferol|cholecalciferol|mesh-list
5560940|NCT04010578|Vitamins|vitamins|mesh-ancestor
5560941|NCT04010578|Micronutrients|micronutrients|mesh-ancestor
5560942|NCT04010578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560943|NCT04010578|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5560944|NCT04010578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5560945|NCT04010318|Anesthetics|anesthetics|mesh-list
5560946|NCT04010318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5560947|NCT04010318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560948|NCT04010305|Dexmedetomidine|dexmedetomidine|mesh-list
5560949|NCT04010305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5560950|NCT04010305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5560951|NCT04010305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560952|NCT04010305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5560953|NCT04010305|Analgesics|analgesics|mesh-ancestor
5560954|NCT04010305|Sensory System Agents|sensory system agents|mesh-ancestor
5560955|NCT04010305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5560956|NCT04010305|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5560957|NCT04010305|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5560958|NCT04010305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5560959|NCT04010305|Adrenergic Agents|adrenergic agents|mesh-ancestor
5560960|NCT04010305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5560961|NCT04010305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560962|NCT04010071|Axitinib|axitinib|mesh-list
5560963|NCT04010071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5560964|NCT04010071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5560965|NCT04010071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5560966|NCT04010071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560967|NCT04009967|Pembrolizumab|pembrolizumab|mesh-list
5560968|NCT04009967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5560969|NCT04009967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5560970|NCT04009759|Morphine|morphine|mesh-list
5560971|NCT04009759|Ketamine|ketamine|mesh-list
5560972|NCT04009759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5560973|NCT04009759|Narcotics|narcotics|mesh-ancestor
6668547|NCT01533090|Laxatives|laxatives|mesh-ancestor
6668548|NCT01533129|Testosterone|testosterone|mesh-list
6668549|NCT01533129|Androgens|androgens|mesh-ancestor
6668550|NCT01533129|Hormones|hormones|mesh-ancestor
6668551|NCT01533129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6668552|NCT01533129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668553|NCT01533155|Quinidine|quinidine|mesh-list
6668554|NCT01533155|Quinidine gluconate|quinidine gluconate|mesh-list
6668555|NCT01533155|Morphine|morphine|mesh-list
6668556|NCT01533155|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6668557|NCT01533155|Narcotics|narcotics|mesh-ancestor
6668558|NCT01533155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6668559|NCT01533155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668560|NCT01533155|Analgesics|analgesics|mesh-ancestor
6668561|NCT01533155|Sensory System Agents|sensory system agents|mesh-ancestor
6668562|NCT01533155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6668563|NCT01533155|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6668564|NCT01533155|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6668565|NCT01533155|Adrenergic Agents|adrenergic agents|mesh-ancestor
6668566|NCT01533155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6668567|NCT01533155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668568|NCT01533155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6668569|NCT01533155|Antimalarials|antimalarials|mesh-ancestor
6668570|NCT01533155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6668571|NCT01533155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6668572|NCT01533155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6668573|NCT01533155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6668574|NCT01533155|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6668575|NCT01533155|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6668576|NCT01533155|Cholinergic Agents|cholinergic agents|mesh-ancestor
6668577|NCT01533155|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6668578|NCT01533155|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5560974|NCT04009759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5560975|NCT04009759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560976|NCT04009759|Analgesics|analgesics|mesh-ancestor
5560977|NCT04009759|Sensory System Agents|sensory system agents|mesh-ancestor
5560978|NCT04009759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5560979|NCT04009759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6668579|NCT01533155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5560980|NCT04009759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5560981|NCT04009759|Anesthetics, General|anesthetics, general|mesh-ancestor
5560982|NCT04009759|Anesthetics|anesthetics|mesh-ancestor
5560983|NCT04009759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5560984|NCT04009759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5560985|NCT04009759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6668580|NCT01533155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6668581|NCT01533155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6668582|NCT01533220|Pheniramine|pheniramine|mesh-list
6668583|NCT01533220|Naphazoline|naphazoline|mesh-list
6668584|NCT01533220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668585|NCT01533220|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6668586|NCT01533220|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6668587|NCT01533220|Adrenergic Agents|adrenergic agents|mesh-ancestor
5560986|NCT04009759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5560987|NCT04009772|Metronidazole|metronidazole|mesh-list
5560988|NCT04009772|Cefepime|cefepime|mesh-list
5560989|NCT04009772|Cefuroxime|cefuroxime|mesh-list
5560990|NCT04009772|Cefuroxime axetil|cefuroxime axetil|mesh-list
5560991|NCT04009772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5560992|NCT04009772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6162472|NCT01536704|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6162473|NCT01536704|Cholinergic Agents|cholinergic agents|mesh-ancestor
6162474|NCT01536704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6162475|NCT01536704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162476|NCT01536886|Betamethasone|betamethasone|mesh-list
6162477|NCT01536886|Calcipotriene|calcipotriene|mesh-list
6162478|NCT01536886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6162479|NCT01536886|Glucocorticoids|glucocorticoids|mesh-ancestor
5560993|NCT04009772|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5560994|NCT04009772|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5560995|NCT04009889|Silicon|silicon|mesh-list
5560996|NCT04009889|Trace Elements|trace elements|mesh-ancestor
5560997|NCT04009889|Micronutrients|micronutrients|mesh-ancestor
5560998|NCT04009889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5560999|NCT04009824|Aluminum Hydroxide|aluminum hydroxide|mesh-list
5561000|NCT04009824|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5561001|NCT04009824|Immunologic Factors|immunologic factors|mesh-ancestor
5561002|NCT04009824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561003|NCT04009824|Antacids|antacids|mesh-ancestor
5561004|NCT04009824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5561005|NCT04009824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5561006|NCT04009616|Chlorhexidine|chlorhexidine|mesh-list
5561007|NCT04009616|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5561008|NCT04009616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5561009|NCT04009616|Disinfectants|disinfectants|mesh-ancestor
6162480|NCT01536886|Hormones|hormones|mesh-ancestor
6162481|NCT01536886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6162482|NCT01536886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162483|NCT01536886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6162484|NCT01536886|Respiratory System Agents|respiratory system agents|mesh-ancestor
6162485|NCT01536886|Dermatologic Agents|dermatologic agents|mesh-ancestor
6162486|NCT01536938|Calcitriol|calcitriol|mesh-list
6162487|NCT01536938|Betamethasone|betamethasone|mesh-list
6162488|NCT01536938|Betamethasone Valerate|betamethasone valerate|mesh-list
6162489|NCT01536938|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
6162490|NCT01536938|Betamethasone benzoate|betamethasone benzoate|mesh-list
6162491|NCT01536938|Calcipotriene|calcipotriene|mesh-list
6162492|NCT01536938|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
6162493|NCT01536938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6162494|NCT01536938|Glucocorticoids|glucocorticoids|mesh-ancestor
6162495|NCT01536938|Hormones|hormones|mesh-ancestor
6162496|NCT01536938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6162497|NCT01536938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162498|NCT01536938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6162499|NCT01536938|Respiratory System Agents|respiratory system agents|mesh-ancestor
6162500|NCT01536938|Dermatologic Agents|dermatologic agents|mesh-ancestor
6162501|NCT01536938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6162502|NCT01536938|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6162503|NCT01536938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6162504|NCT01536938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162505|NCT01536938|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6162506|NCT01536938|Vitamins|vitamins|mesh-ancestor
6162507|NCT01536938|Micronutrients|micronutrients|mesh-ancestor
6206107|NCT02096744|Autonomic Agents|autonomic agents|mesh-ancestor
5561010|NCT04009876|Oxaliplatin|oxaliplatin|mesh-list
5561011|NCT04009876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5561012|NCT04009603|Metformin|metformin|mesh-list
5561013|NCT04009603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5561014|NCT04009603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561015|NCT04009525|Cyclosporine|cyclosporine|mesh-list
5561016|NCT04009525|Mycophenolic Acid|mycophenolic acid|mesh-list
5561017|NCT04009525|Cyclophosphamide|cyclophosphamide|mesh-list
5561018|NCT04009525|Busulfan|busulfan|mesh-list
5561019|NCT04009525|Methotrexate|methotrexate|mesh-list
5561020|NCT04009525|Fludarabine|fludarabine|mesh-list
5561021|NCT04009525|Tacrolimus|tacrolimus|mesh-list
5561022|NCT04009525|Cyclosporins|cyclosporins|mesh-list
5561023|NCT04009525|Thymoglobulin|thymoglobulin|mesh-list
6481793|NCT00549107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481794|NCT00549107|Protective Agents|protective agents|mesh-ancestor
6481795|NCT00549107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481796|NCT00549107|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6481797|NCT00549120|Propranolol|propranolol|mesh-list
6162508|NCT01536938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6162509|NCT01536951|Moxifloxacin|moxifloxacin|mesh-list
6162510|NCT01536951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6162511|NCT01536951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6162512|NCT01536951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6162513|NCT01536951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6162514|NCT01536951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6162515|NCT01536951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162516|NCT01536951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6162517|NCT01537029|Cyclophosphamide|cyclophosphamide|mesh-list
6162518|NCT01537029|Doxorubicin|doxorubicin|mesh-list
6162519|NCT01537029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6162520|NCT01537029|Immunologic Factors|immunologic factors|mesh-ancestor
6162521|NCT01537029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162522|NCT01537029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6162523|NCT01537029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6162524|NCT01537029|Alkylating Agents|alkylating agents|mesh-ancestor
6162525|NCT01537029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162526|NCT01537029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6162527|NCT01537029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6162528|NCT01537029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5561024|NCT04009525|Basiliximab|basiliximab|mesh-list
5561025|NCT04009525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5561026|NCT04009525|Immunologic Factors|immunologic factors|mesh-ancestor
5561027|NCT04009525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561028|NCT04009525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5561029|NCT04009525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5561030|NCT04009525|Alkylating Agents|alkylating agents|mesh-ancestor
5561031|NCT04009525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5561032|NCT04009525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5561033|NCT04009525|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5561034|NCT04009525|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5561035|NCT04009525|Abortifacient Agents|abortifacient agents|mesh-ancestor
5561036|NCT04009525|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5561037|NCT04009525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5561038|NCT04009525|Antimetabolites|antimetabolites|mesh-ancestor
5561039|NCT04009525|Dermatologic Agents|dermatologic agents|mesh-ancestor
6162529|NCT01537029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6481798|NCT00549120|Albuterol|albuterol|mesh-list
6481799|NCT00549120|Ipratropium|ipratropium|mesh-list
6481800|NCT00549120|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6481801|NCT00549120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6481802|NCT00549120|Adrenergic Agents|adrenergic agents|mesh-ancestor
6162530|NCT01537029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6162531|NCT01537029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6162532|NCT01537042|Rotigotine|rotigotine|mesh-list
6162533|NCT01537042|Dopamine Agonists|dopamine agonists|mesh-ancestor
6162534|NCT01537042|Dopamine Agents|dopamine agents|mesh-ancestor
6162535|NCT01537042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6162536|NCT01537042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481803|NCT00549120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6481804|NCT00549120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481805|NCT00549120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481806|NCT00549120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6481807|NCT00549120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5561040|NCT04009525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5561041|NCT04009525|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5561042|NCT04009525|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6481808|NCT00549120|Vasodilator Agents|vasodilator agents|mesh-ancestor
6481809|NCT00549120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6481810|NCT00549120|Autonomic Agents|autonomic agents|mesh-ancestor
6481811|NCT00549120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6481812|NCT00549120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5561043|NCT04009525|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5561044|NCT04009525|Antifungal Agents|antifungal agents|mesh-ancestor
5561045|NCT04009525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5561046|NCT04009525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5561047|NCT04009525|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6481813|NCT00549120|Respiratory System Agents|respiratory system agents|mesh-ancestor
6481814|NCT00549120|Tocolytic Agents|tocolytic agents|mesh-ancestor
6162537|NCT01537042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162538|NCT01537068|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6162539|NCT01537068|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6162540|NCT01537068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6162541|NCT01537068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6162542|NCT01537068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162543|NCT01537068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6162544|NCT01537068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162545|NCT01537068|Antidepressive Agents|antidepressive agents|mesh-ancestor
6162546|NCT01537068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6162547|NCT01537081|Phenylpropanolamine|phenylpropanolamine|mesh-list
6162548|NCT01537081|Guaifenesin|guaifenesin|mesh-list
6162549|NCT01537081|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
6162550|NCT01537081|Expectorants|expectorants|mesh-ancestor
6162551|NCT01537081|Respiratory System Agents|respiratory system agents|mesh-ancestor
6162552|NCT01537081|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6162553|NCT01537081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6162554|NCT01537081|Adrenergic Agents|adrenergic agents|mesh-ancestor
6162555|NCT01537081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6162556|NCT01537081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162557|NCT01537081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162558|NCT01537081|Appetite Depressants|appetite depressants|mesh-ancestor
6162559|NCT01537081|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6162560|NCT01537081|Sympathomimetics|sympathomimetics|mesh-ancestor
6162561|NCT01537081|Autonomic Agents|autonomic agents|mesh-ancestor
5561048|NCT04009525|Antitubercular Agents|antitubercular agents|mesh-ancestor
5561049|NCT04009525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5561050|NCT04009317|Crizotinib|crizotinib|mesh-list
5561051|NCT04009317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5603512|NCT02227199|Etoposide phosphate|etoposide phosphate|mesh-list
6162562|NCT01537081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6162563|NCT01537081|Nasal Decongestants|nasal decongestants|mesh-ancestor
6162564|NCT01537081|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6162565|NCT01537120|Vildagliptin|vildagliptin|mesh-list
6162566|NCT01537120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6162567|NCT01537120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162568|NCT01537120|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6162569|NCT01537120|Protease Inhibitors|protease inhibitors|mesh-ancestor
6162570|NCT01537120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6162571|NCT01537120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162572|NCT01537133|Fluticasone|fluticasone|mesh-list
6162573|NCT01537133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6162574|NCT01537133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6162575|NCT01537133|Autonomic Agents|autonomic agents|mesh-ancestor
6162576|NCT01537133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6162577|NCT01537133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162578|NCT01537133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6481815|NCT00549120|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6481816|NCT00549120|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6481817|NCT00549120|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6481818|NCT00549120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6481819|NCT00549120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6481820|NCT00549120|Cholinergic Agents|cholinergic agents|mesh-ancestor
6481821|NCT00549133|Irbesartan|irbesartan|mesh-list
6481822|NCT00549133|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6481823|NCT00549133|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6481824|NCT00549133|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6481825|NCT00549133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481826|NCT00549146|Fluticasone|fluticasone|mesh-list
6481827|NCT00549146|Xhance|xhance|mesh-list
6481828|NCT00549146|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5561052|NCT04009317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5561053|NCT04009317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5561054|NCT04009317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5561055|NCT04009109|Dexamethasone|dexamethasone|mesh-list
5561056|NCT04009109|Lenalidomide|lenalidomide|mesh-list
5561057|NCT04009109|Daratumumab|daratumumab|mesh-list
5561058|NCT04009109|Ixazomib|ixazomib|mesh-list
5561059|NCT04009109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5561060|NCT04009109|Antiemetics|antiemetics|mesh-ancestor
5561061|NCT04009109|Autonomic Agents|autonomic agents|mesh-ancestor
5561062|NCT04009109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5561063|NCT04009109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561064|NCT04009109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5561065|NCT04009109|Glucocorticoids|glucocorticoids|mesh-ancestor
5561066|NCT04009109|Hormones|hormones|mesh-ancestor
5561067|NCT04009109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5561068|NCT04009109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5561069|NCT04009109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5561070|NCT04009109|Immunologic Factors|immunologic factors|mesh-ancestor
5561071|NCT04009109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5561072|NCT04009109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6162579|NCT01537133|Respiratory System Agents|respiratory system agents|mesh-ancestor
6162580|NCT01537133|Dermatologic Agents|dermatologic agents|mesh-ancestor
6162581|NCT01537133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6162582|NCT01537185|Aluminum sulfate|aluminum sulfate|mesh-list
6162583|NCT01537185|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6481829|NCT00549146|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6481830|NCT00549146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5561073|NCT04009109|Growth Substances|growth substances|mesh-ancestor
5561074|NCT04009109|Growth Inhibitors|growth inhibitors|mesh-ancestor
5561075|NCT04009109|Protease Inhibitors|protease inhibitors|mesh-ancestor
5561076|NCT04009109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5561077|NCT04009109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5561078|NCT04009343|Lumefantrine|lumefantrine|mesh-list
5561079|NCT04009343|Artemether|artemether|mesh-list
6162584|NCT01537185|Immunologic Factors|immunologic factors|mesh-ancestor
6162585|NCT01537185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162586|NCT01537315|Hydroxychloroquine|hydroxychloroquine|mesh-list
6162587|NCT01537315|Antimalarials|antimalarials|mesh-ancestor
5561080|NCT04009343|Piperaquine|piperaquine|mesh-list
5561081|NCT04009343|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
5561082|NCT04009343|Artenimol|artenimol|mesh-list
5561083|NCT04009343|Antimalarials|antimalarials|mesh-ancestor
5561084|NCT04009343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5561085|NCT04009343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5561086|NCT04009343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5561087|NCT04008979|Aspirin|aspirin|mesh-list
5561088|NCT04008979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5561089|NCT04008979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5561090|NCT04008979|Analgesics|analgesics|mesh-ancestor
5561091|NCT04008979|Sensory System Agents|sensory system agents|mesh-ancestor
5561092|NCT04008979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5561093|NCT04008979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561094|NCT04008979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5561095|NCT04008979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5561096|NCT04008979|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5561097|NCT04008979|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5561098|NCT04008979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5561099|NCT04008979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5561100|NCT04008979|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5561101|NCT04008979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6162588|NCT01537315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6162589|NCT01537315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6162590|NCT01537315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6162591|NCT01537315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6162592|NCT01537315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162593|NCT01537315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6162594|NCT01537549|Thioctic Acid|thioctic acid|mesh-list
6162595|NCT01537549|Acetylcarnitine|acetylcarnitine|mesh-list
6162596|NCT01537549|Antioxidants|antioxidants|mesh-ancestor
6162597|NCT01537549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162598|NCT01537549|Protective Agents|protective agents|mesh-ancestor
6162599|NCT01537549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162600|NCT01537549|Vitamin B Complex|vitamin b complex|mesh-ancestor
6162601|NCT01537549|Vitamins|vitamins|mesh-ancestor
6162602|NCT01537549|Micronutrients|micronutrients|mesh-ancestor
6162603|NCT01537549|Nootropic Agents|nootropic agents|mesh-ancestor
6162604|NCT01537666|Vancomycin|vancomycin|mesh-list
6162605|NCT01537666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6481831|NCT00549146|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6481832|NCT00549146|Autonomic Agents|autonomic agents|mesh-ancestor
6481833|NCT00549146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6481834|NCT00549146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481835|NCT00549146|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6481836|NCT00549146|Respiratory System Agents|respiratory system agents|mesh-ancestor
6481837|NCT00549146|Dermatologic Agents|dermatologic agents|mesh-ancestor
6481838|NCT00549146|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6481839|NCT00549146|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6481840|NCT00549146|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6481841|NCT00549146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6481842|NCT00549146|Adrenergic Agents|adrenergic agents|mesh-ancestor
6481843|NCT00549146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6668588|NCT01533220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6668589|NCT01533220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162606|NCT01537666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6162607|NCT01537783|Chlorhexidine|chlorhexidine|mesh-list
6162608|NCT01537783|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6162609|NCT01537783|Mupirocin|mupirocin|mesh-list
6162610|NCT01537783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6162611|NCT01537783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6162612|NCT01537783|Disinfectants|disinfectants|mesh-ancestor
6162613|NCT01537783|Dermatologic Agents|dermatologic agents|mesh-ancestor
6162614|NCT01537783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6162615|NCT01537783|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6162616|NCT01537783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6162617|NCT01537783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162618|NCT01537835|Anti-Infective Agents|anti-infective agents|mesh-list
6162619|NCT01537835|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6162620|NCT01537887|Moxifloxacin|moxifloxacin|mesh-list
6162621|NCT01537887|Evacetrapib|evacetrapib|mesh-list
6162622|NCT01537887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6162623|NCT01537887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6162624|NCT01537887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6162625|NCT01537887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6162626|NCT01537887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6162627|NCT01537887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162628|NCT01537887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6162629|NCT01537887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6162630|NCT01537887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6162631|NCT01537887|Antimetabolites|antimetabolites|mesh-ancestor
6162632|NCT01537887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6162633|NCT01537900|Grazoprevir|grazoprevir|mesh-list
6162634|NCT01537900|Antiviral Agents|antiviral agents|mesh-ancestor
6162635|NCT01537900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6162636|NCT01537926|Acetylcysteine|acetylcysteine|mesh-list
6162637|NCT01537926|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6162638|NCT01537926|Antiviral Agents|antiviral agents|mesh-ancestor
6162639|NCT01537926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6162640|NCT01537926|Expectorants|expectorants|mesh-ancestor
6162641|NCT01537926|Respiratory System Agents|respiratory system agents|mesh-ancestor
6162642|NCT01537926|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6162643|NCT01537926|Antioxidants|antioxidants|mesh-ancestor
6162644|NCT01537926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162645|NCT01537926|Protective Agents|protective agents|mesh-ancestor
6162646|NCT01537926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162647|NCT01537926|Antidotes|antidotes|mesh-ancestor
6162648|NCT01538472|Cytarabine|cytarabine|mesh-list
6162649|NCT01538472|Rituximab|rituximab|mesh-list
6162650|NCT01538472|Melphalan|melphalan|mesh-list
6162651|NCT01538472|Carmustine|carmustine|mesh-list
6162652|NCT01538472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6162653|NCT01538472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6162654|NCT01538472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6162655|NCT01538472|Immunologic Factors|immunologic factors|mesh-ancestor
6162656|NCT01538472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162657|NCT01538472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6162658|NCT01538472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6162659|NCT01538472|Antimetabolites|antimetabolites|mesh-ancestor
6162660|NCT01538472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162661|NCT01538472|Antiviral Agents|antiviral agents|mesh-ancestor
6162662|NCT01538472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6162663|NCT01538472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6488911|NCT00587717|Antimetabolites|antimetabolites|mesh-ancestor
6162664|NCT01538472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6162665|NCT01538472|Alkylating Agents|alkylating agents|mesh-ancestor
6162666|NCT01538472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6162667|NCT01538719|Rilonacept|rilonacept|mesh-list
6162668|NCT01538719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6162669|NCT01538745|Morphine|morphine|mesh-list
6668590|NCT01533220|Nasal Decongestants|nasal decongestants|mesh-ancestor
6668591|NCT01533220|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6668592|NCT01533220|Respiratory System Agents|respiratory system agents|mesh-ancestor
6668593|NCT01533220|Antipruritics|antipruritics|mesh-ancestor
6668594|NCT01533220|Dermatologic Agents|dermatologic agents|mesh-ancestor
6481844|NCT00549146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481845|NCT00549146|Glucocorticoids|glucocorticoids|mesh-ancestor
6481846|NCT00549146|Hormones|hormones|mesh-ancestor
6481847|NCT00549146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6481848|NCT00549146|Sympathomimetics|sympathomimetics|mesh-ancestor
6481849|NCT00549289|Cyclosporine|cyclosporine|mesh-list
6481850|NCT00549289|Cyclosporins|cyclosporins|mesh-list
6481851|NCT00549289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6162670|NCT01538745|Ketamine|ketamine|mesh-list
6162671|NCT01538745|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5561102|NCT04008979|Antipyretics|antipyretics|mesh-ancestor
5561103|NCT04009018|Anesthetics|anesthetics|mesh-list
5561104|NCT04009018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5561105|NCT04009018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561106|NCT04008732|Nitroglycerin|nitroglycerin|mesh-list
5561107|NCT04008732|Vasodilator Agents|vasodilator agents|mesh-ancestor
5561108|NCT04009044|Tamoxifen|tamoxifen|mesh-list
5561109|NCT04009044|Afimoxifene|afimoxifene|mesh-list
5561110|NCT04009044|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5561111|NCT04009044|Hormone Antagonists|hormone antagonists|mesh-ancestor
5561112|NCT04009044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5561113|NCT04009044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561114|NCT04009044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5561115|NCT04009044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5561116|NCT04009044|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5561117|NCT04009044|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5561118|NCT04009044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5561119|NCT04008784|Triamcinolone|triamcinolone|mesh-list
5561120|NCT04008784|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5561121|NCT04008784|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6162672|NCT01538745|Narcotics|narcotics|mesh-ancestor
6162673|NCT01538745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6162674|NCT01538745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162675|NCT01538745|Analgesics|analgesics|mesh-ancestor
6162676|NCT01538745|Sensory System Agents|sensory system agents|mesh-ancestor
6162677|NCT01538745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6162678|NCT01538745|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6162679|NCT01538745|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6162680|NCT01538745|Anesthetics, General|anesthetics, general|mesh-ancestor
5561122|NCT04008784|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5561123|NCT04008784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5561124|NCT04008784|Glucocorticoids|glucocorticoids|mesh-ancestor
5561125|NCT04008784|Hormones|hormones|mesh-ancestor
5561126|NCT04008784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5561127|NCT04008784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561128|NCT04008784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5561129|NCT04008784|Immunologic Factors|immunologic factors|mesh-ancestor
5561130|NCT04008784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5561131|NCT04008784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162681|NCT01538745|Anesthetics|anesthetics|mesh-ancestor
5561132|NCT04008966|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5561133|NCT04008966|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5561134|NCT04008966|Cetrorelix|cetrorelix|mesh-list
6162682|NCT01538745|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6162683|NCT01538745|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6162684|NCT01538745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6162685|NCT01538745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162686|NCT01538862|Sargramostim|sargramostim|mesh-list
6162687|NCT01538862|Lenograstim|lenograstim|mesh-list
6162688|NCT01538862|Immunologic Factors|immunologic factors|mesh-ancestor
6481852|NCT00549289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5561135|NCT04008966|Progesterone|progesterone|mesh-list
5561136|NCT04008966|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
6481853|NCT00549289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5561137|NCT04008966|Progestins|progestins|mesh-ancestor
5561138|NCT04008966|Hormones|hormones|mesh-ancestor
5561139|NCT04008966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5561140|NCT04008966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162689|NCT01538862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162690|NCT01538862|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6162691|NCT01539083|Thalidomide|thalidomide|mesh-list
6162692|NCT01539083|Dexamethasone|dexamethasone|mesh-list
6162693|NCT01539083|Prednisolone|prednisolone|mesh-list
5561141|NCT04008966|Luteolytic Agents|luteolytic agents|mesh-ancestor
5561142|NCT04008966|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5561143|NCT04008966|Contraceptive Agents|contraceptive agents|mesh-ancestor
5561144|NCT04008966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5561145|NCT04008966|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5561146|NCT04008966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5561147|NCT04008966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6162694|NCT01539083|Cyclophosphamide|cyclophosphamide|mesh-list
6162695|NCT01539083|Bortezomib|bortezomib|mesh-list
6162696|NCT01539083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6481854|NCT00549289|Immunologic Factors|immunologic factors|mesh-ancestor
6481855|NCT00549289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481856|NCT00549289|Antifungal Agents|antifungal agents|mesh-ancestor
6481857|NCT00549289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6481858|NCT00549289|Dermatologic Agents|dermatologic agents|mesh-ancestor
5561148|NCT04008966|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5561149|NCT04008966|Fertility Agents|fertility agents|mesh-ancestor
5561150|NCT04008966|Hormone Antagonists|hormone antagonists|mesh-ancestor
5603513|NCT02227199|Ifosfamide|ifosfamide|mesh-list
5603514|NCT02227199|Isophosphamide mustard|isophosphamide mustard|mesh-list
5603515|NCT02227199|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5603516|NCT02227199|Podophyllotoxin|podophyllotoxin|mesh-list
5603517|NCT02227199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6162697|NCT01539083|Immunologic Factors|immunologic factors|mesh-ancestor
6162698|NCT01539083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162699|NCT01539083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6162700|NCT01539083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6162701|NCT01539083|Alkylating Agents|alkylating agents|mesh-ancestor
6162702|NCT01539083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162703|NCT01539083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6162704|NCT01539083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6162705|NCT01539083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6162706|NCT01539083|Antiemetics|antiemetics|mesh-ancestor
6162707|NCT01539083|Autonomic Agents|autonomic agents|mesh-ancestor
6162708|NCT01539083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6162709|NCT01539083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6162710|NCT01539083|Glucocorticoids|glucocorticoids|mesh-ancestor
6162711|NCT01539083|Hormones|hormones|mesh-ancestor
6162712|NCT01539083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6162713|NCT01539083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6162714|NCT01539083|Leprostatic Agents|leprostatic agents|mesh-ancestor
6162715|NCT01539083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6162716|NCT01539083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6162717|NCT01539083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6162718|NCT01539083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6162719|NCT01539083|Growth Substances|growth substances|mesh-ancestor
6162720|NCT01539083|Growth Inhibitors|growth inhibitors|mesh-ancestor
6481859|NCT00549289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6481860|NCT00549289|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6481861|NCT00549341|Botulinum Toxins|botulinum toxins|mesh-list
6481862|NCT00549341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6481863|NCT00549341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6481864|NCT00549341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481865|NCT00549341|Cholinergic Agents|cholinergic agents|mesh-ancestor
6481866|NCT00549341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6481867|NCT00549341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481868|NCT00549419|Dobutamine|dobutamine|mesh-list
6481869|NCT00549419|Norepinephrine|norepinephrine|mesh-list
6481870|NCT00549419|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6481871|NCT00549419|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6481872|NCT00549419|Adrenergic Agents|adrenergic agents|mesh-ancestor
6481873|NCT00549419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6481874|NCT00549419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481875|NCT00549419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481876|NCT00549419|Sympathomimetics|sympathomimetics|mesh-ancestor
6481877|NCT00549419|Autonomic Agents|autonomic agents|mesh-ancestor
6162721|NCT01539135|Methylene Blue|methylene blue|mesh-list
6162722|NCT01539135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6162723|NCT01539135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162724|NCT01539291|Idelalisib|idelalisib|mesh-list
6162725|NCT01539291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6162726|NCT01539291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6162727|NCT01539291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5561151|NCT04008888|Dexamethasone|dexamethasone|mesh-list
5561152|NCT04008888|Dexamethasone acetate|dexamethasone acetate|mesh-list
5561153|NCT04008888|Fludarabine|fludarabine|mesh-list
5561154|NCT04008888|Melphalan|melphalan|mesh-list
5561155|NCT04008888|BB 1101|bb 1101|mesh-list
5561156|NCT04008888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5561157|NCT04008888|Antiemetics|antiemetics|mesh-ancestor
5561158|NCT04008888|Autonomic Agents|autonomic agents|mesh-ancestor
5561159|NCT04008888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5561160|NCT04008888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561161|NCT04008888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6162728|NCT01539317|Lidocaine|lidocaine|mesh-list
6162729|NCT01539317|Anesthetics, Local|anesthetics, local|mesh-ancestor
6162730|NCT01539317|Anesthetics|anesthetics|mesh-ancestor
6162731|NCT01539317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6162732|NCT01539317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162733|NCT01539317|Sensory System Agents|sensory system agents|mesh-ancestor
6162734|NCT01539317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6162735|NCT01539317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6162736|NCT01539317|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5561162|NCT04008888|Glucocorticoids|glucocorticoids|mesh-ancestor
5561163|NCT04008888|Hormones|hormones|mesh-ancestor
5561164|NCT04008888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5561165|NCT04008888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6162737|NCT01539317|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6162738|NCT01539317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6481878|NCT00549419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6481879|NCT00549419|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6481880|NCT00549419|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6481881|NCT00549419|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6481882|NCT00549419|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6481883|NCT00549419|Protective Agents|protective agents|mesh-ancestor
6481884|NCT00549471|Botulinum Toxins|botulinum toxins|mesh-list
6481885|NCT00549471|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6481886|NCT00549471|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6481887|NCT00549471|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6668595|NCT01533220|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6668596|NCT01533220|Histamine Antagonists|histamine antagonists|mesh-ancestor
5561166|NCT04008888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5561167|NCT04008888|Protease Inhibitors|protease inhibitors|mesh-ancestor
5561168|NCT04008888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5561169|NCT04008888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5561170|NCT04008888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6668597|NCT01533220|Histamine Agents|histamine agents|mesh-ancestor
6668598|NCT01533220|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6668599|NCT01533272|Tenofovir|tenofovir|mesh-list
6668600|NCT01533272|Emtricitabine|emtricitabine|mesh-list
6668601|NCT01533272|Lopinavir|lopinavir|mesh-list
6668602|NCT01533272|Maraviroc|maraviroc|mesh-list
6668603|NCT01533272|Antiviral Agents|antiviral agents|mesh-ancestor
6668604|NCT01533272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6668605|NCT01533272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6668606|NCT01533272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6668607|NCT01533272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6668608|NCT01533272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668609|NCT01533272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6668610|NCT01533272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6668611|NCT01533272|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6668612|NCT01533272|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6668613|NCT01533272|Protease Inhibitors|protease inhibitors|mesh-ancestor
6668614|NCT01533272|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6668615|NCT01533272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6668616|NCT01533272|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6668617|NCT01533272|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6668618|NCT01533272|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6672457|NCT01556321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5561171|NCT04008888|Immunologic Factors|immunologic factors|mesh-ancestor
5561172|NCT04008888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6668619|NCT01533324|Leucovorin|leucovorin|mesh-list
6668620|NCT01533324|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
5561173|NCT04008888|Alkylating Agents|alkylating agents|mesh-ancestor
6162739|NCT01539317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162740|NCT01539512|Rituximab|rituximab|mesh-list
6162741|NCT01539512|Idelalisib|idelalisib|mesh-list
6162742|NCT01539512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6162743|NCT01539512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6162744|NCT01539512|Immunologic Factors|immunologic factors|mesh-ancestor
5561174|NCT04008888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5561175|NCT04008511|Capecitabine|capecitabine|mesh-list
5561176|NCT04008511|Oxaliplatin|oxaliplatin|mesh-list
5561177|NCT04008511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5561178|NCT04008511|Antimetabolites|antimetabolites|mesh-ancestor
5561179|NCT04008511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5561180|NCT04008511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5561181|NCT04008290|Liraglutide|liraglutide|mesh-list
5561182|NCT04008290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6162745|NCT01539512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162746|NCT01539512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6162747|NCT01539512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5561183|NCT04008290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561184|NCT04008290|Incretins|incretins|mesh-ancestor
5561185|NCT04008290|Hormones|hormones|mesh-ancestor
5561186|NCT04008290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5561187|NCT04008264|Scopolamine|scopolamine|mesh-list
5561188|NCT04008264|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
5561189|NCT04008264|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5561190|NCT04008264|Antiemetics|antiemetics|mesh-ancestor
5561191|NCT04008264|Autonomic Agents|autonomic agents|mesh-ancestor
5561192|NCT04008264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5561193|NCT04008264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561194|NCT04008264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5561195|NCT04008264|Mydriatics|mydriatics|mesh-ancestor
5561196|NCT04008264|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5561197|NCT04008264|Cholinergic Agents|cholinergic agents|mesh-ancestor
5561198|NCT04008264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5561199|NCT04008264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5561200|NCT04008264|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5561201|NCT04008264|Parasympatholytics|parasympatholytics|mesh-ancestor
5561202|NCT04008186|Metformin|metformin|mesh-list
5561203|NCT04008186|Repaglinide|repaglinide|mesh-list
6162748|NCT01539512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162749|NCT01539538|Sufentanil|sufentanil|mesh-list
6162750|NCT01539538|Morphine|morphine|mesh-list
6162751|NCT01539538|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6162752|NCT01539538|Narcotics|narcotics|mesh-ancestor
6162753|NCT01539538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5561204|NCT04008186|Itraconazole|itraconazole|mesh-list
5561205|NCT04008186|Digoxin|digoxin|mesh-list
5561206|NCT04008186|Verapamil|verapamil|mesh-list
5561207|NCT04008186|Midazolam|midazolam|mesh-list
5561208|NCT04008186|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5561209|NCT04008186|Gemfibrozil|gemfibrozil|mesh-list
5561210|NCT04008186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5561211|NCT04008186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561212|NCT04008186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5561213|NCT04008186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5561214|NCT04008186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5561215|NCT04008186|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5561216|NCT04008186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5561217|NCT04008186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5561218|NCT04008186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5561219|NCT04008186|Anesthetics, General|anesthetics, general|mesh-ancestor
5561220|NCT04008186|Anesthetics|anesthetics|mesh-ancestor
5561221|NCT04008186|GABA Modulators|gaba modulators|mesh-ancestor
5561222|NCT04008186|GABA Agents|gaba agents|mesh-ancestor
6162754|NCT01539538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162755|NCT01539538|Analgesics|analgesics|mesh-ancestor
5561223|NCT04008186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5561224|NCT04008186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5561225|NCT04008186|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6162756|NCT01539538|Sensory System Agents|sensory system agents|mesh-ancestor
6668621|NCT01533324|Antidotes|antidotes|mesh-ancestor
5561226|NCT04008186|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5561227|NCT04008186|Antimetabolites|antimetabolites|mesh-ancestor
5561228|NCT04008186|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5561229|NCT04008186|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6162757|NCT01539538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6162758|NCT01539538|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6162759|NCT01539538|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6162760|NCT01539538|Anesthetics, General|anesthetics, general|mesh-ancestor
6162761|NCT01539538|Anesthetics|anesthetics|mesh-ancestor
6668622|NCT01533324|Protective Agents|protective agents|mesh-ancestor
6668623|NCT01533324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668624|NCT01533324|Vitamin B Complex|vitamin b complex|mesh-ancestor
6162762|NCT01539642|Sufentanil|sufentanil|mesh-list
6162763|NCT01539642|Dsuvia|dsuvia|mesh-list
6162764|NCT01539642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6162765|NCT01539642|Narcotics|narcotics|mesh-ancestor
6162766|NCT01539642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6162767|NCT01539642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162768|NCT01539642|Analgesics|analgesics|mesh-ancestor
6162769|NCT01539642|Sensory System Agents|sensory system agents|mesh-ancestor
6162770|NCT01539642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6162771|NCT01539642|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6162772|NCT01539642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6162773|NCT01539642|Anesthetics, General|anesthetics, general|mesh-ancestor
6162774|NCT01539642|Anesthetics|anesthetics|mesh-ancestor
6162775|NCT01539837|Deferiprone|deferiprone|mesh-list
6162776|NCT01539837|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6162777|NCT01539837|Chelating Agents|chelating agents|mesh-ancestor
6162778|NCT01539837|Sequestering Agents|sequestering agents|mesh-ancestor
6162779|NCT01539837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162780|NCT01540474|Vaccines|vaccines|mesh-list
6162781|NCT01540474|Immunologic Factors|immunologic factors|mesh-ancestor
6162782|NCT01540474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162783|NCT01540487|Metformin|metformin|mesh-list
6162784|NCT01540487|Linagliptin|linagliptin|mesh-list
6162785|NCT01540487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6162786|NCT01540487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162787|NCT01540487|Incretins|incretins|mesh-ancestor
6668625|NCT01533324|Vitamins|vitamins|mesh-ancestor
6668626|NCT01533324|Micronutrients|micronutrients|mesh-ancestor
6668627|NCT01533376|Timolol|timolol|mesh-list
5561230|NCT04008186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6162788|NCT01540487|Hormones|hormones|mesh-ancestor
6162789|NCT01540487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6162790|NCT01540487|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6162791|NCT01540487|Protease Inhibitors|protease inhibitors|mesh-ancestor
6162792|NCT01540487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6162793|NCT01540487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162794|NCT01540565|Veliparib|veliparib|mesh-list
6162795|NCT01540565|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6162796|NCT01540565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6162797|NCT01540565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162798|NCT01540565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6162799|NCT01540838|Acetaminophen|acetaminophen|mesh-list
6162800|NCT01540838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6162801|NCT01540838|Analgesics|analgesics|mesh-ancestor
6162802|NCT01540838|Sensory System Agents|sensory system agents|mesh-ancestor
6162803|NCT01540838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5561231|NCT04008186|Antifungal Agents|antifungal agents|mesh-ancestor
5561232|NCT04008186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5561233|NCT04008186|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5561234|NCT04008186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5561235|NCT04008186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5561236|NCT04008186|Hormone Antagonists|hormone antagonists|mesh-ancestor
5561237|NCT04008186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6162804|NCT01540838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162805|NCT01540838|Antipyretics|antipyretics|mesh-ancestor
6162806|NCT01541215|Metformin|metformin|mesh-list
6162807|NCT01541215|Liraglutide|liraglutide|mesh-list
6162808|NCT01541215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6162809|NCT01541215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162810|NCT01541215|Incretins|incretins|mesh-ancestor
6162811|NCT01541215|Hormones|hormones|mesh-ancestor
6162812|NCT01541215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6162813|NCT01541358|Listerine|listerine|mesh-list
6162814|NCT01541358|Fluorides|fluorides|mesh-list
6162815|NCT01541358|Sodium Fluoride|sodium fluoride|mesh-list
6162816|NCT01541358|Cariostatic Agents|cariostatic agents|mesh-ancestor
6162817|NCT01541358|Protective Agents|protective agents|mesh-ancestor
6162818|NCT01541358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668628|NCT01533376|Lubricant Eye Drops|lubricant eye drops|mesh-list
6162819|NCT01541358|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6162820|NCT01541358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6162821|NCT01541371|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6162822|NCT01541371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6162823|NCT01541371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6162824|NCT01541371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6162825|NCT01541371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162826|NCT01541371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6162827|NCT01541371|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6162828|NCT01541371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6162829|NCT01541371|Serotonin Agents|serotonin agents|mesh-ancestor
6162830|NCT01541371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6162831|NCT01541371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162832|NCT01541371|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6162833|NCT01541371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6162834|NCT01541371|Dopamine Agents|dopamine agents|mesh-ancestor
6162835|NCT01541735|Pantoprazole|pantoprazole|mesh-list
6162836|NCT01541735|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6162837|NCT01541735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6162838|NCT01541735|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6162839|NCT01541735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6162840|NCT01541735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162841|NCT01541891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6162842|NCT01541891|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6162843|NCT01541930|Metronidazole|metronidazole|mesh-list
5561238|NCT04008186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5561239|NCT04008186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5561240|NCT04008186|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5561241|NCT04008186|Protective Agents|protective agents|mesh-ancestor
5561242|NCT04008186|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5561243|NCT04008186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5561244|NCT04008186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6668629|NCT01533376|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6668630|NCT01533376|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6668631|NCT01533376|Adrenergic Agents|adrenergic agents|mesh-ancestor
5561245|NCT04008186|Vasodilator Agents|vasodilator agents|mesh-ancestor
5561246|NCT04008186|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
5561247|NCT04008433|Lidocaine|lidocaine|mesh-list
5561248|NCT04008433|Anesthetics, Local|anesthetics, local|mesh-ancestor
5561249|NCT04008433|Anesthetics|anesthetics|mesh-ancestor
6162844|NCT01541930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6162845|NCT01541930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6162846|NCT01541930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6162847|NCT01541930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6162848|NCT01542034|Deoxycholic Acid|deoxycholic acid|mesh-list
6162849|NCT01542034|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6162850|NCT01542034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6162851|NCT01542125|Lidocaine|lidocaine|mesh-list
6162852|NCT01542125|Anesthetics, Local|anesthetics, local|mesh-ancestor
6162853|NCT01542125|Anesthetics|anesthetics|mesh-ancestor
6162854|NCT01542125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6162855|NCT01542125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668632|NCT01533376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6668633|NCT01533376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603518|NCT02227199|Antibodies|antibodies|mesh-list
6162856|NCT01542125|Sensory System Agents|sensory system agents|mesh-ancestor
6668634|NCT01533376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668635|NCT01533376|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6668636|NCT01533376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5561250|NCT04008433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5561251|NCT04008433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561252|NCT04008433|Sensory System Agents|sensory system agents|mesh-ancestor
6162857|NCT01542125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6162858|NCT01542125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6162859|NCT01542125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6162860|NCT01542125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6162861|NCT01542125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6162862|NCT01542125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162863|NCT01542255|Cyclophosphamide|cyclophosphamide|mesh-list
6162864|NCT01542255|Dacarbazine|dacarbazine|mesh-list
5561253|NCT04008433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5561254|NCT04008433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5561255|NCT04008433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5561256|NCT04008433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5561257|NCT04008433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5561258|NCT04008433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5561259|NCT04008316|Colchicine|colchicine|mesh-list
5561260|NCT04008316|Gout Suppressants|gout suppressants|mesh-ancestor
5561261|NCT04008316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5561262|NCT04008316|Tubulin Modulators|tubulin modulators|mesh-ancestor
5561263|NCT04008316|Antimitotic Agents|antimitotic agents|mesh-ancestor
5561264|NCT04008316|Mitosis Modulators|mitosis modulators|mesh-ancestor
5561265|NCT04008316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5561266|NCT04008316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5561267|NCT04008043|Acetaminophen|acetaminophen|mesh-list
5561268|NCT04008043|Dexamethasone|dexamethasone|mesh-list
5561269|NCT04008043|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
5561270|NCT04008043|Hydrocodone|hydrocodone|mesh-list
5561271|NCT04008043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5561272|NCT04008043|Antiemetics|antiemetics|mesh-ancestor
5561273|NCT04008043|Autonomic Agents|autonomic agents|mesh-ancestor
5561274|NCT04008043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5561275|NCT04008043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561276|NCT04008043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5561277|NCT04008043|Glucocorticoids|glucocorticoids|mesh-ancestor
5561278|NCT04008043|Hormones|hormones|mesh-ancestor
5561279|NCT04008043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5561280|NCT04008043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5561281|NCT04008043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5561282|NCT04008043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5561283|NCT04008043|Analgesics|analgesics|mesh-ancestor
5561284|NCT04008043|Sensory System Agents|sensory system agents|mesh-ancestor
5561285|NCT04008043|Antipyretics|antipyretics|mesh-ancestor
5561286|NCT04008043|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5561287|NCT04008043|Narcotics|narcotics|mesh-ancestor
5561288|NCT04008043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5561289|NCT04008043|Antitussive Agents|antitussive agents|mesh-ancestor
5561290|NCT04008043|Respiratory System Agents|respiratory system agents|mesh-ancestor
5561291|NCT04008043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5561292|NCT04008043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5561293|NCT04007809|Glucagon|glucagon|mesh-list
5561294|NCT04007809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5561295|NCT04007809|Hormones|hormones|mesh-ancestor
5561296|NCT04007809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5561297|NCT04007809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561298|NCT04007744|Pembrolizumab|pembrolizumab|mesh-list
5561299|NCT04007744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5561300|NCT04007744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6162865|NCT01542255|Vinblastine|vinblastine|mesh-list
6162866|NCT01542255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6162867|NCT01542255|Immunologic Factors|immunologic factors|mesh-ancestor
6162868|NCT01542255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561301|NCT04007835|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5561302|NCT04007835|Gefitinib|gefitinib|mesh-list
5561303|NCT04007835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5561304|NCT04007835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5561305|NCT04007835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5561306|NCT04007835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5561307|NCT04008030|Leucovorin|leucovorin|mesh-list
5561308|NCT04008030|Bevacizumab|bevacizumab|mesh-list
5561309|NCT04008030|Nivolumab|nivolumab|mesh-list
5561310|NCT04008030|Cetuximab|cetuximab|mesh-list
5561311|NCT04008030|Ipilimumab|ipilimumab|mesh-list
5561312|NCT04008030|Fluorouracil|fluorouracil|mesh-list
6162869|NCT01542255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6162870|NCT01542255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6162871|NCT01542255|Alkylating Agents|alkylating agents|mesh-ancestor
6162872|NCT01542255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162873|NCT01542255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6162874|NCT01542255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6162875|NCT01542255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6162876|NCT01542255|Tubulin Modulators|tubulin modulators|mesh-ancestor
6162877|NCT01542255|Antimitotic Agents|antimitotic agents|mesh-ancestor
6162878|NCT01542255|Mitosis Modulators|mitosis modulators|mesh-ancestor
6206108|NCT02096744|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6206109|NCT02096744|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6206110|NCT02096744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6206111|NCT02096744|Adrenergic Agents|adrenergic agents|mesh-ancestor
6206112|NCT02096744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5561313|NCT04008030|Oxaliplatin|oxaliplatin|mesh-list
5561314|NCT04008030|Irinotecan|irinotecan|mesh-list
5561315|NCT04008030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5561316|NCT04008030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5561317|NCT04008030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6206113|NCT02096744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206114|NCT02096835|Dexamethasone|dexamethasone|mesh-list
6206115|NCT02096835|Tropisetron|tropisetron|mesh-list
6206116|NCT02096835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6206117|NCT02096835|Antiemetics|antiemetics|mesh-ancestor
6206118|NCT02096835|Autonomic Agents|autonomic agents|mesh-ancestor
6206119|NCT02096835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5561318|NCT04008030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5561319|NCT04008030|Growth Substances|growth substances|mesh-ancestor
6206120|NCT02096835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206121|NCT02096835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6206122|NCT02096835|Glucocorticoids|glucocorticoids|mesh-ancestor
6206123|NCT02096835|Hormones|hormones|mesh-ancestor
6206124|NCT02096835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6206125|NCT02096835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6206126|NCT02096835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6206127|NCT02096835|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6206128|NCT02096835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6206129|NCT02096835|Serotonin Agents|serotonin agents|mesh-ancestor
6206130|NCT02096835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6481888|NCT00549471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6481889|NCT00549471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481890|NCT00549471|Cholinergic Agents|cholinergic agents|mesh-ancestor
6481891|NCT00549471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6481892|NCT00549471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481893|NCT00549471|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6481894|NCT00549471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6481895|NCT00549536|Calcium, Dietary|calcium, dietary|mesh-list
6481896|NCT00549536|Calcium|calcium|mesh-list
6481897|NCT00549536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6481898|NCT00549536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481899|NCT00549536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6481900|NCT00549588|Sunscreening Agents|sunscreening agents|mesh-list
6481901|NCT00549588|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6481902|NCT00549588|Protective Agents|protective agents|mesh-ancestor
6481903|NCT00549588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481904|NCT00549588|Dermatologic Agents|dermatologic agents|mesh-ancestor
6481905|NCT00549614|Acipimox|acipimox|mesh-list
6481906|NCT00549614|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6481907|NCT00549614|Antimetabolites|antimetabolites|mesh-ancestor
6481908|NCT00549614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481909|NCT00549614|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6481910|NCT00549666|Moxifloxacin|moxifloxacin|mesh-list
6481911|NCT00549666|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
6481912|NCT00549666|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
5561320|NCT04008030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561321|NCT04008030|Growth Inhibitors|growth inhibitors|mesh-ancestor
5561322|NCT04008030|Antimetabolites|antimetabolites|mesh-ancestor
5561323|NCT04008030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5561324|NCT04008030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5561325|NCT04008030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5561326|NCT04008030|Immunologic Factors|immunologic factors|mesh-ancestor
5561327|NCT04008030|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6481913|NCT00549666|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6481914|NCT00549666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6481915|NCT00549666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6481916|NCT00549666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481917|NCT00549666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6481918|NCT00549666|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6481919|NCT00549666|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6481920|NCT00549666|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6481921|NCT00549666|Adrenergic Agents|adrenergic agents|mesh-ancestor
6162879|NCT01542372|Prazosin|prazosin|mesh-list
6162880|NCT01542372|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6162881|NCT01542372|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6481922|NCT00549666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6481923|NCT00549666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481924|NCT00549666|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6668637|NCT01533376|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6668638|NCT01533376|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6668639|NCT01533389|Silodosin|silodosin|mesh-list
6668640|NCT01533389|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6668641|NCT01533389|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6668642|NCT01533389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6668643|NCT01533389|Adrenergic Agents|adrenergic agents|mesh-ancestor
6668644|NCT01533389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6668645|NCT01533389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668646|NCT01533389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561328|NCT04008030|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6162882|NCT01542372|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6162883|NCT01542372|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6162884|NCT01542372|Adrenergic Agents|adrenergic agents|mesh-ancestor
5561329|NCT04008030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5561330|NCT04008030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5561331|NCT04008030|Antidotes|antidotes|mesh-ancestor
5561332|NCT04008030|Protective Agents|protective agents|mesh-ancestor
5561333|NCT04008030|Vitamin B Complex|vitamin b complex|mesh-ancestor
5561334|NCT04008030|Vitamins|vitamins|mesh-ancestor
5561335|NCT04008030|Micronutrients|micronutrients|mesh-ancestor
5561336|NCT04008017|Eosinophil Cationic Protein|eosinophil cationic protein|mesh-list
5561337|NCT04008017|Immunologic Factors|immunologic factors|mesh-ancestor
6162885|NCT01542372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6162886|NCT01542372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162887|NCT01542372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162888|NCT01542502|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6162889|NCT01542502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6162890|NCT01542541|Rifaximin|rifaximin|mesh-list
6162891|NCT01542541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5561338|NCT04008017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561339|NCT04007874|Vitamin E|vitamin e|mesh-list
5561340|NCT04007874|Levonorgestrel|levonorgestrel|mesh-list
5561341|NCT04007874|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5561342|NCT04007874|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
5561343|NCT04007874|Vitamins|vitamins|mesh-ancestor
5561344|NCT04007874|Micronutrients|micronutrients|mesh-ancestor
5561345|NCT04007874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561346|NCT04007874|Antioxidants|antioxidants|mesh-ancestor
5561347|NCT04007874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5561348|NCT04007874|Protective Agents|protective agents|mesh-ancestor
5561349|NCT04007874|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6162892|NCT01542541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6162893|NCT01542541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6162894|NCT01542645|Fentanyl|fentanyl|mesh-list
6162895|NCT01542645|Analgesics, Opioid|analgesics, opioid|mesh-list
6162896|NCT01542645|Methadone|methadone|mesh-list
6162897|NCT01542645|Narcotics|narcotics|mesh-ancestor
6162898|NCT01542645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6162899|NCT01542645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162900|NCT01542645|Analgesics|analgesics|mesh-ancestor
6162901|NCT01542645|Sensory System Agents|sensory system agents|mesh-ancestor
5561350|NCT04007874|Contraceptive Agents|contraceptive agents|mesh-ancestor
5561351|NCT04007874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5561352|NCT04007874|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5561353|NCT04007874|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5561354|NCT04007874|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5561355|NCT04007874|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6162902|NCT01542645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6162903|NCT01542645|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6481925|NCT00549666|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6481926|NCT00549666|Serotonin Agents|serotonin agents|mesh-ancestor
6481927|NCT00549666|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6668647|NCT01533389|Urological Agents|urological agents|mesh-ancestor
6668648|NCT01533441|Vitamin K|vitamin k|mesh-list
6162904|NCT01542645|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6162905|NCT01542645|Anesthetics, General|anesthetics, general|mesh-ancestor
6162906|NCT01542645|Anesthetics|anesthetics|mesh-ancestor
5561356|NCT04007874|Estrogens|estrogens|mesh-ancestor
5561357|NCT04007874|Hormones|hormones|mesh-ancestor
5603519|NCT02227199|Immunoglobulins|immunoglobulins|mesh-list
6162907|NCT01542645|Antitussive Agents|antitussive agents|mesh-ancestor
6162908|NCT01542645|Respiratory System Agents|respiratory system agents|mesh-ancestor
6162909|NCT01542684|Azacitidine|azacitidine|mesh-list
6162910|NCT01542684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6162911|NCT01542684|Antimetabolites|antimetabolites|mesh-ancestor
6162912|NCT01542684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162913|NCT01542684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6162914|NCT01542684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6162915|NCT01542788|Sofosbuvir|sofosbuvir|mesh-list
6162916|NCT01542788|Antiviral Agents|antiviral agents|mesh-ancestor
6162917|NCT01542788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6162918|NCT01543074|Allyl sulfide|allyl sulfide|mesh-list
6162919|NCT01543074|Antioxidants|antioxidants|mesh-ancestor
6162920|NCT01543074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162921|NCT01543074|Protective Agents|protective agents|mesh-ancestor
6162922|NCT01543074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162923|NCT01543074|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6162924|NCT01543074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6162925|NCT01543074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6162926|NCT01543074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6162927|NCT01543152|Cyclophosphamide|cyclophosphamide|mesh-list
6162928|NCT01543152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6162929|NCT01543152|Immunologic Factors|immunologic factors|mesh-ancestor
6162930|NCT01543152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162931|NCT01543152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6162932|NCT01543152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6162933|NCT01543152|Alkylating Agents|alkylating agents|mesh-ancestor
6162934|NCT01543152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162935|NCT01543152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6162936|NCT01543152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6162937|NCT01543178|Rifaximin|rifaximin|mesh-list
6481928|NCT00549666|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6481929|NCT00549666|Dopamine Agents|dopamine agents|mesh-ancestor
6481930|NCT00549666|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6162938|NCT01543178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6162939|NCT01543178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6162940|NCT01543178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6162941|NCT01543204|Etanercept|etanercept|mesh-list
6162942|NCT01543204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6162943|NCT01543204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6162944|NCT01543204|Analgesics|analgesics|mesh-ancestor
6162945|NCT01543204|Sensory System Agents|sensory system agents|mesh-ancestor
6162946|NCT01543204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6162947|NCT01543204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668649|NCT01533441|Vitamin K 2|vitamin k 2|mesh-list
6668650|NCT01533441|Vitamins|vitamins|mesh-ancestor
6668651|NCT01533441|Micronutrients|micronutrients|mesh-ancestor
6668652|NCT01533441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668653|NCT01533441|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6481931|NCT00549666|Contraceptive Agents|contraceptive agents|mesh-ancestor
6481932|NCT00549666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6481933|NCT00549666|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5561358|NCT04007874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5561359|NCT04007874|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5561360|NCT04007562|Hydroxychloroquine|hydroxychloroquine|mesh-list
5561361|NCT04007562|Antimalarials|antimalarials|mesh-ancestor
5561362|NCT04007562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5561363|NCT04007562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5561364|NCT04007562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5561365|NCT04007562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5561366|NCT04007562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5561367|NCT04007562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5561368|NCT04007588|Nivolumab|nivolumab|mesh-list
5561369|NCT04007588|Ipilimumab|ipilimumab|mesh-list
5561370|NCT04007588|Linrodostat|linrodostat|mesh-list
5561371|NCT04007588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5561372|NCT04007588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5561373|NCT04007588|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5561374|NCT04007588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5561375|NCT04007588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5561376|NCT04007276|Brimonidine Tartrate|brimonidine tartrate|mesh-list
5561377|NCT04007276|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5561378|NCT04007276|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5561379|NCT04007276|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5561380|NCT04007276|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6162948|NCT01543204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6162949|NCT01543204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6481934|NCT00549666|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6481935|NCT00549666|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6481936|NCT00549666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6481937|NCT00549666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6481938|NCT00549666|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6481939|NCT00549666|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6481940|NCT00549666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6481941|NCT00549666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6481942|NCT00549874|Rosiglitazone|rosiglitazone|mesh-list
6481943|NCT00549874|Glyburide|glyburide|mesh-list
6481944|NCT00549874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6481945|NCT00549874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561381|NCT04007276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5561382|NCT04007276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5561383|NCT04007276|Adrenergic Agents|adrenergic agents|mesh-ancestor
5561384|NCT04007276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5561385|NCT04007276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5561386|NCT04007276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561387|NCT04007328|Methylprednisolone|methylprednisolone|mesh-list
5561388|NCT04007328|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5561389|NCT04007328|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5561390|NCT04007328|Prednisolone|prednisolone|mesh-list
5561391|NCT04007328|Prednisolone acetate|prednisolone acetate|mesh-list
5561392|NCT04007328|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5561393|NCT04007328|Prednisolone phosphate|prednisolone phosphate|mesh-list
5561394|NCT04007328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5561395|NCT04007328|Antiemetics|antiemetics|mesh-ancestor
5561396|NCT04007328|Autonomic Agents|autonomic agents|mesh-ancestor
5561397|NCT04007328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5561398|NCT04007328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561399|NCT04007328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5561400|NCT04007328|Glucocorticoids|glucocorticoids|mesh-ancestor
5561401|NCT04007328|Hormones|hormones|mesh-ancestor
5561402|NCT04007328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5561403|NCT04007328|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5561404|NCT04007328|Protective Agents|protective agents|mesh-ancestor
5561405|NCT04007328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5561406|NCT04007328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5561407|NCT04007341|Dexmedetomidine|dexmedetomidine|mesh-list
5561408|NCT04007341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5561409|NCT04007341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5561410|NCT04007341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561411|NCT04007341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5561412|NCT04007341|Analgesics|analgesics|mesh-ancestor
5561413|NCT04007341|Sensory System Agents|sensory system agents|mesh-ancestor
5561414|NCT04007341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5561415|NCT04007341|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5561416|NCT04007341|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6162950|NCT01543204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6481946|NCT00549887|Insulin|insulin|mesh-list
6481947|NCT00549887|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6481948|NCT00549887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6481949|NCT00549887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481950|NCT00549926|Atorvastatin|atorvastatin|mesh-list
6481951|NCT00549926|Pravastatin|pravastatin|mesh-list
6481952|NCT00549926|Pitavastatin|pitavastatin|mesh-list
6481953|NCT00549926|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6481954|NCT00549926|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6481955|NCT00549926|Antimetabolites|antimetabolites|mesh-ancestor
6481956|NCT00549926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481957|NCT00549926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6481958|NCT00549926|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6481959|NCT00549926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6481960|NCT00549965|Risedronic Acid|risedronic acid|mesh-list
6481961|NCT00549965|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6481962|NCT00549965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6481963|NCT00549965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481964|NCT00549965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6481965|NCT00549965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162951|NCT01543204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6162952|NCT01543204|Immunologic Factors|immunologic factors|mesh-ancestor
6162953|NCT01543568|Aflibercept|aflibercept|mesh-list
6162954|NCT01543568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6162955|NCT01543568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6162956|NCT01543568|Growth Substances|growth substances|mesh-ancestor
6162957|NCT01543568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162958|NCT01543568|Growth Inhibitors|growth inhibitors|mesh-ancestor
6162959|NCT01543568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6162960|NCT01543685|Celecoxib|celecoxib|mesh-list
6162961|NCT01543685|Indomethacin|indomethacin|mesh-list
6162962|NCT01543685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6481966|NCT00549965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5561417|NCT04007341|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5561418|NCT04007341|Adrenergic Agents|adrenergic agents|mesh-ancestor
5561419|NCT04007341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5561420|NCT04007341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5561421|NCT04007393|Topiramate|topiramate|mesh-list
5561422|NCT04007393|Phentermine|phentermine|mesh-list
5561423|NCT04007393|Anticonvulsants|anticonvulsants|mesh-ancestor
5561424|NCT04007393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5561425|NCT04007393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561426|NCT04007393|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5561427|NCT04007393|Appetite Depressants|appetite depressants|mesh-ancestor
5561428|NCT04007393|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5561429|NCT04007393|Sympathomimetics|sympathomimetics|mesh-ancestor
5561430|NCT04007393|Autonomic Agents|autonomic agents|mesh-ancestor
5561431|NCT04007393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5561432|NCT04007393|Adrenergic Agents|adrenergic agents|mesh-ancestor
5561433|NCT04007393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5561434|NCT04007393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5561435|NCT04007289|Apixaban|apixaban|mesh-list
5561436|NCT04007289|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6481967|NCT00549978|Cilostazol|cilostazol|mesh-list
6481968|NCT00549978|Probucol|probucol|mesh-list
6481969|NCT00549978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6481970|NCT00549978|Autonomic Agents|autonomic agents|mesh-ancestor
5561437|NCT04007289|Antithrombins|antithrombins|mesh-ancestor
6162963|NCT01543685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6162964|NCT01543685|Analgesics|analgesics|mesh-ancestor
6162965|NCT01543685|Sensory System Agents|sensory system agents|mesh-ancestor
6162966|NCT01543685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6162967|NCT01543685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162968|NCT01543685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6162969|NCT01543685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5561438|NCT04007289|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5561439|NCT04007289|Protease Inhibitors|protease inhibitors|mesh-ancestor
6162970|NCT01543685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6162971|NCT01543685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6162972|NCT01543685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6162973|NCT01543685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162974|NCT01543685|Gout Suppressants|gout suppressants|mesh-ancestor
6162975|NCT01543685|Tocolytic Agents|tocolytic agents|mesh-ancestor
6162976|NCT01543685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6481971|NCT00549978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5561440|NCT04007289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6162977|NCT01543776|Abiraterone Acetate|abiraterone acetate|mesh-list
6162978|NCT01543776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6162979|NCT01543776|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6162980|NCT01543776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6162981|NCT01543776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162982|NCT01543776|Hormone Antagonists|hormone antagonists|mesh-ancestor
6162983|NCT01543776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6162984|NCT01543776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162985|NCT01543776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6162986|NCT01543958|Sevelamer|sevelamer|mesh-list
6162987|NCT01543958|Chelating Agents|chelating agents|mesh-ancestor
6162988|NCT01543958|Sequestering Agents|sequestering agents|mesh-ancestor
6162989|NCT01543958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6162990|NCT01544062|Acetaminophen|acetaminophen|mesh-list
6162991|NCT01544062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5561441|NCT04007289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5561442|NCT04007289|Anticoagulants|anticoagulants|mesh-ancestor
5561443|NCT04007003|Insulin|insulin|mesh-list
5561444|NCT04007003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5561445|NCT04007003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561446|NCT04007055|Ticagrelor|ticagrelor|mesh-list
5561447|NCT04007055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5561448|NCT04007055|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5561449|NCT04007055|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5561450|NCT04007055|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5561451|NCT04007055|Purinergic Agents|purinergic agents|mesh-ancestor
5561452|NCT04007055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5561453|NCT04007055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5561454|NCT04007055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561455|NCT04006873|Ivacaftor|ivacaftor|mesh-list
5561456|NCT04006873|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
5561457|NCT04006873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5561458|NCT04006873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5561459|NCT04007029|Vidarabine|vidarabine|mesh-list
5561460|NCT04007029|Cyclophosphamide|cyclophosphamide|mesh-list
5561461|NCT04007029|Fludarabine|fludarabine|mesh-list
5561462|NCT04007029|Fludarabine phosphate|fludarabine phosphate|mesh-list
5561463|NCT04007029|Immunoglobulins|immunoglobulins|mesh-list
5561464|NCT04007029|Immunoglobulin G|immunoglobulin g|mesh-list
5561465|NCT04007029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5561466|NCT04007029|Immunologic Factors|immunologic factors|mesh-ancestor
5561467|NCT04007029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162992|NCT01544062|Analgesics|analgesics|mesh-ancestor
6162993|NCT01544062|Sensory System Agents|sensory system agents|mesh-ancestor
6162994|NCT01544062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6162995|NCT01544062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6162996|NCT01544062|Antipyretics|antipyretics|mesh-ancestor
6162997|NCT01544114|Naproxen|naproxen|mesh-list
6162998|NCT01544114|Esomeprazole|esomeprazole|mesh-list
6162999|NCT01544114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6163000|NCT01544114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6163001|NCT01544114|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6163002|NCT01544114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6207883|NCT02121262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6668654|NCT01533441|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6668655|NCT01533441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668656|NCT01533441|Hemostatics|hemostatics|mesh-ancestor
6668657|NCT01533441|Coagulants|coagulants|mesh-ancestor
6668658|NCT01533506|Stiripentol|stiripentol|mesh-list
6668659|NCT01533506|Anticonvulsants|anticonvulsants|mesh-ancestor
6668660|NCT01533545|Epinephrine|epinephrine|mesh-list
6668661|NCT01533545|Mepivacaine|mepivacaine|mesh-list
6668662|NCT01533545|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6668663|NCT01533545|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6668664|NCT01533545|Adrenergic Agents|adrenergic agents|mesh-ancestor
6668665|NCT01533545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6481972|NCT00549978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6481973|NCT00549978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6481974|NCT00549978|Respiratory System Agents|respiratory system agents|mesh-ancestor
6481975|NCT00549978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5561468|NCT04007029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6481976|NCT00549978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6481977|NCT00549978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481978|NCT00549978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6481979|NCT00549978|Vasodilator Agents|vasodilator agents|mesh-ancestor
5561469|NCT04007029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5561470|NCT04007029|Alkylating Agents|alkylating agents|mesh-ancestor
5561471|NCT04007029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5561472|NCT04007029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5561473|NCT04007029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5561474|NCT04007029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5561475|NCT04007029|Antimetabolites|antimetabolites|mesh-ancestor
5561476|NCT04007029|Antiviral Agents|antiviral agents|mesh-ancestor
5561477|NCT04007029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5603520|NCT02227199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5603521|NCT02227199|Immunoconjugates|immunoconjugates|mesh-list
5603522|NCT02227199|Immunologic Factors|immunologic factors|mesh-ancestor
5603523|NCT02227199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603524|NCT02227199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5603525|NCT02227199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5603526|NCT02227199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5603527|NCT02227199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5603528|NCT02227199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5603529|NCT02227199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603530|NCT02227199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5603531|NCT02227199|Alkylating Agents|alkylating agents|mesh-ancestor
5603532|NCT02227199|Keratolytic Agents|keratolytic agents|mesh-ancestor
6481980|NCT00549978|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6481981|NCT00549978|Protective Agents|protective agents|mesh-ancestor
6481982|NCT00549978|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6481983|NCT00549978|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6481984|NCT00549978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6481985|NCT00549978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6481986|NCT00549978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6481987|NCT00549978|Antimetabolites|antimetabolites|mesh-ancestor
6481988|NCT00549978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6481989|NCT00549978|Antioxidants|antioxidants|mesh-ancestor
6481990|NCT00550004|Gemcitabine|gemcitabine|mesh-list
6481991|NCT00550004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6481992|NCT00550004|Antimetabolites|antimetabolites|mesh-ancestor
6481993|NCT00550004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6481994|NCT00550004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6481995|NCT00550004|Antiviral Agents|antiviral agents|mesh-ancestor
6481996|NCT00550004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6481997|NCT00550004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6481998|NCT00550004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6481999|NCT00550004|Immunologic Factors|immunologic factors|mesh-ancestor
6482000|NCT00550004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482001|NCT00550095|Valsartan|valsartan|mesh-list
6482002|NCT00550095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6482003|NCT00550095|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6163003|NCT01544114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163004|NCT01544114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6163005|NCT01544114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6163006|NCT01544114|Analgesics|analgesics|mesh-ancestor
6668666|NCT01533545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668667|NCT01533545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668668|NCT01533545|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6668669|NCT01533545|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6668670|NCT01533545|Autonomic Agents|autonomic agents|mesh-ancestor
6668671|NCT01533545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6668672|NCT01533545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6668673|NCT01533545|Respiratory System Agents|respiratory system agents|mesh-ancestor
6668674|NCT01533545|Mydriatics|mydriatics|mesh-ancestor
6668675|NCT01533545|Sympathomimetics|sympathomimetics|mesh-ancestor
6163007|NCT01544114|Sensory System Agents|sensory system agents|mesh-ancestor
6163008|NCT01544114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6163009|NCT01544114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482004|NCT00550095|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6482005|NCT00550095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6482006|NCT00550108|Ethanol|ethanol|mesh-list
5603533|NCT02227199|Dermatologic Agents|dermatologic agents|mesh-ancestor
5603534|NCT02227199|Tubulin Modulators|tubulin modulators|mesh-ancestor
5603535|NCT02227199|Antimitotic Agents|antimitotic agents|mesh-ancestor
5603536|NCT02227199|Mitosis Modulators|mitosis modulators|mesh-ancestor
5603537|NCT02177695|Gemcitabine|gemcitabine|mesh-list
6482007|NCT00550108|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6482008|NCT00550108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6482009|NCT00550108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6163010|NCT01544114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6163011|NCT01544114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5561478|NCT04006847|Dasatinib|dasatinib|mesh-list
5561479|NCT04006847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5561480|NCT04006847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5561481|NCT04006847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5561482|NCT04006847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5561483|NCT04006821|Apatinib|apatinib|mesh-list
5561484|NCT04006821|Antibodies|antibodies|mesh-list
5561485|NCT04006821|Immunologic Factors|immunologic factors|mesh-ancestor
5561486|NCT04006821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561487|NCT04006821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5561488|NCT04006821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5561489|NCT04006821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5561490|NCT04006821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5561491|NCT04006470|Fluorides|fluorides|mesh-list
5561492|NCT04006470|Tin Fluorides|tin fluorides|mesh-list
5561493|NCT04006470|Cariostatic Agents|cariostatic agents|mesh-ancestor
5561494|NCT04006470|Protective Agents|protective agents|mesh-ancestor
5561495|NCT04006470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561496|NCT04006639|Analgesics|analgesics|mesh-list
5561497|NCT04006639|Sensory System Agents|sensory system agents|mesh-ancestor
5561498|NCT04006639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5561499|NCT04006639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561500|NCT04006483|Fluorides|fluorides|mesh-list
5561501|NCT04006483|Tin Fluorides|tin fluorides|mesh-list
5561502|NCT04006483|Cariostatic Agents|cariostatic agents|mesh-ancestor
5561503|NCT04006483|Protective Agents|protective agents|mesh-ancestor
5561504|NCT04006483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561505|NCT04006262|Nivolumab|nivolumab|mesh-list
5561506|NCT04006262|Ipilimumab|ipilimumab|mesh-list
5561507|NCT04006262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5561508|NCT04006262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5561509|NCT04006262|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5561510|NCT04006262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163012|NCT01544114|Gout Suppressants|gout suppressants|mesh-ancestor
6163013|NCT01544114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6163014|NCT01544153|Nicotine|nicotine|mesh-list
5561511|NCT04006691|Mitomycins|mitomycins|mesh-list
5561512|NCT04006691|Mitomycin|mitomycin|mesh-list
5561513|NCT04006691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5561514|NCT04006691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5561515|NCT04006691|Alkylating Agents|alkylating agents|mesh-ancestor
5561516|NCT04006691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5561517|NCT04006691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5561518|NCT04006691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5561519|NCT04006080|Vedolizumab|vedolizumab|mesh-list
6163015|NCT01544153|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6163016|NCT01544153|Autonomic Agents|autonomic agents|mesh-ancestor
6163017|NCT01544153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6163018|NCT01544153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163019|NCT01544153|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6163020|NCT01544153|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6163021|NCT01544153|Cholinergic Agents|cholinergic agents|mesh-ancestor
6163022|NCT01544153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6163023|NCT01544153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163024|NCT01544179|Pemetrexed|pemetrexed|mesh-list
5561520|NCT04006080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5561521|NCT04006093|Apixaban|apixaban|mesh-list
6163025|NCT01544179|Gefitinib|gefitinib|mesh-list
6163026|NCT01544179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6163027|NCT01544179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6163028|NCT01544179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163029|NCT01544179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6163030|NCT01544179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6163031|NCT01544179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6163032|NCT01544309|Atorvastatin|atorvastatin|mesh-list
6163033|NCT01544309|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6163034|NCT01544309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6482010|NCT00550108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482011|NCT00550121|Ascorbic Acid|ascorbic acid|mesh-list
5561522|NCT04006093|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5561523|NCT04006093|Antithrombins|antithrombins|mesh-ancestor
5561524|NCT04006093|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5561525|NCT04006093|Protease Inhibitors|protease inhibitors|mesh-ancestor
6163035|NCT01544309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5561526|NCT04006093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5561527|NCT04006093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5561528|NCT04006093|Anticoagulants|anticoagulants|mesh-ancestor
5561529|NCT04006041|Paclitaxel|paclitaxel|mesh-list
5561530|NCT04006041|Cisplatin|cisplatin|mesh-list
5561531|NCT04006041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5561532|NCT04006041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5561533|NCT04006041|Tubulin Modulators|tubulin modulators|mesh-ancestor
5561534|NCT04006041|Antimitotic Agents|antimitotic agents|mesh-ancestor
5561535|NCT04006041|Mitosis Modulators|mitosis modulators|mesh-ancestor
6163036|NCT01544309|Antimetabolites|antimetabolites|mesh-ancestor
6163037|NCT01544309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163038|NCT01544309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6163039|NCT01544309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6163040|NCT01544309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6163041|NCT01544348|Omalizumab|omalizumab|mesh-list
6163042|NCT01544348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5561536|NCT04006041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5561537|NCT04006353|Rifampin|rifampin|mesh-list
5561538|NCT04006353|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5561539|NCT04006353|Antitubercular Agents|antitubercular agents|mesh-ancestor
5561540|NCT04006353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5561541|NCT04006353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5561542|NCT04006353|Leprostatic Agents|leprostatic agents|mesh-ancestor
5561543|NCT04006353|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5561544|NCT04006353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5561545|NCT04006353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5561546|NCT04006353|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5561547|NCT04006353|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5561548|NCT04006353|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6163043|NCT01544348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6163044|NCT01544348|Respiratory System Agents|respiratory system agents|mesh-ancestor
6668676|NCT01533545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6668677|NCT01533545|Anesthetics, Local|anesthetics, local|mesh-ancestor
6668678|NCT01533545|Anesthetics|anesthetics|mesh-ancestor
6668679|NCT01533545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6668680|NCT01533545|Sensory System Agents|sensory system agents|mesh-ancestor
6668681|NCT01533558|Caspofungin|caspofungin|mesh-list
6668682|NCT01533558|Antifungal Agents|antifungal agents|mesh-ancestor
6668683|NCT01533558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6668684|NCT01533558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6668685|NCT01533558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668686|NCT01533662|Phenylephrine|phenylephrine|mesh-list
6482012|NCT00550121|Vitamins|vitamins|mesh-ancestor
6482013|NCT00550121|Micronutrients|micronutrients|mesh-ancestor
6482014|NCT00550121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482015|NCT00550121|Antioxidants|antioxidants|mesh-ancestor
6482016|NCT00550121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163045|NCT01544491|Everolimus|everolimus|mesh-list
6163046|NCT01544491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6163047|NCT01544491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6163048|NCT01544491|Immunologic Factors|immunologic factors|mesh-ancestor
6163049|NCT01544491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163050|NCT01544920|Interferons|interferons|mesh-list
6163051|NCT01544920|Ribavirin|ribavirin|mesh-list
6482017|NCT00550121|Protective Agents|protective agents|mesh-ancestor
6482018|NCT00550160|Artesunate|artesunate|mesh-list
6482019|NCT00550160|Amodiaquine|amodiaquine|mesh-list
6482020|NCT00550160|Antimalarials|antimalarials|mesh-ancestor
6482021|NCT00550160|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6482022|NCT00550160|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6482023|NCT00550160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6482024|NCT00550160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6482025|NCT00550160|Antiviral Agents|antiviral agents|mesh-ancestor
6482026|NCT00550160|Schistosomicides|schistosomicides|mesh-ancestor
6482027|NCT00550160|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5561549|NCT04006353|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5561550|NCT04006353|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5561551|NCT04006353|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5561552|NCT04006054|Midazolam|midazolam|mesh-list
5561553|NCT04006054|Dexmedetomidine|dexmedetomidine|mesh-list
5561554|NCT04006054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6163052|NCT01544920|Interferon-alpha|interferon-alpha|mesh-list
6482028|NCT00550160|Anthelmintics|anthelmintics|mesh-ancestor
6482029|NCT00550199|Gemcitabine|gemcitabine|mesh-list
6482030|NCT00550199|Panobinostat|panobinostat|mesh-list
6668687|NCT01533662|Oxymetazoline|oxymetazoline|mesh-list
6668688|NCT01533662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6668689|NCT01533662|Mydriatics|mydriatics|mesh-ancestor
6668690|NCT01533662|Autonomic Agents|autonomic agents|mesh-ancestor
6668691|NCT01533662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5561555|NCT04006054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5561556|NCT04006054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561557|NCT04006054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6668692|NCT01533662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668693|NCT01533662|Sympathomimetics|sympathomimetics|mesh-ancestor
5561558|NCT04006054|Analgesics|analgesics|mesh-ancestor
6163053|NCT01544920|Interferon alpha-2|interferon alpha-2|mesh-list
6163054|NCT01544920|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6163055|NCT01544920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6163056|NCT01544920|Antiviral Agents|antiviral agents|mesh-ancestor
6163057|NCT01544920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6163058|NCT01544920|Antimetabolites|antimetabolites|mesh-ancestor
6163059|NCT01544920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163060|NCT01544920|Immunologic Factors|immunologic factors|mesh-ancestor
6163061|NCT01544920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163062|NCT01544998|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6163063|NCT01544998|Tadalafil|tadalafil|mesh-list
5561559|NCT04006054|Sensory System Agents|sensory system agents|mesh-ancestor
5561560|NCT04006054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5561561|NCT04006054|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5561562|NCT04006054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5561563|NCT04006054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5561564|NCT04006054|Adrenergic Agents|adrenergic agents|mesh-ancestor
5561565|NCT04006054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5561566|NCT04006054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5561567|NCT04006054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5561568|NCT04006054|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5561569|NCT04006054|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6163064|NCT01544998|Vasodilator Agents|vasodilator agents|mesh-ancestor
6163065|NCT01544998|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6163066|NCT01544998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6163067|NCT01544998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6163068|NCT01544998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163069|NCT01544998|Urological Agents|urological agents|mesh-ancestor
6163070|NCT01544998|Natriuretic Agents|natriuretic agents|mesh-ancestor
6163071|NCT01544998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163072|NCT01545076|Immunoglobulin G|immunoglobulin g|mesh-list
6482031|NCT00550199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6482032|NCT00550199|Antimetabolites|antimetabolites|mesh-ancestor
6482033|NCT00550199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6482034|NCT00550199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6163073|NCT01545076|Immunologic Factors|immunologic factors|mesh-ancestor
6163074|NCT01545076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163075|NCT01545141|Interferons|interferons|mesh-list
6163076|NCT01545141|Interferon-alpha|interferon-alpha|mesh-list
6163077|NCT01545141|Interferon alpha-2|interferon alpha-2|mesh-list
6163078|NCT01545141|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
6163079|NCT01545141|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
6163080|NCT01545141|Poly I-C|poly i-c|mesh-list
6163081|NCT01545141|Celecoxib|celecoxib|mesh-list
6163082|NCT01545141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6163083|NCT01545141|Antiviral Agents|antiviral agents|mesh-ancestor
6163084|NCT01545141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6163085|NCT01545141|Immunologic Factors|immunologic factors|mesh-ancestor
6163086|NCT01545141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163087|NCT01545141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6482035|NCT00550199|Antiviral Agents|antiviral agents|mesh-ancestor
6482036|NCT00550199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6482037|NCT00550199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6482038|NCT00550199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6482039|NCT00550199|Immunologic Factors|immunologic factors|mesh-ancestor
6482040|NCT00550199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482041|NCT00550199|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6482042|NCT00550303|Bazedoxifene|bazedoxifene|mesh-list
6482043|NCT00550303|Estrogens|estrogens|mesh-list
6482044|NCT00550303|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6482045|NCT00550303|Hormones|hormones|mesh-ancestor
6482046|NCT00550303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6668694|NCT01533662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6163088|NCT01545141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6163089|NCT01545141|Analgesics|analgesics|mesh-ancestor
5561570|NCT04006054|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5561571|NCT04006054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6163090|NCT01545141|Sensory System Agents|sensory system agents|mesh-ancestor
6163091|NCT01545141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6163092|NCT01545141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6163093|NCT01545141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6163094|NCT01545141|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6163095|NCT01545141|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6163096|NCT01545141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6163097|NCT01545141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163098|NCT01545141|Interferon Inducers|interferon inducers|mesh-ancestor
6163099|NCT01545336|Anastrozole|anastrozole|mesh-list
6163100|NCT01545336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6163101|NCT01545336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6163102|NCT01545336|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6163103|NCT01545336|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5561572|NCT04006054|Anesthetics, General|anesthetics, general|mesh-ancestor
6163104|NCT01545336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6163105|NCT01545336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163106|NCT01545336|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6163107|NCT01545336|Hormone Antagonists|hormone antagonists|mesh-ancestor
6163108|NCT01545336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6163109|NCT01545336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163110|NCT01545375|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6163111|NCT01545375|Immunologic Factors|immunologic factors|mesh-ancestor
6163112|NCT01545375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163113|NCT01545388|Metformin|metformin|mesh-list
6163114|NCT01545388|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6163115|NCT01545388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6163116|NCT01545388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482047|NCT00550303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482048|NCT00550303|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6482049|NCT00550303|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6482050|NCT00550303|Hormone Antagonists|hormone antagonists|mesh-ancestor
6163117|NCT01545388|Incretins|incretins|mesh-ancestor
6163118|NCT01545388|Hormones|hormones|mesh-ancestor
6163119|NCT01545388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6163120|NCT01545388|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6163121|NCT01545388|Protease Inhibitors|protease inhibitors|mesh-ancestor
6163122|NCT01545388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6163123|NCT01545388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163124|NCT01545700|Dexamethasone|dexamethasone|mesh-list
6163125|NCT01545700|Dexamethasone acetate|dexamethasone acetate|mesh-list
6482051|NCT00550303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6163126|NCT01545700|BB 1101|bb 1101|mesh-list
6163127|NCT01545700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6163128|NCT01545700|Antiemetics|antiemetics|mesh-ancestor
6163129|NCT01545700|Autonomic Agents|autonomic agents|mesh-ancestor
6163130|NCT01545700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6163131|NCT01545700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163132|NCT01545700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6482052|NCT00550329|Glipizide|glipizide|mesh-list
6482053|NCT00550329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6482054|NCT00550329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482055|NCT00550342|Rituximab|rituximab|mesh-list
6482056|NCT00550342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6163133|NCT01545700|Glucocorticoids|glucocorticoids|mesh-ancestor
6163134|NCT01545700|Hormones|hormones|mesh-ancestor
6163135|NCT01545700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6163136|NCT01545700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6163137|NCT01545700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6163138|NCT01545700|Protease Inhibitors|protease inhibitors|mesh-ancestor
6163139|NCT01545700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6163140|NCT01545700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163141|NCT01545765|Lidocaine|lidocaine|mesh-list
6163142|NCT01545765|Tetracaine|tetracaine|mesh-list
6163143|NCT01545765|Anesthetics, Local|anesthetics, local|mesh-ancestor
6163144|NCT01545765|Anesthetics|anesthetics|mesh-ancestor
6163145|NCT01545765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6163146|NCT01545765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163147|NCT01545765|Sensory System Agents|sensory system agents|mesh-ancestor
6163148|NCT01545765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6163149|NCT01545765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6163150|NCT01545765|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5561573|NCT04006054|Anesthetics|anesthetics|mesh-ancestor
5561574|NCT04006054|GABA Modulators|gaba modulators|mesh-ancestor
5561575|NCT04006054|GABA Agents|gaba agents|mesh-ancestor
5561576|NCT04005872|Calcium|calcium|mesh-list
5561577|NCT04005872|Fluorides|fluorides|mesh-list
5561578|NCT04005872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5561579|NCT04005872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561580|NCT04005872|Cariostatic Agents|cariostatic agents|mesh-ancestor
5561581|NCT04005872|Protective Agents|protective agents|mesh-ancestor
5561582|NCT04005781|Hydroxychloroquine|hydroxychloroquine|mesh-list
5561583|NCT04005781|Antimalarials|antimalarials|mesh-ancestor
5561584|NCT04005781|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5561585|NCT04005781|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5561586|NCT04005781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5561587|NCT04005781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6163151|NCT01545765|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6163152|NCT01545765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6163153|NCT01545765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163154|NCT01545817|Everolimus|everolimus|mesh-list
6163155|NCT01545817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6163156|NCT01545817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6163157|NCT01545817|Immunologic Factors|immunologic factors|mesh-ancestor
6163158|NCT01545817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163159|NCT01545843|Fluoxetine|fluoxetine|mesh-list
6163160|NCT01545843|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6163161|NCT01545843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6163162|NCT01545843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6163163|NCT01545843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163164|NCT01545843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6163165|NCT01545843|Serotonin Agents|serotonin agents|mesh-ancestor
6163166|NCT01545843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163167|NCT01545843|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6163168|NCT01545843|Antidepressive Agents|antidepressive agents|mesh-ancestor
6163169|NCT01545843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6163170|NCT01545843|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6163171|NCT01545843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6163172|NCT01545843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6163173|NCT01546038|Cytarabine|cytarabine|mesh-list
6163174|NCT01546038|Decitabine|decitabine|mesh-list
6163175|NCT01546038|Daunorubicin|daunorubicin|mesh-list
6163176|NCT01546038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6163177|NCT01546038|Antimetabolites|antimetabolites|mesh-ancestor
6163178|NCT01546038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163179|NCT01546038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6163180|NCT01546038|Antiviral Agents|antiviral agents|mesh-ancestor
6163181|NCT01546038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6163182|NCT01546038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6163183|NCT01546038|Immunologic Factors|immunologic factors|mesh-ancestor
6163184|NCT01546038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163185|NCT01546038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6163186|NCT01546038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6482057|NCT00550342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6482058|NCT00550342|Immunologic Factors|immunologic factors|mesh-ancestor
6668695|NCT01533662|Nasal Decongestants|nasal decongestants|mesh-ancestor
6668696|NCT01533662|Respiratory System Agents|respiratory system agents|mesh-ancestor
5561588|NCT04005781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668697|NCT01533662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6482059|NCT00550342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482060|NCT00550342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6482061|NCT00550433|Bazedoxifene|bazedoxifene|mesh-list
6482062|NCT00550433|Estrogens|estrogens|mesh-list
6482063|NCT00550433|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6482064|NCT00550433|Hormones|hormones|mesh-ancestor
6482065|NCT00550433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6482066|NCT00550433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482067|NCT00550433|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6482068|NCT00550433|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6668698|NCT01533662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6668699|NCT01533662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6163187|NCT01546038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6163188|NCT01546038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6163189|NCT01546142|Deoxycholic Acid|deoxycholic acid|mesh-list
6163190|NCT01546142|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6163191|NCT01546142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6668700|NCT01533662|Adrenergic Agents|adrenergic agents|mesh-ancestor
6668701|NCT01533662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6668702|NCT01533662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668703|NCT01533662|Protective Agents|protective agents|mesh-ancestor
6668704|NCT01533675|Hydrogen Peroxide|hydrogen peroxide|mesh-list
6668705|NCT01533675|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6668706|NCT01533675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6668707|NCT01533740|Leucovorin|leucovorin|mesh-list
6668708|NCT01533740|Folic Acid|folic acid|mesh-list
6668709|NCT01533740|Bevacizumab|bevacizumab|mesh-list
6668710|NCT01533740|Fluorouracil|fluorouracil|mesh-list
6163192|NCT01546402|Dexamethasone|dexamethasone|mesh-list
6163193|NCT01546402|Dexamethasone acetate|dexamethasone acetate|mesh-list
6163194|NCT01546402|BB 1101|bb 1101|mesh-list
6163195|NCT01546402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6163196|NCT01546402|Antiemetics|antiemetics|mesh-ancestor
6163197|NCT01546402|Autonomic Agents|autonomic agents|mesh-ancestor
6163198|NCT01546402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6163199|NCT01546402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163200|NCT01546402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6163201|NCT01546402|Glucocorticoids|glucocorticoids|mesh-ancestor
6163202|NCT01546402|Hormones|hormones|mesh-ancestor
6163203|NCT01546402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6163204|NCT01546402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6163205|NCT01546402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5561589|NCT04005781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5561590|NCT04005768|Hydroxychloroquine|hydroxychloroquine|mesh-list
6163206|NCT01546402|Protease Inhibitors|protease inhibitors|mesh-ancestor
6163207|NCT01546402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6163208|NCT01546402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163209|NCT01546454|Leuprolide|leuprolide|mesh-list
6163210|NCT01546454|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6163211|NCT01546454|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6163212|NCT01546454|Levonorgestrel|levonorgestrel|mesh-list
6163213|NCT01546454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6163214|NCT01546454|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
6482069|NCT00550433|Hormone Antagonists|hormone antagonists|mesh-ancestor
6163215|NCT01546454|Estradiol|estradiol|mesh-list
6482070|NCT00550433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6482071|NCT00550485|Citalopram|citalopram|mesh-list
6482072|NCT00550485|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6482073|NCT00550485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6482074|NCT00550485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6482075|NCT00550485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6482076|NCT00550485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6482077|NCT00550485|Serotonin Agents|serotonin agents|mesh-ancestor
6482078|NCT00550485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482079|NCT00550485|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6482080|NCT00550485|Antidepressive Agents|antidepressive agents|mesh-ancestor
6482081|NCT00550485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6482082|NCT00550563|Cholecalciferol|cholecalciferol|mesh-list
6482083|NCT00550563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6482084|NCT00550563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482085|NCT00550563|Vitamins|vitamins|mesh-ancestor
6482086|NCT00550563|Micronutrients|micronutrients|mesh-ancestor
6482087|NCT00550563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6482088|NCT00550628|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6482089|NCT00550628|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6482090|NCT00550628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6482091|NCT00550693|Chlorhexidine|chlorhexidine|mesh-list
6482092|NCT00550693|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6482093|NCT00550693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6482094|NCT00550693|Disinfectants|disinfectants|mesh-ancestor
6482095|NCT00550784|Paclitaxel|paclitaxel|mesh-list
6482096|NCT00550784|Cyclophosphamide|cyclophosphamide|mesh-list
6482097|NCT00550784|Melphalan|melphalan|mesh-list
6482098|NCT00550784|Topotecan|topotecan|mesh-list
6482099|NCT00550784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6482100|NCT00550784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6482101|NCT00550784|Tubulin Modulators|tubulin modulators|mesh-ancestor
6482102|NCT00550784|Antimitotic Agents|antimitotic agents|mesh-ancestor
6482103|NCT00550784|Mitosis Modulators|mitosis modulators|mesh-ancestor
6482104|NCT00550784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6482105|NCT00550784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6482106|NCT00550784|Immunologic Factors|immunologic factors|mesh-ancestor
6163216|NCT01546454|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6163217|NCT01546454|Progesterone|progesterone|mesh-list
6163218|NCT01546454|Estrogens|estrogens|mesh-ancestor
6163219|NCT01546454|Hormones|hormones|mesh-ancestor
5561591|NCT04005768|Antimalarials|antimalarials|mesh-ancestor
5561592|NCT04005768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5561593|NCT04005768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5561594|NCT04005768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5561595|NCT04005768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5561596|NCT04005768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5561597|NCT04005768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5561598|NCT04005612|Vitamin D|vitamin d|mesh-list
5561599|NCT04005612|Ergocalciferols|ergocalciferols|mesh-list
5561600|NCT04005612|Cholecalciferol|cholecalciferol|mesh-list
5561601|NCT04005612|Vitamins|vitamins|mesh-list
5561602|NCT04005612|Micronutrients|micronutrients|mesh-ancestor
5561603|NCT04005612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561604|NCT04005612|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5561605|NCT04005612|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5561606|NCT04005716|Cisplatin|cisplatin|mesh-list
5561607|NCT04005716|Carboplatin|carboplatin|mesh-list
5561608|NCT04005716|Etoposide|etoposide|mesh-list
5561609|NCT04005716|Etoposide phosphate|etoposide phosphate|mesh-list
5561610|NCT04005716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5561611|NCT04005716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5561612|NCT04005716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6163220|NCT01546454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6163221|NCT01546454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163222|NCT01546454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6163223|NCT01546454|Contraceptive Agents|contraceptive agents|mesh-ancestor
6482107|NCT00550784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482108|NCT00550784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6482109|NCT00550784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6482110|NCT00550784|Alkylating Agents|alkylating agents|mesh-ancestor
6482111|NCT00550784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5561613|NCT04005716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5561614|NCT04005716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5603538|NCT02177695|Doxorubicin|doxorubicin|mesh-list
5561615|NCT04005716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5561616|NCT04005443|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
5561617|NCT04005443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5561618|NCT04005664|Phenylephrine|phenylephrine|mesh-list
5561619|NCT04005664|Oxymetazoline|oxymetazoline|mesh-list
5561620|NCT04005664|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5561621|NCT04005664|Mydriatics|mydriatics|mesh-ancestor
5561622|NCT04005664|Autonomic Agents|autonomic agents|mesh-ancestor
5561623|NCT04005664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5561624|NCT04005664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561625|NCT04005664|Sympathomimetics|sympathomimetics|mesh-ancestor
5561626|NCT04005664|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5561627|NCT04005664|Nasal Decongestants|nasal decongestants|mesh-ancestor
5561628|NCT04005664|Respiratory System Agents|respiratory system agents|mesh-ancestor
5561629|NCT04005664|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5561630|NCT04005664|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5561631|NCT04005664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5561632|NCT04005664|Adrenergic Agents|adrenergic agents|mesh-ancestor
5561633|NCT04005664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5561634|NCT04005664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5561635|NCT04005664|Protective Agents|protective agents|mesh-ancestor
5561636|NCT04005469|Treprostinil|treprostinil|mesh-list
5561637|NCT04005469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5561638|NCT04005599|Magnesium Sulfate|magnesium sulfate|mesh-list
5561639|NCT04005599|Remifentanil|remifentanil|mesh-list
5561640|NCT04005599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5561641|NCT04005599|Narcotics|narcotics|mesh-ancestor
5561642|NCT04005599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5561643|NCT04005599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561644|NCT04005599|Analgesics|analgesics|mesh-ancestor
5561645|NCT04005599|Sensory System Agents|sensory system agents|mesh-ancestor
5561646|NCT04005599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5561647|NCT04005599|Anesthetics|anesthetics|mesh-ancestor
5561648|NCT04005599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5561649|NCT04005599|Anticonvulsants|anticonvulsants|mesh-ancestor
5561650|NCT04005599|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5561651|NCT04005599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5561652|NCT04005599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5561653|NCT04005599|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5561654|NCT04005599|Tocolytic Agents|tocolytic agents|mesh-ancestor
5561655|NCT04005599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5561656|NCT04005430|Dexamethasone|dexamethasone|mesh-list
5561657|NCT04005430|Dexamethasone acetate|dexamethasone acetate|mesh-list
5561658|NCT04005430|BB 1101|bb 1101|mesh-list
5561659|NCT04005430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5561660|NCT04005430|Antiemetics|antiemetics|mesh-ancestor
5561661|NCT04005430|Autonomic Agents|autonomic agents|mesh-ancestor
5561662|NCT04005430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5561663|NCT04005430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561664|NCT04005430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5561665|NCT04005430|Glucocorticoids|glucocorticoids|mesh-ancestor
5561666|NCT04005430|Hormones|hormones|mesh-ancestor
5561667|NCT04005430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5561668|NCT04005430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5561669|NCT04005430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5561670|NCT04005430|Protease Inhibitors|protease inhibitors|mesh-ancestor
5561671|NCT04005430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5561672|NCT04005430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6482112|NCT00550784|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6482113|NCT00550784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6482114|NCT00550784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6482115|NCT00550810|Sunitinib|sunitinib|mesh-list
6482116|NCT00550810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6482117|NCT00550810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6163224|NCT01546454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6163225|NCT01546454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6163226|NCT01546454|Progestins|progestins|mesh-ancestor
6163227|NCT01546454|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6163228|NCT01546454|Fertility Agents|fertility agents|mesh-ancestor
6163229|NCT01546454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6163230|NCT01546454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6163231|NCT01546454|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6163232|NCT01546454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6163233|NCT01546454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6482118|NCT00550810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5561673|NCT04005365|Propranolol|propranolol|mesh-list
6163234|NCT01546454|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6163235|NCT01546623|Leuprolide|leuprolide|mesh-list
6163236|NCT01546623|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6163237|NCT01546623|Fertility Agents|fertility agents|mesh-ancestor
6163238|NCT01546623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6163239|NCT01546623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163240|NCT01546623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6163241|NCT01546623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5561674|NCT04005365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5561675|NCT04005365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5561676|NCT04005365|Adrenergic Agents|adrenergic agents|mesh-ancestor
6163242|NCT01546649|Leuprolide|leuprolide|mesh-list
6163243|NCT01546649|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6163244|NCT01546649|Fertility Agents|fertility agents|mesh-ancestor
6163245|NCT01546649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6163246|NCT01546649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163247|NCT01546649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6163248|NCT01546649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6163249|NCT01546688|Zonisamide|zonisamide|mesh-list
6163250|NCT01546688|Anticonvulsants|anticonvulsants|mesh-ancestor
6163251|NCT01546688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6163252|NCT01546688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6163253|NCT01546688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163254|NCT01546688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6163255|NCT01546688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163256|NCT01546857|Gabapentin|gabapentin|mesh-list
6163257|NCT01546857|Analgesics|analgesics|mesh-ancestor
6163258|NCT01546857|Sensory System Agents|sensory system agents|mesh-ancestor
6163259|NCT01546857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6163260|NCT01546857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163261|NCT01546857|Anticonvulsants|anticonvulsants|mesh-ancestor
6163262|NCT01546857|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6163263|NCT01546857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6163264|NCT01546857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6163265|NCT01546857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6163266|NCT01546857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6163267|NCT01546857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6163268|NCT01546857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6163269|NCT01546857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163270|NCT01546857|Antimanic Agents|antimanic agents|mesh-ancestor
6163271|NCT01546922|Hydrocortisone|hydrocortisone|mesh-list
6163272|NCT01546922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6163273|NCT01547000|Guanfacine|guanfacine|mesh-list
5561677|NCT04005365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5561678|NCT04005365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5561679|NCT04005365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561680|NCT04005365|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5561681|NCT04005365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5561682|NCT04005365|Vasodilator Agents|vasodilator agents|mesh-ancestor
6163274|NCT01547000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6163275|NCT01547000|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6163276|NCT01547000|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6163277|NCT01547000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6163278|NCT01547000|Adrenergic Agents|adrenergic agents|mesh-ancestor
6163279|NCT01547000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6163280|NCT01547000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163281|NCT01547000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482119|NCT00550810|Growth Substances|growth substances|mesh-ancestor
6482120|NCT00550810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482121|NCT00550810|Growth Inhibitors|growth inhibitors|mesh-ancestor
6482122|NCT00550810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6482123|NCT00550810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6482124|NCT00550810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163282|NCT01547286|Methacholine Chloride|methacholine chloride|mesh-list
6163283|NCT01547286|Miotics|miotics|mesh-ancestor
6163284|NCT01547286|Autonomic Agents|autonomic agents|mesh-ancestor
6163285|NCT01547286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6163286|NCT01547286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561683|NCT04005326|Anesthetics|anesthetics|mesh-list
6163287|NCT01547286|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6482125|NCT00550901|Dexrazoxane|dexrazoxane|mesh-list
6482126|NCT00550901|Razoxane|razoxane|mesh-list
6668711|NCT01533740|Irinotecan|irinotecan|mesh-list
5603539|NCT02177695|Methotrexate|methotrexate|mesh-list
5561684|NCT04005326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5561685|NCT04005326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561686|NCT04005222|Selenium|selenium|mesh-list
5561687|NCT04005222|Melatonin|melatonin|mesh-list
5561688|NCT04005222|Antioxidants|antioxidants|mesh-ancestor
5561689|NCT04005222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5561690|NCT04005222|Protective Agents|protective agents|mesh-ancestor
5561691|NCT04005222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561692|NCT04005222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5561693|NCT04005222|Trace Elements|trace elements|mesh-ancestor
5561694|NCT04005222|Micronutrients|micronutrients|mesh-ancestor
5561695|NCT04005417|Fluorides|fluorides|mesh-list
5561696|NCT04005417|Tin Fluorides|tin fluorides|mesh-list
6163288|NCT01547286|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
6163289|NCT01547286|Respiratory System Agents|respiratory system agents|mesh-ancestor
6163290|NCT01547286|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6163291|NCT01547286|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6163292|NCT01547286|Cholinergic Agents|cholinergic agents|mesh-ancestor
6163293|NCT01547286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6163294|NCT01547286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163295|NCT01547299|Leuprolide|leuprolide|mesh-list
6163296|NCT01547299|Dutasteride|dutasteride|mesh-list
6163297|NCT01547299|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6668712|NCT01533740|Levoleucovorin|levoleucovorin|mesh-list
6668713|NCT01533740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6668714|NCT01533740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6668715|NCT01533740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6668716|NCT01533740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6163298|NCT01547299|Fertility Agents|fertility agents|mesh-ancestor
6163299|NCT01547299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6163300|NCT01547299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163301|NCT01547299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6163302|NCT01547299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6163303|NCT01547299|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6163304|NCT01547299|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6163305|NCT01547299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6482127|NCT00550901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6482128|NCT00550901|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6482129|NCT00550901|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6482130|NCT00550901|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6482131|NCT00550901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6482132|NCT00550901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6482133|NCT00550901|Protective Agents|protective agents|mesh-ancestor
6482134|NCT00550901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482135|NCT00550901|Antimitotic Agents|antimitotic agents|mesh-ancestor
6482136|NCT00550901|Mitosis Modulators|mitosis modulators|mesh-ancestor
6482137|NCT00550927|Bevacizumab|bevacizumab|mesh-list
6482138|NCT00550927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6482139|NCT00550927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5561697|NCT04005417|Cariostatic Agents|cariostatic agents|mesh-ancestor
5561698|NCT04005417|Protective Agents|protective agents|mesh-ancestor
5561699|NCT04005417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561700|NCT04005287|Pirenzepine|pirenzepine|mesh-list
5561701|NCT04005287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5561702|NCT04005287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5561703|NCT04005287|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5561704|NCT04005287|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5561705|NCT04005287|Cholinergic Agents|cholinergic agents|mesh-ancestor
5561706|NCT04005287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6482140|NCT00550927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6482141|NCT00550927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6482142|NCT00550927|Growth Substances|growth substances|mesh-ancestor
6482143|NCT00550927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482144|NCT00550927|Growth Inhibitors|growth inhibitors|mesh-ancestor
5561707|NCT04005287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5561708|NCT04005287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561709|NCT04005079|Ofloxacin|ofloxacin|mesh-list
5561710|NCT04005079|Prednisolone|prednisolone|mesh-list
5561711|NCT04005079|Pilocarpine|pilocarpine|mesh-list
5561712|NCT04005079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5561713|NCT04005079|Glucocorticoids|glucocorticoids|mesh-ancestor
5561714|NCT04005079|Hormones|hormones|mesh-ancestor
5561715|NCT04005079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6668717|NCT01533740|Growth Substances|growth substances|mesh-ancestor
5561716|NCT04005079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561717|NCT04005079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5561718|NCT04005079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5561719|NCT04005079|Autonomic Agents|autonomic agents|mesh-ancestor
5561720|NCT04005079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6482145|NCT00550992|Leucovorin|leucovorin|mesh-list
6482146|NCT00550992|Cytarabine|cytarabine|mesh-list
6482147|NCT00550992|Cyclosporine|cyclosporine|mesh-list
6482148|NCT00550992|Prednisone|prednisone|mesh-list
6482149|NCT00550992|Prednisolone|prednisolone|mesh-list
6482150|NCT00550992|Hydrocortisone|hydrocortisone|mesh-list
6482151|NCT00550992|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6482152|NCT00550992|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6482153|NCT00550992|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6482154|NCT00550992|Cyclophosphamide|cyclophosphamide|mesh-list
6482155|NCT00550992|Melphalan|melphalan|mesh-list
6482156|NCT00550992|Busulfan|busulfan|mesh-list
6482157|NCT00550992|Methotrexate|methotrexate|mesh-list
6482158|NCT00550992|Etoposide|etoposide|mesh-list
6163306|NCT01547299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163307|NCT01547299|Hormone Antagonists|hormone antagonists|mesh-ancestor
6163308|NCT01547299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6163309|NCT01547390|Aspirin|aspirin|mesh-list
6163310|NCT01547390|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6163311|NCT01547390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6163312|NCT01547390|Analgesics|analgesics|mesh-ancestor
6163313|NCT01547390|Sensory System Agents|sensory system agents|mesh-ancestor
6163314|NCT01547390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6163315|NCT01547390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163316|NCT01547390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6163317|NCT01547390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6163318|NCT01547390|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6163319|NCT01547390|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6163320|NCT01547390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163321|NCT01547390|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6163322|NCT01547390|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6163323|NCT01547390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6163324|NCT01547390|Antipyretics|antipyretics|mesh-ancestor
6163325|NCT01547598|Timolol|timolol|mesh-list
6163326|NCT01547598|Bimatoprost|bimatoprost|mesh-list
6163327|NCT01547598|Travoprost|travoprost|mesh-list
6482159|NCT00550992|Vincristine|vincristine|mesh-list
6482160|NCT00550992|Daunorubicin|daunorubicin|mesh-list
6482161|NCT00550992|Asparaginase|asparaginase|mesh-list
6482162|NCT00550992|Mercaptopurine|mercaptopurine|mesh-list
6482163|NCT00550992|Mitoxantrone|mitoxantrone|mesh-list
6482164|NCT00550992|Pegaspargase|pegaspargase|mesh-list
6482165|NCT00550992|Thioguanine|thioguanine|mesh-list
6482166|NCT00550992|Cyclosporins|cyclosporins|mesh-list
6482167|NCT00550992|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6482168|NCT00550992|Levoleucovorin|levoleucovorin|mesh-list
6482169|NCT00550992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6163328|NCT01547598|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6163329|NCT01547598|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6482170|NCT00550992|Immunologic Factors|immunologic factors|mesh-ancestor
5561721|NCT04005079|Miotics|miotics|mesh-ancestor
5561722|NCT04005079|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
5561723|NCT04005079|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5561724|NCT04005079|Cholinergic Agents|cholinergic agents|mesh-ancestor
5561725|NCT04005079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5561726|NCT04005079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5561727|NCT04005079|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5561728|NCT04005079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5561729|NCT04005079|Renal Agents|renal agents|mesh-ancestor
5561730|NCT04005079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5561731|NCT04005079|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5561732|NCT04005079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5561733|NCT04005079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5561734|NCT04005079|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6482171|NCT00550992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482172|NCT00550992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6482173|NCT00550992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6163330|NCT01547598|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6163331|NCT01547598|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6482174|NCT00550992|Alkylating Agents|alkylating agents|mesh-ancestor
5561735|NCT04005079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6482175|NCT00550992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6482176|NCT00550992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6482177|NCT00550992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5561736|NCT04004754|Miltefosine|miltefosine|mesh-list
5561737|NCT04004754|Antifungal Agents|antifungal agents|mesh-ancestor
5561738|NCT04004754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5561739|NCT04004754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5561740|NCT04004754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5561741|NCT04004754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5561742|NCT04004819|Rituximab|rituximab|mesh-list
5561743|NCT04004819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5561744|NCT04004819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5561745|NCT04004819|Immunologic Factors|immunologic factors|mesh-ancestor
5561746|NCT04004819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561747|NCT04004819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5561748|NCT04005170|Paclitaxel|paclitaxel|mesh-list
5561749|NCT04005170|Cisplatin|cisplatin|mesh-list
5561750|NCT04005170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5561751|NCT04005170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5561752|NCT04005170|Tubulin Modulators|tubulin modulators|mesh-ancestor
5561753|NCT04005170|Antimitotic Agents|antimitotic agents|mesh-ancestor
5561754|NCT04005170|Mitosis Modulators|mitosis modulators|mesh-ancestor
5561755|NCT04005170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5561756|NCT04004910|Paclitaxel|paclitaxel|mesh-list
5561757|NCT04004910|Carboplatin|carboplatin|mesh-list
5561758|NCT04004910|Antineoplastic Agents|antineoplastic agents|mesh-list
5561759|NCT04004910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5561760|NCT04004910|Tubulin Modulators|tubulin modulators|mesh-ancestor
5561761|NCT04004910|Antimitotic Agents|antimitotic agents|mesh-ancestor
5561762|NCT04004910|Mitosis Modulators|mitosis modulators|mesh-ancestor
5561763|NCT04004910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603540|NCT02177695|Vinblastine|vinblastine|mesh-list
5603541|NCT02177695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5603542|NCT02177695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5603543|NCT02177695|Antimetabolites|antimetabolites|mesh-ancestor
5603544|NCT02177695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603545|NCT02177695|Antiviral Agents|antiviral agents|mesh-ancestor
5603546|NCT02177695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5603547|NCT02177695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5603548|NCT02177695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5603549|NCT02177695|Immunologic Factors|immunologic factors|mesh-ancestor
5603550|NCT02177695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603551|NCT02177695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5603552|NCT02177695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5603553|NCT02177695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5603554|NCT02177695|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5603555|NCT02177695|Abortifacient Agents|abortifacient agents|mesh-ancestor
5603556|NCT02177695|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5603557|NCT02177695|Dermatologic Agents|dermatologic agents|mesh-ancestor
5603558|NCT02177695|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5603559|NCT02177695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5603560|NCT02177695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5603561|NCT02177695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5603562|NCT02177695|Tubulin Modulators|tubulin modulators|mesh-ancestor
5603563|NCT02177695|Antimitotic Agents|antimitotic agents|mesh-ancestor
5603564|NCT02177695|Mitosis Modulators|mitosis modulators|mesh-ancestor
5603565|NCT02176148|Fluocinonide|fluocinonide|mesh-list
5603566|NCT02176148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5603567|NCT02176148|Glucocorticoids|glucocorticoids|mesh-ancestor
5603568|NCT02176148|Hormones|hormones|mesh-ancestor
5603569|NCT02176148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5603570|NCT02176148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603571|NCT02176148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5603572|NCT02145403|Tacrolimus|tacrolimus|mesh-list
5603573|NCT02145403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5603574|NCT02145403|Immunologic Factors|immunologic factors|mesh-ancestor
5603575|NCT02145403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603576|NCT02145403|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5603577|NCT02145403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5603578|NCT02145403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5561764|NCT04004871|Paclitaxel|paclitaxel|mesh-list
5561765|NCT04004871|Cisplatin|cisplatin|mesh-list
5561766|NCT04004871|Fluorouracil|fluorouracil|mesh-list
5561767|NCT04004871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5561768|NCT04004871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5561769|NCT04004871|Tubulin Modulators|tubulin modulators|mesh-ancestor
5561770|NCT04004871|Antimitotic Agents|antimitotic agents|mesh-ancestor
6163332|NCT01547598|Adrenergic Agents|adrenergic agents|mesh-ancestor
6163333|NCT01547598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6163334|NCT01547598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163335|NCT01547598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163336|NCT01547598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6163337|NCT01547598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6163338|NCT01547806|Plerixafor|plerixafor|mesh-list
6163339|NCT01547806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6163340|NCT01547806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6163341|NCT01547806|Antiviral Agents|antiviral agents|mesh-ancestor
6163342|NCT01547806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6482178|NCT00550992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6482179|NCT00550992|Glucocorticoids|glucocorticoids|mesh-ancestor
6482180|NCT00550992|Hormones|hormones|mesh-ancestor
6482181|NCT00550992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6482182|NCT00550992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6482183|NCT00550992|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6482184|NCT00550992|Abortifacient Agents|abortifacient agents|mesh-ancestor
6163343|NCT01548417|Mifepristone|mifepristone|mesh-list
6163344|NCT01548417|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6163345|NCT01548417|Abortifacient Agents|abortifacient agents|mesh-ancestor
6163346|NCT01548417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6163347|NCT01548417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163348|NCT01548417|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6163349|NCT01548417|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6163350|NCT01548417|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6163351|NCT01548417|Contraceptive Agents|contraceptive agents|mesh-ancestor
6163352|NCT01548417|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6163353|NCT01548417|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6163354|NCT01548417|Hormone Antagonists|hormone antagonists|mesh-ancestor
6163355|NCT01548417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6163356|NCT01548417|Luteolytic Agents|luteolytic agents|mesh-ancestor
6163357|NCT01548417|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5561771|NCT04004871|Mitosis Modulators|mitosis modulators|mesh-ancestor
5561772|NCT04004871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5561773|NCT04004871|Antimetabolites|antimetabolites|mesh-ancestor
5561774|NCT04004871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5561775|NCT04004871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5561776|NCT04004871|Immunologic Factors|immunologic factors|mesh-ancestor
5561777|NCT04004871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561778|NCT04004793|Dapagliflozin|dapagliflozin|mesh-list
5561779|NCT04004793|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5561780|NCT04004793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5561781|NCT04004793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6163358|NCT01548417|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6163359|NCT01548573|Thalidomide|thalidomide|mesh-list
6163360|NCT01548573|Dexamethasone|dexamethasone|mesh-list
5561782|NCT04004793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561783|NCT04004884|Ulipristal acetate|ulipristal acetate|mesh-list
5561784|NCT04004884|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5561785|NCT04004884|Contraceptive Agents|contraceptive agents|mesh-ancestor
5561786|NCT04004884|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5561787|NCT04004884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561788|NCT04004884|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5561789|NCT04004988|Tirzepatide|tirzepatide|mesh-list
5561790|NCT04004988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5561791|NCT04004988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561792|NCT04004988|Incretins|incretins|mesh-ancestor
5561793|NCT04004988|Hormones|hormones|mesh-ancestor
5561794|NCT04004988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5561795|NCT04004702|Levetiracetam|levetiracetam|mesh-list
5561796|NCT04004702|Anticonvulsants|anticonvulsants|mesh-ancestor
5561797|NCT04004702|Nootropic Agents|nootropic agents|mesh-ancestor
5561798|NCT04004507|Phentolamine|phentolamine|mesh-list
5561799|NCT04004507|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5561800|NCT04004507|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5603579|NCT02107976|Vitamins|vitamins|mesh-list
6668718|NCT01533740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668719|NCT01533740|Growth Inhibitors|growth inhibitors|mesh-ancestor
6668720|NCT01533740|Antimetabolites|antimetabolites|mesh-ancestor
6668721|NCT01533740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668722|NCT01533740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6668723|NCT01533740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6668724|NCT01533740|Immunologic Factors|immunologic factors|mesh-ancestor
6668725|NCT01533740|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6668726|NCT01533740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6668727|NCT01533740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6668728|NCT01533740|Antidotes|antidotes|mesh-ancestor
6668729|NCT01533740|Protective Agents|protective agents|mesh-ancestor
6668730|NCT01533740|Vitamin B Complex|vitamin b complex|mesh-ancestor
6668731|NCT01533740|Vitamins|vitamins|mesh-ancestor
6668732|NCT01533740|Micronutrients|micronutrients|mesh-ancestor
6668733|NCT01533740|Hematinics|hematinics|mesh-ancestor
6668734|NCT01533818|Amoxicillin|amoxicillin|mesh-list
6668735|NCT01533818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6668736|NCT01533818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6668737|NCT01533870|Rifampin|rifampin|mesh-list
6668738|NCT01533870|Naloxegol|naloxegol|mesh-list
5561801|NCT04004507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5561802|NCT04004507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5561803|NCT04004507|Adrenergic Agents|adrenergic agents|mesh-ancestor
5561804|NCT04004507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5561805|NCT04004507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5561806|NCT04004507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561807|NCT04004507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5561808|NCT04004572|Pegaspargase|pegaspargase|mesh-list
5561809|NCT04004572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5561810|NCT04004078|Antifungal Agents|antifungal agents|mesh-list
5561811|NCT04004078|Clotrimazole|clotrimazole|mesh-list
5561812|NCT04004078|Miconazole|miconazole|mesh-list
5561813|NCT04004078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5561814|NCT04004078|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5561815|NCT04004078|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5561816|NCT04004078|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5561817|NCT04004078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6668739|NCT01533870|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6668740|NCT01533870|Antitubercular Agents|antitubercular agents|mesh-ancestor
6163361|NCT01548573|Cyclophosphamide|cyclophosphamide|mesh-list
6163362|NCT01548573|Melphalan|melphalan|mesh-list
6163363|NCT01548573|Doxorubicin|doxorubicin|mesh-list
6163364|NCT01548573|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6163365|NCT01548573|Etoposide|etoposide|mesh-list
6163366|NCT01548573|Bortezomib|bortezomib|mesh-list
6163367|NCT01548573|Etoposide phosphate|etoposide phosphate|mesh-list
6163368|NCT01548573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6163369|NCT01548573|Immunologic Factors|immunologic factors|mesh-ancestor
6163370|NCT01548573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163371|NCT01548573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6163372|NCT01548573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6163373|NCT01548573|Alkylating Agents|alkylating agents|mesh-ancestor
6163374|NCT01548573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163375|NCT01548573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6163376|NCT01548573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6163377|NCT01548573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6163378|NCT01548573|Antiemetics|antiemetics|mesh-ancestor
6163379|NCT01548573|Autonomic Agents|autonomic agents|mesh-ancestor
6163380|NCT01548573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6163381|NCT01548573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6163382|NCT01548573|Glucocorticoids|glucocorticoids|mesh-ancestor
6163383|NCT01548573|Hormones|hormones|mesh-ancestor
6163384|NCT01548573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6163385|NCT01548573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6163386|NCT01548573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6163387|NCT01548573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6163388|NCT01548573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6163389|NCT01548573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6163390|NCT01548573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6163391|NCT01548573|Leprostatic Agents|leprostatic agents|mesh-ancestor
6163392|NCT01548573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6163393|NCT01548573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6163394|NCT01548573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6163395|NCT01548573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6668741|NCT01533870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6668742|NCT01533870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6163396|NCT01548573|Growth Substances|growth substances|mesh-ancestor
6163397|NCT01548573|Growth Inhibitors|growth inhibitors|mesh-ancestor
6163398|NCT01548638|Galantamine|galantamine|mesh-list
6163399|NCT01548638|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6163400|NCT01548638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6163401|NCT01548638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163402|NCT01548638|Cholinergic Agents|cholinergic agents|mesh-ancestor
6163403|NCT01548638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6163404|NCT01548638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561818|NCT04004078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5561819|NCT04004078|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5561820|NCT04004078|Hormone Antagonists|hormone antagonists|mesh-ancestor
5561821|NCT04004078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5561822|NCT04004078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561823|NCT04004078|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5561824|NCT04004078|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5561825|NCT04004234|Manganese|manganese|mesh-list
5561826|NCT04004234|Gemcitabine|gemcitabine|mesh-list
5561827|NCT04004234|Paclitaxel|paclitaxel|mesh-list
5561828|NCT04004234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5561829|NCT04004234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5561830|NCT04004234|Antibodies|antibodies|mesh-list
5561831|NCT04004234|Immunoglobulins|immunoglobulins|mesh-list
5561832|NCT04004234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5561833|NCT04004234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5561834|NCT04004234|Tubulin Modulators|tubulin modulators|mesh-ancestor
5561835|NCT04004234|Antimitotic Agents|antimitotic agents|mesh-ancestor
5561836|NCT04004234|Mitosis Modulators|mitosis modulators|mesh-ancestor
5561837|NCT04004234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5561838|NCT04004234|Immunologic Factors|immunologic factors|mesh-ancestor
5561839|NCT04004234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561840|NCT04004234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5561841|NCT04004234|Antimetabolites|antimetabolites|mesh-ancestor
5561842|NCT04004234|Antiviral Agents|antiviral agents|mesh-ancestor
5561843|NCT04004234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5561844|NCT04004234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5561845|NCT04004234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5561846|NCT04004234|Trace Elements|trace elements|mesh-ancestor
5561847|NCT04004234|Micronutrients|micronutrients|mesh-ancestor
6163405|NCT01548638|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6163406|NCT01548638|Autonomic Agents|autonomic agents|mesh-ancestor
6163407|NCT01548638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6163408|NCT01548638|Nootropic Agents|nootropic agents|mesh-ancestor
6163409|NCT01548690|Phenylacetic acid|phenylacetic acid|mesh-list
6163410|NCT01548690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6163411|NCT01548690|Antimetabolites|antimetabolites|mesh-ancestor
6163412|NCT01548690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163413|NCT01548690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6163414|NCT01548768|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
6163415|NCT01548768|Antirheumatic Agents|antirheumatic agents|mesh-list
6163416|NCT01548768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6163417|NCT01549002|Fentanyl|fentanyl|mesh-list
6163418|NCT01549002|Morphine|morphine|mesh-list
6163419|NCT01549002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6163420|NCT01549002|Narcotics|narcotics|mesh-ancestor
6163421|NCT01549002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6163422|NCT01549002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163423|NCT01549002|Analgesics|analgesics|mesh-ancestor
6163424|NCT01549002|Sensory System Agents|sensory system agents|mesh-ancestor
6163425|NCT01549002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6163426|NCT01549002|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6163427|NCT01549002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6163428|NCT01549002|Anesthetics, General|anesthetics, general|mesh-ancestor
6163429|NCT01549002|Anesthetics|anesthetics|mesh-ancestor
6163430|NCT01549041|Asenapine|asenapine|mesh-list
6163431|NCT01549041|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6163432|NCT01549041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6163433|NCT01549041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6163434|NCT01549041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163435|NCT01549041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6163436|NCT01549223|Misoprostol|misoprostol|mesh-list
6163437|NCT01549223|Oxytocin|oxytocin|mesh-list
6163438|NCT01549223|Methylergonovine|methylergonovine|mesh-list
6163439|NCT01549223|Carboprost tromethamine|carboprost tromethamine|mesh-list
5561848|NCT04004208|Aflibercept|aflibercept|mesh-list
6163440|NCT01549223|Carboprost|carboprost|mesh-list
6163441|NCT01549223|Maleic acid|maleic acid|mesh-list
5561849|NCT04004208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5561850|NCT04004208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6163442|NCT01549223|Oxytocics|oxytocics|mesh-ancestor
6163443|NCT01549223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6163444|NCT01549223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163445|NCT01549223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6163446|NCT01549223|Abortifacient Agents|abortifacient agents|mesh-ancestor
6163447|NCT01549223|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6163448|NCT01549223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6482185|NCT00550992|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6482186|NCT00550992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6482187|NCT00550992|Antimetabolites|antimetabolites|mesh-ancestor
6482188|NCT00550992|Dermatologic Agents|dermatologic agents|mesh-ancestor
5561851|NCT04004208|Growth Substances|growth substances|mesh-ancestor
5561852|NCT04004208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561853|NCT04004208|Growth Inhibitors|growth inhibitors|mesh-ancestor
5561854|NCT04004208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5561855|NCT04003987|Bupivacaine|bupivacaine|mesh-list
5561856|NCT04003987|Anesthetics, Local|anesthetics, local|mesh-ancestor
5561857|NCT04003987|Anesthetics|anesthetics|mesh-ancestor
5561858|NCT04003987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5561859|NCT04003987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561860|NCT04003987|Sensory System Agents|sensory system agents|mesh-ancestor
5561861|NCT04003987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5561862|NCT04004117|Fentanyl|fentanyl|mesh-list
5561863|NCT04004117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5561864|NCT04004117|Narcotics|narcotics|mesh-ancestor
5561865|NCT04004117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5561866|NCT04004117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561867|NCT04004117|Analgesics|analgesics|mesh-ancestor
5561868|NCT04004117|Sensory System Agents|sensory system agents|mesh-ancestor
5561869|NCT04004117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5561870|NCT04004117|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5561871|NCT04004117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5561872|NCT04004117|Anesthetics, General|anesthetics, general|mesh-ancestor
5561873|NCT04004117|Anesthetics|anesthetics|mesh-ancestor
5561874|NCT04003948|Ibogaine|ibogaine|mesh-list
5561875|NCT04003948|Hallucinogens|hallucinogens|mesh-ancestor
5561876|NCT04003948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561877|NCT04003948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5561878|NCT04003948|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5561879|NCT04003948|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6482189|NCT00550992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6482190|NCT00550992|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6482191|NCT00550992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5561880|NCT04003948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5561881|NCT04003948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5561882|NCT04003844|Aspirin|aspirin|mesh-list
5561883|NCT04003844|Immunoglobulins|immunoglobulins|mesh-list
5561884|NCT04003844|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5561885|NCT04003844|Antibodies|antibodies|mesh-list
6163449|NCT01549223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6163450|NCT01549223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206131|NCT02096835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668743|NCT01533870|Leprostatic Agents|leprostatic agents|mesh-ancestor
6668744|NCT01533870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6668745|NCT01533870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6668746|NCT01533870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668747|NCT01533870|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6668748|NCT01533870|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6668749|NCT01533870|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6206132|NCT02096861|Infliximab|infliximab|mesh-list
5561886|NCT04003844|Immunoglobulin G|immunoglobulin g|mesh-list
5561887|NCT04003844|Immunologic Factors|immunologic factors|mesh-ancestor
5561888|NCT04003844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561889|NCT04003844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5561890|NCT04003844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5561891|NCT04003844|Analgesics|analgesics|mesh-ancestor
6163451|NCT01549587|Listerine|listerine|mesh-list
6163452|NCT01549587|Cetylpyridinium|cetylpyridinium|mesh-list
6163453|NCT01549587|Fluorides|fluorides|mesh-list
5561892|NCT04003844|Sensory System Agents|sensory system agents|mesh-ancestor
5561893|NCT04003844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5561894|NCT04003844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5561895|NCT04003844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6163454|NCT01549587|Sodium Fluoride|sodium fluoride|mesh-list
6163455|NCT01549587|Tin Fluorides|tin fluorides|mesh-list
6163456|NCT01549587|Cariostatic Agents|cariostatic agents|mesh-ancestor
6163457|NCT01549587|Protective Agents|protective agents|mesh-ancestor
6163458|NCT01549587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163459|NCT01549587|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6163460|NCT01549587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6163461|NCT01549613|Vancomycin|vancomycin|mesh-list
6163462|NCT01549613|Daptomycin|daptomycin|mesh-list
5561896|NCT04003844|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6163463|NCT01549613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6163464|NCT01549613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6163465|NCT01549652|Morphine|morphine|mesh-list
6163466|NCT01549652|Ondansetron|ondansetron|mesh-list
6163467|NCT01549652|Naloxone|naloxone|mesh-list
6163468|NCT01549652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6163469|NCT01549652|Narcotics|narcotics|mesh-ancestor
6163470|NCT01549652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6163471|NCT01549652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163472|NCT01549652|Analgesics|analgesics|mesh-ancestor
6163473|NCT01549652|Sensory System Agents|sensory system agents|mesh-ancestor
6163474|NCT01549652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6163475|NCT01549652|Antiemetics|antiemetics|mesh-ancestor
6163476|NCT01549652|Autonomic Agents|autonomic agents|mesh-ancestor
6163477|NCT01549652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6163478|NCT01549652|Antipruritics|antipruritics|mesh-ancestor
6163479|NCT01549652|Dermatologic Agents|dermatologic agents|mesh-ancestor
6163480|NCT01549652|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6163481|NCT01549652|Serotonin Agents|serotonin agents|mesh-ancestor
6163482|NCT01549652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6163483|NCT01549652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6482192|NCT00550992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6482193|NCT00550992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6482194|NCT00550992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6482195|NCT00550992|Antiviral Agents|antiviral agents|mesh-ancestor
6482196|NCT00550992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6482197|NCT00550992|Antidotes|antidotes|mesh-ancestor
6482198|NCT00550992|Protective Agents|protective agents|mesh-ancestor
6482199|NCT00550992|Vitamin B Complex|vitamin b complex|mesh-ancestor
6482200|NCT00550992|Vitamins|vitamins|mesh-ancestor
6668750|NCT01533870|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6163484|NCT01549652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6163485|NCT01549652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6163486|NCT01549652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6163487|NCT01549652|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6163488|NCT01549652|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6163489|NCT01549873|Propofol|propofol|mesh-list
6163490|NCT01549873|Desflurane|desflurane|mesh-list
6163491|NCT01549873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6163492|NCT01549873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6163493|NCT01549873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163494|NCT01549873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6163495|NCT01549873|Anesthetics, General|anesthetics, general|mesh-ancestor
6163496|NCT01549873|Anesthetics|anesthetics|mesh-ancestor
6163497|NCT01549873|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6163498|NCT01549886|Rituximab|rituximab|mesh-list
6163499|NCT01549886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6163500|NCT01549886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6482201|NCT00550992|Micronutrients|micronutrients|mesh-ancestor
5561897|NCT04003844|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5561898|NCT04003844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163501|NCT01549886|Immunologic Factors|immunologic factors|mesh-ancestor
6163502|NCT01549886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163503|NCT01549886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6163504|NCT01549951|Prednisone|prednisone|mesh-list
6163505|NCT01549951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6163506|NCT01549951|Glucocorticoids|glucocorticoids|mesh-ancestor
6163507|NCT01549951|Hormones|hormones|mesh-ancestor
6668751|NCT01533870|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6668752|NCT01533870|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6668753|NCT01533870|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6668754|NCT01533870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668755|NCT01533870|Sensory System Agents|sensory system agents|mesh-ancestor
6163508|NCT01549951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6163509|NCT01549951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163510|NCT01549951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6163511|NCT01549951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6163512|NCT01549964|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6163513|NCT01549964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6163514|NCT01549964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163515|NCT01549964|Incretins|incretins|mesh-ancestor
6163516|NCT01549964|Hormones|hormones|mesh-ancestor
6163517|NCT01549964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6163518|NCT01549964|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6163519|NCT01549964|Protease Inhibitors|protease inhibitors|mesh-ancestor
6163520|NCT01549964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6163521|NCT01549964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163522|NCT01550224|Temozolomide|temozolomide|mesh-list
6163523|NCT01550224|Vorinostat|vorinostat|mesh-list
6163524|NCT01550224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6163525|NCT01550224|Alkylating Agents|alkylating agents|mesh-ancestor
6163526|NCT01550224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163527|NCT01550224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6482202|NCT00550992|Tubulin Modulators|tubulin modulators|mesh-ancestor
6482203|NCT00550992|Antimitotic Agents|antimitotic agents|mesh-ancestor
6482204|NCT00550992|Mitosis Modulators|mitosis modulators|mesh-ancestor
6482205|NCT00550992|Antifungal Agents|antifungal agents|mesh-ancestor
6482206|NCT00550992|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6482207|NCT00550992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6482208|NCT00550992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6482209|NCT00550992|Analgesics|analgesics|mesh-ancestor
6482210|NCT00550992|Sensory System Agents|sensory system agents|mesh-ancestor
6482211|NCT00551005|Celecoxib|celecoxib|mesh-list
6668756|NCT01533870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6668757|NCT01534026|Aspirin|aspirin|mesh-list
6163528|NCT01550224|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6163529|NCT01550224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6163530|NCT01550289|Vaccines|vaccines|mesh-list
6163531|NCT01550289|Immunologic Factors|immunologic factors|mesh-ancestor
6163532|NCT01550289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163533|NCT01550341|Buprenorphine|buprenorphine|mesh-list
6163534|NCT01550341|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6163535|NCT01550341|Naloxone|naloxone|mesh-list
6163536|NCT01550341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6163537|NCT01550341|Narcotics|narcotics|mesh-ancestor
6163538|NCT01550341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6163539|NCT01550341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163540|NCT01550341|Analgesics|analgesics|mesh-ancestor
6163541|NCT01550341|Sensory System Agents|sensory system agents|mesh-ancestor
6163542|NCT01550341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6163543|NCT01550341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6163544|NCT01550367|Hydroxychloroquine|hydroxychloroquine|mesh-list
6163545|NCT01550367|Aldesleukin|aldesleukin|mesh-list
6163546|NCT01550367|Antimalarials|antimalarials|mesh-ancestor
6163547|NCT01550367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6163548|NCT01550367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6163549|NCT01550367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6163550|NCT01550367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6163551|NCT01550367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163552|NCT01550367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6163553|NCT01550367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6163554|NCT01550367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6163555|NCT01550367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6482212|NCT00551005|Etoposide|etoposide|mesh-list
6163556|NCT01550367|Antiviral Agents|antiviral agents|mesh-ancestor
6163557|NCT01550471|Ciclesonide|ciclesonide|mesh-list
6163558|NCT01550471|Beclomethasone|beclomethasone|mesh-list
6163559|NCT01550471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6163560|NCT01550471|Glucocorticoids|glucocorticoids|mesh-ancestor
6163561|NCT01550471|Hormones|hormones|mesh-ancestor
6668758|NCT01534026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6668759|NCT01534026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6668760|NCT01534026|Analgesics|analgesics|mesh-ancestor
6668761|NCT01534026|Sensory System Agents|sensory system agents|mesh-ancestor
6668762|NCT01534026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6163562|NCT01550471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6163563|NCT01550471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163564|NCT01550471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6163565|NCT01550471|Respiratory System Agents|respiratory system agents|mesh-ancestor
6163566|NCT01550471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6163567|NCT01550705|Isoniazid|isoniazid|mesh-list
6163568|NCT01550705|Antitubercular Agents|antitubercular agents|mesh-ancestor
6163569|NCT01550705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6163570|NCT01550705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6163571|NCT01550705|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6163572|NCT01550705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6163573|NCT01550705|Antimetabolites|antimetabolites|mesh-ancestor
5561899|NCT04003844|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5561900|NCT04003844|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6668763|NCT01534026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668764|NCT01534026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6668765|NCT01534026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5561901|NCT04003844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5561902|NCT04003844|Antipyretics|antipyretics|mesh-ancestor
5561903|NCT04003818|Teicoplanin|teicoplanin|mesh-list
5561904|NCT04003818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5561905|NCT04003818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5561906|NCT04003922|Adalimumab|adalimumab|mesh-list
5561907|NCT04003922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5561908|NCT04003922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6163574|NCT01550705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163575|NCT01550705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6163576|NCT01550744|Ustekinumab|ustekinumab|mesh-list
6163577|NCT01550744|Dermatologic Agents|dermatologic agents|mesh-ancestor
6163578|NCT01550965|Adalimumab|adalimumab|mesh-list
6163579|NCT01550965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6163580|NCT01550965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6163581|NCT01551056|Cetirizine|cetirizine|mesh-list
6163582|NCT01551056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6163583|NCT01551056|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6163584|NCT01551056|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6163585|NCT01551056|Histamine Antagonists|histamine antagonists|mesh-ancestor
6163586|NCT01551056|Histamine Agents|histamine agents|mesh-ancestor
6163587|NCT01551056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6163588|NCT01551056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163589|NCT01551056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163590|NCT01551212|Everolimus|everolimus|mesh-list
6163591|NCT01551212|Tacrolimus|tacrolimus|mesh-list
6163592|NCT01551212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6482213|NCT00551005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6482214|NCT00551005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6482215|NCT00551005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6482216|NCT00551005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6482217|NCT00551005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6482218|NCT00551005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163593|NCT01551212|Immunologic Factors|immunologic factors|mesh-ancestor
6163594|NCT01551212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482219|NCT00551005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6482220|NCT00551005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6482221|NCT00551005|Analgesics|analgesics|mesh-ancestor
6482222|NCT00551005|Sensory System Agents|sensory system agents|mesh-ancestor
6482223|NCT00551005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6482224|NCT00551005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482225|NCT00551005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6482226|NCT00551005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6482227|NCT00551005|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6482228|NCT00551005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6482229|NCT00551018|Tenofovir|tenofovir|mesh-list
6482230|NCT00551018|Emtricitabine|emtricitabine|mesh-list
6482231|NCT00551018|Antiviral Agents|antiviral agents|mesh-ancestor
6163595|NCT01551212|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6163596|NCT01551212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6163597|NCT01551212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163598|NCT01551212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6163599|NCT01551303|Oxytocin|oxytocin|mesh-list
6163600|NCT01551303|Oxytocics|oxytocics|mesh-ancestor
6163601|NCT01551303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6163602|NCT01551303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163603|NCT01551745|Bevacizumab|bevacizumab|mesh-list
6163604|NCT01551745|Vaccines|vaccines|mesh-list
6163605|NCT01551745|Immunologic Factors|immunologic factors|mesh-ancestor
6163606|NCT01551745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163607|NCT01551745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6163608|NCT01551745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6163609|NCT01551745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6163610|NCT01551745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6163611|NCT01551745|Growth Substances|growth substances|mesh-ancestor
6163612|NCT01551745|Growth Inhibitors|growth inhibitors|mesh-ancestor
6163613|NCT01551888|Formoterol Fumarate|formoterol fumarate|mesh-list
6163614|NCT01551888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6163615|NCT01551888|Autonomic Agents|autonomic agents|mesh-ancestor
6163616|NCT01551888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6163617|NCT01551888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482232|NCT00551018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6482233|NCT00551018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6482234|NCT00551018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6482235|NCT00551018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6482236|NCT00551018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6482237|NCT00551018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6482238|NCT00551018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6482239|NCT00551044|Bicalutamide|bicalutamide|mesh-list
6482240|NCT00551044|Androgen Antagonists|androgen antagonists|mesh-ancestor
6482241|NCT00551044|Hormone Antagonists|hormone antagonists|mesh-ancestor
6482242|NCT00551044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6482243|NCT00551044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482244|NCT00551044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6482245|NCT00551096|Gemcitabine|gemcitabine|mesh-list
6163618|NCT01551888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6163619|NCT01551888|Respiratory System Agents|respiratory system agents|mesh-ancestor
6163620|NCT01551888|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6163621|NCT01551888|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6163622|NCT01551888|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6163623|NCT01551888|Adrenergic Agents|adrenergic agents|mesh-ancestor
6163624|NCT01551888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6163625|NCT01551888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163626|NCT01552057|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6163627|NCT01552057|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6163628|NCT01552057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6163629|NCT01552057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6163630|NCT01552057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163631|NCT01552057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6163632|NCT01552057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163633|NCT01552057|Analgesics|analgesics|mesh-ancestor
6163634|NCT01552057|Sensory System Agents|sensory system agents|mesh-ancestor
6163635|NCT01552057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6163636|NCT01552057|Antidepressive Agents|antidepressive agents|mesh-ancestor
6163637|NCT01552057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6163638|NCT01552057|Dopamine Agents|dopamine agents|mesh-ancestor
6163639|NCT01552343|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
6163640|NCT01552343|Hemostatics|hemostatics|mesh-ancestor
6163641|NCT01552343|Coagulants|coagulants|mesh-ancestor
6163642|NCT01552343|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6163643|NCT01552343|Natriuretic Agents|natriuretic agents|mesh-ancestor
6163644|NCT01552343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163645|NCT01552369|Valganciclovir|valganciclovir|mesh-list
6482246|NCT00551096|Capecitabine|capecitabine|mesh-list
6482247|NCT00551096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6482248|NCT00551096|Antimetabolites|antimetabolites|mesh-ancestor
6482249|NCT00551096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6482250|NCT00551096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6482251|NCT00551096|Antiviral Agents|antiviral agents|mesh-ancestor
6482252|NCT00551096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5561909|NCT04003792|Bevacizumab|bevacizumab|mesh-list
5561910|NCT04003792|Oxaliplatin|oxaliplatin|mesh-list
5561911|NCT04003792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5561912|NCT04003792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5561913|NCT04003792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5561914|NCT04003792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5561915|NCT04003792|Growth Substances|growth substances|mesh-ancestor
5561916|NCT04003792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561917|NCT04003792|Growth Inhibitors|growth inhibitors|mesh-ancestor
5561918|NCT04003688|Magnesium Sulfate|magnesium sulfate|mesh-list
5561919|NCT04003688|Analgesics|analgesics|mesh-ancestor
5561920|NCT04003688|Sensory System Agents|sensory system agents|mesh-ancestor
5561921|NCT04003688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5561922|NCT04003688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561923|NCT04003688|Anesthetics|anesthetics|mesh-ancestor
5561924|NCT04003688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5561925|NCT04003688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5561926|NCT04003688|Anticonvulsants|anticonvulsants|mesh-ancestor
5561927|NCT04003688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5561928|NCT04003688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5561929|NCT04003688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5561930|NCT04003688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5561931|NCT04003688|Tocolytic Agents|tocolytic agents|mesh-ancestor
5561932|NCT04003688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5561933|NCT04003376|Vitamin D|vitamin d|mesh-list
5561934|NCT04003376|Triamcinolone|triamcinolone|mesh-list
5561935|NCT04003376|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5561936|NCT04003376|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5561937|NCT04003376|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5561938|NCT04003376|Vitamins|vitamins|mesh-ancestor
5561939|NCT04003376|Micronutrients|micronutrients|mesh-ancestor
5561940|NCT04003376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561941|NCT04003376|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5561942|NCT04003376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5561943|NCT04003376|Glucocorticoids|glucocorticoids|mesh-ancestor
5561944|NCT04003376|Hormones|hormones|mesh-ancestor
5561945|NCT04003376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6482253|NCT00551096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6482254|NCT00551096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6482255|NCT00551096|Immunologic Factors|immunologic factors|mesh-ancestor
6482256|NCT00551096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482257|NCT00551109|SA 4503|sa 4503|mesh-list
6482258|NCT00551109|Nootropic Agents|nootropic agents|mesh-ancestor
6482259|NCT00551122|Gemcitabine|gemcitabine|mesh-list
6482260|NCT00551122|Paclitaxel|paclitaxel|mesh-list
6482261|NCT00551122|Ifosfamide|ifosfamide|mesh-list
6482262|NCT00551122|Lenograstim|lenograstim|mesh-list
6482263|NCT00551122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6482264|NCT00551122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6482265|NCT00551122|Tubulin Modulators|tubulin modulators|mesh-ancestor
6482266|NCT00551122|Antimitotic Agents|antimitotic agents|mesh-ancestor
6482267|NCT00551122|Mitosis Modulators|mitosis modulators|mesh-ancestor
6163646|NCT01552369|Antiviral Agents|antiviral agents|mesh-ancestor
5561946|NCT04003376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5561947|NCT04003376|Immunologic Factors|immunologic factors|mesh-ancestor
5561948|NCT04003376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5561949|NCT04003376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5561950|NCT04003467|Teriparatide|teriparatide|mesh-list
5561951|NCT04003467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6163647|NCT01552369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6163648|NCT01552408|Ranibizumab|ranibizumab|mesh-list
6163649|NCT01552408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6163650|NCT01552408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6163651|NCT01552408|Growth Substances|growth substances|mesh-ancestor
6163652|NCT01552408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163653|NCT01552408|Growth Inhibitors|growth inhibitors|mesh-ancestor
6163654|NCT01552408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6482268|NCT00551122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6482269|NCT00551122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6482270|NCT00551122|Antimetabolites|antimetabolites|mesh-ancestor
6482271|NCT00551122|Antiviral Agents|antiviral agents|mesh-ancestor
6482272|NCT00551122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6482273|NCT00551122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5561952|NCT04003467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163655|NCT01552603|Pancrelipase|pancrelipase|mesh-list
6163656|NCT01552603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6482274|NCT00551122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6163657|NCT01552681|Immunoglobulins|immunoglobulins|mesh-list
6163658|NCT01552681|Immunologic Factors|immunologic factors|mesh-ancestor
6163659|NCT01552681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163660|NCT01552694|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6163661|NCT01552694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6163662|NCT01552694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163663|NCT01552694|Incretins|incretins|mesh-ancestor
6163664|NCT01552694|Hormones|hormones|mesh-ancestor
6163665|NCT01552694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6163666|NCT01552694|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6163667|NCT01552694|Protease Inhibitors|protease inhibitors|mesh-ancestor
6163668|NCT01552694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6163669|NCT01552694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5561953|NCT04003467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5561954|NCT04003402|Ethanol|ethanol|mesh-list
5561955|NCT04003402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5561956|NCT04003402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5561957|NCT04003402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5561958|NCT04003402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561959|NCT04003610|Gemcitabine|gemcitabine|mesh-list
5561960|NCT04003610|Carboplatin|carboplatin|mesh-list
5561961|NCT04003610|Pembrolizumab|pembrolizumab|mesh-list
5561962|NCT04003610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5561963|NCT04003610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5561964|NCT04003610|Antimetabolites|antimetabolites|mesh-ancestor
5561965|NCT04003610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5561966|NCT04003610|Antiviral Agents|antiviral agents|mesh-ancestor
5561967|NCT04003610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5561968|NCT04003610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5561969|NCT04003610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5561970|NCT04003610|Immunologic Factors|immunologic factors|mesh-ancestor
5561971|NCT04003610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561972|NCT04003610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5561973|NCT04003350|Acetaminophen|acetaminophen|mesh-list
5561974|NCT04003350|Meloxicam|meloxicam|mesh-list
5561975|NCT04003350|Oxycodone|oxycodone|mesh-list
6163670|NCT01552772|Aripiprazole|aripiprazole|mesh-list
6163671|NCT01552772|Antidepressive Agents|antidepressive agents|mesh-ancestor
6482275|NCT00551122|Immunologic Factors|immunologic factors|mesh-ancestor
6482276|NCT00551122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482277|NCT00551122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6482278|NCT00551122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6482279|NCT00551122|Alkylating Agents|alkylating agents|mesh-ancestor
6482280|NCT00551239|Rituximab|rituximab|mesh-list
6482281|NCT00551239|Fludarabine|fludarabine|mesh-list
6482282|NCT00551239|Fludarabine phosphate|fludarabine phosphate|mesh-list
6482283|NCT00551239|Pixantrone|pixantrone|mesh-list
6482284|NCT00551239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6482285|NCT00551239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6482286|NCT00551239|Immunologic Factors|immunologic factors|mesh-ancestor
6482287|NCT00551239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482288|NCT00551239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6482289|NCT00551239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6482290|NCT00551239|Antimetabolites|antimetabolites|mesh-ancestor
6482291|NCT00551239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6482292|NCT00551239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6482293|NCT00551239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6482294|NCT00551239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6482295|NCT00551239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6482296|NCT00551252|Gemcitabine|gemcitabine|mesh-list
6482297|NCT00551252|Imatinib Mesylate|imatinib mesylate|mesh-list
6482298|NCT00551252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6482299|NCT00551252|Antimetabolites|antimetabolites|mesh-ancestor
6163672|NCT01552772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6163673|NCT01552772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6163674|NCT01552772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6163675|NCT01552772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6163676|NCT01552772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163677|NCT01552772|Dopamine Agonists|dopamine agonists|mesh-ancestor
6163678|NCT01552772|Dopamine Agents|dopamine agents|mesh-ancestor
6163679|NCT01552772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6482300|NCT00551252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6482301|NCT00551252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6482302|NCT00551252|Antiviral Agents|antiviral agents|mesh-ancestor
5561976|NCT04003350|Tramadol|tramadol|mesh-list
5561977|NCT04003350|Gabapentin|gabapentin|mesh-list
6482303|NCT00551252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6482304|NCT00551252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6482305|NCT00551252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6482306|NCT00551252|Immunologic Factors|immunologic factors|mesh-ancestor
6482307|NCT00551252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482308|NCT00551252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6482309|NCT00551265|Cyclophosphamide|cyclophosphamide|mesh-list
6482310|NCT00551265|Oregovomab|oregovomab|mesh-list
6482311|NCT00551265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6482312|NCT00551265|Antibodies|antibodies|mesh-list
6482313|NCT00551265|Immunoglobulins|immunoglobulins|mesh-list
6482314|NCT00551265|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6482315|NCT00551265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6482316|NCT00551265|Immunologic Factors|immunologic factors|mesh-ancestor
6482317|NCT00551265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482318|NCT00551265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6482319|NCT00551265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6482320|NCT00551265|Alkylating Agents|alkylating agents|mesh-ancestor
6482321|NCT00551265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6482322|NCT00551265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6482323|NCT00551265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6482324|NCT00551317|Darapladib|darapladib|mesh-list
6482325|NCT00551317|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
6482326|NCT00551317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6482327|NCT00551317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6482328|NCT00551343|Exenatide|exenatide|mesh-list
6482329|NCT00551343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6482330|NCT00551343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482331|NCT00551343|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6482332|NCT00551343|Incretins|incretins|mesh-ancestor
6482333|NCT00551343|Hormones|hormones|mesh-ancestor
6482334|NCT00551343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5561978|NCT04003350|Esomeprazole|esomeprazole|mesh-list
5561979|NCT04003350|Metaxalone|metaxalone|mesh-list
5561980|NCT04003350|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5561981|NCT04003350|Narcotics|narcotics|mesh-ancestor
5561982|NCT04003350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5561983|NCT04003350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5561984|NCT04003350|Analgesics|analgesics|mesh-ancestor
5561985|NCT04003350|Sensory System Agents|sensory system agents|mesh-ancestor
5561986|NCT04003350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5561987|NCT04003350|Anticonvulsants|anticonvulsants|mesh-ancestor
5561988|NCT04003350|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5561989|NCT04003350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5561990|NCT04003350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5561991|NCT04003350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5561992|NCT04003350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5561993|NCT04003350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6482335|NCT00551356|Insulin Lispro|insulin lispro|mesh-list
6482336|NCT00551356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6482337|NCT00551356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163680|NCT01552772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163681|NCT01552772|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6163682|NCT01552772|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6163683|NCT01552772|Serotonin Agents|serotonin agents|mesh-ancestor
6163684|NCT01552772|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6163685|NCT01552772|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6482338|NCT00551382|Montelukast|montelukast|mesh-list
6482339|NCT00551382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6482340|NCT00551382|Respiratory System Agents|respiratory system agents|mesh-ancestor
6482341|NCT00551382|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5561994|NCT04003350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6482342|NCT00551382|Hormone Antagonists|hormone antagonists|mesh-ancestor
6668766|NCT01534026|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6482343|NCT00551382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6482344|NCT00551382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482345|NCT00551382|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6163686|NCT01552772|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6163687|NCT01552772|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6163688|NCT01552902|Methylphenidate|methylphenidate|mesh-list
6163689|NCT01552902|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6163690|NCT01552902|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6163691|NCT01552902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163692|NCT01552902|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6163693|NCT01552902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6163694|NCT01552902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6163695|NCT01552902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163696|NCT01552902|Dopamine Agents|dopamine agents|mesh-ancestor
6163697|NCT01552902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6163698|NCT01552915|Methylphenidate|methylphenidate|mesh-list
6163699|NCT01552915|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6163700|NCT01552915|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6163701|NCT01552915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163702|NCT01552915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6163703|NCT01552915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6163704|NCT01552915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6163705|NCT01552915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163706|NCT01552915|Dopamine Agents|dopamine agents|mesh-ancestor
6163707|NCT01552915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6163708|NCT01552928|Moxifloxacin|moxifloxacin|mesh-list
6163709|NCT01552928|Anagrelide|anagrelide|mesh-list
6163710|NCT01552928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6163711|NCT01552928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6163712|NCT01552928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6163713|NCT01552928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6163714|NCT01552928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6163715|NCT01552928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163716|NCT01552928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6163717|NCT01552928|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6163718|NCT01552928|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6163719|NCT01552928|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6163720|NCT01552954|Angiotensin II|angiotensin ii|mesh-list
6163721|NCT01552954|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6163722|NCT01553058|Adalimumab|adalimumab|mesh-list
6163723|NCT01553058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6163724|NCT01553058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6163725|NCT01553084|Nicotine|nicotine|mesh-list
6163726|NCT01553084|Varenicline|varenicline|mesh-list
6163727|NCT01553084|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6163728|NCT01553084|Autonomic Agents|autonomic agents|mesh-ancestor
6163729|NCT01553084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6163730|NCT01553084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163731|NCT01553084|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6163732|NCT01553084|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6163733|NCT01553084|Cholinergic Agents|cholinergic agents|mesh-ancestor
6163734|NCT01553084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6163735|NCT01553084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163736|NCT01553136|Varenicline|varenicline|mesh-list
6163737|NCT01553136|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6163738|NCT01553136|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6163739|NCT01553136|Cholinergic Agents|cholinergic agents|mesh-ancestor
6163740|NCT01553136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6163741|NCT01553136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163742|NCT01553136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163743|NCT01553188|Prednisone|prednisone|mesh-list
6163744|NCT01553188|Trebananib|trebananib|mesh-list
6163745|NCT01553188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6163746|NCT01553188|Glucocorticoids|glucocorticoids|mesh-ancestor
6163747|NCT01553188|Hormones|hormones|mesh-ancestor
6163748|NCT01553188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6163749|NCT01553188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163750|NCT01553188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6163751|NCT01553188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5561995|NCT04003350|Antimanic Agents|antimanic agents|mesh-ancestor
6163752|NCT01553188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6163753|NCT01553188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5561996|NCT04003350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5561997|NCT04003350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5561998|NCT04003350|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5561999|NCT04003350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5562000|NCT04003350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5562001|NCT04003350|Antipyretics|antipyretics|mesh-ancestor
5562002|NCT04003350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5562003|NCT04003350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5562004|NCT04003350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5562005|NCT04003350|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5562006|NCT04003350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5562007|NCT04003350|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5562008|NCT04003246|Durvalumab|durvalumab|mesh-list
5562009|NCT04003246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5562010|NCT04003246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5562011|NCT04003246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5562012|NCT04003246|Immunologic Factors|immunologic factors|mesh-ancestor
5562013|NCT04003246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603580|NCT02107976|Ascorbic Acid|ascorbic acid|mesh-list
5603581|NCT02107976|Vitamin E|vitamin e|mesh-list
5603582|NCT02107976|Micronutrients|micronutrients|mesh-ancestor
5603583|NCT02107976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603584|NCT02107976|Antioxidants|antioxidants|mesh-ancestor
5603585|NCT02107976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603586|NCT02107976|Protective Agents|protective agents|mesh-ancestor
5603587|NCT02105636|Docetaxel|docetaxel|mesh-list
5603588|NCT02105636|Methotrexate|methotrexate|mesh-list
5603589|NCT02105636|Nivolumab|nivolumab|mesh-list
5603590|NCT02105636|Cetuximab|cetuximab|mesh-list
5603591|NCT02105636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5603592|NCT02105636|Tubulin Modulators|tubulin modulators|mesh-ancestor
5603593|NCT02105636|Antimitotic Agents|antimitotic agents|mesh-ancestor
5603594|NCT02105636|Mitosis Modulators|mitosis modulators|mesh-ancestor
5603595|NCT02105636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603596|NCT02105636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5603597|NCT02105636|Abortifacient Agents|abortifacient agents|mesh-ancestor
5603598|NCT02105636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5603599|NCT02105636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603600|NCT02105636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5603601|NCT02105636|Antimetabolites|antimetabolites|mesh-ancestor
5603602|NCT02105636|Dermatologic Agents|dermatologic agents|mesh-ancestor
5603603|NCT02105636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5603604|NCT02105636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5603605|NCT02105636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5603606|NCT02105636|Immunologic Factors|immunologic factors|mesh-ancestor
5603607|NCT02105636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5603608|NCT02105636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5603609|NCT02105636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5603610|NCT02105636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6163754|NCT01553188|Growth Substances|growth substances|mesh-ancestor
6163755|NCT01553188|Growth Inhibitors|growth inhibitors|mesh-ancestor
6163756|NCT01553201|Botulinum Toxins|botulinum toxins|mesh-list
6163757|NCT01553201|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6163758|NCT01553201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6163759|NCT01553201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163760|NCT01553201|Cholinergic Agents|cholinergic agents|mesh-ancestor
6163761|NCT01553201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6163762|NCT01553201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163763|NCT01553279|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6163764|NCT01553279|Immunologic Factors|immunologic factors|mesh-ancestor
6163765|NCT01553279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163766|NCT01553292|Pulmonary Surfactants|pulmonary surfactants|mesh-list
6163767|NCT01553292|Respiratory System Agents|respiratory system agents|mesh-ancestor
6163768|NCT01553318|Ketotifen|ketotifen|mesh-list
6163769|NCT01553318|Antipruritics|antipruritics|mesh-ancestor
6482346|NCT00551382|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6482347|NCT00551382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6482348|NCT00551512|Cisplatin|cisplatin|mesh-list
6482349|NCT00551512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6482350|NCT00551538|Insulin Glargine|insulin glargine|mesh-list
6482351|NCT00551538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5603611|NCT02038946|Nivolumab|nivolumab|mesh-list
5603612|NCT02038946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5603613|NCT02038946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5603614|NCT02038946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6482352|NCT00551538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482353|NCT00551564|Rosiglitazone|rosiglitazone|mesh-list
6482354|NCT00551564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6482355|NCT00551564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482356|NCT00551577|Carboplatin|carboplatin|mesh-list
6482357|NCT00551577|Docetaxel|docetaxel|mesh-list
6482358|NCT00551577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6482359|NCT00551577|Tubulin Modulators|tubulin modulators|mesh-ancestor
6482360|NCT00551577|Antimitotic Agents|antimitotic agents|mesh-ancestor
6482361|NCT00551577|Mitosis Modulators|mitosis modulators|mesh-ancestor
6482362|NCT00551577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6482363|NCT00551590|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6482364|NCT00551590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6482365|NCT00551590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482366|NCT00551590|Incretins|incretins|mesh-ancestor
6482367|NCT00551590|Hormones|hormones|mesh-ancestor
6482368|NCT00551590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6482369|NCT00551590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6482370|NCT00551590|Protease Inhibitors|protease inhibitors|mesh-ancestor
6482371|NCT00551590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6482372|NCT00551590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6482373|NCT00551616|Levonorgestrel|levonorgestrel|mesh-list
6482374|NCT00551616|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6482375|NCT00551616|Contraceptive Agents|contraceptive agents|mesh-ancestor
6482376|NCT00551616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6482377|NCT00551616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482378|NCT00551616|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6482379|NCT00551616|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6482380|NCT00551616|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6482381|NCT00551733|Paclitaxel|paclitaxel|mesh-list
6482382|NCT00551733|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6482383|NCT00551733|Carboplatin|carboplatin|mesh-list
6668767|NCT01534026|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6163770|NCT01553318|Dermatologic Agents|dermatologic agents|mesh-ancestor
6163771|NCT01553318|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6163772|NCT01553318|Histamine Antagonists|histamine antagonists|mesh-ancestor
6163773|NCT01553318|Histamine Agents|histamine agents|mesh-ancestor
5562014|NCT04003207|Hormones|hormones|mesh-list
5562015|NCT04003207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5562016|NCT04003207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562017|NCT04003181|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5562018|NCT04003181|Bile Acids and Salts|bile acids and salts|mesh-list
5562019|NCT04003181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5562020|NCT04003181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5562021|NCT04003103|Islatravir|islatravir|mesh-list
5562022|NCT04003103|Antiviral Agents|antiviral agents|mesh-ancestor
5562023|NCT04003103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5562024|NCT04003103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5562025|NCT04003103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562026|NCT04003103|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5562027|NCT04003103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5562028|NCT04003103|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5562029|NCT04003012|Lidocaine|lidocaine|mesh-list
5562030|NCT04003012|Anesthetics, Local|anesthetics, local|mesh-ancestor
5562031|NCT04003012|Anesthetics|anesthetics|mesh-ancestor
5562032|NCT04003012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5562033|NCT04003012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562034|NCT04003012|Sensory System Agents|sensory system agents|mesh-ancestor
5562035|NCT04003012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5562036|NCT04003012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6163774|NCT01553318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6163775|NCT01553318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163776|NCT01553318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163777|NCT01553318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6163778|NCT01553539|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
6163779|NCT01553539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6482384|NCT00551733|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
6668768|NCT01534026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668769|NCT01534026|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6668770|NCT01534026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6668771|NCT01534026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6668772|NCT01534026|Antipyretics|antipyretics|mesh-ancestor
6668773|NCT01534169|Dexamethasone|dexamethasone|mesh-list
6668774|NCT01534169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6163780|NCT01553539|Vasodilator Agents|vasodilator agents|mesh-ancestor
6163781|NCT01553591|Eluxadoline|eluxadoline|mesh-list
6163782|NCT01553591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6163783|NCT01553708|Sulfadiazine|sulfadiazine|mesh-list
5562037|NCT04003012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5562038|NCT04003012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5562039|NCT04003012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5562040|NCT04003012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562041|NCT04003090|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
5562042|NCT04003090|Nootropic Agents|nootropic agents|mesh-ancestor
5562043|NCT04002934|Bazedoxifene|bazedoxifene|mesh-list
5562044|NCT04002934|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6163784|NCT01553708|Silver Sulfadiazine|silver sulfadiazine|mesh-list
6163785|NCT01553708|Mitogens|mitogens|mesh-list
6163786|NCT01553708|Mitosis Modulators|mitosis modulators|mesh-ancestor
6163787|NCT01553708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163788|NCT01553708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6163789|NCT01553708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6163790|NCT01553708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5562045|NCT04002934|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5562046|NCT04002934|Hormone Antagonists|hormone antagonists|mesh-ancestor
5562047|NCT04002934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5562048|NCT04002934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562049|NCT04002934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5562050|NCT04002635|Letrozole|letrozole|mesh-list
5562051|NCT04002635|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5562052|NCT04002635|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5562053|NCT04002635|Estradiol|estradiol|mesh-list
5562054|NCT04002635|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5562055|NCT04002635|Progesterone|progesterone|mesh-list
5562056|NCT04002635|Estrogens|estrogens|mesh-ancestor
5562057|NCT04002635|Hormones|hormones|mesh-ancestor
5562058|NCT04002635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5562059|NCT04002635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562060|NCT04002635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5562061|NCT04002635|Contraceptive Agents|contraceptive agents|mesh-ancestor
6163791|NCT01553708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6163792|NCT01553708|Coccidiostats|coccidiostats|mesh-ancestor
6163793|NCT01553708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6163794|NCT01553747|Eluxadoline|eluxadoline|mesh-list
6163795|NCT01553747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6163796|NCT01553851|Trametinib|trametinib|mesh-list
6163797|NCT01553851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6163798|NCT01553851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6163799|NCT01553851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6163800|NCT01553851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163801|NCT01553916|Lithium Carbonate|lithium carbonate|mesh-list
6163802|NCT01553916|Antidepressive Agents|antidepressive agents|mesh-ancestor
6163803|NCT01553916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6163804|NCT01553916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6163805|NCT01553916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163806|NCT01553916|Antimanic Agents|antimanic agents|mesh-ancestor
6163807|NCT01553916|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6163808|NCT01553916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6163809|NCT01553916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163810|NCT01554241|Vitamin D|vitamin d|mesh-list
6163811|NCT01554241|Cholecalciferol|cholecalciferol|mesh-list
6163812|NCT01554241|Vitamins|vitamins|mesh-ancestor
6163813|NCT01554241|Micronutrients|micronutrients|mesh-ancestor
6163814|NCT01554241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482385|NCT00551733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6482386|NCT00551733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6482387|NCT00551733|Tubulin Modulators|tubulin modulators|mesh-ancestor
6482388|NCT00551733|Antimitotic Agents|antimitotic agents|mesh-ancestor
6482389|NCT00551733|Mitosis Modulators|mitosis modulators|mesh-ancestor
6482390|NCT00551733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6482391|NCT00551824|Mitomycins|mitomycins|mesh-list
6482392|NCT00551824|Mitomycin|mitomycin|mesh-list
5562062|NCT04002635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5562063|NCT04002635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5562064|NCT04002635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5562065|NCT04002635|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5562066|NCT04002635|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5562067|NCT04002635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5562068|NCT04002635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562069|NCT04002635|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5562070|NCT04002635|Hormone Antagonists|hormone antagonists|mesh-ancestor
6482393|NCT00551824|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6482394|NCT00551824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6482395|NCT00551824|Alkylating Agents|alkylating agents|mesh-ancestor
6482396|NCT00551824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6482397|NCT00551824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6482398|NCT00551824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6482399|NCT00551850|MP 412|mp 412|mesh-list
6482400|NCT00551850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6482401|NCT00551850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6482402|NCT00551850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6482403|NCT00551850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562071|NCT04002635|Progestins|progestins|mesh-ancestor
5562072|NCT04002401|Cyclophosphamide|cyclophosphamide|mesh-list
5562073|NCT04002401|Rituximab|rituximab|mesh-list
5562074|NCT04002401|Fludarabine|fludarabine|mesh-list
5562075|NCT04002401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6163815|NCT01554241|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6482404|NCT00551889|Celecoxib|celecoxib|mesh-list
6482405|NCT00551889|Cyclophosphamide|cyclophosphamide|mesh-list
6482406|NCT00551889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6482407|NCT00551889|Immunologic Factors|immunologic factors|mesh-ancestor
6482408|NCT00551889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163816|NCT01554241|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6163817|NCT01554371|Cyclophosphamide|cyclophosphamide|mesh-list
6163818|NCT01554371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6163819|NCT01554371|Immunologic Factors|immunologic factors|mesh-ancestor
6163820|NCT01554371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163821|NCT01554371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6163822|NCT01554371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6163823|NCT01554371|Alkylating Agents|alkylating agents|mesh-ancestor
6163824|NCT01554371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163825|NCT01554371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6163826|NCT01554371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6163827|NCT01554488|Fluticasone|fluticasone|mesh-list
6163828|NCT01554488|Xhance|xhance|mesh-list
6482409|NCT00551889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6482410|NCT00551889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6482411|NCT00551889|Alkylating Agents|alkylating agents|mesh-ancestor
6482412|NCT00551889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6482413|NCT00551889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6482414|NCT00551889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6482415|NCT00551889|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6482416|NCT00551889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5562076|NCT04002401|Immunologic Factors|immunologic factors|mesh-ancestor
5562077|NCT04002401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562078|NCT04002401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5562079|NCT04002401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5562080|NCT04002401|Alkylating Agents|alkylating agents|mesh-ancestor
5562081|NCT04002401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562082|NCT04002401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5562083|NCT04002401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5562084|NCT04002401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6163829|NCT01554488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6482417|NCT00551889|Analgesics|analgesics|mesh-ancestor
6482418|NCT00551889|Sensory System Agents|sensory system agents|mesh-ancestor
6482419|NCT00551889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6482420|NCT00551889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6482421|NCT00551889|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6482422|NCT00551889|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6482423|NCT00551889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6482424|NCT00551928|Prednisone|prednisone|mesh-list
6482425|NCT00551928|Lenalidomide|lenalidomide|mesh-list
6482426|NCT00551928|Melphalan|melphalan|mesh-list
6668775|NCT01534169|Antiemetics|antiemetics|mesh-ancestor
6668776|NCT01534169|Autonomic Agents|autonomic agents|mesh-ancestor
6668777|NCT01534169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6668778|NCT01534169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163830|NCT01554488|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6163831|NCT01554488|Autonomic Agents|autonomic agents|mesh-ancestor
6163832|NCT01554488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6482427|NCT00551928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6482428|NCT00551928|Glucocorticoids|glucocorticoids|mesh-ancestor
6482429|NCT00551928|Hormones|hormones|mesh-ancestor
6482430|NCT00551928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6482431|NCT00551928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482432|NCT00551928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6482433|NCT00551928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6482434|NCT00551928|Immunologic Factors|immunologic factors|mesh-ancestor
6482435|NCT00551928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6482436|NCT00551928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6482437|NCT00551928|Growth Substances|growth substances|mesh-ancestor
6163833|NCT01554488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163834|NCT01554488|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6163835|NCT01554488|Respiratory System Agents|respiratory system agents|mesh-ancestor
6163836|NCT01554488|Dermatologic Agents|dermatologic agents|mesh-ancestor
6163837|NCT01554488|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6163838|NCT01554514|Rituximab|rituximab|mesh-list
6163839|NCT01554514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6163840|NCT01554514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6163841|NCT01554514|Immunologic Factors|immunologic factors|mesh-ancestor
6163842|NCT01554514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163843|NCT01554514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6163844|NCT01554618|Exenatide|exenatide|mesh-list
6482438|NCT00551928|Growth Inhibitors|growth inhibitors|mesh-ancestor
6482439|NCT00551928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6482440|NCT00551928|Alkylating Agents|alkylating agents|mesh-ancestor
6482441|NCT00551928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6482442|NCT00551928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6482443|NCT00551928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6482444|NCT00551954|Acarbose|acarbose|mesh-list
5562085|NCT04002323|Lamivudine|lamivudine|mesh-list
6163845|NCT01554618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6163846|NCT01554618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163847|NCT01554618|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6482445|NCT00551954|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
5562086|NCT04002323|Dolutegravir|dolutegravir|mesh-list
6163848|NCT01554618|Incretins|incretins|mesh-ancestor
6163849|NCT01554618|Hormones|hormones|mesh-ancestor
5562087|NCT04002323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5562088|NCT04002323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5562089|NCT04002323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5562090|NCT04002323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562091|NCT04002323|Antiviral Agents|antiviral agents|mesh-ancestor
5562092|NCT04002323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5562093|NCT04002323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5562094|NCT04002323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5562095|NCT04002323|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5562096|NCT04002323|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5562097|NCT04002271|Propofol|propofol|mesh-list
6163850|NCT01554618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6163851|NCT01554683|Levetiracetam|levetiracetam|mesh-list
6163852|NCT01554683|Anticonvulsants|anticonvulsants|mesh-ancestor
6163853|NCT01554683|Nootropic Agents|nootropic agents|mesh-ancestor
6163854|NCT01555125|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6163855|NCT01555125|Immunologic Factors|immunologic factors|mesh-ancestor
6163856|NCT01555125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163857|NCT01555138|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6163858|NCT01555138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6163859|NCT01555138|Autonomic Agents|autonomic agents|mesh-ancestor
6163860|NCT01555138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6163861|NCT01555138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163862|NCT01555138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5562098|NCT04002271|Sevoflurane|sevoflurane|mesh-list
5562099|NCT04002271|Anesthetics|anesthetics|mesh-ancestor
5562100|NCT04002271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5562101|NCT04002271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562102|NCT04002271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5562103|NCT04002271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5562104|NCT04002271|Anesthetics, General|anesthetics, general|mesh-ancestor
5562105|NCT04002271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5562106|NCT04002271|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5562107|NCT04002700|Haloperidol|haloperidol|mesh-list
5562108|NCT04002700|Haloperidol decanoate|haloperidol decanoate|mesh-list
5562109|NCT04002700|Antipsychotic Agents|antipsychotic agents|mesh-list
5562110|NCT04002700|Antiemetics|antiemetics|mesh-ancestor
6163863|NCT01555138|Respiratory System Agents|respiratory system agents|mesh-ancestor
6163864|NCT01555138|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6163865|NCT01555138|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6163866|NCT01555138|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5562111|NCT04002700|Autonomic Agents|autonomic agents|mesh-ancestor
5562112|NCT04002700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5562113|NCT04002700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562114|NCT04002700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5562115|NCT04002700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5562116|NCT04002700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5562117|NCT04002700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5562118|NCT04002700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5562119|NCT04002700|Dopamine Agents|dopamine agents|mesh-ancestor
5562120|NCT04002700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5562121|NCT04002700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562122|NCT04002700|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5562123|NCT04002453|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5562124|NCT04002453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5562125|NCT04002440|Candesartan cilexetil|candesartan cilexetil|mesh-list
5562126|NCT04002440|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6163867|NCT01555138|Adrenergic Agents|adrenergic agents|mesh-ancestor
6163868|NCT01555138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6163869|NCT01555138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163870|NCT01555151|Mometasone Furoate|mometasone furoate|mesh-list
6163871|NCT01555151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6163872|NCT01555151|Dermatologic Agents|dermatologic agents|mesh-ancestor
6163873|NCT01555151|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6163874|NCT01555164|Metformin|metformin|mesh-list
6163875|NCT01555164|Ranolazine|ranolazine|mesh-list
6163876|NCT01555164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6163877|NCT01555164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163878|NCT01555164|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6163879|NCT01555164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6163880|NCT01555164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163881|NCT01555463|Azelaic acid|azelaic acid|mesh-list
6163882|NCT01555463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6163883|NCT01555463|Dermatologic Agents|dermatologic agents|mesh-ancestor
6163884|NCT01555541|Cytarabine|cytarabine|mesh-list
6163885|NCT01555541|Etoposide|etoposide|mesh-list
6163886|NCT01555541|Ofatumumab|ofatumumab|mesh-list
6163887|NCT01555541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6163888|NCT01555541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6163889|NCT01555541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5562127|NCT04002440|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5562128|NCT04002440|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5562129|NCT04002440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562130|NCT04002349|Budesonide|budesonide|mesh-list
5562131|NCT04002349|Levocabastine|levocabastine|mesh-list
5562132|NCT04002349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5562133|NCT04002349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5562134|NCT04002349|Autonomic Agents|autonomic agents|mesh-ancestor
5562135|NCT04002349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5562136|NCT04002349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562137|NCT04002349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5562138|NCT04002349|Respiratory System Agents|respiratory system agents|mesh-ancestor
5562139|NCT04002349|Glucocorticoids|glucocorticoids|mesh-ancestor
6163890|NCT01555541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6163891|NCT01555541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6163892|NCT01555541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163893|NCT01555541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6163894|NCT01555541|Antimetabolites|antimetabolites|mesh-ancestor
6163895|NCT01555541|Antiviral Agents|antiviral agents|mesh-ancestor
6163896|NCT01555541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6163897|NCT01555541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6163898|NCT01555541|Immunologic Factors|immunologic factors|mesh-ancestor
6163899|NCT01555541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163900|NCT01555671|Meperidine|meperidine|mesh-list
6163901|NCT01555671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6163902|NCT01555671|Narcotics|narcotics|mesh-ancestor
6163903|NCT01555671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5562140|NCT04002349|Hormones|hormones|mesh-ancestor
5562141|NCT04002349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5562142|NCT04002349|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5562143|NCT04002349|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5562144|NCT04002349|Histamine Antagonists|histamine antagonists|mesh-ancestor
5562145|NCT04002349|Histamine Agents|histamine agents|mesh-ancestor
5562146|NCT04002349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5562147|NCT04002349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163904|NCT01555671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482446|NCT00551954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6482447|NCT00551954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6482448|NCT00551954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6482449|NCT00551954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482450|NCT00552149|Cetuximab|cetuximab|mesh-list
6482451|NCT00552149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6482452|NCT00552149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5562148|NCT04002518|Cimetidine|cimetidine|mesh-list
5562149|NCT04002518|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5562150|NCT04002518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5562151|NCT04002518|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5562152|NCT04002518|Histamine Antagonists|histamine antagonists|mesh-ancestor
5562153|NCT04002518|Histamine Agents|histamine agents|mesh-ancestor
6163905|NCT01555671|Analgesics|analgesics|mesh-ancestor
6163906|NCT01555671|Sensory System Agents|sensory system agents|mesh-ancestor
6206133|NCT02096861|Dermatologic Agents|dermatologic agents|mesh-ancestor
5562154|NCT04002518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5562155|NCT04002518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562156|NCT04002518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562157|NCT04002518|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5562158|NCT04002518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5562159|NCT04002518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5562160|NCT04002115|Mycophenolic Acid|mycophenolic acid|mesh-list
5562161|NCT04002115|Cyclophosphamide|cyclophosphamide|mesh-list
5562162|NCT04002115|Busulfan|busulfan|mesh-list
5562163|NCT04002115|Fludarabine|fludarabine|mesh-list
5562164|NCT04002115|Clofarabine|clofarabine|mesh-list
5562165|NCT04002115|Tacrolimus|tacrolimus|mesh-list
5562166|NCT04002115|Lenograstim|lenograstim|mesh-list
5562167|NCT04002115|Sargramostim|sargramostim|mesh-list
5562168|NCT04002115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5562169|NCT04002115|Immunologic Factors|immunologic factors|mesh-ancestor
5562170|NCT04002115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562171|NCT04002115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5562172|NCT04002115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5562173|NCT04002115|Alkylating Agents|alkylating agents|mesh-ancestor
5562174|NCT04002115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562175|NCT04002115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5562176|NCT04002115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5562177|NCT04002115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5562178|NCT04002115|Antimetabolites|antimetabolites|mesh-ancestor
6163907|NCT01555671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6163908|NCT01555671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6163909|NCT01555697|Memantine|memantine|mesh-list
6163910|NCT01555697|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6668779|NCT01534169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5562179|NCT04002115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5562180|NCT04002115|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5562181|NCT04002115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5562182|NCT04002115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5562183|NCT04002115|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6668780|NCT01534169|Glucocorticoids|glucocorticoids|mesh-ancestor
6668781|NCT01534169|Hormones|hormones|mesh-ancestor
6668782|NCT01534169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6668783|NCT01534169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6668784|NCT01534169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6668785|NCT01534247|Metronidazole|metronidazole|mesh-list
6668786|NCT01534247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5562184|NCT04002115|Antitubercular Agents|antitubercular agents|mesh-ancestor
6163911|NCT01555697|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6163912|NCT01555697|Dopamine Agents|dopamine agents|mesh-ancestor
6163913|NCT01555697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6163914|NCT01555697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163915|NCT01555697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163916|NCT01555697|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6163917|NCT01555697|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6163918|NCT01555931|Levonorgestrel|levonorgestrel|mesh-list
6163919|NCT01555931|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6163920|NCT01555931|Contraceptive Agents|contraceptive agents|mesh-ancestor
5562185|NCT04002115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5562186|NCT04002115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5562187|NCT04002141|Letrozole|letrozole|mesh-list
5562188|NCT04002141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5562189|NCT04002141|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5562190|NCT04002141|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5562191|NCT04002141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6163921|NCT01555931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6163922|NCT01555931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163923|NCT01555931|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6163924|NCT01555931|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6163925|NCT01555931|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6163926|NCT01556165|Rasagiline|rasagiline|mesh-list
6163927|NCT01556165|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6163928|NCT01556165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6163929|NCT01556165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163930|NCT01556165|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6163931|NCT01556165|Protective Agents|protective agents|mesh-ancestor
6163932|NCT01556165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163933|NCT01556347|Rituximab|rituximab|mesh-list
6163934|NCT01556347|Bortezomib|bortezomib|mesh-list
6163935|NCT01556347|Thymoglobulin|thymoglobulin|mesh-list
6163936|NCT01556347|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6163937|NCT01556347|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6163938|NCT01556347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6163939|NCT01556347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6163940|NCT01556347|Immunologic Factors|immunologic factors|mesh-ancestor
6163941|NCT01556347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163942|NCT01556347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6163943|NCT01556347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6206134|NCT02096861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6206135|NCT02096861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6206136|NCT02096900|Midazolam|midazolam|mesh-list
6482453|NCT00552201|Tacrolimus|tacrolimus|mesh-list
6482454|NCT00552201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6482455|NCT00552201|Immunologic Factors|immunologic factors|mesh-ancestor
6482456|NCT00552201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562192|NCT04002141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562193|NCT04002141|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5562194|NCT04002141|Hormone Antagonists|hormone antagonists|mesh-ancestor
5562195|NCT04002141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5562196|NCT04002141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562197|NCT04001959|Fluorides|fluorides|mesh-list
5562198|NCT04001959|Cariostatic Agents|cariostatic agents|mesh-ancestor
5562199|NCT04001959|Protective Agents|protective agents|mesh-ancestor
5562200|NCT04001959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482457|NCT00552201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6482458|NCT00552201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6482459|NCT00552201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6482460|NCT00552227|Ruboxistaurin|ruboxistaurin|mesh-list
6482461|NCT00552227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6482462|NCT00552227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6482463|NCT00552266|Methylphenidate|methylphenidate|mesh-list
6482464|NCT00552266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6482465|NCT00552266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482466|NCT00552266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6482467|NCT00552266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5562201|NCT04002089|Bupivacaine|bupivacaine|mesh-list
5562202|NCT04002089|Anesthetics, Local|anesthetics, local|mesh-ancestor
5562203|NCT04002089|Anesthetics|anesthetics|mesh-ancestor
5562204|NCT04002089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5562205|NCT04002089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562206|NCT04002089|Sensory System Agents|sensory system agents|mesh-ancestor
5562207|NCT04002089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5562208|NCT04002245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
5562209|NCT04002245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5562210|NCT04002011|Warfarin|warfarin|mesh-list
5562211|NCT04002011|Rivaroxaban|rivaroxaban|mesh-list
5562212|NCT04002011|Dabigatran|dabigatran|mesh-list
5562213|NCT04002011|Apixaban|apixaban|mesh-list
5562214|NCT04002011|Edoxaban|edoxaban|mesh-list
5562215|NCT04002011|Anticoagulants|anticoagulants|mesh-ancestor
5562216|NCT04002011|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5562217|NCT04002011|Antithrombins|antithrombins|mesh-ancestor
5562218|NCT04002011|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5562219|NCT04002011|Protease Inhibitors|protease inhibitors|mesh-ancestor
5562220|NCT04002011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5562221|NCT04002011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562222|NCT04002024|Salicylic Acid|salicylic acid|mesh-list
5562223|NCT04002024|Salicylates|salicylates|mesh-list
5562224|NCT04002024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5562225|NCT04002024|Antifungal Agents|antifungal agents|mesh-ancestor
5562226|NCT04002024|Keratolytic Agents|keratolytic agents|mesh-ancestor
5562227|NCT04002024|Dermatologic Agents|dermatologic agents|mesh-ancestor
6482468|NCT00552266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6668787|NCT01534247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6668788|NCT01534247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6206137|NCT02096900|Zolpidem|zolpidem|mesh-list
6206138|NCT02096900|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6206139|NCT02096900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6206140|NCT02096900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6206141|NCT02096900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206142|NCT02096900|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6206143|NCT02096900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5562228|NCT04002024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5562229|NCT04002024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5562230|NCT04002024|Analgesics|analgesics|mesh-ancestor
6206144|NCT02096900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6163944|NCT01556425|Naltrexone|naltrexone|mesh-list
6163945|NCT01556425|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6163946|NCT01556425|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6163947|NCT01556425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163948|NCT01556425|Sensory System Agents|sensory system agents|mesh-ancestor
6163949|NCT01556425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6163950|NCT01556438|Dexamethasone|dexamethasone|mesh-list
6163951|NCT01556438|Bortezomib|bortezomib|mesh-list
6163952|NCT01556438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6163953|NCT01556438|Antiemetics|antiemetics|mesh-ancestor
6163954|NCT01556438|Autonomic Agents|autonomic agents|mesh-ancestor
6163955|NCT01556438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6482469|NCT00552266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6482470|NCT00552266|Dopamine Agents|dopamine agents|mesh-ancestor
6482471|NCT00552266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6482472|NCT00552370|Insulin Glargine|insulin glargine|mesh-list
6482473|NCT00552370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6482474|NCT00552370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482475|NCT00552461|Rituximab|rituximab|mesh-list
6482476|NCT00552461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6482477|NCT00552461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6482478|NCT00552461|Immunologic Factors|immunologic factors|mesh-ancestor
6482479|NCT00552461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482480|NCT00552461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6482481|NCT00552500|Valproic Acid|valproic acid|mesh-list
6482482|NCT00552500|Anticonvulsants|anticonvulsants|mesh-ancestor
6482483|NCT00552500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6482484|NCT00552500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6482485|NCT00552500|GABA Agents|gaba agents|mesh-ancestor
6482486|NCT00552500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6482487|NCT00552500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482488|NCT00552500|Antimanic Agents|antimanic agents|mesh-ancestor
6482489|NCT00552500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6482490|NCT00552500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6482491|NCT00552500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6482492|NCT00552526|Anticonvulsants|anticonvulsants|mesh-list
6482493|NCT00552630|Penicillamine|penicillamine|mesh-list
6482494|NCT00552630|Antidotes|antidotes|mesh-ancestor
6482495|NCT00552630|Protective Agents|protective agents|mesh-ancestor
6482496|NCT00552630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163956|NCT01556438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163957|NCT01556438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6163958|NCT01556438|Glucocorticoids|glucocorticoids|mesh-ancestor
6163959|NCT01556438|Hormones|hormones|mesh-ancestor
6163960|NCT01556438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6163961|NCT01556438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6163962|NCT01556438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6163963|NCT01556594|Glucagon|glucagon|mesh-list
6163964|NCT01556594|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6163965|NCT01556594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6163966|NCT01556594|Hormones|hormones|mesh-ancestor
6163967|NCT01556594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6482497|NCT00552630|Chelating Agents|chelating agents|mesh-ancestor
6482498|NCT00552630|Sequestering Agents|sequestering agents|mesh-ancestor
6482499|NCT00552630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6482500|NCT00552630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5562231|NCT04002024|Sensory System Agents|sensory system agents|mesh-ancestor
6163968|NCT01556594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163969|NCT01556594|Incretins|incretins|mesh-ancestor
6163970|NCT01556633|Oseltamivir|oseltamivir|mesh-list
6163971|NCT01556633|Antiviral Agents|antiviral agents|mesh-ancestor
6163972|NCT01556633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6163973|NCT01556633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6163974|NCT01556633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6163975|NCT01556724|Ropivacaine|ropivacaine|mesh-list
6163976|NCT01556724|Anesthetics, Local|anesthetics, local|mesh-ancestor
6163977|NCT01556724|Anesthetics|anesthetics|mesh-ancestor
6163978|NCT01556724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6163979|NCT01556724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163980|NCT01556724|Sensory System Agents|sensory system agents|mesh-ancestor
6163981|NCT01556724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5562232|NCT04002024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5562233|NCT04002024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163982|NCT01556763|Antipsychotic Agents|antipsychotic agents|mesh-list
6163983|NCT01556763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6482501|NCT00552656|Sirolimus|sirolimus|mesh-list
6163984|NCT01556763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6163985|NCT01556763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482502|NCT00552656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6482503|NCT00552656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6163986|NCT01556763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6163987|NCT01556932|Diphenhydramine|diphenhydramine|mesh-list
6163988|NCT01556932|Promethazine|promethazine|mesh-list
6163989|NCT01556932|Lorazepam|lorazepam|mesh-list
6163990|NCT01556932|Haloperidol|haloperidol|mesh-list
6163991|NCT01556932|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6163992|NCT01556932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6163993|NCT01556932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6163994|NCT01556932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6163995|NCT01556932|Anesthetics, Local|anesthetics, local|mesh-ancestor
6163996|NCT01556932|Anesthetics|anesthetics|mesh-ancestor
6163997|NCT01556932|Sensory System Agents|sensory system agents|mesh-ancestor
6482504|NCT00552656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6482505|NCT00552656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6482506|NCT00552656|Antifungal Agents|antifungal agents|mesh-ancestor
6482507|NCT00552656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6482508|NCT00552656|Immunologic Factors|immunologic factors|mesh-ancestor
6482509|NCT00552656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482510|NCT00552682|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6482511|NCT00552682|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6482512|NCT00552682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6482513|NCT00552682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5562234|NCT04002024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5562235|NCT04002024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5562236|NCT04002024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5562237|NCT04002024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5562238|NCT04002024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562239|NCT04001712|Caffeine|caffeine|mesh-list
5562240|NCT04001712|Caffeine citrate|caffeine citrate|mesh-list
5562241|NCT04001712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562242|NCT04001712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5562243|NCT04001712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562244|NCT04001712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5562245|NCT04001712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5562246|NCT04001712|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5562247|NCT04001712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5562248|NCT04001712|Purinergic Agents|purinergic agents|mesh-ancestor
5562249|NCT04001712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5562250|NCT04001855|Acetic Acid|acetic acid|mesh-list
5562251|NCT04001855|Retinol acetate|retinol acetate|mesh-list
5562252|NCT04001855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5562253|NCT04001855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5562254|NCT04001855|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5562255|NCT04001855|Immunologic Factors|immunologic factors|mesh-ancestor
5562256|NCT04001855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562257|NCT04001855|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5562258|NCT04001855|Protective Agents|protective agents|mesh-ancestor
5562259|NCT04001855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5562260|NCT04001725|Metformin|metformin|mesh-list
5562261|NCT04001725|Dexamethasone|dexamethasone|mesh-list
5562262|NCT04001725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5562263|NCT04001725|Antiemetics|antiemetics|mesh-ancestor
5562264|NCT04001725|Autonomic Agents|autonomic agents|mesh-ancestor
5562265|NCT04001725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6163998|NCT01556932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6163999|NCT01556932|Antiemetics|antiemetics|mesh-ancestor
6164000|NCT01556932|Autonomic Agents|autonomic agents|mesh-ancestor
6164001|NCT01556932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6164002|NCT01556932|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6164003|NCT01556932|Histamine Antagonists|histamine antagonists|mesh-ancestor
6164004|NCT01556932|Histamine Agents|histamine agents|mesh-ancestor
6164005|NCT01556932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6164006|NCT01556932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164007|NCT01556932|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6164008|NCT01556932|Antipruritics|antipruritics|mesh-ancestor
6164009|NCT01556932|Dermatologic Agents|dermatologic agents|mesh-ancestor
6164010|NCT01556932|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5562266|NCT04001725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562267|NCT04001725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6164011|NCT01556932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6164012|NCT01556932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6164013|NCT01556932|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6164014|NCT01556932|Dopamine Agents|dopamine agents|mesh-ancestor
6164015|NCT01556932|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6164016|NCT01556932|Anticonvulsants|anticonvulsants|mesh-ancestor
6164017|NCT01556932|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6164018|NCT01556932|GABA Modulators|gaba modulators|mesh-ancestor
6164019|NCT01556932|GABA Agents|gaba agents|mesh-ancestor
6164020|NCT01556997|Amlodipine|amlodipine|mesh-list
6482514|NCT00552682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562268|NCT04001725|Glucocorticoids|glucocorticoids|mesh-ancestor
5562269|NCT04001725|Hormones|hormones|mesh-ancestor
5562270|NCT04001725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5562271|NCT04001725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5562272|NCT04001725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5562273|NCT04001725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5562274|NCT04001647|Ascorbic Acid|ascorbic acid|mesh-list
5562275|NCT04001647|Nitroprusside|nitroprusside|mesh-list
6482515|NCT00552682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6482516|NCT00552682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164021|NCT01556997|Perindopril|perindopril|mesh-list
6164022|NCT01556997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6164023|NCT01556997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6164024|NCT01556997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6164025|NCT01556997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164026|NCT01556997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6164027|NCT01556997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164028|NCT01556997|Vasodilator Agents|vasodilator agents|mesh-ancestor
6164029|NCT01556997|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6164030|NCT01556997|Protease Inhibitors|protease inhibitors|mesh-ancestor
6164031|NCT01556997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6164032|NCT01557166|Liraglutide|liraglutide|mesh-list
6164033|NCT01557166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6164034|NCT01557166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164035|NCT01557166|Incretins|incretins|mesh-ancestor
6164036|NCT01557166|Hormones|hormones|mesh-ancestor
6164037|NCT01557166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6164038|NCT01557244|Fesoterodine|fesoterodine|mesh-list
6668789|NCT01534247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6668790|NCT01534312|Mesalamine|mesalamine|mesh-list
6668791|NCT01534312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6668792|NCT01534312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6668793|NCT01534312|Analgesics|analgesics|mesh-ancestor
6668794|NCT01534312|Sensory System Agents|sensory system agents|mesh-ancestor
6668795|NCT01534312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6668796|NCT01534312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668797|NCT01534312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6668798|NCT01534312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6668799|NCT01534442|Atropine|atropine|mesh-list
5562276|NCT04001647|Acetylcholine|acetylcholine|mesh-list
5562277|NCT04001647|Vitamins|vitamins|mesh-ancestor
5562278|NCT04001647|Micronutrients|micronutrients|mesh-ancestor
5562279|NCT04001647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668800|NCT01534442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6668801|NCT01534442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6668802|NCT01534442|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6668803|NCT01534442|Autonomic Agents|autonomic agents|mesh-ancestor
6668804|NCT01534442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6668805|NCT01534442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668806|NCT01534442|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6668807|NCT01534442|Respiratory System Agents|respiratory system agents|mesh-ancestor
6668808|NCT01534442|Mydriatics|mydriatics|mesh-ancestor
5562280|NCT04001647|Antioxidants|antioxidants|mesh-ancestor
6164039|NCT01557244|Oxybutynin|oxybutynin|mesh-list
6164040|NCT01557244|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6164041|NCT01557244|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6164042|NCT01557244|Cholinergic Agents|cholinergic agents|mesh-ancestor
6164043|NCT01557244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6164044|NCT01557244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6482517|NCT00552682|Analgesics|analgesics|mesh-ancestor
6482518|NCT00552682|Sensory System Agents|sensory system agents|mesh-ancestor
6482519|NCT00552682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6482520|NCT00552682|Antidepressive Agents|antidepressive agents|mesh-ancestor
6482521|NCT00552682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6482522|NCT00552682|Dopamine Agents|dopamine agents|mesh-ancestor
6482523|NCT00552734|Insulin|insulin|mesh-list
6482524|NCT00552734|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6668809|NCT01534442|Parasympatholytics|parasympatholytics|mesh-ancestor
6482525|NCT00552734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6164045|NCT01557244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164046|NCT01557244|Urological Agents|urological agents|mesh-ancestor
5562281|NCT04001647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562282|NCT04001647|Protective Agents|protective agents|mesh-ancestor
5562283|NCT04001647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5562284|NCT04001647|Vasodilator Agents|vasodilator agents|mesh-ancestor
6482526|NCT00552734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482527|NCT00552747|Fenofibrate|fenofibrate|mesh-list
6482528|NCT00552747|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6482529|NCT00552747|Antimetabolites|antimetabolites|mesh-ancestor
6482530|NCT00552747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6482531|NCT00552747|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6164047|NCT01557244|Parasympatholytics|parasympatholytics|mesh-ancestor
6164048|NCT01557244|Autonomic Agents|autonomic agents|mesh-ancestor
5562285|NCT04001647|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5562286|NCT04001647|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5562287|NCT04001647|Cholinergic Agents|cholinergic agents|mesh-ancestor
5562288|NCT04001647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5562289|NCT04001608|Sofosbuvir|sofosbuvir|mesh-list
5562290|NCT04001608|Antiviral Agents|antiviral agents|mesh-ancestor
5562291|NCT04001608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5562292|NCT04001621|Capecitabine|capecitabine|mesh-list
6668810|NCT01534442|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6668811|NCT01534442|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6668812|NCT01534442|Cholinergic Agents|cholinergic agents|mesh-ancestor
6668813|NCT01534442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6668814|NCT01534442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668815|NCT01534455|Lapatinib|lapatinib|mesh-list
6668816|NCT01534455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6164049|NCT01557244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6164050|NCT01557283|Etanercept|etanercept|mesh-list
6164051|NCT01557283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6668817|NCT01534455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6668818|NCT01534455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6668819|NCT01534455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668820|NCT01534494|Psilocybin|psilocybin|mesh-list
6668821|NCT01534494|Hallucinogens|hallucinogens|mesh-ancestor
6668822|NCT01534494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668823|NCT01534494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6668824|NCT01534546|Capecitabine|capecitabine|mesh-list
6668825|NCT01534546|Oxaliplatin|oxaliplatin|mesh-list
6668826|NCT01534546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6668827|NCT01534546|Antimetabolites|antimetabolites|mesh-ancestor
6668828|NCT01534546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562293|NCT04001621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6164052|NCT01557283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6164053|NCT01557283|Analgesics|analgesics|mesh-ancestor
6164054|NCT01557283|Sensory System Agents|sensory system agents|mesh-ancestor
6164055|NCT01557283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6164056|NCT01557283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164057|NCT01557283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6482532|NCT00552799|Penicillins|penicillins|mesh-list
6482533|NCT00552799|Penicillin V|penicillin v|mesh-list
6482534|NCT00552799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6482535|NCT00552799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6482536|NCT00552838|Anti-Infective Agents|anti-infective agents|mesh-list
6482537|NCT00552838|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6482538|NCT00552864|Ropivacaine|ropivacaine|mesh-list
6482539|NCT00552864|Levobupivacaine|levobupivacaine|mesh-list
6482540|NCT00552864|Anesthetics, Local|anesthetics, local|mesh-ancestor
6482541|NCT00552864|Anesthetics|anesthetics|mesh-ancestor
6482542|NCT00552864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6164058|NCT01557283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6164059|NCT01557283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6164060|NCT01557283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6482543|NCT00552864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562294|NCT04001621|Antimetabolites|antimetabolites|mesh-ancestor
5562295|NCT04001621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562296|NCT04001621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6482544|NCT00552864|Sensory System Agents|sensory system agents|mesh-ancestor
6482545|NCT00552864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6488912|NCT00587717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562297|NCT04001465|Methacholine Chloride|methacholine chloride|mesh-list
6488913|NCT00587717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6482546|NCT00553020|Insulin Glargine|insulin glargine|mesh-list
6482547|NCT00553020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6482548|NCT00553020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562298|NCT04001465|Miotics|miotics|mesh-ancestor
5562299|NCT04001465|Autonomic Agents|autonomic agents|mesh-ancestor
5562300|NCT04001465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5562301|NCT04001465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562302|NCT04001465|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5562303|NCT04001465|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
5562304|NCT04001465|Respiratory System Agents|respiratory system agents|mesh-ancestor
5562305|NCT04001465|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
5562306|NCT04001465|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5562307|NCT04001465|Cholinergic Agents|cholinergic agents|mesh-ancestor
6482549|NCT00553072|Magnesium Sulfate|magnesium sulfate|mesh-list
6482550|NCT00553072|Analgesics|analgesics|mesh-ancestor
6482551|NCT00553072|Sensory System Agents|sensory system agents|mesh-ancestor
6482552|NCT00553072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6482553|NCT00553072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482554|NCT00553072|Anesthetics|anesthetics|mesh-ancestor
6482555|NCT00553072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6482556|NCT00553072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6482557|NCT00553072|Anticonvulsants|anticonvulsants|mesh-ancestor
6482558|NCT00553072|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6482559|NCT00553072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5562308|NCT04001465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5562309|NCT04001465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603615|NCT02038946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603616|NCT01988571|Atorvastatin|atorvastatin|mesh-list
5603617|NCT01988571|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5603618|NCT01988571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5603619|NCT01988571|Antimetabolites|antimetabolites|mesh-ancestor
5603620|NCT01988571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603621|NCT01988571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5603622|NCT01988571|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5603623|NCT01988571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5603624|NCT01979367|Analgesics|analgesics|mesh-list
5603625|NCT01979367|Sensory System Agents|sensory system agents|mesh-ancestor
5603626|NCT01979367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5603627|NCT01979367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603628|NCT01973452|Dexmedetomidine|dexmedetomidine|mesh-list
6482560|NCT00553072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6482561|NCT00553072|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6482562|NCT00553072|Tocolytic Agents|tocolytic agents|mesh-ancestor
6482563|NCT00553072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6482564|NCT00553124|Vitamin E|vitamin e|mesh-list
6482565|NCT00553124|Selenium|selenium|mesh-list
6482566|NCT00553124|Vitamins|vitamins|mesh-ancestor
6482567|NCT00553124|Micronutrients|micronutrients|mesh-ancestor
6482568|NCT00553124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482569|NCT00553124|Antioxidants|antioxidants|mesh-ancestor
6482570|NCT00553124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164061|NCT01557283|Immunologic Factors|immunologic factors|mesh-ancestor
5603629|NCT01973452|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5603630|NCT01973452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5603631|NCT01973452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603632|NCT01973452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5603633|NCT01973452|Analgesics|analgesics|mesh-ancestor
5603634|NCT01973452|Sensory System Agents|sensory system agents|mesh-ancestor
5603635|NCT01973452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5603636|NCT01973452|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6164062|NCT01557322|Etanercept|etanercept|mesh-list
6164063|NCT01557322|Methotrexate|methotrexate|mesh-list
6164064|NCT01557322|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6164065|NCT01557322|Abortifacient Agents|abortifacient agents|mesh-ancestor
6164066|NCT01557322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6164067|NCT01557322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164068|NCT01557322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6482571|NCT00553124|Protective Agents|protective agents|mesh-ancestor
6482572|NCT00553124|Trace Elements|trace elements|mesh-ancestor
6482573|NCT00553137|Fluconazole|fluconazole|mesh-list
6482574|NCT00553137|Antifungal Agents|antifungal agents|mesh-ancestor
6482575|NCT00553137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6482576|NCT00553137|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6164069|NCT01557322|Antimetabolites|antimetabolites|mesh-ancestor
6482577|NCT00553137|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6482578|NCT00553137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6482579|NCT00553137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668829|NCT01534546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6668830|NCT01534585|Paclitaxel|paclitaxel|mesh-list
6668831|NCT01534585|Mitogens|mitogens|mesh-list
6482580|NCT00553137|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6482581|NCT00553137|Hormone Antagonists|hormone antagonists|mesh-ancestor
6482582|NCT00553137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6482583|NCT00553137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482584|NCT00553137|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6668832|NCT01534585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6164070|NCT01557322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164071|NCT01557322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6164072|NCT01557322|Dermatologic Agents|dermatologic agents|mesh-ancestor
6164073|NCT01557322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6164074|NCT01557322|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6164075|NCT01557322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6164076|NCT01557322|Immunologic Factors|immunologic factors|mesh-ancestor
6164077|NCT01557322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6164078|NCT01557322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6164079|NCT01557322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6164080|NCT01557322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6164081|NCT01557322|Analgesics|analgesics|mesh-ancestor
6164082|NCT01557322|Sensory System Agents|sensory system agents|mesh-ancestor
6164083|NCT01557322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5562310|NCT04001231|Exenatide|exenatide|mesh-list
5562311|NCT04001231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5562312|NCT04001231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562313|NCT04001231|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5562314|NCT04001231|Incretins|incretins|mesh-ancestor
6668833|NCT01534585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6668834|NCT01534585|Tubulin Modulators|tubulin modulators|mesh-ancestor
6668835|NCT01534585|Antimitotic Agents|antimitotic agents|mesh-ancestor
6668836|NCT01534585|Mitosis Modulators|mitosis modulators|mesh-ancestor
6668837|NCT01534585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668838|NCT01534702|Cytarabine|cytarabine|mesh-list
5562315|NCT04001231|Hormones|hormones|mesh-ancestor
5562316|NCT04001231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5562317|NCT04001400|Rabeprazole|rabeprazole|mesh-list
5562318|NCT04001400|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5562319|NCT04001400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5562320|NCT04001400|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5562321|NCT04001400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5562322|NCT04001400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562323|NCT04001387|Anesthetics|anesthetics|mesh-list
5562324|NCT04001387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5562325|NCT04001387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562326|NCT04001413|Durvalumab|durvalumab|mesh-list
5562327|NCT04001413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5562328|NCT04001413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5562329|NCT04001530|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5562330|NCT04001309|Anti-Infective Agents|anti-infective agents|mesh-list
5562331|NCT04001309|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5562332|NCT04001374|Ticagrelor|ticagrelor|mesh-list
6164084|NCT01557322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6164085|NCT01557322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6164086|NCT01557452|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
6164087|NCT01557452|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6164088|NCT01557452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6164089|NCT01557452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164090|NCT01557504|Metformin|metformin|mesh-list
6164091|NCT01557504|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6164092|NCT01557504|Hormones|hormones|mesh-list
6164093|NCT01557504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6164094|NCT01557504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164095|NCT01557504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6164096|NCT01557504|Incretins|incretins|mesh-ancestor
6164097|NCT01557504|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5562333|NCT04001374|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5562334|NCT04001374|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5562335|NCT04001374|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6164098|NCT01557504|Protease Inhibitors|protease inhibitors|mesh-ancestor
5562336|NCT04001374|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5562337|NCT04001374|Purinergic Agents|purinergic agents|mesh-ancestor
5562338|NCT04001374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6164099|NCT01557504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6164100|NCT01557504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164101|NCT01557517|Clobetasol|clobetasol|mesh-list
6164102|NCT01557517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6164103|NCT01557517|Glucocorticoids|glucocorticoids|mesh-ancestor
6164104|NCT01557517|Hormones|hormones|mesh-ancestor
6164105|NCT01557517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6164106|NCT01557517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164107|NCT01557569|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6164108|NCT01557569|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6164109|NCT01557569|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6164110|NCT01557569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6164111|NCT01557569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164112|NCT01557569|Adrenergic Agents|adrenergic agents|mesh-ancestor
6482585|NCT00553137|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6482586|NCT00553189|Topotecan|topotecan|mesh-list
6482587|NCT00553189|Veliparib|veliparib|mesh-list
6482588|NCT00553189|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6482589|NCT00553189|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6482590|NCT00553189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6482591|NCT00553189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6482592|NCT00553189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6482593|NCT00553189|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6482594|NCT00553293|Hormones|hormones|mesh-list
5562339|NCT04001374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562340|NCT04001374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482595|NCT00553293|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6482596|NCT00553293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6482597|NCT00553293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482598|NCT00553345|Vitamin E|vitamin e|mesh-list
6482599|NCT00553345|Selenium|selenium|mesh-list
6482600|NCT00553345|Vitamins|vitamins|mesh-ancestor
6482601|NCT00553345|Micronutrients|micronutrients|mesh-ancestor
6482602|NCT00553345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482603|NCT00553345|Antioxidants|antioxidants|mesh-ancestor
5562341|NCT04001322|Vaccines|vaccines|mesh-list
5562342|NCT04001322|Immunologic Factors|immunologic factors|mesh-ancestor
5562343|NCT04001322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562344|NCT04001569|Paclitaxel|paclitaxel|mesh-list
5562345|NCT04001569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5562346|NCT04001569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5562347|NCT04001569|Tubulin Modulators|tubulin modulators|mesh-ancestor
5562348|NCT04001569|Antimitotic Agents|antimitotic agents|mesh-ancestor
5562349|NCT04001569|Mitosis Modulators|mitosis modulators|mesh-ancestor
5562350|NCT04001569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562351|NCT04001348|Diazepam|diazepam|mesh-list
5562352|NCT04001348|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5562353|NCT04001348|Anticonvulsants|anticonvulsants|mesh-ancestor
5562354|NCT04001348|Antiemetics|antiemetics|mesh-ancestor
6164113|NCT01557569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6164114|NCT01557569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164115|NCT01557868|Hyaluronic Acid|hyaluronic acid|mesh-list
6164116|NCT01557868|Hylan|hylan|mesh-list
6164117|NCT01557868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6164118|NCT01557868|Immunologic Factors|immunologic factors|mesh-ancestor
5562355|NCT04001348|Autonomic Agents|autonomic agents|mesh-ancestor
5562356|NCT04001348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5562357|NCT04001348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562358|NCT04001348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5562359|NCT04001348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5562360|NCT04001348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5562361|NCT04001348|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5562362|NCT04001348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5562363|NCT04001348|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5562364|NCT04001348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5562365|NCT04001348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6164119|NCT01557868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164120|NCT01557868|Viscosupplements|viscosupplements|mesh-ancestor
6164121|NCT01557868|Protective Agents|protective agents|mesh-ancestor
6164122|NCT01557920|Propofol|propofol|mesh-list
6164123|NCT01557920|Sevoflurane|sevoflurane|mesh-list
5562366|NCT04001348|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5562367|NCT04001348|Anesthetics, General|anesthetics, general|mesh-ancestor
5562368|NCT04001348|Anesthetics|anesthetics|mesh-ancestor
5562369|NCT04001348|GABA Modulators|gaba modulators|mesh-ancestor
5562370|NCT04001348|GABA Agents|gaba agents|mesh-ancestor
5562371|NCT04001348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5562372|NCT04001348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562373|NCT04000919|Carbidopa|carbidopa|mesh-list
5562374|NCT04000919|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5562375|NCT04000919|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5562376|NCT04000919|Dopamine Agents|dopamine agents|mesh-ancestor
5562377|NCT04000919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5562378|NCT04000919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562379|NCT04000919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562380|NCT04000919|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5562381|NCT04000919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5562382|NCT04000789|Vitamins|vitamins|mesh-list
5562383|NCT04000789|Vitamin E|vitamin e|mesh-list
5562384|NCT04000789|Vitamin A|vitamin a|mesh-list
5562385|NCT04000789|Hyaluronic Acid|hyaluronic acid|mesh-list
5562386|NCT04000789|Micronutrients|micronutrients|mesh-ancestor
5562387|NCT04000789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562388|NCT04000789|Antioxidants|antioxidants|mesh-ancestor
6164124|NCT01557920|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6164125|NCT01557920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6164126|NCT01557920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164127|NCT01557920|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6164128|NCT01557920|Anesthetics, General|anesthetics, general|mesh-ancestor
6164129|NCT01557920|Anesthetics|anesthetics|mesh-ancestor
6164130|NCT01557920|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6164131|NCT01557920|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6164132|NCT01557946|Citalopram|citalopram|mesh-list
6164133|NCT01557946|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6164134|NCT01557946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6164135|NCT01557946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6164136|NCT01557946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164137|NCT01557946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6164138|NCT01557946|Serotonin Agents|serotonin agents|mesh-ancestor
6164139|NCT01557946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562389|NCT04000789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562390|NCT04000789|Protective Agents|protective agents|mesh-ancestor
5562391|NCT04000789|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6164140|NCT01557946|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6164141|NCT01557946|Antidepressive Agents|antidepressive agents|mesh-ancestor
6164142|NCT01557946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6164143|NCT01557959|Docetaxel|docetaxel|mesh-list
6164144|NCT01557959|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6164145|NCT01557959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6164146|NCT01557959|Tubulin Modulators|tubulin modulators|mesh-ancestor
6164147|NCT01557959|Antimitotic Agents|antimitotic agents|mesh-ancestor
6164148|NCT01557959|Mitosis Modulators|mitosis modulators|mesh-ancestor
6164149|NCT01557959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164150|NCT01557959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6164151|NCT01557959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5562392|NCT04000789|Immunologic Factors|immunologic factors|mesh-ancestor
5562393|NCT04000789|Viscosupplements|viscosupplements|mesh-ancestor
5562394|NCT04000906|Paclitaxel|paclitaxel|mesh-list
5562395|NCT04000906|Cisplatin|cisplatin|mesh-list
5562396|NCT04000906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5562397|NCT04000906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5562398|NCT04000906|Tubulin Modulators|tubulin modulators|mesh-ancestor
5562399|NCT04000906|Antimitotic Agents|antimitotic agents|mesh-ancestor
5562400|NCT04000906|Mitosis Modulators|mitosis modulators|mesh-ancestor
5562401|NCT04000906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562402|NCT04000854|Calcium|calcium|mesh-list
5562403|NCT04000854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6164152|NCT01558063|Ketamine|ketamine|mesh-list
6164153|NCT01558063|Analgesics|analgesics|mesh-ancestor
5562404|NCT04000854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562405|NCT04000932|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
5562406|NCT04000932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5562407|NCT04000932|Glucocorticoids|glucocorticoids|mesh-ancestor
5562408|NCT04000932|Hormones|hormones|mesh-ancestor
5562409|NCT04000932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5562410|NCT04000932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562411|NCT04000633|Lidocaine|lidocaine|mesh-list
6164154|NCT01558063|Sensory System Agents|sensory system agents|mesh-ancestor
6164155|NCT01558063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6164156|NCT01558063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562412|NCT04000633|Anesthetics, Local|anesthetics, local|mesh-ancestor
5562413|NCT04000633|Anesthetics|anesthetics|mesh-ancestor
5562414|NCT04000633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5562415|NCT04000633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562416|NCT04000633|Sensory System Agents|sensory system agents|mesh-ancestor
5562417|NCT04000633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5562418|NCT04000633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5562419|NCT04000633|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5562420|NCT04000633|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6164157|NCT01558063|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6164158|NCT01558063|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6164159|NCT01558063|Anesthetics, General|anesthetics, general|mesh-ancestor
6164160|NCT01558063|Anesthetics|anesthetics|mesh-ancestor
6164161|NCT01558063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6164162|NCT01558063|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6164163|NCT01558063|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6164164|NCT01558063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6164165|NCT01558063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164166|NCT01558089|Etanercept|etanercept|mesh-list
6164167|NCT01558089|Methotrexate|methotrexate|mesh-list
5562421|NCT04000633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5562422|NCT04000633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562423|NCT04000386|Zinc Oxide|zinc oxide|mesh-list
5562424|NCT04000386|Dermatologic Agents|dermatologic agents|mesh-ancestor
5562425|NCT04000386|Sunscreening Agents|sunscreening agents|mesh-ancestor
6164168|NCT01558089|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6164169|NCT01558089|Abortifacient Agents|abortifacient agents|mesh-ancestor
6164170|NCT01558089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6164171|NCT01558089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164172|NCT01558089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6164173|NCT01558089|Antimetabolites|antimetabolites|mesh-ancestor
6164174|NCT01558089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164175|NCT01558089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6164176|NCT01558089|Dermatologic Agents|dermatologic agents|mesh-ancestor
6164177|NCT01558089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6164178|NCT01558089|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6164179|NCT01558089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6164180|NCT01558089|Immunologic Factors|immunologic factors|mesh-ancestor
6164181|NCT01558089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6164182|NCT01558089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6164183|NCT01558089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6164184|NCT01558089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6164185|NCT01558089|Analgesics|analgesics|mesh-ancestor
6164186|NCT01558089|Sensory System Agents|sensory system agents|mesh-ancestor
6164187|NCT01558089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6164188|NCT01558089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6164189|NCT01558089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6164190|NCT01558128|Amiodarone|amiodarone|mesh-list
6164191|NCT01558128|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6164192|NCT01558128|Vasodilator Agents|vasodilator agents|mesh-ancestor
6164193|NCT01558128|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6482604|NCT00553345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6482605|NCT00553345|Protective Agents|protective agents|mesh-ancestor
6482606|NCT00553345|Trace Elements|trace elements|mesh-ancestor
6482607|NCT00553423|Lactulose|lactulose|mesh-list
6482608|NCT00553423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6482609|NCT00553449|Rabeprazole|rabeprazole|mesh-list
6482610|NCT00553449|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6482611|NCT00553449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6482612|NCT00553449|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6482613|NCT00553449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6482614|NCT00553449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6482615|NCT00553488|Insulin|insulin|mesh-list
6482616|NCT00553488|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6482617|NCT00553488|Insulin Lispro|insulin lispro|mesh-list
6482618|NCT00553488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6482619|NCT00553488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482620|NCT00553553|Morphine|morphine|mesh-list
6482621|NCT00553553|Remifentanil|remifentanil|mesh-list
6482622|NCT00553553|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6482623|NCT00553553|Narcotics|narcotics|mesh-ancestor
6668839|NCT01534702|Clofarabine|clofarabine|mesh-list
6482624|NCT00553553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6482625|NCT00553553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482626|NCT00553553|Analgesics|analgesics|mesh-ancestor
6482627|NCT00553553|Sensory System Agents|sensory system agents|mesh-ancestor
6482628|NCT00553553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6482629|NCT00553618|Aldesleukin|aldesleukin|mesh-list
6482630|NCT00553618|Dacarbazine|dacarbazine|mesh-list
6482631|NCT00553618|Interleukin-2|interleukin-2|mesh-list
6482632|NCT00553618|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6482633|NCT00553618|Alkylating Agents|alkylating agents|mesh-ancestor
6482634|NCT00553618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6482635|NCT00553618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6482636|NCT00553618|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6482637|NCT00553618|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6482638|NCT00553618|Antiviral Agents|antiviral agents|mesh-ancestor
6482639|NCT00553618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6482640|NCT00553618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6482641|NCT00553618|Analgesics|analgesics|mesh-ancestor
6482642|NCT00553618|Sensory System Agents|sensory system agents|mesh-ancestor
6482643|NCT00553618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6482644|NCT00553618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482645|NCT00553683|Cyclophosphamide|cyclophosphamide|mesh-list
6164194|NCT01558128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6164195|NCT01558128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6482646|NCT00553683|Poly ICLC|poly iclc|mesh-list
6668840|NCT01534702|Idarubicin|idarubicin|mesh-list
6668841|NCT01534702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6668842|NCT01534702|Antimetabolites|antimetabolites|mesh-ancestor
5562426|NCT04000386|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5562427|NCT04000386|Protective Agents|protective agents|mesh-ancestor
5562428|NCT04000386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562429|NCT04000347|Benzoyl Peroxide|benzoyl peroxide|mesh-list
5562430|NCT04000347|Dermatologic Agents|dermatologic agents|mesh-ancestor
5562431|NCT04000295|Paclitaxel|paclitaxel|mesh-list
5562432|NCT04000295|Etoposide|etoposide|mesh-list
5562433|NCT04000295|Apatinib|apatinib|mesh-list
5562434|NCT04000295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5562435|NCT04000295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5562436|NCT04000295|Tubulin Modulators|tubulin modulators|mesh-ancestor
5562437|NCT04000295|Antimitotic Agents|antimitotic agents|mesh-ancestor
5562438|NCT04000295|Mitosis Modulators|mitosis modulators|mesh-ancestor
5562439|NCT04000295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562440|NCT04000295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5562441|NCT04000295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6164196|NCT01558128|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6668843|NCT01534702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668844|NCT01534702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6668845|NCT01534702|Antiviral Agents|antiviral agents|mesh-ancestor
6668846|NCT01534702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6668847|NCT01534702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6668848|NCT01534702|Immunologic Factors|immunologic factors|mesh-ancestor
6668849|NCT01534702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668850|NCT01534702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6668851|NCT01534702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6668852|NCT01534702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6668853|NCT01534702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6668854|NCT01534754|Mesalamine|mesalamine|mesh-list
6668855|NCT01534754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6668856|NCT01534754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6668857|NCT01534754|Analgesics|analgesics|mesh-ancestor
6668858|NCT01534754|Sensory System Agents|sensory system agents|mesh-ancestor
6668859|NCT01534754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6668860|NCT01534754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562442|NCT04000295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6164197|NCT01558128|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6164198|NCT01558128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6164199|NCT01558128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6164200|NCT01558128|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6164201|NCT01558128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6164202|NCT01558128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6164203|NCT01558271|Liraglutide|liraglutide|mesh-list
6164204|NCT01558271|Dulaglutide|dulaglutide|mesh-list
6164205|NCT01558271|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6482647|NCT00553683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6482648|NCT00553683|Immunologic Factors|immunologic factors|mesh-ancestor
6164206|NCT01558271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164207|NCT01558271|Incretins|incretins|mesh-ancestor
6482649|NCT00553683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482650|NCT00553683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6482651|NCT00553683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6482652|NCT00553683|Alkylating Agents|alkylating agents|mesh-ancestor
6482653|NCT00553683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6482654|NCT00553683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6482655|NCT00553683|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6482656|NCT00553683|Interferon Inducers|interferon inducers|mesh-ancestor
6482657|NCT00553709|Nicotine|nicotine|mesh-list
6482658|NCT00553709|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6668861|NCT01534754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6164208|NCT01558271|Hormones|hormones|mesh-ancestor
6164209|NCT01558271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6164210|NCT01558661|Axitinib|axitinib|mesh-list
6668862|NCT01534754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6668863|NCT01534806|Ketorolac|ketorolac|mesh-list
6668864|NCT01534806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6668865|NCT01534806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6668866|NCT01534806|Analgesics|analgesics|mesh-ancestor
5562443|NCT04000295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5562444|NCT04000009|Pimavanserin|pimavanserin|mesh-list
5562445|NCT04000009|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5562446|NCT04000009|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5562447|NCT04000009|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5562448|NCT04000009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5562449|NCT04000009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5562450|NCT04000009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562451|NCT04000009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5562452|NCT04000009|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5562453|NCT04000009|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5562454|NCT04000009|Serotonin Agents|serotonin agents|mesh-ancestor
5562455|NCT04000009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5562456|NCT04000009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562457|NCT04000126|Lidocaine|lidocaine|mesh-list
6668867|NCT01534806|Sensory System Agents|sensory system agents|mesh-ancestor
6668868|NCT01534806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6668869|NCT01534806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668870|NCT01534806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6668871|NCT01534806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6668872|NCT01534806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6668873|NCT01534806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6668874|NCT01534806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668875|NCT01534845|Temozolomide|temozolomide|mesh-list
6668876|NCT01534845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6668877|NCT01534845|Alkylating Agents|alkylating agents|mesh-ancestor
6668878|NCT01534845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668879|NCT01534845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6668880|NCT01534858|Polihexanide|polihexanide|mesh-list
6668881|NCT01534858|Betaine|betaine|mesh-list
6668882|NCT01534858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6668883|NCT01534858|Lipotropic Agents|lipotropic agents|mesh-ancestor
6668884|NCT01534858|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6164211|NCT01558661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6164212|NCT01558661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6164213|NCT01558661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6668885|NCT01534858|Antimetabolites|antimetabolites|mesh-ancestor
5562458|NCT04000126|Anesthetics, Local|anesthetics, local|mesh-ancestor
6164214|NCT01558661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164215|NCT01558674|Torsemide|torsemide|mesh-list
6164216|NCT01558674|Furosemide|furosemide|mesh-list
6164217|NCT01558674|Diuretics|diuretics|mesh-ancestor
6164218|NCT01558674|Natriuretic Agents|natriuretic agents|mesh-ancestor
6164219|NCT01558674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164220|NCT01558674|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6164221|NCT01558674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6164222|NCT01558674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164223|NCT01558674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6164224|NCT01558700|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6164225|NCT01558700|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6164226|NCT01558700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6164227|NCT01558700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6164228|NCT01558700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164229|NCT01558700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6164230|NCT01558700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562459|NCT04000126|Anesthetics|anesthetics|mesh-ancestor
5562460|NCT04000126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5562461|NCT04000126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562462|NCT04000126|Sensory System Agents|sensory system agents|mesh-ancestor
5562463|NCT04000126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5562464|NCT04000126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5562465|NCT04000126|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5562466|NCT04000126|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5562467|NCT04000126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5562468|NCT04000126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562469|NCT03999710|Durvalumab|durvalumab|mesh-list
5562470|NCT03999710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5562471|NCT03999710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6164231|NCT01558700|Analgesics|analgesics|mesh-ancestor
6164232|NCT01558700|Sensory System Agents|sensory system agents|mesh-ancestor
6164233|NCT01558700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6164234|NCT01558700|Antidepressive Agents|antidepressive agents|mesh-ancestor
6164235|NCT01558700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6164236|NCT01558700|Dopamine Agents|dopamine agents|mesh-ancestor
6164237|NCT01559012|Clonidine|clonidine|mesh-list
6164238|NCT01559012|Analgesics|analgesics|mesh-ancestor
6164239|NCT01559012|Sensory System Agents|sensory system agents|mesh-ancestor
6482659|NCT00553709|Autonomic Agents|autonomic agents|mesh-ancestor
6164240|NCT01559012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6164241|NCT01559012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164242|NCT01559012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6164243|NCT01559012|Sympatholytics|sympatholytics|mesh-ancestor
6164244|NCT01559012|Autonomic Agents|autonomic agents|mesh-ancestor
6164245|NCT01559012|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6164246|NCT01559012|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6164247|NCT01559012|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6164248|NCT01559012|Adrenergic Agents|adrenergic agents|mesh-ancestor
6164249|NCT01559012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6164250|NCT01559012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164251|NCT01559064|Lidocaine|lidocaine|mesh-list
6164252|NCT01559064|Hyaluronic Acid|hyaluronic acid|mesh-list
6164253|NCT01559064|Anesthetics, Local|anesthetics, local|mesh-ancestor
6164254|NCT01559064|Anesthetics|anesthetics|mesh-ancestor
6164255|NCT01559064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6164256|NCT01559064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164257|NCT01559064|Sensory System Agents|sensory system agents|mesh-ancestor
6164258|NCT01559064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6164259|NCT01559064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6164260|NCT01559064|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6164261|NCT01559064|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6164262|NCT01559064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6164263|NCT01559064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164264|NCT01559064|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6164265|NCT01559064|Immunologic Factors|immunologic factors|mesh-ancestor
6164266|NCT01559064|Viscosupplements|viscosupplements|mesh-ancestor
6164267|NCT01559064|Protective Agents|protective agents|mesh-ancestor
6164268|NCT01559090|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6164269|NCT01559090|Immunologic Factors|immunologic factors|mesh-ancestor
6164270|NCT01559090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164271|NCT01559116|Tiotropium Bromide|tiotropium bromide|mesh-list
6164272|NCT01559116|Olodaterol|olodaterol|mesh-list
6164273|NCT01559116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6164274|NCT01559116|Autonomic Agents|autonomic agents|mesh-ancestor
6482660|NCT00553709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5603637|NCT01973452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5603638|NCT01973452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5603639|NCT01973452|Adrenergic Agents|adrenergic agents|mesh-ancestor
5603640|NCT01973452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5603641|NCT01973452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603642|NCT01964560|Lacosamide|lacosamide|mesh-list
5603643|NCT01964560|Anticonvulsants|anticonvulsants|mesh-ancestor
5603644|NCT01964560|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5603645|NCT01964560|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5603646|NCT01964560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5603647|NCT01964560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164275|NCT01559116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6164276|NCT01559116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164277|NCT01559116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5562472|NCT03999580|Vitamin D|vitamin d|mesh-list
5562473|NCT03999580|Cholecalciferol|cholecalciferol|mesh-list
5562474|NCT03999580|Vitamins|vitamins|mesh-ancestor
5562475|NCT03999580|Micronutrients|micronutrients|mesh-ancestor
5562476|NCT03999580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562477|NCT03999580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5562478|NCT03999580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5562479|NCT03999866|Pyrithione zinc|pyrithione zinc|mesh-list
5562480|NCT03999866|Keratolytic Agents|keratolytic agents|mesh-ancestor
5562481|NCT03999866|Dermatologic Agents|dermatologic agents|mesh-ancestor
5562482|NCT03999749|Nivolumab|nivolumab|mesh-list
5562483|NCT03999749|Ipilimumab|ipilimumab|mesh-list
5562484|NCT03999749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5562485|NCT03999749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5562486|NCT03999749|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5562487|NCT03999749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562488|NCT03999775|Calcium, Dietary|calcium, dietary|mesh-list
5562489|NCT03999775|Vitamin D|vitamin d|mesh-list
5562490|NCT03999775|Ergocalciferols|ergocalciferols|mesh-list
5562491|NCT03999775|Vitamins|vitamins|mesh-list
5562492|NCT03999775|Calcium|calcium|mesh-list
6164278|NCT01559116|Respiratory System Agents|respiratory system agents|mesh-ancestor
6164279|NCT01559116|Parasympatholytics|parasympatholytics|mesh-ancestor
6164280|NCT01559116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6164281|NCT01559116|Cholinergic Agents|cholinergic agents|mesh-ancestor
6164282|NCT01559116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6164283|NCT01559116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164284|NCT01559129|Pomalidomide|pomalidomide|mesh-list
6164285|NCT01559129|Immunologic Factors|immunologic factors|mesh-ancestor
6164286|NCT01559129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164287|NCT01559129|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6164288|NCT01559129|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6164289|NCT01559129|Growth Substances|growth substances|mesh-ancestor
6164290|NCT01559129|Growth Inhibitors|growth inhibitors|mesh-ancestor
6164291|NCT01559129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6164292|NCT01559259|Acetaminophen|acetaminophen|mesh-list
6164293|NCT01559259|Ibuprofen|ibuprofen|mesh-list
6164294|NCT01559259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6164295|NCT01559259|Analgesics|analgesics|mesh-ancestor
5562493|NCT03999775|Micronutrients|micronutrients|mesh-ancestor
5562494|NCT03999775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562495|NCT03999775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5562496|NCT03999775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5562497|NCT03999723|Ascorbic Acid|ascorbic acid|mesh-list
5562498|NCT03999723|Vitamins|vitamins|mesh-ancestor
5562499|NCT03999723|Micronutrients|micronutrients|mesh-ancestor
5562500|NCT03999723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562501|NCT03999723|Antioxidants|antioxidants|mesh-ancestor
5562502|NCT03999723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562503|NCT03999723|Protective Agents|protective agents|mesh-ancestor
6164296|NCT01559259|Sensory System Agents|sensory system agents|mesh-ancestor
6164297|NCT01559259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6164298|NCT01559259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164299|NCT01559259|Antipyretics|antipyretics|mesh-ancestor
6164300|NCT01559259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6668886|NCT01534858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668887|NCT01534858|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6668888|NCT01534858|Disinfectants|disinfectants|mesh-ancestor
6668889|NCT01534858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6668890|NCT01534884|Rituximab|rituximab|mesh-list
6668891|NCT01534884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6164301|NCT01559259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6164302|NCT01559259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6164303|NCT01559259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6164304|NCT01559259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6164305|NCT01559259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164306|NCT01559389|Solifenacin Succinate|solifenacin succinate|mesh-list
6164307|NCT01559389|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6164308|NCT01559389|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6668892|NCT01534884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5562504|NCT03999372|Hyaluronic Acid|hyaluronic acid|mesh-list
5562505|NCT03999372|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5562506|NCT03999372|Immunologic Factors|immunologic factors|mesh-ancestor
6164309|NCT01559389|Cholinergic Agents|cholinergic agents|mesh-ancestor
6164310|NCT01559389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6164311|NCT01559389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164312|NCT01559389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164313|NCT01559389|Urological Agents|urological agents|mesh-ancestor
6482661|NCT00553709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482662|NCT00553709|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6482663|NCT00553709|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6482664|NCT00553709|Cholinergic Agents|cholinergic agents|mesh-ancestor
6482665|NCT00553709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6482666|NCT00553709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6482667|NCT00553722|Eplerenone|eplerenone|mesh-list
6482668|NCT00553722|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6482669|NCT00553722|Hormone Antagonists|hormone antagonists|mesh-ancestor
6668893|NCT01534884|Immunologic Factors|immunologic factors|mesh-ancestor
6164314|NCT01559454|Buprenorphine|buprenorphine|mesh-list
6164315|NCT01559454|Methadone|methadone|mesh-list
6164316|NCT01559454|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6164317|NCT01559454|Naloxone|naloxone|mesh-list
6164318|NCT01559454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6164319|NCT01559454|Narcotics|narcotics|mesh-ancestor
6164320|NCT01559454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6164321|NCT01559454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164322|NCT01559454|Analgesics|analgesics|mesh-ancestor
6164323|NCT01559454|Sensory System Agents|sensory system agents|mesh-ancestor
6164324|NCT01559454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6164325|NCT01559454|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5562507|NCT03999372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562508|NCT03999372|Viscosupplements|viscosupplements|mesh-ancestor
5562509|NCT03999372|Protective Agents|protective agents|mesh-ancestor
5562510|NCT03999437|Terbinafine|terbinafine|mesh-list
5562511|NCT03999437|Butenafine|butenafine|mesh-list
5562512|NCT03999437|Antifungal Agents|antifungal agents|mesh-ancestor
5562513|NCT03999437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6164326|NCT01559454|Antitussive Agents|antitussive agents|mesh-ancestor
6164327|NCT01559454|Respiratory System Agents|respiratory system agents|mesh-ancestor
6164328|NCT01559675|Hydrocortisone|hydrocortisone|mesh-list
6164329|NCT01559675|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6164330|NCT01559675|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6164331|NCT01559675|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6164332|NCT01559675|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6164333|NCT01559675|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6164334|NCT01559675|Methylprednisolone|methylprednisolone|mesh-list
6164335|NCT01559675|Prednisolone|prednisolone|mesh-list
6164336|NCT01559675|Prednisolone acetate|prednisolone acetate|mesh-list
6164337|NCT01559675|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6164338|NCT01559675|Prednisolone phosphate|prednisolone phosphate|mesh-list
5562514|NCT03999437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5562515|NCT03999437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562516|NCT03999554|Vaccines|vaccines|mesh-list
5562517|NCT03999554|Immunologic Factors|immunologic factors|mesh-ancestor
5562518|NCT03999554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164339|NCT01559675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6164340|NCT01559675|Glucocorticoids|glucocorticoids|mesh-ancestor
5562519|NCT03999099|Suvorexant|suvorexant|mesh-list
5562520|NCT03999099|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5562521|NCT03999099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5562522|NCT03999099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5562523|NCT03999099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562524|NCT03999099|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
5562525|NCT03999099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5562526|NCT03999099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562527|NCT03999216|Diuretics|diuretics|mesh-list
5562528|NCT03999216|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
5562529|NCT03999216|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
5562530|NCT03999216|Natriuretic Agents|natriuretic agents|mesh-ancestor
5562531|NCT03999216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562532|NCT03999216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5562533|NCT03999216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562534|NCT03999203|Nitric Oxide|nitric oxide|mesh-list
5562535|NCT03999203|Citric Acid|citric acid|mesh-list
5562536|NCT03999203|Sodium Citrate|sodium citrate|mesh-list
5562537|NCT03999203|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5562538|NCT03999203|Autonomic Agents|autonomic agents|mesh-ancestor
5562539|NCT03999203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6164341|NCT01559675|Hormones|hormones|mesh-ancestor
6164342|NCT01559675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6164343|NCT01559675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164344|NCT01559675|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6164345|NCT01559675|Protective Agents|protective agents|mesh-ancestor
6164346|NCT01559675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6164347|NCT01559675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6164348|NCT01559675|Antiemetics|antiemetics|mesh-ancestor
6164349|NCT01559675|Autonomic Agents|autonomic agents|mesh-ancestor
6164350|NCT01559675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5562540|NCT03999203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562541|NCT03999203|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5562542|NCT03999203|Respiratory System Agents|respiratory system agents|mesh-ancestor
5562543|NCT03999203|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5562544|NCT03999203|Antioxidants|antioxidants|mesh-ancestor
5562545|NCT03999203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562546|NCT03999203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5562547|NCT03999203|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5562548|NCT03999203|Vasodilator Agents|vasodilator agents|mesh-ancestor
5562549|NCT03999203|Gasotransmitters|gasotransmitters|mesh-ancestor
5562550|NCT03999203|Protective Agents|protective agents|mesh-ancestor
5562551|NCT03999203|Anticoagulants|anticoagulants|mesh-ancestor
5562552|NCT03999203|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5562553|NCT03999203|Chelating Agents|chelating agents|mesh-ancestor
5562554|NCT03999203|Sequestering Agents|sequestering agents|mesh-ancestor
5562555|NCT03999190|Raclopride|raclopride|mesh-list
5562556|NCT03999190|Dextroamphetamine|dextroamphetamine|mesh-list
5562557|NCT03999190|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5562558|NCT03999190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164351|NCT01559675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6164352|NCT01559844|Ribavirin|ribavirin|mesh-list
6164353|NCT01559844|Sofosbuvir|sofosbuvir|mesh-list
6164354|NCT01559844|Antimetabolites|antimetabolites|mesh-ancestor
6164355|NCT01559844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164356|NCT01559844|Antiviral Agents|antiviral agents|mesh-ancestor
6164357|NCT01559844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6164358|NCT01559857|Pioglitazone|pioglitazone|mesh-list
6164359|NCT01559857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6164360|NCT01559857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562559|NCT03999190|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5562560|NCT03999190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5562561|NCT03999190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5562562|NCT03999190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562563|NCT03999190|Dopamine Agents|dopamine agents|mesh-ancestor
5562564|NCT03999190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5562565|NCT03999190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5562566|NCT03999190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5562567|NCT03999190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5562568|NCT03999190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5562569|NCT03999190|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5562570|NCT03999008|Budesonide|budesonide|mesh-list
5562571|NCT03999008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5562572|NCT03999008|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5562573|NCT03999008|Autonomic Agents|autonomic agents|mesh-ancestor
5562574|NCT03999008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5562575|NCT03999008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562576|NCT03999008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5562577|NCT03999008|Respiratory System Agents|respiratory system agents|mesh-ancestor
5562578|NCT03999008|Glucocorticoids|glucocorticoids|mesh-ancestor
5562579|NCT03999008|Hormones|hormones|mesh-ancestor
5562580|NCT03999008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5562581|NCT03999125|Dexamethasone|dexamethasone|mesh-list
5562582|NCT03999125|Dexamethasone acetate|dexamethasone acetate|mesh-list
5562583|NCT03999125|Ranibizumab|ranibizumab|mesh-list
5562584|NCT03999125|Aflibercept|aflibercept|mesh-list
5562585|NCT03999125|BB 1101|bb 1101|mesh-list
5562586|NCT03999125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5562587|NCT03999125|Antiemetics|antiemetics|mesh-ancestor
6164361|NCT01559922|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
6164362|NCT01559922|Vasodilator Agents|vasodilator agents|mesh-ancestor
6164363|NCT01559922|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
5562588|NCT03999125|Autonomic Agents|autonomic agents|mesh-ancestor
5562589|NCT03999125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5562590|NCT03999125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562591|NCT03999125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5562592|NCT03999125|Glucocorticoids|glucocorticoids|mesh-ancestor
6164364|NCT01559922|Protective Agents|protective agents|mesh-ancestor
6164365|NCT01559922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164366|NCT01559935|Clarithromycin|clarithromycin|mesh-list
5562593|NCT03999125|Hormones|hormones|mesh-ancestor
5562594|NCT03999125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5562595|NCT03999125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5562596|NCT03999125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6164367|NCT01559935|Dexamethasone|dexamethasone|mesh-list
6164368|NCT01559935|Dexamethasone acetate|dexamethasone acetate|mesh-list
6164369|NCT01559935|Lenalidomide|lenalidomide|mesh-list
6164370|NCT01559935|BB 1101|bb 1101|mesh-list
6164371|NCT01559935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6164372|NCT01559935|Antiemetics|antiemetics|mesh-ancestor
6164373|NCT01559935|Autonomic Agents|autonomic agents|mesh-ancestor
6164374|NCT01559935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6164375|NCT01559935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164376|NCT01559935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6164377|NCT01559935|Glucocorticoids|glucocorticoids|mesh-ancestor
5562597|NCT03999125|Protease Inhibitors|protease inhibitors|mesh-ancestor
5562598|NCT03999125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5562599|NCT03999125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562600|NCT03999125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5562601|NCT03999125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5562602|NCT03999125|Growth Substances|growth substances|mesh-ancestor
5562603|NCT03999125|Growth Inhibitors|growth inhibitors|mesh-ancestor
5562604|NCT03998982|Dexamethasone|dexamethasone|mesh-list
5562605|NCT03998982|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
5562606|NCT03998982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5562607|NCT03998982|Antiemetics|antiemetics|mesh-ancestor
5562608|NCT03998982|Autonomic Agents|autonomic agents|mesh-ancestor
5562609|NCT03998982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5562610|NCT03998982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562611|NCT03998982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5562612|NCT03998982|Glucocorticoids|glucocorticoids|mesh-ancestor
5562613|NCT03998982|Hormones|hormones|mesh-ancestor
5562614|NCT03998982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5562615|NCT03998982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5562616|NCT03998982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5562617|NCT03998969|Pantoprazole|pantoprazole|mesh-list
5562618|NCT03998969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5562619|NCT03998969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5562620|NCT03998969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5562621|NCT03998969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5562622|NCT03998969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562623|NCT03998696|Cisplatin|cisplatin|mesh-list
5562624|NCT03998696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5562625|NCT03998709|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
5562626|NCT03998709|Somatostatin|somatostatin|mesh-list
5562627|NCT03998709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562628|NCT03998709|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
5562629|NCT03998709|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5562630|NCT03998709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5562631|NCT03998709|Hormones|hormones|mesh-ancestor
5562632|NCT03998709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5562633|NCT03998670|Methamphetamine|methamphetamine|mesh-list
5562634|NCT03998670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5562635|NCT03998670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562636|NCT03998670|Sympathomimetics|sympathomimetics|mesh-ancestor
6164378|NCT01559935|Hormones|hormones|mesh-ancestor
6164379|NCT01559935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6164380|NCT01559935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6164381|NCT01559935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6164382|NCT01559935|Protease Inhibitors|protease inhibitors|mesh-ancestor
6164383|NCT01559935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6164384|NCT01559935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164385|NCT01559935|Immunologic Factors|immunologic factors|mesh-ancestor
6164386|NCT01559935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6164387|NCT01559935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6164388|NCT01559935|Growth Substances|growth substances|mesh-ancestor
6164389|NCT01559935|Growth Inhibitors|growth inhibitors|mesh-ancestor
6164390|NCT01559935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6164391|NCT01559935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6164392|NCT01559935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6164393|NCT01559935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6164394|NCT01559935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6164395|NCT01560143|Tigecycline|tigecycline|mesh-list
5562637|NCT03998670|Autonomic Agents|autonomic agents|mesh-ancestor
5562638|NCT03998670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5562639|NCT03998670|Dopamine Agents|dopamine agents|mesh-ancestor
5562640|NCT03998670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5562641|NCT03998670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562642|NCT03998670|Adrenergic Agents|adrenergic agents|mesh-ancestor
5562643|NCT03998670|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5562644|NCT03998670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5562645|NCT03998670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5562646|NCT03998670|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5562647|NCT03998761|Progesterone|progesterone|mesh-list
5562648|NCT03998761|Dydrogesterone|dydrogesterone|mesh-list
5562649|NCT03998761|Progestins|progestins|mesh-ancestor
5562650|NCT03998761|Hormones|hormones|mesh-ancestor
5562651|NCT03998761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5562652|NCT03998761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562653|NCT03998826|Piroxicam|piroxicam|mesh-list
5562654|NCT03998826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5562655|NCT03998826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5562656|NCT03998826|Analgesics|analgesics|mesh-ancestor
5562657|NCT03998826|Sensory System Agents|sensory system agents|mesh-ancestor
5562658|NCT03998826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5562659|NCT03998826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562660|NCT03998826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6164396|NCT01560143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6164397|NCT01560143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6164398|NCT01560143|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6164399|NCT01560143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6164400|NCT01560143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164401|NCT01560403|Teduglutide|teduglutide|mesh-list
6164402|NCT01560403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6164403|NCT01560403|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6164404|NCT01560403|Protective Agents|protective agents|mesh-ancestor
6164405|NCT01560403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164406|NCT01560416|Fulvestrant|fulvestrant|mesh-list
6164407|NCT01560416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6164408|NCT01560416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6164409|NCT01560416|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5562661|NCT03998826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5562662|NCT03998826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5562663|NCT03998826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5562664|NCT03998826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562665|NCT03998592|Vaccines|vaccines|mesh-list
6482670|NCT00553722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6482671|NCT00553722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562666|NCT03998592|Immunologic Factors|immunologic factors|mesh-ancestor
5562667|NCT03998592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562668|NCT03998176|Tenofovir|tenofovir|mesh-list
5562669|NCT03998176|Emtricitabine|emtricitabine|mesh-list
5562670|NCT03998176|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
5562671|NCT03998176|Antiviral Agents|antiviral agents|mesh-ancestor
5562672|NCT03998176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5562673|NCT03998176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5562674|NCT03998176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5562675|NCT03998176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5562676|NCT03998176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562677|NCT03998176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5562678|NCT03998176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5562679|NCT03998215|Vaccines|vaccines|mesh-list
5562680|NCT03998215|Immunologic Factors|immunologic factors|mesh-ancestor
5562681|NCT03998215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562682|NCT03998449|Vaccines|vaccines|mesh-list
5562683|NCT03998449|Immunologic Factors|immunologic factors|mesh-ancestor
5562684|NCT03998449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562685|NCT03998436|Esmolol|esmolol|mesh-list
5562686|NCT03998436|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5562687|NCT03998436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5562688|NCT03998436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5562689|NCT03998436|Adrenergic Agents|adrenergic agents|mesh-ancestor
5562690|NCT03998436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5562691|NCT03998436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562692|NCT03998436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603648|NCT01863550|Dexamethasone|dexamethasone|mesh-list
5603649|NCT01863550|Dexamethasone acetate|dexamethasone acetate|mesh-list
5603650|NCT01863550|Lenalidomide|lenalidomide|mesh-list
5603651|NCT01863550|Bortezomib|bortezomib|mesh-list
5603652|NCT01863550|Ichthammol|ichthammol|mesh-list
6164410|NCT01560416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6164411|NCT01560416|Hormone Antagonists|hormone antagonists|mesh-ancestor
6164412|NCT01560416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6164413|NCT01560416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164414|NCT01560624|Treprostinil|treprostinil|mesh-list
6164415|NCT01560624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6164416|NCT01560780|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6164417|NCT01560780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6164418|NCT01560923|Tryptophan|tryptophan|mesh-list
6164419|NCT01560923|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6164420|NCT01560923|Antidepressive Agents|antidepressive agents|mesh-ancestor
6164421|NCT01560923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6164422|NCT01560949|Gemcitabine|gemcitabine|mesh-list
6164423|NCT01560949|Fluorouracil|fluorouracil|mesh-list
6164424|NCT01560949|Oxaliplatin|oxaliplatin|mesh-list
6164425|NCT01560949|Irinotecan|irinotecan|mesh-list
6164426|NCT01560949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6164427|NCT01560949|Antimetabolites|antimetabolites|mesh-ancestor
6164428|NCT01560949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164429|NCT01560949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6164430|NCT01560949|Antiviral Agents|antiviral agents|mesh-ancestor
6164431|NCT01560949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6164432|NCT01560949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6164433|NCT01560949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5603653|NCT01863550|BB 1101|bb 1101|mesh-list
5603654|NCT01863550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5603655|NCT01863550|Antiemetics|antiemetics|mesh-ancestor
5603656|NCT01863550|Autonomic Agents|autonomic agents|mesh-ancestor
5603657|NCT01863550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5603658|NCT01863550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603659|NCT01863550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5603660|NCT01863550|Glucocorticoids|glucocorticoids|mesh-ancestor
5603661|NCT01863550|Hormones|hormones|mesh-ancestor
5603662|NCT01863550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5603663|NCT01863550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5603664|NCT01863550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5603665|NCT01863550|Immunologic Factors|immunologic factors|mesh-ancestor
5603666|NCT01863550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5603667|NCT01863550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5603668|NCT01863550|Growth Substances|growth substances|mesh-ancestor
5603669|NCT01863550|Growth Inhibitors|growth inhibitors|mesh-ancestor
5603670|NCT01863550|Protease Inhibitors|protease inhibitors|mesh-ancestor
5603671|NCT01863550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5603672|NCT01863550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603673|NCT01863550|Dermatologic Agents|dermatologic agents|mesh-ancestor
5603674|NCT01824875|Capecitabine|capecitabine|mesh-list
5603675|NCT01824875|Temozolomide|temozolomide|mesh-list
5603676|NCT01824875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6164434|NCT01560949|Immunologic Factors|immunologic factors|mesh-ancestor
6164435|NCT01560949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164436|NCT01560949|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6164437|NCT01560949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6164438|NCT01561053|Immunoglobulins|immunoglobulins|mesh-list
6164439|NCT01561053|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5603677|NCT01824875|Antimetabolites|antimetabolites|mesh-ancestor
6164440|NCT01561053|Antibodies|antibodies|mesh-list
6164441|NCT01561053|Immunologic Factors|immunologic factors|mesh-ancestor
6164442|NCT01561053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164443|NCT01561079|Buprenorphine|buprenorphine|mesh-list
6164444|NCT01561079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6164445|NCT01561079|Narcotics|narcotics|mesh-ancestor
6164446|NCT01561079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6164447|NCT01561079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164448|NCT01561079|Analgesics|analgesics|mesh-ancestor
6164449|NCT01561079|Sensory System Agents|sensory system agents|mesh-ancestor
6164450|NCT01561079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6164451|NCT01561079|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6164452|NCT01561313|Adalimumab|adalimumab|mesh-list
6482672|NCT00553722|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6482673|NCT00553722|Diuretics|diuretics|mesh-ancestor
6482674|NCT00553722|Natriuretic Agents|natriuretic agents|mesh-ancestor
6164453|NCT01561313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6164454|NCT01561313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6164455|NCT01561469|Vancomycin|vancomycin|mesh-list
6164456|NCT01561469|Linezolid|linezolid|mesh-list
6164457|NCT01561469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6164458|NCT01561469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6164459|NCT01561469|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5562693|NCT03997968|Gemcitabine|gemcitabine|mesh-list
5562694|NCT03997968|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5562695|NCT03997968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5562696|NCT03997968|Immunologic Factors|immunologic factors|mesh-ancestor
5562697|NCT03997968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562698|NCT03997968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5562699|NCT03997968|Antimetabolites|antimetabolites|mesh-ancestor
5562700|NCT03997968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562701|NCT03997968|Antiviral Agents|antiviral agents|mesh-ancestor
5562702|NCT03997968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5562703|NCT03997968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5562704|NCT03997968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5562705|NCT03997968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5562706|NCT03997968|Alkylating Agents|alkylating agents|mesh-ancestor
5562707|NCT03997903|Imatinib Mesylate|imatinib mesylate|mesh-list
5562708|NCT03997903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5562709|NCT03997903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5562710|NCT03997903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5562711|NCT03997903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164460|NCT01561469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6164461|NCT01561469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164462|NCT01561703|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6164463|NCT01561703|Amoxicillin|amoxicillin|mesh-list
6164464|NCT01561703|Azithromycin|azithromycin|mesh-list
5562712|NCT03997864|Prazosin|prazosin|mesh-list
5562713|NCT03997864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5562714|NCT03997864|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5562715|NCT03997864|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5562716|NCT03997864|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5562717|NCT03997864|Adrenergic Agents|adrenergic agents|mesh-ancestor
5562718|NCT03997864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5562719|NCT03997864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562720|NCT03997864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562721|NCT03997539|Vinorelbine|vinorelbine|mesh-list
5562722|NCT03997539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5562723|NCT03997539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5562724|NCT03997539|Tubulin Modulators|tubulin modulators|mesh-ancestor
5562725|NCT03997539|Antimitotic Agents|antimitotic agents|mesh-ancestor
5562726|NCT03997539|Mitosis Modulators|mitosis modulators|mesh-ancestor
5562727|NCT03997539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562728|NCT03997500|Norepinephrine|norepinephrine|mesh-list
5562729|NCT03997500|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5562730|NCT03997500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5562731|NCT03997500|Adrenergic Agents|adrenergic agents|mesh-ancestor
5562732|NCT03997500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5562733|NCT03997500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562734|NCT03997500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164465|NCT01561703|Clindamycin|clindamycin|mesh-list
6164466|NCT01561703|Clavulanic Acid|clavulanic acid|mesh-list
6164467|NCT01561703|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6164468|NCT01561703|Cephalexin|cephalexin|mesh-list
6164469|NCT01561703|Cefdinir|cefdinir|mesh-list
6164470|NCT01561703|Cefaclor|cefaclor|mesh-list
6482675|NCT00553722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5562735|NCT03997500|Sympathomimetics|sympathomimetics|mesh-ancestor
5562736|NCT03997500|Autonomic Agents|autonomic agents|mesh-ancestor
5562737|NCT03997500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5562738|NCT03997500|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5562739|NCT03997292|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5562740|NCT03997292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5562741|NCT03997292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5562742|NCT03997292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562743|NCT03997279|Amoxicillin|amoxicillin|mesh-list
5562744|NCT03997279|Metronidazole|metronidazole|mesh-list
5562745|NCT03997279|Clarithromycin|clarithromycin|mesh-list
5562746|NCT03997279|Rabeprazole|rabeprazole|mesh-list
5562747|NCT03997279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5562748|NCT03997279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5562749|NCT03997279|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5562750|NCT03997279|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5562751|NCT03997279|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6164471|NCT01561703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6164472|NCT01561703|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6164473|NCT01561703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6164474|NCT01561703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164475|NCT01561703|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6164476|NCT01561755|Immunoglobulins|immunoglobulins|mesh-list
6164477|NCT01561755|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6164478|NCT01561755|Antibodies|antibodies|mesh-list
6164479|NCT01561755|gamma-Globulins|gamma-globulins|mesh-list
6164480|NCT01561755|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5562752|NCT03997279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5562753|NCT03997279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562754|NCT03997279|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5562755|NCT03997279|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5562756|NCT03997279|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6164481|NCT01561755|Immunologic Factors|immunologic factors|mesh-ancestor
6164482|NCT01561755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164483|NCT01561833|Sorafenib|sorafenib|mesh-list
6164484|NCT01561833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6164485|NCT01561833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6164486|NCT01561833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6164487|NCT01561833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164488|NCT01561898|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6164489|NCT01561898|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6164490|NCT01561898|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6164491|NCT01561898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6164492|NCT01561898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164493|NCT01561898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6164494|NCT01561898|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6164495|NCT01561898|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6164496|NCT01561898|Serotonin Agents|serotonin agents|mesh-ancestor
6164497|NCT01561898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6164498|NCT01561898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164499|NCT01561898|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6164500|NCT01561898|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6164501|NCT01561898|Dopamine Agents|dopamine agents|mesh-ancestor
6164502|NCT01561963|Rifampin|rifampin|mesh-list
6164503|NCT01561963|Apremilast|apremilast|mesh-list
6164504|NCT01561963|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6164505|NCT01561963|Antitubercular Agents|antitubercular agents|mesh-ancestor
6164506|NCT01561963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6164507|NCT01561963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6164508|NCT01561963|Leprostatic Agents|leprostatic agents|mesh-ancestor
6164509|NCT01561963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6164510|NCT01561963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6164511|NCT01561963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164512|NCT01561963|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6164513|NCT01561963|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6164514|NCT01561963|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6164515|NCT01561963|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6164516|NCT01561963|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6164517|NCT01561963|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6164518|NCT01561963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6164519|NCT01561963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6164520|NCT01561963|Analgesics|analgesics|mesh-ancestor
5562757|NCT03997279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6164521|NCT01561963|Sensory System Agents|sensory system agents|mesh-ancestor
6164522|NCT01561963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6164523|NCT01561963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164524|NCT01561963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6164525|NCT01561963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5562758|NCT03997279|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5562759|NCT03997266|Gentamicins|gentamicins|mesh-list
5562760|NCT03997266|Ampicillin|ampicillin|mesh-list
5562761|NCT03997266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5562762|NCT03997266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5562763|NCT03997266|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5562764|NCT03997266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5562765|NCT03997266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562766|NCT03997019|Analgesics, Opioid|analgesics, opioid|mesh-list
5562767|NCT03997019|Narcotics|narcotics|mesh-ancestor
5562768|NCT03997019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5562769|NCT03997019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562770|NCT03997019|Analgesics|analgesics|mesh-ancestor
5562771|NCT03997019|Sensory System Agents|sensory system agents|mesh-ancestor
5562772|NCT03997019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5562773|NCT03997006|Atropine|atropine|mesh-list
5562774|NCT03997006|Aminophylline|aminophylline|mesh-list
5562775|NCT03997006|Acefyllin piperazinate|acefyllin piperazinate|mesh-list
5562776|NCT03997006|Neostigmine|neostigmine|mesh-list
6164526|NCT01561963|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6164527|NCT01561963|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6164528|NCT01561976|Metformin|metformin|mesh-list
6164529|NCT01561976|Glimepiride|glimepiride|mesh-list
6164530|NCT01561976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6164531|NCT01561976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164532|NCT01561976|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6164533|NCT01561976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6164534|NCT01561976|Immunologic Factors|immunologic factors|mesh-ancestor
6164535|NCT01562028|Bevacizumab|bevacizumab|mesh-list
6164536|NCT01562028|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6164537|NCT01562028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6164538|NCT01562028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6164539|NCT01562028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6164540|NCT01562028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6164541|NCT01562028|Growth Substances|growth substances|mesh-ancestor
6164542|NCT01562028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164543|NCT01562028|Growth Inhibitors|growth inhibitors|mesh-ancestor
6164544|NCT01562028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6164545|NCT01562028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6164546|NCT01562028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164547|NCT01562041|Ranolazine|ranolazine|mesh-list
6164548|NCT01562041|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6164549|NCT01562041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6164550|NCT01562041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164551|NCT01562132|Fluconazole|fluconazole|mesh-list
6164552|NCT01562132|Flucytosine|flucytosine|mesh-list
6164553|NCT01562132|Antifungal Agents|antifungal agents|mesh-ancestor
6164554|NCT01562132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6164555|NCT01562132|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6164556|NCT01562132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6164557|NCT01562132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6164558|NCT01562132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164559|NCT01562132|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6164560|NCT01562132|Hormone Antagonists|hormone antagonists|mesh-ancestor
6164561|NCT01562132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6164562|NCT01562132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164563|NCT01562132|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6164564|NCT01562132|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6164565|NCT01562132|Antimetabolites|antimetabolites|mesh-ancestor
6164566|NCT01562314|Cannabidiol|cannabidiol|mesh-list
6164567|NCT01562314|Anticonvulsants|anticonvulsants|mesh-ancestor
6164568|NCT01562548|Phenylpropanolamine|phenylpropanolamine|mesh-list
6164569|NCT01562548|Guaifenesin|guaifenesin|mesh-list
6482676|NCT00553748|Alovudine|alovudine|mesh-list
5562777|NCT03997006|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5562778|NCT03997006|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5562779|NCT03997006|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5562780|NCT03997006|Autonomic Agents|autonomic agents|mesh-ancestor
5562781|NCT03997006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5562782|NCT03997006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164570|NCT01562548|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
6164571|NCT01562548|Expectorants|expectorants|mesh-ancestor
6164572|NCT01562548|Respiratory System Agents|respiratory system agents|mesh-ancestor
6164573|NCT01562548|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6164574|NCT01562548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6164575|NCT01562548|Adrenergic Agents|adrenergic agents|mesh-ancestor
6164576|NCT01562548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5562783|NCT03997006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5562784|NCT03997006|Respiratory System Agents|respiratory system agents|mesh-ancestor
5562785|NCT03997006|Mydriatics|mydriatics|mesh-ancestor
5562786|NCT03997006|Parasympatholytics|parasympatholytics|mesh-ancestor
5562787|NCT03997006|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5562788|NCT03997006|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5562789|NCT03997006|Cholinergic Agents|cholinergic agents|mesh-ancestor
5562790|NCT03997006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5562791|NCT03997006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562792|NCT03997006|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5562793|NCT03997006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5562794|NCT03997006|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5562795|NCT03997006|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5562796|NCT03997006|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5562797|NCT03997006|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5562798|NCT03997006|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5562799|NCT03997006|Purinergic Agents|purinergic agents|mesh-ancestor
6164577|NCT01562548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164578|NCT01562548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164579|NCT01562548|Appetite Depressants|appetite depressants|mesh-ancestor
6164580|NCT01562548|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6164581|NCT01562548|Sympathomimetics|sympathomimetics|mesh-ancestor
6164582|NCT01562548|Autonomic Agents|autonomic agents|mesh-ancestor
6164583|NCT01562548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6164584|NCT01562548|Nasal Decongestants|nasal decongestants|mesh-ancestor
6164585|NCT01562548|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6206145|NCT02096900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6206146|NCT02096900|Anesthetics, General|anesthetics, general|mesh-ancestor
6206147|NCT02096900|Anesthetics|anesthetics|mesh-ancestor
6206148|NCT02096900|GABA Modulators|gaba modulators|mesh-ancestor
6206149|NCT02096900|GABA Agents|gaba agents|mesh-ancestor
6206150|NCT02096900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6206151|NCT02096900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206152|NCT02096900|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6206153|NCT02096900|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6206154|NCT02096900|GABA Agonists|gaba agonists|mesh-ancestor
6206155|NCT02096952|Methylphenidate|methylphenidate|mesh-list
6206156|NCT02096952|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6206157|NCT02096952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206158|NCT02096952|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6206159|NCT02096952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5562800|NCT03997006|Protective Agents|protective agents|mesh-ancestor
5562801|NCT03996850|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
6206160|NCT02096952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6206161|NCT02096952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206162|NCT02096952|Dopamine Agents|dopamine agents|mesh-ancestor
6206163|NCT02096952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6206164|NCT02097056|Donepezil|donepezil|mesh-list
6206165|NCT02097056|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6206166|NCT02097056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6206167|NCT02097056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206168|NCT02097056|Cholinergic Agents|cholinergic agents|mesh-ancestor
6206169|NCT02097056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6206170|NCT02097056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206171|NCT02097056|Nootropic Agents|nootropic agents|mesh-ancestor
6206172|NCT02097108|Raltegravir Potassium|raltegravir potassium|mesh-list
6206173|NCT02097108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6206174|NCT02097108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6206175|NCT02097108|Antiviral Agents|antiviral agents|mesh-ancestor
6482677|NCT00553748|Antiviral Agents|antiviral agents|mesh-ancestor
6482678|NCT00553748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6482679|NCT00553800|Bevacizumab|bevacizumab|mesh-list
6482680|NCT00553800|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6482681|NCT00553800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6482682|NCT00553800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6482683|NCT00553800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6482684|NCT00553800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5562802|NCT03996850|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5562803|NCT03996850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562804|NCT03997058|Estazolam|estazolam|mesh-list
5562805|NCT03997058|Anticonvulsants|anticonvulsants|mesh-ancestor
5562806|NCT03997058|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5562807|NCT03997058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5562808|NCT03997058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5562809|NCT03997058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562810|NCT03997058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5562811|NCT03997058|GABA Modulators|gaba modulators|mesh-ancestor
5562812|NCT03997058|GABA Agents|gaba agents|mesh-ancestor
5562813|NCT03997058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5562814|NCT03997058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562815|NCT03996772|Rivaroxaban|rivaroxaban|mesh-list
5562816|NCT03996772|Apixaban|apixaban|mesh-list
5562817|NCT03996772|Edoxaban|edoxaban|mesh-list
5562818|NCT03996772|Dabigatran|dabigatran|mesh-list
5562819|NCT03996772|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5562820|NCT03996772|Antithrombins|antithrombins|mesh-ancestor
5562821|NCT03996772|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5562822|NCT03996772|Protease Inhibitors|protease inhibitors|mesh-ancestor
5562823|NCT03996772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5562824|NCT03996772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562825|NCT03996772|Anticoagulants|anticoagulants|mesh-ancestor
5562826|NCT03996993|Bicalutamide|bicalutamide|mesh-list
5562827|NCT03996993|Androgen Antagonists|androgen antagonists|mesh-ancestor
5562828|NCT03996993|Hormone Antagonists|hormone antagonists|mesh-ancestor
5562829|NCT03996993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5562830|NCT03996993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562831|NCT03996993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5562832|NCT03996538|Metformin|metformin|mesh-list
5562833|NCT03996538|Vaccines|vaccines|mesh-list
5562834|NCT03996538|Immunologic Factors|immunologic factors|mesh-ancestor
6482685|NCT00553800|Growth Substances|growth substances|mesh-ancestor
6482686|NCT00553800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482687|NCT00553800|Growth Inhibitors|growth inhibitors|mesh-ancestor
6482688|NCT00553800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6482689|NCT00553800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6482690|NCT00553800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164586|NCT01562678|Liraglutide|liraglutide|mesh-list
6164587|NCT01562678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6164588|NCT01562678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164589|NCT01562678|Incretins|incretins|mesh-ancestor
6164590|NCT01562678|Hormones|hormones|mesh-ancestor
6164591|NCT01562678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6164592|NCT01562743|Rotigotine|rotigotine|mesh-list
6164593|NCT01562743|Dopamine Agonists|dopamine agonists|mesh-ancestor
6164594|NCT01562743|Dopamine Agents|dopamine agents|mesh-ancestor
6164595|NCT01562743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6164596|NCT01562743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164597|NCT01562743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164598|NCT01562886|Rilpivirine|rilpivirine|mesh-list
6164599|NCT01562886|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6164600|NCT01562886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6164601|NCT01562886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6164602|NCT01562886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164603|NCT01562886|Antiviral Agents|antiviral agents|mesh-ancestor
5562835|NCT03996538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562836|NCT03996538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5562837|NCT03996421|Ferrous fumarate|ferrous fumarate|mesh-list
5562838|NCT03996421|Trace Elements|trace elements|mesh-ancestor
6164604|NCT01562886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6164605|NCT01562886|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6164606|NCT01562886|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6164607|NCT01563029|Fluticasone|fluticasone|mesh-list
6164608|NCT01563029|Xhance|xhance|mesh-list
6482691|NCT00553878|Dutasteride|dutasteride|mesh-list
6482692|NCT00553878|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6482693|NCT00553878|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6482694|NCT00553878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6482695|NCT00553878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6482696|NCT00553878|Hormone Antagonists|hormone antagonists|mesh-ancestor
5562839|NCT03996421|Micronutrients|micronutrients|mesh-ancestor
5562840|NCT03996421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562841|NCT03996577|Lidocaine|lidocaine|mesh-list
5562842|NCT03996577|Anesthetics, Local|anesthetics, local|mesh-ancestor
6164609|NCT01563029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5562843|NCT03996577|Anesthetics|anesthetics|mesh-ancestor
6164610|NCT01563029|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6164611|NCT01563029|Autonomic Agents|autonomic agents|mesh-ancestor
6164612|NCT01563029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6164613|NCT01563029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164614|NCT01563029|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6164615|NCT01563029|Respiratory System Agents|respiratory system agents|mesh-ancestor
6164616|NCT01563029|Dermatologic Agents|dermatologic agents|mesh-ancestor
6164617|NCT01563029|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6164618|NCT01563055|Ofatumumab|ofatumumab|mesh-list
6164619|NCT01563055|Chlorambucil|chlorambucil|mesh-list
6164620|NCT01563055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6164621|NCT01563055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6164622|NCT01563055|Alkylating Agents|alkylating agents|mesh-ancestor
6164623|NCT01563055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164624|NCT01563081|Cetirizine|cetirizine|mesh-list
6164625|NCT01563081|Levocetirizine|levocetirizine|mesh-list
6164626|NCT01563081|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6164627|NCT01563081|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6164628|NCT01563081|Histamine Antagonists|histamine antagonists|mesh-ancestor
5562844|NCT03996577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5562845|NCT03996577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562846|NCT03996577|Sensory System Agents|sensory system agents|mesh-ancestor
5562847|NCT03996577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5562848|NCT03996577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6164629|NCT01563081|Histamine Agents|histamine agents|mesh-ancestor
6164630|NCT01563081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6164631|NCT01563081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164632|NCT01563081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164633|NCT01563081|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6164634|NCT01563172|Listerine|listerine|mesh-list
6164635|NCT01563172|Fluorides|fluorides|mesh-list
6164636|NCT01563172|Sodium Fluoride|sodium fluoride|mesh-list
6164637|NCT01563172|Cariostatic Agents|cariostatic agents|mesh-ancestor
6164638|NCT01563172|Protective Agents|protective agents|mesh-ancestor
6164639|NCT01563172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164640|NCT01563172|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6164641|NCT01563172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6164642|NCT01563185|Ibuprofen|ibuprofen|mesh-list
6164643|NCT01563185|Famotidine|famotidine|mesh-list
6164644|NCT01563185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6164645|NCT01563185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6164646|NCT01563185|Analgesics|analgesics|mesh-ancestor
6164647|NCT01563185|Sensory System Agents|sensory system agents|mesh-ancestor
6164648|NCT01563185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6668894|NCT01534884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668895|NCT01534884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6668896|NCT01534949|Rituximab|rituximab|mesh-list
6668897|NCT01534949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6668898|NCT01534949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6668899|NCT01534949|Immunologic Factors|immunologic factors|mesh-ancestor
6668900|NCT01534949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164649|NCT01563185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164650|NCT01563185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6164651|NCT01563185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6164652|NCT01563185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6164653|NCT01563185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6164654|NCT01563185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164655|NCT01563185|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6164656|NCT01563185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6164657|NCT01563185|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6164658|NCT01563185|Histamine Antagonists|histamine antagonists|mesh-ancestor
6164659|NCT01563185|Histamine Agents|histamine agents|mesh-ancestor
6164660|NCT01563185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6482697|NCT00553878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6482698|NCT00553878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482699|NCT00553930|Interferons|interferons|mesh-list
6482700|NCT00553930|Ribavirin|ribavirin|mesh-list
6482701|NCT00553930|Interferon-alpha|interferon-alpha|mesh-list
6164661|NCT01563198|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
6482702|NCT00553930|Interferon alpha-2|interferon alpha-2|mesh-list
6482703|NCT00553930|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6482704|NCT00553930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6482705|NCT00553930|Antiviral Agents|antiviral agents|mesh-ancestor
6482706|NCT00553930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6164662|NCT01563198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6482707|NCT00553930|Antimetabolites|antimetabolites|mesh-ancestor
5562849|NCT03996577|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5562850|NCT03996577|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5562851|NCT03996577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5562852|NCT03996577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562853|NCT03996603|Estrogens|estrogens|mesh-list
5562854|NCT03996603|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
5562855|NCT03996603|Hormones|hormones|mesh-ancestor
5562856|NCT03996603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5562857|NCT03996603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562858|NCT03996486|Lipoprotein-associated coagulation inhibitor|lipoprotein-associated coagulation inhibitor|mesh-list
5562859|NCT03996486|Immunoglobulins|immunoglobulins|mesh-list
5562860|NCT03996486|Immunoglobulin G|immunoglobulin g|mesh-list
5562861|NCT03996486|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5562862|NCT03996486|Myeloma Proteins|myeloma proteins|mesh-list
5562863|NCT03996486|Paraproteins|paraproteins|mesh-list
5562864|NCT03996486|Immunologic Factors|immunologic factors|mesh-ancestor
5562865|NCT03996486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562866|NCT03996486|Anticoagulants|anticoagulants|mesh-ancestor
5562867|NCT03996486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5562868|NCT03996486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5562869|NCT03996486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562870|NCT03996486|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5562871|NCT03996486|Protease Inhibitors|protease inhibitors|mesh-ancestor
5562872|NCT03996486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5562873|NCT03996486|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5562874|NCT03996486|Antithrombins|antithrombins|mesh-ancestor
5562875|NCT03996564|Acetaminophen|acetaminophen|mesh-list
5562876|NCT03996564|Diclofenac|diclofenac|mesh-list
5562877|NCT03996564|Ketorolac|ketorolac|mesh-list
5562878|NCT03996564|Diazepam|diazepam|mesh-list
5562879|NCT03996564|Hydrocodone|hydrocodone|mesh-list
5562880|NCT03996564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5562881|NCT03996564|Analgesics|analgesics|mesh-ancestor
5562882|NCT03996564|Sensory System Agents|sensory system agents|mesh-ancestor
5562883|NCT03996564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5562884|NCT03996564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562885|NCT03996564|Antipyretics|antipyretics|mesh-ancestor
5562886|NCT03996564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5562887|NCT03996564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5562888|NCT03996564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5562889|NCT03996564|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5562890|NCT03996564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5562891|NCT03996564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562892|NCT03996564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5562893|NCT03996564|Narcotics|narcotics|mesh-ancestor
5562894|NCT03996564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5562895|NCT03996564|Antitussive Agents|antitussive agents|mesh-ancestor
6164663|NCT01563198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164664|NCT01563354|Everolimus|everolimus|mesh-list
6164665|NCT01563354|Pasireotide|pasireotide|mesh-list
6164666|NCT01563354|Somatostatin|somatostatin|mesh-list
6164667|NCT01563354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6164668|NCT01563354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6164669|NCT01563354|Immunologic Factors|immunologic factors|mesh-ancestor
6164670|NCT01563354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164671|NCT01563354|Hormones|hormones|mesh-ancestor
6164672|NCT01563354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6164673|NCT01563406|Ethanol|ethanol|mesh-list
6164674|NCT01563406|Chlorhexidine|chlorhexidine|mesh-list
6164675|NCT01563406|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6164676|NCT01563406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6164677|NCT01563406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6164678|NCT01563406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164679|NCT01563406|Disinfectants|disinfectants|mesh-ancestor
6164680|NCT01563536|Ritonavir|ritonavir|mesh-list
6164681|NCT01563536|Ribavirin|ribavirin|mesh-list
6164682|NCT01563536|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6164683|NCT01563536|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6164684|NCT01563536|Protease Inhibitors|protease inhibitors|mesh-ancestor
6164685|NCT01563536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6164686|NCT01563536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164687|NCT01563536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6164688|NCT01563536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6668901|NCT01534949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5562896|NCT03996564|Respiratory System Agents|respiratory system agents|mesh-ancestor
5562897|NCT03996564|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5562898|NCT03996564|Anticonvulsants|anticonvulsants|mesh-ancestor
5562899|NCT03996564|Antiemetics|antiemetics|mesh-ancestor
5562900|NCT03996564|Autonomic Agents|autonomic agents|mesh-ancestor
5562901|NCT03996564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6164689|NCT01563536|Antiviral Agents|antiviral agents|mesh-ancestor
6164690|NCT01563536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6164691|NCT01563536|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6164692|NCT01563536|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6164693|NCT01563536|Antimetabolites|antimetabolites|mesh-ancestor
6164694|NCT01564277|Allopurinol|allopurinol|mesh-list
6164695|NCT01564277|Rasburicase|rasburicase|mesh-list
6164696|NCT01564277|Antimetabolites|antimetabolites|mesh-ancestor
6164697|NCT01564277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164698|NCT01564277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6164699|NCT01564277|Gout Suppressants|gout suppressants|mesh-ancestor
6164700|NCT01564277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6164701|NCT01564277|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6164702|NCT01564277|Antioxidants|antioxidants|mesh-ancestor
6164703|NCT01564277|Protective Agents|protective agents|mesh-ancestor
6164704|NCT01564277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164705|NCT01564758|Linezolid|linezolid|mesh-list
6164706|NCT01564758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6164707|NCT01564758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6164708|NCT01564758|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6164709|NCT01564758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6164710|NCT01564758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164711|NCT01564784|Cytarabine|cytarabine|mesh-list
5562902|NCT03996564|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5562903|NCT03996564|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5562904|NCT03996564|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5562905|NCT03996564|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6164712|NCT01564784|Fludarabine|fludarabine|mesh-list
6164713|NCT01564784|Mitoxantrone|mitoxantrone|mesh-list
6164714|NCT01564784|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
6164715|NCT01564784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6164716|NCT01564784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6164717|NCT01564784|Antimetabolites|antimetabolites|mesh-ancestor
6164718|NCT01564784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164719|NCT01564784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6164720|NCT01564784|Immunologic Factors|immunologic factors|mesh-ancestor
6164721|NCT01564784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164722|NCT01564784|Antiviral Agents|antiviral agents|mesh-ancestor
6164723|NCT01564784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6164724|NCT01564784|Analgesics|analgesics|mesh-ancestor
6164725|NCT01564784|Sensory System Agents|sensory system agents|mesh-ancestor
6164726|NCT01564784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6164727|NCT01564784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6164728|NCT01564784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6164729|NCT01564784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6164730|NCT01564784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6164731|NCT01564784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6164732|NCT01564862|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6164733|NCT01564862|Vortioxetine|vortioxetine|mesh-list
6164734|NCT01564862|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6164735|NCT01564862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6482708|NCT00553930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6482709|NCT00553930|Immunologic Factors|immunologic factors|mesh-ancestor
6482710|NCT00553930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482711|NCT00553943|Cytarabine|cytarabine|mesh-list
6482712|NCT00553943|Rituximab|rituximab|mesh-list
6482713|NCT00553943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6482714|NCT00553943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6482715|NCT00553943|Immunologic Factors|immunologic factors|mesh-ancestor
6482716|NCT00553943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482717|NCT00553943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6482718|NCT00553943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6482719|NCT00553943|Antimetabolites|antimetabolites|mesh-ancestor
5562906|NCT03996564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6164736|NCT01564862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6164737|NCT01564862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164738|NCT01564862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6482720|NCT00553943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6482721|NCT00553943|Antiviral Agents|antiviral agents|mesh-ancestor
6164739|NCT01564862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164740|NCT01564862|Analgesics|analgesics|mesh-ancestor
6164741|NCT01564862|Sensory System Agents|sensory system agents|mesh-ancestor
6164742|NCT01564862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6164743|NCT01564862|Antidepressive Agents|antidepressive agents|mesh-ancestor
6164744|NCT01564862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6164745|NCT01564862|Dopamine Agents|dopamine agents|mesh-ancestor
6668902|NCT01535027|Alendronate|alendronate|mesh-list
6668903|NCT01535027|Teriparatide|teriparatide|mesh-list
6668904|NCT01535027|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
6668905|NCT01535027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6668906|NCT01535027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668907|NCT01535027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5562907|NCT03996564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5562908|NCT03996564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5562909|NCT03996564|Anesthetics, General|anesthetics, general|mesh-ancestor
5562910|NCT03996564|Anesthetics|anesthetics|mesh-ancestor
5562911|NCT03996564|GABA Modulators|gaba modulators|mesh-ancestor
5562912|NCT03996564|GABA Agents|gaba agents|mesh-ancestor
5562913|NCT03996564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5562914|NCT03996434|Cetrorelix|cetrorelix|mesh-list
5562915|NCT03996434|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5562916|NCT03996434|Fertility Agents|fertility agents|mesh-ancestor
5562917|NCT03996434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5562918|NCT03996434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562919|NCT03996434|Hormone Antagonists|hormone antagonists|mesh-ancestor
5562920|NCT03996434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5603678|NCT01824875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603679|NCT01824875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5603680|NCT01824875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5603681|NCT01824875|Alkylating Agents|alkylating agents|mesh-ancestor
5603682|NCT01792583|Modafinil|modafinil|mesh-list
5603683|NCT01792583|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5603684|NCT01792583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603685|NCT01792583|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
5603686|NCT01792583|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5603687|NCT01792583|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5603688|NCT01792583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603689|NCT01755975|Lenalidomide|lenalidomide|mesh-list
6164746|NCT01564862|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6668908|NCT01535027|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6668909|NCT01535027|Hormone Antagonists|hormone antagonists|mesh-ancestor
6164747|NCT01564862|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6164748|NCT01564862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6164749|NCT01564862|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6482722|NCT00553943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6482723|NCT00553943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6482724|NCT00553995|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
6482725|NCT00553995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6482726|NCT00553995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6482727|NCT00553995|Analgesics|analgesics|mesh-ancestor
6482728|NCT00553995|Sensory System Agents|sensory system agents|mesh-ancestor
6482729|NCT00553995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6482730|NCT00553995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482731|NCT00553995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6482732|NCT00553995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6482733|NCT00554086|Bicalutamide|bicalutamide|mesh-list
6482734|NCT00554086|Androgen Antagonists|androgen antagonists|mesh-ancestor
6164750|NCT01564862|Serotonin Agents|serotonin agents|mesh-ancestor
6164751|NCT01564862|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6164752|NCT01564862|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6164753|NCT01564862|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6164754|NCT01564862|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6164755|NCT01564914|Bevacizumab|bevacizumab|mesh-list
6164756|NCT01564914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6482735|NCT00554086|Hormone Antagonists|hormone antagonists|mesh-ancestor
6164757|NCT01564914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6164758|NCT01564914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6164759|NCT01564914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6164760|NCT01564914|Growth Substances|growth substances|mesh-ancestor
6164761|NCT01564914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164762|NCT01564914|Growth Inhibitors|growth inhibitors|mesh-ancestor
6164763|NCT01565083|Trastuzumab|trastuzumab|mesh-list
6164764|NCT01565083|Pertuzumab|pertuzumab|mesh-list
6482736|NCT00554086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6482737|NCT00554086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482738|NCT00554086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6482739|NCT00554125|Sirolimus|sirolimus|mesh-list
6482740|NCT00554125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6482741|NCT00554125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6482742|NCT00554125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6164765|NCT01565083|Vinorelbine|vinorelbine|mesh-list
6164766|NCT01565083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6164767|NCT01565083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6164768|NCT01565083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6164769|NCT01565083|Tubulin Modulators|tubulin modulators|mesh-ancestor
6164770|NCT01565083|Antimitotic Agents|antimitotic agents|mesh-ancestor
6164771|NCT01565083|Mitosis Modulators|mitosis modulators|mesh-ancestor
6164772|NCT01565083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164773|NCT01565148|Ranibizumab|ranibizumab|mesh-list
6164774|NCT01565148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6164775|NCT01565148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6164776|NCT01565148|Growth Substances|growth substances|mesh-ancestor
6164777|NCT01565148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164778|NCT01565148|Growth Inhibitors|growth inhibitors|mesh-ancestor
6164779|NCT01565148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6164780|NCT01565499|Paclitaxel|paclitaxel|mesh-list
5562921|NCT03996655|Neostigmine|neostigmine|mesh-list
5562922|NCT03996655|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5562923|NCT03996655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5562924|NCT03996655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562925|NCT03996655|Cholinergic Agents|cholinergic agents|mesh-ancestor
5562926|NCT03996655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5562927|NCT03996655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482743|NCT00554125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6482744|NCT00554125|Antifungal Agents|antifungal agents|mesh-ancestor
6668910|NCT01535027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6164781|NCT01565499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6164782|NCT01565499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6164783|NCT01565499|Tubulin Modulators|tubulin modulators|mesh-ancestor
6164784|NCT01565499|Antimitotic Agents|antimitotic agents|mesh-ancestor
6164785|NCT01565499|Mitosis Modulators|mitosis modulators|mesh-ancestor
6164786|NCT01565499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164787|NCT01565538|Pemetrexed|pemetrexed|mesh-list
6164788|NCT01565538|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6164789|NCT01565538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6164790|NCT01565538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6164791|NCT01565538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164792|NCT01565538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6164793|NCT01565538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6164794|NCT01565538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6164795|NCT01565616|Fludarabine|fludarabine|mesh-list
6164796|NCT01565616|Busulfan|busulfan|mesh-list
6482745|NCT00554125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6668911|NCT01535027|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6668912|NCT01535027|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6668913|NCT01535079|Ibuprofen|ibuprofen|mesh-list
6668914|NCT01535079|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6668915|NCT01535079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6668916|NCT01535079|Analgesics|analgesics|mesh-ancestor
6668917|NCT01535079|Sensory System Agents|sensory system agents|mesh-ancestor
6668918|NCT01535079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6668919|NCT01535079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668920|NCT01535079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6668921|NCT01535079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6668922|NCT01535079|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6668923|NCT01535079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6668924|NCT01535079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562928|NCT03996655|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6164797|NCT01565616|Thymoglobulin|thymoglobulin|mesh-list
6164798|NCT01565616|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6164799|NCT01565616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6164800|NCT01565616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164801|NCT01565616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6164802|NCT01565616|Immunologic Factors|immunologic factors|mesh-ancestor
6482746|NCT00554125|Immunologic Factors|immunologic factors|mesh-ancestor
6482747|NCT00554125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482748|NCT00554138|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6482749|NCT00554138|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6482750|NCT00554138|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6482751|NCT00554138|Antimetabolites|antimetabolites|mesh-ancestor
6482752|NCT00554138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6482753|NCT00554138|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6482754|NCT00554138|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6482755|NCT00554138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6482756|NCT00554164|Prednisone|prednisone|mesh-list
6668925|NCT01535092|Silybin|silybin|mesh-list
6668926|NCT01535092|Protective Agents|protective agents|mesh-ancestor
6668927|NCT01535092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668928|NCT01535092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6668929|NCT01535092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6668930|NCT01535157|Ketoconazole|ketoconazole|mesh-list
6668931|NCT01535157|Fenretinide|fenretinide|mesh-list
6668932|NCT01535157|Retinamide|retinamide|mesh-list
6668933|NCT01535157|Antifungal Agents|antifungal agents|mesh-ancestor
5562929|NCT03996655|Autonomic Agents|autonomic agents|mesh-ancestor
6164803|NCT01565616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562930|NCT03996655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5562931|NCT03996057|Methenamine|methenamine|mesh-list
5562932|NCT03996057|Methenamine hippurate|methenamine hippurate|mesh-list
5562933|NCT03996057|Methenamine mandelate|methenamine mandelate|mesh-list
5562934|NCT03996057|Estrogens|estrogens|mesh-list
5562935|NCT03996057|Hormones|hormones|mesh-ancestor
5562936|NCT03996057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5562937|NCT03996057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164804|NCT01565616|Alkylating Agents|alkylating agents|mesh-ancestor
6164805|NCT01565616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6164806|NCT01565616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6164807|NCT01565694|Solifenacin Succinate|solifenacin succinate|mesh-list
6164808|NCT01565694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6164809|NCT01565694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6482757|NCT00554164|Cyclophosphamide|cyclophosphamide|mesh-list
6482758|NCT00554164|Doxorubicin|doxorubicin|mesh-list
6482759|NCT00554164|Vincristine|vincristine|mesh-list
6164810|NCT01565694|Cholinergic Agents|cholinergic agents|mesh-ancestor
6164811|NCT01565694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6164812|NCT01565694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164813|NCT01565694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164814|NCT01565694|Urological Agents|urological agents|mesh-ancestor
6164815|NCT01565707|Solifenacin Succinate|solifenacin succinate|mesh-list
6164816|NCT01565707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6164817|NCT01565707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6164818|NCT01565707|Cholinergic Agents|cholinergic agents|mesh-ancestor
6164819|NCT01565707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6164820|NCT01565707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562938|NCT03996057|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5562939|NCT03996057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6164821|NCT01565707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164822|NCT01565707|Urological Agents|urological agents|mesh-ancestor
6164823|NCT01565850|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6164824|NCT01565850|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6164825|NCT01565850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6164826|NCT01565850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6164827|NCT01565850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164828|NCT01565850|Antiviral Agents|antiviral agents|mesh-ancestor
6164829|NCT01565850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6482760|NCT00554164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6482761|NCT00554164|Immunologic Factors|immunologic factors|mesh-ancestor
6482762|NCT00554164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482763|NCT00554164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6482764|NCT00554164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6668934|NCT01535157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5562940|NCT03996057|Renal Agents|renal agents|mesh-ancestor
6482765|NCT00554164|Alkylating Agents|alkylating agents|mesh-ancestor
6482766|NCT00554164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6482767|NCT00554164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6482768|NCT00554164|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6482769|NCT00554164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6482770|NCT00554164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6482771|NCT00554164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6482772|NCT00554164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6482773|NCT00554164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5562941|NCT03996057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5562942|NCT03996148|Dexmedetomidine|dexmedetomidine|mesh-list
5562943|NCT03996148|Remifentanil|remifentanil|mesh-list
5562944|NCT03996148|Propofol|propofol|mesh-list
5562945|NCT03996148|Desflurane|desflurane|mesh-list
5562946|NCT03996148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5562947|NCT03996148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5562948|NCT03996148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164830|NCT01565850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6164831|NCT01565850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6164832|NCT01565889|Ritonavir|ritonavir|mesh-list
6164833|NCT01565889|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6164834|NCT01565889|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6164835|NCT01565889|Ribavirin|ribavirin|mesh-list
6164836|NCT01565889|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6164837|NCT01565889|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6164838|NCT01565889|Protease Inhibitors|protease inhibitors|mesh-ancestor
6164839|NCT01565889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6164840|NCT01565889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164841|NCT01565889|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6164842|NCT01565889|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6164843|NCT01565889|Antiviral Agents|antiviral agents|mesh-ancestor
6164844|NCT01565889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6164845|NCT01565889|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6164846|NCT01565889|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6164847|NCT01565889|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6164848|NCT01565889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6164849|NCT01565889|Antimetabolites|antimetabolites|mesh-ancestor
5562949|NCT03996148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5562950|NCT03996148|Anesthetics, General|anesthetics, general|mesh-ancestor
5562951|NCT03996148|Anesthetics|anesthetics|mesh-ancestor
5562952|NCT03996148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6164850|NCT01565902|Siponimod|siponimod|mesh-list
6164851|NCT01565902|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6164852|NCT01565902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164853|NCT01565902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6164854|NCT01565902|Immunologic Factors|immunologic factors|mesh-ancestor
6164855|NCT01565902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164856|NCT01565941|Insulin|insulin|mesh-list
6164857|NCT01565941|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6164858|NCT01565941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6164859|NCT01565941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164860|NCT01566162|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
6164861|NCT01566162|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6164862|NCT01566162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6164863|NCT01566162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6164864|NCT01566162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164865|NCT01566162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6164866|NCT01566162|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6164867|NCT01566162|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6164868|NCT01566162|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6164869|NCT01566162|Adrenergic Agents|adrenergic agents|mesh-ancestor
6164870|NCT01566162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6164871|NCT01566162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164872|NCT01566162|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6164873|NCT01566162|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6164874|NCT01566162|Serotonin Agents|serotonin agents|mesh-ancestor
5562953|NCT03996148|Analgesics|analgesics|mesh-ancestor
6164875|NCT01566162|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6164876|NCT01566162|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6164877|NCT01566162|Dopamine Agents|dopamine agents|mesh-ancestor
6164878|NCT01566409|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
6164879|NCT01566409|Laxatives|laxatives|mesh-ancestor
6164880|NCT01566409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6164881|NCT01566435|Paclitaxel|paclitaxel|mesh-list
6164882|NCT01566435|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6164883|NCT01566435|Fluorouracil|fluorouracil|mesh-list
6164884|NCT01566435|Cetuximab|cetuximab|mesh-list
6164885|NCT01566435|Antibodies|antibodies|mesh-list
6164886|NCT01566435|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6164887|NCT01566435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6164888|NCT01566435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6164889|NCT01566435|Tubulin Modulators|tubulin modulators|mesh-ancestor
6164890|NCT01566435|Antimitotic Agents|antimitotic agents|mesh-ancestor
6164891|NCT01566435|Mitosis Modulators|mitosis modulators|mesh-ancestor
6164892|NCT01566435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164893|NCT01566435|Immunologic Factors|immunologic factors|mesh-ancestor
6164894|NCT01566435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164895|NCT01566435|Antimetabolites|antimetabolites|mesh-ancestor
5562954|NCT03996148|Sensory System Agents|sensory system agents|mesh-ancestor
5562955|NCT03996148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5562956|NCT03996148|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5562957|NCT03996148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6164896|NCT01566435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6164897|NCT01566435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6164898|NCT01566435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6164899|NCT01566448|Ketamine|ketamine|mesh-list
6164900|NCT01566448|Analgesics|analgesics|mesh-ancestor
6164901|NCT01566448|Sensory System Agents|sensory system agents|mesh-ancestor
6164902|NCT01566448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6164903|NCT01566448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164904|NCT01566448|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6164905|NCT01566448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6164906|NCT01566448|Anesthetics, General|anesthetics, general|mesh-ancestor
6164907|NCT01566448|Anesthetics|anesthetics|mesh-ancestor
6164908|NCT01566448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6164909|NCT01566448|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6164910|NCT01566448|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6164911|NCT01566448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6164912|NCT01566448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164913|NCT01566526|Dexamethasone|dexamethasone|mesh-list
6164914|NCT01566526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6164915|NCT01566526|Antiemetics|antiemetics|mesh-ancestor
6164916|NCT01566526|Autonomic Agents|autonomic agents|mesh-ancestor
6164917|NCT01566526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6164918|NCT01566526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164919|NCT01566526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6164920|NCT01566526|Glucocorticoids|glucocorticoids|mesh-ancestor
6164921|NCT01566526|Hormones|hormones|mesh-ancestor
6164922|NCT01566526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6164923|NCT01566526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6164924|NCT01566526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6164925|NCT01566539|Vasopressins|vasopressins|mesh-list
6164926|NCT01566539|Arginine Vasopressin|arginine vasopressin|mesh-list
6164927|NCT01566539|Lorazepam|lorazepam|mesh-list
6164928|NCT01566539|Oxytocin|oxytocin|mesh-list
6164929|NCT01566539|Oxytocics|oxytocics|mesh-ancestor
6164930|NCT01566539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6164931|NCT01566539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164932|NCT01566539|Anticonvulsants|anticonvulsants|mesh-ancestor
6164933|NCT01566539|Antiemetics|antiemetics|mesh-ancestor
6164934|NCT01566539|Autonomic Agents|autonomic agents|mesh-ancestor
6164935|NCT01566539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6164936|NCT01566539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5562958|NCT03996148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5562959|NCT03996148|Adrenergic Agents|adrenergic agents|mesh-ancestor
5562960|NCT03996148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5562961|NCT03996148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5562962|NCT03996148|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5562963|NCT03996148|Narcotics|narcotics|mesh-ancestor
5562964|NCT03996148|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5562965|NCT03996044|Anti-Infective Agents|anti-infective agents|mesh-list
5562966|NCT03996044|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5562967|NCT03996252|Calcitriol|calcitriol|mesh-list
5562968|NCT03996252|Fluorouracil|fluorouracil|mesh-list
5562969|NCT03996252|Calcipotriene|calcipotriene|mesh-list
5562970|NCT03996252|Antimetabolites|antimetabolites|mesh-ancestor
6164937|NCT01566539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5562971|NCT03996252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164938|NCT01566539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6164939|NCT01566539|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6164940|NCT01566539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6164941|NCT01566539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6164942|NCT01566539|GABA Modulators|gaba modulators|mesh-ancestor
6164943|NCT01566539|GABA Agents|gaba agents|mesh-ancestor
6164944|NCT01566539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6164945|NCT01566539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164946|NCT01566539|Hemostatics|hemostatics|mesh-ancestor
6164947|NCT01566539|Coagulants|coagulants|mesh-ancestor
6164948|NCT01566539|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6164949|NCT01566539|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6164950|NCT01566539|Natriuretic Agents|natriuretic agents|mesh-ancestor
5562972|NCT03996252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5562973|NCT03996252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5562974|NCT03996252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5562975|NCT03996252|Immunologic Factors|immunologic factors|mesh-ancestor
5562976|NCT03996252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164951|NCT01566604|Glycopyrrolate|glycopyrrolate|mesh-list
6164952|NCT01566604|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6164953|NCT01566604|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5562977|NCT03996252|Dermatologic Agents|dermatologic agents|mesh-ancestor
5562978|NCT03996252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5562979|NCT03996252|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
5562980|NCT03996252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5562981|NCT03996252|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5562982|NCT03996252|Vitamins|vitamins|mesh-ancestor
5562983|NCT03996252|Micronutrients|micronutrients|mesh-ancestor
5562984|NCT03996252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5562985|NCT03996278|Thymoglobulin|thymoglobulin|mesh-list
5562986|NCT03996278|Immunologic Factors|immunologic factors|mesh-ancestor
5562987|NCT03996278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562988|NCT03996278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5562989|NCT03995641|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6482774|NCT00554164|Glucocorticoids|glucocorticoids|mesh-ancestor
6482775|NCT00554164|Hormones|hormones|mesh-ancestor
6482776|NCT00554164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6482777|NCT00554164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6482778|NCT00554164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6482779|NCT00554164|Tubulin Modulators|tubulin modulators|mesh-ancestor
6482780|NCT00554164|Antimitotic Agents|antimitotic agents|mesh-ancestor
6482781|NCT00554164|Mitosis Modulators|mitosis modulators|mesh-ancestor
6482782|NCT00554177|Mifepristone|mifepristone|mesh-list
6482783|NCT00554177|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6482784|NCT00554177|Abortifacient Agents|abortifacient agents|mesh-ancestor
6482785|NCT00554177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6482786|NCT00554177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482787|NCT00554177|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6164954|NCT01566604|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6164955|NCT01566604|Cholinergic Agents|cholinergic agents|mesh-ancestor
6164956|NCT01566604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6164957|NCT01566604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164958|NCT01566604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164959|NCT01566721|Trastuzumab|trastuzumab|mesh-list
6164960|NCT01566721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6164961|NCT01566721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6164962|NCT01566773|Bromides|bromides|mesh-list
6164963|NCT01566773|Tiotropium Bromide|tiotropium bromide|mesh-list
6164964|NCT01566773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6164965|NCT01566773|Autonomic Agents|autonomic agents|mesh-ancestor
6164966|NCT01566773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5562990|NCT03995641|Bupivacaine|bupivacaine|mesh-list
5562991|NCT03995641|Anesthetics, Local|anesthetics, local|mesh-ancestor
5562992|NCT03995641|Anesthetics|anesthetics|mesh-ancestor
5562993|NCT03995641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5562994|NCT03995641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5562995|NCT03995641|Sensory System Agents|sensory system agents|mesh-ancestor
5562996|NCT03995641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6164967|NCT01566773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164968|NCT01566773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6164969|NCT01566773|Respiratory System Agents|respiratory system agents|mesh-ancestor
6164970|NCT01566773|Parasympatholytics|parasympatholytics|mesh-ancestor
6164971|NCT01566773|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6164972|NCT01566773|Cholinergic Agents|cholinergic agents|mesh-ancestor
6164973|NCT01566773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6482788|NCT00554177|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5562997|NCT03995641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5562998|NCT03995641|Glucocorticoids|glucocorticoids|mesh-ancestor
5562999|NCT03995641|Hormones|hormones|mesh-ancestor
5563000|NCT03995641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5563001|NCT03995641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5563002|NCT03995641|Immunologic Factors|immunologic factors|mesh-ancestor
5563003|NCT03995628|Dexamethasone|dexamethasone|mesh-list
5563004|NCT03995628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5563005|NCT03995628|Antiemetics|antiemetics|mesh-ancestor
5563006|NCT03995628|Autonomic Agents|autonomic agents|mesh-ancestor
5563007|NCT03995628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5563008|NCT03995628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164974|NCT01566773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164975|NCT01566773|Anticonvulsants|anticonvulsants|mesh-ancestor
6164976|NCT01566838|Bupivacaine|bupivacaine|mesh-list
6164977|NCT01566838|Anesthetics, Local|anesthetics, local|mesh-ancestor
6164978|NCT01566838|Anesthetics|anesthetics|mesh-ancestor
5563009|NCT03995628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5563010|NCT03995628|Glucocorticoids|glucocorticoids|mesh-ancestor
6164979|NCT01566838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6164980|NCT01566838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164981|NCT01566838|Sensory System Agents|sensory system agents|mesh-ancestor
6164982|NCT01566838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6164983|NCT01567085|Eculizumab|eculizumab|mesh-list
6164984|NCT01567085|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6164985|NCT01567085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6164986|NCT01567085|Immunologic Factors|immunologic factors|mesh-ancestor
6164987|NCT01567085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6164988|NCT01567163|Docetaxel|docetaxel|mesh-list
6164989|NCT01567163|Ramucirumab|ramucirumab|mesh-list
6164990|NCT01567163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6164991|NCT01567163|Tubulin Modulators|tubulin modulators|mesh-ancestor
6164992|NCT01567163|Antimitotic Agents|antimitotic agents|mesh-ancestor
6164993|NCT01567163|Mitosis Modulators|mitosis modulators|mesh-ancestor
6164994|NCT01567163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6164995|NCT01567527|Aripiprazole|aripiprazole|mesh-list
6164996|NCT01567527|Antidepressive Agents|antidepressive agents|mesh-ancestor
6164997|NCT01567527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6482789|NCT00554177|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6482790|NCT00554177|Contraceptive Agents|contraceptive agents|mesh-ancestor
6482791|NCT00554177|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6482792|NCT00554177|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6482793|NCT00554177|Hormone Antagonists|hormone antagonists|mesh-ancestor
6482794|NCT00554177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6482795|NCT00554177|Luteolytic Agents|luteolytic agents|mesh-ancestor
6482796|NCT00554177|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6482797|NCT00554177|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6482798|NCT00554203|Sulfasalazine|sulfasalazine|mesh-list
6482799|NCT00554203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6482800|NCT00554203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6482801|NCT00554203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6482802|NCT00554203|Analgesics|analgesics|mesh-ancestor
6482803|NCT00554203|Sensory System Agents|sensory system agents|mesh-ancestor
6482804|NCT00554203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6482805|NCT00554203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482806|NCT00554203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6482807|NCT00554203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6482808|NCT00554203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6482809|NCT00554242|Ascorbic Acid|ascorbic acid|mesh-list
5563011|NCT03995628|Hormones|hormones|mesh-ancestor
5563012|NCT03995628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5563013|NCT03995628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5563014|NCT03995628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5563015|NCT03995485|Sofosbuvir|sofosbuvir|mesh-list
5563016|NCT03995485|Antiviral Agents|antiviral agents|mesh-ancestor
5563017|NCT03995485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5563018|NCT03995563|Dexamethasone|dexamethasone|mesh-list
6482810|NCT00554242|Grape Seed Extract|grape seed extract|mesh-list
6482811|NCT00554242|Antioxidants|antioxidants|mesh-ancestor
6482812|NCT00554242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668935|NCT01535157|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6668936|NCT01535157|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6668937|NCT01535157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5563019|NCT03995563|Ropivacaine|ropivacaine|mesh-list
6164998|NCT01567527|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6668938|NCT01535157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668939|NCT01535157|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6668940|NCT01535157|Hormone Antagonists|hormone antagonists|mesh-ancestor
6668941|NCT01535157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6668942|NCT01535157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668943|NCT01535157|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6668944|NCT01535157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6668945|NCT01535157|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6668946|NCT01535157|Protective Agents|protective agents|mesh-ancestor
6668947|NCT01535170|Lactoferrin|lactoferrin|mesh-list
6668948|NCT01535170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5563020|NCT03995563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5563021|NCT03995563|Antiemetics|antiemetics|mesh-ancestor
5563022|NCT03995563|Autonomic Agents|autonomic agents|mesh-ancestor
5563023|NCT03995563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5563024|NCT03995563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563025|NCT03995563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5563026|NCT03995563|Glucocorticoids|glucocorticoids|mesh-ancestor
5563027|NCT03995563|Hormones|hormones|mesh-ancestor
5563028|NCT03995563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5563029|NCT03995563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5563030|NCT03995563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5563031|NCT03995563|Anesthetics, Local|anesthetics, local|mesh-ancestor
5563032|NCT03995563|Anesthetics|anesthetics|mesh-ancestor
6668949|NCT01535183|Irinotecan|irinotecan|mesh-list
6668950|NCT01535183|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6668951|NCT01535183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6668952|NCT01535183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6164999|NCT01567527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6165000|NCT01567527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6165001|NCT01567527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165002|NCT01567527|Dopamine Agonists|dopamine agonists|mesh-ancestor
6165003|NCT01567527|Dopamine Agents|dopamine agents|mesh-ancestor
6165004|NCT01567527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6165005|NCT01567527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6165006|NCT01567527|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6165007|NCT01567527|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6165008|NCT01567527|Serotonin Agents|serotonin agents|mesh-ancestor
6165009|NCT01567527|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5563033|NCT03995563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6165010|NCT01567527|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6165011|NCT01567527|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6165012|NCT01567527|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6165013|NCT01567826|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6165014|NCT01567826|Atorvastatin|atorvastatin|mesh-list
6482813|NCT00554242|Protective Agents|protective agents|mesh-ancestor
6482814|NCT00554242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563034|NCT03995563|Sensory System Agents|sensory system agents|mesh-ancestor
5563035|NCT03995251|Testosterone|testosterone|mesh-list
5563036|NCT03995251|Androgens|androgens|mesh-ancestor
5563037|NCT03995251|Hormones|hormones|mesh-ancestor
5563038|NCT03995251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5563039|NCT03995251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563040|NCT03995147|Prednisone|prednisone|mesh-list
6482815|NCT00554242|Vitamins|vitamins|mesh-ancestor
6482816|NCT00554242|Micronutrients|micronutrients|mesh-ancestor
6482817|NCT00554242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6482818|NCT00554242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6482819|NCT00554346|Etoricoxib|etoricoxib|mesh-list
6482820|NCT00554346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6482821|NCT00554346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6668953|NCT01535183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668954|NCT01535183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6672458|NCT01556321|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6672459|NCT01556321|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6672460|NCT01556321|Purinergic Agents|purinergic agents|mesh-ancestor
6482822|NCT00554346|Analgesics|analgesics|mesh-ancestor
6482823|NCT00554346|Sensory System Agents|sensory system agents|mesh-ancestor
6482824|NCT00554346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6482825|NCT00554346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482826|NCT00554346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6482827|NCT00554346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6482828|NCT00554346|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5563041|NCT03995147|Cyclophosphamide|cyclophosphamide|mesh-list
5563042|NCT03995147|Doxorubicin|doxorubicin|mesh-list
5563043|NCT03995147|Pembrolizumab|pembrolizumab|mesh-list
5563044|NCT03995147|Vincristine|vincristine|mesh-list
5563045|NCT03995147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5563046|NCT03995147|Immunologic Factors|immunologic factors|mesh-ancestor
5563047|NCT03995147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563048|NCT03995147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5563049|NCT03995147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6482829|NCT00554346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6672461|NCT01556321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6672462|NCT01556334|Azithromycin|azithromycin|mesh-list
6672463|NCT01556334|Erythromycin|erythromycin|mesh-list
6672464|NCT01556334|Erythromycin Estolate|erythromycin estolate|mesh-list
6672465|NCT01556334|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
6165015|NCT01567826|Simvastatin|simvastatin|mesh-list
6165016|NCT01567826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6165017|NCT01567826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6165018|NCT01567826|Antimetabolites|antimetabolites|mesh-ancestor
6165019|NCT01567826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6165020|NCT01567826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6165021|NCT01567826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6165022|NCT01567826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6165023|NCT01567852|Ketamine|ketamine|mesh-list
6165024|NCT01567852|Methohexital|methohexital|mesh-list
6165025|NCT01567852|Analgesics|analgesics|mesh-ancestor
6165026|NCT01567852|Sensory System Agents|sensory system agents|mesh-ancestor
6165027|NCT01567852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6165028|NCT01567852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563050|NCT03995147|Alkylating Agents|alkylating agents|mesh-ancestor
5563051|NCT03995147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563052|NCT03995147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5563053|NCT03995147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5563054|NCT03995147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5563055|NCT03995147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5563056|NCT03995147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5563057|NCT03995147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5563058|NCT03995147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6165029|NCT01567852|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6165030|NCT01567852|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6165031|NCT01567852|Anesthetics, General|anesthetics, general|mesh-ancestor
6165032|NCT01567852|Anesthetics|anesthetics|mesh-ancestor
6165033|NCT01567852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6165034|NCT01567852|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6165035|NCT01567852|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6165036|NCT01567852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6165037|NCT01567852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6165038|NCT01567865|Vaccines|vaccines|mesh-list
6482830|NCT00554346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6482831|NCT00554346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6482832|NCT00554398|Raltegravir Potassium|raltegravir potassium|mesh-list
6482833|NCT00554398|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6482834|NCT00554398|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6482835|NCT00554398|Antiviral Agents|antiviral agents|mesh-ancestor
6482836|NCT00554398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6482837|NCT00554398|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6482838|NCT00554398|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6482839|NCT00554398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6482840|NCT00554398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6482841|NCT00554424|Lidocaine|lidocaine|mesh-list
6482842|NCT00554424|Anesthetics, Local|anesthetics, local|mesh-ancestor
5563059|NCT03995147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6482843|NCT00554424|Anesthetics|anesthetics|mesh-ancestor
6482844|NCT00554424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6482845|NCT00554424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482846|NCT00554424|Sensory System Agents|sensory system agents|mesh-ancestor
6482847|NCT00554424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6482848|NCT00554424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6482849|NCT00554424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6482850|NCT00554424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6482851|NCT00554424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6482852|NCT00554424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6482853|NCT00554450|Dapagliflozin|dapagliflozin|mesh-list
6165039|NCT01567865|Immunologic Factors|immunologic factors|mesh-ancestor
6165040|NCT01567865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165041|NCT01568008|Bimatoprost|bimatoprost|mesh-list
6165042|NCT01568008|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6165043|NCT01568008|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6165044|NCT01568008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6165045|NCT01568034|Levodopa|levodopa|mesh-list
6165046|NCT01568034|Carbidopa|carbidopa|mesh-list
6165047|NCT01568034|Opicapone|opicapone|mesh-list
6165048|NCT01568034|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6165049|NCT01568034|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6165050|NCT01568034|Dopamine Agents|dopamine agents|mesh-ancestor
6165051|NCT01568034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6165052|NCT01568034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6165053|NCT01568034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165054|NCT01568034|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6165055|NCT01568034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6165056|NCT01568034|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6165057|NCT01568047|Levodopa|levodopa|mesh-list
6165058|NCT01568047|Carbidopa|carbidopa|mesh-list
6165059|NCT01568047|Opicapone|opicapone|mesh-list
6165060|NCT01568047|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6165061|NCT01568047|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6165062|NCT01568047|Dopamine Agents|dopamine agents|mesh-ancestor
6165063|NCT01568047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6482854|NCT00554450|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6482855|NCT00554450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6482856|NCT00554450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6482857|NCT00554450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482858|NCT00554476|Triamcinolone|triamcinolone|mesh-list
6482859|NCT00554476|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6482860|NCT00554476|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6482861|NCT00554476|Indomethacin|indomethacin|mesh-list
6165064|NCT01568047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6482862|NCT00554476|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6482863|NCT00554476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6482864|NCT00554476|Glucocorticoids|glucocorticoids|mesh-ancestor
6482865|NCT00554476|Hormones|hormones|mesh-ancestor
6482866|NCT00554476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6482867|NCT00554476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482868|NCT00554476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6482869|NCT00554476|Immunologic Factors|immunologic factors|mesh-ancestor
6482870|NCT00554476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6482871|NCT00554476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6482872|NCT00554476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6482873|NCT00554476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6482874|NCT00554476|Analgesics|analgesics|mesh-ancestor
6668955|NCT01535417|Celecoxib|celecoxib|mesh-list
5563060|NCT03995147|Glucocorticoids|glucocorticoids|mesh-ancestor
5563061|NCT03995147|Hormones|hormones|mesh-ancestor
5563062|NCT03995147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6482875|NCT00554476|Sensory System Agents|sensory system agents|mesh-ancestor
6482876|NCT00554476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6165065|NCT01568047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165066|NCT01568047|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6165067|NCT01568047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6165068|NCT01568047|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6165069|NCT01568073|Levodopa|levodopa|mesh-list
6165070|NCT01568073|Carbidopa|carbidopa|mesh-list
6165071|NCT01568073|Opicapone|opicapone|mesh-list
6165072|NCT01568073|Entacapone|entacapone|mesh-list
6165073|NCT01568073|Benserazide|benserazide|mesh-list
6165074|NCT01568073|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6165075|NCT01568073|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6165076|NCT01568073|Dopamine Agents|dopamine agents|mesh-ancestor
6165077|NCT01568073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6165078|NCT01568073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6165079|NCT01568073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165080|NCT01568073|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6165081|NCT01568073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6165082|NCT01568073|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6165083|NCT01568112|Aspirin|aspirin|mesh-list
6165084|NCT01568112|Dimethyl Fumarate|dimethyl fumarate|mesh-list
6165085|NCT01568112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6165086|NCT01568112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6165087|NCT01568112|Analgesics|analgesics|mesh-ancestor
6165088|NCT01568112|Sensory System Agents|sensory system agents|mesh-ancestor
6165089|NCT01568112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6165090|NCT01568112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563063|NCT03995147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5563064|NCT03995147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5563065|NCT03995147|Tubulin Modulators|tubulin modulators|mesh-ancestor
5563066|NCT03995147|Antimitotic Agents|antimitotic agents|mesh-ancestor
5563067|NCT03995147|Mitosis Modulators|mitosis modulators|mesh-ancestor
5563068|NCT03995277|Biotin|biotin|mesh-list
5563069|NCT03995277|Vitamin B Complex|vitamin b complex|mesh-ancestor
5563070|NCT03995277|Vitamins|vitamins|mesh-ancestor
5563071|NCT03995277|Micronutrients|micronutrients|mesh-ancestor
5563072|NCT03995277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563073|NCT03995134|Remifentanil|remifentanil|mesh-list
5563074|NCT03995134|Propofol|propofol|mesh-list
5563075|NCT03995134|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5563076|NCT03995134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5563077|NCT03995134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563078|NCT03995134|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5563079|NCT03995134|Anesthetics, General|anesthetics, general|mesh-ancestor
5563080|NCT03995134|Anesthetics|anesthetics|mesh-ancestor
5563081|NCT03995134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5563082|NCT03995134|Narcotics|narcotics|mesh-ancestor
6165091|NCT01568112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6482877|NCT00554476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6482878|NCT00554476|Gout Suppressants|gout suppressants|mesh-ancestor
5563083|NCT03995134|Analgesics|analgesics|mesh-ancestor
5563084|NCT03995134|Sensory System Agents|sensory system agents|mesh-ancestor
5563085|NCT03995134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5563086|NCT03994874|Furosemide|furosemide|mesh-list
5563087|NCT03994874|Dialysis Solutions|dialysis solutions|mesh-list
5563088|NCT03994874|Diuretics|diuretics|mesh-list
5563089|NCT03994874|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
5563090|NCT03994874|Natriuretic Agents|natriuretic agents|mesh-ancestor
5563091|NCT03994874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563092|NCT03994874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5563093|NCT03994874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563094|NCT03994874|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5563095|NCT03994965|Pimavanserin|pimavanserin|mesh-list
6482879|NCT00554476|Tocolytic Agents|tocolytic agents|mesh-ancestor
6482880|NCT00554476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6482881|NCT00554476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6482882|NCT00554502|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6482883|NCT00554502|Immunosuppressive Agents|immunosuppressive agents|mesh-list
6482884|NCT00554502|Protease Inhibitors|protease inhibitors|mesh-ancestor
6482885|NCT00554502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6672466|NCT01556334|Erythromycin stearate|erythromycin stearate|mesh-list
5563096|NCT03994965|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6668956|NCT01535417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6668957|NCT01535417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6668958|NCT01535417|Analgesics|analgesics|mesh-ancestor
6668959|NCT01535417|Sensory System Agents|sensory system agents|mesh-ancestor
6668960|NCT01535417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6668961|NCT01535417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668962|NCT01535417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6668963|NCT01535417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6668964|NCT01535417|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6668965|NCT01535417|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6668966|NCT01535417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5563097|NCT03994965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5563098|NCT03994965|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5563099|NCT03994965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6668967|NCT01535417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668968|NCT01535469|Fluconazole|fluconazole|mesh-list
6668969|NCT01535469|Antifungal Agents|antifungal agents|mesh-ancestor
6668970|NCT01535469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6668971|NCT01535469|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6668972|NCT01535469|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6668973|NCT01535469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6668974|NCT01535469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668975|NCT01535469|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6668976|NCT01535469|Hormone Antagonists|hormone antagonists|mesh-ancestor
6668977|NCT01535469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6165092|NCT01568112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6165093|NCT01568112|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6165094|NCT01568112|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6165095|NCT01568112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6165096|NCT01568112|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6165097|NCT01568112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6165098|NCT01568112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6165099|NCT01568112|Antipyretics|antipyretics|mesh-ancestor
6165100|NCT01568112|Dermatologic Agents|dermatologic agents|mesh-ancestor
6165101|NCT01568112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6165102|NCT01568112|Immunologic Factors|immunologic factors|mesh-ancestor
6482886|NCT00554502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6482887|NCT00554502|Immunologic Factors|immunologic factors|mesh-ancestor
6482888|NCT00554502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482889|NCT00554528|Meloxicam|meloxicam|mesh-list
6482890|NCT00554528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6482891|NCT00554528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6482892|NCT00554528|Analgesics|analgesics|mesh-ancestor
6482893|NCT00554528|Sensory System Agents|sensory system agents|mesh-ancestor
6482894|NCT00554528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6482895|NCT00554528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482896|NCT00554528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6482897|NCT00554528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6482898|NCT00554528|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6482899|NCT00554528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6482900|NCT00554528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6482901|NCT00554528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563100|NCT03994965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6482902|NCT00554632|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6482903|NCT00554632|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6482904|NCT00554632|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6482905|NCT00554632|Norgestimate|norgestimate|mesh-list
6668978|NCT01535469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165103|NCT01568255|Ergocalciferols|ergocalciferols|mesh-list
6165104|NCT01568255|Vitamin D|vitamin d|mesh-list
6165105|NCT01568255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6165106|NCT01568255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165107|NCT01568255|Vitamins|vitamins|mesh-ancestor
6165108|NCT01568255|Micronutrients|micronutrients|mesh-ancestor
6165109|NCT01568255|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6165110|NCT01568528|Oxytocin|oxytocin|mesh-list
6165111|NCT01568528|Oxytocics|oxytocics|mesh-ancestor
6165112|NCT01568528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6165113|NCT01568528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206176|NCT02097108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6206177|NCT02097108|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6206178|NCT02097108|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6206179|NCT02097108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6165114|NCT01568866|Dexamethasone|dexamethasone|mesh-list
6165115|NCT01568866|Bortezomib|bortezomib|mesh-list
6165116|NCT01568866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6165117|NCT01568866|Antiemetics|antiemetics|mesh-ancestor
6165118|NCT01568866|Autonomic Agents|autonomic agents|mesh-ancestor
6165119|NCT01568866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6165120|NCT01568866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165121|NCT01568866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6165122|NCT01568866|Glucocorticoids|glucocorticoids|mesh-ancestor
5563101|NCT03994965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563102|NCT03994965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5563103|NCT03994965|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5563104|NCT03994965|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5563105|NCT03994965|Serotonin Agents|serotonin agents|mesh-ancestor
5563106|NCT03994965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5563107|NCT03994965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563108|NCT03994731|Methotrexate|methotrexate|mesh-list
5563109|NCT03994731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5563110|NCT03994731|Abortifacient Agents|abortifacient agents|mesh-ancestor
5563111|NCT03994731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5563112|NCT03994731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563113|NCT03994731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5563114|NCT03994731|Antimetabolites|antimetabolites|mesh-ancestor
5563115|NCT03994731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563116|NCT03994731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5563117|NCT03994731|Dermatologic Agents|dermatologic agents|mesh-ancestor
5563118|NCT03994731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5563119|NCT03994731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5563120|NCT03994731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5563121|NCT03994731|Immunologic Factors|immunologic factors|mesh-ancestor
6165123|NCT01568866|Hormones|hormones|mesh-ancestor
6165124|NCT01568866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6165125|NCT01568866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6165126|NCT01568866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6165127|NCT01568892|Dolutegravir|dolutegravir|mesh-list
6165128|NCT01568892|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6165129|NCT01568892|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6165130|NCT01568892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6165131|NCT01568892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6165132|NCT01568892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6165133|NCT01568892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6165134|NCT01568892|Antiviral Agents|antiviral agents|mesh-ancestor
6165135|NCT01568892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6165136|NCT01568905|Nicotine|nicotine|mesh-list
6165137|NCT01568905|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6165138|NCT01568905|Autonomic Agents|autonomic agents|mesh-ancestor
6165139|NCT01568905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6165140|NCT01568905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165141|NCT01568905|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6165142|NCT01568905|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6165143|NCT01568905|Cholinergic Agents|cholinergic agents|mesh-ancestor
6165144|NCT01568905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6165145|NCT01568905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6165146|NCT01568944|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6165147|NCT01568944|Lansoprazole|lansoprazole|mesh-list
6165148|NCT01568944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6165149|NCT01568944|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6165150|NCT01568944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6165151|NCT01568944|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6165152|NCT01568944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6165153|NCT01568944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563122|NCT03994731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5563123|NCT03994731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5563124|NCT03994783|Methylprednisolone|methylprednisolone|mesh-list
5563125|NCT03994783|Rituximab|rituximab|mesh-list
5563126|NCT03994783|Immunoglobulins|immunoglobulins|mesh-list
5563127|NCT03994783|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5563128|NCT03994783|Antibodies|antibodies|mesh-list
5563129|NCT03994783|gamma-Globulins|gamma-globulins|mesh-list
5563130|NCT03994783|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5563131|NCT03994783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5563132|NCT03994783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5563133|NCT03994783|Immunologic Factors|immunologic factors|mesh-ancestor
6165154|NCT01569087|Lenograstim|lenograstim|mesh-list
6165155|NCT01569087|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6165156|NCT01569087|Immunologic Factors|immunologic factors|mesh-ancestor
6165157|NCT01569087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563134|NCT03994783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563135|NCT03994783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5563136|NCT03994783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5563137|NCT03994783|Antiemetics|antiemetics|mesh-ancestor
5563138|NCT03994783|Autonomic Agents|autonomic agents|mesh-ancestor
5563139|NCT03994783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5563140|NCT03994783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5563141|NCT03994783|Glucocorticoids|glucocorticoids|mesh-ancestor
5563142|NCT03994783|Hormones|hormones|mesh-ancestor
5563143|NCT03994783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5563144|NCT03994783|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5563145|NCT03994783|Protective Agents|protective agents|mesh-ancestor
5563146|NCT03994705|Cyclophosphamide|cyclophosphamide|mesh-list
5563147|NCT03994705|Fludarabine|fludarabine|mesh-list
5563148|NCT03994705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5563149|NCT03994705|Immunologic Factors|immunologic factors|mesh-ancestor
6165158|NCT01569126|Fluoxetine|fluoxetine|mesh-list
6165159|NCT01569126|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6165160|NCT01569126|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6165161|NCT01569126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6165162|NCT01569126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6165163|NCT01569126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6165164|NCT01569126|Serotonin Agents|serotonin agents|mesh-ancestor
6165165|NCT01569126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165166|NCT01569126|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6165167|NCT01569126|Antidepressive Agents|antidepressive agents|mesh-ancestor
6165168|NCT01569126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6165169|NCT01569126|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6165170|NCT01569126|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6165171|NCT01569126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6165172|NCT01569152|Methotrexate|methotrexate|mesh-list
6165173|NCT01569152|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6165174|NCT01569152|Abortifacient Agents|abortifacient agents|mesh-ancestor
6165175|NCT01569152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6165176|NCT01569152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165177|NCT01569152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6165178|NCT01569152|Antimetabolites|antimetabolites|mesh-ancestor
5563150|NCT03994705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563151|NCT03994705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6165179|NCT01569152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6165180|NCT01569152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6165181|NCT01569152|Dermatologic Agents|dermatologic agents|mesh-ancestor
6165182|NCT01569152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6165183|NCT01569152|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6165184|NCT01569152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6165185|NCT01569152|Immunologic Factors|immunologic factors|mesh-ancestor
6165186|NCT01569152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6165187|NCT01569152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6165188|NCT01569191|Anti-Allergic Agents|anti-allergic agents|mesh-list
6165189|NCT01569191|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6165190|NCT01569191|Lubricant Eye Drops|lubricant eye drops|mesh-list
6165191|NCT01569191|Epinastine|epinastine|mesh-list
5563152|NCT03994705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5563153|NCT03994705|Alkylating Agents|alkylating agents|mesh-ancestor
5563154|NCT03994705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563155|NCT03994705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5563156|NCT03994705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5563157|NCT03994692|Ether|ether|mesh-list
5563158|NCT03994692|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5563159|NCT03994692|Anesthetics, General|anesthetics, general|mesh-ancestor
5563160|NCT03994692|Anesthetics|anesthetics|mesh-ancestor
5563161|NCT03994692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5563162|NCT03994692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563163|NCT03994744|Metformin|metformin|mesh-list
5563164|NCT03994744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5563165|NCT03994744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5563166|NCT03994744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165192|NCT01569191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6165193|NCT01569191|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6165194|NCT01569191|Histamine Antagonists|histamine antagonists|mesh-ancestor
6165195|NCT01569191|Histamine Agents|histamine agents|mesh-ancestor
6165196|NCT01569191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5563167|NCT03994744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6165197|NCT01569191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6165198|NCT01569191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165199|NCT01569295|Rituximab|rituximab|mesh-list
6165200|NCT01569295|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6165201|NCT01569295|Idelalisib|idelalisib|mesh-list
6165202|NCT01569295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6165203|NCT01569295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6165204|NCT01569295|Immunologic Factors|immunologic factors|mesh-ancestor
6165205|NCT01569295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165206|NCT01569295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6165207|NCT01569295|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6165208|NCT01569295|Alkylating Agents|alkylating agents|mesh-ancestor
6165209|NCT01569295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6165210|NCT01569295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6165211|NCT01569451|Rituximab|rituximab|mesh-list
6165212|NCT01569451|Glatiramer Acetate|glatiramer acetate|mesh-list
6165213|NCT01569451|(T,G)-A-L|(t,g)-a-l|mesh-list
6165214|NCT01569451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6165215|NCT01569451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6165216|NCT01569451|Immunologic Factors|immunologic factors|mesh-ancestor
6165217|NCT01569451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165218|NCT01569451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6165219|NCT01569451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6165220|NCT01569451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6165221|NCT01569464|Rotigotine|rotigotine|mesh-list
6165222|NCT01569464|Dopamine Agonists|dopamine agonists|mesh-ancestor
6165223|NCT01569464|Dopamine Agents|dopamine agents|mesh-ancestor
6165224|NCT01569464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6165225|NCT01569464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6165226|NCT01569464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563168|NCT03994744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5603690|NCT01755975|Romidepsin|romidepsin|mesh-list
5603691|NCT01755975|Immunologic Factors|immunologic factors|mesh-ancestor
5603692|NCT01755975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603693|NCT01755975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5603694|NCT01755975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5603695|NCT01755975|Growth Substances|growth substances|mesh-ancestor
5603696|NCT01755975|Growth Inhibitors|growth inhibitors|mesh-ancestor
5603697|NCT01755975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5603698|NCT01755975|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5603699|NCT01715285|Prednisone|prednisone|mesh-list
5603700|NCT01715285|Abiraterone Acetate|abiraterone acetate|mesh-list
5603701|NCT01715285|Androgens|androgens|mesh-list
5603702|NCT01715285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5603703|NCT01715285|Glucocorticoids|glucocorticoids|mesh-ancestor
5603704|NCT01715285|Hormones|hormones|mesh-ancestor
5603705|NCT01715285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5603706|NCT01715285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165227|NCT01569815|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
6165228|NCT01569815|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6165229|NCT01569815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6165230|NCT01569828|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
6165231|NCT01569828|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6482906|NCT00554632|Norelgestromin|norelgestromin|mesh-list
6668979|NCT01535469|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5603707|NCT01715285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5603708|NCT01715285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5603709|NCT01715285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5603710|NCT01715285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5603711|NCT01715285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603712|NCT01715285|Hormone Antagonists|hormone antagonists|mesh-ancestor
5603713|NCT01715285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5603714|NCT01670409|Cisplatin|cisplatin|mesh-list
5603715|NCT01670409|Fluorouracil|fluorouracil|mesh-list
5603716|NCT01670409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5603717|NCT01670409|Antimetabolites|antimetabolites|mesh-ancestor
5603718|NCT01670409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603719|NCT01670409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5603720|NCT01670409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5603721|NCT01670409|Immunologic Factors|immunologic factors|mesh-ancestor
5603722|NCT01670409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603723|NCT01659606|Cyclosporine|cyclosporine|mesh-list
5563169|NCT03994211|Itraconazole|itraconazole|mesh-list
5563170|NCT03994211|Rifampin|rifampin|mesh-list
5563171|NCT03994211|Antifungal Agents|antifungal agents|mesh-ancestor
5563172|NCT03994211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5563173|NCT03994211|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5563174|NCT03994211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5563175|NCT03994211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5563176|NCT03994211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563177|NCT03994211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5563178|NCT03994211|Hormone Antagonists|hormone antagonists|mesh-ancestor
5563179|NCT03994211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5563180|NCT03994211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563181|NCT03994211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5563182|NCT03994211|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5563183|NCT03994211|Antitubercular Agents|antitubercular agents|mesh-ancestor
6668980|NCT01535469|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6668981|NCT01535495|Propranolol|propranolol|mesh-list
6165232|NCT01569828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6165233|NCT01569841|Insulin|insulin|mesh-list
6165234|NCT01569841|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6165235|NCT01569841|Insulin Glargine|insulin glargine|mesh-list
6165236|NCT01569841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6165237|NCT01569841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165238|NCT01570036|Trastuzumab|trastuzumab|mesh-list
6165239|NCT01570036|Molgramostim|molgramostim|mesh-list
6165240|NCT01570036|Sargramostim|sargramostim|mesh-list
6165241|NCT01570036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6165242|NCT01570036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6165243|NCT01570036|Immunologic Factors|immunologic factors|mesh-ancestor
6165244|NCT01570036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165245|NCT01570192|Vancomycin|vancomycin|mesh-list
6165246|NCT01570192|Gentamicins|gentamicins|mesh-list
6165247|NCT01570192|Meropenem|meropenem|mesh-list
6165248|NCT01570192|Linezolid|linezolid|mesh-list
6165249|NCT01570192|Tobramycin|tobramycin|mesh-list
6165250|NCT01570192|Amikacin|amikacin|mesh-list
6165251|NCT01570192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6165252|NCT01570192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6165253|NCT01570192|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6165254|NCT01570192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6165255|NCT01570192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6165256|NCT01570244|Levonorgestrel|levonorgestrel|mesh-list
6165257|NCT01570244|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6165258|NCT01570244|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6165259|NCT01570244|Contraceptive Agents|contraceptive agents|mesh-ancestor
6165260|NCT01570244|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6165261|NCT01570244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165262|NCT01570244|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6165263|NCT01570244|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6165264|NCT01570244|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6165265|NCT01570244|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6668982|NCT01535495|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6668983|NCT01535495|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6482907|NCT00554632|Ortho Evra|ortho evra|mesh-list
6482908|NCT00554632|Estradiol|estradiol|mesh-list
6482909|NCT00554632|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6482910|NCT00554632|Estrogens|estrogens|mesh-ancestor
6482911|NCT00554632|Hormones|hormones|mesh-ancestor
6482912|NCT00554632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6482913|NCT00554632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482914|NCT00554632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6482915|NCT00554632|Contraceptive Agents|contraceptive agents|mesh-ancestor
6482916|NCT00554632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6482917|NCT00554632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6482918|NCT00554632|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6482919|NCT00554632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6482920|NCT00554632|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6482921|NCT00554658|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6482922|NCT00554658|Antidepressive Agents|antidepressive agents|mesh-ancestor
6165266|NCT01570244|Estrogens|estrogens|mesh-ancestor
6165267|NCT01570244|Hormones|hormones|mesh-ancestor
6165268|NCT01570244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6165269|NCT01570309|Ergocalciferols|ergocalciferols|mesh-list
6165270|NCT01570309|Vitamin D|vitamin d|mesh-list
6482923|NCT00554658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6668984|NCT01535495|Adrenergic Agents|adrenergic agents|mesh-ancestor
6165271|NCT01570309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6165272|NCT01570309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165273|NCT01570309|Vitamins|vitamins|mesh-ancestor
6165274|NCT01570309|Micronutrients|micronutrients|mesh-ancestor
6165275|NCT01570309|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6165276|NCT01570348|Mycophenolic Acid|mycophenolic acid|mesh-list
6165277|NCT01570348|Cyclophosphamide|cyclophosphamide|mesh-list
6165278|NCT01570348|Fludarabine|fludarabine|mesh-list
6165279|NCT01570348|Fludarabine phosphate|fludarabine phosphate|mesh-list
6165280|NCT01570348|Tacrolimus|tacrolimus|mesh-list
6165281|NCT01570348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6165282|NCT01570348|Immunologic Factors|immunologic factors|mesh-ancestor
6165283|NCT01570348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482924|NCT00554658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6482925|NCT00554658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6482926|NCT00554658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6482927|NCT00554658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668985|NCT01535495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6165284|NCT01570348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6165285|NCT01570348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6165286|NCT01570348|Alkylating Agents|alkylating agents|mesh-ancestor
6165287|NCT01570348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6165288|NCT01570348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6165289|NCT01570348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6165290|NCT01570348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6165291|NCT01570348|Antimetabolites|antimetabolites|mesh-ancestor
5563184|NCT03994211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5563185|NCT03994211|Leprostatic Agents|leprostatic agents|mesh-ancestor
5563186|NCT03994211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5563187|NCT03994211|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5563188|NCT03994211|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5563189|NCT03994211|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5563190|NCT03994211|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5563191|NCT03994211|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5563192|NCT03994211|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5563193|NCT03994107|Paclitaxel|paclitaxel|mesh-list
5563194|NCT03994107|Doxorubicin|doxorubicin|mesh-list
5563195|NCT03994107|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5563196|NCT03994107|Trastuzumab|trastuzumab|mesh-list
5563197|NCT03994107|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5563198|NCT03994107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5563199|NCT03994107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5563200|NCT03994107|Tubulin Modulators|tubulin modulators|mesh-ancestor
5563201|NCT03994107|Antimitotic Agents|antimitotic agents|mesh-ancestor
5563202|NCT03994107|Mitosis Modulators|mitosis modulators|mesh-ancestor
5563203|NCT03994107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563204|NCT03994107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5563205|NCT03994107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5563206|NCT03994107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5563207|NCT03994107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5563208|NCT03994107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5563209|NCT03994055|Antioxidants|antioxidants|mesh-list
6165292|NCT01570348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6165293|NCT01570348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6165294|NCT01570348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6165295|NCT01570348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6165296|NCT01570348|Antitubercular Agents|antitubercular agents|mesh-ancestor
5563210|NCT03994055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563211|NCT03994055|Protective Agents|protective agents|mesh-ancestor
5603724|NCT01659606|Mycophenolic Acid|mycophenolic acid|mesh-list
6165297|NCT01570348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6165298|NCT01570348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6165299|NCT01570361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
6668986|NCT01535495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668987|NCT01535495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668988|NCT01535495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6668989|NCT01535495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6668990|NCT01535495|Vasodilator Agents|vasodilator agents|mesh-ancestor
6165300|NCT01570387|Dexamethasone|dexamethasone|mesh-list
6165301|NCT01570387|Dexamethasone acetate|dexamethasone acetate|mesh-list
6165302|NCT01570387|Pomalidomide|pomalidomide|mesh-list
6165303|NCT01570387|BB 1101|bb 1101|mesh-list
6165304|NCT01570387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6165305|NCT01570387|Antiemetics|antiemetics|mesh-ancestor
6165306|NCT01570387|Autonomic Agents|autonomic agents|mesh-ancestor
6165307|NCT01570387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5563212|NCT03994055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563213|NCT03994393|Durvalumab|durvalumab|mesh-list
5563214|NCT03994393|Tremelimumab|tremelimumab|mesh-list
5563215|NCT03994393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5563216|NCT03994393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5563217|NCT03993912|Dexamethasone|dexamethasone|mesh-list
5563218|NCT03993912|Lenalidomide|lenalidomide|mesh-list
5563219|NCT03993912|Daratumumab|daratumumab|mesh-list
5563220|NCT03993912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5563221|NCT03993912|Antiemetics|antiemetics|mesh-ancestor
5563222|NCT03993912|Autonomic Agents|autonomic agents|mesh-ancestor
5563223|NCT03993912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5563224|NCT03993912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563225|NCT03993912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5563226|NCT03993912|Glucocorticoids|glucocorticoids|mesh-ancestor
5563227|NCT03993912|Hormones|hormones|mesh-ancestor
5563228|NCT03993912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5563229|NCT03993912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5563230|NCT03993912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5563231|NCT03993912|Immunologic Factors|immunologic factors|mesh-ancestor
5563232|NCT03993912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5563233|NCT03993912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5563234|NCT03993912|Growth Substances|growth substances|mesh-ancestor
5563235|NCT03993912|Growth Inhibitors|growth inhibitors|mesh-ancestor
5563239|NCT03993431|Methamphetamine|methamphetamine|mesh-list
5563240|NCT03993431|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5563241|NCT03993431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563242|NCT03993431|Sympathomimetics|sympathomimetics|mesh-ancestor
5563243|NCT03993431|Autonomic Agents|autonomic agents|mesh-ancestor
5563244|NCT03993431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5563245|NCT03993431|Dopamine Agents|dopamine agents|mesh-ancestor
5563246|NCT03993431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5563247|NCT03993431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563248|NCT03993431|Adrenergic Agents|adrenergic agents|mesh-ancestor
5563249|NCT03993431|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5563250|NCT03993431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5563251|NCT03993431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5563252|NCT03993431|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5563253|NCT03993626|Nivolumab|nivolumab|mesh-list
5563254|NCT03993626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5563255|NCT03993626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5563256|NCT03993626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5563257|NCT03993626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563258|NCT03993535|Serotonin|serotonin|mesh-list
5563259|NCT03993535|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
5563260|NCT03993535|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5563261|NCT03993535|Serotonin Agents|serotonin agents|mesh-ancestor
5563262|NCT03993535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5563263|NCT03993535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563264|NCT03993535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563265|NCT03993535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5563266|NCT03993535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5563267|NCT03993327|Iodine|iodine|mesh-list
5563268|NCT03993327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5563269|NCT03993327|Antibodies|antibodies|mesh-list
5563270|NCT03993327|Immunoglobulins|immunoglobulins|mesh-list
5563271|NCT03993327|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5563272|NCT03993327|Immunologic Factors|immunologic factors|mesh-ancestor
5563273|NCT03993327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563274|NCT03993327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5563275|NCT03993327|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6165308|NCT01570387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165309|NCT01570387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6165310|NCT01570387|Glucocorticoids|glucocorticoids|mesh-ancestor
6165311|NCT01570387|Hormones|hormones|mesh-ancestor
6165312|NCT01570387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6165313|NCT01570387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6165314|NCT01570387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6165315|NCT01570387|Protease Inhibitors|protease inhibitors|mesh-ancestor
6165316|NCT01570387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5563276|NCT03993327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5563277|NCT03993327|Trace Elements|trace elements|mesh-ancestor
5563278|NCT03993327|Micronutrients|micronutrients|mesh-ancestor
5563279|NCT03993457|Citalopram|citalopram|mesh-list
5563280|NCT03993457|Bupropion|bupropion|mesh-list
5563281|NCT03993457|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5563282|NCT03993457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5563283|NCT03993457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5563284|NCT03993457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563285|NCT03993457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5563286|NCT03993457|Serotonin Agents|serotonin agents|mesh-ancestor
5563287|NCT03993457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563288|NCT03993457|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5563289|NCT03993457|Antidepressive Agents|antidepressive agents|mesh-ancestor
5563290|NCT03993457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5563291|NCT03993457|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6165317|NCT01570387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6165318|NCT01570387|Immunologic Factors|immunologic factors|mesh-ancestor
6165319|NCT01570387|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6165320|NCT01570387|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6165321|NCT01570387|Growth Substances|growth substances|mesh-ancestor
6165322|NCT01570387|Growth Inhibitors|growth inhibitors|mesh-ancestor
6165323|NCT01570491|Anesthetics|anesthetics|mesh-list
6165324|NCT01570491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6165325|NCT01570491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165326|NCT01570751|Insulin|insulin|mesh-list
6165327|NCT01570751|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6482928|NCT00554710|Methylprednisolone|methylprednisolone|mesh-list
6482929|NCT00554710|Budesonide|budesonide|mesh-list
6482930|NCT00554710|Azathioprine|azathioprine|mesh-list
6482931|NCT00554710|Infliximab|infliximab|mesh-list
6482932|NCT00554710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6482933|NCT00554710|Antiemetics|antiemetics|mesh-ancestor
6482934|NCT00554710|Autonomic Agents|autonomic agents|mesh-ancestor
6482935|NCT00554710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6482936|NCT00554710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482937|NCT00554710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6482938|NCT00554710|Glucocorticoids|glucocorticoids|mesh-ancestor
6482939|NCT00554710|Hormones|hormones|mesh-ancestor
6482940|NCT00554710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6165328|NCT01570751|Insulin Glargine|insulin glargine|mesh-list
6165329|NCT01570751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6165330|NCT01570751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165331|NCT01570868|Ponatinib|ponatinib|mesh-list
6165332|NCT01570868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6165333|NCT01570868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6482941|NCT00554710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6482942|NCT00554710|Protective Agents|protective agents|mesh-ancestor
6482943|NCT00554710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6482944|NCT00554710|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6482945|NCT00554710|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6482946|NCT00554710|Respiratory System Agents|respiratory system agents|mesh-ancestor
6482947|NCT00554710|Dermatologic Agents|dermatologic agents|mesh-ancestor
6482948|NCT00554710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6482949|NCT00554710|Antimetabolites|antimetabolites|mesh-ancestor
6482950|NCT00554710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6482951|NCT00554710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6482952|NCT00554710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6482953|NCT00554710|Immunologic Factors|immunologic factors|mesh-ancestor
5563292|NCT03993457|Dopamine Agents|dopamine agents|mesh-ancestor
6165334|NCT01570868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6165335|NCT01570868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6165336|NCT01571232|Dexamethasone|dexamethasone|mesh-list
6165337|NCT01571232|Bevacizumab|bevacizumab|mesh-list
6165338|NCT01571232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6165339|NCT01571232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6165340|NCT01571232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6165341|NCT01571232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6165342|NCT01571232|Growth Substances|growth substances|mesh-ancestor
6165343|NCT01571232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165344|NCT01571232|Growth Inhibitors|growth inhibitors|mesh-ancestor
6165345|NCT01571232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6165346|NCT01571232|Antiemetics|antiemetics|mesh-ancestor
6165347|NCT01571232|Autonomic Agents|autonomic agents|mesh-ancestor
6165348|NCT01571232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6165349|NCT01571232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6165350|NCT01571232|Glucocorticoids|glucocorticoids|mesh-ancestor
6165351|NCT01571232|Hormones|hormones|mesh-ancestor
6165352|NCT01571232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5563293|NCT03993457|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5563294|NCT03993457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5563295|NCT03993457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5563296|NCT03993366|Pramlintide|pramlintide|mesh-list
5563297|NCT03993366|Insulin Aspart|insulin aspart|mesh-list
5563298|NCT03993366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5563299|NCT03993366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563300|NCT03993353|Pembrolizumab|pembrolizumab|mesh-list
6165353|NCT01571232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6165354|NCT01571284|Aflibercept|aflibercept|mesh-list
6165355|NCT01571284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6165356|NCT01571284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6165357|NCT01571284|Growth Substances|growth substances|mesh-ancestor
6165358|NCT01571284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165359|NCT01571284|Growth Inhibitors|growth inhibitors|mesh-ancestor
6165360|NCT01571284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6165361|NCT01571362|Naltrexone|naltrexone|mesh-list
6165362|NCT01571362|Oxycodone|oxycodone|mesh-list
6165363|NCT01571362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6165364|NCT01571362|Narcotics|narcotics|mesh-ancestor
6165365|NCT01571362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6165366|NCT01571362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165367|NCT01571362|Analgesics|analgesics|mesh-ancestor
6165368|NCT01571362|Sensory System Agents|sensory system agents|mesh-ancestor
6165369|NCT01571362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6165370|NCT01571362|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6165371|NCT01571362|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6165372|NCT01571453|Vortioxetine|vortioxetine|mesh-list
6165373|NCT01571453|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6165374|NCT01571453|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6165375|NCT01571453|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6165376|NCT01571453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6165377|NCT01571453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6165378|NCT01571453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6165379|NCT01571453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165380|NCT01571453|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6165381|NCT01571453|Antidepressive Agents|antidepressive agents|mesh-ancestor
6165382|NCT01571453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6165383|NCT01571453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5563301|NCT03993353|Tadalafil|tadalafil|mesh-list
5563302|NCT03993353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5563303|NCT03993353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5563304|NCT03993353|Vasodilator Agents|vasodilator agents|mesh-ancestor
5563305|NCT03993353|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5563306|NCT03993353|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5563307|NCT03993353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5563308|NCT03993353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563309|NCT03993353|Urological Agents|urological agents|mesh-ancestor
5563310|NCT03993249|Nivolumab|nivolumab|mesh-list
5563311|NCT03993249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5563312|NCT03993249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5563313|NCT03993249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5563314|NCT03993249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563315|NCT03993236|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5563316|NCT03993236|Ezetimibe|ezetimibe|mesh-list
5563317|NCT03993236|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5563318|NCT03993236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5563319|NCT03993236|Antimetabolites|antimetabolites|mesh-ancestor
5563320|NCT03993236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563321|NCT03993236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5563322|NCT03993236|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5563323|NCT03993236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5563324|NCT03992937|Levonorgestrel|levonorgestrel|mesh-list
5563325|NCT03992937|Progesterone|progesterone|mesh-list
5563326|NCT03992937|Progestins|progestins|mesh-ancestor
5563327|NCT03992937|Hormones|hormones|mesh-ancestor
5563328|NCT03992937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5563329|NCT03992937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165384|NCT01571453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6482954|NCT00554775|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6482955|NCT00554775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6482956|NCT00554775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6482957|NCT00554775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6482958|NCT00554775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488914|NCT00587717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6488915|NCT00587717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6488916|NCT00587873|Leucovorin|leucovorin|mesh-list
6488917|NCT00587873|Methotrexate|methotrexate|mesh-list
6488918|NCT00587873|Thioguanine|thioguanine|mesh-list
6488919|NCT00587873|Calcium|calcium|mesh-list
5563330|NCT03992937|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5563331|NCT03992937|Contraceptive Agents|contraceptive agents|mesh-ancestor
5563332|NCT03992937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6488920|NCT00587873|Levoleucovorin|levoleucovorin|mesh-list
6488921|NCT00587873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6488922|NCT00587873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488923|NCT00587873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6488924|NCT00587873|Abortifacient Agents|abortifacient agents|mesh-ancestor
6488925|NCT00587873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6488926|NCT00587873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6488927|NCT00587873|Antimetabolites|antimetabolites|mesh-ancestor
6488928|NCT00587873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488929|NCT00587873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5563333|NCT03992937|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5563334|NCT03992937|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5563335|NCT03992937|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5563336|NCT03992885|Pemetrexed|pemetrexed|mesh-list
5563337|NCT03992885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5563338|NCT03992885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5563339|NCT03992885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563340|NCT03992885|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5563341|NCT03992885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5563344|NCT03992911|Carboplatin|carboplatin|mesh-list
5563345|NCT03992911|Etoposide|etoposide|mesh-list
5563346|NCT03992911|Etoposide phosphate|etoposide phosphate|mesh-list
5563347|NCT03992911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5563348|NCT03992911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5563349|NCT03992911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5563350|NCT03992911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5563351|NCT03992911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5563352|NCT03992911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563353|NCT03992820|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
5563354|NCT03992820|Anesthetics, Local|anesthetics, local|mesh-ancestor
5563355|NCT03992820|Anesthetics|anesthetics|mesh-ancestor
5563356|NCT03992820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5563357|NCT03992820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488930|NCT00587873|Dermatologic Agents|dermatologic agents|mesh-ancestor
6488931|NCT00587873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6488932|NCT00587873|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6488933|NCT00587873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6488934|NCT00587873|Immunologic Factors|immunologic factors|mesh-ancestor
6488935|NCT00587873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6488936|NCT00587873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6488937|NCT00587873|Antidotes|antidotes|mesh-ancestor
6488938|NCT00587873|Protective Agents|protective agents|mesh-ancestor
6488939|NCT00587873|Vitamin B Complex|vitamin b complex|mesh-ancestor
6488940|NCT00587873|Vitamins|vitamins|mesh-ancestor
6488941|NCT00587873|Micronutrients|micronutrients|mesh-ancestor
6488942|NCT00588003|Anastrozole|anastrozole|mesh-list
6488943|NCT00588003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6488944|NCT00588003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6488945|NCT00588003|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6488946|NCT00588003|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5563358|NCT03992820|Sensory System Agents|sensory system agents|mesh-ancestor
5563359|NCT03992820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5563360|NCT03992820|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
5603725|NCT01659606|Fludarabine|fludarabine|mesh-list
5603726|NCT01659606|Alemtuzumab|alemtuzumab|mesh-list
5603727|NCT01659606|Cyclosporins|cyclosporins|mesh-list
5603728|NCT01659606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5603729|NCT01659606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603730|NCT01659606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5603731|NCT01659606|Immunologic Factors|immunologic factors|mesh-ancestor
6488947|NCT00588003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5563361|NCT03992443|Reteplase|reteplase|mesh-list
5563362|NCT03992443|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5563363|NCT03992443|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5563364|NCT03992443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563365|NCT03992586|Methamphetamine|methamphetamine|mesh-list
5563366|NCT03992586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5563367|NCT03992586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563368|NCT03992586|Sympathomimetics|sympathomimetics|mesh-ancestor
5563369|NCT03992586|Autonomic Agents|autonomic agents|mesh-ancestor
5563370|NCT03992586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5563371|NCT03992586|Dopamine Agents|dopamine agents|mesh-ancestor
5563372|NCT03992586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5563373|NCT03992586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563374|NCT03992586|Adrenergic Agents|adrenergic agents|mesh-ancestor
5563375|NCT03992586|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5563376|NCT03992586|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5563377|NCT03992586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5563378|NCT03992586|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5563379|NCT03992755|Treprostinil|treprostinil|mesh-list
5563380|NCT03992755|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6482959|NCT00554827|Vitamins|vitamins|mesh-list
6482960|NCT00554827|Folic Acid|folic acid|mesh-list
6482961|NCT00554827|Vitamin B 12|vitamin b 12|mesh-list
6482962|NCT00554827|Hydroxocobalamin|hydroxocobalamin|mesh-list
6482963|NCT00554827|Vitamin B Complex|vitamin b complex|mesh-list
5563381|NCT03992170|Daratumumab|daratumumab|mesh-list
5563382|NCT03992170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5563383|NCT03992131|Rucaparib|rucaparib|mesh-list
5563384|NCT03992131|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5563385|NCT03992131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5563386|NCT03992131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563387|NCT03992131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5563388|NCT03992144|Amoxicillin|amoxicillin|mesh-list
5563389|NCT03992144|Metronidazole|metronidazole|mesh-list
5563390|NCT03992144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5563391|NCT03992144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5563392|NCT03992144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5563393|NCT03992144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5563394|NCT03992066|Epoetin Alfa|epoetin alfa|mesh-list
5563395|NCT03992066|Darbepoetin alfa|darbepoetin alfa|mesh-list
5563396|NCT03992066|Hematinics|hematinics|mesh-ancestor
6482964|NCT00554827|10-deazaaminopterin|10-deazaaminopterin|mesh-list
6482965|NCT00554827|Aminopterin|aminopterin|mesh-list
6482966|NCT00554827|Micronutrients|micronutrients|mesh-ancestor
6482967|NCT00554827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482968|NCT00554827|Hematinics|hematinics|mesh-ancestor
6482969|NCT00554827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6482970|NCT00554827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6482971|NCT00554827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6482972|NCT00554827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6482973|NCT00554918|Zoledronic Acid|zoledronic acid|mesh-list
6482974|NCT00554918|Prednisolone|prednisolone|mesh-list
6482975|NCT00554918|Docetaxel|docetaxel|mesh-list
5563397|NCT03992196|Rotigotine|rotigotine|mesh-list
5563398|NCT03992196|Dopamine Agonists|dopamine agonists|mesh-ancestor
5563399|NCT03992196|Dopamine Agents|dopamine agents|mesh-ancestor
5563400|NCT03992196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5563401|NCT03992196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563402|NCT03992196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563403|NCT03992261|Halobetasol|halobetasol|mesh-list
5563404|NCT03992261|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5563405|NCT03992326|Cyclophosphamide|cyclophosphamide|mesh-list
5563406|NCT03992326|Fludarabine|fludarabine|mesh-list
5563407|NCT03992326|Interleukin-2|interleukin-2|mesh-list
5563408|NCT03992326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5563409|NCT03992326|Immunologic Factors|immunologic factors|mesh-ancestor
5563410|NCT03992326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563411|NCT03992326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5563412|NCT03992326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5563413|NCT03992326|Alkylating Agents|alkylating agents|mesh-ancestor
5563414|NCT03992326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563415|NCT03992326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5563416|NCT03992326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5563417|NCT03992326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6668991|NCT01535547|Isavuconazole|isavuconazole|mesh-list
5563418|NCT03992326|Analgesics|analgesics|mesh-ancestor
6482976|NCT00554918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6482977|NCT00554918|Tubulin Modulators|tubulin modulators|mesh-ancestor
6482978|NCT00554918|Antimitotic Agents|antimitotic agents|mesh-ancestor
6482979|NCT00554918|Mitosis Modulators|mitosis modulators|mesh-ancestor
6482980|NCT00554918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6482981|NCT00554918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6482982|NCT00554918|Glucocorticoids|glucocorticoids|mesh-ancestor
6482983|NCT00554918|Hormones|hormones|mesh-ancestor
5563419|NCT03992326|Sensory System Agents|sensory system agents|mesh-ancestor
5563420|NCT03992326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5563421|NCT03992365|Bisacodyl|bisacodyl|mesh-list
5563422|NCT03992365|Sodium sulfate|sodium sulfate|mesh-list
5563423|NCT03992365|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
5563424|NCT03992365|Cathartics|cathartics|mesh-ancestor
5563425|NCT03992365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5563426|NCT03992365|Laxatives|laxatives|mesh-ancestor
5563427|NCT03991936|Triamcinolone|triamcinolone|mesh-list
5563428|NCT03991936|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5563429|NCT03991936|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5563430|NCT03991936|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5563431|NCT03991936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5563432|NCT03991936|Glucocorticoids|glucocorticoids|mesh-ancestor
5563433|NCT03991936|Hormones|hormones|mesh-ancestor
5563434|NCT03991936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6482984|NCT00554918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6482985|NCT00554918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482986|NCT00554918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6482987|NCT00554918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6482988|NCT00555022|Bromides|bromides|mesh-list
6482989|NCT00555022|Tiotropium Bromide|tiotropium bromide|mesh-list
6482990|NCT00555022|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6482991|NCT00555022|Autonomic Agents|autonomic agents|mesh-ancestor
6482992|NCT00555022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6165385|NCT01571453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6165386|NCT01571453|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6165387|NCT01571453|Serotonin Agents|serotonin agents|mesh-ancestor
6165388|NCT01571453|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6165389|NCT01571453|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6165390|NCT01571453|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6165391|NCT01571453|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6165392|NCT01571557|Dexamethasone|dexamethasone|mesh-list
6165393|NCT01571557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6165394|NCT01571557|Antiemetics|antiemetics|mesh-ancestor
6165395|NCT01571557|Autonomic Agents|autonomic agents|mesh-ancestor
6165396|NCT01571557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6165397|NCT01571557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165398|NCT01571557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6165399|NCT01571557|Glucocorticoids|glucocorticoids|mesh-ancestor
6165400|NCT01571557|Hormones|hormones|mesh-ancestor
6165401|NCT01571557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6165402|NCT01571557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6165403|NCT01571557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6165404|NCT01572038|Paclitaxel|paclitaxel|mesh-list
6165405|NCT01572038|Docetaxel|docetaxel|mesh-list
6165406|NCT01572038|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6165407|NCT01572038|Trastuzumab|trastuzumab|mesh-list
6165408|NCT01572038|Pertuzumab|pertuzumab|mesh-list
6165409|NCT01572038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6165410|NCT01572038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5563435|NCT03991936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563436|NCT03991936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5563437|NCT03991936|Immunologic Factors|immunologic factors|mesh-ancestor
6165411|NCT01572038|Tubulin Modulators|tubulin modulators|mesh-ancestor
6165412|NCT01572038|Antimitotic Agents|antimitotic agents|mesh-ancestor
6165413|NCT01572038|Mitosis Modulators|mitosis modulators|mesh-ancestor
6165414|NCT01572038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6165415|NCT01572038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6165416|NCT01572727|Paclitaxel|paclitaxel|mesh-list
6165417|NCT01572727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6165418|NCT01572727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6165419|NCT01572727|Tubulin Modulators|tubulin modulators|mesh-ancestor
6165420|NCT01572727|Antimitotic Agents|antimitotic agents|mesh-ancestor
6165421|NCT01572727|Mitosis Modulators|mitosis modulators|mesh-ancestor
6165422|NCT01572727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6165423|NCT01572740|Liraglutide|liraglutide|mesh-list
5563438|NCT03991936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5563439|NCT03991936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6165424|NCT01572740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5563440|NCT03991845|Levocetirizine|levocetirizine|mesh-list
5563441|NCT03991845|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5563442|NCT03991845|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5563443|NCT03991845|Histamine Antagonists|histamine antagonists|mesh-ancestor
5563444|NCT03991845|Histamine Agents|histamine agents|mesh-ancestor
5563445|NCT03991845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5563446|NCT03991845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563447|NCT03991845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563448|NCT03991910|Ramipril|ramipril|mesh-list
5563449|NCT03991910|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5563450|NCT03991910|Protease Inhibitors|protease inhibitors|mesh-ancestor
5563451|NCT03991910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5563452|NCT03991910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563453|NCT03991910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5563454|NCT03991819|Pembrolizumab|pembrolizumab|mesh-list
5563455|NCT03991819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5563456|NCT03991819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5563457|NCT03991442|Amlodipine|amlodipine|mesh-list
5563458|NCT03991442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5563459|NCT03991442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5563460|NCT03991442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5563461|NCT03991442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563462|NCT03991442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5563463|NCT03991442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563464|NCT03991442|Vasodilator Agents|vasodilator agents|mesh-ancestor
5563465|NCT03991299|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5563466|NCT03991299|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5563467|NCT03991299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5563468|NCT03991299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563469|NCT03991299|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5563470|NCT03991299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5563471|NCT03991299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563472|NCT03991299|Cholinergic Agents|cholinergic agents|mesh-ancestor
5563473|NCT03991299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5563474|NCT03991364|Methamphetamine|methamphetamine|mesh-list
5563475|NCT03991364|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5563476|NCT03991364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563477|NCT03991364|Sympathomimetics|sympathomimetics|mesh-ancestor
5563478|NCT03991364|Autonomic Agents|autonomic agents|mesh-ancestor
5563479|NCT03991364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5563480|NCT03991364|Dopamine Agents|dopamine agents|mesh-ancestor
5563481|NCT03991364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5563482|NCT03991364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563483|NCT03991364|Adrenergic Agents|adrenergic agents|mesh-ancestor
5563484|NCT03991364|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5563485|NCT03991364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5563486|NCT03991364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5563487|NCT03991364|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5563488|NCT03991559|Manganese|manganese|mesh-list
5563489|NCT03991559|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5563490|NCT03991559|Antibodies|antibodies|mesh-list
5563491|NCT03991559|Immunoglobulins|immunoglobulins|mesh-list
6165425|NCT01572740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165426|NCT01572740|Incretins|incretins|mesh-ancestor
6165427|NCT01572740|Hormones|hormones|mesh-ancestor
6165428|NCT01572740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6165429|NCT01572792|Bromides|bromides|mesh-list
6165430|NCT01572792|Formoterol Fumarate|formoterol fumarate|mesh-list
6165431|NCT01572792|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6165432|NCT01572792|Autonomic Agents|autonomic agents|mesh-ancestor
6165433|NCT01572792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6165434|NCT01572792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482993|NCT00555022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6482994|NCT00555022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6482995|NCT00555022|Respiratory System Agents|respiratory system agents|mesh-ancestor
6482996|NCT00555022|Parasympatholytics|parasympatholytics|mesh-ancestor
6482997|NCT00555022|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5563492|NCT03991559|Immunologic Factors|immunologic factors|mesh-ancestor
5563493|NCT03991559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563494|NCT03991559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6165435|NCT01572792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6482998|NCT00555022|Cholinergic Agents|cholinergic agents|mesh-ancestor
6482999|NCT00555022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6483000|NCT00555022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483001|NCT00555022|Anticonvulsants|anticonvulsants|mesh-ancestor
6483002|NCT00555087|Methyltestosterone|methyltestosterone|mesh-list
6483003|NCT00555087|Testosterone|testosterone|mesh-list
6483004|NCT00555087|Testosterone undecanoate|testosterone undecanoate|mesh-list
6483005|NCT00555087|Testosterone enanthate|testosterone enanthate|mesh-list
6483006|NCT00555087|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6483007|NCT00555087|Androgens|androgens|mesh-ancestor
6483008|NCT00555087|Hormones|hormones|mesh-ancestor
6483009|NCT00555087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6483010|NCT00555087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483011|NCT00555087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6483012|NCT00555087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6483013|NCT00555087|Anabolic Agents|anabolic agents|mesh-ancestor
6483014|NCT00555100|Dexamethasone|dexamethasone|mesh-list
6483015|NCT00555100|Lenalidomide|lenalidomide|mesh-list
6483016|NCT00555100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6483017|NCT00555100|Antiemetics|antiemetics|mesh-ancestor
6165436|NCT01572792|Respiratory System Agents|respiratory system agents|mesh-ancestor
6165437|NCT01572792|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6165438|NCT01572792|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6165439|NCT01572792|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6165440|NCT01572792|Adrenergic Agents|adrenergic agents|mesh-ancestor
6165441|NCT01572792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6165442|NCT01572792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563495|NCT03991559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6165443|NCT01572792|Anticonvulsants|anticonvulsants|mesh-ancestor
6165444|NCT01572844|Sodium thiosulfate|sodium thiosulfate|mesh-list
6165445|NCT01572844|Antidotes|antidotes|mesh-ancestor
5563496|NCT03991559|Trace Elements|trace elements|mesh-ancestor
5563497|NCT03991559|Micronutrients|micronutrients|mesh-ancestor
5563498|NCT03991520|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5563499|NCT03991520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5563500|NCT03991312|Itraconazole|itraconazole|mesh-list
5563501|NCT03991312|Rifampin|rifampin|mesh-list
5563502|NCT03991312|Antifungal Agents|antifungal agents|mesh-ancestor
5563503|NCT03991312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6483018|NCT00555100|Autonomic Agents|autonomic agents|mesh-ancestor
6483019|NCT00555100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6483020|NCT00555100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165446|NCT01572844|Protective Agents|protective agents|mesh-ancestor
6165447|NCT01572844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165448|NCT01572844|Antioxidants|antioxidants|mesh-ancestor
6483021|NCT00555100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5563504|NCT03991312|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5563505|NCT03991312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5563506|NCT03991312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5563507|NCT03991312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563508|NCT03991312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5563509|NCT03991312|Hormone Antagonists|hormone antagonists|mesh-ancestor
5563510|NCT03991312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5563511|NCT03991312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563512|NCT03991312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6483022|NCT00555100|Glucocorticoids|glucocorticoids|mesh-ancestor
6483023|NCT00555100|Hormones|hormones|mesh-ancestor
6483024|NCT00555100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6483025|NCT00555100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6483026|NCT00555100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6483027|NCT00555100|Immunologic Factors|immunologic factors|mesh-ancestor
5563513|NCT03991312|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6165449|NCT01572844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6165450|NCT01572844|Antitubercular Agents|antitubercular agents|mesh-ancestor
5563514|NCT03991312|Antitubercular Agents|antitubercular agents|mesh-ancestor
5563515|NCT03991312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5563516|NCT03991312|Leprostatic Agents|leprostatic agents|mesh-ancestor
5563517|NCT03991312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5563518|NCT03991312|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5563519|NCT03991312|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5563520|NCT03991312|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5563521|NCT03991312|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6483028|NCT00555100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6165451|NCT01572844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6165452|NCT01572844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6165453|NCT01572844|Chelating Agents|chelating agents|mesh-ancestor
6165454|NCT01572844|Sequestering Agents|sequestering agents|mesh-ancestor
6165455|NCT01573000|Tositumomab I-131|tositumomab i-131|mesh-list
6165456|NCT01573000|Antibodies|antibodies|mesh-list
6165457|NCT01573000|Immunoglobulins|immunoglobulins|mesh-list
6165458|NCT01573000|Immunologic Factors|immunologic factors|mesh-ancestor
6165459|NCT01573000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165460|NCT01573000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6165461|NCT01573052|Chlordiazepoxide|chlordiazepoxide|mesh-list
6165462|NCT01573052|Gabapentin|gabapentin|mesh-list
6165463|NCT01573052|Analgesics|analgesics|mesh-ancestor
6165464|NCT01573052|Sensory System Agents|sensory system agents|mesh-ancestor
6165465|NCT01573052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5563522|NCT03991312|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5563523|NCT03991312|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5563524|NCT03990974|Anti-Infective Agents|anti-infective agents|mesh-list
5563525|NCT03990974|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5563526|NCT03990883|Lidocaine|lidocaine|mesh-list
5563527|NCT03990883|Anesthetics, Local|anesthetics, local|mesh-ancestor
5563528|NCT03990883|Anesthetics|anesthetics|mesh-ancestor
5563529|NCT03990883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5563530|NCT03990883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563531|NCT03990883|Sensory System Agents|sensory system agents|mesh-ancestor
5563532|NCT03990883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5563533|NCT03990883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5563534|NCT03990883|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5563535|NCT03990883|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5563536|NCT03990883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5563537|NCT03990883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563538|NCT03991208|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
5563539|NCT03991208|Antimalarials|antimalarials|mesh-ancestor
5563540|NCT03991208|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5563541|NCT03991208|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5563542|NCT03991208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5603732|NCT01659606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603733|NCT01659606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5603734|NCT01659606|Antifungal Agents|antifungal agents|mesh-ancestor
5603735|NCT01659606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5603736|NCT01659606|Dermatologic Agents|dermatologic agents|mesh-ancestor
5603737|NCT01659606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5603738|NCT01659606|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5603739|NCT01659606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5603740|NCT01659606|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5603741|NCT01659606|Antitubercular Agents|antitubercular agents|mesh-ancestor
5603742|NCT01659606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5603743|NCT01659606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6165466|NCT01573052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165467|NCT01573052|Anticonvulsants|anticonvulsants|mesh-ancestor
6165468|NCT01573052|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6165469|NCT01573052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5603748|NCT01526135|Gemcitabine|gemcitabine|mesh-list
5603749|NCT01526135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5603750|NCT01526135|Antimetabolites|antimetabolites|mesh-ancestor
5603751|NCT01526135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603752|NCT01526135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5603753|NCT01526135|Antiviral Agents|antiviral agents|mesh-ancestor
5603754|NCT01526135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5563543|NCT03991130|Nivolumab|nivolumab|mesh-list
5563544|NCT03991130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5563545|NCT03991130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5563546|NCT03991130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5725599|NCT03179618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
5725600|NCT03179618|Lipid Regulating Agents|lipid regulating agents|mesh-list
5725601|NCT03179449|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
5725602|NCT03179449|Hematinics|hematinics|mesh-ancestor
5725603|NCT03179449|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6165470|NCT01573052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6165471|NCT01573052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6165472|NCT01573052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6165473|NCT01573052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6165474|NCT01573052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6165475|NCT01573052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6165476|NCT01573052|Antimanic Agents|antimanic agents|mesh-ancestor
6165477|NCT01573052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6165478|NCT01573052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6165479|NCT01573052|GABA Modulators|gaba modulators|mesh-ancestor
6165480|NCT01573052|GABA Agents|gaba agents|mesh-ancestor
6165481|NCT01573169|Enoxaparin|enoxaparin|mesh-list
6165482|NCT01573169|Anticoagulants|anticoagulants|mesh-ancestor
6165483|NCT01573169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6165484|NCT01573169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6165485|NCT01573169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6165486|NCT01573273|Oxytocin|oxytocin|mesh-list
6165487|NCT01573273|Oxytocics|oxytocics|mesh-ancestor
5563547|NCT03991130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563548|NCT03991104|Oxaliplatin|oxaliplatin|mesh-list
5563549|NCT03991104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5563550|NCT03990961|Pembrolizumab|pembrolizumab|mesh-list
5563551|NCT03990961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5563552|NCT03990961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5563553|NCT03990766|Theophylline|theophylline|mesh-list
5563554|NCT03990766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5563555|NCT03990766|Autonomic Agents|autonomic agents|mesh-ancestor
5563556|NCT03990766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5563557|NCT03990766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563558|NCT03990766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5563559|NCT03990766|Respiratory System Agents|respiratory system agents|mesh-ancestor
5563560|NCT03990766|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5563561|NCT03990766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5563562|NCT03990766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563563|NCT03990766|Vasodilator Agents|vasodilator agents|mesh-ancestor
5563564|NCT03990766|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5563565|NCT03990766|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5563566|NCT03990766|Purinergic Agents|purinergic agents|mesh-ancestor
5563567|NCT03990766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5563568|NCT03991013|Dolutegravir|dolutegravir|mesh-list
5563569|NCT03991013|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5563570|NCT03991013|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6165488|NCT01573273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6165489|NCT01573273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165490|NCT01573442|Testosterone|testosterone|mesh-list
6165491|NCT01573442|Androgens|androgens|mesh-ancestor
6165492|NCT01573442|Hormones|hormones|mesh-ancestor
6165493|NCT01573442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6165494|NCT01573442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483029|NCT00555100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6483030|NCT00555100|Growth Substances|growth substances|mesh-ancestor
6483031|NCT00555100|Growth Inhibitors|growth inhibitors|mesh-ancestor
6483032|NCT00555139|Alprazolam|alprazolam|mesh-list
6483033|NCT00555139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6483034|NCT00555139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6483035|NCT00555139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483036|NCT00555139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6483037|NCT00555139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6165495|NCT01573533|Rituximab|rituximab|mesh-list
6165496|NCT01573533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6165497|NCT01573533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6165498|NCT01573533|Immunologic Factors|immunologic factors|mesh-ancestor
6165499|NCT01573533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165500|NCT01573533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6165501|NCT01573702|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5563571|NCT03991013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6165502|NCT01573702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6165503|NCT01573702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6483038|NCT00555139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6483039|NCT00555139|GABA Modulators|gaba modulators|mesh-ancestor
6483040|NCT00555139|GABA Agents|gaba agents|mesh-ancestor
6483041|NCT00555139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6483042|NCT00555139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483043|NCT00555230|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6483044|NCT00555230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6483045|NCT00555230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6483046|NCT00555230|Antimetabolites|antimetabolites|mesh-ancestor
6483047|NCT00555230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483048|NCT00555230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6483049|NCT00555230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6483050|NCT00555230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6483051|NCT00555256|Sirolimus|sirolimus|mesh-list
5563572|NCT03991013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563573|NCT03991013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5563574|NCT03991013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6483052|NCT00555256|Sunitinib|sunitinib|mesh-list
6483053|NCT00555256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6483054|NCT00555256|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6483055|NCT00555256|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6483056|NCT00555256|Growth Substances|growth substances|mesh-ancestor
6483057|NCT00555256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483058|NCT00555256|Growth Inhibitors|growth inhibitors|mesh-ancestor
6483059|NCT00555256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6483060|NCT00555256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6483061|NCT00555256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483062|NCT00555256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6483063|NCT00555256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6483064|NCT00555256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6483065|NCT00555256|Antifungal Agents|antifungal agents|mesh-ancestor
6483066|NCT00555256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6483067|NCT00555256|Immunologic Factors|immunologic factors|mesh-ancestor
6483068|NCT00555334|Lamivudine|lamivudine|mesh-list
6483069|NCT00555334|Entecavir|entecavir|mesh-list
6483070|NCT00555334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6483071|NCT00555334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6483072|NCT00555334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6483073|NCT00555334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483074|NCT00555334|Antiviral Agents|antiviral agents|mesh-ancestor
6483075|NCT00555334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6483076|NCT00555334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6483077|NCT00555334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6483078|NCT00555347|Modafinil|modafinil|mesh-list
6483079|NCT00555347|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6483080|NCT00555347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483081|NCT00555347|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6483082|NCT00555347|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5563575|NCT03991013|Antiviral Agents|antiviral agents|mesh-ancestor
5563576|NCT03991013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5563577|NCT03990701|Metomidate|metomidate|mesh-list
5563578|NCT03990701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5563579|NCT03990701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5563580|NCT03990701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563581|NCT03990922|Morphine|morphine|mesh-list
5563582|NCT03990922|Ropivacaine|ropivacaine|mesh-list
5563583|NCT03990922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5563584|NCT03990922|Narcotics|narcotics|mesh-ancestor
5563585|NCT03990922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5563586|NCT03990922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563587|NCT03990922|Analgesics|analgesics|mesh-ancestor
5563588|NCT03990922|Sensory System Agents|sensory system agents|mesh-ancestor
6483083|NCT00555347|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6668992|NCT01535547|Tacrolimus|tacrolimus|mesh-list
6165504|NCT01573702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6165505|NCT01573702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6165506|NCT01573767|Fluticasone|fluticasone|mesh-list
6165507|NCT01573767|Xhance|xhance|mesh-list
6165508|NCT01573767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6165509|NCT01573767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6165510|NCT01573767|Autonomic Agents|autonomic agents|mesh-ancestor
6165511|NCT01573767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6165512|NCT01573767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165513|NCT01573767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6165514|NCT01573767|Respiratory System Agents|respiratory system agents|mesh-ancestor
6165515|NCT01573767|Dermatologic Agents|dermatologic agents|mesh-ancestor
6165516|NCT01573767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6165517|NCT01573910|Moxifloxacin|moxifloxacin|mesh-list
6165518|NCT01573910|Ofloxacin|ofloxacin|mesh-list
6165519|NCT01573910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6165520|NCT01573910|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6165521|NCT01573910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6165522|NCT01573910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6165523|NCT01573910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6165524|NCT01573910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6165525|NCT01573910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6165526|NCT01573910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563589|NCT03990922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5563590|NCT03990922|Anesthetics, Local|anesthetics, local|mesh-ancestor
5563591|NCT03990922|Anesthetics|anesthetics|mesh-ancestor
6165527|NCT01573910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6165528|NCT01573910|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6165529|NCT01573910|Renal Agents|renal agents|mesh-ancestor
6165530|NCT01573910|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6165531|NCT01573910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6165532|NCT01573949|Metformin|metformin|mesh-list
6165533|NCT01573949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6165534|NCT01573949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165535|NCT01574183|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
6165536|NCT01574183|Antidepressive Agents|antidepressive agents|mesh-ancestor
5563592|NCT03990480|Amlodipine|amlodipine|mesh-list
5563593|NCT03990480|Valsartan|valsartan|mesh-list
5563594|NCT03990480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5563595|NCT03990480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5563596|NCT03990480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6165537|NCT01574183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6165538|NCT01574183|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6165539|NCT01574183|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6165540|NCT01574183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6165541|NCT01574183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6165542|NCT01574183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6165543|NCT01574183|Serotonin Agents|serotonin agents|mesh-ancestor
6165544|NCT01574183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165545|NCT01574183|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6165546|NCT01574183|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6165547|NCT01574248|Icatibant|icatibant|mesh-list
6165548|NCT01574248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6165549|NCT01574248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6165550|NCT01574248|Analgesics|analgesics|mesh-ancestor
6165551|NCT01574248|Sensory System Agents|sensory system agents|mesh-ancestor
6165552|NCT01574248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6165553|NCT01574248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165554|NCT01574248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6165555|NCT01574248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6165556|NCT01574248|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
6165557|NCT01574248|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
6165558|NCT01574248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6165559|NCT01574248|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6165560|NCT01574248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6165561|NCT01574248|Immunologic Factors|immunologic factors|mesh-ancestor
6165562|NCT01574326|Sevelamer|sevelamer|mesh-list
6165563|NCT01574326|Chelating Agents|chelating agents|mesh-ancestor
6165564|NCT01574326|Sequestering Agents|sequestering agents|mesh-ancestor
6165565|NCT01574326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6165566|NCT01574612|Acyclovir|acyclovir|mesh-list
6165567|NCT01574612|Hydrocortisone|hydrocortisone|mesh-list
6165568|NCT01574612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6668993|NCT01535547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5563597|NCT03990480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563598|NCT03990480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5563599|NCT03990480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563600|NCT03990480|Vasodilator Agents|vasodilator agents|mesh-ancestor
6165569|NCT01574612|Antiviral Agents|antiviral agents|mesh-ancestor
6165570|NCT01574612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6165571|NCT01574651|Glycopyrrolate|glycopyrrolate|mesh-list
6165572|NCT01574651|Formoterol Fumarate|formoterol fumarate|mesh-list
6165573|NCT01574651|Tiotropium Bromide|tiotropium bromide|mesh-list
6165574|NCT01574651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6165575|NCT01574651|Autonomic Agents|autonomic agents|mesh-ancestor
6165576|NCT01574651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6165577|NCT01574651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165578|NCT01574651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6165579|NCT01574651|Respiratory System Agents|respiratory system agents|mesh-ancestor
6165580|NCT01574651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6165581|NCT01574651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6165582|NCT01574651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6165583|NCT01574651|Adrenergic Agents|adrenergic agents|mesh-ancestor
6165584|NCT01574651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6165585|NCT01574651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6165586|NCT01574651|Parasympatholytics|parasympatholytics|mesh-ancestor
6165587|NCT01574651|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6165588|NCT01574651|Cholinergic Agents|cholinergic agents|mesh-ancestor
6165589|NCT01574651|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6165590|NCT01574651|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6165591|NCT01574703|Bupropion|bupropion|mesh-list
6165592|NCT01574703|Nicotine|nicotine|mesh-list
6165593|NCT01574703|Varenicline|varenicline|mesh-list
6165594|NCT01574703|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6165595|NCT01574703|Autonomic Agents|autonomic agents|mesh-ancestor
6165596|NCT01574703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6165597|NCT01574703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165598|NCT01574703|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6165599|NCT01574703|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6165600|NCT01574703|Cholinergic Agents|cholinergic agents|mesh-ancestor
6165601|NCT01574703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6165602|NCT01574703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6165603|NCT01574703|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6165604|NCT01574703|Antidepressive Agents|antidepressive agents|mesh-ancestor
6165605|NCT01574703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6165606|NCT01574703|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6165607|NCT01574703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6165608|NCT01574703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6165609|NCT01574703|Dopamine Agents|dopamine agents|mesh-ancestor
6165610|NCT01574703|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6165611|NCT01574703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6165612|NCT01574703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6165613|NCT01574716|Gemcitabine|gemcitabine|mesh-list
6165614|NCT01574716|Docetaxel|docetaxel|mesh-list
6483084|NCT00555347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483085|NCT00555373|Sirolimus|sirolimus|mesh-list
6483086|NCT00555373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6483087|NCT00555373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6483088|NCT00555373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6483089|NCT00555373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6483090|NCT00555373|Antifungal Agents|antifungal agents|mesh-ancestor
6483091|NCT00555373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6483092|NCT00555373|Immunologic Factors|immunologic factors|mesh-ancestor
6483093|NCT00555373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483094|NCT00555386|Selenium|selenium|mesh-list
5563601|NCT03990480|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5563602|NCT03990480|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5563603|NCT03990623|Liver Extracts|liver extracts|mesh-list
5563604|NCT03990623|Hematinics|hematinics|mesh-ancestor
5563605|NCT03990636|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5563606|NCT03990636|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5563607|NCT03990636|Dermatologic Agents|dermatologic agents|mesh-ancestor
5563608|NCT03990129|Dipyrone|dipyrone|mesh-list
5563609|NCT03990129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5563610|NCT03990129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5563611|NCT03990129|Analgesics|analgesics|mesh-ancestor
5563612|NCT03990129|Sensory System Agents|sensory system agents|mesh-ancestor
6165615|NCT01574716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6483095|NCT00555386|Antioxidants|antioxidants|mesh-ancestor
6483096|NCT00555386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6165616|NCT01574716|Antimetabolites|antimetabolites|mesh-ancestor
6165617|NCT01574716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6165618|NCT01574716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6165619|NCT01574716|Antiviral Agents|antiviral agents|mesh-ancestor
6165620|NCT01574716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6165621|NCT01574716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6165622|NCT01574716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6165623|NCT01574716|Immunologic Factors|immunologic factors|mesh-ancestor
6165624|NCT01574716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165625|NCT01574716|Tubulin Modulators|tubulin modulators|mesh-ancestor
6165626|NCT01574716|Antimitotic Agents|antimitotic agents|mesh-ancestor
6165627|NCT01574716|Mitosis Modulators|mitosis modulators|mesh-ancestor
6165628|NCT01574807|Lidocaine|lidocaine|mesh-list
5563613|NCT03990129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5563614|NCT03990129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563615|NCT03990129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6165629|NCT01574807|Mepivacaine|mepivacaine|mesh-list
6165630|NCT01574807|Anesthetics, Local|anesthetics, local|mesh-ancestor
6165631|NCT01574807|Anesthetics|anesthetics|mesh-ancestor
6165632|NCT01574807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6165633|NCT01574807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165634|NCT01574807|Sensory System Agents|sensory system agents|mesh-ancestor
6165635|NCT01574807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6165636|NCT01574807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6165637|NCT01574807|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5563616|NCT03990129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5563617|NCT03990129|Antipyretics|antipyretics|mesh-ancestor
5563618|NCT03990194|Leuprolide|leuprolide|mesh-list
5563619|NCT03990194|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5563620|NCT03990194|Fertility Agents|fertility agents|mesh-ancestor
5563621|NCT03990194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5563622|NCT03990194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563623|NCT03990194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5563624|NCT03990194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5563625|NCT03990103|Paclitaxel|paclitaxel|mesh-list
5563626|NCT03990103|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5563627|NCT03990103|Bevacizumab|bevacizumab|mesh-list
5563628|NCT03990103|Oxaliplatin|oxaliplatin|mesh-list
5563629|NCT03990103|Tegafur|tegafur|mesh-list
5563630|NCT03990103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5563631|NCT03990103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5563632|NCT03990103|Tubulin Modulators|tubulin modulators|mesh-ancestor
5563633|NCT03990103|Antimitotic Agents|antimitotic agents|mesh-ancestor
6165638|NCT01574807|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6165639|NCT01574807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6165640|NCT01574807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6165641|NCT01575054|Botulinum Toxins|botulinum toxins|mesh-list
6165642|NCT01575054|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6165643|NCT01575054|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6165644|NCT01575054|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6165645|NCT01575054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6165646|NCT01575054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6165647|NCT01575054|Cholinergic Agents|cholinergic agents|mesh-ancestor
6165648|NCT01575054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6165649|NCT01575054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165650|NCT01575054|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5563634|NCT03990103|Mitosis Modulators|mitosis modulators|mesh-ancestor
5563635|NCT03990103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563636|NCT03990103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5563637|NCT03990103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5563638|NCT03990103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5563639|NCT03990103|Growth Substances|growth substances|mesh-ancestor
5563640|NCT03990103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563641|NCT03990103|Growth Inhibitors|growth inhibitors|mesh-ancestor
5563642|NCT03990103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5563643|NCT03990103|Antimetabolites|antimetabolites|mesh-ancestor
5563644|NCT03990038|Ropivacaine|ropivacaine|mesh-list
5563645|NCT03990038|Anesthetics, Local|anesthetics, local|mesh-ancestor
5563646|NCT03990038|Anesthetics|anesthetics|mesh-ancestor
5563647|NCT03990038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6483097|NCT00555386|Protective Agents|protective agents|mesh-ancestor
5563648|NCT03990038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563649|NCT03990038|Sensory System Agents|sensory system agents|mesh-ancestor
5563650|NCT03990038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5563651|NCT03990571|Avelumab|avelumab|mesh-list
5563652|NCT03990571|Axitinib|axitinib|mesh-list
5563653|NCT03990571|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5563654|NCT03990571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5563655|NCT03990571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5563656|NCT03990571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5563657|NCT03990571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5563658|NCT03990571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563659|NCT03990571|Immunologic Factors|immunologic factors|mesh-ancestor
5563660|NCT03990571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563661|NCT03989609|Midazolam|midazolam|mesh-list
5563662|NCT03989609|Dexmedetomidine|dexmedetomidine|mesh-list
5563663|NCT03989609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5563664|NCT03989609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5563665|NCT03989609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563666|NCT03989609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5563667|NCT03989609|Analgesics|analgesics|mesh-ancestor
5563668|NCT03989609|Sensory System Agents|sensory system agents|mesh-ancestor
5563669|NCT03989609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5563670|NCT03989609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5563671|NCT03989609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6165651|NCT01575054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6165652|NCT01575275|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6165653|NCT01575275|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6165654|NCT01575275|Dermatologic Agents|dermatologic agents|mesh-ancestor
6165655|NCT01575561|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
6165656|NCT01575561|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6165657|NCT01575561|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6165658|NCT01575561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6165659|NCT01575561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165660|NCT01575561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6165661|NCT01575561|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6165662|NCT01575561|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5563672|NCT03989609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5563673|NCT03989609|Adrenergic Agents|adrenergic agents|mesh-ancestor
5563674|NCT03989609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5563675|NCT03989609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563676|NCT03989609|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6165663|NCT01575561|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6165664|NCT01575561|Adrenergic Agents|adrenergic agents|mesh-ancestor
6165665|NCT01575561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6165666|NCT01575561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6165667|NCT01575561|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6165668|NCT01575561|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6165669|NCT01575561|Serotonin Agents|serotonin agents|mesh-ancestor
6165670|NCT01575561|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6165671|NCT01575561|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6165672|NCT01575561|Dopamine Agents|dopamine agents|mesh-ancestor
6165673|NCT01575834|Denosumab|denosumab|mesh-list
6165674|NCT01575834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6165675|NCT01575834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165676|NCT01575860|Lenalidomide|lenalidomide|mesh-list
6165677|NCT01575860|Immunologic Factors|immunologic factors|mesh-ancestor
6165678|NCT01575860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165679|NCT01575860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6165680|NCT01575860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6165681|NCT01575860|Growth Substances|growth substances|mesh-ancestor
6165682|NCT01575860|Growth Inhibitors|growth inhibitors|mesh-ancestor
6165683|NCT01575860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6165684|NCT01575873|Denosumab|denosumab|mesh-list
6165685|NCT01575873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6165686|NCT01575873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165687|NCT01575899|Amoxicillin|amoxicillin|mesh-list
6165688|NCT01575899|Clarithromycin|clarithromycin|mesh-list
6165689|NCT01575899|Levofloxacin|levofloxacin|mesh-list
6165690|NCT01575899|Ofloxacin|ofloxacin|mesh-list
6165691|NCT01575899|Clavulanic Acid|clavulanic acid|mesh-list
6165692|NCT01575899|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6165693|NCT01575899|Rabeprazole|rabeprazole|mesh-list
6165694|NCT01575899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6165695|NCT01575899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5563677|NCT03989609|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6165696|NCT01575899|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6165697|NCT01575899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6165698|NCT01575899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6165699|NCT01575899|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6165700|NCT01575899|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6165701|NCT01575899|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6165702|NCT01575899|Renal Agents|renal agents|mesh-ancestor
6165703|NCT01575899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6165704|NCT01575899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6165705|NCT01575899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6165706|NCT01575899|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6165707|NCT01575899|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6165708|NCT01575899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6165709|NCT01575899|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6165710|NCT01575899|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6206180|NCT02097108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563678|NCT03989609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5563679|NCT03989609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5563680|NCT03989609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5563681|NCT03989609|Anesthetics, General|anesthetics, general|mesh-ancestor
5563682|NCT03989609|Anesthetics|anesthetics|mesh-ancestor
5563683|NCT03989609|GABA Modulators|gaba modulators|mesh-ancestor
5563684|NCT03989609|GABA Agents|gaba agents|mesh-ancestor
5563685|NCT03989817|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
5563686|NCT03989817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5563687|NCT03989817|Vasodilator Agents|vasodilator agents|mesh-ancestor
5563688|NCT03989817|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5563689|NCT03989817|Protective Agents|protective agents|mesh-ancestor
5563690|NCT03989817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563691|NCT03989778|Vitamin D|vitamin d|mesh-list
5563692|NCT03989778|Vitamins|vitamins|mesh-ancestor
5563693|NCT03989778|Micronutrients|micronutrients|mesh-ancestor
5563694|NCT03989778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563695|NCT03989778|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5563696|NCT03989830|Endostatins|endostatins|mesh-list
6206181|NCT02097238|Halichondrin B|halichondrin b|mesh-list
6206182|NCT02097238|Tubulin Modulators|tubulin modulators|mesh-ancestor
6206183|NCT02097238|Antimitotic Agents|antimitotic agents|mesh-ancestor
6206184|NCT02097238|Mitosis Modulators|mitosis modulators|mesh-ancestor
6206185|NCT02097238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483098|NCT00555386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483099|NCT00555386|Trace Elements|trace elements|mesh-ancestor
6483100|NCT00555386|Micronutrients|micronutrients|mesh-ancestor
6483101|NCT00555399|Temozolomide|temozolomide|mesh-list
6483102|NCT00555399|Vorinostat|vorinostat|mesh-list
6483103|NCT00555399|Isotretinoin|isotretinoin|mesh-list
6483104|NCT00555399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6483105|NCT00555399|Alkylating Agents|alkylating agents|mesh-ancestor
6483106|NCT00555399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483107|NCT00555399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6483108|NCT00555399|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6483109|NCT00555399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6483110|NCT00555399|Dermatologic Agents|dermatologic agents|mesh-ancestor
5563697|NCT03989830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5563698|NCT03989830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5563699|NCT03989830|Growth Substances|growth substances|mesh-ancestor
5563700|NCT03989830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563701|NCT03989830|Growth Inhibitors|growth inhibitors|mesh-ancestor
5563702|NCT03989830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5563703|NCT03989336|Manganese|manganese|mesh-list
5563704|NCT03989336|Paclitaxel|paclitaxel|mesh-list
5563705|NCT03989336|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5563706|NCT03989336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5563707|NCT03989336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5563708|NCT03989336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5563709|NCT03989336|Tubulin Modulators|tubulin modulators|mesh-ancestor
5563710|NCT03989336|Antimitotic Agents|antimitotic agents|mesh-ancestor
5563711|NCT03989336|Mitosis Modulators|mitosis modulators|mesh-ancestor
5563712|NCT03989336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563713|NCT03989336|Trace Elements|trace elements|mesh-ancestor
5563714|NCT03989336|Micronutrients|micronutrients|mesh-ancestor
5563715|NCT03989336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563716|NCT03989310|Manganese|manganese|mesh-list
5563717|NCT03989310|Gemcitabine|gemcitabine|mesh-list
5563718|NCT03989310|Paclitaxel|paclitaxel|mesh-list
6483111|NCT00555412|Loxapine|loxapine|mesh-list
5563719|NCT03989310|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5563720|NCT03989310|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5563721|NCT03989310|Antibodies|antibodies|mesh-list
5563722|NCT03989310|Immunoglobulins|immunoglobulins|mesh-list
5563723|NCT03989310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5563724|NCT03989310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5563725|NCT03989310|Tubulin Modulators|tubulin modulators|mesh-ancestor
5563726|NCT03989310|Antimitotic Agents|antimitotic agents|mesh-ancestor
5563727|NCT03989310|Mitosis Modulators|mitosis modulators|mesh-ancestor
5563728|NCT03989310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563729|NCT03989310|Immunologic Factors|immunologic factors|mesh-ancestor
5563730|NCT03989310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563731|NCT03989310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5563732|NCT03989310|Antimetabolites|antimetabolites|mesh-ancestor
5563733|NCT03989310|Antiviral Agents|antiviral agents|mesh-ancestor
5563734|NCT03989310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5563735|NCT03989310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6483112|NCT00555412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6483113|NCT00555412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6483114|NCT00555412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6483115|NCT00555412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483116|NCT00555412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6165711|NCT01576042|Amiodarone|amiodarone|mesh-list
6165712|NCT01576042|Sotalol|sotalol|mesh-list
6165713|NCT01576042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6165714|NCT01576042|Vasodilator Agents|vasodilator agents|mesh-ancestor
6165715|NCT01576042|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6165716|NCT01576042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6165717|NCT01576042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6165718|NCT01576042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6165719|NCT01576042|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6165720|NCT01576042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6165721|NCT01576042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5563736|NCT03989310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5563737|NCT03989310|Trace Elements|trace elements|mesh-ancestor
5563738|NCT03989310|Micronutrients|micronutrients|mesh-ancestor
5563739|NCT03989700|Thiamine|thiamine|mesh-list
5563740|NCT03989700|Vitamins|vitamins|mesh-ancestor
5563741|NCT03989700|Micronutrients|micronutrients|mesh-ancestor
5563742|NCT03989700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563743|NCT03989700|Vitamin B Complex|vitamin b complex|mesh-ancestor
5563744|NCT03989557|Aspirin|aspirin|mesh-list
5563745|NCT03989557|Clopidogrel|clopidogrel|mesh-list
5563746|NCT03989557|Ticagrelor|ticagrelor|mesh-list
5563747|NCT03989557|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5563748|NCT03989557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5563749|NCT03989557|Analgesics|analgesics|mesh-ancestor
5563750|NCT03989557|Sensory System Agents|sensory system agents|mesh-ancestor
5563751|NCT03989557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5563752|NCT03989557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165722|NCT01576042|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6165723|NCT01576042|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6165724|NCT01576042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6165725|NCT01576042|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6165726|NCT01576042|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6165727|NCT01576042|Adrenergic Agents|adrenergic agents|mesh-ancestor
6165728|NCT01576042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6165729|NCT01576042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165730|NCT01576042|Sympatholytics|sympatholytics|mesh-ancestor
6165731|NCT01576042|Autonomic Agents|autonomic agents|mesh-ancestor
6165732|NCT01576042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6165733|NCT01576172|Prednisone|prednisone|mesh-list
6165734|NCT01576172|Cortisone|cortisone|mesh-list
6165735|NCT01576172|Abiraterone Acetate|abiraterone acetate|mesh-list
6165736|NCT01576172|Veliparib|veliparib|mesh-list
6165737|NCT01576172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6165738|NCT01576172|Glucocorticoids|glucocorticoids|mesh-ancestor
6165739|NCT01576172|Hormones|hormones|mesh-ancestor
6165740|NCT01576172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6165741|NCT01576172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165742|NCT01576172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6165743|NCT01576172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6165744|NCT01576172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6165745|NCT01576172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6483117|NCT00555412|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6483118|NCT00555412|Dopamine Agents|dopamine agents|mesh-ancestor
5563753|NCT03989557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5563754|NCT03989557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5563755|NCT03989557|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6165746|NCT01576172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6165747|NCT01576172|Hormone Antagonists|hormone antagonists|mesh-ancestor
6483119|NCT00555412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6483120|NCT00555412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668994|NCT01535547|Immunologic Factors|immunologic factors|mesh-ancestor
6668995|NCT01535547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6668996|NCT01535547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6668997|NCT01535547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6668998|NCT01535547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6668999|NCT01535547|Antifungal Agents|antifungal agents|mesh-ancestor
6669000|NCT01535547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6669001|NCT01535612|Insulin|insulin|mesh-list
6669002|NCT01535612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6669003|NCT01535612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669004|NCT01535677|Metformin|metformin|mesh-list
6669005|NCT01535677|Dapagliflozin|dapagliflozin|mesh-list
6669006|NCT01535677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6669007|NCT01535677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669008|NCT01535677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6672467|NCT01556334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6165748|NCT01576172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6165749|NCT01576172|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6165750|NCT01576276|Ketorolac|ketorolac|mesh-list
6165751|NCT01576276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6165752|NCT01576276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6165753|NCT01576276|Analgesics|analgesics|mesh-ancestor
6165754|NCT01576276|Sensory System Agents|sensory system agents|mesh-ancestor
6165755|NCT01576276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6165756|NCT01576276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165757|NCT01576276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6165758|NCT01576276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6165759|NCT01576276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6165760|NCT01576276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6165761|NCT01576276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6165762|NCT01576341|Epoetin Alfa|epoetin alfa|mesh-list
6165763|NCT01576341|Hematinics|hematinics|mesh-ancestor
6165764|NCT01576406|Crizotinib|crizotinib|mesh-list
6165765|NCT01576406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6165766|NCT01576406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6165767|NCT01576406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6165768|NCT01576406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483121|NCT00555542|Rituximab|rituximab|mesh-list
6483122|NCT00555542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6483123|NCT00555542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6483124|NCT00555542|Immunologic Factors|immunologic factors|mesh-ancestor
6483125|NCT00555542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563756|NCT03989557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5563757|NCT03989557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563758|NCT03989557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5563759|NCT03989557|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5563760|NCT03989557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6165769|NCT01576484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6165770|NCT01576484|Immunologic Factors|immunologic factors|mesh-ancestor
6483126|NCT00555542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6483127|NCT00555555|Factor VIII|factor viii|mesh-list
6483128|NCT00555555|Coagulants|coagulants|mesh-ancestor
6483129|NCT00555594|Bevacizumab|bevacizumab|mesh-list
6483130|NCT00555594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6483131|NCT00555594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6483132|NCT00555594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6483133|NCT00555594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6483134|NCT00555594|Growth Substances|growth substances|mesh-ancestor
6483135|NCT00555594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165771|NCT01576484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165772|NCT01576523|Complement C1s|complement c1s|mesh-list
6165773|NCT01576523|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
6483136|NCT00555594|Growth Inhibitors|growth inhibitors|mesh-ancestor
6483137|NCT00555607|Prednisolone|prednisolone|mesh-list
6483138|NCT00555607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6483139|NCT00555607|Glucocorticoids|glucocorticoids|mesh-ancestor
6483140|NCT00555607|Hormones|hormones|mesh-ancestor
6483141|NCT00555607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6483142|NCT00555607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483143|NCT00555607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6483144|NCT00555607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6483145|NCT00555776|Gabapentin|gabapentin|mesh-list
6483146|NCT00555776|Analgesics|analgesics|mesh-ancestor
6483147|NCT00555776|Sensory System Agents|sensory system agents|mesh-ancestor
6483148|NCT00555776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6483149|NCT00555776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483150|NCT00555776|Anticonvulsants|anticonvulsants|mesh-ancestor
6483151|NCT00555776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6483152|NCT00555776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6483153|NCT00555776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6483154|NCT00555776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6483155|NCT00555776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6483156|NCT00555776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6483157|NCT00555776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6483158|NCT00555776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563761|NCT03989557|Antipyretics|antipyretics|mesh-ancestor
5563762|NCT03989557|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5563763|NCT03989557|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5563764|NCT03989557|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5563765|NCT03989557|Purinergic Agents|purinergic agents|mesh-ancestor
5563766|NCT03989557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5603755|NCT01526135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5603756|NCT01526135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5603757|NCT01526135|Immunologic Factors|immunologic factors|mesh-ancestor
5603758|NCT01526135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603759|NCT01475110|Imatinib Mesylate|imatinib mesylate|mesh-list
5603760|NCT01475110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5603761|NCT01475110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5603762|NCT01475110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5603763|NCT01475110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483159|NCT00555776|Antimanic Agents|antimanic agents|mesh-ancestor
6165774|NCT01576523|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
6165775|NCT01576523|Immunologic Factors|immunologic factors|mesh-ancestor
6483160|NCT00555854|Benzocaine|benzocaine|mesh-list
6483161|NCT00555854|Anesthetics, Local|anesthetics, local|mesh-ancestor
6483162|NCT00555854|Anesthetics|anesthetics|mesh-ancestor
5603764|NCT01445509|Bevacizumab|bevacizumab|mesh-list
6483163|NCT00555854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6483164|NCT00555854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483165|NCT00555854|Sensory System Agents|sensory system agents|mesh-ancestor
6483166|NCT00555854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6483167|NCT00555867|Anastrozole|anastrozole|mesh-list
6483168|NCT00555867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6483169|NCT00555867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6483170|NCT00555867|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6483171|NCT00555867|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6483172|NCT00555867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6483173|NCT00555867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483174|NCT00555867|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6483175|NCT00555867|Hormone Antagonists|hormone antagonists|mesh-ancestor
6483176|NCT00555867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6483177|NCT00555867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483178|NCT00555984|Remifentanil|remifentanil|mesh-list
6483179|NCT00555984|Propofol|propofol|mesh-list
6483180|NCT00555984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
5603765|NCT01445509|Dasatinib|dasatinib|mesh-list
6483181|NCT00555984|Sevoflurane|sevoflurane|mesh-list
6483182|NCT00555984|Anesthetics|anesthetics|mesh-list
6483183|NCT00555984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6483184|NCT00555984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5563767|NCT03989271|Quercetin|quercetin|mesh-list
5563768|NCT03989271|Antioxidants|antioxidants|mesh-ancestor
5563769|NCT03989271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563770|NCT03989271|Protective Agents|protective agents|mesh-ancestor
5563771|NCT03989271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563772|NCT03989466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5563773|NCT03989466|Alemtuzumab|alemtuzumab|mesh-list
5563774|NCT03989466|Antibodies|antibodies|mesh-list
5563775|NCT03989466|Immunoglobulins|immunoglobulins|mesh-list
5563776|NCT03989466|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5563777|NCT03989466|Immunologic Factors|immunologic factors|mesh-ancestor
5563778|NCT03989466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563779|NCT03989466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5563780|NCT03989115|Osimertinib|osimertinib|mesh-list
5563781|NCT03989115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5563782|NCT03989115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5563783|NCT03989115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5563784|NCT03989115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563785|NCT03989089|Pembrolizumab|pembrolizumab|mesh-list
6483185|NCT00555984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483186|NCT00555984|Anesthetics, General|anesthetics, general|mesh-ancestor
6483187|NCT00555984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6483188|NCT00555984|Narcotics|narcotics|mesh-ancestor
5563786|NCT03989089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5563787|NCT03989089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5563788|NCT03989037|Carboplatin|carboplatin|mesh-list
5563789|NCT03989037|Docetaxel|docetaxel|mesh-list
5563790|NCT03989037|Trastuzumab|trastuzumab|mesh-list
5563791|NCT03989037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5563792|NCT03989037|Tubulin Modulators|tubulin modulators|mesh-ancestor
5563793|NCT03989037|Antimitotic Agents|antimitotic agents|mesh-ancestor
5563794|NCT03989037|Mitosis Modulators|mitosis modulators|mesh-ancestor
5563795|NCT03989037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563796|NCT03989037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5563797|NCT03989024|Clomiphene|clomiphene|mesh-list
5563798|NCT03989024|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
5563799|NCT03989024|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5563800|NCT03989024|Hormone Antagonists|hormone antagonists|mesh-ancestor
5563801|NCT03989024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5563802|NCT03989024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563803|NCT03989024|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5563804|NCT03989024|Fertility Agents|fertility agents|mesh-ancestor
5563805|NCT03989024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5563806|NCT03989024|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5563807|NCT03989024|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5563808|NCT03989024|Hormones|hormones|mesh-ancestor
5563809|NCT03988725|Vitamin E|vitamin e|mesh-list
5563810|NCT03988725|Vitamins|vitamins|mesh-ancestor
5563811|NCT03988725|Micronutrients|micronutrients|mesh-ancestor
5563812|NCT03988725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563813|NCT03988725|Antioxidants|antioxidants|mesh-ancestor
6483189|NCT00555984|Analgesics|analgesics|mesh-ancestor
6483190|NCT00555984|Sensory System Agents|sensory system agents|mesh-ancestor
6483191|NCT00555984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6483192|NCT00555984|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6165776|NCT01576523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165777|NCT01576523|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6165778|NCT01576523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6165779|NCT01576588|Rituximab|rituximab|mesh-list
6165780|NCT01576588|Glucocorticoids|glucocorticoids|mesh-list
6165781|NCT01576588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6165782|NCT01576588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6165783|NCT01576588|Immunologic Factors|immunologic factors|mesh-ancestor
6165784|NCT01576588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165785|NCT01576588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5563814|NCT03988725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563815|NCT03988725|Protective Agents|protective agents|mesh-ancestor
5563816|NCT03988478|Psychotropic Drugs|psychotropic drugs|mesh-list
5563817|NCT03988530|Scopolamine|scopolamine|mesh-list
6483193|NCT00555984|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5563818|NCT03988530|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
5563819|NCT03988530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5563820|NCT03988530|Antiemetics|antiemetics|mesh-ancestor
5563821|NCT03988530|Autonomic Agents|autonomic agents|mesh-ancestor
5563822|NCT03988530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5563823|NCT03988530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563824|NCT03988530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5563825|NCT03988530|Mydriatics|mydriatics|mesh-ancestor
5563826|NCT03988530|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5563827|NCT03988530|Cholinergic Agents|cholinergic agents|mesh-ancestor
5563828|NCT03988530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5563829|NCT03988530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563830|NCT03988530|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5563831|NCT03988530|Parasympatholytics|parasympatholytics|mesh-ancestor
5563832|NCT03988387|Tenofovir|tenofovir|mesh-list
5563833|NCT03988387|Emtricitabine|emtricitabine|mesh-list
6165786|NCT01576588|Hormones|hormones|mesh-ancestor
6165787|NCT01576588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6165788|NCT01576705|Leucovorin|leucovorin|mesh-list
6165789|NCT01576705|Folic Acid|folic acid|mesh-list
6165790|NCT01576705|Hormones|hormones|mesh-list
6165791|NCT01576705|Levoleucovorin|levoleucovorin|mesh-list
6165792|NCT01576705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6165793|NCT01576705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165794|NCT01576705|Antidotes|antidotes|mesh-ancestor
6165795|NCT01576705|Protective Agents|protective agents|mesh-ancestor
6165796|NCT01576705|Vitamin B Complex|vitamin b complex|mesh-ancestor
6165797|NCT01576705|Vitamins|vitamins|mesh-ancestor
6165798|NCT01576705|Micronutrients|micronutrients|mesh-ancestor
6165799|NCT01576705|Hematinics|hematinics|mesh-ancestor
6165800|NCT01576718|Fluticasone|fluticasone|mesh-list
6165801|NCT01576718|Xhance|xhance|mesh-list
6165802|NCT01576718|Albuterol|albuterol|mesh-list
6483194|NCT00556023|Gemcitabine|gemcitabine|mesh-list
6483195|NCT00556023|Tremelimumab|tremelimumab|mesh-list
6483196|NCT00556023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6483197|NCT00556023|Antimetabolites|antimetabolites|mesh-ancestor
6483198|NCT00556023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483199|NCT00556023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6483200|NCT00556023|Antiviral Agents|antiviral agents|mesh-ancestor
6483201|NCT00556023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6483202|NCT00556023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6483203|NCT00556023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6483204|NCT00556023|Immunologic Factors|immunologic factors|mesh-ancestor
6483205|NCT00556023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483206|NCT00556062|Vaccines|vaccines|mesh-list
6165803|NCT01576718|Adrenergic Agonists|adrenergic agonists|mesh-list
5563834|NCT03988387|Antiviral Agents|antiviral agents|mesh-ancestor
5563835|NCT03988387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5563836|NCT03988387|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5563837|NCT03988387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5563838|NCT03988387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5563839|NCT03988387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563840|NCT03988387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5563841|NCT03988387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5563842|NCT03988231|Enoxaparin|enoxaparin|mesh-list
5563843|NCT03988231|Anticoagulants|anticoagulants|mesh-ancestor
5563844|NCT03988231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5563845|NCT03988231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5563846|NCT03988231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563847|NCT03988205|Cytarabine|cytarabine|mesh-list
5563848|NCT03988205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5563849|NCT03988205|Antimetabolites|antimetabolites|mesh-ancestor
5563850|NCT03988205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563851|NCT03988205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5563852|NCT03988205|Antiviral Agents|antiviral agents|mesh-ancestor
5563853|NCT03988205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5563854|NCT03988205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5563855|NCT03988205|Immunologic Factors|immunologic factors|mesh-ancestor
5563856|NCT03988205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563857|NCT03988452|Ritonavir|ritonavir|mesh-list
5563858|NCT03988452|Darunavir|darunavir|mesh-list
5563859|NCT03988452|Tenofovir|tenofovir|mesh-list
6483207|NCT00556062|Immunologic Factors|immunologic factors|mesh-ancestor
6483208|NCT00556062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483209|NCT00556088|Paclitaxel|paclitaxel|mesh-list
6483210|NCT00556088|Bevacizumab|bevacizumab|mesh-list
5563860|NCT03988452|Lamivudine|lamivudine|mesh-list
5563861|NCT03988452|Zidovudine|zidovudine|mesh-list
5563862|NCT03988452|Dolutegravir|dolutegravir|mesh-list
6165804|NCT01576718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6483211|NCT00556088|Carboplatin|carboplatin|mesh-list
5563863|NCT03988452|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5563864|NCT03988452|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6483212|NCT00556088|Panobinostat|panobinostat|mesh-list
6483213|NCT00556088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6483214|NCT00556088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6483215|NCT00556088|Tubulin Modulators|tubulin modulators|mesh-ancestor
6483216|NCT00556088|Antimitotic Agents|antimitotic agents|mesh-ancestor
6483217|NCT00556088|Mitosis Modulators|mitosis modulators|mesh-ancestor
5563865|NCT03988452|Protease Inhibitors|protease inhibitors|mesh-ancestor
5563866|NCT03988452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5563867|NCT03988452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563868|NCT03988452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5563869|NCT03988452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5563870|NCT03988452|Antiviral Agents|antiviral agents|mesh-ancestor
5563871|NCT03988452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5563872|NCT03988452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5563873|NCT03988452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5563874|NCT03988452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5563875|NCT03988452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5563876|NCT03988452|Antimetabolites|antimetabolites|mesh-ancestor
5563877|NCT03988452|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5563878|NCT03988452|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5563879|NCT03988257|Ascorbic Acid|ascorbic acid|mesh-list
5563880|NCT03988257|Vitamins|vitamins|mesh-ancestor
5563881|NCT03988257|Micronutrients|micronutrients|mesh-ancestor
5563882|NCT03988257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563883|NCT03988257|Antioxidants|antioxidants|mesh-ancestor
5563884|NCT03988257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563885|NCT03988257|Protective Agents|protective agents|mesh-ancestor
5563886|NCT03988101|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5563887|NCT03988101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5563888|NCT03988101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5563889|NCT03988101|Antimetabolites|antimetabolites|mesh-ancestor
5563890|NCT03988101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563891|NCT03988101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5563892|NCT03988101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5563893|NCT03988101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5563894|NCT03988010|Amantadine|amantadine|mesh-list
5563895|NCT03988010|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5563896|NCT03988010|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5563897|NCT03988010|Antiviral Agents|antiviral agents|mesh-ancestor
5563898|NCT03988010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5563899|NCT03988010|Dopamine Agents|dopamine agents|mesh-ancestor
5563900|NCT03988010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5563901|NCT03988010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563902|NCT03988010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563903|NCT03988010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5563904|NCT03988010|Analgesics|analgesics|mesh-ancestor
5563905|NCT03988010|Sensory System Agents|sensory system agents|mesh-ancestor
5563906|NCT03988010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5563907|NCT03987867|Paclitaxel|paclitaxel|mesh-list
5563908|NCT03987867|Carboplatin|carboplatin|mesh-list
5563909|NCT03987867|Pemetrexed|pemetrexed|mesh-list
5563910|NCT03987867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5563911|NCT03987867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5563912|NCT03987867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5563913|NCT03987867|Tubulin Modulators|tubulin modulators|mesh-ancestor
5563914|NCT03987867|Antimitotic Agents|antimitotic agents|mesh-ancestor
5563915|NCT03987867|Mitosis Modulators|mitosis modulators|mesh-ancestor
5563916|NCT03987867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563917|NCT03987867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5563918|NCT03987867|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6165805|NCT01576718|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6165806|NCT01576718|Autonomic Agents|autonomic agents|mesh-ancestor
6483218|NCT00556088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483219|NCT00556088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6483220|NCT00556088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6483221|NCT00556088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6483222|NCT00556088|Growth Substances|growth substances|mesh-ancestor
6483223|NCT00556088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483224|NCT00556088|Growth Inhibitors|growth inhibitors|mesh-ancestor
5563919|NCT03987867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5563920|NCT03988075|Acetaminophen|acetaminophen|mesh-list
5563921|NCT03988075|Ibuprofen|ibuprofen|mesh-list
5563922|NCT03988075|Hydrocodone|hydrocodone|mesh-list
6165807|NCT01576718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6165808|NCT01576718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165809|NCT01576718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6165810|NCT01576718|Respiratory System Agents|respiratory system agents|mesh-ancestor
6165811|NCT01576718|Dermatologic Agents|dermatologic agents|mesh-ancestor
6165812|NCT01576718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6165813|NCT01576718|Tocolytic Agents|tocolytic agents|mesh-ancestor
6165814|NCT01576718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6165815|NCT01576718|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6165816|NCT01576718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6165817|NCT01576718|Adrenergic Agents|adrenergic agents|mesh-ancestor
6165818|NCT01576718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6165819|NCT01576718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6165820|NCT01576809|Acetaminophen|acetaminophen|mesh-list
6165821|NCT01576809|Phenylpropanolamine|phenylpropanolamine|mesh-list
6165822|NCT01576809|Phenylephrine|phenylephrine|mesh-list
6165823|NCT01576809|Oxymetazoline|oxymetazoline|mesh-list
6165824|NCT01576809|Guaifenesin|guaifenesin|mesh-list
6165825|NCT01576809|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
6165826|NCT01576809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6165827|NCT01576809|Analgesics|analgesics|mesh-ancestor
6165828|NCT01576809|Sensory System Agents|sensory system agents|mesh-ancestor
6165829|NCT01576809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6165830|NCT01576809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165831|NCT01576809|Antipyretics|antipyretics|mesh-ancestor
6165832|NCT01576809|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6483225|NCT00556088|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5563923|NCT03988075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5563924|NCT03988075|Analgesics|analgesics|mesh-ancestor
5563925|NCT03988075|Sensory System Agents|sensory system agents|mesh-ancestor
6165833|NCT01576809|Mydriatics|mydriatics|mesh-ancestor
6165834|NCT01576809|Autonomic Agents|autonomic agents|mesh-ancestor
6165835|NCT01576809|Sympathomimetics|sympathomimetics|mesh-ancestor
6165836|NCT01576809|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6165837|NCT01576809|Nasal Decongestants|nasal decongestants|mesh-ancestor
6165838|NCT01576809|Respiratory System Agents|respiratory system agents|mesh-ancestor
6165839|NCT01576809|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6165840|NCT01576809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6165841|NCT01576809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6165842|NCT01576809|Adrenergic Agents|adrenergic agents|mesh-ancestor
6165843|NCT01576809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6165844|NCT01576809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6165845|NCT01576809|Protective Agents|protective agents|mesh-ancestor
6165846|NCT01576809|Expectorants|expectorants|mesh-ancestor
6165847|NCT01576809|Appetite Depressants|appetite depressants|mesh-ancestor
6165848|NCT01576809|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6165849|NCT01576874|Oxytocin|oxytocin|mesh-list
6165850|NCT01576874|Oxytocics|oxytocics|mesh-ancestor
6165851|NCT01576874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6165852|NCT01576874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165853|NCT01576952|Bromfenac|bromfenac|mesh-list
6165854|NCT01576952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6165855|NCT01576952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6165856|NCT01576952|Analgesics|analgesics|mesh-ancestor
6165857|NCT01576952|Sensory System Agents|sensory system agents|mesh-ancestor
6165858|NCT01576952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6165859|NCT01576952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165860|NCT01576952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6165861|NCT01576952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6165862|NCT01577160|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6165863|NCT01577160|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6165864|NCT01577160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6165865|NCT01577160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6165866|NCT01577160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165867|NCT01577160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6165868|NCT01577160|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6165869|NCT01577160|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6165870|NCT01577160|Serotonin Agents|serotonin agents|mesh-ancestor
6165871|NCT01577160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6165872|NCT01577160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6165873|NCT01577160|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6165874|NCT01577160|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6165875|NCT01577160|Dopamine Agents|dopamine agents|mesh-ancestor
6165876|NCT01577186|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6165877|NCT01577186|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6165878|NCT01577186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6165879|NCT01577186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6165880|NCT01577186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165881|NCT01577186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6165882|NCT01577186|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6165883|NCT01577186|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6165884|NCT01577186|Serotonin Agents|serotonin agents|mesh-ancestor
6165885|NCT01577186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6165886|NCT01577186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563926|NCT03988075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5563927|NCT03988075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563928|NCT03988075|Antipyretics|antipyretics|mesh-ancestor
5563929|NCT03988075|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5563930|NCT03988075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5563931|NCT03988075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5563932|NCT03988075|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5563933|NCT03988075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5563934|NCT03988075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563935|NCT03988075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5563936|NCT03988075|Narcotics|narcotics|mesh-ancestor
5563937|NCT03988075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5563938|NCT03988075|Antitussive Agents|antitussive agents|mesh-ancestor
6165887|NCT01577186|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6165888|NCT01577186|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6165889|NCT01577186|Dopamine Agents|dopamine agents|mesh-ancestor
6165890|NCT01577706|Alprazolam|alprazolam|mesh-list
6165891|NCT01577706|Dextroamphetamine|dextroamphetamine|mesh-list
6165892|NCT01577706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6165893|NCT01577706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6165894|NCT01577706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165895|NCT01577706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6165896|NCT01577706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6165897|NCT01577706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6165898|NCT01577706|GABA Modulators|gaba modulators|mesh-ancestor
6165899|NCT01577706|GABA Agents|gaba agents|mesh-ancestor
6165900|NCT01577706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6165901|NCT01577706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6165902|NCT01577706|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6165903|NCT01577706|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6165904|NCT01577706|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6165905|NCT01577706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6165906|NCT01577706|Dopamine Agents|dopamine agents|mesh-ancestor
6165907|NCT01577966|Sulfasalazine|sulfasalazine|mesh-list
6165908|NCT01577966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6165909|NCT01577966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6165910|NCT01577966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6165911|NCT01577966|Analgesics|analgesics|mesh-ancestor
6165912|NCT01577966|Sensory System Agents|sensory system agents|mesh-ancestor
6165913|NCT01577966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6165914|NCT01577966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165915|NCT01577966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6165916|NCT01577966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6165917|NCT01577966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6165918|NCT01578239|Octreotide|octreotide|mesh-list
6165919|NCT01578239|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
5563939|NCT03988075|Respiratory System Agents|respiratory system agents|mesh-ancestor
5563940|NCT03987776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
5563941|NCT03988036|Pembrolizumab|pembrolizumab|mesh-list
5563942|NCT03988036|Trastuzumab|trastuzumab|mesh-list
5563943|NCT03988036|Pertuzumab|pertuzumab|mesh-list
5563944|NCT03988036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5563945|NCT03988036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5563946|NCT03988114|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5563947|NCT03988114|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5563948|NCT03988114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5563949|NCT03988114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563950|NCT03988114|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5563951|NCT03988114|Hormone Antagonists|hormone antagonists|mesh-ancestor
5563952|NCT03988114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5563953|NCT03988114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563954|NCT03987893|Lactulose|lactulose|mesh-list
5563955|NCT03987893|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
5563956|NCT03987893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5563957|NCT03987893|Laxatives|laxatives|mesh-ancestor
5563958|NCT03987802|Insulin Aspart|insulin aspart|mesh-list
5563959|NCT03987802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5563960|NCT03987802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165920|NCT01578239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6165921|NCT01578239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6165922|NCT01578239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6165923|NCT01578239|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6165924|NCT01578239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483226|NCT00556088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6483227|NCT00556127|Cytarabine|cytarabine|mesh-list
6483228|NCT00556127|Dexamethasone|dexamethasone|mesh-list
6483229|NCT00556127|Prednisone|prednisone|mesh-list
6483230|NCT00556127|Cyclophosphamide|cyclophosphamide|mesh-list
6483231|NCT00556127|Melphalan|melphalan|mesh-list
6483232|NCT00556127|Carmustine|carmustine|mesh-list
6483233|NCT00556127|Rituximab|rituximab|mesh-list
6483234|NCT00556127|Etoposide|etoposide|mesh-list
6483235|NCT00556127|Vincristine|vincristine|mesh-list
6483236|NCT00556127|Epirubicin|epirubicin|mesh-list
6483237|NCT00556127|Mitoxantrone|mitoxantrone|mesh-list
6483238|NCT00556127|Sargramostim|sargramostim|mesh-list
6483239|NCT00556127|Lenograstim|lenograstim|mesh-list
6483240|NCT00556127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6483241|NCT00556127|Immunologic Factors|immunologic factors|mesh-ancestor
6483242|NCT00556127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483243|NCT00556127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5563961|NCT03987815|Nivolumab|nivolumab|mesh-list
5563962|NCT03987815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5563963|NCT03987815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5563964|NCT03987815|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5563965|NCT03987815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563966|NCT03987698|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5563967|NCT03987698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5563968|NCT03987698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5563969|NCT03987308|Insulin Aspart|insulin aspart|mesh-list
5563970|NCT03987308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5563971|NCT03987308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483244|NCT00556127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6483245|NCT00556127|Alkylating Agents|alkylating agents|mesh-ancestor
6483246|NCT00556127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483247|NCT00556127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6483248|NCT00556127|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6483249|NCT00556127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6483250|NCT00556127|Antiemetics|antiemetics|mesh-ancestor
6483251|NCT00556127|Autonomic Agents|autonomic agents|mesh-ancestor
6483252|NCT00556127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6483253|NCT00556127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6483254|NCT00556127|Glucocorticoids|glucocorticoids|mesh-ancestor
6483255|NCT00556127|Hormones|hormones|mesh-ancestor
6483256|NCT00556127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6483257|NCT00556127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6165925|NCT01578278|Fluticasone|fluticasone|mesh-list
6165926|NCT01578278|Xhance|xhance|mesh-list
6165927|NCT01578278|Bepotastine besilate|bepotastine besilate|mesh-list
6165928|NCT01578278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6165929|NCT01578278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6165930|NCT01578278|Autonomic Agents|autonomic agents|mesh-ancestor
6165931|NCT01578278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5603766|NCT01445509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5603767|NCT01445509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5603768|NCT01445509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5603769|NCT01445509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5603770|NCT01445509|Growth Substances|growth substances|mesh-ancestor
5603771|NCT01445509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603772|NCT01445509|Growth Inhibitors|growth inhibitors|mesh-ancestor
5603773|NCT01445509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5603774|NCT01445509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5603775|NCT01445509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603776|NCT01415752|Rituximab|rituximab|mesh-list
5603777|NCT01415752|Lenalidomide|lenalidomide|mesh-list
5603778|NCT01415752|Bortezomib|bortezomib|mesh-list
5603779|NCT01415752|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5603780|NCT01415752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5603781|NCT01415752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6165932|NCT01578278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483258|NCT00556127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6483259|NCT00556127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5563972|NCT03987503|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
5563973|NCT03987503|Antiviral Agents|antiviral agents|mesh-ancestor
5563974|NCT03987503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5563975|NCT03987529|Propofol|propofol|mesh-list
5563976|NCT03987529|Sevoflurane|sevoflurane|mesh-list
5563977|NCT03987529|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5563978|NCT03987529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5563979|NCT03987529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563980|NCT03987529|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5563981|NCT03987529|Anesthetics, General|anesthetics, general|mesh-ancestor
5563982|NCT03987529|Anesthetics|anesthetics|mesh-ancestor
5563983|NCT03987529|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5563984|NCT03987529|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5563985|NCT03987152|Sirolimus|sirolimus|mesh-list
5563986|NCT03987152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5563987|NCT03987152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5563988|NCT03987152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5563989|NCT03987152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5563990|NCT03987152|Antifungal Agents|antifungal agents|mesh-ancestor
5563991|NCT03987152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5563992|NCT03987152|Immunologic Factors|immunologic factors|mesh-ancestor
5563993|NCT03987152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5563994|NCT03986970|Tenofovir|tenofovir|mesh-list
5563995|NCT03986970|Emtricitabine|emtricitabine|mesh-list
5563996|NCT03986970|Antiviral Agents|antiviral agents|mesh-ancestor
5563997|NCT03986970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5563998|NCT03986970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5563999|NCT03986970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5564000|NCT03986970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5564001|NCT03986970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564002|NCT03986970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5564003|NCT03986970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5564004|NCT03987022|Acetaminophen|acetaminophen|mesh-list
5564005|NCT03987022|Ketorolac|ketorolac|mesh-list
5564006|NCT03987022|Oxycodone|oxycodone|mesh-list
5564007|NCT03987022|Hydromorphone|hydromorphone|mesh-list
5564008|NCT03987022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5564009|NCT03987022|Narcotics|narcotics|mesh-ancestor
5564010|NCT03987022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5564011|NCT03987022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564012|NCT03987022|Analgesics|analgesics|mesh-ancestor
5564013|NCT03987022|Sensory System Agents|sensory system agents|mesh-ancestor
5564014|NCT03987022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6165933|NCT01578278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6165934|NCT01578278|Respiratory System Agents|respiratory system agents|mesh-ancestor
6165935|NCT01578278|Dermatologic Agents|dermatologic agents|mesh-ancestor
6165936|NCT01578278|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6165937|NCT01578317|Vaccines|vaccines|mesh-list
6165938|NCT01578317|Immunologic Factors|immunologic factors|mesh-ancestor
6165939|NCT01578317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564015|NCT03987022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5564016|NCT03987022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5564017|NCT03987022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5564018|NCT03987022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5564019|NCT03987022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5564020|NCT03987022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5603782|NCT01415752|Immunologic Factors|immunologic factors|mesh-ancestor
6483260|NCT00556127|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6483261|NCT00556127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6483262|NCT00556127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6483263|NCT00556127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6483264|NCT00556127|Antimetabolites|antimetabolites|mesh-ancestor
6483265|NCT00556127|Antiviral Agents|antiviral agents|mesh-ancestor
6483266|NCT00556127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6483267|NCT00556127|Tubulin Modulators|tubulin modulators|mesh-ancestor
6483268|NCT00556127|Antimitotic Agents|antimitotic agents|mesh-ancestor
6483269|NCT00556127|Mitosis Modulators|mitosis modulators|mesh-ancestor
6483270|NCT00556127|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5564021|NCT03987022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564022|NCT03987022|Antipyretics|antipyretics|mesh-ancestor
5564023|NCT03986996|Amoxicillin|amoxicillin|mesh-list
5564024|NCT03986996|Metronidazole|metronidazole|mesh-list
5564025|NCT03986996|Doxycycline|doxycycline|mesh-list
5564026|NCT03986996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5564027|NCT03986996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5564028|NCT03986996|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5564029|NCT03986996|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5564030|NCT03986996|Antimalarials|antimalarials|mesh-ancestor
5564031|NCT03986762|Clavulanic Acids|clavulanic acids|mesh-list
5564032|NCT03986762|Clavulanic Acid|clavulanic acid|mesh-list
6669009|NCT01535677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669010|NCT01535690|Methylene Blue|methylene blue|mesh-list
6669011|NCT01535690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6672468|NCT01556334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5564033|NCT03986762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6165940|NCT01578330|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6165941|NCT01578330|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6165942|NCT01578330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6165943|NCT01578330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6165944|NCT01578330|Immunologic Factors|immunologic factors|mesh-ancestor
6165945|NCT01578330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165946|NCT01578486|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
6165947|NCT01578486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6165948|NCT01578486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5564034|NCT03986762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5564035|NCT03986762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5564036|NCT03986762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564037|NCT03986762|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5564038|NCT03986905|Scopolamine|scopolamine|mesh-list
6165949|NCT01578486|Analgesics|analgesics|mesh-ancestor
5564039|NCT03986905|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
5564040|NCT03986905|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5564041|NCT03986905|Antiemetics|antiemetics|mesh-ancestor
5564042|NCT03986905|Autonomic Agents|autonomic agents|mesh-ancestor
5564043|NCT03986905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5564044|NCT03986905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564045|NCT03986905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5564046|NCT03986905|Mydriatics|mydriatics|mesh-ancestor
5564047|NCT03986905|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5564048|NCT03986905|Cholinergic Agents|cholinergic agents|mesh-ancestor
5564049|NCT03986905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5564050|NCT03986905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564051|NCT03986905|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5564052|NCT03986905|Parasympatholytics|parasympatholytics|mesh-ancestor
5564053|NCT03986515|Apatinib|apatinib|mesh-list
5564054|NCT03986515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5564055|NCT03986515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5564056|NCT03986515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5564057|NCT03986515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6165950|NCT01578486|Sensory System Agents|sensory system agents|mesh-ancestor
6165951|NCT01578486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5564058|NCT03986268|Vitamin D|vitamin d|mesh-list
5564059|NCT03986268|Cholecalciferol|cholecalciferol|mesh-list
5564060|NCT03986268|Vitamins|vitamins|mesh-ancestor
5564061|NCT03986268|Micronutrients|micronutrients|mesh-ancestor
5564062|NCT03986268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564063|NCT03986268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5564064|NCT03986268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5564065|NCT03986385|Capecitabine|capecitabine|mesh-list
5564066|NCT03986385|Oxaliplatin|oxaliplatin|mesh-list
5564067|NCT03986385|Apatinib|apatinib|mesh-list
6165952|NCT01578486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165953|NCT01578486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6165954|NCT01578486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6165955|NCT01578499|Methotrexate|methotrexate|mesh-list
6165956|NCT01578499|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6165957|NCT01578499|Bexarotene|bexarotene|mesh-list
6165958|NCT01578499|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6165959|NCT01578499|Abortifacient Agents|abortifacient agents|mesh-ancestor
6165960|NCT01578499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6165961|NCT01578499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483271|NCT00556127|Analgesics|analgesics|mesh-ancestor
5564068|NCT03986385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5564069|NCT03986385|Antimetabolites|antimetabolites|mesh-ancestor
6165962|NCT01578499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6165963|NCT01578499|Antimetabolites|antimetabolites|mesh-ancestor
6165964|NCT01578499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6165965|NCT01578499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6165966|NCT01578499|Dermatologic Agents|dermatologic agents|mesh-ancestor
5564070|NCT03986385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564071|NCT03986385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5564072|NCT03986385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5564073|NCT03986385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5564074|NCT03986294|Leucovorin|leucovorin|mesh-list
5564075|NCT03986294|Antidotes|antidotes|mesh-ancestor
5564076|NCT03986294|Protective Agents|protective agents|mesh-ancestor
5564077|NCT03986294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564078|NCT03986294|Vitamin B Complex|vitamin b complex|mesh-ancestor
5564079|NCT03986294|Vitamins|vitamins|mesh-ancestor
5564080|NCT03986294|Micronutrients|micronutrients|mesh-ancestor
5564081|NCT03986073|Linagliptin|linagliptin|mesh-list
5564082|NCT03986073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5564083|NCT03986073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564084|NCT03986073|Incretins|incretins|mesh-ancestor
5564085|NCT03986073|Hormones|hormones|mesh-ancestor
6165967|NCT01578499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6165968|NCT01578499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6165969|NCT01578499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6165970|NCT01578499|Immunologic Factors|immunologic factors|mesh-ancestor
6165971|NCT01578499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6165972|NCT01578499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6165973|NCT01578499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6165974|NCT01578551|Metformin|metformin|mesh-list
6165975|NCT01578551|Biguanides|biguanides|mesh-list
6165976|NCT01578551|Paclitaxel|paclitaxel|mesh-list
6165977|NCT01578551|Bevacizumab|bevacizumab|mesh-list
5564086|NCT03986073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6165978|NCT01578551|Carboplatin|carboplatin|mesh-list
6165979|NCT01578551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6165980|NCT01578551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6165981|NCT01578551|Tubulin Modulators|tubulin modulators|mesh-ancestor
6165982|NCT01578551|Antimitotic Agents|antimitotic agents|mesh-ancestor
6165983|NCT01578551|Mitosis Modulators|mitosis modulators|mesh-ancestor
6165984|NCT01578551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564087|NCT03986073|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5564088|NCT03986073|Protease Inhibitors|protease inhibitors|mesh-ancestor
5564089|NCT03986073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5564090|NCT03986073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564091|NCT03985891|Antibodies|antibodies|mesh-list
5564092|NCT03985891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5564093|NCT03985891|Immunologic Factors|immunologic factors|mesh-ancestor
5564094|NCT03985891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564095|NCT03986008|Liraglutide|liraglutide|mesh-list
5564096|NCT03986008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6165985|NCT01578551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6165986|NCT01578551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6165987|NCT01578551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6165988|NCT01578551|Growth Substances|growth substances|mesh-ancestor
6165989|NCT01578551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6165990|NCT01578551|Growth Inhibitors|growth inhibitors|mesh-ancestor
6483272|NCT00556127|Sensory System Agents|sensory system agents|mesh-ancestor
6483273|NCT00556127|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6483274|NCT00556153|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
6483275|NCT00556153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483276|NCT00556192|Rituximab|rituximab|mesh-list
6483277|NCT00556192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6483278|NCT00556192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5564097|NCT03986008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483279|NCT00556192|Immunologic Factors|immunologic factors|mesh-ancestor
6483280|NCT00556192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483281|NCT00556192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6483282|NCT00556205|Bevacizumab|bevacizumab|mesh-list
6483283|NCT00556205|Sunitinib|sunitinib|mesh-list
6483284|NCT00556205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6669012|NCT01535690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6165991|NCT01578551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6165992|NCT01578707|Ofatumumab|ofatumumab|mesh-list
6165993|NCT01578707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6165994|NCT01578772|Telmisartan|telmisartan|mesh-list
6165995|NCT01578772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6165996|NCT01578772|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6669013|NCT01535768|Travoprost|travoprost|mesh-list
6669014|NCT01535768|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6669015|NCT01535768|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6669016|NCT01535768|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6165997|NCT01578772|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6165998|NCT01578772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6165999|NCT01578850|Etanercept|etanercept|mesh-list
6166000|NCT01578850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6166001|NCT01578850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6166002|NCT01578850|Analgesics|analgesics|mesh-ancestor
6166003|NCT01578850|Sensory System Agents|sensory system agents|mesh-ancestor
6166004|NCT01578850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6166005|NCT01578850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166006|NCT01578850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6166007|NCT01578850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6166008|NCT01578850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6166009|NCT01578850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6166010|NCT01578850|Immunologic Factors|immunologic factors|mesh-ancestor
6166011|NCT01578980|Pancrelipase|pancrelipase|mesh-list
6166012|NCT01578980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6166013|NCT01579162|Cholic Acids|cholic acids|mesh-list
6166014|NCT01579162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6166015|NCT01579305|Lidocaine|lidocaine|mesh-list
6166016|NCT01579305|Anesthetics, Local|anesthetics, local|mesh-ancestor
6166017|NCT01579305|Anesthetics|anesthetics|mesh-ancestor
6166018|NCT01579305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6166019|NCT01579305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166020|NCT01579305|Sensory System Agents|sensory system agents|mesh-ancestor
6166021|NCT01579305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6166022|NCT01579305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6166023|NCT01579305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6166024|NCT01579305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6166025|NCT01579305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6166026|NCT01579305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166027|NCT01579318|Interleukin-12|interleukin-12|mesh-list
6166028|NCT01579318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6166029|NCT01579318|Immunologic Factors|immunologic factors|mesh-ancestor
6166030|NCT01579318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166031|NCT01579318|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6166032|NCT01579318|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6166033|NCT01579318|Growth Substances|growth substances|mesh-ancestor
5564098|NCT03986008|Incretins|incretins|mesh-ancestor
5564099|NCT03986008|Hormones|hormones|mesh-ancestor
5564100|NCT03986008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5564101|NCT03985969|Indomethacin|indomethacin|mesh-list
5564102|NCT03985969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5564103|NCT03985969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5564104|NCT03985969|Analgesics|analgesics|mesh-ancestor
5564105|NCT03985969|Sensory System Agents|sensory system agents|mesh-ancestor
5564106|NCT03985969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5564107|NCT03985969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564108|NCT03985969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5564109|NCT03985969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5564110|NCT03985969|Gout Suppressants|gout suppressants|mesh-ancestor
5564111|NCT03985969|Tocolytic Agents|tocolytic agents|mesh-ancestor
5564112|NCT03985969|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5564113|NCT03985969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5564114|NCT03985969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6166034|NCT01579318|Growth Inhibitors|growth inhibitors|mesh-ancestor
6669017|NCT01535768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5603783|NCT01415752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564115|NCT03985969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564116|NCT03985982|Botulinum Toxins|botulinum toxins|mesh-list
5564117|NCT03985982|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5564118|NCT03985982|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5564119|NCT03985982|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5564120|NCT03985982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5564121|NCT03985982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564122|NCT03985982|Cholinergic Agents|cholinergic agents|mesh-ancestor
5564123|NCT03985982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5564124|NCT03985982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564125|NCT03985982|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5564126|NCT03985982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5564127|NCT03985865|Quinine|quinine|mesh-list
5564128|NCT03985865|Denatonium|denatonium|mesh-list
6166035|NCT01579318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6166036|NCT01579513|Methylprednisolone|methylprednisolone|mesh-list
6166037|NCT01579513|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6166038|NCT01579513|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6166039|NCT01579513|Prednisolone|prednisolone|mesh-list
6166040|NCT01579513|Prednisolone acetate|prednisolone acetate|mesh-list
6166041|NCT01579513|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6166042|NCT01579513|Prednisolone phosphate|prednisolone phosphate|mesh-list
6669018|NCT01535768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6669019|NCT01535768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5564129|NCT03985865|Antimalarials|antimalarials|mesh-ancestor
6166043|NCT01579513|Glucocorticoids|glucocorticoids|mesh-list
6166044|NCT01579513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6166045|NCT01579513|Antiemetics|antiemetics|mesh-ancestor
6166046|NCT01579513|Autonomic Agents|autonomic agents|mesh-ancestor
6166047|NCT01579513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5564130|NCT03985865|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5564131|NCT03985865|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5564132|NCT03985865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5564133|NCT03985865|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5564134|NCT03985865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564135|NCT03985865|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5564136|NCT03985865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5564137|NCT03985865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5564138|NCT03985865|Analgesics|analgesics|mesh-ancestor
5564139|NCT03985865|Sensory System Agents|sensory system agents|mesh-ancestor
5564140|NCT03985865|Aversive Agents|aversive agents|mesh-ancestor
5564141|NCT03985865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564142|NCT03985865|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
5564143|NCT03985540|Methamphetamine|methamphetamine|mesh-list
5564144|NCT03985540|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5564145|NCT03985540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564146|NCT03985540|Sympathomimetics|sympathomimetics|mesh-ancestor
5564147|NCT03985540|Autonomic Agents|autonomic agents|mesh-ancestor
5564148|NCT03985540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5564149|NCT03985540|Dopamine Agents|dopamine agents|mesh-ancestor
5564150|NCT03985540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5564151|NCT03985540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564152|NCT03985540|Adrenergic Agents|adrenergic agents|mesh-ancestor
5564153|NCT03985540|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5564154|NCT03985540|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5564155|NCT03985540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6166048|NCT01579513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166049|NCT01579513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6166050|NCT01579513|Hormones|hormones|mesh-ancestor
6166051|NCT01579513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6166052|NCT01579513|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6166053|NCT01579513|Protective Agents|protective agents|mesh-ancestor
6166054|NCT01579513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6166055|NCT01579513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6166056|NCT01579578|Paclitaxel|paclitaxel|mesh-list
6166057|NCT01579578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6166058|NCT01579578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6166059|NCT01579578|Tubulin Modulators|tubulin modulators|mesh-ancestor
6166060|NCT01579578|Antimitotic Agents|antimitotic agents|mesh-ancestor
6166061|NCT01579578|Mitosis Modulators|mitosis modulators|mesh-ancestor
6166062|NCT01579578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166063|NCT01579812|Metformin|metformin|mesh-list
6166064|NCT01579812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6669020|NCT01535768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6166065|NCT01579812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166066|NCT01580020|Dexamethasone|dexamethasone|mesh-list
6166067|NCT01580020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6166068|NCT01580020|Antiemetics|antiemetics|mesh-ancestor
6166069|NCT01580020|Autonomic Agents|autonomic agents|mesh-ancestor
6166070|NCT01580020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6166071|NCT01580020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166072|NCT01580020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6166073|NCT01580020|Glucocorticoids|glucocorticoids|mesh-ancestor
6166074|NCT01580020|Hormones|hormones|mesh-ancestor
6166075|NCT01580020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6166076|NCT01580020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6166077|NCT01580020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5564156|NCT03985540|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5603784|NCT01415752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5603785|NCT01415752|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5603786|NCT01415752|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5603787|NCT01415752|Growth Substances|growth substances|mesh-ancestor
5603788|NCT01415752|Growth Inhibitors|growth inhibitors|mesh-ancestor
5603789|NCT01415752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5603790|NCT01415752|Alkylating Agents|alkylating agents|mesh-ancestor
5603791|NCT01415752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603792|NCT01398852|Riboflavin|riboflavin|mesh-list
5603793|NCT01398852|Vitamin B Complex|vitamin b complex|mesh-ancestor
5603794|NCT01398852|Vitamins|vitamins|mesh-ancestor
6166078|NCT01580293|Factor VIII|factor viii|mesh-list
6166079|NCT01580293|Coagulants|coagulants|mesh-ancestor
6166080|NCT01580410|Oxaliplatin|oxaliplatin|mesh-list
6166081|NCT01580410|Mitomycins|mitomycins|mesh-list
6166082|NCT01580410|Mitomycin|mitomycin|mesh-list
6166083|NCT01580410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6166084|NCT01580410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5603795|NCT01398852|Micronutrients|micronutrients|mesh-ancestor
5603796|NCT01398852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603797|NCT01398852|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6166085|NCT01580410|Alkylating Agents|alkylating agents|mesh-ancestor
6166086|NCT01580410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166087|NCT01580410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6166088|NCT01580410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6166089|NCT01580423|Aprepitant|aprepitant|mesh-list
6166090|NCT01580423|Antiemetics|antiemetics|mesh-ancestor
6166091|NCT01580423|Autonomic Agents|autonomic agents|mesh-ancestor
6166092|NCT01580423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6166093|NCT01580423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166094|NCT01580423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6166095|NCT01580423|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5603798|NCT01398852|Dermatologic Agents|dermatologic agents|mesh-ancestor
5603799|NCT01332266|Cetuximab|cetuximab|mesh-list
6166096|NCT01580423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6166097|NCT01580423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166098|NCT01580488|Calcitriol|calcitriol|mesh-list
6166099|NCT01580488|Calcipotriene|calcipotriene|mesh-list
6166100|NCT01580488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6166101|NCT01580488|Dermatologic Agents|dermatologic agents|mesh-ancestor
6166102|NCT01580488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6166103|NCT01580488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166104|NCT01580488|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6166105|NCT01580488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6166106|NCT01580488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669021|NCT01535768|Adrenergic Agents|adrenergic agents|mesh-ancestor
5564157|NCT03985735|Anesthetics|anesthetics|mesh-list
5564158|NCT03985735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6166107|NCT01580488|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6166108|NCT01580488|Vitamins|vitamins|mesh-ancestor
6166109|NCT01580488|Micronutrients|micronutrients|mesh-ancestor
6166110|NCT01580488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6166111|NCT01580592|Omalizumab|omalizumab|mesh-list
6166112|NCT01580592|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6166113|NCT01580592|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6166114|NCT01580592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6166115|NCT01580592|Respiratory System Agents|respiratory system agents|mesh-ancestor
6166116|NCT01580592|Immunologic Factors|immunologic factors|mesh-ancestor
6166117|NCT01580592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166118|NCT01580618|Tenecteplase|tenecteplase|mesh-list
6166119|NCT01580618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6166120|NCT01580618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6166121|NCT01580618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166122|NCT01580670|Infliximab|infliximab|mesh-list
6166123|NCT01580670|Dermatologic Agents|dermatologic agents|mesh-ancestor
6166124|NCT01580670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6166125|NCT01580670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6166126|NCT01580969|Minocycline|minocycline|mesh-list
6166127|NCT01580969|Bevacizumab|bevacizumab|mesh-list
5564159|NCT03985735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564160|NCT03985722|Trabectedin|trabectedin|mesh-list
5564161|NCT03985722|Olaratumab|olaratumab|mesh-list
5564162|NCT03985722|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5564163|NCT03985722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5564164|NCT03985722|Alkylating Agents|alkylating agents|mesh-ancestor
5564165|NCT03985722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564166|NCT03985722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5564167|NCT03985722|Immunologic Factors|immunologic factors|mesh-ancestor
5564168|NCT03985722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564169|NCT03985319|Esomeprazole|esomeprazole|mesh-list
5564170|NCT03985319|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5564171|NCT03985319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5564172|NCT03985319|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5564173|NCT03985319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5564174|NCT03985319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564175|NCT03985410|Moxifloxacin|moxifloxacin|mesh-list
5564176|NCT03985410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5564177|NCT03985410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5564178|NCT03985410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5564179|NCT03985410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6166128|NCT01580969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6166129|NCT01580969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6166130|NCT01580969|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6166131|NCT01580969|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6166132|NCT01580969|Growth Substances|growth substances|mesh-ancestor
6166133|NCT01580969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166134|NCT01580969|Growth Inhibitors|growth inhibitors|mesh-ancestor
5564180|NCT03985410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5564181|NCT03985410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564182|NCT03985410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5564183|NCT03985280|Anesthetics|anesthetics|mesh-list
6166135|NCT01580969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6166136|NCT01580969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6166137|NCT01580995|Valacyclovir|valacyclovir|mesh-list
6166138|NCT01580995|Antiviral Agents|antiviral agents|mesh-ancestor
6166139|NCT01580995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6166140|NCT01581281|Topiramate|topiramate|mesh-list
6166141|NCT01581281|Amitriptyline|amitriptyline|mesh-list
6483285|NCT00556205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6483286|NCT00556205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6483287|NCT00556205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6483288|NCT00556205|Growth Substances|growth substances|mesh-ancestor
6483289|NCT00556205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483290|NCT00556205|Growth Inhibitors|growth inhibitors|mesh-ancestor
6483291|NCT00556205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6483292|NCT00556205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6483293|NCT00556205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669022|NCT01535768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6672469|NCT01556334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6166142|NCT01581281|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6166143|NCT01581281|Anticonvulsants|anticonvulsants|mesh-ancestor
6166144|NCT01581281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6669023|NCT01535768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669024|NCT01535768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669025|NCT01535781|Tranexamic Acid|tranexamic acid|mesh-list
6669026|NCT01535781|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6669027|NCT01535781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6669028|NCT01535781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669029|NCT01535781|Hemostatics|hemostatics|mesh-ancestor
6669030|NCT01535781|Coagulants|coagulants|mesh-ancestor
6669031|NCT01535820|Ortho Evra|ortho evra|mesh-list
6669032|NCT01535820|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6669033|NCT01535820|Contraceptive Agents|contraceptive agents|mesh-ancestor
5564184|NCT03985280|Anesthetics, Local|anesthetics, local|mesh-list
5564185|NCT03985280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5564186|NCT03985280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564187|NCT03985280|Sensory System Agents|sensory system agents|mesh-ancestor
5564188|NCT03985280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5564189|NCT03985514|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5564190|NCT03985514|Ciprofloxacin|ciprofloxacin|mesh-list
5564191|NCT03985514|Tazobactam|tazobactam|mesh-list
5564192|NCT03985514|Piperacillin|piperacillin|mesh-list
5564193|NCT03985514|Metronidazole|metronidazole|mesh-list
5564194|NCT03985514|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
5564195|NCT03985514|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6669034|NCT01535820|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6669035|NCT01535820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669036|NCT01535859|Cabergoline|cabergoline|mesh-list
6669037|NCT01535859|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6166145|NCT01581281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166146|NCT01581281|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6166147|NCT01581281|Antidepressive Agents|antidepressive agents|mesh-ancestor
6166148|NCT01581281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6166149|NCT01581281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6166150|NCT01581281|Analgesics|analgesics|mesh-ancestor
6166151|NCT01581281|Sensory System Agents|sensory system agents|mesh-ancestor
6166152|NCT01581281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6166153|NCT01581281|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6166154|NCT01581281|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6166155|NCT01581281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6166156|NCT01581281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166157|NCT01581281|Adrenergic Agents|adrenergic agents|mesh-ancestor
6166158|NCT01581281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6166159|NCT01581281|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6166160|NCT01581281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6166161|NCT01581281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6669038|NCT01535859|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6669039|NCT01535859|Dopamine Agonists|dopamine agonists|mesh-ancestor
6669040|NCT01535859|Dopamine Agents|dopamine agents|mesh-ancestor
6669041|NCT01535859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6669042|NCT01535859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669043|NCT01535859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669044|NCT01535872|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
6669045|NCT01535872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6669046|NCT01535872|Immunologic Factors|immunologic factors|mesh-ancestor
6669047|NCT01535872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669048|NCT01535989|Sirolimus|sirolimus|mesh-list
6669049|NCT01535989|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
6669050|NCT01535989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6669051|NCT01535989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6669052|NCT01535989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6669053|NCT01535989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6669054|NCT01535989|Antifungal Agents|antifungal agents|mesh-ancestor
6669055|NCT01535989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6669056|NCT01535989|Immunologic Factors|immunologic factors|mesh-ancestor
6669057|NCT01535989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669058|NCT01535989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6669059|NCT01536002|Propofol|propofol|mesh-list
6669060|NCT01536002|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5564196|NCT03985514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5564197|NCT03985514|Antitubercular Agents|antitubercular agents|mesh-ancestor
5564198|NCT03985514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5564199|NCT03985514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5564200|NCT03985514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5564201|NCT03985514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564202|NCT03985514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5564203|NCT03985514|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5564204|NCT03985514|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5564205|NCT03985514|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5564206|NCT03985514|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5564207|NCT03985514|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5564208|NCT03985358|Analgesics, Opioid|analgesics, opioid|mesh-list
5564209|NCT03985358|Narcotics|narcotics|mesh-ancestor
5564210|NCT03985358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5564211|NCT03985358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564212|NCT03985358|Analgesics|analgesics|mesh-ancestor
5564213|NCT03985358|Sensory System Agents|sensory system agents|mesh-ancestor
5564214|NCT03985358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5564215|NCT03984955|Mannitol|mannitol|mesh-list
5564216|NCT03984955|Hyaluronic Acid|hyaluronic acid|mesh-list
5564217|NCT03984955|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5564218|NCT03984955|Diuretics|diuretics|mesh-ancestor
5564219|NCT03984955|Natriuretic Agents|natriuretic agents|mesh-ancestor
5564220|NCT03984955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564221|NCT03984955|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5564222|NCT03984955|Immunologic Factors|immunologic factors|mesh-ancestor
5564223|NCT03984955|Viscosupplements|viscosupplements|mesh-ancestor
6166162|NCT01581307|Leucovorin|leucovorin|mesh-list
6166163|NCT01581307|Folic Acid|folic acid|mesh-list
6166164|NCT01581307|Fluorouracil|fluorouracil|mesh-list
6166165|NCT01581307|Oxaliplatin|oxaliplatin|mesh-list
6166166|NCT01581307|Levoleucovorin|levoleucovorin|mesh-list
6166167|NCT01581307|Antimetabolites|antimetabolites|mesh-ancestor
6166168|NCT01581307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166169|NCT01581307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6166170|NCT01581307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6166171|NCT01581307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6166172|NCT01581307|Immunologic Factors|immunologic factors|mesh-ancestor
6166173|NCT01581307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564224|NCT03984955|Protective Agents|protective agents|mesh-ancestor
5564225|NCT03984656|Lidocaine|lidocaine|mesh-list
5564226|NCT03984656|Anesthetics, Local|anesthetics, local|mesh-ancestor
5564227|NCT03984656|Anesthetics|anesthetics|mesh-ancestor
5564228|NCT03984656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5564229|NCT03984656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564230|NCT03984656|Sensory System Agents|sensory system agents|mesh-ancestor
5564231|NCT03984656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5564232|NCT03984656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5564233|NCT03984656|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5564234|NCT03984656|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5564235|NCT03984656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5564236|NCT03984656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564237|NCT03984565|Cannabidiol|cannabidiol|mesh-list
5564238|NCT03984565|Anticonvulsants|anticonvulsants|mesh-ancestor
5564239|NCT03984760|Sevelamer|sevelamer|mesh-list
5564240|NCT03984760|Chelating Agents|chelating agents|mesh-ancestor
5564241|NCT03984760|Sequestering Agents|sequestering agents|mesh-ancestor
5564242|NCT03984760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564243|NCT03984890|Vitamin D|vitamin d|mesh-list
5564244|NCT03984890|Cholecalciferol|cholecalciferol|mesh-list
5564245|NCT03984890|Vitamins|vitamins|mesh-ancestor
5564246|NCT03984890|Micronutrients|micronutrients|mesh-ancestor
5564247|NCT03984890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564248|NCT03984890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5564249|NCT03984890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6166174|NCT01581307|Antidotes|antidotes|mesh-ancestor
6166175|NCT01581307|Protective Agents|protective agents|mesh-ancestor
6166176|NCT01581307|Vitamin B Complex|vitamin b complex|mesh-ancestor
6166177|NCT01581307|Vitamins|vitamins|mesh-ancestor
6166178|NCT01581307|Micronutrients|micronutrients|mesh-ancestor
6166179|NCT01581307|Hematinics|hematinics|mesh-ancestor
6166180|NCT01581541|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
6669061|NCT01536002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6669062|NCT01536002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669063|NCT01536002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6669064|NCT01536002|Anesthetics, General|anesthetics, general|mesh-ancestor
6669065|NCT01536002|Anesthetics|anesthetics|mesh-ancestor
5564250|NCT03984591|Eplerenone|eplerenone|mesh-list
6166181|NCT01581541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6166182|NCT01581658|Empagliflozin|empagliflozin|mesh-list
6669066|NCT01536028|Insulin|insulin|mesh-list
5564251|NCT03984591|Spironolactone|spironolactone|mesh-list
6669067|NCT01536028|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6669068|NCT01536028|Insulin Aspart|insulin aspart|mesh-list
6669069|NCT01536028|Insulin, Long-Acting|insulin, long-acting|mesh-list
6669070|NCT01536028|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6669071|NCT01536028|Biphasic Insulins|biphasic insulins|mesh-list
6669072|NCT01536028|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6669073|NCT01536028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6669074|NCT01536028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669075|NCT01536054|Sirolimus|sirolimus|mesh-list
6669076|NCT01536054|Sargramostim|sargramostim|mesh-list
6669077|NCT01536054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6166183|NCT01581658|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6166184|NCT01581658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166185|NCT01581658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6166186|NCT01581658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166187|NCT01581710|Montelukast|montelukast|mesh-list
5564252|NCT03984591|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5564253|NCT03984591|Hormone Antagonists|hormone antagonists|mesh-ancestor
5564254|NCT03984591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5564255|NCT03984591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564256|NCT03984591|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5564257|NCT03984591|Diuretics|diuretics|mesh-ancestor
5564258|NCT03984591|Natriuretic Agents|natriuretic agents|mesh-ancestor
5564259|NCT03984591|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5564260|NCT03984578|Pembrolizumab|pembrolizumab|mesh-list
5564261|NCT03984578|Capecitabine|capecitabine|mesh-list
5564262|NCT03984578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5564263|NCT03984578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6166188|NCT01581710|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6166189|NCT01581710|Respiratory System Agents|respiratory system agents|mesh-ancestor
6166190|NCT01581710|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6166191|NCT01581710|Hormone Antagonists|hormone antagonists|mesh-ancestor
6166192|NCT01581710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6166193|NCT01581710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166194|NCT01581710|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6166195|NCT01581710|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6166196|NCT01581710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166197|NCT01581931|Metformin|metformin|mesh-list
6166198|NCT01581931|Linagliptin|linagliptin|mesh-list
6166199|NCT01581931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6166200|NCT01581931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166201|NCT01581931|Incretins|incretins|mesh-ancestor
6166202|NCT01581931|Hormones|hormones|mesh-ancestor
6166203|NCT01581931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6166204|NCT01581931|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6166205|NCT01581931|Protease Inhibitors|protease inhibitors|mesh-ancestor
6166206|NCT01581931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6166207|NCT01581931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166208|NCT01581970|Cyclophosphamide|cyclophosphamide|mesh-list
6166209|NCT01581970|Cetuximab|cetuximab|mesh-list
6166210|NCT01581970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6166211|NCT01581970|Immunologic Factors|immunologic factors|mesh-ancestor
6166212|NCT01581970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166213|NCT01581970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6166214|NCT01581970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6166215|NCT01581970|Alkylating Agents|alkylating agents|mesh-ancestor
6166216|NCT01581970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166217|NCT01581970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6166218|NCT01581970|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6166219|NCT01581970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6166220|NCT01582009|Everolimus|everolimus|mesh-list
6166221|NCT01582009|Panobinostat|panobinostat|mesh-list
6166222|NCT01582009|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
6166223|NCT01582009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6166224|NCT01582009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6166225|NCT01582009|Immunologic Factors|immunologic factors|mesh-ancestor
6166226|NCT01582009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166227|NCT01582009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6166228|NCT01582009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166229|NCT01582061|Pasireotide|pasireotide|mesh-list
6166230|NCT01582061|Hormones|hormones|mesh-ancestor
6669078|NCT01536054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5564264|NCT03984578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5564265|NCT03984578|Antimetabolites|antimetabolites|mesh-ancestor
5564266|NCT03984578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564267|NCT03984526|Atropine|atropine|mesh-list
5564268|NCT03984526|Ephedrine|ephedrine|mesh-list
5564269|NCT03984526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5564270|NCT03984526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5564271|NCT03984526|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5564272|NCT03984526|Autonomic Agents|autonomic agents|mesh-ancestor
5564273|NCT03984526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5564274|NCT03984526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564275|NCT03984526|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5564276|NCT03984526|Respiratory System Agents|respiratory system agents|mesh-ancestor
5564277|NCT03984526|Mydriatics|mydriatics|mesh-ancestor
5564278|NCT03984526|Parasympatholytics|parasympatholytics|mesh-ancestor
5564279|NCT03984526|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5564280|NCT03984526|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6166231|NCT01582061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6166232|NCT01582061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166233|NCT01582152|Bevacizumab|bevacizumab|mesh-list
6166234|NCT01582152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6166235|NCT01582152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6166236|NCT01582152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6166237|NCT01582152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6166238|NCT01582152|Growth Substances|growth substances|mesh-ancestor
6669079|NCT01536054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6669080|NCT01536054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6669081|NCT01536054|Antifungal Agents|antifungal agents|mesh-ancestor
6483294|NCT00556257|Cyclosporine|cyclosporine|mesh-list
6483295|NCT00556257|Cyclosporins|cyclosporins|mesh-list
6483296|NCT00556257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6483297|NCT00556257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483298|NCT00556257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6483299|NCT00556257|Immunologic Factors|immunologic factors|mesh-ancestor
6483300|NCT00556257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166239|NCT01582152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166240|NCT01582152|Growth Inhibitors|growth inhibitors|mesh-ancestor
6206186|NCT02097238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6206187|NCT02097303|Prednisone|prednisone|mesh-list
5564281|NCT03984526|Cholinergic Agents|cholinergic agents|mesh-ancestor
5564282|NCT03984526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5564283|NCT03984526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564284|NCT03984526|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5564285|NCT03984526|Sympathomimetics|sympathomimetics|mesh-ancestor
5564286|NCT03984526|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5564287|NCT03984526|Adrenergic Agents|adrenergic agents|mesh-ancestor
6206188|NCT02097303|Abiraterone Acetate|abiraterone acetate|mesh-list
6206189|NCT02097303|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
6206190|NCT02097303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6206191|NCT02097303|Glucocorticoids|glucocorticoids|mesh-ancestor
5564288|NCT03984188|Theophylline|theophylline|mesh-list
5564289|NCT03984188|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5564290|NCT03984188|Autonomic Agents|autonomic agents|mesh-ancestor
5564291|NCT03984188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5564292|NCT03984188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564293|NCT03984188|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5564294|NCT03984188|Respiratory System Agents|respiratory system agents|mesh-ancestor
5564295|NCT03984188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5564296|NCT03984188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5564297|NCT03984188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206192|NCT02097303|Hormones|hormones|mesh-ancestor
6206193|NCT02097303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6206194|NCT02097303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206195|NCT02097303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6206196|NCT02097303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6206197|NCT02097303|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6206198|NCT02097303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6206199|NCT02097303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206200|NCT02097303|Hormone Antagonists|hormone antagonists|mesh-ancestor
6206201|NCT02097303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6206202|NCT02097472|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6206203|NCT02097472|Immunologic Factors|immunologic factors|mesh-ancestor
6483301|NCT00556257|Antifungal Agents|antifungal agents|mesh-ancestor
6166241|NCT01582243|Vildagliptin|vildagliptin|mesh-list
6166242|NCT01582243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6166243|NCT01582243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166244|NCT01582243|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6166245|NCT01582243|Protease Inhibitors|protease inhibitors|mesh-ancestor
6166246|NCT01582243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6166247|NCT01582243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166248|NCT01582282|Psyllium|psyllium|mesh-list
6483302|NCT00556257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6483303|NCT00556257|Dermatologic Agents|dermatologic agents|mesh-ancestor
6483304|NCT00556257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6483305|NCT00556257|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6483306|NCT00556270|Fentanyl|fentanyl|mesh-list
6483307|NCT00556270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6483308|NCT00556270|Narcotics|narcotics|mesh-ancestor
6166249|NCT01582282|Calcium polycarbophil|calcium polycarbophil|mesh-list
6166250|NCT01582282|Cathartics|cathartics|mesh-ancestor
6166251|NCT01582282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6166252|NCT01582282|Antidiarrheals|antidiarrheals|mesh-ancestor
6166253|NCT01582308|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6166254|NCT01582308|Saxagliptin|saxagliptin|mesh-list
6166255|NCT01582308|Vildagliptin|vildagliptin|mesh-list
6166256|NCT01582308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5564298|NCT03984188|Vasodilator Agents|vasodilator agents|mesh-ancestor
5564299|NCT03984188|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5564300|NCT03984188|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5564301|NCT03984188|Purinergic Agents|purinergic agents|mesh-ancestor
5564302|NCT03984188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5564303|NCT03984409|Potassium Citrate|potassium citrate|mesh-list
5564304|NCT03984409|Diuretics|diuretics|mesh-ancestor
5564305|NCT03984409|Natriuretic Agents|natriuretic agents|mesh-ancestor
5564306|NCT03984409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564307|NCT03984409|Expectorants|expectorants|mesh-ancestor
5564308|NCT03984409|Respiratory System Agents|respiratory system agents|mesh-ancestor
5564309|NCT03984110|Dexamethasone|dexamethasone|mesh-list
5564310|NCT03984110|Aflibercept|aflibercept|mesh-list
5564311|NCT03984110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5564312|NCT03984110|Antiemetics|antiemetics|mesh-ancestor
5564313|NCT03984110|Autonomic Agents|autonomic agents|mesh-ancestor
5564314|NCT03984110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6483309|NCT00556270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6483310|NCT00556270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483311|NCT00556270|Analgesics|analgesics|mesh-ancestor
6483312|NCT00556270|Sensory System Agents|sensory system agents|mesh-ancestor
6483313|NCT00556270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6483314|NCT00556270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6483315|NCT00556270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6483316|NCT00556270|Anesthetics, General|anesthetics, general|mesh-ancestor
6166257|NCT01582308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166258|NCT01582308|Incretins|incretins|mesh-ancestor
6166259|NCT01582308|Hormones|hormones|mesh-ancestor
6669082|NCT01536054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6669083|NCT01536054|Immunologic Factors|immunologic factors|mesh-ancestor
6669084|NCT01536054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669085|NCT01536132|Simendan|simendan|mesh-list
6669086|NCT01536132|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6669087|NCT01536132|Vasodilator Agents|vasodilator agents|mesh-ancestor
6669088|NCT01536132|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6166260|NCT01582308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6166261|NCT01582308|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6166262|NCT01582308|Protease Inhibitors|protease inhibitors|mesh-ancestor
6166263|NCT01582308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6166264|NCT01582308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166265|NCT01582451|Insulin|insulin|mesh-list
6166266|NCT01582451|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6166267|NCT01582451|Insulin Glargine|insulin glargine|mesh-list
6166268|NCT01582451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6166269|NCT01582451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166270|NCT01582477|Bupivacaine|bupivacaine|mesh-list
6166271|NCT01582477|Anesthetics, Local|anesthetics, local|mesh-ancestor
6166272|NCT01582477|Anesthetics|anesthetics|mesh-ancestor
6483317|NCT00556270|Anesthetics|anesthetics|mesh-ancestor
6483318|NCT00556296|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6483319|NCT00556296|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6483320|NCT00556296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564315|NCT03984110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166273|NCT01582477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6166274|NCT01582477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166275|NCT01582477|Sensory System Agents|sensory system agents|mesh-ancestor
6166276|NCT01582477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6166277|NCT01582490|Bupivacaine|bupivacaine|mesh-list
6166278|NCT01582490|Anesthetics, Local|anesthetics, local|mesh-ancestor
6166279|NCT01582490|Anesthetics|anesthetics|mesh-ancestor
6669089|NCT01536132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6669090|NCT01536132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5564316|NCT03984110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5564317|NCT03984110|Glucocorticoids|glucocorticoids|mesh-ancestor
5564318|NCT03984110|Hormones|hormones|mesh-ancestor
6166280|NCT01582490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6166281|NCT01582490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166282|NCT01582490|Sensory System Agents|sensory system agents|mesh-ancestor
6166283|NCT01582490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6166284|NCT01582854|Actovegin|actovegin|mesh-list
6166285|NCT01582854|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6166286|NCT01582854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166287|NCT01582854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6166288|NCT01582854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6166289|NCT01582854|Antioxidants|antioxidants|mesh-ancestor
6166290|NCT01582854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166291|NCT01582854|Protective Agents|protective agents|mesh-ancestor
6166292|NCT01582854|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6166293|NCT01582880|Riboflavin|riboflavin|mesh-list
6166294|NCT01582880|Vitamins|vitamins|mesh-ancestor
6166295|NCT01582880|Micronutrients|micronutrients|mesh-ancestor
6166296|NCT01582880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166297|NCT01582880|Vitamin B Complex|vitamin b complex|mesh-ancestor
6166298|NCT01582880|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6166299|NCT01582880|Dermatologic Agents|dermatologic agents|mesh-ancestor
6166300|NCT01582945|Ketamine|ketamine|mesh-list
6166301|NCT01582945|Analgesics|analgesics|mesh-ancestor
6166302|NCT01582945|Sensory System Agents|sensory system agents|mesh-ancestor
6166303|NCT01582945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6166304|NCT01582945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166305|NCT01582945|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6166306|NCT01582945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6166307|NCT01582945|Anesthetics, General|anesthetics, general|mesh-ancestor
6166308|NCT01582945|Anesthetics|anesthetics|mesh-ancestor
6166309|NCT01582945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6166310|NCT01582945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6166311|NCT01582945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6166312|NCT01582945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6166313|NCT01582945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483321|NCT00556296|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6483322|NCT00556296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6483323|NCT00556296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6483324|NCT00556296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483325|NCT00556296|Dopamine Agents|dopamine agents|mesh-ancestor
6483326|NCT00556296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6483327|NCT00556348|Bevacizumab|bevacizumab|mesh-list
5564319|NCT03984110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5564320|NCT03984110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5564321|NCT03984110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5564322|NCT03984110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5564323|NCT03984110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5564324|NCT03984110|Growth Substances|growth substances|mesh-ancestor
5564325|NCT03984110|Growth Inhibitors|growth inhibitors|mesh-ancestor
5564326|NCT03984240|Midazolam|midazolam|mesh-list
5564327|NCT03984240|Dexmedetomidine|dexmedetomidine|mesh-list
5564328|NCT03984240|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5564329|NCT03984240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5564330|NCT03984240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564331|NCT03984240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5564332|NCT03984240|Analgesics|analgesics|mesh-ancestor
5564333|NCT03984240|Sensory System Agents|sensory system agents|mesh-ancestor
5564334|NCT03984240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5564335|NCT03984240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5564336|NCT03984240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5564337|NCT03984240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6483328|NCT00556348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6483329|NCT00556348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6483330|NCT00556348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6166314|NCT01583166|Epinephrine|epinephrine|mesh-list
6166315|NCT01583166|Bupivacaine|bupivacaine|mesh-list
6166316|NCT01583166|Anesthetics, Local|anesthetics, local|mesh-ancestor
6483331|NCT00556348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6483332|NCT00556348|Growth Substances|growth substances|mesh-ancestor
6483333|NCT00556348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483334|NCT00556348|Growth Inhibitors|growth inhibitors|mesh-ancestor
6483335|NCT00556361|Ketamine|ketamine|mesh-list
6483336|NCT00556361|Analgesics|analgesics|mesh-ancestor
6483337|NCT00556361|Sensory System Agents|sensory system agents|mesh-ancestor
6483338|NCT00556361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6166317|NCT01583166|Anesthetics|anesthetics|mesh-ancestor
6166318|NCT01583166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6166319|NCT01583166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166320|NCT01583166|Sensory System Agents|sensory system agents|mesh-ancestor
6166321|NCT01583166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6166322|NCT01583166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5564338|NCT03984240|Adrenergic Agents|adrenergic agents|mesh-ancestor
5564339|NCT03984240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5564340|NCT03984240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564341|NCT03984240|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5564342|NCT03984240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5564343|NCT03984240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5564344|NCT03984240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5564345|NCT03984240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5564346|NCT03984240|Anesthetics, General|anesthetics, general|mesh-ancestor
5564347|NCT03984240|Anesthetics|anesthetics|mesh-ancestor
5564348|NCT03984240|GABA Modulators|gaba modulators|mesh-ancestor
5564349|NCT03984240|GABA Agents|gaba agents|mesh-ancestor
5564350|NCT03984357|Gemcitabine|gemcitabine|mesh-list
5564351|NCT03984357|Antibodies|antibodies|mesh-list
5564352|NCT03984357|Antibodies, Blocking|antibodies, blocking|mesh-list
5564353|NCT03984357|Immunologic Factors|immunologic factors|mesh-ancestor
5564354|NCT03984357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564355|NCT03984357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5564356|NCT03984357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6166323|NCT01583166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6166324|NCT01583166|Adrenergic Agents|adrenergic agents|mesh-ancestor
6166325|NCT01583166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6166326|NCT01583166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166327|NCT01583166|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6483339|NCT00556361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483340|NCT00556361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6483341|NCT00556361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6483342|NCT00556361|Anesthetics, General|anesthetics, general|mesh-ancestor
6483343|NCT00556361|Anesthetics|anesthetics|mesh-ancestor
6483344|NCT00556361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6483345|NCT00556361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6483346|NCT00556361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6166328|NCT01583166|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6166329|NCT01583166|Autonomic Agents|autonomic agents|mesh-ancestor
6166330|NCT01583166|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6166331|NCT01583166|Respiratory System Agents|respiratory system agents|mesh-ancestor
6166332|NCT01583166|Mydriatics|mydriatics|mesh-ancestor
6166333|NCT01583166|Sympathomimetics|sympathomimetics|mesh-ancestor
6166334|NCT01583166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6166335|NCT01583179|Buprenorphine|buprenorphine|mesh-list
6166336|NCT01583179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6166337|NCT01583179|Narcotics|narcotics|mesh-ancestor
6166338|NCT01583179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6166339|NCT01583179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166340|NCT01583179|Analgesics|analgesics|mesh-ancestor
6166341|NCT01583179|Sensory System Agents|sensory system agents|mesh-ancestor
6166342|NCT01583179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6483347|NCT00556361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6483348|NCT00556361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483349|NCT00556387|Ketamine|ketamine|mesh-list
6483350|NCT00556387|Analgesics|analgesics|mesh-ancestor
6483351|NCT00556387|Sensory System Agents|sensory system agents|mesh-ancestor
6672470|NCT01556334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6166343|NCT01583179|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6166344|NCT01583218|Enoxaparin|enoxaparin|mesh-list
6166345|NCT01583218|Betrixaban|betrixaban|mesh-list
5564357|NCT03984357|Antimetabolites|antimetabolites|mesh-ancestor
5603800|NCT01332266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6166346|NCT01583218|Anticoagulants|anticoagulants|mesh-ancestor
6483352|NCT00556387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6166347|NCT01583218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6166348|NCT01583218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6166349|NCT01583218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166350|NCT01583218|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6166351|NCT01583218|Antithrombins|antithrombins|mesh-ancestor
6166352|NCT01583218|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6166353|NCT01583218|Protease Inhibitors|protease inhibitors|mesh-ancestor
6166354|NCT01583218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6166355|NCT01583374|Thalidomide|thalidomide|mesh-list
6166356|NCT01583374|Apremilast|apremilast|mesh-list
6166357|NCT01583374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6166358|NCT01583374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5564358|NCT03984357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564359|NCT03984357|Antiviral Agents|antiviral agents|mesh-ancestor
5564360|NCT03984357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5564361|NCT03984357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5564362|NCT03984357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5564363|NCT03984097|Dexamethasone|dexamethasone|mesh-list
5564364|NCT03984097|Lenalidomide|lenalidomide|mesh-list
5564365|NCT03984097|Bortezomib|bortezomib|mesh-list
5564366|NCT03984097|Pomalidomide|pomalidomide|mesh-list
5564367|NCT03984097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5564368|NCT03984097|Antiemetics|antiemetics|mesh-ancestor
5564369|NCT03984097|Autonomic Agents|autonomic agents|mesh-ancestor
5564370|NCT03984097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5564371|NCT03984097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166359|NCT01583374|Analgesics|analgesics|mesh-ancestor
6166360|NCT01583374|Sensory System Agents|sensory system agents|mesh-ancestor
6483353|NCT00556387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483354|NCT00556387|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6483355|NCT00556387|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6483356|NCT00556387|Anesthetics, General|anesthetics, general|mesh-ancestor
6483357|NCT00556387|Anesthetics|anesthetics|mesh-ancestor
6483358|NCT00556387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6483359|NCT00556387|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6483360|NCT00556387|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6483361|NCT00556387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6483362|NCT00556387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483363|NCT00556413|Leucovorin|leucovorin|mesh-list
6483364|NCT00556413|Fluorouracil|fluorouracil|mesh-list
6166361|NCT01583374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6166362|NCT01583374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166363|NCT01583374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6483365|NCT00556413|Oxaliplatin|oxaliplatin|mesh-list
6483366|NCT00556413|Irinotecan|irinotecan|mesh-list
6483367|NCT00556413|Cetuximab|cetuximab|mesh-list
6483368|NCT00556413|Calcium|calcium|mesh-list
6483369|NCT00556413|Levoleucovorin|levoleucovorin|mesh-list
6483370|NCT00556413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6166364|NCT01583374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6166365|NCT01583374|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6166366|NCT01583374|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6166367|NCT01583374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6166368|NCT01583374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166369|NCT01583374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6166370|NCT01583374|Immunologic Factors|immunologic factors|mesh-ancestor
6166371|NCT01583374|Leprostatic Agents|leprostatic agents|mesh-ancestor
6166372|NCT01583374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6166373|NCT01583374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6166374|NCT01583374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6166375|NCT01583374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6166376|NCT01583374|Growth Substances|growth substances|mesh-ancestor
6166377|NCT01583374|Growth Inhibitors|growth inhibitors|mesh-ancestor
6166378|NCT01583374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6166379|NCT01583530|Belimumab|belimumab|mesh-list
6166380|NCT01583530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6166381|NCT01583530|Immunologic Factors|immunologic factors|mesh-ancestor
6166382|NCT01583530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672471|NCT01556334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5564372|NCT03984097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5564373|NCT03984097|Glucocorticoids|glucocorticoids|mesh-ancestor
5564374|NCT03984097|Hormones|hormones|mesh-ancestor
5564375|NCT03984097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5564376|NCT03984097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5564377|NCT03984097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5564378|NCT03984097|Immunologic Factors|immunologic factors|mesh-ancestor
6669091|NCT01536132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669092|NCT01536132|Protective Agents|protective agents|mesh-ancestor
6669093|NCT01536132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669094|NCT01536158|Acetaminophen|acetaminophen|mesh-list
6669095|NCT01536158|Ibuprofen|ibuprofen|mesh-list
6669096|NCT01536158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6669097|NCT01536158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6669098|NCT01536158|Analgesics|analgesics|mesh-ancestor
6166383|NCT01583543|Olaparib|olaparib|mesh-list
6166384|NCT01583543|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6166385|NCT01583543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6166386|NCT01583543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166387|NCT01583543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6166388|NCT01583686|Aldesleukin|aldesleukin|mesh-list
6166389|NCT01583686|Cyclophosphamide|cyclophosphamide|mesh-list
6166390|NCT01583686|Fludarabine|fludarabine|mesh-list
6166391|NCT01583686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6669099|NCT01536158|Sensory System Agents|sensory system agents|mesh-ancestor
6669100|NCT01536158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6669101|NCT01536158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669102|NCT01536158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6669103|NCT01536158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6669104|NCT01536158|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6669105|NCT01536158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6166392|NCT01583686|Immunologic Factors|immunologic factors|mesh-ancestor
6166393|NCT01583686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166394|NCT01583686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5564379|NCT03984097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5564380|NCT03984097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5564381|NCT03984097|Growth Substances|growth substances|mesh-ancestor
5564382|NCT03984097|Growth Inhibitors|growth inhibitors|mesh-ancestor
5564383|NCT03983954|Durvalumab|durvalumab|mesh-list
5564384|NCT03983954|Obinutuzumab|obinutuzumab|mesh-list
5564385|NCT03983954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5564386|NCT03983954|Immunoconjugates|immunoconjugates|mesh-list
5564387|NCT03983954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5564388|NCT03983954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5564389|NCT03983954|Immunologic Factors|immunologic factors|mesh-ancestor
5564390|NCT03983954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603801|NCT01332266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5603802|NCT01328808|Acetaminophen|acetaminophen|mesh-list
5603803|NCT01328808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5603804|NCT01328808|Analgesics|analgesics|mesh-ancestor
5603805|NCT01328808|Sensory System Agents|sensory system agents|mesh-ancestor
5603806|NCT01328808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5603807|NCT01328808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603808|NCT01328808|Antipyretics|antipyretics|mesh-ancestor
5603809|NCT01261728|Gemcitabine|gemcitabine|mesh-list
5603810|NCT01261728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5603811|NCT01261728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5603812|NCT01261728|Antimetabolites|antimetabolites|mesh-ancestor
5603813|NCT01261728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166395|NCT01583686|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6166396|NCT01583686|Alkylating Agents|alkylating agents|mesh-ancestor
6166397|NCT01583686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166398|NCT01583686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6166399|NCT01583686|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6166400|NCT01583686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6166401|NCT01583686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6166402|NCT01583686|Antiviral Agents|antiviral agents|mesh-ancestor
6166403|NCT01583686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5603814|NCT01261728|Antiviral Agents|antiviral agents|mesh-ancestor
6166404|NCT01583985|Analgesics, Opioid|analgesics, opioid|mesh-list
6166405|NCT01583985|Narcotics|narcotics|mesh-ancestor
6166406|NCT01583985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6166407|NCT01583985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166408|NCT01583985|Analgesics|analgesics|mesh-ancestor
6166409|NCT01583985|Sensory System Agents|sensory system agents|mesh-ancestor
6166410|NCT01583985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6166411|NCT01584232|Insulin Glargine|insulin glargine|mesh-list
6166412|NCT01584232|Dulaglutide|dulaglutide|mesh-list
6166413|NCT01584232|Biguanides|biguanides|mesh-list
6166414|NCT01584232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6166415|NCT01584232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166416|NCT01584388|Rituximab|rituximab|mesh-list
6166417|NCT01584388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6166418|NCT01584388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6166419|NCT01584388|Immunologic Factors|immunologic factors|mesh-ancestor
6166420|NCT01584388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166421|NCT01584388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6166422|NCT01584440|Quinidine|quinidine|mesh-list
6166423|NCT01584440|Dextromethorphan|dextromethorphan|mesh-list
6166424|NCT01584440|Antitussive Agents|antitussive agents|mesh-ancestor
6166425|NCT01584440|Respiratory System Agents|respiratory system agents|mesh-ancestor
6166426|NCT01584440|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6166427|NCT01584440|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5564391|NCT03983876|Adalimumab|adalimumab|mesh-list
5564392|NCT03983876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5564393|NCT03983876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5564394|NCT03983889|Fentanyl|fentanyl|mesh-list
5564395|NCT03983889|Midazolam|midazolam|mesh-list
6166428|NCT01584440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6166429|NCT01584440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166430|NCT01584440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564396|NCT03983889|Dexmedetomidine|dexmedetomidine|mesh-list
5564397|NCT03983889|Remifentanil|remifentanil|mesh-list
5564398|NCT03983889|Propofol|propofol|mesh-list
5564399|NCT03983889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5564400|NCT03983889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5564401|NCT03983889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564402|NCT03983889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5564403|NCT03983889|Anesthetics, General|anesthetics, general|mesh-ancestor
5564404|NCT03983889|Anesthetics|anesthetics|mesh-ancestor
5564405|NCT03983889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5564406|NCT03983889|Analgesics|analgesics|mesh-ancestor
5564407|NCT03983889|Sensory System Agents|sensory system agents|mesh-ancestor
5564408|NCT03983889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5564409|NCT03983889|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5564410|NCT03983889|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5564411|NCT03983889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5564412|NCT03983889|Adrenergic Agents|adrenergic agents|mesh-ancestor
5564413|NCT03983889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5564414|NCT03983889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564415|NCT03983889|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5564416|NCT03983889|Narcotics|narcotics|mesh-ancestor
5564417|NCT03983889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5564418|NCT03983889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5564419|NCT03983889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5564420|NCT03983889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5564421|NCT03983889|GABA Modulators|gaba modulators|mesh-ancestor
5564422|NCT03983889|GABA Agents|gaba agents|mesh-ancestor
5564423|NCT03983915|Dexmedetomidine|dexmedetomidine|mesh-list
5564424|NCT03983915|Remifentanil|remifentanil|mesh-list
5564425|NCT03983915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5564426|NCT03983915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5564427|NCT03983915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166431|NCT01584440|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6166432|NCT01584440|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6166433|NCT01584440|Adrenergic Agents|adrenergic agents|mesh-ancestor
6166434|NCT01584440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6166435|NCT01584440|Antimalarials|antimalarials|mesh-ancestor
6166436|NCT01584440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6166437|NCT01584440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6166438|NCT01584440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6166439|NCT01584440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5564428|NCT03983915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5564429|NCT03983915|Analgesics|analgesics|mesh-ancestor
5564430|NCT03983915|Sensory System Agents|sensory system agents|mesh-ancestor
5564431|NCT03983915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6166440|NCT01584440|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6166441|NCT01584440|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6166442|NCT01584440|Cholinergic Agents|cholinergic agents|mesh-ancestor
6166443|NCT01584440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5564432|NCT03983915|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5564433|NCT03983915|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5564434|NCT03983915|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5564435|NCT03983915|Adrenergic Agents|adrenergic agents|mesh-ancestor
5564436|NCT03983915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5564437|NCT03983915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564438|NCT03983915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5564439|NCT03983915|Narcotics|narcotics|mesh-ancestor
5564440|NCT03983551|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
5564441|NCT03983551|Protease Inhibitors|protease inhibitors|mesh-ancestor
6166444|NCT01584440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6166445|NCT01584440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6166446|NCT01584440|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6166447|NCT01584440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6166448|NCT01584518|Furosemide|furosemide|mesh-list
6166449|NCT01584518|Diuretics|diuretics|mesh-ancestor
6166450|NCT01584518|Natriuretic Agents|natriuretic agents|mesh-ancestor
6166451|NCT01584518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166452|NCT01584518|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6166453|NCT01584518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6166454|NCT01584518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166455|NCT01584544|Capecitabine|capecitabine|mesh-list
6166456|NCT01584544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6166457|NCT01584544|Antimetabolites|antimetabolites|mesh-ancestor
6166458|NCT01584544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564442|NCT03983551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5564443|NCT03983551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564444|NCT03983551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5564445|NCT03983551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564446|NCT03983668|Pembrolizumab|pembrolizumab|mesh-list
5564447|NCT03983668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5564448|NCT03983668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5564449|NCT03983460|Betamethasone|betamethasone|mesh-list
5564450|NCT03983460|Betamethasone Valerate|betamethasone valerate|mesh-list
5564451|NCT03983460|Clobetasol|clobetasol|mesh-list
5564452|NCT03983460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5564453|NCT03983460|Glucocorticoids|glucocorticoids|mesh-ancestor
5564454|NCT03983460|Hormones|hormones|mesh-ancestor
6166459|NCT01584544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6166460|NCT01584648|Trametinib|trametinib|mesh-list
6166461|NCT01584648|Dabrafenib|dabrafenib|mesh-list
6166462|NCT01584648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5564455|NCT03983460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5564456|NCT03983460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564457|NCT03983460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5564458|NCT03983460|Respiratory System Agents|respiratory system agents|mesh-ancestor
5564459|NCT03983239|Efavirenz|efavirenz|mesh-list
5564460|NCT03983239|Rifampin|rifampin|mesh-list
5564461|NCT03983239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5564462|NCT03983239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5564463|NCT03983239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5564464|NCT03983239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166463|NCT01584648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6166464|NCT01584648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6166465|NCT01584648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166466|NCT01584843|Botulinum Toxins|botulinum toxins|mesh-list
6166467|NCT01584843|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6166468|NCT01584843|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6166469|NCT01584843|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6166470|NCT01584843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6166471|NCT01584843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166472|NCT01584843|Cholinergic Agents|cholinergic agents|mesh-ancestor
6166473|NCT01584843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6166474|NCT01584843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166475|NCT01584843|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6166476|NCT01584843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6483371|NCT00556413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483372|NCT00556413|Antimetabolites|antimetabolites|mesh-ancestor
6483373|NCT00556413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483374|NCT00556413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6166477|NCT01585025|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
6166478|NCT01585025|Cathartics|cathartics|mesh-ancestor
6166479|NCT01585025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6166480|NCT01585038|Efavirenz|efavirenz|mesh-list
6166481|NCT01585038|Rilpivirine|rilpivirine|mesh-list
5564465|NCT03983239|Antiviral Agents|antiviral agents|mesh-ancestor
5564466|NCT03983239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5564467|NCT03983239|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5564468|NCT03983239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5564469|NCT03983239|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5564470|NCT03983239|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5564471|NCT03983239|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5564472|NCT03983239|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5564473|NCT03983239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5564474|NCT03983239|Antitubercular Agents|antitubercular agents|mesh-ancestor
5564475|NCT03983239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5564476|NCT03983239|Leprostatic Agents|leprostatic agents|mesh-ancestor
5564477|NCT03983239|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5564478|NCT03983239|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5564479|NCT03983239|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5564480|NCT03983226|Gemcitabine|gemcitabine|mesh-list
5564481|NCT03983226|Carboplatin|carboplatin|mesh-list
5564482|NCT03983226|Doxorubicin|doxorubicin|mesh-list
5564483|NCT03983226|Niraparib|niraparib|mesh-list
5564484|NCT03983226|Taxane|taxane|mesh-list
5564485|NCT03983226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6166482|NCT01585038|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6166483|NCT01585038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6166484|NCT01585038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6166485|NCT01585038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166486|NCT01585038|Antiviral Agents|antiviral agents|mesh-ancestor
6483375|NCT00556413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6483376|NCT00556413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6483377|NCT00556413|Immunologic Factors|immunologic factors|mesh-ancestor
6483378|NCT00556413|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6483379|NCT00556413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6483380|NCT00556413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6483381|NCT00556413|Antidotes|antidotes|mesh-ancestor
6483382|NCT00556413|Protective Agents|protective agents|mesh-ancestor
6483383|NCT00556413|Vitamin B Complex|vitamin b complex|mesh-ancestor
6483384|NCT00556413|Vitamins|vitamins|mesh-ancestor
6483385|NCT00556413|Micronutrients|micronutrients|mesh-ancestor
6483386|NCT00556413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6483387|NCT00556465|Acetylcysteine|acetylcysteine|mesh-list
6483388|NCT00556465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6483389|NCT00556465|Antiviral Agents|antiviral agents|mesh-ancestor
6483390|NCT00556465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6483391|NCT00556465|Expectorants|expectorants|mesh-ancestor
6483392|NCT00556465|Respiratory System Agents|respiratory system agents|mesh-ancestor
6483393|NCT00556465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6483394|NCT00556465|Antioxidants|antioxidants|mesh-ancestor
6483395|NCT00556465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483396|NCT00556465|Protective Agents|protective agents|mesh-ancestor
6483397|NCT00556465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483398|NCT00556465|Antidotes|antidotes|mesh-ancestor
6483399|NCT00556608|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6483400|NCT00556608|Hyaluronic Acid|hyaluronic acid|mesh-list
6483401|NCT00556608|Hylan|hylan|mesh-list
6483402|NCT00556608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6483403|NCT00556608|Immunologic Factors|immunologic factors|mesh-ancestor
6483404|NCT00556608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483405|NCT00556608|Viscosupplements|viscosupplements|mesh-ancestor
6483406|NCT00556608|Protective Agents|protective agents|mesh-ancestor
6483407|NCT00556621|Gemcitabine|gemcitabine|mesh-list
6483408|NCT00556621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6483409|NCT00556621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6483410|NCT00556621|Antimetabolites|antimetabolites|mesh-ancestor
6483411|NCT00556621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483412|NCT00556621|Antiviral Agents|antiviral agents|mesh-ancestor
6483413|NCT00556621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6483414|NCT00556621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6483415|NCT00556621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5564486|NCT03983226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5564487|NCT03983226|Antimetabolites|antimetabolites|mesh-ancestor
5564488|NCT03983226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564489|NCT03983226|Antiviral Agents|antiviral agents|mesh-ancestor
6483416|NCT00556621|Immunologic Factors|immunologic factors|mesh-ancestor
6483417|NCT00556621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483418|NCT00556634|Efavirenz|efavirenz|mesh-list
6483419|NCT00556634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6483420|NCT00556634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5564490|NCT03983226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5564491|NCT03983226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5564492|NCT03983226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5564493|NCT03983226|Immunologic Factors|immunologic factors|mesh-ancestor
5564494|NCT03983226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564495|NCT03983226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5564496|NCT03983226|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5564497|NCT03983226|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5564498|NCT03983226|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5564499|NCT03982992|Blinatumomab|blinatumomab|mesh-list
5564500|NCT03982992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5564501|NCT03983031|Rituximab|rituximab|mesh-list
5564502|NCT03983031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5564503|NCT03983031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5564504|NCT03983031|Immunologic Factors|immunologic factors|mesh-ancestor
5564505|NCT03983031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564506|NCT03983031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5564507|NCT03983057|Antibodies|antibodies|mesh-list
5564508|NCT03983057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5564509|NCT03983057|Immunologic Factors|immunologic factors|mesh-ancestor
5564510|NCT03983057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564511|NCT03983018|Rituximab|rituximab|mesh-list
5564512|NCT03983018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5564513|NCT03983018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5564514|NCT03983018|Immunologic Factors|immunologic factors|mesh-ancestor
5564515|NCT03983018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564516|NCT03983018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5564517|NCT03982862|Triamcinolone|triamcinolone|mesh-list
5564518|NCT03982862|Lidocaine|lidocaine|mesh-list
5564519|NCT03982862|Botulinum Toxins|botulinum toxins|mesh-list
5564520|NCT03982862|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5564521|NCT03982862|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5564522|NCT03982862|Anesthetics, Local|anesthetics, local|mesh-ancestor
5564523|NCT03982862|Anesthetics|anesthetics|mesh-ancestor
6483421|NCT00556634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6483422|NCT00556634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483423|NCT00556634|Antiviral Agents|antiviral agents|mesh-ancestor
6483424|NCT00556634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6166487|NCT01585038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6166488|NCT01585038|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6166489|NCT01585038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6166490|NCT01585038|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6166491|NCT01585038|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6166492|NCT01585038|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5564524|NCT03982862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5564525|NCT03982862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564526|NCT03982862|Sensory System Agents|sensory system agents|mesh-ancestor
6166493|NCT01585038|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6166494|NCT01585038|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6166495|NCT01585038|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6166496|NCT01585129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6166497|NCT01585129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6166498|NCT01585129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6166499|NCT01585129|Antitubercular Agents|antitubercular agents|mesh-ancestor
6166500|NCT01585168|Memantine|memantine|mesh-list
6166501|NCT01585168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6166502|NCT01585168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6166503|NCT01585168|Dopamine Agents|dopamine agents|mesh-ancestor
6166504|NCT01585168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6166505|NCT01585168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166506|NCT01585168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483425|NCT00556634|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6483426|NCT00556634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6483427|NCT00556634|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5564527|NCT03982862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5564528|NCT03982862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5564529|NCT03982862|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5564530|NCT03982862|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5564531|NCT03982862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5564532|NCT03982862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564533|NCT03982862|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5564534|NCT03982862|Cholinergic Agents|cholinergic agents|mesh-ancestor
5564535|NCT03982862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5564536|NCT03982862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6166507|NCT01585168|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6166508|NCT01585168|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6166509|NCT01585194|Nivolumab|nivolumab|mesh-list
6166510|NCT01585194|Ipilimumab|ipilimumab|mesh-list
6166511|NCT01585194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6166512|NCT01585194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6166513|NCT01585194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6166514|NCT01585194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166515|NCT01585207|Vigabatrin|vigabatrin|mesh-list
6166516|NCT01585207|Anticonvulsants|anticonvulsants|mesh-ancestor
6166517|NCT01585207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6166518|NCT01585207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166519|NCT01585207|GABA Agents|gaba agents|mesh-ancestor
6166520|NCT01585207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6166521|NCT01585207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166522|NCT01585246|Saw palmetto extract|saw palmetto extract|mesh-list
6166523|NCT01585246|Urological Agents|urological agents|mesh-ancestor
6166524|NCT01585272|Rivastigmine|rivastigmine|mesh-list
6166525|NCT01585272|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6166526|NCT01585272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6166527|NCT01585272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166528|NCT01585272|Cholinergic Agents|cholinergic agents|mesh-ancestor
6166529|NCT01585272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6166530|NCT01585272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166531|NCT01585272|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6166532|NCT01585272|Protective Agents|protective agents|mesh-ancestor
6166533|NCT01585298|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6166534|NCT01585298|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6166535|NCT01585298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166536|NCT01585298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6166537|NCT01585298|Immunologic Factors|immunologic factors|mesh-ancestor
6166538|NCT01585298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166539|NCT01585324|Ribavirin|ribavirin|mesh-list
6166540|NCT01585324|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6166541|NCT01585324|Antimetabolites|antimetabolites|mesh-ancestor
6166542|NCT01585324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166543|NCT01585324|Antiviral Agents|antiviral agents|mesh-ancestor
6166544|NCT01585324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6166545|NCT01585428|Aldesleukin|aldesleukin|mesh-list
6166546|NCT01585428|Cyclophosphamide|cyclophosphamide|mesh-list
6166547|NCT01585428|Fludarabine|fludarabine|mesh-list
6166548|NCT01585428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6166549|NCT01585428|Immunologic Factors|immunologic factors|mesh-ancestor
6166550|NCT01585428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166551|NCT01585428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6166552|NCT01585428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6166553|NCT01585428|Alkylating Agents|alkylating agents|mesh-ancestor
6166554|NCT01585428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166555|NCT01585428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6166556|NCT01585428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6166557|NCT01585428|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6166558|NCT01585428|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6166559|NCT01585428|Antiviral Agents|antiviral agents|mesh-ancestor
5564537|NCT03982862|Glucocorticoids|glucocorticoids|mesh-ancestor
5564538|NCT03982862|Hormones|hormones|mesh-ancestor
6166560|NCT01585428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6166561|NCT01585441|Finasteride|finasteride|mesh-list
6166562|NCT01585441|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6166563|NCT01585441|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6166564|NCT01585441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6669106|NCT01536158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669107|NCT01536158|Antipyretics|antipyretics|mesh-ancestor
6669108|NCT01536223|Cisplatin|cisplatin|mesh-list
6669109|NCT01536223|Docetaxel|docetaxel|mesh-list
6669110|NCT01536223|Fluorouracil|fluorouracil|mesh-list
6669111|NCT01536223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6483428|NCT00556634|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6166565|NCT01585441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166566|NCT01585441|Hormone Antagonists|hormone antagonists|mesh-ancestor
5564539|NCT03982862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5564540|NCT03982862|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5564541|NCT03982771|Cyclophosphamide|cyclophosphamide|mesh-list
5564542|NCT03982771|Bortezomib|bortezomib|mesh-list
5564543|NCT03982771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5564544|NCT03982771|Immunologic Factors|immunologic factors|mesh-ancestor
5564545|NCT03982771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166567|NCT01585441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6166568|NCT01585441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166569|NCT01585441|Urological Agents|urological agents|mesh-ancestor
6166570|NCT01585558|Tamoxifen|tamoxifen|mesh-list
6166571|NCT01585558|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6166572|NCT01585558|Hormone Antagonists|hormone antagonists|mesh-ancestor
6166573|NCT01585558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6166574|NCT01585558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166575|NCT01585558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6166576|NCT01585558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6166577|NCT01585558|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6166578|NCT01585558|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6166579|NCT01585558|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6166580|NCT01585584|Protease Inhibitors|protease inhibitors|mesh-list
6166581|NCT01585584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6166582|NCT01585584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166583|NCT01585831|Testosterone|testosterone|mesh-list
6166584|NCT01585831|Androgens|androgens|mesh-ancestor
6166585|NCT01585831|Hormones|hormones|mesh-ancestor
6166586|NCT01585831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6166587|NCT01585831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166588|NCT01585987|Ipilimumab|ipilimumab|mesh-list
6166589|NCT01585987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6166590|NCT01585987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6166591|NCT01585987|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6166592|NCT01585987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166593|NCT01586091|Fexofenadine|fexofenadine|mesh-list
6166594|NCT01586091|Levocetirizine|levocetirizine|mesh-list
6166595|NCT01586091|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6166596|NCT01586091|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6166597|NCT01586091|Histamine Antagonists|histamine antagonists|mesh-ancestor
6166598|NCT01586091|Histamine Agents|histamine agents|mesh-ancestor
6166599|NCT01586091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6166600|NCT01586091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166601|NCT01586091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166602|NCT01586091|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6166603|NCT01586156|Carvedilol|carvedilol|mesh-list
6166604|NCT01586156|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6166605|NCT01586156|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6166606|NCT01586156|Adrenergic Agents|adrenergic agents|mesh-ancestor
6166607|NCT01586156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6166608|NCT01586156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166609|NCT01586156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483429|NCT00556634|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6483430|NCT00556634|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6483431|NCT00556699|Rituximab|rituximab|mesh-list
6483432|NCT00556699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6483433|NCT00556699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6483434|NCT00556699|Immunologic Factors|immunologic factors|mesh-ancestor
6483435|NCT00556699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483436|NCT00556699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6488948|NCT00588003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669112|NCT01536223|Tubulin Modulators|tubulin modulators|mesh-ancestor
5564546|NCT03982771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6166610|NCT01586156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6166611|NCT01586156|Antioxidants|antioxidants|mesh-ancestor
6483437|NCT00556959|Clonidine|clonidine|mesh-list
6483438|NCT00556959|Analgesics|analgesics|mesh-ancestor
6483439|NCT00556959|Sensory System Agents|sensory system agents|mesh-ancestor
6483440|NCT00556959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6483441|NCT00556959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483442|NCT00556959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6483443|NCT00556959|Sympatholytics|sympatholytics|mesh-ancestor
6483444|NCT00556959|Autonomic Agents|autonomic agents|mesh-ancestor
6483445|NCT00556959|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6483446|NCT00556959|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6483447|NCT00556959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6483448|NCT00556959|Adrenergic Agents|adrenergic agents|mesh-ancestor
6483449|NCT00556959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6483450|NCT00556959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483451|NCT00557011|Amphetamine|amphetamine|mesh-list
6483452|NCT00557011|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6483453|NCT00557011|Adderall|adderall|mesh-list
6483454|NCT00557011|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6483455|NCT00557011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483456|NCT00557011|Sympathomimetics|sympathomimetics|mesh-ancestor
6483457|NCT00557011|Autonomic Agents|autonomic agents|mesh-ancestor
6483458|NCT00557011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6483459|NCT00557011|Dopamine Agents|dopamine agents|mesh-ancestor
6483460|NCT00557011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6166612|NCT01586156|Protective Agents|protective agents|mesh-ancestor
6166613|NCT01586156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6166614|NCT01586156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6166615|NCT01586156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6166616|NCT01586156|Vasodilator Agents|vasodilator agents|mesh-ancestor
6166617|NCT01586156|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6166618|NCT01586156|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6166619|NCT01586195|Vemurafenib|vemurafenib|mesh-list
6166620|NCT01586195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6166621|NCT01586195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6483461|NCT00557011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483462|NCT00557011|Adrenergic Agents|adrenergic agents|mesh-ancestor
6483463|NCT00557011|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6483464|NCT00557011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6483465|NCT00557011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6483466|NCT00557011|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6483467|NCT00557102|Leucovorin|leucovorin|mesh-list
6483468|NCT00557102|Fluorouracil|fluorouracil|mesh-list
6483469|NCT00557102|Irinotecan|irinotecan|mesh-list
6483470|NCT00557102|Cetuximab|cetuximab|mesh-list
6483471|NCT00557102|Calcium|calcium|mesh-list
6166622|NCT01586195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6166623|NCT01586195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166624|NCT01586312|Hyaluronic Acid|hyaluronic acid|mesh-list
6166625|NCT01586312|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6166626|NCT01586312|Immunologic Factors|immunologic factors|mesh-ancestor
6166627|NCT01586312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166628|NCT01586312|Viscosupplements|viscosupplements|mesh-ancestor
6166629|NCT01586312|Protective Agents|protective agents|mesh-ancestor
6669113|NCT01536223|Antimitotic Agents|antimitotic agents|mesh-ancestor
6669114|NCT01536223|Mitosis Modulators|mitosis modulators|mesh-ancestor
6669115|NCT01536223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669116|NCT01536223|Antimetabolites|antimetabolites|mesh-ancestor
6669117|NCT01536223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6166630|NCT01586338|Hylan|hylan|mesh-list
6166631|NCT01586338|Viscosupplements|viscosupplements|mesh-ancestor
6166632|NCT01586338|Protective Agents|protective agents|mesh-ancestor
6483472|NCT00557102|Levoleucovorin|levoleucovorin|mesh-list
6483473|NCT00557102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6483474|NCT00557102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483475|NCT00557102|Antimetabolites|antimetabolites|mesh-ancestor
6483476|NCT00557102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483477|NCT00557102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6483478|NCT00557102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6483479|NCT00557102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6483480|NCT00557102|Immunologic Factors|immunologic factors|mesh-ancestor
5564547|NCT03982771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5564548|NCT03982771|Alkylating Agents|alkylating agents|mesh-ancestor
5564549|NCT03982771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564550|NCT03982771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5564551|NCT03982771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5564552|NCT03982849|Silymarin|silymarin|mesh-list
5564553|NCT03982849|Hydroquinone|hydroquinone|mesh-list
5564554|NCT03982849|Antioxidants|antioxidants|mesh-ancestor
5564555|NCT03982849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564556|NCT03982849|Protective Agents|protective agents|mesh-ancestor
5564557|NCT03982849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564558|NCT03982849|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5564559|NCT03982810|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5564560|NCT03982810|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5564561|NCT03982810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5564562|NCT03982810|Antitubercular Agents|antitubercular agents|mesh-ancestor
5564563|NCT03982537|Acetylcysteine|acetylcysteine|mesh-list
5564564|NCT03982537|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5564565|NCT03982537|Antiviral Agents|antiviral agents|mesh-ancestor
5564566|NCT03982537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5564567|NCT03982537|Expectorants|expectorants|mesh-ancestor
5564568|NCT03982537|Respiratory System Agents|respiratory system agents|mesh-ancestor
5564569|NCT03982537|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5564570|NCT03982537|Antioxidants|antioxidants|mesh-ancestor
5564571|NCT03982537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564572|NCT03982537|Protective Agents|protective agents|mesh-ancestor
5564573|NCT03982537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564574|NCT03982537|Antidotes|antidotes|mesh-ancestor
5564575|NCT03982693|Edetic Acid|edetic acid|mesh-list
5564576|NCT03982693|Pentetic Acid|pentetic acid|mesh-list
5564577|NCT03982693|Anticoagulants|anticoagulants|mesh-ancestor
5564578|NCT03982693|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5564579|NCT03982693|Chelating Agents|chelating agents|mesh-ancestor
5564580|NCT03982693|Sequestering Agents|sequestering agents|mesh-ancestor
5564581|NCT03982693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564582|NCT03982693|Antidotes|antidotes|mesh-ancestor
5564583|NCT03982693|Protective Agents|protective agents|mesh-ancestor
5564584|NCT03982693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564585|NCT03982693|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5564586|NCT03982784|Morphine|morphine|mesh-list
5564587|NCT03982784|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5564588|NCT03982784|Narcotics|narcotics|mesh-ancestor
5564589|NCT03982784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5564590|NCT03982784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564591|NCT03982784|Analgesics|analgesics|mesh-ancestor
5564592|NCT03982784|Sensory System Agents|sensory system agents|mesh-ancestor
5564593|NCT03982784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5564594|NCT03982381|Metformin|metformin|mesh-list
6483481|NCT00557102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5564595|NCT03982381|Dapagliflozin|dapagliflozin|mesh-list
5564596|NCT03982381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5564597|NCT03982381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564598|NCT03982381|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5564599|NCT03982381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564600|NCT03982680|Gemcitabine|gemcitabine|mesh-list
5564601|NCT03982680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5564602|NCT03982680|Antimetabolites|antimetabolites|mesh-ancestor
5564603|NCT03982680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564604|NCT03982680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5564605|NCT03982680|Antiviral Agents|antiviral agents|mesh-ancestor
5564606|NCT03982680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5564607|NCT03982680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5564608|NCT03982680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5564609|NCT03982680|Immunologic Factors|immunologic factors|mesh-ancestor
5564610|NCT03982680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564611|NCT03982134|Panobinostat|panobinostat|mesh-list
5564612|NCT03982134|Spartalizumab|spartalizumab|mesh-list
5564613|NCT03982134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5564614|NCT03982134|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5564615|NCT03982134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5564616|NCT03982134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564617|NCT03982134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5603815|NCT01261728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5603816|NCT01261728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5603817|NCT01261728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5603818|NCT01261728|Immunologic Factors|immunologic factors|mesh-ancestor
5603819|NCT01261728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603820|NCT01222754|Lenalidomide|lenalidomide|mesh-list
5603821|NCT01222754|Immunologic Factors|immunologic factors|mesh-ancestor
5603822|NCT01222754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603823|NCT01222754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5603824|NCT01222754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5603825|NCT01222754|Growth Substances|growth substances|mesh-ancestor
5603826|NCT01222754|Growth Inhibitors|growth inhibitors|mesh-ancestor
5603827|NCT01222754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5603828|NCT01150890|Brodalumab|brodalumab|mesh-list
5603829|NCT01150890|Dermatologic Agents|dermatologic agents|mesh-ancestor
5603830|NCT01143779|Telbivudine|telbivudine|mesh-list
5603831|NCT01143779|Antiviral Agents|antiviral agents|mesh-ancestor
5603832|NCT01143779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5603833|NCT01143779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5603834|NCT01143779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5603835|NCT01143779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603836|NCT01140867|Zonisamide|zonisamide|mesh-list
5603837|NCT01140867|Anticonvulsants|anticonvulsants|mesh-ancestor
5603838|NCT01140867|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5603839|NCT01140867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6483482|NCT00557102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6483483|NCT00557102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6483484|NCT00557102|Antidotes|antidotes|mesh-ancestor
6483485|NCT00557102|Protective Agents|protective agents|mesh-ancestor
6483486|NCT00557102|Vitamin B Complex|vitamin b complex|mesh-ancestor
6483487|NCT00557102|Vitamins|vitamins|mesh-ancestor
5603840|NCT01140867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603841|NCT01140867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5603842|NCT01140867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603843|NCT01137773|Insulin|insulin|mesh-list
5603844|NCT01137773|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5603845|NCT01137773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5603846|NCT01137773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603847|NCT01127256|Carbamazepine|carbamazepine|mesh-list
5603848|NCT01127256|Zonisamide|zonisamide|mesh-list
5603849|NCT01127256|Anticonvulsants|anticonvulsants|mesh-ancestor
5603850|NCT01127256|Antimanic Agents|antimanic agents|mesh-ancestor
5603851|NCT01127256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5603852|NCT01127256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5603853|NCT01127256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603854|NCT01127256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5603855|NCT01127256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5603856|NCT01127256|Analgesics|analgesics|mesh-ancestor
5603857|NCT01127256|Sensory System Agents|sensory system agents|mesh-ancestor
5603858|NCT01127256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5603859|NCT01127256|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5603860|NCT01127256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5603861|NCT01127256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483488|NCT00557102|Micronutrients|micronutrients|mesh-ancestor
5564618|NCT03982277|Rifampin|rifampin|mesh-list
5564619|NCT03982277|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5564620|NCT03982277|Antitubercular Agents|antitubercular agents|mesh-ancestor
5564621|NCT03982277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5564622|NCT03982277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5564623|NCT03982277|Leprostatic Agents|leprostatic agents|mesh-ancestor
5564624|NCT03982277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5564625|NCT03982277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5564626|NCT03982277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564627|NCT03982277|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5564628|NCT03982277|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5564629|NCT03982277|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5564630|NCT03982277|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5564631|NCT03982277|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6483489|NCT00557102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6483490|NCT00557180|Beclomethasone|beclomethasone|mesh-list
6483491|NCT00557180|Bromides|bromides|mesh-list
6483492|NCT00557180|Tiotropium Bromide|tiotropium bromide|mesh-list
6166633|NCT01586338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166634|NCT01586806|Dexamethasone|dexamethasone|mesh-list
6166635|NCT01586806|Dexamethasone acetate|dexamethasone acetate|mesh-list
6166636|NCT01586806|Bupivacaine|bupivacaine|mesh-list
6166637|NCT01586806|BB 1101|bb 1101|mesh-list
6166638|NCT01586806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6166639|NCT01586806|Antiemetics|antiemetics|mesh-ancestor
6166640|NCT01586806|Autonomic Agents|autonomic agents|mesh-ancestor
6166641|NCT01586806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6166642|NCT01586806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166643|NCT01586806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6166644|NCT01586806|Glucocorticoids|glucocorticoids|mesh-ancestor
6166645|NCT01586806|Hormones|hormones|mesh-ancestor
6483493|NCT00557180|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6483494|NCT00557180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6483495|NCT00557180|Autonomic Agents|autonomic agents|mesh-ancestor
6483496|NCT00557180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6483497|NCT00557180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483498|NCT00557180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6483499|NCT00557180|Respiratory System Agents|respiratory system agents|mesh-ancestor
6483500|NCT00557180|Parasympatholytics|parasympatholytics|mesh-ancestor
6483501|NCT00557180|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6483502|NCT00557180|Cholinergic Agents|cholinergic agents|mesh-ancestor
6483503|NCT00557180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6483504|NCT00557180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483505|NCT00557180|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6483506|NCT00557180|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6483507|NCT00557180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6483508|NCT00557180|Adrenergic Agents|adrenergic agents|mesh-ancestor
6483509|NCT00557180|Anticonvulsants|anticonvulsants|mesh-ancestor
6483510|NCT00557180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6483511|NCT00557180|Glucocorticoids|glucocorticoids|mesh-ancestor
6483512|NCT00557180|Hormones|hormones|mesh-ancestor
6483513|NCT00557180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6483514|NCT00557206|Docetaxel|docetaxel|mesh-list
6483515|NCT00557206|Oxaliplatin|oxaliplatin|mesh-list
6483516|NCT00557206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6483517|NCT00557206|Tubulin Modulators|tubulin modulators|mesh-ancestor
6166646|NCT01586806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6166647|NCT01586806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6166648|NCT01586806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6166649|NCT01586806|Protease Inhibitors|protease inhibitors|mesh-ancestor
6166650|NCT01586806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6166651|NCT01586806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166652|NCT01586806|Anesthetics, Local|anesthetics, local|mesh-ancestor
6166653|NCT01586806|Anesthetics|anesthetics|mesh-ancestor
5564632|NCT03982277|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5564633|NCT03982082|Coal Tar|coal tar|mesh-list
6166654|NCT01586806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6166655|NCT01586806|Sensory System Agents|sensory system agents|mesh-ancestor
6166656|NCT01586819|Botulinum Toxins|botulinum toxins|mesh-list
6166657|NCT01586819|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6166658|NCT01586819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6166659|NCT01586819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166660|NCT01586819|Cholinergic Agents|cholinergic agents|mesh-ancestor
6483518|NCT00557206|Antimitotic Agents|antimitotic agents|mesh-ancestor
5564634|NCT03982082|Keratolytic Agents|keratolytic agents|mesh-ancestor
5564635|NCT03982082|Dermatologic Agents|dermatologic agents|mesh-ancestor
5564636|NCT03982212|Glatiramer Acetate|glatiramer acetate|mesh-list
5564637|NCT03982212|(T,G)-A-L|(t,g)-a-l|mesh-list
5564638|NCT03982212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5564639|NCT03982212|Immunologic Factors|immunologic factors|mesh-ancestor
5564640|NCT03982212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564641|NCT03982212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5564642|NCT03982212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5564643|NCT03982225|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
5564644|NCT03982225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5564645|NCT03982225|Antimetabolites|antimetabolites|mesh-ancestor
5564646|NCT03982225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564647|NCT03982225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6166661|NCT01586819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6166662|NCT01586819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166663|NCT01586962|Acetaminophen|acetaminophen|mesh-list
5564651|NCT03982173|Durvalumab|durvalumab|mesh-list
5564652|NCT03982173|Tremelimumab|tremelimumab|mesh-list
5564653|NCT03982173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5564654|NCT03982173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5564655|NCT03982238|Metformin|metformin|mesh-list
5564656|NCT03982238|Dapagliflozin|dapagliflozin|mesh-list
5564657|NCT03982238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5564658|NCT03982238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564659|NCT03982238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5564660|NCT03982238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564661|NCT03982121|Nivolumab|nivolumab|mesh-list
5564662|NCT03982121|Ipilimumab|ipilimumab|mesh-list
5564663|NCT03982121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5564664|NCT03982121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5564665|NCT03982121|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5564666|NCT03982121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564667|NCT03982004|Pembrolizumab|pembrolizumab|mesh-list
5564668|NCT03982004|Imiquimod|imiquimod|mesh-list
5564669|NCT03982004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5564670|NCT03982004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5564671|NCT03982004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5564672|NCT03982004|Immunologic Factors|immunologic factors|mesh-ancestor
5564673|NCT03982004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564674|NCT03982004|Interferon Inducers|interferon inducers|mesh-ancestor
5564675|NCT03981887|Nafithromycin|nafithromycin|mesh-list
5564676|NCT03981887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5564677|NCT03981887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5564678|NCT03981887|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5564679|NCT03981887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5564680|NCT03981887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564681|NCT03981900|Tofacitinib|tofacitinib|mesh-list
5564682|NCT03981900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6166664|NCT01586962|Pseudoephedrine|pseudoephedrine|mesh-list
6669118|NCT01536223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6669119|NCT01536223|Immunologic Factors|immunologic factors|mesh-ancestor
6669120|NCT01536223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669121|NCT01536249|Pramipexole|pramipexole|mesh-list
6669122|NCT01536249|Cimetidine|cimetidine|mesh-list
5564683|NCT03981900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6166665|NCT01586962|Ephedrine|ephedrine|mesh-list
6166666|NCT01586962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6166667|NCT01586962|Analgesics|analgesics|mesh-ancestor
6166668|NCT01586962|Sensory System Agents|sensory system agents|mesh-ancestor
6166669|NCT01586962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6166670|NCT01586962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166671|NCT01586962|Antipyretics|antipyretics|mesh-ancestor
6166672|NCT01586962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6166673|NCT01586962|Autonomic Agents|autonomic agents|mesh-ancestor
6166674|NCT01586962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6166675|NCT01586962|Respiratory System Agents|respiratory system agents|mesh-ancestor
6166676|NCT01586962|Nasal Decongestants|nasal decongestants|mesh-ancestor
6166677|NCT01586962|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6166678|NCT01586962|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6166679|NCT01586962|Sympathomimetics|sympathomimetics|mesh-ancestor
6166680|NCT01586962|Adrenergic Agents|adrenergic agents|mesh-ancestor
6166681|NCT01586962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6483519|NCT00557206|Mitosis Modulators|mitosis modulators|mesh-ancestor
6166682|NCT01586962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669123|NCT01536249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6669124|NCT01536249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6483520|NCT00557206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483521|NCT00557219|Fenoldopam|fenoldopam|mesh-list
6483522|NCT00557219|Ketanserin|ketanserin|mesh-list
6483523|NCT00557219|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6483524|NCT00557219|Vasodilator Agents|vasodilator agents|mesh-ancestor
6483525|NCT00557219|Dopamine Agonists|dopamine agonists|mesh-ancestor
6483526|NCT00557219|Dopamine Agents|dopamine agents|mesh-ancestor
6669125|NCT01536249|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6669126|NCT01536249|Histamine Antagonists|histamine antagonists|mesh-ancestor
6166683|NCT01586975|Aspirin|aspirin|mesh-list
6166684|NCT01586975|Clopidogrel|clopidogrel|mesh-list
6166685|NCT01586975|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6166686|NCT01586975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6166687|NCT01586975|Analgesics|analgesics|mesh-ancestor
6166688|NCT01586975|Sensory System Agents|sensory system agents|mesh-ancestor
6166689|NCT01586975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6166690|NCT01586975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166691|NCT01586975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6166692|NCT01586975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6166693|NCT01586975|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6166694|NCT01586975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6166695|NCT01586975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166696|NCT01586975|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6166697|NCT01586975|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6166698|NCT01586975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6166699|NCT01586975|Antipyretics|antipyretics|mesh-ancestor
6166700|NCT01586975|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6166701|NCT01586975|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6166702|NCT01586975|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6166703|NCT01586975|Purinergic Agents|purinergic agents|mesh-ancestor
6166704|NCT01586975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5564684|NCT03981900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564685|NCT03981601|Lovastatin|lovastatin|mesh-list
5564686|NCT03981601|L 647318|l 647318|mesh-list
5564687|NCT03981601|Dihydromevinolin|dihydromevinolin|mesh-list
5564688|NCT03981601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5564689|NCT03981601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5564690|NCT03981601|Antimetabolites|antimetabolites|mesh-ancestor
5564691|NCT03981601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166705|NCT01587001|Acetylcysteine|acetylcysteine|mesh-list
6166706|NCT01587001|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6166707|NCT01587001|Antiviral Agents|antiviral agents|mesh-ancestor
6166708|NCT01587001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6166709|NCT01587001|Expectorants|expectorants|mesh-ancestor
6166710|NCT01587001|Respiratory System Agents|respiratory system agents|mesh-ancestor
6166711|NCT01587001|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6669127|NCT01536249|Histamine Agents|histamine agents|mesh-ancestor
5564692|NCT03981601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5564693|NCT03981601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5564694|NCT03981601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5564695|NCT03981627|Insulin Aspart|insulin aspart|mesh-list
5564696|NCT03981627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5564697|NCT03981627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564698|NCT03981770|Anesthetics|anesthetics|mesh-list
5564699|NCT03981770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5564700|NCT03981770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564701|NCT03981484|Thrombin|thrombin|mesh-list
5564702|NCT03981484|Hemostatics|hemostatics|mesh-ancestor
5564703|NCT03981484|Coagulants|coagulants|mesh-ancestor
5564704|NCT03981523|Benzonidazole|benzonidazole|mesh-list
5564705|NCT03981523|Nifurtimox|nifurtimox|mesh-list
5564706|NCT03981523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5564707|NCT03981523|Immunologic Factors|immunologic factors|mesh-ancestor
5564708|NCT03981523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564709|NCT03981523|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5564710|NCT03981523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6166712|NCT01587001|Antioxidants|antioxidants|mesh-ancestor
6669128|NCT01536249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5564711|NCT03981523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5564712|NCT03981523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6166713|NCT01587001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166714|NCT01587001|Protective Agents|protective agents|mesh-ancestor
6166715|NCT01587001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483527|NCT00557219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5564713|NCT03981458|Hyaluronic Acid|hyaluronic acid|mesh-list
6488949|NCT00588003|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6166716|NCT01587001|Antidotes|antidotes|mesh-ancestor
6166717|NCT01587027|Aminophylline|aminophylline|mesh-list
6166718|NCT01587027|Methazolamide|methazolamide|mesh-list
6166719|NCT01587027|Theophylline|theophylline|mesh-list
6166720|NCT01587027|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5564714|NCT03981458|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5564715|NCT03981458|Immunologic Factors|immunologic factors|mesh-ancestor
5564716|NCT03981458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564717|NCT03981458|Viscosupplements|viscosupplements|mesh-ancestor
5564718|NCT03981458|Protective Agents|protective agents|mesh-ancestor
5564719|NCT03981341|Bazedoxifene|bazedoxifene|mesh-list
5564720|NCT03981341|Estrogens|estrogens|mesh-list
6166721|NCT01587027|Autonomic Agents|autonomic agents|mesh-ancestor
6166722|NCT01587027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6166723|NCT01587027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564721|NCT03981341|Hormones|hormones|mesh-ancestor
5564722|NCT03981341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5564723|NCT03981341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564724|NCT03981341|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5564725|NCT03981341|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5564726|NCT03981341|Hormone Antagonists|hormone antagonists|mesh-ancestor
5564727|NCT03981341|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5564728|NCT03981146|Nivolumab|nivolumab|mesh-list
5564729|NCT03981146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5564730|NCT03981146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5564731|NCT03981146|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5564732|NCT03981146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564733|NCT03981211|Sofosbuvir|sofosbuvir|mesh-list
5564734|NCT03981211|Antiviral Agents|antiviral agents|mesh-ancestor
5564735|NCT03981211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5564736|NCT03981068|Nimorazole|nimorazole|mesh-list
5564737|NCT03981068|Cisplatin|cisplatin|mesh-list
5564738|NCT03981068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5564739|NCT03981068|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
5564740|NCT03981068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5564741|NCT03981068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5564742|NCT03981068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5564743|NCT03981081|Prednisone|prednisone|mesh-list
5564744|NCT03981081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5564745|NCT03981081|Glucocorticoids|glucocorticoids|mesh-ancestor
5564746|NCT03981081|Hormones|hormones|mesh-ancestor
5564747|NCT03981081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5564748|NCT03981081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564749|NCT03981081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5564750|NCT03981081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5564751|NCT03981094|Pirfenidone|pirfenidone|mesh-list
6166724|NCT01587027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6166725|NCT01587027|Respiratory System Agents|respiratory system agents|mesh-ancestor
6166726|NCT01587027|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6166727|NCT01587027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6166728|NCT01587027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166729|NCT01587027|Vasodilator Agents|vasodilator agents|mesh-ancestor
6166730|NCT01587027|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6166731|NCT01587027|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6166732|NCT01587027|Purinergic Agents|purinergic agents|mesh-ancestor
6669129|NCT01536249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669130|NCT01536249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564752|NCT03981094|Analgesics|analgesics|mesh-ancestor
5564753|NCT03981094|Sensory System Agents|sensory system agents|mesh-ancestor
5564754|NCT03981094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5564755|NCT03981094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564756|NCT03981094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5564757|NCT03981094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5564758|NCT03981094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6669131|NCT01536249|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6669132|NCT01536249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6669133|NCT01536249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6669134|NCT01536249|Antioxidants|antioxidants|mesh-ancestor
6669135|NCT01536249|Protective Agents|protective agents|mesh-ancestor
6669136|NCT01536249|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6669137|NCT01536249|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6669138|NCT01536249|Dopamine Agonists|dopamine agonists|mesh-ancestor
6669139|NCT01536249|Dopamine Agents|dopamine agents|mesh-ancestor
5564759|NCT03981094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6166733|NCT01587027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6669140|NCT01536301|Morphine|morphine|mesh-list
6669141|NCT01536301|Oxycodone|oxycodone|mesh-list
6483528|NCT00557219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483529|NCT00557219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483530|NCT00557219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6483531|NCT00557219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6483532|NCT00557219|Serotonin Agents|serotonin agents|mesh-ancestor
5564760|NCT03981094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5564761|NCT03981029|Folic Acid|folic acid|mesh-list
5564762|NCT03981029|Hematinics|hematinics|mesh-ancestor
5564763|NCT03981029|Vitamin B Complex|vitamin b complex|mesh-ancestor
5564764|NCT03981029|Vitamins|vitamins|mesh-ancestor
5564765|NCT03981029|Micronutrients|micronutrients|mesh-ancestor
5564766|NCT03981029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564767|NCT03980847|Alendronate|alendronate|mesh-list
5564768|NCT03980847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6166734|NCT01587027|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6166735|NCT01587027|Protective Agents|protective agents|mesh-ancestor
6166736|NCT01587027|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6166737|NCT01587027|Diuretics|diuretics|mesh-ancestor
6166738|NCT01587027|Natriuretic Agents|natriuretic agents|mesh-ancestor
6166739|NCT01587079|Tiotropium Bromide|tiotropium bromide|mesh-list
6166740|NCT01587079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6166741|NCT01587079|Autonomic Agents|autonomic agents|mesh-ancestor
6166742|NCT01587079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6166743|NCT01587079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166744|NCT01587079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6166745|NCT01587079|Respiratory System Agents|respiratory system agents|mesh-ancestor
6166746|NCT01587079|Parasympatholytics|parasympatholytics|mesh-ancestor
6166747|NCT01587079|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6166748|NCT01587079|Cholinergic Agents|cholinergic agents|mesh-ancestor
6166749|NCT01587079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6166750|NCT01587079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564769|NCT03980847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564770|NCT03980951|Analgesics, Opioid|analgesics, opioid|mesh-list
5564771|NCT03980951|Narcotics|narcotics|mesh-ancestor
5564772|NCT03980951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5564773|NCT03980951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564774|NCT03980951|Analgesics|analgesics|mesh-ancestor
5564775|NCT03980951|Sensory System Agents|sensory system agents|mesh-ancestor
5564776|NCT03980951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6166751|NCT01587118|Asenapine|asenapine|mesh-list
6166752|NCT01587118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6166753|NCT01587118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6166754|NCT01587118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6166755|NCT01587118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166756|NCT01587118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6166757|NCT01587274|Acetaminophen|acetaminophen|mesh-list
6166758|NCT01587274|Naproxen|naproxen|mesh-list
6166759|NCT01587274|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
6166760|NCT01587274|Oxycodone|oxycodone|mesh-list
6166761|NCT01587274|Cyclobenzaprine|cyclobenzaprine|mesh-list
5564777|NCT03980925|Carboplatin|carboplatin|mesh-list
5564778|NCT03980925|Nivolumab|nivolumab|mesh-list
5564779|NCT03980925|Etoposide|etoposide|mesh-list
5564780|NCT03980925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5564781|NCT03980925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5564782|NCT03980925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5564783|NCT03980925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564784|NCT03980925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5564785|NCT03980925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5564786|NCT03980925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5564787|NCT03980925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5564788|NCT03980990|Metformin|metformin|mesh-list
5564789|NCT03980990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5564790|NCT03980990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564791|NCT03980756|Esomeprazole|esomeprazole|mesh-list
5564792|NCT03980756|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5564793|NCT03980756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5564794|NCT03980756|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5564795|NCT03980756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5564796|NCT03980756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564797|NCT03980665|Arsenic Trioxide|arsenic trioxide|mesh-list
5564798|NCT03980665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5603862|NCT01127256|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6166762|NCT01587274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6669142|NCT01536301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5564799|NCT03980379|Rituximab|rituximab|mesh-list
5564800|NCT03980379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5564801|NCT03980379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5564802|NCT03980379|Immunologic Factors|immunologic factors|mesh-ancestor
5564803|NCT03980379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564804|NCT03980379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5564805|NCT03980496|Omeprazole|omeprazole|mesh-list
5564806|NCT03980496|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5564807|NCT03980496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5564808|NCT03980496|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5564809|NCT03980496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5564810|NCT03980496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564811|NCT03980509|Curcumin|curcumin|mesh-list
5564812|NCT03980509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5564813|NCT03980509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5564814|NCT03980509|Analgesics|analgesics|mesh-ancestor
5564815|NCT03980509|Sensory System Agents|sensory system agents|mesh-ancestor
5564816|NCT03980509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5564817|NCT03980509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564818|NCT03980509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5564819|NCT03980509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5564820|NCT03980509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5564821|NCT03980509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5564822|NCT03980509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564823|NCT03980223|Doxycycline|doxycycline|mesh-list
5564824|NCT03980223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6166763|NCT01587274|Analgesics|analgesics|mesh-ancestor
6166764|NCT01587274|Sensory System Agents|sensory system agents|mesh-ancestor
6166765|NCT01587274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6166766|NCT01587274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669143|NCT01536301|Narcotics|narcotics|mesh-ancestor
6669144|NCT01536301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6669145|NCT01536301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669146|NCT01536301|Analgesics|analgesics|mesh-ancestor
6669147|NCT01536301|Sensory System Agents|sensory system agents|mesh-ancestor
6669148|NCT01536301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6669149|NCT01536314|Memantine|memantine|mesh-list
6669150|NCT01536314|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6669151|NCT01536314|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6669152|NCT01536314|Dopamine Agents|dopamine agents|mesh-ancestor
6669153|NCT01536314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6669154|NCT01536314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564825|NCT03980223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5564826|NCT03980223|Antimalarials|antimalarials|mesh-ancestor
5564827|NCT03980223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6166767|NCT01587274|Antipyretics|antipyretics|mesh-ancestor
6166768|NCT01587274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6669155|NCT01536314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669156|NCT01536314|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6669157|NCT01536314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6669158|NCT01536353|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
6669159|NCT01536353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6669160|NCT01536431|Insulin|insulin|mesh-list
6166769|NCT01587274|Narcotics|narcotics|mesh-ancestor
6483533|NCT00557232|Bevacizumab|bevacizumab|mesh-list
6483534|NCT00557232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6483535|NCT00557232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6483536|NCT00557232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6483537|NCT00557232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6483538|NCT00557232|Growth Substances|growth substances|mesh-ancestor
6483539|NCT00557232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483540|NCT00557232|Growth Inhibitors|growth inhibitors|mesh-ancestor
6483541|NCT00557427|Fluoxetine|fluoxetine|mesh-list
6483542|NCT00557427|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6483543|NCT00557427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6483544|NCT00557427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6483545|NCT00557427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483546|NCT00557427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6483547|NCT00557427|Serotonin Agents|serotonin agents|mesh-ancestor
6483548|NCT00557427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483549|NCT00557427|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6483550|NCT00557427|Antidepressive Agents|antidepressive agents|mesh-ancestor
6483551|NCT00557427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5564828|NCT03980223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5564829|NCT03980249|Carvedilol|carvedilol|mesh-list
5564830|NCT03980249|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5564831|NCT03980249|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5564832|NCT03980249|Adrenergic Agents|adrenergic agents|mesh-ancestor
5564833|NCT03980249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5564834|NCT03980249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564835|NCT03980249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564836|NCT03980249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5564837|NCT03980249|Antioxidants|antioxidants|mesh-ancestor
5564838|NCT03980249|Protective Agents|protective agents|mesh-ancestor
5564839|NCT03980249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5564840|NCT03980249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5564841|NCT03980249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5564842|NCT03980249|Vasodilator Agents|vasodilator agents|mesh-ancestor
5564843|NCT03980249|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5564844|NCT03980249|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5564845|NCT03980041|Nivolumab|nivolumab|mesh-list
5564846|NCT03980041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5564847|NCT03980041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5564848|NCT03980041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5564849|NCT03980041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564850|NCT03980184|Guanfacine|guanfacine|mesh-list
5564851|NCT03980184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5564852|NCT03980184|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5564853|NCT03980184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5564854|NCT03980184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5564855|NCT03980184|Adrenergic Agents|adrenergic agents|mesh-ancestor
5564856|NCT03980184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5564857|NCT03980184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564858|NCT03980184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564859|NCT03979976|Ramipril|ramipril|mesh-list
5564860|NCT03979976|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
5564861|NCT03979976|Enzyme Inhibitors|enzyme inhibitors|mesh-list
5564862|NCT03979976|Protease Inhibitors|protease inhibitors|mesh-ancestor
5564863|NCT03979976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564864|NCT03979976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5564865|NCT03980171|Lenalidomide|lenalidomide|mesh-list
5564866|NCT03980171|Venetoclax|venetoclax|mesh-list
5564867|NCT03980171|Obinutuzumab|obinutuzumab|mesh-list
5564868|NCT03980171|Immunologic Factors|immunologic factors|mesh-ancestor
5564869|NCT03980171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564870|NCT03980171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5564871|NCT03980171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5564872|NCT03980171|Growth Substances|growth substances|mesh-ancestor
5564873|NCT03980171|Growth Inhibitors|growth inhibitors|mesh-ancestor
5564874|NCT03980171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5564875|NCT03980171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5564876|NCT03980002|Thalidomide|thalidomide|mesh-list
5564877|NCT03980002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5564878|NCT03980002|Immunologic Factors|immunologic factors|mesh-ancestor
5564879|NCT03980002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564880|NCT03980002|Leprostatic Agents|leprostatic agents|mesh-ancestor
5564881|NCT03980002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5564882|NCT03980002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5564883|NCT03980002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5564884|NCT03980002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6483552|NCT00557427|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6483553|NCT00557427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6483554|NCT00557427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6483555|NCT00557453|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6483556|NCT00557453|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5564885|NCT03980002|Growth Substances|growth substances|mesh-ancestor
5564886|NCT03980002|Growth Inhibitors|growth inhibitors|mesh-ancestor
5564887|NCT03980002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6483557|NCT00557453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6483558|NCT00557453|Antitubercular Agents|antitubercular agents|mesh-ancestor
6483559|NCT00557544|Ketoprofen|ketoprofen|mesh-list
6483560|NCT00557544|Metoclopramide|metoclopramide|mesh-list
6483561|NCT00557544|Antiemetics|antiemetics|mesh-ancestor
6483562|NCT00557544|Autonomic Agents|autonomic agents|mesh-ancestor
6483563|NCT00557544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6483564|NCT00557544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483565|NCT00557544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6483566|NCT00557544|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6483567|NCT00557544|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5564888|NCT03979859|Nafithromycin|nafithromycin|mesh-list
5564889|NCT03979859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5564890|NCT03979859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5564891|NCT03979859|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6483568|NCT00557544|Dopamine Agents|dopamine agents|mesh-ancestor
6483569|NCT00557544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6483570|NCT00557544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483571|NCT00557544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6483572|NCT00557544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6483573|NCT00557544|Analgesics|analgesics|mesh-ancestor
6483574|NCT00557544|Sensory System Agents|sensory system agents|mesh-ancestor
6483575|NCT00557544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6483576|NCT00557544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6483577|NCT00557544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6483578|NCT00557544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6483579|NCT00557557|Oxaliplatin|oxaliplatin|mesh-list
6483580|NCT00557557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6483581|NCT00557700|Bromides|bromides|mesh-list
6483582|NCT00557700|Tiotropium Bromide|tiotropium bromide|mesh-list
6483583|NCT00557700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6483584|NCT00557700|Autonomic Agents|autonomic agents|mesh-ancestor
6483585|NCT00557700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6483586|NCT00557700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483587|NCT00557700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6483588|NCT00557700|Respiratory System Agents|respiratory system agents|mesh-ancestor
5564892|NCT03979859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5564893|NCT03979859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564894|NCT03980015|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5564895|NCT03980015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5564896|NCT03979989|Tapentadol|tapentadol|mesh-list
5564897|NCT03979989|Omeprazole|omeprazole|mesh-list
5564898|NCT03979989|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5564899|NCT03979989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5564900|NCT03979989|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6483589|NCT00557700|Parasympatholytics|parasympatholytics|mesh-ancestor
6166770|NCT01587274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6166771|NCT01587274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6166772|NCT01587274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6166773|NCT01587274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6166774|NCT01587274|Gout Suppressants|gout suppressants|mesh-ancestor
6166775|NCT01587274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6166776|NCT01587274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6166777|NCT01587274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166778|NCT01587274|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6166779|NCT01587274|Antidepressive Agents|antidepressive agents|mesh-ancestor
6166780|NCT01587274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6166781|NCT01587274|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6166782|NCT01587274|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6166783|NCT01587274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6166784|NCT01587651|Ticagrelor|ticagrelor|mesh-list
6166785|NCT01587651|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6166786|NCT01587651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6166787|NCT01587651|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6166788|NCT01587651|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6166789|NCT01587651|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6166790|NCT01587651|Purinergic Agents|purinergic agents|mesh-ancestor
6166791|NCT01587651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6166792|NCT01587651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166793|NCT01587651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564901|NCT03979989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5564902|NCT03979989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564903|NCT03979989|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5564904|NCT03979989|Narcotics|narcotics|mesh-ancestor
5564905|NCT03979989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5564906|NCT03979989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564907|NCT03979989|Analgesics|analgesics|mesh-ancestor
5564908|NCT03979989|Sensory System Agents|sensory system agents|mesh-ancestor
5564909|NCT03979989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5564910|NCT03979989|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5564911|NCT03979989|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5564912|NCT03979989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5564913|NCT03979989|Adrenergic Agents|adrenergic agents|mesh-ancestor
5564914|NCT03979989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6166794|NCT01587885|Omeprazole|omeprazole|mesh-list
6166795|NCT01587885|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6166796|NCT01587885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6166797|NCT01587885|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5564915|NCT03979664|Dexamethasone|dexamethasone|mesh-list
5564916|NCT03979664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5564917|NCT03979664|Antiemetics|antiemetics|mesh-ancestor
5564918|NCT03979664|Autonomic Agents|autonomic agents|mesh-ancestor
5564919|NCT03979664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5564920|NCT03979664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564921|NCT03979664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5564922|NCT03979664|Glucocorticoids|glucocorticoids|mesh-ancestor
5564923|NCT03979664|Hormones|hormones|mesh-ancestor
5564924|NCT03979664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5564925|NCT03979664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5564926|NCT03979664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5564927|NCT03979651|Hydroxychloroquine|hydroxychloroquine|mesh-list
6483590|NCT00557700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6483591|NCT00557700|Cholinergic Agents|cholinergic agents|mesh-ancestor
6483592|NCT00557700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6483593|NCT00557700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483594|NCT00557700|Anticonvulsants|anticonvulsants|mesh-ancestor
5564928|NCT03979651|Trametinib|trametinib|mesh-list
5564929|NCT03979651|Antimalarials|antimalarials|mesh-ancestor
5564930|NCT03979651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6166798|NCT01587885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6166799|NCT01587885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166800|NCT01587989|Methotrexate|methotrexate|mesh-list
6166801|NCT01587989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6166802|NCT01587989|Abortifacient Agents|abortifacient agents|mesh-ancestor
6166803|NCT01587989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6166804|NCT01587989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166805|NCT01587989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6166806|NCT01587989|Antimetabolites|antimetabolites|mesh-ancestor
6166807|NCT01587989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166808|NCT01587989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6166809|NCT01587989|Dermatologic Agents|dermatologic agents|mesh-ancestor
6166810|NCT01587989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6166811|NCT01587989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6166812|NCT01587989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6166813|NCT01587989|Immunologic Factors|immunologic factors|mesh-ancestor
6166814|NCT01587989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6166815|NCT01587989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6166816|NCT01588158|Acetaminophen|acetaminophen|mesh-list
6166817|NCT01588158|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
6166818|NCT01588158|Hydrocodone|hydrocodone|mesh-list
6166819|NCT01588158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6166820|NCT01588158|Analgesics|analgesics|mesh-ancestor
6166821|NCT01588158|Sensory System Agents|sensory system agents|mesh-ancestor
6166822|NCT01588158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6166823|NCT01588158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166824|NCT01588158|Antipyretics|antipyretics|mesh-ancestor
6166825|NCT01588158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6166826|NCT01588158|Narcotics|narcotics|mesh-ancestor
6166827|NCT01588158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6166828|NCT01588158|Antitussive Agents|antitussive agents|mesh-ancestor
6483595|NCT00557713|Bevacizumab|bevacizumab|mesh-list
6483596|NCT00557713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6483597|NCT00557713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6483598|NCT00557713|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6483599|NCT00557713|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6483600|NCT00557713|Growth Substances|growth substances|mesh-ancestor
6483601|NCT00557713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483602|NCT00557713|Growth Inhibitors|growth inhibitors|mesh-ancestor
6483603|NCT00557739|Mometasone Furoate|mometasone furoate|mesh-list
6483604|NCT00557739|Nortriptyline|nortriptyline|mesh-list
6483605|NCT00557739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6483606|NCT00557739|Dermatologic Agents|dermatologic agents|mesh-ancestor
6483607|NCT00557739|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6483608|NCT00557739|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6483609|NCT00557739|Antidepressive Agents|antidepressive agents|mesh-ancestor
6483610|NCT00557739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6483611|NCT00557739|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6483612|NCT00557739|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6483613|NCT00557739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6166829|NCT01588158|Respiratory System Agents|respiratory system agents|mesh-ancestor
5564931|NCT03979651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5564932|NCT03979651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5564933|NCT03979651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5564934|NCT03979651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564935|NCT03979651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5564936|NCT03979651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5564937|NCT03979651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6166830|NCT01588158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6166831|NCT01588158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6166832|NCT01588158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6166833|NCT01588184|Bevacizumab|bevacizumab|mesh-list
6483614|NCT00557739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483615|NCT00557739|Adrenergic Agents|adrenergic agents|mesh-ancestor
5564938|NCT03979456|Rituximab|rituximab|mesh-list
5564939|NCT03979456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5564940|NCT03979456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5564941|NCT03979456|Immunologic Factors|immunologic factors|mesh-ancestor
5564942|NCT03979456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564943|NCT03979456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5564944|NCT03979469|Fentanyl|fentanyl|mesh-list
5564945|NCT03979469|Dexmedetomidine|dexmedetomidine|mesh-list
5564946|NCT03979469|Ketamine|ketamine|mesh-list
5564947|NCT03979469|Remifentanil|remifentanil|mesh-list
5564948|NCT03979469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5564949|NCT03979469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5564950|NCT03979469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564951|NCT03979469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5564952|NCT03979469|Analgesics|analgesics|mesh-ancestor
5564953|NCT03979469|Sensory System Agents|sensory system agents|mesh-ancestor
5564954|NCT03979469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5564955|NCT03979469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5564956|NCT03979469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5564957|NCT03979469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5564958|NCT03979469|Adrenergic Agents|adrenergic agents|mesh-ancestor
5564959|NCT03979469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5564960|NCT03979469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483616|NCT00557739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6483617|NCT00557739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483618|NCT00557791|Ranibizumab|ranibizumab|mesh-list
6483619|NCT00557791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6483620|NCT00557791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6483621|NCT00557791|Growth Substances|growth substances|mesh-ancestor
6483622|NCT00557791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483623|NCT00557791|Growth Inhibitors|growth inhibitors|mesh-ancestor
6166834|NCT01588184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6166835|NCT01588184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6166836|NCT01588184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6166837|NCT01588184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6166838|NCT01588184|Growth Substances|growth substances|mesh-ancestor
6166839|NCT01588184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166840|NCT01588184|Growth Inhibitors|growth inhibitors|mesh-ancestor
6166841|NCT01588405|Treprostinil|treprostinil|mesh-list
5564961|NCT03979469|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5564962|NCT03979469|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5564963|NCT03979469|Anesthetics, General|anesthetics, general|mesh-ancestor
5564964|NCT03979469|Anesthetics|anesthetics|mesh-ancestor
5564965|NCT03979469|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5564966|NCT03979469|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5564967|NCT03979469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5564968|NCT03979469|Narcotics|narcotics|mesh-ancestor
5564969|NCT03979469|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5564970|NCT03979248|BMS-986165|bms-986165|mesh-list
5564971|NCT03979248|Rabeprazole|rabeprazole|mesh-list
5564972|NCT03979248|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5564973|NCT03979248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5564974|NCT03979248|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5564975|NCT03979248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5564976|NCT03979248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564977|NCT03979248|Dermatologic Agents|dermatologic agents|mesh-ancestor
5564978|NCT03979248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5564979|NCT03979586|Hyaluronic Acid|hyaluronic acid|mesh-list
5564980|NCT03979586|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5564981|NCT03979586|Immunologic Factors|immunologic factors|mesh-ancestor
5564982|NCT03979586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166842|NCT01588405|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6166843|NCT01588418|Exenatide|exenatide|mesh-list
6166844|NCT01588418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6166845|NCT01588418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166846|NCT01588418|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6166847|NCT01588418|Incretins|incretins|mesh-ancestor
6166848|NCT01588418|Hormones|hormones|mesh-ancestor
6166849|NCT01588418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6166850|NCT01588457|Lamotrigine|lamotrigine|mesh-list
6166851|NCT01588457|Valproic Acid|valproic acid|mesh-list
6166852|NCT01588457|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6166853|NCT01588457|Lithium Carbonate|lithium carbonate|mesh-list
6166854|NCT01588457|Antidepressive Agents|antidepressive agents|mesh-ancestor
6166855|NCT01588457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6166856|NCT01588457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6166857|NCT01588457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6166858|NCT01588457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6166859|NCT01588457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166860|NCT01588457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6166861|NCT01588457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166862|NCT01588457|Antimanic Agents|antimanic agents|mesh-ancestor
6166863|NCT01588457|Anticonvulsants|anticonvulsants|mesh-ancestor
6166864|NCT01588457|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6166865|NCT01588457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6166866|NCT01588457|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6166867|NCT01588457|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6166868|NCT01588457|GABA Agents|gaba agents|mesh-ancestor
6166869|NCT01588457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6166870|NCT01588470|Pioglitazone|pioglitazone|mesh-list
6166871|NCT01588470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5564983|NCT03979586|Viscosupplements|viscosupplements|mesh-ancestor
5564984|NCT03979586|Protective Agents|protective agents|mesh-ancestor
5564985|NCT03979352|Empagliflozin|empagliflozin|mesh-list
5564986|NCT03979352|Pancrelipase|pancrelipase|mesh-list
5564987|NCT03979352|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5564988|NCT03979352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5564989|NCT03979352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5564990|NCT03979352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564991|NCT03979352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5564992|NCT03979599|Magnesium Sulfate|magnesium sulfate|mesh-list
5564993|NCT03979599|Levobupivacaine|levobupivacaine|mesh-list
5564994|NCT03979599|Analgesics|analgesics|mesh-ancestor
5564995|NCT03979599|Sensory System Agents|sensory system agents|mesh-ancestor
5564996|NCT03979599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5564997|NCT03979599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5564998|NCT03979599|Anesthetics|anesthetics|mesh-ancestor
5564999|NCT03979599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5565000|NCT03979599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5565001|NCT03979599|Anticonvulsants|anticonvulsants|mesh-ancestor
5565002|NCT03979599|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5565003|NCT03979599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5565004|NCT03979599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5565005|NCT03979599|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5565006|NCT03979599|Tocolytic Agents|tocolytic agents|mesh-ancestor
5565007|NCT03979599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5565008|NCT03979599|Anesthetics, Local|anesthetics, local|mesh-ancestor
5565009|NCT03979209|Mometasone Furoate|mometasone furoate|mesh-list
5565010|NCT03979209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5565011|NCT03979209|Dermatologic Agents|dermatologic agents|mesh-ancestor
6166872|NCT01588470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166873|NCT01588496|Evolocumab|evolocumab|mesh-list
6166874|NCT01588496|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6166875|NCT01588496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6669161|NCT01536431|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6669162|NCT01536431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6669163|NCT01536431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669164|NCT01536470|Norepinephrine|norepinephrine|mesh-list
6669165|NCT01536470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6669166|NCT01536470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6669167|NCT01536470|Adrenergic Agents|adrenergic agents|mesh-ancestor
6669168|NCT01536470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6669169|NCT01536470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5565012|NCT03979209|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6166876|NCT01588496|Antimetabolites|antimetabolites|mesh-ancestor
6206204|NCT02097472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565013|NCT03978988|Aspirin|aspirin|mesh-list
6166877|NCT01588496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483624|NCT00557791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6483625|NCT00557817|Darbepoetin alfa|darbepoetin alfa|mesh-list
6483626|NCT00557817|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6483627|NCT00557817|Hematinics|hematinics|mesh-ancestor
6483628|NCT00557843|Bupivacaine|bupivacaine|mesh-list
6483629|NCT00557843|Anesthetics, Local|anesthetics, local|mesh-ancestor
6483630|NCT00557843|Anesthetics|anesthetics|mesh-ancestor
6483631|NCT00557843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6483632|NCT00557843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483633|NCT00557843|Sensory System Agents|sensory system agents|mesh-ancestor
6483634|NCT00557843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5565014|NCT03978988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6166878|NCT01588496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6206205|NCT02097537|Methacholine Chloride|methacholine chloride|mesh-list
6206206|NCT02097537|Miotics|miotics|mesh-ancestor
6206207|NCT02097537|Autonomic Agents|autonomic agents|mesh-ancestor
6206208|NCT02097537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6483635|NCT00557921|Aspirin|aspirin|mesh-list
5565015|NCT03978988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5565016|NCT03978988|Analgesics|analgesics|mesh-ancestor
5565017|NCT03978988|Sensory System Agents|sensory system agents|mesh-ancestor
5565018|NCT03978988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5565019|NCT03978988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565020|NCT03978988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5565021|NCT03978988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5565022|NCT03978988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5565023|NCT03978988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5565024|NCT03978988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5565025|NCT03978988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5565026|NCT03978988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5565027|NCT03978988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5565028|NCT03978988|Antipyretics|antipyretics|mesh-ancestor
5565029|NCT03979105|Ketamine|ketamine|mesh-list
5565030|NCT03979105|Analgesics|analgesics|mesh-ancestor
5565031|NCT03979105|Sensory System Agents|sensory system agents|mesh-ancestor
5565032|NCT03979105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5565033|NCT03979105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565034|NCT03979105|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5565035|NCT03979105|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5565036|NCT03979105|Anesthetics, General|anesthetics, general|mesh-ancestor
5565037|NCT03979105|Anesthetics|anesthetics|mesh-ancestor
5565038|NCT03979105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5565039|NCT03979105|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5565040|NCT03979105|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5565041|NCT03979105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5565042|NCT03979105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5565043|NCT03978884|Losartan|losartan|mesh-list
5565044|NCT03978884|Amlodipine|amlodipine|mesh-list
5565045|NCT03978884|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5565046|NCT03978884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5565047|NCT03978884|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5565048|NCT03978884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5565049|NCT03978884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5565050|NCT03978884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6206209|NCT02097537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206210|NCT02097537|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6206211|NCT02097537|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
6206212|NCT02097537|Respiratory System Agents|respiratory system agents|mesh-ancestor
6206213|NCT02097537|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6206214|NCT02097537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6206215|NCT02097537|Cholinergic Agents|cholinergic agents|mesh-ancestor
6206216|NCT02097537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6206217|NCT02097537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206218|NCT02097641|Plasma-lyte 148|plasma-lyte 148|mesh-list
6206219|NCT02097641|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6206220|NCT02097641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6206221|NCT02097719|Timolol|timolol|mesh-list
6206222|NCT02097719|Bimatoprost|bimatoprost|mesh-list
6206223|NCT02097719|Travoprost|travoprost|mesh-list
6206224|NCT02097719|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6206225|NCT02097719|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6206226|NCT02097719|Adrenergic Agents|adrenergic agents|mesh-ancestor
6483636|NCT00557921|Omeprazole|omeprazole|mesh-list
6669170|NCT01536470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669171|NCT01536470|Sympathomimetics|sympathomimetics|mesh-ancestor
6166879|NCT01588561|Nicotine|nicotine|mesh-list
6166880|NCT01588561|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6166881|NCT01588561|Autonomic Agents|autonomic agents|mesh-ancestor
6166882|NCT01588561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6166883|NCT01588561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483637|NCT00557921|Clopidogrel|clopidogrel|mesh-list
6483638|NCT00557921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6483639|NCT00557921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6483640|NCT00557921|Analgesics|analgesics|mesh-ancestor
6483641|NCT00557921|Sensory System Agents|sensory system agents|mesh-ancestor
6483642|NCT00557921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6483643|NCT00557921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483644|NCT00557921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6483645|NCT00557921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6483646|NCT00557921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6483647|NCT00557921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6483648|NCT00557921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483649|NCT00557921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6483650|NCT00557921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6483651|NCT00557921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6669172|NCT01536470|Autonomic Agents|autonomic agents|mesh-ancestor
6166884|NCT01588561|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6166885|NCT01588561|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6166886|NCT01588561|Cholinergic Agents|cholinergic agents|mesh-ancestor
6166887|NCT01588561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6166888|NCT01588561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166889|NCT01588951|Cytarabine|cytarabine|mesh-list
6166890|NCT01588951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6166891|NCT01588951|Antimetabolites|antimetabolites|mesh-ancestor
6166892|NCT01588951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166893|NCT01588951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6166894|NCT01588951|Antiviral Agents|antiviral agents|mesh-ancestor
6166895|NCT01588951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6166896|NCT01588951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6166897|NCT01588951|Immunologic Factors|immunologic factors|mesh-ancestor
6166898|NCT01588951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166899|NCT01588990|Leucovorin|leucovorin|mesh-list
6166900|NCT01588990|Bevacizumab|bevacizumab|mesh-list
6166901|NCT01588990|Capecitabine|capecitabine|mesh-list
6166902|NCT01588990|Oxaliplatin|oxaliplatin|mesh-list
6166903|NCT01588990|Irinotecan|irinotecan|mesh-list
6166904|NCT01588990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6166905|NCT01588990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6166906|NCT01588990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6166907|NCT01588990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6669173|NCT01536470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6669174|NCT01536470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6669175|NCT01536600|Insulin Aspart|insulin aspart|mesh-list
6669176|NCT01536600|Biphasic Insulins|biphasic insulins|mesh-list
6669177|NCT01536600|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6669178|NCT01536600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6669179|NCT01536600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669180|NCT01536613|Insulin Aspart|insulin aspart|mesh-list
6669181|NCT01536613|Biphasic Insulins|biphasic insulins|mesh-list
6669182|NCT01536613|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6669183|NCT01536613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6669184|NCT01536613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669185|NCT01536626|Insulin Aspart|insulin aspart|mesh-list
6669186|NCT01536626|Biphasic Insulins|biphasic insulins|mesh-list
6669187|NCT01536626|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6669188|NCT01536626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6669189|NCT01536626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669190|NCT01536639|Insulin Aspart|insulin aspart|mesh-list
6669191|NCT01536639|Biphasic Insulins|biphasic insulins|mesh-list
6166908|NCT01588990|Growth Substances|growth substances|mesh-ancestor
6166909|NCT01588990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166910|NCT01588990|Growth Inhibitors|growth inhibitors|mesh-ancestor
6166911|NCT01588990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6166912|NCT01588990|Antimetabolites|antimetabolites|mesh-ancestor
6166913|NCT01588990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166914|NCT01588990|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6166915|NCT01588990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5565051|NCT03978884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565052|NCT03978884|Vasodilator Agents|vasodilator agents|mesh-ancestor
5565053|NCT03978884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5565054|NCT03978884|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5565055|NCT03978884|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5565056|NCT03978884|Diuretics|diuretics|mesh-ancestor
5565057|NCT03978884|Natriuretic Agents|natriuretic agents|mesh-ancestor
5565058|NCT03978884|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5565059|NCT03979131|Avelumab|avelumab|mesh-list
5565060|NCT03979131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5565061|NCT03979131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5603863|NCT01127256|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5603864|NCT01127256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5603865|NCT01127256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5603866|NCT00978458|Temozolomide|temozolomide|mesh-list
5603867|NCT00978458|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5603868|NCT00978458|Alkylating Agents|alkylating agents|mesh-ancestor
5603869|NCT00978458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603870|NCT00978458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5603871|NCT00769327|Imatinib Mesylate|imatinib mesylate|mesh-list
5603872|NCT00769327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5603873|NCT00769327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5603874|NCT00769327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6669192|NCT01536639|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6669193|NCT01536639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6669194|NCT01536639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669195|NCT01536652|Insulin Aspart|insulin aspart|mesh-list
6669196|NCT01536652|Biphasic Insulins|biphasic insulins|mesh-list
6669197|NCT01536652|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6669198|NCT01536652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6166916|NCT01588990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6166917|NCT01588990|Antidotes|antidotes|mesh-ancestor
5603875|NCT00769327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603876|NCT00482833|Methotrexate|methotrexate|mesh-list
5603877|NCT00482833|Mercaptopurine|mercaptopurine|mesh-list
5603878|NCT00482833|Idarubicin|idarubicin|mesh-list
6166918|NCT01588990|Protective Agents|protective agents|mesh-ancestor
6166919|NCT01588990|Vitamin B Complex|vitamin b complex|mesh-ancestor
6166920|NCT01588990|Vitamins|vitamins|mesh-ancestor
6166921|NCT01588990|Micronutrients|micronutrients|mesh-ancestor
6166922|NCT01589094|Gemcitabine|gemcitabine|mesh-list
6166923|NCT01589094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6166924|NCT01589094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6166925|NCT01589094|Antimetabolites|antimetabolites|mesh-ancestor
6166926|NCT01589094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166927|NCT01589094|Antiviral Agents|antiviral agents|mesh-ancestor
6166928|NCT01589094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6166929|NCT01589094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6669199|NCT01536652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669200|NCT01536665|Liraglutide|liraglutide|mesh-list
6669201|NCT01536665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6669202|NCT01536665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669203|NCT01536665|Incretins|incretins|mesh-ancestor
6166930|NCT01589094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6166931|NCT01589094|Immunologic Factors|immunologic factors|mesh-ancestor
6166932|NCT01589094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166933|NCT01589263|Tamsulosin|tamsulosin|mesh-list
6166934|NCT01589263|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6166935|NCT01589263|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6166936|NCT01589263|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6166937|NCT01589263|Adrenergic Agents|adrenergic agents|mesh-ancestor
6166938|NCT01589263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6166939|NCT01589263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6166940|NCT01589263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166941|NCT01589263|Urological Agents|urological agents|mesh-ancestor
6166942|NCT01589445|Metformin|metformin|mesh-list
6166943|NCT01589445|Pioglitazone|pioglitazone|mesh-list
6166944|NCT01589445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6166945|NCT01589445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603879|NCT00482833|Tretinoin|tretinoin|mesh-list
5603880|NCT00482833|Arsenic Trioxide|arsenic trioxide|mesh-list
6166946|NCT01589497|Moxifloxacin|moxifloxacin|mesh-list
5603881|NCT00482833|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5603882|NCT00482833|Abortifacient Agents|abortifacient agents|mesh-ancestor
6166947|NCT01589497|Rifampin|rifampin|mesh-list
6166948|NCT01589497|Isoniazid|isoniazid|mesh-list
6166949|NCT01589497|Pyrazinamide|pyrazinamide|mesh-list
6483652|NCT00557921|Antipyretics|antipyretics|mesh-ancestor
6483653|NCT00557921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6483654|NCT00557921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6483655|NCT00557921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6483656|NCT00557921|Purinergic Agents|purinergic agents|mesh-ancestor
6483657|NCT00557921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6483658|NCT00557921|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6483659|NCT00557921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6483660|NCT00557921|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6483661|NCT00557934|Dobutamine|dobutamine|mesh-list
6483662|NCT00557934|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6483663|NCT00557934|Sympathomimetics|sympathomimetics|mesh-ancestor
6483664|NCT00557934|Autonomic Agents|autonomic agents|mesh-ancestor
6483665|NCT00557934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6483666|NCT00557934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483667|NCT00557934|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6483668|NCT00557934|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6483669|NCT00557934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6166950|NCT01589497|Ethambutol|ethambutol|mesh-list
6166951|NCT01589497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6166952|NCT01589497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6166953|NCT01589497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6166954|NCT01589497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6669204|NCT01536665|Hormones|hormones|mesh-ancestor
6669205|NCT01536665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6669206|NCT01536691|Ondansetron|ondansetron|mesh-list
6669207|NCT01536691|Aprepitant|aprepitant|mesh-list
6166955|NCT01589497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6166956|NCT01589497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483670|NCT00557934|Adrenergic Agents|adrenergic agents|mesh-ancestor
6483671|NCT00557934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6483672|NCT00557934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483673|NCT00557934|Protective Agents|protective agents|mesh-ancestor
6483674|NCT00557960|Amphetamine|amphetamine|mesh-list
6483675|NCT00557960|Adderall|adderall|mesh-list
6483676|NCT00557960|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6483677|NCT00557960|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6166957|NCT01589497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6166958|NCT01589497|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6483678|NCT00557960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5565062|NCT03978845|Lidocaine|lidocaine|mesh-list
5565063|NCT03978845|Anesthetics, Local|anesthetics, local|mesh-list
5565064|NCT03978845|Anesthetics|anesthetics|mesh-list
5565065|NCT03978845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5565066|NCT03978845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565067|NCT03978845|Sensory System Agents|sensory system agents|mesh-ancestor
5565068|NCT03978845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5565069|NCT03978845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5565070|NCT03978845|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5565071|NCT03978845|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5565072|NCT03978845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5565073|NCT03978845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5565074|NCT03978689|Pembrolizumab|pembrolizumab|mesh-list
6483679|NCT00557960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6483680|NCT00557960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483681|NCT00557960|Adrenergic Agents|adrenergic agents|mesh-ancestor
6483682|NCT00557960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6483683|NCT00557960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483684|NCT00557960|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6483685|NCT00557960|Sympathomimetics|sympathomimetics|mesh-ancestor
6483686|NCT00557960|Autonomic Agents|autonomic agents|mesh-ancestor
6483687|NCT00557960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6483688|NCT00557960|Dopamine Agents|dopamine agents|mesh-ancestor
6483689|NCT00557960|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6483690|NCT00558051|Vaccines|vaccines|mesh-list
6483691|NCT00558051|Immunologic Factors|immunologic factors|mesh-ancestor
6483692|NCT00558051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483693|NCT00558077|Metformin|metformin|mesh-list
6483694|NCT00558077|Clomiphene|clomiphene|mesh-list
6483695|NCT00558077|Enclomiphene|enclomiphene|mesh-list
6483696|NCT00558077|Zuclomiphene|zuclomiphene|mesh-list
6483697|NCT00558077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6483698|NCT00558077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669208|NCT01536691|Fosaprepitant|fosaprepitant|mesh-list
6166959|NCT01589497|Antitubercular Agents|antitubercular agents|mesh-ancestor
6166960|NCT01589497|Leprostatic Agents|leprostatic agents|mesh-ancestor
6166961|NCT01589497|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6166962|NCT01589497|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6166963|NCT01589497|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6166964|NCT01589497|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6166965|NCT01589497|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6166966|NCT01589497|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6166967|NCT01589497|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6166968|NCT01589497|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6166969|NCT01589497|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6166970|NCT01589497|Antimetabolites|antimetabolites|mesh-ancestor
6166971|NCT01589497|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6166972|NCT01589510|Bimatoprost|bimatoprost|mesh-list
6166973|NCT01589510|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6166974|NCT01589510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5565075|NCT03978689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5565076|NCT03978689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5565077|NCT03978598|Etonogestrel|etonogestrel|mesh-list
5565078|NCT03978598|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5565079|NCT03978598|Contraceptive Agents|contraceptive agents|mesh-ancestor
5565080|NCT03978598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5565081|NCT03978598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565082|NCT03978598|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5565083|NCT03978442|Bupropion|bupropion|mesh-list
5565084|NCT03978442|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5565085|NCT03978442|Antidepressive Agents|antidepressive agents|mesh-ancestor
5565086|NCT03978442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5565087|NCT03978442|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5565088|NCT03978442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5565089|NCT03978442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5565090|NCT03978442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5565091|NCT03978442|Dopamine Agents|dopamine agents|mesh-ancestor
5565092|NCT03978442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5565093|NCT03978442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565094|NCT03978442|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5565095|NCT03978442|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6166975|NCT01589510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6166976|NCT01589653|Insulin|insulin|mesh-list
6166977|NCT01589653|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6166978|NCT01589653|Insulin Aspart|insulin aspart|mesh-list
6166979|NCT01589653|Insulin, Long-Acting|insulin, long-acting|mesh-list
6166980|NCT01589653|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6166981|NCT01589653|Biphasic Insulins|biphasic insulins|mesh-list
6166982|NCT01589653|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6166983|NCT01589653|Insulin, Isophane|insulin, isophane|mesh-list
6166984|NCT01589653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6166985|NCT01589653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6166986|NCT01589822|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
5565096|NCT03978442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5565097|NCT03978494|Tacrolimus|tacrolimus|mesh-list
5565098|NCT03978494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5565099|NCT03978494|Immunologic Factors|immunologic factors|mesh-ancestor
5565100|NCT03978494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565101|NCT03978494|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5565102|NCT03978494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5565103|NCT03978494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5565104|NCT03978559|Trimethoprim|trimethoprim|mesh-list
6166987|NCT01589822|Hemostatics|hemostatics|mesh-ancestor
6166988|NCT01589822|Coagulants|coagulants|mesh-ancestor
6166989|NCT01589978|Aspirin|aspirin|mesh-list
6166990|NCT01589978|Salicylic Acid|salicylic acid|mesh-list
6166991|NCT01589978|Salicylates|salicylates|mesh-list
6166992|NCT01589978|Ticlopidine|ticlopidine|mesh-list
6166993|NCT01589978|Clopidogrel|clopidogrel|mesh-list
6166994|NCT01589978|Ticagrelor|ticagrelor|mesh-list
6166995|NCT01589978|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6166996|NCT01589978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6166997|NCT01589978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6166998|NCT01589978|Analgesics|analgesics|mesh-ancestor
6166999|NCT01589978|Sensory System Agents|sensory system agents|mesh-ancestor
6167000|NCT01589978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6167001|NCT01589978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167002|NCT01589978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6167003|NCT01589978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6167004|NCT01589978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6669209|NCT01536691|Ramosetron|ramosetron|mesh-list
6669210|NCT01536691|Antiemetics|antiemetics|mesh-ancestor
6669211|NCT01536691|Autonomic Agents|autonomic agents|mesh-ancestor
6669212|NCT01536691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6669213|NCT01536691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167005|NCT01589978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6167006|NCT01589978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6167007|NCT01589978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6167008|NCT01589978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6167009|NCT01589978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6167010|NCT01589978|Antipyretics|antipyretics|mesh-ancestor
6167011|NCT01589978|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6483699|NCT00558077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6483700|NCT00558077|Hormone Antagonists|hormone antagonists|mesh-ancestor
6483701|NCT00558077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6483702|NCT00558077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6483703|NCT00558077|Fertility Agents|fertility agents|mesh-ancestor
6483704|NCT00558077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6483705|NCT00558077|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6483706|NCT00558077|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6483707|NCT00558090|Morphine|morphine|mesh-list
6483708|NCT00558090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6483709|NCT00558090|Narcotics|narcotics|mesh-ancestor
6483710|NCT00558090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6483711|NCT00558090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483712|NCT00558090|Analgesics|analgesics|mesh-ancestor
6167012|NCT01589978|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6167013|NCT01589978|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6167014|NCT01589978|Purinergic Agents|purinergic agents|mesh-ancestor
6167015|NCT01589978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6167016|NCT01589978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6167017|NCT01589978|Antifungal Agents|antifungal agents|mesh-ancestor
6167018|NCT01589978|Keratolytic Agents|keratolytic agents|mesh-ancestor
6167019|NCT01589978|Dermatologic Agents|dermatologic agents|mesh-ancestor
6167020|NCT01589978|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6167021|NCT01589978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6167022|NCT01590017|Cisplatin|cisplatin|mesh-list
6167023|NCT01590017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6167024|NCT01590082|Doxycycline|doxycycline|mesh-list
6167025|NCT01590082|Temozolomide|temozolomide|mesh-list
6669214|NCT01536691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6669215|NCT01536691|Antipruritics|antipruritics|mesh-ancestor
6488950|NCT00588003|Hormone Antagonists|hormone antagonists|mesh-ancestor
5565105|NCT03978559|Caspofungin|caspofungin|mesh-list
5565106|NCT03978559|Sulfisoxazole|sulfisoxazole|mesh-list
6167026|NCT01590082|Ipilimumab|ipilimumab|mesh-list
6167027|NCT01590082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6669216|NCT01536691|Dermatologic Agents|dermatologic agents|mesh-ancestor
6669217|NCT01536691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6669218|NCT01536691|Serotonin Agents|serotonin agents|mesh-ancestor
6669219|NCT01536691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6669220|NCT01536691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669221|NCT01536691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6669222|NCT01536691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6669223|NCT01536691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6669224|NCT01536691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6669225|NCT01536691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6669226|NCT01536691|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6669227|NCT01536717|Carticaine|carticaine|mesh-list
6669228|NCT01536717|Anesthetics, Local|anesthetics, local|mesh-ancestor
6669229|NCT01536717|Anesthetics|anesthetics|mesh-ancestor
6669230|NCT01536717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6669231|NCT01536717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669232|NCT01536717|Sensory System Agents|sensory system agents|mesh-ancestor
6669233|NCT01536717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6669234|NCT01536743|Palbociclib|palbociclib|mesh-list
6669235|NCT01536743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6669236|NCT01536743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6669237|NCT01536743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6669238|NCT01536743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669239|NCT01536873|Dolutegravir|dolutegravir|mesh-list
6669240|NCT01536873|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6669241|NCT01536873|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6669242|NCT01536873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6669243|NCT01536873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669244|NCT01536873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6669245|NCT01536873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6669246|NCT01536873|Antiviral Agents|antiviral agents|mesh-ancestor
6669247|NCT01536873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6669248|NCT01536964|Morphine|morphine|mesh-list
6669249|NCT01536964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6669250|NCT01536964|Narcotics|narcotics|mesh-ancestor
6669251|NCT01536964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6669252|NCT01536964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669253|NCT01536964|Analgesics|analgesics|mesh-ancestor
6669254|NCT01536964|Sensory System Agents|sensory system agents|mesh-ancestor
6669255|NCT01536964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6669256|NCT01537055|Amoxicillin|amoxicillin|mesh-list
6669257|NCT01537055|Levofloxacin|levofloxacin|mesh-list
6669258|NCT01537055|Ofloxacin|ofloxacin|mesh-list
6669259|NCT01537055|Lansoprazole|lansoprazole|mesh-list
6669260|NCT01537055|Dexlansoprazole|dexlansoprazole|mesh-list
6483713|NCT00558090|Sensory System Agents|sensory system agents|mesh-ancestor
6483714|NCT00558090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6483715|NCT00558142|Acetylcysteine|acetylcysteine|mesh-list
6483716|NCT00558142|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6483717|NCT00558142|Antiviral Agents|antiviral agents|mesh-ancestor
6483718|NCT00558142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6483719|NCT00558142|Expectorants|expectorants|mesh-ancestor
6483720|NCT00558142|Respiratory System Agents|respiratory system agents|mesh-ancestor
6483721|NCT00558142|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6483722|NCT00558142|Antioxidants|antioxidants|mesh-ancestor
6483723|NCT00558142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483724|NCT00558142|Protective Agents|protective agents|mesh-ancestor
6483725|NCT00558142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669261|NCT01537055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6669262|NCT01537055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6669263|NCT01537055|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6669264|NCT01537055|Renal Agents|renal agents|mesh-ancestor
6669265|NCT01537055|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6669266|NCT01537055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6669267|NCT01537055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6669268|NCT01537055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669269|NCT01537055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6669270|NCT01537055|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6669271|NCT01537055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6669272|NCT01537055|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6669273|NCT01537055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6669274|NCT01537055|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6669275|NCT01537094|Vitamins|vitamins|mesh-list
6483726|NCT00558142|Antidotes|antidotes|mesh-ancestor
6483727|NCT00558181|Methylprednisolone|methylprednisolone|mesh-list
6669276|NCT01537094|Ascorbic Acid|ascorbic acid|mesh-list
6669277|NCT01537094|Micronutrients|micronutrients|mesh-ancestor
6669278|NCT01537094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669279|NCT01537094|Antioxidants|antioxidants|mesh-ancestor
6669280|NCT01537094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669281|NCT01537094|Protective Agents|protective agents|mesh-ancestor
6669282|NCT01537107|Sirolimus|sirolimus|mesh-list
6669283|NCT01537107|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6669284|NCT01537107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6669285|NCT01537107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6167028|NCT01590082|Alkylating Agents|alkylating agents|mesh-ancestor
6167029|NCT01590082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6167030|NCT01590082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6167031|NCT01590082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6167032|NCT01590082|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6167033|NCT01590082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6167034|NCT01590082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5565107|NCT03978559|Methylprednisolone|methylprednisolone|mesh-list
5565108|NCT03978559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5565109|NCT03978559|Antiemetics|antiemetics|mesh-ancestor
5565110|NCT03978559|Autonomic Agents|autonomic agents|mesh-ancestor
5565111|NCT03978559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5565112|NCT03978559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565113|NCT03978559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5565114|NCT03978559|Glucocorticoids|glucocorticoids|mesh-ancestor
5565115|NCT03978559|Hormones|hormones|mesh-ancestor
5565116|NCT03978559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5565117|NCT03978559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5565118|NCT03978559|Protective Agents|protective agents|mesh-ancestor
5565119|NCT03978559|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5565120|NCT03978559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5565121|NCT03978559|Renal Agents|renal agents|mesh-ancestor
5565122|NCT03978559|Antimalarials|antimalarials|mesh-ancestor
5565123|NCT03978559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5565124|NCT03978559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5565125|NCT03978559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5565126|NCT03978559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5565127|NCT03978559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5565128|NCT03978559|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6167035|NCT01590082|Antimalarials|antimalarials|mesh-ancestor
6167036|NCT01590082|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6167037|NCT01590082|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6167038|NCT01590433|Exenatide|exenatide|mesh-list
6483728|NCT00558181|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6483729|NCT00558181|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6483730|NCT00558181|Prednisolone|prednisolone|mesh-list
6483731|NCT00558181|Prednisolone acetate|prednisolone acetate|mesh-list
5565129|NCT03978559|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
5565130|NCT03978559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5565131|NCT03978559|Antifungal Agents|antifungal agents|mesh-ancestor
6483732|NCT00558181|Rituximab|rituximab|mesh-list
6167039|NCT01590433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6167040|NCT01590433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167041|NCT01590433|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5565132|NCT03978364|Azacitidine|azacitidine|mesh-list
6167042|NCT01590433|Incretins|incretins|mesh-ancestor
6167043|NCT01590433|Hormones|hormones|mesh-ancestor
6167044|NCT01590433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6167045|NCT01590550|Dialysis Solutions|dialysis solutions|mesh-list
6167046|NCT01590550|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6167047|NCT01590758|Pexiganan|pexiganan|mesh-list
6167048|NCT01590758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6167049|NCT01590758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6167050|NCT01590771|Metformin|metformin|mesh-list
6483733|NCT00558181|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6483734|NCT00558181|Prednisolone phosphate|prednisolone phosphate|mesh-list
6483735|NCT00558181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6483736|NCT00558181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6483737|NCT00558181|Immunologic Factors|immunologic factors|mesh-ancestor
6483738|NCT00558181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167051|NCT01590771|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6669286|NCT01537107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6669287|NCT01537107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6669288|NCT01537107|Antifungal Agents|antifungal agents|mesh-ancestor
6669289|NCT01537107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6669290|NCT01537107|Immunologic Factors|immunologic factors|mesh-ancestor
6669291|NCT01537107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669292|NCT01537107|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6669293|NCT01537107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669294|NCT01537146|Ropivacaine|ropivacaine|mesh-list
6669295|NCT01537146|Anesthetics, Local|anesthetics, local|mesh-ancestor
6669296|NCT01537146|Anesthetics|anesthetics|mesh-ancestor
6669297|NCT01537146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6669298|NCT01537146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669299|NCT01537146|Sensory System Agents|sensory system agents|mesh-ancestor
6669300|NCT01537146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6672472|NCT01556334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672473|NCT01556477|Lenalidomide|lenalidomide|mesh-list
6672474|NCT01556477|Azacitidine|azacitidine|mesh-list
5565133|NCT03978364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5565134|NCT03978364|Antimetabolites|antimetabolites|mesh-ancestor
5565135|NCT03978364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5565136|NCT03978364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5565137|NCT03978364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5565138|NCT03978286|Vortioxetine|vortioxetine|mesh-list
5565139|NCT03978286|Sertraline|sertraline|mesh-list
5565140|NCT03978286|Antidepressive Agents|antidepressive agents|mesh-ancestor
5565141|NCT03978286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5565142|NCT03978286|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5565143|NCT03978286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5565144|NCT03978286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5565145|NCT03978286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5565146|NCT03978286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5565147|NCT03978286|Serotonin Agents|serotonin agents|mesh-ancestor
5565148|NCT03978286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565149|NCT03978286|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5565150|NCT03978286|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5565151|NCT03978286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5565152|NCT03978286|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6167052|NCT01590771|Glimepiride|glimepiride|mesh-list
6167053|NCT01590771|Gliclazide|gliclazide|mesh-list
6167054|NCT01590771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6167055|NCT01590771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167056|NCT01590771|Incretins|incretins|mesh-ancestor
5565153|NCT03978286|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5565154|NCT03978286|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5565155|NCT03978286|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5565156|NCT03978208|Naproxen|naproxen|mesh-list
5565157|NCT03978208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5565158|NCT03978208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5565159|NCT03978208|Analgesics|analgesics|mesh-ancestor
5565160|NCT03978208|Sensory System Agents|sensory system agents|mesh-ancestor
5565161|NCT03978208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5565162|NCT03978208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565163|NCT03978208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5565164|NCT03978208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5565165|NCT03978208|Gout Suppressants|gout suppressants|mesh-ancestor
5565166|NCT03978208|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5565167|NCT03978208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5565168|NCT03978208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5565169|NCT03978052|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
5565170|NCT03978052|Antioxidants|antioxidants|mesh-ancestor
6167057|NCT01590771|Hormones|hormones|mesh-ancestor
6167058|NCT01590771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6167059|NCT01590771|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6167060|NCT01590771|Protease Inhibitors|protease inhibitors|mesh-ancestor
6167061|NCT01590771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6483739|NCT00558181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6483740|NCT00558181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6483741|NCT00558181|Antiemetics|antiemetics|mesh-ancestor
6483742|NCT00558181|Autonomic Agents|autonomic agents|mesh-ancestor
6483743|NCT00558181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6483744|NCT00558181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6483745|NCT00558181|Glucocorticoids|glucocorticoids|mesh-ancestor
6483746|NCT00558181|Hormones|hormones|mesh-ancestor
6483747|NCT00558181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6483748|NCT00558181|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6483749|NCT00558181|Protective Agents|protective agents|mesh-ancestor
6483750|NCT00558181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6483751|NCT00558298|Risperidone|risperidone|mesh-list
6483752|NCT00558298|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6672475|NCT01556477|Immunologic Factors|immunologic factors|mesh-ancestor
5565171|NCT03978052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5565172|NCT03978052|Protective Agents|protective agents|mesh-ancestor
6167062|NCT01590771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6167063|NCT01590771|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6167064|NCT01590771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6167065|NCT01590771|Immunologic Factors|immunologic factors|mesh-ancestor
5565173|NCT03978052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565174|NCT03978052|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
5565175|NCT03978052|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5565176|NCT03978052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5565177|NCT03978052|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5565178|NCT03978156|Dronabinol|dronabinol|mesh-list
5565179|NCT03978156|Hallucinogens|hallucinogens|mesh-ancestor
5565180|NCT03978156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167066|NCT01590797|Metformin|metformin|mesh-list
6167067|NCT01590797|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6167068|NCT01590797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6167069|NCT01590797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167070|NCT01590797|Incretins|incretins|mesh-ancestor
6167071|NCT01590797|Hormones|hormones|mesh-ancestor
6167072|NCT01590797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6167073|NCT01590797|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6167074|NCT01590797|Protease Inhibitors|protease inhibitors|mesh-ancestor
6167075|NCT01590797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6167076|NCT01590797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6167077|NCT01590875|Adenosine|adenosine|mesh-list
6167078|NCT01590875|Analgesics|analgesics|mesh-ancestor
6167079|NCT01590875|Sensory System Agents|sensory system agents|mesh-ancestor
6167080|NCT01590875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6167081|NCT01590875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167082|NCT01590875|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6167083|NCT01590875|Vasodilator Agents|vasodilator agents|mesh-ancestor
6167084|NCT01590875|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6167085|NCT01590875|Purinergic Agonists|purinergic agonists|mesh-ancestor
6167086|NCT01590875|Purinergic Agents|purinergic agents|mesh-ancestor
6167087|NCT01590875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6167088|NCT01590875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6167089|NCT01590979|Ranolazine|ranolazine|mesh-list
6167090|NCT01590979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6167091|NCT01590979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6167092|NCT01590979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6167093|NCT01591317|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6167094|NCT01591317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6167095|NCT01591382|Ketamine|ketamine|mesh-list
6167096|NCT01591382|Hydromorphone|hydromorphone|mesh-list
6167097|NCT01591382|Analgesics|analgesics|mesh-ancestor
6167098|NCT01591382|Sensory System Agents|sensory system agents|mesh-ancestor
6167099|NCT01591382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6167100|NCT01591382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565181|NCT03978156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5565182|NCT03978156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5565183|NCT03978156|Analgesics|analgesics|mesh-ancestor
5565184|NCT03978156|Sensory System Agents|sensory system agents|mesh-ancestor
5565185|NCT03978156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5565186|NCT03978156|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5565187|NCT03978156|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5565188|NCT03978156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6167101|NCT01591382|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6167102|NCT01591382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6167103|NCT01591382|Anesthetics, General|anesthetics, general|mesh-ancestor
6167104|NCT01591382|Anesthetics|anesthetics|mesh-ancestor
6167105|NCT01591382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6167106|NCT01591382|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6167107|NCT01591382|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6167108|NCT01591382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6167109|NCT01591382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6167110|NCT01591382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6167111|NCT01591382|Narcotics|narcotics|mesh-ancestor
6669301|NCT01537250|Levofloxacin|levofloxacin|mesh-list
6669302|NCT01537250|Ofloxacin|ofloxacin|mesh-list
6669303|NCT01537250|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6669304|NCT01537250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6669305|NCT01537250|Renal Agents|renal agents|mesh-ancestor
6669306|NCT01537250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6167112|NCT01591460|Ribavirin|ribavirin|mesh-list
6167113|NCT01591460|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6167114|NCT01591460|Interferon-alpha|interferon-alpha|mesh-list
6167115|NCT01591460|Antimetabolites|antimetabolites|mesh-ancestor
6167116|NCT01591460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6167117|NCT01591460|Antiviral Agents|antiviral agents|mesh-ancestor
6167118|NCT01591460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6167119|NCT01591460|Immunologic Factors|immunologic factors|mesh-ancestor
6669307|NCT01537250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6669308|NCT01537250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6669309|NCT01537250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6669310|NCT01537250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669311|NCT01537250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6669312|NCT01537250|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6669313|NCT01537250|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6669314|NCT01537354|Poractant alfa|poractant alfa|mesh-list
6669315|NCT01537354|Beractant|beractant|mesh-list
6669316|NCT01537354|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
6669317|NCT01537354|Respiratory System Agents|respiratory system agents|mesh-ancestor
6167120|NCT01591460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669318|NCT01537380|Cefazolin|cefazolin|mesh-list
6669319|NCT01537380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6669320|NCT01537380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6669321|NCT01537471|Meclizine|meclizine|mesh-list
6669322|NCT01537471|Dimenhydrinate|dimenhydrinate|mesh-list
6669323|NCT01537471|Antiemetics|antiemetics|mesh-ancestor
6669324|NCT01537471|Autonomic Agents|autonomic agents|mesh-ancestor
6669325|NCT01537471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6669326|NCT01537471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669327|NCT01537471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6669328|NCT01537471|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6669329|NCT01537471|Histamine Antagonists|histamine antagonists|mesh-ancestor
6669330|NCT01537471|Histamine Agents|histamine agents|mesh-ancestor
6669331|NCT01537471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6669332|NCT01537471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669333|NCT01537471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6669334|NCT01537575|Immunoglobulins|immunoglobulins|mesh-list
6669335|NCT01537575|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6669336|NCT01537575|Antibodies|antibodies|mesh-list
6669337|NCT01537575|gamma-Globulins|gamma-globulins|mesh-list
6669338|NCT01537575|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6669339|NCT01537575|Immunologic Factors|immunologic factors|mesh-ancestor
6669340|NCT01537575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669341|NCT01537601|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6669342|NCT01537601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6669343|NCT01537640|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6669344|NCT01537640|Immunologic Factors|immunologic factors|mesh-ancestor
6669345|NCT01537640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669346|NCT01537744|Azacitidine|azacitidine|mesh-list
6669347|NCT01537744|Romidepsin|romidepsin|mesh-list
6669348|NCT01537744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6669349|NCT01537744|Antimetabolites|antimetabolites|mesh-ancestor
6669350|NCT01537744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669351|NCT01537744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6669352|NCT01537744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6669353|NCT01537744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6669354|NCT01537770|Lidocaine|lidocaine|mesh-list
6669355|NCT01537770|Anesthetics, Local|anesthetics, local|mesh-ancestor
5565189|NCT03978156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5565190|NCT03978156|Hormones|hormones|mesh-ancestor
5565191|NCT03978156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5565192|NCT03978234|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5565193|NCT03978234|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5565194|NCT03978234|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5565195|NCT03978234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5565196|NCT03978234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5565197|NCT03978234|Cholinergic Agents|cholinergic agents|mesh-ancestor
5565198|NCT03978234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5565199|NCT03978234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565200|NCT03978234|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5565201|NCT03978234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5565202|NCT03977675|Ketamine|ketamine|mesh-list
5565203|NCT03977675|Analgesics|analgesics|mesh-ancestor
5565204|NCT03977675|Sensory System Agents|sensory system agents|mesh-ancestor
6167121|NCT01591616|Lidocaine|lidocaine|mesh-list
6167122|NCT01591616|Prilocaine|prilocaine|mesh-list
6669356|NCT01537770|Anesthetics|anesthetics|mesh-ancestor
6669357|NCT01537770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5565205|NCT03977675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5565206|NCT03977675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565207|NCT03977675|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5565208|NCT03977675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5565209|NCT03977675|Anesthetics, General|anesthetics, general|mesh-ancestor
6669358|NCT01537770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669359|NCT01537770|Sensory System Agents|sensory system agents|mesh-ancestor
6669360|NCT01537770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6167123|NCT01591616|Anesthetics, Local|anesthetics, local|mesh-ancestor
6167124|NCT01591616|Anesthetics|anesthetics|mesh-ancestor
6167125|NCT01591616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6167126|NCT01591616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167127|NCT01591616|Sensory System Agents|sensory system agents|mesh-ancestor
6167128|NCT01591616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6167129|NCT01591616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6167130|NCT01591616|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6167131|NCT01591616|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6167132|NCT01591616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6167133|NCT01591616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6167134|NCT01591733|Capecitabine|capecitabine|mesh-list
6167135|NCT01591733|Oxaliplatin|oxaliplatin|mesh-list
6167136|NCT01591733|Irinotecan|irinotecan|mesh-list
6483753|NCT00558298|Serotonin Agents|serotonin agents|mesh-ancestor
6483754|NCT00558298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6483755|NCT00558298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483756|NCT00558298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483757|NCT00558298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6483758|NCT00558298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6483759|NCT00558298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6483760|NCT00558298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6483761|NCT00558298|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6483762|NCT00558298|Dopamine Agents|dopamine agents|mesh-ancestor
6483763|NCT00558337|Levodopa|levodopa|mesh-list
6483764|NCT00558337|Carbidopa|carbidopa|mesh-list
6483765|NCT00558337|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
6483766|NCT00558337|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6483767|NCT00558337|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6483768|NCT00558337|Dopamine Agents|dopamine agents|mesh-ancestor
6483769|NCT00558337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6483770|NCT00558337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6167137|NCT01591733|Folfirinox|folfirinox|mesh-list
6167138|NCT01591733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6167139|NCT01591733|Antimetabolites|antimetabolites|mesh-ancestor
6167140|NCT01591733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6167141|NCT01591733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6167142|NCT01591733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6167143|NCT01591733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6167144|NCT01591733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6167145|NCT01591746|Botulinum Toxins|botulinum toxins|mesh-list
6167146|NCT01591746|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6167147|NCT01591746|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6167148|NCT01591746|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6167149|NCT01591746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6483771|NCT00558337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483772|NCT00558337|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6483773|NCT00558337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5565210|NCT03977675|Anesthetics|anesthetics|mesh-ancestor
5565211|NCT03977675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5565212|NCT03977675|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5565213|NCT03977675|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5565214|NCT03977675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5565215|NCT03977675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5565216|NCT03977792|Docosanol|docosanol|mesh-list
5565217|NCT03977792|Antiviral Agents|antiviral agents|mesh-ancestor
5565218|NCT03977792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5565219|NCT03977649|Erenumab|erenumab|mesh-list
5565220|NCT03977649|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
6167150|NCT01591746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483774|NCT00558337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6483775|NCT00558337|Immunologic Factors|immunologic factors|mesh-ancestor
6167151|NCT01591746|Cholinergic Agents|cholinergic agents|mesh-ancestor
6167152|NCT01591746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6167153|NCT01591746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167154|NCT01591746|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6167155|NCT01591746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6167156|NCT01591785|Retapamulin|retapamulin|mesh-list
6167157|NCT01591785|Petrolatum|petrolatum|mesh-list
5565221|NCT03977649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5565222|NCT03977649|Analgesics|analgesics|mesh-ancestor
5565223|NCT03977649|Sensory System Agents|sensory system agents|mesh-ancestor
5565224|NCT03977649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5565225|NCT03977649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565226|NCT03977493|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
5565227|NCT03977493|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5565228|NCT03977493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5565229|NCT03977493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565230|NCT03977493|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5565231|NCT03977493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5565232|NCT03977493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5565233|NCT03977493|Cholinergic Agents|cholinergic agents|mesh-ancestor
5565234|NCT03977493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5565235|NCT03977441|Pramipexole|pramipexole|mesh-list
5565236|NCT03977441|S 20098|s 20098|mesh-list
5565237|NCT03977441|Antioxidants|antioxidants|mesh-ancestor
5565238|NCT03977441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5565239|NCT03977441|Protective Agents|protective agents|mesh-ancestor
5565240|NCT03977441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565241|NCT03977441|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5565242|NCT03977441|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5565243|NCT03977441|Dopamine Agonists|dopamine agonists|mesh-ancestor
5565244|NCT03977441|Dopamine Agents|dopamine agents|mesh-ancestor
5565245|NCT03977441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5565246|NCT03977441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5565247|NCT03977441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6167158|NCT01591785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6167159|NCT01591785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6167160|NCT01591785|Emollients|emollients|mesh-ancestor
5565248|NCT03977571|Nivolumab|nivolumab|mesh-list
5565249|NCT03977571|Ipilimumab|ipilimumab|mesh-list
5565250|NCT03977571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5565251|NCT03977571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5565252|NCT03977571|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5565253|NCT03977571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5565254|NCT03977298|Chlorhexidine|chlorhexidine|mesh-list
6167161|NCT01591785|Dermatologic Agents|dermatologic agents|mesh-ancestor
6167162|NCT01591837|Vaccines|vaccines|mesh-list
6167163|NCT01591837|Immunologic Factors|immunologic factors|mesh-ancestor
6167164|NCT01591837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167165|NCT01591863|Fidaxomicin|fidaxomicin|mesh-list
6167166|NCT01591863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6167167|NCT01591863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6167168|NCT01592006|Ribavirin|ribavirin|mesh-list
6167169|NCT01592006|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6167170|NCT01592006|Antimetabolites|antimetabolites|mesh-ancestor
6167171|NCT01592006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6167172|NCT01592006|Antiviral Agents|antiviral agents|mesh-ancestor
6167173|NCT01592006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6167174|NCT01592045|Aldesleukin|aldesleukin|mesh-list
6167175|NCT01592045|Molgramostim|molgramostim|mesh-list
6167176|NCT01592045|Dinutuximab|dinutuximab|mesh-list
6483776|NCT00558337|Dopamine Agonists|dopamine agonists|mesh-ancestor
6483777|NCT00558376|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
5565255|NCT03977298|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5565256|NCT03977298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5565257|NCT03977298|Disinfectants|disinfectants|mesh-ancestor
5565258|NCT03977220|Paclitaxel|paclitaxel|mesh-list
6167177|NCT01592045|Isotretinoin|isotretinoin|mesh-list
6167178|NCT01592045|Sargramostim|sargramostim|mesh-list
6483778|NCT00558376|Laxatives|laxatives|mesh-ancestor
6483779|NCT00558376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6483780|NCT00558454|Ferrous succinate|ferrous succinate|mesh-list
6483781|NCT00558454|Hematinics|hematinics|mesh-ancestor
6483782|NCT00558480|Vitamins|vitamins|mesh-list
6483783|NCT00558480|Vitamin A|vitamin a|mesh-list
6483784|NCT00558480|Retinol palmitate|retinol palmitate|mesh-list
6483785|NCT00558480|Micronutrients|micronutrients|mesh-ancestor
6483786|NCT00558480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483787|NCT00558480|Antioxidants|antioxidants|mesh-ancestor
6483788|NCT00558480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6167179|NCT01592045|Immunologic Factors|immunologic factors|mesh-ancestor
5565259|NCT03977220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5565260|NCT03977220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5565261|NCT03977220|Tubulin Modulators|tubulin modulators|mesh-ancestor
5565262|NCT03977220|Antimitotic Agents|antimitotic agents|mesh-ancestor
5565263|NCT03977220|Mitosis Modulators|mitosis modulators|mesh-ancestor
5565264|NCT03977220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5565265|NCT03977324|Chlorhexidine|chlorhexidine|mesh-list
5565266|NCT03977324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6167180|NCT01592045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167181|NCT01592045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6167182|NCT01592045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6167183|NCT01592045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6167184|NCT01592045|Antiviral Agents|antiviral agents|mesh-ancestor
6167185|NCT01592045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6167186|NCT01592045|Dermatologic Agents|dermatologic agents|mesh-ancestor
6167187|NCT01592240|Bococizumab|bococizumab|mesh-list
6167188|NCT01592240|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6167189|NCT01592240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6167190|NCT01592240|Antimetabolites|antimetabolites|mesh-ancestor
6167191|NCT01592240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6167192|NCT01592240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6167193|NCT01592292|Adalimumab|adalimumab|mesh-list
6167194|NCT01592292|Etanercept|etanercept|mesh-list
6167195|NCT01592292|Rituximab|rituximab|mesh-list
6167196|NCT01592292|Infliximab|infliximab|mesh-list
6167197|NCT01592292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6167198|NCT01592292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6167199|NCT01592292|Immunologic Factors|immunologic factors|mesh-ancestor
6167200|NCT01592292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167201|NCT01592292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6167202|NCT01592292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5565267|NCT03977324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5565268|NCT03977324|Disinfectants|disinfectants|mesh-ancestor
5565269|NCT03977454|Ropivacaine|ropivacaine|mesh-list
5565270|NCT03977454|Anesthetics, Local|anesthetics, local|mesh-ancestor
5565271|NCT03977454|Anesthetics|anesthetics|mesh-ancestor
5565272|NCT03977454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5565273|NCT03977454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565274|NCT03977454|Sensory System Agents|sensory system agents|mesh-ancestor
5565275|NCT03977454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6167203|NCT01592292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5565277|NCT03977285|Chlorhexidine|chlorhexidine|mesh-list
5565278|NCT03977285|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5565279|NCT03977285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5565280|NCT03977285|Disinfectants|disinfectants|mesh-ancestor
5565281|NCT03976973|Acetylcysteine|acetylcysteine|mesh-list
5565282|NCT03976973|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5565283|NCT03976973|Antiviral Agents|antiviral agents|mesh-ancestor
5565284|NCT03976973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5565285|NCT03976973|Expectorants|expectorants|mesh-ancestor
5565286|NCT03976973|Respiratory System Agents|respiratory system agents|mesh-ancestor
5565287|NCT03976973|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5565288|NCT03976973|Antioxidants|antioxidants|mesh-ancestor
5565289|NCT03976973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5565290|NCT03976973|Protective Agents|protective agents|mesh-ancestor
5565291|NCT03976973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565292|NCT03976973|Antidotes|antidotes|mesh-ancestor
5565293|NCT03977012|Buprenorphine|buprenorphine|mesh-list
5565294|NCT03977012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5565295|NCT03977012|Narcotics|narcotics|mesh-ancestor
6167204|NCT01592292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6167205|NCT01592292|Analgesics|analgesics|mesh-ancestor
6167206|NCT01592292|Sensory System Agents|sensory system agents|mesh-ancestor
6167207|NCT01592292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6483789|NCT00558480|Protective Agents|protective agents|mesh-ancestor
6483790|NCT00558480|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6483791|NCT00558480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6483792|NCT00558493|Clevudine|clevudine|mesh-list
6483793|NCT00558493|Antiviral Agents|antiviral agents|mesh-ancestor
6483794|NCT00558493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6483795|NCT00558506|Abatacept|abatacept|mesh-list
6483796|NCT00558506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6483797|NCT00558506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483798|NCT00558506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6483799|NCT00558506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6483800|NCT00558506|Immunologic Factors|immunologic factors|mesh-ancestor
6483801|NCT00558506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483802|NCT00558506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6483803|NCT00558623|Calcium Carbonate|calcium carbonate|mesh-list
6483804|NCT00558623|Calcium|calcium|mesh-list
6483805|NCT00558623|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6483806|NCT00558623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483807|NCT00558623|Antacids|antacids|mesh-ancestor
6483808|NCT00558623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483809|NCT00558623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6483810|NCT00558662|Monensin|monensin|mesh-list
6483811|NCT00558662|Antifungal Agents|antifungal agents|mesh-ancestor
6483812|NCT00558662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6483813|NCT00558662|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6483814|NCT00558662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6483815|NCT00558662|Coccidiostats|coccidiostats|mesh-ancestor
6483816|NCT00558662|Proton Ionophores|proton ionophores|mesh-ancestor
6483817|NCT00558662|Uncoupling Agents|uncoupling agents|mesh-ancestor
6483818|NCT00558662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6483819|NCT00558662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483820|NCT00558662|Ionophores|ionophores|mesh-ancestor
6483821|NCT00558662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6483822|NCT00558662|Sodium Ionophores|sodium ionophores|mesh-ancestor
6483823|NCT00558818|Clevudine|clevudine|mesh-list
6483824|NCT00558818|Antiviral Agents|antiviral agents|mesh-ancestor
6483825|NCT00558818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6483826|NCT00558883|Acarbose|acarbose|mesh-list
6483827|NCT00558883|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6483828|NCT00558883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6483829|NCT00558883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483830|NCT00558883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6483831|NCT00558883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488951|NCT00588003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6488952|NCT00588003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488953|NCT00588016|Itraconazole|itraconazole|mesh-list
6488954|NCT00588016|Antifungal Agents|antifungal agents|mesh-ancestor
6488955|NCT00588016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6488956|NCT00588016|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6488957|NCT00588016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6488958|NCT00588016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6488959|NCT00588016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488960|NCT00588016|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6488961|NCT00588016|Hormone Antagonists|hormone antagonists|mesh-ancestor
6488962|NCT00588016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6488963|NCT00588016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488964|NCT00588016|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6489051|NCT00589082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489052|NCT00589134|Ganirelix|ganirelix|mesh-list
6489053|NCT00589134|Hormone Antagonists|hormone antagonists|mesh-ancestor
6489054|NCT00589134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6489055|NCT00589134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489056|NCT00589186|Celecoxib|celecoxib|mesh-list
6489057|NCT00589186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6489058|NCT00589186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6489059|NCT00589186|Analgesics|analgesics|mesh-ancestor
6489060|NCT00589186|Sensory System Agents|sensory system agents|mesh-ancestor
6489061|NCT00589186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6489062|NCT00589186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489063|NCT00589186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6489064|NCT00589186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6489065|NCT00589186|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6489066|NCT00589186|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6489067|NCT00589186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6489068|NCT00589186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489069|NCT00589238|Paclitaxel|paclitaxel|mesh-list
6489070|NCT00589238|Cyclophosphamide|cyclophosphamide|mesh-list
6489071|NCT00589238|Carboplatin|carboplatin|mesh-list
6489072|NCT00589238|Doxorubicin|doxorubicin|mesh-list
6489073|NCT00589238|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6489074|NCT00589238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6489075|NCT00589238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6489076|NCT00589238|Tubulin Modulators|tubulin modulators|mesh-ancestor
6489077|NCT00589238|Antimitotic Agents|antimitotic agents|mesh-ancestor
6489078|NCT00589238|Mitosis Modulators|mitosis modulators|mesh-ancestor
5565296|NCT03977012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5565297|NCT03977012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565298|NCT03977012|Analgesics|analgesics|mesh-ancestor
5565299|NCT03977012|Sensory System Agents|sensory system agents|mesh-ancestor
5565300|NCT03977012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5565301|NCT03977012|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5565302|NCT03977233|Leucovorin|leucovorin|mesh-list
5565303|NCT03977233|Oxaliplatin|oxaliplatin|mesh-list
5565304|NCT03977233|Irinotecan|irinotecan|mesh-list
5565305|NCT03977233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6483832|NCT00558961|Imatinib Mesylate|imatinib mesylate|mesh-list
6483833|NCT00558961|Chlorambucil|chlorambucil|mesh-list
6483834|NCT00558961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6483835|NCT00558961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6483836|NCT00558961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6483837|NCT00558961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483838|NCT00558961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6483839|NCT00558961|Alkylating Agents|alkylating agents|mesh-ancestor
6483840|NCT00559026|Dacarbazine|dacarbazine|mesh-list
6483841|NCT00559026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6483842|NCT00559026|Alkylating Agents|alkylating agents|mesh-ancestor
6483843|NCT00559026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669361|NCT01537770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6669362|NCT01537770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6483844|NCT00559026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6483845|NCT00559052|Pancrelipase|pancrelipase|mesh-list
6483846|NCT00559052|Pancreatin|pancreatin|mesh-list
6483847|NCT00559052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6483848|NCT00559091|Ribavirin|ribavirin|mesh-list
6483849|NCT00559091|Antimetabolites|antimetabolites|mesh-ancestor
6483850|NCT00559091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669363|NCT01537770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6669364|NCT01537770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6669365|NCT01537770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669366|NCT01537809|Vitamin D|vitamin d|mesh-list
6669367|NCT01537809|Ergocalciferols|ergocalciferols|mesh-list
6669368|NCT01537809|Cholecalciferol|cholecalciferol|mesh-list
6669369|NCT01537809|Vitamins|vitamins|mesh-list
6669370|NCT01537809|Micronutrients|micronutrients|mesh-ancestor
5565306|NCT03977233|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6669371|NCT01537809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669372|NCT01537809|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6669373|NCT01537809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6669374|NCT01537861|Thalidomide|thalidomide|mesh-list
5565307|NCT03977233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5565308|NCT03977233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5565309|NCT03977233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5565310|NCT03977233|Antidotes|antidotes|mesh-ancestor
5565311|NCT03977233|Protective Agents|protective agents|mesh-ancestor
5565312|NCT03977233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565313|NCT03977233|Vitamin B Complex|vitamin b complex|mesh-ancestor
5565314|NCT03977233|Vitamins|vitamins|mesh-ancestor
5565315|NCT03977233|Micronutrients|micronutrients|mesh-ancestor
5603883|NCT00482833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5603884|NCT00482833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603885|NCT00482833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5603886|NCT00482833|Antimetabolites|antimetabolites|mesh-ancestor
5603887|NCT00482833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603888|NCT00482833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5603889|NCT00482833|Dermatologic Agents|dermatologic agents|mesh-ancestor
5603890|NCT00482833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5603891|NCT00482833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5603892|NCT00482833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5603893|NCT00482833|Immunologic Factors|immunologic factors|mesh-ancestor
5603894|NCT00482833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5603895|NCT00482833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5603896|NCT00482833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5603897|NCT00482833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5603898|NCT00482833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5603899|NCT00482833|Keratolytic Agents|keratolytic agents|mesh-ancestor
5603900|NCT00381381|Donepezil|donepezil|mesh-list
6167208|NCT01592292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6167209|NCT01592292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6167210|NCT01592292|Dermatologic Agents|dermatologic agents|mesh-ancestor
6167211|NCT01592409|Dronabinol|dronabinol|mesh-list
6483851|NCT00559091|Antiviral Agents|antiviral agents|mesh-ancestor
5565316|NCT03976713|Bromides|bromides|mesh-list
5565317|NCT03976713|Tiotropium Bromide|tiotropium bromide|mesh-list
5565318|NCT03976713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5565319|NCT03976713|Autonomic Agents|autonomic agents|mesh-ancestor
5565320|NCT03976713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5565321|NCT03976713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669375|NCT01537861|Dexamethasone|dexamethasone|mesh-list
6669376|NCT01537861|Cyclophosphamide|cyclophosphamide|mesh-list
6669377|NCT01537861|Lenalidomide|lenalidomide|mesh-list
6167212|NCT01592409|Hallucinogens|hallucinogens|mesh-ancestor
6167213|NCT01592409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167214|NCT01592409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6167215|NCT01592409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6167216|NCT01592409|Analgesics|analgesics|mesh-ancestor
6167217|NCT01592409|Sensory System Agents|sensory system agents|mesh-ancestor
6167218|NCT01592409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6167219|NCT01592409|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6167220|NCT01592409|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6167221|NCT01592409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6167222|NCT01592409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6167223|NCT01592409|Hormones|hormones|mesh-ancestor
6167224|NCT01592409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6167225|NCT01592695|Ethanol|ethanol|mesh-list
6167226|NCT01592695|Bupropion|bupropion|mesh-list
6167227|NCT01592695|Nicotine|nicotine|mesh-list
6167228|NCT01592695|Varenicline|varenicline|mesh-list
6167229|NCT01592695|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6167230|NCT01592695|Autonomic Agents|autonomic agents|mesh-ancestor
5565322|NCT03976713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5565323|NCT03976713|Respiratory System Agents|respiratory system agents|mesh-ancestor
5565324|NCT03976713|Parasympatholytics|parasympatholytics|mesh-ancestor
5565325|NCT03976713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5565326|NCT03976713|Cholinergic Agents|cholinergic agents|mesh-ancestor
5565327|NCT03976713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5565328|NCT03976713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6167231|NCT01592695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6167232|NCT01592695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167233|NCT01592695|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6167234|NCT01592695|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6167235|NCT01592695|Cholinergic Agents|cholinergic agents|mesh-ancestor
6167236|NCT01592695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6167237|NCT01592695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6167238|NCT01592695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6167239|NCT01592695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6167240|NCT01592695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6167241|NCT01592695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6167242|NCT01592695|Antidepressive Agents|antidepressive agents|mesh-ancestor
6167243|NCT01592695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6167244|NCT01592695|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6167245|NCT01592695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6167246|NCT01592695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6167247|NCT01592695|Dopamine Agents|dopamine agents|mesh-ancestor
6167248|NCT01592695|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6167249|NCT01592695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6167250|NCT01592695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6167251|NCT01592708|Erythromycin|erythromycin|mesh-list
6167252|NCT01592708|Ibuprofen|ibuprofen|mesh-list
6167253|NCT01592708|Ketorolac|ketorolac|mesh-list
6167254|NCT01592708|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6167255|NCT01592708|Fentanyl|fentanyl|mesh-list
6167256|NCT01592708|Scopolamine|scopolamine|mesh-list
6167257|NCT01592708|Droperidol|droperidol|mesh-list
6167258|NCT01592708|Remifentanil|remifentanil|mesh-list
6167259|NCT01592708|Hydrocodone|hydrocodone|mesh-list
6669378|NCT01537861|Bortezomib|bortezomib|mesh-list
6669379|NCT01537861|Pomalidomide|pomalidomide|mesh-list
6669380|NCT01537861|Lenograstim|lenograstim|mesh-list
6669381|NCT01537861|Sargramostim|sargramostim|mesh-list
6669382|NCT01537861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6167260|NCT01592708|Ondansetron|ondansetron|mesh-list
6167261|NCT01592708|Antiemetics|antiemetics|mesh-list
6167262|NCT01592708|Propofol|propofol|mesh-list
6167263|NCT01592708|Anesthetics|anesthetics|mesh-ancestor
6167264|NCT01592708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6669383|NCT01537861|Immunologic Factors|immunologic factors|mesh-ancestor
6167265|NCT01592708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669384|NCT01537861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669385|NCT01537861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5565329|NCT03976713|Anticonvulsants|anticonvulsants|mesh-ancestor
5565330|NCT03976518|Atezolizumab|atezolizumab|mesh-list
5565331|NCT03976518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5565332|NCT03976544|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5565333|NCT03976544|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5565334|NCT03976544|Estradiol|estradiol|mesh-list
5565335|NCT03976544|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5565336|NCT03976544|Progesterone|progesterone|mesh-list
5565337|NCT03976544|Estrogens|estrogens|mesh-ancestor
5565338|NCT03976544|Hormones|hormones|mesh-ancestor
5565339|NCT03976544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5565340|NCT03976544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565341|NCT03976544|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5565342|NCT03976544|Contraceptive Agents|contraceptive agents|mesh-ancestor
5565343|NCT03976544|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5565344|NCT03976544|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5565345|NCT03976544|Progestins|progestins|mesh-ancestor
5565346|NCT03976245|Etanercept|etanercept|mesh-list
6167266|NCT01592708|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6167267|NCT01592708|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6483852|NCT00559091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6483853|NCT00559169|Verapamil|verapamil|mesh-list
6483854|NCT00559169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6483855|NCT00559169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6483856|NCT00559169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6483857|NCT00559169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483858|NCT00559169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6483859|NCT00559169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483860|NCT00559169|Vasodilator Agents|vasodilator agents|mesh-ancestor
6483861|NCT00559182|Omeprazole|omeprazole|mesh-list
6483862|NCT00559182|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6483863|NCT00559182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6483864|NCT00559182|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6483865|NCT00559182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6483866|NCT00559182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483867|NCT00559195|Epoetin Alfa|epoetin alfa|mesh-list
6483868|NCT00559195|Hematinics|hematinics|mesh-ancestor
6483869|NCT00559286|Telmisartan|telmisartan|mesh-list
6483870|NCT00559286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6483871|NCT00559286|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6483872|NCT00559286|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6483873|NCT00559286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483874|NCT00559312|Fluticasone|fluticasone|mesh-list
6483875|NCT00559312|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6167268|NCT01592708|Anesthetics, General|anesthetics, general|mesh-ancestor
6167269|NCT01592708|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6167270|NCT01592708|Narcotics|narcotics|mesh-ancestor
6167271|NCT01592708|Analgesics|analgesics|mesh-ancestor
6167272|NCT01592708|Sensory System Agents|sensory system agents|mesh-ancestor
6167273|NCT01592708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6167274|NCT01592708|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6167275|NCT01592708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6167276|NCT01592708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6167277|NCT01592708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6167278|NCT01592708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6167279|NCT01592708|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6167280|NCT01592708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6167281|NCT01592708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6167282|NCT01592708|Autonomic Agents|autonomic agents|mesh-ancestor
6167283|NCT01592708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6167284|NCT01592708|Antipruritics|antipruritics|mesh-ancestor
6167285|NCT01592708|Dermatologic Agents|dermatologic agents|mesh-ancestor
6167286|NCT01592708|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6167287|NCT01592708|Serotonin Agents|serotonin agents|mesh-ancestor
6167288|NCT01592708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5565347|NCT03976245|Tofacitinib|tofacitinib|mesh-list
6167289|NCT01592708|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6167290|NCT01592708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6167291|NCT01592708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6167292|NCT01592708|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6167293|NCT01592708|Antitussive Agents|antitussive agents|mesh-ancestor
6167294|NCT01592708|Respiratory System Agents|respiratory system agents|mesh-ancestor
6167295|NCT01592708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6167296|NCT01592708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6167297|NCT01592708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6167298|NCT01592708|Mydriatics|mydriatics|mesh-ancestor
6167299|NCT01592708|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6167300|NCT01592708|Cholinergic Agents|cholinergic agents|mesh-ancestor
6167301|NCT01592708|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6167302|NCT01592708|Glucocorticoids|glucocorticoids|mesh-ancestor
6167303|NCT01592708|Hormones|hormones|mesh-ancestor
6167304|NCT01592708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6167305|NCT01592708|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6167306|NCT01592708|Protective Agents|protective agents|mesh-ancestor
6167307|NCT01592708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6167308|NCT01592708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6167309|NCT01592708|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6167310|NCT01592708|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6167311|NCT01592708|Dopamine Agents|dopamine agents|mesh-ancestor
6167312|NCT01592747|Memantine|memantine|mesh-list
6167313|NCT01592747|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6167314|NCT01592747|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5565348|NCT03976245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5565349|NCT03976245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5565350|NCT03976245|Analgesics|analgesics|mesh-ancestor
5565351|NCT03976245|Sensory System Agents|sensory system agents|mesh-ancestor
5565352|NCT03976245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6167315|NCT01592747|Dopamine Agents|dopamine agents|mesh-ancestor
6167316|NCT01592747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6167317|NCT01592747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6167318|NCT01592747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167319|NCT01592747|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6483876|NCT00559312|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6483877|NCT00559312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6483878|NCT00559312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6483879|NCT00559312|Autonomic Agents|autonomic agents|mesh-ancestor
6483880|NCT00559312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6483881|NCT00559312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483882|NCT00559312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6483883|NCT00559312|Respiratory System Agents|respiratory system agents|mesh-ancestor
6483884|NCT00559312|Dermatologic Agents|dermatologic agents|mesh-ancestor
6669386|NCT01537861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6669387|NCT01537861|Alkylating Agents|alkylating agents|mesh-ancestor
6669388|NCT01537861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669389|NCT01537861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6669390|NCT01537861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6669391|NCT01537861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6669392|NCT01537861|Antiemetics|antiemetics|mesh-ancestor
6669393|NCT01537861|Autonomic Agents|autonomic agents|mesh-ancestor
6669394|NCT01537861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6669395|NCT01537861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6669396|NCT01537861|Glucocorticoids|glucocorticoids|mesh-ancestor
6669397|NCT01537861|Hormones|hormones|mesh-ancestor
6669398|NCT01537861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6669399|NCT01537861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6669400|NCT01537861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6669401|NCT01537861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6669402|NCT01537861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6669403|NCT01537861|Growth Substances|growth substances|mesh-ancestor
6669404|NCT01537861|Growth Inhibitors|growth inhibitors|mesh-ancestor
6669405|NCT01537861|Leprostatic Agents|leprostatic agents|mesh-ancestor
6669406|NCT01537861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6669407|NCT01537861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6669408|NCT01538095|Trebananib|trebananib|mesh-list
6669409|NCT01538095|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6669410|NCT01538095|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6669411|NCT01538095|Growth Substances|growth substances|mesh-ancestor
6669412|NCT01538095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669413|NCT01538095|Growth Inhibitors|growth inhibitors|mesh-ancestor
6669414|NCT01538095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6669415|NCT01538108|Paclitaxel|paclitaxel|mesh-list
6669416|NCT01538108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6669417|NCT01538108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6669418|NCT01538108|Tubulin Modulators|tubulin modulators|mesh-ancestor
6669419|NCT01538108|Antimitotic Agents|antimitotic agents|mesh-ancestor
6669420|NCT01538108|Mitosis Modulators|mitosis modulators|mesh-ancestor
6669421|NCT01538108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669422|NCT01538225|Nabiximols|nabiximols|mesh-list
6669423|NCT01538225|Analgesics|analgesics|mesh-ancestor
6669424|NCT01538225|Sensory System Agents|sensory system agents|mesh-ancestor
6669425|NCT01538225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6669426|NCT01538225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669427|NCT01538316|Genistein|genistein|mesh-list
6669428|NCT01538316|Quercetin|quercetin|mesh-list
6669429|NCT01538316|Antioxidants|antioxidants|mesh-ancestor
6669430|NCT01538316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669431|NCT01538316|Protective Agents|protective agents|mesh-ancestor
6669432|NCT01538316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669433|NCT01538316|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6669434|NCT01538316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6669435|NCT01538316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6669436|NCT01538316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6669437|NCT01538316|Phytoestrogens|phytoestrogens|mesh-ancestor
6669438|NCT01538316|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6669439|NCT01538316|Estrogens|estrogens|mesh-ancestor
6669440|NCT01538316|Hormones|hormones|mesh-ancestor
6669441|NCT01538316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6669442|NCT01538329|Amantadine|amantadine|mesh-list
6669443|NCT01538329|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6669444|NCT01538329|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6669445|NCT01538329|Antiviral Agents|antiviral agents|mesh-ancestor
6669446|NCT01538329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6669447|NCT01538329|Dopamine Agents|dopamine agents|mesh-ancestor
6669448|NCT01538329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6669449|NCT01538329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669450|NCT01538329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669451|NCT01538329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6669452|NCT01538329|Analgesics|analgesics|mesh-ancestor
5565353|NCT03976245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565354|NCT03976245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6669453|NCT01538329|Sensory System Agents|sensory system agents|mesh-ancestor
6167320|NCT01592747|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6167321|NCT01592773|Memantine|memantine|mesh-list
6167322|NCT01592773|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6167323|NCT01592773|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6167324|NCT01592773|Dopamine Agents|dopamine agents|mesh-ancestor
6167325|NCT01592773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6167326|NCT01592773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6167327|NCT01592773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167328|NCT01592773|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6167329|NCT01592773|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6167330|NCT01592786|Memantine|memantine|mesh-list
6167331|NCT01592786|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6167332|NCT01592786|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6167333|NCT01592786|Dopamine Agents|dopamine agents|mesh-ancestor
6167334|NCT01592786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6167335|NCT01592786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6167336|NCT01592786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167337|NCT01592786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6167338|NCT01592786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5565355|NCT03976245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5565356|NCT03976245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5565357|NCT03976245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5565358|NCT03976245|Immunologic Factors|immunologic factors|mesh-ancestor
5565359|NCT03976245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5565360|NCT03976245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5565361|NCT03976245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5565362|NCT03976271|Hypoglycemic Agents|hypoglycemic agents|mesh-list
5565363|NCT03976271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565364|NCT03976258|Naltrexone|naltrexone|mesh-list
5565365|NCT03976258|Buprenorphine|buprenorphine|mesh-list
5565366|NCT03976258|Methadone|methadone|mesh-list
5565367|NCT03976258|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
5565368|NCT03976258|Heroin|heroin|mesh-list
5565369|NCT03976258|Naloxone|naloxone|mesh-list
5565370|NCT03976258|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5565371|NCT03976258|Narcotics|narcotics|mesh-ancestor
5565372|NCT03976258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5565373|NCT03976258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565374|NCT03976258|Analgesics|analgesics|mesh-ancestor
5565375|NCT03976258|Sensory System Agents|sensory system agents|mesh-ancestor
5565376|NCT03976258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5565377|NCT03976258|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5565378|NCT03976258|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5565379|NCT03976258|Antitussive Agents|antitussive agents|mesh-ancestor
5565380|NCT03976258|Respiratory System Agents|respiratory system agents|mesh-ancestor
5565381|NCT03976102|Rituximab|rituximab|mesh-list
5565382|NCT03976102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5565383|NCT03976102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5565384|NCT03976102|Immunologic Factors|immunologic factors|mesh-ancestor
5565385|NCT03976102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565386|NCT03976102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5565387|NCT03976063|Nifedipine|nifedipine|mesh-list
5565388|NCT03976063|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5565389|NCT03976063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5565390|NCT03976063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5565391|NCT03976063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5565392|NCT03976063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565393|NCT03976063|Vasodilator Agents|vasodilator agents|mesh-ancestor
5565394|NCT03976063|Tocolytic Agents|tocolytic agents|mesh-ancestor
5565395|NCT03976063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5565396|NCT03975829|Trametinib|trametinib|mesh-list
5565397|NCT03975829|Dabrafenib|dabrafenib|mesh-list
5565398|NCT03975829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5565399|NCT03975829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5565400|NCT03975829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5565401|NCT03975829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5565402|NCT03976037|Misoprostol|misoprostol|mesh-list
5565403|NCT03976037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5565404|NCT03976037|Abortifacient Agents|abortifacient agents|mesh-ancestor
5565405|NCT03976037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5565406|NCT03976037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565407|NCT03976037|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5565408|NCT03976037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5565409|NCT03976037|Oxytocics|oxytocics|mesh-ancestor
5565410|NCT03975374|Tobramycin|tobramycin|mesh-list
5565411|NCT03975374|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
5565412|NCT03975374|Dexamethasone|dexamethasone|mesh-list
5565413|NCT03975374|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5565414|NCT03975374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5565415|NCT03975374|Antiemetics|antiemetics|mesh-ancestor
5565416|NCT03975374|Autonomic Agents|autonomic agents|mesh-ancestor
5565417|NCT03975374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5565418|NCT03975374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565419|NCT03975374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5565420|NCT03975374|Glucocorticoids|glucocorticoids|mesh-ancestor
5565421|NCT03975374|Hormones|hormones|mesh-ancestor
5565422|NCT03975374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5565423|NCT03975374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6167339|NCT01592851|Fluorides|fluorides|mesh-list
6167340|NCT01592851|Tin Fluorides|tin fluorides|mesh-list
6167341|NCT01592851|Fluorophosphate|fluorophosphate|mesh-list
6167342|NCT01592851|Cariostatic Agents|cariostatic agents|mesh-ancestor
6167343|NCT01592851|Protective Agents|protective agents|mesh-ancestor
6167344|NCT01592851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167345|NCT01592864|Fluorides|fluorides|mesh-list
6167346|NCT01592864|Tin Fluorides|tin fluorides|mesh-list
6167347|NCT01592864|Fluorophosphate|fluorophosphate|mesh-list
6167348|NCT01592864|Cariostatic Agents|cariostatic agents|mesh-ancestor
6167349|NCT01592864|Protective Agents|protective agents|mesh-ancestor
6167350|NCT01592864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167351|NCT01593020|Paclitaxel|paclitaxel|mesh-list
6167352|NCT01593020|Cyclophosphamide|cyclophosphamide|mesh-list
6167353|NCT01593020|Doxorubicin|doxorubicin|mesh-list
6167354|NCT01593020|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6167355|NCT01593020|Fluorouracil|fluorouracil|mesh-list
6167356|NCT01593020|Epirubicin|epirubicin|mesh-list
6483885|NCT00559312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6483886|NCT00559312|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6483887|NCT00559312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6483888|NCT00559312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6483889|NCT00559312|Adrenergic Agents|adrenergic agents|mesh-ancestor
6483890|NCT00559312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6483891|NCT00559312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483892|NCT00559312|Glucocorticoids|glucocorticoids|mesh-ancestor
6483893|NCT00559312|Hormones|hormones|mesh-ancestor
6483894|NCT00559312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6483895|NCT00559312|Sympathomimetics|sympathomimetics|mesh-ancestor
6483896|NCT00559338|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6483897|NCT00559338|Natriuretic Agents|natriuretic agents|mesh-ancestor
5565424|NCT03975374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5565425|NCT03975374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5565426|NCT03975374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5565427|NCT03975374|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5565428|NCT03975283|Bupivacaine|bupivacaine|mesh-list
5565429|NCT03975283|Anesthetics, Local|anesthetics, local|mesh-ancestor
5565430|NCT03975283|Anesthetics|anesthetics|mesh-ancestor
5565431|NCT03975283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5565432|NCT03975283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565433|NCT03975283|Sensory System Agents|sensory system agents|mesh-ancestor
5565434|NCT03975283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6483898|NCT00559338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483899|NCT00559351|Fluorouracil|fluorouracil|mesh-list
6483900|NCT00559351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6483901|NCT00559351|Antimetabolites|antimetabolites|mesh-ancestor
6488965|NCT00588133|Tranexamic Acid|tranexamic acid|mesh-list
5565435|NCT03975270|Paclitaxel|paclitaxel|mesh-list
5565436|NCT03975270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5565437|NCT03975270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5565438|NCT03975270|Tubulin Modulators|tubulin modulators|mesh-ancestor
5565439|NCT03975270|Antimitotic Agents|antimitotic agents|mesh-ancestor
5565440|NCT03975270|Mitosis Modulators|mitosis modulators|mesh-ancestor
5565441|NCT03975270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5565442|NCT03975114|Durvalumab|durvalumab|mesh-list
6167357|NCT01593020|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5565443|NCT03975114|Tremelimumab|tremelimumab|mesh-list
5565444|NCT03975114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5565445|NCT03975114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6167358|NCT01593020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6167359|NCT01593020|Tubulin Modulators|tubulin modulators|mesh-ancestor
6167360|NCT01593020|Antimitotic Agents|antimitotic agents|mesh-ancestor
6167361|NCT01593020|Mitosis Modulators|mitosis modulators|mesh-ancestor
6167362|NCT01593020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6167363|NCT01593020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6167364|NCT01593020|Immunologic Factors|immunologic factors|mesh-ancestor
6483902|NCT00559351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483903|NCT00559351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6483904|NCT00559351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6483905|NCT00559351|Immunologic Factors|immunologic factors|mesh-ancestor
6483906|NCT00559351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167365|NCT01593020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167366|NCT01593020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6167367|NCT01593020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6167368|NCT01593020|Alkylating Agents|alkylating agents|mesh-ancestor
6167369|NCT01593020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6167370|NCT01593020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5565446|NCT03975088|Ranibizumab|ranibizumab|mesh-list
5565447|NCT03975088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5565448|NCT03975088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5565449|NCT03975088|Growth Substances|growth substances|mesh-ancestor
5565450|NCT03975088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167371|NCT01593020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6669454|NCT01538329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6669455|NCT01538381|Afatinib|afatinib|mesh-list
6669456|NCT01538381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6669457|NCT01538381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6669458|NCT01538381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6483907|NCT00559429|Docetaxel|docetaxel|mesh-list
6483908|NCT00559429|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
6483909|NCT00559429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6483910|NCT00559429|Tubulin Modulators|tubulin modulators|mesh-ancestor
6483911|NCT00559429|Antimitotic Agents|antimitotic agents|mesh-ancestor
6483912|NCT00559429|Mitosis Modulators|mitosis modulators|mesh-ancestor
6483913|NCT00559429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483914|NCT00559429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6167372|NCT01593020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6167373|NCT01593020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6167374|NCT01593020|Antimetabolites|antimetabolites|mesh-ancestor
6167375|NCT01593020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6167376|NCT01593215|Yohimbine|yohimbine|mesh-list
6167377|NCT01593215|Mydriatics|mydriatics|mesh-ancestor
6167378|NCT01593215|Autonomic Agents|autonomic agents|mesh-ancestor
6167379|NCT01593215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6167380|NCT01593215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167381|NCT01593215|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6167382|NCT01593215|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6167383|NCT01593215|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6167384|NCT01593215|Adrenergic Agents|adrenergic agents|mesh-ancestor
6167385|NCT01593215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6167386|NCT01593215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6167387|NCT01593215|Urological Agents|urological agents|mesh-ancestor
6167388|NCT01593592|Amoxicillin|amoxicillin|mesh-list
6167389|NCT01593592|Clarithromycin|clarithromycin|mesh-list
6167390|NCT01593592|Omeprazole|omeprazole|mesh-list
5565451|NCT03975088|Growth Inhibitors|growth inhibitors|mesh-ancestor
5565452|NCT03975088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5603901|NCT00381381|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5603902|NCT00381381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5603903|NCT00381381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603904|NCT00381381|Cholinergic Agents|cholinergic agents|mesh-ancestor
5603905|NCT00381381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5603906|NCT00381381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603907|NCT00381381|Nootropic Agents|nootropic agents|mesh-ancestor
5603908|NCT00102648|Temozolomide|temozolomide|mesh-list
5603909|NCT00102648|Lonafarnib|lonafarnib|mesh-list
5603910|NCT00102648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5603911|NCT00102648|Alkylating Agents|alkylating agents|mesh-ancestor
5603912|NCT00102648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603913|NCT00102648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5603914|NCT00102648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5603915|NCT00038675|Imatinib Mesylate|imatinib mesylate|mesh-list
5603916|NCT00038675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5603917|NCT00038675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6167391|NCT01593592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6167392|NCT01593592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6167393|NCT01593592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6167394|NCT01593592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6167395|NCT01593592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6167396|NCT01593592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6167397|NCT01593592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669459|NCT01538381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669460|NCT01538394|Nicotine|nicotine|mesh-list
6669461|NCT01538394|Varenicline|varenicline|mesh-list
6669462|NCT01538394|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6669463|NCT01538394|Autonomic Agents|autonomic agents|mesh-ancestor
6167398|NCT01593592|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6167399|NCT01593592|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6167400|NCT01593592|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6167401|NCT01593670|Decitabine|decitabine|mesh-list
6167402|NCT01593670|Interleukin-2|interleukin-2|mesh-list
6167403|NCT01593670|Vorinostat|vorinostat|mesh-list
6167404|NCT01593670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6167405|NCT01593670|Antimetabolites|antimetabolites|mesh-ancestor
6167406|NCT01593670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6167407|NCT01593670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6167408|NCT01593670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6167409|NCT01593670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6167410|NCT01593670|Analgesics|analgesics|mesh-ancestor
6167411|NCT01593670|Sensory System Agents|sensory system agents|mesh-ancestor
6167412|NCT01593670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6167413|NCT01593670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167414|NCT01593670|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6167415|NCT01593722|Ivermectin|ivermectin|mesh-list
6167416|NCT01593722|Diethylcarbamazine|diethylcarbamazine|mesh-list
6669464|NCT01538394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6669465|NCT01538394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565453|NCT03975231|Trametinib|trametinib|mesh-list
5565454|NCT03975231|Dabrafenib|dabrafenib|mesh-list
5565455|NCT03975231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5565456|NCT03975231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6669466|NCT01538394|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6669467|NCT01538394|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6669468|NCT01538394|Cholinergic Agents|cholinergic agents|mesh-ancestor
6669469|NCT01538394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6483915|NCT00559429|Analgesics|analgesics|mesh-ancestor
6483916|NCT00559429|Sensory System Agents|sensory system agents|mesh-ancestor
6483917|NCT00559429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6483918|NCT00559429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483919|NCT00559455|Leucovorin|leucovorin|mesh-list
6669470|NCT01538394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669471|NCT01538446|Clopidogrel|clopidogrel|mesh-list
6669472|NCT01538446|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6669473|NCT01538446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6669474|NCT01538446|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6669475|NCT01538446|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6167417|NCT01593722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6167418|NCT01593722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6167419|NCT01593722|Filaricides|filaricides|mesh-ancestor
6167420|NCT01593722|Antinematodal Agents|antinematodal agents|mesh-ancestor
6167421|NCT01593722|Anthelmintics|anthelmintics|mesh-ancestor
6167422|NCT01593722|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6167423|NCT01593722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6167424|NCT01593722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483920|NCT00559455|Fluorouracil|fluorouracil|mesh-list
6669476|NCT01538446|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6669477|NCT01538446|Purinergic Agents|purinergic agents|mesh-ancestor
6669478|NCT01538446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6669479|NCT01538446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669480|NCT01538446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669481|NCT01538459|Dexamethasone|dexamethasone|mesh-list
6669482|NCT01538459|Bupivacaine|bupivacaine|mesh-list
5565457|NCT03975231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5565458|NCT03975231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5565459|NCT03975166|Fluticasone|fluticasone|mesh-list
5565460|NCT03975166|Xhance|xhance|mesh-list
6483921|NCT00559455|Oxaliplatin|oxaliplatin|mesh-list
6483922|NCT00559455|Antimetabolites|antimetabolites|mesh-ancestor
6483923|NCT00559455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483924|NCT00559455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5565461|NCT03975166|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5565462|NCT03975166|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
5565463|NCT03975166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5565464|NCT03975166|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5565465|NCT03975166|Autonomic Agents|autonomic agents|mesh-ancestor
6167425|NCT01593748|Gemcitabine|gemcitabine|mesh-list
6167426|NCT01593748|Docetaxel|docetaxel|mesh-list
6167427|NCT01593748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6167428|NCT01593748|Antimetabolites|antimetabolites|mesh-ancestor
6167429|NCT01593748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6167430|NCT01593748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6167431|NCT01593748|Antiviral Agents|antiviral agents|mesh-ancestor
6167432|NCT01593748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6167433|NCT01593748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6167434|NCT01593748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6167435|NCT01593748|Immunologic Factors|immunologic factors|mesh-ancestor
6167436|NCT01593748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167437|NCT01593748|Tubulin Modulators|tubulin modulators|mesh-ancestor
6167438|NCT01593748|Antimitotic Agents|antimitotic agents|mesh-ancestor
6167439|NCT01593748|Mitosis Modulators|mitosis modulators|mesh-ancestor
6167440|NCT01593787|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
6167441|NCT01593787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6167442|NCT01593787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6167443|NCT01594125|Nintedanib|nintedanib|mesh-list
6167444|NCT01594125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6167445|NCT01594125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6167446|NCT01594125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6167447|NCT01594125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6167448|NCT01594281|Ranibizumab|ranibizumab|mesh-list
6167449|NCT01594281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6167450|NCT01594281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6167451|NCT01594281|Growth Substances|growth substances|mesh-ancestor
6167452|NCT01594281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167453|NCT01594281|Growth Inhibitors|growth inhibitors|mesh-ancestor
6167454|NCT01594281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6167455|NCT01594294|Contact Lens Solutions|contact lens solutions|mesh-list
6167456|NCT01594294|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6167457|NCT01594294|Disinfectants|disinfectants|mesh-ancestor
6167458|NCT01594294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6167459|NCT01594333|Methotrexate|methotrexate|mesh-list
6167460|NCT01594333|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6167461|NCT01594333|Abortifacient Agents|abortifacient agents|mesh-ancestor
6167462|NCT01594333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6167463|NCT01594333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167464|NCT01594333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6167465|NCT01594333|Antimetabolites|antimetabolites|mesh-ancestor
5565466|NCT03975166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5565467|NCT03975166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565468|NCT03975166|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5565469|NCT03975166|Respiratory System Agents|respiratory system agents|mesh-ancestor
5565470|NCT03975166|Dermatologic Agents|dermatologic agents|mesh-ancestor
5565471|NCT03975166|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5565472|NCT03975166|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5565473|NCT03975166|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5565474|NCT03975166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5565475|NCT03975166|Adrenergic Agents|adrenergic agents|mesh-ancestor
5565476|NCT03975166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5565477|NCT03975166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5565478|NCT03975166|Glucocorticoids|glucocorticoids|mesh-ancestor
5565479|NCT03975166|Hormones|hormones|mesh-ancestor
5565480|NCT03975166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5565481|NCT03975166|Sympathomimetics|sympathomimetics|mesh-ancestor
5565482|NCT03975205|Doxorubicin|doxorubicin|mesh-list
5565483|NCT03975205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5565484|NCT03975205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5565485|NCT03975205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5565486|NCT03975205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5565487|NCT03975205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5565488|NCT03975205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6167466|NCT01594333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6167467|NCT01594333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6167468|NCT01594333|Dermatologic Agents|dermatologic agents|mesh-ancestor
6167469|NCT01594333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5565489|NCT03975036|Antibodies|antibodies|mesh-list
5565490|NCT03975036|Immunologic Factors|immunologic factors|mesh-ancestor
5565491|NCT03975036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565492|NCT03975010|Naltrexone|naltrexone|mesh-list
5565493|NCT03975010|Buprenorphine|buprenorphine|mesh-list
6167470|NCT01594333|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6167471|NCT01594333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6167472|NCT01594333|Immunologic Factors|immunologic factors|mesh-ancestor
6167473|NCT01594333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6167474|NCT01594333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6167475|NCT01594424|Immunoglobulins|immunoglobulins|mesh-list
6167476|NCT01594424|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6167477|NCT01594424|Antibodies|antibodies|mesh-list
6167478|NCT01594424|gamma-Globulins|gamma-globulins|mesh-list
6167479|NCT01594424|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6167480|NCT01594424|Immunologic Factors|immunologic factors|mesh-ancestor
6167481|NCT01594424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483925|NCT00559455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6483926|NCT00559455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6483927|NCT00559455|Immunologic Factors|immunologic factors|mesh-ancestor
6483928|NCT00559455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565494|NCT03975010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5565495|NCT03975010|Narcotics|narcotics|mesh-ancestor
5565496|NCT03975010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6167482|NCT01594476|Levonorgestrel|levonorgestrel|mesh-list
6167483|NCT01594476|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5565497|NCT03975010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565498|NCT03975010|Analgesics|analgesics|mesh-ancestor
5565499|NCT03975010|Sensory System Agents|sensory system agents|mesh-ancestor
5565500|NCT03975010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5565501|NCT03975010|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5565502|NCT03975010|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5565503|NCT03975062|Dabigatran|dabigatran|mesh-list
5565504|NCT03975062|Antithrombins|antithrombins|mesh-ancestor
5565505|NCT03975062|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5565506|NCT03975062|Protease Inhibitors|protease inhibitors|mesh-ancestor
5565507|NCT03975062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6167484|NCT01594476|Contraceptive Agents|contraceptive agents|mesh-ancestor
6167485|NCT01594476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6167486|NCT01594476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167487|NCT01594476|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6167488|NCT01594476|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5565508|NCT03975062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5565509|NCT03975062|Anticoagulants|anticoagulants|mesh-ancestor
5565510|NCT03974984|Anesthetics|anesthetics|mesh-list
5565511|NCT03974984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5565512|NCT03974984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565513|NCT03974789|Dexamethasone|dexamethasone|mesh-list
5565514|NCT03974789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5565515|NCT03974789|Antiemetics|antiemetics|mesh-ancestor
5565516|NCT03974789|Autonomic Agents|autonomic agents|mesh-ancestor
5565517|NCT03974789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5565518|NCT03974789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565519|NCT03974789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5565520|NCT03974789|Glucocorticoids|glucocorticoids|mesh-ancestor
5565521|NCT03974789|Hormones|hormones|mesh-ancestor
5565522|NCT03974789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5565523|NCT03974789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5565524|NCT03974789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6167489|NCT01594476|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5565525|NCT03974854|Gemcitabine|gemcitabine|mesh-list
5565526|NCT03974854|Capecitabine|capecitabine|mesh-list
6167490|NCT01594749|Dexamethasone|dexamethasone|mesh-list
6167491|NCT01594749|Dexamethasone acetate|dexamethasone acetate|mesh-list
6167492|NCT01594749|Ondansetron|ondansetron|mesh-list
6167493|NCT01594749|Fosaprepitant|fosaprepitant|mesh-list
6167494|NCT01594749|Aprepitant|aprepitant|mesh-list
6167495|NCT01594749|BB 1101|bb 1101|mesh-list
6167496|NCT01594749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6167497|NCT01594749|Antiemetics|antiemetics|mesh-ancestor
6167498|NCT01594749|Autonomic Agents|autonomic agents|mesh-ancestor
6167499|NCT01594749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6167500|NCT01594749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483929|NCT00559455|Antidotes|antidotes|mesh-ancestor
6483930|NCT00559455|Protective Agents|protective agents|mesh-ancestor
6483931|NCT00559455|Vitamin B Complex|vitamin b complex|mesh-ancestor
6483932|NCT00559455|Vitamins|vitamins|mesh-ancestor
6483933|NCT00559455|Micronutrients|micronutrients|mesh-ancestor
6483934|NCT00559481|Ketoconazole|ketoconazole|mesh-list
6483935|NCT00559481|Dexamethasone|dexamethasone|mesh-list
6483936|NCT00559481|Hydrocortisone|hydrocortisone|mesh-list
6483937|NCT00559481|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6483938|NCT00559481|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6483939|NCT00559481|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6483940|NCT00559481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6483941|NCT00559481|Antiemetics|antiemetics|mesh-ancestor
6483942|NCT00559481|Autonomic Agents|autonomic agents|mesh-ancestor
6483943|NCT00559481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6483944|NCT00559481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483945|NCT00559481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6483946|NCT00559481|Glucocorticoids|glucocorticoids|mesh-ancestor
6483947|NCT00559481|Hormones|hormones|mesh-ancestor
6483948|NCT00559481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6167501|NCT01594749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6167502|NCT01594749|Glucocorticoids|glucocorticoids|mesh-ancestor
6167503|NCT01594749|Hormones|hormones|mesh-ancestor
6167504|NCT01594749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6167505|NCT01594749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6167506|NCT01594749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6483949|NCT00559481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6483950|NCT00559481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6483951|NCT00559481|Antifungal Agents|antifungal agents|mesh-ancestor
6483952|NCT00559481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6483953|NCT00559481|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6167507|NCT01594749|Protease Inhibitors|protease inhibitors|mesh-ancestor
6167508|NCT01594749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6167509|NCT01594749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6167510|NCT01594749|Antipruritics|antipruritics|mesh-ancestor
6167511|NCT01594749|Dermatologic Agents|dermatologic agents|mesh-ancestor
6167512|NCT01594749|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6167513|NCT01594749|Serotonin Agents|serotonin agents|mesh-ancestor
6167514|NCT01594749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6167515|NCT01594749|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6167516|NCT01594749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6167517|NCT01594749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6167518|NCT01594749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6167519|NCT01594749|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6167520|NCT01594749|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6167521|NCT01594762|Pexiganan|pexiganan|mesh-list
6483954|NCT00559481|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6483955|NCT00559481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6483956|NCT00559481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483957|NCT00559481|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6483958|NCT00559481|Hormone Antagonists|hormone antagonists|mesh-ancestor
6483959|NCT00559481|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6483960|NCT00559494|Minocycline|minocycline|mesh-list
6483961|NCT00559494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6483962|NCT00559494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6483963|NCT00559546|Montelukast|montelukast|mesh-list
6483964|NCT00559546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6483965|NCT00559546|Respiratory System Agents|respiratory system agents|mesh-ancestor
6483966|NCT00559546|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6483967|NCT00559546|Hormone Antagonists|hormone antagonists|mesh-ancestor
6483968|NCT00559546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6483969|NCT00559546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483970|NCT00559546|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5565527|NCT03974854|Irinotecan|irinotecan|mesh-list
5565528|NCT03974854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5565529|NCT03974854|Antimetabolites|antimetabolites|mesh-ancestor
5565530|NCT03974854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5565531|NCT03974854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5565532|NCT03974854|Antiviral Agents|antiviral agents|mesh-ancestor
5565533|NCT03974854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5565534|NCT03974854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5565535|NCT03974854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5565536|NCT03974854|Immunologic Factors|immunologic factors|mesh-ancestor
5565537|NCT03974854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565538|NCT03974854|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6483971|NCT00559546|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6483972|NCT00559546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483973|NCT00559676|Leucovorin|leucovorin|mesh-list
6483974|NCT00559676|Fluorouracil|fluorouracil|mesh-list
6483975|NCT00559676|Capecitabine|capecitabine|mesh-list
6483976|NCT00559676|Oxaliplatin|oxaliplatin|mesh-list
6483977|NCT00559676|Irinotecan|irinotecan|mesh-list
6483978|NCT00559676|Calcium|calcium|mesh-list
6167522|NCT01594762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6167523|NCT01594762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6167524|NCT01594827|Chlorhexidine|chlorhexidine|mesh-list
6167525|NCT01594827|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6669483|NCT01538459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6669484|NCT01538459|Antiemetics|antiemetics|mesh-ancestor
6669485|NCT01538459|Autonomic Agents|autonomic agents|mesh-ancestor
6669486|NCT01538459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6669487|NCT01538459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669488|NCT01538459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5565539|NCT03974854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5565540|NCT03974932|Acetaminophen|acetaminophen|mesh-list
5565541|NCT03974932|Ibuprofen|ibuprofen|mesh-list
5565542|NCT03974932|Celecoxib|celecoxib|mesh-list
5565543|NCT03974932|Bupivacaine|bupivacaine|mesh-list
5565544|NCT03974932|Anesthetics, Local|anesthetics, local|mesh-ancestor
5565545|NCT03974932|Anesthetics|anesthetics|mesh-ancestor
5565546|NCT03974932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6669489|NCT01538459|Glucocorticoids|glucocorticoids|mesh-ancestor
6669490|NCT01538459|Hormones|hormones|mesh-ancestor
6669491|NCT01538459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6669492|NCT01538459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6669493|NCT01538459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6483979|NCT00559676|Levoleucovorin|levoleucovorin|mesh-list
6483980|NCT00559676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6483981|NCT00559676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6483982|NCT00559676|Antimetabolites|antimetabolites|mesh-ancestor
6483983|NCT00559676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6483984|NCT00559676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6483985|NCT00559676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6483986|NCT00559676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6483987|NCT00559676|Immunologic Factors|immunologic factors|mesh-ancestor
6483988|NCT00559676|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6483989|NCT00559676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6483990|NCT00559676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6483991|NCT00559676|Antidotes|antidotes|mesh-ancestor
6483992|NCT00559676|Protective Agents|protective agents|mesh-ancestor
6483993|NCT00559676|Vitamin B Complex|vitamin b complex|mesh-ancestor
5565547|NCT03974932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565548|NCT03974932|Sensory System Agents|sensory system agents|mesh-ancestor
5565549|NCT03974932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6483994|NCT00559676|Vitamins|vitamins|mesh-ancestor
6483995|NCT00559676|Micronutrients|micronutrients|mesh-ancestor
6483996|NCT00559689|Budesonide|budesonide|mesh-list
6483997|NCT00559689|Beclomethasone|beclomethasone|mesh-list
6483998|NCT00559689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6483999|NCT00559689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6484000|NCT00559689|Autonomic Agents|autonomic agents|mesh-ancestor
6484001|NCT00559689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6484002|NCT00559689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484003|NCT00559689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6484004|NCT00559689|Respiratory System Agents|respiratory system agents|mesh-ancestor
6484005|NCT00559689|Glucocorticoids|glucocorticoids|mesh-ancestor
6484006|NCT00559689|Hormones|hormones|mesh-ancestor
6484007|NCT00559689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6484008|NCT00559702|Natalizumab|natalizumab|mesh-list
6484009|NCT00559702|Immunologic Factors|immunologic factors|mesh-ancestor
6484010|NCT00559702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484011|NCT00559715|Bevacizumab|bevacizumab|mesh-list
5565550|NCT03974932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5565551|NCT03974932|Analgesics|analgesics|mesh-ancestor
5565552|NCT03974932|Antipyretics|antipyretics|mesh-ancestor
5565553|NCT03974932|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5565554|NCT03974932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5565555|NCT03974932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6484012|NCT00559715|Ranibizumab|ranibizumab|mesh-list
6484013|NCT00559715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6484014|NCT00559715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6484015|NCT00559715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6484016|NCT00559715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6484017|NCT00559715|Growth Substances|growth substances|mesh-ancestor
6484018|NCT00559715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484019|NCT00559715|Growth Inhibitors|growth inhibitors|mesh-ancestor
6484020|NCT00559741|Leucovorin|leucovorin|mesh-list
6484021|NCT00559741|Fluorouracil|fluorouracil|mesh-list
6484022|NCT00559741|Irinotecan|irinotecan|mesh-list
6484023|NCT00559741|Cetuximab|cetuximab|mesh-list
6484024|NCT00559741|Calcium|calcium|mesh-list
6484025|NCT00559741|Levoleucovorin|levoleucovorin|mesh-list
6484026|NCT00559741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6484027|NCT00559741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565556|NCT03974932|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5565557|NCT03974932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5565558|NCT03974932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5565559|NCT03974932|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5565560|NCT03974594|Trifluridine|trifluridine|mesh-list
5565561|NCT03974594|Antimetabolites|antimetabolites|mesh-ancestor
5565562|NCT03974594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5565563|NCT03974594|Antiviral Agents|antiviral agents|mesh-ancestor
5565564|NCT03974594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5565565|NCT03974685|Niacinamide|niacinamide|mesh-list
5565566|NCT03974685|Niacin|niacin|mesh-list
5565567|NCT03974685|Nicotinic Acids|nicotinic acids|mesh-list
5565568|NCT03974685|Arginyl-glycyl-aspartic acid|arginyl-glycyl-aspartic acid|mesh-list
5565569|NCT03974685|Vitamin B Complex|vitamin b complex|mesh-ancestor
5565570|NCT03974685|Vitamins|vitamins|mesh-ancestor
5565571|NCT03974685|Micronutrients|micronutrients|mesh-ancestor
5565572|NCT03974685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565573|NCT03974685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5565574|NCT03974685|Antimetabolites|antimetabolites|mesh-ancestor
5565575|NCT03974685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5565576|NCT03974685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6484028|NCT00559741|Antimetabolites|antimetabolites|mesh-ancestor
6484029|NCT00559741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484030|NCT00559741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6484031|NCT00559741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6484032|NCT00559741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6484033|NCT00559741|Immunologic Factors|immunologic factors|mesh-ancestor
6484034|NCT00559741|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6484035|NCT00559741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6484036|NCT00559741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6669494|NCT01538459|Anesthetics, Local|anesthetics, local|mesh-ancestor
6669495|NCT01538459|Anesthetics|anesthetics|mesh-ancestor
6669496|NCT01538459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6669497|NCT01538459|Sensory System Agents|sensory system agents|mesh-ancestor
5565577|NCT03974685|Vasodilator Agents|vasodilator agents|mesh-ancestor
6484037|NCT00559741|Antidotes|antidotes|mesh-ancestor
6484038|NCT00559741|Protective Agents|protective agents|mesh-ancestor
6484039|NCT00559741|Vitamin B Complex|vitamin b complex|mesh-ancestor
6669498|NCT01538485|Cholecalciferol|cholecalciferol|mesh-list
6484040|NCT00559741|Vitamins|vitamins|mesh-ancestor
6484041|NCT00559741|Micronutrients|micronutrients|mesh-ancestor
6484042|NCT00559741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6484043|NCT00559858|Pyridoxine|pyridoxine|mesh-list
5565578|NCT03974685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5565579|NCT03974867|Prednisone|prednisone|mesh-list
5565580|NCT03974867|Methylprednisolone|methylprednisolone|mesh-list
5565581|NCT03974867|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5565582|NCT03974867|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5565583|NCT03974867|Prednisolone|prednisolone|mesh-list
5565584|NCT03974867|Prednisolone acetate|prednisolone acetate|mesh-list
5565585|NCT03974867|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5565586|NCT03974867|Prednisolone phosphate|prednisolone phosphate|mesh-list
5565587|NCT03974867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5565588|NCT03974867|Glucocorticoids|glucocorticoids|mesh-ancestor
5565589|NCT03974867|Hormones|hormones|mesh-ancestor
5565590|NCT03974867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6167526|NCT01594827|Vancomycin|vancomycin|mesh-list
6167527|NCT01594827|Doxycycline|doxycycline|mesh-list
6167528|NCT01594827|Rifampin|rifampin|mesh-list
6167529|NCT01594827|Trimethoprim|trimethoprim|mesh-list
6167530|NCT01594827|Sulfamethoxazole|sulfamethoxazole|mesh-list
6167531|NCT01594827|Mupirocin|mupirocin|mesh-list
5565591|NCT03974867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565592|NCT03974867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5565593|NCT03974867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5565594|NCT03974867|Antiemetics|antiemetics|mesh-ancestor
5565595|NCT03974867|Autonomic Agents|autonomic agents|mesh-ancestor
5565596|NCT03974867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5565597|NCT03974867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5565598|NCT03974867|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5565599|NCT03974867|Protective Agents|protective agents|mesh-ancestor
5565600|NCT03974243|Chiauranib|chiauranib|mesh-list
5565601|NCT03974243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5565602|NCT03974243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5565603|NCT03974243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5565604|NCT03974243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5565605|NCT03974217|Talazoparib|talazoparib|mesh-list
5565606|NCT03974217|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5565607|NCT03974217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5565608|NCT03974217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5565609|NCT03974217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5565610|NCT03974139|Metformin|metformin|mesh-list
5565611|NCT03974139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5565612|NCT03974139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565613|NCT03974152|Nicotine|nicotine|mesh-list
5565614|NCT03974152|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5565615|NCT03974152|Autonomic Agents|autonomic agents|mesh-ancestor
5565616|NCT03974152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5565617|NCT03974152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565618|NCT03974152|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5565619|NCT03974152|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5565620|NCT03974152|Cholinergic Agents|cholinergic agents|mesh-ancestor
6167532|NCT01594827|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6167533|NCT01594827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6167534|NCT01594827|Disinfectants|disinfectants|mesh-ancestor
6167535|NCT01594827|Dermatologic Agents|dermatologic agents|mesh-ancestor
6167536|NCT01594827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6167537|NCT01594827|Antimalarials|antimalarials|mesh-ancestor
6167538|NCT01594827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6167539|NCT01594827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6167540|NCT01594827|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6484044|NCT00559858|Vitamin B 6|vitamin b 6|mesh-list
5565621|NCT03974152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5603918|NCT00038675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6167541|NCT01594827|Antitubercular Agents|antitubercular agents|mesh-ancestor
6167542|NCT01594827|Leprostatic Agents|leprostatic agents|mesh-ancestor
6484045|NCT00559858|Vitamin B Complex|vitamin b complex|mesh-ancestor
6484046|NCT00559858|Vitamins|vitamins|mesh-ancestor
6484047|NCT00559858|Micronutrients|micronutrients|mesh-ancestor
6484048|NCT00559858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484049|NCT00559975|Vaccines|vaccines|mesh-list
6484050|NCT00559975|Immunologic Factors|immunologic factors|mesh-ancestor
6484051|NCT00559975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484052|NCT00560079|Allopurinol|allopurinol|mesh-list
6484053|NCT00560079|Dipyridamole|dipyridamole|mesh-list
6484054|NCT00560079|Antimetabolites|antimetabolites|mesh-ancestor
6484055|NCT00560079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6167543|NCT01594827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6167544|NCT01594827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6167545|NCT01594827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6167546|NCT01594827|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6167547|NCT01594827|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6167548|NCT01594827|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6167549|NCT01594827|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5565622|NCT03974152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5565623|NCT03974360|Erenumab|erenumab|mesh-list
5565624|NCT03974360|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
5565625|NCT03974360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5565626|NCT03974360|Analgesics|analgesics|mesh-ancestor
5565627|NCT03974360|Sensory System Agents|sensory system agents|mesh-ancestor
5565628|NCT03974360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6167550|NCT01594827|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6167551|NCT01594827|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6167552|NCT01594827|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6167553|NCT01594827|Renal Agents|renal agents|mesh-ancestor
6167554|NCT01594827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6167555|NCT01594827|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6167556|NCT01594827|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6167557|NCT01594827|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6167558|NCT01594827|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6167559|NCT01594931|Artesunate|artesunate|mesh-list
6167560|NCT01594931|Pyronaridine|pyronaridine|mesh-list
6167561|NCT01594931|Antimalarials|antimalarials|mesh-ancestor
6167562|NCT01594931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6167563|NCT01594931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6167564|NCT01594931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6167565|NCT01594931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6167566|NCT01594931|Antiviral Agents|antiviral agents|mesh-ancestor
6167567|NCT01594931|Schistosomicides|schistosomicides|mesh-ancestor
5565629|NCT03974360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565630|NCT03974425|Aflibercept|aflibercept|mesh-list
5565631|NCT03974425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5565632|NCT03974425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5565633|NCT03974425|Growth Substances|growth substances|mesh-ancestor
5565634|NCT03974425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565635|NCT03974425|Growth Inhibitors|growth inhibitors|mesh-ancestor
5565636|NCT03974425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5565637|NCT03974100|Denosumab|denosumab|mesh-list
5565638|NCT03974100|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5565639|NCT03974100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565640|NCT03973840|Methyltestosterone|methyltestosterone|mesh-list
5565641|NCT03973840|Testosterone|testosterone|mesh-list
5565642|NCT03973840|Testosterone undecanoate|testosterone undecanoate|mesh-list
5565643|NCT03973840|Testosterone enanthate|testosterone enanthate|mesh-list
5565644|NCT03973840|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5565645|NCT03973840|Androgens|androgens|mesh-ancestor
5565646|NCT03973840|Hormones|hormones|mesh-ancestor
5565647|NCT03973840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5565648|NCT03973840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565649|NCT03973840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5565650|NCT03973840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5565651|NCT03973840|Anabolic Agents|anabolic agents|mesh-ancestor
5565652|NCT03973775|Permethrin|permethrin|mesh-list
6167568|NCT01594931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6167569|NCT01594931|Anthelmintics|anthelmintics|mesh-ancestor
6167570|NCT01594970|Bimatoprost|bimatoprost|mesh-list
6167571|NCT01594970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6167572|NCT01595282|Ibuprofen|ibuprofen|mesh-list
6167573|NCT01595282|Ketorolac|ketorolac|mesh-list
6167574|NCT01595282|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6167575|NCT01595282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6167576|NCT01595282|Analgesics|analgesics|mesh-ancestor
6484056|NCT00560079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6484057|NCT00560079|Gout Suppressants|gout suppressants|mesh-ancestor
6484058|NCT00560079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6484059|NCT00560079|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6484060|NCT00560079|Antioxidants|antioxidants|mesh-ancestor
6484061|NCT00560079|Protective Agents|protective agents|mesh-ancestor
6484062|NCT00560079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484063|NCT00560079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6484064|NCT00560079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6484065|NCT00560079|Vasodilator Agents|vasodilator agents|mesh-ancestor
6484066|NCT00560092|Magnesium Sulfate|magnesium sulfate|mesh-list
6484067|NCT00560092|Analgesics|analgesics|mesh-ancestor
6484068|NCT00560092|Sensory System Agents|sensory system agents|mesh-ancestor
6484069|NCT00560092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6484070|NCT00560092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484071|NCT00560092|Anesthetics|anesthetics|mesh-ancestor
6484072|NCT00560092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6484073|NCT00560092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6484074|NCT00560092|Anticonvulsants|anticonvulsants|mesh-ancestor
6484075|NCT00560092|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6484076|NCT00560092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6484077|NCT00560092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484078|NCT00560092|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6484079|NCT00560092|Tocolytic Agents|tocolytic agents|mesh-ancestor
6484080|NCT00560092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6484081|NCT00560118|Fotemustine|fotemustine|mesh-list
6484082|NCT00560118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6484083|NCT00560144|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6484084|NCT00560144|Immunologic Factors|immunologic factors|mesh-ancestor
6484085|NCT00560144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484086|NCT00560170|Simvastatin|simvastatin|mesh-list
6484087|NCT00560170|Ezetimibe|ezetimibe|mesh-list
6484088|NCT00560170|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
6484089|NCT00560170|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6167577|NCT01595282|Sensory System Agents|sensory system agents|mesh-ancestor
6167578|NCT01595282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6167579|NCT01595282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167580|NCT01595282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6167581|NCT01595282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6167582|NCT01595282|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6167583|NCT01595282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6167584|NCT01595282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206227|NCT02097719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6206228|NCT02097719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206229|NCT02097719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206230|NCT02097719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6206231|NCT02097719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6207884|NCT02121262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207885|NCT02121262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6207886|NCT02121262|Glucocorticoids|glucocorticoids|mesh-ancestor
6207887|NCT02121262|Hormones|hormones|mesh-ancestor
6207888|NCT02121262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6207889|NCT02121262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6207890|NCT02121262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6207891|NCT02121301|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6207892|NCT02121301|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6207893|NCT02121392|Bupivacaine|bupivacaine|mesh-list
6207894|NCT02121392|Anesthetics, Local|anesthetics, local|mesh-ancestor
6207895|NCT02121392|Anesthetics|anesthetics|mesh-ancestor
6207896|NCT02121392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6207897|NCT02121392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207898|NCT02121392|Sensory System Agents|sensory system agents|mesh-ancestor
6207899|NCT02121392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6207900|NCT02121418|Cytarabine|cytarabine|mesh-list
6207901|NCT02121418|Decitabine|decitabine|mesh-list
6207902|NCT02121418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6207903|NCT02121418|Antimetabolites|antimetabolites|mesh-ancestor
6207904|NCT02121418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207905|NCT02121418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6207906|NCT02121418|Antiviral Agents|antiviral agents|mesh-ancestor
6207907|NCT02121418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6207908|NCT02121418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6207909|NCT02121418|Immunologic Factors|immunologic factors|mesh-ancestor
6484090|NCT00560170|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5565653|NCT03973775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5565654|NCT03973775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5565655|NCT03973879|Atezolizumab|atezolizumab|mesh-list
5565656|NCT03973879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5565657|NCT03973957|Fentanyl|fentanyl|mesh-list
5565658|NCT03973957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5565659|NCT03973957|Narcotics|narcotics|mesh-ancestor
5565660|NCT03973957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5565661|NCT03973957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565662|NCT03973957|Analgesics|analgesics|mesh-ancestor
5565663|NCT03973957|Sensory System Agents|sensory system agents|mesh-ancestor
5565664|NCT03973957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5565665|NCT03973957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5565666|NCT03973957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5565667|NCT03973957|Anesthetics, General|anesthetics, general|mesh-ancestor
5565668|NCT03973957|Anesthetics|anesthetics|mesh-ancestor
5565669|NCT03974035|Ropivacaine|ropivacaine|mesh-list
5565670|NCT03974035|Anesthetics, Local|anesthetics, local|mesh-ancestor
6167585|NCT01595386|Hydrocortisone|hydrocortisone|mesh-list
6167586|NCT01595386|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6167587|NCT01595386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6167588|NCT01595438|Ciprofloxacin|ciprofloxacin|mesh-list
6167589|NCT01595438|Ceftazidime|ceftazidime|mesh-list
6167590|NCT01595438|Doripenem|doripenem|mesh-list
6167591|NCT01595438|Avibactam|avibactam|mesh-list
6167592|NCT01595438|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6167593|NCT01595438|Trimethoprim|trimethoprim|mesh-list
6167594|NCT01595438|Sulfamethoxazole|sulfamethoxazole|mesh-list
6167595|NCT01595438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6484091|NCT00560170|Antimetabolites|antimetabolites|mesh-ancestor
6484092|NCT00560170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484093|NCT00560170|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6484094|NCT00560170|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6484095|NCT00560170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6484096|NCT00560209|Landiolol|landiolol|mesh-list
6484097|NCT00560209|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6484098|NCT00560209|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6484099|NCT00560209|Adrenergic Agents|adrenergic agents|mesh-ancestor
6484100|NCT00560209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6484101|NCT00560209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484102|NCT00560209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484103|NCT00560209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6484104|NCT00560222|Lactoferrin|lactoferrin|mesh-list
6484105|NCT00560222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6484106|NCT00560274|Ribavirin|ribavirin|mesh-list
6484107|NCT00560274|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6484108|NCT00560274|Antimetabolites|antimetabolites|mesh-ancestor
6484109|NCT00560274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484110|NCT00560274|Antiviral Agents|antiviral agents|mesh-ancestor
6484111|NCT00560274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5565671|NCT03974035|Anesthetics|anesthetics|mesh-ancestor
5565672|NCT03974035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5565673|NCT03974035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565674|NCT03974035|Sensory System Agents|sensory system agents|mesh-ancestor
5565675|NCT03974035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5565676|NCT03973489|Methamphetamine|methamphetamine|mesh-list
5565677|NCT03973489|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5565678|NCT03973489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565679|NCT03973489|Sympathomimetics|sympathomimetics|mesh-ancestor
5565680|NCT03973489|Autonomic Agents|autonomic agents|mesh-ancestor
6484112|NCT00560300|Vitamin D|vitamin d|mesh-list
6484113|NCT00560300|Cholecalciferol|cholecalciferol|mesh-list
6484114|NCT00560300|Calcitriol|calcitriol|mesh-list
6484115|NCT00560300|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
6484116|NCT00560300|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
6484117|NCT00560300|Calcium Carbonate|calcium carbonate|mesh-list
5565681|NCT03973489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5565682|NCT03973489|Dopamine Agents|dopamine agents|mesh-ancestor
5565683|NCT03973489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5565684|NCT03973489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6167596|NCT01595438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6484118|NCT00560300|Calcium|calcium|mesh-list
6484119|NCT00560300|Sevelamer|sevelamer|mesh-list
6484120|NCT00560300|Vitamins|vitamins|mesh-ancestor
6167597|NCT01595438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6484121|NCT00560300|Micronutrients|micronutrients|mesh-ancestor
6484122|NCT00560300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484123|NCT00560300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6484124|NCT00560300|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6484125|NCT00560300|Antacids|antacids|mesh-ancestor
6484126|NCT00560300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484127|NCT00560300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6484128|NCT00560300|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6484129|NCT00560300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6484130|NCT00560300|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6484131|NCT00560300|Chelating Agents|chelating agents|mesh-ancestor
5565685|NCT03973489|Adrenergic Agents|adrenergic agents|mesh-ancestor
5565686|NCT03973489|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5565687|NCT03973489|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5565688|NCT03973489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5565689|NCT03973489|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5603919|NCT00038675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606801|NCT03770130|Sensory System Agents|sensory system agents|mesh-ancestor
6484132|NCT00560300|Sequestering Agents|sequestering agents|mesh-ancestor
6484133|NCT00560326|Tacrolimus|tacrolimus|mesh-list
6484134|NCT00560326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6484135|NCT00560326|Immunologic Factors|immunologic factors|mesh-ancestor
6484136|NCT00560326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484137|NCT00560326|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6484138|NCT00560326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6484139|NCT00560326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6167598|NCT01595438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6167599|NCT01595438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6167600|NCT01595438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6167601|NCT01595438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6167602|NCT01595438|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6167603|NCT01595438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6167604|NCT01595438|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6167605|NCT01595438|Renal Agents|renal agents|mesh-ancestor
6167606|NCT01595438|Antimalarials|antimalarials|mesh-ancestor
6167607|NCT01595438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6167608|NCT01595438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6167609|NCT01595438|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6167610|NCT01595438|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6167611|NCT01595438|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6167612|NCT01595438|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6167613|NCT01595516|Ascorbic Acid|ascorbic acid|mesh-list
6167614|NCT01595516|Metoprolol|metoprolol|mesh-list
6167615|NCT01595516|Nebivolol|nebivolol|mesh-list
6167616|NCT01595516|Bradykinin|bradykinin|mesh-list
6167617|NCT01595516|Kininogens|kininogens|mesh-list
6167618|NCT01595516|Vitamins|vitamins|mesh-ancestor
5606802|NCT03770130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5606803|NCT03770130|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5606804|NCT03770130|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5606805|NCT03770130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5606806|NCT03770130|Adrenergic Agents|adrenergic agents|mesh-ancestor
5606807|NCT03770130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5606808|NCT03770130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606809|NCT03747939|Thalidomide|thalidomide|mesh-list
5606810|NCT03747939|Apremilast|apremilast|mesh-list
5606811|NCT03747939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5606812|NCT03747939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5606813|NCT03747939|Analgesics|analgesics|mesh-ancestor
5606814|NCT03747939|Sensory System Agents|sensory system agents|mesh-ancestor
5606815|NCT03747939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5606816|NCT03747939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606817|NCT03747939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5606818|NCT03747939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5606819|NCT03747939|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5606820|NCT03747939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5606821|NCT03747939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5606822|NCT03747939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606823|NCT03747939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5606824|NCT03747939|Immunologic Factors|immunologic factors|mesh-ancestor
5606825|NCT03747939|Leprostatic Agents|leprostatic agents|mesh-ancestor
5606826|NCT03747939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5606827|NCT03747939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6167619|NCT01595516|Micronutrients|micronutrients|mesh-ancestor
6167620|NCT01595516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167621|NCT01595516|Antioxidants|antioxidants|mesh-ancestor
5565690|NCT03973177|Phenol|phenol|mesh-list
5565691|NCT03973177|Methylprednisolone|methylprednisolone|mesh-list
5565692|NCT03973177|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5565693|NCT03973177|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5565694|NCT03973177|Prednisolone|prednisolone|mesh-list
5565695|NCT03973177|Prednisolone acetate|prednisolone acetate|mesh-list
6167622|NCT01595516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6167623|NCT01595516|Protective Agents|protective agents|mesh-ancestor
6167624|NCT01595516|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6167625|NCT01595516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6167626|NCT01595516|Sympatholytics|sympatholytics|mesh-ancestor
6167627|NCT01595516|Autonomic Agents|autonomic agents|mesh-ancestor
6167628|NCT01595516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6167629|NCT01595516|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6167630|NCT01595516|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6484140|NCT00560378|Tacrolimus|tacrolimus|mesh-list
6484141|NCT00560378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6484142|NCT00560378|Immunologic Factors|immunologic factors|mesh-ancestor
6484143|NCT00560378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484144|NCT00560378|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6484145|NCT00560378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6484146|NCT00560378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484147|NCT00560430|Telmisartan|telmisartan|mesh-list
6484148|NCT00560430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6484149|NCT00560430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6484150|NCT00560430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6484151|NCT00560430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484152|NCT00560443|Ketorolac|ketorolac|mesh-list
6484153|NCT00560443|Tramadol|tramadol|mesh-list
6484154|NCT00560443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5565696|NCT03973177|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5565697|NCT03973177|Prednisolone phosphate|prednisolone phosphate|mesh-list
6484155|NCT00560443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6484156|NCT00560443|Analgesics|analgesics|mesh-ancestor
6484157|NCT00560443|Sensory System Agents|sensory system agents|mesh-ancestor
6484158|NCT00560443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6484159|NCT00560443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484160|NCT00560443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6484161|NCT00560443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6167631|NCT01595516|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6484162|NCT00560443|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6484163|NCT00560443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6484164|NCT00560443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484165|NCT00560443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6484166|NCT00560443|Narcotics|narcotics|mesh-ancestor
6484167|NCT00560443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6484168|NCT00560495|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
6484169|NCT00560495|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
6484170|NCT00560495|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6484171|NCT00560495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484172|NCT00560495|Chelating Agents|chelating agents|mesh-ancestor
6484173|NCT00560495|Sequestering Agents|sequestering agents|mesh-ancestor
6484174|NCT00560495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5565698|NCT03973177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5565699|NCT03973177|Antiemetics|antiemetics|mesh-ancestor
5565700|NCT03973177|Autonomic Agents|autonomic agents|mesh-ancestor
5565701|NCT03973177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5565702|NCT03973177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565703|NCT03973177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5565704|NCT03973177|Glucocorticoids|glucocorticoids|mesh-ancestor
5565705|NCT03973177|Hormones|hormones|mesh-ancestor
5565706|NCT03973177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5565707|NCT03973177|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5565708|NCT03973177|Protective Agents|protective agents|mesh-ancestor
5565709|NCT03973177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5565710|NCT03973177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5565711|NCT03973177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5565712|NCT03973177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5565713|NCT03973177|Disinfectants|disinfectants|mesh-ancestor
5565714|NCT03973177|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
5565715|NCT03973177|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5565716|NCT03973567|Norepinephrine|norepinephrine|mesh-list
5565717|NCT03973567|Antidepressive Agents|antidepressive agents|mesh-list
5565718|NCT03973567|Serotonin|serotonin|mesh-list
5565719|NCT03973567|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
6484175|NCT00560495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6484176|NCT00560495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6484177|NCT00560495|Growth Substances|growth substances|mesh-ancestor
6484178|NCT00560495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484179|NCT00560495|Growth Inhibitors|growth inhibitors|mesh-ancestor
6484180|NCT00560495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6484181|NCT00560547|Epoetin Alfa|epoetin alfa|mesh-list
6167632|NCT01595516|Adrenergic Agents|adrenergic agents|mesh-ancestor
6167633|NCT01595516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6167634|NCT01595516|Vasodilator Agents|vasodilator agents|mesh-ancestor
6167635|NCT01595516|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6167636|NCT01595516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6167637|NCT01595516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6167638|NCT01595516|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
6167639|NCT01595516|Protease Inhibitors|protease inhibitors|mesh-ancestor
6167640|NCT01595516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6167641|NCT01595529|Trimethoprim|trimethoprim|mesh-list
6167642|NCT01595529|Sulfamethoxazole|sulfamethoxazole|mesh-list
6167643|NCT01595529|Cephalexin|cephalexin|mesh-list
6167644|NCT01595529|Cefixime|cefixime|mesh-list
6167645|NCT01595529|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6167646|NCT01595529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6167647|NCT01595529|Renal Agents|renal agents|mesh-ancestor
6167648|NCT01595529|Antimalarials|antimalarials|mesh-ancestor
5565720|NCT03973567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5565721|NCT03973567|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5565722|NCT03973567|Serotonin Agents|serotonin agents|mesh-ancestor
5565723|NCT03973567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5565724|NCT03973567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5565725|NCT03973567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565726|NCT03973567|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5565727|NCT03973567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5565728|NCT03973567|Adrenergic Agents|adrenergic agents|mesh-ancestor
5565729|NCT03973567|Sympathomimetics|sympathomimetics|mesh-ancestor
5565730|NCT03973567|Autonomic Agents|autonomic agents|mesh-ancestor
5565731|NCT03973567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5565732|NCT03973567|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5565733|NCT03973567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5565734|NCT03973567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6167649|NCT01595529|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6167650|NCT01595529|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6167651|NCT01595529|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6484182|NCT00560547|Hematinics|hematinics|mesh-ancestor
6484183|NCT00560586|Budesonide|budesonide|mesh-list
6484184|NCT00560586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6484185|NCT00560586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6484186|NCT00560586|Autonomic Agents|autonomic agents|mesh-ancestor
6484187|NCT00560586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6484188|NCT00560586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484189|NCT00560586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6484190|NCT00560586|Respiratory System Agents|respiratory system agents|mesh-ancestor
6669499|NCT01538485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6669500|NCT01538485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669501|NCT01538485|Vitamins|vitamins|mesh-ancestor
6669502|NCT01538485|Micronutrients|micronutrients|mesh-ancestor
6669503|NCT01538485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6167652|NCT01595529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6669504|NCT01538511|Insulin|insulin|mesh-list
6167653|NCT01595529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6167654|NCT01595529|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5565735|NCT03973138|Ranibizumab|ranibizumab|mesh-list
5565736|NCT03973138|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5565737|NCT03973138|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5565738|NCT03973138|Growth Substances|growth substances|mesh-ancestor
5565739|NCT03973138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565740|NCT03973138|Growth Inhibitors|growth inhibitors|mesh-ancestor
5565741|NCT03973138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5565742|NCT03973411|Ondansetron|ondansetron|mesh-list
5565743|NCT03973411|Antiemetics|antiemetics|mesh-ancestor
5565744|NCT03973411|Autonomic Agents|autonomic agents|mesh-ancestor
5565745|NCT03973411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5565746|NCT03973411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565747|NCT03973411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5565748|NCT03973411|Antipruritics|antipruritics|mesh-ancestor
5565749|NCT03973411|Dermatologic Agents|dermatologic agents|mesh-ancestor
5565750|NCT03973411|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5565751|NCT03973411|Serotonin Agents|serotonin agents|mesh-ancestor
5565752|NCT03973411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5565753|NCT03973411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5565754|NCT03973411|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5565755|NCT03973411|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5565756|NCT03973411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5565757|NCT03973411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5565758|NCT03973411|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5565759|NCT03973203|Niacin|niacin|mesh-list
6167655|NCT01595529|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6167656|NCT01595529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6167657|NCT01595529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6167658|NCT01595646|Insulin|insulin|mesh-list
6167659|NCT01595646|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6167660|NCT01595646|Insulin Detemir|insulin detemir|mesh-list
6167661|NCT01595646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6167662|NCT01595646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167663|NCT01595854|Dabigatran|dabigatran|mesh-list
6167664|NCT01595854|Ticagrelor|ticagrelor|mesh-list
6167665|NCT01595854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6167666|NCT01595854|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6167667|NCT01595854|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6167668|NCT01595854|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6167669|NCT01595854|Purinergic Agents|purinergic agents|mesh-ancestor
6167670|NCT01595854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6167671|NCT01595854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5565760|NCT03973203|Nicotinic Acids|nicotinic acids|mesh-list
5565761|NCT03973203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5565762|NCT03973203|Antimetabolites|antimetabolites|mesh-ancestor
5565763|NCT03973203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5565764|NCT03973203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5565765|NCT03973203|Vasodilator Agents|vasodilator agents|mesh-ancestor
5565766|NCT03973203|Vitamin B Complex|vitamin b complex|mesh-ancestor
5565767|NCT03973203|Vitamins|vitamins|mesh-ancestor
5565768|NCT03973203|Micronutrients|micronutrients|mesh-ancestor
5565769|NCT03973203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565770|NCT03973086|Cardiac Glycosides|cardiac glycosides|mesh-list
5565771|NCT03973086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5565772|NCT03973086|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5565773|NCT03973086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5565774|NCT03973086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5565775|NCT03973086|Protective Agents|protective agents|mesh-ancestor
5565776|NCT03973086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565777|NCT03972748|Itraconazole|itraconazole|mesh-list
5565778|NCT03972748|Antifungal Agents|antifungal agents|mesh-ancestor
5565779|NCT03972748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5565780|NCT03972748|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5565781|NCT03972748|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5565782|NCT03972748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5565783|NCT03972748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5565784|NCT03972748|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5565785|NCT03972748|Hormone Antagonists|hormone antagonists|mesh-ancestor
5565786|NCT03972748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5565787|NCT03972748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565788|NCT03972748|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5565789|NCT03972982|Insulin|insulin|mesh-list
6167672|NCT01595854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167673|NCT01595854|Antithrombins|antithrombins|mesh-ancestor
6669505|NCT01538511|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6669506|NCT01538511|Insulin Aspart|insulin aspart|mesh-list
6669507|NCT01538511|Insulin, Long-Acting|insulin, long-acting|mesh-list
6669508|NCT01538511|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6669509|NCT01538511|Biphasic Insulins|biphasic insulins|mesh-list
6669510|NCT01538511|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6669511|NCT01538511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6669512|NCT01538511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669513|NCT01538537|ON 01910|on 01910|mesh-list
6167674|NCT01595854|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6167675|NCT01595854|Protease Inhibitors|protease inhibitors|mesh-ancestor
6167676|NCT01595854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6167677|NCT01595854|Anticoagulants|anticoagulants|mesh-ancestor
6167678|NCT01596062|Cyclosporine|cyclosporine|mesh-list
6669514|NCT01538537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6669515|NCT01538537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6669516|NCT01538537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6484191|NCT00560586|Glucocorticoids|glucocorticoids|mesh-ancestor
6484192|NCT00560586|Hormones|hormones|mesh-ancestor
6484193|NCT00560586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6484194|NCT00560599|Chlorhexidine|chlorhexidine|mesh-list
6484195|NCT00560599|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6484196|NCT00560599|Mupirocin|mupirocin|mesh-list
6484197|NCT00560599|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6484198|NCT00560599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6484199|NCT00560599|Disinfectants|disinfectants|mesh-ancestor
6484200|NCT00560599|Dermatologic Agents|dermatologic agents|mesh-ancestor
6484201|NCT00560599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6484202|NCT00560599|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6484203|NCT00560599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6484204|NCT00560599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5565790|NCT03972982|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5565791|NCT03972982|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5565792|NCT03972982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565793|NCT03973047|Ondansetron|ondansetron|mesh-list
5565794|NCT03973047|Antiemetics|antiemetics|mesh-ancestor
5565795|NCT03973047|Autonomic Agents|autonomic agents|mesh-ancestor
5565796|NCT03973047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5565797|NCT03973047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565798|NCT03973047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5565799|NCT03973047|Antipruritics|antipruritics|mesh-ancestor
5565800|NCT03973047|Dermatologic Agents|dermatologic agents|mesh-ancestor
5565801|NCT03973047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5565802|NCT03973047|Serotonin Agents|serotonin agents|mesh-ancestor
5565803|NCT03973047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5565804|NCT03973047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669517|NCT01538537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669518|NCT01538563|ON 01910|on 01910|mesh-list
5565805|NCT03973047|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5565806|NCT03973047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5565807|NCT03973047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5565808|NCT03973047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5565809|NCT03973047|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5565810|NCT03972592|Sirolimus|sirolimus|mesh-list
5565811|NCT03972592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5565812|NCT03972592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5565813|NCT03972592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5565814|NCT03972592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5565815|NCT03972592|Antifungal Agents|antifungal agents|mesh-ancestor
5565816|NCT03972592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5565817|NCT03972592|Immunologic Factors|immunologic factors|mesh-ancestor
5565818|NCT03972592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565819|NCT03972683|Atropine|atropine|mesh-list
5565820|NCT03972683|Adenosine|adenosine|mesh-list
5565821|NCT03972683|Nitroprusside|nitroprusside|mesh-list
5565822|NCT03972683|Phenylephrine|phenylephrine|mesh-list
5565823|NCT03972683|Oxymetazoline|oxymetazoline|mesh-list
5565824|NCT03972683|Acetylcholine|acetylcholine|mesh-list
6669519|NCT01538563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6669520|NCT01538563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6669521|NCT01538563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6669522|NCT01538563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669523|NCT01538576|Insulin Aspart|insulin aspart|mesh-list
6669524|NCT01538576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6484205|NCT00560638|Loteprednol Etabonate|loteprednol etabonate|mesh-list
6484206|NCT00560638|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6669525|NCT01538576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669526|NCT01538589|Insulin Aspart|insulin aspart|mesh-list
6669527|NCT01538589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6669528|NCT01538589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669529|NCT01538641|Gemcitabine|gemcitabine|mesh-list
5565825|NCT03972683|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6669530|NCT01538641|Rituximab|rituximab|mesh-list
6669531|NCT01538641|Oxaliplatin|oxaliplatin|mesh-list
6167679|NCT01596062|Mycophenolic Acid|mycophenolic acid|mesh-list
6167680|NCT01596062|Everolimus|everolimus|mesh-list
6167681|NCT01596062|Cyclosporins|cyclosporins|mesh-list
6167682|NCT01596062|Basiliximab|basiliximab|mesh-list
6167683|NCT01596062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6167684|NCT01596062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488966|NCT00588133|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6488967|NCT00588133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6488968|NCT00588133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488969|NCT00588133|Hemostatics|hemostatics|mesh-ancestor
6488970|NCT00588133|Coagulants|coagulants|mesh-ancestor
6488971|NCT00588172|Metformin|metformin|mesh-list
6488972|NCT00588172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6488973|NCT00588172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488974|NCT00588185|Deoxyglucose|deoxyglucose|mesh-list
6488975|NCT00588185|Testosterone|testosterone|mesh-list
6488976|NCT00588185|Dihydrotestosterone|dihydrotestosterone|mesh-list
6488977|NCT00588185|Androgens|androgens|mesh-ancestor
6488978|NCT00588185|Hormones|hormones|mesh-ancestor
6167685|NCT01596062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6167686|NCT01596062|Immunologic Factors|immunologic factors|mesh-ancestor
6167687|NCT01596062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167688|NCT01596062|Antifungal Agents|antifungal agents|mesh-ancestor
6167689|NCT01596062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6167690|NCT01596062|Dermatologic Agents|dermatologic agents|mesh-ancestor
6167691|NCT01596062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6167692|NCT01596062|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6167693|NCT01596062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6167694|NCT01596062|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6167695|NCT01596062|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6167696|NCT01596062|Antitubercular Agents|antitubercular agents|mesh-ancestor
6167697|NCT01596062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6167698|NCT01596088|Dexrazoxane|dexrazoxane|mesh-list
6167699|NCT01596088|Razoxane|razoxane|mesh-list
6167700|NCT01596088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6167701|NCT01596088|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6167702|NCT01596088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6167703|NCT01596088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6167704|NCT01596088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6167705|NCT01596088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6167706|NCT01596088|Protective Agents|protective agents|mesh-ancestor
6167707|NCT01596088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167708|NCT01596088|Antimitotic Agents|antimitotic agents|mesh-ancestor
6167709|NCT01596088|Mitosis Modulators|mitosis modulators|mesh-ancestor
6167710|NCT01596127|Rituximab|rituximab|mesh-list
6488979|NCT00588185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5565826|NCT03972683|Mydriatics|mydriatics|mesh-ancestor
5565827|NCT03972683|Autonomic Agents|autonomic agents|mesh-ancestor
5565828|NCT03972683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5565829|NCT03972683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565830|NCT03972683|Sympathomimetics|sympathomimetics|mesh-ancestor
5565831|NCT03972683|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5565832|NCT03972683|Nasal Decongestants|nasal decongestants|mesh-ancestor
5565833|NCT03972683|Respiratory System Agents|respiratory system agents|mesh-ancestor
5565834|NCT03972683|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5565835|NCT03972683|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5565836|NCT03972683|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5565837|NCT03972683|Adrenergic Agents|adrenergic agents|mesh-ancestor
5565838|NCT03972683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5565839|NCT03972683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5565840|NCT03972683|Protective Agents|protective agents|mesh-ancestor
5565841|NCT03972683|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5565842|NCT03972683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5565843|NCT03972683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5565844|NCT03972683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5565845|NCT03972683|Parasympatholytics|parasympatholytics|mesh-ancestor
6167711|NCT01596127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6167712|NCT01596127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6669532|NCT01538641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6167713|NCT01596127|Immunologic Factors|immunologic factors|mesh-ancestor
6167714|NCT01596127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167715|NCT01596127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6167716|NCT01596335|Immunoglobulins|immunoglobulins|mesh-list
6167717|NCT01596335|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6167718|NCT01596335|Antibodies|antibodies|mesh-list
6167719|NCT01596335|Immunologic Factors|immunologic factors|mesh-ancestor
6167720|NCT01596335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167721|NCT01596504|Metformin|metformin|mesh-list
5565846|NCT03972683|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5565847|NCT03972683|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5565848|NCT03972683|Cholinergic Agents|cholinergic agents|mesh-ancestor
5565849|NCT03972683|Analgesics|analgesics|mesh-ancestor
5565850|NCT03972683|Sensory System Agents|sensory system agents|mesh-ancestor
5565851|NCT03972683|Vasodilator Agents|vasodilator agents|mesh-ancestor
5565852|NCT03972683|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5565853|NCT03972683|Purinergic Agonists|purinergic agonists|mesh-ancestor
5565854|NCT03972683|Purinergic Agents|purinergic agents|mesh-ancestor
5565855|NCT03972683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5565856|NCT03972683|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5565857|NCT03972683|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5565858|NCT03972397|Bupivacaine|bupivacaine|mesh-list
5565859|NCT03972397|Anesthetics, Local|anesthetics, local|mesh-ancestor
5565860|NCT03972397|Anesthetics|anesthetics|mesh-ancestor
5565861|NCT03972397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5565862|NCT03972397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565863|NCT03972397|Sensory System Agents|sensory system agents|mesh-ancestor
5565864|NCT03972397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5565865|NCT03972358|Misoprostol|misoprostol|mesh-list
5565866|NCT03972358|Mifepristone|mifepristone|mesh-list
5565867|NCT03972358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5565868|NCT03972358|Abortifacient Agents|abortifacient agents|mesh-ancestor
5565869|NCT03972358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5565870|NCT03972358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565871|NCT03972358|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5565872|NCT03972358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5565873|NCT03972358|Oxytocics|oxytocics|mesh-ancestor
6167722|NCT01596504|Insulin Glargine|insulin glargine|mesh-list
6167723|NCT01596504|Liraglutide|liraglutide|mesh-list
6167724|NCT01596504|Lixisenatide|lixisenatide|mesh-list
6167725|NCT01596504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6167726|NCT01596504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167727|NCT01596504|Incretins|incretins|mesh-ancestor
6167728|NCT01596504|Hormones|hormones|mesh-ancestor
6167729|NCT01596504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6167730|NCT01596699|Fludarabine|fludarabine|mesh-list
6167731|NCT01596699|Busulfan|busulfan|mesh-list
6167732|NCT01596699|Alemtuzumab|alemtuzumab|mesh-list
6167733|NCT01596699|Clofarabine|clofarabine|mesh-list
6167734|NCT01596699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6167735|NCT01596699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6167736|NCT01596699|Antimetabolites|antimetabolites|mesh-ancestor
6167737|NCT01596699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6167738|NCT01596699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6167739|NCT01596699|Immunologic Factors|immunologic factors|mesh-ancestor
6167740|NCT01596699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167741|NCT01596699|Alkylating Agents|alkylating agents|mesh-ancestor
6167742|NCT01596699|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6167743|NCT01596699|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6167744|NCT01596699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6167745|NCT01596842|Cholecalciferol|cholecalciferol|mesh-list
6167746|NCT01596842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6167747|NCT01596842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167748|NCT01596842|Vitamins|vitamins|mesh-ancestor
6167749|NCT01596842|Micronutrients|micronutrients|mesh-ancestor
5565874|NCT03972358|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5565875|NCT03972358|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5565876|NCT03972358|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5565877|NCT03972358|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5565878|NCT03972358|Contraceptive Agents|contraceptive agents|mesh-ancestor
5565879|NCT03972358|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5565880|NCT03972358|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5565881|NCT03972358|Hormone Antagonists|hormone antagonists|mesh-ancestor
5565882|NCT03972358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5565883|NCT03972358|Luteolytic Agents|luteolytic agents|mesh-ancestor
6167750|NCT01596842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6167751|NCT01597193|Fulvestrant|fulvestrant|mesh-list
6167752|NCT01597193|Anastrozole|anastrozole|mesh-list
6167753|NCT01597193|Exemestane|exemestane|mesh-list
6167754|NCT01597193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6167755|NCT01597193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6167756|NCT01597193|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5565884|NCT03972358|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5565885|NCT03972358|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5565886|NCT03972462|Sirolimus|sirolimus|mesh-list
5565887|NCT03972462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5565888|NCT03972462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5565889|NCT03972462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5565890|NCT03972462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5565891|NCT03972462|Antifungal Agents|antifungal agents|mesh-ancestor
5565892|NCT03972462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5565893|NCT03972462|Immunologic Factors|immunologic factors|mesh-ancestor
5565894|NCT03972462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565895|NCT03972046|Trametinib|trametinib|mesh-list
5565896|NCT03972046|Dabrafenib|dabrafenib|mesh-list
5565897|NCT03972046|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
5565898|NCT03972046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5565899|NCT03972046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5565900|NCT03972046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5565901|NCT03972046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6167757|NCT01597193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5565902|NCT03972046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5565903|NCT03972228|Antineoplastic Agents|antineoplastic agents|mesh-list
5565904|NCT03971877|Polymyxins|polymyxins|mesh-list
5565905|NCT03971877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5565906|NCT03971877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5565907|NCT03971708|Lidocaine|lidocaine|mesh-list
5565908|NCT03971708|Ropivacaine|ropivacaine|mesh-list
5565909|NCT03971708|Anesthetics, Local|anesthetics, local|mesh-ancestor
5565910|NCT03971708|Anesthetics|anesthetics|mesh-ancestor
5565911|NCT03971708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5565912|NCT03971708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565913|NCT03971708|Sensory System Agents|sensory system agents|mesh-ancestor
6167758|NCT01597193|Hormone Antagonists|hormone antagonists|mesh-ancestor
6167759|NCT01597193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6167760|NCT01597193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167761|NCT01597193|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6167762|NCT01597193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6167763|NCT01597193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6167764|NCT01597193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6167765|NCT01597245|Etanercept|etanercept|mesh-list
6484207|NCT00560690|Metformin|metformin|mesh-list
6484208|NCT00560690|Interferons|interferons|mesh-list
6484209|NCT00560690|Ribavirin|ribavirin|mesh-list
6484210|NCT00560690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6484211|NCT00560690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167766|NCT01597245|Ixekizumab|ixekizumab|mesh-list
6167767|NCT01597245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6167768|NCT01597245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6167769|NCT01597245|Analgesics|analgesics|mesh-ancestor
6167770|NCT01597245|Sensory System Agents|sensory system agents|mesh-ancestor
6167771|NCT01597245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6167772|NCT01597245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167773|NCT01597245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6167774|NCT01597245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6167775|NCT01597245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6167776|NCT01597245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6167777|NCT01597245|Immunologic Factors|immunologic factors|mesh-ancestor
6167778|NCT01597245|Dermatologic Agents|dermatologic agents|mesh-ancestor
6167779|NCT01597258|Crizotinib|crizotinib|mesh-list
6167780|NCT01597258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6167781|NCT01597258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6167782|NCT01597258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6484212|NCT00560690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5565914|NCT03971708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5565915|NCT03971708|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6484213|NCT00560690|Antiviral Agents|antiviral agents|mesh-ancestor
6484214|NCT00560690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6484215|NCT00560690|Antimetabolites|antimetabolites|mesh-ancestor
6484216|NCT00560690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484217|NCT00560820|Deferasirox|deferasirox|mesh-list
5565916|NCT03971708|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5565917|NCT03971708|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5565918|NCT03971708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6167783|NCT01597258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6167784|NCT01597375|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6167785|NCT01597375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5565919|NCT03971708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5565920|NCT03971604|Vitamins|vitamins|mesh-list
5565921|NCT03971604|Vitamin E|vitamin e|mesh-list
5565922|NCT03971604|Vitamin A|vitamin a|mesh-list
5565923|NCT03971604|Micronutrients|micronutrients|mesh-ancestor
5565924|NCT03971604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565925|NCT03971604|Antioxidants|antioxidants|mesh-ancestor
5565926|NCT03971604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5565927|NCT03971604|Protective Agents|protective agents|mesh-ancestor
6167786|NCT01597479|Anesthetics|anesthetics|mesh-list
6167787|NCT01597479|Levobupivacaine|levobupivacaine|mesh-list
6167788|NCT01597479|Anesthetics, Local|anesthetics, local|mesh-list
6167789|NCT01597479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6167790|NCT01597479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167791|NCT01597479|Sensory System Agents|sensory system agents|mesh-ancestor
6167792|NCT01597479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6167793|NCT01597492|Vaccines|vaccines|mesh-list
6167794|NCT01597492|Belimumab|belimumab|mesh-list
5603920|NCT05179733|Rituximab|rituximab|mesh-list
5603921|NCT05179733|Lenalidomide|lenalidomide|mesh-list
5603922|NCT05179733|Zanubrutinib|zanubrutinib|mesh-list
5603923|NCT05179733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6167795|NCT01597492|Immunologic Factors|immunologic factors|mesh-ancestor
6167796|NCT01597492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167797|NCT01597492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6167798|NCT01597505|Vancomycin|vancomycin|mesh-list
6167799|NCT01597505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6167800|NCT01597505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6167801|NCT01597557|Magnesium Sulfate|magnesium sulfate|mesh-list
6167802|NCT01597557|Analgesics|analgesics|mesh-ancestor
6167803|NCT01597557|Sensory System Agents|sensory system agents|mesh-ancestor
6167804|NCT01597557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6167805|NCT01597557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167806|NCT01597557|Anesthetics|anesthetics|mesh-ancestor
6167807|NCT01597557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6167808|NCT01597557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6167809|NCT01597557|Anticonvulsants|anticonvulsants|mesh-ancestor
6167810|NCT01597557|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6167811|NCT01597557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6167812|NCT01597557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6167813|NCT01597557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6484218|NCT00560820|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6484219|NCT00560820|Chelating Agents|chelating agents|mesh-ancestor
6484220|NCT00560820|Sequestering Agents|sequestering agents|mesh-ancestor
6484221|NCT00560820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484222|NCT00560898|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6484223|NCT00560924|Estradiol|estradiol|mesh-list
6484224|NCT00560924|Estrogens|estrogens|mesh-ancestor
6484225|NCT00560924|Hormones|hormones|mesh-ancestor
6484226|NCT00560924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6484227|NCT00560924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484228|NCT00560963|Everolimus|everolimus|mesh-list
6484229|NCT00560963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6484230|NCT00560963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6484231|NCT00560963|Immunologic Factors|immunologic factors|mesh-ancestor
6484232|NCT00560963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484233|NCT00560976|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6484234|NCT00560976|Ferric gluconate|ferric gluconate|mesh-list
6484235|NCT00560976|Hematinics|hematinics|mesh-ancestor
6484236|NCT00561028|Antibodies|antibodies|mesh-list
6484237|NCT00561028|Immunologic Factors|immunologic factors|mesh-ancestor
6484238|NCT00561028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484239|NCT00561054|Cetuximab|cetuximab|mesh-list
6484240|NCT00561054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6484241|NCT00561054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6484242|NCT00561067|Methylprednisolone|methylprednisolone|mesh-list
6484243|NCT00561067|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6167814|NCT01597557|Tocolytic Agents|tocolytic agents|mesh-ancestor
6484244|NCT00561067|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6484245|NCT00561067|Prednisolone|prednisolone|mesh-list
6484246|NCT00561067|Prednisolone acetate|prednisolone acetate|mesh-list
6167815|NCT01597557|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6167816|NCT01597622|Belimumab|belimumab|mesh-list
6167817|NCT01597622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6167818|NCT01597622|Immunologic Factors|immunologic factors|mesh-ancestor
6167819|NCT01597622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167820|NCT01597908|Trametinib|trametinib|mesh-list
6167821|NCT01597908|Vemurafenib|vemurafenib|mesh-list
6167822|NCT01597908|Dabrafenib|dabrafenib|mesh-list
6484247|NCT00561067|Epoetin Alfa|epoetin alfa|mesh-list
6484248|NCT00561067|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6484249|NCT00561067|Prednisolone phosphate|prednisolone phosphate|mesh-list
6484250|NCT00561067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6484251|NCT00561067|Antiemetics|antiemetics|mesh-ancestor
6167823|NCT01597908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6167824|NCT01597908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6167825|NCT01597908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6167826|NCT01597908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6167827|NCT01597973|Meropenem|meropenem|mesh-list
6167828|NCT01597973|Colistin|colistin|mesh-list
6167829|NCT01597973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6167830|NCT01597973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6167831|NCT01598090|Ribavirin|ribavirin|mesh-list
6167832|NCT01598090|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6167833|NCT01598090|Antimetabolites|antimetabolites|mesh-ancestor
6167834|NCT01598090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6167835|NCT01598090|Antiviral Agents|antiviral agents|mesh-ancestor
6167836|NCT01598090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6167837|NCT01598207|Dronabinol|dronabinol|mesh-list
6167838|NCT01598207|Hallucinogens|hallucinogens|mesh-ancestor
6167839|NCT01598207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565928|NCT03971409|Doxorubicin|doxorubicin|mesh-list
5565929|NCT03971409|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5565930|NCT03971409|Avelumab|avelumab|mesh-list
5565931|NCT03971409|Camptothecin|camptothecin|mesh-list
5565932|NCT03971409|Antibodies|antibodies|mesh-list
5565933|NCT03971409|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5565934|NCT03971409|Immunoconjugates|immunoconjugates|mesh-list
5565935|NCT03971409|Immunoglobulin G|immunoglobulin g|mesh-list
5565936|NCT03971409|Immunologic Factors|immunologic factors|mesh-ancestor
5565937|NCT03971409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565938|NCT03971409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5565939|NCT03971409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5565940|NCT03971409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5565941|NCT03971409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5565942|NCT03971409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5565943|NCT03971409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5565944|NCT03971409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5565945|NCT03971409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5565946|NCT03971409|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5565947|NCT03971370|Vaccines|vaccines|mesh-list
5565948|NCT03971370|Immunologic Factors|immunologic factors|mesh-ancestor
5565949|NCT03971370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565950|NCT03971461|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
6167840|NCT01598207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6167841|NCT01598207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6167842|NCT01598207|Analgesics|analgesics|mesh-ancestor
6167843|NCT01598207|Sensory System Agents|sensory system agents|mesh-ancestor
5725604|NCT03179449|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5725605|NCT03179332|Insulin Lispro|insulin lispro|mesh-list
5725606|NCT03179332|Insulin Aspart|insulin aspart|mesh-list
5725607|NCT03179332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6484252|NCT00561067|Autonomic Agents|autonomic agents|mesh-ancestor
5565951|NCT03971461|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5565952|NCT03971461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5565953|NCT03971487|Ocrelizumab|ocrelizumab|mesh-list
5565954|NCT03971487|Immunologic Factors|immunologic factors|mesh-ancestor
5565955|NCT03971487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565956|NCT03971201|Sorafenib|sorafenib|mesh-list
6484253|NCT00561067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5565957|NCT03971201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5565958|NCT03971201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5565959|NCT03971201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5565960|NCT03971201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6167844|NCT01598207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5565961|NCT03971279|Dexamethasone|dexamethasone|mesh-list
6167845|NCT01598207|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6206232|NCT02097732|Ipilimumab|ipilimumab|mesh-list
6484254|NCT00561067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484255|NCT00561067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6484256|NCT00561067|Glucocorticoids|glucocorticoids|mesh-ancestor
6484257|NCT00561067|Hormones|hormones|mesh-ancestor
6484258|NCT00561067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6484259|NCT00561067|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6484260|NCT00561067|Protective Agents|protective agents|mesh-ancestor
6484261|NCT00561067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6167846|NCT01598207|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6167847|NCT01598207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6167848|NCT01598207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6167849|NCT01598207|Hormones|hormones|mesh-ancestor
6167850|NCT01598207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6167851|NCT01598298|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6484262|NCT00561067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6484263|NCT00561067|Hematinics|hematinics|mesh-ancestor
6484264|NCT00561093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
6484265|NCT00561093|Pentoxifylline|pentoxifylline|mesh-list
6484266|NCT00561093|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6484267|NCT00561093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6484268|NCT00561093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484269|NCT00561093|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6484270|NCT00561093|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6669533|NCT01538641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6669534|NCT01538641|Immunologic Factors|immunologic factors|mesh-ancestor
6669535|NCT01538641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484271|NCT00561093|Protective Agents|protective agents|mesh-ancestor
6484272|NCT00561093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484273|NCT00561093|Vasodilator Agents|vasodilator agents|mesh-ancestor
6484274|NCT00561093|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6484275|NCT00561093|Antioxidants|antioxidants|mesh-ancestor
6484276|NCT00561106|Valacyclovir|valacyclovir|mesh-list
6484277|NCT00561106|Prednisone|prednisone|mesh-list
6484278|NCT00561106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6484279|NCT00561106|Glucocorticoids|glucocorticoids|mesh-ancestor
6484280|NCT00561106|Hormones|hormones|mesh-ancestor
6484281|NCT00561106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6484282|NCT00561106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484283|NCT00561106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6484284|NCT00561106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6484285|NCT00561106|Antiviral Agents|antiviral agents|mesh-ancestor
6484286|NCT00561106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6484287|NCT00561119|Gemcitabine|gemcitabine|mesh-list
6484288|NCT00561119|Paclitaxel|paclitaxel|mesh-list
6484289|NCT00561119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6484290|NCT00561119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6484291|NCT00561119|Tubulin Modulators|tubulin modulators|mesh-ancestor
6484292|NCT00561119|Antimitotic Agents|antimitotic agents|mesh-ancestor
6484293|NCT00561119|Mitosis Modulators|mitosis modulators|mesh-ancestor
6167852|NCT01598298|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6484294|NCT00561119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484295|NCT00561119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6484296|NCT00561119|Antimetabolites|antimetabolites|mesh-ancestor
6484297|NCT00561119|Antiviral Agents|antiviral agents|mesh-ancestor
6484298|NCT00561119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6484299|NCT00561119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6484300|NCT00561119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6484301|NCT00561119|Immunologic Factors|immunologic factors|mesh-ancestor
6484302|NCT00561119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484303|NCT00561132|Vanadyl sulfate|vanadyl sulfate|mesh-list
6484304|NCT00561132|Magnesium Oxide|magnesium oxide|mesh-list
6484305|NCT00561132|Antacids|antacids|mesh-ancestor
6488980|NCT00588185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669536|NCT01538641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6669537|NCT01538641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6669538|NCT01538641|Antimetabolites|antimetabolites|mesh-ancestor
5565962|NCT03971279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5565963|NCT03971279|Antiemetics|antiemetics|mesh-ancestor
5565964|NCT03971279|Autonomic Agents|autonomic agents|mesh-ancestor
5565965|NCT03971279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5565966|NCT03971279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565967|NCT03971279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5565968|NCT03971279|Glucocorticoids|glucocorticoids|mesh-ancestor
5565969|NCT03971279|Hormones|hormones|mesh-ancestor
5565970|NCT03971279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5565971|NCT03971279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5565972|NCT03971279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5565973|NCT03971214|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5565974|NCT03971214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6167853|NCT01598298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6167854|NCT01598298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6167855|NCT01598298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6167856|NCT01598298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6167857|NCT01598298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167858|NCT01598298|Analgesics|analgesics|mesh-ancestor
6167859|NCT01598298|Sensory System Agents|sensory system agents|mesh-ancestor
6167860|NCT01598298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5565975|NCT03971214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5565976|NCT03970798|Midazolam|midazolam|mesh-list
5565977|NCT03970798|Caffeine|caffeine|mesh-list
5565978|NCT03970798|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5565979|NCT03970798|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5565980|NCT03970798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5565981|NCT03970798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5565982|NCT03970798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5565983|NCT03970798|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5565984|NCT03970798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5565985|NCT03970798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5565986|NCT03970798|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5565987|NCT03970798|Anesthetics, General|anesthetics, general|mesh-ancestor
5565988|NCT03970798|Anesthetics|anesthetics|mesh-ancestor
5565989|NCT03970798|GABA Modulators|gaba modulators|mesh-ancestor
5565990|NCT03970798|GABA Agents|gaba agents|mesh-ancestor
5565991|NCT03970798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5565992|NCT03970798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5565993|NCT03970798|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5565994|NCT03970798|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5565995|NCT03970798|Antimetabolites|antimetabolites|mesh-ancestor
5565996|NCT03970798|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5565997|NCT03970798|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5565998|NCT03970798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5565999|NCT03970798|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5566000|NCT03970798|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5566001|NCT03970798|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5566002|NCT03970798|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5566003|NCT03970798|Purinergic Agents|purinergic agents|mesh-ancestor
5566004|NCT03971045|Cyclophosphamide|cyclophosphamide|mesh-list
5566005|NCT03971045|Pembrolizumab|pembrolizumab|mesh-list
5566006|NCT03971045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6167861|NCT01598298|Antidepressive Agents|antidepressive agents|mesh-ancestor
6167862|NCT01598298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6167863|NCT01598298|Dopamine Agents|dopamine agents|mesh-ancestor
6167864|NCT01598311|Vancomycin|vancomycin|mesh-list
6167865|NCT01598311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6167866|NCT01598311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6167867|NCT01598506|Hydromorphone|hydromorphone|mesh-list
6167868|NCT01598506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6167869|NCT01598506|Narcotics|narcotics|mesh-ancestor
6167870|NCT01598506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6167871|NCT01598506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167872|NCT01598506|Analgesics|analgesics|mesh-ancestor
6167873|NCT01598506|Sensory System Agents|sensory system agents|mesh-ancestor
6167874|NCT01598506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6167875|NCT01598545|Hydromorphone|hydromorphone|mesh-list
6167876|NCT01598545|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6167877|NCT01598545|Narcotics|narcotics|mesh-ancestor
6167878|NCT01598545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6167879|NCT01598545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167880|NCT01598545|Analgesics|analgesics|mesh-ancestor
6167881|NCT01598545|Sensory System Agents|sensory system agents|mesh-ancestor
6167882|NCT01598545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6167883|NCT01598662|Levonorgestrel|levonorgestrel|mesh-list
6488981|NCT00588185|Antimetabolites|antimetabolites|mesh-ancestor
5566007|NCT03971045|Immunologic Factors|immunologic factors|mesh-ancestor
5566008|NCT03971045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566009|NCT03971045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5566010|NCT03971045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5566011|NCT03971045|Alkylating Agents|alkylating agents|mesh-ancestor
5603924|NCT05179733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5566012|NCT03971045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566013|NCT03971045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5566014|NCT03971045|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5566015|NCT03971045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5566016|NCT03970954|Interleukin-2|interleukin-2|mesh-list
5566017|NCT03970954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5566018|NCT03970954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5566019|NCT03970954|Analgesics|analgesics|mesh-ancestor
6484306|NCT00561132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484307|NCT00561132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6484308|NCT00561132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6484309|NCT00561132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484310|NCT00561184|Vaccines|vaccines|mesh-list
5566020|NCT03970954|Sensory System Agents|sensory system agents|mesh-ancestor
5566021|NCT03970954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6167884|NCT01598662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6167885|NCT01598662|Contraceptive Agents|contraceptive agents|mesh-ancestor
6167886|NCT01598662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6167887|NCT01598662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167888|NCT01598662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6167889|NCT01598662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6167890|NCT01598662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6167891|NCT01598701|Acetaminophen|acetaminophen|mesh-list
6167892|NCT01598701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6167893|NCT01598701|Analgesics|analgesics|mesh-ancestor
6167894|NCT01598701|Sensory System Agents|sensory system agents|mesh-ancestor
6669539|NCT01538641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669540|NCT01538641|Antiviral Agents|antiviral agents|mesh-ancestor
6669541|NCT01538641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6669542|NCT01538641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6669543|NCT01538641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6669544|NCT01538667|Ciprofloxacin|ciprofloxacin|mesh-list
6669545|NCT01538667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6669546|NCT01538667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6669547|NCT01538667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5566022|NCT03970954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566023|NCT03970772|Glucagon|glucagon|mesh-list
5566024|NCT03970772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5566025|NCT03970772|Hormones|hormones|mesh-ancestor
5566026|NCT03970772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5566027|NCT03970772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566028|NCT03970616|Durvalumab|durvalumab|mesh-list
5566029|NCT03970616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5566030|NCT03970616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5566031|NCT03970720|Metoclopramide|metoclopramide|mesh-list
5566032|NCT03970720|Antiemetics|antiemetics|mesh-ancestor
5566033|NCT03970720|Autonomic Agents|autonomic agents|mesh-ancestor
5566034|NCT03970720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6167895|NCT01598701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6167896|NCT01598701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167897|NCT01598701|Antipyretics|antipyretics|mesh-ancestor
6167898|NCT01598740|Spironolactone|spironolactone|mesh-list
6167899|NCT01598740|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6167900|NCT01598740|Hormone Antagonists|hormone antagonists|mesh-ancestor
6167901|NCT01598740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6167902|NCT01598740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167903|NCT01598740|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6167904|NCT01598740|Diuretics|diuretics|mesh-ancestor
6167905|NCT01598740|Natriuretic Agents|natriuretic agents|mesh-ancestor
6167906|NCT01598753|Tramadol|tramadol|mesh-list
6167907|NCT01598753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5566035|NCT03970720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566036|NCT03970720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5566037|NCT03970720|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5566038|NCT03970720|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5566039|NCT03970720|Dopamine Agents|dopamine agents|mesh-ancestor
5566040|NCT03970720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5603925|NCT05179733|Immunologic Factors|immunologic factors|mesh-ancestor
6484311|NCT00561184|Immunologic Factors|immunologic factors|mesh-ancestor
6484312|NCT00561184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484313|NCT00561197|Gossypol acetic acid|gossypol acetic acid|mesh-list
6484314|NCT00561197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6484315|NCT00561197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6484316|NCT00561197|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6669548|NCT01538667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6669549|NCT01538667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6669550|NCT01538667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669551|NCT01538667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6669552|NCT01538667|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6167908|NCT01598753|Narcotics|narcotics|mesh-ancestor
6167909|NCT01598753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6167910|NCT01598753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167911|NCT01598753|Analgesics|analgesics|mesh-ancestor
6167912|NCT01598753|Sensory System Agents|sensory system agents|mesh-ancestor
6167913|NCT01598753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6167914|NCT01598896|Clonidine|clonidine|mesh-list
6167915|NCT01598896|Dronabinol|dronabinol|mesh-list
6167916|NCT01598896|Analgesics|analgesics|mesh-ancestor
6167917|NCT01598896|Sensory System Agents|sensory system agents|mesh-ancestor
6167918|NCT01598896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6167919|NCT01598896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167920|NCT01598896|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6167921|NCT01598896|Sympatholytics|sympatholytics|mesh-ancestor
6167922|NCT01598896|Autonomic Agents|autonomic agents|mesh-ancestor
6167923|NCT01598896|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6167924|NCT01598896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6167925|NCT01598896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6167926|NCT01598896|Adrenergic Agents|adrenergic agents|mesh-ancestor
6167927|NCT01598896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6167928|NCT01598896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6167929|NCT01598896|Hallucinogens|hallucinogens|mesh-ancestor
6167930|NCT01598896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6167931|NCT01598896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6167932|NCT01598896|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6167933|NCT01598896|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6167934|NCT01598896|Hormones|hormones|mesh-ancestor
6167935|NCT01598896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6167936|NCT01598987|Cyclosporine|cyclosporine|mesh-list
6167937|NCT01598987|Everolimus|everolimus|mesh-list
6167938|NCT01598987|Tacrolimus|tacrolimus|mesh-list
6167939|NCT01598987|Cyclosporins|cyclosporins|mesh-list
6167940|NCT01598987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5566041|NCT03970720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566042|NCT03970694|Capecitabine|capecitabine|mesh-list
5566043|NCT03970694|Oxaliplatin|oxaliplatin|mesh-list
5566044|NCT03970694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5566045|NCT03970694|Antimetabolites|antimetabolites|mesh-ancestor
5566046|NCT03970694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566047|NCT03970694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5566048|NCT03971019|Calcium, Dietary|calcium, dietary|mesh-list
5566049|NCT03971019|Atorvastatin|atorvastatin|mesh-list
5566050|NCT03971019|Simvastatin|simvastatin|mesh-list
5566051|NCT03971019|Calcium|calcium|mesh-list
5566052|NCT03971019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5566053|NCT03971019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566054|NCT03971019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5566055|NCT03971019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6167941|NCT01598987|Immunologic Factors|immunologic factors|mesh-ancestor
6167942|NCT01598987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167943|NCT01598987|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6167944|NCT01598987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6167945|NCT01598987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6167946|NCT01598987|Antifungal Agents|antifungal agents|mesh-ancestor
6167947|NCT01598987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6167948|NCT01598987|Dermatologic Agents|dermatologic agents|mesh-ancestor
6167949|NCT01598987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6167950|NCT01598987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6167951|NCT01599104|Olmesartan|olmesartan|mesh-list
6167952|NCT01599104|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
6167953|NCT01599104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6167954|NCT01599104|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6167955|NCT01599104|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6167956|NCT01599104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6167957|NCT01599234|Nabiximols|nabiximols|mesh-list
6167958|NCT01599234|Analgesics|analgesics|mesh-ancestor
6167959|NCT01599234|Sensory System Agents|sensory system agents|mesh-ancestor
6484317|NCT00561197|Contraceptive Agents|contraceptive agents|mesh-ancestor
5566056|NCT03971019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5566057|NCT03971019|Antimetabolites|antimetabolites|mesh-ancestor
5566058|NCT03971019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566059|NCT03971019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5566060|NCT03971019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5566061|NCT03971019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5566062|NCT03970759|Fluorides|fluorides|mesh-list
5566063|NCT03970759|Tin Fluorides|tin fluorides|mesh-list
6167960|NCT01599234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6167961|NCT01599234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669553|NCT01538667|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6669554|NCT01538693|Cyproheptadine|cyproheptadine|mesh-list
6669555|NCT01538693|Dexetimide|dexetimide|mesh-list
6669556|NCT01538693|Citalopram|citalopram|mesh-list
6669557|NCT01538693|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6669558|NCT01538693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6669559|NCT01538693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6669560|NCT01538693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669561|NCT01538693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5566064|NCT03970759|Cariostatic Agents|cariostatic agents|mesh-ancestor
5566065|NCT03970759|Protective Agents|protective agents|mesh-ancestor
5566066|NCT03970759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566067|NCT03970577|Prednisone|prednisone|mesh-list
5566068|NCT03970577|Rituximab|rituximab|mesh-list
5566069|NCT03970577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5566070|NCT03970577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5566071|NCT03970577|Immunologic Factors|immunologic factors|mesh-ancestor
5566072|NCT03970577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566073|NCT03970577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5566074|NCT03970577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5566075|NCT03970577|Glucocorticoids|glucocorticoids|mesh-ancestor
5566076|NCT03970577|Hormones|hormones|mesh-ancestor
5566077|NCT03970577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5566078|NCT03970577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5566079|NCT03970668|Insulin|insulin|mesh-list
6167962|NCT01599325|Azacitidine|azacitidine|mesh-list
6167963|NCT01599325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6167964|NCT01599325|Antimetabolites|antimetabolites|mesh-ancestor
6167965|NCT01599325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6167966|NCT01599325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6167967|NCT01599325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6484318|NCT00561197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6484319|NCT00561197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484320|NCT00561197|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
6484321|NCT00561197|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
6484322|NCT00561197|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6484323|NCT00561223|Iloprost|iloprost|mesh-list
6484324|NCT00561223|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6167968|NCT01599650|Ranibizumab|ranibizumab|mesh-list
6167969|NCT01599650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6167970|NCT01599650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6167971|NCT01599650|Growth Substances|growth substances|mesh-ancestor
6167972|NCT01599650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6167973|NCT01599650|Growth Inhibitors|growth inhibitors|mesh-ancestor
6167974|NCT01599650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6167975|NCT01599754|Axitinib|axitinib|mesh-list
6167976|NCT01599754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6167977|NCT01599754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6167978|NCT01599754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6167979|NCT01599754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6167980|NCT01599806|Ciprofloxacin|ciprofloxacin|mesh-list
6167981|NCT01599806|Ceftazidime|ceftazidime|mesh-list
6167982|NCT01599806|Doripenem|doripenem|mesh-list
5566080|NCT03970668|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5566081|NCT03970668|Linagliptin|linagliptin|mesh-list
5566082|NCT03970668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5566083|NCT03970668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566084|NCT03970668|Incretins|incretins|mesh-ancestor
5566085|NCT03970668|Hormones|hormones|mesh-ancestor
5566086|NCT03970668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5566087|NCT03970668|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5566088|NCT03970668|Protease Inhibitors|protease inhibitors|mesh-ancestor
5566089|NCT03970668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6167983|NCT01599806|Avibactam|avibactam|mesh-list
6484325|NCT00561223|Vasodilator Agents|vasodilator agents|mesh-ancestor
6484326|NCT00561288|Acetaminophen|acetaminophen|mesh-list
6484327|NCT00561288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6167984|NCT01599806|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6167985|NCT01599806|Trimethoprim|trimethoprim|mesh-list
6167986|NCT01599806|Sulfamethoxazole|sulfamethoxazole|mesh-list
6167987|NCT01599806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6167988|NCT01599806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6167989|NCT01599806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6167990|NCT01599806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6167991|NCT01599806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6167992|NCT01599806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6167993|NCT01599806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6167994|NCT01599806|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6167995|NCT01599806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6167996|NCT01599806|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6167997|NCT01599806|Renal Agents|renal agents|mesh-ancestor
6167998|NCT01599806|Antimalarials|antimalarials|mesh-ancestor
6167999|NCT01599806|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6168000|NCT01599806|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6168001|NCT01599806|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6168002|NCT01599806|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6168003|NCT01599806|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6168004|NCT01599806|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6168005|NCT01600053|Lenalidomide|lenalidomide|mesh-list
6168006|NCT01600053|Immunologic Factors|immunologic factors|mesh-ancestor
6168007|NCT01600053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168008|NCT01600053|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6168009|NCT01600053|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6168010|NCT01600053|Growth Substances|growth substances|mesh-ancestor
6168011|NCT01600053|Growth Inhibitors|growth inhibitors|mesh-ancestor
6168012|NCT01600053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6168013|NCT01600170|Atorvastatin|atorvastatin|mesh-list
6168014|NCT01600170|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6168015|NCT01600170|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6168016|NCT01600170|Antimetabolites|antimetabolites|mesh-ancestor
6168017|NCT01600170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566090|NCT03970668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566091|NCT03970356|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5566092|NCT03970356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5566093|NCT03970213|Tranexamic Acid|tranexamic acid|mesh-list
5566094|NCT03970213|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5566095|NCT03970213|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5566096|NCT03970213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566097|NCT03970213|Hemostatics|hemostatics|mesh-ancestor
5566098|NCT03970213|Coagulants|coagulants|mesh-ancestor
5566099|NCT03970239|Ketanserin|ketanserin|mesh-list
6168018|NCT01600170|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6168019|NCT01600170|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6168020|NCT01600170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6168021|NCT01600287|Propofol|propofol|mesh-list
6168022|NCT01600287|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6168023|NCT01600287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6168024|NCT01600287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484328|NCT00561288|Analgesics|analgesics|mesh-ancestor
6484329|NCT00561288|Sensory System Agents|sensory system agents|mesh-ancestor
6484330|NCT00561288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6484331|NCT00561288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484332|NCT00561288|Antipyretics|antipyretics|mesh-ancestor
6484333|NCT00561327|Losartan|losartan|mesh-list
6484334|NCT00561327|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6484335|NCT00561327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6484336|NCT00561327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6484337|NCT00561327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6484338|NCT00561327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484339|NCT00561379|Rituximab|rituximab|mesh-list
6484340|NCT00561379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6484341|NCT00561379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6484342|NCT00561379|Immunologic Factors|immunologic factors|mesh-ancestor
6484343|NCT00561379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484344|NCT00561379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6484345|NCT00561496|Tenofovir|tenofovir|mesh-list
6484346|NCT00561496|Antiviral Agents|antiviral agents|mesh-ancestor
5566100|NCT03970239|Fluorides|fluorides|mesh-list
6168025|NCT01600287|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6168026|NCT01600287|Anesthetics, General|anesthetics, general|mesh-ancestor
6168027|NCT01600287|Anesthetics|anesthetics|mesh-ancestor
6669562|NCT01538693|Serotonin Agents|serotonin agents|mesh-ancestor
6484347|NCT00561496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5566101|NCT03970239|Altanserin|altanserin|mesh-list
5566102|NCT03970239|Cariostatic Agents|cariostatic agents|mesh-ancestor
5566103|NCT03970239|Protective Agents|protective agents|mesh-ancestor
5566104|NCT03970239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566105|NCT03970239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5566106|NCT03970239|Serotonin Agents|serotonin agents|mesh-ancestor
5566107|NCT03970239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5566108|NCT03970239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566109|NCT03970239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5566110|NCT03970239|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5566111|NCT03970330|Naltrexone|naltrexone|mesh-list
5566112|NCT03970330|Norethindrone|norethindrone|mesh-list
5566113|NCT03970330|Norethindrone Acetate|norethindrone acetate|mesh-list
5566114|NCT03970330|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5566115|NCT03970330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5566116|NCT03970330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566117|NCT03970330|Sensory System Agents|sensory system agents|mesh-ancestor
5566118|NCT03970330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5566119|NCT03970330|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5566120|NCT03970330|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5566121|NCT03970330|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5566122|NCT03970330|Contraceptive Agents|contraceptive agents|mesh-ancestor
5566123|NCT03970330|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5566124|NCT03970330|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6484348|NCT00561496|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6484349|NCT00561496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6484350|NCT00561496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6484351|NCT00561496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484352|NCT00561496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6484353|NCT00561496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6484354|NCT00561509|Antidepressive Agents|antidepressive agents|mesh-list
6484355|NCT00561509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5566125|NCT03970330|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5566126|NCT03970044|Dapagliflozin|dapagliflozin|mesh-list
5566127|NCT03970044|Exenatide|exenatide|mesh-list
5566128|NCT03970044|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5566129|NCT03970044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566130|NCT03970044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5566131|NCT03970044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566132|NCT03970044|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5566133|NCT03970044|Incretins|incretins|mesh-ancestor
5566134|NCT03970044|Hormones|hormones|mesh-ancestor
5566135|NCT03970044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5566136|NCT03969823|Osimertinib|osimertinib|mesh-list
5566137|NCT03969823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5566138|NCT03969823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5566139|NCT03969823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6168028|NCT01600703|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6168029|NCT01600703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6168030|NCT01600703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168031|NCT01600703|Incretins|incretins|mesh-ancestor
6168032|NCT01600703|Hormones|hormones|mesh-ancestor
6168033|NCT01600703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6168034|NCT01600703|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6168035|NCT01600703|Protease Inhibitors|protease inhibitors|mesh-ancestor
6168036|NCT01600703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6168037|NCT01600703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484356|NCT00561522|Capecitabine|capecitabine|mesh-list
6484357|NCT00561522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6484358|NCT00561522|Antimetabolites|antimetabolites|mesh-ancestor
6484359|NCT00561522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484360|NCT00561522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6484361|NCT00561587|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6484362|NCT00561587|Antidepressive Agents|antidepressive agents|mesh-ancestor
6484363|NCT00561587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6484364|NCT00561587|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6484365|NCT00561587|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6484366|NCT00561587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6484367|NCT00561587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484368|NCT00561613|Spermatocidal Agents|spermatocidal agents|mesh-list
6484369|NCT00561613|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
6484370|NCT00561613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484371|NCT00561613|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6484372|NCT00561613|Contraceptive Agents|contraceptive agents|mesh-ancestor
6484373|NCT00561613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6168038|NCT01600716|Botulinum Toxins|botulinum toxins|mesh-list
6168039|NCT01600716|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6168040|NCT01600716|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6168041|NCT01600716|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6168042|NCT01600716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6168043|NCT01600716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168044|NCT01600716|Cholinergic Agents|cholinergic agents|mesh-ancestor
6168045|NCT01600716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6168046|NCT01600716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168047|NCT01600716|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6168048|NCT01600716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6168049|NCT01600885|Guanfacine|guanfacine|mesh-list
6168050|NCT01600885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6484374|NCT00561691|Nimotuzumab|nimotuzumab|mesh-list
6484375|NCT00561691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5566140|NCT03969823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603926|NCT05179733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603927|NCT05179733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6484376|NCT00561691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6484377|NCT00561704|Losartan|losartan|mesh-list
6484378|NCT00561704|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6484379|NCT00561704|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6484380|NCT00561704|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6484381|NCT00561704|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6484382|NCT00561704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484383|NCT00561717|Cetirizine|cetirizine|mesh-list
6484384|NCT00561717|Loratadine|loratadine|mesh-list
6484385|NCT00561717|Azelastine|azelastine|mesh-list
6484386|NCT00561717|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6484387|NCT00561717|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6484388|NCT00561717|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6168051|NCT01600885|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6168052|NCT01600885|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6168053|NCT01600885|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6168054|NCT01600885|Adrenergic Agents|adrenergic agents|mesh-ancestor
6168055|NCT01600885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6168056|NCT01600885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168057|NCT01600885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168058|NCT01600950|Insulin Glargine|insulin glargine|mesh-list
6168059|NCT01600950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6168060|NCT01600950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168061|NCT01601132|Colchicine|colchicine|mesh-list
6168062|NCT01601132|Theophylline|theophylline|mesh-list
5603928|NCT05179733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5603929|NCT05179733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6168063|NCT01601132|Gout Suppressants|gout suppressants|mesh-ancestor
6168064|NCT01601132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6168065|NCT01601132|Tubulin Modulators|tubulin modulators|mesh-ancestor
6168066|NCT01601132|Antimitotic Agents|antimitotic agents|mesh-ancestor
6168067|NCT01601132|Mitosis Modulators|mitosis modulators|mesh-ancestor
6168068|NCT01601132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168069|NCT01601132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6168070|NCT01601132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6168071|NCT01601132|Autonomic Agents|autonomic agents|mesh-ancestor
6484389|NCT00561717|Histamine Antagonists|histamine antagonists|mesh-ancestor
6484390|NCT00561717|Histamine Agents|histamine agents|mesh-ancestor
5566141|NCT03969758|Metronidazole|metronidazole|mesh-list
5566142|NCT03969758|Ciprofloxacin|ciprofloxacin|mesh-list
5566143|NCT03969758|Cefixime|cefixime|mesh-list
5566144|NCT03969758|Liver Extracts|liver extracts|mesh-list
5566145|NCT03969758|Hematinics|hematinics|mesh-ancestor
5566146|NCT03969758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5566147|NCT03969758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5566148|NCT03969758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5566149|NCT03969758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5566150|NCT03969758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5566151|NCT03969758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5566152|NCT03969758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5566153|NCT03969758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566154|NCT03969758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5566155|NCT03969758|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5566156|NCT03969758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5566157|NCT03968913|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5566158|NCT03968913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5566159|NCT03969017|Interferons|interferons|mesh-list
5566160|NCT03969017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5566161|NCT03969017|Antiviral Agents|antiviral agents|mesh-ancestor
5566162|NCT03969017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5566163|NCT03968835|Bacitracin|bacitracin|mesh-list
5566164|NCT03968835|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5566165|NCT03968835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5566166|NCT03968835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5566167|NCT03968640|Coenzyme Q10|coenzyme q10|mesh-list
5566168|NCT03968640|Vitamins|vitamins|mesh-ancestor
6168072|NCT01601132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6168073|NCT01601132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168074|NCT01601132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5566169|NCT03968640|Micronutrients|micronutrients|mesh-ancestor
5566170|NCT03968640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566171|NCT03968588|Mycophenolic Acid|mycophenolic acid|mesh-list
5566172|NCT03968588|Tacrolimus|tacrolimus|mesh-list
5566173|NCT03968588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5566174|NCT03968588|Immunologic Factors|immunologic factors|mesh-ancestor
5566175|NCT03968588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566176|NCT03968588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6168075|NCT01601132|Respiratory System Agents|respiratory system agents|mesh-ancestor
6168076|NCT01601132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6168077|NCT01601132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6168078|NCT01601132|Vasodilator Agents|vasodilator agents|mesh-ancestor
6168079|NCT01601132|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6168080|NCT01601132|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6168081|NCT01601132|Purinergic Agents|purinergic agents|mesh-ancestor
6168082|NCT01601132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6168083|NCT01601236|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6168084|NCT01601236|Hormones|hormones|mesh-ancestor
6168085|NCT01601236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6168086|NCT01601236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168087|NCT01601470|Sildenafil Citrate|sildenafil citrate|mesh-list
6484391|NCT00561717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6168088|NCT01601470|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5566177|NCT03968588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5566178|NCT03968588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566179|NCT03968588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5566180|NCT03968588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5566181|NCT03968588|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5566182|NCT03968588|Antitubercular Agents|antitubercular agents|mesh-ancestor
5566183|NCT03968588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5566184|NCT03968588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5566185|NCT03968861|Xenon|xenon|mesh-list
5566186|NCT03968861|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5566187|NCT03968861|Anesthetics, General|anesthetics, general|mesh-ancestor
5566188|NCT03968861|Anesthetics|anesthetics|mesh-ancestor
5566189|NCT03968861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5566190|NCT03968861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566191|NCT03968263|Hydrocodone|hydrocodone|mesh-list
5566192|NCT03968263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5566193|NCT03968263|Narcotics|narcotics|mesh-ancestor
5566194|NCT03968263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5566195|NCT03968263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566196|NCT03968263|Analgesics|analgesics|mesh-ancestor
5566197|NCT03968263|Sensory System Agents|sensory system agents|mesh-ancestor
5566198|NCT03968263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6168089|NCT01601470|Vasodilator Agents|vasodilator agents|mesh-ancestor
6168090|NCT01601470|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6168091|NCT01601470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6168092|NCT01601470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6168093|NCT01601470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168094|NCT01601470|Urological Agents|urological agents|mesh-ancestor
6168095|NCT01601470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6168096|NCT01601535|Irinotecan|irinotecan|mesh-list
6168097|NCT01601535|Temozolomide|temozolomide|mesh-list
6168098|NCT01601535|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6168099|NCT01601535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6168100|NCT01601535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6168101|NCT01601535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168102|NCT01601535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6168103|NCT01601535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6168104|NCT01601535|Alkylating Agents|alkylating agents|mesh-ancestor
6168105|NCT01601626|Pyridoxine|pyridoxine|mesh-list
6168106|NCT01601626|Vitamin B 6|vitamin b 6|mesh-list
6168107|NCT01601626|Ritonavir|ritonavir|mesh-list
6168108|NCT01601626|Lopinavir|lopinavir|mesh-list
6168109|NCT01601626|Raltegravir Potassium|raltegravir potassium|mesh-list
6168110|NCT01601626|Rifampin|rifampin|mesh-list
6168111|NCT01601626|Isoniazid|isoniazid|mesh-list
6168112|NCT01601626|Pyrazinamide|pyrazinamide|mesh-list
6168113|NCT01601626|Ethambutol|ethambutol|mesh-list
6168114|NCT01601626|Rifabutin|rifabutin|mesh-list
6168115|NCT01601626|Vitamins|vitamins|mesh-ancestor
6484392|NCT00561717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484393|NCT00561717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484394|NCT00561717|Antipruritics|antipruritics|mesh-ancestor
6484395|NCT00561717|Dermatologic Agents|dermatologic agents|mesh-ancestor
6484396|NCT00561717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6484397|NCT00561717|Autonomic Agents|autonomic agents|mesh-ancestor
6484398|NCT00561717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6484399|NCT00561717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6484400|NCT00561717|Respiratory System Agents|respiratory system agents|mesh-ancestor
6484401|NCT00561717|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6484402|NCT00561717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6484403|NCT00561756|Vaccines|vaccines|mesh-list
6484404|NCT00561756|Immunologic Factors|immunologic factors|mesh-ancestor
6484405|NCT00561756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484406|NCT00561886|Formoterol Fumarate|formoterol fumarate|mesh-list
6484407|NCT00561886|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6484408|NCT00561886|Autonomic Agents|autonomic agents|mesh-ancestor
6484409|NCT00561886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6484410|NCT00561886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484411|NCT00561886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6484412|NCT00561886|Respiratory System Agents|respiratory system agents|mesh-ancestor
6484413|NCT00561886|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6484414|NCT00561886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6484415|NCT00561886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6484416|NCT00561886|Adrenergic Agents|adrenergic agents|mesh-ancestor
6484417|NCT00561886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6484418|NCT00561886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484419|NCT00561899|Piperaquine|piperaquine|mesh-list
6168116|NCT01601626|Micronutrients|micronutrients|mesh-ancestor
6168117|NCT01601626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168118|NCT01601626|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5566199|NCT03968263|Antitussive Agents|antitussive agents|mesh-ancestor
5566200|NCT03968263|Respiratory System Agents|respiratory system agents|mesh-ancestor
5566201|NCT03968341|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5566202|NCT03968341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5566203|NCT03968393|Rivaroxaban|rivaroxaban|mesh-list
5566204|NCT03968393|Apixaban|apixaban|mesh-list
5566205|NCT03968393|Edoxaban|edoxaban|mesh-list
6168119|NCT01601626|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6168120|NCT01601626|Protease Inhibitors|protease inhibitors|mesh-ancestor
6168121|NCT01601626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6168122|NCT01601626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168123|NCT01601626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6168124|NCT01601626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6168125|NCT01601626|Antiviral Agents|antiviral agents|mesh-ancestor
5566206|NCT03968393|Dabigatran|dabigatran|mesh-list
5566207|NCT03968393|Anticoagulants|anticoagulants|mesh-list
6168126|NCT01601626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5566208|NCT03968393|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6168127|NCT01601626|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6168128|NCT01601626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6168129|NCT01601626|Vitamin B Complex|vitamin b complex|mesh-ancestor
6168130|NCT01601626|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6168131|NCT01601626|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5566209|NCT03968393|Antithrombins|antithrombins|mesh-ancestor
5566210|NCT03968393|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5566211|NCT03968393|Protease Inhibitors|protease inhibitors|mesh-ancestor
5566212|NCT03968393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5566213|NCT03968393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566214|NCT03968185|Analgesics|analgesics|mesh-list
5566215|NCT03968185|Sensory System Agents|sensory system agents|mesh-ancestor
5566216|NCT03968185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5566217|NCT03968185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566218|NCT03968146|Acetaminophen|acetaminophen|mesh-list
5566219|NCT03968146|Ketorolac|ketorolac|mesh-list
6168132|NCT01601626|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6168133|NCT01601626|Antitubercular Agents|antitubercular agents|mesh-ancestor
5566220|NCT03968146|Fentanyl|fentanyl|mesh-list
5566221|NCT03968146|Meperidine|meperidine|mesh-list
5566222|NCT03968146|Morphine|morphine|mesh-list
6168134|NCT01601626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6168135|NCT01601626|Leprostatic Agents|leprostatic agents|mesh-ancestor
6168136|NCT01601626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6168137|NCT01601626|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6168138|NCT01601626|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6168139|NCT01601626|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6168140|NCT01601626|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6669563|NCT01538693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669564|NCT01538693|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6669565|NCT01538693|Antidepressive Agents|antidepressive agents|mesh-ancestor
6669566|NCT01538693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6669567|NCT01538693|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6669568|NCT01538693|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6669569|NCT01538693|Parasympatholytics|parasympatholytics|mesh-ancestor
6669570|NCT01538693|Autonomic Agents|autonomic agents|mesh-ancestor
6168141|NCT01601626|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6168142|NCT01601626|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6168143|NCT01601626|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6168144|NCT01601626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6168145|NCT01601626|Antimetabolites|antimetabolites|mesh-ancestor
6168146|NCT01601626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6206233|NCT02097732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6206234|NCT02097732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6206235|NCT02097732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5566223|NCT03968146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5566224|NCT03968146|Narcotics|narcotics|mesh-ancestor
5566225|NCT03968146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5566226|NCT03968146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566227|NCT03968146|Analgesics|analgesics|mesh-ancestor
5566228|NCT03968146|Sensory System Agents|sensory system agents|mesh-ancestor
5566229|NCT03968146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5566230|NCT03968146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5566231|NCT03968146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6206236|NCT02097732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206237|NCT02097745|Rituximab|rituximab|mesh-list
6206238|NCT02097745|Methotrexate|methotrexate|mesh-list
6206239|NCT02097745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6206240|NCT02097745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6206241|NCT02097745|Immunologic Factors|immunologic factors|mesh-ancestor
6206242|NCT02097745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206243|NCT02097745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6206244|NCT02097745|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6206245|NCT02097745|Abortifacient Agents|abortifacient agents|mesh-ancestor
6206246|NCT02097745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6206247|NCT02097745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6206248|NCT02097745|Antimetabolites|antimetabolites|mesh-ancestor
6206249|NCT02097745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206250|NCT02097745|Dermatologic Agents|dermatologic agents|mesh-ancestor
6206251|NCT02097745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6206252|NCT02097745|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6206253|NCT02097745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6206254|NCT02097745|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6206255|NCT02097823|Olanzapine|olanzapine|mesh-list
6206256|NCT02097823|Aprepitant|aprepitant|mesh-list
6168147|NCT01601704|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
6168148|NCT01601704|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6168149|NCT01601821|Sirolimus|sirolimus|mesh-list
6168150|NCT01601821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6168151|NCT01601821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6168152|NCT01601821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6168153|NCT01601821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6168154|NCT01601821|Antifungal Agents|antifungal agents|mesh-ancestor
6168155|NCT01601821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6168156|NCT01601821|Immunologic Factors|immunologic factors|mesh-ancestor
6168157|NCT01601821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168158|NCT01601847|Vitamin D|vitamin d|mesh-list
5566232|NCT03968146|Anesthetics, General|anesthetics, general|mesh-ancestor
5566233|NCT03968146|Anesthetics|anesthetics|mesh-ancestor
5566234|NCT03968146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5566235|NCT03968146|Antipyretics|antipyretics|mesh-ancestor
5566236|NCT03968146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5566237|NCT03968146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5566238|NCT03968146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5566239|NCT03968146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5566240|NCT03968146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5566241|NCT03968146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566242|NCT03968224|Metformin|metformin|mesh-list
5566243|NCT03968224|Dapagliflozin|dapagliflozin|mesh-list
5566244|NCT03968224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5566245|NCT03968224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566246|NCT03968224|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5566247|NCT03968224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566248|NCT03968406|Talazoparib|talazoparib|mesh-list
5566249|NCT03968406|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5566250|NCT03968406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6168159|NCT01601847|Cholecalciferol|cholecalciferol|mesh-list
6168160|NCT01601847|Vitamins|vitamins|mesh-ancestor
6168161|NCT01601847|Micronutrients|micronutrients|mesh-ancestor
6168162|NCT01601847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168163|NCT01601847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6168164|NCT01601847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6168165|NCT01601873|Heparin|heparin|mesh-list
6168166|NCT01601873|Anticoagulants|anticoagulants|mesh-ancestor
6168167|NCT01601873|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6168168|NCT01601873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6168169|NCT01601873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168170|NCT01602068|Dexamethasone|dexamethasone|mesh-list
6168171|NCT01602068|Citric Acid|citric acid|mesh-list
6168172|NCT01602068|Sodium Citrate|sodium citrate|mesh-list
6168173|NCT01602068|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
6168174|NCT01602068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6168175|NCT01602068|Antiemetics|antiemetics|mesh-ancestor
6168176|NCT01602068|Autonomic Agents|autonomic agents|mesh-ancestor
6168177|NCT01602068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6168178|NCT01602068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168179|NCT01602068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6168180|NCT01602068|Glucocorticoids|glucocorticoids|mesh-ancestor
6168181|NCT01602068|Hormones|hormones|mesh-ancestor
6168182|NCT01602068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6168183|NCT01602068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6168184|NCT01602068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6168185|NCT01602068|Anticoagulants|anticoagulants|mesh-ancestor
6168186|NCT01602068|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6168187|NCT01602068|Chelating Agents|chelating agents|mesh-ancestor
6168188|NCT01602068|Sequestering Agents|sequestering agents|mesh-ancestor
6168189|NCT01602068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168190|NCT01602224|Dexamethasone|dexamethasone|mesh-list
6168191|NCT01602224|Bortezomib|bortezomib|mesh-list
6168192|NCT01602224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6168193|NCT01602224|Antiemetics|antiemetics|mesh-ancestor
6168194|NCT01602224|Autonomic Agents|autonomic agents|mesh-ancestor
6168195|NCT01602224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6168196|NCT01602224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168197|NCT01602224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6168198|NCT01602224|Glucocorticoids|glucocorticoids|mesh-ancestor
6168199|NCT01602224|Hormones|hormones|mesh-ancestor
5566251|NCT03968406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168200|NCT01602224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6168201|NCT01602224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6168202|NCT01602224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6168203|NCT01602315|Cetuximab|cetuximab|mesh-list
6168204|NCT01602315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6168205|NCT01602315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6168206|NCT01602380|Fulvestrant|fulvestrant|mesh-list
6168207|NCT01602380|Anastrozole|anastrozole|mesh-list
6168208|NCT01602380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6168209|NCT01602380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6168210|NCT01602380|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6168211|NCT01602380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6168212|NCT01602380|Hormone Antagonists|hormone antagonists|mesh-ancestor
5566252|NCT03968406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5566253|NCT03968237|Buprenorphine|buprenorphine|mesh-list
5566254|NCT03968237|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
5566255|NCT03968237|Naloxone|naloxone|mesh-list
5566256|NCT03968237|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5566257|NCT03968237|Narcotics|narcotics|mesh-ancestor
5566258|NCT03968237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5566259|NCT03968237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566260|NCT03968237|Analgesics|analgesics|mesh-ancestor
5566261|NCT03968237|Sensory System Agents|sensory system agents|mesh-ancestor
5566262|NCT03968237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5566263|NCT03968237|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5566264|NCT03967964|Methyltestosterone|methyltestosterone|mesh-list
5566265|NCT03967964|Testosterone|testosterone|mesh-list
5566266|NCT03967964|Testosterone undecanoate|testosterone undecanoate|mesh-list
5566267|NCT03967964|Testosterone enanthate|testosterone enanthate|mesh-list
5566268|NCT03967964|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5566269|NCT03967964|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
5566270|NCT03967964|Androgens|androgens|mesh-ancestor
5566271|NCT03967964|Hormones|hormones|mesh-ancestor
5566272|NCT03967964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5566273|NCT03967964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566274|NCT03967964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5566275|NCT03967964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5566276|NCT03967964|Anabolic Agents|anabolic agents|mesh-ancestor
5566277|NCT03967964|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6168213|NCT01602380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6168214|NCT01602380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566278|NCT03967964|Immunologic Factors|immunologic factors|mesh-ancestor
5566279|NCT03967977|Gemcitabine|gemcitabine|mesh-list
5566280|NCT03967977|Carboplatin|carboplatin|mesh-list
5566281|NCT03967977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5566282|NCT03967977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5566283|NCT03967977|Antimetabolites|antimetabolites|mesh-ancestor
5566284|NCT03967977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566285|NCT03967977|Antiviral Agents|antiviral agents|mesh-ancestor
5603930|NCT05179733|Growth Substances|growth substances|mesh-ancestor
6168215|NCT01602380|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6168216|NCT01602380|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6168217|NCT01602380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6168218|NCT01602380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168219|NCT01602510|Lamotrigine|lamotrigine|mesh-list
6168220|NCT01602510|Anticonvulsants|anticonvulsants|mesh-ancestor
6168221|NCT01602510|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6168222|NCT01602510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6168223|NCT01602510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168224|NCT01602510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6168225|NCT01602510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168226|NCT01602510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6168227|NCT01602510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6206257|NCT02097823|Antiemetics|antiemetics|mesh-ancestor
5566286|NCT03967977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5566287|NCT03967977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5566288|NCT03967977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5566289|NCT03967977|Immunologic Factors|immunologic factors|mesh-ancestor
5566290|NCT03967977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603931|NCT05179733|Growth Inhibitors|growth inhibitors|mesh-ancestor
5603932|NCT05179733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5603933|NCT05179733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5603934|NCT05179733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603935|NCT05179525|Risperidone|risperidone|mesh-list
5603936|NCT05179525|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5603937|NCT05179525|Serotonin Agents|serotonin agents|mesh-ancestor
5603938|NCT05179525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5603939|NCT05179525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603940|NCT05179525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603941|NCT05179525|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5603942|NCT05179525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5603943|NCT05179525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5603944|NCT05179525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5603945|NCT05179525|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5603946|NCT05179525|Dopamine Agents|dopamine agents|mesh-ancestor
6168228|NCT01602510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6168229|NCT01602510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6168230|NCT01602510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6168231|NCT01602562|Valacyclovir|valacyclovir|mesh-list
6168232|NCT01602562|Antiviral Agents|antiviral agents|mesh-ancestor
6168233|NCT01602562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6168234|NCT01602679|Progesterone|progesterone|mesh-list
5603947|NCT05179512|Fluticasone|fluticasone|mesh-list
5603948|NCT05179512|Tiotropium Bromide|tiotropium bromide|mesh-list
5603949|NCT05179512|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6168235|NCT01602679|Progestins|progestins|mesh-ancestor
6168236|NCT01602679|Hormones|hormones|mesh-ancestor
6168237|NCT01602679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6168238|NCT01602679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168239|NCT01602692|Lidocaine|lidocaine|mesh-list
6168240|NCT01602692|Epinephrine|epinephrine|mesh-list
6168241|NCT01602692|Racepinephrine|racepinephrine|mesh-list
6168242|NCT01602692|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6168243|NCT01602692|Epinephryl borate|epinephryl borate|mesh-list
6168244|NCT01602692|Anesthetics, Local|anesthetics, local|mesh-ancestor
6168245|NCT01602692|Anesthetics|anesthetics|mesh-ancestor
6168246|NCT01602692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6168247|NCT01602692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168248|NCT01602692|Sensory System Agents|sensory system agents|mesh-ancestor
6168249|NCT01602692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6168250|NCT01602692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6168251|NCT01602692|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6168252|NCT01602692|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6168253|NCT01602692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6168254|NCT01602692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168255|NCT01602692|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6168256|NCT01602692|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6168257|NCT01602692|Adrenergic Agents|adrenergic agents|mesh-ancestor
6168258|NCT01602692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6168259|NCT01602692|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6168260|NCT01602692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6168261|NCT01602692|Autonomic Agents|autonomic agents|mesh-ancestor
6168262|NCT01602692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6168263|NCT01602692|Respiratory System Agents|respiratory system agents|mesh-ancestor
6669571|NCT01538693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6669572|NCT01538693|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5603950|NCT05179512|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
5603951|NCT05179512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5603952|NCT05179512|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5603953|NCT05179512|Autonomic Agents|autonomic agents|mesh-ancestor
5603954|NCT05179512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5603955|NCT05179512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603956|NCT05179512|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5603957|NCT05179512|Respiratory System Agents|respiratory system agents|mesh-ancestor
5603958|NCT05179512|Dermatologic Agents|dermatologic agents|mesh-ancestor
5603959|NCT05179512|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5603960|NCT05179512|Parasympatholytics|parasympatholytics|mesh-ancestor
5603961|NCT05179512|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5603962|NCT05179512|Cholinergic Agents|cholinergic agents|mesh-ancestor
6669573|NCT01538693|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6669574|NCT01538693|Cholinergic Agents|cholinergic agents|mesh-ancestor
6669575|NCT01538693|Antipruritics|antipruritics|mesh-ancestor
6669576|NCT01538693|Dermatologic Agents|dermatologic agents|mesh-ancestor
6669577|NCT01538693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6669578|NCT01538693|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5566291|NCT03967886|Esomeprazole|esomeprazole|mesh-list
5566292|NCT03967886|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5566293|NCT03967886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5566294|NCT03967886|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5566295|NCT03967886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5566296|NCT03967886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566297|NCT03967925|Prednisone|prednisone|mesh-list
5566298|NCT03967925|Prednisolone|prednisolone|mesh-list
5566299|NCT03967925|Rituximab|rituximab|mesh-list
5566300|NCT03967925|Belimumab|belimumab|mesh-list
5566301|NCT03967925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5566302|NCT03967925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5566303|NCT03967925|Immunologic Factors|immunologic factors|mesh-ancestor
5566304|NCT03967925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566305|NCT03967925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5566306|NCT03967925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5566307|NCT03967925|Glucocorticoids|glucocorticoids|mesh-ancestor
5566308|NCT03967925|Hormones|hormones|mesh-ancestor
5566309|NCT03967925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5566310|NCT03967925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5566311|NCT03967925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5566312|NCT03968042|Thiamine|thiamine|mesh-list
5566313|NCT03968042|Edaravone|edaravone|mesh-list
5566314|NCT03968042|Mitogens|mitogens|mesh-list
5566315|NCT03968042|Vitamins|vitamins|mesh-ancestor
5566316|NCT03968042|Micronutrients|micronutrients|mesh-ancestor
6669579|NCT01538693|Histamine Antagonists|histamine antagonists|mesh-ancestor
6669580|NCT01538693|Histamine Agents|histamine agents|mesh-ancestor
6669581|NCT01538693|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6669582|NCT01538693|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6669583|NCT01538732|Alitretinoin|alitretinoin|mesh-list
6669584|NCT01538732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6669585|NCT01538732|Dermatologic Agents|dermatologic agents|mesh-ancestor
6669586|NCT01538771|Darbepoetin alfa|darbepoetin alfa|mesh-list
6669587|NCT01538771|Hematinics|hematinics|mesh-ancestor
6672476|NCT01556477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672477|NCT01556477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6672478|NCT01556477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6672479|NCT01556477|Growth Substances|growth substances|mesh-ancestor
6672480|NCT01556477|Growth Inhibitors|growth inhibitors|mesh-ancestor
6672481|NCT01556477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5566317|NCT03968042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566318|NCT03968042|Mitosis Modulators|mitosis modulators|mesh-ancestor
5566319|NCT03968042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566320|NCT03968042|Vitamin B Complex|vitamin b complex|mesh-ancestor
5566321|NCT03968042|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5566322|NCT03968042|Antioxidants|antioxidants|mesh-ancestor
6672482|NCT01556477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6672483|NCT01556477|Antimetabolites|antimetabolites|mesh-ancestor
6672484|NCT01556477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672485|NCT01556477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6672486|NCT01556529|Unithiol|unithiol|mesh-list
6168264|NCT01602692|Mydriatics|mydriatics|mesh-ancestor
6168265|NCT01602692|Sympathomimetics|sympathomimetics|mesh-ancestor
6168266|NCT01602692|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6168267|NCT01603082|Clopidogrel|clopidogrel|mesh-list
6168268|NCT01603082|Ticagrelor|ticagrelor|mesh-list
6168269|NCT01603082|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6168270|NCT01603082|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6168271|NCT01603082|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6168272|NCT01603082|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6168273|NCT01603082|Purinergic Agents|purinergic agents|mesh-ancestor
6168274|NCT01603082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6168275|NCT01603082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168276|NCT01603082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168277|NCT01603277|Antibodies|antibodies|mesh-list
6168278|NCT01603277|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6168279|NCT01603277|Immunologic Factors|immunologic factors|mesh-ancestor
6168280|NCT01603277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168281|NCT01603420|Ascorbic Acid|ascorbic acid|mesh-list
6168282|NCT01603420|Docetaxel|docetaxel|mesh-list
6672487|NCT01556529|Antidotes|antidotes|mesh-ancestor
6672488|NCT01556529|Protective Agents|protective agents|mesh-ancestor
5566323|NCT03968042|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5566324|NCT03968042|Protective Agents|protective agents|mesh-ancestor
5566325|NCT03967847|Ketorolac|ketorolac|mesh-list
5566326|NCT03967847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5566327|NCT03967847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5566328|NCT03967847|Analgesics|analgesics|mesh-ancestor
5566329|NCT03967847|Sensory System Agents|sensory system agents|mesh-ancestor
5566330|NCT03967847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5566331|NCT03967847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566332|NCT03967847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5566333|NCT03967847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5566334|NCT03967847|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5566335|NCT03967847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5566336|NCT03967847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566337|NCT03967938|Olaparib|olaparib|mesh-list
5566338|NCT03967938|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5566339|NCT03967938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5566340|NCT03967938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566341|NCT03967938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5566342|NCT03967665|Acetylcysteine|acetylcysteine|mesh-list
6168283|NCT01603420|Methyltestosterone|methyltestosterone|mesh-list
6168284|NCT01603420|Hormones|hormones|mesh-list
6168285|NCT01603420|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6168286|NCT01603420|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
6168287|NCT01603420|Androgens|androgens|mesh-list
6168288|NCT01603420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6168289|NCT01603420|Tubulin Modulators|tubulin modulators|mesh-ancestor
6168290|NCT01603420|Antimitotic Agents|antimitotic agents|mesh-ancestor
6669588|NCT01538797|Ranitidine|ranitidine|mesh-list
6669589|NCT01538797|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
6669590|NCT01538797|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6669591|NCT01538797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6669592|NCT01538797|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6669593|NCT01538797|Histamine Antagonists|histamine antagonists|mesh-ancestor
6669594|NCT01538797|Histamine Agents|histamine agents|mesh-ancestor
6669595|NCT01538797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6168291|NCT01603420|Mitosis Modulators|mitosis modulators|mesh-ancestor
6168292|NCT01603420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168293|NCT01603420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6168294|NCT01603420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168295|NCT01603420|Antioxidants|antioxidants|mesh-ancestor
6168296|NCT01603420|Protective Agents|protective agents|mesh-ancestor
6168297|NCT01603420|Vitamins|vitamins|mesh-ancestor
6168298|NCT01603420|Micronutrients|micronutrients|mesh-ancestor
6168299|NCT01603420|Estrogens|estrogens|mesh-ancestor
6168300|NCT01603420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6168301|NCT01603420|Anabolic Agents|anabolic agents|mesh-ancestor
6168302|NCT01603459|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
6168303|NCT01603459|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6168304|NCT01603459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6168305|NCT01603459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168306|NCT01603459|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6168307|NCT01603459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6168308|NCT01603459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168309|NCT01603459|Cholinergic Agents|cholinergic agents|mesh-ancestor
6168310|NCT01603459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6168311|NCT01603602|Botulinum Toxins|botulinum toxins|mesh-list
6168312|NCT01603602|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6168313|NCT01603602|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6168314|NCT01603602|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6168315|NCT01603602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6168316|NCT01603602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168317|NCT01603602|Cholinergic Agents|cholinergic agents|mesh-ancestor
6168318|NCT01603602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6168319|NCT01603602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168320|NCT01603602|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6168321|NCT01603602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6168322|NCT01603615|Botulinum Toxins|botulinum toxins|mesh-list
6168323|NCT01603615|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6168324|NCT01603615|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6168325|NCT01603615|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6168326|NCT01603615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6206258|NCT02097823|Autonomic Agents|autonomic agents|mesh-ancestor
5566343|NCT03967665|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5566344|NCT03967665|Antiviral Agents|antiviral agents|mesh-ancestor
5566345|NCT03967665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5566346|NCT03967665|Expectorants|expectorants|mesh-ancestor
5566347|NCT03967665|Respiratory System Agents|respiratory system agents|mesh-ancestor
5566348|NCT03967665|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5566349|NCT03967665|Antioxidants|antioxidants|mesh-ancestor
5566350|NCT03967665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566351|NCT03967665|Protective Agents|protective agents|mesh-ancestor
5566352|NCT03967665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566353|NCT03967665|Antidotes|antidotes|mesh-ancestor
5566354|NCT03967392|Lidocaine|lidocaine|mesh-list
5566355|NCT03967392|Anesthetics, Local|anesthetics, local|mesh-ancestor
5566356|NCT03967392|Anesthetics|anesthetics|mesh-ancestor
5566357|NCT03967392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6168327|NCT01603615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168328|NCT01603615|Cholinergic Agents|cholinergic agents|mesh-ancestor
6168329|NCT01603615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6168330|NCT01603615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168331|NCT01603615|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6168332|NCT01603615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6168333|NCT01603628|Botulinum Toxins|botulinum toxins|mesh-list
6168334|NCT01603628|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6168335|NCT01603628|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6168336|NCT01603628|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6168337|NCT01603628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6168338|NCT01603628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168339|NCT01603628|Cholinergic Agents|cholinergic agents|mesh-ancestor
6168340|NCT01603628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6168341|NCT01603628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168342|NCT01603628|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6168343|NCT01603628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6168344|NCT01603641|Botulinum Toxins|botulinum toxins|mesh-list
6168345|NCT01603641|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6168346|NCT01603641|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6168347|NCT01603641|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6168348|NCT01603641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6168349|NCT01603641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168350|NCT01603641|Cholinergic Agents|cholinergic agents|mesh-ancestor
6168351|NCT01603641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6168352|NCT01603641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168353|NCT01603641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6168354|NCT01603641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6168355|NCT01603940|Losartan|losartan|mesh-list
6168356|NCT01603940|Benazepril|benazepril|mesh-list
6168357|NCT01603940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6168358|NCT01603940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6168359|NCT01603940|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6168360|NCT01603940|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6168361|NCT01603940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168362|NCT01603940|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6168363|NCT01603940|Protease Inhibitors|protease inhibitors|mesh-ancestor
5566358|NCT03967392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566359|NCT03967392|Sensory System Agents|sensory system agents|mesh-ancestor
5566360|NCT03967392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5566361|NCT03967392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5566362|NCT03967392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5566363|NCT03967392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5566364|NCT03967392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5566365|NCT03967392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566366|NCT03967054|Ivermectin|ivermectin|mesh-list
5566367|NCT03967054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5566368|NCT03967054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5566369|NCT03967171|Oxytocin|oxytocin|mesh-list
5566370|NCT03967171|Oxytocics|oxytocics|mesh-ancestor
5566371|NCT03967171|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5566372|NCT03967171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566373|NCT03967496|Metformin|metformin|mesh-list
5566374|NCT03967496|Amlodipine|amlodipine|mesh-list
5566375|NCT03967496|Lisinopril|lisinopril|mesh-list
5566376|NCT03967496|Bisoprolol|bisoprolol|mesh-list
5566377|NCT03967496|Hydralazine|hydralazine|mesh-list
5566378|NCT03967496|Anesthetics|anesthetics|mesh-list
5566379|NCT03967496|Atorvastatin|atorvastatin|mesh-list
5566380|NCT03967496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5566381|NCT03967496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168364|NCT01603940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6168365|NCT01604109|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
6168366|NCT01604109|Caseins|caseins|mesh-list
6168367|NCT01604109|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6168368|NCT01604109|Serotonin Agents|serotonin agents|mesh-ancestor
6168369|NCT01604109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6168370|NCT01604109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168371|NCT01604109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168372|NCT01604109|Chelating Agents|chelating agents|mesh-ancestor
6168373|NCT01604109|Sequestering Agents|sequestering agents|mesh-ancestor
6168374|NCT01604265|Nabiximols|nabiximols|mesh-list
6168375|NCT01604265|Analgesics|analgesics|mesh-ancestor
6168376|NCT01604265|Sensory System Agents|sensory system agents|mesh-ancestor
6168377|NCT01604265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6168378|NCT01604265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168379|NCT01604278|Glycopyrrolate|glycopyrrolate|mesh-list
6168380|NCT01604278|Bromides|bromides|mesh-list
6168381|NCT01604278|Anticonvulsants|anticonvulsants|mesh-ancestor
6168382|NCT01604278|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6168383|NCT01604278|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6168384|NCT01604278|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6168385|NCT01604278|Cholinergic Agents|cholinergic agents|mesh-ancestor
6168386|NCT01604278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6168387|NCT01604278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168388|NCT01604278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168389|NCT01604343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6168390|NCT01604343|Immunologic Factors|immunologic factors|mesh-ancestor
6168391|NCT01604343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168392|NCT01604785|Dopamine|dopamine|mesh-list
6168393|NCT01604785|Propofol|propofol|mesh-list
6168394|NCT01604785|Dopamine Antagonists|dopamine antagonists|mesh-list
6168395|NCT01604785|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6168396|NCT01604785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6168397|NCT01604785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168398|NCT01604785|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6168399|NCT01604785|Anesthetics, General|anesthetics, general|mesh-ancestor
6168400|NCT01604785|Anesthetics|anesthetics|mesh-ancestor
6168401|NCT01604785|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6168402|NCT01604785|Sympathomimetics|sympathomimetics|mesh-ancestor
6168403|NCT01604785|Autonomic Agents|autonomic agents|mesh-ancestor
6168404|NCT01604785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6168405|NCT01604785|Dopamine Agents|dopamine agents|mesh-ancestor
6168406|NCT01604785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6168407|NCT01604785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168408|NCT01604785|Protective Agents|protective agents|mesh-ancestor
6168409|NCT01604850|Sofosbuvir|sofosbuvir|mesh-list
6168410|NCT01604850|Antiviral Agents|antiviral agents|mesh-ancestor
6168411|NCT01604850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6168412|NCT01605032|Bortezomib|bortezomib|mesh-list
6168413|NCT01605032|Melphalan|melphalan|mesh-list
6168414|NCT01605032|Busulfan|busulfan|mesh-list
6168415|NCT01605032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6168416|NCT01605032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6168417|NCT01605032|Alkylating Agents|alkylating agents|mesh-ancestor
6168418|NCT01605032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168419|NCT01605032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6168420|NCT01605032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6168421|NCT01605032|Immunologic Factors|immunologic factors|mesh-ancestor
6168422|NCT01605032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168423|NCT01605071|Estradiol|estradiol|mesh-list
6168424|NCT01605071|Estrogens|estrogens|mesh-ancestor
6168425|NCT01605071|Hormones|hormones|mesh-ancestor
6168426|NCT01605071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6168427|NCT01605071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168428|NCT01605136|Afamelanotide|afamelanotide|mesh-list
5566382|NCT03967496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5566383|NCT03967496|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6168429|NCT01605136|Dermatologic Agents|dermatologic agents|mesh-ancestor
6168430|NCT01605227|Prednisone|prednisone|mesh-list
6669596|NCT01538797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669597|NCT01538797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669598|NCT01538849|Esomeprazole|esomeprazole|mesh-list
6168431|NCT01605227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6168432|NCT01605227|Glucocorticoids|glucocorticoids|mesh-ancestor
6168433|NCT01605227|Hormones|hormones|mesh-ancestor
6168434|NCT01605227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6168435|NCT01605227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168436|NCT01605227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6168437|NCT01605227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6168438|NCT01605396|Exemestane|exemestane|mesh-list
6669599|NCT01538849|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6669600|NCT01538849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6669601|NCT01538849|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6669602|NCT01538849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5566384|NCT03967496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6168439|NCT01605396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6168440|NCT01605396|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6168441|NCT01605396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6168442|NCT01605396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6168443|NCT01605396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168444|NCT01605396|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6168445|NCT01605396|Hormone Antagonists|hormone antagonists|mesh-ancestor
6168446|NCT01605396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6168447|NCT01605396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168448|NCT01605539|Cannabidiol|cannabidiol|mesh-list
6168449|NCT01605539|Anticonvulsants|anticonvulsants|mesh-ancestor
5566385|NCT03967496|Antimetabolites|antimetabolites|mesh-ancestor
5566386|NCT03967496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566387|NCT03967496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5566388|NCT03967496|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5566389|NCT03967496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5566390|NCT03967496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5566391|NCT03967496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5566392|NCT03967496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5566393|NCT03967496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5566394|NCT03967496|Vasodilator Agents|vasodilator agents|mesh-ancestor
5566395|NCT03967496|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5566396|NCT03967496|Protease Inhibitors|protease inhibitors|mesh-ancestor
5566397|NCT03967496|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5566398|NCT03967496|Protective Agents|protective agents|mesh-ancestor
5566399|NCT03967496|Sympatholytics|sympatholytics|mesh-ancestor
5566400|NCT03967496|Autonomic Agents|autonomic agents|mesh-ancestor
5566401|NCT03967496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5566402|NCT03967496|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5566403|NCT03967496|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5566404|NCT03967496|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5566405|NCT03967496|Adrenergic Agents|adrenergic agents|mesh-ancestor
5566406|NCT03967496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5566407|NCT03967548|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5566408|NCT03967548|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5566409|NCT03967327|Morphine|morphine|mesh-list
5566410|NCT03967327|Buprenorphine|buprenorphine|mesh-list
5566411|NCT03967327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5566412|NCT03967327|Narcotics|narcotics|mesh-ancestor
5566413|NCT03967327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5566414|NCT03967327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566415|NCT03967327|Analgesics|analgesics|mesh-ancestor
5566416|NCT03967327|Sensory System Agents|sensory system agents|mesh-ancestor
5566417|NCT03967327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5566418|NCT03967327|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5566419|NCT03967288|Bupivacaine|bupivacaine|mesh-list
5566420|NCT03967288|Chloroprocaine|chloroprocaine|mesh-list
5566421|NCT03967288|Procaine|procaine|mesh-list
5566422|NCT03967288|Anesthetics, Local|anesthetics, local|mesh-ancestor
5566423|NCT03967288|Anesthetics|anesthetics|mesh-ancestor
5566424|NCT03967288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6168450|NCT01605825|4-Aminopyridine|4-aminopyridine|mesh-list
6168451|NCT01605825|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5566425|NCT03967288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168452|NCT01605825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6168453|NCT01605825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168454|NCT01605890|Tenofovir|tenofovir|mesh-list
6168455|NCT01605890|Emtricitabine|emtricitabine|mesh-list
6168456|NCT01605890|Raltegravir Potassium|raltegravir potassium|mesh-list
6168457|NCT01605890|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6168458|NCT01605890|Antiviral Agents|antiviral agents|mesh-ancestor
6168459|NCT01605890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6168460|NCT01605890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5566426|NCT03967288|Sensory System Agents|sensory system agents|mesh-ancestor
5566427|NCT03967288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5566428|NCT03967197|Lidocaine|lidocaine|mesh-list
5566429|NCT03967197|Anesthetics, Local|anesthetics, local|mesh-ancestor
5566430|NCT03967197|Anesthetics|anesthetics|mesh-ancestor
5566431|NCT03967197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5566432|NCT03967197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566433|NCT03967197|Sensory System Agents|sensory system agents|mesh-ancestor
5566434|NCT03967197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5566435|NCT03967197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5566436|NCT03967197|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5566437|NCT03967197|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5566438|NCT03967197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5566439|NCT03967197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168461|NCT01605890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6168462|NCT01605890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6168463|NCT01605890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168464|NCT01605890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6168465|NCT01605890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6168466|NCT01605890|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5566440|NCT03966651|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
5566441|NCT03966651|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5566442|NCT03966651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566443|NCT03966560|Timolol|timolol|mesh-list
5566444|NCT03966560|Brimonidine Tartrate|brimonidine tartrate|mesh-list
5566445|NCT03966560|Bimatoprost|bimatoprost|mesh-list
5566446|NCT03966560|Travoprost|travoprost|mesh-list
5566447|NCT03966560|Dorzolamide|dorzolamide|mesh-list
5566448|NCT03966560|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6168467|NCT01605890|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6168468|NCT01605903|Acetaminophen|acetaminophen|mesh-list
6168469|NCT01605903|Ibuprofen|ibuprofen|mesh-list
6168470|NCT01605903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6168471|NCT01605903|Analgesics|analgesics|mesh-ancestor
6168472|NCT01605903|Sensory System Agents|sensory system agents|mesh-ancestor
6168473|NCT01605903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6168474|NCT01605903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168475|NCT01605903|Antipyretics|antipyretics|mesh-ancestor
6168476|NCT01605903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6168477|NCT01605903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6168478|NCT01605903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6168479|NCT01605903|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5566449|NCT03966560|Latanoprost|latanoprost|mesh-list
5566450|NCT03966560|Brinzolamide|brinzolamide|mesh-list
5566451|NCT03966560|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5566452|NCT03966560|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5566453|NCT03966560|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5566454|NCT03966560|Adrenergic Agents|adrenergic agents|mesh-ancestor
5566455|NCT03966560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5566456|NCT03966560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566457|NCT03966560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566458|NCT03966560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5566459|NCT03966560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5566460|NCT03966560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5566461|NCT03966560|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5566462|NCT03966560|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5566463|NCT03966560|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6168480|NCT01605903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6206259|NCT02097823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5566464|NCT03966560|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5566465|NCT03966859|Atorvastatin|atorvastatin|mesh-list
5566466|NCT03966859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5566467|NCT03966859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5566468|NCT03966859|Antimetabolites|antimetabolites|mesh-ancestor
5566469|NCT03966859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168481|NCT01605903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168482|NCT01605942|Dexamethasone|dexamethasone|mesh-list
6669603|NCT01538849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669604|NCT01538875|Hydralazine|hydralazine|mesh-list
6669605|NCT01538875|Labetalol|labetalol|mesh-list
6669606|NCT01538875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6669607|NCT01538875|Vasodilator Agents|vasodilator agents|mesh-ancestor
6669608|NCT01538875|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6669609|NCT01538875|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6669610|NCT01538875|Adrenergic Agents|adrenergic agents|mesh-ancestor
6669611|NCT01538875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5566470|NCT03966859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5566471|NCT03966859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5566472|NCT03966859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5566473|NCT03966950|Melatonin|melatonin|mesh-list
5566474|NCT03966950|Antioxidants|antioxidants|mesh-ancestor
5566475|NCT03966950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566476|NCT03966950|Protective Agents|protective agents|mesh-ancestor
5566477|NCT03966950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566478|NCT03966950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5566479|NCT03966547|Anesthetics|anesthetics|mesh-list
5566480|NCT03966547|Anesthetics, Local|anesthetics, local|mesh-list
5566481|NCT03966547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5566482|NCT03966547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168483|NCT01605942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6669612|NCT01538875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669613|NCT01538875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669614|NCT01538875|Sympathomimetics|sympathomimetics|mesh-ancestor
6669615|NCT01538875|Autonomic Agents|autonomic agents|mesh-ancestor
6669616|NCT01538875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6669617|NCT01538875|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6168484|NCT01605942|Antiemetics|antiemetics|mesh-ancestor
6168485|NCT01605942|Autonomic Agents|autonomic agents|mesh-ancestor
6168486|NCT01605942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6168487|NCT01605942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168488|NCT01605942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6168489|NCT01605942|Glucocorticoids|glucocorticoids|mesh-ancestor
6168490|NCT01605942|Hormones|hormones|mesh-ancestor
6168491|NCT01605942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6168492|NCT01605942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6168493|NCT01605942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6168494|NCT01606007|Metformin|metformin|mesh-list
6168495|NCT01606007|Dapagliflozin|dapagliflozin|mesh-list
6168496|NCT01606007|Saxagliptin|saxagliptin|mesh-list
6168497|NCT01606007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6168498|NCT01606007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168499|NCT01606007|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6168500|NCT01606007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168501|NCT01606007|Incretins|incretins|mesh-ancestor
6168502|NCT01606007|Hormones|hormones|mesh-ancestor
6168503|NCT01606007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6168504|NCT01606007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6168505|NCT01606007|Protease Inhibitors|protease inhibitors|mesh-ancestor
6168506|NCT01606007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6168507|NCT01606124|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
6168508|NCT01606124|Antioxidants|antioxidants|mesh-ancestor
6168509|NCT01606124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168510|NCT01606124|Protective Agents|protective agents|mesh-ancestor
6168511|NCT01606124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168512|NCT01606124|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
6168513|NCT01606124|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6168514|NCT01606124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6168515|NCT01606124|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6168516|NCT01606137|Nabiximols|nabiximols|mesh-list
6168517|NCT01606137|Analgesics|analgesics|mesh-ancestor
6168518|NCT01606137|Sensory System Agents|sensory system agents|mesh-ancestor
6168519|NCT01606137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6168520|NCT01606137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168521|NCT01606176|Nabiximols|nabiximols|mesh-list
6168522|NCT01606176|Analgesics|analgesics|mesh-ancestor
6168523|NCT01606176|Sensory System Agents|sensory system agents|mesh-ancestor
6168524|NCT01606176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6168525|NCT01606176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566483|NCT03966547|Sensory System Agents|sensory system agents|mesh-ancestor
5566484|NCT03966547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5566485|NCT03966378|Grape Seed Extract|grape seed extract|mesh-list
5566486|NCT03966378|Calcium|calcium|mesh-list
5566487|NCT03966378|Caseins|caseins|mesh-list
5566488|NCT03966378|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6669618|NCT01538875|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6669619|NCT01538901|Imiquimod|imiquimod|mesh-list
6669620|NCT01538901|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6168526|NCT01606189|Nabiximols|nabiximols|mesh-list
6168527|NCT01606189|Analgesics|analgesics|mesh-ancestor
6168528|NCT01606189|Sensory System Agents|sensory system agents|mesh-ancestor
6168529|NCT01606189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6168530|NCT01606189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168531|NCT01606202|Nabiximols|nabiximols|mesh-list
6168532|NCT01606202|Analgesics|analgesics|mesh-ancestor
6168533|NCT01606202|Sensory System Agents|sensory system agents|mesh-ancestor
6168534|NCT01606202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6168535|NCT01606202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168536|NCT01606228|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6168537|NCT01606228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6168538|NCT01606228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6168539|NCT01606228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6168540|NCT01606228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168541|NCT01606228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6168542|NCT01606228|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6168543|NCT01606228|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6168544|NCT01606228|Serotonin Agents|serotonin agents|mesh-ancestor
6168545|NCT01606228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6168546|NCT01606228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168547|NCT01606228|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5566489|NCT03966378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566490|NCT03966378|Chelating Agents|chelating agents|mesh-ancestor
5566491|NCT03966378|Sequestering Agents|sequestering agents|mesh-ancestor
5566492|NCT03966378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566493|NCT03966378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5566494|NCT03966378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5566495|NCT03966378|Antioxidants|antioxidants|mesh-ancestor
5566496|NCT03966378|Protective Agents|protective agents|mesh-ancestor
5566497|NCT03966898|Letrozole|letrozole|mesh-list
5566498|NCT03966898|Anastrozole|anastrozole|mesh-list
5566499|NCT03966898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5566500|NCT03966898|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5566501|NCT03966898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6168548|NCT01606228|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6168549|NCT01606228|Dopamine Agents|dopamine agents|mesh-ancestor
6168550|NCT01606254|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6168551|NCT01606254|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6168552|NCT01606254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6168553|NCT01606254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6168554|NCT01606254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168555|NCT01606254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6168556|NCT01606254|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6168557|NCT01606254|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5566502|NCT03966898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5566503|NCT03966898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566504|NCT03966898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5566505|NCT03966898|Hormone Antagonists|hormone antagonists|mesh-ancestor
5566506|NCT03966898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5566507|NCT03966898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566508|NCT03966898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5566509|NCT03966170|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
5566510|NCT03966170|Nootropic Agents|nootropic agents|mesh-ancestor
5566511|NCT03966326|Fentanyl|fentanyl|mesh-list
5566512|NCT03966326|Anesthetics|anesthetics|mesh-list
5566513|NCT03966326|Sevoflurane|sevoflurane|mesh-list
5566514|NCT03966326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5566515|NCT03966326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168558|NCT01606254|Serotonin Agents|serotonin agents|mesh-ancestor
6168559|NCT01606254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6168560|NCT01606254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168561|NCT01606254|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5566516|NCT03966326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5566517|NCT03966326|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5566518|NCT03966326|Anesthetics, General|anesthetics, general|mesh-ancestor
5566519|NCT03966326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5566520|NCT03966326|Narcotics|narcotics|mesh-ancestor
5566521|NCT03966326|Analgesics|analgesics|mesh-ancestor
5566522|NCT03966326|Sensory System Agents|sensory system agents|mesh-ancestor
5566523|NCT03966326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5566524|NCT03966326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5566525|NCT03966326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5566526|NCT03966235|Melatonin|melatonin|mesh-list
5566527|NCT03966235|Antioxidants|antioxidants|mesh-ancestor
6168562|NCT01606254|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6168563|NCT01606254|Dopamine Agents|dopamine agents|mesh-ancestor
6168564|NCT01606306|Fluticasone|fluticasone|mesh-list
6168565|NCT01606306|Xhance|xhance|mesh-list
6168566|NCT01606306|Montelukast|montelukast|mesh-list
6168567|NCT01606306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6168568|NCT01606306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6168569|NCT01606306|Autonomic Agents|autonomic agents|mesh-ancestor
6168570|NCT01606306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6168571|NCT01606306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168572|NCT01606306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6168573|NCT01606306|Respiratory System Agents|respiratory system agents|mesh-ancestor
6168574|NCT01606306|Dermatologic Agents|dermatologic agents|mesh-ancestor
6168575|NCT01606306|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6168576|NCT01606306|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6168577|NCT01606306|Hormone Antagonists|hormone antagonists|mesh-ancestor
6168578|NCT01606306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6168579|NCT01606306|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6168580|NCT01606306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6168581|NCT01606306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168582|NCT01606319|Acetaminophen|acetaminophen|mesh-list
6168583|NCT01606319|Ibuprofen|ibuprofen|mesh-list
5566528|NCT03966235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566529|NCT03966235|Protective Agents|protective agents|mesh-ancestor
5566530|NCT03966235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566531|NCT03966235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5566532|NCT03966079|Plasminogen|plasminogen|mesh-list
5566533|NCT03966079|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5566534|NCT03966079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5566535|NCT03966079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5566536|NCT03966079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603963|NCT05179512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5603964|NCT05179512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603965|NCT05179512|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6168584|NCT01606319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
6168585|NCT01606319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
6168586|NCT01606319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6168587|NCT01606319|Analgesics|analgesics|mesh-ancestor
6168588|NCT01606319|Sensory System Agents|sensory system agents|mesh-ancestor
6168589|NCT01606319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6168590|NCT01606319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168591|NCT01606319|Antipyretics|antipyretics|mesh-ancestor
6168592|NCT01606319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6168593|NCT01606319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6168594|NCT01606319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6168595|NCT01606319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168596|NCT01606748|Gemcitabine|gemcitabine|mesh-list
6168597|NCT01606748|Necitumumab|necitumumab|mesh-list
6168598|NCT01606748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6168599|NCT01606748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6168600|NCT01606748|Antimetabolites|antimetabolites|mesh-ancestor
6168601|NCT01606748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168602|NCT01606748|Antiviral Agents|antiviral agents|mesh-ancestor
6168603|NCT01606748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6168604|NCT01606748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6168605|NCT01606748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6168606|NCT01606748|Immunologic Factors|immunologic factors|mesh-ancestor
6168607|NCT01606748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168608|NCT01606748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6168609|NCT01606761|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6168610|NCT01606761|Immunologic Factors|immunologic factors|mesh-ancestor
6168611|NCT01606761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168612|NCT01606787|Mannitol|mannitol|mesh-list
6168613|NCT01606787|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6168614|NCT01606787|Diuretics|diuretics|mesh-ancestor
6168615|NCT01606787|Natriuretic Agents|natriuretic agents|mesh-ancestor
6168616|NCT01606787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168617|NCT01606800|Ribavirin|ribavirin|mesh-list
6168618|NCT01606800|Interferon alpha-2|interferon alpha-2|mesh-list
6168619|NCT01606800|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6168620|NCT01606800|Antimetabolites|antimetabolites|mesh-ancestor
6168621|NCT01606800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168622|NCT01606800|Antiviral Agents|antiviral agents|mesh-ancestor
6168623|NCT01606800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6168624|NCT01606800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6168625|NCT01606852|Dexmedetomidine|dexmedetomidine|mesh-list
6168626|NCT01606852|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6168627|NCT01606852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6168628|NCT01606852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168629|NCT01606852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6168630|NCT01606852|Analgesics|analgesics|mesh-ancestor
6168631|NCT01606852|Sensory System Agents|sensory system agents|mesh-ancestor
6168632|NCT01606852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6168633|NCT01606852|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6168634|NCT01606852|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6168635|NCT01606852|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6168636|NCT01606852|Adrenergic Agents|adrenergic agents|mesh-ancestor
6168637|NCT01606852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6168638|NCT01606852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168639|NCT01607073|Verapamil|verapamil|mesh-list
6168640|NCT01607073|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6168641|NCT01607073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6168642|NCT01607073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6168643|NCT01607073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168644|NCT01607073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6168645|NCT01607073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168646|NCT01607073|Vasodilator Agents|vasodilator agents|mesh-ancestor
6168647|NCT01607203|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6168648|NCT01607203|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5566537|NCT03966209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5566538|NCT03966209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566539|NCT03966209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5566540|NCT03966040|Vaccines|vaccines|mesh-list
6168649|NCT01607203|Luteolytic Agents|luteolytic agents|mesh-ancestor
6168650|NCT01607203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6168651|NCT01607203|Contraceptive Agents|contraceptive agents|mesh-ancestor
6168652|NCT01607203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6168653|NCT01607203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168654|NCT01607203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6168655|NCT01607203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6168656|NCT01607203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6168657|NCT01607346|Ezogabine|ezogabine|mesh-list
6168658|NCT01607346|Anticonvulsants|anticonvulsants|mesh-ancestor
6168659|NCT01607346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6168660|NCT01607346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168661|NCT01607411|Fluorides|fluorides|mesh-list
6168662|NCT01607411|Cariostatic Agents|cariostatic agents|mesh-ancestor
6168663|NCT01607411|Protective Agents|protective agents|mesh-ancestor
6168664|NCT01607411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168665|NCT01607450|Glucagon|glucagon|mesh-list
6168666|NCT01607450|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6168667|NCT01607450|Incretins|incretins|mesh-ancestor
6168668|NCT01607450|Hormones|hormones|mesh-ancestor
6168669|NCT01607450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6168670|NCT01607450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168671|NCT01607450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6168672|NCT01607476|Corticosterone|corticosterone|mesh-list
6168673|NCT01607476|Flutemetamol|flutemetamol|mesh-list
6484420|NCT00561899|Amodiaquine|amodiaquine|mesh-list
5566541|NCT03966040|Immunologic Factors|immunologic factors|mesh-ancestor
5566542|NCT03966040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566543|NCT03965962|Vaccines|vaccines|mesh-list
5566544|NCT03965962|Immunoglobulins|immunoglobulins|mesh-list
5566545|NCT03965962|Antibodies|antibodies|mesh-list
5566546|NCT03965962|gamma-Globulins|gamma-globulins|mesh-list
5566547|NCT03965962|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5566548|NCT03965962|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5566549|NCT03965962|Immunologic Factors|immunologic factors|mesh-ancestor
5566550|NCT03965962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168674|NCT01607476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6168675|NCT01607476|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6168676|NCT01607476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168677|NCT01607554|Irinotecan|irinotecan|mesh-list
6168678|NCT01607554|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6168679|NCT01607554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6168680|NCT01607554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6168681|NCT01607554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168682|NCT01607554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6168683|NCT01607593|Sertraline|sertraline|mesh-list
6168684|NCT01607593|Antidepressive Agents|antidepressive agents|mesh-ancestor
6168685|NCT01607593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6168686|NCT01607593|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6168687|NCT01607593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6168688|NCT01607593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6168689|NCT01607593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168690|NCT01607593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6168691|NCT01607593|Serotonin Agents|serotonin agents|mesh-ancestor
6168692|NCT01607593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168693|NCT01607645|Cytarabine|cytarabine|mesh-list
6168694|NCT01607645|Decitabine|decitabine|mesh-list
6168695|NCT01607645|Azacitidine|azacitidine|mesh-list
6168696|NCT01607645|Idarubicin|idarubicin|mesh-list
6168697|NCT01607645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6168698|NCT01607645|Antimetabolites|antimetabolites|mesh-ancestor
6168699|NCT01607645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168700|NCT01607645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6168701|NCT01607645|Antiviral Agents|antiviral agents|mesh-ancestor
6168702|NCT01607645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6168703|NCT01607645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6168704|NCT01607645|Immunologic Factors|immunologic factors|mesh-ancestor
6168705|NCT01607645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168706|NCT01607645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6168707|NCT01607645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6168708|NCT01607645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6168709|NCT01607645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6206260|NCT02097823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206261|NCT02097823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6206262|NCT02097823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6206263|NCT02097823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6206264|NCT02097823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6206265|NCT02097823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6206266|NCT02097823|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6206267|NCT02097823|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6206268|NCT02097823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6206269|NCT02097823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206270|NCT02097823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6206271|NCT02097823|Serotonin Agents|serotonin agents|mesh-ancestor
6206272|NCT02097823|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6206273|NCT02097849|Interferons|interferons|mesh-list
6484421|NCT00561899|Antimalarials|antimalarials|mesh-ancestor
5566551|NCT03965871|Esketamine|esketamine|mesh-list
6168710|NCT01607853|Calcitriol|calcitriol|mesh-list
6168711|NCT01607853|Betamethasone|betamethasone|mesh-list
6168712|NCT01607853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6168713|NCT01607853|Glucocorticoids|glucocorticoids|mesh-ancestor
5566552|NCT03965871|Antidepressive Agents|antidepressive agents|mesh-ancestor
5566553|NCT03965871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5566554|NCT03966014|Amoxicillin|amoxicillin|mesh-list
5566555|NCT03966014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5566556|NCT03966014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5566557|NCT03966118|Paclitaxel|paclitaxel|mesh-list
5566558|NCT03966118|Avelumab|avelumab|mesh-list
5566559|NCT03966118|Ramucirumab|ramucirumab|mesh-list
5566560|NCT03966118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5566561|NCT03966118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5566562|NCT03966118|Tubulin Modulators|tubulin modulators|mesh-ancestor
5566563|NCT03966118|Antimitotic Agents|antimitotic agents|mesh-ancestor
5566564|NCT03966118|Mitosis Modulators|mitosis modulators|mesh-ancestor
5566565|NCT03966118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566566|NCT03966118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5566567|NCT03965949|Hormones|hormones|mesh-list
5566568|NCT03965949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5566569|NCT03965949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566570|NCT03965767|Tranexamic Acid|tranexamic acid|mesh-list
5566571|NCT03965767|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5566572|NCT03965767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5566573|NCT03965767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566574|NCT03965767|Hemostatics|hemostatics|mesh-ancestor
5566575|NCT03965767|Coagulants|coagulants|mesh-ancestor
5566576|NCT03965858|Esketamine|esketamine|mesh-list
5566577|NCT03965858|Antidepressive Agents|antidepressive agents|mesh-ancestor
5566578|NCT03965858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5566579|NCT03965819|Acetaminophen|acetaminophen|mesh-list
5566580|NCT03965819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5566581|NCT03965819|Analgesics|analgesics|mesh-ancestor
5566582|NCT03965819|Sensory System Agents|sensory system agents|mesh-ancestor
5566583|NCT03965819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5566584|NCT03965819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566585|NCT03965819|Antipyretics|antipyretics|mesh-ancestor
5566586|NCT03966066|Erythromycin|erythromycin|mesh-list
6168714|NCT01607853|Hormones|hormones|mesh-ancestor
6168715|NCT01607853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6168716|NCT01607853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168717|NCT01607853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6168718|NCT01607853|Respiratory System Agents|respiratory system agents|mesh-ancestor
6168719|NCT01607853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6168720|NCT01607853|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6168721|NCT01607853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6168722|NCT01607853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168723|NCT01607853|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6168724|NCT01607853|Vitamins|vitamins|mesh-ancestor
6168725|NCT01607853|Micronutrients|micronutrients|mesh-ancestor
6168726|NCT01607853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6168727|NCT01607905|Acetaminophen|acetaminophen|mesh-list
6168728|NCT01607905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6168729|NCT01607905|Analgesics|analgesics|mesh-ancestor
6168730|NCT01607905|Sensory System Agents|sensory system agents|mesh-ancestor
6168731|NCT01607905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5566587|NCT03966066|Erythromycin Estolate|erythromycin estolate|mesh-list
5566588|NCT03966066|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
5566589|NCT03966066|Erythromycin stearate|erythromycin stearate|mesh-list
5566590|NCT03966066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5566591|NCT03966066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5566592|NCT03966066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6168732|NCT01607905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168733|NCT01607905|Antipyretics|antipyretics|mesh-ancestor
6168734|NCT01608087|Bevacizumab|bevacizumab|mesh-list
6168735|NCT01608087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6168736|NCT01608087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6168737|NCT01608087|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6168738|NCT01608087|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6168739|NCT01608087|Growth Substances|growth substances|mesh-ancestor
6168740|NCT01608087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168741|NCT01608087|Growth Inhibitors|growth inhibitors|mesh-ancestor
6168742|NCT01608295|Paroxetine|paroxetine|mesh-list
6168743|NCT01608295|Antidepressive Agents|antidepressive agents|mesh-list
6168744|NCT01608295|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
6168745|NCT01608295|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6168746|NCT01608295|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6168747|NCT01608295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6168748|NCT01608295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168749|NCT01608295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6168750|NCT01608295|Serotonin Agents|serotonin agents|mesh-ancestor
6168751|NCT01608295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168752|NCT01608295|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6168753|NCT01608295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6168754|NCT01608295|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6168755|NCT01608295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6168756|NCT01608295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6168757|NCT01608295|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6168758|NCT01608295|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6168759|NCT01608308|Acetaminophen|acetaminophen|mesh-list
5566593|NCT03966066|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5566594|NCT03966066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5566595|NCT03966066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566596|NCT03965546|Sorafenib|sorafenib|mesh-list
5566597|NCT03965546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5566598|NCT03965546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5566599|NCT03965546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5566600|NCT03965546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566601|NCT03965624|Ixazomib|ixazomib|mesh-list
5566602|NCT03965624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5566603|NCT03965624|Protease Inhibitors|protease inhibitors|mesh-ancestor
5566604|NCT03965624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5566605|NCT03965624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566606|NCT03965468|Paclitaxel|paclitaxel|mesh-list
5566607|NCT03965468|Carboplatin|carboplatin|mesh-list
5566608|NCT03965468|Durvalumab|durvalumab|mesh-list
5566609|NCT03965468|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5566610|NCT03965468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6168760|NCT01608308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6168761|NCT01608308|Analgesics|analgesics|mesh-ancestor
6168762|NCT01608308|Sensory System Agents|sensory system agents|mesh-ancestor
6168763|NCT01608308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6168764|NCT01608308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168765|NCT01608308|Antipyretics|antipyretics|mesh-ancestor
6168766|NCT01608659|Botulinum Toxins|botulinum toxins|mesh-list
6168767|NCT01608659|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6168768|NCT01608659|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6168769|NCT01608659|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6168770|NCT01608659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6168771|NCT01608659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168772|NCT01608659|Cholinergic Agents|cholinergic agents|mesh-ancestor
6168773|NCT01608659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6168774|NCT01608659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168775|NCT01608659|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5566611|NCT03965468|Tubulin Modulators|tubulin modulators|mesh-ancestor
5566612|NCT03965468|Antimitotic Agents|antimitotic agents|mesh-ancestor
5566613|NCT03965468|Mitosis Modulators|mitosis modulators|mesh-ancestor
5566614|NCT03965468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566615|NCT03965468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5566616|NCT03965442|Esmolol|esmolol|mesh-list
5603966|NCT05179512|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6168776|NCT01608659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6168777|NCT01608672|Botulinum Toxins|botulinum toxins|mesh-list
6168778|NCT01608672|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6168779|NCT01608672|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6168780|NCT01608672|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6168781|NCT01608672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6168782|NCT01608672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168783|NCT01608672|Cholinergic Agents|cholinergic agents|mesh-ancestor
6168784|NCT01608672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6168785|NCT01608672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168786|NCT01608672|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6168787|NCT01608672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6168788|NCT01608724|Saxagliptin|saxagliptin|mesh-list
6669621|NCT01538901|Immunologic Factors|immunologic factors|mesh-ancestor
6669622|NCT01538901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484422|NCT00561899|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6484423|NCT00561899|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6484424|NCT00561899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6484425|NCT00561964|Irbesartan|irbesartan|mesh-list
6484426|NCT00561964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6484427|NCT00561964|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6484428|NCT00561964|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5566617|NCT03965442|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5566618|NCT03965442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5566619|NCT03965442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5566620|NCT03965442|Adrenergic Agents|adrenergic agents|mesh-ancestor
6484429|NCT00561964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484430|NCT00561990|Nimotuzumab|nimotuzumab|mesh-list
6484431|NCT00561990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6669623|NCT01538901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6669624|NCT01538901|Interferon Inducers|interferon inducers|mesh-ancestor
6669625|NCT01538927|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6168789|NCT01608724|Incretins|incretins|mesh-ancestor
6168790|NCT01608724|Hormones|hormones|mesh-ancestor
6168791|NCT01608724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6168792|NCT01608724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168793|NCT01608724|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6168794|NCT01608724|Protease Inhibitors|protease inhibitors|mesh-ancestor
6168795|NCT01608724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6168796|NCT01608724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168797|NCT01608724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6168798|NCT01609010|Interferons|interferons|mesh-list
6168799|NCT01609010|Interferon alpha-2|interferon alpha-2|mesh-list
6168800|NCT01609010|Rituximab|rituximab|mesh-list
6168801|NCT01609010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6168802|NCT01609010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6168803|NCT01609010|Immunologic Factors|immunologic factors|mesh-ancestor
6168804|NCT01609010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168805|NCT01609010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6168806|NCT01609010|Antiviral Agents|antiviral agents|mesh-ancestor
6168807|NCT01609010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6168808|NCT01609023|Rituximab|rituximab|mesh-list
6168809|NCT01609023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6168810|NCT01609023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6168811|NCT01609023|Immunologic Factors|immunologic factors|mesh-ancestor
6168812|NCT01609023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168813|NCT01609023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6168814|NCT01609218|Charcoal|charcoal|mesh-list
6168815|NCT01609218|Antidotes|antidotes|mesh-ancestor
6484432|NCT00561990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6484433|NCT00562055|Reboxetine|reboxetine|mesh-list
6484434|NCT00562055|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6484435|NCT00562055|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6669626|NCT01538927|Hemostatics|hemostatics|mesh-ancestor
6168816|NCT01609218|Protective Agents|protective agents|mesh-ancestor
6168817|NCT01609218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168818|NCT01609348|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6168819|NCT01609348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6168820|NCT01609348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5566621|NCT03965442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5566622|NCT03965442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566623|NCT03965442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566624|NCT03965637|Ascorbic Acid|ascorbic acid|mesh-list
5566625|NCT03965637|Vitamins|vitamins|mesh-ancestor
6168821|NCT01609348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6168822|NCT01609348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168823|NCT01609348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6168824|NCT01609348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168825|NCT01609348|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6168826|NCT01609348|Antidepressive Agents|antidepressive agents|mesh-ancestor
6168827|NCT01609348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5566626|NCT03965637|Micronutrients|micronutrients|mesh-ancestor
5566627|NCT03965637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566628|NCT03965637|Antioxidants|antioxidants|mesh-ancestor
5566629|NCT03965637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566630|NCT03965637|Protective Agents|protective agents|mesh-ancestor
5566631|NCT03965286|Sofosbuvir|sofosbuvir|mesh-list
6168828|NCT01609478|Mometasone Furoate|mometasone furoate|mesh-list
6168829|NCT01609478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6168830|NCT01609478|Dermatologic Agents|dermatologic agents|mesh-ancestor
6168831|NCT01609478|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6168832|NCT01609543|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6669627|NCT01538927|Coagulants|coagulants|mesh-ancestor
6669628|NCT01538940|Vaccines|vaccines|mesh-list
5566632|NCT03965286|Ledipasvir|ledipasvir|mesh-list
5566633|NCT03965286|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
5566634|NCT03965286|Antiviral Agents|antiviral agents|mesh-ancestor
5566635|NCT03965286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5566636|NCT03965117|Norepinephrine|norepinephrine|mesh-list
5566637|NCT03965117|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5566638|NCT03965117|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5566639|NCT03965117|Adrenergic Agents|adrenergic agents|mesh-ancestor
5566640|NCT03965117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5566641|NCT03965117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566642|NCT03965117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566643|NCT03965117|Sympathomimetics|sympathomimetics|mesh-ancestor
5566644|NCT03965117|Autonomic Agents|autonomic agents|mesh-ancestor
5566645|NCT03965117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5566646|NCT03965117|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5566647|NCT03965078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
5566648|NCT03965078|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5566649|NCT03965078|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5566650|NCT03965247|Lithium Carbonate|lithium carbonate|mesh-list
5566651|NCT03965247|Antidepressive Agents|antidepressive agents|mesh-ancestor
5566652|NCT03965247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5566653|NCT03965247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5566654|NCT03965247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566655|NCT03965247|Antimanic Agents|antimanic agents|mesh-ancestor
5566656|NCT03965247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5566657|NCT03965247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5566658|NCT03965247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566659|NCT03965208|Heparin|heparin|mesh-list
5566660|NCT03965208|Calcium heparin|calcium heparin|mesh-list
5566661|NCT03965208|Bivalirudin|bivalirudin|mesh-list
5566662|NCT03965208|Anticoagulants|anticoagulants|mesh-ancestor
5566663|NCT03965208|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5566664|NCT03965208|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5566665|NCT03965208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566666|NCT03965208|Antithrombins|antithrombins|mesh-ancestor
5566667|NCT03965208|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5566668|NCT03965208|Protease Inhibitors|protease inhibitors|mesh-ancestor
5566669|NCT03965208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5566670|NCT03964935|Minocycline|minocycline|mesh-list
5566671|NCT03964935|Lycopene|lycopene|mesh-list
5566672|NCT03964935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5566673|NCT03964935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5566674|NCT03964935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5566675|NCT03964935|Antioxidants|antioxidants|mesh-ancestor
6669629|NCT01538940|Immunologic Factors|immunologic factors|mesh-ancestor
6168833|NCT01609543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6168834|NCT01609543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6168835|NCT01609543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6168836|NCT01609543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168837|NCT01609556|Maytansine|maytansine|mesh-list
6168838|NCT01609556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6168839|NCT01609556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6168840|NCT01609556|Tubulin Modulators|tubulin modulators|mesh-ancestor
6669630|NCT01538940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566676|NCT03964935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566677|NCT03964935|Protective Agents|protective agents|mesh-ancestor
5566678|NCT03964935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566679|NCT03964935|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5566680|NCT03964935|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5566681|NCT03964935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5566682|NCT03965013|Insulin Glargine|insulin glargine|mesh-list
5566683|NCT03965013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6168841|NCT01609556|Antimitotic Agents|antimitotic agents|mesh-ancestor
6168842|NCT01609556|Mitosis Modulators|mitosis modulators|mesh-ancestor
6168843|NCT01609556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168844|NCT01609933|Interferons|interferons|mesh-list
6168845|NCT01609933|Ritonavir|ritonavir|mesh-list
6168846|NCT01609933|Ribavirin|ribavirin|mesh-list
5566684|NCT03965013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566685|NCT03965195|Vaccines|vaccines|mesh-list
5566686|NCT03965195|Immunologic Factors|immunologic factors|mesh-ancestor
5566687|NCT03965195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566688|NCT03964753|Paclitaxel|paclitaxel|mesh-list
5566689|NCT03964753|Cisplatin|cisplatin|mesh-list
5566690|NCT03964753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5566691|NCT03964753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5566692|NCT03964753|Tubulin Modulators|tubulin modulators|mesh-ancestor
5566693|NCT03964753|Antimitotic Agents|antimitotic agents|mesh-ancestor
5566694|NCT03964753|Mitosis Modulators|mitosis modulators|mesh-ancestor
5566695|NCT03964753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566696|NCT03964688|Ascorbic Acid|ascorbic acid|mesh-list
5566697|NCT03964688|Vitamins|vitamins|mesh-ancestor
5566698|NCT03964688|Micronutrients|micronutrients|mesh-ancestor
5566699|NCT03964688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566700|NCT03964688|Antioxidants|antioxidants|mesh-ancestor
5566701|NCT03964688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566702|NCT03964688|Protective Agents|protective agents|mesh-ancestor
5566703|NCT03964779|Antibodies|antibodies|mesh-list
5566704|NCT03964779|Immunoglobulins|immunoglobulins|mesh-list
5566705|NCT03964779|Immunologic Factors|immunologic factors|mesh-ancestor
5566706|NCT03964779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566707|NCT03964493|Vancomycin|vancomycin|mesh-list
6168847|NCT01609933|Interferon-alpha|interferon-alpha|mesh-list
6168848|NCT01609933|Interferon alpha-2|interferon alpha-2|mesh-list
6168849|NCT01609933|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6168850|NCT01609933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6168851|NCT01609933|Antiviral Agents|antiviral agents|mesh-ancestor
6168852|NCT01609933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6168853|NCT01609933|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6168854|NCT01609933|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6168855|NCT01609933|Protease Inhibitors|protease inhibitors|mesh-ancestor
6168856|NCT01609933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6168857|NCT01609933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168858|NCT01609933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6168859|NCT01609933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6168860|NCT01609933|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6168861|NCT01609933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6168862|NCT01609933|Antimetabolites|antimetabolites|mesh-ancestor
6168863|NCT01609933|Immunologic Factors|immunologic factors|mesh-ancestor
6168864|NCT01609933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168865|NCT01610011|Glycine|glycine|mesh-list
6168866|NCT01610011|Glycine Agents|glycine agents|mesh-ancestor
6168867|NCT01610011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6168868|NCT01610011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168869|NCT01610011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168870|NCT01610037|Tiotropium Bromide|tiotropium bromide|mesh-list
6168871|NCT01610037|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6168872|NCT01610037|Autonomic Agents|autonomic agents|mesh-ancestor
6168873|NCT01610037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6168874|NCT01610037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168875|NCT01610037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6168876|NCT01610037|Respiratory System Agents|respiratory system agents|mesh-ancestor
6168877|NCT01610037|Parasympatholytics|parasympatholytics|mesh-ancestor
6168878|NCT01610037|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6168879|NCT01610037|Cholinergic Agents|cholinergic agents|mesh-ancestor
6168880|NCT01610037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6168881|NCT01610037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168882|NCT01610154|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5566708|NCT03964493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5566709|NCT03964493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5566710|NCT03964350|Ethanol|ethanol|mesh-list
6168883|NCT01610154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5603967|NCT05179512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6484436|NCT00562055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6484437|NCT00562055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6484438|NCT00562055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484439|NCT00562055|Adrenergic Agents|adrenergic agents|mesh-ancestor
6484440|NCT00562055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6484441|NCT00562055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484442|NCT00562055|Antidepressive Agents|antidepressive agents|mesh-ancestor
6168884|NCT01610154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168885|NCT01610154|Incretins|incretins|mesh-ancestor
6168886|NCT01610154|Hormones|hormones|mesh-ancestor
6168887|NCT01610154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6168888|NCT01610154|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6168889|NCT01610154|Protease Inhibitors|protease inhibitors|mesh-ancestor
6168890|NCT01610154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6168891|NCT01610154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168892|NCT01610167|Listerine|listerine|mesh-list
6168893|NCT01610167|Fluorides|fluorides|mesh-list
6168894|NCT01610167|Sodium Fluoride|sodium fluoride|mesh-list
6168895|NCT01610167|Cariostatic Agents|cariostatic agents|mesh-ancestor
6168896|NCT01610167|Protective Agents|protective agents|mesh-ancestor
6168897|NCT01610167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168898|NCT01610167|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6168899|NCT01610167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6168900|NCT01610206|Gemcitabine|gemcitabine|mesh-list
6168901|NCT01610206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6168902|NCT01610206|Antimetabolites|antimetabolites|mesh-ancestor
6168903|NCT01610206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168904|NCT01610206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6168905|NCT01610206|Antiviral Agents|antiviral agents|mesh-ancestor
6168906|NCT01610206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6168907|NCT01610206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5566711|NCT03964350|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5566712|NCT03964350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5566713|NCT03964350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6168908|NCT01610206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6168909|NCT01610206|Immunologic Factors|immunologic factors|mesh-ancestor
6168910|NCT01610206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168911|NCT01610284|Fulvestrant|fulvestrant|mesh-list
6168912|NCT01610284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6168913|NCT01610284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6168914|NCT01610284|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6168915|NCT01610284|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6168916|NCT01610284|Hormone Antagonists|hormone antagonists|mesh-ancestor
6168917|NCT01610284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6168918|NCT01610284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168919|NCT01610297|Deferasirox|deferasirox|mesh-list
6168920|NCT01610297|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6168921|NCT01610297|Chelating Agents|chelating agents|mesh-ancestor
6168922|NCT01610297|Sequestering Agents|sequestering agents|mesh-ancestor
6168923|NCT01610297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484443|NCT00562055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6484444|NCT00562068|Prednisolone|prednisolone|mesh-list
6484445|NCT00562068|Cyclophosphamide|cyclophosphamide|mesh-list
6484446|NCT00562068|Doxorubicin|doxorubicin|mesh-list
6484447|NCT00562068|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6168924|NCT01610336|Gefitinib|gefitinib|mesh-list
6168925|NCT01610336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6168926|NCT01610336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6168927|NCT01610336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6168928|NCT01610336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168929|NCT01610492|Belimumab|belimumab|mesh-list
6168930|NCT01610492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6168931|NCT01610492|Immunologic Factors|immunologic factors|mesh-ancestor
6168932|NCT01610492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168933|NCT01610557|Bevacizumab|bevacizumab|mesh-list
6168934|NCT01610557|Ranibizumab|ranibizumab|mesh-list
6168935|NCT01610557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6168936|NCT01610557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6168937|NCT01610557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6168938|NCT01610557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6168939|NCT01610557|Growth Substances|growth substances|mesh-ancestor
6168940|NCT01610557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168941|NCT01610557|Growth Inhibitors|growth inhibitors|mesh-ancestor
6168942|NCT01610570|Plicamycin|plicamycin|mesh-list
5566714|NCT03964350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603968|NCT05179512|Adrenergic Agents|adrenergic agents|mesh-ancestor
5603969|NCT05179512|Glucocorticoids|glucocorticoids|mesh-ancestor
5603970|NCT05179512|Hormones|hormones|mesh-ancestor
5603971|NCT05179512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5603972|NCT05179512|Sympathomimetics|sympathomimetics|mesh-ancestor
5603973|NCT05179356|Dapagliflozin|dapagliflozin|mesh-list
5603974|NCT05179356|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6168943|NCT01610570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6168944|NCT01610570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168945|NCT01610570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6168946|NCT01610570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6168947|NCT01610570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6168948|NCT01610570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6168949|NCT01610570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168950|NCT01610570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6168951|NCT01610596|Halobetasol|halobetasol|mesh-list
6168952|NCT01610596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6168953|NCT01610687|Nabiximols|nabiximols|mesh-list
6168954|NCT01610687|Analgesics|analgesics|mesh-ancestor
6168955|NCT01610687|Sensory System Agents|sensory system agents|mesh-ancestor
6168956|NCT01610687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6168957|NCT01610687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168958|NCT01610700|Nabiximols|nabiximols|mesh-list
6168959|NCT01610700|Analgesics|analgesics|mesh-ancestor
6168960|NCT01610700|Sensory System Agents|sensory system agents|mesh-ancestor
5603975|NCT05179356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603976|NCT05179356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5603977|NCT05179356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603978|NCT05179239|Paclitaxel|paclitaxel|mesh-list
5603979|NCT05179239|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5603980|NCT05179239|Cisplatin|cisplatin|mesh-list
5603981|NCT05179239|Carboplatin|carboplatin|mesh-list
5603982|NCT05179239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5603983|NCT05179239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5603984|NCT05179239|Tubulin Modulators|tubulin modulators|mesh-ancestor
5603985|NCT05179239|Antimitotic Agents|antimitotic agents|mesh-ancestor
5603986|NCT05179239|Mitosis Modulators|mitosis modulators|mesh-ancestor
5603987|NCT05179239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603988|NCT05179213|Azacitidine|azacitidine|mesh-list
5603989|NCT05179213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5603990|NCT05179213|Antimetabolites|antimetabolites|mesh-ancestor
5603991|NCT05179213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5603992|NCT05179213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5603993|NCT05179213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5603994|NCT05179070|Carvedilol|carvedilol|mesh-list
5603995|NCT05179070|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5603996|NCT05179070|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5603997|NCT05179070|Adrenergic Agents|adrenergic agents|mesh-ancestor
5603998|NCT05179070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6168961|NCT01610700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6168962|NCT01610700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168963|NCT01610713|Nabiximols|nabiximols|mesh-list
6168964|NCT01610713|Analgesics|analgesics|mesh-ancestor
6168965|NCT01610713|Sensory System Agents|sensory system agents|mesh-ancestor
6168966|NCT01610713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6168967|NCT01610713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168968|NCT01611090|Rituximab|rituximab|mesh-list
6168969|NCT01611090|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6168970|NCT01611090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6168971|NCT01611090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6168972|NCT01611090|Immunologic Factors|immunologic factors|mesh-ancestor
6168973|NCT01611090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168974|NCT01611090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6168975|NCT01611090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6168976|NCT01611090|Alkylating Agents|alkylating agents|mesh-ancestor
6168977|NCT01611090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168978|NCT01611155|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6168979|NCT01611155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6168980|NCT01611155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6168981|NCT01611155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6168982|NCT01611155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6168983|NCT01611155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5566715|NCT03964324|Nitric Oxide|nitric oxide|mesh-list
5566716|NCT03964324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5566717|NCT03964324|Autonomic Agents|autonomic agents|mesh-ancestor
5566718|NCT03964324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5566719|NCT03964324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566720|NCT03964324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5566721|NCT03964324|Respiratory System Agents|respiratory system agents|mesh-ancestor
5566722|NCT03964324|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5566723|NCT03964324|Antioxidants|antioxidants|mesh-ancestor
5566724|NCT03964324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566725|NCT03964324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5566726|NCT03964324|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5566727|NCT03964324|Vasodilator Agents|vasodilator agents|mesh-ancestor
5566728|NCT03964324|Gasotransmitters|gasotransmitters|mesh-ancestor
5566729|NCT03964324|Protective Agents|protective agents|mesh-ancestor
5566730|NCT03963895|Thrombin|thrombin|mesh-list
5566731|NCT03963895|Hemostatics|hemostatics|mesh-ancestor
5566732|NCT03963895|Coagulants|coagulants|mesh-ancestor
5566733|NCT03963960|Dialysis Solutions|dialysis solutions|mesh-list
5566734|NCT03963960|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5566735|NCT03964051|Omalizumab|omalizumab|mesh-list
5566736|NCT03964051|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5566737|NCT03964051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5566738|NCT03964051|Respiratory System Agents|respiratory system agents|mesh-ancestor
5566739|NCT03963752|Megestrol|megestrol|mesh-list
5566740|NCT03963752|Megestrol Acetate|megestrol acetate|mesh-list
5566741|NCT03963752|Leuprolide|leuprolide|mesh-list
5566742|NCT03963752|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5566743|NCT03963752|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5566744|NCT03963752|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5566745|NCT03963752|Contraceptive Agents|contraceptive agents|mesh-ancestor
5566746|NCT03963752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5566747|NCT03963752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566748|NCT03963752|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5566749|NCT03963752|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5566750|NCT03963752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5566751|NCT03963752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5566752|NCT03963752|Appetite Stimulants|appetite stimulants|mesh-ancestor
5566753|NCT03963752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5566754|NCT03963752|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5566755|NCT03963752|Fertility Agents|fertility agents|mesh-ancestor
5566756|NCT03963648|Nitric Oxide|nitric oxide|mesh-list
5566757|NCT03963648|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5566758|NCT03963648|Autonomic Agents|autonomic agents|mesh-ancestor
5566759|NCT03963648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5566760|NCT03963648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566761|NCT03963648|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5566762|NCT03963648|Respiratory System Agents|respiratory system agents|mesh-ancestor
6168984|NCT01611155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168985|NCT01611155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6168986|NCT01611155|Antidepressive Agents|antidepressive agents|mesh-ancestor
6168987|NCT01611155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6168988|NCT01611259|Rituximab|rituximab|mesh-list
6168989|NCT01611259|Lenalidomide|lenalidomide|mesh-list
6168990|NCT01611259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6168991|NCT01611259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6168992|NCT01611259|Immunologic Factors|immunologic factors|mesh-ancestor
6168993|NCT01611259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168994|NCT01611259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6168995|NCT01611259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6168996|NCT01611259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6168997|NCT01611259|Growth Substances|growth substances|mesh-ancestor
5566763|NCT03963648|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5566764|NCT03963648|Antioxidants|antioxidants|mesh-ancestor
5566765|NCT03963648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566766|NCT03963648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5566767|NCT03963648|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5566768|NCT03963648|Vasodilator Agents|vasodilator agents|mesh-ancestor
5566769|NCT03963648|Gasotransmitters|gasotransmitters|mesh-ancestor
5566770|NCT03963648|Protective Agents|protective agents|mesh-ancestor
5566771|NCT03963375|Cladribine|cladribine|mesh-list
5566772|NCT03963375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5566773|NCT03963375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5566774|NCT03963375|Immunologic Factors|immunologic factors|mesh-ancestor
6669631|NCT01538953|Sodium Hypochlorite|sodium hypochlorite|mesh-list
6669632|NCT01538953|Disinfectants|disinfectants|mesh-list
6669633|NCT01538953|Eusol|eusol|mesh-list
6669634|NCT01538953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6669635|NCT01538966|Octreotide|octreotide|mesh-list
6669636|NCT01538966|Lanreotide|lanreotide|mesh-list
6669637|NCT01538966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6669638|NCT01538966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6669639|NCT01538966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6669640|NCT01539018|Sorafenib|sorafenib|mesh-list
6669641|NCT01539018|Tegafur|tegafur|mesh-list
6669642|NCT01539018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5566775|NCT03963375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6168998|NCT01611259|Growth Inhibitors|growth inhibitors|mesh-ancestor
6168999|NCT01611298|Vaccines|vaccines|mesh-list
6169000|NCT01611298|Immunologic Factors|immunologic factors|mesh-ancestor
6169001|NCT01611298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169002|NCT01611558|Ipilimumab|ipilimumab|mesh-list
5566776|NCT03963466|Tranexamic Acid|tranexamic acid|mesh-list
5566777|NCT03963466|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5566778|NCT03963466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5566779|NCT03963466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566780|NCT03963466|Hemostatics|hemostatics|mesh-ancestor
5566781|NCT03963466|Coagulants|coagulants|mesh-ancestor
5566782|NCT03963479|Vitamin B 6|vitamin b 6|mesh-list
5566783|NCT03963479|Pyridoxal|pyridoxal|mesh-list
5566784|NCT03963479|Pyridoxine|pyridoxine|mesh-list
5566785|NCT03963479|Vitamins|vitamins|mesh-ancestor
5566786|NCT03963479|Micronutrients|micronutrients|mesh-ancestor
5566787|NCT03963479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566788|NCT03963479|Vitamin B Complex|vitamin b complex|mesh-ancestor
5566789|NCT03963414|Carboplatin|carboplatin|mesh-list
5566790|NCT03963414|Etoposide|etoposide|mesh-list
5566791|NCT03963414|Etoposide phosphate|etoposide phosphate|mesh-list
6169003|NCT01611558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6169004|NCT01611558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6169005|NCT01611558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6169006|NCT01611558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6169007|NCT01611571|Teriparatide|teriparatide|mesh-list
6169008|NCT01611571|Risedronic Acid|risedronic acid|mesh-list
6169009|NCT01611571|Etidronic Acid|etidronic acid|mesh-list
6169010|NCT01611571|Parathyroid Hormone|parathyroid hormone|mesh-list
6169011|NCT01611571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5566792|NCT03963414|Durvalumab|durvalumab|mesh-list
6206274|NCT02097849|Dimethyl Fumarate|dimethyl fumarate|mesh-list
6669643|NCT01539018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6669644|NCT01539018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6169012|NCT01611571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169013|NCT01611571|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6169014|NCT01611571|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6169015|NCT01611571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6169016|NCT01611571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6169017|NCT01611662|Gemcitabine|gemcitabine|mesh-list
6169018|NCT01611662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6169019|NCT01611662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6169020|NCT01611662|Antimetabolites|antimetabolites|mesh-ancestor
6169021|NCT01611662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6169022|NCT01611662|Antiviral Agents|antiviral agents|mesh-ancestor
6169023|NCT01611662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6169024|NCT01611662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6169025|NCT01611662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6484448|NCT00562068|Vincristine|vincristine|mesh-list
6484449|NCT00562068|Alemtuzumab|alemtuzumab|mesh-list
6484450|NCT00562068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6484451|NCT00562068|Immunologic Factors|immunologic factors|mesh-ancestor
6169026|NCT01611662|Immunologic Factors|immunologic factors|mesh-ancestor
6169027|NCT01611662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169028|NCT01611857|Leucovorin|leucovorin|mesh-list
6169029|NCT01611857|Fluorouracil|fluorouracil|mesh-list
6169030|NCT01611857|Oxaliplatin|oxaliplatin|mesh-list
6169031|NCT01611857|Levoleucovorin|levoleucovorin|mesh-list
6169032|NCT01611857|Antimetabolites|antimetabolites|mesh-ancestor
6169033|NCT01611857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6169034|NCT01611857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6169035|NCT01611857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6169036|NCT01611857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6169037|NCT01611857|Immunologic Factors|immunologic factors|mesh-ancestor
6484452|NCT00562068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484453|NCT00562068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6484454|NCT00562068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5566793|NCT03963414|Tremelimumab|tremelimumab|mesh-list
6169038|NCT01611857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169039|NCT01611857|Antidotes|antidotes|mesh-ancestor
6169040|NCT01611857|Protective Agents|protective agents|mesh-ancestor
6169041|NCT01611857|Vitamin B Complex|vitamin b complex|mesh-ancestor
6169042|NCT01611857|Vitamins|vitamins|mesh-ancestor
6169043|NCT01611857|Micronutrients|micronutrients|mesh-ancestor
6169044|NCT01611935|Vasopressins|vasopressins|mesh-list
6169045|NCT01611935|Arginine Vasopressin|arginine vasopressin|mesh-list
6169046|NCT01611935|Hemostatics|hemostatics|mesh-ancestor
6169047|NCT01611935|Coagulants|coagulants|mesh-ancestor
6169048|NCT01611935|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6169049|NCT01611935|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6169050|NCT01611935|Natriuretic Agents|natriuretic agents|mesh-ancestor
6169051|NCT01611935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169052|NCT01611948|Aprepitant|aprepitant|mesh-list
6169053|NCT01611948|Antiemetics|antiemetics|mesh-ancestor
6169054|NCT01611948|Autonomic Agents|autonomic agents|mesh-ancestor
6169055|NCT01611948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6169056|NCT01611948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169057|NCT01611948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6169058|NCT01611948|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6169059|NCT01611948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6169060|NCT01611948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566794|NCT03963414|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5566795|NCT03963414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6169061|NCT01611974|Maribavir|maribavir|mesh-list
6169062|NCT01611974|Antiviral Agents|antiviral agents|mesh-ancestor
6169063|NCT01611974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6169064|NCT01612000|Hemagglutinins|hemagglutinins|mesh-list
6169065|NCT01612000|Agglutinins|agglutinins|mesh-ancestor
6169066|NCT01612000|Immunologic Factors|immunologic factors|mesh-ancestor
6169067|NCT01612000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169068|NCT01612156|Lidocaine|lidocaine|mesh-list
6169069|NCT01612156|Anesthetics, Local|anesthetics, local|mesh-ancestor
6169070|NCT01612156|Anesthetics|anesthetics|mesh-ancestor
6169071|NCT01612156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6169072|NCT01612156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169073|NCT01612156|Sensory System Agents|sensory system agents|mesh-ancestor
6169074|NCT01612156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6169075|NCT01612156|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6484455|NCT00562068|Alkylating Agents|alkylating agents|mesh-ancestor
5566796|NCT03963414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6169076|NCT01612156|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6169077|NCT01612156|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6169078|NCT01612156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6169079|NCT01612156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6169080|NCT01612221|Acetylcysteine|acetylcysteine|mesh-list
6169081|NCT01612221|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6169082|NCT01612221|Antiviral Agents|antiviral agents|mesh-ancestor
6169083|NCT01612221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6169084|NCT01612221|Expectorants|expectorants|mesh-ancestor
6169085|NCT01612221|Respiratory System Agents|respiratory system agents|mesh-ancestor
6169086|NCT01612221|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6169087|NCT01612221|Antioxidants|antioxidants|mesh-ancestor
5566797|NCT03963414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5566798|NCT03963414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5566799|NCT03963414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5566800|NCT03963414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566801|NCT03963414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5566802|NCT03963414|Immunologic Factors|immunologic factors|mesh-ancestor
5566803|NCT03963414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566804|NCT03963336|Acetazolamide|acetazolamide|mesh-list
5566805|NCT03963336|Anticonvulsants|anticonvulsants|mesh-ancestor
5566806|NCT03963336|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5566807|NCT03963336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5566808|NCT03963336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566809|NCT03963336|Diuretics|diuretics|mesh-ancestor
5566810|NCT03963336|Natriuretic Agents|natriuretic agents|mesh-ancestor
5566811|NCT03963336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566812|NCT03963193|Cisplatin|cisplatin|mesh-list
5566813|NCT03963193|Irinotecan|irinotecan|mesh-list
5566814|NCT03963193|Etoposide|etoposide|mesh-list
5566815|NCT03963193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5566816|NCT03963193|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5566817|NCT03963193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5566818|NCT03963193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5566819|NCT03963193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566820|NCT03963193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5566821|NCT03963193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5566822|NCT03963115|Epinephrine|epinephrine|mesh-list
5566823|NCT03963115|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5566824|NCT03963115|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5566825|NCT03963115|Adrenergic Agents|adrenergic agents|mesh-ancestor
5566826|NCT03963115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5566827|NCT03963115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566828|NCT03963115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169088|NCT01612221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6169089|NCT01612221|Protective Agents|protective agents|mesh-ancestor
6169090|NCT01612221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169091|NCT01612221|Antidotes|antidotes|mesh-ancestor
6169092|NCT01612546|Camptothecin|camptothecin|mesh-list
6169093|NCT01612546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6169094|NCT01612546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5566829|NCT03963115|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5566830|NCT03963115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5566831|NCT03963115|Autonomic Agents|autonomic agents|mesh-ancestor
5566832|NCT03963115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5566833|NCT03963115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5566834|NCT03963115|Respiratory System Agents|respiratory system agents|mesh-ancestor
5566835|NCT03963115|Mydriatics|mydriatics|mesh-ancestor
5566836|NCT03963115|Sympathomimetics|sympathomimetics|mesh-ancestor
5566837|NCT03963115|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5566838|NCT03963024|Treosulfan|treosulfan|mesh-list
5566839|NCT03963024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5566840|NCT03963024|Alkylating Agents|alkylating agents|mesh-ancestor
5566841|NCT03963024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6169095|NCT01612546|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6169096|NCT01612546|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6169097|NCT01612546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6169098|NCT01612546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6169099|NCT01612702|Dexamethasone|dexamethasone|mesh-list
5566842|NCT03963024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5566843|NCT03963128|Vitamin D|vitamin d|mesh-list
5566844|NCT03963128|Cholecalciferol|cholecalciferol|mesh-list
5566845|NCT03963128|Vitamins|vitamins|mesh-ancestor
5566846|NCT03963128|Micronutrients|micronutrients|mesh-ancestor
6169100|NCT01612702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5566847|NCT03963128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566848|NCT03963128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5566849|NCT03963128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5566850|NCT03962881|Vaccines|vaccines|mesh-list
5566851|NCT03962881|Immunologic Factors|immunologic factors|mesh-ancestor
6169101|NCT01612702|Antiemetics|antiemetics|mesh-ancestor
6169102|NCT01612702|Autonomic Agents|autonomic agents|mesh-ancestor
6169103|NCT01612702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6169104|NCT01612702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169105|NCT01612702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5566852|NCT03962881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566853|NCT03962920|Tigecycline|tigecycline|mesh-list
5566854|NCT03962920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5566855|NCT03962920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5566856|NCT03962920|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5566857|NCT03962920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5566858|NCT03962920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566859|NCT03962907|Chlorhexidine|chlorhexidine|mesh-list
5566860|NCT03962907|Mupirocin|mupirocin|mesh-list
5566861|NCT03962907|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6169106|NCT01612702|Glucocorticoids|glucocorticoids|mesh-ancestor
6169107|NCT01612702|Hormones|hormones|mesh-ancestor
6169108|NCT01612702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6169109|NCT01612702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6169110|NCT01612702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6169111|NCT01612858|Metformin|metformin|mesh-list
6169112|NCT01612858|Pioglitazone|pioglitazone|mesh-list
5566862|NCT03962907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5566863|NCT03962907|Disinfectants|disinfectants|mesh-ancestor
5566864|NCT03962907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5566865|NCT03962907|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5566866|NCT03962907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5566867|NCT03962907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566868|NCT03962829|1-(3-chlorophenyl)piperazine|1-(3-chlorophenyl)piperazine|mesh-list
5566869|NCT03962829|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5566870|NCT03962829|Serotonin Agents|serotonin agents|mesh-ancestor
5566871|NCT03962829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5566872|NCT03962829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566873|NCT03962829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566874|NCT03962647|Letrozole|letrozole|mesh-list
5566875|NCT03962647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5566876|NCT03962647|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5566877|NCT03962647|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6169113|NCT01612858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6169114|NCT01612858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169115|NCT01612884|Clopidogrel|clopidogrel|mesh-list
6169116|NCT01612884|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6169117|NCT01612884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6669645|NCT01539018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669646|NCT01539018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6669647|NCT01539018|Antimetabolites|antimetabolites|mesh-ancestor
6669648|NCT01539031|Donepezil|donepezil|mesh-list
6669649|NCT01539031|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5566878|NCT03962647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5566879|NCT03962647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566880|NCT03962647|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5566881|NCT03962647|Hormone Antagonists|hormone antagonists|mesh-ancestor
5566882|NCT03962647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5566883|NCT03962647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566884|NCT03962725|Dexmedetomidine|dexmedetomidine|mesh-list
5566885|NCT03962725|Ketamine|ketamine|mesh-list
5566886|NCT03962725|Propofol|propofol|mesh-list
5566887|NCT03962725|Anesthetics|anesthetics|mesh-list
5566888|NCT03962725|Rocuronium|rocuronium|mesh-list
5566889|NCT03962725|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
6669650|NCT01539031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6669651|NCT01539031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669652|NCT01539031|Cholinergic Agents|cholinergic agents|mesh-ancestor
6669653|NCT01539031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6669654|NCT01539031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669655|NCT01539031|Nootropic Agents|nootropic agents|mesh-ancestor
6669656|NCT01539044|Atropine|atropine|mesh-list
6669657|NCT01539044|Neostigmine|neostigmine|mesh-list
5566890|NCT03962725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6669658|NCT01539044|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6169118|NCT01612884|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6669659|NCT01539044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6669660|NCT01539044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6669661|NCT01539044|Autonomic Agents|autonomic agents|mesh-ancestor
6669662|NCT01539044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6669663|NCT01539044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669664|NCT01539044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6669665|NCT01539044|Respiratory System Agents|respiratory system agents|mesh-ancestor
6669666|NCT01539044|Mydriatics|mydriatics|mesh-ancestor
6669667|NCT01539044|Parasympatholytics|parasympatholytics|mesh-ancestor
6669668|NCT01539044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6669669|NCT01539044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6669670|NCT01539044|Cholinergic Agents|cholinergic agents|mesh-ancestor
6669671|NCT01539044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6669672|NCT01539044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669673|NCT01539044|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6669674|NCT01539044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6169119|NCT01612884|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6169120|NCT01612884|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6169121|NCT01612884|Purinergic Agents|purinergic agents|mesh-ancestor
6169122|NCT01612884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6169123|NCT01612884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6169124|NCT01612884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169125|NCT01613027|Rituximab|rituximab|mesh-list
6169126|NCT01613027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6169127|NCT01613027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6169128|NCT01613027|Immunologic Factors|immunologic factors|mesh-ancestor
6169129|NCT01613027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169130|NCT01613027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6169131|NCT01613118|Irbesartan|irbesartan|mesh-list
6169132|NCT01613118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6169133|NCT01613118|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6169134|NCT01613118|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6169135|NCT01613118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6169136|NCT01613131|Estradiol|estradiol|mesh-list
5566891|NCT03962725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5566892|NCT03962725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566893|NCT03962725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5566894|NCT03962725|Anesthetics, General|anesthetics, general|mesh-ancestor
5566895|NCT03962725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5566896|NCT03962725|Analgesics|analgesics|mesh-ancestor
6169137|NCT01613131|Estrogens|estrogens|mesh-ancestor
6169138|NCT01613131|Hormones|hormones|mesh-ancestor
6169139|NCT01613131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6169140|NCT01613131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169141|NCT01613326|Glycopyrrolate|glycopyrrolate|mesh-list
6169142|NCT01613326|Albuterol|albuterol|mesh-list
6169143|NCT01613326|Tiotropium Bromide|tiotropium bromide|mesh-list
6669675|NCT01539044|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6669676|NCT01539174|Prednisone|prednisone|mesh-list
6669677|NCT01539174|Cyclophosphamide|cyclophosphamide|mesh-list
6669678|NCT01539174|Rituximab|rituximab|mesh-list
6669679|NCT01539174|Doxorubicin|doxorubicin|mesh-list
6669680|NCT01539174|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6669681|NCT01539174|Vincristine|vincristine|mesh-list
6669682|NCT01539174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6669683|NCT01539174|Immunologic Factors|immunologic factors|mesh-ancestor
6669684|NCT01539174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669685|NCT01539174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6669686|NCT01539174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6669687|NCT01539174|Alkylating Agents|alkylating agents|mesh-ancestor
6669688|NCT01539174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669689|NCT01539174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6669690|NCT01539174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6669691|NCT01539174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6669692|NCT01539174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6669693|NCT01539174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6669694|NCT01539174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6669695|NCT01539174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5566897|NCT03962725|Sensory System Agents|sensory system agents|mesh-ancestor
5566898|NCT03962725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5566899|NCT03962725|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5566900|NCT03962725|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5566901|NCT03962725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5566902|NCT03962725|Adrenergic Agents|adrenergic agents|mesh-ancestor
5566903|NCT03962725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6169144|NCT01613326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6669696|NCT01539174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6669697|NCT01539174|Glucocorticoids|glucocorticoids|mesh-ancestor
6484456|NCT00562068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484457|NCT00562068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6484458|NCT00562068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6484459|NCT00562068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6484460|NCT00562068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6484461|NCT00562068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6484462|NCT00562068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6484463|NCT00562068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6484464|NCT00562068|Tubulin Modulators|tubulin modulators|mesh-ancestor
6484465|NCT00562068|Antimitotic Agents|antimitotic agents|mesh-ancestor
6484466|NCT00562068|Mitosis Modulators|mitosis modulators|mesh-ancestor
6484467|NCT00562068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6484468|NCT00562068|Glucocorticoids|glucocorticoids|mesh-ancestor
6484469|NCT00562068|Hormones|hormones|mesh-ancestor
6484470|NCT00562068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6484471|NCT00562068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6484472|NCT00562068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6484473|NCT00562133|Insulin|insulin|mesh-list
6484474|NCT00562133|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6484475|NCT00562133|Insulin glulisine|insulin glulisine|mesh-list
6484476|NCT00562133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6484477|NCT00562133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484478|NCT00562172|Metformin|metformin|mesh-list
6669698|NCT01539174|Hormones|hormones|mesh-ancestor
6669699|NCT01539174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6669700|NCT01539174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6669701|NCT01539174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6169145|NCT01613326|Autonomic Agents|autonomic agents|mesh-ancestor
6169146|NCT01613326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6169147|NCT01613326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169148|NCT01613326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6169149|NCT01613326|Respiratory System Agents|respiratory system agents|mesh-ancestor
6169150|NCT01613326|Parasympatholytics|parasympatholytics|mesh-ancestor
6169151|NCT01613326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6169152|NCT01613326|Cholinergic Agents|cholinergic agents|mesh-ancestor
6169153|NCT01613326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6169154|NCT01613326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6169155|NCT01613326|Tocolytic Agents|tocolytic agents|mesh-ancestor
6169156|NCT01613326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6169157|NCT01613326|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6169158|NCT01613326|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6484479|NCT00562172|Insulin Glargine|insulin glargine|mesh-list
6484480|NCT00562172|Glimepiride|glimepiride|mesh-list
6484481|NCT00562172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6484482|NCT00562172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484483|NCT00562172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6484484|NCT00562172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6484485|NCT00562172|Immunologic Factors|immunologic factors|mesh-ancestor
6484486|NCT00562185|Carboplatin|carboplatin|mesh-list
6484487|NCT00562185|Doxorubicin|doxorubicin|mesh-list
6484488|NCT00562185|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6484489|NCT00562185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6484490|NCT00562185|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6484491|NCT00562185|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6484492|NCT00562185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6484493|NCT00562185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6484494|NCT00562185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484495|NCT00562198|Carbidopa|carbidopa|mesh-list
6669702|NCT01539174|Tubulin Modulators|tubulin modulators|mesh-ancestor
6169159|NCT01613326|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6169160|NCT01613326|Adrenergic Agents|adrenergic agents|mesh-ancestor
6169161|NCT01613326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6169162|NCT01613326|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6169163|NCT01613599|Rituximab|rituximab|mesh-list
6169164|NCT01613599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6484496|NCT00562198|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
5566904|NCT03962725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566905|NCT03962725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5566906|NCT03962725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5566907|NCT03962725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5566908|NCT03962725|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5566909|NCT03962725|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5566910|NCT03962777|Chlorhexidine|chlorhexidine|mesh-list
5566911|NCT03962777|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5566912|NCT03962777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5566913|NCT03962777|Disinfectants|disinfectants|mesh-ancestor
5566914|NCT03962803|Vaccines|vaccines|mesh-list
5566915|NCT03962803|Immunologic Factors|immunologic factors|mesh-ancestor
5566916|NCT03962803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566917|NCT03962816|Vaccines|vaccines|mesh-list
5566918|NCT03962816|Immunologic Factors|immunologic factors|mesh-ancestor
5566919|NCT03962816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5603999|NCT05179070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604000|NCT05179070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484497|NCT00562198|Entacapone|entacapone|mesh-list
6484498|NCT00562198|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6484499|NCT00562198|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6484500|NCT00562198|Dopamine Agents|dopamine agents|mesh-ancestor
6169165|NCT01613599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6169166|NCT01613599|Immunologic Factors|immunologic factors|mesh-ancestor
6169167|NCT01613599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169168|NCT01613599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6169169|NCT01613716|Dexamethasone|dexamethasone|mesh-list
6169170|NCT01613716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6169171|NCT01613716|Antiemetics|antiemetics|mesh-ancestor
6169172|NCT01613716|Autonomic Agents|autonomic agents|mesh-ancestor
6169173|NCT01613716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6169174|NCT01613716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169175|NCT01613716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6169176|NCT01613716|Glucocorticoids|glucocorticoids|mesh-ancestor
6169177|NCT01613716|Hormones|hormones|mesh-ancestor
6669703|NCT01539174|Antimitotic Agents|antimitotic agents|mesh-ancestor
6669704|NCT01539174|Mitosis Modulators|mitosis modulators|mesh-ancestor
6669705|NCT01539265|Silodosin|silodosin|mesh-list
6669706|NCT01539265|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6669707|NCT01539265|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6669708|NCT01539265|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6169178|NCT01613716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6669709|NCT01539265|Adrenergic Agents|adrenergic agents|mesh-ancestor
6669710|NCT01539265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6669711|NCT01539265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669712|NCT01539265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669713|NCT01539265|Urological Agents|urological agents|mesh-ancestor
6669714|NCT01539330|Voriconazole|voriconazole|mesh-list
6669715|NCT01539330|Antifungal Agents|antifungal agents|mesh-ancestor
6669716|NCT01539330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6669717|NCT01539330|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6669718|NCT01539330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6669719|NCT01539330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6169179|NCT01613716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6169180|NCT01613716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6169181|NCT01614093|Oxytocin|oxytocin|mesh-list
6169182|NCT01614093|Oxytocics|oxytocics|mesh-ancestor
6169183|NCT01614093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6169184|NCT01614093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169185|NCT01614210|Tamoxifen|tamoxifen|mesh-list
6169186|NCT01614210|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6169187|NCT01614210|Hormone Antagonists|hormone antagonists|mesh-ancestor
6169188|NCT01614210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6206275|NCT02097849|Vaccines|vaccines|mesh-list
6484501|NCT00562198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6484502|NCT00562198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484503|NCT00562198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484504|NCT00562198|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6484505|NCT00562198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6484506|NCT00562198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6484507|NCT00562198|Immunologic Factors|immunologic factors|mesh-ancestor
6484508|NCT00562198|Dopamine Agonists|dopamine agonists|mesh-ancestor
6484509|NCT00562198|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6484510|NCT00562224|Abexinostat|abexinostat|mesh-list
6484511|NCT00562224|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6484512|NCT00562224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6484513|NCT00562224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484514|NCT00562250|Dapagliflozin|dapagliflozin|mesh-list
6484515|NCT00562250|Glimepiride|glimepiride|mesh-list
6484516|NCT00562250|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6484517|NCT00562250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484518|NCT00562250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6484519|NCT00562250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484520|NCT00562250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6484521|NCT00562250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6484522|NCT00562250|Immunologic Factors|immunologic factors|mesh-ancestor
6484523|NCT00562289|Aspirin|aspirin|mesh-list
6484524|NCT00562289|Dipyridamole|dipyridamole|mesh-list
5566920|NCT03962686|Metformin|metformin|mesh-list
5566921|NCT03962686|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5566922|NCT03962686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566923|NCT03962062|Moxidectin|moxidectin|mesh-list
5566924|NCT03962062|Anthelmintics|anthelmintics|mesh-ancestor
5566925|NCT03962062|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5566926|NCT03962062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5566927|NCT03962062|Antinematodal Agents|antinematodal agents|mesh-ancestor
5566928|NCT03962114|Niacinamide|niacinamide|mesh-list
5566929|NCT03962114|Vitamins|vitamins|mesh-ancestor
5566930|NCT03962114|Micronutrients|micronutrients|mesh-ancestor
5566931|NCT03962114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566932|NCT03962114|Vitamin B Complex|vitamin b complex|mesh-ancestor
5566933|NCT03962296|Calcium Dobesilate|calcium dobesilate|mesh-list
5566934|NCT03962296|Calcium|calcium|mesh-list
5566935|NCT03962296|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5566936|NCT03962296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566937|NCT03962296|Hemostatics|hemostatics|mesh-ancestor
5566938|NCT03962296|Coagulants|coagulants|mesh-ancestor
5566939|NCT03962283|Rifaximin|rifaximin|mesh-list
5566940|NCT03962283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5566941|NCT03962283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5566942|NCT03962283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5566943|NCT03961867|Docetaxel|docetaxel|mesh-list
5566944|NCT03961867|Oxaliplatin|oxaliplatin|mesh-list
5566945|NCT03961867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5566946|NCT03961867|Tubulin Modulators|tubulin modulators|mesh-ancestor
5566947|NCT03961867|Antimitotic Agents|antimitotic agents|mesh-ancestor
5566948|NCT03961867|Mitosis Modulators|mitosis modulators|mesh-ancestor
5566949|NCT03961867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566950|NCT03961958|Propofol|propofol|mesh-list
5566951|NCT03961958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5566952|NCT03961958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5566953|NCT03961958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566954|NCT03961958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5566955|NCT03961958|Anesthetics, General|anesthetics, general|mesh-ancestor
5566956|NCT03961958|Anesthetics|anesthetics|mesh-ancestor
5566957|NCT03961919|Fludarabine|fludarabine|mesh-list
5566958|NCT03961919|Treosulfan|treosulfan|mesh-list
5566959|NCT03961919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5566960|NCT03961919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566961|NCT03961919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5566962|NCT03961919|Alkylating Agents|alkylating agents|mesh-ancestor
6169189|NCT01614210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169190|NCT01614210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6169191|NCT01614210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6169192|NCT01614210|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6169193|NCT01614210|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6169194|NCT01614210|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6169195|NCT01614457|Ivacaftor|ivacaftor|mesh-list
6169196|NCT01614457|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6169197|NCT01614457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6207910|NCT02121418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566963|NCT03961841|Oxaliplatin|oxaliplatin|mesh-list
5566964|NCT03961841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6484525|NCT00562289|Rivaroxaban|rivaroxaban|mesh-list
6484526|NCT00562289|Apixaban|apixaban|mesh-list
6484527|NCT00562289|Dabigatran|dabigatran|mesh-list
6484528|NCT00562289|Antivitamins K|antivitamins k|mesh-list
6484529|NCT00562289|Clopidogrel|clopidogrel|mesh-list
6484530|NCT00562289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6484531|NCT00562289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6484532|NCT00562289|Analgesics|analgesics|mesh-ancestor
6484533|NCT00562289|Sensory System Agents|sensory system agents|mesh-ancestor
6484534|NCT00562289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6169198|NCT01614457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6169199|NCT01614470|Ivacaftor|ivacaftor|mesh-list
6169200|NCT01614470|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6169201|NCT01614470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6169202|NCT01614470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6169203|NCT01614509|Triamcinolone|triamcinolone|mesh-list
6169204|NCT01614509|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6169205|NCT01614509|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6169206|NCT01614509|Bevacizumab|bevacizumab|mesh-list
6169207|NCT01614509|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6169208|NCT01614509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6169209|NCT01614509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6169210|NCT01614509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6169211|NCT01614509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6169212|NCT01614509|Growth Substances|growth substances|mesh-ancestor
6169213|NCT01614509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169214|NCT01614509|Growth Inhibitors|growth inhibitors|mesh-ancestor
6169215|NCT01614509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6169216|NCT01614509|Glucocorticoids|glucocorticoids|mesh-ancestor
6169217|NCT01614509|Hormones|hormones|mesh-ancestor
5566965|NCT03961828|Sofosbuvir|sofosbuvir|mesh-list
5566966|NCT03961828|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
5566967|NCT03961828|Ledipasvir|ledipasvir|mesh-list
5566968|NCT03961828|Antiviral Agents|antiviral agents|mesh-ancestor
5566969|NCT03961828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5566970|NCT03961659|Metformin|metformin|mesh-list
5566971|NCT03961659|Dapagliflozin|dapagliflozin|mesh-list
5566972|NCT03961659|Acarbose|acarbose|mesh-list
5566973|NCT03961659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5566974|NCT03961659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5566975|NCT03961659|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5566976|NCT03961659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566977|NCT03961659|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
5566978|NCT03961659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5566979|NCT03961464|Cycloserine|cycloserine|mesh-list
5566980|NCT03961464|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5566981|NCT03961464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5566982|NCT03961464|Renal Agents|renal agents|mesh-ancestor
5566983|NCT03961464|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5566984|NCT03961464|Antitubercular Agents|antitubercular agents|mesh-ancestor
5566985|NCT03961464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5566986|NCT03961464|Antimetabolites|antimetabolites|mesh-ancestor
5566987|NCT03961464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5566988|NCT03961607|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5566989|NCT03961607|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5566990|NCT03961607|Dermatologic Agents|dermatologic agents|mesh-ancestor
5566991|NCT03961503|Vancomycin|vancomycin|mesh-list
5566992|NCT03961503|Daptomycin|daptomycin|mesh-list
5566993|NCT03961503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5566994|NCT03961503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5566995|NCT03961698|Paclitaxel|paclitaxel|mesh-list
5566996|NCT03961698|Bevacizumab|bevacizumab|mesh-list
5566997|NCT03961698|Atezolizumab|atezolizumab|mesh-list
5566998|NCT03961698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5566999|NCT03961698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6169218|NCT01614509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6169219|NCT01614509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6169220|NCT01614509|Immunologic Factors|immunologic factors|mesh-ancestor
6169221|NCT01614509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6169222|NCT01614509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206276|NCT02097849|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6206277|NCT02097849|Immunologic Factors|immunologic factors|mesh-ancestor
6484535|NCT00562289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484536|NCT00562289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5567000|NCT03961698|Tubulin Modulators|tubulin modulators|mesh-ancestor
5567001|NCT03961698|Antimitotic Agents|antimitotic agents|mesh-ancestor
6484537|NCT00562289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6484538|NCT00562289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6484539|NCT00562289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6484540|NCT00562289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484541|NCT00562289|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6484542|NCT00562289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6484543|NCT00562289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6169223|NCT01614743|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
6169224|NCT01614743|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6169225|NCT01614743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6169226|NCT01614743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567002|NCT03961698|Mitosis Modulators|mitosis modulators|mesh-ancestor
5567003|NCT03961698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5567004|NCT03961698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5567005|NCT03961698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5567006|NCT03961698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5567007|NCT03961698|Growth Substances|growth substances|mesh-ancestor
5567008|NCT03961698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567009|NCT03961698|Growth Inhibitors|growth inhibitors|mesh-ancestor
5567010|NCT03961360|Aspirin|aspirin|mesh-list
5567011|NCT03961360|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5567012|NCT03961360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6169227|NCT01614743|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6169228|NCT01614743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6169229|NCT01614743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6169230|NCT01614743|Cholinergic Agents|cholinergic agents|mesh-ancestor
6169231|NCT01614743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6169232|NCT01614769|Glimepiride|glimepiride|mesh-list
6169233|NCT01614769|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6169234|NCT01614769|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6169235|NCT01614769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169236|NCT01614769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6169237|NCT01614769|Immunologic Factors|immunologic factors|mesh-ancestor
6169238|NCT01614795|Sirolimus|sirolimus|mesh-list
6169239|NCT01614795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6669720|NCT01539330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669721|NCT01539330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6669722|NCT01539330|Hormone Antagonists|hormone antagonists|mesh-ancestor
6669723|NCT01539330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6669724|NCT01539330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669725|NCT01539330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6669726|NCT01539343|Anti-Infective Agents|anti-infective agents|mesh-list
6669727|NCT01539343|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6669728|NCT01539408|Misoprostol|misoprostol|mesh-list
6669729|NCT01539408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6169240|NCT01614795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6169241|NCT01614795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6169242|NCT01614795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6169243|NCT01614795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6484544|NCT00562289|Antipyretics|antipyretics|mesh-ancestor
6484545|NCT00562289|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6484546|NCT00562289|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6484547|NCT00562289|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6484548|NCT00562289|Purinergic Agents|purinergic agents|mesh-ancestor
6484549|NCT00562289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6484550|NCT00562289|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6484551|NCT00562289|Antithrombins|antithrombins|mesh-ancestor
6669730|NCT01539408|Abortifacient Agents|abortifacient agents|mesh-ancestor
6669731|NCT01539408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6669732|NCT01539408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669733|NCT01539408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6669734|NCT01539408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6669735|NCT01539408|Oxytocics|oxytocics|mesh-ancestor
6169244|NCT01614795|Antifungal Agents|antifungal agents|mesh-ancestor
5567013|NCT03961360|Analgesics|analgesics|mesh-ancestor
5567014|NCT03961360|Sensory System Agents|sensory system agents|mesh-ancestor
6169245|NCT01614795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6169246|NCT01614795|Immunologic Factors|immunologic factors|mesh-ancestor
6169247|NCT01614795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169248|NCT01614847|Lubricant Eye Drops|lubricant eye drops|mesh-list
6169249|NCT01614847|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6169250|NCT01614847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6484552|NCT00562289|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5567015|NCT03961360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5567016|NCT03961360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567017|NCT03961360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6484553|NCT00562289|Protease Inhibitors|protease inhibitors|mesh-ancestor
6484554|NCT00562289|Anticoagulants|anticoagulants|mesh-ancestor
6484555|NCT00562289|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6484556|NCT00562289|Vasodilator Agents|vasodilator agents|mesh-ancestor
6484557|NCT00562406|Ranibizumab|ranibizumab|mesh-list
6484558|NCT00562406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6484559|NCT00562406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6484560|NCT00562406|Growth Substances|growth substances|mesh-ancestor
6484561|NCT00562406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484562|NCT00562406|Growth Inhibitors|growth inhibitors|mesh-ancestor
6484563|NCT00562406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6484564|NCT00562419|Irinotecan|irinotecan|mesh-list
5567018|NCT03961360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6169251|NCT01614886|Rivastigmine|rivastigmine|mesh-list
6169252|NCT01614886|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6169253|NCT01614886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6169254|NCT01614886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6169255|NCT01614886|Cholinergic Agents|cholinergic agents|mesh-ancestor
6169256|NCT01614886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6169257|NCT01614886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169258|NCT01614886|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6169259|NCT01614886|Protective Agents|protective agents|mesh-ancestor
6169260|NCT01614899|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
5567019|NCT03961360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5567020|NCT03961360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5567021|NCT03961360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5567022|NCT03961360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5567023|NCT03961360|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5567024|NCT03961360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5567025|NCT03961360|Antipyretics|antipyretics|mesh-ancestor
5567026|NCT03960970|Azithromycin|azithromycin|mesh-list
5567027|NCT03960970|Cefoxitin|cefoxitin|mesh-list
5567028|NCT03960970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5567029|NCT03960970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5567030|NCT03961334|Aspirin|aspirin|mesh-list
5567031|NCT03961334|Dabigatran|dabigatran|mesh-list
5567032|NCT03961334|Apixaban|apixaban|mesh-list
5567033|NCT03961334|Edoxaban|edoxaban|mesh-list
5567034|NCT03961334|Clopidogrel|clopidogrel|mesh-list
5567035|NCT03961334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5567036|NCT03961334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5567037|NCT03961334|Analgesics|analgesics|mesh-ancestor
5567038|NCT03961334|Sensory System Agents|sensory system agents|mesh-ancestor
5567039|NCT03961334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5567040|NCT03961334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567041|NCT03961334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5567042|NCT03961334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5567043|NCT03961334|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5567044|NCT03961334|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5567045|NCT03961334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5567046|NCT03961334|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5567047|NCT03961334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6169261|NCT01614899|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6169262|NCT01614899|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6169263|NCT01614899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6169264|NCT01614899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169265|NCT01614899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6169266|NCT01614899|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6169267|NCT01614899|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6169268|NCT01614899|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5567048|NCT03961334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6484565|NCT00562419|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6484566|NCT00562419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5567049|NCT03961334|Antipyretics|antipyretics|mesh-ancestor
5567050|NCT03961334|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5567051|NCT03961334|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5567052|NCT03961334|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5567053|NCT03961334|Purinergic Agents|purinergic agents|mesh-ancestor
5567054|NCT03961334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5567055|NCT03961334|Antithrombins|antithrombins|mesh-ancestor
5567056|NCT03961334|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6169269|NCT01614899|Adrenergic Agents|adrenergic agents|mesh-ancestor
6169270|NCT01614899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6169271|NCT01614899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6169272|NCT01614899|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6169273|NCT01614899|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6669736|NCT01539473|Tedizolid phosphate|tedizolid phosphate|mesh-list
6669737|NCT01539473|Tedizolid|tedizolid|mesh-list
6669738|NCT01539473|Tyramine|tyramine|mesh-list
6669739|NCT01539473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6669740|NCT01539473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6669741|NCT01539473|Sympathomimetics|sympathomimetics|mesh-ancestor
6169274|NCT01614899|Serotonin Agents|serotonin agents|mesh-ancestor
6169275|NCT01614899|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6169276|NCT01614899|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6169277|NCT01614899|Dopamine Agents|dopamine agents|mesh-ancestor
6169278|NCT01614912|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
6169279|NCT01614912|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6169280|NCT01614912|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6169281|NCT01614912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6169282|NCT01614912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484567|NCT00562419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6484568|NCT00562419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484569|NCT00562419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6484570|NCT00562458|Anastrozole|anastrozole|mesh-list
6484571|NCT00562458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6484572|NCT00562458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6169283|NCT01614912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6169284|NCT01614912|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6169285|NCT01614912|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6169286|NCT01614912|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6169287|NCT01614912|Adrenergic Agents|adrenergic agents|mesh-ancestor
6169288|NCT01614912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6169289|NCT01614912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6169290|NCT01614912|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6169291|NCT01614912|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6169292|NCT01614912|Serotonin Agents|serotonin agents|mesh-ancestor
6169293|NCT01614912|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6169294|NCT01614912|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6169295|NCT01614912|Dopamine Agents|dopamine agents|mesh-ancestor
6169296|NCT01615198|Olmesartan|olmesartan|mesh-list
6169297|NCT01615198|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
6169298|NCT01615198|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6169299|NCT01615198|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6169300|NCT01615198|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6169301|NCT01615198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484573|NCT00562458|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6484574|NCT00562458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6484575|NCT00562458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6484576|NCT00562458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484577|NCT00562458|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6169302|NCT01615484|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6169303|NCT01615731|Digoxin|digoxin|mesh-list
6169304|NCT01615731|Misoprostol|misoprostol|mesh-list
6169305|NCT01615731|Mifepristone|mifepristone|mesh-list
6169306|NCT01615731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6169307|NCT01615731|Abortifacient Agents|abortifacient agents|mesh-ancestor
6169308|NCT01615731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6169309|NCT01615731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169310|NCT01615731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6169311|NCT01615731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6169312|NCT01615731|Oxytocics|oxytocics|mesh-ancestor
6484578|NCT00562458|Hormone Antagonists|hormone antagonists|mesh-ancestor
6484579|NCT00562458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6484580|NCT00562458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669742|NCT01539473|Autonomic Agents|autonomic agents|mesh-ancestor
6169313|NCT01615731|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5567057|NCT03961334|Protease Inhibitors|protease inhibitors|mesh-ancestor
5567058|NCT03961334|Anticoagulants|anticoagulants|mesh-ancestor
5567059|NCT03961334|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5567060|NCT03961126|Clobetasol|clobetasol|mesh-list
5567061|NCT03961126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5567062|NCT03961126|Glucocorticoids|glucocorticoids|mesh-ancestor
5567063|NCT03961126|Hormones|hormones|mesh-ancestor
5567064|NCT03961126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5567065|NCT03961126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567066|NCT03961165|Scopolamine|scopolamine|mesh-list
5567067|NCT03961165|Bromides|bromides|mesh-list
5567068|NCT03961165|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
5567069|NCT03961165|Anticonvulsants|anticonvulsants|mesh-ancestor
5567070|NCT03961165|Parasympatholytics|parasympatholytics|mesh-ancestor
5567071|NCT03961165|Autonomic Agents|autonomic agents|mesh-ancestor
5567072|NCT03961165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6169314|NCT01615731|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6169315|NCT01615731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5567073|NCT03961165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567074|NCT03961165|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5567075|NCT03961165|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5567076|NCT03961165|Cholinergic Agents|cholinergic agents|mesh-ancestor
5567077|NCT03961165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5567078|NCT03961165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5567079|NCT03961165|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5567080|NCT03961165|Antiemetics|antiemetics|mesh-ancestor
5567081|NCT03961165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5567082|NCT03961165|Mydriatics|mydriatics|mesh-ancestor
5567083|NCT03961048|Ropivacaine|ropivacaine|mesh-list
5567084|NCT03961048|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5567085|NCT03961048|Anesthetics, Local|anesthetics, local|mesh-ancestor
5567086|NCT03961048|Anesthetics|anesthetics|mesh-ancestor
5567087|NCT03961048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5567088|NCT03961048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567089|NCT03961048|Sensory System Agents|sensory system agents|mesh-ancestor
5567090|NCT03961048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5567091|NCT03961256|Exenatide|exenatide|mesh-list
5567092|NCT03961256|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5567093|NCT03961256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567094|NCT03961256|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5567095|NCT03961256|Incretins|incretins|mesh-ancestor
6169316|NCT01615731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6169317|NCT01615731|Protective Agents|protective agents|mesh-ancestor
6169318|NCT01615731|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6169319|NCT01615731|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6169320|NCT01615731|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6169321|NCT01615731|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6169322|NCT01615731|Contraceptive Agents|contraceptive agents|mesh-ancestor
6484581|NCT00562510|Raltegravir Potassium|raltegravir potassium|mesh-list
6484582|NCT00562510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6169323|NCT01615731|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6169324|NCT01615731|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6169325|NCT01615731|Hormone Antagonists|hormone antagonists|mesh-ancestor
6169326|NCT01615731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6484583|NCT00562510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5567096|NCT03961256|Hormones|hormones|mesh-ancestor
5567097|NCT03961256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6169327|NCT01615731|Luteolytic Agents|luteolytic agents|mesh-ancestor
6169328|NCT01615731|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6169329|NCT01615731|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6169330|NCT01615809|Amphotericin B|amphotericin b|mesh-list
6169331|NCT01615809|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6169332|NCT01615809|Amebicides|amebicides|mesh-ancestor
6169333|NCT01615809|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6169334|NCT01615809|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6169335|NCT01615809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6169336|NCT01615809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6169337|NCT01615809|Antifungal Agents|antifungal agents|mesh-ancestor
6169338|NCT01615822|Artefenomel|artefenomel|mesh-list
6169339|NCT01615822|Antimalarials|antimalarials|mesh-ancestor
6169340|NCT01615822|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6169341|NCT01615822|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6169342|NCT01615822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6169343|NCT01615939|Bupivacaine|bupivacaine|mesh-list
6169344|NCT01615939|Ropivacaine|ropivacaine|mesh-list
6169345|NCT01615939|Anesthetics, Local|anesthetics, local|mesh-ancestor
6169346|NCT01615939|Anesthetics|anesthetics|mesh-ancestor
6169347|NCT01615939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6169348|NCT01615939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169349|NCT01615939|Sensory System Agents|sensory system agents|mesh-ancestor
6169350|NCT01615939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6169351|NCT01616082|Phentermine|phentermine|mesh-list
6669743|NCT01539473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6669744|NCT01539473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669745|NCT01539473|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6169352|NCT01616082|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6169353|NCT01616082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169354|NCT01616082|Appetite Depressants|appetite depressants|mesh-ancestor
6169355|NCT01616082|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6169356|NCT01616082|Sympathomimetics|sympathomimetics|mesh-ancestor
6669746|NCT01539473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6669747|NCT01539473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6669748|NCT01539473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5567098|NCT03960905|Meropenem|meropenem|mesh-list
5567099|NCT03960905|Ceftazidime|ceftazidime|mesh-list
5567100|NCT03960905|Cefepime|cefepime|mesh-list
5567101|NCT03960905|Anti-Infective Agents|anti-infective agents|mesh-list
5567102|NCT03960905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5567103|NCT03961087|Ubiquinone|ubiquinone|mesh-list
5567104|NCT03961087|Coenzyme Q10|coenzyme q10|mesh-list
5567105|NCT03961087|Meclofenoxate|meclofenoxate|mesh-list
5567106|NCT03961087|Micronutrients|micronutrients|mesh-ancestor
5567107|NCT03961087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567108|NCT03961087|Vitamins|vitamins|mesh-ancestor
5567109|NCT03961087|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5567110|NCT03961087|Protective Agents|protective agents|mesh-ancestor
5567111|NCT03961087|Nootropic Agents|nootropic agents|mesh-ancestor
5567112|NCT03960775|Dexmedetomidine|dexmedetomidine|mesh-list
5567113|NCT03960775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5567114|NCT03960775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5567115|NCT03960775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567116|NCT03960775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5567117|NCT03960775|Analgesics|analgesics|mesh-ancestor
5567118|NCT03960775|Sensory System Agents|sensory system agents|mesh-ancestor
5567119|NCT03960775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5567120|NCT03960775|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5567121|NCT03960775|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5567122|NCT03960775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5567123|NCT03960775|Adrenergic Agents|adrenergic agents|mesh-ancestor
5567124|NCT03960775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5567125|NCT03960775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604001|NCT05179070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5604002|NCT05179070|Antioxidants|antioxidants|mesh-ancestor
5604003|NCT05179070|Protective Agents|protective agents|mesh-ancestor
5604004|NCT05179070|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5604005|NCT05179070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5604006|NCT05179070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5604007|NCT05179070|Vasodilator Agents|vasodilator agents|mesh-ancestor
5604008|NCT05179070|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5604009|NCT05179070|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6669749|NCT01539473|Adrenergic Agents|adrenergic agents|mesh-ancestor
5604010|NCT05179018|Autoantibodies|autoantibodies|mesh-list
5604011|NCT05179018|Immunologic Factors|immunologic factors|mesh-ancestor
6169357|NCT01616082|Autonomic Agents|autonomic agents|mesh-ancestor
5567126|NCT03960866|Phentolamine|phentolamine|mesh-list
5567127|NCT03960866|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5567128|NCT03960866|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5567129|NCT03960866|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5567130|NCT03960866|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5567131|NCT03960866|Adrenergic Agents|adrenergic agents|mesh-ancestor
6669750|NCT01539473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6669751|NCT01539564|Minocycline|minocycline|mesh-list
6669752|NCT01539564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6669753|NCT01539564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5567132|NCT03960866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5567133|NCT03960866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5567134|NCT03960866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567135|NCT03960866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5567136|NCT03960801|Remifentanil|remifentanil|mesh-list
5567137|NCT03960801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5567138|NCT03960801|Narcotics|narcotics|mesh-ancestor
5567139|NCT03960801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5567140|NCT03960801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567141|NCT03960801|Analgesics|analgesics|mesh-ancestor
5567142|NCT03960801|Sensory System Agents|sensory system agents|mesh-ancestor
5567143|NCT03960801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5567144|NCT03960814|Insulin Detemir|insulin detemir|mesh-list
5567145|NCT03960814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5567146|NCT03960814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669754|NCT01539577|Dexamethasone|dexamethasone|mesh-list
6669755|NCT01539577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6669756|NCT01539577|Antiemetics|antiemetics|mesh-ancestor
6669757|NCT01539577|Autonomic Agents|autonomic agents|mesh-ancestor
6669758|NCT01539577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6669759|NCT01539577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669760|NCT01539577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6669761|NCT01539577|Glucocorticoids|glucocorticoids|mesh-ancestor
6669762|NCT01539577|Hormones|hormones|mesh-ancestor
6669763|NCT01539577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6669764|NCT01539577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6669765|NCT01539577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6169358|NCT01616082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6169359|NCT01616082|Adrenergic Agents|adrenergic agents|mesh-ancestor
6169360|NCT01616082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6169361|NCT01616082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6169362|NCT01616160|Mometasone Furoate|mometasone furoate|mesh-list
6169363|NCT01616160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6169364|NCT01616160|Dermatologic Agents|dermatologic agents|mesh-ancestor
5567147|NCT03960671|Midazolam|midazolam|mesh-list
5567148|NCT03960671|Diazepam|diazepam|mesh-list
5567149|NCT03960671|Propofol|propofol|mesh-list
5567150|NCT03960671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5567151|NCT03960671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5567152|NCT03960671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567153|NCT03960671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5567154|NCT03960671|Anesthetics, General|anesthetics, general|mesh-ancestor
5567155|NCT03960671|Anesthetics|anesthetics|mesh-ancestor
6484584|NCT00562510|Antiviral Agents|antiviral agents|mesh-ancestor
6484585|NCT00562510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6484586|NCT00562510|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6484587|NCT00562510|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6484588|NCT00562510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6484589|NCT00562510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484590|NCT00562523|Sorafenib|sorafenib|mesh-list
6484591|NCT00562523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6484592|NCT00562523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6484593|NCT00562523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6484594|NCT00562523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488982|NCT00588185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488983|NCT00588185|Antiviral Agents|antiviral agents|mesh-ancestor
6488984|NCT00588185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6488985|NCT00588302|Moexipril|moexipril|mesh-list
6488986|NCT00588302|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6488987|NCT00588302|Protease Inhibitors|protease inhibitors|mesh-ancestor
6488988|NCT00588302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6488989|NCT00588302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669766|NCT01539603|Sirolimus|sirolimus|mesh-list
5567156|NCT03960671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5567157|NCT03960671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6484595|NCT00562640|Cyclophosphamide|cyclophosphamide|mesh-list
6484596|NCT00562640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6484597|NCT00562640|Immunologic Factors|immunologic factors|mesh-ancestor
6484598|NCT00562640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484599|NCT00562640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6484600|NCT00562640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6484601|NCT00562640|Alkylating Agents|alkylating agents|mesh-ancestor
6484602|NCT00562640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484603|NCT00562640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6484604|NCT00562640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6484605|NCT00562692|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6484606|NCT00562692|Natriuretic Agents|natriuretic agents|mesh-ancestor
6484607|NCT00562692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484608|NCT00562705|Hormones|hormones|mesh-list
6484609|NCT00562705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6484610|NCT00562705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484611|NCT00562770|Valacyclovir|valacyclovir|mesh-list
6484612|NCT00562770|Valganciclovir|valganciclovir|mesh-list
6484613|NCT00562770|Antiviral Agents|antiviral agents|mesh-ancestor
6484614|NCT00562770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6169365|NCT01616160|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6169366|NCT01616173|Dexamethasone|dexamethasone|mesh-list
6169367|NCT01616173|Dexamethasone acetate|dexamethasone acetate|mesh-list
6169368|NCT01616173|BB 1101|bb 1101|mesh-list
6169369|NCT01616173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6169370|NCT01616173|Antiemetics|antiemetics|mesh-ancestor
6169371|NCT01616173|Autonomic Agents|autonomic agents|mesh-ancestor
6169372|NCT01616173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6169373|NCT01616173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169374|NCT01616173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6169375|NCT01616173|Glucocorticoids|glucocorticoids|mesh-ancestor
5567158|NCT03960671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5567159|NCT03960671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5567160|NCT03960671|GABA Modulators|gaba modulators|mesh-ancestor
5567161|NCT03960671|GABA Agents|gaba agents|mesh-ancestor
5567162|NCT03960671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5567163|NCT03960671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6169376|NCT01616173|Hormones|hormones|mesh-ancestor
6169377|NCT01616173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6169378|NCT01616173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6169379|NCT01616173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6169380|NCT01616173|Protease Inhibitors|protease inhibitors|mesh-ancestor
6169381|NCT01616173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6169382|NCT01616173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6169383|NCT01616459|Vaccines|vaccines|mesh-list
6169384|NCT01616459|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6169385|NCT01616459|Immunologic Factors|immunologic factors|mesh-ancestor
6169386|NCT01616459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169387|NCT01616654|Tazarotene|tazarotene|mesh-list
6169388|NCT01616654|Trifarotene|trifarotene|mesh-list
6169389|NCT01616654|Dermatologic Agents|dermatologic agents|mesh-ancestor
6169390|NCT01616654|Keratolytic Agents|keratolytic agents|mesh-ancestor
6169391|NCT01616693|Zinc|zinc|mesh-list
6169392|NCT01616693|Vaccines|vaccines|mesh-list
6169393|NCT01616693|Immunologic Factors|immunologic factors|mesh-ancestor
5567164|NCT03960671|Anticonvulsants|anticonvulsants|mesh-ancestor
6169394|NCT01616693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169395|NCT01616693|Trace Elements|trace elements|mesh-ancestor
6169396|NCT01616693|Micronutrients|micronutrients|mesh-ancestor
6169397|NCT01617083|Azithromycin|azithromycin|mesh-list
5567165|NCT03960671|Antiemetics|antiemetics|mesh-ancestor
5567166|NCT03960671|Autonomic Agents|autonomic agents|mesh-ancestor
5567167|NCT03960671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5567168|NCT03960671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6169398|NCT01617083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6169399|NCT01617083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6169400|NCT01617148|Aflibercept|aflibercept|mesh-list
6169401|NCT01617148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6169402|NCT01617148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6169403|NCT01617148|Growth Substances|growth substances|mesh-ancestor
6169404|NCT01617148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169405|NCT01617148|Growth Inhibitors|growth inhibitors|mesh-ancestor
6169406|NCT01617148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6169407|NCT01617434|Liraglutide|liraglutide|mesh-list
6169408|NCT01617434|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6169409|NCT01617434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169410|NCT01617434|Incretins|incretins|mesh-ancestor
6169411|NCT01617434|Hormones|hormones|mesh-ancestor
6169412|NCT01617434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6169413|NCT01617447|Aripiprazole|aripiprazole|mesh-list
6169414|NCT01617447|Antidepressive Agents|antidepressive agents|mesh-ancestor
6169415|NCT01617447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6169416|NCT01617447|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6484615|NCT00562809|Irbesartan|irbesartan|mesh-list
6484616|NCT00562809|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6484617|NCT00562809|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6484618|NCT00562809|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6484619|NCT00562809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484620|NCT00562835|Thiamine|thiamine|mesh-list
6484621|NCT00562835|Methylprednisolone|methylprednisolone|mesh-list
6484622|NCT00562835|Vitamins|vitamins|mesh-ancestor
6484623|NCT00562835|Micronutrients|micronutrients|mesh-ancestor
6484624|NCT00562835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484625|NCT00562835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6484626|NCT00562835|Antiemetics|antiemetics|mesh-ancestor
6484627|NCT00562835|Autonomic Agents|autonomic agents|mesh-ancestor
6484628|NCT00562835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6484629|NCT00562835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6484630|NCT00562835|Glucocorticoids|glucocorticoids|mesh-ancestor
6484631|NCT00562835|Hormones|hormones|mesh-ancestor
6484632|NCT00562835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6484633|NCT00562835|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6484634|NCT00562835|Protective Agents|protective agents|mesh-ancestor
6484635|NCT00562835|Vitamin B Complex|vitamin b complex|mesh-ancestor
6484636|NCT00562913|Sorafenib|sorafenib|mesh-list
6484637|NCT00562913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5567169|NCT03960671|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5567170|NCT03960671|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5567171|NCT03960554|Denosumab|denosumab|mesh-list
6169417|NCT01617447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6169418|NCT01617447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6169419|NCT01617447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169420|NCT01617447|Dopamine Agonists|dopamine agonists|mesh-ancestor
6169421|NCT01617447|Dopamine Agents|dopamine agents|mesh-ancestor
6169422|NCT01617447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6169423|NCT01617447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6169424|NCT01617447|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6169425|NCT01617447|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6169426|NCT01617447|Serotonin Agents|serotonin agents|mesh-ancestor
6169427|NCT01617447|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5567172|NCT03960554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5567173|NCT03960554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567174|NCT03960268|Brodalumab|brodalumab|mesh-list
5567175|NCT03960268|Dermatologic Agents|dermatologic agents|mesh-ancestor
5567176|NCT03960411|Doxycycline|doxycycline|mesh-list
5567177|NCT03960411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6169428|NCT01617447|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6169429|NCT01617447|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6169430|NCT01617447|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6169431|NCT01617460|Aripiprazole|aripiprazole|mesh-list
6169432|NCT01617460|Antidepressive Agents|antidepressive agents|mesh-ancestor
6169433|NCT01617460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6169434|NCT01617460|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6169435|NCT01617460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6169436|NCT01617460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6169437|NCT01617460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169438|NCT01617460|Dopamine Agonists|dopamine agonists|mesh-ancestor
6169439|NCT01617460|Dopamine Agents|dopamine agents|mesh-ancestor
6169440|NCT01617460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6169441|NCT01617460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6169442|NCT01617460|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6484638|NCT00562913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6169443|NCT01617460|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6169444|NCT01617460|Serotonin Agents|serotonin agents|mesh-ancestor
6169445|NCT01617460|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6169446|NCT01617460|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6169447|NCT01617460|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6169448|NCT01617460|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6169449|NCT01617577|Lenograstim|lenograstim|mesh-list
6169450|NCT01617577|Sargramostim|sargramostim|mesh-list
6169451|NCT01617577|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6169452|NCT01617577|Immunologic Factors|immunologic factors|mesh-ancestor
6169453|NCT01617577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169454|NCT01617655|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6169455|NCT01617655|Immunologic Factors|immunologic factors|mesh-ancestor
6484639|NCT00562913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6484640|NCT00562913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484641|NCT00562939|Vaccines|vaccines|mesh-list
6484642|NCT00562939|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6484643|NCT00562939|Immunologic Factors|immunologic factors|mesh-ancestor
6484644|NCT00562939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484645|NCT00562952|Telmisartan|telmisartan|mesh-list
6484646|NCT00562952|Bisoprolol|bisoprolol|mesh-list
6169456|NCT01617655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567178|NCT03960411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5567179|NCT03960411|Antimalarials|antimalarials|mesh-ancestor
5567180|NCT03960411|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5567181|NCT03960411|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5567182|NCT03960151|Dexamethasone|dexamethasone|mesh-list
5567183|NCT03960151|Olanzapine|olanzapine|mesh-list
5567184|NCT03960151|Palonosetron|palonosetron|mesh-list
5567185|NCT03960151|Rolapitant|rolapitant|mesh-list
5567186|NCT03960151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5567187|NCT03960151|Antiemetics|antiemetics|mesh-ancestor
5567188|NCT03960151|Autonomic Agents|autonomic agents|mesh-ancestor
5567189|NCT03960151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5567190|NCT03960151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567191|NCT03960151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5567192|NCT03960151|Glucocorticoids|glucocorticoids|mesh-ancestor
5567193|NCT03960151|Hormones|hormones|mesh-ancestor
5567194|NCT03960151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5567195|NCT03960151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5567196|NCT03960151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5567197|NCT03960151|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5567198|NCT03960151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5567199|NCT03960151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5567200|NCT03960151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5567201|NCT03960151|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5567202|NCT03960151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5567203|NCT03960151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5567204|NCT03960151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5567205|NCT03960151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6169457|NCT01617668|Paclitaxel|paclitaxel|mesh-list
6169458|NCT01617668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6169459|NCT01617668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6169460|NCT01617668|Tubulin Modulators|tubulin modulators|mesh-ancestor
6169461|NCT01617668|Antimitotic Agents|antimitotic agents|mesh-ancestor
6169462|NCT01617668|Mitosis Modulators|mitosis modulators|mesh-ancestor
6484647|NCT00562952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5567206|NCT03960151|Serotonin Agents|serotonin agents|mesh-ancestor
5567207|NCT03960151|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5567208|NCT03960151|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5567209|NCT03960151|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5567210|NCT03960008|Doxorubicin|doxorubicin|mesh-list
5567211|NCT03960008|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5567212|NCT03960008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5567213|NCT03960008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5567214|NCT03960008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5567215|NCT03960008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5567216|NCT03960008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5567217|NCT03960008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5567218|NCT03960125|Imipramine|imipramine|mesh-list
5567219|NCT03960125|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5567220|NCT03960125|Antidepressive Agents|antidepressive agents|mesh-ancestor
5567221|NCT03960125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5567222|NCT03960125|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6206278|NCT02097849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169463|NCT01617668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6169464|NCT01617681|Valsartan|valsartan|mesh-list
6169465|NCT01617681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6169466|NCT01617681|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6207911|NCT02121418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6484648|NCT00562952|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6484649|NCT00562952|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6484650|NCT00562952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484651|NCT00562952|Sympatholytics|sympatholytics|mesh-ancestor
6484652|NCT00562952|Autonomic Agents|autonomic agents|mesh-ancestor
6484653|NCT00562952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6484654|NCT00562952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484655|NCT00562952|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6484656|NCT00562952|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6484657|NCT00562952|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6484658|NCT00562952|Adrenergic Agents|adrenergic agents|mesh-ancestor
6484659|NCT00562952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6484660|NCT00563017|Risperidone|risperidone|mesh-list
6484661|NCT00563017|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6484662|NCT00563017|Serotonin Agents|serotonin agents|mesh-ancestor
6484663|NCT00563017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6484664|NCT00563017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484665|NCT00563017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484666|NCT00563017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6484667|NCT00563017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6484668|NCT00563017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6484669|NCT00563017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6484670|NCT00563017|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5567223|NCT03960125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5567224|NCT03960125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5567225|NCT03960125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5567226|NCT03960125|Adrenergic Agents|adrenergic agents|mesh-ancestor
5567227|NCT03960125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5567228|NCT03960125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567229|NCT03959852|Fentanyl|fentanyl|mesh-list
5567230|NCT03959852|Ketamine|ketamine|mesh-list
5567231|NCT03959852|Analgesics|analgesics|mesh-ancestor
5567232|NCT03959852|Sensory System Agents|sensory system agents|mesh-ancestor
5567233|NCT03959852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5567234|NCT03959852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484671|NCT00563017|Dopamine Agents|dopamine agents|mesh-ancestor
6484672|NCT00563056|Fluticasone|fluticasone|mesh-list
6484673|NCT00563056|Formoterol Fumarate|formoterol fumarate|mesh-list
6484674|NCT00563056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6484675|NCT00563056|Autonomic Agents|autonomic agents|mesh-ancestor
6484676|NCT00563056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6484677|NCT00563056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484678|NCT00563056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6484679|NCT00563056|Respiratory System Agents|respiratory system agents|mesh-ancestor
6484680|NCT00563056|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6484681|NCT00563056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5567235|NCT03959852|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5567236|NCT03959852|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5567237|NCT03959852|Anesthetics, General|anesthetics, general|mesh-ancestor
5567238|NCT03959852|Anesthetics|anesthetics|mesh-ancestor
5567239|NCT03959852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5567240|NCT03959852|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5567241|NCT03959852|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5567242|NCT03959852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5567243|NCT03959852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5567244|NCT03959852|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5567245|NCT03959852|Narcotics|narcotics|mesh-ancestor
5567246|NCT03959852|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5567247|NCT03959761|Nivolumab|nivolumab|mesh-list
5567248|NCT03959761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5567249|NCT03959761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5567250|NCT03959761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5567251|NCT03959761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5567252|NCT03959969|Ibuprofen|ibuprofen|mesh-list
5567253|NCT03959969|Oxycodone|oxycodone|mesh-list
5567254|NCT03959969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5567255|NCT03959969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6484682|NCT00563056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6484683|NCT00563056|Adrenergic Agents|adrenergic agents|mesh-ancestor
6484684|NCT00563056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6484685|NCT00563056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5567256|NCT03959969|Analgesics|analgesics|mesh-ancestor
5567257|NCT03959969|Sensory System Agents|sensory system agents|mesh-ancestor
5567258|NCT03959969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5567259|NCT03959969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567260|NCT03959969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6484686|NCT00563056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6169467|NCT01617681|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6169468|NCT01617681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6169469|NCT01618162|Liraglutide|liraglutide|mesh-list
6169470|NCT01618162|Xultophy|xultophy|mesh-list
6169471|NCT01618162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6169472|NCT01618162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169473|NCT01618162|Incretins|incretins|mesh-ancestor
6169474|NCT01618162|Hormones|hormones|mesh-ancestor
6169475|NCT01618162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6169476|NCT01618214|Insulin Aspart|insulin aspart|mesh-list
6169477|NCT01618214|Biphasic Insulins|biphasic insulins|mesh-list
6169478|NCT01618214|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6169479|NCT01618214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6169480|NCT01618214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169481|NCT01618266|Dexamethasone|dexamethasone|mesh-list
6484687|NCT00563056|Dermatologic Agents|dermatologic agents|mesh-ancestor
6484688|NCT00563056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6484689|NCT00563069|Midazolam|midazolam|mesh-list
6484690|NCT00563069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6484691|NCT00563069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6669767|NCT01539603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6669768|NCT01539603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6669769|NCT01539603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6169482|NCT01618266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5567261|NCT03959969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5567262|NCT03959969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5567263|NCT03959969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5567264|NCT03959969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5567265|NCT03959969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5567266|NCT03959969|Narcotics|narcotics|mesh-ancestor
5567267|NCT03959969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5567268|NCT03959865|Glucagon|glucagon|mesh-list
5567269|NCT03959865|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5567270|NCT03959865|Incretins|incretins|mesh-ancestor
5567271|NCT03959865|Hormones|hormones|mesh-ancestor
5567272|NCT03959865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5567273|NCT03959865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567274|NCT03959865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5567275|NCT03959527|Azithromycin|azithromycin|mesh-list
5567276|NCT03959527|Ceftriaxone|ceftriaxone|mesh-list
6169483|NCT01618266|Antiemetics|antiemetics|mesh-ancestor
6169484|NCT01618266|Autonomic Agents|autonomic agents|mesh-ancestor
6169485|NCT01618266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6169486|NCT01618266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169487|NCT01618266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6169488|NCT01618266|Glucocorticoids|glucocorticoids|mesh-ancestor
6169489|NCT01618266|Hormones|hormones|mesh-ancestor
6169490|NCT01618266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6169491|NCT01618266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6169492|NCT01618266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6169493|NCT01618305|Lamivudine|lamivudine|mesh-list
6169494|NCT01618305|Zidovudine|zidovudine|mesh-list
6169495|NCT01618305|Efavirenz|efavirenz|mesh-list
6169496|NCT01618305|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6169497|NCT01618305|Raltegravir Potassium|raltegravir potassium|mesh-list
6484692|NCT00563069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6484693|NCT00563069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484694|NCT00563069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6484695|NCT00563069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6484696|NCT00563069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6484697|NCT00563069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6484698|NCT00563069|Anesthetics, General|anesthetics, general|mesh-ancestor
6484699|NCT00563069|Anesthetics|anesthetics|mesh-ancestor
6484700|NCT00563069|GABA Modulators|gaba modulators|mesh-ancestor
6484701|NCT00563069|GABA Agents|gaba agents|mesh-ancestor
6207912|NCT02121483|Empagliflozin|empagliflozin|mesh-list
6484702|NCT00563069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6484703|NCT00563069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484704|NCT00563095|Interferons|interferons|mesh-list
6484705|NCT00563095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6484706|NCT00563095|Antiviral Agents|antiviral agents|mesh-ancestor
6484707|NCT00563095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6484708|NCT00563108|Basiliximab|basiliximab|mesh-list
6484709|NCT00563108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6484710|NCT00563108|Immunologic Factors|immunologic factors|mesh-ancestor
6484711|NCT00563108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484712|NCT00563147|Sirolimus|sirolimus|mesh-list
6484713|NCT00563147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6484714|NCT00563147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6484715|NCT00563147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6484716|NCT00563147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6484717|NCT00563147|Antifungal Agents|antifungal agents|mesh-ancestor
6484718|NCT00563147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6484719|NCT00563147|Immunologic Factors|immunologic factors|mesh-ancestor
5567277|NCT03959527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6169498|NCT01618305|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6169499|NCT01618305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6169500|NCT01618305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6169501|NCT01618305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6169502|NCT01618305|Antiviral Agents|antiviral agents|mesh-ancestor
6169503|NCT01618305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6169504|NCT01618305|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6169505|NCT01618305|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6169506|NCT01618305|Antimetabolites|antimetabolites|mesh-ancestor
6169507|NCT01618305|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6169508|NCT01618305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6169509|NCT01618305|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6169510|NCT01618305|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6169511|NCT01618305|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6169512|NCT01618305|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5567278|NCT03959527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5567279|NCT03959436|Carbetocin|carbetocin|mesh-list
5567280|NCT03959436|Oxytocics|oxytocics|mesh-ancestor
5567281|NCT03959436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5567282|NCT03959436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567283|NCT03959306|Hypoglycemic Agents|hypoglycemic agents|mesh-list
5567284|NCT03959306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567285|NCT03959540|Levodopa|levodopa|mesh-list
5567286|NCT03959540|Opicapone|opicapone|mesh-list
5567287|NCT03959540|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5567288|NCT03959540|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5567289|NCT03959540|Dopamine Agents|dopamine agents|mesh-ancestor
5567290|NCT03959540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5567291|NCT03959540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6169513|NCT01618305|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6169514|NCT01618305|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6484720|NCT00563147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567292|NCT03959540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567293|NCT03959540|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
5567294|NCT03959540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5567295|NCT03959501|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5567296|NCT03959501|Dapagliflozin|dapagliflozin|mesh-list
5567297|NCT03959501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5567298|NCT03959501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567299|NCT03959501|Incretins|incretins|mesh-ancestor
5567300|NCT03959501|Hormones|hormones|mesh-ancestor
5567301|NCT03959501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5567302|NCT03959501|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5567303|NCT03959501|Protease Inhibitors|protease inhibitors|mesh-ancestor
5567304|NCT03959501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5567305|NCT03959501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5567306|NCT03959501|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5567307|NCT03959514|Insulin Aspart|insulin aspart|mesh-list
5567308|NCT03959514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5567309|NCT03959514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567310|NCT03959384|Poractant alfa|poractant alfa|mesh-list
5567311|NCT03959384|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
6484721|NCT00563160|Gemcitabine|gemcitabine|mesh-list
5567312|NCT03959384|Respiratory System Agents|respiratory system agents|mesh-ancestor
5567313|NCT03959293|Durvalumab|durvalumab|mesh-list
5567314|NCT03959293|Tremelimumab|tremelimumab|mesh-list
5567315|NCT03959293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5567316|NCT03959293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5567317|NCT03959397|Paclitaxel|paclitaxel|mesh-list
5567318|NCT03959397|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5567319|NCT03959397|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5567320|NCT03959397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5567321|NCT03959397|Tubulin Modulators|tubulin modulators|mesh-ancestor
5567322|NCT03959397|Antimitotic Agents|antimitotic agents|mesh-ancestor
5567323|NCT03959397|Mitosis Modulators|mitosis modulators|mesh-ancestor
6169515|NCT01618669|Regadenoson|regadenoson|mesh-list
6169516|NCT01618669|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
6169517|NCT01618669|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6169518|NCT01618669|Purinergic Agonists|purinergic agonists|mesh-ancestor
6169519|NCT01618669|Purinergic Agents|purinergic agents|mesh-ancestor
6169520|NCT01618669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6169521|NCT01618669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6169522|NCT01618669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169523|NCT01618708|Hylan|hylan|mesh-list
6169524|NCT01618708|Viscosupplements|viscosupplements|mesh-ancestor
6169525|NCT01618708|Protective Agents|protective agents|mesh-ancestor
6169526|NCT01618708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169527|NCT01619059|Metformin|metformin|mesh-list
6169528|NCT01619059|Dapagliflozin|dapagliflozin|mesh-list
6169529|NCT01619059|Saxagliptin|saxagliptin|mesh-list
5567324|NCT03959397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5567325|NCT03959592|Carotenoids|carotenoids|mesh-list
5567326|NCT03959592|Antioxidants|antioxidants|mesh-ancestor
5567327|NCT03959592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5567328|NCT03959592|Protective Agents|protective agents|mesh-ancestor
5567329|NCT03959592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567330|NCT03959176|Brimonidine Tartrate|brimonidine tartrate|mesh-list
5567331|NCT03959176|Phenylephrine|phenylephrine|mesh-list
5567332|NCT03959176|Oxymetazoline|oxymetazoline|mesh-list
6169530|NCT01619059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6169531|NCT01619059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169532|NCT01619059|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6169533|NCT01619059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6169534|NCT01619059|Incretins|incretins|mesh-ancestor
6169535|NCT01619059|Hormones|hormones|mesh-ancestor
6169536|NCT01619059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6169537|NCT01619059|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6169538|NCT01619059|Protease Inhibitors|protease inhibitors|mesh-ancestor
6169539|NCT01619059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6484722|NCT00563160|Carboplatin|carboplatin|mesh-list
6484723|NCT00563160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6484724|NCT00563160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5567333|NCT03959176|Tropicamide|tropicamide|mesh-list
5567334|NCT03959176|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5567335|NCT03959176|Mydriatics|mydriatics|mesh-ancestor
5567336|NCT03959176|Autonomic Agents|autonomic agents|mesh-ancestor
5567337|NCT03959176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5567338|NCT03959176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567339|NCT03959176|Sympathomimetics|sympathomimetics|mesh-ancestor
5567340|NCT03959176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5567341|NCT03959176|Nasal Decongestants|nasal decongestants|mesh-ancestor
5567342|NCT03959176|Respiratory System Agents|respiratory system agents|mesh-ancestor
5567343|NCT03959176|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5567344|NCT03959176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5567345|NCT03959176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5567346|NCT03959176|Adrenergic Agents|adrenergic agents|mesh-ancestor
5567347|NCT03959176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5567348|NCT03959176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5567349|NCT03959176|Protective Agents|protective agents|mesh-ancestor
5567350|NCT03959176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5567351|NCT03959176|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5567352|NCT03959176|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6484725|NCT00563160|Antimetabolites|antimetabolites|mesh-ancestor
6484726|NCT00563160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6169545|NCT01619410|Clindamycin|clindamycin|mesh-list
6484727|NCT00563160|Antiviral Agents|antiviral agents|mesh-ancestor
5567353|NCT03959176|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5567354|NCT03959176|Cholinergic Agents|cholinergic agents|mesh-ancestor
5567355|NCT03959150|Capecitabine|capecitabine|mesh-list
5567356|NCT03959150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5567357|NCT03959150|Antimetabolites|antimetabolites|mesh-ancestor
5567358|NCT03959150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5567359|NCT03959150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5567360|NCT03958942|Bupivacaine|bupivacaine|mesh-list
5567361|NCT03958942|Anesthetics, Local|anesthetics, local|mesh-ancestor
5567362|NCT03958942|Anesthetics|anesthetics|mesh-ancestor
5567363|NCT03958942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5567364|NCT03958942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567365|NCT03958942|Sensory System Agents|sensory system agents|mesh-ancestor
5567366|NCT03958942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5604012|NCT05179018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169546|NCT01619410|Clindamycin palmitate|clindamycin palmitate|mesh-list
6169547|NCT01619410|Clindamycin phosphate|clindamycin phosphate|mesh-list
6169548|NCT01619410|Linezolid|linezolid|mesh-list
6169549|NCT01619410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6169550|NCT01619410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6169551|NCT01619410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6169552|NCT01619410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6169553|NCT01619410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6169554|NCT01619423|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
6169555|NCT01619423|Edetic Acid|edetic acid|mesh-list
6169556|NCT01619423|Anticoagulants|anticoagulants|mesh-ancestor
6169557|NCT01619423|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6169558|NCT01619423|Chelating Agents|chelating agents|mesh-ancestor
6169559|NCT01619423|Sequestering Agents|sequestering agents|mesh-ancestor
6169560|NCT01619423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6169561|NCT01619423|Vitamin B Complex|vitamin b complex|mesh-ancestor
6169562|NCT01619423|Vitamins|vitamins|mesh-ancestor
6484728|NCT00563160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6484729|NCT00563160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6484730|NCT00563160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6484731|NCT00563160|Immunologic Factors|immunologic factors|mesh-ancestor
6484732|NCT00563160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484733|NCT00563212|Interferons|interferons|mesh-list
6169563|NCT01619423|Micronutrients|micronutrients|mesh-ancestor
6169564|NCT01619423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169565|NCT01619774|Trametinib|trametinib|mesh-list
6169566|NCT01619774|Dabrafenib|dabrafenib|mesh-list
6169567|NCT01619774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6169568|NCT01619774|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6169569|NCT01619774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6169570|NCT01619774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6169571|NCT01619852|Lidocaine|lidocaine|mesh-list
6169572|NCT01619852|Anesthetics, Local|anesthetics, local|mesh-ancestor
6169573|NCT01619852|Anesthetics|anesthetics|mesh-ancestor
6669770|NCT01539603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6669771|NCT01539603|Antifungal Agents|antifungal agents|mesh-ancestor
5604013|NCT05179005|Imidacloprid|imidacloprid|mesh-list
6169574|NCT01619852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6169575|NCT01619852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169576|NCT01619852|Sensory System Agents|sensory system agents|mesh-ancestor
6169577|NCT01619852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5604014|NCT05179005|Cholinergic Agents|cholinergic agents|mesh-ancestor
5604015|NCT05179005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5604016|NCT05179005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604017|NCT05179005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604018|NCT05178953|Zinc|zinc|mesh-list
5604019|NCT05178953|Pentoxifylline|pentoxifylline|mesh-list
5604020|NCT05178953|Zinc Sulfate|zinc sulfate|mesh-list
5604021|NCT05178953|Trace Elements|trace elements|mesh-ancestor
5604022|NCT05178953|Micronutrients|micronutrients|mesh-ancestor
5604023|NCT05178953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604024|NCT05178953|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5604025|NCT05178953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5604026|NCT05178953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604027|NCT05178953|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5604028|NCT05178953|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6169578|NCT01619852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6169579|NCT01619852|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6169580|NCT01619852|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6169581|NCT01619852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6169582|NCT01619852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6169583|NCT01619865|Edotreotide|edotreotide|mesh-list
6169584|NCT01619865|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6169585|NCT01619865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6169586|NCT01619878|Lumefantrine|lumefantrine|mesh-list
6169587|NCT01619878|Artemether|artemether|mesh-list
6169588|NCT01619878|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6169589|NCT01619878|Antimalarials|antimalarials|mesh-ancestor
6169590|NCT01619878|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6169591|NCT01619878|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5567367|NCT03959124|Memantine|memantine|mesh-list
5567368|NCT03959124|Rivastigmine|rivastigmine|mesh-list
5567369|NCT03959124|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5567370|NCT03959124|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5567371|NCT03959124|Dopamine Agents|dopamine agents|mesh-ancestor
5567372|NCT03959124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5567373|NCT03959124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5567374|NCT03959124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567375|NCT03959124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5567376|NCT03959124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5567377|NCT03959124|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5567378|NCT03959124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5567379|NCT03959124|Cholinergic Agents|cholinergic agents|mesh-ancestor
5567380|NCT03959124|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6169592|NCT01619878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6169593|NCT01619982|Vancomycin|vancomycin|mesh-list
6169594|NCT01619982|Cefazolin|cefazolin|mesh-list
6169595|NCT01619982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6169596|NCT01619982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6169597|NCT01620047|Fentanyl|fentanyl|mesh-list
6169598|NCT01620047|Ropivacaine|ropivacaine|mesh-list
6169599|NCT01620047|Anesthetics, Local|anesthetics, local|mesh-ancestor
6169600|NCT01620047|Anesthetics|anesthetics|mesh-ancestor
5567381|NCT03959124|Protective Agents|protective agents|mesh-ancestor
5567382|NCT03958799|Vaccines|vaccines|mesh-list
5567383|NCT03958799|Immunologic Factors|immunologic factors|mesh-ancestor
5567384|NCT03958799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567385|NCT03958877|Interferons|interferons|mesh-list
5567386|NCT03958877|Interferon-beta|interferon-beta|mesh-list
5567387|NCT03958877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5567388|NCT03958877|Antiviral Agents|antiviral agents|mesh-ancestor
5567389|NCT03958877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5567390|NCT03958877|Immunologic Factors|immunologic factors|mesh-ancestor
6169601|NCT01620047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6169602|NCT01620047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169603|NCT01620047|Sensory System Agents|sensory system agents|mesh-ancestor
5567391|NCT03958877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567392|NCT03958721|Capecitabine|capecitabine|mesh-list
5567393|NCT03958721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5567394|NCT03958721|Antimetabolites|antimetabolites|mesh-ancestor
5567395|NCT03958721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5567396|NCT03958721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5567397|NCT03958708|Rifaximin|rifaximin|mesh-list
5567398|NCT03958708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5567399|NCT03958708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5567400|NCT03958708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5567401|NCT03958513|Bupivacaine|bupivacaine|mesh-list
5567402|NCT03958513|Anesthetics, Local|anesthetics, local|mesh-ancestor
5567403|NCT03958513|Anesthetics|anesthetics|mesh-ancestor
5567404|NCT03958513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5567405|NCT03958513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169604|NCT01620047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6169605|NCT01620047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6169606|NCT01620047|Narcotics|narcotics|mesh-ancestor
6169607|NCT01620047|Analgesics|analgesics|mesh-ancestor
6169608|NCT01620047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6169609|NCT01620047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6169610|NCT01620047|Anesthetics, General|anesthetics, general|mesh-ancestor
6169611|NCT01620060|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
6169612|NCT01620060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6169613|NCT01620060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6169614|NCT01620060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6169615|NCT01620060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169616|NCT01620060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6169617|NCT01620060|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5567406|NCT03958513|Sensory System Agents|sensory system agents|mesh-ancestor
6169618|NCT01620060|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6169619|NCT01620060|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6169620|NCT01620060|Adrenergic Agents|adrenergic agents|mesh-ancestor
6169621|NCT01620060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6169622|NCT01620060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6169623|NCT01620060|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6669772|NCT01539603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6669773|NCT01539603|Immunologic Factors|immunologic factors|mesh-ancestor
6669774|NCT01539603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669775|NCT01539616|Fenofibrate|fenofibrate|mesh-list
6669776|NCT01539616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6669777|NCT01539616|Antimetabolites|antimetabolites|mesh-ancestor
6669778|NCT01539616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669779|NCT01539616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6669780|NCT01539655|Omeprazole|omeprazole|mesh-list
6669781|NCT01539655|Ranitidine|ranitidine|mesh-list
6169624|NCT01620060|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6169625|NCT01620060|Serotonin Agents|serotonin agents|mesh-ancestor
5567407|NCT03958513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6669782|NCT01539655|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
6669783|NCT01539655|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5567408|NCT03958461|Anti-Infective Agents|anti-infective agents|mesh-list
6169626|NCT01620060|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6169627|NCT01620060|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6169628|NCT01620060|Dopamine Agents|dopamine agents|mesh-ancestor
6169629|NCT01620138|Cabergoline|cabergoline|mesh-list
6169630|NCT01620138|Pasireotide|pasireotide|mesh-list
6169631|NCT01620138|Hormones|hormones|mesh-ancestor
6169632|NCT01620138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5567409|NCT03958500|Methylene Blue|methylene blue|mesh-list
5567410|NCT03958500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5567411|NCT03958500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5567412|NCT03958344|Prednisolone|prednisolone|mesh-list
5567413|NCT03958344|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5567414|NCT03958344|Methylprednisolone|methylprednisolone|mesh-list
5567415|NCT03958344|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5567416|NCT03958344|Prednisolone acetate|prednisolone acetate|mesh-list
5567417|NCT03958344|Triamcinolone|triamcinolone|mesh-list
5567418|NCT03958344|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5567419|NCT03958344|Prednisolone phosphate|prednisolone phosphate|mesh-list
5567420|NCT03958344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5567421|NCT03958344|Glucocorticoids|glucocorticoids|mesh-ancestor
5567422|NCT03958344|Hormones|hormones|mesh-ancestor
5567423|NCT03958344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5567424|NCT03958344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567425|NCT03958344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5567426|NCT03958344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5567427|NCT03958344|Antiemetics|antiemetics|mesh-ancestor
6169633|NCT01620138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169634|NCT01620138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6169635|NCT01620138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6169636|NCT01620138|Dopamine Agonists|dopamine agonists|mesh-ancestor
6169637|NCT01620138|Dopamine Agents|dopamine agents|mesh-ancestor
6169638|NCT01620138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6169639|NCT01620138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6169640|NCT01620177|Ethanol|ethanol|mesh-list
6169641|NCT01620177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6169642|NCT01620177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6169643|NCT01620177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6169644|NCT01620177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169645|NCT01620190|Paclitaxel|paclitaxel|mesh-list
6169646|NCT01620190|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6169647|NCT01620190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6169648|NCT01620190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6169649|NCT01620190|Tubulin Modulators|tubulin modulators|mesh-ancestor
6169650|NCT01620190|Antimitotic Agents|antimitotic agents|mesh-ancestor
6169651|NCT01620190|Mitosis Modulators|mitosis modulators|mesh-ancestor
6169652|NCT01620190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6169653|NCT01620216|Sorafenib|sorafenib|mesh-list
6169654|NCT01620216|Sunitinib|sunitinib|mesh-list
6169655|NCT01620216|Dasatinib|dasatinib|mesh-list
6169656|NCT01620216|Ponatinib|ponatinib|mesh-list
6169657|NCT01620216|Idelalisib|idelalisib|mesh-list
6169658|NCT01620216|Antineoplastic Agents|antineoplastic agents|mesh-list
6169659|NCT01620216|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
6669784|NCT01539655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6669785|NCT01539655|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6669786|NCT01539655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6169660|NCT01620216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6169661|NCT01620216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6169662|NCT01620216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6169663|NCT01620216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6169664|NCT01620216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6169665|NCT01620216|Growth Substances|growth substances|mesh-ancestor
6169666|NCT01620216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169667|NCT01620216|Growth Inhibitors|growth inhibitors|mesh-ancestor
6169668|NCT01620489|Liraglutide|liraglutide|mesh-list
6169669|NCT01620489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6169670|NCT01620489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484734|NCT00563212|Interferon-gamma|interferon-gamma|mesh-list
6484735|NCT00563212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6484736|NCT00563212|Antiviral Agents|antiviral agents|mesh-ancestor
6484737|NCT00563212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6484738|NCT00563225|Insulin Glargine|insulin glargine|mesh-list
6669787|NCT01539655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669788|NCT01539655|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6669789|NCT01539655|Histamine Antagonists|histamine antagonists|mesh-ancestor
6169671|NCT01620489|Incretins|incretins|mesh-ancestor
6169672|NCT01620489|Hormones|hormones|mesh-ancestor
6169673|NCT01620489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6169674|NCT01620593|Metformin|metformin|mesh-list
6169675|NCT01620593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6169676|NCT01620593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169677|NCT01621009|Bupropion|bupropion|mesh-list
6169678|NCT01621009|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6169679|NCT01621009|Antidepressive Agents|antidepressive agents|mesh-ancestor
6169680|NCT01621009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6169681|NCT01621009|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6169682|NCT01621009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6169683|NCT01621009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6169684|NCT01621009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6169685|NCT01621009|Dopamine Agents|dopamine agents|mesh-ancestor
6169686|NCT01621009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6169687|NCT01621009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169688|NCT01621009|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6169689|NCT01621009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6169690|NCT01621009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6169691|NCT01621178|Insulin|insulin|mesh-list
6169692|NCT01621178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6169693|NCT01621178|Insulin Glargine|insulin glargine|mesh-list
6169694|NCT01621178|Insulin Lispro|insulin lispro|mesh-list
6169695|NCT01621178|Dulaglutide|dulaglutide|mesh-list
6169696|NCT01621178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6169697|NCT01621178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169698|NCT01621191|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6169699|NCT01621191|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6169700|NCT01621191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6169701|NCT01621191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6169702|NCT01621191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6169703|NCT01621191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6169704|NCT01621191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169705|NCT01621191|Analgesics|analgesics|mesh-ancestor
6169706|NCT01621191|Sensory System Agents|sensory system agents|mesh-ancestor
6169707|NCT01621191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6169708|NCT01621191|Antidepressive Agents|antidepressive agents|mesh-ancestor
6169709|NCT01621191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6169710|NCT01621191|Dopamine Agents|dopamine agents|mesh-ancestor
6484739|NCT00563225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6484740|NCT00563225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484741|NCT00563238|Metoprolol|metoprolol|mesh-list
6169711|NCT01621230|Fentanyl|fentanyl|mesh-list
6169712|NCT01621230|Bupivacaine|bupivacaine|mesh-list
6484742|NCT00563238|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6484743|NCT00563238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6484744|NCT00563238|Sympatholytics|sympatholytics|mesh-ancestor
6484745|NCT00563238|Autonomic Agents|autonomic agents|mesh-ancestor
6484746|NCT00563238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6484747|NCT00563238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484748|NCT00563238|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6484749|NCT00563238|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6484750|NCT00563238|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6669790|NCT01539655|Histamine Agents|histamine agents|mesh-ancestor
6169713|NCT01621230|Anesthetics, Local|anesthetics, local|mesh-ancestor
6169714|NCT01621230|Anesthetics|anesthetics|mesh-ancestor
6169715|NCT01621230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6169716|NCT01621230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169717|NCT01621230|Sensory System Agents|sensory system agents|mesh-ancestor
6169718|NCT01621230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6169719|NCT01621230|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6169720|NCT01621230|Narcotics|narcotics|mesh-ancestor
6169721|NCT01621230|Analgesics|analgesics|mesh-ancestor
6169722|NCT01621230|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6169723|NCT01621230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6169724|NCT01621230|Anesthetics, General|anesthetics, general|mesh-ancestor
6169725|NCT01621477|Cytarabine|cytarabine|mesh-list
6169726|NCT01621477|Plerixafor|plerixafor|mesh-list
6169727|NCT01621477|Mycophenolic Acid|mycophenolic acid|mesh-list
6169728|NCT01621477|Cyclophosphamide|cyclophosphamide|mesh-list
6169729|NCT01621477|Busulfan|busulfan|mesh-list
6169730|NCT01621477|Clofarabine|clofarabine|mesh-list
6169731|NCT01621477|Tacrolimus|tacrolimus|mesh-list
6169732|NCT01621477|Thymoglobulin|thymoglobulin|mesh-list
6169733|NCT01621477|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6169734|NCT01621477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6169735|NCT01621477|Immunologic Factors|immunologic factors|mesh-ancestor
6484751|NCT00563238|Adrenergic Agents|adrenergic agents|mesh-ancestor
6484752|NCT00563238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6484753|NCT00563238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484754|NCT00563251|Azithromycin|azithromycin|mesh-list
6169736|NCT01621477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169737|NCT01621477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6169738|NCT01621477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6169739|NCT01621477|Alkylating Agents|alkylating agents|mesh-ancestor
6169740|NCT01621477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6169741|NCT01621477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6169742|NCT01621477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6169743|NCT01621477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6169744|NCT01621477|Antimetabolites|antimetabolites|mesh-ancestor
6169745|NCT01621477|Antiviral Agents|antiviral agents|mesh-ancestor
6169746|NCT01621477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6169747|NCT01621477|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6169748|NCT01621477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6169749|NCT01621477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6169750|NCT01621477|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6169751|NCT01621477|Antitubercular Agents|antitubercular agents|mesh-ancestor
6169752|NCT01621477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6169753|NCT01621477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6169754|NCT01621477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6206279|NCT02097849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6206280|NCT02097849|Antiviral Agents|antiviral agents|mesh-ancestor
6206281|NCT02097849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6206282|NCT02097849|Dermatologic Agents|dermatologic agents|mesh-ancestor
6206283|NCT02097849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6206284|NCT02098109|Plerixafor|plerixafor|mesh-list
6206285|NCT02098109|Lenograstim|lenograstim|mesh-list
6206286|NCT02098109|Sargramostim|sargramostim|mesh-list
6206287|NCT02098109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6206288|NCT02098109|Immunologic Factors|immunologic factors|mesh-ancestor
6206289|NCT02098109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484755|NCT00563251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6484756|NCT00563251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6484757|NCT00563303|Hydrocortisone|hydrocortisone|mesh-list
6484758|NCT00563303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6484759|NCT00563342|Ethanol|ethanol|mesh-list
6484760|NCT00563342|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6484761|NCT00563342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6484762|NCT00563342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6484763|NCT00563342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484764|NCT00563355|Epoetin Alfa|epoetin alfa|mesh-list
6484765|NCT00563355|Hematinics|hematinics|mesh-ancestor
6484766|NCT00563394|Ofloxacin|ofloxacin|mesh-list
6484767|NCT00563394|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6484768|NCT00563394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6484769|NCT00563394|Renal Agents|renal agents|mesh-ancestor
6484770|NCT00563394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6484771|NCT00563394|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6484772|NCT00563394|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6484773|NCT00563394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6206290|NCT02098109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6206291|NCT02098109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6206292|NCT02098109|Antiviral Agents|antiviral agents|mesh-ancestor
6484774|NCT00563394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484775|NCT00563394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6484776|NCT00563394|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6484777|NCT00563394|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6484778|NCT00563433|Ofloxacin|ofloxacin|mesh-list
6484779|NCT00563433|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6484780|NCT00563433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6484781|NCT00563433|Renal Agents|renal agents|mesh-ancestor
6484782|NCT00563433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6484783|NCT00563433|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6484784|NCT00563433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6484785|NCT00563433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6484786|NCT00563433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5567428|NCT03958344|Autonomic Agents|autonomic agents|mesh-ancestor
5567429|NCT03958344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5567430|NCT03958344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5567431|NCT03958344|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5567432|NCT03958344|Protective Agents|protective agents|mesh-ancestor
5567433|NCT03958201|Rocuronium|rocuronium|mesh-list
5567434|NCT03958201|Neostigmine|neostigmine|mesh-list
5567435|NCT03958201|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5567436|NCT03958201|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5567437|NCT03958201|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5567438|NCT03958201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5567439|NCT03958201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567440|NCT03958201|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5567441|NCT03958201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5567442|NCT03958201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5567443|NCT03958201|Cholinergic Agents|cholinergic agents|mesh-ancestor
5567444|NCT03958201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5567445|NCT03958201|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5567446|NCT03958201|Autonomic Agents|autonomic agents|mesh-ancestor
5567447|NCT03958123|Moxifloxacin|moxifloxacin|mesh-list
5567448|NCT03958123|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
5567449|NCT03958123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5567450|NCT03958123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5567451|NCT03958123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5567452|NCT03958123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5567453|NCT03958123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5567454|NCT03958123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5567455|NCT03958123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5567456|NCT03958123|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5567457|NCT03958123|Contraceptive Agents|contraceptive agents|mesh-ancestor
5567458|NCT03958123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5567459|NCT03958123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567460|NCT03958123|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5567461|NCT03958123|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5567462|NCT03958123|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5567463|NCT03958058|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6484787|NCT00563433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6484788|NCT00563433|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6484789|NCT00563433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6484790|NCT00563446|Darbepoetin alfa|darbepoetin alfa|mesh-list
6484791|NCT00563446|Hematinics|hematinics|mesh-ancestor
6484792|NCT00563472|Desogestrel|desogestrel|mesh-list
6484793|NCT00563472|Progesterone|progesterone|mesh-list
6484794|NCT00563472|Progestins|progestins|mesh-ancestor
6484795|NCT00563472|Hormones|hormones|mesh-ancestor
6484796|NCT00563472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6484797|NCT00563472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484798|NCT00563472|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6484799|NCT00563472|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6484800|NCT00563472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6484801|NCT00563472|Contraceptive Agents|contraceptive agents|mesh-ancestor
6484802|NCT00563472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6484803|NCT00563472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6484804|NCT00563472|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6484805|NCT00563485|Doxazosin|doxazosin|mesh-list
6484806|NCT00563485|Terazosin|terazosin|mesh-list
6484807|NCT00563485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6484808|NCT00563485|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5567464|NCT03958058|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6484809|NCT00563485|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6484810|NCT00563485|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6484811|NCT00563485|Adrenergic Agents|adrenergic agents|mesh-ancestor
6484812|NCT00563485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6484813|NCT00563485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484814|NCT00563485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484815|NCT00563485|Urological Agents|urological agents|mesh-ancestor
6484816|NCT00563524|Fezakinumab|fezakinumab|mesh-list
5567465|NCT03958058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5567466|NCT03958058|Antitubercular Agents|antitubercular agents|mesh-ancestor
5567467|NCT03958396|Remifentanil|remifentanil|mesh-list
5567468|NCT03958396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5567469|NCT03958396|Narcotics|narcotics|mesh-ancestor
5567470|NCT03958396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5567471|NCT03958396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567472|NCT03958396|Analgesics|analgesics|mesh-ancestor
5567473|NCT03958396|Sensory System Agents|sensory system agents|mesh-ancestor
5567474|NCT03958396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5567475|NCT03958097|Antibodies|antibodies|mesh-list
5567476|NCT03958097|Immunologic Factors|immunologic factors|mesh-ancestor
5567477|NCT03958097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567478|NCT03957902|Aspirin|aspirin|mesh-list
5567479|NCT03957902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5567480|NCT03957902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5567481|NCT03957902|Analgesics|analgesics|mesh-ancestor
5567482|NCT03957902|Sensory System Agents|sensory system agents|mesh-ancestor
5567483|NCT03957902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5567484|NCT03957902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567485|NCT03957902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5567486|NCT03957902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6484817|NCT00563524|Dermatologic Agents|dermatologic agents|mesh-ancestor
6484818|NCT00563589|Cyclosporine|cyclosporine|mesh-list
6484819|NCT00563589|Mycophenolic Acid|mycophenolic acid|mesh-list
6484820|NCT00563589|Methotrexate|methotrexate|mesh-list
6669791|NCT01539655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6669792|NCT01539655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669793|NCT01539681|Sorafenib|sorafenib|mesh-list
6669794|NCT01539681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6669795|NCT01539681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6669796|NCT01539681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6669797|NCT01539681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5567487|NCT03957902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6169755|NCT01621490|Nivolumab|nivolumab|mesh-list
6169756|NCT01621490|Ipilimumab|ipilimumab|mesh-list
5567488|NCT03957902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5567489|NCT03957902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5567490|NCT03957902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5567491|NCT03957902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5567492|NCT03957902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5567493|NCT03957902|Antipyretics|antipyretics|mesh-ancestor
5567494|NCT03958045|Nivolumab|nivolumab|mesh-list
5567495|NCT03958045|Rucaparib|rucaparib|mesh-list
5567496|NCT03958045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5567497|NCT03958045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5567498|NCT03958045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5567499|NCT03958045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5567500|NCT03958045|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5567501|NCT03958045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5567502|NCT03957720|Penicillamine|penicillamine|mesh-list
5567503|NCT03957720|Succimer|succimer|mesh-list
5567504|NCT03957720|Antidotes|antidotes|mesh-ancestor
5567505|NCT03957720|Protective Agents|protective agents|mesh-ancestor
5567506|NCT03957720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567507|NCT03957720|Chelating Agents|chelating agents|mesh-ancestor
5567508|NCT03957720|Sequestering Agents|sequestering agents|mesh-ancestor
5567509|NCT03957720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5567510|NCT03957720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5567511|NCT03957876|Cytarabine|cytarabine|mesh-list
5567512|NCT03957876|Daunorubicin|daunorubicin|mesh-list
5567513|NCT03957876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5567514|NCT03957876|Antimetabolites|antimetabolites|mesh-ancestor
6169757|NCT01621490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6169758|NCT01621490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6169759|NCT01621490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6669798|NCT01539707|Solifenacin Succinate|solifenacin succinate|mesh-list
5567515|NCT03957876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484821|NCT00563589|Cyclosporins|cyclosporins|mesh-list
6169760|NCT01621490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6169761|NCT01621633|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
6169762|NCT01621633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6169763|NCT01621633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6169764|NCT01621672|Lenalidomide|lenalidomide|mesh-list
6169765|NCT01621672|Immunologic Factors|immunologic factors|mesh-ancestor
6169766|NCT01621672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169767|NCT01621672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6169768|NCT01621672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6169769|NCT01621672|Growth Substances|growth substances|mesh-ancestor
6169770|NCT01621672|Growth Inhibitors|growth inhibitors|mesh-ancestor
6169771|NCT01621672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6169772|NCT01621776|Insulin|insulin|mesh-list
6169773|NCT01621776|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6169774|NCT01621776|Insulin Aspart|insulin aspart|mesh-list
6169775|NCT01621776|Insulin Lispro|insulin lispro|mesh-list
6484822|NCT00563589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6484823|NCT00563589|Abortifacient Agents|abortifacient agents|mesh-ancestor
6484824|NCT00563589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6484825|NCT00563589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484826|NCT00563589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6484827|NCT00563589|Antimetabolites|antimetabolites|mesh-ancestor
6484828|NCT00563589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484829|NCT00563589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6484830|NCT00563589|Dermatologic Agents|dermatologic agents|mesh-ancestor
6484831|NCT00563589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6484832|NCT00563589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6484833|NCT00563589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6484834|NCT00563589|Immunologic Factors|immunologic factors|mesh-ancestor
6484835|NCT00563589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6484836|NCT00563589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6484837|NCT00563589|Antifungal Agents|antifungal agents|mesh-ancestor
6484838|NCT00563589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6484839|NCT00563589|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6484840|NCT00563589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6484841|NCT00563589|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6484842|NCT00563589|Antitubercular Agents|antitubercular agents|mesh-ancestor
6484843|NCT00563589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6484844|NCT00563615|Tegaserod|tegaserod|mesh-list
6484845|NCT00563615|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6484846|NCT00563615|Serotonin Agents|serotonin agents|mesh-ancestor
6484847|NCT00563615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5567516|NCT03957876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5567517|NCT03957876|Antiviral Agents|antiviral agents|mesh-ancestor
5567518|NCT03957876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5567519|NCT03957876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5567520|NCT03957876|Immunologic Factors|immunologic factors|mesh-ancestor
5567521|NCT03957876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567522|NCT03957876|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5567523|NCT03957876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5567524|NCT03957876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5567525|NCT03957876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6169776|NCT01621776|Insulin glulisine|insulin glulisine|mesh-list
6169777|NCT01621776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6169778|NCT01621776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169779|NCT01621880|Methylprednisolone|methylprednisolone|mesh-list
6169780|NCT01621880|Bevacizumab|bevacizumab|mesh-list
6169781|NCT01621880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6169782|NCT01621880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6169783|NCT01621880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6169784|NCT01621880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6169785|NCT01621880|Growth Substances|growth substances|mesh-ancestor
6169786|NCT01621880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567526|NCT03957681|Brodalumab|brodalumab|mesh-list
5567527|NCT03957681|Dermatologic Agents|dermatologic agents|mesh-ancestor
5567528|NCT03957668|Lactulose|lactulose|mesh-list
5567529|NCT03957668|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
5567530|NCT03957668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5567531|NCT03957668|Laxatives|laxatives|mesh-ancestor
5567532|NCT03957499|Dexamethasone|dexamethasone|mesh-list
5567533|NCT03957499|Magnesium Sulfate|magnesium sulfate|mesh-list
5567534|NCT03957499|Bupivacaine|bupivacaine|mesh-list
5567535|NCT03957499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6169787|NCT01621880|Growth Inhibitors|growth inhibitors|mesh-ancestor
6169788|NCT01621880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6169789|NCT01621880|Antiemetics|antiemetics|mesh-ancestor
6169790|NCT01621880|Autonomic Agents|autonomic agents|mesh-ancestor
6169791|NCT01621880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6169792|NCT01621880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6169793|NCT01621880|Glucocorticoids|glucocorticoids|mesh-ancestor
6169794|NCT01621880|Hormones|hormones|mesh-ancestor
6169795|NCT01621880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6169796|NCT01621880|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6669799|NCT01539707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6669800|NCT01539707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6169797|NCT01621880|Protective Agents|protective agents|mesh-ancestor
6169798|NCT01622231|Fluticasone|fluticasone|mesh-list
6169799|NCT01622231|Xhance|xhance|mesh-list
6169800|NCT01622231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6169801|NCT01622231|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6169802|NCT01622231|Autonomic Agents|autonomic agents|mesh-ancestor
6169803|NCT01622231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6169804|NCT01622231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169805|NCT01622231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6169806|NCT01622231|Respiratory System Agents|respiratory system agents|mesh-ancestor
6169807|NCT01622231|Dermatologic Agents|dermatologic agents|mesh-ancestor
6169808|NCT01622231|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6169809|NCT01622257|Metformin|metformin|mesh-list
6169810|NCT01622257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6169811|NCT01622257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484848|NCT00563615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484849|NCT00563615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484850|NCT00563641|Pulmonary Surfactants|pulmonary surfactants|mesh-list
6484851|NCT00563641|Respiratory System Agents|respiratory system agents|mesh-ancestor
6484852|NCT00563654|Alfuzosin|alfuzosin|mesh-list
6169812|NCT01622296|Lidocaine|lidocaine|mesh-list
6169813|NCT01622296|Epinephrine|epinephrine|mesh-list
6169814|NCT01622296|Anesthetics, Local|anesthetics, local|mesh-list
6169815|NCT01622296|Anesthetics|anesthetics|mesh-list
6169816|NCT01622296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6169817|NCT01622296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169818|NCT01622296|Sensory System Agents|sensory system agents|mesh-ancestor
6169819|NCT01622296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6169820|NCT01622296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6169821|NCT01622296|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6169822|NCT01622296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6169823|NCT01622296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6169824|NCT01622296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6169825|NCT01622296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6169826|NCT01622296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6169827|NCT01622296|Adrenergic Agents|adrenergic agents|mesh-ancestor
6169828|NCT01622296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6169829|NCT01622296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6169830|NCT01622296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6169831|NCT01622296|Autonomic Agents|autonomic agents|mesh-ancestor
6169832|NCT01622296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6169833|NCT01622296|Respiratory System Agents|respiratory system agents|mesh-ancestor
6169834|NCT01622296|Mydriatics|mydriatics|mesh-ancestor
6169835|NCT01622296|Sympathomimetics|sympathomimetics|mesh-ancestor
6169836|NCT01622296|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6169837|NCT01622543|Leucovorin|leucovorin|mesh-list
5567536|NCT03957499|Antiemetics|antiemetics|mesh-ancestor
5567537|NCT03957499|Autonomic Agents|autonomic agents|mesh-ancestor
5567538|NCT03957499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6169838|NCT01622543|Bevacizumab|bevacizumab|mesh-list
6169839|NCT01622543|Fluorouracil|fluorouracil|mesh-list
6169840|NCT01622543|Oxaliplatin|oxaliplatin|mesh-list
6484853|NCT00563654|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6484854|NCT00563654|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6484855|NCT00563654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6484856|NCT00563654|Adrenergic Agents|adrenergic agents|mesh-ancestor
6169841|NCT01622543|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6169842|NCT01622543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6169843|NCT01622543|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6169844|NCT01622543|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6169845|NCT01622543|Growth Substances|growth substances|mesh-ancestor
6169846|NCT01622543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169847|NCT01622543|Growth Inhibitors|growth inhibitors|mesh-ancestor
6169848|NCT01622543|Antimetabolites|antimetabolites|mesh-ancestor
6169849|NCT01622543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6169850|NCT01622543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6169851|NCT01622543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6169852|NCT01622543|Immunologic Factors|immunologic factors|mesh-ancestor
6169853|NCT01622543|Antidotes|antidotes|mesh-ancestor
6169854|NCT01622543|Protective Agents|protective agents|mesh-ancestor
6169855|NCT01622543|Vitamin B Complex|vitamin b complex|mesh-ancestor
6169856|NCT01622543|Vitamins|vitamins|mesh-ancestor
6169857|NCT01622543|Micronutrients|micronutrients|mesh-ancestor
6169858|NCT01622569|Fluticasone|fluticasone|mesh-list
6169859|NCT01622569|Xhance|xhance|mesh-list
6169860|NCT01622569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6169861|NCT01622569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6169862|NCT01622569|Autonomic Agents|autonomic agents|mesh-ancestor
6169863|NCT01622569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6169864|NCT01622569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169865|NCT01622569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5567539|NCT03957499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567540|NCT03957499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5567541|NCT03957499|Glucocorticoids|glucocorticoids|mesh-ancestor
5567542|NCT03957499|Hormones|hormones|mesh-ancestor
5567543|NCT03957499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5567544|NCT03957499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5567545|NCT03957499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5567546|NCT03957499|Anesthetics, Local|anesthetics, local|mesh-ancestor
6169866|NCT01622569|Respiratory System Agents|respiratory system agents|mesh-ancestor
6169867|NCT01622569|Dermatologic Agents|dermatologic agents|mesh-ancestor
6169868|NCT01622569|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6169869|NCT01622660|Gemcitabine|gemcitabine|mesh-list
6169870|NCT01622660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5567547|NCT03957499|Anesthetics|anesthetics|mesh-ancestor
5567548|NCT03957499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5567549|NCT03957499|Sensory System Agents|sensory system agents|mesh-ancestor
5567550|NCT03957499|Analgesics|analgesics|mesh-ancestor
6169871|NCT01622660|Antimetabolites|antimetabolites|mesh-ancestor
6169872|NCT01622660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6169873|NCT01622660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6169874|NCT01622660|Antiviral Agents|antiviral agents|mesh-ancestor
6169875|NCT01622660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6169876|NCT01622660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6169877|NCT01622660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6169878|NCT01622660|Immunologic Factors|immunologic factors|mesh-ancestor
6169879|NCT01622660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169880|NCT01622673|Raltegravir Potassium|raltegravir potassium|mesh-list
6169881|NCT01622673|Calcium Carbonate|calcium carbonate|mesh-list
6169882|NCT01622673|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6169883|NCT01622673|Antacids|antacids|mesh-list
6169884|NCT01622673|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
6169885|NCT01622673|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
6169886|NCT01622673|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
6169887|NCT01622673|TEMPO|tempo|mesh-list
6169888|NCT01622673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169889|NCT01622673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6169890|NCT01622673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6169891|NCT01622673|Antiviral Agents|antiviral agents|mesh-ancestor
6169892|NCT01622673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6169893|NCT01622673|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6169894|NCT01622673|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5567551|NCT03957499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5567552|NCT03957499|Anticonvulsants|anticonvulsants|mesh-ancestor
5567553|NCT03957499|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5567554|NCT03957499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5567555|NCT03957499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5567556|NCT03957499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6169895|NCT01622673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6169896|NCT01622673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6169897|NCT01622673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6169898|NCT01622673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6169899|NCT01622673|Immunologic Factors|immunologic factors|mesh-ancestor
6169900|NCT01622673|Antioxidants|antioxidants|mesh-ancestor
6169901|NCT01622673|Protective Agents|protective agents|mesh-ancestor
6169902|NCT01623115|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6169903|NCT01623115|Immunologic Factors|immunologic factors|mesh-ancestor
6169904|NCT01623115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169905|NCT01623167|Cyclosporine|cyclosporine|mesh-list
6169906|NCT01623167|Cyclosporins|cyclosporins|mesh-list
6169907|NCT01623167|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6169908|NCT01623167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5567557|NCT03957499|Tocolytic Agents|tocolytic agents|mesh-ancestor
5567558|NCT03957499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5567559|NCT03957629|Interferons|interferons|mesh-list
5567560|NCT03957629|Tenofovir|tenofovir|mesh-list
5567561|NCT03957629|Interferon-alpha|interferon-alpha|mesh-list
5567562|NCT03957629|Interferon alpha-2|interferon alpha-2|mesh-list
5567563|NCT03957629|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5567564|NCT03957629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5567565|NCT03957629|Antiviral Agents|antiviral agents|mesh-ancestor
5567566|NCT03957629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5567567|NCT03957629|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5567568|NCT03957629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5567569|NCT03957629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5567570|NCT03957629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5567571|NCT03957629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5567572|NCT03957629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6484857|NCT00563654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6484858|NCT00563654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484859|NCT00563654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567573|NCT03957629|Immunologic Factors|immunologic factors|mesh-ancestor
6169909|NCT01623167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6169910|NCT01623167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6169911|NCT01623167|Immunologic Factors|immunologic factors|mesh-ancestor
6169912|NCT01623167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169913|NCT01623167|Antifungal Agents|antifungal agents|mesh-ancestor
6169914|NCT01623167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6169915|NCT01623167|Dermatologic Agents|dermatologic agents|mesh-ancestor
6169916|NCT01623167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5567574|NCT03957629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567575|NCT03957551|Pembrolizumab|pembrolizumab|mesh-list
5567576|NCT03957551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5567577|NCT03957551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5567578|NCT03957291|Chlorhexidine|chlorhexidine|mesh-list
5567579|NCT03957291|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5567580|NCT03957291|Povidone-Iodine|povidone-iodine|mesh-list
5567581|NCT03957291|Povidone|povidone|mesh-list
5567582|NCT03957291|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5567583|NCT03957291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5567584|NCT03957291|Disinfectants|disinfectants|mesh-ancestor
5567585|NCT03957291|Dermatologic Agents|dermatologic agents|mesh-ancestor
5567586|NCT03957291|Plasma Substitutes|plasma substitutes|mesh-ancestor
6169917|NCT01623167|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6169918|NCT01623271|Gabapentin|gabapentin|mesh-list
6169919|NCT01623271|Analgesics|analgesics|mesh-ancestor
6169920|NCT01623271|Sensory System Agents|sensory system agents|mesh-ancestor
6169921|NCT01623271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6169922|NCT01623271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169923|NCT01623271|Anticonvulsants|anticonvulsants|mesh-ancestor
6169924|NCT01623271|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6169925|NCT01623271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6169926|NCT01623271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6169927|NCT01623271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6169928|NCT01623271|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6169929|NCT01623271|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6169930|NCT01623271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6169931|NCT01623271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6169932|NCT01623271|Antimanic Agents|antimanic agents|mesh-ancestor
6169933|NCT01623310|Fluticasone|fluticasone|mesh-list
6169934|NCT01623310|Xhance|xhance|mesh-list
6169935|NCT01623310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6169936|NCT01623310|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6169937|NCT01623310|Autonomic Agents|autonomic agents|mesh-ancestor
6169938|NCT01623310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5567587|NCT03957291|Blood Substitutes|blood substitutes|mesh-ancestor
5567588|NCT03957174|Rivastigmine|rivastigmine|mesh-list
6169939|NCT01623310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169940|NCT01623310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6169941|NCT01623310|Respiratory System Agents|respiratory system agents|mesh-ancestor
6169942|NCT01623310|Dermatologic Agents|dermatologic agents|mesh-ancestor
6169943|NCT01623310|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6169944|NCT01623323|Fluticasone|fluticasone|mesh-list
6169945|NCT01623323|Xhance|xhance|mesh-list
6169946|NCT01623323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6169947|NCT01623323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6169948|NCT01623323|Autonomic Agents|autonomic agents|mesh-ancestor
6169949|NCT01623323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6169950|NCT01623323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169951|NCT01623323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6169952|NCT01623323|Respiratory System Agents|respiratory system agents|mesh-ancestor
6169953|NCT01623323|Dermatologic Agents|dermatologic agents|mesh-ancestor
6169954|NCT01623323|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6169955|NCT01623466|Contraceptive Agents|contraceptive agents|mesh-list
5567589|NCT03957174|Reboxetine|reboxetine|mesh-list
5567590|NCT03957174|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5567591|NCT03957174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5567592|NCT03957174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5567593|NCT03957174|Cholinergic Agents|cholinergic agents|mesh-ancestor
5567594|NCT03957174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5567595|NCT03957174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169956|NCT01623466|Levonorgestrel|levonorgestrel|mesh-list
6169957|NCT01623466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6169958|NCT01623466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169959|NCT01623466|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6169960|NCT01623466|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6169961|NCT01623466|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6169962|NCT01623466|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6169963|NCT01623479|Bimatoprost|bimatoprost|mesh-list
6169964|NCT01623479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6169965|NCT01623596|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6169966|NCT01623596|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6169967|NCT01623596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6169968|NCT01623596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6169969|NCT01623596|Immunologic Factors|immunologic factors|mesh-ancestor
6169970|NCT01623596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169971|NCT01623752|Etanercept|etanercept|mesh-list
6169972|NCT01623752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6484860|NCT00563654|Urological Agents|urological agents|mesh-ancestor
6484861|NCT00563758|Tegaserod|tegaserod|mesh-list
6484862|NCT00563758|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6484863|NCT00563758|Serotonin Agents|serotonin agents|mesh-ancestor
6484864|NCT00563758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6484865|NCT00563758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484866|NCT00563758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484867|NCT00563771|Rasburicase|rasburicase|mesh-list
6484868|NCT00563771|Gout Suppressants|gout suppressants|mesh-ancestor
6484869|NCT00563771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6484870|NCT00563823|Vatalanib|vatalanib|mesh-list
6484871|NCT00563823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6169973|NCT01623752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5567596|NCT03957174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6169974|NCT01623752|Analgesics|analgesics|mesh-ancestor
6169975|NCT01623752|Sensory System Agents|sensory system agents|mesh-ancestor
6169976|NCT01623752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6169977|NCT01623752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567597|NCT03957174|Protective Agents|protective agents|mesh-ancestor
5567598|NCT03957174|Antidepressive Agents|antidepressive agents|mesh-ancestor
5567599|NCT03957174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6484872|NCT00563823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5567600|NCT03957174|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5567601|NCT03957174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5567602|NCT03957174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6169978|NCT01623752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6169979|NCT01623752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6169980|NCT01623752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6169981|NCT01623752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6169982|NCT01623752|Immunologic Factors|immunologic factors|mesh-ancestor
6169983|NCT01623869|Trebananib|trebananib|mesh-list
6169984|NCT01623869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6169985|NCT01623869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6169986|NCT01623869|Growth Substances|growth substances|mesh-ancestor
6169987|NCT01623869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169988|NCT01623869|Growth Inhibitors|growth inhibitors|mesh-ancestor
5567603|NCT03957174|Adrenergic Agents|adrenergic agents|mesh-ancestor
5604029|NCT05178953|Protective Agents|protective agents|mesh-ancestor
5604030|NCT05178953|Vasodilator Agents|vasodilator agents|mesh-ancestor
5604031|NCT05178953|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5604032|NCT05178953|Antioxidants|antioxidants|mesh-ancestor
5604033|NCT05178953|Astringents|astringents|mesh-ancestor
5604034|NCT05178953|Dermatologic Agents|dermatologic agents|mesh-ancestor
5604035|NCT05178862|Fluconazole|fluconazole|mesh-list
5604036|NCT05178862|Caspofungin|caspofungin|mesh-list
5604037|NCT05178862|Micafungin|micafungin|mesh-list
5604038|NCT05178862|Anidulafungin|anidulafungin|mesh-list
5604039|NCT05178862|Ibrexafungerp|ibrexafungerp|mesh-list
5604040|NCT05178862|Echinocandins|echinocandins|mesh-list
5604041|NCT05178862|Antifungal Agents|antifungal agents|mesh-ancestor
5604042|NCT05178862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5604043|NCT05178862|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5604044|NCT05178862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5604045|NCT05178862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5604046|NCT05178862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604047|NCT05178862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6169989|NCT01623869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6169990|NCT01624090|Plicamycin|plicamycin|mesh-list
6169991|NCT01624090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6169992|NCT01624090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6169993|NCT01624090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6169994|NCT01624090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5604048|NCT05178862|Hormone Antagonists|hormone antagonists|mesh-ancestor
5604049|NCT05178862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5604050|NCT05178862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604051|NCT05178862|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5604052|NCT05178862|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5604053|NCT05178745|Fluorouracil|fluorouracil|mesh-list
5604054|NCT05178745|Irinotecan|irinotecan|mesh-list
5604055|NCT05178745|Aflibercept|aflibercept|mesh-list
5604056|NCT05178745|Antimetabolites|antimetabolites|mesh-ancestor
5604057|NCT05178745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604058|NCT05178745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5604059|NCT05178745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5604060|NCT05178745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5604061|NCT05178745|Immunologic Factors|immunologic factors|mesh-ancestor
5604062|NCT05178745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604063|NCT05178745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5604064|NCT05178745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5604065|NCT05178745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5604066|NCT05178745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5604067|NCT05178745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5604068|NCT05178745|Growth Substances|growth substances|mesh-ancestor
5604069|NCT05178745|Growth Inhibitors|growth inhibitors|mesh-ancestor
5604070|NCT05178511|Ensartinib|ensartinib|mesh-list
5604071|NCT05178511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5604072|NCT05178511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5604073|NCT05178511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5604074|NCT05178511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604075|NCT05178407|Micronutrients|micronutrients|mesh-list
5604076|NCT05178407|Trace Elements|trace elements|mesh-list
5604077|NCT05178407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604078|NCT05178043|Nivolumab|nivolumab|mesh-list
5604079|NCT05178043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6169995|NCT01624090|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5604080|NCT05178043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5604081|NCT05178043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6484873|NCT00563823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484874|NCT00563836|Catumaxomab|catumaxomab|mesh-list
6484875|NCT00563836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5567604|NCT03957304|Dexmedetomidine|dexmedetomidine|mesh-list
5567605|NCT03957304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5567606|NCT03957304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5567607|NCT03957304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567608|NCT03957304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5567609|NCT03957304|Analgesics|analgesics|mesh-ancestor
5567610|NCT03957304|Sensory System Agents|sensory system agents|mesh-ancestor
5567611|NCT03957304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5567612|NCT03957304|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5567613|NCT03957304|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5567614|NCT03957304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5567615|NCT03957304|Adrenergic Agents|adrenergic agents|mesh-ancestor
5567616|NCT03957304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5567617|NCT03957304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484876|NCT00563849|Leflunomide|leflunomide|mesh-list
6484877|NCT00563849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6484878|NCT00563849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484879|NCT00563849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6484880|NCT00563849|Immunologic Factors|immunologic factors|mesh-ancestor
6484881|NCT00563849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484882|NCT00563862|Fluorouracil|fluorouracil|mesh-list
6484883|NCT00563862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6484884|NCT00563862|Antimetabolites|antimetabolites|mesh-ancestor
6484885|NCT00563862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5567618|NCT03957057|Iron|iron|mesh-list
5567619|NCT03957057|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
5567620|NCT03957057|Trace Elements|trace elements|mesh-ancestor
5567621|NCT03957057|Micronutrients|micronutrients|mesh-ancestor
5567622|NCT03957057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567623|NCT03957057|Hematinics|hematinics|mesh-ancestor
5567624|NCT03956966|Dexamethasone|dexamethasone|mesh-list
5567625|NCT03956966|Bupivacaine|bupivacaine|mesh-list
5567626|NCT03956966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6484886|NCT00563862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6484887|NCT00563862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6484888|NCT00563862|Immunologic Factors|immunologic factors|mesh-ancestor
6484889|NCT00563862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484890|NCT00563875|Aspirin|aspirin|mesh-list
6484891|NCT00563875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6484892|NCT00563875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6484893|NCT00563875|Analgesics|analgesics|mesh-ancestor
6484894|NCT00563875|Sensory System Agents|sensory system agents|mesh-ancestor
6484895|NCT00563875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6484896|NCT00563875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484897|NCT00563875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6484898|NCT00563875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6484899|NCT00563875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6484900|NCT00563875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6484901|NCT00563875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484902|NCT00563875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6484903|NCT00563875|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6484904|NCT00563875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6484905|NCT00563875|Antipyretics|antipyretics|mesh-ancestor
6484906|NCT00563914|Amodiaquine|amodiaquine|mesh-list
6484907|NCT00563914|Ferroquine|ferroquine|mesh-list
6669801|NCT01539707|Cholinergic Agents|cholinergic agents|mesh-ancestor
6669802|NCT01539707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6669803|NCT01539707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669804|NCT01539707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669805|NCT01539707|Urological Agents|urological agents|mesh-ancestor
6669806|NCT01539720|Levonorgestrel|levonorgestrel|mesh-list
6669807|NCT01539720|Ulipristal acetate|ulipristal acetate|mesh-list
6669808|NCT01539720|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6669809|NCT01539720|Contraceptive Agents|contraceptive agents|mesh-ancestor
6669810|NCT01539720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6669811|NCT01539720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669812|NCT01539720|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6669813|NCT01539720|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5567627|NCT03956966|Antiemetics|antiemetics|mesh-ancestor
5567628|NCT03956966|Autonomic Agents|autonomic agents|mesh-ancestor
5567629|NCT03956966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5567630|NCT03956966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567631|NCT03956966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5567632|NCT03956966|Glucocorticoids|glucocorticoids|mesh-ancestor
5567633|NCT03956966|Hormones|hormones|mesh-ancestor
5567634|NCT03956966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5567635|NCT03956966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5567636|NCT03956966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5567637|NCT03956966|Anesthetics, Local|anesthetics, local|mesh-ancestor
5567638|NCT03956966|Anesthetics|anesthetics|mesh-ancestor
5567639|NCT03956966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5567640|NCT03956966|Sensory System Agents|sensory system agents|mesh-ancestor
5567641|NCT03957109|Anesthetics|anesthetics|mesh-list
5567642|NCT03957109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5567643|NCT03957109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567644|NCT03956953|BMS-986165|bms-986165|mesh-list
5567645|NCT03956953|Dermatologic Agents|dermatologic agents|mesh-ancestor
5567646|NCT03956953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5567647|NCT03956953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5567648|NCT03956953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5567649|NCT03956732|Vitamin D|vitamin d|mesh-list
5567650|NCT03956732|Caseins|caseins|mesh-list
5567651|NCT03956732|Vitamins|vitamins|mesh-ancestor
5567652|NCT03956732|Micronutrients|micronutrients|mesh-ancestor
5567653|NCT03956732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567654|NCT03956732|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5567655|NCT03956732|Chelating Agents|chelating agents|mesh-ancestor
5567656|NCT03956732|Sequestering Agents|sequestering agents|mesh-ancestor
5567657|NCT03956732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5567658|NCT03956823|Amlodipine|amlodipine|mesh-list
5567659|NCT03956823|Telmisartan|telmisartan|mesh-list
5567660|NCT03956823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5567661|NCT03956823|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5567662|NCT03956823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5567663|NCT03956823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5567664|NCT03956823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5567665|NCT03956823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567666|NCT03956823|Vasodilator Agents|vasodilator agents|mesh-ancestor
5567667|NCT03956823|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5567668|NCT03956823|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5567669|NCT03957083|Oxytocin|oxytocin|mesh-list
6169996|NCT01624090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6169997|NCT01624090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484908|NCT00563914|Antimalarials|antimalarials|mesh-ancestor
6484909|NCT00563914|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5567670|NCT03957083|Oxytocics|oxytocics|mesh-ancestor
5567671|NCT03957083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5567672|NCT03957083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567673|NCT03956797|Anesthetics|anesthetics|mesh-list
5567674|NCT03956797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5567675|NCT03956797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567676|NCT03956888|Acetylcysteine|acetylcysteine|mesh-list
5567677|NCT03956888|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5567678|NCT03956888|Antiviral Agents|antiviral agents|mesh-ancestor
5567679|NCT03956888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5567680|NCT03956888|Expectorants|expectorants|mesh-ancestor
5567681|NCT03956888|Respiratory System Agents|respiratory system agents|mesh-ancestor
5567682|NCT03956888|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5567683|NCT03956888|Antioxidants|antioxidants|mesh-ancestor
5567684|NCT03956888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5567685|NCT03956888|Protective Agents|protective agents|mesh-ancestor
5567686|NCT03956888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567687|NCT03956888|Antidotes|antidotes|mesh-ancestor
5567688|NCT03956303|Levobupivacaine|levobupivacaine|mesh-list
5567689|NCT03956303|Anesthetics, Local|anesthetics, local|mesh-ancestor
5567690|NCT03956303|Anesthetics|anesthetics|mesh-ancestor
5567691|NCT03956303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5567692|NCT03956303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567693|NCT03956303|Sensory System Agents|sensory system agents|mesh-ancestor
5567694|NCT03956303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5567695|NCT03956680|Nivolumab|nivolumab|mesh-list
5567696|NCT03956680|Ipilimumab|ipilimumab|mesh-list
5567697|NCT03956680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5567698|NCT03956680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5567699|NCT03956680|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5567700|NCT03956680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484910|NCT00563914|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5567701|NCT03956212|Doxycycline|doxycycline|mesh-list
5567702|NCT03956212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5567703|NCT03956212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5567704|NCT03956212|Antimalarials|antimalarials|mesh-ancestor
5567705|NCT03956212|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5567706|NCT03956212|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5567707|NCT03956446|Doxycycline|doxycycline|mesh-list
5567708|NCT03956446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6169998|NCT01624090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6169999|NCT01624142|Evolocumab|evolocumab|mesh-list
6170000|NCT01624142|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6170001|NCT01624142|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6170002|NCT01624142|Antimetabolites|antimetabolites|mesh-ancestor
6170003|NCT01624142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669814|NCT01539720|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6669815|NCT01539733|Haloperidol|haloperidol|mesh-list
6669816|NCT01539733|Olanzapine|olanzapine|mesh-list
6669817|NCT01539733|Haloperidol decanoate|haloperidol decanoate|mesh-list
5567709|NCT03956446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6170004|NCT01624142|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5567710|NCT03956446|Antimalarials|antimalarials|mesh-ancestor
5567711|NCT03956446|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5567712|NCT03956446|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5567713|NCT03956056|Poly I-C|poly i-c|mesh-list
5567714|NCT03956056|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
5567715|NCT03956056|Poly ICLC|poly iclc|mesh-list
5567716|NCT03956056|Interferon Inducers|interferon inducers|mesh-ancestor
5567717|NCT03956056|Immunologic Factors|immunologic factors|mesh-ancestor
5567718|NCT03956056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567719|NCT03956056|Laxatives|laxatives|mesh-ancestor
5567720|NCT03956056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5567721|NCT03956056|Antiviral Agents|antiviral agents|mesh-ancestor
5567722|NCT03956056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5567723|NCT03956017|Ubiquinone|ubiquinone|mesh-list
6170005|NCT01624194|Oxytocin|oxytocin|mesh-list
6170006|NCT01624194|Oxytocics|oxytocics|mesh-ancestor
6170007|NCT01624194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6170008|NCT01624194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170009|NCT01624233|Ixekizumab|ixekizumab|mesh-list
6170010|NCT01624233|Dermatologic Agents|dermatologic agents|mesh-ancestor
6170011|NCT01624259|Metformin|metformin|mesh-list
6170012|NCT01624259|Liraglutide|liraglutide|mesh-list
6170013|NCT01624259|Dulaglutide|dulaglutide|mesh-list
6170014|NCT01624259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6170015|NCT01624259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170016|NCT01624259|Incretins|incretins|mesh-ancestor
6170017|NCT01624259|Hormones|hormones|mesh-ancestor
6170018|NCT01624259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6170019|NCT01624467|Necitumumab|necitumumab|mesh-list
6170020|NCT01624467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6170021|NCT01624467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6170022|NCT01624662|Fluticasone|fluticasone|mesh-list
5567724|NCT03956017|Coenzyme Q10|coenzyme q10|mesh-list
5567725|NCT03956017|Micronutrients|micronutrients|mesh-ancestor
5567726|NCT03956017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567727|NCT03956017|Vitamins|vitamins|mesh-ancestor
5567728|NCT03955939|Midazolam|midazolam|mesh-list
5567729|NCT03955939|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5567730|NCT03955939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5567731|NCT03955939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5567732|NCT03955939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567733|NCT03955939|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6170023|NCT01624662|Xhance|xhance|mesh-list
6170024|NCT01624662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6170025|NCT01624662|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6170026|NCT01624662|Autonomic Agents|autonomic agents|mesh-ancestor
6170027|NCT01624662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5567734|NCT03955939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5567735|NCT03955939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5567736|NCT03955939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6170028|NCT01624662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170029|NCT01624662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6170030|NCT01624662|Respiratory System Agents|respiratory system agents|mesh-ancestor
6170031|NCT01624662|Dermatologic Agents|dermatologic agents|mesh-ancestor
6170032|NCT01624662|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5567737|NCT03955939|Anesthetics, General|anesthetics, general|mesh-ancestor
6170033|NCT01624948|Mycophenolic Acid|mycophenolic acid|mesh-list
5567738|NCT03955939|Anesthetics|anesthetics|mesh-ancestor
5567739|NCT03955939|GABA Modulators|gaba modulators|mesh-ancestor
6170034|NCT01624948|Everolimus|everolimus|mesh-list
6669818|NCT01539733|Antiemetics|antiemetics|mesh-ancestor
6669819|NCT01539733|Autonomic Agents|autonomic agents|mesh-ancestor
5567740|NCT03955939|GABA Agents|gaba agents|mesh-ancestor
5567741|NCT03955939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5567742|NCT03955939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5567743|NCT03955809|Ketamine|ketamine|mesh-list
5567744|NCT03955809|Analgesics|analgesics|mesh-ancestor
6170035|NCT01624948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6170036|NCT01624948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6170037|NCT01624948|Immunologic Factors|immunologic factors|mesh-ancestor
6170038|NCT01624948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484911|NCT00563914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6484912|NCT00563927|Fluorouracil|fluorouracil|mesh-list
6484913|NCT00563927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6484914|NCT00563927|Antimetabolites|antimetabolites|mesh-ancestor
6484915|NCT00563927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484916|NCT00563927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6170039|NCT01624948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6170040|NCT01624948|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5567745|NCT03955809|Sensory System Agents|sensory system agents|mesh-ancestor
5567746|NCT03955809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5567747|NCT03955809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567748|NCT03955809|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5567749|NCT03955809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5567750|NCT03955809|Anesthetics, General|anesthetics, general|mesh-ancestor
5567751|NCT03955809|Anesthetics|anesthetics|mesh-ancestor
5567752|NCT03955809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5567753|NCT03955809|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5567754|NCT03955809|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5567755|NCT03955809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5567756|NCT03955809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5567757|NCT03956134|Tapentadol|tapentadol|mesh-list
5567758|NCT03956134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5567759|NCT03956134|Narcotics|narcotics|mesh-ancestor
5567760|NCT03956134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5567761|NCT03956134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567762|NCT03956134|Analgesics|analgesics|mesh-ancestor
5567763|NCT03956134|Sensory System Agents|sensory system agents|mesh-ancestor
5567764|NCT03956134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5567765|NCT03956134|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5567766|NCT03956134|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5567767|NCT03956134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5567768|NCT03956134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5567769|NCT03956134|Adrenergic Agents|adrenergic agents|mesh-ancestor
5567770|NCT03956134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5567771|NCT03956173|Hypoglycemic Agents|hypoglycemic agents|mesh-list
5567772|NCT03956173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567773|NCT03956121|Magnesium Sulfate|magnesium sulfate|mesh-list
5567774|NCT03956121|Analgesics|analgesics|mesh-ancestor
5567775|NCT03956121|Sensory System Agents|sensory system agents|mesh-ancestor
5567776|NCT03956121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5567777|NCT03956121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567778|NCT03956121|Anesthetics|anesthetics|mesh-ancestor
6170041|NCT01624948|Antitubercular Agents|antitubercular agents|mesh-ancestor
6170042|NCT01624948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6170043|NCT01624948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6170044|NCT01624948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6170045|NCT01624948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170046|NCT01624974|Montelukast|montelukast|mesh-list
6170047|NCT01624974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6170048|NCT01624974|Respiratory System Agents|respiratory system agents|mesh-ancestor
6170049|NCT01624974|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6170050|NCT01624974|Hormone Antagonists|hormone antagonists|mesh-ancestor
6170051|NCT01624974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6170052|NCT01624974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170053|NCT01624974|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6170054|NCT01624974|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6170055|NCT01624974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170056|NCT01625000|Risperidone|risperidone|mesh-list
6170057|NCT01625000|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6170058|NCT01625000|Serotonin Agents|serotonin agents|mesh-ancestor
6484917|NCT00563927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6484918|NCT00563927|Immunologic Factors|immunologic factors|mesh-ancestor
6484919|NCT00563927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484920|NCT00563953|Doxorubicin|doxorubicin|mesh-list
6170059|NCT01625000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6170060|NCT01625000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170061|NCT01625000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170062|NCT01625000|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6170063|NCT01625000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6170064|NCT01625000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6170065|NCT01625000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6170066|NCT01625000|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6170067|NCT01625000|Dopamine Agents|dopamine agents|mesh-ancestor
6170068|NCT01625013|Hylan|hylan|mesh-list
6170069|NCT01625013|Viscosupplements|viscosupplements|mesh-ancestor
6170070|NCT01625013|Protective Agents|protective agents|mesh-ancestor
6484921|NCT00563953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6484922|NCT00563953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6170071|NCT01625013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170072|NCT01625091|Naltrexone|naltrexone|mesh-list
6170073|NCT01625091|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6170074|NCT01625091|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6170075|NCT01625091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170076|NCT01625091|Sensory System Agents|sensory system agents|mesh-ancestor
6170077|NCT01625091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6170078|NCT01625169|Etravirine|etravirine|mesh-list
6170079|NCT01625169|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6170080|NCT01625169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6170081|NCT01625169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6170082|NCT01625169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170083|NCT01625169|Antiviral Agents|antiviral agents|mesh-ancestor
6170084|NCT01625169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6170085|NCT01625182|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6170086|NCT01625182|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6669820|NCT01539733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6170087|NCT01625182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170088|NCT01625182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6170089|NCT01625182|Immunologic Factors|immunologic factors|mesh-ancestor
6170090|NCT01625182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170091|NCT01625338|Sofosbuvir|sofosbuvir|mesh-list
6170092|NCT01625338|Antiviral Agents|antiviral agents|mesh-ancestor
6170093|NCT01625338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5567779|NCT03956121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5567780|NCT03956121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5567781|NCT03956121|Anticonvulsants|anticonvulsants|mesh-ancestor
5567782|NCT03956121|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5567783|NCT03956121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5567784|NCT03956121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5567785|NCT03956121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5567786|NCT03956121|Tocolytic Agents|tocolytic agents|mesh-ancestor
5567787|NCT03956121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5567788|NCT03955783|Venetoclax|venetoclax|mesh-list
5567789|NCT03955783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5567790|NCT03955575|Liraglutide|liraglutide|mesh-list
5567791|NCT03955575|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
5567792|NCT03955575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5567793|NCT03955575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567794|NCT03955575|Incretins|incretins|mesh-ancestor
5567795|NCT03955575|Hormones|hormones|mesh-ancestor
5567796|NCT03955575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5567797|NCT03955575|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5567798|NCT03955575|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5567799|NCT03955575|Antimetabolites|antimetabolites|mesh-ancestor
5567800|NCT03955575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5567801|NCT03955575|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5567802|NCT03955601|Cyclophosphamide|cyclophosphamide|mesh-list
5567803|NCT03955601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5567804|NCT03955601|Immunologic Factors|immunologic factors|mesh-ancestor
5567805|NCT03955601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567806|NCT03955601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6170094|NCT01625377|Mycophenolic Acid|mycophenolic acid|mesh-list
6484923|NCT00563953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6484924|NCT00563953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6484925|NCT00563953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6484926|NCT00563953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484927|NCT00563992|Valproic Acid|valproic acid|mesh-list
6484928|NCT00563992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6170095|NCT01625377|Everolimus|everolimus|mesh-list
6170096|NCT01625377|Tacrolimus|tacrolimus|mesh-list
6170097|NCT01625377|Basiliximab|basiliximab|mesh-list
5567807|NCT03955601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5567808|NCT03955601|Alkylating Agents|alkylating agents|mesh-ancestor
5567809|NCT03955601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5567810|NCT03955601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5567811|NCT03955601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6170098|NCT01625377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6170099|NCT01625377|Immunologic Factors|immunologic factors|mesh-ancestor
6170100|NCT01625377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484929|NCT00563992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6484930|NCT00563992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484931|NCT00563992|Antimanic Agents|antimanic agents|mesh-ancestor
6484932|NCT00563992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6484933|NCT00563992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5567812|NCT03955705|Nefopam|nefopam|mesh-list
5567813|NCT03955705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5567814|NCT03955705|Analgesics|analgesics|mesh-ancestor
5567815|NCT03955705|Sensory System Agents|sensory system agents|mesh-ancestor
5567816|NCT03955705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5567817|NCT03955705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604082|NCT05178043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606828|NCT03747939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5606829|NCT03747939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6484934|NCT00563992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484935|NCT00563992|Anticonvulsants|anticonvulsants|mesh-ancestor
6484936|NCT00563992|GABA Agents|gaba agents|mesh-ancestor
6484937|NCT00563992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6484938|NCT00564031|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6669821|NCT01539733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669822|NCT01539733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6669823|NCT01539733|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6669824|NCT01539733|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6669825|NCT01539733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6669826|NCT01539733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6170101|NCT01625377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5606830|NCT03747939|Growth Substances|growth substances|mesh-ancestor
5606831|NCT03747939|Growth Inhibitors|growth inhibitors|mesh-ancestor
5606832|NCT03747939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5606833|NCT03732352|Deoxyglucose|deoxyglucose|mesh-list
5606834|NCT03732352|Osimertinib|osimertinib|mesh-list
6170102|NCT01625377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6170103|NCT01625377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170104|NCT01625377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6170105|NCT01625377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5606835|NCT03732352|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5606836|NCT03732352|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5606837|NCT03732352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606838|NCT03732352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5606839|NCT03732352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5606840|NCT03732352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5606841|NCT03732352|Antimetabolites|antimetabolites|mesh-ancestor
5606842|NCT03732352|Antiviral Agents|antiviral agents|mesh-ancestor
5606843|NCT03732352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5606844|NCT03727971|Omalizumab|omalizumab|mesh-list
5606845|NCT03727971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5606846|NCT03727971|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5606847|NCT03727971|Respiratory System Agents|respiratory system agents|mesh-ancestor
5606848|NCT03674112|Trastuzumab|trastuzumab|mesh-list
5606849|NCT03674112|Pertuzumab|pertuzumab|mesh-list
5606850|NCT03674112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5606851|NCT03674112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5606852|NCT03593018|Gemcitabine|gemcitabine|mesh-list
5606853|NCT03593018|Azacitidine|azacitidine|mesh-list
5606854|NCT03593018|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5606855|NCT03593018|Romidepsin|romidepsin|mesh-list
5606856|NCT03593018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5606857|NCT03593018|Antimetabolites|antimetabolites|mesh-ancestor
5606858|NCT03593018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606859|NCT03593018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5606860|NCT03593018|Antiviral Agents|antiviral agents|mesh-ancestor
5606861|NCT03593018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5606862|NCT03593018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6170106|NCT01625377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6484939|NCT00564031|Medroxyprogesterone|medroxyprogesterone|mesh-list
6170107|NCT01625377|Antitubercular Agents|antitubercular agents|mesh-ancestor
6170108|NCT01625377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6170109|NCT01625377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6170110|NCT01625455|Aprepitant|aprepitant|mesh-list
6170111|NCT01625455|Antiemetics|antiemetics|mesh-ancestor
6170112|NCT01625455|Autonomic Agents|autonomic agents|mesh-ancestor
6170113|NCT01625455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6170114|NCT01625455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170115|NCT01625455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6170116|NCT01625455|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6170117|NCT01625455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6170118|NCT01625455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5567818|NCT03955406|Anesthetics|anesthetics|mesh-list
5567819|NCT03955406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5567820|NCT03955406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567821|NCT03955354|Apatinib|apatinib|mesh-list
5567822|NCT03955354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5567823|NCT03955354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5567824|NCT03955354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5567825|NCT03955354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5567826|NCT03955341|Chlorhexidine|chlorhexidine|mesh-list
5567827|NCT03955341|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5567828|NCT03955341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5567829|NCT03955341|Disinfectants|disinfectants|mesh-ancestor
5567830|NCT03955393|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
5567831|NCT03955393|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5567832|NCT03955393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5567833|NCT03955458|Bupivacaine|bupivacaine|mesh-list
5567834|NCT03955458|Ropivacaine|ropivacaine|mesh-list
5567835|NCT03955458|Anesthetics, Local|anesthetics, local|mesh-ancestor
5567836|NCT03955458|Anesthetics|anesthetics|mesh-ancestor
5567837|NCT03955458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6170119|NCT01625845|Pentoxifylline|pentoxifylline|mesh-list
6170120|NCT01625845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6170121|NCT01625845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6170122|NCT01625845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5567838|NCT03955458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567839|NCT03955458|Sensory System Agents|sensory system agents|mesh-ancestor
5567840|NCT03955458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5567841|NCT03955172|Everolimus|everolimus|mesh-list
5567842|NCT03955172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5567843|NCT03955172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5567844|NCT03955172|Immunologic Factors|immunologic factors|mesh-ancestor
6170123|NCT01625845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6170124|NCT01625845|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6170125|NCT01625845|Protective Agents|protective agents|mesh-ancestor
6170126|NCT01625845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170127|NCT01625845|Vasodilator Agents|vasodilator agents|mesh-ancestor
6170128|NCT01625845|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6170129|NCT01625845|Antioxidants|antioxidants|mesh-ancestor
6170130|NCT01625897|Risperidone|risperidone|mesh-list
6170131|NCT01625897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6170132|NCT01625897|Serotonin Agents|serotonin agents|mesh-ancestor
6170133|NCT01625897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6170134|NCT01625897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170135|NCT01625897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170136|NCT01625897|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6170137|NCT01625897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6170138|NCT01625897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6170139|NCT01625897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6170140|NCT01625897|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6170141|NCT01625897|Dopamine Agents|dopamine agents|mesh-ancestor
6170142|NCT01625923|Olanzapine|olanzapine|mesh-list
6170143|NCT01625923|Antiemetics|antiemetics|mesh-ancestor
5567845|NCT03955172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567846|NCT03955211|Acetaminophen|acetaminophen|mesh-list
5567847|NCT03955211|Ibuprofen|ibuprofen|mesh-list
5567848|NCT03955211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5567849|NCT03955211|Analgesics|analgesics|mesh-ancestor
5567850|NCT03955211|Sensory System Agents|sensory system agents|mesh-ancestor
5567851|NCT03955211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5567852|NCT03955211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567853|NCT03955211|Antipyretics|antipyretics|mesh-ancestor
5567854|NCT03955211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5567855|NCT03955211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6170144|NCT01625923|Autonomic Agents|autonomic agents|mesh-ancestor
6170145|NCT01625923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6484940|NCT00564031|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6484941|NCT00564031|Contraceptive Agents|contraceptive agents|mesh-ancestor
6484942|NCT00564031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6484943|NCT00564031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484944|NCT00564031|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5567856|NCT03955211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5567857|NCT03955211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5567858|NCT03955211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5567859|NCT03955211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5567860|NCT03955497|Hyaluronic Acid|hyaluronic acid|mesh-list
5567861|NCT03955497|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5567862|NCT03955497|Immunologic Factors|immunologic factors|mesh-ancestor
5567863|NCT03955497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567864|NCT03955497|Viscosupplements|viscosupplements|mesh-ancestor
5567865|NCT03955497|Protective Agents|protective agents|mesh-ancestor
5567866|NCT03954990|Metronidazole|metronidazole|mesh-list
5567867|NCT03954990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5567868|NCT03954990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6484945|NCT00564031|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5567869|NCT03954990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6170146|NCT01625923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170147|NCT01625923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6170148|NCT01625923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6170149|NCT01625923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6170150|NCT01625923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6170151|NCT01625923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6170152|NCT01625923|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6170153|NCT01625923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6170154|NCT01625923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6170155|NCT01625923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170156|NCT01625923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6170157|NCT01625923|Serotonin Agents|serotonin agents|mesh-ancestor
6170158|NCT01626092|Cyclosporine|cyclosporine|mesh-list
6170159|NCT01626092|Mycophenolic Acid|mycophenolic acid|mesh-list
6170160|NCT01626092|Melphalan|melphalan|mesh-list
6170161|NCT01626092|Alemtuzumab|alemtuzumab|mesh-list
6170162|NCT01626092|Clofarabine|clofarabine|mesh-list
6170163|NCT01626092|Cyclosporins|cyclosporins|mesh-list
6170164|NCT01626092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6170165|NCT01626092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170166|NCT01626092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6170167|NCT01626092|Immunologic Factors|immunologic factors|mesh-ancestor
6170168|NCT01626092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170169|NCT01626092|Antifungal Agents|antifungal agents|mesh-ancestor
6170170|NCT01626092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6170171|NCT01626092|Dermatologic Agents|dermatologic agents|mesh-ancestor
6170172|NCT01626092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6170173|NCT01626092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6170174|NCT01626092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6170175|NCT01626092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6170176|NCT01626092|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6170177|NCT01626092|Antitubercular Agents|antitubercular agents|mesh-ancestor
6170178|NCT01626092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6170179|NCT01626092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6170180|NCT01626092|Alkylating Agents|alkylating agents|mesh-ancestor
6170181|NCT01626092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6170182|NCT01626092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6170183|NCT01626092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6170184|NCT01626092|Antimetabolites|antimetabolites|mesh-ancestor
6170185|NCT01626118|Indomethacin|indomethacin|mesh-list
6170186|NCT01626118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6170187|NCT01626118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6170188|NCT01626118|Analgesics|analgesics|mesh-ancestor
6170189|NCT01626118|Sensory System Agents|sensory system agents|mesh-ancestor
5567870|NCT03954990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5567871|NCT03954964|Analgesics, Opioid|analgesics, opioid|mesh-list
5567872|NCT03954964|Narcotics|narcotics|mesh-ancestor
6170190|NCT01626118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6170191|NCT01626118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170192|NCT01626118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6170193|NCT01626118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6170194|NCT01626118|Gout Suppressants|gout suppressants|mesh-ancestor
6170195|NCT01626118|Tocolytic Agents|tocolytic agents|mesh-ancestor
6170196|NCT01626118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6170197|NCT01626118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6170198|NCT01626118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6170199|NCT01626118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170200|NCT01626352|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6170201|NCT01626352|Ofatumumab|ofatumumab|mesh-list
5567873|NCT03954964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5567874|NCT03954964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567875|NCT03954964|Analgesics|analgesics|mesh-ancestor
5567876|NCT03954964|Sensory System Agents|sensory system agents|mesh-ancestor
5567877|NCT03954964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5567878|NCT03954860|Tranexamic Acid|tranexamic acid|mesh-list
5567879|NCT03954860|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5567880|NCT03954860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5567881|NCT03954860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5567882|NCT03954860|Hemostatics|hemostatics|mesh-ancestor
5567883|NCT03954860|Coagulants|coagulants|mesh-ancestor
5567884|NCT03954873|Glucagon|glucagon|mesh-list
5567885|NCT03954873|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5567886|NCT03954873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567887|NCT03954873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5567888|NCT03954873|Hormones|hormones|mesh-ancestor
5567889|NCT03954873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5567890|NCT03954873|Incretins|incretins|mesh-ancestor
5567891|NCT03955042|Pemetrexed|pemetrexed|mesh-list
5567892|NCT03955042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6170202|NCT01626352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6170203|NCT01626352|Alkylating Agents|alkylating agents|mesh-ancestor
6170204|NCT01626352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170205|NCT01626352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6170206|NCT01626664|Gemcitabine|gemcitabine|mesh-list
6170207|NCT01626664|Oxaliplatin|oxaliplatin|mesh-list
6170208|NCT01626664|Mogamulizumab|mogamulizumab|mesh-list
6170209|NCT01626664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6170210|NCT01626664|Antimetabolites|antimetabolites|mesh-ancestor
6170211|NCT01626664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170212|NCT01626664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6170213|NCT01626664|Antiviral Agents|antiviral agents|mesh-ancestor
6170214|NCT01626664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6170215|NCT01626664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6170216|NCT01626664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6170217|NCT01626664|Immunologic Factors|immunologic factors|mesh-ancestor
6170218|NCT01626664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170219|NCT01626872|Risperidone|risperidone|mesh-list
6170220|NCT01626872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6170221|NCT01626872|Serotonin Agents|serotonin agents|mesh-ancestor
6170222|NCT01626872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6170223|NCT01626872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170224|NCT01626872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170225|NCT01626872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6170226|NCT01626872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6170227|NCT01626872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5567893|NCT03955042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6170228|NCT01626872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6170229|NCT01626872|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6170230|NCT01626872|Dopamine Agents|dopamine agents|mesh-ancestor
6170231|NCT01627067|Metformin|metformin|mesh-list
6170232|NCT01627067|Everolimus|everolimus|mesh-list
6170233|NCT01627067|Exemestane|exemestane|mesh-list
6170234|NCT01627067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6170235|NCT01627067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170236|NCT01627067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6170237|NCT01627067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6170238|NCT01627067|Immunologic Factors|immunologic factors|mesh-ancestor
6170239|NCT01627067|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6170240|NCT01627067|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6170241|NCT01627067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6170242|NCT01627067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170243|NCT01627067|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6170244|NCT01627067|Hormone Antagonists|hormone antagonists|mesh-ancestor
6170245|NCT01627067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5567894|NCT03955042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5567895|NCT03955042|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5567896|NCT03955042|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5567903|NCT03954639|Bupivacaine|bupivacaine|mesh-list
5567904|NCT03954639|Anesthetics, Local|anesthetics, local|mesh-ancestor
5567905|NCT03954639|Anesthetics|anesthetics|mesh-ancestor
5567906|NCT03954639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5567907|NCT03954639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170246|NCT01627249|Bevacizumab|bevacizumab|mesh-list
6170247|NCT01627249|Ranibizumab|ranibizumab|mesh-list
6170248|NCT01627249|Aflibercept|aflibercept|mesh-list
5567908|NCT03954639|Sensory System Agents|sensory system agents|mesh-ancestor
5567909|NCT03954639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5567910|NCT03954366|Rucaparib|rucaparib|mesh-list
5567911|NCT03954366|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6170249|NCT01627249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6170250|NCT01627249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6170251|NCT01627249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6170252|NCT01627249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6170253|NCT01627249|Growth Substances|growth substances|mesh-ancestor
6170254|NCT01627249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170255|NCT01627249|Growth Inhibitors|growth inhibitors|mesh-ancestor
6170256|NCT01627327|Fluticasone|fluticasone|mesh-list
6170257|NCT01627327|Xhance|xhance|mesh-list
6170258|NCT01627327|Bromides|bromides|mesh-list
6170259|NCT01627327|Tiotropium Bromide|tiotropium bromide|mesh-list
6170260|NCT01627327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6484946|NCT00564031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6484947|NCT00564031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6484948|NCT00564031|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6484949|NCT00564031|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6170261|NCT01627327|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6170262|NCT01627327|Autonomic Agents|autonomic agents|mesh-ancestor
6170263|NCT01627327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6170264|NCT01627327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170265|NCT01627327|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6170266|NCT01627327|Respiratory System Agents|respiratory system agents|mesh-ancestor
6170267|NCT01627327|Dermatologic Agents|dermatologic agents|mesh-ancestor
6170268|NCT01627327|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6669827|NCT01539733|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6669828|NCT01539733|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6669829|NCT01539733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6669830|NCT01539733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5567912|NCT03954366|Contraceptive Agents|contraceptive agents|mesh-list
5567913|NCT03954366|Contraceptives, Oral|contraceptives, oral|mesh-list
5567914|NCT03954366|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5567915|NCT03954366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5567916|NCT03954366|Antimetabolites|antimetabolites|mesh-ancestor
5567917|NCT03954366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170269|NCT01627327|Parasympatholytics|parasympatholytics|mesh-ancestor
6170270|NCT01627327|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6170271|NCT01627327|Cholinergic Agents|cholinergic agents|mesh-ancestor
6170272|NCT01627327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6170273|NCT01627327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170274|NCT01627327|Anticonvulsants|anticonvulsants|mesh-ancestor
6170275|NCT01627782|Ketamine|ketamine|mesh-list
6170276|NCT01627782|Analgesics|analgesics|mesh-ancestor
6170277|NCT01627782|Sensory System Agents|sensory system agents|mesh-ancestor
6170278|NCT01627782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6170279|NCT01627782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170280|NCT01627782|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6170281|NCT01627782|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6170282|NCT01627782|Anesthetics, General|anesthetics, general|mesh-ancestor
6170283|NCT01627782|Anesthetics|anesthetics|mesh-ancestor
6170284|NCT01627782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6170285|NCT01627782|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6170286|NCT01627782|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6170287|NCT01627782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6170288|NCT01627782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170289|NCT01627860|Topiramate|topiramate|mesh-list
6170290|NCT01627860|Anticonvulsants|anticonvulsants|mesh-ancestor
6170291|NCT01627860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6170292|NCT01627860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170293|NCT01628107|Epoetin Alfa|epoetin alfa|mesh-list
6170294|NCT01628107|Hematinics|hematinics|mesh-ancestor
6170295|NCT01628120|Epoetin Alfa|epoetin alfa|mesh-list
6170296|NCT01628120|Hematinics|hematinics|mesh-ancestor
6170297|NCT01628393|Ozanimod|ozanimod|mesh-list
6170298|NCT01628393|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6170299|NCT01628393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170300|NCT01628393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6170301|NCT01628393|Immunologic Factors|immunologic factors|mesh-ancestor
6170302|NCT01628393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206293|NCT02098109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6206294|NCT02098395|Liraglutide|liraglutide|mesh-list
6206295|NCT02098395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6206296|NCT02098395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206297|NCT02098395|Incretins|incretins|mesh-ancestor
6206298|NCT02098395|Hormones|hormones|mesh-ancestor
5567918|NCT03954366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5567919|NCT03954366|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5567920|NCT03954366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5567921|NCT03954366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5567922|NCT03954366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567923|NCT03954366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5567924|NCT03954366|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5567925|NCT03954366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5567926|NCT03954379|Analgesics|analgesics|mesh-list
5567927|NCT03954379|Sensory System Agents|sensory system agents|mesh-ancestor
5567928|NCT03954379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5567929|NCT03954379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567930|NCT03954756|Apatinib|apatinib|mesh-list
5567931|NCT03954756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5567932|NCT03954756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5567933|NCT03954756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5567934|NCT03954756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5567935|NCT03954483|Triazolam|triazolam|mesh-list
5567936|NCT03954483|Buspirone|buspirone|mesh-list
5567937|NCT03954483|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5567938|NCT03954483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5567939|NCT03954483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5567940|NCT03954483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567941|NCT03954483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5567942|NCT03954483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5567943|NCT03954483|Serotonin Agents|serotonin agents|mesh-ancestor
5567944|NCT03954483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5567945|NCT03954483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5567946|NCT03954483|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5567947|NCT03954483|GABA Modulators|gaba modulators|mesh-ancestor
5567948|NCT03954483|GABA Agents|gaba agents|mesh-ancestor
5567949|NCT03954327|Tenofovir|tenofovir|mesh-list
5567950|NCT03954327|Emtricitabine|emtricitabine|mesh-list
5567951|NCT03954327|Raltegravir Potassium|raltegravir potassium|mesh-list
5567952|NCT03954327|Antiviral Agents|antiviral agents|mesh-ancestor
6208003|NCT02123134|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5567953|NCT03954327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5567954|NCT03954327|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5567955|NCT03954327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5567956|NCT03954327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5567957|NCT03954327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170303|NCT01628549|Sarecycline|sarecycline|mesh-list
6170304|NCT01628549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5567958|NCT03954327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5567959|NCT03954327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5567960|NCT03954327|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5567961|NCT03954327|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5567962|NCT03954314|Tranexamic Acid|tranexamic acid|mesh-list
5567963|NCT03954314|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5567964|NCT03954314|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5567965|NCT03954314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5567966|NCT03954314|Hemostatics|hemostatics|mesh-ancestor
6170305|NCT01628549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6170306|NCT01628549|Dermatologic Agents|dermatologic agents|mesh-ancestor
6170307|NCT01628588|Bimatoprost|bimatoprost|mesh-list
6170308|NCT01628588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6170309|NCT01628601|Timolol|timolol|mesh-list
6170310|NCT01628601|Bimatoprost|bimatoprost|mesh-list
6170311|NCT01628601|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6170312|NCT01628601|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6170313|NCT01628601|Adrenergic Agents|adrenergic agents|mesh-ancestor
6170314|NCT01628601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6170315|NCT01628601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170316|NCT01628601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170317|NCT01628601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6170318|NCT01628601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6170319|NCT01628692|Ribavirin|ribavirin|mesh-list
6170320|NCT01628692|Simeprevir|simeprevir|mesh-list
6170321|NCT01628692|Antimetabolites|antimetabolites|mesh-ancestor
6170322|NCT01628692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170323|NCT01628692|Antiviral Agents|antiviral agents|mesh-ancestor
6170324|NCT01628692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6170325|NCT01628692|Protease Inhibitors|protease inhibitors|mesh-ancestor
6170326|NCT01628692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6170327|NCT01628874|Lidocaine|lidocaine|mesh-list
6170328|NCT01628874|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
5567967|NCT03954314|Coagulants|coagulants|mesh-ancestor
5567968|NCT03954197|Hormones|hormones|mesh-list
5567969|NCT03954197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5567970|NCT03954197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567971|NCT03953989|Ranolazine|ranolazine|mesh-list
5567972|NCT03953989|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5567973|NCT03953989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6170329|NCT01628874|Anesthetics, Local|anesthetics, local|mesh-ancestor
6170330|NCT01628874|Anesthetics|anesthetics|mesh-ancestor
6170331|NCT01628874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6170332|NCT01628874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170333|NCT01628874|Sensory System Agents|sensory system agents|mesh-ancestor
6484950|NCT00564031|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6484951|NCT00564057|Candesartan|candesartan|mesh-list
6484952|NCT00564057|Lercanidipine|lercanidipine|mesh-list
6484953|NCT00564057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6484954|NCT00564057|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6484955|NCT00564057|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6484956|NCT00564057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484957|NCT00564057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6484958|NCT00564057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6484959|NCT00564057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6484960|NCT00564057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484961|NCT00564148|Bevacizumab|bevacizumab|mesh-list
6484962|NCT00564148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6484963|NCT00564148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6484964|NCT00564148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6484965|NCT00564148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6484966|NCT00564148|Growth Substances|growth substances|mesh-ancestor
6484967|NCT00564148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484968|NCT00564148|Growth Inhibitors|growth inhibitors|mesh-ancestor
6488990|NCT00588302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6488991|NCT00588523|Temozolomide|temozolomide|mesh-list
6488992|NCT00588523|Busulfan|busulfan|mesh-list
6170334|NCT01628874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6170335|NCT01628874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6170336|NCT01628874|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6170337|NCT01628874|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6170338|NCT01628874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6170339|NCT01628874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170340|NCT01628874|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
6170341|NCT01628913|Everolimus|everolimus|mesh-list
6484969|NCT00564174|Aspirin|aspirin|mesh-list
6484970|NCT00564174|Heparin|heparin|mesh-list
6484971|NCT00564174|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6484972|NCT00564174|Tinzaparin|tinzaparin|mesh-list
6484973|NCT00564174|Dalteparin|dalteparin|mesh-list
6484974|NCT00564174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6484975|NCT00564174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6484976|NCT00564174|Analgesics|analgesics|mesh-ancestor
5567974|NCT03953989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5567975|NCT03953950|Losartan|losartan|mesh-list
5567976|NCT03953950|Spironolactone|spironolactone|mesh-list
5567977|NCT03953950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5567978|NCT03953950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5567979|NCT03953950|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5567980|NCT03953950|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5567981|NCT03953950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5567982|NCT03953950|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6484977|NCT00564174|Sensory System Agents|sensory system agents|mesh-ancestor
6484978|NCT00564174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6484979|NCT00564174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484980|NCT00564174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6170342|NCT01628913|Dactolisib|dactolisib|mesh-list
6170343|NCT01628913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6170344|NCT01628913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5567983|NCT03953950|Hormone Antagonists|hormone antagonists|mesh-ancestor
5567984|NCT03953950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5567985|NCT03953950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567986|NCT03953950|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5567987|NCT03953950|Diuretics|diuretics|mesh-ancestor
5567988|NCT03953950|Natriuretic Agents|natriuretic agents|mesh-ancestor
5567989|NCT03953833|Antibodies|antibodies|mesh-list
5567990|NCT03953833|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5567991|NCT03953833|Immunologic Factors|immunologic factors|mesh-ancestor
5567992|NCT03953833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567993|NCT03954262|Propofol|propofol|mesh-list
5567994|NCT03954262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5567995|NCT03954262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5567996|NCT03954262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5567997|NCT03954262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5567998|NCT03954262|Anesthetics, General|anesthetics, general|mesh-ancestor
5567999|NCT03954262|Anesthetics|anesthetics|mesh-ancestor
5568000|NCT03953807|Dexamethasone|dexamethasone|mesh-list
5568001|NCT03953807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5568002|NCT03953807|Antiemetics|antiemetics|mesh-ancestor
5568003|NCT03953807|Autonomic Agents|autonomic agents|mesh-ancestor
5568004|NCT03953807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5568005|NCT03953807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568006|NCT03953807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5568007|NCT03953807|Glucocorticoids|glucocorticoids|mesh-ancestor
5568008|NCT03953807|Hormones|hormones|mesh-ancestor
5568009|NCT03953807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5568010|NCT03953807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5568011|NCT03953807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5568012|NCT03953781|Levetiracetam|levetiracetam|mesh-list
5568013|NCT03953781|Anticonvulsants|anticonvulsants|mesh-ancestor
5568014|NCT03953781|Nootropic Agents|nootropic agents|mesh-ancestor
5568015|NCT03953677|Dexmedetomidine|dexmedetomidine|mesh-list
5568016|NCT03953677|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6170345|NCT01628913|Immunologic Factors|immunologic factors|mesh-ancestor
6170346|NCT01628913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170347|NCT01628926|Ropinirole|ropinirole|mesh-list
6484981|NCT00564174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5568017|NCT03953677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5568018|NCT03953677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5568019|NCT03953677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568020|NCT03953677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5568021|NCT03953677|Analgesics|analgesics|mesh-ancestor
5568022|NCT03953677|Sensory System Agents|sensory system agents|mesh-ancestor
5568023|NCT03953677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5568024|NCT03953677|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5568025|NCT03953677|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5568026|NCT03953677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5568027|NCT03953677|Adrenergic Agents|adrenergic agents|mesh-ancestor
5568028|NCT03953677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6170348|NCT01628926|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6170349|NCT01628926|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6170350|NCT01628926|Dopamine Agonists|dopamine agonists|mesh-ancestor
6170351|NCT01628926|Dopamine Agents|dopamine agents|mesh-ancestor
6170352|NCT01628926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6170353|NCT01628926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170354|NCT01628926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170355|NCT01628965|Rotigotine|rotigotine|mesh-list
6170356|NCT01628965|Dopamine Agonists|dopamine agonists|mesh-ancestor
6170357|NCT01628965|Dopamine Agents|dopamine agents|mesh-ancestor
6170358|NCT01628965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6170359|NCT01628965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170360|NCT01628965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170361|NCT01629134|Hyaluronic Acid|hyaluronic acid|mesh-list
6170362|NCT01629134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6170363|NCT01629134|Immunologic Factors|immunologic factors|mesh-ancestor
6170364|NCT01629134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170365|NCT01629134|Viscosupplements|viscosupplements|mesh-ancestor
6170366|NCT01629134|Protective Agents|protective agents|mesh-ancestor
6170367|NCT01629290|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
6170368|NCT01629290|Cariostatic Agents|cariostatic agents|mesh-ancestor
6170369|NCT01629290|Protective Agents|protective agents|mesh-ancestor
6170370|NCT01629290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170371|NCT01629381|Rivaroxaban|rivaroxaban|mesh-list
6170372|NCT01629381|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6170373|NCT01629381|Antithrombins|antithrombins|mesh-ancestor
6170374|NCT01629381|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6170375|NCT01629381|Protease Inhibitors|protease inhibitors|mesh-ancestor
6170376|NCT01629381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6170377|NCT01629381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170378|NCT01629381|Anticoagulants|anticoagulants|mesh-ancestor
6484982|NCT00564174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6484983|NCT00564174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6484984|NCT00564174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484985|NCT00564174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6484986|NCT00564174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6484987|NCT00564174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6484988|NCT00564174|Antipyretics|antipyretics|mesh-ancestor
6484989|NCT00564174|Anticoagulants|anticoagulants|mesh-ancestor
6484990|NCT00564187|Irbesartan|irbesartan|mesh-list
6484991|NCT00564187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6484992|NCT00564187|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6484993|NCT00564187|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5568029|NCT03953677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568030|NCT03953729|Ibuprofen|ibuprofen|mesh-list
5568031|NCT03953729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6484994|NCT00564187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6484995|NCT00564200|Dexamethasone|dexamethasone|mesh-list
6484996|NCT00564200|Fludarabine|fludarabine|mesh-list
6484997|NCT00564200|Bortezomib|bortezomib|mesh-list
5568032|NCT03953729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5568033|NCT03953729|Analgesics|analgesics|mesh-ancestor
5568034|NCT03953729|Sensory System Agents|sensory system agents|mesh-ancestor
5568035|NCT03953729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5568036|NCT03953729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6484998|NCT00564200|Melphalan|melphalan|mesh-list
6484999|NCT00564200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6485000|NCT00564200|Antiemetics|antiemetics|mesh-ancestor
6485001|NCT00564200|Autonomic Agents|autonomic agents|mesh-ancestor
6485002|NCT00564200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6485003|NCT00564200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485004|NCT00564200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6485005|NCT00564200|Glucocorticoids|glucocorticoids|mesh-ancestor
5568037|NCT03953729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5568038|NCT03953729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5568039|NCT03953729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5568040|NCT03953729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6485006|NCT00564200|Hormones|hormones|mesh-ancestor
6485007|NCT00564200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6485008|NCT00564200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6485009|NCT00564200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6485010|NCT00564200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485011|NCT00564200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6485012|NCT00564200|Immunologic Factors|immunologic factors|mesh-ancestor
6485013|NCT00564200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6485014|NCT00564200|Alkylating Agents|alkylating agents|mesh-ancestor
6170379|NCT01629563|Ulipristal acetate|ulipristal acetate|mesh-list
6170380|NCT01629563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6170381|NCT01629563|Contraceptive Agents|contraceptive agents|mesh-ancestor
6485015|NCT00564200|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6485016|NCT00564213|Mitomycins|mitomycins|mesh-list
6485017|NCT00564213|Mitomycin|mitomycin|mesh-list
6485018|NCT00564213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6485019|NCT00564213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6485020|NCT00564213|Alkylating Agents|alkylating agents|mesh-ancestor
6485021|NCT00564213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485022|NCT00564213|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6485023|NCT00564213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6485024|NCT00564252|Finasteride|finasteride|mesh-list
6485025|NCT00564252|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6485026|NCT00564252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6485027|NCT00564252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6485028|NCT00564252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170382|NCT01629563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6170383|NCT01629563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170384|NCT01629563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6170385|NCT01629589|Vaccines|vaccines|mesh-list
6170386|NCT01629589|Immunologic Factors|immunologic factors|mesh-ancestor
6170387|NCT01629589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170388|NCT01629667|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6170389|NCT01629667|Immunologic Factors|immunologic factors|mesh-ancestor
6170390|NCT01629667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170391|NCT01629966|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
6170392|NCT01629966|Antidepressive Agents|antidepressive agents|mesh-ancestor
6170393|NCT01629966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6170394|NCT01629966|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6170395|NCT01629966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6170396|NCT01629966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6170397|NCT01629966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170398|NCT01629966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6170399|NCT01629966|Serotonin Agents|serotonin agents|mesh-ancestor
6170400|NCT01629966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170401|NCT01629966|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6170402|NCT01629966|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6170403|NCT01630109|Metoclopramide|metoclopramide|mesh-list
6170404|NCT01630109|Antiemetics|antiemetics|mesh-ancestor
6170405|NCT01630109|Autonomic Agents|autonomic agents|mesh-ancestor
6170406|NCT01630109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6170407|NCT01630109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170408|NCT01630109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6170409|NCT01630109|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6170410|NCT01630109|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6170411|NCT01630109|Dopamine Agents|dopamine agents|mesh-ancestor
6170412|NCT01630109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6170413|NCT01630109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170414|NCT01630135|Fluticasone|fluticasone|mesh-list
6170415|NCT01630135|Xhance|xhance|mesh-list
6170416|NCT01630135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6170417|NCT01630135|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6170418|NCT01630135|Autonomic Agents|autonomic agents|mesh-ancestor
6170419|NCT01630135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5568041|NCT03953729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604083|NCT05177991|Bupivacaine|bupivacaine|mesh-list
5604084|NCT05177991|Anesthetics, Local|anesthetics, local|mesh-ancestor
5604085|NCT05177991|Anesthetics|anesthetics|mesh-ancestor
5604086|NCT05177991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6170420|NCT01630135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170421|NCT01630135|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6170422|NCT01630135|Respiratory System Agents|respiratory system agents|mesh-ancestor
6170423|NCT01630135|Dermatologic Agents|dermatologic agents|mesh-ancestor
6170424|NCT01630135|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6170425|NCT01630811|Quinidine|quinidine|mesh-list
6485029|NCT00564252|Hormone Antagonists|hormone antagonists|mesh-ancestor
6485030|NCT00564252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6485031|NCT00564252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485032|NCT00564252|Urological Agents|urological agents|mesh-ancestor
6485033|NCT00564330|Esomeprazole|esomeprazole|mesh-list
6485034|NCT00564330|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6485035|NCT00564330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6485036|NCT00564330|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6485037|NCT00564330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6485038|NCT00564330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485039|NCT00564408|Carbachol|carbachol|mesh-list
6485040|NCT00564408|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6485041|NCT00564408|Miotics|miotics|mesh-ancestor
6485042|NCT00564408|Autonomic Agents|autonomic agents|mesh-ancestor
6485043|NCT00564408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6485044|NCT00564408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485045|NCT00564408|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6485046|NCT00564408|Cholinergic Agents|cholinergic agents|mesh-ancestor
6485047|NCT00564408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6485048|NCT00564408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485049|NCT00564408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6485050|NCT00564408|Analgesics|analgesics|mesh-ancestor
6485051|NCT00564408|Sensory System Agents|sensory system agents|mesh-ancestor
6485052|NCT00564408|Protective Agents|protective agents|mesh-ancestor
6485053|NCT00564460|Finasteride|finasteride|mesh-list
6170426|NCT01630811|Dextromethorphan|dextromethorphan|mesh-list
6170427|NCT01630811|Antitussive Agents|antitussive agents|mesh-ancestor
6170428|NCT01630811|Respiratory System Agents|respiratory system agents|mesh-ancestor
6170429|NCT01630811|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6170430|NCT01630811|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6170431|NCT01630811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6170432|NCT01630811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170433|NCT01630811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170434|NCT01630811|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6170435|NCT01630811|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6170436|NCT01630811|Adrenergic Agents|adrenergic agents|mesh-ancestor
5568042|NCT03953716|Desogestrel|desogestrel|mesh-list
5568043|NCT03953716|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5568044|NCT03953716|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5568045|NCT03953716|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5568046|NCT03953716|Contraceptive Agents|contraceptive agents|mesh-ancestor
5568047|NCT03953716|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5568048|NCT03953716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170437|NCT01630811|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6170438|NCT01630811|Antimalarials|antimalarials|mesh-ancestor
6170439|NCT01630811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6170440|NCT01630811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6170441|NCT01630811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6170442|NCT01630811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6170443|NCT01630811|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6170444|NCT01630811|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6170445|NCT01630811|Cholinergic Agents|cholinergic agents|mesh-ancestor
6170446|NCT01630811|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6170447|NCT01630811|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6170448|NCT01630811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6170449|NCT01630811|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6170450|NCT01630811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6170451|NCT01631110|Vaccines|vaccines|mesh-list
6170452|NCT01631110|Immunologic Factors|immunologic factors|mesh-ancestor
6170453|NCT01631110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170454|NCT01631149|Rocuronium|rocuronium|mesh-list
6170455|NCT01631149|Atracurium|atracurium|mesh-list
6170456|NCT01631149|Mivacurium|mivacurium|mesh-list
6170457|NCT01631149|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6170458|NCT01631149|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6170459|NCT01631149|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6170460|NCT01631149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6485054|NCT00564460|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6485055|NCT00564460|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6485056|NCT00564460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6485057|NCT00564460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485058|NCT00564460|Hormone Antagonists|hormone antagonists|mesh-ancestor
6485059|NCT00564460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6485060|NCT00564460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568049|NCT03953716|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5568050|NCT03953716|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5568051|NCT03953716|Progestins|progestins|mesh-ancestor
5568052|NCT03953716|Hormones|hormones|mesh-ancestor
5568053|NCT03953716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5568054|NCT03953261|Curcumin|curcumin|mesh-list
5568055|NCT03953261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5568056|NCT03953261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5568057|NCT03953261|Analgesics|analgesics|mesh-ancestor
5568058|NCT03953261|Sensory System Agents|sensory system agents|mesh-ancestor
5568059|NCT03953261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5568060|NCT03953261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568061|NCT03953261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5568062|NCT03953261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5568063|NCT03953261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5568064|NCT03953261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5568065|NCT03953261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568066|NCT03953300|Benralizumab|benralizumab|mesh-list
5568067|NCT03953300|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5568068|NCT03953300|Respiratory System Agents|respiratory system agents|mesh-ancestor
5568069|NCT03953326|Nitroprusside|nitroprusside|mesh-list
5568070|NCT03953326|Acetylcholine|acetylcholine|mesh-list
5568071|NCT03953326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5568072|NCT03953326|Vasodilator Agents|vasodilator agents|mesh-ancestor
5568073|NCT03953326|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5568074|NCT03953326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568075|NCT03953326|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6485061|NCT00564460|Urological Agents|urological agents|mesh-ancestor
6485062|NCT00564512|Cyclophosphamide|cyclophosphamide|mesh-list
6485063|NCT00564512|Rituximab|rituximab|mesh-list
6485064|NCT00564512|Fludarabine|fludarabine|mesh-list
6485065|NCT00564512|Alemtuzumab|alemtuzumab|mesh-list
6485066|NCT00564512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6485067|NCT00564512|Immunologic Factors|immunologic factors|mesh-ancestor
6485068|NCT00564512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485069|NCT00564512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6485070|NCT00564512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6485071|NCT00564512|Alkylating Agents|alkylating agents|mesh-ancestor
6485072|NCT00564512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485073|NCT00564512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6485074|NCT00564512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6485075|NCT00564512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6485076|NCT00564525|Amitriptyline|amitriptyline|mesh-list
6488993|NCT00588523|Thiotepa|thiotepa|mesh-list
5568076|NCT03953326|Cholinergic Agents|cholinergic agents|mesh-ancestor
5568077|NCT03953326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5568078|NCT03953326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568079|NCT03953235|Nivolumab|nivolumab|mesh-list
5568080|NCT03953235|Ipilimumab|ipilimumab|mesh-list
5568081|NCT03953235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5568082|NCT03953235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5568083|NCT03953235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5568084|NCT03953235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568085|NCT03953170|Teduglutide|teduglutide|mesh-list
5568086|NCT03953170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5568087|NCT03953170|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5568088|NCT03953170|Protective Agents|protective agents|mesh-ancestor
5568089|NCT03953170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568090|NCT03953001|Lidocaine|lidocaine|mesh-list
5568091|NCT03953001|Epinephrine|epinephrine|mesh-list
5568092|NCT03953001|Anesthetics, Local|anesthetics, local|mesh-list
5568093|NCT03953001|Anesthetics|anesthetics|mesh-list
5568094|NCT03953001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5568095|NCT03953001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568096|NCT03953001|Sensory System Agents|sensory system agents|mesh-ancestor
5568097|NCT03953001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5568098|NCT03953001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5568099|NCT03953001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5568100|NCT03953001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5568101|NCT03953001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5568102|NCT03953001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568103|NCT03953001|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5568104|NCT03953001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5568105|NCT03953001|Adrenergic Agents|adrenergic agents|mesh-ancestor
5568106|NCT03953001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5568107|NCT03953001|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5568108|NCT03953001|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5568109|NCT03953001|Autonomic Agents|autonomic agents|mesh-ancestor
5568110|NCT03953001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5568111|NCT03953001|Respiratory System Agents|respiratory system agents|mesh-ancestor
5568112|NCT03953001|Mydriatics|mydriatics|mesh-ancestor
5568113|NCT03953001|Sympathomimetics|sympathomimetics|mesh-ancestor
5568114|NCT03953001|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5568115|NCT03953287|Acetaminophen|acetaminophen|mesh-list
5568116|NCT03953287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5568117|NCT03953287|Analgesics|analgesics|mesh-ancestor
5568118|NCT03953287|Sensory System Agents|sensory system agents|mesh-ancestor
5568119|NCT03953287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5568120|NCT03953287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568121|NCT03953287|Antipyretics|antipyretics|mesh-ancestor
5568122|NCT03953131|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
5568123|NCT03953131|Chelating Agents|chelating agents|mesh-ancestor
5568124|NCT03953131|Sequestering Agents|sequestering agents|mesh-ancestor
6170461|NCT01631149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170462|NCT01631149|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
6170463|NCT01631149|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6170464|NCT01631149|Cholinergic Agents|cholinergic agents|mesh-ancestor
6170465|NCT01631149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6170466|NCT01631149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170467|NCT01631214|Alendronate|alendronate|mesh-list
6170468|NCT01631214|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6170469|NCT01631214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5568125|NCT03953131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568126|NCT03953209|Spironolactone|spironolactone|mesh-list
5568127|NCT03953209|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5568128|NCT03953209|Hormone Antagonists|hormone antagonists|mesh-ancestor
5568129|NCT03953209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5568130|NCT03953209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568131|NCT03953209|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5568132|NCT03953209|Diuretics|diuretics|mesh-ancestor
5568133|NCT03953209|Natriuretic Agents|natriuretic agents|mesh-ancestor
5568134|NCT03953066|Melatonin|melatonin|mesh-list
5568135|NCT03953066|Antioxidants|antioxidants|mesh-ancestor
5568136|NCT03953066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170470|NCT01631214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170471|NCT01631214|Immunologic Factors|immunologic factors|mesh-ancestor
6170472|NCT01631227|Eprosartan|eprosartan|mesh-list
6170473|NCT01631227|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6170474|NCT01631227|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
6170475|NCT01631227|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6170476|NCT01631227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170477|NCT01631630|Pioglitazone|pioglitazone|mesh-list
6170478|NCT01631630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6170479|NCT01631630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568137|NCT03953066|Protective Agents|protective agents|mesh-ancestor
5568138|NCT03953066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568139|NCT03953066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6170480|NCT01631656|Azelaic acid|azelaic acid|mesh-list
6170481|NCT01631656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6170482|NCT01631656|Dermatologic Agents|dermatologic agents|mesh-ancestor
5568140|NCT03952715|Ibuprofen|ibuprofen|mesh-list
5568141|NCT03952715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5568142|NCT03952715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5568143|NCT03952715|Analgesics|analgesics|mesh-ancestor
5568144|NCT03952715|Sensory System Agents|sensory system agents|mesh-ancestor
6170483|NCT01631682|Propranolol|propranolol|mesh-list
6170484|NCT01631682|Oxytocin|oxytocin|mesh-list
6170485|NCT01631682|Mifepristone|mifepristone|mesh-list
6170486|NCT01631682|Oxytocics|oxytocics|mesh-ancestor
6170487|NCT01631682|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6170488|NCT01631682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170489|NCT01631682|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5568145|NCT03952715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5568146|NCT03952715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568147|NCT03952715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5568148|NCT03952715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5568149|NCT03952715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5568150|NCT03952715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6170490|NCT01631682|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6170491|NCT01631682|Adrenergic Agents|adrenergic agents|mesh-ancestor
6170492|NCT01631682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6170493|NCT01631682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170494|NCT01631682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5568151|NCT03952715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568152|NCT03953118|Azithromycin|azithromycin|mesh-list
5568153|NCT03953118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5568154|NCT03953118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5568155|NCT03952832|Leflunomide|leflunomide|mesh-list
5568156|NCT03952832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5568157|NCT03952832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568158|NCT03952832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5568159|NCT03952832|Immunologic Factors|immunologic factors|mesh-ancestor
5568160|NCT03952832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568161|NCT03952650|Chloroquine|chloroquine|mesh-list
5568162|NCT03952650|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
5568163|NCT03952650|Pyrimethamine|pyrimethamine|mesh-list
5568164|NCT03952650|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
5568165|NCT03952650|Ibuprofen|ibuprofen|mesh-list
5568166|NCT03952650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5568167|NCT03952650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5568168|NCT03952650|Analgesics|analgesics|mesh-ancestor
5568169|NCT03952650|Sensory System Agents|sensory system agents|mesh-ancestor
5568170|NCT03952650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5568171|NCT03952650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568172|NCT03952650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5568173|NCT03952650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5568174|NCT03952650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5568175|NCT03952650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5568176|NCT03952650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568177|NCT03952650|Amebicides|amebicides|mesh-ancestor
5568178|NCT03952650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5568179|NCT03952650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5568180|NCT03952650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6170495|NCT01631682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6170496|NCT01631682|Vasodilator Agents|vasodilator agents|mesh-ancestor
6170497|NCT01631682|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6170498|NCT01631682|Abortifacient Agents|abortifacient agents|mesh-ancestor
6170499|NCT01631682|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6170500|NCT01631682|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6170501|NCT01631682|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6170502|NCT01631682|Contraceptive Agents|contraceptive agents|mesh-ancestor
6170503|NCT01631682|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6170504|NCT01631682|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6170505|NCT01631682|Hormone Antagonists|hormone antagonists|mesh-ancestor
6170506|NCT01631682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6170507|NCT01631682|Luteolytic Agents|luteolytic agents|mesh-ancestor
6170508|NCT01631682|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6170509|NCT01631682|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6170510|NCT01631825|Rotigotine|rotigotine|mesh-list
6170511|NCT01631825|Dopamine Agonists|dopamine agonists|mesh-ancestor
6170512|NCT01631825|Dopamine Agents|dopamine agents|mesh-ancestor
6170513|NCT01631825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6170514|NCT01631825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170515|NCT01631825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170516|NCT01631864|Amlodipine|amlodipine|mesh-list
6170517|NCT01631864|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
6170518|NCT01631864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6170519|NCT01631864|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6170520|NCT01631864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6170521|NCT01631864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170522|NCT01631864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6170523|NCT01631864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170524|NCT01631864|Vasodilator Agents|vasodilator agents|mesh-ancestor
6170525|NCT01631864|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6170526|NCT01632150|Thalidomide|thalidomide|mesh-list
6170527|NCT01632150|Dexamethasone|dexamethasone|mesh-list
6170528|NCT01632150|Dexamethasone acetate|dexamethasone acetate|mesh-list
6170529|NCT01632150|Cyclophosphamide|cyclophosphamide|mesh-list
6170530|NCT01632150|Elotuzumab|elotuzumab|mesh-list
6170531|NCT01632150|BB 1101|bb 1101|mesh-list
6170532|NCT01632150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6170533|NCT01632150|Immunologic Factors|immunologic factors|mesh-ancestor
6170534|NCT01632150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170535|NCT01632150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6170536|NCT01632150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6170537|NCT01632150|Alkylating Agents|alkylating agents|mesh-ancestor
6170538|NCT01632150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170539|NCT01632150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6170540|NCT01632150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6170541|NCT01632150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6485077|NCT00564525|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6485078|NCT00564525|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6485079|NCT00564525|Antidepressive Agents|antidepressive agents|mesh-ancestor
6485080|NCT00564525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6485081|NCT00564525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6485082|NCT00564525|Analgesics|analgesics|mesh-ancestor
6485083|NCT00564525|Sensory System Agents|sensory system agents|mesh-ancestor
6485084|NCT00564525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6485085|NCT00564525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485086|NCT00564525|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6485087|NCT00564525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6485088|NCT00564525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6485089|NCT00564525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568181|NCT03952650|Antimalarials|antimalarials|mesh-ancestor
5568182|NCT03952650|Filaricides|filaricides|mesh-ancestor
5568183|NCT03952650|Antinematodal Agents|antinematodal agents|mesh-ancestor
5568184|NCT03952650|Anthelmintics|anthelmintics|mesh-ancestor
5568185|NCT03952650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5568186|NCT03952572|Prednisone|prednisone|mesh-list
5568187|NCT03952572|Cyclophosphamide|cyclophosphamide|mesh-list
5568188|NCT03952572|Doxorubicin|doxorubicin|mesh-list
6485090|NCT00564525|Adrenergic Agents|adrenergic agents|mesh-ancestor
6485091|NCT00564525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6485092|NCT00564525|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6485093|NCT00564525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6485094|NCT00564525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6485095|NCT00564538|Tacrolimus|tacrolimus|mesh-list
6485096|NCT00564538|Thymoglobulin|thymoglobulin|mesh-list
6485097|NCT00564538|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6485098|NCT00564538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6485099|NCT00564538|Immunologic Factors|immunologic factors|mesh-ancestor
6485100|NCT00564538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485101|NCT00564538|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6485102|NCT00564538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6485103|NCT00564538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485104|NCT00564551|Calcium, Dietary|calcium, dietary|mesh-list
6485105|NCT00564551|Calcium|calcium|mesh-list
6485106|NCT00564551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6485107|NCT00564551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485108|NCT00564551|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6485109|NCT00564564|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6485110|NCT00564564|Clomipramine|clomipramine|mesh-list
6485111|NCT00564564|Antidepressive Agents|antidepressive agents|mesh-ancestor
5568189|NCT03952572|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5568190|NCT03952572|Vincristine|vincristine|mesh-list
6170542|NCT01632150|Antiemetics|antiemetics|mesh-ancestor
6170543|NCT01632150|Autonomic Agents|autonomic agents|mesh-ancestor
6170544|NCT01632150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6170545|NCT01632150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6170546|NCT01632150|Glucocorticoids|glucocorticoids|mesh-ancestor
6170547|NCT01632150|Hormones|hormones|mesh-ancestor
5568191|NCT03952572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5568192|NCT03952572|Immunologic Factors|immunologic factors|mesh-ancestor
5568193|NCT03952572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568194|NCT03952572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5568195|NCT03952572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5568196|NCT03952572|Alkylating Agents|alkylating agents|mesh-ancestor
5568197|NCT03952572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170548|NCT01632150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6170549|NCT01632150|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6170550|NCT01632150|Protease Inhibitors|protease inhibitors|mesh-ancestor
6170551|NCT01632150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6170552|NCT01632150|Leprostatic Agents|leprostatic agents|mesh-ancestor
6170553|NCT01632150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6170554|NCT01632150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5568198|NCT03952572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5568199|NCT03952572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5568200|NCT03952572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5568201|NCT03952572|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6170555|NCT01632150|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6485112|NCT00564564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6170556|NCT01632150|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6170557|NCT01632150|Growth Substances|growth substances|mesh-ancestor
5568202|NCT03952572|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5568203|NCT03952572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5568204|NCT03952572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5568205|NCT03952572|Glucocorticoids|glucocorticoids|mesh-ancestor
5568206|NCT03952572|Hormones|hormones|mesh-ancestor
5568207|NCT03952572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5568208|NCT03952572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5568209|NCT03952572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6170558|NCT01632150|Growth Inhibitors|growth inhibitors|mesh-ancestor
6170559|NCT01632215|Gabapentin|gabapentin|mesh-list
6170560|NCT01632215|Anticonvulsants|anticonvulsants|mesh-list
6170561|NCT01632215|Analgesics|analgesics|mesh-ancestor
6170562|NCT01632215|Sensory System Agents|sensory system agents|mesh-ancestor
6170563|NCT01632215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6170564|NCT01632215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170565|NCT01632215|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5568210|NCT03952572|Tubulin Modulators|tubulin modulators|mesh-ancestor
5568211|NCT03952572|Antimitotic Agents|antimitotic agents|mesh-ancestor
5568212|NCT03952572|Mitosis Modulators|mitosis modulators|mesh-ancestor
5568213|NCT03952481|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5568214|NCT03952481|Lifitegrast|lifitegrast|mesh-list
5568215|NCT03952481|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5568216|NCT03952403|Bevacizumab|bevacizumab|mesh-list
6170566|NCT01632215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6170567|NCT01632215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6170568|NCT01632215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6170569|NCT01632215|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6170570|NCT01632215|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6170571|NCT01632215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6170572|NCT01632215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170573|NCT01632215|Antimanic Agents|antimanic agents|mesh-ancestor
6170574|NCT01632241|Belimumab|belimumab|mesh-list
6170575|NCT01632241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6170576|NCT01632241|Immunologic Factors|immunologic factors|mesh-ancestor
6170577|NCT01632241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170578|NCT01632306|Leucovorin|leucovorin|mesh-list
6170579|NCT01632306|Gemcitabine|gemcitabine|mesh-list
6170580|NCT01632306|Paclitaxel|paclitaxel|mesh-list
6170581|NCT01632306|Fluorouracil|fluorouracil|mesh-list
6170582|NCT01632306|Oxaliplatin|oxaliplatin|mesh-list
6170583|NCT01632306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6170584|NCT01632306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6170585|NCT01632306|Tubulin Modulators|tubulin modulators|mesh-ancestor
6170586|NCT01632306|Antimitotic Agents|antimitotic agents|mesh-ancestor
6170587|NCT01632306|Mitosis Modulators|mitosis modulators|mesh-ancestor
6170588|NCT01632306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568217|NCT03952403|Carboplatin|carboplatin|mesh-list
5568218|NCT03952403|Pemetrexed|pemetrexed|mesh-list
5568219|NCT03952403|Antibodies|antibodies|mesh-list
5568220|NCT03952403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5568221|NCT03952403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6170589|NCT01632306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6170590|NCT01632306|Antimetabolites|antimetabolites|mesh-ancestor
6170591|NCT01632306|Antiviral Agents|antiviral agents|mesh-ancestor
6170592|NCT01632306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6170593|NCT01632306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6170594|NCT01632306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6170595|NCT01632306|Immunologic Factors|immunologic factors|mesh-ancestor
6170596|NCT01632306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170597|NCT01632306|Antidotes|antidotes|mesh-ancestor
6170598|NCT01632306|Protective Agents|protective agents|mesh-ancestor
6170599|NCT01632306|Vitamin B Complex|vitamin b complex|mesh-ancestor
6170600|NCT01632306|Vitamins|vitamins|mesh-ancestor
6170601|NCT01632306|Micronutrients|micronutrients|mesh-ancestor
6170602|NCT01632345|Efavirenz|efavirenz|mesh-list
6170603|NCT01632345|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6170604|NCT01632345|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6170605|NCT01632345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6170606|NCT01632345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6170607|NCT01632345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170608|NCT01632345|Antiviral Agents|antiviral agents|mesh-ancestor
5568222|NCT03952403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5568223|NCT03952403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6170609|NCT01632345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6485113|NCT00564564|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5568224|NCT03952403|Growth Substances|growth substances|mesh-ancestor
5568225|NCT03952403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568226|NCT03952403|Growth Inhibitors|growth inhibitors|mesh-ancestor
5568227|NCT03952403|Immunologic Factors|immunologic factors|mesh-ancestor
5568228|NCT03952403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5568229|NCT03952403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568230|NCT03952403|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5568231|NCT03952403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5568232|NCT03952325|Pembrolizumab|pembrolizumab|mesh-list
5568233|NCT03952325|Nivolumab|nivolumab|mesh-list
5568234|NCT03952325|Atezolizumab|atezolizumab|mesh-list
5568235|NCT03952325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5568236|NCT03952325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5568237|NCT03952325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5568238|NCT03952325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568239|NCT03952273|Sirolimus|sirolimus|mesh-list
5568240|NCT03952273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5568241|NCT03952273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5568242|NCT03952273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5568243|NCT03952273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5568244|NCT03952273|Antifungal Agents|antifungal agents|mesh-ancestor
5568245|NCT03952273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5568246|NCT03952273|Immunologic Factors|immunologic factors|mesh-ancestor
5568247|NCT03952273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568248|NCT03952260|Anesthetics|anesthetics|mesh-list
5568249|NCT03952260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5568250|NCT03952260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568251|NCT03951987|Charcoal|charcoal|mesh-list
5568252|NCT03951987|Antidotes|antidotes|mesh-ancestor
5568253|NCT03951987|Protective Agents|protective agents|mesh-ancestor
5568254|NCT03951987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170610|NCT01632345|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6170611|NCT01632345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6170612|NCT01632345|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6170613|NCT01632345|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6170614|NCT01632345|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6170615|NCT01632345|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6170616|NCT01632345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6170617|NCT01632345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6170618|NCT01632423|Bimatoprost|bimatoprost|mesh-list
6485114|NCT00564564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6485115|NCT00564564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5568255|NCT03951558|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5568256|NCT03951558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5568257|NCT03951558|Diuretics|diuretics|mesh-ancestor
5568258|NCT03951558|Natriuretic Agents|natriuretic agents|mesh-ancestor
6485116|NCT00564564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485117|NCT00564564|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5568259|NCT03951558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568260|NCT03951558|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5568261|NCT03951558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5568262|NCT03951558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568263|NCT03951831|Docetaxel|docetaxel|mesh-list
5568264|NCT03951831|Leuprolide|leuprolide|mesh-list
5568265|NCT03951831|Cemiplimab|cemiplimab|mesh-list
5568266|NCT03951831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5568267|NCT03951831|Tubulin Modulators|tubulin modulators|mesh-ancestor
5568268|NCT03951831|Antimitotic Agents|antimitotic agents|mesh-ancestor
5568269|NCT03951831|Mitosis Modulators|mitosis modulators|mesh-ancestor
6485118|NCT00564564|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6485119|NCT00564564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6485120|NCT00564564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6485121|NCT00564564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485122|NCT00564564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6485123|NCT00564564|Serotonin Agents|serotonin agents|mesh-ancestor
6485124|NCT00564590|Melatonin|melatonin|mesh-list
6485125|NCT00564590|Omeprazole|omeprazole|mesh-list
6485126|NCT00564590|Antioxidants|antioxidants|mesh-ancestor
6485127|NCT00564590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485128|NCT00564590|Protective Agents|protective agents|mesh-ancestor
6485129|NCT00564590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485130|NCT00564590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5568270|NCT03951831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568271|NCT03951831|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6485131|NCT00564590|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6485132|NCT00564590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6485133|NCT00564590|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6485134|NCT00564590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6485135|NCT00564603|Dexamethasone|dexamethasone|mesh-list
6485136|NCT00564603|Dexamethasone acetate|dexamethasone acetate|mesh-list
6485137|NCT00564603|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
6485138|NCT00564603|BB 1101|bb 1101|mesh-list
6485139|NCT00564603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6485140|NCT00564603|Antiemetics|antiemetics|mesh-ancestor
6485141|NCT00564603|Autonomic Agents|autonomic agents|mesh-ancestor
6485142|NCT00564603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6485143|NCT00564603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485144|NCT00564603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6485145|NCT00564603|Glucocorticoids|glucocorticoids|mesh-ancestor
6485146|NCT00564603|Hormones|hormones|mesh-ancestor
6485147|NCT00564603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6485148|NCT00564603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6485149|NCT00564603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6485150|NCT00564603|Protease Inhibitors|protease inhibitors|mesh-ancestor
6485151|NCT00564603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6485152|NCT00564603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485153|NCT00564642|Acetylcysteine|acetylcysteine|mesh-list
6485154|NCT00564642|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6485155|NCT00564642|Antiviral Agents|antiviral agents|mesh-ancestor
6485156|NCT00564642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6485157|NCT00564642|Expectorants|expectorants|mesh-ancestor
6485158|NCT00564642|Respiratory System Agents|respiratory system agents|mesh-ancestor
6170619|NCT01632423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6170620|NCT01632566|Celecoxib|celecoxib|mesh-list
6170621|NCT01632566|Simvastatin|simvastatin|mesh-list
6170622|NCT01632566|LY3031207|ly3031207|mesh-list
6170623|NCT01632566|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6170624|NCT01632566|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6170625|NCT01632566|Antimetabolites|antimetabolites|mesh-ancestor
6170626|NCT01632566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568272|NCT03951831|Fertility Agents|fertility agents|mesh-ancestor
5568273|NCT03951831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5568274|NCT03951831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568275|NCT03951831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5568276|NCT03951831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6170627|NCT01632566|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6170628|NCT01632566|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6170629|NCT01632566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6170630|NCT01632566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6170631|NCT01632566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6170632|NCT01632566|Analgesics|analgesics|mesh-ancestor
6170633|NCT01632566|Sensory System Agents|sensory system agents|mesh-ancestor
6170634|NCT01632566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6170635|NCT01632566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170636|NCT01632566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6170637|NCT01632566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6170638|NCT01632566|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6170639|NCT01632566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6170640|NCT01632566|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
6170641|NCT01632566|Hormone Antagonists|hormone antagonists|mesh-ancestor
6170642|NCT01632566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6170643|NCT01632579|Celecoxib|celecoxib|mesh-list
6170644|NCT01632579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6170645|NCT01632579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6170646|NCT01632579|Analgesics|analgesics|mesh-ancestor
6170647|NCT01632579|Sensory System Agents|sensory system agents|mesh-ancestor
6170648|NCT01632579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6170649|NCT01632579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170650|NCT01632579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6170651|NCT01632579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6170652|NCT01632579|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6170653|NCT01632579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6170654|NCT01632579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6485159|NCT00564642|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6485160|NCT00564642|Antioxidants|antioxidants|mesh-ancestor
5604087|NCT05177991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604088|NCT05177991|Sensory System Agents|sensory system agents|mesh-ancestor
6170655|NCT01632579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170656|NCT01632709|Bupivacaine|bupivacaine|mesh-list
6170657|NCT01632709|Anesthetics, Local|anesthetics, local|mesh-ancestor
6170658|NCT01632709|Anesthetics|anesthetics|mesh-ancestor
6170659|NCT01632709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6170660|NCT01632709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170661|NCT01632709|Sensory System Agents|sensory system agents|mesh-ancestor
6170662|NCT01632709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6170663|NCT01632891|Ritonavir|ritonavir|mesh-list
6170664|NCT01632891|Lopinavir|lopinavir|mesh-list
6170665|NCT01632891|Tenofovir|tenofovir|mesh-list
6170666|NCT01632891|Emtricitabine|emtricitabine|mesh-list
6170667|NCT01632891|Nevirapine|nevirapine|mesh-list
6170668|NCT01632891|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6170669|NCT01632891|Efavirenz|efavirenz|mesh-list
6170670|NCT01632891|Trimethoprim|trimethoprim|mesh-list
6170671|NCT01632891|Sulfamethoxazole|sulfamethoxazole|mesh-list
6485161|NCT00564642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485162|NCT00564642|Protective Agents|protective agents|mesh-ancestor
6485163|NCT00564642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170672|NCT01632891|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6170673|NCT01632891|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6170674|NCT01632891|Protease Inhibitors|protease inhibitors|mesh-ancestor
6170675|NCT01632891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6170676|NCT01632891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170677|NCT01632891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6170678|NCT01632891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6170679|NCT01632891|Antiviral Agents|antiviral agents|mesh-ancestor
6170680|NCT01632891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6170681|NCT01632891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6170682|NCT01632891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6170683|NCT01632891|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6170684|NCT01632891|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6170685|NCT01632891|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6170686|NCT01632891|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6170687|NCT01632891|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6170688|NCT01632891|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6170689|NCT01632891|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6170690|NCT01632891|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6170691|NCT01632891|Renal Agents|renal agents|mesh-ancestor
6170692|NCT01632891|Antimalarials|antimalarials|mesh-ancestor
6170693|NCT01632891|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6170694|NCT01632891|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6170695|NCT01632891|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6170696|NCT01632891|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6170697|NCT01632891|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6170698|NCT01632904|Hydroxyurea|hydroxyurea|mesh-list
6170699|NCT01632904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6170700|NCT01632904|Antisickling Agents|antisickling agents|mesh-ancestor
6170701|NCT01632904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6170702|NCT01632904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170703|NCT01632904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6170704|NCT01632995|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6170705|NCT01632995|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6170706|NCT01632995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6170707|NCT01632995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6170708|NCT01632995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170709|NCT01632995|Antiviral Agents|antiviral agents|mesh-ancestor
6170710|NCT01632995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6170711|NCT01632995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6170712|NCT01632995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6170713|NCT01633060|Fulvestrant|fulvestrant|mesh-list
6170714|NCT01633060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6170715|NCT01633060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6170716|NCT01633060|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6170717|NCT01633060|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6170718|NCT01633060|Hormone Antagonists|hormone antagonists|mesh-ancestor
6170719|NCT01633060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6170720|NCT01633060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170721|NCT01633112|Glatiramer Acetate|glatiramer acetate|mesh-list
6170722|NCT01633112|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6170723|NCT01633112|(T,G)-A-L|(t,g)-a-l|mesh-list
6170724|NCT01633112|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6170725|NCT01633112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170726|NCT01633112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6170727|NCT01633112|Immunologic Factors|immunologic factors|mesh-ancestor
6170728|NCT01633112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170729|NCT01633112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6170730|NCT01633112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6170731|NCT01633827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
6170732|NCT01633827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6170733|NCT01633827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485164|NCT00564642|Antidotes|antidotes|mesh-ancestor
6485165|NCT00564655|Epinephrine|epinephrine|mesh-list
6485166|NCT00564655|Racepinephrine|racepinephrine|mesh-list
6485167|NCT00564655|Bupivacaine|bupivacaine|mesh-list
6485168|NCT00564655|Epinephryl borate|epinephryl borate|mesh-list
6485169|NCT00564655|Anesthetics, Local|anesthetics, local|mesh-ancestor
6485170|NCT00564655|Anesthetics|anesthetics|mesh-ancestor
6485171|NCT00564655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6485172|NCT00564655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485173|NCT00564655|Sensory System Agents|sensory system agents|mesh-ancestor
6485174|NCT00564655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6485175|NCT00564655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6485176|NCT00564655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6485177|NCT00564655|Adrenergic Agents|adrenergic agents|mesh-ancestor
6485178|NCT00564655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6485179|NCT00564655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485180|NCT00564655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6485181|NCT00564655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6485182|NCT00564655|Autonomic Agents|autonomic agents|mesh-ancestor
6485183|NCT00564655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6485184|NCT00564655|Respiratory System Agents|respiratory system agents|mesh-ancestor
6485185|NCT00564655|Mydriatics|mydriatics|mesh-ancestor
6485186|NCT00564655|Sympathomimetics|sympathomimetics|mesh-ancestor
6485187|NCT00564655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6485188|NCT00564668|Insulin Aspart|insulin aspart|mesh-list
6485189|NCT00564668|Biphasic Insulins|biphasic insulins|mesh-list
6485190|NCT00564668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6669831|NCT01539733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6669832|NCT01539733|Serotonin Agents|serotonin agents|mesh-ancestor
6170734|NCT01633853|Vitamin D|vitamin d|mesh-list
6170735|NCT01633853|Ergocalciferols|ergocalciferols|mesh-list
6170736|NCT01633853|Calcitriol|calcitriol|mesh-list
6170737|NCT01633853|Vitamins|vitamins|mesh-list
6170738|NCT01633853|Micronutrients|micronutrients|mesh-ancestor
6170739|NCT01633853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170740|NCT01633853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6170741|NCT01633853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6170742|NCT01633853|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6170743|NCT01633853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6170744|NCT01633853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170745|NCT01633853|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6170746|NCT01633944|Buprenorphine|buprenorphine|mesh-list
6170747|NCT01633944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6170748|NCT01633944|Narcotics|narcotics|mesh-ancestor
6485191|NCT00564668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669833|NCT01539733|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6669834|NCT01539733|Dopamine Agents|dopamine agents|mesh-ancestor
6669835|NCT01539733|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6669836|NCT01539798|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6669837|NCT01539902|Cyclophosphamide|cyclophosphamide|mesh-list
6669838|NCT01539902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6669839|NCT01539902|Immunologic Factors|immunologic factors|mesh-ancestor
6669840|NCT01539902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669841|NCT01539902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6669842|NCT01539902|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6669843|NCT01539902|Alkylating Agents|alkylating agents|mesh-ancestor
6669844|NCT01539902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669845|NCT01539902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6669846|NCT01539902|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6669847|NCT01540032|Salicylates|salicylates|mesh-list
6669848|NCT01540032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6669849|NCT01540032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6669850|NCT01540032|Analgesics|analgesics|mesh-ancestor
6669851|NCT01540032|Sensory System Agents|sensory system agents|mesh-ancestor
6485192|NCT00564707|Botulinum Toxins|botulinum toxins|mesh-list
6669852|NCT01540032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6669853|NCT01540032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669854|NCT01540032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5568277|NCT03951636|Chlorhexidine|chlorhexidine|mesh-list
5568278|NCT03951636|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5568279|NCT03951636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5568280|NCT03951636|Disinfectants|disinfectants|mesh-ancestor
5568281|NCT03951753|Tirzepatide|tirzepatide|mesh-list
5568282|NCT03951753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5568283|NCT03951753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568284|NCT03951753|Incretins|incretins|mesh-ancestor
5568285|NCT03951753|Hormones|hormones|mesh-ancestor
5568286|NCT03951753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6669855|NCT01540032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6669856|NCT01540032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6669857|NCT01540032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6669858|NCT01540032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669859|NCT01540084|Propofol|propofol|mesh-list
6669860|NCT01540084|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6669861|NCT01540084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6669862|NCT01540084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669863|NCT01540084|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6669864|NCT01540084|Anesthetics, General|anesthetics, general|mesh-ancestor
6669865|NCT01540084|Anesthetics|anesthetics|mesh-ancestor
6669866|NCT01540110|Cyclophosphamide|cyclophosphamide|mesh-list
6669867|NCT01540110|Docetaxel|docetaxel|mesh-list
6170749|NCT01633944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5568287|NCT03951597|Gemcitabine|gemcitabine|mesh-list
5568288|NCT03951597|Oxaliplatin|oxaliplatin|mesh-list
5568289|NCT03951597|Lenvatinib|lenvatinib|mesh-list
5568290|NCT03951597|Antibodies|antibodies|mesh-list
5568291|NCT03951597|Immunologic Factors|immunologic factors|mesh-ancestor
5568292|NCT03951597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170750|NCT01633944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170751|NCT01633944|Analgesics|analgesics|mesh-ancestor
6170752|NCT01633944|Sensory System Agents|sensory system agents|mesh-ancestor
6170753|NCT01633944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6170754|NCT01633944|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6170755|NCT01634100|Empagliflozin|empagliflozin|mesh-list
6170756|NCT01634100|Rifampin|rifampin|mesh-list
6170757|NCT01634100|Probenecid|probenecid|mesh-list
6170758|NCT01634100|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6170759|NCT01634100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170760|NCT01634100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6170761|NCT01634100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170762|NCT01634100|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6170763|NCT01634100|Antitubercular Agents|antitubercular agents|mesh-ancestor
6669868|NCT01540110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6170764|NCT01634100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6170765|NCT01634100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6669869|NCT01540110|Immunologic Factors|immunologic factors|mesh-ancestor
5568293|NCT03951597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5568294|NCT03951597|Antimetabolites|antimetabolites|mesh-ancestor
5568295|NCT03951597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568296|NCT03951597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5568297|NCT03951597|Antiviral Agents|antiviral agents|mesh-ancestor
5568298|NCT03951597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5568299|NCT03951597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5568300|NCT03951597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5568301|NCT03951597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5568302|NCT03951415|Durvalumab|durvalumab|mesh-list
5568303|NCT03951415|Olaparib|olaparib|mesh-list
5568304|NCT03951415|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
5568305|NCT03951415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5568306|NCT03951415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5568307|NCT03951415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6170766|NCT01634100|Leprostatic Agents|leprostatic agents|mesh-ancestor
6170767|NCT01634100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6170768|NCT01634100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6170769|NCT01634100|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6170770|NCT01634100|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6170771|NCT01634100|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6170772|NCT01634100|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6170773|NCT01634100|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6170774|NCT01634100|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6669870|NCT01540110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669871|NCT01540110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6669872|NCT01540110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6669873|NCT01540110|Alkylating Agents|alkylating agents|mesh-ancestor
6170775|NCT01634100|Uricosuric Agents|uricosuric agents|mesh-ancestor
6170776|NCT01634100|Gout Suppressants|gout suppressants|mesh-ancestor
6170777|NCT01634100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6170778|NCT01634100|Renal Agents|renal agents|mesh-ancestor
6170779|NCT01634113|Bromides|bromides|mesh-list
6170780|NCT01634113|Tiotropium Bromide|tiotropium bromide|mesh-list
6170781|NCT01634113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6170782|NCT01634113|Autonomic Agents|autonomic agents|mesh-ancestor
5568308|NCT03951415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568309|NCT03951493|Zoledronic Acid|zoledronic acid|mesh-list
5568310|NCT03951493|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5568311|NCT03951493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568312|NCT03951402|Moxifloxacin|moxifloxacin|mesh-list
5568313|NCT03951402|Tapentadol|tapentadol|mesh-list
5568314|NCT03951402|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6170783|NCT01634113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6170784|NCT01634113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170785|NCT01634113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6170786|NCT01634113|Respiratory System Agents|respiratory system agents|mesh-ancestor
6170787|NCT01634113|Parasympatholytics|parasympatholytics|mesh-ancestor
6170788|NCT01634113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6170789|NCT01634113|Cholinergic Agents|cholinergic agents|mesh-ancestor
6170790|NCT01634113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6170791|NCT01634113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170792|NCT01634113|Anticonvulsants|anticonvulsants|mesh-ancestor
6170793|NCT01634139|Tiotropium Bromide|tiotropium bromide|mesh-list
6170794|NCT01634139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6170795|NCT01634139|Autonomic Agents|autonomic agents|mesh-ancestor
6170796|NCT01634139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6170797|NCT01634139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170798|NCT01634139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6170799|NCT01634139|Respiratory System Agents|respiratory system agents|mesh-ancestor
6170800|NCT01634139|Parasympatholytics|parasympatholytics|mesh-ancestor
6170801|NCT01634139|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6170802|NCT01634139|Cholinergic Agents|cholinergic agents|mesh-ancestor
6170803|NCT01634139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6170804|NCT01634139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170805|NCT01634152|Tiotropium Bromide|tiotropium bromide|mesh-list
6170806|NCT01634152|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6170807|NCT01634152|Autonomic Agents|autonomic agents|mesh-ancestor
6170808|NCT01634152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6170809|NCT01634152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170810|NCT01634152|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6170811|NCT01634152|Respiratory System Agents|respiratory system agents|mesh-ancestor
6170812|NCT01634152|Parasympatholytics|parasympatholytics|mesh-ancestor
6170813|NCT01634152|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5568315|NCT03951402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5568316|NCT03951402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5568317|NCT03951402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5568318|NCT03951402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5568319|NCT03951402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5568320|NCT03951402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568321|NCT03951402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5568322|NCT03951402|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5568323|NCT03951402|Contraceptive Agents|contraceptive agents|mesh-ancestor
5568324|NCT03951402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5568325|NCT03951402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170814|NCT01634152|Cholinergic Agents|cholinergic agents|mesh-ancestor
6170815|NCT01634152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6669874|NCT01540110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669875|NCT01540110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6669876|NCT01540110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6669877|NCT01540110|Tubulin Modulators|tubulin modulators|mesh-ancestor
6669878|NCT01540110|Antimitotic Agents|antimitotic agents|mesh-ancestor
6669879|NCT01540110|Mitosis Modulators|mitosis modulators|mesh-ancestor
6669880|NCT01540136|Nedaplatin|nedaplatin|mesh-list
6669881|NCT01540136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6669882|NCT01540240|Zidovudine|zidovudine|mesh-list
6669883|NCT01540240|Antimetabolites|antimetabolites|mesh-ancestor
6669884|NCT01540240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669885|NCT01540240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5568326|NCT03951402|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5568327|NCT03951402|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5568328|NCT03951402|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5568329|NCT03951402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5568330|NCT03951402|Narcotics|narcotics|mesh-ancestor
6669886|NCT01540240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6669887|NCT01540240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6669888|NCT01540240|Antiviral Agents|antiviral agents|mesh-ancestor
6669889|NCT01540240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6669890|NCT01540240|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6669891|NCT01540240|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6170816|NCT01634152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170817|NCT01634165|Insulin Glargine|insulin glargine|mesh-list
6170818|NCT01634165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6170819|NCT01634165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170820|NCT01634178|Apremilast|apremilast|mesh-list
6170821|NCT01634178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6170822|NCT01634178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6170823|NCT01634178|Analgesics|analgesics|mesh-ancestor
6170824|NCT01634178|Sensory System Agents|sensory system agents|mesh-ancestor
6170825|NCT01634178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6170826|NCT01634178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568331|NCT03951402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5568332|NCT03951402|Analgesics|analgesics|mesh-ancestor
5568333|NCT03951402|Sensory System Agents|sensory system agents|mesh-ancestor
6170827|NCT01634178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6170828|NCT01634178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6170829|NCT01634178|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6170830|NCT01634178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6170831|NCT01634178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6170832|NCT01634178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170833|NCT01634191|Apremilast|apremilast|mesh-list
6170834|NCT01634191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6170835|NCT01634191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6669892|NCT01540253|Docetaxel|docetaxel|mesh-list
6669893|NCT01540253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6669894|NCT01540253|Tubulin Modulators|tubulin modulators|mesh-ancestor
6669895|NCT01540253|Antimitotic Agents|antimitotic agents|mesh-ancestor
6669896|NCT01540253|Mitosis Modulators|mitosis modulators|mesh-ancestor
6485193|NCT00564707|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6485194|NCT00564707|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6485195|NCT00564707|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6485196|NCT00564707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6485197|NCT00564707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485198|NCT00564707|Cholinergic Agents|cholinergic agents|mesh-ancestor
6485199|NCT00564707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6485200|NCT00564707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568334|NCT03951402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5568335|NCT03951402|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5568336|NCT03951402|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5568337|NCT03951402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5568338|NCT03951402|Adrenergic Agents|adrenergic agents|mesh-ancestor
5568339|NCT03951402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5568340|NCT03951285|Niacinamide|niacinamide|mesh-list
5568341|NCT03951285|Vitamin B Complex|vitamin b complex|mesh-ancestor
5568342|NCT03951285|Vitamins|vitamins|mesh-ancestor
5568343|NCT03951285|Micronutrients|micronutrients|mesh-ancestor
6485201|NCT00564707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6485202|NCT00564707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6485203|NCT00564720|Gemcitabine|gemcitabine|mesh-list
6485204|NCT00564720|Oxaliplatin|oxaliplatin|mesh-list
6485205|NCT00564720|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6485206|NCT00564720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6485207|NCT00564720|Antimetabolites|antimetabolites|mesh-ancestor
6485208|NCT00564720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485209|NCT00564720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6485210|NCT00564720|Antiviral Agents|antiviral agents|mesh-ancestor
6485211|NCT00564720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6669897|NCT01540253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568344|NCT03951285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170836|NCT01634191|Analgesics|analgesics|mesh-ancestor
6170837|NCT01634191|Sensory System Agents|sensory system agents|mesh-ancestor
6170838|NCT01634191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6485212|NCT00564720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6485213|NCT00564720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6485214|NCT00564720|Immunologic Factors|immunologic factors|mesh-ancestor
6485215|NCT00564720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485216|NCT00564720|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6485217|NCT00564772|Ritonavir|ritonavir|mesh-list
5568351|NCT03951207|Amlodipine|amlodipine|mesh-list
5568352|NCT03951207|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
5568353|NCT03951207|Atorvastatin|atorvastatin|mesh-list
5568354|NCT03951207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6485218|NCT00564772|Lopinavir|lopinavir|mesh-list
6170839|NCT01634191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170840|NCT01634191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6170841|NCT01634191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6170842|NCT01634191|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6170843|NCT01634191|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6170844|NCT01634191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6170845|NCT01634191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170846|NCT01634243|Rotigotine|rotigotine|mesh-list
6170847|NCT01634243|Dopamine Agonists|dopamine agonists|mesh-ancestor
6170848|NCT01634243|Dopamine Agents|dopamine agents|mesh-ancestor
6170849|NCT01634243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6170850|NCT01634243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170851|NCT01634243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170852|NCT01634555|Leucovorin|leucovorin|mesh-list
6170853|NCT01634555|Folic Acid|folic acid|mesh-list
6170854|NCT01634555|Fluorouracil|fluorouracil|mesh-list
6170855|NCT01634555|Irinotecan|irinotecan|mesh-list
6170856|NCT01634555|Ramucirumab|ramucirumab|mesh-list
6170857|NCT01634555|Levoleucovorin|levoleucovorin|mesh-list
6485219|NCT00564772|Raltegravir Potassium|raltegravir potassium|mesh-list
6485220|NCT00564772|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6485221|NCT00564772|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5568355|NCT03951207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5568356|NCT03951207|Antimetabolites|antimetabolites|mesh-ancestor
6170858|NCT01634555|Antimetabolites|antimetabolites|mesh-ancestor
6170859|NCT01634555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170860|NCT01634555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6170861|NCT01634555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6170862|NCT01634555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6170863|NCT01634555|Immunologic Factors|immunologic factors|mesh-ancestor
6170864|NCT01634555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170865|NCT01634555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6170866|NCT01634555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6170867|NCT01634555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6170868|NCT01634555|Antidotes|antidotes|mesh-ancestor
6170869|NCT01634555|Protective Agents|protective agents|mesh-ancestor
6170870|NCT01634555|Vitamin B Complex|vitamin b complex|mesh-ancestor
6170871|NCT01634555|Vitamins|vitamins|mesh-ancestor
6170872|NCT01634555|Micronutrients|micronutrients|mesh-ancestor
6170873|NCT01634555|Hematinics|hematinics|mesh-ancestor
6170874|NCT01634854|Misoprostol|misoprostol|mesh-list
6170875|NCT01634854|Oxytocin|oxytocin|mesh-list
6170876|NCT01634854|Oxytocics|oxytocics|mesh-ancestor
6170877|NCT01634854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6170878|NCT01634854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170879|NCT01634854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6170880|NCT01634854|Abortifacient Agents|abortifacient agents|mesh-ancestor
6170881|NCT01634854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6170882|NCT01634854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6170883|NCT01635062|Calcitriol|calcitriol|mesh-list
6170884|NCT01635062|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
6170885|NCT01635062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6170886|NCT01635062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170887|NCT01635062|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6170888|NCT01635062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6170889|NCT01635062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170890|NCT01635062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6170891|NCT01635062|Vitamins|vitamins|mesh-ancestor
6170892|NCT01635062|Micronutrients|micronutrients|mesh-ancestor
6170893|NCT01635062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6170894|NCT01635101|Acetaminophen|acetaminophen|mesh-list
5568357|NCT03951207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568358|NCT03951207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5568359|NCT03951207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5568360|NCT03951207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5568361|NCT03951207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5568362|NCT03951207|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5568363|NCT03951207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5568364|NCT03951207|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5568365|NCT03951207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568366|NCT03951207|Vasodilator Agents|vasodilator agents|mesh-ancestor
6170895|NCT01635101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6170896|NCT01635101|Analgesics|analgesics|mesh-ancestor
6170897|NCT01635101|Sensory System Agents|sensory system agents|mesh-ancestor
6170898|NCT01635101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6485222|NCT00564772|Protease Inhibitors|protease inhibitors|mesh-ancestor
6485223|NCT00564772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6485224|NCT00564772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170899|NCT01635101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170900|NCT01635101|Antipyretics|antipyretics|mesh-ancestor
6170901|NCT01635153|Micronutrients|micronutrients|mesh-list
6170902|NCT01635153|Trace Elements|trace elements|mesh-list
6170903|NCT01635153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206299|NCT02098395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6206300|NCT02098733|Pioglitazone|pioglitazone|mesh-list
6206301|NCT02098733|Glimepiride|glimepiride|mesh-list
6206302|NCT02098733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6206303|NCT02098733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206304|NCT02098733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6206305|NCT02098733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6206306|NCT02098733|Immunologic Factors|immunologic factors|mesh-ancestor
6206307|NCT02098746|Pioglitazone|pioglitazone|mesh-list
6206308|NCT02098746|Glimepiride|glimepiride|mesh-list
6206309|NCT02098746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6206310|NCT02098746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206311|NCT02098746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6206312|NCT02098746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6206313|NCT02098746|Immunologic Factors|immunologic factors|mesh-ancestor
6206314|NCT02098993|Heparin|heparin|mesh-list
6485225|NCT00564772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6485226|NCT00564772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6485227|NCT00564772|Antiviral Agents|antiviral agents|mesh-ancestor
6485228|NCT00564772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6485229|NCT00564772|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6485230|NCT00564772|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6485231|NCT00564772|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6485232|NCT00564772|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6485233|NCT00564824|Caffeine|caffeine|mesh-list
6485234|NCT00564824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6206315|NCT02098993|Calcium heparin|calcium heparin|mesh-list
6206316|NCT02098993|Anticoagulants|anticoagulants|mesh-ancestor
6206317|NCT02098993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5568367|NCT03950830|Disulfiram|disulfiram|mesh-list
5568368|NCT03950830|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5568369|NCT03950830|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
5568370|NCT03950830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5568371|NCT03950830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568372|NCT03950960|Itraconazole|itraconazole|mesh-list
5568373|NCT03950960|Antifungal Agents|antifungal agents|mesh-ancestor
5568374|NCT03950960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5568375|NCT03950960|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6206318|NCT02098993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6206319|NCT02098993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568376|NCT03950960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5568377|NCT03950960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5568378|NCT03950960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568379|NCT03950960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5568380|NCT03950960|Hormone Antagonists|hormone antagonists|mesh-ancestor
5568381|NCT03950960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5568382|NCT03950960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568383|NCT03950960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6206320|NCT02099006|Ketoprofen|ketoprofen|mesh-list
6206321|NCT02099006|Ketamine|ketamine|mesh-list
6206322|NCT02099006|Gabapentin|gabapentin|mesh-list
6206323|NCT02099006|Amitriptyline|amitriptyline|mesh-list
6170904|NCT01635218|Fluoxetine|fluoxetine|mesh-list
6170905|NCT01635218|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6170906|NCT01635218|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6170907|NCT01635218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6170908|NCT01635218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170909|NCT01635218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6170910|NCT01635218|Serotonin Agents|serotonin agents|mesh-ancestor
6170911|NCT01635218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170912|NCT01635218|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6170913|NCT01635218|Antidepressive Agents|antidepressive agents|mesh-ancestor
6170914|NCT01635218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5568384|NCT03951051|Olmesartan|olmesartan|mesh-list
5568385|NCT03951051|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
5568386|NCT03951051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5568387|NCT03951051|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5568388|NCT03951051|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5568389|NCT03951051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568390|NCT03951142|Losartan|losartan|mesh-list
5568391|NCT03951142|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5568392|NCT03951142|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5568393|NCT03951142|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5568394|NCT03951142|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5568395|NCT03951142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568396|NCT03950700|Epinephrine|epinephrine|mesh-list
5568397|NCT03950700|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
5568398|NCT03950700|Bupivacaine|bupivacaine|mesh-list
6170915|NCT01635218|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6170916|NCT01635218|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6170917|NCT01635218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6170918|NCT01635439|Dinoprostone|dinoprostone|mesh-list
6170919|NCT01635439|Oxytocics|oxytocics|mesh-ancestor
6170920|NCT01635439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6170921|NCT01635439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170922|NCT01635504|Botulinum Toxins|botulinum toxins|mesh-list
6170923|NCT01635504|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5568399|NCT03950700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5568400|NCT03950700|Anesthetics, Local|anesthetics, local|mesh-ancestor
5568401|NCT03950700|Anesthetics|anesthetics|mesh-ancestor
5568402|NCT03950700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5568403|NCT03950700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568404|NCT03950700|Sensory System Agents|sensory system agents|mesh-ancestor
5568405|NCT03950700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5568406|NCT03950700|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5568407|NCT03950700|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5568408|NCT03950700|Adrenergic Agents|adrenergic agents|mesh-ancestor
5568409|NCT03950700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5568410|NCT03950700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568411|NCT03950700|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5568412|NCT03950700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5568413|NCT03950700|Autonomic Agents|autonomic agents|mesh-ancestor
6170924|NCT01635504|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6170925|NCT01635504|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6170926|NCT01635504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6170927|NCT01635504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170928|NCT01635504|Cholinergic Agents|cholinergic agents|mesh-ancestor
6170929|NCT01635504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6170930|NCT01635504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170931|NCT01635504|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6170932|NCT01635504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6170933|NCT01635764|Adalimumab|adalimumab|mesh-list
6170934|NCT01635764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6170935|NCT01635764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6170936|NCT01636063|Misoprostol|misoprostol|mesh-list
6170937|NCT01636063|Mifepristone|mifepristone|mesh-list
6170938|NCT01636063|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6170939|NCT01636063|Abortifacient Agents|abortifacient agents|mesh-ancestor
6170940|NCT01636063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6170941|NCT01636063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170942|NCT01636063|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6170943|NCT01636063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6170944|NCT01636063|Oxytocics|oxytocics|mesh-ancestor
6170945|NCT01636063|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6170946|NCT01636063|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6170947|NCT01636063|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6170948|NCT01636063|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6170949|NCT01636063|Contraceptive Agents|contraceptive agents|mesh-ancestor
6170950|NCT01636063|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6170951|NCT01636063|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6170952|NCT01636063|Hormone Antagonists|hormone antagonists|mesh-ancestor
5568414|NCT03950700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5568415|NCT03950700|Respiratory System Agents|respiratory system agents|mesh-ancestor
5568416|NCT03950700|Mydriatics|mydriatics|mesh-ancestor
5568417|NCT03950700|Sympathomimetics|sympathomimetics|mesh-ancestor
5568418|NCT03950739|Treprostinil|treprostinil|mesh-list
5568419|NCT03950739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5568420|NCT03950804|Eculizumab|eculizumab|mesh-list
6170953|NCT01636063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6170954|NCT01636063|Luteolytic Agents|luteolytic agents|mesh-ancestor
6170955|NCT01636063|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6170956|NCT01636063|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6170957|NCT01636076|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6170958|NCT01636076|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6170959|NCT01636076|Autonomic Agents|autonomic agents|mesh-ancestor
6170960|NCT01636076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6170961|NCT01636076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170962|NCT01636076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6170963|NCT01636076|Respiratory System Agents|respiratory system agents|mesh-ancestor
6170964|NCT01636076|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6170965|NCT01636076|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6170966|NCT01636076|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6170967|NCT01636076|Adrenergic Agents|adrenergic agents|mesh-ancestor
6170968|NCT01636076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6170969|NCT01636076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6170970|NCT01636206|Lifitegrast|lifitegrast|mesh-list
6170971|NCT01636206|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6170972|NCT01636206|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6170973|NCT01636687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6170974|NCT01636687|Immunologic Factors|immunologic factors|mesh-ancestor
6170975|NCT01636687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170976|NCT01636934|Minocycline|minocycline|mesh-list
6170977|NCT01636934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6170978|NCT01636934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6170979|NCT01636947|Dexamethasone|dexamethasone|mesh-list
6170980|NCT01636947|Dexamethasone acetate|dexamethasone acetate|mesh-list
6170981|NCT01636947|Ondansetron|ondansetron|mesh-list
6170982|NCT01636947|Aprepitant|aprepitant|mesh-list
6170983|NCT01636947|Fosaprepitant|fosaprepitant|mesh-list
6170984|NCT01636947|Metoclopramide|metoclopramide|mesh-list
6170985|NCT01636947|Granisetron|granisetron|mesh-list
6170986|NCT01636947|Tropisetron|tropisetron|mesh-list
6170987|NCT01636947|Dolasetron|dolasetron|mesh-list
6170988|NCT01636947|Alizapride|alizapride|mesh-list
6170989|NCT01636947|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
6669898|NCT01540435|Bevacizumab|bevacizumab|mesh-list
6669899|NCT01540435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6669900|NCT01540435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5568421|NCT03950804|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5568422|NCT03950804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5568423|NCT03950804|Immunologic Factors|immunologic factors|mesh-ancestor
5568424|NCT03950804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568425|NCT03950817|Ketamine|ketamine|mesh-list
5568426|NCT03950817|Analgesics|analgesics|mesh-ancestor
5568427|NCT03950817|Sensory System Agents|sensory system agents|mesh-ancestor
5568428|NCT03950817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5568429|NCT03950817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568430|NCT03950817|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5568431|NCT03950817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5568432|NCT03950817|Anesthetics, General|anesthetics, general|mesh-ancestor
5568433|NCT03950817|Anesthetics|anesthetics|mesh-ancestor
5568434|NCT03950817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5568435|NCT03950817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5568436|NCT03950817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5568437|NCT03950817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5568438|NCT03950817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568439|NCT03950505|Pioglitazone|pioglitazone|mesh-list
5568440|NCT03950505|Alogliptin|alogliptin|mesh-list
6170990|NCT01636947|BB 1101|bb 1101|mesh-list
6170991|NCT01636947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6170992|NCT01636947|Antiemetics|antiemetics|mesh-ancestor
6170993|NCT01636947|Autonomic Agents|autonomic agents|mesh-ancestor
6669901|NCT01540435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6669902|NCT01540435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6669903|NCT01540435|Growth Substances|growth substances|mesh-ancestor
6669904|NCT01540435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669905|NCT01540435|Growth Inhibitors|growth inhibitors|mesh-ancestor
6669906|NCT01540500|Fluvoxamine|fluvoxamine|mesh-list
6669907|NCT01540500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6669908|NCT01540500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6485235|NCT00564824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485236|NCT00564824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6485237|NCT00564824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6485238|NCT00564824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485239|NCT00564824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6485240|NCT00564824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6485241|NCT00564824|Purinergic Agents|purinergic agents|mesh-ancestor
6485242|NCT00564824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6485243|NCT00564941|Deferasirox|deferasirox|mesh-list
6485244|NCT00564941|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6485245|NCT00564941|Chelating Agents|chelating agents|mesh-ancestor
6485246|NCT00564941|Sequestering Agents|sequestering agents|mesh-ancestor
6485247|NCT00564941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485248|NCT00564993|Dobutamine|dobutamine|mesh-list
6485249|NCT00564993|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6485250|NCT00564993|Sympathomimetics|sympathomimetics|mesh-ancestor
6485251|NCT00564993|Autonomic Agents|autonomic agents|mesh-ancestor
6485252|NCT00564993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6669909|NCT01540500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5568441|NCT03950505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5568442|NCT03950505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568443|NCT03950505|Incretins|incretins|mesh-ancestor
5568444|NCT03950505|Hormones|hormones|mesh-ancestor
5568445|NCT03950505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5568446|NCT03950505|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5568447|NCT03950505|Protease Inhibitors|protease inhibitors|mesh-ancestor
5568448|NCT03950505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5568449|NCT03950505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568450|NCT03950518|Levamisole|levamisole|mesh-list
5568451|NCT03950518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5568452|NCT03950518|Immunologic Factors|immunologic factors|mesh-ancestor
5568453|NCT03950518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568454|NCT03950518|Antinematodal Agents|antinematodal agents|mesh-ancestor
5568455|NCT03950518|Anthelmintics|anthelmintics|mesh-ancestor
5568456|NCT03950518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5568457|NCT03950518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5568458|NCT03950518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5568459|NCT03950427|Bupropion|bupropion|mesh-list
5568460|NCT03950427|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5568461|NCT03950427|Antidepressive Agents|antidepressive agents|mesh-ancestor
5568462|NCT03950427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5568463|NCT03950427|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5568464|NCT03950427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6170994|NCT01636947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6170995|NCT01636947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6170996|NCT01636947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6170997|NCT01636947|Glucocorticoids|glucocorticoids|mesh-ancestor
6170998|NCT01636947|Hormones|hormones|mesh-ancestor
6170999|NCT01636947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6171000|NCT01636947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6171001|NCT01636947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6171002|NCT01636947|Protease Inhibitors|protease inhibitors|mesh-ancestor
6171003|NCT01636947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6171004|NCT01636947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6171005|NCT01636947|Antipruritics|antipruritics|mesh-ancestor
6171006|NCT01636947|Dermatologic Agents|dermatologic agents|mesh-ancestor
6171007|NCT01636947|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6171008|NCT01636947|Serotonin Agents|serotonin agents|mesh-ancestor
6171009|NCT01636947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6171010|NCT01636947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6171011|NCT01636947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6171012|NCT01636947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6171013|NCT01636947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6171014|NCT01636947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6171015|NCT01636947|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6485253|NCT00564993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171016|NCT01636947|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6171017|NCT01636947|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6171018|NCT01636947|Dopamine Agents|dopamine agents|mesh-ancestor
6171019|NCT01636947|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6171020|NCT01636960|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6171021|NCT01636960|Antiviral Agents|antiviral agents|mesh-ancestor
6171022|NCT01636960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6171023|NCT01637077|Pregabalin|pregabalin|mesh-list
6171024|NCT01637077|Analgesics|analgesics|mesh-ancestor
6171025|NCT01637077|Sensory System Agents|sensory system agents|mesh-ancestor
6171026|NCT01637077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6171027|NCT01637077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171028|NCT01637077|Anticonvulsants|anticonvulsants|mesh-ancestor
6171029|NCT01637077|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6171030|NCT01637077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6171031|NCT01637077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6171032|NCT01637077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6171033|NCT01637077|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6171034|NCT01637077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6171035|NCT01637077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6171036|NCT01637077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6171037|NCT01637090|Everolimus|everolimus|mesh-list
6171038|NCT01637090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6171039|NCT01637090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6171040|NCT01637090|Immunologic Factors|immunologic factors|mesh-ancestor
6171041|NCT01637090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171042|NCT01637272|Pasireotide|pasireotide|mesh-list
6171043|NCT01637272|Hormones|hormones|mesh-ancestor
6171044|NCT01637272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6171045|NCT01637272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568465|NCT03950427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5568466|NCT03950427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568467|NCT03950427|Dopamine Agents|dopamine agents|mesh-ancestor
5568468|NCT03950427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5568469|NCT03950427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568470|NCT03950427|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5568471|NCT03950427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5568472|NCT03950427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5568473|NCT03950544|Meropenem|meropenem|mesh-list
5568474|NCT03950544|Fosfomycin|fosfomycin|mesh-list
5568475|NCT03950544|Tigecycline|tigecycline|mesh-list
6171046|NCT01637402|Prednisone|prednisone|mesh-list
6171047|NCT01637402|Abiraterone Acetate|abiraterone acetate|mesh-list
6171048|NCT01637402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6171049|NCT01637402|Glucocorticoids|glucocorticoids|mesh-ancestor
6171050|NCT01637402|Hormones|hormones|mesh-ancestor
6171051|NCT01637402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6171052|NCT01637402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171053|NCT01637402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6171054|NCT01637402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6171055|NCT01637402|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6171056|NCT01637402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6171057|NCT01637402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6171058|NCT01637402|Hormone Antagonists|hormone antagonists|mesh-ancestor
6171059|NCT01637402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6171060|NCT01637584|Prazosin|prazosin|mesh-list
6171061|NCT01637584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6171062|NCT01637584|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6171063|NCT01637584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5568476|NCT03950544|Polymyxins|polymyxins|mesh-list
5568477|NCT03950544|Polymyxin B|polymyxin b|mesh-list
6171064|NCT01637584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6171065|NCT01637584|Adrenergic Agents|adrenergic agents|mesh-ancestor
6171066|NCT01637584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6171067|NCT01637584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6171068|NCT01637584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171069|NCT01637623|Allopurinol|allopurinol|mesh-list
6171070|NCT01637623|Losartan|losartan|mesh-list
6171071|NCT01637623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6171072|NCT01637623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5568478|NCT03950544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5568479|NCT03950544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5568480|NCT03950544|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5568481|NCT03950544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5568482|NCT03950544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568483|NCT03950037|Albendazole|albendazole|mesh-list
5568484|NCT03950037|Anthelmintics|anthelmintics|mesh-ancestor
5568485|NCT03950037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5568486|NCT03950037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5568487|NCT03950037|Anticestodal Agents|anticestodal agents|mesh-ancestor
5568488|NCT03950037|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5568489|NCT03950037|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5568490|NCT03950037|Tubulin Modulators|tubulin modulators|mesh-ancestor
5568491|NCT03950037|Antimitotic Agents|antimitotic agents|mesh-ancestor
5568492|NCT03950037|Mitosis Modulators|mitosis modulators|mesh-ancestor
5568493|NCT03950037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568494|NCT03950037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6485254|NCT00564993|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6485255|NCT00564993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6485256|NCT00564993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6485257|NCT00564993|Adrenergic Agents|adrenergic agents|mesh-ancestor
6485258|NCT00564993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6485259|NCT00564993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485260|NCT00564993|Protective Agents|protective agents|mesh-ancestor
6485261|NCT00565006|Anacetrapib|anacetrapib|mesh-list
6485262|NCT00565006|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6485263|NCT00565006|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5568495|NCT03950141|Apatinib|apatinib|mesh-list
5568496|NCT03950141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5568497|NCT03950141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5568498|NCT03950141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5568499|NCT03950141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568500|NCT03950362|Avelumab|avelumab|mesh-list
5568501|NCT03950362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5568502|NCT03950362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6485264|NCT00565006|Antimetabolites|antimetabolites|mesh-ancestor
6485265|NCT00565006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485266|NCT00565006|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6485267|NCT00565019|Triamcinolone|triamcinolone|mesh-list
5568503|NCT03950154|Bevacizumab|bevacizumab|mesh-list
6171073|NCT01637623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6171074|NCT01637623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6171075|NCT01637623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6171076|NCT01637623|Antimetabolites|antimetabolites|mesh-ancestor
6171077|NCT01637623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6171078|NCT01637623|Gout Suppressants|gout suppressants|mesh-ancestor
6171079|NCT01637623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6171080|NCT01637623|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6171081|NCT01637623|Antioxidants|antioxidants|mesh-ancestor
6171082|NCT01637623|Protective Agents|protective agents|mesh-ancestor
6171083|NCT01637623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171084|NCT01637935|Pioglitazone|pioglitazone|mesh-list
6171085|NCT01637935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6171086|NCT01637935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171087|NCT01638000|Solifenacin Succinate|solifenacin succinate|mesh-list
6171088|NCT01638000|Mirabegron|mirabegron|mesh-list
6171089|NCT01638000|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6171090|NCT01638000|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6171091|NCT01638000|Cholinergic Agents|cholinergic agents|mesh-ancestor
6171092|NCT01638000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5568504|NCT03950154|Capecitabine|capecitabine|mesh-list
5568505|NCT03950154|Oxaliplatin|oxaliplatin|mesh-list
6171093|NCT01638000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568506|NCT03950154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6171094|NCT01638000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171095|NCT01638000|Urological Agents|urological agents|mesh-ancestor
6171096|NCT01638000|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6171097|NCT01638000|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6171098|NCT01638000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6171099|NCT01638000|Adrenergic Agents|adrenergic agents|mesh-ancestor
6171100|NCT01638013|Peficitinib|peficitinib|mesh-list
6171101|NCT01638013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6171102|NCT01638013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485268|NCT00565019|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6485269|NCT00565019|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6485270|NCT00565019|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6485271|NCT00565019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6485272|NCT00565019|Glucocorticoids|glucocorticoids|mesh-ancestor
6485273|NCT00565019|Hormones|hormones|mesh-ancestor
6485274|NCT00565019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6485275|NCT00565019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485276|NCT00565019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6485277|NCT00565019|Immunologic Factors|immunologic factors|mesh-ancestor
6485278|NCT00565019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6485279|NCT00565019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485280|NCT00565097|Lanreotide|lanreotide|mesh-list
6485281|NCT00565097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6485282|NCT00565123|Levofloxacin|levofloxacin|mesh-list
6485283|NCT00565123|Ofloxacin|ofloxacin|mesh-list
6485284|NCT00565123|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5568507|NCT03950154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5568508|NCT03950154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5568509|NCT03950154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5568510|NCT03950154|Growth Substances|growth substances|mesh-ancestor
5568511|NCT03950154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568512|NCT03950154|Growth Inhibitors|growth inhibitors|mesh-ancestor
5568513|NCT03950154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5568514|NCT03950154|Antimetabolites|antimetabolites|mesh-ancestor
5568515|NCT03950154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568516|NCT03950271|Capecitabine|capecitabine|mesh-list
5568517|NCT03950271|Oxaliplatin|oxaliplatin|mesh-list
5568518|NCT03950271|Trastuzumab|trastuzumab|mesh-list
5568519|NCT03950271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5568520|NCT03950271|Antimetabolites|antimetabolites|mesh-ancestor
5568521|NCT03950271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568522|NCT03950271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6485285|NCT00565123|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6485286|NCT00565123|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6485287|NCT00565123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5568523|NCT03950271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5604089|NCT05177991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5604090|NCT05177926|Tenofovir|tenofovir|mesh-list
5604091|NCT05177926|Antiviral Agents|antiviral agents|mesh-list
5604092|NCT05177926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5604093|NCT05177926|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5604094|NCT05177926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5604095|NCT05177926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5604096|NCT05177926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604097|NCT05177926|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5604098|NCT05177926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5604099|NCT05177796|Paclitaxel|paclitaxel|mesh-list
5604100|NCT05177796|Cyclophosphamide|cyclophosphamide|mesh-list
5604101|NCT05177796|Carboplatin|carboplatin|mesh-list
5604102|NCT05177796|Doxorubicin|doxorubicin|mesh-list
5604103|NCT05177796|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5604104|NCT05177796|Pembrolizumab|pembrolizumab|mesh-list
5604105|NCT05177796|Panitumumab|panitumumab|mesh-list
5604106|NCT05177796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5604107|NCT05177796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5604108|NCT05177796|Tubulin Modulators|tubulin modulators|mesh-ancestor
5604109|NCT05177796|Antimitotic Agents|antimitotic agents|mesh-ancestor
5604110|NCT05177796|Mitosis Modulators|mitosis modulators|mesh-ancestor
5604111|NCT05177796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604112|NCT05177796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6485288|NCT00565123|Renal Agents|renal agents|mesh-ancestor
6485289|NCT00565123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6485290|NCT00565123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5604113|NCT05177796|Immunologic Factors|immunologic factors|mesh-ancestor
6485291|NCT00565123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6485292|NCT00565123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6485293|NCT00565123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485294|NCT00565123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6485295|NCT00565123|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6485296|NCT00565123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6485297|NCT00565162|Insulin Glargine|insulin glargine|mesh-list
6485298|NCT00565162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6485299|NCT00565162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485300|NCT00565175|Famotidine|famotidine|mesh-list
6485301|NCT00565175|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6485302|NCT00565175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6485303|NCT00565175|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6485304|NCT00565175|Histamine Antagonists|histamine antagonists|mesh-ancestor
6485305|NCT00565175|Histamine Agents|histamine agents|mesh-ancestor
6485306|NCT00565175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6485307|NCT00565175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485308|NCT00565175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485309|NCT00565188|Adenosine|adenosine|mesh-list
6485310|NCT00565188|Analgesics|analgesics|mesh-ancestor
6485311|NCT00565188|Sensory System Agents|sensory system agents|mesh-ancestor
6485312|NCT00565188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5568524|NCT03950050|Ambroxol|ambroxol|mesh-list
5568525|NCT03950050|Expectorants|expectorants|mesh-ancestor
5568526|NCT03950050|Respiratory System Agents|respiratory system agents|mesh-ancestor
5568527|NCT03949764|Sofosbuvir|sofosbuvir|mesh-list
5568528|NCT03949764|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
5568529|NCT03949764|Velpatasvir|velpatasvir|mesh-list
5568530|NCT03949764|Antiviral Agents|antiviral agents|mesh-ancestor
5568531|NCT03949764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5568532|NCT03949985|Hemostatics|hemostatics|mesh-list
5568533|NCT03949985|Contraceptive Agents|contraceptive agents|mesh-list
5568534|NCT03949985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5568535|NCT03949985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568536|NCT03949985|Coagulants|coagulants|mesh-ancestor
5568537|NCT03949855|Rituximab|rituximab|mesh-list
5568538|NCT03949855|Belimumab|belimumab|mesh-list
5568539|NCT03949855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5568540|NCT03949855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6485313|NCT00565188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485314|NCT00565188|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6485315|NCT00565188|Vasodilator Agents|vasodilator agents|mesh-ancestor
6485316|NCT00565188|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6485317|NCT00565188|Purinergic Agonists|purinergic agonists|mesh-ancestor
5568541|NCT03949855|Immunologic Factors|immunologic factors|mesh-ancestor
5568542|NCT03949855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568543|NCT03949855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5568544|NCT03949855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5568545|NCT03949686|Bupivacaine|bupivacaine|mesh-list
5568546|NCT03949686|Anesthetics, Local|anesthetics, local|mesh-ancestor
5568547|NCT03949686|Anesthetics|anesthetics|mesh-ancestor
5568548|NCT03949686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6485318|NCT00565188|Purinergic Agents|purinergic agents|mesh-ancestor
6485319|NCT00565188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6485320|NCT00565188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485321|NCT00565214|Vitamins|vitamins|mesh-list
6485322|NCT00565214|Vitamin E|vitamin e|mesh-list
6485323|NCT00565214|Selenium|selenium|mesh-list
6485324|NCT00565214|Micronutrients|micronutrients|mesh-ancestor
6485325|NCT00565214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485326|NCT00565214|Antioxidants|antioxidants|mesh-ancestor
6485327|NCT00565214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485328|NCT00565214|Protective Agents|protective agents|mesh-ancestor
6485329|NCT00565214|Trace Elements|trace elements|mesh-ancestor
6485330|NCT00565227|Docetaxel|docetaxel|mesh-list
6485331|NCT00565227|Vorinostat|vorinostat|mesh-list
6485332|NCT00565227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6485333|NCT00565227|Tubulin Modulators|tubulin modulators|mesh-ancestor
6485334|NCT00565227|Antimitotic Agents|antimitotic agents|mesh-ancestor
5568549|NCT03949686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568550|NCT03949686|Sensory System Agents|sensory system agents|mesh-ancestor
6485335|NCT00565227|Mitosis Modulators|mitosis modulators|mesh-ancestor
6485336|NCT00565227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485337|NCT00565227|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6485338|NCT00565227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6485339|NCT00565240|Letrozole|letrozole|mesh-list
5568551|NCT03949686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5568552|NCT03949842|Fluticasone|fluticasone|mesh-list
5568553|NCT03949842|Xhance|xhance|mesh-list
6485340|NCT00565240|NuvaRing|nuvaring|mesh-list
6485341|NCT00565240|Desogestrel|desogestrel|mesh-list
6485342|NCT00565240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6485343|NCT00565240|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6485344|NCT00565240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6485345|NCT00565240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6485346|NCT00565240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485347|NCT00565240|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6485348|NCT00565240|Hormone Antagonists|hormone antagonists|mesh-ancestor
6485349|NCT00565240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6485350|NCT00565240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485351|NCT00565240|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6485352|NCT00565240|Contraceptive Agents|contraceptive agents|mesh-ancestor
6485353|NCT00565240|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6485354|NCT00565240|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6485355|NCT00565240|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6485356|NCT00565240|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6485357|NCT00565240|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6485358|NCT00565240|Progestins|progestins|mesh-ancestor
6485359|NCT00565240|Hormones|hormones|mesh-ancestor
6171103|NCT01638013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6171104|NCT01638013|Immunologic Factors|immunologic factors|mesh-ancestor
6171105|NCT01638013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171106|NCT01638052|Clonidine|clonidine|mesh-list
5568554|NCT03949842|Adrenergic Agents|adrenergic agents|mesh-list
5568555|NCT03949842|Cholinergic Agents|cholinergic agents|mesh-list
5568556|NCT03949842|Muscarinic Antagonists|muscarinic antagonists|mesh-list
5568557|NCT03949842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5568558|NCT03949842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5568559|NCT03949842|Autonomic Agents|autonomic agents|mesh-ancestor
5568560|NCT03949842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5568561|NCT03949842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171107|NCT01638052|Bupivacaine|bupivacaine|mesh-list
6485360|NCT00565253|Nitric Oxide|nitric oxide|mesh-list
6485361|NCT00565253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6485362|NCT00565253|Autonomic Agents|autonomic agents|mesh-ancestor
6485363|NCT00565253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6485364|NCT00565253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485365|NCT00565253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6485366|NCT00565253|Respiratory System Agents|respiratory system agents|mesh-ancestor
6485367|NCT00565253|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6485368|NCT00565253|Antioxidants|antioxidants|mesh-ancestor
6485369|NCT00565253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485370|NCT00565253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6485371|NCT00565253|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6485372|NCT00565253|Vasodilator Agents|vasodilator agents|mesh-ancestor
6485373|NCT00565253|Gasotransmitters|gasotransmitters|mesh-ancestor
6485374|NCT00565253|Protective Agents|protective agents|mesh-ancestor
6485375|NCT00565292|Anacetrapib|anacetrapib|mesh-list
6485376|NCT00565292|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6485377|NCT00565292|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6485378|NCT00565292|Antimetabolites|antimetabolites|mesh-ancestor
6485379|NCT00565292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485380|NCT00565292|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6485381|NCT00565318|Benphothiamine|benphothiamine|mesh-list
6485382|NCT00565318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5725608|NCT03179332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725609|NCT03179527|Vasodilator Agents|vasodilator agents|mesh-list
5568562|NCT03949842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5568563|NCT03949842|Respiratory System Agents|respiratory system agents|mesh-ancestor
6171108|NCT01638052|Anesthetics, Local|anesthetics, local|mesh-ancestor
6171109|NCT01638052|Anesthetics|anesthetics|mesh-ancestor
6171110|NCT01638052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6171111|NCT01638052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171112|NCT01638052|Sensory System Agents|sensory system agents|mesh-ancestor
5568564|NCT03949842|Dermatologic Agents|dermatologic agents|mesh-ancestor
5568565|NCT03949842|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5568566|NCT03949842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5568567|NCT03949842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568568|NCT03949842|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5568569|NCT03949517|Piperidine|piperidine|mesh-list
6171113|NCT01638052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6171114|NCT01638052|Analgesics|analgesics|mesh-ancestor
5725610|NCT03179527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
5725611|NCT03179527|Lipid Regulating Agents|lipid regulating agents|mesh-list
5568570|NCT03949517|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5568571|NCT03949517|Bombesin|bombesin|mesh-list
5568572|NCT03949517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568573|NCT03949517|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5568574|NCT03949517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5568575|NCT03949517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568576|NCT03949517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5568577|NCT03949517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5568578|NCT03949517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5568579|NCT03949374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5568580|NCT03949374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5568581|NCT03949374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5568582|NCT03949374|Antimetabolites|antimetabolites|mesh-ancestor
5568583|NCT03949374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568584|NCT03949374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5568585|NCT03949374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5568586|NCT03949374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5568587|NCT03949634|Paclitaxel|paclitaxel|mesh-list
5568588|NCT03949634|Docetaxel|docetaxel|mesh-list
6171115|NCT01638052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6171116|NCT01638052|Sympatholytics|sympatholytics|mesh-ancestor
6171117|NCT01638052|Autonomic Agents|autonomic agents|mesh-ancestor
6171118|NCT01638052|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6171119|NCT01638052|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6171120|NCT01638052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6171121|NCT01638052|Adrenergic Agents|adrenergic agents|mesh-ancestor
6171122|NCT01638052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6171123|NCT01638052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6171124|NCT01638429|Rifaximin|rifaximin|mesh-list
6171125|NCT01638429|Neomycin|neomycin|mesh-list
6171126|NCT01638429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6171127|NCT01638429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6171128|NCT01638429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6171129|NCT01638429|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6171130|NCT01638429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6171131|NCT01638429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6171132|NCT01638546|Temozolomide|temozolomide|mesh-list
6171133|NCT01638546|Veliparib|veliparib|mesh-list
6171134|NCT01638546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6171135|NCT01638546|Alkylating Agents|alkylating agents|mesh-ancestor
6171136|NCT01638546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6171137|NCT01638546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6171138|NCT01638546|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6171139|NCT01638546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5568589|NCT03949634|Doxorubicin|doxorubicin|mesh-list
5568590|NCT03949634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5568591|NCT03949634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5568592|NCT03949634|Tubulin Modulators|tubulin modulators|mesh-ancestor
5568593|NCT03949634|Antimitotic Agents|antimitotic agents|mesh-ancestor
5568594|NCT03949634|Mitosis Modulators|mitosis modulators|mesh-ancestor
5568595|NCT03949634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568596|NCT03949634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5568597|NCT03949634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5568598|NCT03949634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5568599|NCT03949634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5568600|NCT03949478|Ibuprofen|ibuprofen|mesh-list
5568601|NCT03949478|Nifedipine|nifedipine|mesh-list
5568602|NCT03949478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5568603|NCT03949478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5568604|NCT03949478|Analgesics|analgesics|mesh-ancestor
5568605|NCT03949478|Sensory System Agents|sensory system agents|mesh-ancestor
5568606|NCT03949478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5568607|NCT03949478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171140|NCT01639001|Carboplatin|carboplatin|mesh-list
6171141|NCT01639001|Pemetrexed|pemetrexed|mesh-list
6171142|NCT01639001|Crizotinib|crizotinib|mesh-list
6171143|NCT01639001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6171144|NCT01639001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6171145|NCT01639001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6171146|NCT01639001|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6171147|NCT01639001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6171148|NCT01639001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6171149|NCT01639040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5568608|NCT03949478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5568609|NCT03949478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5568610|NCT03949478|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5568611|NCT03949478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6171150|NCT01639040|Immunologic Factors|immunologic factors|mesh-ancestor
6171151|NCT01639040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171152|NCT01639157|Buspirone|buspirone|mesh-list
6171153|NCT01639157|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6171154|NCT01639157|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6171155|NCT01639157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6171156|NCT01639157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171157|NCT01639157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6171158|NCT01639157|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6171159|NCT01639157|Serotonin Agents|serotonin agents|mesh-ancestor
6171160|NCT01639157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6171161|NCT01639157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6171162|NCT01639222|Calcium, Dietary|calcium, dietary|mesh-list
6171163|NCT01639222|Vitamin D|vitamin d|mesh-list
6171164|NCT01639222|Cholecalciferol|cholecalciferol|mesh-list
6171165|NCT01639222|Calcium|calcium|mesh-list
6669910|NCT01540500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669911|NCT01540500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6669912|NCT01540500|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6669913|NCT01540500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6669914|NCT01540500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6669915|NCT01540500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669916|NCT01540500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5568612|NCT03949478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568613|NCT03949478|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5568614|NCT03949478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5568615|NCT03949478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5568616|NCT03949478|Vasodilator Agents|vasodilator agents|mesh-ancestor
5568617|NCT03949478|Tocolytic Agents|tocolytic agents|mesh-ancestor
5568618|NCT03949478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5568619|NCT03949101|Atropine|atropine|mesh-list
5568620|NCT03949101|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5568621|NCT03949101|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5568622|NCT03949101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5568623|NCT03949101|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6171166|NCT01639222|Vitamins|vitamins|mesh-ancestor
6171167|NCT01639222|Micronutrients|micronutrients|mesh-ancestor
6171168|NCT01639222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171169|NCT01639222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6171170|NCT01639222|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6171171|NCT01639339|Belimumab|belimumab|mesh-list
6171172|NCT01639339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6171173|NCT01639339|Immunologic Factors|immunologic factors|mesh-ancestor
6485383|NCT00565318|Immunologic Factors|immunologic factors|mesh-ancestor
6485384|NCT00565318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485385|NCT00565318|Chelating Agents|chelating agents|mesh-ancestor
6485386|NCT00565318|Sequestering Agents|sequestering agents|mesh-ancestor
6485387|NCT00565318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485388|NCT00565331|Rituximab|rituximab|mesh-list
5568624|NCT03949101|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5568625|NCT03949101|Autonomic Agents|autonomic agents|mesh-ancestor
5568626|NCT03949101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5568627|NCT03949101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568628|NCT03949101|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5568629|NCT03949101|Respiratory System Agents|respiratory system agents|mesh-ancestor
5568630|NCT03949101|Mydriatics|mydriatics|mesh-ancestor
5568631|NCT03949101|Parasympatholytics|parasympatholytics|mesh-ancestor
5568632|NCT03949101|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5568633|NCT03949101|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5568634|NCT03949101|Cholinergic Agents|cholinergic agents|mesh-ancestor
5568635|NCT03949101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6171174|NCT01639339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171175|NCT01639352|Pasireotide|pasireotide|mesh-list
5568636|NCT03949101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568637|NCT03949049|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
5568638|NCT03949049|Nootropic Agents|nootropic agents|mesh-ancestor
5568639|NCT03949062|Rituximab|rituximab|mesh-list
6171176|NCT01639352|Hormones|hormones|mesh-ancestor
6171177|NCT01639352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6171178|NCT01639352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171179|NCT01639560|Varenicline|varenicline|mesh-list
6171180|NCT01639560|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6171181|NCT01639560|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6171182|NCT01639560|Cholinergic Agents|cholinergic agents|mesh-ancestor
6171183|NCT01639560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6171184|NCT01639560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6171185|NCT01639560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171186|NCT01639599|Dexamethasone|dexamethasone|mesh-list
6171187|NCT01639599|Dexamethasone acetate|dexamethasone acetate|mesh-list
6171188|NCT01639599|Haloperidol|haloperidol|mesh-list
6171189|NCT01639599|Haloperidol decanoate|haloperidol decanoate|mesh-list
6171190|NCT01639599|BB 1101|bb 1101|mesh-list
6171191|NCT01639599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6171192|NCT01639599|Antiemetics|antiemetics|mesh-ancestor
6171193|NCT01639599|Autonomic Agents|autonomic agents|mesh-ancestor
6171194|NCT01639599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6171195|NCT01639599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171196|NCT01639599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6171197|NCT01639599|Glucocorticoids|glucocorticoids|mesh-ancestor
6171198|NCT01639599|Hormones|hormones|mesh-ancestor
6171199|NCT01639599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6171200|NCT01639599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5568640|NCT03949062|Lenalidomide|lenalidomide|mesh-list
5568641|NCT03949062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5568642|NCT03949062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5568643|NCT03949062|Immunologic Factors|immunologic factors|mesh-ancestor
5568644|NCT03949062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568645|NCT03949062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5725612|NCT03179605|Clobetasol|clobetasol|mesh-list
6171201|NCT01639599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6171202|NCT01639599|Protease Inhibitors|protease inhibitors|mesh-ancestor
6171203|NCT01639599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6171204|NCT01639599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6171205|NCT01639599|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6171206|NCT01639599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6171207|NCT01639599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6171208|NCT01639599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6171209|NCT01639599|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6171210|NCT01639599|Dopamine Agents|dopamine agents|mesh-ancestor
6171211|NCT01639599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6171212|NCT01639599|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6171213|NCT01639729|Sufentanil|sufentanil|mesh-list
6171214|NCT01639729|Dsuvia|dsuvia|mesh-list
6171215|NCT01639729|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6171216|NCT01639729|Narcotics|narcotics|mesh-ancestor
6171217|NCT01639729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6171218|NCT01639729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171219|NCT01639729|Analgesics|analgesics|mesh-ancestor
6171220|NCT01639729|Sensory System Agents|sensory system agents|mesh-ancestor
6171221|NCT01639729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6171222|NCT01639729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6171223|NCT01639729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6171224|NCT01639729|Anesthetics, General|anesthetics, general|mesh-ancestor
6171225|NCT01639729|Anesthetics|anesthetics|mesh-ancestor
6171226|NCT01639833|Hemostatics|hemostatics|mesh-list
6171227|NCT01639833|Coagulants|coagulants|mesh-ancestor
6171228|NCT01639872|Risperidone|risperidone|mesh-list
6171229|NCT01639872|Clozapine|clozapine|mesh-list
6171230|NCT01639872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6171231|NCT01639872|Serotonin Agents|serotonin agents|mesh-ancestor
6171232|NCT01639872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6171233|NCT01639872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725613|NCT03179605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5725614|NCT03179605|Glucocorticoids|glucocorticoids|mesh-ancestor
5725615|NCT03179605|Hormones|hormones|mesh-ancestor
6485389|NCT00565331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6485390|NCT00565331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6485391|NCT00565331|Immunologic Factors|immunologic factors|mesh-ancestor
6485392|NCT00565331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485393|NCT00565331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5568646|NCT03949062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5568647|NCT03949062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6485394|NCT00565383|Fentanyl|fentanyl|mesh-list
6485395|NCT00565383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6485396|NCT00565383|Narcotics|narcotics|mesh-ancestor
6485397|NCT00565383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6485398|NCT00565383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485399|NCT00565383|Analgesics|analgesics|mesh-ancestor
6485400|NCT00565383|Sensory System Agents|sensory system agents|mesh-ancestor
6485401|NCT00565383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6485402|NCT00565383|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6485403|NCT00565383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6485404|NCT00565383|Anesthetics, General|anesthetics, general|mesh-ancestor
6485405|NCT00565383|Anesthetics|anesthetics|mesh-ancestor
6485406|NCT00565396|Losartan|losartan|mesh-list
6485407|NCT00565396|Fosinopril|fosinopril|mesh-list
6485408|NCT00565396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6485409|NCT00565396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6485410|NCT00565396|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6485411|NCT00565396|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6485412|NCT00565396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485413|NCT00565396|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6485414|NCT00565396|Protease Inhibitors|protease inhibitors|mesh-ancestor
6485415|NCT00565396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6485416|NCT00565422|Citalopram|citalopram|mesh-list
6485417|NCT00565422|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6485418|NCT00565422|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6485419|NCT00565422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6485420|NCT00565422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485421|NCT00565422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5568648|NCT03949062|Growth Substances|growth substances|mesh-ancestor
5568649|NCT03949062|Growth Inhibitors|growth inhibitors|mesh-ancestor
5568650|NCT03949075|Enalapril|enalapril|mesh-list
5568651|NCT03949075|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5568652|NCT03949075|Protease Inhibitors|protease inhibitors|mesh-ancestor
5568653|NCT03949075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5568654|NCT03949075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568655|NCT03949075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5568656|NCT03948568|Tamoxifen|tamoxifen|mesh-list
5568657|NCT03948568|Letrozole|letrozole|mesh-list
5568658|NCT03948568|Anastrozole|anastrozole|mesh-list
5568659|NCT03948568|Exemestane|exemestane|mesh-list
5568660|NCT03948568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5568661|NCT03948568|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5568662|NCT03948568|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5568663|NCT03948568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5568664|NCT03948568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568665|NCT03948568|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5568666|NCT03948568|Hormone Antagonists|hormone antagonists|mesh-ancestor
5568667|NCT03948568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5568668|NCT03948568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568669|NCT03948568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5568670|NCT03948568|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5568671|NCT03948568|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5568672|NCT03948568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5568673|NCT03948685|Carvedilol|carvedilol|mesh-list
5568674|NCT03948685|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5568675|NCT03948685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5568676|NCT03948685|Adrenergic Agents|adrenergic agents|mesh-ancestor
5568677|NCT03948685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6485422|NCT00565422|Serotonin Agents|serotonin agents|mesh-ancestor
5568678|NCT03948685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568679|NCT03948685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568680|NCT03948685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5568681|NCT03948685|Antioxidants|antioxidants|mesh-ancestor
5568682|NCT03948685|Protective Agents|protective agents|mesh-ancestor
5568683|NCT03948685|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5568684|NCT03948685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5568685|NCT03948685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5568686|NCT03948685|Vasodilator Agents|vasodilator agents|mesh-ancestor
5568687|NCT03948685|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5568688|NCT03948685|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5568689|NCT03948737|Tocopherols|tocopherols|mesh-list
5568690|NCT03948737|Vitamin E|vitamin e|mesh-list
5568691|NCT03948737|Tocotrienols|tocotrienols|mesh-list
5568692|NCT03948737|alpha-Tocopherol|alpha-tocopherol|mesh-list
5568693|NCT03948737|Antioxidants|antioxidants|mesh-ancestor
6485423|NCT00565422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568694|NCT03948737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568695|NCT03948737|Protective Agents|protective agents|mesh-ancestor
5568696|NCT03948737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568697|NCT03948737|Vitamins|vitamins|mesh-ancestor
5568698|NCT03948737|Micronutrients|micronutrients|mesh-ancestor
5568699|NCT03948620|Penicillins|penicillins|mesh-list
5568700|NCT03948620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5568701|NCT03948620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5568702|NCT03948477|Pantoprazole|pantoprazole|mesh-list
5568703|NCT03948477|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5568704|NCT03948477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5568705|NCT03948477|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5568706|NCT03948477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5568707|NCT03948477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568708|NCT03948347|Liraglutide|liraglutide|mesh-list
5568709|NCT03948347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5568710|NCT03948347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171234|NCT01639872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171235|NCT01639872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6171236|NCT01639872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6171237|NCT01639872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6171238|NCT01639872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6171239|NCT01639872|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6171240|NCT01639872|Dopamine Agents|dopamine agents|mesh-ancestor
6171241|NCT01639872|GABA Antagonists|gaba antagonists|mesh-ancestor
6171242|NCT01639872|GABA Agents|gaba agents|mesh-ancestor
6171243|NCT01640171|Ketorolac|ketorolac|mesh-list
5568711|NCT03948347|Incretins|incretins|mesh-ancestor
5568712|NCT03948347|Hormones|hormones|mesh-ancestor
5568713|NCT03948347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6171244|NCT01640171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
6171245|NCT01640171|Lidocaine|lidocaine|mesh-list
6171246|NCT01640171|Proxymetacaine|proxymetacaine|mesh-list
6171247|NCT01640171|Anesthetics|anesthetics|mesh-list
6171248|NCT01640171|Anesthetics, Local|anesthetics, local|mesh-ancestor
6171249|NCT01640171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6171250|NCT01640171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171251|NCT01640171|Sensory System Agents|sensory system agents|mesh-ancestor
6171252|NCT01640171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6171253|NCT01640171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6171254|NCT01640171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6171255|NCT01640171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6171256|NCT01640171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6171257|NCT01640171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6171258|NCT01640171|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6171259|NCT01640171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6171260|NCT01640171|Analgesics|analgesics|mesh-ancestor
6171261|NCT01640171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6171262|NCT01640171|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6171263|NCT01640171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6171264|NCT01640184|Vitamin D|vitamin d|mesh-list
6171265|NCT01640184|Vitamins|vitamins|mesh-ancestor
6171266|NCT01640184|Micronutrients|micronutrients|mesh-ancestor
6171267|NCT01640184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171268|NCT01640184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6171269|NCT01640197|Resveratrol|resveratrol|mesh-list
6171270|NCT01640197|Antioxidants|antioxidants|mesh-ancestor
6171271|NCT01640197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6171272|NCT01640197|Protective Agents|protective agents|mesh-ancestor
6171273|NCT01640197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171274|NCT01640197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6171275|NCT01640197|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6171276|NCT01640340|Dexamethasone|dexamethasone|mesh-list
6171277|NCT01640340|Ondansetron|ondansetron|mesh-list
6171278|NCT01640340|Aprepitant|aprepitant|mesh-list
6171279|NCT01640340|Palonosetron|palonosetron|mesh-list
6171280|NCT01640340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6171281|NCT01640340|Antiemetics|antiemetics|mesh-ancestor
6171282|NCT01640340|Autonomic Agents|autonomic agents|mesh-ancestor
6171283|NCT01640340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6171284|NCT01640340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171285|NCT01640340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6171286|NCT01640340|Glucocorticoids|glucocorticoids|mesh-ancestor
6171287|NCT01640340|Hormones|hormones|mesh-ancestor
6171288|NCT01640340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6171289|NCT01640340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6171290|NCT01640340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6171291|NCT01640340|Antipruritics|antipruritics|mesh-ancestor
6171292|NCT01640340|Dermatologic Agents|dermatologic agents|mesh-ancestor
6171293|NCT01640340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6171294|NCT01640340|Serotonin Agents|serotonin agents|mesh-ancestor
6171295|NCT01640340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6171296|NCT01640340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6171297|NCT01640340|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6171298|NCT01640340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6171299|NCT01640340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6171300|NCT01640340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6171301|NCT01640340|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6171302|NCT01640340|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6171303|NCT01640340|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6171304|NCT01640834|Glucagon|glucagon|mesh-list
6171305|NCT01640834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6171306|NCT01640834|Hormones|hormones|mesh-ancestor
6171307|NCT01640834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6171308|NCT01640834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171309|NCT01640925|Chlorhexidine|chlorhexidine|mesh-list
6171310|NCT01640925|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6171311|NCT01640925|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6171312|NCT01640925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6171313|NCT01640925|Disinfectants|disinfectants|mesh-ancestor
5568714|NCT03948321|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5568715|NCT03948321|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5568716|NCT03948321|Dermatologic Agents|dermatologic agents|mesh-ancestor
5568717|NCT03948243|Tolbutamide|tolbutamide|mesh-list
5568718|NCT03948243|Dextromethorphan|dextromethorphan|mesh-list
5568719|NCT03948243|Alprazolam|alprazolam|mesh-list
5568720|NCT03948243|Caffeine|caffeine|mesh-list
5568721|NCT03948243|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5568722|NCT03948243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568723|NCT03948243|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5568724|NCT03948243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6171314|NCT01640925|Dermatologic Agents|dermatologic agents|mesh-ancestor
6171315|NCT01640951|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6171316|NCT01640951|Immunologic Factors|immunologic factors|mesh-ancestor
6171317|NCT01640951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171318|NCT01640964|Terlipressin|terlipressin|mesh-list
6171319|NCT01640964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6171320|NCT01640964|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6171321|NCT01641081|Formoterol Fumarate|formoterol fumarate|mesh-list
6171322|NCT01641081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6171323|NCT01641081|Autonomic Agents|autonomic agents|mesh-ancestor
6171324|NCT01641081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6171325|NCT01641081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171326|NCT01641081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6171327|NCT01641081|Respiratory System Agents|respiratory system agents|mesh-ancestor
6171328|NCT01641081|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5568725|NCT03948243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568726|NCT03948243|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5568727|NCT03948243|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5568728|NCT03948243|Purinergic Agents|purinergic agents|mesh-ancestor
5568729|NCT03948243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5568730|NCT03948243|Antitussive Agents|antitussive agents|mesh-ancestor
5568731|NCT03948243|Respiratory System Agents|respiratory system agents|mesh-ancestor
5568732|NCT03948243|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6171329|NCT01641081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6171330|NCT01641081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6171331|NCT01641081|Adrenergic Agents|adrenergic agents|mesh-ancestor
6171332|NCT01641081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6171333|NCT01641081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568733|NCT03948243|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5568734|NCT03948243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5568735|NCT03948243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5568736|NCT03948243|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5568737|NCT03948243|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5568738|NCT03948243|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5568739|NCT03948243|GABA Modulators|gaba modulators|mesh-ancestor
5568740|NCT03948243|GABA Agents|gaba agents|mesh-ancestor
5568741|NCT03948243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5568742|NCT03948191|Methylene diphosphonate|methylene diphosphonate|mesh-list
6171334|NCT01641120|Interferons|interferons|mesh-list
6171335|NCT01641120|Interferon-beta|interferon-beta|mesh-list
5568743|NCT03948191|Methylprednisolone|methylprednisolone|mesh-list
5568744|NCT03948191|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5568745|NCT03948191|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5568746|NCT03948191|Prednisolone|prednisolone|mesh-list
5568747|NCT03948191|Prednisolone acetate|prednisolone acetate|mesh-list
5568748|NCT03948191|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5568749|NCT03948191|Prednisolone phosphate|prednisolone phosphate|mesh-list
5568750|NCT03948191|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
5568751|NCT03948191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5568752|NCT03948191|Antiemetics|antiemetics|mesh-ancestor
5568753|NCT03948191|Autonomic Agents|autonomic agents|mesh-ancestor
5568754|NCT03948191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5568755|NCT03948191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568756|NCT03948191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5568757|NCT03948191|Glucocorticoids|glucocorticoids|mesh-ancestor
5568758|NCT03948191|Hormones|hormones|mesh-ancestor
5568759|NCT03948191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5568760|NCT03948191|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6171336|NCT01641120|Interferon beta-1a|interferon beta-1a|mesh-list
6171337|NCT01641120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6171338|NCT01641120|Antiviral Agents|antiviral agents|mesh-ancestor
6171339|NCT01641120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6171340|NCT01641120|Immunologic Factors|immunologic factors|mesh-ancestor
6171341|NCT01641120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171342|NCT01641120|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6171343|NCT01641133|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6171344|NCT01641133|Immunologic Factors|immunologic factors|mesh-ancestor
6171345|NCT01641133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171346|NCT01641159|Buspirone|buspirone|mesh-list
6485424|NCT00565422|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6485425|NCT00565422|Antidepressive Agents|antidepressive agents|mesh-ancestor
6485426|NCT00565422|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6485427|NCT00565461|Vaccines|vaccines|mesh-list
6485428|NCT00565461|Immunologic Factors|immunologic factors|mesh-ancestor
6485429|NCT00565461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485430|NCT00565487|Capecitabine|capecitabine|mesh-list
6485431|NCT00565487|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6485432|NCT00565487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6485433|NCT00565487|Antimetabolites|antimetabolites|mesh-ancestor
6485434|NCT00565487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485435|NCT00565487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5568761|NCT03948191|Protective Agents|protective agents|mesh-ancestor
5568762|NCT03948191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5568763|NCT03948191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5568764|NCT03948191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5568765|NCT03948191|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6485436|NCT00565487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6485437|NCT00565487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6485438|NCT00565500|Ibuprofen|ibuprofen|mesh-list
6485439|NCT00565500|Celecoxib|celecoxib|mesh-list
6485440|NCT00565500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6485441|NCT00565500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6485442|NCT00565500|Analgesics|analgesics|mesh-ancestor
6485443|NCT00565500|Sensory System Agents|sensory system agents|mesh-ancestor
6485444|NCT00565500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6485445|NCT00565500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568766|NCT03948191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6171347|NCT01641159|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5568767|NCT03947827|Minocycline|minocycline|mesh-list
5568768|NCT03947827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5568769|NCT03947827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6485446|NCT00565500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6485447|NCT00565500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6171348|NCT01641159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6171349|NCT01641159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6171350|NCT01641159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171351|NCT01641159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6171352|NCT01641159|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6171353|NCT01641159|Serotonin Agents|serotonin agents|mesh-ancestor
6171354|NCT01641159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6171355|NCT01641159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6171356|NCT01641237|Listerine|listerine|mesh-list
6171357|NCT01641237|Fluorides|fluorides|mesh-list
6171358|NCT01641237|Sodium Fluoride|sodium fluoride|mesh-list
6171359|NCT01641237|Cariostatic Agents|cariostatic agents|mesh-ancestor
6171360|NCT01641237|Protective Agents|protective agents|mesh-ancestor
6171361|NCT01641237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171362|NCT01641237|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6171363|NCT01641237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6206324|NCT02099006|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6206325|NCT02099006|Baclofen|baclofen|mesh-list
6206326|NCT02099006|Loperamide|loperamide|mesh-list
6206327|NCT02099006|Antidiarrheals|antidiarrheals|mesh-list
6206328|NCT02099006|Analgesics|analgesics|mesh-ancestor
6206329|NCT02099006|Sensory System Agents|sensory system agents|mesh-ancestor
6206330|NCT02099006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6206331|NCT02099006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206332|NCT02099006|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6206333|NCT02099006|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6206334|NCT02099006|Anesthetics, General|anesthetics, general|mesh-ancestor
6206335|NCT02099006|Anesthetics|anesthetics|mesh-ancestor
6206336|NCT02099006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6206337|NCT02099006|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6206338|NCT02099006|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6206339|NCT02099006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6485448|NCT00565500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6485449|NCT00565500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5568786|NCT03947775|Vaccines|vaccines|mesh-list
5568787|NCT03947775|Immunologic Factors|immunologic factors|mesh-ancestor
5568788|NCT03947775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568789|NCT03947671|Acetaminophen|acetaminophen|mesh-list
5568790|NCT03947671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5568791|NCT03947671|Analgesics|analgesics|mesh-ancestor
5568792|NCT03947671|Sensory System Agents|sensory system agents|mesh-ancestor
5568793|NCT03947671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5568794|NCT03947671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568795|NCT03947671|Antipyretics|antipyretics|mesh-ancestor
5568796|NCT03948178|Simendan|simendan|mesh-list
5568797|NCT03948178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5568798|NCT03948178|Vasodilator Agents|vasodilator agents|mesh-ancestor
5568799|NCT03948178|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5568800|NCT03948178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5568801|NCT03948178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5568802|NCT03948178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568803|NCT03948178|Protective Agents|protective agents|mesh-ancestor
5568804|NCT03948178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568805|NCT03947528|Sarpogrelate|sarpogrelate|mesh-list
5568806|NCT03947528|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5568807|NCT03947528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5568808|NCT03947528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568809|NCT03947528|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5568810|NCT03947528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5568811|NCT03947528|Serotonin Agents|serotonin agents|mesh-ancestor
5568812|NCT03947528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5568813|NCT03947528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568814|NCT03947242|Trastuzumab|trastuzumab|mesh-list
5568815|NCT03947242|Vinorelbine|vinorelbine|mesh-list
5568816|NCT03947242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5568817|NCT03947242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5568818|NCT03947242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5568819|NCT03947242|Tubulin Modulators|tubulin modulators|mesh-ancestor
5568820|NCT03947242|Antimitotic Agents|antimitotic agents|mesh-ancestor
5568821|NCT03947242|Mitosis Modulators|mitosis modulators|mesh-ancestor
6485450|NCT00565500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485451|NCT00565500|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6485452|NCT00565539|Interferons|interferons|mesh-list
6485453|NCT00565539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6485454|NCT00565539|Antiviral Agents|antiviral agents|mesh-ancestor
6485455|NCT00565539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6485456|NCT00565591|Albuterol|albuterol|mesh-list
6485457|NCT00565591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6485458|NCT00565591|Autonomic Agents|autonomic agents|mesh-ancestor
6485459|NCT00565591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6485460|NCT00565591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485461|NCT00565591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6485462|NCT00565591|Respiratory System Agents|respiratory system agents|mesh-ancestor
6485463|NCT00565591|Tocolytic Agents|tocolytic agents|mesh-ancestor
6485464|NCT00565591|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6485465|NCT00565591|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6485466|NCT00565591|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6485467|NCT00565591|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6171364|NCT01641367|Tenofovir|tenofovir|mesh-list
6171365|NCT01641367|Emtricitabine|emtricitabine|mesh-list
6171366|NCT01641367|Raltegravir Potassium|raltegravir potassium|mesh-list
6171367|NCT01641367|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6171368|NCT01641367|Darunavir|darunavir|mesh-list
6171369|NCT01641367|Etravirine|etravirine|mesh-list
6171370|NCT01641367|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
6171371|NCT01641367|Protease Inhibitors|protease inhibitors|mesh-list
6171372|NCT01641367|Antiviral Agents|antiviral agents|mesh-ancestor
6485468|NCT00565591|Adrenergic Agents|adrenergic agents|mesh-ancestor
6485469|NCT00565591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6485470|NCT00565591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485471|NCT00565630|Moxifloxacin|moxifloxacin|mesh-list
6485472|NCT00565630|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6485473|NCT00565630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6485474|NCT00565630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6485475|NCT00565630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6485476|NCT00565630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6485477|NCT00565630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6485478|NCT00565630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485479|NCT00565630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6485480|NCT00565630|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6485481|NCT00565630|Contraceptive Agents|contraceptive agents|mesh-ancestor
6485482|NCT00565630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6485483|NCT00565630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485484|NCT00565630|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5568822|NCT03947242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6171373|NCT01641367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6171374|NCT01641367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6171375|NCT01641367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6171376|NCT01641367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6171377|NCT01641367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6171378|NCT01641367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6171379|NCT01641367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6171380|NCT01641367|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6171381|NCT01641367|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6171382|NCT01641367|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6171383|NCT01641445|Topiramate|topiramate|mesh-list
5568823|NCT03947229|Clopidogrel|clopidogrel|mesh-list
6171384|NCT01641445|Anticonvulsants|anticonvulsants|mesh-ancestor
5568824|NCT03947229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5568825|NCT03947229|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5568826|NCT03947229|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5568827|NCT03947229|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6171385|NCT01641445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6171386|NCT01641445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171387|NCT01641640|Sofosbuvir|sofosbuvir|mesh-list
6171388|NCT01641640|Ribavirin|ribavirin|mesh-list
6171389|NCT01641640|Antiviral Agents|antiviral agents|mesh-ancestor
6171390|NCT01641640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6171391|NCT01641640|Antimetabolites|antimetabolites|mesh-ancestor
5568828|NCT03947229|Purinergic Agents|purinergic agents|mesh-ancestor
5568829|NCT03947229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5568830|NCT03947229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568831|NCT03947229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568832|NCT03947489|Sarpogrelate|sarpogrelate|mesh-list
5568833|NCT03947489|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5568834|NCT03947489|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5568835|NCT03947489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568836|NCT03947489|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6171392|NCT01641640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6171393|NCT01641653|Midazolam|midazolam|mesh-list
6171394|NCT01641653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6171395|NCT01641653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6171396|NCT01641653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6171397|NCT01641653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171398|NCT01641653|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6171399|NCT01641653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6171400|NCT01641653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6171401|NCT01641653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6171402|NCT01641653|Anesthetics, General|anesthetics, general|mesh-ancestor
6171403|NCT01641653|Anesthetics|anesthetics|mesh-ancestor
6171404|NCT01641653|GABA Modulators|gaba modulators|mesh-ancestor
6171405|NCT01641653|GABA Agents|gaba agents|mesh-ancestor
6171406|NCT01641653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6171407|NCT01641653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6171408|NCT01641692|Albuterol|albuterol|mesh-list
6171409|NCT01641692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6171410|NCT01641692|Autonomic Agents|autonomic agents|mesh-ancestor
6171411|NCT01641692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6171412|NCT01641692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171413|NCT01641692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6171414|NCT01641692|Respiratory System Agents|respiratory system agents|mesh-ancestor
6171415|NCT01641692|Tocolytic Agents|tocolytic agents|mesh-ancestor
6171416|NCT01641692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6171417|NCT01641692|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6171418|NCT01641692|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6171419|NCT01641692|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6485485|NCT00565630|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6485486|NCT00565630|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6485487|NCT00565656|Bevacizumab|bevacizumab|mesh-list
6485488|NCT00565656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6485489|NCT00565656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6171420|NCT01641692|Adrenergic Agents|adrenergic agents|mesh-ancestor
6171421|NCT01641692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6171422|NCT01641692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6171423|NCT01641809|Tenofovir|tenofovir|mesh-list
6171424|NCT01641809|Lamivudine|lamivudine|mesh-list
6171425|NCT01641809|Emtricitabine|emtricitabine|mesh-list
6171426|NCT01641809|Efavirenz|efavirenz|mesh-list
6171427|NCT01641809|Abacavir|abacavir|mesh-list
6171428|NCT01641809|Rilpivirine|rilpivirine|mesh-list
5568837|NCT03947489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5568838|NCT03947489|Serotonin Agents|serotonin agents|mesh-ancestor
5568839|NCT03947489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6171429|NCT01641809|Cabotegravir|cabotegravir|mesh-list
6171430|NCT01641809|Antiviral Agents|antiviral agents|mesh-ancestor
6171431|NCT01641809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6171432|NCT01641809|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6171433|NCT01641809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6171434|NCT01641809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6171435|NCT01641809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6171436|NCT01641809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6485490|NCT00565656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6171437|NCT01641809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6669917|NCT01540500|Serotonin Agents|serotonin agents|mesh-ancestor
6171438|NCT01641809|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6171439|NCT01641809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6171440|NCT01641809|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6171441|NCT01641809|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6171442|NCT01641809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6171443|NCT01641809|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6171444|NCT01641809|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6171445|NCT01641809|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6171446|NCT01641822|Tobramycin|tobramycin|mesh-list
6171447|NCT01641822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6171448|NCT01641822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6171449|NCT01641900|Eszopiclone|eszopiclone|mesh-list
6171450|NCT01641900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6171451|NCT01641900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6171452|NCT01641900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171453|NCT01641926|Interferons|interferons|mesh-list
6171454|NCT01641926|Interferon-alpha|interferon-alpha|mesh-list
6171455|NCT01641926|Interferon alpha-2|interferon alpha-2|mesh-list
6171456|NCT01641926|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6171457|NCT01641926|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6171458|NCT01641926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6171459|NCT01641926|Antiviral Agents|antiviral agents|mesh-ancestor
6171460|NCT01641926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6171461|NCT01641926|Immunologic Factors|immunologic factors|mesh-ancestor
6171462|NCT01641926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171463|NCT01641939|Trastuzumab|trastuzumab|mesh-list
6171464|NCT01641939|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
6171465|NCT01641939|Maytansine|maytansine|mesh-list
6171466|NCT01641939|Taxane|taxane|mesh-list
6171467|NCT01641939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6171468|NCT01641939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6171469|NCT01641939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6171470|NCT01641939|Tubulin Modulators|tubulin modulators|mesh-ancestor
6171471|NCT01641939|Antimitotic Agents|antimitotic agents|mesh-ancestor
6485491|NCT00565656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6485492|NCT00565656|Growth Substances|growth substances|mesh-ancestor
6485493|NCT00565656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485494|NCT00565656|Growth Inhibitors|growth inhibitors|mesh-ancestor
6485495|NCT00565682|Etoricoxib|etoricoxib|mesh-list
6485496|NCT00565682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6485497|NCT00565682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6485498|NCT00565682|Analgesics|analgesics|mesh-ancestor
6171472|NCT01641939|Mitosis Modulators|mitosis modulators|mesh-ancestor
6171473|NCT01641939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6171474|NCT01641952|Rituximab|rituximab|mesh-list
6171475|NCT01641952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6171476|NCT01641952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6171477|NCT01641952|Immunologic Factors|immunologic factors|mesh-ancestor
6171478|NCT01641952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171479|NCT01641952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6171480|NCT01642082|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
6485499|NCT00565682|Sensory System Agents|sensory system agents|mesh-ancestor
6485500|NCT00565682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6485501|NCT00565682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485502|NCT00565682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6485503|NCT00565682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6171481|NCT01642082|Immunologic Factors|immunologic factors|mesh-ancestor
6171482|NCT01642082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171483|NCT01642147|Anesthetics|anesthetics|mesh-list
6171484|NCT01642147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6171485|NCT01642147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171486|NCT01642212|Budesonide|budesonide|mesh-list
6171487|NCT01642212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6171488|NCT01642212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6171489|NCT01642212|Autonomic Agents|autonomic agents|mesh-ancestor
6171490|NCT01642212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6171491|NCT01642212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171492|NCT01642212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6171493|NCT01642212|Respiratory System Agents|respiratory system agents|mesh-ancestor
6171494|NCT01642212|Glucocorticoids|glucocorticoids|mesh-ancestor
6171495|NCT01642212|Hormones|hormones|mesh-ancestor
6171496|NCT01642212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6171497|NCT01642238|Aspirin|aspirin|mesh-list
6485504|NCT00565682|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5568840|NCT03947489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568841|NCT03947411|Oseltamivir|oseltamivir|mesh-list
5568842|NCT03947411|Antiviral Agents|antiviral agents|mesh-ancestor
5568843|NCT03947411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5568844|NCT03947411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5568845|NCT03947411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568846|NCT03947125|Buprenorphine|buprenorphine|mesh-list
5568847|NCT03947125|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5568848|NCT03947125|Narcotics|narcotics|mesh-ancestor
5568849|NCT03947125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5568850|NCT03947125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568851|NCT03947125|Analgesics|analgesics|mesh-ancestor
5568852|NCT03947125|Sensory System Agents|sensory system agents|mesh-ancestor
5568853|NCT03947125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5568854|NCT03947125|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5568855|NCT03946878|Venetoclax|venetoclax|mesh-list
5568856|NCT03946878|Acalabrutinib|acalabrutinib|mesh-list
5568857|NCT03946878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5568858|NCT03946657|Anesthetics|anesthetics|mesh-list
5568859|NCT03946657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
6171498|NCT01642238|Hirudins|hirudins|mesh-list
6171499|NCT01642238|Bivalirudin|bivalirudin|mesh-list
6171500|NCT01642238|Clopidogrel|clopidogrel|mesh-list
6171501|NCT01642238|Ticagrelor|ticagrelor|mesh-list
6171502|NCT01642238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6171503|NCT01642238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6171504|NCT01642238|Analgesics|analgesics|mesh-ancestor
6171505|NCT01642238|Sensory System Agents|sensory system agents|mesh-ancestor
6171506|NCT01642238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6171507|NCT01642238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171508|NCT01642238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6171509|NCT01642238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6171510|NCT01642238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6171511|NCT01642238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6171512|NCT01642238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568860|NCT03946657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5568861|NCT03946657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568862|NCT03946657|Anesthetics, General|anesthetics, general|mesh-ancestor
6171513|NCT01642238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6171514|NCT01642238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6171515|NCT01642238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6171516|NCT01642238|Antipyretics|antipyretics|mesh-ancestor
6171517|NCT01642238|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6171518|NCT01642238|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6171519|NCT01642238|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5568870|NCT03946826|Halometasone|halometasone|mesh-list
5568871|NCT03946826|Petrolatum|petrolatum|mesh-list
5568872|NCT03946826|Emollients|emollients|mesh-ancestor
5568873|NCT03946826|Dermatologic Agents|dermatologic agents|mesh-ancestor
5568874|NCT03946826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5568875|NCT03946826|Glucocorticoids|glucocorticoids|mesh-ancestor
6171520|NCT01642238|Purinergic Agents|purinergic agents|mesh-ancestor
6171521|NCT01642238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6171522|NCT01642238|Antithrombins|antithrombins|mesh-ancestor
6171523|NCT01642238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6171524|NCT01642238|Protease Inhibitors|protease inhibitors|mesh-ancestor
6171525|NCT01642238|Anticoagulants|anticoagulants|mesh-ancestor
6171526|NCT01642251|Cisplatin|cisplatin|mesh-list
6171527|NCT01642251|Etoposide|etoposide|mesh-list
6171528|NCT01642251|Etoposide phosphate|etoposide phosphate|mesh-list
6485505|NCT00565682|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6485506|NCT00565682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6171529|NCT01642251|Veliparib|veliparib|mesh-list
6171530|NCT01642251|Podophyllotoxin|podophyllotoxin|mesh-list
6171531|NCT01642251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6171532|NCT01642251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5568876|NCT03946826|Hormones|hormones|mesh-ancestor
5568877|NCT03946826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6171533|NCT01642251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6171534|NCT01642251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6171535|NCT01642251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5568878|NCT03946826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604114|NCT05177796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171536|NCT01642251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6171537|NCT01642251|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6171538|NCT01642251|Keratolytic Agents|keratolytic agents|mesh-ancestor
6171539|NCT01642251|Dermatologic Agents|dermatologic agents|mesh-ancestor
6171540|NCT01642251|Tubulin Modulators|tubulin modulators|mesh-ancestor
6171541|NCT01642251|Antimitotic Agents|antimitotic agents|mesh-ancestor
6171542|NCT01642251|Mitosis Modulators|mitosis modulators|mesh-ancestor
6171543|NCT01642277|Solifenacin Succinate|solifenacin succinate|mesh-list
5568879|NCT03946514|Losartan|losartan|mesh-list
5568880|NCT03946514|Amlodipine|amlodipine|mesh-list
5568881|NCT03946514|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5568882|NCT03946514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5568883|NCT03946514|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5568884|NCT03946514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5568885|NCT03946514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568886|NCT03946514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5568887|NCT03946514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568888|NCT03946514|Vasodilator Agents|vasodilator agents|mesh-ancestor
5568889|NCT03946514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5568890|NCT03946514|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5568891|NCT03946514|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5568892|NCT03946514|Diuretics|diuretics|mesh-ancestor
5568893|NCT03946514|Natriuretic Agents|natriuretic agents|mesh-ancestor
5568894|NCT03946514|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5568895|NCT03946358|Atezolizumab|atezolizumab|mesh-list
5568896|NCT03946358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5568897|NCT03945864|Anti-Infective Agents|anti-infective agents|mesh-list
5568898|NCT03945864|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5568899|NCT03945903|Golimumab|golimumab|mesh-list
5568900|NCT03945903|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
5568901|NCT03945903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5568902|NCT03945903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6171544|NCT01642277|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6171545|NCT01642277|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6171546|NCT01642277|Cholinergic Agents|cholinergic agents|mesh-ancestor
6171547|NCT01642277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6485507|NCT00565682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485508|NCT00565708|Aspirin|aspirin|mesh-list
6485509|NCT00565708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6485510|NCT00565708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6485511|NCT00565708|Analgesics|analgesics|mesh-ancestor
6485512|NCT00565708|Sensory System Agents|sensory system agents|mesh-ancestor
6485513|NCT00565708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6485514|NCT00565708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485515|NCT00565708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6485516|NCT00565708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6485517|NCT00565708|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6485518|NCT00565708|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6669918|NCT01540500|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6669919|NCT01540500|Antidepressive Agents|antidepressive agents|mesh-ancestor
6669920|NCT01540500|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6171548|NCT01642277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6171549|NCT01642277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171550|NCT01642277|Urological Agents|urological agents|mesh-ancestor
6171551|NCT01642407|Sildenafil Citrate|sildenafil citrate|mesh-list
6171552|NCT01642407|Vasodilator Agents|vasodilator agents|mesh-ancestor
6171553|NCT01642407|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6171554|NCT01642407|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6171555|NCT01642407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6171556|NCT01642407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6171557|NCT01642407|Urological Agents|urological agents|mesh-ancestor
5568903|NCT03945903|Immunologic Factors|immunologic factors|mesh-ancestor
6171558|NCT01642485|Moxifloxacin|moxifloxacin|mesh-list
6171559|NCT01642485|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6171560|NCT01642485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171561|NCT01642485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6171562|NCT01642485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6171563|NCT01642485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6171564|NCT01642485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6171565|NCT01642485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6171566|NCT01642485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6171567|NCT01642485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6171568|NCT01642485|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6171569|NCT01642485|Contraceptive Agents|contraceptive agents|mesh-ancestor
6171570|NCT01642485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6171571|NCT01642485|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5568904|NCT03945903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568905|NCT03945656|Insulin|insulin|mesh-list
5568906|NCT03945656|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5568907|NCT03945656|Insulin Glargine|insulin glargine|mesh-list
5568908|NCT03945656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5568909|NCT03945656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568910|NCT03945591|Cyclophosphamide|cyclophosphamide|mesh-list
5568911|NCT03945591|Bortezomib|bortezomib|mesh-list
5568912|NCT03945591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5568913|NCT03945591|Immunologic Factors|immunologic factors|mesh-ancestor
5568914|NCT03945591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171572|NCT01642485|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6171573|NCT01642485|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6171574|NCT01642589|Vaccines|vaccines|mesh-list
6171575|NCT01642589|Immunologic Factors|immunologic factors|mesh-ancestor
6171576|NCT01642589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171577|NCT01642602|Dexlansoprazole|dexlansoprazole|mesh-list
6171578|NCT01642602|Lansoprazole|lansoprazole|mesh-list
6171579|NCT01642602|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6171580|NCT01642602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6171581|NCT01642602|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6171582|NCT01642602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6171583|NCT01642602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6171584|NCT01642615|Dexlansoprazole|dexlansoprazole|mesh-list
6171585|NCT01642615|Lansoprazole|lansoprazole|mesh-list
6171586|NCT01642615|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5568915|NCT03945591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5568916|NCT03945591|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5568917|NCT03945591|Alkylating Agents|alkylating agents|mesh-ancestor
5568918|NCT03945591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568919|NCT03945591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5568920|NCT03945591|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5568921|NCT03945955|Melatonin|melatonin|mesh-list
6171587|NCT01642615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6171588|NCT01642615|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6171589|NCT01642615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6171590|NCT01642615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6171591|NCT01642914|Linaclotide|linaclotide|mesh-list
6171592|NCT01642914|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
6171593|NCT01642914|Enzyme Activators|enzyme activators|mesh-ancestor
6171594|NCT01642914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6171595|NCT01642914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6171596|NCT01643382|Insulin|insulin|mesh-list
6171597|NCT01643382|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6171598|NCT01643382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6171599|NCT01643382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171600|NCT01643408|Asparaginase|asparaginase|mesh-list
6171601|NCT01643408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6171602|NCT01643616|Midazolam|midazolam|mesh-list
6171603|NCT01643616|Ropivacaine|ropivacaine|mesh-list
6171604|NCT01643616|Prilocaine|prilocaine|mesh-list
6171605|NCT01643616|Anesthetics, Local|anesthetics, local|mesh-ancestor
6171606|NCT01643616|Anesthetics|anesthetics|mesh-ancestor
6171607|NCT01643616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6171608|NCT01643616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171609|NCT01643616|Sensory System Agents|sensory system agents|mesh-ancestor
6171610|NCT01643616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6171611|NCT01643616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6171612|NCT01643616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6171613|NCT01643616|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6171614|NCT01643616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6171615|NCT01643616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6171616|NCT01643616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6171617|NCT01643616|Anesthetics, General|anesthetics, general|mesh-ancestor
6171618|NCT01643616|GABA Modulators|gaba modulators|mesh-ancestor
6171619|NCT01643616|GABA Agents|gaba agents|mesh-ancestor
6171620|NCT01643616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6171621|NCT01643616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6171622|NCT01643668|Busulfan|busulfan|mesh-list
6171623|NCT01643668|Clofarabine|clofarabine|mesh-list
6171624|NCT01643668|Alkylating Agents|alkylating agents|mesh-ancestor
6171625|NCT01643668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6171626|NCT01643668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5568922|NCT03945955|Antioxidants|antioxidants|mesh-ancestor
6171627|NCT01643668|Immunologic Factors|immunologic factors|mesh-ancestor
6171628|NCT01643668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171629|NCT01643668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5568923|NCT03945955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568924|NCT03945955|Protective Agents|protective agents|mesh-ancestor
5568925|NCT03945955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568926|NCT03945955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5568927|NCT03945539|Itraconazole|itraconazole|mesh-list
5568928|NCT03945539|Antifungal Agents|antifungal agents|mesh-ancestor
5568929|NCT03945539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5568930|NCT03945539|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5568931|NCT03945539|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5568932|NCT03945539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5568933|NCT03945539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568934|NCT03945539|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5568935|NCT03945539|Hormone Antagonists|hormone antagonists|mesh-ancestor
5568936|NCT03945539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5568937|NCT03945539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568938|NCT03945539|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6171630|NCT01643668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6171631|NCT01643668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6171632|NCT01643668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6171633|NCT01643668|Antimetabolites|antimetabolites|mesh-ancestor
6171634|NCT01643772|Oxycodone|oxycodone|mesh-list
6171635|NCT01643772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6171636|NCT01643772|Narcotics|narcotics|mesh-ancestor
6171637|NCT01643772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6485519|NCT00565708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485520|NCT00565708|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6485521|NCT00565708|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6485522|NCT00565708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6485523|NCT00565708|Antipyretics|antipyretics|mesh-ancestor
6485524|NCT00565955|Montelukast|montelukast|mesh-list
6485525|NCT00565955|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6485526|NCT00565955|Respiratory System Agents|respiratory system agents|mesh-ancestor
6485527|NCT00565955|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6485528|NCT00565955|Hormone Antagonists|hormone antagonists|mesh-ancestor
6485529|NCT00565955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6485530|NCT00565955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485531|NCT00565955|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6171638|NCT01643772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171639|NCT01643772|Analgesics|analgesics|mesh-ancestor
6171640|NCT01643772|Sensory System Agents|sensory system agents|mesh-ancestor
6171641|NCT01643772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6171642|NCT01643902|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6171643|NCT01643902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6171644|NCT01643902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6171645|NCT01643902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6171646|NCT01643928|Rituximab|rituximab|mesh-list
5568939|NCT03945513|Dienogest|dienogest|mesh-list
5568940|NCT03945513|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6171647|NCT01643928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6171648|NCT01643928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6171649|NCT01643928|Immunologic Factors|immunologic factors|mesh-ancestor
6171650|NCT01643928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171651|NCT01643928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6171652|NCT01644175|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6171653|NCT01644175|Immunologic Factors|immunologic factors|mesh-ancestor
6171654|NCT01644175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485532|NCT00565955|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6485533|NCT00565955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485534|NCT00565968|Sorafenib|sorafenib|mesh-list
6485535|NCT00565968|Melphalan|melphalan|mesh-list
6485536|NCT00565968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6171655|NCT01644188|Ezetimibe|ezetimibe|mesh-list
6171656|NCT01644188|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6171657|NCT01644188|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6171658|NCT01644188|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6171659|NCT01644188|Antimetabolites|antimetabolites|mesh-ancestor
6485537|NCT00565968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6485538|NCT00565968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6485539|NCT00565968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485540|NCT00565968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6485541|NCT00565968|Alkylating Agents|alkylating agents|mesh-ancestor
6485542|NCT00565968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5568941|NCT03945513|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6171660|NCT01644188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6171661|NCT01644188|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6171662|NCT01644188|Immunologic Factors|immunologic factors|mesh-ancestor
6171663|NCT01644188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171664|NCT01644331|Tolvaptan|tolvaptan|mesh-list
6171665|NCT01644331|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6171666|NCT01644331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6171667|NCT01644331|Natriuretic Agents|natriuretic agents|mesh-ancestor
6171668|NCT01644331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171669|NCT01644396|Adalimumab|adalimumab|mesh-list
6171670|NCT01644396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6171671|NCT01644396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6171672|NCT01644474|Ezetimibe|ezetimibe|mesh-list
6171673|NCT01644474|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6171674|NCT01644474|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6171675|NCT01644474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6171676|NCT01644474|Antimetabolites|antimetabolites|mesh-ancestor
6171677|NCT01644474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568942|NCT03945513|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5568943|NCT03945513|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5568944|NCT03945513|Contraceptive Agents|contraceptive agents|mesh-ancestor
5568945|NCT03945513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5568946|NCT03945513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568947|NCT03945513|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5568948|NCT03945513|Estrogens|estrogens|mesh-ancestor
5568949|NCT03945513|Hormones|hormones|mesh-ancestor
5568950|NCT03945513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5568951|NCT03945513|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5568952|NCT03945513|Hormone Antagonists|hormone antagonists|mesh-ancestor
5568953|NCT03945513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5568954|NCT03945513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5568955|NCT03945643|Sildenafil Citrate|sildenafil citrate|mesh-list
5568956|NCT03945643|Vasodilator Agents|vasodilator agents|mesh-ancestor
5568957|NCT03945643|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5568958|NCT03945643|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5568959|NCT03945643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5568960|NCT03945643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568961|NCT03945643|Urological Agents|urological agents|mesh-ancestor
5568962|NCT03945604|Apatinib|apatinib|mesh-list
5568963|NCT03945604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5568964|NCT03945604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5568965|NCT03945604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5568966|NCT03945604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568967|NCT03945227|Spartalizumab|spartalizumab|mesh-list
6171678|NCT01644474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6171679|NCT01644474|Immunologic Factors|immunologic factors|mesh-ancestor
6171680|NCT01644474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171681|NCT01644500|Glimepiride|glimepiride|mesh-list
6171682|NCT01644500|Dulaglutide|dulaglutide|mesh-list
6171683|NCT01644500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6171684|NCT01644500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6669921|NCT01540500|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6669922|NCT01540500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6669923|NCT01540500|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6669924|NCT01540526|Axitinib|axitinib|mesh-list
6669925|NCT01540526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6669926|NCT01540526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6669927|NCT01540526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6669928|NCT01540526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669929|NCT01540591|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6171685|NCT01644500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171686|NCT01644500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6171687|NCT01644500|Immunologic Factors|immunologic factors|mesh-ancestor
6171688|NCT01644643|Metronidazole|metronidazole|mesh-list
6171689|NCT01644643|Ceftazidime|ceftazidime|mesh-list
6171690|NCT01644643|Avibactam|avibactam|mesh-list
6171691|NCT01644643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6171692|NCT01644643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6171693|NCT01644643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6171694|NCT01644643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6171695|NCT01644643|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6171696|NCT01644643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6171697|NCT01644643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568968|NCT03945227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6171698|NCT01644734|Tiotropium Bromide|tiotropium bromide|mesh-list
6171699|NCT01644734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5568969|NCT03945227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568970|NCT03945227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5568971|NCT03945019|Infliximab|infliximab|mesh-list
5568972|NCT03945019|Dermatologic Agents|dermatologic agents|mesh-ancestor
5568973|NCT03945019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6171700|NCT01644734|Autonomic Agents|autonomic agents|mesh-ancestor
6171701|NCT01644734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6171702|NCT01644734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171703|NCT01644734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6171704|NCT01644734|Respiratory System Agents|respiratory system agents|mesh-ancestor
6171705|NCT01644734|Parasympatholytics|parasympatholytics|mesh-ancestor
6171706|NCT01644734|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6171707|NCT01644734|Cholinergic Agents|cholinergic agents|mesh-ancestor
6171708|NCT01644734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6171709|NCT01644734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6171710|NCT01644890|Paclitaxel|paclitaxel|mesh-list
6171711|NCT01644890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6171712|NCT01644890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6171713|NCT01644890|Tubulin Modulators|tubulin modulators|mesh-ancestor
6171714|NCT01644890|Antimitotic Agents|antimitotic agents|mesh-ancestor
6171715|NCT01644890|Mitosis Modulators|mitosis modulators|mesh-ancestor
6171716|NCT01644890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6171717|NCT01645098|Dexmedetomidine|dexmedetomidine|mesh-list
6171718|NCT01645098|Ketamine|ketamine|mesh-list
6171719|NCT01645098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6485543|NCT00565968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6485544|NCT00565968|Immunologic Factors|immunologic factors|mesh-ancestor
6485545|NCT00565968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488994|NCT00588523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6488995|NCT00588523|Alkylating Agents|alkylating agents|mesh-ancestor
6488996|NCT00588523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488997|NCT00588523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6488998|NCT00588523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6171720|NCT01645098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6171721|NCT01645098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171722|NCT01645098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6171723|NCT01645098|Analgesics|analgesics|mesh-ancestor
6171724|NCT01645098|Sensory System Agents|sensory system agents|mesh-ancestor
6171725|NCT01645098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6171726|NCT01645098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6171727|NCT01645098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6171728|NCT01645098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6171729|NCT01645098|Adrenergic Agents|adrenergic agents|mesh-ancestor
6171730|NCT01645098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6171731|NCT01645098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568974|NCT03945019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5568975|NCT03945344|Tiotropium Bromide|tiotropium bromide|mesh-list
5568976|NCT03945344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5568977|NCT03945344|Autonomic Agents|autonomic agents|mesh-ancestor
5568978|NCT03945344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5568979|NCT03945344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5568980|NCT03945344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5568981|NCT03945344|Respiratory System Agents|respiratory system agents|mesh-ancestor
6171732|NCT01645098|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6171733|NCT01645098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6171734|NCT01645098|Anesthetics, General|anesthetics, general|mesh-ancestor
6171735|NCT01645098|Anesthetics|anesthetics|mesh-ancestor
6171736|NCT01645098|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6171737|NCT01645098|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6171738|NCT01645111|Clevidipine|clevidipine|mesh-list
6488999|NCT00588523|Immunologic Factors|immunologic factors|mesh-ancestor
5568982|NCT03945344|Parasympatholytics|parasympatholytics|mesh-ancestor
6171739|NCT01645111|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6171740|NCT01645111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6669930|NCT01540591|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6669931|NCT01540591|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6669932|NCT01540591|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6171741|NCT01645111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6171742|NCT01645111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6171743|NCT01645111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171744|NCT01645176|Hydroxychloroquine|hydroxychloroquine|mesh-list
6171745|NCT01645176|Atorvastatin|atorvastatin|mesh-list
6171746|NCT01645176|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6171747|NCT01645176|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6171748|NCT01645176|Antimetabolites|antimetabolites|mesh-ancestor
6171749|NCT01645176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6171750|NCT01645176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6171751|NCT01645176|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6171752|NCT01645176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6171753|NCT01645176|Antimalarials|antimalarials|mesh-ancestor
6171754|NCT01645176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6669933|NCT01540682|Cetuximab|cetuximab|mesh-list
6669934|NCT01540682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6669935|NCT01540682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6669936|NCT01540708|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6669937|NCT01540708|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6669938|NCT01540708|Autonomic Agents|autonomic agents|mesh-ancestor
6669939|NCT01540708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6669940|NCT01540708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171755|NCT01645176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6171756|NCT01645176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6171757|NCT01645176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6171758|NCT01645280|Methotrexate|methotrexate|mesh-list
6171759|NCT01645280|Ustekinumab|ustekinumab|mesh-list
6171760|NCT01645280|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6171761|NCT01645280|Abortifacient Agents|abortifacient agents|mesh-ancestor
6171762|NCT01645280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6171763|NCT01645280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171764|NCT01645280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6171765|NCT01645280|Antimetabolites|antimetabolites|mesh-ancestor
6171766|NCT01645280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6171767|NCT01645280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6171768|NCT01645280|Dermatologic Agents|dermatologic agents|mesh-ancestor
6171769|NCT01645280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6171770|NCT01645280|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6171771|NCT01645280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6171772|NCT01645280|Immunologic Factors|immunologic factors|mesh-ancestor
6171773|NCT01645280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6171774|NCT01645280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6171775|NCT01645735|Vancomycin|vancomycin|mesh-list
6171776|NCT01645735|Ceftriaxone|ceftriaxone|mesh-list
6171777|NCT01645735|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
6171778|NCT01645735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6171779|NCT01645735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6171780|NCT01645930|Dexamethasone|dexamethasone|mesh-list
6171781|NCT01645930|Lenalidomide|lenalidomide|mesh-list
6171782|NCT01645930|Ixazomib|ixazomib|mesh-list
6171783|NCT01645930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6171784|NCT01645930|Antiemetics|antiemetics|mesh-ancestor
6171785|NCT01645930|Autonomic Agents|autonomic agents|mesh-ancestor
6171786|NCT01645930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5568983|NCT03945344|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5568984|NCT03945344|Cholinergic Agents|cholinergic agents|mesh-ancestor
5568985|NCT03945344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5568986|NCT03945344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6171787|NCT01645930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171788|NCT01645930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6171789|NCT01645930|Glucocorticoids|glucocorticoids|mesh-ancestor
6171790|NCT01645930|Hormones|hormones|mesh-ancestor
5568987|NCT03945396|Calcium Carbonate|calcium carbonate|mesh-list
5568988|NCT03945396|Antacids|antacids|mesh-ancestor
5568989|NCT03945396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568990|NCT03945396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5568991|NCT03945084|Niraparib|niraparib|mesh-list
5568992|NCT03945084|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5568993|NCT03945084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5604115|NCT05177796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5568994|NCT03945084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5568995|NCT03945084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5568996|NCT03944980|Docetaxel|docetaxel|mesh-list
5568997|NCT03944980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5568998|NCT03944980|Tubulin Modulators|tubulin modulators|mesh-ancestor
5568999|NCT03944980|Antimitotic Agents|antimitotic agents|mesh-ancestor
5569000|NCT03944980|Mitosis Modulators|mitosis modulators|mesh-ancestor
5569001|NCT03944980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569002|NCT03944889|Capsaicin|capsaicin|mesh-list
5569003|NCT03944889|Antipruritics|antipruritics|mesh-ancestor
5569004|NCT03944889|Dermatologic Agents|dermatologic agents|mesh-ancestor
5569005|NCT03944889|Sensory System Agents|sensory system agents|mesh-ancestor
5569006|NCT03944889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5569007|NCT03944889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569008|NCT03944915|Paclitaxel|paclitaxel|mesh-list
5569009|NCT03944915|Carboplatin|carboplatin|mesh-list
5569010|NCT03944915|Fluorouracil|fluorouracil|mesh-list
5569011|NCT03944915|Nivolumab|nivolumab|mesh-list
5569012|NCT03944915|Hydroxyurea|hydroxyurea|mesh-list
5569013|NCT03944915|Lenograstim|lenograstim|mesh-list
5569014|NCT03944915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6171791|NCT01645930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6171792|NCT01645930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6171793|NCT01645930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6171794|NCT01645930|Immunologic Factors|immunologic factors|mesh-ancestor
6171795|NCT01645930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6171796|NCT01645930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6171797|NCT01645930|Growth Substances|growth substances|mesh-ancestor
6171798|NCT01645930|Growth Inhibitors|growth inhibitors|mesh-ancestor
6171799|NCT01645930|Protease Inhibitors|protease inhibitors|mesh-ancestor
6171800|NCT01645930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6171801|NCT01645930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6171802|NCT01646021|Sirolimus|sirolimus|mesh-list
6171803|NCT01646021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6171804|NCT01646021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6171805|NCT01646021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6171806|NCT01646021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6171807|NCT01646021|Antifungal Agents|antifungal agents|mesh-ancestor
6171808|NCT01646021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6171809|NCT01646021|Immunologic Factors|immunologic factors|mesh-ancestor
6171810|NCT01646021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171811|NCT01646073|Adalimumab|adalimumab|mesh-list
6171812|NCT01646073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6171813|NCT01646073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6171814|NCT01646125|Docetaxel|docetaxel|mesh-list
6171815|NCT01646125|Pemetrexed|pemetrexed|mesh-list
6171816|NCT01646125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6171817|NCT01646125|Tubulin Modulators|tubulin modulators|mesh-ancestor
6171818|NCT01646125|Antimitotic Agents|antimitotic agents|mesh-ancestor
6171819|NCT01646125|Mitosis Modulators|mitosis modulators|mesh-ancestor
6171820|NCT01646125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6171821|NCT01646125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6171822|NCT01646125|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6171823|NCT01646125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6171824|NCT01646151|Bimatoprost|bimatoprost|mesh-list
6171825|NCT01646151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6171826|NCT01646177|Etanercept|etanercept|mesh-list
6171827|NCT01646177|Ixekizumab|ixekizumab|mesh-list
6171828|NCT01646177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6171829|NCT01646177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6171830|NCT01646177|Analgesics|analgesics|mesh-ancestor
6171831|NCT01646177|Sensory System Agents|sensory system agents|mesh-ancestor
6171832|NCT01646177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6171833|NCT01646177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171834|NCT01646177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5569015|NCT03944915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6171835|NCT01646177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6171836|NCT01646177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6171837|NCT01646177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6171838|NCT01646177|Immunologic Factors|immunologic factors|mesh-ancestor
5569016|NCT03944915|Tubulin Modulators|tubulin modulators|mesh-ancestor
5569017|NCT03944915|Antimitotic Agents|antimitotic agents|mesh-ancestor
5569018|NCT03944915|Mitosis Modulators|mitosis modulators|mesh-ancestor
5569019|NCT03944915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569020|NCT03944915|Antimetabolites|antimetabolites|mesh-ancestor
5569021|NCT03944915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5569022|NCT03944915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5569023|NCT03944915|Immunologic Factors|immunologic factors|mesh-ancestor
5569024|NCT03944915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569025|NCT03944915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5569026|NCT03944915|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5569027|NCT03944915|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5569028|NCT03944915|Antisickling Agents|antisickling agents|mesh-ancestor
5569029|NCT03944915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5569030|NCT03944915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5569031|NCT03944954|Dronabinol|dronabinol|mesh-list
5569032|NCT03944954|Hallucinogens|hallucinogens|mesh-ancestor
5569033|NCT03944954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569034|NCT03944954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5569035|NCT03944954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5569036|NCT03944954|Analgesics|analgesics|mesh-ancestor
5569037|NCT03944954|Sensory System Agents|sensory system agents|mesh-ancestor
5569038|NCT03944954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5569039|NCT03944954|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5569040|NCT03944954|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5569041|NCT03944954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5569042|NCT03944954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569043|NCT03944954|Hormones|hormones|mesh-ancestor
5569044|NCT03944954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5569045|NCT03944733|Iron|iron|mesh-list
5569046|NCT03944733|Trace Elements|trace elements|mesh-ancestor
6171839|NCT01646177|Dermatologic Agents|dermatologic agents|mesh-ancestor
6171840|NCT01646255|Levodopa|levodopa|mesh-list
6171841|NCT01646255|Rotigotine|rotigotine|mesh-list
6171842|NCT01646255|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6171843|NCT01646255|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6171844|NCT01646255|Dopamine Agents|dopamine agents|mesh-ancestor
6171845|NCT01646255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6171846|NCT01646255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6171847|NCT01646255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171848|NCT01646255|Dopamine Agonists|dopamine agonists|mesh-ancestor
6171849|NCT01646268|Rotigotine|rotigotine|mesh-list
6171850|NCT01646268|Dopamine Agonists|dopamine agonists|mesh-ancestor
6171851|NCT01646268|Dopamine Agents|dopamine agents|mesh-ancestor
6171852|NCT01646268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6171853|NCT01646268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6171854|NCT01646268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171855|NCT01646320|Metformin|metformin|mesh-list
6171856|NCT01646320|Dapagliflozin|dapagliflozin|mesh-list
6171857|NCT01646320|Saxagliptin|saxagliptin|mesh-list
6171858|NCT01646320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6171859|NCT01646320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171860|NCT01646320|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5569047|NCT03944733|Micronutrients|micronutrients|mesh-ancestor
5569048|NCT03944733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569049|NCT03944863|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5569050|NCT03944863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5604116|NCT05177796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5604117|NCT05177796|Alkylating Agents|alkylating agents|mesh-ancestor
5604118|NCT05177796|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5604119|NCT05177796|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5604120|NCT05177796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5604121|NCT05177796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5604122|NCT05177796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5604123|NCT05177796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6171861|NCT01646320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6171862|NCT01646320|Incretins|incretins|mesh-ancestor
6171863|NCT01646320|Hormones|hormones|mesh-ancestor
6171864|NCT01646320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6171865|NCT01646320|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5604124|NCT05177731|Cytarabine|cytarabine|mesh-list
5604125|NCT05177731|Decitabine|decitabine|mesh-list
6171866|NCT01646320|Protease Inhibitors|protease inhibitors|mesh-ancestor
6171867|NCT01646320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6171868|NCT01646385|Etanercept|etanercept|mesh-list
6171869|NCT01646385|Antirheumatic Agents|antirheumatic agents|mesh-list
6171870|NCT01646385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6171871|NCT01646385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6171872|NCT01646385|Analgesics|analgesics|mesh-ancestor
6171873|NCT01646385|Sensory System Agents|sensory system agents|mesh-ancestor
6171874|NCT01646385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6485546|NCT00565981|Fludarabine|fludarabine|mesh-list
6485547|NCT00565981|Fludarabine phosphate|fludarabine phosphate|mesh-list
6485548|NCT00565981|Alemtuzumab|alemtuzumab|mesh-list
6485549|NCT00565981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6171875|NCT01646385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569051|NCT03944655|Anesthetics|anesthetics|mesh-list
5569052|NCT03944655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5569053|NCT03944655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569054|NCT03944681|Droperidol|droperidol|mesh-list
5569055|NCT03944681|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5569056|NCT03944681|Antiemetics|antiemetics|mesh-ancestor
5569057|NCT03944681|Autonomic Agents|autonomic agents|mesh-ancestor
5569058|NCT03944681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5569059|NCT03944681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569060|NCT03944681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5569061|NCT03944681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5569062|NCT03944681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6171876|NCT01646385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6171877|NCT01646385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6171878|NCT01646385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6171879|NCT01646385|Immunologic Factors|immunologic factors|mesh-ancestor
6171880|NCT01646398|Vaccines|vaccines|mesh-list
6171881|NCT01646398|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6171882|NCT01646398|Immunologic Factors|immunologic factors|mesh-ancestor
6171883|NCT01646398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171884|NCT01646671|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5569063|NCT03944681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5569064|NCT03944681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5569065|NCT03944681|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5569066|NCT03944681|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5569067|NCT03944681|Dopamine Agents|dopamine agents|mesh-ancestor
5569068|NCT03944681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5569069|NCT03944681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569070|NCT03944473|Neostigmine|neostigmine|mesh-list
5569071|NCT03944473|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6171885|NCT01646671|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6171886|NCT01646671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6171887|NCT01646762|Paclitaxel|paclitaxel|mesh-list
6171888|NCT01646762|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6171889|NCT01646762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6171890|NCT01646762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6171891|NCT01646762|Tubulin Modulators|tubulin modulators|mesh-ancestor
6171892|NCT01646762|Antimitotic Agents|antimitotic agents|mesh-ancestor
6171893|NCT01646762|Mitosis Modulators|mitosis modulators|mesh-ancestor
6171894|NCT01646762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6171895|NCT01646814|Aspirin|aspirin|mesh-list
6171896|NCT01646814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6171897|NCT01646814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6171898|NCT01646814|Analgesics|analgesics|mesh-ancestor
6171899|NCT01646814|Sensory System Agents|sensory system agents|mesh-ancestor
6171900|NCT01646814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6171901|NCT01646814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171902|NCT01646814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6171903|NCT01646814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5569072|NCT03944473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5569073|NCT03944473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569074|NCT03944473|Cholinergic Agents|cholinergic agents|mesh-ancestor
5569075|NCT03944473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5569076|NCT03944473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569077|NCT03944473|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5569078|NCT03944473|Autonomic Agents|autonomic agents|mesh-ancestor
5569079|NCT03944473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5569080|NCT03944512|Pravastatin|pravastatin|mesh-list
5569081|NCT03944512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5569082|NCT03944512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5569083|NCT03944512|Antimetabolites|antimetabolites|mesh-ancestor
6171904|NCT01646814|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6171905|NCT01646814|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6171906|NCT01646814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6171907|NCT01646814|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6171908|NCT01646814|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6171909|NCT01646814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6171910|NCT01646814|Antipyretics|antipyretics|mesh-ancestor
6171911|NCT01646827|Aripiprazole|aripiprazole|mesh-list
6171912|NCT01646827|Antidepressive Agents|antidepressive agents|mesh-ancestor
6171913|NCT01646827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6171914|NCT01646827|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6171915|NCT01646827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6171916|NCT01646827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6171917|NCT01646827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171918|NCT01646827|Dopamine Agonists|dopamine agonists|mesh-ancestor
6171919|NCT01646827|Dopamine Agents|dopamine agents|mesh-ancestor
6171920|NCT01646827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6171921|NCT01646827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6171922|NCT01646827|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6171923|NCT01646827|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6171924|NCT01646827|Serotonin Agents|serotonin agents|mesh-ancestor
6171925|NCT01646827|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6171926|NCT01646827|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6171927|NCT01646827|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6171928|NCT01646827|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6171929|NCT01647282|Minocycline|minocycline|mesh-list
6171930|NCT01647282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6171931|NCT01647282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6171932|NCT01647516|Ozanimod|ozanimod|mesh-list
6171933|NCT01647516|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6171934|NCT01647516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569084|NCT03944512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569085|NCT03944512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5569086|NCT03944512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5569087|NCT03944512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5569088|NCT03944317|Azithromycin|azithromycin|mesh-list
5569089|NCT03944317|Pyrimethamine|pyrimethamine|mesh-list
5569090|NCT03944317|Sulfadoxine|sulfadoxine|mesh-list
6171935|NCT01647516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6171936|NCT01647516|Immunologic Factors|immunologic factors|mesh-ancestor
6171937|NCT01647516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569091|NCT03944317|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
5569092|NCT03944317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5569093|NCT03944317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5569094|NCT03944317|Antimalarials|antimalarials|mesh-ancestor
5569095|NCT03944317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5569096|NCT03944317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5569097|NCT03944317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5569098|NCT03944317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5569099|NCT03944317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569100|NCT03944317|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6171938|NCT01647581|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6171939|NCT01647581|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
6171940|NCT01647581|beta-Endorphin|beta-endorphin|mesh-list
6171941|NCT01647581|Hormones|hormones|mesh-ancestor
6171942|NCT01647581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6171943|NCT01647581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171944|NCT01647581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6171945|NCT01647581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6171946|NCT01647945|Tacrolimus|tacrolimus|mesh-list
6171947|NCT01647945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6171948|NCT01647945|Immunologic Factors|immunologic factors|mesh-ancestor
6171949|NCT01647945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171950|NCT01647945|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6171951|NCT01647945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6171952|NCT01647945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6171953|NCT01648101|Ezogabine|ezogabine|mesh-list
6171954|NCT01648101|Anticonvulsants|anticonvulsants|mesh-ancestor
6171955|NCT01648101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6171956|NCT01648101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6171957|NCT01648140|Interferons|interferons|mesh-list
6171958|NCT01648140|Ribavirin|ribavirin|mesh-list
5569101|NCT03944317|Renal Agents|renal agents|mesh-ancestor
6171959|NCT01648140|Interferon-alpha|interferon-alpha|mesh-list
6171960|NCT01648140|Interferon alpha-2|interferon alpha-2|mesh-list
6171961|NCT01648140|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6171962|NCT01648140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6171963|NCT01648140|Antiviral Agents|antiviral agents|mesh-ancestor
6171964|NCT01648140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6171965|NCT01648140|Antimetabolites|antimetabolites|mesh-ancestor
6171966|NCT01648140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6171967|NCT01648140|Immunologic Factors|immunologic factors|mesh-ancestor
6171968|NCT01648140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206340|NCT02099006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206341|NCT02099006|Anticonvulsants|anticonvulsants|mesh-ancestor
6206342|NCT02099006|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6206343|NCT02099006|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6206344|NCT02099006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6206345|NCT02099006|Antimanic Agents|antimanic agents|mesh-ancestor
6206346|NCT02099006|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6206347|NCT02099006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6206348|NCT02099006|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6206349|NCT02099006|GABA Agonists|gaba agonists|mesh-ancestor
6206350|NCT02099006|GABA Agents|gaba agents|mesh-ancestor
6206351|NCT02099006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6206352|NCT02099006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6206353|NCT02099006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6206354|NCT02099006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6206355|NCT02099006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6669941|NCT01540708|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6669942|NCT01540708|Respiratory System Agents|respiratory system agents|mesh-ancestor
6669943|NCT01540708|Glucocorticoids|glucocorticoids|mesh-ancestor
6669944|NCT01540708|Hormones|hormones|mesh-ancestor
6669945|NCT01540708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6669946|NCT01540708|Sympathomimetics|sympathomimetics|mesh-ancestor
6669947|NCT01540721|Acetaminophen|acetaminophen|mesh-list
6669948|NCT01540721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6206356|NCT02099006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6206357|NCT02099006|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6206358|NCT02099006|Antidepressive Agents|antidepressive agents|mesh-ancestor
6206359|NCT02099006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6206360|NCT02099006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6206361|NCT02099006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6206362|NCT02099006|Adrenergic Agents|adrenergic agents|mesh-ancestor
6206363|NCT02099006|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6206364|NCT02099006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6206365|NCT02099084|Teduglutide|teduglutide|mesh-list
6206366|NCT02099084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6206367|NCT02099084|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6206368|NCT02099084|Protective Agents|protective agents|mesh-ancestor
6206369|NCT02099084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206370|NCT02099110|Metformin|metformin|mesh-list
6206371|NCT02099110|Insulin Glargine|insulin glargine|mesh-list
6206372|NCT02099110|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6206373|NCT02099110|Glimepiride|glimepiride|mesh-list
6206374|NCT02099110|Ertugliflozin|ertugliflozin|mesh-list
6206375|NCT02099110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6206376|NCT02099110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206377|NCT02099110|Incretins|incretins|mesh-ancestor
6206378|NCT02099110|Hormones|hormones|mesh-ancestor
6206379|NCT02099110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6206380|NCT02099110|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6206381|NCT02099110|Protease Inhibitors|protease inhibitors|mesh-ancestor
6669949|NCT01540721|Analgesics|analgesics|mesh-ancestor
6206382|NCT02099110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6206383|NCT02099110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206384|NCT02099110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6485550|NCT00565981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6485551|NCT00565981|Antimetabolites|antimetabolites|mesh-ancestor
6485552|NCT00565981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485553|NCT00565981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6485554|NCT00565981|Immunologic Factors|immunologic factors|mesh-ancestor
6485555|NCT00565981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485556|NCT00565981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6485557|NCT00566046|Levetiracetam|levetiracetam|mesh-list
6485558|NCT00566046|Anticonvulsants|anticonvulsants|mesh-ancestor
6485559|NCT00566046|Nootropic Agents|nootropic agents|mesh-ancestor
6485560|NCT00566124|Insulin|insulin|mesh-list
6485561|NCT00566124|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5569102|NCT03944291|Bupivacaine|bupivacaine|mesh-list
5569103|NCT03944291|Anesthetics, Local|anesthetics, local|mesh-ancestor
5569104|NCT03944291|Anesthetics|anesthetics|mesh-ancestor
5569105|NCT03944291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5569106|NCT03944291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569107|NCT03944291|Sensory System Agents|sensory system agents|mesh-ancestor
5569108|NCT03944291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5569109|NCT03944434|Leuprolide|leuprolide|mesh-list
5569110|NCT03944434|Goserelin|goserelin|mesh-list
5569111|NCT03944434|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5569112|NCT03944434|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5569113|NCT03944434|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6485562|NCT00566124|Insulin Glargine|insulin glargine|mesh-list
6485563|NCT00566124|Insulin Detemir|insulin detemir|mesh-list
6171969|NCT01648283|Methadone|methadone|mesh-list
6171970|NCT01648283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6171971|NCT01648283|Narcotics|narcotics|mesh-ancestor
6171972|NCT01648283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6171973|NCT01648283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569114|NCT03944434|Fertility Agents|fertility agents|mesh-ancestor
5569115|NCT03944434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5569116|NCT03944434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569117|NCT03944434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5569118|NCT03944434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5569119|NCT03944434|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5569120|NCT03944434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5569121|NCT03944434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569122|NCT03944434|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5569123|NCT03944434|Hormone Antagonists|hormone antagonists|mesh-ancestor
5569124|NCT03944434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5569125|NCT03944434|Luteolytic Agents|luteolytic agents|mesh-ancestor
5569126|NCT03944434|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5569127|NCT03944434|Contraceptive Agents|contraceptive agents|mesh-ancestor
6485564|NCT00566124|Isophane Insulin, Human|isophane insulin, human|mesh-list
6485565|NCT00566124|Insulin, Isophane|insulin, isophane|mesh-list
6485566|NCT00566124|Isophane insulin, beef|isophane insulin, beef|mesh-list
6485567|NCT00566124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6485568|NCT00566124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485569|NCT00566241|Mecasermin|mecasermin|mesh-list
6485570|NCT00566241|Growth Substances|growth substances|mesh-ancestor
6485571|NCT00566241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485572|NCT00566267|Simvastatin|simvastatin|mesh-list
6485573|NCT00566267|Ezetimibe|ezetimibe|mesh-list
6485574|NCT00566267|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6485575|NCT00566267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6485576|NCT00566267|Antimetabolites|antimetabolites|mesh-ancestor
6485577|NCT00566267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485578|NCT00566267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6485579|NCT00566267|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6485580|NCT00566267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6485581|NCT00566332|Fludarabine|fludarabine|mesh-list
6485582|NCT00566332|Chlorambucil|chlorambucil|mesh-list
6485583|NCT00566332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6485584|NCT00566332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485585|NCT00566332|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6485586|NCT00566332|Alkylating Agents|alkylating agents|mesh-ancestor
6485587|NCT00566371|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6485588|NCT00566371|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6485589|NCT00566371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6485590|NCT00566371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6485591|NCT00566371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485592|NCT00566371|Adrenergic Agents|adrenergic agents|mesh-ancestor
5569128|NCT03944434|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5569129|NCT03944304|Paclitaxel|paclitaxel|mesh-list
5569130|NCT03944304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5569131|NCT03944304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5569132|NCT03944304|Tubulin Modulators|tubulin modulators|mesh-ancestor
5569133|NCT03944304|Antimitotic Agents|antimitotic agents|mesh-ancestor
5569134|NCT03944304|Mitosis Modulators|mitosis modulators|mesh-ancestor
5569135|NCT03944304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569136|NCT03944252|Cetuximab|cetuximab|mesh-list
5569137|NCT03944252|Avelumab|avelumab|mesh-list
5569138|NCT03944252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5604126|NCT05177731|Venetoclax|venetoclax|mesh-list
6171974|NCT01648283|Analgesics|analgesics|mesh-ancestor
6485593|NCT00566371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6485594|NCT00566371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485595|NCT00566384|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
6485596|NCT00566384|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6485597|NCT00566384|Immunologic Factors|immunologic factors|mesh-ancestor
5569139|NCT03944252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5569140|NCT03944070|Ranibizumab|ranibizumab|mesh-list
5569141|NCT03944070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5569142|NCT03944070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5569143|NCT03944070|Growth Substances|growth substances|mesh-ancestor
5569144|NCT03944070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569145|NCT03944070|Growth Inhibitors|growth inhibitors|mesh-ancestor
5569146|NCT03944070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5569147|NCT03944044|Acetaminophen|acetaminophen|mesh-list
5569148|NCT03944044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5569149|NCT03944044|Analgesics|analgesics|mesh-ancestor
5569150|NCT03944044|Sensory System Agents|sensory system agents|mesh-ancestor
5569151|NCT03944044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5569152|NCT03944044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569153|NCT03944044|Antipyretics|antipyretics|mesh-ancestor
5569154|NCT03943888|Atropine|atropine|mesh-list
5569155|NCT03943888|Neostigmine|neostigmine|mesh-list
5569156|NCT03943888|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5569157|NCT03943888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5569158|NCT03943888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5569159|NCT03943888|Autonomic Agents|autonomic agents|mesh-ancestor
5569160|NCT03943888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6485598|NCT00566384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485599|NCT00566488|Parathyroid Hormone|parathyroid hormone|mesh-list
6485600|NCT00566488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6485601|NCT00566488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485602|NCT00566553|Grape Seed Extract|grape seed extract|mesh-list
6485603|NCT00566553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6485604|NCT00566553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6485605|NCT00566553|Antioxidants|antioxidants|mesh-ancestor
6485606|NCT00566553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485607|NCT00566553|Protective Agents|protective agents|mesh-ancestor
6485608|NCT00566553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569161|NCT03943888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171975|NCT01648283|Sensory System Agents|sensory system agents|mesh-ancestor
6171976|NCT01648283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6171977|NCT01648283|Antitussive Agents|antitussive agents|mesh-ancestor
6171978|NCT01648283|Respiratory System Agents|respiratory system agents|mesh-ancestor
6171979|NCT01648348|Bevacizumab|bevacizumab|mesh-list
6171980|NCT01648348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6171981|NCT01648348|Endothelial Growth Factors|endothelial growth factors|mesh-list
5569162|NCT03943888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5569163|NCT03943888|Respiratory System Agents|respiratory system agents|mesh-ancestor
5569164|NCT03943888|Mydriatics|mydriatics|mesh-ancestor
5569165|NCT03943888|Parasympatholytics|parasympatholytics|mesh-ancestor
5569166|NCT03943888|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5569167|NCT03943888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6171982|NCT01648348|Antibodies|antibodies|mesh-list
6171983|NCT01648348|Immunoglobulins|immunoglobulins|mesh-list
6171984|NCT01648348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6171985|NCT01648348|Immunoglobulin G|immunoglobulin g|mesh-list
6171986|NCT01648348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6171987|NCT01648348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6171988|NCT01648348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6171989|NCT01648348|Growth Substances|growth substances|mesh-ancestor
6171990|NCT01648348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171991|NCT01648348|Growth Inhibitors|growth inhibitors|mesh-ancestor
6171992|NCT01648348|Immunologic Factors|immunologic factors|mesh-ancestor
6171993|NCT01648582|Metformin|metformin|mesh-list
6171994|NCT01648582|Insulin Glargine|insulin glargine|mesh-list
6171995|NCT01648582|Dulaglutide|dulaglutide|mesh-list
6171996|NCT01648582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6171997|NCT01648582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6171998|NCT01648699|Hydromorphone|hydromorphone|mesh-list
6171999|NCT01648699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6172000|NCT01648699|Narcotics|narcotics|mesh-ancestor
6172001|NCT01648699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5569168|NCT03943888|Cholinergic Agents|cholinergic agents|mesh-ancestor
5569169|NCT03943888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6172002|NCT01648699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172003|NCT01648699|Analgesics|analgesics|mesh-ancestor
6172004|NCT01648699|Sensory System Agents|sensory system agents|mesh-ancestor
5569170|NCT03943888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569171|NCT03943888|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5569172|NCT03943888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5569173|NCT03943888|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5569174|NCT03943927|Metoprolol|metoprolol|mesh-list
5569175|NCT03943927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5569176|NCT03943927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5569177|NCT03943927|Sympatholytics|sympatholytics|mesh-ancestor
6172005|NCT01648699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6485609|NCT00566592|Ethanol|ethanol|mesh-list
6485610|NCT00566592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6485611|NCT00566592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6485612|NCT00566592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6485613|NCT00566592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172006|NCT01648790|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6172007|NCT01648790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6172008|NCT01649180|Axitinib|axitinib|mesh-list
6172009|NCT01649180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6172010|NCT01649180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6172011|NCT01649180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6172012|NCT01649180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172013|NCT01649271|Trastuzumab|trastuzumab|mesh-list
6172014|NCT01649271|Afatinib|afatinib|mesh-list
6172015|NCT01649271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6172016|NCT01649271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6485614|NCT00566644|Levonorgestrel|levonorgestrel|mesh-list
6485615|NCT00566644|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6485616|NCT00566644|Contraceptive Agents|contraceptive agents|mesh-ancestor
6485617|NCT00566644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6485618|NCT00566644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172017|NCT01649271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6172018|NCT01649271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6172019|NCT01649271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172020|NCT01649297|Empagliflozin|empagliflozin|mesh-list
6172021|NCT01649297|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6172022|NCT01649297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172023|NCT01649297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6172024|NCT01649297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172025|NCT01649375|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6172026|NCT01649375|Immunologic Factors|immunologic factors|mesh-ancestor
5569178|NCT03943927|Autonomic Agents|autonomic agents|mesh-ancestor
5569179|NCT03943927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5569180|NCT03943927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569181|NCT03943927|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5569182|NCT03943927|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5569183|NCT03943927|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5569184|NCT03943927|Adrenergic Agents|adrenergic agents|mesh-ancestor
5569185|NCT03943927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5569186|NCT03943927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569187|NCT03944005|Anesthetics|anesthetics|mesh-list
5569188|NCT03944005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5569189|NCT03944005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569190|NCT03943992|Esomeprazole|esomeprazole|mesh-list
5569191|NCT03943992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5569192|NCT03943992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5569193|NCT03943992|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5569194|NCT03943992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5569195|NCT03943992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569196|NCT03943459|Atorvastatin|atorvastatin|mesh-list
6172027|NCT01649375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172028|NCT01649427|Tacrolimus|tacrolimus|mesh-list
6172029|NCT01649427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6172030|NCT01649427|Immunologic Factors|immunologic factors|mesh-ancestor
6172031|NCT01649427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172032|NCT01649427|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6172033|NCT01649427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6172034|NCT01649427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485619|NCT00566644|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6485620|NCT00566644|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6485621|NCT00566644|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6485622|NCT00566683|Meperidine|meperidine|mesh-list
5569197|NCT03943459|Quercetin|quercetin|mesh-list
5569198|NCT03943459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6485623|NCT00566683|Diazepam|diazepam|mesh-list
6172035|NCT01649609|Mycophenolic Acid|mycophenolic acid|mesh-list
6172036|NCT01649609|Sirolimus|sirolimus|mesh-list
6172037|NCT01649609|Tacrolimus|tacrolimus|mesh-list
6172038|NCT01649609|Antimetabolites|antimetabolites|mesh-list
6172039|NCT01649609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6172040|NCT01649609|Immunologic Factors|immunologic factors|mesh-ancestor
6172041|NCT01649609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172042|NCT01649609|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6172043|NCT01649609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6172044|NCT01649609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172045|NCT01649609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6172046|NCT01649609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6172047|NCT01649609|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5569199|NCT03943459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5569200|NCT03943459|Antimetabolites|antimetabolites|mesh-ancestor
5569201|NCT03943459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569202|NCT03943459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5569203|NCT03943459|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5569204|NCT03943459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5569205|NCT03943459|Antioxidants|antioxidants|mesh-ancestor
5569206|NCT03943459|Protective Agents|protective agents|mesh-ancestor
5569207|NCT03943459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569208|NCT03943589|Immunoglobulins|immunoglobulins|mesh-list
5569209|NCT03943589|Immunoglobulin G|immunoglobulin g|mesh-list
5569210|NCT03943589|Immunologic Factors|immunologic factors|mesh-ancestor
5569211|NCT03943589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569212|NCT03943537|Insulin|insulin|mesh-list
5569213|NCT03943537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5569214|NCT03943537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569215|NCT03943784|Propranolol|propranolol|mesh-list
5569216|NCT03943784|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
5569217|NCT03943784|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5569218|NCT03943784|Adrenergic Agents|adrenergic agents|mesh-ancestor
5569219|NCT03943784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5569220|NCT03943784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569221|NCT03943784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172048|NCT01649609|Antitubercular Agents|antitubercular agents|mesh-ancestor
6172049|NCT01649609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5569222|NCT03943784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5569223|NCT03943784|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5569224|NCT03943784|Vasodilator Agents|vasodilator agents|mesh-ancestor
5569225|NCT03943823|Estrogens|estrogens|mesh-list
5569226|NCT03943823|Hormones|hormones|mesh-ancestor
5569227|NCT03943823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5569228|NCT03943823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569229|NCT03943472|Cyclophosphamide|cyclophosphamide|mesh-list
5569230|NCT03943472|Fludarabine|fludarabine|mesh-list
5569231|NCT03943472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5569232|NCT03943472|Immunologic Factors|immunologic factors|mesh-ancestor
5569233|NCT03943472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569234|NCT03943472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5569235|NCT03943472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5569236|NCT03943472|Alkylating Agents|alkylating agents|mesh-ancestor
5569237|NCT03943472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569238|NCT03943472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5569239|NCT03943472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5569240|NCT03943186|Hyaluronic Acid|hyaluronic acid|mesh-list
6485624|NCT00566683|Alfentanil|alfentanil|mesh-list
6485625|NCT00566683|Propofol|propofol|mesh-list
6485626|NCT00566683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6485627|NCT00566683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6485628|NCT00566683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485629|NCT00566683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6485630|NCT00566683|Anesthetics, General|anesthetics, general|mesh-ancestor
6485631|NCT00566683|Anesthetics|anesthetics|mesh-ancestor
6485632|NCT00566683|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6485633|NCT00566683|Narcotics|narcotics|mesh-ancestor
6485634|NCT00566683|Analgesics|analgesics|mesh-ancestor
6485635|NCT00566683|Sensory System Agents|sensory system agents|mesh-ancestor
6485636|NCT00566683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6485637|NCT00566683|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6485638|NCT00566683|Anticonvulsants|anticonvulsants|mesh-ancestor
6485639|NCT00566683|Antiemetics|antiemetics|mesh-ancestor
6172050|NCT01649609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6485640|NCT00566683|Autonomic Agents|autonomic agents|mesh-ancestor
6669950|NCT01540721|Sensory System Agents|sensory system agents|mesh-ancestor
6669951|NCT01540721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6172051|NCT01649609|Antifungal Agents|antifungal agents|mesh-ancestor
5569241|NCT03943186|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5569242|NCT03943186|Immunologic Factors|immunologic factors|mesh-ancestor
5569243|NCT03943186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569244|NCT03943186|Viscosupplements|viscosupplements|mesh-ancestor
5569245|NCT03943186|Protective Agents|protective agents|mesh-ancestor
5569246|NCT03943407|Imiquimod|imiquimod|mesh-list
5569247|NCT03943407|Cinnamaldehyde|cinnamaldehyde|mesh-list
5569248|NCT03943407|Doxepin|doxepin|mesh-list
5569249|NCT03943407|Menthol|menthol|mesh-list
5569250|NCT03943407|Histamine|histamine|mesh-list
5569251|NCT03943407|Antipruritics|antipruritics|mesh-ancestor
5569252|NCT03943407|Dermatologic Agents|dermatologic agents|mesh-ancestor
5569253|NCT03943407|Histamine Agonists|histamine agonists|mesh-ancestor
5569254|NCT03943407|Histamine Agents|histamine agents|mesh-ancestor
5569255|NCT03943407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6172052|NCT01649765|Belimumab|belimumab|mesh-list
6172053|NCT01649765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6172054|NCT01649765|Immunologic Factors|immunologic factors|mesh-ancestor
6172055|NCT01649765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172056|NCT01649791|Lenalidomide|lenalidomide|mesh-list
6172057|NCT01649791|Immunologic Factors|immunologic factors|mesh-ancestor
6172058|NCT01649791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172059|NCT01649791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6172060|NCT01649791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6172061|NCT01649791|Growth Substances|growth substances|mesh-ancestor
6172062|NCT01649791|Growth Inhibitors|growth inhibitors|mesh-ancestor
6172063|NCT01649791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6172064|NCT01649856|Rituximab|rituximab|mesh-list
6172065|NCT01649856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6172066|NCT01649856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6172067|NCT01649856|Immunologic Factors|immunologic factors|mesh-ancestor
6172068|NCT01649856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172069|NCT01649856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6172070|NCT01649869|Valganciclovir|valganciclovir|mesh-list
6172071|NCT01649869|Antiviral Agents|antiviral agents|mesh-ancestor
6485641|NCT00566683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6485642|NCT00566683|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5569256|NCT03943407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569257|NCT03943407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569258|NCT03943407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5569259|NCT03943407|Immunologic Factors|immunologic factors|mesh-ancestor
5569260|NCT03943407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5569261|NCT03943407|Interferon Inducers|interferon inducers|mesh-ancestor
5569262|NCT03943407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5569263|NCT03943407|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
5569264|NCT03943407|Protective Agents|protective agents|mesh-ancestor
5569265|NCT03943407|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5569266|NCT03943407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5569267|NCT03943407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5569268|NCT03943407|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5569269|NCT03943407|Antidepressive Agents|antidepressive agents|mesh-ancestor
5569270|NCT03943407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5569271|NCT03943407|Histamine Antagonists|histamine antagonists|mesh-ancestor
5569272|NCT03943043|Gemcitabine|gemcitabine|mesh-list
5569273|NCT03943043|Paclitaxel|paclitaxel|mesh-list
5569274|NCT03943043|Oxaliplatin|oxaliplatin|mesh-list
5569275|NCT03943043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5569276|NCT03943043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5569277|NCT03943043|Tubulin Modulators|tubulin modulators|mesh-ancestor
6485643|NCT00566683|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6485644|NCT00566683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6485645|NCT00566683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6485646|NCT00566683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6485647|NCT00566683|GABA Modulators|gaba modulators|mesh-ancestor
6485648|NCT00566683|GABA Agents|gaba agents|mesh-ancestor
6485649|NCT00566683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6485650|NCT00566683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485651|NCT00566761|Triamcinolone|triamcinolone|mesh-list
6485652|NCT00566761|Bevacizumab|bevacizumab|mesh-list
6485653|NCT00566761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5569278|NCT03943043|Antimitotic Agents|antimitotic agents|mesh-ancestor
5569279|NCT03943043|Mitosis Modulators|mitosis modulators|mesh-ancestor
6172072|NCT01649869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6172073|NCT01649947|Hydroxychloroquine|hydroxychloroquine|mesh-list
6485654|NCT00566761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5569280|NCT03943043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569281|NCT03943043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5569282|NCT03943043|Antimetabolites|antimetabolites|mesh-ancestor
5569283|NCT03943043|Antiviral Agents|antiviral agents|mesh-ancestor
5569284|NCT03943043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6485655|NCT00566761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6485656|NCT00566761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6485657|NCT00566761|Growth Substances|growth substances|mesh-ancestor
6485658|NCT00566761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172074|NCT01649947|Paclitaxel|paclitaxel|mesh-list
6172075|NCT01649947|Bevacizumab|bevacizumab|mesh-list
6172076|NCT01649947|Carboplatin|carboplatin|mesh-list
6172077|NCT01649947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6172078|NCT01649947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6172079|NCT01649947|Tubulin Modulators|tubulin modulators|mesh-ancestor
6172080|NCT01649947|Antimitotic Agents|antimitotic agents|mesh-ancestor
6172081|NCT01649947|Mitosis Modulators|mitosis modulators|mesh-ancestor
6172082|NCT01649947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172083|NCT01649947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6172084|NCT01649947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6172085|NCT01649947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6172086|NCT01649947|Growth Substances|growth substances|mesh-ancestor
6172087|NCT01649947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172088|NCT01649947|Growth Inhibitors|growth inhibitors|mesh-ancestor
6172089|NCT01649947|Antimalarials|antimalarials|mesh-ancestor
6172090|NCT01649947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6172091|NCT01649947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6172092|NCT01649947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5569285|NCT03943043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5569286|NCT03943043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5569287|NCT03943043|Immunologic Factors|immunologic factors|mesh-ancestor
5569288|NCT03943043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569289|NCT03942861|Methylprednisolone|methylprednisolone|mesh-list
5569290|NCT03942861|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5569291|NCT03942861|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5569292|NCT03942861|Prednisolone|prednisolone|mesh-list
5569293|NCT03942861|Prednisolone acetate|prednisolone acetate|mesh-list
5569294|NCT03942861|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5569295|NCT03942861|Prednisolone phosphate|prednisolone phosphate|mesh-list
6172093|NCT01649947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6172094|NCT01649947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6172095|NCT01650194|Prednisone|prednisone|mesh-list
6172096|NCT01650194|Abiraterone Acetate|abiraterone acetate|mesh-list
6172097|NCT01650194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6172098|NCT01650194|Glucocorticoids|glucocorticoids|mesh-ancestor
6172099|NCT01650194|Hormones|hormones|mesh-ancestor
6172100|NCT01650194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6172101|NCT01650194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485659|NCT00566761|Growth Inhibitors|growth inhibitors|mesh-ancestor
6485660|NCT00566761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6485661|NCT00566761|Glucocorticoids|glucocorticoids|mesh-ancestor
6485662|NCT00566761|Hormones|hormones|mesh-ancestor
6485663|NCT00566761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6485664|NCT00566800|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6485665|NCT00566800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6485666|NCT00566800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6485667|NCT00566800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6485668|NCT00566800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485669|NCT00566865|Gemfibrozil|gemfibrozil|mesh-list
6485670|NCT00566865|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6485671|NCT00566865|Antimetabolites|antimetabolites|mesh-ancestor
6485672|NCT00566865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485673|NCT00566865|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6485674|NCT00566865|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6485675|NCT00566865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6485676|NCT00566865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6485677|NCT00566891|Tirofiban|tirofiban|mesh-list
6485678|NCT00566891|Clopidogrel|clopidogrel|mesh-list
6485679|NCT00566891|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6485680|NCT00566891|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6485681|NCT00566891|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6669952|NCT01540721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669953|NCT01540721|Antipyretics|antipyretics|mesh-ancestor
5569296|NCT03942861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5569297|NCT03942861|Antiemetics|antiemetics|mesh-ancestor
6669954|NCT01540734|Acetaminophen|acetaminophen|mesh-list
6669955|NCT01540734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6669956|NCT01540734|Analgesics|analgesics|mesh-ancestor
6669957|NCT01540734|Sensory System Agents|sensory system agents|mesh-ancestor
6669958|NCT01540734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6669959|NCT01540734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669960|NCT01540734|Antipyretics|antipyretics|mesh-ancestor
6669961|NCT01540747|Folic Acid|folic acid|mesh-list
6669962|NCT01540747|Vitamin B Complex|vitamin b complex|mesh-list
5569298|NCT03942861|Autonomic Agents|autonomic agents|mesh-ancestor
5569299|NCT03942861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5569300|NCT03942861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569301|NCT03942861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5569302|NCT03942861|Glucocorticoids|glucocorticoids|mesh-ancestor
5569303|NCT03942861|Hormones|hormones|mesh-ancestor
5569304|NCT03942861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5569305|NCT03942861|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6669963|NCT01540747|Inositol|inositol|mesh-list
6669964|NCT01540747|Melatonin|melatonin|mesh-list
6172102|NCT01650194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6172103|NCT01650194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6172104|NCT01650194|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6172105|NCT01650194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6172106|NCT01650194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172107|NCT01650194|Hormone Antagonists|hormone antagonists|mesh-ancestor
6172108|NCT01650194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6172109|NCT01650246|Lesinurad|lesinurad|mesh-list
6172110|NCT01650246|Gout Suppressants|gout suppressants|mesh-ancestor
6172111|NCT01650246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6172112|NCT01650246|Uricosuric Agents|uricosuric agents|mesh-ancestor
6172113|NCT01650246|Renal Agents|renal agents|mesh-ancestor
6172114|NCT01650298|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
6172115|NCT01650298|Thrombin|thrombin|mesh-list
5569306|NCT03942861|Protective Agents|protective agents|mesh-ancestor
5569307|NCT03942861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5569308|NCT03942861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5569309|NCT03942991|Mepivacaine|mepivacaine|mesh-list
5569310|NCT03942991|Carticaine|carticaine|mesh-list
5569311|NCT03942991|Anesthetics, Local|anesthetics, local|mesh-ancestor
5569312|NCT03942991|Anesthetics|anesthetics|mesh-ancestor
5569313|NCT03942991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5569314|NCT03942991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569315|NCT03942991|Sensory System Agents|sensory system agents|mesh-ancestor
5569316|NCT03942991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5604127|NCT05177731|Idarubicin|idarubicin|mesh-list
6172116|NCT01650298|Hemostatics|hemostatics|mesh-ancestor
6172117|NCT01650298|Coagulants|coagulants|mesh-ancestor
6172118|NCT01650298|Antithrombins|antithrombins|mesh-ancestor
6172119|NCT01650298|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6172120|NCT01650298|Protease Inhibitors|protease inhibitors|mesh-ancestor
6172121|NCT01650298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6172122|NCT01650298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172123|NCT01650298|Anticoagulants|anticoagulants|mesh-ancestor
6172124|NCT01650350|Naltrexone|naltrexone|mesh-list
6172125|NCT01650350|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6172126|NCT01650350|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6172127|NCT01650350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172128|NCT01650350|Sensory System Agents|sensory system agents|mesh-ancestor
6172129|NCT01650350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6172130|NCT01650402|Antihypertensive Agents|antihypertensive agents|mesh-list
6172131|NCT01650519|Ibuprofen|ibuprofen|mesh-list
6172132|NCT01650519|Ketorolac|ketorolac|mesh-list
6172133|NCT01650519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6172134|NCT01650519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6172135|NCT01650519|Analgesics|analgesics|mesh-ancestor
6172136|NCT01650519|Sensory System Agents|sensory system agents|mesh-ancestor
5604128|NCT05177731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5604129|NCT05177731|Antimetabolites|antimetabolites|mesh-ancestor
5604130|NCT05177731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604131|NCT05177731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5604132|NCT05177731|Antiviral Agents|antiviral agents|mesh-ancestor
5604133|NCT05177731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5604134|NCT05177731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5604135|NCT05177731|Immunologic Factors|immunologic factors|mesh-ancestor
6172137|NCT01650519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6669965|NCT01540747|Antioxidants|antioxidants|mesh-ancestor
6669966|NCT01540747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6669967|NCT01540747|Protective Agents|protective agents|mesh-ancestor
5569317|NCT03942757|Bilirubin|bilirubin|mesh-list
5569318|NCT03942757|Antioxidants|antioxidants|mesh-ancestor
5569319|NCT03942757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569320|NCT03942757|Protective Agents|protective agents|mesh-ancestor
5569321|NCT03942757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569322|NCT03942926|Sirolimus|sirolimus|mesh-list
5569323|NCT03942926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5569324|NCT03942926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5569325|NCT03942926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5569326|NCT03942926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5569327|NCT03942926|Antifungal Agents|antifungal agents|mesh-ancestor
5569328|NCT03942926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5569329|NCT03942926|Immunologic Factors|immunologic factors|mesh-ancestor
5569330|NCT03942926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569331|NCT03942796|Pregabalin|pregabalin|mesh-list
5569332|NCT03942796|Analgesics|analgesics|mesh-ancestor
5569333|NCT03942796|Sensory System Agents|sensory system agents|mesh-ancestor
5569334|NCT03942796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5569335|NCT03942796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569336|NCT03942796|Anticonvulsants|anticonvulsants|mesh-ancestor
5569337|NCT03942796|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6172138|NCT01650519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172139|NCT01650519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6172140|NCT01650519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6172141|NCT01650519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6172142|NCT01650519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6172143|NCT01650519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172144|NCT01650545|Cyclosporine|cyclosporine|mesh-list
6172145|NCT01650545|Sirolimus|sirolimus|mesh-list
6172146|NCT01650545|Tacrolimus|tacrolimus|mesh-list
5569338|NCT03942796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5569339|NCT03942796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569340|NCT03942796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5569341|NCT03942796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5569342|NCT03942796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5569343|NCT03942796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5569344|NCT03942796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5569345|NCT03942887|Methylprednisolone|methylprednisolone|mesh-list
5569346|NCT03942887|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6172147|NCT01650545|Cyclosporins|cyclosporins|mesh-list
6172148|NCT01650545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6172149|NCT01650545|Immunologic Factors|immunologic factors|mesh-ancestor
6172150|NCT01650545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172151|NCT01650545|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6172152|NCT01650545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6172153|NCT01650545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172154|NCT01650545|Antifungal Agents|antifungal agents|mesh-ancestor
6172155|NCT01650545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6172156|NCT01650545|Dermatologic Agents|dermatologic agents|mesh-ancestor
6172157|NCT01650545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6172158|NCT01650545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6172159|NCT01650545|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6172160|NCT01650545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6172161|NCT01650558|Chloroquine|chloroquine|mesh-list
6172162|NCT01650558|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6172163|NCT01650558|Amebicides|amebicides|mesh-ancestor
6172164|NCT01650558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6172165|NCT01650558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6172166|NCT01650558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6172167|NCT01650558|Antimalarials|antimalarials|mesh-ancestor
6172168|NCT01650558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6172169|NCT01650558|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6172170|NCT01650558|Renal Agents|renal agents|mesh-ancestor
6172171|NCT01650558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6172172|NCT01650805|Imatinib Mesylate|imatinib mesylate|mesh-list
6172173|NCT01650805|Ponatinib|ponatinib|mesh-list
6172174|NCT01650805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6172175|NCT01650805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6172176|NCT01650805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6172177|NCT01650805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172178|NCT01651000|Calcifediol|calcifediol|mesh-list
6172179|NCT01651000|Vitamins|vitamins|mesh-ancestor
6485682|NCT00566891|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5569347|NCT03942887|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5569348|NCT03942887|Prednisolone|prednisolone|mesh-list
6172180|NCT01651000|Micronutrients|micronutrients|mesh-ancestor
6172181|NCT01651000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172182|NCT01651000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6172183|NCT01651039|Dexamethasone|dexamethasone|mesh-list
6172184|NCT01651039|Lenalidomide|lenalidomide|mesh-list
6172185|NCT01651039|Panobinostat|panobinostat|mesh-list
6172186|NCT01651039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6172187|NCT01651039|Antiemetics|antiemetics|mesh-ancestor
6172188|NCT01651039|Autonomic Agents|autonomic agents|mesh-ancestor
6172189|NCT01651039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6172190|NCT01651039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172191|NCT01651039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6172192|NCT01651039|Glucocorticoids|glucocorticoids|mesh-ancestor
6172193|NCT01651039|Hormones|hormones|mesh-ancestor
6172194|NCT01651039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6172195|NCT01651039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6172196|NCT01651039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6172197|NCT01651039|Immunologic Factors|immunologic factors|mesh-ancestor
6172198|NCT01651039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6172199|NCT01651039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6669968|NCT01540747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669969|NCT01540747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6669970|NCT01540747|Hematinics|hematinics|mesh-ancestor
6669971|NCT01540747|Vitamins|vitamins|mesh-ancestor
6669972|NCT01540747|Micronutrients|micronutrients|mesh-ancestor
6669973|NCT01540812|Cytarabine|cytarabine|mesh-list
6669974|NCT01540812|Dexamethasone|dexamethasone|mesh-list
6669975|NCT01540812|Dexamethasone acetate|dexamethasone acetate|mesh-list
6669976|NCT01540812|Prednisone|prednisone|mesh-list
6669977|NCT01540812|Hydrocortisone|hydrocortisone|mesh-list
6172200|NCT01651039|Growth Substances|growth substances|mesh-ancestor
6172201|NCT01651039|Growth Inhibitors|growth inhibitors|mesh-ancestor
6172202|NCT01651039|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6172203|NCT01651039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6172204|NCT01651039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172205|NCT01651351|Protease Inhibitors|protease inhibitors|mesh-list
6172206|NCT01651351|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
5569349|NCT03942887|Prednisolone acetate|prednisolone acetate|mesh-list
5569350|NCT03942887|Cyclophosphamide|cyclophosphamide|mesh-list
5569351|NCT03942887|Rituximab|rituximab|mesh-list
5569352|NCT03942887|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5569353|NCT03942887|Prednisolone phosphate|prednisolone phosphate|mesh-list
5569354|NCT03942887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5569355|NCT03942887|Immunologic Factors|immunologic factors|mesh-ancestor
5569356|NCT03942887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569357|NCT03942887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5569358|NCT03942887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5569359|NCT03942887|Alkylating Agents|alkylating agents|mesh-ancestor
5569360|NCT03942887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569361|NCT03942887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5569362|NCT03942887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5569363|NCT03942887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5569364|NCT03942887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6172207|NCT01651351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6172208|NCT01651351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172209|NCT01651351|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6172210|NCT01651351|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6172211|NCT01651442|Zolpidem|zolpidem|mesh-list
6172212|NCT01651442|Trazodone|trazodone|mesh-list
6172213|NCT01651442|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5569365|NCT03942887|Antiemetics|antiemetics|mesh-ancestor
5569366|NCT03942887|Autonomic Agents|autonomic agents|mesh-ancestor
5569367|NCT03942887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5569368|NCT03942887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5569369|NCT03942887|Glucocorticoids|glucocorticoids|mesh-ancestor
5569370|NCT03942887|Hormones|hormones|mesh-ancestor
5569371|NCT03942887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5569372|NCT03942887|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5569373|NCT03942887|Protective Agents|protective agents|mesh-ancestor
6172214|NCT01651442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6172215|NCT01651442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6172216|NCT01651442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172217|NCT01651442|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6172218|NCT01651442|GABA Agonists|gaba agonists|mesh-ancestor
6172219|NCT01651442|GABA Agents|gaba agents|mesh-ancestor
6172220|NCT01651442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6669978|NCT01540812|Fludarabine|fludarabine|mesh-list
6669979|NCT01540812|Vincristine|vincristine|mesh-list
6172221|NCT01651442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172222|NCT01651442|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6172223|NCT01651442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6172224|NCT01651442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6172225|NCT01651442|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6172226|NCT01651442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6172227|NCT01651442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6172228|NCT01651442|Serotonin Agents|serotonin agents|mesh-ancestor
6172229|NCT01651442|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6172230|NCT01651442|Antidepressive Agents|antidepressive agents|mesh-ancestor
6172231|NCT01651780|Heparin|heparin|mesh-list
6172232|NCT01651780|Calcium heparin|calcium heparin|mesh-list
6172233|NCT01651780|Bivalirudin|bivalirudin|mesh-list
6172234|NCT01651780|Anticoagulants|anticoagulants|mesh-ancestor
6172235|NCT01651780|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6172236|NCT01651780|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6172237|NCT01651780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172238|NCT01651780|Antithrombins|antithrombins|mesh-ancestor
6172239|NCT01651780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6172240|NCT01651780|Protease Inhibitors|protease inhibitors|mesh-ancestor
6172241|NCT01651780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6172242|NCT01651793|Caffeine|caffeine|mesh-list
6172243|NCT01651793|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6172244|NCT01651793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172245|NCT01651793|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6172246|NCT01651793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6172247|NCT01651793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172248|NCT01651793|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6172249|NCT01651793|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6172250|NCT01651793|Purinergic Agents|purinergic agents|mesh-ancestor
6172251|NCT01651793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5569374|NCT03942887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5569375|NCT03942601|Sirolimus|sirolimus|mesh-list
5569376|NCT03942601|Dexamethasone|dexamethasone|mesh-list
5569377|NCT03942601|Dexamethasone acetate|dexamethasone acetate|mesh-list
5569378|NCT03942601|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
5569379|NCT03942601|BB 1101|bb 1101|mesh-list
5569380|NCT03942601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5569381|NCT03942601|Antiemetics|antiemetics|mesh-ancestor
5569382|NCT03942601|Autonomic Agents|autonomic agents|mesh-ancestor
5569383|NCT03942601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5569384|NCT03942601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569385|NCT03942601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5569386|NCT03942601|Glucocorticoids|glucocorticoids|mesh-ancestor
5569387|NCT03942601|Hormones|hormones|mesh-ancestor
5569388|NCT03942601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5569389|NCT03942601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5569390|NCT03942601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5569391|NCT03942601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5569392|NCT03942601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5569393|NCT03942601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5569394|NCT03942601|Antifungal Agents|antifungal agents|mesh-ancestor
5569395|NCT03942601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6172252|NCT01651806|Tranexamic Acid|tranexamic acid|mesh-list
6172253|NCT01651806|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6172254|NCT01651806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6172255|NCT01651806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172256|NCT01651806|Hemostatics|hemostatics|mesh-ancestor
6172257|NCT01651806|Coagulants|coagulants|mesh-ancestor
6172258|NCT01651936|Methotrexate|methotrexate|mesh-list
6172259|NCT01651936|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6172260|NCT01651936|Abortifacient Agents|abortifacient agents|mesh-ancestor
6172261|NCT01651936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6172262|NCT01651936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172263|NCT01651936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6172264|NCT01651936|Antimetabolites|antimetabolites|mesh-ancestor
6172265|NCT01651936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172266|NCT01651936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6172267|NCT01651936|Dermatologic Agents|dermatologic agents|mesh-ancestor
6172268|NCT01651936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6172269|NCT01651936|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6172270|NCT01651936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6172271|NCT01651936|Immunologic Factors|immunologic factors|mesh-ancestor
6172272|NCT01651936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5569396|NCT03942601|Immunologic Factors|immunologic factors|mesh-ancestor
5569397|NCT03942601|Protease Inhibitors|protease inhibitors|mesh-ancestor
5569398|NCT03942601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5569399|NCT03942601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569400|NCT03942354|Moxifloxacin|moxifloxacin|mesh-list
5569401|NCT03942354|Linezolid|linezolid|mesh-list
5569402|NCT03942354|Bedaquiline|bedaquiline|mesh-list
5569403|NCT03942354|Clofazimine|clofazimine|mesh-list
5569404|NCT03942354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5569405|NCT03942354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5569406|NCT03942354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5569407|NCT03942354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5569408|NCT03942354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5569409|NCT03942354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569410|NCT03942354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5569411|NCT03942354|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5569412|NCT03942354|Antitubercular Agents|antitubercular agents|mesh-ancestor
5569413|NCT03942354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6172273|NCT01651936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6172274|NCT01652040|Methyltestosterone|methyltestosterone|mesh-list
5569414|NCT03942354|Leprostatic Agents|leprostatic agents|mesh-ancestor
5569415|NCT03942289|Norepinephrine|norepinephrine|mesh-list
5569416|NCT03942289|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5569417|NCT03942289|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5569418|NCT03942289|Adrenergic Agents|adrenergic agents|mesh-ancestor
5569419|NCT03942289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6172275|NCT01652040|Testosterone|testosterone|mesh-list
6172276|NCT01652040|Testosterone undecanoate|testosterone undecanoate|mesh-list
6172277|NCT01652040|Testosterone enanthate|testosterone enanthate|mesh-list
6172278|NCT01652040|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6172279|NCT01652040|Androgens|androgens|mesh-ancestor
6172280|NCT01652040|Hormones|hormones|mesh-ancestor
6172281|NCT01652040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6172282|NCT01652040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172283|NCT01652040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6172284|NCT01652040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6172285|NCT01652040|Anabolic Agents|anabolic agents|mesh-ancestor
6172286|NCT01652469|Docetaxel|docetaxel|mesh-list
6172287|NCT01652469|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6172288|NCT01652469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6172289|NCT01652469|Tubulin Modulators|tubulin modulators|mesh-ancestor
6172290|NCT01652469|Antimitotic Agents|antimitotic agents|mesh-ancestor
6172291|NCT01652469|Mitosis Modulators|mitosis modulators|mesh-ancestor
6172292|NCT01652469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172293|NCT01652469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6172294|NCT01652469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6172295|NCT01652495|Methylprednisolone|methylprednisolone|mesh-list
6172296|NCT01652495|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6172297|NCT01652495|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6172298|NCT01652495|Prednisolone|prednisolone|mesh-list
6172299|NCT01652495|Prednisolone acetate|prednisolone acetate|mesh-list
6172300|NCT01652495|Triamcinolone|triamcinolone|mesh-list
6172301|NCT01652495|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6172302|NCT01652495|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6172303|NCT01652495|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6172304|NCT01652495|Prednisolone phosphate|prednisolone phosphate|mesh-list
6172305|NCT01652495|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6172306|NCT01652495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6172307|NCT01652495|Antiemetics|antiemetics|mesh-ancestor
6172308|NCT01652495|Autonomic Agents|autonomic agents|mesh-ancestor
6172309|NCT01652495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6172310|NCT01652495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172311|NCT01652495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6172312|NCT01652495|Glucocorticoids|glucocorticoids|mesh-ancestor
6172313|NCT01652495|Hormones|hormones|mesh-ancestor
6172314|NCT01652495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6172315|NCT01652495|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6172316|NCT01652495|Protective Agents|protective agents|mesh-ancestor
6172317|NCT01652495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6172318|NCT01652495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6172319|NCT01652495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6172320|NCT01652495|Immunologic Factors|immunologic factors|mesh-ancestor
6172321|NCT01652495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6172322|NCT01652495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172323|NCT01652573|Calcitonin|calcitonin|mesh-list
6172324|NCT01652573|Salmon calcitonin|salmon calcitonin|mesh-list
5569420|NCT03942289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172325|NCT01652573|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
6172326|NCT01652573|Katacalcin|katacalcin|mesh-list
6172327|NCT01652573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6172328|NCT01652573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485683|NCT00566891|Purinergic Agents|purinergic agents|mesh-ancestor
6485684|NCT00566891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6485685|NCT00566891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485686|NCT00566891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485687|NCT00566891|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6485688|NCT00566891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6485689|NCT00566904|Aspirin|aspirin|mesh-list
6485690|NCT00566904|Lidocaine|lidocaine|mesh-list
6485691|NCT00566904|Anesthetics, Local|anesthetics, local|mesh-list
6485692|NCT00566904|Anesthetics|anesthetics|mesh-list
6485693|NCT00566904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6485694|NCT00566904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485695|NCT00566904|Sensory System Agents|sensory system agents|mesh-ancestor
6485696|NCT00566904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6485697|NCT00566904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6485698|NCT00566904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5569421|NCT03942289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569422|NCT03942289|Sympathomimetics|sympathomimetics|mesh-ancestor
5569423|NCT03942289|Autonomic Agents|autonomic agents|mesh-ancestor
5569424|NCT03942289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5569425|NCT03942289|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5569426|NCT03941951|Anti-Infective Agents|anti-infective agents|mesh-list
5569427|NCT03941951|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5569428|NCT03941925|Levan|levan|mesh-list
5569429|NCT03941925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5569430|NCT03941964|Azacitidine|azacitidine|mesh-list
5569431|NCT03941964|Decitabine|decitabine|mesh-list
6485699|NCT00566904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6485700|NCT00566904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6485701|NCT00566904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485702|NCT00566904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6485703|NCT00566904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6485704|NCT00566904|Analgesics|analgesics|mesh-ancestor
5569432|NCT03941964|Venetoclax|venetoclax|mesh-list
5569433|NCT03941964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6172329|NCT01652573|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6172330|NCT01652573|Vasodilator Agents|vasodilator agents|mesh-ancestor
6172331|NCT01652664|Timolol|timolol|mesh-list
6172332|NCT01652664|Travoprost|travoprost|mesh-list
6172333|NCT01652664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6172334|NCT01652664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6172335|NCT01652664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6172336|NCT01652664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6172337|NCT01652664|Adrenergic Agents|adrenergic agents|mesh-ancestor
6172338|NCT01652664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6172339|NCT01652664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172340|NCT01652664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569434|NCT03941964|Antimetabolites|antimetabolites|mesh-ancestor
5569435|NCT03941964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569436|NCT03941964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5569437|NCT03941964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5569438|NCT03941990|Nitrous Oxide|nitrous oxide|mesh-list
5569439|NCT03941990|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6172341|NCT01652664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6172342|NCT01652664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6172343|NCT01652690|Denosumab|denosumab|mesh-list
6172344|NCT01652690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6172345|NCT01652690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172346|NCT01652703|Evolocumab|evolocumab|mesh-list
6172347|NCT01652703|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6172348|NCT01652703|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6172349|NCT01652703|Antimetabolites|antimetabolites|mesh-ancestor
6172350|NCT01652703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172351|NCT01652703|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6172352|NCT01652716|Exenatide|exenatide|mesh-list
6172353|NCT01652716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6172354|NCT01652716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172355|NCT01652716|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6172356|NCT01652716|Incretins|incretins|mesh-ancestor
6172357|NCT01652716|Hormones|hormones|mesh-ancestor
5569440|NCT03941990|Anesthetics, General|anesthetics, general|mesh-ancestor
5569441|NCT03941990|Anesthetics|anesthetics|mesh-ancestor
6172358|NCT01652716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6172359|NCT01652729|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6172360|NCT01652729|Exenatide|exenatide|mesh-list
6172361|NCT01652729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6172362|NCT01652729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172363|NCT01652729|Incretins|incretins|mesh-ancestor
6172364|NCT01652729|Hormones|hormones|mesh-ancestor
6172365|NCT01652729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6172366|NCT01652729|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6172367|NCT01652729|Protease Inhibitors|protease inhibitors|mesh-ancestor
6172368|NCT01652729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6172369|NCT01652729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172370|NCT01652729|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6172371|NCT01652872|Darbepoetin alfa|darbepoetin alfa|mesh-list
6172372|NCT01652872|Hematinics|hematinics|mesh-ancestor
6172373|NCT01652976|Leucovorin|leucovorin|mesh-list
6172374|NCT01652976|Fluorouracil|fluorouracil|mesh-list
6172375|NCT01652976|Oxaliplatin|oxaliplatin|mesh-list
6172376|NCT01652976|Dasatinib|dasatinib|mesh-list
6172377|NCT01652976|Antimetabolites|antimetabolites|mesh-ancestor
6172378|NCT01652976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172379|NCT01652976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6172380|NCT01652976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6172381|NCT01652976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6172382|NCT01652976|Immunologic Factors|immunologic factors|mesh-ancestor
6172383|NCT01652976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172384|NCT01652976|Antidotes|antidotes|mesh-ancestor
6172385|NCT01652976|Protective Agents|protective agents|mesh-ancestor
6172386|NCT01652976|Vitamin B Complex|vitamin b complex|mesh-ancestor
6172387|NCT01652976|Vitamins|vitamins|mesh-ancestor
6669980|NCT01540812|Daunorubicin|daunorubicin|mesh-list
6669981|NCT01540812|Idarubicin|idarubicin|mesh-list
6669982|NCT01540812|Methotrexate|methotrexate|mesh-list
6669983|NCT01540812|Pegaspargase|pegaspargase|mesh-list
6669984|NCT01540812|Asparaginase|asparaginase|mesh-list
6669985|NCT01540812|BB 1101|bb 1101|mesh-list
6669986|NCT01540812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6669987|NCT01540812|Antiemetics|antiemetics|mesh-ancestor
6172388|NCT01652976|Micronutrients|micronutrients|mesh-ancestor
6172389|NCT01652976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6172390|NCT01652976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6172391|NCT01653158|Docetaxel|docetaxel|mesh-list
6172392|NCT01653158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6172393|NCT01653158|Tubulin Modulators|tubulin modulators|mesh-ancestor
6172394|NCT01653158|Antimitotic Agents|antimitotic agents|mesh-ancestor
6172395|NCT01653158|Mitosis Modulators|mitosis modulators|mesh-ancestor
6172396|NCT01653158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172397|NCT01653262|Brivaracetam|brivaracetam|mesh-list
6172398|NCT01653262|Anticonvulsants|anticonvulsants|mesh-ancestor
6172399|NCT01653327|Ketamine|ketamine|mesh-list
6172400|NCT01653327|Analgesics|analgesics|mesh-ancestor
6172401|NCT01653327|Sensory System Agents|sensory system agents|mesh-ancestor
5569442|NCT03941990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5569443|NCT03941990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569444|NCT03941990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5569445|NCT03941990|Analgesics|analgesics|mesh-ancestor
5569446|NCT03941990|Sensory System Agents|sensory system agents|mesh-ancestor
5569447|NCT03941990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6172402|NCT01653327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6172403|NCT01653327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172404|NCT01653327|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6172405|NCT01653327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6172406|NCT01653327|Anesthetics, General|anesthetics, general|mesh-ancestor
6172407|NCT01653327|Anesthetics|anesthetics|mesh-ancestor
6172408|NCT01653327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6172409|NCT01653327|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6172410|NCT01653327|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6172411|NCT01653327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6172412|NCT01653327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172413|NCT01653418|Cytarabine|cytarabine|mesh-list
6172414|NCT01653418|Etoposide|etoposide|mesh-list
6172415|NCT01653418|Bortezomib|bortezomib|mesh-list
6172416|NCT01653418|Melphalan|melphalan|mesh-list
6172417|NCT01653418|Carmustine|carmustine|mesh-list
6172418|NCT01653418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6669988|NCT01540812|Autonomic Agents|autonomic agents|mesh-ancestor
6172419|NCT01653418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6669989|NCT01540812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6172420|NCT01653418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5569448|NCT03942029|Fluconazole|fluconazole|mesh-list
5569449|NCT03942029|Antifungal Agents|antifungal agents|mesh-ancestor
5569450|NCT03942029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5569451|NCT03942029|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5569452|NCT03942029|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5569453|NCT03942029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6172421|NCT01653418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5569454|NCT03942029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569455|NCT03942029|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5569456|NCT03942029|Hormone Antagonists|hormone antagonists|mesh-ancestor
5569457|NCT03942029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5569458|NCT03942029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569459|NCT03942029|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5569460|NCT03942029|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5569461|NCT03941899|Levobupivacaine|levobupivacaine|mesh-list
5569462|NCT03941899|Anesthetics, Local|anesthetics, local|mesh-ancestor
5569463|NCT03941899|Anesthetics|anesthetics|mesh-ancestor
5569464|NCT03941899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5569465|NCT03941899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569466|NCT03941899|Sensory System Agents|sensory system agents|mesh-ancestor
5569467|NCT03941899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5569468|NCT03941886|Aspirin|aspirin|mesh-list
5569469|NCT03941886|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5569470|NCT03941886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5569471|NCT03941886|Analgesics|analgesics|mesh-ancestor
5569472|NCT03941886|Sensory System Agents|sensory system agents|mesh-ancestor
5569473|NCT03941886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5569474|NCT03941886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569475|NCT03941886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5569476|NCT03941886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5569477|NCT03941886|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5569478|NCT03941886|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5569479|NCT03941886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569480|NCT03941886|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5569481|NCT03941886|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5569482|NCT03941886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5569483|NCT03941886|Antipyretics|antipyretics|mesh-ancestor
5569484|NCT03942068|Paclitaxel|paclitaxel|mesh-list
5569485|NCT03942068|Apatinib|apatinib|mesh-list
5569486|NCT03942068|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5569487|NCT03942068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6172422|NCT01653418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6172423|NCT01653418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172424|NCT01653418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5569488|NCT03942068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5569489|NCT03942068|Tubulin Modulators|tubulin modulators|mesh-ancestor
5569490|NCT03942068|Antimitotic Agents|antimitotic agents|mesh-ancestor
5569491|NCT03942068|Mitosis Modulators|mitosis modulators|mesh-ancestor
5569492|NCT03942068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569493|NCT03942068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5569494|NCT03942068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5569495|NCT03942458|Clopidogrel|clopidogrel|mesh-list
5569496|NCT03942458|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5569497|NCT03942458|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5569498|NCT03942458|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5569499|NCT03942458|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5569500|NCT03942458|Purinergic Agents|purinergic agents|mesh-ancestor
5569501|NCT03942458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5569502|NCT03942458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569503|NCT03942458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172425|NCT01653418|Antimetabolites|antimetabolites|mesh-ancestor
6172426|NCT01653418|Antiviral Agents|antiviral agents|mesh-ancestor
6172427|NCT01653418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6172428|NCT01653418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6172429|NCT01653418|Immunologic Factors|immunologic factors|mesh-ancestor
6172430|NCT01653418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172431|NCT01653418|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6172432|NCT01653418|Alkylating Agents|alkylating agents|mesh-ancestor
6172433|NCT01653418|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6172434|NCT01653509|Acyclovir|acyclovir|mesh-list
6172435|NCT01653509|Antiviral Agents|antiviral agents|mesh-ancestor
6172436|NCT01653509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5569504|NCT03941561|Tegafur|tegafur|mesh-list
5569505|NCT03941561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5569506|NCT03941561|Antimetabolites|antimetabolites|mesh-ancestor
5569507|NCT03941561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569508|NCT03941561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5569509|NCT03941795|Axitinib|axitinib|mesh-list
5569510|NCT03941795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5569511|NCT03941795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5569512|NCT03941795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5569513|NCT03941795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569514|NCT03941587|Aflibercept|aflibercept|mesh-list
6172437|NCT01653743|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6172438|NCT01653743|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5569515|NCT03941587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5569516|NCT03941587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5569517|NCT03941587|Growth Substances|growth substances|mesh-ancestor
5569518|NCT03941587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569519|NCT03941587|Growth Inhibitors|growth inhibitors|mesh-ancestor
5569520|NCT03941587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5569521|NCT03941496|Azacitidine|azacitidine|mesh-list
5569522|NCT03941496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5569523|NCT03941496|Antimetabolites|antimetabolites|mesh-ancestor
5569524|NCT03941496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569525|NCT03941496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5569526|NCT03941496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5569527|NCT03941535|Vitamin K|vitamin k|mesh-list
5569528|NCT03941535|Vitamins|vitamins|mesh-ancestor
5569529|NCT03941535|Micronutrients|micronutrients|mesh-ancestor
5569530|NCT03941535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569531|NCT03941535|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5569532|NCT03941535|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5569533|NCT03941535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569534|NCT03941535|Hemostatics|hemostatics|mesh-ancestor
5569535|NCT03941535|Coagulants|coagulants|mesh-ancestor
5569536|NCT03941340|Aflutinib|aflutinib|mesh-list
5569537|NCT03941340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5569538|NCT03941340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5569539|NCT03941340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569540|NCT03941093|Leucovorin|leucovorin|mesh-list
5569541|NCT03941093|Gemcitabine|gemcitabine|mesh-list
5569542|NCT03941093|Paclitaxel|paclitaxel|mesh-list
5569543|NCT03941093|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5569544|NCT03941093|Irinotecan|irinotecan|mesh-list
5569545|NCT03941093|Fluorouracil|fluorouracil|mesh-list
5569546|NCT03941093|Folfirinox|folfirinox|mesh-list
5569547|NCT03941093|Levoleucovorin|levoleucovorin|mesh-list
5569548|NCT03941093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5569549|NCT03941093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5569550|NCT03941093|Tubulin Modulators|tubulin modulators|mesh-ancestor
5569551|NCT03941093|Antimitotic Agents|antimitotic agents|mesh-ancestor
5569552|NCT03941093|Mitosis Modulators|mitosis modulators|mesh-ancestor
5569553|NCT03941093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569554|NCT03941093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5569555|NCT03941093|Antimetabolites|antimetabolites|mesh-ancestor
5569556|NCT03941093|Antiviral Agents|antiviral agents|mesh-ancestor
5569557|NCT03941093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5569558|NCT03941093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5569559|NCT03941093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5569560|NCT03941093|Immunologic Factors|immunologic factors|mesh-ancestor
5569561|NCT03941093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569562|NCT03941093|Antidotes|antidotes|mesh-ancestor
5569563|NCT03941093|Protective Agents|protective agents|mesh-ancestor
5569564|NCT03941093|Vitamin B Complex|vitamin b complex|mesh-ancestor
5569565|NCT03941093|Vitamins|vitamins|mesh-ancestor
5569566|NCT03941093|Micronutrients|micronutrients|mesh-ancestor
6172439|NCT01653743|Hormones|hormones|mesh-ancestor
6172440|NCT01653743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6172441|NCT01653743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172442|NCT01653743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6172443|NCT01653847|Mycophenolic Acid|mycophenolic acid|mesh-list
6172444|NCT01653847|Everolimus|everolimus|mesh-list
5569567|NCT03941093|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5569568|NCT03941093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6172445|NCT01653847|Tacrolimus|tacrolimus|mesh-list
5569569|NCT03941288|Cannabidiol|cannabidiol|mesh-list
5569570|NCT03941288|Anticonvulsants|anticonvulsants|mesh-ancestor
6172446|NCT01653847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6172447|NCT01653847|Immunologic Factors|immunologic factors|mesh-ancestor
6172448|NCT01653847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172449|NCT01653847|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6172450|NCT01653847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6172451|NCT01653847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172452|NCT01653847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6172453|NCT01653847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5569571|NCT03940976|Afatinib|afatinib|mesh-list
5569572|NCT03940976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5569573|NCT03940976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5569574|NCT03940976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5569575|NCT03940976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569576|NCT03940742|Tirzepatide|tirzepatide|mesh-list
5569577|NCT03940742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5569578|NCT03940742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569579|NCT03940742|Incretins|incretins|mesh-ancestor
5569580|NCT03940742|Hormones|hormones|mesh-ancestor
5569581|NCT03940742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6172454|NCT01653847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6172455|NCT01653847|Antitubercular Agents|antitubercular agents|mesh-ancestor
6172456|NCT01653847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6172457|NCT01653847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6172458|NCT01653912|Paclitaxel|paclitaxel|mesh-list
6172459|NCT01653912|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6172460|NCT01653912|Carboplatin|carboplatin|mesh-list
6172461|NCT01653912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6172462|NCT01653912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6172463|NCT01653912|Tubulin Modulators|tubulin modulators|mesh-ancestor
6172464|NCT01653912|Antimitotic Agents|antimitotic agents|mesh-ancestor
6172465|NCT01653912|Mitosis Modulators|mitosis modulators|mesh-ancestor
6172466|NCT01653912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172467|NCT01654107|Nicotine|nicotine|mesh-list
6172468|NCT01654107|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6172469|NCT01654107|Autonomic Agents|autonomic agents|mesh-ancestor
6172470|NCT01654107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6172471|NCT01654107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172472|NCT01654107|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6172473|NCT01654107|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6172474|NCT01654107|Cholinergic Agents|cholinergic agents|mesh-ancestor
5569582|NCT03940664|Formaldehyde|formaldehyde|mesh-list
5569583|NCT03940664|Disinfectants|disinfectants|mesh-ancestor
5569584|NCT03940664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5569585|NCT03940807|Estradiol|estradiol|mesh-list
6172475|NCT01654107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6172476|NCT01654107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172477|NCT01654224|Vaccines|vaccines|mesh-list
6172478|NCT01654224|Immunologic Factors|immunologic factors|mesh-ancestor
6172479|NCT01654224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172480|NCT01654276|Febuxostat|febuxostat|mesh-list
6172481|NCT01654276|Gout Suppressants|gout suppressants|mesh-ancestor
6172482|NCT01654276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6206385|NCT02099110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6206386|NCT02099110|Immunologic Factors|immunologic factors|mesh-ancestor
6206387|NCT02099110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6206388|NCT02099461|Denosumab|denosumab|mesh-list
6206389|NCT02099461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6206390|NCT02099461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206391|NCT02099682|Lansoprazole|lansoprazole|mesh-list
6206392|NCT02099682|Dexlansoprazole|dexlansoprazole|mesh-list
6206393|NCT02099682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6206394|NCT02099682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6206395|NCT02099682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6206396|NCT02099682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6206397|NCT02099682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206398|NCT02099708|Lansoprazole|lansoprazole|mesh-list
6206399|NCT02099708|Dexlansoprazole|dexlansoprazole|mesh-list
6206400|NCT02099708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6206401|NCT02099708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6206402|NCT02099708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6206403|NCT02099708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6206404|NCT02099708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206405|NCT02099838|Metformin|metformin|mesh-list
6206406|NCT02099838|Pioglitazone|pioglitazone|mesh-list
6206407|NCT02099838|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6206408|NCT02099838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206409|NCT02100007|Topotecan|topotecan|mesh-list
5569586|NCT03940807|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
5569587|NCT03940807|Estrogens|estrogens|mesh-ancestor
5569588|NCT03940807|Hormones|hormones|mesh-ancestor
5569589|NCT03940807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5569590|NCT03940807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569591|NCT03940651|Anesthetics|anesthetics|mesh-list
5569592|NCT03940651|Anesthetics, General|anesthetics, general|mesh-list
6172483|NCT01654302|Lidocaine|lidocaine|mesh-list
6172484|NCT01654302|Tetracaine|tetracaine|mesh-list
6172485|NCT01654302|Anesthetics, Local|anesthetics, local|mesh-ancestor
6172486|NCT01654302|Anesthetics|anesthetics|mesh-ancestor
6172487|NCT01654302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6172488|NCT01654302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172489|NCT01654302|Sensory System Agents|sensory system agents|mesh-ancestor
6172490|NCT01654302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5569593|NCT03940651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5569594|NCT03940651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569595|NCT03940729|Chlorhexidine|chlorhexidine|mesh-list
5569596|NCT03940729|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5569597|NCT03940729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5569598|NCT03940729|Disinfectants|disinfectants|mesh-ancestor
5569599|NCT03940378|Levamisole|levamisole|mesh-list
5569600|NCT03940378|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5569601|NCT03940378|Immunologic Factors|immunologic factors|mesh-ancestor
5569602|NCT03940378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569603|NCT03940378|Antinematodal Agents|antinematodal agents|mesh-ancestor
5569604|NCT03940378|Anthelmintics|anthelmintics|mesh-ancestor
5569605|NCT03940378|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5569606|NCT03940378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5569607|NCT03940378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5569608|NCT03940131|Panitumumab|panitumumab|mesh-list
5569609|NCT03940131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5569610|NCT03940131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5569611|NCT03940235|Androgens|androgens|mesh-list
5569612|NCT03940235|Hormones|hormones|mesh-ancestor
5569613|NCT03940235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6172491|NCT01654302|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6172492|NCT01654302|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6172493|NCT01654302|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6172494|NCT01654302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6172495|NCT01654302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172496|NCT01654380|Insulin Glargine|insulin glargine|mesh-list
6172497|NCT01654380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6669990|NCT01540812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6669991|NCT01540812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6669992|NCT01540812|Glucocorticoids|glucocorticoids|mesh-ancestor
6669993|NCT01540812|Hormones|hormones|mesh-ancestor
6669994|NCT01540812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6669995|NCT01540812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6669996|NCT01540812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6669997|NCT01540812|Protease Inhibitors|protease inhibitors|mesh-ancestor
6669998|NCT01540812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6669999|NCT01540812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670000|NCT01540812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6670001|NCT01540812|Antimetabolites|antimetabolites|mesh-ancestor
6670002|NCT01540812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5569614|NCT03940235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569615|NCT03940391|Chlorpheniramine|chlorpheniramine|mesh-list
5569616|NCT03940391|Midazolam|midazolam|mesh-list
5569617|NCT03940391|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5569618|NCT03940391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5569619|NCT03940391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5569620|NCT03940391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569621|NCT03940391|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5569622|NCT03940391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5569623|NCT03940391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5569624|NCT03940391|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6172498|NCT01654380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172499|NCT01654445|Tenecteplase|tenecteplase|mesh-list
6172500|NCT01654445|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6172501|NCT01654445|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6172502|NCT01654445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172503|NCT01654536|Ciclesonide|ciclesonide|mesh-list
6172504|NCT01654536|Glucocorticoids|glucocorticoids|mesh-ancestor
6172505|NCT01654536|Hormones|hormones|mesh-ancestor
6172506|NCT01654536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6172507|NCT01654536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172508|NCT01654536|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6172509|NCT01654601|Clozapine|clozapine|mesh-list
6172510|NCT01654601|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6172511|NCT01654601|Serotonin Agents|serotonin agents|mesh-ancestor
6172512|NCT01654601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6172513|NCT01654601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172514|NCT01654601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172515|NCT01654601|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6172516|NCT01654601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6172517|NCT01654601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6172518|NCT01654601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6172519|NCT01654601|GABA Antagonists|gaba antagonists|mesh-ancestor
5569625|NCT03940391|Anesthetics, General|anesthetics, general|mesh-ancestor
5569626|NCT03940391|Anesthetics|anesthetics|mesh-ancestor
5569627|NCT03940391|GABA Modulators|gaba modulators|mesh-ancestor
5569628|NCT03940391|GABA Agents|gaba agents|mesh-ancestor
5569629|NCT03940391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5569630|NCT03940391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569631|NCT03940391|Antipruritics|antipruritics|mesh-ancestor
5569632|NCT03940391|Dermatologic Agents|dermatologic agents|mesh-ancestor
5569633|NCT03940391|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5569634|NCT03940391|Histamine Antagonists|histamine antagonists|mesh-ancestor
5569635|NCT03940391|Histamine Agents|histamine agents|mesh-ancestor
5569636|NCT03940391|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5569637|NCT03940430|Lactoferrin|lactoferrin|mesh-list
5569638|NCT03940430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6172520|NCT01654601|GABA Agents|gaba agents|mesh-ancestor
6172521|NCT01654861|Ascorbic Acid|ascorbic acid|mesh-list
6172522|NCT01654861|Gemcitabine|gemcitabine|mesh-list
6172523|NCT01654861|Vitamins|vitamins|mesh-ancestor
6172524|NCT01654861|Micronutrients|micronutrients|mesh-ancestor
6172525|NCT01654861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172526|NCT01654861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6172527|NCT01654861|Antimetabolites|antimetabolites|mesh-ancestor
6172528|NCT01654861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172529|NCT01654861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6172530|NCT01654861|Antiviral Agents|antiviral agents|mesh-ancestor
6172531|NCT01654861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6172532|NCT01654861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6172533|NCT01654861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6172534|NCT01654861|Immunologic Factors|immunologic factors|mesh-ancestor
6172535|NCT01654861|Antioxidants|antioxidants|mesh-ancestor
6172536|NCT01654861|Protective Agents|protective agents|mesh-ancestor
6172537|NCT01655043|Regadenoson|regadenoson|mesh-list
6172538|NCT01655043|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
6172539|NCT01655043|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6172540|NCT01655043|Purinergic Agonists|purinergic agonists|mesh-ancestor
6172541|NCT01655043|Purinergic Agents|purinergic agents|mesh-ancestor
6172542|NCT01655043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6172543|NCT01655043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172544|NCT01655043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569639|NCT03940469|Dexamethasone|dexamethasone|mesh-list
5569640|NCT03940469|Dexamethasone acetate|dexamethasone acetate|mesh-list
6172545|NCT01655069|Solifenacin Succinate|solifenacin succinate|mesh-list
6172546|NCT01655069|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5569641|NCT03940469|Dexmedetomidine|dexmedetomidine|mesh-list
6172547|NCT01655069|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6172548|NCT01655069|Cholinergic Agents|cholinergic agents|mesh-ancestor
6172549|NCT01655069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6172550|NCT01655069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172551|NCT01655069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172552|NCT01655069|Urological Agents|urological agents|mesh-ancestor
6172553|NCT01655563|Tacrolimus|tacrolimus|mesh-list
6172554|NCT01655563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6172555|NCT01655563|Immunologic Factors|immunologic factors|mesh-ancestor
6172556|NCT01655563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172557|NCT01655563|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6172558|NCT01655563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6172559|NCT01655563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172560|NCT01655693|Doxorubicin|doxorubicin|mesh-list
6172561|NCT01655693|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6172562|NCT01655693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6172563|NCT01655693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6172564|NCT01655693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6172565|NCT01655693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6172566|NCT01655693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6172567|NCT01655693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172568|NCT01655719|Pioglitazone|pioglitazone|mesh-list
6670003|NCT01540812|Immunologic Factors|immunologic factors|mesh-ancestor
6172569|NCT01655719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6670004|NCT01540812|Antiviral Agents|antiviral agents|mesh-ancestor
5569642|NCT03940469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6670005|NCT01540812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6670006|NCT01540812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6670007|NCT01540812|Tubulin Modulators|tubulin modulators|mesh-ancestor
6670008|NCT01540812|Antimitotic Agents|antimitotic agents|mesh-ancestor
6670009|NCT01540812|Mitosis Modulators|mitosis modulators|mesh-ancestor
6670010|NCT01540812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6670011|NCT01540812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6670012|NCT01540812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6670013|NCT01540812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6670014|NCT01540812|Abortifacient Agents|abortifacient agents|mesh-ancestor
6670015|NCT01540812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6670016|NCT01540812|Dermatologic Agents|dermatologic agents|mesh-ancestor
6670017|NCT01540812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6172570|NCT01655719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172571|NCT01655823|Tetrodotoxin|tetrodotoxin|mesh-list
6172572|NCT01655823|Anesthetics, Local|anesthetics, local|mesh-ancestor
6172573|NCT01655823|Anesthetics|anesthetics|mesh-ancestor
6172574|NCT01655823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6172575|NCT01655823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172576|NCT01655823|Sensory System Agents|sensory system agents|mesh-ancestor
6172577|NCT01655823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6172578|NCT01655823|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6172579|NCT01655823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6172580|NCT01655823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172581|NCT01656031|Cytarabine|cytarabine|mesh-list
6172582|NCT01656031|Clofarabine|clofarabine|mesh-list
6172583|NCT01656031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6172584|NCT01656031|Antimetabolites|antimetabolites|mesh-ancestor
6172585|NCT01656031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172586|NCT01656031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6172587|NCT01656031|Antiviral Agents|antiviral agents|mesh-ancestor
6172588|NCT01656031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6172589|NCT01656031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6172590|NCT01656031|Immunologic Factors|immunologic factors|mesh-ancestor
6172591|NCT01656031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172592|NCT01656161|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6172593|NCT01656161|Luteolytic Agents|luteolytic agents|mesh-ancestor
6172594|NCT01656161|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6172595|NCT01656161|Contraceptive Agents|contraceptive agents|mesh-ancestor
6172596|NCT01656161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6172597|NCT01656161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172598|NCT01656161|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6172599|NCT01656161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6172600|NCT01656161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6172601|NCT01656187|Memantine|memantine|mesh-list
6172602|NCT01656187|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6172603|NCT01656187|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6172604|NCT01656187|Dopamine Agents|dopamine agents|mesh-ancestor
6172605|NCT01656187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6172606|NCT01656187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172607|NCT01656187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172608|NCT01656187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6172609|NCT01656187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6172610|NCT01656252|Cytarabine|cytarabine|mesh-list
6172611|NCT01656252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6172612|NCT01656252|Antimetabolites|antimetabolites|mesh-ancestor
6172613|NCT01656252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172614|NCT01656252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6172615|NCT01656252|Antiviral Agents|antiviral agents|mesh-ancestor
6172616|NCT01656252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6172617|NCT01656252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6172618|NCT01656252|Immunologic Factors|immunologic factors|mesh-ancestor
6172619|NCT01656252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172620|NCT01656304|Bevacizumab|bevacizumab|mesh-list
6172621|NCT01656304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6172622|NCT01656304|Antibodies|antibodies|mesh-list
6172623|NCT01656304|Immunoglobulins|immunoglobulins|mesh-list
6172624|NCT01656304|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6172625|NCT01656304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6172626|NCT01656304|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6172627|NCT01656304|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6172628|NCT01656304|Growth Substances|growth substances|mesh-ancestor
6172629|NCT01656304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172630|NCT01656304|Growth Inhibitors|growth inhibitors|mesh-ancestor
6172631|NCT01656304|Immunologic Factors|immunologic factors|mesh-ancestor
6172632|NCT01656395|Montelukast|montelukast|mesh-list
6172633|NCT01656395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5569643|NCT03940469|Antiemetics|antiemetics|mesh-ancestor
5569644|NCT03940469|Autonomic Agents|autonomic agents|mesh-ancestor
5569645|NCT03940469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5569646|NCT03940469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569647|NCT03940469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5569648|NCT03940469|Glucocorticoids|glucocorticoids|mesh-ancestor
5569649|NCT03940469|Hormones|hormones|mesh-ancestor
5569650|NCT03940469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5569651|NCT03940469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5569652|NCT03940469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5569653|NCT03940469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5569654|NCT03940469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5569655|NCT03940469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5569656|NCT03940469|Analgesics|analgesics|mesh-ancestor
5569657|NCT03940469|Sensory System Agents|sensory system agents|mesh-ancestor
5569658|NCT03940469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5569659|NCT03940469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5569660|NCT03940469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5569661|NCT03940469|Adrenergic Agents|adrenergic agents|mesh-ancestor
5569662|NCT03940469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5569663|NCT03940469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569664|NCT03939663|Misoprostol|misoprostol|mesh-list
5569665|NCT03939663|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5569666|NCT03939663|Abortifacient Agents|abortifacient agents|mesh-ancestor
5569667|NCT03939663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5569668|NCT03939663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569669|NCT03939663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5569670|NCT03939663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5569671|NCT03939663|Oxytocics|oxytocics|mesh-ancestor
5569672|NCT03939884|Diclofenac|diclofenac|mesh-list
6172634|NCT01656395|Respiratory System Agents|respiratory system agents|mesh-ancestor
6172635|NCT01656395|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6172636|NCT01656395|Hormone Antagonists|hormone antagonists|mesh-ancestor
6172637|NCT01656395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6172638|NCT01656395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172639|NCT01656395|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6172640|NCT01656395|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6172641|NCT01656395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172642|NCT01656629|Vitamin D|vitamin d|mesh-list
6172643|NCT01656629|Alendronate|alendronate|mesh-list
6172644|NCT01656629|Teriparatide|teriparatide|mesh-list
6172645|NCT01656629|Calcium|calcium|mesh-list
6172646|NCT01656629|Vitamins|vitamins|mesh-ancestor
6172647|NCT01656629|Micronutrients|micronutrients|mesh-ancestor
6172648|NCT01656629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569673|NCT03939884|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5569674|NCT03939884|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5569675|NCT03939884|Analgesics|analgesics|mesh-ancestor
5569676|NCT03939884|Sensory System Agents|sensory system agents|mesh-ancestor
5569677|NCT03939884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5569678|NCT03939884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569679|NCT03939884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5569680|NCT03939884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5569681|NCT03939884|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5569682|NCT03939884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5569683|NCT03939884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569684|NCT03939923|Glycopyrrolate|glycopyrrolate|mesh-list
5569685|NCT03939923|Rocuronium|rocuronium|mesh-list
6485705|NCT00566904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6485706|NCT00566904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6485707|NCT00566904|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6485708|NCT00566904|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6485709|NCT00566904|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5569686|NCT03939923|Neostigmine|neostigmine|mesh-list
5569687|NCT03939923|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5569688|NCT03939923|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5569689|NCT03939923|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5569690|NCT03939923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5569691|NCT03939923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569692|NCT03939923|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5569693|NCT03939923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5569694|NCT03939923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172649|NCT01656629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6172650|NCT01656629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6172651|NCT01656733|Nicotine|nicotine|mesh-list
6172652|NCT01656733|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6172653|NCT01656733|Autonomic Agents|autonomic agents|mesh-ancestor
6172654|NCT01656733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6172655|NCT01656733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172656|NCT01656733|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6172657|NCT01656733|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6172658|NCT01656733|Cholinergic Agents|cholinergic agents|mesh-ancestor
6172659|NCT01656733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6172660|NCT01656733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485710|NCT00566904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6485711|NCT00566904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6485712|NCT00566904|Antipyretics|antipyretics|mesh-ancestor
6485713|NCT00567034|Naltrexone|naltrexone|mesh-list
6485714|NCT00567034|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6485715|NCT00567034|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6485716|NCT00567034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485717|NCT00567034|Sensory System Agents|sensory system agents|mesh-ancestor
6485718|NCT00567034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6485719|NCT00567047|Vildagliptin|vildagliptin|mesh-list
6485720|NCT00567047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6485721|NCT00567047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485722|NCT00567047|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6485723|NCT00567047|Protease Inhibitors|protease inhibitors|mesh-ancestor
6485724|NCT00567047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6485725|NCT00567047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485726|NCT00567060|Piracetam|piracetam|mesh-list
6485727|NCT00567060|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5569695|NCT03939923|Cholinergic Agents|cholinergic agents|mesh-ancestor
5569696|NCT03939923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5569697|NCT03939923|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5569698|NCT03939923|Autonomic Agents|autonomic agents|mesh-ancestor
5569699|NCT03939923|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5569700|NCT03939923|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5569701|NCT03939923|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5569702|NCT03939637|Immunoglobulins|immunoglobulins|mesh-list
5569703|NCT03939637|Antibodies|antibodies|mesh-list
5569704|NCT03939637|gamma-Globulins|gamma-globulins|mesh-list
5569705|NCT03939637|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5569706|NCT03939637|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5569707|NCT03939637|Immunologic Factors|immunologic factors|mesh-ancestor
5569708|NCT03939637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569709|NCT03939975|Pembrolizumab|pembrolizumab|mesh-list
5569710|NCT03939975|Nivolumab|nivolumab|mesh-list
5569711|NCT03939975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5569712|NCT03939975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5569713|NCT03939975|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6485728|NCT00567060|Protective Agents|protective agents|mesh-ancestor
6485729|NCT00567060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485730|NCT00567060|Nootropic Agents|nootropic agents|mesh-ancestor
6485731|NCT00567099|Aripiprazole|aripiprazole|mesh-list
6485732|NCT00567099|Antidepressive Agents|antidepressive agents|mesh-ancestor
6485733|NCT00567099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6485734|NCT00567099|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6485735|NCT00567099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6485736|NCT00567099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6485737|NCT00567099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670018|NCT01540812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6670019|NCT01540812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6670020|NCT01540877|Anesthetics|anesthetics|mesh-list
6172661|NCT01657019|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6172662|NCT01657019|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6172663|NCT01657019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172664|NCT01657019|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6172665|NCT01657019|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6172666|NCT01657019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6172667|NCT01657019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172668|NCT01657019|Dopamine Agents|dopamine agents|mesh-ancestor
6670021|NCT01540877|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
6670022|NCT01540877|Anesthetics, Local|anesthetics, local|mesh-list
6670023|NCT01540877|Capsaicin|capsaicin|mesh-list
6670024|NCT01540877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6670025|NCT01540877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670026|NCT01540877|Sensory System Agents|sensory system agents|mesh-ancestor
6670027|NCT01540877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6670028|NCT01540877|Antipruritics|antipruritics|mesh-ancestor
6670029|NCT01540877|Dermatologic Agents|dermatologic agents|mesh-ancestor
6670030|NCT01540877|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
6670031|NCT01541059|Ropivacaine|ropivacaine|mesh-list
6670032|NCT01541059|Anesthetics, Local|anesthetics, local|mesh-ancestor
6670033|NCT01541059|Anesthetics|anesthetics|mesh-ancestor
5569714|NCT03939975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569715|NCT03939871|Vinorelbine|vinorelbine|mesh-list
5569716|NCT03939871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5569717|NCT03939871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5569718|NCT03939871|Tubulin Modulators|tubulin modulators|mesh-ancestor
5569719|NCT03939871|Antimitotic Agents|antimitotic agents|mesh-ancestor
5569720|NCT03939871|Mitosis Modulators|mitosis modulators|mesh-ancestor
5569721|NCT03939871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569722|NCT03940001|Paclitaxel|paclitaxel|mesh-list
5569723|NCT03940001|Carboplatin|carboplatin|mesh-list
5569724|NCT03940001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5569725|NCT03940001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5569726|NCT03940001|Tubulin Modulators|tubulin modulators|mesh-ancestor
5569727|NCT03940001|Antimitotic Agents|antimitotic agents|mesh-ancestor
5569728|NCT03940001|Mitosis Modulators|mitosis modulators|mesh-ancestor
5569729|NCT03940001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569730|NCT03939806|Oxytocin|oxytocin|mesh-list
5569731|NCT03939806|Carbetocin|carbetocin|mesh-list
5569732|NCT03939806|Oxytocics|oxytocics|mesh-ancestor
5569733|NCT03939806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5569734|NCT03939806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604136|NCT05177731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604137|NCT05177731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5604138|NCT05177731|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5604139|NCT05177731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5604140|NCT05177731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5604141|NCT05161468|Triamcinolone|triamcinolone|mesh-list
5604142|NCT05161468|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5604143|NCT05161468|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5604144|NCT05161468|Lidocaine|lidocaine|mesh-list
5604145|NCT05161468|Acid citrate dextrose|acid citrate dextrose|mesh-list
5604146|NCT05161468|Glucocorticoids|glucocorticoids|mesh-list
5604147|NCT05161468|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5604148|NCT05161468|Anesthetics, Local|anesthetics, local|mesh-ancestor
5604149|NCT05161468|Anesthetics|anesthetics|mesh-ancestor
5604150|NCT05161468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5604151|NCT05161468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485738|NCT00567099|Dopamine Agonists|dopamine agonists|mesh-ancestor
6670034|NCT01541059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6670035|NCT01541059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172669|NCT01657019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5569735|NCT03939182|Abexinostat|abexinostat|mesh-list
5569736|NCT03939182|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5569737|NCT03939182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5569738|NCT03939182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569739|NCT03939624|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
5569740|NCT03939624|Protease Inhibitors|protease inhibitors|mesh-ancestor
5569741|NCT03939624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5569742|NCT03939624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569743|NCT03939624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5569744|NCT03939624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569745|NCT03939273|Metronidazole|metronidazole|mesh-list
5569746|NCT03939273|Vancomycin|vancomycin|mesh-list
5569747|NCT03939273|Ciprofloxacin|ciprofloxacin|mesh-list
5569748|NCT03939273|Fluconazole|fluconazole|mesh-list
5569749|NCT03939273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5569750|NCT03939273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5569751|NCT03939273|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5569752|NCT03939273|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5569753|NCT03939273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5569754|NCT03939273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5569755|NCT03939273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5569756|NCT03939273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569757|NCT03939273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5569758|NCT03939273|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5569759|NCT03939273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6172670|NCT01657162|Alendronate|alendronate|mesh-list
6172671|NCT01657162|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6172672|NCT01657162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172673|NCT01657266|Nepafenac|nepafenac|mesh-list
6172674|NCT01657266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6172675|NCT01657266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6172676|NCT01657266|Analgesics|analgesics|mesh-ancestor
6172677|NCT01657266|Sensory System Agents|sensory system agents|mesh-ancestor
6172678|NCT01657266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6172679|NCT01657266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172680|NCT01657266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6172681|NCT01657266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6172682|NCT01657292|Octenidine|octenidine|mesh-list
6172683|NCT01657292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6172684|NCT01657292|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6172685|NCT01657461|Plasminogen|plasminogen|mesh-list
5569760|NCT03939273|Antifungal Agents|antifungal agents|mesh-ancestor
5569761|NCT03939273|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5569762|NCT03939273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5569763|NCT03939273|Hormone Antagonists|hormone antagonists|mesh-ancestor
5569764|NCT03939273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5569765|NCT03939273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172686|NCT01657461|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6172687|NCT01657461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6172688|NCT01657461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6172689|NCT01657461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172690|NCT01657760|Citalopram|citalopram|mesh-list
6172691|NCT01657760|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6172692|NCT01657760|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6172693|NCT01657760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6172694|NCT01657760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172695|NCT01657760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6172696|NCT01657760|Serotonin Agents|serotonin agents|mesh-ancestor
6172697|NCT01657760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172698|NCT01657760|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6172699|NCT01657760|Antidepressive Agents|antidepressive agents|mesh-ancestor
6172700|NCT01657760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6172701|NCT01657799|Veliparib|veliparib|mesh-list
6172702|NCT01657799|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6172703|NCT01657799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6172704|NCT01657799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172705|NCT01657799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6172706|NCT01657877|Calcium|calcium|mesh-list
6172707|NCT01657877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6172708|NCT01657877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172709|NCT01657903|Listerine|listerine|mesh-list
6172710|NCT01657903|Fluorides|fluorides|mesh-list
6172711|NCT01657903|Sodium Fluoride|sodium fluoride|mesh-list
6172712|NCT01657903|Cariostatic Agents|cariostatic agents|mesh-ancestor
6172713|NCT01657903|Protective Agents|protective agents|mesh-ancestor
6670036|NCT01541059|Sensory System Agents|sensory system agents|mesh-ancestor
6670037|NCT01541059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6670038|NCT01541072|Lenograstim|lenograstim|mesh-list
6670039|NCT01541072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6670040|NCT01541072|Immunologic Factors|immunologic factors|mesh-ancestor
6670041|NCT01541072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670042|NCT01541085|Ritonavir|ritonavir|mesh-list
6670043|NCT01541085|Darunavir|darunavir|mesh-list
6670044|NCT01541085|Efavirenz|efavirenz|mesh-list
6670045|NCT01541085|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5569766|NCT03939273|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5569767|NCT03939273|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5569768|NCT03938740|Insulin|insulin|mesh-list
5569769|NCT03938740|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5569770|NCT03938740|Insulin Lispro|insulin lispro|mesh-list
5569771|NCT03938740|Insulin, Long-Acting|insulin, long-acting|mesh-list
5569772|NCT03938740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5569773|NCT03938740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670046|NCT01541085|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6670047|NCT01541085|Protease Inhibitors|protease inhibitors|mesh-ancestor
6670048|NCT01541085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6670049|NCT01541085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670050|NCT01541085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6670051|NCT01541085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6670052|NCT01541085|Antiviral Agents|antiviral agents|mesh-ancestor
6670053|NCT01541085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6670054|NCT01541085|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6670055|NCT01541085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6670056|NCT01541085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6670057|NCT01541085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6670058|NCT01541085|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6670059|NCT01541085|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6670060|NCT01541085|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6172714|NCT01657903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172715|NCT01657903|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6172716|NCT01657903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6172717|NCT01658020|Moxifloxacin|moxifloxacin|mesh-list
6172718|NCT01658020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6172719|NCT01658020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6172720|NCT01658020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6172721|NCT01658020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6172722|NCT01658020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6172723|NCT01658020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172724|NCT01658020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6172725|NCT01658150|Isradipine|isradipine|mesh-list
6172726|NCT01658150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6172727|NCT01658150|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6172728|NCT01658150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6172729|NCT01658150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172730|NCT01658150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6172731|NCT01658150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485739|NCT00567099|Dopamine Agents|dopamine agents|mesh-ancestor
6485740|NCT00567099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6485741|NCT00567099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485742|NCT00567099|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6485743|NCT00567099|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6485744|NCT00567099|Serotonin Agents|serotonin agents|mesh-ancestor
6485745|NCT00567099|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6485746|NCT00567099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6485747|NCT00567099|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6485748|NCT00567099|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6485749|NCT00567177|Cyclosporine|cyclosporine|mesh-list
6485750|NCT00567177|Cyclosporins|cyclosporins|mesh-list
6485751|NCT00567177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6485752|NCT00567177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485753|NCT00567177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6485754|NCT00567177|Immunologic Factors|immunologic factors|mesh-ancestor
6485755|NCT00567177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569774|NCT03938831|Fentanyl|fentanyl|mesh-list
5569775|NCT03938831|Dexmedetomidine|dexmedetomidine|mesh-list
6485756|NCT00567177|Antifungal Agents|antifungal agents|mesh-ancestor
6485757|NCT00567177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6485758|NCT00567177|Dermatologic Agents|dermatologic agents|mesh-ancestor
6485759|NCT00567177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6485760|NCT00567177|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6485761|NCT00567216|Nadolol|nadolol|mesh-list
6485762|NCT00567216|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6485763|NCT00567216|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6485764|NCT00567216|Adrenergic Agents|adrenergic agents|mesh-ancestor
6485765|NCT00567216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6485766|NCT00567216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485767|NCT00567216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485768|NCT00567216|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6485769|NCT00567216|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6485770|NCT00567216|Sympatholytics|sympatholytics|mesh-ancestor
5569776|NCT03938831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5569777|NCT03938831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6172732|NCT01658150|Vasodilator Agents|vasodilator agents|mesh-ancestor
6172733|NCT01658228|Donepezil|donepezil|mesh-list
6172734|NCT01658228|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6172735|NCT01658228|Citalopram|citalopram|mesh-list
6172736|NCT01658228|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6172737|NCT01658228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6172738|NCT01658228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172739|NCT01658228|Cholinergic Agents|cholinergic agents|mesh-ancestor
6172740|NCT01658228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6172741|NCT01658228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569778|NCT03938831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569779|NCT03938831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5569780|NCT03938831|Analgesics|analgesics|mesh-ancestor
5569781|NCT03938831|Sensory System Agents|sensory system agents|mesh-ancestor
5569782|NCT03938831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5569783|NCT03938831|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5569784|NCT03938831|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5569785|NCT03938831|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5569786|NCT03938831|Adrenergic Agents|adrenergic agents|mesh-ancestor
5569787|NCT03938831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6172742|NCT01658228|Nootropic Agents|nootropic agents|mesh-ancestor
6172743|NCT01658228|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6172744|NCT01658228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6172745|NCT01658228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6172746|NCT01658228|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6172747|NCT01658228|Antidepressive Agents|antidepressive agents|mesh-ancestor
6172748|NCT01658228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6172749|NCT01658228|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6172750|NCT01658228|Serotonin Agents|serotonin agents|mesh-ancestor
6172751|NCT01658436|Dactolisib|dactolisib|mesh-list
6172752|NCT01658436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6172753|NCT01658579|Insulin|insulin|mesh-list
6172754|NCT01658579|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6172755|NCT01658579|Insulin Glargine|insulin glargine|mesh-list
6172756|NCT01658579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6172757|NCT01658579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172758|NCT01658657|Metoprolol|metoprolol|mesh-list
6172759|NCT01658657|Amlodipine|amlodipine|mesh-list
6172760|NCT01658657|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6172761|NCT01658657|Lisinopril|lisinopril|mesh-list
6172762|NCT01658657|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
6172763|NCT01658657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6172764|NCT01658657|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6172765|NCT01658657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6172766|NCT01658657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172767|NCT01658657|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6172768|NCT01658657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172769|NCT01658657|Vasodilator Agents|vasodilator agents|mesh-ancestor
6172770|NCT01658657|Diuretics|diuretics|mesh-ancestor
6172771|NCT01658657|Natriuretic Agents|natriuretic agents|mesh-ancestor
6172772|NCT01658657|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6172773|NCT01658657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6172774|NCT01658657|Sympatholytics|sympatholytics|mesh-ancestor
6172775|NCT01658657|Autonomic Agents|autonomic agents|mesh-ancestor
6172776|NCT01658657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6172777|NCT01658657|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6485771|NCT00567216|Autonomic Agents|autonomic agents|mesh-ancestor
6172778|NCT01658657|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6172779|NCT01658657|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6172780|NCT01658657|Adrenergic Agents|adrenergic agents|mesh-ancestor
6172781|NCT01658657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6172782|NCT01658657|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6172783|NCT01658657|Protease Inhibitors|protease inhibitors|mesh-ancestor
6172784|NCT01658657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6172785|NCT01658657|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6172786|NCT01658657|Protective Agents|protective agents|mesh-ancestor
6172787|NCT01658839|Travoprost|travoprost|mesh-list
6172788|NCT01658839|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6172789|NCT01658839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6172790|NCT01658839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6172791|NCT01658904|Melphalan|melphalan|mesh-list
6172792|NCT01658904|Immunologic Factors|immunologic factors|mesh-ancestor
5569788|NCT03938831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569789|NCT03938831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5569790|NCT03938831|Narcotics|narcotics|mesh-ancestor
5569791|NCT03938831|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5569792|NCT03938831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5569793|NCT03938831|Anesthetics, General|anesthetics, general|mesh-ancestor
5569794|NCT03938831|Anesthetics|anesthetics|mesh-ancestor
5569795|NCT03938883|Hyaluronic Acid|hyaluronic acid|mesh-list
5569796|NCT03938883|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5569797|NCT03938883|Immunologic Factors|immunologic factors|mesh-ancestor
5569798|NCT03938883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569799|NCT03938883|Viscosupplements|viscosupplements|mesh-ancestor
5569800|NCT03938883|Protective Agents|protective agents|mesh-ancestor
5569801|NCT03938662|Choline|choline|mesh-list
6172793|NCT01658904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172794|NCT01658904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6172795|NCT01658904|Alkylating Agents|alkylating agents|mesh-ancestor
6172796|NCT01658904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172797|NCT01658904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6172798|NCT01658904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6172799|NCT01658904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6172800|NCT01658943|Fluorouracil|fluorouracil|mesh-list
6172801|NCT01658943|Oxaliplatin|oxaliplatin|mesh-list
6172802|NCT01658943|Antimetabolites|antimetabolites|mesh-ancestor
6172803|NCT01658943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172804|NCT01658943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6172805|NCT01658943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6172806|NCT01658943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6172807|NCT01658943|Immunologic Factors|immunologic factors|mesh-ancestor
6172808|NCT01658943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172809|NCT01658995|Doxycycline|doxycycline|mesh-list
6172810|NCT01658995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5569802|NCT03938662|Lipotropic Agents|lipotropic agents|mesh-ancestor
5569803|NCT03938662|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5569804|NCT03938662|Antimetabolites|antimetabolites|mesh-ancestor
5569805|NCT03938662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569806|NCT03938662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5569807|NCT03938662|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5569808|NCT03938662|Nootropic Agents|nootropic agents|mesh-ancestor
5569809|NCT03938389|Valsartan|valsartan|mesh-list
5569810|NCT03938389|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5569811|NCT03938389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5569812|NCT03938389|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5569813|NCT03938389|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5569814|NCT03938389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569815|NCT03938467|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
5569816|NCT03938467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5569817|NCT03938363|Botulinum Toxins|botulinum toxins|mesh-list
6172811|NCT01658995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6172812|NCT01658995|Antimalarials|antimalarials|mesh-ancestor
6172813|NCT01658995|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6172814|NCT01658995|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6172815|NCT01659021|Ofatumumab|ofatumumab|mesh-list
6172816|NCT01659021|Idelalisib|idelalisib|mesh-list
6172817|NCT01659021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6172818|NCT01659021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6172819|NCT01659021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172820|NCT01659320|Minocycline|minocycline|mesh-list
6172821|NCT01659320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6172822|NCT01659320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6172823|NCT01659567|Interferons|interferons|mesh-list
6172824|NCT01659567|Ribavirin|ribavirin|mesh-list
6172825|NCT01659567|Interferon-alpha|interferon-alpha|mesh-list
6172826|NCT01659567|Interferon alpha-2|interferon alpha-2|mesh-list
6172827|NCT01659567|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6172828|NCT01659567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6172829|NCT01659567|Antiviral Agents|antiviral agents|mesh-ancestor
6172830|NCT01659567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6172831|NCT01659567|Antimetabolites|antimetabolites|mesh-ancestor
6172832|NCT01659567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172833|NCT01659567|Immunologic Factors|immunologic factors|mesh-ancestor
6172834|NCT01659567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172835|NCT01659853|Azelaic acid|azelaic acid|mesh-list
6485772|NCT00567216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6485773|NCT00567372|Bevacizumab|bevacizumab|mesh-list
6485774|NCT00567372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6485775|NCT00567372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6485776|NCT00567372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6485777|NCT00567372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6485778|NCT00567372|Growth Substances|growth substances|mesh-ancestor
6485779|NCT00567372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485780|NCT00567372|Growth Inhibitors|growth inhibitors|mesh-ancestor
6485781|NCT00567411|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6485782|NCT00567411|Apraclonidine|apraclonidine|mesh-list
6485783|NCT00567411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6172836|NCT01659853|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6172837|NCT01659853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6172838|NCT01659853|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6172839|NCT01659853|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6172840|NCT01659853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6172841|NCT01659853|Adrenergic Agents|adrenergic agents|mesh-ancestor
6172842|NCT01659853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6172843|NCT01659853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172844|NCT01659853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172845|NCT01659853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6172846|NCT01659853|Dermatologic Agents|dermatologic agents|mesh-ancestor
6172847|NCT01659866|Ciprofloxacin|ciprofloxacin|mesh-list
6172848|NCT01659866|Gentamicins|gentamicins|mesh-list
6172849|NCT01659866|Ceftriaxone|ceftriaxone|mesh-list
6172850|NCT01659866|Imipenem|imipenem|mesh-list
6172851|NCT01659866|Amikacin|amikacin|mesh-list
6172852|NCT01659866|Cefuroxime|cefuroxime|mesh-list
6172853|NCT01659866|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6172854|NCT01659866|Aztreonam|aztreonam|mesh-list
5569818|NCT03938363|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5569819|NCT03938363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5569820|NCT03938363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569821|NCT03938363|Cholinergic Agents|cholinergic agents|mesh-ancestor
5569822|NCT03938363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5569823|NCT03938363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569824|NCT03937843|Carboplatin|carboplatin|mesh-list
5569825|NCT03937843|Etoposide|etoposide|mesh-list
5569826|NCT03937843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5569827|NCT03937843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5569828|NCT03937843|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5569829|NCT03937843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5569830|NCT03937843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5569831|NCT03937843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569832|NCT03938259|Fentanyl|fentanyl|mesh-list
6172855|NCT01659866|Trimethoprim|trimethoprim|mesh-list
6172856|NCT01659866|Sulfamethoxazole|sulfamethoxazole|mesh-list
6172857|NCT01659866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6485784|NCT00567411|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6485785|NCT00567411|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6485786|NCT00567411|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6485787|NCT00567411|Adrenergic Agents|adrenergic agents|mesh-ancestor
6172858|NCT01659866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6485788|NCT00567411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6485789|NCT00567411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485790|NCT00567411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485791|NCT00567450|Ropivacaine|ropivacaine|mesh-list
5569833|NCT03938259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5569834|NCT03938259|Narcotics|narcotics|mesh-ancestor
5569835|NCT03938259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5569836|NCT03938259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569837|NCT03938259|Analgesics|analgesics|mesh-ancestor
5569838|NCT03938259|Sensory System Agents|sensory system agents|mesh-ancestor
5569839|NCT03938259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5569840|NCT03938259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5569841|NCT03938259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5569842|NCT03938259|Anesthetics, General|anesthetics, general|mesh-ancestor
5569843|NCT03938259|Anesthetics|anesthetics|mesh-ancestor
5569844|NCT03937895|Pembrolizumab|pembrolizumab|mesh-list
5569845|NCT03937895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5569846|NCT03937895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5569847|NCT03937869|Secnidazole|secnidazole|mesh-list
5569848|NCT03937869|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6485792|NCT00567450|Mepivacaine|mepivacaine|mesh-list
6485793|NCT00567450|Anesthetics, Local|anesthetics, local|mesh-ancestor
6485794|NCT00567450|Anesthetics|anesthetics|mesh-ancestor
6485795|NCT00567450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6485796|NCT00567450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485797|NCT00567450|Sensory System Agents|sensory system agents|mesh-ancestor
6485798|NCT00567450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6485799|NCT00567463|Fluticasone|fluticasone|mesh-list
6485800|NCT00567463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6485801|NCT00567463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6485802|NCT00567463|Autonomic Agents|autonomic agents|mesh-ancestor
6485803|NCT00567463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6485804|NCT00567463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485805|NCT00567463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6485806|NCT00567463|Respiratory System Agents|respiratory system agents|mesh-ancestor
6485807|NCT00567463|Dermatologic Agents|dermatologic agents|mesh-ancestor
6485808|NCT00567463|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6485809|NCT00567528|Ibuprofen|ibuprofen|mesh-list
6485810|NCT00567528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6172859|NCT01659866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6172860|NCT01659866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6172861|NCT01659866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6172862|NCT01659866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172863|NCT01659866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6172864|NCT01659866|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6172865|NCT01659866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6172866|NCT01659866|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6172867|NCT01659866|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6172868|NCT01659866|Renal Agents|renal agents|mesh-ancestor
6172869|NCT01659866|Antimalarials|antimalarials|mesh-ancestor
6172870|NCT01659866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6172871|NCT01659866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6172872|NCT01659866|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6172873|NCT01659866|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6172874|NCT01659866|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6172875|NCT01660022|Piperaquine|piperaquine|mesh-list
6172876|NCT01660022|Artefenomel|artefenomel|mesh-list
6172877|NCT01660022|Antimalarials|antimalarials|mesh-ancestor
6172878|NCT01660022|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6172879|NCT01660022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6172880|NCT01660022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6172881|NCT01660191|Atorvastatin|atorvastatin|mesh-list
6172882|NCT01660191|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6172883|NCT01660191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6172884|NCT01660191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6172885|NCT01660191|Antimetabolites|antimetabolites|mesh-ancestor
6172886|NCT01660191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172887|NCT01660191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6172888|NCT01660191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6172889|NCT01660191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6172890|NCT01660256|Rebamipide|rebamipide|mesh-list
6172891|NCT01660256|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6172892|NCT01660256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6172893|NCT01660256|Antioxidants|antioxidants|mesh-ancestor
6172894|NCT01660256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172895|NCT01660256|Protective Agents|protective agents|mesh-ancestor
6172896|NCT01660256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172897|NCT01660256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6172898|NCT01660334|Voriconazole|voriconazole|mesh-list
6172899|NCT01660334|Antifungal Agents|antifungal agents|mesh-ancestor
6172900|NCT01660334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6172901|NCT01660334|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6172902|NCT01660334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6172903|NCT01660334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6172904|NCT01660334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172905|NCT01660334|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6172906|NCT01660334|Hormone Antagonists|hormone antagonists|mesh-ancestor
6172907|NCT01660334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6172908|NCT01660334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172909|NCT01660334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6172910|NCT01660672|Levetiracetam|levetiracetam|mesh-list
6172911|NCT01660672|Anticonvulsants|anticonvulsants|mesh-ancestor
5569849|NCT03937869|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5569850|NCT03937869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5569851|NCT03937518|Strontium ranelate|strontium ranelate|mesh-list
5569852|NCT03937518|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5569853|NCT03937518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569854|NCT03937713|Eszopiclone|eszopiclone|mesh-list
5569855|NCT03937713|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5569856|NCT03937713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6172912|NCT01660672|Nootropic Agents|nootropic agents|mesh-ancestor
6172913|NCT01660711|Leucovorin|leucovorin|mesh-list
6172914|NCT01660711|Fluorouracil|fluorouracil|mesh-list
6172915|NCT01660711|Oxaliplatin|oxaliplatin|mesh-list
6172916|NCT01660711|Irinotecan|irinotecan|mesh-list
6172917|NCT01660711|Antimetabolites|antimetabolites|mesh-ancestor
6172918|NCT01660711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172919|NCT01660711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6172920|NCT01660711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6172921|NCT01660711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6172922|NCT01660711|Immunologic Factors|immunologic factors|mesh-ancestor
6670061|NCT01541085|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6670062|NCT01541085|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6670063|NCT01541124|Morphine|morphine|mesh-list
6670064|NCT01541124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6670065|NCT01541124|Narcotics|narcotics|mesh-ancestor
6670066|NCT01541124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6670067|NCT01541124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670068|NCT01541124|Analgesics|analgesics|mesh-ancestor
6670069|NCT01541124|Sensory System Agents|sensory system agents|mesh-ancestor
6670070|NCT01541124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6670071|NCT01541137|Diclofenac|diclofenac|mesh-list
6670072|NCT01541137|Parecoxib|parecoxib|mesh-list
6670073|NCT01541137|Valdecoxib|valdecoxib|mesh-list
6670074|NCT01541137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6670075|NCT01541137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6670076|NCT01541137|Analgesics|analgesics|mesh-ancestor
6670077|NCT01541137|Sensory System Agents|sensory system agents|mesh-ancestor
6670078|NCT01541137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6670079|NCT01541137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670080|NCT01541137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6670081|NCT01541137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6670082|NCT01541137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6670083|NCT01541137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6670084|NCT01541137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670085|NCT01541137|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6670086|NCT01541189|Valsartan|valsartan|mesh-list
6670087|NCT01541189|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6670088|NCT01541189|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6670089|NCT01541189|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6670090|NCT01541189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670091|NCT01541267|Telmisartan|telmisartan|mesh-list
6670092|NCT01541267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6670093|NCT01541267|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6670094|NCT01541267|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6670095|NCT01541267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670096|NCT01541280|Azacitidine|azacitidine|mesh-list
5569857|NCT03937713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569858|NCT03937687|Caffeine|caffeine|mesh-list
6172923|NCT01660711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172924|NCT01660711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6172925|NCT01660711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6172926|NCT01660711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6172927|NCT01660711|Antidotes|antidotes|mesh-ancestor
6172928|NCT01660711|Protective Agents|protective agents|mesh-ancestor
6172929|NCT01660711|Vitamin B Complex|vitamin b complex|mesh-ancestor
6172930|NCT01660711|Vitamins|vitamins|mesh-ancestor
6172931|NCT01660711|Micronutrients|micronutrients|mesh-ancestor
5569859|NCT03937687|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5569860|NCT03937687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569861|NCT03937687|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5569862|NCT03937687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5569863|NCT03937687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569864|NCT03937687|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5569865|NCT03937687|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5569866|NCT03937687|Purinergic Agents|purinergic agents|mesh-ancestor
5569867|NCT03937687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5604152|NCT05161468|Sensory System Agents|sensory system agents|mesh-ancestor
5604153|NCT05161468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5604154|NCT05161468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5604155|NCT05161468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5604156|NCT05161468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5604157|NCT05161468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5604158|NCT05161468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604159|NCT05161468|Anticoagulants|anticoagulants|mesh-ancestor
5604160|NCT05161468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5604161|NCT05161468|Hormones|hormones|mesh-ancestor
5604162|NCT05161468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5604163|NCT05161468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5604164|NCT05161468|Immunologic Factors|immunologic factors|mesh-ancestor
5604165|NCT05161468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5604166|NCT05158491|Irinotecan|irinotecan|mesh-list
5604167|NCT05158491|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5604168|NCT05158491|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5604169|NCT05158491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5604170|NCT05158491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604171|NCT05158491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5604172|NCT05157464|Losartan|losartan|mesh-list
5604173|NCT05157464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5604174|NCT05157464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5604175|NCT05157464|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5604176|NCT05157464|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5604177|NCT05157464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604178|NCT05156905|Docetaxel|docetaxel|mesh-list
5604179|NCT05156905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5604180|NCT05156905|Tubulin Modulators|tubulin modulators|mesh-ancestor
6172932|NCT01660763|Sufentanil|sufentanil|mesh-list
6172933|NCT01660763|Dsuvia|dsuvia|mesh-list
6172934|NCT01660763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6172935|NCT01660763|Narcotics|narcotics|mesh-ancestor
6172936|NCT01660763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5604181|NCT05156905|Antimitotic Agents|antimitotic agents|mesh-ancestor
6172937|NCT01660763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172938|NCT01660763|Analgesics|analgesics|mesh-ancestor
6172939|NCT01660763|Sensory System Agents|sensory system agents|mesh-ancestor
6172940|NCT01660763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6172941|NCT01660763|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6172942|NCT01660763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6172943|NCT01660763|Anesthetics, General|anesthetics, general|mesh-ancestor
6172944|NCT01660763|Anesthetics|anesthetics|mesh-ancestor
6172945|NCT01660802|Dexamethasone|dexamethasone|mesh-list
6172946|NCT01660802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6172947|NCT01660802|Antiemetics|antiemetics|mesh-ancestor
6172948|NCT01660802|Autonomic Agents|autonomic agents|mesh-ancestor
6172949|NCT01660802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6172950|NCT01660802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172951|NCT01660802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6172952|NCT01660802|Glucocorticoids|glucocorticoids|mesh-ancestor
6172953|NCT01660802|Hormones|hormones|mesh-ancestor
6172954|NCT01660802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6172955|NCT01660802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6172956|NCT01660802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6172957|NCT01660893|Phenylephrine|phenylephrine|mesh-list
5569868|NCT03937609|Infliximab|infliximab|mesh-list
5569869|NCT03937609|Dermatologic Agents|dermatologic agents|mesh-ancestor
5569870|NCT03937609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5569871|NCT03937609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5569872|NCT03937544|Cyclophosphamide|cyclophosphamide|mesh-list
5569873|NCT03937544|Fludarabine|fludarabine|mesh-list
5569874|NCT03937544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5569875|NCT03937544|Immunologic Factors|immunologic factors|mesh-ancestor
5569876|NCT03937544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569877|NCT03937544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5569878|NCT03937544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5569879|NCT03937544|Alkylating Agents|alkylating agents|mesh-ancestor
5569880|NCT03937544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569881|NCT03937544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5569882|NCT03937544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6172958|NCT01660893|Oxymetazoline|oxymetazoline|mesh-list
6485811|NCT00567528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6485812|NCT00567528|Analgesics|analgesics|mesh-ancestor
6485813|NCT00567528|Sensory System Agents|sensory system agents|mesh-ancestor
6485814|NCT00567528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6485815|NCT00567528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485816|NCT00567528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6485817|NCT00567528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6485818|NCT00567528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6485819|NCT00567528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6485820|NCT00567528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485821|NCT00567554|Paclitaxel|paclitaxel|mesh-list
5569883|NCT03937648|Lasmiditan|lasmiditan|mesh-list
5569884|NCT03937648|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5569885|NCT03937648|Serotonin Agents|serotonin agents|mesh-ancestor
5569886|NCT03937648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5569887|NCT03937648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569888|NCT03937648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569889|NCT03937401|Oxytocin|oxytocin|mesh-list
6485822|NCT00567554|Docetaxel|docetaxel|mesh-list
6485823|NCT00567554|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6485824|NCT00567554|Cyclophosphamide|cyclophosphamide|mesh-list
6485825|NCT00567554|Bevacizumab|bevacizumab|mesh-list
6485826|NCT00567554|Trastuzumab|trastuzumab|mesh-list
6485827|NCT00567554|Everolimus|everolimus|mesh-list
6485828|NCT00567554|Epirubicin|epirubicin|mesh-list
6485829|NCT00567554|Lapatinib|lapatinib|mesh-list
6485830|NCT00567554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6485831|NCT00567554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6485832|NCT00567554|Tubulin Modulators|tubulin modulators|mesh-ancestor
6485833|NCT00567554|Antimitotic Agents|antimitotic agents|mesh-ancestor
6485834|NCT00567554|Mitosis Modulators|mitosis modulators|mesh-ancestor
6485835|NCT00567554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485836|NCT00567554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6485837|NCT00567554|Immunologic Factors|immunologic factors|mesh-ancestor
5569890|NCT03937401|Oxytocics|oxytocics|mesh-ancestor
6172959|NCT01660893|Tetracaine|tetracaine|mesh-list
6172960|NCT01660893|Anesthetics, Local|anesthetics, local|mesh-ancestor
6172961|NCT01660893|Anesthetics|anesthetics|mesh-ancestor
5569891|NCT03937401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5569892|NCT03937401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569893|NCT03937219|Nivolumab|nivolumab|mesh-list
5569894|NCT03937219|Ipilimumab|ipilimumab|mesh-list
5569895|NCT03937219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5569896|NCT03937219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5569897|NCT03937219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5569898|NCT03937219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569899|NCT03937258|Probenecid|probenecid|mesh-list
5569900|NCT03937258|Abrocitinib|abrocitinib|mesh-list
5569901|NCT03937258|Uricosuric Agents|uricosuric agents|mesh-ancestor
5569902|NCT03937258|Gout Suppressants|gout suppressants|mesh-ancestor
5569903|NCT03937258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5569904|NCT03937258|Renal Agents|renal agents|mesh-ancestor
5569905|NCT03937258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5569906|NCT03937258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5569907|NCT03937258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569908|NCT03936907|Nabiximols|nabiximols|mesh-list
6172962|NCT01660893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6172963|NCT01660893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485838|NCT00567554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569909|NCT03936907|Analgesics|analgesics|mesh-ancestor
6172964|NCT01660893|Sensory System Agents|sensory system agents|mesh-ancestor
6172965|NCT01660893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6172966|NCT01660893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6172967|NCT01660893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6172968|NCT01660893|Adrenergic Agents|adrenergic agents|mesh-ancestor
6172969|NCT01660893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6172970|NCT01660893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172971|NCT01660893|Sympathomimetics|sympathomimetics|mesh-ancestor
6172972|NCT01660893|Autonomic Agents|autonomic agents|mesh-ancestor
6172973|NCT01660893|Nasal Decongestants|nasal decongestants|mesh-ancestor
6172974|NCT01660893|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6172975|NCT01660893|Respiratory System Agents|respiratory system agents|mesh-ancestor
6172976|NCT01660893|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6172977|NCT01660893|Mydriatics|mydriatics|mesh-ancestor
6172978|NCT01660893|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6172979|NCT01660893|Protective Agents|protective agents|mesh-ancestor
6172980|NCT01660906|Dasatinib|dasatinib|mesh-list
6172981|NCT01660906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6172982|NCT01660906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6172983|NCT01660906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6172984|NCT01660906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172985|NCT01661088|Folfirinox|folfirinox|mesh-list
6172986|NCT01661088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6172987|NCT01661114|Gemcitabine|gemcitabine|mesh-list
6172988|NCT01661114|Fluorouracil|fluorouracil|mesh-list
6172989|NCT01661114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6172990|NCT01661114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6172991|NCT01661114|Antimetabolites|antimetabolites|mesh-ancestor
6172992|NCT01661114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6172993|NCT01661114|Antiviral Agents|antiviral agents|mesh-ancestor
6172994|NCT01661114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6172995|NCT01661114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6172996|NCT01661114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6172997|NCT01661114|Immunologic Factors|immunologic factors|mesh-ancestor
6172998|NCT01661114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6172999|NCT01661140|Methotrexate|methotrexate|mesh-list
6173000|NCT01661140|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6173001|NCT01661140|Abortifacient Agents|abortifacient agents|mesh-ancestor
6173002|NCT01661140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6173003|NCT01661140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173004|NCT01661140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6670097|NCT01541280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6670098|NCT01541280|Antimetabolites|antimetabolites|mesh-ancestor
6670099|NCT01541280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670100|NCT01541280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6670101|NCT01541280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6670102|NCT01541293|Lidocaine|lidocaine|mesh-list
6173005|NCT01661140|Antimetabolites|antimetabolites|mesh-ancestor
6173006|NCT01661140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173007|NCT01661140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6173008|NCT01661140|Dermatologic Agents|dermatologic agents|mesh-ancestor
6173009|NCT01661140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6173010|NCT01661140|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6173011|NCT01661140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5569910|NCT03936907|Sensory System Agents|sensory system agents|mesh-ancestor
5569911|NCT03936907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5569912|NCT03936907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569913|NCT03936894|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5569914|NCT03936894|Immunologic Factors|immunologic factors|mesh-ancestor
5569915|NCT03936894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569916|NCT03936998|Vancomycin|vancomycin|mesh-list
5569917|NCT03936998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5569918|NCT03936998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5569919|NCT03936777|Fenfluramine|fenfluramine|mesh-list
5569920|NCT03936777|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5569921|NCT03936777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5569922|NCT03936777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5569923|NCT03936777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569924|NCT03936777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5569925|NCT03936777|Serotonin Agents|serotonin agents|mesh-ancestor
5569926|NCT03936777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569927|NCT03936517|Prednisolone|prednisolone|mesh-list
5569928|NCT03936517|Hydrocortisone|hydrocortisone|mesh-list
5569929|NCT03936517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5569930|NCT03936517|Glucocorticoids|glucocorticoids|mesh-ancestor
5569931|NCT03936517|Hormones|hormones|mesh-ancestor
5569932|NCT03936517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5569933|NCT03936517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569934|NCT03936517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5569935|NCT03936517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5569936|NCT03936491|Methylphenidate|methylphenidate|mesh-list
5569937|NCT03936491|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
5569938|NCT03936491|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5569939|NCT03936491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173012|NCT01661140|Immunologic Factors|immunologic factors|mesh-ancestor
6173013|NCT01661140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6173014|NCT01661140|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6173015|NCT01661270|Aflibercept|aflibercept|mesh-list
6173016|NCT01661270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6173017|NCT01661270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6173018|NCT01661270|Growth Substances|growth substances|mesh-ancestor
6173019|NCT01661270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173020|NCT01661270|Growth Inhibitors|growth inhibitors|mesh-ancestor
6173021|NCT01661270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6206410|NCT02100007|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6206411|NCT02100007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6206412|NCT02100007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6206413|NCT02100007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206414|NCT02100007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5569940|NCT03936491|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5569941|NCT03936491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5569942|NCT03936491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5569943|NCT03936491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569944|NCT03936491|Dopamine Agents|dopamine agents|mesh-ancestor
5569945|NCT03936491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5569946|NCT03936491|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5569947|NCT03936491|Adrenergic Agents|adrenergic agents|mesh-ancestor
6206415|NCT02100124|Contraceptive Agents|contraceptive agents|mesh-list
6206416|NCT02100124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6206417|NCT02100124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206418|NCT02100228|Vitamin K|vitamin k|mesh-list
6206419|NCT02100228|Heparin|heparin|mesh-list
6670103|NCT01541293|Anesthetics, Local|anesthetics, local|mesh-ancestor
6670104|NCT01541293|Anesthetics|anesthetics|mesh-ancestor
6670105|NCT01541293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6670106|NCT01541293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670107|NCT01541293|Sensory System Agents|sensory system agents|mesh-ancestor
6670108|NCT01541293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6670109|NCT01541293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6670110|NCT01541293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6670111|NCT01541293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6670112|NCT01541293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5569948|NCT03936192|Meloxicam|meloxicam|mesh-list
5569949|NCT03936192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5569950|NCT03936192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5569951|NCT03936192|Analgesics|analgesics|mesh-ancestor
5569952|NCT03936192|Sensory System Agents|sensory system agents|mesh-ancestor
5569953|NCT03936192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5569954|NCT03936192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569955|NCT03936192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5569956|NCT03936192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5569957|NCT03936192|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5569958|NCT03936192|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5569959|NCT03936192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5569960|NCT03936192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569961|NCT03936426|Copper|copper|mesh-list
5569962|NCT03936426|Trace Elements|trace elements|mesh-ancestor
5569963|NCT03936426|Micronutrients|micronutrients|mesh-ancestor
5569964|NCT03936426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569965|NCT03936062|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5569966|NCT03936062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5569967|NCT03936062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569968|NCT03936062|Incretins|incretins|mesh-ancestor
5569969|NCT03936062|Hormones|hormones|mesh-ancestor
5569970|NCT03936062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5569971|NCT03936062|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5569972|NCT03936062|Protease Inhibitors|protease inhibitors|mesh-ancestor
5569973|NCT03936062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5569974|NCT03936062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569975|NCT03936166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6670113|NCT01541293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670114|NCT01541332|Dexamethasone|dexamethasone|mesh-list
6670115|NCT01541332|Doxorubicin|doxorubicin|mesh-list
6670116|NCT01541332|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6670117|NCT01541332|Pomalidomide|pomalidomide|mesh-list
6670118|NCT01541332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6670119|NCT01541332|Antiemetics|antiemetics|mesh-ancestor
6173022|NCT01661283|Bevacizumab|bevacizumab|mesh-list
6173023|NCT01661283|Everolimus|everolimus|mesh-list
6173024|NCT01661283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6173025|NCT01661283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6173026|NCT01661283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6173027|NCT01661283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6173028|NCT01661283|Growth Substances|growth substances|mesh-ancestor
6173029|NCT01661283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173030|NCT01661283|Growth Inhibitors|growth inhibitors|mesh-ancestor
6173031|NCT01661283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6173032|NCT01661283|Immunologic Factors|immunologic factors|mesh-ancestor
6173033|NCT01661595|Sildenafil Citrate|sildenafil citrate|mesh-list
6173034|NCT01661595|Tadalafil|tadalafil|mesh-list
6173035|NCT01661595|Vasodilator Agents|vasodilator agents|mesh-ancestor
6173036|NCT01661595|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6173037|NCT01661595|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6173038|NCT01661595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6173039|NCT01661595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173040|NCT01661595|Urological Agents|urological agents|mesh-ancestor
6173041|NCT01661621|Doxazosin|doxazosin|mesh-list
6173042|NCT01661621|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6173043|NCT01661621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6173044|NCT01661621|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6173045|NCT01661621|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6173046|NCT01661621|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6173047|NCT01661621|Adrenergic Agents|adrenergic agents|mesh-ancestor
6173048|NCT01661621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6173049|NCT01661621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173050|NCT01661621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173051|NCT01661621|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6173052|NCT01661621|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6173053|NCT01661621|Cholinergic Agents|cholinergic agents|mesh-ancestor
6173054|NCT01661621|Urological Agents|urological agents|mesh-ancestor
6173055|NCT01661790|Bevacizumab|bevacizumab|mesh-list
6173056|NCT01661790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6173057|NCT01661790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6173058|NCT01661790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5569976|NCT03936374|Omeprazole|omeprazole|mesh-list
5569977|NCT03936374|Linrodostat|linrodostat|mesh-list
5569978|NCT03936374|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5569979|NCT03936374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5569980|NCT03936374|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5569981|NCT03936374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5569982|NCT03936374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569983|NCT03936205|Dexmedetomidine|dexmedetomidine|mesh-list
5569984|NCT03936205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5569985|NCT03936205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5569986|NCT03936205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5569987|NCT03936205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5569988|NCT03936205|Analgesics|analgesics|mesh-ancestor
5569989|NCT03936205|Sensory System Agents|sensory system agents|mesh-ancestor
6173059|NCT01661790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6173060|NCT01661790|Growth Substances|growth substances|mesh-ancestor
6173061|NCT01661790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173062|NCT01661790|Growth Inhibitors|growth inhibitors|mesh-ancestor
6173063|NCT01661881|Cytarabine|cytarabine|mesh-list
6173064|NCT01661881|Rituximab|rituximab|mesh-list
6173065|NCT01661881|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6173066|NCT01661881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6173067|NCT01661881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6173068|NCT01661881|Immunologic Factors|immunologic factors|mesh-ancestor
6173069|NCT01661881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173070|NCT01661881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6173071|NCT01661881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6173072|NCT01661881|Antimetabolites|antimetabolites|mesh-ancestor
6173073|NCT01661881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173074|NCT01661881|Antiviral Agents|antiviral agents|mesh-ancestor
6173075|NCT01661881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6670120|NCT01541332|Autonomic Agents|autonomic agents|mesh-ancestor
6173076|NCT01661881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6173077|NCT01661881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6173078|NCT01661881|Alkylating Agents|alkylating agents|mesh-ancestor
6173079|NCT01661946|Bevacizumab|bevacizumab|mesh-list
5569990|NCT03936205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5569991|NCT03936205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5569992|NCT03936205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5569993|NCT03936205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5569994|NCT03936205|Adrenergic Agents|adrenergic agents|mesh-ancestor
6173080|NCT01661946|Ranibizumab|ranibizumab|mesh-list
6173081|NCT01661946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6485839|NCT00567554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5569995|NCT03936205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5569996|NCT03936205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5569997|NCT03936049|Liraglutide|liraglutide|mesh-list
5569998|NCT03936049|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
5569999|NCT03936049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5570000|NCT03936049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570001|NCT03936049|Incretins|incretins|mesh-ancestor
5570002|NCT03936049|Hormones|hormones|mesh-ancestor
5570003|NCT03936049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5570004|NCT03936049|Protease Inhibitors|protease inhibitors|mesh-ancestor
5570005|NCT03936049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5570006|NCT03936049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570007|NCT03936153|Abexinostat|abexinostat|mesh-list
5570008|NCT03936153|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5570009|NCT03936153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5570010|NCT03936153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570011|NCT03936140|Iloprost|iloprost|mesh-list
5570012|NCT03936140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5570013|NCT03936140|Vasodilator Agents|vasodilator agents|mesh-ancestor
5570014|NCT03936036|Linagliptin|linagliptin|mesh-list
5570015|NCT03936036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5570016|NCT03936036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570017|NCT03936036|Incretins|incretins|mesh-ancestor
5570018|NCT03936036|Hormones|hormones|mesh-ancestor
5570019|NCT03936036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5570020|NCT03936036|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5570021|NCT03936036|Protease Inhibitors|protease inhibitors|mesh-ancestor
5570022|NCT03936036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5570023|NCT03936036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570024|NCT03936023|Saxagliptin|saxagliptin|mesh-list
5570025|NCT03936023|Incretins|incretins|mesh-ancestor
6485840|NCT00567554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6485841|NCT00567554|Alkylating Agents|alkylating agents|mesh-ancestor
6173082|NCT01661946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6173083|NCT01661946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6173084|NCT01661946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6173085|NCT01661946|Growth Substances|growth substances|mesh-ancestor
6173086|NCT01661946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173087|NCT01661946|Growth Inhibitors|growth inhibitors|mesh-ancestor
6173088|NCT01661972|Capecitabine|capecitabine|mesh-list
6173089|NCT01661972|Aflibercept|aflibercept|mesh-list
6173090|NCT01661972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6173091|NCT01661972|Antimetabolites|antimetabolites|mesh-ancestor
6173092|NCT01661972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173093|NCT01661972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6173094|NCT01661972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6173095|NCT01661972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6173096|NCT01661972|Growth Substances|growth substances|mesh-ancestor
6206420|NCT02100228|Apixaban|apixaban|mesh-list
5570026|NCT03936023|Hormones|hormones|mesh-ancestor
5570027|NCT03936023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5570028|NCT03936023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570029|NCT03936023|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5570030|NCT03936023|Protease Inhibitors|protease inhibitors|mesh-ancestor
5570031|NCT03936023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5570032|NCT03936023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570033|NCT03936023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5570034|NCT03936010|Canagliflozin|canagliflozin|mesh-list
5570035|NCT03936010|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
5570036|NCT03936010|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6485842|NCT00567554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6173097|NCT01661972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173098|NCT01661972|Growth Inhibitors|growth inhibitors|mesh-ancestor
6173099|NCT01662115|Nicotine|nicotine|mesh-list
6173100|NCT01662115|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6173101|NCT01662115|Autonomic Agents|autonomic agents|mesh-ancestor
6173102|NCT01662115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6173103|NCT01662115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173104|NCT01662115|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6173105|NCT01662115|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6173106|NCT01662115|Cholinergic Agents|cholinergic agents|mesh-ancestor
6173107|NCT01662115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6173108|NCT01662115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173109|NCT01662297|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6173110|NCT01662297|Trazodone|trazodone|mesh-list
6485843|NCT00567554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6485844|NCT00567554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6485845|NCT00567554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6485846|NCT00567554|Growth Substances|growth substances|mesh-ancestor
5570037|NCT03936010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570038|NCT03936010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5570039|NCT03936010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485847|NCT00567554|Growth Inhibitors|growth inhibitors|mesh-ancestor
6485848|NCT00567554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6485849|NCT00567554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6485850|NCT00567554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6485851|NCT00567554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6485852|NCT00567554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6485853|NCT00567606|Risedronic Acid|risedronic acid|mesh-list
6485854|NCT00567606|Calcium|calcium|mesh-list
6485855|NCT00567606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6173111|NCT01662297|Antidepressive Agents|antidepressive agents|mesh-ancestor
6173112|NCT01662297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6173113|NCT01662297|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6173114|NCT01662297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6173115|NCT01662297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6173116|NCT01662297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173117|NCT01662297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6173118|NCT01662297|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6173119|NCT01662297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6173120|NCT01662297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6173121|NCT01662297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173122|NCT01662297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6173123|NCT01662297|Serotonin Agents|serotonin agents|mesh-ancestor
6173124|NCT01662297|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6173125|NCT01662310|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6173126|NCT01662310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6173127|NCT01662310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6173128|NCT01662310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6173129|NCT01662310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173130|NCT01662310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6173131|NCT01662310|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6173132|NCT01662310|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6173133|NCT01662310|Serotonin Agents|serotonin agents|mesh-ancestor
6173134|NCT01662310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6173135|NCT01662310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173136|NCT01662310|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6173137|NCT01662310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6173138|NCT01662310|Dopamine Agents|dopamine agents|mesh-ancestor
6173139|NCT01662336|Ritonavir|ritonavir|mesh-list
6173140|NCT01662336|Lopinavir|lopinavir|mesh-list
6173141|NCT01662336|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6173142|NCT01662336|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6173143|NCT01662336|Protease Inhibitors|protease inhibitors|mesh-ancestor
6173144|NCT01662336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6173145|NCT01662336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173146|NCT01662336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6173147|NCT01662336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6173148|NCT01662336|Antiviral Agents|antiviral agents|mesh-ancestor
6173149|NCT01662336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6173150|NCT01662336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5570040|NCT03936010|Protease Inhibitors|protease inhibitors|mesh-ancestor
5570041|NCT03936010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5570042|NCT03935893|Cyclophosphamide|cyclophosphamide|mesh-list
5570043|NCT03935893|Fludarabine|fludarabine|mesh-list
5570044|NCT03935893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5570045|NCT03935893|Immunologic Factors|immunologic factors|mesh-ancestor
5570046|NCT03935893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570047|NCT03935893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5570048|NCT03935893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5570049|NCT03935893|Alkylating Agents|alkylating agents|mesh-ancestor
5570050|NCT03935893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570051|NCT03935893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5570052|NCT03935893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5570053|NCT03935958|Curcumin|curcumin|mesh-list
5570054|NCT03935958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5570055|NCT03935958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5570056|NCT03935958|Analgesics|analgesics|mesh-ancestor
5570057|NCT03935958|Sensory System Agents|sensory system agents|mesh-ancestor
5570058|NCT03935958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5570059|NCT03935958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570060|NCT03935958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5570061|NCT03935958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5570062|NCT03935958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5570063|NCT03935958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5570064|NCT03935958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570065|NCT03935685|Mirtazapine|mirtazapine|mesh-list
5570066|NCT03935685|Antidepressive Agents|antidepressive agents|mesh-ancestor
5570067|NCT03935685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5570068|NCT03935685|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5570069|NCT03935685|Histamine Antagonists|histamine antagonists|mesh-ancestor
5570070|NCT03935685|Histamine Agents|histamine agents|mesh-ancestor
6173151|NCT01662336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6173152|NCT01662492|Botulinum Toxins|botulinum toxins|mesh-list
6173153|NCT01662492|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6173154|NCT01662492|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6173155|NCT01662492|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6173156|NCT01662492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6173157|NCT01662492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173158|NCT01662492|Cholinergic Agents|cholinergic agents|mesh-ancestor
6173159|NCT01662492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6173160|NCT01662492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173161|NCT01662492|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6173162|NCT01662492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6173163|NCT01662648|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6173164|NCT01662648|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6173165|NCT01662648|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6173166|NCT01662648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6173167|NCT01662648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173168|NCT01662648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6173169|NCT01662648|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6173170|NCT01662648|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6173171|NCT01662648|Serotonin Agents|serotonin agents|mesh-ancestor
6173172|NCT01662648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6173173|NCT01662648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173174|NCT01662648|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6173175|NCT01662648|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6173176|NCT01662648|Dopamine Agents|dopamine agents|mesh-ancestor
6173177|NCT01662791|Rifaximin|rifaximin|mesh-list
6173178|NCT01662791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5570071|NCT03935685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5570072|NCT03935685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570073|NCT03935685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570074|NCT03935685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5570075|NCT03935685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5570076|NCT03935685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5570077|NCT03935685|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5570078|NCT03935685|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5570079|NCT03935685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5570080|NCT03935685|Adrenergic Agents|adrenergic agents|mesh-ancestor
5570081|NCT03935685|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5570082|NCT03935685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5570083|NCT03935685|Serotonin Agents|serotonin agents|mesh-ancestor
5570084|NCT03935685|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5604182|NCT05156905|Mitosis Modulators|mitosis modulators|mesh-ancestor
5604183|NCT05156905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570085|NCT03935815|Ropivacaine|ropivacaine|mesh-list
6173179|NCT01662791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6173180|NCT01662791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6173181|NCT01662856|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6173182|NCT01662856|Hemostatics|hemostatics|mesh-ancestor
6173183|NCT01662856|Coagulants|coagulants|mesh-ancestor
6173184|NCT01662895|Deferoxamine|deferoxamine|mesh-list
6173185|NCT01662895|Siderophores|siderophores|mesh-ancestor
6173186|NCT01662895|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6173187|NCT01662895|Chelating Agents|chelating agents|mesh-ancestor
6173188|NCT01662895|Sequestering Agents|sequestering agents|mesh-ancestor
6173189|NCT01662895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173190|NCT01662908|Heparin|heparin|mesh-list
6173191|NCT01662908|Enoxaparin|enoxaparin|mesh-list
6173192|NCT01662908|Calcium heparin|calcium heparin|mesh-list
6173193|NCT01662908|Warfarin|warfarin|mesh-list
6173194|NCT01662908|Edoxaban|edoxaban|mesh-list
6173195|NCT01662908|Anticoagulants|anticoagulants|mesh-ancestor
6173196|NCT01662908|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6173197|NCT01662908|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6173198|NCT01662908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570086|NCT03935815|Anesthetics, Local|anesthetics, local|mesh-ancestor
6173199|NCT01662908|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6173200|NCT01662908|Antithrombins|antithrombins|mesh-ancestor
6173201|NCT01662908|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6173202|NCT01662908|Protease Inhibitors|protease inhibitors|mesh-ancestor
6485856|NCT00567606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485857|NCT00567606|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6485858|NCT00567606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6485859|NCT00567606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485860|NCT00567606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6485861|NCT00567658|Esomeprazole|esomeprazole|mesh-list
6485862|NCT00567658|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6485863|NCT00567658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6173203|NCT01662908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6173204|NCT01662986|Bromides|bromides|mesh-list
6173205|NCT01662986|Tiotropium Bromide|tiotropium bromide|mesh-list
6173206|NCT01662986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6173207|NCT01662986|Autonomic Agents|autonomic agents|mesh-ancestor
6173208|NCT01662986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6173209|NCT01662986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173210|NCT01662986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6173211|NCT01662986|Respiratory System Agents|respiratory system agents|mesh-ancestor
6173212|NCT01662986|Parasympatholytics|parasympatholytics|mesh-ancestor
6173213|NCT01662986|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6173214|NCT01662986|Cholinergic Agents|cholinergic agents|mesh-ancestor
6173215|NCT01662986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6173216|NCT01662986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173217|NCT01662986|Anticonvulsants|anticonvulsants|mesh-ancestor
6173218|NCT01662999|Dapagliflozin|dapagliflozin|mesh-list
6173219|NCT01662999|Saxagliptin|saxagliptin|mesh-list
6173220|NCT01662999|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6173221|NCT01662999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173222|NCT01662999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6173223|NCT01662999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173224|NCT01662999|Incretins|incretins|mesh-ancestor
6173225|NCT01662999|Hormones|hormones|mesh-ancestor
6173226|NCT01662999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6173227|NCT01662999|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6173228|NCT01662999|Protease Inhibitors|protease inhibitors|mesh-ancestor
6173229|NCT01662999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6173230|NCT01663012|Etirinotecan pegol|etirinotecan pegol|mesh-list
6173231|NCT01663012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6173232|NCT01663012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6173233|NCT01663012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6173234|NCT01663012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6173235|NCT01663012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173236|NCT01663103|Rilonacept|rilonacept|mesh-list
6173237|NCT01663103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6173238|NCT01663233|Amlodipine|amlodipine|mesh-list
6485864|NCT00567658|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6485865|NCT00567658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6485866|NCT00567658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485867|NCT00567697|Ranibizumab|ranibizumab|mesh-list
5570087|NCT03935815|Anesthetics|anesthetics|mesh-ancestor
5570088|NCT03935815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5570089|NCT03935815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570090|NCT03935815|Sensory System Agents|sensory system agents|mesh-ancestor
5570091|NCT03935815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5570092|NCT03935984|Calcitonin|calcitonin|mesh-list
5570093|NCT03935984|Salmon calcitonin|salmon calcitonin|mesh-list
5570094|NCT03935984|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
5570095|NCT03935984|Katacalcin|katacalcin|mesh-list
5570096|NCT03935984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5570097|NCT03935984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485868|NCT00567697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6485869|NCT00567697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6485870|NCT00567697|Growth Substances|growth substances|mesh-ancestor
6485871|NCT00567697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485872|NCT00567697|Growth Inhibitors|growth inhibitors|mesh-ancestor
6670121|NCT01541332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6173239|NCT01663233|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
6173240|NCT01663233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6173241|NCT01663233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6173242|NCT01663233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6173243|NCT01663233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173244|NCT01663233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6173245|NCT01663233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173246|NCT01663233|Vasodilator Agents|vasodilator agents|mesh-ancestor
6173247|NCT01663233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6173248|NCT01663259|Cetuximab|cetuximab|mesh-list
6173249|NCT01663259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6173250|NCT01663259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6173251|NCT01663272|Gemcitabine|gemcitabine|mesh-list
6173252|NCT01663272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6173253|NCT01663272|Antimetabolites|antimetabolites|mesh-ancestor
6173254|NCT01663272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173255|NCT01663272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6173256|NCT01663272|Antiviral Agents|antiviral agents|mesh-ancestor
6173257|NCT01663272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6173258|NCT01663272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6173259|NCT01663272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6173260|NCT01663272|Immunologic Factors|immunologic factors|mesh-ancestor
6173261|NCT01663272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173262|NCT01663532|Aripiprazole|aripiprazole|mesh-list
6173263|NCT01663532|Antidepressive Agents|antidepressive agents|mesh-ancestor
6173264|NCT01663532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6173265|NCT01663532|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6173266|NCT01663532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6173267|NCT01663532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6173268|NCT01663532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173269|NCT01663532|Dopamine Agonists|dopamine agonists|mesh-ancestor
6173270|NCT01663532|Dopamine Agents|dopamine agents|mesh-ancestor
6173271|NCT01663532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6173272|NCT01663532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173273|NCT01663532|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6173274|NCT01663532|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6173275|NCT01663532|Serotonin Agents|serotonin agents|mesh-ancestor
6173276|NCT01663532|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6485873|NCT00567697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6670122|NCT01541332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670123|NCT01541332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5570098|NCT03935984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6670124|NCT01541332|Glucocorticoids|glucocorticoids|mesh-ancestor
6670125|NCT01541332|Hormones|hormones|mesh-ancestor
5570099|NCT03935984|Vasodilator Agents|vasodilator agents|mesh-ancestor
5570100|NCT03935555|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
5570101|NCT03935555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5570102|NCT03935646|Adderall|adderall|mesh-list
5570103|NCT03935646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5570104|NCT03935646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570105|NCT03935451|Apixaban|apixaban|mesh-list
5570106|NCT03935451|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5570107|NCT03935451|Antithrombins|antithrombins|mesh-ancestor
5570108|NCT03935451|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5570109|NCT03935451|Protease Inhibitors|protease inhibitors|mesh-ancestor
5570110|NCT03935451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5570111|NCT03935451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570112|NCT03935451|Anticoagulants|anticoagulants|mesh-ancestor
5570113|NCT03935152|Dydrogesterone|dydrogesterone|mesh-list
5570114|NCT03935152|Progestins|progestins|mesh-ancestor
5570115|NCT03935152|Hormones|hormones|mesh-ancestor
5570116|NCT03935152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6670126|NCT01541332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6670127|NCT01541332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6670128|NCT01541332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5570117|NCT03935152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670129|NCT01541332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6670130|NCT01541332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6485874|NCT00567710|Risperidone|risperidone|mesh-list
6485875|NCT00567710|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6485876|NCT00567710|Serotonin Agents|serotonin agents|mesh-ancestor
5570118|NCT03935139|Glycerol|glycerol|mesh-list
5570119|NCT03935139|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
5570120|NCT03935139|Protective Agents|protective agents|mesh-ancestor
5570121|NCT03935139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570122|NCT03935217|Secnidazole|secnidazole|mesh-list
5570123|NCT03935217|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5570124|NCT03935217|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5570125|NCT03935217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5570126|NCT03935295|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5570127|NCT03935295|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5570128|NCT03935295|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5570129|NCT03935295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5570130|NCT03935295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570131|NCT03935295|Cholinergic Agents|cholinergic agents|mesh-ancestor
5570132|NCT03935295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5570133|NCT03935295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570134|NCT03935295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5570135|NCT03935295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5570136|NCT03935074|Melphalan|melphalan|mesh-list
5570137|NCT03935074|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5570138|NCT03935074|Alkylating Agents|alkylating agents|mesh-ancestor
5570139|NCT03935074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570140|NCT03935074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5570141|NCT03935074|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5570142|NCT03935074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5570143|NCT03935074|Immunologic Factors|immunologic factors|mesh-ancestor
5570144|NCT03935074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570145|NCT03935347|Vidarabine|vidarabine|mesh-list
5570146|NCT03935347|Aldesleukin|aldesleukin|mesh-list
6206421|NCT02100228|Vitamins|vitamins|mesh-ancestor
6485877|NCT00567710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6485878|NCT00567710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485879|NCT00567710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485880|NCT00567710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6485881|NCT00567710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6485882|NCT00567710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6670131|NCT01541332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6173277|NCT01663532|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6173278|NCT01663532|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6173279|NCT01663532|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6173280|NCT01663623|Azathioprine|azathioprine|mesh-list
6173281|NCT01663623|Belimumab|belimumab|mesh-list
6173282|NCT01663623|Antimetabolites|antimetabolites|mesh-ancestor
6173283|NCT01663623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173284|NCT01663623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6173285|NCT01663623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6173286|NCT01663623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6173287|NCT01663623|Immunologic Factors|immunologic factors|mesh-ancestor
6173288|NCT01663623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173289|NCT01663623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6173290|NCT01663714|Tositumomab I-131|tositumomab i-131|mesh-list
6173291|NCT01663714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6173292|NCT01663727|Paclitaxel|paclitaxel|mesh-list
6173293|NCT01663727|Bevacizumab|bevacizumab|mesh-list
6173294|NCT01663727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6173295|NCT01663727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6173296|NCT01663727|Tubulin Modulators|tubulin modulators|mesh-ancestor
6173297|NCT01663727|Antimitotic Agents|antimitotic agents|mesh-ancestor
6173298|NCT01663727|Mitosis Modulators|mitosis modulators|mesh-ancestor
6173299|NCT01663727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173300|NCT01663727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6173301|NCT01663727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6173302|NCT01663727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6173303|NCT01663727|Growth Substances|growth substances|mesh-ancestor
6173304|NCT01663727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485883|NCT00567710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5570147|NCT03935347|Cyclophosphamide|cyclophosphamide|mesh-list
5570148|NCT03935347|Pembrolizumab|pembrolizumab|mesh-list
5570149|NCT03935347|Fludarabine|fludarabine|mesh-list
5570150|NCT03935347|Fludarabine phosphate|fludarabine phosphate|mesh-list
5570151|NCT03935347|Interleukin-2|interleukin-2|mesh-list
5570152|NCT03935347|Immunoglobulins|immunoglobulins|mesh-list
5570153|NCT03935347|Immunoglobulin G|immunoglobulin g|mesh-list
5570154|NCT03935347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5570155|NCT03935347|Immunologic Factors|immunologic factors|mesh-ancestor
5570156|NCT03935347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570157|NCT03935347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5570158|NCT03935347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5570159|NCT03935347|Alkylating Agents|alkylating agents|mesh-ancestor
5570160|NCT03935347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570161|NCT03935347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5570162|NCT03935347|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5570163|NCT03935347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5570164|NCT03935347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5570165|NCT03935347|Antimetabolites|antimetabolites|mesh-ancestor
5570166|NCT03935347|Antiviral Agents|antiviral agents|mesh-ancestor
5570167|NCT03935347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5570168|NCT03935347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5570169|NCT03935347|Analgesics|analgesics|mesh-ancestor
5570170|NCT03935347|Sensory System Agents|sensory system agents|mesh-ancestor
5570171|NCT03935347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5570172|NCT03935347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5570173|NCT03935347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5570174|NCT03935256|Paclitaxel|paclitaxel|mesh-list
5570175|NCT03935256|Carboplatin|carboplatin|mesh-list
5570176|NCT03935256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5570177|NCT03935256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5570178|NCT03935256|Tubulin Modulators|tubulin modulators|mesh-ancestor
6485884|NCT00567710|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6485885|NCT00567710|Dopamine Agents|dopamine agents|mesh-ancestor
6485886|NCT00567762|Tacrolimus|tacrolimus|mesh-list
6485887|NCT00567762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6485888|NCT00567762|Immunologic Factors|immunologic factors|mesh-ancestor
6485889|NCT00567762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485890|NCT00567762|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6485891|NCT00567762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6485892|NCT00567762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485893|NCT00567775|Insulin|insulin|mesh-list
6485894|NCT00567775|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6485895|NCT00567775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5570179|NCT03935256|Antimitotic Agents|antimitotic agents|mesh-ancestor
5570180|NCT03935256|Mitosis Modulators|mitosis modulators|mesh-ancestor
6173305|NCT01663727|Growth Inhibitors|growth inhibitors|mesh-ancestor
6173306|NCT01663740|Valganciclovir|valganciclovir|mesh-list
6485896|NCT00567775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485897|NCT00567788|Bimatoprost|bimatoprost|mesh-list
6485898|NCT00567788|Latanoprost|latanoprost|mesh-list
6173307|NCT01663740|Antiviral Agents|antiviral agents|mesh-ancestor
6173308|NCT01663740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6173309|NCT01663857|Gemcitabine|gemcitabine|mesh-list
6173310|NCT01663857|Carboplatin|carboplatin|mesh-list
6173311|NCT01663857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5570181|NCT03935256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570182|NCT03934567|Abexinostat|abexinostat|mesh-list
5570183|NCT03934567|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5570184|NCT03934567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5570185|NCT03934567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570186|NCT03934710|Serotonin|serotonin|mesh-list
6173312|NCT01663857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6173313|NCT01663857|Antimetabolites|antimetabolites|mesh-ancestor
6173314|NCT01663857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173315|NCT01663857|Antiviral Agents|antiviral agents|mesh-ancestor
6173316|NCT01663857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6173317|NCT01663857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6173318|NCT01663857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6173319|NCT01663857|Immunologic Factors|immunologic factors|mesh-ancestor
6173320|NCT01663857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173321|NCT01663935|Levodopa|levodopa|mesh-list
6670132|NCT01541332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6670133|NCT01541332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670134|NCT01541332|Immunologic Factors|immunologic factors|mesh-ancestor
6670135|NCT01541332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6670136|NCT01541332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6670137|NCT01541332|Growth Substances|growth substances|mesh-ancestor
6670138|NCT01541332|Growth Inhibitors|growth inhibitors|mesh-ancestor
6670139|NCT01541436|Capsaicin|capsaicin|mesh-list
6670140|NCT01541436|Antipruritics|antipruritics|mesh-ancestor
6670141|NCT01541436|Dermatologic Agents|dermatologic agents|mesh-ancestor
5570187|NCT03934710|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-list
6173322|NCT01663935|Carbidopa|carbidopa|mesh-list
6173323|NCT01663935|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6173324|NCT01663935|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6173325|NCT01663935|Dopamine Agents|dopamine agents|mesh-ancestor
6173326|NCT01663935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6173327|NCT01663935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173328|NCT01663935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173329|NCT01663935|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6173330|NCT01663935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6173331|NCT01663987|Bromides|bromides|mesh-list
6173332|NCT01663987|Tiotropium Bromide|tiotropium bromide|mesh-list
6173333|NCT01663987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6173334|NCT01663987|Autonomic Agents|autonomic agents|mesh-ancestor
6173335|NCT01663987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6173336|NCT01663987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173337|NCT01663987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6173338|NCT01663987|Respiratory System Agents|respiratory system agents|mesh-ancestor
6173339|NCT01663987|Parasympatholytics|parasympatholytics|mesh-ancestor
6173340|NCT01663987|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6173341|NCT01663987|Cholinergic Agents|cholinergic agents|mesh-ancestor
6173342|NCT01663987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6173343|NCT01663987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485899|NCT00567788|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6485900|NCT00567788|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6485901|NCT00567788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6485902|NCT00567814|Oxazepam|oxazepam|mesh-list
6485903|NCT00567814|Metyrapone|metyrapone|mesh-list
6485904|NCT00567814|Antimetabolites|antimetabolites|mesh-ancestor
6485905|NCT00567814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485906|NCT00567814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6485907|NCT00567814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6485908|NCT00567814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6485909|NCT00567814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485910|NCT00567814|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6485911|NCT00567814|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6485912|NCT00567814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6485913|NCT00567814|GABA Modulators|gaba modulators|mesh-ancestor
6485914|NCT00567814|GABA Agents|gaba agents|mesh-ancestor
6485915|NCT00567814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5570188|NCT03934710|Serotonin Agents|serotonin agents|mesh-ancestor
6670142|NCT01541436|Sensory System Agents|sensory system agents|mesh-ancestor
6670143|NCT01541436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6173344|NCT01663987|Anticonvulsants|anticonvulsants|mesh-ancestor
6173345|NCT01664039|Bimatoprost|bimatoprost|mesh-list
6173346|NCT01664039|Travoprost|travoprost|mesh-list
6173347|NCT01664039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6173348|NCT01664039|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6173349|NCT01664039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6173350|NCT01664247|Liraglutide|liraglutide|mesh-list
6173351|NCT01664247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6173352|NCT01664247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570189|NCT03934710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5570190|NCT03934710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570191|NCT03934710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570192|NCT03934450|Primaquine|primaquine|mesh-list
5570193|NCT03934450|Antimalarials|antimalarials|mesh-ancestor
5570194|NCT03934450|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5570195|NCT03934450|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5570196|NCT03934450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6173353|NCT01664247|Incretins|incretins|mesh-ancestor
6173354|NCT01664247|Hormones|hormones|mesh-ancestor
6173355|NCT01664247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6173356|NCT01664494|Capecitabine|capecitabine|mesh-list
6173357|NCT01664494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6173358|NCT01664494|Antimetabolites|antimetabolites|mesh-ancestor
6173359|NCT01664494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173360|NCT01664494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6173361|NCT01664533|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6173362|NCT01664533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6173363|NCT01664533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6173364|NCT01664533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6173365|NCT01664533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670144|NCT01541436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670145|NCT01541475|Dexetimide|dexetimide|mesh-list
6670146|NCT01541475|Citalopram|citalopram|mesh-list
6670147|NCT01541475|Bupropion|bupropion|mesh-list
6670148|NCT01541475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6670149|NCT01541475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6670150|NCT01541475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5570197|NCT03934411|Tramadol|tramadol|mesh-list
5570198|NCT03934411|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5570199|NCT03934411|Narcotics|narcotics|mesh-ancestor
5570200|NCT03934411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5570201|NCT03934411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570202|NCT03934411|Analgesics|analgesics|mesh-ancestor
5570203|NCT03934411|Sensory System Agents|sensory system agents|mesh-ancestor
5570204|NCT03934411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6485916|NCT00567866|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6485917|NCT00567866|Antidepressive Agents|antidepressive agents|mesh-ancestor
6485918|NCT00567866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5570205|NCT03934216|BMS-986165|bms-986165|mesh-list
5570206|NCT03934216|Dermatologic Agents|dermatologic agents|mesh-ancestor
5570207|NCT03934216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5570208|NCT03934216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5570209|NCT03934216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570210|NCT03934203|Moxifloxacin|moxifloxacin|mesh-list
5570211|NCT03934203|BI 409306|bi 409306|mesh-list
5570212|NCT03934203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6173366|NCT01664559|Ketorolac|ketorolac|mesh-list
6206422|NCT02100228|Micronutrients|micronutrients|mesh-ancestor
5570213|NCT03934203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6485919|NCT00567866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6485920|NCT00567866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6485921|NCT00567866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6485922|NCT00567866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485923|NCT00567918|Tacrolimus|tacrolimus|mesh-list
6485924|NCT00567918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6485925|NCT00567918|Immunologic Factors|immunologic factors|mesh-ancestor
6485926|NCT00567918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485927|NCT00567918|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6485928|NCT00567918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6485929|NCT00567918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485930|NCT00567931|Tryptophan|tryptophan|mesh-list
6485931|NCT00567931|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6485932|NCT00567931|Antidepressive Agents|antidepressive agents|mesh-ancestor
5604184|NCT05135910|Terbinafine|terbinafine|mesh-list
6670151|NCT01541475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173367|NCT01664559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6173368|NCT01664559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6173369|NCT01664559|Analgesics|analgesics|mesh-ancestor
6173370|NCT01664559|Sensory System Agents|sensory system agents|mesh-ancestor
6173371|NCT01664559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6173372|NCT01664559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173373|NCT01664559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6173374|NCT01664559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6173375|NCT01664559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6173376|NCT01664559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6173377|NCT01664559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173378|NCT01664624|Exenatide|exenatide|mesh-list
6173379|NCT01664624|Alogliptin|alogliptin|mesh-list
6173380|NCT01664624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6173381|NCT01664624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173382|NCT01664624|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6173383|NCT01664624|Incretins|incretins|mesh-ancestor
6173384|NCT01664624|Hormones|hormones|mesh-ancestor
6173385|NCT01664624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6173386|NCT01664624|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6173387|NCT01664624|Protease Inhibitors|protease inhibitors|mesh-ancestor
6173388|NCT01664624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6173389|NCT01664624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173390|NCT01664741|Nicotine|nicotine|mesh-list
6173391|NCT01664741|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6173392|NCT01664741|Autonomic Agents|autonomic agents|mesh-ancestor
6173393|NCT01664741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6173394|NCT01664741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173395|NCT01664741|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6173396|NCT01664741|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6173397|NCT01664741|Cholinergic Agents|cholinergic agents|mesh-ancestor
6173398|NCT01664741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6173399|NCT01664741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670152|NCT01541475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6670153|NCT01541475|Serotonin Agents|serotonin agents|mesh-ancestor
6670154|NCT01541475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670155|NCT01541475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6670156|NCT01541475|Antidepressive Agents|antidepressive agents|mesh-ancestor
6670157|NCT01541475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6670158|NCT01541475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6670159|NCT01541475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6670160|NCT01541475|Parasympatholytics|parasympatholytics|mesh-ancestor
6670161|NCT01541475|Autonomic Agents|autonomic agents|mesh-ancestor
5570214|NCT03934203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5570215|NCT03934203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5570216|NCT03934203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5570217|NCT03934203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570218|NCT03934203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5570219|NCT03934203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5570220|NCT03934047|Tranexamic Acid|tranexamic acid|mesh-list
5570221|NCT03934047|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5570222|NCT03934047|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5570223|NCT03934047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570224|NCT03934047|Hemostatics|hemostatics|mesh-ancestor
5570225|NCT03934047|Coagulants|coagulants|mesh-ancestor
5570226|NCT03934294|Metoclopramide|metoclopramide|mesh-list
5570227|NCT03934294|Antiemetics|antiemetics|mesh-ancestor
6670162|NCT01541475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6670163|NCT01541475|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6670164|NCT01541475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6670165|NCT01541475|Cholinergic Agents|cholinergic agents|mesh-ancestor
6670166|NCT01541475|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5570228|NCT03934294|Autonomic Agents|autonomic agents|mesh-ancestor
5570229|NCT03934294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5570230|NCT03934294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570231|NCT03934294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5570232|NCT03934294|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5570233|NCT03934294|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5570234|NCT03934294|Dopamine Agents|dopamine agents|mesh-ancestor
5570235|NCT03934294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5570236|NCT03934294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570237|NCT03933956|Empagliflozin|empagliflozin|mesh-list
5604185|NCT05135910|Antifungal Agents|antifungal agents|mesh-ancestor
6670167|NCT01541475|Dopamine Agents|dopamine agents|mesh-ancestor
6670168|NCT01541475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6670169|NCT01541475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6670170|NCT01541475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6670171|NCT01541605|Methylphenidate|methylphenidate|mesh-list
6670172|NCT01541605|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6670173|NCT01541605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670174|NCT01541605|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6173400|NCT01664793|Vaccines|vaccines|mesh-list
6173401|NCT01664793|Immunologic Factors|immunologic factors|mesh-ancestor
5570238|NCT03933956|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5570239|NCT03933956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570240|NCT03933956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5570241|NCT03933956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604186|NCT05135910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5604187|NCT05135910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5604188|NCT05135910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604189|NCT05123703|Ocrelizumab|ocrelizumab|mesh-list
5604190|NCT05123703|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
5604191|NCT05123703|Immunologic Factors|immunologic factors|mesh-ancestor
5604192|NCT05123703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604193|NCT05123703|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5604194|NCT05123703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604195|NCT05123703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5604196|NCT05121714|Fluvoxamine|fluvoxamine|mesh-list
5604197|NCT05121714|Caffeine|caffeine|mesh-list
5604198|NCT05121714|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5604199|NCT05121714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604200|NCT05121714|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5604201|NCT05121714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5604202|NCT05121714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604203|NCT05121714|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5604204|NCT05121714|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5604205|NCT05121714|Purinergic Agents|purinergic agents|mesh-ancestor
5604206|NCT05121714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6173402|NCT01664793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173403|NCT01664858|Calcium|calcium|mesh-list
6173404|NCT01664858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6173405|NCT01664858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173406|NCT01664897|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6173407|NCT01664897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6173408|NCT01664897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6173409|NCT01664897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6173410|NCT01664897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173411|NCT01664923|Bicalutamide|bicalutamide|mesh-list
6173412|NCT01664923|Androgen Antagonists|androgen antagonists|mesh-ancestor
6173413|NCT01664923|Hormone Antagonists|hormone antagonists|mesh-ancestor
6173414|NCT01664923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6173415|NCT01664923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173416|NCT01664923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6173417|NCT01664949|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6173418|NCT01664949|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6173419|NCT01664949|Lubricant Eye Drops|lubricant eye drops|mesh-list
6173420|NCT01664949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6173421|NCT01664949|Laxatives|laxatives|mesh-ancestor
6173422|NCT01664949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6173423|NCT01665508|Nebivolol|nebivolol|mesh-list
6173424|NCT01665508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6173425|NCT01665508|Vasodilator Agents|vasodilator agents|mesh-ancestor
6173426|NCT01665508|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6173427|NCT01665508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6173428|NCT01665508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6173429|NCT01665508|Adrenergic Agents|adrenergic agents|mesh-ancestor
6173430|NCT01665508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6173431|NCT01665508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173432|NCT01665508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173433|NCT01665599|Testosterone|testosterone|mesh-list
6173434|NCT01665599|Androgens|androgens|mesh-ancestor
6173435|NCT01665599|Hormones|hormones|mesh-ancestor
6173436|NCT01665599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6173437|NCT01665599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173438|NCT01665768|Rituximab|rituximab|mesh-list
6173439|NCT01665768|Everolimus|everolimus|mesh-list
5570242|NCT03934333|Budesonide|budesonide|mesh-list
5570243|NCT03934333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5570244|NCT03934333|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6173440|NCT01665768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6173441|NCT01665768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6173442|NCT01665768|Immunologic Factors|immunologic factors|mesh-ancestor
6173443|NCT01665768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173444|NCT01665768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6173445|NCT01665768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6173446|NCT01665911|Listerine|listerine|mesh-list
6173447|NCT01665911|Fluorides|fluorides|mesh-list
6173448|NCT01665911|Sodium Fluoride|sodium fluoride|mesh-list
6173449|NCT01665911|Cariostatic Agents|cariostatic agents|mesh-ancestor
6173450|NCT01665911|Protective Agents|protective agents|mesh-ancestor
6173451|NCT01665911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173452|NCT01665911|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6173453|NCT01665911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6173454|NCT01665950|Simvastatin|simvastatin|mesh-list
6173455|NCT01665950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6173456|NCT01665950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6173457|NCT01665950|Antimetabolites|antimetabolites|mesh-ancestor
6173458|NCT01665950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173459|NCT01665950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6173460|NCT01665950|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6173461|NCT01665950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6173462|NCT01666119|Buprenorphine|buprenorphine|mesh-list
6173463|NCT01666119|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6173464|NCT01666119|Narcotics|narcotics|mesh-ancestor
6173465|NCT01666119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6173466|NCT01666119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173467|NCT01666119|Analgesics|analgesics|mesh-ancestor
6173468|NCT01666119|Sensory System Agents|sensory system agents|mesh-ancestor
6173469|NCT01666119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6173470|NCT01666119|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6173471|NCT01666197|Diclofenac|diclofenac|mesh-list
6173472|NCT01666197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6173473|NCT01666197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6173474|NCT01666197|Analgesics|analgesics|mesh-ancestor
6173475|NCT01666197|Sensory System Agents|sensory system agents|mesh-ancestor
6173476|NCT01666197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6173477|NCT01666197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173478|NCT01666197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6173479|NCT01666197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6173480|NCT01666197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6173481|NCT01666197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6173482|NCT01666197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570245|NCT03934333|Autonomic Agents|autonomic agents|mesh-ancestor
5570246|NCT03934333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5570247|NCT03934333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570248|NCT03934333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5570249|NCT03934333|Respiratory System Agents|respiratory system agents|mesh-ancestor
5570250|NCT03934333|Glucocorticoids|glucocorticoids|mesh-ancestor
5570251|NCT03934333|Hormones|hormones|mesh-ancestor
5570252|NCT03934333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5570253|NCT03933982|Vinorelbine|vinorelbine|mesh-list
5570254|NCT03933982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5570255|NCT03933982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5570256|NCT03933982|Tubulin Modulators|tubulin modulators|mesh-ancestor
6173483|NCT01666210|Dexamethasone|dexamethasone|mesh-list
6173484|NCT01666210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6173485|NCT01666210|Antiemetics|antiemetics|mesh-ancestor
6173486|NCT01666210|Autonomic Agents|autonomic agents|mesh-ancestor
6173487|NCT01666210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6173488|NCT01666210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173489|NCT01666210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6173490|NCT01666210|Glucocorticoids|glucocorticoids|mesh-ancestor
6173491|NCT01666210|Hormones|hormones|mesh-ancestor
6173492|NCT01666210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6173493|NCT01666210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6670175|NCT01541605|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6670176|NCT01541605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6670177|NCT01541605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173494|NCT01666210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6173495|NCT01666314|Prednisone|prednisone|mesh-list
5570257|NCT03933982|Antimitotic Agents|antimitotic agents|mesh-ancestor
5570258|NCT03933982|Mitosis Modulators|mitosis modulators|mesh-ancestor
5570259|NCT03933982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570260|NCT03933865|Ketamine|ketamine|mesh-list
6173496|NCT01666314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6173497|NCT01666314|Glucocorticoids|glucocorticoids|mesh-ancestor
6173498|NCT01666314|Hormones|hormones|mesh-ancestor
6173499|NCT01666314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6173500|NCT01666314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173501|NCT01666314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6173502|NCT01666314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6173503|NCT01666444|Doxorubicin|doxorubicin|mesh-list
6173504|NCT01666444|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6173505|NCT01666444|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6173506|NCT01666444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6173507|NCT01666444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6173508|NCT01666444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6173509|NCT01666444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6173510|NCT01666444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173511|NCT01666652|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6173512|NCT01666652|Aluminum sulfate|aluminum sulfate|mesh-list
6485933|NCT00567931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6485934|NCT00567957|Remifentanil|remifentanil|mesh-list
6485935|NCT00567957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6485936|NCT00567957|Narcotics|narcotics|mesh-ancestor
6485937|NCT00567957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6485938|NCT00567957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485939|NCT00567957|Analgesics|analgesics|mesh-ancestor
6485940|NCT00567957|Sensory System Agents|sensory system agents|mesh-ancestor
6485941|NCT00567957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6485942|NCT00567983|Cyclosporine|cyclosporine|mesh-list
6485943|NCT00567983|Cyclosporins|cyclosporins|mesh-list
6670178|NCT01541605|Dopamine Agents|dopamine agents|mesh-ancestor
6670179|NCT01541605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6670180|NCT01541631|Albendazole|albendazole|mesh-list
6670181|NCT01541631|Praziquantel|praziquantel|mesh-list
6670182|NCT01541631|Anthelmintics|anthelmintics|mesh-ancestor
6670183|NCT01541631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6670184|NCT01541631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6670185|NCT01541631|Anticestodal Agents|anticestodal agents|mesh-ancestor
5570261|NCT03933865|Hydromorphone|hydromorphone|mesh-list
5570262|NCT03933865|Analgesics|analgesics|mesh-ancestor
5570263|NCT03933865|Sensory System Agents|sensory system agents|mesh-ancestor
5570264|NCT03933865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5570265|NCT03933865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570266|NCT03933865|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5570267|NCT03933865|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6670186|NCT01541631|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6670187|NCT01541631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6670188|NCT01541631|Tubulin Modulators|tubulin modulators|mesh-ancestor
6485944|NCT00567983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6485945|NCT00567983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570268|NCT03933865|Anesthetics, General|anesthetics, general|mesh-ancestor
6173513|NCT01666652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6173514|NCT01666652|Immunologic Factors|immunologic factors|mesh-ancestor
6173515|NCT01666652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173516|NCT01666652|Antacids|antacids|mesh-ancestor
6173517|NCT01666652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173518|NCT01666652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6173519|NCT01666730|Leucovorin|leucovorin|mesh-list
6173520|NCT01666730|Metformin|metformin|mesh-list
6173521|NCT01666730|Fluorouracil|fluorouracil|mesh-list
6173522|NCT01666730|Oxaliplatin|oxaliplatin|mesh-list
6173523|NCT01666730|Calcium|calcium|mesh-list
6173524|NCT01666730|Levoleucovorin|levoleucovorin|mesh-list
6173525|NCT01666730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6173526|NCT01666730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173527|NCT01666730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6173528|NCT01666730|Antimetabolites|antimetabolites|mesh-ancestor
6173529|NCT01666730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173530|NCT01666730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6173531|NCT01666730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6173532|NCT01666730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6173533|NCT01666730|Immunologic Factors|immunologic factors|mesh-ancestor
6173534|NCT01666730|Antidotes|antidotes|mesh-ancestor
6173535|NCT01666730|Protective Agents|protective agents|mesh-ancestor
6670189|NCT01541631|Antimitotic Agents|antimitotic agents|mesh-ancestor
6670190|NCT01541631|Mitosis Modulators|mitosis modulators|mesh-ancestor
5570269|NCT03933865|Anesthetics|anesthetics|mesh-ancestor
5570270|NCT03933865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5570271|NCT03933865|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5570272|NCT03933865|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5570273|NCT03933865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5570274|NCT03933865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570275|NCT03933865|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5570276|NCT03933865|Narcotics|narcotics|mesh-ancestor
5570277|NCT03933631|Ofloxacin|ofloxacin|mesh-list
5570278|NCT03933631|Prednisolone|prednisolone|mesh-list
5570279|NCT03933631|Prednisolone acetate|prednisolone acetate|mesh-list
5570280|NCT03933631|Pilocarpine|pilocarpine|mesh-list
6173536|NCT01666730|Vitamin B Complex|vitamin b complex|mesh-ancestor
6173537|NCT01666730|Vitamins|vitamins|mesh-ancestor
6173538|NCT01666730|Micronutrients|micronutrients|mesh-ancestor
6173539|NCT01666782|Vaccines|vaccines|mesh-list
6173540|NCT01666782|Immunologic Factors|immunologic factors|mesh-ancestor
5570281|NCT03933631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5570282|NCT03933631|Glucocorticoids|glucocorticoids|mesh-ancestor
5570283|NCT03933631|Hormones|hormones|mesh-ancestor
5570284|NCT03933631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5570285|NCT03933631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570286|NCT03933631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5570287|NCT03933631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5570288|NCT03933631|Autonomic Agents|autonomic agents|mesh-ancestor
6173541|NCT01666782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173542|NCT01666912|Contraceptive Agents|contraceptive agents|mesh-list
6173543|NCT01666912|Etonogestrel|etonogestrel|mesh-list
6173544|NCT01666912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6173545|NCT01666912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173546|NCT01666912|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6173547|NCT01666912|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6206423|NCT02100228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206424|NCT02100228|Anticoagulants|anticoagulants|mesh-ancestor
5570289|NCT03933631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5570290|NCT03933631|Miotics|miotics|mesh-ancestor
5570291|NCT03933631|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
5570292|NCT03933631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5570293|NCT03933631|Cholinergic Agents|cholinergic agents|mesh-ancestor
5570294|NCT03933631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5570295|NCT03933631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570296|NCT03933631|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5570297|NCT03933631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5570298|NCT03933631|Renal Agents|renal agents|mesh-ancestor
5570299|NCT03933631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5570300|NCT03933631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5570301|NCT03933631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6206425|NCT02100228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6206426|NCT02100228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6206427|NCT02100228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670191|NCT01541631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670192|NCT01541631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6670193|NCT01541670|Antibodies|antibodies|mesh-list
6670194|NCT01541670|Immunologic Factors|immunologic factors|mesh-ancestor
6670195|NCT01541670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670196|NCT01541683|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6670197|NCT01541709|Imatinib Mesylate|imatinib mesylate|mesh-list
6670198|NCT01541709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6670199|NCT01541709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6670200|NCT01541709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6670201|NCT01541709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670202|NCT01541904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6670203|NCT01541904|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6670204|NCT01541943|Losartan|losartan|mesh-list
6670205|NCT01541943|Atorvastatin|atorvastatin|mesh-list
6670206|NCT01541943|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6670207|NCT01541943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6670208|NCT01541943|Antimetabolites|antimetabolites|mesh-ancestor
6670209|NCT01541943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670210|NCT01541943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6670211|NCT01541943|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6670212|NCT01541943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6670213|NCT01541943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6206428|NCT02100228|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6670214|NCT01541943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6670215|NCT01541943|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6670216|NCT01541943|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6173548|NCT01666951|Tacrolimus|tacrolimus|mesh-list
6173549|NCT01666951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6173550|NCT01666951|Immunologic Factors|immunologic factors|mesh-ancestor
6173551|NCT01666951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173552|NCT01666951|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6173553|NCT01666951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6173554|NCT01666951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173555|NCT01667029|Sulfasalazine|sulfasalazine|mesh-list
6173556|NCT01667029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6173557|NCT01667029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6173558|NCT01667029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6173559|NCT01667029|Analgesics|analgesics|mesh-ancestor
6173560|NCT01667029|Sensory System Agents|sensory system agents|mesh-ancestor
6173561|NCT01667029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6173562|NCT01667029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173563|NCT01667029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6173564|NCT01667029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5570302|NCT03933631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5570303|NCT03933631|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5570304|NCT03933631|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5570305|NCT03933787|Saxagliptin|saxagliptin|mesh-list
6173565|NCT01667029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6173566|NCT01667107|Posaconazole|posaconazole|mesh-list
6173567|NCT01667107|Antifungal Agents|antifungal agents|mesh-ancestor
6173568|NCT01667107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6173569|NCT01667107|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6173570|NCT01667107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6173571|NCT01667107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6173572|NCT01667107|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6173573|NCT01667107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6173574|NCT01667107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6173575|NCT01667107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173576|NCT01667107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6173577|NCT01667107|Hormone Antagonists|hormone antagonists|mesh-ancestor
6173578|NCT01667107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6173579|NCT01667107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173580|NCT01667419|Vemurafenib|vemurafenib|mesh-list
6173581|NCT01667419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6173582|NCT01667419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6173583|NCT01667419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6173584|NCT01667419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173585|NCT01667432|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6173586|NCT01667432|Antiviral Agents|antiviral agents|mesh-ancestor
6173587|NCT01667432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6173588|NCT01667562|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6173589|NCT01667562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6173590|NCT01667562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6173591|NCT01667562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6173592|NCT01667562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173593|NCT01667679|Sumatriptan|sumatriptan|mesh-list
6173594|NCT01667679|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6173595|NCT01667679|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6173596|NCT01667679|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6173597|NCT01667679|Serotonin Agents|serotonin agents|mesh-ancestor
6173598|NCT01667679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6173599|NCT01667679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173600|NCT01667679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173601|NCT01667731|Sofosbuvir|sofosbuvir|mesh-list
6173602|NCT01667731|Antiviral Agents|antiviral agents|mesh-ancestor
6173603|NCT01667731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6173604|NCT01667796|Vitamin D|vitamin d|mesh-list
6173605|NCT01667796|Cholecalciferol|cholecalciferol|mesh-list
6173606|NCT01667796|Vitamins|vitamins|mesh-ancestor
6173607|NCT01667796|Micronutrients|micronutrients|mesh-ancestor
6173608|NCT01667796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173609|NCT01667796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6173610|NCT01667796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6173611|NCT01667900|Dulaglutide|dulaglutide|mesh-list
6173612|NCT01667900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6206429|NCT02100228|Antithrombins|antithrombins|mesh-ancestor
6670217|NCT01541956|Metformin|metformin|mesh-list
6173613|NCT01667900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173614|NCT01667926|Ketamine|ketamine|mesh-list
6173615|NCT01667926|Analgesics|analgesics|mesh-ancestor
6173616|NCT01667926|Sensory System Agents|sensory system agents|mesh-ancestor
6173617|NCT01667926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6173618|NCT01667926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173619|NCT01667926|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6173620|NCT01667926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6173621|NCT01667926|Anesthetics, General|anesthetics, general|mesh-ancestor
6173622|NCT01667926|Anesthetics|anesthetics|mesh-ancestor
6173623|NCT01667926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6173624|NCT01667926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6173625|NCT01667926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6173626|NCT01667926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6173627|NCT01667926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173628|NCT01667978|Ritonavir|ritonavir|mesh-list
6173629|NCT01667978|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6173630|NCT01667978|Norethindrone|norethindrone|mesh-list
6173631|NCT01667978|Norethindrone Acetate|norethindrone acetate|mesh-list
6173632|NCT01667978|Protease Inhibitors|protease inhibitors|mesh-list
6173633|NCT01667978|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6173634|NCT01667978|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6173635|NCT01667978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6173636|NCT01667978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173637|NCT01667978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6173638|NCT01667978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6173639|NCT01667978|Antiviral Agents|antiviral agents|mesh-ancestor
6173640|NCT01667978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6173641|NCT01667978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6173642|NCT01667978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6173643|NCT01667978|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6173644|NCT01667978|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6173645|NCT01667978|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6173646|NCT01667978|Contraceptive Agents|contraceptive agents|mesh-ancestor
6173647|NCT01667978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6173648|NCT01667978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173649|NCT01667978|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6173650|NCT01667978|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6173651|NCT01668004|Golimumab|golimumab|mesh-list
6173652|NCT01668004|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6173653|NCT01668004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6173654|NCT01668004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6173655|NCT01668004|Immunologic Factors|immunologic factors|mesh-ancestor
6173656|NCT01668004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173657|NCT01668017|Niacinamide|niacinamide|mesh-list
6173658|NCT01668017|Vitamin B Complex|vitamin b complex|mesh-ancestor
6173659|NCT01668017|Vitamins|vitamins|mesh-ancestor
6173660|NCT01668017|Micronutrients|micronutrients|mesh-ancestor
6173661|NCT01668017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173662|NCT01668030|Bacitracin|bacitracin|mesh-list
6173663|NCT01668030|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6173664|NCT01668030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6173665|NCT01668030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6173666|NCT01668654|Ezogabine|ezogabine|mesh-list
6173667|NCT01668654|Anticonvulsants|anticonvulsants|mesh-ancestor
6173668|NCT01668654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6173669|NCT01668654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173670|NCT01668667|Gabapentin|gabapentin|mesh-list
6173671|NCT01668667|Analgesics|analgesics|mesh-ancestor
6173672|NCT01668667|Sensory System Agents|sensory system agents|mesh-ancestor
6173673|NCT01668667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6173674|NCT01668667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173675|NCT01668667|Anticonvulsants|anticonvulsants|mesh-ancestor
6173676|NCT01668667|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5570306|NCT03933787|Incretins|incretins|mesh-ancestor
5570307|NCT03933787|Hormones|hormones|mesh-ancestor
5570308|NCT03933787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5570309|NCT03933787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570310|NCT03933787|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5570311|NCT03933787|Protease Inhibitors|protease inhibitors|mesh-ancestor
5570312|NCT03933787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5570313|NCT03933787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570314|NCT03933787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5570315|NCT03933748|Teicoplanin|teicoplanin|mesh-list
5570316|NCT03933748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6173677|NCT01668667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6670218|NCT01541956|Vildagliptin|vildagliptin|mesh-list
6670219|NCT01541956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6670220|NCT01541956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173678|NCT01668667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6173679|NCT01668667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6173680|NCT01668667|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6173681|NCT01668667|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6173682|NCT01668667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6173683|NCT01668667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173684|NCT01668667|Antimanic Agents|antimanic agents|mesh-ancestor
6485946|NCT00567983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6485947|NCT00567983|Immunologic Factors|immunologic factors|mesh-ancestor
6485948|NCT00567983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485949|NCT00567983|Antifungal Agents|antifungal agents|mesh-ancestor
6485950|NCT00567983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6485951|NCT00567983|Dermatologic Agents|dermatologic agents|mesh-ancestor
6173685|NCT01668719|Dexamethasone|dexamethasone|mesh-list
6173686|NCT01668719|Dexamethasone acetate|dexamethasone acetate|mesh-list
6173687|NCT01668719|Lenalidomide|lenalidomide|mesh-list
6173688|NCT01668719|Bortezomib|bortezomib|mesh-list
6173689|NCT01668719|Elotuzumab|elotuzumab|mesh-list
6173690|NCT01668719|Ichthammol|ichthammol|mesh-list
6173691|NCT01668719|BB 1101|bb 1101|mesh-list
6173692|NCT01668719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6173693|NCT01668719|Antiemetics|antiemetics|mesh-ancestor
6173694|NCT01668719|Autonomic Agents|autonomic agents|mesh-ancestor
6173695|NCT01668719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6173696|NCT01668719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173697|NCT01668719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6173698|NCT01668719|Glucocorticoids|glucocorticoids|mesh-ancestor
6173699|NCT01668719|Hormones|hormones|mesh-ancestor
6173700|NCT01668719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6173701|NCT01668719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6173702|NCT01668719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6173703|NCT01668719|Immunologic Factors|immunologic factors|mesh-ancestor
6173704|NCT01668719|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6173705|NCT01668719|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6173706|NCT01668719|Growth Substances|growth substances|mesh-ancestor
6173707|NCT01668719|Growth Inhibitors|growth inhibitors|mesh-ancestor
6173708|NCT01668719|Protease Inhibitors|protease inhibitors|mesh-ancestor
6173709|NCT01668719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6173710|NCT01668719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173711|NCT01668719|Dermatologic Agents|dermatologic agents|mesh-ancestor
6173712|NCT01668784|Nivolumab|nivolumab|mesh-list
6173713|NCT01668784|Everolimus|everolimus|mesh-list
6173714|NCT01668784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6173715|NCT01668784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6173716|NCT01668784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6173717|NCT01668784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173718|NCT01668784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6173719|NCT01668784|Immunologic Factors|immunologic factors|mesh-ancestor
6173720|NCT01668784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173721|NCT01668797|Brexpiprazole|brexpiprazole|mesh-list
6173722|NCT01668797|Serotonin Agents|serotonin agents|mesh-ancestor
6173723|NCT01668797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6173724|NCT01668797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173725|NCT01668797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485952|NCT00567983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5570317|NCT03933748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5570318|NCT03933501|Amoxicillin|amoxicillin|mesh-list
5570319|NCT03933501|Metronidazole|metronidazole|mesh-list
5570320|NCT03933501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5570321|NCT03933501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6485953|NCT00567983|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6489000|NCT00588523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489001|NCT00588523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6489002|NCT00588835|Dexamethasone|dexamethasone|mesh-list
6489003|NCT00588835|Ondansetron|ondansetron|mesh-list
6489004|NCT00588835|Aprepitant|aprepitant|mesh-list
6489005|NCT00588835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6489006|NCT00588835|Antiemetics|antiemetics|mesh-ancestor
6489007|NCT00588835|Autonomic Agents|autonomic agents|mesh-ancestor
6670221|NCT01541956|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6670222|NCT01541956|Protease Inhibitors|protease inhibitors|mesh-ancestor
6670223|NCT01541956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5570322|NCT03933501|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5570323|NCT03933501|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5570324|NCT03933397|Morphine|morphine|mesh-list
6173726|NCT01668797|Dopamine Agonists|dopamine agonists|mesh-ancestor
6173727|NCT01668797|Dopamine Agents|dopamine agents|mesh-ancestor
6173728|NCT01668836|Resveratrol|resveratrol|mesh-list
6173729|NCT01668836|Antioxidants|antioxidants|mesh-ancestor
6173730|NCT01668836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173731|NCT01668836|Protective Agents|protective agents|mesh-ancestor
6173732|NCT01668836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173733|NCT01668836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6173734|NCT01668836|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6173735|NCT01669122|Nicotine|nicotine|mesh-list
6173736|NCT01669122|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6173737|NCT01669122|Autonomic Agents|autonomic agents|mesh-ancestor
6173738|NCT01669122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6173739|NCT01669122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173740|NCT01669122|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6173741|NCT01669122|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6173742|NCT01669122|Cholinergic Agents|cholinergic agents|mesh-ancestor
6173743|NCT01669122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6173744|NCT01669122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173745|NCT01669343|Letrozole|letrozole|mesh-list
6173746|NCT01669343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5570325|NCT03933397|Hydromorphone|hydromorphone|mesh-list
5570326|NCT03933397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6173747|NCT01669343|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6173748|NCT01669343|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6173749|NCT01669343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6173750|NCT01669343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173751|NCT01669343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6173752|NCT01669343|Hormone Antagonists|hormone antagonists|mesh-ancestor
6173753|NCT01669343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6173754|NCT01669343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173755|NCT01669421|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
6173756|NCT01669421|Protein C Inhibitor|protein c inhibitor|mesh-list
6173757|NCT01669421|Protease Inhibitors|protease inhibitors|mesh-list
6173758|NCT01669421|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6173759|NCT01669421|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6173760|NCT01669421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6173761|NCT01669421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173762|NCT01669434|Ramipril|ramipril|mesh-list
6173763|NCT01669434|Enalapril|enalapril|mesh-list
6173764|NCT01669434|Enalaprilat|enalaprilat|mesh-list
6173765|NCT01669434|Lisinopril|lisinopril|mesh-list
6173766|NCT01669434|Perindopril|perindopril|mesh-list
6173767|NCT01669434|Benazepril|benazepril|mesh-list
6173768|NCT01669434|Captopril|captopril|mesh-list
6173769|NCT01669434|Quinapril|quinapril|mesh-list
6173770|NCT01669434|Trandolapril|trandolapril|mesh-list
6173771|NCT01669434|Fosinopril|fosinopril|mesh-list
6173772|NCT01669434|Moexipril|moexipril|mesh-list
6173773|NCT01669434|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6173774|NCT01669434|Protease Inhibitors|protease inhibitors|mesh-ancestor
6173775|NCT01669434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6173776|NCT01669434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173777|NCT01669434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6173778|NCT01669434|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6173779|NCT01669434|Protective Agents|protective agents|mesh-ancestor
6173780|NCT01669434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173781|NCT01669538|Galantamine|galantamine|mesh-list
6173782|NCT01669538|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6173783|NCT01669538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6173784|NCT01669538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173785|NCT01669538|Cholinergic Agents|cholinergic agents|mesh-ancestor
6173786|NCT01669538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6173787|NCT01669538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173788|NCT01669538|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6173789|NCT01669538|Autonomic Agents|autonomic agents|mesh-ancestor
6173790|NCT01669538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6485954|NCT00568048|Bevacizumab|bevacizumab|mesh-list
6485955|NCT00568048|Temozolomide|temozolomide|mesh-list
6485956|NCT00568048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6485957|NCT00568048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6485958|NCT00568048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6485959|NCT00568048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6485960|NCT00568048|Growth Substances|growth substances|mesh-ancestor
6485961|NCT00568048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485962|NCT00568048|Growth Inhibitors|growth inhibitors|mesh-ancestor
6485963|NCT00568048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6485964|NCT00568048|Alkylating Agents|alkylating agents|mesh-ancestor
6485965|NCT00568048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485966|NCT00568074|Repaglinide|repaglinide|mesh-list
6485967|NCT00568074|Acarbose|acarbose|mesh-list
6485968|NCT00568074|Gliquidone|gliquidone|mesh-list
6485969|NCT00568074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6485970|NCT00568074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6485971|NCT00568074|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6485972|NCT00568074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5570327|NCT03933397|Narcotics|narcotics|mesh-ancestor
5570328|NCT03933397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5570329|NCT03933397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570330|NCT03933397|Analgesics|analgesics|mesh-ancestor
5570331|NCT03933397|Sensory System Agents|sensory system agents|mesh-ancestor
5570332|NCT03933397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5570333|NCT03933280|Dexmedetomidine|dexmedetomidine|mesh-list
5570334|NCT03933280|Nalbuphine|nalbuphine|mesh-list
5570335|NCT03933280|Propofol|propofol|mesh-list
5570336|NCT03933280|Benoxinate|benoxinate|mesh-list
5570337|NCT03933280|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5570338|NCT03933280|Anesthetics|anesthetics|mesh-ancestor
5570339|NCT03933280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5570340|NCT03933280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570341|NCT03933280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5570342|NCT03933280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6173791|NCT01669538|Nootropic Agents|nootropic agents|mesh-ancestor
6173792|NCT01669642|Ketamine|ketamine|mesh-list
6173793|NCT01669642|Analgesics|analgesics|mesh-ancestor
6173794|NCT01669642|Sensory System Agents|sensory system agents|mesh-ancestor
6173795|NCT01669642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6173796|NCT01669642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173797|NCT01669642|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6173798|NCT01669642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6173799|NCT01669642|Anesthetics, General|anesthetics, general|mesh-ancestor
6173800|NCT01669642|Anesthetics|anesthetics|mesh-ancestor
6173801|NCT01669642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6173802|NCT01669642|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6173803|NCT01669642|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6173804|NCT01669642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6173805|NCT01669642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173806|NCT01669720|Aflibercept|aflibercept|mesh-list
6173807|NCT01669720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6173808|NCT01669720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6173809|NCT01669720|Growth Substances|growth substances|mesh-ancestor
6173810|NCT01669720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173811|NCT01669720|Growth Inhibitors|growth inhibitors|mesh-ancestor
6173812|NCT01669720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6173813|NCT01669785|Listerine|listerine|mesh-list
6173814|NCT01669785|Fluorides|fluorides|mesh-list
6173815|NCT01669785|Sodium Fluoride|sodium fluoride|mesh-list
6173816|NCT01669785|Cariostatic Agents|cariostatic agents|mesh-ancestor
6173817|NCT01669785|Protective Agents|protective agents|mesh-ancestor
6173818|NCT01669785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173819|NCT01669785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6173820|NCT01669785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6173821|NCT01669798|Nintedanib|nintedanib|mesh-list
6173822|NCT01669798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6173823|NCT01669798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6173824|NCT01669798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6485973|NCT00568074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485974|NCT00568113|Acetylcysteine|acetylcysteine|mesh-list
5570343|NCT03933280|Anesthetics, General|anesthetics, general|mesh-ancestor
5570344|NCT03933280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5570345|NCT03933280|Analgesics|analgesics|mesh-ancestor
5570346|NCT03933280|Sensory System Agents|sensory system agents|mesh-ancestor
5570347|NCT03933280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5570348|NCT03933280|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5570349|NCT03933280|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5570350|NCT03933280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5570351|NCT03933280|Adrenergic Agents|adrenergic agents|mesh-ancestor
5570352|NCT03933280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6173825|NCT01669798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173826|NCT01669811|Esomeprazole|esomeprazole|mesh-list
6173827|NCT01669811|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6173828|NCT01669811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6173829|NCT01669811|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6173830|NCT01669811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6173831|NCT01669811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173832|NCT01669928|Antihypertensive Agents|antihypertensive agents|mesh-list
6485975|NCT00568113|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6485976|NCT00568113|Antiviral Agents|antiviral agents|mesh-ancestor
6485977|NCT00568113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6485978|NCT00568113|Expectorants|expectorants|mesh-ancestor
6485979|NCT00568113|Respiratory System Agents|respiratory system agents|mesh-ancestor
6485980|NCT00568113|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6485981|NCT00568113|Antioxidants|antioxidants|mesh-ancestor
6173833|NCT01669928|Calcium Channel Blockers|calcium channel blockers|mesh-list
6173834|NCT01669928|Angiotensin II|angiotensin ii|mesh-list
6173835|NCT01669928|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6173836|NCT01669928|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
6485982|NCT00568113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485983|NCT00568113|Protective Agents|protective agents|mesh-ancestor
6485984|NCT00568113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173837|NCT01669928|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6173838|NCT01669928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173839|NCT01669928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173840|NCT01669928|Protease Inhibitors|protease inhibitors|mesh-ancestor
6173841|NCT01669928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6173842|NCT01669928|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6173843|NCT01669928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6173844|NCT01670019|Asenapine|asenapine|mesh-list
6173845|NCT01670019|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6485985|NCT00568113|Antidotes|antidotes|mesh-ancestor
6485986|NCT00568152|Aspirin|aspirin|mesh-list
6485987|NCT00568152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6485988|NCT00568152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6485989|NCT00568152|Analgesics|analgesics|mesh-ancestor
6485990|NCT00568152|Sensory System Agents|sensory system agents|mesh-ancestor
6485991|NCT00568152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6485992|NCT00568152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173846|NCT01670019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6173847|NCT01670019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6173848|NCT01670019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570353|NCT03933280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570354|NCT03933280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5570355|NCT03933280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5570356|NCT03933280|Narcotics|narcotics|mesh-ancestor
5570357|NCT03933280|Anesthetics, Local|anesthetics, local|mesh-ancestor
5570358|NCT03933605|Midazolam|midazolam|mesh-list
5570359|NCT03933605|Palonosetron|palonosetron|mesh-list
5570360|NCT03933605|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5570361|NCT03933605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5570362|NCT03933605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5570363|NCT03933605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570364|NCT03933605|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5570365|NCT03933605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5570366|NCT03933605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5570367|NCT03933605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6173849|NCT01670019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6173850|NCT01670097|Dexamethasone|dexamethasone|mesh-list
6173851|NCT01670097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6173852|NCT01670097|Antiemetics|antiemetics|mesh-ancestor
6485993|NCT00568152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5570368|NCT03933605|Anesthetics, General|anesthetics, general|mesh-ancestor
5570369|NCT03933605|Anesthetics|anesthetics|mesh-ancestor
5570370|NCT03933605|GABA Modulators|gaba modulators|mesh-ancestor
5570371|NCT03933605|GABA Agents|gaba agents|mesh-ancestor
5570372|NCT03933605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6173853|NCT01670097|Autonomic Agents|autonomic agents|mesh-ancestor
6173854|NCT01670097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6173855|NCT01670097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173856|NCT01670097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6173857|NCT01670097|Glucocorticoids|glucocorticoids|mesh-ancestor
6485994|NCT00568152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6485995|NCT00568152|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6485996|NCT00568152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6485997|NCT00568152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6485998|NCT00568152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6485999|NCT00568152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6173858|NCT01670097|Hormones|hormones|mesh-ancestor
6173859|NCT01670097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6173860|NCT01670097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6173861|NCT01670097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6173862|NCT01670110|Pasireotide|pasireotide|mesh-list
6173863|NCT01670110|Hormones|hormones|mesh-ancestor
6173864|NCT01670110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6173865|NCT01670110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173866|NCT01670279|Brexpiprazole|brexpiprazole|mesh-list
6173867|NCT01670279|Serotonin Agents|serotonin agents|mesh-ancestor
6173868|NCT01670279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6173869|NCT01670279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173870|NCT01670279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173871|NCT01670279|Dopamine Agonists|dopamine agonists|mesh-ancestor
6173872|NCT01670279|Dopamine Agents|dopamine agents|mesh-ancestor
6173873|NCT01670500|Cyclophosphamide|cyclophosphamide|mesh-list
6173874|NCT01670500|Cisplatin|cisplatin|mesh-list
6173875|NCT01670500|Doxorubicin|doxorubicin|mesh-list
6173876|NCT01670500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6173877|NCT01670500|Immunologic Factors|immunologic factors|mesh-ancestor
5570373|NCT03933605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570374|NCT03933605|Antiemetics|antiemetics|mesh-ancestor
5570375|NCT03933605|Autonomic Agents|autonomic agents|mesh-ancestor
5570376|NCT03933605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5570377|NCT03933605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6173878|NCT01670500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173879|NCT01670500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6173880|NCT01670500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6173881|NCT01670500|Alkylating Agents|alkylating agents|mesh-ancestor
6173882|NCT01670500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173883|NCT01670500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6173884|NCT01670500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6173885|NCT01670500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6173886|NCT01670500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6173887|NCT01670500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6173888|NCT01670500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6173889|NCT01670526|Rivastigmine|rivastigmine|mesh-list
6173890|NCT01670526|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
6173891|NCT01670526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6173892|NCT01670526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173893|NCT01670526|Cholinergic Agents|cholinergic agents|mesh-ancestor
6173894|NCT01670526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6486000|NCT00568152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6486001|NCT00568152|Antipyretics|antipyretics|mesh-ancestor
6486002|NCT00568217|Acetaminophen|acetaminophen|mesh-list
6486003|NCT00568217|Ibuprofen|ibuprofen|mesh-list
6486004|NCT00568217|Diclofenac|diclofenac|mesh-list
6486005|NCT00568217|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6486006|NCT00568217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6486007|NCT00568217|Analgesics|analgesics|mesh-ancestor
6486008|NCT00568217|Sensory System Agents|sensory system agents|mesh-ancestor
6486009|NCT00568217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6486010|NCT00568217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486011|NCT00568217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6486012|NCT00568217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6486013|NCT00568217|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6486014|NCT00568217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6486015|NCT00568217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486016|NCT00568217|Antipyretics|antipyretics|mesh-ancestor
5570378|NCT03933605|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6173895|NCT01670526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486017|NCT00568295|Acetaminophen|acetaminophen|mesh-list
6486018|NCT00568295|Rofecoxib|rofecoxib|mesh-list
6173896|NCT01670526|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6173897|NCT01670526|Protective Agents|protective agents|mesh-ancestor
6173898|NCT01670721|Leucovorin|leucovorin|mesh-list
6173899|NCT01670721|Fluorouracil|fluorouracil|mesh-list
6173900|NCT01670721|Irinotecan|irinotecan|mesh-list
6173901|NCT01670721|Aflibercept|aflibercept|mesh-list
6173902|NCT01670721|Antimetabolites|antimetabolites|mesh-ancestor
6173903|NCT01670721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173904|NCT01670721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6173905|NCT01670721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6173906|NCT01670721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6173907|NCT01670721|Immunologic Factors|immunologic factors|mesh-ancestor
6173908|NCT01670721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173909|NCT01670721|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6173910|NCT01670721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6173911|NCT01670721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6670224|NCT01541956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670225|NCT01542021|Androgens|androgens|mesh-list
6173912|NCT01670721|Antidotes|antidotes|mesh-ancestor
6173913|NCT01670721|Protective Agents|protective agents|mesh-ancestor
6173914|NCT01670721|Vitamin B Complex|vitamin b complex|mesh-ancestor
6173915|NCT01670721|Vitamins|vitamins|mesh-ancestor
6173916|NCT01670721|Micronutrients|micronutrients|mesh-ancestor
6173917|NCT01670721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6173918|NCT01670721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6173919|NCT01670721|Growth Substances|growth substances|mesh-ancestor
6173920|NCT01670721|Growth Inhibitors|growth inhibitors|mesh-ancestor
6173921|NCT01671280|Azithromycin|azithromycin|mesh-list
6173922|NCT01671280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6173923|NCT01671280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6173924|NCT01671319|Cyclophosphamide|cyclophosphamide|mesh-list
6173925|NCT01671319|Docetaxel|docetaxel|mesh-list
6173926|NCT01671319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6173927|NCT01671319|Immunologic Factors|immunologic factors|mesh-ancestor
6173928|NCT01671319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486019|NCT00568295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6486020|NCT00568295|Analgesics|analgesics|mesh-ancestor
6486021|NCT00568295|Sensory System Agents|sensory system agents|mesh-ancestor
6486022|NCT00568295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6486023|NCT00568295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486024|NCT00568295|Antipyretics|antipyretics|mesh-ancestor
6486025|NCT00568295|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6486026|NCT00568295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6486027|NCT00568295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6486028|NCT00568295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670226|NCT01542021|Hormones|hormones|mesh-ancestor
6173929|NCT01671319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6173930|NCT01671319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6173931|NCT01671319|Alkylating Agents|alkylating agents|mesh-ancestor
6173932|NCT01671319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173933|NCT01671319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6173934|NCT01671319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6173935|NCT01671319|Tubulin Modulators|tubulin modulators|mesh-ancestor
6173936|NCT01671319|Antimitotic Agents|antimitotic agents|mesh-ancestor
6173937|NCT01671319|Mitosis Modulators|mitosis modulators|mesh-ancestor
6173938|NCT01671332|Suramin|suramin|mesh-list
6173939|NCT01671332|Docetaxel|docetaxel|mesh-list
6173940|NCT01671332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6173941|NCT01671332|Tubulin Modulators|tubulin modulators|mesh-ancestor
6173942|NCT01671332|Antimitotic Agents|antimitotic agents|mesh-ancestor
6173943|NCT01671332|Mitosis Modulators|mitosis modulators|mesh-ancestor
6173944|NCT01671332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173945|NCT01671332|Antinematodal Agents|antinematodal agents|mesh-ancestor
6173946|NCT01671332|Anthelmintics|anthelmintics|mesh-ancestor
6173947|NCT01671332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6173948|NCT01671332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6173949|NCT01671332|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6173950|NCT01671332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6173951|NCT01671423|Prednisone|prednisone|mesh-list
6173952|NCT01671423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6173953|NCT01671423|Glucocorticoids|glucocorticoids|mesh-ancestor
6173954|NCT01671423|Hormones|hormones|mesh-ancestor
6173955|NCT01671423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6173956|NCT01671423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173957|NCT01671423|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6173958|NCT01671423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6173959|NCT01671488|Mitomycins|mitomycins|mesh-list
6486029|NCT00568295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6486030|NCT00568295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6486031|NCT00568295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6486032|NCT00568347|Fluticasone|fluticasone|mesh-list
6486033|NCT00568347|Xhance|xhance|mesh-list
6486034|NCT00568347|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6486035|NCT00568347|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6486036|NCT00568347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6486037|NCT00568347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6486038|NCT00568347|Autonomic Agents|autonomic agents|mesh-ancestor
6486039|NCT00568347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6486040|NCT00568347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486041|NCT00568347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6486042|NCT00568347|Respiratory System Agents|respiratory system agents|mesh-ancestor
6486043|NCT00568347|Dermatologic Agents|dermatologic agents|mesh-ancestor
6486044|NCT00568347|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6486045|NCT00568347|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6486046|NCT00568347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6486047|NCT00568347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6486048|NCT00568347|Adrenergic Agents|adrenergic agents|mesh-ancestor
6486049|NCT00568347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6486050|NCT00568347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486051|NCT00568347|Glucocorticoids|glucocorticoids|mesh-ancestor
6486052|NCT00568347|Hormones|hormones|mesh-ancestor
6486053|NCT00568347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6486054|NCT00568347|Sympathomimetics|sympathomimetics|mesh-ancestor
6486055|NCT00568412|Pimecrolimus|pimecrolimus|mesh-list
6486056|NCT00568412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6486057|NCT00568412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6486058|NCT00568412|Analgesics|analgesics|mesh-ancestor
6486059|NCT00568412|Sensory System Agents|sensory system agents|mesh-ancestor
6486060|NCT00568412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6486061|NCT00568412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486062|NCT00568412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6486063|NCT00568412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6486064|NCT00568412|Dermatologic Agents|dermatologic agents|mesh-ancestor
6173960|NCT01671488|Mitomycin|mitomycin|mesh-list
6173961|NCT01671488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6173962|NCT01671488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6173963|NCT01671488|Alkylating Agents|alkylating agents|mesh-ancestor
6173964|NCT01671488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173965|NCT01671488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6173966|NCT01671488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6173967|NCT01672710|Niacin|niacin|mesh-list
6173968|NCT01672710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6173969|NCT01672710|Antimetabolites|antimetabolites|mesh-ancestor
6173970|NCT01672710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6173971|NCT01672710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6173972|NCT01672710|Vasodilator Agents|vasodilator agents|mesh-ancestor
6173973|NCT01672710|Vitamin B Complex|vitamin b complex|mesh-ancestor
6173974|NCT01672710|Vitamins|vitamins|mesh-ancestor
6173975|NCT01672710|Micronutrients|micronutrients|mesh-ancestor
6173976|NCT01672710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173977|NCT01672723|Naltrexone|naltrexone|mesh-list
6173978|NCT01672723|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6173979|NCT01672723|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6173980|NCT01672723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173981|NCT01672723|Sensory System Agents|sensory system agents|mesh-ancestor
6173982|NCT01672723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6173983|NCT01672736|Dexamethasone|dexamethasone|mesh-list
6173984|NCT01672736|Dexamethasone acetate|dexamethasone acetate|mesh-list
6173985|NCT01672736|Bortezomib|bortezomib|mesh-list
6173986|NCT01672736|BB 1101|bb 1101|mesh-list
6173987|NCT01672736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6173988|NCT01672736|Antiemetics|antiemetics|mesh-ancestor
6173989|NCT01672736|Autonomic Agents|autonomic agents|mesh-ancestor
6173990|NCT01672736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5570379|NCT03933605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5570380|NCT03933605|Serotonin Agents|serotonin agents|mesh-ancestor
5570381|NCT03933293|Ezetimibe|ezetimibe|mesh-list
5570382|NCT03933293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5570383|NCT03933293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6173991|NCT01672736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6173992|NCT01672736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6173993|NCT01672736|Glucocorticoids|glucocorticoids|mesh-ancestor
6173994|NCT01672736|Hormones|hormones|mesh-ancestor
6173995|NCT01672736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6173996|NCT01672736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5570384|NCT03933293|Antimetabolites|antimetabolites|mesh-ancestor
5570385|NCT03933293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570386|NCT03933293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5570387|NCT03933345|Naloxone|naloxone|mesh-list
5570388|NCT03933345|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6486065|NCT00568412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6486066|NCT00568412|Immunologic Factors|immunologic factors|mesh-ancestor
6486067|NCT00568412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6173997|NCT01672736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6173998|NCT01672736|Protease Inhibitors|protease inhibitors|mesh-ancestor
6173999|NCT01672736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6174000|NCT01672736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174001|NCT01672788|Metformin|metformin|mesh-list
6174002|NCT01672788|Empagliflozin|empagliflozin|mesh-list
6174003|NCT01672788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6174004|NCT01672788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174005|NCT01672788|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6174006|NCT01672788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174007|NCT01672801|Nimodipine|nimodipine|mesh-list
6174008|NCT01672801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6174009|NCT01672801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5570389|NCT03933345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570390|NCT03933345|Sensory System Agents|sensory system agents|mesh-ancestor
5570391|NCT03933345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5570392|NCT03933358|Hormones|hormones|mesh-list
5570393|NCT03933358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5570394|NCT03933358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570395|NCT03933306|Dexmedetomidine|dexmedetomidine|mesh-list
5570396|NCT03933306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5570397|NCT03933306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5570398|NCT03933306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570399|NCT03933306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5570400|NCT03933306|Analgesics|analgesics|mesh-ancestor
5570401|NCT03933306|Sensory System Agents|sensory system agents|mesh-ancestor
5570402|NCT03933306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5570403|NCT03933306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5570404|NCT03933306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5570405|NCT03933306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5570406|NCT03933306|Adrenergic Agents|adrenergic agents|mesh-ancestor
5570407|NCT03933306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6486068|NCT00568412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6486069|NCT00568412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570408|NCT03933306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570409|NCT03933319|Doxorubicin|doxorubicin|mesh-list
5570410|NCT03933319|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5570411|NCT03933319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5570412|NCT03933319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5570413|NCT03933319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5570414|NCT03933319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5570415|NCT03933319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5570416|NCT03933319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570417|NCT03932916|Donepezil|donepezil|mesh-list
6174010|NCT01672801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6174011|NCT01672801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486070|NCT00568477|Rituximab|rituximab|mesh-list
6486071|NCT00568477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6486072|NCT00568477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6486073|NCT00568477|Immunologic Factors|immunologic factors|mesh-ancestor
6670227|NCT01542021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6670228|NCT01542021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670229|NCT01542047|Carboplatin|carboplatin|mesh-list
6670230|NCT01542047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6670231|NCT01542060|Insulin Aspart|insulin aspart|mesh-list
6670232|NCT01542060|Biphasic Insulins|biphasic insulins|mesh-list
6174012|NCT01672801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6174013|NCT01672801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174014|NCT01672801|Vasodilator Agents|vasodilator agents|mesh-ancestor
6174015|NCT01672827|Flutemetamol|flutemetamol|mesh-list
6174016|NCT01672827|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6174017|NCT01672827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174018|NCT01672957|Mycophenolic Acid|mycophenolic acid|mesh-list
6174019|NCT01672957|Immunosuppressive Agents|immunosuppressive agents|mesh-list
6174020|NCT01672957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6174021|NCT01672957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6174022|NCT01672957|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6174023|NCT01672957|Antitubercular Agents|antitubercular agents|mesh-ancestor
6174024|NCT01672957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6174025|NCT01672957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6174026|NCT01672957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6174027|NCT01672957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174028|NCT01672957|Immunologic Factors|immunologic factors|mesh-ancestor
6174029|NCT01672957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174030|NCT01672983|Ritonavir|ritonavir|mesh-list
6174031|NCT01672983|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5570418|NCT03932916|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5570419|NCT03932916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6174032|NCT01672983|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6174033|NCT01672983|Protease Inhibitors|protease inhibitors|mesh-ancestor
6174034|NCT01672983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5570420|NCT03932916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570421|NCT03932916|Cholinergic Agents|cholinergic agents|mesh-ancestor
5570422|NCT03932916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5570423|NCT03932916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570424|NCT03932916|Nootropic Agents|nootropic agents|mesh-ancestor
5570425|NCT03932864|Plerixafor|plerixafor|mesh-list
5570426|NCT03932864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5570427|NCT03932864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5570428|NCT03932864|Antiviral Agents|antiviral agents|mesh-ancestor
5570429|NCT03932864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5570430|NCT03932825|Nitrous Oxide|nitrous oxide|mesh-list
5570431|NCT03932825|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5570432|NCT03932825|Anesthetics, General|anesthetics, general|mesh-ancestor
5570433|NCT03932825|Anesthetics|anesthetics|mesh-ancestor
5570434|NCT03932825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6174035|NCT01672983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174036|NCT01672983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6174037|NCT01672983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6174038|NCT01672983|Antiviral Agents|antiviral agents|mesh-ancestor
6174039|NCT01672983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6174040|NCT01672983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5570435|NCT03932825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570436|NCT03932825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5570437|NCT03932825|Analgesics|analgesics|mesh-ancestor
5570438|NCT03932825|Sensory System Agents|sensory system agents|mesh-ancestor
5570439|NCT03932825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5570440|NCT03932981|Temozolomide|temozolomide|mesh-list
5570441|NCT03932981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5570442|NCT03932981|Alkylating Agents|alkylating agents|mesh-ancestor
5570443|NCT03932981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570444|NCT03932981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5570445|NCT03933098|Vaccines|vaccines|mesh-list
5570446|NCT03933098|Immunologic Factors|immunologic factors|mesh-ancestor
5570447|NCT03933098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570448|NCT03932578|Atropine|atropine|mesh-list
5570449|NCT03932578|Metoclopramide|metoclopramide|mesh-list
5570450|NCT03932578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5570451|NCT03932578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5570452|NCT03932578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5570453|NCT03932578|Autonomic Agents|autonomic agents|mesh-ancestor
5570454|NCT03932578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5570455|NCT03932578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174041|NCT01672983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6174042|NCT01673009|Imatinib Mesylate|imatinib mesylate|mesh-list
6174043|NCT01673009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6174044|NCT01673009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6174045|NCT01673009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6174046|NCT01673009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206430|NCT02100228|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6206431|NCT02100228|Protease Inhibitors|protease inhibitors|mesh-ancestor
6206432|NCT02100228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6206433|NCT02100228|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6206434|NCT02100228|Hemostatics|hemostatics|mesh-ancestor
6206435|NCT02100228|Coagulants|coagulants|mesh-ancestor
6206436|NCT02100319|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
6206437|NCT02100319|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6206438|NCT02100319|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6206439|NCT02100319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206440|NCT02100475|Insulin|insulin|mesh-list
6206441|NCT02100475|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6206442|NCT02100475|Insulin Aspart|insulin aspart|mesh-list
6670233|NCT01542060|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6670234|NCT01542060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6670235|NCT01542060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670236|NCT01542099|Remifentanil|remifentanil|mesh-list
6670237|NCT01542099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6670238|NCT01542099|Narcotics|narcotics|mesh-ancestor
6670239|NCT01542099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6670240|NCT01542099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670241|NCT01542099|Analgesics|analgesics|mesh-ancestor
6670242|NCT01542099|Sensory System Agents|sensory system agents|mesh-ancestor
6670243|NCT01542099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6670244|NCT01542138|Niacinamide|niacinamide|mesh-list
6670245|NCT01542138|Niacin|niacin|mesh-list
6670246|NCT01542138|Nicotinic Acids|nicotinic acids|mesh-list
6670247|NCT01542138|Desonide|desonide|mesh-list
6670248|NCT01542138|Vitamin B Complex|vitamin b complex|mesh-ancestor
6670249|NCT01542138|Vitamins|vitamins|mesh-ancestor
6670250|NCT01542138|Micronutrients|micronutrients|mesh-ancestor
6670251|NCT01542138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206443|NCT02100475|Liraglutide|liraglutide|mesh-list
6206444|NCT02100475|Xultophy|xultophy|mesh-list
6206445|NCT02100475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6206446|NCT02100475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486074|NCT00568477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486075|NCT00568477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6486076|NCT00568503|Bromides|bromides|mesh-list
6486077|NCT00568503|Tiotropium Bromide|tiotropium bromide|mesh-list
6486078|NCT00568503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6486079|NCT00568503|Autonomic Agents|autonomic agents|mesh-ancestor
6486080|NCT00568503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6486081|NCT00568503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486082|NCT00568503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6486083|NCT00568503|Respiratory System Agents|respiratory system agents|mesh-ancestor
6486084|NCT00568503|Parasympatholytics|parasympatholytics|mesh-ancestor
6486085|NCT00568503|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6486086|NCT00568503|Cholinergic Agents|cholinergic agents|mesh-ancestor
6486087|NCT00568503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6486088|NCT00568503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486089|NCT00568503|Anticonvulsants|anticonvulsants|mesh-ancestor
6486090|NCT00568529|Capecitabine|capecitabine|mesh-list
6486091|NCT00568529|Oxaliplatin|oxaliplatin|mesh-list
6486092|NCT00568529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6486093|NCT00568529|Antimetabolites|antimetabolites|mesh-ancestor
6486094|NCT00568529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486095|NCT00568529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6486096|NCT00568542|Epoetin Alfa|epoetin alfa|mesh-list
6486097|NCT00568542|Hematinics|hematinics|mesh-ancestor
6486098|NCT00568568|Hormones|hormones|mesh-list
6206447|NCT02100475|Incretins|incretins|mesh-ancestor
6486099|NCT00568568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6670252|NCT01542138|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6670253|NCT01542138|Antimetabolites|antimetabolites|mesh-ancestor
6486100|NCT00568568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486101|NCT00568672|Olanzapine|olanzapine|mesh-list
6486102|NCT00568672|Antiemetics|antiemetics|mesh-ancestor
6486103|NCT00568672|Autonomic Agents|autonomic agents|mesh-ancestor
6486104|NCT00568672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6486105|NCT00568672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486106|NCT00568672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6486107|NCT00568672|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6486108|NCT00568672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6486109|NCT00568672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6486110|NCT00568672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6486111|NCT00568672|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6486112|NCT00568672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6486113|NCT00568672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6486114|NCT00568672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174047|NCT01673191|Dexamethasone|dexamethasone|mesh-list
6174048|NCT01673191|Prednisolone acetate|prednisolone acetate|mesh-list
6174049|NCT01673191|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6174050|NCT01673191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6174051|NCT01673191|Antiemetics|antiemetics|mesh-ancestor
6174052|NCT01673191|Autonomic Agents|autonomic agents|mesh-ancestor
6174053|NCT01673191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6486115|NCT00568672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6486116|NCT00568672|Serotonin Agents|serotonin agents|mesh-ancestor
6486117|NCT00568711|Doxycycline|doxycycline|mesh-list
6486118|NCT00568711|Rifampin|rifampin|mesh-list
6486119|NCT00568711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6486120|NCT00568711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6486121|NCT00568711|Antimalarials|antimalarials|mesh-ancestor
5570456|NCT03932578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5570457|NCT03932578|Respiratory System Agents|respiratory system agents|mesh-ancestor
5570458|NCT03932578|Mydriatics|mydriatics|mesh-ancestor
5570459|NCT03932578|Parasympatholytics|parasympatholytics|mesh-ancestor
5570460|NCT03932578|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5570461|NCT03932578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5570462|NCT03932578|Cholinergic Agents|cholinergic agents|mesh-ancestor
5570463|NCT03932578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5570464|NCT03932578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570465|NCT03932578|Antiemetics|antiemetics|mesh-ancestor
5570466|NCT03932578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5570467|NCT03932578|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5570468|NCT03932578|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6670254|NCT01542138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174054|NCT01673191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174055|NCT01673191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6174056|NCT01673191|Glucocorticoids|glucocorticoids|mesh-ancestor
6174057|NCT01673191|Hormones|hormones|mesh-ancestor
6174058|NCT01673191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6174059|NCT01673191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6174060|NCT01673191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6670255|NCT01542138|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5570469|NCT03932578|Dopamine Agents|dopamine agents|mesh-ancestor
5570470|NCT03932435|Bepotastine besilate|bepotastine besilate|mesh-list
5570471|NCT03932435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5570472|NCT03932656|Psychotropic Drugs|psychotropic drugs|mesh-list
5570473|NCT03932721|Evolocumab|evolocumab|mesh-list
5570474|NCT03932721|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5570475|NCT03932721|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5570476|NCT03932721|Antimetabolites|antimetabolites|mesh-ancestor
5570477|NCT03932721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570478|NCT03932721|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5570479|NCT03932292|Calcium|calcium|mesh-list
5570480|NCT03932292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5570481|NCT03932292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604207|NCT05121714|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5604208|NCT05121714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5604209|NCT05121714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5604210|NCT05121714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5604211|NCT05121714|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5604212|NCT05121714|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5604213|NCT05121714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5604214|NCT05121714|Serotonin Agents|serotonin agents|mesh-ancestor
5604215|NCT05121714|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6486122|NCT00568711|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5604216|NCT05121714|Antidepressive Agents|antidepressive agents|mesh-ancestor
6670256|NCT01542138|Vasodilator Agents|vasodilator agents|mesh-ancestor
5570482|NCT03932409|Paclitaxel|paclitaxel|mesh-list
5570483|NCT03932409|Carboplatin|carboplatin|mesh-list
5570484|NCT03932409|Pembrolizumab|pembrolizumab|mesh-list
5570485|NCT03932409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5570486|NCT03932409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5570487|NCT03932409|Tubulin Modulators|tubulin modulators|mesh-ancestor
6670257|NCT01542138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6672489|NCT01556529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672490|NCT01556529|Chelating Agents|chelating agents|mesh-ancestor
6672491|NCT01556529|Sequestering Agents|sequestering agents|mesh-ancestor
6672492|NCT01556529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672493|NCT01556542|Paclitaxel|paclitaxel|mesh-list
6672494|NCT01556542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6672495|NCT01556542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5570488|NCT03932409|Antimitotic Agents|antimitotic agents|mesh-ancestor
5570489|NCT03932409|Mitosis Modulators|mitosis modulators|mesh-ancestor
5570490|NCT03932409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570491|NCT03932409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5570492|NCT03932526|Apatinib|apatinib|mesh-list
6672496|NCT01556542|Tubulin Modulators|tubulin modulators|mesh-ancestor
6672497|NCT01556542|Antimitotic Agents|antimitotic agents|mesh-ancestor
6672498|NCT01556542|Mitosis Modulators|mitosis modulators|mesh-ancestor
6672499|NCT01556542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672500|NCT01556646|Tolvaptan|tolvaptan|mesh-list
6672501|NCT01556646|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6672502|NCT01556646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672503|NCT01556646|Natriuretic Agents|natriuretic agents|mesh-ancestor
6672504|NCT01556646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174061|NCT01673191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6174062|NCT01673282|Lacosamide|lacosamide|mesh-list
6174063|NCT01673282|Anticonvulsants|anticonvulsants|mesh-ancestor
6174064|NCT01673282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6174065|NCT01673282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6174066|NCT01673282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6174067|NCT01673282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174068|NCT01673386|Sunitinib|sunitinib|mesh-list
6174069|NCT01673386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6486123|NCT00568711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6486124|NCT00568711|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6486125|NCT00568711|Antitubercular Agents|antitubercular agents|mesh-ancestor
6486126|NCT00568711|Leprostatic Agents|leprostatic agents|mesh-ancestor
6486127|NCT00568711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6174070|NCT01673386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6174071|NCT01673386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6174072|NCT01673386|Growth Substances|growth substances|mesh-ancestor
6174073|NCT01673386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486128|NCT00568711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6486129|NCT00568711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486130|NCT00568711|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6486131|NCT00568711|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6486132|NCT00568711|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6486133|NCT00568711|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6486134|NCT00568711|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6486135|NCT00568711|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6486136|NCT00568737|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
6486137|NCT00568737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6174074|NCT01673386|Growth Inhibitors|growth inhibitors|mesh-ancestor
6174075|NCT01673386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6174076|NCT01673386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6174077|NCT01673386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174078|NCT01673490|Tamsulosin|tamsulosin|mesh-list
6174079|NCT01673490|Dutasteride|dutasteride|mesh-list
6174080|NCT01673490|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6174081|NCT01673490|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6174082|NCT01673490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5570493|NCT03932526|Vinorelbine|vinorelbine|mesh-list
5570494|NCT03932526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5570495|NCT03932526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5570496|NCT03932526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5570497|NCT03932526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570498|NCT03932526|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5570499|NCT03932526|Tubulin Modulators|tubulin modulators|mesh-ancestor
5570500|NCT03932526|Antimitotic Agents|antimitotic agents|mesh-ancestor
6174083|NCT01673490|Adrenergic Agents|adrenergic agents|mesh-ancestor
6670258|NCT01542190|Ketorolac|ketorolac|mesh-list
5570501|NCT03932526|Mitosis Modulators|mitosis modulators|mesh-ancestor
5570502|NCT03932123|Vancomycin|vancomycin|mesh-list
5570503|NCT03932123|Meropenem|meropenem|mesh-list
5570504|NCT03932123|Tazobactam|tazobactam|mesh-list
5570505|NCT03932123|Piperacillin|piperacillin|mesh-list
5570506|NCT03932123|Cefotaxime|cefotaxime|mesh-list
5570507|NCT03932123|Cefoxitin|cefoxitin|mesh-list
5570508|NCT03932123|Azlocillin|azlocillin|mesh-list
5570509|NCT03932123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5570510|NCT03932123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5570511|NCT03932123|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5570512|NCT03932123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5570513|NCT03932123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570514|NCT03932344|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5570515|NCT03932344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5570516|NCT03932266|Docetaxel|docetaxel|mesh-list
5570517|NCT03932266|Endostar protein|endostar protein|mesh-list
5570518|NCT03932266|Endostatins|endostatins|mesh-list
5570519|NCT03932266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5570520|NCT03932266|Tubulin Modulators|tubulin modulators|mesh-ancestor
5570521|NCT03932266|Antimitotic Agents|antimitotic agents|mesh-ancestor
5570522|NCT03932266|Mitosis Modulators|mitosis modulators|mesh-ancestor
5570523|NCT03932266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570524|NCT03932266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5570525|NCT03932266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5570526|NCT03932266|Growth Substances|growth substances|mesh-ancestor
5570527|NCT03932266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570528|NCT03932266|Growth Inhibitors|growth inhibitors|mesh-ancestor
5570529|NCT03931915|Leuprolide|leuprolide|mesh-list
5570530|NCT03931915|Relugolix|relugolix|mesh-list
5570531|NCT03931915|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6670259|NCT01542190|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6670260|NCT01542190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6670261|NCT01542190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5570532|NCT03931915|Fertility Agents|fertility agents|mesh-ancestor
5570533|NCT03931915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5570534|NCT03931915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570535|NCT03931915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5570536|NCT03931915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5570537|NCT03931915|Androgen Antagonists|androgen antagonists|mesh-ancestor
5570538|NCT03931915|Hormone Antagonists|hormone antagonists|mesh-ancestor
5570539|NCT03931915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5570540|NCT03932071|Zoledronic Acid|zoledronic acid|mesh-list
5570541|NCT03932071|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5570542|NCT03932071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670262|NCT01542190|Analgesics|analgesics|mesh-ancestor
6670263|NCT01542190|Sensory System Agents|sensory system agents|mesh-ancestor
5570543|NCT03931668|Maleic acid|maleic acid|mesh-list
5570544|NCT03931668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5570545|NCT03931668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570546|NCT03931863|Ondansetron|ondansetron|mesh-list
5570547|NCT03931863|Antiemetics|antiemetics|mesh-ancestor
5570548|NCT03931863|Autonomic Agents|autonomic agents|mesh-ancestor
6486138|NCT00568750|Dasatinib|dasatinib|mesh-list
6486139|NCT00568750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6486140|NCT00568750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6486141|NCT00568750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6486142|NCT00568750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486143|NCT00568763|Sargramostim|sargramostim|mesh-list
6486144|NCT00568763|Immunologic Factors|immunologic factors|mesh-ancestor
6670264|NCT01542190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6670265|NCT01542190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670266|NCT01542190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6670267|NCT01542190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6174084|NCT01673490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6174085|NCT01673490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486145|NCT00568763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486146|NCT00568789|Zolpidem|zolpidem|mesh-list
6486147|NCT00568789|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6670268|NCT01542190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5570549|NCT03931863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5570550|NCT03931863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670269|NCT01542190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6486148|NCT00568789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6486149|NCT00568789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6174086|NCT01673490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174087|NCT01673490|Urological Agents|urological agents|mesh-ancestor
6174088|NCT01673490|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6174089|NCT01673490|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6174090|NCT01673490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6174091|NCT01673490|Hormone Antagonists|hormone antagonists|mesh-ancestor
6174092|NCT01673490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6174093|NCT01673594|Naltrexone|naltrexone|mesh-list
6486150|NCT00568789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486151|NCT00568789|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6486152|NCT00568789|GABA Agonists|gaba agonists|mesh-ancestor
6486153|NCT00568789|GABA Agents|gaba agents|mesh-ancestor
6486154|NCT00568789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6486155|NCT00568789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486156|NCT00568815|Rituximab|rituximab|mesh-list
6486157|NCT00568815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6486158|NCT00568815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6486159|NCT00568815|Immunologic Factors|immunologic factors|mesh-ancestor
6486160|NCT00568815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486161|NCT00568815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6486162|NCT00568841|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6486163|NCT00568841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6486164|NCT00568841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6486165|NCT00568841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6486166|NCT00568841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486167|NCT00568880|Hydroxychloroquine|hydroxychloroquine|mesh-list
6486168|NCT00568880|Bortezomib|bortezomib|mesh-list
6486169|NCT00568880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6486170|NCT00568880|Antimalarials|antimalarials|mesh-ancestor
6486171|NCT00568880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6486172|NCT00568880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6486173|NCT00568880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6486174|NCT00568880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6486175|NCT00568880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486176|NCT00568880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6486177|NCT00568893|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
6174094|NCT01673594|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6174095|NCT01673594|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6174096|NCT01673594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174097|NCT01673594|Sensory System Agents|sensory system agents|mesh-ancestor
6174098|NCT01673594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6174099|NCT01673646|Pasireotide|pasireotide|mesh-list
6174100|NCT01673646|Hormones|hormones|mesh-ancestor
6174101|NCT01673646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6174102|NCT01673646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174103|NCT01673828|Pregnanolone|pregnanolone|mesh-list
6174104|NCT01673828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6174105|NCT01673828|Anesthetics|anesthetics|mesh-ancestor
6174106|NCT01673828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6174107|NCT01673828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670270|NCT01542190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670271|NCT01542242|Liraglutide|liraglutide|mesh-list
6670272|NCT01542242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6670273|NCT01542242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670274|NCT01542242|Incretins|incretins|mesh-ancestor
6174108|NCT01673854|Ipilimumab|ipilimumab|mesh-list
6174109|NCT01673854|Vemurafenib|vemurafenib|mesh-list
6174110|NCT01673854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6174111|NCT01673854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6174112|NCT01673854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6174113|NCT01673854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174114|NCT01673854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6174115|NCT01673854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6486178|NCT00568893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6486179|NCT00568971|Docetaxel|docetaxel|mesh-list
6486180|NCT00568971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6486181|NCT00568971|Tubulin Modulators|tubulin modulators|mesh-ancestor
6486182|NCT00568971|Antimitotic Agents|antimitotic agents|mesh-ancestor
6486183|NCT00568971|Mitosis Modulators|mitosis modulators|mesh-ancestor
6486184|NCT00568971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486185|NCT00568984|Metformin|metformin|mesh-list
6486186|NCT00568984|Repaglinide|repaglinide|mesh-list
6670275|NCT01542242|Hormones|hormones|mesh-ancestor
6174116|NCT01673867|Docetaxel|docetaxel|mesh-list
6174117|NCT01673867|Nivolumab|nivolumab|mesh-list
6174118|NCT01673867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6174119|NCT01673867|Tubulin Modulators|tubulin modulators|mesh-ancestor
6174120|NCT01673867|Antimitotic Agents|antimitotic agents|mesh-ancestor
6174121|NCT01673867|Mitosis Modulators|mitosis modulators|mesh-ancestor
6174122|NCT01673867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174123|NCT01673867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6174124|NCT01673867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6174125|NCT01673984|Goserelin|goserelin|mesh-list
6174126|NCT01673984|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6174127|NCT01673984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6174128|NCT01673984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6174129|NCT01673984|Luteolytic Agents|luteolytic agents|mesh-ancestor
6174130|NCT01673984|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6174131|NCT01673984|Contraceptive Agents|contraceptive agents|mesh-ancestor
6174132|NCT01673984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6486187|NCT00568984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6486188|NCT00568984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486189|NCT00569088|Mannitol|mannitol|mesh-list
6486190|NCT00569088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6486191|NCT00569088|Diuretics|diuretics|mesh-ancestor
6486192|NCT00569088|Natriuretic Agents|natriuretic agents|mesh-ancestor
6486193|NCT00569088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486194|NCT00569101|Tacrolimus|tacrolimus|mesh-list
5570551|NCT03931863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5570552|NCT03931863|Antipruritics|antipruritics|mesh-ancestor
5570553|NCT03931863|Dermatologic Agents|dermatologic agents|mesh-ancestor
5570554|NCT03931863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5570555|NCT03931863|Serotonin Agents|serotonin agents|mesh-ancestor
5570556|NCT03931863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6174133|NCT01673984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570557|NCT03931863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570558|NCT03931863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5570559|NCT03931863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5570560|NCT03931863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5570561|NCT03931863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5570562|NCT03931863|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5570563|NCT03931928|Tamoxifen|tamoxifen|mesh-list
5570564|NCT03931928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5570565|NCT03931928|Hormone Antagonists|hormone antagonists|mesh-ancestor
5570566|NCT03931928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5570567|NCT03931928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570568|NCT03931928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5570569|NCT03931928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5570570|NCT03931928|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6174134|NCT01673984|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6174135|NCT01674010|Inositol|inositol|mesh-list
6174136|NCT01674010|Lamotrigine|lamotrigine|mesh-list
6174137|NCT01674010|Valproic Acid|valproic acid|mesh-list
6174138|NCT01674010|Anticonvulsants|anticonvulsants|mesh-ancestor
6174139|NCT01674010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6174140|NCT01674010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6174141|NCT01674010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174142|NCT01674010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6174143|NCT01674010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174144|NCT01674010|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6174145|NCT01674010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6174146|NCT01674010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6174147|NCT01674010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6174148|NCT01674010|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6174149|NCT01674010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6174150|NCT01674010|GABA Agents|gaba agents|mesh-ancestor
6174151|NCT01674010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6174152|NCT01674010|Antimanic Agents|antimanic agents|mesh-ancestor
6174153|NCT01674010|Vitamin B Complex|vitamin b complex|mesh-ancestor
6174154|NCT01674010|Vitamins|vitamins|mesh-ancestor
6486195|NCT00569101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6486196|NCT00569101|Immunologic Factors|immunologic factors|mesh-ancestor
6486197|NCT00569101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570571|NCT03931928|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5570572|NCT03931928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5570573|NCT03931889|Vitamin D|vitamin d|mesh-list
6174155|NCT01674010|Micronutrients|micronutrients|mesh-ancestor
6486198|NCT00569101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6174156|NCT01674062|Trastuzumab|trastuzumab|mesh-list
5570574|NCT03931889|Cholecalciferol|cholecalciferol|mesh-list
5570575|NCT03931889|Vitamins|vitamins|mesh-ancestor
5570576|NCT03931889|Micronutrients|micronutrients|mesh-ancestor
5570577|NCT03931889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570578|NCT03931889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5570579|NCT03931889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5570580|NCT03931408|Gentamicins|gentamicins|mesh-list
5570581|NCT03931408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5570582|NCT03931408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5570583|NCT03931408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5570584|NCT03931408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5570585|NCT03931408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570586|NCT03931551|Trastuzumab|trastuzumab|mesh-list
5570587|NCT03931551|Olaparib|olaparib|mesh-list
5570588|NCT03931551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5570589|NCT03931551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5570590|NCT03931551|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5570591|NCT03931551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5570592|NCT03931551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570593|NCT03931343|Epinephrine|epinephrine|mesh-list
5570594|NCT03931343|Racepinephrine|racepinephrine|mesh-list
5570595|NCT03931343|Bupivacaine|bupivacaine|mesh-list
5570596|NCT03931343|Epinephryl borate|epinephryl borate|mesh-list
5570597|NCT03931343|Anesthetics, Local|anesthetics, local|mesh-ancestor
6486199|NCT00569101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6486200|NCT00569101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486201|NCT00569244|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
6486202|NCT00569244|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6486203|NCT00569244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486204|NCT00569296|Aldesleukin|aldesleukin|mesh-list
6486205|NCT00569296|Sargramostim|sargramostim|mesh-list
6486206|NCT00569296|Immunologic Factors|immunologic factors|mesh-ancestor
6486207|NCT00569296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486208|NCT00569296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6486209|NCT00569296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6486210|NCT00569296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6486211|NCT00569296|Antiviral Agents|antiviral agents|mesh-ancestor
6486212|NCT00569296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6486213|NCT00569335|Bevacizumab|bevacizumab|mesh-list
6486214|NCT00569335|Irinotecan|irinotecan|mesh-list
6670276|NCT01542242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6670277|NCT01542268|Pentoxifylline|pentoxifylline|mesh-list
6670278|NCT01542268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6670279|NCT01542268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6670280|NCT01542268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670281|NCT01542268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6670282|NCT01542268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6670283|NCT01542268|Protective Agents|protective agents|mesh-ancestor
6670284|NCT01542268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670285|NCT01542268|Vasodilator Agents|vasodilator agents|mesh-ancestor
6670286|NCT01542268|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6670287|NCT01542268|Antioxidants|antioxidants|mesh-ancestor
6670288|NCT01542294|Oxaliplatin|oxaliplatin|mesh-list
6670289|NCT01542294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6670290|NCT01542424|Insulin|insulin|mesh-list
6670291|NCT01542424|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6670292|NCT01542424|Insulin Aspart|insulin aspart|mesh-list
6670293|NCT01542424|Insulin Detemir|insulin detemir|mesh-list
6670294|NCT01542424|Biphasic Insulins|biphasic insulins|mesh-list
6670295|NCT01542424|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6670296|NCT01542424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6670297|NCT01542424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670298|NCT01542437|Afatinib|afatinib|mesh-list
6670299|NCT01542437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6670300|NCT01542437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6670301|NCT01542437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6174157|NCT01674062|Pertuzumab|pertuzumab|mesh-list
6174158|NCT01674062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6174159|NCT01674062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6174160|NCT01674569|Ranibizumab|ranibizumab|mesh-list
6174161|NCT01674569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6174162|NCT01674569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6174163|NCT01674569|Growth Substances|growth substances|mesh-ancestor
6672505|NCT01556659|Acenocoumarol|acenocoumarol|mesh-list
5570598|NCT03931343|Anesthetics|anesthetics|mesh-ancestor
6174164|NCT01674569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570599|NCT03931343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5570600|NCT03931343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570601|NCT03931343|Sensory System Agents|sensory system agents|mesh-ancestor
5570602|NCT03931343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5570603|NCT03931343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5570604|NCT03931343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5570605|NCT03931343|Adrenergic Agents|adrenergic agents|mesh-ancestor
5570606|NCT03931343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5570607|NCT03931343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570608|NCT03931343|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5570609|NCT03931343|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5570610|NCT03931343|Autonomic Agents|autonomic agents|mesh-ancestor
5570611|NCT03931343|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5570612|NCT03931343|Respiratory System Agents|respiratory system agents|mesh-ancestor
5570613|NCT03931343|Mydriatics|mydriatics|mesh-ancestor
5570614|NCT03931343|Sympathomimetics|sympathomimetics|mesh-ancestor
5570615|NCT03931343|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5570616|NCT03931239|Vaccines|vaccines|mesh-list
5570617|NCT03931239|Immunologic Factors|immunologic factors|mesh-ancestor
5570618|NCT03931239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570619|NCT03931317|Timolol|timolol|mesh-list
5570620|NCT03931317|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5570621|NCT03931317|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5570622|NCT03931317|Adrenergic Agents|adrenergic agents|mesh-ancestor
5570623|NCT03931317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5570624|NCT03931317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570625|NCT03931317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570626|NCT03931317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5570627|NCT03931317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5570628|NCT03931135|Dexamethasone|dexamethasone|mesh-list
5570629|NCT03931135|Morphine|morphine|mesh-list
5570630|NCT03931135|Cyclizine|cyclizine|mesh-list
5570631|NCT03931135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5570632|NCT03931135|Antiemetics|antiemetics|mesh-ancestor
5570633|NCT03931135|Autonomic Agents|autonomic agents|mesh-ancestor
5570634|NCT03931135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5570635|NCT03931135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570636|NCT03931135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5570637|NCT03931135|Glucocorticoids|glucocorticoids|mesh-ancestor
5570638|NCT03931135|Hormones|hormones|mesh-ancestor
5570639|NCT03931135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5570640|NCT03931135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5570641|NCT03931135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5570642|NCT03931135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5570643|NCT03931135|Narcotics|narcotics|mesh-ancestor
5570644|NCT03931135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5570645|NCT03931135|Analgesics|analgesics|mesh-ancestor
5570646|NCT03931135|Sensory System Agents|sensory system agents|mesh-ancestor
5570647|NCT03931135|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5570648|NCT03931135|Histamine Antagonists|histamine antagonists|mesh-ancestor
6174165|NCT01674569|Growth Inhibitors|growth inhibitors|mesh-ancestor
6174166|NCT01674569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6174167|NCT01674621|Abaloparatide|abaloparatide|mesh-list
5570649|NCT03931135|Histamine Agents|histamine agents|mesh-ancestor
5570650|NCT03931135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5570651|NCT03931135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570652|NCT03930992|Zoledronic Acid|zoledronic acid|mesh-list
5570653|NCT03930992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5570654|NCT03930992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570655|NCT03931369|Tolvaptan|tolvaptan|mesh-list
5570656|NCT03931369|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
5570657|NCT03931369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570658|NCT03931369|Natriuretic Agents|natriuretic agents|mesh-ancestor
5570659|NCT03931369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570660|NCT03930875|Aspirin|aspirin|mesh-list
5570661|NCT03930875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5570662|NCT03930875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5570663|NCT03930875|Analgesics|analgesics|mesh-ancestor
5570664|NCT03930875|Sensory System Agents|sensory system agents|mesh-ancestor
6672506|NCT01556659|Anticoagulants|anticoagulants|mesh-ancestor
5570665|NCT03930875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6174168|NCT01674621|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
6174169|NCT01674621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6174170|NCT01674621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206448|NCT02100475|Hormones|hormones|mesh-ancestor
6174171|NCT01674621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6174172|NCT01674647|Vitamin K|vitamin k|mesh-list
6174173|NCT01674647|Rivaroxaban|rivaroxaban|mesh-list
6174174|NCT01674647|Vitamins|vitamins|mesh-ancestor
6174175|NCT01674647|Micronutrients|micronutrients|mesh-ancestor
6174176|NCT01674647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174177|NCT01674647|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6174178|NCT01674647|Antithrombins|antithrombins|mesh-ancestor
6174179|NCT01674647|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5570666|NCT03930875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570667|NCT03930875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5570668|NCT03930875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5570669|NCT03930875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5570670|NCT03930875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5570671|NCT03930875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570672|NCT03930875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5570673|NCT03930875|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5570674|NCT03930875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5570675|NCT03930875|Antipyretics|antipyretics|mesh-ancestor
5570676|NCT03931161|Evolocumab|evolocumab|mesh-list
5570677|NCT03931161|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5570678|NCT03931161|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5570679|NCT03931161|Antimetabolites|antimetabolites|mesh-ancestor
5570680|NCT03931161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570681|NCT03931161|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5570682|NCT03930680|Dexrazoxane|dexrazoxane|mesh-list
6174180|NCT01674647|Protease Inhibitors|protease inhibitors|mesh-ancestor
6174181|NCT01674647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6672507|NCT01556672|Adalimumab|adalimumab|mesh-list
5570683|NCT03930680|Razoxane|razoxane|mesh-list
5570684|NCT03930680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5570685|NCT03930680|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5570686|NCT03930680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6174182|NCT01674647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174183|NCT01674647|Anticoagulants|anticoagulants|mesh-ancestor
5570687|NCT03930680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5570688|NCT03930680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5570689|NCT03930680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570690|NCT03930680|Protective Agents|protective agents|mesh-ancestor
5570691|NCT03930680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570692|NCT03930680|Antimitotic Agents|antimitotic agents|mesh-ancestor
5570693|NCT03930680|Mitosis Modulators|mitosis modulators|mesh-ancestor
5604217|NCT05121714|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5604218|NCT05121714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5604219|NCT05121714|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5604220|NCT05117710|Ebselen|ebselen|mesh-list
5604221|NCT05117710|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5604222|NCT05117710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5604223|NCT05117710|Analgesics|analgesics|mesh-ancestor
5604224|NCT05117710|Sensory System Agents|sensory system agents|mesh-ancestor
5604225|NCT05117710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5604226|NCT05117710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604227|NCT05117710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5604228|NCT05117710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5604229|NCT05117710|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5604230|NCT05117710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5604231|NCT05117710|Antioxidants|antioxidants|mesh-ancestor
6174184|NCT01674647|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6174185|NCT01674647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6174186|NCT01674647|Hemostatics|hemostatics|mesh-ancestor
6174187|NCT01674647|Coagulants|coagulants|mesh-ancestor
6174188|NCT01674712|Simvastatin|simvastatin|mesh-list
6174189|NCT01674712|Fenofibrate|fenofibrate|mesh-list
6174190|NCT01674712|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6174191|NCT01674712|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6174192|NCT01674712|Antimetabolites|antimetabolites|mesh-ancestor
5604232|NCT05117710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604233|NCT05117710|Protective Agents|protective agents|mesh-ancestor
5604234|NCT05117710|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5604235|NCT05117710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6174193|NCT01674712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174194|NCT01674712|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6174195|NCT01674712|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6174196|NCT01674712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6174197|NCT01674725|Ribavirin|ribavirin|mesh-list
6174198|NCT01674725|Antimetabolites|antimetabolites|mesh-ancestor
6174199|NCT01674725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174200|NCT01674725|Antiviral Agents|antiviral agents|mesh-ancestor
6174201|NCT01674725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6174202|NCT01675050|Cyproheptadine|cyproheptadine|mesh-list
6174203|NCT01675050|Antipruritics|antipruritics|mesh-ancestor
6174204|NCT01675050|Dermatologic Agents|dermatologic agents|mesh-ancestor
6174205|NCT01675050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6174206|NCT01675050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6174207|NCT01675050|Histamine Antagonists|histamine antagonists|mesh-ancestor
6174208|NCT01675050|Histamine Agents|histamine agents|mesh-ancestor
5570694|NCT03930706|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5570695|NCT03930706|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5570696|NCT03930706|Estradiol|estradiol|mesh-list
5570697|NCT03930706|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5570698|NCT03930706|Estrogens|estrogens|mesh-ancestor
5570699|NCT03930706|Hormones|hormones|mesh-ancestor
5570700|NCT03930706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5570701|NCT03930706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570702|NCT03930706|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5570703|NCT03930706|Contraceptive Agents|contraceptive agents|mesh-ancestor
5570704|NCT03930706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5570705|NCT03930706|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6486215|NCT00569335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6486216|NCT00569335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6486217|NCT00569335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6486218|NCT00569335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6486219|NCT00569335|Growth Substances|growth substances|mesh-ancestor
6486220|NCT00569335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486221|NCT00569335|Growth Inhibitors|growth inhibitors|mesh-ancestor
6486222|NCT00569335|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6486223|NCT00569335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6486224|NCT00569335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5570706|NCT03930433|Nebivolol|nebivolol|mesh-list
5570707|NCT03930433|Diltiazem|diltiazem|mesh-list
5570708|NCT03930433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5570709|NCT03930433|Vasodilator Agents|vasodilator agents|mesh-ancestor
5570710|NCT03930433|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5570711|NCT03930433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5570712|NCT03930433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5570713|NCT03930433|Adrenergic Agents|adrenergic agents|mesh-ancestor
5570714|NCT03930433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5570715|NCT03930433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570716|NCT03930433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570717|NCT03930433|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5570718|NCT03930433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5570719|NCT03930433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5570720|NCT03930446|Ethanol|ethanol|mesh-list
5570721|NCT03930446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5570722|NCT03930446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5570723|NCT03930446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6486225|NCT00569335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486226|NCT00569400|Insulin|insulin|mesh-list
6486227|NCT00569400|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6486228|NCT00569400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6486229|NCT00569400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174209|NCT01675050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6208004|NCT02123134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6486230|NCT00569452|Insulin|insulin|mesh-list
6486231|NCT00569452|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6486232|NCT00569452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6174210|NCT01675050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174211|NCT01675050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174212|NCT01675050|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6174213|NCT01675050|Serotonin Agents|serotonin agents|mesh-ancestor
6174214|NCT01675050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6174215|NCT01675128|Irinotecan|irinotecan|mesh-list
6174216|NCT01675128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6174217|NCT01675128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6174218|NCT01675128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6174219|NCT01675128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174220|NCT01675128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6174221|NCT01675141|Lenalidomide|lenalidomide|mesh-list
6174222|NCT01675141|Immunologic Factors|immunologic factors|mesh-ancestor
6174223|NCT01675141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174224|NCT01675141|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6174225|NCT01675141|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6174226|NCT01675141|Growth Substances|growth substances|mesh-ancestor
6174227|NCT01675141|Growth Inhibitors|growth inhibitors|mesh-ancestor
6174228|NCT01675141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6486233|NCT00569452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486234|NCT00569465|Acetylcysteine|acetylcysteine|mesh-list
6486235|NCT00569465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6486236|NCT00569465|Antiviral Agents|antiviral agents|mesh-ancestor
6486237|NCT00569465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6486238|NCT00569465|Expectorants|expectorants|mesh-ancestor
6486239|NCT00569465|Respiratory System Agents|respiratory system agents|mesh-ancestor
6486240|NCT00569465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6486241|NCT00569465|Antioxidants|antioxidants|mesh-ancestor
6486242|NCT00569465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486243|NCT00569465|Protective Agents|protective agents|mesh-ancestor
6486244|NCT00569465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174229|NCT01675154|Orlistat|orlistat|mesh-list
6174230|NCT01675154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6486245|NCT00569465|Antidotes|antidotes|mesh-ancestor
6486246|NCT00569621|Moxaverine|moxaverine|mesh-list
6486247|NCT00569621|Parasympatholytics|parasympatholytics|mesh-ancestor
6486248|NCT00569621|Autonomic Agents|autonomic agents|mesh-ancestor
6486249|NCT00569621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6486250|NCT00569621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486251|NCT00569699|Bevacizumab|bevacizumab|mesh-list
6486252|NCT00569699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6486253|NCT00569699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6486254|NCT00569699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6486255|NCT00569699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6486256|NCT00569699|Growth Substances|growth substances|mesh-ancestor
6486257|NCT00569699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486258|NCT00569699|Growth Inhibitors|growth inhibitors|mesh-ancestor
6486259|NCT00569712|Budesonide|budesonide|mesh-list
6486260|NCT00569712|Formoterol Fumarate|formoterol fumarate|mesh-list
6486261|NCT00569712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6486262|NCT00569712|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6486263|NCT00569712|Autonomic Agents|autonomic agents|mesh-ancestor
6486264|NCT00569712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6486265|NCT00569712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486266|NCT00569712|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6486267|NCT00569712|Respiratory System Agents|respiratory system agents|mesh-ancestor
6486268|NCT00569712|Glucocorticoids|glucocorticoids|mesh-ancestor
6486269|NCT00569712|Hormones|hormones|mesh-ancestor
6486270|NCT00569712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6486271|NCT00569712|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6486272|NCT00569712|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6486273|NCT00569712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6486274|NCT00569712|Adrenergic Agents|adrenergic agents|mesh-ancestor
6486275|NCT00569712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6174231|NCT01675154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174232|NCT01675154|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5570724|NCT03930446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570725|NCT03930069|Vasopressins|vasopressins|mesh-list
5570726|NCT03930069|Arginine Vasopressin|arginine vasopressin|mesh-list
5570727|NCT03930069|Misoprostol|misoprostol|mesh-list
5570728|NCT03930069|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5570729|NCT03930069|Abortifacient Agents|abortifacient agents|mesh-ancestor
5570730|NCT03930069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6486276|NCT00569712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486277|NCT00569751|Paclitaxel|paclitaxel|mesh-list
6486278|NCT00569751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6486279|NCT00569751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6174233|NCT01675154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6174234|NCT01675167|Buprenorphine|buprenorphine|mesh-list
6174235|NCT01675167|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6174236|NCT01675167|Narcotics|narcotics|mesh-ancestor
6174237|NCT01675167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6174238|NCT01675167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174239|NCT01675167|Analgesics|analgesics|mesh-ancestor
6174240|NCT01675167|Sensory System Agents|sensory system agents|mesh-ancestor
6174241|NCT01675167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5570731|NCT03930069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570732|NCT03930069|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5570733|NCT03930069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5570734|NCT03930069|Oxytocics|oxytocics|mesh-ancestor
5570735|NCT03930069|Hemostatics|hemostatics|mesh-ancestor
6174242|NCT01675167|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6174243|NCT01675297|Cholecalciferol|cholecalciferol|mesh-list
6174244|NCT01675297|Risedronic Acid|risedronic acid|mesh-list
6174245|NCT01675297|Etidronic Acid|etidronic acid|mesh-list
6174246|NCT01675297|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6174247|NCT01675297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174248|NCT01675297|Vitamins|vitamins|mesh-ancestor
6174249|NCT01675297|Micronutrients|micronutrients|mesh-ancestor
6174250|NCT01675297|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6174251|NCT01675297|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6174252|NCT01675297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6174253|NCT01675297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174254|NCT01675531|Oxycodone|oxycodone|mesh-list
6174255|NCT01675531|Naloxone|naloxone|mesh-list
6174256|NCT01675531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6174257|NCT01675531|Narcotics|narcotics|mesh-ancestor
6174258|NCT01675531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6174259|NCT01675531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174260|NCT01675531|Analgesics|analgesics|mesh-ancestor
5570736|NCT03930069|Coagulants|coagulants|mesh-ancestor
5570737|NCT03930069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5570738|NCT03930069|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5570739|NCT03930069|Natriuretic Agents|natriuretic agents|mesh-ancestor
5570740|NCT03930212|Progesterone|progesterone|mesh-list
5570741|NCT03930212|Progestins|progestins|mesh-ancestor
5570742|NCT03930212|Hormones|hormones|mesh-ancestor
5570743|NCT03930212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6174261|NCT01675531|Sensory System Agents|sensory system agents|mesh-ancestor
6174262|NCT01675531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6174263|NCT01675531|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6174264|NCT01675622|Morphine|morphine|mesh-list
6174265|NCT01675622|Oxycodone|oxycodone|mesh-list
6174266|NCT01675622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6174267|NCT01675622|Narcotics|narcotics|mesh-ancestor
6174268|NCT01675622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6174269|NCT01675622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174270|NCT01675622|Analgesics|analgesics|mesh-ancestor
6174271|NCT01675622|Sensory System Agents|sensory system agents|mesh-ancestor
6174272|NCT01675622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6174273|NCT01675635|Morphine|morphine|mesh-list
6174274|NCT01675635|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6174275|NCT01675635|Narcotics|narcotics|mesh-ancestor
6174276|NCT01675635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6174277|NCT01675635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174278|NCT01675635|Analgesics|analgesics|mesh-ancestor
6174279|NCT01675635|Sensory System Agents|sensory system agents|mesh-ancestor
6174280|NCT01675635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6174281|NCT01675661|Acetylcysteine|acetylcysteine|mesh-list
6174282|NCT01675661|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6174283|NCT01675661|Antiviral Agents|antiviral agents|mesh-ancestor
5570744|NCT03930212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174284|NCT01675661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5570745|NCT03929861|Fluconazole|fluconazole|mesh-list
6174285|NCT01675661|Expectorants|expectorants|mesh-ancestor
6174286|NCT01675661|Respiratory System Agents|respiratory system agents|mesh-ancestor
6174287|NCT01675661|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6174288|NCT01675661|Antioxidants|antioxidants|mesh-ancestor
6174289|NCT01675661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570746|NCT03929861|Antifungal Agents|antifungal agents|mesh-ancestor
5570747|NCT03929861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5570748|NCT03929861|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5570749|NCT03929861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5570750|NCT03929861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6174290|NCT01675661|Protective Agents|protective agents|mesh-ancestor
6174291|NCT01675661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174292|NCT01675661|Antidotes|antidotes|mesh-ancestor
6174293|NCT01675765|Cyclophosphamide|cyclophosphamide|mesh-list
6174294|NCT01675765|Cisplatin|cisplatin|mesh-list
6174295|NCT01675765|Pemetrexed|pemetrexed|mesh-list
6174296|NCT01675765|Immunologic Factors|immunologic factors|mesh-list
5570751|NCT03929861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570752|NCT03929861|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5570753|NCT03929861|Hormone Antagonists|hormone antagonists|mesh-ancestor
5570754|NCT03929861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5570755|NCT03929861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570756|NCT03929861|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5570757|NCT03929861|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5570758|NCT03929835|Chlorophyllin|chlorophyllin|mesh-list
5570759|NCT03929835|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
5570760|NCT03929835|Protective Agents|protective agents|mesh-ancestor
5570761|NCT03929835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570762|NCT03929419|Insulin|insulin|mesh-list
5570763|NCT03929419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5570764|NCT03929419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174297|NCT01675765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6174298|NCT01675765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174299|NCT01675765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6174300|NCT01675765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6174301|NCT01675765|Alkylating Agents|alkylating agents|mesh-ancestor
6174302|NCT01675765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174303|NCT01675765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6486280|NCT00569751|Tubulin Modulators|tubulin modulators|mesh-ancestor
5570765|NCT03929640|Acetaminophen|acetaminophen|mesh-list
5570766|NCT03929640|Ibuprofen|ibuprofen|mesh-list
5570767|NCT03929640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5570768|NCT03929640|Analgesics|analgesics|mesh-ancestor
5570769|NCT03929640|Sensory System Agents|sensory system agents|mesh-ancestor
6486281|NCT00569751|Antimitotic Agents|antimitotic agents|mesh-ancestor
6486282|NCT00569751|Mitosis Modulators|mitosis modulators|mesh-ancestor
6486283|NCT00569751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486284|NCT00569790|Bevacizumab|bevacizumab|mesh-list
6486285|NCT00569790|Irinotecan|irinotecan|mesh-list
5570770|NCT03929640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5570771|NCT03929640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570772|NCT03929640|Antipyretics|antipyretics|mesh-ancestor
5570773|NCT03929640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5570774|NCT03929640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5570775|NCT03929640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5570776|NCT03929640|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5570777|NCT03929640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5570778|NCT03929640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570779|NCT03929601|Rituximab|rituximab|mesh-list
5570780|NCT03929601|Abatacept|abatacept|mesh-list
5570781|NCT03929601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5570782|NCT03929601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5570783|NCT03929601|Immunologic Factors|immunologic factors|mesh-ancestor
5570784|NCT03929601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570785|NCT03929601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5570786|NCT03929601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5570787|NCT03929601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570788|NCT03929601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6486286|NCT00569790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6486287|NCT00569790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6486288|NCT00569790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6486289|NCT00569790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6486290|NCT00569790|Growth Substances|growth substances|mesh-ancestor
6174304|NCT01675765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5570789|NCT03929744|Midazolam|midazolam|mesh-list
5570790|NCT03929744|Atorvastatin|atorvastatin|mesh-list
5570791|NCT03929744|Simvastatin|simvastatin|mesh-list
5570792|NCT03929744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5570793|NCT03929744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5570794|NCT03929744|Antimetabolites|antimetabolites|mesh-ancestor
5570795|NCT03929744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570796|NCT03929744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5570797|NCT03929744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5570798|NCT03929744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5570799|NCT03929744|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5570800|NCT03929744|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5570801|NCT03929744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5570802|NCT03929744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570803|NCT03929744|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5570804|NCT03929744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5570805|NCT03929744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5570806|NCT03929744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5570807|NCT03929744|Anesthetics, General|anesthetics, general|mesh-ancestor
5570808|NCT03929744|Anesthetics|anesthetics|mesh-ancestor
5570809|NCT03929744|GABA Modulators|gaba modulators|mesh-ancestor
5570810|NCT03929744|GABA Agents|gaba agents|mesh-ancestor
5570811|NCT03929744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5570812|NCT03929575|Calcium|calcium|mesh-list
5570813|NCT03929575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5570814|NCT03929575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570815|NCT03929666|Leucovorin|leucovorin|mesh-list
5570816|NCT03929666|Gemcitabine|gemcitabine|mesh-list
5570817|NCT03929666|Bevacizumab|bevacizumab|mesh-list
6486291|NCT00569790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486292|NCT00569790|Growth Inhibitors|growth inhibitors|mesh-ancestor
6486293|NCT00569790|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6486294|NCT00569790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6486295|NCT00569790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6486296|NCT00569790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486297|NCT00569816|Sevoflurane|sevoflurane|mesh-list
6486298|NCT00569816|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6486299|NCT00569816|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6486300|NCT00569816|Anesthetics, General|anesthetics, general|mesh-ancestor
6486301|NCT00569816|Anesthetics|anesthetics|mesh-ancestor
6486302|NCT00569816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6174305|NCT01675765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6174306|NCT01675765|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6174307|NCT01675765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6174308|NCT01675778|Hydromorphone|hydromorphone|mesh-list
6174309|NCT01675778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6174310|NCT01675778|Narcotics|narcotics|mesh-ancestor
6486303|NCT00569816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486304|NCT00569881|Moxifloxacin|moxifloxacin|mesh-list
6486305|NCT00569881|Gatifloxacin|gatifloxacin|mesh-list
6486306|NCT00569881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6486307|NCT00569881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5570818|NCT03929666|Fluorouracil|fluorouracil|mesh-list
5570819|NCT03929666|Capecitabine|capecitabine|mesh-list
5570820|NCT03929666|Oxaliplatin|oxaliplatin|mesh-list
5570821|NCT03929666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6486308|NCT00569881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6486309|NCT00569881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6486310|NCT00569881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6486311|NCT00569881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486312|NCT00569881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6486313|NCT00569881|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6174311|NCT01675778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6174312|NCT01675778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174313|NCT01675778|Analgesics|analgesics|mesh-ancestor
6174314|NCT01675778|Sensory System Agents|sensory system agents|mesh-ancestor
6174315|NCT01675778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6174316|NCT01676116|Liraglutide|liraglutide|mesh-list
5570822|NCT03929666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5570823|NCT03929666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5570824|NCT03929666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5570825|NCT03929666|Growth Substances|growth substances|mesh-ancestor
5570826|NCT03929666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570827|NCT03929666|Growth Inhibitors|growth inhibitors|mesh-ancestor
5570828|NCT03929666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6174317|NCT01676116|Exenatide|exenatide|mesh-list
6174318|NCT01676116|Xultophy|xultophy|mesh-list
5570829|NCT03929666|Antimetabolites|antimetabolites|mesh-ancestor
5570830|NCT03929666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570831|NCT03929666|Antiviral Agents|antiviral agents|mesh-ancestor
5570832|NCT03929666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5570833|NCT03929666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5570834|NCT03929666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5570835|NCT03929666|Immunologic Factors|immunologic factors|mesh-ancestor
5570836|NCT03929666|Antidotes|antidotes|mesh-ancestor
5570837|NCT03929666|Protective Agents|protective agents|mesh-ancestor
5570838|NCT03929666|Vitamin B Complex|vitamin b complex|mesh-ancestor
5570839|NCT03929666|Vitamins|vitamins|mesh-ancestor
5570840|NCT03929666|Micronutrients|micronutrients|mesh-ancestor
5570841|NCT03929627|Hydrocortisone|hydrocortisone|mesh-list
5570842|NCT03929627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5570843|NCT03929224|Bacitracin|bacitracin|mesh-list
5570844|NCT03929224|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5570845|NCT03929224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5570846|NCT03929224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5570847|NCT03929094|Gemcitabine|gemcitabine|mesh-list
5570848|NCT03929094|Paclitaxel|paclitaxel|mesh-list
5570849|NCT03929094|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5570850|NCT03929094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5570851|NCT03929094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5570852|NCT03929094|Tubulin Modulators|tubulin modulators|mesh-ancestor
5570853|NCT03929094|Antimitotic Agents|antimitotic agents|mesh-ancestor
5570854|NCT03929094|Mitosis Modulators|mitosis modulators|mesh-ancestor
5570855|NCT03929094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570856|NCT03929094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5570857|NCT03929094|Antimetabolites|antimetabolites|mesh-ancestor
5570858|NCT03929094|Antiviral Agents|antiviral agents|mesh-ancestor
5570859|NCT03929094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5570860|NCT03929094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5570861|NCT03929094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5570862|NCT03929094|Immunologic Factors|immunologic factors|mesh-ancestor
5570863|NCT03929094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570864|NCT03929211|Hydroxychloroquine|hydroxychloroquine|mesh-list
5570865|NCT03929211|Antimalarials|antimalarials|mesh-ancestor
5570866|NCT03929211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5570867|NCT03929211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5570868|NCT03929211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5570869|NCT03929211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5570870|NCT03929211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570871|NCT03929211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5570872|NCT03929068|Levodopa|levodopa|mesh-list
5570873|NCT03929068|Carbidopa|carbidopa|mesh-list
5570874|NCT03929068|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
5570875|NCT03929068|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5570876|NCT03929068|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5570877|NCT03929068|Dopamine Agents|dopamine agents|mesh-ancestor
5570878|NCT03929068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5570879|NCT03929068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570880|NCT03929068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570881|NCT03929068|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5570882|NCT03929068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5570883|NCT03929068|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5570884|NCT03929068|Immunologic Factors|immunologic factors|mesh-ancestor
5570885|NCT03929068|Dopamine Agonists|dopamine agonists|mesh-ancestor
6174319|NCT01676116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6174320|NCT01676116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174321|NCT01676116|Incretins|incretins|mesh-ancestor
6174322|NCT01676116|Hormones|hormones|mesh-ancestor
6174323|NCT01676116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6174324|NCT01676116|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6174325|NCT01676220|Insulin|insulin|mesh-list
6174326|NCT01676220|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6174327|NCT01676220|Insulin Glargine|insulin glargine|mesh-list
6174328|NCT01676220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6174329|NCT01676220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174330|NCT01676311|Huperzine A|huperzine a|mesh-list
6174331|NCT01676311|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6174332|NCT01676311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6174333|NCT01676311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174334|NCT01676311|Cholinergic Agents|cholinergic agents|mesh-ancestor
6174335|NCT01676311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5604236|NCT05117710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5604237|NCT05113940|Midazolam|midazolam|mesh-list
5604238|NCT05113940|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6174336|NCT01676311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174337|NCT01676311|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6174338|NCT01676311|Protective Agents|protective agents|mesh-ancestor
6174339|NCT01676415|Mometasone Furoate|mometasone furoate|mesh-list
6174340|NCT01676415|Prednisone|prednisone|mesh-list
6174341|NCT01676415|Glucocorticoids|glucocorticoids|mesh-list
6174342|NCT01676415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6174343|NCT01676415|Hormones|hormones|mesh-ancestor
6174344|NCT01676415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6174345|NCT01676415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174346|NCT01676415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6174347|NCT01676415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6174348|NCT01676415|Dermatologic Agents|dermatologic agents|mesh-ancestor
6174349|NCT01676415|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6174350|NCT01677195|Calcium Carbonate|calcium carbonate|mesh-list
6174351|NCT01677195|Antacids|antacids|mesh-ancestor
6174352|NCT01677195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174353|NCT01677195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6174354|NCT01677286|Doxycycline|doxycycline|mesh-list
6174355|NCT01677286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6174356|NCT01677286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6174357|NCT01677286|Antimalarials|antimalarials|mesh-ancestor
6174358|NCT01677286|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6174359|NCT01677286|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6174360|NCT01677299|Metformin|metformin|mesh-list
6174361|NCT01677299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6174362|NCT01677299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174363|NCT01677377|Risperidone|risperidone|mesh-list
5570886|NCT03928496|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5570887|NCT03928496|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5570888|NCT03928496|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5570889|NCT03928496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5570890|NCT03928496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570891|NCT03928496|Cholinergic Agents|cholinergic agents|mesh-ancestor
5570892|NCT03928496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5570893|NCT03928496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570894|NCT03928496|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5570895|NCT03928496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5570896|NCT03928691|Magnesium Sulfate|magnesium sulfate|mesh-list
5570897|NCT03928691|Analgesics|analgesics|mesh-ancestor
5570898|NCT03928691|Sensory System Agents|sensory system agents|mesh-ancestor
5570899|NCT03928691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5570900|NCT03928691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570901|NCT03928691|Anesthetics|anesthetics|mesh-ancestor
5570902|NCT03928691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6174364|NCT01677377|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6174365|NCT01677377|Serotonin Agents|serotonin agents|mesh-ancestor
6174366|NCT01677377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6174367|NCT01677377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174368|NCT01677377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174369|NCT01677377|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6174370|NCT01677377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6174371|NCT01677377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6174372|NCT01677377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6174373|NCT01677377|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6174374|NCT01677377|Dopamine Agents|dopamine agents|mesh-ancestor
5570903|NCT03928691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5570904|NCT03928691|Anticonvulsants|anticonvulsants|mesh-ancestor
5570905|NCT03928691|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5570906|NCT03928691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5570907|NCT03928691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570908|NCT03928691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5570909|NCT03928691|Tocolytic Agents|tocolytic agents|mesh-ancestor
5570910|NCT03928691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5570911|NCT03928340|Metformin|metformin|mesh-list
5570912|NCT03928340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5570913|NCT03928340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570914|NCT03928353|Ticagrelor|ticagrelor|mesh-list
5570915|NCT03928353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5570916|NCT03928353|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5570917|NCT03928353|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5570918|NCT03928353|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6174375|NCT01677507|Timolol|timolol|mesh-list
6174376|NCT01677507|Latanoprost|latanoprost|mesh-list
6174377|NCT01677507|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5570919|NCT03928353|Purinergic Agents|purinergic agents|mesh-ancestor
5570920|NCT03928353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5570921|NCT03928353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570922|NCT03928353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570923|NCT03928314|Paclitaxel|paclitaxel|mesh-list
5570924|NCT03928314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6174378|NCT01677507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6174379|NCT01677507|Adrenergic Agents|adrenergic agents|mesh-ancestor
6174380|NCT01677507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6174381|NCT01677507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174382|NCT01677507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174383|NCT01677507|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6174384|NCT01677507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6174385|NCT01677507|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6174386|NCT01677507|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6174387|NCT01677741|Dabrafenib|dabrafenib|mesh-list
6174388|NCT01677741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6174389|NCT01677741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6174390|NCT01677741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6174391|NCT01677741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174392|NCT01677858|Dexamethasone|dexamethasone|mesh-list
6174393|NCT01677858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6174394|NCT01677858|Antiemetics|antiemetics|mesh-ancestor
6174395|NCT01677858|Autonomic Agents|autonomic agents|mesh-ancestor
6174396|NCT01677858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6174397|NCT01677858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174398|NCT01677858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6174399|NCT01677858|Glucocorticoids|glucocorticoids|mesh-ancestor
6174400|NCT01677858|Hormones|hormones|mesh-ancestor
6174401|NCT01677858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6174402|NCT01677858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6174403|NCT01677858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6174404|NCT01677988|Folfirinox|folfirinox|mesh-list
6174405|NCT01677988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6174406|NCT01678131|Ribavirin|ribavirin|mesh-list
6174407|NCT01678131|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6174408|NCT01678131|Interferon alpha-2|interferon alpha-2|mesh-list
6174409|NCT01678131|Liver Extracts|liver extracts|mesh-list
6174410|NCT01678131|Antimetabolites|antimetabolites|mesh-ancestor
6174411|NCT01678131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174412|NCT01678131|Antiviral Agents|antiviral agents|mesh-ancestor
6174413|NCT01678131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6174414|NCT01678131|Hematinics|hematinics|mesh-ancestor
6174415|NCT01678131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5570925|NCT03928314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5570926|NCT03928314|Tubulin Modulators|tubulin modulators|mesh-ancestor
5570927|NCT03928314|Antimitotic Agents|antimitotic agents|mesh-ancestor
5570928|NCT03928314|Mitosis Modulators|mitosis modulators|mesh-ancestor
6174416|NCT01678209|Methylphenidate|methylphenidate|mesh-list
6174417|NCT01678209|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6174418|NCT01678209|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6174419|NCT01678209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174420|NCT01678209|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6174421|NCT01678209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6174422|NCT01678209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6174423|NCT01678209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174424|NCT01678209|Dopamine Agents|dopamine agents|mesh-ancestor
6174425|NCT01678209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6174426|NCT01678209|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6174427|NCT01678209|Adrenergic Agents|adrenergic agents|mesh-ancestor
6174428|NCT01678313|Celecoxib|celecoxib|mesh-list
6174429|NCT01678313|Doxazosin|doxazosin|mesh-list
6174430|NCT01678313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6174431|NCT01678313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6174432|NCT01678313|Analgesics|analgesics|mesh-ancestor
6174433|NCT01678313|Sensory System Agents|sensory system agents|mesh-ancestor
6670302|NCT01542437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670303|NCT01542450|Insulin|insulin|mesh-list
6670304|NCT01542450|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6670305|NCT01542450|Insulin Detemir|insulin detemir|mesh-list
6670306|NCT01542450|Isophane Insulin, Human|isophane insulin, human|mesh-list
6174434|NCT01678313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6174435|NCT01678313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174436|NCT01678313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6174437|NCT01678313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6174438|NCT01678313|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6174439|NCT01678313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6486314|NCT00569881|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5570929|NCT03928314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570930|NCT03928366|Remifentanil|remifentanil|mesh-list
5570931|NCT03928366|Propofol|propofol|mesh-list
5570932|NCT03928366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5570933|NCT03928366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5570934|NCT03928366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570935|NCT03928366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5570936|NCT03928366|Anesthetics, General|anesthetics, general|mesh-ancestor
5570937|NCT03928366|Anesthetics|anesthetics|mesh-ancestor
5570938|NCT03928366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5570939|NCT03928366|Narcotics|narcotics|mesh-ancestor
5570940|NCT03928366|Analgesics|analgesics|mesh-ancestor
5570941|NCT03928366|Sensory System Agents|sensory system agents|mesh-ancestor
5570942|NCT03928366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5570943|NCT03928145|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5570944|NCT03928145|Chlorthalidone|chlorthalidone|mesh-list
5570945|NCT03928145|Amiloride|amiloride|mesh-list
5570946|NCT03928145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5570947|NCT03928145|Diuretics|diuretics|mesh-ancestor
5570948|NCT03928145|Natriuretic Agents|natriuretic agents|mesh-ancestor
5570949|NCT03928145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570950|NCT03928145|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5570951|NCT03928145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5570952|NCT03928145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570953|NCT03928145|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
5570954|NCT03928145|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5570955|NCT03928145|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
5570956|NCT03928145|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5570957|NCT03928262|Benralizumab|benralizumab|mesh-list
5570958|NCT03928262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6486315|NCT00569920|Dexamethasone|dexamethasone|mesh-list
6486316|NCT00569920|Dexamethasone acetate|dexamethasone acetate|mesh-list
6486317|NCT00569920|BB 1101|bb 1101|mesh-list
6486318|NCT00569920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6486319|NCT00569920|Antiemetics|antiemetics|mesh-ancestor
6486320|NCT00569920|Autonomic Agents|autonomic agents|mesh-ancestor
6486321|NCT00569920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6486322|NCT00569920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486323|NCT00569920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6486324|NCT00569920|Glucocorticoids|glucocorticoids|mesh-ancestor
6486325|NCT00569920|Hormones|hormones|mesh-ancestor
6174440|NCT01678313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6174441|NCT01678313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174442|NCT01678313|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6174443|NCT01678313|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6174444|NCT01678313|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6174445|NCT01678313|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6174446|NCT01678313|Adrenergic Agents|adrenergic agents|mesh-ancestor
6174447|NCT01678313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6174448|NCT01678443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6174449|NCT01678443|Antibodies|antibodies|mesh-list
6486326|NCT00569920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6486327|NCT00569920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6486328|NCT00569920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6486329|NCT00569920|Protease Inhibitors|protease inhibitors|mesh-ancestor
6486330|NCT00569920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6486331|NCT00569920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570959|NCT03928262|Respiratory System Agents|respiratory system agents|mesh-ancestor
5570960|NCT03928275|Aldesleukin|aldesleukin|mesh-list
5570961|NCT03928275|Interleukin-2|interleukin-2|mesh-list
5570962|NCT03928275|BCG Vaccine|bcg vaccine|mesh-list
5570963|NCT03928275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6670307|NCT01542450|Insulin, Isophane|insulin, isophane|mesh-list
6486332|NCT00569985|Cyclophosphamide|cyclophosphamide|mesh-list
6486333|NCT00569985|Carmustine|carmustine|mesh-list
6486334|NCT00569985|Etoposide|etoposide|mesh-list
6486335|NCT00569985|Etoposide phosphate|etoposide phosphate|mesh-list
6486336|NCT00569985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6486337|NCT00569985|Immunologic Factors|immunologic factors|mesh-ancestor
6486338|NCT00569985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570964|NCT03928275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5570965|NCT03928275|Analgesics|analgesics|mesh-ancestor
5570966|NCT03928275|Sensory System Agents|sensory system agents|mesh-ancestor
5570967|NCT03928275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5570968|NCT03928275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570969|NCT03928275|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5570970|NCT03928275|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5570971|NCT03928275|Antiviral Agents|antiviral agents|mesh-ancestor
5570972|NCT03928275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5570973|NCT03928275|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5570974|NCT03928275|Immunologic Factors|immunologic factors|mesh-ancestor
5570975|NCT03928288|Cabergoline|cabergoline|mesh-list
5570976|NCT03928288|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5570977|NCT03928288|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5570978|NCT03928288|Dopamine Agonists|dopamine agonists|mesh-ancestor
5570979|NCT03928288|Dopamine Agents|dopamine agents|mesh-ancestor
5570980|NCT03928288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5570981|NCT03928288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570982|NCT03928288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570983|NCT03928600|Misoprostol|misoprostol|mesh-list
5570984|NCT03928600|Dinoprostone|dinoprostone|mesh-list
5570985|NCT03928600|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5570986|NCT03928600|Abortifacient Agents|abortifacient agents|mesh-ancestor
5570987|NCT03928600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5570988|NCT03928600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486339|NCT00569985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6670308|NCT01542450|Isophane insulin, beef|isophane insulin, beef|mesh-list
6174450|NCT01678443|Immunoglobulins|immunoglobulins|mesh-list
6174451|NCT01678443|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6174452|NCT01678443|Immunologic Factors|immunologic factors|mesh-ancestor
6174453|NCT01678443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174454|NCT01678443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6174455|NCT01678794|Candesartan|candesartan|mesh-list
6174456|NCT01678794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6174457|NCT01678794|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6174458|NCT01678794|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6174459|NCT01678794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174460|NCT01678820|Metformin|metformin|mesh-list
6174461|NCT01678820|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6174462|NCT01678820|Glimepiride|glimepiride|mesh-list
6670309|NCT01542450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6670310|NCT01542450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670311|NCT01542463|Insulin Detemir|insulin detemir|mesh-list
6486340|NCT00569985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6486341|NCT00569985|Alkylating Agents|alkylating agents|mesh-ancestor
6174463|NCT01678820|Simvastatin|simvastatin|mesh-list
6174464|NCT01678820|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6174465|NCT01678820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174466|NCT01678820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6174467|NCT01678820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6174468|NCT01678820|Antimetabolites|antimetabolites|mesh-ancestor
6486342|NCT00569985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486343|NCT00569985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6486344|NCT00569985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6486345|NCT00569985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6486346|NCT00569985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6486347|NCT00569985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6486348|NCT00569985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5570989|NCT03928600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5570990|NCT03928600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5570991|NCT03928600|Oxytocics|oxytocics|mesh-ancestor
5570992|NCT03928210|Digoxin|digoxin|mesh-list
5570993|NCT03928210|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5570994|NCT03928210|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5570995|NCT03928210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5570996|NCT03928210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5570997|NCT03928210|Protective Agents|protective agents|mesh-ancestor
5570998|NCT03928210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5570999|NCT03927963|Dexmedetomidine|dexmedetomidine|mesh-list
6486349|NCT00570050|Insulin|insulin|mesh-list
6486350|NCT00570050|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6486351|NCT00570050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6486352|NCT00570050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486353|NCT00570180|Bortezomib|bortezomib|mesh-list
6486354|NCT00570180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6486355|NCT00570193|Ranibizumab|ranibizumab|mesh-list
6486356|NCT00570193|Verteporfin|verteporfin|mesh-list
5571000|NCT03927963|Propofol|propofol|mesh-list
5571001|NCT03927963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5571002|NCT03927963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5571003|NCT03927963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571004|NCT03927963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5571005|NCT03927963|Anesthetics, General|anesthetics, general|mesh-ancestor
5571006|NCT03927963|Anesthetics|anesthetics|mesh-ancestor
5571007|NCT03927963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5571008|NCT03927963|Analgesics|analgesics|mesh-ancestor
5571009|NCT03927963|Sensory System Agents|sensory system agents|mesh-ancestor
6486357|NCT00570193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6486358|NCT00570193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6174469|NCT01678820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174470|NCT01678820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6174471|NCT01678820|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6174472|NCT01678820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6174473|NCT01678820|Incretins|incretins|mesh-ancestor
6174474|NCT01678820|Hormones|hormones|mesh-ancestor
6174475|NCT01678820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6174476|NCT01678820|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6174477|NCT01678820|Protease Inhibitors|protease inhibitors|mesh-ancestor
6486359|NCT00570193|Growth Substances|growth substances|mesh-ancestor
6486360|NCT00570193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486361|NCT00570193|Growth Inhibitors|growth inhibitors|mesh-ancestor
6486362|NCT00570193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6486363|NCT00570193|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6174478|NCT01678820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6174479|NCT01678820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6174480|NCT01678820|Immunologic Factors|immunologic factors|mesh-ancestor
6174481|NCT01678911|Gabapentin|gabapentin|mesh-list
6174482|NCT01678911|Analgesics|analgesics|mesh-ancestor
6174483|NCT01678911|Sensory System Agents|sensory system agents|mesh-ancestor
6174484|NCT01678911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6174485|NCT01678911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174486|NCT01678911|Anticonvulsants|anticonvulsants|mesh-ancestor
6174487|NCT01678911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6174488|NCT01678911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6174489|NCT01678911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6174490|NCT01678911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6174491|NCT01678911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6174492|NCT01678911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6174493|NCT01678911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6174494|NCT01678911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174495|NCT01678911|Antimanic Agents|antimanic agents|mesh-ancestor
6174496|NCT01678976|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
6174497|NCT01678976|Oxcarbazepine|oxcarbazepine|mesh-list
6174498|NCT01678976|Anticonvulsants|anticonvulsants|mesh-ancestor
6174499|NCT01678976|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6174500|NCT01678976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6174501|NCT01678976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6174502|NCT01678976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174503|NCT01678976|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6174504|NCT01678976|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6174505|NCT01679002|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
6174506|NCT01679002|Oxcarbazepine|oxcarbazepine|mesh-list
6174507|NCT01679002|Anticonvulsants|anticonvulsants|mesh-ancestor
6174508|NCT01679002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6174509|NCT01679002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6174510|NCT01679002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6174511|NCT01679002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174512|NCT01679002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6174513|NCT01679002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6174514|NCT01679405|Gemcitabine|gemcitabine|mesh-list
6174515|NCT01679405|Cisplatin|cisplatin|mesh-list
6486364|NCT00570193|Dermatologic Agents|dermatologic agents|mesh-ancestor
6486365|NCT00570219|Valproic Acid|valproic acid|mesh-list
6486366|NCT00570219|Anticonvulsants|anticonvulsants|mesh-ancestor
6486367|NCT00570219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6486368|NCT00570219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486369|NCT00570219|GABA Agents|gaba agents|mesh-ancestor
6486370|NCT00570219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6670312|NCT01542463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6670313|NCT01542463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670314|NCT01542476|Insulin Detemir|insulin detemir|mesh-list
6670315|NCT01542476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6670316|NCT01542476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571010|NCT03927963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6174516|NCT01679405|Afatinib|afatinib|mesh-list
6174517|NCT01679405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6174518|NCT01679405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6174519|NCT01679405|Antimetabolites|antimetabolites|mesh-ancestor
6174520|NCT01679405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174521|NCT01679405|Antiviral Agents|antiviral agents|mesh-ancestor
6174522|NCT01679405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6174523|NCT01679405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6174524|NCT01679405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6174525|NCT01679405|Immunologic Factors|immunologic factors|mesh-ancestor
6486371|NCT00570219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486372|NCT00570219|Antimanic Agents|antimanic agents|mesh-ancestor
6486373|NCT00570219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6486374|NCT00570219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6486375|NCT00570219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6486376|NCT00570245|Nitric Oxide|nitric oxide|mesh-list
6486377|NCT00570245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6486378|NCT00570245|Autonomic Agents|autonomic agents|mesh-ancestor
6486379|NCT00570245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6486380|NCT00570245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486381|NCT00570245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6486382|NCT00570245|Respiratory System Agents|respiratory system agents|mesh-ancestor
6486383|NCT00570245|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6486384|NCT00570245|Antioxidants|antioxidants|mesh-ancestor
6486385|NCT00570245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486386|NCT00570245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5571011|NCT03927963|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5571012|NCT03927963|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6486387|NCT00570245|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6486388|NCT00570245|Vasodilator Agents|vasodilator agents|mesh-ancestor
6486389|NCT00570245|Gasotransmitters|gasotransmitters|mesh-ancestor
6486390|NCT00570245|Protective Agents|protective agents|mesh-ancestor
6486391|NCT00570284|Panobinostat|panobinostat|mesh-list
6486392|NCT00570284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6486393|NCT00570284|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5571013|NCT03927963|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5571014|NCT03927963|Adrenergic Agents|adrenergic agents|mesh-ancestor
6174526|NCT01679405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174527|NCT01679405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6206449|NCT02100475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6206450|NCT02100514|Bococizumab|bococizumab|mesh-list
6206451|NCT02100514|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5571015|NCT03927963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5571016|NCT03927963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5571017|NCT03928093|Pregabalin|pregabalin|mesh-list
5571018|NCT03928093|Analgesics|analgesics|mesh-ancestor
5571019|NCT03928093|Sensory System Agents|sensory system agents|mesh-ancestor
5571020|NCT03928093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5571021|NCT03928093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571022|NCT03928093|Anticonvulsants|anticonvulsants|mesh-ancestor
5571023|NCT03928093|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5571024|NCT03928093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5571025|NCT03928093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206452|NCT02100514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6206453|NCT02100514|Antimetabolites|antimetabolites|mesh-ancestor
6206454|NCT02100514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206455|NCT02100514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6206456|NCT02100579|Bupivacaine|bupivacaine|mesh-list
6206457|NCT02100579|Anesthetics, Local|anesthetics, local|mesh-ancestor
6486394|NCT00570284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6670317|NCT01542489|Insulin|insulin|mesh-list
6670318|NCT01542489|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6174528|NCT01679613|Ketoconazole|ketoconazole|mesh-list
5571026|NCT03928093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5571027|NCT03928093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5571028|NCT03928093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5571029|NCT03928093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5571030|NCT03928093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5571031|NCT03927807|Misoprostol|misoprostol|mesh-list
5571032|NCT03927807|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5571033|NCT03927807|Abortifacient Agents|abortifacient agents|mesh-ancestor
5571034|NCT03927807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5571035|NCT03927807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571036|NCT03927807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5571037|NCT03927807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5571038|NCT03927807|Oxytocics|oxytocics|mesh-ancestor
5571039|NCT03927989|Nicotine|nicotine|mesh-list
5571040|NCT03927989|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5571041|NCT03927989|Autonomic Agents|autonomic agents|mesh-ancestor
5571042|NCT03927989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5571043|NCT03927989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571044|NCT03927989|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5571045|NCT03927989|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5571046|NCT03927989|Cholinergic Agents|cholinergic agents|mesh-ancestor
5571047|NCT03927989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5571048|NCT03927989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5571049|NCT03928015|Analgesics|analgesics|mesh-list
5571050|NCT03928015|Dronabinol|dronabinol|mesh-list
6174529|NCT01679613|Nintedanib|nintedanib|mesh-list
6174530|NCT01679613|Antifungal Agents|antifungal agents|mesh-ancestor
6174531|NCT01679613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6174532|NCT01679613|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6174533|NCT01679613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6174534|NCT01679613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6489008|NCT00588835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5571051|NCT03928015|Sensory System Agents|sensory system agents|mesh-ancestor
5571052|NCT03928015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5571053|NCT03928015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571054|NCT03928015|Hallucinogens|hallucinogens|mesh-ancestor
5571055|NCT03928015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5571056|NCT03928015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5571057|NCT03928015|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5571058|NCT03928015|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5571059|NCT03928015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5571060|NCT03928015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5571061|NCT03928015|Hormones|hormones|mesh-ancestor
5571062|NCT03928015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5571063|NCT03927729|Methoxyflurane|methoxyflurane|mesh-list
5571064|NCT03927729|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5571065|NCT03927729|Anesthetics, General|anesthetics, general|mesh-ancestor
5571066|NCT03927729|Anesthetics|anesthetics|mesh-ancestor
5571067|NCT03927729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5571068|NCT03927729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571069|NCT03927378|Ketamine|ketamine|mesh-list
5571070|NCT03927378|Esketamine|esketamine|mesh-list
5571071|NCT03927378|Analgesics|analgesics|mesh-ancestor
5571072|NCT03927378|Sensory System Agents|sensory system agents|mesh-ancestor
5571073|NCT03927378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5571074|NCT03927378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571075|NCT03927378|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5571076|NCT03927378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5571077|NCT03927378|Anesthetics, General|anesthetics, general|mesh-ancestor
5571078|NCT03927378|Anesthetics|anesthetics|mesh-ancestor
5571079|NCT03927378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5571080|NCT03927378|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5571081|NCT03927378|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5571082|NCT03927378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5571083|NCT03927378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174535|NCT01679613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174536|NCT01679613|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6174537|NCT01679613|Hormone Antagonists|hormone antagonists|mesh-ancestor
6174538|NCT01679613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6174539|NCT01679613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174540|NCT01679613|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6174541|NCT01679613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5571084|NCT03927378|Antidepressive Agents|antidepressive agents|mesh-ancestor
5571085|NCT03927378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5571086|NCT03927352|Adalimumab|adalimumab|mesh-list
5571087|NCT03927352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5571088|NCT03927352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6486395|NCT00570284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486396|NCT00570375|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6486397|NCT00570375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6486398|NCT00570375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6486399|NCT00570375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6486400|NCT00570375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486401|NCT00570440|Levonorgestrel|levonorgestrel|mesh-list
6486402|NCT00570440|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6486403|NCT00570440|Contraceptive Agents|contraceptive agents|mesh-list
5571089|NCT03927456|Fulvestrant|fulvestrant|mesh-list
5571090|NCT03927456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5571091|NCT03927456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5571092|NCT03927456|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5571093|NCT03927456|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6486404|NCT00570440|Contraceptives, Oral|contraceptives, oral|mesh-list
6486405|NCT00570440|Estradiol|estradiol|mesh-list
6486406|NCT00570440|Estrogens|estrogens|mesh-ancestor
6486407|NCT00570440|Hormones|hormones|mesh-ancestor
6486408|NCT00570440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6486409|NCT00570440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486410|NCT00570440|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6486411|NCT00570440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6486412|NCT00570440|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6174542|NCT01679613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6174543|NCT01680172|Ketamine|ketamine|mesh-list
6174544|NCT01680172|Analgesics|analgesics|mesh-ancestor
6174545|NCT01680172|Sensory System Agents|sensory system agents|mesh-ancestor
6174546|NCT01680172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6174547|NCT01680172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174548|NCT01680172|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6174549|NCT01680172|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6174550|NCT01680172|Anesthetics, General|anesthetics, general|mesh-ancestor
6174551|NCT01680172|Anesthetics|anesthetics|mesh-ancestor
6174552|NCT01680172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6486413|NCT00570440|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6486414|NCT00570440|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6486415|NCT00570479|Anecortave|anecortave|mesh-list
6486416|NCT00570479|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6486417|NCT00570479|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6486418|NCT00570479|Growth Substances|growth substances|mesh-ancestor
5571094|NCT03927456|Hormone Antagonists|hormone antagonists|mesh-ancestor
6174553|NCT01680172|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6174554|NCT01680172|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6174555|NCT01680172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6174556|NCT01680172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174557|NCT01680341|Insulin|insulin|mesh-list
6174558|NCT01680341|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6174559|NCT01680341|Insulin Aspart|insulin aspart|mesh-list
6174560|NCT01680341|Insulin, Long-Acting|insulin, long-acting|mesh-list
5571095|NCT03927456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5571096|NCT03927456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571097|NCT03927495|Paclitaxel|paclitaxel|mesh-list
5571098|NCT03927495|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5571099|NCT03927495|Cisplatin|cisplatin|mesh-list
5571100|NCT03927495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5571101|NCT03927495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5571102|NCT03927495|Tubulin Modulators|tubulin modulators|mesh-ancestor
5571103|NCT03927495|Antimitotic Agents|antimitotic agents|mesh-ancestor
5571104|NCT03927495|Mitosis Modulators|mitosis modulators|mesh-ancestor
5571105|NCT03927495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5571106|NCT03927118|Dexamethasone|dexamethasone|mesh-list
5571107|NCT03927118|Dexamethasone acetate|dexamethasone acetate|mesh-list
5571108|NCT03927118|BB 1101|bb 1101|mesh-list
5571109|NCT03927118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5571110|NCT03927118|Antiemetics|antiemetics|mesh-ancestor
5571111|NCT03927118|Autonomic Agents|autonomic agents|mesh-ancestor
6174561|NCT01680341|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6174562|NCT01680341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5571112|NCT03927118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6206458|NCT02100579|Anesthetics|anesthetics|mesh-ancestor
5571113|NCT03927118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174563|NCT01680341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174564|NCT01680458|Fluconazole|fluconazole|mesh-list
6174565|NCT01680458|Antifungal Agents|antifungal agents|mesh-ancestor
6174566|NCT01680458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6174567|NCT01680458|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6174568|NCT01680458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6174569|NCT01680458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6174570|NCT01680458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174571|NCT01680458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6174572|NCT01680458|Hormone Antagonists|hormone antagonists|mesh-ancestor
6174573|NCT01680458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6174574|NCT01680458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174575|NCT01680458|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6174576|NCT01680458|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6174577|NCT01680497|Hyaluronic Acid|hyaluronic acid|mesh-list
6174578|NCT01680497|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6174579|NCT01680497|Immunologic Factors|immunologic factors|mesh-ancestor
6174580|NCT01680497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174581|NCT01680497|Viscosupplements|viscosupplements|mesh-ancestor
6486419|NCT00570479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486420|NCT00570479|Growth Inhibitors|growth inhibitors|mesh-ancestor
6486421|NCT00570479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6486422|NCT00570544|Tiotropium Bromide|tiotropium bromide|mesh-list
6486423|NCT00570544|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6486424|NCT00570544|Autonomic Agents|autonomic agents|mesh-ancestor
6486425|NCT00570544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6486426|NCT00570544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486427|NCT00570544|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6486428|NCT00570544|Respiratory System Agents|respiratory system agents|mesh-ancestor
6486429|NCT00570544|Parasympatholytics|parasympatholytics|mesh-ancestor
6486430|NCT00570544|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6486431|NCT00570544|Cholinergic Agents|cholinergic agents|mesh-ancestor
6486432|NCT00570544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6486433|NCT00570544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486434|NCT00570622|Pioglitazone|pioglitazone|mesh-list
5571114|NCT03927118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5571115|NCT03927118|Glucocorticoids|glucocorticoids|mesh-ancestor
5571116|NCT03927118|Hormones|hormones|mesh-ancestor
6486435|NCT00570622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6486436|NCT00570622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486437|NCT00570648|Hyaluronic Acid|hyaluronic acid|mesh-list
6486438|NCT00570648|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6486439|NCT00570648|Immunologic Factors|immunologic factors|mesh-ancestor
6486440|NCT00570648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486441|NCT00570648|Viscosupplements|viscosupplements|mesh-ancestor
6486442|NCT00570648|Protective Agents|protective agents|mesh-ancestor
6486443|NCT00570726|Ranibizumab|ranibizumab|mesh-list
6486444|NCT00570726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6486445|NCT00570726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6486446|NCT00570726|Growth Substances|growth substances|mesh-ancestor
6486447|NCT00570726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486448|NCT00570726|Growth Inhibitors|growth inhibitors|mesh-ancestor
6486449|NCT00570726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6486450|NCT00570830|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
6486451|NCT00570830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6486452|NCT00570830|Glucocorticoids|glucocorticoids|mesh-ancestor
6486453|NCT00570830|Hormones|hormones|mesh-ancestor
5571117|NCT03927118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5571118|NCT03927118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5571119|NCT03927118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5571120|NCT03927118|Protease Inhibitors|protease inhibitors|mesh-ancestor
5571121|NCT03927118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5571122|NCT03927118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5571123|NCT03927170|Metformin|metformin|mesh-list
5571124|NCT03927170|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5571125|NCT03927170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5571126|NCT03927170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571127|NCT03927170|Incretins|incretins|mesh-ancestor
5571128|NCT03927170|Hormones|hormones|mesh-ancestor
5571129|NCT03927170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5571130|NCT03927170|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5571131|NCT03927170|Protease Inhibitors|protease inhibitors|mesh-ancestor
6486454|NCT00570830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6486455|NCT00570830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486456|NCT00570843|Lubricant Eye Drops|lubricant eye drops|mesh-list
6486457|NCT00570843|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6486458|NCT00570843|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6486459|NCT00570856|Folic Acid|folic acid|mesh-list
6486460|NCT00570856|Hematinics|hematinics|mesh-ancestor
6486461|NCT00570856|Vitamin B Complex|vitamin b complex|mesh-ancestor
6486462|NCT00570856|Vitamins|vitamins|mesh-ancestor
6486463|NCT00570856|Micronutrients|micronutrients|mesh-ancestor
6486464|NCT00570856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486465|NCT00570882|Sunitinib|sunitinib|mesh-list
6486466|NCT00570882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6486467|NCT00570882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6486468|NCT00570882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6486469|NCT00570882|Growth Substances|growth substances|mesh-ancestor
6486470|NCT00570882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486471|NCT00570882|Growth Inhibitors|growth inhibitors|mesh-ancestor
6174582|NCT01680497|Protective Agents|protective agents|mesh-ancestor
6174583|NCT01680549|Gabapentin|gabapentin|mesh-list
6174584|NCT01680549|Analgesics|analgesics|mesh-ancestor
6174585|NCT01680549|Sensory System Agents|sensory system agents|mesh-ancestor
6174586|NCT01680549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6174587|NCT01680549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486472|NCT00570882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6486473|NCT00570882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6486474|NCT00570882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486475|NCT00570895|Ascorbic Acid|ascorbic acid|mesh-list
5571132|NCT03927170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5571133|NCT03927170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604239|NCT05113940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5604240|NCT05113940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5604241|NCT05113940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604242|NCT05113940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6486476|NCT00570895|Vitamins|vitamins|mesh-ancestor
6486477|NCT00570895|Micronutrients|micronutrients|mesh-ancestor
6486478|NCT00570895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486479|NCT00570895|Antioxidants|antioxidants|mesh-ancestor
6486480|NCT00570895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486481|NCT00570895|Protective Agents|protective agents|mesh-ancestor
6486482|NCT00570934|Calcium, Dietary|calcium, dietary|mesh-list
6486483|NCT00570934|Cholecalciferol|cholecalciferol|mesh-list
6486484|NCT00570934|Calcium|calcium|mesh-list
6486485|NCT00570934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6486486|NCT00570934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486487|NCT00570934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6486488|NCT00570934|Vitamins|vitamins|mesh-ancestor
5604243|NCT05113940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6174588|NCT01680549|Anticonvulsants|anticonvulsants|mesh-ancestor
6174589|NCT01680549|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6174590|NCT01680549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6174591|NCT01680549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6174592|NCT01680549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6174593|NCT01680549|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6174594|NCT01680549|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6174595|NCT01680549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6174596|NCT01680549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174597|NCT01680549|Antimanic Agents|antimanic agents|mesh-ancestor
6174598|NCT01680653|Glucagon|glucagon|mesh-list
6174599|NCT01680653|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5604244|NCT05113940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5604245|NCT05113940|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5604246|NCT05113940|Anesthetics, General|anesthetics, general|mesh-ancestor
5604247|NCT05113940|Anesthetics|anesthetics|mesh-ancestor
5604248|NCT05113940|GABA Modulators|gaba modulators|mesh-ancestor
5604249|NCT05113940|GABA Agents|gaba agents|mesh-ancestor
5604250|NCT05113940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5604251|NCT05113940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604252|NCT05107219|Linaclotide|linaclotide|mesh-list
5604253|NCT05107219|Plecanatide|plecanatide|mesh-list
6174600|NCT01680653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6174601|NCT01680653|Hormones|hormones|mesh-ancestor
6174602|NCT01680653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6174603|NCT01680653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174604|NCT01680653|Incretins|incretins|mesh-ancestor
6174605|NCT01680861|Mycophenolic Acid|mycophenolic acid|mesh-list
5571134|NCT03927313|Aspirin|aspirin|mesh-list
5571135|NCT03927313|Rifampin|rifampin|mesh-list
5571136|NCT03927313|Linezolid|linezolid|mesh-list
5571137|NCT03927313|Dexamethasone|dexamethasone|mesh-list
5571138|NCT03927313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5571139|NCT03927313|Antiemetics|antiemetics|mesh-ancestor
5571140|NCT03927313|Autonomic Agents|autonomic agents|mesh-ancestor
5571141|NCT03927313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5571142|NCT03927313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571143|NCT03927313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5571144|NCT03927313|Glucocorticoids|glucocorticoids|mesh-ancestor
5571145|NCT03927313|Hormones|hormones|mesh-ancestor
5571146|NCT03927313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5571147|NCT03927313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5571148|NCT03927313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5571149|NCT03927313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5571150|NCT03927313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5571151|NCT03927313|Analgesics|analgesics|mesh-ancestor
5571152|NCT03927313|Sensory System Agents|sensory system agents|mesh-ancestor
5571153|NCT03927313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5571154|NCT03927313|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5571155|NCT03927313|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5571156|NCT03927313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5571157|NCT03927313|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5571158|NCT03927313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5571159|NCT03927313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6174606|NCT01680861|Methylprednisolone|methylprednisolone|mesh-list
6174607|NCT01680861|Everolimus|everolimus|mesh-list
6174608|NCT01680861|Tacrolimus|tacrolimus|mesh-list
6486489|NCT00570934|Micronutrients|micronutrients|mesh-ancestor
6486490|NCT00570999|Mitogens|mitogens|mesh-list
6486491|NCT00570999|Mitosis Modulators|mitosis modulators|mesh-ancestor
6486492|NCT00570999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486493|NCT00571116|Arsenic Trioxide|arsenic trioxide|mesh-list
6486494|NCT00571116|Disulfiram|disulfiram|mesh-list
6486495|NCT00571116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6486496|NCT00571116|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6486497|NCT00571116|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
6486498|NCT00571116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6486499|NCT00571116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486500|NCT00571129|Mitomycins|mitomycins|mesh-list
6486501|NCT00571129|Mitomycin|mitomycin|mesh-list
5571160|NCT03927313|Antipyretics|antipyretics|mesh-ancestor
5571161|NCT03927313|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5571162|NCT03927313|Antitubercular Agents|antitubercular agents|mesh-ancestor
5571163|NCT03927313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5571164|NCT03927313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5571165|NCT03927313|Leprostatic Agents|leprostatic agents|mesh-ancestor
6174609|NCT01680861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6174610|NCT01680861|Immunologic Factors|immunologic factors|mesh-ancestor
6174611|NCT01680861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174612|NCT01680861|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6174613|NCT01680861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6174614|NCT01680861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174615|NCT01680861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6174616|NCT01680861|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6174617|NCT01680861|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6174618|NCT01680861|Antitubercular Agents|antitubercular agents|mesh-ancestor
6486502|NCT00571129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6486503|NCT00571129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6486504|NCT00571129|Alkylating Agents|alkylating agents|mesh-ancestor
6486505|NCT00571129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486506|NCT00571129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6486507|NCT00571129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6174619|NCT01680861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6174620|NCT01680861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6486508|NCT00571142|Bevacizumab|bevacizumab|mesh-list
6486509|NCT00571142|Temazepam|temazepam|mesh-list
6486510|NCT00571142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6486511|NCT00571142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6486512|NCT00571142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6486513|NCT00571142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6486514|NCT00571142|Growth Substances|growth substances|mesh-ancestor
6486515|NCT00571142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486516|NCT00571142|Growth Inhibitors|growth inhibitors|mesh-ancestor
5571166|NCT03927313|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6486517|NCT00571142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6486518|NCT00571142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6486519|NCT00571142|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6486520|NCT00571142|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6486521|NCT00571142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6486522|NCT00571142|GABA Modulators|gaba modulators|mesh-ancestor
6486523|NCT00571142|GABA Agents|gaba agents|mesh-ancestor
6486524|NCT00571142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6486525|NCT00571142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486526|NCT00571155|Levetiracetam|levetiracetam|mesh-list
6486527|NCT00571155|Anticonvulsants|anticonvulsants|mesh-ancestor
6486528|NCT00571155|Nootropic Agents|nootropic agents|mesh-ancestor
6486529|NCT00571246|Topiramate|topiramate|mesh-list
6486530|NCT00571246|Lamotrigine|lamotrigine|mesh-list
6486531|NCT00571246|Anticonvulsants|anticonvulsants|mesh-ancestor
6486532|NCT00571246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6486533|NCT00571246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486534|NCT00571246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6174621|NCT01680861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6174622|NCT01680861|Antiemetics|antiemetics|mesh-ancestor
6174623|NCT01680861|Autonomic Agents|autonomic agents|mesh-ancestor
6174624|NCT01680861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6174625|NCT01680861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6174626|NCT01680861|Glucocorticoids|glucocorticoids|mesh-ancestor
6174627|NCT01680861|Hormones|hormones|mesh-ancestor
6174628|NCT01680861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6174629|NCT01680861|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6174630|NCT01680861|Protective Agents|protective agents|mesh-ancestor
6486535|NCT00571246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6486536|NCT00571246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486537|NCT00571246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6486538|NCT00571246|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6486539|NCT00571246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6174631|NCT01680887|Varenicline|varenicline|mesh-list
6174632|NCT01680887|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6174633|NCT01680887|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6174634|NCT01680887|Cholinergic Agents|cholinergic agents|mesh-ancestor
6174635|NCT01680887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6174636|NCT01680887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174637|NCT01680887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174638|NCT01680900|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
6174639|NCT01680900|Antidepressive Agents|antidepressive agents|mesh-ancestor
6174640|NCT01680900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6174641|NCT01680900|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6174642|NCT01680900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6174643|NCT01680900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6174644|NCT01680900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174645|NCT01680900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5571167|NCT03927313|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5571168|NCT03927313|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5571169|NCT03927313|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5571170|NCT03927313|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5571171|NCT03927313|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5571172|NCT03927313|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5571173|NCT03927313|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5571174|NCT03927222|Temozolomide|temozolomide|mesh-list
6174646|NCT01680900|Serotonin Agents|serotonin agents|mesh-ancestor
6174647|NCT01680900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174648|NCT01680900|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6174649|NCT01680900|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6174650|NCT01680965|Ofatumumab|ofatumumab|mesh-list
6174651|NCT01680965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6174652|NCT01680991|Obinutuzumab|obinutuzumab|mesh-list
6486540|NCT00571246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5571175|NCT03927222|Molgramostim|molgramostim|mesh-list
5571176|NCT03927222|Sargramostim|sargramostim|mesh-list
5571177|NCT03927222|Immunologic Factors|immunologic factors|mesh-ancestor
5571178|NCT03927222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571179|NCT03927222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5571180|NCT03927222|Alkylating Agents|alkylating agents|mesh-ancestor
5571181|NCT03927222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5571182|NCT03927222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5571183|NCT03927248|Nivolumab|nivolumab|mesh-list
5571184|NCT03927248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5571185|NCT03927248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5571186|NCT03927248|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5571187|NCT03927248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5571188|NCT03927079|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6174653|NCT01680991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6174654|NCT01680991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6486541|NCT00571246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6486542|NCT00571246|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6486543|NCT00571285|Vitamin D|vitamin d|mesh-list
6486544|NCT00571285|Ergocalciferols|ergocalciferols|mesh-list
6486545|NCT00571285|Cholecalciferol|cholecalciferol|mesh-list
6486546|NCT00571285|Vitamins|vitamins|mesh-list
6486547|NCT00571285|Micronutrients|micronutrients|mesh-ancestor
6486548|NCT00571285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486549|NCT00571285|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5571189|NCT03927079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5571190|NCT03927079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5571191|NCT03927079|Antitubercular Agents|antitubercular agents|mesh-ancestor
5571192|NCT03926780|Warfarin|warfarin|mesh-list
5571193|NCT03926780|Rivaroxaban|rivaroxaban|mesh-list
5571194|NCT03926780|Anticoagulants|anticoagulants|mesh-ancestor
5571195|NCT03926780|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5571196|NCT03926780|Antithrombins|antithrombins|mesh-ancestor
5571197|NCT03926780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5571198|NCT03926780|Protease Inhibitors|protease inhibitors|mesh-ancestor
5571199|NCT03926780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5571200|NCT03926780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486550|NCT00571285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6486551|NCT00571298|Gemcitabine|gemcitabine|mesh-list
6486552|NCT00571298|Sodium thiosulfate|sodium thiosulfate|mesh-list
6486553|NCT00571298|Amifostine|amifostine|mesh-list
6486554|NCT00571298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6486555|NCT00571298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6486556|NCT00571298|Antimetabolites|antimetabolites|mesh-ancestor
5571201|NCT03926806|Vitamins|vitamins|mesh-list
5571202|NCT03926806|Vitamin B Complex|vitamin b complex|mesh-list
5571203|NCT03926806|Micronutrients|micronutrients|mesh-ancestor
5571204|NCT03926806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571205|NCT03926962|Nafithromycin|nafithromycin|mesh-list
5571206|NCT03926962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5571207|NCT03926962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5571208|NCT03926962|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5571209|NCT03926962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5571210|NCT03926962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5571211|NCT03926936|Fulvestrant|fulvestrant|mesh-list
6174655|NCT01681030|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6174656|NCT01681030|Hemostatics|hemostatics|mesh-ancestor
6174657|NCT01681030|Coagulants|coagulants|mesh-ancestor
6174658|NCT01681095|Tryptophan|tryptophan|mesh-list
6174659|NCT01681095|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6174660|NCT01681095|Antidepressive Agents|antidepressive agents|mesh-ancestor
6174661|NCT01681095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6174662|NCT01681186|Lansoprazole|lansoprazole|mesh-list
6174663|NCT01681186|Dexlansoprazole|dexlansoprazole|mesh-list
6174664|NCT01681186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6174665|NCT01681186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6174666|NCT01681186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6174667|NCT01681186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6174668|NCT01681186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174669|NCT01681212|Ipilimumab|ipilimumab|mesh-list
6670319|NCT01542489|Insulin Aspart|insulin aspart|mesh-list
6670320|NCT01542489|Insulin Detemir|insulin detemir|mesh-list
5571212|NCT03926936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6174670|NCT01681212|Dacarbazine|dacarbazine|mesh-list
6486557|NCT00571298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670321|NCT01542489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6670322|NCT01542489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571213|NCT03926936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5571214|NCT03926936|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5571215|NCT03926936|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5571216|NCT03926936|Hormone Antagonists|hormone antagonists|mesh-ancestor
5571217|NCT03926936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5571218|NCT03926936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571219|NCT03926663|Dexmedetomidine|dexmedetomidine|mesh-list
5571220|NCT03926663|Bupivacaine|bupivacaine|mesh-list
5571221|NCT03926663|Anesthetics, Local|anesthetics, local|mesh-ancestor
5571222|NCT03926663|Anesthetics|anesthetics|mesh-ancestor
5571223|NCT03926663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5571224|NCT03926663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571225|NCT03926663|Sensory System Agents|sensory system agents|mesh-ancestor
5571226|NCT03926663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5571227|NCT03926663|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5571228|NCT03926663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6670323|NCT01542697|Magnesium Sulfate|magnesium sulfate|mesh-list
6670324|NCT01542697|Analgesics|analgesics|mesh-ancestor
6670325|NCT01542697|Sensory System Agents|sensory system agents|mesh-ancestor
6670326|NCT01542697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6670327|NCT01542697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670328|NCT01542697|Anesthetics|anesthetics|mesh-ancestor
6670329|NCT01542697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6670330|NCT01542697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6670331|NCT01542697|Anticonvulsants|anticonvulsants|mesh-ancestor
6670332|NCT01542697|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6670333|NCT01542697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6670334|NCT01542697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5571229|NCT03926663|Analgesics|analgesics|mesh-ancestor
5571230|NCT03926663|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5571231|NCT03926663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5571232|NCT03926663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5571233|NCT03926663|Adrenergic Agents|adrenergic agents|mesh-ancestor
5571234|NCT03926663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5571235|NCT03926663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5571236|NCT03926702|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
5571237|NCT03926702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5571238|NCT03926754|Mirabegron|mirabegron|mesh-list
5571239|NCT03926754|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
5571240|NCT03926754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6670335|NCT01542697|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6670336|NCT01542697|Tocolytic Agents|tocolytic agents|mesh-ancestor
6670337|NCT01542697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6670338|NCT01542710|Timolol|timolol|mesh-list
6670339|NCT01542710|Bimatoprost|bimatoprost|mesh-list
6670340|NCT01542710|Travoprost|travoprost|mesh-list
6670341|NCT01542710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6670342|NCT01542710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6670343|NCT01542710|Adrenergic Agents|adrenergic agents|mesh-ancestor
6670344|NCT01542710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6670345|NCT01542710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670346|NCT01542710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670347|NCT01542710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6670348|NCT01542710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6670349|NCT01542723|Nadroparin|nadroparin|mesh-list
6670350|NCT01542723|Anticoagulants|anticoagulants|mesh-ancestor
6670351|NCT01542723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6670352|NCT01542723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6670353|NCT01542723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670354|NCT01542762|Nadroparin|nadroparin|mesh-list
6670355|NCT01542762|Anticoagulants|anticoagulants|mesh-ancestor
6670356|NCT01542762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6670357|NCT01542762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6670358|NCT01542762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670359|NCT01542801|Ciprofloxacin|ciprofloxacin|mesh-list
6670360|NCT01542801|Norfloxacin|norfloxacin|mesh-list
6670361|NCT01542801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6670362|NCT01542801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5571241|NCT03926754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5571242|NCT03926754|Adrenergic Agents|adrenergic agents|mesh-ancestor
6174671|NCT01681212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6670363|NCT01542801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6670364|NCT01542801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6670365|NCT01542801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6486558|NCT00571298|Antiviral Agents|antiviral agents|mesh-ancestor
6486559|NCT00571298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6486560|NCT00571298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5571243|NCT03926754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5571244|NCT03926754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5571245|NCT03926754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571246|NCT03926754|Urological Agents|urological agents|mesh-ancestor
5571247|NCT03926559|Morphine|morphine|mesh-list
5571248|NCT03926559|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5571249|NCT03926559|Narcotics|narcotics|mesh-ancestor
5571250|NCT03926559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5571251|NCT03926559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571252|NCT03926559|Analgesics|analgesics|mesh-ancestor
6486561|NCT00571298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6486562|NCT00571298|Immunologic Factors|immunologic factors|mesh-ancestor
6486563|NCT00571298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486564|NCT00571298|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6486565|NCT00571298|Protective Agents|protective agents|mesh-ancestor
6486566|NCT00571298|Antidotes|antidotes|mesh-ancestor
6486567|NCT00571298|Antioxidants|antioxidants|mesh-ancestor
6486568|NCT00571298|Antitubercular Agents|antitubercular agents|mesh-ancestor
6486569|NCT00571298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6486570|NCT00571298|Chelating Agents|chelating agents|mesh-ancestor
6486571|NCT00571298|Sequestering Agents|sequestering agents|mesh-ancestor
6486572|NCT00571337|Infliximab|infliximab|mesh-list
6486573|NCT00571337|Dermatologic Agents|dermatologic agents|mesh-ancestor
6486574|NCT00571337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6486575|NCT00571337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6486576|NCT00571506|Pioglitazone|pioglitazone|mesh-list
6486577|NCT00571506|Rosiglitazone|rosiglitazone|mesh-list
6486578|NCT00571506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6486579|NCT00571506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486580|NCT00571558|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6486581|NCT00571558|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6670366|NCT01542801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5571253|NCT03926559|Sensory System Agents|sensory system agents|mesh-ancestor
5571254|NCT03926559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5571255|NCT03926377|Clobetasol|clobetasol|mesh-list
5571256|NCT03926377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5571257|NCT03926377|Glucocorticoids|glucocorticoids|mesh-ancestor
5571258|NCT03926377|Hormones|hormones|mesh-ancestor
5571259|NCT03926377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5571260|NCT03926377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174672|NCT01681212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6174673|NCT01681212|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6174674|NCT01681212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174675|NCT01681212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6174676|NCT01681212|Alkylating Agents|alkylating agents|mesh-ancestor
6174677|NCT01681433|Prednisone|prednisone|mesh-list
6174678|NCT01681433|Abiraterone Acetate|abiraterone acetate|mesh-list
6174679|NCT01681433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6174680|NCT01681433|Glucocorticoids|glucocorticoids|mesh-ancestor
6174681|NCT01681433|Hormones|hormones|mesh-ancestor
5571261|NCT03926403|Anesthetics|anesthetics|mesh-list
5571262|NCT03926403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5571263|NCT03926403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571264|NCT03926338|Celecoxib|celecoxib|mesh-list
5571265|NCT03926338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
5571266|NCT03926338|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
6174682|NCT01681433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6174683|NCT01681433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174684|NCT01681433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6174685|NCT01681433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6174686|NCT01681433|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6174687|NCT01681433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6174688|NCT01681433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174689|NCT01681433|Hormone Antagonists|hormone antagonists|mesh-ancestor
6174690|NCT01681433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6174691|NCT01681472|Leucovorin|leucovorin|mesh-list
6174692|NCT01681472|Tetrahydrofolates|tetrahydrofolates|mesh-list
6174693|NCT01681472|Levoleucovorin|levoleucovorin|mesh-list
6174694|NCT01681472|Antidotes|antidotes|mesh-ancestor
6174695|NCT01681472|Protective Agents|protective agents|mesh-ancestor
6486582|NCT00571558|Dermatologic Agents|dermatologic agents|mesh-ancestor
6486583|NCT00571636|Fentanyl|fentanyl|mesh-list
6486584|NCT00571636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6486585|NCT00571636|Narcotics|narcotics|mesh-ancestor
5571267|NCT03926338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5571268|NCT03926338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5571269|NCT03926338|Analgesics|analgesics|mesh-ancestor
5571270|NCT03926338|Sensory System Agents|sensory system agents|mesh-ancestor
5571271|NCT03926338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5571272|NCT03926338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571273|NCT03926338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5571274|NCT03926338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6486586|NCT00571636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6486587|NCT00571636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486588|NCT00571636|Analgesics|analgesics|mesh-ancestor
6486589|NCT00571636|Sensory System Agents|sensory system agents|mesh-ancestor
6486590|NCT00571636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6486591|NCT00571636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6486592|NCT00571636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6486593|NCT00571636|Anesthetics, General|anesthetics, general|mesh-ancestor
6486594|NCT00571636|Anesthetics|anesthetics|mesh-ancestor
6486595|NCT00571675|Prednisone|prednisone|mesh-list
6486596|NCT00571675|Docetaxel|docetaxel|mesh-list
6486597|NCT00571675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5571275|NCT03926338|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5571276|NCT03926338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5571277|NCT03926338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5571278|NCT03926338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5571279|NCT03926182|Aflutinib|aflutinib|mesh-list
6486598|NCT00571675|Tubulin Modulators|tubulin modulators|mesh-ancestor
6486599|NCT00571675|Antimitotic Agents|antimitotic agents|mesh-ancestor
6486600|NCT00571675|Mitosis Modulators|mitosis modulators|mesh-ancestor
6486601|NCT00571675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486602|NCT00571675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6486603|NCT00571675|Glucocorticoids|glucocorticoids|mesh-ancestor
6486604|NCT00571675|Hormones|hormones|mesh-ancestor
6486605|NCT00571675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6486606|NCT00571675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486607|NCT00571675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6486608|NCT00571714|Ribavirin|ribavirin|mesh-list
6486609|NCT00571714|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6486610|NCT00571714|Interferon-alpha|interferon-alpha|mesh-list
6486611|NCT00571714|Betaine|betaine|mesh-list
5571280|NCT03926182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5571281|NCT03926182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5571282|NCT03926182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5571283|NCT03926156|Warfarin|warfarin|mesh-list
5571284|NCT03926156|Rivaroxaban|rivaroxaban|mesh-list
5571285|NCT03926156|Anticoagulants|anticoagulants|mesh-ancestor
5571286|NCT03926156|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5571287|NCT03926156|Antithrombins|antithrombins|mesh-ancestor
5571288|NCT03926156|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5571289|NCT03926156|Protease Inhibitors|protease inhibitors|mesh-ancestor
5571290|NCT03926156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5571291|NCT03926156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5571292|NCT03926000|Pregabalin|pregabalin|mesh-list
5571293|NCT03926000|Analgesics|analgesics|mesh-ancestor
5571294|NCT03926000|Sensory System Agents|sensory system agents|mesh-ancestor
6486612|NCT00571714|Antimetabolites|antimetabolites|mesh-ancestor
6486613|NCT00571714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486614|NCT00571714|Antiviral Agents|antiviral agents|mesh-ancestor
6486615|NCT00571714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6486616|NCT00571714|Immunologic Factors|immunologic factors|mesh-ancestor
6486617|NCT00571714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486618|NCT00571714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5571295|NCT03926000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5571296|NCT03926000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174696|NCT01681472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174697|NCT01681472|Vitamin B Complex|vitamin b complex|mesh-ancestor
6174698|NCT01681472|Vitamins|vitamins|mesh-ancestor
6174699|NCT01681472|Micronutrients|micronutrients|mesh-ancestor
6174700|NCT01681576|Valsartan|valsartan|mesh-list
5571297|NCT03926000|Anticonvulsants|anticonvulsants|mesh-ancestor
6174701|NCT01681576|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
6174702|NCT01681576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6208005|NCT02123446|Cephalexin|cephalexin|mesh-list
6486619|NCT00571714|Lipotropic Agents|lipotropic agents|mesh-ancestor
6486620|NCT00571714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6174703|NCT01681576|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6486621|NCT00571714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6486622|NCT00571727|Mecasermin|mecasermin|mesh-list
6486623|NCT00571727|Growth Substances|growth substances|mesh-ancestor
6486624|NCT00571727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486625|NCT00571740|Leucovorin|leucovorin|mesh-list
5571298|NCT03926000|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5571299|NCT03926000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5571300|NCT03926000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5571301|NCT03926000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5571302|NCT03926000|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5571303|NCT03926000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5571304|NCT03926000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5571305|NCT03926000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5571306|NCT03925818|Metronidazole|metronidazole|mesh-list
5571307|NCT03925818|Tetracycline|tetracycline|mesh-list
5571308|NCT03925818|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
5571309|NCT03925818|Pantoprazole|pantoprazole|mesh-list
5571310|NCT03925818|Bismuth|bismuth|mesh-list
5571311|NCT03925818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5571312|NCT03925818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5571313|NCT03925818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5571314|NCT03925818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6486626|NCT00571740|Bevacizumab|bevacizumab|mesh-list
6486627|NCT00571740|Cetuximab|cetuximab|mesh-list
6486628|NCT00571740|Fluorouracil|fluorouracil|mesh-list
6486629|NCT00571740|Oxaliplatin|oxaliplatin|mesh-list
6486630|NCT00571740|Calcium|calcium|mesh-list
6486631|NCT00571740|Levoleucovorin|levoleucovorin|mesh-list
6486632|NCT00571740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6486633|NCT00571740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6486634|NCT00571740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6174704|NCT01681576|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6174705|NCT01681576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174706|NCT01681849|Paroxetine|paroxetine|mesh-list
6174707|NCT01681849|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6174708|NCT01681849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6174709|NCT01681849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6174710|NCT01681849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174711|NCT01681849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6486635|NCT00571740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6486636|NCT00571740|Growth Substances|growth substances|mesh-ancestor
6486637|NCT00571740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486638|NCT00571740|Growth Inhibitors|growth inhibitors|mesh-ancestor
6486639|NCT00571740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6486640|NCT00571740|Antimetabolites|antimetabolites|mesh-ancestor
6486641|NCT00571740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486642|NCT00571740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6486643|NCT00571740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6486644|NCT00571740|Immunologic Factors|immunologic factors|mesh-ancestor
6486645|NCT00571740|Antidotes|antidotes|mesh-ancestor
6486646|NCT00571740|Protective Agents|protective agents|mesh-ancestor
6486647|NCT00571740|Vitamin B Complex|vitamin b complex|mesh-ancestor
6486648|NCT00571740|Vitamins|vitamins|mesh-ancestor
6486649|NCT00571740|Micronutrients|micronutrients|mesh-ancestor
6486650|NCT00571753|Isoniazid|isoniazid|mesh-list
6486651|NCT00571753|Antitubercular Agents|antitubercular agents|mesh-ancestor
6486652|NCT00571753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6486653|NCT00571753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6486654|NCT00571753|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6486655|NCT00571753|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6486656|NCT00571753|Antimetabolites|antimetabolites|mesh-ancestor
6486657|NCT00571753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486658|NCT00571753|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6486659|NCT00571805|Varenicline|varenicline|mesh-list
6486660|NCT00571805|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6486661|NCT00571805|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6486662|NCT00571805|Cholinergic Agents|cholinergic agents|mesh-ancestor
6486663|NCT00571805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5571315|NCT03925818|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5571316|NCT03925818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5571317|NCT03925818|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5571318|NCT03925818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6486664|NCT00571805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5571319|NCT03925818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486665|NCT00571805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571320|NCT03925818|Antacids|antacids|mesh-ancestor
5571321|NCT03925818|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5571322|NCT03926091|Cyclophosphamide|cyclophosphamide|mesh-list
5571323|NCT03926091|Docetaxel|docetaxel|mesh-list
5571324|NCT03926091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5571325|NCT03926091|Immunologic Factors|immunologic factors|mesh-ancestor
5571326|NCT03926091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571327|NCT03926091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5571328|NCT03926091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5571329|NCT03926091|Alkylating Agents|alkylating agents|mesh-ancestor
6486666|NCT00571870|Cetrorelix|cetrorelix|mesh-list
6486667|NCT00571870|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6486668|NCT00571870|Fertility Agents|fertility agents|mesh-ancestor
6486669|NCT00571870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6486670|NCT00571870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486671|NCT00571870|Hormone Antagonists|hormone antagonists|mesh-ancestor
6486672|NCT00571870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5571330|NCT03926091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5571331|NCT03926091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5571332|NCT03926091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5571333|NCT03926091|Tubulin Modulators|tubulin modulators|mesh-ancestor
5571334|NCT03926091|Antimitotic Agents|antimitotic agents|mesh-ancestor
5571335|NCT03926091|Mitosis Modulators|mitosis modulators|mesh-ancestor
5571336|NCT03925714|Metformin|metformin|mesh-list
5571337|NCT03925714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5571338|NCT03925714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571339|NCT03925779|Dexmedetomidine|dexmedetomidine|mesh-list
5571340|NCT03925779|Remifentanil|remifentanil|mesh-list
5571341|NCT03925779|Propofol|propofol|mesh-list
6489009|NCT00588835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489010|NCT00588835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6489011|NCT00588835|Glucocorticoids|glucocorticoids|mesh-ancestor
6174712|NCT01681849|Serotonin Agents|serotonin agents|mesh-ancestor
6174713|NCT01681849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174714|NCT01681849|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6174715|NCT01681849|Antidepressive Agents|antidepressive agents|mesh-ancestor
6174716|NCT01681849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6174717|NCT01681849|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6174718|NCT01681849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6174719|NCT01681849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5571342|NCT03925779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5571343|NCT03925779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5571344|NCT03925779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571345|NCT03925779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5571346|NCT03925779|Anesthetics, General|anesthetics, general|mesh-ancestor
5571347|NCT03925779|Anesthetics|anesthetics|mesh-ancestor
5571348|NCT03925779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5571349|NCT03925779|Analgesics|analgesics|mesh-ancestor
5571350|NCT03925779|Sensory System Agents|sensory system agents|mesh-ancestor
5571351|NCT03925779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5571352|NCT03925779|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5571353|NCT03925779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5571354|NCT03925779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5571355|NCT03925779|Adrenergic Agents|adrenergic agents|mesh-ancestor
5571356|NCT03925779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5571357|NCT03925779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5571358|NCT03925779|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5571359|NCT03925779|Narcotics|narcotics|mesh-ancestor
5571360|NCT03925740|Listerine|listerine|mesh-list
5571361|NCT03925740|Fluorides|fluorides|mesh-list
5571362|NCT03925740|Sodium Fluoride|sodium fluoride|mesh-list
5571363|NCT03925740|Cariostatic Agents|cariostatic agents|mesh-ancestor
5571364|NCT03925740|Protective Agents|protective agents|mesh-ancestor
5571365|NCT03925740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571366|NCT03925740|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5571367|NCT03925740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5571368|NCT03925701|Metformin|metformin|mesh-list
5571369|NCT03925701|Vildagliptin|vildagliptin|mesh-list
6174720|NCT01681992|Vaccines|vaccines|mesh-list
6174721|NCT01681992|Immunologic Factors|immunologic factors|mesh-ancestor
6174722|NCT01681992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571370|NCT03925701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5571371|NCT03925701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571372|NCT03925701|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5571373|NCT03925701|Protease Inhibitors|protease inhibitors|mesh-ancestor
5571374|NCT03925701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6174723|NCT01682031|Selenium|selenium|mesh-list
6174724|NCT01682031|Antioxidants|antioxidants|mesh-ancestor
6174725|NCT01682031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174726|NCT01682031|Protective Agents|protective agents|mesh-ancestor
6174727|NCT01682031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174728|NCT01682031|Trace Elements|trace elements|mesh-ancestor
6174729|NCT01682031|Micronutrients|micronutrients|mesh-ancestor
6174730|NCT01682044|Rituximab|rituximab|mesh-list
6174731|NCT01682044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6174732|NCT01682044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6174733|NCT01682044|Immunologic Factors|immunologic factors|mesh-ancestor
6174734|NCT01682044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174735|NCT01682044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6174736|NCT01682083|Trametinib|trametinib|mesh-list
6174737|NCT01682083|Dabrafenib|dabrafenib|mesh-list
6174738|NCT01682083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6174739|NCT01682083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6174740|NCT01682083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6174741|NCT01682083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174742|NCT01682135|Ramucirumab|ramucirumab|mesh-list
6174743|NCT01682135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6174744|NCT01682148|Botulinum Toxins|botulinum toxins|mesh-list
6174745|NCT01682148|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6174746|NCT01682148|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6174747|NCT01682148|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6174748|NCT01682148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6174749|NCT01682148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174750|NCT01682148|Cholinergic Agents|cholinergic agents|mesh-ancestor
6174751|NCT01682148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6174752|NCT01682148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174753|NCT01682148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6174754|NCT01682148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6174755|NCT01682213|Dabrafenib|dabrafenib|mesh-list
6174756|NCT01682213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6174757|NCT01682213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5571375|NCT03925701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5571376|NCT03925662|Mebendazole|mebendazole|mesh-list
5571377|NCT03925662|Piperazine|piperazine|mesh-list
5571378|NCT03925662|Piperazine citrate|piperazine citrate|mesh-list
5571379|NCT03925662|Bevacizumab|bevacizumab|mesh-list
5571380|NCT03925662|DMP 777|dmp 777|mesh-list
5571381|NCT03925662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5571382|NCT03925662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5571383|NCT03925662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5571384|NCT03925662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5571385|NCT03925662|Growth Substances|growth substances|mesh-ancestor
5571386|NCT03925662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571387|NCT03925662|Growth Inhibitors|growth inhibitors|mesh-ancestor
5571388|NCT03925662|Antinematodal Agents|antinematodal agents|mesh-ancestor
6174758|NCT01682213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6174759|NCT01682213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174760|NCT01682460|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5571389|NCT03925662|Anthelmintics|anthelmintics|mesh-ancestor
5571390|NCT03925662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5571391|NCT03925662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5571392|NCT03925662|Tubulin Modulators|tubulin modulators|mesh-ancestor
5571393|NCT03925662|Antimitotic Agents|antimitotic agents|mesh-ancestor
5571394|NCT03925662|Mitosis Modulators|mitosis modulators|mesh-ancestor
5571395|NCT03925662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5571396|NCT03925662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5604254|NCT05107219|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
5604255|NCT05107219|Enzyme Activators|enzyme activators|mesh-ancestor
5604256|NCT05107219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174761|NCT01682460|Lubricant Eye Drops|lubricant eye drops|mesh-list
6174762|NCT01682460|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6174763|NCT01682512|Rituximab|rituximab|mesh-list
6174764|NCT01682512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6174765|NCT01682512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6174766|NCT01682512|Immunologic Factors|immunologic factors|mesh-ancestor
6174767|NCT01682512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174768|NCT01682512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6174769|NCT01682538|Nitisinone|nitisinone|mesh-list
6174770|NCT01682538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5604257|NCT05107219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6206459|NCT02100579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6174771|NCT01682538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174772|NCT01682603|Botulinum Toxins|botulinum toxins|mesh-list
6174773|NCT01682603|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6174774|NCT01682603|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6174775|NCT01682603|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6486673|NCT00571935|Insulin|insulin|mesh-list
6486674|NCT00571935|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6486675|NCT00571935|Insulin Aspart|insulin aspart|mesh-list
6486676|NCT00571935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6486677|NCT00571935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486678|NCT00572013|Rituximab|rituximab|mesh-list
6486679|NCT00572013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6486680|NCT00572013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6486681|NCT00572013|Immunologic Factors|immunologic factors|mesh-ancestor
6486682|NCT00572013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486683|NCT00572013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6486684|NCT00572026|Methylphenidate|methylphenidate|mesh-list
6486685|NCT00572026|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6486686|NCT00572026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486687|NCT00572026|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6486688|NCT00572026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6486689|NCT00572026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6486690|NCT00572026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486691|NCT00572026|Dopamine Agents|dopamine agents|mesh-ancestor
6486692|NCT00572026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6486693|NCT00572065|Cytarabine|cytarabine|mesh-list
6486694|NCT00572065|Arsenic Trioxide|arsenic trioxide|mesh-list
6486695|NCT00572065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6486696|NCT00572065|Antimetabolites|antimetabolites|mesh-ancestor
6174776|NCT01682603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6174777|NCT01682603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174778|NCT01682603|Cholinergic Agents|cholinergic agents|mesh-ancestor
6174779|NCT01682603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6174780|NCT01682603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174781|NCT01682603|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6174782|NCT01682603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6174783|NCT01682642|Goserelin|goserelin|mesh-list
6174784|NCT01682642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6174785|NCT01682642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6174786|NCT01682681|Topiramate|topiramate|mesh-list
6174787|NCT01682681|Anticonvulsants|anticonvulsants|mesh-ancestor
6174788|NCT01682681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6174789|NCT01682681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174790|NCT01682720|Sofosbuvir|sofosbuvir|mesh-list
6174791|NCT01682720|Antiviral Agents|antiviral agents|mesh-ancestor
6174792|NCT01682720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6174793|NCT01682759|Metformin|metformin|mesh-list
6486697|NCT00572065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486698|NCT00572065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6486699|NCT00572065|Antiviral Agents|antiviral agents|mesh-ancestor
6174794|NCT01682759|Insulin Glargine|insulin glargine|mesh-list
6174795|NCT01682759|Glimepiride|glimepiride|mesh-list
6174796|NCT01682759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6174797|NCT01682759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174798|NCT01682759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6174799|NCT01682759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6174800|NCT01682759|Immunologic Factors|immunologic factors|mesh-ancestor
6174801|NCT01682811|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6174802|NCT01682811|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6174803|NCT01682811|Dermatologic Agents|dermatologic agents|mesh-ancestor
6174804|NCT01682837|Potassium Citrate|potassium citrate|mesh-list
6174805|NCT01682837|Magnesium citrate|magnesium citrate|mesh-list
6174806|NCT01682837|Citric Acid|citric acid|mesh-list
6486700|NCT00572065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6486701|NCT00572065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6486702|NCT00572065|Immunologic Factors|immunologic factors|mesh-ancestor
6670367|NCT01542801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6670368|NCT01542801|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6670369|NCT01542801|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6670370|NCT01542827|Analgesics|analgesics|mesh-list
6670371|NCT01542827|Sensory System Agents|sensory system agents|mesh-ancestor
6174807|NCT01682837|Sodium Citrate|sodium citrate|mesh-list
6174808|NCT01682837|Anticoagulants|anticoagulants|mesh-ancestor
6174809|NCT01682837|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6174810|NCT01682837|Chelating Agents|chelating agents|mesh-ancestor
6174811|NCT01682837|Sequestering Agents|sequestering agents|mesh-ancestor
5571397|NCT03925194|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5571398|NCT03925194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5571399|NCT03925233|Tamoxifen|tamoxifen|mesh-list
5571400|NCT03925233|Toremifene|toremifene|mesh-list
5571401|NCT03925233|Gemcitabine|gemcitabine|mesh-list
5571402|NCT03925233|Vinorelbine|vinorelbine|mesh-list
5571403|NCT03925233|Cyclophosphamide|cyclophosphamide|mesh-list
5571404|NCT03925233|Bevacizumab|bevacizumab|mesh-list
5571405|NCT03925233|Carboplatin|carboplatin|mesh-list
5571406|NCT03925233|Doxorubicin|doxorubicin|mesh-list
5571407|NCT03925233|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5571408|NCT03925233|Fluorouracil|fluorouracil|mesh-list
5571409|NCT03925233|Capecitabine|capecitabine|mesh-list
5571410|NCT03925233|Methotrexate|methotrexate|mesh-list
5571411|NCT03925233|Trastuzumab|trastuzumab|mesh-list
5571412|NCT03925233|Letrozole|letrozole|mesh-list
5571413|NCT03925233|Apatinib|apatinib|mesh-list
5571414|NCT03925233|Epirubicin|epirubicin|mesh-list
5571415|NCT03925233|Olaparib|olaparib|mesh-list
5571416|NCT03925233|Fulvestrant|fulvestrant|mesh-list
5571417|NCT03925233|Anastrozole|anastrozole|mesh-list
5571418|NCT03925233|Exemestane|exemestane|mesh-list
6486703|NCT00572065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486704|NCT00572078|Sorafenib|sorafenib|mesh-list
6486705|NCT00572078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5571419|NCT03925233|Endostatins|endostatins|mesh-list
5571420|NCT03925233|Pirarubicin|pirarubicin|mesh-list
5571421|NCT03925233|Citric Acid|citric acid|mesh-list
5571422|NCT03925233|Sodium Citrate|sodium citrate|mesh-list
5571423|NCT03925233|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5571424|NCT03925233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5571425|NCT03925233|Tubulin Modulators|tubulin modulators|mesh-ancestor
5571426|NCT03925233|Antimitotic Agents|antimitotic agents|mesh-ancestor
5571427|NCT03925233|Mitosis Modulators|mitosis modulators|mesh-ancestor
5571428|NCT03925233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5571429|NCT03925233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5571430|NCT03925233|Immunologic Factors|immunologic factors|mesh-ancestor
5571431|NCT03925233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571432|NCT03925233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5571433|NCT03925233|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5571434|NCT03925233|Alkylating Agents|alkylating agents|mesh-ancestor
5571435|NCT03925233|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5571436|NCT03925233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5571437|NCT03925233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6486706|NCT00572078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6174812|NCT01682837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174813|NCT01682837|Diuretics|diuretics|mesh-ancestor
6174814|NCT01682837|Natriuretic Agents|natriuretic agents|mesh-ancestor
6174815|NCT01682837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174816|NCT01682837|Expectorants|expectorants|mesh-ancestor
5571438|NCT03925233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5571439|NCT03925233|Growth Substances|growth substances|mesh-ancestor
5571440|NCT03925233|Growth Inhibitors|growth inhibitors|mesh-ancestor
5571441|NCT03925233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5571442|NCT03925233|Antimetabolites|antimetabolites|mesh-ancestor
5571443|NCT03925233|Antiviral Agents|antiviral agents|mesh-ancestor
5571444|NCT03925233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5571445|NCT03925233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5571446|NCT03925233|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5571447|NCT03925233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5571448|NCT03925233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5571449|NCT03925233|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5571450|NCT03925233|Abortifacient Agents|abortifacient agents|mesh-ancestor
5571451|NCT03925233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5571452|NCT03925233|Dermatologic Agents|dermatologic agents|mesh-ancestor
5571453|NCT03925233|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5571454|NCT03925233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6174817|NCT01682837|Respiratory System Agents|respiratory system agents|mesh-ancestor
6174818|NCT01682837|Cathartics|cathartics|mesh-ancestor
6174819|NCT01682837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6174820|NCT01682863|Glycopyrrolate|glycopyrrolate|mesh-list
6174821|NCT01682863|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6174822|NCT01682863|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6486707|NCT00572078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6489012|NCT00588835|Hormones|hormones|mesh-ancestor
5571455|NCT03925233|Anticoagulants|anticoagulants|mesh-ancestor
5571456|NCT03925233|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5571457|NCT03925233|Chelating Agents|chelating agents|mesh-ancestor
5571458|NCT03925233|Sequestering Agents|sequestering agents|mesh-ancestor
5571459|NCT03925233|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5604258|NCT05069545|Insulin|insulin|mesh-list
5571460|NCT03925233|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5571461|NCT03925233|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5571462|NCT03925233|Hormone Antagonists|hormone antagonists|mesh-ancestor
5571463|NCT03925233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5571464|NCT03925233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5571465|NCT03925233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5571466|NCT03925233|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5571467|NCT03925233|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5571468|NCT03925233|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5571469|NCT03925233|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5571470|NCT03925233|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6174823|NCT01682863|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6174824|NCT01682863|Cholinergic Agents|cholinergic agents|mesh-ancestor
6486708|NCT00572078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486709|NCT00572169|Thalidomide|thalidomide|mesh-list
6486710|NCT00572169|Dexamethasone|dexamethasone|mesh-list
6486711|NCT00572169|Cyclophosphamide|cyclophosphamide|mesh-list
6486712|NCT00572169|Cisplatin|cisplatin|mesh-list
6486713|NCT00572169|Doxorubicin|doxorubicin|mesh-list
6486714|NCT00572169|Etoposide|etoposide|mesh-list
6486715|NCT00572169|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6486716|NCT00572169|Bortezomib|bortezomib|mesh-list
6486717|NCT00572169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6486718|NCT00572169|Immunologic Factors|immunologic factors|mesh-ancestor
6486719|NCT00572169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486720|NCT00572169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6486721|NCT00572169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6486722|NCT00572169|Alkylating Agents|alkylating agents|mesh-ancestor
6486723|NCT00572169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486724|NCT00572169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6486725|NCT00572169|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5571471|NCT03925285|Bevacizumab|bevacizumab|mesh-list
5571472|NCT03925285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5571473|NCT03925285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5571474|NCT03925285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5571475|NCT03925285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6174825|NCT01682863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6174826|NCT01682863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174827|NCT01682863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174828|NCT01683058|Aripiprazole|aripiprazole|mesh-list
6174829|NCT01683058|Antidepressive Agents|antidepressive agents|mesh-ancestor
6174830|NCT01683058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6174831|NCT01683058|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6174832|NCT01683058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6174833|NCT01683058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6486726|NCT00572169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6486727|NCT00572169|Antiemetics|antiemetics|mesh-ancestor
6486728|NCT00572169|Autonomic Agents|autonomic agents|mesh-ancestor
6486729|NCT00572169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6486730|NCT00572169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6486731|NCT00572169|Glucocorticoids|glucocorticoids|mesh-ancestor
6174834|NCT01683058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174835|NCT01683058|Dopamine Agonists|dopamine agonists|mesh-ancestor
6174836|NCT01683058|Dopamine Agents|dopamine agents|mesh-ancestor
6174837|NCT01683058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6174838|NCT01683058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174839|NCT01683058|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6174840|NCT01683058|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6174841|NCT01683058|Serotonin Agents|serotonin agents|mesh-ancestor
6174842|NCT01683058|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6174843|NCT01683058|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6486732|NCT00572169|Hormones|hormones|mesh-ancestor
6486733|NCT00572169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6174844|NCT01683058|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6174845|NCT01683058|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6174846|NCT01683071|Bupivacaine|bupivacaine|mesh-list
6174847|NCT01683071|Anesthetics, Local|anesthetics, local|mesh-ancestor
6174848|NCT01683071|Anesthetics|anesthetics|mesh-ancestor
5571476|NCT03925285|Growth Substances|growth substances|mesh-ancestor
5571477|NCT03925285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571478|NCT03925285|Growth Inhibitors|growth inhibitors|mesh-ancestor
5571479|NCT03925428|Entinostat|entinostat|mesh-list
5571480|NCT03925428|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
5571481|NCT03925428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5571482|NCT03925428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5571483|NCT03925428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5571484|NCT03925402|Ertapenem|ertapenem|mesh-list
5571485|NCT03925402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5571486|NCT03925402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5571487|NCT03925480|Azithromycin|azithromycin|mesh-list
5571488|NCT03925480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5571489|NCT03925480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5571490|NCT03925090|Cisplatin|cisplatin|mesh-list
5571491|NCT03925090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5571492|NCT03925155|Iodine|iodine|mesh-list
5571493|NCT03925155|Chlorhexidine|chlorhexidine|mesh-list
5571494|NCT03925155|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5571495|NCT03925155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5571496|NCT03925155|Disinfectants|disinfectants|mesh-ancestor
5571497|NCT03925155|Trace Elements|trace elements|mesh-ancestor
5571498|NCT03925155|Micronutrients|micronutrients|mesh-ancestor
5571499|NCT03925155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571500|NCT03925051|Denosumab|denosumab|mesh-list
5571501|NCT03925051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5571502|NCT03925051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571503|NCT03925025|Magnesium Sulfate|magnesium sulfate|mesh-list
5571504|NCT03925025|Nimodipine|nimodipine|mesh-list
5571505|NCT03925025|Analgesics|analgesics|mesh-ancestor
6174849|NCT01683071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6174850|NCT01683071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174851|NCT01683071|Sensory System Agents|sensory system agents|mesh-ancestor
6174852|NCT01683071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6174853|NCT01683266|Insulin|insulin|mesh-list
6174854|NCT01683266|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6174855|NCT01683266|Insulin Glargine|insulin glargine|mesh-list
6174856|NCT01683266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6174857|NCT01683266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174858|NCT01683331|Insulin|insulin|mesh-list
6174859|NCT01683331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5571506|NCT03925025|Sensory System Agents|sensory system agents|mesh-ancestor
5571507|NCT03925025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5571508|NCT03925025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571509|NCT03925025|Anesthetics|anesthetics|mesh-ancestor
5571510|NCT03925025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5571511|NCT03925025|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5571512|NCT03925025|Anticonvulsants|anticonvulsants|mesh-ancestor
5571513|NCT03925025|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5571514|NCT03925025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5571515|NCT03925025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5571516|NCT03925025|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5571517|NCT03925025|Tocolytic Agents|tocolytic agents|mesh-ancestor
5571518|NCT03925025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5571519|NCT03925025|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5571520|NCT03925025|Vasodilator Agents|vasodilator agents|mesh-ancestor
5571521|NCT03924791|Dexamethasone|dexamethasone|mesh-list
5571522|NCT03924791|Methylprednisolone|methylprednisolone|mesh-list
5571523|NCT03924791|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5571524|NCT03924791|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5571525|NCT03924791|Prednisolone|prednisolone|mesh-list
5571526|NCT03924791|Prednisolone acetate|prednisolone acetate|mesh-list
5571527|NCT03924791|Lidocaine|lidocaine|mesh-list
5571528|NCT03924791|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5571529|NCT03924791|Prednisolone phosphate|prednisolone phosphate|mesh-list
5571530|NCT03924791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5571531|NCT03924791|Antiemetics|antiemetics|mesh-ancestor
5571532|NCT03924791|Autonomic Agents|autonomic agents|mesh-ancestor
5571533|NCT03924791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5571534|NCT03924791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174860|NCT01683331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571535|NCT03924791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5571536|NCT03924791|Glucocorticoids|glucocorticoids|mesh-ancestor
5571537|NCT03924791|Hormones|hormones|mesh-ancestor
5571538|NCT03924791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5571539|NCT03924791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5571540|NCT03924791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6174861|NCT01683422|Gemcitabine|gemcitabine|mesh-list
6174862|NCT01683422|Capecitabine|capecitabine|mesh-list
6174863|NCT01683422|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6174864|NCT01683422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6174865|NCT01683422|Antimetabolites|antimetabolites|mesh-ancestor
6174866|NCT01683422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174867|NCT01683422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6174868|NCT01683422|Antiviral Agents|antiviral agents|mesh-ancestor
6174869|NCT01683422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6174870|NCT01683422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6174871|NCT01683422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6174872|NCT01683422|Immunologic Factors|immunologic factors|mesh-ancestor
6174873|NCT01683422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174874|NCT01683422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6174875|NCT01683838|4-Aminopyridine|4-aminopyridine|mesh-list
6174876|NCT01683838|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6174877|NCT01683838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6174878|NCT01683838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174879|NCT01683994|Prednisone|prednisone|mesh-list
6174880|NCT01683994|Docetaxel|docetaxel|mesh-list
6174881|NCT01683994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6174882|NCT01683994|Tubulin Modulators|tubulin modulators|mesh-ancestor
6174883|NCT01683994|Antimitotic Agents|antimitotic agents|mesh-ancestor
6174884|NCT01683994|Mitosis Modulators|mitosis modulators|mesh-ancestor
6174885|NCT01683994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174886|NCT01683994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6174887|NCT01683994|Glucocorticoids|glucocorticoids|mesh-ancestor
6174888|NCT01683994|Hormones|hormones|mesh-ancestor
6174889|NCT01683994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6174890|NCT01683994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174891|NCT01683994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6174892|NCT01684020|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6174893|NCT01684020|Hemostatics|hemostatics|mesh-ancestor
6174894|NCT01684020|Coagulants|coagulants|mesh-ancestor
6174895|NCT01684202|Tolvaptan|tolvaptan|mesh-list
6174896|NCT01684202|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6174897|NCT01684202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174898|NCT01684202|Natriuretic Agents|natriuretic agents|mesh-ancestor
6174899|NCT01684202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174900|NCT01684215|Letrozole|letrozole|mesh-list
6174901|NCT01684215|Palbociclib|palbociclib|mesh-list
6174902|NCT01684215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6174903|NCT01684215|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6174904|NCT01684215|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6174905|NCT01684215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6174906|NCT01684215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174907|NCT01684215|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6174908|NCT01684215|Hormone Antagonists|hormone antagonists|mesh-ancestor
6174909|NCT01684215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6174910|NCT01684215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174911|NCT01684215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6174912|NCT01684410|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
6174913|NCT01684410|Protein C Inhibitor|protein c inhibitor|mesh-list
6174914|NCT01684410|Protease Inhibitors|protease inhibitors|mesh-list
6174915|NCT01684410|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6174916|NCT01684410|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6174917|NCT01684410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6174918|NCT01684410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174919|NCT01684423|Rivaroxaban|rivaroxaban|mesh-list
6174920|NCT01684423|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5571541|NCT03924791|Anesthetics, Local|anesthetics, local|mesh-ancestor
5571542|NCT03924791|Anesthetics|anesthetics|mesh-ancestor
5571543|NCT03924791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5571544|NCT03924791|Sensory System Agents|sensory system agents|mesh-ancestor
5571545|NCT03924791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5571546|NCT03924791|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5571547|NCT03924791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5571548|NCT03924791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5604259|NCT05069545|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5571549|NCT03924791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5571550|NCT03924791|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5571551|NCT03924791|Protective Agents|protective agents|mesh-ancestor
5571552|NCT03925116|Contraceptive Agents|contraceptive agents|mesh-list
5571553|NCT03925116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5571554|NCT03925116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571555|NCT03924544|Mitomycins|mitomycins|mesh-list
6174921|NCT01684423|Antithrombins|antithrombins|mesh-ancestor
6174922|NCT01684423|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6174923|NCT01684423|Protease Inhibitors|protease inhibitors|mesh-ancestor
6174924|NCT01684423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6174925|NCT01684423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174926|NCT01684423|Anticoagulants|anticoagulants|mesh-ancestor
6174927|NCT01684722|Vitamin D|vitamin d|mesh-list
6486734|NCT00572169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6486735|NCT00572169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6486736|NCT00572169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6486737|NCT00572169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6486738|NCT00572169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6486739|NCT00572169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6486740|NCT00572169|Leprostatic Agents|leprostatic agents|mesh-ancestor
6486741|NCT00572169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6486742|NCT00572169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6486743|NCT00572169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6486744|NCT00572169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6486745|NCT00572169|Growth Substances|growth substances|mesh-ancestor
6486746|NCT00572169|Growth Inhibitors|growth inhibitors|mesh-ancestor
6486747|NCT00572208|Gabapentin|gabapentin|mesh-list
6486748|NCT00572208|Analgesics|analgesics|mesh-ancestor
6486749|NCT00572208|Sensory System Agents|sensory system agents|mesh-ancestor
6486750|NCT00572208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6486751|NCT00572208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486752|NCT00572208|Anticonvulsants|anticonvulsants|mesh-ancestor
6486753|NCT00572208|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6486754|NCT00572208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6486755|NCT00572208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6486756|NCT00572208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6486757|NCT00572208|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6486758|NCT00572208|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6486759|NCT00572208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5571556|NCT03924544|Mitomycin|mitomycin|mesh-list
5571557|NCT03924544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5571558|NCT03924544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5571559|NCT03924544|Alkylating Agents|alkylating agents|mesh-ancestor
6486760|NCT00572208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486761|NCT00572208|Antimanic Agents|antimanic agents|mesh-ancestor
6486762|NCT00572299|Alendronate|alendronate|mesh-list
6486763|NCT00572299|Prednisone|prednisone|mesh-list
6486764|NCT00572299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6486765|NCT00572299|Glucocorticoids|glucocorticoids|mesh-ancestor
5571560|NCT03924544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5571561|NCT03924544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5571562|NCT03924544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5571563|NCT03924596|Boswellic acid|boswellic acid|mesh-list
5571564|NCT03924596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6174928|NCT01684722|Ergocalciferols|ergocalciferols|mesh-list
6670372|NCT01542827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6174929|NCT01684722|Vitamins|vitamins|mesh-list
6486766|NCT00572299|Hormones|hormones|mesh-ancestor
6486767|NCT00572299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6174930|NCT01684722|Micronutrients|micronutrients|mesh-ancestor
6174931|NCT01684722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174932|NCT01684722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6174933|NCT01684722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6174934|NCT01684748|Olmesartan|olmesartan|mesh-list
6174935|NCT01684748|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6174936|NCT01684748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6174937|NCT01684748|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6174938|NCT01684748|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6174939|NCT01684748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174940|NCT01684878|Gemcitabine|gemcitabine|mesh-list
6174941|NCT01684878|Paclitaxel|paclitaxel|mesh-list
6174942|NCT01684878|Topotecan|topotecan|mesh-list
6174943|NCT01684878|Pertuzumab|pertuzumab|mesh-list
6174944|NCT01684878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6174945|NCT01684878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6174946|NCT01684878|Tubulin Modulators|tubulin modulators|mesh-ancestor
6174947|NCT01684878|Antimitotic Agents|antimitotic agents|mesh-ancestor
6174948|NCT01684878|Mitosis Modulators|mitosis modulators|mesh-ancestor
6174949|NCT01684878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174950|NCT01684878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6174951|NCT01684878|Antimetabolites|antimetabolites|mesh-ancestor
6486768|NCT00572299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486769|NCT00572299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6486770|NCT00572299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6486771|NCT00572299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6486772|NCT00572312|Atorvastatin|atorvastatin|mesh-list
6486773|NCT00572312|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6486774|NCT00572312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6486775|NCT00572312|Antimetabolites|antimetabolites|mesh-ancestor
6486776|NCT00572312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486777|NCT00572312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5571565|NCT03924596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5571566|NCT03924596|Analgesics|analgesics|mesh-ancestor
5571567|NCT03924596|Sensory System Agents|sensory system agents|mesh-ancestor
5571568|NCT03924596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5571569|NCT03924596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571570|NCT03924596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5571571|NCT03924596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5571572|NCT03924401|Abatacept|abatacept|mesh-list
6174952|NCT01684878|Antiviral Agents|antiviral agents|mesh-ancestor
6174953|NCT01684878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6174954|NCT01684878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6174955|NCT01684878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6174956|NCT01684878|Immunologic Factors|immunologic factors|mesh-ancestor
6174957|NCT01684878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174958|NCT01684878|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6174959|NCT01684878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6174960|NCT01684878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6174961|NCT01684943|Insulin|insulin|mesh-list
6174962|NCT01684943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6174963|NCT01684943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174964|NCT01685060|Ceritinib|ceritinib|mesh-list
5571573|NCT03924401|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5571574|NCT03924401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5571575|NCT03924401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5571576|NCT03924401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5571577|NCT03924401|Immunologic Factors|immunologic factors|mesh-ancestor
5571578|NCT03924401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571579|NCT03924401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5571580|NCT03924427|BMS-986165|bms-986165|mesh-list
5571581|NCT03924427|Dermatologic Agents|dermatologic agents|mesh-ancestor
5571582|NCT03924427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5571583|NCT03924427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5571584|NCT03924427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174965|NCT01685060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6174966|NCT01685060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6174967|NCT01685060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6174968|NCT01685060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174969|NCT01685073|Zolpidem|zolpidem|mesh-list
6174970|NCT01685073|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6174971|NCT01685073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6174972|NCT01685073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6174973|NCT01685073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174974|NCT01685073|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6174975|NCT01685073|GABA Agonists|gaba agonists|mesh-ancestor
6174976|NCT01685073|GABA Agents|gaba agents|mesh-ancestor
6174977|NCT01685073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6174978|NCT01685073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174979|NCT01685138|Ceritinib|ceritinib|mesh-list
6174980|NCT01685138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6174981|NCT01685138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6174982|NCT01685138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6174983|NCT01685138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174984|NCT01685203|Ribavirin|ribavirin|mesh-list
6174985|NCT01685203|Antimetabolites|antimetabolites|mesh-ancestor
6174986|NCT01685203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174987|NCT01685203|Antiviral Agents|antiviral agents|mesh-ancestor
6174988|NCT01685203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6206460|NCT02100579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206461|NCT02100579|Sensory System Agents|sensory system agents|mesh-ancestor
6206462|NCT02100579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5571585|NCT03924323|Citalopram|citalopram|mesh-list
5571586|NCT03924323|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5571587|NCT03924323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5571588|NCT03924323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5571589|NCT03924323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5571590|NCT03924323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5571591|NCT03924323|Serotonin Agents|serotonin agents|mesh-ancestor
5571592|NCT03924323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206463|NCT02100644|Lamotrigine|lamotrigine|mesh-list
6206464|NCT02100644|Anticonvulsants|anticonvulsants|mesh-ancestor
6206465|NCT02100644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6206466|NCT02100644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6206467|NCT02100644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5571593|NCT03924323|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5571594|NCT03924323|Antidepressive Agents|antidepressive agents|mesh-ancestor
5571595|NCT03924323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5571596|NCT03924518|Granisetron|granisetron|mesh-list
5571597|NCT03924518|Serotonin|serotonin|mesh-list
5571598|NCT03924518|Antiemetics|antiemetics|mesh-ancestor
5571599|NCT03924518|Autonomic Agents|autonomic agents|mesh-ancestor
5571600|NCT03924518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5571601|NCT03924518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571602|NCT03924518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5571603|NCT03924518|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5571604|NCT03924518|Serotonin Agents|serotonin agents|mesh-ancestor
5571605|NCT03924518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5571606|NCT03924518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5571607|NCT03924518|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5571608|NCT03924245|Olaparib|olaparib|mesh-list
6206468|NCT02100644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6206469|NCT02100644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206470|NCT02100644|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5571609|NCT03924245|Entinostat|entinostat|mesh-list
5571610|NCT03924245|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5571611|NCT03924245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5571612|NCT03924245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5571613|NCT03924245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5571614|NCT03924245|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5571615|NCT03924440|Nonoxynol|nonoxynol|mesh-list
5571616|NCT03924440|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
5571617|NCT03924440|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
5571618|NCT03924440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571619|NCT03924440|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5571620|NCT03924440|Contraceptive Agents|contraceptive agents|mesh-ancestor
5571621|NCT03924440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5571622|NCT03924440|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5571623|NCT03924492|Pregnanolone|pregnanolone|mesh-list
5571624|NCT03924492|Brexanolone|brexanolone|mesh-list
5571625|NCT03924492|Neurosteroids|neurosteroids|mesh-ancestor
5571626|NCT03924492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5571627|NCT03924492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5571628|NCT03924492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571629|NCT03924492|GABA Modulators|gaba modulators|mesh-ancestor
5571630|NCT03924492|GABA Agents|gaba agents|mesh-ancestor
5571631|NCT03924492|Anesthetics|anesthetics|mesh-ancestor
5571632|NCT03924492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6206471|NCT02100644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6670373|NCT01542827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670374|NCT01542879|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
6670375|NCT01542879|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6670376|NCT01542879|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6670377|NCT01542879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670378|NCT01542879|Hematinics|hematinics|mesh-ancestor
6670379|NCT01542879|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6670380|NCT01542879|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6670381|NCT01542918|Rituximab|rituximab|mesh-list
6670382|NCT01542918|Lenalidomide|lenalidomide|mesh-list
6670383|NCT01542918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6670384|NCT01542918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5571633|NCT03923881|Cetuximab|cetuximab|mesh-list
6670385|NCT01542918|Immunologic Factors|immunologic factors|mesh-ancestor
6670386|NCT01542918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670387|NCT01542918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6670388|NCT01542918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6670389|NCT01542918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6670390|NCT01542918|Growth Substances|growth substances|mesh-ancestor
6670391|NCT01542918|Growth Inhibitors|growth inhibitors|mesh-ancestor
6670392|NCT01543035|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6670393|NCT01543035|Antiviral Agents|antiviral agents|mesh-ancestor
6670394|NCT01543035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6670395|NCT01543061|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6670396|NCT01543061|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6174989|NCT01685242|Cetirizine|cetirizine|mesh-list
6174990|NCT01685242|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6174991|NCT01685242|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6174992|NCT01685242|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6174993|NCT01685242|Histamine Antagonists|histamine antagonists|mesh-ancestor
6174994|NCT01685242|Histamine Agents|histamine agents|mesh-ancestor
6174995|NCT01685242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6174996|NCT01685242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6174997|NCT01685242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6174998|NCT01685372|Vaccines|vaccines|mesh-list
6174999|NCT01685372|Immunologic Factors|immunologic factors|mesh-ancestor
6175000|NCT01685372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175001|NCT01685411|Mycophenolic Acid|mycophenolic acid|mesh-list
5571634|NCT03923881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5571635|NCT03923881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5571636|NCT03923842|Denosumab|denosumab|mesh-list
5571637|NCT03923842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5571638|NCT03923842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571639|NCT03923959|Tranexamic Acid|tranexamic acid|mesh-list
5571640|NCT03923959|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5571641|NCT03923959|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5571642|NCT03923959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486778|NCT00572312|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6486779|NCT00572312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6486780|NCT00572364|Olaparib|olaparib|mesh-list
6486781|NCT00572364|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
5571643|NCT03923959|Hemostatics|hemostatics|mesh-ancestor
5571644|NCT03923959|Coagulants|coagulants|mesh-ancestor
5571645|NCT03923725|Artesunate|artesunate|mesh-list
5571646|NCT03923725|Lumefantrine|lumefantrine|mesh-list
5571647|NCT03923725|Artemether|artemether|mesh-list
5571648|NCT03923725|Piperaquine|piperaquine|mesh-list
5571649|NCT03923725|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
5571650|NCT03923725|Amodiaquine|amodiaquine|mesh-list
5571651|NCT03923725|Mefloquine|mefloquine|mesh-list
5571652|NCT03923725|Antimalarials|antimalarials|mesh-ancestor
6175002|NCT01685411|Cyclophosphamide|cyclophosphamide|mesh-list
6175003|NCT01685411|Busulfan|busulfan|mesh-list
6175004|NCT01685411|Allopurinol|allopurinol|mesh-list
6175005|NCT01685411|Levetiracetam|levetiracetam|mesh-list
6175006|NCT01685411|Tacrolimus|tacrolimus|mesh-list
6175007|NCT01685411|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6175008|NCT01685411|Lenograstim|lenograstim|mesh-list
6175009|NCT01685411|Sargramostim|sargramostim|mesh-list
6175010|NCT01685411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6175011|NCT01685411|Immunologic Factors|immunologic factors|mesh-ancestor
6175012|NCT01685411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175013|NCT01685411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6175014|NCT01685411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6175015|NCT01685411|Alkylating Agents|alkylating agents|mesh-ancestor
6175016|NCT01685411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175017|NCT01685411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6175018|NCT01685411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6486782|NCT00572364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6486783|NCT00572364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486784|NCT00572364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6486785|NCT00572390|Estrogens|estrogens|mesh-list
6670397|NCT01543139|Valproic Acid|valproic acid|mesh-list
6670398|NCT01543139|Anticonvulsants|anticonvulsants|mesh-ancestor
6670399|NCT01543139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6670400|NCT01543139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670401|NCT01543139|GABA Agents|gaba agents|mesh-ancestor
5571653|NCT03923725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5571654|NCT03923725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5571655|NCT03923725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6175019|NCT01685411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5571656|NCT03923725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5571657|NCT03923725|Antiviral Agents|antiviral agents|mesh-ancestor
5571658|NCT03923725|Schistosomicides|schistosomicides|mesh-ancestor
5571659|NCT03923725|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5571660|NCT03923725|Anthelmintics|anthelmintics|mesh-ancestor
6670402|NCT01543139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6670403|NCT01543139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670404|NCT01543139|Antimanic Agents|antimanic agents|mesh-ancestor
6670405|NCT01543139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5571661|NCT03923803|Calcitonin|calcitonin|mesh-list
6175020|NCT01685411|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6175021|NCT01685411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5571662|NCT03923803|Salmon calcitonin|salmon calcitonin|mesh-list
5571663|NCT03923803|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
5571664|NCT03923803|Katacalcin|katacalcin|mesh-list
5571665|NCT03923803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5571666|NCT03923803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571667|NCT03923803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5571668|NCT03923803|Vasodilator Agents|vasodilator agents|mesh-ancestor
5571669|NCT03923556|Neostigmine|neostigmine|mesh-list
5571670|NCT03923556|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5571671|NCT03923556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5571672|NCT03923556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5571673|NCT03923556|Cholinergic Agents|cholinergic agents|mesh-ancestor
5571674|NCT03923556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5571675|NCT03923556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571676|NCT03923556|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5571677|NCT03923556|Autonomic Agents|autonomic agents|mesh-ancestor
5571678|NCT03923556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5571679|NCT03923829|Zinc|zinc|mesh-list
5571680|NCT03923829|Zinc Sulfate|zinc sulfate|mesh-list
5571681|NCT03923829|Trace Elements|trace elements|mesh-ancestor
5571682|NCT03923829|Micronutrients|micronutrients|mesh-ancestor
5571683|NCT03923829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571684|NCT03923829|Astringents|astringents|mesh-ancestor
5571685|NCT03923829|Dermatologic Agents|dermatologic agents|mesh-ancestor
5604260|NCT05069545|Insulin Aspart|insulin aspart|mesh-list
5604261|NCT05069545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5604262|NCT05069545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604263|NCT05068726|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
5604264|NCT05068726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604265|NCT05060315|Treprostinil|treprostinil|mesh-list
5604266|NCT05060315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5604267|NCT05043870|Infliximab|infliximab|mesh-list
5604268|NCT05043870|Immunosuppressive Agents|immunosuppressive agents|mesh-list
5604269|NCT05043870|Dermatologic Agents|dermatologic agents|mesh-ancestor
5604270|NCT05043870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5604271|NCT05043870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5604272|NCT05043870|Immunologic Factors|immunologic factors|mesh-ancestor
5604273|NCT05043870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604274|NCT05035303|Epinephrine|epinephrine|mesh-list
5604275|NCT05035303|Norepinephrine|norepinephrine|mesh-list
5604276|NCT05035303|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5604277|NCT05035303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5604278|NCT05035303|Adrenergic Agents|adrenergic agents|mesh-ancestor
5604279|NCT05035303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5604280|NCT05035303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604281|NCT05035303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175022|NCT01685411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6175023|NCT01685411|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6175024|NCT01685411|Antitubercular Agents|antitubercular agents|mesh-ancestor
6175025|NCT01685411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6175026|NCT01685411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5604282|NCT05035303|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5604283|NCT05035303|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5604284|NCT05035303|Autonomic Agents|autonomic agents|mesh-ancestor
5604285|NCT05035303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5604286|NCT05035303|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5604287|NCT05035303|Respiratory System Agents|respiratory system agents|mesh-ancestor
5604288|NCT05035303|Mydriatics|mydriatics|mesh-ancestor
5604289|NCT05035303|Sympathomimetics|sympathomimetics|mesh-ancestor
5604290|NCT05035303|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5604291|NCT05029960|Brivaracetam|brivaracetam|mesh-list
5604292|NCT05029960|Anticonvulsants|anticonvulsants|mesh-ancestor
5604293|NCT05025865|Hyaluronic Acid|hyaluronic acid|mesh-list
5604294|NCT05025865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5604295|NCT05025865|Immunologic Factors|immunologic factors|mesh-ancestor
5571686|NCT03923751|Anesthetics|anesthetics|mesh-list
5571687|NCT03923751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5571688|NCT03923751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571689|NCT03923114|Exenatide|exenatide|mesh-list
5571690|NCT03923114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5571691|NCT03923114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175027|NCT01685411|Anticonvulsants|anticonvulsants|mesh-ancestor
6175028|NCT01685411|Nootropic Agents|nootropic agents|mesh-ancestor
6175029|NCT01685411|Antimetabolites|antimetabolites|mesh-ancestor
6175030|NCT01685411|Gout Suppressants|gout suppressants|mesh-ancestor
6175031|NCT01685411|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6486786|NCT00572390|Hormones|hormones|mesh-ancestor
6486787|NCT00572390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5571692|NCT03923114|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5571693|NCT03923114|Incretins|incretins|mesh-ancestor
5571694|NCT03923114|Hormones|hormones|mesh-ancestor
5571695|NCT03923114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5571696|NCT03923166|Capecitabine|capecitabine|mesh-list
5571697|NCT03923166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5571698|NCT03923166|Antimetabolites|antimetabolites|mesh-ancestor
5571699|NCT03923166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5571700|NCT03923166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5571701|NCT03923361|Propofol|propofol|mesh-list
5571702|NCT03923361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5571703|NCT03923361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5571704|NCT03923361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571705|NCT03923361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5571706|NCT03923361|Anesthetics, General|anesthetics, general|mesh-ancestor
5571707|NCT03923361|Anesthetics|anesthetics|mesh-ancestor
5571708|NCT03923218|Vitamin D|vitamin d|mesh-list
6486788|NCT00572390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486789|NCT00572559|Vancomycin|vancomycin|mesh-list
6486790|NCT00572559|Linezolid|linezolid|mesh-list
6486791|NCT00572559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6486792|NCT00572559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6486793|NCT00572559|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6486794|NCT00572559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6486795|NCT00572559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486796|NCT00572637|Delanzomib|delanzomib|mesh-list
6486797|NCT00572637|Proteasome Inhibitors|proteasome inhibitors|mesh-ancestor
6486798|NCT00572637|Protease Inhibitors|protease inhibitors|mesh-ancestor
6486799|NCT00572637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6486800|NCT00572637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486801|NCT00572650|Vildagliptin|vildagliptin|mesh-list
6486802|NCT00572650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6486803|NCT00572650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571709|NCT03923218|Cholecalciferol|cholecalciferol|mesh-list
5571710|NCT03923218|Vitamins|vitamins|mesh-ancestor
5571711|NCT03923218|Micronutrients|micronutrients|mesh-ancestor
5571712|NCT03923218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571713|NCT03923218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5571714|NCT03923218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5571715|NCT03923140|Tranilast|tranilast|mesh-list
5571716|NCT03923140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5571717|NCT03923140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5571718|NCT03923140|Analgesics|analgesics|mesh-ancestor
5571719|NCT03923140|Sensory System Agents|sensory system agents|mesh-ancestor
5571720|NCT03923140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5571721|NCT03923140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571722|NCT03923140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5571723|NCT03923140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5571724|NCT03923140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5571725|NCT03923140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5571726|NCT03923140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5571727|NCT03923140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5571728|NCT03923140|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5571729|NCT03923140|Histamine Antagonists|histamine antagonists|mesh-ancestor
5571730|NCT03923140|Histamine Agents|histamine agents|mesh-ancestor
5571731|NCT03923140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5571732|NCT03923140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5571733|NCT03923140|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5571734|NCT03923075|Dexmedetomidine|dexmedetomidine|mesh-list
5571735|NCT03923075|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6175032|NCT01685411|Antioxidants|antioxidants|mesh-ancestor
6486804|NCT00572650|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6486805|NCT00572650|Protease Inhibitors|protease inhibitors|mesh-ancestor
6486806|NCT00572650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6486807|NCT00572650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486808|NCT00572663|Acetylcysteine|acetylcysteine|mesh-list
6175033|NCT01685411|Protective Agents|protective agents|mesh-ancestor
6175034|NCT01685684|Oxycodone|oxycodone|mesh-list
6175035|NCT01685684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6175036|NCT01685684|Narcotics|narcotics|mesh-ancestor
6175037|NCT01685684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6175038|NCT01685684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175039|NCT01685684|Analgesics|analgesics|mesh-ancestor
6175040|NCT01685684|Sensory System Agents|sensory system agents|mesh-ancestor
6175041|NCT01685684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6175042|NCT01685801|Ivacaftor|ivacaftor|mesh-list
6175043|NCT01685801|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6175044|NCT01685801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5571736|NCT03923075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5571737|NCT03923075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571738|NCT03923075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5571739|NCT03923075|Analgesics|analgesics|mesh-ancestor
5571740|NCT03923075|Sensory System Agents|sensory system agents|mesh-ancestor
5571741|NCT03923075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5571742|NCT03923075|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5571743|NCT03923075|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5571744|NCT03923075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5571745|NCT03923075|Adrenergic Agents|adrenergic agents|mesh-ancestor
5571746|NCT03923075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5571747|NCT03923075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175045|NCT01685801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175046|NCT01685983|Prednisolone|prednisolone|mesh-list
6175047|NCT01685983|Abiraterone Acetate|abiraterone acetate|mesh-list
6175048|NCT01685983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6175049|NCT01685983|Glucocorticoids|glucocorticoids|mesh-ancestor
6175050|NCT01685983|Hormones|hormones|mesh-ancestor
6486809|NCT00572663|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6486810|NCT00572663|Antiviral Agents|antiviral agents|mesh-ancestor
6486811|NCT00572663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6486812|NCT00572663|Expectorants|expectorants|mesh-ancestor
6486813|NCT00572663|Respiratory System Agents|respiratory system agents|mesh-ancestor
6175051|NCT01685983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6175052|NCT01685983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175053|NCT01685983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6175054|NCT01685983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6175055|NCT01685983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6175056|NCT01685983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6175057|NCT01685983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175058|NCT01685983|Hormone Antagonists|hormone antagonists|mesh-ancestor
6175059|NCT01685983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6175060|NCT01685996|Zonisamide|zonisamide|mesh-list
6175061|NCT01685996|Anticonvulsants|anticonvulsants|mesh-ancestor
6175062|NCT01685996|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6175063|NCT01685996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6175064|NCT01685996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175065|NCT01685996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6175066|NCT01685996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175067|NCT01686152|Imiquimod|imiquimod|mesh-list
6175068|NCT01686152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6175069|NCT01686152|Immunologic Factors|immunologic factors|mesh-ancestor
6175070|NCT01686152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175071|NCT01686152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6175072|NCT01686152|Interferon Inducers|interferon inducers|mesh-ancestor
6175073|NCT01686165|Rituximab|rituximab|mesh-list
6175074|NCT01686165|Belinostat|belinostat|mesh-list
6175075|NCT01686165|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6175076|NCT01686165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6175077|NCT01686165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6175078|NCT01686165|Immunologic Factors|immunologic factors|mesh-ancestor
6175079|NCT01686165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175080|NCT01686165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6175081|NCT01686165|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6175082|NCT01686165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6175083|NCT01686165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175084|NCT01686451|Simvastatin|simvastatin|mesh-list
5571748|NCT03923257|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
5571749|NCT03923257|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5571750|NCT03923257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5571751|NCT03923231|Ritonavir|ritonavir|mesh-list
5571752|NCT03923231|Atazanavir Sulfate|atazanavir sulfate|mesh-list
5571753|NCT03923231|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5571754|NCT03923231|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5571755|NCT03923231|Protease Inhibitors|protease inhibitors|mesh-ancestor
5571756|NCT03923231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5571757|NCT03923231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5571758|NCT03923231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5571759|NCT03923231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6175085|NCT01686451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6175086|NCT01686451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6175087|NCT01686451|Antimetabolites|antimetabolites|mesh-ancestor
6175088|NCT01686451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175089|NCT01686451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6175090|NCT01686451|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6175091|NCT01686451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6175092|NCT01686581|Botulinum Toxins|botulinum toxins|mesh-list
6175093|NCT01686581|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6175094|NCT01686581|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6175095|NCT01686581|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5571760|NCT03923231|Antiviral Agents|antiviral agents|mesh-ancestor
5571761|NCT03923231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5571762|NCT03923231|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5571763|NCT03923231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5571764|NCT03923179|Etoposide|etoposide|mesh-list
5571765|NCT03923179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5571766|NCT03923179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5571767|NCT03923179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5571768|NCT03923179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5571769|NCT03923179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5571770|NCT03923179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5571771|NCT03923010|Itraconazole|itraconazole|mesh-list
5571772|NCT03923010|Antifungal Agents|antifungal agents|mesh-ancestor
5571773|NCT03923010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5571774|NCT03923010|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5571775|NCT03923010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5571776|NCT03923010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5571777|NCT03923010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5571778|NCT03923010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5571779|NCT03923010|Hormone Antagonists|hormone antagonists|mesh-ancestor
5571780|NCT03923010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5571781|NCT03923010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571782|NCT03923010|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6175096|NCT01686581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6175097|NCT01686581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175098|NCT01686581|Cholinergic Agents|cholinergic agents|mesh-ancestor
6175099|NCT01686581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6175100|NCT01686581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175101|NCT01686581|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6175102|NCT01686581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6175103|NCT01686633|Fluticasone|fluticasone|mesh-list
6175104|NCT01686633|Xhance|xhance|mesh-list
5571783|NCT03922815|Fentanyl|fentanyl|mesh-list
5571784|NCT03922815|Propofol|propofol|mesh-list
5571785|NCT03922815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5571786|NCT03922815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5571787|NCT03922815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571788|NCT03922815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6175105|NCT01686633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6175106|NCT01686633|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6175107|NCT01686633|Autonomic Agents|autonomic agents|mesh-ancestor
6175108|NCT01686633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6175109|NCT01686633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175110|NCT01686633|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6175111|NCT01686633|Respiratory System Agents|respiratory system agents|mesh-ancestor
6175112|NCT01686633|Dermatologic Agents|dermatologic agents|mesh-ancestor
6175113|NCT01686633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6175114|NCT01686646|Acetaminophen|acetaminophen|mesh-list
6175115|NCT01686646|Caffeine|caffeine|mesh-list
6175116|NCT01686646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6175117|NCT01686646|Analgesics|analgesics|mesh-ancestor
6175118|NCT01686646|Sensory System Agents|sensory system agents|mesh-ancestor
6175119|NCT01686646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6175120|NCT01686646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175121|NCT01686646|Antipyretics|antipyretics|mesh-ancestor
6175122|NCT01686646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6175123|NCT01686646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6175124|NCT01686646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6175125|NCT01686646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175126|NCT01686646|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6175127|NCT01686646|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6175128|NCT01686646|Purinergic Agents|purinergic agents|mesh-ancestor
6175129|NCT01686646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6175130|NCT01686828|Letrozole|letrozole|mesh-list
6175131|NCT01686828|Methyltestosterone|methyltestosterone|mesh-list
6175132|NCT01686828|Acyline|acyline|mesh-list
6175133|NCT01686828|Testosterone|testosterone|mesh-list
6175134|NCT01686828|Testosterone undecanoate|testosterone undecanoate|mesh-list
6175135|NCT01686828|Testosterone enanthate|testosterone enanthate|mesh-list
6175136|NCT01686828|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6175137|NCT01686828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6175138|NCT01686828|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6175139|NCT01686828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6175140|NCT01686828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6175141|NCT01686828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175142|NCT01686828|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6175143|NCT01686828|Hormone Antagonists|hormone antagonists|mesh-ancestor
6175144|NCT01686828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6175145|NCT01686828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175146|NCT01686828|Androgens|androgens|mesh-ancestor
6175147|NCT01686828|Hormones|hormones|mesh-ancestor
6175148|NCT01686828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6175149|NCT01686828|Anabolic Agents|anabolic agents|mesh-ancestor
6175150|NCT01686932|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6175151|NCT01686932|Vildagliptin|vildagliptin|mesh-list
6175152|NCT01686932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6175153|NCT01686932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175154|NCT01686932|Incretins|incretins|mesh-ancestor
6175155|NCT01686932|Hormones|hormones|mesh-ancestor
6175156|NCT01686932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6175157|NCT01686932|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6175158|NCT01686932|Protease Inhibitors|protease inhibitors|mesh-ancestor
6486814|NCT00572663|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6486815|NCT00572663|Antioxidants|antioxidants|mesh-ancestor
6486816|NCT00572663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486817|NCT00572663|Protective Agents|protective agents|mesh-ancestor
6486818|NCT00572663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486819|NCT00572663|Antidotes|antidotes|mesh-ancestor
6486820|NCT00572689|Exenatide|exenatide|mesh-list
6486821|NCT00572689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6486822|NCT00572689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486823|NCT00572689|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6486824|NCT00572689|Incretins|incretins|mesh-ancestor
6486825|NCT00572689|Hormones|hormones|mesh-ancestor
6486826|NCT00572689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6486827|NCT00572741|Ascorbic Acid|ascorbic acid|mesh-list
6486828|NCT00572741|Cod Liver Oil|cod liver oil|mesh-list
6486829|NCT00572741|Vitamins|vitamins|mesh-ancestor
6486830|NCT00572741|Micronutrients|micronutrients|mesh-ancestor
6486831|NCT00572741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486832|NCT00572741|Antioxidants|antioxidants|mesh-ancestor
6486833|NCT00572741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486834|NCT00572741|Protective Agents|protective agents|mesh-ancestor
6486835|NCT00572806|Insulin Aspart|insulin aspart|mesh-list
6486836|NCT00572806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6486837|NCT00572806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486838|NCT00572819|Misoprostol|misoprostol|mesh-list
6486839|NCT00572819|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6486840|NCT00572819|Abortifacient Agents|abortifacient agents|mesh-ancestor
6486841|NCT00572819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6486842|NCT00572819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486843|NCT00572819|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6486844|NCT00572819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6486845|NCT00572819|Oxytocics|oxytocics|mesh-ancestor
6486846|NCT00572884|Permethrin|permethrin|mesh-list
6486847|NCT00572884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6486848|NCT00572884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486849|NCT00573001|Ritonavir|ritonavir|mesh-list
6486850|NCT00573001|Lopinavir|lopinavir|mesh-list
6486851|NCT00573001|Tenofovir|tenofovir|mesh-list
6486852|NCT00573001|Zidovudine|zidovudine|mesh-list
6486853|NCT00573001|Emtricitabine|emtricitabine|mesh-list
6486854|NCT00573001|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6486855|NCT00573001|Nevirapine|nevirapine|mesh-list
6486856|NCT00573001|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6486857|NCT00573001|Efavirenz|efavirenz|mesh-list
6486858|NCT00573001|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6486859|NCT00573001|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6486860|NCT00573001|Protease Inhibitors|protease inhibitors|mesh-ancestor
6486861|NCT00573001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6486862|NCT00573001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486863|NCT00573001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6486864|NCT00573001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6486865|NCT00573001|Antiviral Agents|antiviral agents|mesh-ancestor
6486866|NCT00573001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6486867|NCT00573001|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6486868|NCT00573001|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6486869|NCT00573001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6486870|NCT00573001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6175159|NCT01686932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6175160|NCT01686932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175161|NCT01687101|Menthol|menthol|mesh-list
6175162|NCT01687101|Antipruritics|antipruritics|mesh-ancestor
6175163|NCT01687101|Dermatologic Agents|dermatologic agents|mesh-ancestor
6175164|NCT01687166|Acifluorfen|acifluorfen|mesh-list
6175165|NCT01687166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6175166|NCT01687166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175167|NCT01687179|Sirolimus|sirolimus|mesh-list
6175168|NCT01687179|Hydroxychloroquine|hydroxychloroquine|mesh-list
6175169|NCT01687179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6175170|NCT01687179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6175171|NCT01687179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5571789|NCT03922815|Anesthetics, General|anesthetics, general|mesh-ancestor
5571790|NCT03922815|Anesthetics|anesthetics|mesh-ancestor
6175172|NCT01687179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6175173|NCT01687179|Antifungal Agents|antifungal agents|mesh-ancestor
6175174|NCT01687179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6175175|NCT01687179|Immunologic Factors|immunologic factors|mesh-ancestor
6175176|NCT01687179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175177|NCT01687179|Antimalarials|antimalarials|mesh-ancestor
6175178|NCT01687179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6175179|NCT01687179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6175180|NCT01687179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6175181|NCT01687179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175182|NCT01687179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6175183|NCT01687218|Tenofovir|tenofovir|mesh-list
6175184|NCT01687218|Emtricitabine|emtricitabine|mesh-list
6175185|NCT01687218|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6175186|NCT01687218|Glycerol|glycerol|mesh-list
6175187|NCT01687218|Antiviral Agents|antiviral agents|mesh-ancestor
6175188|NCT01687218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6175189|NCT01687218|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6175190|NCT01687218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6175191|NCT01687218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6486871|NCT00573001|Antimetabolites|antimetabolites|mesh-ancestor
5571791|NCT03922815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5571792|NCT03922815|Narcotics|narcotics|mesh-ancestor
5571793|NCT03922815|Analgesics|analgesics|mesh-ancestor
5571794|NCT03922815|Sensory System Agents|sensory system agents|mesh-ancestor
5571795|NCT03922815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5571796|NCT03922815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5571797|NCT03922919|Ceftriaxone|ceftriaxone|mesh-list
5571798|NCT03922919|Cefotaxime|cefotaxime|mesh-list
5571799|NCT03922919|Cefoxitin|cefoxitin|mesh-list
5571800|NCT03922919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5571801|NCT03922919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5571802|NCT03922451|Cefazolin|cefazolin|mesh-list
5571803|NCT03922451|Tazobactam|tazobactam|mesh-list
6175192|NCT01687218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175193|NCT01687218|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6175194|NCT01687218|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6175195|NCT01687218|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6175196|NCT01687218|Protective Agents|protective agents|mesh-ancestor
6175197|NCT01687218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175198|NCT01687257|Sofosbuvir|sofosbuvir|mesh-list
6175199|NCT01687257|Antiviral Agents|antiviral agents|mesh-ancestor
6175200|NCT01687257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5571804|NCT03922451|Piperacillin|piperacillin|mesh-list
5571805|NCT03922451|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
5571806|NCT03922451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5571807|NCT03922451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5571808|NCT03922451|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5571809|NCT03922451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5571810|NCT03922451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5571811|NCT03923036|Cetuximab|cetuximab|mesh-list
5571812|NCT03923036|Panitumumab|panitumumab|mesh-list
5571813|NCT03923036|Aflibercept|aflibercept|mesh-list
5571814|NCT03923036|Capecitabine|capecitabine|mesh-list
5571815|NCT03923036|Irinotecan|irinotecan|mesh-list
5571816|NCT03923036|Antineoplastic Agents|antineoplastic agents|mesh-list
5571817|NCT03923036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5571818|NCT03923036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5571819|NCT03923036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6175201|NCT01687270|Sofosbuvir|sofosbuvir|mesh-list
6175202|NCT01687270|Ribavirin|ribavirin|mesh-list
6175203|NCT01687270|Antiviral Agents|antiviral agents|mesh-ancestor
6175204|NCT01687270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6175205|NCT01687270|Antimetabolites|antimetabolites|mesh-ancestor
6175206|NCT01687270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175207|NCT01687283|Fluticasone|fluticasone|mesh-list
6175208|NCT01687283|Xhance|xhance|mesh-list
6175209|NCT01687283|Budesonide|budesonide|mesh-list
6175210|NCT01687283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6175211|NCT01687283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6175212|NCT01687283|Autonomic Agents|autonomic agents|mesh-ancestor
6175213|NCT01687283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6486872|NCT00573001|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6486873|NCT00573001|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6486874|NCT00573001|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6486875|NCT00573001|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6486876|NCT00573001|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6486877|NCT00573222|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6486878|NCT00573222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6486879|NCT00573222|Respiratory System Agents|respiratory system agents|mesh-ancestor
6175214|NCT01687283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175215|NCT01687283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6175216|NCT01687283|Respiratory System Agents|respiratory system agents|mesh-ancestor
6175217|NCT01687283|Dermatologic Agents|dermatologic agents|mesh-ancestor
6175218|NCT01687283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6175219|NCT01687283|Glucocorticoids|glucocorticoids|mesh-ancestor
6175220|NCT01687283|Hormones|hormones|mesh-ancestor
6175221|NCT01687283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6175222|NCT01687296|Fluticasone|fluticasone|mesh-list
6175223|NCT01687296|Xhance|xhance|mesh-list
6175224|NCT01687296|Prednisone|prednisone|mesh-list
5571820|NCT03923036|Growth Substances|growth substances|mesh-ancestor
5571821|NCT03923036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571822|NCT03923036|Growth Inhibitors|growth inhibitors|mesh-ancestor
5571823|NCT03923036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6175225|NCT01687296|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6175226|NCT01687296|Albuterol|albuterol|mesh-list
6175227|NCT01687296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6175228|NCT01687296|Glucocorticoids|glucocorticoids|mesh-ancestor
6175229|NCT01687296|Hormones|hormones|mesh-ancestor
6175230|NCT01687296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6175231|NCT01687296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175232|NCT01687296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6175233|NCT01687296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6175234|NCT01687296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6175235|NCT01687296|Autonomic Agents|autonomic agents|mesh-ancestor
6175236|NCT01687296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6175237|NCT01687296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6175238|NCT01687296|Respiratory System Agents|respiratory system agents|mesh-ancestor
6175239|NCT01687296|Dermatologic Agents|dermatologic agents|mesh-ancestor
6175240|NCT01687296|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6175241|NCT01687296|Tocolytic Agents|tocolytic agents|mesh-ancestor
6175242|NCT01687296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6175243|NCT01687296|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6175244|NCT01687296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6175245|NCT01687296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6175246|NCT01687296|Adrenergic Agents|adrenergic agents|mesh-ancestor
6175247|NCT01687296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6175248|NCT01687296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175249|NCT01687387|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6175250|NCT01687400|Decitabine|decitabine|mesh-list
6175251|NCT01687400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6175252|NCT01687400|Antimetabolites|antimetabolites|mesh-ancestor
6175253|NCT01687400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175254|NCT01687400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6175255|NCT01687400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6175256|NCT01687413|Cisplatin|cisplatin|mesh-list
6175257|NCT01687413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6175258|NCT01687478|Olanzapine|olanzapine|mesh-list
6175259|NCT01687478|Fluoxetine|fluoxetine|mesh-list
6175260|NCT01687478|Antiemetics|antiemetics|mesh-ancestor
6175261|NCT01687478|Autonomic Agents|autonomic agents|mesh-ancestor
5571824|NCT03923036|Antimetabolites|antimetabolites|mesh-ancestor
5571825|NCT03923036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5571826|NCT03923036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5571827|NCT03923036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5571828|NCT03923036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5571829|NCT03922542|Riboflavin|riboflavin|mesh-list
5571830|NCT03922542|Vitamin B Complex|vitamin b complex|mesh-ancestor
5571831|NCT03922542|Vitamins|vitamins|mesh-ancestor
5571832|NCT03922542|Micronutrients|micronutrients|mesh-ancestor
5571833|NCT03922542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571834|NCT03922542|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5571835|NCT03922542|Dermatologic Agents|dermatologic agents|mesh-ancestor
5571836|NCT03922373|Benzonatate|benzonatate|mesh-list
5571837|NCT03922373|Antitussive Agents|antitussive agents|mesh-ancestor
5571838|NCT03922373|Respiratory System Agents|respiratory system agents|mesh-ancestor
6175262|NCT01687478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6175263|NCT01687478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175264|NCT01687478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6175265|NCT01687478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6175266|NCT01687478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6175267|NCT01687478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6175268|NCT01687478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6175269|NCT01687478|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6175270|NCT01687478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6175271|NCT01687478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6175272|NCT01687478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175273|NCT01687478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6175274|NCT01687478|Serotonin Agents|serotonin agents|mesh-ancestor
6175275|NCT01687478|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6175276|NCT01687478|Antidepressive Agents|antidepressive agents|mesh-ancestor
6175277|NCT01687478|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6175278|NCT01687478|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6175279|NCT01687478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6175280|NCT01687673|Sirolimus|sirolimus|mesh-list
6175281|NCT01687673|Sorafenib|sorafenib|mesh-list
6175282|NCT01687673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6175283|NCT01687673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6175284|NCT01687673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6175285|NCT01687673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175286|NCT01687673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6175287|NCT01687673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5571839|NCT03922139|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5571840|NCT03922139|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5571841|NCT03922139|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5571842|NCT03922139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5571843|NCT03922139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571844|NCT03922139|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5571845|NCT03922139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5571846|NCT03922139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175288|NCT01687673|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6175289|NCT01687673|Antifungal Agents|antifungal agents|mesh-ancestor
6175290|NCT01687673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6175291|NCT01687673|Immunologic Factors|immunologic factors|mesh-ancestor
6175292|NCT01687673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175293|NCT01687712|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6175294|NCT01687712|Hormones|hormones|mesh-ancestor
5571847|NCT03922139|Cholinergic Agents|cholinergic agents|mesh-ancestor
5571848|NCT03922139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5571849|NCT03922048|Bupivacaine|bupivacaine|mesh-list
6175295|NCT01687712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6175296|NCT01687712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175297|NCT01687998|Evacetrapib|evacetrapib|mesh-list
6175298|NCT01687998|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6175299|NCT01687998|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6175300|NCT01687998|Antimetabolites|antimetabolites|mesh-ancestor
6175301|NCT01687998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175302|NCT01687998|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6175303|NCT01688037|Tetrabenazine|tetrabenazine|mesh-list
6175304|NCT01688037|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6175305|NCT01688037|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6175306|NCT01688037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6175307|NCT01688037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175308|NCT01688037|Adrenergic Agents|adrenergic agents|mesh-ancestor
6175309|NCT01688037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6175310|NCT01688037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175311|NCT01688102|Vitamin D|vitamin d|mesh-list
6175312|NCT01688102|Cholecalciferol|cholecalciferol|mesh-list
6175313|NCT01688102|Vitamins|vitamins|mesh-ancestor
6175314|NCT01688102|Micronutrients|micronutrients|mesh-ancestor
6175315|NCT01688102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175316|NCT01688102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6175317|NCT01688102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6175318|NCT01688336|Leucovorin|leucovorin|mesh-list
5571850|NCT03922048|Anesthetics, Local|anesthetics, local|mesh-ancestor
5571851|NCT03922048|Anesthetics|anesthetics|mesh-ancestor
5571852|NCT03922048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5571853|NCT03922048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571854|NCT03922048|Sensory System Agents|sensory system agents|mesh-ancestor
5571855|NCT03922048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5571856|NCT03921684|Capecitabine|capecitabine|mesh-list
5571857|NCT03921684|Nivolumab|nivolumab|mesh-list
5571858|NCT03921684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5571859|NCT03921684|Antimetabolites|antimetabolites|mesh-ancestor
5571860|NCT03921684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5571861|NCT03921684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5571862|NCT03921684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5571863|NCT03921684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5571864|NCT03921736|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5571865|NCT03921736|Perindopril|perindopril|mesh-list
5571866|NCT03921736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5571867|NCT03921736|Diuretics|diuretics|mesh-ancestor
5571868|NCT03921736|Natriuretic Agents|natriuretic agents|mesh-ancestor
5571869|NCT03921736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571870|NCT03921736|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5571871|NCT03921736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5571872|NCT03921736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5571873|NCT03921736|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5571874|NCT03921736|Protease Inhibitors|protease inhibitors|mesh-ancestor
5571875|NCT03921736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5604296|NCT05025865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604297|NCT05025865|Viscosupplements|viscosupplements|mesh-ancestor
5604298|NCT05025865|Protective Agents|protective agents|mesh-ancestor
5606863|NCT03593018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5606864|NCT03593018|Immunologic Factors|immunologic factors|mesh-ancestor
5606865|NCT03593018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571876|NCT03921645|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5571877|NCT03921645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5571878|NCT03921671|Paclitaxel|paclitaxel|mesh-list
5571879|NCT03921671|Carboplatin|carboplatin|mesh-list
5571880|NCT03921671|Ramucirumab|ramucirumab|mesh-list
5571881|NCT03921671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5571882|NCT03921671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5571883|NCT03921671|Tubulin Modulators|tubulin modulators|mesh-ancestor
5571884|NCT03921671|Antimitotic Agents|antimitotic agents|mesh-ancestor
5571885|NCT03921671|Mitosis Modulators|mitosis modulators|mesh-ancestor
5571886|NCT03921671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175319|NCT01688336|Oxaliplatin|oxaliplatin|mesh-list
6175320|NCT01688336|Irinotecan|irinotecan|mesh-list
6486880|NCT00573326|Imatinib Mesylate|imatinib mesylate|mesh-list
6486881|NCT00573326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6486882|NCT00573326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6486883|NCT00573326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6486884|NCT00573326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486885|NCT00573378|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6486886|NCT00573378|Antiviral Agents|antiviral agents|mesh-ancestor
6486887|NCT00573378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6486888|NCT00573404|Sunitinib|sunitinib|mesh-list
6486889|NCT00573404|Imatinib Mesylate|imatinib mesylate|mesh-list
6486890|NCT00573404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5571887|NCT03921593|Pancrelipase|pancrelipase|mesh-list
5571888|NCT03921593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5571889|NCT03921567|Lidocaine|lidocaine|mesh-list
5571890|NCT03921567|Ketamine|ketamine|mesh-list
5571891|NCT03921567|Anesthetics, Local|anesthetics, local|mesh-ancestor
5571892|NCT03921567|Anesthetics|anesthetics|mesh-ancestor
5571893|NCT03921567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5571894|NCT03921567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571895|NCT03921567|Sensory System Agents|sensory system agents|mesh-ancestor
5571896|NCT03921567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5571897|NCT03921567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5571898|NCT03921567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5571899|NCT03921567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5571900|NCT03921567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5571901|NCT03921567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5571902|NCT03921567|Analgesics|analgesics|mesh-ancestor
5571903|NCT03921567|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5571904|NCT03921567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5571905|NCT03921567|Anesthetics, General|anesthetics, general|mesh-ancestor
5571906|NCT03921567|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5571907|NCT03921567|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5571908|NCT03921567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5571909|NCT03921775|Propofol|propofol|mesh-list
5571910|NCT03921775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5571911|NCT03921775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6486891|NCT00573404|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6486892|NCT00573404|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6486893|NCT00573404|Growth Substances|growth substances|mesh-ancestor
6486894|NCT00573404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486895|NCT00573404|Growth Inhibitors|growth inhibitors|mesh-ancestor
6486896|NCT00573404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6486897|NCT00573404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6486898|NCT00573404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486899|NCT00573417|Modafinil|modafinil|mesh-list
5571912|NCT03921775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571913|NCT03921775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5571914|NCT03921775|Anesthetics, General|anesthetics, general|mesh-ancestor
5571915|NCT03921775|Anesthetics|anesthetics|mesh-ancestor
5571916|NCT03921086|Antihypertensive Agents|antihypertensive agents|mesh-list
5571917|NCT03921177|Micronutrients|micronutrients|mesh-list
5571918|NCT03921177|Trace Elements|trace elements|mesh-list
5571919|NCT03921177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571920|NCT03921034|Ropivacaine|ropivacaine|mesh-list
5571921|NCT03921034|Anesthetics, Local|anesthetics, local|mesh-ancestor
6486900|NCT00573417|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6486901|NCT00573417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486902|NCT00573417|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6486903|NCT00573417|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5571922|NCT03921034|Anesthetics|anesthetics|mesh-ancestor
5571923|NCT03921034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5571924|NCT03921034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175321|NCT01688336|Folfirinox|folfirinox|mesh-list
6486904|NCT00573417|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6670406|NCT01543139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6175322|NCT01688336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6175323|NCT01688336|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6175324|NCT01688336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6175325|NCT01688336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6175326|NCT01688336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175327|NCT01688336|Antidotes|antidotes|mesh-ancestor
6175328|NCT01688336|Protective Agents|protective agents|mesh-ancestor
6175329|NCT01688336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175330|NCT01688336|Vitamin B Complex|vitamin b complex|mesh-ancestor
6175331|NCT01688336|Vitamins|vitamins|mesh-ancestor
6175332|NCT01688336|Micronutrients|micronutrients|mesh-ancestor
6175333|NCT01688466|Pomalidomide|pomalidomide|mesh-list
6175334|NCT01688466|Immunologic Factors|immunologic factors|mesh-ancestor
6175335|NCT01688466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175336|NCT01688466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5571925|NCT03921034|Sensory System Agents|sensory system agents|mesh-ancestor
5571926|NCT03921034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5571927|NCT03921099|Ascorbic Acid|ascorbic acid|mesh-list
5571928|NCT03921099|Vitamins|vitamins|mesh-ancestor
5571929|NCT03921099|Micronutrients|micronutrients|mesh-ancestor
5571930|NCT03921099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571931|NCT03921099|Antioxidants|antioxidants|mesh-ancestor
5571932|NCT03921099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175337|NCT01688466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6175338|NCT01688466|Growth Substances|growth substances|mesh-ancestor
6175339|NCT01688466|Growth Inhibitors|growth inhibitors|mesh-ancestor
6175340|NCT01688466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5571933|NCT03921099|Protective Agents|protective agents|mesh-ancestor
5571934|NCT03920657|Deferasirox|deferasirox|mesh-list
5571935|NCT03920657|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5571936|NCT03920657|Chelating Agents|chelating agents|mesh-ancestor
5571937|NCT03920657|Sequestering Agents|sequestering agents|mesh-ancestor
5571938|NCT03920657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5571939|NCT03920631|Nivolumab|nivolumab|mesh-list
5571940|NCT03920631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5571941|NCT03920631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5571942|NCT03920631|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5571943|NCT03920631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5571944|NCT03920813|Mercaptopurine|mercaptopurine|mesh-list
5571945|NCT03920813|Antimetabolites|antimetabolites|mesh-ancestor
5571946|NCT03920813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5571947|NCT03920813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5571948|NCT03920813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5571949|NCT03920813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5571950|NCT03920813|Immunologic Factors|immunologic factors|mesh-ancestor
5571951|NCT03920813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571952|NCT03920813|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6175341|NCT01688596|Bupivacaine|bupivacaine|mesh-list
6175342|NCT01688596|Anesthetics, Local|anesthetics, local|mesh-ancestor
6175343|NCT01688596|Anesthetics|anesthetics|mesh-ancestor
6175344|NCT01688596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6175345|NCT01688596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175346|NCT01688596|Sensory System Agents|sensory system agents|mesh-ancestor
6175347|NCT01688596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6175348|NCT01688609|Paclitaxel|paclitaxel|mesh-list
6175349|NCT01688609|Trastuzumab|trastuzumab|mesh-list
6175350|NCT01688609|Lapatinib|lapatinib|mesh-list
6175351|NCT01688609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6175352|NCT01688609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6175353|NCT01688609|Tubulin Modulators|tubulin modulators|mesh-ancestor
5571953|NCT03920813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5571954|NCT03921008|Paclitaxel|paclitaxel|mesh-list
6175354|NCT01688609|Antimitotic Agents|antimitotic agents|mesh-ancestor
6175355|NCT01688609|Mitosis Modulators|mitosis modulators|mesh-ancestor
6175356|NCT01688609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175357|NCT01688609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6175358|NCT01688609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6175359|NCT01688609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6175360|NCT01688635|Insulin Glargine|insulin glargine|mesh-list
6175361|NCT01688635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6175362|NCT01688635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175363|NCT01688726|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6175364|NCT01688726|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6175365|NCT01688739|Erenumab|erenumab|mesh-list
6175366|NCT01688739|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
6175367|NCT01688739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175368|NCT01688739|Analgesics|analgesics|mesh-ancestor
6175369|NCT01688739|Sensory System Agents|sensory system agents|mesh-ancestor
6175370|NCT01688739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6175371|NCT01688739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175372|NCT01688830|Dabigatran|dabigatran|mesh-list
6175373|NCT01688830|Antithrombins|antithrombins|mesh-ancestor
6175374|NCT01688830|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6486905|NCT00573417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486906|NCT00573495|BIRC5 protein, human|birc5 protein, human|mesh-list
6486907|NCT00573495|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
6486908|NCT00573495|Protease Inhibitors|protease inhibitors|mesh-ancestor
6486909|NCT00573495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6486910|NCT00573495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486911|NCT00573547|Fluoxetine|fluoxetine|mesh-list
6486912|NCT00573547|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6486913|NCT00573547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6486914|NCT00573547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5571955|NCT03921008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5571956|NCT03921008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5571957|NCT03921008|Tubulin Modulators|tubulin modulators|mesh-ancestor
6175375|NCT01688830|Protease Inhibitors|protease inhibitors|mesh-ancestor
6175376|NCT01688830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6175377|NCT01688830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175378|NCT01688830|Anticoagulants|anticoagulants|mesh-ancestor
6175379|NCT01688921|Vaccines|vaccines|mesh-list
6175380|NCT01688921|Immunologic Factors|immunologic factors|mesh-ancestor
6175381|NCT01688921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175382|NCT01688973|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6175383|NCT01688973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6175384|NCT01688973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6175385|NCT01688973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5571958|NCT03921008|Antimitotic Agents|antimitotic agents|mesh-ancestor
5571959|NCT03921008|Mitosis Modulators|mitosis modulators|mesh-ancestor
5571960|NCT03921008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5571961|NCT03920878|Aflibercept|aflibercept|mesh-list
5571962|NCT03920878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5571963|NCT03920878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6175386|NCT01688973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175387|NCT01689207|Aztreonam|aztreonam|mesh-list
6175388|NCT01689207|Avibactam|avibactam|mesh-list
6175389|NCT01689207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6175390|NCT01689207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6175391|NCT01689207|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6175392|NCT01689207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6175393|NCT01689207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175394|NCT01689324|Vaccines|vaccines|mesh-list
6175395|NCT01689324|Immunologic Factors|immunologic factors|mesh-ancestor
6175396|NCT01689324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175397|NCT01689363|Histamine|histamine|mesh-list
5571964|NCT03920878|Growth Substances|growth substances|mesh-ancestor
5571965|NCT03920878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571966|NCT03920878|Growth Inhibitors|growth inhibitors|mesh-ancestor
5571967|NCT03920878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5571968|NCT03920618|Tenofovir|tenofovir|mesh-list
6175398|NCT01689363|Histamine Agonists|histamine agonists|mesh-ancestor
6175399|NCT01689363|Histamine Agents|histamine agents|mesh-ancestor
6175400|NCT01689363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6175401|NCT01689363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175402|NCT01689363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571969|NCT03920618|Entecavir|entecavir|mesh-list
5571970|NCT03920618|Antiviral Agents|antiviral agents|mesh-ancestor
5571971|NCT03920618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5571972|NCT03920618|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5571973|NCT03920618|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5571974|NCT03920618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5571975|NCT03920618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5571976|NCT03920618|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5571977|NCT03920618|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5571978|NCT03920839|Gemcitabine|gemcitabine|mesh-list
5571979|NCT03920839|Paclitaxel|paclitaxel|mesh-list
5571980|NCT03920839|Carboplatin|carboplatin|mesh-list
5571981|NCT03920839|Pemetrexed|pemetrexed|mesh-list
5571982|NCT03920839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5571983|NCT03920839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5571984|NCT03920839|Tubulin Modulators|tubulin modulators|mesh-ancestor
5571985|NCT03920839|Antimitotic Agents|antimitotic agents|mesh-ancestor
5571986|NCT03920839|Mitosis Modulators|mitosis modulators|mesh-ancestor
5571987|NCT03920839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5571988|NCT03920839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5571989|NCT03920839|Antimetabolites|antimetabolites|mesh-ancestor
5571990|NCT03920839|Antiviral Agents|antiviral agents|mesh-ancestor
5571991|NCT03920839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5571992|NCT03920839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5571993|NCT03920839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5571994|NCT03920839|Immunologic Factors|immunologic factors|mesh-ancestor
5571995|NCT03920839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5571996|NCT03920839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5571997|NCT03920839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5571998|NCT03920644|Scopolamine|scopolamine|mesh-list
5571999|NCT03920644|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
5572000|NCT03920644|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5572001|NCT03920644|Antiemetics|antiemetics|mesh-ancestor
5572002|NCT03920644|Autonomic Agents|autonomic agents|mesh-ancestor
5572003|NCT03920644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5572004|NCT03920644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572005|NCT03920644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5572006|NCT03920644|Mydriatics|mydriatics|mesh-ancestor
6175403|NCT01689441|Calcitriol|calcitriol|mesh-list
6175404|NCT01689441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6175405|NCT01689441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175406|NCT01689441|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6175407|NCT01689441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6175408|NCT01689441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175409|NCT01689441|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6175410|NCT01689441|Vitamins|vitamins|mesh-ancestor
6175411|NCT01689441|Micronutrients|micronutrients|mesh-ancestor
6175412|NCT01689441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6175413|NCT01689519|Vemurafenib|vemurafenib|mesh-list
6175414|NCT01689519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6175415|NCT01689519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6175416|NCT01689519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6175417|NCT01689519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175418|NCT01689532|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6175419|NCT01689532|Immunologic Factors|immunologic factors|mesh-ancestor
6175420|NCT01689532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175421|NCT01689649|Topiramate|topiramate|mesh-list
6175422|NCT01689649|Anticonvulsants|anticonvulsants|mesh-ancestor
6175423|NCT01689649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6486915|NCT00573547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486916|NCT00573547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6486917|NCT00573547|Serotonin Agents|serotonin agents|mesh-ancestor
6486918|NCT00573547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486919|NCT00573547|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6486920|NCT00573547|Antidepressive Agents|antidepressive agents|mesh-ancestor
6486921|NCT00573547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6486922|NCT00573547|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6486923|NCT00573547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6486924|NCT00573547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6486925|NCT00573599|Diphenhydramine|diphenhydramine|mesh-list
6486926|NCT00573599|Prochlorperazine|prochlorperazine|mesh-list
6486927|NCT00573599|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5572007|NCT03920644|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6175424|NCT01689649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175425|NCT01689779|Vitamin D|vitamin d|mesh-list
6175426|NCT01689779|Cholecalciferol|cholecalciferol|mesh-list
6175427|NCT01689779|Vitamins|vitamins|mesh-ancestor
6175428|NCT01689779|Micronutrients|micronutrients|mesh-ancestor
5572008|NCT03920644|Cholinergic Agents|cholinergic agents|mesh-ancestor
5572009|NCT03920644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5572010|NCT03920644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572011|NCT03920644|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5572012|NCT03920644|Parasympatholytics|parasympatholytics|mesh-ancestor
5572013|NCT03920605|Tenofovir|tenofovir|mesh-list
5572014|NCT03920605|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5572015|NCT03920605|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
5572016|NCT03920605|Antiviral Agents|antiviral agents|mesh-ancestor
5572017|NCT03920605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5572018|NCT03920605|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5572019|NCT03920605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5572020|NCT03920605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5572021|NCT03920605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175429|NCT01689779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175430|NCT01689779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6175431|NCT01689779|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6175432|NCT01690000|Melatonin|melatonin|mesh-list
6175433|NCT01690000|Antioxidants|antioxidants|mesh-ancestor
6175434|NCT01690000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175435|NCT01690000|Protective Agents|protective agents|mesh-ancestor
5572022|NCT03920605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5572023|NCT03920605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5572024|NCT03920553|Hyaluronic Acid|hyaluronic acid|mesh-list
5572025|NCT03920553|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5572026|NCT03920553|Immunologic Factors|immunologic factors|mesh-ancestor
5572027|NCT03920553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572028|NCT03920553|Viscosupplements|viscosupplements|mesh-ancestor
5572029|NCT03920553|Protective Agents|protective agents|mesh-ancestor
5572030|NCT03920514|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5572031|NCT03920514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5572032|NCT03920514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572033|NCT03920150|Vitamin D|vitamin d|mesh-list
5572034|NCT03920150|Ergocalciferols|ergocalciferols|mesh-list
5572035|NCT03920150|Cholecalciferol|cholecalciferol|mesh-list
5572036|NCT03920150|Vitamins|vitamins|mesh-list
5572037|NCT03920150|Micronutrients|micronutrients|mesh-ancestor
5572038|NCT03920150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572039|NCT03920150|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5572040|NCT03920150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5572041|NCT03920137|Nicotine|nicotine|mesh-list
6175436|NCT01690000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175437|NCT01690000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6175438|NCT01690052|Pilocarpine|pilocarpine|mesh-list
6175439|NCT01690052|Cevimeline|cevimeline|mesh-list
6175440|NCT01690052|Miotics|miotics|mesh-ancestor
6175441|NCT01690052|Autonomic Agents|autonomic agents|mesh-ancestor
6175442|NCT01690052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6175443|NCT01690052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175444|NCT01690052|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6175445|NCT01690052|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6175446|NCT01690052|Cholinergic Agents|cholinergic agents|mesh-ancestor
6175447|NCT01690052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6175448|NCT01690052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175449|NCT01690052|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6175450|NCT01690143|Melphalan|melphalan|mesh-list
6175451|NCT01690143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6175452|NCT01690143|Alkylating Agents|alkylating agents|mesh-ancestor
6175453|NCT01690143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175454|NCT01690143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6175455|NCT01690143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6175456|NCT01690143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6175457|NCT01690143|Immunologic Factors|immunologic factors|mesh-ancestor
6175458|NCT01690143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175459|NCT01690299|Etanercept|etanercept|mesh-list
6175460|NCT01690299|Apremilast|apremilast|mesh-list
6175461|NCT01690299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6175462|NCT01690299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6175463|NCT01690299|Analgesics|analgesics|mesh-ancestor
6175464|NCT01690299|Sensory System Agents|sensory system agents|mesh-ancestor
5572042|NCT03920137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6175465|NCT01690299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5572043|NCT03920137|Autonomic Agents|autonomic agents|mesh-ancestor
6175466|NCT01690299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175467|NCT01690299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6175468|NCT01690299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6175469|NCT01690299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6175470|NCT01690299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6175471|NCT01690299|Immunologic Factors|immunologic factors|mesh-ancestor
6175472|NCT01690299|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6175473|NCT01690299|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6486928|NCT00573599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6486929|NCT00573599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6486930|NCT00573599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486931|NCT00573599|Anesthetics, Local|anesthetics, local|mesh-ancestor
6486932|NCT00573599|Anesthetics|anesthetics|mesh-ancestor
6486933|NCT00573599|Sensory System Agents|sensory system agents|mesh-ancestor
6486934|NCT00573599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6486935|NCT00573599|Antiemetics|antiemetics|mesh-ancestor
6486936|NCT00573599|Autonomic Agents|autonomic agents|mesh-ancestor
6175474|NCT01690299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6175475|NCT01690299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175476|NCT01690520|Cyclosporine|cyclosporine|mesh-list
6175477|NCT01690520|Mycophenolic Acid|mycophenolic acid|mesh-list
6175478|NCT01690520|Cyclophosphamide|cyclophosphamide|mesh-list
6175479|NCT01690520|Thiotepa|thiotepa|mesh-list
6175480|NCT01690520|Fludarabine|fludarabine|mesh-list
6175481|NCT01690520|Fludarabine phosphate|fludarabine phosphate|mesh-list
5572044|NCT03920137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5572045|NCT03920137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572046|NCT03920137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5572047|NCT03920137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5572048|NCT03920137|Cholinergic Agents|cholinergic agents|mesh-ancestor
5572049|NCT03920137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5572050|NCT03920137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572051|NCT03920475|Sertraline|sertraline|mesh-list
5572052|NCT03920475|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
5572053|NCT03920475|Antidepressive Agents|antidepressive agents|mesh-ancestor
5572054|NCT03920475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5572055|NCT03920475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5572056|NCT03920475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5572057|NCT03920475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5572058|NCT03920475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572059|NCT03920475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5572060|NCT03920475|Serotonin Agents|serotonin agents|mesh-ancestor
5572061|NCT03920475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572062|NCT03920475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6175482|NCT01690520|Cyclosporins|cyclosporins|mesh-list
6175483|NCT01690520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6175484|NCT01690520|Immunologic Factors|immunologic factors|mesh-ancestor
6175485|NCT01690520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175486|NCT01690520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6175487|NCT01690520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6175488|NCT01690520|Alkylating Agents|alkylating agents|mesh-ancestor
6175489|NCT01690520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175490|NCT01690520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6670407|NCT01543139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6670408|NCT01543165|Ketorolac|ketorolac|mesh-list
6670409|NCT01543165|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6670410|NCT01543165|Morphine|morphine|mesh-list
6670411|NCT01543165|Analgesics|analgesics|mesh-list
6670412|NCT01543165|Nefopam|nefopam|mesh-list
6670413|NCT01543165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6670414|NCT01543165|Narcotics|narcotics|mesh-ancestor
6670415|NCT01543165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6670416|NCT01543165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670417|NCT01543165|Sensory System Agents|sensory system agents|mesh-ancestor
6670418|NCT01543165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6670419|NCT01543165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6670420|NCT01543165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6670421|NCT01543165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6670422|NCT01543165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6670423|NCT01543165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6175491|NCT01690520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6175492|NCT01690520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6175493|NCT01690520|Antimetabolites|antimetabolites|mesh-ancestor
6486937|NCT00573599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6670424|NCT01543165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6672508|NCT01556672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6672509|NCT01556672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6175494|NCT01690520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6175495|NCT01690520|Antifungal Agents|antifungal agents|mesh-ancestor
6175496|NCT01690520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6175497|NCT01690520|Dermatologic Agents|dermatologic agents|mesh-ancestor
6175498|NCT01690520|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6175499|NCT01690520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6175500|NCT01690520|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6175501|NCT01690520|Antitubercular Agents|antitubercular agents|mesh-ancestor
6175502|NCT01690520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6175503|NCT01690546|Naltrexone|naltrexone|mesh-list
6175504|NCT01690546|Buprenorphine|buprenorphine|mesh-list
6175505|NCT01690546|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6175506|NCT01690546|Naloxone|naloxone|mesh-list
6175507|NCT01690546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6175508|NCT01690546|Narcotics|narcotics|mesh-ancestor
5572063|NCT03920475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5572064|NCT03920319|Bupropion|bupropion|mesh-list
5572065|NCT03920319|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5572066|NCT03920319|Antidepressive Agents|antidepressive agents|mesh-ancestor
5572067|NCT03920319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5572068|NCT03920319|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5572069|NCT03920319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5572070|NCT03920319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5572071|NCT03920319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572072|NCT03920319|Dopamine Agents|dopamine agents|mesh-ancestor
6175509|NCT01690546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6175510|NCT01690546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175511|NCT01690546|Analgesics|analgesics|mesh-ancestor
6175512|NCT01690546|Sensory System Agents|sensory system agents|mesh-ancestor
6175513|NCT01690546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6175514|NCT01690546|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6175515|NCT01690546|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6175516|NCT01690663|Dexamethasone|dexamethasone|mesh-list
6175517|NCT01690663|Bupivacaine|bupivacaine|mesh-list
6175518|NCT01690663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6175519|NCT01690663|Antiemetics|antiemetics|mesh-ancestor
6175520|NCT01690663|Autonomic Agents|autonomic agents|mesh-ancestor
6175521|NCT01690663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6175522|NCT01690663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175523|NCT01690663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6175524|NCT01690663|Glucocorticoids|glucocorticoids|mesh-ancestor
6175525|NCT01690663|Hormones|hormones|mesh-ancestor
6175526|NCT01690663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6175527|NCT01690663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6175528|NCT01690663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6175529|NCT01690663|Anesthetics, Local|anesthetics, local|mesh-ancestor
6175530|NCT01690663|Anesthetics|anesthetics|mesh-ancestor
6175531|NCT01690663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6175532|NCT01690663|Sensory System Agents|sensory system agents|mesh-ancestor
6175533|NCT01690988|Ketamine|ketamine|mesh-list
6175534|NCT01690988|Analgesics|analgesics|mesh-ancestor
6175535|NCT01690988|Sensory System Agents|sensory system agents|mesh-ancestor
6175536|NCT01690988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6175537|NCT01690988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175538|NCT01690988|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6175539|NCT01690988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6175540|NCT01690988|Anesthetics, General|anesthetics, general|mesh-ancestor
6175541|NCT01690988|Anesthetics|anesthetics|mesh-ancestor
6175542|NCT01690988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6175543|NCT01690988|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6175544|NCT01690988|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6175545|NCT01690988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6175546|NCT01690988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175547|NCT01691092|Ketamine|ketamine|mesh-list
6175548|NCT01691092|Analgesics|analgesics|mesh-ancestor
6175549|NCT01691092|Sensory System Agents|sensory system agents|mesh-ancestor
6175550|NCT01691092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6175551|NCT01691092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175552|NCT01691092|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6175553|NCT01691092|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6175554|NCT01691092|Anesthetics, General|anesthetics, general|mesh-ancestor
6175555|NCT01691092|Anesthetics|anesthetics|mesh-ancestor
6175556|NCT01691092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6175557|NCT01691092|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5572073|NCT03920319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5572074|NCT03920319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572075|NCT03920319|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5572076|NCT03920319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5572077|NCT03920319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5572078|NCT03920293|Ravulizumab|ravulizumab|mesh-list
5572079|NCT03920293|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5572080|NCT03920293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5572081|NCT03920293|Immunologic Factors|immunologic factors|mesh-ancestor
5572082|NCT03920293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572083|NCT03920397|Cholecalciferol|cholecalciferol|mesh-list
5572084|NCT03920397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5572085|NCT03920397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572086|NCT03920397|Vitamins|vitamins|mesh-ancestor
5572087|NCT03920397|Micronutrients|micronutrients|mesh-ancestor
5572088|NCT03920397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5572089|NCT03920449|Botulinum Toxins|botulinum toxins|mesh-list
5572090|NCT03920449|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5572091|NCT03920449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5572092|NCT03920449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572093|NCT03920449|Cholinergic Agents|cholinergic agents|mesh-ancestor
5572094|NCT03920449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5572095|NCT03920449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572096|NCT03920059|Mycophenolic Acid|mycophenolic acid|mesh-list
5572097|NCT03920059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5572098|NCT03920059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5572099|NCT03920059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5572100|NCT03920059|Antitubercular Agents|antitubercular agents|mesh-ancestor
5572101|NCT03920059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5572102|NCT03920059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5572103|NCT03920059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5572104|NCT03920059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572105|NCT03919851|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5572106|NCT03919851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5604299|NCT05018481|Hyaluronic Acid|hyaluronic acid|mesh-list
5604300|NCT05018481|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5604301|NCT05018481|Immunologic Factors|immunologic factors|mesh-ancestor
5604302|NCT05018481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604303|NCT05018481|Viscosupplements|viscosupplements|mesh-ancestor
5604304|NCT05018481|Protective Agents|protective agents|mesh-ancestor
5604305|NCT05011149|Ibuprofen|ibuprofen|mesh-list
5604306|NCT05011149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5604307|NCT05011149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5604308|NCT05011149|Analgesics|analgesics|mesh-ancestor
5604309|NCT05011149|Sensory System Agents|sensory system agents|mesh-ancestor
5604310|NCT05011149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6175558|NCT01691092|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6175559|NCT01691092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6175560|NCT01691092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206472|NCT02100644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6206473|NCT02100644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6206474|NCT02100644|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6206475|NCT02100657|Dexamethasone|dexamethasone|mesh-list
6206476|NCT02100657|Bortezomib|bortezomib|mesh-list
5604311|NCT05011149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604312|NCT05011149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5604313|NCT05011149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5604314|NCT05011149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5604315|NCT05011149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5604316|NCT05011149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604317|NCT04995978|Pioglitazone|pioglitazone|mesh-list
5604318|NCT04995978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5604319|NCT04995978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604320|NCT04965597|Vidarabine|vidarabine|mesh-list
5604321|NCT04965597|Methotrexate|methotrexate|mesh-list
5604322|NCT04965597|Fludarabine phosphate|fludarabine phosphate|mesh-list
5604323|NCT04965597|Fludarabine|fludarabine|mesh-list
5604324|NCT04965597|Treosulfan|treosulfan|mesh-list
6206477|NCT02100657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6206478|NCT02100657|Antiemetics|antiemetics|mesh-ancestor
6206479|NCT02100657|Autonomic Agents|autonomic agents|mesh-ancestor
6206480|NCT02100657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6206481|NCT02100657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206482|NCT02100657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6206483|NCT02100657|Glucocorticoids|glucocorticoids|mesh-ancestor
5572107|NCT03919786|Anesthetics|anesthetics|mesh-list
5572108|NCT03919786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5572109|NCT03919786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572110|NCT03919617|Volagidemab|volagidemab|mesh-list
5572111|NCT03919617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5572112|NCT03919617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572113|NCT03919955|Oxybutynin|oxybutynin|mesh-list
5572114|NCT03919955|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6175561|NCT01691248|Fidaxomicin|fidaxomicin|mesh-list
6175562|NCT01691248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6175563|NCT01691248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6175564|NCT01691313|Vanoxerine|vanoxerine|mesh-list
6175565|NCT01691313|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6175566|NCT01691313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6175567|NCT01691313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6175568|NCT01691313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175569|NCT01691313|Dopamine Agents|dopamine agents|mesh-ancestor
6175570|NCT01691313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6175571|NCT01691313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175572|NCT01691326|Vaccines|vaccines|mesh-list
6175573|NCT01691326|Immunologic Factors|immunologic factors|mesh-ancestor
6175574|NCT01691326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175575|NCT01691339|Vaccines|vaccines|mesh-list
6175576|NCT01691339|Immunologic Factors|immunologic factors|mesh-ancestor
6175577|NCT01691339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175578|NCT01691482|Albuterol|albuterol|mesh-list
6175579|NCT01691482|Ipratropium|ipratropium|mesh-list
6175580|NCT01691482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6175581|NCT01691482|Autonomic Agents|autonomic agents|mesh-ancestor
6175582|NCT01691482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6175583|NCT01691482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175584|NCT01691482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6175585|NCT01691482|Respiratory System Agents|respiratory system agents|mesh-ancestor
6175586|NCT01691482|Tocolytic Agents|tocolytic agents|mesh-ancestor
6175587|NCT01691482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6175588|NCT01691482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6175589|NCT01691482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6175590|NCT01691482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6175591|NCT01691482|Adrenergic Agents|adrenergic agents|mesh-ancestor
6175592|NCT01691482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6175593|NCT01691482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175594|NCT01691482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6175595|NCT01691482|Cholinergic Agents|cholinergic agents|mesh-ancestor
6175596|NCT01691508|Prednisone|prednisone|mesh-list
6670425|NCT01543165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670426|NCT01543321|Tetrabenazine|tetrabenazine|mesh-list
6670427|NCT01543321|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6670428|NCT01543321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6670429|NCT01543321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6670430|NCT01543321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670431|NCT01543321|Adrenergic Agents|adrenergic agents|mesh-ancestor
6670432|NCT01543321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6670433|NCT01543321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670434|NCT01543347|Temocillin|temocillin|mesh-list
6670435|NCT01543347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6670436|NCT01543347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6670437|NCT01543386|Curcumin|curcumin|mesh-list
6670438|NCT01543386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6670439|NCT01543386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6670440|NCT01543386|Analgesics|analgesics|mesh-ancestor
6670441|NCT01543386|Sensory System Agents|sensory system agents|mesh-ancestor
6670442|NCT01543386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6670443|NCT01543386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670444|NCT01543386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6670445|NCT01543386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6670446|NCT01543386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6670447|NCT01543386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6670448|NCT01543386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670449|NCT01543399|Tibolone|tibolone|mesh-list
6670450|NCT01543399|Androgen Antagonists|androgen antagonists|mesh-ancestor
5572115|NCT03919955|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5604325|NCT04965597|Busulfan|busulfan|mesh-list
6175597|NCT01691508|Prednisolone|prednisolone|mesh-list
6175598|NCT01691508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6175599|NCT01691508|Glucocorticoids|glucocorticoids|mesh-ancestor
5572116|NCT03919955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5572117|NCT03919955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5572118|NCT03919955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572119|NCT03919955|Adrenergic Agents|adrenergic agents|mesh-ancestor
5572120|NCT03919955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5572121|NCT03919955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572122|NCT03919955|Parasympatholytics|parasympatholytics|mesh-ancestor
5572123|NCT03919955|Autonomic Agents|autonomic agents|mesh-ancestor
5572124|NCT03919955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5572125|NCT03919955|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5572126|NCT03919955|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5572127|NCT03919955|Cholinergic Agents|cholinergic agents|mesh-ancestor
5572128|NCT03919955|Urological Agents|urological agents|mesh-ancestor
5572129|NCT03919942|Chlorhexidine|chlorhexidine|mesh-list
5572130|NCT03919942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5572131|NCT03919942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5572132|NCT03919942|Disinfectants|disinfectants|mesh-ancestor
5572133|NCT03919812|Cholecalciferol|cholecalciferol|mesh-list
5572134|NCT03919812|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5572135|NCT03919812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572136|NCT03919812|Vitamins|vitamins|mesh-ancestor
5572137|NCT03919812|Micronutrients|micronutrients|mesh-ancestor
5572138|NCT03919812|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5572139|NCT03919656|Dapagliflozin|dapagliflozin|mesh-list
5572140|NCT03919656|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5572141|NCT03919656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572142|NCT03919656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5572143|NCT03919656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572144|NCT03919552|Cisplatin|cisplatin|mesh-list
5572145|NCT03919552|Carboplatin|carboplatin|mesh-list
5572146|NCT03919552|Docetaxel|docetaxel|mesh-list
5572147|NCT03919552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5572148|NCT03919552|Tubulin Modulators|tubulin modulators|mesh-ancestor
5572149|NCT03919552|Antimitotic Agents|antimitotic agents|mesh-ancestor
5572150|NCT03919552|Mitosis Modulators|mitosis modulators|mesh-ancestor
5572151|NCT03919552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572152|NCT03919565|Tenofovir|tenofovir|mesh-list
5572153|NCT03919565|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5572154|NCT03919565|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
5572155|NCT03919565|Antiviral Agents|antiviral agents|mesh-ancestor
5572156|NCT03919565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5572157|NCT03919565|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5572158|NCT03919565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6175600|NCT01691508|Hormones|hormones|mesh-ancestor
6175601|NCT01691508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6175602|NCT01691508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175603|NCT01691508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6175604|NCT01691508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6175605|NCT01691534|Pyrazinamide|pyrazinamide|mesh-list
6175606|NCT01691534|Clofazimine|clofazimine|mesh-list
6175607|NCT01691534|Antitubercular Agents|antitubercular agents|mesh-ancestor
6175608|NCT01691534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6175609|NCT01691534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6175610|NCT01691534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6175611|NCT01691534|Leprostatic Agents|leprostatic agents|mesh-ancestor
6175612|NCT01691560|Calcium, Dietary|calcium, dietary|mesh-list
6175613|NCT01691560|Listerine|listerine|mesh-list
6175614|NCT01691560|Calcium|calcium|mesh-list
6175615|NCT01691560|Fluorides|fluorides|mesh-list
6175616|NCT01691560|Sodium Fluoride|sodium fluoride|mesh-list
6175617|NCT01691560|Fluorophosphate|fluorophosphate|mesh-list
6175618|NCT01691560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6175619|NCT01691560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175620|NCT01691560|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6175621|NCT01691560|Cariostatic Agents|cariostatic agents|mesh-ancestor
6175622|NCT01691560|Protective Agents|protective agents|mesh-ancestor
6175623|NCT01691560|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6175624|NCT01691560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6175625|NCT01691690|Acetaminophen|acetaminophen|mesh-list
6175626|NCT01691690|Dexamethasone|dexamethasone|mesh-list
6175627|NCT01691690|Midazolam|midazolam|mesh-list
6175628|NCT01691690|Morphine|morphine|mesh-list
6175629|NCT01691690|Nitrous Oxide|nitrous oxide|mesh-list
6175630|NCT01691690|Ondansetron|ondansetron|mesh-list
6175631|NCT01691690|Propofol|propofol|mesh-list
6175632|NCT01691690|Sevoflurane|sevoflurane|mesh-list
6175633|NCT01691690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6175634|NCT01691690|Antiemetics|antiemetics|mesh-ancestor
5572159|NCT03919565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5572160|NCT03919565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175635|NCT01691690|Autonomic Agents|autonomic agents|mesh-ancestor
6175636|NCT01691690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6175637|NCT01691690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175638|NCT01691690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6175639|NCT01691690|Glucocorticoids|glucocorticoids|mesh-ancestor
6175640|NCT01691690|Hormones|hormones|mesh-ancestor
6175641|NCT01691690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6175642|NCT01691690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6175643|NCT01691690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6175644|NCT01691690|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6175645|NCT01691690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6175646|NCT01691690|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6175647|NCT01691690|Anesthetics, General|anesthetics, general|mesh-ancestor
6175648|NCT01691690|Anesthetics|anesthetics|mesh-ancestor
6175649|NCT01691690|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6175650|NCT01691690|Narcotics|narcotics|mesh-ancestor
6175651|NCT01691690|Analgesics|analgesics|mesh-ancestor
6175652|NCT01691690|Sensory System Agents|sensory system agents|mesh-ancestor
6175653|NCT01691690|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6175654|NCT01691690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6175655|NCT01691690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6175656|NCT01691690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6175657|NCT01691690|GABA Modulators|gaba modulators|mesh-ancestor
6175658|NCT01691690|GABA Agents|gaba agents|mesh-ancestor
6175659|NCT01691690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6175660|NCT01691690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175661|NCT01691690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6175662|NCT01691690|Antipyretics|antipyretics|mesh-ancestor
6175663|NCT01691690|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6175664|NCT01691690|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6175665|NCT01691690|Antipruritics|antipruritics|mesh-ancestor
6175666|NCT01691690|Dermatologic Agents|dermatologic agents|mesh-ancestor
6175667|NCT01691690|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6670451|NCT01543399|Hormone Antagonists|hormone antagonists|mesh-ancestor
6670452|NCT01543399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6670453|NCT01543399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670454|NCT01543399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6670455|NCT01543399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6670456|NCT01543399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6670457|NCT01543399|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6175668|NCT01691690|Serotonin Agents|serotonin agents|mesh-ancestor
6175669|NCT01691690|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6175670|NCT01691768|Tenofovir|tenofovir|mesh-list
6175671|NCT01691768|Antiviral Agents|antiviral agents|mesh-ancestor
6175672|NCT01691768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6175673|NCT01691768|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6175674|NCT01691768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6175675|NCT01691768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6175676|NCT01691768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175677|NCT01691768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6175678|NCT01691768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6175679|NCT01691781|Lisinopril|lisinopril|mesh-list
6175680|NCT01691781|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6175681|NCT01691781|Protease Inhibitors|protease inhibitors|mesh-ancestor
6175682|NCT01691781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6175683|NCT01691781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175684|NCT01691781|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6175685|NCT01691781|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6175686|NCT01691781|Protective Agents|protective agents|mesh-ancestor
6175687|NCT01691781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175688|NCT01691794|Ritonavir|ritonavir|mesh-list
6175689|NCT01691794|Atazanavir Sulfate|atazanavir sulfate|mesh-list
5572161|NCT03919565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5572162|NCT03919565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5572163|NCT03919253|Paclitaxel|paclitaxel|mesh-list
5572164|NCT03919253|Maleic acid|maleic acid|mesh-list
5572165|NCT03919253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5572166|NCT03919253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5572167|NCT03919253|Tubulin Modulators|tubulin modulators|mesh-ancestor
5572168|NCT03919253|Antimitotic Agents|antimitotic agents|mesh-ancestor
6670458|NCT01543399|Anabolic Agents|anabolic agents|mesh-ancestor
5572169|NCT03919253|Mitosis Modulators|mitosis modulators|mesh-ancestor
6175690|NCT01691794|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6206484|NCT02100657|Hormones|hormones|mesh-ancestor
6670459|NCT01543399|Hormones|hormones|mesh-ancestor
6670460|NCT01543464|Temozolomide|temozolomide|mesh-list
6670461|NCT01543464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6670462|NCT01543464|Alkylating Agents|alkylating agents|mesh-ancestor
5572170|NCT03919253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572171|NCT03919253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5572172|NCT03919526|Cyclophosphamide|cyclophosphamide|mesh-list
5572173|NCT03919526|Fludarabine|fludarabine|mesh-list
5572174|NCT03919526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5572175|NCT03919526|Immunologic Factors|immunologic factors|mesh-ancestor
5572176|NCT03919526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572177|NCT03919526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5572178|NCT03919526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5572179|NCT03919526|Alkylating Agents|alkylating agents|mesh-ancestor
5572180|NCT03919526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572181|NCT03919526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5572182|NCT03919526|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5572183|NCT03919383|Lenvatinib|lenvatinib|mesh-list
5572184|NCT03919383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5572185|NCT03919383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5572186|NCT03919383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5572187|NCT03919383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572188|NCT03919448|Bevacizumab|bevacizumab|mesh-list
5572189|NCT03919448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5572190|NCT03919448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5572191|NCT03919448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5572192|NCT03919448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5572193|NCT03919448|Growth Substances|growth substances|mesh-ancestor
5572194|NCT03919448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572195|NCT03919448|Growth Inhibitors|growth inhibitors|mesh-ancestor
5572196|NCT03919084|Nicotine|nicotine|mesh-list
5572197|NCT03919084|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5572198|NCT03919084|Autonomic Agents|autonomic agents|mesh-ancestor
5572199|NCT03919084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5572200|NCT03919084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572201|NCT03919084|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5572202|NCT03919084|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5572203|NCT03919084|Cholinergic Agents|cholinergic agents|mesh-ancestor
5572204|NCT03919084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5572205|NCT03919084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572206|NCT03919461|Etodolac|etodolac|mesh-list
5572207|NCT03919461|Propranolol|propranolol|mesh-list
5572208|NCT03919461|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5572209|NCT03919461|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5572210|NCT03919461|Adrenergic Agents|adrenergic agents|mesh-ancestor
5572211|NCT03919461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5572212|NCT03919461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572213|NCT03919461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670463|NCT01543464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670464|NCT01543464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6670465|NCT01543555|Atorvastatin|atorvastatin|mesh-list
6670466|NCT01543555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6670467|NCT01543555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6670468|NCT01543555|Antimetabolites|antimetabolites|mesh-ancestor
6670469|NCT01543555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670470|NCT01543555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6670471|NCT01543555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6670472|NCT01543555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6175691|NCT01691794|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6175692|NCT01691794|Protease Inhibitors|protease inhibitors|mesh-ancestor
6175693|NCT01691794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6175694|NCT01691794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175695|NCT01691794|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6175696|NCT01691794|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6175697|NCT01691794|Antiviral Agents|antiviral agents|mesh-ancestor
6175698|NCT01691794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6175699|NCT01691794|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6175700|NCT01691794|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6175701|NCT01691833|Vitamin D|vitamin d|mesh-list
6175702|NCT01691833|Vitamins|vitamins|mesh-ancestor
6670473|NCT01543724|Lithium Carbonate|lithium carbonate|mesh-list
5572214|NCT03919461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5572215|NCT03919461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6175703|NCT01691833|Micronutrients|micronutrients|mesh-ancestor
6175704|NCT01691833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175705|NCT01691833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6175706|NCT01691885|Fluticasone|fluticasone|mesh-list
6175707|NCT01691885|Xhance|xhance|mesh-list
6175708|NCT01691885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6175709|NCT01691885|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6175710|NCT01691885|Autonomic Agents|autonomic agents|mesh-ancestor
6175711|NCT01691885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6175712|NCT01691885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175713|NCT01691885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6175714|NCT01691885|Respiratory System Agents|respiratory system agents|mesh-ancestor
6175715|NCT01691885|Dermatologic Agents|dermatologic agents|mesh-ancestor
6175716|NCT01691885|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6175717|NCT01691898|Rituximab|rituximab|mesh-list
6175718|NCT01691898|Obinutuzumab|obinutuzumab|mesh-list
6175719|NCT01691898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6175720|NCT01691898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6175721|NCT01691898|Immunologic Factors|immunologic factors|mesh-ancestor
6175722|NCT01691898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175723|NCT01691898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6175724|NCT01692197|Cytarabine|cytarabine|mesh-list
6175725|NCT01692197|Dexamethasone|dexamethasone|mesh-list
6175726|NCT01692197|Idarubicin|idarubicin|mesh-list
6175727|NCT01692197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6175728|NCT01692197|Antiemetics|antiemetics|mesh-ancestor
6175729|NCT01692197|Autonomic Agents|autonomic agents|mesh-ancestor
6175730|NCT01692197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6175731|NCT01692197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175732|NCT01692197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6175733|NCT01692197|Glucocorticoids|glucocorticoids|mesh-ancestor
6175734|NCT01692197|Hormones|hormones|mesh-ancestor
5572216|NCT03919461|Vasodilator Agents|vasodilator agents|mesh-ancestor
5572217|NCT03919461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5572218|NCT03919461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5572219|NCT03919461|Analgesics|analgesics|mesh-ancestor
6175735|NCT01692197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6175736|NCT01692197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6175737|NCT01692197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6175738|NCT01692197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6175739|NCT01692197|Antimetabolites|antimetabolites|mesh-ancestor
5572220|NCT03919461|Sensory System Agents|sensory system agents|mesh-ancestor
5572221|NCT03919461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5572222|NCT03919461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5572223|NCT03919461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6175740|NCT01692197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175741|NCT01692197|Antiviral Agents|antiviral agents|mesh-ancestor
6175742|NCT01692197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6175743|NCT01692197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6175744|NCT01692197|Immunologic Factors|immunologic factors|mesh-ancestor
6175745|NCT01692197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6175746|NCT01692197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6175747|NCT01692197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6175748|NCT01692197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6175749|NCT01692301|Amlodipine|amlodipine|mesh-list
6175750|NCT01692301|Valsartan|valsartan|mesh-list
6175751|NCT01692301|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6175752|NCT01692301|Olmesartan|olmesartan|mesh-list
6175753|NCT01692301|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6175754|NCT01692301|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
6175755|NCT01692301|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6175756|NCT01692301|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6175757|NCT01692301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6175758|NCT01692301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175759|NCT01692301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6175760|NCT01692301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175761|NCT01692301|Vasodilator Agents|vasodilator agents|mesh-ancestor
6175762|NCT01692301|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6175763|NCT01692301|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6175764|NCT01692301|Diuretics|diuretics|mesh-ancestor
6175765|NCT01692301|Natriuretic Agents|natriuretic agents|mesh-ancestor
6175766|NCT01692301|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6175767|NCT01692340|Lycopene|lycopene|mesh-list
5572224|NCT03919461|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6175768|NCT01692340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6175769|NCT01692340|Antioxidants|antioxidants|mesh-ancestor
6175770|NCT01692340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175771|NCT01692340|Protective Agents|protective agents|mesh-ancestor
6175772|NCT01692340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175773|NCT01692340|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6175774|NCT01692340|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6175775|NCT01692340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6175776|NCT01692626|Pimecrolimus|pimecrolimus|mesh-list
6175777|NCT01692626|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5572225|NCT03919461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5572226|NCT03919461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5572227|NCT03919175|Rituximab|rituximab|mesh-list
5572228|NCT03919175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5572229|NCT03919175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6175778|NCT01692626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6175779|NCT01692626|Analgesics|analgesics|mesh-ancestor
6175780|NCT01692626|Sensory System Agents|sensory system agents|mesh-ancestor
6175781|NCT01692626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6175782|NCT01692626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175783|NCT01692626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6175784|NCT01692626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6175785|NCT01692626|Dermatologic Agents|dermatologic agents|mesh-ancestor
6175786|NCT01692626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5572230|NCT03919175|Immunologic Factors|immunologic factors|mesh-ancestor
5572231|NCT03919175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572232|NCT03919175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5572233|NCT03918993|Tadalafil|tadalafil|mesh-list
5572234|NCT03918993|Vasodilator Agents|vasodilator agents|mesh-ancestor
5572235|NCT03918993|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5572236|NCT03918993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5572237|NCT03918993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5572238|NCT03918993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572239|NCT03918993|Urological Agents|urological agents|mesh-ancestor
5572240|NCT03918616|Dopamine|dopamine|mesh-list
6175787|NCT01692626|Immunologic Factors|immunologic factors|mesh-ancestor
6175788|NCT01692626|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6175789|NCT01692626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6175790|NCT01692626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175791|NCT01692756|Triamcinolone|triamcinolone|mesh-list
6175792|NCT01692756|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6175793|NCT01692756|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6175794|NCT01692756|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6175795|NCT01692756|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6175796|NCT01692756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6175797|NCT01692756|Glucocorticoids|glucocorticoids|mesh-ancestor
6175798|NCT01692756|Hormones|hormones|mesh-ancestor
6175799|NCT01692756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6175800|NCT01692756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175801|NCT01692756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6175802|NCT01692756|Immunologic Factors|immunologic factors|mesh-ancestor
6175803|NCT01692756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6175804|NCT01692756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175805|NCT01693029|Epoetin Alfa|epoetin alfa|mesh-list
5572241|NCT03918616|Memantine|memantine|mesh-list
5572242|NCT03918616|Dopamine Agonists|dopamine agonists|mesh-list
5572243|NCT03918616|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5572244|NCT03918616|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5572245|NCT03918616|Dopamine Agents|dopamine agents|mesh-ancestor
5572246|NCT03918616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5572247|NCT03918616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572248|NCT03918616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572249|NCT03918616|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5572250|NCT03918616|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5572251|NCT03918616|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5572252|NCT03918616|Sympathomimetics|sympathomimetics|mesh-ancestor
5572253|NCT03918616|Autonomic Agents|autonomic agents|mesh-ancestor
5572254|NCT03918616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5572255|NCT03918616|Protective Agents|protective agents|mesh-ancestor
5572256|NCT03918590|Nepafenac|nepafenac|mesh-list
5572257|NCT03918590|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
5572258|NCT03918590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5572259|NCT03918590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5572260|NCT03918590|Analgesics|analgesics|mesh-ancestor
5572261|NCT03918590|Sensory System Agents|sensory system agents|mesh-ancestor
5572262|NCT03918590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6175806|NCT01693029|Hematinics|hematinics|mesh-ancestor
6175807|NCT01693068|Dacarbazine|dacarbazine|mesh-list
6175808|NCT01693068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6175809|NCT01693068|Alkylating Agents|alkylating agents|mesh-ancestor
6175810|NCT01693068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175811|NCT01693068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6175812|NCT01693185|Midazolam|midazolam|mesh-list
6175813|NCT01693185|Meperidine|meperidine|mesh-list
5572263|NCT03918590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572264|NCT03918590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5572265|NCT03918590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5572266|NCT03918590|Laxatives|laxatives|mesh-ancestor
5572267|NCT03918590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5572268|NCT03918694|Ascorbic Acid|ascorbic acid|mesh-list
5572269|NCT03918694|Vitamins|vitamins|mesh-ancestor
5572270|NCT03918694|Micronutrients|micronutrients|mesh-ancestor
5572271|NCT03918694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572272|NCT03918694|Antioxidants|antioxidants|mesh-ancestor
5572273|NCT03918694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572274|NCT03918694|Protective Agents|protective agents|mesh-ancestor
5572275|NCT03918889|Midazolam|midazolam|mesh-list
5572276|NCT03918889|Dexmedetomidine|dexmedetomidine|mesh-list
6175814|NCT01693185|Remifentanil|remifentanil|mesh-list
6175815|NCT01693185|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6175816|NCT01693185|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6175817|NCT01693185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6486938|NCT00573599|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6486939|NCT00573599|Histamine Antagonists|histamine antagonists|mesh-ancestor
6486940|NCT00573599|Histamine Agents|histamine agents|mesh-ancestor
6486941|NCT00573599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6486942|NCT00573599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486943|NCT00573599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6486944|NCT00573599|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6486945|NCT00573599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6486946|NCT00573599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6486947|NCT00573599|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6486948|NCT00573599|Dopamine Agents|dopamine agents|mesh-ancestor
6486949|NCT00573638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6486950|NCT00573638|Latanoprost|latanoprost|mesh-list
6486951|NCT00573638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6486952|NCT00573664|Gabapentin|gabapentin|mesh-list
6486953|NCT00573664|Analgesics|analgesics|mesh-ancestor
6486954|NCT00573664|Sensory System Agents|sensory system agents|mesh-ancestor
6486955|NCT00573664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6486956|NCT00573664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486957|NCT00573664|Anticonvulsants|anticonvulsants|mesh-ancestor
6175818|NCT01693185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175819|NCT01693185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6175820|NCT01693185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6175821|NCT01693185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6175822|NCT01693185|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6175823|NCT01693185|Anesthetics, General|anesthetics, general|mesh-ancestor
6175824|NCT01693185|Anesthetics|anesthetics|mesh-ancestor
6175825|NCT01693185|GABA Modulators|gaba modulators|mesh-ancestor
6175826|NCT01693185|GABA Agents|gaba agents|mesh-ancestor
6175827|NCT01693185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6175828|NCT01693185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175829|NCT01693185|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6175830|NCT01693185|Narcotics|narcotics|mesh-ancestor
6175831|NCT01693185|Analgesics|analgesics|mesh-ancestor
6175832|NCT01693185|Sensory System Agents|sensory system agents|mesh-ancestor
6175833|NCT01693185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5572277|NCT03918889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5572278|NCT03918889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5572279|NCT03918889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572280|NCT03918889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6175834|NCT01693523|Minocycline|minocycline|mesh-list
6175835|NCT01693523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6175836|NCT01693523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6175837|NCT01693562|Durvalumab|durvalumab|mesh-list
5572281|NCT03918889|Analgesics|analgesics|mesh-ancestor
5572282|NCT03918889|Sensory System Agents|sensory system agents|mesh-ancestor
5572283|NCT03918889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6175838|NCT01693562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6175839|NCT01693562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6175840|NCT01694108|BCG Vaccine|bcg vaccine|mesh-list
6486958|NCT00573664|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5572284|NCT03918889|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5572285|NCT03918889|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5572286|NCT03918889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5572287|NCT03918889|Adrenergic Agents|adrenergic agents|mesh-ancestor
5572288|NCT03918889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5572289|NCT03918889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572290|NCT03918889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5572291|NCT03918889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5572292|NCT03918889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5572293|NCT03918889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5572294|NCT03918889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5572295|NCT03918889|Anesthetics, General|anesthetics, general|mesh-ancestor
5572296|NCT03918889|Anesthetics|anesthetics|mesh-ancestor
5572297|NCT03918889|GABA Modulators|gaba modulators|mesh-ancestor
5572298|NCT03918889|GABA Agents|gaba agents|mesh-ancestor
5572299|NCT03918551|Febuxostat|febuxostat|mesh-list
5572300|NCT03918551|Gout Suppressants|gout suppressants|mesh-ancestor
5572301|NCT03918551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5572302|NCT03918499|Cyclophosphamide|cyclophosphamide|mesh-list
5572303|NCT03918499|Pembrolizumab|pembrolizumab|mesh-list
5572304|NCT03918499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6175841|NCT01694108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6175842|NCT01694108|Immunologic Factors|immunologic factors|mesh-ancestor
6175843|NCT01694108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175844|NCT01694420|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6175845|NCT01694420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6175846|NCT01694420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6175847|NCT01694420|Antiviral Agents|antiviral agents|mesh-ancestor
6175848|NCT01694420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6175849|NCT01694433|Vitamin D|vitamin d|mesh-list
6175850|NCT01694433|Calcitriol|calcitriol|mesh-list
6175851|NCT01694433|Calcipotriene|calcipotriene|mesh-list
6175852|NCT01694433|Vitamins|vitamins|mesh-ancestor
6175853|NCT01694433|Micronutrients|micronutrients|mesh-ancestor
6175854|NCT01694433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486959|NCT00573664|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6486960|NCT00573664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6486961|NCT00573664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6486962|NCT00573664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6486963|NCT00573664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6486964|NCT00573664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6670474|NCT01543724|Antidepressive Agents|antidepressive agents|mesh-ancestor
6175855|NCT01694433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6175856|NCT01694433|Dermatologic Agents|dermatologic agents|mesh-ancestor
6175857|NCT01694433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6175858|NCT01694433|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6175859|NCT01694433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6175860|NCT01694433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175861|NCT01694433|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6175862|NCT01694706|Omeprazole|omeprazole|mesh-list
6175863|NCT01694706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6175864|NCT01694706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6175865|NCT01694706|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6175866|NCT01694706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6175867|NCT01694706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175868|NCT01694771|Tiotropium Bromide|tiotropium bromide|mesh-list
6175869|NCT01694771|Olodaterol|olodaterol|mesh-list
6175870|NCT01694771|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6175871|NCT01694771|Autonomic Agents|autonomic agents|mesh-ancestor
6175872|NCT01694771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6175873|NCT01694771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175874|NCT01694771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6175875|NCT01694771|Respiratory System Agents|respiratory system agents|mesh-ancestor
6175876|NCT01694771|Parasympatholytics|parasympatholytics|mesh-ancestor
6175877|NCT01694771|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6175878|NCT01694771|Cholinergic Agents|cholinergic agents|mesh-ancestor
6175879|NCT01694771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6175880|NCT01694771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175881|NCT01694966|Methylene Blue|methylene blue|mesh-list
6175882|NCT01694966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6175883|NCT01694966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175884|NCT01695135|Prednisone|prednisone|mesh-list
6175885|NCT01695135|Abiraterone Acetate|abiraterone acetate|mesh-list
6175886|NCT01695135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6175887|NCT01695135|Glucocorticoids|glucocorticoids|mesh-ancestor
5572305|NCT03918499|Immunologic Factors|immunologic factors|mesh-ancestor
5604326|NCT04965597|Tacrolimus|tacrolimus|mesh-list
6175888|NCT01695135|Hormones|hormones|mesh-ancestor
6175889|NCT01695135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6175890|NCT01695135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175891|NCT01695135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6175892|NCT01695135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6175893|NCT01695135|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6175894|NCT01695135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6175895|NCT01695135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175896|NCT01695135|Hormone Antagonists|hormone antagonists|mesh-ancestor
6175897|NCT01695135|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6175898|NCT01695239|Adalimumab|adalimumab|mesh-list
6175899|NCT01695239|Ixekizumab|ixekizumab|mesh-list
6175900|NCT01695239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6175901|NCT01695239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6175902|NCT01695239|Dermatologic Agents|dermatologic agents|mesh-ancestor
6175903|NCT01695291|Minocycline|minocycline|mesh-list
6175904|NCT01695291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6175905|NCT01695291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6175906|NCT01695330|Bortezomib|bortezomib|mesh-list
6486965|NCT00573664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6486966|NCT00573664|Antimanic Agents|antimanic agents|mesh-ancestor
6486967|NCT00573690|Carboplatin|carboplatin|mesh-list
6486968|NCT00573690|Etoposide|etoposide|mesh-list
6486969|NCT00573690|Pemetrexed|pemetrexed|mesh-list
6486970|NCT00573690|Sorafenib|sorafenib|mesh-list
6486971|NCT00573690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6486972|NCT00573690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6486973|NCT00573690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6486974|NCT00573690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6486975|NCT00573690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5572306|NCT03918499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572307|NCT03918499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5572308|NCT03918499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5572309|NCT03918499|Alkylating Agents|alkylating agents|mesh-ancestor
5572310|NCT03918499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572311|NCT03918499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5572312|NCT03918499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5572313|NCT03918499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5572314|NCT03918265|Tacrolimus|tacrolimus|mesh-list
5572315|NCT03918265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5572316|NCT03918265|Immunologic Factors|immunologic factors|mesh-ancestor
5572317|NCT03918265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572318|NCT03918265|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5572319|NCT03918265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5572320|NCT03918265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572321|NCT03918252|Nivolumab|nivolumab|mesh-list
5572322|NCT03918252|Ipilimumab|ipilimumab|mesh-list
5572323|NCT03918252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5572324|NCT03918252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5572325|NCT03918252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5572326|NCT03918252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604327|NCT04965597|Thymoglobulin|thymoglobulin|mesh-list
5604328|NCT04965597|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5604329|NCT04965597|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5604330|NCT04965597|Abortifacient Agents|abortifacient agents|mesh-ancestor
5604331|NCT04965597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5604332|NCT04965597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604333|NCT04965597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5604334|NCT04965597|Antimetabolites|antimetabolites|mesh-ancestor
6175907|NCT01695330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6175908|NCT01695668|Loteprednol Etabonate|loteprednol etabonate|mesh-list
6175909|NCT01695668|Cyclosporine|cyclosporine|mesh-list
6175910|NCT01695668|Cyclosporins|cyclosporins|mesh-list
6175911|NCT01695668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6486976|NCT00573690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670475|NCT01543724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6670476|NCT01543724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6670477|NCT01543724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670478|NCT01543724|Antimanic Agents|antimanic agents|mesh-ancestor
6670479|NCT01543724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6670480|NCT01543724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6670481|NCT01543724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670482|NCT01543737|Hyaluronic Acid|hyaluronic acid|mesh-list
6670483|NCT01543737|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6670484|NCT01543737|Immunologic Factors|immunologic factors|mesh-ancestor
6670485|NCT01543737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486977|NCT00573690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6486978|NCT00573690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6486979|NCT00573690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6486980|NCT00573742|Candesartan|candesartan|mesh-list
6486981|NCT00573742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6486982|NCT00573742|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6486983|NCT00573742|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6486984|NCT00573742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175912|NCT01695668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175913|NCT01695668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6175914|NCT01695668|Immunologic Factors|immunologic factors|mesh-ancestor
6175915|NCT01695668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175916|NCT01695668|Antifungal Agents|antifungal agents|mesh-ancestor
6175917|NCT01695668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6175918|NCT01695668|Dermatologic Agents|dermatologic agents|mesh-ancestor
6175919|NCT01695668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6175920|NCT01695668|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6175921|NCT01695668|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6175922|NCT01695772|Bevacizumab|bevacizumab|mesh-list
6175923|NCT01695772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6175924|NCT01695772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6175925|NCT01695772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6175926|NCT01695772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6175927|NCT01695772|Growth Substances|growth substances|mesh-ancestor
6175928|NCT01695772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175929|NCT01695772|Growth Inhibitors|growth inhibitors|mesh-ancestor
6175930|NCT01695954|Ritonavir|ritonavir|mesh-list
6175931|NCT01695954|Darunavir|darunavir|mesh-list
6489013|NCT00588835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6489014|NCT00588835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6489015|NCT00588835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6489016|NCT00588835|Antipruritics|antipruritics|mesh-ancestor
5572327|NCT03918187|Midazolam|midazolam|mesh-list
5572328|NCT03918187|Nalbuphine|nalbuphine|mesh-list
5572329|NCT03918187|Bupivacaine|bupivacaine|mesh-list
6489017|NCT00588835|Dermatologic Agents|dermatologic agents|mesh-ancestor
6489018|NCT00588835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6489019|NCT00588835|Serotonin Agents|serotonin agents|mesh-ancestor
6489020|NCT00588835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5572330|NCT03918187|Anesthetics, Local|anesthetics, local|mesh-ancestor
5572331|NCT03918187|Anesthetics|anesthetics|mesh-ancestor
5572332|NCT03918187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5572333|NCT03918187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572334|NCT03918187|Sensory System Agents|sensory system agents|mesh-ancestor
5572335|NCT03918187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5572336|NCT03918187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5572337|NCT03918187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5572338|NCT03918187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5572339|NCT03918187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6489021|NCT00588835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489022|NCT00588835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6489023|NCT00588835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6489024|NCT00588835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6489025|NCT00588835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6175932|NCT01695954|Efavirenz|efavirenz|mesh-list
6175933|NCT01695954|Pitavastatin|pitavastatin|mesh-list
6175934|NCT01695954|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6175935|NCT01695954|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6175936|NCT01695954|Protease Inhibitors|protease inhibitors|mesh-ancestor
6175937|NCT01695954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6175938|NCT01695954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175939|NCT01695954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6175940|NCT01695954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6175941|NCT01695954|Antiviral Agents|antiviral agents|mesh-ancestor
5572340|NCT03918187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5572341|NCT03918187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5572342|NCT03918187|Anesthetics, General|anesthetics, general|mesh-ancestor
5572343|NCT03918187|GABA Modulators|gaba modulators|mesh-ancestor
5572344|NCT03918187|GABA Agents|gaba agents|mesh-ancestor
5572345|NCT03918187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6175942|NCT01695954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5572346|NCT03918187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572347|NCT03918187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5572348|NCT03918187|Narcotics|narcotics|mesh-ancestor
5572349|NCT03918187|Analgesics|analgesics|mesh-ancestor
5572350|NCT03917914|Bisoprolol|bisoprolol|mesh-list
5572351|NCT03917914|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6175943|NCT01695954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6175944|NCT01695954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6175945|NCT01695954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6175946|NCT01695954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6175947|NCT01695954|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6175948|NCT01695954|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5572352|NCT03917914|Sympatholytics|sympatholytics|mesh-ancestor
5572353|NCT03917914|Autonomic Agents|autonomic agents|mesh-ancestor
5572354|NCT03917914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5572355|NCT03917914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572356|NCT03917914|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5572357|NCT03917914|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5572358|NCT03917914|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5572359|NCT03917914|Adrenergic Agents|adrenergic agents|mesh-ancestor
5572360|NCT03917914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5572361|NCT03917914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572362|NCT03918135|Acetaminophen|acetaminophen|mesh-list
5572363|NCT03918135|Ibuprofen|ibuprofen|mesh-list
5572364|NCT03918135|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5572365|NCT03918135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5572366|NCT03918135|Analgesics|analgesics|mesh-ancestor
5572367|NCT03918135|Sensory System Agents|sensory system agents|mesh-ancestor
5572368|NCT03918135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5572369|NCT03918135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572370|NCT03918135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5572371|NCT03918135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5572372|NCT03918135|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5572373|NCT03918135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5572374|NCT03918135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572375|NCT03918135|Antipyretics|antipyretics|mesh-ancestor
6175949|NCT01695954|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6175950|NCT01695954|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6175951|NCT01695954|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6175952|NCT01695954|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6175953|NCT01695954|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6175954|NCT01695954|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6175955|NCT01695954|Antimetabolites|antimetabolites|mesh-ancestor
6175956|NCT01695954|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6175957|NCT01696032|Gemcitabine|gemcitabine|mesh-list
6175958|NCT01696032|Paclitaxel|paclitaxel|mesh-list
6175959|NCT01696032|Carboplatin|carboplatin|mesh-list
6175960|NCT01696032|Doxorubicin|doxorubicin|mesh-list
6175961|NCT01696032|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6175962|NCT01696032|Topotecan|topotecan|mesh-list
6670486|NCT01543737|Viscosupplements|viscosupplements|mesh-ancestor
6670487|NCT01543737|Protective Agents|protective agents|mesh-ancestor
6670488|NCT01543750|4-Aminopyridine|4-aminopyridine|mesh-list
5572376|NCT03917940|Glimepiride|glimepiride|mesh-list
5572377|NCT03917940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5572378|NCT03917940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6175963|NCT01696032|Guadecitabine|guadecitabine|mesh-list
6175964|NCT01696032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6175965|NCT01696032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6175966|NCT01696032|Tubulin Modulators|tubulin modulators|mesh-ancestor
6175967|NCT01696032|Antimitotic Agents|antimitotic agents|mesh-ancestor
6175968|NCT01696032|Mitosis Modulators|mitosis modulators|mesh-ancestor
6175969|NCT01696032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175970|NCT01696032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6175971|NCT01696032|Antimetabolites|antimetabolites|mesh-ancestor
6175972|NCT01696032|Antiviral Agents|antiviral agents|mesh-ancestor
6175973|NCT01696032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6175974|NCT01696032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6175975|NCT01696032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6175976|NCT01696032|Immunologic Factors|immunologic factors|mesh-ancestor
6175977|NCT01696032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175978|NCT01696032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6175979|NCT01696032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6175980|NCT01696032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6175981|NCT01696032|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6175982|NCT01696045|Ipilimumab|ipilimumab|mesh-list
6670489|NCT01543750|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6175983|NCT01696045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6175984|NCT01696045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6175985|NCT01696045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6175986|NCT01696045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6175987|NCT01696058|Tiotropium Bromide|tiotropium bromide|mesh-list
6175988|NCT01696058|Olodaterol|olodaterol|mesh-list
6175989|NCT01696058|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6175990|NCT01696058|Autonomic Agents|autonomic agents|mesh-ancestor
5572379|NCT03917940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572380|NCT03917940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5572381|NCT03917940|Immunologic Factors|immunologic factors|mesh-ancestor
5572382|NCT03917784|Curcumin|curcumin|mesh-list
5572383|NCT03917784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5572384|NCT03917784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5572385|NCT03917784|Analgesics|analgesics|mesh-ancestor
5572386|NCT03917784|Sensory System Agents|sensory system agents|mesh-ancestor
5572387|NCT03917784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5572388|NCT03917784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572389|NCT03917784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5572390|NCT03917784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5572391|NCT03917784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5572392|NCT03917784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5572393|NCT03917784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572394|NCT03917758|Dapagliflozin|dapagliflozin|mesh-list
5572395|NCT03917758|Empagliflozin|empagliflozin|mesh-list
5572396|NCT03917758|Canagliflozin|canagliflozin|mesh-list
5572397|NCT03917758|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
5572398|NCT03917758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572399|NCT03917758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5572400|NCT03917758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572401|NCT03917966|Docetaxel|docetaxel|mesh-list
5572402|NCT03917966|Nedaplatin|nedaplatin|mesh-list
5572403|NCT03917966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5572404|NCT03917966|Tubulin Modulators|tubulin modulators|mesh-ancestor
5572405|NCT03917966|Antimitotic Agents|antimitotic agents|mesh-ancestor
5572406|NCT03917966|Mitosis Modulators|mitosis modulators|mesh-ancestor
5572407|NCT03917966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572408|NCT03917459|Enalapril|enalapril|mesh-list
5572409|NCT03917459|Enalaprilat|enalaprilat|mesh-list
5572410|NCT03917459|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5572411|NCT03917459|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5572412|NCT03917459|Protease Inhibitors|protease inhibitors|mesh-ancestor
5572413|NCT03917459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5572414|NCT03917459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572415|NCT03917459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5572416|NCT03917459|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5572417|NCT03917446|Propofol|propofol|mesh-list
5572418|NCT03917446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5572419|NCT03917446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6175991|NCT01696058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6175992|NCT01696058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6175993|NCT01696058|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6486985|NCT00573885|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
6486986|NCT00573885|Antioxidants|antioxidants|mesh-ancestor
5572420|NCT03917446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572421|NCT03917446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5572422|NCT03917446|Anesthetics, General|anesthetics, general|mesh-ancestor
5572423|NCT03917446|Anesthetics|anesthetics|mesh-ancestor
5572424|NCT03917537|Nivolumab|nivolumab|mesh-list
5572425|NCT03917537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5572426|NCT03917537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5572427|NCT03917537|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5572428|NCT03917537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572429|NCT03917628|Adalimumab|adalimumab|mesh-list
5572430|NCT03917628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5572431|NCT03917628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5572432|NCT03917420|Tenofovir|tenofovir|mesh-list
5572433|NCT03917420|Emtricitabine|emtricitabine|mesh-list
5572434|NCT03917420|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5572435|NCT03917420|Antiviral Agents|antiviral agents|mesh-ancestor
5572436|NCT03917420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5572437|NCT03917420|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5572438|NCT03917420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5572439|NCT03917420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6486987|NCT00573885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670490|NCT01543750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6175994|NCT01696058|Respiratory System Agents|respiratory system agents|mesh-ancestor
6175995|NCT01696058|Parasympatholytics|parasympatholytics|mesh-ancestor
6175996|NCT01696058|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6175997|NCT01696058|Cholinergic Agents|cholinergic agents|mesh-ancestor
6175998|NCT01696058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6175999|NCT01696058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176000|NCT01696071|Tiotropium Bromide|tiotropium bromide|mesh-list
6176001|NCT01696071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6176002|NCT01696071|Autonomic Agents|autonomic agents|mesh-ancestor
6176003|NCT01696071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6176004|NCT01696071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176005|NCT01696071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6176006|NCT01696071|Respiratory System Agents|respiratory system agents|mesh-ancestor
6176007|NCT01696071|Parasympatholytics|parasympatholytics|mesh-ancestor
6176008|NCT01696071|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6176009|NCT01696071|Cholinergic Agents|cholinergic agents|mesh-ancestor
5572440|NCT03917420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572441|NCT03917420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5572442|NCT03917420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5572443|NCT03917303|Adalimumab|adalimumab|mesh-list
6176010|NCT01696071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6176011|NCT01696071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176012|NCT01696084|Cytarabine|cytarabine|mesh-list
6176013|NCT01696084|Daunorubicin|daunorubicin|mesh-list
6176014|NCT01696084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6176015|NCT01696084|Antimetabolites|antimetabolites|mesh-ancestor
6176016|NCT01696084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176017|NCT01696084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6176018|NCT01696084|Antiviral Agents|antiviral agents|mesh-ancestor
6176019|NCT01696084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6176020|NCT01696084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6176021|NCT01696084|Immunologic Factors|immunologic factors|mesh-ancestor
6176022|NCT01696084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176023|NCT01696084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6176024|NCT01696084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6176025|NCT01696084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6176026|NCT01696084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6176027|NCT01696214|Fluticasone|fluticasone|mesh-list
6176028|NCT01696214|Xhance|xhance|mesh-list
6176029|NCT01696214|Theophylline|theophylline|mesh-list
6176030|NCT01696214|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6176031|NCT01696214|Ipratropium|ipratropium|mesh-list
6176032|NCT01696214|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6176033|NCT01696214|Montelukast|montelukast|mesh-list
6176034|NCT01696214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6176035|NCT01696214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6176036|NCT01696214|Autonomic Agents|autonomic agents|mesh-ancestor
6176037|NCT01696214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6176038|NCT01696214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176039|NCT01696214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6176040|NCT01696214|Respiratory System Agents|respiratory system agents|mesh-ancestor
6176041|NCT01696214|Dermatologic Agents|dermatologic agents|mesh-ancestor
6176042|NCT01696214|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6176043|NCT01696214|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6176044|NCT01696214|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6176045|NCT01696214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6176046|NCT01696214|Adrenergic Agents|adrenergic agents|mesh-ancestor
6176047|NCT01696214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6176048|NCT01696214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176049|NCT01696214|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6176050|NCT01696214|Hormone Antagonists|hormone antagonists|mesh-ancestor
6176051|NCT01696214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6176052|NCT01696214|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6176053|NCT01696214|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6176054|NCT01696214|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5572444|NCT03917303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5572445|NCT03917303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5572446|NCT03917004|Nitroglycerin|nitroglycerin|mesh-list
5572447|NCT03917004|Vasodilator Agents|vasodilator agents|mesh-ancestor
5572448|NCT03917095|Mesalamine|mesalamine|mesh-list
5572449|NCT03917095|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5572450|NCT03917095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5572451|NCT03917095|Analgesics|analgesics|mesh-ancestor
5572452|NCT03917095|Sensory System Agents|sensory system agents|mesh-ancestor
5572453|NCT03917095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5572454|NCT03917095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572455|NCT03917095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5572456|NCT03917095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5572457|NCT03916926|Fluorides|fluorides|mesh-list
5572458|NCT03916926|Fluorides, Topical|fluorides, topical|mesh-list
5572459|NCT03916926|Cariostatic Agents|cariostatic agents|mesh-ancestor
5572460|NCT03916926|Protective Agents|protective agents|mesh-ancestor
5572461|NCT03916926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572462|NCT03917134|Metronidazole|metronidazole|mesh-list
5572463|NCT03917134|Cephalosporins|cephalosporins|mesh-list
5572464|NCT03917134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5572465|NCT03917134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5572466|NCT03917134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5572467|NCT03917134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5572468|NCT03917082|Tamoxifen|tamoxifen|mesh-list
5572469|NCT03917082|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5572470|NCT03917082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572471|NCT03917082|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5572472|NCT03917082|Hormone Antagonists|hormone antagonists|mesh-ancestor
5572473|NCT03917082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6176055|NCT01696214|Cholinergic Agents|cholinergic agents|mesh-ancestor
6176056|NCT01696214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6176057|NCT01696214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6176058|NCT01696214|Vasodilator Agents|vasodilator agents|mesh-ancestor
6176059|NCT01696214|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6176060|NCT01696214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6176061|NCT01696214|Purinergic Agents|purinergic agents|mesh-ancestor
6176062|NCT01696214|Glucocorticoids|glucocorticoids|mesh-ancestor
6176063|NCT01696214|Hormones|hormones|mesh-ancestor
6176064|NCT01696214|Sympathomimetics|sympathomimetics|mesh-ancestor
6176065|NCT01696279|Calcium Carbonate|calcium carbonate|mesh-list
6176066|NCT01696279|Calcium|calcium|mesh-list
6176067|NCT01696279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6486988|NCT00573885|Protective Agents|protective agents|mesh-ancestor
6486989|NCT00573885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6486990|NCT00573885|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
6486991|NCT00573885|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6486992|NCT00573885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6176068|NCT01696279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176069|NCT01696279|Antacids|antacids|mesh-ancestor
6176070|NCT01696279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176071|NCT01696279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6176072|NCT01696695|Capecitabine|capecitabine|mesh-list
6176073|NCT01696695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6176074|NCT01696695|Antimetabolites|antimetabolites|mesh-ancestor
5572474|NCT03917082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572475|NCT03917082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5572476|NCT03917082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5572477|NCT03917082|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5572478|NCT03917082|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5572479|NCT03917082|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5572480|NCT03917082|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5572481|NCT03917082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5572482|NCT03917394|Iron|iron|mesh-list
5572483|NCT03917394|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
5572484|NCT03917394|Trace Elements|trace elements|mesh-ancestor
5572485|NCT03917394|Micronutrients|micronutrients|mesh-ancestor
5572486|NCT03917394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572487|NCT03917394|Hematinics|hematinics|mesh-ancestor
5572488|NCT03917186|Sevoflurane|sevoflurane|mesh-list
5572489|NCT03917186|Desflurane|desflurane|mesh-list
5572490|NCT03917186|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5572491|NCT03917186|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5572492|NCT03917186|Anesthetics, General|anesthetics, general|mesh-ancestor
5572493|NCT03917186|Anesthetics|anesthetics|mesh-ancestor
5572494|NCT03917186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6208006|NCT02123446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6486993|NCT00573885|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6486994|NCT00573924|Lansoprazole|lansoprazole|mesh-list
6486995|NCT00573924|Dexlansoprazole|dexlansoprazole|mesh-list
6486996|NCT00573924|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
6486997|NCT00573924|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6486998|NCT00573924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6486999|NCT00573924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6487000|NCT00573924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6487001|NCT00573950|Cilostazol|cilostazol|mesh-list
6487002|NCT00573950|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6487003|NCT00573950|Autonomic Agents|autonomic agents|mesh-ancestor
6487004|NCT00573950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6487005|NCT00573950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572495|NCT03917186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572496|NCT03916679|Cyclophosphamide|cyclophosphamide|mesh-list
5572497|NCT03916679|Fludarabine|fludarabine|mesh-list
5572498|NCT03916679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5572499|NCT03916679|Immunologic Factors|immunologic factors|mesh-ancestor
5572500|NCT03916679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572501|NCT03916679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5572502|NCT03916679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5572503|NCT03916679|Alkylating Agents|alkylating agents|mesh-ancestor
5572504|NCT03916679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6487006|NCT00573950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6487007|NCT00573950|Respiratory System Agents|respiratory system agents|mesh-ancestor
6176075|NCT01696695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176076|NCT01696695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6176077|NCT01696760|Aspirin|aspirin|mesh-list
6176078|NCT01696760|Enoxaparin|enoxaparin|mesh-list
6176079|NCT01696760|Enoxaparin sodium|enoxaparin sodium|mesh-list
6176080|NCT01696760|Anticoagulants|anticoagulants|mesh-ancestor
6176081|NCT01696760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6176082|NCT01696760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6176083|NCT01696760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176084|NCT01696760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6176085|NCT01696760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6176086|NCT01696760|Analgesics|analgesics|mesh-ancestor
6487008|NCT00573950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6487009|NCT00573950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6487010|NCT00573950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6487011|NCT00573950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6487012|NCT00573950|Vasodilator Agents|vasodilator agents|mesh-ancestor
6487013|NCT00573950|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5572505|NCT03916679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5572506|NCT03916679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5572507|NCT03916640|Insulin Lispro|insulin lispro|mesh-list
6487014|NCT00573950|Protective Agents|protective agents|mesh-ancestor
6487015|NCT00573950|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6487016|NCT00573950|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6487017|NCT00573950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6487018|NCT00573963|Ropivacaine|ropivacaine|mesh-list
6487019|NCT00573963|Anesthetics, Local|anesthetics, local|mesh-ancestor
6487020|NCT00573963|Anesthetics|anesthetics|mesh-ancestor
6487021|NCT00573963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6487022|NCT00573963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487023|NCT00573963|Sensory System Agents|sensory system agents|mesh-ancestor
6487024|NCT00573963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6487025|NCT00574015|Acetaminophen|acetaminophen|mesh-list
6487026|NCT00574015|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
6487027|NCT00574015|Hydrocodone|hydrocodone|mesh-list
6487028|NCT00574015|Bupivacaine|bupivacaine|mesh-list
6487029|NCT00574015|Anesthetics, Local|anesthetics, local|mesh-ancestor
6487030|NCT00574015|Anesthetics|anesthetics|mesh-ancestor
6487031|NCT00574015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6487032|NCT00574015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487033|NCT00574015|Sensory System Agents|sensory system agents|mesh-ancestor
5572508|NCT03916640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5572509|NCT03916640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572510|NCT03916601|Insulin|insulin|mesh-list
5572511|NCT03916601|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5572512|NCT03916601|Insulin Aspart|insulin aspart|mesh-list
5572513|NCT03916601|Insulin, Long-Acting|insulin, long-acting|mesh-list
6487034|NCT00574015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6487035|NCT00574015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6176087|NCT01696760|Sensory System Agents|sensory system agents|mesh-ancestor
6487036|NCT00574015|Analgesics|analgesics|mesh-ancestor
6487037|NCT00574015|Antipyretics|antipyretics|mesh-ancestor
6487038|NCT00574015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6487039|NCT00574015|Narcotics|narcotics|mesh-ancestor
6176088|NCT01696760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6176089|NCT01696760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176090|NCT01696760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5572514|NCT03916601|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
5572515|NCT03916601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5572516|NCT03916601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572517|NCT03916250|Petrolatum|petrolatum|mesh-list
5572518|NCT03916250|PF-06700841|pf-06700841|mesh-list
5572519|NCT03916250|Emollients|emollients|mesh-ancestor
5572520|NCT03916250|Dermatologic Agents|dermatologic agents|mesh-ancestor
5572521|NCT03916250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5572522|NCT03916250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5572523|NCT03916250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572524|NCT03916328|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
5572525|NCT03916328|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5572526|NCT03916328|Contraceptive Agents|contraceptive agents|mesh-ancestor
5572527|NCT03916328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5572528|NCT03916328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572529|NCT03916328|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5572530|NCT03916328|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5572531|NCT03916328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5572532|NCT03916328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5572533|NCT03916510|Capecitabine|capecitabine|mesh-list
5572534|NCT03916510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5572535|NCT03916510|Antimetabolites|antimetabolites|mesh-ancestor
5572536|NCT03916510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572537|NCT03916510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5604335|NCT04965597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604336|NCT04965597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6176091|NCT01696760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6176092|NCT01696760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6176093|NCT01696760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6176094|NCT01696760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6176095|NCT01696760|Antipyretics|antipyretics|mesh-ancestor
6176096|NCT01696877|Cyclophosphamide|cyclophosphamide|mesh-list
6176097|NCT01696877|Molgramostim|molgramostim|mesh-list
6176098|NCT01696877|Sargramostim|sargramostim|mesh-list
6176099|NCT01696877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6176100|NCT01696877|Immunologic Factors|immunologic factors|mesh-ancestor
6176101|NCT01696877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176102|NCT01696877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6487040|NCT00574015|Antitussive Agents|antitussive agents|mesh-ancestor
6487041|NCT00574015|Respiratory System Agents|respiratory system agents|mesh-ancestor
6487042|NCT00574015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6176103|NCT01696877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6176104|NCT01696877|Alkylating Agents|alkylating agents|mesh-ancestor
6176105|NCT01696877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176106|NCT01696877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6176107|NCT01696877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6176108|NCT01696942|Mesalamine|mesalamine|mesh-list
6176109|NCT01696942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176110|NCT01696942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6176111|NCT01696942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6176112|NCT01696942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6176113|NCT01696942|Analgesics|analgesics|mesh-ancestor
6176114|NCT01696942|Sensory System Agents|sensory system agents|mesh-ancestor
6176115|NCT01696942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6176116|NCT01696942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6176117|NCT01696955|Cetuximab|cetuximab|mesh-list
6176118|NCT01696955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6487043|NCT00574015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6670491|NCT01543750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670492|NCT01543763|Abexinostat|abexinostat|mesh-list
6487044|NCT00574015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6487045|NCT00574041|Interferons|interferons|mesh-list
6487046|NCT00574041|Interferon-beta|interferon-beta|mesh-list
6487047|NCT00574041|Interferon beta-1a|interferon beta-1a|mesh-list
6487048|NCT00574041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6487049|NCT00574041|Antiviral Agents|antiviral agents|mesh-ancestor
6487050|NCT00574041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5572538|NCT03916432|Sirolimus|sirolimus|mesh-list
5572539|NCT03916432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6176119|NCT01696955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6176120|NCT01697345|Testosterone|testosterone|mesh-list
6176121|NCT01697345|Androgens|androgens|mesh-ancestor
6176122|NCT01697345|Hormones|hormones|mesh-ancestor
6176123|NCT01697345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6176124|NCT01697345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572540|NCT03916432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5572541|NCT03916432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5572542|NCT03916432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5572543|NCT03916432|Antifungal Agents|antifungal agents|mesh-ancestor
5572544|NCT03916432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5572545|NCT03916432|Immunologic Factors|immunologic factors|mesh-ancestor
6176125|NCT01697579|Ondansetron|ondansetron|mesh-list
6176126|NCT01697579|Fosaprepitant|fosaprepitant|mesh-list
6176127|NCT01697579|Aprepitant|aprepitant|mesh-list
6176128|NCT01697579|Serotonin|serotonin|mesh-list
6176129|NCT01697579|Antiemetics|antiemetics|mesh-ancestor
6176130|NCT01697579|Autonomic Agents|autonomic agents|mesh-ancestor
6176131|NCT01697579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6176132|NCT01697579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176133|NCT01697579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6176134|NCT01697579|Antipruritics|antipruritics|mesh-ancestor
6176135|NCT01697579|Dermatologic Agents|dermatologic agents|mesh-ancestor
6176136|NCT01697579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6176137|NCT01697579|Serotonin Agents|serotonin agents|mesh-ancestor
6176138|NCT01697579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6176139|NCT01697579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176140|NCT01697579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6176141|NCT01697579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6176142|NCT01697579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6176143|NCT01697579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6176144|NCT01697579|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6176145|NCT01697579|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6487051|NCT00574041|Immunologic Factors|immunologic factors|mesh-ancestor
6487052|NCT00574041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487053|NCT00574041|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6487054|NCT00574093|Ranibizumab|ranibizumab|mesh-list
6487055|NCT00574093|Verteporfin|verteporfin|mesh-list
6487056|NCT00574093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6487057|NCT00574093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6487058|NCT00574093|Growth Substances|growth substances|mesh-ancestor
5572546|NCT03916432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572547|NCT03916406|Midazolam|midazolam|mesh-list
5572548|NCT03916406|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5572549|NCT03916406|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5572550|NCT03916406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5572551|NCT03916406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572552|NCT03916406|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5572553|NCT03916406|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5572554|NCT03916406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5572555|NCT03916406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5572556|NCT03916406|Anesthetics, General|anesthetics, general|mesh-ancestor
5572557|NCT03916406|Anesthetics|anesthetics|mesh-ancestor
5572558|NCT03916406|GABA Modulators|gaba modulators|mesh-ancestor
5572559|NCT03916406|GABA Agents|gaba agents|mesh-ancestor
5572560|NCT03916406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5604337|NCT04965597|Dermatologic Agents|dermatologic agents|mesh-ancestor
6176146|NCT01697579|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6487059|NCT00574093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487060|NCT00574093|Growth Inhibitors|growth inhibitors|mesh-ancestor
6487061|NCT00574093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6487062|NCT00574093|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6487063|NCT00574093|Dermatologic Agents|dermatologic agents|mesh-ancestor
6487064|NCT00574353|Misonidazole|misonidazole|mesh-list
6487065|NCT00574353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6487066|NCT00574353|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6487067|NCT00574353|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6487068|NCT00574353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6487069|NCT00574366|Everolimus|everolimus|mesh-list
6487070|NCT00574366|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6487071|NCT00574366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6487072|NCT00574366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6487073|NCT00574366|Immunologic Factors|immunologic factors|mesh-ancestor
6487074|NCT00574366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487075|NCT00574366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6487076|NCT00574366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6487077|NCT00574366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176147|NCT01697696|Glycopyrrolate|glycopyrrolate|mesh-list
6176148|NCT01697696|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6176149|NCT01697696|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6176150|NCT01697696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6176151|NCT01697696|Cholinergic Agents|cholinergic agents|mesh-ancestor
6176152|NCT01697696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6176153|NCT01697696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176154|NCT01697696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176155|NCT01697709|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6176156|NCT01697709|Antidepressive Agents|antidepressive agents|mesh-ancestor
6176157|NCT01697709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6176158|NCT01697709|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6176159|NCT01697709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6176160|NCT01697709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6176161|NCT01697709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176162|NCT01697956|Beclomethasone|beclomethasone|mesh-list
6176163|NCT01697956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6176164|NCT01697956|Glucocorticoids|glucocorticoids|mesh-ancestor
6176165|NCT01697956|Hormones|hormones|mesh-ancestor
6176166|NCT01697956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6176167|NCT01697956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176168|NCT01697956|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6176169|NCT01697956|Respiratory System Agents|respiratory system agents|mesh-ancestor
6176170|NCT01697969|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
6176171|NCT01697969|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6176172|NCT01697969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6176173|NCT01697969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6176174|NCT01697969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6176175|NCT01697969|Analgesics|analgesics|mesh-ancestor
6176176|NCT01697969|Sensory System Agents|sensory system agents|mesh-ancestor
6176177|NCT01697969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6176178|NCT01697969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176179|NCT01697969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6176180|NCT01697969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6176181|NCT01697969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6176182|NCT01697969|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6176183|NCT01697969|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6176184|NCT01697969|Histamine Antagonists|histamine antagonists|mesh-ancestor
6176185|NCT01697969|Histamine Agents|histamine agents|mesh-ancestor
6176186|NCT01697969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6176187|NCT01697969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176188|NCT01698320|Albuterol|albuterol|mesh-list
6176189|NCT01698320|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6487078|NCT00574470|Infliximab|infliximab|mesh-list
6487079|NCT00574470|Daclizumab|daclizumab|mesh-list
6487080|NCT00574470|Dermatologic Agents|dermatologic agents|mesh-ancestor
6487081|NCT00574470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6487082|NCT00574470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6176190|NCT01698320|Autonomic Agents|autonomic agents|mesh-ancestor
6176191|NCT01698320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6487083|NCT00574470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6487084|NCT00574470|Immunologic Factors|immunologic factors|mesh-ancestor
6487085|NCT00574470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176192|NCT01698320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176193|NCT01698320|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6176194|NCT01698320|Respiratory System Agents|respiratory system agents|mesh-ancestor
6176195|NCT01698320|Tocolytic Agents|tocolytic agents|mesh-ancestor
6176196|NCT01698320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6176197|NCT01698320|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6176198|NCT01698320|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6176199|NCT01698320|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6176200|NCT01698320|Adrenergic Agents|adrenergic agents|mesh-ancestor
6176201|NCT01698320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6176202|NCT01698320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176203|NCT01698554|Bimatoprost|bimatoprost|mesh-list
6176204|NCT01698554|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6176205|NCT01698554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6176206|NCT01698710|Paclitaxel|paclitaxel|mesh-list
6176207|NCT01698710|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6176208|NCT01698710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6176209|NCT01698710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6176210|NCT01698710|Tubulin Modulators|tubulin modulators|mesh-ancestor
6176211|NCT01698710|Antimitotic Agents|antimitotic agents|mesh-ancestor
6176212|NCT01698710|Mitosis Modulators|mitosis modulators|mesh-ancestor
6176213|NCT01698710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176214|NCT01698775|Glipizide|glipizide|mesh-list
6176215|NCT01698775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5572561|NCT03916406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572562|NCT03916068|Vitamin E|vitamin e|mesh-list
5572563|NCT03916068|Pentoxifylline|pentoxifylline|mesh-list
5572564|NCT03916068|Vitamins|vitamins|mesh-ancestor
5572565|NCT03916068|Micronutrients|micronutrients|mesh-ancestor
5572566|NCT03916068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572567|NCT03916068|Antioxidants|antioxidants|mesh-ancestor
5572568|NCT03916068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572569|NCT03916068|Protective Agents|protective agents|mesh-ancestor
5572570|NCT03916068|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5572571|NCT03916068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5572572|NCT03916068|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5572573|NCT03916068|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5572574|NCT03916068|Vasodilator Agents|vasodilator agents|mesh-ancestor
6176216|NCT01698775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176217|NCT01698801|Dexamethasone|dexamethasone|mesh-list
6176218|NCT01698801|Lenalidomide|lenalidomide|mesh-list
6176219|NCT01698801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6176220|NCT01698801|Antiemetics|antiemetics|mesh-ancestor
6176221|NCT01698801|Autonomic Agents|autonomic agents|mesh-ancestor
6176222|NCT01698801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6176223|NCT01698801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176224|NCT01698801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6176225|NCT01698801|Glucocorticoids|glucocorticoids|mesh-ancestor
6176226|NCT01698801|Hormones|hormones|mesh-ancestor
6176227|NCT01698801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6176228|NCT01698801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6176229|NCT01698801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6176230|NCT01698801|Immunologic Factors|immunologic factors|mesh-ancestor
6176231|NCT01698801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6176232|NCT01698801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6487086|NCT00574483|Quinacrine|quinacrine|mesh-list
6487087|NCT00574483|Anticestodal Agents|anticestodal agents|mesh-ancestor
5572575|NCT03916068|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5572576|NCT03915964|Adalimumab|adalimumab|mesh-list
5572577|NCT03915964|Etanercept|etanercept|mesh-list
5572578|NCT03915964|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
5572579|NCT03915964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5572580|NCT03915964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5572581|NCT03915964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5572582|NCT03915964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5572583|NCT03915964|Analgesics|analgesics|mesh-ancestor
5572584|NCT03915964|Sensory System Agents|sensory system agents|mesh-ancestor
6487088|NCT00574483|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6487089|NCT00574483|Anthelmintics|anthelmintics|mesh-ancestor
5572585|NCT03915964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5572586|NCT03915964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572587|NCT03915964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5572588|NCT03915964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5572589|NCT03915964|Immunologic Factors|immunologic factors|mesh-ancestor
5572590|NCT03915938|Ketamine|ketamine|mesh-list
5572591|NCT03915938|Analgesics|analgesics|mesh-ancestor
5572592|NCT03915938|Sensory System Agents|sensory system agents|mesh-ancestor
5572593|NCT03915938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5572594|NCT03915938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572595|NCT03915938|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5572596|NCT03915938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6487090|NCT00574483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6487091|NCT00574483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6487092|NCT00574483|Antimalarials|antimalarials|mesh-ancestor
6487093|NCT00574483|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6487094|NCT00574483|Antinematodal Agents|antinematodal agents|mesh-ancestor
6487095|NCT00574483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6487096|NCT00574483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6487097|NCT00574483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6487098|NCT00574509|Tositumomab I-131|tositumomab i-131|mesh-list
6487099|NCT00574509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6487100|NCT00574600|Vaccines|vaccines|mesh-list
6487101|NCT00574600|Immunologic Factors|immunologic factors|mesh-ancestor
6487102|NCT00574600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487103|NCT00574639|Alprazolam|alprazolam|mesh-list
6487104|NCT00574639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5572597|NCT03915938|Anesthetics, General|anesthetics, general|mesh-ancestor
5572598|NCT03915938|Anesthetics|anesthetics|mesh-ancestor
5572599|NCT03915938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5572600|NCT03915938|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5572601|NCT03915938|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5572602|NCT03915938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6487105|NCT00574639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6487106|NCT00574639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176233|NCT01698801|Growth Substances|growth substances|mesh-ancestor
6176234|NCT01698801|Growth Inhibitors|growth inhibitors|mesh-ancestor
6176235|NCT01698814|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
6176236|NCT01698814|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6176237|NCT01698814|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6176238|NCT01698814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6176239|NCT01698814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5572603|NCT03915938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572604|NCT03916094|Trastuzumab|trastuzumab|mesh-list
5572605|NCT03916094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5572606|NCT03916094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5572607|NCT03915626|Rivastigmine|rivastigmine|mesh-list
5572608|NCT03915626|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5572609|NCT03915626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5572610|NCT03915626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176240|NCT01698814|Analgesics|analgesics|mesh-ancestor
6176241|NCT01698814|Sensory System Agents|sensory system agents|mesh-ancestor
6176242|NCT01698814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6176243|NCT01698814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176244|NCT01698814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6176245|NCT01698814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6176246|NCT01698814|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6176247|NCT01698814|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6176248|NCT01698814|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6176249|NCT01698814|Histamine Antagonists|histamine antagonists|mesh-ancestor
6487107|NCT00574639|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6176250|NCT01698814|Histamine Agents|histamine agents|mesh-ancestor
6176251|NCT01698814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6176252|NCT01698814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176253|NCT01698879|Gemtuzumab|gemtuzumab|mesh-list
6176254|NCT01698879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6176255|NCT01698879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6176256|NCT01699022|CycloProvera|cycloprovera|mesh-list
5572611|NCT03915626|Cholinergic Agents|cholinergic agents|mesh-ancestor
5572612|NCT03915626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5572613|NCT03915626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572614|NCT03915626|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5572615|NCT03915626|Protective Agents|protective agents|mesh-ancestor
5572616|NCT03915366|Valganciclovir|valganciclovir|mesh-list
5572617|NCT03915366|Antitubercular Agents|antitubercular agents|mesh-list
5572618|NCT03915366|Antiviral Agents|antiviral agents|mesh-ancestor
5572619|NCT03915366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5572620|NCT03915366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5572621|NCT03915327|Dextrans|dextrans|mesh-list
5572622|NCT03915327|Iron-Dextran Complex|iron-dextran complex|mesh-list
6176257|NCT01699022|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6176258|NCT01699022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6176259|NCT01699022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6176260|NCT01699022|Contraceptive Agents|contraceptive agents|mesh-ancestor
6176261|NCT01699022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6176262|NCT01699022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487108|NCT00574639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6487109|NCT00574639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6487110|NCT00574639|GABA Modulators|gaba modulators|mesh-ancestor
6487111|NCT00574639|GABA Agents|gaba agents|mesh-ancestor
6487112|NCT00574639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6176263|NCT01699022|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6176264|NCT01699022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6176265|NCT01699178|Methyltestosterone|methyltestosterone|mesh-list
6176266|NCT01699178|Testosterone|testosterone|mesh-list
6176267|NCT01699178|Testosterone undecanoate|testosterone undecanoate|mesh-list
6487113|NCT00574639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6487114|NCT00574652|Aldesleukin|aldesleukin|mesh-list
6487115|NCT00574652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6487116|NCT00574652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6487117|NCT00574652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6487118|NCT00574652|Antiviral Agents|antiviral agents|mesh-ancestor
6487119|NCT00574652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6487120|NCT00574730|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6487121|NCT00574730|Rituximab|rituximab|mesh-list
6487122|NCT00574730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6176268|NCT01699178|Testosterone enanthate|testosterone enanthate|mesh-list
6176269|NCT01699178|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6176270|NCT01699178|Androgens|androgens|mesh-ancestor
6176271|NCT01699178|Hormones|hormones|mesh-ancestor
6176272|NCT01699178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6176273|NCT01699178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176274|NCT01699178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6176275|NCT01699178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6176276|NCT01699178|Anabolic Agents|anabolic agents|mesh-ancestor
6176277|NCT01699607|Amphetamine|amphetamine|mesh-list
6176278|NCT01699607|Dextroamphetamine|dextroamphetamine|mesh-list
6176279|NCT01699607|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6176280|NCT01699607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176281|NCT01699607|Sympathomimetics|sympathomimetics|mesh-ancestor
6176282|NCT01699607|Autonomic Agents|autonomic agents|mesh-ancestor
6176283|NCT01699607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6176284|NCT01699607|Dopamine Agents|dopamine agents|mesh-ancestor
6176285|NCT01699607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6176286|NCT01699607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176287|NCT01699607|Adrenergic Agents|adrenergic agents|mesh-ancestor
6176288|NCT01699607|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6487123|NCT00574730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5572623|NCT03915327|Anticoagulants|anticoagulants|mesh-ancestor
5572624|NCT03915327|Plasma Substitutes|plasma substitutes|mesh-ancestor
5572625|NCT03915327|Blood Substitutes|blood substitutes|mesh-ancestor
5572626|NCT03915327|Hematinics|hematinics|mesh-ancestor
5572627|NCT03915444|Gemcitabine|gemcitabine|mesh-list
5572628|NCT03915444|Paclitaxel|paclitaxel|mesh-list
5572629|NCT03915444|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6487124|NCT00574730|Immunologic Factors|immunologic factors|mesh-ancestor
6487125|NCT00574730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572630|NCT03915444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6176289|NCT01699607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6670493|NCT01543763|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6670494|NCT01543763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6670495|NCT01543763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672510|NCT01556698|Nitric Oxide|nitric oxide|mesh-list
5572631|NCT03915444|Tubulin Modulators|tubulin modulators|mesh-ancestor
5572632|NCT03915444|Antimitotic Agents|antimitotic agents|mesh-ancestor
5572633|NCT03915444|Mitosis Modulators|mitosis modulators|mesh-ancestor
5572634|NCT03915444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572635|NCT03915444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5572636|NCT03915444|Antimetabolites|antimetabolites|mesh-ancestor
5572637|NCT03915444|Antiviral Agents|antiviral agents|mesh-ancestor
5572638|NCT03915444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6672511|NCT01556698|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6672512|NCT01556698|Autonomic Agents|autonomic agents|mesh-ancestor
6672513|NCT01556698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6487126|NCT00574730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6487127|NCT00574730|Antiviral Agents|antiviral agents|mesh-ancestor
6487128|NCT00574730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6487129|NCT00574743|Mycophenolic Acid|mycophenolic acid|mesh-list
6487130|NCT00574743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5572639|NCT03915444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5572640|NCT03915444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5572641|NCT03915444|Immunologic Factors|immunologic factors|mesh-ancestor
5572642|NCT03915444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572643|NCT03915561|Parecoxib|parecoxib|mesh-list
5572644|NCT03915561|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5572645|NCT03915561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5572646|NCT03915561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5572647|NCT03915561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604338|NCT04965597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6176290|NCT01699607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6672514|NCT01556698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672515|NCT01556698|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6672516|NCT01556698|Respiratory System Agents|respiratory system agents|mesh-ancestor
6672517|NCT01556698|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6672518|NCT01556698|Antioxidants|antioxidants|mesh-ancestor
6176291|NCT01699607|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6176292|NCT01699685|Glycopyrrolate|glycopyrrolate|mesh-list
6672519|NCT01556698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672520|NCT01556698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6176293|NCT01699685|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6176294|NCT01699685|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6176295|NCT01699685|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6176296|NCT01699685|Cholinergic Agents|cholinergic agents|mesh-ancestor
6176297|NCT01699685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6176298|NCT01699685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176299|NCT01699685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176300|NCT01699815|Acetaminophen|acetaminophen|mesh-list
6176301|NCT01699815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6176302|NCT01699815|Analgesics|analgesics|mesh-ancestor
6176303|NCT01699815|Sensory System Agents|sensory system agents|mesh-ancestor
6176304|NCT01699815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6176305|NCT01699815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176306|NCT01699815|Antipyretics|antipyretics|mesh-ancestor
6176307|NCT01700036|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
6176308|NCT01700036|Protein C Inhibitor|protein c inhibitor|mesh-list
6176309|NCT01700036|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6176310|NCT01700036|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6176311|NCT01700036|Protease Inhibitors|protease inhibitors|mesh-ancestor
6176312|NCT01700036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6487131|NCT00574743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6487132|NCT00574743|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6487133|NCT00574743|Antitubercular Agents|antitubercular agents|mesh-ancestor
6487134|NCT00574743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6487135|NCT00574743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6176313|NCT01700036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176314|NCT01700179|Ribavirin|ribavirin|mesh-list
6176315|NCT01700179|Antimetabolites|antimetabolites|mesh-ancestor
6176316|NCT01700179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176317|NCT01700179|Antiviral Agents|antiviral agents|mesh-ancestor
6176318|NCT01700179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6176319|NCT01700192|Mometasone Furoate|mometasone furoate|mesh-list
6487136|NCT00574743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6176320|NCT01700192|Loratadine|loratadine|mesh-list
6670496|NCT01543906|Retinol acetate|retinol acetate|mesh-list
6670497|NCT01543906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6670498|NCT01543906|Immunologic Factors|immunologic factors|mesh-ancestor
6670499|NCT01543906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670500|NCT01543906|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6670501|NCT01543906|Protective Agents|protective agents|mesh-ancestor
6670502|NCT01543906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6670503|NCT01543932|Clopidogrel|clopidogrel|mesh-list
6670504|NCT01543932|Ticagrelor|ticagrelor|mesh-list
6670505|NCT01543932|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6670506|NCT01543932|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6670507|NCT01543932|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6176321|NCT01700192|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
6176322|NCT01700192|Epinephrine|epinephrine|mesh-list
6176323|NCT01700192|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6670508|NCT01543932|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5572648|NCT03915561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5572649|NCT03915561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5572650|NCT03915561|Analgesics|analgesics|mesh-ancestor
5572651|NCT03915561|Sensory System Agents|sensory system agents|mesh-ancestor
5572652|NCT03915561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5572653|NCT03915561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670509|NCT01543932|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6670510|NCT01543932|Purinergic Agents|purinergic agents|mesh-ancestor
6670511|NCT01543932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6670512|NCT01543932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572654|NCT03915561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6176324|NCT01700192|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6176325|NCT01700192|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6176326|NCT01700192|Adrenergic Agents|adrenergic agents|mesh-ancestor
6176327|NCT01700192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6176328|NCT01700192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176329|NCT01700192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176330|NCT01700192|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6176331|NCT01700192|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6176332|NCT01700192|Autonomic Agents|autonomic agents|mesh-ancestor
6176333|NCT01700192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6176334|NCT01700192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6176335|NCT01700192|Respiratory System Agents|respiratory system agents|mesh-ancestor
6176336|NCT01700192|Mydriatics|mydriatics|mesh-ancestor
6176337|NCT01700192|Sympathomimetics|sympathomimetics|mesh-ancestor
6176338|NCT01700192|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6176339|NCT01700192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5572655|NCT03915561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5572656|NCT03915665|Chlorhexidine|chlorhexidine|mesh-list
5572657|NCT03915665|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5572658|NCT03915665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5572659|NCT03915665|Disinfectants|disinfectants|mesh-ancestor
5572660|NCT03915340|Propafenone|propafenone|mesh-list
5572661|NCT03915340|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5572662|NCT03915340|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5572663|NCT03915340|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6176340|NCT01700192|Dermatologic Agents|dermatologic agents|mesh-ancestor
6176341|NCT01700192|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6176342|NCT01700192|Antipruritics|antipruritics|mesh-ancestor
6176343|NCT01700192|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6176344|NCT01700192|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6176345|NCT01700192|Histamine Antagonists|histamine antagonists|mesh-ancestor
6176346|NCT01700192|Histamine Agents|histamine agents|mesh-ancestor
6176347|NCT01700192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6176348|NCT01700192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6176349|NCT01700192|Analgesics|analgesics|mesh-ancestor
6176350|NCT01700192|Sensory System Agents|sensory system agents|mesh-ancestor
6176351|NCT01700192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6176352|NCT01700192|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6176353|NCT01700387|Topiramate|topiramate|mesh-list
6176354|NCT01700387|Botulinum Toxins|botulinum toxins|mesh-list
6176355|NCT01700387|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6176356|NCT01700387|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5572664|NCT03915340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5572665|NCT03915340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572666|NCT03914963|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6176357|NCT01700387|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6670513|NCT01543932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572667|NCT03914963|Hemostatics|hemostatics|mesh-ancestor
5572668|NCT03914963|Coagulants|coagulants|mesh-ancestor
5572669|NCT03915223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
5572670|NCT03915223|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5572671|NCT03915223|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5572672|NCT03915223|Methylprednisolone|methylprednisolone|mesh-list
6176358|NCT01700387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6176359|NCT01700387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176360|NCT01700387|Cholinergic Agents|cholinergic agents|mesh-ancestor
6176361|NCT01700387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6176362|NCT01700387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176363|NCT01700387|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6176364|NCT01700387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6176365|NCT01700387|Anticonvulsants|anticonvulsants|mesh-ancestor
6176366|NCT01700387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6176367|NCT01700517|Anesthetics|anesthetics|mesh-list
6176368|NCT01700517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5572673|NCT03915223|Prednisolone|prednisolone|mesh-list
5572674|NCT03915223|Prednisolone acetate|prednisolone acetate|mesh-list
5572675|NCT03915223|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5572676|NCT03915223|Prednisolone phosphate|prednisolone phosphate|mesh-list
5572677|NCT03915223|Glucocorticoids|glucocorticoids|mesh-ancestor
5572678|NCT03915223|Hormones|hormones|mesh-ancestor
5572679|NCT03915223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5572680|NCT03915223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572681|NCT03915223|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5572682|NCT03915223|Protective Agents|protective agents|mesh-ancestor
6176369|NCT01700517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176370|NCT01700530|Simvastatin|simvastatin|mesh-list
6176371|NCT01700530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
6176372|NCT01700530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6176373|NCT01700530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6176374|NCT01700530|Antimetabolites|antimetabolites|mesh-ancestor
6176375|NCT01700530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176376|NCT01700530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6176377|NCT01700530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6176378|NCT01700621|Vaccines|vaccines|mesh-list
5572683|NCT03915223|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5572684|NCT03915223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5572685|NCT03915223|Antiemetics|antiemetics|mesh-ancestor
5572686|NCT03915223|Autonomic Agents|autonomic agents|mesh-ancestor
5572687|NCT03915223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5572688|NCT03915223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5572689|NCT03915132|Nimotuzumab|nimotuzumab|mesh-list
5572690|NCT03915132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5572691|NCT03915132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5572692|NCT03914755|Tucatinib|tucatinib|mesh-list
6176379|NCT01700621|Immunologic Factors|immunologic factors|mesh-ancestor
6176380|NCT01700621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176381|NCT01700673|Azacitidine|azacitidine|mesh-list
6176382|NCT01700673|Sargramostim|sargramostim|mesh-list
6176383|NCT01700673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6176384|NCT01700673|Antimetabolites|antimetabolites|mesh-ancestor
6176385|NCT01700673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176386|NCT01700673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6176387|NCT01700673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6176388|NCT01700673|Immunologic Factors|immunologic factors|mesh-ancestor
6176389|NCT01700673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176390|NCT01700829|Midazolam|midazolam|mesh-list
6176391|NCT01700829|Ketamine|ketamine|mesh-list
5572693|NCT03914755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5572694|NCT03914755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5572695|NCT03914755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5572696|NCT03914755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604339|NCT04965597|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5604340|NCT04965597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5604341|NCT04965597|Immunologic Factors|immunologic factors|mesh-ancestor
5604342|NCT04965597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5604343|NCT04965597|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5604344|NCT04965597|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5604345|NCT04965597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5604346|NCT04965597|Alkylating Agents|alkylating agents|mesh-ancestor
5604347|NCT04965597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6176392|NCT01700829|Analgesics|analgesics|mesh-ancestor
6176393|NCT01700829|Sensory System Agents|sensory system agents|mesh-ancestor
6489026|NCT00588835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6176394|NCT01700829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6176395|NCT01700829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670514|NCT01543945|Dexamethasone|dexamethasone|mesh-list
6670515|NCT01543945|Dexamethasone acetate|dexamethasone acetate|mesh-list
6670516|NCT01543945|Ondansetron|ondansetron|mesh-list
5572697|NCT03914690|Epoetin Alfa|epoetin alfa|mesh-list
6176396|NCT01700829|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6176397|NCT01700829|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6176398|NCT01700829|Anesthetics, General|anesthetics, general|mesh-ancestor
6176399|NCT01700829|Anesthetics|anesthetics|mesh-ancestor
6176400|NCT01700829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6176401|NCT01700829|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6176402|NCT01700829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5572698|NCT03914690|Hematinics|hematinics|mesh-ancestor
5572699|NCT03914638|Albuterol|albuterol|mesh-list
5572700|NCT03914638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6176403|NCT01700829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6176404|NCT01700829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176405|NCT01700829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6176406|NCT01700829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6176407|NCT01700829|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6176408|NCT01700829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6176409|NCT01700829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6176410|NCT01700829|GABA Modulators|gaba modulators|mesh-ancestor
6176411|NCT01700829|GABA Agents|gaba agents|mesh-ancestor
6176412|NCT01700907|Sevoflurane|sevoflurane|mesh-list
6176413|NCT01700907|Desflurane|desflurane|mesh-list
6176414|NCT01700907|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6176415|NCT01700907|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6176416|NCT01700907|Anesthetics, General|anesthetics, general|mesh-ancestor
6176417|NCT01700907|Anesthetics|anesthetics|mesh-ancestor
6176418|NCT01700907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6176419|NCT01700907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176420|NCT01700959|Melatonin|melatonin|mesh-list
6176421|NCT01700959|Antioxidants|antioxidants|mesh-ancestor
6176422|NCT01700959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176423|NCT01700959|Protective Agents|protective agents|mesh-ancestor
6176424|NCT01700959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176425|NCT01700959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6176426|NCT01701037|Trametinib|trametinib|mesh-list
6176427|NCT01701037|Dabrafenib|dabrafenib|mesh-list
6176428|NCT01701037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6176429|NCT01701037|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6176430|NCT01701037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6670517|NCT01543945|Antiemetics|antiemetics|mesh-list
6670518|NCT01543945|Dimenhydrinate|dimenhydrinate|mesh-list
5572701|NCT03914638|Autonomic Agents|autonomic agents|mesh-ancestor
5572702|NCT03914638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5572703|NCT03914638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572704|NCT03914638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5572705|NCT03914638|Respiratory System Agents|respiratory system agents|mesh-ancestor
5572706|NCT03914638|Tocolytic Agents|tocolytic agents|mesh-ancestor
5572707|NCT03914638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5572708|NCT03914638|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5572709|NCT03914638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5572710|NCT03914638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5572711|NCT03914638|Adrenergic Agents|adrenergic agents|mesh-ancestor
5572712|NCT03914638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5572713|NCT03914638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572714|NCT03914443|Cisplatin|cisplatin|mesh-list
5572715|NCT03914443|Docetaxel|docetaxel|mesh-list
5572716|NCT03914443|Fluorouracil|fluorouracil|mesh-list
5572717|NCT03914443|Nivolumab|nivolumab|mesh-list
5572718|NCT03914443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6670519|NCT01543945|BB 1101|bb 1101|mesh-list
6670520|NCT01543945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6670521|NCT01543945|Autonomic Agents|autonomic agents|mesh-ancestor
6176431|NCT01701037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176432|NCT01701063|Ribavirin|ribavirin|mesh-list
6176433|NCT01701063|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6176434|NCT01701063|Antimetabolites|antimetabolites|mesh-ancestor
6176435|NCT01701063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176436|NCT01701063|Antiviral Agents|antiviral agents|mesh-ancestor
6176437|NCT01701063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6670522|NCT01543945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6670523|NCT01543945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572719|NCT03914443|Tubulin Modulators|tubulin modulators|mesh-ancestor
5572720|NCT03914443|Antimitotic Agents|antimitotic agents|mesh-ancestor
5572721|NCT03914443|Mitosis Modulators|mitosis modulators|mesh-ancestor
5572722|NCT03914443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572723|NCT03914443|Antimetabolites|antimetabolites|mesh-ancestor
5572724|NCT03914443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5572725|NCT03914443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5572726|NCT03914443|Immunologic Factors|immunologic factors|mesh-ancestor
6176438|NCT01701102|Fentanyl|fentanyl|mesh-list
6176439|NCT01701102|Mepivacaine|mepivacaine|mesh-list
6176440|NCT01701102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6176441|NCT01701102|Narcotics|narcotics|mesh-ancestor
6176442|NCT01701102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6176443|NCT01701102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176444|NCT01701102|Analgesics|analgesics|mesh-ancestor
6176445|NCT01701102|Sensory System Agents|sensory system agents|mesh-ancestor
6176446|NCT01701102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6176447|NCT01701102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6176448|NCT01701102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6176449|NCT01701102|Anesthetics, General|anesthetics, general|mesh-ancestor
6176450|NCT01701102|Anesthetics|anesthetics|mesh-ancestor
6176451|NCT01701102|Anesthetics, Local|anesthetics, local|mesh-ancestor
6176452|NCT01701115|Bupivacaine|bupivacaine|mesh-list
6176453|NCT01701115|Anesthetics, Local|anesthetics, local|mesh-list
6176454|NCT01701115|Mepivacaine|mepivacaine|mesh-list
6176455|NCT01701115|Anesthetics|anesthetics|mesh-list
6176456|NCT01701115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6176457|NCT01701115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176458|NCT01701115|Sensory System Agents|sensory system agents|mesh-ancestor
6176459|NCT01701115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6176460|NCT01701258|Amisulpride|amisulpride|mesh-list
6176461|NCT01701258|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6176462|NCT01701258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6176463|NCT01701258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6487137|NCT00574743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604348|NCT04965597|Antiviral Agents|antiviral agents|mesh-ancestor
6176464|NCT01701258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176465|NCT01701258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6176466|NCT01701258|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6176467|NCT01701258|Dopamine Agents|dopamine agents|mesh-ancestor
6176468|NCT01701258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6176469|NCT01701258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176470|NCT01701258|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6176471|NCT01701258|Antidepressive Agents|antidepressive agents|mesh-ancestor
6176472|NCT01701362|Pregabalin|pregabalin|mesh-list
6176473|NCT01701362|Analgesics|analgesics|mesh-ancestor
6176474|NCT01701362|Sensory System Agents|sensory system agents|mesh-ancestor
6176475|NCT01701362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6176476|NCT01701362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176477|NCT01701362|Anticonvulsants|anticonvulsants|mesh-ancestor
6176478|NCT01701362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6176479|NCT01701362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6176480|NCT01701362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176481|NCT01701362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6176482|NCT01701362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6176483|NCT01701362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6176484|NCT01701362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6176485|NCT01701362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6176486|NCT01701375|Palbociclib|palbociclib|mesh-list
6176487|NCT01701375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6176488|NCT01701375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6176489|NCT01701375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6176490|NCT01701375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176491|NCT01701401|Sofosbuvir|sofosbuvir|mesh-list
6176492|NCT01701401|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
6176493|NCT01701401|Ledipasvir|ledipasvir|mesh-list
5572727|NCT03914443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572728|NCT03914443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5572729|NCT03914443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5572730|NCT03914404|Thioctic Acid|thioctic acid|mesh-list
5572731|NCT03914404|Antioxidants|antioxidants|mesh-ancestor
5572732|NCT03914404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572733|NCT03914404|Protective Agents|protective agents|mesh-ancestor
5572734|NCT03914404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487138|NCT00574756|Ranolazine|ranolazine|mesh-list
6487139|NCT00574756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6487140|NCT00574756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6487141|NCT00574756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6487142|NCT00574769|Bevacizumab|bevacizumab|mesh-list
6487143|NCT00574769|Docetaxel|docetaxel|mesh-list
6487144|NCT00574769|Everolimus|everolimus|mesh-list
6487145|NCT00574769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6487146|NCT00574769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6487147|NCT00574769|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6487148|NCT00574769|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6487149|NCT00574769|Growth Substances|growth substances|mesh-ancestor
6487150|NCT00574769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487151|NCT00574769|Growth Inhibitors|growth inhibitors|mesh-ancestor
6487152|NCT00574769|Tubulin Modulators|tubulin modulators|mesh-ancestor
6487153|NCT00574769|Antimitotic Agents|antimitotic agents|mesh-ancestor
6487154|NCT00574769|Mitosis Modulators|mitosis modulators|mesh-ancestor
6487155|NCT00574769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6487156|NCT00574769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6487157|NCT00574769|Immunologic Factors|immunologic factors|mesh-ancestor
6487158|NCT00574925|Esomeprazole|esomeprazole|mesh-list
6487159|NCT00574925|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6487160|NCT00574925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6487161|NCT00574925|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6487162|NCT00574925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6176494|NCT01701401|Antiviral Agents|antiviral agents|mesh-ancestor
6176495|NCT01701401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6176496|NCT01701414|Bupivacaine|bupivacaine|mesh-list
6670524|NCT01543945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6670525|NCT01543945|Glucocorticoids|glucocorticoids|mesh-ancestor
6670526|NCT01543945|Hormones|hormones|mesh-ancestor
6176497|NCT01701414|Anesthetics, Local|anesthetics, local|mesh-ancestor
6176498|NCT01701414|Anesthetics|anesthetics|mesh-ancestor
6176499|NCT01701414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6176500|NCT01701414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176501|NCT01701414|Sensory System Agents|sensory system agents|mesh-ancestor
6176502|NCT01701414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6176503|NCT01701505|Phenylephrine|phenylephrine|mesh-list
5572735|NCT03914404|Vitamin B Complex|vitamin b complex|mesh-ancestor
5572736|NCT03914404|Vitamins|vitamins|mesh-ancestor
5572737|NCT03914404|Micronutrients|micronutrients|mesh-ancestor
5572738|NCT03914677|Mecamylamine|mecamylamine|mesh-list
5572739|NCT03914677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5572740|NCT03914677|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
5572741|NCT03914677|Autonomic Agents|autonomic agents|mesh-ancestor
5572742|NCT03914677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5572743|NCT03914677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572744|NCT03914677|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
5572745|NCT03914677|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5572746|NCT03914677|Cholinergic Agents|cholinergic agents|mesh-ancestor
6176504|NCT01701505|Oxymetazoline|oxymetazoline|mesh-list
6176505|NCT01701505|Tetracaine|tetracaine|mesh-list
6176506|NCT01701505|Anesthetics, Local|anesthetics, local|mesh-ancestor
6176507|NCT01701505|Anesthetics|anesthetics|mesh-ancestor
6176508|NCT01701505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6176509|NCT01701505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176510|NCT01701505|Sensory System Agents|sensory system agents|mesh-ancestor
6176511|NCT01701505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6176512|NCT01701505|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6487163|NCT00574925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6487164|NCT00574964|Temozolomide|temozolomide|mesh-list
6487165|NCT00574964|Carmustine|carmustine|mesh-list
6487166|NCT00574964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5572747|NCT03914677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6176513|NCT01701505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6176514|NCT01701505|Adrenergic Agents|adrenergic agents|mesh-ancestor
6176515|NCT01701505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6208007|NCT02123446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6176516|NCT01701505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176517|NCT01701505|Sympathomimetics|sympathomimetics|mesh-ancestor
6176518|NCT01701505|Autonomic Agents|autonomic agents|mesh-ancestor
6176519|NCT01701505|Nasal Decongestants|nasal decongestants|mesh-ancestor
6176520|NCT01701505|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6176521|NCT01701505|Respiratory System Agents|respiratory system agents|mesh-ancestor
5572748|NCT03914677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572749|NCT03914534|Valproic Acid|valproic acid|mesh-list
5572750|NCT03914534|Anticonvulsants|anticonvulsants|mesh-ancestor
5572751|NCT03914534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6176522|NCT01701505|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6176523|NCT01701505|Mydriatics|mydriatics|mesh-ancestor
6176524|NCT01701505|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6176525|NCT01701505|Protective Agents|protective agents|mesh-ancestor
6176526|NCT01701973|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6176527|NCT01701973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6176528|NCT01701973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176529|NCT01701973|Incretins|incretins|mesh-ancestor
6176530|NCT01701973|Hormones|hormones|mesh-ancestor
6176531|NCT01701973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6176532|NCT01701973|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6670527|NCT01543945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6670528|NCT01543945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6670529|NCT01543945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6670530|NCT01543945|Protease Inhibitors|protease inhibitors|mesh-ancestor
6670531|NCT01543945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6176533|NCT01701973|Protease Inhibitors|protease inhibitors|mesh-ancestor
6176534|NCT01701973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6176535|NCT01701973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176536|NCT01702025|Aminophylline|aminophylline|mesh-list
6176537|NCT01702025|Methazolamide|methazolamide|mesh-list
6176538|NCT01702025|Theophylline|theophylline|mesh-list
6176539|NCT01702025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6176540|NCT01702025|Autonomic Agents|autonomic agents|mesh-ancestor
6176541|NCT01702025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6176542|NCT01702025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572752|NCT03914534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572753|NCT03914534|GABA Agents|gaba agents|mesh-ancestor
5572754|NCT03914534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5572755|NCT03914534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572756|NCT03914534|Antimanic Agents|antimanic agents|mesh-ancestor
5572757|NCT03914534|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5572758|NCT03914534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5572759|NCT03914534|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5572760|NCT03914352|Antibodies|antibodies|mesh-list
5572761|NCT03914352|Immunologic Factors|immunologic factors|mesh-ancestor
5572762|NCT03914352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572763|NCT03914118|Modafinil|modafinil|mesh-list
5572764|NCT03914118|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5572765|NCT03914118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176543|NCT01702025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6176544|NCT01702025|Respiratory System Agents|respiratory system agents|mesh-ancestor
6176545|NCT01702025|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6176546|NCT01702025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6176547|NCT01702025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176548|NCT01702025|Vasodilator Agents|vasodilator agents|mesh-ancestor
6176549|NCT01702025|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6176550|NCT01702025|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6176551|NCT01702025|Purinergic Agents|purinergic agents|mesh-ancestor
6176552|NCT01702025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6176553|NCT01702025|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5572766|NCT03914118|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
5572767|NCT03914118|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5572768|NCT03914118|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5572769|NCT03914118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176554|NCT01702025|Protective Agents|protective agents|mesh-ancestor
5572770|NCT03914092|Triamcinolone|triamcinolone|mesh-list
5572771|NCT03914092|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5572772|NCT03914092|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6176555|NCT01702025|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6176556|NCT01702025|Diuretics|diuretics|mesh-ancestor
6176557|NCT01702025|Natriuretic Agents|natriuretic agents|mesh-ancestor
6176558|NCT01702233|Dexamethasone|dexamethasone|mesh-list
5572773|NCT03914092|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5572774|NCT03914092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5572775|NCT03914092|Glucocorticoids|glucocorticoids|mesh-ancestor
5572776|NCT03914092|Hormones|hormones|mesh-ancestor
5572777|NCT03914092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5572778|NCT03914092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572779|NCT03914092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5572780|NCT03914092|Immunologic Factors|immunologic factors|mesh-ancestor
5572781|NCT03914092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5572782|NCT03914092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572783|NCT03913884|Mitogens|mitogens|mesh-list
5572784|NCT03913884|Mitosis Modulators|mitosis modulators|mesh-ancestor
5572785|NCT03913884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572786|NCT03914235|Lidocaine|lidocaine|mesh-list
5572787|NCT03914235|Anesthetics, Local|anesthetics, local|mesh-ancestor
5572788|NCT03914235|Anesthetics|anesthetics|mesh-ancestor
5572789|NCT03914235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5572790|NCT03914235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572791|NCT03914235|Sensory System Agents|sensory system agents|mesh-ancestor
5572792|NCT03914235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5572793|NCT03914235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5572794|NCT03914235|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5572795|NCT03914235|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5572796|NCT03914235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5572797|NCT03914235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572798|NCT03913819|Cholinergic Antagonists|cholinergic antagonists|mesh-list
5572799|NCT03913819|Cholinergic Agents|cholinergic agents|mesh-ancestor
5572800|NCT03913819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5572801|NCT03913819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572802|NCT03913819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572803|NCT03913858|Anesthetics|anesthetics|mesh-list
5572804|NCT03913858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5572805|NCT03913858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572806|NCT03913832|Sirolimus|sirolimus|mesh-list
5572807|NCT03913832|Paclitaxel|paclitaxel|mesh-list
5572808|NCT03913832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5572809|NCT03913832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5572810|NCT03913832|Tubulin Modulators|tubulin modulators|mesh-ancestor
5572811|NCT03913832|Antimitotic Agents|antimitotic agents|mesh-ancestor
5572812|NCT03913832|Mitosis Modulators|mitosis modulators|mesh-ancestor
5572813|NCT03913832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572814|NCT03913832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5572815|NCT03913832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5572816|NCT03913832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5572817|NCT03913832|Antifungal Agents|antifungal agents|mesh-ancestor
5572818|NCT03913832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5572819|NCT03913832|Immunologic Factors|immunologic factors|mesh-ancestor
5572820|NCT03913832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572821|NCT03913650|Bupivacaine|bupivacaine|mesh-list
5572822|NCT03913650|Anesthetics, Local|anesthetics, local|mesh-ancestor
5572823|NCT03913650|Anesthetics|anesthetics|mesh-ancestor
5572824|NCT03913650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5572825|NCT03913650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572826|NCT03913650|Sensory System Agents|sensory system agents|mesh-ancestor
6487167|NCT00574964|Alkylating Agents|alkylating agents|mesh-ancestor
6487168|NCT00574964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6487169|NCT00574964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6487170|NCT00575068|Galiximab|galiximab|mesh-list
6487171|NCT00575068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6487172|NCT00575068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6487173|NCT00575224|Interferons|interferons|mesh-list
6487174|NCT00575224|Ribavirin|ribavirin|mesh-list
6487175|NCT00575224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6487176|NCT00575224|Antiviral Agents|antiviral agents|mesh-ancestor
6487177|NCT00575224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6487178|NCT00575224|Antimetabolites|antimetabolites|mesh-ancestor
5572827|NCT03913650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5572828|NCT03913702|Methylprednisolone|methylprednisolone|mesh-list
5572829|NCT03913702|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5572830|NCT03913702|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5572831|NCT03913702|Prednisolone|prednisolone|mesh-list
5572832|NCT03913702|Prednisolone acetate|prednisolone acetate|mesh-list
5572833|NCT03913702|Ketorolac|ketorolac|mesh-list
6487179|NCT00575224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6487180|NCT00575302|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6487181|NCT00575302|Hormones|hormones|mesh-ancestor
6176559|NCT01702233|Dexamethasone acetate|dexamethasone acetate|mesh-list
6176560|NCT01702233|BB 1101|bb 1101|mesh-list
6176561|NCT01702233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6176562|NCT01702233|Antiemetics|antiemetics|mesh-ancestor
6176563|NCT01702233|Autonomic Agents|autonomic agents|mesh-ancestor
6176564|NCT01702233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6487182|NCT00575302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6487183|NCT00575302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487184|NCT00575341|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
6487185|NCT00575341|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6487186|NCT00575341|Immunologic Factors|immunologic factors|mesh-ancestor
6487187|NCT00575341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487188|NCT00575354|Sevoflurane|sevoflurane|mesh-list
6487189|NCT00575354|Isoflurane|isoflurane|mesh-list
6487190|NCT00575354|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6487191|NCT00575354|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6487192|NCT00575354|Anesthetics, General|anesthetics, general|mesh-ancestor
6487193|NCT00575354|Anesthetics|anesthetics|mesh-ancestor
6487194|NCT00575354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6487195|NCT00575354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487196|NCT00575393|Gold Sodium Thiomalate|gold sodium thiomalate|mesh-list
6487197|NCT00575393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6487198|NCT00575406|Prednisolone|prednisolone|mesh-list
6487199|NCT00575406|Cyclophosphamide|cyclophosphamide|mesh-list
6487200|NCT00575406|Rituximab|rituximab|mesh-list
6487201|NCT00575406|Doxorubicin|doxorubicin|mesh-list
6487202|NCT00575406|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6487203|NCT00575406|Vincristine|vincristine|mesh-list
6487204|NCT00575406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5572834|NCT03913702|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
5572835|NCT03913702|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5572836|NCT03913702|Prednisolone phosphate|prednisolone phosphate|mesh-list
5572837|NCT03913702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5572838|NCT03913702|Antiemetics|antiemetics|mesh-ancestor
6176565|NCT01702233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176566|NCT01702233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6176567|NCT01702233|Glucocorticoids|glucocorticoids|mesh-ancestor
6176568|NCT01702233|Hormones|hormones|mesh-ancestor
6176569|NCT01702233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6176570|NCT01702233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6176571|NCT01702233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6176572|NCT01702233|Protease Inhibitors|protease inhibitors|mesh-ancestor
6176573|NCT01702233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6176574|NCT01702233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176575|NCT01702246|Simvastatin|simvastatin|mesh-list
6487205|NCT00575406|Immunologic Factors|immunologic factors|mesh-ancestor
6487206|NCT00575406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487207|NCT00575406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6176576|NCT01702246|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6176577|NCT01702246|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6176578|NCT01702246|Antimetabolites|antimetabolites|mesh-ancestor
6176579|NCT01702246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176580|NCT01702246|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6176581|NCT01702246|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6176582|NCT01702246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6176583|NCT01702298|Metformin|metformin|mesh-list
6176584|NCT01702298|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6176585|NCT01702298|Simvastatin|simvastatin|mesh-list
6176586|NCT01702298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6176587|NCT01702298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176588|NCT01702298|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6176589|NCT01702298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6176590|NCT01702298|Antimetabolites|antimetabolites|mesh-ancestor
5572839|NCT03913702|Autonomic Agents|autonomic agents|mesh-ancestor
5572840|NCT03913702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5572841|NCT03913702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176591|NCT01702298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176592|NCT01702298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6176593|NCT01702298|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6176594|NCT01702298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6176595|NCT01702298|Incretins|incretins|mesh-ancestor
6176596|NCT01702298|Hormones|hormones|mesh-ancestor
6176597|NCT01702298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6176598|NCT01702298|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6176599|NCT01702298|Protease Inhibitors|protease inhibitors|mesh-ancestor
6176600|NCT01702311|Insulin Aspart|insulin aspart|mesh-list
6176601|NCT01702311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6176602|NCT01702311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176603|NCT01702428|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6176604|NCT01702428|Immunologic Factors|immunologic factors|mesh-ancestor
6176605|NCT01702428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176606|NCT01702519|Nicotine|nicotine|mesh-list
6176607|NCT01702519|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6176608|NCT01702519|Autonomic Agents|autonomic agents|mesh-ancestor
6176609|NCT01702519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6176610|NCT01702519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176611|NCT01702519|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6176612|NCT01702519|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6176613|NCT01702519|Cholinergic Agents|cholinergic agents|mesh-ancestor
6176614|NCT01702519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6176615|NCT01702519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176616|NCT01702532|Nicotine|nicotine|mesh-list
6176617|NCT01702532|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5572842|NCT03913702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5572843|NCT03913702|Glucocorticoids|glucocorticoids|mesh-ancestor
5572844|NCT03913702|Hormones|hormones|mesh-ancestor
6176618|NCT01702532|Autonomic Agents|autonomic agents|mesh-ancestor
6176619|NCT01702532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6176620|NCT01702532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176621|NCT01702532|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6176622|NCT01702532|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6176623|NCT01702532|Cholinergic Agents|cholinergic agents|mesh-ancestor
6176624|NCT01702532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6176625|NCT01702532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176626|NCT01702558|Capecitabine|capecitabine|mesh-list
6176627|NCT01702558|Trastuzumab|trastuzumab|mesh-list
6176628|NCT01702558|Maytansine|maytansine|mesh-list
6176629|NCT01702558|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
6176630|NCT01702558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6176631|NCT01702558|Antimetabolites|antimetabolites|mesh-ancestor
6176632|NCT01702558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176633|NCT01702558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6176634|NCT01702558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6176635|NCT01702558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6176636|NCT01702558|Tubulin Modulators|tubulin modulators|mesh-ancestor
6176637|NCT01702558|Antimitotic Agents|antimitotic agents|mesh-ancestor
5572845|NCT03913702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5572846|NCT03913702|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5572847|NCT03913702|Protective Agents|protective agents|mesh-ancestor
6176638|NCT01702558|Mitosis Modulators|mitosis modulators|mesh-ancestor
6176639|NCT01702571|Trastuzumab|trastuzumab|mesh-list
6176640|NCT01702571|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
6176641|NCT01702571|Maytansine|maytansine|mesh-list
6176642|NCT01702571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6176643|NCT01702571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6670532|NCT01543945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176644|NCT01702571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6176645|NCT01702571|Tubulin Modulators|tubulin modulators|mesh-ancestor
6176646|NCT01702571|Antimitotic Agents|antimitotic agents|mesh-ancestor
6670533|NCT01543945|Antipruritics|antipruritics|mesh-ancestor
6670534|NCT01543945|Dermatologic Agents|dermatologic agents|mesh-ancestor
6670535|NCT01543945|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6670536|NCT01543945|Serotonin Agents|serotonin agents|mesh-ancestor
6670537|NCT01543945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6670538|NCT01543945|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6670539|NCT01543945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6670540|NCT01543945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6670541|NCT01543945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6670542|NCT01543945|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6670543|NCT01543945|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6176647|NCT01702571|Mitosis Modulators|mitosis modulators|mesh-ancestor
6176648|NCT01702571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176649|NCT01702844|Paclitaxel|paclitaxel|mesh-list
6176650|NCT01702844|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6176651|NCT01702844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6176652|NCT01702844|Tubulin Modulators|tubulin modulators|mesh-ancestor
6176653|NCT01702844|Antimitotic Agents|antimitotic agents|mesh-ancestor
6176654|NCT01702844|Mitosis Modulators|mitosis modulators|mesh-ancestor
6176655|NCT01702844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176656|NCT01702961|Cytarabine|cytarabine|mesh-list
6176657|NCT01702961|Etoposide|etoposide|mesh-list
6176658|NCT01702961|Rituximab|rituximab|mesh-list
6176659|NCT01702961|Melphalan|melphalan|mesh-list
6176660|NCT01702961|Carmustine|carmustine|mesh-list
6176661|NCT01702961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6176662|NCT01702961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6176663|NCT01702961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6176664|NCT01702961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6176665|NCT01702961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6176666|NCT01702961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176667|NCT01702961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6176668|NCT01702961|Antimetabolites|antimetabolites|mesh-ancestor
6176669|NCT01702961|Antiviral Agents|antiviral agents|mesh-ancestor
6176670|NCT01702961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6176671|NCT01702961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6487208|NCT00575406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6487209|NCT00575406|Alkylating Agents|alkylating agents|mesh-ancestor
6487210|NCT00575406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6487211|NCT00575406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6487212|NCT00575406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6487213|NCT00575406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6487214|NCT00575406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6487215|NCT00575406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6487216|NCT00575406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6487217|NCT00575406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6487218|NCT00575406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6670544|NCT01543945|Histamine Antagonists|histamine antagonists|mesh-ancestor
6670545|NCT01543945|Histamine Agents|histamine agents|mesh-ancestor
6670546|NCT01543971|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
6670547|NCT01543971|Lenograstim|lenograstim|mesh-list
6670548|NCT01543971|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6670549|NCT01543971|Immunologic Factors|immunologic factors|mesh-ancestor
6670550|NCT01543971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670551|NCT01543971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6670552|NCT01543971|Vasodilator Agents|vasodilator agents|mesh-ancestor
6670553|NCT01544075|Vaccines|vaccines|mesh-list
6670554|NCT01544075|Immunologic Factors|immunologic factors|mesh-ancestor
6670555|NCT01544075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670556|NCT01544140|Midazolam|midazolam|mesh-list
6670557|NCT01544140|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6670558|NCT01544140|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6670559|NCT01544140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6670560|NCT01544140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670561|NCT01544140|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6670562|NCT01544140|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6670563|NCT01544140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6670564|NCT01544140|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6670565|NCT01544140|Anesthetics, General|anesthetics, general|mesh-ancestor
5572848|NCT03913702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5572849|NCT03913702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5572850|NCT03913702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6176672|NCT01702961|Immunologic Factors|immunologic factors|mesh-ancestor
6176673|NCT01702961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176674|NCT01702961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6176675|NCT01702961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6176676|NCT01702961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6176677|NCT01702961|Alkylating Agents|alkylating agents|mesh-ancestor
6176678|NCT01702961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6176679|NCT01702987|Coenzyme Q10|coenzyme q10|mesh-list
6176680|NCT01702987|Atorvastatin|atorvastatin|mesh-list
6176681|NCT01702987|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6176682|NCT01702987|Simvastatin|simvastatin|mesh-list
6176683|NCT01702987|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6176684|NCT01702987|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6176685|NCT01702987|Antimetabolites|antimetabolites|mesh-ancestor
6176686|NCT01702987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176687|NCT01702987|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6176688|NCT01702987|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6176689|NCT01702987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6176690|NCT01702987|Micronutrients|micronutrients|mesh-ancestor
6176691|NCT01702987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176692|NCT01702987|Vitamins|vitamins|mesh-ancestor
6176693|NCT01703039|Riluzole|riluzole|mesh-list
6176694|NCT01703039|Sertraline|sertraline|mesh-list
6176695|NCT01703039|Antidepressive Agents|antidepressive agents|mesh-ancestor
6176696|NCT01703039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6176697|NCT01703039|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6176698|NCT01703039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6176699|NCT01703039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6176700|NCT01703039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176701|NCT01703039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6176702|NCT01703039|Serotonin Agents|serotonin agents|mesh-ancestor
5572851|NCT03913702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5572852|NCT03913702|Analgesics|analgesics|mesh-ancestor
5572853|NCT03913702|Sensory System Agents|sensory system agents|mesh-ancestor
5572854|NCT03913702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5572855|NCT03913702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5572856|NCT03913702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5572857|NCT03913702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572858|NCT03913806|Bevacizumab|bevacizumab|mesh-list
5572859|NCT03913806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5572860|NCT03913806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5572861|NCT03913806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5572862|NCT03913806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5572863|NCT03913806|Growth Substances|growth substances|mesh-ancestor
5572864|NCT03913806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176703|NCT01703039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176704|NCT01703039|Anticonvulsants|anticonvulsants|mesh-ancestor
6176705|NCT01703039|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6176706|NCT01703039|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6176707|NCT01703039|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6176708|NCT01703039|Protective Agents|protective agents|mesh-ancestor
6176709|NCT01703091|Docetaxel|docetaxel|mesh-list
6176710|NCT01703091|Ramucirumab|ramucirumab|mesh-list
6176711|NCT01703091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6176712|NCT01703091|Tubulin Modulators|tubulin modulators|mesh-ancestor
6176713|NCT01703091|Antimitotic Agents|antimitotic agents|mesh-ancestor
6176714|NCT01703091|Mitosis Modulators|mitosis modulators|mesh-ancestor
6176715|NCT01703091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176716|NCT01703117|Riluzole|riluzole|mesh-list
6176717|NCT01703117|Anticonvulsants|anticonvulsants|mesh-ancestor
6176718|NCT01703117|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5572865|NCT03913806|Growth Inhibitors|growth inhibitors|mesh-ancestor
5572866|NCT03913455|Carboplatin|carboplatin|mesh-list
5572867|NCT03913455|Guadecitabine|guadecitabine|mesh-list
6487219|NCT00575406|Glucocorticoids|glucocorticoids|mesh-ancestor
6487220|NCT00575406|Hormones|hormones|mesh-ancestor
6487221|NCT00575406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6487222|NCT00575406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5572868|NCT03913455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5572869|NCT03913559|Acetaminophen|acetaminophen|mesh-list
5572870|NCT03913559|Diphenhydramine|diphenhydramine|mesh-list
5572871|NCT03913559|Promethazine|promethazine|mesh-list
5572872|NCT03913559|Cytarabine|cytarabine|mesh-list
5572873|NCT03913559|Methylprednisolone|methylprednisolone|mesh-list
5572874|NCT03913559|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5572875|NCT03913559|Hydrocortisone|hydrocortisone|mesh-list
5572876|NCT03913559|Methotrexate|methotrexate|mesh-list
5572877|NCT03913559|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
5572878|NCT03913559|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5572879|NCT03913559|Abortifacient Agents|abortifacient agents|mesh-ancestor
5572880|NCT03913559|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5572881|NCT03913559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572882|NCT03913559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6176719|NCT01703117|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6176720|NCT01703117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6176721|NCT01703117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176722|NCT01703117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176723|NCT01703117|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6176724|NCT01703117|Protective Agents|protective agents|mesh-ancestor
6176725|NCT01703221|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6176726|NCT01703221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6176727|NCT01703221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176728|NCT01703221|Incretins|incretins|mesh-ancestor
6176729|NCT01703221|Hormones|hormones|mesh-ancestor
6176730|NCT01703221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6176731|NCT01703221|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6176732|NCT01703221|Protease Inhibitors|protease inhibitors|mesh-ancestor
6176733|NCT01703221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6176734|NCT01703221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176735|NCT01703260|Pioglitazone|pioglitazone|mesh-list
6176736|NCT01703260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6176737|NCT01703260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176738|NCT01703286|Glimepiride|glimepiride|mesh-list
6176739|NCT01703286|Linagliptin|linagliptin|mesh-list
6176740|NCT01703286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6176741|NCT01703286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6176742|NCT01703286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176743|NCT01703286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6176744|NCT01703286|Immunologic Factors|immunologic factors|mesh-ancestor
6176745|NCT01703286|Incretins|incretins|mesh-ancestor
5572883|NCT03913559|Antimetabolites|antimetabolites|mesh-ancestor
5572884|NCT03913559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572885|NCT03913559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5572886|NCT03913559|Dermatologic Agents|dermatologic agents|mesh-ancestor
5572887|NCT03913559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5572888|NCT03913559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5572889|NCT03913559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5572890|NCT03913559|Immunologic Factors|immunologic factors|mesh-ancestor
5572891|NCT03913559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6176746|NCT01703286|Hormones|hormones|mesh-ancestor
6176747|NCT01703286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6176748|NCT01703286|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6176749|NCT01703286|Protease Inhibitors|protease inhibitors|mesh-ancestor
6176750|NCT01703286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6176751|NCT01703286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176752|NCT01703507|Ipilimumab|ipilimumab|mesh-list
6176753|NCT01703507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6487223|NCT00575406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6487224|NCT00575406|Tubulin Modulators|tubulin modulators|mesh-ancestor
5572892|NCT03913559|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5572893|NCT03913559|Antiviral Agents|antiviral agents|mesh-ancestor
6487225|NCT00575406|Antimitotic Agents|antimitotic agents|mesh-ancestor
6487226|NCT00575406|Mitosis Modulators|mitosis modulators|mesh-ancestor
6487227|NCT00575419|Acetylcysteine|acetylcysteine|mesh-list
6487228|NCT00575419|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6487229|NCT00575419|Antiviral Agents|antiviral agents|mesh-ancestor
6487230|NCT00575419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6487231|NCT00575419|Expectorants|expectorants|mesh-ancestor
6487232|NCT00575419|Respiratory System Agents|respiratory system agents|mesh-ancestor
6487233|NCT00575419|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6487234|NCT00575419|Antioxidants|antioxidants|mesh-ancestor
6487235|NCT00575419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6487236|NCT00575419|Protective Agents|protective agents|mesh-ancestor
6176754|NCT01703507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6176755|NCT01703507|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6176756|NCT01703507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206485|NCT02100657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6206486|NCT02100657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6206487|NCT02100657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6206488|NCT02100670|Diclofenac|diclofenac|mesh-list
6206489|NCT02100670|Menthol|menthol|mesh-list
6206490|NCT02100670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6487237|NCT00575419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487238|NCT00575419|Antidotes|antidotes|mesh-ancestor
6487239|NCT00575523|Atropine|atropine|mesh-list
6487240|NCT00575523|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6487241|NCT00575523|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6206491|NCT02100670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6206492|NCT02100670|Analgesics|analgesics|mesh-ancestor
6206493|NCT02100670|Sensory System Agents|sensory system agents|mesh-ancestor
6206494|NCT02100670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6206495|NCT02100670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206496|NCT02100670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6206497|NCT02100670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6206498|NCT02100670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6206499|NCT02100670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6206500|NCT02100670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206501|NCT02100670|Antipruritics|antipruritics|mesh-ancestor
6206502|NCT02100670|Dermatologic Agents|dermatologic agents|mesh-ancestor
6206503|NCT02100696|Etrolizumab|etrolizumab|mesh-list
6206504|NCT02100696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6206505|NCT02100696|Immunologic Factors|immunologic factors|mesh-ancestor
6206506|NCT02100696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206507|NCT02100748|Morphine|morphine|mesh-list
6206508|NCT02100748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6206509|NCT02100748|Narcotics|narcotics|mesh-ancestor
6206510|NCT02100748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6206511|NCT02100748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206512|NCT02100748|Analgesics|analgesics|mesh-ancestor
6206513|NCT02100748|Sensory System Agents|sensory system agents|mesh-ancestor
6206514|NCT02100748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6206515|NCT02100826|Cephalexin|cephalexin|mesh-list
6206516|NCT02100826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6206517|NCT02100826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6206518|NCT02100930|Molgramostim|molgramostim|mesh-list
5572894|NCT03913559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5572895|NCT03913559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5572896|NCT03913559|Analgesics|analgesics|mesh-ancestor
5572897|NCT03913559|Sensory System Agents|sensory system agents|mesh-ancestor
5572898|NCT03913559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5572899|NCT03913559|Antipyretics|antipyretics|mesh-ancestor
5572900|NCT03913559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5572901|NCT03913559|Antiemetics|antiemetics|mesh-ancestor
5572902|NCT03913559|Autonomic Agents|autonomic agents|mesh-ancestor
5572903|NCT03913559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5572904|NCT03913559|Glucocorticoids|glucocorticoids|mesh-ancestor
6206519|NCT02100930|Isotretinoin|isotretinoin|mesh-list
6206520|NCT02100930|Antibodies|antibodies|mesh-list
6206521|NCT02100930|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6206522|NCT02100930|Sargramostim|sargramostim|mesh-list
6206523|NCT02100930|Immunologic Factors|immunologic factors|mesh-ancestor
6206524|NCT02100930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206525|NCT02100930|Dermatologic Agents|dermatologic agents|mesh-ancestor
6206526|NCT02100930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6206527|NCT02100969|Immunoglobulins|immunoglobulins|mesh-list
6487242|NCT00575523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5572905|NCT03913559|Hormones|hormones|mesh-ancestor
6206528|NCT02100969|gamma-Globulins|gamma-globulins|mesh-list
6487243|NCT00575523|Autonomic Agents|autonomic agents|mesh-ancestor
5572906|NCT03913559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5572907|NCT03913559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5572908|NCT03913559|Protective Agents|protective agents|mesh-ancestor
5572909|NCT03913559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5572910|NCT03913559|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5572911|NCT03913559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5572912|NCT03913559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5572913|NCT03913559|Anesthetics, Local|anesthetics, local|mesh-ancestor
5572914|NCT03913559|Anesthetics|anesthetics|mesh-ancestor
6176757|NCT01703741|Testosterone|testosterone|mesh-list
6176758|NCT01703741|Androgens|androgens|mesh-ancestor
6176759|NCT01703741|Hormones|hormones|mesh-ancestor
6176760|NCT01703741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6487244|NCT00575523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6487245|NCT00575523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487246|NCT00575523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6487247|NCT00575523|Respiratory System Agents|respiratory system agents|mesh-ancestor
5572915|NCT03913559|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5572916|NCT03913559|Histamine Antagonists|histamine antagonists|mesh-ancestor
5572917|NCT03913559|Histamine Agents|histamine agents|mesh-ancestor
6487248|NCT00575523|Mydriatics|mydriatics|mesh-ancestor
6487249|NCT00575523|Parasympatholytics|parasympatholytics|mesh-ancestor
6487250|NCT00575523|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5572918|NCT03913559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5572919|NCT03913559|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5572920|NCT03913559|Antipruritics|antipruritics|mesh-ancestor
5572921|NCT03913559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5572922|NCT03913559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5572923|NCT03913468|Ascorbic Acid|ascorbic acid|mesh-list
6487251|NCT00575523|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6487252|NCT00575523|Cholinergic Agents|cholinergic agents|mesh-ancestor
6487253|NCT00575523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6487254|NCT00575523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6487255|NCT00575549|Dobutamine|dobutamine|mesh-list
6487256|NCT00575549|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5572924|NCT03913468|Antioxidants|antioxidants|mesh-ancestor
5572925|NCT03913468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572926|NCT03913468|Protective Agents|protective agents|mesh-ancestor
5572927|NCT03913468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572928|NCT03913468|Vitamins|vitamins|mesh-ancestor
5572929|NCT03913468|Micronutrients|micronutrients|mesh-ancestor
5572930|NCT03913442|Colchicine|colchicine|mesh-list
5572931|NCT03913442|Gout Suppressants|gout suppressants|mesh-ancestor
5572932|NCT03913442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5572933|NCT03913442|Tubulin Modulators|tubulin modulators|mesh-ancestor
5572934|NCT03913442|Antimitotic Agents|antimitotic agents|mesh-ancestor
5572935|NCT03913442|Mitosis Modulators|mitosis modulators|mesh-ancestor
5572936|NCT03913442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572937|NCT03913442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5572938|NCT03913234|Trastuzumab|trastuzumab|mesh-list
5572939|NCT03913234|Letrozole|letrozole|mesh-list
5572940|NCT03913234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5572941|NCT03913234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5572942|NCT03913234|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5572943|NCT03913234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5572944|NCT03913234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5572945|NCT03913234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572946|NCT03913234|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5572947|NCT03913234|Hormone Antagonists|hormone antagonists|mesh-ancestor
5572948|NCT03913234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5572949|NCT03913234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572950|NCT03913221|Caffeine|caffeine|mesh-list
5572951|NCT03913221|Caffeine citrate|caffeine citrate|mesh-list
5572952|NCT03913221|Citric Acid|citric acid|mesh-list
5572953|NCT03913221|Sodium Citrate|sodium citrate|mesh-list
5572954|NCT03913221|Anticoagulants|anticoagulants|mesh-ancestor
5572955|NCT03913221|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5572956|NCT03913221|Chelating Agents|chelating agents|mesh-ancestor
5572957|NCT03913221|Sequestering Agents|sequestering agents|mesh-ancestor
5572958|NCT03913221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572959|NCT03913221|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6208008|NCT02123459|Cephalexin|cephalexin|mesh-list
5572960|NCT03913221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572961|NCT03913221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5572962|NCT03913221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6487257|NCT00575549|Sympathomimetics|sympathomimetics|mesh-ancestor
6487258|NCT00575549|Autonomic Agents|autonomic agents|mesh-ancestor
5572963|NCT03913221|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5572964|NCT03913221|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5572965|NCT03913221|Purinergic Agents|purinergic agents|mesh-ancestor
6487259|NCT00575549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6487260|NCT00575549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487261|NCT00575549|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6487262|NCT00575549|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6487263|NCT00575549|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5572966|NCT03913221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5572967|NCT03912974|Citalopram|citalopram|mesh-list
5572968|NCT03912974|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5572969|NCT03912974|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5572970|NCT03912974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5572971|NCT03912974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572972|NCT03912974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5572973|NCT03912974|Serotonin Agents|serotonin agents|mesh-ancestor
5572974|NCT03912974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572975|NCT03912974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6487264|NCT00575549|Adrenergic Agents|adrenergic agents|mesh-ancestor
6487265|NCT00575549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6487266|NCT00575549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176761|NCT01703741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176762|NCT01703845|Tiotropium Bromide|tiotropium bromide|mesh-list
6176763|NCT01703845|Olodaterol|olodaterol|mesh-list
6176764|NCT01703845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6176765|NCT01703845|Autonomic Agents|autonomic agents|mesh-ancestor
6176766|NCT01703845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6176767|NCT01703845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176768|NCT01703845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6176769|NCT01703845|Respiratory System Agents|respiratory system agents|mesh-ancestor
6487267|NCT00575549|Protective Agents|protective agents|mesh-ancestor
6487268|NCT00575601|Simvastatin|simvastatin|mesh-list
5572976|NCT03912974|Antidepressive Agents|antidepressive agents|mesh-ancestor
5572977|NCT03912974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5572978|NCT03912857|Apatinib|apatinib|mesh-list
5572979|NCT03912857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5572980|NCT03912857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5572981|NCT03912857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5572982|NCT03912857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604349|NCT04965597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5604350|NCT04950426|Propranolol|propranolol|mesh-list
5604351|NCT04950426|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5604352|NCT04950426|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5604353|NCT04950426|Adrenergic Agents|adrenergic agents|mesh-ancestor
5604354|NCT04950426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5604355|NCT04950426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604356|NCT04950426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604357|NCT04950426|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5604358|NCT04950426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5604359|NCT04950426|Vasodilator Agents|vasodilator agents|mesh-ancestor
5604360|NCT04950322|Leucovorin|leucovorin|mesh-list
5604361|NCT04950322|Fluorouracil|fluorouracil|mesh-list
5604362|NCT04950322|Oxaliplatin|oxaliplatin|mesh-list
5604363|NCT04950322|Antimetabolites|antimetabolites|mesh-ancestor
5604364|NCT04950322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604365|NCT04950322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5604366|NCT04950322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5604367|NCT04950322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5604368|NCT04950322|Immunologic Factors|immunologic factors|mesh-ancestor
5604369|NCT04950322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604370|NCT04950322|Antidotes|antidotes|mesh-ancestor
5604371|NCT04950322|Protective Agents|protective agents|mesh-ancestor
5604372|NCT04950322|Vitamin B Complex|vitamin b complex|mesh-ancestor
5604373|NCT04950322|Vitamins|vitamins|mesh-ancestor
5604374|NCT04950322|Micronutrients|micronutrients|mesh-ancestor
5604375|NCT04939636|Vitamin D|vitamin d|mesh-list
5604376|NCT04939636|Ergocalciferols|ergocalciferols|mesh-list
5604377|NCT04939636|Cholecalciferol|cholecalciferol|mesh-list
5604378|NCT04939636|Vitamins|vitamins|mesh-list
5604379|NCT04939636|Micronutrients|micronutrients|mesh-ancestor
5604380|NCT04939636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604381|NCT04939636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6487269|NCT00575601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6176770|NCT01703845|Parasympatholytics|parasympatholytics|mesh-ancestor
6176771|NCT01703845|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6176772|NCT01703845|Cholinergic Agents|cholinergic agents|mesh-ancestor
6176773|NCT01703845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6176774|NCT01703845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176775|NCT01703858|Pantoprazole|pantoprazole|mesh-list
6176776|NCT01703858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6176777|NCT01703858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6176778|NCT01703858|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6176779|NCT01703858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6176780|NCT01703858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6487270|NCT00575601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6487271|NCT00575601|Antimetabolites|antimetabolites|mesh-ancestor
6176781|NCT01704079|Calcifediol|calcifediol|mesh-list
6176782|NCT01704079|Vitamins|vitamins|mesh-ancestor
6176783|NCT01704079|Micronutrients|micronutrients|mesh-ancestor
6176784|NCT01704079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176785|NCT01704079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6176786|NCT01704261|Metformin|metformin|mesh-list
6176787|NCT01704261|Glimepiride|glimepiride|mesh-list
6176788|NCT01704261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6176789|NCT01704261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176790|NCT01704261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6176791|NCT01704261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6176792|NCT01704261|Immunologic Factors|immunologic factors|mesh-ancestor
6176793|NCT01704287|Paclitaxel|paclitaxel|mesh-list
6176794|NCT01704287|Carboplatin|carboplatin|mesh-list
6176795|NCT01704287|Pembrolizumab|pembrolizumab|mesh-list
6176796|NCT01704287|Temozolomide|temozolomide|mesh-list
6176797|NCT01704287|Dacarbazine|dacarbazine|mesh-list
5572983|NCT03912909|Empagliflozin|empagliflozin|mesh-list
5572984|NCT03912909|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5572985|NCT03912909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572986|NCT03912909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5572987|NCT03912909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572988|NCT03913182|Apatinib|apatinib|mesh-list
5572989|NCT03913182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5572990|NCT03913182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6176798|NCT01704287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6176799|NCT01704287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6176800|NCT01704287|Tubulin Modulators|tubulin modulators|mesh-ancestor
6176801|NCT01704287|Antimitotic Agents|antimitotic agents|mesh-ancestor
6176802|NCT01704287|Mitosis Modulators|mitosis modulators|mesh-ancestor
6176803|NCT01704287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176804|NCT01704287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6176805|NCT01704287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6176806|NCT01704287|Alkylating Agents|alkylating agents|mesh-ancestor
6176807|NCT01704521|Ribavirin|ribavirin|mesh-list
6176808|NCT01704521|Antimetabolites|antimetabolites|mesh-ancestor
6176809|NCT01704521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176810|NCT01704521|Antiviral Agents|antiviral agents|mesh-ancestor
6176811|NCT01704521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6176812|NCT01704599|Vitamins|vitamins|mesh-list
6176813|NCT01704599|Folic Acid|folic acid|mesh-list
6176814|NCT01704599|Vitamin B 12|vitamin b 12|mesh-list
6176815|NCT01704599|Pyridoxine|pyridoxine|mesh-list
6176816|NCT01704599|Vitamin B 6|vitamin b 6|mesh-list
5572991|NCT03913182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5572992|NCT03913182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5572993|NCT03913052|Viscosupplements|viscosupplements|mesh-list
5572994|NCT03913052|Protective Agents|protective agents|mesh-ancestor
5572995|NCT03913052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5572996|NCT03912818|Gemcitabine|gemcitabine|mesh-list
5572997|NCT03912818|Carboplatin|carboplatin|mesh-list
5572998|NCT03912818|Doxorubicin|doxorubicin|mesh-list
5572999|NCT03912818|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5573000|NCT03912818|Methotrexate|methotrexate|mesh-list
5573001|NCT03912818|Durvalumab|durvalumab|mesh-list
5573002|NCT03912818|Daunorubicin|daunorubicin|mesh-list
6176817|NCT01704599|Vitamin B Complex|vitamin b complex|mesh-list
6176818|NCT01704599|Adalimumab|adalimumab|mesh-list
6176819|NCT01704599|Micronutrients|micronutrients|mesh-ancestor
6176820|NCT01704599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573003|NCT03912818|Vinblastine|vinblastine|mesh-list
5573004|NCT03912818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6176821|NCT01704599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6176822|NCT01704599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6176823|NCT01704599|Hematinics|hematinics|mesh-ancestor
6176824|NCT01704651|Alvimopan|alvimopan|mesh-list
6489027|NCT00588835|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5573005|NCT03912818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5573006|NCT03912818|Antimetabolites|antimetabolites|mesh-ancestor
5573007|NCT03912818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176825|NCT01704651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6176826|NCT01704755|Ribavirin|ribavirin|mesh-list
6176827|NCT01704755|Antimetabolites|antimetabolites|mesh-ancestor
6176828|NCT01704755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176829|NCT01704755|Antiviral Agents|antiviral agents|mesh-ancestor
6176830|NCT01704755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6176831|NCT01704781|Lenalidomide|lenalidomide|mesh-list
6176832|NCT01704781|Immunologic Factors|immunologic factors|mesh-ancestor
6176833|NCT01704781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176834|NCT01704781|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6176835|NCT01704781|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6176836|NCT01704781|Growth Substances|growth substances|mesh-ancestor
6176837|NCT01704781|Growth Inhibitors|growth inhibitors|mesh-ancestor
6176838|NCT01704781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6176839|NCT01705145|Ivacaftor|ivacaftor|mesh-list
6176840|NCT01705145|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6176841|NCT01705145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6176842|NCT01705145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176843|NCT01705236|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6176844|NCT01705236|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5573008|NCT03912818|Antiviral Agents|antiviral agents|mesh-ancestor
5573009|NCT03912818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5573010|NCT03912818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5573011|NCT03912818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5573012|NCT03912818|Immunologic Factors|immunologic factors|mesh-ancestor
5573013|NCT03912818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573014|NCT03912818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5573015|NCT03912818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5573016|NCT03912818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5573017|NCT03912818|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5573018|NCT03912818|Abortifacient Agents|abortifacient agents|mesh-ancestor
5573019|NCT03912818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5573020|NCT03912818|Dermatologic Agents|dermatologic agents|mesh-ancestor
5573021|NCT03912818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5573022|NCT03912818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5573023|NCT03912818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5573024|NCT03912818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5573025|NCT03912818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5573026|NCT03912818|Tubulin Modulators|tubulin modulators|mesh-ancestor
5573027|NCT03912818|Antimitotic Agents|antimitotic agents|mesh-ancestor
5573028|NCT03912818|Mitosis Modulators|mitosis modulators|mesh-ancestor
5573029|NCT03912766|Arginine Vasopressin|arginine vasopressin|mesh-list
5573030|NCT03912766|Hemostatics|hemostatics|mesh-ancestor
5573031|NCT03912766|Coagulants|coagulants|mesh-ancestor
5573032|NCT03912766|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5573033|NCT03912766|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5573034|NCT03912766|Natriuretic Agents|natriuretic agents|mesh-ancestor
5573035|NCT03912766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573036|NCT03912727|Thioctic Acid|thioctic acid|mesh-list
5573037|NCT03912727|Antioxidants|antioxidants|mesh-ancestor
5573038|NCT03912727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573039|NCT03912727|Protective Agents|protective agents|mesh-ancestor
5573040|NCT03912727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573041|NCT03912727|Vitamin B Complex|vitamin b complex|mesh-ancestor
5573042|NCT03912727|Vitamins|vitamins|mesh-ancestor
5573043|NCT03912727|Micronutrients|micronutrients|mesh-ancestor
5573044|NCT03912740|Dexmedetomidine|dexmedetomidine|mesh-list
5573045|NCT03912740|Remifentanil|remifentanil|mesh-list
5573046|NCT03912740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5573047|NCT03912740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5573048|NCT03912740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573049|NCT03912740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5573050|NCT03912740|Analgesics|analgesics|mesh-ancestor
5573051|NCT03912740|Sensory System Agents|sensory system agents|mesh-ancestor
5573052|NCT03912740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5573053|NCT03912740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5573054|NCT03912740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6176845|NCT01705236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176846|NCT01705236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6176847|NCT01705236|Immunologic Factors|immunologic factors|mesh-ancestor
5573055|NCT03912740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5573056|NCT03912740|Adrenergic Agents|adrenergic agents|mesh-ancestor
5573057|NCT03912740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5573058|NCT03912740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573059|NCT03912740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6176848|NCT01705236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176849|NCT01705288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
6176850|NCT01705288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
6176851|NCT01705288|Morphine|morphine|mesh-list
6176852|NCT01705288|Narcotics|narcotics|mesh-list
6176853|NCT01705288|Anesthetics|anesthetics|mesh-list
6176854|NCT01705288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6176855|NCT01705288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176856|NCT01705288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6176857|NCT01705288|Analgesics|analgesics|mesh-ancestor
6176858|NCT01705288|Sensory System Agents|sensory system agents|mesh-ancestor
6176859|NCT01705288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6176860|NCT01705288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6176861|NCT01705288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6176862|NCT01705496|Fialuridine|fialuridine|mesh-list
6176863|NCT01705496|Antiviral Agents|antiviral agents|mesh-ancestor
6176864|NCT01705496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5573060|NCT03912740|Narcotics|narcotics|mesh-ancestor
5573061|NCT03912402|Paclitaxel|paclitaxel|mesh-list
5573062|NCT03912402|Bevacizumab|bevacizumab|mesh-list
6176865|NCT01705496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6176866|NCT01705496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6176867|NCT01705496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176868|NCT01705509|Ranolazine|ranolazine|mesh-list
6176869|NCT01705509|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6176870|NCT01705509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6176871|NCT01705509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176872|NCT01705574|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6176873|NCT01705574|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6176874|NCT01705574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5573063|NCT03912402|Carboplatin|carboplatin|mesh-list
6176875|NCT01705574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6176876|NCT01705574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176877|NCT01705574|Antiviral Agents|antiviral agents|mesh-ancestor
6176878|NCT01705574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6176879|NCT01705574|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6176880|NCT01705574|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6176881|NCT01705587|Teriparatide|teriparatide|mesh-list
6176882|NCT01705587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6176883|NCT01705587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176884|NCT01705587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6176885|NCT01705691|Paclitaxel|paclitaxel|mesh-list
6176886|NCT01705691|Cyclophosphamide|cyclophosphamide|mesh-list
6176887|NCT01705691|Doxorubicin|doxorubicin|mesh-list
6176888|NCT01705691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6176889|NCT01705691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6176890|NCT01705691|Tubulin Modulators|tubulin modulators|mesh-ancestor
6176891|NCT01705691|Antimitotic Agents|antimitotic agents|mesh-ancestor
6176892|NCT01705691|Mitosis Modulators|mitosis modulators|mesh-ancestor
6176893|NCT01705691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176894|NCT01705691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6176895|NCT01705691|Immunologic Factors|immunologic factors|mesh-ancestor
6176896|NCT01705691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176897|NCT01705691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5573064|NCT03912402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5573065|NCT03912402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5573066|NCT03912402|Tubulin Modulators|tubulin modulators|mesh-ancestor
5573067|NCT03912402|Antimitotic Agents|antimitotic agents|mesh-ancestor
5573068|NCT03912402|Mitosis Modulators|mitosis modulators|mesh-ancestor
5573069|NCT03912402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573070|NCT03912402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5573071|NCT03912402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5573072|NCT03912402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5573073|NCT03912402|Growth Substances|growth substances|mesh-ancestor
5573074|NCT03912402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573075|NCT03912402|Growth Inhibitors|growth inhibitors|mesh-ancestor
5573076|NCT03912389|Carboplatin|carboplatin|mesh-list
5573077|NCT03912389|Pemetrexed|pemetrexed|mesh-list
5573078|NCT03912389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5573079|NCT03912389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5573080|NCT03912389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573081|NCT03912389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5573082|NCT03912389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5573083|NCT03912220|Niacinamide|niacinamide|mesh-list
5573084|NCT03912220|Niacin|niacin|mesh-list
5573085|NCT03912220|Nicotinic Acids|nicotinic acids|mesh-list
5573086|NCT03912220|Vitamin B Complex|vitamin b complex|mesh-ancestor
5573087|NCT03912220|Vitamins|vitamins|mesh-ancestor
5573088|NCT03912220|Micronutrients|micronutrients|mesh-ancestor
5573089|NCT03912220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573090|NCT03912220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5573091|NCT03912220|Antimetabolites|antimetabolites|mesh-ancestor
5573092|NCT03912220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573093|NCT03912220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5573094|NCT03912220|Vasodilator Agents|vasodilator agents|mesh-ancestor
5573095|NCT03912415|Paclitaxel|paclitaxel|mesh-list
5573096|NCT03912415|Bevacizumab|bevacizumab|mesh-list
5573097|NCT03912415|Carboplatin|carboplatin|mesh-list
6176898|NCT01705691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6176899|NCT01705691|Alkylating Agents|alkylating agents|mesh-ancestor
6176900|NCT01705691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6176901|NCT01705691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6176902|NCT01705691|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6176903|NCT01705691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6176904|NCT01705691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6176905|NCT01705964|Epinephrine|epinephrine|mesh-list
6176906|NCT01705964|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5573098|NCT03912415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5573099|NCT03912415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5573100|NCT03912415|Tubulin Modulators|tubulin modulators|mesh-ancestor
5573101|NCT03912415|Antimitotic Agents|antimitotic agents|mesh-ancestor
5573102|NCT03912415|Mitosis Modulators|mitosis modulators|mesh-ancestor
5573103|NCT03912415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573104|NCT03912415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5573105|NCT03912415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5573106|NCT03912415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5573107|NCT03912415|Growth Substances|growth substances|mesh-ancestor
6176907|NCT01705964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6176908|NCT01705964|Adrenergic Agents|adrenergic agents|mesh-ancestor
6176909|NCT01705964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6176910|NCT01705964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176911|NCT01705964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176912|NCT01705964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6176913|NCT01705964|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6176914|NCT01705964|Autonomic Agents|autonomic agents|mesh-ancestor
6176915|NCT01705964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6176916|NCT01705964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6176917|NCT01705964|Respiratory System Agents|respiratory system agents|mesh-ancestor
6176918|NCT01705964|Mydriatics|mydriatics|mesh-ancestor
6176919|NCT01705964|Sympathomimetics|sympathomimetics|mesh-ancestor
6176920|NCT01705964|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6176921|NCT01705977|Belimumab|belimumab|mesh-list
6176922|NCT01705977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6176923|NCT01705977|Immunologic Factors|immunologic factors|mesh-ancestor
6176924|NCT01705977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176925|NCT01706146|Rivaroxaban|rivaroxaban|mesh-list
6176926|NCT01706146|Apixaban|apixaban|mesh-list
6176927|NCT01706146|Dabigatran|dabigatran|mesh-list
6176928|NCT01706146|Anticoagulants|anticoagulants|mesh-list
6176929|NCT01706146|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6176930|NCT01706146|Antithrombins|antithrombins|mesh-ancestor
6176931|NCT01706146|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6176932|NCT01706146|Protease Inhibitors|protease inhibitors|mesh-ancestor
6176933|NCT01706146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6176934|NCT01706146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176935|NCT01706198|Fluticasone|fluticasone|mesh-list
6176936|NCT01706198|Xhance|xhance|mesh-list
6176937|NCT01706198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6176938|NCT01706198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6176939|NCT01706198|Autonomic Agents|autonomic agents|mesh-ancestor
6176940|NCT01706198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6176941|NCT01706198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487272|NCT00575601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573108|NCT03912415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176942|NCT01706198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6176943|NCT01706198|Respiratory System Agents|respiratory system agents|mesh-ancestor
5573109|NCT03912415|Growth Inhibitors|growth inhibitors|mesh-ancestor
5573110|NCT03912285|Losartan|losartan|mesh-list
5573111|NCT03912285|Amlodipine|amlodipine|mesh-list
5573112|NCT03912285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5573113|NCT03912285|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5573114|NCT03912285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5573115|NCT03912285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573116|NCT03912285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5573117|NCT03912285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573118|NCT03912285|Vasodilator Agents|vasodilator agents|mesh-ancestor
5573119|NCT03912285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6176944|NCT01706198|Dermatologic Agents|dermatologic agents|mesh-ancestor
6176945|NCT01706198|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6176946|NCT01706250|Salicylic Acid|salicylic acid|mesh-list
6176947|NCT01706250|Salicylates|salicylates|mesh-list
6176948|NCT01706250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6176949|NCT01706250|Antifungal Agents|antifungal agents|mesh-ancestor
6176950|NCT01706250|Keratolytic Agents|keratolytic agents|mesh-ancestor
6176951|NCT01706250|Dermatologic Agents|dermatologic agents|mesh-ancestor
6176952|NCT01706250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6176953|NCT01706250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6176954|NCT01706250|Analgesics|analgesics|mesh-ancestor
5573120|NCT03912285|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5573121|NCT03912285|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5573122|NCT03911817|Midodrine|midodrine|mesh-list
5573123|NCT03911817|Sympathomimetics|sympathomimetics|mesh-ancestor
5573124|NCT03911817|Autonomic Agents|autonomic agents|mesh-ancestor
5573125|NCT03911817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5573126|NCT03911817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573127|NCT03911817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5573128|NCT03911817|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5573129|NCT03911817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5573130|NCT03911817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5573131|NCT03911817|Adrenergic Agents|adrenergic agents|mesh-ancestor
5573132|NCT03911817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5573133|NCT03911817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573134|NCT03911648|Lidocaine|lidocaine|mesh-list
5573135|NCT03911648|Bupivacaine|bupivacaine|mesh-list
5573136|NCT03911648|Anesthetics, Local|anesthetics, local|mesh-ancestor
5573137|NCT03911648|Anesthetics|anesthetics|mesh-ancestor
5573138|NCT03911648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5573139|NCT03911648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573140|NCT03911648|Sensory System Agents|sensory system agents|mesh-ancestor
5573141|NCT03911648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5573142|NCT03911648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5573143|NCT03911648|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5573144|NCT03911648|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5573145|NCT03911648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6176955|NCT01706250|Sensory System Agents|sensory system agents|mesh-ancestor
6176956|NCT01706250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6176957|NCT01706250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176958|NCT01706250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5573146|NCT03911648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573147|NCT03911440|Azithromycin|azithromycin|mesh-list
5573148|NCT03911440|Doxycycline|doxycycline|mesh-list
5573149|NCT03911440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6176959|NCT01706250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6176960|NCT01706250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6176961|NCT01706250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6176962|NCT01706250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176963|NCT01706263|Salicylic Acid|salicylic acid|mesh-list
6176964|NCT01706263|Salicylates|salicylates|mesh-list
6176965|NCT01706263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6176966|NCT01706263|Antifungal Agents|antifungal agents|mesh-ancestor
6176967|NCT01706263|Keratolytic Agents|keratolytic agents|mesh-ancestor
6176968|NCT01706263|Dermatologic Agents|dermatologic agents|mesh-ancestor
6176969|NCT01706263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6176970|NCT01706263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6176971|NCT01706263|Analgesics|analgesics|mesh-ancestor
6176972|NCT01706263|Sensory System Agents|sensory system agents|mesh-ancestor
6176973|NCT01706263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6176974|NCT01706263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176975|NCT01706263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6176976|NCT01706263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6487273|NCT00575601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6487274|NCT00575601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6487275|NCT00575601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6487276|NCT00575614|Prucalopride|prucalopride|mesh-list
6487277|NCT00575614|Laxatives|laxatives|mesh-ancestor
6487278|NCT00575614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6487279|NCT00575614|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
6487280|NCT00575614|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6487281|NCT00575614|Serotonin Agents|serotonin agents|mesh-ancestor
6487282|NCT00575614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6487283|NCT00575614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6487284|NCT00575614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487285|NCT00575627|Interferons|interferons|mesh-list
6487286|NCT00575627|Ribavirin|ribavirin|mesh-list
6487287|NCT00575627|Interferon-alpha|interferon-alpha|mesh-list
6487288|NCT00575627|Interferon alpha-2|interferon alpha-2|mesh-list
6487289|NCT00575627|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6487290|NCT00575627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6487291|NCT00575627|Antiviral Agents|antiviral agents|mesh-ancestor
6487292|NCT00575627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6487293|NCT00575627|Antimetabolites|antimetabolites|mesh-ancestor
6487294|NCT00575627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6487295|NCT00575627|Immunologic Factors|immunologic factors|mesh-ancestor
6487296|NCT00575627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487297|NCT00575640|Hydralazine|hydralazine|mesh-list
6487298|NCT00575640|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6487299|NCT00575640|Vasodilator Agents|vasodilator agents|mesh-ancestor
5573150|NCT03911440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6176977|NCT01706263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5573151|NCT03911440|Antimalarials|antimalarials|mesh-ancestor
5573152|NCT03911440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5573153|NCT03911440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5573154|NCT03911336|Acetaminophen|acetaminophen|mesh-list
5573155|NCT03911336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
5573156|NCT03911336|Ketoprofen|ketoprofen|mesh-list
5573157|NCT03911336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5573158|NCT03911336|Analgesics|analgesics|mesh-ancestor
5573159|NCT03911336|Sensory System Agents|sensory system agents|mesh-ancestor
5573160|NCT03911336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5573161|NCT03911336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573162|NCT03911336|Antipyretics|antipyretics|mesh-ancestor
5573163|NCT03911336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6176978|NCT01706263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6176979|NCT01706263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176980|NCT01706328|Fluticasone|fluticasone|mesh-list
6176981|NCT01706328|Xhance|xhance|mesh-list
6176982|NCT01706328|Albuterol|albuterol|mesh-list
6176983|NCT01706328|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6176984|NCT01706328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6176985|NCT01706328|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6176986|NCT01706328|Autonomic Agents|autonomic agents|mesh-ancestor
6176987|NCT01706328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6176988|NCT01706328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6176989|NCT01706328|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6176990|NCT01706328|Respiratory System Agents|respiratory system agents|mesh-ancestor
6176991|NCT01706328|Dermatologic Agents|dermatologic agents|mesh-ancestor
6176992|NCT01706328|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6176993|NCT01706328|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6176994|NCT01706328|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6176995|NCT01706328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6176996|NCT01706328|Adrenergic Agents|adrenergic agents|mesh-ancestor
6176997|NCT01706328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6176998|NCT01706328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6176999|NCT01706328|Tocolytic Agents|tocolytic agents|mesh-ancestor
6177000|NCT01706328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6177001|NCT01706575|Interferons|interferons|mesh-list
6177002|NCT01706575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6177003|NCT01706575|Antiviral Agents|antiviral agents|mesh-ancestor
6177004|NCT01706575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5573164|NCT03911336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5573165|NCT03911336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5573166|NCT03911336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5573167|NCT03911336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573168|NCT03911570|Acetaminophen|acetaminophen|mesh-list
5573169|NCT03911570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
6177005|NCT01706588|Diclofenac|diclofenac|mesh-list
6489028|NCT00588913|Zoledronic Acid|zoledronic acid|mesh-list
5573170|NCT03911570|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
5573171|NCT03911570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5573172|NCT03911570|Analgesics|analgesics|mesh-ancestor
5573173|NCT03911570|Sensory System Agents|sensory system agents|mesh-ancestor
5573174|NCT03911570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5573175|NCT03911570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573176|NCT03911570|Antipyretics|antipyretics|mesh-ancestor
5573177|NCT03911570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5573178|NCT03911557|Durvalumab|durvalumab|mesh-list
5573179|NCT03911557|Tremelimumab|tremelimumab|mesh-list
5573180|NCT03911557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5573181|NCT03911557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6177006|NCT01706588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6177007|NCT01706588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6177008|NCT01706588|Analgesics|analgesics|mesh-ancestor
6177009|NCT01706588|Sensory System Agents|sensory system agents|mesh-ancestor
6177010|NCT01706588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6177011|NCT01706588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177012|NCT01706588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6177013|NCT01706588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6177014|NCT01706588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6177015|NCT01706588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6177016|NCT01706588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177017|NCT01706666|Dexamethasone|dexamethasone|mesh-list
6487300|NCT00575718|Nicotine|nicotine|mesh-list
6487301|NCT00575718|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6487302|NCT00575718|Autonomic Agents|autonomic agents|mesh-ancestor
6487303|NCT00575718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6487304|NCT00575718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177018|NCT01706666|Cyclophosphamide|cyclophosphamide|mesh-list
6177019|NCT01706666|Lenalidomide|lenalidomide|mesh-list
6487305|NCT00575718|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6487306|NCT00575718|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6487307|NCT00575718|Cholinergic Agents|cholinergic agents|mesh-ancestor
6177020|NCT01706666|Bortezomib|bortezomib|mesh-list
6177021|NCT01706666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6487308|NCT00575718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6177022|NCT01706666|Immunologic Factors|immunologic factors|mesh-ancestor
6177023|NCT01706666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177024|NCT01706666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6177025|NCT01706666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5573187|NCT03911414|Inositol|inositol|mesh-list
5573188|NCT03911414|Acetylcysteine|acetylcysteine|mesh-list
5573189|NCT03911414|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5573190|NCT03911414|Antiviral Agents|antiviral agents|mesh-ancestor
5573191|NCT03911414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5573192|NCT03911414|Expectorants|expectorants|mesh-ancestor
5573193|NCT03911414|Respiratory System Agents|respiratory system agents|mesh-ancestor
5573194|NCT03911414|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5573195|NCT03911414|Antioxidants|antioxidants|mesh-ancestor
5573196|NCT03911414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573197|NCT03911414|Protective Agents|protective agents|mesh-ancestor
5573198|NCT03911414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573199|NCT03911414|Antidotes|antidotes|mesh-ancestor
5573200|NCT03911414|Vitamin B Complex|vitamin b complex|mesh-ancestor
5573201|NCT03911414|Vitamins|vitamins|mesh-ancestor
5573202|NCT03911414|Micronutrients|micronutrients|mesh-ancestor
5573203|NCT03911271|Atropine|atropine|mesh-list
5573204|NCT03911271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5573205|NCT03911271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5573206|NCT03911271|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5573207|NCT03911271|Autonomic Agents|autonomic agents|mesh-ancestor
5573208|NCT03911271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5573209|NCT03911271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573210|NCT03911271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5573211|NCT03911271|Respiratory System Agents|respiratory system agents|mesh-ancestor
6489029|NCT00588913|Aldesleukin|aldesleukin|mesh-list
6177026|NCT01706666|Alkylating Agents|alkylating agents|mesh-ancestor
6177027|NCT01706666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177028|NCT01706666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6177029|NCT01706666|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6177030|NCT01706666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6177031|NCT01706666|Antiemetics|antiemetics|mesh-ancestor
6177032|NCT01706666|Autonomic Agents|autonomic agents|mesh-ancestor
6177033|NCT01706666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6177034|NCT01706666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6670566|NCT01544140|Anesthetics|anesthetics|mesh-ancestor
6670567|NCT01544140|GABA Modulators|gaba modulators|mesh-ancestor
6670568|NCT01544140|GABA Agents|gaba agents|mesh-ancestor
6670569|NCT01544140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6670570|NCT01544140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670571|NCT01544192|Tocopherols|tocopherols|mesh-list
6670572|NCT01544192|Vitamin E|vitamin e|mesh-list
6670573|NCT01544192|Tocotrienols|tocotrienols|mesh-list
6670574|NCT01544192|alpha-Tocopherol|alpha-tocopherol|mesh-list
5573212|NCT03911271|Mydriatics|mydriatics|mesh-ancestor
6177035|NCT01706666|Glucocorticoids|glucocorticoids|mesh-ancestor
6177036|NCT01706666|Hormones|hormones|mesh-ancestor
6177037|NCT01706666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6177038|NCT01706666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6177039|NCT01706666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6177040|NCT01706666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6177041|NCT01706666|Growth Substances|growth substances|mesh-ancestor
6177042|NCT01706666|Growth Inhibitors|growth inhibitors|mesh-ancestor
6177043|NCT01706926|Mavrilimumab|mavrilimumab|mesh-list
6177044|NCT01706926|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6177045|NCT01706926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6177046|NCT01706926|Immunologic Factors|immunologic factors|mesh-ancestor
6177047|NCT01706926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177048|NCT01706952|Epinephrine|epinephrine|mesh-list
6177049|NCT01706952|Racepinephrine|racepinephrine|mesh-list
6177050|NCT01706952|Cocaine|cocaine|mesh-list
6177051|NCT01706952|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6177052|NCT01706952|Epinephryl borate|epinephryl borate|mesh-list
6177053|NCT01706952|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6177054|NCT01706952|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6177055|NCT01706952|Adrenergic Agents|adrenergic agents|mesh-ancestor
6177056|NCT01706952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6177057|NCT01706952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177058|NCT01706952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177059|NCT01706952|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6177060|NCT01706952|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6177061|NCT01706952|Autonomic Agents|autonomic agents|mesh-ancestor
6177062|NCT01706952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6177063|NCT01706952|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6177064|NCT01706952|Respiratory System Agents|respiratory system agents|mesh-ancestor
6177065|NCT01706952|Mydriatics|mydriatics|mesh-ancestor
5573213|NCT03911271|Parasympatholytics|parasympatholytics|mesh-ancestor
5573214|NCT03911271|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5573215|NCT03911271|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5573216|NCT03911271|Cholinergic Agents|cholinergic agents|mesh-ancestor
5573217|NCT03911271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5573218|NCT03911271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573219|NCT03910998|Rocuronium|rocuronium|mesh-list
5573220|NCT03910998|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5573221|NCT03910998|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5573222|NCT03910998|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5573223|NCT03910998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5573224|NCT03910998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177066|NCT01706952|Sympathomimetics|sympathomimetics|mesh-ancestor
6177067|NCT01706952|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6177068|NCT01706952|Anesthetics, Local|anesthetics, local|mesh-ancestor
6177069|NCT01706952|Anesthetics|anesthetics|mesh-ancestor
6177070|NCT01706952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6177071|NCT01706952|Sensory System Agents|sensory system agents|mesh-ancestor
6177072|NCT01706952|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6177073|NCT01706952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6177074|NCT01706952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6177075|NCT01706952|Dopamine Agents|dopamine agents|mesh-ancestor
6177076|NCT01707004|Vidarabine|vidarabine|mesh-list
6177077|NCT01707004|Mycophenolic Acid|mycophenolic acid|mesh-list
6177078|NCT01707004|Cyclophosphamide|cyclophosphamide|mesh-list
6177079|NCT01707004|Busulfan|busulfan|mesh-list
6670575|NCT01544192|Antioxidants|antioxidants|mesh-list
5573225|NCT03910803|Brodalumab|brodalumab|mesh-list
5573226|NCT03910803|Dermatologic Agents|dermatologic agents|mesh-ancestor
5573227|NCT03910647|Pantoprazole|pantoprazole|mesh-list
5573228|NCT03910647|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5573229|NCT03910647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5573230|NCT03910647|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5573231|NCT03910647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5573232|NCT03910647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573233|NCT03910634|Carboplatin|carboplatin|mesh-list
6177080|NCT01707004|Fludarabine|fludarabine|mesh-list
6177081|NCT01707004|Fludarabine phosphate|fludarabine phosphate|mesh-list
6177082|NCT01707004|Azacitidine|azacitidine|mesh-list
6177083|NCT01707004|Decitabine|decitabine|mesh-list
6177084|NCT01707004|Tacrolimus|tacrolimus|mesh-list
6177085|NCT01707004|Lenograstim|lenograstim|mesh-list
6177086|NCT01707004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6177087|NCT01707004|Immunologic Factors|immunologic factors|mesh-ancestor
6177088|NCT01707004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177089|NCT01707004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6487309|NCT00575718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6487310|NCT00575796|Vinblastine|vinblastine|mesh-list
6487311|NCT00575796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6487312|NCT00575796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6487313|NCT00575796|Tubulin Modulators|tubulin modulators|mesh-ancestor
6487314|NCT00575796|Antimitotic Agents|antimitotic agents|mesh-ancestor
6487315|NCT00575796|Mitosis Modulators|mitosis modulators|mesh-ancestor
6487316|NCT00575796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6487317|NCT00575835|Vitamin D|vitamin d|mesh-list
6487318|NCT00575835|Ergocalciferols|ergocalciferols|mesh-list
6487319|NCT00575835|Cholecalciferol|cholecalciferol|mesh-list
6487320|NCT00575835|Vitamins|vitamins|mesh-list
6487321|NCT00575835|Micronutrients|micronutrients|mesh-ancestor
6487322|NCT00575835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177090|NCT01707004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6177091|NCT01707004|Alkylating Agents|alkylating agents|mesh-ancestor
6177092|NCT01707004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573234|NCT03910634|Fluorouracil|fluorouracil|mesh-list
5573235|NCT03910634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5573236|NCT03910634|Antimetabolites|antimetabolites|mesh-ancestor
5573237|NCT03910634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573238|NCT03910634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5573239|NCT03910634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5573240|NCT03910634|Immunologic Factors|immunologic factors|mesh-ancestor
5573241|NCT03910634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573242|NCT03910712|Trastuzumab|trastuzumab|mesh-list
5573243|NCT03910712|Letrozole|letrozole|mesh-list
5573244|NCT03910712|Anastrozole|anastrozole|mesh-list
6177093|NCT01707004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6177094|NCT01707004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6177095|NCT01707004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6177096|NCT01707004|Antimetabolites|antimetabolites|mesh-ancestor
6177097|NCT01707004|Antiviral Agents|antiviral agents|mesh-ancestor
6177098|NCT01707004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6177099|NCT01707004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6177100|NCT01707004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6177101|NCT01707004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6177102|NCT01707004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6177103|NCT01707004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6177104|NCT01707004|Antitubercular Agents|antitubercular agents|mesh-ancestor
6177105|NCT01707004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6177106|NCT01707043|Calcitriol|calcitriol|mesh-list
5573245|NCT03910712|Exemestane|exemestane|mesh-list
5573246|NCT03910712|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5573247|NCT03910712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5573248|NCT03910712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5573249|NCT03910712|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5573250|NCT03910712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5573251|NCT03910712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573252|NCT03910712|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5573253|NCT03910712|Hormone Antagonists|hormone antagonists|mesh-ancestor
5573254|NCT03910712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5573255|NCT03910712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573256|NCT03910712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5573257|NCT03910556|Propofol|propofol|mesh-list
5573258|NCT03910556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6177107|NCT01707043|Betamethasone|betamethasone|mesh-list
6177108|NCT01707043|Betamethasone Valerate|betamethasone valerate|mesh-list
5573259|NCT03910556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5573260|NCT03910556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177109|NCT01707043|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
6177110|NCT01707043|Betamethasone benzoate|betamethasone benzoate|mesh-list
6177111|NCT01707043|Calcipotriene|calcipotriene|mesh-list
6177112|NCT01707043|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
6177113|NCT01707043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6177114|NCT01707043|Glucocorticoids|glucocorticoids|mesh-ancestor
6177115|NCT01707043|Hormones|hormones|mesh-ancestor
6177116|NCT01707043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6177117|NCT01707043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177118|NCT01707043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6177119|NCT01707043|Respiratory System Agents|respiratory system agents|mesh-ancestor
6177120|NCT01707043|Dermatologic Agents|dermatologic agents|mesh-ancestor
6177121|NCT01707043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6177122|NCT01707043|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
5573261|NCT03910556|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5573262|NCT03910556|Anesthetics, General|anesthetics, general|mesh-ancestor
5573263|NCT03910556|Anesthetics|anesthetics|mesh-ancestor
5573264|NCT03910543|Tofacitinib|tofacitinib|mesh-list
5573265|NCT03910543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6177123|NCT01707043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6177124|NCT01707043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177125|NCT01707043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6177126|NCT01707043|Vitamins|vitamins|mesh-ancestor
6177127|NCT01707043|Micronutrients|micronutrients|mesh-ancestor
6177128|NCT01707043|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6177129|NCT01707147|Linagliptin|linagliptin|mesh-list
6177130|NCT01707147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6177131|NCT01707147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177132|NCT01707147|Incretins|incretins|mesh-ancestor
6177133|NCT01707147|Hormones|hormones|mesh-ancestor
6177134|NCT01707147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5573266|NCT03910543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5573267|NCT03910543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573268|NCT03910361|Pioglitazone|pioglitazone|mesh-list
5573269|NCT03910361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5573270|NCT03910361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573271|NCT03910504|Rocuronium|rocuronium|mesh-list
5573272|NCT03910504|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5573273|NCT03910504|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5573274|NCT03910504|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5573275|NCT03910504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5573276|NCT03910504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573277|NCT03910101|Botulinum Toxins|botulinum toxins|mesh-list
6177135|NCT01707147|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6177136|NCT01707147|Protease Inhibitors|protease inhibitors|mesh-ancestor
6177137|NCT01707147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6177138|NCT01707147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177139|NCT01707225|Octreotide|octreotide|mesh-list
6177140|NCT01707225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6177141|NCT01707225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6177142|NCT01707225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6177143|NCT01707290|Ivacaftor|ivacaftor|mesh-list
6177144|NCT01707290|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6177145|NCT01707290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6177146|NCT01707290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177147|NCT01707381|Timolol|timolol|mesh-list
6177148|NCT01707381|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6177149|NCT01707381|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5573278|NCT03910101|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6177150|NCT01707381|Adrenergic Agents|adrenergic agents|mesh-ancestor
6177151|NCT01707381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6177152|NCT01707381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177153|NCT01707381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177154|NCT01707381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6177155|NCT01707381|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6177156|NCT01707420|Gabapentin|gabapentin|mesh-list
6177157|NCT01707420|Analgesics|analgesics|mesh-ancestor
6177158|NCT01707420|Sensory System Agents|sensory system agents|mesh-ancestor
6487323|NCT00575835|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6487324|NCT00575835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6487325|NCT00575848|Glycine|glycine|mesh-list
6487326|NCT00575848|Glycine Agents|glycine agents|mesh-ancestor
6487327|NCT00575848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5573279|NCT03910101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5573280|NCT03910101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177159|NCT01707420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6177160|NCT01707420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177161|NCT01707420|Anticonvulsants|anticonvulsants|mesh-ancestor
6177162|NCT01707420|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6177163|NCT01707420|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6177164|NCT01707420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6177165|NCT01707420|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6177166|NCT01707420|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6177167|NCT01707420|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6177168|NCT01707420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6177169|NCT01707420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177170|NCT01707420|Antimanic Agents|antimanic agents|mesh-ancestor
6177171|NCT01707667|Prucalopride|prucalopride|mesh-list
6177172|NCT01707667|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
6177173|NCT01707667|Laxatives|laxatives|mesh-ancestor
6177174|NCT01707667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6177175|NCT01707667|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
6177176|NCT01707667|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6177177|NCT01707667|Serotonin Agents|serotonin agents|mesh-ancestor
6177178|NCT01707667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6177179|NCT01707667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177180|NCT01707667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177181|NCT01708122|Fentanyl|fentanyl|mesh-list
6177182|NCT01708122|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6177183|NCT01708122|Narcotics|narcotics|mesh-ancestor
6177184|NCT01708122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6177185|NCT01708122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177186|NCT01708122|Analgesics|analgesics|mesh-ancestor
6177187|NCT01708122|Sensory System Agents|sensory system agents|mesh-ancestor
6177188|NCT01708122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6177189|NCT01708122|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6177190|NCT01708122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6177191|NCT01708122|Anesthetics, General|anesthetics, general|mesh-ancestor
6177192|NCT01708122|Anesthetics|anesthetics|mesh-ancestor
6177193|NCT01708278|Folic Acid|folic acid|mesh-list
6177194|NCT01708278|Quercetin|quercetin|mesh-list
6177195|NCT01708278|Hematinics|hematinics|mesh-ancestor
6177196|NCT01708278|Vitamin B Complex|vitamin b complex|mesh-ancestor
6177197|NCT01708278|Vitamins|vitamins|mesh-ancestor
6177198|NCT01708278|Micronutrients|micronutrients|mesh-ancestor
6177199|NCT01708278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177200|NCT01708278|Antioxidants|antioxidants|mesh-ancestor
6177201|NCT01708278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177202|NCT01708278|Protective Agents|protective agents|mesh-ancestor
5573281|NCT03910101|Cholinergic Agents|cholinergic agents|mesh-ancestor
6177203|NCT01708525|Deuterium Oxide|deuterium oxide|mesh-list
6177204|NCT01708525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6177205|NCT01708525|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6177206|NCT01708525|Protective Agents|protective agents|mesh-ancestor
6177207|NCT01708525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177208|NCT01708590|Brodalumab|brodalumab|mesh-list
6177209|NCT01708590|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6177210|NCT01708590|Dermatologic Agents|dermatologic agents|mesh-ancestor
6177211|NCT01708590|Immunologic Factors|immunologic factors|mesh-ancestor
6177212|NCT01708590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177213|NCT01708603|Ustekinumab|ustekinumab|mesh-list
6177214|NCT01708603|Brodalumab|brodalumab|mesh-list
6177215|NCT01708603|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6177216|NCT01708603|Dermatologic Agents|dermatologic agents|mesh-ancestor
6177217|NCT01708603|Immunologic Factors|immunologic factors|mesh-ancestor
6177218|NCT01708603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177219|NCT01708629|Ustekinumab|ustekinumab|mesh-list
6177220|NCT01708629|Brodalumab|brodalumab|mesh-list
6177221|NCT01708629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6177222|NCT01708629|Dermatologic Agents|dermatologic agents|mesh-ancestor
6177223|NCT01708629|Immunologic Factors|immunologic factors|mesh-ancestor
6177224|NCT01708629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177225|NCT01708902|Metformin|metformin|mesh-list
6177226|NCT01708902|Linagliptin|linagliptin|mesh-list
6177227|NCT01708902|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6177228|NCT01708902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177229|NCT01708902|Incretins|incretins|mesh-ancestor
6177230|NCT01708902|Hormones|hormones|mesh-ancestor
5573282|NCT03910101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5573283|NCT03910101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573284|NCT03910244|Pomalidomide|pomalidomide|mesh-list
5573285|NCT03910244|Immunologic Factors|immunologic factors|mesh-ancestor
5573286|NCT03910244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573287|NCT03910244|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5573288|NCT03910244|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5573289|NCT03910244|Growth Substances|growth substances|mesh-ancestor
5573290|NCT03910244|Growth Inhibitors|growth inhibitors|mesh-ancestor
5573291|NCT03910244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5573292|NCT03910231|Tolvaptan|tolvaptan|mesh-list
5573293|NCT03910231|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
5573294|NCT03910231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573295|NCT03910231|Natriuretic Agents|natriuretic agents|mesh-ancestor
5573296|NCT03910231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573297|NCT03910088|Acetaminophen|acetaminophen|mesh-list
5573298|NCT03910088|Hydrocortisone|hydrocortisone|mesh-list
5573299|NCT03910088|Diclofenac|diclofenac|mesh-list
6177231|NCT01708902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6177232|NCT01708902|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6177233|NCT01708902|Protease Inhibitors|protease inhibitors|mesh-ancestor
6177234|NCT01708902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6177235|NCT01708902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177236|NCT01708915|Nicotinic Acids|nicotinic acids|mesh-list
6177237|NCT01708915|Capsaicin|capsaicin|mesh-list
6177238|NCT01708915|Nonivamide|nonivamide|mesh-list
6177239|NCT01708915|Vitamin B Complex|vitamin b complex|mesh-ancestor
6177240|NCT01708915|Vitamins|vitamins|mesh-ancestor
6177241|NCT01708915|Micronutrients|micronutrients|mesh-ancestor
6177242|NCT01708915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177243|NCT01708915|Sensory System Agents|sensory system agents|mesh-ancestor
6177244|NCT01708915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6177245|NCT01708915|Antipruritics|antipruritics|mesh-ancestor
6487328|NCT00575848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6487329|NCT00575848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487330|NCT00575861|Zileuton|zileuton|mesh-list
6487331|NCT00575861|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6487332|NCT00575861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5573300|NCT03910088|Pregabalin|pregabalin|mesh-list
5573301|NCT03910088|Caffeine|caffeine|mesh-list
5573302|NCT03910088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5573303|NCT03910088|Analgesics|analgesics|mesh-ancestor
5573304|NCT03910088|Sensory System Agents|sensory system agents|mesh-ancestor
5573305|NCT03910088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5573306|NCT03910088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573307|NCT03910088|Antipyretics|antipyretics|mesh-ancestor
5573308|NCT03910088|Anticonvulsants|anticonvulsants|mesh-ancestor
6177246|NCT01708915|Dermatologic Agents|dermatologic agents|mesh-ancestor
6177247|NCT01708941|Interferons|interferons|mesh-list
6177248|NCT01708941|Interferon-alpha|interferon-alpha|mesh-list
6177249|NCT01708941|Interferon alpha-2|interferon alpha-2|mesh-list
6177250|NCT01708941|Ipilimumab|ipilimumab|mesh-list
6177251|NCT01708941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6177252|NCT01708941|Antiviral Agents|antiviral agents|mesh-ancestor
6177253|NCT01708941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6177254|NCT01708941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6177255|NCT01708941|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6177256|NCT01708941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177257|NCT01708941|Immunologic Factors|immunologic factors|mesh-ancestor
6177258|NCT01708941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177259|NCT01708954|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6177260|NCT01708954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6177261|NCT01708954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6177262|NCT01708954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6177263|NCT01708954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177264|NCT01709032|Deferasirox|deferasirox|mesh-list
6177265|NCT01709032|Deferiprone|deferiprone|mesh-list
6177266|NCT01709032|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6177267|NCT01709032|Chelating Agents|chelating agents|mesh-ancestor
6177268|NCT01709032|Sequestering Agents|sequestering agents|mesh-ancestor
6177269|NCT01709032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177270|NCT01709084|Tenofovir|tenofovir|mesh-list
6177271|NCT01709084|Emtricitabine|emtricitabine|mesh-list
6177272|NCT01709084|Efavirenz|efavirenz|mesh-list
6177273|NCT01709084|Rilpivirine|rilpivirine|mesh-list
6177274|NCT01709084|Antiviral Agents|antiviral agents|mesh-ancestor
6177275|NCT01709084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6177276|NCT01709084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6177277|NCT01709084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6177278|NCT01709084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6177279|NCT01709084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177280|NCT01709084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6177281|NCT01709084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5573309|NCT03910088|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5573310|NCT03910088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5573311|NCT03910088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573312|NCT03910088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5573313|NCT03910088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5573314|NCT03910088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5573315|NCT03910088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5573316|NCT03910088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6177282|NCT01709084|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6177283|NCT01709084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6177284|NCT01709084|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6177285|NCT01709084|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6177286|NCT01709084|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6177287|NCT01709084|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6177288|NCT01709110|Vitamin D|vitamin d|mesh-list
6177289|NCT01709110|Teriparatide|teriparatide|mesh-list
6177290|NCT01709110|Risedronic Acid|risedronic acid|mesh-list
6177291|NCT01709110|Calcium|calcium|mesh-list
5573317|NCT03910088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5573318|NCT03910088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5573319|NCT03910088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5573320|NCT03910088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5573321|NCT03910088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5573322|NCT03910088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5573323|NCT03910088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5573324|NCT03910088|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5573325|NCT03910088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5573326|NCT03910088|Purinergic Agents|purinergic agents|mesh-ancestor
6177292|NCT01709110|Vitamins|vitamins|mesh-ancestor
6177293|NCT01709110|Micronutrients|micronutrients|mesh-ancestor
6177294|NCT01709110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177295|NCT01709110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6177296|NCT01709110|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6487333|NCT00575861|Analgesics|analgesics|mesh-ancestor
6487334|NCT00575861|Sensory System Agents|sensory system agents|mesh-ancestor
6487335|NCT00575861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6487336|NCT00575861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487337|NCT00575861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5573327|NCT03910088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5573328|NCT03909776|Cisplatin|cisplatin|mesh-list
5573329|NCT03909776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5573330|NCT03909594|Ketamine|ketamine|mesh-list
5573331|NCT03909594|Bupivacaine|bupivacaine|mesh-list
5573332|NCT03909594|Anesthetics, Local|anesthetics, local|mesh-ancestor
5573333|NCT03909594|Anesthetics|anesthetics|mesh-ancestor
5573334|NCT03909594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5573335|NCT03909594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573336|NCT03909594|Sensory System Agents|sensory system agents|mesh-ancestor
5573337|NCT03909594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5573338|NCT03909594|Analgesics|analgesics|mesh-ancestor
5573339|NCT03909594|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5573340|NCT03909594|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5573341|NCT03909594|Anesthetics, General|anesthetics, general|mesh-ancestor
5573342|NCT03909594|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5573343|NCT03909594|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5573344|NCT03909594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6487338|NCT00575861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6487339|NCT00575861|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6487340|NCT00575861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6487341|NCT00575861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670576|NCT01544192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670577|NCT01544192|Protective Agents|protective agents|mesh-ancestor
6670578|NCT01544192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573345|NCT03909594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573346|NCT03909477|Xenon|xenon|mesh-list
6670579|NCT01544192|Vitamins|vitamins|mesh-ancestor
6670580|NCT01544192|Micronutrients|micronutrients|mesh-ancestor
6670581|NCT01544283|Triamcinolone|triamcinolone|mesh-list
6177297|NCT01709110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6177298|NCT01709110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6177299|NCT01709110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177300|NCT01709149|Riluzole|riluzole|mesh-list
6177301|NCT01709149|Anticonvulsants|anticonvulsants|mesh-ancestor
6177302|NCT01709149|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6487342|NCT00575861|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6487343|NCT00575861|Hormone Antagonists|hormone antagonists|mesh-ancestor
6487344|NCT00575861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6487345|NCT00575874|Pioglitazone|pioglitazone|mesh-list
6487346|NCT00575874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6177303|NCT01709149|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6177304|NCT01709149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6177305|NCT01709149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177306|NCT01709149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177307|NCT01709149|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6177308|NCT01709149|Protective Agents|protective agents|mesh-ancestor
6177309|NCT01709162|Ipilimumab|ipilimumab|mesh-list
6177310|NCT01709162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6177311|NCT01709162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6177312|NCT01709162|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6177313|NCT01709162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177314|NCT01709227|Furosemide|furosemide|mesh-list
6177315|NCT01709227|Diuretics|diuretics|mesh-ancestor
6177316|NCT01709227|Natriuretic Agents|natriuretic agents|mesh-ancestor
6177317|NCT01709227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487347|NCT00575874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487348|NCT00575913|Alfuzosin|alfuzosin|mesh-list
6487349|NCT00575913|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6177318|NCT01709227|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6177319|NCT01709227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6177320|NCT01709227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177321|NCT01709305|Metformin|metformin|mesh-list
6177322|NCT01709305|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6177323|NCT01709305|Glimepiride|glimepiride|mesh-list
6177324|NCT01709305|Acarbose|acarbose|mesh-list
6177325|NCT01709305|Repaglinide|repaglinide|mesh-list
6177326|NCT01709305|Gliclazide|gliclazide|mesh-list
6177327|NCT01709305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6177328|NCT01709305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177329|NCT01709305|Incretins|incretins|mesh-ancestor
6177330|NCT01709305|Hormones|hormones|mesh-ancestor
6177331|NCT01709305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6177332|NCT01709305|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6177333|NCT01709305|Protease Inhibitors|protease inhibitors|mesh-ancestor
5573347|NCT03909477|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5573348|NCT03909477|Anesthetics, General|anesthetics, general|mesh-ancestor
5573349|NCT03909477|Anesthetics|anesthetics|mesh-ancestor
5573350|NCT03909477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5573351|NCT03909477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573352|NCT03909724|Sunitinib|sunitinib|mesh-list
5573353|NCT03909724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5573354|NCT03909724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5573355|NCT03909724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6177334|NCT01709305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6177335|NCT01709305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177336|NCT01709305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6177337|NCT01709305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6177338|NCT01709305|Immunologic Factors|immunologic factors|mesh-ancestor
6177339|NCT01709305|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6177340|NCT01709409|Poractant alfa|poractant alfa|mesh-list
6177341|NCT01709409|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
5573356|NCT03909724|Growth Substances|growth substances|mesh-ancestor
5573357|NCT03909724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573358|NCT03909724|Growth Inhibitors|growth inhibitors|mesh-ancestor
5573359|NCT03909724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5573360|NCT03909724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5573361|NCT03909724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573362|NCT03909737|Azithromycin|azithromycin|mesh-list
6670582|NCT01544283|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6670583|NCT01544283|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6670584|NCT01544283|Lidocaine|lidocaine|mesh-list
6670585|NCT01544283|Tetracaine|tetracaine|mesh-list
5573363|NCT03909737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5573364|NCT03909737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5573365|NCT03909529|Digoxin|digoxin|mesh-list
5573366|NCT03909529|Spironolactone|spironolactone|mesh-list
5573367|NCT03909529|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5573368|NCT03909529|Hormone Antagonists|hormone antagonists|mesh-ancestor
5573369|NCT03909529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5573370|NCT03909529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573371|NCT03909529|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5573372|NCT03909529|Diuretics|diuretics|mesh-ancestor
5573373|NCT03909529|Natriuretic Agents|natriuretic agents|mesh-ancestor
5573374|NCT03909529|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5573375|NCT03909529|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5573376|NCT03909529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5573377|NCT03909529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177342|NCT01709409|Respiratory System Agents|respiratory system agents|mesh-ancestor
6177343|NCT01709422|Midazolam|midazolam|mesh-list
5573378|NCT03909529|Protective Agents|protective agents|mesh-ancestor
5573379|NCT03909607|Ketamine|ketamine|mesh-list
5573380|NCT03909607|Analgesics|analgesics|mesh-ancestor
5573381|NCT03909607|Sensory System Agents|sensory system agents|mesh-ancestor
5573382|NCT03909607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5573383|NCT03909607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573384|NCT03909607|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5573385|NCT03909607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5573386|NCT03909607|Anesthetics, General|anesthetics, general|mesh-ancestor
5573387|NCT03909607|Anesthetics|anesthetics|mesh-ancestor
5573388|NCT03909607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5573389|NCT03909607|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5573390|NCT03909607|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5573391|NCT03909607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5573392|NCT03909607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573393|NCT03909451|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
5573394|NCT03909451|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5573395|NCT03909451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573396|NCT03909451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5573397|NCT03909451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573398|NCT03909412|Dexamethasone|dexamethasone|mesh-list
5573399|NCT03909412|Cyclophosphamide|cyclophosphamide|mesh-list
6177344|NCT01709422|Meperidine|meperidine|mesh-list
6177345|NCT01709422|Propofol|propofol|mesh-list
6177346|NCT01709422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6177347|NCT01709422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6177348|NCT01709422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573400|NCT03909412|Lenograstim|lenograstim|mesh-list
5573401|NCT03909412|Sargramostim|sargramostim|mesh-list
5573402|NCT03909412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5573403|NCT03909412|Immunologic Factors|immunologic factors|mesh-ancestor
5573404|NCT03909412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573405|NCT03909412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5573406|NCT03909412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5573407|NCT03909412|Alkylating Agents|alkylating agents|mesh-ancestor
5573408|NCT03909412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573409|NCT03909412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6177349|NCT01709422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6177350|NCT01709422|Anesthetics, General|anesthetics, general|mesh-ancestor
6177351|NCT01709422|Anesthetics|anesthetics|mesh-ancestor
6177352|NCT01709422|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6177353|NCT01709422|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6177354|NCT01709422|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6177355|NCT01709422|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6177356|NCT01709422|GABA Modulators|gaba modulators|mesh-ancestor
6670586|NCT01544283|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5573410|NCT03909412|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5573411|NCT03909412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5573412|NCT03909412|Antiemetics|antiemetics|mesh-ancestor
5573413|NCT03909412|Autonomic Agents|autonomic agents|mesh-ancestor
5573414|NCT03909412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5573415|NCT03909412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5573416|NCT03909412|Glucocorticoids|glucocorticoids|mesh-ancestor
5573417|NCT03909412|Hormones|hormones|mesh-ancestor
5573418|NCT03909412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5573419|NCT03909412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5573420|NCT03909412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5573421|NCT03909269|Carbon Monoxide|carbon monoxide|mesh-list
6670587|NCT01544283|Anesthetics, Local|anesthetics, local|mesh-ancestor
6177357|NCT01709422|GABA Agents|gaba agents|mesh-ancestor
6177358|NCT01709422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6177359|NCT01709422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177360|NCT01709422|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6177361|NCT01709422|Narcotics|narcotics|mesh-ancestor
6177362|NCT01709422|Analgesics|analgesics|mesh-ancestor
6177363|NCT01709422|Sensory System Agents|sensory system agents|mesh-ancestor
6177364|NCT01709422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6177365|NCT01709474|Vitamin D|vitamin d|mesh-list
6177366|NCT01709474|Ergocalciferols|ergocalciferols|mesh-list
6177367|NCT01709474|Cholecalciferol|cholecalciferol|mesh-list
6177368|NCT01709474|Vitamins|vitamins|mesh-list
6177369|NCT01709474|Micronutrients|micronutrients|mesh-ancestor
6177370|NCT01709474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177371|NCT01709474|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5573422|NCT03909269|Antimetabolites|antimetabolites|mesh-ancestor
5573423|NCT03909269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573424|NCT03909269|Gasotransmitters|gasotransmitters|mesh-ancestor
6177372|NCT01709474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6177373|NCT01709500|Atorvastatin|atorvastatin|mesh-list
6177374|NCT01709500|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6177375|NCT01709500|Simvastatin|simvastatin|mesh-list
6177376|NCT01709500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6177377|NCT01709500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6177378|NCT01709500|Antimetabolites|antimetabolites|mesh-ancestor
6177379|NCT01709500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177380|NCT01709500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6177381|NCT01709500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6177382|NCT01709500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6206529|NCT02100969|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6206530|NCT02100969|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6206531|NCT02100969|Immunologic Factors|immunologic factors|mesh-ancestor
6206532|NCT02100969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573425|NCT03909269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5573426|NCT03909269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573427|NCT03909646|Fluorouracil|fluorouracil|mesh-list
5573428|NCT03909646|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5573429|NCT03909646|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
6206533|NCT02101008|Disulfiram|disulfiram|mesh-list
6206534|NCT02101008|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6206535|NCT02101008|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
6206536|NCT02101008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6206537|NCT02101008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206538|NCT02101021|Gemcitabine|gemcitabine|mesh-list
6206539|NCT02101021|Paclitaxel|paclitaxel|mesh-list
6206540|NCT02101021|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
6206541|NCT02101021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5573430|NCT03909646|Antimetabolites|antimetabolites|mesh-ancestor
5573431|NCT03909646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573432|NCT03909646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5573433|NCT03909646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5573434|NCT03909646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5573435|NCT03909646|Immunologic Factors|immunologic factors|mesh-ancestor
5573436|NCT03909646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573437|NCT03909646|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5573438|NCT03909646|Dermatologic Agents|dermatologic agents|mesh-ancestor
5573439|NCT03909152|Anastrozole|anastrozole|mesh-list
5573440|NCT03909152|Onapristone|onapristone|mesh-list
5573441|NCT03909152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5573442|NCT03909152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5573443|NCT03909152|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6206542|NCT02101021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6177383|NCT01709513|Atorvastatin|atorvastatin|mesh-list
6177384|NCT01709513|Ezetimibe|ezetimibe|mesh-list
6177385|NCT01709513|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6177386|NCT01709513|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6177387|NCT01709513|Antimetabolites|antimetabolites|mesh-ancestor
6177388|NCT01709513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177389|NCT01709513|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6177390|NCT01709513|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6177391|NCT01709513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6177392|NCT01709578|Hydroxychloroquine|hydroxychloroquine|mesh-list
6177393|NCT01709578|Sulfasalazine|sulfasalazine|mesh-list
6177394|NCT01709578|Methotrexate|methotrexate|mesh-list
6177395|NCT01709578|Leflunomide|leflunomide|mesh-list
6177396|NCT01709578|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6177397|NCT01709578|Abortifacient Agents|abortifacient agents|mesh-ancestor
6177398|NCT01709578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6177399|NCT01709578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177400|NCT01709578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6177401|NCT01709578|Antimetabolites|antimetabolites|mesh-ancestor
6177402|NCT01709578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573444|NCT03909152|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5573445|NCT03909152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5573446|NCT03909152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573447|NCT03909152|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5573448|NCT03909152|Hormone Antagonists|hormone antagonists|mesh-ancestor
5573449|NCT03909152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5573450|NCT03909152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573451|NCT03909152|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5573452|NCT03909152|Fertility Agents|fertility agents|mesh-ancestor
5573453|NCT03909152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5604382|NCT04939636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6177403|NCT01709578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6177404|NCT01709578|Dermatologic Agents|dermatologic agents|mesh-ancestor
6177405|NCT01709578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6177406|NCT01709578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6177407|NCT01709578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6177408|NCT01709578|Immunologic Factors|immunologic factors|mesh-ancestor
6177409|NCT01709578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6177410|NCT01709578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6177411|NCT01709578|Antimalarials|antimalarials|mesh-ancestor
6177412|NCT01709578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6177413|NCT01709578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6177414|NCT01709578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6177415|NCT01709578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6177416|NCT01709578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6177417|NCT01709578|Analgesics|analgesics|mesh-ancestor
6177418|NCT01709578|Sensory System Agents|sensory system agents|mesh-ancestor
6177419|NCT01709578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6177420|NCT01709578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6177421|NCT01709578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6177422|NCT01709695|Guanfacine|guanfacine|mesh-list
6177423|NCT01709695|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6177424|NCT01709695|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5604383|NCT04929548|Maleic acid|maleic acid|mesh-list
5604384|NCT04929548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5604385|NCT04929548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604386|NCT04921722|Sirolimus|sirolimus|mesh-list
5604387|NCT04921722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5604388|NCT04921722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6177425|NCT01709695|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6177426|NCT01709695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6177427|NCT01709695|Adrenergic Agents|adrenergic agents|mesh-ancestor
6177428|NCT01709695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6177429|NCT01709695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177430|NCT01709695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177431|NCT01709708|Bupivacaine|bupivacaine|mesh-list
5573454|NCT03909074|Vaccines|vaccines|mesh-list
5573455|NCT03909074|Immunologic Factors|immunologic factors|mesh-ancestor
5573456|NCT03909074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573457|NCT03908892|Tetracycline|tetracycline|mesh-list
5573458|NCT03908892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5573459|NCT03908892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5573460|NCT03908892|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5573461|NCT03908892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5573462|NCT03908892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573463|NCT03908944|Methadone|methadone|mesh-list
5573464|NCT03908944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5573465|NCT03908944|Narcotics|narcotics|mesh-ancestor
6177432|NCT01709708|Anesthetics, Local|anesthetics, local|mesh-ancestor
6177433|NCT01709708|Anesthetics|anesthetics|mesh-ancestor
6177434|NCT01709708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6177435|NCT01709708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177436|NCT01709708|Sensory System Agents|sensory system agents|mesh-ancestor
6177437|NCT01709708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6177438|NCT01709721|Hydromorphone|hydromorphone|mesh-list
6177439|NCT01709721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6177440|NCT01709721|Narcotics|narcotics|mesh-ancestor
6177441|NCT01709721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6177442|NCT01709721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177443|NCT01709721|Analgesics|analgesics|mesh-ancestor
6177444|NCT01709721|Sensory System Agents|sensory system agents|mesh-ancestor
6177445|NCT01709721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6177446|NCT01709747|Hydromorphone|hydromorphone|mesh-list
6177447|NCT01709747|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6177448|NCT01709747|Narcotics|narcotics|mesh-ancestor
6177449|NCT01709747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6177450|NCT01709747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177451|NCT01709747|Analgesics|analgesics|mesh-ancestor
6177452|NCT01709747|Sensory System Agents|sensory system agents|mesh-ancestor
6177453|NCT01709747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6177454|NCT01709838|Deferasirox|deferasirox|mesh-list
6177455|NCT01709838|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6177456|NCT01709838|Chelating Agents|chelating agents|mesh-ancestor
6177457|NCT01709838|Sequestering Agents|sequestering agents|mesh-ancestor
6177458|NCT01709838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177459|NCT01709864|Glycopyrrolate|glycopyrrolate|mesh-list
5573466|NCT03908944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5573467|NCT03908944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573468|NCT03908944|Analgesics|analgesics|mesh-ancestor
5573469|NCT03908944|Sensory System Agents|sensory system agents|mesh-ancestor
5573470|NCT03908944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5573471|NCT03908944|Antitussive Agents|antitussive agents|mesh-ancestor
5573472|NCT03908944|Respiratory System Agents|respiratory system agents|mesh-ancestor
5573473|NCT03908619|Esomeprazole|esomeprazole|mesh-list
5573474|NCT03908619|Omeprazole|omeprazole|mesh-list
5573475|NCT03908619|Rabeprazole|rabeprazole|mesh-list
5573476|NCT03908619|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6177460|NCT01709864|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6177461|NCT01709864|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6177462|NCT01709864|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6177463|NCT01709864|Cholinergic Agents|cholinergic agents|mesh-ancestor
6177464|NCT01709864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6177465|NCT01709864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177466|NCT01709864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177467|NCT01709903|Fluticasone|fluticasone|mesh-list
6177468|NCT01709903|Xhance|xhance|mesh-list
6177469|NCT01709903|Glycopyrrolate|glycopyrrolate|mesh-list
6177470|NCT01709903|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6177471|NCT01709903|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
5573477|NCT03908619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5573478|NCT03908619|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5573479|NCT03908619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5573480|NCT03908619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573481|NCT03908736|Picolinic acid|picolinic acid|mesh-list
5573482|NCT03908736|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5573483|NCT03908736|Chelating Agents|chelating agents|mesh-ancestor
5573484|NCT03908736|Sequestering Agents|sequestering agents|mesh-ancestor
5573485|NCT03908736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573486|NCT03908580|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5573487|NCT03908580|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5573488|NCT03908580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5573489|NCT03908580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573490|NCT03908580|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5573491|NCT03908580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5573492|NCT03908580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573493|NCT03908580|Cholinergic Agents|cholinergic agents|mesh-ancestor
5573494|NCT03908580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5573495|NCT03908593|Pantoprazole|pantoprazole|mesh-list
5573496|NCT03908593|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5573497|NCT03908593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6177472|NCT01709903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6177473|NCT01709903|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6177474|NCT01709903|Autonomic Agents|autonomic agents|mesh-ancestor
6177475|NCT01709903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6177476|NCT01709903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177477|NCT01709903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6177478|NCT01709903|Respiratory System Agents|respiratory system agents|mesh-ancestor
6177479|NCT01709903|Dermatologic Agents|dermatologic agents|mesh-ancestor
5573498|NCT03908593|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5573499|NCT03908593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5573500|NCT03908593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573501|NCT03908528|Thioctic Acid|thioctic acid|mesh-list
5573502|NCT03908528|Cyclophosphamide|cyclophosphamide|mesh-list
5573503|NCT03908528|Doxorubicin|doxorubicin|mesh-list
6177480|NCT01709903|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6177481|NCT01709903|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6177482|NCT01709903|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6177483|NCT01709903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6177484|NCT01709903|Adrenergic Agents|adrenergic agents|mesh-ancestor
6177485|NCT01709903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6177486|NCT01709903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177487|NCT01709903|Glucocorticoids|glucocorticoids|mesh-ancestor
6177488|NCT01709903|Hormones|hormones|mesh-ancestor
6177489|NCT01709903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6177490|NCT01709903|Sympathomimetics|sympathomimetics|mesh-ancestor
6177491|NCT01709903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6177492|NCT01709903|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6177493|NCT01709903|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6177494|NCT01709903|Cholinergic Agents|cholinergic agents|mesh-ancestor
6177495|NCT01709981|Colchicine|colchicine|mesh-list
6177496|NCT01709981|Gout Suppressants|gout suppressants|mesh-ancestor
5573504|NCT03908528|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5573505|NCT03908528|Paclitaxel|paclitaxel|mesh-list
5573506|NCT03908528|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5573507|NCT03908528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5573508|NCT03908528|Immunologic Factors|immunologic factors|mesh-ancestor
5573509|NCT03908528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177497|NCT01709981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6177498|NCT01709981|Tubulin Modulators|tubulin modulators|mesh-ancestor
6177499|NCT01709981|Antimitotic Agents|antimitotic agents|mesh-ancestor
6177500|NCT01709981|Mitosis Modulators|mitosis modulators|mesh-ancestor
6177501|NCT01709981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177502|NCT01709981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6177503|NCT01710020|Tofacitinib|tofacitinib|mesh-list
6177504|NCT01710020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6177505|NCT01710020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6177506|NCT01710020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177507|NCT01710033|Tofacitinib|tofacitinib|mesh-list
6670588|NCT01544283|Anesthetics|anesthetics|mesh-ancestor
6670589|NCT01544283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6177508|NCT01710033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6177509|NCT01710033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6206543|NCT02101021|Tubulin Modulators|tubulin modulators|mesh-ancestor
6177510|NCT01710033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177511|NCT01710046|Tofacitinib|tofacitinib|mesh-list
6177512|NCT01710046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6177513|NCT01710046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6177514|NCT01710046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177515|NCT01710137|Varenicline|varenicline|mesh-list
6177516|NCT01710137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6177517|NCT01710137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6177518|NCT01710137|Cholinergic Agents|cholinergic agents|mesh-ancestor
6177519|NCT01710137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6177520|NCT01710137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177521|NCT01710137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177522|NCT01710254|Regadenoson|regadenoson|mesh-list
6177523|NCT01710254|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
6177524|NCT01710254|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6177525|NCT01710254|Purinergic Agonists|purinergic agonists|mesh-ancestor
6177526|NCT01710254|Purinergic Agents|purinergic agents|mesh-ancestor
6177527|NCT01710254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6177528|NCT01710254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573510|NCT03908528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5573511|NCT03908528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5573512|NCT03908528|Alkylating Agents|alkylating agents|mesh-ancestor
5573513|NCT03908528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573514|NCT03908528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5573515|NCT03908528|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5573516|NCT03908528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5573517|NCT03908528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5573518|NCT03908528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5573519|NCT03908528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5573520|NCT03908528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5573521|NCT03908528|Tubulin Modulators|tubulin modulators|mesh-ancestor
5573522|NCT03908528|Antimitotic Agents|antimitotic agents|mesh-ancestor
5573523|NCT03908528|Mitosis Modulators|mitosis modulators|mesh-ancestor
5573524|NCT03908528|Antioxidants|antioxidants|mesh-ancestor
5573525|NCT03908528|Protective Agents|protective agents|mesh-ancestor
5573526|NCT03908528|Vitamin B Complex|vitamin b complex|mesh-ancestor
5573527|NCT03908528|Vitamins|vitamins|mesh-ancestor
5573528|NCT03908528|Micronutrients|micronutrients|mesh-ancestor
5573529|NCT03908814|Antibodies|antibodies|mesh-list
5573530|NCT03908814|Immunologic Factors|immunologic factors|mesh-ancestor
5573531|NCT03908814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573532|NCT03908489|Allyl sulfide|allyl sulfide|mesh-list
5573533|NCT03908489|Antioxidants|antioxidants|mesh-ancestor
5573534|NCT03908489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177529|NCT01710254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177530|NCT01710332|Aflibercept|aflibercept|mesh-list
6177531|NCT01710332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6177532|NCT01710332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6177533|NCT01710332|Growth Substances|growth substances|mesh-ancestor
6177534|NCT01710332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177535|NCT01710332|Growth Inhibitors|growth inhibitors|mesh-ancestor
6177536|NCT01710332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6177537|NCT01710345|Sufentanil|sufentanil|mesh-list
6177538|NCT01710345|Dsuvia|dsuvia|mesh-list
6177539|NCT01710345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6177540|NCT01710345|Narcotics|narcotics|mesh-ancestor
6177541|NCT01710345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6177542|NCT01710345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177543|NCT01710345|Analgesics|analgesics|mesh-ancestor
6177544|NCT01710345|Sensory System Agents|sensory system agents|mesh-ancestor
6177545|NCT01710345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6177546|NCT01710345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6177547|NCT01710345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6177548|NCT01710345|Anesthetics, General|anesthetics, general|mesh-ancestor
6177549|NCT01710345|Anesthetics|anesthetics|mesh-ancestor
6177550|NCT01710358|Adalimumab|adalimumab|mesh-list
6177551|NCT01710358|Methotrexate|methotrexate|mesh-list
6177552|NCT01710358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6177553|NCT01710358|Abortifacient Agents|abortifacient agents|mesh-ancestor
6177554|NCT01710358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6177555|NCT01710358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177556|NCT01710358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5573535|NCT03908489|Protective Agents|protective agents|mesh-ancestor
5573536|NCT03908489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573537|NCT03908489|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6177557|NCT01710358|Antimetabolites|antimetabolites|mesh-ancestor
6177558|NCT01710358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177559|NCT01710358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6177560|NCT01710358|Dermatologic Agents|dermatologic agents|mesh-ancestor
6177561|NCT01710358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5573538|NCT03908489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5573539|NCT03908489|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5573540|NCT03908489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5573541|NCT03908333|Ascorbic Acid|ascorbic acid|mesh-list
5573542|NCT03908333|Gemcitabine|gemcitabine|mesh-list
5573543|NCT03908333|Paclitaxel|paclitaxel|mesh-list
5573544|NCT03908333|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5573545|NCT03908333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5573546|NCT03908333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5573547|NCT03908333|Tubulin Modulators|tubulin modulators|mesh-ancestor
6177562|NCT01710358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6177563|NCT01710358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6177564|NCT01710358|Immunologic Factors|immunologic factors|mesh-ancestor
6177565|NCT01710358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6177566|NCT01710358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6177567|NCT01710358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6177568|NCT01710501|Interferons|interferons|mesh-list
6177569|NCT01710501|Ribavirin|ribavirin|mesh-list
6177570|NCT01710501|Interferon-alpha|interferon-alpha|mesh-list
6177571|NCT01710501|Interferon alpha-2|interferon alpha-2|mesh-list
6177572|NCT01710501|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6177573|NCT01710501|Grazoprevir|grazoprevir|mesh-list
6177574|NCT01710501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6177575|NCT01710501|Antiviral Agents|antiviral agents|mesh-ancestor
6177576|NCT01710501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6177577|NCT01710501|Antimetabolites|antimetabolites|mesh-ancestor
6177578|NCT01710501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177579|NCT01710501|Immunologic Factors|immunologic factors|mesh-ancestor
6177580|NCT01710501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177581|NCT01710527|Metformin|metformin|mesh-list
5573548|NCT03908333|Antimitotic Agents|antimitotic agents|mesh-ancestor
5573549|NCT03908333|Mitosis Modulators|mitosis modulators|mesh-ancestor
5573550|NCT03908333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573551|NCT03908333|Vitamins|vitamins|mesh-ancestor
5573552|NCT03908333|Micronutrients|micronutrients|mesh-ancestor
5573553|NCT03908333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573554|NCT03908333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5573555|NCT03908333|Antimetabolites|antimetabolites|mesh-ancestor
5573556|NCT03908333|Antiviral Agents|antiviral agents|mesh-ancestor
5573557|NCT03908333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5573558|NCT03908333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5573559|NCT03908333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5573560|NCT03908333|Immunologic Factors|immunologic factors|mesh-ancestor
5573561|NCT03908333|Antioxidants|antioxidants|mesh-ancestor
5573562|NCT03908333|Protective Agents|protective agents|mesh-ancestor
5573563|NCT03908242|Salvianolic acid A|salvianolic acid a|mesh-list
5573564|NCT03908242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5573565|NCT03908242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5573566|NCT03908242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177582|NCT01710527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6177583|NCT01710527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177584|NCT01710657|Lacosamide|lacosamide|mesh-list
6177585|NCT01710657|Anticonvulsants|anticonvulsants|mesh-ancestor
6177586|NCT01710657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6177587|NCT01710657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6177588|NCT01710657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6177589|NCT01710657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177590|NCT01710709|Aripiprazole|aripiprazole|mesh-list
6177591|NCT01710709|Antidepressive Agents|antidepressive agents|mesh-ancestor
6177592|NCT01710709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6177593|NCT01710709|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6177594|NCT01710709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6177595|NCT01710709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6177596|NCT01710709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177597|NCT01710709|Dopamine Agonists|dopamine agonists|mesh-ancestor
6177598|NCT01710709|Dopamine Agents|dopamine agents|mesh-ancestor
6177599|NCT01710709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6177600|NCT01710709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573567|NCT03908242|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5573568|NCT03908060|Morphine|morphine|mesh-list
6177601|NCT01710709|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5573569|NCT03908060|Methadone|methadone|mesh-list
5573570|NCT03908060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6177602|NCT01710709|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6177603|NCT01710709|Serotonin Agents|serotonin agents|mesh-ancestor
6177604|NCT01710709|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6177605|NCT01710709|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6177606|NCT01710709|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6177607|NCT01710709|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6177608|NCT01710787|Phenylephrine|phenylephrine|mesh-list
6177609|NCT01710787|Oxymetazoline|oxymetazoline|mesh-list
6177610|NCT01710787|Tetracaine|tetracaine|mesh-list
6177611|NCT01710787|Anesthetics, Local|anesthetics, local|mesh-ancestor
6177612|NCT01710787|Anesthetics|anesthetics|mesh-ancestor
6177613|NCT01710787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6177614|NCT01710787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177615|NCT01710787|Sensory System Agents|sensory system agents|mesh-ancestor
6177616|NCT01710787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6177617|NCT01710787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6177618|NCT01710787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6177619|NCT01710787|Adrenergic Agents|adrenergic agents|mesh-ancestor
6177620|NCT01710787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6177621|NCT01710787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177622|NCT01710787|Sympathomimetics|sympathomimetics|mesh-ancestor
6177623|NCT01710787|Autonomic Agents|autonomic agents|mesh-ancestor
6177624|NCT01710787|Nasal Decongestants|nasal decongestants|mesh-ancestor
6177625|NCT01710787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6177626|NCT01710787|Respiratory System Agents|respiratory system agents|mesh-ancestor
6177627|NCT01710787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6177628|NCT01710787|Mydriatics|mydriatics|mesh-ancestor
6177629|NCT01710787|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6177630|NCT01710787|Protective Agents|protective agents|mesh-ancestor
6177631|NCT01710800|Esomeprazole|esomeprazole|mesh-list
6177632|NCT01710800|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6177633|NCT01710800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6177634|NCT01710800|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6177635|NCT01710800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6177636|NCT01710800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177637|NCT01710839|Ranibizumab|ranibizumab|mesh-list
6177638|NCT01710839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6177639|NCT01710839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6177640|NCT01710839|Growth Substances|growth substances|mesh-ancestor
6177641|NCT01710839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177642|NCT01710839|Growth Inhibitors|growth inhibitors|mesh-ancestor
6177643|NCT01710839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6177644|NCT01711177|Travoprost|travoprost|mesh-list
6177645|NCT01711177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6177646|NCT01711359|Folic Acid|folic acid|mesh-list
6177647|NCT01711359|Methotrexate|methotrexate|mesh-list
6177648|NCT01711359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6487350|NCT00575913|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6487351|NCT00575913|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6487352|NCT00575913|Adrenergic Agents|adrenergic agents|mesh-ancestor
6487353|NCT00575913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5573571|NCT03908060|Narcotics|narcotics|mesh-ancestor
6177649|NCT01711359|Abortifacient Agents|abortifacient agents|mesh-ancestor
5573572|NCT03908060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5573573|NCT03908060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177650|NCT01711359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6177651|NCT01711359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177652|NCT01711359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6177653|NCT01711359|Antimetabolites|antimetabolites|mesh-ancestor
6177654|NCT01711359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177655|NCT01711359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6177656|NCT01711359|Dermatologic Agents|dermatologic agents|mesh-ancestor
6177657|NCT01711359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6177658|NCT01711359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6177659|NCT01711359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6177660|NCT01711359|Immunologic Factors|immunologic factors|mesh-ancestor
6177661|NCT01711359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6177662|NCT01711359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6177663|NCT01711359|Hematinics|hematinics|mesh-ancestor
6177664|NCT01711359|Vitamin B Complex|vitamin b complex|mesh-ancestor
6177665|NCT01711359|Vitamins|vitamins|mesh-ancestor
6177666|NCT01711359|Micronutrients|micronutrients|mesh-ancestor
6177667|NCT01711645|Aluminum phosphate|aluminum phosphate|mesh-list
6177668|NCT01711645|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5573574|NCT03908060|Analgesics|analgesics|mesh-ancestor
5573575|NCT03908060|Sensory System Agents|sensory system agents|mesh-ancestor
5573576|NCT03908060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5573577|NCT03908060|Antitussive Agents|antitussive agents|mesh-ancestor
5573578|NCT03908060|Respiratory System Agents|respiratory system agents|mesh-ancestor
5573579|NCT03908372|Docetaxel|docetaxel|mesh-list
5573580|NCT03908372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5573581|NCT03908372|Tubulin Modulators|tubulin modulators|mesh-ancestor
5573582|NCT03908372|Antimitotic Agents|antimitotic agents|mesh-ancestor
5573583|NCT03908372|Mitosis Modulators|mitosis modulators|mesh-ancestor
6177669|NCT01711645|Immunologic Factors|immunologic factors|mesh-ancestor
6177670|NCT01711645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177671|NCT01711645|Antacids|antacids|mesh-ancestor
6177672|NCT01711645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177673|NCT01711645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6177674|NCT01711658|Lapatinib|lapatinib|mesh-list
6177675|NCT01711658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6177676|NCT01711658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5573584|NCT03908372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573585|NCT03908008|Botulinum Toxins|botulinum toxins|mesh-list
5573586|NCT03908008|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5573587|NCT03908008|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5573588|NCT03908008|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6177677|NCT01711658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6177678|NCT01711658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177679|NCT01711853|Dabigatran|dabigatran|mesh-list
6177680|NCT01711853|Antithrombins|antithrombins|mesh-ancestor
6177681|NCT01711853|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6177682|NCT01711853|Protease Inhibitors|protease inhibitors|mesh-ancestor
6177683|NCT01711853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6177684|NCT01711853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177685|NCT01711853|Anticoagulants|anticoagulants|mesh-ancestor
6177686|NCT01711866|Rotigotine|rotigotine|mesh-list
6177687|NCT01711866|Dopamine Agonists|dopamine agonists|mesh-ancestor
6177688|NCT01711866|Dopamine Agents|dopamine agents|mesh-ancestor
6177689|NCT01711866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5573589|NCT03908008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5573590|NCT03908008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573591|NCT03908008|Cholinergic Agents|cholinergic agents|mesh-ancestor
5573592|NCT03908008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5573593|NCT03908008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573594|NCT03908008|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5573595|NCT03908008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6177690|NCT01711866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177691|NCT01711866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177692|NCT01711879|Aflibercept|aflibercept|mesh-list
6177693|NCT01711879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6177694|NCT01711879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6177695|NCT01711879|Growth Substances|growth substances|mesh-ancestor
6177696|NCT01711879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177697|NCT01711879|Growth Inhibitors|growth inhibitors|mesh-ancestor
6177698|NCT01711879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6177699|NCT01711918|Domperidone|domperidone|mesh-list
6177700|NCT01711918|Antiemetics|antiemetics|mesh-ancestor
6177701|NCT01711918|Autonomic Agents|autonomic agents|mesh-ancestor
6177702|NCT01711918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6177703|NCT01711918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573613|NCT03907800|Paclitaxel|paclitaxel|mesh-list
6177704|NCT01711918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5573614|NCT03907800|Carboplatin|carboplatin|mesh-list
5573615|NCT03907800|Trastuzumab|trastuzumab|mesh-list
5573616|NCT03907800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5573617|NCT03907800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5573618|NCT03907800|Tubulin Modulators|tubulin modulators|mesh-ancestor
5573619|NCT03907800|Antimitotic Agents|antimitotic agents|mesh-ancestor
5573620|NCT03907800|Mitosis Modulators|mitosis modulators|mesh-ancestor
5573621|NCT03907800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573622|NCT03907800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5573623|NCT03907852|Cyclophosphamide|cyclophosphamide|mesh-list
5573624|NCT03907852|Fludarabine|fludarabine|mesh-list
6177705|NCT01711918|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6177706|NCT01711918|Dopamine Agents|dopamine agents|mesh-ancestor
6177707|NCT01711918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6177708|NCT01711918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177709|NCT01712009|Loratadine|loratadine|mesh-list
6177710|NCT01712009|Naproxen|naproxen|mesh-list
6177711|NCT01712009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6177712|NCT01712009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6177713|NCT01712009|Analgesics|analgesics|mesh-ancestor
6177714|NCT01712009|Sensory System Agents|sensory system agents|mesh-ancestor
6177715|NCT01712009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6177716|NCT01712009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177717|NCT01712009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6177718|NCT01712009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6670590|NCT01544283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670591|NCT01544283|Sensory System Agents|sensory system agents|mesh-ancestor
6670592|NCT01544283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6670593|NCT01544283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6670594|NCT01544283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6670595|NCT01544283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6670596|NCT01544283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6670597|NCT01544283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573625|NCT03907852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5573626|NCT03907852|Immunologic Factors|immunologic factors|mesh-ancestor
5573627|NCT03907852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573628|NCT03907852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5573629|NCT03907852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5573630|NCT03907852|Alkylating Agents|alkylating agents|mesh-ancestor
5573631|NCT03907852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177719|NCT01712009|Gout Suppressants|gout suppressants|mesh-ancestor
6177720|NCT01712009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6177721|NCT01712009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6177722|NCT01712009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177723|NCT01712009|Antipruritics|antipruritics|mesh-ancestor
6177724|NCT01712009|Dermatologic Agents|dermatologic agents|mesh-ancestor
6177725|NCT01712009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6177726|NCT01712009|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6177727|NCT01712009|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6177728|NCT01712009|Histamine Antagonists|histamine antagonists|mesh-ancestor
6177729|NCT01712009|Histamine Agents|histamine agents|mesh-ancestor
6177730|NCT01712009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6177731|NCT01712178|Adalimumab|adalimumab|mesh-list
6177732|NCT01712178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6177733|NCT01712178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6177734|NCT01712204|Febuxostat|febuxostat|mesh-list
6177735|NCT01712204|Gout Suppressants|gout suppressants|mesh-ancestor
6177736|NCT01712204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6177737|NCT01712230|Leuprolide|leuprolide|mesh-list
6177738|NCT01712230|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6177739|NCT01712230|Fertility Agents|fertility agents|mesh-ancestor
6177740|NCT01712230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6177741|NCT01712230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487354|NCT00575913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6487355|NCT00575913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487356|NCT00575913|Urological Agents|urological agents|mesh-ancestor
6487357|NCT00575952|Paclitaxel|paclitaxel|mesh-list
6487358|NCT00575952|Doxorubicin|doxorubicin|mesh-list
6487359|NCT00575952|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6487360|NCT00575952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6487361|NCT00575952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6487362|NCT00575952|Tubulin Modulators|tubulin modulators|mesh-ancestor
6487363|NCT00575952|Antimitotic Agents|antimitotic agents|mesh-ancestor
6177742|NCT01712230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6177743|NCT01712230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6177744|NCT01712360|Naftifine|naftifine|mesh-list
6177745|NCT01712360|Antifungal Agents|antifungal agents|mesh-ancestor
5573632|NCT03907852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5573633|NCT03907852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5573634|NCT03907813|Bupivacaine|bupivacaine|mesh-list
5573635|NCT03907813|Anesthetics, Local|anesthetics, local|mesh-ancestor
5573636|NCT03907813|Anesthetics|anesthetics|mesh-ancestor
5573637|NCT03907813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5573638|NCT03907813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177746|NCT01712360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6177747|NCT01712399|Mavrilimumab|mavrilimumab|mesh-list
6177748|NCT01712399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6177749|NCT01712516|Glycopyrrolate|glycopyrrolate|mesh-list
6177750|NCT01712516|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6177751|NCT01712516|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6177752|NCT01712516|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6177753|NCT01712516|Cholinergic Agents|cholinergic agents|mesh-ancestor
6177754|NCT01712516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6177755|NCT01712516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177756|NCT01712516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177757|NCT01712984|Fluconazole|fluconazole|mesh-list
6177758|NCT01712984|Vaccines|vaccines|mesh-list
6177759|NCT01712984|Immunologic Factors|immunologic factors|mesh-ancestor
6177760|NCT01712984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177761|NCT01712984|Antifungal Agents|antifungal agents|mesh-ancestor
6177762|NCT01712984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6177763|NCT01712984|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6177764|NCT01712984|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6177765|NCT01712984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6177766|NCT01712984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177767|NCT01712984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6177768|NCT01712984|Hormone Antagonists|hormone antagonists|mesh-ancestor
6177769|NCT01712984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6177770|NCT01712984|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6177771|NCT01712984|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6177772|NCT01713283|Sofosbuvir|sofosbuvir|mesh-list
6177773|NCT01713283|Antiviral Agents|antiviral agents|mesh-ancestor
6177774|NCT01713283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6177775|NCT01713400|Sirolimus|sirolimus|mesh-list
6177776|NCT01713400|Ustekinumab|ustekinumab|mesh-list
6177777|NCT01713400|Tacrolimus|tacrolimus|mesh-list
6177778|NCT01713400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6177779|NCT01713400|Immunologic Factors|immunologic factors|mesh-ancestor
6177780|NCT01713400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177781|NCT01713400|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6177782|NCT01713400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6177783|NCT01713400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177784|NCT01713400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5573639|NCT03907813|Sensory System Agents|sensory system agents|mesh-ancestor
5573640|NCT03907813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5573641|NCT03907423|Metformin|metformin|mesh-list
5573642|NCT03907423|Glimepiride|glimepiride|mesh-list
5573643|NCT03907423|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5573644|NCT03907423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6177785|NCT01713400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6177786|NCT01713400|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6177787|NCT01713400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6177788|NCT01713400|Antifungal Agents|antifungal agents|mesh-ancestor
6177789|NCT01713400|Dermatologic Agents|dermatologic agents|mesh-ancestor
6177790|NCT01713530|Insulin|insulin|mesh-list
6177791|NCT01713530|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6177792|NCT01713530|Insulin Aspart|insulin aspart|mesh-list
6177793|NCT01713530|Insulin, Long-Acting|insulin, long-acting|mesh-list
6177794|NCT01713530|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6177795|NCT01713530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6177796|NCT01713530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177797|NCT01713608|Artefenomel|artefenomel|mesh-list
6177798|NCT01713608|Antimalarials|antimalarials|mesh-ancestor
6177799|NCT01713608|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6177800|NCT01713608|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6177801|NCT01713608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6177802|NCT01713621|Artefenomel|artefenomel|mesh-list
6177803|NCT01713621|Antimalarials|antimalarials|mesh-ancestor
6177804|NCT01713621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5573645|NCT03907423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670598|NCT01544283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6670599|NCT01544283|Glucocorticoids|glucocorticoids|mesh-ancestor
6670600|NCT01544283|Hormones|hormones|mesh-ancestor
6670601|NCT01544283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6670602|NCT01544283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6670603|NCT01544283|Immunologic Factors|immunologic factors|mesh-ancestor
6670604|NCT01544283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6177805|NCT01713621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6177806|NCT01713621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6177807|NCT01713946|Everolimus|everolimus|mesh-list
5573646|NCT03907423|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5573647|NCT03907423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5573648|NCT03907423|Antimetabolites|antimetabolites|mesh-ancestor
5573649|NCT03907423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573650|NCT03907423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5573651|NCT03907423|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5573652|NCT03907423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5573653|NCT03907423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5573654|NCT03907423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5573655|NCT03907423|Immunologic Factors|immunologic factors|mesh-ancestor
5573656|NCT03907475|Gemcitabine|gemcitabine|mesh-list
5573657|NCT03907475|Paclitaxel|paclitaxel|mesh-list
5573658|NCT03907475|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5573659|NCT03907475|Carboplatin|carboplatin|mesh-list
5573660|NCT03907475|Doxorubicin|doxorubicin|mesh-list
5573661|NCT03907475|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6177808|NCT01713946|Anticonvulsants|anticonvulsants|mesh-list
6177809|NCT01713946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6177810|NCT01713946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6177811|NCT01713946|Immunologic Factors|immunologic factors|mesh-ancestor
6177812|NCT01713946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177813|NCT01714310|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6177814|NCT01714310|Fluoxetine|fluoxetine|mesh-list
6177815|NCT01714310|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6177816|NCT01714310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6177817|NCT01714310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5573662|NCT03907475|Capecitabine|capecitabine|mesh-list
5573663|NCT03907475|Durvalumab|durvalumab|mesh-list
5573664|NCT03907475|Immunoglobulins|immunoglobulins|mesh-list
5573665|NCT03907475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5573666|NCT03907475|Immunoglobulin G|immunoglobulin g|mesh-list
5573667|NCT03907475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5573668|NCT03907475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5573669|NCT03907475|Tubulin Modulators|tubulin modulators|mesh-ancestor
5573670|NCT03907475|Antimitotic Agents|antimitotic agents|mesh-ancestor
5573671|NCT03907475|Mitosis Modulators|mitosis modulators|mesh-ancestor
5573672|NCT03907475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573673|NCT03907475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5573674|NCT03907475|Antimetabolites|antimetabolites|mesh-ancestor
5573675|NCT03907475|Antiviral Agents|antiviral agents|mesh-ancestor
5573676|NCT03907475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5573677|NCT03907475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5573678|NCT03907475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5573679|NCT03907475|Immunologic Factors|immunologic factors|mesh-ancestor
5573680|NCT03907475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573681|NCT03907475|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5573682|NCT03907475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5573683|NCT03907475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5573684|NCT03907475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5604389|NCT04921722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5604390|NCT04921722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5604391|NCT04921722|Antifungal Agents|antifungal agents|mesh-ancestor
5604392|NCT04921722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5604393|NCT04921722|Immunologic Factors|immunologic factors|mesh-ancestor
5604394|NCT04921722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604395|NCT04900038|Lamivudine|lamivudine|mesh-list
5604396|NCT04900038|Dolutegravir|dolutegravir|mesh-list
5604397|NCT04900038|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5604398|NCT04900038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5604399|NCT04900038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5604400|NCT04900038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604401|NCT04900038|Antiviral Agents|antiviral agents|mesh-ancestor
5604402|NCT04900038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5604403|NCT04900038|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5604404|NCT04900038|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6670605|NCT01544439|Salicylic Acid|salicylic acid|mesh-list
5573685|NCT03907371|Donepezil|donepezil|mesh-list
5573686|NCT03907371|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5573687|NCT03907371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5573688|NCT03907371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177818|NCT01714310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177819|NCT01714310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6177820|NCT01714310|Serotonin Agents|serotonin agents|mesh-ancestor
6177821|NCT01714310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177822|NCT01714310|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6177823|NCT01714310|Antidepressive Agents|antidepressive agents|mesh-ancestor
6177824|NCT01714310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6177825|NCT01714310|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6177826|NCT01714310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6177827|NCT01714310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6177828|NCT01714310|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6177829|NCT01714310|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6177830|NCT01714310|Dopamine Agents|dopamine agents|mesh-ancestor
6177831|NCT01714336|Tranexamic Acid|tranexamic acid|mesh-list
6177832|NCT01714336|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6177833|NCT01714336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6177834|NCT01714336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177835|NCT01714336|Hemostatics|hemostatics|mesh-ancestor
6177836|NCT01714336|Coagulants|coagulants|mesh-ancestor
6177837|NCT01714544|Clocortolone pivalate|clocortolone pivalate|mesh-list
6177838|NCT01714544|Glucocorticoids|glucocorticoids|mesh-ancestor
6177839|NCT01714544|Hormones|hormones|mesh-ancestor
6177840|NCT01714544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6177841|NCT01714544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177842|NCT01714609|Sorafenib|sorafenib|mesh-list
6177843|NCT01714609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6177844|NCT01714609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6177845|NCT01714609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6177846|NCT01714609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177847|NCT01715129|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6177848|NCT01715129|Luteolytic Agents|luteolytic agents|mesh-ancestor
6177849|NCT01715129|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6487364|NCT00575952|Mitosis Modulators|mitosis modulators|mesh-ancestor
5573689|NCT03907371|Cholinergic Agents|cholinergic agents|mesh-ancestor
5573690|NCT03907371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5573691|NCT03907371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573692|NCT03907371|Nootropic Agents|nootropic agents|mesh-ancestor
5573693|NCT03907098|Endostar protein|endostar protein|mesh-list
5573694|NCT03907098|Endostatins|endostatins|mesh-list
6487365|NCT00575952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6487366|NCT00575952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6487367|NCT00575952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5573695|NCT03907098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5573696|NCT03907098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5573697|NCT03907098|Growth Substances|growth substances|mesh-ancestor
5573698|NCT03907098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573699|NCT03907098|Growth Inhibitors|growth inhibitors|mesh-ancestor
5573700|NCT03907098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5573701|NCT03906877|Hyaluronic Acid|hyaluronic acid|mesh-list
5573702|NCT03906877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5573703|NCT03906877|Immunologic Factors|immunologic factors|mesh-ancestor
5573704|NCT03906877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573705|NCT03906877|Viscosupplements|viscosupplements|mesh-ancestor
6487368|NCT00575952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6487369|NCT00575952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6487370|NCT00575978|Hydralazine|hydralazine|mesh-list
6177850|NCT01715129|Contraceptive Agents|contraceptive agents|mesh-ancestor
6177851|NCT01715129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6177852|NCT01715129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177853|NCT01715129|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6177854|NCT01715129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6177855|NCT01715129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6177856|NCT01715207|Atenolol|atenolol|mesh-list
6177857|NCT01715207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6177858|NCT01715207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6177859|NCT01715207|Sympatholytics|sympatholytics|mesh-ancestor
6177860|NCT01715207|Autonomic Agents|autonomic agents|mesh-ancestor
6177861|NCT01715207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6177862|NCT01715207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206544|NCT02101021|Antimitotic Agents|antimitotic agents|mesh-ancestor
5573706|NCT03906877|Protective Agents|protective agents|mesh-ancestor
5573707|NCT03906916|Micafungin|micafungin|mesh-list
5573708|NCT03906916|Antifungal Agents|antifungal agents|mesh-ancestor
5573709|NCT03906916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5573710|NCT03907124|Psychotropic Drugs|psychotropic drugs|mesh-list
5573711|NCT03907215|Citalopram|citalopram|mesh-list
5573712|NCT03907215|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5573713|NCT03907215|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5573714|NCT03907215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5573715|NCT03907215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573716|NCT03907215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5573717|NCT03907215|Serotonin Agents|serotonin agents|mesh-ancestor
5573718|NCT03907215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573719|NCT03907215|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5573720|NCT03907215|Antidepressive Agents|antidepressive agents|mesh-ancestor
5573721|NCT03907215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5573722|NCT03907163|Dronabinol|dronabinol|mesh-list
5573723|NCT03907163|Hallucinogens|hallucinogens|mesh-ancestor
5573724|NCT03907163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573725|NCT03907163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5573726|NCT03907163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5573727|NCT03907163|Analgesics|analgesics|mesh-ancestor
5573728|NCT03907163|Sensory System Agents|sensory system agents|mesh-ancestor
5573729|NCT03907163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6177863|NCT01715207|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6177864|NCT01715207|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6177865|NCT01715207|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6177866|NCT01715207|Adrenergic Agents|adrenergic agents|mesh-ancestor
6177867|NCT01715207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6177868|NCT01715207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177869|NCT01715233|Leucovorin|leucovorin|mesh-list
6177870|NCT01715233|Carboplatin|carboplatin|mesh-list
5573730|NCT03907163|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5573731|NCT03907163|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5573732|NCT03907163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5573733|NCT03907163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573734|NCT03907163|Hormones|hormones|mesh-ancestor
5573735|NCT03907163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5573736|NCT03907111|Chitosan|chitosan|mesh-list
6177871|NCT01715233|Docetaxel|docetaxel|mesh-list
6177872|NCT01715233|Fluorouracil|fluorouracil|mesh-list
6177873|NCT01715233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6177874|NCT01715233|Tubulin Modulators|tubulin modulators|mesh-ancestor
6177875|NCT01715233|Antimitotic Agents|antimitotic agents|mesh-ancestor
6177876|NCT01715233|Mitosis Modulators|mitosis modulators|mesh-ancestor
6177877|NCT01715233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177878|NCT01715233|Antimetabolites|antimetabolites|mesh-ancestor
6177879|NCT01715233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5573737|NCT03907111|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5573738|NCT03907111|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5573739|NCT03907111|Antimetabolites|antimetabolites|mesh-ancestor
6177880|NCT01715233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6177881|NCT01715233|Immunologic Factors|immunologic factors|mesh-ancestor
6177882|NCT01715233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177883|NCT01715233|Antidotes|antidotes|mesh-ancestor
6177884|NCT01715233|Protective Agents|protective agents|mesh-ancestor
6177885|NCT01715233|Vitamin B Complex|vitamin b complex|mesh-ancestor
6177886|NCT01715233|Vitamins|vitamins|mesh-ancestor
6177887|NCT01715233|Micronutrients|micronutrients|mesh-ancestor
6177888|NCT01715298|Glycopyrrolate|glycopyrrolate|mesh-list
6177889|NCT01715298|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6177890|NCT01715298|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6177891|NCT01715298|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6177892|NCT01715298|Cholinergic Agents|cholinergic agents|mesh-ancestor
6177893|NCT01715298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6177894|NCT01715298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177895|NCT01715298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177896|NCT01715415|Ribavirin|ribavirin|mesh-list
6177897|NCT01715415|Antimetabolites|antimetabolites|mesh-ancestor
6670606|NCT01544439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5573740|NCT03907111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573741|NCT03907111|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5573742|NCT03907111|Chelating Agents|chelating agents|mesh-ancestor
5573743|NCT03907111|Sequestering Agents|sequestering agents|mesh-ancestor
6177898|NCT01715415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177899|NCT01715415|Antiviral Agents|antiviral agents|mesh-ancestor
6177900|NCT01715415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6177901|NCT01715805|Cariprazine|cariprazine|mesh-list
6177902|NCT01715805|Antidepressive Agents|antidepressive agents|mesh-list
6177903|NCT01715805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6177904|NCT01715805|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6177905|NCT01715805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5573744|NCT03907111|Hemostatics|hemostatics|mesh-ancestor
5573745|NCT03907111|Coagulants|coagulants|mesh-ancestor
5573746|NCT03906721|Oxycodone|oxycodone|mesh-list
5573747|NCT03906721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5573748|NCT03906721|Narcotics|narcotics|mesh-ancestor
5573749|NCT03906721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5573750|NCT03906721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573751|NCT03906721|Analgesics|analgesics|mesh-ancestor
5573752|NCT03906721|Sensory System Agents|sensory system agents|mesh-ancestor
5573753|NCT03906721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5573754|NCT03906838|Ropivacaine|ropivacaine|mesh-list
5573755|NCT03906838|Anesthetics, Local|anesthetics, local|mesh-ancestor
5573756|NCT03906838|Anesthetics|anesthetics|mesh-ancestor
5573757|NCT03906838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5573758|NCT03906838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573759|NCT03906838|Sensory System Agents|sensory system agents|mesh-ancestor
6177906|NCT01715805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6177907|NCT01715805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206545|NCT02101021|Mitosis Modulators|mitosis modulators|mesh-ancestor
6206546|NCT02101021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206547|NCT02101021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6206548|NCT02101021|Antimetabolites|antimetabolites|mesh-ancestor
6206549|NCT02101021|Antiviral Agents|antiviral agents|mesh-ancestor
6206550|NCT02101021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6206551|NCT02101021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6206552|NCT02101021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6206553|NCT02101021|Immunologic Factors|immunologic factors|mesh-ancestor
6206554|NCT02101021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206555|NCT02101021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6206556|NCT02101034|Cetuximab|cetuximab|mesh-list
6206557|NCT02101034|Palbociclib|palbociclib|mesh-list
6206558|NCT02101034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5573760|NCT03906838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5573761|NCT03906669|Tamoxifen|tamoxifen|mesh-list
5573762|NCT03906669|Letrozole|letrozole|mesh-list
5573763|NCT03906669|Progesterone|progesterone|mesh-list
5573764|NCT03906669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5573765|NCT03906669|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6206559|NCT02101034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6206560|NCT02101034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6206561|NCT02101034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6487371|NCT00575978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5573766|NCT03906669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6206562|NCT02101034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206563|NCT02101112|Apixaban|apixaban|mesh-list
6206564|NCT02101112|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6206565|NCT02101112|Antithrombins|antithrombins|mesh-ancestor
6206566|NCT02101112|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6206567|NCT02101112|Protease Inhibitors|protease inhibitors|mesh-ancestor
6206568|NCT02101112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6206569|NCT02101112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206570|NCT02101112|Anticoagulants|anticoagulants|mesh-ancestor
6206571|NCT02101190|Opicapone|opicapone|mesh-list
6206572|NCT02101190|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6206573|NCT02101190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6206574|NCT02101190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206575|NCT02101190|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6206576|NCT02101190|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6206577|NCT02101281|Mitogens|mitogens|mesh-list
6206578|NCT02101281|Mitosis Modulators|mitosis modulators|mesh-ancestor
6206579|NCT02101281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206580|NCT02101359|Tetracaine|tetracaine|mesh-list
6206581|NCT02101359|Tropicamide|tropicamide|mesh-list
6206582|NCT02101359|Mydriatics|mydriatics|mesh-list
6206583|NCT02101359|Anesthetics, Local|anesthetics, local|mesh-ancestor
6206584|NCT02101359|Anesthetics|anesthetics|mesh-ancestor
6206585|NCT02101359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6206586|NCT02101359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206587|NCT02101359|Sensory System Agents|sensory system agents|mesh-ancestor
5573767|NCT03906669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6177908|NCT01715896|Golimumab|golimumab|mesh-list
6177909|NCT01715896|Mavrilimumab|mavrilimumab|mesh-list
5573768|NCT03906669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573769|NCT03906669|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5573770|NCT03906669|Hormone Antagonists|hormone antagonists|mesh-ancestor
5573771|NCT03906669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5573772|NCT03906669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573773|NCT03906669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5573774|NCT03906669|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5573775|NCT03906669|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5573776|NCT03906669|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5573777|NCT03906669|Progestins|progestins|mesh-ancestor
5573778|NCT03906669|Hormones|hormones|mesh-ancestor
5573779|NCT03905798|Lorazepam|lorazepam|mesh-list
5573780|NCT03905798|Anticonvulsants|anticonvulsants|mesh-ancestor
5573781|NCT03905798|Antiemetics|antiemetics|mesh-ancestor
5573782|NCT03905798|Autonomic Agents|autonomic agents|mesh-ancestor
5573783|NCT03905798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6177910|NCT01715896|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6177911|NCT01715896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6177912|NCT01715896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6177913|NCT01715896|Immunologic Factors|immunologic factors|mesh-ancestor
6177914|NCT01715896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177915|NCT01715896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6177916|NCT01716039|Adalimumab|adalimumab|mesh-list
5573784|NCT03905798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573785|NCT03905798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5573786|NCT03905798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5573787|NCT03905798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5573788|NCT03905798|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5573789|NCT03905798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5573790|NCT03905798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5573791|NCT03905798|GABA Modulators|gaba modulators|mesh-ancestor
5573792|NCT03905798|GABA Agents|gaba agents|mesh-ancestor
5573793|NCT03905798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5573794|NCT03905798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573795|NCT03905928|Nicotine|nicotine|mesh-list
5573796|NCT03905928|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5573797|NCT03905928|Autonomic Agents|autonomic agents|mesh-ancestor
5573798|NCT03905928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5573799|NCT03905928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573800|NCT03905928|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5573801|NCT03905928|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5573802|NCT03905928|Cholinergic Agents|cholinergic agents|mesh-ancestor
5573803|NCT03905928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5573804|NCT03905928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573805|NCT03905837|Lidocaine|lidocaine|mesh-list
5573806|NCT03905837|Piperidine|piperidine|mesh-list
6177917|NCT01716039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6177918|NCT01716039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6177919|NCT01716117|Calcium Carbonate|calcium carbonate|mesh-list
6177920|NCT01716117|Antacids|antacids|mesh-ancestor
6177921|NCT01716117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573807|NCT03905837|Remifentanil|remifentanil|mesh-list
5573808|NCT03905837|Anesthetics, Local|anesthetics, local|mesh-ancestor
5573809|NCT03905837|Anesthetics|anesthetics|mesh-ancestor
5573810|NCT03905837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5573811|NCT03905837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573812|NCT03905837|Sensory System Agents|sensory system agents|mesh-ancestor
5573813|NCT03905837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5573814|NCT03905837|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5573815|NCT03905837|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5573816|NCT03905837|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5573817|NCT03905837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5573818|NCT03905837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573819|NCT03905837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6177922|NCT01716117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6177923|NCT01716156|Ribavirin|ribavirin|mesh-list
6177924|NCT01716156|Grazoprevir|grazoprevir|mesh-list
5573820|NCT03905837|Narcotics|narcotics|mesh-ancestor
5573821|NCT03905837|Analgesics|analgesics|mesh-ancestor
5573822|NCT03905837|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5573823|NCT03905837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6177925|NCT01716156|Antimetabolites|antimetabolites|mesh-ancestor
6177926|NCT01716156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573824|NCT03905941|Metformin|metformin|mesh-list
5573825|NCT03905941|Contraceptive Agents|contraceptive agents|mesh-list
5573826|NCT03905941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5573827|NCT03905941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573828|NCT03905941|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5573829|NCT03906123|3-n-butylphthalide|3-n-butylphthalide|mesh-list
5573830|NCT03906123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5573831|NCT03906123|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5573832|NCT03906123|Protective Agents|protective agents|mesh-ancestor
5573833|NCT03906123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573834|NCT03905967|Lenvatinib|lenvatinib|mesh-list
5573835|NCT03905967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5573836|NCT03905967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5573837|NCT03905967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5573838|NCT03905967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177927|NCT01716156|Antiviral Agents|antiviral agents|mesh-ancestor
6177928|NCT01716156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6177929|NCT01716195|Paclitaxel|paclitaxel|mesh-list
6177930|NCT01716195|Carboplatin|carboplatin|mesh-list
6177931|NCT01716195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6177932|NCT01716195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6177933|NCT01716195|Tubulin Modulators|tubulin modulators|mesh-ancestor
6177934|NCT01716195|Antimitotic Agents|antimitotic agents|mesh-ancestor
6177935|NCT01716195|Mitosis Modulators|mitosis modulators|mesh-ancestor
6177936|NCT01716195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177937|NCT01716208|Ofatumumab|ofatumumab|mesh-list
6177938|NCT01716208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6177939|NCT01716221|Dexetimide|dexetimide|mesh-list
6177940|NCT01716221|Bupropion|bupropion|mesh-list
5725616|NCT03179605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5573839|NCT03905759|Colchicine|colchicine|mesh-list
5573840|NCT03905759|Amiodarone|amiodarone|mesh-list
5573841|NCT03905759|Dronedarone|dronedarone|mesh-list
5573842|NCT03905759|Gout Suppressants|gout suppressants|mesh-ancestor
5573843|NCT03905759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5573844|NCT03905759|Tubulin Modulators|tubulin modulators|mesh-ancestor
5573845|NCT03905759|Antimitotic Agents|antimitotic agents|mesh-ancestor
5573846|NCT03905759|Mitosis Modulators|mitosis modulators|mesh-ancestor
5573847|NCT03905759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573848|NCT03905759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5573849|NCT03905759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5573850|NCT03905759|Vasodilator Agents|vasodilator agents|mesh-ancestor
5573851|NCT03905759|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5573852|NCT03905759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5573853|NCT03905759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5573854|NCT03905759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5573855|NCT03905759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5573856|NCT03905759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5573857|NCT03905759|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5573858|NCT03905759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5573859|NCT03905759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5604405|NCT04900038|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5604406|NCT04900038|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5604407|NCT04865835|Metformin|metformin|mesh-list
5604408|NCT04865835|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5604409|NCT04865835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604410|NCT04842045|Midazolam|midazolam|mesh-list
5604411|NCT04842045|Psilocybin|psilocybin|mesh-list
5604412|NCT04842045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5604413|NCT04842045|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5604414|NCT04842045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5604415|NCT04842045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604416|NCT04842045|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5604417|NCT04842045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5604418|NCT04842045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5604419|NCT04842045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5604420|NCT04842045|Anesthetics, General|anesthetics, general|mesh-ancestor
5604421|NCT04842045|Anesthetics|anesthetics|mesh-ancestor
5604422|NCT04842045|GABA Modulators|gaba modulators|mesh-ancestor
5604423|NCT04842045|GABA Agents|gaba agents|mesh-ancestor
5604424|NCT04842045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5604425|NCT04842045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604426|NCT04842045|Hallucinogens|hallucinogens|mesh-ancestor
5604427|NCT04781972|Methylphenidate|methylphenidate|mesh-list
5604428|NCT04781972|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6177941|NCT01716221|Citalopram|citalopram|mesh-list
6487372|NCT00575978|Vasodilator Agents|vasodilator agents|mesh-ancestor
5573860|NCT03905603|Cosyntropin|cosyntropin|mesh-list
5573861|NCT03905603|Hormones|hormones|mesh-ancestor
5573862|NCT03905603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5573863|NCT03905603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573864|NCT03905317|Bevacizumab|bevacizumab|mesh-list
5573865|NCT03905317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5573866|NCT03905317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5573867|NCT03905317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5573868|NCT03905317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5573869|NCT03905317|Growth Substances|growth substances|mesh-ancestor
5573870|NCT03905317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573871|NCT03905317|Growth Inhibitors|growth inhibitors|mesh-ancestor
5573872|NCT03905486|Pregabalin|pregabalin|mesh-list
5573873|NCT03905486|Analgesics|analgesics|mesh-ancestor
5725617|NCT03179605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725618|NCT03179514|Vasodilator Agents|vasodilator agents|mesh-list
5725619|NCT03179514|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
5725620|NCT03179514|Lipid Regulating Agents|lipid regulating agents|mesh-list
5725621|NCT03179384|Ceftriaxone|ceftriaxone|mesh-list
5725622|NCT03179384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6177942|NCT01716221|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6177943|NCT01716221|Antidepressive Agents|antidepressive agents|mesh-ancestor
6177944|NCT01716221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6177945|NCT01716221|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6177946|NCT01716221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6177947|NCT01716221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6177948|NCT01716221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177949|NCT01716221|Dopamine Agents|dopamine agents|mesh-ancestor
6177950|NCT01716221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6177951|NCT01716221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177952|NCT01716221|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6177953|NCT01716221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6177954|NCT01716221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6177955|NCT01716221|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6177956|NCT01716221|Serotonin Agents|serotonin agents|mesh-ancestor
6177957|NCT01716221|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6177958|NCT01716221|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6177959|NCT01716221|Parasympatholytics|parasympatholytics|mesh-ancestor
6177960|NCT01716221|Autonomic Agents|autonomic agents|mesh-ancestor
6177961|NCT01716221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6177962|NCT01716221|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6177963|NCT01716221|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6177964|NCT01716221|Cholinergic Agents|cholinergic agents|mesh-ancestor
6177965|NCT01716234|Posaconazole|posaconazole|mesh-list
6177966|NCT01716234|Antifungal Agents|antifungal agents|mesh-ancestor
6177967|NCT01716234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6177968|NCT01716234|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6177969|NCT01716234|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6177970|NCT01716234|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6177971|NCT01716234|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6177972|NCT01716234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6177973|NCT01716234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6177974|NCT01716234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177975|NCT01716234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6177976|NCT01716234|Hormone Antagonists|hormone antagonists|mesh-ancestor
6177977|NCT01716234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6177978|NCT01716234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177979|NCT01716585|Ribavirin|ribavirin|mesh-list
6177980|NCT01716585|Antimetabolites|antimetabolites|mesh-ancestor
6177981|NCT01716585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177982|NCT01716585|Antiviral Agents|antiviral agents|mesh-ancestor
6177983|NCT01716585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6177984|NCT01716715|Paclitaxel|paclitaxel|mesh-list
5573874|NCT03905486|Sensory System Agents|sensory system agents|mesh-ancestor
5573875|NCT03905486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5573876|NCT03905486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573877|NCT03905486|Anticonvulsants|anticonvulsants|mesh-ancestor
5573878|NCT03905486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5573879|NCT03905486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5573880|NCT03905486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573881|NCT03905486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5573882|NCT03905486|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5725623|NCT03179384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6177985|NCT01716715|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6177986|NCT01716715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6177987|NCT01716715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6177988|NCT01716715|Tubulin Modulators|tubulin modulators|mesh-ancestor
5573883|NCT03905486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5573884|NCT03905486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5573885|NCT03905486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5573886|NCT03905655|Nitazoxanide|nitazoxanide|mesh-list
5573887|NCT03905655|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5573888|NCT03905655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5573889|NCT03905564|Pyridoxine|pyridoxine|mesh-list
5573890|NCT03905564|Vitamin B 6|vitamin b 6|mesh-list
5573891|NCT03905564|Doxylamine|doxylamine|mesh-list
5573892|NCT03905564|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
5573893|NCT03905564|Doxylamine succinate|doxylamine succinate|mesh-list
5573894|NCT03905564|Vitamin B Complex|vitamin b complex|mesh-ancestor
5573895|NCT03905564|Vitamins|vitamins|mesh-ancestor
5573896|NCT03905564|Micronutrients|micronutrients|mesh-ancestor
5573897|NCT03905564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177989|NCT01716715|Antimitotic Agents|antimitotic agents|mesh-ancestor
6177990|NCT01716715|Mitosis Modulators|mitosis modulators|mesh-ancestor
6177991|NCT01716715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6177992|NCT01716754|Omalizumab|omalizumab|mesh-list
6177993|NCT01716754|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6177994|NCT01716754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6177995|NCT01716754|Respiratory System Agents|respiratory system agents|mesh-ancestor
6177996|NCT01717040|Pioglitazone|pioglitazone|mesh-list
6177997|NCT01717040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6177998|NCT01717040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6177999|NCT01717053|Prednisone|prednisone|mesh-list
6178000|NCT01717053|Abiraterone Acetate|abiraterone acetate|mesh-list
6178001|NCT01717053|Androgens|androgens|mesh-list
6487373|NCT00576017|Fentanyl|fentanyl|mesh-list
6487374|NCT00576017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6487375|NCT00576017|Narcotics|narcotics|mesh-ancestor
6487376|NCT00576017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6487377|NCT00576017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487378|NCT00576017|Analgesics|analgesics|mesh-ancestor
6487379|NCT00576017|Sensory System Agents|sensory system agents|mesh-ancestor
6487380|NCT00576017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6487381|NCT00576017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6487382|NCT00576017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6487383|NCT00576017|Anesthetics, General|anesthetics, general|mesh-ancestor
6487384|NCT00576017|Anesthetics|anesthetics|mesh-ancestor
6487385|NCT00576069|Fluticasone|fluticasone|mesh-list
6487386|NCT00576069|Mometasone Furoate|mometasone furoate|mesh-list
6487387|NCT00576069|Prednisone|prednisone|mesh-list
6487388|NCT00576069|Budesonide|budesonide|mesh-list
6487389|NCT00576069|Formoterol Fumarate|formoterol fumarate|mesh-list
6487390|NCT00576069|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6487391|NCT00576069|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6487392|NCT00576069|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6487393|NCT00576069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6487394|NCT00576069|Glucocorticoids|glucocorticoids|mesh-ancestor
6487395|NCT00576069|Hormones|hormones|mesh-ancestor
6487396|NCT00576069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6487397|NCT00576069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487398|NCT00576069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6670607|NCT01544439|Antifungal Agents|antifungal agents|mesh-ancestor
5573898|NCT03905564|Antiemetics|antiemetics|mesh-ancestor
6178002|NCT01717053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6178003|NCT01717053|Glucocorticoids|glucocorticoids|mesh-ancestor
6178004|NCT01717053|Hormones|hormones|mesh-ancestor
6178005|NCT01717053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6178006|NCT01717053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178007|NCT01717053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6178008|NCT01717053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6178009|NCT01717053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6178010|NCT01717053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6178011|NCT01717053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178012|NCT01717053|Hormone Antagonists|hormone antagonists|mesh-ancestor
6178013|NCT01717053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5573899|NCT03905564|Autonomic Agents|autonomic agents|mesh-ancestor
5573900|NCT03905564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6178014|NCT01717209|Epoprostenol|epoprostenol|mesh-list
6178015|NCT01717209|Nitric Oxide|nitric oxide|mesh-list
6487399|NCT00576069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5573901|NCT03905564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5573902|NCT03905564|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5573903|NCT03905564|Histamine Antagonists|histamine antagonists|mesh-ancestor
5573904|NCT03905564|Histamine Agents|histamine agents|mesh-ancestor
5573905|NCT03905564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5573906|NCT03905564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573907|NCT03904849|Cannabidiol|cannabidiol|mesh-list
5573908|NCT03904849|Anticonvulsants|anticonvulsants|mesh-ancestor
5573909|NCT03905018|Tadalafil|tadalafil|mesh-list
5573910|NCT03905018|Vasodilator Agents|vasodilator agents|mesh-ancestor
5573911|NCT03905018|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5573912|NCT03905018|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5573913|NCT03905018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5573914|NCT03905018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573915|NCT03905018|Urological Agents|urological agents|mesh-ancestor
5573916|NCT03904836|Tobramycin|tobramycin|mesh-list
5573917|NCT03904836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5573918|NCT03904836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5573919|NCT03904888|Anesthetics|anesthetics|mesh-list
5573920|NCT03904888|Anesthetics, Local|anesthetics, local|mesh-list
5573921|NCT03904888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5573922|NCT03904888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573923|NCT03904888|Sensory System Agents|sensory system agents|mesh-ancestor
5573924|NCT03904888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5573925|NCT03904680|Vitamin D|vitamin d|mesh-list
5573926|NCT03904680|Methotrexate|methotrexate|mesh-list
5573927|NCT03904680|Vitamins|vitamins|mesh-ancestor
5573928|NCT03904680|Micronutrients|micronutrients|mesh-ancestor
5573929|NCT03904680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573930|NCT03904680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5573931|NCT03904680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5573932|NCT03904680|Abortifacient Agents|abortifacient agents|mesh-ancestor
5573933|NCT03904680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5573934|NCT03904680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5573935|NCT03904680|Antimetabolites|antimetabolites|mesh-ancestor
6178016|NCT01717209|Tezosentan|tezosentan|mesh-list
6178017|NCT01717209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6178018|NCT01717209|Autonomic Agents|autonomic agents|mesh-ancestor
6178019|NCT01717209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6178020|NCT01717209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178021|NCT01717209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6178022|NCT01717209|Respiratory System Agents|respiratory system agents|mesh-ancestor
6178023|NCT01717209|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6178024|NCT01717209|Antioxidants|antioxidants|mesh-ancestor
6178025|NCT01717209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178026|NCT01717209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6178027|NCT01717209|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6178028|NCT01717209|Vasodilator Agents|vasodilator agents|mesh-ancestor
6178029|NCT01717209|Gasotransmitters|gasotransmitters|mesh-ancestor
6178030|NCT01717209|Protective Agents|protective agents|mesh-ancestor
6178031|NCT01717209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6178032|NCT01717209|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6178033|NCT01717287|Raltegravir Potassium|raltegravir potassium|mesh-list
6178034|NCT01717287|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6178035|NCT01717287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6178036|NCT01717287|Antiviral Agents|antiviral agents|mesh-ancestor
6178037|NCT01717287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5573936|NCT03904680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573937|NCT03904680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5573938|NCT03904680|Dermatologic Agents|dermatologic agents|mesh-ancestor
5573939|NCT03904680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5573940|NCT03904680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6178038|NCT01717287|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6178039|NCT01717287|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6178040|NCT01717287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6178041|NCT01717287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178042|NCT01717313|Metformin|metformin|mesh-list
6178043|NCT01717313|Glimepiride|glimepiride|mesh-list
6178044|NCT01717313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6178045|NCT01717313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670608|NCT01544439|Keratolytic Agents|keratolytic agents|mesh-ancestor
6670609|NCT01544439|Dermatologic Agents|dermatologic agents|mesh-ancestor
6670610|NCT01544504|Norepinephrine|norepinephrine|mesh-list
6670611|NCT01544504|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5573941|NCT03904680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5573942|NCT03904680|Immunologic Factors|immunologic factors|mesh-ancestor
6670612|NCT01544504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6670613|NCT01544504|Adrenergic Agents|adrenergic agents|mesh-ancestor
6670614|NCT01544504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6178046|NCT01717313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6178047|NCT01717313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6178048|NCT01717313|Immunologic Factors|immunologic factors|mesh-ancestor
6178049|NCT01717326|Ribavirin|ribavirin|mesh-list
6178050|NCT01717326|Grazoprevir|grazoprevir|mesh-list
6178051|NCT01717326|Antimetabolites|antimetabolites|mesh-ancestor
6178052|NCT01717326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178053|NCT01717326|Antiviral Agents|antiviral agents|mesh-ancestor
6178054|NCT01717326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6178055|NCT01717456|Loperamide|loperamide|mesh-list
6178056|NCT01717456|Antidiarrheals|antidiarrheals|mesh-list
6178057|NCT01717456|Laxatives|laxatives|mesh-list
6178058|NCT01717456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6178059|NCT01717638|Vaccines|vaccines|mesh-list
6178060|NCT01717638|Immunologic Factors|immunologic factors|mesh-ancestor
6178061|NCT01717638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178062|NCT01717742|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6178063|NCT01717742|Plasminogen|plasminogen|mesh-list
6178064|NCT01717742|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6178065|NCT01717742|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6178066|NCT01717742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178067|NCT01717768|Testosterone|testosterone|mesh-list
6178068|NCT01717768|Androgens|androgens|mesh-ancestor
6178069|NCT01717768|Hormones|hormones|mesh-ancestor
6178070|NCT01717768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6178071|NCT01717768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178072|NCT01717872|Pyrithione zinc|pyrithione zinc|mesh-list
6178073|NCT01717872|Keratolytic Agents|keratolytic agents|mesh-ancestor
6178074|NCT01717872|Dermatologic Agents|dermatologic agents|mesh-ancestor
6178075|NCT01717898|Prednisone|prednisone|mesh-list
6178076|NCT01717898|Abiraterone Acetate|abiraterone acetate|mesh-list
6178077|NCT01717898|Dactolisib|dactolisib|mesh-list
6178078|NCT01717898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6178079|NCT01717898|Glucocorticoids|glucocorticoids|mesh-ancestor
6178080|NCT01717898|Hormones|hormones|mesh-ancestor
6178081|NCT01717898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5573943|NCT03904680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5573944|NCT03904680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5573945|NCT03904550|Rocuronium|rocuronium|mesh-list
5573946|NCT03904550|Cisatracurium|cisatracurium|mesh-list
5573947|NCT03904550|Neostigmine|neostigmine|mesh-list
5573948|NCT03904550|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5573949|NCT03904550|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5573950|NCT03904550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5573951|NCT03904550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5573952|NCT03904550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178082|NCT01717898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178083|NCT01717898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6178084|NCT01717898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6178085|NCT01717898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6178086|NCT01717898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6178087|NCT01717898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178088|NCT01717898|Hormone Antagonists|hormone antagonists|mesh-ancestor
6178089|NCT01717898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6178090|NCT01718353|Prednisone|prednisone|mesh-list
6178091|NCT01718353|Docetaxel|docetaxel|mesh-list
6178092|NCT01718353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6178093|NCT01718353|Tubulin Modulators|tubulin modulators|mesh-ancestor
6178094|NCT01718353|Antimitotic Agents|antimitotic agents|mesh-ancestor
6178095|NCT01718353|Mitosis Modulators|mitosis modulators|mesh-ancestor
6178096|NCT01718353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178097|NCT01718353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6178098|NCT01718353|Glucocorticoids|glucocorticoids|mesh-ancestor
6178099|NCT01718353|Hormones|hormones|mesh-ancestor
6178100|NCT01718353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6178101|NCT01718353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178102|NCT01718353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6178103|NCT01718483|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6178104|NCT01718483|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6178105|NCT01718483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178106|NCT01718483|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5573953|NCT03904550|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6178107|NCT01718483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6178108|NCT01718483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6178109|NCT01718483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178110|NCT01718483|Dopamine Agents|dopamine agents|mesh-ancestor
6178111|NCT01718483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6178112|NCT01718509|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6487400|NCT00576069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6487401|NCT00576069|Autonomic Agents|autonomic agents|mesh-ancestor
6487402|NCT00576069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5573954|NCT03904550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6178113|NCT01718509|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6178114|NCT01718509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573955|NCT03904550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573956|NCT03904550|Cholinergic Agents|cholinergic agents|mesh-ancestor
5573957|NCT03904550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6178115|NCT01718509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6178116|NCT01718509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6178117|NCT01718509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6178118|NCT01718509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178119|NCT01718509|Dopamine Agents|dopamine agents|mesh-ancestor
6178120|NCT01718509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6178121|NCT01718691|Rituximab|rituximab|mesh-list
6178122|NCT01718691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6178123|NCT01718691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6178124|NCT01718691|Immunologic Factors|immunologic factors|mesh-ancestor
6178125|NCT01718691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178126|NCT01718691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6178127|NCT01719003|Metformin|metformin|mesh-list
6178128|NCT01719003|Empagliflozin|empagliflozin|mesh-list
6178129|NCT01719003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6178130|NCT01719003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178131|NCT01719003|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6178132|NCT01719003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178133|NCT01719172|Hemostatics|hemostatics|mesh-list
6178134|NCT01719172|Coagulants|coagulants|mesh-ancestor
6178135|NCT01719367|Atenolol|atenolol|mesh-list
6178136|NCT01719367|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5573958|NCT03904550|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5573959|NCT03904550|Autonomic Agents|autonomic agents|mesh-ancestor
5573960|NCT03904719|Vorolanib|vorolanib|mesh-list
6178137|NCT01719367|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6178138|NCT01719367|Sympatholytics|sympatholytics|mesh-ancestor
6178139|NCT01719367|Autonomic Agents|autonomic agents|mesh-ancestor
6178140|NCT01719367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6178141|NCT01719367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178142|NCT01719367|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6178143|NCT01719367|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6178144|NCT01719367|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5573961|NCT03904719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5573962|NCT03904719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5573963|NCT03904719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573964|NCT03904446|Methylergonovine|methylergonovine|mesh-list
5573965|NCT03904446|Oxytocics|oxytocics|mesh-ancestor
5573966|NCT03904446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5573967|NCT03904446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573968|NCT03904745|Atosiban|atosiban|mesh-list
5573969|NCT03904745|Hormone Antagonists|hormone antagonists|mesh-ancestor
5573970|NCT03904745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5573971|NCT03904745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573972|NCT03904745|Tocolytic Agents|tocolytic agents|mesh-ancestor
5573973|NCT03904745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5573974|NCT03904563|Bevacizumab|bevacizumab|mesh-list
5573975|NCT03904563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5573976|NCT03904563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5573977|NCT03904563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5573978|NCT03904563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5573979|NCT03904563|Growth Substances|growth substances|mesh-ancestor
5573980|NCT03904563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573981|NCT03904563|Growth Inhibitors|growth inhibitors|mesh-ancestor
5573982|NCT03904732|Aspirin|aspirin|mesh-list
5573983|NCT03904732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6487403|NCT00576069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6178145|NCT01719367|Adrenergic Agents|adrenergic agents|mesh-ancestor
6178146|NCT01719367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6178147|NCT01719367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178148|NCT01719380|Cetuximab|cetuximab|mesh-list
6178149|NCT01719380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6178150|NCT01719380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6178151|NCT01719653|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
6178152|NCT01719653|Laxatives|laxatives|mesh-ancestor
6178153|NCT01719653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6178154|NCT01719757|Oxycodone|oxycodone|mesh-list
6178155|NCT01719757|Naloxone|naloxone|mesh-list
6178156|NCT01719757|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6178157|NCT01719757|Narcotics|narcotics|mesh-ancestor
6178158|NCT01719757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6178159|NCT01719757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178160|NCT01719757|Analgesics|analgesics|mesh-ancestor
6178161|NCT01719757|Sensory System Agents|sensory system agents|mesh-ancestor
6178162|NCT01719757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6178163|NCT01719757|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5573984|NCT03904732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5573985|NCT03904732|Analgesics|analgesics|mesh-ancestor
5573986|NCT03904732|Sensory System Agents|sensory system agents|mesh-ancestor
5573987|NCT03904732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5573988|NCT03904732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573989|NCT03904732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5573990|NCT03904732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5573991|NCT03904732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5573992|NCT03904732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5573993|NCT03904732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5573994|NCT03904732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5573995|NCT03904732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5573996|NCT03904732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6178164|NCT01719783|Vaccines|vaccines|mesh-list
6178165|NCT01719783|Immunologic Factors|immunologic factors|mesh-ancestor
6178166|NCT01719783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178167|NCT01719861|Desipramine|desipramine|mesh-list
6178168|NCT01719861|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6178169|NCT01719861|Antidepressive Agents|antidepressive agents|mesh-ancestor
6178170|NCT01719861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6178171|NCT01719861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6178172|NCT01719861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178173|NCT01719861|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6178174|NCT01719861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6178175|NCT01719861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6178176|NCT01719861|Adrenergic Agents|adrenergic agents|mesh-ancestor
6178177|NCT01719861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6178178|NCT01719861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178179|NCT01720043|Bortezomib|bortezomib|mesh-list
6178180|NCT01720043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6178181|NCT01720173|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
6178182|NCT01720173|Immunologic Factors|immunologic factors|mesh-ancestor
6178183|NCT01720173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5573997|NCT03904732|Antipyretics|antipyretics|mesh-ancestor
5573998|NCT03904537|Antibodies|antibodies|mesh-list
5573999|NCT03904537|Immunologic Factors|immunologic factors|mesh-ancestor
5574000|NCT03904537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574001|NCT03904381|Fluorouracil|fluorouracil|mesh-list
5574002|NCT03904381|Antimetabolites|antimetabolites|mesh-ancestor
5574003|NCT03904381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574004|NCT03904381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5574005|NCT03904381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5574006|NCT03904381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5574007|NCT03904381|Immunologic Factors|immunologic factors|mesh-ancestor
5574008|NCT03904381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574009|NCT03904355|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5574010|NCT03904355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6178184|NCT01720225|Azacitidine|azacitidine|mesh-list
6178185|NCT01720225|Decitabine|decitabine|mesh-list
6178186|NCT01720225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6178187|NCT01720225|Antimetabolites|antimetabolites|mesh-ancestor
6178188|NCT01720225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178189|NCT01720225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6178190|NCT01720225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6178191|NCT01720264|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5574011|NCT03904355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178192|NCT01720264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6178193|NCT01720264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178194|NCT01720264|Incretins|incretins|mesh-ancestor
6178195|NCT01720264|Hormones|hormones|mesh-ancestor
6178196|NCT01720264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6178197|NCT01720264|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6178198|NCT01720264|Protease Inhibitors|protease inhibitors|mesh-ancestor
6178199|NCT01720264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6178200|NCT01720264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178201|NCT01720277|Vaccines|vaccines|mesh-list
6178202|NCT01720277|Immunologic Factors|immunologic factors|mesh-ancestor
6178203|NCT01720277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178204|NCT01720316|Glycine|glycine|mesh-list
6178205|NCT01720316|Glycine Agents|glycine agents|mesh-ancestor
6178206|NCT01720316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6178207|NCT01720316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178208|NCT01720316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178209|NCT01720524|Sildenafil Citrate|sildenafil citrate|mesh-list
6178210|NCT01720524|Vasodilator Agents|vasodilator agents|mesh-ancestor
6178211|NCT01720524|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6178212|NCT01720524|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6178213|NCT01720524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6178214|NCT01720524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178215|NCT01720524|Urological Agents|urological agents|mesh-ancestor
6178216|NCT01720602|Letrozole|letrozole|mesh-list
6178217|NCT01720602|Vorinostat|vorinostat|mesh-list
6178218|NCT01720602|Anastrozole|anastrozole|mesh-list
6178219|NCT01720602|Exemestane|exemestane|mesh-list
6178220|NCT01720602|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6178221|NCT01720602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6178222|NCT01720602|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6178223|NCT01720602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6178224|NCT01720602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6178225|NCT01720602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178226|NCT01720602|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6178227|NCT01720602|Hormone Antagonists|hormone antagonists|mesh-ancestor
6178228|NCT01720602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6178229|NCT01720602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178230|NCT01720602|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6178231|NCT01720602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6178232|NCT01720602|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6178233|NCT01720667|Levetiracetam|levetiracetam|mesh-list
6178234|NCT01720667|Phenobarbital|phenobarbital|mesh-list
5574012|NCT03904368|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5574013|NCT03904368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5574014|NCT03904368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574015|NCT03903952|Vitamin B 12|vitamin b 12|mesh-list
5574016|NCT03903952|Hydroxocobalamin|hydroxocobalamin|mesh-list
5574017|NCT03903952|Vitamins|vitamins|mesh-ancestor
5574018|NCT03903952|Micronutrients|micronutrients|mesh-ancestor
5574019|NCT03903952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574020|NCT03903952|Vitamin B Complex|vitamin b complex|mesh-ancestor
5574021|NCT03903952|Hematinics|hematinics|mesh-ancestor
5574022|NCT03904108|Ramucirumab|ramucirumab|mesh-list
5574023|NCT03904108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5574024|NCT03904251|Cytarabine|cytarabine|mesh-list
5574025|NCT03904251|Daunorubicin|daunorubicin|mesh-list
5574026|NCT03904251|Gemtuzumab|gemtuzumab|mesh-list
5574027|NCT03904251|Calicheamicins|calicheamicins|mesh-list
5574028|NCT03904251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5574029|NCT03904251|Antimetabolites|antimetabolites|mesh-ancestor
5574030|NCT03904251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574031|NCT03904251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5574032|NCT03904251|Antiviral Agents|antiviral agents|mesh-ancestor
5574033|NCT03904251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5574034|NCT03904251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5574035|NCT03904251|Immunologic Factors|immunologic factors|mesh-ancestor
5574036|NCT03904251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574037|NCT03904251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5574038|NCT03904251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5574039|NCT03904251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5574040|NCT03904251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5574041|NCT03904251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5604429|NCT04781972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604430|NCT04781972|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5574042|NCT03904225|Tegafur|tegafur|mesh-list
5574043|NCT03904225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5574044|NCT03904225|Antimetabolites|antimetabolites|mesh-ancestor
5574045|NCT03904225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574046|NCT03904225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5574047|NCT03903835|Prednisone|prednisone|mesh-list
5574048|NCT03903835|Carboplatin|carboplatin|mesh-list
5574049|NCT03903835|Docetaxel|docetaxel|mesh-list
5574050|NCT03903835|Abiraterone Acetate|abiraterone acetate|mesh-list
5574051|NCT03903835|Niraparib|niraparib|mesh-list
6178235|NCT01720667|Anticonvulsants|anticonvulsants|mesh-ancestor
6178236|NCT01720667|Nootropic Agents|nootropic agents|mesh-ancestor
6178237|NCT01720667|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6178238|NCT01720667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6178239|NCT01720667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178240|NCT01720667|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5574052|NCT03903835|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
5574053|NCT03903835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5574054|NCT03903835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5574055|NCT03903835|Tubulin Modulators|tubulin modulators|mesh-ancestor
5574056|NCT03903835|Antimitotic Agents|antimitotic agents|mesh-ancestor
5574057|NCT03903835|Mitosis Modulators|mitosis modulators|mesh-ancestor
5574058|NCT03903835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574059|NCT03903835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5574060|NCT03903835|Glucocorticoids|glucocorticoids|mesh-ancestor
5574061|NCT03903835|Hormones|hormones|mesh-ancestor
5574062|NCT03903835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5574063|NCT03903835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574064|NCT03903835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5574065|NCT03903835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5574066|NCT03903835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5574067|NCT03903835|Hormone Antagonists|hormone antagonists|mesh-ancestor
5574068|NCT03903835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5574069|NCT03903835|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5574070|NCT03904056|Ranibizumab|ranibizumab|mesh-list
5574071|NCT03904056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5574072|NCT03904056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5574073|NCT03904056|Growth Substances|growth substances|mesh-ancestor
5574074|NCT03904056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178241|NCT01720667|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6178242|NCT01720667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6178243|NCT01720667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178244|NCT01720667|GABA Modulators|gaba modulators|mesh-ancestor
6178245|NCT01720667|GABA Agents|gaba agents|mesh-ancestor
6178246|NCT01720667|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6178247|NCT01720667|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6178248|NCT01720667|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6178249|NCT01720797|Chlorhexidine|chlorhexidine|mesh-list
6178250|NCT01720797|Anesthetics|anesthetics|mesh-list
6178251|NCT01720797|Anesthetics, Local|anesthetics, local|mesh-list
6178252|NCT01720797|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6178253|NCT01720797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6178254|NCT01720797|Disinfectants|disinfectants|mesh-ancestor
6178255|NCT01720797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6178256|NCT01720797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178257|NCT01720797|Sensory System Agents|sensory system agents|mesh-ancestor
6178258|NCT01720797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6178259|NCT01721070|Ketoconazole|ketoconazole|mesh-list
6178260|NCT01721070|Sufentanil|sufentanil|mesh-list
6178261|NCT01721070|Dsuvia|dsuvia|mesh-list
6178262|NCT01721070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6178263|NCT01721070|Narcotics|narcotics|mesh-ancestor
6178264|NCT01721070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6178265|NCT01721070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178266|NCT01721070|Analgesics|analgesics|mesh-ancestor
6178267|NCT01721070|Sensory System Agents|sensory system agents|mesh-ancestor
6178268|NCT01721070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6178269|NCT01721070|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6178270|NCT01721070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6178271|NCT01721070|Anesthetics, General|anesthetics, general|mesh-ancestor
6178272|NCT01721070|Anesthetics|anesthetics|mesh-ancestor
6178273|NCT01721070|Antifungal Agents|antifungal agents|mesh-ancestor
6178274|NCT01721070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5574075|NCT03904056|Growth Inhibitors|growth inhibitors|mesh-ancestor
5574076|NCT03904056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5574077|NCT03903887|Antibodies|antibodies|mesh-list
5574078|NCT03903887|Immunologic Factors|immunologic factors|mesh-ancestor
5574079|NCT03903887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574080|NCT03904004|Botulinum Toxins|botulinum toxins|mesh-list
5574081|NCT03904004|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5574082|NCT03904004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5574083|NCT03904004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574084|NCT03904004|Cholinergic Agents|cholinergic agents|mesh-ancestor
5574085|NCT03904004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6178275|NCT01721070|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6178276|NCT01721070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6178277|NCT01721070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6178278|NCT01721070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178279|NCT01721070|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6178280|NCT01721070|Hormone Antagonists|hormone antagonists|mesh-ancestor
6178281|NCT01721070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6178282|NCT01721070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6178283|NCT01721109|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6178284|NCT01721109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6178285|NCT01721109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6178286|NCT01721109|Antiviral Agents|antiviral agents|mesh-ancestor
6178287|NCT01721109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6178288|NCT01721226|Opiate Alkaloids|opiate alkaloids|mesh-list
6487404|NCT00576069|Respiratory System Agents|respiratory system agents|mesh-ancestor
6487405|NCT00576069|Dermatologic Agents|dermatologic agents|mesh-ancestor
5574086|NCT03904004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574087|NCT03903809|Epoetin Alfa|epoetin alfa|mesh-list
5574088|NCT03903809|Hematinics|hematinics|mesh-ancestor
5574089|NCT03903718|Oseltamivir|oseltamivir|mesh-list
5574090|NCT03903718|MEDI8852|medi8852|mesh-list
5574091|NCT03903718|Antiviral Agents|antiviral agents|mesh-ancestor
5574092|NCT03903718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6487406|NCT00576069|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6487407|NCT00576069|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6487408|NCT00576069|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6487409|NCT00576069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6487410|NCT00576069|Adrenergic Agents|adrenergic agents|mesh-ancestor
6487411|NCT00576069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6487412|NCT00576069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6487413|NCT00576069|Sympathomimetics|sympathomimetics|mesh-ancestor
6178289|NCT01721226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6178290|NCT01721226|Narcotics|narcotics|mesh-ancestor
6178291|NCT01721226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6178292|NCT01721226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178293|NCT01721226|Analgesics|analgesics|mesh-ancestor
6178294|NCT01721226|Sensory System Agents|sensory system agents|mesh-ancestor
6178295|NCT01721226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6178296|NCT01721317|Ezogabine|ezogabine|mesh-list
6178297|NCT01721317|Anticonvulsants|anticonvulsants|mesh-ancestor
6178298|NCT01721317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6178299|NCT01721317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178300|NCT01721330|Naltrexone|naltrexone|mesh-list
6487414|NCT00576173|Acetaminophen|acetaminophen|mesh-list
6487415|NCT00576173|Tramadol|tramadol|mesh-list
6487416|NCT00576173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6487417|NCT00576173|Analgesics|analgesics|mesh-ancestor
6487418|NCT00576173|Sensory System Agents|sensory system agents|mesh-ancestor
6487419|NCT00576173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6487420|NCT00576173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487421|NCT00576173|Antipyretics|antipyretics|mesh-ancestor
6487422|NCT00576173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6487423|NCT00576173|Narcotics|narcotics|mesh-ancestor
6487424|NCT00576173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6487425|NCT00576225|Paclitaxel|paclitaxel|mesh-list
6487426|NCT00576225|Carboplatin|carboplatin|mesh-list
5574093|NCT03903718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5574094|NCT03903718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574095|NCT03903783|Ceftriaxone|ceftriaxone|mesh-list
5574096|NCT03903783|Cefotaxime|cefotaxime|mesh-list
5574097|NCT03903783|Cefoxitin|cefoxitin|mesh-list
5574098|NCT03903783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5574099|NCT03903783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5574100|NCT03903640|Nivolumab|nivolumab|mesh-list
5574101|NCT03903640|Ipilimumab|ipilimumab|mesh-list
5574102|NCT03903640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5574103|NCT03903640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5574104|NCT03903640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5574105|NCT03903640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574106|NCT03903419|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5574107|NCT03903419|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5574108|NCT03903419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574109|NCT03903367|Fentanyl|fentanyl|mesh-list
5574110|NCT03903367|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6487427|NCT00576225|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
6487428|NCT00576225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5574111|NCT03903367|Narcotics|narcotics|mesh-ancestor
5574112|NCT03903367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5574113|NCT03903367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574114|NCT03903367|Analgesics|analgesics|mesh-ancestor
5574115|NCT03903367|Sensory System Agents|sensory system agents|mesh-ancestor
5574116|NCT03903367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5574117|NCT03903367|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5574118|NCT03903367|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5574119|NCT03903367|Anesthetics, General|anesthetics, general|mesh-ancestor
5574120|NCT03903367|Anesthetics|anesthetics|mesh-ancestor
5574121|NCT03903458|Nivolumab|nivolumab|mesh-list
5574122|NCT03903458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5574123|NCT03903458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5574124|NCT03903458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6487429|NCT00576225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6487430|NCT00576225|Tubulin Modulators|tubulin modulators|mesh-ancestor
6487431|NCT00576225|Antimitotic Agents|antimitotic agents|mesh-ancestor
5574125|NCT03903458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574126|NCT03903302|Valproic Acid|valproic acid|mesh-list
5574127|NCT03903302|Anticonvulsants|anticonvulsants|mesh-ancestor
5574128|NCT03903302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5574129|NCT03903302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6487432|NCT00576225|Mitosis Modulators|mitosis modulators|mesh-ancestor
6487433|NCT00576225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6487434|NCT00576238|Betamethasone|betamethasone|mesh-list
6487435|NCT00576238|Betamethasone Valerate|betamethasone valerate|mesh-list
6487436|NCT00576238|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
6487437|NCT00576238|Betamethasone benzoate|betamethasone benzoate|mesh-list
5574130|NCT03903302|GABA Agents|gaba agents|mesh-ancestor
6178301|NCT01721330|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5574131|NCT03903302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6487438|NCT00576238|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
6178302|NCT01721330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6178303|NCT01721330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178304|NCT01721330|Sensory System Agents|sensory system agents|mesh-ancestor
6178305|NCT01721330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6178306|NCT01721408|Imipenem|imipenem|mesh-list
6178307|NCT01721408|Tigecycline|tigecycline|mesh-list
6178308|NCT01721408|Cilastatin|cilastatin|mesh-list
5574132|NCT03903302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574133|NCT03903302|Antimanic Agents|antimanic agents|mesh-ancestor
5574134|NCT03903302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5574135|NCT03903302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5574136|NCT03903302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5574137|NCT03903653|Botulinum Toxins|botulinum toxins|mesh-list
5574138|NCT03903653|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5574139|NCT03903653|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5574140|NCT03903653|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5574141|NCT03903653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5574142|NCT03903653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574143|NCT03903653|Cholinergic Agents|cholinergic agents|mesh-ancestor
5574144|NCT03903653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5574145|NCT03903653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574146|NCT03903653|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5574147|NCT03903653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5574148|NCT03903185|Sofosbuvir|sofosbuvir|mesh-list
5574149|NCT03903185|Ledipasvir|ledipasvir|mesh-list
5574150|NCT03903185|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
5574151|NCT03903185|Antiviral Agents|antiviral agents|mesh-ancestor
5574152|NCT03903185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5574153|NCT03903029|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5574154|NCT03903029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6178309|NCT01721408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6178310|NCT01721408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6178311|NCT01721408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6178312|NCT01721408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6178313|NCT01721408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178314|NCT01721408|Protease Inhibitors|protease inhibitors|mesh-ancestor
6178315|NCT01721460|Dexmedetomidine|dexmedetomidine|mesh-list
6178316|NCT01721460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6178317|NCT01721460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6178318|NCT01721460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178319|NCT01721460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5574155|NCT03903029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5574156|NCT03903029|Antimetabolites|antimetabolites|mesh-ancestor
5574157|NCT03903029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574158|NCT03903029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5574159|NCT03903029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5574160|NCT03903029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5574161|NCT03903133|Vitamin E|vitamin e|mesh-list
5574162|NCT03903133|Antioxidants|antioxidants|mesh-list
5574163|NCT03903133|Vitamins|vitamins|mesh-ancestor
5574164|NCT03903133|Micronutrients|micronutrients|mesh-ancestor
5574165|NCT03903133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574166|NCT03903133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574167|NCT03903133|Protective Agents|protective agents|mesh-ancestor
5574168|NCT03902912|Prednisolone|prednisolone|mesh-list
5574169|NCT03902912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6178320|NCT01721460|Analgesics|analgesics|mesh-ancestor
6178321|NCT01721460|Sensory System Agents|sensory system agents|mesh-ancestor
6178322|NCT01721460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6178323|NCT01721460|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6178324|NCT01721460|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6178325|NCT01721460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6178326|NCT01721460|Adrenergic Agents|adrenergic agents|mesh-ancestor
6178327|NCT01721460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6178328|NCT01721460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178329|NCT01721486|Acetaminophen|acetaminophen|mesh-list
6178330|NCT01721486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6178331|NCT01721486|Analgesics|analgesics|mesh-ancestor
6178332|NCT01721486|Sensory System Agents|sensory system agents|mesh-ancestor
6178333|NCT01721486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6178334|NCT01721486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574170|NCT03902912|Glucocorticoids|glucocorticoids|mesh-ancestor
5574171|NCT03902912|Hormones|hormones|mesh-ancestor
5604431|NCT04781972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6178335|NCT01721486|Antipyretics|antipyretics|mesh-ancestor
5574172|NCT03902912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5574173|NCT03902912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574174|NCT03902912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5574175|NCT03902912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5574176|NCT03902925|Lidocaine|lidocaine|mesh-list
5574177|NCT03902925|Ropivacaine|ropivacaine|mesh-list
5574178|NCT03902925|Anesthetics, Local|anesthetics, local|mesh-ancestor
6178336|NCT01721564|Bosentan|bosentan|mesh-list
6178337|NCT01721564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6178338|NCT01721564|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6178339|NCT01721564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178340|NCT01721603|Trametinib|trametinib|mesh-list
6178341|NCT01721603|Dabrafenib|dabrafenib|mesh-list
6178342|NCT01721603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6178343|NCT01721603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6178344|NCT01721603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6178345|NCT01721603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178346|NCT01721746|Paclitaxel|paclitaxel|mesh-list
6178347|NCT01721746|Carboplatin|carboplatin|mesh-list
6178348|NCT01721746|Nivolumab|nivolumab|mesh-list
6178349|NCT01721746|Dacarbazine|dacarbazine|mesh-list
6178350|NCT01721746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6178351|NCT01721746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6178352|NCT01721746|Tubulin Modulators|tubulin modulators|mesh-ancestor
6178353|NCT01721746|Antimitotic Agents|antimitotic agents|mesh-ancestor
6178354|NCT01721746|Mitosis Modulators|mitosis modulators|mesh-ancestor
6178355|NCT01721746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178356|NCT01721746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6178357|NCT01721746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6178358|NCT01721746|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6178359|NCT01721746|Alkylating Agents|alkylating agents|mesh-ancestor
6178360|NCT01721772|Nivolumab|nivolumab|mesh-list
6178361|NCT01721772|Dacarbazine|dacarbazine|mesh-list
6178362|NCT01721772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6178363|NCT01721772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6178364|NCT01721772|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6178365|NCT01721772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178366|NCT01721772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6178367|NCT01721772|Alkylating Agents|alkylating agents|mesh-ancestor
6178368|NCT01721876|Cytarabine|cytarabine|mesh-list
6178369|NCT01721876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6178370|NCT01721876|Antimetabolites|antimetabolites|mesh-ancestor
6178371|NCT01721876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178372|NCT01721876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6178373|NCT01721876|Antiviral Agents|antiviral agents|mesh-ancestor
6178374|NCT01721876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5574179|NCT03902925|Anesthetics|anesthetics|mesh-ancestor
5574180|NCT03902925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5574181|NCT03902925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574182|NCT03902925|Sensory System Agents|sensory system agents|mesh-ancestor
5725624|NCT03179293|Propofol|propofol|mesh-list
6178375|NCT01721876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6178376|NCT01721876|Immunologic Factors|immunologic factors|mesh-ancestor
6178377|NCT01721876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178378|NCT01721967|Ranolazine|ranolazine|mesh-list
6178379|NCT01721967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6178380|NCT01721967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6178381|NCT01721967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178382|NCT01722045|Aflibercept|aflibercept|mesh-list
6178383|NCT01722045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6178384|NCT01722045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6178385|NCT01722045|Growth Substances|growth substances|mesh-ancestor
6178386|NCT01722045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178387|NCT01722045|Growth Inhibitors|growth inhibitors|mesh-ancestor
6178388|NCT01722045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6178389|NCT01722071|Oxytocin|oxytocin|mesh-list
6178390|NCT01722071|Oxytocics|oxytocics|mesh-ancestor
6178391|NCT01722071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6178392|NCT01722071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206588|NCT02101359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6206589|NCT02101359|Autonomic Agents|autonomic agents|mesh-ancestor
6206590|NCT02101359|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6206591|NCT02101359|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6206592|NCT02101359|Cholinergic Agents|cholinergic agents|mesh-ancestor
6206593|NCT02101359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5574183|NCT03902925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5574184|NCT03902925|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5574185|NCT03902925|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5574186|NCT03902925|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5574187|NCT03902925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5574188|NCT03902925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178393|NCT01722097|Rocuronium|rocuronium|mesh-list
6178394|NCT01722097|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6178395|NCT01722097|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6178396|NCT01722097|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6178397|NCT01722097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6178398|NCT01722097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178399|NCT01722162|Bevacizumab|bevacizumab|mesh-list
6178400|NCT01722162|Capecitabine|capecitabine|mesh-list
6178401|NCT01722162|Levocetirizine|levocetirizine|mesh-list
6178402|NCT01722162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6178403|NCT01722162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6178404|NCT01722162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6178405|NCT01722162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6178406|NCT01722162|Growth Substances|growth substances|mesh-ancestor
6178407|NCT01722162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178408|NCT01722162|Growth Inhibitors|growth inhibitors|mesh-ancestor
6178409|NCT01722162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6178410|NCT01722162|Antimetabolites|antimetabolites|mesh-ancestor
6178411|NCT01722162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178412|NCT01722162|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6178413|NCT01722162|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6178414|NCT01722162|Histamine Antagonists|histamine antagonists|mesh-ancestor
6178415|NCT01722162|Histamine Agents|histamine agents|mesh-ancestor
6178416|NCT01722162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6178417|NCT01722266|Liraglutide|liraglutide|mesh-list
6178418|NCT01722266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6178419|NCT01722266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178420|NCT01722266|Incretins|incretins|mesh-ancestor
6178421|NCT01722266|Hormones|hormones|mesh-ancestor
6178422|NCT01722266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6178423|NCT01722292|Carboplatin|carboplatin|mesh-list
6178424|NCT01722292|Etoposide|etoposide|mesh-list
6178425|NCT01722292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6178426|NCT01722292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6178427|NCT01722292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5574189|NCT03903016|Insulin|insulin|mesh-list
5574190|NCT03903016|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5574191|NCT03903016|Insulin Lispro|insulin lispro|mesh-list
5574192|NCT03903016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5574193|NCT03903016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574194|NCT03902782|Dexamethasone|dexamethasone|mesh-list
5574195|NCT03902782|Dexamethasone acetate|dexamethasone acetate|mesh-list
5574196|NCT03902782|Epinephrine|epinephrine|mesh-list
5574197|NCT03902782|Bupivacaine|bupivacaine|mesh-list
5574198|NCT03902782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5574199|NCT03902782|Antiemetics|antiemetics|mesh-ancestor
6670615|NCT01544504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670616|NCT01544504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670617|NCT01544504|Sympathomimetics|sympathomimetics|mesh-ancestor
6670618|NCT01544504|Autonomic Agents|autonomic agents|mesh-ancestor
6670619|NCT01544504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6670620|NCT01544504|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6670621|NCT01544517|Amoxicillin|amoxicillin|mesh-list
6670622|NCT01544517|Levofloxacin|levofloxacin|mesh-list
6670623|NCT01544517|Ofloxacin|ofloxacin|mesh-list
6670624|NCT01544517|Tinidazole|tinidazole|mesh-list
6670625|NCT01544517|Esomeprazole|esomeprazole|mesh-list
6178428|NCT01722292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6178429|NCT01722292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6178430|NCT01722292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670626|NCT01544517|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
6670627|NCT01544517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6670628|NCT01544517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6670629|NCT01544517|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6670630|NCT01544517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6670631|NCT01544517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6670632|NCT01544517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670633|NCT01544517|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6670634|NCT01544517|Renal Agents|renal agents|mesh-ancestor
6178431|NCT01722318|Plecanatide|plecanatide|mesh-list
6670635|NCT01544517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6670636|NCT01544517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6670637|NCT01544517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6670638|NCT01544517|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6670639|NCT01544517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6670640|NCT01544517|Alkylating Agents|alkylating agents|mesh-ancestor
6670641|NCT01544517|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
6670642|NCT01544517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6670643|NCT01544517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6670644|NCT01544634|Beclomethasone|beclomethasone|mesh-list
6670645|NCT01544634|Propranolol|propranolol|mesh-list
5574200|NCT03902782|Autonomic Agents|autonomic agents|mesh-ancestor
5574201|NCT03902782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5574202|NCT03902782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574203|NCT03902782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5574204|NCT03902782|Glucocorticoids|glucocorticoids|mesh-ancestor
5574205|NCT03902782|Hormones|hormones|mesh-ancestor
5574206|NCT03902782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5574207|NCT03902782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5574208|NCT03902782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5574209|NCT03902782|Anesthetics, Local|anesthetics, local|mesh-ancestor
5574210|NCT03902782|Anesthetics|anesthetics|mesh-ancestor
5574211|NCT03902782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5574212|NCT03902782|Sensory System Agents|sensory system agents|mesh-ancestor
5574213|NCT03902782|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6178432|NCT01722318|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
6178433|NCT01722318|Enzyme Activators|enzyme activators|mesh-ancestor
6178434|NCT01722318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178435|NCT01722318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6178436|NCT01722331|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6178437|NCT01722331|Immunologic Factors|immunologic factors|mesh-ancestor
6178438|NCT01722331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178439|NCT01722435|Opiate Alkaloids|opiate alkaloids|mesh-list
6178440|NCT01722435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6178441|NCT01722435|Narcotics|narcotics|mesh-ancestor
6178442|NCT01722435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6178443|NCT01722435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178444|NCT01722435|Analgesics|analgesics|mesh-ancestor
6178445|NCT01722435|Sensory System Agents|sensory system agents|mesh-ancestor
6178446|NCT01722435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6178447|NCT01722487|Chlorambucil|chlorambucil|mesh-list
6178448|NCT01722487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6178449|NCT01722487|Alkylating Agents|alkylating agents|mesh-ancestor
6178450|NCT01722487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178451|NCT01722487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6178452|NCT01722604|Brinzolamide|brinzolamide|mesh-list
6178453|NCT01722604|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6178454|NCT01722604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6178455|NCT01722604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178456|NCT01722669|Quercetin|quercetin|mesh-list
6178457|NCT01722669|Antioxidants|antioxidants|mesh-ancestor
6178458|NCT01722669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178459|NCT01722669|Protective Agents|protective agents|mesh-ancestor
6178460|NCT01722669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178461|NCT01723072|Omalizumab|omalizumab|mesh-list
6178462|NCT01723072|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5574214|NCT03902782|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5574215|NCT03902782|Adrenergic Agents|adrenergic agents|mesh-ancestor
5574216|NCT03902782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5574217|NCT03902782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574218|NCT03902782|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5574219|NCT03902782|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5574220|NCT03902782|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5574221|NCT03902782|Respiratory System Agents|respiratory system agents|mesh-ancestor
5574222|NCT03902782|Mydriatics|mydriatics|mesh-ancestor
6178463|NCT01723072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6178464|NCT01723072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6178465|NCT01723072|Respiratory System Agents|respiratory system agents|mesh-ancestor
6178466|NCT01723072|Immunologic Factors|immunologic factors|mesh-ancestor
6178467|NCT01723072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178468|NCT01723228|Rasagiline|rasagiline|mesh-list
6178469|NCT01723228|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6178470|NCT01723228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6670646|NCT01544634|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5574223|NCT03902782|Sympathomimetics|sympathomimetics|mesh-ancestor
5574224|NCT03902782|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5574225|NCT03902418|Tenofovir|tenofovir|mesh-list
5574226|NCT03902418|Emtricitabine|emtricitabine|mesh-list
5574227|NCT03902418|Antiviral Agents|antiviral agents|mesh-ancestor
5574228|NCT03902418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5574229|NCT03902418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5574230|NCT03902418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5574231|NCT03902418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5574232|NCT03902418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574233|NCT03902418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5574234|NCT03902418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5574235|NCT03902522|Leronlimab|leronlimab|mesh-list
6178471|NCT01723228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178472|NCT01723228|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6178473|NCT01723228|Protective Agents|protective agents|mesh-ancestor
6178474|NCT01723228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178475|NCT01723254|Immunoglobulin E|immunoglobulin e|mesh-list
6178476|NCT01723254|Immunologic Factors|immunologic factors|mesh-ancestor
6178477|NCT01723254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178478|NCT01723384|Naltrexone|naltrexone|mesh-list
6178479|NCT01723384|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5574236|NCT03902522|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5574237|NCT03902522|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5574238|NCT03902522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574239|NCT03902522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5574240|NCT03902522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5574241|NCT03902522|Antiviral Agents|antiviral agents|mesh-ancestor
5574242|NCT03902522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5604432|NCT04781972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5604433|NCT04781972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178480|NCT01723384|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6178481|NCT01723384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178482|NCT01723384|Sensory System Agents|sensory system agents|mesh-ancestor
6178483|NCT01723384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6178484|NCT01723514|Erenumab|erenumab|mesh-list
6178485|NCT01723514|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
6178486|NCT01723514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178487|NCT01723514|Analgesics|analgesics|mesh-ancestor
6178488|NCT01723514|Sensory System Agents|sensory system agents|mesh-ancestor
6178489|NCT01723514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6178490|NCT01723514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178491|NCT01723696|Vitamins|vitamins|mesh-list
6178492|NCT01723696|Ascorbic Acid|ascorbic acid|mesh-list
6178493|NCT01723696|Micronutrients|micronutrients|mesh-ancestor
6178494|NCT01723696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178495|NCT01723696|Antioxidants|antioxidants|mesh-ancestor
6178496|NCT01723696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178497|NCT01723696|Protective Agents|protective agents|mesh-ancestor
6178498|NCT01723722|Methadone|methadone|mesh-list
6178499|NCT01723722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6178500|NCT01723722|Narcotics|narcotics|mesh-ancestor
5604434|NCT04781972|Dopamine Agents|dopamine agents|mesh-ancestor
5604435|NCT04781972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5604436|NCT04772274|Ustekinumab|ustekinumab|mesh-list
5604437|NCT04772274|Dermatologic Agents|dermatologic agents|mesh-ancestor
5604438|NCT04752774|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5604439|NCT04752774|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5604440|NCT04752774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5604441|NCT04752774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604442|NCT04752774|Cholinergic Agents|cholinergic agents|mesh-ancestor
5604443|NCT04752774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5604444|NCT04752774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604445|NCT04745845|Norepinephrine|norepinephrine|mesh-list
5604446|NCT04745845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5604447|NCT04745845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5604448|NCT04745845|Adrenergic Agents|adrenergic agents|mesh-ancestor
6178501|NCT01723722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6178502|NCT01723722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178503|NCT01723722|Analgesics|analgesics|mesh-ancestor
6178504|NCT01723722|Sensory System Agents|sensory system agents|mesh-ancestor
6178505|NCT01723722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6178506|NCT01723722|Antitussive Agents|antitussive agents|mesh-ancestor
5604449|NCT04745845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6178507|NCT01723722|Respiratory System Agents|respiratory system agents|mesh-ancestor
6178508|NCT01723904|Rotigotine|rotigotine|mesh-list
6178509|NCT01723904|Dopamine Agonists|dopamine agonists|mesh-ancestor
6178510|NCT01723904|Dopamine Agents|dopamine agents|mesh-ancestor
6178511|NCT01723904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6178512|NCT01723904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178513|NCT01723904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178514|NCT01724021|Prednisone|prednisone|mesh-list
6178515|NCT01724021|Prednisolone|prednisolone|mesh-list
6178516|NCT01724021|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6178517|NCT01724021|Methylprednisolone|methylprednisolone|mesh-list
6178518|NCT01724021|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6178519|NCT01724021|Prednisolone acetate|prednisolone acetate|mesh-list
6178520|NCT01724021|Cyclophosphamide|cyclophosphamide|mesh-list
6178521|NCT01724021|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6178522|NCT01724021|Rituximab|rituximab|mesh-list
6178523|NCT01724021|Vincristine|vincristine|mesh-list
6178524|NCT01724021|Doxorubicin|doxorubicin|mesh-list
6178525|NCT01724021|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6178526|NCT01724021|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6178527|NCT01724021|Prednisolone phosphate|prednisolone phosphate|mesh-list
6178528|NCT01724021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6178529|NCT01724021|Immunologic Factors|immunologic factors|mesh-ancestor
6178530|NCT01724021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178531|NCT01724021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6178532|NCT01724021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6178533|NCT01724021|Alkylating Agents|alkylating agents|mesh-ancestor
6178534|NCT01724021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178535|NCT01724021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6178536|NCT01724021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6178537|NCT01724021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6178538|NCT01724021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6178539|NCT01724021|Glucocorticoids|glucocorticoids|mesh-ancestor
6178540|NCT01724021|Hormones|hormones|mesh-ancestor
6178541|NCT01724021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6178542|NCT01724021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6178543|NCT01724021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6178544|NCT01724021|Tubulin Modulators|tubulin modulators|mesh-ancestor
6178545|NCT01724021|Antimitotic Agents|antimitotic agents|mesh-ancestor
6178546|NCT01724021|Mitosis Modulators|mitosis modulators|mesh-ancestor
6178547|NCT01724021|Antiemetics|antiemetics|mesh-ancestor
6178548|NCT01724021|Autonomic Agents|autonomic agents|mesh-ancestor
6178549|NCT01724021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6178550|NCT01724021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6178551|NCT01724021|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6178552|NCT01724021|Protective Agents|protective agents|mesh-ancestor
6178553|NCT01724021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6178554|NCT01724021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6178555|NCT01724021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6178556|NCT01724021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6178557|NCT01724177|Lenalidomide|lenalidomide|mesh-list
6178558|NCT01724177|Immunologic Factors|immunologic factors|mesh-ancestor
6178559|NCT01724177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178560|NCT01724177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6178561|NCT01724177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6178562|NCT01724177|Growth Substances|growth substances|mesh-ancestor
6178563|NCT01724177|Growth Inhibitors|growth inhibitors|mesh-ancestor
6178564|NCT01724177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6178565|NCT01724359|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6178566|NCT01724359|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6178567|NCT01724359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6178568|NCT01724359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6178569|NCT01724359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178570|NCT01724359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6178571|NCT01724359|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6178572|NCT01724359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6178573|NCT01724359|Serotonin Agents|serotonin agents|mesh-ancestor
6178574|NCT01724359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6178575|NCT01724359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574243|NCT03902106|Albuterol|albuterol|mesh-list
5574244|NCT03902106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5574245|NCT03902106|Autonomic Agents|autonomic agents|mesh-ancestor
6178576|NCT01724359|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6178577|NCT01724359|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6178578|NCT01724359|Dopamine Agents|dopamine agents|mesh-ancestor
6178579|NCT01724489|Hormones|hormones|mesh-list
5574246|NCT03902106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5574247|NCT03902106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574248|NCT03902106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5574249|NCT03902106|Respiratory System Agents|respiratory system agents|mesh-ancestor
5574250|NCT03902106|Tocolytic Agents|tocolytic agents|mesh-ancestor
5574251|NCT03902106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5574252|NCT03902106|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5574253|NCT03902106|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5574254|NCT03902106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5574255|NCT03902106|Adrenergic Agents|adrenergic agents|mesh-ancestor
5574256|NCT03902106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5574257|NCT03902106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574258|NCT03902340|Analgesics|analgesics|mesh-list
5574259|NCT03902340|Sensory System Agents|sensory system agents|mesh-ancestor
5574260|NCT03902340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5574261|NCT03902340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574262|NCT03902249|Dexamethasone|dexamethasone|mesh-list
5574263|NCT03902249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5574264|NCT03902249|Antiemetics|antiemetics|mesh-ancestor
5574265|NCT03902249|Autonomic Agents|autonomic agents|mesh-ancestor
6178580|NCT01724489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6178581|NCT01724489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178582|NCT01724528|Allopurinol|allopurinol|mesh-list
6178583|NCT01724528|Febuxostat|febuxostat|mesh-list
6178584|NCT01724528|Antimetabolites|antimetabolites|mesh-ancestor
6178585|NCT01724528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178586|NCT01724528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6178587|NCT01724528|Gout Suppressants|gout suppressants|mesh-ancestor
6178588|NCT01724528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6178589|NCT01724528|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6178590|NCT01724528|Antioxidants|antioxidants|mesh-ancestor
6178591|NCT01724528|Protective Agents|protective agents|mesh-ancestor
6178592|NCT01724528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178593|NCT01725126|Metformin|metformin|mesh-list
6178594|NCT01725126|Liraglutide|liraglutide|mesh-list
6178595|NCT01725126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6178596|NCT01725126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178597|NCT01725126|Incretins|incretins|mesh-ancestor
6178598|NCT01725126|Hormones|hormones|mesh-ancestor
6178599|NCT01725126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6178600|NCT01725282|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6178601|NCT01725282|Antidepressive Agents|antidepressive agents|mesh-ancestor
6178602|NCT01725282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6178603|NCT01725282|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6178604|NCT01725282|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6178605|NCT01725282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6178606|NCT01725282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178607|NCT01725308|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6178608|NCT01725308|Antidepressive Agents|antidepressive agents|mesh-ancestor
6178609|NCT01725308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6178610|NCT01725308|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6178611|NCT01725308|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6178612|NCT01725308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6178613|NCT01725308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178614|NCT01725386|Capecitabine|capecitabine|mesh-list
6178615|NCT01725386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6178616|NCT01725386|Antimetabolites|antimetabolites|mesh-ancestor
6178617|NCT01725386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178618|NCT01725386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6178619|NCT01725451|Testosterone|testosterone|mesh-list
6178620|NCT01725451|Androgens|androgens|mesh-ancestor
6178621|NCT01725451|Hormones|hormones|mesh-ancestor
6178622|NCT01725451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6178623|NCT01725451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178624|NCT01725529|Ribavirin|ribavirin|mesh-list
6670647|NCT01544634|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6670648|NCT01544634|Adrenergic Agents|adrenergic agents|mesh-ancestor
6670649|NCT01544634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6178625|NCT01725529|Simeprevir|simeprevir|mesh-list
6178626|NCT01725529|Antimetabolites|antimetabolites|mesh-ancestor
6178627|NCT01725529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178628|NCT01725529|Antiviral Agents|antiviral agents|mesh-ancestor
6178629|NCT01725529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6178630|NCT01725529|Protease Inhibitors|protease inhibitors|mesh-ancestor
6178631|NCT01725529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6178632|NCT01726023|Metronidazole|metronidazole|mesh-list
5574266|NCT03902249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5574267|NCT03902249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574268|NCT03902249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5574269|NCT03902249|Glucocorticoids|glucocorticoids|mesh-ancestor
5574270|NCT03902249|Hormones|hormones|mesh-ancestor
6178633|NCT01726023|Meropenem|meropenem|mesh-list
6178634|NCT01726023|Ceftazidime|ceftazidime|mesh-list
6178635|NCT01726023|Avibactam|avibactam|mesh-list
6178636|NCT01726023|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
6178637|NCT01726023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6178638|NCT01726023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6178639|NCT01726023|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6178640|NCT01726023|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6178641|NCT01726023|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5574271|NCT03902249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5574272|NCT03902249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5574273|NCT03902249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5574274|NCT03901729|Furosemide|furosemide|mesh-list
5574275|NCT03901729|Diuretics|diuretics|mesh-ancestor
5574276|NCT03901729|Natriuretic Agents|natriuretic agents|mesh-ancestor
5574277|NCT03901729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574278|NCT03901729|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5574279|NCT03901729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5574280|NCT03901729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574281|NCT03901716|Fentanyl|fentanyl|mesh-list
5574282|NCT03901716|Midazolam|midazolam|mesh-list
5574283|NCT03901716|Sufentanil|sufentanil|mesh-list
5574284|NCT03901716|Remifentanil|remifentanil|mesh-list
5574285|NCT03901716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5574286|NCT03901716|Narcotics|narcotics|mesh-ancestor
5574287|NCT03901716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5574288|NCT03901716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574289|NCT03901716|Analgesics|analgesics|mesh-ancestor
5574290|NCT03901716|Sensory System Agents|sensory system agents|mesh-ancestor
6178642|NCT01726023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6178643|NCT01726023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178644|NCT01726049|Sildenafil Citrate|sildenafil citrate|mesh-list
6178645|NCT01726049|Vasodilator Agents|vasodilator agents|mesh-ancestor
6178646|NCT01726049|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6178647|NCT01726049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6178648|NCT01726049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6178649|NCT01726049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178650|NCT01726049|Urological Agents|urological agents|mesh-ancestor
6178651|NCT01726270|Tamsulosin|tamsulosin|mesh-list
6178652|NCT01726270|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6178653|NCT01726270|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6178654|NCT01726270|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6178655|NCT01726270|Adrenergic Agents|adrenergic agents|mesh-ancestor
6178656|NCT01726270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6178657|NCT01726270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178658|NCT01726270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178659|NCT01726270|Urological Agents|urological agents|mesh-ancestor
6178660|NCT01726335|Risperidone|risperidone|mesh-list
6178661|NCT01726335|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6178662|NCT01726335|Serotonin Agents|serotonin agents|mesh-ancestor
6178663|NCT01726335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6178664|NCT01726335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178665|NCT01726335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178666|NCT01726335|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6178667|NCT01726335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6178668|NCT01726335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6178669|NCT01726335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6178670|NCT01726335|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6178671|NCT01726335|Dopamine Agents|dopamine agents|mesh-ancestor
6178672|NCT01726517|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
6178673|NCT01726517|Antiviral Agents|antiviral agents|mesh-ancestor
6178674|NCT01726517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6178675|NCT01726621|Insulin|insulin|mesh-list
6178676|NCT01726621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6178677|NCT01726621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178678|NCT01726738|Trametinib|trametinib|mesh-list
6178679|NCT01726738|Dabrafenib|dabrafenib|mesh-list
6178680|NCT01726738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6178681|NCT01726738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6178682|NCT01726738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5574291|NCT03901716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5574292|NCT03901716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5574293|NCT03901716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5574294|NCT03901716|Anesthetics, General|anesthetics, general|mesh-ancestor
5574295|NCT03901716|Anesthetics|anesthetics|mesh-ancestor
5574296|NCT03901716|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5574297|NCT03901716|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6178683|NCT01726738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178684|NCT01727024|Tiotropium Bromide|tiotropium bromide|mesh-list
6178685|NCT01727024|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6178686|NCT01727024|Autonomic Agents|autonomic agents|mesh-ancestor
6178687|NCT01727024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6178688|NCT01727024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178689|NCT01727024|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6178690|NCT01727024|Respiratory System Agents|respiratory system agents|mesh-ancestor
6178691|NCT01727024|Parasympatholytics|parasympatholytics|mesh-ancestor
6178692|NCT01727024|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5574298|NCT03901716|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5574299|NCT03901716|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5574300|NCT03901716|GABA Modulators|gaba modulators|mesh-ancestor
5574301|NCT03901716|GABA Agents|gaba agents|mesh-ancestor
5574302|NCT03901716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6178693|NCT01727024|Cholinergic Agents|cholinergic agents|mesh-ancestor
6178694|NCT01727024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6178695|NCT01727024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574303|NCT03901716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574304|NCT03901612|Ropivacaine|ropivacaine|mesh-list
5574305|NCT03901612|Anesthetics, Local|anesthetics, local|mesh-ancestor
5574306|NCT03901612|Anesthetics|anesthetics|mesh-ancestor
5574307|NCT03901612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5574308|NCT03901612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574309|NCT03901612|Sensory System Agents|sensory system agents|mesh-ancestor
5574310|NCT03901612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5574311|NCT03901768|Dexamethasone|dexamethasone|mesh-list
5574312|NCT03901768|Triamcinolone|triamcinolone|mesh-list
6178696|NCT01727089|Bevacizumab|bevacizumab|mesh-list
6178697|NCT01727089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6178698|NCT01727089|Endothelial Growth Factors|endothelial growth factors|mesh-list
6178699|NCT01727089|Antibodies|antibodies|mesh-list
6178700|NCT01727089|Immunoglobulins|immunoglobulins|mesh-list
6178701|NCT01727089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6178702|NCT01727089|Immunoglobulin G|immunoglobulin g|mesh-list
6178703|NCT01727089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6178704|NCT01727089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5574313|NCT03901768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5574314|NCT03901768|Antiemetics|antiemetics|mesh-ancestor
5574315|NCT03901768|Autonomic Agents|autonomic agents|mesh-ancestor
5574316|NCT03901768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5574317|NCT03901768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574318|NCT03901768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5574319|NCT03901768|Glucocorticoids|glucocorticoids|mesh-ancestor
5574320|NCT03901768|Hormones|hormones|mesh-ancestor
5574321|NCT03901768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5574322|NCT03901768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5574323|NCT03901768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5574324|NCT03901482|Dihydroergotamine|dihydroergotamine|mesh-list
5574325|NCT03901482|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5574326|NCT03901482|Dopamine Agonists|dopamine agonists|mesh-ancestor
5574327|NCT03901482|Dopamine Agents|dopamine agents|mesh-ancestor
5574328|NCT03901482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5574329|NCT03901482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574330|NCT03901482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574331|NCT03901482|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5574332|NCT03901482|Analgesics|analgesics|mesh-ancestor
5574333|NCT03901482|Sensory System Agents|sensory system agents|mesh-ancestor
5574334|NCT03901482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5574335|NCT03901690|Imiquimod|imiquimod|mesh-list
5574336|NCT03901690|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5574337|NCT03901690|Immunologic Factors|immunologic factors|mesh-ancestor
5574338|NCT03901690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574339|NCT03901690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5574340|NCT03901690|Interferon Inducers|interferon inducers|mesh-ancestor
5574341|NCT03901378|Pembrolizumab|pembrolizumab|mesh-list
5574342|NCT03901378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5574343|NCT03901378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6178705|NCT01727089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6178706|NCT01727089|Growth Substances|growth substances|mesh-ancestor
5574344|NCT03901118|Paclitaxel|paclitaxel|mesh-list
5574345|NCT03901118|Etoposide|etoposide|mesh-list
5574346|NCT03901118|Chiauranib|chiauranib|mesh-list
5574347|NCT03901118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5574348|NCT03901118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5574349|NCT03901118|Tubulin Modulators|tubulin modulators|mesh-ancestor
5574350|NCT03901118|Antimitotic Agents|antimitotic agents|mesh-ancestor
6178707|NCT01727089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178708|NCT01727089|Growth Inhibitors|growth inhibitors|mesh-ancestor
6178709|NCT01727089|Immunologic Factors|immunologic factors|mesh-ancestor
6178710|NCT01727141|Glycopyrrolate|glycopyrrolate|mesh-list
6178711|NCT01727141|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6178712|NCT01727141|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6178713|NCT01727141|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6178714|NCT01727141|Cholinergic Agents|cholinergic agents|mesh-ancestor
6178715|NCT01727141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6178716|NCT01727141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178717|NCT01727141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178718|NCT01727258|Fluorides|fluorides|mesh-list
6178719|NCT01727258|Cariostatic Agents|cariostatic agents|mesh-ancestor
6178720|NCT01727258|Protective Agents|protective agents|mesh-ancestor
6178721|NCT01727258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178722|NCT01727336|Axitinib|axitinib|mesh-list
6178723|NCT01727336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6178724|NCT01727336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6178725|NCT01727336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6178726|NCT01727336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178727|NCT01727414|Methylphenidate|methylphenidate|mesh-list
6178728|NCT01727414|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6178729|NCT01727414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178730|NCT01727414|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6178731|NCT01727414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6178732|NCT01727414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6178733|NCT01727414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178734|NCT01727414|Dopamine Agents|dopamine agents|mesh-ancestor
6178735|NCT01727414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6178736|NCT01727700|Aripiprazole|aripiprazole|mesh-list
6178737|NCT01727700|Antidepressive Agents|antidepressive agents|mesh-ancestor
6178738|NCT01727700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6178739|NCT01727700|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6178740|NCT01727700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6178741|NCT01727700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6178742|NCT01727700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178743|NCT01727700|Dopamine Agonists|dopamine agonists|mesh-ancestor
6178744|NCT01727700|Dopamine Agents|dopamine agents|mesh-ancestor
5574351|NCT03901118|Mitosis Modulators|mitosis modulators|mesh-ancestor
5574352|NCT03901118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574353|NCT03901118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5574354|NCT03901118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6178745|NCT01727700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6178746|NCT01727700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178747|NCT01727700|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6178748|NCT01727700|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6178749|NCT01727700|Serotonin Agents|serotonin agents|mesh-ancestor
6178750|NCT01727700|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6178751|NCT01727700|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6178752|NCT01727700|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6178753|NCT01727700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6178754|NCT01727713|Aripiprazole|aripiprazole|mesh-list
6178755|NCT01727713|Antidepressive Agents|antidepressive agents|mesh-ancestor
6178756|NCT01727713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6178757|NCT01727713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6178758|NCT01727713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6178759|NCT01727713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6178760|NCT01727713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178761|NCT01727713|Dopamine Agonists|dopamine agonists|mesh-ancestor
6178762|NCT01727713|Dopamine Agents|dopamine agents|mesh-ancestor
6178763|NCT01727713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6178764|NCT01727713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178765|NCT01727713|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5574355|NCT03901118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5574356|NCT03901118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5574357|NCT03901170|Letrozole|letrozole|mesh-list
5574358|NCT03901170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5574359|NCT03901170|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5574360|NCT03901170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5574361|NCT03901170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5574362|NCT03901170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574363|NCT03901170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5574364|NCT03901170|Hormone Antagonists|hormone antagonists|mesh-ancestor
5574365|NCT03901170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5574366|NCT03901170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574367|NCT03900988|Acetylcysteine|acetylcysteine|mesh-list
5574368|NCT03900988|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5574369|NCT03900988|Antiviral Agents|antiviral agents|mesh-ancestor
5574370|NCT03900988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5574371|NCT03900988|Expectorants|expectorants|mesh-ancestor
5574372|NCT03900988|Respiratory System Agents|respiratory system agents|mesh-ancestor
5574373|NCT03900988|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5574374|NCT03900988|Antioxidants|antioxidants|mesh-ancestor
5574375|NCT03900988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574376|NCT03900988|Protective Agents|protective agents|mesh-ancestor
5574377|NCT03900988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178766|NCT01727713|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6178767|NCT01727713|Serotonin Agents|serotonin agents|mesh-ancestor
6178768|NCT01727713|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6178769|NCT01727713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6178770|NCT01727713|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6178771|NCT01727713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6178772|NCT01727726|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6178773|NCT01727726|Brexpiprazole|brexpiprazole|mesh-list
6178774|NCT01727726|Antidepressive Agents|antidepressive agents|mesh-ancestor
6178775|NCT01727726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6178776|NCT01727726|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6178777|NCT01727726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6178778|NCT01727726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6178779|NCT01727726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178780|NCT01727726|Serotonin Agents|serotonin agents|mesh-ancestor
6178781|NCT01727726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6178782|NCT01727726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178783|NCT01727726|Dopamine Agonists|dopamine agonists|mesh-ancestor
6178784|NCT01727726|Dopamine Agents|dopamine agents|mesh-ancestor
6178785|NCT01727791|Pregabalin|pregabalin|mesh-list
6178786|NCT01727791|Analgesics|analgesics|mesh-ancestor
6178787|NCT01727791|Sensory System Agents|sensory system agents|mesh-ancestor
6178788|NCT01727791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6178789|NCT01727791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178790|NCT01727791|Anticonvulsants|anticonvulsants|mesh-ancestor
6178791|NCT01727791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6178792|NCT01727791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6178793|NCT01727791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178794|NCT01727791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6178795|NCT01727791|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5574378|NCT03900988|Antidotes|antidotes|mesh-ancestor
5574379|NCT03901001|Sirolimus|sirolimus|mesh-list
6178796|NCT01727791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6178797|NCT01727791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6178798|NCT01727791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6487439|NCT00576238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6487440|NCT00576238|Glucocorticoids|glucocorticoids|mesh-ancestor
6487441|NCT00576238|Hormones|hormones|mesh-ancestor
6487442|NCT00576238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6487443|NCT00576238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487444|NCT00576238|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6487445|NCT00576238|Respiratory System Agents|respiratory system agents|mesh-ancestor
6487446|NCT00576329|Ketorolac|ketorolac|mesh-list
6487447|NCT00576329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6487448|NCT00576329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6487449|NCT00576329|Analgesics|analgesics|mesh-ancestor
6487450|NCT00576329|Sensory System Agents|sensory system agents|mesh-ancestor
6487451|NCT00576329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6487452|NCT00576329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487453|NCT00576329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6487454|NCT00576329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5574380|NCT03901001|Oseltamivir|oseltamivir|mesh-list
6487455|NCT00576329|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6487456|NCT00576329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6487457|NCT00576329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178799|NCT01728077|Brivaracetam|brivaracetam|mesh-list
6178800|NCT01728077|Anticonvulsants|anticonvulsants|mesh-ancestor
6178801|NCT01728194|Citalopram|citalopram|mesh-list
6178802|NCT01728194|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6178803|NCT01728194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6178804|NCT01728194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6178805|NCT01728194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178806|NCT01728194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6178807|NCT01728194|Serotonin Agents|serotonin agents|mesh-ancestor
6178808|NCT01728194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178809|NCT01728194|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6178810|NCT01728194|Antidepressive Agents|antidepressive agents|mesh-ancestor
6178811|NCT01728194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6178812|NCT01728246|Acetaminophen|acetaminophen|mesh-list
6178813|NCT01728246|Tramadol|tramadol|mesh-list
6178814|NCT01728246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6178815|NCT01728246|Analgesics|analgesics|mesh-ancestor
6178816|NCT01728246|Sensory System Agents|sensory system agents|mesh-ancestor
6178817|NCT01728246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6178818|NCT01728246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178819|NCT01728246|Antipyretics|antipyretics|mesh-ancestor
6178820|NCT01728246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6178821|NCT01728246|Narcotics|narcotics|mesh-ancestor
6178822|NCT01728246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5574381|NCT03901001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5574382|NCT03901001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5574383|NCT03901001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5574384|NCT03901001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5574385|NCT03901001|Antifungal Agents|antifungal agents|mesh-ancestor
5574386|NCT03901001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5574387|NCT03901001|Immunologic Factors|immunologic factors|mesh-ancestor
5574388|NCT03901001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178823|NCT01728324|Ribavirin|ribavirin|mesh-list
6178824|NCT01728324|Antimetabolites|antimetabolites|mesh-ancestor
6178825|NCT01728324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178826|NCT01728324|Antiviral Agents|antiviral agents|mesh-ancestor
6178827|NCT01728324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6178828|NCT01728337|Botulinum Toxins|botulinum toxins|mesh-list
6178829|NCT01728337|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6178830|NCT01728337|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6178831|NCT01728337|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6178832|NCT01728337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6178833|NCT01728337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178834|NCT01728337|Cholinergic Agents|cholinergic agents|mesh-ancestor
6178835|NCT01728337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5574389|NCT03901001|Antiviral Agents|antiviral agents|mesh-ancestor
5574390|NCT03901001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5574391|NCT03901001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574392|NCT03900949|Cytarabine|cytarabine|mesh-list
5574393|NCT03900949|Daunorubicin|daunorubicin|mesh-list
6178836|NCT01728337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178837|NCT01728337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6178838|NCT01728337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6178839|NCT01728376|Daptomycin|daptomycin|mesh-list
6178840|NCT01728376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6178841|NCT01728376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6178842|NCT01728584|Bromides|bromides|mesh-list
6178843|NCT01728584|Rocuronium|rocuronium|mesh-list
6178844|NCT01728584|Anticonvulsants|anticonvulsants|mesh-ancestor
6178845|NCT01728584|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6178846|NCT01728584|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6178847|NCT01728584|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6178848|NCT01728584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6178849|NCT01728584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178850|NCT01728623|Lenvatinib|lenvatinib|mesh-list
6178851|NCT01728623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6178852|NCT01728623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6178853|NCT01728623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6178854|NCT01728623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178855|NCT01728636|Tranexamic Acid|tranexamic acid|mesh-list
6487458|NCT00576368|Insulin Glargine|insulin glargine|mesh-list
5574394|NCT03900949|Gemtuzumab|gemtuzumab|mesh-list
6178856|NCT01728636|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6178857|NCT01728636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6178858|NCT01728636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178859|NCT01728636|Hemostatics|hemostatics|mesh-ancestor
6178860|NCT01728636|Coagulants|coagulants|mesh-ancestor
6178861|NCT01728779|Nelfinavir|nelfinavir|mesh-list
6178862|NCT01728779|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6178863|NCT01728779|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6178864|NCT01728779|Protease Inhibitors|protease inhibitors|mesh-ancestor
6178865|NCT01728779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6178866|NCT01728779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178867|NCT01728779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6178868|NCT01728779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6178869|NCT01728779|Antiviral Agents|antiviral agents|mesh-ancestor
6178870|NCT01728779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6178871|NCT01728805|Vorinostat|vorinostat|mesh-list
6178872|NCT01728805|Mogamulizumab|mogamulizumab|mesh-list
6178873|NCT01728805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6178874|NCT01728805|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6178875|NCT01728805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6178876|NCT01728805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178877|NCT01729156|Metformin|metformin|mesh-list
6178878|NCT01729156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6487459|NCT00576368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6487460|NCT00576368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487461|NCT00576394|Insulin|insulin|mesh-list
6487462|NCT00576394|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6487463|NCT00576394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6487464|NCT00576394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487465|NCT00576433|Rituximab|rituximab|mesh-list
6178879|NCT01729156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178880|NCT01729338|Cyclophosphamide|cyclophosphamide|mesh-list
6178881|NCT01729338|Lenalidomide|lenalidomide|mesh-list
6487466|NCT00576433|Methotrexate|methotrexate|mesh-list
6487467|NCT00576433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6178882|NCT01729338|Bortezomib|bortezomib|mesh-list
6178883|NCT01729338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6178884|NCT01729338|Immunologic Factors|immunologic factors|mesh-ancestor
6178885|NCT01729338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178886|NCT01729338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6178887|NCT01729338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6178888|NCT01729338|Alkylating Agents|alkylating agents|mesh-ancestor
6178889|NCT01729338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178890|NCT01729338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6178891|NCT01729338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6178892|NCT01729338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6178893|NCT01729338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6178894|NCT01729338|Growth Substances|growth substances|mesh-ancestor
6178895|NCT01729338|Growth Inhibitors|growth inhibitors|mesh-ancestor
6178896|NCT01729494|Mycophenolic Acid|mycophenolic acid|mesh-list
6178897|NCT01729494|Prednisone|prednisone|mesh-list
6178898|NCT01729494|Alemtuzumab|alemtuzumab|mesh-list
6178899|NCT01729494|Abatacept|abatacept|mesh-list
6178900|NCT01729494|Tacrolimus|tacrolimus|mesh-list
6178901|NCT01729494|Thymoglobulin|thymoglobulin|mesh-list
6178902|NCT01729494|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6178903|NCT01729494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6178904|NCT01729494|Glucocorticoids|glucocorticoids|mesh-ancestor
6178905|NCT01729494|Hormones|hormones|mesh-ancestor
6178906|NCT01729494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6178907|NCT01729494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178908|NCT01729494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6178909|NCT01729494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6178910|NCT01729494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6178911|NCT01729494|Immunologic Factors|immunologic factors|mesh-ancestor
6178912|NCT01729494|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6178913|NCT01729494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6178914|NCT01729494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178915|NCT01729494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6178916|NCT01729494|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6178917|NCT01729494|Antitubercular Agents|antitubercular agents|mesh-ancestor
6178918|NCT01729494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6178919|NCT01729494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6178920|NCT01729494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6178921|NCT01729494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6178922|NCT01729494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6178923|NCT01729559|Heparin|heparin|mesh-list
6487468|NCT00576433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6178924|NCT01729559|Enoxaparin|enoxaparin|mesh-list
6178925|NCT01729559|Calcium heparin|calcium heparin|mesh-list
6178926|NCT01729559|Enoxaparin sodium|enoxaparin sodium|mesh-list
6178927|NCT01729559|Anticoagulants|anticoagulants|mesh-ancestor
6178928|NCT01729559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6178929|NCT01729559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6178930|NCT01729559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178931|NCT01729598|Valproic Acid|valproic acid|mesh-list
6178932|NCT01729598|Anticonvulsants|anticonvulsants|mesh-ancestor
6178933|NCT01729598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5574395|NCT03900949|Midostaurin|midostaurin|mesh-list
5574396|NCT03900949|Calicheamicins|calicheamicins|mesh-list
5574397|NCT03900949|Staurosporine|staurosporine|mesh-list
5574398|NCT03900949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5574399|NCT03900949|Antimetabolites|antimetabolites|mesh-ancestor
5574400|NCT03900949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574401|NCT03900949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5574402|NCT03900949|Antiviral Agents|antiviral agents|mesh-ancestor
5574403|NCT03900949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5574404|NCT03900949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5574405|NCT03900949|Immunologic Factors|immunologic factors|mesh-ancestor
5574406|NCT03900949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574407|NCT03900949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5574408|NCT03900949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5574409|NCT03900949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5574410|NCT03900949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5574411|NCT03900949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5574412|NCT03900949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5574413|NCT03900884|Letrozole|letrozole|mesh-list
5574414|NCT03900884|Venetoclax|venetoclax|mesh-list
5574415|NCT03900884|Palbociclib|palbociclib|mesh-list
5574416|NCT03900884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5574417|NCT03900884|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5574418|NCT03900884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5574419|NCT03900884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5574420|NCT03900884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574421|NCT03900884|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5574422|NCT03900884|Hormone Antagonists|hormone antagonists|mesh-ancestor
5574423|NCT03900884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5574424|NCT03900884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574425|NCT03900884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5574426|NCT03900871|Aspirin|aspirin|mesh-list
5574427|NCT03900871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5574428|NCT03900871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5574429|NCT03900871|Analgesics|analgesics|mesh-ancestor
5574430|NCT03900871|Sensory System Agents|sensory system agents|mesh-ancestor
5574431|NCT03900871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5574432|NCT03900871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574433|NCT03900871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5574434|NCT03900871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5574435|NCT03900871|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6178934|NCT01729598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178935|NCT01729598|GABA Agents|gaba agents|mesh-ancestor
6178936|NCT01729598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6178937|NCT01729598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178938|NCT01729598|Antimanic Agents|antimanic agents|mesh-ancestor
6178939|NCT01729598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6178940|NCT01729598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6178941|NCT01729598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6178942|NCT01729728|Tapentadol|tapentadol|mesh-list
6178943|NCT01729728|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6178944|NCT01729728|Narcotics|narcotics|mesh-ancestor
5574436|NCT03900871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5574437|NCT03900871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574438|NCT03900871|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5574439|NCT03900871|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5574440|NCT03900871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5574441|NCT03900871|Antipyretics|antipyretics|mesh-ancestor
5574442|NCT03900858|Isoniazid|isoniazid|mesh-list
5574443|NCT03900858|Rifapentine|rifapentine|mesh-list
5574444|NCT03900858|Rifampin|rifampin|mesh-list
5574445|NCT03900858|Antitubercular Agents|antitubercular agents|mesh-ancestor
5574446|NCT03900858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5574447|NCT03900858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5574448|NCT03900858|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6178945|NCT01729728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5574449|NCT03900858|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5574450|NCT03900858|Antimetabolites|antimetabolites|mesh-ancestor
5574451|NCT03900858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574452|NCT03900858|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5574453|NCT03900858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5574454|NCT03900858|Leprostatic Agents|leprostatic agents|mesh-ancestor
5574455|NCT03900858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5574456|NCT03900858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5574457|NCT03900858|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5574458|NCT03900858|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5574459|NCT03900858|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5574460|NCT03900858|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5574461|NCT03900858|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5574462|NCT03900858|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5574463|NCT03900793|Sunitinib|sunitinib|mesh-list
5574464|NCT03900793|Losartan|losartan|mesh-list
5574465|NCT03900793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6670650|NCT01544634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670651|NCT01544634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487469|NCT00576433|Immunologic Factors|immunologic factors|mesh-ancestor
6487470|NCT00576433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487471|NCT00576433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6178946|NCT01729728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178947|NCT01729728|Analgesics|analgesics|mesh-ancestor
6178948|NCT01729728|Sensory System Agents|sensory system agents|mesh-ancestor
6178949|NCT01729728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6178950|NCT01729728|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6178951|NCT01729728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6178952|NCT01729728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6178953|NCT01729728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178954|NCT01729728|Adrenergic Agents|adrenergic agents|mesh-ancestor
6178955|NCT01729728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6178956|NCT01729819|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
6178957|NCT01729819|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6178958|NCT01729819|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6178959|NCT01729819|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6178960|NCT01729819|Cholinergic Agents|cholinergic agents|mesh-ancestor
6178961|NCT01729819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6178962|NCT01729819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178963|NCT01729819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178964|NCT01729819|Urological Agents|urological agents|mesh-ancestor
6178965|NCT01729819|Hemostatics|hemostatics|mesh-ancestor
6178966|NCT01729819|Coagulants|coagulants|mesh-ancestor
6178967|NCT01729819|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5574466|NCT03900793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5574467|NCT03900793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5574468|NCT03900793|Growth Substances|growth substances|mesh-ancestor
5574469|NCT03900793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178968|NCT01729819|Natriuretic Agents|natriuretic agents|mesh-ancestor
6178969|NCT01729845|Cytarabine|cytarabine|mesh-list
6178970|NCT01729845|Etoposide|etoposide|mesh-list
6178971|NCT01729845|Podophyllotoxin|podophyllotoxin|mesh-list
6178972|NCT01729845|Mitoxantrone|mitoxantrone|mesh-list
6178973|NCT01729845|Etoposide phosphate|etoposide phosphate|mesh-list
6178974|NCT01729845|Decitabine|decitabine|mesh-list
6178975|NCT01729845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6178976|NCT01729845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6178977|NCT01729845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6178978|NCT01729845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6178979|NCT01729845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6178980|NCT01729845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6178981|NCT01729845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6178982|NCT01729845|Antimetabolites|antimetabolites|mesh-ancestor
6178983|NCT01729845|Antiviral Agents|antiviral agents|mesh-ancestor
6487472|NCT00576433|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5574470|NCT03900793|Growth Inhibitors|growth inhibitors|mesh-ancestor
5574471|NCT03900793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5574472|NCT03900793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5574473|NCT03900793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574474|NCT03900793|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6487473|NCT00576433|Abortifacient Agents|abortifacient agents|mesh-ancestor
6487474|NCT00576433|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6487475|NCT00576433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6178984|NCT01729845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6178985|NCT01729845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6178986|NCT01729845|Immunologic Factors|immunologic factors|mesh-ancestor
6178987|NCT01729845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6178988|NCT01729845|Analgesics|analgesics|mesh-ancestor
5574475|NCT03900793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5574476|NCT03900793|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5574477|NCT03900793|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6178989|NCT01729845|Sensory System Agents|sensory system agents|mesh-ancestor
6178990|NCT01729845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6178991|NCT01729845|Keratolytic Agents|keratolytic agents|mesh-ancestor
6178992|NCT01729845|Dermatologic Agents|dermatologic agents|mesh-ancestor
6178993|NCT01729845|Tubulin Modulators|tubulin modulators|mesh-ancestor
6178994|NCT01729845|Antimitotic Agents|antimitotic agents|mesh-ancestor
6487476|NCT00576433|Antimetabolites|antimetabolites|mesh-ancestor
6487477|NCT00576433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6487478|NCT00576433|Dermatologic Agents|dermatologic agents|mesh-ancestor
6487479|NCT00576433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6487480|NCT00576433|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6487481|NCT00576433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6487482|NCT00576433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6487483|NCT00576459|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
6178995|NCT01729845|Mitosis Modulators|mitosis modulators|mesh-ancestor
6178996|NCT01729871|Vitamin K|vitamin k|mesh-list
6178997|NCT01729871|Rivaroxaban|rivaroxaban|mesh-list
6178998|NCT01729871|Vitamins|vitamins|mesh-ancestor
6178999|NCT01729871|Micronutrients|micronutrients|mesh-ancestor
6179000|NCT01729871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179001|NCT01729871|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5574478|NCT03900624|Dexamethasone|dexamethasone|mesh-list
5574479|NCT03900624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5574480|NCT03900624|Antiemetics|antiemetics|mesh-ancestor
5574481|NCT03900624|Autonomic Agents|autonomic agents|mesh-ancestor
5574482|NCT03900624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5574483|NCT03900624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574484|NCT03900624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5574485|NCT03900624|Glucocorticoids|glucocorticoids|mesh-ancestor
5574486|NCT03900624|Hormones|hormones|mesh-ancestor
5574487|NCT03900624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6179002|NCT01729871|Antithrombins|antithrombins|mesh-ancestor
6179003|NCT01729871|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6179004|NCT01729871|Protease Inhibitors|protease inhibitors|mesh-ancestor
6179005|NCT01729871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6179006|NCT01729871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179007|NCT01729871|Anticoagulants|anticoagulants|mesh-ancestor
6179008|NCT01729871|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6179009|NCT01729871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6179010|NCT01729871|Hemostatics|hemostatics|mesh-ancestor
6179011|NCT01729871|Coagulants|coagulants|mesh-ancestor
6179012|NCT01729923|Celecoxib|celecoxib|mesh-list
6179013|NCT01729923|Capecitabine|capecitabine|mesh-list
6487484|NCT00576459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6487485|NCT00576459|Glucocorticoids|glucocorticoids|mesh-ancestor
6487486|NCT00576459|Hormones|hormones|mesh-ancestor
6487487|NCT00576459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5574488|NCT03900624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6179014|NCT01729923|Benzenesulfonamide|benzenesulfonamide|mesh-list
6179015|NCT01729923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6179016|NCT01729923|Antimetabolites|antimetabolites|mesh-ancestor
6179017|NCT01729923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179018|NCT01729923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6179019|NCT01729923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6179020|NCT01729923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6179021|NCT01729923|Analgesics|analgesics|mesh-ancestor
6179022|NCT01729923|Sensory System Agents|sensory system agents|mesh-ancestor
6179023|NCT01729923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6487488|NCT00576459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179024|NCT01729923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179025|NCT01729923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6179026|NCT01729923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6179027|NCT01729923|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6179028|NCT01729923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6179029|NCT01729923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6179030|NCT01729923|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6179031|NCT01730040|Atorvastatin|atorvastatin|mesh-list
6179032|NCT01730040|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6179033|NCT01730040|Ezetimibe|ezetimibe|mesh-list
6179034|NCT01730040|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6179035|NCT01730040|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6179036|NCT01730040|Antimetabolites|antimetabolites|mesh-ancestor
6179037|NCT01730040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179038|NCT01730040|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6179039|NCT01730040|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6179040|NCT01730040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6206594|NCT02101359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206595|NCT02101918|Aflibercept|aflibercept|mesh-list
6206596|NCT02101918|Endothelial Growth Factors|endothelial growth factors|mesh-list
6206597|NCT02101918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6206598|NCT02101918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6206599|NCT02101918|Growth Substances|growth substances|mesh-ancestor
6206600|NCT02101918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206601|NCT02101918|Growth Inhibitors|growth inhibitors|mesh-ancestor
6206602|NCT02101918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6206603|NCT02101983|Cytarabine|cytarabine|mesh-list
6206604|NCT02101983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6206605|NCT02101983|Antimetabolites|antimetabolites|mesh-ancestor
6206606|NCT02101983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206607|NCT02101983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6206608|NCT02101983|Antiviral Agents|antiviral agents|mesh-ancestor
6206609|NCT02101983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6206610|NCT02101983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6206611|NCT02101983|Immunologic Factors|immunologic factors|mesh-ancestor
6206612|NCT02101983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206613|NCT02102100|Menthol|menthol|mesh-list
6206614|NCT02102100|Nicotine|nicotine|mesh-list
6206615|NCT02102100|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6206616|NCT02102100|Autonomic Agents|autonomic agents|mesh-ancestor
6206617|NCT02102100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6206618|NCT02102100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206619|NCT02102100|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6206620|NCT02102100|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6206621|NCT02102100|Cholinergic Agents|cholinergic agents|mesh-ancestor
6206622|NCT02102100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6206623|NCT02102100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206624|NCT02102100|Antipruritics|antipruritics|mesh-ancestor
6206625|NCT02102100|Dermatologic Agents|dermatologic agents|mesh-ancestor
6206626|NCT02102932|Metformin|metformin|mesh-list
6206627|NCT02102932|Empagliflozin|empagliflozin|mesh-list
6206628|NCT02102932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6206629|NCT02102932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206630|NCT02102932|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6206631|NCT02102932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206632|NCT02103062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6487489|NCT00576511|Prucalopride|prucalopride|mesh-list
6487490|NCT00576511|Laxatives|laxatives|mesh-ancestor
6487491|NCT00576511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6487492|NCT00576511|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
6206633|NCT02103062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6206634|NCT02103114|Antithrombin III|antithrombin iii|mesh-list
6206635|NCT02103114|Antithrombins|antithrombins|mesh-list
6206636|NCT02103114|Thrombin|thrombin|mesh-list
6206637|NCT02103114|Hemostatics|hemostatics|mesh-ancestor
6206638|NCT02103114|Coagulants|coagulants|mesh-ancestor
6487493|NCT00576511|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6179041|NCT01730053|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6179042|NCT01730053|Ezetimibe|ezetimibe|mesh-list
5574489|NCT03900624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5574490|NCT03900637|Letrozole|letrozole|mesh-list
5574491|NCT03900637|Leuprolide|leuprolide|mesh-list
5574492|NCT03900637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5574493|NCT03900637|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6179043|NCT01730053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6179044|NCT01730053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6179045|NCT01730053|Antimetabolites|antimetabolites|mesh-ancestor
6179046|NCT01730053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179047|NCT01730053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6179048|NCT01730053|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6179049|NCT01730053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6179050|NCT01730378|Vaccines|vaccines|mesh-list
6179051|NCT01730378|Immunologic Factors|immunologic factors|mesh-ancestor
6179052|NCT01730378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179053|NCT01730534|Dapagliflozin|dapagliflozin|mesh-list
6179054|NCT01730534|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6179055|NCT01730534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179056|NCT01730534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6179057|NCT01730534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179058|NCT01730586|Paclitaxel|paclitaxel|mesh-list
6179059|NCT01730586|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6179060|NCT01730586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6179061|NCT01730586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6179062|NCT01730586|Tubulin Modulators|tubulin modulators|mesh-ancestor
6179063|NCT01730586|Antimitotic Agents|antimitotic agents|mesh-ancestor
6179064|NCT01730586|Mitosis Modulators|mitosis modulators|mesh-ancestor
6179065|NCT01730586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179066|NCT01730729|Cabergoline|cabergoline|mesh-list
6179067|NCT01730729|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6179068|NCT01730729|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6179069|NCT01730729|Dopamine Agonists|dopamine agonists|mesh-ancestor
6179070|NCT01730729|Dopamine Agents|dopamine agents|mesh-ancestor
6179071|NCT01730729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6179072|NCT01730729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179073|NCT01730729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179074|NCT01730846|Doxazosin|doxazosin|mesh-list
6179075|NCT01730846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6179076|NCT01730846|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6179077|NCT01730846|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6179078|NCT01730846|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6179079|NCT01730846|Adrenergic Agents|adrenergic agents|mesh-ancestor
6179080|NCT01730846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6179081|NCT01730846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179082|NCT01730846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574494|NCT03900637|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5574495|NCT03900637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5574496|NCT03900637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574497|NCT03900637|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5574498|NCT03900637|Hormone Antagonists|hormone antagonists|mesh-ancestor
5574499|NCT03900637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5574500|NCT03900637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574501|NCT03900637|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5574502|NCT03900637|Fertility Agents|fertility agents|mesh-ancestor
5574503|NCT03900637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5574504|NCT03900637|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5604450|NCT04745845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604451|NCT04745845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604452|NCT04745845|Sympathomimetics|sympathomimetics|mesh-ancestor
5604453|NCT04745845|Autonomic Agents|autonomic agents|mesh-ancestor
5604454|NCT04745845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5604455|NCT04745845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6179083|NCT01730872|Prednisolone|prednisolone|mesh-list
6179084|NCT01730872|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6179085|NCT01730872|Methylprednisolone|methylprednisolone|mesh-list
6179086|NCT01730872|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6179087|NCT01730872|Prednisolone acetate|prednisolone acetate|mesh-list
6179088|NCT01730872|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6179089|NCT01730872|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6179090|NCT01730872|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6179091|NCT01730872|Prednisolone phosphate|prednisolone phosphate|mesh-list
6179092|NCT01730872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6179093|NCT01730872|Glucocorticoids|glucocorticoids|mesh-ancestor
6179094|NCT01730872|Hormones|hormones|mesh-ancestor
6179095|NCT01730872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6179096|NCT01730872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179097|NCT01730872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6179098|NCT01730872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6179099|NCT01730872|Antiemetics|antiemetics|mesh-ancestor
5574505|NCT03900377|Rituximab|rituximab|mesh-list
5574506|NCT03900377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5574507|NCT03900377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5574508|NCT03900377|Immunologic Factors|immunologic factors|mesh-ancestor
5574509|NCT03900377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574510|NCT03900377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5574511|NCT03900026|Evolocumab|evolocumab|mesh-list
5574512|NCT03900026|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5574513|NCT03900026|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5574514|NCT03900026|Antimetabolites|antimetabolites|mesh-ancestor
5574515|NCT03900026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574516|NCT03900026|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5574517|NCT03899675|Caffeine|caffeine|mesh-list
5574518|NCT03899675|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5574519|NCT03899675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574520|NCT03899675|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5574521|NCT03899675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5574522|NCT03899675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574523|NCT03899675|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5574524|NCT03899675|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5574525|NCT03899675|Purinergic Agents|purinergic agents|mesh-ancestor
6179100|NCT01730872|Autonomic Agents|autonomic agents|mesh-ancestor
6179101|NCT01730872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6179102|NCT01730872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6179103|NCT01730872|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6179104|NCT01730872|Protective Agents|protective agents|mesh-ancestor
5574526|NCT03899675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5574527|NCT03899805|Pembrolizumab|pembrolizumab|mesh-list
5574528|NCT03899805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5574529|NCT03899805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6179105|NCT01730950|Bevacizumab|bevacizumab|mesh-list
6179106|NCT01730950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6179107|NCT01730950|Antibodies|antibodies|mesh-list
6179108|NCT01730950|Immunoglobulins|immunoglobulins|mesh-list
6179109|NCT01730950|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6179110|NCT01730950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6179111|NCT01730950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6179112|NCT01730950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6179113|NCT01730950|Growth Substances|growth substances|mesh-ancestor
6179114|NCT01730950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179115|NCT01730950|Growth Inhibitors|growth inhibitors|mesh-ancestor
6179116|NCT01730950|Immunologic Factors|immunologic factors|mesh-ancestor
6179117|NCT01731002|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6179118|NCT01731002|Latanoprost|latanoprost|mesh-list
6179119|NCT01731002|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6179120|NCT01731041|Ticagrelor|ticagrelor|mesh-list
6179121|NCT01731041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6179122|NCT01731041|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6179123|NCT01731041|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6179124|NCT01731041|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6179125|NCT01731041|Purinergic Agents|purinergic agents|mesh-ancestor
6179126|NCT01731041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6179127|NCT01731041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179128|NCT01731041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179129|NCT01731119|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
6179130|NCT01731119|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6179131|NCT01731119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6179132|NCT01731119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6179133|NCT01731119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179134|NCT01731119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6179135|NCT01731119|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6179136|NCT01731119|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6179137|NCT01731119|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5574530|NCT03899961|Oxytocin|oxytocin|mesh-list
5574531|NCT03899961|Carbetocin|carbetocin|mesh-list
5574532|NCT03899961|Oxytocics|oxytocics|mesh-ancestor
5574533|NCT03899961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5574534|NCT03899961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574535|NCT03899610|Durvalumab|durvalumab|mesh-list
5574536|NCT03899610|Tremelimumab|tremelimumab|mesh-list
5574537|NCT03899610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5574538|NCT03899610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5574539|NCT03899636|Folfirinox|folfirinox|mesh-list
5574540|NCT03899636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6179138|NCT01731119|Adrenergic Agents|adrenergic agents|mesh-ancestor
6179139|NCT01731119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6179140|NCT01731119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179141|NCT01731119|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6179142|NCT01731119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6179143|NCT01731119|Serotonin Agents|serotonin agents|mesh-ancestor
6179144|NCT01731119|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6179145|NCT01731119|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6179146|NCT01731119|Dopamine Agents|dopamine agents|mesh-ancestor
6179147|NCT01731691|Protease Inhibitors|protease inhibitors|mesh-list
6179148|NCT01731691|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
6179149|NCT01731691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6179150|NCT01731691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179151|NCT01731691|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6179152|NCT01731691|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6179153|NCT01731886|Dexamethasone|dexamethasone|mesh-list
6179154|NCT01731886|Cyclophosphamide|cyclophosphamide|mesh-list
6179155|NCT01731886|Melphalan|melphalan|mesh-list
6179156|NCT01731886|Lenalidomide|lenalidomide|mesh-list
6179157|NCT01731886|Lenograstim|lenograstim|mesh-list
6179158|NCT01731886|Sargramostim|sargramostim|mesh-list
6179159|NCT01731886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6179160|NCT01731886|Immunologic Factors|immunologic factors|mesh-ancestor
6179161|NCT01731886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179162|NCT01731886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6179163|NCT01731886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6179164|NCT01731886|Alkylating Agents|alkylating agents|mesh-ancestor
6179165|NCT01731886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179166|NCT01731886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6179167|NCT01731886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6179168|NCT01731886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6179169|NCT01731886|Antiemetics|antiemetics|mesh-ancestor
6179170|NCT01731886|Autonomic Agents|autonomic agents|mesh-ancestor
5574541|NCT03899428|Sorafenib|sorafenib|mesh-list
5574542|NCT03899428|Durvalumab|durvalumab|mesh-list
6179171|NCT01731886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6179172|NCT01731886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6179173|NCT01731886|Glucocorticoids|glucocorticoids|mesh-ancestor
6179174|NCT01731886|Hormones|hormones|mesh-ancestor
6179175|NCT01731886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6179176|NCT01731886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6179177|NCT01731886|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6179178|NCT01731886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6179179|NCT01731886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6179180|NCT01731886|Growth Substances|growth substances|mesh-ancestor
5574543|NCT03899428|Lenvatinib|lenvatinib|mesh-list
5574544|NCT03899428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5574545|NCT03899428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5574546|NCT03899428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5574547|NCT03899428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574548|NCT03899428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5574549|NCT03899506|Midazolam|midazolam|mesh-list
5574550|NCT03899506|Olanzapine|olanzapine|mesh-list
5574551|NCT03899506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5574552|NCT03899506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5574553|NCT03899506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5574554|NCT03899506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179181|NCT01731886|Growth Inhibitors|growth inhibitors|mesh-ancestor
6487494|NCT00576511|Serotonin Agents|serotonin agents|mesh-ancestor
5574555|NCT03899506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5574556|NCT03899506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5574557|NCT03899506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5574558|NCT03899506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5574559|NCT03899506|Anesthetics, General|anesthetics, general|mesh-ancestor
5574560|NCT03899506|Anesthetics|anesthetics|mesh-ancestor
5574561|NCT03899506|GABA Modulators|gaba modulators|mesh-ancestor
5574562|NCT03899506|GABA Agents|gaba agents|mesh-ancestor
6179182|NCT01731938|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6179183|NCT01731938|Hemostatics|hemostatics|mesh-ancestor
6179184|NCT01731938|Coagulants|coagulants|mesh-ancestor
6179185|NCT01731951|Imetelstat|imetelstat|mesh-list
6179186|NCT01731951|Motesanib diphosphate|motesanib diphosphate|mesh-list
6179187|NCT01731951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6179188|NCT01731951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574563|NCT03899506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5574564|NCT03899506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574565|NCT03899506|Antiemetics|antiemetics|mesh-ancestor
5574566|NCT03899506|Autonomic Agents|autonomic agents|mesh-ancestor
5574567|NCT03899506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5574568|NCT03899506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5574569|NCT03899506|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5574570|NCT03899506|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5574571|NCT03899506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5574572|NCT03899506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5574573|NCT03899506|Serotonin Agents|serotonin agents|mesh-ancestor
5574574|NCT03899337|Prednisolone|prednisolone|mesh-list
5574575|NCT03899337|Cyclophosphamide|cyclophosphamide|mesh-list
5574576|NCT03899337|Rituximab|rituximab|mesh-list
5574577|NCT03899337|Doxorubicin|doxorubicin|mesh-list
6179189|NCT01731951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6179190|NCT01732445|Danazol|danazol|mesh-list
6179191|NCT01732445|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
6179192|NCT01732445|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6179193|NCT01732445|Hormone Antagonists|hormone antagonists|mesh-ancestor
6179194|NCT01732445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6179195|NCT01732445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179196|NCT01732445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6179197|NCT01732445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6179198|NCT01732445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179199|NCT01732458|Ondansetron|ondansetron|mesh-list
6179200|NCT01732458|Aprepitant|aprepitant|mesh-list
6179201|NCT01732458|Fosaprepitant|fosaprepitant|mesh-list
6179202|NCT01732458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6179203|NCT01732458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179204|NCT01732458|Antiemetics|antiemetics|mesh-ancestor
6179205|NCT01732458|Autonomic Agents|autonomic agents|mesh-ancestor
6179206|NCT01732458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6179207|NCT01732458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6179208|NCT01732458|Antipruritics|antipruritics|mesh-ancestor
6179209|NCT01732458|Dermatologic Agents|dermatologic agents|mesh-ancestor
6179210|NCT01732458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6179211|NCT01732458|Serotonin Agents|serotonin agents|mesh-ancestor
6179212|NCT01732458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6179213|NCT01732458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179214|NCT01732458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6179215|NCT01732458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6179216|NCT01732458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6179217|NCT01732458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6179218|NCT01732458|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6179219|NCT01732536|Mometasone Furoate|mometasone furoate|mesh-list
6179220|NCT01732536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6179221|NCT01732536|Dermatologic Agents|dermatologic agents|mesh-ancestor
6179222|NCT01732536|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6179223|NCT01732588|Artefenomel|artefenomel|mesh-list
6179224|NCT01732588|Antimalarials|antimalarials|mesh-ancestor
6179225|NCT01732588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6179226|NCT01732588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6179227|NCT01732588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5574578|NCT03899337|Vincristine|vincristine|mesh-list
5574579|NCT03899337|Acalabrutinib|acalabrutinib|mesh-list
5574580|NCT03899337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6179228|NCT01732627|Vaccines|vaccines|mesh-list
6179229|NCT01732627|Immunologic Factors|immunologic factors|mesh-ancestor
6179230|NCT01732627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574581|NCT03899337|Immunologic Factors|immunologic factors|mesh-ancestor
5574582|NCT03899337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574583|NCT03899337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6179231|NCT01732640|Paclitaxel|paclitaxel|mesh-list
6179232|NCT01732640|Cisplatin|cisplatin|mesh-list
6179233|NCT01732640|Carboplatin|carboplatin|mesh-list
6179234|NCT01732640|Afatinib|afatinib|mesh-list
6179235|NCT01732640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6179236|NCT01732640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6179237|NCT01732640|Tubulin Modulators|tubulin modulators|mesh-ancestor
6179238|NCT01732640|Antimitotic Agents|antimitotic agents|mesh-ancestor
6179239|NCT01732640|Mitosis Modulators|mitosis modulators|mesh-ancestor
6179240|NCT01732640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179241|NCT01732640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6179242|NCT01732640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6179243|NCT01732718|Atorvastatin|atorvastatin|mesh-list
6179244|NCT01732718|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6179245|NCT01732718|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6179246|NCT01732718|Antimetabolites|antimetabolites|mesh-ancestor
6179247|NCT01732718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179248|NCT01732718|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6179249|NCT01732718|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6179250|NCT01732718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6179251|NCT01732757|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
6179252|NCT01732757|Dextrans|dextrans|mesh-list
6179253|NCT01732757|Alcaftadine|alcaftadine|mesh-list
6179254|NCT01732757|Anticoagulants|anticoagulants|mesh-ancestor
5574584|NCT03899337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5574585|NCT03899337|Alkylating Agents|alkylating agents|mesh-ancestor
5574586|NCT03899337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574587|NCT03899337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5574588|NCT03899337|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5574589|NCT03899337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5574590|NCT03899337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5574591|NCT03899337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5574592|NCT03899337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5574593|NCT03899337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5574594|NCT03899337|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5574595|NCT03899337|Tubulin Modulators|tubulin modulators|mesh-ancestor
5574596|NCT03899337|Antimitotic Agents|antimitotic agents|mesh-ancestor
6179255|NCT01732757|Plasma Substitutes|plasma substitutes|mesh-ancestor
6179256|NCT01732757|Blood Substitutes|blood substitutes|mesh-ancestor
6179257|NCT01732757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6179258|NCT01732757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6179259|NCT01732757|Analgesics|analgesics|mesh-ancestor
6179260|NCT01732757|Sensory System Agents|sensory system agents|mesh-ancestor
6179261|NCT01732757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6179262|NCT01732757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179263|NCT01732757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6179264|NCT01732757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6179265|NCT01732757|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6179266|NCT01732757|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5574597|NCT03899337|Mitosis Modulators|mitosis modulators|mesh-ancestor
5574598|NCT03899337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5574599|NCT03899337|Glucocorticoids|glucocorticoids|mesh-ancestor
5574600|NCT03899337|Hormones|hormones|mesh-ancestor
5574601|NCT03899337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5574602|NCT03899337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5574603|NCT03899246|Capsaicin|capsaicin|mesh-list
5574604|NCT03899246|Antipruritics|antipruritics|mesh-ancestor
5574605|NCT03899246|Dermatologic Agents|dermatologic agents|mesh-ancestor
5574606|NCT03899246|Sensory System Agents|sensory system agents|mesh-ancestor
5574607|NCT03899246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5574608|NCT03899246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574609|NCT03899584|4-Aminopyridine|4-aminopyridine|mesh-list
5574610|NCT03899584|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5574611|NCT03899584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5574612|NCT03899584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179267|NCT01732757|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6179268|NCT01732757|Histamine Antagonists|histamine antagonists|mesh-ancestor
6179269|NCT01732757|Histamine Agents|histamine agents|mesh-ancestor
6179270|NCT01732757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6179271|NCT01732757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6487495|NCT00576511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6487496|NCT00576511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6487497|NCT00576511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487498|NCT00576550|Betamethasone|betamethasone|mesh-list
6487499|NCT00576550|Betamethasone Valerate|betamethasone valerate|mesh-list
6487500|NCT00576550|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5574613|NCT03899571|Oseltamivir|oseltamivir|mesh-list
5574614|NCT03899571|Antiviral Agents|antiviral agents|mesh-ancestor
5574615|NCT03899571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5574616|NCT03899571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5574617|NCT03899571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574618|NCT03899402|Dapagliflozin|dapagliflozin|mesh-list
5574619|NCT03899402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5574620|NCT03899402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574621|NCT03899402|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5574622|NCT03899402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574623|NCT03899597|Oxytocin|oxytocin|mesh-list
5574624|NCT03899597|Oxytocics|oxytocics|mesh-ancestor
6487501|NCT00576550|Betamethasone benzoate|betamethasone benzoate|mesh-list
6487502|NCT00576550|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
6487503|NCT00576550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6487504|NCT00576550|Glucocorticoids|glucocorticoids|mesh-ancestor
6487505|NCT00576550|Hormones|hormones|mesh-ancestor
6487506|NCT00576550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6487507|NCT00576550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487508|NCT00576550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6487509|NCT00576550|Respiratory System Agents|respiratory system agents|mesh-ancestor
6487510|NCT00576602|Epoetin Alfa|epoetin alfa|mesh-list
6179272|NCT01732770|Zoledronic Acid|zoledronic acid|mesh-list
6179273|NCT01732770|Denosumab|denosumab|mesh-list
6487511|NCT00576602|Hematinics|hematinics|mesh-ancestor
6487512|NCT00576615|Propofol|propofol|mesh-list
6487513|NCT00576615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6487514|NCT00576615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6487515|NCT00576615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487516|NCT00576615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6487517|NCT00576615|Anesthetics, General|anesthetics, general|mesh-ancestor
6487518|NCT00576615|Anesthetics|anesthetics|mesh-ancestor
6487519|NCT00576706|Misoprostol|misoprostol|mesh-list
6487520|NCT00576706|Rebamipide|rebamipide|mesh-list
6487521|NCT00576706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6487522|NCT00576706|Abortifacient Agents|abortifacient agents|mesh-ancestor
6487523|NCT00576706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6487524|NCT00576706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487525|NCT00576706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6487526|NCT00576706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6487527|NCT00576706|Oxytocics|oxytocics|mesh-ancestor
6487528|NCT00576706|Antioxidants|antioxidants|mesh-ancestor
6487529|NCT00576706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6487530|NCT00576706|Protective Agents|protective agents|mesh-ancestor
6487531|NCT00576706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6670652|NCT01544634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6670653|NCT01544634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6670654|NCT01544634|Vasodilator Agents|vasodilator agents|mesh-ancestor
6670655|NCT01544634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6670656|NCT01544634|Glucocorticoids|glucocorticoids|mesh-ancestor
6670657|NCT01544634|Hormones|hormones|mesh-ancestor
6670658|NCT01544634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5574625|NCT03899597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5574626|NCT03899597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574627|NCT03899324|Bumetanide|bumetanide|mesh-list
5574628|NCT03899324|Diuretics|diuretics|mesh-ancestor
5574629|NCT03899324|Natriuretic Agents|natriuretic agents|mesh-ancestor
6179274|NCT01732770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6179275|NCT01732770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179276|NCT01732783|Panitumumab|panitumumab|mesh-list
6179277|NCT01732783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6179278|NCT01732783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6179279|NCT01732796|Ribavirin|ribavirin|mesh-list
6179280|NCT01732796|Antimetabolites|antimetabolites|mesh-ancestor
6179281|NCT01732796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179282|NCT01732796|Antiviral Agents|antiviral agents|mesh-ancestor
6179283|NCT01732796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6179284|NCT01732809|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6179285|NCT01732809|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6179286|NCT01732809|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6179287|NCT01732809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6179288|NCT01732809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179289|NCT01732809|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6179290|NCT01732809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6179291|NCT01732809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574630|NCT03899324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574631|NCT03899324|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5574632|NCT03899324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5574633|NCT03899324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574634|NCT03899233|Tranexamic Acid|tranexamic acid|mesh-list
5574635|NCT03899233|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5574636|NCT03899233|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5574637|NCT03899233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574638|NCT03899233|Hemostatics|hemostatics|mesh-ancestor
5574639|NCT03899233|Coagulants|coagulants|mesh-ancestor
6179292|NCT01732809|Cholinergic Agents|cholinergic agents|mesh-ancestor
6179293|NCT01732809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6179294|NCT01732822|Clopidogrel|clopidogrel|mesh-list
6179295|NCT01732822|Ticagrelor|ticagrelor|mesh-list
6179296|NCT01732822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6179297|NCT01732822|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6179298|NCT01732822|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6179299|NCT01732822|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6179300|NCT01732822|Purinergic Agents|purinergic agents|mesh-ancestor
6179301|NCT01732822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6487532|NCT00576784|Pioglitazone|pioglitazone|mesh-list
6487533|NCT00576784|Glimepiride|glimepiride|mesh-list
6487534|NCT00576784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6179302|NCT01732822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179303|NCT01732822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179304|NCT01733121|Tetrabenazine|tetrabenazine|mesh-list
6179305|NCT01733121|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6179306|NCT01733121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6179307|NCT01733121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6179308|NCT01733121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179309|NCT01733121|Adrenergic Agents|adrenergic agents|mesh-ancestor
6179310|NCT01733121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6179311|NCT01733121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179312|NCT01733316|Cysteamine|cysteamine|mesh-list
6179313|NCT01733316|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
6179314|NCT01733316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179315|NCT01733329|Folic Acid|folic acid|mesh-list
6179316|NCT01733329|Misoprostol|misoprostol|mesh-list
6179317|NCT01733329|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6179318|NCT01733329|Abortifacient Agents|abortifacient agents|mesh-ancestor
6179319|NCT01733329|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6179320|NCT01733329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179321|NCT01733329|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6179322|NCT01733329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6179323|NCT01733329|Oxytocics|oxytocics|mesh-ancestor
6179324|NCT01733329|Hematinics|hematinics|mesh-ancestor
6179325|NCT01733329|Vitamin B Complex|vitamin b complex|mesh-ancestor
5574640|NCT03899194|Citalopram|citalopram|mesh-list
5574641|NCT03899194|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5574642|NCT03899194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5574643|NCT03899194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5574644|NCT03899194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574645|NCT03899194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5574646|NCT03899194|Serotonin Agents|serotonin agents|mesh-ancestor
5574647|NCT03899194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574648|NCT03899194|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5574649|NCT03899194|Antidepressive Agents|antidepressive agents|mesh-ancestor
5574650|NCT03899194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5574651|NCT03899142|Immunoglobulins|immunoglobulins|mesh-list
5574652|NCT03899142|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5574653|NCT03899142|Antibodies|antibodies|mesh-list
6179326|NCT01733329|Vitamins|vitamins|mesh-ancestor
6179327|NCT01733329|Micronutrients|micronutrients|mesh-ancestor
6179328|NCT01733472|Remifentanil|remifentanil|mesh-list
6179329|NCT01733472|Propofol|propofol|mesh-list
6179330|NCT01733472|Anesthetics|anesthetics|mesh-ancestor
6179331|NCT01733472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6179332|NCT01733472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179333|NCT01733472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6179334|NCT01733472|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6179335|NCT01733472|Anesthetics, General|anesthetics, general|mesh-ancestor
6179336|NCT01733472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6179337|NCT01733472|Narcotics|narcotics|mesh-ancestor
6179338|NCT01733472|Analgesics|analgesics|mesh-ancestor
6487535|NCT00576784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574654|NCT03899142|Immunologic Factors|immunologic factors|mesh-ancestor
5574655|NCT03899142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574656|NCT03898986|Vaccines|vaccines|mesh-list
5574657|NCT03898986|Immunologic Factors|immunologic factors|mesh-ancestor
5574658|NCT03898986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574659|NCT03899077|Goserelin|goserelin|mesh-list
5574660|NCT03899077|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5574661|NCT03899077|Leuprolide|leuprolide|mesh-list
5574662|NCT03899077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5574663|NCT03899077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5574664|NCT03899077|Luteolytic Agents|luteolytic agents|mesh-ancestor
5574665|NCT03899077|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5574666|NCT03899077|Contraceptive Agents|contraceptive agents|mesh-ancestor
5574667|NCT03899077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5574668|NCT03899077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574669|NCT03899077|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5574670|NCT03899077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5574671|NCT03899077|Fertility Agents|fertility agents|mesh-ancestor
5574672|NCT03899038|Anesthetics|anesthetics|mesh-list
6179339|NCT01733472|Sensory System Agents|sensory system agents|mesh-ancestor
6179340|NCT01733472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6179341|NCT01733680|Amiloride|amiloride|mesh-list
6179342|NCT01733680|Diuretics|diuretics|mesh-ancestor
6179343|NCT01733680|Natriuretic Agents|natriuretic agents|mesh-ancestor
6179344|NCT01733680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179345|NCT01733680|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
6179346|NCT01733680|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6179347|NCT01733680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6179348|NCT01733680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179349|NCT01733680|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
6179350|NCT01733680|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6179351|NCT01733732|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6179352|NCT01733732|Lubricant Eye Drops|lubricant eye drops|mesh-list
5574673|NCT03899038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5574674|NCT03899038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574675|NCT03899103|Mycophenolic Acid|mycophenolic acid|mesh-list
5574676|NCT03899103|Rituximab|rituximab|mesh-list
5574677|NCT03899103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5574678|NCT03899103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5574679|NCT03899103|Immunologic Factors|immunologic factors|mesh-ancestor
5574680|NCT03899103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574681|NCT03899103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5574682|NCT03899103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5574683|NCT03899103|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5574684|NCT03899103|Antitubercular Agents|antitubercular agents|mesh-ancestor
5574685|NCT03899103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6179353|NCT01733732|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6179354|NCT01733745|Vitamins|vitamins|mesh-list
6179355|NCT01733745|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6179356|NCT01733745|Micronutrients|micronutrients|mesh-ancestor
6179357|NCT01733745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179358|NCT01733745|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6179359|NCT01733758|Liraglutide|liraglutide|mesh-list
6179360|NCT01733758|rGLP-1 protein|rglp-1 protein|mesh-list
6179361|NCT01733758|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6179362|NCT01733758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6179363|NCT01733758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179364|NCT01733758|Incretins|incretins|mesh-ancestor
6179365|NCT01733758|Hormones|hormones|mesh-ancestor
6179366|NCT01733758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6179367|NCT01733953|Atorvastatin|atorvastatin|mesh-list
6179368|NCT01733953|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6179369|NCT01733953|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6179370|NCT01733953|Antimetabolites|antimetabolites|mesh-ancestor
6179371|NCT01733953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179372|NCT01733953|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6179373|NCT01733953|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6179374|NCT01733953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6179375|NCT01734161|Dexamethasone|dexamethasone|mesh-list
6179376|NCT01734161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6179377|NCT01734161|Antiemetics|antiemetics|mesh-ancestor
5574686|NCT03899103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5574687|NCT03899103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6179378|NCT01734161|Autonomic Agents|autonomic agents|mesh-ancestor
5574688|NCT03899103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574689|NCT03898752|Coenzyme Q10|coenzyme q10|mesh-list
6179379|NCT01734161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6179380|NCT01734161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179381|NCT01734161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6179382|NCT01734161|Glucocorticoids|glucocorticoids|mesh-ancestor
6179383|NCT01734161|Hormones|hormones|mesh-ancestor
5574690|NCT03898752|Vitamins|vitamins|mesh-ancestor
5574691|NCT03898752|Micronutrients|micronutrients|mesh-ancestor
5574692|NCT03898752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604456|NCT04740294|Magnesium Sulfate|magnesium sulfate|mesh-list
5604457|NCT04740294|Analgesics|analgesics|mesh-ancestor
5604458|NCT04740294|Sensory System Agents|sensory system agents|mesh-ancestor
5604459|NCT04740294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5604460|NCT04740294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604461|NCT04740294|Anesthetics|anesthetics|mesh-ancestor
5604462|NCT04740294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5604463|NCT04740294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5604464|NCT04740294|Anticonvulsants|anticonvulsants|mesh-ancestor
5604465|NCT04740294|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6179384|NCT01734161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6179385|NCT01734161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6179386|NCT01734161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6179387|NCT01734239|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6179388|NCT01734239|Immunologic Factors|immunologic factors|mesh-ancestor
6179389|NCT01734239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179390|NCT01734395|Galantamine|galantamine|mesh-list
6179391|NCT01734395|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6179392|NCT01734395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6179393|NCT01734395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179394|NCT01734395|Cholinergic Agents|cholinergic agents|mesh-ancestor
6179395|NCT01734395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6179396|NCT01734395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179397|NCT01734395|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6179398|NCT01734395|Autonomic Agents|autonomic agents|mesh-ancestor
6670659|NCT01544634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6670660|NCT01544634|Respiratory System Agents|respiratory system agents|mesh-ancestor
6670661|NCT01544673|Linezolid|linezolid|mesh-list
6670662|NCT01544673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6670663|NCT01544673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6670664|NCT01544673|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6670665|NCT01544673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5604466|NCT04740294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5604467|NCT04740294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604468|NCT04740294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5604469|NCT04740294|Tocolytic Agents|tocolytic agents|mesh-ancestor
5604470|NCT04740294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5604471|NCT04736745|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5604472|NCT04736745|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5604473|NCT04736745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5604474|NCT04736745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604475|NCT04736745|Cholinergic Agents|cholinergic agents|mesh-ancestor
5604476|NCT04736745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5604477|NCT04736745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604478|NCT04730349|Nivolumab|nivolumab|mesh-list
5604479|NCT04730349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5604480|NCT04730349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5604481|NCT04730349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5604482|NCT04730349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604483|NCT04728646|Dexamethasone|dexamethasone|mesh-list
5604484|NCT04728646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5604485|NCT04728646|Antiemetics|antiemetics|mesh-ancestor
5604486|NCT04728646|Autonomic Agents|autonomic agents|mesh-ancestor
5604487|NCT04728646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5604488|NCT04728646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604489|NCT04728646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6179399|NCT01734395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6179400|NCT01734395|Nootropic Agents|nootropic agents|mesh-ancestor
6179401|NCT01734512|Everolimus|everolimus|mesh-list
6179402|NCT01734512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6179403|NCT01734512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6179404|NCT01734512|Immunologic Factors|immunologic factors|mesh-ancestor
6179405|NCT01734512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670666|NCT01544673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179406|NCT01734525|Anidulafungin|anidulafungin|mesh-list
6179407|NCT01734525|Antifungal Agents|antifungal agents|mesh-ancestor
6179408|NCT01734525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6179409|NCT01734551|Clonidine|clonidine|mesh-list
6179410|NCT01734551|Morphine|morphine|mesh-list
6179411|NCT01734551|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6179412|NCT01734551|Narcotics|narcotics|mesh-ancestor
6179413|NCT01734551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6179414|NCT01734551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179415|NCT01734551|Analgesics|analgesics|mesh-ancestor
6179416|NCT01734551|Sensory System Agents|sensory system agents|mesh-ancestor
6179417|NCT01734551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6179418|NCT01734551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6179419|NCT01734551|Sympatholytics|sympatholytics|mesh-ancestor
6179420|NCT01734551|Autonomic Agents|autonomic agents|mesh-ancestor
6179421|NCT01734551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6179422|NCT01734551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6179423|NCT01734551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6179424|NCT01734551|Adrenergic Agents|adrenergic agents|mesh-ancestor
6179425|NCT01734551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6179426|NCT01734551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179427|NCT01734772|Dabigatran|dabigatran|mesh-list
6179428|NCT01734772|Ticagrelor|ticagrelor|mesh-list
6179429|NCT01734772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6179430|NCT01734772|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6179431|NCT01734772|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6179432|NCT01734772|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6179433|NCT01734772|Purinergic Agents|purinergic agents|mesh-ancestor
6179434|NCT01734772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6179435|NCT01734772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179436|NCT01734772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179437|NCT01734772|Antithrombins|antithrombins|mesh-ancestor
6179438|NCT01734772|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6179439|NCT01734772|Protease Inhibitors|protease inhibitors|mesh-ancestor
6179440|NCT01734772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6179441|NCT01734772|Anticoagulants|anticoagulants|mesh-ancestor
6179442|NCT01734785|Empagliflozin|empagliflozin|mesh-list
6179443|NCT01734785|Linagliptin|linagliptin|mesh-list
6179444|NCT01734785|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6179445|NCT01734785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179446|NCT01734785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6179447|NCT01734785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179448|NCT01734785|Incretins|incretins|mesh-ancestor
6179449|NCT01734785|Hormones|hormones|mesh-ancestor
6179450|NCT01734785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6179451|NCT01734785|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6179452|NCT01734785|Protease Inhibitors|protease inhibitors|mesh-ancestor
6179453|NCT01734785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6179454|NCT01734850|Busulfan|busulfan|mesh-list
6179455|NCT01734850|Alkylating Agents|alkylating agents|mesh-ancestor
6179456|NCT01734850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179457|NCT01734850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6179458|NCT01734850|Immunologic Factors|immunologic factors|mesh-ancestor
6179459|NCT01734850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179460|NCT01734850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6179461|NCT01734850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6179462|NCT01734850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6179463|NCT01734889|Nitisinone|nitisinone|mesh-list
6179464|NCT01734889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6179465|NCT01734889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179466|NCT01734902|Scopolamine|scopolamine|mesh-list
6179467|NCT01734902|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
6179468|NCT01734902|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6179469|NCT01734902|Antiemetics|antiemetics|mesh-ancestor
6179470|NCT01734902|Autonomic Agents|autonomic agents|mesh-ancestor
6179471|NCT01734902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6179472|NCT01734902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179473|NCT01734902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6179474|NCT01734902|Mydriatics|mydriatics|mesh-ancestor
6179475|NCT01734902|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6179476|NCT01734902|Cholinergic Agents|cholinergic agents|mesh-ancestor
6179477|NCT01734902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6179478|NCT01734902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179479|NCT01734902|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6179480|NCT01734902|Parasympatholytics|parasympatholytics|mesh-ancestor
5574693|NCT03899285|Citalopram|citalopram|mesh-list
5574694|NCT03899285|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5574695|NCT03899285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5574696|NCT03899285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5574697|NCT03899285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574698|NCT03899285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5574699|NCT03899285|Serotonin Agents|serotonin agents|mesh-ancestor
5574700|NCT03899285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574701|NCT03899285|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6670667|NCT01544725|Ketamine|ketamine|mesh-list
6670668|NCT01544725|Propofol|propofol|mesh-list
5574702|NCT03899285|Antidepressive Agents|antidepressive agents|mesh-ancestor
5574703|NCT03899285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5574704|NCT03898882|Oxytocin|oxytocin|mesh-list
5574705|NCT03898882|Oxytocics|oxytocics|mesh-ancestor
5574706|NCT03898882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5574707|NCT03898882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574708|NCT03898895|Gemcitabine|gemcitabine|mesh-list
5574709|NCT03898895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5574710|NCT03898895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5574711|NCT03898895|Antimetabolites|antimetabolites|mesh-ancestor
5574712|NCT03898895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574713|NCT03898895|Antiviral Agents|antiviral agents|mesh-ancestor
5574714|NCT03898895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5574715|NCT03898895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5574716|NCT03898895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5574717|NCT03898895|Immunologic Factors|immunologic factors|mesh-ancestor
5574718|NCT03898895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574719|NCT03898635|Linezolid|linezolid|mesh-list
5574720|NCT03898635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5574721|NCT03898635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5574722|NCT03898635|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5574723|NCT03898635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5574724|NCT03898635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574725|NCT03898583|Calcitriol|calcitriol|mesh-list
5574726|NCT03898583|Betamethasone|betamethasone|mesh-list
5574727|NCT03898583|Betamethasone Valerate|betamethasone valerate|mesh-list
5574728|NCT03898583|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5574729|NCT03898583|Betamethasone benzoate|betamethasone benzoate|mesh-list
5574730|NCT03898583|Calcipotriene|calcipotriene|mesh-list
5574731|NCT03898583|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
6670669|NCT01544725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6670670|NCT01544725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6179481|NCT01735279|Mineral Oil|mineral oil|mesh-list
6179482|NCT01735279|Emollients|emollients|mesh-ancestor
6179483|NCT01735279|Dermatologic Agents|dermatologic agents|mesh-ancestor
6179484|NCT01735396|Abiraterone Acetate|abiraterone acetate|mesh-list
6179485|NCT01735396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6179486|NCT01735396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6179487|NCT01735396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6179488|NCT01735396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179489|NCT01735396|Hormone Antagonists|hormone antagonists|mesh-ancestor
6179490|NCT01735396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6179491|NCT01735396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179492|NCT01735396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6179493|NCT01735617|Hydrocortisone|hydrocortisone|mesh-list
6179494|NCT01735617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6179495|NCT01735630|Inositol|inositol|mesh-list
6179496|NCT01735630|Vitamin B Complex|vitamin b complex|mesh-ancestor
6179497|NCT01735630|Vitamins|vitamins|mesh-ancestor
6179498|NCT01735630|Micronutrients|micronutrients|mesh-ancestor
6179499|NCT01735630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179500|NCT01736085|Nicotine|nicotine|mesh-list
6179501|NCT01736085|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6179502|NCT01736085|Autonomic Agents|autonomic agents|mesh-ancestor
6487536|NCT00576784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6487537|NCT00576784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6487538|NCT00576784|Immunologic Factors|immunologic factors|mesh-ancestor
6487539|NCT00576862|Insulin Glargine|insulin glargine|mesh-list
6487540|NCT00576862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6487541|NCT00576862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487542|NCT00576914|Endostatins|endostatins|mesh-list
6670671|NCT01544725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574732|NCT03898583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6179503|NCT01736085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6487543|NCT00576914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6487544|NCT00576914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6487545|NCT00576914|Growth Substances|growth substances|mesh-ancestor
6487546|NCT00576914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487547|NCT00576914|Growth Inhibitors|growth inhibitors|mesh-ancestor
6487548|NCT00576914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6487549|NCT00576979|Cyclophosphamide|cyclophosphamide|mesh-list
6487550|NCT00576979|Etoposide|etoposide|mesh-list
6487551|NCT00576979|Etoposide phosphate|etoposide phosphate|mesh-list
6487552|NCT00576979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6487553|NCT00576979|Immunologic Factors|immunologic factors|mesh-ancestor
6487554|NCT00576979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179504|NCT01736085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179505|NCT01736085|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6179506|NCT01736085|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6179507|NCT01736085|Cholinergic Agents|cholinergic agents|mesh-ancestor
6179508|NCT01736085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6179509|NCT01736085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179510|NCT01736176|Levodopa|levodopa|mesh-list
6179511|NCT01736176|Carbidopa|carbidopa|mesh-list
6179512|NCT01736176|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
6179513|NCT01736176|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6179514|NCT01736176|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6179515|NCT01736176|Dopamine Agents|dopamine agents|mesh-ancestor
6179516|NCT01736176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6179517|NCT01736176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179518|NCT01736176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179519|NCT01736176|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6487555|NCT00576979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6487556|NCT00576979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6487557|NCT00576979|Alkylating Agents|alkylating agents|mesh-ancestor
6487558|NCT00576979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6487559|NCT00576979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6487560|NCT00576979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6487561|NCT00576979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6487562|NCT00576979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6487563|NCT00576979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6487564|NCT00576979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6487565|NCT00577018|Prucalopride|prucalopride|mesh-list
6179520|NCT01736176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6179521|NCT01736176|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6179522|NCT01736176|Immunologic Factors|immunologic factors|mesh-ancestor
6179523|NCT01736176|Dopamine Agonists|dopamine agonists|mesh-ancestor
6179524|NCT01736189|Adalimumab|adalimumab|mesh-list
6179525|NCT01736189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6179526|NCT01736189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6179527|NCT01736215|Epoetin Alfa|epoetin alfa|mesh-list
6179528|NCT01736215|Hematinics|hematinics|mesh-ancestor
6179529|NCT01736254|Gemfibrozil|gemfibrozil|mesh-list
6179530|NCT01736254|Evacetrapib|evacetrapib|mesh-list
6179531|NCT01736254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6179532|NCT01736254|Antimetabolites|antimetabolites|mesh-ancestor
6487566|NCT00577018|Laxatives|laxatives|mesh-ancestor
6487567|NCT00577018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6487568|NCT00577018|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
6487569|NCT00577018|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6487570|NCT00577018|Serotonin Agents|serotonin agents|mesh-ancestor
6487571|NCT00577018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6487572|NCT00577018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6487573|NCT00577018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574733|NCT03898583|Glucocorticoids|glucocorticoids|mesh-ancestor
5574734|NCT03898583|Hormones|hormones|mesh-ancestor
5574735|NCT03898583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5574736|NCT03898583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574737|NCT03898583|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5574738|NCT03898583|Respiratory System Agents|respiratory system agents|mesh-ancestor
5574739|NCT03898583|Dermatologic Agents|dermatologic agents|mesh-ancestor
5574740|NCT03898583|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5574741|NCT03898583|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
5574742|NCT03898583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5574743|NCT03898583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574744|NCT03898583|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5574745|NCT03898583|Vitamins|vitamins|mesh-ancestor
6179533|NCT01736254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179534|NCT01736254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6487574|NCT00577057|Fluorouracil|fluorouracil|mesh-list
6487575|NCT00577057|Capecitabine|capecitabine|mesh-list
5574746|NCT03898583|Micronutrients|micronutrients|mesh-ancestor
5574747|NCT03898583|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5574748|NCT03898193|Montelukast|montelukast|mesh-list
5574749|NCT03898193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5574750|NCT03898193|Respiratory System Agents|respiratory system agents|mesh-ancestor
5574751|NCT03898193|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5574752|NCT03898193|Hormone Antagonists|hormone antagonists|mesh-ancestor
5574753|NCT03898193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5574754|NCT03898193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574755|NCT03898193|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5574756|NCT03898193|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5574757|NCT03898193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574758|NCT03898466|Fluticasone|fluticasone|mesh-list
5574759|NCT03898466|Xhance|xhance|mesh-list
6487576|NCT00577057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6487577|NCT00577057|Antimetabolites|antimetabolites|mesh-ancestor
6487578|NCT00577057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6487579|NCT00577057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6487580|NCT00577057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5574760|NCT03898466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5574761|NCT03898466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5574762|NCT03898466|Autonomic Agents|autonomic agents|mesh-ancestor
5574763|NCT03898466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5574764|NCT03898466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574765|NCT03898466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5574766|NCT03898466|Respiratory System Agents|respiratory system agents|mesh-ancestor
5574767|NCT03898466|Dermatologic Agents|dermatologic agents|mesh-ancestor
5574768|NCT03898466|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5574769|NCT03898011|Lamotrigine|lamotrigine|mesh-list
5574770|NCT03898011|Anticonvulsants|anticonvulsants|mesh-ancestor
6179535|NCT01736254|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6487581|NCT00577057|Immunologic Factors|immunologic factors|mesh-ancestor
6179536|NCT01736254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6179537|NCT01736254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6179538|NCT01736254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6206639|NCT02103114|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6206640|NCT02103114|Protease Inhibitors|protease inhibitors|mesh-ancestor
6206641|NCT02103114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6206642|NCT02103114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206643|NCT02103114|Anticoagulants|anticoagulants|mesh-ancestor
6206644|NCT02103439|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6206645|NCT02103439|Antiviral Agents|antiviral agents|mesh-ancestor
6206646|NCT02103439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6206647|NCT02103478|Decitabine|decitabine|mesh-list
6206648|NCT02103478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6206649|NCT02103478|Antimetabolites|antimetabolites|mesh-ancestor
6206650|NCT02103478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206651|NCT02103478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6206652|NCT02103478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6206653|NCT02103855|Abatacept|abatacept|mesh-list
6206654|NCT02103855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6206655|NCT02103855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206656|NCT02103855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6206657|NCT02103855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6206658|NCT02103855|Immunologic Factors|immunologic factors|mesh-ancestor
6206659|NCT02103855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206660|NCT02103855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6206661|NCT02104414|Epinephrine|epinephrine|mesh-list
6487582|NCT00577057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574771|NCT03898011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5574772|NCT03898011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5574773|NCT03898011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574774|NCT03898011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5574775|NCT03898011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574776|NCT03898011|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5574777|NCT03898011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5574778|NCT03898011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5574779|NCT03898011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5574780|NCT03898011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5574781|NCT03898128|Immunotoxins|immunotoxins|mesh-list
5574782|NCT03898128|Immunologic Factors|immunologic factors|mesh-ancestor
5574783|NCT03898128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574784|NCT03898336|Micronutrients|micronutrients|mesh-list
5574785|NCT03898336|Trace Elements|trace elements|mesh-list
5574786|NCT03898336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574787|NCT03897621|Tranexamic Acid|tranexamic acid|mesh-list
5574788|NCT03897621|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5574789|NCT03897621|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5604490|NCT04728646|Glucocorticoids|glucocorticoids|mesh-ancestor
6179539|NCT01736358|Ketorolac|ketorolac|mesh-list
6179540|NCT01736358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6179541|NCT01736358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6179542|NCT01736358|Analgesics|analgesics|mesh-ancestor
6179543|NCT01736358|Sensory System Agents|sensory system agents|mesh-ancestor
6179544|NCT01736358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6179545|NCT01736358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179546|NCT01736358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6487583|NCT00577109|Leucovorin|leucovorin|mesh-list
6487584|NCT00577109|Bevacizumab|bevacizumab|mesh-list
6487585|NCT00577109|Cetuximab|cetuximab|mesh-list
6487586|NCT00577109|Irinotecan|irinotecan|mesh-list
6487587|NCT00577109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6487588|NCT00577109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6487589|NCT00577109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6487590|NCT00577109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6179547|NCT01736358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6179548|NCT01736358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6179549|NCT01736358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6179550|NCT01736358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179551|NCT01736475|Factor VIII|factor viii|mesh-list
6179552|NCT01736475|BAX 855|bax 855|mesh-list
6179553|NCT01736475|Coagulants|coagulants|mesh-ancestor
6179554|NCT01736527|Loteprednol Etabonate|loteprednol etabonate|mesh-list
6179555|NCT01736527|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6179556|NCT01736579|Immunoglobulins|immunoglobulins|mesh-list
6179557|NCT01736579|Antibodies|antibodies|mesh-list
6179558|NCT01736579|gamma-Globulins|gamma-globulins|mesh-list
6179559|NCT01736579|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6179560|NCT01736579|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6487591|NCT00577109|Growth Substances|growth substances|mesh-ancestor
6670672|NCT01544725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6670673|NCT01544725|Anesthetics, General|anesthetics, general|mesh-ancestor
6670674|NCT01544725|Anesthetics|anesthetics|mesh-ancestor
6670675|NCT01544725|Analgesics|analgesics|mesh-ancestor
6670676|NCT01544725|Sensory System Agents|sensory system agents|mesh-ancestor
6670677|NCT01544725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6670678|NCT01544725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6670679|NCT01544725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6670680|NCT01544725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6670681|NCT01544725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6670682|NCT01544725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670683|NCT01544751|Metformin|metformin|mesh-list
6670684|NCT01544751|Atorvastatin|atorvastatin|mesh-list
6670685|NCT01544751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6670686|NCT01544751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670687|NCT01544751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6670688|NCT01544751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6670689|NCT01544751|Antimetabolites|antimetabolites|mesh-ancestor
6670690|NCT01544751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670691|NCT01544751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6670692|NCT01544751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6670693|NCT01544751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6670694|NCT01544829|Theobromine|theobromine|mesh-list
6670695|NCT01544829|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6670696|NCT01544829|Autonomic Agents|autonomic agents|mesh-ancestor
6670697|NCT01544829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6670698|NCT01544829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487592|NCT00577109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487593|NCT00577109|Growth Inhibitors|growth inhibitors|mesh-ancestor
6487594|NCT00577109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6487595|NCT00577109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6487596|NCT00577109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5574790|NCT03897621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574791|NCT03897621|Hemostatics|hemostatics|mesh-ancestor
5574792|NCT03897621|Coagulants|coagulants|mesh-ancestor
5574793|NCT03897660|Vitamins|vitamins|mesh-list
5574794|NCT03897660|Vitamin K|vitamin k|mesh-list
5574795|NCT03897660|Vitamin K 2|vitamin k 2|mesh-list
5574796|NCT03897660|Micronutrients|micronutrients|mesh-ancestor
6670699|NCT01544829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6670700|NCT01544829|Respiratory System Agents|respiratory system agents|mesh-ancestor
6670701|NCT01544829|Vasodilator Agents|vasodilator agents|mesh-ancestor
6670702|NCT01544842|Triamcinolone|triamcinolone|mesh-list
6670703|NCT01544842|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6670704|NCT01544842|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6670705|NCT01544842|Tacrolimus|tacrolimus|mesh-list
6670706|NCT01544842|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6670707|NCT01544842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5574797|NCT03897660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574798|NCT03897660|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5574799|NCT03897660|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5574800|NCT03897660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574801|NCT03897660|Hemostatics|hemostatics|mesh-ancestor
5574802|NCT03897660|Coagulants|coagulants|mesh-ancestor
5574803|NCT03897868|Losartan|losartan|mesh-list
5574804|NCT03897868|Amlodipine|amlodipine|mesh-list
5574805|NCT03897868|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5574806|NCT03897868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5574807|NCT03897868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5574808|NCT03897868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574809|NCT03897868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5574810|NCT03897868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574811|NCT03897868|Vasodilator Agents|vasodilator agents|mesh-ancestor
6670708|NCT01544842|Immunologic Factors|immunologic factors|mesh-ancestor
6670709|NCT01544842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670710|NCT01544842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6670711|NCT01544842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5574812|NCT03897868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6179561|NCT01736579|Immunologic Factors|immunologic factors|mesh-ancestor
6179562|NCT01736579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179563|NCT01736696|Tofacitinib|tofacitinib|mesh-list
6179564|NCT01736696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6179565|NCT01736696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6179566|NCT01736696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179567|NCT01736852|Oxytocin|oxytocin|mesh-list
6179568|NCT01736852|Oxytocics|oxytocics|mesh-ancestor
6487597|NCT00577109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6487598|NCT00577109|Antidotes|antidotes|mesh-ancestor
5574813|NCT03897868|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5574814|NCT03897868|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5574815|NCT03897439|Bupropion|bupropion|mesh-list
5574816|NCT03897439|Nicotine|nicotine|mesh-list
5574817|NCT03897439|Varenicline|varenicline|mesh-list
5574818|NCT03897439|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5574819|NCT03897439|Autonomic Agents|autonomic agents|mesh-ancestor
5574820|NCT03897439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6487599|NCT00577109|Protective Agents|protective agents|mesh-ancestor
5574821|NCT03897439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574822|NCT03897439|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5574823|NCT03897439|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6179569|NCT01736852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6179570|NCT01736852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179571|NCT01736865|Cholecalciferol|cholecalciferol|mesh-list
6179572|NCT01736865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6179573|NCT01736865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179574|NCT01736865|Vitamins|vitamins|mesh-ancestor
6179575|NCT01736865|Micronutrients|micronutrients|mesh-ancestor
6179576|NCT01736865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5574824|NCT03897439|Cholinergic Agents|cholinergic agents|mesh-ancestor
5574825|NCT03897439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5574826|NCT03897439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574827|NCT03897439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5574828|NCT03897439|Antidepressive Agents|antidepressive agents|mesh-ancestor
6179577|NCT01736917|Dexamethasone|dexamethasone|mesh-list
6179578|NCT01736917|Fosaprepitant|fosaprepitant|mesh-list
6179579|NCT01736917|Aprepitant|aprepitant|mesh-list
6179580|NCT01736917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6179581|NCT01736917|Antiemetics|antiemetics|mesh-ancestor
6487600|NCT00577109|Vitamin B Complex|vitamin b complex|mesh-ancestor
6487601|NCT00577109|Vitamins|vitamins|mesh-ancestor
6487602|NCT00577109|Micronutrients|micronutrients|mesh-ancestor
6487603|NCT00577161|Vidarabine|vidarabine|mesh-list
6487604|NCT00577161|Rituximab|rituximab|mesh-list
6179582|NCT01736917|Autonomic Agents|autonomic agents|mesh-ancestor
6179583|NCT01736917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6179584|NCT01736917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179585|NCT01736917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6179586|NCT01736917|Glucocorticoids|glucocorticoids|mesh-ancestor
6179587|NCT01736917|Hormones|hormones|mesh-ancestor
6179588|NCT01736917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6179589|NCT01736917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6179590|NCT01736917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6179591|NCT01736917|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6179592|NCT01736917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6179593|NCT01736917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179594|NCT01736943|Doxorubicin|doxorubicin|mesh-list
6179595|NCT01736943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6179596|NCT01736943|Bortezomib|bortezomib|mesh-list
6179597|NCT01736943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6179598|NCT01736943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6179599|NCT01736943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6179600|NCT01736943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6179601|NCT01736943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6179602|NCT01736943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179603|NCT01737268|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6179604|NCT01737268|Antidepressive Agents|antidepressive agents|mesh-ancestor
6179605|NCT01737268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6179606|NCT01737268|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6179607|NCT01737268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6179608|NCT01737268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6179609|NCT01737268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179610|NCT01737593|Acetaminophen|acetaminophen|mesh-list
6179611|NCT01737593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6179612|NCT01737593|Analgesics|analgesics|mesh-ancestor
6179613|NCT01737593|Sensory System Agents|sensory system agents|mesh-ancestor
6179614|NCT01737593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6179615|NCT01737593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179616|NCT01737593|Antipyretics|antipyretics|mesh-ancestor
6179617|NCT01737710|Vaccines|vaccines|mesh-list
6179618|NCT01737710|Immunologic Factors|immunologic factors|mesh-ancestor
6179619|NCT01737710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179620|NCT01737840|Pantoprazole|pantoprazole|mesh-list
6487605|NCT00577161|Fludarabine|fludarabine|mesh-list
6487606|NCT00577161|Fludarabine phosphate|fludarabine phosphate|mesh-list
6487607|NCT00577161|Pixantrone|pixantrone|mesh-list
6487608|NCT00577161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6487609|NCT00577161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6487610|NCT00577161|Immunologic Factors|immunologic factors|mesh-ancestor
6487611|NCT00577161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487612|NCT00577161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6487613|NCT00577161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6487614|NCT00577161|Antimetabolites|antimetabolites|mesh-ancestor
6179621|NCT01737840|Ranitidine|ranitidine|mesh-list
6179622|NCT01737840|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
6487615|NCT00577161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179623|NCT01737840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6179624|NCT01737840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6179625|NCT01737840|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6179626|NCT01737840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6179627|NCT01737840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179628|NCT01737840|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6179629|NCT01737840|Histamine Antagonists|histamine antagonists|mesh-ancestor
6179630|NCT01737840|Histamine Agents|histamine agents|mesh-ancestor
5574829|NCT03897439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5574830|NCT03897439|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5574831|NCT03897439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5574832|NCT03897439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5574833|NCT03897439|Dopamine Agents|dopamine agents|mesh-ancestor
5574834|NCT03897439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5574835|NCT03897439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5574836|NCT03897439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5574837|NCT03897309|Vaccines|vaccines|mesh-list
5574838|NCT03897309|Immunologic Factors|immunologic factors|mesh-ancestor
5574839|NCT03897309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574840|NCT03897335|Aminophylline|aminophylline|mesh-list
6179631|NCT01737840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6179632|NCT01737840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179633|NCT01737879|Epoetin Alfa|epoetin alfa|mesh-list
6179634|NCT01737879|Hematinics|hematinics|mesh-ancestor
6179635|NCT01737931|Diphenhydramine|diphenhydramine|mesh-list
6179636|NCT01737931|Promethazine|promethazine|mesh-list
6179637|NCT01737931|Dexamethasone|dexamethasone|mesh-list
6179638|NCT01737931|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
6179639|NCT01737931|Histamine Antagonists|histamine antagonists|mesh-list
6179640|NCT01737931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6179641|NCT01737931|Antiemetics|antiemetics|mesh-ancestor
6179642|NCT01737931|Autonomic Agents|autonomic agents|mesh-ancestor
6179643|NCT01737931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6179644|NCT01737931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179645|NCT01737931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6179646|NCT01737931|Glucocorticoids|glucocorticoids|mesh-ancestor
6179647|NCT01737931|Hormones|hormones|mesh-ancestor
6179648|NCT01737931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6179649|NCT01737931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6179650|NCT01737931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6179651|NCT01737931|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6179652|NCT01737931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6179653|NCT01737931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6179654|NCT01737931|Anesthetics, Local|anesthetics, local|mesh-ancestor
6179655|NCT01737931|Anesthetics|anesthetics|mesh-ancestor
6179656|NCT01737931|Sensory System Agents|sensory system agents|mesh-ancestor
6179657|NCT01737931|Histamine Agents|histamine agents|mesh-ancestor
6179658|NCT01737931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6179659|NCT01737931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179660|NCT01737931|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5574841|NCT03897335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5574842|NCT03897335|Autonomic Agents|autonomic agents|mesh-ancestor
5574843|NCT03897335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5574844|NCT03897335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574845|NCT03897335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5574846|NCT03897335|Respiratory System Agents|respiratory system agents|mesh-ancestor
5574847|NCT03897335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5574848|NCT03897335|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5574849|NCT03897335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5574850|NCT03897335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574851|NCT03897335|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5574852|NCT03897335|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5574853|NCT03897335|Purinergic Agents|purinergic agents|mesh-ancestor
5574854|NCT03897335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5574855|NCT03897335|Protective Agents|protective agents|mesh-ancestor
5574856|NCT03897413|Antacids|antacids|mesh-list
5574857|NCT03897413|Calcium Carbonate|calcium carbonate|mesh-list
5574858|NCT03897413|Calcium|calcium|mesh-list
5574859|NCT03897413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5574860|NCT03897413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574861|NCT03897413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574862|NCT03897413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5574863|NCT03897452|Fentanyl|fentanyl|mesh-list
5574864|NCT03897452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5574865|NCT03897452|Narcotics|narcotics|mesh-ancestor
5574866|NCT03897452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5574867|NCT03897452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574868|NCT03897452|Analgesics|analgesics|mesh-ancestor
5574869|NCT03897452|Sensory System Agents|sensory system agents|mesh-ancestor
5574870|NCT03897452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6179661|NCT01737931|Antipruritics|antipruritics|mesh-ancestor
6179662|NCT01737931|Dermatologic Agents|dermatologic agents|mesh-ancestor
6179663|NCT01737944|Methotrexate|methotrexate|mesh-list
6179664|NCT01737944|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6179665|NCT01737944|Abortifacient Agents|abortifacient agents|mesh-ancestor
6179666|NCT01737944|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6179667|NCT01737944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179668|NCT01737944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6179669|NCT01737944|Antimetabolites|antimetabolites|mesh-ancestor
6179670|NCT01737944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179671|NCT01737944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6179672|NCT01737944|Dermatologic Agents|dermatologic agents|mesh-ancestor
6179673|NCT01737944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6179674|NCT01737944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6179675|NCT01737944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6179676|NCT01737944|Immunologic Factors|immunologic factors|mesh-ancestor
6179677|NCT01737944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6487616|NCT00577161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6487617|NCT00577161|Antiviral Agents|antiviral agents|mesh-ancestor
6487618|NCT00577161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6487619|NCT00577161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5574871|NCT03897452|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6179678|NCT01737944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6179679|NCT01738191|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6179680|NCT01738191|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6179681|NCT01738191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6179682|NCT01738191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5574872|NCT03897452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5574873|NCT03897452|Anesthetics, General|anesthetics, general|mesh-ancestor
5574874|NCT03897452|Anesthetics|anesthetics|mesh-ancestor
5574875|NCT03896971|Cyclosporine|cyclosporine|mesh-list
5574876|NCT03896971|Cyclosporins|cyclosporins|mesh-list
5574877|NCT03896971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5574878|NCT03896971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574879|NCT03896971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5574880|NCT03896971|Immunologic Factors|immunologic factors|mesh-ancestor
5574881|NCT03896971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574882|NCT03896971|Antifungal Agents|antifungal agents|mesh-ancestor
6179683|NCT01738191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179684|NCT01738191|Adrenergic Agents|adrenergic agents|mesh-ancestor
6179685|NCT01738191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6179686|NCT01738191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179687|NCT01738503|Buprenorphine|buprenorphine|mesh-list
6179688|NCT01738503|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6179689|NCT01738503|Narcotics|narcotics|mesh-ancestor
6179690|NCT01738503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6487620|NCT00577161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5574883|NCT03896971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5574884|NCT03896971|Dermatologic Agents|dermatologic agents|mesh-ancestor
5574885|NCT03896971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5574886|NCT03896971|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5574887|NCT03896932|Immunoglobulins|immunoglobulins|mesh-list
5574888|NCT03896932|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5574889|NCT03896932|Antibodies|antibodies|mesh-list
5574890|NCT03896932|gamma-Globulins|gamma-globulins|mesh-list
5574891|NCT03896932|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5574892|NCT03896932|Immunologic Factors|immunologic factors|mesh-ancestor
5574893|NCT03896932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574894|NCT03897062|Suvorexant|suvorexant|mesh-list
5574895|NCT03897062|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5574896|NCT03897062|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5574897|NCT03897062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5574898|NCT03897062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574899|NCT03897062|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
5574900|NCT03897062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5574901|NCT03897062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574902|NCT03896893|Emollients|emollients|mesh-list
5574903|NCT03896893|Dermatologic Agents|dermatologic agents|mesh-ancestor
5604491|NCT04728646|Hormones|hormones|mesh-ancestor
5606866|NCT03593018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6179691|NCT01738503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179692|NCT01738503|Analgesics|analgesics|mesh-ancestor
6179693|NCT01738503|Sensory System Agents|sensory system agents|mesh-ancestor
6179694|NCT01738503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6179695|NCT01738503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6179696|NCT01738594|Romidepsin|romidepsin|mesh-list
5574904|NCT03896685|Linezolid|linezolid|mesh-list
5574905|NCT03896685|Bedaquiline|bedaquiline|mesh-list
5574906|NCT03896685|Clofazimine|clofazimine|mesh-list
5574907|NCT03896685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5574908|NCT03896685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5574909|NCT03896685|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5574910|NCT03896685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5574911|NCT03896685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179697|NCT01738594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6179698|NCT01738594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6179699|NCT01738646|Bevacizumab|bevacizumab|mesh-list
5574912|NCT03896685|Antitubercular Agents|antitubercular agents|mesh-ancestor
5574913|NCT03896685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5574914|NCT03896685|Leprostatic Agents|leprostatic agents|mesh-ancestor
5574915|NCT03896737|Thalidomide|thalidomide|mesh-list
5574916|NCT03896737|Dexamethasone|dexamethasone|mesh-list
5574917|NCT03896737|Dexamethasone acetate|dexamethasone acetate|mesh-list
5574918|NCT03896737|Cyclophosphamide|cyclophosphamide|mesh-list
5574919|NCT03896737|Bortezomib|bortezomib|mesh-list
5574920|NCT03896737|Daratumumab|daratumumab|mesh-list
5574921|NCT03896737|BB 1101|bb 1101|mesh-list
5574922|NCT03896737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5574923|NCT03896737|Immunologic Factors|immunologic factors|mesh-ancestor
5574924|NCT03896737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179700|NCT01738646|Vorinostat|vorinostat|mesh-list
6179701|NCT01738646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6179702|NCT01738646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6179703|NCT01738646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6179704|NCT01738646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6179705|NCT01738646|Growth Substances|growth substances|mesh-ancestor
6179706|NCT01738646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179707|NCT01738646|Growth Inhibitors|growth inhibitors|mesh-ancestor
6179708|NCT01738646|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6179709|NCT01738646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6179710|NCT01738646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179711|NCT01738672|Nitrous Oxide|nitrous oxide|mesh-list
6179712|NCT01738672|Entonox|entonox|mesh-list
6179713|NCT01738672|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6179714|NCT01738672|Anesthetics, General|anesthetics, general|mesh-ancestor
6179715|NCT01738672|Anesthetics|anesthetics|mesh-ancestor
6179716|NCT01738672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6179717|NCT01738672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179718|NCT01738672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5574925|NCT03896737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5574926|NCT03896737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5574927|NCT03896737|Alkylating Agents|alkylating agents|mesh-ancestor
5574928|NCT03896737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574929|NCT03896737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5574930|NCT03896737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5574931|NCT03896737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6179719|NCT01738672|Analgesics|analgesics|mesh-ancestor
5574932|NCT03896737|Antiemetics|antiemetics|mesh-ancestor
5574933|NCT03896737|Autonomic Agents|autonomic agents|mesh-ancestor
5574934|NCT03896737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5574935|NCT03896737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5574936|NCT03896737|Glucocorticoids|glucocorticoids|mesh-ancestor
5574937|NCT03896737|Hormones|hormones|mesh-ancestor
5574938|NCT03896737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5574939|NCT03896737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5574940|NCT03896737|Protease Inhibitors|protease inhibitors|mesh-ancestor
5574941|NCT03896737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5574942|NCT03896737|Leprostatic Agents|leprostatic agents|mesh-ancestor
5574943|NCT03896737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5574944|NCT03896737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5574945|NCT03896737|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5574946|NCT03896737|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5574947|NCT03896737|Growth Substances|growth substances|mesh-ancestor
5574948|NCT03896737|Growth Inhibitors|growth inhibitors|mesh-ancestor
5574949|NCT03896477|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6179720|NCT01738672|Sensory System Agents|sensory system agents|mesh-ancestor
6179721|NCT01738672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6179722|NCT01738672|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
6179723|NCT01738971|Progestins|progestins|mesh-list
6179724|NCT01738971|Hormones|hormones|mesh-ancestor
6179725|NCT01738971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6179726|NCT01738971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179727|NCT01739335|Mifepristone|mifepristone|mesh-list
6179728|NCT01739335|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6179729|NCT01739335|Abortifacient Agents|abortifacient agents|mesh-ancestor
6179730|NCT01739335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5574950|NCT03896477|Immunologic Factors|immunologic factors|mesh-ancestor
5574951|NCT03896477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574952|NCT03896646|Iminodiacetic acid|iminodiacetic acid|mesh-list
6670712|NCT01544842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670713|NCT01544842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6670714|NCT01544842|Glucocorticoids|glucocorticoids|mesh-ancestor
6670715|NCT01544842|Hormones|hormones|mesh-ancestor
5574953|NCT03896646|Chelating Agents|chelating agents|mesh-ancestor
5574954|NCT03896646|Sequestering Agents|sequestering agents|mesh-ancestor
5574955|NCT03896646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574956|NCT03896321|Anticoagulants|anticoagulants|mesh-list
5574957|NCT03896321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
5574958|NCT03896256|Ketamine|ketamine|mesh-list
5574959|NCT03896256|Analgesics|analgesics|mesh-ancestor
5574960|NCT03896256|Sensory System Agents|sensory system agents|mesh-ancestor
5574961|NCT03896256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5574962|NCT03896256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574963|NCT03896256|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5574964|NCT03896256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5574965|NCT03896256|Anesthetics, General|anesthetics, general|mesh-ancestor
5574966|NCT03896256|Anesthetics|anesthetics|mesh-ancestor
5574967|NCT03896256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5574968|NCT03896256|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5574969|NCT03896256|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5574970|NCT03896256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5574971|NCT03896256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574972|NCT03896113|Celecoxib|celecoxib|mesh-list
5574973|NCT03896113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5574974|NCT03896113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6179731|NCT01739335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179732|NCT01739335|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6179733|NCT01739335|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6179734|NCT01739335|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6179735|NCT01739335|Contraceptive Agents|contraceptive agents|mesh-ancestor
6179736|NCT01739335|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6179737|NCT01739335|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6179738|NCT01739335|Hormone Antagonists|hormone antagonists|mesh-ancestor
6179739|NCT01739335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6179740|NCT01739335|Luteolytic Agents|luteolytic agents|mesh-ancestor
6179741|NCT01739335|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6179742|NCT01739335|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6179743|NCT01739361|Acetaminophen|acetaminophen|mesh-list
6179744|NCT01739361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6179745|NCT01739361|Analgesics|analgesics|mesh-ancestor
6179746|NCT01739361|Sensory System Agents|sensory system agents|mesh-ancestor
6179747|NCT01739361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6179748|NCT01739361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179749|NCT01739361|Antipyretics|antipyretics|mesh-ancestor
6179750|NCT01739400|Macitentan|macitentan|mesh-list
6179751|NCT01739400|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
6179752|NCT01739400|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6179753|NCT01739400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179754|NCT01739400|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
6179755|NCT01739595|Enclomiphene|enclomiphene|mesh-list
6179756|NCT01739595|Clomiphene|clomiphene|mesh-list
6179757|NCT01739595|Zuclomiphene|zuclomiphene|mesh-list
5574975|NCT03896113|Analgesics|analgesics|mesh-ancestor
5574976|NCT03896113|Sensory System Agents|sensory system agents|mesh-ancestor
5574977|NCT03896113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5574978|NCT03896113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574979|NCT03896113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5574980|NCT03896113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6179758|NCT01739595|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6179759|NCT01739595|Hormone Antagonists|hormone antagonists|mesh-ancestor
6670716|NCT01544842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5574981|NCT03896113|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5574982|NCT03896113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5574983|NCT03896113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5574984|NCT03896113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574985|NCT03896074|Bevacizumab|bevacizumab|mesh-list
5574986|NCT03896074|Atezolizumab|atezolizumab|mesh-list
5574987|NCT03896074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5574988|NCT03896074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5574989|NCT03896074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5574990|NCT03896074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5574991|NCT03896074|Growth Substances|growth substances|mesh-ancestor
5574992|NCT03896074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5574993|NCT03896074|Growth Inhibitors|growth inhibitors|mesh-ancestor
6179760|NCT01739595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6179761|NCT01739595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179762|NCT01739595|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6670717|NCT01544881|Insulin|insulin|mesh-list
6670718|NCT01544881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6670719|NCT01544881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670720|NCT01544894|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
6670721|NCT01544894|Strontium ranelate|strontium ranelate|mesh-list
6670722|NCT01544894|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6670723|NCT01544894|Hormone Antagonists|hormone antagonists|mesh-ancestor
6670724|NCT01544894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6670725|NCT01544894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670726|NCT01544894|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6670727|NCT01544894|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6670728|NCT01544894|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6670729|NCT01544907|Paclitaxel|paclitaxel|mesh-list
6670730|NCT01544907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6670731|NCT01544907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6670732|NCT01544907|Tubulin Modulators|tubulin modulators|mesh-ancestor
6670733|NCT01544907|Antimitotic Agents|antimitotic agents|mesh-ancestor
6670734|NCT01544907|Mitosis Modulators|mitosis modulators|mesh-ancestor
6670735|NCT01544907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670736|NCT01544959|Fentanyl|fentanyl|mesh-list
6670737|NCT01544959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
6670738|NCT01544959|Esmolol|esmolol|mesh-list
5574994|NCT03896269|Cytarabine|cytarabine|mesh-list
5574995|NCT03896269|Daunorubicin|daunorubicin|mesh-list
5574996|NCT03896269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5574997|NCT03896269|Antimetabolites|antimetabolites|mesh-ancestor
5574998|NCT03896269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5574999|NCT03896269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5575000|NCT03896269|Antiviral Agents|antiviral agents|mesh-ancestor
5575001|NCT03896269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5575002|NCT03896269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6670739|NCT01544959|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6670740|NCT01544959|Narcotics|narcotics|mesh-ancestor
6670741|NCT01544959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6670742|NCT01544959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575003|NCT03896269|Immunologic Factors|immunologic factors|mesh-ancestor
5575004|NCT03896269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575005|NCT03896269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6670743|NCT01544959|Analgesics|analgesics|mesh-ancestor
6670744|NCT01544959|Sensory System Agents|sensory system agents|mesh-ancestor
6670745|NCT01544959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6670746|NCT01544959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6670747|NCT01544959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6670748|NCT01544959|Anesthetics, General|anesthetics, general|mesh-ancestor
6670749|NCT01544959|Anesthetics|anesthetics|mesh-ancestor
6670750|NCT01544959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5575006|NCT03896269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5575007|NCT03896269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6179763|NCT01739595|Fertility Agents|fertility agents|mesh-ancestor
6179764|NCT01739595|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6179765|NCT01739595|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5575008|NCT03896269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5575009|NCT03895892|Caffeine|caffeine|mesh-list
5575010|NCT03895892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5575011|NCT03895892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179766|NCT01739595|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6179767|NCT01739699|Acetaminophen|acetaminophen|mesh-list
6179768|NCT01739699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6179769|NCT01739699|Analgesics|analgesics|mesh-ancestor
6179770|NCT01739699|Sensory System Agents|sensory system agents|mesh-ancestor
6179771|NCT01739699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6179772|NCT01739699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179773|NCT01739699|Antipyretics|antipyretics|mesh-ancestor
6179774|NCT01739764|Vemurafenib|vemurafenib|mesh-list
6179775|NCT01739764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6179776|NCT01739764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6179777|NCT01739764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6179778|NCT01739764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179779|NCT01739790|Acetylcysteine|acetylcysteine|mesh-list
6179780|NCT01739790|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6670751|NCT01544959|Adrenergic Agents|adrenergic agents|mesh-ancestor
6670752|NCT01544959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6670753|NCT01544959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179781|NCT01739790|Antiviral Agents|antiviral agents|mesh-ancestor
6179782|NCT01739790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6179783|NCT01739790|Expectorants|expectorants|mesh-ancestor
6179784|NCT01739790|Respiratory System Agents|respiratory system agents|mesh-ancestor
6179785|NCT01739790|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6179786|NCT01739790|Antioxidants|antioxidants|mesh-ancestor
6179787|NCT01739790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179788|NCT01739790|Protective Agents|protective agents|mesh-ancestor
6179789|NCT01739790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179790|NCT01739790|Antidotes|antidotes|mesh-ancestor
6179791|NCT01739933|Dexmedetomidine|dexmedetomidine|mesh-list
6179792|NCT01739933|Propofol|propofol|mesh-list
6179793|NCT01739933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6179794|NCT01739933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6179795|NCT01739933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179796|NCT01739933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6179797|NCT01739933|Anesthetics, General|anesthetics, general|mesh-ancestor
6179798|NCT01739933|Anesthetics|anesthetics|mesh-ancestor
6179799|NCT01739933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6179800|NCT01739933|Analgesics|analgesics|mesh-ancestor
6179801|NCT01739933|Sensory System Agents|sensory system agents|mesh-ancestor
6179802|NCT01739933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6670754|NCT01544959|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6670755|NCT01544972|Acetaminophen|acetaminophen|mesh-list
6670756|NCT01544972|Ibuprofen|ibuprofen|mesh-list
6670757|NCT01544972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6670758|NCT01544972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6670759|NCT01544972|Analgesics|analgesics|mesh-ancestor
6670760|NCT01544972|Sensory System Agents|sensory system agents|mesh-ancestor
6670761|NCT01544972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6670762|NCT01544972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670763|NCT01544972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6670764|NCT01544972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6670765|NCT01544972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6670766|NCT01544972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6670767|NCT01544972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670768|NCT01544972|Antipyretics|antipyretics|mesh-ancestor
6670769|NCT01545024|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6670770|NCT01545024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6670771|NCT01545024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575012|NCT03895892|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5575013|NCT03895892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5575014|NCT03895892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575015|NCT03895892|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5575016|NCT03895892|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5575017|NCT03895892|Purinergic Agents|purinergic agents|mesh-ancestor
5575018|NCT03895892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5575019|NCT03896217|Simvastatin|simvastatin|mesh-list
5575020|NCT03896217|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5575021|NCT03896217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5575022|NCT03896217|Antimetabolites|antimetabolites|mesh-ancestor
5575023|NCT03896217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575024|NCT03896217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5575025|NCT03896217|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5575026|NCT03896217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5575027|NCT03895788|Niraparib|niraparib|mesh-list
5606867|NCT03593018|Alkylating Agents|alkylating agents|mesh-ancestor
6179803|NCT01739933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5575028|NCT03895788|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5575029|NCT03895788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5575030|NCT03895788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575031|NCT03895788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5575032|NCT03895840|Triamcinolone|triamcinolone|mesh-list
5575033|NCT03895840|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5575034|NCT03895840|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5575035|NCT03895840|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5575036|NCT03895840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5575037|NCT03895840|Glucocorticoids|glucocorticoids|mesh-ancestor
5575038|NCT03895840|Hormones|hormones|mesh-ancestor
5575039|NCT03895840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5575040|NCT03895840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575041|NCT03895840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5575042|NCT03895840|Immunologic Factors|immunologic factors|mesh-ancestor
5575043|NCT03895840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5575044|NCT03895840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575045|NCT03895801|Prednisone|prednisone|mesh-list
5575046|NCT03895801|Glucocorticoids|glucocorticoids|mesh-list
5575047|NCT03895801|Vilobelimab|vilobelimab|mesh-list
5575048|NCT03895801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5575049|NCT03895801|Hormones|hormones|mesh-ancestor
5575050|NCT03895801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5575051|NCT03895801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575052|NCT03895801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6487621|NCT00577161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6487622|NCT00577200|Midazolam|midazolam|mesh-list
6487623|NCT00577200|Sufentanil|sufentanil|mesh-list
6487624|NCT00577200|Propofol|propofol|mesh-list
6487625|NCT00577200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6487626|NCT00577200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6487627|NCT00577200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487628|NCT00577200|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6487629|NCT00577200|Anesthetics, General|anesthetics, general|mesh-ancestor
6487630|NCT00577200|Anesthetics|anesthetics|mesh-ancestor
6487631|NCT00577200|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6487632|NCT00577200|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6487633|NCT00577200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6487634|NCT00577200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6487635|NCT00577200|GABA Modulators|gaba modulators|mesh-ancestor
6487636|NCT00577200|GABA Agents|gaba agents|mesh-ancestor
6487637|NCT00577200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6487638|NCT00577200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6487639|NCT00577200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6487640|NCT00577200|Narcotics|narcotics|mesh-ancestor
6487641|NCT00577200|Analgesics|analgesics|mesh-ancestor
6487642|NCT00577200|Sensory System Agents|sensory system agents|mesh-ancestor
6487643|NCT00577200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6487644|NCT00577278|Sirolimus|sirolimus|mesh-list
6487645|NCT00577278|Rituximab|rituximab|mesh-list
6487646|NCT00577278|Fludarabine|fludarabine|mesh-list
6487647|NCT00577278|Fludarabine phosphate|fludarabine phosphate|mesh-list
6487648|NCT00577278|Melphalan|melphalan|mesh-list
6487649|NCT00577278|Tacrolimus|tacrolimus|mesh-list
6487650|NCT00577278|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6487651|NCT00577278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6487652|NCT00577278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6487653|NCT00577278|Immunologic Factors|immunologic factors|mesh-ancestor
6487654|NCT00577278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487655|NCT00577278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6487656|NCT00577278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6487657|NCT00577278|Antimetabolites|antimetabolites|mesh-ancestor
6487658|NCT00577278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6487659|NCT00577278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6487660|NCT00577278|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6487661|NCT00577278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6487662|NCT00577278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6487663|NCT00577278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6487664|NCT00577278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6487665|NCT00577278|Antifungal Agents|antifungal agents|mesh-ancestor
6487666|NCT00577278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6487667|NCT00577278|Alkylating Agents|alkylating agents|mesh-ancestor
6487668|NCT00577278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6487669|NCT00577304|Nitroglycerin|nitroglycerin|mesh-list
6487670|NCT00577304|Vasodilator Agents|vasodilator agents|mesh-ancestor
6487671|NCT00577369|Desflurane|desflurane|mesh-list
6487672|NCT00577369|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5575053|NCT03895801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5575054|NCT03895801|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5575055|NCT03895801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5575056|NCT03895801|Immunologic Factors|immunologic factors|mesh-ancestor
5575057|NCT03895671|Azacitidine|azacitidine|mesh-list
5575058|NCT03895671|Ponatinib|ponatinib|mesh-list
5575059|NCT03895671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5575060|NCT03895671|Antimetabolites|antimetabolites|mesh-ancestor
5575061|NCT03895671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575062|NCT03895671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5575063|NCT03895671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5575064|NCT03895671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5575065|NCT03895528|Lonafarnib|lonafarnib|mesh-list
5575066|NCT03895528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5575067|NCT03895528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575068|NCT03895567|Ceftriaxone|ceftriaxone|mesh-list
5575069|NCT03895567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5575070|NCT03895567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6487673|NCT00577369|Anesthetics, General|anesthetics, general|mesh-ancestor
6487674|NCT00577369|Anesthetics|anesthetics|mesh-ancestor
6487675|NCT00577369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6487676|NCT00577369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179804|NCT01739933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6179805|NCT01739933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5575071|NCT03895970|Pembrolizumab|pembrolizumab|mesh-list
5575072|NCT03895970|Lenvatinib|lenvatinib|mesh-list
5575073|NCT03895970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5575074|NCT03895970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5575075|NCT03895970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5575076|NCT03895970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5575077|NCT03895970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575078|NCT03895502|Edoxaban|edoxaban|mesh-list
5575079|NCT03895502|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5575080|NCT03895502|Antithrombins|antithrombins|mesh-ancestor
5575081|NCT03895502|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5575082|NCT03895502|Protease Inhibitors|protease inhibitors|mesh-ancestor
5575083|NCT03895502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5575084|NCT03895502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179806|NCT01739933|Adrenergic Agents|adrenergic agents|mesh-ancestor
6179807|NCT01739933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6179808|NCT01739933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179809|NCT01740089|Ribavirin|ribavirin|mesh-list
6179810|NCT01740089|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6179811|NCT01740089|Antimetabolites|antimetabolites|mesh-ancestor
6179812|NCT01740089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179813|NCT01740089|Antiviral Agents|antiviral agents|mesh-ancestor
6179814|NCT01740089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6179815|NCT01740206|Methylphenidate|methylphenidate|mesh-list
6179816|NCT01740206|Amphetamine|amphetamine|mesh-list
6179817|NCT01740206|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6179818|NCT01740206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179819|NCT01740206|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6179820|NCT01740206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6179821|NCT01740206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5575085|NCT03895502|Anticoagulants|anticoagulants|mesh-ancestor
5575086|NCT03895229|Empagliflozin|empagliflozin|mesh-list
5575087|NCT03895229|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5575088|NCT03895229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575089|NCT03895229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5575090|NCT03895229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575091|NCT03895411|Sotalol|sotalol|mesh-list
5575092|NCT03895411|Propafenone|propafenone|mesh-list
5575093|NCT03895411|Metoprolol|metoprolol|mesh-list
5575094|NCT03895411|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6179822|NCT01740206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179823|NCT01740206|Dopamine Agents|dopamine agents|mesh-ancestor
6179824|NCT01740206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6179825|NCT01740206|Sympathomimetics|sympathomimetics|mesh-ancestor
6179826|NCT01740206|Autonomic Agents|autonomic agents|mesh-ancestor
6179827|NCT01740206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6179828|NCT01740206|Adrenergic Agents|adrenergic agents|mesh-ancestor
6179829|NCT01740206|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6179830|NCT01740258|Bevacizumab|bevacizumab|mesh-list
6179831|NCT01740258|Temozolomide|temozolomide|mesh-list
5575095|NCT03895411|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5575096|NCT03895411|Adrenergic Agents|adrenergic agents|mesh-ancestor
5575097|NCT03895411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5575098|NCT03895411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575099|NCT03895411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575100|NCT03895411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5575101|NCT03895411|Sympatholytics|sympatholytics|mesh-ancestor
5575102|NCT03895411|Autonomic Agents|autonomic agents|mesh-ancestor
5575103|NCT03895411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5575104|NCT03895411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5575105|NCT03895411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5575106|NCT03895411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5575107|NCT03895411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5575108|NCT03895411|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5604492|NCT04728646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5604493|NCT04728646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5604494|NCT04728646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5604495|NCT04708886|Alendronate|alendronate|mesh-list
5604496|NCT04708886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5604497|NCT04708886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179832|NCT01740258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6179833|NCT01740258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6179834|NCT01740258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6179835|NCT01740258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6179836|NCT01740258|Growth Substances|growth substances|mesh-ancestor
6179837|NCT01740258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179838|NCT01740258|Growth Inhibitors|growth inhibitors|mesh-ancestor
6179839|NCT01740258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6179840|NCT01740258|Alkylating Agents|alkylating agents|mesh-ancestor
6179841|NCT01740258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179842|NCT01740297|Ipilimumab|ipilimumab|mesh-list
6179843|NCT01740297|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
6179844|NCT01740297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6179845|NCT01740297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6179846|NCT01740297|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6179847|NCT01740297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179848|NCT01740323|Curcumin|curcumin|mesh-list
6179849|NCT01740323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6179850|NCT01740323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6179851|NCT01740323|Analgesics|analgesics|mesh-ancestor
6179852|NCT01740323|Sensory System Agents|sensory system agents|mesh-ancestor
6179853|NCT01740323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6179854|NCT01740323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604498|NCT04674826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5604499|NCT04674826|Immunologic Factors|immunologic factors|mesh-ancestor
5604500|NCT04674826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604501|NCT04671043|Caffeine|caffeine|mesh-list
5604502|NCT04671043|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5604503|NCT04671043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604504|NCT04671043|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5604505|NCT04671043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5604506|NCT04671043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179855|NCT01740323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6179856|NCT01740323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6179857|NCT01740323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6179858|NCT01740323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6179859|NCT01740323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179860|NCT01740362|Tofacitinib|tofacitinib|mesh-list
6179861|NCT01740362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6179862|NCT01740362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6179863|NCT01740362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179864|NCT01740388|Besifloxacin|besifloxacin|mesh-list
6179865|NCT01740388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6179866|NCT01740388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6179867|NCT01740388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6179868|NCT01740388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6179869|NCT01740388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6179870|NCT01740388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179871|NCT01740388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6179872|NCT01740401|Cyclophosphamide|cyclophosphamide|mesh-list
6179873|NCT01740401|Ipilimumab|ipilimumab|mesh-list
6179874|NCT01740401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6179875|NCT01740401|Immunologic Factors|immunologic factors|mesh-ancestor
6179876|NCT01740401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179877|NCT01740401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6179878|NCT01740401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6179879|NCT01740401|Alkylating Agents|alkylating agents|mesh-ancestor
5575109|NCT03894904|Heparin|heparin|mesh-list
5575110|NCT03894904|Papaverine|papaverine|mesh-list
5575111|NCT03894904|Anticoagulants|anticoagulants|mesh-ancestor
5575112|NCT03894904|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5575113|NCT03894904|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5575114|NCT03894904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575115|NCT03894904|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5575116|NCT03894904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5575117|NCT03894904|Vasodilator Agents|vasodilator agents|mesh-ancestor
5575118|NCT03894904|Urological Agents|urological agents|mesh-ancestor
5575119|NCT03894891|Docetaxel|docetaxel|mesh-list
5575120|NCT03894891|Nivolumab|nivolumab|mesh-list
5575121|NCT03894891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5575122|NCT03894891|Tubulin Modulators|tubulin modulators|mesh-ancestor
5575123|NCT03894891|Antimitotic Agents|antimitotic agents|mesh-ancestor
5575124|NCT03894891|Mitosis Modulators|mitosis modulators|mesh-ancestor
5575125|NCT03894891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575126|NCT03894891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5575127|NCT03894891|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5575128|NCT03894839|Chlorhexidine|chlorhexidine|mesh-list
5575129|NCT03894839|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6179880|NCT01740401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179881|NCT01740401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6179882|NCT01740401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6179883|NCT01740401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6179884|NCT01740401|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6179885|NCT01740414|Ibudilast|ibudilast|mesh-list
6179886|NCT01740414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6179887|NCT01740414|Autonomic Agents|autonomic agents|mesh-ancestor
6179888|NCT01740414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6179889|NCT01740414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179890|NCT01740414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6179891|NCT01740414|Respiratory System Agents|respiratory system agents|mesh-ancestor
6179892|NCT01740414|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6179893|NCT01740414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6179894|NCT01740414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575130|NCT03894839|Sodium Hypochlorite|sodium hypochlorite|mesh-list
5575131|NCT03894839|Glutaral|glutaral|mesh-list
5575132|NCT03894839|Eusol|eusol|mesh-list
5575133|NCT03894839|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5575134|NCT03894839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5575135|NCT03894839|Disinfectants|disinfectants|mesh-ancestor
5575136|NCT03894839|Dermatologic Agents|dermatologic agents|mesh-ancestor
5575137|NCT03894826|Vorinostat|vorinostat|mesh-list
5575138|NCT03894826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5575139|NCT03894826|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5575140|NCT03894826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5575141|NCT03894826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575142|NCT03894722|Povidone-Iodine|povidone-iodine|mesh-list
5575143|NCT03894722|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5575144|NCT03894722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5575145|NCT03894748|Botulinum Toxins|botulinum toxins|mesh-list
5575146|NCT03894748|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5575147|NCT03894748|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5575148|NCT03894748|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5575149|NCT03894748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5575150|NCT03894748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575151|NCT03894748|Cholinergic Agents|cholinergic agents|mesh-ancestor
6179895|NCT01740414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6179896|NCT01740414|Vasodilator Agents|vasodilator agents|mesh-ancestor
6179897|NCT01740427|Letrozole|letrozole|mesh-list
6179898|NCT01740427|Palbociclib|palbociclib|mesh-list
6179899|NCT01740427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6179900|NCT01740427|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6179901|NCT01740427|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6179902|NCT01740427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6179903|NCT01740427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179904|NCT01740427|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6179905|NCT01740427|Hormone Antagonists|hormone antagonists|mesh-ancestor
5575152|NCT03894748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6179906|NCT01740427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6179907|NCT01740427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179908|NCT01740427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6179909|NCT01740713|Deferiprone|deferiprone|mesh-list
6179910|NCT01740713|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6179911|NCT01740713|Chelating Agents|chelating agents|mesh-ancestor
6179912|NCT01740713|Sequestering Agents|sequestering agents|mesh-ancestor
6179913|NCT01740713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179914|NCT01740726|Fluoxetine|fluoxetine|mesh-list
6179915|NCT01740726|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6670772|NCT01545024|Incretins|incretins|mesh-ancestor
6670773|NCT01545024|Hormones|hormones|mesh-ancestor
6670774|NCT01545024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5575153|NCT03894748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575154|NCT03894748|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5575155|NCT03894748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5575156|NCT03894800|Fentanyl|fentanyl|mesh-list
5575157|NCT03894800|Methoxyflurane|methoxyflurane|mesh-list
5575158|NCT03894800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5575159|NCT03894800|Narcotics|narcotics|mesh-ancestor
5575160|NCT03894800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5575161|NCT03894800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575162|NCT03894800|Analgesics|analgesics|mesh-ancestor
5575163|NCT03894800|Sensory System Agents|sensory system agents|mesh-ancestor
5575164|NCT03894800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5575165|NCT03894800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5575166|NCT03894800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5575167|NCT03894800|Anesthetics, General|anesthetics, general|mesh-ancestor
5575168|NCT03894800|Anesthetics|anesthetics|mesh-ancestor
5575169|NCT03894800|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5575170|NCT03894683|Melatonin|melatonin|mesh-list
5575171|NCT03894683|Antioxidants|antioxidants|mesh-ancestor
5575172|NCT03894683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575173|NCT03894683|Protective Agents|protective agents|mesh-ancestor
5575174|NCT03894683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575175|NCT03894683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5575176|NCT03894189|Theophylline|theophylline|mesh-list
5575177|NCT03894189|Doxapram|doxapram|mesh-list
5575178|NCT03894189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5575179|NCT03894189|Autonomic Agents|autonomic agents|mesh-ancestor
5575180|NCT03894189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5575181|NCT03894189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575182|NCT03894189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5575183|NCT03894189|Respiratory System Agents|respiratory system agents|mesh-ancestor
5575184|NCT03894189|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5575185|NCT03894189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5575186|NCT03894189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575187|NCT03894189|Vasodilator Agents|vasodilator agents|mesh-ancestor
5575188|NCT03894189|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5575189|NCT03894189|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5575190|NCT03894189|Purinergic Agents|purinergic agents|mesh-ancestor
5575191|NCT03894189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5575192|NCT03894189|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5575193|NCT03894085|Paroxetine|paroxetine|mesh-list
6179916|NCT01740726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6179917|NCT01740726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6179918|NCT01740726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179919|NCT01740726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6179920|NCT01740726|Serotonin Agents|serotonin agents|mesh-ancestor
6179921|NCT01740726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179922|NCT01740726|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6179923|NCT01740726|Antidepressive Agents|antidepressive agents|mesh-ancestor
6179924|NCT01740726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6179925|NCT01740726|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6179926|NCT01740726|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6179927|NCT01740726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6179928|NCT01740791|Velpatasvir|velpatasvir|mesh-list
6179929|NCT01740791|Antiviral Agents|antiviral agents|mesh-ancestor
6179930|NCT01740791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6206662|NCT02104414|Bupivacaine|bupivacaine|mesh-list
6487677|NCT00577421|Risedronic Acid|risedronic acid|mesh-list
6487678|NCT00577421|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6487679|NCT00577421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6179931|NCT01740817|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6179932|NCT01740817|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6179933|NCT01740817|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6179934|NCT01740817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6179935|NCT01741259|Meperidine|meperidine|mesh-list
6179936|NCT01741259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6179937|NCT01741259|Narcotics|narcotics|mesh-ancestor
6179938|NCT01741259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6179939|NCT01741259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179940|NCT01741259|Analgesics|analgesics|mesh-ancestor
6179941|NCT01741259|Sensory System Agents|sensory system agents|mesh-ancestor
6179942|NCT01741259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6179943|NCT01741259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6179944|NCT01741454|Tamsulosin|tamsulosin|mesh-list
6179945|NCT01741454|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6179946|NCT01741454|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6179947|NCT01741454|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6179948|NCT01741454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6179949|NCT01741454|Adrenergic Agents|adrenergic agents|mesh-ancestor
6179950|NCT01741454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6179951|NCT01741454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179952|NCT01741454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179953|NCT01741454|Urological Agents|urological agents|mesh-ancestor
6179954|NCT01741454|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5575194|NCT03894085|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5575195|NCT03894085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5575196|NCT03894085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5575197|NCT03894085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575198|NCT03894085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5575199|NCT03894085|Serotonin Agents|serotonin agents|mesh-ancestor
5575200|NCT03894085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575201|NCT03894085|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5575202|NCT03894085|Antidepressive Agents|antidepressive agents|mesh-ancestor
6179955|NCT01741454|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6179956|NCT01741454|Cholinergic Agents|cholinergic agents|mesh-ancestor
6179957|NCT01741532|Deferiprone|deferiprone|mesh-list
6179958|NCT01741532|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5575203|NCT03894085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5575204|NCT03894085|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5575205|NCT03894085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5575206|NCT03894085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5575207|NCT03894345|Prazosin|prazosin|mesh-list
5575208|NCT03894345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5575209|NCT03894345|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5575210|NCT03894345|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5575211|NCT03894345|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5575212|NCT03894345|Adrenergic Agents|adrenergic agents|mesh-ancestor
6179959|NCT01741532|Chelating Agents|chelating agents|mesh-ancestor
6179960|NCT01741532|Sequestering Agents|sequestering agents|mesh-ancestor
6179961|NCT01741532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179962|NCT01741545|Interferons|interferons|mesh-list
6179963|NCT01741545|Ribavirin|ribavirin|mesh-list
6179964|NCT01741545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6179965|NCT01741545|Antiviral Agents|antiviral agents|mesh-ancestor
6179966|NCT01741545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6179967|NCT01741545|Antimetabolites|antimetabolites|mesh-ancestor
6179968|NCT01741545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179969|NCT01741792|Blinatumomab|blinatumomab|mesh-list
6179970|NCT01741792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6179971|NCT01742117|Clopidogrel|clopidogrel|mesh-list
6179972|NCT01742117|Ticagrelor|ticagrelor|mesh-list
6179973|NCT01742117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6179974|NCT01742117|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6179975|NCT01742117|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6179976|NCT01742117|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6179977|NCT01742117|Purinergic Agents|purinergic agents|mesh-ancestor
6179978|NCT01742117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6179979|NCT01742117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206663|NCT02104414|Anesthetics, Local|anesthetics, local|mesh-ancestor
6670775|NCT01545024|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6487680|NCT00577421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6487681|NCT00577421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6670776|NCT01545024|Protease Inhibitors|protease inhibitors|mesh-ancestor
6179980|NCT01742117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179981|NCT01742208|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
6179982|NCT01742208|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5575213|NCT03894345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5575214|NCT03894345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575215|NCT03894345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575216|NCT03894280|Fluticasone|fluticasone|mesh-list
5575217|NCT03894280|Xhance|xhance|mesh-list
5575218|NCT03894280|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5575219|NCT03894280|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
5575220|NCT03894280|Charcoal|charcoal|mesh-list
5575221|NCT03894280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5575222|NCT03894280|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5575223|NCT03894280|Autonomic Agents|autonomic agents|mesh-ancestor
5575224|NCT03894280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5575225|NCT03894280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575226|NCT03894280|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5575227|NCT03894280|Respiratory System Agents|respiratory system agents|mesh-ancestor
5575228|NCT03894280|Dermatologic Agents|dermatologic agents|mesh-ancestor
5575229|NCT03894280|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5575230|NCT03894280|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5575231|NCT03894280|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5575232|NCT03894280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5575233|NCT03894280|Adrenergic Agents|adrenergic agents|mesh-ancestor
5575234|NCT03894280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5575235|NCT03894280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575236|NCT03894280|Glucocorticoids|glucocorticoids|mesh-ancestor
5575237|NCT03894280|Hormones|hormones|mesh-ancestor
5575238|NCT03894280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5575239|NCT03894280|Sympathomimetics|sympathomimetics|mesh-ancestor
6179983|NCT01742208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179984|NCT01742208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6179985|NCT01742208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179986|NCT01742286|Ceritinib|ceritinib|mesh-list
6179987|NCT01742286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6179988|NCT01742286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5575240|NCT03894280|Antidotes|antidotes|mesh-ancestor
5575241|NCT03894280|Protective Agents|protective agents|mesh-ancestor
5575242|NCT03894046|Imipenem|imipenem|mesh-list
5575243|NCT03894046|Colistin|colistin|mesh-list
5575244|NCT03894046|Sulbactam|sulbactam|mesh-list
5575245|NCT03894046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5575246|NCT03894046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5575247|NCT03894046|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5575248|NCT03894046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5575249|NCT03894046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575250|NCT03894007|Maytansine|maytansine|mesh-list
5575251|NCT03894007|Docetaxel|docetaxel|mesh-list
5575252|NCT03894007|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
5575253|NCT03894007|Cyclophosphamide|cyclophosphamide|mesh-list
5575254|NCT03894007|Carboplatin|carboplatin|mesh-list
5575255|NCT03894007|Trastuzumab|trastuzumab|mesh-list
5575256|NCT03894007|Atezolizumab|atezolizumab|mesh-list
5575257|NCT03894007|Epirubicin|epirubicin|mesh-list
5575258|NCT03894007|Pertuzumab|pertuzumab|mesh-list
5575259|NCT03894007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5575260|NCT03894007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5575261|NCT03894007|Tubulin Modulators|tubulin modulators|mesh-ancestor
5575262|NCT03894007|Antimitotic Agents|antimitotic agents|mesh-ancestor
5575263|NCT03894007|Mitosis Modulators|mitosis modulators|mesh-ancestor
5575264|NCT03894007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575265|NCT03894007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6179989|NCT01742286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6179990|NCT01742286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6179991|NCT01742832|Citalopram|citalopram|mesh-list
6179992|NCT01742832|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
6179993|NCT01742832|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6179994|NCT01742832|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6179995|NCT01742832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6179996|NCT01742832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206664|NCT02104414|Anesthetics|anesthetics|mesh-ancestor
5575266|NCT03894007|Immunologic Factors|immunologic factors|mesh-ancestor
5575267|NCT03894007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6179997|NCT01742832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6179998|NCT01742832|Serotonin Agents|serotonin agents|mesh-ancestor
6179999|NCT01742832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180000|NCT01742832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6180001|NCT01742832|Antidepressive Agents|antidepressive agents|mesh-ancestor
6180002|NCT01742832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6180003|NCT01742832|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6180004|NCT01742832|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6180005|NCT01742897|Fentanyl|fentanyl|mesh-list
6180006|NCT01742897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6487682|NCT00577421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487683|NCT00577421|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6487684|NCT00577668|Thalidomide|thalidomide|mesh-list
6487685|NCT00577668|Dexamethasone|dexamethasone|mesh-list
6487686|NCT00577668|Melphalan|melphalan|mesh-list
6487687|NCT00577668|Bortezomib|bortezomib|mesh-list
6487688|NCT00577668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6487689|NCT00577668|Antiemetics|antiemetics|mesh-ancestor
6487690|NCT00577668|Autonomic Agents|autonomic agents|mesh-ancestor
6487691|NCT00577668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6487692|NCT00577668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575268|NCT03894007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6180007|NCT01742897|Narcotics|narcotics|mesh-ancestor
6180008|NCT01742897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6180009|NCT01742897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180010|NCT01742897|Analgesics|analgesics|mesh-ancestor
6180011|NCT01742897|Sensory System Agents|sensory system agents|mesh-ancestor
6180012|NCT01742897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6180013|NCT01742897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6180014|NCT01742897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6180015|NCT01742897|Anesthetics, General|anesthetics, general|mesh-ancestor
6180016|NCT01742897|Anesthetics|anesthetics|mesh-ancestor
6180017|NCT01743001|Macitentan|macitentan|mesh-list
6180018|NCT01743001|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
6180019|NCT01743001|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6180020|NCT01743001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180021|NCT01743001|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
6180022|NCT01743027|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
6180023|NCT01743027|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6180024|NCT01743027|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6180025|NCT01743027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6180026|NCT01743027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6180027|NCT01743027|Analgesics|analgesics|mesh-ancestor
6180028|NCT01743027|Sensory System Agents|sensory system agents|mesh-ancestor
6180029|NCT01743027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6180030|NCT01743027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180031|NCT01743027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6180032|NCT01743027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6180033|NCT01743027|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6180034|NCT01743027|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6180035|NCT01743027|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6180036|NCT01743027|Histamine Antagonists|histamine antagonists|mesh-ancestor
5575269|NCT03894007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5575270|NCT03894007|Alkylating Agents|alkylating agents|mesh-ancestor
5575271|NCT03894007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5575272|NCT03894007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5575273|NCT03894007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5575274|NCT03894007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5575275|NCT03894007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5575276|NCT03894007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5575277|NCT03893695|Nivolumab|nivolumab|mesh-list
5575278|NCT03893695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5575279|NCT03893695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5575280|NCT03893695|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5575281|NCT03893695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575282|NCT03893734|Methadone|methadone|mesh-list
5575283|NCT03893734|Hydromorphone|hydromorphone|mesh-list
5575284|NCT03893734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5575285|NCT03893734|Narcotics|narcotics|mesh-ancestor
5575286|NCT03893734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5575287|NCT03893734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575288|NCT03893734|Analgesics|analgesics|mesh-ancestor
6180037|NCT01743027|Histamine Agents|histamine agents|mesh-ancestor
6487693|NCT00577668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6487694|NCT00577668|Glucocorticoids|glucocorticoids|mesh-ancestor
6180038|NCT01743027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5575289|NCT03893734|Sensory System Agents|sensory system agents|mesh-ancestor
5575290|NCT03893734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5575291|NCT03893734|Antitussive Agents|antitussive agents|mesh-ancestor
5575292|NCT03893734|Respiratory System Agents|respiratory system agents|mesh-ancestor
5575293|NCT03893591|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5575294|NCT03893591|Dalteparin|dalteparin|mesh-list
5575295|NCT03893591|Anticoagulants|anticoagulants|mesh-ancestor
5575296|NCT03893591|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5575297|NCT03893591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5575298|NCT03893591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575299|NCT03893864|Ubiquinone|ubiquinone|mesh-list
5575300|NCT03893864|Coenzyme Q10|coenzyme q10|mesh-list
5575301|NCT03893864|Antioxidants|antioxidants|mesh-list
5575302|NCT03893864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575303|NCT03893864|Protective Agents|protective agents|mesh-ancestor
5575304|NCT03893864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575305|NCT03893864|Micronutrients|micronutrients|mesh-ancestor
5575306|NCT03893864|Vitamins|vitamins|mesh-ancestor
5575307|NCT03893630|Aspirin|aspirin|mesh-list
5575308|NCT03893630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5575309|NCT03893630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5575310|NCT03893630|Analgesics|analgesics|mesh-ancestor
5575311|NCT03893630|Sensory System Agents|sensory system agents|mesh-ancestor
5575312|NCT03893630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5575313|NCT03893630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575314|NCT03893630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5575315|NCT03893630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5575316|NCT03893630|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5575317|NCT03893630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5575318|NCT03893630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575319|NCT03893630|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5575320|NCT03893630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5575321|NCT03893630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5575322|NCT03893630|Antipyretics|antipyretics|mesh-ancestor
5575323|NCT03893747|Vaccines|vaccines|mesh-list
5575324|NCT03893747|Immunologic Factors|immunologic factors|mesh-ancestor
5575325|NCT03893747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575326|NCT03893526|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5575327|NCT03893526|Valsartan|valsartan|mesh-list
5575328|NCT03893526|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5575329|NCT03893526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5575330|NCT03893526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575331|NCT03893526|Incretins|incretins|mesh-ancestor
5575332|NCT03893526|Hormones|hormones|mesh-ancestor
5575333|NCT03893526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5575334|NCT03893526|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5575335|NCT03893526|Protease Inhibitors|protease inhibitors|mesh-ancestor
5575336|NCT03893526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5575337|NCT03893526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575338|NCT03893526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5575339|NCT03893526|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5575340|NCT03893526|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5575341|NCT03893435|Valsartan|valsartan|mesh-list
5575342|NCT03893435|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5575343|NCT03893435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5575344|NCT03893435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5575345|NCT03893435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5575346|NCT03893435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575347|NCT03893097|Artesunate|artesunate|mesh-list
5575348|NCT03893097|Mefloquine|mefloquine|mesh-list
5575349|NCT03893097|Praziquantel|praziquantel|mesh-list
5575350|NCT03893097|Antimalarials|antimalarials|mesh-ancestor
5575351|NCT03893097|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5575352|NCT03893097|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6180039|NCT01743027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180040|NCT01743131|Abatacept|abatacept|mesh-list
6180041|NCT01743131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6180042|NCT01743131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575353|NCT03893097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5575354|NCT03893097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5575355|NCT03893097|Antiviral Agents|antiviral agents|mesh-ancestor
5575356|NCT03893097|Schistosomicides|schistosomicides|mesh-ancestor
5575357|NCT03893097|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6180043|NCT01743131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5575358|NCT03893097|Anthelmintics|anthelmintics|mesh-ancestor
5575359|NCT03893175|Acetaminophen|acetaminophen|mesh-list
5575360|NCT03893175|Ibuprofen|ibuprofen|mesh-list
5575361|NCT03893175|Oxycodone|oxycodone|mesh-list
5575362|NCT03893175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5575363|NCT03893175|Analgesics|analgesics|mesh-ancestor
5575364|NCT03893175|Sensory System Agents|sensory system agents|mesh-ancestor
5575365|NCT03893175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5575366|NCT03893175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575367|NCT03893175|Antipyretics|antipyretics|mesh-ancestor
5575368|NCT03893175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5575369|NCT03893175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5575370|NCT03893175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5575371|NCT03893175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5575372|NCT03893175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5575373|NCT03893175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575374|NCT03893175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6180044|NCT01743131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6180045|NCT01743131|Immunologic Factors|immunologic factors|mesh-ancestor
6180046|NCT01743131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575375|NCT03893175|Narcotics|narcotics|mesh-ancestor
5575376|NCT03893175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5604507|NCT04671043|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5604508|NCT04671043|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5604509|NCT04671043|Purinergic Agents|purinergic agents|mesh-ancestor
5604510|NCT04671043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5604511|NCT04664738|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
5604512|NCT04664738|Hemostatics|hemostatics|mesh-ancestor
5604513|NCT04664738|Coagulants|coagulants|mesh-ancestor
5604514|NCT04652960|Nivolumab|nivolumab|mesh-list
5604515|NCT04652960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5604516|NCT04652960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5604517|NCT04652960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5604518|NCT04652960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604519|NCT04652557|4-Aminopyridine|4-aminopyridine|mesh-list
5604520|NCT04652557|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5604521|NCT04652557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5604522|NCT04652557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604523|NCT04633278|Pembrolizumab|pembrolizumab|mesh-list
5604524|NCT04633278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5604525|NCT04633278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5604526|NCT04631029|Carboplatin|carboplatin|mesh-list
6670777|NCT01545024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6670778|NCT01545024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670779|NCT01545271|Xenon|xenon|mesh-list
6670780|NCT01545271|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6670781|NCT01545271|Anesthetics, General|anesthetics, general|mesh-ancestor
6180047|NCT01743131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6206665|NCT02104414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6206666|NCT02104414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206667|NCT02104414|Sensory System Agents|sensory system agents|mesh-ancestor
6206668|NCT02104414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6670782|NCT01545271|Anesthetics|anesthetics|mesh-ancestor
6670783|NCT01545271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6670784|NCT01545271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670785|NCT01545284|Acitretin|acitretin|mesh-list
6206669|NCT02104414|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6206670|NCT02104414|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6206671|NCT02104414|Adrenergic Agents|adrenergic agents|mesh-ancestor
6206672|NCT02104414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6206673|NCT02104414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206674|NCT02104414|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6206675|NCT02104414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6206676|NCT02104414|Autonomic Agents|autonomic agents|mesh-ancestor
6206677|NCT02104414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6206678|NCT02104414|Respiratory System Agents|respiratory system agents|mesh-ancestor
6206679|NCT02104414|Mydriatics|mydriatics|mesh-ancestor
6206680|NCT02104414|Sympathomimetics|sympathomimetics|mesh-ancestor
6206681|NCT02104414|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6206682|NCT02104505|Tocopherols|tocopherols|mesh-list
6206683|NCT02104505|Vitamin E|vitamin e|mesh-list
5604527|NCT04631029|Etoposide|etoposide|mesh-list
5604528|NCT04631029|Etoposide phosphate|etoposide phosphate|mesh-list
5604529|NCT04631029|Atezolizumab|atezolizumab|mesh-list
6206684|NCT02104505|Tocotrienols|tocotrienols|mesh-list
6180048|NCT01743521|Ribavirin|ribavirin|mesh-list
6180049|NCT01743521|Antimetabolites|antimetabolites|mesh-ancestor
6180050|NCT01743521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180051|NCT01743521|Antiviral Agents|antiviral agents|mesh-ancestor
6180052|NCT01743521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6180053|NCT01743560|Everolimus|everolimus|mesh-list
6180054|NCT01743560|Exemestane|exemestane|mesh-list
6180055|NCT01743560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6180056|NCT01743560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6180057|NCT01743560|Immunologic Factors|immunologic factors|mesh-ancestor
6180058|NCT01743560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180059|NCT01743560|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6180060|NCT01743560|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6180061|NCT01743560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6180062|NCT01743560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180063|NCT01743560|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6180064|NCT01743560|Hormone Antagonists|hormone antagonists|mesh-ancestor
6180065|NCT01743560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6180066|NCT01743677|Moxifloxacin|moxifloxacin|mesh-list
6180067|NCT01743677|Tofacitinib|tofacitinib|mesh-list
6180068|NCT01743677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6180069|NCT01743677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6180070|NCT01743677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6180071|NCT01743677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6180072|NCT01743677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6180073|NCT01743677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180074|NCT01743677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6180075|NCT01743677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6180076|NCT01743729|Lifitegrast|lifitegrast|mesh-list
6180077|NCT01743729|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6180078|NCT01743729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6180079|NCT01743859|Lenalidomide|lenalidomide|mesh-list
6180080|NCT01743859|Azacitidine|azacitidine|mesh-list
6180081|NCT01743859|Immunologic Factors|immunologic factors|mesh-ancestor
6180082|NCT01743859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180083|NCT01743859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6180084|NCT01743859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6180085|NCT01743859|Growth Substances|growth substances|mesh-ancestor
6180086|NCT01743859|Growth Inhibitors|growth inhibitors|mesh-ancestor
6180087|NCT01743859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6180088|NCT01743859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6180089|NCT01743859|Antimetabolites|antimetabolites|mesh-ancestor
5575377|NCT03893032|Modafinil|modafinil|mesh-list
5575378|NCT03893032|Amphetamine|amphetamine|mesh-list
5575379|NCT03893032|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5575380|NCT03893032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575381|NCT03893032|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
5575382|NCT03893032|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5575383|NCT03893032|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5575384|NCT03893032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575385|NCT03893032|Sympathomimetics|sympathomimetics|mesh-ancestor
5575386|NCT03893032|Autonomic Agents|autonomic agents|mesh-ancestor
5575387|NCT03893032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5575388|NCT03893032|Dopamine Agents|dopamine agents|mesh-ancestor
5575389|NCT03893032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5575390|NCT03893032|Adrenergic Agents|adrenergic agents|mesh-ancestor
5575391|NCT03893032|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5575392|NCT03893032|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5575393|NCT03893032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5575394|NCT03893032|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5575395|NCT03893136|Leflunomide|leflunomide|mesh-list
5575396|NCT03893136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5575397|NCT03893136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575398|NCT03893136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5575399|NCT03893136|Immunologic Factors|immunologic factors|mesh-ancestor
5575400|NCT03893136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575401|NCT03893045|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
5575402|NCT03893045|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
5575403|NCT03893045|Hematinics|hematinics|mesh-ancestor
5575404|NCT03893045|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5575405|NCT03893045|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5575406|NCT03893240|Antibodies|antibodies|mesh-list
5575407|NCT03893240|Antibodies, Blocking|antibodies, blocking|mesh-list
5575408|NCT03893240|Immunologic Factors|immunologic factors|mesh-ancestor
6180090|NCT01743859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180091|NCT01743859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6180092|NCT01743976|Donepezil|donepezil|mesh-list
6180093|NCT01743976|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6180094|NCT01743976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6180095|NCT01743976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180096|NCT01743976|Cholinergic Agents|cholinergic agents|mesh-ancestor
5575409|NCT03893240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575410|NCT03892902|Zopiclone|zopiclone|mesh-list
5575411|NCT03892902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5575412|NCT03892902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5575413|NCT03892902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575414|NCT03892668|Tranexamic Acid|tranexamic acid|mesh-list
5575415|NCT03892668|Oxytocin|oxytocin|mesh-list
5575416|NCT03892668|Oxytocics|oxytocics|mesh-ancestor
5575417|NCT03892668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5575418|NCT03892668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575419|NCT03892668|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5575420|NCT03892668|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5575421|NCT03892668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575422|NCT03892668|Hemostatics|hemostatics|mesh-ancestor
5575423|NCT03892668|Coagulants|coagulants|mesh-ancestor
5575424|NCT03892525|Atezolizumab|atezolizumab|mesh-list
5575425|NCT03892525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5575426|NCT03892928|Dexmedetomidine|dexmedetomidine|mesh-list
5575427|NCT03892928|Propofol|propofol|mesh-list
5575428|NCT03892928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5575429|NCT03892928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5575430|NCT03892928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575431|NCT03892928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5575432|NCT03892928|Anesthetics, General|anesthetics, general|mesh-ancestor
5575433|NCT03892928|Anesthetics|anesthetics|mesh-ancestor
5575434|NCT03892928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5575435|NCT03892928|Analgesics|analgesics|mesh-ancestor
5575436|NCT03892928|Sensory System Agents|sensory system agents|mesh-ancestor
5575437|NCT03892928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5575438|NCT03892928|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5575439|NCT03892928|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5575440|NCT03892928|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5575441|NCT03892928|Adrenergic Agents|adrenergic agents|mesh-ancestor
5575442|NCT03892928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5575443|NCT03892928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575444|NCT03892499|Itraconazole|itraconazole|mesh-list
5575445|NCT03892499|Antifungal Agents|antifungal agents|mesh-ancestor
5575446|NCT03892499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5575447|NCT03892499|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5575448|NCT03892499|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5575449|NCT03892499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5575450|NCT03892499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575451|NCT03892499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6180097|NCT01743976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6180098|NCT01743976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180099|NCT01743976|Nootropic Agents|nootropic agents|mesh-ancestor
6180100|NCT01744093|Doxycycline|doxycycline|mesh-list
6180101|NCT01744093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6180102|NCT01744093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6180103|NCT01744093|Antimalarials|antimalarials|mesh-ancestor
6180104|NCT01744093|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6180105|NCT01744093|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6180106|NCT01744197|Lidocaine|lidocaine|mesh-list
6180107|NCT01744197|Tetracaine|tetracaine|mesh-list
6487695|NCT00577668|Hormones|hormones|mesh-ancestor
6487696|NCT00577668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6487697|NCT00577668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6487698|NCT00577668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6487699|NCT00577668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6487700|NCT00577668|Alkylating Agents|alkylating agents|mesh-ancestor
6487701|NCT00577668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6487702|NCT00577668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6487703|NCT00577668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6487704|NCT00577668|Immunologic Factors|immunologic factors|mesh-ancestor
6180108|NCT01744197|Anesthetics, Local|anesthetics, local|mesh-ancestor
6180109|NCT01744197|Anesthetics|anesthetics|mesh-ancestor
6180110|NCT01744197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6180111|NCT01744197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575452|NCT03892499|Hormone Antagonists|hormone antagonists|mesh-ancestor
6180112|NCT01744197|Sensory System Agents|sensory system agents|mesh-ancestor
6180113|NCT01744197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6180114|NCT01744197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6180115|NCT01744197|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6180116|NCT01744197|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6180117|NCT01744197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6180118|NCT01744197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180119|NCT01744353|Oxaliplatin|oxaliplatin|mesh-list
6180120|NCT01744353|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6180121|NCT01744353|Paclitaxel|paclitaxel|mesh-list
6180122|NCT01744353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6180123|NCT01744353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180124|NCT01744353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6180125|NCT01744353|Tubulin Modulators|tubulin modulators|mesh-ancestor
6180126|NCT01744353|Antimitotic Agents|antimitotic agents|mesh-ancestor
5575453|NCT03892499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5575454|NCT03892499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575455|NCT03892499|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6180127|NCT01744353|Mitosis Modulators|mitosis modulators|mesh-ancestor
6180128|NCT01744496|Rotigotine|rotigotine|mesh-list
6180129|NCT01744496|Dopamine Agonists|dopamine agonists|mesh-ancestor
6180130|NCT01744496|Dopamine Agents|dopamine agents|mesh-ancestor
6180131|NCT01744496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6180132|NCT01744496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180133|NCT01744496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180134|NCT01744574|Progesterone|progesterone|mesh-list
6180135|NCT01744574|Progestins|progestins|mesh-ancestor
6180136|NCT01744574|Hormones|hormones|mesh-ancestor
6180137|NCT01744574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6180138|NCT01744574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180139|NCT01744704|Mitogens|mitogens|mesh-list
6180140|NCT01744704|Mitosis Modulators|mitosis modulators|mesh-ancestor
6180141|NCT01744704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180142|NCT01744730|Clindamycin|clindamycin|mesh-list
6180143|NCT01744730|Clindamycin palmitate|clindamycin palmitate|mesh-list
6180144|NCT01744730|Clindamycin phosphate|clindamycin phosphate|mesh-list
6180145|NCT01744730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6180146|NCT01744730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5575456|NCT03892447|Ferulic acid|ferulic acid|mesh-list
5575457|NCT03892447|Dopamine|dopamine|mesh-list
5575458|NCT03892447|Alprostadil|alprostadil|mesh-list
5575459|NCT03892447|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5575460|NCT03892447|Sympathomimetics|sympathomimetics|mesh-ancestor
5575461|NCT03892447|Autonomic Agents|autonomic agents|mesh-ancestor
5575462|NCT03892447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5575463|NCT03892447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575464|NCT03892447|Dopamine Agents|dopamine agents|mesh-ancestor
5575465|NCT03892447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5575466|NCT03892447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575467|NCT03892447|Protective Agents|protective agents|mesh-ancestor
5575468|NCT03892447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5575469|NCT03892447|Vasodilator Agents|vasodilator agents|mesh-ancestor
5575470|NCT03892447|Urological Agents|urological agents|mesh-ancestor
5575471|NCT03892447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5575472|NCT03892447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5575473|NCT03892447|Analgesics|analgesics|mesh-ancestor
5575474|NCT03892447|Sensory System Agents|sensory system agents|mesh-ancestor
5575475|NCT03892447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6180147|NCT01744730|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6180148|NCT01744730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6180149|NCT01744730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180150|NCT01744782|Cysteamine|cysteamine|mesh-list
6180151|NCT01744782|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
6180152|NCT01744782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180153|NCT01744821|Vitamin D|vitamin d|mesh-list
6180154|NCT01744821|Cholecalciferol|cholecalciferol|mesh-list
6180155|NCT01744821|Vitamins|vitamins|mesh-ancestor
6180156|NCT01744821|Micronutrients|micronutrients|mesh-ancestor
6180157|NCT01744821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180158|NCT01744821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6180159|NCT01744821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6180160|NCT01745055|Methotrexate|methotrexate|mesh-list
6180161|NCT01745055|Tofacitinib|tofacitinib|mesh-list
6180162|NCT01745055|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6180163|NCT01745055|Abortifacient Agents|abortifacient agents|mesh-ancestor
6180164|NCT01745055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6180165|NCT01745055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180166|NCT01745055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6180167|NCT01745055|Antimetabolites|antimetabolites|mesh-ancestor
6180168|NCT01745055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180169|NCT01745055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6180170|NCT01745055|Dermatologic Agents|dermatologic agents|mesh-ancestor
6180171|NCT01745055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6180172|NCT01745055|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6180173|NCT01745055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6180174|NCT01745055|Immunologic Factors|immunologic factors|mesh-ancestor
6180175|NCT01745055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6180176|NCT01745055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6180177|NCT01745055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6180178|NCT01745094|Solifenacin Succinate|solifenacin succinate|mesh-list
6180179|NCT01745094|Mirabegron|mirabegron|mesh-list
6180180|NCT01745094|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6180181|NCT01745094|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6180182|NCT01745094|Cholinergic Agents|cholinergic agents|mesh-ancestor
6180183|NCT01745094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6180184|NCT01745094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180185|NCT01745094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180186|NCT01745094|Urological Agents|urological agents|mesh-ancestor
6180187|NCT01745094|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6180188|NCT01745094|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6180189|NCT01745094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6180190|NCT01745094|Adrenergic Agents|adrenergic agents|mesh-ancestor
6180191|NCT01745133|Calcitriol|calcitriol|mesh-list
6180192|NCT01745133|Clobetasol|clobetasol|mesh-list
6180193|NCT01745133|Calcipotriene|calcipotriene|mesh-list
6180194|NCT01745133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6180195|NCT01745133|Glucocorticoids|glucocorticoids|mesh-ancestor
6180196|NCT01745133|Hormones|hormones|mesh-ancestor
6180197|NCT01745133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6180198|NCT01745133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180199|NCT01745133|Dermatologic Agents|dermatologic agents|mesh-ancestor
6180200|NCT01745133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6180201|NCT01745133|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6180202|NCT01745133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6180203|NCT01745133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180204|NCT01745133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6180205|NCT01745133|Vitamins|vitamins|mesh-ancestor
6180206|NCT01745133|Micronutrients|micronutrients|mesh-ancestor
6180207|NCT01745133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6180208|NCT01745367|Paclitaxel|paclitaxel|mesh-list
6180209|NCT01745367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5575476|NCT03892447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5575477|NCT03892447|Anticoagulants|anticoagulants|mesh-ancestor
5575478|NCT03892447|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5575479|NCT03892447|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5575480|NCT03892447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5575481|NCT03892447|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5575482|NCT03892447|Antioxidants|antioxidants|mesh-ancestor
5575483|NCT03892512|Dexmedetomidine|dexmedetomidine|mesh-list
5575484|NCT03892512|Esmolol|esmolol|mesh-list
5575485|NCT03892512|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5575486|NCT03892512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6180210|NCT01745367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6180211|NCT01745367|Tubulin Modulators|tubulin modulators|mesh-ancestor
6180212|NCT01745367|Antimitotic Agents|antimitotic agents|mesh-ancestor
6180213|NCT01745367|Mitosis Modulators|mitosis modulators|mesh-ancestor
6180214|NCT01745367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180215|NCT01745380|Phenylephrine|phenylephrine|mesh-list
6180216|NCT01745380|Oxymetazoline|oxymetazoline|mesh-list
6180217|NCT01745380|Tetracaine|tetracaine|mesh-list
6180218|NCT01745380|Anesthetics, Local|anesthetics, local|mesh-ancestor
6180219|NCT01745380|Anesthetics|anesthetics|mesh-ancestor
6180220|NCT01745380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6180221|NCT01745380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180222|NCT01745380|Sensory System Agents|sensory system agents|mesh-ancestor
6180223|NCT01745380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6180224|NCT01745380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5575487|NCT03892512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575488|NCT03892512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5575489|NCT03892512|Analgesics|analgesics|mesh-ancestor
5575490|NCT03892512|Sensory System Agents|sensory system agents|mesh-ancestor
5575491|NCT03892512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5575492|NCT03892512|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5575493|NCT03892512|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5575494|NCT03892512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5575495|NCT03892512|Adrenergic Agents|adrenergic agents|mesh-ancestor
5575496|NCT03892512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5575497|NCT03892512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575498|NCT03892512|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5575499|NCT03892512|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5575500|NCT03892512|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5575501|NCT03892434|Dexamethasone|dexamethasone|mesh-list
5575502|NCT03892434|Dexamethasone acetate|dexamethasone acetate|mesh-list
5575503|NCT03892434|Bevacizumab|bevacizumab|mesh-list
5575504|NCT03892434|BB 1101|bb 1101|mesh-list
5575505|NCT03892434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5575506|NCT03892434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5575507|NCT03892434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5575508|NCT03892434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5575509|NCT03892434|Growth Substances|growth substances|mesh-ancestor
5575510|NCT03892434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575511|NCT03892434|Growth Inhibitors|growth inhibitors|mesh-ancestor
5575512|NCT03892434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6180225|NCT01745380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6180226|NCT01745380|Adrenergic Agents|adrenergic agents|mesh-ancestor
6180227|NCT01745380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6180228|NCT01745380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180229|NCT01745380|Sympathomimetics|sympathomimetics|mesh-ancestor
6180230|NCT01745380|Autonomic Agents|autonomic agents|mesh-ancestor
6180231|NCT01745380|Nasal Decongestants|nasal decongestants|mesh-ancestor
6180232|NCT01745380|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6180233|NCT01745380|Respiratory System Agents|respiratory system agents|mesh-ancestor
6180234|NCT01745380|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6180235|NCT01745380|Mydriatics|mydriatics|mesh-ancestor
6180236|NCT01745380|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6180237|NCT01745380|Protective Agents|protective agents|mesh-ancestor
6180238|NCT01745822|Tenofovir|tenofovir|mesh-list
6180239|NCT01745822|Antiviral Agents|antiviral agents|mesh-ancestor
6180240|NCT01745822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6180241|NCT01745822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6180242|NCT01745822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6180243|NCT01745822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6180244|NCT01745822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180245|NCT01745822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6180246|NCT01745822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6180247|NCT01746043|Minocycline|minocycline|mesh-list
6180248|NCT01746043|Modafinil|modafinil|mesh-list
6180249|NCT01746043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6180250|NCT01746043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6180251|NCT01746043|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6180252|NCT01746043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180253|NCT01746043|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6180254|NCT01746043|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6180255|NCT01746043|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6180256|NCT01746043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180257|NCT01746095|Vancomycin|vancomycin|mesh-list
5575513|NCT03892434|Antiemetics|antiemetics|mesh-ancestor
5575514|NCT03892434|Autonomic Agents|autonomic agents|mesh-ancestor
5575515|NCT03892434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5575516|NCT03892434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5575517|NCT03892434|Glucocorticoids|glucocorticoids|mesh-ancestor
5575518|NCT03892434|Hormones|hormones|mesh-ancestor
5575519|NCT03892434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5575520|NCT03892434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5575521|NCT03892434|Protease Inhibitors|protease inhibitors|mesh-ancestor
5575522|NCT03892434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5575523|NCT03892434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575524|NCT03892330|Oxytetracycline|oxytetracycline|mesh-list
5575525|NCT03892330|Cyclophosphamide|cyclophosphamide|mesh-list
5575526|NCT03892330|Doxorubicin|doxorubicin|mesh-list
5575527|NCT03892330|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5575528|NCT03892330|Vincristine|vincristine|mesh-list
6180258|NCT01746095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6180259|NCT01746095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5575529|NCT03892330|Pirarubicin|pirarubicin|mesh-list
5575530|NCT03892330|Epirubicin|epirubicin|mesh-list
5575531|NCT03892330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5575532|NCT03892330|Immunologic Factors|immunologic factors|mesh-ancestor
5575533|NCT03892330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575534|NCT03892330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5575535|NCT03892330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5575536|NCT03892330|Alkylating Agents|alkylating agents|mesh-ancestor
5575537|NCT03892330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180260|NCT01746173|Gemcitabine|gemcitabine|mesh-list
6180261|NCT01746173|Plerixafor|plerixafor|mesh-list
6180262|NCT01746173|Prednisone|prednisone|mesh-list
6180263|NCT01746173|Cyclophosphamide|cyclophosphamide|mesh-list
6180264|NCT01746173|Melphalan|melphalan|mesh-list
6180265|NCT01746173|Busulfan|busulfan|mesh-list
6180266|NCT01746173|Doxorubicin|doxorubicin|mesh-list
6180267|NCT01746173|Etoposide|etoposide|mesh-list
6180268|NCT01746173|Etoposide phosphate|etoposide phosphate|mesh-list
6180269|NCT01746173|Vincristine|vincristine|mesh-list
6180270|NCT01746173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6180271|NCT01746173|Immunologic Factors|immunologic factors|mesh-ancestor
6180272|NCT01746173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180273|NCT01746173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6180274|NCT01746173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6180275|NCT01746173|Alkylating Agents|alkylating agents|mesh-ancestor
6180276|NCT01746173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180277|NCT01746173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6180278|NCT01746173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6180279|NCT01746173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6180280|NCT01746173|Antimetabolites|antimetabolites|mesh-ancestor
6180281|NCT01746173|Antiviral Agents|antiviral agents|mesh-ancestor
6180282|NCT01746173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6180283|NCT01746173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6180284|NCT01746173|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6180285|NCT01746173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6180286|NCT01746173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6180287|NCT01746173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6180288|NCT01746173|Glucocorticoids|glucocorticoids|mesh-ancestor
6180289|NCT01746173|Hormones|hormones|mesh-ancestor
6180290|NCT01746173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6180291|NCT01746173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6180292|NCT01746173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6180293|NCT01746173|Tubulin Modulators|tubulin modulators|mesh-ancestor
6180294|NCT01746173|Antimitotic Agents|antimitotic agents|mesh-ancestor
6180295|NCT01746173|Mitosis Modulators|mitosis modulators|mesh-ancestor
6180296|NCT01746173|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6180297|NCT01746173|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6180298|NCT01746225|Paclitaxel|paclitaxel|mesh-list
6180299|NCT01746225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6180300|NCT01746225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6180301|NCT01746225|Tubulin Modulators|tubulin modulators|mesh-ancestor
6180302|NCT01746225|Antimitotic Agents|antimitotic agents|mesh-ancestor
6180303|NCT01746225|Mitosis Modulators|mitosis modulators|mesh-ancestor
6180304|NCT01746225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180305|NCT01746264|Vitamin D|vitamin d|mesh-list
6180306|NCT01746264|Cholecalciferol|cholecalciferol|mesh-list
6180307|NCT01746264|Vitamins|vitamins|mesh-ancestor
6180308|NCT01746264|Micronutrients|micronutrients|mesh-ancestor
6180309|NCT01746264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180310|NCT01746264|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6180311|NCT01746264|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6180312|NCT01746420|Becaplermin|becaplermin|mesh-list
6180313|NCT01746420|Anticoagulants|anticoagulants|mesh-ancestor
6180314|NCT01746420|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
5604530|NCT04631029|Podophyllotoxin|podophyllotoxin|mesh-list
6180315|NCT01746420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6180316|NCT01746420|Growth Substances|growth substances|mesh-ancestor
6180317|NCT01746420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180318|NCT01746511|Glycerol|glycerol|mesh-list
6180319|NCT01746511|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6180320|NCT01746511|Protective Agents|protective agents|mesh-ancestor
5575538|NCT03892330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5575539|NCT03892330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5575540|NCT03892330|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5575541|NCT03892330|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5575542|NCT03892330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5575543|NCT03892330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5575544|NCT03892330|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5575545|NCT03892330|Tubulin Modulators|tubulin modulators|mesh-ancestor
5575546|NCT03892330|Antimitotic Agents|antimitotic agents|mesh-ancestor
5575547|NCT03892330|Mitosis Modulators|mitosis modulators|mesh-ancestor
5575548|NCT03892330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6180321|NCT01746511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180322|NCT01746732|Moxifloxacin|moxifloxacin|mesh-list
6180323|NCT01746732|Evacetrapib|evacetrapib|mesh-list
6180324|NCT01746732|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6180325|NCT01746732|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6180326|NCT01746732|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6180327|NCT01746732|Antimetabolites|antimetabolites|mesh-ancestor
6180328|NCT01746732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180329|NCT01746732|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6180330|NCT01746732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6180331|NCT01746732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6180332|NCT01746732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6180333|NCT01746732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6180334|NCT01746732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6180335|NCT01746732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6180336|NCT01746732|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6180337|NCT01746732|Contraceptive Agents|contraceptive agents|mesh-ancestor
6180338|NCT01746732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5575549|NCT03892330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5575550|NCT03892642|Avelumab|avelumab|mesh-list
5575551|NCT03892642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5575552|NCT03892642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5575553|NCT03892785|Prednisone|prednisone|mesh-list
5575554|NCT03892785|Methotrexate|methotrexate|mesh-list
5575555|NCT03892785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5575556|NCT03892785|Glucocorticoids|glucocorticoids|mesh-ancestor
5575557|NCT03892785|Hormones|hormones|mesh-ancestor
5575558|NCT03892785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6180339|NCT01746732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487705|NCT00577668|Leprostatic Agents|leprostatic agents|mesh-ancestor
6487706|NCT00577668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6487707|NCT00577668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6487708|NCT00577668|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5575559|NCT03892785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180340|NCT01746732|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6180341|NCT01746732|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6180342|NCT01746732|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5575560|NCT03892785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5575561|NCT03892785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5575562|NCT03892785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5575563|NCT03892785|Abortifacient Agents|abortifacient agents|mesh-ancestor
5575564|NCT03892785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5575565|NCT03892785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5575566|NCT03892785|Antimetabolites|antimetabolites|mesh-ancestor
5575567|NCT03892785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575568|NCT03892785|Dermatologic Agents|dermatologic agents|mesh-ancestor
6180343|NCT01746901|Naltrexone|naltrexone|mesh-list
6180344|NCT01746901|Oxycodone|oxycodone|mesh-list
6180345|NCT01746901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6180346|NCT01746901|Narcotics|narcotics|mesh-ancestor
6180347|NCT01746901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6180348|NCT01746901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180349|NCT01746901|Analgesics|analgesics|mesh-ancestor
6180350|NCT01746901|Sensory System Agents|sensory system agents|mesh-ancestor
6180351|NCT01746901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6180352|NCT01746901|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6180353|NCT01746901|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6180354|NCT01746940|Cocaine|cocaine|mesh-list
6180355|NCT01746940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6180356|NCT01746940|Anesthetics, Local|anesthetics, local|mesh-ancestor
6180357|NCT01746940|Anesthetics|anesthetics|mesh-ancestor
6180358|NCT01746940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6180359|NCT01746940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180360|NCT01746940|Sensory System Agents|sensory system agents|mesh-ancestor
6180361|NCT01746940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6180362|NCT01746940|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6180363|NCT01746940|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6180364|NCT01746940|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6180365|NCT01746940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6180366|NCT01746940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180367|NCT01746940|Dopamine Agents|dopamine agents|mesh-ancestor
6180368|NCT01746940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6180369|NCT01746979|Gemcitabine|gemcitabine|mesh-list
6180370|NCT01746979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6180371|NCT01746979|Antimetabolites|antimetabolites|mesh-ancestor
6180372|NCT01746979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180373|NCT01746979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6180374|NCT01746979|Antiviral Agents|antiviral agents|mesh-ancestor
6180375|NCT01746979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6180376|NCT01746979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6180377|NCT01746979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6180378|NCT01746979|Immunologic Factors|immunologic factors|mesh-ancestor
6180379|NCT01746979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180380|NCT01747330|Pancreatin|pancreatin|mesh-list
6180381|NCT01747330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6180382|NCT01747499|Azacitidine|azacitidine|mesh-list
6180383|NCT01747499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6180384|NCT01747499|Antimetabolites|antimetabolites|mesh-ancestor
6180385|NCT01747499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180386|NCT01747499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6180387|NCT01747499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5575569|NCT03892785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5575570|NCT03892785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5575571|NCT03892785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5575572|NCT03892785|Immunologic Factors|immunologic factors|mesh-ancestor
5575573|NCT03892785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5575574|NCT03892785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5575575|NCT03892421|Cytarabine|cytarabine|mesh-list
5575576|NCT03892421|Dexamethasone|dexamethasone|mesh-list
5575577|NCT03892421|Rituximab|rituximab|mesh-list
5575578|NCT03892421|Carboplatin|carboplatin|mesh-list
5575579|NCT03892421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5575580|NCT03892421|Antiemetics|antiemetics|mesh-ancestor
5575581|NCT03892421|Autonomic Agents|autonomic agents|mesh-ancestor
5575582|NCT03892421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5575583|NCT03892421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575584|NCT03892421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5575585|NCT03892421|Glucocorticoids|glucocorticoids|mesh-ancestor
5575586|NCT03892421|Hormones|hormones|mesh-ancestor
5575587|NCT03892421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5575588|NCT03892421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5575589|NCT03892421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5575590|NCT03892421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5575591|NCT03892421|Immunologic Factors|immunologic factors|mesh-ancestor
6180388|NCT01747551|Leucovorin|leucovorin|mesh-list
6180389|NCT01747551|Fluorouracil|fluorouracil|mesh-list
6180390|NCT01747551|Oxaliplatin|oxaliplatin|mesh-list
6180391|NCT01747551|Aflibercept|aflibercept|mesh-list
6180392|NCT01747551|Antimetabolites|antimetabolites|mesh-ancestor
6180393|NCT01747551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180394|NCT01747551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6180395|NCT01747551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5575592|NCT03892421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5575593|NCT03892421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5575594|NCT03892421|Antimetabolites|antimetabolites|mesh-ancestor
5575595|NCT03892421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575596|NCT03892421|Antiviral Agents|antiviral agents|mesh-ancestor
6180396|NCT01747551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6180397|NCT01747551|Immunologic Factors|immunologic factors|mesh-ancestor
6180398|NCT01747551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180399|NCT01747551|Antidotes|antidotes|mesh-ancestor
6180400|NCT01747551|Protective Agents|protective agents|mesh-ancestor
6180401|NCT01747551|Vitamin B Complex|vitamin b complex|mesh-ancestor
6180402|NCT01747551|Vitamins|vitamins|mesh-ancestor
5575597|NCT03892421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5575598|NCT03892421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5575599|NCT03892122|Dexmedetomidine|dexmedetomidine|mesh-list
5575600|NCT03892122|Propofol|propofol|mesh-list
5575601|NCT03892122|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5575602|NCT03892122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5575603|NCT03892122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575604|NCT03892122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5575605|NCT03892122|Anesthetics, General|anesthetics, general|mesh-ancestor
5575606|NCT03892122|Anesthetics|anesthetics|mesh-ancestor
5575607|NCT03892122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6180403|NCT01747551|Micronutrients|micronutrients|mesh-ancestor
6180404|NCT01747551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6180405|NCT01747551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5575608|NCT03892122|Analgesics|analgesics|mesh-ancestor
5575609|NCT03892122|Sensory System Agents|sensory system agents|mesh-ancestor
5575610|NCT03892122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5575611|NCT03892122|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5575612|NCT03892122|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5575613|NCT03892122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5575614|NCT03892122|Adrenergic Agents|adrenergic agents|mesh-ancestor
5575615|NCT03892122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5575616|NCT03892122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575617|NCT03892395|Vitamin D|vitamin d|mesh-list
5575618|NCT03892395|Ergocalciferols|ergocalciferols|mesh-list
5575619|NCT03892395|Vitamins|vitamins|mesh-list
5575620|NCT03892395|Vitamin B Complex|vitamin b complex|mesh-list
5575621|NCT03892395|Micronutrients|micronutrients|mesh-ancestor
5575622|NCT03892395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575623|NCT03892395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5575624|NCT03892395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5575625|NCT03892213|Benzonidazole|benzonidazole|mesh-list
5575626|NCT03892213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5575627|NCT03892213|Immunologic Factors|immunologic factors|mesh-ancestor
5575628|NCT03892213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575629|NCT03892213|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5575630|NCT03892213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5575631|NCT03892213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5575632|NCT03892213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5575633|NCT03892148|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5575634|NCT03892148|Furosemide|furosemide|mesh-list
5575635|NCT03892148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5575636|NCT03892148|Diuretics|diuretics|mesh-ancestor
5575637|NCT03892148|Natriuretic Agents|natriuretic agents|mesh-ancestor
5575638|NCT03892148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575639|NCT03892148|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5575640|NCT03892148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6180406|NCT01747551|Growth Substances|growth substances|mesh-ancestor
6180407|NCT01747551|Growth Inhibitors|growth inhibitors|mesh-ancestor
6180408|NCT01747629|Albuterol|albuterol|mesh-list
6180409|NCT01747629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6180410|NCT01747629|Autonomic Agents|autonomic agents|mesh-ancestor
6180411|NCT01747629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6180412|NCT01747629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180413|NCT01747629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6180414|NCT01747629|Respiratory System Agents|respiratory system agents|mesh-ancestor
5575641|NCT03892148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575642|NCT03892148|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5575643|NCT03892044|Nivolumab|nivolumab|mesh-list
5575644|NCT03892044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5575645|NCT03892044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5575646|NCT03892044|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5575647|NCT03892044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575648|NCT03891979|Metronidazole|metronidazole|mesh-list
5575649|NCT03891979|Ciprofloxacin|ciprofloxacin|mesh-list
6180415|NCT01747629|Tocolytic Agents|tocolytic agents|mesh-ancestor
6180416|NCT01747629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5575650|NCT03891979|Pembrolizumab|pembrolizumab|mesh-list
6180417|NCT01747629|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6180418|NCT01747629|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6180419|NCT01747629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6180420|NCT01747629|Adrenergic Agents|adrenergic agents|mesh-ancestor
6180421|NCT01747629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6487709|NCT00577668|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6487710|NCT00577668|Growth Substances|growth substances|mesh-ancestor
6487711|NCT00577668|Growth Inhibitors|growth inhibitors|mesh-ancestor
6487712|NCT00577681|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6487713|NCT00577681|Antiviral Agents|antiviral agents|mesh-ancestor
6670786|NCT01545284|Keratolytic Agents|keratolytic agents|mesh-ancestor
6670787|NCT01545284|Dermatologic Agents|dermatologic agents|mesh-ancestor
6670788|NCT01545297|Dexmedetomidine|dexmedetomidine|mesh-list
6670789|NCT01545297|Remifentanil|remifentanil|mesh-list
6670790|NCT01545297|Propofol|propofol|mesh-list
6670791|NCT01545297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6670792|NCT01545297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6180422|NCT01747629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180423|NCT01747850|Ethanol|ethanol|mesh-list
6180424|NCT01747850|Nabiximols|nabiximols|mesh-list
6180425|NCT01747850|Dronabinol|dronabinol|mesh-list
6180426|NCT01747850|Cannabidiol|cannabidiol|mesh-list
6487714|NCT00577681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6487715|NCT00577694|Clofarabine|clofarabine|mesh-list
6487716|NCT00577694|Gemtuzumab|gemtuzumab|mesh-list
6487717|NCT00577694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6487718|NCT00577694|Antimetabolites|antimetabolites|mesh-ancestor
6487719|NCT00577694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6487720|NCT00577694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6487721|NCT00577694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6670793|NCT01545297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180427|NCT01747850|Peppermint oil|peppermint oil|mesh-list
6180428|NCT01747850|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6180429|NCT01747850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6180430|NCT01747850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6180431|NCT01747850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180432|NCT01747850|Anticonvulsants|anticonvulsants|mesh-ancestor
5575651|NCT03891979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5575652|NCT03891979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5575653|NCT03891979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5575654|NCT03891979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5575655|NCT03891979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5575656|NCT03891979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5575657|NCT03891979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5575658|NCT03891979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5575659|NCT03891979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5575660|NCT03891979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575661|NCT03891979|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5575662|NCT03891979|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5575663|NCT03892070|Mannitol|mannitol|mesh-list
5575664|NCT03892070|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5575665|NCT03892070|Diuretics|diuretics|mesh-ancestor
5575666|NCT03892070|Natriuretic Agents|natriuretic agents|mesh-ancestor
5575667|NCT03892070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575668|NCT03892161|Ritonavir|ritonavir|mesh-list
5575669|NCT03892161|Darunavir|darunavir|mesh-list
5575670|NCT03892161|Rifampin|rifampin|mesh-list
5575671|NCT03892161|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5575672|NCT03892161|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5575673|NCT03892161|Protease Inhibitors|protease inhibitors|mesh-ancestor
6180433|NCT01747850|Analgesics|analgesics|mesh-ancestor
6180434|NCT01747850|Sensory System Agents|sensory system agents|mesh-ancestor
6180435|NCT01747850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5575674|NCT03892161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5575675|NCT03892161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575676|NCT03892161|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5575677|NCT03892161|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5575678|NCT03892161|Antiviral Agents|antiviral agents|mesh-ancestor
5575679|NCT03892161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5575680|NCT03892161|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5575681|NCT03892161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5575682|NCT03892161|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5575683|NCT03892161|Antitubercular Agents|antitubercular agents|mesh-ancestor
6180436|NCT01747850|Hallucinogens|hallucinogens|mesh-ancestor
6670794|NCT01545297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6180437|NCT01747850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6670795|NCT01545297|Anesthetics, General|anesthetics, general|mesh-ancestor
6670796|NCT01545297|Anesthetics|anesthetics|mesh-ancestor
6670797|NCT01545297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6670798|NCT01545297|Analgesics|analgesics|mesh-ancestor
6670799|NCT01545297|Sensory System Agents|sensory system agents|mesh-ancestor
6670800|NCT01545297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6670801|NCT01545297|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6670802|NCT01545297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6670803|NCT01545297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6670804|NCT01545297|Adrenergic Agents|adrenergic agents|mesh-ancestor
6670805|NCT01545297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6670806|NCT01545297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670807|NCT01545297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6670808|NCT01545297|Narcotics|narcotics|mesh-ancestor
6670809|NCT01545427|Imatinib Mesylate|imatinib mesylate|mesh-list
6670810|NCT01545427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6670811|NCT01545427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6670812|NCT01545427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6670813|NCT01545427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670814|NCT01545440|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6670815|NCT01545440|Immunologic Factors|immunologic factors|mesh-ancestor
6670816|NCT01545440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670817|NCT01545479|Captopril|captopril|mesh-list
6670818|NCT01545479|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6670819|NCT01545479|Protease Inhibitors|protease inhibitors|mesh-ancestor
6670820|NCT01545479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6670821|NCT01545479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670822|NCT01545479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6672521|NCT01556698|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6672522|NCT01556698|Vasodilator Agents|vasodilator agents|mesh-ancestor
5575684|NCT03892161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6180438|NCT01747850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6180439|NCT01747850|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6180440|NCT01747850|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6180441|NCT01747850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6180442|NCT01747850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180443|NCT01747850|Hormones|hormones|mesh-ancestor
6180444|NCT01747850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6180445|NCT01747850|Antiemetics|antiemetics|mesh-ancestor
6180446|NCT01747850|Autonomic Agents|autonomic agents|mesh-ancestor
6180447|NCT01747850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5575685|NCT03892161|Leprostatic Agents|leprostatic agents|mesh-ancestor
5575686|NCT03892161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5575687|NCT03892161|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5575688|NCT03892161|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5575689|NCT03892161|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5575690|NCT03892161|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5575691|NCT03892161|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5575692|NCT03892161|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5575693|NCT03891667|Disulfiram|disulfiram|mesh-list
5575694|NCT03891667|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5575695|NCT03891667|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
5575696|NCT03891667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5575697|NCT03891667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575698|NCT03891615|Niraparib|niraparib|mesh-list
6180448|NCT01747850|Parasympatholytics|parasympatholytics|mesh-ancestor
6180449|NCT01747915|Pregabalin|pregabalin|mesh-list
6672523|NCT01556698|Gasotransmitters|gasotransmitters|mesh-ancestor
5575699|NCT03891615|Osimertinib|osimertinib|mesh-list
5575700|NCT03891615|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5575701|NCT03891615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5575702|NCT03891615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575703|NCT03891615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5575704|NCT03891615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5575705|NCT03891472|Fluorouracil|fluorouracil|mesh-list
5575706|NCT03891472|Oxaliplatin|oxaliplatin|mesh-list
5575707|NCT03891472|Irinotecan|irinotecan|mesh-list
5575708|NCT03891472|Antimetabolites|antimetabolites|mesh-ancestor
5575709|NCT03891472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575710|NCT03891472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5575711|NCT03891472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5575712|NCT03891472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5575713|NCT03891472|Immunologic Factors|immunologic factors|mesh-ancestor
5575714|NCT03891472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180450|NCT01747915|Analgesics|analgesics|mesh-ancestor
5575715|NCT03891472|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6487722|NCT00577798|Doxorubicin|doxorubicin|mesh-list
6487723|NCT00577798|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6487724|NCT00577798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6487725|NCT00577798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6487726|NCT00577798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6487727|NCT00577798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6487728|NCT00577798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6487729|NCT00577798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6487730|NCT00577837|Risedronic Acid|risedronic acid|mesh-list
6487731|NCT00577837|Etidronic Acid|etidronic acid|mesh-list
6487732|NCT00577837|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6487733|NCT00577837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6180451|NCT01747915|Sensory System Agents|sensory system agents|mesh-ancestor
6180452|NCT01747915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6180453|NCT01747915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180454|NCT01747915|Anticonvulsants|anticonvulsants|mesh-ancestor
6180455|NCT01747915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6180456|NCT01747915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6180457|NCT01747915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180458|NCT01747915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6180459|NCT01747915|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6180460|NCT01747915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6180461|NCT01747915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6180462|NCT01747915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6180463|NCT01748045|Nitric Oxide|nitric oxide|mesh-list
6180464|NCT01748045|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6180465|NCT01748045|Autonomic Agents|autonomic agents|mesh-ancestor
6180466|NCT01748045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6180467|NCT01748045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575716|NCT03891472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5575717|NCT03891472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5575718|NCT03891914|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5575719|NCT03891914|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5575720|NCT03891914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575721|NCT03891524|Enoxaparin|enoxaparin|mesh-list
5575722|NCT03891524|Anticoagulants|anticoagulants|mesh-ancestor
5575723|NCT03891524|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5575724|NCT03891524|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5575725|NCT03891524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575726|NCT03891420|Galidesivir|galidesivir|mesh-list
5575727|NCT03891420|Antiviral Agents|antiviral agents|mesh-ancestor
5575728|NCT03891420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5575729|NCT03891433|Meropenem|meropenem|mesh-list
5575730|NCT03891433|Tazobactam|tazobactam|mesh-list
5575731|NCT03891433|Piperacillin|piperacillin|mesh-list
5575732|NCT03891433|Ertapenem|ertapenem|mesh-list
5575733|NCT03891433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5575734|NCT03891433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5575735|NCT03891433|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5575736|NCT03891433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5575737|NCT03891433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575738|NCT03891576|Niraparib|niraparib|mesh-list
5575739|NCT03891576|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5575740|NCT03891576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5575741|NCT03891576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575742|NCT03891576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5575743|NCT03891550|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
6180468|NCT01748045|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6180469|NCT01748045|Respiratory System Agents|respiratory system agents|mesh-ancestor
6180470|NCT01748045|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6180471|NCT01748045|Antioxidants|antioxidants|mesh-ancestor
6206685|NCT02104505|alpha-Tocopherol|alpha-tocopherol|mesh-list
6670823|NCT01545557|Lidocaine|lidocaine|mesh-list
6670824|NCT01545557|Hyaluronic Acid|hyaluronic acid|mesh-list
6670825|NCT01545557|Anesthetics, Local|anesthetics, local|mesh-ancestor
6670826|NCT01545557|Anesthetics|anesthetics|mesh-ancestor
6670827|NCT01545557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6670828|NCT01545557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670829|NCT01545557|Sensory System Agents|sensory system agents|mesh-ancestor
5575744|NCT03891550|Antiviral Agents|antiviral agents|mesh-ancestor
5575745|NCT03891550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5575746|NCT03891264|Cannabidiol|cannabidiol|mesh-list
6487734|NCT00577837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670830|NCT01545557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5575747|NCT03891264|Anticonvulsants|anticonvulsants|mesh-ancestor
5604531|NCT04631029|Entinostat|entinostat|mesh-list
5604532|NCT04631029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5604533|NCT04631029|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
5604534|NCT04631029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6670831|NCT01545557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6487735|NCT00577837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6487736|NCT00577837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487737|NCT00577837|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6487738|NCT00577850|Alendronate|alendronate|mesh-list
6487739|NCT00577850|Risedronic Acid|risedronic acid|mesh-list
6180472|NCT01748045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180473|NCT01748045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6180474|NCT01748045|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6180475|NCT01748045|Vasodilator Agents|vasodilator agents|mesh-ancestor
6180476|NCT01748045|Gasotransmitters|gasotransmitters|mesh-ancestor
6180477|NCT01748045|Protective Agents|protective agents|mesh-ancestor
6180478|NCT01748240|Azacitidine|azacitidine|mesh-list
6180479|NCT01748240|Vorinostat|vorinostat|mesh-list
6180480|NCT01748240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6180481|NCT01748240|Antimetabolites|antimetabolites|mesh-ancestor
6180482|NCT01748240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180483|NCT01748240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6180484|NCT01748240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6180485|NCT01748240|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6180486|NCT01748292|Ranibizumab|ranibizumab|mesh-list
6180487|NCT01748292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5604535|NCT04631029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5604536|NCT04631029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5604537|NCT04631029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6180488|NCT01748292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6180489|NCT01748292|Growth Substances|growth substances|mesh-ancestor
6180490|NCT01748292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180491|NCT01748292|Growth Inhibitors|growth inhibitors|mesh-ancestor
6180492|NCT01748292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6180493|NCT01748643|Glycopyrrolate|glycopyrrolate|mesh-list
6180494|NCT01748643|Rocuronium|rocuronium|mesh-list
6180495|NCT01748643|Neostigmine|neostigmine|mesh-list
6180496|NCT01748643|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6180497|NCT01748643|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5604538|NCT04631029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5604539|NCT04631029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604540|NCT04631029|Immunologic Factors|immunologic factors|mesh-ancestor
5604541|NCT04631029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604542|NCT04631029|Keratolytic Agents|keratolytic agents|mesh-ancestor
5604543|NCT04631029|Dermatologic Agents|dermatologic agents|mesh-ancestor
5604544|NCT04631029|Tubulin Modulators|tubulin modulators|mesh-ancestor
5604545|NCT04631029|Antimitotic Agents|antimitotic agents|mesh-ancestor
6180498|NCT01748643|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6180499|NCT01748643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6180500|NCT01748643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180501|NCT01748643|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6180502|NCT01748643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6180503|NCT01748643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180504|NCT01748643|Cholinergic Agents|cholinergic agents|mesh-ancestor
6180505|NCT01748643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6180506|NCT01748643|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6487740|NCT00577850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6487741|NCT00577850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670832|NCT01545557|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6670833|NCT01545557|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6670834|NCT01545557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6670835|NCT01545557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670836|NCT01545557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6670837|NCT01545557|Immunologic Factors|immunologic factors|mesh-ancestor
6670838|NCT01545557|Viscosupplements|viscosupplements|mesh-ancestor
6670839|NCT01545557|Protective Agents|protective agents|mesh-ancestor
6670840|NCT01545596|Anesthetics|anesthetics|mesh-list
6670841|NCT01545596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5604546|NCT04631029|Mitosis Modulators|mitosis modulators|mesh-ancestor
6487742|NCT00577850|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6487743|NCT00577850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6670842|NCT01545596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575748|NCT03891316|Sevoflurane|sevoflurane|mesh-list
5575749|NCT03891316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5575750|NCT03891316|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5575751|NCT03891316|Anesthetics, General|anesthetics, general|mesh-ancestor
6670843|NCT01545635|Thrombin|thrombin|mesh-list
6670844|NCT01545635|Hemostatics|hemostatics|mesh-ancestor
6670845|NCT01545635|Coagulants|coagulants|mesh-ancestor
6670846|NCT01545778|Oxycodone|oxycodone|mesh-list
6670847|NCT01545778|Tapentadol|tapentadol|mesh-list
6670848|NCT01545778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5575752|NCT03891316|Anesthetics|anesthetics|mesh-ancestor
5575753|NCT03891316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5575754|NCT03891316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575755|NCT03891277|Ferrous succinate|ferrous succinate|mesh-list
5575756|NCT03891277|Hematinics|hematinics|mesh-ancestor
6180507|NCT01748643|Autonomic Agents|autonomic agents|mesh-ancestor
6180508|NCT01748643|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6180509|NCT01748643|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5575757|NCT03891095|Oxytocin|oxytocin|mesh-list
5575758|NCT03891095|Oxytocics|oxytocics|mesh-ancestor
5575759|NCT03891095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5575760|NCT03891095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575761|NCT03891238|Avelumab|avelumab|mesh-list
5575762|NCT03891238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5575763|NCT03891238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6487744|NCT00577850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6487745|NCT00577850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6487746|NCT00577967|Gabapentin|gabapentin|mesh-list
6487747|NCT00577967|Analgesics|analgesics|mesh-ancestor
6487748|NCT00577967|Sensory System Agents|sensory system agents|mesh-ancestor
6487749|NCT00577967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5575764|NCT03890952|Bevacizumab|bevacizumab|mesh-list
5575765|NCT03890952|Nivolumab|nivolumab|mesh-list
5575766|NCT03890952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
5575767|NCT03890952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5575768|NCT03890952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5575769|NCT03890952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5575770|NCT03890952|Growth Substances|growth substances|mesh-ancestor
5575771|NCT03890952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575772|NCT03890952|Growth Inhibitors|growth inhibitors|mesh-ancestor
5575773|NCT03890952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5575774|NCT03890952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575775|NCT03891173|Vinorelbine|vinorelbine|mesh-list
5575776|NCT03891173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5575777|NCT03891173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5575778|NCT03891173|Tubulin Modulators|tubulin modulators|mesh-ancestor
5575779|NCT03891173|Antimitotic Agents|antimitotic agents|mesh-ancestor
6180510|NCT01748643|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6180511|NCT01748799|Ethanol|ethanol|mesh-list
6487750|NCT00577967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487751|NCT00577967|Anticonvulsants|anticonvulsants|mesh-ancestor
6487752|NCT00577967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6487753|NCT00577967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6487754|NCT00577967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6487755|NCT00577967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6487756|NCT00577967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6487757|NCT00577967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6487758|NCT00577967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6487759|NCT00577967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670849|NCT01545778|Narcotics|narcotics|mesh-ancestor
5575780|NCT03891173|Mitosis Modulators|mitosis modulators|mesh-ancestor
5575781|NCT03891173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575782|NCT03890809|BMS-986165|bms-986165|mesh-list
5575783|NCT03890809|Dermatologic Agents|dermatologic agents|mesh-ancestor
5575784|NCT03890809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6180512|NCT01748799|Nabiximols|nabiximols|mesh-list
6180513|NCT01748799|Dronabinol|dronabinol|mesh-list
6180514|NCT01748799|Cannabidiol|cannabidiol|mesh-list
6180515|NCT01748799|Peppermint oil|peppermint oil|mesh-list
5575785|NCT03890809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5575786|NCT03890809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575787|NCT03891121|Botulinum Toxins|botulinum toxins|mesh-list
5575788|NCT03891121|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5575789|NCT03891121|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5575790|NCT03891121|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5575791|NCT03891121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5575792|NCT03891121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575793|NCT03891121|Cholinergic Agents|cholinergic agents|mesh-ancestor
5575794|NCT03891121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5575795|NCT03891121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575796|NCT03891121|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5575797|NCT03891121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5575798|NCT03891043|Selenium|selenium|mesh-list
5575799|NCT03891043|Antioxidants|antioxidants|mesh-ancestor
5575800|NCT03891043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575801|NCT03891043|Protective Agents|protective agents|mesh-ancestor
5575802|NCT03891043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575803|NCT03891043|Trace Elements|trace elements|mesh-ancestor
5575804|NCT03891043|Micronutrients|micronutrients|mesh-ancestor
5575805|NCT03890770|BMS-986165|bms-986165|mesh-list
5575806|NCT03890770|Dermatologic Agents|dermatologic agents|mesh-ancestor
5575807|NCT03890770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5575808|NCT03890770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5575809|NCT03890770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575810|NCT03890341|Drospirenone|drospirenone|mesh-list
5575811|NCT03890341|Midazolam|midazolam|mesh-list
5575812|NCT03890341|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5575813|NCT03890341|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
5575814|NCT03890341|Betadex|betadex|mesh-list
5575815|NCT03890341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6180516|NCT01748799|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6180517|NCT01748799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5575816|NCT03890341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5575817|NCT03890341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5575818|NCT03890341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575819|NCT03890341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5575820|NCT03890341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5575821|NCT03890341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5575822|NCT03890341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5575823|NCT03890341|Anesthetics, General|anesthetics, general|mesh-ancestor
5575824|NCT03890341|Anesthetics|anesthetics|mesh-ancestor
5575825|NCT03890341|GABA Modulators|gaba modulators|mesh-ancestor
5575826|NCT03890341|GABA Agents|gaba agents|mesh-ancestor
5575827|NCT03890341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5575828|NCT03890341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575829|NCT03890341|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5575830|NCT03890341|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5575831|NCT03890341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5575832|NCT03890341|Contraceptive Agents|contraceptive agents|mesh-ancestor
6206686|NCT02104505|gamma-Tocopherol|gamma-tocopherol|mesh-list
6180518|NCT01748799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6180519|NCT01748799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180520|NCT01748799|Anticonvulsants|anticonvulsants|mesh-ancestor
6180521|NCT01748799|Analgesics|analgesics|mesh-ancestor
6180522|NCT01748799|Sensory System Agents|sensory system agents|mesh-ancestor
5575833|NCT03890341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5575834|NCT03890341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5575835|NCT03890341|Estrogens|estrogens|mesh-ancestor
5575836|NCT03890341|Hormones|hormones|mesh-ancestor
5575837|NCT03890341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5575838|NCT03890341|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5575839|NCT03890341|Hormone Antagonists|hormone antagonists|mesh-ancestor
5575840|NCT03890341|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5575841|NCT03890341|Diuretics|diuretics|mesh-ancestor
5575842|NCT03890341|Natriuretic Agents|natriuretic agents|mesh-ancestor
5575843|NCT03890341|Sequestering Agents|sequestering agents|mesh-ancestor
6180523|NCT01748799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6180524|NCT01748799|Hallucinogens|hallucinogens|mesh-ancestor
6180525|NCT01748799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6180526|NCT01748799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6180527|NCT01748799|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6180528|NCT01748799|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6180529|NCT01748799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6180530|NCT01748799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180531|NCT01748799|Hormones|hormones|mesh-ancestor
6180532|NCT01748799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6180533|NCT01748799|Antiemetics|antiemetics|mesh-ancestor
6180534|NCT01748799|Autonomic Agents|autonomic agents|mesh-ancestor
6180535|NCT01748799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6180536|NCT01748799|Parasympatholytics|parasympatholytics|mesh-ancestor
6180537|NCT01748825|Adavosertib|adavosertib|mesh-list
6180538|NCT01748825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6180539|NCT01748825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180540|NCT01748942|Dexamethasone|dexamethasone|mesh-list
5575844|NCT03890406|Rocuronium|rocuronium|mesh-list
5575845|NCT03890406|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5575846|NCT03890406|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5575847|NCT03890406|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5575848|NCT03890406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5575849|NCT03890406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575850|NCT03890510|Anesthetics|anesthetics|mesh-list
6180541|NCT01748942|Dexamethasone acetate|dexamethasone acetate|mesh-list
6180542|NCT01748942|Ichthammol|ichthammol|mesh-list
6180543|NCT01748942|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
6180544|NCT01748942|BB 1101|bb 1101|mesh-list
6180545|NCT01748942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5575851|NCT03890510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5575852|NCT03890510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575853|NCT03890094|Sufentanil|sufentanil|mesh-list
5575854|NCT03890094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5575855|NCT03890094|Narcotics|narcotics|mesh-ancestor
5575856|NCT03890094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5575857|NCT03890094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575858|NCT03890094|Analgesics|analgesics|mesh-ancestor
5575859|NCT03890094|Sensory System Agents|sensory system agents|mesh-ancestor
5575860|NCT03890094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5575861|NCT03890094|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5575862|NCT03890094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5575863|NCT03890094|Anesthetics, General|anesthetics, general|mesh-ancestor
5575864|NCT03890094|Anesthetics|anesthetics|mesh-ancestor
5575865|NCT03889717|Vitamin D|vitamin d|mesh-list
5575866|NCT03889717|Vitamins|vitamins|mesh-ancestor
5575867|NCT03889717|Micronutrients|micronutrients|mesh-ancestor
6180546|NCT01748942|Antiemetics|antiemetics|mesh-ancestor
6180547|NCT01748942|Autonomic Agents|autonomic agents|mesh-ancestor
6180548|NCT01748942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6180549|NCT01748942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670850|NCT01545778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6180550|NCT01748942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6180551|NCT01748942|Glucocorticoids|glucocorticoids|mesh-ancestor
6180552|NCT01748942|Hormones|hormones|mesh-ancestor
6180553|NCT01748942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6180554|NCT01748942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5575868|NCT03889717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180555|NCT01748942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5575869|NCT03889717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5575870|NCT03889808|Antitoxins|antitoxins|mesh-list
5575871|NCT03889808|Immunologic Factors|immunologic factors|mesh-ancestor
5575872|NCT03889808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575873|NCT03890042|Dienogest|dienogest|mesh-list
5575874|NCT03890042|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5575875|NCT03890042|Gestodene|gestodene|mesh-list
5575876|NCT03890042|Femovan|femovan|mesh-list
5575877|NCT03890042|Estradiol|estradiol|mesh-list
6180556|NCT01748942|Protease Inhibitors|protease inhibitors|mesh-ancestor
6180557|NCT01748942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6180558|NCT01748942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180559|NCT01748942|Dermatologic Agents|dermatologic agents|mesh-ancestor
6180560|NCT01748955|Bupropion|bupropion|mesh-list
6180561|NCT01748955|Paroxetine|paroxetine|mesh-list
5575878|NCT03890042|Estrogens|estrogens|mesh-ancestor
5575879|NCT03890042|Hormones|hormones|mesh-ancestor
5575880|NCT03890042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5575881|NCT03890042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180562|NCT01748955|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6180563|NCT01748955|Antidepressive Agents|antidepressive agents|mesh-ancestor
6670851|NCT01545778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670852|NCT01545778|Analgesics|analgesics|mesh-ancestor
6670853|NCT01545778|Sensory System Agents|sensory system agents|mesh-ancestor
6670854|NCT01545778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6180564|NCT01748955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6180565|NCT01748955|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6180566|NCT01748955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6180567|NCT01748955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6180568|NCT01748955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180569|NCT01748955|Dopamine Agents|dopamine agents|mesh-ancestor
6180570|NCT01748955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6180571|NCT01748955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180572|NCT01748955|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6180573|NCT01748955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6180574|NCT01748955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6180575|NCT01748955|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6180576|NCT01748955|Serotonin Agents|serotonin agents|mesh-ancestor
6180577|NCT01748994|Pioglitazone|pioglitazone|mesh-list
6180578|NCT01748994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6180579|NCT01748994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180580|NCT01749215|Topiramate|topiramate|mesh-list
6180581|NCT01749215|Anticonvulsants|anticonvulsants|mesh-ancestor
6180582|NCT01749215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6180583|NCT01749215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180584|NCT01749293|Cyclophosphamide|cyclophosphamide|mesh-list
6180585|NCT01749293|Busulfan|busulfan|mesh-list
6180586|NCT01749293|Fludarabine|fludarabine|mesh-list
6180587|NCT01749293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6180588|NCT01749293|Immunologic Factors|immunologic factors|mesh-ancestor
6180589|NCT01749293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180590|NCT01749293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6180591|NCT01749293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6180592|NCT01749293|Alkylating Agents|alkylating agents|mesh-ancestor
6180593|NCT01749293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670855|NCT01545778|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6670856|NCT01545778|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6670857|NCT01545778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6670858|NCT01545778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670859|NCT01545778|Adrenergic Agents|adrenergic agents|mesh-ancestor
6670860|NCT01545778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5575882|NCT03890042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5575883|NCT03890042|Contraceptive Agents|contraceptive agents|mesh-ancestor
5575884|NCT03890042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5575885|NCT03890042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5575886|NCT03890042|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5575887|NCT03890042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5575888|NCT03890042|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5575889|NCT03890042|Hormone Antagonists|hormone antagonists|mesh-ancestor
5575890|NCT03890042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5575891|NCT03890042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5575892|NCT03890042|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5575893|NCT03890042|Progestins|progestins|mesh-ancestor
5575894|NCT03890042|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5575895|NCT03889886|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5575896|NCT03889886|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6180594|NCT01749293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6180595|NCT01749293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6180596|NCT01749410|Botulinum Toxins|botulinum toxins|mesh-list
6180597|NCT01749410|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6180598|NCT01749410|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6180599|NCT01749410|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6180600|NCT01749410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6180601|NCT01749410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180602|NCT01749410|Cholinergic Agents|cholinergic agents|mesh-ancestor
6180603|NCT01749410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6180604|NCT01749410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180605|NCT01749410|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6180606|NCT01749410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6180607|NCT01749501|Rocuronium|rocuronium|mesh-list
6180608|NCT01749501|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6180609|NCT01749501|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6180610|NCT01749501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6180611|NCT01749501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6180612|NCT01749501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180613|NCT01749605|Ciprofloxacin|ciprofloxacin|mesh-list
6180614|NCT01749605|Nitrofurantoin|nitrofurantoin|mesh-list
6180615|NCT01749605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6180616|NCT01749605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6180617|NCT01749605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6180618|NCT01749605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6180619|NCT01749605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6180620|NCT01749605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180621|NCT01749605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6180622|NCT01749605|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6180623|NCT01749605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6180624|NCT01749605|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6180625|NCT01749605|Renal Agents|renal agents|mesh-ancestor
6180626|NCT01749904|Timolol|timolol|mesh-list
6180627|NCT01749904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6180628|NCT01749904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6180629|NCT01749904|Adrenergic Agents|adrenergic agents|mesh-ancestor
6180630|NCT01749904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6180631|NCT01749904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180632|NCT01749904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180633|NCT01749904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6180634|NCT01749904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6180635|NCT01749930|Timolol|timolol|mesh-list
5575897|NCT03889756|Midazolam|midazolam|mesh-list
5575898|NCT03889756|Ketamine|ketamine|mesh-list
5575899|NCT03889756|Analgesics|analgesics|mesh-ancestor
5604547|NCT04594408|Epinephrine|epinephrine|mesh-list
6180636|NCT01749930|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6180637|NCT01749930|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6180638|NCT01749930|Adrenergic Agents|adrenergic agents|mesh-ancestor
6180639|NCT01749930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6180640|NCT01749930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180641|NCT01749930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180642|NCT01749930|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6180643|NCT01749930|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6180644|NCT01749956|Leucovorin|leucovorin|mesh-list
6180645|NCT01749956|Fluorouracil|fluorouracil|mesh-list
6180646|NCT01749956|Oxaliplatin|oxaliplatin|mesh-list
6180647|NCT01749956|Aflibercept|aflibercept|mesh-list
6180648|NCT01749956|Antimetabolites|antimetabolites|mesh-ancestor
6180649|NCT01749956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180650|NCT01749956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6180651|NCT01749956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6180652|NCT01749956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6180653|NCT01749956|Immunologic Factors|immunologic factors|mesh-ancestor
6180654|NCT01749956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180655|NCT01749956|Antidotes|antidotes|mesh-ancestor
6180656|NCT01749956|Protective Agents|protective agents|mesh-ancestor
6180657|NCT01749956|Vitamin B Complex|vitamin b complex|mesh-ancestor
6180658|NCT01749956|Vitamins|vitamins|mesh-ancestor
6180659|NCT01749956|Micronutrients|micronutrients|mesh-ancestor
5575900|NCT03889756|Sensory System Agents|sensory system agents|mesh-ancestor
5575901|NCT03889756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5575902|NCT03889756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575903|NCT03889756|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5575904|NCT03889756|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5575905|NCT03889756|Anesthetics, General|anesthetics, general|mesh-ancestor
5575906|NCT03889756|Anesthetics|anesthetics|mesh-ancestor
5575907|NCT03889756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5575908|NCT03889756|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5575909|NCT03889756|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5575910|NCT03889756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5575911|NCT03889756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575912|NCT03889756|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6180660|NCT01749956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6180661|NCT01749956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6180662|NCT01749956|Growth Substances|growth substances|mesh-ancestor
6180663|NCT01749956|Growth Inhibitors|growth inhibitors|mesh-ancestor
6180664|NCT01749982|Choline|choline|mesh-list
6180665|NCT01749982|Betaine|betaine|mesh-list
6180666|NCT01749982|Lipotropic Agents|lipotropic agents|mesh-ancestor
6180667|NCT01749982|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6180668|NCT01749982|Antimetabolites|antimetabolites|mesh-ancestor
6180669|NCT01749982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180670|NCT01749982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6180671|NCT01749982|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6180672|NCT01749982|Nootropic Agents|nootropic agents|mesh-ancestor
5575913|NCT03889756|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5575914|NCT03889756|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6180673|NCT01750086|Denosumab|denosumab|mesh-list
6180674|NCT01750086|Alendronate|alendronate|mesh-list
6180675|NCT01750086|Teriparatide|teriparatide|mesh-list
6180676|NCT01750086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6180677|NCT01750086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180678|NCT01750086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6206687|NCT02104505|Antioxidants|antioxidants|mesh-ancestor
6206688|NCT02104505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206689|NCT02104505|Protective Agents|protective agents|mesh-ancestor
5575915|NCT03889756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5575916|NCT03889756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5575917|NCT03889756|GABA Modulators|gaba modulators|mesh-ancestor
5575918|NCT03889756|GABA Agents|gaba agents|mesh-ancestor
6206690|NCT02104505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206691|NCT02104505|Vitamins|vitamins|mesh-ancestor
6206692|NCT02104505|Micronutrients|micronutrients|mesh-ancestor
6206693|NCT02104739|Exenatide|exenatide|mesh-list
6206694|NCT02104739|Saxagliptin|saxagliptin|mesh-list
6206695|NCT02104739|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6206696|NCT02104739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206697|NCT02104739|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6206698|NCT02104739|Incretins|incretins|mesh-ancestor
5575919|NCT03890003|Insulin Lispro|insulin lispro|mesh-list
6206699|NCT02104739|Hormones|hormones|mesh-ancestor
6206700|NCT02104739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6180679|NCT01750268|Topiramate|topiramate|mesh-list
6180680|NCT01750268|Anticonvulsants|anticonvulsants|mesh-ancestor
6180681|NCT01750268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6180682|NCT01750268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180683|NCT01750294|Chlorthalidone|chlorthalidone|mesh-list
6180684|NCT01750294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6180685|NCT01750294|Diuretics|diuretics|mesh-ancestor
6180686|NCT01750294|Natriuretic Agents|natriuretic agents|mesh-ancestor
6180687|NCT01750294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180688|NCT01750294|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6180689|NCT01750294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6180690|NCT01750294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6487760|NCT00577967|Antimanic Agents|antimanic agents|mesh-ancestor
6487761|NCT00577980|Testosterone|testosterone|mesh-list
6180691|NCT01750398|Methyltestosterone|methyltestosterone|mesh-list
6180692|NCT01750398|Leuprolide|leuprolide|mesh-list
6180693|NCT01750398|Goserelin|goserelin|mesh-list
6180694|NCT01750398|Testosterone|testosterone|mesh-list
6180695|NCT01750398|Testosterone undecanoate|testosterone undecanoate|mesh-list
6180696|NCT01750398|Testosterone enanthate|testosterone enanthate|mesh-list
6180697|NCT01750398|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6180698|NCT01750398|Androgens|androgens|mesh-ancestor
6180699|NCT01750398|Hormones|hormones|mesh-ancestor
6180700|NCT01750398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6180701|NCT01750398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180702|NCT01750398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6180703|NCT01750398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5575920|NCT03890003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5575921|NCT03890003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575922|NCT03889912|Cemiplimab|cemiplimab|mesh-list
5575923|NCT03889912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5575924|NCT03889912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5575925|NCT03889470|Nitroglycerin|nitroglycerin|mesh-list
5575926|NCT03889470|Vasodilator Agents|vasodilator agents|mesh-ancestor
5575927|NCT03889288|Analgesics|analgesics|mesh-list
5575928|NCT03889288|Sensory System Agents|sensory system agents|mesh-ancestor
5575929|NCT03889288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5575930|NCT03889288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180704|NCT01750398|Anabolic Agents|anabolic agents|mesh-ancestor
6180705|NCT01750398|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6180706|NCT01750398|Fertility Agents|fertility agents|mesh-ancestor
6180707|NCT01750398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6180708|NCT01750697|Rituximab|rituximab|mesh-list
6180709|NCT01750697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6180710|NCT01750697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6180711|NCT01750697|Immunologic Factors|immunologic factors|mesh-ancestor
6180712|NCT01750697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180713|NCT01750697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6180714|NCT01750840|Cimetidine|cimetidine|mesh-list
6487762|NCT00577980|Androgens|androgens|mesh-ancestor
6487763|NCT00577980|Hormones|hormones|mesh-ancestor
6487764|NCT00577980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6487765|NCT00577980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487766|NCT00578097|Botulinum Toxins|botulinum toxins|mesh-list
6487767|NCT00578097|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6487768|NCT00578097|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6487769|NCT00578097|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6487770|NCT00578097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6487771|NCT00578097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6487772|NCT00578097|Cholinergic Agents|cholinergic agents|mesh-ancestor
6487773|NCT00578097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6487774|NCT00578097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180715|NCT01750840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6180716|NCT01750840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6180717|NCT01750840|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6180718|NCT01750840|Histamine Antagonists|histamine antagonists|mesh-ancestor
6180719|NCT01750840|Histamine Agents|histamine agents|mesh-ancestor
6180720|NCT01750840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6180721|NCT01750840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180722|NCT01750840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180723|NCT01750840|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6180724|NCT01750840|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6180725|NCT01750840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6180726|NCT01750918|Fluorouracil|fluorouracil|mesh-list
6180727|NCT01750918|Panitumumab|panitumumab|mesh-list
6180728|NCT01750918|Trametinib|trametinib|mesh-list
6180729|NCT01750918|Dabrafenib|dabrafenib|mesh-list
6180730|NCT01750918|Antimetabolites|antimetabolites|mesh-ancestor
6180731|NCT01750918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180732|NCT01750918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6180733|NCT01750918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6180734|NCT01750918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6180735|NCT01750918|Immunologic Factors|immunologic factors|mesh-ancestor
6180736|NCT01750918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180737|NCT01750918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6180738|NCT01750918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6180739|NCT01750918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6180740|NCT01750931|Meloxicam|meloxicam|mesh-list
6180741|NCT01750931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6180742|NCT01750931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6180743|NCT01750931|Analgesics|analgesics|mesh-ancestor
6180744|NCT01750931|Sensory System Agents|sensory system agents|mesh-ancestor
6180745|NCT01750931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6180746|NCT01750931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180747|NCT01750931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6180748|NCT01750931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6180749|NCT01750931|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6180750|NCT01750931|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6180751|NCT01750931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6180752|NCT01750931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180753|NCT01751087|Vitamins|vitamins|mesh-list
6180754|NCT01751087|Vitamin B 12|vitamin b 12|mesh-list
6180755|NCT01751087|Misoprostol|misoprostol|mesh-list
6180756|NCT01751087|Mifepristone|mifepristone|mesh-list
6670861|NCT01545791|Insulin Detemir|insulin detemir|mesh-list
6670862|NCT01545791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6670863|NCT01545791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670864|NCT01545804|Lenalidomide|lenalidomide|mesh-list
6670865|NCT01545804|Immunologic Factors|immunologic factors|mesh-ancestor
6670866|NCT01545804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670867|NCT01545804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6670868|NCT01545804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6670869|NCT01545804|Growth Substances|growth substances|mesh-ancestor
6670870|NCT01545804|Growth Inhibitors|growth inhibitors|mesh-ancestor
6670871|NCT01545804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6670872|NCT01545830|Vitamin D|vitamin d|mesh-list
6670873|NCT01545830|Cholecalciferol|cholecalciferol|mesh-list
6670874|NCT01545830|Vitamins|vitamins|mesh-ancestor
6670875|NCT01545830|Micronutrients|micronutrients|mesh-ancestor
5575931|NCT03889379|Albuterol|albuterol|mesh-list
6180757|NCT01751087|Micronutrients|micronutrients|mesh-ancestor
6180758|NCT01751087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180759|NCT01751087|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6180760|NCT01751087|Abortifacient Agents|abortifacient agents|mesh-ancestor
6180761|NCT01751087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6180762|NCT01751087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6180763|NCT01751087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6180764|NCT01751087|Oxytocics|oxytocics|mesh-ancestor
6180765|NCT01751087|Vitamin B Complex|vitamin b complex|mesh-ancestor
6180766|NCT01751087|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6180767|NCT01751087|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6180768|NCT01751087|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6180769|NCT01751087|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6180770|NCT01751087|Contraceptive Agents|contraceptive agents|mesh-ancestor
6180771|NCT01751087|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6487775|NCT00578097|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6487776|NCT00578097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6487777|NCT00578149|Paclitaxel|paclitaxel|mesh-list
6487778|NCT00578149|Bevacizumab|bevacizumab|mesh-list
6487779|NCT00578149|Carboplatin|carboplatin|mesh-list
6180772|NCT01751087|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6180773|NCT01751087|Hormone Antagonists|hormone antagonists|mesh-ancestor
6180774|NCT01751087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6487780|NCT00578149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6487781|NCT00578149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6487782|NCT00578149|Tubulin Modulators|tubulin modulators|mesh-ancestor
6487783|NCT00578149|Antimitotic Agents|antimitotic agents|mesh-ancestor
6487784|NCT00578149|Mitosis Modulators|mitosis modulators|mesh-ancestor
6487785|NCT00578149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6487786|NCT00578149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6670876|NCT01545830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575932|NCT03889379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5575933|NCT03889379|Autonomic Agents|autonomic agents|mesh-ancestor
5575934|NCT03889379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6487787|NCT00578149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6487788|NCT00578149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6487789|NCT00578149|Growth Substances|growth substances|mesh-ancestor
6487790|NCT00578149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575935|NCT03889379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575936|NCT03889379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6180775|NCT01751087|Luteolytic Agents|luteolytic agents|mesh-ancestor
6180776|NCT01751087|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6180777|NCT01751087|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5575937|NCT03889379|Respiratory System Agents|respiratory system agents|mesh-ancestor
5575938|NCT03889379|Tocolytic Agents|tocolytic agents|mesh-ancestor
6180778|NCT01751113|Fluticasone|fluticasone|mesh-list
6180779|NCT01751113|Xhance|xhance|mesh-list
6180780|NCT01751113|Bromides|bromides|mesh-list
6180781|NCT01751113|Tiotropium Bromide|tiotropium bromide|mesh-list
6180782|NCT01751113|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6180783|NCT01751113|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6180784|NCT01751113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6180785|NCT01751113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6180786|NCT01751113|Autonomic Agents|autonomic agents|mesh-ancestor
6180787|NCT01751113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6180788|NCT01751113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180789|NCT01751113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6180790|NCT01751113|Respiratory System Agents|respiratory system agents|mesh-ancestor
6180791|NCT01751113|Dermatologic Agents|dermatologic agents|mesh-ancestor
6180792|NCT01751113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6180793|NCT01751113|Parasympatholytics|parasympatholytics|mesh-ancestor
6180794|NCT01751113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6180795|NCT01751113|Cholinergic Agents|cholinergic agents|mesh-ancestor
6180796|NCT01751113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6180797|NCT01751113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180798|NCT01751113|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6180799|NCT01751113|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6180800|NCT01751113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6180801|NCT01751113|Adrenergic Agents|adrenergic agents|mesh-ancestor
6180802|NCT01751113|Anticonvulsants|anticonvulsants|mesh-ancestor
6180803|NCT01751113|Glucocorticoids|glucocorticoids|mesh-ancestor
6180804|NCT01751113|Hormones|hormones|mesh-ancestor
6180805|NCT01751113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6180806|NCT01751113|Sympathomimetics|sympathomimetics|mesh-ancestor
6180807|NCT01751178|Ethanol|ethanol|mesh-list
6180808|NCT01751178|Chlorhexidine|chlorhexidine|mesh-list
6487791|NCT00578149|Growth Inhibitors|growth inhibitors|mesh-ancestor
6487792|NCT00578201|Cetuximab|cetuximab|mesh-list
6487793|NCT00578201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6180809|NCT01751178|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6180810|NCT01751178|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6180811|NCT01751178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6180812|NCT01751178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6180813|NCT01751178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180814|NCT01751178|Disinfectants|disinfectants|mesh-ancestor
6180815|NCT01751178|Dermatologic Agents|dermatologic agents|mesh-ancestor
6180816|NCT01751386|Baclofen|baclofen|mesh-list
6180817|NCT01751386|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6180818|NCT01751386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180819|NCT01751386|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6180820|NCT01751386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6180821|NCT01751386|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6670877|NCT01545830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6670878|NCT01545830|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6670879|NCT01545856|Levodopa|levodopa|mesh-list
6670880|NCT01545856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6180822|NCT01751386|GABA Agonists|gaba agonists|mesh-ancestor
6180823|NCT01751386|GABA Agents|gaba agents|mesh-ancestor
6180824|NCT01751386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6180825|NCT01751386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180826|NCT01751451|Abiraterone Acetate|abiraterone acetate|mesh-list
6180827|NCT01751451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6180828|NCT01751451|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6487794|NCT00578201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6487795|NCT00578266|Cyclophosphamide|cyclophosphamide|mesh-list
6487796|NCT00578266|Alemtuzumab|alemtuzumab|mesh-list
6487797|NCT00578266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5575939|NCT03889379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5575940|NCT03889379|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5575941|NCT03889379|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5575942|NCT03889379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5575943|NCT03889379|Adrenergic Agents|adrenergic agents|mesh-ancestor
5575944|NCT03889379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5575945|NCT03889379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575946|NCT03889626|Capecitabine|capecitabine|mesh-list
5575947|NCT03889626|Apatinib|apatinib|mesh-list
5575948|NCT03889626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5575949|NCT03889626|Antimetabolites|antimetabolites|mesh-ancestor
5575950|NCT03889626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575951|NCT03889626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5575952|NCT03889626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5575953|NCT03889626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5575954|NCT03889314|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6180829|NCT01751451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6180830|NCT01751451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180831|NCT01751451|Hormone Antagonists|hormone antagonists|mesh-ancestor
6180832|NCT01751451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6180833|NCT01751451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180834|NCT01751451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6180835|NCT01751568|Raltegravir Potassium|raltegravir potassium|mesh-list
6180836|NCT01751568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6180837|NCT01751568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6180838|NCT01751568|Antiviral Agents|antiviral agents|mesh-ancestor
6180839|NCT01751568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6180840|NCT01751568|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6180841|NCT01751568|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6180842|NCT01751568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6180843|NCT01751568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180844|NCT01751646|Vitamin D|vitamin d|mesh-list
6180845|NCT01751646|Ergocalciferols|ergocalciferols|mesh-list
6180846|NCT01751646|Cholecalciferol|cholecalciferol|mesh-list
6180847|NCT01751646|Vitamins|vitamins|mesh-list
6180848|NCT01751646|Micronutrients|micronutrients|mesh-ancestor
6180849|NCT01751646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180850|NCT01751646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6180851|NCT01751646|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6180852|NCT01751724|Caffeine|caffeine|mesh-list
6180853|NCT01751724|Caffeine citrate|caffeine citrate|mesh-list
6180854|NCT01751724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180855|NCT01751724|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5575955|NCT03889314|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5575956|NCT03889314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5575957|NCT03889314|Antimetabolites|antimetabolites|mesh-ancestor
5575958|NCT03889314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575959|NCT03889314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5575960|NCT03889314|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5575961|NCT03889314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5575962|NCT03889366|Aprepitant|aprepitant|mesh-list
5575963|NCT03889366|Antiemetics|antiemetics|mesh-ancestor
5575964|NCT03889366|Autonomic Agents|autonomic agents|mesh-ancestor
5575965|NCT03889366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5575966|NCT03889366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575967|NCT03889366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5575968|NCT03889366|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5575969|NCT03889366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5575970|NCT03889366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575971|NCT03888924|Vaccines|vaccines|mesh-list
5575972|NCT03888924|BCG Vaccine|bcg vaccine|mesh-list
5575973|NCT03888924|Immunologic Factors|immunologic factors|mesh-ancestor
5575974|NCT03888924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575975|NCT03888924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5575976|NCT03888846|Colchicine|colchicine|mesh-list
5575977|NCT03888846|Pentoxifylline|pentoxifylline|mesh-list
5575978|NCT03888846|Gout Suppressants|gout suppressants|mesh-ancestor
6180856|NCT01751724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180857|NCT01751724|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6180858|NCT01751724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6487798|NCT00578266|Immunologic Factors|immunologic factors|mesh-ancestor
6487799|NCT00578266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575979|NCT03888846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5575980|NCT03888846|Tubulin Modulators|tubulin modulators|mesh-ancestor
5575981|NCT03888846|Antimitotic Agents|antimitotic agents|mesh-ancestor
5575982|NCT03888846|Mitosis Modulators|mitosis modulators|mesh-ancestor
5575983|NCT03888846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5575984|NCT03888846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5575985|NCT03888846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5575986|NCT03888846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5575987|NCT03888846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5575988|NCT03888846|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5575989|NCT03888846|Protective Agents|protective agents|mesh-ancestor
5575990|NCT03888846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5575991|NCT03888846|Vasodilator Agents|vasodilator agents|mesh-ancestor
6180859|NCT01751724|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6180860|NCT01751724|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6180861|NCT01751724|Purinergic Agents|purinergic agents|mesh-ancestor
6180862|NCT01751724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6180863|NCT01751802|Ecopipam|ecopipam|mesh-list
6180864|NCT01751802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6180865|NCT01751802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6180866|NCT01751802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6180867|NCT01751802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180868|NCT01751802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6180869|NCT01751802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6180870|NCT01751802|Dopamine Agents|dopamine agents|mesh-ancestor
6180871|NCT01751802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6180872|NCT01751802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180873|NCT01751867|Decitabine|decitabine|mesh-list
6180874|NCT01751867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6180875|NCT01751867|Antimetabolites|antimetabolites|mesh-ancestor
6180876|NCT01751867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180877|NCT01751867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6180878|NCT01751867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6180879|NCT01752413|Ferrous gluconate|ferrous gluconate|mesh-list
6180880|NCT01752413|Hematinics|hematinics|mesh-ancestor
6180881|NCT01752426|Deuterium Oxide|deuterium oxide|mesh-list
6180882|NCT01752426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6180883|NCT01752426|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6180884|NCT01752426|Protective Agents|protective agents|mesh-ancestor
6180885|NCT01752426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180886|NCT01752712|Oxytocin|oxytocin|mesh-list
6180887|NCT01752712|Oxytocics|oxytocics|mesh-ancestor
6180888|NCT01752712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6180889|NCT01752712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180890|NCT01752842|Fenofibrate|fenofibrate|mesh-list
6180891|NCT01752842|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6180892|NCT01752842|Antimetabolites|antimetabolites|mesh-ancestor
6180893|NCT01752842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180894|NCT01752842|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6180895|NCT01752855|Adalimumab|adalimumab|mesh-list
6180896|NCT01752855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6180897|NCT01752855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6180898|NCT01752933|Guadecitabine|guadecitabine|mesh-list
6180899|NCT01752933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6180900|NCT01753115|Ciprofloxacin|ciprofloxacin|mesh-list
6180901|NCT01753115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6180902|NCT01753115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6180903|NCT01753115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6180904|NCT01753115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6487800|NCT00578266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6487801|NCT00578266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6487802|NCT00578266|Alkylating Agents|alkylating agents|mesh-ancestor
6487803|NCT00578266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6487804|NCT00578266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6487805|NCT00578266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6180905|NCT01753115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6180906|NCT01753115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180907|NCT01753115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6487806|NCT00578266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6487807|NCT00578370|Cyclosporine|cyclosporine|mesh-list
6487808|NCT00578370|Betamethasone|betamethasone|mesh-list
6487809|NCT00578370|Calcipotriene|calcipotriene|mesh-list
6487810|NCT00578370|Cyclosporins|cyclosporins|mesh-list
6487811|NCT00578370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6487812|NCT00578370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6487813|NCT00578370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6487814|NCT00578370|Immunologic Factors|immunologic factors|mesh-ancestor
6487815|NCT00578370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487816|NCT00578370|Antifungal Agents|antifungal agents|mesh-ancestor
6487817|NCT00578370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5575992|NCT03888846|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5575993|NCT03888846|Antioxidants|antioxidants|mesh-ancestor
5575994|NCT03889145|Amlodipine|amlodipine|mesh-list
5575995|NCT03889145|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5575996|NCT03889145|Telmisartan|telmisartan|mesh-list
5575997|NCT03889145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5575998|NCT03889145|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5575999|NCT03889145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6487818|NCT00578370|Dermatologic Agents|dermatologic agents|mesh-ancestor
6487819|NCT00578370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6487820|NCT00578370|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6487821|NCT00578370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6487822|NCT00578370|Glucocorticoids|glucocorticoids|mesh-ancestor
6487823|NCT00578370|Hormones|hormones|mesh-ancestor
6487824|NCT00578370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6487825|NCT00578370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5576000|NCT03889145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5576001|NCT03889145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5576002|NCT03889145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576003|NCT03889145|Vasodilator Agents|vasodilator agents|mesh-ancestor
5576004|NCT03889145|Diuretics|diuretics|mesh-ancestor
5576005|NCT03889145|Natriuretic Agents|natriuretic agents|mesh-ancestor
5576006|NCT03889145|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5576007|NCT03889145|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5576008|NCT03889145|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6487826|NCT00578370|Respiratory System Agents|respiratory system agents|mesh-ancestor
6487827|NCT00578435|Cyclophosphamide|cyclophosphamide|mesh-list
6487828|NCT00578435|Busulfan|busulfan|mesh-list
6487829|NCT00578435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6487830|NCT00578435|Immunologic Factors|immunologic factors|mesh-ancestor
6487831|NCT00578435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576009|NCT03889106|Ribavirin|ribavirin|mesh-list
6180908|NCT01753115|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6180909|NCT01753115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6180910|NCT01753297|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6180911|NCT01753297|Luteolytic Agents|luteolytic agents|mesh-ancestor
6180912|NCT01753297|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5576010|NCT03889106|Antimetabolites|antimetabolites|mesh-ancestor
5576011|NCT03889106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5576012|NCT03889106|Antiviral Agents|antiviral agents|mesh-ancestor
5576013|NCT03889106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5576014|NCT03888677|Cyclophosphamide|cyclophosphamide|mesh-list
5576015|NCT03888677|Epirubicin|epirubicin|mesh-list
5576016|NCT03888677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5576017|NCT03888677|Immunologic Factors|immunologic factors|mesh-ancestor
5576018|NCT03888677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576019|NCT03888677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5576020|NCT03888677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5576021|NCT03888677|Alkylating Agents|alkylating agents|mesh-ancestor
5576022|NCT03888677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5576023|NCT03888677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5576024|NCT03888677|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5576025|NCT03888677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5576026|NCT03888677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5576027|NCT03888677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5576028|NCT03888677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5576029|NCT03888664|Interferons|interferons|mesh-list
5576030|NCT03888664|Interferon-gamma|interferon-gamma|mesh-list
5576031|NCT03888664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5576032|NCT03888664|Antiviral Agents|antiviral agents|mesh-ancestor
5576033|NCT03888664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6180913|NCT01753297|Contraceptive Agents|contraceptive agents|mesh-ancestor
6180914|NCT01753297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6180915|NCT01753297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180916|NCT01753297|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6180917|NCT01753297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6180918|NCT01753297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6180919|NCT01753310|Botulinum Toxins|botulinum toxins|mesh-list
6180920|NCT01753310|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6180921|NCT01753310|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6180922|NCT01753310|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6487832|NCT00578435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6180923|NCT01753310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6180924|NCT01753310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180925|NCT01753310|Cholinergic Agents|cholinergic agents|mesh-ancestor
6180926|NCT01753310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6180927|NCT01753310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180928|NCT01753310|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5576034|NCT03888729|Velpatasvir|velpatasvir|mesh-list
5576035|NCT03888729|Antiviral Agents|antiviral agents|mesh-ancestor
5576036|NCT03888729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5576037|NCT03888534|Ixazomib|ixazomib|mesh-list
5576038|NCT03888534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6180929|NCT01753310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6180930|NCT01753336|Botulinum Toxins|botulinum toxins|mesh-list
6180931|NCT01753336|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6180932|NCT01753336|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6180933|NCT01753336|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6180934|NCT01753336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6180935|NCT01753336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180936|NCT01753336|Cholinergic Agents|cholinergic agents|mesh-ancestor
6180937|NCT01753336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6180938|NCT01753336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180939|NCT01753336|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6180940|NCT01753336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6180941|NCT01753362|Liraglutide|liraglutide|mesh-list
6487833|NCT00578435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6487834|NCT00578435|Alkylating Agents|alkylating agents|mesh-ancestor
6487835|NCT00578435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5576039|NCT03888534|Protease Inhibitors|protease inhibitors|mesh-ancestor
6487836|NCT00578435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6487837|NCT00578435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6487838|NCT00578526|Sunitinib|sunitinib|mesh-list
6487839|NCT00578526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6487840|NCT00578526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6487841|NCT00578526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6487842|NCT00578526|Growth Substances|growth substances|mesh-ancestor
6487843|NCT00578526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487844|NCT00578526|Growth Inhibitors|growth inhibitors|mesh-ancestor
5576040|NCT03888534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5576041|NCT03888534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5576042|NCT03888183|Lubricant Eye Drops|lubricant eye drops|mesh-list
5576043|NCT03888183|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5576044|NCT03888183|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5576045|NCT03888157|Liraglutide|liraglutide|mesh-list
5576046|NCT03888157|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5576047|NCT03888157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576048|NCT03888157|Incretins|incretins|mesh-ancestor
5576049|NCT03888157|Hormones|hormones|mesh-ancestor
5576050|NCT03888157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5576051|NCT03888144|Ketorolac|ketorolac|mesh-list
5576052|NCT03888144|Oxycodone|oxycodone|mesh-list
5576053|NCT03888144|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6487845|NCT00578526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6487846|NCT00578526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6487847|NCT00578526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6487848|NCT00578591|Rituximab|rituximab|mesh-list
6487849|NCT00578591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6487850|NCT00578591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6487851|NCT00578591|Immunologic Factors|immunologic factors|mesh-ancestor
6487852|NCT00578591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487853|NCT00578591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6487854|NCT00578721|Aspirin|aspirin|mesh-list
6487855|NCT00578721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6487856|NCT00578721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6487857|NCT00578721|Analgesics|analgesics|mesh-ancestor
6487858|NCT00578721|Sensory System Agents|sensory system agents|mesh-ancestor
6487859|NCT00578721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6487860|NCT00578721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487861|NCT00578721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6487862|NCT00578721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6487863|NCT00578721|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6487864|NCT00578721|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6487865|NCT00578721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5576054|NCT03888144|Narcotics|narcotics|mesh-ancestor
5576055|NCT03888144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6487866|NCT00578721|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6487867|NCT00578721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6487868|NCT00578721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6487869|NCT00578721|Antipyretics|antipyretics|mesh-ancestor
6487870|NCT00578760|Aspirin|aspirin|mesh-list
6487871|NCT00578760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6487872|NCT00578760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6487873|NCT00578760|Analgesics|analgesics|mesh-ancestor
6487874|NCT00578760|Sensory System Agents|sensory system agents|mesh-ancestor
6487875|NCT00578760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6487876|NCT00578760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487877|NCT00578760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5576056|NCT03888144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576057|NCT03888144|Analgesics|analgesics|mesh-ancestor
5576058|NCT03888144|Sensory System Agents|sensory system agents|mesh-ancestor
5576059|NCT03888144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5576060|NCT03888144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5576061|NCT03888144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5576062|NCT03888144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5576063|NCT03888144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5576064|NCT03888144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5576065|NCT03888144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5576066|NCT03888144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6487878|NCT00578760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6487879|NCT00578760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6487880|NCT00578760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6487881|NCT00578760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6487882|NCT00578760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6487883|NCT00578760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6487884|NCT00578760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6487885|NCT00578760|Antipyretics|antipyretics|mesh-ancestor
6487886|NCT00578825|Ritonavir|ritonavir|mesh-list
6487887|NCT00578825|Lopinavir|lopinavir|mesh-list
6487888|NCT00578825|Ribavirin|ribavirin|mesh-list
6487889|NCT00578825|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6487890|NCT00578825|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6487891|NCT00578825|Protease Inhibitors|protease inhibitors|mesh-ancestor
6487892|NCT00578825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6487893|NCT00578825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6487894|NCT00578825|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6487895|NCT00578825|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6487896|NCT00578825|Antiviral Agents|antiviral agents|mesh-ancestor
6487897|NCT00578825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6487898|NCT00578825|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6487899|NCT00578825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6487900|NCT00578825|Antimetabolites|antimetabolites|mesh-ancestor
6487901|NCT00579046|Darbepoetin alfa|darbepoetin alfa|mesh-list
6487902|NCT00579046|Hematinics|hematinics|mesh-ancestor
6487903|NCT00579085|Ketamine|ketamine|mesh-list
6487904|NCT00579085|Analgesics|analgesics|mesh-ancestor
6487905|NCT00579085|Sensory System Agents|sensory system agents|mesh-ancestor
6487906|NCT00579085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6487907|NCT00579085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487908|NCT00579085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6487909|NCT00579085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6487910|NCT00579085|Anesthetics, General|anesthetics, general|mesh-ancestor
6487911|NCT00579085|Anesthetics|anesthetics|mesh-ancestor
6487912|NCT00579085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5576067|NCT03888131|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
5576068|NCT03888131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5576069|NCT03888131|Respiratory System Agents|respiratory system agents|mesh-ancestor
5576070|NCT03887884|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
5576071|NCT03887884|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5576072|NCT03887884|Immunologic Factors|immunologic factors|mesh-ancestor
5576073|NCT03887884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576074|NCT03887884|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5576075|NCT03887884|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5576076|NCT03887884|Dopamine Agonists|dopamine agonists|mesh-ancestor
5576077|NCT03887884|Dopamine Agents|dopamine agents|mesh-ancestor
5576078|NCT03887884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5576079|NCT03887884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5576080|NCT03887702|Tenofovir|tenofovir|mesh-list
6487913|NCT00579085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6487914|NCT00579085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6487915|NCT00579085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6487916|NCT00579085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6487917|NCT00579475|Mifepristone|mifepristone|mesh-list
6487918|NCT00579475|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6487919|NCT00579475|Abortifacient Agents|abortifacient agents|mesh-ancestor
6487920|NCT00579475|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6487921|NCT00579475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180942|NCT01753362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6180943|NCT01753362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180944|NCT01753362|Incretins|incretins|mesh-ancestor
6180945|NCT01753362|Hormones|hormones|mesh-ancestor
6180946|NCT01753362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6180947|NCT01753401|Prednisone|prednisone|mesh-list
6180948|NCT01753401|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6180949|NCT01753401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6180950|NCT01753401|Glucocorticoids|glucocorticoids|mesh-ancestor
6180951|NCT01753401|Hormones|hormones|mesh-ancestor
6180952|NCT01753401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6180953|NCT01753401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180954|NCT01753401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6180955|NCT01753401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6180956|NCT01753557|Interferon alpha-2|interferon alpha-2|mesh-list
5576081|NCT03887702|Entecavir|entecavir|mesh-list
5576082|NCT03887702|Antiviral Agents|antiviral agents|mesh-ancestor
5576083|NCT03887702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5576084|NCT03887702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5576085|NCT03887702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5576086|NCT03887702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5576087|NCT03887702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5576088|NCT03887702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5576089|NCT03887702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5576090|NCT03887650|Dexamethasone|dexamethasone|mesh-list
5576091|NCT03887650|Epinephrine|epinephrine|mesh-list
5576092|NCT03887650|Bupivacaine|bupivacaine|mesh-list
5576093|NCT03887650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6180957|NCT01753557|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6180958|NCT01753557|Antiviral Agents|antiviral agents|mesh-ancestor
6180959|NCT01753557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5576094|NCT03887650|Antiemetics|antiemetics|mesh-ancestor
5576095|NCT03887650|Autonomic Agents|autonomic agents|mesh-ancestor
5576096|NCT03887650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5576097|NCT03887650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576098|NCT03887650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6180960|NCT01753557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6180961|NCT01753570|Interferon-beta|interferon-beta|mesh-list
6180962|NCT01753570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6180963|NCT01753570|Antiviral Agents|antiviral agents|mesh-ancestor
6180964|NCT01753570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6180965|NCT01753570|Immunologic Factors|immunologic factors|mesh-ancestor
6180966|NCT01753570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180967|NCT01753739|Bepotastine besilate|bepotastine besilate|mesh-list
6180968|NCT01753739|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5576099|NCT03887650|Glucocorticoids|glucocorticoids|mesh-ancestor
5576100|NCT03887650|Hormones|hormones|mesh-ancestor
5576101|NCT03887650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5576102|NCT03887650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5576103|NCT03887650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5576104|NCT03887650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5576105|NCT03887650|Anesthetics, Local|anesthetics, local|mesh-ancestor
5576106|NCT03887650|Anesthetics|anesthetics|mesh-ancestor
5576107|NCT03887650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5576108|NCT03887650|Sensory System Agents|sensory system agents|mesh-ancestor
5576109|NCT03887650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5576110|NCT03887650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5576111|NCT03887650|Adrenergic Agents|adrenergic agents|mesh-ancestor
5576112|NCT03887650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5576113|NCT03887650|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5576114|NCT03887650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5576115|NCT03887650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5576116|NCT03887650|Respiratory System Agents|respiratory system agents|mesh-ancestor
5576117|NCT03887650|Mydriatics|mydriatics|mesh-ancestor
5576118|NCT03887650|Sympathomimetics|sympathomimetics|mesh-ancestor
5576119|NCT03887650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6180969|NCT01753856|Vitamin D|vitamin d|mesh-list
6180970|NCT01753856|Denosumab|denosumab|mesh-list
6180971|NCT01753856|Teriparatide|teriparatide|mesh-list
6180972|NCT01753856|Tetracycline|tetracycline|mesh-list
5576120|NCT03887754|Risperidone|risperidone|mesh-list
5576121|NCT03887754|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5576122|NCT03887754|Serotonin Agents|serotonin agents|mesh-ancestor
5576123|NCT03887754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5576124|NCT03887754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5576125|NCT03887754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576126|NCT03887754|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5576127|NCT03887754|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5576128|NCT03887754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5576129|NCT03887754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5576130|NCT03887754|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5576131|NCT03887754|Dopamine Agents|dopamine agents|mesh-ancestor
6180973|NCT01753856|Demeclocycline|demeclocycline|mesh-list
6487922|NCT00579475|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6487923|NCT00579475|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6487924|NCT00579475|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6487925|NCT00579475|Contraceptive Agents|contraceptive agents|mesh-ancestor
6487926|NCT00579475|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6487927|NCT00579475|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6487928|NCT00579475|Hormone Antagonists|hormone antagonists|mesh-ancestor
6487929|NCT00579475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6487930|NCT00579475|Luteolytic Agents|luteolytic agents|mesh-ancestor
5604548|NCT04594408|Racepinephrine|racepinephrine|mesh-list
5604549|NCT04594408|Tranexamic Acid|tranexamic acid|mesh-list
5604550|NCT04594408|Epinephryl borate|epinephryl borate|mesh-list
5604551|NCT04594408|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6487931|NCT00579475|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6487932|NCT00579475|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6487933|NCT00579592|Mycophenolic Acid|mycophenolic acid|mesh-list
6487934|NCT00579592|Rituximab|rituximab|mesh-list
6487935|NCT00579592|Alemtuzumab|alemtuzumab|mesh-list
6487936|NCT00579592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6487937|NCT00579592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6487938|NCT00579592|Immunologic Factors|immunologic factors|mesh-ancestor
6487939|NCT00579592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487940|NCT00579592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6487941|NCT00579592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6487942|NCT00579592|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6487943|NCT00579592|Antitubercular Agents|antitubercular agents|mesh-ancestor
5604552|NCT04594408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5604553|NCT04594408|Adrenergic Agents|adrenergic agents|mesh-ancestor
5604554|NCT04594408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5604555|NCT04594408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604556|NCT04594408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604557|NCT04594408|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5604558|NCT04594408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5604559|NCT04594408|Autonomic Agents|autonomic agents|mesh-ancestor
5604560|NCT04594408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5604561|NCT04594408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5604562|NCT04594408|Respiratory System Agents|respiratory system agents|mesh-ancestor
5604563|NCT04594408|Mydriatics|mydriatics|mesh-ancestor
5604564|NCT04594408|Sympathomimetics|sympathomimetics|mesh-ancestor
5604565|NCT04594408|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5604566|NCT04594408|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5604567|NCT04594408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6487944|NCT00579592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6487945|NCT00579592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6487946|NCT00579592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6487947|NCT00579592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6487948|NCT00579644|Minocycline|minocycline|mesh-list
5604568|NCT04594408|Hemostatics|hemostatics|mesh-ancestor
6180974|NCT01753856|Calcium|calcium|mesh-list
6180975|NCT01753856|Vitamins|vitamins|mesh-ancestor
6180976|NCT01753856|Micronutrients|micronutrients|mesh-ancestor
6180977|NCT01753856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180978|NCT01753856|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6180979|NCT01753856|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6180980|NCT01753856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6180981|NCT01753856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6180982|NCT01753856|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6180983|NCT01753856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6180984|NCT01753856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180985|NCT01754259|Ranolazine|ranolazine|mesh-list
6180986|NCT01754259|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5576132|NCT03887871|Tamsulosin|tamsulosin|mesh-list
5576133|NCT03887871|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6180987|NCT01754259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6180988|NCT01754259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6180989|NCT01754376|Aldesleukin|aldesleukin|mesh-list
6180990|NCT01754376|Interleukin-2|interleukin-2|mesh-list
6180991|NCT01754376|Vemurafenib|vemurafenib|mesh-list
6670881|NCT01545856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6670882|NCT01545856|Dopamine Agents|dopamine agents|mesh-ancestor
6670883|NCT01545856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6670884|NCT01545856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670885|NCT01545856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180992|NCT01754376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6180993|NCT01754376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6180994|NCT01754376|Analgesics|analgesics|mesh-ancestor
6180995|NCT01754376|Sensory System Agents|sensory system agents|mesh-ancestor
6180996|NCT01754376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6180997|NCT01754376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6180998|NCT01754376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6180999|NCT01754376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6181000|NCT01754376|Antiviral Agents|antiviral agents|mesh-ancestor
6181001|NCT01754376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6181002|NCT01754376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6181003|NCT01754376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6181004|NCT01754376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181005|NCT01754389|Sirolimus|sirolimus|mesh-list
6181006|NCT01754389|Methotrexate|methotrexate|mesh-list
6181007|NCT01754389|Bortezomib|bortezomib|mesh-list
6181008|NCT01754389|Tacrolimus|tacrolimus|mesh-list
6181009|NCT01754389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6181010|NCT01754389|Abortifacient Agents|abortifacient agents|mesh-ancestor
6181011|NCT01754389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6181012|NCT01754389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181013|NCT01754389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6181014|NCT01754389|Antimetabolites|antimetabolites|mesh-ancestor
6181015|NCT01754389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181016|NCT01754389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6181017|NCT01754389|Dermatologic Agents|dermatologic agents|mesh-ancestor
6181018|NCT01754389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6181019|NCT01754389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6181020|NCT01754389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6181021|NCT01754389|Immunologic Factors|immunologic factors|mesh-ancestor
6181022|NCT01754389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6181023|NCT01754389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6181024|NCT01754389|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6181025|NCT01754389|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6670886|NCT01545947|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6670887|NCT01545947|Azacitidine|azacitidine|mesh-list
6670888|NCT01545947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5604569|NCT04594408|Coagulants|coagulants|mesh-ancestor
6181026|NCT01754389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5576134|NCT03887871|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5576135|NCT03887871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5576136|NCT03887871|Adrenergic Agents|adrenergic agents|mesh-ancestor
5576137|NCT03887871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5576138|NCT03887871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5576139|NCT03887871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576140|NCT03887871|Urological Agents|urological agents|mesh-ancestor
5576141|NCT03887858|Tamsulosin|tamsulosin|mesh-list
6670889|NCT01545947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6670890|NCT01545947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6670891|NCT01545947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670892|NCT01545947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6670893|NCT01545947|Antimetabolites|antimetabolites|mesh-ancestor
6181027|NCT01754389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6181028|NCT01754389|Antifungal Agents|antifungal agents|mesh-ancestor
6181029|NCT01754402|Dexamethasone|dexamethasone|mesh-list
6181030|NCT01754402|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6181031|NCT01754402|Pomalidomide|pomalidomide|mesh-list
6181032|NCT01754402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6181033|NCT01754402|Antiemetics|antiemetics|mesh-ancestor
6181034|NCT01754402|Autonomic Agents|autonomic agents|mesh-ancestor
6181035|NCT01754402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6181036|NCT01754402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181037|NCT01754402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6181038|NCT01754402|Glucocorticoids|glucocorticoids|mesh-ancestor
6181039|NCT01754402|Hormones|hormones|mesh-ancestor
6181040|NCT01754402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6181041|NCT01754402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6181042|NCT01754402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6181043|NCT01754402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6181044|NCT01754402|Alkylating Agents|alkylating agents|mesh-ancestor
6181045|NCT01754402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181046|NCT01754402|Immunologic Factors|immunologic factors|mesh-ancestor
6181047|NCT01754402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6181048|NCT01754402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6181049|NCT01754402|Growth Substances|growth substances|mesh-ancestor
5576142|NCT03887858|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5576143|NCT03887858|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5576144|NCT03887858|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5576145|NCT03887858|Adrenergic Agents|adrenergic agents|mesh-ancestor
5576146|NCT03887858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5576147|NCT03887858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5576148|NCT03887858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576149|NCT03887858|Urological Agents|urological agents|mesh-ancestor
5576150|NCT03887624|Ethosuximide|ethosuximide|mesh-list
6181050|NCT01754402|Growth Inhibitors|growth inhibitors|mesh-ancestor
6181051|NCT01754480|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6181052|NCT01754480|Hemostatics|hemostatics|mesh-ancestor
6181053|NCT01754480|Coagulants|coagulants|mesh-ancestor
6181054|NCT01754493|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6181055|NCT01754493|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6181056|NCT01754493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5576151|NCT03887624|Citalopram|citalopram|mesh-list
5576152|NCT03887624|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5576153|NCT03887624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5576154|NCT03887624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5604570|NCT04593940|Remdesivir|remdesivir|mesh-list
6181057|NCT01754493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6181058|NCT01754493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181059|NCT01754493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6670894|NCT01546051|BCI-838|bci-838|mesh-list
6670895|NCT01546051|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6670896|NCT01546051|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6181060|NCT01754493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181061|NCT01754493|Analgesics|analgesics|mesh-ancestor
6181062|NCT01754493|Sensory System Agents|sensory system agents|mesh-ancestor
6181063|NCT01754493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6181064|NCT01754493|Antidepressive Agents|antidepressive agents|mesh-ancestor
6181065|NCT01754493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6181066|NCT01754493|Dopamine Agents|dopamine agents|mesh-ancestor
6181067|NCT01754623|Gemcitabine|gemcitabine|mesh-list
6181068|NCT01754623|Fluorouracil|fluorouracil|mesh-list
6181069|NCT01754623|Capecitabine|capecitabine|mesh-list
6181070|NCT01754623|Docetaxel|docetaxel|mesh-list
6181071|NCT01754623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6181072|NCT01754623|Antimetabolites|antimetabolites|mesh-ancestor
6181073|NCT01754623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181074|NCT01754623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6181075|NCT01754623|Antiviral Agents|antiviral agents|mesh-ancestor
6181076|NCT01754623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6181077|NCT01754623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6181078|NCT01754623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6181079|NCT01754623|Immunologic Factors|immunologic factors|mesh-ancestor
6181080|NCT01754623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181081|NCT01754623|Tubulin Modulators|tubulin modulators|mesh-ancestor
6181082|NCT01754623|Antimitotic Agents|antimitotic agents|mesh-ancestor
6181083|NCT01754623|Mitosis Modulators|mitosis modulators|mesh-ancestor
6181084|NCT01754909|Enalapril|enalapril|mesh-list
6181085|NCT01754909|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6181086|NCT01754909|Protease Inhibitors|protease inhibitors|mesh-ancestor
6181087|NCT01754909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6181088|NCT01754909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181089|NCT01754909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6181090|NCT01755026|Cefazolin|cefazolin|mesh-list
6181091|NCT01755026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5576155|NCT03887624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5576156|NCT03887624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5576157|NCT03887624|Serotonin Agents|serotonin agents|mesh-ancestor
5576158|NCT03887624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576159|NCT03887624|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5576160|NCT03887624|Antidepressive Agents|antidepressive agents|mesh-ancestor
5576161|NCT03887624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6181092|NCT01755026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6181093|NCT01755091|Dronabinol|dronabinol|mesh-list
6181094|NCT01755091|Hallucinogens|hallucinogens|mesh-ancestor
6181095|NCT01755091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181096|NCT01755091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6181097|NCT01755091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6181098|NCT01755091|Analgesics|analgesics|mesh-ancestor
5576162|NCT03887624|Anticonvulsants|anticonvulsants|mesh-ancestor
5576163|NCT03888079|Anesthetics|anesthetics|mesh-list
5576164|NCT03888079|Anesthetics, Local|anesthetics, local|mesh-list
5576165|NCT03888079|Anesthetics, General|anesthetics, general|mesh-list
5576166|NCT03888079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5576167|NCT03888079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576168|NCT03888079|Sensory System Agents|sensory system agents|mesh-ancestor
5576169|NCT03888079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5576170|NCT03887416|Dapagliflozin|dapagliflozin|mesh-list
5576171|NCT03887416|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5576172|NCT03887416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5576173|NCT03887416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5576174|NCT03887416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576175|NCT03887260|Fentanyl|fentanyl|mesh-list
5576176|NCT03887260|Morphine|morphine|mesh-list
5576177|NCT03887260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5576178|NCT03887260|Narcotics|narcotics|mesh-ancestor
5576179|NCT03887260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5576180|NCT03887260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576181|NCT03887260|Analgesics|analgesics|mesh-ancestor
5576182|NCT03887260|Sensory System Agents|sensory system agents|mesh-ancestor
5576183|NCT03887260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5576184|NCT03887260|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5576185|NCT03887260|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5576186|NCT03887260|Anesthetics, General|anesthetics, general|mesh-ancestor
5576187|NCT03887260|Anesthetics|anesthetics|mesh-ancestor
5576188|NCT03887169|Vitamin B 12|vitamin b 12|mesh-list
5576189|NCT03887169|Hydroxocobalamin|hydroxocobalamin|mesh-list
6181099|NCT01755091|Sensory System Agents|sensory system agents|mesh-ancestor
6181100|NCT01755091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6181101|NCT01755091|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5576190|NCT03887169|Vitamins|vitamins|mesh-ancestor
5576191|NCT03887169|Micronutrients|micronutrients|mesh-ancestor
5576192|NCT03887169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576193|NCT03887169|Vitamin B Complex|vitamin b complex|mesh-ancestor
5576194|NCT03887169|Hematinics|hematinics|mesh-ancestor
5576195|NCT03887130|Gemcitabine|gemcitabine|mesh-list
6181102|NCT01755091|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6181103|NCT01755091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6181104|NCT01755091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181105|NCT01755091|Hormones|hormones|mesh-ancestor
6181106|NCT01755091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6181107|NCT01755156|Metformin|metformin|mesh-list
6181108|NCT01755156|Insulin Glargine|insulin glargine|mesh-list
6181109|NCT01755156|Glimepiride|glimepiride|mesh-list
6181110|NCT01755156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6181111|NCT01755156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181112|NCT01755156|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6181113|NCT01755156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6181114|NCT01755156|Immunologic Factors|immunologic factors|mesh-ancestor
6181115|NCT01755169|Ketamine|ketamine|mesh-list
6181116|NCT01755169|Analgesics|analgesics|mesh-ancestor
6181117|NCT01755169|Sensory System Agents|sensory system agents|mesh-ancestor
5576196|NCT03887130|Paclitaxel|paclitaxel|mesh-list
5576197|NCT03887130|Vinorelbine|vinorelbine|mesh-list
5576198|NCT03887130|Docetaxel|docetaxel|mesh-list
5576199|NCT03887130|Capecitabine|capecitabine|mesh-list
5576200|NCT03887130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5576201|NCT03887130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6181118|NCT01755169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6181119|NCT01755169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181120|NCT01755169|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6181121|NCT01755169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6181122|NCT01755169|Anesthetics, General|anesthetics, general|mesh-ancestor
6181123|NCT01755169|Anesthetics|anesthetics|mesh-ancestor
6181124|NCT01755169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6181125|NCT01755169|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6181126|NCT01755169|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6181127|NCT01755169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6181128|NCT01755169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181129|NCT01755234|Propofol|propofol|mesh-list
6181130|NCT01755234|Sevoflurane|sevoflurane|mesh-list
6181131|NCT01755234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6487949|NCT00579644|Methotrexate|methotrexate|mesh-list
6487950|NCT00579644|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6487951|NCT00579644|Abortifacient Agents|abortifacient agents|mesh-ancestor
6487952|NCT00579644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6487953|NCT00579644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487954|NCT00579644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6487955|NCT00579644|Antimetabolites|antimetabolites|mesh-ancestor
5576202|NCT03887130|Tubulin Modulators|tubulin modulators|mesh-ancestor
5576203|NCT03887130|Antimitotic Agents|antimitotic agents|mesh-ancestor
6181132|NCT01755234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6181133|NCT01755234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181134|NCT01755234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6181135|NCT01755234|Anesthetics, General|anesthetics, general|mesh-ancestor
6181136|NCT01755234|Anesthetics|anesthetics|mesh-ancestor
6181137|NCT01755234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6181138|NCT01755234|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6181139|NCT01755416|Insulin|insulin|mesh-list
6181140|NCT01755416|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6181141|NCT01755416|Liraglutide|liraglutide|mesh-list
6181142|NCT01755416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6181143|NCT01755416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181144|NCT01755416|Incretins|incretins|mesh-ancestor
6181145|NCT01755416|Hormones|hormones|mesh-ancestor
6181146|NCT01755416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6181147|NCT01755546|Buprenorphine|buprenorphine|mesh-list
6181148|NCT01755546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6181149|NCT01755546|Narcotics|narcotics|mesh-ancestor
6181150|NCT01755546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6181151|NCT01755546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181152|NCT01755546|Analgesics|analgesics|mesh-ancestor
6181153|NCT01755546|Sensory System Agents|sensory system agents|mesh-ancestor
6181154|NCT01755546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6181155|NCT01755546|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6181156|NCT01755637|Albendazole|albendazole|mesh-list
6181157|NCT01755637|Anthelmintics|anthelmintics|mesh-ancestor
5576204|NCT03887130|Mitosis Modulators|mitosis modulators|mesh-ancestor
5576205|NCT03887130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6487956|NCT00579644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6487957|NCT00579644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6487958|NCT00579644|Dermatologic Agents|dermatologic agents|mesh-ancestor
6487959|NCT00579644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6487960|NCT00579644|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6487961|NCT00579644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5576206|NCT03887130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5576207|NCT03887130|Antimetabolites|antimetabolites|mesh-ancestor
5576208|NCT03887130|Antiviral Agents|antiviral agents|mesh-ancestor
5576209|NCT03887130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5576210|NCT03887130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5576211|NCT03887130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5576212|NCT03887130|Immunologic Factors|immunologic factors|mesh-ancestor
5576213|NCT03887130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576214|NCT03886896|Lidocaine|lidocaine|mesh-list
5576215|NCT03886896|Anesthetics, Local|anesthetics, local|mesh-ancestor
5576216|NCT03886896|Anesthetics|anesthetics|mesh-ancestor
6487962|NCT00579644|Immunologic Factors|immunologic factors|mesh-ancestor
6487963|NCT00579644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6487964|NCT00579644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6487965|NCT00579644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6181158|NCT01755637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6181159|NCT01755637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6181160|NCT01755637|Anticestodal Agents|anticestodal agents|mesh-ancestor
6181161|NCT01755637|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6181162|NCT01755637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6181163|NCT01755637|Tubulin Modulators|tubulin modulators|mesh-ancestor
6181164|NCT01755637|Antimitotic Agents|antimitotic agents|mesh-ancestor
6181165|NCT01755637|Mitosis Modulators|mitosis modulators|mesh-ancestor
6181166|NCT01755637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181167|NCT01755637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6181168|NCT01755702|Acetaminophen|acetaminophen|mesh-list
6181169|NCT01755702|Ibuprofen|ibuprofen|mesh-list
6181170|NCT01755702|Caffeine|caffeine|mesh-list
6181171|NCT01755702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6181172|NCT01755702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6181173|NCT01755702|Analgesics|analgesics|mesh-ancestor
6181174|NCT01755702|Sensory System Agents|sensory system agents|mesh-ancestor
6181175|NCT01755702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6181176|NCT01755702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181177|NCT01755702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6181178|NCT01755702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6181179|NCT01755702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6181180|NCT01755702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6181181|NCT01755702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181182|NCT01755702|Antipyretics|antipyretics|mesh-ancestor
6181183|NCT01755702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6181184|NCT01755702|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6181185|NCT01755702|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6181186|NCT01755702|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6181187|NCT01755702|Purinergic Agents|purinergic agents|mesh-ancestor
6181188|NCT01755702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6181189|NCT01755949|Colchicine|colchicine|mesh-list
6181190|NCT01755949|Gout Suppressants|gout suppressants|mesh-ancestor
6181191|NCT01755949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6181192|NCT01755949|Tubulin Modulators|tubulin modulators|mesh-ancestor
6487966|NCT00579644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5576217|NCT03886896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6181193|NCT01755949|Antimitotic Agents|antimitotic agents|mesh-ancestor
6181194|NCT01755949|Mitosis Modulators|mitosis modulators|mesh-ancestor
6181195|NCT01755949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670897|NCT01546051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6670898|NCT01546051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670899|NCT01546051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670900|NCT01546090|Alprazolam|alprazolam|mesh-list
6670901|NCT01546090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6670902|NCT01546090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6670903|NCT01546090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670904|NCT01546090|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6670905|NCT01546090|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6670906|NCT01546090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6670907|NCT01546090|GABA Modulators|gaba modulators|mesh-ancestor
6670908|NCT01546090|GABA Agents|gaba agents|mesh-ancestor
6670909|NCT01546090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6670910|NCT01546090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670911|NCT01546103|Vitamin D|vitamin d|mesh-list
5576218|NCT03886896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576219|NCT03886896|Sensory System Agents|sensory system agents|mesh-ancestor
5576220|NCT03886896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6487967|NCT00579956|Meropenem|meropenem|mesh-list
6487968|NCT00579956|Ceftazidime|ceftazidime|mesh-list
6487969|NCT00579956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6487970|NCT00579956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6487971|NCT00579969|Timolol|timolol|mesh-list
6487972|NCT00579969|Latanoprost|latanoprost|mesh-list
6487973|NCT00579969|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6487974|NCT00579969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6181196|NCT01755949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6206701|NCT02104739|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6206702|NCT02104739|Protease Inhibitors|protease inhibitors|mesh-ancestor
6206703|NCT02104739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6206704|NCT02104739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206705|NCT02104752|Curcumin|curcumin|mesh-list
6206706|NCT02104752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6206707|NCT02104752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6206708|NCT02104752|Analgesics|analgesics|mesh-ancestor
6206709|NCT02104752|Sensory System Agents|sensory system agents|mesh-ancestor
6206710|NCT02104752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6206711|NCT02104752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206712|NCT02104752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6206713|NCT02104752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6206714|NCT02104752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6206715|NCT02104752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6206716|NCT02104752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206717|NCT02104804|Insulin|insulin|mesh-list
6206718|NCT02104804|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6206719|NCT02104804|Metformin|metformin|mesh-list
6206720|NCT02104804|Saxagliptin|saxagliptin|mesh-list
6206721|NCT02104804|Insulin, Short-Acting|insulin, short-acting|mesh-list
5576221|NCT03886896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5576222|NCT03886896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5576223|NCT03886896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5576224|NCT03886896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5576225|NCT03886896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5576226|NCT03886779|Nepafenac|nepafenac|mesh-list
5576227|NCT03886779|Bromfenac|bromfenac|mesh-list
5576228|NCT03886779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5576229|NCT03886779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5576230|NCT03886779|Analgesics|analgesics|mesh-ancestor
5576231|NCT03886779|Sensory System Agents|sensory system agents|mesh-ancestor
5576232|NCT03886779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5576233|NCT03886779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206722|NCT02104804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6206723|NCT02104804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206724|NCT02104804|Incretins|incretins|mesh-ancestor
6206725|NCT02104804|Hormones|hormones|mesh-ancestor
6206726|NCT02104804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6206727|NCT02104804|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6487975|NCT00579969|Adrenergic Agents|adrenergic agents|mesh-ancestor
6487976|NCT00579969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6489030|NCT00588913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6670912|NCT01546103|Ergocalciferols|ergocalciferols|mesh-list
6670913|NCT01546103|Cholecalciferol|cholecalciferol|mesh-list
6181197|NCT01756079|Ribavirin|ribavirin|mesh-list
6181198|NCT01756079|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6181199|NCT01756079|Antimetabolites|antimetabolites|mesh-ancestor
5576234|NCT03886779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5576235|NCT03886779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5576236|NCT03886948|Mirikizumab|mirikizumab|mesh-list
5576237|NCT03886948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5576238|NCT03886948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6181200|NCT01756079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181201|NCT01756079|Antiviral Agents|antiviral agents|mesh-ancestor
6181202|NCT01756079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6181203|NCT01756157|Complement C1s|complement c1s|mesh-list
6181204|NCT01756157|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
6181205|NCT01756157|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
6181206|NCT01756157|Immunologic Factors|immunologic factors|mesh-ancestor
6181207|NCT01756157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181208|NCT01756157|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6181209|NCT01756157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6181210|NCT01756209|Acetaminophen|acetaminophen|mesh-list
6181211|NCT01756209|Ibuprofen|ibuprofen|mesh-list
6181212|NCT01756209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6181213|NCT01756209|Analgesics|analgesics|mesh-ancestor
6181214|NCT01756209|Sensory System Agents|sensory system agents|mesh-ancestor
6181215|NCT01756209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6181216|NCT01756209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181217|NCT01756209|Antipyretics|antipyretics|mesh-ancestor
6181218|NCT01756209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6181219|NCT01756209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6181220|NCT01756209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6181221|NCT01756209|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6181222|NCT01756209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6181223|NCT01756209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5576239|NCT03886948|Analgesics|analgesics|mesh-ancestor
5576240|NCT03886948|Sensory System Agents|sensory system agents|mesh-ancestor
5576241|NCT03886948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5576242|NCT03886948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576243|NCT03886948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5576244|NCT03886948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5576245|NCT03886948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5576246|NCT03886948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5576247|NCT03886922|Cromakalim|cromakalim|mesh-list
5576248|NCT03886922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5576249|NCT03886922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5576250|NCT03886922|Autonomic Agents|autonomic agents|mesh-ancestor
5576251|NCT03886922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6181224|NCT01756456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6181225|NCT01756456|Mitogens|mitogens|mesh-list
6181226|NCT01756456|Mitosis Modulators|mitosis modulators|mesh-ancestor
6181227|NCT01756456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181228|NCT01756833|Doxycycline|doxycycline|mesh-list
6181229|NCT01756833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6181230|NCT01756833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6181231|NCT01756833|Antimalarials|antimalarials|mesh-ancestor
5576252|NCT03886922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576253|NCT03886922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5576254|NCT03886922|Respiratory System Agents|respiratory system agents|mesh-ancestor
5576255|NCT03886922|Parasympatholytics|parasympatholytics|mesh-ancestor
5576256|NCT03886922|Vasodilator Agents|vasodilator agents|mesh-ancestor
6181232|NCT01756833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6181233|NCT01756833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6181234|NCT01756885|Varenicline|varenicline|mesh-list
6181235|NCT01756885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6181236|NCT01756885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6181237|NCT01756885|Cholinergic Agents|cholinergic agents|mesh-ancestor
6181238|NCT01756885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6181239|NCT01756885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181240|NCT01756885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181241|NCT01757275|Esomeprazole|esomeprazole|mesh-list
6487977|NCT00579969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6487978|NCT00579969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487979|NCT00579969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6487980|NCT00579969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6487981|NCT00579969|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6487982|NCT00579969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6487983|NCT00579995|Acetylcysteine|acetylcysteine|mesh-list
5576257|NCT03887013|Trimetazidine|trimetazidine|mesh-list
5576258|NCT03887013|Vasodilator Agents|vasodilator agents|mesh-ancestor
5576259|NCT03886766|Efavirenz|efavirenz|mesh-list
5576260|NCT03886766|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5576261|NCT03886766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5576262|NCT03886766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5576263|NCT03886766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5576264|NCT03886766|Antiviral Agents|antiviral agents|mesh-ancestor
5576265|NCT03886766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5576266|NCT03886766|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5576267|NCT03886766|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5576268|NCT03886766|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5576269|NCT03886766|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5576270|NCT03886766|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5576271|NCT03886766|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5576272|NCT03886441|Beclomethasone|beclomethasone|mesh-list
5576273|NCT03886441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5576274|NCT03886441|Glucocorticoids|glucocorticoids|mesh-ancestor
5576275|NCT03886441|Hormones|hormones|mesh-ancestor
5576276|NCT03886441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5576277|NCT03886441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576278|NCT03886441|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5576279|NCT03886441|Respiratory System Agents|respiratory system agents|mesh-ancestor
5576280|NCT03886662|LB100|lb100|mesh-list
5576281|NCT03886662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5576282|NCT03886662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5576283|NCT03886662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5576284|NCT03886311|Nivolumab|nivolumab|mesh-list
5576285|NCT03886311|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
6181242|NCT01757275|Cimetidine|cimetidine|mesh-list
6181243|NCT01757275|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6181244|NCT01757275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6181245|NCT01757275|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6181246|NCT01757275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6181247|NCT01757275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181248|NCT01757275|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6181249|NCT01757275|Histamine Antagonists|histamine antagonists|mesh-ancestor
5576286|NCT03886311|Trabectedin|trabectedin|mesh-list
5576287|NCT03886311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5576288|NCT03886311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5576289|NCT03886311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5576290|NCT03886311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181250|NCT01757275|Histamine Agents|histamine agents|mesh-ancestor
6181251|NCT01757275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6181252|NCT01757275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181253|NCT01757275|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6181254|NCT01757275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6181255|NCT01757288|Paclitaxel|paclitaxel|mesh-list
6181256|NCT01757288|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6181257|NCT01757288|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6181258|NCT01757288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6181259|NCT01757288|Tubulin Modulators|tubulin modulators|mesh-ancestor
6181260|NCT01757288|Antimitotic Agents|antimitotic agents|mesh-ancestor
6181261|NCT01757288|Mitosis Modulators|mitosis modulators|mesh-ancestor
6181262|NCT01757288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181263|NCT01757561|Propofol|propofol|mesh-list
6181264|NCT01757561|Sevoflurane|sevoflurane|mesh-list
6181265|NCT01757561|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6181266|NCT01757561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6181267|NCT01757561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181268|NCT01757561|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6181269|NCT01757561|Anesthetics, General|anesthetics, general|mesh-ancestor
6181270|NCT01757561|Anesthetics|anesthetics|mesh-ancestor
6181271|NCT01757561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6181272|NCT01757561|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6181273|NCT01757691|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6181274|NCT01757691|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5576291|NCT03886311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5576292|NCT03886311|Alkylating Agents|alkylating agents|mesh-ancestor
5576293|NCT03885947|Fludarabine|fludarabine|mesh-list
5576294|NCT03885947|Cyclophosphamide|cyclophosphamide|mesh-list
5576295|NCT03885947|Thiotepa|thiotepa|mesh-list
5576296|NCT03885947|Valproic Acid|valproic acid|mesh-list
5576297|NCT03885947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5576298|NCT03885947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181275|NCT01757691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181276|NCT01757691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6181277|NCT01757691|Immunologic Factors|immunologic factors|mesh-ancestor
6181278|NCT01757691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181279|NCT01758432|Apixaban|apixaban|mesh-list
6181280|NCT01758432|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6181281|NCT01758432|Antithrombins|antithrombins|mesh-ancestor
6181282|NCT01758432|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6181283|NCT01758432|Protease Inhibitors|protease inhibitors|mesh-ancestor
6181284|NCT01758432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6181285|NCT01758432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181286|NCT01758432|Anticoagulants|anticoagulants|mesh-ancestor
6181287|NCT01758523|Dutasteride|dutasteride|mesh-list
6181288|NCT01758523|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6181289|NCT01758523|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6181290|NCT01758523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6181291|NCT01758523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181292|NCT01758523|Hormone Antagonists|hormone antagonists|mesh-ancestor
6181293|NCT01758523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6181294|NCT01758523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181295|NCT01758588|Interferons|interferons|mesh-list
6181296|NCT01758588|Interferon-alpha|interferon-alpha|mesh-list
6181297|NCT01758588|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6181298|NCT01758588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6181299|NCT01758588|Antiviral Agents|antiviral agents|mesh-ancestor
6181300|NCT01758588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6181301|NCT01758588|Immunologic Factors|immunologic factors|mesh-ancestor
6181302|NCT01758588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181303|NCT01758731|Cetuximab|cetuximab|mesh-list
6181304|NCT01758731|Olaparib|olaparib|mesh-list
6181305|NCT01758731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6181306|NCT01758731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6181307|NCT01758731|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6181308|NCT01758731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6181309|NCT01758731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6487984|NCT00579995|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6487985|NCT00579995|Antiviral Agents|antiviral agents|mesh-ancestor
6487986|NCT00579995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6487987|NCT00579995|Expectorants|expectorants|mesh-ancestor
5576299|NCT03885947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5576300|NCT03885947|Immunologic Factors|immunologic factors|mesh-ancestor
5576301|NCT03885947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576302|NCT03885947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5576303|NCT03885947|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5576304|NCT03885947|Alkylating Agents|alkylating agents|mesh-ancestor
5576305|NCT03885947|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5576306|NCT03885947|Anticonvulsants|anticonvulsants|mesh-ancestor
5576307|NCT03885947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5576308|NCT03885947|GABA Agents|gaba agents|mesh-ancestor
5576309|NCT03885947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5576310|NCT03885947|Antimanic Agents|antimanic agents|mesh-ancestor
5576311|NCT03885947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5576312|NCT03885947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5576313|NCT03885947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5604571|NCT04593940|Cenicriviroc|cenicriviroc|mesh-list
5604572|NCT04593940|Abatacept|abatacept|mesh-list
6487988|NCT00579995|Respiratory System Agents|respiratory system agents|mesh-ancestor
6487989|NCT00579995|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6487990|NCT00579995|Antioxidants|antioxidants|mesh-ancestor
6487991|NCT00579995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6487992|NCT00579995|Protective Agents|protective agents|mesh-ancestor
6487993|NCT00579995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6487994|NCT00579995|Antidotes|antidotes|mesh-ancestor
6487995|NCT00580060|Molgramostim|molgramostim|mesh-list
6670914|NCT01546103|Vitamins|vitamins|mesh-list
6670915|NCT01546103|Micronutrients|micronutrients|mesh-ancestor
6670916|NCT01546103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670917|NCT01546103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6670918|NCT01546103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5604573|NCT04593940|Infliximab|infliximab|mesh-list
6181310|NCT01759277|Anesthetics|anesthetics|mesh-list
6181311|NCT01759277|Anesthetics, Local|anesthetics, local|mesh-list
6487996|NCT00580060|Sargramostim|sargramostim|mesh-list
5604574|NCT04593940|Dermatologic Agents|dermatologic agents|mesh-ancestor
6487997|NCT00580060|Immunologic Factors|immunologic factors|mesh-ancestor
5576314|NCT03885895|Tranexamic Acid|tranexamic acid|mesh-list
5576315|NCT03885895|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5576316|NCT03885895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5576317|NCT03885895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5576318|NCT03885895|Hemostatics|hemostatics|mesh-ancestor
5576319|NCT03885895|Coagulants|coagulants|mesh-ancestor
5576320|NCT03886233|Immunosuppressive Agents|immunosuppressive agents|mesh-list
5576321|NCT03886233|Immunologic Factors|immunologic factors|mesh-ancestor
6181312|NCT01759277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6181313|NCT01759277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181314|NCT01759277|Sensory System Agents|sensory system agents|mesh-ancestor
6181315|NCT01759277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6181316|NCT01759407|Epinephrine|epinephrine|mesh-list
6181317|NCT01759407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6181318|NCT01759407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6670919|NCT01546116|Lamivudine|lamivudine|mesh-list
6670920|NCT01546116|Adefovir|adefovir|mesh-list
5576322|NCT03886233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576323|NCT03885830|Imatinib Mesylate|imatinib mesylate|mesh-list
5576324|NCT03885830|Dasatinib|dasatinib|mesh-list
5576325|NCT03885830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5576326|NCT03885830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5576327|NCT03885830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6181319|NCT01759407|Adrenergic Agents|adrenergic agents|mesh-ancestor
6670921|NCT01546116|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6670922|NCT01546116|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6670923|NCT01546116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6670924|NCT01546116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6670925|NCT01546116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670926|NCT01546116|Antiviral Agents|antiviral agents|mesh-ancestor
6181320|NCT01759407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6181321|NCT01759407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181322|NCT01759407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181323|NCT01759407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6181324|NCT01759407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6181325|NCT01759407|Autonomic Agents|autonomic agents|mesh-ancestor
6181326|NCT01759407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6181327|NCT01759407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6181328|NCT01759407|Respiratory System Agents|respiratory system agents|mesh-ancestor
6181329|NCT01759407|Mydriatics|mydriatics|mesh-ancestor
6181330|NCT01759407|Sympathomimetics|sympathomimetics|mesh-ancestor
6181331|NCT01759407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6181332|NCT01759420|Ondansetron|ondansetron|mesh-list
6181333|NCT01759420|Antiemetics|antiemetics|mesh-ancestor
6181334|NCT01759420|Autonomic Agents|autonomic agents|mesh-ancestor
6181335|NCT01759420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6181336|NCT01759420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181337|NCT01759420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6181338|NCT01759420|Antipruritics|antipruritics|mesh-ancestor
6181339|NCT01759420|Dermatologic Agents|dermatologic agents|mesh-ancestor
6181340|NCT01759420|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6181341|NCT01759420|Serotonin Agents|serotonin agents|mesh-ancestor
6181342|NCT01759420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6181343|NCT01759420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181344|NCT01759420|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6181345|NCT01759420|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6181346|NCT01759420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6181347|NCT01759420|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6181348|NCT01759420|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6181349|NCT01759602|Complement C1s|complement c1s|mesh-list
6181350|NCT01759602|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
6181351|NCT01759602|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
6181352|NCT01759602|Immunologic Factors|immunologic factors|mesh-ancestor
6181353|NCT01759602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181354|NCT01759602|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6181355|NCT01759602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6181356|NCT01759862|Aminophylline|aminophylline|mesh-list
6181357|NCT01759862|Theophylline|theophylline|mesh-list
6181358|NCT01759862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6181359|NCT01759862|Autonomic Agents|autonomic agents|mesh-ancestor
6181360|NCT01759862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6181361|NCT01759862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181362|NCT01759862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6206728|NCT02104804|Protease Inhibitors|protease inhibitors|mesh-ancestor
5576328|NCT03885830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181363|NCT01759862|Respiratory System Agents|respiratory system agents|mesh-ancestor
6181364|NCT01759862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6181365|NCT01759862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6181366|NCT01759862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181367|NCT01759862|Vasodilator Agents|vasodilator agents|mesh-ancestor
6181368|NCT01759862|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6181369|NCT01759862|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6181370|NCT01759862|Purinergic Agents|purinergic agents|mesh-ancestor
6181371|NCT01759862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6181372|NCT01759862|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6181373|NCT01759862|Protective Agents|protective agents|mesh-ancestor
6181374|NCT01760304|Budesonide|budesonide|mesh-list
6181375|NCT01760304|Formoterol Fumarate|formoterol fumarate|mesh-list
6181376|NCT01760304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6181377|NCT01760304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6181378|NCT01760304|Autonomic Agents|autonomic agents|mesh-ancestor
6181379|NCT01760304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6181380|NCT01760304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576329|NCT03885804|Dexmedetomidine|dexmedetomidine|mesh-list
5576330|NCT03885804|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5576331|NCT03885804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5576332|NCT03885804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576333|NCT03885804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5576334|NCT03885804|Analgesics|analgesics|mesh-ancestor
5576335|NCT03885804|Sensory System Agents|sensory system agents|mesh-ancestor
5576336|NCT03885804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5576337|NCT03885804|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6181381|NCT01760304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6181382|NCT01760304|Respiratory System Agents|respiratory system agents|mesh-ancestor
6181383|NCT01760304|Glucocorticoids|glucocorticoids|mesh-ancestor
6181384|NCT01760304|Hormones|hormones|mesh-ancestor
6181385|NCT01760304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6181386|NCT01760304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6181387|NCT01760304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6181388|NCT01760304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6181389|NCT01760304|Adrenergic Agents|adrenergic agents|mesh-ancestor
6181390|NCT01760304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6181391|NCT01760304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181392|NCT01760447|Metformin|metformin|mesh-list
6670927|NCT01546116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6670928|NCT01546116|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6670929|NCT01546116|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6670930|NCT01546389|Chloroquine|chloroquine|mesh-list
5576338|NCT03885804|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6181393|NCT01760447|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6181394|NCT01760447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6181395|NCT01760447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181396|NCT01760447|Incretins|incretins|mesh-ancestor
6181397|NCT01760447|Hormones|hormones|mesh-ancestor
5576339|NCT03885804|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5576340|NCT03885804|Adrenergic Agents|adrenergic agents|mesh-ancestor
5576341|NCT03885804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5576342|NCT03885804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5576343|NCT03885713|Adalimumab|adalimumab|mesh-list
5576344|NCT03885713|Golimumab|golimumab|mesh-list
5576345|NCT03885713|Infliximab|infliximab|mesh-list
5576346|NCT03885713|Ustekinumab|ustekinumab|mesh-list
5576347|NCT03885713|Vedolizumab|vedolizumab|mesh-list
5576348|NCT03885713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5576349|NCT03885713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5576350|NCT03885713|Dermatologic Agents|dermatologic agents|mesh-ancestor
5576351|NCT03885713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5576352|NCT03885713|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
5576353|NCT03885713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5576354|NCT03885713|Immunologic Factors|immunologic factors|mesh-ancestor
5576355|NCT03885713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576356|NCT03885258|Melatonin|melatonin|mesh-list
5576357|NCT03885258|Antioxidants|antioxidants|mesh-ancestor
5576358|NCT03885258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5576359|NCT03885258|Protective Agents|protective agents|mesh-ancestor
5576360|NCT03885258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576361|NCT03885258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6487998|NCT00580060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670931|NCT01546389|Amebicides|amebicides|mesh-ancestor
5576362|NCT03885427|Ketamine|ketamine|mesh-list
5576363|NCT03885427|Analgesics|analgesics|mesh-ancestor
5576364|NCT03885427|Sensory System Agents|sensory system agents|mesh-ancestor
5576365|NCT03885427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5576366|NCT03885427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576367|NCT03885427|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5576368|NCT03885427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5576369|NCT03885427|Anesthetics, General|anesthetics, general|mesh-ancestor
5576370|NCT03885427|Anesthetics|anesthetics|mesh-ancestor
5576371|NCT03885427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5576372|NCT03885427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5576373|NCT03885427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5576374|NCT03885427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5576375|NCT03885427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5576376|NCT03885219|Paclitaxel|paclitaxel|mesh-list
5576377|NCT03885219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5576378|NCT03885219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5576379|NCT03885219|Tubulin Modulators|tubulin modulators|mesh-ancestor
5576380|NCT03885219|Antimitotic Agents|antimitotic agents|mesh-ancestor
5576381|NCT03885219|Mitosis Modulators|mitosis modulators|mesh-ancestor
5576382|NCT03885219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5576383|NCT03885180|Warfarin|warfarin|mesh-list
6181398|NCT01760447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6181399|NCT01760447|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6181400|NCT01760447|Protease Inhibitors|protease inhibitors|mesh-ancestor
6181401|NCT01760447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6181402|NCT01760447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181403|NCT01760785|Valproic Acid|valproic acid|mesh-list
6181404|NCT01760785|Anticonvulsants|anticonvulsants|mesh-ancestor
6181405|NCT01760785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6181406|NCT01760785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181407|NCT01760785|GABA Agents|gaba agents|mesh-ancestor
6181408|NCT01760785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5576384|NCT03885180|Anticoagulants|anticoagulants|mesh-ancestor
5576385|NCT03885388|Dactinomycin|dactinomycin|mesh-list
5576386|NCT03885388|Methotrexate|methotrexate|mesh-list
6181409|NCT01760785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181410|NCT01760785|Antimanic Agents|antimanic agents|mesh-ancestor
6181411|NCT01760785|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6181412|NCT01760785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6181413|NCT01760785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6181414|NCT01761266|Sorafenib|sorafenib|mesh-list
6181415|NCT01761266|Lenvatinib|lenvatinib|mesh-list
6181416|NCT01761266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6181417|NCT01761266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6181418|NCT01761266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6181419|NCT01761266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181420|NCT01761292|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
6181421|NCT01761292|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6181422|NCT01761292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6181423|NCT01761292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181424|NCT01761747|Ponatinib|ponatinib|mesh-list
6181425|NCT01761747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6181426|NCT01761747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6181427|NCT01761747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6181428|NCT01761747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181429|NCT01762059|Pancrelipase|pancrelipase|mesh-list
6181430|NCT01762059|Pancreatin|pancreatin|mesh-list
6181431|NCT01762059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6181432|NCT01762501|Amlodipine|amlodipine|mesh-list
6181433|NCT01762501|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
6181434|NCT01762501|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6181435|NCT01762501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6181436|NCT01762501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6181437|NCT01762501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181438|NCT01762501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5576387|NCT03885388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5576388|NCT03885388|Abortifacient Agents|abortifacient agents|mesh-ancestor
5576389|NCT03885388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5576390|NCT03885388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576391|NCT03885388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5576392|NCT03885388|Antimetabolites|antimetabolites|mesh-ancestor
5576393|NCT03885388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5576394|NCT03885388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6181439|NCT01762501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181440|NCT01762501|Vasodilator Agents|vasodilator agents|mesh-ancestor
6181441|NCT01762501|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6181442|NCT01762501|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6181443|NCT01762800|Fluticasone|fluticasone|mesh-list
6181444|NCT01762800|Xhance|xhance|mesh-list
6181445|NCT01762800|Bromides|bromides|mesh-list
6181446|NCT01762800|Tiotropium Bromide|tiotropium bromide|mesh-list
6181447|NCT01762800|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6181448|NCT01762800|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6181449|NCT01762800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6181450|NCT01762800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6181451|NCT01762800|Autonomic Agents|autonomic agents|mesh-ancestor
6181452|NCT01762800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6181453|NCT01762800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181454|NCT01762800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6181455|NCT01762800|Respiratory System Agents|respiratory system agents|mesh-ancestor
6181456|NCT01762800|Dermatologic Agents|dermatologic agents|mesh-ancestor
6181457|NCT01762800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6181458|NCT01762800|Parasympatholytics|parasympatholytics|mesh-ancestor
6181459|NCT01762800|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6181460|NCT01762800|Cholinergic Agents|cholinergic agents|mesh-ancestor
6181461|NCT01762800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6181462|NCT01762800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181463|NCT01762800|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6181464|NCT01762800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6181465|NCT01762800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6181466|NCT01762800|Adrenergic Agents|adrenergic agents|mesh-ancestor
6181467|NCT01762800|Anticonvulsants|anticonvulsants|mesh-ancestor
6181468|NCT01762800|Glucocorticoids|glucocorticoids|mesh-ancestor
6181469|NCT01762800|Hormones|hormones|mesh-ancestor
6181470|NCT01762800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6181471|NCT01762800|Sympathomimetics|sympathomimetics|mesh-ancestor
6181472|NCT01762904|Ethanol|ethanol|mesh-list
6181473|NCT01762904|Chlorhexidine|chlorhexidine|mesh-list
6181474|NCT01762904|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6181475|NCT01762904|Triclosan|triclosan|mesh-list
6181476|NCT01762904|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
6181477|NCT01762904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6181478|NCT01762904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6181479|NCT01762904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181480|NCT01762904|Disinfectants|disinfectants|mesh-ancestor
6181481|NCT01762904|Dermatologic Agents|dermatologic agents|mesh-ancestor
6181482|NCT01762904|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6181483|NCT01762904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6181484|NCT01762904|Antimetabolites|antimetabolites|mesh-ancestor
6181485|NCT01762904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181486|NCT01762904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6181487|NCT01762943|Leuprolide|leuprolide|mesh-list
6181488|NCT01762943|Estradiol|estradiol|mesh-list
6181489|NCT01762943|Progesterone|progesterone|mesh-list
6181490|NCT01762943|Estrogens|estrogens|mesh-ancestor
6181491|NCT01762943|Hormones|hormones|mesh-ancestor
6181492|NCT01762943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6181493|NCT01762943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181494|NCT01762943|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6181495|NCT01762943|Progestins|progestins|mesh-ancestor
6181496|NCT01762943|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6181497|NCT01762943|Fertility Agents|fertility agents|mesh-ancestor
6181498|NCT01762943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6181499|NCT01762943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6181500|NCT01762982|Benzalkonium Compounds|benzalkonium compounds|mesh-list
6181501|NCT01762982|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6181502|NCT01762982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6181503|NCT01763164|Dacarbazine|dacarbazine|mesh-list
6181504|NCT01763164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6181505|NCT01763164|Alkylating Agents|alkylating agents|mesh-ancestor
6181506|NCT01763164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181507|NCT01763164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6670932|NCT01546389|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6670933|NCT01546389|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6181508|NCT01763346|Metformin|metformin|mesh-list
6487999|NCT00580060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6488000|NCT00580112|Dexamethasone|dexamethasone|mesh-list
6488001|NCT00580112|Trabectedin|trabectedin|mesh-list
6488002|NCT00580112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6672524|NCT01556698|Protective Agents|protective agents|mesh-ancestor
6181509|NCT01763346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6181510|NCT01763346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181511|NCT01763606|Aspirin|aspirin|mesh-list
6181512|NCT01763606|Enoxaparin|enoxaparin|mesh-list
6181513|NCT01763606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6181514|NCT01763606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6181515|NCT01763606|Analgesics|analgesics|mesh-ancestor
6181516|NCT01763606|Sensory System Agents|sensory system agents|mesh-ancestor
6181517|NCT01763606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6181518|NCT01763606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181519|NCT01763606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6181520|NCT01763606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6181521|NCT01763606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6181522|NCT01763606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6181523|NCT01763606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181524|NCT01763606|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6181525|NCT01763606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6181526|NCT01763606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6181527|NCT01763606|Antipyretics|antipyretics|mesh-ancestor
5576395|NCT03885388|Dermatologic Agents|dermatologic agents|mesh-ancestor
5576396|NCT03885388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5576397|NCT03885388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5576398|NCT03885388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5576399|NCT03885388|Immunologic Factors|immunologic factors|mesh-ancestor
5576400|NCT03885388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5576401|NCT03885388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5576402|NCT03885388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5576403|NCT03885388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5576404|NCT03885388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5576405|NCT03885388|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5576406|NCT03885297|Liraglutide|liraglutide|mesh-list
5576407|NCT03885297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5576408|NCT03885297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576409|NCT03885297|Incretins|incretins|mesh-ancestor
5576410|NCT03885297|Hormones|hormones|mesh-ancestor
5576411|NCT03885297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5576412|NCT03884881|Meropenem|meropenem|mesh-list
5576413|NCT03884881|Imipenem|imipenem|mesh-list
5576414|NCT03884881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5576415|NCT03884881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6181528|NCT01763606|Anticoagulants|anticoagulants|mesh-ancestor
6181529|NCT01763645|Paclitaxel|paclitaxel|mesh-list
6181530|NCT01763645|Bevacizumab|bevacizumab|mesh-list
5576416|NCT03885141|Zolpidem|zolpidem|mesh-list
5576417|NCT03885141|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5576418|NCT03885141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5576419|NCT03885141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6181531|NCT01763645|Carboplatin|carboplatin|mesh-list
6181532|NCT01763645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6181533|NCT01763645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6181534|NCT01763645|Tubulin Modulators|tubulin modulators|mesh-ancestor
6181535|NCT01763645|Antimitotic Agents|antimitotic agents|mesh-ancestor
6181536|NCT01763645|Mitosis Modulators|mitosis modulators|mesh-ancestor
6181537|NCT01763645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670934|NCT01546389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6670935|NCT01546389|Antimalarials|antimalarials|mesh-ancestor
6670936|NCT01546389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6670937|NCT01546558|Metformin|metformin|mesh-list
6670938|NCT01546558|Ranolazine|ranolazine|mesh-list
6670939|NCT01546558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6670940|NCT01546558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670941|NCT01546558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6670942|NCT01546558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6670943|NCT01546558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670944|NCT01546597|Metformin|metformin|mesh-list
6670945|NCT01546597|Ranolazine|ranolazine|mesh-list
6670946|NCT01546597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6670947|NCT01546597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670948|NCT01546597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6670949|NCT01546597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6670950|NCT01546597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670951|NCT01546701|Morphine|morphine|mesh-list
5576420|NCT03885141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181538|NCT01763645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5576421|NCT03885141|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6670952|NCT01546701|Buprenorphine|buprenorphine|mesh-list
6670953|NCT01546701|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6670954|NCT01546701|Narcotics|narcotics|mesh-ancestor
6670955|NCT01546701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6670956|NCT01546701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670957|NCT01546701|Analgesics|analgesics|mesh-ancestor
5576422|NCT03885141|GABA Agonists|gaba agonists|mesh-ancestor
5576423|NCT03885141|GABA Agents|gaba agents|mesh-ancestor
5576424|NCT03885141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5576425|NCT03885141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5576426|NCT03884972|Venetoclax|venetoclax|mesh-list
5576427|NCT03884972|Trabectedin|trabectedin|mesh-list
5576428|NCT03884972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5576429|NCT03884972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5576430|NCT03884972|Alkylating Agents|alkylating agents|mesh-ancestor
5576431|NCT03884972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5576432|NCT03884491|Vortioxetine|vortioxetine|mesh-list
5576433|NCT03884491|Antidepressive Agents|antidepressive agents|mesh-ancestor
5576434|NCT03884491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5576435|NCT03884491|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5576436|NCT03884491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5576437|NCT03884491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5576438|NCT03884491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576439|NCT03884491|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6670958|NCT01546701|Sensory System Agents|sensory system agents|mesh-ancestor
6670959|NCT01546701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6670960|NCT01546701|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6670961|NCT01546896|Alprazolam|alprazolam|mesh-list
5576440|NCT03884491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5576441|NCT03884491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5576442|NCT03884491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5576443|NCT03884491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5576444|NCT03884491|Serotonin Agents|serotonin agents|mesh-ancestor
5576445|NCT03884491|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5576446|NCT03884491|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5576447|NCT03884491|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6181539|NCT01763645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6181540|NCT01763645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6670962|NCT01546896|Buspirone|buspirone|mesh-list
6670963|NCT01546896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6670964|NCT01546896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6670965|NCT01546896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670966|NCT01546896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6670967|NCT01546896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6670968|NCT01546896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6181541|NCT01763645|Growth Substances|growth substances|mesh-ancestor
6181542|NCT01763645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181543|NCT01763645|Growth Inhibitors|growth inhibitors|mesh-ancestor
6181544|NCT01763827|Ezetimibe|ezetimibe|mesh-list
6181545|NCT01763827|Evolocumab|evolocumab|mesh-list
6181546|NCT01763827|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6181547|NCT01763827|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6181548|NCT01763827|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6181549|NCT01763827|Antimetabolites|antimetabolites|mesh-ancestor
6181550|NCT01763827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181551|NCT01763827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6181552|NCT01763827|Immunologic Factors|immunologic factors|mesh-ancestor
6181553|NCT01763827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181554|NCT01763866|Atorvastatin|atorvastatin|mesh-list
6181555|NCT01763866|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6181556|NCT01763866|Simvastatin|simvastatin|mesh-list
6181557|NCT01763866|Ezetimibe|ezetimibe|mesh-list
6181558|NCT01763866|Evolocumab|evolocumab|mesh-list
6181559|NCT01763866|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6181560|NCT01763866|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6181561|NCT01763866|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6181562|NCT01763866|Antimetabolites|antimetabolites|mesh-ancestor
6181563|NCT01763866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181564|NCT01763866|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6181565|NCT01763866|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6181566|NCT01763866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6181567|NCT01763866|Immunologic Factors|immunologic factors|mesh-ancestor
6181568|NCT01763866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181569|NCT01763905|Ezetimibe|ezetimibe|mesh-list
6181570|NCT01763905|Evolocumab|evolocumab|mesh-list
6181571|NCT01763905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6670969|NCT01546896|GABA Modulators|gaba modulators|mesh-ancestor
6181572|NCT01763905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6181573|NCT01763905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6181574|NCT01763905|Antimetabolites|antimetabolites|mesh-ancestor
6181575|NCT01763905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181576|NCT01763905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5576448|NCT03884491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5576449|NCT03884348|Amoxicillin|amoxicillin|mesh-list
5576450|NCT03884348|Metronidazole|metronidazole|mesh-list
5576451|NCT03884348|Clarithromycin|clarithromycin|mesh-list
5576452|NCT03884348|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
5576453|NCT03884348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5576454|NCT03884348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5576455|NCT03884348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5576456|NCT03884348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5576457|NCT03884348|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5576458|NCT03884348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5576459|NCT03884348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5576460|NCT03884348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5576461|NCT03884348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5576462|NCT03884465|Treprostinil|treprostinil|mesh-list
5576463|NCT03884465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5604575|NCT04593940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5604576|NCT04593940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5604577|NCT04593940|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5604578|NCT04593940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604579|NCT04593940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6181577|NCT01763905|Immunologic Factors|immunologic factors|mesh-ancestor
6181578|NCT01763905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181579|NCT01763918|Evolocumab|evolocumab|mesh-list
6181580|NCT01763918|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6181581|NCT01763918|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5604580|NCT04593940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5604581|NCT04593940|Immunologic Factors|immunologic factors|mesh-ancestor
5604582|NCT04593940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181582|NCT01763918|Antimetabolites|antimetabolites|mesh-ancestor
6181583|NCT01763918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181584|NCT01763918|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6181585|NCT01763931|Digoxin|digoxin|mesh-list
6181586|NCT01763931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6181587|NCT01763931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6181588|NCT01763931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6181589|NCT01763931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181590|NCT01763931|Protective Agents|protective agents|mesh-ancestor
6181591|NCT01763931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181592|NCT01763996|Febuxostat|febuxostat|mesh-list
6181593|NCT01763996|Gout Suppressants|gout suppressants|mesh-ancestor
6181594|NCT01763996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6181595|NCT01764022|Paclitaxel|paclitaxel|mesh-list
6181596|NCT01764022|Trastuzumab|trastuzumab|mesh-list
6181597|NCT01764022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6181598|NCT01764022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6181599|NCT01764022|Tubulin Modulators|tubulin modulators|mesh-ancestor
6181600|NCT01764022|Antimitotic Agents|antimitotic agents|mesh-ancestor
6181601|NCT01764022|Mitosis Modulators|mitosis modulators|mesh-ancestor
6181602|NCT01764022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181603|NCT01764022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6181604|NCT01764464|Gabapentin|gabapentin|mesh-list
6181605|NCT01764464|Analgesics|analgesics|mesh-ancestor
6181606|NCT01764464|Sensory System Agents|sensory system agents|mesh-ancestor
6181607|NCT01764464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6181608|NCT01764464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181609|NCT01764464|Anticonvulsants|anticonvulsants|mesh-ancestor
6181610|NCT01764464|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6181611|NCT01764464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6181612|NCT01764464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6181613|NCT01764464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6181614|NCT01764464|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6670970|NCT01546896|GABA Agents|gaba agents|mesh-ancestor
6670971|NCT01546896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6670972|NCT01546896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670973|NCT01546896|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5604583|NCT04593940|Antimetabolites|antimetabolites|mesh-ancestor
6181615|NCT01764464|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5604584|NCT04593940|Antiviral Agents|antiviral agents|mesh-ancestor
6181616|NCT01764464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6181617|NCT01764464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181618|NCT01764464|Antimanic Agents|antimanic agents|mesh-ancestor
6181619|NCT01764607|Sirolimus|sirolimus|mesh-list
6181620|NCT01764607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6181621|NCT01764607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6181622|NCT01764607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6181623|NCT01764607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6181624|NCT01764607|Antifungal Agents|antifungal agents|mesh-ancestor
6181625|NCT01764607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5576464|NCT03884530|Aspirin|aspirin|mesh-list
5576465|NCT03884530|Ticagrelor|ticagrelor|mesh-list
5576466|NCT03884530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5576467|NCT03884530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5576468|NCT03884530|Analgesics|analgesics|mesh-ancestor
5576469|NCT03884530|Sensory System Agents|sensory system agents|mesh-ancestor
5576470|NCT03884530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5576471|NCT03884530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576472|NCT03884530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5576473|NCT03884530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5576474|NCT03884530|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6181626|NCT01764607|Immunologic Factors|immunologic factors|mesh-ancestor
6181627|NCT01764607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206729|NCT02104804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6206730|NCT02104804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206731|NCT02104830|Lenograstim|lenograstim|mesh-list
6206732|NCT02104830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6206733|NCT02104830|Immunologic Factors|immunologic factors|mesh-ancestor
6206734|NCT02104830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207913|NCT02121483|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6207914|NCT02121483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488003|NCT00580112|Antiemetics|antiemetics|mesh-ancestor
6488004|NCT00580112|Autonomic Agents|autonomic agents|mesh-ancestor
5576475|NCT03884530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5576476|NCT03884530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5576477|NCT03884530|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6488005|NCT00580112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6488006|NCT00580112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488007|NCT00580112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6488008|NCT00580112|Glucocorticoids|glucocorticoids|mesh-ancestor
6488009|NCT00580112|Hormones|hormones|mesh-ancestor
6488010|NCT00580112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6489031|NCT00588913|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6670974|NCT01546896|Serotonin Agents|serotonin agents|mesh-ancestor
6207915|NCT02121483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6207916|NCT02121483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207917|NCT02121509|Metformin|metformin|mesh-list
6207918|NCT02121509|Linagliptin|linagliptin|mesh-list
6207919|NCT02121509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6207920|NCT02121509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207921|NCT02121509|Incretins|incretins|mesh-ancestor
5576478|NCT03884530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5576479|NCT03884530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6207922|NCT02121509|Hormones|hormones|mesh-ancestor
6207923|NCT02121509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6207924|NCT02121509|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6207925|NCT02121509|Protease Inhibitors|protease inhibitors|mesh-ancestor
6207926|NCT02121509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6207927|NCT02121509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207928|NCT02121756|Dipyridamole|dipyridamole|mesh-list
6207929|NCT02121756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6207930|NCT02121756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6207931|NCT02121756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207932|NCT02121756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6207933|NCT02121756|Vasodilator Agents|vasodilator agents|mesh-ancestor
6207934|NCT02121795|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6207935|NCT02121795|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6207936|NCT02121795|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6207937|NCT02121795|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6670975|NCT01546909|Vaccines|vaccines|mesh-list
6670976|NCT01546909|Immunologic Factors|immunologic factors|mesh-ancestor
6670977|NCT01546909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6670978|NCT01546935|Oseltamivir|oseltamivir|mesh-list
5576480|NCT03884530|Antipyretics|antipyretics|mesh-ancestor
6670979|NCT01546935|Antiviral Agents|antiviral agents|mesh-ancestor
6670980|NCT01546935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6670981|NCT01546935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6670982|NCT01546935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6670983|NCT01546961|Chloroquine|chloroquine|mesh-list
6670984|NCT01546961|Amebicides|amebicides|mesh-ancestor
6670985|NCT01546961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6670986|NCT01546961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6670987|NCT01546961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6181628|NCT01764633|Evolocumab|evolocumab|mesh-list
6181629|NCT01764633|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6181630|NCT01764633|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6181631|NCT01764633|Antimetabolites|antimetabolites|mesh-ancestor
6181632|NCT01764633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181633|NCT01764633|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6181634|NCT01764685|Topiramate|topiramate|mesh-list
6181635|NCT01764685|Anticonvulsants|anticonvulsants|mesh-ancestor
6181636|NCT01764685|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6181637|NCT01764685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181638|NCT01764841|Ciprofloxacin|ciprofloxacin|mesh-list
6181639|NCT01764841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6181640|NCT01764841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6181641|NCT01764841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6181642|NCT01764841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6181643|NCT01764841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6181644|NCT01764841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181645|NCT01764841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6181646|NCT01764841|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6181647|NCT01764841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6181648|NCT01765179|Methyltestosterone|methyltestosterone|mesh-list
6181649|NCT01765179|Testosterone|testosterone|mesh-list
6181650|NCT01765179|Testosterone undecanoate|testosterone undecanoate|mesh-list
6181651|NCT01765179|Testosterone enanthate|testosterone enanthate|mesh-list
6181652|NCT01765179|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6181653|NCT01765179|Androgens|androgens|mesh-ancestor
6181654|NCT01765179|Hormones|hormones|mesh-ancestor
6181655|NCT01765179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6181656|NCT01765179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181657|NCT01765179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6181658|NCT01765179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6181659|NCT01765179|Anabolic Agents|anabolic agents|mesh-ancestor
6181660|NCT01765192|Montelukast|montelukast|mesh-list
6181661|NCT01765192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6181662|NCT01765192|Respiratory System Agents|respiratory system agents|mesh-ancestor
6181663|NCT01765192|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6181664|NCT01765192|Hormone Antagonists|hormone antagonists|mesh-ancestor
6181665|NCT01765192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6181666|NCT01765192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181667|NCT01765192|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6181668|NCT01765192|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6181669|NCT01765192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181670|NCT01765270|Saxagliptin|saxagliptin|mesh-list
6181671|NCT01765270|Incretins|incretins|mesh-ancestor
6181672|NCT01765270|Hormones|hormones|mesh-ancestor
6181673|NCT01765270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6181674|NCT01765270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181675|NCT01765270|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6181676|NCT01765270|Protease Inhibitors|protease inhibitors|mesh-ancestor
6181677|NCT01765270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6181678|NCT01765270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181679|NCT01765270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6181680|NCT01765543|Rifampin|rifampin|mesh-list
6181681|NCT01765543|Vemurafenib|vemurafenib|mesh-list
6181682|NCT01765543|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6181683|NCT01765543|Antitubercular Agents|antitubercular agents|mesh-ancestor
6181684|NCT01765543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6181685|NCT01765543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6181686|NCT01765543|Leprostatic Agents|leprostatic agents|mesh-ancestor
6181687|NCT01765543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6181688|NCT01765543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6181689|NCT01765543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181690|NCT01765543|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6670988|NCT01546961|Antimalarials|antimalarials|mesh-ancestor
6181691|NCT01765543|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6181692|NCT01765543|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6181693|NCT01765543|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6181694|NCT01765543|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6181695|NCT01765543|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6181696|NCT01765543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6181697|NCT01765543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6181698|NCT01765569|Vemurafenib|vemurafenib|mesh-list
6181699|NCT01765569|Digoxin|digoxin|mesh-list
6181700|NCT01765569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6181701|NCT01765569|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6181702|NCT01765569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6181703|NCT01765569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181704|NCT01765569|Protective Agents|protective agents|mesh-ancestor
6181705|NCT01765569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181706|NCT01765569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6181707|NCT01765569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6181708|NCT01765582|Leucovorin|leucovorin|mesh-list
6181709|NCT01765582|Folic Acid|folic acid|mesh-list
6181710|NCT01765582|Bevacizumab|bevacizumab|mesh-list
6181711|NCT01765582|Fluorouracil|fluorouracil|mesh-list
6181712|NCT01765582|Capecitabine|capecitabine|mesh-list
6181713|NCT01765582|Oxaliplatin|oxaliplatin|mesh-list
6181714|NCT01765582|Irinotecan|irinotecan|mesh-list
6181715|NCT01765582|Levoleucovorin|levoleucovorin|mesh-list
6181716|NCT01765582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6181717|NCT01765582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6181718|NCT01765582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6181719|NCT01765582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6181720|NCT01765582|Growth Substances|growth substances|mesh-ancestor
6181721|NCT01765582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181722|NCT01765582|Growth Inhibitors|growth inhibitors|mesh-ancestor
6181723|NCT01765582|Antimetabolites|antimetabolites|mesh-ancestor
6181724|NCT01765582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181725|NCT01765582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6181726|NCT01765582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6181727|NCT01765582|Immunologic Factors|immunologic factors|mesh-ancestor
6181728|NCT01765582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6181729|NCT01765582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6181730|NCT01765582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6181731|NCT01765582|Antidotes|antidotes|mesh-ancestor
6181732|NCT01765582|Protective Agents|protective agents|mesh-ancestor
6181733|NCT01765582|Vitamin B Complex|vitamin b complex|mesh-ancestor
6181734|NCT01765582|Vitamins|vitamins|mesh-ancestor
6181735|NCT01765582|Micronutrients|micronutrients|mesh-ancestor
6181736|NCT01765582|Hematinics|hematinics|mesh-ancestor
5576481|NCT03884530|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5576482|NCT03884530|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5576483|NCT03884530|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5576484|NCT03884530|Purinergic Agents|purinergic agents|mesh-ancestor
5576485|NCT03884530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5576486|NCT03884127|Orlistat|orlistat|mesh-list
5576487|NCT03884127|Ezetimibe|ezetimibe|mesh-list
5576488|NCT03884127|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5576489|NCT03884127|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6181737|NCT01765764|Bimatoprost|bimatoprost|mesh-list
6181738|NCT01765764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6181739|NCT01765764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6181740|NCT01765803|Thioridazine|thioridazine|mesh-list
6181741|NCT01765803|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6181742|NCT01765803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6181743|NCT01765803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5576490|NCT03884127|Antimetabolites|antimetabolites|mesh-ancestor
5576491|NCT03884127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5576492|NCT03884127|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5576493|NCT03884127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5576494|NCT03884127|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5576495|NCT03883841|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
5576496|NCT03883841|Hematinics|hematinics|mesh-ancestor
5576497|NCT03883880|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
5576498|NCT03883880|Capsaicin|capsaicin|mesh-list
5576499|NCT03883880|Antipruritics|antipruritics|mesh-ancestor
5576500|NCT03883880|Dermatologic Agents|dermatologic agents|mesh-ancestor
5576501|NCT03883880|Sensory System Agents|sensory system agents|mesh-ancestor
5576502|NCT03883880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6181744|NCT01765803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181745|NCT01765803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6181746|NCT01765803|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5576503|NCT03883880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181747|NCT01765803|Dopamine Agents|dopamine agents|mesh-ancestor
6181748|NCT01765803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6181749|NCT01765803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181750|NCT01766024|Interferons|interferons|mesh-list
6181751|NCT01766024|Interferon-beta|interferon-beta|mesh-list
6181752|NCT01766024|Interferon beta-1a|interferon beta-1a|mesh-list
6181753|NCT01766024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6181754|NCT01766024|Antiviral Agents|antiviral agents|mesh-ancestor
5576504|NCT03883880|Antioxidants|antioxidants|mesh-ancestor
5576505|NCT03883880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5576506|NCT03883880|Protective Agents|protective agents|mesh-ancestor
5576507|NCT03883880|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
5576508|NCT03883880|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5576509|NCT03883880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5576510|NCT03883880|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5576511|NCT03883919|Vitamin D|vitamin d|mesh-list
5576512|NCT03883919|Leucovorin|leucovorin|mesh-list
5576513|NCT03883919|Fluorouracil|fluorouracil|mesh-list
5576514|NCT03883919|Irinotecan|irinotecan|mesh-list
5576515|NCT03883919|Vitamins|vitamins|mesh-ancestor
6181755|NCT01766024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6181756|NCT01766024|Immunologic Factors|immunologic factors|mesh-ancestor
6181757|NCT01766024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181758|NCT01766024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6181759|NCT01766050|Abatacept|abatacept|mesh-list
6181760|NCT01766050|Losartan|losartan|mesh-list
6181761|NCT01766050|Midazolam|midazolam|mesh-list
6181762|NCT01766050|Dextromethorphan|dextromethorphan|mesh-list
6181763|NCT01766050|Caffeine|caffeine|mesh-list
6181764|NCT01766050|Omeprazole|omeprazole|mesh-list
6181765|NCT01766050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6181766|NCT01766050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6181767|NCT01766050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6181768|NCT01766050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181769|NCT01766050|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6181770|NCT01766050|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6181771|NCT01766050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6181772|NCT01766050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6181773|NCT01766050|Anesthetics, General|anesthetics, general|mesh-ancestor
6181774|NCT01766050|Anesthetics|anesthetics|mesh-ancestor
6181775|NCT01766050|GABA Modulators|gaba modulators|mesh-ancestor
6181776|NCT01766050|GABA Agents|gaba agents|mesh-ancestor
6181777|NCT01766050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6181778|NCT01766050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181779|NCT01766050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6181780|NCT01766050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6181781|NCT01766050|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6181782|NCT01766050|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6181783|NCT01766050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6181784|NCT01766050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6181785|NCT01766050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6181786|NCT01766050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6181787|NCT01766050|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6181788|NCT01766050|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6181789|NCT01766050|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6181790|NCT01766050|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6181791|NCT01766050|Purinergic Agents|purinergic agents|mesh-ancestor
6181792|NCT01766050|Antitussive Agents|antitussive agents|mesh-ancestor
6181793|NCT01766050|Respiratory System Agents|respiratory system agents|mesh-ancestor
6181794|NCT01766050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6181795|NCT01766050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6181796|NCT01766050|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6181797|NCT01766050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6181798|NCT01766050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6181799|NCT01766050|Immunologic Factors|immunologic factors|mesh-ancestor
6181800|NCT01766050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5576516|NCT03883919|Micronutrients|micronutrients|mesh-ancestor
5576517|NCT03883919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576518|NCT03883919|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5576519|NCT03883919|Antimetabolites|antimetabolites|mesh-ancestor
5576520|NCT03883919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5576521|NCT03883919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6181801|NCT01766076|Atorvastatin|atorvastatin|mesh-list
6181802|NCT01766076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6181803|NCT01766076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5576522|NCT03883919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5576523|NCT03883919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5576524|NCT03883919|Immunologic Factors|immunologic factors|mesh-ancestor
5576525|NCT03883919|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6181804|NCT01766076|Antimetabolites|antimetabolites|mesh-ancestor
6181805|NCT01766076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181806|NCT01766076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6181807|NCT01766076|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6181808|NCT01766076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6181809|NCT01766219|Thioctic Acid|thioctic acid|mesh-list
6181810|NCT01766219|Antioxidants|antioxidants|mesh-ancestor
6181811|NCT01766219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181812|NCT01766219|Protective Agents|protective agents|mesh-ancestor
6181813|NCT01766219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181814|NCT01766219|Vitamin B Complex|vitamin b complex|mesh-ancestor
6181815|NCT01766219|Vitamins|vitamins|mesh-ancestor
6181816|NCT01766219|Micronutrients|micronutrients|mesh-ancestor
5576526|NCT03883919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5576527|NCT03883919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5576528|NCT03883919|Antidotes|antidotes|mesh-ancestor
6181817|NCT01766310|Folic Acid|folic acid|mesh-list
6181818|NCT01766310|Hematinics|hematinics|mesh-ancestor
6181819|NCT01766310|Vitamin B Complex|vitamin b complex|mesh-ancestor
6181820|NCT01766310|Vitamins|vitamins|mesh-ancestor
6181821|NCT01766310|Micronutrients|micronutrients|mesh-ancestor
6181822|NCT01766310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181823|NCT01766336|Inositol|inositol|mesh-list
6181824|NCT01766336|Vitamin B Complex|vitamin b complex|mesh-ancestor
6181825|NCT01766336|Vitamins|vitamins|mesh-ancestor
6181826|NCT01766336|Micronutrients|micronutrients|mesh-ancestor
6181827|NCT01766336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181828|NCT01766440|Calcitriol|calcitriol|mesh-list
6181829|NCT01766440|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6181830|NCT01766440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181831|NCT01766440|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6181832|NCT01766440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6181833|NCT01766440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181834|NCT01766440|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6181835|NCT01766440|Vitamins|vitamins|mesh-ancestor
6181836|NCT01766440|Micronutrients|micronutrients|mesh-ancestor
6181837|NCT01766440|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6181838|NCT01766466|Ticagrelor|ticagrelor|mesh-list
6181839|NCT01766466|Cangrelor|cangrelor|mesh-list
6181840|NCT01766466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6181841|NCT01766466|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6181842|NCT01766466|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6181843|NCT01766466|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6181844|NCT01766466|Purinergic Agents|purinergic agents|mesh-ancestor
6181845|NCT01766466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6181846|NCT01766466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181847|NCT01766466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181848|NCT01766713|Ezetimibe|ezetimibe|mesh-list
6670989|NCT01546961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6670990|NCT01546987|Leuprolide|leuprolide|mesh-list
6670991|NCT01546987|Goserelin|goserelin|mesh-list
6670992|NCT01546987|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6670993|NCT01546987|Flutamide|flutamide|mesh-list
6670994|NCT01546987|Bicalutamide|bicalutamide|mesh-list
6670995|NCT01546987|Buserelin|buserelin|mesh-list
6670996|NCT01546987|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6670997|NCT01546987|Fertility Agents|fertility agents|mesh-ancestor
6670998|NCT01546987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6670999|NCT01546987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671000|NCT01546987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6671001|NCT01546987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6671002|NCT01546987|Androgen Antagonists|androgen antagonists|mesh-ancestor
6671003|NCT01546987|Hormone Antagonists|hormone antagonists|mesh-ancestor
6671004|NCT01546987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6671005|NCT01546987|Luteolytic Agents|luteolytic agents|mesh-ancestor
6671006|NCT01546987|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6671007|NCT01546987|Contraceptive Agents|contraceptive agents|mesh-ancestor
6671008|NCT01546987|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6671009|NCT01547091|Antirheumatic Agents|antirheumatic agents|mesh-list
6671010|NCT01547104|Glimepiride|glimepiride|mesh-list
6671011|NCT01547104|Linagliptin|linagliptin|mesh-list
6671012|NCT01547104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6671013|NCT01547104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6181849|NCT01766713|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6672525|NCT01556737|Genistein|genistein|mesh-list
6671014|NCT01547104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576529|NCT03883919|Protective Agents|protective agents|mesh-ancestor
6181850|NCT01766713|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6181851|NCT01766713|Antimetabolites|antimetabolites|mesh-ancestor
6181852|NCT01766713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181853|NCT01766713|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6181854|NCT01766778|Metformin|metformin|mesh-list
6181855|NCT01766778|Vildagliptin|vildagliptin|mesh-list
6181856|NCT01766778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6181857|NCT01766778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576530|NCT03883919|Vitamin B Complex|vitamin b complex|mesh-ancestor
5576531|NCT03884101|Paclitaxel|paclitaxel|mesh-list
5576532|NCT03884101|Carboplatin|carboplatin|mesh-list
5576533|NCT03884101|Pembrolizumab|pembrolizumab|mesh-list
5576534|NCT03884101|Lenvatinib|lenvatinib|mesh-list
5576535|NCT03884101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5576536|NCT03884101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5576537|NCT03884101|Tubulin Modulators|tubulin modulators|mesh-ancestor
5576538|NCT03884101|Antimitotic Agents|antimitotic agents|mesh-ancestor
5576539|NCT03884101|Mitosis Modulators|mitosis modulators|mesh-ancestor
5576540|NCT03884101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5576541|NCT03884101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5576542|NCT03884101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5576543|NCT03884101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5576544|NCT03884036|Vitamin D|vitamin d|mesh-list
5576545|NCT03884036|Vitamins|vitamins|mesh-ancestor
5576546|NCT03884036|Micronutrients|micronutrients|mesh-ancestor
5576547|NCT03884036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576548|NCT03884036|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5576549|NCT03883984|Cysteamine|cysteamine|mesh-list
6181858|NCT01766778|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6181859|NCT01766778|Protease Inhibitors|protease inhibitors|mesh-ancestor
6181860|NCT01766778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6181861|NCT01766778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181862|NCT01767103|Deferiprone|deferiprone|mesh-list
6181863|NCT01767103|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6181864|NCT01767103|Chelating Agents|chelating agents|mesh-ancestor
6181865|NCT01767103|Sequestering Agents|sequestering agents|mesh-ancestor
6181866|NCT01767103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181867|NCT01767116|Ribavirin|ribavirin|mesh-list
6181868|NCT01767116|Antimetabolites|antimetabolites|mesh-ancestor
6181869|NCT01767116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181870|NCT01767116|Antiviral Agents|antiviral agents|mesh-ancestor
6181871|NCT01767116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6181872|NCT01767155|Doxorubicin|doxorubicin|mesh-list
6181873|NCT01767155|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6181874|NCT01767155|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6181875|NCT01767155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5576550|NCT03883984|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
5576551|NCT03883984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5576552|NCT03883776|Octreotide|octreotide|mesh-list
5576553|NCT03883776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5576554|NCT03883776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5576555|NCT03883776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5576556|NCT03883763|Bupivacaine|bupivacaine|mesh-list
5576557|NCT03883763|Anesthetics, Local|anesthetics, local|mesh-ancestor
5576558|NCT03883763|Anesthetics|anesthetics|mesh-ancestor
5576559|NCT03883763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5576560|NCT03883763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576561|NCT03883763|Sensory System Agents|sensory system agents|mesh-ancestor
5576562|NCT03883763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5576563|NCT03883893|Acetaminophen|acetaminophen|mesh-list
5576564|NCT03883893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5576565|NCT03883893|Analgesics|analgesics|mesh-ancestor
5576566|NCT03883893|Sensory System Agents|sensory system agents|mesh-ancestor
5576567|NCT03883893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5576568|NCT03883893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576569|NCT03883893|Antipyretics|antipyretics|mesh-ancestor
5576570|NCT03883412|Liraglutide|liraglutide|mesh-list
5576571|NCT03883412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5576572|NCT03883412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576573|NCT03883412|Incretins|incretins|mesh-ancestor
5576574|NCT03883412|Hormones|hormones|mesh-ancestor
5576575|NCT03883412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5576576|NCT03883347|Dexmedetomidine|dexmedetomidine|mesh-list
5576577|NCT03883347|Remifentanil|remifentanil|mesh-list
5576578|NCT03883347|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6181876|NCT01767155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6181877|NCT01767155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6181878|NCT01767155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6181879|NCT01767155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181880|NCT01767194|Sirolimus|sirolimus|mesh-list
6181881|NCT01767194|Irinotecan|irinotecan|mesh-list
6181882|NCT01767194|Camptothecin|camptothecin|mesh-list
6181883|NCT01767194|Temozolomide|temozolomide|mesh-list
6181884|NCT01767194|Dinutuximab|dinutuximab|mesh-list
6181885|NCT01767194|Sargramostim|sargramostim|mesh-list
6181886|NCT01767194|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6181887|NCT01767194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6181888|NCT01767194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6181889|NCT01767194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181890|NCT01767194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6181891|NCT01767194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6181892|NCT01767194|Alkylating Agents|alkylating agents|mesh-ancestor
6181893|NCT01767194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6181894|NCT01767194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6181895|NCT01767194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6181896|NCT01767194|Antifungal Agents|antifungal agents|mesh-ancestor
6181897|NCT01767194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6181898|NCT01767194|Immunologic Factors|immunologic factors|mesh-ancestor
6181899|NCT01767194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181900|NCT01767194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6181901|NCT01767285|Etonogestrel|etonogestrel|mesh-list
6181902|NCT01767285|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6181903|NCT01767285|Contraceptive Agents|contraceptive agents|mesh-ancestor
6181904|NCT01767285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6181905|NCT01767285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181906|NCT01767285|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6181907|NCT01767506|Azithromycin|azithromycin|mesh-list
6181908|NCT01767506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6181909|NCT01767506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6181910|NCT01767519|Solifenacin Succinate|solifenacin succinate|mesh-list
6181911|NCT01767519|Botulinum Toxins|botulinum toxins|mesh-list
6181912|NCT01767519|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6181913|NCT01767519|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5576579|NCT03883347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5576580|NCT03883347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576581|NCT03883347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5576582|NCT03883347|Analgesics|analgesics|mesh-ancestor
5576583|NCT03883347|Sensory System Agents|sensory system agents|mesh-ancestor
5576584|NCT03883347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5576585|NCT03883347|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6181914|NCT01767519|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6181915|NCT01767519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6181916|NCT01767519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181917|NCT01767519|Cholinergic Agents|cholinergic agents|mesh-ancestor
6181918|NCT01767519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6181919|NCT01767519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181920|NCT01767519|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6181921|NCT01767519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6181922|NCT01767519|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6181923|NCT01767519|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6181924|NCT01767519|Urological Agents|urological agents|mesh-ancestor
6181925|NCT01767701|Raltegravir Potassium|raltegravir potassium|mesh-list
6181926|NCT01767701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6181927|NCT01767701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6181928|NCT01767701|Antiviral Agents|antiviral agents|mesh-ancestor
6181929|NCT01767701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6181930|NCT01767701|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6181931|NCT01767701|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6181932|NCT01767701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6181933|NCT01767701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181934|NCT01767792|Bevacizumab|bevacizumab|mesh-list
5576586|NCT03883347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5576587|NCT03883347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5576588|NCT03883347|Adrenergic Agents|adrenergic agents|mesh-ancestor
5576589|NCT03883347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5576590|NCT03883347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5576591|NCT03883347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6181935|NCT01767792|Endothelial Growth Factors|endothelial growth factors|mesh-list
6181936|NCT01767792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6181937|NCT01767792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6181938|NCT01767792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6181939|NCT01767792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6181940|NCT01767792|Growth Substances|growth substances|mesh-ancestor
6181941|NCT01767792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181942|NCT01767792|Growth Inhibitors|growth inhibitors|mesh-ancestor
6181943|NCT01767909|Insulin|insulin|mesh-list
6181944|NCT01767909|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6181945|NCT01767909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6181946|NCT01767909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181947|NCT01767987|Ranolazine|ranolazine|mesh-list
6181948|NCT01767987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6181949|NCT01767987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6181950|NCT01767987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181951|NCT01768286|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
6181952|NCT01768286|Ledipasvir|ledipasvir|mesh-list
6181953|NCT01768286|Antiviral Agents|antiviral agents|mesh-ancestor
6181954|NCT01768286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6181955|NCT01768520|Celecoxib|celecoxib|mesh-list
6488011|NCT00580112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6488012|NCT00580112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6488013|NCT00580112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6488014|NCT00580112|Alkylating Agents|alkylating agents|mesh-ancestor
6488015|NCT00580112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488016|NCT00580190|Alprazolam|alprazolam|mesh-list
6488017|NCT00580190|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6488018|NCT00580190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6488019|NCT00580190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488020|NCT00580190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6488021|NCT00580190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6488022|NCT00580190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6488023|NCT00580190|GABA Modulators|gaba modulators|mesh-ancestor
6488024|NCT00580190|GABA Agents|gaba agents|mesh-ancestor
6488025|NCT00580190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6488026|NCT00580190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488027|NCT00580242|Lenalidomide|lenalidomide|mesh-list
6488028|NCT00580242|Bortezomib|bortezomib|mesh-list
6488029|NCT00580242|Immunologic Factors|immunologic factors|mesh-ancestor
6488030|NCT00580242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488031|NCT00580242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6488032|NCT00580242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5576592|NCT03883347|Narcotics|narcotics|mesh-ancestor
5576593|NCT03883360|Cannabidiol|cannabidiol|mesh-list
6181956|NCT01768520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6181957|NCT01768520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6181958|NCT01768520|Analgesics|analgesics|mesh-ancestor
5576594|NCT03883360|Anticonvulsants|anticonvulsants|mesh-ancestor
5576595|NCT03883698|Sofosbuvir|sofosbuvir|mesh-list
5576596|NCT03883698|Antiviral Agents|antiviral agents|mesh-ancestor
5576597|NCT03883698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6181959|NCT01768520|Sensory System Agents|sensory system agents|mesh-ancestor
6181960|NCT01768520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6181961|NCT01768520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181962|NCT01768520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6181963|NCT01768520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6181964|NCT01768520|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6181965|NCT01768520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5576598|NCT03883269|Ethanol|ethanol|mesh-list
5576599|NCT03883269|Clindamycin|clindamycin|mesh-list
5576600|NCT03883269|Clindamycin palmitate|clindamycin palmitate|mesh-list
5576601|NCT03883269|Clindamycin phosphate|clindamycin phosphate|mesh-list
5576602|NCT03883269|Erythromycin|erythromycin|mesh-list
5576603|NCT03883269|Erythromycin Estolate|erythromycin estolate|mesh-list
5576604|NCT03883269|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
5576605|NCT03883269|Erythromycin stearate|erythromycin stearate|mesh-list
5576606|NCT03883269|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5576607|NCT03883269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5576608|NCT03883269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5576609|NCT03883269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576610|NCT03883269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5576611|NCT03883269|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5576612|NCT03883269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5576613|NCT03883269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181966|NCT01768520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5576614|NCT03883269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5576615|NCT03883334|Inosine Pranobex|inosine pranobex|mesh-list
6181967|NCT01768520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181968|NCT01768559|Insulin|insulin|mesh-list
6181969|NCT01768559|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6181970|NCT01768559|Metformin|metformin|mesh-list
6181971|NCT01768559|Insulin Glargine|insulin glargine|mesh-list
6181972|NCT01768559|Insulin glulisine|insulin glulisine|mesh-list
6181973|NCT01768559|Lixisenatide|lixisenatide|mesh-list
6181974|NCT01768559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6181975|NCT01768559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181976|NCT01768572|Hydroxychloroquine|hydroxychloroquine|mesh-list
6181977|NCT01768572|Sulfasalazine|sulfasalazine|mesh-list
6181978|NCT01768572|Methotrexate|methotrexate|mesh-list
6181979|NCT01768572|Leflunomide|leflunomide|mesh-list
6181980|NCT01768572|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6181981|NCT01768572|Abortifacient Agents|abortifacient agents|mesh-ancestor
6181982|NCT01768572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6181983|NCT01768572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6181984|NCT01768572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6181985|NCT01768572|Antimetabolites|antimetabolites|mesh-ancestor
6181986|NCT01768572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6181987|NCT01768572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6181988|NCT01768572|Dermatologic Agents|dermatologic agents|mesh-ancestor
6181989|NCT01768572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6181990|NCT01768572|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6181991|NCT01768572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6181992|NCT01768572|Immunologic Factors|immunologic factors|mesh-ancestor
6181993|NCT01768572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6181994|NCT01768572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5576616|NCT03883334|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5576617|NCT03883334|Immunologic Factors|immunologic factors|mesh-ancestor
5576618|NCT03883334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576619|NCT03883334|Antiviral Agents|antiviral agents|mesh-ancestor
6181995|NCT01768572|Antimalarials|antimalarials|mesh-ancestor
6181996|NCT01768572|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6181997|NCT01768572|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6181998|NCT01768572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6181999|NCT01768572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6182000|NCT01768572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6182001|NCT01768572|Analgesics|analgesics|mesh-ancestor
6182002|NCT01768572|Sensory System Agents|sensory system agents|mesh-ancestor
6182003|NCT01768572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6182004|NCT01768572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6182005|NCT01768572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6182006|NCT01768637|Aspirin|aspirin|mesh-list
6182007|NCT01768637|Clopidogrel|clopidogrel|mesh-list
6182008|NCT01768637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6182009|NCT01768637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6182010|NCT01768637|Analgesics|analgesics|mesh-ancestor
6182011|NCT01768637|Sensory System Agents|sensory system agents|mesh-ancestor
6182012|NCT01768637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6182013|NCT01768637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182014|NCT01768637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6182015|NCT01768637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6182016|NCT01768637|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5576620|NCT03883334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5576621|NCT03883022|Vancomycin|vancomycin|mesh-list
5576622|NCT03883022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5576623|NCT03883022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6182017|NCT01768637|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6182018|NCT01768637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182019|NCT01768637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6182020|NCT01768637|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6182021|NCT01768637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6182022|NCT01768637|Antipyretics|antipyretics|mesh-ancestor
6182023|NCT01768637|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6182024|NCT01768637|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6182025|NCT01768637|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6182026|NCT01768637|Purinergic Agents|purinergic agents|mesh-ancestor
6182027|NCT01768637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6182028|NCT01768858|Adalimumab|adalimumab|mesh-list
6182029|NCT01768858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6182030|NCT01768858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6182031|NCT01769170|Cidofovir|cidofovir|mesh-list
6182032|NCT01769170|Brincidofovir|brincidofovir|mesh-list
5576624|NCT03883074|Magnesium trisilicate|magnesium trisilicate|mesh-list
6182033|NCT01769170|Antiviral Agents|antiviral agents|mesh-ancestor
6182034|NCT01769170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5576625|NCT03883074|Hyaluronic Acid|hyaluronic acid|mesh-list
5576626|NCT03883074|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5576627|NCT03883074|Immunologic Factors|immunologic factors|mesh-ancestor
5576628|NCT03883074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576629|NCT03883074|Viscosupplements|viscosupplements|mesh-ancestor
5576630|NCT03883074|Protective Agents|protective agents|mesh-ancestor
5576631|NCT03883074|Antacids|antacids|mesh-ancestor
5576632|NCT03883074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5576633|NCT03883074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5576634|NCT03883204|Risperidone|risperidone|mesh-list
5576635|NCT03883204|Aripiprazole|aripiprazole|mesh-list
5576636|NCT03883204|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5576637|NCT03883204|Serotonin Agents|serotonin agents|mesh-ancestor
5576638|NCT03883204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5576639|NCT03883204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5576640|NCT03883204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576641|NCT03883204|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5576642|NCT03883204|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5576643|NCT03883204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5576644|NCT03883204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5576645|NCT03883204|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5576646|NCT03883204|Dopamine Agents|dopamine agents|mesh-ancestor
5576647|NCT03883204|Antidepressive Agents|antidepressive agents|mesh-ancestor
6182035|NCT01769170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6182036|NCT01769170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182037|NCT01769209|Cytarabine|cytarabine|mesh-list
6671015|NCT01547104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6671016|NCT01547104|Immunologic Factors|immunologic factors|mesh-ancestor
6671017|NCT01547104|Incretins|incretins|mesh-ancestor
6671018|NCT01547104|Hormones|hormones|mesh-ancestor
6671019|NCT01547104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6671020|NCT01547104|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6671021|NCT01547104|Protease Inhibitors|protease inhibitors|mesh-ancestor
6671022|NCT01547104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6672526|NCT01556737|Daidzein|daidzein|mesh-list
6488033|NCT00580242|Growth Substances|growth substances|mesh-ancestor
6488034|NCT00580242|Growth Inhibitors|growth inhibitors|mesh-ancestor
6488035|NCT00580242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6488036|NCT00580320|Bortezomib|bortezomib|mesh-list
6488037|NCT00580320|Dacarbazine|dacarbazine|mesh-list
6488038|NCT00580320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6182038|NCT01769209|Dexamethasone|dexamethasone|mesh-list
6182039|NCT01769209|Doxorubicin|doxorubicin|mesh-list
6182040|NCT01769209|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6182041|NCT01769209|Methotrexate|methotrexate|mesh-list
6182042|NCT01769209|Vincristine|vincristine|mesh-list
6182043|NCT01769209|Bortezomib|bortezomib|mesh-list
6182044|NCT01769209|Asparaginase|asparaginase|mesh-list
6182045|NCT01769209|Pegaspargase|pegaspargase|mesh-list
6182046|NCT01769209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6488039|NCT00580320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6488040|NCT00580320|Alkylating Agents|alkylating agents|mesh-ancestor
6488041|NCT00580320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488042|NCT00580359|Capecitabine|capecitabine|mesh-list
6182047|NCT01769209|Antiemetics|antiemetics|mesh-ancestor
6182048|NCT01769209|Autonomic Agents|autonomic agents|mesh-ancestor
6182049|NCT01769209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6182050|NCT01769209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182051|NCT01769209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6182052|NCT01769209|Glucocorticoids|glucocorticoids|mesh-ancestor
5576648|NCT03883204|Dopamine Agonists|dopamine agonists|mesh-ancestor
5576649|NCT03883204|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5576650|NCT03883204|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5576651|NCT03883204|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5576652|NCT03883204|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5576653|NCT03882463|Insulin|insulin|mesh-list
5576654|NCT03882463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5576655|NCT03882463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576656|NCT03882710|Metoprolol|metoprolol|mesh-list
5576657|NCT03882710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5576658|NCT03882710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6182053|NCT01769209|Hormones|hormones|mesh-ancestor
6182054|NCT01769209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5576659|NCT03882710|Sympatholytics|sympatholytics|mesh-ancestor
5576660|NCT03882710|Autonomic Agents|autonomic agents|mesh-ancestor
6182055|NCT01769209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6182056|NCT01769209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6206735|NCT02105272|Carteolol|carteolol|mesh-list
6182057|NCT01769209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6182058|NCT01769209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6182059|NCT01769209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6182060|NCT01769209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5576661|NCT03882710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5576662|NCT03882710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576663|NCT03882710|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5576664|NCT03882710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5576665|NCT03882710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5576666|NCT03882710|Adrenergic Agents|adrenergic agents|mesh-ancestor
5576667|NCT03882710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5576668|NCT03882710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5576669|NCT03882814|Meperidine|meperidine|mesh-list
5576670|NCT03882814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5576671|NCT03882814|Narcotics|narcotics|mesh-ancestor
6182061|NCT01769209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182062|NCT01769209|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6182063|NCT01769209|Abortifacient Agents|abortifacient agents|mesh-ancestor
6182064|NCT01769209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6182065|NCT01769209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6182066|NCT01769209|Antimetabolites|antimetabolites|mesh-ancestor
6182067|NCT01769209|Dermatologic Agents|dermatologic agents|mesh-ancestor
6182068|NCT01769209|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6182069|NCT01769209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6182070|NCT01769209|Immunologic Factors|immunologic factors|mesh-ancestor
6182071|NCT01769209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6182072|NCT01769209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6182073|NCT01769209|Antiviral Agents|antiviral agents|mesh-ancestor
6182074|NCT01769209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6182075|NCT01769209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6182076|NCT01769209|Tubulin Modulators|tubulin modulators|mesh-ancestor
6182077|NCT01769209|Antimitotic Agents|antimitotic agents|mesh-ancestor
6182078|NCT01769209|Mitosis Modulators|mitosis modulators|mesh-ancestor
6182079|NCT01769222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6182080|NCT01769222|Ipilimumab|ipilimumab|mesh-list
6182081|NCT01769222|Antibodies|antibodies|mesh-list
6182082|NCT01769222|Immunoglobulins|immunoglobulins|mesh-list
6182083|NCT01769222|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6182084|NCT01769222|Immunologic Factors|immunologic factors|mesh-ancestor
6182085|NCT01769222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182086|NCT01769222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6182087|NCT01769222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6182088|NCT01769222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182089|NCT01769339|Miconazole|miconazole|mesh-list
6182090|NCT01769339|Hydrocortisone|hydrocortisone|mesh-list
6182091|NCT01769339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6182092|NCT01769339|Antifungal Agents|antifungal agents|mesh-ancestor
6182093|NCT01769339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6182094|NCT01769339|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6182095|NCT01769339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6182096|NCT01769339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6182097|NCT01769339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182098|NCT01769339|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6182099|NCT01769339|Hormone Antagonists|hormone antagonists|mesh-ancestor
6182100|NCT01769339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6182101|NCT01769339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182102|NCT01769339|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6182103|NCT01769339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6182104|NCT01769352|Prednisolone acetate|prednisolone acetate|mesh-list
6182105|NCT01769352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6182106|NCT01769365|Amoxicillin|amoxicillin|mesh-list
6182107|NCT01769365|Metronidazole|metronidazole|mesh-list
6182108|NCT01769365|Clarithromycin|clarithromycin|mesh-list
6182109|NCT01769365|Pantoprazole|pantoprazole|mesh-list
6182110|NCT01769365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6182111|NCT01769365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6182112|NCT01769365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6182113|NCT01769365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6182114|NCT01769365|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6182115|NCT01769365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5576672|NCT03882814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5576673|NCT03882814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576674|NCT03882814|Analgesics|analgesics|mesh-ancestor
5576675|NCT03882814|Sensory System Agents|sensory system agents|mesh-ancestor
5576676|NCT03882814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5576677|NCT03882814|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5576678|NCT03882775|Heparin|heparin|mesh-list
5576679|NCT03882775|Bivalirudin|bivalirudin|mesh-list
5576680|NCT03882775|Anticoagulants|anticoagulants|mesh-ancestor
5576681|NCT03882775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5576682|NCT03882775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5576683|NCT03882775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5576684|NCT03882775|Antithrombins|antithrombins|mesh-ancestor
5576685|NCT03882775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5576686|NCT03882775|Protease Inhibitors|protease inhibitors|mesh-ancestor
5576687|NCT03882775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5604585|NCT04593940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5604586|NCT04593940|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6182116|NCT01769365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182117|NCT01769365|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6182118|NCT01769365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6182119|NCT01769365|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6182120|NCT01769365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6182121|NCT01769365|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6182122|NCT01769378|Glimepiride|glimepiride|mesh-list
6182123|NCT01769378|Dulaglutide|dulaglutide|mesh-list
6182124|NCT01769378|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6182125|NCT01769378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6182126|NCT01769378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182127|NCT01769378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6182128|NCT01769378|Immunologic Factors|immunologic factors|mesh-ancestor
6182129|NCT01769391|Paclitaxel|paclitaxel|mesh-list
6182130|NCT01769391|Carboplatin|carboplatin|mesh-list
6182131|NCT01769391|Necitumumab|necitumumab|mesh-list
6182132|NCT01769391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6182133|NCT01769391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6182134|NCT01769391|Tubulin Modulators|tubulin modulators|mesh-ancestor
6182135|NCT01769391|Antimitotic Agents|antimitotic agents|mesh-ancestor
6182136|NCT01769391|Mitosis Modulators|mitosis modulators|mesh-ancestor
6182137|NCT01769391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182138|NCT01769391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6182139|NCT01769404|Insulin Glargine|insulin glargine|mesh-list
6182140|NCT01769404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6182141|NCT01769404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182142|NCT01769456|Tenofovir|tenofovir|mesh-list
6182143|NCT01769456|Emtricitabine|emtricitabine|mesh-list
6182144|NCT01769456|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6182145|NCT01769456|Antiviral Agents|antiviral agents|mesh-ancestor
6182146|NCT01769456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6182147|NCT01769456|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6182148|NCT01769456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6182149|NCT01769456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6182150|NCT01769456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182151|NCT01769456|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6182152|NCT01769456|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6182153|NCT01769469|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6182154|NCT01769469|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6182155|NCT01769469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6182156|NCT01769469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6182157|NCT01769469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182158|NCT01769469|Antiviral Agents|antiviral agents|mesh-ancestor
6182159|NCT01769469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6182160|NCT01769469|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6182161|NCT01769469|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6182162|NCT01769508|Fluorouracil|fluorouracil|mesh-list
6182163|NCT01769508|Oxaliplatin|oxaliplatin|mesh-list
5604587|NCT04593940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5604588|NCT04593940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5604589|NCT04585958|Trastuzumab|trastuzumab|mesh-list
5604590|NCT04585958|Olaparib|olaparib|mesh-list
5604591|NCT04585958|Camptothecin|camptothecin|mesh-list
5604592|NCT04585958|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
5604593|NCT04585958|Immunoconjugates|immunoconjugates|mesh-list
5604594|NCT04585958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5604595|NCT04585958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5604596|NCT04585958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5604597|NCT04585958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604598|NCT04585958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5576688|NCT03882788|Fentanyl|fentanyl|mesh-list
5576689|NCT03882788|Isoflurane|isoflurane|mesh-list
5576690|NCT03882788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5576691|NCT03882788|Narcotics|narcotics|mesh-ancestor
5576692|NCT03882788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5576693|NCT03882788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576694|NCT03882788|Analgesics|analgesics|mesh-ancestor
5576695|NCT03882788|Sensory System Agents|sensory system agents|mesh-ancestor
5576696|NCT03882788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5576697|NCT03882788|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5576698|NCT03882788|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5576699|NCT03882788|Anesthetics, General|anesthetics, general|mesh-ancestor
5576700|NCT03882788|Anesthetics|anesthetics|mesh-ancestor
5576701|NCT03882788|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5576702|NCT03882489|Chloroprocaine|chloroprocaine|mesh-list
5576703|NCT03882489|Anesthetics, Local|anesthetics, local|mesh-ancestor
5576704|NCT03882489|Anesthetics|anesthetics|mesh-ancestor
5576705|NCT03882489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5576706|NCT03882489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576707|NCT03882489|Sensory System Agents|sensory system agents|mesh-ancestor
5576708|NCT03882489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5576709|NCT03882541|Midazolam|midazolam|mesh-list
5576710|NCT03882541|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5576711|NCT03882541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5576712|NCT03882541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5576713|NCT03882541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576714|NCT03882541|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5576715|NCT03882541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5576716|NCT03882541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5576717|NCT03882541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5576718|NCT03882541|Anesthetics, General|anesthetics, general|mesh-ancestor
5576719|NCT03882541|Anesthetics|anesthetics|mesh-ancestor
5576720|NCT03882541|GABA Modulators|gaba modulators|mesh-ancestor
5576721|NCT03882541|GABA Agents|gaba agents|mesh-ancestor
5576722|NCT03882541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5576723|NCT03882541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5576724|NCT03882580|Antineoplastic Agents|antineoplastic agents|mesh-list
5576725|NCT03882099|Vitamin D|vitamin d|mesh-list
5576726|NCT03882099|Vitamins|vitamins|mesh-ancestor
5576727|NCT03882099|Micronutrients|micronutrients|mesh-ancestor
5576728|NCT03882099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576729|NCT03882099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5576730|NCT03882164|Tacrolimus|tacrolimus|mesh-list
5576731|NCT03882164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5576732|NCT03882164|Immunologic Factors|immunologic factors|mesh-ancestor
5576733|NCT03882164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576734|NCT03882164|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5576735|NCT03882164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5576736|NCT03882164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5576737|NCT03882307|Sofosbuvir|sofosbuvir|mesh-list
5576738|NCT03882307|Antiviral Agents|antiviral agents|mesh-ancestor
5576739|NCT03882307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5576740|NCT03882255|Propranolol|propranolol|mesh-list
5576741|NCT03882255|Ponesimod|ponesimod|mesh-list
5576742|NCT03882255|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5576743|NCT03882255|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5576744|NCT03882255|Adrenergic Agents|adrenergic agents|mesh-ancestor
5576745|NCT03882255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5576746|NCT03882255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5576747|NCT03882255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576748|NCT03882255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5576749|NCT03882255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5576750|NCT03882255|Vasodilator Agents|vasodilator agents|mesh-ancestor
5576751|NCT03882255|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5576752|NCT03882255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5576753|NCT03882255|Immunologic Factors|immunologic factors|mesh-ancestor
5576754|NCT03882008|Abatacept|abatacept|mesh-list
5576755|NCT03882008|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5576756|NCT03882008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5576757|NCT03882008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6182164|NCT01769508|Lapatinib|lapatinib|mesh-list
6182165|NCT01769508|Antimetabolites|antimetabolites|mesh-ancestor
6182166|NCT01769508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207938|NCT02121795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5576758|NCT03882008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5576759|NCT03882008|Immunologic Factors|immunologic factors|mesh-ancestor
5576760|NCT03882008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182167|NCT01769508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6182168|NCT01769508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6182169|NCT01769508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6182170|NCT01769508|Immunologic Factors|immunologic factors|mesh-ancestor
6182171|NCT01769508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182172|NCT01769508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6182173|NCT01769508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6182174|NCT01769586|Diphenhydramine|diphenhydramine|mesh-list
6182175|NCT01769586|Promethazine|promethazine|mesh-list
6182176|NCT01769586|Midazolam|midazolam|mesh-list
6182177|NCT01769586|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6182178|NCT01769586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6182179|NCT01769586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6182180|NCT01769586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182181|NCT01769586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6182182|NCT01769586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6182183|NCT01769586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6182184|NCT01769586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6182185|NCT01769586|Anesthetics, General|anesthetics, general|mesh-ancestor
6182186|NCT01769586|Anesthetics|anesthetics|mesh-ancestor
6182187|NCT01769586|GABA Modulators|gaba modulators|mesh-ancestor
6182188|NCT01769586|GABA Agents|gaba agents|mesh-ancestor
6182189|NCT01769586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6182190|NCT01769586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488043|NCT00580359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6488044|NCT00580359|Antimetabolites|antimetabolites|mesh-ancestor
5576761|NCT03882008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5576762|NCT03881995|Insulin Glargine|insulin glargine|mesh-list
5576763|NCT03881995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5576764|NCT03881995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576765|NCT03882060|Epoetin Alfa|epoetin alfa|mesh-list
5576766|NCT03882060|Hematinics|hematinics|mesh-ancestor
5576767|NCT03881943|Aspirin|aspirin|mesh-list
5576768|NCT03881943|Ticagrelor|ticagrelor|mesh-list
5576769|NCT03881943|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6488045|NCT00580359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488046|NCT00580359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6488047|NCT00580424|Norethindrone|norethindrone|mesh-list
6488048|NCT00580424|Norethindrone Acetate|norethindrone acetate|mesh-list
6488049|NCT00580424|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6488050|NCT00580424|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6488051|NCT00580424|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6488052|NCT00580424|Contraceptive Agents|contraceptive agents|mesh-ancestor
6488053|NCT00580424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6488054|NCT00580424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488055|NCT00580424|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5576770|NCT03881943|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5576771|NCT03881943|Analgesics|analgesics|mesh-ancestor
5576772|NCT03881943|Sensory System Agents|sensory system agents|mesh-ancestor
5576773|NCT03881943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5576774|NCT03881943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576775|NCT03881943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5576776|NCT03881943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5576777|NCT03881943|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5576778|NCT03881943|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5576779|NCT03881943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5576780|NCT03881943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5576781|NCT03881943|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5576782|NCT03881943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5576783|NCT03881943|Antipyretics|antipyretics|mesh-ancestor
5576784|NCT03881943|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5576785|NCT03881943|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5576786|NCT03881943|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5576787|NCT03881943|Purinergic Agents|purinergic agents|mesh-ancestor
5576788|NCT03881943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5576789|NCT03881904|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5576790|NCT03881904|Gestodene|gestodene|mesh-list
5576791|NCT03881904|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5576792|NCT03881904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6182191|NCT01769586|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6182192|NCT01769586|Anesthetics, Local|anesthetics, local|mesh-ancestor
6182193|NCT01769586|Sensory System Agents|sensory system agents|mesh-ancestor
6182194|NCT01769586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6182195|NCT01769586|Antiemetics|antiemetics|mesh-ancestor
6182196|NCT01769586|Autonomic Agents|autonomic agents|mesh-ancestor
6488056|NCT00580424|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6488057|NCT00580437|Dobutamine|dobutamine|mesh-list
6488058|NCT00580437|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6488059|NCT00580437|Sympathomimetics|sympathomimetics|mesh-ancestor
6488060|NCT00580437|Autonomic Agents|autonomic agents|mesh-ancestor
6488061|NCT00580437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6488062|NCT00580437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488063|NCT00580437|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6488064|NCT00580437|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6671023|NCT01547104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182197|NCT01769586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6182198|NCT01769586|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6182199|NCT01769586|Histamine Antagonists|histamine antagonists|mesh-ancestor
6182200|NCT01769586|Histamine Agents|histamine agents|mesh-ancestor
6182201|NCT01769586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5576793|NCT03881904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5576794|NCT03881904|Contraceptive Agents|contraceptive agents|mesh-ancestor
5576795|NCT03881904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5576796|NCT03881904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576797|NCT03881904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5576798|NCT03881904|Estrogens|estrogens|mesh-ancestor
5576799|NCT03881904|Hormones|hormones|mesh-ancestor
5576800|NCT03881904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5576801|NCT03881904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6182202|NCT01769586|Antipruritics|antipruritics|mesh-ancestor
6182203|NCT01769586|Dermatologic Agents|dermatologic agents|mesh-ancestor
6182204|NCT01770145|Levodopa|levodopa|mesh-list
6182205|NCT01770145|Carbidopa|carbidopa|mesh-list
6182206|NCT01770145|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
6182207|NCT01770145|Trimethobenzamide|trimethobenzamide|mesh-list
6182208|NCT01770145|Apomorphine|apomorphine|mesh-list
6182209|NCT01770145|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6182210|NCT01770145|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6182211|NCT01770145|Dopamine Agents|dopamine agents|mesh-ancestor
6182212|NCT01770145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6182213|NCT01770145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182214|NCT01770145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182215|NCT01770145|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6182216|NCT01770145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6182217|NCT01770145|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6182218|NCT01770145|Immunologic Factors|immunologic factors|mesh-ancestor
6182219|NCT01770145|Dopamine Agonists|dopamine agonists|mesh-ancestor
6182220|NCT01770145|Emetics|emetics|mesh-ancestor
6182221|NCT01770145|Autonomic Agents|autonomic agents|mesh-ancestor
6182222|NCT01770145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6182223|NCT01770145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6182224|NCT01770145|Antiemetics|antiemetics|mesh-ancestor
6182225|NCT01770353|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
6182226|NCT01770353|Hematinics|hematinics|mesh-ancestor
6182227|NCT01770353|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6182228|NCT01770353|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6206736|NCT02105272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6206737|NCT02105272|Latanoprost|latanoprost|mesh-list
5576802|NCT03881904|Progestins|progestins|mesh-ancestor
5576803|NCT03881644|Sumatriptan|sumatriptan|mesh-list
6206738|NCT02105272|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6206739|NCT02105272|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6206740|NCT02105272|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6206741|NCT02105272|Adrenergic Agents|adrenergic agents|mesh-ancestor
6206742|NCT02105272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6206743|NCT02105272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206744|NCT02105272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206745|NCT02105272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6206746|NCT02105272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6206747|NCT02105272|Sympatholytics|sympatholytics|mesh-ancestor
6206748|NCT02105272|Autonomic Agents|autonomic agents|mesh-ancestor
6206749|NCT02105272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6671024|NCT01547143|Cyclosporine|cyclosporine|mesh-list
6671025|NCT01547143|Dexamethasone|dexamethasone|mesh-list
6671026|NCT01547143|Etoposide|etoposide|mesh-list
6671027|NCT01547143|Cyclosporins|cyclosporins|mesh-list
6671028|NCT01547143|gamma-Globulins|gamma-globulins|mesh-list
6671029|NCT01547143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5576804|NCT03881644|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
6206750|NCT02105285|Carteolol|carteolol|mesh-list
6206751|NCT02105285|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6671030|NCT01547143|Antiemetics|antiemetics|mesh-ancestor
6671031|NCT01547143|Autonomic Agents|autonomic agents|mesh-ancestor
6671032|NCT01547143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6671033|NCT01547143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671034|NCT01547143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6671035|NCT01547143|Glucocorticoids|glucocorticoids|mesh-ancestor
6671036|NCT01547143|Hormones|hormones|mesh-ancestor
6671037|NCT01547143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6671038|NCT01547143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6671039|NCT01547143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6671040|NCT01547143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6671041|NCT01547143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671042|NCT01547143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5576805|NCT03881644|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6182229|NCT01770392|Rifampin|rifampin|mesh-list
6182230|NCT01770392|Nintedanib|nintedanib|mesh-list
6182231|NCT01770392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6182232|NCT01770392|Antitubercular Agents|antitubercular agents|mesh-ancestor
6182233|NCT01770392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6182234|NCT01770392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6182235|NCT01770392|Leprostatic Agents|leprostatic agents|mesh-ancestor
6182236|NCT01770392|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6182237|NCT01770392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6182238|NCT01770392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182239|NCT01770392|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6182240|NCT01770392|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6182241|NCT01770392|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6182242|NCT01770392|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6182243|NCT01770392|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6182244|NCT01770392|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6182245|NCT01770392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6182246|NCT01770392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5576806|NCT03881644|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5576807|NCT03881644|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5576808|NCT03881644|Serotonin Agents|serotonin agents|mesh-ancestor
5576809|NCT03881644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5576810|NCT03881644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5576811|NCT03881644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576812|NCT03881644|Growth Substances|growth substances|mesh-ancestor
5576813|NCT03881644|Vasodilator Agents|vasodilator agents|mesh-ancestor
5576814|NCT03881696|Omalizumab|omalizumab|mesh-list
5576815|NCT03881696|Immunologic Factors|immunologic factors|mesh-list
5576816|NCT03881696|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5576817|NCT03881696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576818|NCT03881696|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5576819|NCT03881696|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5576820|NCT03881696|Respiratory System Agents|respiratory system agents|mesh-ancestor
5576821|NCT03881787|Cetuximab|cetuximab|mesh-list
5576822|NCT03881787|Antibodies|antibodies|mesh-list
5576823|NCT03881787|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5576824|NCT03881787|Immunologic Factors|immunologic factors|mesh-ancestor
5576825|NCT03881787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576826|NCT03881787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5576827|NCT03881787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5576828|NCT03881306|Oxaliplatin|oxaliplatin|mesh-list
5576829|NCT03881306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5576830|NCT03881423|Bromides|bromides|mesh-list
5576831|NCT03881423|Rocuronium|rocuronium|mesh-list
5576832|NCT03881423|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
5576833|NCT03881423|Anticonvulsants|anticonvulsants|mesh-ancestor
5576834|NCT03881423|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5576835|NCT03881423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5576836|NCT03881423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5576837|NCT03881423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576838|NCT03881293|Lidocaine|lidocaine|mesh-list
5576839|NCT03881293|Anesthetics, Local|anesthetics, local|mesh-ancestor
5576840|NCT03881293|Anesthetics|anesthetics|mesh-ancestor
5576841|NCT03881293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5576842|NCT03881293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576843|NCT03881293|Sensory System Agents|sensory system agents|mesh-ancestor
5576844|NCT03881293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5576845|NCT03881293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5576846|NCT03881293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5576847|NCT03881293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5576848|NCT03881293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5576849|NCT03881293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182247|NCT01770483|Interferons|interferons|mesh-list
6182248|NCT01770483|Ribavirin|ribavirin|mesh-list
6182249|NCT01770483|Interferon-alpha|interferon-alpha|mesh-list
6182250|NCT01770483|Nitazoxanide|nitazoxanide|mesh-list
6182251|NCT01770483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6182252|NCT01770483|Antiviral Agents|antiviral agents|mesh-ancestor
6182253|NCT01770483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6182254|NCT01770483|Antimetabolites|antimetabolites|mesh-ancestor
6182255|NCT01770483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182256|NCT01770483|Immunologic Factors|immunologic factors|mesh-ancestor
6182257|NCT01770483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182258|NCT01770483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6182259|NCT01770652|Deferiprone|deferiprone|mesh-list
6182260|NCT01770652|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6182261|NCT01770652|Chelating Agents|chelating agents|mesh-ancestor
6182262|NCT01770652|Sequestering Agents|sequestering agents|mesh-ancestor
6182263|NCT01770652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182264|NCT01770743|Vaccines|vaccines|mesh-list
6182265|NCT01770743|Immunologic Factors|immunologic factors|mesh-ancestor
6182266|NCT01770743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182267|NCT01770912|Triamcinolone|triamcinolone|mesh-list
6182268|NCT01770912|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6182269|NCT01770912|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6182270|NCT01770912|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6182271|NCT01770912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6182272|NCT01770912|Glucocorticoids|glucocorticoids|mesh-ancestor
5576850|NCT03881111|Pembrolizumab|pembrolizumab|mesh-list
5576851|NCT03881111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5576852|NCT03881111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5576853|NCT03881449|Aripiprazole|aripiprazole|mesh-list
5576854|NCT03881449|Antidepressive Agents|antidepressive agents|mesh-ancestor
5576855|NCT03881449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5576856|NCT03881449|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5576857|NCT03881449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5576858|NCT03881449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5576859|NCT03881449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576860|NCT03881449|Dopamine Agonists|dopamine agonists|mesh-ancestor
5576861|NCT03881449|Dopamine Agents|dopamine agents|mesh-ancestor
5576862|NCT03881449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5576863|NCT03881449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5576864|NCT03881449|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5576865|NCT03881449|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6182273|NCT01770912|Hormones|hormones|mesh-ancestor
6182274|NCT01770912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5576866|NCT03881449|Serotonin Agents|serotonin agents|mesh-ancestor
5576867|NCT03881449|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5576868|NCT03881449|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5576869|NCT03881449|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5576870|NCT03881449|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5576871|NCT03881345|Anticoagulants|anticoagulants|mesh-list
5576872|NCT03881319|Contraceptive Agents|contraceptive agents|mesh-list
5576873|NCT03881319|Contraceptives, Oral|contraceptives, oral|mesh-list
5576874|NCT03881319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5576875|NCT03881319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576876|NCT03881319|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5576877|NCT03880981|Acetaminophen|acetaminophen|mesh-list
5576878|NCT03880981|Ibuprofen|ibuprofen|mesh-list
5576879|NCT03880981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5576880|NCT03880981|Analgesics|analgesics|mesh-ancestor
5576881|NCT03880981|Sensory System Agents|sensory system agents|mesh-ancestor
6182275|NCT01770912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182276|NCT01770912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6182277|NCT01770912|Immunologic Factors|immunologic factors|mesh-ancestor
6182278|NCT01770912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6182279|NCT01770912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182280|NCT01771250|Insulin|insulin|mesh-list
6182281|NCT01771250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6182282|NCT01771250|Insulin Glargine|insulin glargine|mesh-list
6182283|NCT01771250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6182284|NCT01771250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182285|NCT01771627|Nicotine|nicotine|mesh-list
6182286|NCT01771627|Varenicline|varenicline|mesh-list
5576882|NCT03880981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6182287|NCT01771627|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6182288|NCT01771627|Autonomic Agents|autonomic agents|mesh-ancestor
6182289|NCT01771627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6182290|NCT01771627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182291|NCT01771627|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5576883|NCT03880981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576884|NCT03880981|Antipyretics|antipyretics|mesh-ancestor
5576885|NCT03880981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5576886|NCT03880981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5576887|NCT03880981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5576888|NCT03880981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5576889|NCT03880981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5576890|NCT03880981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604599|NCT04585958|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5604600|NCT04585958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5604601|NCT04585958|Immunologic Factors|immunologic factors|mesh-ancestor
5604602|NCT04585958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604603|NCT04580134|Risperidone|risperidone|mesh-list
5604604|NCT04580134|Clozapine|clozapine|mesh-list
5604605|NCT04580134|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5604606|NCT04580134|Serotonin Agents|serotonin agents|mesh-ancestor
5604607|NCT04580134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6182292|NCT01771627|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6182293|NCT01771627|Cholinergic Agents|cholinergic agents|mesh-ancestor
6182294|NCT01771627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6182295|NCT01771627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182296|NCT01771666|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
6182297|NCT01771666|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6182298|NCT01771666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182299|NCT01771952|Hyaluronic Acid|hyaluronic acid|mesh-list
5604608|NCT04580134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604609|NCT04580134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604610|NCT04580134|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5604611|NCT04580134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5604612|NCT04580134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5604613|NCT04580134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6182300|NCT01771952|Hylan|hylan|mesh-list
6182301|NCT01771952|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6182302|NCT01771952|Immunologic Factors|immunologic factors|mesh-ancestor
6182303|NCT01771952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182304|NCT01771952|Viscosupplements|viscosupplements|mesh-ancestor
6182305|NCT01771952|Protective Agents|protective agents|mesh-ancestor
6182306|NCT01772134|Fluticasone|fluticasone|mesh-list
6182307|NCT01772134|Xhance|xhance|mesh-list
6182308|NCT01772134|Bromides|bromides|mesh-list
6182309|NCT01772134|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6182310|NCT01772134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6182311|NCT01772134|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6182312|NCT01772134|Autonomic Agents|autonomic agents|mesh-ancestor
6182313|NCT01772134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6182314|NCT01772134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182315|NCT01772134|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6182316|NCT01772134|Respiratory System Agents|respiratory system agents|mesh-ancestor
6182317|NCT01772134|Dermatologic Agents|dermatologic agents|mesh-ancestor
6182318|NCT01772134|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6182319|NCT01772134|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6182320|NCT01772134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6182321|NCT01772134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6182322|NCT01772134|Adrenergic Agents|adrenergic agents|mesh-ancestor
6182323|NCT01772134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6182324|NCT01772134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182325|NCT01772134|Anticonvulsants|anticonvulsants|mesh-ancestor
6182326|NCT01772147|Fluticasone|fluticasone|mesh-list
6182327|NCT01772147|Xhance|xhance|mesh-list
6182328|NCT01772147|Bromides|bromides|mesh-list
6182329|NCT01772147|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6182330|NCT01772147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6182331|NCT01772147|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5604614|NCT04580134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5604615|NCT04580134|Dopamine Agents|dopamine agents|mesh-ancestor
5604616|NCT04580134|GABA Antagonists|gaba antagonists|mesh-ancestor
5604617|NCT04580134|GABA Agents|gaba agents|mesh-ancestor
5604618|NCT04567420|Fulvestrant|fulvestrant|mesh-list
5604619|NCT04567420|Palbociclib|palbociclib|mesh-list
5604620|NCT04567420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5604621|NCT04567420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6182332|NCT01772147|Autonomic Agents|autonomic agents|mesh-ancestor
6182333|NCT01772147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6182334|NCT01772147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182335|NCT01772147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6182336|NCT01772147|Respiratory System Agents|respiratory system agents|mesh-ancestor
5576891|NCT03880903|Albuterol|albuterol|mesh-list
5576892|NCT03880903|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5576893|NCT03880903|Autonomic Agents|autonomic agents|mesh-ancestor
5576894|NCT03880903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5576895|NCT03880903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576896|NCT03880903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5576897|NCT03880903|Respiratory System Agents|respiratory system agents|mesh-ancestor
5576898|NCT03880903|Tocolytic Agents|tocolytic agents|mesh-ancestor
5576899|NCT03880903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5576900|NCT03880903|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5576901|NCT03880903|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5576902|NCT03880903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6182337|NCT01772147|Dermatologic Agents|dermatologic agents|mesh-ancestor
6182338|NCT01772147|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6182339|NCT01772147|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6182340|NCT01772147|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6182341|NCT01772147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6182342|NCT01772147|Adrenergic Agents|adrenergic agents|mesh-ancestor
6182343|NCT01772147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6182344|NCT01772147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182345|NCT01772147|Anticonvulsants|anticonvulsants|mesh-ancestor
6182346|NCT01772368|Fluticasone|fluticasone|mesh-list
6182347|NCT01772368|Xhance|xhance|mesh-list
5576903|NCT03880903|Adrenergic Agents|adrenergic agents|mesh-ancestor
5576904|NCT03880903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5576905|NCT03880903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5576906|NCT03880968|Etanercept|etanercept|mesh-list
5576907|NCT03880968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6182348|NCT01772368|Albuterol|albuterol|mesh-list
6182349|NCT01772368|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6182350|NCT01772368|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6182351|NCT01772368|Adrenergic Agonists|adrenergic agonists|mesh-list
6182352|NCT01772368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6182353|NCT01772368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6182354|NCT01772368|Autonomic Agents|autonomic agents|mesh-ancestor
6182355|NCT01772368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6182356|NCT01772368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182357|NCT01772368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6182358|NCT01772368|Respiratory System Agents|respiratory system agents|mesh-ancestor
6182359|NCT01772368|Dermatologic Agents|dermatologic agents|mesh-ancestor
5576908|NCT03880968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5576909|NCT03880968|Analgesics|analgesics|mesh-ancestor
5576910|NCT03880968|Sensory System Agents|sensory system agents|mesh-ancestor
5576911|NCT03880968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5576912|NCT03880968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576913|NCT03880968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5576914|NCT03880968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5576915|NCT03880968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5576916|NCT03880968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5576917|NCT03880968|Immunologic Factors|immunologic factors|mesh-ancestor
5576918|NCT03880916|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5576919|NCT03880916|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6182360|NCT01772368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6182361|NCT01772368|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6182362|NCT01772368|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6182363|NCT01772368|Adrenergic Agents|adrenergic agents|mesh-ancestor
6182364|NCT01772368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6182365|NCT01772368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182366|NCT01772368|Tocolytic Agents|tocolytic agents|mesh-ancestor
6182367|NCT01772368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6182368|NCT01772368|Glucocorticoids|glucocorticoids|mesh-ancestor
6182369|NCT01772368|Hormones|hormones|mesh-ancestor
6182370|NCT01772368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6182371|NCT01772368|Sympathomimetics|sympathomimetics|mesh-ancestor
6182372|NCT01772537|Propofol|propofol|mesh-list
6182373|NCT01772537|Isoflurane|isoflurane|mesh-list
6182374|NCT01772537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6182375|NCT01772537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6182376|NCT01772537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182377|NCT01772537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6182378|NCT01772537|Anesthetics, General|anesthetics, general|mesh-ancestor
6182379|NCT01772537|Anesthetics|anesthetics|mesh-ancestor
5576920|NCT03880916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5576921|NCT03880916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5576922|NCT03880916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5576923|NCT03880916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5576924|NCT03880916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576925|NCT03880916|Analgesics|analgesics|mesh-ancestor
5576926|NCT03880916|Sensory System Agents|sensory system agents|mesh-ancestor
5576927|NCT03880916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5576928|NCT03880916|Antidepressive Agents|antidepressive agents|mesh-ancestor
5576929|NCT03880916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5576930|NCT03880916|Dopamine Agents|dopamine agents|mesh-ancestor
5576931|NCT03880734|Cholecalciferol|cholecalciferol|mesh-list
5576932|NCT03880734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5576933|NCT03880734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576934|NCT03880734|Vitamins|vitamins|mesh-ancestor
5576935|NCT03880734|Micronutrients|micronutrients|mesh-ancestor
5576936|NCT03880734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5576937|NCT03880877|Leucovorin|leucovorin|mesh-list
5576938|NCT03880877|Antidotes|antidotes|mesh-ancestor
5576939|NCT03880877|Protective Agents|protective agents|mesh-ancestor
5576940|NCT03880877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576941|NCT03880877|Vitamin B Complex|vitamin b complex|mesh-ancestor
5576942|NCT03880877|Vitamins|vitamins|mesh-ancestor
5576943|NCT03880877|Micronutrients|micronutrients|mesh-ancestor
5576944|NCT03880695|Doxorubicin|doxorubicin|mesh-list
5576945|NCT03880695|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5576946|NCT03880695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5576947|NCT03880695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5576948|NCT03880695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5576949|NCT03880695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5576950|NCT03880695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5576951|NCT03880695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5576952|NCT03880448|Metronidazole|metronidazole|mesh-list
5576953|NCT03880448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5576954|NCT03880448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5576955|NCT03880448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5576956|NCT03880448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5576957|NCT03880539|Vancomycin|vancomycin|mesh-list
5576958|NCT03880539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5576959|NCT03880539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5576960|NCT03880487|Oxycodone|oxycodone|mesh-list
6182380|NCT01772537|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6182381|NCT01772758|Antioxidants|antioxidants|mesh-list
6182382|NCT01772758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5576961|NCT03880487|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6182383|NCT01772758|Protective Agents|protective agents|mesh-ancestor
6182384|NCT01772758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182385|NCT01772823|Tenofovir|tenofovir|mesh-list
6182386|NCT01772823|Emtricitabine|emtricitabine|mesh-list
6182387|NCT01772823|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6182388|NCT01772823|Antiviral Agents|antiviral agents|mesh-ancestor
6182389|NCT01772823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6182390|NCT01772823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6182391|NCT01772823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6182392|NCT01772823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6182393|NCT01772823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182394|NCT01772823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6182395|NCT01772823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6182396|NCT01773070|Ritonavir|ritonavir|mesh-list
6182397|NCT01773070|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6182398|NCT01773070|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6182399|NCT01773070|Protease Inhibitors|protease inhibitors|mesh-ancestor
6182400|NCT01773070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6182401|NCT01773070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182402|NCT01773070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6182403|NCT01773070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6182404|NCT01773070|Antiviral Agents|antiviral agents|mesh-ancestor
6182405|NCT01773070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6182406|NCT01773070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6182407|NCT01773070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6182408|NCT01773109|Irinotecan|irinotecan|mesh-list
6182409|NCT01773109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
6182410|NCT01773109|Etirinotecan pegol|etirinotecan pegol|mesh-list
6182411|NCT01773109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6182412|NCT01773109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5576962|NCT03880487|Narcotics|narcotics|mesh-ancestor
6182413|NCT01773109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671043|NCT01547143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6671044|NCT01547143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6671045|NCT01547143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6671046|NCT01547143|Immunologic Factors|immunologic factors|mesh-ancestor
6671047|NCT01547143|Antifungal Agents|antifungal agents|mesh-ancestor
6671048|NCT01547143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6671049|NCT01547143|Dermatologic Agents|dermatologic agents|mesh-ancestor
6671050|NCT01547143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6671051|NCT01547143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6671052|NCT01547169|Insulin|insulin|mesh-list
6671053|NCT01547169|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6671054|NCT01547169|Insulin Detemir|insulin detemir|mesh-list
5576963|NCT03880487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5576964|NCT03880487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576965|NCT03880487|Analgesics|analgesics|mesh-ancestor
5576966|NCT03880487|Sensory System Agents|sensory system agents|mesh-ancestor
5576967|NCT03880487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6671055|NCT01547169|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6671056|NCT01547169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671057|NCT01547221|Clotrimazole|clotrimazole|mesh-list
6671058|NCT01547221|Miconazole|miconazole|mesh-list
6671059|NCT01547221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6671060|NCT01547221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6671061|NCT01547221|Antifungal Agents|antifungal agents|mesh-ancestor
6671062|NCT01547221|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6671063|NCT01547221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6671064|NCT01547221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6671065|NCT01547221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671066|NCT01547221|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6671067|NCT01547221|Hormone Antagonists|hormone antagonists|mesh-ancestor
6671068|NCT01547221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6671069|NCT01547221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671070|NCT01547221|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6671071|NCT01547221|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6671072|NCT01547260|Gemcitabine|gemcitabine|mesh-list
6671073|NCT01547260|Lenalidomide|lenalidomide|mesh-list
6671074|NCT01547260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6671075|NCT01547260|Antimetabolites|antimetabolites|mesh-ancestor
6671076|NCT01547260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671077|NCT01547260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6671078|NCT01547260|Antiviral Agents|antiviral agents|mesh-ancestor
6671079|NCT01547260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5576968|NCT03880825|Metformin|metformin|mesh-list
6182414|NCT01773109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6182415|NCT01773109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6182416|NCT01773122|Dapsone|dapsone|mesh-list
6182417|NCT01773122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6182418|NCT01773122|Antimalarials|antimalarials|mesh-ancestor
6182419|NCT01773122|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6182420|NCT01773122|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6182421|NCT01773122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6182422|NCT01773122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6182423|NCT01773122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182424|NCT01773122|Leprostatic Agents|leprostatic agents|mesh-ancestor
6182425|NCT01773122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6182426|NCT01773473|Insulin|insulin|mesh-list
6182427|NCT01773473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6182428|NCT01773473|Insulin Lispro|insulin lispro|mesh-list
6182429|NCT01773473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6182430|NCT01773473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182431|NCT01773889|Interferon alpha-2|interferon alpha-2|mesh-list
6182432|NCT01773889|Denileukin diftitox|denileukin diftitox|mesh-list
6182433|NCT01773889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6182434|NCT01773889|Antiviral Agents|antiviral agents|mesh-ancestor
6182435|NCT01773889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6182436|NCT01773954|Aflibercept|aflibercept|mesh-list
6182437|NCT01773954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6182438|NCT01773954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6182439|NCT01773954|Growth Substances|growth substances|mesh-ancestor
6182440|NCT01773954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182441|NCT01773954|Growth Inhibitors|growth inhibitors|mesh-ancestor
6182442|NCT01773954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6182443|NCT01773993|Pregabalin|pregabalin|mesh-list
6182444|NCT01773993|Analgesics|analgesics|mesh-ancestor
6182445|NCT01773993|Sensory System Agents|sensory system agents|mesh-ancestor
6182446|NCT01773993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6182447|NCT01773993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182448|NCT01773993|Anticonvulsants|anticonvulsants|mesh-ancestor
6182449|NCT01773993|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6182450|NCT01773993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6182451|NCT01773993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182452|NCT01773993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6182453|NCT01773993|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5576969|NCT03880825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5576970|NCT03880825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576971|NCT03880357|Betamethasone|betamethasone|mesh-list
5576972|NCT03880357|Betamethasone Valerate|betamethasone valerate|mesh-list
5576973|NCT03880357|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5576974|NCT03880357|Betamethasone benzoate|betamethasone benzoate|mesh-list
5576975|NCT03880357|Calcipotriene|calcipotriene|mesh-list
5576976|NCT03880357|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
5576977|NCT03880357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5576978|NCT03880357|Glucocorticoids|glucocorticoids|mesh-ancestor
5576979|NCT03880357|Hormones|hormones|mesh-ancestor
5576980|NCT03880357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5576981|NCT03880357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576982|NCT03880357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5576983|NCT03880357|Respiratory System Agents|respiratory system agents|mesh-ancestor
5576984|NCT03880357|Dermatologic Agents|dermatologic agents|mesh-ancestor
5576985|NCT03880396|Cisplatin|cisplatin|mesh-list
6182454|NCT01773993|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6182455|NCT01773993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6182456|NCT01773993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6182457|NCT01774149|Diazepam|diazepam|mesh-list
6182458|NCT01774149|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6182459|NCT01774149|Anticonvulsants|anticonvulsants|mesh-ancestor
6182460|NCT01774149|Antiemetics|antiemetics|mesh-ancestor
6182461|NCT01774149|Autonomic Agents|autonomic agents|mesh-ancestor
6182462|NCT01774149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6182463|NCT01774149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182464|NCT01774149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6182465|NCT01774149|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5576986|NCT03880396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5576987|NCT03880409|Lidocaine|lidocaine|mesh-list
5576988|NCT03880409|Epinephrine|epinephrine|mesh-list
5576989|NCT03880409|Racepinephrine|racepinephrine|mesh-list
5576990|NCT03880409|Carticaine|carticaine|mesh-list
6182466|NCT01774149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6182467|NCT01774149|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6182468|NCT01774149|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6182469|NCT01774149|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6182470|NCT01774149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6182471|NCT01774149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6182472|NCT01774149|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6182473|NCT01774149|Anesthetics, General|anesthetics, general|mesh-ancestor
6182474|NCT01774149|Anesthetics|anesthetics|mesh-ancestor
6182475|NCT01774149|GABA Modulators|gaba modulators|mesh-ancestor
6182476|NCT01774149|GABA Agents|gaba agents|mesh-ancestor
6182477|NCT01774149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6182478|NCT01774149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182479|NCT01774305|Dexmedetomidine|dexmedetomidine|mesh-list
6182480|NCT01774305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6488065|NCT00580437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6488066|NCT00580437|Adrenergic Agents|adrenergic agents|mesh-ancestor
6488067|NCT00580437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6671080|NCT01547260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5576991|NCT03880409|Epinephryl borate|epinephryl borate|mesh-list
5576992|NCT03880409|Anesthetics, Local|anesthetics, local|mesh-ancestor
5576993|NCT03880409|Anesthetics|anesthetics|mesh-ancestor
5576994|NCT03880409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5576995|NCT03880409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5576996|NCT03880409|Sensory System Agents|sensory system agents|mesh-ancestor
5576997|NCT03880409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5576998|NCT03880409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5576999|NCT03880409|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5577000|NCT03880409|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5577001|NCT03880409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5577002|NCT03880409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577003|NCT03880409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5577004|NCT03880409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5577005|NCT03880409|Adrenergic Agents|adrenergic agents|mesh-ancestor
5577006|NCT03880409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5577007|NCT03880409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5577008|NCT03880409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5577009|NCT03880409|Autonomic Agents|autonomic agents|mesh-ancestor
5577010|NCT03880409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5577011|NCT03880409|Respiratory System Agents|respiratory system agents|mesh-ancestor
5577012|NCT03880409|Mydriatics|mydriatics|mesh-ancestor
5577013|NCT03880409|Sympathomimetics|sympathomimetics|mesh-ancestor
5577014|NCT03880409|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5577015|NCT03880045|Vasopressins|vasopressins|mesh-list
5577016|NCT03880045|Arginine Vasopressin|arginine vasopressin|mesh-list
5577017|NCT03880045|Hemostatics|hemostatics|mesh-ancestor
5577018|NCT03880045|Coagulants|coagulants|mesh-ancestor
5577019|NCT03880045|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5577020|NCT03880045|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5577021|NCT03880045|Natriuretic Agents|natriuretic agents|mesh-ancestor
6488068|NCT00580437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488069|NCT00580437|Protective Agents|protective agents|mesh-ancestor
6488070|NCT00580450|Thymalfasin|thymalfasin|mesh-list
6488071|NCT00580450|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6488072|NCT00580450|Immunologic Factors|immunologic factors|mesh-ancestor
6488073|NCT00580450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488074|NCT00580489|Fentanyl|fentanyl|mesh-list
6488075|NCT00580489|Morphine|morphine|mesh-list
6488076|NCT00580489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6488077|NCT00580489|Narcotics|narcotics|mesh-ancestor
6488078|NCT00580489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6488079|NCT00580489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488080|NCT00580489|Analgesics|analgesics|mesh-ancestor
6488081|NCT00580489|Sensory System Agents|sensory system agents|mesh-ancestor
6488082|NCT00580489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6488083|NCT00580489|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6488084|NCT00580489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6488085|NCT00580489|Anesthetics, General|anesthetics, general|mesh-ancestor
6488086|NCT00580489|Anesthetics|anesthetics|mesh-ancestor
6488087|NCT00580619|Methyldopa|methyldopa|mesh-list
6488088|NCT00580619|Trimethaphan|trimethaphan|mesh-list
6488089|NCT00580619|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
6488090|NCT00580619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182481|NCT01774305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6182482|NCT01774305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182483|NCT01774305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6182484|NCT01774305|Analgesics|analgesics|mesh-ancestor
6182485|NCT01774305|Sensory System Agents|sensory system agents|mesh-ancestor
6182486|NCT01774305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6182487|NCT01774305|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6182488|NCT01774305|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6182489|NCT01774305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6182490|NCT01774305|Adrenergic Agents|adrenergic agents|mesh-ancestor
6182491|NCT01774305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6182492|NCT01774305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182493|NCT01774591|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
6182494|NCT01774591|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6182495|NCT01774591|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6182496|NCT01774591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577022|NCT03880045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577023|NCT03879889|Nicotine|nicotine|mesh-list
5577024|NCT03879889|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5577025|NCT03879889|Autonomic Agents|autonomic agents|mesh-ancestor
5577026|NCT03879889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5577027|NCT03879889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577028|NCT03879889|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5577029|NCT03879889|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5577030|NCT03879889|Cholinergic Agents|cholinergic agents|mesh-ancestor
5577031|NCT03879889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5577032|NCT03879889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577033|NCT03880123|Ixazomib|ixazomib|mesh-list
6182497|NCT01774604|Indomethacin|indomethacin|mesh-list
6182498|NCT01774604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6182499|NCT01774604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6182500|NCT01774604|Analgesics|analgesics|mesh-ancestor
6182501|NCT01774604|Sensory System Agents|sensory system agents|mesh-ancestor
6182502|NCT01774604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6488091|NCT00580619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6488092|NCT00580619|Sympatholytics|sympatholytics|mesh-ancestor
5577034|NCT03880123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6182503|NCT01774604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182504|NCT01774604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6182505|NCT01774604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6182506|NCT01774604|Gout Suppressants|gout suppressants|mesh-ancestor
6182507|NCT01774604|Tocolytic Agents|tocolytic agents|mesh-ancestor
5577035|NCT03880123|Protease Inhibitors|protease inhibitors|mesh-ancestor
5577036|NCT03880123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5577037|NCT03880123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577038|NCT03879837|Fluticasone|fluticasone|mesh-list
5577039|NCT03879837|Xhance|xhance|mesh-list
5577040|NCT03879837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5577041|NCT03879837|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5577042|NCT03879837|Autonomic Agents|autonomic agents|mesh-ancestor
5577043|NCT03879837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5577044|NCT03879837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577045|NCT03879837|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5577046|NCT03879837|Respiratory System Agents|respiratory system agents|mesh-ancestor
6182508|NCT01774604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6182509|NCT01774604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6182510|NCT01774604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6182511|NCT01774604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182512|NCT01774786|Fluorouracil|fluorouracil|mesh-list
6182513|NCT01774786|Capecitabine|capecitabine|mesh-list
6182514|NCT01774786|Trastuzumab|trastuzumab|mesh-list
6182515|NCT01774786|Pertuzumab|pertuzumab|mesh-list
6182516|NCT01774786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6182517|NCT01774786|Antimetabolites|antimetabolites|mesh-ancestor
6182518|NCT01774786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182519|NCT01774786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6182520|NCT01774786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6182521|NCT01774786|Immunologic Factors|immunologic factors|mesh-ancestor
6182522|NCT01774786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182523|NCT01774786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6182524|NCT01774851|Paclitaxel|paclitaxel|mesh-list
6182525|NCT01774851|Trastuzumab|trastuzumab|mesh-list
6182526|NCT01774851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6182527|NCT01774851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6182528|NCT01774851|Tubulin Modulators|tubulin modulators|mesh-ancestor
6182529|NCT01774851|Antimitotic Agents|antimitotic agents|mesh-ancestor
6182530|NCT01774851|Mitosis Modulators|mitosis modulators|mesh-ancestor
6182531|NCT01774851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182532|NCT01774851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6182533|NCT01774903|Fentanyl|fentanyl|mesh-list
6182534|NCT01774903|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6182535|NCT01774903|Narcotics|narcotics|mesh-ancestor
6182536|NCT01774903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5577047|NCT03879837|Dermatologic Agents|dermatologic agents|mesh-ancestor
5577048|NCT03879837|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5577049|NCT03879811|Nivolumab|nivolumab|mesh-list
5577050|NCT03879811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5577051|NCT03879811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5577052|NCT03879811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5577053|NCT03879811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577054|NCT03879798|Irinotecan|irinotecan|mesh-list
5577055|NCT03879798|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5577056|NCT03879798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5577057|NCT03879798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5577058|NCT03879798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577059|NCT03879798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5577060|NCT03879707|Melatonin|melatonin|mesh-list
5577061|NCT03879707|Antioxidants|antioxidants|mesh-ancestor
5577062|NCT03879707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577063|NCT03879707|Protective Agents|protective agents|mesh-ancestor
5577064|NCT03879707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182537|NCT01774903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182538|NCT01774903|Analgesics|analgesics|mesh-ancestor
6182539|NCT01774903|Sensory System Agents|sensory system agents|mesh-ancestor
6182540|NCT01774903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6182541|NCT01774903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6182542|NCT01774903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5577065|NCT03879707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5577066|NCT03879577|Tamoxifen|tamoxifen|mesh-list
6182543|NCT01774903|Anesthetics, General|anesthetics, general|mesh-ancestor
6182544|NCT01774903|Anesthetics|anesthetics|mesh-ancestor
6182545|NCT01774929|Fentanyl|fentanyl|mesh-list
5577067|NCT03879577|Docetaxel|docetaxel|mesh-list
6182546|NCT01774929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6182547|NCT01774929|Narcotics|narcotics|mesh-ancestor
6182548|NCT01774929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6182549|NCT01774929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182550|NCT01774929|Analgesics|analgesics|mesh-ancestor
6182551|NCT01774929|Sensory System Agents|sensory system agents|mesh-ancestor
6182552|NCT01774929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6182553|NCT01774929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6182554|NCT01774929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6182555|NCT01774929|Anesthetics, General|anesthetics, general|mesh-ancestor
6182556|NCT01774929|Anesthetics|anesthetics|mesh-ancestor
6182557|NCT01774968|Insulin|insulin|mesh-list
6182558|NCT01774968|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6182559|NCT01774968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6182560|NCT01774968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182561|NCT01775124|Ranibizumab|ranibizumab|mesh-list
6182562|NCT01775124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6182563|NCT01775124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6182564|NCT01775124|Growth Substances|growth substances|mesh-ancestor
6182565|NCT01775124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182566|NCT01775124|Growth Inhibitors|growth inhibitors|mesh-ancestor
6182567|NCT01775124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5577068|NCT03879577|Trastuzumab|trastuzumab|mesh-list
5577069|NCT03879577|Letrozole|letrozole|mesh-list
5577070|NCT03879577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5577071|NCT03879577|Tubulin Modulators|tubulin modulators|mesh-ancestor
5577072|NCT03879577|Antimitotic Agents|antimitotic agents|mesh-ancestor
5577073|NCT03879577|Mitosis Modulators|mitosis modulators|mesh-ancestor
5577074|NCT03879577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577075|NCT03879577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5577076|NCT03879577|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5577077|NCT03879577|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5577078|NCT03879577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5577079|NCT03879577|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5577080|NCT03879577|Hormone Antagonists|hormone antagonists|mesh-ancestor
5577081|NCT03879577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6182568|NCT01775189|Naltrexone|naltrexone|mesh-list
6182569|NCT01775189|Oxycodone|oxycodone|mesh-list
6182570|NCT01775189|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5577082|NCT03879577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577083|NCT03879577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6182571|NCT01775189|Narcotics|narcotics|mesh-ancestor
6182572|NCT01775189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6182573|NCT01775189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182574|NCT01775189|Analgesics|analgesics|mesh-ancestor
6182575|NCT01775189|Sensory System Agents|sensory system agents|mesh-ancestor
6182576|NCT01775189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6182577|NCT01775189|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6182578|NCT01775189|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6182579|NCT01775501|Leucovorin|leucovorin|mesh-list
6182580|NCT01775501|Fluorouracil|fluorouracil|mesh-list
6182581|NCT01775501|Oxaliplatin|oxaliplatin|mesh-list
6182582|NCT01775501|Sorafenib|sorafenib|mesh-list
6182583|NCT01775501|Antimetabolites|antimetabolites|mesh-ancestor
6182584|NCT01775501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182585|NCT01775501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6182586|NCT01775501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6182587|NCT01775501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6182588|NCT01775501|Immunologic Factors|immunologic factors|mesh-ancestor
6182589|NCT01775501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182590|NCT01775501|Antidotes|antidotes|mesh-ancestor
5577084|NCT03879577|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5577085|NCT03879577|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5577086|NCT03879577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6182591|NCT01775501|Protective Agents|protective agents|mesh-ancestor
6182592|NCT01775501|Vitamin B Complex|vitamin b complex|mesh-ancestor
6182593|NCT01775501|Vitamins|vitamins|mesh-ancestor
5577087|NCT03879694|Octreotide|octreotide|mesh-list
5577088|NCT03879694|Sargramostim|sargramostim|mesh-list
5577089|NCT03879694|Freund's Adjuvant|freund's adjuvant|mesh-list
5577090|NCT03879694|Immunologic Factors|immunologic factors|mesh-ancestor
5577091|NCT03879694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577092|NCT03879694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6182594|NCT01775501|Micronutrients|micronutrients|mesh-ancestor
6182595|NCT01775501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6182596|NCT01775501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6182597|NCT01775787|Menthol|menthol|mesh-list
6182598|NCT01775787|Nicotine|nicotine|mesh-list
5577093|NCT03879694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5577094|NCT03879694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5577095|NCT03879694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6182599|NCT01775787|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6182600|NCT01775787|Autonomic Agents|autonomic agents|mesh-ancestor
6182601|NCT01775787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5577096|NCT03879746|Paroxetine|paroxetine|mesh-list
5577097|NCT03879746|Tamsulosin|tamsulosin|mesh-list
5577098|NCT03879746|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5577099|NCT03879746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5577100|NCT03879746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5577101|NCT03879746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577102|NCT03879746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5577103|NCT03879746|Serotonin Agents|serotonin agents|mesh-ancestor
5577104|NCT03879746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577105|NCT03879746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5577106|NCT03879746|Antidepressive Agents|antidepressive agents|mesh-ancestor
5577107|NCT03879746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5577108|NCT03879746|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5577109|NCT03879746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5577110|NCT03879746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5577111|NCT03879746|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5577112|NCT03879746|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5577113|NCT03879746|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5577114|NCT03879746|Adrenergic Agents|adrenergic agents|mesh-ancestor
5577115|NCT03879746|Urological Agents|urological agents|mesh-ancestor
5577116|NCT03879590|Budesonide|budesonide|mesh-list
5577117|NCT03879590|Doxofylline|doxofylline|mesh-list
5577118|NCT03879590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5577119|NCT03879590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5577120|NCT03879590|Autonomic Agents|autonomic agents|mesh-ancestor
5577121|NCT03879590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5577122|NCT03879590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577123|NCT03879590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5577124|NCT03879590|Respiratory System Agents|respiratory system agents|mesh-ancestor
5577125|NCT03879590|Glucocorticoids|glucocorticoids|mesh-ancestor
5577126|NCT03879590|Hormones|hormones|mesh-ancestor
6182602|NCT01775787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182603|NCT01775787|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6182604|NCT01775787|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5577127|NCT03879590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5577128|NCT03879590|Antitussive Agents|antitussive agents|mesh-ancestor
5577129|NCT03879590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5577130|NCT03879590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5577131|NCT03879590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577132|NCT03879460|Naltrexone|naltrexone|mesh-list
5577133|NCT03879460|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5577134|NCT03879460|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5577135|NCT03879460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577136|NCT03879460|Sensory System Agents|sensory system agents|mesh-ancestor
5577137|NCT03879460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5577138|NCT03879564|Ketamine|ketamine|mesh-list
5577139|NCT03879564|Analgesics|analgesics|mesh-ancestor
5577140|NCT03879564|Sensory System Agents|sensory system agents|mesh-ancestor
5577141|NCT03879564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5577142|NCT03879564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577143|NCT03879564|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6182605|NCT01775787|Cholinergic Agents|cholinergic agents|mesh-ancestor
6182606|NCT01775787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6182607|NCT01775787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182608|NCT01775787|Antipruritics|antipruritics|mesh-ancestor
6182609|NCT01775787|Dermatologic Agents|dermatologic agents|mesh-ancestor
6182610|NCT01775865|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
6182611|NCT01775865|Sodium Salicylate|sodium salicylate|mesh-list
6182612|NCT01775865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6182613|NCT01775865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6182614|NCT01775865|Analgesics|analgesics|mesh-ancestor
6182615|NCT01775865|Sensory System Agents|sensory system agents|mesh-ancestor
6182616|NCT01775865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6182617|NCT01775865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182618|NCT01775865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6182619|NCT01775865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6182620|NCT01775865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6182621|NCT01775865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6182622|NCT01775865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182623|NCT01776008|Anastrozole|anastrozole|mesh-list
6182624|NCT01776008|Goserelin|goserelin|mesh-list
6182625|NCT01776008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6182626|NCT01776008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6671081|NCT01547260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5577144|NCT03879564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5577145|NCT03879564|Anesthetics, General|anesthetics, general|mesh-ancestor
5577146|NCT03879564|Anesthetics|anesthetics|mesh-ancestor
5577147|NCT03879564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5577148|NCT03879564|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5577149|NCT03879564|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5577150|NCT03879564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5577151|NCT03879564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577152|NCT03879486|Povidone-Iodine|povidone-iodine|mesh-list
5577153|NCT03879486|Formaldehyde|formaldehyde|mesh-list
5577154|NCT03879486|Povidone|povidone|mesh-list
5577155|NCT03879486|Plasma Substitutes|plasma substitutes|mesh-ancestor
5577156|NCT03879486|Blood Substitutes|blood substitutes|mesh-ancestor
5577157|NCT03879486|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5577158|NCT03879486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5577159|NCT03879486|Disinfectants|disinfectants|mesh-ancestor
6671082|NCT01547260|Immunologic Factors|immunologic factors|mesh-ancestor
6671083|NCT01547260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671084|NCT01547260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6671085|NCT01547260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6671086|NCT01547260|Growth Substances|growth substances|mesh-ancestor
6671087|NCT01547260|Growth Inhibitors|growth inhibitors|mesh-ancestor
6672527|NCT01556737|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6672528|NCT01556737|Protective Agents|protective agents|mesh-ancestor
6672529|NCT01556737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672530|NCT01556737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6672531|NCT01556737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6672532|NCT01556737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6672533|NCT01556737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672534|NCT01556737|Phytoestrogens|phytoestrogens|mesh-ancestor
6672535|NCT01556737|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6672536|NCT01556737|Estrogens|estrogens|mesh-ancestor
6672537|NCT01556737|Hormones|hormones|mesh-ancestor
6672538|NCT01556737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5577160|NCT03879356|Acetylcysteine|acetylcysteine|mesh-list
5577161|NCT03879356|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5577162|NCT03879356|Antiviral Agents|antiviral agents|mesh-ancestor
5577163|NCT03879356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5577164|NCT03879356|Expectorants|expectorants|mesh-ancestor
5577165|NCT03879356|Respiratory System Agents|respiratory system agents|mesh-ancestor
5577166|NCT03879356|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5577167|NCT03879356|Antioxidants|antioxidants|mesh-ancestor
6672539|NCT01556815|Sorafenib|sorafenib|mesh-list
6672540|NCT01556815|Chlorotrianisene|chlorotrianisene|mesh-list
6672541|NCT01556815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6672542|NCT01556815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6672543|NCT01556815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6672544|NCT01556815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577168|NCT03879356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577169|NCT03879356|Protective Agents|protective agents|mesh-ancestor
5577170|NCT03879356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182627|NCT01776008|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6182628|NCT01776008|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6182629|NCT01776008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6182630|NCT01776008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182631|NCT01776008|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6182632|NCT01776008|Hormone Antagonists|hormone antagonists|mesh-ancestor
6182633|NCT01776008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5577171|NCT03879356|Antidotes|antidotes|mesh-ancestor
5577172|NCT03879382|Cyclophosphamide|cyclophosphamide|mesh-list
5577173|NCT03879382|Fludarabine|fludarabine|mesh-list
5577174|NCT03879382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5577175|NCT03879382|Immunologic Factors|immunologic factors|mesh-ancestor
6182634|NCT01776008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182635|NCT01776307|Capecitabine|capecitabine|mesh-list
6182636|NCT01776307|Cetuximab|cetuximab|mesh-list
6182637|NCT01776307|Panitumumab|panitumumab|mesh-list
6182638|NCT01776307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6182639|NCT01776307|Antimetabolites|antimetabolites|mesh-ancestor
6182640|NCT01776307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182641|NCT01776307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6182642|NCT01776307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6182643|NCT01776424|Aspirin|aspirin|mesh-list
6182644|NCT01776424|Pantoprazole|pantoprazole|mesh-list
6182645|NCT01776424|Rivaroxaban|rivaroxaban|mesh-list
6182646|NCT01776424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6182647|NCT01776424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6182648|NCT01776424|Analgesics|analgesics|mesh-ancestor
6182649|NCT01776424|Sensory System Agents|sensory system agents|mesh-ancestor
6182650|NCT01776424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6182651|NCT01776424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182652|NCT01776424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6182653|NCT01776424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6182654|NCT01776424|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6182655|NCT01776424|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6182656|NCT01776424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182657|NCT01776424|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6182658|NCT01776424|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6182659|NCT01776424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6182660|NCT01776424|Antipyretics|antipyretics|mesh-ancestor
5577176|NCT03879382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577177|NCT03879382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5577178|NCT03879382|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5577179|NCT03879382|Alkylating Agents|alkylating agents|mesh-ancestor
5577180|NCT03879382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577181|NCT03879382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5577182|NCT03879382|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5577183|NCT03879174|Tamoxifen|tamoxifen|mesh-list
5577184|NCT03879174|Pembrolizumab|pembrolizumab|mesh-list
5577185|NCT03879174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5577186|NCT03879174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5577187|NCT03879174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6182661|NCT01776424|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6182662|NCT01776424|Antithrombins|antithrombins|mesh-ancestor
6182663|NCT01776424|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6182664|NCT01776424|Protease Inhibitors|protease inhibitors|mesh-ancestor
6182665|NCT01776424|Anticoagulants|anticoagulants|mesh-ancestor
6182666|NCT01776424|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6182667|NCT01776424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6182668|NCT01776424|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6182669|NCT01777139|Ezogabine|ezogabine|mesh-list
6182670|NCT01777139|Anticonvulsants|anticonvulsants|mesh-ancestor
6182671|NCT01777139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6182672|NCT01777139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182673|NCT01777152|Prednisone|prednisone|mesh-list
6182674|NCT01777152|Cyclophosphamide|cyclophosphamide|mesh-list
6182675|NCT01777152|Doxorubicin|doxorubicin|mesh-list
6182676|NCT01777152|Vincristine|vincristine|mesh-list
6182677|NCT01777152|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6182678|NCT01777152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6182679|NCT01777152|Immunologic Factors|immunologic factors|mesh-ancestor
6182680|NCT01777152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182681|NCT01777152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6182682|NCT01777152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6182683|NCT01777152|Alkylating Agents|alkylating agents|mesh-ancestor
6182684|NCT01777152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182685|NCT01777152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6182686|NCT01777152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6182687|NCT01777152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6182688|NCT01777152|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6182689|NCT01777152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6182690|NCT01777152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6182691|NCT01777152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5577188|NCT03879174|Hormone Antagonists|hormone antagonists|mesh-ancestor
5577189|NCT03879174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5577190|NCT03879174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577191|NCT03879174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5577192|NCT03879174|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5577193|NCT03879174|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6182692|NCT01777152|Glucocorticoids|glucocorticoids|mesh-ancestor
6182693|NCT01777152|Hormones|hormones|mesh-ancestor
6182694|NCT01777152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6206752|NCT02105285|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6182695|NCT01777152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6182696|NCT01777152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6182697|NCT01777152|Tubulin Modulators|tubulin modulators|mesh-ancestor
6182698|NCT01777152|Antimitotic Agents|antimitotic agents|mesh-ancestor
5577194|NCT03879174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5577195|NCT03879122|Docetaxel|docetaxel|mesh-list
5577196|NCT03879122|Nivolumab|nivolumab|mesh-list
5577197|NCT03879122|Ipilimumab|ipilimumab|mesh-list
5577198|NCT03879122|Androgens|androgens|mesh-list
5577199|NCT03879122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5577200|NCT03879122|Tubulin Modulators|tubulin modulators|mesh-ancestor
5577201|NCT03879122|Antimitotic Agents|antimitotic agents|mesh-ancestor
5577202|NCT03879122|Mitosis Modulators|mitosis modulators|mesh-ancestor
5577203|NCT03879122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577204|NCT03879122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5577205|NCT03879122|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5577206|NCT03879122|Hormones|hormones|mesh-ancestor
5577207|NCT03879122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5577208|NCT03879122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604622|NCT04567420|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5604623|NCT04567420|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5604624|NCT04567420|Hormone Antagonists|hormone antagonists|mesh-ancestor
5604625|NCT04567420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5604626|NCT04567420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604627|NCT04567420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5604628|NCT04567420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5604629|NCT04567420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604630|NCT04555811|Rituximab|rituximab|mesh-list
5604631|NCT04555811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5604632|NCT04555811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5604633|NCT04555811|Immunologic Factors|immunologic factors|mesh-ancestor
5604634|NCT04555811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604635|NCT04555811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5604636|NCT04545424|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
5604637|NCT04545424|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5604638|NCT04545424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5604639|NCT04545424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604640|NCT04543383|Thrombin|thrombin|mesh-list
5604641|NCT04543383|Hemostatics|hemostatics|mesh-ancestor
5604642|NCT04543383|Coagulants|coagulants|mesh-ancestor
5604643|NCT04529720|Vaccines|vaccines|mesh-list
5604644|NCT04529720|Immunologic Factors|immunologic factors|mesh-ancestor
5604645|NCT04529720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604646|NCT04522284|Capecitabine|capecitabine|mesh-list
5604647|NCT04522284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6182699|NCT01777152|Mitosis Modulators|mitosis modulators|mesh-ancestor
6182700|NCT01777152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6182701|NCT01777191|Ixekizumab|ixekizumab|mesh-list
6182702|NCT01777191|Dermatologic Agents|dermatologic agents|mesh-ancestor
6182703|NCT01777217|Solifenacin Succinate|solifenacin succinate|mesh-list
6182704|NCT01777217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6182705|NCT01777217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6182706|NCT01777217|Cholinergic Agents|cholinergic agents|mesh-ancestor
6182707|NCT01777217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6182708|NCT01777217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182709|NCT01777217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182710|NCT01777217|Urological Agents|urological agents|mesh-ancestor
6182711|NCT01777269|Tamsulosin|tamsulosin|mesh-list
6182712|NCT01777269|Dutasteride|dutasteride|mesh-list
6182713|NCT01777269|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6182714|NCT01777269|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6182715|NCT01777269|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6182716|NCT01777269|Adrenergic Agents|adrenergic agents|mesh-ancestor
6182717|NCT01777269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6182718|NCT01777269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182719|NCT01777269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182720|NCT01777269|Urological Agents|urological agents|mesh-ancestor
6182721|NCT01777269|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
5604648|NCT04522284|Antimetabolites|antimetabolites|mesh-ancestor
5604649|NCT04522284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604650|NCT04522284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5604651|NCT04509791|Immunoglobulins|immunoglobulins|mesh-list
5604652|NCT04509791|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5604653|NCT04509791|Antibodies|antibodies|mesh-list
5577209|NCT03879278|Immunoglobulins|immunoglobulins|mesh-list
5577210|NCT03879278|Immunoglobulin G|immunoglobulin g|mesh-list
5577211|NCT03879278|Immunologic Factors|immunologic factors|mesh-ancestor
6182722|NCT01777269|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6182723|NCT01777269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6182724|NCT01777269|Hormone Antagonists|hormone antagonists|mesh-ancestor
6182725|NCT01777269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6182726|NCT01777282|Biguanides|biguanides|mesh-list
6182727|NCT01777282|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
6182728|NCT01777282|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
6182729|NCT01777282|rGLP-1 protein|rglp-1 protein|mesh-list
6182730|NCT01777282|Incretins|incretins|mesh-ancestor
6182731|NCT01777282|Hormones|hormones|mesh-ancestor
6182732|NCT01777282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6182733|NCT01777282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182734|NCT01777282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6182735|NCT01777282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5577212|NCT03879278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577213|NCT03879057|Antibodies|antibodies|mesh-list
5577214|NCT03879057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5577215|NCT03879057|Immunologic Factors|immunologic factors|mesh-ancestor
5577216|NCT03879057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577217|NCT03878888|Bupivacaine|bupivacaine|mesh-list
5577218|NCT03878888|Anesthetics, Local|anesthetics, local|mesh-ancestor
5577219|NCT03878888|Anesthetics|anesthetics|mesh-ancestor
5577220|NCT03878888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5577221|NCT03878888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577222|NCT03878888|Sensory System Agents|sensory system agents|mesh-ancestor
5577223|NCT03878888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5577229|NCT03879005|Technetium Tc 99m Dimercaptosuccinic Acid|technetium tc 99m dimercaptosuccinic acid|mesh-list
6182736|NCT01777282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206753|NCT02105285|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6206754|NCT02105285|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6206755|NCT02105285|Adrenergic Agents|adrenergic agents|mesh-ancestor
6206756|NCT02105285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6206757|NCT02105285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577230|NCT03879005|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5577231|NCT03879005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577232|NCT03878771|Clobetasol|clobetasol|mesh-list
5577233|NCT03878771|Benzocaine|benzocaine|mesh-list
5577234|NCT03878771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5577235|NCT03878771|Glucocorticoids|glucocorticoids|mesh-ancestor
5577236|NCT03878771|Hormones|hormones|mesh-ancestor
5577237|NCT03878771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5577238|NCT03878771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577239|NCT03878771|Anesthetics, Local|anesthetics, local|mesh-ancestor
5577240|NCT03878771|Anesthetics|anesthetics|mesh-ancestor
5577241|NCT03878771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5577242|NCT03878771|Sensory System Agents|sensory system agents|mesh-ancestor
5577243|NCT03878771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5577244|NCT03878784|Sumatriptan|sumatriptan|mesh-list
5577245|NCT03878784|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5577246|NCT03878784|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5577247|NCT03878784|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5577248|NCT03878784|Serotonin Agents|serotonin agents|mesh-ancestor
5577249|NCT03878784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5577250|NCT03878784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577251|NCT03878784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206758|NCT02105285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206759|NCT02105285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6206760|NCT02105285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6206761|NCT02105285|Sympatholytics|sympatholytics|mesh-ancestor
6206762|NCT02105285|Autonomic Agents|autonomic agents|mesh-ancestor
6206763|NCT02105285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6206764|NCT02105324|Pancrelipase|pancrelipase|mesh-list
6206765|NCT02105324|Pancreatin|pancreatin|mesh-list
6206766|NCT02105324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6206767|NCT02105415|Ketamine|ketamine|mesh-list
6206768|NCT02105415|Propofol|propofol|mesh-list
6206769|NCT02105415|Etomidate|etomidate|mesh-list
5577252|NCT03878654|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
5577253|NCT03878654|Antiviral Agents|antiviral agents|mesh-ancestor
5577254|NCT03878654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5577255|NCT03878654|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5577256|NCT03878654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5577257|NCT03878693|Fomepizole|fomepizole|mesh-list
5577258|NCT03878693|Antidotes|antidotes|mesh-ancestor
5577259|NCT03878693|Protective Agents|protective agents|mesh-ancestor
5577260|NCT03878693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182737|NCT01777334|Tiotropium Bromide|tiotropium bromide|mesh-list
6182738|NCT01777334|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6182739|NCT01777334|Autonomic Agents|autonomic agents|mesh-ancestor
6182740|NCT01777334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6182741|NCT01777334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182742|NCT01777334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6182743|NCT01777334|Respiratory System Agents|respiratory system agents|mesh-ancestor
6182744|NCT01777334|Parasympatholytics|parasympatholytics|mesh-ancestor
6182745|NCT01777334|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6182746|NCT01777334|Cholinergic Agents|cholinergic agents|mesh-ancestor
6182747|NCT01777334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6182748|NCT01777334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182749|NCT01777412|Bevacizumab|bevacizumab|mesh-list
6182750|NCT01777412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6182751|NCT01777412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6182752|NCT01777412|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6182753|NCT01777412|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6182754|NCT01777412|Growth Substances|growth substances|mesh-ancestor
6182755|NCT01777412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182756|NCT01777412|Growth Inhibitors|growth inhibitors|mesh-ancestor
6182757|NCT01777542|Insulin|insulin|mesh-list
6182758|NCT01777542|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6182759|NCT01777542|Mitogens|mitogens|mesh-list
6182760|NCT01777542|Mecasermin|mecasermin|mesh-list
6182761|NCT01777542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6182762|NCT01777542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182763|NCT01777542|Mitosis Modulators|mitosis modulators|mesh-ancestor
6182764|NCT01777542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182765|NCT01777542|Growth Substances|growth substances|mesh-ancestor
6182766|NCT01777581|Milnacipran|milnacipran|mesh-list
6182767|NCT01777581|Levomilnacipran|levomilnacipran|mesh-list
6182768|NCT01777581|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6182769|NCT01777581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6182770|NCT01777581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6182771|NCT01777581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182772|NCT01777581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6182773|NCT01777581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182774|NCT01777581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6182775|NCT01777581|Analgesics|analgesics|mesh-ancestor
6182776|NCT01777581|Sensory System Agents|sensory system agents|mesh-ancestor
6182777|NCT01777581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6182778|NCT01777581|Antidepressive Agents|antidepressive agents|mesh-ancestor
6671088|NCT01547312|Interferons|interferons|mesh-list
6671089|NCT01547312|Ribavirin|ribavirin|mesh-list
6671090|NCT01547312|Grazoprevir|grazoprevir|mesh-list
6671091|NCT01547312|Liver Extracts|liver extracts|mesh-list
6671092|NCT01547312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6671093|NCT01547312|Antiviral Agents|antiviral agents|mesh-ancestor
6671094|NCT01547312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6671095|NCT01547312|Antimetabolites|antimetabolites|mesh-ancestor
6671096|NCT01547312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182779|NCT01777581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6182780|NCT01777620|Botulinum Toxins|botulinum toxins|mesh-list
6182781|NCT01777620|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6182782|NCT01777620|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6182783|NCT01777620|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6182784|NCT01777620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6182785|NCT01777620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182786|NCT01777620|Cholinergic Agents|cholinergic agents|mesh-ancestor
6182787|NCT01777620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6182788|NCT01777620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182789|NCT01777620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6182790|NCT01777620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6182791|NCT01777763|Posaconazole|posaconazole|mesh-list
6671097|NCT01547312|Hematinics|hematinics|mesh-ancestor
6671098|NCT01547325|Doxycycline|doxycycline|mesh-list
6671099|NCT01547325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5577261|NCT03878693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5577262|NCT03878693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577263|NCT03878667|Calcium, Dietary|calcium, dietary|mesh-list
5577264|NCT03878667|Calcium Carbonate|calcium carbonate|mesh-list
5577265|NCT03878667|Calcium|calcium|mesh-list
5577266|NCT03878667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5577267|NCT03878667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577268|NCT03878667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5577269|NCT03878667|Antacids|antacids|mesh-ancestor
5577270|NCT03878667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577271|NCT03878667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5577272|NCT03878368|Sulforaphane|sulforaphane|mesh-list
5577273|NCT03878368|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6182792|NCT01777763|Antifungal Agents|antifungal agents|mesh-ancestor
6182793|NCT01777763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6182794|NCT01777763|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6182795|NCT01777763|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6182796|NCT01777763|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6182797|NCT01777763|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6182798|NCT01777763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6182799|NCT01777763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6182800|NCT01777763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182801|NCT01777763|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6182802|NCT01777763|Hormone Antagonists|hormone antagonists|mesh-ancestor
6182803|NCT01777763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6182804|NCT01777763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182805|NCT01777945|Docetaxel|docetaxel|mesh-list
6182806|NCT01777945|Capecitabine|capecitabine|mesh-list
6182807|NCT01777945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6182808|NCT01777945|Tubulin Modulators|tubulin modulators|mesh-ancestor
6182809|NCT01777945|Antimitotic Agents|antimitotic agents|mesh-ancestor
6182810|NCT01777945|Mitosis Modulators|mitosis modulators|mesh-ancestor
6182811|NCT01777945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577274|NCT03878368|Protective Agents|protective agents|mesh-ancestor
5577275|NCT03878368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577276|NCT03878368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5577277|NCT03878264|Cortisone|cortisone|mesh-list
5577278|NCT03878264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5577279|NCT03878472|Oxaliplatin|oxaliplatin|mesh-list
5577280|NCT03878472|Apatinib|apatinib|mesh-list
5577281|NCT03878472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5577282|NCT03878472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5577283|NCT03878472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5577284|NCT03878472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577285|NCT03878069|Elapegademase|elapegademase|mesh-list
5577286|NCT03878069|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
5577287|NCT03878069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5577288|NCT03878069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577289|NCT03878082|Acetaminophen|acetaminophen|mesh-list
5577290|NCT03878082|Propacetamol|propacetamol|mesh-list
5577291|NCT03878082|Analgesics|analgesics|mesh-ancestor
5577292|NCT03878082|Sensory System Agents|sensory system agents|mesh-ancestor
5577293|NCT03878082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5577294|NCT03878082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577295|NCT03878082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5577296|NCT03878082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5577297|NCT03878082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5577298|NCT03878082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5577299|NCT03878082|Antipyretics|antipyretics|mesh-ancestor
5577300|NCT03877991|Cannabidiol|cannabidiol|mesh-list
5577301|NCT03877991|Anticonvulsants|anticonvulsants|mesh-ancestor
5577302|NCT03877705|Listerine|listerine|mesh-list
5577303|NCT03877705|Sodium Fluoride|sodium fluoride|mesh-list
5577304|NCT03877705|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5577305|NCT03877705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5577306|NCT03877705|Cariostatic Agents|cariostatic agents|mesh-ancestor
5577307|NCT03877705|Protective Agents|protective agents|mesh-ancestor
6182812|NCT01777945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6182813|NCT01777945|Antimetabolites|antimetabolites|mesh-ancestor
6182814|NCT01777997|Tenofovir|tenofovir|mesh-list
6182815|NCT01777997|Emtricitabine|emtricitabine|mesh-list
6182816|NCT01777997|Rilpivirine|rilpivirine|mesh-list
6182817|NCT01777997|Antiviral Agents|antiviral agents|mesh-ancestor
5577308|NCT03877705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182818|NCT01777997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6182819|NCT01777997|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5577309|NCT03877718|Promethazine|promethazine|mesh-list
5577310|NCT03877718|Diphenhydramine|diphenhydramine|mesh-list
5577311|NCT03877718|Sumatriptan|sumatriptan|mesh-list
5577312|NCT03877718|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6182820|NCT01777997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6182821|NCT01777997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6182822|NCT01777997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182823|NCT01777997|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6182824|NCT01777997|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6182825|NCT01778010|Cocaine|cocaine|mesh-list
6182826|NCT01778010|Modafinil|modafinil|mesh-list
6182827|NCT01778010|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6182828|NCT01778010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182829|NCT01778010|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6182830|NCT01778010|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6182831|NCT01778010|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6182832|NCT01778010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182833|NCT01778010|Anesthetics, Local|anesthetics, local|mesh-ancestor
6182834|NCT01778010|Anesthetics|anesthetics|mesh-ancestor
6182835|NCT01778010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6182836|NCT01778010|Sensory System Agents|sensory system agents|mesh-ancestor
6182837|NCT01778010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6182838|NCT01778010|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6182839|NCT01778010|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6182840|NCT01778010|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6182841|NCT01778010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5577313|NCT03877718|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5577314|NCT03877718|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5577315|NCT03877718|Serotonin Agents|serotonin agents|mesh-ancestor
5577316|NCT03877718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5577317|NCT03877718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577318|NCT03877718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577319|NCT03877718|Antipruritics|antipruritics|mesh-ancestor
5577320|NCT03877718|Dermatologic Agents|dermatologic agents|mesh-ancestor
5577321|NCT03877718|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5577322|NCT03877718|Histamine Antagonists|histamine antagonists|mesh-ancestor
5577323|NCT03877718|Histamine Agents|histamine agents|mesh-ancestor
5577324|NCT03877718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5577325|NCT03877718|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6182842|NCT01778010|Dopamine Agents|dopamine agents|mesh-ancestor
6182843|NCT01778010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6182844|NCT01778049|Empagliflozin|empagliflozin|mesh-list
6182845|NCT01778049|Linagliptin|linagliptin|mesh-list
6182846|NCT01778049|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6182847|NCT01778049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182848|NCT01778049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6182849|NCT01778049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577326|NCT03877718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5577327|NCT03877718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5577328|NCT03877718|Anesthetics, Local|anesthetics, local|mesh-ancestor
5577329|NCT03877718|Anesthetics|anesthetics|mesh-ancestor
5577330|NCT03877718|Sensory System Agents|sensory system agents|mesh-ancestor
5577331|NCT03877718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5577332|NCT03877718|Antiemetics|antiemetics|mesh-ancestor
5577333|NCT03877718|Autonomic Agents|autonomic agents|mesh-ancestor
5577334|NCT03877718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5577335|NCT03877965|Digoxin|digoxin|mesh-list
5577336|NCT03877965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6182850|NCT01778049|Incretins|incretins|mesh-ancestor
6182851|NCT01778049|Hormones|hormones|mesh-ancestor
6182852|NCT01778049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6182853|NCT01778049|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6182854|NCT01778049|Protease Inhibitors|protease inhibitors|mesh-ancestor
6182855|NCT01778049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6182856|NCT01778465|Salicylic Acid|salicylic acid|mesh-list
6182857|NCT01778465|Salicylates|salicylates|mesh-list
6182858|NCT01778465|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6182859|NCT01778465|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6182860|NCT01778465|Analgesics|analgesics|mesh-ancestor
6182861|NCT01778465|Sensory System Agents|sensory system agents|mesh-ancestor
6182862|NCT01778465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6182863|NCT01778465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577337|NCT03877965|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6182864|NCT01778465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5577338|NCT03877965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5577339|NCT03877965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577340|NCT03877965|Protective Agents|protective agents|mesh-ancestor
5577341|NCT03877965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577342|NCT03877536|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5577343|NCT03877536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5577344|NCT03877536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5577345|NCT03877536|Antiviral Agents|antiviral agents|mesh-ancestor
5577346|NCT03877536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5577347|NCT03877549|Dexamethasone|dexamethasone|mesh-list
5577348|NCT03877549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5577349|NCT03877549|Antiemetics|antiemetics|mesh-ancestor
5577350|NCT03877549|Autonomic Agents|autonomic agents|mesh-ancestor
6182865|NCT01778465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6182866|NCT01778465|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6182867|NCT01778465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6182868|NCT01778465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182869|NCT01778465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6182870|NCT01778465|Antifungal Agents|antifungal agents|mesh-ancestor
6182871|NCT01778465|Keratolytic Agents|keratolytic agents|mesh-ancestor
5577351|NCT03877549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5577352|NCT03877549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577353|NCT03877549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5577354|NCT03877549|Glucocorticoids|glucocorticoids|mesh-ancestor
5577355|NCT03877549|Hormones|hormones|mesh-ancestor
5577356|NCT03877549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5577357|NCT03877549|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5577358|NCT03877549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6182872|NCT01778465|Dermatologic Agents|dermatologic agents|mesh-ancestor
6182873|NCT01778634|Azithromycin|azithromycin|mesh-list
6182874|NCT01778634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6182875|NCT01778634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6182876|NCT01778985|Estrogens|estrogens|mesh-list
6182877|NCT01778985|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6182878|NCT01778985|Hormones|hormones|mesh-ancestor
6182879|NCT01778985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5577359|NCT03877809|Sirolimus|sirolimus|mesh-list
5604654|NCT04509791|Thymoglobulin|thymoglobulin|mesh-list
6182880|NCT01778985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182881|NCT01779167|Thalidomide|thalidomide|mesh-list
6182882|NCT01779167|Rituximab|rituximab|mesh-list
6182883|NCT01779167|Lenalidomide|lenalidomide|mesh-list
6182884|NCT01779167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6182885|NCT01779167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6182886|NCT01779167|Immunologic Factors|immunologic factors|mesh-ancestor
6182887|NCT01779167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182888|NCT01779167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6182889|NCT01779167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6182890|NCT01779167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6182891|NCT01779167|Growth Substances|growth substances|mesh-ancestor
6182892|NCT01779167|Growth Inhibitors|growth inhibitors|mesh-ancestor
6182893|NCT01779167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6182894|NCT01779167|Leprostatic Agents|leprostatic agents|mesh-ancestor
6182895|NCT01779167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6182896|NCT01779167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6182897|NCT01779375|Metformin|metformin|mesh-list
6182898|NCT01779375|Insulin Glargine|insulin glargine|mesh-list
6182899|NCT01779375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6182900|NCT01779375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182901|NCT01779700|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6182902|NCT01779700|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6182903|NCT01779700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182904|NCT01779700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6182905|NCT01779700|Immunologic Factors|immunologic factors|mesh-ancestor
6182906|NCT01779700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577360|NCT03877809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5577361|NCT03877809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5577362|NCT03877809|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5577363|NCT03877809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5577364|NCT03877809|Antifungal Agents|antifungal agents|mesh-ancestor
5577365|NCT03877809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5577366|NCT03877809|Immunologic Factors|immunologic factors|mesh-ancestor
5577367|NCT03877809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577368|NCT03877874|Terbutaline|terbutaline|mesh-list
5577369|NCT03877874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6182907|NCT01779869|Regadenoson|regadenoson|mesh-list
6182908|NCT01779869|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
6182909|NCT01779869|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6182910|NCT01779869|Purinergic Agonists|purinergic agonists|mesh-ancestor
6182911|NCT01779869|Purinergic Agents|purinergic agents|mesh-ancestor
6182912|NCT01779869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6182913|NCT01779869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577370|NCT03877874|Autonomic Agents|autonomic agents|mesh-ancestor
5577371|NCT03877874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5577372|NCT03877874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577373|NCT03877874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5577374|NCT03877874|Respiratory System Agents|respiratory system agents|mesh-ancestor
5577375|NCT03877874|Sympathomimetics|sympathomimetics|mesh-ancestor
5577376|NCT03877874|Tocolytic Agents|tocolytic agents|mesh-ancestor
5577377|NCT03877874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6182914|NCT01779869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182915|NCT01780324|Lidocaine|lidocaine|mesh-list
6182916|NCT01780324|Anesthetics, Local|anesthetics, local|mesh-ancestor
6182917|NCT01780324|Anesthetics|anesthetics|mesh-ancestor
6182918|NCT01780324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6182919|NCT01780324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182920|NCT01780324|Sensory System Agents|sensory system agents|mesh-ancestor
6182921|NCT01780324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6182922|NCT01780324|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6182923|NCT01780324|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6182924|NCT01780324|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6182925|NCT01780324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6182926|NCT01780324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182927|NCT01780337|Oxytocin|oxytocin|mesh-list
6182928|NCT01780337|Oxytocics|oxytocics|mesh-ancestor
6182929|NCT01780337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6182930|NCT01780337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182931|NCT01780389|Milnacipran|milnacipran|mesh-list
6182932|NCT01780389|Levomilnacipran|levomilnacipran|mesh-list
6182933|NCT01780389|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6182934|NCT01780389|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6182935|NCT01780389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6182936|NCT01780389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182937|NCT01780389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6182938|NCT01780389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182939|NCT01780389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6182940|NCT01780389|Analgesics|analgesics|mesh-ancestor
6182941|NCT01780389|Sensory System Agents|sensory system agents|mesh-ancestor
6182942|NCT01780389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6182943|NCT01780389|Antidepressive Agents|antidepressive agents|mesh-ancestor
6182944|NCT01780389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6182945|NCT01780454|Rituximab|rituximab|mesh-list
6182946|NCT01780454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6182947|NCT01780454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6182948|NCT01780454|Immunologic Factors|immunologic factors|mesh-ancestor
6182949|NCT01780454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182950|NCT01780454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6206770|NCT02105415|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5577378|NCT03877874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5577379|NCT03877874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5577380|NCT03877874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5577381|NCT03877874|Adrenergic Agents|adrenergic agents|mesh-ancestor
5577382|NCT03877874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5577383|NCT03877874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577384|NCT03877692|Labetalol|labetalol|mesh-list
5577385|NCT03877692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5577386|NCT03877692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5577387|NCT03877692|Adrenergic Agents|adrenergic agents|mesh-ancestor
5577388|NCT03877692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5577389|NCT03877692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577390|NCT03877692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577391|NCT03877692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6182951|NCT01780506|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6182952|NCT01780506|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6182953|NCT01780506|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6182954|NCT01780506|Antiviral Agents|antiviral agents|mesh-ancestor
6182955|NCT01780506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6182956|NCT01780545|Docetaxel|docetaxel|mesh-list
6182957|NCT01780545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6182958|NCT01780545|Tubulin Modulators|tubulin modulators|mesh-ancestor
6182959|NCT01780545|Antimitotic Agents|antimitotic agents|mesh-ancestor
6182960|NCT01780545|Mitosis Modulators|mitosis modulators|mesh-ancestor
6182961|NCT01780545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182962|NCT01780662|Gemcitabine|gemcitabine|mesh-list
6182963|NCT01780662|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6182964|NCT01780662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6182965|NCT01780662|Antibodies|antibodies|mesh-list
6182966|NCT01780662|Immunoglobulins|immunoglobulins|mesh-list
6182967|NCT01780662|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5577392|NCT03877692|Sympathomimetics|sympathomimetics|mesh-ancestor
5577393|NCT03877692|Autonomic Agents|autonomic agents|mesh-ancestor
5577394|NCT03877692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5577395|NCT03877692|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5577396|NCT03877692|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5577397|NCT03877679|Triamcinolone|triamcinolone|mesh-list
5577398|NCT03877679|Curcumin|curcumin|mesh-list
5577399|NCT03877679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5577400|NCT03877679|Glucocorticoids|glucocorticoids|mesh-ancestor
5577401|NCT03877679|Hormones|hormones|mesh-ancestor
5577402|NCT03877679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5577403|NCT03877679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577404|NCT03877679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5577405|NCT03877679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577406|NCT03877679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5577407|NCT03877679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5577408|NCT03877679|Analgesics|analgesics|mesh-ancestor
5577409|NCT03877679|Sensory System Agents|sensory system agents|mesh-ancestor
5577410|NCT03877679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5577411|NCT03877679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5577412|NCT03877679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5577413|NCT03877562|Olanzapine|olanzapine|mesh-list
5577414|NCT03877562|Antiemetics|antiemetics|mesh-ancestor
5577415|NCT03877562|Autonomic Agents|autonomic agents|mesh-ancestor
5577416|NCT03877562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5577417|NCT03877562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577418|NCT03877562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5577419|NCT03877562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5577420|NCT03877562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5577421|NCT03877562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5577422|NCT03877562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5577423|NCT03877562|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5577424|NCT03877562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5577425|NCT03877562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5577426|NCT03877562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577427|NCT03877562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5577428|NCT03877562|Serotonin Agents|serotonin agents|mesh-ancestor
5577429|NCT03877601|Bevacizumab|bevacizumab|mesh-list
5577430|NCT03877601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5577431|NCT03877601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5577432|NCT03877601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6182968|NCT01780662|Immunoconjugates|immunoconjugates|mesh-list
6182969|NCT01780662|Immunologic Factors|immunologic factors|mesh-ancestor
6182970|NCT01780662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182971|NCT01780662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6182972|NCT01780662|Antimetabolites|antimetabolites|mesh-ancestor
6182973|NCT01780662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577433|NCT03877601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5577434|NCT03877601|Growth Substances|growth substances|mesh-ancestor
5577435|NCT03877601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577436|NCT03877601|Growth Inhibitors|growth inhibitors|mesh-ancestor
5577437|NCT03877315|Cimetidine|cimetidine|mesh-list
5577438|NCT03877315|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5577439|NCT03877315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5577440|NCT03877315|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5577441|NCT03877315|Histamine Antagonists|histamine antagonists|mesh-ancestor
6182974|NCT01780662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6182975|NCT01780662|Antiviral Agents|antiviral agents|mesh-ancestor
6182976|NCT01780662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6182977|NCT01780662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6182978|NCT01780662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6182979|NCT01780831|Raltegravir Potassium|raltegravir potassium|mesh-list
6182980|NCT01780831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6182981|NCT01780831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6182982|NCT01780831|Antiviral Agents|antiviral agents|mesh-ancestor
6182983|NCT01780831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6182984|NCT01780831|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6182985|NCT01780831|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6182986|NCT01780831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5577442|NCT03877315|Histamine Agents|histamine agents|mesh-ancestor
5577443|NCT03877315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5577444|NCT03877315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577445|NCT03877315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577446|NCT03877315|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5577447|NCT03877315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5577448|NCT03877315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6182987|NCT01780831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182988|NCT01780935|Ranibizumab|ranibizumab|mesh-list
5604655|NCT04509791|Immunologic Factors|immunologic factors|mesh-ancestor
5604656|NCT04509791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604657|NCT04509791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5604658|NCT04507555|Antidepressive Agents|antidepressive agents|mesh-list
5604659|NCT04507555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5604660|NCT04449250|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
6182989|NCT01780935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6182990|NCT01780935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6182991|NCT01780935|Growth Substances|growth substances|mesh-ancestor
6182992|NCT01780935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6182993|NCT01780935|Growth Inhibitors|growth inhibitors|mesh-ancestor
6182994|NCT01780935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6182995|NCT01780974|Thioctic Acid|thioctic acid|mesh-list
6182996|NCT01780974|Antioxidants|antioxidants|mesh-ancestor
6182997|NCT01780974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6182998|NCT01780974|Protective Agents|protective agents|mesh-ancestor
6182999|NCT01780974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183000|NCT01780974|Vitamin B Complex|vitamin b complex|mesh-ancestor
6183001|NCT01780974|Vitamins|vitamins|mesh-ancestor
6183002|NCT01780974|Micronutrients|micronutrients|mesh-ancestor
6183003|NCT01780987|Heparin|heparin|mesh-list
6183004|NCT01780987|Calcium heparin|calcium heparin|mesh-list
6183005|NCT01780987|Warfarin|warfarin|mesh-list
6183006|NCT01780987|Apixaban|apixaban|mesh-list
6183007|NCT01780987|Anticoagulants|anticoagulants|mesh-ancestor
5604661|NCT04449250|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5604662|NCT04449250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604663|NCT04449250|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5604664|NCT04449250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5604665|NCT04449250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5604666|NCT04449250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604667|NCT04449250|Dopamine Agents|dopamine agents|mesh-ancestor
5604668|NCT04449250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6183008|NCT01780987|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6183009|NCT01780987|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6183010|NCT01780987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183011|NCT01780987|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6183012|NCT01780987|Antithrombins|antithrombins|mesh-ancestor
6488093|NCT00580619|Autonomic Agents|autonomic agents|mesh-ancestor
6183013|NCT01780987|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6183014|NCT01780987|Protease Inhibitors|protease inhibitors|mesh-ancestor
6183015|NCT01780987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6183016|NCT01781169|Vitamin D|vitamin d|mesh-list
6183017|NCT01781169|Vitamins|vitamins|mesh-ancestor
6183018|NCT01781169|Micronutrients|micronutrients|mesh-ancestor
6183019|NCT01781169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183020|NCT01781169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6183021|NCT01781234|Insulin|insulin|mesh-list
6183022|NCT01781234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6183023|NCT01781234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183024|NCT01781403|Capecitabine|capecitabine|mesh-list
5577449|NCT03877406|Empagliflozin|empagliflozin|mesh-list
5577450|NCT03877406|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
5577451|NCT03877406|Hypoglycemic Agents|hypoglycemic agents|mesh-list
5577452|NCT03877406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577453|NCT03877406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577454|NCT03877120|Diazepam|diazepam|mesh-list
5577455|NCT03877120|Dexmedetomidine|dexmedetomidine|mesh-list
5577456|NCT03877120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5577457|NCT03877120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5577458|NCT03877120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577459|NCT03877120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5577460|NCT03877120|Analgesics|analgesics|mesh-ancestor
5577461|NCT03877120|Sensory System Agents|sensory system agents|mesh-ancestor
5577462|NCT03877120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5577463|NCT03877120|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5577464|NCT03877120|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5577465|NCT03877120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5577466|NCT03877120|Adrenergic Agents|adrenergic agents|mesh-ancestor
5577467|NCT03877120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5577468|NCT03877120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577469|NCT03877120|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5577470|NCT03877120|Anticonvulsants|anticonvulsants|mesh-ancestor
5577471|NCT03877120|Antiemetics|antiemetics|mesh-ancestor
5577472|NCT03877120|Autonomic Agents|autonomic agents|mesh-ancestor
5577473|NCT03877120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5577474|NCT03877120|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5577475|NCT03877120|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5577476|NCT03877120|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5577477|NCT03877120|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5577478|NCT03877120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5577479|NCT03877120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5577480|NCT03877120|Anesthetics, General|anesthetics, general|mesh-ancestor
5577481|NCT03877120|Anesthetics|anesthetics|mesh-ancestor
5577482|NCT03877120|GABA Modulators|gaba modulators|mesh-ancestor
5577483|NCT03877120|GABA Agents|gaba agents|mesh-ancestor
5577484|NCT03877003|Choline|choline|mesh-list
5577485|NCT03877003|Lipotropic Agents|lipotropic agents|mesh-ancestor
5577486|NCT03877003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6183025|NCT01781403|Temozolomide|temozolomide|mesh-list
6183026|NCT01781403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6183027|NCT01781403|Antimetabolites|antimetabolites|mesh-ancestor
6183028|NCT01781403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183029|NCT01781403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6183030|NCT01781403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6183031|NCT01781403|Alkylating Agents|alkylating agents|mesh-ancestor
6183032|NCT01781468|Modafinil|modafinil|mesh-list
6183033|NCT01781468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6183034|NCT01781468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183035|NCT01781468|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6183036|NCT01781468|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6183037|NCT01781468|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6183038|NCT01781468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183039|NCT01781611|Aspirin|aspirin|mesh-list
6183040|NCT01781611|Dipyridamole|dipyridamole|mesh-list
6183041|NCT01781611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6183042|NCT01781611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6183043|NCT01781611|Analgesics|analgesics|mesh-ancestor
6183044|NCT01781611|Sensory System Agents|sensory system agents|mesh-ancestor
6183045|NCT01781611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6183046|NCT01781611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183047|NCT01781611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5577487|NCT03877003|Antimetabolites|antimetabolites|mesh-ancestor
5577488|NCT03877003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183048|NCT01781611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6671100|NCT01547325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6671101|NCT01547325|Antimalarials|antimalarials|mesh-ancestor
6671102|NCT01547325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6671103|NCT01547325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6671104|NCT01547377|Zinc|zinc|mesh-list
6671105|NCT01547377|Selenium|selenium|mesh-list
6671106|NCT01547377|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6671107|NCT01547377|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6671108|NCT01547377|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6671109|NCT01547377|Antimetabolites|antimetabolites|mesh-ancestor
6183049|NCT01781611|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6183050|NCT01781611|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6183051|NCT01781611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183052|NCT01781611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6183053|NCT01781611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6183054|NCT01781611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6183055|NCT01781611|Antipyretics|antipyretics|mesh-ancestor
6183056|NCT01781611|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6183057|NCT01781611|Vasodilator Agents|vasodilator agents|mesh-ancestor
6183058|NCT01781806|Tenofovir|tenofovir|mesh-list
6183059|NCT01781806|Emtricitabine|emtricitabine|mesh-list
6183060|NCT01781806|Antiviral Agents|antiviral agents|mesh-ancestor
6183061|NCT01781806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6183062|NCT01781806|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6183063|NCT01781806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6183064|NCT01781806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6183065|NCT01781806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671110|NCT01547377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671111|NCT01547377|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6671112|NCT01547377|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6671113|NCT01547377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6671114|NCT01547377|Trace Elements|trace elements|mesh-ancestor
6671115|NCT01547377|Micronutrients|micronutrients|mesh-ancestor
6671116|NCT01547377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671117|NCT01547377|Antioxidants|antioxidants|mesh-ancestor
6671118|NCT01547377|Protective Agents|protective agents|mesh-ancestor
6671119|NCT01547416|Fentanyl|fentanyl|mesh-list
6671120|NCT01547416|Ropivacaine|ropivacaine|mesh-list
6671121|NCT01547416|Anesthetics, Local|anesthetics, local|mesh-ancestor
6671122|NCT01547416|Anesthetics|anesthetics|mesh-ancestor
6671123|NCT01547416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6671124|NCT01547416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671125|NCT01547416|Sensory System Agents|sensory system agents|mesh-ancestor
6671126|NCT01547416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6671127|NCT01547416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6671128|NCT01547416|Narcotics|narcotics|mesh-ancestor
6671129|NCT01547416|Analgesics|analgesics|mesh-ancestor
6671130|NCT01547416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6671131|NCT01547416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6671132|NCT01547416|Anesthetics, General|anesthetics, general|mesh-ancestor
6183066|NCT01781806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6183067|NCT01781806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6183068|NCT01781975|Imatinib Mesylate|imatinib mesylate|mesh-list
6183069|NCT01781975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6183070|NCT01781975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6183071|NCT01781975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6183072|NCT01781975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183073|NCT01782131|Voriconazole|voriconazole|mesh-list
6671133|NCT01547455|Atorvastatin|atorvastatin|mesh-list
6671134|NCT01547455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5577489|NCT03877003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5577490|NCT03877003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5577491|NCT03877003|Nootropic Agents|nootropic agents|mesh-ancestor
5577492|NCT03876899|Evening primrose oil|evening primrose oil|mesh-list
5577493|NCT03876899|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5577494|NCT03876899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5577495|NCT03876899|Analgesics|analgesics|mesh-ancestor
5577496|NCT03876899|Sensory System Agents|sensory system agents|mesh-ancestor
5577497|NCT03876899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5577498|NCT03876899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577499|NCT03876899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5577500|NCT03876899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5577501|NCT03876899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5577502|NCT03876899|Antimetabolites|antimetabolites|mesh-ancestor
6183074|NCT01782131|Posaconazole|posaconazole|mesh-list
6671135|NCT01547455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6671136|NCT01547455|Antimetabolites|antimetabolites|mesh-ancestor
5577503|NCT03876899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577504|NCT03876899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5577505|NCT03876899|Dermatologic Agents|dermatologic agents|mesh-ancestor
5577506|NCT03876873|Anesthetics|anesthetics|mesh-list
5577507|NCT03876873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5577508|NCT03876873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577509|NCT03876704|Vitamins|vitamins|mesh-list
5577510|NCT03876704|Micronutrients|micronutrients|mesh-ancestor
5577511|NCT03876704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577512|NCT03876938|Olanzapine|olanzapine|mesh-list
5577513|NCT03876938|Aprepitant|aprepitant|mesh-list
5577514|NCT03876938|Antiemetics|antiemetics|mesh-ancestor
5577515|NCT03876938|Autonomic Agents|autonomic agents|mesh-ancestor
5577516|NCT03876938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6183075|NCT01782131|Antifungal Agents|antifungal agents|mesh-ancestor
6183076|NCT01782131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6183077|NCT01782131|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6183078|NCT01782131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6183079|NCT01782131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6183080|NCT01782131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183081|NCT01782131|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6183082|NCT01782131|Hormone Antagonists|hormone antagonists|mesh-ancestor
6183083|NCT01782131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6183084|NCT01782131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183085|NCT01782131|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6183086|NCT01782131|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6183087|NCT01782131|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6183088|NCT01782131|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6183089|NCT01782222|Rotigotine|rotigotine|mesh-list
6183090|NCT01782222|Dopamine Agonists|dopamine agonists|mesh-ancestor
6183091|NCT01782222|Dopamine Agents|dopamine agents|mesh-ancestor
6183092|NCT01782222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6183093|NCT01782222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183094|NCT01782222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183095|NCT01782495|Ritonavir|ritonavir|mesh-list
6183096|NCT01782495|Ribavirin|ribavirin|mesh-list
6183097|NCT01782495|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6183098|NCT01782495|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5577517|NCT03876938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577518|NCT03876938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5577519|NCT03876938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5577520|NCT03876938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5577521|NCT03876938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5577522|NCT03876938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5577523|NCT03876938|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5577524|NCT03876938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5577525|NCT03876938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6183099|NCT01782495|Protease Inhibitors|protease inhibitors|mesh-ancestor
6183100|NCT01782495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6183101|NCT01782495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183102|NCT01782495|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6183103|NCT01782495|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6183104|NCT01782495|Antiviral Agents|antiviral agents|mesh-ancestor
6183105|NCT01782495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6183106|NCT01782495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6183107|NCT01782495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6183108|NCT01782495|Antimetabolites|antimetabolites|mesh-ancestor
6183109|NCT01782690|Gemcitabine|gemcitabine|mesh-list
6183110|NCT01782690|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6183111|NCT01782690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6183112|NCT01782690|Antimetabolites|antimetabolites|mesh-ancestor
6183113|NCT01782690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183114|NCT01782690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6183115|NCT01782690|Antiviral Agents|antiviral agents|mesh-ancestor
6183116|NCT01782690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6183117|NCT01782690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5577526|NCT03876938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577527|NCT03876938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5577528|NCT03876938|Serotonin Agents|serotonin agents|mesh-ancestor
5577529|NCT03876938|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5577530|NCT03876886|Paclitaxel|paclitaxel|mesh-list
5577531|NCT03876886|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5577532|NCT03876886|Cyclophosphamide|cyclophosphamide|mesh-list
5577533|NCT03876886|Carboplatin|carboplatin|mesh-list
6183118|NCT01782690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6183119|NCT01782690|Immunologic Factors|immunologic factors|mesh-ancestor
6183120|NCT01782690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183121|NCT01782690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6183122|NCT01782742|Bexarotene|bexarotene|mesh-list
5577534|NCT03876886|Epirubicin|epirubicin|mesh-list
5577535|NCT03876886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5577536|NCT03876886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5577537|NCT03876886|Tubulin Modulators|tubulin modulators|mesh-ancestor
5577538|NCT03876886|Antimitotic Agents|antimitotic agents|mesh-ancestor
5577539|NCT03876886|Mitosis Modulators|mitosis modulators|mesh-ancestor
5577540|NCT03876886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577541|NCT03876886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5577542|NCT03876886|Immunologic Factors|immunologic factors|mesh-ancestor
5577543|NCT03876886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577544|NCT03876886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5577545|NCT03876886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5577546|NCT03876886|Alkylating Agents|alkylating agents|mesh-ancestor
5577547|NCT03876886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5577548|NCT03876886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5577549|NCT03876886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5577550|NCT03876886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5577551|NCT03876886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5577552|NCT03876444|Methylprednisolone|methylprednisolone|mesh-list
5577553|NCT03876444|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5577554|NCT03876444|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5577555|NCT03876444|Prednisolone|prednisolone|mesh-list
5577556|NCT03876444|Prednisolone acetate|prednisolone acetate|mesh-list
5577557|NCT03876444|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5577558|NCT03876444|Prednisolone phosphate|prednisolone phosphate|mesh-list
6183123|NCT01782742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6183124|NCT01782859|Prednisone|prednisone|mesh-list
6183125|NCT01782859|Hydrocortisone|hydrocortisone|mesh-list
6183126|NCT01782859|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6183127|NCT01782859|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6183128|NCT01782859|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6183129|NCT01782859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6183130|NCT01782859|Glucocorticoids|glucocorticoids|mesh-ancestor
6183131|NCT01782859|Hormones|hormones|mesh-ancestor
6183132|NCT01782859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6183133|NCT01782859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183134|NCT01782859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6183135|NCT01782859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6183136|NCT01782872|Ropivacaine|ropivacaine|mesh-list
6183137|NCT01782872|Anesthetics, Local|anesthetics, local|mesh-ancestor
6183138|NCT01782872|Anesthetics|anesthetics|mesh-ancestor
6183139|NCT01782872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6183140|NCT01782872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183141|NCT01782872|Sensory System Agents|sensory system agents|mesh-ancestor
6183142|NCT01782872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6183143|NCT01782885|Acetaminophen|acetaminophen|mesh-list
6183144|NCT01782885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6183145|NCT01782885|Analgesics|analgesics|mesh-ancestor
5577559|NCT03876444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5577560|NCT03876444|Antiemetics|antiemetics|mesh-ancestor
5577561|NCT03876444|Autonomic Agents|autonomic agents|mesh-ancestor
5577562|NCT03876444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5577563|NCT03876444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577564|NCT03876444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5577565|NCT03876444|Glucocorticoids|glucocorticoids|mesh-ancestor
5577566|NCT03876444|Hormones|hormones|mesh-ancestor
5577567|NCT03876444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5577568|NCT03876444|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5577569|NCT03876444|Protective Agents|protective agents|mesh-ancestor
5577570|NCT03876444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6183146|NCT01782885|Sensory System Agents|sensory system agents|mesh-ancestor
6183147|NCT01782885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6183148|NCT01782885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183149|NCT01782885|Antipyretics|antipyretics|mesh-ancestor
6183150|NCT01782898|Esmolol|esmolol|mesh-list
6183151|NCT01782898|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6183152|NCT01782898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5577571|NCT03876444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5577572|NCT03876548|Iodine|iodine|mesh-list
6183153|NCT01782898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6183154|NCT01782898|Adrenergic Agents|adrenergic agents|mesh-ancestor
5577573|NCT03876548|Cadexomer iodine|cadexomer iodine|mesh-list
5577574|NCT03876548|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6183155|NCT01782898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6183156|NCT01782898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183157|NCT01782898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183158|NCT01782963|Dexamethasone|dexamethasone|mesh-list
6183159|NCT01782963|Lenalidomide|lenalidomide|mesh-list
6183160|NCT01782963|Bortezomib|bortezomib|mesh-list
6183161|NCT01782963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6183162|NCT01782963|Antiemetics|antiemetics|mesh-ancestor
5577575|NCT03876548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5577576|NCT03876548|Trace Elements|trace elements|mesh-ancestor
5577577|NCT03876548|Micronutrients|micronutrients|mesh-ancestor
5577578|NCT03876548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577579|NCT03876587|Docetaxel|docetaxel|mesh-list
5577580|NCT03876587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5577581|NCT03876587|Tubulin Modulators|tubulin modulators|mesh-ancestor
5577582|NCT03876587|Antimitotic Agents|antimitotic agents|mesh-ancestor
5577583|NCT03876587|Mitosis Modulators|mitosis modulators|mesh-ancestor
5577584|NCT03876587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577585|NCT03876574|Gemcitabine|gemcitabine|mesh-list
5577586|NCT03876574|Dexamethasone|dexamethasone|mesh-list
5577587|NCT03876574|Floxuridine|floxuridine|mesh-list
6183163|NCT01782963|Autonomic Agents|autonomic agents|mesh-ancestor
6183164|NCT01782963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6183165|NCT01782963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183166|NCT01782963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6183167|NCT01782963|Glucocorticoids|glucocorticoids|mesh-ancestor
6183168|NCT01782963|Hormones|hormones|mesh-ancestor
6183169|NCT01782963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6183170|NCT01782963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6183171|NCT01782963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6183172|NCT01782963|Immunologic Factors|immunologic factors|mesh-ancestor
6183173|NCT01782963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6183174|NCT01782963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6183175|NCT01782963|Growth Substances|growth substances|mesh-ancestor
6183176|NCT01782963|Growth Inhibitors|growth inhibitors|mesh-ancestor
6183177|NCT01783054|Gemcitabine|gemcitabine|mesh-list
6183178|NCT01783054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6183179|NCT01783054|Antimetabolites|antimetabolites|mesh-ancestor
6183180|NCT01783054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183181|NCT01783054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6183182|NCT01783054|Antiviral Agents|antiviral agents|mesh-ancestor
6183183|NCT01783054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6183184|NCT01783054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6183185|NCT01783054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6183186|NCT01783054|Immunologic Factors|immunologic factors|mesh-ancestor
6183187|NCT01783054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183188|NCT01783236|Acetaminophen|acetaminophen|mesh-list
6183189|NCT01783236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6183190|NCT01783236|Analgesics|analgesics|mesh-ancestor
6183191|NCT01783236|Sensory System Agents|sensory system agents|mesh-ancestor
6183192|NCT01783236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6183193|NCT01783236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183194|NCT01783236|Antipyretics|antipyretics|mesh-ancestor
6183195|NCT01783444|Capecitabine|capecitabine|mesh-list
6183196|NCT01783444|Everolimus|everolimus|mesh-list
6183197|NCT01783444|Exemestane|exemestane|mesh-list
6183198|NCT01783444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6183199|NCT01783444|Antimetabolites|antimetabolites|mesh-ancestor
6183200|NCT01783444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183201|NCT01783444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6183202|NCT01783444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6183203|NCT01783444|Immunologic Factors|immunologic factors|mesh-ancestor
6183204|NCT01783444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183205|NCT01783444|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6183206|NCT01783444|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6183207|NCT01783444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6183208|NCT01783444|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6183209|NCT01783444|Hormone Antagonists|hormone antagonists|mesh-ancestor
6183210|NCT01783444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6183211|NCT01783470|Mirabegron|mirabegron|mesh-list
6488094|NCT00580619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5577588|NCT03876574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6183212|NCT01783470|Adrenergic Agents|adrenergic agents|mesh-list
5577589|NCT03876574|Antiemetics|antiemetics|mesh-ancestor
5577590|NCT03876574|Autonomic Agents|autonomic agents|mesh-ancestor
6183213|NCT01783470|Adrenergic Agonists|adrenergic agonists|mesh-list
6183214|NCT01783470|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6183215|NCT01783470|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6183216|NCT01783470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6183217|NCT01783470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183218|NCT01783470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183219|NCT01783470|Urological Agents|urological agents|mesh-ancestor
6183220|NCT01783548|Beclomethasone|beclomethasone|mesh-list
6183221|NCT01783548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6183222|NCT01783548|Glucocorticoids|glucocorticoids|mesh-ancestor
6183223|NCT01783548|Hormones|hormones|mesh-ancestor
6183224|NCT01783548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6183225|NCT01783548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183226|NCT01783548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6183227|NCT01783548|Respiratory System Agents|respiratory system agents|mesh-ancestor
6183228|NCT01783561|Caffeine|caffeine|mesh-list
6183229|NCT01783561|Caffeine citrate|caffeine citrate|mesh-list
6183230|NCT01783561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183231|NCT01783561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6183232|NCT01783561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183233|NCT01783561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6183234|NCT01783561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6183235|NCT01783561|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5577591|NCT03876574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5577592|NCT03876574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577593|NCT03876574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5577594|NCT03876574|Glucocorticoids|glucocorticoids|mesh-ancestor
5577595|NCT03876574|Hormones|hormones|mesh-ancestor
5577596|NCT03876574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5577597|NCT03876574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5577598|NCT03876574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5577599|NCT03876574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5577600|NCT03876574|Antimetabolites|antimetabolites|mesh-ancestor
5577601|NCT03876574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577602|NCT03876574|Antiviral Agents|antiviral agents|mesh-ancestor
5577603|NCT03876574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6183236|NCT01783561|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6183237|NCT01783561|Purinergic Agents|purinergic agents|mesh-ancestor
6183238|NCT01783561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6183239|NCT01783574|Methyltestosterone|methyltestosterone|mesh-list
6183240|NCT01783574|Testosterone|testosterone|mesh-list
5577604|NCT03876574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5577605|NCT03876574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5577606|NCT03876574|Immunologic Factors|immunologic factors|mesh-ancestor
5577607|NCT03876288|Immunoglobulins|immunoglobulins|mesh-list
5577608|NCT03876288|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6183241|NCT01783574|Testosterone undecanoate|testosterone undecanoate|mesh-list
6183242|NCT01783574|Testosterone enanthate|testosterone enanthate|mesh-list
6183243|NCT01783574|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6183244|NCT01783574|Androgens|androgens|mesh-ancestor
6183245|NCT01783574|Hormones|hormones|mesh-ancestor
6183246|NCT01783574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6183247|NCT01783574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183248|NCT01783574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6183249|NCT01783574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6183250|NCT01783574|Anabolic Agents|anabolic agents|mesh-ancestor
6206771|NCT02105415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6206772|NCT02105415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206773|NCT02105415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6206774|NCT02105415|Anesthetics, General|anesthetics, general|mesh-ancestor
6206775|NCT02105415|Anesthetics|anesthetics|mesh-ancestor
6206776|NCT02105415|Analgesics|analgesics|mesh-ancestor
6206777|NCT02105415|Sensory System Agents|sensory system agents|mesh-ancestor
6206778|NCT02105415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6206779|NCT02105415|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6206780|NCT02105415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5577609|NCT03876288|gamma-Globulins|gamma-globulins|mesh-list
5577610|NCT03876288|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5577611|NCT03876288|Immunologic Factors|immunologic factors|mesh-ancestor
5577612|NCT03876288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577613|NCT03876119|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5577614|NCT03876119|Plasminogen|plasminogen|mesh-list
5577615|NCT03876119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6183251|NCT01783678|Sofosbuvir|sofosbuvir|mesh-list
6183252|NCT01783678|Antiviral Agents|antiviral agents|mesh-ancestor
6183253|NCT01783678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6183254|NCT01783821|Budesonide|budesonide|mesh-list
6183255|NCT01783821|Formoterol Fumarate|formoterol fumarate|mesh-list
6183256|NCT01783821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5577616|NCT03876119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5577617|NCT03876119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577618|NCT03876262|Ivermectin|ivermectin|mesh-list
5577619|NCT03876262|Moxidectin|moxidectin|mesh-list
6183257|NCT01783821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6183258|NCT01783821|Autonomic Agents|autonomic agents|mesh-ancestor
6183259|NCT01783821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6183260|NCT01783821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183261|NCT01783821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6183262|NCT01783821|Respiratory System Agents|respiratory system agents|mesh-ancestor
6183263|NCT01783821|Glucocorticoids|glucocorticoids|mesh-ancestor
6183264|NCT01783821|Hormones|hormones|mesh-ancestor
6183265|NCT01783821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6183266|NCT01783821|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6183267|NCT01783821|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6183268|NCT01783821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6183269|NCT01783821|Adrenergic Agents|adrenergic agents|mesh-ancestor
6183270|NCT01783821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6183271|NCT01783821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183272|NCT01783847|Prednisolone|prednisolone|mesh-list
6183273|NCT01783847|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6183274|NCT01783847|Methylprednisolone|methylprednisolone|mesh-list
6183275|NCT01783847|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6183276|NCT01783847|Prednisolone acetate|prednisolone acetate|mesh-list
6183277|NCT01783847|Epoetin Alfa|epoetin alfa|mesh-list
6183278|NCT01783847|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6183279|NCT01783847|Prednisolone phosphate|prednisolone phosphate|mesh-list
6183280|NCT01783847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6183281|NCT01783847|Glucocorticoids|glucocorticoids|mesh-ancestor
6183282|NCT01783847|Hormones|hormones|mesh-ancestor
6183283|NCT01783847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6183284|NCT01783847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183285|NCT01783847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6183286|NCT01783847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6183287|NCT01783847|Antiemetics|antiemetics|mesh-ancestor
5577620|NCT03876262|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5577621|NCT03876262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5577622|NCT03876262|Anthelmintics|anthelmintics|mesh-ancestor
5577623|NCT03876262|Antinematodal Agents|antinematodal agents|mesh-ancestor
5577624|NCT03876041|Dexamethasone|dexamethasone|mesh-list
5577625|NCT03876041|Dexamethasone acetate|dexamethasone acetate|mesh-list
5577626|NCT03876041|Methylprednisolone|methylprednisolone|mesh-list
6183288|NCT01783847|Autonomic Agents|autonomic agents|mesh-ancestor
6183289|NCT01783847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6183290|NCT01783847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6183291|NCT01783847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6183292|NCT01783847|Protective Agents|protective agents|mesh-ancestor
6183293|NCT01783847|Hematinics|hematinics|mesh-ancestor
6183294|NCT01783860|Azithromycin|azithromycin|mesh-list
6671137|NCT01547455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577627|NCT03876041|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5577628|NCT03876041|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
5577629|NCT03876041|BB 1101|bb 1101|mesh-list
6671138|NCT01547455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5577630|NCT03876041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6183295|NCT01783860|Doxycycline|doxycycline|mesh-list
6183296|NCT01783860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6183297|NCT01783860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6183298|NCT01783860|Antimalarials|antimalarials|mesh-ancestor
6183299|NCT01783860|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6183300|NCT01783860|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6183301|NCT01783886|Aflibercept|aflibercept|mesh-list
6183302|NCT01783886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6183303|NCT01783886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6183304|NCT01783886|Growth Substances|growth substances|mesh-ancestor
6183305|NCT01783886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577631|NCT03876041|Antiemetics|antiemetics|mesh-ancestor
5577632|NCT03876041|Autonomic Agents|autonomic agents|mesh-ancestor
6183306|NCT01783886|Growth Inhibitors|growth inhibitors|mesh-ancestor
6183307|NCT01783886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6183308|NCT01783912|Nicotine|nicotine|mesh-list
6183309|NCT01783912|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6183310|NCT01783912|Autonomic Agents|autonomic agents|mesh-ancestor
6183311|NCT01783912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6183312|NCT01783912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183313|NCT01783912|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6183314|NCT01783912|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6183315|NCT01783912|Cholinergic Agents|cholinergic agents|mesh-ancestor
6183316|NCT01783912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6183317|NCT01783912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183318|NCT01783938|Nivolumab|nivolumab|mesh-list
6183319|NCT01783938|Ipilimumab|ipilimumab|mesh-list
6183320|NCT01783938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6183321|NCT01783938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5577633|NCT03876041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5577634|NCT03876041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577635|NCT03876041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5577636|NCT03876041|Glucocorticoids|glucocorticoids|mesh-ancestor
5577637|NCT03876041|Hormones|hormones|mesh-ancestor
5577638|NCT03876041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5577639|NCT03876041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5577640|NCT03876041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5577641|NCT03876041|Protease Inhibitors|protease inhibitors|mesh-ancestor
5577642|NCT03876041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5577643|NCT03876041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577644|NCT03876041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5577645|NCT03876041|Protective Agents|protective agents|mesh-ancestor
5577646|NCT03875963|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5577647|NCT03875963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5577648|NCT03876067|Cardioplegic Solutions|cardioplegic solutions|mesh-list
5577649|NCT03876067|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5577650|NCT03875911|Mitomycins|mitomycins|mesh-list
5577651|NCT03875911|Mitomycin|mitomycin|mesh-list
5577652|NCT03875911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5577653|NCT03875911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5577654|NCT03875911|Alkylating Agents|alkylating agents|mesh-ancestor
5577655|NCT03875911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577656|NCT03875911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5577657|NCT03875911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5577658|NCT03875872|Propofol|propofol|mesh-list
5577659|NCT03875872|Anesthetics|anesthetics|mesh-list
5577660|NCT03875872|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
5577661|NCT03875872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6183322|NCT01783938|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6183323|NCT01783938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183324|NCT01783990|Hydroxyurea|hydroxyurea|mesh-list
6183325|NCT01783990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6183326|NCT01783990|Antisickling Agents|antisickling agents|mesh-ancestor
6183327|NCT01783990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6183328|NCT01783990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183329|NCT01783990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6183330|NCT01784029|Vitamin D|vitamin d|mesh-list
6183331|NCT01784029|Cholecalciferol|cholecalciferol|mesh-list
6183332|NCT01784029|Vitamins|vitamins|mesh-ancestor
6183333|NCT01784029|Micronutrients|micronutrients|mesh-ancestor
6183334|NCT01784029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183335|NCT01784029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6183336|NCT01784029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5577662|NCT03875872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5577663|NCT03875872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577664|NCT03875872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5577665|NCT03875872|Anesthetics, General|anesthetics, general|mesh-ancestor
5577666|NCT03875573|Durvalumab|durvalumab|mesh-list
6183337|NCT01784211|Insulin Glargine|insulin glargine|mesh-list
6183338|NCT01784211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6183339|NCT01784211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183340|NCT01784419|Ivacaftor|ivacaftor|mesh-list
6183341|NCT01784419|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6183342|NCT01784419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6183343|NCT01784419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183344|NCT01784523|Hydroxychloroquine|hydroxychloroquine|mesh-list
6183345|NCT01784523|Antimalarials|antimalarials|mesh-ancestor
6183346|NCT01784523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6183347|NCT01784523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6183348|NCT01784523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5577667|NCT03875573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5577668|NCT03875573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5577669|NCT03875755|Inositol|inositol|mesh-list
5577670|NCT03875755|Vitamin B Complex|vitamin b complex|mesh-ancestor
5577671|NCT03875755|Vitamins|vitamins|mesh-ancestor
5577672|NCT03875755|Micronutrients|micronutrients|mesh-ancestor
5577673|NCT03875755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604669|NCT04429685|Ketamine|ketamine|mesh-list
5604670|NCT04429685|Analgesics|analgesics|mesh-ancestor
6183349|NCT01784523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6183350|NCT01784523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183351|NCT01784523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6183352|NCT01784614|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6183353|NCT01784666|Isradipine|isradipine|mesh-list
6183354|NCT01784666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6183355|NCT01784666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6183356|NCT01784666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6183357|NCT01784666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183358|NCT01784666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6183359|NCT01784666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183360|NCT01784666|Vasodilator Agents|vasodilator agents|mesh-ancestor
6183361|NCT01784770|Azithromycin|azithromycin|mesh-list
6183362|NCT01784770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6183363|NCT01784770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6183364|NCT01784861|Everolimus|everolimus|mesh-list
6183365|NCT01784861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6183366|NCT01784861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6183367|NCT01784861|Immunologic Factors|immunologic factors|mesh-ancestor
6183368|NCT01784861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183369|NCT01784965|Liraglutide|liraglutide|mesh-list
6183370|NCT01784965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6183371|NCT01784965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183372|NCT01784965|Incretins|incretins|mesh-ancestor
6183373|NCT01784965|Hormones|hormones|mesh-ancestor
6183374|NCT01784965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6183375|NCT01785095|Hormones|hormones|mesh-list
6183376|NCT01785095|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6183377|NCT01785095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6183378|NCT01785095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183379|NCT01785160|Raltegravir Potassium|raltegravir potassium|mesh-list
5604671|NCT04429685|Sensory System Agents|sensory system agents|mesh-ancestor
5604672|NCT04429685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5604673|NCT04429685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604674|NCT04429685|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5604675|NCT04429685|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5604676|NCT04429685|Anesthetics, General|anesthetics, general|mesh-ancestor
5604677|NCT04429685|Anesthetics|anesthetics|mesh-ancestor
5604678|NCT04429685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5604679|NCT04429685|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5604680|NCT04429685|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5604681|NCT04429685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5604682|NCT04429685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604683|NCT04423237|Deferasirox|deferasirox|mesh-list
5604684|NCT04423237|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5604685|NCT04423237|Chelating Agents|chelating agents|mesh-ancestor
5604686|NCT04423237|Sequestering Agents|sequestering agents|mesh-ancestor
5604687|NCT04423237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604688|NCT04413266|Curcumin|curcumin|mesh-list
5604689|NCT04413266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5604690|NCT04413266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5604691|NCT04413266|Analgesics|analgesics|mesh-ancestor
5604692|NCT04413266|Sensory System Agents|sensory system agents|mesh-ancestor
5604693|NCT04413266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5604694|NCT04413266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604695|NCT04413266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5604696|NCT04413266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5604697|NCT04413266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5604698|NCT04413266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5604699|NCT04413266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604700|NCT04409795|Metformin|metformin|mesh-list
5604701|NCT04409795|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6183380|NCT01785160|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5604702|NCT04409795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6183381|NCT01785160|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6183382|NCT01785160|Antiviral Agents|antiviral agents|mesh-ancestor
5604703|NCT04409795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577674|NCT03875391|Oxytocin|oxytocin|mesh-list
5577675|NCT03875391|Oxytocics|oxytocics|mesh-ancestor
6183383|NCT01785160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6183384|NCT01785160|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6183385|NCT01785160|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6183386|NCT01785160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6183387|NCT01785160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183388|NCT01785186|Pyridoxine|pyridoxine|mesh-list
6183389|NCT01785186|Moxifloxacin|moxifloxacin|mesh-list
6183390|NCT01785186|Rifampin|rifampin|mesh-list
6183391|NCT01785186|Isoniazid|isoniazid|mesh-list
6183392|NCT01785186|Pyrazinamide|pyrazinamide|mesh-list
6183393|NCT01785186|Ethambutol|ethambutol|mesh-list
6183394|NCT01785186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6183395|NCT01785186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6183396|NCT01785186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6183397|NCT01785186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5577676|NCT03875391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5577677|NCT03875391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577678|NCT03875274|Morphine|morphine|mesh-list
5577679|NCT03875274|Ropivacaine|ropivacaine|mesh-list
6183398|NCT01785186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6183399|NCT01785186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183400|NCT01785186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6183401|NCT01785186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183402|NCT01785186|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6183403|NCT01785186|Antitubercular Agents|antitubercular agents|mesh-ancestor
6183404|NCT01785186|Leprostatic Agents|leprostatic agents|mesh-ancestor
6183405|NCT01785186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5577680|NCT03875274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5577681|NCT03875274|Narcotics|narcotics|mesh-ancestor
5577682|NCT03875274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5577683|NCT03875274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577684|NCT03875274|Analgesics|analgesics|mesh-ancestor
5577685|NCT03875274|Sensory System Agents|sensory system agents|mesh-ancestor
5577686|NCT03875274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5577687|NCT03875274|Anesthetics, Local|anesthetics, local|mesh-ancestor
5577688|NCT03875274|Anesthetics|anesthetics|mesh-ancestor
5577689|NCT03874975|Vitamin D|vitamin d|mesh-list
5577690|NCT03874975|Vitamins|vitamins|mesh-ancestor
5577691|NCT03874975|Micronutrients|micronutrients|mesh-ancestor
5577692|NCT03874975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577693|NCT03874975|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5577694|NCT03874832|Dihydroergotamine|dihydroergotamine|mesh-list
5577695|NCT03874832|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5577696|NCT03874832|Dopamine Agonists|dopamine agonists|mesh-ancestor
5577697|NCT03874832|Dopamine Agents|dopamine agents|mesh-ancestor
5577698|NCT03874832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5577699|NCT03874832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577700|NCT03874832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577701|NCT03874832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5577702|NCT03874832|Analgesics|analgesics|mesh-ancestor
5577703|NCT03874832|Sensory System Agents|sensory system agents|mesh-ancestor
5577704|NCT03874832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5577705|NCT03874936|Dexamethasone|dexamethasone|mesh-list
5577706|NCT03874936|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5577707|NCT03874936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5577708|NCT03874936|Antiemetics|antiemetics|mesh-ancestor
5577709|NCT03874936|Autonomic Agents|autonomic agents|mesh-ancestor
5577710|NCT03874936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5577711|NCT03874936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577712|NCT03874936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5577713|NCT03874936|Glucocorticoids|glucocorticoids|mesh-ancestor
5577714|NCT03874936|Hormones|hormones|mesh-ancestor
5577715|NCT03874936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5577716|NCT03874936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5577717|NCT03874936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5577718|NCT03874884|Olaparib|olaparib|mesh-list
5577719|NCT03874884|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5577720|NCT03874884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5577721|NCT03874884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577722|NCT03874884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5577723|NCT03874806|Ropivacaine|ropivacaine|mesh-list
6183406|NCT01785186|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5577724|NCT03874806|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5577725|NCT03874806|Anesthetics, Local|anesthetics, local|mesh-ancestor
6183407|NCT01785186|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5577726|NCT03874806|Anesthetics|anesthetics|mesh-ancestor
5577727|NCT03874806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5577728|NCT03874806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577729|NCT03874806|Sensory System Agents|sensory system agents|mesh-ancestor
5577730|NCT03874806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5577731|NCT03874741|Cetuximab|cetuximab|mesh-list
5577732|NCT03874741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5577733|NCT03874741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5577734|NCT03874585|Nicotine|nicotine|mesh-list
5577735|NCT03874585|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5577736|NCT03874585|Autonomic Agents|autonomic agents|mesh-ancestor
5577737|NCT03874585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5577738|NCT03874585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577739|NCT03874585|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5577740|NCT03874585|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5577741|NCT03874585|Cholinergic Agents|cholinergic agents|mesh-ancestor
5577742|NCT03874585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5577743|NCT03874585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577744|NCT03874364|Lidocaine|lidocaine|mesh-list
5577745|NCT03874364|Anesthetics, Local|anesthetics, local|mesh-ancestor
5577746|NCT03874364|Anesthetics|anesthetics|mesh-ancestor
5577747|NCT03874364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5577748|NCT03874364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577749|NCT03874364|Sensory System Agents|sensory system agents|mesh-ancestor
5577750|NCT03874364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5577751|NCT03874364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5577752|NCT03874364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5577753|NCT03874364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5577754|NCT03874364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5577755|NCT03874364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577756|NCT03874338|Colchicine|colchicine|mesh-list
6183408|NCT01785186|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6183409|NCT01785186|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6183410|NCT01785186|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6183411|NCT01785186|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6183412|NCT01785186|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6183413|NCT01785186|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6183414|NCT01785186|Antimetabolites|antimetabolites|mesh-ancestor
6183415|NCT01785186|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6183416|NCT01785186|Vitamin B Complex|vitamin b complex|mesh-ancestor
6183417|NCT01785186|Vitamins|vitamins|mesh-ancestor
6183418|NCT01785186|Micronutrients|micronutrients|mesh-ancestor
6183419|NCT01785459|Prochlorperazine|prochlorperazine|mesh-list
6183420|NCT01785459|Bupivacaine|bupivacaine|mesh-list
6183421|NCT01785459|Anesthetics, Local|anesthetics, local|mesh-ancestor
6183422|NCT01785459|Anesthetics|anesthetics|mesh-ancestor
6183423|NCT01785459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6183424|NCT01785459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183425|NCT01785459|Sensory System Agents|sensory system agents|mesh-ancestor
6183426|NCT01785459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6183427|NCT01785459|Antiemetics|antiemetics|mesh-ancestor
6183428|NCT01785459|Autonomic Agents|autonomic agents|mesh-ancestor
6183429|NCT01785459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6183430|NCT01785459|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6183431|NCT01785459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6183432|NCT01785459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6183433|NCT01785459|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6183434|NCT01785459|Dopamine Agents|dopamine agents|mesh-ancestor
6183435|NCT01785459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6183436|NCT01785459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183437|NCT01785472|Olmesartan|olmesartan|mesh-list
6183438|NCT01785472|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6183439|NCT01785472|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
6183440|NCT01785472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6183441|NCT01785472|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6183442|NCT01785472|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6183443|NCT01785472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183444|NCT01785615|Atorvastatin|atorvastatin|mesh-list
6183445|NCT01785615|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6183446|NCT01785615|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6183447|NCT01785615|Antimetabolites|antimetabolites|mesh-ancestor
6183448|NCT01785615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183449|NCT01785615|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5577757|NCT03874338|Gout Suppressants|gout suppressants|mesh-ancestor
6183450|NCT01785615|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6183451|NCT01785615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6183452|NCT01785810|Maraviroc|maraviroc|mesh-list
6183453|NCT01785810|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6183454|NCT01785810|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6183455|NCT01785810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577758|NCT03874338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5577759|NCT03874338|Tubulin Modulators|tubulin modulators|mesh-ancestor
5577760|NCT03874338|Antimitotic Agents|antimitotic agents|mesh-ancestor
5577761|NCT03874338|Mitosis Modulators|mitosis modulators|mesh-ancestor
5577762|NCT03874338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577763|NCT03874338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5577764|NCT03874273|Crizotinib|crizotinib|mesh-list
5577765|NCT03874273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5577766|NCT03874273|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5577767|NCT03874273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5577768|NCT03874273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577769|NCT03874286|Liver Extracts|liver extracts|mesh-list
5577770|NCT03874286|Hematinics|hematinics|mesh-ancestor
5577771|NCT03874130|Scopolamine|scopolamine|mesh-list
5577772|NCT03874130|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
6183456|NCT01785810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6183457|NCT01785810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6183458|NCT01785810|Antiviral Agents|antiviral agents|mesh-ancestor
6183459|NCT01785810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6183460|NCT01785810|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6183461|NCT01786109|Dronabinol|dronabinol|mesh-list
6183462|NCT01786109|Hallucinogens|hallucinogens|mesh-ancestor
6183463|NCT01786109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183464|NCT01786109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6183465|NCT01786109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6183466|NCT01786109|Analgesics|analgesics|mesh-ancestor
6183467|NCT01786109|Sensory System Agents|sensory system agents|mesh-ancestor
6183468|NCT01786109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6183469|NCT01786109|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6183470|NCT01786109|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6183471|NCT01786109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6183472|NCT01786109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183473|NCT01786109|Hormones|hormones|mesh-ancestor
6183474|NCT01786109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6183475|NCT01786161|Vancomycin|vancomycin|mesh-list
6183476|NCT01786161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6183477|NCT01786161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6183478|NCT01786174|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6183479|NCT01786174|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6183480|NCT01786174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183481|NCT01786174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6183482|NCT01786174|Immunologic Factors|immunologic factors|mesh-ancestor
6183483|NCT01786174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577773|NCT03874130|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5577774|NCT03874130|Antiemetics|antiemetics|mesh-ancestor
5577775|NCT03874130|Autonomic Agents|autonomic agents|mesh-ancestor
5577776|NCT03874130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5577777|NCT03874130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577778|NCT03874130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5577779|NCT03874130|Mydriatics|mydriatics|mesh-ancestor
5577780|NCT03874130|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5577781|NCT03874130|Cholinergic Agents|cholinergic agents|mesh-ancestor
5577782|NCT03874130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5577783|NCT03874130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577784|NCT03874130|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5577785|NCT03874130|Parasympatholytics|parasympatholytics|mesh-ancestor
5577786|NCT03874260|Fenofibrate|fenofibrate|mesh-list
5577787|NCT03874260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5577788|NCT03874260|Antimetabolites|antimetabolites|mesh-ancestor
5577789|NCT03874260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577790|NCT03874260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5577791|NCT03874000|Metformin|metformin|mesh-list
5577792|NCT03874000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6183484|NCT01786239|Risperidone|risperidone|mesh-list
6488095|NCT00580619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577793|NCT03874000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183485|NCT01786239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6183486|NCT01786239|Serotonin Agents|serotonin agents|mesh-ancestor
6183487|NCT01786239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6183488|NCT01786239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183489|NCT01786239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183490|NCT01786239|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6183491|NCT01786239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6183492|NCT01786239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6183493|NCT01786239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6183494|NCT01786239|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6183495|NCT01786239|Dopamine Agents|dopamine agents|mesh-ancestor
5577794|NCT03874026|Cetuximab|cetuximab|mesh-list
5577795|NCT03874026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5577796|NCT03874026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5577797|NCT03874052|Venetoclax|venetoclax|mesh-list
5577798|NCT03874052|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
5577799|NCT03874052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5577800|NCT03874052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5577801|NCT03874052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5577802|NCT03874052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577803|NCT03874156|Atorvastatin|atorvastatin|mesh-list
5577804|NCT03874156|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5577805|NCT03874156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5577806|NCT03874156|Antimetabolites|antimetabolites|mesh-ancestor
5577807|NCT03874156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577808|NCT03874156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5577809|NCT03874156|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5577810|NCT03874156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5577811|NCT03873974|Immunoglobulin G|immunoglobulin g|mesh-list
5577812|NCT03873974|Immunoglobulin M|immunoglobulin m|mesh-list
5577813|NCT03873974|Immunologic Factors|immunologic factors|mesh-ancestor
5577814|NCT03873974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577815|NCT03873883|Pembrolizumab|pembrolizumab|mesh-list
5577816|NCT03873883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5577817|NCT03873883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5577818|NCT03873727|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5577819|NCT03873727|Immunologic Factors|immunologic factors|mesh-ancestor
5577820|NCT03873727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577821|NCT03873805|Vidarabine|vidarabine|mesh-list
5577822|NCT03873805|Cyclophosphamide|cyclophosphamide|mesh-list
5577823|NCT03873805|Fludarabine|fludarabine|mesh-list
5577824|NCT03873805|Fludarabine phosphate|fludarabine phosphate|mesh-list
5577825|NCT03873805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5577826|NCT03873805|Immunologic Factors|immunologic factors|mesh-ancestor
5577827|NCT03873805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577828|NCT03873805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5577829|NCT03873805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5577830|NCT03873805|Alkylating Agents|alkylating agents|mesh-ancestor
5577831|NCT03873805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577832|NCT03873805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5577833|NCT03873805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5577834|NCT03873805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5577835|NCT03873805|Antimetabolites|antimetabolites|mesh-ancestor
5577836|NCT03873805|Antiviral Agents|antiviral agents|mesh-ancestor
5577837|NCT03873805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5577838|NCT03873857|Venetoclax|venetoclax|mesh-list
5577839|NCT03873857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5577840|NCT03873389|Ocrelizumab|ocrelizumab|mesh-list
6183496|NCT01786252|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6183497|NCT01786252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6183498|NCT01786252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183499|NCT01786343|Decitabine|decitabine|mesh-list
6183500|NCT01786343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6183501|NCT01786343|Antimetabolites|antimetabolites|mesh-ancestor
6183502|NCT01786343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183503|NCT01786343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6183504|NCT01786343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6183505|NCT01786551|Eplerenone|eplerenone|mesh-list
5577841|NCT03873389|Immunologic Factors|immunologic factors|mesh-ancestor
5577842|NCT03873389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604704|NCT04409795|Incretins|incretins|mesh-ancestor
5604705|NCT04409795|Hormones|hormones|mesh-ancestor
5604706|NCT04409795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6488096|NCT00580619|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5725625|NCT03179293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6488097|NCT00580619|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5725626|NCT03179293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5725627|NCT03179293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725628|NCT03179293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5725629|NCT03179293|Anesthetics, General|anesthetics, general|mesh-ancestor
5725630|NCT03179293|Anesthetics|anesthetics|mesh-ancestor
5725631|NCT03179280|Insulin|insulin|mesh-list
5725632|NCT03179280|Insulin Aspart|insulin aspart|mesh-list
5725633|NCT03179280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5725634|NCT03179280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725635|NCT03178994|Ketoconazole|ketoconazole|mesh-list
5725636|NCT03178994|Antifungal Agents|antifungal agents|mesh-ancestor
6183506|NCT01786551|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6183507|NCT01786551|Hormone Antagonists|hormone antagonists|mesh-ancestor
6183508|NCT01786551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6183509|NCT01786551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183510|NCT01786551|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6183511|NCT01786551|Diuretics|diuretics|mesh-ancestor
6183512|NCT01786551|Natriuretic Agents|natriuretic agents|mesh-ancestor
6183513|NCT01786551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6183514|NCT01786603|Rasagiline|rasagiline|mesh-list
6183515|NCT01786603|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6183516|NCT01786603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6183517|NCT01786603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183518|NCT01786603|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6183519|NCT01786603|Protective Agents|protective agents|mesh-ancestor
6183520|NCT01786603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183521|NCT01786668|Tofacitinib|tofacitinib|mesh-list
6183522|NCT01786668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6183523|NCT01786668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6183524|NCT01786668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183525|NCT01786707|Metformin|metformin|mesh-list
6183526|NCT01786707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6183527|NCT01786707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183528|NCT01786902|Hormones|hormones|mesh-list
5577843|NCT03873298|Nitric Oxide|nitric oxide|mesh-list
5577844|NCT03873298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5577845|NCT03873298|Autonomic Agents|autonomic agents|mesh-ancestor
5577846|NCT03873298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5577847|NCT03873298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577848|NCT03873298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5577849|NCT03873298|Respiratory System Agents|respiratory system agents|mesh-ancestor
5577850|NCT03873298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5577851|NCT03873298|Antioxidants|antioxidants|mesh-ancestor
5577852|NCT03873298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577853|NCT03873298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5577854|NCT03873298|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5577855|NCT03873298|Vasodilator Agents|vasodilator agents|mesh-ancestor
5577856|NCT03873298|Gasotransmitters|gasotransmitters|mesh-ancestor
5577857|NCT03873298|Protective Agents|protective agents|mesh-ancestor
5577858|NCT03873337|Nicotine|nicotine|mesh-list
5577859|NCT03873337|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5577860|NCT03873337|Autonomic Agents|autonomic agents|mesh-ancestor
5577861|NCT03873337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5577862|NCT03873337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577863|NCT03873337|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5577864|NCT03873337|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5577865|NCT03873337|Cholinergic Agents|cholinergic agents|mesh-ancestor
5577866|NCT03873337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5577867|NCT03873337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577868|NCT03873311|Cytarabine|cytarabine|mesh-list
5577869|NCT03873311|Azacitidine|azacitidine|mesh-list
5577870|NCT03873311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5577871|NCT03873311|Antimetabolites|antimetabolites|mesh-ancestor
5577872|NCT03873311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577873|NCT03873311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5577874|NCT03873311|Antiviral Agents|antiviral agents|mesh-ancestor
5577875|NCT03873311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5577876|NCT03873311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5577877|NCT03873311|Immunologic Factors|immunologic factors|mesh-ancestor
5577878|NCT03873311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183529|NCT01786902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5725637|NCT03178994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6183530|NCT01786902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183531|NCT01786967|Fesoterodine|fesoterodine|mesh-list
5577879|NCT03873311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5577880|NCT03873740|Vaccines|vaccines|mesh-list
5577881|NCT03873740|Immunologic Factors|immunologic factors|mesh-ancestor
5577882|NCT03873740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577883|NCT03873025|Pembrolizumab|pembrolizumab|mesh-list
5577884|NCT03873025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5577885|NCT03873025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5577886|NCT03872661|Bevacizumab|bevacizumab|mesh-list
5577887|NCT03872661|Carboplatin|carboplatin|mesh-list
5577888|NCT03872661|Pemetrexed|pemetrexed|mesh-list
5577889|NCT03872661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5577890|NCT03872661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6183532|NCT01786967|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6183533|NCT01786967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6183534|NCT01786967|Cholinergic Agents|cholinergic agents|mesh-ancestor
6183535|NCT01786967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6183536|NCT01786967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183537|NCT01786967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183538|NCT01786967|Urological Agents|urological agents|mesh-ancestor
6183539|NCT01787006|Fluorouracil|fluorouracil|mesh-list
6183540|NCT01787006|Cetuximab|cetuximab|mesh-list
6183541|NCT01787006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6183542|NCT01787006|Antimetabolites|antimetabolites|mesh-ancestor
6183543|NCT01787006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183544|NCT01787006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6183545|NCT01787006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5577891|NCT03872661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5577892|NCT03872661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5577893|NCT03872661|Growth Substances|growth substances|mesh-ancestor
5577894|NCT03872661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183546|NCT01787006|Immunologic Factors|immunologic factors|mesh-ancestor
6183547|NCT01787006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183548|NCT01787006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6183549|NCT01787032|Ketoconazole|ketoconazole|mesh-list
6183550|NCT01787032|Voriconazole|voriconazole|mesh-list
6183551|NCT01787032|Antifungal Agents|antifungal agents|mesh-ancestor
6183552|NCT01787032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5577895|NCT03872661|Growth Inhibitors|growth inhibitors|mesh-ancestor
5577896|NCT03872661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5577897|NCT03872661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577898|NCT03872661|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5577899|NCT03872661|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5577900|NCT03872700|Fentanyl|fentanyl|mesh-list
5577901|NCT03872700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5577902|NCT03872700|Narcotics|narcotics|mesh-ancestor
5577903|NCT03872700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5577904|NCT03872700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577905|NCT03872700|Analgesics|analgesics|mesh-ancestor
5577906|NCT03872700|Sensory System Agents|sensory system agents|mesh-ancestor
5577907|NCT03872700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5577908|NCT03872700|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5577909|NCT03872700|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5577910|NCT03872700|Anesthetics, General|anesthetics, general|mesh-ancestor
5577911|NCT03872700|Anesthetics|anesthetics|mesh-ancestor
5577912|NCT03872830|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
5577913|NCT03872830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5577914|NCT03872830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5577915|NCT03872830|Analgesics|analgesics|mesh-ancestor
5577916|NCT03872830|Sensory System Agents|sensory system agents|mesh-ancestor
5577917|NCT03872830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5577918|NCT03872830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577919|NCT03872830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5577920|NCT03872830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5577921|NCT03872596|Quetiapine Fumarate|quetiapine fumarate|mesh-list
5577922|NCT03872596|Antidepressive Agents|antidepressive agents|mesh-ancestor
5577923|NCT03872596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5577924|NCT03872596|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5577925|NCT03872596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5577926|NCT03872596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5577927|NCT03872596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577928|NCT03872570|Phenylephrine|phenylephrine|mesh-list
6183553|NCT01787032|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6183554|NCT01787032|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5577929|NCT03872570|Oxymetazoline|oxymetazoline|mesh-list
5577930|NCT03872570|Norepinephrine|norepinephrine|mesh-list
6183555|NCT01787032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6183556|NCT01787032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183557|NCT01787032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6183558|NCT01787032|Hormone Antagonists|hormone antagonists|mesh-ancestor
6183559|NCT01787032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6183560|NCT01787032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183561|NCT01787032|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6183562|NCT01787097|Formoterol Fumarate|formoterol fumarate|mesh-list
5577931|NCT03872570|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5577932|NCT03872570|Mydriatics|mydriatics|mesh-ancestor
5577933|NCT03872570|Autonomic Agents|autonomic agents|mesh-ancestor
5577934|NCT03872570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5577935|NCT03872570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5577936|NCT03872570|Sympathomimetics|sympathomimetics|mesh-ancestor
5577937|NCT03872570|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6183563|NCT01787097|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6183564|NCT01787097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6183565|NCT01787097|Autonomic Agents|autonomic agents|mesh-ancestor
6183566|NCT01787097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6183567|NCT01787097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183568|NCT01787097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6183569|NCT01787097|Respiratory System Agents|respiratory system agents|mesh-ancestor
5577938|NCT03872570|Nasal Decongestants|nasal decongestants|mesh-ancestor
5577939|NCT03872570|Respiratory System Agents|respiratory system agents|mesh-ancestor
5577940|NCT03872570|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5577941|NCT03872570|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5577942|NCT03872570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5577943|NCT03872570|Adrenergic Agents|adrenergic agents|mesh-ancestor
5577944|NCT03872570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5577945|NCT03872570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577946|NCT03872570|Protective Agents|protective agents|mesh-ancestor
5577947|NCT03872505|Paclitaxel|paclitaxel|mesh-list
5577948|NCT03872505|Carboplatin|carboplatin|mesh-list
5577949|NCT03872505|Durvalumab|durvalumab|mesh-list
5577950|NCT03872505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5577951|NCT03872505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5577952|NCT03872505|Tubulin Modulators|tubulin modulators|mesh-ancestor
5577953|NCT03872505|Antimitotic Agents|antimitotic agents|mesh-ancestor
5577954|NCT03872505|Mitosis Modulators|mitosis modulators|mesh-ancestor
5577955|NCT03872505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183570|NCT01787097|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6183571|NCT01787097|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6183572|NCT01787097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6183573|NCT01787097|Adrenergic Agents|adrenergic agents|mesh-ancestor
6183574|NCT01787097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6183575|NCT01787097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183576|NCT01787188|Meloxicam|meloxicam|mesh-list
6183577|NCT01787188|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5577956|NCT03872505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5577957|NCT03872336|Labetalol|labetalol|mesh-list
5577958|NCT03872336|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5577959|NCT03872336|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5577960|NCT03872336|Adrenergic Agents|adrenergic agents|mesh-ancestor
5577961|NCT03872336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5577962|NCT03872336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577963|NCT03872336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183578|NCT01787188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6183579|NCT01787188|Analgesics|analgesics|mesh-ancestor
5577964|NCT03872336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5577965|NCT03872336|Sympathomimetics|sympathomimetics|mesh-ancestor
5577966|NCT03872336|Autonomic Agents|autonomic agents|mesh-ancestor
5577967|NCT03872336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5577968|NCT03872336|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5577969|NCT03872336|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5577970|NCT03873415|BMS-986165|bms-986165|mesh-list
5577971|NCT03873415|Dermatologic Agents|dermatologic agents|mesh-ancestor
5577972|NCT03873415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5577973|NCT03873415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5577974|NCT03873415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577975|NCT03873532|Capecitabine|capecitabine|mesh-list
5577976|NCT03873532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5577977|NCT03873532|Antimetabolites|antimetabolites|mesh-ancestor
5604707|NCT04409795|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5577978|NCT03873532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577979|NCT03873532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5577980|NCT03872232|Telmisartan|telmisartan|mesh-list
5577981|NCT03872232|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5577982|NCT03872232|Ezetimibe|ezetimibe|mesh-list
5577983|NCT03872232|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5577984|NCT03872232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5577985|NCT03872232|Antimetabolites|antimetabolites|mesh-ancestor
5577986|NCT03872232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5577987|NCT03872232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5577988|NCT03872232|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5577989|NCT03872232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5577990|NCT03872232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5577991|NCT03872232|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5577992|NCT03872232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5577993|NCT03872388|Capecitabine|capecitabine|mesh-list
5577994|NCT03872388|Atorvastatin|atorvastatin|mesh-list
5577995|NCT03872388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5577996|NCT03872388|Antimetabolites|antimetabolites|mesh-ancestor
5577997|NCT03872388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183580|NCT01787188|Sensory System Agents|sensory system agents|mesh-ancestor
6183581|NCT01787188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6183582|NCT01787188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183583|NCT01787188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6183584|NCT01787188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6183585|NCT01787188|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6183586|NCT01787188|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6183587|NCT01787188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5577998|NCT03872388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5577999|NCT03872388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5578000|NCT03872388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5578001|NCT03872388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5578002|NCT03872388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5578003|NCT03872388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5578004|NCT03871972|Sirolimus|sirolimus|mesh-list
5578005|NCT03871972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5578006|NCT03871972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6183588|NCT01787188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183589|NCT01787240|Citalopram|citalopram|mesh-list
6183590|NCT01787240|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6183591|NCT01787240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6183592|NCT01787240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6183593|NCT01787240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183594|NCT01787240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6183595|NCT01787240|Serotonin Agents|serotonin agents|mesh-ancestor
6183596|NCT01787240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183597|NCT01787240|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6183598|NCT01787240|Antidepressive Agents|antidepressive agents|mesh-ancestor
6183599|NCT01787240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6183600|NCT01787279|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6183601|NCT01787279|Antiviral Agents|antiviral agents|mesh-ancestor
6183602|NCT01787279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6183603|NCT01787331|Itraconazole|itraconazole|mesh-list
6183604|NCT01787331|Antifungal Agents|antifungal agents|mesh-ancestor
6183605|NCT01787331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6183606|NCT01787331|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6183607|NCT01787331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6183608|NCT01787331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6183609|NCT01787331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183610|NCT01787331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6183611|NCT01787331|Hormone Antagonists|hormone antagonists|mesh-ancestor
6183612|NCT01787331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6183613|NCT01787331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183614|NCT01787331|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6183615|NCT01787916|Liraglutide|liraglutide|mesh-list
6183616|NCT01787916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6183617|NCT01787916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183618|NCT01787916|Incretins|incretins|mesh-ancestor
6183619|NCT01787916|Hormones|hormones|mesh-ancestor
6183620|NCT01787916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6183621|NCT01788215|Doxycycline|doxycycline|mesh-list
6488098|NCT00580619|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6183622|NCT01788215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6183623|NCT01788215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6183624|NCT01788215|Antimalarials|antimalarials|mesh-ancestor
6183625|NCT01788215|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6183626|NCT01788215|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6183627|NCT01788228|Vaccines|vaccines|mesh-list
6183628|NCT01788228|Immunologic Factors|immunologic factors|mesh-ancestor
6183629|NCT01788228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183630|NCT01788358|Candesartan|candesartan|mesh-list
6183631|NCT01788358|Candesartan cilexetil|candesartan cilexetil|mesh-list
6183632|NCT01788358|Nifedipine|nifedipine|mesh-list
6183633|NCT01788358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5578007|NCT03871972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5578008|NCT03871972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5578009|NCT03871972|Antifungal Agents|antifungal agents|mesh-ancestor
6183634|NCT01788358|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6183635|NCT01788358|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6183636|NCT01788358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183637|NCT01788358|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6183638|NCT01788358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6183639|NCT01788358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6183640|NCT01788358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183641|NCT01788358|Vasodilator Agents|vasodilator agents|mesh-ancestor
6183642|NCT01788358|Tocolytic Agents|tocolytic agents|mesh-ancestor
6183643|NCT01788358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6183644|NCT01788566|Gemcitabine|gemcitabine|mesh-list
6183645|NCT01788566|Necitumumab|necitumumab|mesh-list
6183646|NCT01788566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6183647|NCT01788566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6183648|NCT01788566|Antimetabolites|antimetabolites|mesh-ancestor
6183649|NCT01788566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183650|NCT01788566|Antiviral Agents|antiviral agents|mesh-ancestor
6183651|NCT01788566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6183652|NCT01788566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6183653|NCT01788566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6183654|NCT01788566|Immunologic Factors|immunologic factors|mesh-ancestor
6183655|NCT01788566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183656|NCT01788566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6183657|NCT01788631|Regadenoson|regadenoson|mesh-list
6183658|NCT01788631|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
6183659|NCT01788631|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6183660|NCT01788631|Purinergic Agonists|purinergic agonists|mesh-ancestor
6183661|NCT01788631|Purinergic Agents|purinergic agents|mesh-ancestor
6183662|NCT01788631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6183663|NCT01788631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183664|NCT01788631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183665|NCT01789047|Topiramate|topiramate|mesh-list
6183666|NCT01789047|Amantadine|amantadine|mesh-list
6183667|NCT01789047|Anticonvulsants|anticonvulsants|mesh-ancestor
6183668|NCT01789047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6183669|NCT01789047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183670|NCT01789047|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6183671|NCT01789047|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6183672|NCT01789047|Antiviral Agents|antiviral agents|mesh-ancestor
6183673|NCT01789047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6183674|NCT01789047|Dopamine Agents|dopamine agents|mesh-ancestor
6183675|NCT01789047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6183676|NCT01789047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183677|NCT01789047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6183678|NCT01789047|Analgesics|analgesics|mesh-ancestor
6183679|NCT01789047|Sensory System Agents|sensory system agents|mesh-ancestor
6183680|NCT01789047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6183681|NCT01789203|Ciprofloxacin|ciprofloxacin|mesh-list
6183682|NCT01789203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6183683|NCT01789203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6183684|NCT01789203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6183685|NCT01789203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6183686|NCT01789203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6183687|NCT01789203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183688|NCT01789203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6183689|NCT01789203|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6183690|NCT01789203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6183691|NCT01789255|Cyclosporine|cyclosporine|mesh-list
6183692|NCT01789255|Methotrexate|methotrexate|mesh-list
6183693|NCT01789255|Vorinostat|vorinostat|mesh-list
5578010|NCT03871972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5578011|NCT03871972|Immunologic Factors|immunologic factors|mesh-ancestor
5578012|NCT03871972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578013|NCT03871959|Pembrolizumab|pembrolizumab|mesh-list
5578014|NCT03871959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5578015|NCT03871959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5578016|NCT03872011|Vitamins|vitamins|mesh-list
5578017|NCT03872011|Ascorbic Acid|ascorbic acid|mesh-list
5578018|NCT03872011|Thiamine|thiamine|mesh-list
5578019|NCT03872011|Hydrocortisone|hydrocortisone|mesh-list
5578020|NCT03872011|Micronutrients|micronutrients|mesh-ancestor
5578021|NCT03872011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578022|NCT03872011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5578023|NCT03872011|Antioxidants|antioxidants|mesh-ancestor
5578024|NCT03872011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578025|NCT03872011|Protective Agents|protective agents|mesh-ancestor
5578026|NCT03872011|Vitamin B Complex|vitamin b complex|mesh-ancestor
5578027|NCT03871777|Chlorhexidine|chlorhexidine|mesh-list
5578028|NCT03871777|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5578029|NCT03871777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6183694|NCT01789255|Tacrolimus|tacrolimus|mesh-list
6183695|NCT01789255|Cyclosporins|cyclosporins|mesh-list
6183696|NCT01789255|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6183697|NCT01789255|Abortifacient Agents|abortifacient agents|mesh-ancestor
6183698|NCT01789255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6183699|NCT01789255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183700|NCT01789255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6183701|NCT01789255|Antimetabolites|antimetabolites|mesh-ancestor
6183702|NCT01789255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183703|NCT01789255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6183704|NCT01789255|Dermatologic Agents|dermatologic agents|mesh-ancestor
6183705|NCT01789255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6183706|NCT01789255|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6183707|NCT01789255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6183708|NCT01789255|Immunologic Factors|immunologic factors|mesh-ancestor
6183709|NCT01789255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6183710|NCT01789255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6183711|NCT01789255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6183712|NCT01789255|Antifungal Agents|antifungal agents|mesh-ancestor
6183713|NCT01789255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6183714|NCT01789255|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6183715|NCT01789281|Everolimus|everolimus|mesh-list
6183716|NCT01789281|Octreotide|octreotide|mesh-list
6183717|NCT01789281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5578030|NCT03871777|Disinfectants|disinfectants|mesh-ancestor
5578031|NCT03871621|Metformin|metformin|mesh-list
5578032|NCT03871621|Dapagliflozin|dapagliflozin|mesh-list
5578033|NCT03871621|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
5578034|NCT03871621|Meglitinide|meglitinide|mesh-list
5578035|NCT03871621|Hypoglycemic Agents|hypoglycemic agents|mesh-list
5578036|NCT03871621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183718|NCT01789281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6183719|NCT01789281|Immunologic Factors|immunologic factors|mesh-ancestor
6183720|NCT01789281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183721|NCT01789281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6183722|NCT01789281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6183723|NCT01789320|Triamcinolone|triamcinolone|mesh-list
6183724|NCT01789320|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6183725|NCT01789320|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6183726|NCT01789320|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6183727|NCT01789320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6183728|NCT01789320|Glucocorticoids|glucocorticoids|mesh-ancestor
6183729|NCT01789320|Hormones|hormones|mesh-ancestor
6183730|NCT01789320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6183731|NCT01789320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578037|NCT03871621|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5578038|NCT03871621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183732|NCT01789320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6183733|NCT01789320|Immunologic Factors|immunologic factors|mesh-ancestor
6183734|NCT01789320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6183735|NCT01789320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183736|NCT01789606|Ibuprofen|ibuprofen|mesh-list
6183737|NCT01789606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5578039|NCT03871803|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
5578040|NCT03871803|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5578041|NCT03871803|Adrenergic Agents|adrenergic agents|mesh-ancestor
5578042|NCT03871803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5578043|NCT03871803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578044|NCT03871803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578045|NCT03871517|Aspirin|aspirin|mesh-list
5578046|NCT03871517|Indobufen|indobufen|mesh-list
5578047|NCT03871517|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5578048|NCT03871517|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5578049|NCT03871517|Analgesics|analgesics|mesh-ancestor
5578050|NCT03871517|Sensory System Agents|sensory system agents|mesh-ancestor
5578051|NCT03871517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5578052|NCT03871517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578053|NCT03871517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6183738|NCT01789606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6183739|NCT01789606|Analgesics|analgesics|mesh-ancestor
6183740|NCT01789606|Sensory System Agents|sensory system agents|mesh-ancestor
6183741|NCT01789606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6183742|NCT01789606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183743|NCT01789606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6183744|NCT01789606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6183745|NCT01789606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6183746|NCT01789606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6183747|NCT01789606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206781|NCT02105415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6206782|NCT02105415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6206783|NCT02105415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206784|NCT02105454|Ribavirin|ribavirin|mesh-list
6206785|NCT02105454|Grazoprevir|grazoprevir|mesh-list
6206786|NCT02105454|Antimetabolites|antimetabolites|mesh-ancestor
6206787|NCT02105454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671139|NCT01547455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6671140|NCT01547455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6671141|NCT01547468|Analgesics, Opioid|analgesics, opioid|mesh-list
6671142|NCT01547468|Narcotics|narcotics|mesh-ancestor
6671143|NCT01547468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6671144|NCT01547468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671145|NCT01547468|Analgesics|analgesics|mesh-ancestor
6671146|NCT01547468|Sensory System Agents|sensory system agents|mesh-ancestor
6671147|NCT01547468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6671148|NCT01547494|Vitamins|vitamins|mesh-list
6671149|NCT01547494|Micronutrients|micronutrients|mesh-ancestor
6206788|NCT02105454|Antiviral Agents|antiviral agents|mesh-ancestor
6206789|NCT02105454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6206790|NCT02105467|Grazoprevir|grazoprevir|mesh-list
6206791|NCT02105467|Antiviral Agents|antiviral agents|mesh-ancestor
5578054|NCT03871517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5578055|NCT03871517|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5578056|NCT03871517|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5578057|NCT03871517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578058|NCT03871517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5578059|NCT03871517|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5578060|NCT03871517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5578061|NCT03871517|Antipyretics|antipyretics|mesh-ancestor
5578062|NCT03871491|Azithromycin|azithromycin|mesh-list
5578063|NCT03871491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6206792|NCT02105467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6206793|NCT02105558|Anesthetics|anesthetics|mesh-list
6206794|NCT02105558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6206795|NCT02105558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206796|NCT02105662|Grazoprevir|grazoprevir|mesh-list
6206797|NCT02105662|Antiviral Agents|antiviral agents|mesh-ancestor
6206798|NCT02105662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6206799|NCT02105688|Grazoprevir|grazoprevir|mesh-list
6206800|NCT02105688|Antiviral Agents|antiviral agents|mesh-ancestor
6206801|NCT02105688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6206802|NCT02105701|Ribavirin|ribavirin|mesh-list
6206803|NCT02105701|Grazoprevir|grazoprevir|mesh-list
5578064|NCT03871491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6183748|NCT01789814|Clopidogrel|clopidogrel|mesh-list
6183749|NCT01789814|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6183750|NCT01789814|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6183751|NCT01789814|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6183752|NCT01789814|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6183753|NCT01789814|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6183754|NCT01789814|Purinergic Agents|purinergic agents|mesh-ancestor
6183755|NCT01789814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6183756|NCT01789814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183757|NCT01789814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183758|NCT01789905|Tigecycline|tigecycline|mesh-list
6183759|NCT01789905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5578065|NCT03871361|Abatacept|abatacept|mesh-list
5578066|NCT03871361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5578067|NCT03871361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578068|NCT03871361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5578069|NCT03871361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5578070|NCT03871361|Immunologic Factors|immunologic factors|mesh-ancestor
5578071|NCT03871361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578072|NCT03871361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5578073|NCT03871218|Hyaluronic Acid|hyaluronic acid|mesh-list
6183760|NCT01789905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6671150|NCT01547494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671151|NCT01547520|Meperidine|meperidine|mesh-list
6671152|NCT01547520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6671153|NCT01547520|Narcotics|narcotics|mesh-ancestor
6671154|NCT01547520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6183761|NCT01789905|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6183762|NCT01789905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6183763|NCT01789905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183764|NCT01789970|Hydrocodone|hydrocodone|mesh-list
6183765|NCT01789970|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6183766|NCT01789970|Narcotics|narcotics|mesh-ancestor
6183767|NCT01789970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6183768|NCT01789970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183769|NCT01789970|Analgesics|analgesics|mesh-ancestor
6183770|NCT01789970|Sensory System Agents|sensory system agents|mesh-ancestor
6183771|NCT01789970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6183772|NCT01789970|Antitussive Agents|antitussive agents|mesh-ancestor
6183773|NCT01789970|Respiratory System Agents|respiratory system agents|mesh-ancestor
6183774|NCT01790126|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6183775|NCT01790126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6183776|NCT01790126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6183777|NCT01790126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6183778|NCT01790126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183779|NCT01790126|Luteolytic Agents|luteolytic agents|mesh-ancestor
6183780|NCT01790126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6183781|NCT01790126|Contraceptive Agents|contraceptive agents|mesh-ancestor
6183782|NCT01790126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6183783|NCT01790438|Insulin|insulin|mesh-list
6183784|NCT01790438|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6183785|NCT01790438|Isophane Insulin, Human|isophane insulin, human|mesh-list
6183786|NCT01790438|Insulin, Isophane|insulin, isophane|mesh-list
6183787|NCT01790438|Isophane insulin, beef|isophane insulin, beef|mesh-list
6183788|NCT01790438|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6183789|NCT01790438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183790|NCT01790490|Ketamine|ketamine|mesh-list
6183791|NCT01790490|Lorazepam|lorazepam|mesh-list
6183792|NCT01790490|Analgesics|analgesics|mesh-ancestor
6183793|NCT01790490|Sensory System Agents|sensory system agents|mesh-ancestor
6183794|NCT01790490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6183795|NCT01790490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183796|NCT01790490|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6183797|NCT01790490|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6183798|NCT01790490|Anesthetics, General|anesthetics, general|mesh-ancestor
6183799|NCT01790490|Anesthetics|anesthetics|mesh-ancestor
6183800|NCT01790490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6183801|NCT01790490|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6183802|NCT01790490|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6183803|NCT01790490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6206804|NCT02105701|Antimetabolites|antimetabolites|mesh-ancestor
6671155|NCT01547520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578074|NCT03871218|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5578075|NCT03871218|Immunologic Factors|immunologic factors|mesh-ancestor
5578076|NCT03871218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183804|NCT01790490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183805|NCT01790490|Anticonvulsants|anticonvulsants|mesh-ancestor
5578077|NCT03871218|Viscosupplements|viscosupplements|mesh-ancestor
5578078|NCT03871218|Protective Agents|protective agents|mesh-ancestor
5578079|NCT03871322|Vitamin D|vitamin d|mesh-list
5578080|NCT03871322|Ergocalciferols|ergocalciferols|mesh-list
5578081|NCT03871322|Vitamins|vitamins|mesh-list
5578082|NCT03871322|Micronutrients|micronutrients|mesh-ancestor
5578083|NCT03871322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578084|NCT03871322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5578085|NCT03871322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5578086|NCT03871478|Lidocaine|lidocaine|mesh-list
5578087|NCT03871478|Bupivacaine|bupivacaine|mesh-list
5578088|NCT03871478|Anesthetics, Local|anesthetics, local|mesh-ancestor
5578089|NCT03871478|Anesthetics|anesthetics|mesh-ancestor
5578090|NCT03871478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5578091|NCT03871478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578092|NCT03871478|Sensory System Agents|sensory system agents|mesh-ancestor
5578093|NCT03871478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5578094|NCT03871478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5578095|NCT03871478|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5578096|NCT03871478|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5578097|NCT03871478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5578098|NCT03871478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578099|NCT03871036|Paclitaxel|paclitaxel|mesh-list
5578100|NCT03871036|Durvalumab|durvalumab|mesh-list
5578101|NCT03871036|Tremelimumab|tremelimumab|mesh-list
6183806|NCT01790490|Antiemetics|antiemetics|mesh-ancestor
6183807|NCT01790490|Autonomic Agents|autonomic agents|mesh-ancestor
6183808|NCT01790490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6183809|NCT01790490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6183810|NCT01790490|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6183811|NCT01790490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6183812|NCT01790490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6183813|NCT01790490|GABA Modulators|gaba modulators|mesh-ancestor
6183814|NCT01790490|GABA Agents|gaba agents|mesh-ancestor
6183815|NCT01790503|Temozolomide|temozolomide|mesh-list
6183816|NCT01790503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5578102|NCT03871036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5578103|NCT03871036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5578104|NCT03871036|Tubulin Modulators|tubulin modulators|mesh-ancestor
5578105|NCT03871036|Antimitotic Agents|antimitotic agents|mesh-ancestor
5578106|NCT03871036|Mitosis Modulators|mitosis modulators|mesh-ancestor
5578107|NCT03871036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578108|NCT03871036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5578109|NCT03871062|Anesthetics|anesthetics|mesh-list
5578110|NCT03871062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5578111|NCT03871062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183817|NCT01790503|Alkylating Agents|alkylating agents|mesh-ancestor
6183818|NCT01790503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183819|NCT01790503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6183820|NCT01790516|Cetuximab|cetuximab|mesh-list
6183821|NCT01790516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6183822|NCT01790516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6183823|NCT01790568|Methotrexate|methotrexate|mesh-list
6183824|NCT01790568|Vorinostat|vorinostat|mesh-list
6183825|NCT01790568|Tacrolimus|tacrolimus|mesh-list
6183826|NCT01790568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6183827|NCT01790568|Abortifacient Agents|abortifacient agents|mesh-ancestor
6183828|NCT01790568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6183829|NCT01790568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183830|NCT01790568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6183831|NCT01790568|Antimetabolites|antimetabolites|mesh-ancestor
6183832|NCT01790568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183833|NCT01790568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6183834|NCT01790568|Dermatologic Agents|dermatologic agents|mesh-ancestor
6183835|NCT01790568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6183836|NCT01790568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6183837|NCT01790568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6183838|NCT01790568|Immunologic Factors|immunologic factors|mesh-ancestor
6183839|NCT01790568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6183840|NCT01790568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6183841|NCT01790568|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6183842|NCT01790568|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6183843|NCT01790594|Mycophenolic Acid|mycophenolic acid|mesh-list
6183844|NCT01790594|Methylprednisolone|methylprednisolone|mesh-list
6183845|NCT01790594|Abatacept|abatacept|mesh-list
6183846|NCT01790594|Tacrolimus|tacrolimus|mesh-list
6183847|NCT01790594|Thymoglobulin|thymoglobulin|mesh-list
5578129|NCT03871114|Triamcinolone|triamcinolone|mesh-list
5578130|NCT03871114|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5578131|NCT03871114|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5578132|NCT03871114|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5578133|NCT03871114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5578134|NCT03871114|Glucocorticoids|glucocorticoids|mesh-ancestor
5578135|NCT03871114|Hormones|hormones|mesh-ancestor
5578136|NCT03871114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5578137|NCT03871114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578138|NCT03871114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5578139|NCT03871114|Immunologic Factors|immunologic factors|mesh-ancestor
5578140|NCT03871114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6183848|NCT01790594|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6183849|NCT01790594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6183850|NCT01790594|Immunologic Factors|immunologic factors|mesh-ancestor
6183851|NCT01790594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183852|NCT01790594|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6183853|NCT01790594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6183854|NCT01790594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183855|NCT01790594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6183856|NCT01790594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6183857|NCT01790594|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6183858|NCT01790594|Antitubercular Agents|antitubercular agents|mesh-ancestor
6183859|NCT01790594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6183860|NCT01790594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6183861|NCT01790594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6183862|NCT01790594|Antiemetics|antiemetics|mesh-ancestor
6183863|NCT01790594|Autonomic Agents|autonomic agents|mesh-ancestor
6183864|NCT01790594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6183865|NCT01790594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6183866|NCT01790594|Glucocorticoids|glucocorticoids|mesh-ancestor
6183867|NCT01790594|Hormones|hormones|mesh-ancestor
6183868|NCT01790594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6183869|NCT01790594|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6183870|NCT01790594|Protective Agents|protective agents|mesh-ancestor
6183871|NCT01790594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6183872|NCT01790594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6183873|NCT01790659|Gentamicins|gentamicins|mesh-list
6183874|NCT01790659|Paromomycin|paromomycin|mesh-list
6183875|NCT01790659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6183876|NCT01790659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5578141|NCT03871114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183877|NCT01790659|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6183878|NCT01790659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6183879|NCT01790659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183880|NCT01790659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6183881|NCT01790659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6183882|NCT01790685|Dexamethasone|dexamethasone|mesh-list
6183883|NCT01790685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6183884|NCT01790685|Antiemetics|antiemetics|mesh-ancestor
6183885|NCT01790685|Autonomic Agents|autonomic agents|mesh-ancestor
6183886|NCT01790685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6183887|NCT01790685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183888|NCT01790685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6183889|NCT01790685|Glucocorticoids|glucocorticoids|mesh-ancestor
6183890|NCT01790685|Hormones|hormones|mesh-ancestor
6183891|NCT01790685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6183892|NCT01790685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6183893|NCT01790685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6183894|NCT01790828|Factor VIII|factor viii|mesh-list
6183895|NCT01790828|Coagulants|coagulants|mesh-ancestor
6183896|NCT01791153|Prednisone|prednisone|mesh-list
6183897|NCT01791153|Methotrexate|methotrexate|mesh-list
6183898|NCT01791153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6183899|NCT01791153|Glucocorticoids|glucocorticoids|mesh-ancestor
6183900|NCT01791153|Hormones|hormones|mesh-ancestor
6183901|NCT01791153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6183902|NCT01791153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183903|NCT01791153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6183904|NCT01791153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6183905|NCT01791153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6183906|NCT01791153|Abortifacient Agents|abortifacient agents|mesh-ancestor
6183907|NCT01791153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5578142|NCT03871153|Paclitaxel|paclitaxel|mesh-list
5578143|NCT03871153|Carboplatin|carboplatin|mesh-list
5578144|NCT03871153|Durvalumab|durvalumab|mesh-list
5578145|NCT03871153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5578146|NCT03871153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5578147|NCT03871153|Tubulin Modulators|tubulin modulators|mesh-ancestor
5578148|NCT03871153|Antimitotic Agents|antimitotic agents|mesh-ancestor
5578149|NCT03871153|Mitosis Modulators|mitosis modulators|mesh-ancestor
5578150|NCT03871153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578151|NCT03871153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5578152|NCT03870919|Palbociclib|palbociclib|mesh-list
5578153|NCT03870919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5578154|NCT03870919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5578155|NCT03870919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5578156|NCT03870919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578157|NCT03870763|Dimethyl Fumarate|dimethyl fumarate|mesh-list
5578158|NCT03870763|Dermatologic Agents|dermatologic agents|mesh-ancestor
5578159|NCT03870763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5578160|NCT03870763|Immunologic Factors|immunologic factors|mesh-ancestor
5578161|NCT03870763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578162|NCT03870581|Warfarin|warfarin|mesh-list
5578163|NCT03870581|Anticoagulants|anticoagulants|mesh-ancestor
5578164|NCT03870711|Lidocaine|lidocaine|mesh-list
5578165|NCT03870711|Anesthetics, Local|anesthetics, local|mesh-ancestor
5578166|NCT03870711|Anesthetics|anesthetics|mesh-ancestor
5578167|NCT03870711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5578168|NCT03870711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578169|NCT03870711|Sensory System Agents|sensory system agents|mesh-ancestor
6183908|NCT01791153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6183909|NCT01791153|Antimetabolites|antimetabolites|mesh-ancestor
6183910|NCT01791153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183911|NCT01791153|Dermatologic Agents|dermatologic agents|mesh-ancestor
6183912|NCT01791153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6183913|NCT01791153|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6183914|NCT01791153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6183915|NCT01791153|Immunologic Factors|immunologic factors|mesh-ancestor
6183916|NCT01791153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6183917|NCT01791153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6183918|NCT01791413|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6183919|NCT01791413|Medroxyprogesterone|medroxyprogesterone|mesh-list
6183920|NCT01791413|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6183921|NCT01791413|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6183922|NCT01791413|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6183923|NCT01791413|Contraceptive Agents|contraceptive agents|mesh-ancestor
6183924|NCT01791413|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6183925|NCT01791413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183926|NCT01791413|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6183927|NCT01791413|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6183928|NCT01791413|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6183929|NCT01791413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6183930|NCT01791413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6183931|NCT01791465|Exenatide|exenatide|mesh-list
5578170|NCT03870711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5578171|NCT03870711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5578172|NCT03870711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5578173|NCT03870711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5578174|NCT03870711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5578175|NCT03870711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578176|NCT03870646|Hyaluronic Acid|hyaluronic acid|mesh-list
5578177|NCT03870646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5578178|NCT03870646|Immunologic Factors|immunologic factors|mesh-ancestor
5578179|NCT03870646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578180|NCT03870646|Viscosupplements|viscosupplements|mesh-ancestor
5578181|NCT03870646|Protective Agents|protective agents|mesh-ancestor
5578182|NCT03870503|Misoprostol|misoprostol|mesh-list
5578183|NCT03870503|Oxytocin|oxytocin|mesh-list
5578184|NCT03870503|Carbetocin|carbetocin|mesh-list
5578185|NCT03870503|Oxytocics|oxytocics|mesh-ancestor
5578186|NCT03870503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5578187|NCT03870503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578188|NCT03870503|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5578189|NCT03870503|Abortifacient Agents|abortifacient agents|mesh-ancestor
5578190|NCT03870503|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5578191|NCT03870503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5578192|NCT03870490|Cefepime|cefepime|mesh-list
6183932|NCT01791465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6183933|NCT01791465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183934|NCT01791465|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6183935|NCT01791465|Incretins|incretins|mesh-ancestor
6183936|NCT01791465|Hormones|hormones|mesh-ancestor
6183937|NCT01791465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6183938|NCT01791491|Abatacept|abatacept|mesh-list
6183939|NCT01791491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6183940|NCT01791491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183941|NCT01791491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5578193|NCT03870490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5578194|NCT03870490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5578195|NCT03870256|Misoprostol|misoprostol|mesh-list
5578196|NCT03870256|Carbetocin|carbetocin|mesh-list
5578197|NCT03870256|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5578198|NCT03870256|Abortifacient Agents|abortifacient agents|mesh-ancestor
5578199|NCT03870256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5578200|NCT03870256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578201|NCT03870256|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5578202|NCT03870256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5578203|NCT03870256|Oxytocics|oxytocics|mesh-ancestor
5578204|NCT03870399|Tamoxifen|tamoxifen|mesh-list
5578205|NCT03870399|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5578206|NCT03870399|Hormone Antagonists|hormone antagonists|mesh-ancestor
5578207|NCT03870399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5578208|NCT03870399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578209|NCT03870399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5578210|NCT03870399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5578211|NCT03870399|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5578212|NCT03870399|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5578213|NCT03870399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6183942|NCT01791491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6183943|NCT01791491|Immunologic Factors|immunologic factors|mesh-ancestor
6183944|NCT01791491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183945|NCT01791491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6183946|NCT01791517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6183947|NCT01791803|Nicotine|nicotine|mesh-list
6671156|NCT01547520|Analgesics|analgesics|mesh-ancestor
6671157|NCT01547520|Sensory System Agents|sensory system agents|mesh-ancestor
6671158|NCT01547520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6671159|NCT01547520|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6671160|NCT01547546|GDC-0084|gdc-0084|mesh-list
6671161|NCT01547546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6671162|NCT01547546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671163|NCT01547559|Geranylgeranylacetone|geranylgeranylacetone|mesh-list
6671164|NCT01547559|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6671165|NCT01547559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6671166|NCT01547559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6671167|NCT01547741|Paclitaxel|paclitaxel|mesh-list
6671168|NCT01547741|Docetaxel|docetaxel|mesh-list
6671169|NCT01547741|Cyclophosphamide|cyclophosphamide|mesh-list
6671170|NCT01547741|Doxorubicin|doxorubicin|mesh-list
6671171|NCT01547741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6671172|NCT01547741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6671173|NCT01547741|Tubulin Modulators|tubulin modulators|mesh-ancestor
6671174|NCT01547741|Antimitotic Agents|antimitotic agents|mesh-ancestor
6671175|NCT01547741|Mitosis Modulators|mitosis modulators|mesh-ancestor
6671176|NCT01547741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671177|NCT01547741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6671178|NCT01547741|Immunologic Factors|immunologic factors|mesh-ancestor
6671179|NCT01547741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671180|NCT01547741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6671181|NCT01547741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6671182|NCT01547741|Alkylating Agents|alkylating agents|mesh-ancestor
6671183|NCT01547741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6671184|NCT01547741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6671185|NCT01547741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6671186|NCT01547741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6671187|NCT01547741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6671188|NCT01548001|Methotrexate|methotrexate|mesh-list
6671189|NCT01548001|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6671190|NCT01548001|Abortifacient Agents|abortifacient agents|mesh-ancestor
6671191|NCT01548001|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5578214|NCT03869944|Lamivudine|lamivudine|mesh-list
5578215|NCT03869944|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5578216|NCT03869944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5578217|NCT03869944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5578218|NCT03869944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578219|NCT03869944|Antiviral Agents|antiviral agents|mesh-ancestor
5578220|NCT03869944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5578221|NCT03869944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5578222|NCT03869944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5578223|NCT03870022|Carbon Monoxide|carbon monoxide|mesh-list
5578224|NCT03870022|Antimetabolites|antimetabolites|mesh-ancestor
5578225|NCT03870022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578226|NCT03870022|Gasotransmitters|gasotransmitters|mesh-ancestor
5578227|NCT03870022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5578228|NCT03870022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604708|NCT04409795|Protease Inhibitors|protease inhibitors|mesh-ancestor
5604709|NCT04409795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5604710|NCT04409795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183948|NCT01791803|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6183949|NCT01791803|Autonomic Agents|autonomic agents|mesh-ancestor
6183950|NCT01791803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6183951|NCT01791803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183952|NCT01791803|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6183953|NCT01791803|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6183954|NCT01791803|Cholinergic Agents|cholinergic agents|mesh-ancestor
6183955|NCT01791803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6183956|NCT01791803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671192|NCT01548001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671193|NCT01548001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6671194|NCT01548001|Antimetabolites|antimetabolites|mesh-ancestor
6671195|NCT01548001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671196|NCT01548001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6671197|NCT01548001|Dermatologic Agents|dermatologic agents|mesh-ancestor
6183957|NCT01791894|Arsenic Trioxide|arsenic trioxide|mesh-list
6183958|NCT01791894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6183959|NCT01791972|Albuterol|albuterol|mesh-list
6183960|NCT01791972|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6183961|NCT01791972|Autonomic Agents|autonomic agents|mesh-ancestor
6183962|NCT01791972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6183963|NCT01791972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183964|NCT01791972|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6183965|NCT01791972|Respiratory System Agents|respiratory system agents|mesh-ancestor
6183966|NCT01791972|Tocolytic Agents|tocolytic agents|mesh-ancestor
6183967|NCT01791972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6183968|NCT01791972|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6183969|NCT01791972|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6183970|NCT01791972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6183971|NCT01791972|Adrenergic Agents|adrenergic agents|mesh-ancestor
6183972|NCT01791972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6183973|NCT01791972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183974|NCT01792115|Vitamins|vitamins|mesh-list
6183975|NCT01792115|Vitamin E|vitamin e|mesh-list
6183976|NCT01792115|Tocopherols|tocopherols|mesh-list
6183977|NCT01792115|Tocotrienols|tocotrienols|mesh-list
6183978|NCT01792115|alpha-Tocopherol|alpha-tocopherol|mesh-list
6183979|NCT01792115|Micronutrients|micronutrients|mesh-ancestor
6183980|NCT01792115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183981|NCT01792115|Antioxidants|antioxidants|mesh-ancestor
5578229|NCT03869996|Cytarabine|cytarabine|mesh-list
5578230|NCT03869996|Methotrexate|methotrexate|mesh-list
5578231|NCT03869996|Etoposide|etoposide|mesh-list
5578232|NCT03869996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5578233|NCT03869996|Antimetabolites|antimetabolites|mesh-ancestor
5578234|NCT03869996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578235|NCT03869996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5578236|NCT03869996|Antiviral Agents|antiviral agents|mesh-ancestor
5578237|NCT03869996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5578238|NCT03869996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5578239|NCT03869996|Immunologic Factors|immunologic factors|mesh-ancestor
5578240|NCT03869996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183982|NCT01792115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183983|NCT01792115|Protective Agents|protective agents|mesh-ancestor
6183984|NCT01792284|Insulin|insulin|mesh-list
6183985|NCT01792284|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6183986|NCT01792284|Insulin Lispro|insulin lispro|mesh-list
6183987|NCT01792284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6183988|NCT01792284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183989|NCT01792518|Linagliptin|linagliptin|mesh-list
6183990|NCT01792518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6183991|NCT01792518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6183992|NCT01792518|Incretins|incretins|mesh-ancestor
6183993|NCT01792518|Hormones|hormones|mesh-ancestor
6183994|NCT01792518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6183995|NCT01792518|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6183996|NCT01792518|Protease Inhibitors|protease inhibitors|mesh-ancestor
6183997|NCT01792518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6183998|NCT01792518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6183999|NCT01792830|Metformin|metformin|mesh-list
6184000|NCT01792830|Insulin Glargine|insulin glargine|mesh-list
6184001|NCT01792830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6184002|NCT01792830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184003|NCT01793051|Minocycline|minocycline|mesh-list
6184004|NCT01793051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6184005|NCT01793051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6184006|NCT01793285|Etanercept|etanercept|mesh-list
6184007|NCT01793285|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6184008|NCT01793285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6184009|NCT01793285|Analgesics|analgesics|mesh-ancestor
6184010|NCT01793285|Sensory System Agents|sensory system agents|mesh-ancestor
6184011|NCT01793285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6184012|NCT01793285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184013|NCT01793285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5578241|NCT03869996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5578242|NCT03869996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5578243|NCT03869996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5578244|NCT03869996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5578245|NCT03869996|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5578246|NCT03869996|Abortifacient Agents|abortifacient agents|mesh-ancestor
5578247|NCT03869996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5578248|NCT03869996|Dermatologic Agents|dermatologic agents|mesh-ancestor
5578249|NCT03869996|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5578250|NCT03869996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5578251|NCT03869996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5578252|NCT03869931|Fenofibrate|fenofibrate|mesh-list
5578253|NCT03869931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5578254|NCT03869931|Antimetabolites|antimetabolites|mesh-ancestor
5578255|NCT03869931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578256|NCT03869931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5578257|NCT03869762|Denosumab|denosumab|mesh-list
5578258|NCT03869762|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5578259|NCT03869762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578260|NCT03869736|Nitrous Oxide|nitrous oxide|mesh-list
5578261|NCT03869736|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5578262|NCT03869736|Anesthetics, General|anesthetics, general|mesh-ancestor
5578263|NCT03869736|Anesthetics|anesthetics|mesh-ancestor
5578264|NCT03869736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5578265|NCT03869736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578266|NCT03869736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5578267|NCT03869736|Analgesics|analgesics|mesh-ancestor
5578268|NCT03869736|Sensory System Agents|sensory system agents|mesh-ancestor
5578269|NCT03869736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6184014|NCT01793285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5578270|NCT03869528|Lidocaine|lidocaine|mesh-list
5578271|NCT03869528|Anesthetics, Local|anesthetics, local|mesh-ancestor
6184015|NCT01793285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6184016|NCT01793285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6184017|NCT01793285|Immunologic Factors|immunologic factors|mesh-ancestor
5578272|NCT03869528|Anesthetics|anesthetics|mesh-ancestor
5578273|NCT03869528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5578274|NCT03869528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578275|NCT03869528|Sensory System Agents|sensory system agents|mesh-ancestor
5578276|NCT03869528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5578277|NCT03869528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5578278|NCT03869528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5578279|NCT03869528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5578280|NCT03869528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5578281|NCT03869528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578282|NCT03869281|Pancrelipase|pancrelipase|mesh-list
5578283|NCT03869281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5578284|NCT03869398|Calcitriol|calcitriol|mesh-list
5578285|NCT03869398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5578286|NCT03869398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578287|NCT03869398|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
5578288|NCT03869398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5578289|NCT03869398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578290|NCT03869398|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5578291|NCT03869398|Vitamins|vitamins|mesh-ancestor
5578292|NCT03869398|Micronutrients|micronutrients|mesh-ancestor
6184018|NCT01793688|Ampicillin|ampicillin|mesh-list
6184019|NCT01793688|Sulbactam|sulbactam|mesh-list
6184020|NCT01793688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6184021|NCT01793688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6184022|NCT01793688|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6184023|NCT01793688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6184024|NCT01793688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6184025|NCT01793883|Laninamivir|laninamivir|mesh-list
6184026|NCT01793883|Zanamivir|zanamivir|mesh-list
6184027|NCT01793883|Antiviral Agents|antiviral agents|mesh-ancestor
6184028|NCT01793883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6671198|NCT01548001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6671199|NCT01548001|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6671200|NCT01548001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5578293|NCT03869398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5578294|NCT03869268|Aspirin|aspirin|mesh-list
5578295|NCT03869268|Ticagrelor|ticagrelor|mesh-list
5578296|NCT03869268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5578297|NCT03869268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5578298|NCT03869268|Analgesics|analgesics|mesh-ancestor
5578299|NCT03869268|Sensory System Agents|sensory system agents|mesh-ancestor
5578300|NCT03869268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5578301|NCT03869268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578302|NCT03869268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6184029|NCT01793883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6671201|NCT01548001|Immunologic Factors|immunologic factors|mesh-ancestor
6671202|NCT01548001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6671203|NCT01548001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6671204|NCT01548027|Anesthetics|anesthetics|mesh-list
6671205|NCT01548027|Anesthetics, Local|anesthetics, local|mesh-list
6671206|NCT01548027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6671207|NCT01548027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184030|NCT01793883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6184031|NCT01794000|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6184032|NCT01794000|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6671208|NCT01548027|Sensory System Agents|sensory system agents|mesh-ancestor
6671209|NCT01548027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6671210|NCT01548066|Valproic Acid|valproic acid|mesh-list
6671211|NCT01548066|Anticonvulsants|anticonvulsants|mesh-ancestor
5578303|NCT03869268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5578304|NCT03869268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5578305|NCT03869268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5578306|NCT03869268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578307|NCT03869268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5578308|NCT03869268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5578309|NCT03869268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5578310|NCT03869268|Antipyretics|antipyretics|mesh-ancestor
5578311|NCT03869268|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5578312|NCT03869268|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5578313|NCT03869268|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5578314|NCT03869268|Purinergic Agents|purinergic agents|mesh-ancestor
5578315|NCT03869268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5578316|NCT03869047|Dexmedetomidine|dexmedetomidine|mesh-list
5578317|NCT03869047|Bupivacaine|bupivacaine|mesh-list
5578318|NCT03869047|Anesthetics, Local|anesthetics, local|mesh-ancestor
5578319|NCT03869047|Anesthetics|anesthetics|mesh-ancestor
5578320|NCT03869047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6671212|NCT01548066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6671213|NCT01548066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578321|NCT03869047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578322|NCT03869047|Sensory System Agents|sensory system agents|mesh-ancestor
5578323|NCT03869047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5578324|NCT03869047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5578325|NCT03869047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5578326|NCT03869047|Analgesics|analgesics|mesh-ancestor
5578327|NCT03869047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5578328|NCT03869047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5578329|NCT03869047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5578330|NCT03869047|Adrenergic Agents|adrenergic agents|mesh-ancestor
5578331|NCT03869047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5578332|NCT03869047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578333|NCT03868852|Apatinib|apatinib|mesh-list
5578334|NCT03868852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5578335|NCT03868852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5578336|NCT03868852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5578337|NCT03868852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578338|NCT03869073|Evolocumab|evolocumab|mesh-list
5578339|NCT03869073|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5578340|NCT03869073|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5578341|NCT03869073|Antimetabolites|antimetabolites|mesh-ancestor
5578342|NCT03869073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578343|NCT03869073|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5578344|NCT03868969|Fosfomycin|fosfomycin|mesh-list
5578345|NCT03868969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5578346|NCT03868969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5578347|NCT03868839|Telmisartan|telmisartan|mesh-list
6184033|NCT01794039|Dexamethasone|dexamethasone|mesh-list
6184034|NCT01794039|Dexamethasone acetate|dexamethasone acetate|mesh-list
6184035|NCT01794039|Lenalidomide|lenalidomide|mesh-list
6184036|NCT01794039|Pomalidomide|pomalidomide|mesh-list
6184037|NCT01794039|Ichthammol|ichthammol|mesh-list
6184038|NCT01794039|BB 1101|bb 1101|mesh-list
6184039|NCT01794039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6184040|NCT01794039|Antiemetics|antiemetics|mesh-ancestor
5578348|NCT03868839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5578349|NCT03868839|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6184041|NCT01794039|Autonomic Agents|autonomic agents|mesh-ancestor
6184042|NCT01794039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6184043|NCT01794039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184044|NCT01794039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6184045|NCT01794039|Glucocorticoids|glucocorticoids|mesh-ancestor
6184046|NCT01794039|Hormones|hormones|mesh-ancestor
6184047|NCT01794039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6184048|NCT01794039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6184049|NCT01794039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6184050|NCT01794039|Immunologic Factors|immunologic factors|mesh-ancestor
6488099|NCT00580619|Adrenergic Agents|adrenergic agents|mesh-ancestor
6488100|NCT00580619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6488101|NCT00580619|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6488102|NCT00580619|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
6488103|NCT00580619|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
6488104|NCT00580619|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6184051|NCT01794039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6488105|NCT00580619|Cholinergic Agents|cholinergic agents|mesh-ancestor
6184052|NCT01794039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6184053|NCT01794039|Growth Substances|growth substances|mesh-ancestor
6184054|NCT01794039|Growth Inhibitors|growth inhibitors|mesh-ancestor
6184055|NCT01794039|Protease Inhibitors|protease inhibitors|mesh-ancestor
6184056|NCT01794039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6184057|NCT01794039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6184058|NCT01794039|Dermatologic Agents|dermatologic agents|mesh-ancestor
6184059|NCT01794117|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6184060|NCT01794117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6184061|NCT01794455|Candesartan|candesartan|mesh-list
6184062|NCT01794455|Sertraline|sertraline|mesh-list
6184063|NCT01794455|Antidepressive Agents|antidepressive agents|mesh-ancestor
6184064|NCT01794455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6184065|NCT01794455|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6184066|NCT01794455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5578350|NCT03868839|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5578351|NCT03868839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578352|NCT03868436|Methoxyflurane|methoxyflurane|mesh-list
5578353|NCT03868436|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5578354|NCT03868436|Anesthetics, General|anesthetics, general|mesh-ancestor
5578355|NCT03868436|Anesthetics|anesthetics|mesh-ancestor
5578356|NCT03868436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5578357|NCT03868436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578358|NCT03868722|Venetoclax|venetoclax|mesh-list
6184067|NCT01794455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6184068|NCT01794455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6184069|NCT01794455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6184070|NCT01794455|Serotonin Agents|serotonin agents|mesh-ancestor
6184071|NCT01794455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184072|NCT01794455|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6184073|NCT01794455|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6184074|NCT01794455|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6184075|NCT01794689|Morphine|morphine|mesh-list
6184076|NCT01794689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6184077|NCT01794689|Narcotics|narcotics|mesh-ancestor
6184078|NCT01794689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6184079|NCT01794689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578359|NCT03868722|Acalabrutinib|acalabrutinib|mesh-list
5578360|NCT03868722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5578361|NCT03868657|Moxifloxacin|moxifloxacin|mesh-list
5578362|NCT03868657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5578363|NCT03868657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5578364|NCT03868657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5578365|NCT03868657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5578366|NCT03868657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5578367|NCT03868657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578368|NCT03868657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5578369|NCT03868072|Tofacitinib|tofacitinib|mesh-list
5578370|NCT03868072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5578371|NCT03868072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5578372|NCT03868072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578373|NCT03868124|Travoprost|travoprost|mesh-list
5578374|NCT03868124|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5578375|NCT03868124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5578376|NCT03868124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6184080|NCT01794689|Analgesics|analgesics|mesh-ancestor
6184081|NCT01794689|Sensory System Agents|sensory system agents|mesh-ancestor
6184082|NCT01794689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6184083|NCT01794702|Cytarabine|cytarabine|mesh-list
6184084|NCT01794702|Decitabine|decitabine|mesh-list
6671214|NCT01548066|GABA Agents|gaba agents|mesh-ancestor
6671215|NCT01548066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5578377|NCT03868137|Ibuprofen|ibuprofen|mesh-list
5578378|NCT03868137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5578379|NCT03868137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6671216|NCT01548066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671217|NCT01548066|Antimanic Agents|antimanic agents|mesh-ancestor
6671218|NCT01548066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6671219|NCT01548066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5578380|NCT03868137|Analgesics|analgesics|mesh-ancestor
6184085|NCT01794702|Clofarabine|clofarabine|mesh-list
6184086|NCT01794702|Idarubicin|idarubicin|mesh-list
6184087|NCT01794702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6184088|NCT01794702|Antimetabolites|antimetabolites|mesh-ancestor
6671220|NCT01548066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6671221|NCT01548079|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
5578381|NCT03868137|Sensory System Agents|sensory system agents|mesh-ancestor
5578382|NCT03868137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5578383|NCT03868137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578384|NCT03868137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5578385|NCT03868137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5578386|NCT03868137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5578387|NCT03868137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5578388|NCT03868137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578389|NCT03868111|Sufentanil|sufentanil|mesh-list
5578390|NCT03868111|Remifentanil|remifentanil|mesh-list
5578391|NCT03868111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5578392|NCT03868111|Narcotics|narcotics|mesh-ancestor
5578393|NCT03868111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5578394|NCT03868111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578395|NCT03868111|Analgesics|analgesics|mesh-ancestor
5578396|NCT03868111|Sensory System Agents|sensory system agents|mesh-ancestor
5578397|NCT03868111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5578398|NCT03868111|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5578399|NCT03868111|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5578400|NCT03868111|Anesthetics, General|anesthetics, general|mesh-ancestor
6671222|NCT01548079|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6671223|NCT01548079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6671224|NCT01548118|Vaccines|vaccines|mesh-list
6671225|NCT01548118|Immunologic Factors|immunologic factors|mesh-ancestor
6671226|NCT01548118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671227|NCT01548144|Pemetrexed|pemetrexed|mesh-list
6184089|NCT01794702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6184090|NCT01794702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6184091|NCT01794702|Antiviral Agents|antiviral agents|mesh-ancestor
6184092|NCT01794702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6184093|NCT01794702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6184094|NCT01794702|Immunologic Factors|immunologic factors|mesh-ancestor
6184095|NCT01794702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184096|NCT01794702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6184097|NCT01794702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6184098|NCT01794702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6184099|NCT01794702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6184100|NCT01794741|Fluticasone|fluticasone|mesh-list
6184101|NCT01794741|Xhance|xhance|mesh-list
6184102|NCT01794741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6184103|NCT01794741|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6184104|NCT01794741|Autonomic Agents|autonomic agents|mesh-ancestor
6184105|NCT01794741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6184106|NCT01794741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184107|NCT01794741|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6184108|NCT01794741|Respiratory System Agents|respiratory system agents|mesh-ancestor
6184109|NCT01794741|Dermatologic Agents|dermatologic agents|mesh-ancestor
6184110|NCT01794741|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6184111|NCT01794780|Fluticasone|fluticasone|mesh-list
6184112|NCT01794780|Budesonide|budesonide|mesh-list
6184113|NCT01794780|Theophylline|theophylline|mesh-list
6184114|NCT01794780|Formoterol Fumarate|formoterol fumarate|mesh-list
6184115|NCT01794780|Tiotropium Bromide|tiotropium bromide|mesh-list
6184116|NCT01794780|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6184117|NCT01794780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6184118|NCT01794780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6184119|NCT01794780|Autonomic Agents|autonomic agents|mesh-ancestor
6184120|NCT01794780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5725638|NCT03178994|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5725639|NCT03178994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5725640|NCT03178994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5725641|NCT03178994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725642|NCT03178994|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5725643|NCT03178994|Hormone Antagonists|hormone antagonists|mesh-ancestor
6184121|NCT01794780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184122|NCT01794780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6184123|NCT01794780|Respiratory System Agents|respiratory system agents|mesh-ancestor
6184124|NCT01794780|Dermatologic Agents|dermatologic agents|mesh-ancestor
6184125|NCT01794780|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6184126|NCT01794780|Glucocorticoids|glucocorticoids|mesh-ancestor
6184127|NCT01794780|Hormones|hormones|mesh-ancestor
6184128|NCT01794780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6184129|NCT01794780|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6671228|NCT01548144|Crizotinib|crizotinib|mesh-list
5578401|NCT03868111|Anesthetics|anesthetics|mesh-ancestor
6184130|NCT01794780|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6184131|NCT01794780|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6184132|NCT01794780|Adrenergic Agents|adrenergic agents|mesh-ancestor
6184133|NCT01794780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6184134|NCT01794780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6184135|NCT01794780|Parasympatholytics|parasympatholytics|mesh-ancestor
6184136|NCT01794780|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6184137|NCT01794780|Cholinergic Agents|cholinergic agents|mesh-ancestor
6184138|NCT01794780|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6184139|NCT01794780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6184140|NCT01794780|Vasodilator Agents|vasodilator agents|mesh-ancestor
6184141|NCT01794780|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6184142|NCT01794780|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6184143|NCT01794780|Purinergic Agents|purinergic agents|mesh-ancestor
6184144|NCT01794845|Docetaxel|docetaxel|mesh-list
6184145|NCT01794845|Cetuximab|cetuximab|mesh-list
6184146|NCT01794845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6184147|NCT01794845|Tubulin Modulators|tubulin modulators|mesh-ancestor
6184148|NCT01794845|Antimitotic Agents|antimitotic agents|mesh-ancestor
6184149|NCT01794845|Mitosis Modulators|mitosis modulators|mesh-ancestor
6184150|NCT01794845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671229|NCT01548144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6671230|NCT01548144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6671231|NCT01548144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671232|NCT01548144|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6671233|NCT01548144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6671234|NCT01548144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6671235|NCT01548157|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6671236|NCT01548157|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5578402|NCT03868202|Estradiol|estradiol|mesh-list
5578403|NCT03868202|Progesterone|progesterone|mesh-list
5578404|NCT03868202|Estrogens|estrogens|mesh-ancestor
5578405|NCT03868202|Hormones|hormones|mesh-ancestor
5578406|NCT03868202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5578407|NCT03868202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578408|NCT03868202|Progestins|progestins|mesh-ancestor
6671237|NCT01548157|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6671238|NCT01548157|Antimetabolites|antimetabolites|mesh-ancestor
6671239|NCT01548157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671240|NCT01548157|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6671241|NCT01548157|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6671242|NCT01548157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6671243|NCT01548170|Ketoconazole|ketoconazole|mesh-list
6671244|NCT01548170|Sunitinib|sunitinib|mesh-list
6671245|NCT01548170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6671246|NCT01548170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6184151|NCT01794845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6184152|NCT01795495|Magnesium Sulfate|magnesium sulfate|mesh-list
6184153|NCT01795495|Remifentanil|remifentanil|mesh-list
6184154|NCT01795495|Methadone|methadone|mesh-list
6184155|NCT01795495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6184156|NCT01795495|Narcotics|narcotics|mesh-ancestor
6184157|NCT01795495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6184158|NCT01795495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184159|NCT01795495|Analgesics|analgesics|mesh-ancestor
6184160|NCT01795495|Sensory System Agents|sensory system agents|mesh-ancestor
6184161|NCT01795495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6184162|NCT01795495|Anesthetics|anesthetics|mesh-ancestor
6184163|NCT01795495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6184164|NCT01795495|Anticonvulsants|anticonvulsants|mesh-ancestor
5578409|NCT03868033|Zoledronic Acid|zoledronic acid|mesh-list
5578410|NCT03868033|Denosumab|denosumab|mesh-list
5578411|NCT03868033|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5578412|NCT03868033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184165|NCT01795495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6184166|NCT01795495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6184167|NCT01795495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6184168|NCT01795495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6184169|NCT01795495|Tocolytic Agents|tocolytic agents|mesh-ancestor
6184170|NCT01795495|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6184171|NCT01795495|Antitussive Agents|antitussive agents|mesh-ancestor
6184172|NCT01795495|Respiratory System Agents|respiratory system agents|mesh-ancestor
6184173|NCT01795547|Aripiprazole|aripiprazole|mesh-list
6184174|NCT01795547|Paliperidone Palmitate|paliperidone palmitate|mesh-list
5578413|NCT03868046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
6184175|NCT01795547|Antidepressive Agents|antidepressive agents|mesh-ancestor
6184176|NCT01795547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6184177|NCT01795547|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6184178|NCT01795547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6184179|NCT01795547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6184180|NCT01795547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184181|NCT01795547|Dopamine Agonists|dopamine agonists|mesh-ancestor
6184182|NCT01795547|Dopamine Agents|dopamine agents|mesh-ancestor
6184183|NCT01795547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6184184|NCT01795547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578414|NCT03868046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578415|NCT03868046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5578416|NCT03867929|Vitamin D|vitamin d|mesh-list
5578417|NCT03867929|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
5578418|NCT03867929|Calcifediol|calcifediol|mesh-list
5578419|NCT03867929|Vitamins|vitamins|mesh-ancestor
5578420|NCT03867929|Micronutrients|micronutrients|mesh-ancestor
5578421|NCT03867929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578422|NCT03867929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5578423|NCT03867994|Carvedilol|carvedilol|mesh-list
5578424|NCT03867994|Atorvastatin|atorvastatin|mesh-list
5578425|NCT03867994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6184185|NCT01795547|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6184186|NCT01795547|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6184187|NCT01795547|Serotonin Agents|serotonin agents|mesh-ancestor
6184188|NCT01795547|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6184189|NCT01795547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6184190|NCT01795547|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6184191|NCT01795547|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6184192|NCT01795716|Imatinib Mesylate|imatinib mesylate|mesh-list
6184193|NCT01795716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6184194|NCT01795716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6184195|NCT01795716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6184196|NCT01795716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6184197|NCT01795898|Fentanyl|fentanyl|mesh-list
6184198|NCT01795898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5578426|NCT03867994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5578427|NCT03867994|Antimetabolites|antimetabolites|mesh-ancestor
5578428|NCT03867994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6184199|NCT01795898|Narcotics|narcotics|mesh-ancestor
6184200|NCT01795898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6184201|NCT01795898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184202|NCT01795898|Analgesics|analgesics|mesh-ancestor
6184203|NCT01795898|Sensory System Agents|sensory system agents|mesh-ancestor
6184204|NCT01795898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6184205|NCT01795898|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6671247|NCT01548170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6671248|NCT01548170|Growth Substances|growth substances|mesh-ancestor
6671249|NCT01548170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578429|NCT03867994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6184206|NCT01795898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6184207|NCT01795898|Anesthetics, General|anesthetics, general|mesh-ancestor
6184208|NCT01795898|Anesthetics|anesthetics|mesh-ancestor
6184209|NCT01795937|Itraconazole|itraconazole|mesh-list
6184210|NCT01795937|Atorvastatin|atorvastatin|mesh-list
6184211|NCT01795937|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6184212|NCT01795937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6184213|NCT01795937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5578430|NCT03867994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5578431|NCT03867994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5578432|NCT03867994|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5578433|NCT03867994|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5578434|NCT03867994|Adrenergic Agents|adrenergic agents|mesh-ancestor
5578435|NCT03867994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5578436|NCT03867994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578437|NCT03867994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5578438|NCT03867994|Antioxidants|antioxidants|mesh-ancestor
5578439|NCT03867994|Protective Agents|protective agents|mesh-ancestor
5578440|NCT03867994|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5578441|NCT03867994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5578442|NCT03867994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5578443|NCT03867994|Vasodilator Agents|vasodilator agents|mesh-ancestor
5578444|NCT03867994|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5578445|NCT03867994|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5578446|NCT03867617|Immunosuppressive Agents|immunosuppressive agents|mesh-list
5578447|NCT03867617|Immunologic Factors|immunologic factors|mesh-ancestor
5578448|NCT03867617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578449|NCT03867500|Niacin|niacin|mesh-list
5578450|NCT03867500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5578451|NCT03867500|Antimetabolites|antimetabolites|mesh-ancestor
5578452|NCT03867500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578453|NCT03867500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5578454|NCT03867500|Vasodilator Agents|vasodilator agents|mesh-ancestor
6671250|NCT01548170|Growth Inhibitors|growth inhibitors|mesh-ancestor
6671251|NCT01548170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6671252|NCT01548170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5578455|NCT03867500|Vitamin B Complex|vitamin b complex|mesh-ancestor
5578456|NCT03867500|Vitamins|vitamins|mesh-ancestor
5578457|NCT03867500|Micronutrients|micronutrients|mesh-ancestor
5578458|NCT03867500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578459|NCT03867695|Ropivacaine|ropivacaine|mesh-list
5578460|NCT03867695|Anesthetics, Local|anesthetics, local|mesh-ancestor
5578461|NCT03867695|Anesthetics|anesthetics|mesh-ancestor
5578462|NCT03867695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5578463|NCT03867695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578464|NCT03867695|Sensory System Agents|sensory system agents|mesh-ancestor
5578465|NCT03867695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5578466|NCT03867799|Nivolumab|nivolumab|mesh-list
5578467|NCT03867799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5578468|NCT03867799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5578469|NCT03867799|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5578470|NCT03867799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578471|NCT03867851|Heparin|heparin|mesh-list
5578472|NCT03867851|Anticoagulants|anticoagulants|mesh-ancestor
5578473|NCT03867851|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5578474|NCT03867851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6671253|NCT01548170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578475|NCT03867851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578476|NCT03867682|Venetoclax|venetoclax|mesh-list
5578477|NCT03867682|Lintuzumab|lintuzumab|mesh-list
5578478|NCT03867682|Spironolactone|spironolactone|mesh-list
5578479|NCT03867682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5578480|NCT03867682|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5578481|NCT03867682|Hormone Antagonists|hormone antagonists|mesh-ancestor
5578482|NCT03867682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6184214|NCT01795937|Antimetabolites|antimetabolites|mesh-ancestor
6184215|NCT01795937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6184216|NCT01795937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6184217|NCT01795937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6184218|NCT01795937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6184219|NCT01795937|Antifungal Agents|antifungal agents|mesh-ancestor
6184220|NCT01795937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6184221|NCT01795937|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6184222|NCT01795937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6184223|NCT01795937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6184224|NCT01795937|Hormone Antagonists|hormone antagonists|mesh-ancestor
6184225|NCT01795937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6184226|NCT01795937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184227|NCT01795937|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6184228|NCT01796301|Teriparatide|teriparatide|mesh-list
6184229|NCT01796301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6184230|NCT01796301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488106|NCT00580619|Vasodilator Agents|vasodilator agents|mesh-ancestor
6488107|NCT00580814|Methylphenidate|methylphenidate|mesh-list
6488108|NCT00580814|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6488109|NCT00580814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488110|NCT00580814|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6488111|NCT00580814|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6488112|NCT00580814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6488113|NCT00580814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488114|NCT00580814|Dopamine Agents|dopamine agents|mesh-ancestor
6488115|NCT00580814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6488116|NCT00580827|Disulfiram|disulfiram|mesh-list
6488117|NCT00580827|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6488118|NCT00580827|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
6488119|NCT00580827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6488120|NCT00580827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671254|NCT01548170|Antifungal Agents|antifungal agents|mesh-ancestor
6671255|NCT01548170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6671256|NCT01548170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6671257|NCT01548170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6671258|NCT01548170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6671259|NCT01548170|Hormone Antagonists|hormone antagonists|mesh-ancestor
6671260|NCT01548170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6671261|NCT01548170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6671262|NCT01548209|Dexmedetomidine|dexmedetomidine|mesh-list
6671263|NCT01548209|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6671264|NCT01548209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6671265|NCT01548209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671266|NCT01548209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6671267|NCT01548209|Analgesics|analgesics|mesh-ancestor
6671268|NCT01548209|Sensory System Agents|sensory system agents|mesh-ancestor
6671269|NCT01548209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6671270|NCT01548209|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6671271|NCT01548209|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6671272|NCT01548209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6671273|NCT01548209|Adrenergic Agents|adrenergic agents|mesh-ancestor
6671274|NCT01548209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6671275|NCT01548209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671276|NCT01548235|Insulin Aspart|insulin aspart|mesh-list
6671277|NCT01548235|Biphasic Insulins|biphasic insulins|mesh-list
6671278|NCT01548235|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6671279|NCT01548235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6671280|NCT01548235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578483|NCT03867682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184231|NCT01796301|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6184232|NCT01796470|Idelalisib|idelalisib|mesh-list
6184233|NCT01796470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6184234|NCT01796470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6184235|NCT01796470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6184236|NCT01796665|Clindamycin|clindamycin|mesh-list
6184237|NCT01796665|Clindamycin palmitate|clindamycin palmitate|mesh-list
6184238|NCT01796665|Clindamycin phosphate|clindamycin phosphate|mesh-list
6184239|NCT01796665|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6184240|NCT01796665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6184241|NCT01796665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6184242|NCT01796665|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6184243|NCT01796665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6184244|NCT01796665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6184245|NCT01796665|Dermatologic Agents|dermatologic agents|mesh-ancestor
6184246|NCT01796964|Aflibercept|aflibercept|mesh-list
6184247|NCT01796964|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5578484|NCT03867682|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5578485|NCT03867682|Diuretics|diuretics|mesh-ancestor
5578486|NCT03867682|Natriuretic Agents|natriuretic agents|mesh-ancestor
5578487|NCT03867682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5578488|NCT03867487|Empagliflozin|empagliflozin|mesh-list
5578489|NCT03867487|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5578490|NCT03867487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578491|NCT03867487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5578492|NCT03867487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578493|NCT03867097|Iloprost|iloprost|mesh-list
5578494|NCT03867097|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5578495|NCT03867097|Vasodilator Agents|vasodilator agents|mesh-ancestor
5578496|NCT03867383|Calcium, Dietary|calcium, dietary|mesh-list
6184248|NCT01796964|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6184249|NCT01796964|Growth Substances|growth substances|mesh-ancestor
6184250|NCT01796964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184251|NCT01796964|Growth Inhibitors|growth inhibitors|mesh-ancestor
6184252|NCT01796964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6184253|NCT01797081|Botulinum Toxins|botulinum toxins|mesh-list
6184254|NCT01797081|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5578497|NCT03867383|Calcium|calcium|mesh-list
5578498|NCT03867383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5578499|NCT03867383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578500|NCT03867383|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5578501|NCT03867071|Epoetin Alfa|epoetin alfa|mesh-list
5578502|NCT03867071|Hematinics|hematinics|mesh-ancestor
5578503|NCT03867370|Lenvatinib|lenvatinib|mesh-list
6184255|NCT01797081|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5578504|NCT03867370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5578505|NCT03867370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5578506|NCT03867370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5578507|NCT03867370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578508|NCT03867175|Pembrolizumab|pembrolizumab|mesh-list
5578509|NCT03867175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5578510|NCT03867175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6184256|NCT01797081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6184257|NCT01797081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6184258|NCT01797081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6184259|NCT01797081|Cholinergic Agents|cholinergic agents|mesh-ancestor
6184260|NCT01797081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6184261|NCT01797081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184262|NCT01797081|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6184263|NCT01797081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6184264|NCT01797094|Botulinum Toxins|botulinum toxins|mesh-list
6184265|NCT01797094|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6184266|NCT01797094|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5578511|NCT03867214|Tranexamic Acid|tranexamic acid|mesh-list
5578512|NCT03867214|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5578513|NCT03867214|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5578514|NCT03867214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578515|NCT03867214|Hemostatics|hemostatics|mesh-ancestor
5578516|NCT03867214|Coagulants|coagulants|mesh-ancestor
5578517|NCT03867344|Hypoglycemic Agents|hypoglycemic agents|mesh-list
5578518|NCT03867344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578519|NCT03867123|Temozolomide|temozolomide|mesh-list
5578520|NCT03867123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5578521|NCT03867123|Alkylating Agents|alkylating agents|mesh-ancestor
5578522|NCT03867123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578523|NCT03867123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5578524|NCT03867240|Gabapentin|gabapentin|mesh-list
5578525|NCT03867240|Analgesics|analgesics|mesh-ancestor
5578526|NCT03867240|Sensory System Agents|sensory system agents|mesh-ancestor
5578527|NCT03867240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5578528|NCT03867240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578529|NCT03867240|Anticonvulsants|anticonvulsants|mesh-ancestor
5578530|NCT03867240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5578531|NCT03867240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5578532|NCT03867240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5578533|NCT03867240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5578534|NCT03867240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5578535|NCT03867240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5578536|NCT03867240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5578537|NCT03867240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578538|NCT03867240|Antimanic Agents|antimanic agents|mesh-ancestor
5578539|NCT03866980|Carboplatin|carboplatin|mesh-list
5578540|NCT03866980|Pemetrexed|pemetrexed|mesh-list
5578541|NCT03866980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5578542|NCT03866980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5578543|NCT03866980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578544|NCT03866980|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5578545|NCT03866980|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5578546|NCT03866993|Paclitaxel|paclitaxel|mesh-list
5578547|NCT03866993|Carboplatin|carboplatin|mesh-list
5578548|NCT03866993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5578549|NCT03866993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5578550|NCT03866993|Tubulin Modulators|tubulin modulators|mesh-ancestor
5578551|NCT03866993|Antimitotic Agents|antimitotic agents|mesh-ancestor
5578552|NCT03866993|Mitosis Modulators|mitosis modulators|mesh-ancestor
5578553|NCT03866993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578554|NCT03866928|Stiripentol|stiripentol|mesh-list
5578555|NCT03866928|Anticonvulsants|anticonvulsants|mesh-ancestor
6184267|NCT01797094|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6184268|NCT01797094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6184269|NCT01797094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6184270|NCT01797094|Cholinergic Agents|cholinergic agents|mesh-ancestor
6184271|NCT01797094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6184272|NCT01797094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184273|NCT01797094|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6184274|NCT01797094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6184275|NCT01797120|Everolimus|everolimus|mesh-list
6184276|NCT01797120|Fulvestrant|fulvestrant|mesh-list
5578556|NCT03866746|Aflibercept|aflibercept|mesh-list
6184277|NCT01797120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6184278|NCT01797120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6184279|NCT01797120|Immunologic Factors|immunologic factors|mesh-ancestor
6184280|NCT01797120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184281|NCT01797120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6184282|NCT01797120|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6184283|NCT01797120|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6184284|NCT01797120|Hormone Antagonists|hormone antagonists|mesh-ancestor
6184285|NCT01797120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6184286|NCT01797302|Vitamin D|vitamin d|mesh-list
6184287|NCT01797302|Cholecalciferol|cholecalciferol|mesh-list
6184288|NCT01797302|Vitamins|vitamins|mesh-ancestor
5578557|NCT03866746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5578558|NCT03866746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5578559|NCT03866746|Growth Substances|growth substances|mesh-ancestor
5578560|NCT03866746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578561|NCT03866746|Growth Inhibitors|growth inhibitors|mesh-ancestor
5578562|NCT03866746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5578563|NCT03866837|Micronutrients|micronutrients|mesh-list
5578564|NCT03866837|Trace Elements|trace elements|mesh-list
5578565|NCT03866837|Lactoferrin|lactoferrin|mesh-list
5578566|NCT03866837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578567|NCT03866837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5578568|NCT03866681|Sirolimus|sirolimus|mesh-list
5578569|NCT03866681|Warfarin|warfarin|mesh-list
5578570|NCT03866681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5578571|NCT03866681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5578572|NCT03866681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5578573|NCT03866681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5578574|NCT03866681|Antifungal Agents|antifungal agents|mesh-ancestor
6184289|NCT01797302|Micronutrients|micronutrients|mesh-ancestor
6184290|NCT01797302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184291|NCT01797302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6184292|NCT01797302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6184293|NCT01797432|Triamcinolone|triamcinolone|mesh-list
6184294|NCT01797432|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6671281|NCT01548248|Insulin|insulin|mesh-list
6671282|NCT01548248|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6671283|NCT01548248|Insulin Aspart|insulin aspart|mesh-list
6671284|NCT01548248|Insulin Detemir|insulin detemir|mesh-list
6671285|NCT01548248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6671286|NCT01548248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671287|NCT01548274|Sarpogrelate|sarpogrelate|mesh-list
6671288|NCT01548274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6671289|NCT01548274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6671290|NCT01548274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671291|NCT01548274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6671292|NCT01548274|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6671293|NCT01548274|Serotonin Agents|serotonin agents|mesh-ancestor
6671294|NCT01548274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6671295|NCT01548274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671296|NCT01548326|Atorvastatin|atorvastatin|mesh-list
6671297|NCT01548326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6671298|NCT01548326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6671299|NCT01548326|Antimetabolites|antimetabolites|mesh-ancestor
6671300|NCT01548326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671301|NCT01548326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6671302|NCT01548326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6671303|NCT01548326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6671304|NCT01548482|Sirolimus|sirolimus|mesh-list
6671305|NCT01548482|Trebananib|trebananib|mesh-list
6671306|NCT01548482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6671307|NCT01548482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6671308|NCT01548482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6671309|NCT01548482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6671310|NCT01548482|Antifungal Agents|antifungal agents|mesh-ancestor
6671311|NCT01548482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6671312|NCT01548482|Immunologic Factors|immunologic factors|mesh-ancestor
6671313|NCT01548482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671314|NCT01548482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6671315|NCT01548482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6671316|NCT01548482|Growth Substances|growth substances|mesh-ancestor
6671317|NCT01548482|Growth Inhibitors|growth inhibitors|mesh-ancestor
6671318|NCT01548521|Oxytocin|oxytocin|mesh-list
6184295|NCT01797432|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6184296|NCT01797432|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6671319|NCT01548521|Oxytocics|oxytocics|mesh-ancestor
6671320|NCT01548521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6671321|NCT01548521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671322|NCT01548560|Dapivirine|dapivirine|mesh-list
6671323|NCT01548560|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6671324|NCT01548560|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6671325|NCT01548560|Antiviral Agents|antiviral agents|mesh-ancestor
6671326|NCT01548560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6671327|NCT01548612|Nitroprusside|nitroprusside|mesh-list
6671328|NCT01548612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6671329|NCT01548612|Vasodilator Agents|vasodilator agents|mesh-ancestor
6671330|NCT01548612|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6671331|NCT01548612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671332|NCT01548677|Trastuzumab|trastuzumab|mesh-list
6671333|NCT01548677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6671334|NCT01548677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6671335|NCT01548703|BCI-838|bci-838|mesh-list
6671336|NCT01548703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6671337|NCT01548703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6671338|NCT01548703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6671339|NCT01548703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578575|NCT03866681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5578576|NCT03866681|Immunologic Factors|immunologic factors|mesh-ancestor
5578577|NCT03866681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578578|NCT03866681|Anticoagulants|anticoagulants|mesh-ancestor
5578579|NCT03866629|Lifitegrast|lifitegrast|mesh-list
5578580|NCT03866629|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5578581|NCT03866629|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5578582|NCT03866733|Narcotics|narcotics|mesh-list
5578583|NCT03866733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5578584|NCT03866733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578585|NCT03866733|Analgesics|analgesics|mesh-ancestor
5578586|NCT03866733|Sensory System Agents|sensory system agents|mesh-ancestor
5578587|NCT03866733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5578588|NCT03866577|Immunoglobulins|immunoglobulins|mesh-list
5578589|NCT03866577|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5578590|NCT03866577|Antibodies|antibodies|mesh-list
5578591|NCT03866577|gamma-Globulins|gamma-globulins|mesh-list
5578592|NCT03866577|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5578593|NCT03866577|Immunologic Factors|immunologic factors|mesh-ancestor
5578594|NCT03866577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578595|NCT03866772|Misoprostol|misoprostol|mesh-list
5578596|NCT03866772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5578597|NCT03866772|Abortifacient Agents|abortifacient agents|mesh-ancestor
5578598|NCT03866772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6184297|NCT01797432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6184298|NCT01797432|Glucocorticoids|glucocorticoids|mesh-ancestor
6184299|NCT01797432|Hormones|hormones|mesh-ancestor
6184300|NCT01797432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6184301|NCT01797432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184302|NCT01797432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6184303|NCT01797432|Immunologic Factors|immunologic factors|mesh-ancestor
6184304|NCT01797432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6184305|NCT01797432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6184306|NCT01797445|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6488121|NCT00580905|Adenosine|adenosine|mesh-list
6488122|NCT00580905|Nitroprusside|nitroprusside|mesh-list
6488123|NCT00580905|Analgesics|analgesics|mesh-ancestor
6488124|NCT00580905|Sensory System Agents|sensory system agents|mesh-ancestor
6488125|NCT00580905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6488126|NCT00580905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488127|NCT00580905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6488128|NCT00580905|Vasodilator Agents|vasodilator agents|mesh-ancestor
6488129|NCT00580905|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6488130|NCT00580905|Purinergic Agonists|purinergic agonists|mesh-ancestor
6488131|NCT00580905|Purinergic Agents|purinergic agents|mesh-ancestor
6488132|NCT00580905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6488133|NCT00580905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488134|NCT00580905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6488135|NCT00580905|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6488136|NCT00580931|Niacinamide|niacinamide|mesh-list
6488137|NCT00580931|Niacin|niacin|mesh-list
6488138|NCT00580931|Nicotinic Acids|nicotinic acids|mesh-list
6488139|NCT00580931|Vitamin B Complex|vitamin b complex|mesh-ancestor
6488140|NCT00580931|Vitamins|vitamins|mesh-ancestor
6488141|NCT00580931|Micronutrients|micronutrients|mesh-ancestor
6671340|NCT01548703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671341|NCT01548794|Lidocaine|lidocaine|mesh-list
6671342|NCT01548794|Bupivacaine|bupivacaine|mesh-list
6671343|NCT01548794|Anesthetics|anesthetics|mesh-list
6671344|NCT01548794|Anesthetics, Local|anesthetics, local|mesh-ancestor
6184307|NCT01797445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6184308|NCT01797445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6184309|NCT01797445|Antiviral Agents|antiviral agents|mesh-ancestor
6184310|NCT01797445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6206805|NCT02105701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206806|NCT02105701|Antiviral Agents|antiviral agents|mesh-ancestor
6206807|NCT02105701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6206808|NCT02105974|Fluticasone|fluticasone|mesh-list
6206809|NCT02105974|Xhance|xhance|mesh-list
6206810|NCT02105974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6206811|NCT02105974|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6206812|NCT02105974|Autonomic Agents|autonomic agents|mesh-ancestor
6206813|NCT02105974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6206814|NCT02105974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206815|NCT02105974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6206816|NCT02105974|Respiratory System Agents|respiratory system agents|mesh-ancestor
6206817|NCT02105974|Dermatologic Agents|dermatologic agents|mesh-ancestor
6206818|NCT02105974|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6206819|NCT02106156|Interferons|interferons|mesh-list
6671345|NCT01548794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5578599|NCT03866772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578600|NCT03866772|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5578601|NCT03866772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5578602|NCT03866772|Oxytocics|oxytocics|mesh-ancestor
5578603|NCT03866369|Moxifloxacin|moxifloxacin|mesh-list
5578604|NCT03866369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5578605|NCT03866369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5578606|NCT03866369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5578607|NCT03866369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6206820|NCT02106156|Ribavirin|ribavirin|mesh-list
6206821|NCT02106156|Interferon-alpha|interferon-alpha|mesh-list
6206822|NCT02106156|Interferon alpha-2|interferon alpha-2|mesh-list
5578608|NCT03866369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5578609|NCT03866369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578610|NCT03866369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5578611|NCT03866499|Gefitinib|gefitinib|mesh-list
6206823|NCT02106156|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6206824|NCT02106156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6206825|NCT02106156|Antiviral Agents|antiviral agents|mesh-ancestor
6206826|NCT02106156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6206827|NCT02106156|Antimetabolites|antimetabolites|mesh-ancestor
6206828|NCT02106156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206829|NCT02106156|Immunologic Factors|immunologic factors|mesh-ancestor
6206830|NCT02106156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206831|NCT02106325|Diphenhydramine|diphenhydramine|mesh-list
6206832|NCT02106325|Promethazine|promethazine|mesh-list
6206833|NCT02106325|Ketamine|ketamine|mesh-list
6206834|NCT02106325|Analgesics|analgesics|mesh-ancestor
6206835|NCT02106325|Sensory System Agents|sensory system agents|mesh-ancestor
6206836|NCT02106325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6206837|NCT02106325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206838|NCT02106325|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6488142|NCT00580931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488143|NCT00580931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6488144|NCT00580931|Antimetabolites|antimetabolites|mesh-ancestor
6488145|NCT00580931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488146|NCT00580931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6488147|NCT00580931|Vasodilator Agents|vasodilator agents|mesh-ancestor
6488148|NCT00581009|Lithium Carbonate|lithium carbonate|mesh-list
6488149|NCT00581009|Sertraline|sertraline|mesh-list
6488150|NCT00581009|Antidepressive Agents|antidepressive agents|mesh-ancestor
6488151|NCT00581009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6488152|NCT00581009|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6488153|NCT00581009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6488154|NCT00581009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6488155|NCT00581009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488156|NCT00581009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6488157|NCT00581009|Serotonin Agents|serotonin agents|mesh-ancestor
6206839|NCT02106325|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6206840|NCT02106325|Anesthetics, General|anesthetics, general|mesh-ancestor
6206841|NCT02106325|Anesthetics|anesthetics|mesh-ancestor
6671346|NCT01548794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184311|NCT01797484|Ranolazine|ranolazine|mesh-list
6184312|NCT01797484|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6184313|NCT01797484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5578612|NCT03866499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5578613|NCT03866499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5578614|NCT03866499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5578615|NCT03866499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578616|NCT03866525|Irinotecan|irinotecan|mesh-list
5578617|NCT03866525|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5578618|NCT03866525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5578619|NCT03866525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5578620|NCT03866525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6184314|NCT01797484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6184315|NCT01797575|Aspirin|aspirin|mesh-list
6184316|NCT01797575|Acetylcysteine|acetylcysteine|mesh-list
6184317|NCT01797575|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6184318|NCT01797575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6184319|NCT01797575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6184320|NCT01797575|Analgesics|analgesics|mesh-ancestor
6184321|NCT01797575|Sensory System Agents|sensory system agents|mesh-ancestor
6184322|NCT01797575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6184323|NCT01797575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184324|NCT01797575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6184325|NCT01797575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6184326|NCT01797575|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6184327|NCT01797575|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6184328|NCT01797575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6184329|NCT01797575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6184330|NCT01797575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6184331|NCT01797575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6184332|NCT01797575|Antipyretics|antipyretics|mesh-ancestor
6184333|NCT01797575|Antiviral Agents|antiviral agents|mesh-ancestor
6184334|NCT01797575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6184335|NCT01797575|Expectorants|expectorants|mesh-ancestor
6184336|NCT01797575|Respiratory System Agents|respiratory system agents|mesh-ancestor
6184337|NCT01797575|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6184338|NCT01797575|Antioxidants|antioxidants|mesh-ancestor
6184339|NCT01797575|Protective Agents|protective agents|mesh-ancestor
6184340|NCT01797575|Antidotes|antidotes|mesh-ancestor
6184341|NCT01797822|Dexamethasone|dexamethasone|mesh-list
6184342|NCT01797822|Lubricant Eye Drops|lubricant eye drops|mesh-list
6184343|NCT01797822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6184344|NCT01797822|Antiemetics|antiemetics|mesh-ancestor
6184345|NCT01797822|Autonomic Agents|autonomic agents|mesh-ancestor
6184346|NCT01797822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6184347|NCT01797822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184348|NCT01797822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6184349|NCT01797822|Glucocorticoids|glucocorticoids|mesh-ancestor
6184350|NCT01797822|Hormones|hormones|mesh-ancestor
6184351|NCT01797822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6184352|NCT01797822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6184353|NCT01797822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6184354|NCT01797822|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6184355|NCT01797822|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6184356|NCT01797965|Daclizumab|daclizumab|mesh-list
6184357|NCT01797965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6184358|NCT01797965|Immunologic Factors|immunologic factors|mesh-ancestor
6184359|NCT01797965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184360|NCT01798004|Cyclophosphamide|cyclophosphamide|mesh-list
6184361|NCT01798004|Melphalan|melphalan|mesh-list
6184362|NCT01798004|Busulfan|busulfan|mesh-list
6184363|NCT01798004|Doxorubicin|doxorubicin|mesh-list
6184364|NCT01798004|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6184365|NCT01798004|Etoposide|etoposide|mesh-list
6184366|NCT01798004|Vincristine|vincristine|mesh-list
6184367|NCT01798004|Etoposide phosphate|etoposide phosphate|mesh-list
6184368|NCT01798004|Topotecan|topotecan|mesh-list
6184369|NCT01798004|Mesna|mesna|mesh-list
6184370|NCT01798004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6184371|NCT01798004|Immunologic Factors|immunologic factors|mesh-ancestor
6184372|NCT01798004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488158|NCT00581009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578621|NCT03866525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6184373|NCT01798004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6184374|NCT01798004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6184375|NCT01798004|Alkylating Agents|alkylating agents|mesh-ancestor
6184376|NCT01798004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6184377|NCT01798004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6671347|NCT01548794|Sensory System Agents|sensory system agents|mesh-ancestor
6671348|NCT01548794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6671349|NCT01548794|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6671350|NCT01548794|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6671351|NCT01548794|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6671352|NCT01548794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6671353|NCT01548794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671354|NCT01548807|Everolimus|everolimus|mesh-list
6671355|NCT01548807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6671356|NCT01548807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6671357|NCT01548807|Immunologic Factors|immunologic factors|mesh-ancestor
6671358|NCT01548807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672545|NCT01556815|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6672546|NCT01556815|Estrogens|estrogens|mesh-ancestor
6672547|NCT01556815|Hormones|hormones|mesh-ancestor
6672548|NCT01556815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6672549|NCT01556815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672550|NCT01556815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6672551|NCT01556867|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
6672552|NCT01556867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6672553|NCT01557075|Atorvastatin|atorvastatin|mesh-list
5578622|NCT03866421|Liver Extracts|liver extracts|mesh-list
5578623|NCT03866421|Hematinics|hematinics|mesh-ancestor
5578624|NCT03866408|Pioglitazone|pioglitazone|mesh-list
5578625|NCT03866408|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5578626|NCT03866408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578627|NCT03866447|Vitamin D|vitamin d|mesh-list
5578628|NCT03866447|Adapalene|adapalene|mesh-list
5578629|NCT03866447|Vitamins|vitamins|mesh-ancestor
5578630|NCT03866447|Micronutrients|micronutrients|mesh-ancestor
5578631|NCT03866447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578632|NCT03866447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5578633|NCT03866447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5578634|NCT03866447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5578635|NCT03866447|Analgesics|analgesics|mesh-ancestor
5578636|NCT03866447|Sensory System Agents|sensory system agents|mesh-ancestor
5578637|NCT03866447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5578638|NCT03866447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5578639|NCT03866447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6672554|NCT01557075|Pravastatin|pravastatin|mesh-list
6184378|NCT01798004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6184379|NCT01798004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6184380|NCT01798004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6184381|NCT01798004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6184382|NCT01798004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6184383|NCT01798004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6184384|NCT01798004|Tubulin Modulators|tubulin modulators|mesh-ancestor
6184385|NCT01798004|Antimitotic Agents|antimitotic agents|mesh-ancestor
6184386|NCT01798004|Mitosis Modulators|mitosis modulators|mesh-ancestor
6184387|NCT01798004|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5578640|NCT03866447|Dermatologic Agents|dermatologic agents|mesh-ancestor
5578641|NCT03866252|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
5578642|NCT03866252|Hallucinogens|hallucinogens|mesh-ancestor
5578643|NCT03866252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578644|NCT03866252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5578645|NCT03866252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5578646|NCT03866252|Serotonin Agents|serotonin agents|mesh-ancestor
5578647|NCT03866252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5578648|NCT03866252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6184388|NCT01798004|Protective Agents|protective agents|mesh-ancestor
6184389|NCT01798056|Vaccines|vaccines|mesh-list
6184390|NCT01798056|Immunologic Factors|immunologic factors|mesh-ancestor
6184391|NCT01798056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184392|NCT01798225|Doxycycline|doxycycline|mesh-list
6184393|NCT01798225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6184394|NCT01798225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6672555|NCT01557075|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
6672556|NCT01557075|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6672557|NCT01557075|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6672558|NCT01557075|Antimetabolites|antimetabolites|mesh-ancestor
5578649|NCT03866252|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6184395|NCT01798225|Antimalarials|antimalarials|mesh-ancestor
6671359|NCT01548859|Midazolam|midazolam|mesh-list
6671360|NCT01548859|Sevoflurane|sevoflurane|mesh-list
6671361|NCT01548859|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6671362|NCT01548859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6671363|NCT01548859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6671364|NCT01548859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671365|NCT01548859|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6671366|NCT01548859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6671367|NCT01548859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6671368|NCT01548859|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6671369|NCT01548859|Anesthetics, General|anesthetics, general|mesh-ancestor
6671370|NCT01548859|Anesthetics|anesthetics|mesh-ancestor
6671371|NCT01548859|GABA Modulators|gaba modulators|mesh-ancestor
6671372|NCT01548859|GABA Agents|gaba agents|mesh-ancestor
6671373|NCT01548859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6671374|NCT01548859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671375|NCT01548859|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6671376|NCT01548859|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6671377|NCT01548872|Cardioplegic Solutions|cardioplegic solutions|mesh-list
6671378|NCT01548872|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6671379|NCT01548911|Gemtuzumab|gemtuzumab|mesh-list
5578669|NCT03865992|Curcumin|curcumin|mesh-list
6671380|NCT01548911|Calicheamicins|calicheamicins|mesh-list
6671381|NCT01548911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6671382|NCT01548911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6671383|NCT01548911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5578670|NCT03865992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5578671|NCT03865992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5578672|NCT03865992|Analgesics|analgesics|mesh-ancestor
5578673|NCT03865992|Sensory System Agents|sensory system agents|mesh-ancestor
5578674|NCT03865992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5578675|NCT03865992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578676|NCT03865992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5578677|NCT03865992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5578678|NCT03865992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5578679|NCT03865992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5578680|NCT03865992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578681|NCT03865888|Cyclosporine|cyclosporine|mesh-list
5578682|NCT03865888|Tacrolimus|tacrolimus|mesh-list
5578683|NCT03865888|Cyclosporins|cyclosporins|mesh-list
5578684|NCT03865888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5578685|NCT03865888|Immunologic Factors|immunologic factors|mesh-ancestor
5578686|NCT03865888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578687|NCT03865888|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5578688|NCT03865888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5578689|NCT03865888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578690|NCT03865888|Antifungal Agents|antifungal agents|mesh-ancestor
5578691|NCT03865888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5578692|NCT03865888|Dermatologic Agents|dermatologic agents|mesh-ancestor
5578693|NCT03865888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5578694|NCT03865706|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5578695|NCT03865706|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5578696|NCT03865706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5578697|NCT03865706|Antitubercular Agents|antitubercular agents|mesh-ancestor
6671384|NCT01548924|Paclitaxel|paclitaxel|mesh-list
6671385|NCT01548924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6671386|NCT01548924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6671387|NCT01548924|Tubulin Modulators|tubulin modulators|mesh-ancestor
6671388|NCT01548924|Antimitotic Agents|antimitotic agents|mesh-ancestor
6671389|NCT01548924|Mitosis Modulators|mitosis modulators|mesh-ancestor
6671390|NCT01548924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671391|NCT01548950|Bosentan|bosentan|mesh-list
6671392|NCT01548950|Sildenafil Citrate|sildenafil citrate|mesh-list
6671393|NCT01548950|Vasodilator Agents|vasodilator agents|mesh-ancestor
6671394|NCT01548950|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6671395|NCT01548950|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6671396|NCT01548950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5578698|NCT03865615|Oxytocin|oxytocin|mesh-list
5578699|NCT03865615|Oxytocics|oxytocics|mesh-ancestor
5578700|NCT03865615|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5578701|NCT03865615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578702|NCT03865550|Ketamine|ketamine|mesh-list
5578703|NCT03865550|Analgesics|analgesics|mesh-ancestor
5578704|NCT03865550|Sensory System Agents|sensory system agents|mesh-ancestor
5578705|NCT03865550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5578706|NCT03865550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578707|NCT03865550|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5578708|NCT03865550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5578709|NCT03865550|Anesthetics, General|anesthetics, general|mesh-ancestor
5578710|NCT03865550|Anesthetics|anesthetics|mesh-ancestor
5578711|NCT03865550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5578712|NCT03865550|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5578713|NCT03865550|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5578714|NCT03865550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5578715|NCT03865550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578716|NCT03865563|Gemcitabine|gemcitabine|mesh-list
5578717|NCT03865563|Ethiodized Oil|ethiodized oil|mesh-list
5578718|NCT03865563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5578719|NCT03865563|Antimetabolites|antimetabolites|mesh-ancestor
5578720|NCT03865563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578721|NCT03865563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5578722|NCT03865563|Antiviral Agents|antiviral agents|mesh-ancestor
5578723|NCT03865563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5578724|NCT03865563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5578725|NCT03865563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5578726|NCT03865563|Immunologic Factors|immunologic factors|mesh-ancestor
5578727|NCT03865563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578728|NCT03865680|Fluorides|fluorides|mesh-list
5578729|NCT03865680|Sodium Fluoride|sodium fluoride|mesh-list
5578730|NCT03865680|Fluorides, Topical|fluorides, topical|mesh-list
5578731|NCT03865680|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
5578732|NCT03865680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578733|NCT03865680|Cariostatic Agents|cariostatic agents|mesh-ancestor
5578734|NCT03865680|Protective Agents|protective agents|mesh-ancestor
5578735|NCT03865732|Pregnanolone|pregnanolone|mesh-list
5578736|NCT03865732|Ganaxolone|ganaxolone|mesh-list
5578737|NCT03865732|Neurosteroids|neurosteroids|mesh-ancestor
6671397|NCT01548950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671398|NCT01548950|Urological Agents|urological agents|mesh-ancestor
6671399|NCT01548950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6671400|NCT01548950|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6671401|NCT01549093|Gemcitabine|gemcitabine|mesh-list
6671402|NCT01549093|Carboplatin|carboplatin|mesh-list
6671403|NCT01549093|Endostar protein|endostar protein|mesh-list
6671404|NCT01549093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5578738|NCT03865732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5578739|NCT03865732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578740|NCT03865732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578741|NCT03865732|GABA Modulators|gaba modulators|mesh-ancestor
5578742|NCT03865732|GABA Agents|gaba agents|mesh-ancestor
5578743|NCT03865732|Anesthetics|anesthetics|mesh-ancestor
5578744|NCT03865732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5578745|NCT03865511|Osimertinib|osimertinib|mesh-list
5578746|NCT03865511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5578747|NCT03865511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5578748|NCT03865511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5578749|NCT03865511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578750|NCT03865290|Ondansetron|ondansetron|mesh-list
5578751|NCT03865290|Antiemetics|antiemetics|mesh-ancestor
5578752|NCT03865290|Autonomic Agents|autonomic agents|mesh-ancestor
5578753|NCT03865290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5578754|NCT03865290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578755|NCT03865290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5578756|NCT03865290|Antipruritics|antipruritics|mesh-ancestor
5578757|NCT03865290|Dermatologic Agents|dermatologic agents|mesh-ancestor
5578758|NCT03865290|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5578759|NCT03865290|Serotonin Agents|serotonin agents|mesh-ancestor
6671405|NCT01549093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6671406|NCT01549093|Antimetabolites|antimetabolites|mesh-ancestor
6671407|NCT01549093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671408|NCT01549093|Antiviral Agents|antiviral agents|mesh-ancestor
6184396|NCT01798225|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6184397|NCT01798225|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6184398|NCT01798264|Exenatide|exenatide|mesh-list
6184399|NCT01798264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6184400|NCT01798264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184401|NCT01798264|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6184402|NCT01798264|Incretins|incretins|mesh-ancestor
6184403|NCT01798264|Hormones|hormones|mesh-ancestor
6184404|NCT01798264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6184405|NCT01798316|Acetaminophen|acetaminophen|mesh-list
6184406|NCT01798316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6184407|NCT01798316|Analgesics|analgesics|mesh-ancestor
6184408|NCT01798316|Sensory System Agents|sensory system agents|mesh-ancestor
5578760|NCT03865290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5578761|NCT03865290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578762|NCT03865290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5578763|NCT03865290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5578764|NCT03865290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5578765|NCT03865290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5578766|NCT03865290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5578767|NCT03865160|Atropine|atropine|mesh-list
5578768|NCT03865160|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5578769|NCT03865160|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6184409|NCT01798316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6184410|NCT01798316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184411|NCT01798316|Antipyretics|antipyretics|mesh-ancestor
6184412|NCT01798394|Progesterone|progesterone|mesh-list
6184413|NCT01798394|Progestins|progestins|mesh-ancestor
6184414|NCT01798394|Hormones|hormones|mesh-ancestor
6671409|NCT01549093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6671410|NCT01549093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6671411|NCT01549093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6671412|NCT01549093|Immunologic Factors|immunologic factors|mesh-ancestor
6671413|NCT01549093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671414|NCT01549093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6671415|NCT01549093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6671416|NCT01549093|Growth Substances|growth substances|mesh-ancestor
6184415|NCT01798394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6184416|NCT01798394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578770|NCT03865160|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5578771|NCT03865160|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5578772|NCT03865160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5578773|NCT03865160|Autonomic Agents|autonomic agents|mesh-ancestor
5578774|NCT03865160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5578775|NCT03865160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578776|NCT03865160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5578777|NCT03865160|Respiratory System Agents|respiratory system agents|mesh-ancestor
5578778|NCT03865160|Mydriatics|mydriatics|mesh-ancestor
5578779|NCT03865160|Parasympatholytics|parasympatholytics|mesh-ancestor
5578780|NCT03865160|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5578781|NCT03865160|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5578782|NCT03865160|Cholinergic Agents|cholinergic agents|mesh-ancestor
6184417|NCT01798485|Docetaxel|docetaxel|mesh-list
6184418|NCT01798485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6184419|NCT01798485|Tubulin Modulators|tubulin modulators|mesh-ancestor
6184420|NCT01798485|Antimitotic Agents|antimitotic agents|mesh-ancestor
6184421|NCT01798485|Mitosis Modulators|mitosis modulators|mesh-ancestor
6184422|NCT01798485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6184423|NCT01798550|Enoxaparin|enoxaparin|mesh-list
6184424|NCT01798550|Anticoagulants|anticoagulants|mesh-ancestor
6184425|NCT01798550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6184426|NCT01798550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6184427|NCT01798550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6184428|NCT01798706|Lixisenatide|lixisenatide|mesh-list
6184429|NCT01798706|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6184430|NCT01798706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184431|NCT01798992|Metoprolol|metoprolol|mesh-list
6184432|NCT01798992|Carvedilol|carvedilol|mesh-list
6184433|NCT01798992|Doxazosin|doxazosin|mesh-list
5578783|NCT03865160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6184434|NCT01798992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6184435|NCT01798992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6184436|NCT01798992|Sympatholytics|sympatholytics|mesh-ancestor
6184437|NCT01798992|Autonomic Agents|autonomic agents|mesh-ancestor
6184438|NCT01798992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6184439|NCT01798992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184440|NCT01798992|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6184441|NCT01798992|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6184442|NCT01798992|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6184443|NCT01798992|Adrenergic Agents|adrenergic agents|mesh-ancestor
6184444|NCT01798992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6184445|NCT01798992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6184446|NCT01798992|Antioxidants|antioxidants|mesh-ancestor
6184447|NCT01798992|Protective Agents|protective agents|mesh-ancestor
6184448|NCT01798992|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6184449|NCT01798992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5578784|NCT03865160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578785|NCT03865004|Acetaminophen|acetaminophen|mesh-list
5578786|NCT03865004|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
5578787|NCT03865004|Morphine|morphine|mesh-list
5578788|NCT03865004|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5578789|NCT03865004|Narcotics|narcotics|mesh-ancestor
5578790|NCT03865004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5578791|NCT03865004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578792|NCT03865004|Analgesics|analgesics|mesh-ancestor
5578793|NCT03865004|Sensory System Agents|sensory system agents|mesh-ancestor
5578794|NCT03865004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5578795|NCT03865004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5578796|NCT03865004|Antipyretics|antipyretics|mesh-ancestor
5578797|NCT03865004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5578798|NCT03865004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5578799|NCT03865004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5578800|NCT03864913|Testosterone|testosterone|mesh-list
5578801|NCT03864913|Androgens|androgens|mesh-ancestor
5578802|NCT03864913|Hormones|hormones|mesh-ancestor
5578803|NCT03864913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5578804|NCT03864913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578805|NCT03865147|Acetaminophen|acetaminophen|mesh-list
5578806|NCT03865147|Cetrimonium|cetrimonium|mesh-list
5578807|NCT03865147|Ibuprofen|ibuprofen|mesh-list
5578808|NCT03865147|Lidocaine|lidocaine|mesh-list
6184450|NCT01798992|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6184451|NCT01798992|Vasodilator Agents|vasodilator agents|mesh-ancestor
6184452|NCT01798992|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6184453|NCT01798992|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6184454|NCT01799213|Meloxicam|meloxicam|mesh-list
6184455|NCT01799213|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6184456|NCT01799213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6184457|NCT01799213|Analgesics|analgesics|mesh-ancestor
6184458|NCT01799213|Sensory System Agents|sensory system agents|mesh-ancestor
6184459|NCT01799213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6184460|NCT01799213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184461|NCT01799213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6184462|NCT01799213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6184463|NCT01799213|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6184464|NCT01799213|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6184465|NCT01799213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6184466|NCT01799213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6184467|NCT01799226|Triclosan|triclosan|mesh-list
5578809|NCT03865147|Epinephrine|epinephrine|mesh-list
5578810|NCT03865147|Racepinephrine|racepinephrine|mesh-list
5578811|NCT03865147|Bupivacaine|bupivacaine|mesh-list
5578812|NCT03865147|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
5578813|NCT03865147|Epinephryl borate|epinephryl borate|mesh-list
5578814|NCT03865147|Anesthetics, Local|anesthetics, local|mesh-ancestor
5578815|NCT03865147|Anesthetics|anesthetics|mesh-ancestor
5578816|NCT03865147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5578817|NCT03865147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578818|NCT03865147|Sensory System Agents|sensory system agents|mesh-ancestor
5578819|NCT03865147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5578820|NCT03865147|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5578821|NCT03865147|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5578822|NCT03865147|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6184468|NCT01799226|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5578823|NCT03865147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5578824|NCT03865147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578825|NCT03865147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5578826|NCT03865147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5578827|NCT03865147|Analgesics|analgesics|mesh-ancestor
5578828|NCT03865147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5578829|NCT03865147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6184469|NCT01799226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6184470|NCT01799226|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6184471|NCT01799226|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6184472|NCT01799226|Antimetabolites|antimetabolites|mesh-ancestor
6184473|NCT01799226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6184474|NCT01799226|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6184475|NCT01799590|Topiramate|topiramate|mesh-list
6184476|NCT01799590|Anticonvulsants|anticonvulsants|mesh-ancestor
6184477|NCT01799590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6184478|NCT01799590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184479|NCT01799941|Quinidine|quinidine|mesh-list
6184480|NCT01799941|Dextromethorphan|dextromethorphan|mesh-list
5578830|NCT03865147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6184481|NCT01799941|Antitussive Agents|antitussive agents|mesh-ancestor
6184482|NCT01799941|Respiratory System Agents|respiratory system agents|mesh-ancestor
6184483|NCT01799941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6184484|NCT01799941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6184485|NCT01799941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6184486|NCT01799941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6184487|NCT01799941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184488|NCT01799941|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6184489|NCT01799941|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6184490|NCT01799941|Adrenergic Agents|adrenergic agents|mesh-ancestor
6184491|NCT01799941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6184492|NCT01799941|Antimalarials|antimalarials|mesh-ancestor
6184493|NCT01799941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6184494|NCT01799941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6184495|NCT01799941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6184496|NCT01799941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6184497|NCT01799941|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6184498|NCT01799941|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6184499|NCT01799941|Cholinergic Agents|cholinergic agents|mesh-ancestor
6184500|NCT01799941|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6184501|NCT01799941|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6184502|NCT01799941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6184503|NCT01799941|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6184504|NCT01799941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6184505|NCT01799993|Amikacin|amikacin|mesh-list
6184506|NCT01799993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6184507|NCT01799993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6184508|NCT01800838|Silicon|silicon|mesh-list
6184509|NCT01800838|Silicon phthalocyanine|silicon phthalocyanine|mesh-list
6184510|NCT01800838|Trace Elements|trace elements|mesh-ancestor
6184511|NCT01800838|Micronutrients|micronutrients|mesh-ancestor
6671417|NCT01549093|Growth Inhibitors|growth inhibitors|mesh-ancestor
6671418|NCT01549158|Torsemide|torsemide|mesh-list
6671419|NCT01549158|Furosemide|furosemide|mesh-list
6671420|NCT01549158|Diuretics|diuretics|mesh-ancestor
6671421|NCT01549158|Natriuretic Agents|natriuretic agents|mesh-ancestor
6671422|NCT01549158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671423|NCT01549158|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6671424|NCT01549158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6671425|NCT01549158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671426|NCT01549158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5578831|NCT03865147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5578832|NCT03865147|Antipyretics|antipyretics|mesh-ancestor
5578833|NCT03865147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5578834|NCT03865147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5578835|NCT03865147|Adrenergic Agents|adrenergic agents|mesh-ancestor
5578836|NCT03865147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5578837|NCT03865147|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5578838|NCT03865147|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5578839|NCT03865147|Autonomic Agents|autonomic agents|mesh-ancestor
5578840|NCT03865147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5578841|NCT03865147|Respiratory System Agents|respiratory system agents|mesh-ancestor
5578842|NCT03865147|Mydriatics|mydriatics|mesh-ancestor
5578843|NCT03865147|Sympathomimetics|sympathomimetics|mesh-ancestor
5578844|NCT03865147|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5578845|NCT03865147|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
5578846|NCT03865147|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5578847|NCT03865147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5578848|NCT03865121|Nicotine|nicotine|mesh-list
5578849|NCT03865121|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6184512|NCT01800838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184513|NCT01800838|Antimalarials|antimalarials|mesh-ancestor
6184514|NCT01800838|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6184515|NCT01800838|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6184516|NCT01800838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6184517|NCT01800838|Antiviral Agents|antiviral agents|mesh-ancestor
6184518|NCT01800838|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6184519|NCT01800838|Dermatologic Agents|dermatologic agents|mesh-ancestor
6184520|NCT01800877|Phenylephrine|phenylephrine|mesh-list
6184521|NCT01800877|Dopamine|dopamine|mesh-list
6184522|NCT01800877|Vasopressins|vasopressins|mesh-list
6184523|NCT01800877|Epinephrine|epinephrine|mesh-list
6184524|NCT01800877|Norepinephrine|norepinephrine|mesh-list
6184525|NCT01800877|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
6184526|NCT01800877|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6184527|NCT01800877|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6184528|NCT01800877|Adrenergic Agents|adrenergic agents|mesh-ancestor
6184529|NCT01800877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6184530|NCT01800877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6184531|NCT01800877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184532|NCT01800877|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5578850|NCT03865121|Autonomic Agents|autonomic agents|mesh-ancestor
5578851|NCT03865121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5578852|NCT03865121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578853|NCT03865121|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5578854|NCT03865121|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5578855|NCT03865121|Cholinergic Agents|cholinergic agents|mesh-ancestor
5578856|NCT03865121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5578857|NCT03865121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578858|NCT03864978|Rifaximin|rifaximin|mesh-list
5578859|NCT03864978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5578860|NCT03864978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5578861|NCT03864978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5578862|NCT03864783|Curcumin|curcumin|mesh-list
5578863|NCT03864783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5578864|NCT03864783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6184533|NCT01800877|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6184534|NCT01800877|Autonomic Agents|autonomic agents|mesh-ancestor
6184535|NCT01800877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6184536|NCT01800877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6184537|NCT01800877|Respiratory System Agents|respiratory system agents|mesh-ancestor
6184538|NCT01800877|Mydriatics|mydriatics|mesh-ancestor
6184539|NCT01800877|Sympathomimetics|sympathomimetics|mesh-ancestor
6184540|NCT01800877|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6671427|NCT01549171|Iloprost|iloprost|mesh-list
6671428|NCT01549171|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6671429|NCT01549171|Vasodilator Agents|vasodilator agents|mesh-ancestor
6671430|NCT01549236|Benzonidazole|benzonidazole|mesh-list
6671431|NCT01549236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6671432|NCT01549236|Immunologic Factors|immunologic factors|mesh-ancestor
6671433|NCT01549236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671434|NCT01549236|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6671435|NCT01549236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5578865|NCT03864783|Analgesics|analgesics|mesh-ancestor
5578866|NCT03864783|Sensory System Agents|sensory system agents|mesh-ancestor
5578867|NCT03864783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5578868|NCT03864783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578869|NCT03864783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5578870|NCT03864783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5578871|NCT03864783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5578872|NCT03864783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5578873|NCT03864783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578874|NCT03864666|Cilostazol|cilostazol|mesh-list
5578875|NCT03864666|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5578876|NCT03864666|Autonomic Agents|autonomic agents|mesh-ancestor
5578877|NCT03864666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5578878|NCT03864666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578879|NCT03864666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5578880|NCT03864666|Respiratory System Agents|respiratory system agents|mesh-ancestor
5578881|NCT03864666|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5578882|NCT03864666|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5578883|NCT03864666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578884|NCT03864666|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5578885|NCT03864666|Vasodilator Agents|vasodilator agents|mesh-ancestor
6184541|NCT01800877|Nasal Decongestants|nasal decongestants|mesh-ancestor
6671436|NCT01549236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6671437|NCT01549236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6488159|NCT00581009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6671438|NCT01549301|Lenograstim|lenograstim|mesh-list
5578886|NCT03864666|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5578887|NCT03864666|Protective Agents|protective agents|mesh-ancestor
5578888|NCT03864666|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5578889|NCT03864666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5578890|NCT03864666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5578891|NCT03864705|Metformin|metformin|mesh-list
5578892|NCT03864705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5578893|NCT03864705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184542|NCT01800877|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6184543|NCT01800877|Protective Agents|protective agents|mesh-ancestor
6184544|NCT01800877|Hemostatics|hemostatics|mesh-ancestor
6184545|NCT01800877|Coagulants|coagulants|mesh-ancestor
6184546|NCT01800877|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5604727|NCT04375033|Buprenorphine|buprenorphine|mesh-list
5604728|NCT04375033|Naloxone|naloxone|mesh-list
5604729|NCT04375033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5604730|NCT04375033|Narcotics|narcotics|mesh-ancestor
5604731|NCT04375033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5604732|NCT04375033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604733|NCT04375033|Analgesics|analgesics|mesh-ancestor
6671439|NCT01549301|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6671440|NCT01549301|Immunologic Factors|immunologic factors|mesh-ancestor
6671441|NCT01549301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184547|NCT01800877|Natriuretic Agents|natriuretic agents|mesh-ancestor
6184548|NCT01800877|Dopamine Agents|dopamine agents|mesh-ancestor
6184549|NCT01800968|Liraglutide|liraglutide|mesh-list
6184550|NCT01800968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6184551|NCT01800968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184552|NCT01800968|Incretins|incretins|mesh-ancestor
6184553|NCT01800968|Hormones|hormones|mesh-ancestor
6184554|NCT01800968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6184555|NCT01801111|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6184556|NCT01801111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6184557|NCT01801111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6184558|NCT01801111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6184559|NCT01801111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671442|NCT01549418|Aspirin|aspirin|mesh-list
6671443|NCT01549418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6671444|NCT01549418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6671445|NCT01549418|Analgesics|analgesics|mesh-ancestor
6671446|NCT01549418|Sensory System Agents|sensory system agents|mesh-ancestor
6671447|NCT01549418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6184560|NCT01801124|Bupivacaine|bupivacaine|mesh-list
6184561|NCT01801124|Anesthetics, Local|anesthetics, local|mesh-ancestor
6184562|NCT01801124|Anesthetics|anesthetics|mesh-ancestor
6184563|NCT01801124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6184564|NCT01801124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184565|NCT01801124|Sensory System Agents|sensory system agents|mesh-ancestor
6184566|NCT01801124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5604734|NCT04375033|Sensory System Agents|sensory system agents|mesh-ancestor
5604735|NCT04375033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5604736|NCT04375033|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5604737|NCT04367740|Antibodies|antibodies|mesh-list
5604738|NCT04367740|Immunoglobulin G|immunoglobulin g|mesh-list
5604739|NCT04367740|Immunologic Factors|immunologic factors|mesh-ancestor
5604740|NCT04367740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604741|NCT04348747|Interferons|interferons|mesh-list
5604742|NCT04348747|Interferon-alpha|interferon-alpha|mesh-list
5604743|NCT04348747|Interferon alpha-2|interferon alpha-2|mesh-list
5604744|NCT04348747|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
5604745|NCT04348747|Celecoxib|celecoxib|mesh-list
5604746|NCT04348747|Pembrolizumab|pembrolizumab|mesh-list
5604747|NCT04348747|Vaccines|vaccines|mesh-list
5604748|NCT04348747|Benzenesulfonamide|benzenesulfonamide|mesh-list
6184567|NCT01801280|Mycophenolic Acid|mycophenolic acid|mesh-list
6184568|NCT01801280|Pantoprazole|pantoprazole|mesh-list
6184569|NCT01801280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6184570|NCT01801280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6184571|NCT01801280|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5578894|NCT03864250|Prednisone|prednisone|mesh-list
5578895|NCT03864250|Tacrolimus|tacrolimus|mesh-list
5578896|NCT03864250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5578897|NCT03864250|Glucocorticoids|glucocorticoids|mesh-ancestor
5578898|NCT03864250|Hormones|hormones|mesh-ancestor
5578899|NCT03864250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5578900|NCT03864250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184572|NCT01801280|Antitubercular Agents|antitubercular agents|mesh-ancestor
6184573|NCT01801280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6184574|NCT01801280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5578901|NCT03864250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5578902|NCT03864250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5578903|NCT03864250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5578904|NCT03864250|Immunologic Factors|immunologic factors|mesh-ancestor
5578905|NCT03864250|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5578906|NCT03864250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5578907|NCT03864250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578908|NCT03864523|Pioglitazone|pioglitazone|mesh-list
5578909|NCT03864523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5578910|NCT03864523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578911|NCT03864419|Prednisone|prednisone|mesh-list
5578912|NCT03864419|Cyclophosphamide|cyclophosphamide|mesh-list
5578913|NCT03864419|Rituximab|rituximab|mesh-list
5578914|NCT03864419|Doxorubicin|doxorubicin|mesh-list
5578915|NCT03864419|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5578916|NCT03864419|Methotrexate|methotrexate|mesh-list
5578917|NCT03864419|Etoposide|etoposide|mesh-list
5578918|NCT03864419|Vincristine|vincristine|mesh-list
5578919|NCT03864419|Daunorubicin|daunorubicin|mesh-list
5578920|NCT03864419|Podophyllotoxin|podophyllotoxin|mesh-list
6184575|NCT01801280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6184576|NCT01801280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6184577|NCT01801280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6184578|NCT01801280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6184579|NCT01801280|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6184580|NCT01801436|Bortezomib|bortezomib|mesh-list
6184581|NCT01801436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6184582|NCT01801449|Rilonacept|rilonacept|mesh-list
6184583|NCT01801449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6184584|NCT01801475|Ondansetron|ondansetron|mesh-list
6184585|NCT01801475|Antiemetics|antiemetics|mesh-ancestor
6184586|NCT01801475|Autonomic Agents|autonomic agents|mesh-ancestor
6184587|NCT01801475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6184588|NCT01801475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184589|NCT01801475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6184590|NCT01801475|Antipruritics|antipruritics|mesh-ancestor
6184591|NCT01801475|Dermatologic Agents|dermatologic agents|mesh-ancestor
6184592|NCT01801475|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6184593|NCT01801475|Serotonin Agents|serotonin agents|mesh-ancestor
6184594|NCT01801475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6184595|NCT01801475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6184596|NCT01801475|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6184597|NCT01801475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6184598|NCT01801475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6184599|NCT01801475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6184600|NCT01801475|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6184601|NCT01801735|Meloxicam|meloxicam|mesh-list
6184602|NCT01801735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6184603|NCT01801735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6184604|NCT01801735|Analgesics|analgesics|mesh-ancestor
6184605|NCT01801735|Sensory System Agents|sensory system agents|mesh-ancestor
6184606|NCT01801735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6184607|NCT01801735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184608|NCT01801735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6184609|NCT01801735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6184610|NCT01801735|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6184611|NCT01801735|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6184612|NCT01801735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6184613|NCT01801735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578921|NCT03864419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5578922|NCT03864419|Antibodies|antibodies|mesh-list
5578923|NCT03864419|Immunoglobulins|immunoglobulins|mesh-list
6184614|NCT01801917|Siponimod|siponimod|mesh-list
5578924|NCT03864419|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5578925|NCT03864419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6184615|NCT01801917|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6184616|NCT01801917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6184617|NCT01801917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6184618|NCT01801917|Immunologic Factors|immunologic factors|mesh-ancestor
6184619|NCT01801917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184620|NCT01802073|Vancomycin|vancomycin|mesh-list
6184621|NCT01802073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6184622|NCT01802073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6184623|NCT01802216|Minocycline|minocycline|mesh-list
6184624|NCT01802216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6184625|NCT01802216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6184626|NCT01802333|Cytarabine|cytarabine|mesh-list
6184627|NCT01802333|Daunorubicin|daunorubicin|mesh-list
6184628|NCT01802333|Vorinostat|vorinostat|mesh-list
6184629|NCT01802333|Idarubicin|idarubicin|mesh-list
6184630|NCT01802333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6184631|NCT01802333|Antimetabolites|antimetabolites|mesh-ancestor
6184632|NCT01802333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6184633|NCT01802333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6184634|NCT01802333|Antiviral Agents|antiviral agents|mesh-ancestor
6184635|NCT01802333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6184636|NCT01802333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6184637|NCT01802333|Immunologic Factors|immunologic factors|mesh-ancestor
6184638|NCT01802333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184639|NCT01802333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6184640|NCT01802333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6184641|NCT01802333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6184642|NCT01802333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6184643|NCT01802333|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6184644|NCT01802385|Sertraline|sertraline|mesh-list
6184645|NCT01802385|Antidepressive Agents|antidepressive agents|mesh-ancestor
6184646|NCT01802385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6184647|NCT01802385|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6184648|NCT01802385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6184649|NCT01802385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6184650|NCT01802385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6184651|NCT01802385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6671448|NCT01549418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671449|NCT01549418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6671450|NCT01549418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6671451|NCT01549418|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6671452|NCT01549418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6671453|NCT01549418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671454|NCT01549418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6671455|NCT01549418|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6671456|NCT01549418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6671457|NCT01549418|Antipyretics|antipyretics|mesh-ancestor
5578926|NCT03864419|Immunologic Factors|immunologic factors|mesh-ancestor
5578927|NCT03864419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184652|NCT01802385|Serotonin Agents|serotonin agents|mesh-ancestor
6184653|NCT01802385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184654|NCT01802437|Fluoxetine|fluoxetine|mesh-list
5578928|NCT03864419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5578929|NCT03864419|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5578930|NCT03864419|Alkylating Agents|alkylating agents|mesh-ancestor
5578931|NCT03864419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578932|NCT03864419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5578933|NCT03864419|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5578934|NCT03864419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5578935|NCT03864419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5578936|NCT03864419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5578937|NCT03864419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5578938|NCT03864419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5578939|NCT03864419|Glucocorticoids|glucocorticoids|mesh-ancestor
5578940|NCT03864419|Hormones|hormones|mesh-ancestor
5578941|NCT03864419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5578942|NCT03864419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5578943|NCT03864419|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5578944|NCT03864419|Abortifacient Agents|abortifacient agents|mesh-ancestor
5578945|NCT03864419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5578946|NCT03864419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6184655|NCT01802437|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5578947|NCT03864419|Antimetabolites|antimetabolites|mesh-ancestor
5578948|NCT03864419|Dermatologic Agents|dermatologic agents|mesh-ancestor
5578949|NCT03864419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5578950|NCT03864419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5578951|NCT03864419|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5578952|NCT03864419|Tubulin Modulators|tubulin modulators|mesh-ancestor
6671458|NCT01549431|Dexamethasone|dexamethasone|mesh-list
6671459|NCT01549431|Panobinostat|panobinostat|mesh-list
6671460|NCT01549431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6671461|NCT01549431|Antiemetics|antiemetics|mesh-ancestor
6671462|NCT01549431|Autonomic Agents|autonomic agents|mesh-ancestor
6671463|NCT01549431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6671464|NCT01549431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671465|NCT01549431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6671466|NCT01549431|Glucocorticoids|glucocorticoids|mesh-ancestor
5578953|NCT03864419|Antimitotic Agents|antimitotic agents|mesh-ancestor
5578954|NCT03864419|Mitosis Modulators|mitosis modulators|mesh-ancestor
5578955|NCT03864419|Keratolytic Agents|keratolytic agents|mesh-ancestor
5578956|NCT03864588|Ropivacaine|ropivacaine|mesh-list
5578957|NCT03864588|Anesthetics, Local|anesthetics, local|mesh-ancestor
5578958|NCT03864588|Anesthetics|anesthetics|mesh-ancestor
5578959|NCT03864588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5578960|NCT03864588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578961|NCT03864588|Sensory System Agents|sensory system agents|mesh-ancestor
6671467|NCT01549431|Hormones|hormones|mesh-ancestor
6671468|NCT01549431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6671469|NCT01549431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6671470|NCT01549431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6671471|NCT01549431|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6671472|NCT01549431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6671473|NCT01549431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671474|NCT01549496|Amlodipine|amlodipine|mesh-list
6671475|NCT01549496|Diltiazem|diltiazem|mesh-list
6671476|NCT01549496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5578962|NCT03864588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5578963|NCT03864575|Celecoxib|celecoxib|mesh-list
5578964|NCT03864575|Nivolumab|nivolumab|mesh-list
5578965|NCT03864575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5578966|NCT03864575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5578967|NCT03864575|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5578968|NCT03864575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5578969|NCT03864575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5578970|NCT03864575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5578971|NCT03864575|Analgesics|analgesics|mesh-ancestor
5578972|NCT03864575|Sensory System Agents|sensory system agents|mesh-ancestor
5578973|NCT03864575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5578974|NCT03864575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671477|NCT01549496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6671478|NCT01549496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6671479|NCT01549496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671480|NCT01549496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6671481|NCT01549496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671482|NCT01549496|Vasodilator Agents|vasodilator agents|mesh-ancestor
6671483|NCT01549548|Ponatinib|ponatinib|mesh-list
6184656|NCT01802437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6184657|NCT01802437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6184658|NCT01802437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6184659|NCT01802437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6184660|NCT01802437|Serotonin Agents|serotonin agents|mesh-ancestor
6184661|NCT01802437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184662|NCT01802437|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6184663|NCT01802437|Antidepressive Agents|antidepressive agents|mesh-ancestor
6184664|NCT01802437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6184665|NCT01802437|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6184666|NCT01802437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6184667|NCT01802437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6184668|NCT01802515|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6184669|NCT01802515|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6184670|NCT01802515|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6671484|NCT01549548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6671485|NCT01549548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6671486|NCT01549548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5578975|NCT03864575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5578976|NCT03864575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5578977|NCT03864575|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5578978|NCT03864575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5578979|NCT03864575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5578980|NCT03864185|Rituximab|rituximab|mesh-list
5578981|NCT03864185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5578982|NCT03864185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5578983|NCT03864185|Immunologic Factors|immunologic factors|mesh-ancestor
5578984|NCT03864185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578985|NCT03864185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5578986|NCT03864172|Calcium, Dietary|calcium, dietary|mesh-list
5578987|NCT03864172|Calcium|calcium|mesh-list
5578988|NCT03864172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5578989|NCT03864172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578990|NCT03864172|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5578991|NCT03864068|Inositol|inositol|mesh-list
5578992|NCT03864068|Vitamin B Complex|vitamin b complex|mesh-ancestor
6184671|NCT01802515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6184672|NCT01802515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6184673|NCT01802515|Adrenergic Agents|adrenergic agents|mesh-ancestor
6184674|NCT01802515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6184675|NCT01802515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184676|NCT01802580|Fluocinonide|fluocinonide|mesh-list
6184677|NCT01802580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6184678|NCT01802580|Glucocorticoids|glucocorticoids|mesh-ancestor
6184679|NCT01802580|Hormones|hormones|mesh-ancestor
6184680|NCT01802580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6184681|NCT01802580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184682|NCT01802580|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6184683|NCT01802775|Aspirin|aspirin|mesh-list
6671487|NCT01549548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671488|NCT01549574|Crizotinib|crizotinib|mesh-list
6671489|NCT01549574|Esomeprazole|esomeprazole|mesh-list
6671490|NCT01549574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6671491|NCT01549574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6671492|NCT01549574|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6671493|NCT01549574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6671494|NCT01549574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671495|NCT01549574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6671496|NCT01549574|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6671497|NCT01549600|Psyllium|psyllium|mesh-list
6671498|NCT01549600|Cathartics|cathartics|mesh-ancestor
6671499|NCT01549600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6671500|NCT01549691|Alprazolam|alprazolam|mesh-list
6184684|NCT01802775|Edoxaban|edoxaban|mesh-list
6184685|NCT01802775|Clopidogrel|clopidogrel|mesh-list
6184686|NCT01802775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6184687|NCT01802775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6184688|NCT01802775|Analgesics|analgesics|mesh-ancestor
6184689|NCT01802775|Sensory System Agents|sensory system agents|mesh-ancestor
6184690|NCT01802775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6184691|NCT01802775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184692|NCT01802775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6184693|NCT01802775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6184694|NCT01802775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6184695|NCT01802775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6184696|NCT01802775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6184697|NCT01802775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6184698|NCT01802775|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6184699|NCT01802775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6184700|NCT01802775|Antipyretics|antipyretics|mesh-ancestor
6184701|NCT01802775|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6184702|NCT01802775|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6184703|NCT01802775|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6184704|NCT01802775|Purinergic Agents|purinergic agents|mesh-ancestor
6184705|NCT01802775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6184706|NCT01802775|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6184707|NCT01802775|Antithrombins|antithrombins|mesh-ancestor
6671501|NCT01549691|Zopiclone|zopiclone|mesh-list
6671502|NCT01549691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5578993|NCT03864068|Vitamins|vitamins|mesh-ancestor
5578994|NCT03864068|Micronutrients|micronutrients|mesh-ancestor
5604749|NCT04348747|Immunologic Factors|immunologic factors|mesh-ancestor
6671503|NCT01549691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6671504|NCT01549691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671505|NCT01549691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6671506|NCT01549691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5578995|NCT03864068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5578996|NCT03863925|Propofol|propofol|mesh-list
5578997|NCT03863925|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5578998|NCT03863925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5578999|NCT03863925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579000|NCT03863925|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5579001|NCT03863925|Anesthetics, General|anesthetics, general|mesh-ancestor
5579002|NCT03863925|Anesthetics|anesthetics|mesh-ancestor
5579003|NCT03863977|Dexamethasone|dexamethasone|mesh-list
5579004|NCT03863977|Dexamethasone acetate|dexamethasone acetate|mesh-list
5579005|NCT03863977|Bupivacaine|bupivacaine|mesh-list
6184708|NCT01802775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6184709|NCT01802775|Protease Inhibitors|protease inhibitors|mesh-ancestor
6184710|NCT01802775|Anticoagulants|anticoagulants|mesh-ancestor
6184711|NCT01802879|Panobinostat|panobinostat|mesh-list
6184712|NCT01802879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6184713|NCT01802879|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6184714|NCT01802879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6184715|NCT01802879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6184716|NCT01803074|Ritonavir|ritonavir|mesh-list
6184717|NCT01803074|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6184718|NCT01803074|Tenofovir|tenofovir|mesh-list
6671507|NCT01549691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6671508|NCT01549691|GABA Modulators|gaba modulators|mesh-ancestor
6671509|NCT01549691|GABA Agents|gaba agents|mesh-ancestor
6671510|NCT01549691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6671511|NCT01549691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671512|NCT01549704|Ropivacaine|ropivacaine|mesh-list
6671513|NCT01549704|Anesthetics, Local|anesthetics, local|mesh-ancestor
6671514|NCT01549704|Anesthetics|anesthetics|mesh-ancestor
6671515|NCT01549704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6184719|NCT01803074|Emtricitabine|emtricitabine|mesh-list
6184720|NCT01803074|BMS-955176|bms-955176|mesh-list
6184721|NCT01803074|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6184722|NCT01803074|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6184723|NCT01803074|Protease Inhibitors|protease inhibitors|mesh-ancestor
6184724|NCT01803074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5579006|NCT03863977|BB 1101|bb 1101|mesh-list
5579007|NCT03863977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5579008|NCT03863977|Antiemetics|antiemetics|mesh-ancestor
6184725|NCT01803074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6184726|NCT01803074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6184727|NCT01803074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6184728|NCT01803074|Antiviral Agents|antiviral agents|mesh-ancestor
6184729|NCT01803074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6184730|NCT01803074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5579009|NCT03863977|Autonomic Agents|autonomic agents|mesh-ancestor
5579010|NCT03863977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5579011|NCT03863977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579012|NCT03863977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5579013|NCT03863977|Glucocorticoids|glucocorticoids|mesh-ancestor
5579014|NCT03863977|Hormones|hormones|mesh-ancestor
5579015|NCT03863977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5579016|NCT03863977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5579017|NCT03863977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5579018|NCT03863977|Protease Inhibitors|protease inhibitors|mesh-ancestor
5579019|NCT03863977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6184731|NCT01803074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6184732|NCT01803074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6184733|NCT01803074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6184734|NCT01803269|Topotecan|topotecan|mesh-list
6184735|NCT01803269|Camptothecin|camptothecin|mesh-list
6184736|NCT01803269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6184737|NCT01803269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6184738|NCT01803269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6184739|NCT01803269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6184740|NCT01803269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6184741|NCT01803269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6184742|NCT01803282|Leucovorin|leucovorin|mesh-list
6184743|NCT01803282|Gemcitabine|gemcitabine|mesh-list
6184744|NCT01803282|Paclitaxel|paclitaxel|mesh-list
6671516|NCT01549704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671517|NCT01549704|Sensory System Agents|sensory system agents|mesh-ancestor
6184745|NCT01803282|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6184746|NCT01803282|Bevacizumab|bevacizumab|mesh-list
5579020|NCT03863977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5579021|NCT03863977|Anesthetics, Local|anesthetics, local|mesh-ancestor
5579022|NCT03863977|Anesthetics|anesthetics|mesh-ancestor
5579023|NCT03863977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5579024|NCT03863977|Sensory System Agents|sensory system agents|mesh-ancestor
5579025|NCT03864016|Sufentanil|sufentanil|mesh-list
5579026|NCT03864016|Dsuvia|dsuvia|mesh-list
5579027|NCT03864016|Anesthetics|anesthetics|mesh-ancestor
5579028|NCT03864016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5579029|NCT03864016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579030|NCT03864016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5579031|NCT03864016|Narcotics|narcotics|mesh-ancestor
5579032|NCT03864016|Analgesics|analgesics|mesh-ancestor
5579033|NCT03864016|Sensory System Agents|sensory system agents|mesh-ancestor
5579034|NCT03864016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5579035|NCT03864016|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5579036|NCT03864016|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5579037|NCT03864016|Anesthetics, General|anesthetics, general|mesh-ancestor
5579038|NCT03864094|Phenylephrine|phenylephrine|mesh-list
5579039|NCT03864094|Oxymetazoline|oxymetazoline|mesh-list
5579040|NCT03864094|Norepinephrine|norepinephrine|mesh-list
5579041|NCT03864094|Ephedrine|ephedrine|mesh-list
5579042|NCT03864094|Pseudoephedrine|pseudoephedrine|mesh-list
5579043|NCT03864094|Remifentanil|remifentanil|mesh-list
5579044|NCT03864094|Propofol|propofol|mesh-list
5579045|NCT03864094|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5579046|NCT03864094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5579047|NCT03864094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579048|NCT03864094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5579049|NCT03864094|Anesthetics, General|anesthetics, general|mesh-ancestor
5579050|NCT03864094|Anesthetics|anesthetics|mesh-ancestor
5579051|NCT03864094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5579052|NCT03864094|Narcotics|narcotics|mesh-ancestor
5579053|NCT03864094|Analgesics|analgesics|mesh-ancestor
5579054|NCT03864094|Sensory System Agents|sensory system agents|mesh-ancestor
5579055|NCT03864094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5579056|NCT03864094|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5579057|NCT03864094|Mydriatics|mydriatics|mesh-ancestor
5579058|NCT03864094|Autonomic Agents|autonomic agents|mesh-ancestor
5579059|NCT03864094|Sympathomimetics|sympathomimetics|mesh-ancestor
5579060|NCT03864094|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5579061|NCT03864094|Nasal Decongestants|nasal decongestants|mesh-ancestor
5579062|NCT03864094|Respiratory System Agents|respiratory system agents|mesh-ancestor
5579063|NCT03864094|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5579064|NCT03864094|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5579065|NCT03864094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5579066|NCT03864094|Adrenergic Agents|adrenergic agents|mesh-ancestor
5579067|NCT03864094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5579068|NCT03864094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5579069|NCT03864094|Protective Agents|protective agents|mesh-ancestor
5579070|NCT03864094|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5579071|NCT03864094|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5579072|NCT03864094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5579073|NCT03863899|Anesthetics|anesthetics|mesh-list
5579074|NCT03863899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5579075|NCT03863899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579076|NCT03863691|Amisulpride|amisulpride|mesh-list
5579077|NCT03863691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5579078|NCT03863691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5579079|NCT03863691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5579080|NCT03863691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579081|NCT03863691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6184747|NCT01803282|Carboplatin|carboplatin|mesh-list
6184748|NCT01803282|Oxaliplatin|oxaliplatin|mesh-list
6184749|NCT01803282|Irinotecan|irinotecan|mesh-list
6184750|NCT01803282|Pemetrexed|pemetrexed|mesh-list
6184751|NCT01803282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6184752|NCT01803282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6184753|NCT01803282|Tubulin Modulators|tubulin modulators|mesh-ancestor
6488160|NCT00581009|Antimanic Agents|antimanic agents|mesh-ancestor
6671518|NCT01549704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6671519|NCT01549730|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
6671520|NCT01549730|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5579082|NCT03863691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5579083|NCT03863691|Dopamine Agents|dopamine agents|mesh-ancestor
5579084|NCT03863691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5579085|NCT03863691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6184754|NCT01803282|Antimitotic Agents|antimitotic agents|mesh-ancestor
6671521|NCT01549730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671522|NCT01549743|Celecoxib|celecoxib|mesh-list
6671523|NCT01549743|Rebamipide|rebamipide|mesh-list
6671524|NCT01549743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6671525|NCT01549743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6671526|NCT01549743|Analgesics|analgesics|mesh-ancestor
6671527|NCT01549743|Sensory System Agents|sensory system agents|mesh-ancestor
6671528|NCT01549743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6671529|NCT01549743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671530|NCT01549743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6671531|NCT01549743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6671532|NCT01549743|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6671533|NCT01549743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6671534|NCT01549743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6671535|NCT01549743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671536|NCT01549743|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6671537|NCT01549743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6671538|NCT01549743|Antioxidants|antioxidants|mesh-ancestor
6184755|NCT01803282|Mitosis Modulators|mitosis modulators|mesh-ancestor
6184756|NCT01803282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6184757|NCT01803282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6184758|NCT01803282|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6184759|NCT01803282|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6184760|NCT01803282|Growth Substances|growth substances|mesh-ancestor
6184761|NCT01803282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184762|NCT01803282|Growth Inhibitors|growth inhibitors|mesh-ancestor
6184763|NCT01803282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6184764|NCT01803282|Antimetabolites|antimetabolites|mesh-ancestor
6184765|NCT01803282|Antiviral Agents|antiviral agents|mesh-ancestor
6184766|NCT01803282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6184767|NCT01803282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6184768|NCT01803282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6184769|NCT01803282|Immunologic Factors|immunologic factors|mesh-ancestor
6184770|NCT01803282|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6184771|NCT01803282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6184772|NCT01803282|Antidotes|antidotes|mesh-ancestor
6184773|NCT01803282|Protective Agents|protective agents|mesh-ancestor
6184774|NCT01803282|Vitamin B Complex|vitamin b complex|mesh-ancestor
6184775|NCT01803282|Vitamins|vitamins|mesh-ancestor
6184776|NCT01803282|Micronutrients|micronutrients|mesh-ancestor
6184777|NCT01803282|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6671539|NCT01549743|Protective Agents|protective agents|mesh-ancestor
6671540|NCT01549795|Capecitabine|capecitabine|mesh-list
6671541|NCT01549795|Liver Extracts|liver extracts|mesh-list
6184778|NCT01803282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6184779|NCT01804036|Zolpidem|zolpidem|mesh-list
6184780|NCT01804036|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6184781|NCT01804036|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6184782|NCT01804036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6184783|NCT01804036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671542|NCT01549795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6671543|NCT01549795|Antimetabolites|antimetabolites|mesh-ancestor
5579086|NCT03863691|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5579087|NCT03863691|Antidepressive Agents|antidepressive agents|mesh-ancestor
5579088|NCT03863405|Metformin|metformin|mesh-list
5579089|NCT03863405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5579090|NCT03863405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579091|NCT03863587|Ramucirumab|ramucirumab|mesh-list
5579092|NCT03863587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5579093|NCT03863392|Misoprostol|misoprostol|mesh-list
5579094|NCT03863392|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5579095|NCT03863392|Abortifacient Agents|abortifacient agents|mesh-ancestor
5579096|NCT03863392|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5579097|NCT03863392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579098|NCT03863392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5579099|NCT03863392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5579100|NCT03863392|Oxytocics|oxytocics|mesh-ancestor
5579101|NCT03863626|Furosemide|furosemide|mesh-list
5579102|NCT03863626|Diuretics|diuretics|mesh-ancestor
5579103|NCT03863626|Natriuretic Agents|natriuretic agents|mesh-ancestor
5579104|NCT03863626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579105|NCT03863626|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5579106|NCT03863626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5604750|NCT04348747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184784|NCT01804036|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6184785|NCT01804036|GABA Agonists|gaba agonists|mesh-ancestor
6184786|NCT01804036|GABA Agents|gaba agents|mesh-ancestor
6184787|NCT01804036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6184788|NCT01804036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6184789|NCT01804049|Metformin|metformin|mesh-list
6184790|NCT01804049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6184791|NCT01804049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184792|NCT01804075|Morphine|morphine|mesh-list
6671544|NCT01549795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671545|NCT01549795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6671546|NCT01549795|Hematinics|hematinics|mesh-ancestor
6671547|NCT01549847|Piracetam|piracetam|mesh-list
6671548|NCT01549847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6184793|NCT01804075|Methadone|methadone|mesh-list
6184794|NCT01804075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6184795|NCT01804075|Narcotics|narcotics|mesh-ancestor
6184796|NCT01804075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6184797|NCT01804075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184798|NCT01804075|Analgesics|analgesics|mesh-ancestor
6184799|NCT01804075|Sensory System Agents|sensory system agents|mesh-ancestor
6184800|NCT01804075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6184801|NCT01804075|Antitussive Agents|antitussive agents|mesh-ancestor
6184802|NCT01804075|Respiratory System Agents|respiratory system agents|mesh-ancestor
6184803|NCT01804101|Cytarabine|cytarabine|mesh-list
6184804|NCT01804101|Daunorubicin|daunorubicin|mesh-list
6184805|NCT01804101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6184806|NCT01804101|Antimetabolites|antimetabolites|mesh-ancestor
6184807|NCT01804101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6184808|NCT01804101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6184809|NCT01804101|Antiviral Agents|antiviral agents|mesh-ancestor
6184810|NCT01804101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6184811|NCT01804101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6184812|NCT01804101|Immunologic Factors|immunologic factors|mesh-ancestor
6184813|NCT01804101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184814|NCT01804101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6184815|NCT01804101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6184816|NCT01804101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6184817|NCT01804101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6671549|NCT01549847|Protective Agents|protective agents|mesh-ancestor
6671550|NCT01549847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671551|NCT01549847|Nootropic Agents|nootropic agents|mesh-ancestor
6671552|NCT01549938|Cholecalciferol|cholecalciferol|mesh-list
6671553|NCT01549938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6671554|NCT01549938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671555|NCT01549938|Vitamins|vitamins|mesh-ancestor
6671556|NCT01549938|Micronutrients|micronutrients|mesh-ancestor
6671557|NCT01549938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6671558|NCT01549990|Sevoflurane|sevoflurane|mesh-list
6671559|NCT01549990|Desflurane|desflurane|mesh-list
6671560|NCT01549990|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6671561|NCT01549990|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6671562|NCT01549990|Anesthetics, General|anesthetics, general|mesh-ancestor
6671563|NCT01549990|Anesthetics|anesthetics|mesh-ancestor
6671564|NCT01549990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6671565|NCT01549990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671566|NCT01550003|Certolizumab Pegol|certolizumab pegol|mesh-list
6671567|NCT01550003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6671568|NCT01550003|Immunologic Factors|immunologic factors|mesh-ancestor
6671569|NCT01550003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671570|NCT01550003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6671571|NCT01550055|Irinotecan|irinotecan|mesh-list
6671572|NCT01550055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6671573|NCT01550055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6671574|NCT01550055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6671575|NCT01550055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671576|NCT01550055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6671577|NCT01550107|Allopurinol|allopurinol|mesh-list
6184818|NCT01804465|Ipilimumab|ipilimumab|mesh-list
6184819|NCT01804465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6184820|NCT01804465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6184821|NCT01804465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6184822|NCT01804465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671578|NCT01550107|Antimetabolites|antimetabolites|mesh-ancestor
6671579|NCT01550107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671580|NCT01550107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6184823|NCT01804673|Fentanyl|fentanyl|mesh-list
5579107|NCT03863626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671581|NCT01550107|Gout Suppressants|gout suppressants|mesh-ancestor
6671582|NCT01550107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6671583|NCT01550107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6671584|NCT01550107|Antioxidants|antioxidants|mesh-ancestor
6671585|NCT01550107|Protective Agents|protective agents|mesh-ancestor
6671586|NCT01550107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671587|NCT01550146|Dexamethasone|dexamethasone|mesh-list
6671588|NCT01550146|Dexamethasone acetate|dexamethasone acetate|mesh-list
6671589|NCT01550146|BB 1101|bb 1101|mesh-list
6671590|NCT01550146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6184824|NCT01804673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6184825|NCT01804673|Narcotics|narcotics|mesh-ancestor
6184826|NCT01804673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6184827|NCT01804673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184828|NCT01804673|Analgesics|analgesics|mesh-ancestor
6184829|NCT01804673|Sensory System Agents|sensory system agents|mesh-ancestor
6184830|NCT01804673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6184831|NCT01804673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6184832|NCT01804673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6184833|NCT01804673|Anesthetics, General|anesthetics, general|mesh-ancestor
6184834|NCT01804673|Anesthetics|anesthetics|mesh-ancestor
6184835|NCT01804946|Oseltamivir|oseltamivir|mesh-list
6184836|NCT01804946|Antiviral Agents|antiviral agents|mesh-ancestor
6184837|NCT01804946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6184838|NCT01804946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6184839|NCT01804946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206842|NCT02106325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6206843|NCT02106325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6206844|NCT02106325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6206845|NCT02106325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6206846|NCT02106325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206847|NCT02106325|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6206848|NCT02106325|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6206849|NCT02106325|Anesthetics, Local|anesthetics, local|mesh-ancestor
6206850|NCT02106325|Antiemetics|antiemetics|mesh-ancestor
6206851|NCT02106325|Autonomic Agents|autonomic agents|mesh-ancestor
6206852|NCT02106325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6206853|NCT02106325|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6206854|NCT02106325|Histamine Antagonists|histamine antagonists|mesh-ancestor
6206855|NCT02106325|Histamine Agents|histamine agents|mesh-ancestor
6206856|NCT02106325|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6206857|NCT02106325|Antipruritics|antipruritics|mesh-ancestor
6206858|NCT02106325|Dermatologic Agents|dermatologic agents|mesh-ancestor
6206859|NCT02106351|Botulinum Toxins|botulinum toxins|mesh-list
6206860|NCT02106351|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6206861|NCT02106351|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6206862|NCT02106351|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6671591|NCT01550146|Antiemetics|antiemetics|mesh-ancestor
6671592|NCT01550146|Autonomic Agents|autonomic agents|mesh-ancestor
6671593|NCT01550146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6671594|NCT01550146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671595|NCT01550146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6671596|NCT01550146|Glucocorticoids|glucocorticoids|mesh-ancestor
6206863|NCT02106351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6206864|NCT02106351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206865|NCT02106351|Cholinergic Agents|cholinergic agents|mesh-ancestor
6206866|NCT02106351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6671597|NCT01550146|Hormones|hormones|mesh-ancestor
5579108|NCT03863613|Progesterone|progesterone|mesh-list
5579109|NCT03863613|Progestins|progestins|mesh-ancestor
5579110|NCT03863613|Hormones|hormones|mesh-ancestor
5579111|NCT03863613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5579112|NCT03863613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579113|NCT03863366|Prucalopride|prucalopride|mesh-list
5579114|NCT03863366|Laxatives|laxatives|mesh-ancestor
5579115|NCT03863366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6184840|NCT01805037|Rituximab|rituximab|mesh-list
6184841|NCT01805037|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6184842|NCT01805037|Antibodies|antibodies|mesh-list
6184843|NCT01805037|Immunoglobulins|immunoglobulins|mesh-list
6184844|NCT01805037|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6184845|NCT01805037|Immunoconjugates|immunoconjugates|mesh-list
6184846|NCT01805037|Immunologic Factors|immunologic factors|mesh-ancestor
6184847|NCT01805037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184848|NCT01805037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6184849|NCT01805037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6184850|NCT01805037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6184851|NCT01805089|Melatonin|melatonin|mesh-list
6184852|NCT01805089|Antioxidants|antioxidants|mesh-ancestor
6184853|NCT01805089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6184854|NCT01805089|Protective Agents|protective agents|mesh-ancestor
6184855|NCT01805089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579116|NCT03863366|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
5579117|NCT03863366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5579118|NCT03863366|Serotonin Agents|serotonin agents|mesh-ancestor
5579119|NCT03863366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5579120|NCT03863366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5579121|NCT03863366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579122|NCT03863249|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5579123|NCT03863249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5579124|NCT03863223|Docetaxel|docetaxel|mesh-list
5579125|NCT03863223|Trastuzumab|trastuzumab|mesh-list
6184856|NCT01805089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6184857|NCT01805297|Aflibercept|aflibercept|mesh-list
5579126|NCT03863223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5579127|NCT03863223|Tubulin Modulators|tubulin modulators|mesh-ancestor
5579128|NCT03863223|Antimitotic Agents|antimitotic agents|mesh-ancestor
5579129|NCT03863223|Mitosis Modulators|mitosis modulators|mesh-ancestor
5579130|NCT03863223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5579131|NCT03863223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5579132|NCT03862833|Zoledronic Acid|zoledronic acid|mesh-list
5579133|NCT03862833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5579134|NCT03862833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604751|NCT04348747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5604752|NCT04348747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5604753|NCT04348747|Antiviral Agents|antiviral agents|mesh-ancestor
5604754|NCT04348747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5604755|NCT04348747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6184858|NCT01805297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6184859|NCT01805297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6184860|NCT01805297|Growth Substances|growth substances|mesh-ancestor
6184861|NCT01805297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184862|NCT01805297|Growth Inhibitors|growth inhibitors|mesh-ancestor
6184863|NCT01805297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5604756|NCT04348747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5604757|NCT04348747|Analgesics|analgesics|mesh-ancestor
5604758|NCT04348747|Sensory System Agents|sensory system agents|mesh-ancestor
5604759|NCT04348747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5604760|NCT04348747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5604761|NCT04348747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5604762|NCT04348747|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5604763|NCT04348747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5604764|NCT04348747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5604765|NCT04348747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604766|NCT04348747|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5604767|NCT04344873|Abatacept|abatacept|mesh-list
5604768|NCT04344873|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5604769|NCT04344873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604770|NCT04344873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5604771|NCT04344873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5604772|NCT04344873|Immunologic Factors|immunologic factors|mesh-ancestor
5604773|NCT04344873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604774|NCT04344873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5604775|NCT04301843|Eflornithine|eflornithine|mesh-list
5604776|NCT04301843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5604777|NCT04301843|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5604778|NCT04301843|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5604779|NCT04301843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6184864|NCT01805323|Dexamethasone|dexamethasone|mesh-list
6184865|NCT01805323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6184866|NCT01805323|Antiemetics|antiemetics|mesh-ancestor
6184867|NCT01805323|Autonomic Agents|autonomic agents|mesh-ancestor
6184868|NCT01805323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6184869|NCT01805323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184870|NCT01805323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6184871|NCT01805323|Glucocorticoids|glucocorticoids|mesh-ancestor
6184872|NCT01805323|Hormones|hormones|mesh-ancestor
6184873|NCT01805323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6184874|NCT01805323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6184875|NCT01805323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6184876|NCT01805687|Zileuton|zileuton|mesh-list
6184877|NCT01805687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6184878|NCT01805687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6184879|NCT01805687|Analgesics|analgesics|mesh-ancestor
6184880|NCT01805687|Sensory System Agents|sensory system agents|mesh-ancestor
6184881|NCT01805687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6184882|NCT01805687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184883|NCT01805687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6184884|NCT01805687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6184885|NCT01805687|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6184886|NCT01805687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6184887|NCT01805687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6184888|NCT01805687|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6184889|NCT01805687|Hormone Antagonists|hormone antagonists|mesh-ancestor
6184890|NCT01805687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6184891|NCT01805882|Sofosbuvir|sofosbuvir|mesh-list
6184892|NCT01805882|Ledipasvir|ledipasvir|mesh-list
5579135|NCT03862950|Metformin|metformin|mesh-list
5579136|NCT03862950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5579137|NCT03862950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579138|NCT03862716|Insulin|insulin|mesh-list
5579139|NCT03862716|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5579140|NCT03862716|Metformin|metformin|mesh-list
5579141|NCT03862716|Liraglutide|liraglutide|mesh-list
5579142|NCT03862716|Insulin, Long-Acting|insulin, long-acting|mesh-list
6184893|NCT01805882|Antiviral Agents|antiviral agents|mesh-ancestor
6184894|NCT01805882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6184895|NCT01805895|Minocycline|minocycline|mesh-list
6184896|NCT01805895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6184897|NCT01805895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6184898|NCT01806064|Axitinib|axitinib|mesh-list
6184899|NCT01806064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6184900|NCT01806064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6184901|NCT01806064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6184902|NCT01806064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6184903|NCT01806259|Ketorolac|ketorolac|mesh-list
6184904|NCT01806259|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6184905|NCT01806259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6184906|NCT01806259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6184907|NCT01806259|Analgesics|analgesics|mesh-ancestor
6184908|NCT01806259|Sensory System Agents|sensory system agents|mesh-ancestor
6184909|NCT01806259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6184910|NCT01806259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671598|NCT01550146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6671599|NCT01550146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5579143|NCT03862716|Xultophy|xultophy|mesh-list
5579144|NCT03862716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5579145|NCT03862716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579146|NCT03862716|Incretins|incretins|mesh-ancestor
5579147|NCT03862716|Hormones|hormones|mesh-ancestor
5579148|NCT03862716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5579149|NCT03862690|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
5579150|NCT03862690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5579151|NCT03862690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579152|NCT03862768|Sunitinib|sunitinib|mesh-list
5579153|NCT03862768|Imatinib Mesylate|imatinib mesylate|mesh-list
5579154|NCT03862768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6671600|NCT01550146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6671601|NCT01550146|Protease Inhibitors|protease inhibitors|mesh-ancestor
6671602|NCT01550146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6671603|NCT01550146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671604|NCT01550302|Bupivacaine|bupivacaine|mesh-list
6671605|NCT01550302|Anesthetics, Local|anesthetics, local|mesh-ancestor
6184911|NCT01806259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5579155|NCT03862768|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5579156|NCT03862768|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5579157|NCT03862768|Growth Substances|growth substances|mesh-ancestor
5579158|NCT03862768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579159|NCT03862768|Growth Inhibitors|growth inhibitors|mesh-ancestor
5579160|NCT03862768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5579161|NCT03862768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5579162|NCT03862768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5579163|NCT03862456|Azithromycin|azithromycin|mesh-list
6671606|NCT01550302|Anesthetics|anesthetics|mesh-ancestor
6671607|NCT01550302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6671608|NCT01550302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671609|NCT01550302|Sensory System Agents|sensory system agents|mesh-ancestor
6671610|NCT01550302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6671611|NCT01550354|Alfentanil|alfentanil|mesh-list
6671612|NCT01550354|Propofol|propofol|mesh-list
6671613|NCT01550354|Rocuronium|rocuronium|mesh-list
6671614|NCT01550354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6671615|NCT01550354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6671616|NCT01550354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671617|NCT01550354|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6671618|NCT01550354|Anesthetics, General|anesthetics, general|mesh-ancestor
6671619|NCT01550354|Anesthetics|anesthetics|mesh-ancestor
6671620|NCT01550354|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6671621|NCT01550354|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6671622|NCT01550354|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6184912|NCT01806259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6184913|NCT01806259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6184914|NCT01806259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6184915|NCT01806259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6184916|NCT01806298|Hormones|hormones|mesh-list
6184917|NCT01806298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6184918|NCT01806298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184919|NCT01806545|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
6184920|NCT01806545|Hemostatics|hemostatics|mesh-ancestor
6184921|NCT01806545|Coagulants|coagulants|mesh-ancestor
6184922|NCT01806571|Cytarabine|cytarabine|mesh-list
6184923|NCT01806571|Daunorubicin|daunorubicin|mesh-list
6184924|NCT01806571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6184925|NCT01806571|Antimetabolites|antimetabolites|mesh-ancestor
6671623|NCT01550354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6671624|NCT01550354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6671625|NCT01550354|Narcotics|narcotics|mesh-ancestor
6671626|NCT01550354|Analgesics|analgesics|mesh-ancestor
6671627|NCT01550354|Sensory System Agents|sensory system agents|mesh-ancestor
6671628|NCT01550419|Atorvastatin|atorvastatin|mesh-list
6671629|NCT01550419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6671630|NCT01550419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6671631|NCT01550419|Antimetabolites|antimetabolites|mesh-ancestor
6671632|NCT01550419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671633|NCT01550419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6671634|NCT01550419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6671635|NCT01550419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6671636|NCT01550432|Acetylcysteine|acetylcysteine|mesh-list
6671637|NCT01550432|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6671638|NCT01550432|Antiviral Agents|antiviral agents|mesh-ancestor
6671639|NCT01550432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6671640|NCT01550432|Expectorants|expectorants|mesh-ancestor
5579164|NCT03862456|Metronidazole|metronidazole|mesh-list
6184926|NCT01806571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6184927|NCT01806571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6184928|NCT01806571|Antiviral Agents|antiviral agents|mesh-ancestor
6184929|NCT01806571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6184930|NCT01806571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6184931|NCT01806571|Immunologic Factors|immunologic factors|mesh-ancestor
6184932|NCT01806571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579165|NCT03862456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5579166|NCT03862456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5579167|NCT03862456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5579168|NCT03862456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5579169|NCT03862586|Acetylcysteine|acetylcysteine|mesh-list
5579170|NCT03862586|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5579171|NCT03862586|Antiviral Agents|antiviral agents|mesh-ancestor
5579172|NCT03862586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6671641|NCT01550432|Respiratory System Agents|respiratory system agents|mesh-ancestor
6671642|NCT01550432|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6184933|NCT01806571|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6671643|NCT01550432|Antioxidants|antioxidants|mesh-ancestor
6184934|NCT01806571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6184935|NCT01806571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6184936|NCT01806571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6184937|NCT01806584|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
6184938|NCT01806584|Hemostatics|hemostatics|mesh-ancestor
6184939|NCT01806584|Coagulants|coagulants|mesh-ancestor
6184940|NCT01806597|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6184941|NCT01806597|Immunologic Factors|immunologic factors|mesh-ancestor
6671644|NCT01550432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671645|NCT01550432|Protective Agents|protective agents|mesh-ancestor
6671646|NCT01550432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671647|NCT01550432|Antidotes|antidotes|mesh-ancestor
6671648|NCT01550445|Prednisolone|prednisolone|mesh-list
6671649|NCT01550445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6671650|NCT01550445|Glucocorticoids|glucocorticoids|mesh-ancestor
6671651|NCT01550445|Hormones|hormones|mesh-ancestor
6671652|NCT01550445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5579173|NCT03862586|Expectorants|expectorants|mesh-ancestor
5579174|NCT03862586|Respiratory System Agents|respiratory system agents|mesh-ancestor
5579175|NCT03862586|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5579176|NCT03862586|Antioxidants|antioxidants|mesh-ancestor
5579177|NCT03862586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5579178|NCT03862586|Protective Agents|protective agents|mesh-ancestor
5579179|NCT03862586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579180|NCT03862586|Antidotes|antidotes|mesh-ancestor
5579181|NCT03862495|Azithromycin|azithromycin|mesh-list
5579182|NCT03862495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5579183|NCT03862495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5579184|NCT03862651|Cangrelor|cangrelor|mesh-list
5579185|NCT03862651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5579186|NCT03862651|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5579187|NCT03862651|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5579188|NCT03862651|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5579189|NCT03862651|Purinergic Agents|purinergic agents|mesh-ancestor
5579190|NCT03862651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5579191|NCT03862651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5579192|NCT03862651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579193|NCT03862612|Anesthetics|anesthetics|mesh-list
5579194|NCT03862612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5579195|NCT03862612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579196|NCT03862404|Epinephrine|epinephrine|mesh-list
5579197|NCT03862404|Bupivacaine|bupivacaine|mesh-list
5579198|NCT03862404|Anesthetics, Local|anesthetics, local|mesh-ancestor
5579199|NCT03862404|Anesthetics|anesthetics|mesh-ancestor
5579200|NCT03862404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5579201|NCT03862404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579202|NCT03862404|Sensory System Agents|sensory system agents|mesh-ancestor
5579203|NCT03862404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5579204|NCT03862404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5579205|NCT03862404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5579206|NCT03862404|Adrenergic Agents|adrenergic agents|mesh-ancestor
5579207|NCT03862404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5579208|NCT03862404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5579209|NCT03862404|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5579210|NCT03862404|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5579211|NCT03862404|Autonomic Agents|autonomic agents|mesh-ancestor
5579212|NCT03862404|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5579213|NCT03862404|Respiratory System Agents|respiratory system agents|mesh-ancestor
5579214|NCT03862404|Mydriatics|mydriatics|mesh-ancestor
6184942|NCT01806597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184943|NCT01806623|Fluconazole|fluconazole|mesh-list
6184944|NCT01806623|Antifungal Agents|antifungal agents|mesh-ancestor
6184945|NCT01806623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6184946|NCT01806623|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6488161|NCT00581009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6184947|NCT01806623|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6184948|NCT01806623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6184949|NCT01806623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6184950|NCT01806623|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6184951|NCT01806623|Hormone Antagonists|hormone antagonists|mesh-ancestor
6184952|NCT01806623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6184953|NCT01806623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184954|NCT01806623|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6184955|NCT01806623|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6184956|NCT01806662|Ustekinumab|ustekinumab|mesh-list
6184957|NCT01806662|Dermatologic Agents|dermatologic agents|mesh-ancestor
6184958|NCT01806675|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6184959|NCT01806675|Glycine|glycine|mesh-list
6184960|NCT01806675|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6184961|NCT01806675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6184962|NCT01806675|Glycine Agents|glycine agents|mesh-ancestor
6184963|NCT01806675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6184964|NCT01806675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184965|NCT01806740|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
6184966|NCT01806740|Chelating Agents|chelating agents|mesh-ancestor
6184967|NCT01806740|Sequestering Agents|sequestering agents|mesh-ancestor
5579215|NCT03862404|Sympathomimetics|sympathomimetics|mesh-ancestor
5579216|NCT03862404|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5579217|NCT03862391|Analgesics|analgesics|mesh-list
5579218|NCT03862391|Antiemetics|antiemetics|mesh-list
5579219|NCT03862391|Sensory System Agents|sensory system agents|mesh-ancestor
6184968|NCT01806740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6184969|NCT01806779|Bupropion|bupropion|mesh-list
6184970|NCT01806779|Nicotine|nicotine|mesh-list
5579220|NCT03862391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5579221|NCT03862391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579222|NCT03862391|Autonomic Agents|autonomic agents|mesh-ancestor
5579223|NCT03862391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5579224|NCT03861988|Ketamine|ketamine|mesh-list
5579225|NCT03861988|Analgesics|analgesics|mesh-ancestor
5579226|NCT03861988|Sensory System Agents|sensory system agents|mesh-ancestor
5579227|NCT03861988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5579228|NCT03861988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579229|NCT03861988|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5579230|NCT03861988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5579231|NCT03861988|Anesthetics, General|anesthetics, general|mesh-ancestor
5579232|NCT03861988|Anesthetics|anesthetics|mesh-ancestor
6184971|NCT01806779|Varenicline|varenicline|mesh-list
6184972|NCT01806779|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5579233|NCT03861988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5579234|NCT03861988|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5579235|NCT03861988|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5579236|NCT03861988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5579237|NCT03861988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5579238|NCT03862287|Lidocaine|lidocaine|mesh-list
5579239|NCT03862287|Bupivacaine|bupivacaine|mesh-list
5579240|NCT03862287|Anesthetics, Local|anesthetics, local|mesh-ancestor
5579241|NCT03862287|Anesthetics|anesthetics|mesh-ancestor
5579242|NCT03862287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5579243|NCT03862287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579244|NCT03862287|Sensory System Agents|sensory system agents|mesh-ancestor
6184973|NCT01806779|Autonomic Agents|autonomic agents|mesh-ancestor
6184974|NCT01806779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6184975|NCT01806779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184976|NCT01806779|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6184977|NCT01806779|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6184978|NCT01806779|Cholinergic Agents|cholinergic agents|mesh-ancestor
6184979|NCT01806779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6671653|NCT01550445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671654|NCT01550445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6671655|NCT01550445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6671656|NCT01550458|Mibefradil|mibefradil|mesh-list
6671657|NCT01550458|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6671658|NCT01550458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6184980|NCT01806779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6184981|NCT01806779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6184982|NCT01806779|Antidepressive Agents|antidepressive agents|mesh-ancestor
6671659|NCT01550458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6184983|NCT01806779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6184984|NCT01806779|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6184985|NCT01806779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6184986|NCT01806779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6184987|NCT01806779|Dopamine Agents|dopamine agents|mesh-ancestor
6184988|NCT01806779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6184989|NCT01806779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6184990|NCT01806779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6184991|NCT01806857|Quinidine|quinidine|mesh-list
6184992|NCT01806857|Dextromethorphan|dextromethorphan|mesh-list
6184993|NCT01806857|Antitussive Agents|antitussive agents|mesh-ancestor
6671660|NCT01550458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671661|NCT01550458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6671662|NCT01550458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671663|NCT01550458|Vasodilator Agents|vasodilator agents|mesh-ancestor
6671664|NCT01550458|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6671665|NCT01550458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6671666|NCT01550458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6672559|NCT01557075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672560|NCT01557075|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6672561|NCT01557075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5579245|NCT03862287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5579246|NCT03862287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5579247|NCT03862287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5579248|NCT03862287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5579249|NCT03862287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5579250|NCT03862287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5579251|NCT03862053|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5579252|NCT03862053|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5579253|NCT03862079|Tazobactam|tazobactam|mesh-list
5579254|NCT03862079|Piperacillin|piperacillin|mesh-list
5579255|NCT03862079|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
5579256|NCT03862079|Nystatin|nystatin|mesh-list
5579257|NCT03862079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5579258|NCT03862079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5579259|NCT03862079|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5579260|NCT03862079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5579261|NCT03862079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5579262|NCT03862079|Antifungal Agents|antifungal agents|mesh-ancestor
5579263|NCT03862079|Ionophores|ionophores|mesh-ancestor
5579264|NCT03862079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5579265|NCT03862157|Azacitidine|azacitidine|mesh-list
5579266|NCT03862157|Venetoclax|venetoclax|mesh-list
5579267|NCT03862157|Enzyme Inhibitors|enzyme inhibitors|mesh-list
5579268|NCT03862157|Pevonedistat|pevonedistat|mesh-list
5579269|NCT03862157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5579270|NCT03862157|Antimetabolites|antimetabolites|mesh-ancestor
5579271|NCT03862157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5579272|NCT03862157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5579273|NCT03862170|Ciprofloxacin|ciprofloxacin|mesh-list
5579274|NCT03862170|Cefazolin|cefazolin|mesh-list
5579275|NCT03862170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5579276|NCT03862170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5579277|NCT03862170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5579278|NCT03862170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5579279|NCT03862170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5579280|NCT03862170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5579281|NCT03862170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5579282|NCT03862170|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5579283|NCT03862170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5579284|NCT03862144|Palonosetron|palonosetron|mesh-list
5579285|NCT03862144|Antiemetics|antiemetics|mesh-ancestor
5579286|NCT03862144|Autonomic Agents|autonomic agents|mesh-ancestor
5579287|NCT03862144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5579288|NCT03862144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579289|NCT03862144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5579290|NCT03862144|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5579291|NCT03862144|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5579292|NCT03862144|Serotonin Agents|serotonin agents|mesh-ancestor
5579293|NCT03862144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5579294|NCT03862144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6184994|NCT01806857|Respiratory System Agents|respiratory system agents|mesh-ancestor
6184995|NCT01806857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6184996|NCT01806857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6184997|NCT01806857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5579295|NCT03861871|Fenfluramine|fenfluramine|mesh-list
5579296|NCT03861871|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5579297|NCT03861871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5579298|NCT03861871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5579299|NCT03861871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5579300|NCT03861871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5579301|NCT03861871|Serotonin Agents|serotonin agents|mesh-ancestor
5579302|NCT03861871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579303|NCT03861767|Metformin|metformin|mesh-list
5579304|NCT03861767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5579305|NCT03861767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579306|NCT03861598|Carvedilol|carvedilol|mesh-list
5579307|NCT03861598|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5579308|NCT03861598|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5579309|NCT03861598|Adrenergic Agents|adrenergic agents|mesh-ancestor
5579310|NCT03861598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5579311|NCT03861598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5579312|NCT03861598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6184998|NCT01806857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6184999|NCT01806857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185000|NCT01806857|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6185001|NCT01806857|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6185002|NCT01806857|Adrenergic Agents|adrenergic agents|mesh-ancestor
6185003|NCT01806857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6185004|NCT01806857|Antimalarials|antimalarials|mesh-ancestor
6185005|NCT01806857|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6185006|NCT01806857|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6185007|NCT01806857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6185008|NCT01806857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6185009|NCT01806857|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6185010|NCT01806857|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6185011|NCT01806857|Cholinergic Agents|cholinergic agents|mesh-ancestor
6185012|NCT01806857|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6185013|NCT01806857|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6185014|NCT01806857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6185015|NCT01806857|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6185016|NCT01806857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6185017|NCT01807000|Prucalopride|prucalopride|mesh-list
6185018|NCT01807000|Laxatives|laxatives|mesh-ancestor
6185019|NCT01807000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6185020|NCT01807000|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
6185021|NCT01807000|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6185022|NCT01807000|Serotonin Agents|serotonin agents|mesh-ancestor
6185023|NCT01807000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6185024|NCT01807000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185025|NCT01807000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185026|NCT01807221|Eplerenone|eplerenone|mesh-list
6185027|NCT01807221|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6185028|NCT01807221|Hormone Antagonists|hormone antagonists|mesh-ancestor
6206867|NCT02106351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671667|NCT01550640|Remifentanil|remifentanil|mesh-list
6671668|NCT01550640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6671669|NCT01550640|Narcotics|narcotics|mesh-ancestor
6671670|NCT01550640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6671671|NCT01550640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671672|NCT01550640|Analgesics|analgesics|mesh-ancestor
6671673|NCT01550640|Sensory System Agents|sensory system agents|mesh-ancestor
6671674|NCT01550640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6671675|NCT01550653|Liraglutide|liraglutide|mesh-list
6671676|NCT01550653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5579313|NCT03861598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5579314|NCT03861598|Antioxidants|antioxidants|mesh-ancestor
5579315|NCT03861598|Protective Agents|protective agents|mesh-ancestor
5579316|NCT03861598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5579317|NCT03861598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5579318|NCT03861598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5579319|NCT03861598|Vasodilator Agents|vasodilator agents|mesh-ancestor
5579320|NCT03861598|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5579321|NCT03861598|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5579322|NCT03861611|Ibuprofen|ibuprofen|mesh-list
5579323|NCT03861611|Diclofenac|diclofenac|mesh-list
5579324|NCT03861611|Ketorolac|ketorolac|mesh-list
5579325|NCT03861611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5579326|NCT03861611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5579327|NCT03861611|Analgesics|analgesics|mesh-ancestor
5579328|NCT03861611|Sensory System Agents|sensory system agents|mesh-ancestor
5579329|NCT03861611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5579330|NCT03861611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579331|NCT03861611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6671677|NCT01550653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671678|NCT01550653|Incretins|incretins|mesh-ancestor
6671679|NCT01550653|Hormones|hormones|mesh-ancestor
6671680|NCT01550653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6671681|NCT01550770|Propofol|propofol|mesh-list
6671682|NCT01550770|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6671683|NCT01550770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6671684|NCT01550770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671685|NCT01550770|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6671686|NCT01550770|Anesthetics, General|anesthetics, general|mesh-ancestor
5579332|NCT03861611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5579333|NCT03861611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5579334|NCT03861611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5579335|NCT03861611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5579336|NCT03861481|Rozanolixizumab|rozanolixizumab|mesh-list
5579337|NCT03861481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5579338|NCT03861481|Immunologic Factors|immunologic factors|mesh-ancestor
6671687|NCT01550770|Anesthetics|anesthetics|mesh-ancestor
6671688|NCT01550848|Gemcitabine|gemcitabine|mesh-list
6671689|NCT01550848|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6671690|NCT01550848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6671691|NCT01550848|Antimetabolites|antimetabolites|mesh-ancestor
6671692|NCT01550848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671693|NCT01550848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6671694|NCT01550848|Antiviral Agents|antiviral agents|mesh-ancestor
6671695|NCT01550848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6671696|NCT01550848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6671697|NCT01550848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6671698|NCT01550848|Immunologic Factors|immunologic factors|mesh-ancestor
6671699|NCT01550848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579339|NCT03861481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579340|NCT03861299|Anesthetics|anesthetics|mesh-list
5579341|NCT03861299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5579342|NCT03861299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579343|NCT03861403|Cyclophosphamide|cyclophosphamide|mesh-list
5579344|NCT03861403|Avelumab|avelumab|mesh-list
5579345|NCT03861403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5579346|NCT03861403|Immunologic Factors|immunologic factors|mesh-ancestor
5579347|NCT03861403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579348|NCT03861403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5579349|NCT03861403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5579350|NCT03861403|Alkylating Agents|alkylating agents|mesh-ancestor
5579351|NCT03861403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5579352|NCT03861403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5579353|NCT03861403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6671700|NCT01550900|Metformin|metformin|mesh-list
6671701|NCT01550900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6671702|NCT01550900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671703|NCT01550926|Orlistat|orlistat|mesh-list
6671704|NCT01550926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6671705|NCT01550926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671706|NCT01550926|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6671707|NCT01550926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6671708|NCT01551069|Hydroxychloroquine|hydroxychloroquine|mesh-list
6671709|NCT01551069|Antimalarials|antimalarials|mesh-ancestor
6206868|NCT02106351|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5579354|NCT03861403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5579355|NCT03861416|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5579356|NCT03861377|Remifentanil|remifentanil|mesh-list
5579357|NCT03861377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5579358|NCT03861377|Narcotics|narcotics|mesh-ancestor
5579359|NCT03861377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5579360|NCT03861377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579361|NCT03861377|Analgesics|analgesics|mesh-ancestor
5579362|NCT03861377|Sensory System Agents|sensory system agents|mesh-ancestor
5579363|NCT03861377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5579364|NCT03861364|Propofol|propofol|mesh-list
5579365|NCT03861364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5579366|NCT03861364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5579367|NCT03861364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579368|NCT03861364|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5579369|NCT03861364|Anesthetics, General|anesthetics, general|mesh-ancestor
5579370|NCT03861364|Anesthetics|anesthetics|mesh-ancestor
5604780|NCT04301843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5604781|NCT04301843|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
5604782|NCT04301843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5604783|NCT04301843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604784|NCT04297605|Paclitaxel|paclitaxel|mesh-list
5604785|NCT04297605|Pembrolizumab|pembrolizumab|mesh-list
5604786|NCT04297605|Pemetrexed|pemetrexed|mesh-list
5604787|NCT04297605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5604788|NCT04297605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5604789|NCT04297605|Tubulin Modulators|tubulin modulators|mesh-ancestor
5604790|NCT04297605|Antimitotic Agents|antimitotic agents|mesh-ancestor
5604791|NCT04297605|Mitosis Modulators|mitosis modulators|mesh-ancestor
5604792|NCT04297605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604793|NCT04297605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5604794|NCT04297605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5604795|NCT04297605|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5604796|NCT04297605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5604797|NCT04274517|Chlorhexidine|chlorhexidine|mesh-list
6671710|NCT01551069|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6671711|NCT01551069|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6671712|NCT01551069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6671713|NCT01551069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6671714|NCT01551069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671715|NCT01551069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6671716|NCT01551147|Montelukast|montelukast|mesh-list
5604798|NCT04274517|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5604799|NCT04274517|Povidone-Iodine|povidone-iodine|mesh-list
5604800|NCT04274517|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5604801|NCT04274517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5604802|NCT04274517|Disinfectants|disinfectants|mesh-ancestor
5604803|NCT04274517|Dermatologic Agents|dermatologic agents|mesh-ancestor
5604804|NCT04262024|Cabergoline|cabergoline|mesh-list
5604805|NCT04262024|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5604806|NCT04262024|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5604807|NCT04262024|Dopamine Agonists|dopamine agonists|mesh-ancestor
5604808|NCT04262024|Dopamine Agents|dopamine agents|mesh-ancestor
6671717|NCT01551147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6671718|NCT01551147|Respiratory System Agents|respiratory system agents|mesh-ancestor
6671719|NCT01551147|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6671720|NCT01551147|Hormone Antagonists|hormone antagonists|mesh-ancestor
5604809|NCT04262024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5604810|NCT04262024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604811|NCT04262024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604812|NCT04222426|Atezolizumab|atezolizumab|mesh-list
5604813|NCT04222426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5604814|NCT04195204|Tropisetron|tropisetron|mesh-list
5604815|NCT04195204|Antiemetics|antiemetics|mesh-ancestor
5604816|NCT04195204|Autonomic Agents|autonomic agents|mesh-ancestor
5604817|NCT04195204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5604818|NCT04195204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604819|NCT04195204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5604820|NCT04195204|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5604821|NCT04195204|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5604822|NCT04195204|Serotonin Agents|serotonin agents|mesh-ancestor
5604823|NCT04195204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5604824|NCT04195204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604825|NCT04183101|Enalapril|enalapril|mesh-list
6672562|NCT01557114|Ipilimumab|ipilimumab|mesh-list
5604826|NCT04183101|Enalaprilat|enalaprilat|mesh-list
6671721|NCT01551147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6671722|NCT01551147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671723|NCT01551147|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6671724|NCT01551147|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6671725|NCT01551147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671726|NCT01551225|Citalopram|citalopram|mesh-list
6671727|NCT01551225|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6671728|NCT01551225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6671729|NCT01551225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6671730|NCT01551225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671731|NCT01551225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6671732|NCT01551225|Serotonin Agents|serotonin agents|mesh-ancestor
6671733|NCT01551225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671734|NCT01551225|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6671735|NCT01551225|Antidepressive Agents|antidepressive agents|mesh-ancestor
6671736|NCT01551225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6671737|NCT01551290|Infliximab|infliximab|mesh-list
6671738|NCT01551290|Dermatologic Agents|dermatologic agents|mesh-ancestor
6671739|NCT01551290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6671740|NCT01551290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6671741|NCT01551329|Ketamine|ketamine|mesh-list
6671742|NCT01551329|Analgesics|analgesics|mesh-ancestor
6671743|NCT01551329|Sensory System Agents|sensory system agents|mesh-ancestor
6671744|NCT01551329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6671745|NCT01551329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671746|NCT01551329|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6671747|NCT01551329|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6671748|NCT01551329|Anesthetics, General|anesthetics, general|mesh-ancestor
6671749|NCT01551329|Anesthetics|anesthetics|mesh-ancestor
6671750|NCT01551329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6671751|NCT01551329|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6671752|NCT01551329|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6671753|NCT01551329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6671754|NCT01551329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671755|NCT01551368|Nimodipine|nimodipine|mesh-list
6671756|NCT01551368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6671757|NCT01551368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6671758|NCT01551368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6671759|NCT01551368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671760|NCT01551368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6671761|NCT01551368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671762|NCT01551368|Vasodilator Agents|vasodilator agents|mesh-ancestor
6671763|NCT01551394|Gentamicins|gentamicins|mesh-list
6671764|NCT01551394|Meropenem|meropenem|mesh-list
6671765|NCT01551394|Ampicillin|ampicillin|mesh-list
6671766|NCT01551394|Cefotaxime|cefotaxime|mesh-list
5579371|NCT03861052|Dulaglutide|dulaglutide|mesh-list
5579372|NCT03861052|Tirzepatide|tirzepatide|mesh-list
5579373|NCT03861052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5579374|NCT03861052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579375|NCT03861052|Incretins|incretins|mesh-ancestor
5579376|NCT03861052|Hormones|hormones|mesh-ancestor
5579377|NCT03861052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5579378|NCT03860870|Clenbuterol|clenbuterol|mesh-list
5579379|NCT03860870|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5579380|NCT03860870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6671767|NCT01551394|Cefoxitin|cefoxitin|mesh-list
6671768|NCT01551394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6671769|NCT01551394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6671770|NCT01551394|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6671771|NCT01551394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6671772|NCT01551394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671773|NCT01551459|Sunitinib|sunitinib|mesh-list
6671774|NCT01551459|Dacarbazine|dacarbazine|mesh-list
6671775|NCT01551459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6671776|NCT01551459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6671777|NCT01551459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6671778|NCT01551459|Growth Substances|growth substances|mesh-ancestor
6671779|NCT01551459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579381|NCT03860870|Adrenergic Agents|adrenergic agents|mesh-ancestor
5579382|NCT03860870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5579383|NCT03860870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5579384|NCT03860870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579385|NCT03860870|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5579386|NCT03860870|Autonomic Agents|autonomic agents|mesh-ancestor
6671780|NCT01551459|Growth Inhibitors|growth inhibitors|mesh-ancestor
6671781|NCT01551459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6671782|NCT01551459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6671783|NCT01551459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671784|NCT01551459|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6671785|NCT01551459|Alkylating Agents|alkylating agents|mesh-ancestor
5579387|NCT03860870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5579388|NCT03860870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5579389|NCT03860870|Respiratory System Agents|respiratory system agents|mesh-ancestor
5579390|NCT03860870|Sympathomimetics|sympathomimetics|mesh-ancestor
5579391|NCT03860597|Memantine|memantine|mesh-list
5579392|NCT03860597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5579393|NCT03860597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5579394|NCT03860597|Dopamine Agents|dopamine agents|mesh-ancestor
5579395|NCT03860597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5579396|NCT03860597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5579397|NCT03860597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671786|NCT01551472|Vitamin E|vitamin e|mesh-list
6671787|NCT01551472|Vitamins|vitamins|mesh-ancestor
6671788|NCT01551472|Micronutrients|micronutrients|mesh-ancestor
6671789|NCT01551472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185029|NCT01807221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6185030|NCT01807221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185031|NCT01807221|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6185032|NCT01807221|Diuretics|diuretics|mesh-ancestor
6185033|NCT01807221|Natriuretic Agents|natriuretic agents|mesh-ancestor
6185034|NCT01807221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6185035|NCT01807234|Ketorolac|ketorolac|mesh-list
6185036|NCT01807234|Sumatriptan|sumatriptan|mesh-list
5579398|NCT03860597|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5579399|NCT03860597|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5579400|NCT03860831|Midazolam|midazolam|mesh-list
5579401|NCT03860831|Ketamine|ketamine|mesh-list
5579402|NCT03860831|Analgesics|analgesics|mesh-ancestor
5579403|NCT03860831|Sensory System Agents|sensory system agents|mesh-ancestor
5579404|NCT03860831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5579405|NCT03860831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579406|NCT03860831|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5579407|NCT03860831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5579408|NCT03860831|Anesthetics, General|anesthetics, general|mesh-ancestor
5579409|NCT03860831|Anesthetics|anesthetics|mesh-ancestor
5579410|NCT03860831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5579411|NCT03860831|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5579412|NCT03860831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5579413|NCT03860831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5579414|NCT03860831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5579415|NCT03860831|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5579416|NCT03860831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5579417|NCT03860831|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5579418|NCT03860831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5579419|NCT03860831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5579420|NCT03860831|GABA Modulators|gaba modulators|mesh-ancestor
5579421|NCT03860831|GABA Agents|gaba agents|mesh-ancestor
5579422|NCT03860662|Baclofen|baclofen|mesh-list
5579423|NCT03860662|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5579424|NCT03860662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579425|NCT03860662|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5579426|NCT03860662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5579427|NCT03860662|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
5579428|NCT03860662|GABA Agonists|gaba agonists|mesh-ancestor
5579429|NCT03860662|GABA Agents|gaba agents|mesh-ancestor
5579430|NCT03860662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5579431|NCT03860662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5579432|NCT03860636|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5579433|NCT03860636|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5579434|NCT03860636|Estradiol|estradiol|mesh-list
5579435|NCT03860636|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6185037|NCT01807234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6185038|NCT01807234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6185039|NCT01807234|Analgesics|analgesics|mesh-ancestor
6185040|NCT01807234|Sensory System Agents|sensory system agents|mesh-ancestor
6671790|NCT01551472|Antioxidants|antioxidants|mesh-ancestor
5579436|NCT03860636|Progesterone|progesterone|mesh-list
5579437|NCT03860636|Estrogens|estrogens|mesh-ancestor
5579438|NCT03860636|Hormones|hormones|mesh-ancestor
5579439|NCT03860636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5579440|NCT03860636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579441|NCT03860636|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6185041|NCT01807234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6185042|NCT01807234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185043|NCT01807234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6185044|NCT01807234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6185045|NCT01807234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6185046|NCT01807234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5579442|NCT03860636|Contraceptive Agents|contraceptive agents|mesh-ancestor
6185047|NCT01807234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185048|NCT01807234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6185049|NCT01807234|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6185050|NCT01807234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6185051|NCT01807234|Serotonin Agents|serotonin agents|mesh-ancestor
6185052|NCT01807234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5579443|NCT03860636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5579444|NCT03860636|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6185053|NCT01807455|Lidocaine|lidocaine|mesh-list
6185054|NCT01807455|Anesthetics, Local|anesthetics, local|mesh-ancestor
6185055|NCT01807455|Anesthetics|anesthetics|mesh-ancestor
6185056|NCT01807455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6185057|NCT01807455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185058|NCT01807455|Sensory System Agents|sensory system agents|mesh-ancestor
6185059|NCT01807455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6185060|NCT01807455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6185061|NCT01807455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6185062|NCT01807455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6185063|NCT01807455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6185064|NCT01807455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185065|NCT01807520|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6185066|NCT01807520|Immunologic Factors|immunologic factors|mesh-ancestor
6185067|NCT01807520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185068|NCT01807598|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5579445|NCT03860636|Progestins|progestins|mesh-ancestor
5579446|NCT03860480|Bupivacaine|bupivacaine|mesh-list
5579447|NCT03860480|Anesthetics, Local|anesthetics, local|mesh-ancestor
5579448|NCT03860480|Anesthetics|anesthetics|mesh-ancestor
5579449|NCT03860480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5579450|NCT03860480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579451|NCT03860480|Sensory System Agents|sensory system agents|mesh-ancestor
5579452|NCT03860480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5579453|NCT03860428|Acetaminophen|acetaminophen|mesh-list
5579454|NCT03860428|Ibuprofen|ibuprofen|mesh-list
5579455|NCT03860428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
5579456|NCT03860428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5579457|NCT03860428|Analgesics|analgesics|mesh-ancestor
5579458|NCT03860428|Sensory System Agents|sensory system agents|mesh-ancestor
5579459|NCT03860428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5579460|NCT03860428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579461|NCT03860428|Antipyretics|antipyretics|mesh-ancestor
5579462|NCT03860428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5579463|NCT03860428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5579464|NCT03860428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6185069|NCT01807598|Immunoconjugates|immunoconjugates|mesh-list
6185070|NCT01807598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6185071|NCT01807598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6185072|NCT01807598|Immunologic Factors|immunologic factors|mesh-ancestor
6185073|NCT01807598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579465|NCT03860428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5579466|NCT03860428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5579467|NCT03860012|Folic Acid|folic acid|mesh-list
5579468|NCT03860012|Hematinics|hematinics|mesh-ancestor
5579469|NCT03860012|Vitamin B Complex|vitamin b complex|mesh-ancestor
5579470|NCT03860012|Vitamins|vitamins|mesh-ancestor
5579471|NCT03860012|Micronutrients|micronutrients|mesh-ancestor
5579472|NCT03860012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579473|NCT03860129|Sevoflurane|sevoflurane|mesh-list
5579474|NCT03860129|Desflurane|desflurane|mesh-list
5579475|NCT03860129|Isoflurane|isoflurane|mesh-list
5579476|NCT03860129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5579477|NCT03860129|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6185074|NCT01807624|Phenylephrine|phenylephrine|mesh-list
6185075|NCT01807624|Oxymetazoline|oxymetazoline|mesh-list
6185076|NCT01807624|Tetracaine|tetracaine|mesh-list
6185077|NCT01807624|Anesthetics, Local|anesthetics, local|mesh-ancestor
6185078|NCT01807624|Anesthetics|anesthetics|mesh-ancestor
6185079|NCT01807624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6185080|NCT01807624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185081|NCT01807624|Sensory System Agents|sensory system agents|mesh-ancestor
6185082|NCT01807624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6185083|NCT01807624|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6185084|NCT01807624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6185085|NCT01807624|Adrenergic Agents|adrenergic agents|mesh-ancestor
6185086|NCT01807624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6185087|NCT01807624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185088|NCT01807624|Sympathomimetics|sympathomimetics|mesh-ancestor
6185089|NCT01807624|Autonomic Agents|autonomic agents|mesh-ancestor
6185090|NCT01807624|Nasal Decongestants|nasal decongestants|mesh-ancestor
6185091|NCT01807624|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6185092|NCT01807624|Respiratory System Agents|respiratory system agents|mesh-ancestor
6185093|NCT01807624|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6185094|NCT01807624|Mydriatics|mydriatics|mesh-ancestor
6185095|NCT01807624|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6185096|NCT01807624|Protective Agents|protective agents|mesh-ancestor
6185097|NCT01807871|Nicotine|nicotine|mesh-list
6185098|NCT01807871|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6185099|NCT01807871|Autonomic Agents|autonomic agents|mesh-ancestor
6671791|NCT01551472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671792|NCT01551472|Protective Agents|protective agents|mesh-ancestor
5579478|NCT03860129|Anesthetics, General|anesthetics, general|mesh-ancestor
5579479|NCT03860129|Anesthetics|anesthetics|mesh-ancestor
5579480|NCT03860129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5579481|NCT03860129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579482|NCT03860220|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
5579483|NCT03860220|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5579484|NCT03860220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6671793|NCT01551485|Zolpidem|zolpidem|mesh-list
6671794|NCT01551485|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6671795|NCT01551485|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6671796|NCT01551485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6671797|NCT01551485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671798|NCT01551485|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6671799|NCT01551485|GABA Agonists|gaba agonists|mesh-ancestor
6671800|NCT01551485|GABA Agents|gaba agents|mesh-ancestor
6671801|NCT01551485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6671802|NCT01551485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671803|NCT01551511|Dronabinol|dronabinol|mesh-list
6671804|NCT01551511|Hallucinogens|hallucinogens|mesh-ancestor
6671805|NCT01551511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671806|NCT01551511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5579485|NCT03860220|Antimetabolites|antimetabolites|mesh-ancestor
5579486|NCT03860220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185100|NCT01807871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6671807|NCT01551511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5579487|NCT03860220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5579488|NCT03860220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5579489|NCT03860220|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5579490|NCT03860220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5579491|NCT03860220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6671808|NCT01551511|Analgesics|analgesics|mesh-ancestor
6671809|NCT01551511|Sensory System Agents|sensory system agents|mesh-ancestor
6671810|NCT01551511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6671811|NCT01551511|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6671812|NCT01551511|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6671813|NCT01551511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6671814|NCT01551511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671815|NCT01551511|Hormones|hormones|mesh-ancestor
6671816|NCT01551511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6671817|NCT01551589|Docetaxel|docetaxel|mesh-list
6671818|NCT01551589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6671819|NCT01551589|Tubulin Modulators|tubulin modulators|mesh-ancestor
6671820|NCT01551589|Antimitotic Agents|antimitotic agents|mesh-ancestor
6671821|NCT01551589|Mitosis Modulators|mitosis modulators|mesh-ancestor
6671822|NCT01551589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671823|NCT01551615|Metformin|metformin|mesh-list
6671824|NCT01551615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6671825|NCT01551615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671826|NCT01551628|BCT-100|bct-100|mesh-list
6671827|NCT01551628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6671828|NCT01551641|Thalidomide|thalidomide|mesh-list
6671829|NCT01551641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6671830|NCT01551641|Immunologic Factors|immunologic factors|mesh-ancestor
5579492|NCT03860220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579493|NCT03860220|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5579494|NCT03860220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5579495|NCT03860207|Antibodies|antibodies|mesh-list
5579496|NCT03860207|Immunoglobulins|immunoglobulins|mesh-list
5579497|NCT03860207|Antibodies, Bispecific|antibodies, bispecific|mesh-list
5579498|NCT03860207|Immunologic Factors|immunologic factors|mesh-ancestor
6488162|NCT00581009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6488163|NCT00581035|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6185101|NCT01807871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185102|NCT01807871|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6185103|NCT01807871|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6185104|NCT01807871|Cholinergic Agents|cholinergic agents|mesh-ancestor
6185105|NCT01807871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6185106|NCT01807871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185107|NCT01807923|Ivacaftor|ivacaftor|mesh-list
6185108|NCT01807923|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6488164|NCT00581035|Immunologic Factors|immunologic factors|mesh-ancestor
6488165|NCT00581035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488166|NCT00581139|Midazolam|midazolam|mesh-list
6488167|NCT00581139|Anesthetics|anesthetics|mesh-ancestor
6488168|NCT00581139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6488169|NCT00581139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488170|NCT00581139|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6488171|NCT00581139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6488172|NCT00581139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5579499|NCT03860207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579500|NCT03859934|Melatonin|melatonin|mesh-list
5579501|NCT03859934|Antioxidants|antioxidants|mesh-ancestor
6185109|NCT01807923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6185110|NCT01807923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185111|NCT01807949|Ivacaftor|ivacaftor|mesh-list
6185112|NCT01807949|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6185113|NCT01807949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6185114|NCT01807949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185115|NCT01808092|Meropenem|meropenem|mesh-list
6185116|NCT01808092|Ceftazidime|ceftazidime|mesh-list
6185117|NCT01808092|Avibactam|avibactam|mesh-list
6185118|NCT01808092|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
6185119|NCT01808092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6185120|NCT01808092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6185121|NCT01808092|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6671831|NCT01551641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671832|NCT01551641|Leprostatic Agents|leprostatic agents|mesh-ancestor
6671833|NCT01551641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6671834|NCT01551641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6671835|NCT01551641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6185122|NCT01808092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6185123|NCT01808092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671836|NCT01551641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6671837|NCT01551641|Growth Substances|growth substances|mesh-ancestor
6671838|NCT01551641|Growth Inhibitors|growth inhibitors|mesh-ancestor
6671839|NCT01551641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6671840|NCT01551667|Antibodies|antibodies|mesh-list
6671841|NCT01551667|Immunologic Factors|immunologic factors|mesh-ancestor
6671842|NCT01551667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671843|NCT01551680|Iniparib|iniparib|mesh-list
6671844|NCT01551680|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6671845|NCT01551680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6671846|NCT01551680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671847|NCT01551680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6185124|NCT01808118|Adalimumab|adalimumab|mesh-list
6185125|NCT01808118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6185126|NCT01808118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6671848|NCT01551719|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6671849|NCT01551719|Vancomycin|vancomycin|mesh-list
6671850|NCT01551719|Linezolid|linezolid|mesh-list
6185127|NCT01808144|Febuxostat|febuxostat|mesh-list
6185128|NCT01808144|Lesinurad|lesinurad|mesh-list
6185129|NCT01808144|Gout Suppressants|gout suppressants|mesh-ancestor
6185130|NCT01808144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6185131|NCT01808144|Uricosuric Agents|uricosuric agents|mesh-ancestor
6185132|NCT01808144|Renal Agents|renal agents|mesh-ancestor
6185133|NCT01808196|Losartan|losartan|mesh-list
6185134|NCT01808196|Angiotensin II|angiotensin ii|mesh-list
6185135|NCT01808196|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
6185136|NCT01808196|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6185137|NCT01808196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6185138|NCT01808196|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6206869|NCT02106351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6671851|NCT01551719|Daptomycin|daptomycin|mesh-list
6671852|NCT01551719|Penicillins|penicillins|mesh-list
6185139|NCT01808196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5579502|NCT03859934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5579503|NCT03859934|Protective Agents|protective agents|mesh-ancestor
5579504|NCT03859934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579505|NCT03859934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5579506|NCT03859908|Ethanol|ethanol|mesh-list
5579507|NCT03859908|Chlorhexidine|chlorhexidine|mesh-list
5579508|NCT03859908|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5579509|NCT03859908|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5579510|NCT03859908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5579511|NCT03859908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5579512|NCT03859908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579513|NCT03859908|Disinfectants|disinfectants|mesh-ancestor
6185140|NCT01808196|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6185141|NCT01808248|Sofosbuvir|sofosbuvir|mesh-list
6185142|NCT01808248|Antiviral Agents|antiviral agents|mesh-ancestor
6185143|NCT01808248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6671853|NCT01551719|Tigecycline|tigecycline|mesh-list
6671854|NCT01551719|Cephalosporins|cephalosporins|mesh-list
6671855|NCT01551719|Teicoplanin|teicoplanin|mesh-list
6185144|NCT01808313|Ambrisentan|ambrisentan|mesh-list
6185145|NCT01808313|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6185146|NCT01808326|Chlorambucil|chlorambucil|mesh-list
6185147|NCT01808326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6185148|NCT01808326|Alkylating Agents|alkylating agents|mesh-ancestor
6185149|NCT01808326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185150|NCT01808326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6185151|NCT01808339|Fluticasone|fluticasone|mesh-list
6185152|NCT01808339|Xhance|xhance|mesh-list
6185153|NCT01808339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6185154|NCT01808339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6185155|NCT01808339|Autonomic Agents|autonomic agents|mesh-ancestor
6185156|NCT01808339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6185157|NCT01808339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185158|NCT01808339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6185159|NCT01808339|Respiratory System Agents|respiratory system agents|mesh-ancestor
5579514|NCT03859908|Dermatologic Agents|dermatologic agents|mesh-ancestor
5579515|NCT03860077|Nicotine|nicotine|mesh-list
5579516|NCT03860077|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5579517|NCT03860077|Autonomic Agents|autonomic agents|mesh-ancestor
5579518|NCT03860077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5579519|NCT03860077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579520|NCT03860077|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5579521|NCT03860077|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5579522|NCT03860077|Cholinergic Agents|cholinergic agents|mesh-ancestor
5579523|NCT03860077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5579524|NCT03860077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5579525|NCT03859921|Dydrogesterone|dydrogesterone|mesh-list
5579526|NCT03859921|Progestins|progestins|mesh-ancestor
5579527|NCT03859921|Hormones|hormones|mesh-ancestor
5579528|NCT03859921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5579529|NCT03859921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579530|NCT03859856|Hormones|hormones|mesh-list
6185160|NCT01808339|Dermatologic Agents|dermatologic agents|mesh-ancestor
6185161|NCT01808339|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6185162|NCT01808534|Isophosphamide mustard|isophosphamide mustard|mesh-list
6185163|NCT01808534|Ifosfamide|ifosfamide|mesh-list
6671856|NCT01551719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6671857|NCT01551719|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6671858|NCT01551719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6671859|NCT01551719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671860|NCT01551797|Acetaminophen|acetaminophen|mesh-list
6671861|NCT01551797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6671862|NCT01551797|Analgesics|analgesics|mesh-ancestor
6671863|NCT01551797|Sensory System Agents|sensory system agents|mesh-ancestor
6671864|NCT01551797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6671865|NCT01551797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671866|NCT01551797|Antipyretics|antipyretics|mesh-ancestor
6671867|NCT01551810|Vaccines|vaccines|mesh-list
6671868|NCT01551810|Immunologic Factors|immunologic factors|mesh-ancestor
6671869|NCT01551810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579531|NCT03859856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6185164|NCT01808534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6185165|NCT01808534|Alkylating Agents|alkylating agents|mesh-ancestor
5579532|NCT03859856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671870|NCT01551823|Vaccines|vaccines|mesh-list
5579533|NCT03859583|Capsaicin|capsaicin|mesh-list
5579534|NCT03859583|Antipruritics|antipruritics|mesh-ancestor
5579535|NCT03859583|Dermatologic Agents|dermatologic agents|mesh-ancestor
5579536|NCT03859583|Sensory System Agents|sensory system agents|mesh-ancestor
5579537|NCT03859583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5579538|NCT03859583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579539|NCT03859869|Pancrelipase|pancrelipase|mesh-list
5579540|NCT03859869|Pancreatin|pancreatin|mesh-list
5579541|NCT03859869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5579542|NCT03859570|Pentoxifylline|pentoxifylline|mesh-list
5579543|NCT03859570|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5579544|NCT03859570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6185166|NCT01808534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185167|NCT01808534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6185168|NCT01808547|Bromfenac|bromfenac|mesh-list
6185169|NCT01808547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6185170|NCT01808547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6185171|NCT01808547|Analgesics|analgesics|mesh-ancestor
6185172|NCT01808547|Sensory System Agents|sensory system agents|mesh-ancestor
6185173|NCT01808547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6185174|NCT01808547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185175|NCT01808547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6185176|NCT01808547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6185177|NCT01808573|Capecitabine|capecitabine|mesh-list
6185178|NCT01808573|Lapatinib|lapatinib|mesh-list
6185179|NCT01808573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6185180|NCT01808573|Antimetabolites|antimetabolites|mesh-ancestor
6185181|NCT01808573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185182|NCT01808573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6185183|NCT01808573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6185184|NCT01808573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6185185|NCT01808612|Fluoxetine|fluoxetine|mesh-list
6185186|NCT01808612|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6185187|NCT01808612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6185188|NCT01808612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6185189|NCT01808612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185190|NCT01808612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6185191|NCT01808612|Serotonin Agents|serotonin agents|mesh-ancestor
6185192|NCT01808612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488173|NCT00581139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6671871|NCT01551823|Immunologic Factors|immunologic factors|mesh-ancestor
5579545|NCT03859570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5579546|NCT03859570|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5579547|NCT03859570|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5579548|NCT03859570|Protective Agents|protective agents|mesh-ancestor
5579549|NCT03859570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579550|NCT03859570|Vasodilator Agents|vasodilator agents|mesh-ancestor
5579551|NCT03859570|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5579552|NCT03859570|Antioxidants|antioxidants|mesh-ancestor
5579553|NCT03859687|Vitamins|vitamins|mesh-list
6488174|NCT00581139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6488175|NCT00581139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6488176|NCT00581139|Anesthetics, General|anesthetics, general|mesh-ancestor
6488177|NCT00581139|GABA Modulators|gaba modulators|mesh-ancestor
6488178|NCT00581139|GABA Agents|gaba agents|mesh-ancestor
6488179|NCT00581139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5579554|NCT03859687|Vitamin A|vitamin a|mesh-list
5579555|NCT03859687|Retinol palmitate|retinol palmitate|mesh-list
6489032|NCT00588913|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5579556|NCT03859687|Micronutrients|micronutrients|mesh-ancestor
6671872|NCT01551823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671873|NCT01551836|Acetaminophen|acetaminophen|mesh-list
6671874|NCT01551836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6671875|NCT01551836|Analgesics|analgesics|mesh-ancestor
5579557|NCT03859687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579558|NCT03859687|Antioxidants|antioxidants|mesh-ancestor
5579559|NCT03859687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5579560|NCT03859687|Protective Agents|protective agents|mesh-ancestor
5579561|NCT03859687|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5579562|NCT03859687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5579563|NCT03859635|Bupivacaine|bupivacaine|mesh-list
5579564|NCT03859635|Anesthetics, Local|anesthetics, local|mesh-ancestor
5579565|NCT03859635|Anesthetics|anesthetics|mesh-ancestor
5579566|NCT03859635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5579567|NCT03859635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579568|NCT03859635|Sensory System Agents|sensory system agents|mesh-ancestor
5579569|NCT03859635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5604827|NCT04183101|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5604828|NCT04183101|Protease Inhibitors|protease inhibitors|mesh-ancestor
5604829|NCT04183101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5604830|NCT04183101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604831|NCT04183101|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6185193|NCT01808612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6185194|NCT01808612|Antidepressive Agents|antidepressive agents|mesh-ancestor
6185195|NCT01808612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6185196|NCT01808612|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6185197|NCT01808612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6185198|NCT01808612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6185199|NCT01808651|Fluoxetine|fluoxetine|mesh-list
6185200|NCT01808651|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6185201|NCT01808651|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6185202|NCT01808651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6185203|NCT01808651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185204|NCT01808651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6185205|NCT01808651|Serotonin Agents|serotonin agents|mesh-ancestor
6185206|NCT01808651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185207|NCT01808651|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6185208|NCT01808651|Antidepressive Agents|antidepressive agents|mesh-ancestor
6185209|NCT01808651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6488180|NCT00581139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488181|NCT00581165|Etanercept|etanercept|mesh-list
6488182|NCT00581165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6488183|NCT00581165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6488184|NCT00581165|Analgesics|analgesics|mesh-ancestor
6488185|NCT00581165|Sensory System Agents|sensory system agents|mesh-ancestor
6488186|NCT00581165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6488187|NCT00581165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488188|NCT00581165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6488189|NCT00581165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5579570|NCT03859362|Ertapenem|ertapenem|mesh-list
5579571|NCT03859362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5579572|NCT03859362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5579573|NCT03859375|Disinfectants|disinfectants|mesh-list
5579574|NCT03859375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5579575|NCT03859141|Vaccines|vaccines|mesh-list
5579576|NCT03859141|Immunologic Factors|immunologic factors|mesh-ancestor
5579577|NCT03859141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579578|NCT03859024|Acetaminophen|acetaminophen|mesh-list
5579579|NCT03859024|Dexamethasone|dexamethasone|mesh-list
5579580|NCT03859024|Ibuprofen|ibuprofen|mesh-list
5579581|NCT03859024|Celecoxib|celecoxib|mesh-list
5579582|NCT03859024|Oxycodone|oxycodone|mesh-list
5579583|NCT03859024|Gabapentin|gabapentin|mesh-list
5579584|NCT03859024|Bupivacaine|bupivacaine|mesh-list
5579585|NCT03859024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5579586|NCT03859024|Antiemetics|antiemetics|mesh-ancestor
5579587|NCT03859024|Autonomic Agents|autonomic agents|mesh-ancestor
5579588|NCT03859024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5579589|NCT03859024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579590|NCT03859024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5579591|NCT03859024|Glucocorticoids|glucocorticoids|mesh-ancestor
5579592|NCT03859024|Hormones|hormones|mesh-ancestor
5579593|NCT03859024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5579594|NCT03859024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5579595|NCT03859024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6185210|NCT01808651|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6185211|NCT01808651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6185212|NCT01808651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6185213|NCT01808690|Metformin|metformin|mesh-list
6185214|NCT01808690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6185215|NCT01808690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579596|NCT03859024|Anesthetics, Local|anesthetics, local|mesh-ancestor
5579597|NCT03859024|Anesthetics|anesthetics|mesh-ancestor
5579598|NCT03859024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5579599|NCT03859024|Sensory System Agents|sensory system agents|mesh-ancestor
5579600|NCT03859024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5579601|NCT03859024|Analgesics|analgesics|mesh-ancestor
5579602|NCT03859024|Antipyretics|antipyretics|mesh-ancestor
5579603|NCT03859024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5579604|NCT03859024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5579605|NCT03859024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5579606|NCT03859024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5579607|NCT03859024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5579608|NCT03859024|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5579609|NCT03859024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5579610|NCT03859024|Narcotics|narcotics|mesh-ancestor
5579611|NCT03859024|Anticonvulsants|anticonvulsants|mesh-ancestor
5579612|NCT03859024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5579613|NCT03859024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5579614|NCT03859024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5579615|NCT03859024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5579616|NCT03859024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5579617|NCT03859024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5579618|NCT03859024|Antimanic Agents|antimanic agents|mesh-ancestor
5579619|NCT03859102|Acetaminophen|acetaminophen|mesh-list
6185216|NCT01808755|Trimethoprim|trimethoprim|mesh-list
6185217|NCT01808755|Sulfamethoxazole|sulfamethoxazole|mesh-list
6185218|NCT01808755|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6185219|NCT01808755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6185220|NCT01808755|Renal Agents|renal agents|mesh-ancestor
6185221|NCT01808755|Antimalarials|antimalarials|mesh-ancestor
6185222|NCT01808755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6185223|NCT01808755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6185224|NCT01808755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6185225|NCT01808755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6185226|NCT01808755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185227|NCT01808755|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6185228|NCT01808755|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6185229|NCT01808755|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6185230|NCT01809054|Aspirin|aspirin|mesh-list
5579620|NCT03859102|Dexamethasone|dexamethasone|mesh-list
5579621|NCT03859102|Gabapentin|gabapentin|mesh-list
5579622|NCT03859102|Ondansetron|ondansetron|mesh-list
6185231|NCT01809054|Fondaparinux|fondaparinux|mesh-list
5579623|NCT03859102|Anesthetics|anesthetics|mesh-list
5579624|NCT03859102|Anesthetics, Local|anesthetics, local|mesh-list
6206870|NCT02106390|Vaccines|vaccines|mesh-list
5579625|NCT03859102|Lansoprazole|lansoprazole|mesh-list
5579626|NCT03859102|Dexlansoprazole|dexlansoprazole|mesh-list
6185232|NCT01809054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6185233|NCT01809054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6185234|NCT01809054|Analgesics|analgesics|mesh-ancestor
6185235|NCT01809054|Sensory System Agents|sensory system agents|mesh-ancestor
6185236|NCT01809054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6185237|NCT01809054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185238|NCT01809054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6185239|NCT01809054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6185240|NCT01809054|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6185241|NCT01809054|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5579627|NCT03859102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5579628|NCT03859102|Antiemetics|antiemetics|mesh-ancestor
5579629|NCT03859102|Autonomic Agents|autonomic agents|mesh-ancestor
5579630|NCT03859102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5579631|NCT03859102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579632|NCT03859102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5579633|NCT03859102|Glucocorticoids|glucocorticoids|mesh-ancestor
5579634|NCT03859102|Hormones|hormones|mesh-ancestor
5579635|NCT03859102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5579636|NCT03859102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5579637|NCT03859102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5579638|NCT03859102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6185242|NCT01809054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185243|NCT01809054|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6185244|NCT01809054|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6185245|NCT01809054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6185246|NCT01809054|Antipyretics|antipyretics|mesh-ancestor
6185247|NCT01809054|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6185248|NCT01809054|Antithrombins|antithrombins|mesh-ancestor
6185249|NCT01809054|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6185250|NCT01809054|Protease Inhibitors|protease inhibitors|mesh-ancestor
6185251|NCT01809054|Anticoagulants|anticoagulants|mesh-ancestor
6185252|NCT01809106|Fentanyl|fentanyl|mesh-list
6185253|NCT01809106|Morphine|morphine|mesh-list
6185254|NCT01809106|Oxycodone|oxycodone|mesh-list
6185255|NCT01809106|Buprenorphine|buprenorphine|mesh-list
6185256|NCT01809106|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6185257|NCT01809106|Narcotics|narcotics|mesh-ancestor
6185258|NCT01809106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6185259|NCT01809106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185260|NCT01809106|Analgesics|analgesics|mesh-ancestor
6185261|NCT01809106|Sensory System Agents|sensory system agents|mesh-ancestor
6185262|NCT01809106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6185263|NCT01809106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6185264|NCT01809106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6185265|NCT01809106|Anesthetics, General|anesthetics, general|mesh-ancestor
6185266|NCT01809106|Anesthetics|anesthetics|mesh-ancestor
6185267|NCT01809106|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6185268|NCT01809132|Zinc|zinc|mesh-list
6185269|NCT01809132|Methylprednisolone|methylprednisolone|mesh-list
6185270|NCT01809132|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6185271|NCT01809132|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6185272|NCT01809132|Prednisolone|prednisolone|mesh-list
6185273|NCT01809132|Prednisolone acetate|prednisolone acetate|mesh-list
6185274|NCT01809132|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6185275|NCT01809132|Pentoxifylline|pentoxifylline|mesh-list
6185276|NCT01809132|Zinc Sulfate|zinc sulfate|mesh-list
6185277|NCT01809132|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6185278|NCT01809132|Prednisolone phosphate|prednisolone phosphate|mesh-list
6185279|NCT01809132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6185280|NCT01809132|Antiemetics|antiemetics|mesh-ancestor
6185281|NCT01809132|Autonomic Agents|autonomic agents|mesh-ancestor
6185282|NCT01809132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6185283|NCT01809132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185284|NCT01809132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6185285|NCT01809132|Glucocorticoids|glucocorticoids|mesh-ancestor
6185286|NCT01809132|Hormones|hormones|mesh-ancestor
6185287|NCT01809132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6185288|NCT01809132|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6185289|NCT01809132|Protective Agents|protective agents|mesh-ancestor
6185290|NCT01809132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6185291|NCT01809132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6185292|NCT01809132|Trace Elements|trace elements|mesh-ancestor
6185293|NCT01809132|Micronutrients|micronutrients|mesh-ancestor
6185294|NCT01809132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6185295|NCT01809132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6185296|NCT01809132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6185297|NCT01809132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185298|NCT01809132|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6185299|NCT01809132|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6185300|NCT01809132|Vasodilator Agents|vasodilator agents|mesh-ancestor
5579639|NCT03859102|Analgesics|analgesics|mesh-ancestor
5579640|NCT03859102|Sensory System Agents|sensory system agents|mesh-ancestor
5579641|NCT03859102|Antipyretics|antipyretics|mesh-ancestor
5579642|NCT03859102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5579643|NCT03859102|Anticonvulsants|anticonvulsants|mesh-ancestor
5579644|NCT03859102|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5579645|NCT03859102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5579646|NCT03859102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5579647|NCT03859102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5579648|NCT03859102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5579649|NCT03859102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5579650|NCT03859102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5579651|NCT03859102|Antimanic Agents|antimanic agents|mesh-ancestor
5579652|NCT03859102|Antipruritics|antipruritics|mesh-ancestor
5579653|NCT03859102|Dermatologic Agents|dermatologic agents|mesh-ancestor
5579654|NCT03859102|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5579655|NCT03859102|Serotonin Agents|serotonin agents|mesh-ancestor
5579656|NCT03859102|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5579657|NCT03859102|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5579658|NCT03859102|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5579659|NCT03859102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5579660|NCT03859219|Rozanolixizumab|rozanolixizumab|mesh-list
5579661|NCT03859219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5579662|NCT03859219|Immunologic Factors|immunologic factors|mesh-ancestor
5579663|NCT03859219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579664|NCT03858972|Capecitabine|capecitabine|mesh-list
6185301|NCT01809132|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6185302|NCT01809132|Antioxidants|antioxidants|mesh-ancestor
6185303|NCT01809132|Astringents|astringents|mesh-ancestor
6185304|NCT01809132|Dermatologic Agents|dermatologic agents|mesh-ancestor
6185305|NCT01809197|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6185306|NCT01809210|Gemcitabine|gemcitabine|mesh-list
6185307|NCT01809210|Carboplatin|carboplatin|mesh-list
6185308|NCT01809210|Pemetrexed|pemetrexed|mesh-list
6185309|NCT01809210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6185310|NCT01809210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6185311|NCT01809210|Antimetabolites|antimetabolites|mesh-ancestor
6185312|NCT01809210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185313|NCT01809210|Antiviral Agents|antiviral agents|mesh-ancestor
6185314|NCT01809210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6185315|NCT01809210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6185316|NCT01809210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6185317|NCT01809210|Immunologic Factors|immunologic factors|mesh-ancestor
6185318|NCT01809210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185319|NCT01809210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6185320|NCT01809210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6185321|NCT01809314|Epoetin Alfa|epoetin alfa|mesh-list
6185322|NCT01809314|Hematinics|hematinics|mesh-ancestor
5579665|NCT03858972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5579666|NCT03858972|Antimetabolites|antimetabolites|mesh-ancestor
5579667|NCT03858972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5579668|NCT03858972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5579669|NCT03858621|Fentanyl|fentanyl|mesh-list
5579670|NCT03858621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5579671|NCT03858621|Narcotics|narcotics|mesh-ancestor
5579672|NCT03858621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5579673|NCT03858621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579674|NCT03858621|Analgesics|analgesics|mesh-ancestor
5579675|NCT03858621|Sensory System Agents|sensory system agents|mesh-ancestor
5579676|NCT03858621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5579677|NCT03858621|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5579678|NCT03858621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5579679|NCT03858621|Anesthetics, General|anesthetics, general|mesh-ancestor
5579680|NCT03858621|Anesthetics|anesthetics|mesh-ancestor
5579681|NCT03858582|Pembrolizumab|pembrolizumab|mesh-list
5579682|NCT03858582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5579683|NCT03858582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5579684|NCT03858465|Phenylephrine|phenylephrine|mesh-list
5579685|NCT03858465|Oxymetazoline|oxymetazoline|mesh-list
5579686|NCT03858465|Ephedrine|ephedrine|mesh-list
5579687|NCT03858465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5579688|NCT03858465|Mydriatics|mydriatics|mesh-ancestor
5579689|NCT03858465|Autonomic Agents|autonomic agents|mesh-ancestor
5579690|NCT03858465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5579691|NCT03858465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579692|NCT03858465|Sympathomimetics|sympathomimetics|mesh-ancestor
5579693|NCT03858465|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5579694|NCT03858465|Nasal Decongestants|nasal decongestants|mesh-ancestor
5579695|NCT03858465|Respiratory System Agents|respiratory system agents|mesh-ancestor
5579696|NCT03858465|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5579697|NCT03858465|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5579698|NCT03858465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5579699|NCT03858465|Adrenergic Agents|adrenergic agents|mesh-ancestor
5579700|NCT03858465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5579701|NCT03858465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5579702|NCT03858465|Protective Agents|protective agents|mesh-ancestor
5579703|NCT03858465|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6185323|NCT01809327|Metformin|metformin|mesh-list
6185324|NCT01809327|Canagliflozin|canagliflozin|mesh-list
6185325|NCT01809327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6185326|NCT01809327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185327|NCT01809327|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6185328|NCT01809327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185329|NCT01809639|Progesterone|progesterone|mesh-list
6185330|NCT01809639|Progestins|progestins|mesh-ancestor
6185331|NCT01809639|Hormones|hormones|mesh-ancestor
6185332|NCT01809639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6185333|NCT01809639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579704|NCT03858491|Cobicistat|cobicistat|mesh-list
5579705|NCT03858491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6185334|NCT01810016|Poly I-C|poly i-c|mesh-list
6185335|NCT01810016|Ipilimumab|ipilimumab|mesh-list
6185336|NCT01810016|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
5579706|NCT03858491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5579707|NCT03858491|Antiviral Agents|antiviral agents|mesh-ancestor
5579708|NCT03858491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6185337|NCT01810016|Vaccines|vaccines|mesh-list
6185338|NCT01810016|Poly ICLC|poly iclc|mesh-list
5579709|NCT03858491|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5579710|NCT03858491|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5579711|NCT03858491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5579712|NCT03858491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185339|NCT01810016|Immunologic Factors|immunologic factors|mesh-ancestor
6185340|NCT01810016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185341|NCT01810016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6185342|NCT01810016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6185343|NCT01810016|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6185344|NCT01810016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185345|NCT01810016|Interferon Inducers|interferon inducers|mesh-ancestor
6185346|NCT01810016|Laxatives|laxatives|mesh-ancestor
6185347|NCT01810016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6185348|NCT01810016|Antiviral Agents|antiviral agents|mesh-ancestor
6185349|NCT01810016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6185350|NCT01810042|Ranibizumab|ranibizumab|mesh-list
6185351|NCT01810042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6185352|NCT01810042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6185353|NCT01810042|Growth Substances|growth substances|mesh-ancestor
6185354|NCT01810042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671876|NCT01551836|Sensory System Agents|sensory system agents|mesh-ancestor
6671877|NCT01551836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6671878|NCT01551836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671879|NCT01551836|Antipyretics|antipyretics|mesh-ancestor
6672563|NCT01557114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6672564|NCT01557114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6672565|NCT01557114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6672566|NCT01557114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672567|NCT01557127|Sorafenib|sorafenib|mesh-list
6185355|NCT01810042|Growth Inhibitors|growth inhibitors|mesh-ancestor
6185356|NCT01810042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6185357|NCT01810380|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6185358|NCT01810380|Brexpiprazole|brexpiprazole|mesh-list
6185359|NCT01810380|Antidepressive Agents|antidepressive agents|mesh-ancestor
6185360|NCT01810380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6185361|NCT01810380|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6185362|NCT01810380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6185363|NCT01810380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6185364|NCT01810380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185365|NCT01810380|Serotonin Agents|serotonin agents|mesh-ancestor
6185366|NCT01810380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6185367|NCT01810380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185368|NCT01810380|Dopamine Agonists|dopamine agonists|mesh-ancestor
6185369|NCT01810380|Dopamine Agents|dopamine agents|mesh-ancestor
6185370|NCT01810432|Evacetrapib|evacetrapib|mesh-list
6185371|NCT01810432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6185372|NCT01810432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6185373|NCT01810432|Antimetabolites|antimetabolites|mesh-ancestor
6206871|NCT02106390|Immunologic Factors|immunologic factors|mesh-ancestor
6672568|NCT01557127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6672569|NCT01557127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6672570|NCT01557127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6672571|NCT01557127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672572|NCT01557140|Carvedilol|carvedilol|mesh-list
6672573|NCT01557140|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6672574|NCT01557140|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6672575|NCT01557140|Adrenergic Agents|adrenergic agents|mesh-ancestor
6672576|NCT01557140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6672577|NCT01557140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672578|NCT01557140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672579|NCT01557140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6672580|NCT01557140|Antioxidants|antioxidants|mesh-ancestor
6672581|NCT01557140|Protective Agents|protective agents|mesh-ancestor
5579713|NCT03858387|Meropenem|meropenem|mesh-list
5579714|NCT03858387|Imipenem|imipenem|mesh-list
5579715|NCT03858387|Cilastatin|cilastatin|mesh-list
5579716|NCT03858387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5579717|NCT03858387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5579718|NCT03858387|Protease Inhibitors|protease inhibitors|mesh-ancestor
5579719|NCT03858387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5579720|NCT03858387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5579721|NCT03858231|Acetaminophen|acetaminophen|mesh-list
5579722|NCT03858231|Ibuprofen|ibuprofen|mesh-list
5579723|NCT03858231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6672582|NCT01557140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6671880|NCT01552005|Saxagliptin|saxagliptin|mesh-list
6671881|NCT01552005|Incretins|incretins|mesh-ancestor
6671882|NCT01552005|Hormones|hormones|mesh-ancestor
6671883|NCT01552005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6671884|NCT01552005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671885|NCT01552005|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6671886|NCT01552005|Protease Inhibitors|protease inhibitors|mesh-ancestor
6185374|NCT01810432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185375|NCT01810432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6185376|NCT01810666|Factor VIII|factor viii|mesh-list
6185377|NCT01810666|Coagulants|coagulants|mesh-ancestor
6185378|NCT01810692|Tiotropium Bromide|tiotropium bromide|mesh-list
6185379|NCT01810692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6185380|NCT01810692|Autonomic Agents|autonomic agents|mesh-ancestor
6671887|NCT01552005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6671888|NCT01552005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671889|NCT01552005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6671890|NCT01552018|Saxagliptin|saxagliptin|mesh-list
6671891|NCT01552018|Incretins|incretins|mesh-ancestor
6671892|NCT01552018|Hormones|hormones|mesh-ancestor
6185381|NCT01810692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6185382|NCT01810692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185383|NCT01810692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6185384|NCT01810692|Respiratory System Agents|respiratory system agents|mesh-ancestor
5579724|NCT03858231|Analgesics|analgesics|mesh-ancestor
5579725|NCT03858231|Sensory System Agents|sensory system agents|mesh-ancestor
5579726|NCT03858231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5579727|NCT03858231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579728|NCT03858231|Antipyretics|antipyretics|mesh-ancestor
5579729|NCT03858231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5579730|NCT03858231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5579731|NCT03858231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5579732|NCT03858231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5579733|NCT03858231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5579734|NCT03858231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185385|NCT01810692|Parasympatholytics|parasympatholytics|mesh-ancestor
6185386|NCT01810692|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6185387|NCT01810692|Cholinergic Agents|cholinergic agents|mesh-ancestor
6185388|NCT01810692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6185389|NCT01810692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185390|NCT01810783|Brexpiprazole|brexpiprazole|mesh-list
6185391|NCT01810783|Serotonin Agents|serotonin agents|mesh-ancestor
6185392|NCT01810783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6185393|NCT01810783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185394|NCT01810783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671893|NCT01552018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5579735|NCT03858192|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5579736|NCT03858192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5579737|NCT03858270|Memantine|memantine|mesh-list
6185395|NCT01810783|Dopamine Agonists|dopamine agonists|mesh-ancestor
6185396|NCT01810783|Dopamine Agents|dopamine agents|mesh-ancestor
6185397|NCT01810952|Insulin|insulin|mesh-list
6185398|NCT01810952|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6185399|NCT01810952|Insulin Glargine|insulin glargine|mesh-list
6185400|NCT01810952|Insulin, Isophane|insulin, isophane|mesh-list
5579738|NCT03858270|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5579739|NCT03858270|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5579740|NCT03858270|Dopamine Agents|dopamine agents|mesh-ancestor
5579741|NCT03858270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5579742|NCT03858270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5579743|NCT03858270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579744|NCT03858270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6185401|NCT01810952|Isophane Insulin, Human|isophane insulin, human|mesh-list
6185402|NCT01810952|Isophane insulin, beef|isophane insulin, beef|mesh-list
6185403|NCT01810952|Insulin Lispro|insulin lispro|mesh-list
6185404|NCT01810952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6185405|NCT01810952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185406|NCT01811147|Norepinephrine|norepinephrine|mesh-list
6185407|NCT01811147|Serotonin|serotonin|mesh-list
6185408|NCT01811147|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
6185409|NCT01811147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6185410|NCT01811147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6671894|NCT01552018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579745|NCT03858270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6185411|NCT01811147|Adrenergic Agents|adrenergic agents|mesh-ancestor
6185412|NCT01811147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6185413|NCT01811147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185414|NCT01811147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185415|NCT01811147|Sympathomimetics|sympathomimetics|mesh-ancestor
6185416|NCT01811147|Autonomic Agents|autonomic agents|mesh-ancestor
6185417|NCT01811147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6185418|NCT01811147|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6185419|NCT01811147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6185420|NCT01811147|Serotonin Agents|serotonin agents|mesh-ancestor
6185421|NCT01811147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6185422|NCT01811147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6185423|NCT01811186|Oxycodone|oxycodone|mesh-list
6185424|NCT01811186|Naloxone|naloxone|mesh-list
5579746|NCT03858062|Insulin|insulin|mesh-list
5579747|NCT03858062|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5579748|NCT03858062|Pancrelipase|pancrelipase|mesh-list
6185425|NCT01811186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6185426|NCT01811186|Narcotics|narcotics|mesh-ancestor
6185427|NCT01811186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6185428|NCT01811186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185429|NCT01811186|Analgesics|analgesics|mesh-ancestor
6185430|NCT01811186|Sensory System Agents|sensory system agents|mesh-ancestor
6185431|NCT01811186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6185432|NCT01811186|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5579749|NCT03858062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5579750|NCT03858062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579751|NCT03858062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5579752|NCT03857854|Pirfenidone|pirfenidone|mesh-list
5579753|NCT03857854|Analgesics|analgesics|mesh-ancestor
5579754|NCT03857854|Sensory System Agents|sensory system agents|mesh-ancestor
5579755|NCT03857854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5579756|NCT03857854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185433|NCT01811225|Progesterone|progesterone|mesh-list
6185434|NCT01811225|Progestins|progestins|mesh-ancestor
6185435|NCT01811225|Hormones|hormones|mesh-ancestor
6185436|NCT01811225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6185437|NCT01811225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185438|NCT01811238|Oxycodone|oxycodone|mesh-list
6185439|NCT01811238|Naloxone|naloxone|mesh-list
6185440|NCT01811238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6185441|NCT01811238|Narcotics|narcotics|mesh-ancestor
6185442|NCT01811238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6185443|NCT01811238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185444|NCT01811238|Analgesics|analgesics|mesh-ancestor
6185445|NCT01811238|Sensory System Agents|sensory system agents|mesh-ancestor
6185446|NCT01811238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6185447|NCT01811238|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6206872|NCT02106390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206873|NCT02106403|Disinfectants|disinfectants|mesh-list
6206874|NCT02106403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6206875|NCT02106442|Risedronic Acid|risedronic acid|mesh-list
6206876|NCT02106442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6206877|NCT02106442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6206878|NCT02106442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206879|NCT02106442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6206880|NCT02106442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671895|NCT01552018|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6671896|NCT01552018|Protease Inhibitors|protease inhibitors|mesh-ancestor
6671897|NCT01552018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6671898|NCT01552018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671899|NCT01552018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6671900|NCT01552044|Spironolactone|spironolactone|mesh-list
6671901|NCT01552044|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6671902|NCT01552044|Hormone Antagonists|hormone antagonists|mesh-ancestor
6671903|NCT01552044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6671904|NCT01552044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671905|NCT01552044|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6671906|NCT01552044|Diuretics|diuretics|mesh-ancestor
6671907|NCT01552044|Natriuretic Agents|natriuretic agents|mesh-ancestor
5579757|NCT03857854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5579758|NCT03857854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5579759|NCT03857854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5579760|NCT03857854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6206881|NCT02106442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5579761|NCT03857854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5579762|NCT03857672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
5579763|NCT03857672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5579764|NCT03857672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671908|NCT01552122|Vitamin D|vitamin d|mesh-list
6671909|NCT01552122|Cholecalciferol|cholecalciferol|mesh-list
6671910|NCT01552122|Alendronate|alendronate|mesh-list
6671911|NCT01552122|Calcium Carbonate|calcium carbonate|mesh-list
6671912|NCT01552122|Calcium|calcium|mesh-list
6671913|NCT01552122|Vitamins|vitamins|mesh-ancestor
6671914|NCT01552122|Micronutrients|micronutrients|mesh-ancestor
6671915|NCT01552122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671916|NCT01552122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6671917|NCT01552122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6671918|NCT01552122|Antacids|antacids|mesh-ancestor
6671919|NCT01552122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671920|NCT01552122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6671921|NCT01552148|Morphine|morphine|mesh-list
6671922|NCT01552148|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6185448|NCT01811355|Mexiletine|mexiletine|mesh-list
6185449|NCT01811355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6185450|NCT01811355|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5606868|NCT03593018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5606869|NCT03563742|Tenofovir|tenofovir|mesh-list
5606870|NCT03563742|Lamivudine|lamivudine|mesh-list
5606871|NCT03563742|Rilpivirine|rilpivirine|mesh-list
5606872|NCT03563742|Antiviral Agents|antiviral agents|mesh-ancestor
5606873|NCT03563742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5606874|NCT03563742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5606875|NCT03563742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6185451|NCT01811355|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6185452|NCT01811355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6185453|NCT01811355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185454|NCT01811654|Hyaluronic Acid|hyaluronic acid|mesh-list
6185455|NCT01811654|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6185456|NCT01811654|Immunologic Factors|immunologic factors|mesh-ancestor
6185457|NCT01811654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185458|NCT01811654|Viscosupplements|viscosupplements|mesh-ancestor
6185459|NCT01811654|Protective Agents|protective agents|mesh-ancestor
6185460|NCT01811693|Nitroglycerin|nitroglycerin|mesh-list
6185461|NCT01811693|Vasodilator Agents|vasodilator agents|mesh-ancestor
6185462|NCT01811706|4-Aminopyridine|4-aminopyridine|mesh-list
6185463|NCT01811706|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6185464|NCT01811706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6185465|NCT01811706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185466|NCT01811732|Vancomycin|vancomycin|mesh-list
6185467|NCT01811732|Aztreonam|aztreonam|mesh-list
6671923|NCT01552148|Narcotics|narcotics|mesh-ancestor
6671924|NCT01552148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6671925|NCT01552148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671926|NCT01552148|Analgesics|analgesics|mesh-ancestor
6671927|NCT01552148|Sensory System Agents|sensory system agents|mesh-ancestor
6671928|NCT01552148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6671929|NCT01552187|Colchicine|colchicine|mesh-list
6671930|NCT01552187|Gout Suppressants|gout suppressants|mesh-ancestor
6671931|NCT01552187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6185468|NCT01811732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6185469|NCT01811732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6185470|NCT01811940|Topiramate|topiramate|mesh-list
6185471|NCT01811940|Adderall|adderall|mesh-list
6671932|NCT01552187|Tubulin Modulators|tubulin modulators|mesh-ancestor
5606876|NCT03563742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5606877|NCT03563742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606878|NCT03563742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5606879|NCT03563742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5606880|NCT03548428|Atezolizumab|atezolizumab|mesh-list
6185472|NCT01811940|Anticonvulsants|anticonvulsants|mesh-ancestor
6671933|NCT01552187|Antimitotic Agents|antimitotic agents|mesh-ancestor
5606881|NCT03548428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6185473|NCT01811940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5579765|NCT03857399|Caspofungin|caspofungin|mesh-list
5579766|NCT03857399|Antifungal Agents|antifungal agents|mesh-ancestor
5579767|NCT03857399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5579768|NCT03857399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5579769|NCT03857399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5579770|NCT03857711|Amiodarone|amiodarone|mesh-list
5579771|NCT03857711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5579772|NCT03857711|Vasodilator Agents|vasodilator agents|mesh-ancestor
5579773|NCT03857711|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5579774|NCT03857711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5579775|NCT03857711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5579776|NCT03857711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5579777|NCT03857711|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5579778|NCT03857711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5579779|NCT03857711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5579780|NCT03857711|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5579781|NCT03857711|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5579782|NCT03857711|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5579783|NCT03857763|Paclitaxel|paclitaxel|mesh-list
5579784|NCT03857763|Apatinib|apatinib|mesh-list
6185474|NCT01811940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671934|NCT01552187|Mitosis Modulators|mitosis modulators|mesh-ancestor
6671935|NCT01552187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671936|NCT01552187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6672583|NCT01557140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6672584|NCT01557140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6672585|NCT01557140|Vasodilator Agents|vasodilator agents|mesh-ancestor
6672586|NCT01557140|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6672587|NCT01557140|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6672588|NCT01557153|Amlodipine|amlodipine|mesh-list
6672589|NCT01557153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6672590|NCT01557153|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6672591|NCT01557153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6672592|NCT01557153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672593|NCT01557153|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6672594|NCT01557153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672595|NCT01557153|Vasodilator Agents|vasodilator agents|mesh-ancestor
6672596|NCT01557257|Naltrexone|naltrexone|mesh-list
6672597|NCT01557257|Oxycodone|oxycodone|mesh-list
6672598|NCT01557257|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6672599|NCT01557257|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6672600|NCT01557257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672601|NCT01557257|Sensory System Agents|sensory system agents|mesh-ancestor
6672602|NCT01557257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6672603|NCT01557257|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6672604|NCT01557257|Narcotics|narcotics|mesh-ancestor
6672605|NCT01557257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6672606|NCT01557257|Analgesics|analgesics|mesh-ancestor
6672607|NCT01557270|Dexmedetomidine|dexmedetomidine|mesh-list
6672608|NCT01557270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5579785|NCT03857763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5579786|NCT03857763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5579787|NCT03857763|Tubulin Modulators|tubulin modulators|mesh-ancestor
5579788|NCT03857763|Antimitotic Agents|antimitotic agents|mesh-ancestor
5579789|NCT03857763|Mitosis Modulators|mitosis modulators|mesh-ancestor
6185475|NCT01811940|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6185476|NCT01811953|Metformin|metformin|mesh-list
6185477|NCT01811953|Empagliflozin|empagliflozin|mesh-list
6185478|NCT01811953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6185479|NCT01811953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185480|NCT01811953|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6185481|NCT01811953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185482|NCT01812005|Rituximab|rituximab|mesh-list
5579790|NCT03857763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5579791|NCT03857763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5579792|NCT03857763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5579793|NCT03857386|Anesthetics|anesthetics|mesh-list
5579794|NCT03857386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5579795|NCT03857386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579796|NCT03857815|Antibodies|antibodies|mesh-list
5579797|NCT03857815|Immunologic Factors|immunologic factors|mesh-ancestor
5579798|NCT03857815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185483|NCT01812005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6185484|NCT01812005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6185485|NCT01812005|Immunologic Factors|immunologic factors|mesh-ancestor
6185486|NCT01812005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579799|NCT03857581|Olanzapine|olanzapine|mesh-list
5579800|NCT03857581|Clozapine|clozapine|mesh-list
5579801|NCT03857581|Antiemetics|antiemetics|mesh-ancestor
5579802|NCT03857581|Autonomic Agents|autonomic agents|mesh-ancestor
5579803|NCT03857581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5579804|NCT03857581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579805|NCT03857581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5579806|NCT03857581|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6185487|NCT01812005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6185488|NCT01812044|Lidocaine|lidocaine|mesh-list
6185489|NCT01812044|Bupivacaine|bupivacaine|mesh-list
6185490|NCT01812044|Anesthetics, Local|anesthetics, local|mesh-list
6185491|NCT01812044|Anesthetics|anesthetics|mesh-list
6185492|NCT01812044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5579807|NCT03857581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5579808|NCT03857581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5579809|NCT03857581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5579810|NCT03857581|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5579811|NCT03857581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5579812|NCT03857581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5579813|NCT03857581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185493|NCT01812044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185494|NCT01812044|Sensory System Agents|sensory system agents|mesh-ancestor
6185495|NCT01812044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6185496|NCT01812044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6185497|NCT01812044|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6185498|NCT01812044|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6185499|NCT01812044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6185500|NCT01812044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185501|NCT01812057|Dexamethasone|dexamethasone|mesh-list
6185502|NCT01812057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6185503|NCT01812057|Antiemetics|antiemetics|mesh-ancestor
6185504|NCT01812057|Autonomic Agents|autonomic agents|mesh-ancestor
6185505|NCT01812057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6185506|NCT01812057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185507|NCT01812057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6185508|NCT01812057|Glucocorticoids|glucocorticoids|mesh-ancestor
6185509|NCT01812057|Hormones|hormones|mesh-ancestor
6185510|NCT01812057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6185511|NCT01812057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6185512|NCT01812057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6185513|NCT01812668|Fluorides|fluorides|mesh-list
6185514|NCT01812668|Cariostatic Agents|cariostatic agents|mesh-ancestor
6185515|NCT01812668|Protective Agents|protective agents|mesh-ancestor
6185516|NCT01812668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185517|NCT01812707|Atorvastatin|atorvastatin|mesh-list
6185518|NCT01812707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6185519|NCT01812707|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5579814|NCT03857581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5579815|NCT03857581|Serotonin Agents|serotonin agents|mesh-ancestor
5579816|NCT03857581|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6185520|NCT01812707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6185521|NCT01812707|Antimetabolites|antimetabolites|mesh-ancestor
6185522|NCT01812707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185523|NCT01812707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6185524|NCT01812707|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6185525|NCT01812707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6185526|NCT01812707|Immunologic Factors|immunologic factors|mesh-ancestor
6185527|NCT01812707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185528|NCT01812759|Fentanyl|fentanyl|mesh-list
6185529|NCT01812759|Hydromorphone|hydromorphone|mesh-list
6185530|NCT01812759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6185531|NCT01812759|Narcotics|narcotics|mesh-ancestor
6185532|NCT01812759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6185533|NCT01812759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185534|NCT01812759|Analgesics|analgesics|mesh-ancestor
6185535|NCT01812759|Sensory System Agents|sensory system agents|mesh-ancestor
6185536|NCT01812759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6185537|NCT01812759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6185538|NCT01812759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5579817|NCT03857581|GABA Antagonists|gaba antagonists|mesh-ancestor
6185539|NCT01812759|Anesthetics, General|anesthetics, general|mesh-ancestor
6185540|NCT01812759|Anesthetics|anesthetics|mesh-ancestor
6185541|NCT01812837|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6185542|NCT01812837|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6185543|NCT01812837|Dermatologic Agents|dermatologic agents|mesh-ancestor
6185544|NCT01813058|Tranexamic Acid|tranexamic acid|mesh-list
6185545|NCT01813058|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6185546|NCT01813058|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6185547|NCT01813058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185548|NCT01813058|Hemostatics|hemostatics|mesh-ancestor
6185549|NCT01813058|Coagulants|coagulants|mesh-ancestor
6185550|NCT01813149|Clonidine|clonidine|mesh-list
6185551|NCT01813149|Phenylephrine|phenylephrine|mesh-list
6185552|NCT01813149|Oxymetazoline|oxymetazoline|mesh-list
6185553|NCT01813149|Anesthetics|anesthetics|mesh-list
6185554|NCT01813149|Anesthetics, Local|anesthetics, local|mesh-list
6671937|NCT01552330|Artesunate|artesunate|mesh-list
6671938|NCT01552330|Primaquine|primaquine|mesh-list
6185555|NCT01813149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6185556|NCT01813149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185557|NCT01813149|Sensory System Agents|sensory system agents|mesh-ancestor
6185558|NCT01813149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6185559|NCT01813149|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6185560|NCT01813149|Mydriatics|mydriatics|mesh-ancestor
6185561|NCT01813149|Autonomic Agents|autonomic agents|mesh-ancestor
6185562|NCT01813149|Sympathomimetics|sympathomimetics|mesh-ancestor
6185563|NCT01813149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6185564|NCT01813149|Nasal Decongestants|nasal decongestants|mesh-ancestor
6185565|NCT01813149|Respiratory System Agents|respiratory system agents|mesh-ancestor
6185566|NCT01813149|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6185567|NCT01813149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6185568|NCT01813149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6185569|NCT01813149|Adrenergic Agents|adrenergic agents|mesh-ancestor
6185570|NCT01813149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5579818|NCT03857581|GABA Agents|gaba agents|mesh-ancestor
5579819|NCT03857334|Cortivazol|cortivazol|mesh-list
5579820|NCT03857334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5579821|NCT03857139|Nicotine|nicotine|mesh-list
5579822|NCT03857139|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5579823|NCT03857139|Autonomic Agents|autonomic agents|mesh-ancestor
5579824|NCT03857139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5579825|NCT03857139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579826|NCT03857139|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5579827|NCT03857139|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5579828|NCT03857139|Cholinergic Agents|cholinergic agents|mesh-ancestor
6185571|NCT01813149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185572|NCT01813149|Protective Agents|protective agents|mesh-ancestor
6185573|NCT01813149|Analgesics|analgesics|mesh-ancestor
6185574|NCT01813149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6185575|NCT01813149|Sympatholytics|sympatholytics|mesh-ancestor
6185576|NCT01813149|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6185577|NCT01813214|Vemurafenib|vemurafenib|mesh-list
6185578|NCT01813214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6185579|NCT01813214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6185580|NCT01813214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6185581|NCT01813214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185582|NCT01813357|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6185583|NCT01813357|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6185584|NCT01813357|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6185585|NCT01813357|Antimetabolites|antimetabolites|mesh-ancestor
6671939|NCT01552330|Pyronaridine|pyronaridine|mesh-list
5579829|NCT03857139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5579830|NCT03857139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5579831|NCT03856853|Pirfenidone|pirfenidone|mesh-list
5579832|NCT03856853|Analgesics|analgesics|mesh-ancestor
5579833|NCT03856853|Sensory System Agents|sensory system agents|mesh-ancestor
5579834|NCT03856853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5579835|NCT03856853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579836|NCT03856853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5579837|NCT03856853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5579838|NCT03856853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5579839|NCT03856853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5579840|NCT03856853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6185586|NCT01813357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185587|NCT01813357|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6185588|NCT01813357|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6185589|NCT01813357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6185590|NCT01813422|Evolocumab|evolocumab|mesh-list
6185591|NCT01813422|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6185592|NCT01813422|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6185593|NCT01813422|Antimetabolites|antimetabolites|mesh-ancestor
6185594|NCT01813422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185595|NCT01813422|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6185596|NCT01813435|Aspirin|aspirin|mesh-list
6185597|NCT01813435|Clopidogrel|clopidogrel|mesh-list
6185598|NCT01813435|Ticagrelor|ticagrelor|mesh-list
6185599|NCT01813435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6185600|NCT01813435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6671940|NCT01552330|Antimalarials|antimalarials|mesh-ancestor
6671941|NCT01552330|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6671942|NCT01552330|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6671943|NCT01552330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6671944|NCT01552330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6671945|NCT01552330|Antiviral Agents|antiviral agents|mesh-ancestor
6671946|NCT01552330|Schistosomicides|schistosomicides|mesh-ancestor
6671947|NCT01552330|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6671948|NCT01552330|Anthelmintics|anthelmintics|mesh-ancestor
6671949|NCT01552590|Tolvaptan|tolvaptan|mesh-list
6671950|NCT01552590|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6671951|NCT01552590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671952|NCT01552590|Natriuretic Agents|natriuretic agents|mesh-ancestor
6671953|NCT01552590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671954|NCT01552629|Cyclosporine|cyclosporine|mesh-list
6671955|NCT01552629|Cyclosporins|cyclosporins|mesh-list
6671956|NCT01552629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6671957|NCT01552629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671958|NCT01552629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6671959|NCT01552629|Immunologic Factors|immunologic factors|mesh-ancestor
6671960|NCT01552629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671961|NCT01552629|Antifungal Agents|antifungal agents|mesh-ancestor
6671962|NCT01552629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6671963|NCT01552629|Dermatologic Agents|dermatologic agents|mesh-ancestor
6671964|NCT01552629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5579841|NCT03856866|Hydroxychloroquine|hydroxychloroquine|mesh-list
5579842|NCT03856866|Antimalarials|antimalarials|mesh-ancestor
5579843|NCT03856866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5579844|NCT03856866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5579845|NCT03856866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5579846|NCT03856866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5579847|NCT03856866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185601|NCT01813435|Analgesics|analgesics|mesh-ancestor
6185602|NCT01813435|Sensory System Agents|sensory system agents|mesh-ancestor
6185603|NCT01813435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6185604|NCT01813435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185605|NCT01813435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6185606|NCT01813435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6185607|NCT01813435|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6185608|NCT01813435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6185609|NCT01813435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185610|NCT01813435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6185611|NCT01813435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6185612|NCT01813435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6185613|NCT01813435|Antipyretics|antipyretics|mesh-ancestor
6185614|NCT01813435|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6206882|NCT02106455|Risedronic Acid|risedronic acid|mesh-list
6185615|NCT01813435|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6185616|NCT01813435|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6185617|NCT01813435|Purinergic Agents|purinergic agents|mesh-ancestor
6185618|NCT01813435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6185619|NCT01813474|Olaparib|olaparib|mesh-list
6185620|NCT01813474|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6185621|NCT01813474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6185622|NCT01813474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185623|NCT01813474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6185624|NCT01813734|Ponatinib|ponatinib|mesh-list
6185625|NCT01813734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6185626|NCT01813734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6185627|NCT01813734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6185628|NCT01813734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185629|NCT01813890|Tapentadol|tapentadol|mesh-list
6185630|NCT01813890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6185631|NCT01813890|Narcotics|narcotics|mesh-ancestor
6185632|NCT01813890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6185633|NCT01813890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185634|NCT01813890|Analgesics|analgesics|mesh-ancestor
6185635|NCT01813890|Sensory System Agents|sensory system agents|mesh-ancestor
6185636|NCT01813890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5579848|NCT03856866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5579849|NCT03856970|Glyburide|glyburide|mesh-list
5579850|NCT03856970|Digoxin|digoxin|mesh-list
5579851|NCT03856970|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5579852|NCT03856970|Norethindrone|norethindrone|mesh-list
5579853|NCT03856970|Estradiol|estradiol|mesh-list
5579854|NCT03856970|Estrogens|estrogens|mesh-ancestor
5579855|NCT03856970|Hormones|hormones|mesh-ancestor
5579856|NCT03856970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5579857|NCT03856970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579858|NCT03856970|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5579859|NCT03856970|Contraceptive Agents|contraceptive agents|mesh-ancestor
5579860|NCT03856970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5579861|NCT03856970|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5579862|NCT03856970|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5579863|NCT03856970|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5579864|NCT03856970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5579865|NCT03856970|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5579866|NCT03856970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5579867|NCT03856970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5579868|NCT03856970|Protective Agents|protective agents|mesh-ancestor
5579869|NCT03856970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5579870|NCT03856970|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5579871|NCT03856658|Floxuridine|floxuridine|mesh-list
5579872|NCT03856658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5579873|NCT03856658|Antimetabolites|antimetabolites|mesh-ancestor
5579874|NCT03856658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5579875|NCT03856658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5579876|NCT03856437|Vaccines|vaccines|mesh-list
5579877|NCT03856437|Immunologic Factors|immunologic factors|mesh-ancestor
5579878|NCT03856437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579879|NCT03856515|Nicotine|nicotine|mesh-list
5579880|NCT03856515|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5579881|NCT03856515|Autonomic Agents|autonomic agents|mesh-ancestor
5579882|NCT03856515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5579883|NCT03856515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579884|NCT03856515|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5579885|NCT03856515|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5579886|NCT03856515|Cholinergic Agents|cholinergic agents|mesh-ancestor
6185637|NCT01813890|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6185638|NCT01813890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6185639|NCT01813890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6185640|NCT01813890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185641|NCT01813890|Adrenergic Agents|adrenergic agents|mesh-ancestor
6185642|NCT01813890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6185643|NCT01814046|Aldesleukin|aldesleukin|mesh-list
6185644|NCT01814046|Cyclophosphamide|cyclophosphamide|mesh-list
6185645|NCT01814046|Fludarabine|fludarabine|mesh-list
6185646|NCT01814046|Interleukin-2|interleukin-2|mesh-list
6185647|NCT01814046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5579887|NCT03856515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5579888|NCT03856515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5579889|NCT03856671|Metronidazole|metronidazole|mesh-list
6185648|NCT01814046|Immunologic Factors|immunologic factors|mesh-ancestor
6185649|NCT01814046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185650|NCT01814046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6185651|NCT01814046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6185652|NCT01814046|Alkylating Agents|alkylating agents|mesh-ancestor
6185653|NCT01814046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5579890|NCT03856671|Neomycin|neomycin|mesh-list
5579891|NCT03856671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5579892|NCT03856671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5579893|NCT03856671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5579894|NCT03856671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5579895|NCT03856671|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5579896|NCT03856671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5579897|NCT03856671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5579898|NCT03856632|Liraglutide|liraglutide|mesh-list
6185654|NCT01814046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6185655|NCT01814046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6185656|NCT01814046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6185657|NCT01814046|Analgesics|analgesics|mesh-ancestor
6185658|NCT01814046|Sensory System Agents|sensory system agents|mesh-ancestor
6185659|NCT01814046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6185660|NCT01814046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6185661|NCT01814046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6185662|NCT01814046|Antiviral Agents|antiviral agents|mesh-ancestor
6185663|NCT01814046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6185664|NCT01814137|Insulin|insulin|mesh-list
6185665|NCT01814137|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6185666|NCT01814137|Insulin Aspart|insulin aspart|mesh-list
6185667|NCT01814137|Insulin, Long-Acting|insulin, long-acting|mesh-list
6185668|NCT01814137|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6185669|NCT01814137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6185670|NCT01814137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185671|NCT01814371|Mupirocin|mupirocin|mesh-list
6185672|NCT01814371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6185673|NCT01814371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6185674|NCT01814371|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6185675|NCT01814371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6185676|NCT01814371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185677|NCT01814397|Letrozole|letrozole|mesh-list
6185678|NCT01814397|Anastrozole|anastrozole|mesh-list
6185679|NCT01814397|Exemestane|exemestane|mesh-list
6185680|NCT01814397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6185681|NCT01814397|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6185682|NCT01814397|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6185683|NCT01814397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5579899|NCT03856632|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
5579900|NCT03856632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5579901|NCT03856632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185684|NCT01814397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185685|NCT01814397|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6185686|NCT01814397|Hormone Antagonists|hormone antagonists|mesh-ancestor
5579902|NCT03856632|Incretins|incretins|mesh-ancestor
5579903|NCT03856632|Hormones|hormones|mesh-ancestor
5579904|NCT03856632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5579905|NCT03856697|Gefitinib|gefitinib|mesh-list
5579906|NCT03856697|Maleic acid|maleic acid|mesh-list
5579907|NCT03856697|Abivertinib|abivertinib|mesh-list
5579908|NCT03856697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5579909|NCT03856697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5579910|NCT03856697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6185687|NCT01814397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6185688|NCT01814397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185689|NCT01814397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6185690|NCT01814553|Afatinib|afatinib|mesh-list
6185691|NCT01814553|Loperamide|loperamide|mesh-list
6185692|NCT01814553|Antidiarrheals|antidiarrheals|mesh-list
6185693|NCT01814553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6671965|NCT01552629|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6671966|NCT01552668|Fidaxomicin|fidaxomicin|mesh-list
6671967|NCT01552668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6671968|NCT01552668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6671969|NCT01552798|Aspirin|aspirin|mesh-list
5579911|NCT03856697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5579912|NCT03856502|Dexamethasone|dexamethasone|mesh-list
5579913|NCT03856502|Dexamethasone acetate|dexamethasone acetate|mesh-list
6185694|NCT01814553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6671970|NCT01552798|Acetaminophen|acetaminophen|mesh-list
6185695|NCT01814553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6185696|NCT01814553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5579914|NCT03856502|Levobupivacaine|levobupivacaine|mesh-list
5579915|NCT03856502|BB 1101|bb 1101|mesh-list
5579916|NCT03856502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5579917|NCT03856502|Antiemetics|antiemetics|mesh-ancestor
5579918|NCT03856502|Autonomic Agents|autonomic agents|mesh-ancestor
5579919|NCT03856502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5579920|NCT03856502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579921|NCT03856502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5579922|NCT03856502|Glucocorticoids|glucocorticoids|mesh-ancestor
5579923|NCT03856502|Hormones|hormones|mesh-ancestor
5579924|NCT03856502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5579925|NCT03856502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5579926|NCT03856502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5579927|NCT03856502|Protease Inhibitors|protease inhibitors|mesh-ancestor
5579928|NCT03856502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5579929|NCT03856502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185697|NCT01814553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6185698|NCT01814670|Botulinum Toxins|botulinum toxins|mesh-list
6185699|NCT01814670|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6185700|NCT01814670|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6185701|NCT01814670|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6185702|NCT01814670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6185703|NCT01814670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185704|NCT01814670|Cholinergic Agents|cholinergic agents|mesh-ancestor
6185705|NCT01814670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6185706|NCT01814670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185707|NCT01814670|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6185708|NCT01814670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6185709|NCT01814748|Metformin|metformin|mesh-list
6185710|NCT01814748|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6185711|NCT01814748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185712|NCT01814761|Bimatoprost|bimatoprost|mesh-list
6185713|NCT01814761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6185714|NCT01814800|Immunoglobulins|immunoglobulins|mesh-list
6185715|NCT01814800|Immunologic Factors|immunologic factors|mesh-ancestor
6185716|NCT01814800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185717|NCT01814813|Bevacizumab|bevacizumab|mesh-list
6185718|NCT01814813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6185719|NCT01814813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6185720|NCT01814813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6185721|NCT01814813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6185722|NCT01814813|Growth Substances|growth substances|mesh-ancestor
6185723|NCT01814813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185724|NCT01814813|Growth Inhibitors|growth inhibitors|mesh-ancestor
6185725|NCT01814878|Acetaminophen|acetaminophen|mesh-list
6185726|NCT01814878|Tramadol|tramadol|mesh-list
6185727|NCT01814878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6185728|NCT01814878|Analgesics|analgesics|mesh-ancestor
6185729|NCT01814878|Sensory System Agents|sensory system agents|mesh-ancestor
6185730|NCT01814878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6185731|NCT01814878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185732|NCT01814878|Antipyretics|antipyretics|mesh-ancestor
6185733|NCT01814878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6185734|NCT01814878|Narcotics|narcotics|mesh-ancestor
6185735|NCT01814878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6185736|NCT01815008|Aspirin|aspirin|mesh-list
6185737|NCT01815008|Clopidogrel|clopidogrel|mesh-list
6185738|NCT01815008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6185739|NCT01815008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5579930|NCT03856502|Anesthetics, Local|anesthetics, local|mesh-ancestor
5579931|NCT03856502|Anesthetics|anesthetics|mesh-ancestor
6185740|NCT01815008|Analgesics|analgesics|mesh-ancestor
6185741|NCT01815008|Sensory System Agents|sensory system agents|mesh-ancestor
6185742|NCT01815008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6185743|NCT01815008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185744|NCT01815008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5579932|NCT03856502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6185745|NCT01815008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6185746|NCT01815008|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6185747|NCT01815008|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6185748|NCT01815008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185749|NCT01815008|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6185750|NCT01815008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6185751|NCT01815008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6185752|NCT01815008|Antipyretics|antipyretics|mesh-ancestor
6185753|NCT01815008|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6185754|NCT01815008|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6185755|NCT01815008|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6185756|NCT01815008|Purinergic Agents|purinergic agents|mesh-ancestor
5579933|NCT03856502|Sensory System Agents|sensory system agents|mesh-ancestor
5579934|NCT03855917|Sofosbuvir|sofosbuvir|mesh-list
5579935|NCT03855917|Antiviral Agents|antiviral agents|mesh-ancestor
5579936|NCT03855917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5579937|NCT03856216|Rituximab|rituximab|mesh-list
5579938|NCT03856216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5579939|NCT03856216|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
5579940|NCT03856216|Methotrexate|methotrexate|mesh-list
5579941|NCT03856216|Fludarabine|fludarabine|mesh-list
5579942|NCT03856216|Melphalan|melphalan|mesh-list
5579943|NCT03856216|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5579944|NCT03856216|Mechlorethamine|mechlorethamine|mesh-list
5579945|NCT03856216|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
5579946|NCT03856216|Antibodies|antibodies|mesh-list
5579947|NCT03856216|Immunoglobulins|immunoglobulins|mesh-list
5579948|NCT03856216|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5579949|NCT03856216|Lenograstim|lenograstim|mesh-list
5579950|NCT03856216|Tacrolimus|tacrolimus|mesh-list
5579951|NCT03856216|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5579952|NCT03856216|Immunologic Factors|immunologic factors|mesh-ancestor
5579953|NCT03856216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579954|NCT03856216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5579955|NCT03856216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5579956|NCT03856216|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5579957|NCT03856216|Abortifacient Agents|abortifacient agents|mesh-ancestor
5579958|NCT03856216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5579959|NCT03856216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5579960|NCT03856216|Antimetabolites|antimetabolites|mesh-ancestor
5579961|NCT03856216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5579962|NCT03856216|Dermatologic Agents|dermatologic agents|mesh-ancestor
5579963|NCT03856216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5579964|NCT03856216|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5579965|NCT03856216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5579966|NCT03856216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5579967|NCT03856216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5579968|NCT03856216|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5579969|NCT03856216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5579970|NCT03856216|Alkylating Agents|alkylating agents|mesh-ancestor
6185757|NCT01815008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6185758|NCT01815138|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6185759|NCT01815138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6185760|NCT01815138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185761|NCT01815333|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
6185762|NCT01815333|Hematinics|hematinics|mesh-ancestor
6185763|NCT01815333|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6185764|NCT01815333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6185765|NCT01815424|Tofacitinib|tofacitinib|mesh-list
6185766|NCT01815424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6185767|NCT01815424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6185768|NCT01815424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185769|NCT01815736|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6206883|NCT02106455|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5579971|NCT03856216|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5579972|NCT03856216|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5604846|NCT04084626|Lenalidomide|lenalidomide|mesh-list
5604847|NCT04084626|Antibodies|antibodies|mesh-list
5604848|NCT04084626|Immunologic Factors|immunologic factors|mesh-ancestor
5604849|NCT04084626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185770|NCT01815736|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6185771|NCT01815736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6185772|NCT01815736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6185773|NCT01815736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6185774|NCT01815736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185775|NCT01815736|Antiviral Agents|antiviral agents|mesh-ancestor
6185776|NCT01815736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6185777|NCT01815736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6185778|NCT01815736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6185779|NCT01815918|Hydrocortisone|hydrocortisone|mesh-list
6185780|NCT01815918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5579973|NCT03856242|Tamsulosin|tamsulosin|mesh-list
5579974|NCT03856242|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5579975|NCT03856242|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5579976|NCT03856242|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5579977|NCT03856242|Adrenergic Agents|adrenergic agents|mesh-ancestor
5579978|NCT03856242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5579979|NCT03856242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5579980|NCT03856242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579981|NCT03856242|Urological Agents|urological agents|mesh-ancestor
5579982|NCT03856112|Dexamethasone|dexamethasone|mesh-list
5579983|NCT03856112|Dexamethasone acetate|dexamethasone acetate|mesh-list
5579984|NCT03856112|Venetoclax|venetoclax|mesh-list
5579985|NCT03856112|Ixazomib|ixazomib|mesh-list
5579986|NCT03856112|Ichthammol|ichthammol|mesh-list
5579987|NCT03856112|BB 1101|bb 1101|mesh-list
5579988|NCT03856112|Glycine|glycine|mesh-list
5579989|NCT03856112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5579990|NCT03856112|Antiemetics|antiemetics|mesh-ancestor
5579991|NCT03856112|Autonomic Agents|autonomic agents|mesh-ancestor
5579992|NCT03856112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5579993|NCT03856112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5579994|NCT03856112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5579995|NCT03856112|Glucocorticoids|glucocorticoids|mesh-ancestor
5579996|NCT03856112|Hormones|hormones|mesh-ancestor
5579997|NCT03856112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5579998|NCT03856112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5579999|NCT03856112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5580000|NCT03856112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5580001|NCT03856112|Protease Inhibitors|protease inhibitors|mesh-ancestor
5580002|NCT03856112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5580003|NCT03856112|Glycine Agents|glycine agents|mesh-ancestor
5580004|NCT03856112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5580005|NCT03856112|Dermatologic Agents|dermatologic agents|mesh-ancestor
5580006|NCT03855865|Vortioxetine|vortioxetine|mesh-list
5580007|NCT03855865|Antidepressive Agents|antidepressive agents|mesh-ancestor
5580008|NCT03855865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5580009|NCT03855865|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5580010|NCT03855865|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5580011|NCT03855865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5580012|NCT03855865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580013|NCT03855865|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5580014|NCT03855865|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5580015|NCT03855865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6185781|NCT01816048|Listerine|listerine|mesh-list
6185782|NCT01816048|Fluorides|fluorides|mesh-list
6185783|NCT01816048|Sodium Fluoride|sodium fluoride|mesh-list
6185784|NCT01816048|Cariostatic Agents|cariostatic agents|mesh-ancestor
6185785|NCT01816048|Protective Agents|protective agents|mesh-ancestor
6185786|NCT01816048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185787|NCT01816048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6185788|NCT01816048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6185789|NCT01816074|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6185790|NCT01816074|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6185791|NCT01816074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185792|NCT01816074|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6185793|NCT01816074|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6185794|NCT01816074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6185795|NCT01816074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185796|NCT01816074|Dopamine Agents|dopamine agents|mesh-ancestor
6185797|NCT01816074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6185798|NCT01816243|Fentanyl|fentanyl|mesh-list
6185799|NCT01816243|Morphine|morphine|mesh-list
6672609|NCT01557270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5606882|NCT03517969|Carboplatin|carboplatin|mesh-list
6185800|NCT01816243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6185801|NCT01816243|Narcotics|narcotics|mesh-ancestor
6185802|NCT01816243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6185803|NCT01816243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185804|NCT01816243|Analgesics|analgesics|mesh-ancestor
6185805|NCT01816243|Sensory System Agents|sensory system agents|mesh-ancestor
6185806|NCT01816243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6185807|NCT01816243|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5580016|NCT03855865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5580017|NCT03855865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5580018|NCT03855865|Serotonin Agents|serotonin agents|mesh-ancestor
5580019|NCT03855865|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5580020|NCT03855865|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5580021|NCT03855865|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5580022|NCT03855865|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5580023|NCT03855826|Amiodarone|amiodarone|mesh-list
5580024|NCT03855826|Nifekalant|nifekalant|mesh-list
5580025|NCT03855826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5580026|NCT03855826|Vasodilator Agents|vasodilator agents|mesh-ancestor
5580027|NCT03855826|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6185808|NCT01816243|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6185809|NCT01816243|Anesthetics, General|anesthetics, general|mesh-ancestor
6185810|NCT01816243|Anesthetics|anesthetics|mesh-ancestor
6185811|NCT01816295|Methyltestosterone|methyltestosterone|mesh-list
6185812|NCT01816295|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6185813|NCT01816295|Testosterone|testosterone|mesh-list
5580028|NCT03855826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5580029|NCT03855826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5580030|NCT03855826|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5580031|NCT03855826|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5580032|NCT03855826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5580033|NCT03855826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5580034|NCT03855826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5580035|NCT03855826|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5580036|NCT03855826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5580037|NCT03855501|Calcium|calcium|mesh-list
5580038|NCT03855501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5580039|NCT03855501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580040|NCT03855579|Simendan|simendan|mesh-list
5580041|NCT03855579|Milrinone|milrinone|mesh-list
5580042|NCT03855579|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5580043|NCT03855579|Vasodilator Agents|vasodilator agents|mesh-ancestor
5580044|NCT03855579|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5580045|NCT03855579|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6185814|NCT01816295|Testosterone undecanoate|testosterone undecanoate|mesh-list
6185815|NCT01816295|Testosterone enanthate|testosterone enanthate|mesh-list
6185816|NCT01816295|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6185817|NCT01816295|Androgens|androgens|mesh-ancestor
6185818|NCT01816295|Hormones|hormones|mesh-ancestor
6185819|NCT01816295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6185820|NCT01816295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185821|NCT01816295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6185822|NCT01816295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6185823|NCT01816295|Anabolic Agents|anabolic agents|mesh-ancestor
6185824|NCT01816477|Ropivacaine|ropivacaine|mesh-list
6185825|NCT01816477|Anesthetics, Local|anesthetics, local|mesh-ancestor
6185826|NCT01816477|Anesthetics|anesthetics|mesh-ancestor
6185827|NCT01816477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6185828|NCT01816477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185829|NCT01816477|Sensory System Agents|sensory system agents|mesh-ancestor
6185830|NCT01816477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6185831|NCT01816594|Paclitaxel|paclitaxel|mesh-list
6185832|NCT01816594|Trastuzumab|trastuzumab|mesh-list
6185833|NCT01816594|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6185834|NCT01816594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6185835|NCT01816594|Tubulin Modulators|tubulin modulators|mesh-ancestor
6185836|NCT01816594|Antimitotic Agents|antimitotic agents|mesh-ancestor
6185837|NCT01816594|Mitosis Modulators|mitosis modulators|mesh-ancestor
6185838|NCT01816594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185839|NCT01816594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6185840|NCT01816893|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6185841|NCT01816893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185842|NCT01816984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6185843|NCT01816984|Cetuximab|cetuximab|mesh-list
5580046|NCT03855579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5580047|NCT03855579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5580048|NCT03855579|Protective Agents|protective agents|mesh-ancestor
5580049|NCT03855579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580050|NCT03855579|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5580051|NCT03855423|Tocotrienols|tocotrienols|mesh-list
5580052|NCT03855423|Vitamin E|vitamin e|mesh-list
5580053|NCT03855423|Tocopherols|tocopherols|mesh-list
5580054|NCT03855423|Tocovid|tocovid|mesh-list
5580055|NCT03855423|Antioxidants|antioxidants|mesh-ancestor
5580056|NCT03855423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5580057|NCT03855423|Protective Agents|protective agents|mesh-ancestor
5580058|NCT03855423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580059|NCT03855423|Vitamins|vitamins|mesh-ancestor
5580060|NCT03855423|Micronutrients|micronutrients|mesh-ancestor
5580061|NCT03855527|Chlorhexidine|chlorhexidine|mesh-list
5580062|NCT03855527|Fluorides|fluorides|mesh-list
5580063|NCT03855527|Cariostatic Agents|cariostatic agents|mesh-ancestor
5580064|NCT03855527|Protective Agents|protective agents|mesh-ancestor
5580065|NCT03855527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580066|NCT03855527|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5580067|NCT03855527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6185844|NCT01816984|Antibodies|antibodies|mesh-list
6185845|NCT01816984|Immunoglobulins|immunoglobulins|mesh-list
6185846|NCT01816984|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6671971|NCT01552798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6671972|NCT01552798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6671973|NCT01552798|Analgesics|analgesics|mesh-ancestor
6671974|NCT01552798|Sensory System Agents|sensory system agents|mesh-ancestor
6671975|NCT01552798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6671976|NCT01552798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671977|NCT01552798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6671978|NCT01552798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6671979|NCT01552798|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6671980|NCT01552798|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6671981|NCT01552798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6671982|NCT01552798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6671983|NCT01552798|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5580068|NCT03855527|Disinfectants|disinfectants|mesh-ancestor
5580069|NCT03855306|Glyburide|glyburide|mesh-list
5580070|NCT03855306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5580071|NCT03855306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580072|NCT03855384|Cisplatin|cisplatin|mesh-list
5580073|NCT03855384|Carboplatin|carboplatin|mesh-list
5580074|NCT03855384|Fluorouracil|fluorouracil|mesh-list
5580075|NCT03855384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5580076|NCT03855384|Antimetabolites|antimetabolites|mesh-ancestor
5580077|NCT03855384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5580078|NCT03855384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5580079|NCT03855384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6671984|NCT01552798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6671985|NCT01552798|Antipyretics|antipyretics|mesh-ancestor
6671986|NCT01552837|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6671987|NCT01552837|Antidepressive Agents|antidepressive agents|mesh-ancestor
6671988|NCT01552837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6671989|NCT01552837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6671990|NCT01552837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6671991|NCT01552837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6671992|NCT01552837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671993|NCT01552850|Oxycodone|oxycodone|mesh-list
5580080|NCT03855384|Immunologic Factors|immunologic factors|mesh-ancestor
5580081|NCT03855384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580082|NCT03855332|Cilostazol|cilostazol|mesh-list
5580083|NCT03855332|Sildenafil Citrate|sildenafil citrate|mesh-list
5580084|NCT03855332|Vasodilator Agents|vasodilator agents|mesh-ancestor
5580085|NCT03855332|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5580086|NCT03855332|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5580087|NCT03855332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5580088|NCT03855332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5580089|NCT03855332|Urological Agents|urological agents|mesh-ancestor
5580090|NCT03855332|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5580091|NCT03855332|Autonomic Agents|autonomic agents|mesh-ancestor
6671994|NCT01552850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5580092|NCT03855332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5580093|NCT03855332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580094|NCT03855332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6185847|NCT01816984|Immunologic Factors|immunologic factors|mesh-ancestor
6671995|NCT01552850|Narcotics|narcotics|mesh-ancestor
6671996|NCT01552850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6671997|NCT01552850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671998|NCT01552850|Analgesics|analgesics|mesh-ancestor
6185848|NCT01816984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185849|NCT01816984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6185850|NCT01817075|Chlorhexidine|chlorhexidine|mesh-list
6185851|NCT01817075|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5580095|NCT03855332|Respiratory System Agents|respiratory system agents|mesh-ancestor
5580096|NCT03855332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5580097|NCT03855332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5580098|NCT03855332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5580099|NCT03855332|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5580100|NCT03855332|Protective Agents|protective agents|mesh-ancestor
5580101|NCT03855332|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5580102|NCT03855267|Propofol|propofol|mesh-list
5580103|NCT03855267|Etomidate|etomidate|mesh-list
5580104|NCT03855267|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5580105|NCT03855267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5580106|NCT03855267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580107|NCT03855267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5580108|NCT03855267|Anesthetics, General|anesthetics, general|mesh-ancestor
5580109|NCT03855267|Anesthetics|anesthetics|mesh-ancestor
5580110|NCT03855371|Decitabine|decitabine|mesh-list
5580111|NCT03855371|Arsenic Trioxide|arsenic trioxide|mesh-list
5580112|NCT03855371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5580113|NCT03855371|Antimetabolites|antimetabolites|mesh-ancestor
6185852|NCT01817075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6185853|NCT01817075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6185854|NCT01817075|Disinfectants|disinfectants|mesh-ancestor
6185855|NCT01817075|Dermatologic Agents|dermatologic agents|mesh-ancestor
6185856|NCT01817530|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5580114|NCT03855371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5580115|NCT03855371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5580116|NCT03855371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5580117|NCT03855007|Hydroxychloroquine|hydroxychloroquine|mesh-list
5580118|NCT03855007|Prednisone|prednisone|mesh-list
5580119|NCT03855007|Methotrexate|methotrexate|mesh-list
5580120|NCT03855007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5580121|NCT03855007|Glucocorticoids|glucocorticoids|mesh-ancestor
5580122|NCT03855007|Hormones|hormones|mesh-ancestor
5580123|NCT03855007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5580124|NCT03855007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580125|NCT03855007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5580126|NCT03855007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5580127|NCT03855007|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5580128|NCT03855007|Abortifacient Agents|abortifacient agents|mesh-ancestor
5580129|NCT03855007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5580130|NCT03855007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5580131|NCT03855007|Antimetabolites|antimetabolites|mesh-ancestor
5580132|NCT03855007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5580133|NCT03855007|Dermatologic Agents|dermatologic agents|mesh-ancestor
5580134|NCT03855007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5580135|NCT03855007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5580136|NCT03855007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5580137|NCT03855007|Immunologic Factors|immunologic factors|mesh-ancestor
5580138|NCT03855007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5580139|NCT03855007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5580140|NCT03855007|Antimalarials|antimalarials|mesh-ancestor
6185857|NCT01817530|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6185858|NCT01817530|Norethindrone|norethindrone|mesh-list
6185859|NCT01817530|Norethindrone Acetate|norethindrone acetate|mesh-list
6185860|NCT01817530|Estradiol|estradiol|mesh-list
6185861|NCT01817530|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6185862|NCT01817530|Estrogens|estrogens|mesh-ancestor
6185863|NCT01817530|Hormones|hormones|mesh-ancestor
6185864|NCT01817530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6185865|NCT01817530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185866|NCT01817530|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5580141|NCT03855007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5580142|NCT03855007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5580143|NCT03855007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5580144|NCT03854799|Capecitabine|capecitabine|mesh-list
5580145|NCT03854799|Avelumab|avelumab|mesh-list
5580146|NCT03854799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5580147|NCT03854799|Antimetabolites|antimetabolites|mesh-ancestor
6185867|NCT01817530|Contraceptive Agents|contraceptive agents|mesh-ancestor
6185868|NCT01817530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6185869|NCT01817530|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6185870|NCT01817530|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6185871|NCT01817530|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6185872|NCT01817530|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6185873|NCT01817582|Loteprednol Etabonate|loteprednol etabonate|mesh-list
6185874|NCT01817582|Cyclosporine|cyclosporine|mesh-list
6185875|NCT01817582|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6185876|NCT01817582|Lubricant Eye Drops|lubricant eye drops|mesh-list
6185877|NCT01817582|Cyclosporins|cyclosporins|mesh-list
6185878|NCT01817582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6185879|NCT01817582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185880|NCT01817582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6185881|NCT01817582|Immunologic Factors|immunologic factors|mesh-ancestor
6185882|NCT01817582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6671999|NCT01552850|Sensory System Agents|sensory system agents|mesh-ancestor
6672000|NCT01552850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6672001|NCT01552863|Oxycodone|oxycodone|mesh-list
6185883|NCT01817582|Antifungal Agents|antifungal agents|mesh-ancestor
6185884|NCT01817582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6185885|NCT01817582|Dermatologic Agents|dermatologic agents|mesh-ancestor
6185886|NCT01817582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6185887|NCT01817582|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6185888|NCT01817582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6185889|NCT01817582|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6185890|NCT01817751|Sorafenib|sorafenib|mesh-list
6185891|NCT01817751|Sildenafil Citrate|sildenafil citrate|mesh-list
6185892|NCT01817751|Valproic Acid|valproic acid|mesh-list
6185893|NCT01817751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185894|NCT01817751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6185895|NCT01817751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5580148|NCT03854799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5580149|NCT03854799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5580150|NCT03854799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5580151|NCT03854929|Azithromycin|azithromycin|mesh-list
5580152|NCT03854929|Ciprofloxacin|ciprofloxacin|mesh-list
5580153|NCT03854929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5580154|NCT03854929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5580155|NCT03854929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5580156|NCT03854929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5580157|NCT03854929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5580158|NCT03854929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5580159|NCT03854929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5580160|NCT03854929|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5580161|NCT03854929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5580162|NCT03854812|Magnesium Sulfate|magnesium sulfate|mesh-list
5580163|NCT03854812|Fentanyl|fentanyl|mesh-list
5580164|NCT03854812|Propofol|propofol|mesh-list
5580165|NCT03854812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5580166|NCT03854812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5580167|NCT03854812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580168|NCT03854812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5580169|NCT03854812|Anesthetics, General|anesthetics, general|mesh-ancestor
5580170|NCT03854812|Anesthetics|anesthetics|mesh-ancestor
5580171|NCT03854812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5580172|NCT03854812|Narcotics|narcotics|mesh-ancestor
5580173|NCT03854812|Analgesics|analgesics|mesh-ancestor
5580174|NCT03854812|Sensory System Agents|sensory system agents|mesh-ancestor
5580175|NCT03854812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5580176|NCT03854812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5580177|NCT03854812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5580178|NCT03854812|Anticonvulsants|anticonvulsants|mesh-ancestor
6185896|NCT01817751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6185897|NCT01817751|Vasodilator Agents|vasodilator agents|mesh-ancestor
6185898|NCT01817751|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6185899|NCT01817751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6672002|NCT01552863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6185900|NCT01817751|Urological Agents|urological agents|mesh-ancestor
6185901|NCT01817751|Anticonvulsants|anticonvulsants|mesh-ancestor
6185902|NCT01817751|GABA Agents|gaba agents|mesh-ancestor
6185903|NCT01817751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6185904|NCT01817751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185905|NCT01817751|Antimanic Agents|antimanic agents|mesh-ancestor
6185906|NCT01817751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6185907|NCT01817751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6185908|NCT01817751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6185909|NCT01817764|Fluticasone|fluticasone|mesh-list
6185910|NCT01817764|Xhance|xhance|mesh-list
6185911|NCT01817764|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6185912|NCT01817764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6185913|NCT01817764|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6185914|NCT01817764|Autonomic Agents|autonomic agents|mesh-ancestor
6185915|NCT01817764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6185916|NCT01817764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185917|NCT01817764|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6185918|NCT01817764|Respiratory System Agents|respiratory system agents|mesh-ancestor
5580179|NCT03854812|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5580180|NCT03854812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5580181|NCT03854812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5580182|NCT03854812|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5580183|NCT03854812|Tocolytic Agents|tocolytic agents|mesh-ancestor
5580184|NCT03854812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5580185|NCT03854942|Naltrexone|naltrexone|mesh-list
5580186|NCT03854942|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5580187|NCT03854942|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5580188|NCT03854942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580189|NCT03854942|Sensory System Agents|sensory system agents|mesh-ancestor
5580190|NCT03854942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5580191|NCT03854708|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
5580192|NCT03854708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5580193|NCT03854708|Hormones|hormones|mesh-ancestor
5580194|NCT03854708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6185919|NCT01817764|Dermatologic Agents|dermatologic agents|mesh-ancestor
6185920|NCT01817764|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6185921|NCT01817764|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6185922|NCT01817764|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6185923|NCT01817764|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6185924|NCT01817764|Adrenergic Agents|adrenergic agents|mesh-ancestor
6185925|NCT01817764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5580195|NCT03854708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580196|NCT03854383|Isosorbide|isosorbide|mesh-list
5580197|NCT03854383|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
5580198|NCT03854383|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
5580199|NCT03854383|Misoprostol|misoprostol|mesh-list
5580200|NCT03854383|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5580201|NCT03854383|Abortifacient Agents|abortifacient agents|mesh-ancestor
5580202|NCT03854383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5580203|NCT03854383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580204|NCT03854383|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5580205|NCT03854383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5580206|NCT03854383|Oxytocics|oxytocics|mesh-ancestor
6185926|NCT01817764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185927|NCT01817777|Metformin|metformin|mesh-list
6185928|NCT01817777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6185929|NCT01817777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185930|NCT01817790|Fluticasone|fluticasone|mesh-list
6185931|NCT01817790|Xhance|xhance|mesh-list
6185932|NCT01817790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6185933|NCT01817790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6185934|NCT01817790|Autonomic Agents|autonomic agents|mesh-ancestor
6185935|NCT01817790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6185936|NCT01817790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580207|NCT03854383|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5580208|NCT03854383|Diuretics|diuretics|mesh-ancestor
5580209|NCT03854383|Natriuretic Agents|natriuretic agents|mesh-ancestor
5580210|NCT03854383|Vasodilator Agents|vasodilator agents|mesh-ancestor
5580211|NCT03854383|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5580212|NCT03854383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5580213|NCT03854617|Vinorelbine|vinorelbine|mesh-list
5580214|NCT03854617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5580215|NCT03854617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6185937|NCT01817790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6185938|NCT01817790|Respiratory System Agents|respiratory system agents|mesh-ancestor
6185939|NCT01817790|Dermatologic Agents|dermatologic agents|mesh-ancestor
6185940|NCT01817790|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5580216|NCT03854617|Tubulin Modulators|tubulin modulators|mesh-ancestor
5580217|NCT03854617|Antimitotic Agents|antimitotic agents|mesh-ancestor
5580218|NCT03854617|Mitosis Modulators|mitosis modulators|mesh-ancestor
5580219|NCT03854617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5580220|NCT03854409|Aripiprazole|aripiprazole|mesh-list
5580221|NCT03854409|Antidepressive Agents|antidepressive agents|mesh-ancestor
5580222|NCT03854409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5580223|NCT03854409|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5580224|NCT03854409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5580225|NCT03854409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5580226|NCT03854409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580227|NCT03854409|Dopamine Agonists|dopamine agonists|mesh-ancestor
5580228|NCT03854409|Dopamine Agents|dopamine agents|mesh-ancestor
5580229|NCT03854409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6185941|NCT01817855|AZD7624|azd7624|mesh-list
6185942|NCT01817855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6185943|NCT01817855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6185944|NCT01817855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185945|NCT01817907|Trazodone|trazodone|mesh-list
6185946|NCT01817907|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6185947|NCT01817907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6185948|NCT01817907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6185949|NCT01817907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185950|NCT01817907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6185951|NCT01817907|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6185952|NCT01817907|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6185953|NCT01817907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6185954|NCT01817907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185955|NCT01817907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6185956|NCT01817907|Serotonin Agents|serotonin agents|mesh-ancestor
6185957|NCT01817907|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6185958|NCT01817907|Antidepressive Agents|antidepressive agents|mesh-ancestor
6206884|NCT02106455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6206885|NCT02106455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206886|NCT02106455|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6206887|NCT02106455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206888|NCT02106455|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6206889|NCT02106494|Dexamethasone|dexamethasone|mesh-list
6206890|NCT02106494|Ondansetron|ondansetron|mesh-list
6206891|NCT02106494|Fosaprepitant|fosaprepitant|mesh-list
6206892|NCT02106494|Aprepitant|aprepitant|mesh-list
6206893|NCT02106494|Granisetron|granisetron|mesh-list
6206894|NCT02106494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6206895|NCT02106494|Antiemetics|antiemetics|mesh-ancestor
6206896|NCT02106494|Autonomic Agents|autonomic agents|mesh-ancestor
6206897|NCT02106494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6206898|NCT02106494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206899|NCT02106494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6206900|NCT02106494|Glucocorticoids|glucocorticoids|mesh-ancestor
6206901|NCT02106494|Hormones|hormones|mesh-ancestor
6206902|NCT02106494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6206903|NCT02106494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6206904|NCT02106494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6206905|NCT02106494|Antipruritics|antipruritics|mesh-ancestor
6206906|NCT02106494|Dermatologic Agents|dermatologic agents|mesh-ancestor
6206907|NCT02106494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6206908|NCT02106494|Serotonin Agents|serotonin agents|mesh-ancestor
6206909|NCT02106494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5580230|NCT03854409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5580231|NCT03854409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5580232|NCT03854409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5580233|NCT03854409|Serotonin Agents|serotonin agents|mesh-ancestor
5580234|NCT03854409|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5580235|NCT03854409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5580236|NCT03854409|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5580237|NCT03854409|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5580238|NCT03854344|Lidocaine|lidocaine|mesh-list
5580239|NCT03854344|Bupivacaine|bupivacaine|mesh-list
5580240|NCT03854344|Anesthetics, Local|anesthetics, local|mesh-ancestor
5580241|NCT03854344|Anesthetics|anesthetics|mesh-ancestor
5580242|NCT03854344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5580243|NCT03854344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185959|NCT01818063|Paclitaxel|paclitaxel|mesh-list
6185960|NCT01818063|Cyclophosphamide|cyclophosphamide|mesh-list
6185961|NCT01818063|Carboplatin|carboplatin|mesh-list
6185962|NCT01818063|Doxorubicin|doxorubicin|mesh-list
6185963|NCT01818063|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6185964|NCT01818063|Veliparib|veliparib|mesh-list
6185965|NCT01818063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6185966|NCT01818063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6185967|NCT01818063|Tubulin Modulators|tubulin modulators|mesh-ancestor
6185968|NCT01818063|Antimitotic Agents|antimitotic agents|mesh-ancestor
6185969|NCT01818063|Mitosis Modulators|mitosis modulators|mesh-ancestor
6185970|NCT01818063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185971|NCT01818063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6185972|NCT01818063|Immunologic Factors|immunologic factors|mesh-ancestor
6185973|NCT01818063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6185974|NCT01818063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6185975|NCT01818063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6185976|NCT01818063|Alkylating Agents|alkylating agents|mesh-ancestor
6185977|NCT01818063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6185978|NCT01818063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6185979|NCT01818063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6185980|NCT01818063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6185981|NCT01818063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6185982|NCT01818063|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6185983|NCT01818141|Vancomycin|vancomycin|mesh-list
6185984|NCT01818141|Fidaxomicin|fidaxomicin|mesh-list
6185985|NCT01818141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6185986|NCT01818141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6185987|NCT01818258|Ritonavir|ritonavir|mesh-list
6185988|NCT01818258|Lopinavir|lopinavir|mesh-list
6185989|NCT01818258|Lamivudine|lamivudine|mesh-list
6185990|NCT01818258|Zidovudine|zidovudine|mesh-list
6185991|NCT01818258|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6185992|NCT01818258|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6185993|NCT01818258|Protease Inhibitors|protease inhibitors|mesh-ancestor
5580244|NCT03854344|Sensory System Agents|sensory system agents|mesh-ancestor
6185994|NCT01818258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6185995|NCT01818258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6185996|NCT01818258|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6185997|NCT01818258|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6185998|NCT01818258|Antiviral Agents|antiviral agents|mesh-ancestor
6185999|NCT01818258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6186000|NCT01818258|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6186001|NCT01818258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6186002|NCT01818258|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6186003|NCT01818258|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6186004|NCT01818258|Antimetabolites|antimetabolites|mesh-ancestor
6186005|NCT01818284|Plerixafor|plerixafor|mesh-list
6186006|NCT01818284|Lenograstim|lenograstim|mesh-list
6186007|NCT01818284|Sargramostim|sargramostim|mesh-list
6186008|NCT01818284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6186009|NCT01818284|Immunologic Factors|immunologic factors|mesh-ancestor
6186010|NCT01818284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186011|NCT01818284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6186012|NCT01818284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6186013|NCT01818284|Antiviral Agents|antiviral agents|mesh-ancestor
6186014|NCT01818284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6186015|NCT01818336|Amoxicillin|amoxicillin|mesh-list
5580245|NCT03854344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5580246|NCT03854344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5580247|NCT03854344|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5580248|NCT03854344|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5580249|NCT03854344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6186016|NCT01818336|Penicillins|penicillins|mesh-list
6186017|NCT01818336|Penicillin G|penicillin g|mesh-list
6488190|NCT00581165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6186018|NCT01818336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6186019|NCT01818336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5580250|NCT03854344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604850|NCT04084626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5604851|NCT04084626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5604852|NCT04084626|Growth Substances|growth substances|mesh-ancestor
5604853|NCT04084626|Growth Inhibitors|growth inhibitors|mesh-ancestor
5604854|NCT04084626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5604855|NCT04082533|Hydrocortisone|hydrocortisone|mesh-list
5604856|NCT04082533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5604857|NCT04081337|Tirzepatide|tirzepatide|mesh-list
5604858|NCT04081337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5604859|NCT04081337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604860|NCT04081337|Incretins|incretins|mesh-ancestor
5604861|NCT04081337|Hormones|hormones|mesh-ancestor
5604862|NCT04081337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6186020|NCT01818414|Vitamins|vitamins|mesh-list
6186021|NCT01818414|Folic Acid|folic acid|mesh-list
6186022|NCT01818414|Misoprostol|misoprostol|mesh-list
6186023|NCT01818414|Micronutrients|micronutrients|mesh-ancestor
6186024|NCT01818414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186025|NCT01818414|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6186026|NCT01818414|Abortifacient Agents|abortifacient agents|mesh-ancestor
6186027|NCT01818414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6186028|NCT01818414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6186029|NCT01818414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6186030|NCT01818414|Oxytocics|oxytocics|mesh-ancestor
6186031|NCT01818414|Hematinics|hematinics|mesh-ancestor
6186032|NCT01818414|Vitamin B Complex|vitamin b complex|mesh-ancestor
6186033|NCT01818596|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6186034|NCT01818596|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6186035|NCT01818596|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6186036|NCT01818596|Antiviral Agents|antiviral agents|mesh-ancestor
6186037|NCT01818596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6186038|NCT01818700|Buprenorphine|buprenorphine|mesh-list
6186039|NCT01818700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6186040|NCT01818700|Narcotics|narcotics|mesh-ancestor
6186041|NCT01818700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6186042|NCT01818700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186043|NCT01818700|Analgesics|analgesics|mesh-ancestor
6186044|NCT01818700|Sensory System Agents|sensory system agents|mesh-ancestor
6186045|NCT01818700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6186046|NCT01818700|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6186047|NCT01818726|Deferasirox|deferasirox|mesh-list
6186048|NCT01818726|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6186049|NCT01818726|Chelating Agents|chelating agents|mesh-ancestor
6186050|NCT01818726|Sequestering Agents|sequestering agents|mesh-ancestor
6186051|NCT01818726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186052|NCT01818739|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6186053|NCT01818752|Prednisone|prednisone|mesh-list
6186054|NCT01818752|Bortezomib|bortezomib|mesh-list
6186055|NCT01818752|Melphalan|melphalan|mesh-list
6186056|NCT01818752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6186057|NCT01818752|Glucocorticoids|glucocorticoids|mesh-ancestor
6186058|NCT01818752|Hormones|hormones|mesh-ancestor
6186059|NCT01818752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6186060|NCT01818752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186061|NCT01818752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6186062|NCT01818752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6186063|NCT01818752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6186064|NCT01818752|Alkylating Agents|alkylating agents|mesh-ancestor
6186065|NCT01818752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604863|NCT04078568|Aspirin|aspirin|mesh-list
5604864|NCT04078568|Prednisolone|prednisolone|mesh-list
6186066|NCT01818752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6186067|NCT01818752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6186068|NCT01818752|Immunologic Factors|immunologic factors|mesh-ancestor
6186069|NCT01819129|Insulin|insulin|mesh-list
6186070|NCT01819129|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6186071|NCT01819129|Insulin Glargine|insulin glargine|mesh-list
6186072|NCT01819129|Insulin Aspart|insulin aspart|mesh-list
6186073|NCT01819129|Insulin, Long-Acting|insulin, long-acting|mesh-list
6186074|NCT01819129|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6186075|NCT01819129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6186076|NCT01819129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580251|NCT03854396|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
5580252|NCT03854396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5580253|NCT03854396|Immunologic Factors|immunologic factors|mesh-ancestor
5580254|NCT03854396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580255|NCT03854266|Heparin|heparin|mesh-list
5580256|NCT03854266|Calcium heparin|calcium heparin|mesh-list
5580257|NCT03854266|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6186077|NCT01819415|Bevacizumab|bevacizumab|mesh-list
6186078|NCT01819415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6186079|NCT01819415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6186080|NCT01819415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6186081|NCT01819415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6186082|NCT01819415|Growth Substances|growth substances|mesh-ancestor
6186083|NCT01819415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186084|NCT01819415|Growth Inhibitors|growth inhibitors|mesh-ancestor
6186085|NCT01819935|Vancomycin|vancomycin|mesh-list
6186086|NCT01819935|Linezolid|linezolid|mesh-list
6186087|NCT01819935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6186088|NCT01819935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6186089|NCT01819935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6186090|NCT01819935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6186091|NCT01819935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186092|NCT01820559|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
6186093|NCT01820559|Anticonvulsants|anticonvulsants|mesh-ancestor
6186094|NCT01820559|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6186095|NCT01820559|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6186096|NCT01820559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6186097|NCT01820559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186098|NCT01820572|Cyclosporine|cyclosporine|mesh-list
6186099|NCT01820572|Abatacept|abatacept|mesh-list
6186100|NCT01820572|Tacrolimus|tacrolimus|mesh-list
6186101|NCT01820572|Cyclosporins|cyclosporins|mesh-list
6186102|NCT01820572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6186103|NCT01820572|Immunologic Factors|immunologic factors|mesh-ancestor
6186104|NCT01820572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186105|NCT01820572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6186106|NCT01820572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6186107|NCT01820572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186108|NCT01820572|Antifungal Agents|antifungal agents|mesh-ancestor
6186109|NCT01820572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6186110|NCT01820572|Dermatologic Agents|dermatologic agents|mesh-ancestor
6186111|NCT01820572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6186112|NCT01820572|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6186113|NCT01820572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6186114|NCT01820585|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
6186115|NCT01820585|Anticonvulsants|anticonvulsants|mesh-ancestor
6186116|NCT01820585|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6186117|NCT01820585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6186118|NCT01820585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6186119|NCT01820585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186120|NCT01820637|Paclitaxel|paclitaxel|mesh-list
6186121|NCT01820637|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6186122|NCT01820637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5580258|NCT03854266|Anticoagulants|anticoagulants|mesh-ancestor
6186123|NCT01820637|Tubulin Modulators|tubulin modulators|mesh-ancestor
6186124|NCT01820637|Antimitotic Agents|antimitotic agents|mesh-ancestor
6186125|NCT01820637|Mitosis Modulators|mitosis modulators|mesh-ancestor
6186126|NCT01820637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186127|NCT01820754|Paclitaxel|paclitaxel|mesh-list
6186128|NCT01820754|Carboplatin|carboplatin|mesh-list
6186129|NCT01820754|Ipilimumab|ipilimumab|mesh-list
6186130|NCT01820754|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6186131|NCT01820754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6186132|NCT01820754|Tubulin Modulators|tubulin modulators|mesh-ancestor
6186133|NCT01820754|Antimitotic Agents|antimitotic agents|mesh-ancestor
6186134|NCT01820754|Mitosis Modulators|mitosis modulators|mesh-ancestor
6186135|NCT01820754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186136|NCT01820754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6186137|NCT01820754|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6186138|NCT01821105|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6186139|NCT01821105|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6186140|NCT01821105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186141|NCT01821378|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
6186142|NCT01821378|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6186143|NCT01821378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6186144|NCT01821378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6186145|NCT01821378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186146|NCT01821378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6186147|NCT01821378|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6186148|NCT01821378|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6186149|NCT01821378|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6186150|NCT01821378|Adrenergic Agents|adrenergic agents|mesh-ancestor
6186151|NCT01821378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6186152|NCT01821378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186153|NCT01821378|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6186154|NCT01821378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6186155|NCT01821378|Serotonin Agents|serotonin agents|mesh-ancestor
6186156|NCT01821378|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6186157|NCT01821378|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6186158|NCT01821378|Dopamine Agents|dopamine agents|mesh-ancestor
6186159|NCT01821391|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
6186160|NCT01821391|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6186161|NCT01821391|Dermatologic Agents|dermatologic agents|mesh-ancestor
6186162|NCT01821560|Baclofen|baclofen|mesh-list
6186163|NCT01821560|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6186164|NCT01821560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186165|NCT01821560|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6186166|NCT01821560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6186167|NCT01821560|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6186168|NCT01821560|GABA Agonists|gaba agonists|mesh-ancestor
6186169|NCT01821560|GABA Agents|gaba agents|mesh-ancestor
5580259|NCT03854266|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5580260|NCT03854266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5580261|NCT03854266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5580262|NCT03854175|Sildenafil Citrate|sildenafil citrate|mesh-list
5580263|NCT03854175|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5580264|NCT03854175|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5580265|NCT03854175|Estradiol|estradiol|mesh-list
5580266|NCT03854175|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5580267|NCT03854175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5580268|NCT03854175|Estrogens|estrogens|mesh-ancestor
5580269|NCT03854175|Hormones|hormones|mesh-ancestor
5580270|NCT03854175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5580271|NCT03854175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580272|NCT03854175|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5580273|NCT03854175|Contraceptive Agents|contraceptive agents|mesh-ancestor
5580274|NCT03854175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5580275|NCT03854175|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5580276|NCT03854175|Vasodilator Agents|vasodilator agents|mesh-ancestor
5580277|NCT03854175|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5580278|NCT03854175|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5580279|NCT03854175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5580280|NCT03854175|Urological Agents|urological agents|mesh-ancestor
5580281|NCT03853954|Methoxyflurane|methoxyflurane|mesh-list
5580282|NCT03853954|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5580283|NCT03853954|Anesthetics, General|anesthetics, general|mesh-ancestor
5580284|NCT03853954|Anesthetics|anesthetics|mesh-ancestor
5580285|NCT03853954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6186170|NCT01821560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6186171|NCT01821560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186172|NCT01821729|Leucovorin|leucovorin|mesh-list
6186173|NCT01821729|Fluorouracil|fluorouracil|mesh-list
6186174|NCT01821729|Oxaliplatin|oxaliplatin|mesh-list
6186175|NCT01821729|Folfirinox|folfirinox|mesh-list
5580286|NCT03853954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580287|NCT03853993|Vaccines|vaccines|mesh-list
5580288|NCT03853993|Immunologic Factors|immunologic factors|mesh-ancestor
5580289|NCT03853993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580290|NCT03853785|Podophyllin|podophyllin|mesh-list
5580291|NCT03853785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5580292|NCT03853785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5580293|NCT03853785|Keratolytic Agents|keratolytic agents|mesh-ancestor
5580294|NCT03853785|Dermatologic Agents|dermatologic agents|mesh-ancestor
5580295|NCT03853707|Paclitaxel|paclitaxel|mesh-list
5580296|NCT03853707|Carboplatin|carboplatin|mesh-list
5580297|NCT03853707|Capecitabine|capecitabine|mesh-list
5580298|NCT03853707|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5580299|NCT03853707|Atezolizumab|atezolizumab|mesh-list
5580300|NCT03853707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5580301|NCT03853707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5580302|NCT03853707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5580303|NCT03853707|Tubulin Modulators|tubulin modulators|mesh-ancestor
5580304|NCT03853707|Antimitotic Agents|antimitotic agents|mesh-ancestor
5580305|NCT03853707|Mitosis Modulators|mitosis modulators|mesh-ancestor
5580306|NCT03853707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5580307|NCT03853707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5580308|NCT03853707|Antimetabolites|antimetabolites|mesh-ancestor
5580309|NCT03853707|Immunologic Factors|immunologic factors|mesh-ancestor
5580310|NCT03853707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580311|NCT03853525|Petrolatum|petrolatum|mesh-list
5580312|NCT03853525|Emollients|emollients|mesh-ancestor
5580313|NCT03853525|Dermatologic Agents|dermatologic agents|mesh-ancestor
5580314|NCT03853746|Ocrelizumab|ocrelizumab|mesh-list
5580315|NCT03853746|Immunologic Factors|immunologic factors|mesh-ancestor
5580316|NCT03853746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580317|NCT03853642|Nitric Oxide|nitric oxide|mesh-list
5580318|NCT03853642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5580319|NCT03853642|Autonomic Agents|autonomic agents|mesh-ancestor
5580320|NCT03853642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5580321|NCT03853642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186176|NCT01821729|Losartan|losartan|mesh-list
6186177|NCT01821729|Antimetabolites|antimetabolites|mesh-ancestor
6186178|NCT01821729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186179|NCT01821729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6186180|NCT01821729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6186181|NCT01821729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6186182|NCT01821729|Immunologic Factors|immunologic factors|mesh-ancestor
6186183|NCT01821729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186184|NCT01821729|Antidotes|antidotes|mesh-ancestor
6186185|NCT01821729|Protective Agents|protective agents|mesh-ancestor
6186186|NCT01821729|Vitamin B Complex|vitamin b complex|mesh-ancestor
6186187|NCT01821729|Vitamins|vitamins|mesh-ancestor
6186188|NCT01821729|Micronutrients|micronutrients|mesh-ancestor
6186189|NCT01821729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6186190|NCT01821729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6186191|NCT01821729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6186192|NCT01821729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6186193|NCT01822132|Naltrexone|naltrexone|mesh-list
6186194|NCT01822132|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6186195|NCT01822132|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6186196|NCT01822132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580322|NCT03853642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5580323|NCT03853642|Respiratory System Agents|respiratory system agents|mesh-ancestor
5580324|NCT03853642|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5580325|NCT03853642|Antioxidants|antioxidants|mesh-ancestor
5580326|NCT03853642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5580327|NCT03853642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5580328|NCT03853642|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5580329|NCT03853642|Vasodilator Agents|vasodilator agents|mesh-ancestor
5580330|NCT03853642|Gasotransmitters|gasotransmitters|mesh-ancestor
5580331|NCT03853642|Protective Agents|protective agents|mesh-ancestor
5580332|NCT03853538|Petrolatum|petrolatum|mesh-list
5580333|NCT03853538|Emollients|emollients|mesh-ancestor
6186197|NCT01822132|Sensory System Agents|sensory system agents|mesh-ancestor
6186198|NCT01822132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5580334|NCT03853538|Dermatologic Agents|dermatologic agents|mesh-ancestor
5580335|NCT03853694|Morphine|morphine|mesh-list
5580336|NCT03853694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5580337|NCT03853694|Narcotics|narcotics|mesh-ancestor
5580338|NCT03853694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5580339|NCT03853694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186199|NCT01822496|Paclitaxel|paclitaxel|mesh-list
6186200|NCT01822496|Etoposide|etoposide|mesh-list
6186201|NCT01822496|Podophyllotoxin|podophyllotoxin|mesh-list
6186202|NCT01822496|Cisplatin|cisplatin|mesh-list
6186203|NCT01822496|Carboplatin|carboplatin|mesh-list
6186204|NCT01822496|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6186205|NCT01822496|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6186206|NCT01822496|Etoposide phosphate|etoposide phosphate|mesh-list
6186207|NCT01822496|Crizotinib|crizotinib|mesh-list
6186208|NCT01822496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6186209|NCT01822496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6186210|NCT01822496|Tubulin Modulators|tubulin modulators|mesh-ancestor
6186211|NCT01822496|Antimitotic Agents|antimitotic agents|mesh-ancestor
6186212|NCT01822496|Mitosis Modulators|mitosis modulators|mesh-ancestor
6186213|NCT01822496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186214|NCT01822496|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6186215|NCT01822496|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6186216|NCT01822496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6186217|NCT01822496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6186218|NCT01822496|Keratolytic Agents|keratolytic agents|mesh-ancestor
6186219|NCT01822496|Dermatologic Agents|dermatologic agents|mesh-ancestor
6186220|NCT01822535|Midodrine|midodrine|mesh-list
6186221|NCT01822535|Sympathomimetics|sympathomimetics|mesh-ancestor
6186222|NCT01822535|Autonomic Agents|autonomic agents|mesh-ancestor
6186223|NCT01822535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6186224|NCT01822535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580340|NCT03853694|Analgesics|analgesics|mesh-ancestor
5580341|NCT03853694|Sensory System Agents|sensory system agents|mesh-ancestor
5580342|NCT03853694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5580343|NCT03853304|Folic Acid|folic acid|mesh-list
5580344|NCT03853304|Vitamin B 12|vitamin b 12|mesh-list
5580345|NCT03853304|Hydroxocobalamin|hydroxocobalamin|mesh-list
5580346|NCT03853304|Vitamins|vitamins|mesh-ancestor
5580347|NCT03853304|Micronutrients|micronutrients|mesh-ancestor
5580348|NCT03853304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580349|NCT03853304|Hematinics|hematinics|mesh-ancestor
5580350|NCT03853304|Vitamin B Complex|vitamin b complex|mesh-ancestor
5580351|NCT03853512|Petrolatum|petrolatum|mesh-list
5580352|NCT03853512|Emollients|emollients|mesh-ancestor
5580353|NCT03853512|Dermatologic Agents|dermatologic agents|mesh-ancestor
5580354|NCT03853369|Nifekalant|nifekalant|mesh-list
5580355|NCT03853369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5580356|NCT03853395|Antibodies|antibodies|mesh-list
5580357|NCT03853395|Immunologic Factors|immunologic factors|mesh-ancestor
5580358|NCT03853395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580359|NCT03853330|Bupivacaine|bupivacaine|mesh-list
5580360|NCT03853330|Anesthetics, Local|anesthetics, local|mesh-ancestor
5580361|NCT03853330|Anesthetics|anesthetics|mesh-ancestor
5580362|NCT03853330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5580363|NCT03853330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580364|NCT03853330|Sensory System Agents|sensory system agents|mesh-ancestor
5580365|NCT03853330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5580366|NCT03853200|Chlorhexidine|chlorhexidine|mesh-list
5580367|NCT03853200|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5580368|NCT03853200|Acetic Acid|acetic acid|mesh-list
5580369|NCT03853200|Root Canal Irrigants|root canal irrigants|mesh-list
5580370|NCT03853200|Edetic Acid|edetic acid|mesh-list
5580371|NCT03853200|Pentetic Acid|pentetic acid|mesh-list
5580372|NCT03853200|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5580373|NCT03853200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5580374|NCT03853200|Disinfectants|disinfectants|mesh-ancestor
5580375|NCT03853200|Dermatologic Agents|dermatologic agents|mesh-ancestor
5580376|NCT03853200|Anticoagulants|anticoagulants|mesh-ancestor
5580377|NCT03853200|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5580378|NCT03853200|Chelating Agents|chelating agents|mesh-ancestor
5580379|NCT03853200|Sequestering Agents|sequestering agents|mesh-ancestor
5580380|NCT03853200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5580381|NCT03853200|Antidotes|antidotes|mesh-ancestor
5580382|NCT03853200|Protective Agents|protective agents|mesh-ancestor
5580383|NCT03853200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580384|NCT03853200|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5580385|NCT03853200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5580386|NCT03853200|Dental Disinfectants|dental disinfectants|mesh-ancestor
5580387|NCT03853096|Cefazolin|cefazolin|mesh-list
5580388|NCT03853096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6186225|NCT01822535|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6489033|NCT00588913|Antiviral Agents|antiviral agents|mesh-ancestor
6186226|NCT01822535|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6186227|NCT01822535|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6186228|NCT01822535|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6186229|NCT01822535|Adrenergic Agents|adrenergic agents|mesh-ancestor
6186230|NCT01822535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6186231|NCT01822535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186232|NCT01822548|Metformin|metformin|mesh-list
6186233|NCT01822548|Vildagliptin|vildagliptin|mesh-list
6186234|NCT01822548|Glyburide|glyburide|mesh-list
6186235|NCT01822548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6186236|NCT01822548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186237|NCT01822548|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6186238|NCT01822548|Protease Inhibitors|protease inhibitors|mesh-ancestor
6186239|NCT01822548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6186240|NCT01822548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186241|NCT01822561|Eplerenone|eplerenone|mesh-list
6186242|NCT01822561|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6672003|NCT01552863|Narcotics|narcotics|mesh-ancestor
6672004|NCT01552863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6672005|NCT01552863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672006|NCT01552863|Analgesics|analgesics|mesh-ancestor
6672007|NCT01552863|Sensory System Agents|sensory system agents|mesh-ancestor
5580389|NCT03853096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6186243|NCT01822561|Hormone Antagonists|hormone antagonists|mesh-ancestor
6186244|NCT01822561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6186245|NCT01822561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186246|NCT01822561|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6186247|NCT01822561|Diuretics|diuretics|mesh-ancestor
6186248|NCT01822561|Natriuretic Agents|natriuretic agents|mesh-ancestor
6186249|NCT01822561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6186250|NCT01822587|Propranolol|propranolol|mesh-list
6186251|NCT01822587|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5580390|NCT03852979|Paclitaxel|paclitaxel|mesh-list
5580391|NCT03852979|Carboplatin|carboplatin|mesh-list
5580392|NCT03852979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5580393|NCT03852979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5580394|NCT03852979|Tubulin Modulators|tubulin modulators|mesh-ancestor
6186252|NCT01822587|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6186253|NCT01822587|Adrenergic Agents|adrenergic agents|mesh-ancestor
6186254|NCT01822587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6186255|NCT01822587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186256|NCT01822587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186257|NCT01822587|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6186258|NCT01822587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6186259|NCT01822587|Vasodilator Agents|vasodilator agents|mesh-ancestor
6186260|NCT01822665|Acetaminophen|acetaminophen|mesh-list
6186261|NCT01822665|Ibuprofen|ibuprofen|mesh-list
6186262|NCT01822665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6186263|NCT01822665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6186264|NCT01822665|Analgesics|analgesics|mesh-ancestor
6186265|NCT01822665|Sensory System Agents|sensory system agents|mesh-ancestor
6186266|NCT01822665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6186267|NCT01822665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186268|NCT01822665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6186269|NCT01822665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6186270|NCT01822665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6186271|NCT01822665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6186272|NCT01822665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5580395|NCT03852979|Antimitotic Agents|antimitotic agents|mesh-ancestor
5580396|NCT03852979|Mitosis Modulators|mitosis modulators|mesh-ancestor
5580397|NCT03852979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5580398|NCT03852992|Minoxidil|minoxidil|mesh-list
5580399|NCT03852992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5580400|NCT03852992|Vasodilator Agents|vasodilator agents|mesh-ancestor
5580401|NCT03852914|Hyaluronic Acid|hyaluronic acid|mesh-list
5580402|NCT03852914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5580403|NCT03852914|Immunologic Factors|immunologic factors|mesh-ancestor
5580404|NCT03852914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580405|NCT03852914|Viscosupplements|viscosupplements|mesh-ancestor
5580406|NCT03852914|Protective Agents|protective agents|mesh-ancestor
5580407|NCT03853044|Prednisone|prednisone|mesh-list
5580408|NCT03853044|Cyclophosphamide|cyclophosphamide|mesh-list
5580409|NCT03853044|Doxorubicin|doxorubicin|mesh-list
5580410|NCT03853044|Vincristine|vincristine|mesh-list
5580411|NCT03853044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5580412|NCT03853044|Immunologic Factors|immunologic factors|mesh-ancestor
5580413|NCT03853044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580414|NCT03853044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5580415|NCT03853044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5580416|NCT03853044|Alkylating Agents|alkylating agents|mesh-ancestor
5580417|NCT03853044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5580418|NCT03853044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5580419|NCT03853044|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5580420|NCT03853044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5580421|NCT03853044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5580422|NCT03853044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6186273|NCT01822665|Antipyretics|antipyretics|mesh-ancestor
6186274|NCT01822678|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
6186275|NCT01822678|Anticonvulsants|anticonvulsants|mesh-ancestor
6186276|NCT01822678|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6186277|NCT01822678|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6186278|NCT01822678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6186279|NCT01822678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186280|NCT01822756|Gemcitabine|gemcitabine|mesh-list
6186281|NCT01822756|Paclitaxel|paclitaxel|mesh-list
6186282|NCT01822756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6186283|NCT01822756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6186284|NCT01822756|Tubulin Modulators|tubulin modulators|mesh-ancestor
6186285|NCT01822756|Antimitotic Agents|antimitotic agents|mesh-ancestor
6186286|NCT01822756|Mitosis Modulators|mitosis modulators|mesh-ancestor
6186287|NCT01822756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186288|NCT01822756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6186289|NCT01822756|Antimetabolites|antimetabolites|mesh-ancestor
6186290|NCT01822756|Antiviral Agents|antiviral agents|mesh-ancestor
6186291|NCT01822756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6186292|NCT01822756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6186293|NCT01822756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6186294|NCT01822756|Immunologic Factors|immunologic factors|mesh-ancestor
6186295|NCT01822756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186296|NCT01822821|Acetaminophen|acetaminophen|mesh-list
6186297|NCT01822821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6186298|NCT01822821|Analgesics|analgesics|mesh-ancestor
6186299|NCT01822821|Sensory System Agents|sensory system agents|mesh-ancestor
6186300|NCT01822821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6186301|NCT01822821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186302|NCT01822821|Antipyretics|antipyretics|mesh-ancestor
6186303|NCT01822886|Gemcitabine|gemcitabine|mesh-list
6186304|NCT01822886|Romidepsin|romidepsin|mesh-list
6186305|NCT01822886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6186306|NCT01822886|Antimetabolites|antimetabolites|mesh-ancestor
6186307|NCT01822886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186308|NCT01822886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6186309|NCT01822886|Antiviral Agents|antiviral agents|mesh-ancestor
6186310|NCT01822886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6186311|NCT01822886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6186312|NCT01822886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5580423|NCT03853044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5580424|NCT03853044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5580425|NCT03853044|Glucocorticoids|glucocorticoids|mesh-ancestor
5580426|NCT03853044|Hormones|hormones|mesh-ancestor
5580427|NCT03853044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5580428|NCT03853044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6186313|NCT01822886|Immunologic Factors|immunologic factors|mesh-ancestor
6186314|NCT01822886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186315|NCT01822886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6186316|NCT01822899|Fluticasone|fluticasone|mesh-list
6186317|NCT01822899|Xhance|xhance|mesh-list
6186318|NCT01822899|Bromides|bromides|mesh-list
6186319|NCT01822899|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6186320|NCT01822899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6186321|NCT01822899|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6186322|NCT01822899|Autonomic Agents|autonomic agents|mesh-ancestor
6186323|NCT01822899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6186324|NCT01822899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186325|NCT01822899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6186326|NCT01822899|Respiratory System Agents|respiratory system agents|mesh-ancestor
6186327|NCT01822899|Dermatologic Agents|dermatologic agents|mesh-ancestor
6186328|NCT01822899|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6186329|NCT01822899|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6186330|NCT01822899|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6186331|NCT01822899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6186332|NCT01822899|Adrenergic Agents|adrenergic agents|mesh-ancestor
6186333|NCT01822899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6186334|NCT01822899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186335|NCT01822899|Anticonvulsants|anticonvulsants|mesh-ancestor
6186336|NCT01823146|Oxytocin|oxytocin|mesh-list
6186337|NCT01823146|Oxytocics|oxytocics|mesh-ancestor
5580429|NCT03853044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5580430|NCT03853044|Tubulin Modulators|tubulin modulators|mesh-ancestor
5580431|NCT03853044|Antimitotic Agents|antimitotic agents|mesh-ancestor
5580432|NCT03853044|Mitosis Modulators|mitosis modulators|mesh-ancestor
5580433|NCT03852797|Ketamine|ketamine|mesh-list
5580434|NCT03852797|Propofol|propofol|mesh-list
5580435|NCT03852797|Etomidate|etomidate|mesh-list
5580436|NCT03852797|Oxytocin|oxytocin|mesh-list
5580437|NCT03852797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5580438|NCT03852797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5580439|NCT03852797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580440|NCT03852797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6186338|NCT01823146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6186339|NCT01823146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186340|NCT01823224|Acetaminophen|acetaminophen|mesh-list
6186341|NCT01823224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6186342|NCT01823224|Analgesics|analgesics|mesh-ancestor
6186343|NCT01823224|Sensory System Agents|sensory system agents|mesh-ancestor
6186344|NCT01823224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6186345|NCT01823224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186346|NCT01823224|Antipyretics|antipyretics|mesh-ancestor
5580441|NCT03852797|Anesthetics, General|anesthetics, general|mesh-ancestor
5580442|NCT03852797|Anesthetics|anesthetics|mesh-ancestor
5580443|NCT03852797|Analgesics|analgesics|mesh-ancestor
5580444|NCT03852797|Sensory System Agents|sensory system agents|mesh-ancestor
5580445|NCT03852797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5580446|NCT03852797|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5580447|NCT03852797|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5580448|NCT03852797|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5580449|NCT03852797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5580450|NCT03852797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5580451|NCT03852797|Oxytocics|oxytocics|mesh-ancestor
5580452|NCT03852797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5604865|NCT04078568|Immunoglobulins|immunoglobulins|mesh-list
5604866|NCT04078568|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5604867|NCT04078568|gamma-Globulins|gamma-globulins|mesh-list
5604868|NCT04078568|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5604869|NCT04078568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5604870|NCT04078568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5604871|NCT04078568|Analgesics|analgesics|mesh-ancestor
6186347|NCT01823289|Itraconazole|itraconazole|mesh-list
6186348|NCT01823289|Antifungal Agents|antifungal agents|mesh-ancestor
6186349|NCT01823289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6186350|NCT01823289|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6186351|NCT01823289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5604872|NCT04078568|Sensory System Agents|sensory system agents|mesh-ancestor
5604873|NCT04078568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5604874|NCT04078568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604875|NCT04078568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5604876|NCT04078568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5604877|NCT04078568|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5604878|NCT04078568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5604879|NCT04078568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604880|NCT04078568|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5604881|NCT04078568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5604882|NCT04078568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5604883|NCT04078568|Antipyretics|antipyretics|mesh-ancestor
5604884|NCT04078568|Glucocorticoids|glucocorticoids|mesh-ancestor
5604885|NCT04078568|Hormones|hormones|mesh-ancestor
6186352|NCT01823289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5580453|NCT03852628|Naltrexone|naltrexone|mesh-list
5580454|NCT03852628|Buprenorphine|buprenorphine|mesh-list
5580455|NCT03852628|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6186353|NCT01823289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672008|NCT01552863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6672009|NCT01552967|Capecitabine|capecitabine|mesh-list
6672010|NCT01552967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6672011|NCT01552967|Antimetabolites|antimetabolites|mesh-ancestor
6672012|NCT01552967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672013|NCT01552967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6672014|NCT01552980|Oxaliplatin|oxaliplatin|mesh-list
6672015|NCT01552980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6672016|NCT01552993|Acetaminophen|acetaminophen|mesh-list
6672017|NCT01552993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6672018|NCT01552993|Analgesics|analgesics|mesh-ancestor
5580456|NCT03852628|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5580457|NCT03852628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580458|NCT03852628|Sensory System Agents|sensory system agents|mesh-ancestor
5580459|NCT03852628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5580460|NCT03852628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6672019|NCT01552993|Sensory System Agents|sensory system agents|mesh-ancestor
6672020|NCT01552993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5580461|NCT03852628|Narcotics|narcotics|mesh-ancestor
6186354|NCT01823289|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6186355|NCT01823289|Hormone Antagonists|hormone antagonists|mesh-ancestor
6186356|NCT01823289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6186357|NCT01823289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186358|NCT01823289|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6186359|NCT01823328|Ketamine|ketamine|mesh-list
6186360|NCT01823328|Etomidate|etomidate|mesh-list
6186361|NCT01823328|Analgesics|analgesics|mesh-ancestor
6186362|NCT01823328|Sensory System Agents|sensory system agents|mesh-ancestor
6186363|NCT01823328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6186364|NCT01823328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186365|NCT01823328|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6186366|NCT01823328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6186367|NCT01823328|Anesthetics, General|anesthetics, general|mesh-ancestor
6186368|NCT01823328|Anesthetics|anesthetics|mesh-ancestor
6186369|NCT01823328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6186370|NCT01823328|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6186371|NCT01823328|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6186372|NCT01823328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6186373|NCT01823328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186374|NCT01823328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6186375|NCT01823497|Morphine|morphine|mesh-list
6186376|NCT01823497|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6186377|NCT01823497|Narcotics|narcotics|mesh-ancestor
6186378|NCT01823497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6186379|NCT01823497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186380|NCT01823497|Analgesics|analgesics|mesh-ancestor
6186381|NCT01823497|Sensory System Agents|sensory system agents|mesh-ancestor
6186382|NCT01823497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5580462|NCT03852628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5580463|NCT03852628|Analgesics|analgesics|mesh-ancestor
5580464|NCT03852303|Ivermectin|ivermectin|mesh-list
5580465|NCT03852303|Anticonvulsants|anticonvulsants|mesh-list
5580466|NCT03852303|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5580467|NCT03852303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5580468|NCT03852602|Analgesics|analgesics|mesh-list
5580469|NCT03852602|Sensory System Agents|sensory system agents|mesh-ancestor
5580470|NCT03852602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5580471|NCT03852602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580472|NCT03852446|Tryptophan|tryptophan|mesh-list
5580473|NCT03852446|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5580474|NCT03852446|Antidepressive Agents|antidepressive agents|mesh-ancestor
5580475|NCT03852446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5580476|NCT03852407|Cyclophosphamide|cyclophosphamide|mesh-list
5580477|NCT03852407|Melphalan|melphalan|mesh-list
5580478|NCT03852407|Fludarabine|fludarabine|mesh-list
6186383|NCT01823510|Aspirin|aspirin|mesh-list
6186384|NCT01823510|Clopidogrel|clopidogrel|mesh-list
6186385|NCT01823510|Ticagrelor|ticagrelor|mesh-list
5580479|NCT03852407|Thymoglobulin|thymoglobulin|mesh-list
5580480|NCT03852407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6672021|NCT01552993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580481|NCT03852407|Immunologic Factors|immunologic factors|mesh-ancestor
5580482|NCT03852407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186386|NCT01823510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6186387|NCT01823510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6186388|NCT01823510|Analgesics|analgesics|mesh-ancestor
6186389|NCT01823510|Sensory System Agents|sensory system agents|mesh-ancestor
6186390|NCT01823510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6186391|NCT01823510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186392|NCT01823510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6186393|NCT01823510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6186394|NCT01823510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6186395|NCT01823510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6186396|NCT01823510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186397|NCT01823510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6186398|NCT01823510|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6186399|NCT01823510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6186400|NCT01823510|Antipyretics|antipyretics|mesh-ancestor
6186401|NCT01823510|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6186402|NCT01823510|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6186403|NCT01823510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6186404|NCT01823510|Purinergic Agents|purinergic agents|mesh-ancestor
6186405|NCT01823510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6186406|NCT01823679|Capecitabine|capecitabine|mesh-list
6186407|NCT01823679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6186408|NCT01823679|Antimetabolites|antimetabolites|mesh-ancestor
6186409|NCT01823679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186410|NCT01823679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6186411|NCT01823835|Palbociclib|palbociclib|mesh-list
6186412|NCT01823835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6186413|NCT01823835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6186414|NCT01823835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6186415|NCT01823835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186416|NCT01824290|Tadalafil|tadalafil|mesh-list
6186417|NCT01824290|Vasodilator Agents|vasodilator agents|mesh-ancestor
6186418|NCT01824290|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6186419|NCT01824290|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6186420|NCT01824290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6186421|NCT01824290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186422|NCT01824290|Urological Agents|urological agents|mesh-ancestor
6186423|NCT01824342|Denosumab|denosumab|mesh-list
6186424|NCT01824342|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6186425|NCT01824342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206910|NCT02106494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206911|NCT02106494|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6206912|NCT02106494|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6206913|NCT02106494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6206914|NCT02106494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6206915|NCT02106494|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5580483|NCT03852407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5580484|NCT03852407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5580485|NCT03852407|Alkylating Agents|alkylating agents|mesh-ancestor
5580486|NCT03852407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5580487|NCT03852407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5580488|NCT03852407|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5580489|NCT03852563|Petrolatum|petrolatum|mesh-list
6206916|NCT02106494|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6206917|NCT02106832|Ciprofloxacin|ciprofloxacin|mesh-list
6206918|NCT02106832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6206919|NCT02106832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6206920|NCT02106832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6206921|NCT02106832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6206922|NCT02106832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6206923|NCT02106832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206924|NCT02106832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6206925|NCT02106832|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6206926|NCT02106832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6206927|NCT02106884|Gemcitabine|gemcitabine|mesh-list
6206928|NCT02106884|Paclitaxel|paclitaxel|mesh-list
6206929|NCT02106884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6206930|NCT02106884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6206931|NCT02106884|Tubulin Modulators|tubulin modulators|mesh-ancestor
6206932|NCT02106884|Antimitotic Agents|antimitotic agents|mesh-ancestor
6206933|NCT02106884|Mitosis Modulators|mitosis modulators|mesh-ancestor
6672022|NCT01552993|Antipyretics|antipyretics|mesh-ancestor
5580490|NCT03852563|Emollients|emollients|mesh-ancestor
5580491|NCT03852563|Dermatologic Agents|dermatologic agents|mesh-ancestor
5580492|NCT03852251|Capecitabine|capecitabine|mesh-list
5580493|NCT03852251|Oxaliplatin|oxaliplatin|mesh-list
5580494|NCT03852251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6186426|NCT01824602|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
6186427|NCT01824602|Anticonvulsants|anticonvulsants|mesh-ancestor
6186428|NCT01824602|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6186429|NCT01824602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6186430|NCT01824602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6186431|NCT01824602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186432|NCT01824693|Mycophenolic Acid|mycophenolic acid|mesh-list
6186433|NCT01824693|Cyclophosphamide|cyclophosphamide|mesh-list
6186434|NCT01824693|Melphalan|melphalan|mesh-list
6186435|NCT01824693|Busulfan|busulfan|mesh-list
6186436|NCT01824693|Mechlorethamine|mechlorethamine|mesh-list
6186437|NCT01824693|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
6186438|NCT01824693|Fludarabine|fludarabine|mesh-list
6186439|NCT01824693|Fludarabine phosphate|fludarabine phosphate|mesh-list
6186440|NCT01824693|Tacrolimus|tacrolimus|mesh-list
6186441|NCT01824693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6186442|NCT01824693|Immunologic Factors|immunologic factors|mesh-ancestor
6186443|NCT01824693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186444|NCT01824693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6186445|NCT01824693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5580495|NCT03852251|Antimetabolites|antimetabolites|mesh-ancestor
5580496|NCT03852251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5580497|NCT03852251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5580498|NCT03852160|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5580499|NCT03852160|Mirtazapine|mirtazapine|mesh-list
5580500|NCT03852160|Trazodone|trazodone|mesh-list
5580501|NCT03852160|S 20098|s 20098|mesh-list
5580502|NCT03852160|Citalopram|citalopram|mesh-list
5580503|NCT03852160|Bupropion|bupropion|mesh-list
5580504|NCT03852160|Sertraline|sertraline|mesh-list
5580505|NCT03852160|Esketamine|esketamine|mesh-list
5580506|NCT03852160|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5580507|NCT03852160|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5580508|NCT03852160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6186446|NCT01824693|Alkylating Agents|alkylating agents|mesh-ancestor
6186447|NCT01824693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186448|NCT01824693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6186449|NCT01824693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6186450|NCT01824693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6186451|NCT01824693|Antimetabolites|antimetabolites|mesh-ancestor
6186452|NCT01824693|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6186453|NCT01824693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6186454|NCT01824693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6186455|NCT01824693|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6186456|NCT01824693|Antitubercular Agents|antitubercular agents|mesh-ancestor
6186457|NCT01824693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6186458|NCT01824693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6186459|NCT01824823|Afatinib|afatinib|mesh-list
6186460|NCT01824823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5580509|NCT03852160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5580510|NCT03852160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5580511|NCT03852160|Serotonin Agents|serotonin agents|mesh-ancestor
5580512|NCT03852160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580513|NCT03852160|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5580514|NCT03852160|Antidepressive Agents|antidepressive agents|mesh-ancestor
5580515|NCT03852160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5580516|NCT03852160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6186461|NCT01824823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6186462|NCT01824823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6186463|NCT01824823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186464|NCT01824901|Docetaxel|docetaxel|mesh-list
6186465|NCT01824901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6186466|NCT01824901|Tubulin Modulators|tubulin modulators|mesh-ancestor
6186467|NCT01824901|Antimitotic Agents|antimitotic agents|mesh-ancestor
6186468|NCT01824901|Mitosis Modulators|mitosis modulators|mesh-ancestor
6186469|NCT01824901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186470|NCT01825122|Nadolol|nadolol|mesh-list
6186471|NCT01825122|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6186472|NCT01825122|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5580517|NCT03852160|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6186473|NCT01825122|Adrenergic Agents|adrenergic agents|mesh-ancestor
6186474|NCT01825122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5580518|NCT03852160|Dopamine Agents|dopamine agents|mesh-ancestor
5580519|NCT03852160|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5580520|NCT03852160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5580521|NCT03852160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5580522|NCT03852160|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5580523|NCT03852160|Analgesics|analgesics|mesh-ancestor
5580524|NCT03852160|Sensory System Agents|sensory system agents|mesh-ancestor
6186475|NCT01825122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186476|NCT01825122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186477|NCT01825122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6186478|NCT01825122|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6186479|NCT01825122|Sympatholytics|sympatholytics|mesh-ancestor
6186480|NCT01825122|Autonomic Agents|autonomic agents|mesh-ancestor
6186481|NCT01825122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6186482|NCT01825408|Azithromycin|azithromycin|mesh-list
6186483|NCT01825408|Doxycycline|doxycycline|mesh-list
6186484|NCT01825408|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6186485|NCT01825408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6186486|NCT01825408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6186487|NCT01825408|Antimalarials|antimalarials|mesh-ancestor
5580525|NCT03852160|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5580526|NCT03852160|Histamine Antagonists|histamine antagonists|mesh-ancestor
5580527|NCT03852160|Histamine Agents|histamine agents|mesh-ancestor
5580528|NCT03852160|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5580529|NCT03852160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6186488|NCT01825408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6186489|NCT01825408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6186490|NCT01825408|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6186491|NCT01825408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6186492|NCT01825408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5580530|NCT03852160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5580531|NCT03852160|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5580532|NCT03852160|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5580533|NCT03852160|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5580534|NCT03852160|Adrenergic Agents|adrenergic agents|mesh-ancestor
5580535|NCT03852160|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5580536|NCT03852160|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5580537|NCT03852160|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5580538|NCT03852160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5580539|NCT03852056|Fluorides|fluorides|mesh-list
5580540|NCT03852056|Tin Fluorides|tin fluorides|mesh-list
5580541|NCT03852056|Cariostatic Agents|cariostatic agents|mesh-ancestor
5580542|NCT03852056|Protective Agents|protective agents|mesh-ancestor
5580543|NCT03852056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580544|NCT03851835|Ondansetron|ondansetron|mesh-list
5580545|NCT03851835|Antiemetics|antiemetics|mesh-ancestor
5580546|NCT03851835|Autonomic Agents|autonomic agents|mesh-ancestor
5580547|NCT03851835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5580548|NCT03851835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580549|NCT03851835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5580550|NCT03851835|Antipruritics|antipruritics|mesh-ancestor
5580551|NCT03851835|Dermatologic Agents|dermatologic agents|mesh-ancestor
5580552|NCT03851835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5580553|NCT03851835|Serotonin Agents|serotonin agents|mesh-ancestor
5580554|NCT03851835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5580555|NCT03851835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5580556|NCT03851835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5580557|NCT03851835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6186493|NCT01825512|Deferasirox|deferasirox|mesh-list
6186494|NCT01825512|Deferiprone|deferiprone|mesh-list
6186495|NCT01825512|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6186496|NCT01825512|Chelating Agents|chelating agents|mesh-ancestor
6186497|NCT01825512|Sequestering Agents|sequestering agents|mesh-ancestor
6186498|NCT01825512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186499|NCT01825577|Methylphenidate|methylphenidate|mesh-list
5580558|NCT03851835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5580559|NCT03851835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5580560|NCT03851835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5580561|NCT03851731|Naltrexone|naltrexone|mesh-list
6186500|NCT01825577|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6186501|NCT01825577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186502|NCT01825577|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6186503|NCT01825577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6672023|NCT01553006|Cefditoren pivoxil|cefditoren pivoxil|mesh-list
5580562|NCT03851731|Naloxone|naloxone|mesh-list
6186504|NCT01825577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6186505|NCT01825577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186506|NCT01825577|Dopamine Agents|dopamine agents|mesh-ancestor
5580563|NCT03851731|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5580564|NCT03851731|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5580565|NCT03851731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580566|NCT03851731|Sensory System Agents|sensory system agents|mesh-ancestor
5580567|NCT03851731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5580568|NCT03851679|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
5580569|NCT03851679|Natriuretic Agents|natriuretic agents|mesh-ancestor
6186507|NCT01825577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6186508|NCT01825655|Cetirizine|cetirizine|mesh-list
6186509|NCT01825655|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6186510|NCT01825655|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6186511|NCT01825655|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6186512|NCT01825655|Histamine Antagonists|histamine antagonists|mesh-ancestor
6186513|NCT01825655|Histamine Agents|histamine agents|mesh-ancestor
6186514|NCT01825655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6186515|NCT01825655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186516|NCT01825655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186517|NCT01825798|Metformin|metformin|mesh-list
6186518|NCT01825798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6186519|NCT01825798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186520|NCT01825837|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
6186521|NCT01825837|Anticonvulsants|anticonvulsants|mesh-ancestor
6186522|NCT01825837|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6186523|NCT01825837|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6186524|NCT01825837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6186525|NCT01825837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186526|NCT01825876|Warfarin|warfarin|mesh-list
6186527|NCT01825876|Evacetrapib|evacetrapib|mesh-list
6186528|NCT01825876|Anticoagulants|anticoagulants|mesh-ancestor
6186529|NCT01825876|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6186530|NCT01825876|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6186531|NCT01825876|Antimetabolites|antimetabolites|mesh-ancestor
6186532|NCT01825876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186533|NCT01825876|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6186534|NCT01825889|Evacetrapib|evacetrapib|mesh-list
6186535|NCT01825889|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6186536|NCT01825889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6186537|NCT01825889|Antimetabolites|antimetabolites|mesh-ancestor
5580570|NCT03851679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580571|NCT03851432|Metformin|metformin|mesh-list
5580572|NCT03851432|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5580573|NCT03851432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580574|NCT03851562|Alprostadil|alprostadil|mesh-list
5580575|NCT03851562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5580576|NCT03851562|Vasodilator Agents|vasodilator agents|mesh-ancestor
5580577|NCT03851562|Urological Agents|urological agents|mesh-ancestor
5580578|NCT03851289|Calcium|calcium|mesh-list
5580579|NCT03851289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6186538|NCT01825889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186539|NCT01825889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6186540|NCT01825941|Diphenhydramine|diphenhydramine|mesh-list
6186541|NCT01825941|Promethazine|promethazine|mesh-list
6186542|NCT01825941|Metoclopramide|metoclopramide|mesh-list
6186543|NCT01825941|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6186544|NCT01825941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6186545|NCT01825941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6186546|NCT01825941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186547|NCT01825941|Anesthetics, Local|anesthetics, local|mesh-ancestor
6186548|NCT01825941|Anesthetics|anesthetics|mesh-ancestor
6186549|NCT01825941|Sensory System Agents|sensory system agents|mesh-ancestor
6186550|NCT01825941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6186551|NCT01825941|Antiemetics|antiemetics|mesh-ancestor
6186552|NCT01825941|Autonomic Agents|autonomic agents|mesh-ancestor
6186553|NCT01825941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6186554|NCT01825941|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6186555|NCT01825941|Histamine Antagonists|histamine antagonists|mesh-ancestor
6186556|NCT01825941|Histamine Agents|histamine agents|mesh-ancestor
6186557|NCT01825941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6186558|NCT01825941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186559|NCT01825941|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6186560|NCT01825941|Antipruritics|antipruritics|mesh-ancestor
5580580|NCT03851289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186561|NCT01825941|Dermatologic Agents|dermatologic agents|mesh-ancestor
6186562|NCT01825941|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6186563|NCT01825941|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6186564|NCT01825941|Dopamine Agents|dopamine agents|mesh-ancestor
6186565|NCT01826370|Linagliptin|linagliptin|mesh-list
6186566|NCT01826370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6186567|NCT01826370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186568|NCT01826370|Incretins|incretins|mesh-ancestor
6186569|NCT01826370|Hormones|hormones|mesh-ancestor
6186570|NCT01826370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6186571|NCT01826370|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6186572|NCT01826370|Protease Inhibitors|protease inhibitors|mesh-ancestor
6186573|NCT01826370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6186574|NCT01826370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186575|NCT01826448|Vemurafenib|vemurafenib|mesh-list
6186576|NCT01826448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6186577|NCT01826448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5580581|NCT03851341|Metformin|metformin|mesh-list
5580582|NCT03851341|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5580583|NCT03851341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5580584|NCT03851341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580585|NCT03851341|Incretins|incretins|mesh-ancestor
5580586|NCT03851341|Hormones|hormones|mesh-ancestor
5580587|NCT03851341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5580588|NCT03851341|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6186578|NCT01826448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6186579|NCT01826448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186580|NCT01826851|Bupivacaine|bupivacaine|mesh-list
6186581|NCT01826851|Anesthetics, Local|anesthetics, local|mesh-ancestor
6186582|NCT01826851|Anesthetics|anesthetics|mesh-ancestor
5580589|NCT03851341|Protease Inhibitors|protease inhibitors|mesh-ancestor
5580590|NCT03851341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5580591|NCT03851341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5580592|NCT03851614|Durvalumab|durvalumab|mesh-list
5580593|NCT03851614|Olaparib|olaparib|mesh-list
5580594|NCT03851614|Cediranib|cediranib|mesh-list
5580595|NCT03851614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5580596|NCT03851614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5580597|NCT03851614|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6186583|NCT01826851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6186584|NCT01826851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186585|NCT01826851|Sensory System Agents|sensory system agents|mesh-ancestor
6186586|NCT01826851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6186587|NCT01826981|Sofosbuvir|sofosbuvir|mesh-list
6186588|NCT01826981|Antiviral Agents|antiviral agents|mesh-ancestor
6186589|NCT01826981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6186590|NCT01827046|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6186591|NCT01827046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6186592|NCT01827046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6186593|NCT01827046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186594|NCT01827163|Paclitaxel|paclitaxel|mesh-list
6186595|NCT01827163|Trastuzumab|trastuzumab|mesh-list
6186596|NCT01827163|Lapatinib|lapatinib|mesh-list
6186597|NCT01827163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6186598|NCT01827163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6186599|NCT01827163|Tubulin Modulators|tubulin modulators|mesh-ancestor
6186600|NCT01827163|Antimitotic Agents|antimitotic agents|mesh-ancestor
6186601|NCT01827163|Mitosis Modulators|mitosis modulators|mesh-ancestor
6186602|NCT01827163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186603|NCT01827163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6186604|NCT01827163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6186605|NCT01827163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6186606|NCT01827254|Sunitinib|sunitinib|mesh-list
6186607|NCT01827254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6186608|NCT01827254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6186609|NCT01827254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6186610|NCT01827254|Growth Substances|growth substances|mesh-ancestor
6186611|NCT01827254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186612|NCT01827254|Growth Inhibitors|growth inhibitors|mesh-ancestor
6186613|NCT01827254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6186614|NCT01827254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6186615|NCT01827254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186616|NCT01827267|Sirolimus|sirolimus|mesh-list
6186617|NCT01827267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6186618|NCT01827267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5580598|NCT03851614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6186619|NCT01827267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6186620|NCT01827267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6186621|NCT01827267|Antifungal Agents|antifungal agents|mesh-ancestor
6186622|NCT01827267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6186623|NCT01827267|Immunologic Factors|immunologic factors|mesh-ancestor
6186624|NCT01827267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186625|NCT01827332|Oxytocin|oxytocin|mesh-list
6186626|NCT01827332|Oxytocics|oxytocics|mesh-ancestor
6186627|NCT01827332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6186628|NCT01827332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186629|NCT01827358|Calcium, Dietary|calcium, dietary|mesh-list
6186630|NCT01827358|Mupirocin|mupirocin|mesh-list
6186631|NCT01827358|Calcium|calcium|mesh-list
6186632|NCT01827358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6186633|NCT01827358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186634|NCT01827358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6186635|NCT01827358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6186636|NCT01827358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6186637|NCT01827358|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6186638|NCT01827358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6186639|NCT01827358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186640|NCT01827462|Vaccines|vaccines|mesh-list
6186641|NCT01827462|Immunologic Factors|immunologic factors|mesh-ancestor
5580599|NCT03851614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5580600|NCT03851614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5580601|NCT03851627|Methyltestosterone|methyltestosterone|mesh-list
5580602|NCT03851627|Testosterone|testosterone|mesh-list
5580603|NCT03851627|Testosterone undecanoate|testosterone undecanoate|mesh-list
6186642|NCT01827462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186643|NCT01827475|Acetaminophen|acetaminophen|mesh-list
6186644|NCT01827475|Ibuprofen|ibuprofen|mesh-list
6186645|NCT01827475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6186646|NCT01827475|Analgesics|analgesics|mesh-ancestor
6186647|NCT01827475|Sensory System Agents|sensory system agents|mesh-ancestor
6186648|NCT01827475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6186649|NCT01827475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186650|NCT01827475|Antipyretics|antipyretics|mesh-ancestor
6186651|NCT01827475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6186652|NCT01827475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6186653|NCT01827475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6186654|NCT01827475|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6186655|NCT01827475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6186656|NCT01827475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186657|NCT01827670|Fluorides|fluorides|mesh-list
6186658|NCT01827670|Tin Fluorides|tin fluorides|mesh-list
6186659|NCT01827670|Fluorophosphate|fluorophosphate|mesh-list
6186660|NCT01827670|Cariostatic Agents|cariostatic agents|mesh-ancestor
6186661|NCT01827670|Protective Agents|protective agents|mesh-ancestor
6186662|NCT01827670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186663|NCT01827839|Vaccines|vaccines|mesh-list
6186664|NCT01827839|Immunologic Factors|immunologic factors|mesh-ancestor
6186665|NCT01827839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186666|NCT01827930|Imatinib Mesylate|imatinib mesylate|mesh-list
6186667|NCT01827930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6186668|NCT01827930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6186669|NCT01827930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6186670|NCT01827930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186671|NCT01827943|Sirolimus|sirolimus|mesh-list
6186672|NCT01827943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6186673|NCT01827943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6186674|NCT01827943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6186675|NCT01827943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5580604|NCT03851627|Testosterone enanthate|testosterone enanthate|mesh-list
5580605|NCT03851627|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6186676|NCT01827943|Antifungal Agents|antifungal agents|mesh-ancestor
6186677|NCT01827943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6186678|NCT01827943|Immunologic Factors|immunologic factors|mesh-ancestor
6186679|NCT01827943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186680|NCT01828034|Gemcitabine|gemcitabine|mesh-list
6186681|NCT01828034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6186682|NCT01828034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6186683|NCT01828034|Antimetabolites|antimetabolites|mesh-ancestor
6186684|NCT01828034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5580606|NCT03851627|Androgens|androgens|mesh-ancestor
5580607|NCT03851627|Hormones|hormones|mesh-ancestor
5580608|NCT03851627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5580609|NCT03851627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580610|NCT03851627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5580611|NCT03851627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6186685|NCT01828034|Antiviral Agents|antiviral agents|mesh-ancestor
6186686|NCT01828034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6186687|NCT01828034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6186688|NCT01828034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6186689|NCT01828034|Immunologic Factors|immunologic factors|mesh-ancestor
6186690|NCT01828034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186691|NCT01828073|Raltegravir Potassium|raltegravir potassium|mesh-list
6186692|NCT01828073|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6186693|NCT01828073|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6186694|NCT01828073|Antiviral Agents|antiviral agents|mesh-ancestor
6186695|NCT01828073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6186696|NCT01828073|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6186697|NCT01828073|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6186698|NCT01828073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6186699|NCT01828073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186700|NCT01828112|Docetaxel|docetaxel|mesh-list
6186701|NCT01828112|Pemetrexed|pemetrexed|mesh-list
6186702|NCT01828112|Ceritinib|ceritinib|mesh-list
6186703|NCT01828112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6186704|NCT01828112|Tubulin Modulators|tubulin modulators|mesh-ancestor
6186705|NCT01828112|Antimitotic Agents|antimitotic agents|mesh-ancestor
6186706|NCT01828112|Mitosis Modulators|mitosis modulators|mesh-ancestor
6186707|NCT01828112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186708|NCT01828112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6186709|NCT01828112|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6186710|NCT01828112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6186711|NCT01828112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6186712|NCT01828476|Hydroxychloroquine|hydroxychloroquine|mesh-list
6186713|NCT01828476|Navitoclax|navitoclax|mesh-list
6186714|NCT01828476|Antimalarials|antimalarials|mesh-ancestor
6186715|NCT01828476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6186716|NCT01828476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6186717|NCT01828476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6186718|NCT01828476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6186719|NCT01828476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186720|NCT01828476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6186721|NCT01828476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6186722|NCT01828515|Hydrocortisone|hydrocortisone|mesh-list
6186723|NCT01828515|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
6186724|NCT01828515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6186725|NCT01828515|Antidepressive Agents|antidepressive agents|mesh-ancestor
6186726|NCT01828515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6186727|NCT01828515|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6186728|NCT01828515|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6186729|NCT01828515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6186730|NCT01828515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186731|NCT01828515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6186732|NCT01828515|Serotonin Agents|serotonin agents|mesh-ancestor
6186733|NCT01828515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580612|NCT03851627|Anabolic Agents|anabolic agents|mesh-ancestor
5580613|NCT03851588|Dolutegravir|dolutegravir|mesh-list
5580614|NCT03851588|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5580615|NCT03851588|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5580616|NCT03851588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5580617|NCT03851588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5580618|NCT03851588|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5580619|NCT03851588|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6186734|NCT01828515|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5580620|NCT03851588|Antiviral Agents|antiviral agents|mesh-ancestor
5580621|NCT03851588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5580622|NCT03851172|Ketorolac|ketorolac|mesh-list
5580623|NCT03851172|Nepafenac|nepafenac|mesh-list
5580624|NCT03851172|Cyclopentolate|cyclopentolate|mesh-list
5580625|NCT03851172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5580626|NCT03851172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5580627|NCT03851172|Analgesics|analgesics|mesh-ancestor
5580628|NCT03851172|Sensory System Agents|sensory system agents|mesh-ancestor
5580629|NCT03851172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5580630|NCT03851172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580631|NCT03851172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5580632|NCT03851172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6186735|NCT01828515|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6186736|NCT01828554|Capecitabine|capecitabine|mesh-list
6186737|NCT01828554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6186738|NCT01828554|Antimetabolites|antimetabolites|mesh-ancestor
6186739|NCT01828554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186740|NCT01828554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6186741|NCT01828593|Immunoglobulins|immunoglobulins|mesh-list
6186742|NCT01828593|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6186743|NCT01828593|Antibodies|antibodies|mesh-list
6186744|NCT01828593|Immunologic Factors|immunologic factors|mesh-ancestor
6186745|NCT01828593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186746|NCT01829217|Sunitinib|sunitinib|mesh-list
6186747|NCT01829217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6186748|NCT01829217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6186749|NCT01829217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6186750|NCT01829217|Growth Substances|growth substances|mesh-ancestor
6186751|NCT01829217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186752|NCT01829217|Growth Inhibitors|growth inhibitors|mesh-ancestor
6186753|NCT01829217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6186754|NCT01829217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6186755|NCT01829217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5580633|NCT03851172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5580634|NCT03851172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5580635|NCT03851172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5580636|NCT03851172|Mydriatics|mydriatics|mesh-ancestor
5580637|NCT03851172|Autonomic Agents|autonomic agents|mesh-ancestor
6186756|NCT01829243|Milnacipran|milnacipran|mesh-list
6186757|NCT01829243|Levomilnacipran|levomilnacipran|mesh-list
6186758|NCT01829243|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6186759|NCT01829243|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6186760|NCT01829243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6186761|NCT01829243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186762|NCT01829243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6186763|NCT01829243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186764|NCT01829243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6186765|NCT01829243|Analgesics|analgesics|mesh-ancestor
6186766|NCT01829243|Sensory System Agents|sensory system agents|mesh-ancestor
6186767|NCT01829243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6186768|NCT01829243|Antidepressive Agents|antidepressive agents|mesh-ancestor
6186769|NCT01829243|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5580638|NCT03851172|Parasympatholytics|parasympatholytics|mesh-ancestor
5580639|NCT03851172|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5580640|NCT03851172|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5580641|NCT03851172|Cholinergic Agents|cholinergic agents|mesh-ancestor
5580642|NCT03851172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5580643|NCT03851393|Citric Acid|citric acid|mesh-list
5580644|NCT03851393|Sodium Citrate|sodium citrate|mesh-list
5580645|NCT03851393|Anticoagulants|anticoagulants|mesh-ancestor
5580646|NCT03851393|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5580647|NCT03851393|Chelating Agents|chelating agents|mesh-ancestor
5580648|NCT03851393|Sequestering Agents|sequestering agents|mesh-ancestor
5580649|NCT03851393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5580650|NCT03851159|Mannitol|mannitol|mesh-list
6186770|NCT01829295|Mycophenolic Acid|mycophenolic acid|mesh-list
6186771|NCT01829295|Prednisone|prednisone|mesh-list
6186772|NCT01829295|Methotrexate|methotrexate|mesh-list
6186773|NCT01829295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6186774|NCT01829295|Glucocorticoids|glucocorticoids|mesh-ancestor
6186775|NCT01829295|Hormones|hormones|mesh-ancestor
6186776|NCT01829295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6186777|NCT01829295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186778|NCT01829295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5580651|NCT03851159|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6186779|NCT01829295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6186780|NCT01829295|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6186781|NCT01829295|Abortifacient Agents|abortifacient agents|mesh-ancestor
6186782|NCT01829295|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6186783|NCT01829295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6186784|NCT01829295|Antimetabolites|antimetabolites|mesh-ancestor
6186785|NCT01829295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186786|NCT01829295|Dermatologic Agents|dermatologic agents|mesh-ancestor
6186787|NCT01829295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6186788|NCT01829295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6186789|NCT01829295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6186790|NCT01829295|Immunologic Factors|immunologic factors|mesh-ancestor
6186791|NCT01829295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6186792|NCT01829295|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6186793|NCT01829295|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6186794|NCT01829295|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6186795|NCT01829295|Antitubercular Agents|antitubercular agents|mesh-ancestor
6186796|NCT01829295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6186797|NCT01829295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6186798|NCT01829399|Epinephrine|epinephrine|mesh-list
6186799|NCT01829399|Bupivacaine|bupivacaine|mesh-list
6186800|NCT01829399|Anesthetics, Local|anesthetics, local|mesh-ancestor
6186801|NCT01829399|Anesthetics|anesthetics|mesh-ancestor
6186802|NCT01829399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6186803|NCT01829399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186804|NCT01829399|Sensory System Agents|sensory system agents|mesh-ancestor
6186805|NCT01829399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6186806|NCT01829399|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6186807|NCT01829399|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6186808|NCT01829399|Adrenergic Agents|adrenergic agents|mesh-ancestor
6186809|NCT01829399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6186810|NCT01829399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186811|NCT01829399|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6186812|NCT01829399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6186813|NCT01829399|Autonomic Agents|autonomic agents|mesh-ancestor
6186814|NCT01829399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6186815|NCT01829399|Respiratory System Agents|respiratory system agents|mesh-ancestor
6186816|NCT01829399|Mydriatics|mydriatics|mesh-ancestor
6186817|NCT01829399|Sympathomimetics|sympathomimetics|mesh-ancestor
6186818|NCT01829399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6186819|NCT01829425|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6186820|NCT01829425|Oxybutynin|oxybutynin|mesh-list
6186821|NCT01829425|Cholinergic Antagonists|cholinergic antagonists|mesh-list
6186822|NCT01829425|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6186823|NCT01829425|Cholinergic Agents|cholinergic agents|mesh-ancestor
6186824|NCT01829425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5580652|NCT03851159|Diuretics|diuretics|mesh-ancestor
5580653|NCT03851159|Natriuretic Agents|natriuretic agents|mesh-ancestor
5580654|NCT03851159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186825|NCT01829425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186826|NCT01829425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186827|NCT01829425|Urological Agents|urological agents|mesh-ancestor
6186828|NCT01829425|Parasympatholytics|parasympatholytics|mesh-ancestor
6186829|NCT01829425|Autonomic Agents|autonomic agents|mesh-ancestor
6186830|NCT01829425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6186831|NCT01829503|Cytarabine|cytarabine|mesh-list
6186832|NCT01829503|Decitabine|decitabine|mesh-list
6186833|NCT01829503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6186834|NCT01829503|Antimetabolites|antimetabolites|mesh-ancestor
6186835|NCT01829503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186836|NCT01829503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6186837|NCT01829503|Antiviral Agents|antiviral agents|mesh-ancestor
6186838|NCT01829503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6186839|NCT01829503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6186840|NCT01829503|Immunologic Factors|immunologic factors|mesh-ancestor
6186841|NCT01829503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186842|NCT01829503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6186843|NCT01829516|Oxytocin|oxytocin|mesh-list
6186844|NCT01829516|Oxytocics|oxytocics|mesh-ancestor
6186845|NCT01829516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6186846|NCT01829516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186847|NCT01829919|Paroxetine|paroxetine|mesh-list
6186848|NCT01829919|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6186849|NCT01829919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5580655|NCT03851263|Evolocumab|evolocumab|mesh-list
6186850|NCT01829919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6186851|NCT01829919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186852|NCT01829919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6186853|NCT01829919|Serotonin Agents|serotonin agents|mesh-ancestor
6186854|NCT01829919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186855|NCT01829919|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6186856|NCT01829919|Antidepressive Agents|antidepressive agents|mesh-ancestor
6186857|NCT01829919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6186858|NCT01829919|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6186859|NCT01829919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6186860|NCT01829919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6186861|NCT01830127|Ribavirin|ribavirin|mesh-list
5580656|NCT03851263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5580657|NCT03851263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5580658|NCT03851263|Antimetabolites|antimetabolites|mesh-ancestor
5580659|NCT03851263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5580660|NCT03851263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5604886|NCT04078568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5604887|NCT04078568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6186862|NCT01830127|Antimetabolites|antimetabolites|mesh-ancestor
6186863|NCT01830127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186864|NCT01830127|Antiviral Agents|antiviral agents|mesh-ancestor
6186865|NCT01830127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6186866|NCT01830140|Bimatoprost|bimatoprost|mesh-list
6186867|NCT01830140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6186868|NCT01830543|Aspirin|aspirin|mesh-list
6186869|NCT01830543|Vitamin K|vitamin k|mesh-list
6186870|NCT01830543|Rivaroxaban|rivaroxaban|mesh-list
6186871|NCT01830543|Clopidogrel|clopidogrel|mesh-list
6186872|NCT01830543|Ticagrelor|ticagrelor|mesh-list
6186873|NCT01830543|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6186874|NCT01830543|Vitamins|vitamins|mesh-ancestor
6186875|NCT01830543|Micronutrients|micronutrients|mesh-ancestor
6186876|NCT01830543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186877|NCT01830543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6186878|NCT01830543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6186879|NCT01830543|Analgesics|analgesics|mesh-ancestor
6186880|NCT01830543|Sensory System Agents|sensory system agents|mesh-ancestor
6186881|NCT01830543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6186882|NCT01830543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6186883|NCT01830543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6186884|NCT01830543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6186885|NCT01830543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6186886|NCT01830543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186887|NCT01830543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6186888|NCT01830543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6186889|NCT01830543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6186890|NCT01830543|Antipyretics|antipyretics|mesh-ancestor
6186891|NCT01830543|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6186892|NCT01830543|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6186893|NCT01830543|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6186894|NCT01830543|Purinergic Agents|purinergic agents|mesh-ancestor
6186895|NCT01830543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6186896|NCT01830543|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6186897|NCT01830543|Antithrombins|antithrombins|mesh-ancestor
6186898|NCT01830543|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6186899|NCT01830543|Protease Inhibitors|protease inhibitors|mesh-ancestor
6186900|NCT01830543|Anticoagulants|anticoagulants|mesh-ancestor
6186901|NCT01830543|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6186902|NCT01830543|Hemostatics|hemostatics|mesh-ancestor
6186903|NCT01830543|Coagulants|coagulants|mesh-ancestor
6186904|NCT01830595|Lactoferrin|lactoferrin|mesh-list
6186905|NCT01830595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6186906|NCT01830699|Triamcinolone|triamcinolone|mesh-list
6186907|NCT01830699|Rilonacept|rilonacept|mesh-list
6186908|NCT01830699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6186909|NCT01830699|Glucocorticoids|glucocorticoids|mesh-ancestor
6186910|NCT01830699|Hormones|hormones|mesh-ancestor
6186911|NCT01830699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6186912|NCT01830699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186913|NCT01830816|Ixazomib|ixazomib|mesh-list
6186914|NCT01830816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6186915|NCT01830816|Protease Inhibitors|protease inhibitors|mesh-ancestor
6186916|NCT01830816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6186917|NCT01830816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186918|NCT01830842|Nicotine|nicotine|mesh-list
6186919|NCT01830842|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5580661|NCT03850886|Niacinamide|niacinamide|mesh-list
5580662|NCT03850886|Niacin|niacin|mesh-list
5580663|NCT03850886|Nicotinic Acids|nicotinic acids|mesh-list
5580664|NCT03850886|Hypoglycemic Agents|hypoglycemic agents|mesh-list
5580665|NCT03850886|Vitamins|vitamins|mesh-ancestor
5580666|NCT03850886|Micronutrients|micronutrients|mesh-ancestor
5580667|NCT03850886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580668|NCT03850886|Vitamin B Complex|vitamin b complex|mesh-ancestor
5580669|NCT03850886|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5580670|NCT03850886|Antimetabolites|antimetabolites|mesh-ancestor
5580671|NCT03850886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5580672|NCT03850886|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5580673|NCT03850886|Vasodilator Agents|vasodilator agents|mesh-ancestor
5580674|NCT03850769|Paclitaxel|paclitaxel|mesh-list
5580675|NCT03850769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5580676|NCT03850769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5580677|NCT03850769|Tubulin Modulators|tubulin modulators|mesh-ancestor
5580678|NCT03850769|Antimitotic Agents|antimitotic agents|mesh-ancestor
5580679|NCT03850769|Mitosis Modulators|mitosis modulators|mesh-ancestor
5580680|NCT03850769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186920|NCT01830842|Autonomic Agents|autonomic agents|mesh-ancestor
6186921|NCT01830842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6186922|NCT01830842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186923|NCT01830842|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6186924|NCT01830842|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6186925|NCT01830842|Cholinergic Agents|cholinergic agents|mesh-ancestor
6186926|NCT01830842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6186927|NCT01830842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186928|NCT01830881|Ibuprofen|ibuprofen|mesh-list
6186929|NCT01830881|Lidocaine|lidocaine|mesh-list
6186930|NCT01830881|Midazolam|midazolam|mesh-list
6186931|NCT01830881|Anesthetics, Local|anesthetics, local|mesh-ancestor
6186932|NCT01830881|Anesthetics|anesthetics|mesh-ancestor
6186933|NCT01830881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5580681|NCT03850561|Ubiquinone|ubiquinone|mesh-list
5580682|NCT03850561|Coenzyme Q10|coenzyme q10|mesh-list
5580683|NCT03850561|Micronutrients|micronutrients|mesh-ancestor
5580684|NCT03850561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580685|NCT03850561|Vitamins|vitamins|mesh-ancestor
5580686|NCT03850652|Iron|iron|mesh-list
5580687|NCT03850652|Trace Elements|trace elements|mesh-ancestor
6186934|NCT01830881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186935|NCT01830881|Sensory System Agents|sensory system agents|mesh-ancestor
6186936|NCT01830881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6186937|NCT01830881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6186938|NCT01830881|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6186939|NCT01830881|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6186940|NCT01830881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6186941|NCT01830881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186942|NCT01830881|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6186943|NCT01830881|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6186944|NCT01830881|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6186945|NCT01830881|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6186946|NCT01830881|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6186947|NCT01830881|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6186948|NCT01830881|Anesthetics, General|anesthetics, general|mesh-ancestor
6186949|NCT01830881|GABA Modulators|gaba modulators|mesh-ancestor
6186950|NCT01830881|GABA Agents|gaba agents|mesh-ancestor
6186951|NCT01830881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5580688|NCT03850652|Micronutrients|micronutrients|mesh-ancestor
5580689|NCT03850652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580690|NCT03850691|Aldesleukin|aldesleukin|mesh-list
5580691|NCT03850691|Nivolumab|nivolumab|mesh-list
5580692|NCT03850691|Ipilimumab|ipilimumab|mesh-list
5580693|NCT03850691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5580694|NCT03850691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6186952|NCT01830881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6186953|NCT01830881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6186954|NCT01830881|Analgesics|analgesics|mesh-ancestor
6186955|NCT01830881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6186956|NCT01830881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6186957|NCT01830881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6186958|NCT01830881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5580695|NCT03850691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5580696|NCT03850691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5580697|NCT03850691|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5580698|NCT03850691|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5580699|NCT03850691|Antiviral Agents|antiviral agents|mesh-ancestor
5580700|NCT03850691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5580701|NCT03850483|PF-06700841|pf-06700841|mesh-list
5580702|NCT03850483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6186959|NCT01831076|Tamoxifen|tamoxifen|mesh-list
6186960|NCT01831076|Exemestane|exemestane|mesh-list
6186961|NCT01831076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6186962|NCT01831076|Hormone Antagonists|hormone antagonists|mesh-ancestor
6186963|NCT01831076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6186964|NCT01831076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186965|NCT01831076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6186966|NCT01831076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6186967|NCT01831076|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6186968|NCT01831076|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6186969|NCT01831076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6186970|NCT01831076|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6186971|NCT01831076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6186972|NCT01831076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6186973|NCT01831076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186974|NCT01831089|Paclitaxel|paclitaxel|mesh-list
6186975|NCT01831089|Bevacizumab|bevacizumab|mesh-list
6186976|NCT01831089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6186977|NCT01831089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6186978|NCT01831089|Tubulin Modulators|tubulin modulators|mesh-ancestor
6186979|NCT01831089|Antimitotic Agents|antimitotic agents|mesh-ancestor
6186980|NCT01831089|Mitosis Modulators|mitosis modulators|mesh-ancestor
6186981|NCT01831089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186982|NCT01831089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6186983|NCT01831089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6186984|NCT01831089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6186985|NCT01831089|Growth Substances|growth substances|mesh-ancestor
6186986|NCT01831089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6186987|NCT01831089|Growth Inhibitors|growth inhibitors|mesh-ancestor
6186988|NCT01831232|Cytarabine|cytarabine|mesh-list
6186989|NCT01831232|Idarubicin|idarubicin|mesh-list
6186990|NCT01831232|Pravastatin|pravastatin|mesh-list
6186991|NCT01831232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6186992|NCT01831232|Antimetabolites|antimetabolites|mesh-ancestor
6186993|NCT01831232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6186994|NCT01831232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6186995|NCT01831232|Antiviral Agents|antiviral agents|mesh-ancestor
6186996|NCT01831232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6186997|NCT01831232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6186998|NCT01831232|Immunologic Factors|immunologic factors|mesh-ancestor
6672024|NCT01553006|Cefditoren|cefditoren|mesh-list
6186999|NCT01831232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187000|NCT01831232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6187001|NCT01831232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6187002|NCT01831232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6187003|NCT01831232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6187004|NCT01831232|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6187005|NCT01831232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6187006|NCT01831232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6187007|NCT01831232|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6206934|NCT02106884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206935|NCT02106884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6206936|NCT02106884|Antimetabolites|antimetabolites|mesh-ancestor
6206937|NCT02106884|Antiviral Agents|antiviral agents|mesh-ancestor
6206938|NCT02106884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6206939|NCT02106884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6206940|NCT02106884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6206941|NCT02106884|Immunologic Factors|immunologic factors|mesh-ancestor
6206942|NCT02106884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206943|NCT02106923|Metformin|metformin|mesh-list
6206944|NCT02106923|Empagliflozin|empagliflozin|mesh-list
6206945|NCT02106923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6206946|NCT02106923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206947|NCT02106923|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6206948|NCT02106923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206949|NCT02106962|Bacitracin|bacitracin|mesh-list
6206950|NCT02106962|Tranexamic Acid|tranexamic acid|mesh-list
5580703|NCT03850483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5580704|NCT03850483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5580705|NCT03850587|Celecoxib|celecoxib|mesh-list
5580706|NCT03850587|Tramadol|tramadol|mesh-list
5580707|NCT03850587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5580708|NCT03850587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5580709|NCT03850587|Analgesics|analgesics|mesh-ancestor
5580710|NCT03850587|Sensory System Agents|sensory system agents|mesh-ancestor
5580711|NCT03850587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5580712|NCT03850587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580713|NCT03850587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5580714|NCT03850587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5580715|NCT03850587|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5580716|NCT03850587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6206951|NCT02106962|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6206952|NCT02106962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6206953|NCT02106962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206954|NCT02106962|Hemostatics|hemostatics|mesh-ancestor
6206955|NCT02106962|Coagulants|coagulants|mesh-ancestor
6206956|NCT02106962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6206957|NCT02106962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6206958|NCT02106962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6206959|NCT02106975|Ascorbic Acid|ascorbic acid|mesh-list
6206960|NCT02106975|Vitamins|vitamins|mesh-ancestor
5580717|NCT03850587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5580718|NCT03850587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5580719|NCT03850587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5580720|NCT03850587|Narcotics|narcotics|mesh-ancestor
5580721|NCT03850587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5580722|NCT03850535|Cytarabine|cytarabine|mesh-list
5580723|NCT03850535|Daunorubicin|daunorubicin|mesh-list
6206961|NCT02106975|Micronutrients|micronutrients|mesh-ancestor
6206962|NCT02106975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206963|NCT02106975|Antioxidants|antioxidants|mesh-ancestor
6206964|NCT02106975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6206965|NCT02106975|Protective Agents|protective agents|mesh-ancestor
6206966|NCT02107014|Naltrexone|naltrexone|mesh-list
6206967|NCT02107014|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6206968|NCT02107014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6206969|NCT02107014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206970|NCT02107014|Sensory System Agents|sensory system agents|mesh-ancestor
6206971|NCT02107014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6206972|NCT02107131|Ranibizumab|ranibizumab|mesh-list
6206973|NCT02107131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6206974|NCT02107131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6206975|NCT02107131|Growth Substances|growth substances|mesh-ancestor
6206976|NCT02107131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206977|NCT02107131|Growth Inhibitors|growth inhibitors|mesh-ancestor
6206978|NCT02107131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6187008|NCT01831427|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6187009|NCT01831427|Immunologic Factors|immunologic factors|mesh-ancestor
6187010|NCT01831427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187011|NCT01831466|Tofacitinib|tofacitinib|mesh-list
6187012|NCT01831466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6187013|NCT01831466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6187014|NCT01831466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187015|NCT01831765|Insulin|insulin|mesh-list
5580724|NCT03850535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5580725|NCT03850535|Antimetabolites|antimetabolites|mesh-ancestor
5580726|NCT03850535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5580727|NCT03850535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5580728|NCT03850535|Antiviral Agents|antiviral agents|mesh-ancestor
5580729|NCT03850535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6187016|NCT01831765|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6187017|NCT01831765|Insulin Aspart|insulin aspart|mesh-list
6187018|NCT01831765|Insulin, Long-Acting|insulin, long-acting|mesh-list
6187019|NCT01831765|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6187020|NCT01831765|Insulin Detemir|insulin detemir|mesh-list
6187021|NCT01831765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5580730|NCT03850535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5580731|NCT03850535|Immunologic Factors|immunologic factors|mesh-ancestor
5580732|NCT03850535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580733|NCT03850535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5580734|NCT03850535|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5580735|NCT03850535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5580736|NCT03850535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5580737|NCT03850314|Glycine|glycine|mesh-list
5580738|NCT03850314|Glycine Agents|glycine agents|mesh-ancestor
5580739|NCT03850314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5580740|NCT03850314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5580741|NCT03850314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580742|NCT03850301|Etifoxine|etifoxine|mesh-list
5580743|NCT03850301|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6187022|NCT01831765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187023|NCT01831791|Dutasteride|dutasteride|mesh-list
6187024|NCT01831791|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6187025|NCT01831791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6187026|NCT01831791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6187027|NCT01831791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187028|NCT01831791|Hormone Antagonists|hormone antagonists|mesh-ancestor
6187029|NCT01831791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6187030|NCT01831791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187031|NCT01831817|Calcium, Dietary|calcium, dietary|mesh-list
6187032|NCT01831817|Listerine|listerine|mesh-list
6187033|NCT01831817|Calcium|calcium|mesh-list
6187034|NCT01831817|Fluorides|fluorides|mesh-list
6187035|NCT01831817|Sodium Fluoride|sodium fluoride|mesh-list
6187036|NCT01831817|Fluorophosphate|fluorophosphate|mesh-list
6187037|NCT01831817|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6187038|NCT01831817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187039|NCT01831817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6187040|NCT01831817|Cariostatic Agents|cariostatic agents|mesh-ancestor
6187041|NCT01831817|Protective Agents|protective agents|mesh-ancestor
6187042|NCT01831817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6187043|NCT01831817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6187044|NCT01831934|Vaccines|vaccines|mesh-list
6187045|NCT01831934|Immunologic Factors|immunologic factors|mesh-ancestor
6187046|NCT01831934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187047|NCT01832038|Lacosamide|lacosamide|mesh-list
6187048|NCT01832038|Anticonvulsants|anticonvulsants|mesh-ancestor
6187049|NCT01832038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6187050|NCT01832038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6187051|NCT01832038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6187052|NCT01832038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187053|NCT01832402|Fentanyl|fentanyl|mesh-list
6187054|NCT01832402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6187055|NCT01832402|Narcotics|narcotics|mesh-ancestor
6187056|NCT01832402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6187057|NCT01832402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187058|NCT01832402|Analgesics|analgesics|mesh-ancestor
6187059|NCT01832402|Sensory System Agents|sensory system agents|mesh-ancestor
6187060|NCT01832402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6187061|NCT01832402|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6187062|NCT01832402|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5580744|NCT03850301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5580745|NCT03850301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5580746|NCT03850301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580747|NCT03850301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5580748|NCT03849885|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6187063|NCT01832402|Anesthetics, General|anesthetics, general|mesh-ancestor
6187064|NCT01832402|Anesthetics|anesthetics|mesh-ancestor
6187065|NCT01832532|Liraglutide|liraglutide|mesh-list
6187066|NCT01832532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6187067|NCT01832532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187068|NCT01832532|Incretins|incretins|mesh-ancestor
6187069|NCT01832532|Hormones|hormones|mesh-ancestor
6187070|NCT01832532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6187071|NCT01832727|Dexamethasone|dexamethasone|mesh-list
6187072|NCT01832727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6187073|NCT01832727|Antiemetics|antiemetics|mesh-ancestor
6187074|NCT01832727|Autonomic Agents|autonomic agents|mesh-ancestor
5580749|NCT03849885|Dermatologic Agents|dermatologic agents|mesh-ancestor
5580750|NCT03850028|Atezolizumab|atezolizumab|mesh-list
5580751|NCT03850028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5580752|NCT03849833|Vitamin D|vitamin d|mesh-list
5580753|NCT03849833|Cholecalciferol|cholecalciferol|mesh-list
5580754|NCT03849833|Vitamins|vitamins|mesh-ancestor
5580755|NCT03849833|Micronutrients|micronutrients|mesh-ancestor
5580756|NCT03849833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187075|NCT01832727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6187076|NCT01832727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187077|NCT01832727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5580757|NCT03849833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5580758|NCT03849833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6187078|NCT01832727|Glucocorticoids|glucocorticoids|mesh-ancestor
6187079|NCT01832727|Hormones|hormones|mesh-ancestor
6187080|NCT01832727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6187081|NCT01832727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6187082|NCT01832727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6187083|NCT01832766|Dronabinol|dronabinol|mesh-list
6187084|NCT01832766|Hallucinogens|hallucinogens|mesh-ancestor
6187085|NCT01832766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187086|NCT01832766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6187087|NCT01832766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6187088|NCT01832766|Analgesics|analgesics|mesh-ancestor
6187089|NCT01832766|Sensory System Agents|sensory system agents|mesh-ancestor
6187090|NCT01832766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6187091|NCT01832766|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6187092|NCT01832766|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6187093|NCT01832766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6187094|NCT01832766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5580776|NCT03849508|Phenylephrine|phenylephrine|mesh-list
5580777|NCT03849508|Oxymetazoline|oxymetazoline|mesh-list
5580778|NCT03849508|Norepinephrine|norepinephrine|mesh-list
5580779|NCT03849508|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5580780|NCT03849508|Mydriatics|mydriatics|mesh-ancestor
5580781|NCT03849508|Autonomic Agents|autonomic agents|mesh-ancestor
5580782|NCT03849508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5580783|NCT03849508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580784|NCT03849508|Sympathomimetics|sympathomimetics|mesh-ancestor
5580785|NCT03849508|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5580786|NCT03849508|Nasal Decongestants|nasal decongestants|mesh-ancestor
5580787|NCT03849508|Respiratory System Agents|respiratory system agents|mesh-ancestor
5580788|NCT03849508|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5580789|NCT03849508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5580790|NCT03849508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5580791|NCT03849508|Adrenergic Agents|adrenergic agents|mesh-ancestor
5580792|NCT03849508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5580793|NCT03849508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5580794|NCT03849508|Protective Agents|protective agents|mesh-ancestor
6187095|NCT01832766|Hormones|hormones|mesh-ancestor
6187096|NCT01832766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6187097|NCT01832961|Bronchodilator Agents|bronchodilator agents|mesh-list
6187098|NCT01832961|Autonomic Agents|autonomic agents|mesh-ancestor
6187099|NCT01832961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6187100|NCT01832961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187101|NCT01832961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5580795|NCT03849612|Insulin Lispro|insulin lispro|mesh-list
5580796|NCT03849612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6187102|NCT01832961|Respiratory System Agents|respiratory system agents|mesh-ancestor
5580797|NCT03849612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580798|NCT03849664|Riboflavin|riboflavin|mesh-list
5580799|NCT03849664|Niacinamide|niacinamide|mesh-list
5580800|NCT03849664|Niacin|niacin|mesh-list
5580801|NCT03849664|Nicotinic Acids|nicotinic acids|mesh-list
5580802|NCT03849664|Flavin Mononucleotide|flavin mononucleotide|mesh-list
5580803|NCT03849664|Povidone|povidone|mesh-list
5580804|NCT03849664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5580805|NCT03849664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580806|NCT03849664|Plasma Substitutes|plasma substitutes|mesh-ancestor
5580807|NCT03849664|Blood Substitutes|blood substitutes|mesh-ancestor
5580808|NCT03849664|Vitamin B Complex|vitamin b complex|mesh-ancestor
5580809|NCT03849664|Vitamins|vitamins|mesh-ancestor
5580810|NCT03849664|Micronutrients|micronutrients|mesh-ancestor
5580811|NCT03849664|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5580812|NCT03849664|Dermatologic Agents|dermatologic agents|mesh-ancestor
5580813|NCT03849664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5580814|NCT03849664|Antimetabolites|antimetabolites|mesh-ancestor
5580815|NCT03849664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5580816|NCT03849664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5580817|NCT03849664|Vasodilator Agents|vasodilator agents|mesh-ancestor
5580818|NCT03849729|Phentermine|phentermine|mesh-list
5580819|NCT03849729|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6187103|NCT01833026|Albuterol|albuterol|mesh-list
6187104|NCT01833026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6187105|NCT01833026|Autonomic Agents|autonomic agents|mesh-ancestor
6187106|NCT01833026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6187107|NCT01833026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187108|NCT01833026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6187109|NCT01833026|Respiratory System Agents|respiratory system agents|mesh-ancestor
6187110|NCT01833026|Tocolytic Agents|tocolytic agents|mesh-ancestor
6187111|NCT01833026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6187112|NCT01833026|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6187113|NCT01833026|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6187114|NCT01833026|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6187115|NCT01833026|Adrenergic Agents|adrenergic agents|mesh-ancestor
6187116|NCT01833026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6187117|NCT01833026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187118|NCT01833130|Botulinum Toxins|botulinum toxins|mesh-list
6187119|NCT01833130|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6187120|NCT01833130|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6187121|NCT01833130|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6187122|NCT01833130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6187123|NCT01833130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187124|NCT01833130|Cholinergic Agents|cholinergic agents|mesh-ancestor
6187125|NCT01833130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6187126|NCT01833130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187127|NCT01833130|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6187128|NCT01833130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6187129|NCT01833143|Acyclovir|acyclovir|mesh-list
6187130|NCT01833143|Bortezomib|bortezomib|mesh-list
6187131|NCT01833143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6187132|NCT01833143|Antiviral Agents|antiviral agents|mesh-ancestor
6187133|NCT01833143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6187134|NCT01833455|Flecainide|flecainide|mesh-list
6187135|NCT01833455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6187136|NCT01833455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6187137|NCT01833455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6187138|NCT01833455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6187139|NCT01833455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187140|NCT01833533|Ribavirin|ribavirin|mesh-list
6187141|NCT01833533|Antimetabolites|antimetabolites|mesh-ancestor
6187142|NCT01833533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187143|NCT01833533|Antiviral Agents|antiviral agents|mesh-ancestor
6187144|NCT01833533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6187145|NCT01833546|Gemcitabine|gemcitabine|mesh-list
6187146|NCT01833546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6187147|NCT01833546|Antimetabolites|antimetabolites|mesh-ancestor
6187148|NCT01833546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187149|NCT01833546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5580820|NCT03849729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580821|NCT03849729|Appetite Depressants|appetite depressants|mesh-ancestor
6187150|NCT01833546|Antiviral Agents|antiviral agents|mesh-ancestor
5580822|NCT03849729|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5580823|NCT03849729|Sympathomimetics|sympathomimetics|mesh-ancestor
5580824|NCT03849729|Autonomic Agents|autonomic agents|mesh-ancestor
5580825|NCT03849729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6187151|NCT01833546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6187152|NCT01833546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6187153|NCT01833546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6187154|NCT01833546|Immunologic Factors|immunologic factors|mesh-ancestor
6187155|NCT01833546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187156|NCT01833741|Bimatoprost|bimatoprost|mesh-list
6187157|NCT01833741|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6187158|NCT01833832|Sodium thiosulfate|sodium thiosulfate|mesh-list
6187159|NCT01833832|Antidotes|antidotes|mesh-ancestor
6187160|NCT01833832|Protective Agents|protective agents|mesh-ancestor
6187161|NCT01833832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187162|NCT01833832|Antioxidants|antioxidants|mesh-ancestor
6187163|NCT01833832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187164|NCT01833832|Antitubercular Agents|antitubercular agents|mesh-ancestor
6187165|NCT01833832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6187166|NCT01833832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6187167|NCT01833832|Chelating Agents|chelating agents|mesh-ancestor
6187168|NCT01833832|Sequestering Agents|sequestering agents|mesh-ancestor
6187169|NCT01833845|Ribavirin|ribavirin|mesh-list
6187170|NCT01833845|Hydroxychloroquine|hydroxychloroquine|mesh-list
6187171|NCT01833845|Antimetabolites|antimetabolites|mesh-ancestor
6187172|NCT01833845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187173|NCT01833845|Antiviral Agents|antiviral agents|mesh-ancestor
6187174|NCT01833845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6187175|NCT01833845|Antimalarials|antimalarials|mesh-ancestor
6187176|NCT01833845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6187177|NCT01833845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6187178|NCT01833845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6187179|NCT01833845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6187180|NCT01833897|Cycloserine|cycloserine|mesh-list
6187181|NCT01833897|Ketamine|ketamine|mesh-list
6187182|NCT01833897|Olanzapine|olanzapine|mesh-list
6187183|NCT01833897|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6187184|NCT01833897|Fluoxetine|fluoxetine|mesh-list
6187185|NCT01833897|Analgesics|analgesics|mesh-ancestor
6187186|NCT01833897|Sensory System Agents|sensory system agents|mesh-ancestor
6187187|NCT01833897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6187188|NCT01833897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580826|NCT03849729|Adrenergic Agents|adrenergic agents|mesh-ancestor
5580827|NCT03849729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5580828|NCT03849729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5580829|NCT03849534|Salicylic Acid|salicylic acid|mesh-list
5580830|NCT03849534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5580831|NCT03849534|Antifungal Agents|antifungal agents|mesh-ancestor
5580832|NCT03849534|Keratolytic Agents|keratolytic agents|mesh-ancestor
5580833|NCT03849534|Dermatologic Agents|dermatologic agents|mesh-ancestor
5580834|NCT03849404|Adalimumab|adalimumab|mesh-list
6187189|NCT01833897|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6187190|NCT01833897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6187191|NCT01833897|Anesthetics, General|anesthetics, general|mesh-ancestor
6187192|NCT01833897|Anesthetics|anesthetics|mesh-ancestor
6187193|NCT01833897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6187194|NCT01833897|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6187195|NCT01833897|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6187196|NCT01833897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5580835|NCT03849404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5580836|NCT03849404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5580837|NCT03849209|Pancrelipase|pancrelipase|mesh-list
5580838|NCT03849209|Pancreatin|pancreatin|mesh-list
5580839|NCT03849209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6187197|NCT01833897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187198|NCT01833897|Antiemetics|antiemetics|mesh-ancestor
6187199|NCT01833897|Autonomic Agents|autonomic agents|mesh-ancestor
6187200|NCT01833897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6187201|NCT01833897|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6187202|NCT01833897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6187203|NCT01833897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6187204|NCT01833897|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6187205|NCT01833897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6187206|NCT01833897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6187207|NCT01833897|Serotonin Agents|serotonin agents|mesh-ancestor
6187208|NCT01833897|Antidepressive Agents|antidepressive agents|mesh-ancestor
6187209|NCT01833897|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6187210|NCT01833897|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6187211|NCT01833897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6187212|NCT01833897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6187213|NCT01833897|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6187214|NCT01833897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6187215|NCT01833897|Renal Agents|renal agents|mesh-ancestor
6187216|NCT01833897|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6187217|NCT01833897|Antitubercular Agents|antitubercular agents|mesh-ancestor
6187218|NCT01833897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6187219|NCT01833897|Antimetabolites|antimetabolites|mesh-ancestor
6187220|NCT01833988|Pancrelipase|pancrelipase|mesh-list
6187221|NCT01833988|Pancreatin|pancreatin|mesh-list
6187222|NCT01833988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6187223|NCT01834261|Oxytocin|oxytocin|mesh-list
6187224|NCT01834261|Oxytocics|oxytocics|mesh-ancestor
6187225|NCT01834261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6187226|NCT01834261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187227|NCT01834274|Metformin|metformin|mesh-list
6187228|NCT01834274|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6187229|NCT01834274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6187230|NCT01834274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187231|NCT01834274|Incretins|incretins|mesh-ancestor
6187232|NCT01834274|Hormones|hormones|mesh-ancestor
6187233|NCT01834274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6187234|NCT01834274|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6187235|NCT01834274|Protease Inhibitors|protease inhibitors|mesh-ancestor
5580840|NCT03849183|Nitroglycerin|nitroglycerin|mesh-list
5580841|NCT03849183|Vasodilator Agents|vasodilator agents|mesh-ancestor
5580842|NCT03849235|Glucagon|glucagon|mesh-list
5580843|NCT03849235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5580844|NCT03849235|Hormones|hormones|mesh-ancestor
5580845|NCT03849235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5580846|NCT03849235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580847|NCT03849313|Adalimumab|adalimumab|mesh-list
5580848|NCT03849313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6187236|NCT01834274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6187237|NCT01834274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187238|NCT01834404|Topiramate|topiramate|mesh-list
6187239|NCT01834404|Phentermine|phentermine|mesh-list
6187240|NCT01834404|Anticonvulsants|anticonvulsants|mesh-ancestor
6187241|NCT01834404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6187242|NCT01834404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187243|NCT01834404|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6187244|NCT01834404|Appetite Depressants|appetite depressants|mesh-ancestor
6187245|NCT01834404|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6187246|NCT01834404|Sympathomimetics|sympathomimetics|mesh-ancestor
6187247|NCT01834404|Autonomic Agents|autonomic agents|mesh-ancestor
6187248|NCT01834404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6187249|NCT01834404|Adrenergic Agents|adrenergic agents|mesh-ancestor
6187250|NCT01834404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6187251|NCT01834404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187252|NCT01834586|Anesthetics|anesthetics|mesh-list
6187253|NCT01834586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6187254|NCT01834586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187255|NCT01834729|Alfuzosin|alfuzosin|mesh-list
6187256|NCT01834729|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6187257|NCT01834729|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6187258|NCT01834729|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5580849|NCT03849313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5580850|NCT03849196|Bisacodyl|bisacodyl|mesh-list
5580851|NCT03849196|Cathartics|cathartics|mesh-ancestor
5580852|NCT03849196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5580853|NCT03849196|Laxatives|laxatives|mesh-ancestor
5580854|NCT03849170|Vaccines|vaccines|mesh-list
5580855|NCT03849170|Immunologic Factors|immunologic factors|mesh-ancestor
5580856|NCT03849170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604888|NCT04078568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5604889|NCT04078568|Immunologic Factors|immunologic factors|mesh-ancestor
6187259|NCT01834729|Adrenergic Agents|adrenergic agents|mesh-ancestor
6187260|NCT01834729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6187261|NCT01834729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187262|NCT01834729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187263|NCT01834729|Urological Agents|urological agents|mesh-ancestor
6187264|NCT01835158|Sunitinib|sunitinib|mesh-list
6187265|NCT01835158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6187266|NCT01835158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6187267|NCT01835158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6187268|NCT01835158|Growth Substances|growth substances|mesh-ancestor
6187269|NCT01835158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187270|NCT01835158|Growth Inhibitors|growth inhibitors|mesh-ancestor
6187271|NCT01835158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6187272|NCT01835158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6187273|NCT01835158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187274|NCT01835262|Morphine|morphine|mesh-list
6187275|NCT01835262|Ketamine|ketamine|mesh-list
6187276|NCT01835262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6187277|NCT01835262|Narcotics|narcotics|mesh-ancestor
6187278|NCT01835262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6187279|NCT01835262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187280|NCT01835262|Analgesics|analgesics|mesh-ancestor
6187281|NCT01835262|Sensory System Agents|sensory system agents|mesh-ancestor
6187282|NCT01835262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6187283|NCT01835262|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6187284|NCT01835262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6187285|NCT01835262|Anesthetics, General|anesthetics, general|mesh-ancestor
6187286|NCT01835262|Anesthetics|anesthetics|mesh-ancestor
6187287|NCT01835262|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6187288|NCT01835262|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6187289|NCT01835262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6187290|NCT01835262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187291|NCT01835431|Insulin|insulin|mesh-list
6187292|NCT01835431|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6187293|NCT01835431|Insulin Aspart|insulin aspart|mesh-list
6187294|NCT01835431|Insulin, Long-Acting|insulin, long-acting|mesh-list
5604899|NCT03994601|Nivolumab|nivolumab|mesh-list
5604900|NCT03994601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5604901|NCT03994601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5604902|NCT03994601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6187295|NCT01835431|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6187296|NCT01835431|Insulin Detemir|insulin detemir|mesh-list
6187297|NCT01835431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6187298|NCT01835431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187299|NCT01835470|Abatacept|abatacept|mesh-list
6187300|NCT01835470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6187301|NCT01835470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187302|NCT01835470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6187303|NCT01835470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6187304|NCT01835470|Immunologic Factors|immunologic factors|mesh-ancestor
6187305|NCT01835470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187306|NCT01835470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6187307|NCT01835496|Deferiprone|deferiprone|mesh-list
6187308|NCT01835496|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6187309|NCT01835496|Chelating Agents|chelating agents|mesh-ancestor
5606883|NCT03517969|Docetaxel|docetaxel|mesh-list
6187310|NCT01835496|Sequestering Agents|sequestering agents|mesh-ancestor
6187311|NCT01835496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187312|NCT01835587|Cc-486|cc-486|mesh-list
6187313|NCT01835587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6187314|NCT01835912|Citric Acid|citric acid|mesh-list
6187315|NCT01835912|Sodium Citrate|sodium citrate|mesh-list
6187316|NCT01835912|Anticoagulants|anticoagulants|mesh-ancestor
6187317|NCT01835912|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6187318|NCT01835912|Chelating Agents|chelating agents|mesh-ancestor
6187319|NCT01835912|Sequestering Agents|sequestering agents|mesh-ancestor
6187320|NCT01835912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187321|NCT01836029|Carboplatin|carboplatin|mesh-list
6187322|NCT01836029|Fluorouracil|fluorouracil|mesh-list
6187323|NCT01836029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6187324|NCT01836029|Antimetabolites|antimetabolites|mesh-ancestor
6187325|NCT01836029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187326|NCT01836029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6187327|NCT01836029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6187328|NCT01836029|Immunologic Factors|immunologic factors|mesh-ancestor
6187329|NCT01836029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187330|NCT01836133|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6187331|NCT01836133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6187332|NCT01836133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6187333|NCT01836133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6187334|NCT01836133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187335|NCT01836185|Evacetrapib|evacetrapib|mesh-list
6187336|NCT01836185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6187337|NCT01836185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6187338|NCT01836185|Antimetabolites|antimetabolites|mesh-ancestor
6187339|NCT01836185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187340|NCT01836185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6187341|NCT01836198|Clarithromycin|clarithromycin|mesh-list
6187342|NCT01836198|Ketoconazole|ketoconazole|mesh-list
6187343|NCT01836198|Gemfibrozil|gemfibrozil|mesh-list
6187344|NCT01836198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6187345|NCT01836198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6187346|NCT01836198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6187347|NCT01836198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6187348|NCT01836198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187349|NCT01836198|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6187350|NCT01836198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6187351|NCT01836198|Antifungal Agents|antifungal agents|mesh-ancestor
6187352|NCT01836198|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6187353|NCT01836198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6187354|NCT01836198|Hormone Antagonists|hormone antagonists|mesh-ancestor
6187355|NCT01836198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6187356|NCT01836198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187357|NCT01836198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6187358|NCT01836198|Antimetabolites|antimetabolites|mesh-ancestor
6187359|NCT01836198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6187360|NCT01836198|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6187361|NCT01836276|Varenicline|varenicline|mesh-list
5580857|NCT03849027|Methoxyflurane|methoxyflurane|mesh-list
5580858|NCT03849027|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5580859|NCT03849027|Anesthetics, General|anesthetics, general|mesh-ancestor
5580860|NCT03849027|Anesthetics|anesthetics|mesh-ancestor
5580861|NCT03849027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5580862|NCT03849027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580863|NCT03848611|Vorolanib|vorolanib|mesh-list
5580864|NCT03848611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5580865|NCT03848611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6187362|NCT01836276|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6187363|NCT01836276|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6187364|NCT01836276|Cholinergic Agents|cholinergic agents|mesh-ancestor
6187365|NCT01836276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6187366|NCT01836276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187367|NCT01836276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187368|NCT01836471|Fluticasone|fluticasone|mesh-list
6187369|NCT01836471|Xhance|xhance|mesh-list
6187370|NCT01836471|Indoleacetic Acids|indoleacetic acids|mesh-list
6187371|NCT01836471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6187372|NCT01836471|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6187373|NCT01836471|Autonomic Agents|autonomic agents|mesh-ancestor
6206979|NCT02107274|Azithromycin|azithromycin|mesh-list
5580866|NCT03848611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5580867|NCT03848767|Insulin Lispro|insulin lispro|mesh-list
5580868|NCT03848767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5580869|NCT03848767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580870|NCT03848806|Calcitriol|calcitriol|mesh-list
5580871|NCT03848806|Calcipotriene|calcipotriene|mesh-list
5580872|NCT03848806|Dermatologic Agents|dermatologic agents|mesh-ancestor
5580873|NCT03848806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5580874|NCT03848806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580875|NCT03848806|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6187374|NCT01836471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6187375|NCT01836471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187376|NCT01836471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6187377|NCT01836471|Respiratory System Agents|respiratory system agents|mesh-ancestor
6187378|NCT01836471|Dermatologic Agents|dermatologic agents|mesh-ancestor
6187379|NCT01836471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6187380|NCT01836471|Plant Growth Regulators|plant growth regulators|mesh-ancestor
6187381|NCT01836471|Growth Substances|growth substances|mesh-ancestor
6187382|NCT01836523|Liraglutide|liraglutide|mesh-list
6187383|NCT01836523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6187384|NCT01836523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187385|NCT01836523|Incretins|incretins|mesh-ancestor
6187386|NCT01836523|Hormones|hormones|mesh-ancestor
6187387|NCT01836523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6187388|NCT01836549|Imetelstat|imetelstat|mesh-list
6187389|NCT01836549|Motesanib diphosphate|motesanib diphosphate|mesh-list
6187390|NCT01836549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6187391|NCT01836549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187392|NCT01836549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6187393|NCT01837069|Metoprolol|metoprolol|mesh-list
6187394|NCT01837069|Lisinopril|lisinopril|mesh-list
6187395|NCT01837069|Atorvastatin|atorvastatin|mesh-list
6187396|NCT01837069|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6187397|NCT01837069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6187398|NCT01837069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6187399|NCT01837069|Antimetabolites|antimetabolites|mesh-ancestor
6187400|NCT01837069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187401|NCT01837069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6187402|NCT01837069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6187403|NCT01837069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6187404|NCT01837069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6187405|NCT01837069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6187406|NCT01837069|Sympatholytics|sympatholytics|mesh-ancestor
6187407|NCT01837069|Autonomic Agents|autonomic agents|mesh-ancestor
6187408|NCT01837069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6187409|NCT01837069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187410|NCT01837069|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6187411|NCT01837069|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6187412|NCT01837069|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6187413|NCT01837069|Adrenergic Agents|adrenergic agents|mesh-ancestor
6187414|NCT01837069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6187415|NCT01837069|Protease Inhibitors|protease inhibitors|mesh-ancestor
6187416|NCT01837069|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6187417|NCT01837069|Protective Agents|protective agents|mesh-ancestor
6187418|NCT01837680|Insulin|insulin|mesh-list
6187419|NCT01837680|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5580876|NCT03848806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5580877|NCT03848806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5580878|NCT03848806|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5580879|NCT03848806|Vitamins|vitamins|mesh-ancestor
5580880|NCT03848806|Micronutrients|micronutrients|mesh-ancestor
5580881|NCT03848806|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5580882|NCT03848533|Metformin|metformin|mesh-list
6187420|NCT01837680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6187421|NCT01837680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187422|NCT01837719|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6187423|NCT01837719|Cobicistat|cobicistat|mesh-list
6187424|NCT01837719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6187425|NCT01837719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6187426|NCT01837719|Protease Inhibitors|protease inhibitors|mesh-ancestor
6187427|NCT01837719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6187428|NCT01837719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187429|NCT01837719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6187430|NCT01837719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6187431|NCT01837719|Antiviral Agents|antiviral agents|mesh-ancestor
5580883|NCT03848533|Melatonin|melatonin|mesh-list
5580884|NCT03848533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5580885|NCT03848533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580886|NCT03848533|Antioxidants|antioxidants|mesh-ancestor
5580887|NCT03848533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5580888|NCT03848533|Protective Agents|protective agents|mesh-ancestor
5580889|NCT03848533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5580890|NCT03848182|Gemcitabine|gemcitabine|mesh-list
6187432|NCT01837719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6187433|NCT01837719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6187434|NCT01837719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6187435|NCT01837797|Brexpiprazole|brexpiprazole|mesh-list
6187436|NCT01837797|Serotonin Agents|serotonin agents|mesh-ancestor
6187437|NCT01837797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6187438|NCT01837797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187439|NCT01837797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187440|NCT01837797|Dopamine Agonists|dopamine agonists|mesh-ancestor
6187441|NCT01837797|Dopamine Agents|dopamine agents|mesh-ancestor
6187442|NCT01837823|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6187443|NCT01837823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6187444|NCT01837823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6187445|NCT01837823|Antimetabolites|antimetabolites|mesh-ancestor
6187446|NCT01837823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187447|NCT01837823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6187448|NCT01837823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6187449|NCT01837823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6187450|NCT01838044|Celecoxib|celecoxib|mesh-list
6187451|NCT01838044|Pregabalin|pregabalin|mesh-list
6187452|NCT01838044|Analgesics|analgesics|mesh-ancestor
6187453|NCT01838044|Sensory System Agents|sensory system agents|mesh-ancestor
6187454|NCT01838044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6187455|NCT01838044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187456|NCT01838044|Anticonvulsants|anticonvulsants|mesh-ancestor
6187457|NCT01838044|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6187458|NCT01838044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6187459|NCT01838044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187460|NCT01838044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6187461|NCT01838044|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6187462|NCT01838044|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6187463|NCT01838044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6187464|NCT01838044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6187465|NCT01838044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6187466|NCT01838044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5580891|NCT03848182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5580892|NCT03848182|Antimetabolites|antimetabolites|mesh-ancestor
5580893|NCT03848182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5580894|NCT03848182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5580895|NCT03848182|Antiviral Agents|antiviral agents|mesh-ancestor
5580896|NCT03848182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5580897|NCT03848182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5580898|NCT03848182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5580899|NCT03848182|Immunologic Factors|immunologic factors|mesh-ancestor
5580900|NCT03848182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580901|NCT03848780|Desflurane|desflurane|mesh-list
6187467|NCT01838044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6187468|NCT01838044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6187469|NCT01838044|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6187470|NCT01838044|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6187471|NCT01838044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6187472|NCT01838200|Isoniazid|isoniazid|mesh-list
5580902|NCT03848780|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5580903|NCT03848780|Anesthetics, General|anesthetics, general|mesh-ancestor
5580904|NCT03848780|Anesthetics|anesthetics|mesh-ancestor
5580905|NCT03848780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5580906|NCT03848780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580907|NCT03848234|Estradiol|estradiol|mesh-list
5580908|NCT03848234|Estrogens|estrogens|mesh-ancestor
5580909|NCT03848234|Hormones|hormones|mesh-ancestor
5580910|NCT03848234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5580911|NCT03848234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580912|NCT03848104|Cefoxitin|cefoxitin|mesh-list
6187473|NCT01838200|Ipilimumab|ipilimumab|mesh-list
6187474|NCT01838200|BCG Vaccine|bcg vaccine|mesh-list
6187475|NCT01838200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6187476|NCT01838200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6187477|NCT01838200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5580913|NCT03848104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5580914|NCT03848104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5580915|NCT03848065|Vaccines|vaccines|mesh-list
5580916|NCT03848065|Immunologic Factors|immunologic factors|mesh-ancestor
5580917|NCT03848065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580918|NCT03848091|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5580919|NCT03848091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5580920|NCT03848039|Vaccines|vaccines|mesh-list
6187478|NCT01838200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187479|NCT01838200|Antitubercular Agents|antitubercular agents|mesh-ancestor
5580921|NCT03848039|Immunologic Factors|immunologic factors|mesh-ancestor
5580922|NCT03848039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580923|NCT03847818|Carboplatin|carboplatin|mesh-list
5580924|NCT03847818|Docetaxel|docetaxel|mesh-list
5580925|NCT03847818|Trastuzumab|trastuzumab|mesh-list
6187480|NCT01838200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6187481|NCT01838200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6187482|NCT01838200|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6187483|NCT01838200|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6187484|NCT01838200|Antimetabolites|antimetabolites|mesh-ancestor
6187485|NCT01838200|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6187486|NCT01838200|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6187487|NCT01838200|Immunologic Factors|immunologic factors|mesh-ancestor
6187488|NCT01838200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206980|NCT02107274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6206981|NCT02107274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6206982|NCT02107339|Methadone|methadone|mesh-list
6206983|NCT02107339|Hydromorphone|hydromorphone|mesh-list
6206984|NCT02107339|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6206985|NCT02107339|Narcotics|narcotics|mesh-ancestor
6206986|NCT02107339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6206987|NCT02107339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6206988|NCT02107339|Analgesics|analgesics|mesh-ancestor
6206989|NCT02107339|Sensory System Agents|sensory system agents|mesh-ancestor
6206990|NCT02107339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5580926|NCT03847818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5580927|NCT03847818|Tubulin Modulators|tubulin modulators|mesh-ancestor
5580928|NCT03847818|Antimitotic Agents|antimitotic agents|mesh-ancestor
5580929|NCT03847818|Mitosis Modulators|mitosis modulators|mesh-ancestor
5580930|NCT03847818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5580931|NCT03847818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5580932|NCT03847792|Dexamethasone|dexamethasone|mesh-list
5580933|NCT03847792|Fentanyl|fentanyl|mesh-list
6206991|NCT02107339|Antitussive Agents|antitussive agents|mesh-ancestor
6206992|NCT02107339|Respiratory System Agents|respiratory system agents|mesh-ancestor
6206993|NCT02107703|Fulvestrant|fulvestrant|mesh-list
6206994|NCT02107703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6206995|NCT02107703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6206996|NCT02107703|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6206997|NCT02107703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6206998|NCT02107703|Hormone Antagonists|hormone antagonists|mesh-ancestor
6206999|NCT02107703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6207000|NCT02107703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207001|NCT02107898|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6207002|NCT02107898|Immunologic Factors|immunologic factors|mesh-ancestor
6207003|NCT02107898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207004|NCT02108171|Dexmedetomidine|dexmedetomidine|mesh-list
5580934|NCT03847792|Bupivacaine|bupivacaine|mesh-list
5580935|NCT03847792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5580936|NCT03847792|Antiemetics|antiemetics|mesh-ancestor
5580937|NCT03847792|Autonomic Agents|autonomic agents|mesh-ancestor
5580938|NCT03847792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5580939|NCT03847792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580940|NCT03847792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5580941|NCT03847792|Glucocorticoids|glucocorticoids|mesh-ancestor
5580942|NCT03847792|Hormones|hormones|mesh-ancestor
5580943|NCT03847792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5580944|NCT03847792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5580945|NCT03847792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5580946|NCT03847792|Anesthetics, Local|anesthetics, local|mesh-ancestor
5580947|NCT03847792|Anesthetics|anesthetics|mesh-ancestor
5580948|NCT03847792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5580949|NCT03847792|Sensory System Agents|sensory system agents|mesh-ancestor
5580950|NCT03847792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5580951|NCT03847792|Narcotics|narcotics|mesh-ancestor
5580952|NCT03847792|Analgesics|analgesics|mesh-ancestor
5580953|NCT03847792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6187489|NCT01838317|Pioglitazone|pioglitazone|mesh-list
6187490|NCT01838317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5580954|NCT03847792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5580955|NCT03847792|Anesthetics, General|anesthetics, general|mesh-ancestor
5580956|NCT03847857|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
5580957|NCT03847857|Hemostatics|hemostatics|mesh-ancestor
5580958|NCT03847857|Coagulants|coagulants|mesh-ancestor
5580959|NCT03847571|Acetazolamide|acetazolamide|mesh-list
5580960|NCT03847571|Anticonvulsants|anticonvulsants|mesh-ancestor
5580961|NCT03847571|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5580962|NCT03847571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5580963|NCT03847571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5580964|NCT03847571|Diuretics|diuretics|mesh-ancestor
5580965|NCT03847571|Natriuretic Agents|natriuretic agents|mesh-ancestor
5580966|NCT03847571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580967|NCT03847922|Lidocaine|lidocaine|mesh-list
5580968|NCT03847922|Nitrous Oxide|nitrous oxide|mesh-list
5580969|NCT03847922|Anesthetics, Local|anesthetics, local|mesh-ancestor
5580970|NCT03847922|Anesthetics|anesthetics|mesh-ancestor
5580971|NCT03847922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5580972|NCT03847922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580973|NCT03847922|Sensory System Agents|sensory system agents|mesh-ancestor
5580974|NCT03847922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5580975|NCT03847922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5580976|NCT03847922|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5580977|NCT03847922|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5580978|NCT03847922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5580979|NCT03847922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5580980|NCT03847922|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6187491|NCT01838317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187492|NCT01838447|Vitamin D|vitamin d|mesh-list
6187493|NCT01838447|Cholecalciferol|cholecalciferol|mesh-list
6187494|NCT01838447|Vitamins|vitamins|mesh-ancestor
6187495|NCT01838447|Micronutrients|micronutrients|mesh-ancestor
6187496|NCT01838447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187497|NCT01838447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5580981|NCT03847922|Anesthetics, General|anesthetics, general|mesh-ancestor
5580982|NCT03847922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5580983|NCT03847922|Analgesics|analgesics|mesh-ancestor
5580984|NCT03847896|Budesonide|budesonide|mesh-list
5580985|NCT03847896|Albuterol|albuterol|mesh-list
5580986|NCT03847896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5580987|NCT03847896|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5580988|NCT03847896|Autonomic Agents|autonomic agents|mesh-ancestor
5580989|NCT03847896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5580990|NCT03847896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5580991|NCT03847896|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5580992|NCT03847896|Respiratory System Agents|respiratory system agents|mesh-ancestor
5580993|NCT03847896|Glucocorticoids|glucocorticoids|mesh-ancestor
5580994|NCT03847896|Hormones|hormones|mesh-ancestor
5580995|NCT03847896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5580996|NCT03847896|Tocolytic Agents|tocolytic agents|mesh-ancestor
5580997|NCT03847896|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5580998|NCT03847896|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5580999|NCT03847896|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5581000|NCT03847896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5581001|NCT03847896|Adrenergic Agents|adrenergic agents|mesh-ancestor
5581002|NCT03847896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5581003|NCT03847896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581004|NCT03847506|Amlodipine|amlodipine|mesh-list
5581005|NCT03847506|Candesartan|candesartan|mesh-list
5581006|NCT03847506|Candesartan cilexetil|candesartan cilexetil|mesh-list
5581007|NCT03847506|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5581008|NCT03847506|Ezetimibe|ezetimibe|mesh-list
5581009|NCT03847506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5581010|NCT03847506|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5581011|NCT03847506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5581012|NCT03847506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581013|NCT03847506|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5581014|NCT03847506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581015|NCT03847506|Vasodilator Agents|vasodilator agents|mesh-ancestor
5581016|NCT03847506|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5581017|NCT03847506|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5581018|NCT03847506|Antimetabolites|antimetabolites|mesh-ancestor
6187498|NCT01838447|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6187499|NCT01838590|Sofosbuvir|sofosbuvir|mesh-list
5581019|NCT03847506|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5581020|NCT03847506|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6187500|NCT01838590|Antiviral Agents|antiviral agents|mesh-ancestor
6187501|NCT01838590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6187502|NCT01838616|Oxycodone|oxycodone|mesh-list
6187503|NCT01838616|Tapentadol|tapentadol|mesh-list
6187504|NCT01838616|Naloxone|naloxone|mesh-list
6187505|NCT01838616|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6187506|NCT01838616|Narcotics|narcotics|mesh-ancestor
6187507|NCT01838616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5581021|NCT03847506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5581022|NCT03847506|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5581023|NCT03847506|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5581024|NCT03847545|4-Aminopyridine|4-aminopyridine|mesh-list
5581025|NCT03847545|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5581026|NCT03847545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5581027|NCT03847545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581028|NCT03847623|Curcumin|curcumin|mesh-list
5581029|NCT03847623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5581030|NCT03847623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5581031|NCT03847623|Analgesics|analgesics|mesh-ancestor
5581032|NCT03847623|Sensory System Agents|sensory system agents|mesh-ancestor
5581033|NCT03847623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5581034|NCT03847623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581035|NCT03847623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5581036|NCT03847623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5581037|NCT03847623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5581038|NCT03847623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5581039|NCT03847623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581040|NCT03847558|Hormones|hormones|mesh-list
6187508|NCT01838616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187509|NCT01838616|Analgesics|analgesics|mesh-ancestor
6187510|NCT01838616|Sensory System Agents|sensory system agents|mesh-ancestor
6187511|NCT01838616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6187512|NCT01838616|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6187513|NCT01838616|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6187514|NCT01838616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6187515|NCT01838616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6187516|NCT01838616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187517|NCT01838616|Adrenergic Agents|adrenergic agents|mesh-ancestor
6187518|NCT01838616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6187519|NCT01838642|Ponatinib|ponatinib|mesh-list
6187520|NCT01838642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6187521|NCT01838642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6187522|NCT01838642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6187523|NCT01838642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187524|NCT01838655|Nitisinone|nitisinone|mesh-list
6187525|NCT01838655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6187526|NCT01838655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187527|NCT01838681|Brexpiprazole|brexpiprazole|mesh-list
6187528|NCT01838681|Serotonin Agents|serotonin agents|mesh-ancestor
6187529|NCT01838681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6187530|NCT01838681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187531|NCT01838681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187532|NCT01838681|Dopamine Agonists|dopamine agonists|mesh-ancestor
6187533|NCT01838681|Dopamine Agents|dopamine agents|mesh-ancestor
6187534|NCT01838876|Cariprazine|cariprazine|mesh-list
6187535|NCT01838876|Antidepressive Agents|antidepressive agents|mesh-list
6187536|NCT01838876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6187537|NCT01838876|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6187538|NCT01838876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6187539|NCT01838876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6187540|NCT01838876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187541|NCT01838941|Betaine|betaine|mesh-list
6187542|NCT01838941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6187543|NCT01838941|Lipotropic Agents|lipotropic agents|mesh-ancestor
6187544|NCT01838941|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6187545|NCT01838941|Antimetabolites|antimetabolites|mesh-ancestor
6187546|NCT01838941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187547|NCT01838941|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6187548|NCT01839110|Ranolazine|ranolazine|mesh-list
6187549|NCT01839110|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6187550|NCT01839110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6187551|NCT01839110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581041|NCT03847558|Testosterone|testosterone|mesh-list
5581042|NCT03847558|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5581043|NCT03847558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5581044|NCT03847558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581045|NCT03847558|Androgens|androgens|mesh-ancestor
5581046|NCT03847363|Anesthetics|anesthetics|mesh-list
5581047|NCT03847363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5581048|NCT03847363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581049|NCT03847207|Pasireotide|pasireotide|mesh-list
5581050|NCT03847207|Hormones|hormones|mesh-ancestor
5581051|NCT03847207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5581052|NCT03847207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581053|NCT03847246|Entecavir|entecavir|mesh-list
6187552|NCT01839188|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6187553|NCT01839188|Immunologic Factors|immunologic factors|mesh-ancestor
6187554|NCT01839188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187555|NCT01839279|Moxifloxacin|moxifloxacin|mesh-list
6187556|NCT01839279|Tizanidine|tizanidine|mesh-list
6187557|NCT01839279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6187558|NCT01839279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6187559|NCT01839279|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6187560|NCT01839279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6187561|NCT01839279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6187562|NCT01839279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187563|NCT01839279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6187564|NCT01839279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187565|NCT01839279|Analgesics|analgesics|mesh-ancestor
6187566|NCT01839279|Sensory System Agents|sensory system agents|mesh-ancestor
6187567|NCT01839279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6187568|NCT01839279|Anticonvulsants|anticonvulsants|mesh-ancestor
6187569|NCT01839279|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5581054|NCT03847246|Antiviral Agents|antiviral agents|mesh-ancestor
5581055|NCT03847246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5604903|NCT03994601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604904|NCT03985371|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5604905|NCT03985371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5604906|NCT03979365|Tacrolimus|tacrolimus|mesh-list
5604907|NCT03979365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5604908|NCT03979365|Immunologic Factors|immunologic factors|mesh-ancestor
5604909|NCT03979365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604910|NCT03979365|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6187570|NCT01839279|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6187571|NCT01839279|Parasympatholytics|parasympatholytics|mesh-ancestor
6187572|NCT01839279|Autonomic Agents|autonomic agents|mesh-ancestor
6187573|NCT01839279|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6187574|NCT01839279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6187575|NCT01839279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6187576|NCT01839279|Adrenergic Agents|adrenergic agents|mesh-ancestor
6187577|NCT01839279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6187578|NCT01839487|Gemcitabine|gemcitabine|mesh-list
6187579|NCT01839487|Dexamethasone|dexamethasone|mesh-list
6187580|NCT01839487|Paclitaxel|paclitaxel|mesh-list
6187581|NCT01839487|Enoxaparin|enoxaparin|mesh-list
6187582|NCT01839487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6187583|NCT01839487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6187584|NCT01839487|Tubulin Modulators|tubulin modulators|mesh-ancestor
6187585|NCT01839487|Antimitotic Agents|antimitotic agents|mesh-ancestor
6187586|NCT01839487|Mitosis Modulators|mitosis modulators|mesh-ancestor
6187587|NCT01839487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187588|NCT01839487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6187589|NCT01839487|Antiemetics|antiemetics|mesh-ancestor
6187590|NCT01839487|Autonomic Agents|autonomic agents|mesh-ancestor
6187591|NCT01839487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6187592|NCT01839487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187593|NCT01839487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6187594|NCT01839487|Glucocorticoids|glucocorticoids|mesh-ancestor
6187595|NCT01839487|Hormones|hormones|mesh-ancestor
6187596|NCT01839487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6187597|NCT01839487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6187598|NCT01839487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6187599|NCT01839487|Antimetabolites|antimetabolites|mesh-ancestor
6187600|NCT01839487|Antiviral Agents|antiviral agents|mesh-ancestor
6187601|NCT01839487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6187602|NCT01839487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6187603|NCT01839487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5581056|NCT03847155|Nicotine|nicotine|mesh-list
5581057|NCT03847155|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6187604|NCT01839487|Immunologic Factors|immunologic factors|mesh-ancestor
6187605|NCT01839487|Anticoagulants|anticoagulants|mesh-ancestor
6187606|NCT01839487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6187607|NCT01839487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6187608|NCT01839799|Gemcitabine|gemcitabine|mesh-list
6187609|NCT01839799|Paclitaxel|paclitaxel|mesh-list
6187610|NCT01839799|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6187611|NCT01839799|Folfirinox|folfirinox|mesh-list
6187612|NCT01839799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6187613|NCT01839799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6187614|NCT01839799|Tubulin Modulators|tubulin modulators|mesh-ancestor
6187615|NCT01839799|Antimitotic Agents|antimitotic agents|mesh-ancestor
6187616|NCT01839799|Mitosis Modulators|mitosis modulators|mesh-ancestor
6187617|NCT01839799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187618|NCT01839799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6187619|NCT01839799|Antimetabolites|antimetabolites|mesh-ancestor
6187620|NCT01839799|Antiviral Agents|antiviral agents|mesh-ancestor
6187621|NCT01839799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6187622|NCT01839799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6187623|NCT01839799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6187624|NCT01839799|Immunologic Factors|immunologic factors|mesh-ancestor
6187625|NCT01839799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187626|NCT01840072|Antihypertensive Agents|antihypertensive agents|mesh-list
6187627|NCT01840228|Progesterone|progesterone|mesh-list
6187628|NCT01840228|Progestins|progestins|mesh-ancestor
6187629|NCT01840228|Hormones|hormones|mesh-ancestor
6187630|NCT01840228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6187631|NCT01840228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187632|NCT01840345|Acetylcysteine|acetylcysteine|mesh-list
6187633|NCT01840345|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6187634|NCT01840345|Antiviral Agents|antiviral agents|mesh-ancestor
6187635|NCT01840345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6187636|NCT01840345|Expectorants|expectorants|mesh-ancestor
5581058|NCT03847155|Autonomic Agents|autonomic agents|mesh-ancestor
5581059|NCT03847155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5581060|NCT03847155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581061|NCT03847155|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5581062|NCT03847155|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5581063|NCT03847155|Cholinergic Agents|cholinergic agents|mesh-ancestor
5581064|NCT03847155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5581065|NCT03847155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581066|NCT03847272|Prednisone|prednisone|mesh-list
6187637|NCT01840345|Respiratory System Agents|respiratory system agents|mesh-ancestor
6187638|NCT01840345|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6187639|NCT01840345|Antioxidants|antioxidants|mesh-ancestor
6187640|NCT01840345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187641|NCT01840345|Protective Agents|protective agents|mesh-ancestor
5581067|NCT03847272|Ustekinumab|ustekinumab|mesh-list
5581068|NCT03847272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5581069|NCT03847272|Glucocorticoids|glucocorticoids|mesh-ancestor
5581070|NCT03847272|Hormones|hormones|mesh-ancestor
5581071|NCT03847272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5581072|NCT03847272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581073|NCT03847272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5581074|NCT03847272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5581075|NCT03847272|Dermatologic Agents|dermatologic agents|mesh-ancestor
5581076|NCT03847441|Vitamin D|vitamin d|mesh-list
5581077|NCT03847441|Cholecalciferol|cholecalciferol|mesh-list
5581078|NCT03847441|Calcipotriene|calcipotriene|mesh-list
5581079|NCT03847441|Vitamins|vitamins|mesh-ancestor
5581080|NCT03847441|Micronutrients|micronutrients|mesh-ancestor
5581081|NCT03847441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187642|NCT01840345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187643|NCT01840345|Antidotes|antidotes|mesh-ancestor
6187644|NCT01840410|Ranibizumab|ranibizumab|mesh-list
5581082|NCT03847441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5581083|NCT03847441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5581084|NCT03847441|Dermatologic Agents|dermatologic agents|mesh-ancestor
5581085|NCT03847376|Rilpivirine|rilpivirine|mesh-list
5581086|NCT03847376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5581087|NCT03847376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5581088|NCT03847376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5604911|NCT03979365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6187645|NCT01840410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6187646|NCT01840410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6187647|NCT01840410|Growth Substances|growth substances|mesh-ancestor
6187648|NCT01840410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187649|NCT01840410|Growth Inhibitors|growth inhibitors|mesh-ancestor
6187650|NCT01840410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6187651|NCT01840579|Paclitaxel|paclitaxel|mesh-list
6187652|NCT01840579|Etoposide|etoposide|mesh-list
6187653|NCT01840579|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6187654|NCT01840579|Carboplatin|carboplatin|mesh-list
6187655|NCT01840579|Pembrolizumab|pembrolizumab|mesh-list
6187656|NCT01840579|Pemetrexed|pemetrexed|mesh-list
6187657|NCT01840579|Ipilimumab|ipilimumab|mesh-list
6187658|NCT01840579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6187659|NCT01840579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6187660|NCT01840579|Tubulin Modulators|tubulin modulators|mesh-ancestor
6187661|NCT01840579|Antimitotic Agents|antimitotic agents|mesh-ancestor
6187662|NCT01840579|Mitosis Modulators|mitosis modulators|mesh-ancestor
6187663|NCT01840579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187664|NCT01840579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6187665|NCT01840579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6187666|NCT01840579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6187667|NCT01840579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6187668|NCT01840579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6187669|NCT01840579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6187670|NCT01840579|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6187671|NCT01840605|Ketotifen|ketotifen|mesh-list
6187672|NCT01840605|Bepotastine besilate|bepotastine besilate|mesh-list
6187673|NCT01840605|Antipruritics|antipruritics|mesh-ancestor
6187674|NCT01840605|Dermatologic Agents|dermatologic agents|mesh-ancestor
6187675|NCT01840605|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6187676|NCT01840605|Histamine Antagonists|histamine antagonists|mesh-ancestor
6187677|NCT01840605|Histamine Agents|histamine agents|mesh-ancestor
6187678|NCT01840605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6187679|NCT01840605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187680|NCT01840605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581089|NCT03847376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581090|NCT03847376|Antiviral Agents|antiviral agents|mesh-ancestor
5581091|NCT03847376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5581092|NCT03847376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5581093|NCT03847376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5581094|NCT03846739|Oxytocin|oxytocin|mesh-list
5581095|NCT03846739|Oxytocics|oxytocics|mesh-ancestor
5581096|NCT03846739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5581097|NCT03846739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581098|NCT03846973|Tranexamic Acid|tranexamic acid|mesh-list
5581099|NCT03846973|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5581100|NCT03846973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5581101|NCT03846973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581102|NCT03846973|Hemostatics|hemostatics|mesh-ancestor
5581103|NCT03846973|Coagulants|coagulants|mesh-ancestor
5581104|NCT03846843|Phenylacetic acid|phenylacetic acid|mesh-list
6187681|NCT01840605|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6187682|NCT01840943|Topotecan|topotecan|mesh-list
6187683|NCT01840943|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6187684|NCT01840943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6187685|NCT01840943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6187686|NCT01840943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187687|NCT01840943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6187688|NCT01841021|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6187689|NCT01841021|Immunoconjugates|immunoconjugates|mesh-list
6187690|NCT01841021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6187691|NCT01841021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6187692|NCT01841021|Immunologic Factors|immunologic factors|mesh-ancestor
6187693|NCT01841021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187694|NCT01841593|Raltegravir Potassium|raltegravir potassium|mesh-list
6187695|NCT01841593|Amlodipine|amlodipine|mesh-list
6187696|NCT01841593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6187697|NCT01841593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6187698|NCT01841593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6187699|NCT01841593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187700|NCT01841593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6187701|NCT01841593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187702|NCT01841593|Vasodilator Agents|vasodilator agents|mesh-ancestor
6187703|NCT01841593|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6187704|NCT01841593|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5581105|NCT03846843|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6187705|NCT01841593|Antiviral Agents|antiviral agents|mesh-ancestor
6187706|NCT01841593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6187707|NCT01841593|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6187708|NCT01841593|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6187709|NCT01841593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6187710|NCT01841606|Ondansetron|ondansetron|mesh-list
6187711|NCT01841606|Antiemetics|antiemetics|mesh-ancestor
6187712|NCT01841606|Autonomic Agents|autonomic agents|mesh-ancestor
6187713|NCT01841606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6187714|NCT01841606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187715|NCT01841606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6187716|NCT01841606|Antipruritics|antipruritics|mesh-ancestor
6187717|NCT01841606|Dermatologic Agents|dermatologic agents|mesh-ancestor
6187718|NCT01841606|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6187719|NCT01841606|Serotonin Agents|serotonin agents|mesh-ancestor
6187720|NCT01841606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6187721|NCT01841606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187722|NCT01841606|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6187723|NCT01841606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6187724|NCT01841606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5581106|NCT03846843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5581107|NCT03846843|Antimetabolites|antimetabolites|mesh-ancestor
5581108|NCT03846843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581109|NCT03846843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5581110|NCT03846960|Pulmonary Surfactants|pulmonary surfactants|mesh-list
5581111|NCT03846960|Respiratory System Agents|respiratory system agents|mesh-ancestor
5581112|NCT03846765|Phenylephrine|phenylephrine|mesh-list
5581113|NCT03846765|Dobutamine|dobutamine|mesh-list
5581114|NCT03846765|Oxymetazoline|oxymetazoline|mesh-list
5581115|NCT03846765|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6187725|NCT01841606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6187726|NCT01841606|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6187727|NCT01841697|Metformin|metformin|mesh-list
6187728|NCT01841697|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6187729|NCT01841697|Glimepiride|glimepiride|mesh-list
6187730|NCT01841697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6187731|NCT01841697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187732|NCT01841697|Incretins|incretins|mesh-ancestor
6187733|NCT01841697|Hormones|hormones|mesh-ancestor
6187734|NCT01841697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6187735|NCT01841697|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6187736|NCT01841697|Protease Inhibitors|protease inhibitors|mesh-ancestor
6187737|NCT01841697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6187738|NCT01841697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187739|NCT01841697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6187740|NCT01841697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6187741|NCT01841697|Immunologic Factors|immunologic factors|mesh-ancestor
6187742|NCT01841762|Macitentan|macitentan|mesh-list
6187743|NCT01841762|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
6187744|NCT01841762|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6187745|NCT01841762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187746|NCT01841762|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
6187747|NCT01842308|Melphalan|melphalan|mesh-list
6187748|NCT01842308|Mechlorethamine|mechlorethamine|mesh-list
6187749|NCT01842308|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
6187750|NCT01842308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5581116|NCT03846765|Mydriatics|mydriatics|mesh-ancestor
5581117|NCT03846765|Autonomic Agents|autonomic agents|mesh-ancestor
5581118|NCT03846765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5581119|NCT03846765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581120|NCT03846765|Sympathomimetics|sympathomimetics|mesh-ancestor
5581121|NCT03846765|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5581122|NCT03846765|Nasal Decongestants|nasal decongestants|mesh-ancestor
5581123|NCT03846765|Respiratory System Agents|respiratory system agents|mesh-ancestor
5581124|NCT03846765|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5581125|NCT03846765|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5581126|NCT03846765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5581127|NCT03846765|Adrenergic Agents|adrenergic agents|mesh-ancestor
5581128|NCT03846765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6187751|NCT01842308|Alkylating Agents|alkylating agents|mesh-ancestor
6187752|NCT01842308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187753|NCT01842308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6187754|NCT01842308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6187755|NCT01842308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6187756|NCT01842308|Immunologic Factors|immunologic factors|mesh-ancestor
5581129|NCT03846765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187757|NCT01842308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187758|NCT01842334|Nicotine|nicotine|mesh-list
6187759|NCT01842334|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6187760|NCT01842334|Autonomic Agents|autonomic agents|mesh-ancestor
6187761|NCT01842334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5581130|NCT03846765|Protective Agents|protective agents|mesh-ancestor
5581131|NCT03846765|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5581132|NCT03846765|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5581133|NCT03846453|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5581134|NCT03846453|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5581135|NCT03846271|Oxytocin|oxytocin|mesh-list
5581136|NCT03846271|Oxytocics|oxytocics|mesh-ancestor
5581137|NCT03846271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5581138|NCT03846271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581139|NCT03846570|Beclomethasone|beclomethasone|mesh-list
5581140|NCT03846570|Formoterol Fumarate|formoterol fumarate|mesh-list
5581141|NCT03846570|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5581142|NCT03846570|Autonomic Agents|autonomic agents|mesh-ancestor
5581143|NCT03846570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5581144|NCT03846570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581145|NCT03846570|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5581146|NCT03846570|Respiratory System Agents|respiratory system agents|mesh-ancestor
5581147|NCT03846570|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5581148|NCT03846570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5581149|NCT03846570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5581150|NCT03846570|Adrenergic Agents|adrenergic agents|mesh-ancestor
6187762|NCT01842334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187763|NCT01842334|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6187764|NCT01842334|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6187765|NCT01842334|Cholinergic Agents|cholinergic agents|mesh-ancestor
6187766|NCT01842334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6187767|NCT01842334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187768|NCT01842581|Rifaximin|rifaximin|mesh-list
6187769|NCT01842581|Lactulose|lactulose|mesh-list
6187770|NCT01842581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6187771|NCT01842581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6187772|NCT01842581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6187773|NCT01842594|Sirolimus|sirolimus|mesh-list
6187774|NCT01842594|Hydroxychloroquine|hydroxychloroquine|mesh-list
6187775|NCT01842594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6187776|NCT01842594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6187777|NCT01842594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6187778|NCT01842594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6187779|NCT01842594|Antifungal Agents|antifungal agents|mesh-ancestor
5581151|NCT03846570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5581152|NCT03846570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581153|NCT03846570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5581154|NCT03846570|Glucocorticoids|glucocorticoids|mesh-ancestor
6187780|NCT01842594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6187781|NCT01842594|Immunologic Factors|immunologic factors|mesh-ancestor
6187782|NCT01842594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187783|NCT01842594|Antimalarials|antimalarials|mesh-ancestor
6187784|NCT01842594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6187785|NCT01842594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6187786|NCT01842594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6187787|NCT01842594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187788|NCT01842594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6187789|NCT01842620|Metformin|metformin|mesh-list
6187790|NCT01842620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6187791|NCT01842620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187792|NCT01842633|Acetaminophen|acetaminophen|mesh-list
6187793|NCT01842633|Ibuprofen|ibuprofen|mesh-list
6187794|NCT01842633|Caffeine|caffeine|mesh-list
6187795|NCT01842633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6187796|NCT01842633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6187797|NCT01842633|Analgesics|analgesics|mesh-ancestor
6187798|NCT01842633|Sensory System Agents|sensory system agents|mesh-ancestor
6187799|NCT01842633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6187800|NCT01842633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187801|NCT01842633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6187802|NCT01842633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6187803|NCT01842633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6187804|NCT01842633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6187805|NCT01842633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187806|NCT01842633|Antipyretics|antipyretics|mesh-ancestor
6187807|NCT01842633|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6187808|NCT01842633|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6187809|NCT01842633|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6187810|NCT01842633|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6187811|NCT01842633|Purinergic Agents|purinergic agents|mesh-ancestor
6187812|NCT01842633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6187813|NCT01843023|Naltrexone|naltrexone|mesh-list
6187814|NCT01843023|Buprenorphine|buprenorphine|mesh-list
6187815|NCT01843023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6187816|NCT01843023|Narcotics|narcotics|mesh-ancestor
6187817|NCT01843023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6187818|NCT01843023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187819|NCT01843023|Analgesics|analgesics|mesh-ancestor
5581155|NCT03846570|Hormones|hormones|mesh-ancestor
5581156|NCT03846570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5581157|NCT03846388|Hormones|hormones|mesh-list
5581158|NCT03846388|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5581159|NCT03846388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5581160|NCT03846388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581161|NCT03846258|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5581162|NCT03846583|Trastuzumab|trastuzumab|mesh-list
5581163|NCT03846583|Tucatinib|tucatinib|mesh-list
5581164|NCT03846583|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5581165|NCT03846583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6187820|NCT01843023|Sensory System Agents|sensory system agents|mesh-ancestor
6187821|NCT01843023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6187822|NCT01843023|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6187823|NCT01843023|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6187824|NCT01843205|Methamphetamine|methamphetamine|mesh-list
6187825|NCT01843205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6187826|NCT01843205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187827|NCT01843205|Sympathomimetics|sympathomimetics|mesh-ancestor
6187828|NCT01843205|Autonomic Agents|autonomic agents|mesh-ancestor
6187829|NCT01843205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6187830|NCT01843205|Dopamine Agents|dopamine agents|mesh-ancestor
6187831|NCT01843205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6187832|NCT01843205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187833|NCT01843205|Adrenergic Agents|adrenergic agents|mesh-ancestor
6187834|NCT01843205|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6187835|NCT01843205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6187836|NCT01843205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6187837|NCT01843205|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6187838|NCT01843348|Cyclosporine|cyclosporine|mesh-list
6187839|NCT01843348|Mycophenolic Acid|mycophenolic acid|mesh-list
6187840|NCT01843348|Everolimus|everolimus|mesh-list
6187841|NCT01843348|Tacrolimus|tacrolimus|mesh-list
6187842|NCT01843348|Cyclosporins|cyclosporins|mesh-list
6187843|NCT01843348|Basiliximab|basiliximab|mesh-list
6187844|NCT01843348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6187845|NCT01843348|Immunologic Factors|immunologic factors|mesh-ancestor
6187846|NCT01843348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187847|NCT01843348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6187848|NCT01843348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6187849|NCT01843348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187850|NCT01843348|Antifungal Agents|antifungal agents|mesh-ancestor
6187851|NCT01843348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5581166|NCT03846583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5581167|NCT03846583|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5581168|NCT03846583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5581169|NCT03846583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581170|NCT03846583|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5581171|NCT03846583|Hormone Antagonists|hormone antagonists|mesh-ancestor
6187852|NCT01843348|Dermatologic Agents|dermatologic agents|mesh-ancestor
6187853|NCT01843348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6187854|NCT01843348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6187855|NCT01843348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6187856|NCT01843348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6187857|NCT01843348|Antitubercular Agents|antitubercular agents|mesh-ancestor
6187858|NCT01843348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6187859|NCT01843374|Tremelimumab|tremelimumab|mesh-list
6187860|NCT01843374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6187861|NCT01843621|Vaccines|vaccines|mesh-list
6187862|NCT01843621|Immunologic Factors|immunologic factors|mesh-ancestor
6187863|NCT01843621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187864|NCT01843660|Acetaminophen|acetaminophen|mesh-list
6187865|NCT01843660|Tramadol|tramadol|mesh-list
6187866|NCT01843660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6187867|NCT01843660|Analgesics|analgesics|mesh-ancestor
6187868|NCT01843660|Sensory System Agents|sensory system agents|mesh-ancestor
5581172|NCT03846583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5581173|NCT03846583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581174|NCT03846583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5581175|NCT03846310|Carboplatin|carboplatin|mesh-list
5581176|NCT03846310|Pembrolizumab|pembrolizumab|mesh-list
5581177|NCT03846310|Pemetrexed|pemetrexed|mesh-list
5581178|NCT03846310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5581179|NCT03846310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5581180|NCT03846310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5581181|NCT03846310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581182|NCT03846310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5581183|NCT03846310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5581184|NCT03846180|Octreotide|octreotide|mesh-list
5581185|NCT03846180|Terlipressin|terlipressin|mesh-list
5581186|NCT03846180|Somatostatin|somatostatin|mesh-list
5581187|NCT03846180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5581188|NCT03846180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5581189|NCT03846180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5581190|NCT03846180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5581191|NCT03846180|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5581192|NCT03846180|Hormones|hormones|mesh-ancestor
5581193|NCT03846180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5581194|NCT03846180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581195|NCT03846284|Magnesium Sulfate|magnesium sulfate|mesh-list
6187869|NCT01843660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6187870|NCT01843660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187871|NCT01843660|Antipyretics|antipyretics|mesh-ancestor
6187872|NCT01843660|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6187873|NCT01843660|Narcotics|narcotics|mesh-ancestor
6187874|NCT01843660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6187875|NCT01843751|Buprenorphine|buprenorphine|mesh-list
6187876|NCT01843751|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6187877|NCT01843751|Naloxone|naloxone|mesh-list
6187878|NCT01843751|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6187879|NCT01843751|Narcotics|narcotics|mesh-ancestor
6187880|NCT01843751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6187881|NCT01843751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187882|NCT01843751|Analgesics|analgesics|mesh-ancestor
6187883|NCT01843751|Sensory System Agents|sensory system agents|mesh-ancestor
6187884|NCT01843751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6187885|NCT01843751|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6187886|NCT01843920|Trimethoprim|trimethoprim|mesh-list
6187887|NCT01843920|Polymyxins|polymyxins|mesh-list
6187888|NCT01843920|Polymyxin B|polymyxin b|mesh-list
5581196|NCT03846284|Bupivacaine|bupivacaine|mesh-list
5581197|NCT03846284|Anesthetics, Local|anesthetics, local|mesh-list
5581198|NCT03846284|Anesthetics|anesthetics|mesh-list
5581199|NCT03846284|N-Methylaspartate|n-methylaspartate|mesh-list
5581200|NCT03846284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5581201|NCT03846284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581202|NCT03846284|Sensory System Agents|sensory system agents|mesh-ancestor
5581203|NCT03846284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5581204|NCT03846284|Analgesics|analgesics|mesh-ancestor
5581205|NCT03846284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5581206|NCT03846284|Anticonvulsants|anticonvulsants|mesh-ancestor
5581207|NCT03846284|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6187889|NCT01843920|Prednisolone|prednisolone|mesh-list
6187890|NCT01843920|Timolol|timolol|mesh-list
6187891|NCT01843920|Dorzolamide|dorzolamide|mesh-list
6187892|NCT01843920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6187893|NCT01843920|Glucocorticoids|glucocorticoids|mesh-ancestor
6187894|NCT01843920|Hormones|hormones|mesh-ancestor
6187895|NCT01843920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6187896|NCT01843920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187897|NCT01843920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6187898|NCT01843920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6187899|NCT01843920|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6187900|NCT01843920|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6187901|NCT01843920|Adrenergic Agents|adrenergic agents|mesh-ancestor
6187902|NCT01843920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6187903|NCT01843920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187904|NCT01843920|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6187905|NCT01843920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6187906|NCT01843920|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6187907|NCT01843920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6187908|NCT01843920|Renal Agents|renal agents|mesh-ancestor
6187909|NCT01843920|Antimalarials|antimalarials|mesh-ancestor
6187910|NCT01843920|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6187911|NCT01843920|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6187912|NCT01843920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6187913|NCT01843920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6187914|NCT01843920|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6187915|NCT01843920|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6187916|NCT01843920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6187917|NCT01843920|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6187918|NCT01843920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6187919|NCT01844076|Quinacrine|quinacrine|mesh-list
6187920|NCT01844076|Capecitabine|capecitabine|mesh-list
6187921|NCT01844076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6187922|NCT01844076|Antimetabolites|antimetabolites|mesh-ancestor
6187923|NCT01844076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187924|NCT01844076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6187925|NCT01844076|Anticestodal Agents|anticestodal agents|mesh-ancestor
6187926|NCT01844076|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6187927|NCT01844076|Anthelmintics|anthelmintics|mesh-ancestor
6187928|NCT01844076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6187929|NCT01844076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6187930|NCT01844076|Antimalarials|antimalarials|mesh-ancestor
6187931|NCT01844076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6187932|NCT01844076|Antinematodal Agents|antinematodal agents|mesh-ancestor
6187933|NCT01844076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6187934|NCT01844115|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
6187935|NCT01844115|Antidepressive Agents|antidepressive agents|mesh-ancestor
6187936|NCT01844115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6187937|NCT01844115|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6187938|NCT01844115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6187939|NCT01844115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6187940|NCT01844115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187941|NCT01844115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6187942|NCT01844115|Serotonin Agents|serotonin agents|mesh-ancestor
6187943|NCT01844115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187944|NCT01844115|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6187945|NCT01844115|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6187946|NCT01844388|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6187947|NCT01844388|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6187948|NCT01844388|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6187949|NCT01844388|Laxatives|laxatives|mesh-ancestor
6187950|NCT01844388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6187951|NCT01844531|Metformin|metformin|mesh-list
6187952|NCT01844531|Empagliflozin|empagliflozin|mesh-list
6187953|NCT01844531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6187954|NCT01844531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187955|NCT01844531|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6187956|NCT01844531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187957|NCT01844583|Rifampin|rifampin|mesh-list
6187958|NCT01844583|Esomeprazole|esomeprazole|mesh-list
6187959|NCT01844583|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6187960|NCT01844583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6187961|NCT01844583|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6187962|NCT01844583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6187963|NCT01844583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187964|NCT01844583|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6187965|NCT01844583|Antitubercular Agents|antitubercular agents|mesh-ancestor
6187966|NCT01844583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6187967|NCT01844583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6187968|NCT01844583|Leprostatic Agents|leprostatic agents|mesh-ancestor
6187969|NCT01844583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6187970|NCT01844583|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6187971|NCT01844583|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5581208|NCT03846284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5581209|NCT03846284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581210|NCT03846284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5581211|NCT03846284|Tocolytic Agents|tocolytic agents|mesh-ancestor
5581212|NCT03846284|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5581213|NCT03846284|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
5581214|NCT03846284|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5581215|NCT03846284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6187972|NCT01844583|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6187973|NCT01844583|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6187974|NCT01844583|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6187975|NCT01844583|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6187976|NCT01844687|Cannabidiol|cannabidiol|mesh-list
6187977|NCT01844687|Anticonvulsants|anticonvulsants|mesh-ancestor
6187978|NCT01844700|Risperidone|risperidone|mesh-list
6187979|NCT01844700|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6187980|NCT01844700|Aripiprazole|aripiprazole|mesh-list
6187981|NCT01844700|Ziprasidone|ziprasidone|mesh-list
6187982|NCT01844700|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6187983|NCT01844700|Serotonin Agents|serotonin agents|mesh-ancestor
6187984|NCT01844700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6187985|NCT01844700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6187986|NCT01844700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187987|NCT01844700|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6187988|NCT01844700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6187989|NCT01844700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6187990|NCT01844700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5581216|NCT03846427|Zanubrutinib|zanubrutinib|mesh-list
5581217|NCT03846427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5581218|NCT03846427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5581219|NCT03846427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5581220|NCT03846427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581221|NCT03846102|Acetaminophen|acetaminophen|mesh-list
5581222|NCT03846102|Morphine|morphine|mesh-list
5581223|NCT03846102|Levobupivacaine|levobupivacaine|mesh-list
5581224|NCT03846102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5581225|NCT03846102|Narcotics|narcotics|mesh-ancestor
5581226|NCT03846102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5581227|NCT03846102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6187991|NCT01844700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6187992|NCT01844700|Dopamine Agents|dopamine agents|mesh-ancestor
6187993|NCT01844700|Antidepressive Agents|antidepressive agents|mesh-ancestor
6187994|NCT01844700|Dopamine Agonists|dopamine agonists|mesh-ancestor
6187995|NCT01844700|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6187996|NCT01844700|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6187997|NCT01844700|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6187998|NCT01844700|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6207005|NCT02108171|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6207006|NCT02108171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6207007|NCT02108171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207008|NCT02108171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6207009|NCT02108171|Analgesics|analgesics|mesh-ancestor
6207010|NCT02108171|Sensory System Agents|sensory system agents|mesh-ancestor
6207011|NCT02108171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6207012|NCT02108171|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6207013|NCT02108171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5581228|NCT03846102|Analgesics|analgesics|mesh-ancestor
5581229|NCT03846102|Sensory System Agents|sensory system agents|mesh-ancestor
5581230|NCT03846102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5581231|NCT03846102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5581232|NCT03846102|Antipyretics|antipyretics|mesh-ancestor
5581233|NCT03846102|Anesthetics, Local|anesthetics, local|mesh-ancestor
5581234|NCT03846102|Anesthetics|anesthetics|mesh-ancestor
6207014|NCT02108171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6207015|NCT02108171|Adrenergic Agents|adrenergic agents|mesh-ancestor
6207016|NCT02108171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6207017|NCT02108171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207018|NCT02108288|Carteolol|carteolol|mesh-list
6207019|NCT02108288|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6207020|NCT02108288|Latanoprost|latanoprost|mesh-list
6207021|NCT02108288|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6207022|NCT02108288|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6207023|NCT02108288|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6207024|NCT02108288|Adrenergic Agents|adrenergic agents|mesh-ancestor
6207025|NCT02108288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6207026|NCT02108288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207027|NCT02108288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207028|NCT02108288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6207029|NCT02108288|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6207030|NCT02108288|Sympatholytics|sympatholytics|mesh-ancestor
6207031|NCT02108288|Autonomic Agents|autonomic agents|mesh-ancestor
5581235|NCT03845699|Fentanyl|fentanyl|mesh-list
5581236|NCT03845699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5581237|NCT03845699|Narcotics|narcotics|mesh-ancestor
6187999|NCT01844778|Tobramycin|tobramycin|mesh-list
6188000|NCT01844778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5581238|NCT03845699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5581239|NCT03845699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581240|NCT03845699|Analgesics|analgesics|mesh-ancestor
5581241|NCT03845699|Sensory System Agents|sensory system agents|mesh-ancestor
5581242|NCT03845699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5581243|NCT03845699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5581244|NCT03845699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5581245|NCT03845699|Anesthetics, General|anesthetics, general|mesh-ancestor
5581246|NCT03845699|Anesthetics|anesthetics|mesh-ancestor
5581247|NCT03845777|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
5581248|NCT03845777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5581249|NCT03845881|Oxycodone|oxycodone|mesh-list
5581250|NCT03845881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5581251|NCT03845881|Narcotics|narcotics|mesh-ancestor
5581252|NCT03845881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5581253|NCT03845881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581254|NCT03845881|Analgesics|analgesics|mesh-ancestor
5581255|NCT03845881|Sensory System Agents|sensory system agents|mesh-ancestor
5581256|NCT03845881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5581257|NCT03845621|Salicylic Acid|salicylic acid|mesh-list
5581258|NCT03845621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6188001|NCT01844778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6188002|NCT01844830|Phenylephrine|phenylephrine|mesh-list
6188003|NCT01844830|Oxymetazoline|oxymetazoline|mesh-list
6188004|NCT01844830|Tetracaine|tetracaine|mesh-list
6188005|NCT01844830|Anesthetics, Local|anesthetics, local|mesh-ancestor
6188006|NCT01844830|Anesthetics|anesthetics|mesh-ancestor
6188007|NCT01844830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6188008|NCT01844830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188009|NCT01844830|Sensory System Agents|sensory system agents|mesh-ancestor
6188010|NCT01844830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6188011|NCT01844830|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6188012|NCT01844830|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6188013|NCT01844830|Adrenergic Agents|adrenergic agents|mesh-ancestor
6188014|NCT01844830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6188015|NCT01844830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188016|NCT01844830|Sympathomimetics|sympathomimetics|mesh-ancestor
6188017|NCT01844830|Autonomic Agents|autonomic agents|mesh-ancestor
6188018|NCT01844830|Nasal Decongestants|nasal decongestants|mesh-ancestor
6188019|NCT01844830|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6188020|NCT01844830|Respiratory System Agents|respiratory system agents|mesh-ancestor
6188021|NCT01844830|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6188022|NCT01844830|Mydriatics|mydriatics|mesh-ancestor
6188023|NCT01844830|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6188024|NCT01844830|Protective Agents|protective agents|mesh-ancestor
6188025|NCT01844895|Abatacept|abatacept|mesh-list
6188026|NCT01844895|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6188027|NCT01844895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188028|NCT01844895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6188029|NCT01844895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6188030|NCT01844895|Immunologic Factors|immunologic factors|mesh-ancestor
6188031|NCT01844895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188032|NCT01844895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6188033|NCT01845025|Fluticasone|fluticasone|mesh-list
6188034|NCT01845025|Xhance|xhance|mesh-list
6188035|NCT01845025|Formoterol Fumarate|formoterol fumarate|mesh-list
6188036|NCT01845025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6188037|NCT01845025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6188038|NCT01845025|Autonomic Agents|autonomic agents|mesh-ancestor
6188039|NCT01845025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6188040|NCT01845025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188041|NCT01845025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6188042|NCT01845025|Respiratory System Agents|respiratory system agents|mesh-ancestor
6188043|NCT01845025|Dermatologic Agents|dermatologic agents|mesh-ancestor
6188044|NCT01845025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6188045|NCT01845025|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6188046|NCT01845025|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6188047|NCT01845025|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6188048|NCT01845025|Adrenergic Agents|adrenergic agents|mesh-ancestor
6188049|NCT01845025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6188050|NCT01845025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581259|NCT03845621|Antifungal Agents|antifungal agents|mesh-ancestor
6188051|NCT01845077|Metformin|metformin|mesh-list
5581260|NCT03845621|Keratolytic Agents|keratolytic agents|mesh-ancestor
6188052|NCT01845077|Linagliptin|linagliptin|mesh-list
6188053|NCT01845077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6188054|NCT01845077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188055|NCT01845077|Incretins|incretins|mesh-ancestor
6188056|NCT01845077|Hormones|hormones|mesh-ancestor
6188057|NCT01845077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6188058|NCT01845077|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6188059|NCT01845077|Protease Inhibitors|protease inhibitors|mesh-ancestor
6188060|NCT01845077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6188061|NCT01845077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188062|NCT01845636|Atropine|atropine|mesh-list
6188063|NCT01845636|Donepezil|donepezil|mesh-list
6188064|NCT01845636|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6188065|NCT01845636|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6188066|NCT01845636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6188067|NCT01845636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6188068|NCT01845636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188069|NCT01845636|Cholinergic Agents|cholinergic agents|mesh-ancestor
6188070|NCT01845636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6188071|NCT01845636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188072|NCT01845636|Nootropic Agents|nootropic agents|mesh-ancestor
6188073|NCT01845636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6188074|NCT01845636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6188075|NCT01845636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6188076|NCT01845636|Autonomic Agents|autonomic agents|mesh-ancestor
6188077|NCT01845636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6188078|NCT01845636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6188079|NCT01845636|Respiratory System Agents|respiratory system agents|mesh-ancestor
6188080|NCT01845636|Mydriatics|mydriatics|mesh-ancestor
6188081|NCT01845636|Parasympatholytics|parasympatholytics|mesh-ancestor
6188082|NCT01845636|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6188083|NCT01845636|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6188084|NCT01845792|Abiraterone Acetate|abiraterone acetate|mesh-list
6188085|NCT01845792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6188086|NCT01845792|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6188087|NCT01845792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6188088|NCT01845792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188089|NCT01845792|Hormone Antagonists|hormone antagonists|mesh-ancestor
6188090|NCT01845792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6188091|NCT01845792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188092|NCT01845792|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6188093|NCT01845831|Metformin|metformin|mesh-list
6188094|NCT01845831|Insulin Glargine|insulin glargine|mesh-list
6188095|NCT01845831|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6188096|NCT01845831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6188097|NCT01845831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188098|NCT01845831|Incretins|incretins|mesh-ancestor
6188099|NCT01845831|Hormones|hormones|mesh-ancestor
6188100|NCT01845831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6188101|NCT01845831|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6188102|NCT01845831|Protease Inhibitors|protease inhibitors|mesh-ancestor
6188103|NCT01845831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6188104|NCT01845831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188105|NCT01846039|Hyaluronic Acid|hyaluronic acid|mesh-list
6188106|NCT01846039|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6188107|NCT01846039|Immunologic Factors|immunologic factors|mesh-ancestor
6188108|NCT01846039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188109|NCT01846039|Viscosupplements|viscosupplements|mesh-ancestor
6188110|NCT01846039|Protective Agents|protective agents|mesh-ancestor
6188111|NCT01846104|Vaccines|vaccines|mesh-list
6188112|NCT01846104|Immunologic Factors|immunologic factors|mesh-ancestor
6188113|NCT01846104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188114|NCT01846221|Clonidine|clonidine|mesh-list
6188115|NCT01846221|Fentanyl|fentanyl|mesh-list
6188116|NCT01846221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6188117|NCT01846221|Narcotics|narcotics|mesh-ancestor
6188118|NCT01846221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6188119|NCT01846221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188120|NCT01846221|Analgesics|analgesics|mesh-ancestor
6188121|NCT01846221|Sensory System Agents|sensory system agents|mesh-ancestor
6188122|NCT01846221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6188123|NCT01846221|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6188124|NCT01846221|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6188125|NCT01846221|Anesthetics, General|anesthetics, general|mesh-ancestor
6188126|NCT01846221|Anesthetics|anesthetics|mesh-ancestor
6188127|NCT01846221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6188128|NCT01846221|Sympatholytics|sympatholytics|mesh-ancestor
5581261|NCT03845621|Dermatologic Agents|dermatologic agents|mesh-ancestor
5581262|NCT03845673|Psyllium|psyllium|mesh-list
5581263|NCT03845673|Cathartics|cathartics|mesh-ancestor
5581264|NCT03845673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5581265|NCT03845387|Pramipexole|pramipexole|mesh-list
5581266|NCT03845387|Antioxidants|antioxidants|mesh-ancestor
5581267|NCT03845387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581268|NCT03845387|Protective Agents|protective agents|mesh-ancestor
5581269|NCT03845387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581270|NCT03845387|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6188129|NCT01846221|Autonomic Agents|autonomic agents|mesh-ancestor
6188130|NCT01846221|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6188131|NCT01846221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6188132|NCT01846221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6188133|NCT01846221|Adrenergic Agents|adrenergic agents|mesh-ancestor
6188134|NCT01846221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6188135|NCT01846221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188136|NCT01846299|Ranibizumab|ranibizumab|mesh-list
6188137|NCT01846299|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5581271|NCT03845387|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5581272|NCT03845387|Dopamine Agonists|dopamine agonists|mesh-ancestor
5581273|NCT03845387|Dopamine Agents|dopamine agents|mesh-ancestor
5581274|NCT03845387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5604912|NCT03979365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604913|NCT03962465|Cytarabine|cytarabine|mesh-list
5604914|NCT03962465|Prednisone|prednisone|mesh-list
5604915|NCT03962465|Methotrexate|methotrexate|mesh-list
6188138|NCT01846299|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6188139|NCT01846299|Growth Substances|growth substances|mesh-ancestor
6188140|NCT01846299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188141|NCT01846299|Growth Inhibitors|growth inhibitors|mesh-ancestor
6188142|NCT01846299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6188143|NCT01846416|Atezolizumab|atezolizumab|mesh-list
6188144|NCT01846416|Antibodies|antibodies|mesh-list
6188145|NCT01846416|Immunologic Factors|immunologic factors|mesh-ancestor
6188146|NCT01846416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188147|NCT01846416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6188148|NCT01846442|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
6188149|NCT01846442|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6188150|NCT01846442|Immunologic Factors|immunologic factors|mesh-ancestor
6188151|NCT01846442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188152|NCT01846455|Promethazine|promethazine|mesh-list
6188153|NCT01846455|Diphenhydramine|diphenhydramine|mesh-list
6188154|NCT01846455|Buprenorphine|buprenorphine|mesh-list
6188155|NCT01846455|Naloxone|naloxone|mesh-list
6188156|NCT01846455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6188157|NCT01846455|Narcotics|narcotics|mesh-ancestor
6188158|NCT01846455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6188159|NCT01846455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188160|NCT01846455|Analgesics|analgesics|mesh-ancestor
6188161|NCT01846455|Sensory System Agents|sensory system agents|mesh-ancestor
6188162|NCT01846455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6188163|NCT01846455|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6188164|NCT01846455|Antipruritics|antipruritics|mesh-ancestor
6188165|NCT01846455|Dermatologic Agents|dermatologic agents|mesh-ancestor
6188166|NCT01846455|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6188167|NCT01846455|Histamine Antagonists|histamine antagonists|mesh-ancestor
6188168|NCT01846455|Histamine Agents|histamine agents|mesh-ancestor
6188169|NCT01846455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6188170|NCT01846455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188171|NCT01846455|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6188172|NCT01846455|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6188173|NCT01846455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6188174|NCT01846455|Anesthetics, Local|anesthetics, local|mesh-ancestor
6188175|NCT01846455|Anesthetics|anesthetics|mesh-ancestor
6188176|NCT01846455|Antiemetics|antiemetics|mesh-ancestor
6188177|NCT01846455|Autonomic Agents|autonomic agents|mesh-ancestor
6188178|NCT01846455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6188179|NCT01846507|Tranexamic Acid|tranexamic acid|mesh-list
6188180|NCT01846507|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6188181|NCT01846507|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6188182|NCT01846507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188183|NCT01846507|Hemostatics|hemostatics|mesh-ancestor
6188184|NCT01846507|Coagulants|coagulants|mesh-ancestor
6188185|NCT01846611|Dexamethasone|dexamethasone|mesh-list
6188186|NCT01846611|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5604916|NCT03962465|Vincristine|vincristine|mesh-list
6188187|NCT01846611|Doxorubicin|doxorubicin|mesh-list
6188188|NCT01846611|Trabectedin|trabectedin|mesh-list
6188189|NCT01846611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6188190|NCT01846611|Antiemetics|antiemetics|mesh-ancestor
6188191|NCT01846611|Autonomic Agents|autonomic agents|mesh-ancestor
6188192|NCT01846611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6188193|NCT01846611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188194|NCT01846611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6188195|NCT01846611|Glucocorticoids|glucocorticoids|mesh-ancestor
6188196|NCT01846611|Hormones|hormones|mesh-ancestor
6188197|NCT01846611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6188198|NCT01846611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6188199|NCT01846611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6188200|NCT01846611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6188201|NCT01846611|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6188202|NCT01846611|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6188203|NCT01846611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6188204|NCT01846611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188205|NCT01846611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6188206|NCT01846611|Alkylating Agents|alkylating agents|mesh-ancestor
6188207|NCT01846624|Decitabine|decitabine|mesh-list
6188208|NCT01846624|Azacitidine|azacitidine|mesh-list
6188209|NCT01846624|Midostaurin|midostaurin|mesh-list
5581275|NCT03845348|Ketoconazole|ketoconazole|mesh-list
5581276|NCT03845348|Antifungal Agents|antifungal agents|mesh-ancestor
5581277|NCT03845348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6188210|NCT01846624|Staurosporine|staurosporine|mesh-list
6188211|NCT01846624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6188212|NCT01846624|Antimetabolites|antimetabolites|mesh-ancestor
6188213|NCT01846624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188214|NCT01846624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6188215|NCT01846624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6188216|NCT01846624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6188217|NCT01846728|Estrogens|estrogens|mesh-list
6188218|NCT01846728|Hormones|hormones|mesh-ancestor
6188219|NCT01846728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6188220|NCT01846728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188221|NCT01847001|Paclitaxel|paclitaxel|mesh-list
6188222|NCT01847001|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6188223|NCT01847001|Cyclophosphamide|cyclophosphamide|mesh-list
6188224|NCT01847001|Doxorubicin|doxorubicin|mesh-list
5581278|NCT03845348|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5581279|NCT03845348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5581280|NCT03845348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5581281|NCT03845348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581282|NCT03845348|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5581283|NCT03845348|Hormone Antagonists|hormone antagonists|mesh-ancestor
5581284|NCT03845348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5581285|NCT03845348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581286|NCT03845348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5581287|NCT03845322|Curcumin|curcumin|mesh-list
5581288|NCT03845322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5581289|NCT03845322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5581290|NCT03845322|Analgesics|analgesics|mesh-ancestor
5581291|NCT03845322|Sensory System Agents|sensory system agents|mesh-ancestor
5581292|NCT03845322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5581293|NCT03845322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581294|NCT03845322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5581295|NCT03845322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5581296|NCT03845322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5581297|NCT03845322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5581298|NCT03845322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581299|NCT03845270|Docetaxel|docetaxel|mesh-list
5581300|NCT03845270|Trastuzumab|trastuzumab|mesh-list
5581301|NCT03845270|Pertuzumab|pertuzumab|mesh-list
5581302|NCT03845270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6188225|NCT01847001|Trastuzumab|trastuzumab|mesh-list
6188226|NCT01847001|Pertuzumab|pertuzumab|mesh-list
6188227|NCT01847001|Propranolol|propranolol|mesh-list
6188228|NCT01847001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6188229|NCT01847001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6188230|NCT01847001|Tubulin Modulators|tubulin modulators|mesh-ancestor
6188231|NCT01847001|Antimitotic Agents|antimitotic agents|mesh-ancestor
6188232|NCT01847001|Mitosis Modulators|mitosis modulators|mesh-ancestor
6188233|NCT01847001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188234|NCT01847001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5581303|NCT03845270|Tubulin Modulators|tubulin modulators|mesh-ancestor
5581304|NCT03845270|Antimitotic Agents|antimitotic agents|mesh-ancestor
5581305|NCT03845270|Mitosis Modulators|mitosis modulators|mesh-ancestor
5581306|NCT03845270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581307|NCT03845270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6188235|NCT01847001|Immunologic Factors|immunologic factors|mesh-ancestor
6188236|NCT01847001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188237|NCT01847001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6188238|NCT01847001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6188239|NCT01847001|Alkylating Agents|alkylating agents|mesh-ancestor
6188240|NCT01847001|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5581308|NCT03845179|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5581309|NCT03845179|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
5581310|NCT03845179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5581311|NCT03845179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581312|NCT03845179|Incretins|incretins|mesh-ancestor
5581313|NCT03845179|Hormones|hormones|mesh-ancestor
5581314|NCT03845179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5581315|NCT03845179|Protease Inhibitors|protease inhibitors|mesh-ancestor
5581316|NCT03845179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5581317|NCT03845179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581318|NCT03845153|Metformin|metformin|mesh-list
5581319|NCT03845153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5581320|NCT03845153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581321|NCT03845010|Verapamil|verapamil|mesh-list
5581322|NCT03845010|Sotalol|sotalol|mesh-list
5581323|NCT03845010|Flecainide|flecainide|mesh-list
5581324|NCT03845010|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5581325|NCT03845010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6188241|NCT01847001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6188242|NCT01847001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6188243|NCT01847001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6188244|NCT01847001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6188245|NCT01847001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6188246|NCT01847001|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6188247|NCT01847001|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6188248|NCT01847001|Adrenergic Agents|adrenergic agents|mesh-ancestor
6188249|NCT01847001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6188250|NCT01847001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6188251|NCT01847001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6188252|NCT01847001|Vasodilator Agents|vasodilator agents|mesh-ancestor
6188253|NCT01847014|Macitentan|macitentan|mesh-list
6188254|NCT01847014|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
5581326|NCT03845010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5581327|NCT03845010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581328|NCT03845010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5581329|NCT03845010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581330|NCT03845010|Vasodilator Agents|vasodilator agents|mesh-ancestor
5581331|NCT03845010|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5581332|NCT03845010|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5581333|NCT03845010|Adrenergic Agents|adrenergic agents|mesh-ancestor
5581334|NCT03845010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5581335|NCT03845010|Sympatholytics|sympatholytics|mesh-ancestor
6188255|NCT01847014|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6188256|NCT01847014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188257|NCT01847014|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
6188258|NCT01847131|Phenylephrine|phenylephrine|mesh-list
6188259|NCT01847131|Oxymetazoline|oxymetazoline|mesh-list
6188260|NCT01847131|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6188261|NCT01847131|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6188262|NCT01847131|Adrenergic Agents|adrenergic agents|mesh-ancestor
6188263|NCT01847131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6188264|NCT01847131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188265|NCT01847131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188266|NCT01847131|Sympathomimetics|sympathomimetics|mesh-ancestor
6188267|NCT01847131|Autonomic Agents|autonomic agents|mesh-ancestor
6188268|NCT01847131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6188269|NCT01847131|Nasal Decongestants|nasal decongestants|mesh-ancestor
6188270|NCT01847131|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6188271|NCT01847131|Respiratory System Agents|respiratory system agents|mesh-ancestor
6188272|NCT01847131|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6188273|NCT01847131|Mydriatics|mydriatics|mesh-ancestor
6188274|NCT01847131|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5581336|NCT03845010|Autonomic Agents|autonomic agents|mesh-ancestor
6188275|NCT01847131|Protective Agents|protective agents|mesh-ancestor
6188276|NCT01847313|Liraglutide|liraglutide|mesh-list
6188277|NCT01847313|Glucagon|glucagon|mesh-list
6188278|NCT01847313|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6188279|NCT01847313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6188280|NCT01847313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188281|NCT01847313|Incretins|incretins|mesh-ancestor
6188282|NCT01847313|Hormones|hormones|mesh-ancestor
6188283|NCT01847313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6188284|NCT01847313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6188285|NCT01847443|Nicotine|nicotine|mesh-list
6188286|NCT01847443|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6188287|NCT01847443|Autonomic Agents|autonomic agents|mesh-ancestor
6188288|NCT01847443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6188289|NCT01847443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188290|NCT01847443|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6188291|NCT01847443|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6188292|NCT01847443|Cholinergic Agents|cholinergic agents|mesh-ancestor
6188293|NCT01847443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6188294|NCT01847443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188295|NCT01847469|Zonisamide|zonisamide|mesh-list
6188296|NCT01847469|Anticonvulsants|anticonvulsants|mesh-ancestor
6188297|NCT01847469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6188298|NCT01847469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6188299|NCT01847469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188300|NCT01847469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6188301|NCT01847469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188302|NCT01847638|Nepafenac|nepafenac|mesh-list
6188303|NCT01847638|Bromfenac|bromfenac|mesh-list
6188304|NCT01847638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6188305|NCT01847638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6188306|NCT01847638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6188307|NCT01847638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6188308|NCT01847638|Analgesics|analgesics|mesh-ancestor
6188309|NCT01847638|Sensory System Agents|sensory system agents|mesh-ancestor
6188310|NCT01847638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6188311|NCT01847638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188312|NCT01847638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6188313|NCT01847638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6188314|NCT01848041|Phenylephrine|phenylephrine|mesh-list
6188315|NCT01848041|Oxymetazoline|oxymetazoline|mesh-list
6188316|NCT01848041|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6188317|NCT01848041|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6188318|NCT01848041|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6188319|NCT01848041|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6188320|NCT01848041|Adrenergic Agents|adrenergic agents|mesh-ancestor
6188321|NCT01848041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6188322|NCT01848041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188323|NCT01848041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188324|NCT01848041|Sympathomimetics|sympathomimetics|mesh-ancestor
6188325|NCT01848041|Autonomic Agents|autonomic agents|mesh-ancestor
6188326|NCT01848041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6188327|NCT01848041|Nasal Decongestants|nasal decongestants|mesh-ancestor
6188328|NCT01848041|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6188329|NCT01848041|Respiratory System Agents|respiratory system agents|mesh-ancestor
6188330|NCT01848041|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6188331|NCT01848041|Mydriatics|mydriatics|mesh-ancestor
6188332|NCT01848041|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6188333|NCT01848041|Protective Agents|protective agents|mesh-ancestor
6188334|NCT01848054|Buprenorphine|buprenorphine|mesh-list
6188335|NCT01848054|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6188336|NCT01848054|Naloxone|naloxone|mesh-list
6188337|NCT01848054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6188338|NCT01848054|Narcotics|narcotics|mesh-ancestor
6188339|NCT01848054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6188340|NCT01848054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188341|NCT01848054|Analgesics|analgesics|mesh-ancestor
6188342|NCT01848054|Sensory System Agents|sensory system agents|mesh-ancestor
6188343|NCT01848054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6188344|NCT01848054|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6188345|NCT01848067|Prednisone|prednisone|mesh-list
6188346|NCT01848067|Abiraterone Acetate|abiraterone acetate|mesh-list
6188347|NCT01848067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6188348|NCT01848067|Glucocorticoids|glucocorticoids|mesh-ancestor
6188349|NCT01848067|Hormones|hormones|mesh-ancestor
6188350|NCT01848067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5581337|NCT03845010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5581338|NCT03845010|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5581339|NCT03845010|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5581340|NCT03845049|Aflibercept|aflibercept|mesh-list
5581341|NCT03845049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5581342|NCT03845049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5581343|NCT03845049|Growth Substances|growth substances|mesh-ancestor
5581344|NCT03845049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581345|NCT03845049|Growth Inhibitors|growth inhibitors|mesh-ancestor
5581346|NCT03845049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5581347|NCT03844997|Palbociclib|palbociclib|mesh-list
5581348|NCT03844997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5581349|NCT03844997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5581350|NCT03844997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5581351|NCT03844997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581352|NCT03844841|Dexmedetomidine|dexmedetomidine|mesh-list
5581353|NCT03844841|Propofol|propofol|mesh-list
5581354|NCT03844841|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5581355|NCT03844841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5581356|NCT03844841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581357|NCT03844841|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5581358|NCT03844841|Anesthetics, General|anesthetics, general|mesh-ancestor
5581359|NCT03844841|Anesthetics|anesthetics|mesh-ancestor
5581360|NCT03844841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5581361|NCT03844841|Analgesics|analgesics|mesh-ancestor
5581362|NCT03844841|Sensory System Agents|sensory system agents|mesh-ancestor
5581363|NCT03844841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6188351|NCT01848067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188352|NCT01848067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6188353|NCT01848067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6188354|NCT01848067|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6188355|NCT01848067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6188356|NCT01848067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188357|NCT01848067|Hormone Antagonists|hormone antagonists|mesh-ancestor
6188358|NCT01848067|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6188359|NCT01848145|Ofatumumab|ofatumumab|mesh-list
6188360|NCT01848145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6188361|NCT01848210|Troxerutin|troxerutin|mesh-list
6188362|NCT01848210|Anticoagulants|anticoagulants|mesh-ancestor
6188363|NCT01848457|Methotrexate|methotrexate|mesh-list
6188364|NCT01848457|Pantoprazole|pantoprazole|mesh-list
6188365|NCT01848457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6188366|NCT01848457|Abortifacient Agents|abortifacient agents|mesh-ancestor
6188367|NCT01848457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6188368|NCT01848457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188369|NCT01848457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6188370|NCT01848457|Antimetabolites|antimetabolites|mesh-ancestor
6188371|NCT01848457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188372|NCT01848457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6188373|NCT01848457|Dermatologic Agents|dermatologic agents|mesh-ancestor
6188374|NCT01848457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6188375|NCT01848457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6188376|NCT01848457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6188377|NCT01848457|Immunologic Factors|immunologic factors|mesh-ancestor
6188378|NCT01848457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6188379|NCT01848457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6188380|NCT01848457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6188381|NCT01848457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6188382|NCT01848457|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6188383|NCT01848834|Pembrolizumab|pembrolizumab|mesh-list
6188384|NCT01848834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6188385|NCT01848834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6188386|NCT01848899|Bivalirudin|bivalirudin|mesh-list
6188387|NCT01848899|Antithrombins|antithrombins|mesh-ancestor
6188388|NCT01848899|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6188389|NCT01848899|Protease Inhibitors|protease inhibitors|mesh-ancestor
6188390|NCT01848899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5581364|NCT03844841|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5581365|NCT03844841|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5581366|NCT03844841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5581367|NCT03844841|Adrenergic Agents|adrenergic agents|mesh-ancestor
5581368|NCT03844841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5581369|NCT03844841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581370|NCT03844984|Lidocaine|lidocaine|mesh-list
6188391|NCT01848899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188392|NCT01848899|Anticoagulants|anticoagulants|mesh-ancestor
6188393|NCT01848990|Insulin|insulin|mesh-list
6188394|NCT01848990|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6188395|NCT01848990|Insulin Aspart|insulin aspart|mesh-list
6188396|NCT01848990|Insulin Lispro|insulin lispro|mesh-list
6188397|NCT01848990|Insulin glulisine|insulin glulisine|mesh-list
6188398|NCT01848990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6188399|NCT01848990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581371|NCT03844984|Midazolam|midazolam|mesh-list
5581372|NCT03844984|Ketamine|ketamine|mesh-list
6188400|NCT01849055|Celecoxib|celecoxib|mesh-list
6188401|NCT01849055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6188402|NCT01849055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6188403|NCT01849055|Analgesics|analgesics|mesh-ancestor
6188404|NCT01849055|Sensory System Agents|sensory system agents|mesh-ancestor
6188405|NCT01849055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6188406|NCT01849055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188407|NCT01849055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6188408|NCT01849055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6188409|NCT01849055|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6188410|NCT01849055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6188411|NCT01849055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6188412|NCT01849055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188413|NCT01849068|Ezetimibe|ezetimibe|mesh-list
6188414|NCT01849068|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6188415|NCT01849068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6188416|NCT01849068|Antimetabolites|antimetabolites|mesh-ancestor
6188417|NCT01849068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188418|NCT01849068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6188419|NCT01849276|Metformin|metformin|mesh-list
6188420|NCT01849276|Cytarabine|cytarabine|mesh-list
6188421|NCT01849276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6188422|NCT01849276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188423|NCT01849276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6188424|NCT01849276|Antimetabolites|antimetabolites|mesh-ancestor
6188425|NCT01849276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188426|NCT01849276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6188427|NCT01849276|Antiviral Agents|antiviral agents|mesh-ancestor
6188428|NCT01849276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6188429|NCT01849276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6188430|NCT01849276|Immunologic Factors|immunologic factors|mesh-ancestor
6188431|NCT01849289|Insulin|insulin|mesh-list
6188432|NCT01849289|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6188433|NCT01849289|Insulin Glargine|insulin glargine|mesh-list
6188434|NCT01849289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6188435|NCT01849289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188436|NCT01849419|Oxytocin|oxytocin|mesh-list
6188437|NCT01849419|Oxytocics|oxytocics|mesh-ancestor
6188438|NCT01849419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6188439|NCT01849419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188440|NCT01849497|Evolocumab|evolocumab|mesh-list
6188441|NCT01849497|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6188442|NCT01849497|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6188443|NCT01849497|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6188444|NCT01849497|Antimetabolites|antimetabolites|mesh-ancestor
6188445|NCT01849497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188446|NCT01849497|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6188447|NCT01849497|Immunologic Factors|immunologic factors|mesh-ancestor
6188448|NCT01849497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188449|NCT01849562|Ribavirin|ribavirin|mesh-list
6188450|NCT01849562|Odalasvir|odalasvir|mesh-list
6188451|NCT01849562|Antimetabolites|antimetabolites|mesh-ancestor
6188452|NCT01849562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188453|NCT01849562|Antiviral Agents|antiviral agents|mesh-ancestor
6188454|NCT01849562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6188455|NCT01849588|Sorafenib|sorafenib|mesh-list
6188456|NCT01849588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6188457|NCT01849588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6188458|NCT01849588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6188459|NCT01849588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581373|NCT03844984|Anesthetics, Local|anesthetics, local|mesh-ancestor
5581374|NCT03844984|Anesthetics|anesthetics|mesh-ancestor
5581375|NCT03844984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5581376|NCT03844984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581377|NCT03844984|Sensory System Agents|sensory system agents|mesh-ancestor
5581378|NCT03844984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5581379|NCT03844984|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5581380|NCT03844984|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5581381|NCT03844984|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5581382|NCT03844984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5581383|NCT03844984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581384|NCT03844984|Analgesics|analgesics|mesh-ancestor
5581385|NCT03844984|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5581386|NCT03844984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5581387|NCT03844984|Anesthetics, General|anesthetics, general|mesh-ancestor
5581388|NCT03844984|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5581389|NCT03844984|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6188460|NCT01849692|Ranibizumab|ranibizumab|mesh-list
6188461|NCT01849692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6188462|NCT01849692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6188463|NCT01849692|Growth Substances|growth substances|mesh-ancestor
6188464|NCT01849692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188465|NCT01849692|Growth Inhibitors|growth inhibitors|mesh-ancestor
6188466|NCT01849692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6188467|NCT01849770|Mexiletine|mexiletine|mesh-list
6188468|NCT01849770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6188469|NCT01849770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6188470|NCT01849770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6188471|NCT01849770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5581390|NCT03844984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5581391|NCT03844984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5581392|NCT03844984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6188472|NCT01849770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188473|NCT01850030|Progesterone|progesterone|mesh-list
6188474|NCT01850030|Dydrogesterone|dydrogesterone|mesh-list
6188475|NCT01850030|Progestins|progestins|mesh-ancestor
6188476|NCT01850030|Hormones|hormones|mesh-ancestor
6188477|NCT01850030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6188478|NCT01850030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188479|NCT01850394|Tranexamic Acid|tranexamic acid|mesh-list
6188480|NCT01850394|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6188481|NCT01850394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6188482|NCT01850394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188483|NCT01850394|Hemostatics|hemostatics|mesh-ancestor
6188484|NCT01850394|Coagulants|coagulants|mesh-ancestor
5581393|NCT03844984|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5581394|NCT03844984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5581395|NCT03844984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5581396|NCT03844984|GABA Modulators|gaba modulators|mesh-ancestor
5581397|NCT03844984|GABA Agents|gaba agents|mesh-ancestor
6188485|NCT01850446|Oseltamivir|oseltamivir|mesh-list
6188486|NCT01850446|Antiviral Agents|antiviral agents|mesh-ancestor
6188487|NCT01850446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6188488|NCT01850446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6188489|NCT01850446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188490|NCT01850524|Dexamethasone|dexamethasone|mesh-list
6188491|NCT01850524|Lenalidomide|lenalidomide|mesh-list
6188492|NCT01850524|Ixazomib|ixazomib|mesh-list
5581398|NCT03844932|Cyclosporine|cyclosporine|mesh-list
5581399|NCT03844932|Cyclosporins|cyclosporins|mesh-list
6188493|NCT01850524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6188494|NCT01850524|Antiemetics|antiemetics|mesh-ancestor
6188495|NCT01850524|Autonomic Agents|autonomic agents|mesh-ancestor
6188496|NCT01850524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6188497|NCT01850524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188498|NCT01850524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6188499|NCT01850524|Glucocorticoids|glucocorticoids|mesh-ancestor
6188500|NCT01850524|Hormones|hormones|mesh-ancestor
5581400|NCT03844932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5581401|NCT03844932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581402|NCT03844932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5581403|NCT03844932|Immunologic Factors|immunologic factors|mesh-ancestor
5581404|NCT03844932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581405|NCT03844932|Antifungal Agents|antifungal agents|mesh-ancestor
5581406|NCT03844932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5581407|NCT03844932|Dermatologic Agents|dermatologic agents|mesh-ancestor
5581408|NCT03844932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5581409|NCT03844932|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5581410|NCT03844854|Salicylic Acid|salicylic acid|mesh-list
5581411|NCT03844854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5581412|NCT03844854|Antifungal Agents|antifungal agents|mesh-ancestor
5581413|NCT03844854|Keratolytic Agents|keratolytic agents|mesh-ancestor
5581414|NCT03844854|Dermatologic Agents|dermatologic agents|mesh-ancestor
5581415|NCT03844815|Decitabine|decitabine|mesh-list
5581416|NCT03844815|Venetoclax|venetoclax|mesh-list
6188501|NCT01850524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6188502|NCT01850524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6188503|NCT01850524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6188504|NCT01850524|Immunologic Factors|immunologic factors|mesh-ancestor
6188505|NCT01850524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6188506|NCT01850524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6188507|NCT01850524|Growth Substances|growth substances|mesh-ancestor
6188508|NCT01850524|Growth Inhibitors|growth inhibitors|mesh-ancestor
6188509|NCT01850524|Protease Inhibitors|protease inhibitors|mesh-ancestor
6188510|NCT01850524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6188511|NCT01850524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188512|NCT01850602|Sevelamer|sevelamer|mesh-list
6188513|NCT01850602|Chelating Agents|chelating agents|mesh-ancestor
6188514|NCT01850602|Sequestering Agents|sequestering agents|mesh-ancestor
6188515|NCT01850602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188516|NCT01850615|Insulin|insulin|mesh-list
6188517|NCT01850615|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6188518|NCT01850615|Insulin Aspart|insulin aspart|mesh-list
6188519|NCT01850615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5581417|NCT03844815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5581418|NCT03844815|Antimetabolites|antimetabolites|mesh-ancestor
5581419|NCT03844815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581420|NCT03844815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5581421|NCT03844815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5581422|NCT03844581|Propiverine|propiverine|mesh-list
5581423|NCT03844581|Parasympatholytics|parasympatholytics|mesh-ancestor
5581424|NCT03844581|Autonomic Agents|autonomic agents|mesh-ancestor
5581425|NCT03844581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5581426|NCT03844581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581427|NCT03844581|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5581428|NCT03844581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5581429|NCT03844581|Cholinergic Agents|cholinergic agents|mesh-ancestor
5581430|NCT03844581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5581431|NCT03844581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581432|NCT03844581|Urological Agents|urological agents|mesh-ancestor
5581433|NCT03844633|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
5581434|NCT03844633|Medroxyprogesterone|medroxyprogesterone|mesh-list
6188520|NCT01850615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188521|NCT01850823|Mometasone Furoate|mometasone furoate|mesh-list
6188522|NCT01850823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6188523|NCT01850823|Dermatologic Agents|dermatologic agents|mesh-ancestor
6672025|NCT01553006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6672026|NCT01553006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6672027|NCT01553019|Gemcitabine|gemcitabine|mesh-list
6672028|NCT01553019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6672029|NCT01553019|Antimetabolites|antimetabolites|mesh-ancestor
5581435|NCT03844633|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6188524|NCT01850823|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6188525|NCT01851330|Sofosbuvir|sofosbuvir|mesh-list
6188526|NCT01851330|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
6188527|NCT01851330|Ledipasvir|ledipasvir|mesh-list
6188528|NCT01851330|Antiviral Agents|antiviral agents|mesh-ancestor
6188529|NCT01851330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6188530|NCT01851590|Terbinafine|terbinafine|mesh-list
6188531|NCT01851590|Amorolfine|amorolfine|mesh-list
6188532|NCT01851590|Antifungal Agents|antifungal agents|mesh-ancestor
6188533|NCT01851590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5581436|NCT03844633|Contraceptive Agents|contraceptive agents|mesh-ancestor
5581437|NCT03844633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5581438|NCT03844633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581439|NCT03844633|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5581440|NCT03844633|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5581441|NCT03844633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5581442|NCT03844633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5581443|NCT03844633|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5581444|NCT03844633|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5581445|NCT03844633|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5581446|NCT03844451|Epinephrine|epinephrine|mesh-list
5581447|NCT03844451|Bupivacaine|bupivacaine|mesh-list
5581448|NCT03844451|Anesthetics, Local|anesthetics, local|mesh-ancestor
5581449|NCT03844451|Anesthetics|anesthetics|mesh-ancestor
6188534|NCT01851590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6188535|NCT01851590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188536|NCT01851720|Fentanyl|fentanyl|mesh-list
6188537|NCT01851720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6188538|NCT01851720|Narcotics|narcotics|mesh-ancestor
6188539|NCT01851720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6188540|NCT01851720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188541|NCT01851720|Analgesics|analgesics|mesh-ancestor
6188542|NCT01851720|Sensory System Agents|sensory system agents|mesh-ancestor
6188543|NCT01851720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6188544|NCT01851720|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6188545|NCT01851720|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6188546|NCT01851720|Anesthetics, General|anesthetics, general|mesh-ancestor
6188547|NCT01851720|Anesthetics|anesthetics|mesh-ancestor
6207032|NCT02108288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6207033|NCT02109029|Insulin|insulin|mesh-list
6207034|NCT02109029|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6207035|NCT02109029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6207036|NCT02109029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207037|NCT02109133|Rocuronium|rocuronium|mesh-list
6207038|NCT02109133|Atracurium|atracurium|mesh-list
6207039|NCT02109133|Neostigmine|neostigmine|mesh-list
6207040|NCT02109133|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6207041|NCT02109133|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6207042|NCT02109133|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6207043|NCT02109133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6207044|NCT02109133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207045|NCT02109133|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6207046|NCT02109133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6207047|NCT02109133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207048|NCT02109133|Cholinergic Agents|cholinergic agents|mesh-ancestor
6207049|NCT02109133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6207050|NCT02109133|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6207051|NCT02109133|Autonomic Agents|autonomic agents|mesh-ancestor
6207052|NCT02109133|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
6207053|NCT02109133|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6207054|NCT02109445|Gemcitabine|gemcitabine|mesh-list
6207055|NCT02109445|Paclitaxel|paclitaxel|mesh-list
6207056|NCT02109445|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6207057|NCT02109445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5581450|NCT03844451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5581451|NCT03844451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581452|NCT03844451|Sensory System Agents|sensory system agents|mesh-ancestor
5581453|NCT03844451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5581454|NCT03844451|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5581455|NCT03844451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5581456|NCT03844451|Adrenergic Agents|adrenergic agents|mesh-ancestor
5581457|NCT03844451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5581458|NCT03844451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581459|NCT03844451|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5581460|NCT03844451|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5581461|NCT03844451|Autonomic Agents|autonomic agents|mesh-ancestor
5581462|NCT03844451|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5581463|NCT03844451|Respiratory System Agents|respiratory system agents|mesh-ancestor
5581464|NCT03844451|Mydriatics|mydriatics|mesh-ancestor
5581465|NCT03844451|Sympathomimetics|sympathomimetics|mesh-ancestor
6207058|NCT02109445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6207059|NCT02109445|Tubulin Modulators|tubulin modulators|mesh-ancestor
6207060|NCT02109445|Antimitotic Agents|antimitotic agents|mesh-ancestor
6207061|NCT02109445|Mitosis Modulators|mitosis modulators|mesh-ancestor
6207062|NCT02109445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581466|NCT03844451|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5581467|NCT03844776|Acetaminophen|acetaminophen|mesh-list
5581468|NCT03844776|Amoxicillin|amoxicillin|mesh-list
5581469|NCT03844776|Metronidazole|metronidazole|mesh-list
5581470|NCT03844776|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5581471|NCT03844776|Chlorhexidine|chlorhexidine|mesh-list
5581472|NCT03844776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5581473|NCT03844776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5581474|NCT03844776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5581475|NCT03844776|Analgesics|analgesics|mesh-ancestor
5581476|NCT03844776|Sensory System Agents|sensory system agents|mesh-ancestor
5581477|NCT03844776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5581478|NCT03844776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581479|NCT03844776|Antipyretics|antipyretics|mesh-ancestor
5581480|NCT03844776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5581481|NCT03844776|Disinfectants|disinfectants|mesh-ancestor
5581482|NCT03844776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5581483|NCT03844776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5581484|NCT03844776|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5581485|NCT03844776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5581486|NCT03844776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581487|NCT03844620|Trifluridine|trifluridine|mesh-list
5581488|NCT03844620|Antimetabolites|antimetabolites|mesh-ancestor
5581489|NCT03844620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581490|NCT03844620|Antiviral Agents|antiviral agents|mesh-ancestor
5581491|NCT03844620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5581492|NCT03844529|Lidocaine|lidocaine|mesh-list
5581493|NCT03844529|Anesthetics, Local|anesthetics, local|mesh-ancestor
5581494|NCT03844529|Anesthetics|anesthetics|mesh-ancestor
5581495|NCT03844529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5581496|NCT03844529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581497|NCT03844529|Sensory System Agents|sensory system agents|mesh-ancestor
5581498|NCT03844529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5581499|NCT03844529|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5581500|NCT03844529|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5581501|NCT03844529|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5581502|NCT03844529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5581503|NCT03844529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581504|NCT03844594|Eptifibatide|eptifibatide|mesh-list
5581505|NCT03844594|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5581506|NCT03844763|Cyclophosphamide|cyclophosphamide|mesh-list
5581507|NCT03844763|Avelumab|avelumab|mesh-list
5581508|NCT03844763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5581509|NCT03844763|Immunologic Factors|immunologic factors|mesh-ancestor
5581510|NCT03844763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581511|NCT03844763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5581512|NCT03844763|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5581513|NCT03844763|Alkylating Agents|alkylating agents|mesh-ancestor
5581514|NCT03844763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581515|NCT03844763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5581516|NCT03844763|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5581517|NCT03844763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5581518|NCT03844100|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
5581519|NCT03844100|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5581520|NCT03844100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5581521|NCT03844139|Glycerol|glycerol|mesh-list
5581522|NCT03844139|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
5581523|NCT03844139|Protective Agents|protective agents|mesh-ancestor
5581524|NCT03844139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581525|NCT03844256|Capecitabine|capecitabine|mesh-list
5581526|NCT03844256|Nivolumab|nivolumab|mesh-list
5581527|NCT03844256|Ipilimumab|ipilimumab|mesh-list
5581528|NCT03844256|Mitomycins|mitomycins|mesh-list
5581529|NCT03844256|Mitomycin|mitomycin|mesh-list
5581530|NCT03844256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6188548|NCT01851863|Flupenthixol|flupenthixol|mesh-list
6188549|NCT01851863|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
6188550|NCT01851863|Omeprazole|omeprazole|mesh-list
6188551|NCT01851863|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6188552|NCT01851863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6188553|NCT01851863|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6188554|NCT01851863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6188555|NCT01851863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188556|NCT01851863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5581531|NCT03844256|Antimetabolites|antimetabolites|mesh-ancestor
5581532|NCT03844256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188557|NCT01851863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6188558|NCT01851863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6188559|NCT01851863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581533|NCT03844256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5581534|NCT03844256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5581535|NCT03844256|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5581536|NCT03844256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5581537|NCT03844256|Alkylating Agents|alkylating agents|mesh-ancestor
5581538|NCT03844256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5581539|NCT03844256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5581540|NCT03844061|Mycophenolic Acid|mycophenolic acid|mesh-list
5581541|NCT03844061|Rituximab|rituximab|mesh-list
5581542|NCT03844061|Belimumab|belimumab|mesh-list
5581543|NCT03844061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5581544|NCT03844061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5581545|NCT03844061|Immunologic Factors|immunologic factors|mesh-ancestor
5581546|NCT03844061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581547|NCT03844061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5581548|NCT03844061|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5581549|NCT03844061|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5581550|NCT03844061|Antitubercular Agents|antitubercular agents|mesh-ancestor
5581551|NCT03844061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5581552|NCT03844061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5581553|NCT03844061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5581554|NCT03844061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581555|NCT03844061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5581556|NCT03844217|Tryptophan|tryptophan|mesh-list
5581557|NCT03844217|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5581558|NCT03844217|Antidepressive Agents|antidepressive agents|mesh-ancestor
5581559|NCT03844217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5581560|NCT03844360|Anti-Infective Agents|anti-infective agents|mesh-list
5581561|NCT03844360|Bortezomib|bortezomib|mesh-list
5581562|NCT03844360|Imatinib Mesylate|imatinib mesylate|mesh-list
5581563|NCT03844360|Dasatinib|dasatinib|mesh-list
5581564|NCT03844360|Pegaspargase|pegaspargase|mesh-list
5581565|NCT03844360|Sargramostim|sargramostim|mesh-list
5581566|NCT03844360|Lenograstim|lenograstim|mesh-list
5581567|NCT03844360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6188560|NCT01851863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6188561|NCT01851863|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6188562|NCT01851863|Dopamine Agents|dopamine agents|mesh-ancestor
6188563|NCT01851863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6188564|NCT01852019|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6188565|NCT01852019|Cangrelor|cangrelor|mesh-list
6188566|NCT01852019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6188567|NCT01852019|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6188568|NCT01852019|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6188569|NCT01852019|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6188570|NCT01852019|Purinergic Agents|purinergic agents|mesh-ancestor
6188571|NCT01852019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6188572|NCT01852019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188573|NCT01852019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188574|NCT01852045|Botulinum Toxins|botulinum toxins|mesh-list
6188575|NCT01852045|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6188576|NCT01852045|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6188577|NCT01852045|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6188578|NCT01852045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5581568|NCT03844360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5581569|NCT03844360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5581570|NCT03844360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581571|NCT03844360|Immunologic Factors|immunologic factors|mesh-ancestor
5581572|NCT03844360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581573|NCT03844360|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5581574|NCT03844243|Mitogens|mitogens|mesh-list
5581575|NCT03844243|Mitosis Modulators|mitosis modulators|mesh-ancestor
5581576|NCT03844243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581577|NCT03843970|Bupivacaine|bupivacaine|mesh-list
5581578|NCT03843970|Levobupivacaine|levobupivacaine|mesh-list
5581579|NCT03843970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5581580|NCT03843970|Anesthetics, Local|anesthetics, local|mesh-ancestor
6188579|NCT01852045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188580|NCT01852045|Cholinergic Agents|cholinergic agents|mesh-ancestor
5581581|NCT03843970|Anesthetics|anesthetics|mesh-ancestor
5581582|NCT03843970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5581583|NCT03843970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188581|NCT01852045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6188582|NCT01852045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188583|NCT01852045|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6188584|NCT01852045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6188585|NCT01852058|Botulinum Toxins|botulinum toxins|mesh-list
6188586|NCT01852058|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6188587|NCT01852058|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6188588|NCT01852058|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6188589|NCT01852058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6188590|NCT01852058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188591|NCT01852058|Cholinergic Agents|cholinergic agents|mesh-ancestor
6188592|NCT01852058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6188593|NCT01852058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188594|NCT01852058|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6188595|NCT01852058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6188596|NCT01852071|Busulfan|busulfan|mesh-list
6188597|NCT01852071|Alkylating Agents|alkylating agents|mesh-ancestor
6672030|NCT01553019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672031|NCT01553019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6672032|NCT01553019|Antiviral Agents|antiviral agents|mesh-ancestor
6188598|NCT01852071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188599|NCT01852071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6188600|NCT01852071|Immunologic Factors|immunologic factors|mesh-ancestor
6188601|NCT01852071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188602|NCT01852071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6188603|NCT01852071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6188604|NCT01852071|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5581584|NCT03843970|Sensory System Agents|sensory system agents|mesh-ancestor
5581585|NCT03843970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5581586|NCT03843749|Trastuzumab|trastuzumab|mesh-list
5581587|NCT03843749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5581588|NCT03843749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5581589|NCT03844178|Tetracaine|tetracaine|mesh-list
6188605|NCT01852162|Dabigatran|dabigatran|mesh-list
6188606|NCT01852162|Antithrombins|antithrombins|mesh-ancestor
6188607|NCT01852162|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6188608|NCT01852162|Protease Inhibitors|protease inhibitors|mesh-ancestor
6188609|NCT01852162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6188610|NCT01852162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188611|NCT01852162|Anticoagulants|anticoagulants|mesh-ancestor
6188612|NCT01852175|Ticagrelor|ticagrelor|mesh-list
6188613|NCT01852175|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6188614|NCT01852175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6188615|NCT01852175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6188616|NCT01852175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6188617|NCT01852175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6188618|NCT01852175|Purinergic Agents|purinergic agents|mesh-ancestor
6188619|NCT01852175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6188620|NCT01852175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188621|NCT01852175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188622|NCT01852214|Ticagrelor|ticagrelor|mesh-list
6188623|NCT01852214|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6188624|NCT01852214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6188625|NCT01852214|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6188626|NCT01852214|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6188627|NCT01852214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6188628|NCT01852214|Purinergic Agents|purinergic agents|mesh-ancestor
6188629|NCT01852214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6188630|NCT01852214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188631|NCT01852214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188632|NCT01852292|Paclitaxel|paclitaxel|mesh-list
6188633|NCT01852292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6188634|NCT01852292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6188635|NCT01852292|Tubulin Modulators|tubulin modulators|mesh-ancestor
6188636|NCT01852292|Antimitotic Agents|antimitotic agents|mesh-ancestor
6188637|NCT01852292|Mitosis Modulators|mitosis modulators|mesh-ancestor
6188638|NCT01852292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188639|NCT01852344|Methylphenidate|methylphenidate|mesh-list
6188640|NCT01852344|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6188641|NCT01852344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188642|NCT01852344|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5581590|NCT03844178|Anesthetics, Local|anesthetics, local|mesh-ancestor
5581591|NCT03844178|Anesthetics|anesthetics|mesh-ancestor
5581592|NCT03844178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5581593|NCT03844178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581594|NCT03844178|Sensory System Agents|sensory system agents|mesh-ancestor
5581595|NCT03844178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5581596|NCT03843853|Bevacizumab|bevacizumab|mesh-list
5581597|NCT03843853|Pemetrexed|pemetrexed|mesh-list
5581598|NCT03843853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5581599|NCT03843853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5581600|NCT03843853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5581601|NCT03843853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5581602|NCT03843853|Growth Substances|growth substances|mesh-ancestor
6188643|NCT01852344|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6188644|NCT01852344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6188645|NCT01852344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188646|NCT01852344|Dopamine Agents|dopamine agents|mesh-ancestor
6188647|NCT01852344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6188648|NCT01852383|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6188649|NCT01852383|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6188650|NCT01852383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6188651|NCT01852383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6188652|NCT01852383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188653|NCT01852383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6188654|NCT01852383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581603|NCT03843853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581604|NCT03843853|Growth Inhibitors|growth inhibitors|mesh-ancestor
5581605|NCT03843853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5581606|NCT03843853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581607|NCT03843853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5581608|NCT03843853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5581609|NCT03843879|Lidocaine|lidocaine|mesh-list
5581610|NCT03843879|Anesthetics, Local|anesthetics, local|mesh-ancestor
5581611|NCT03843879|Anesthetics|anesthetics|mesh-ancestor
6188655|NCT01852383|Analgesics|analgesics|mesh-ancestor
6188656|NCT01852383|Sensory System Agents|sensory system agents|mesh-ancestor
6188657|NCT01852383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6188658|NCT01852383|Antidepressive Agents|antidepressive agents|mesh-ancestor
6188659|NCT01852383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6188660|NCT01852383|Dopamine Agents|dopamine agents|mesh-ancestor
6188661|NCT01852591|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6188662|NCT01852591|Immunologic Factors|immunologic factors|mesh-ancestor
6188663|NCT01852591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188664|NCT01852669|Furosemide|furosemide|mesh-list
6188665|NCT01852669|Diuretics|diuretics|mesh-ancestor
6188666|NCT01852669|Natriuretic Agents|natriuretic agents|mesh-ancestor
6188667|NCT01852669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188668|NCT01852669|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6188669|NCT01852669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6188670|NCT01852669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188671|NCT01852942|Losartan|losartan|mesh-list
5581612|NCT03843879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5581613|NCT03843879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581614|NCT03843879|Sensory System Agents|sensory system agents|mesh-ancestor
5581615|NCT03843879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5581616|NCT03843879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5581617|NCT03843879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5581618|NCT03843879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5581619|NCT03843879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5581620|NCT03843879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604917|NCT03962465|Daunorubicin|daunorubicin|mesh-list
5604918|NCT03962465|Pegaspargase|pegaspargase|mesh-list
5604919|NCT03962465|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
5604920|NCT03962465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5604921|NCT03962465|Glucocorticoids|glucocorticoids|mesh-ancestor
5604922|NCT03962465|Hormones|hormones|mesh-ancestor
5604923|NCT03962465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5604924|NCT03962465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604925|NCT03962465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6188672|NCT01852942|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6188673|NCT01852942|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6188674|NCT01852942|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6188675|NCT01852942|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6188676|NCT01852942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188677|NCT01852955|Acetaminophen|acetaminophen|mesh-list
6188678|NCT01852955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6188679|NCT01852955|Analgesics|analgesics|mesh-ancestor
6188680|NCT01852955|Sensory System Agents|sensory system agents|mesh-ancestor
6188681|NCT01852955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6188682|NCT01852955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188683|NCT01852955|Antipyretics|antipyretics|mesh-ancestor
6188684|NCT01853072|Prednisolone|prednisolone|mesh-list
6188685|NCT01853072|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6188686|NCT01853072|Methylprednisolone|methylprednisolone|mesh-list
6188687|NCT01853072|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6188688|NCT01853072|Prednisolone acetate|prednisolone acetate|mesh-list
6188689|NCT01853072|Nepafenac|nepafenac|mesh-list
6188690|NCT01853072|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6188691|NCT01853072|Prednisolone phosphate|prednisolone phosphate|mesh-list
6188692|NCT01853072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6188693|NCT01853072|Glucocorticoids|glucocorticoids|mesh-ancestor
6188694|NCT01853072|Hormones|hormones|mesh-ancestor
6188695|NCT01853072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6188696|NCT01853072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188697|NCT01853072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6188698|NCT01853072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6188699|NCT01853072|Antiemetics|antiemetics|mesh-ancestor
6188700|NCT01853072|Autonomic Agents|autonomic agents|mesh-ancestor
6188701|NCT01853072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6188702|NCT01853072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6188703|NCT01853072|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6188704|NCT01853072|Protective Agents|protective agents|mesh-ancestor
5581621|NCT03843736|Drospirenone|drospirenone|mesh-list
5581622|NCT03843736|Contraceptive Agents|contraceptive agents|mesh-list
5581623|NCT03843736|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5581624|NCT03843736|Contraceptives, Oral|contraceptives, oral|mesh-list
5581625|NCT03843736|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
5581626|NCT03843736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5581627|NCT03843736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581628|NCT03843736|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5581629|NCT03843736|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5581630|NCT03843736|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5581631|NCT03843736|Estrogens|estrogens|mesh-ancestor
5581632|NCT03843736|Hormones|hormones|mesh-ancestor
5581633|NCT03843736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5581634|NCT03843736|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5581635|NCT03843736|Hormone Antagonists|hormone antagonists|mesh-ancestor
5581636|NCT03843736|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5581637|NCT03843736|Diuretics|diuretics|mesh-ancestor
5581638|NCT03843736|Natriuretic Agents|natriuretic agents|mesh-ancestor
6188705|NCT01853072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6188706|NCT01853072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6188707|NCT01853072|Analgesics|analgesics|mesh-ancestor
6188708|NCT01853072|Sensory System Agents|sensory system agents|mesh-ancestor
6188709|NCT01853072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6188710|NCT01853085|Bimatoprost|bimatoprost|mesh-list
6188711|NCT01853085|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6188712|NCT01853085|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6188713|NCT01853085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6188714|NCT01853228|Cytarabine|cytarabine|mesh-list
6188715|NCT01853228|Decitabine|decitabine|mesh-list
6188716|NCT01853228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6188717|NCT01853228|Antimetabolites|antimetabolites|mesh-ancestor
6188718|NCT01853228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188719|NCT01853228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6188720|NCT01853228|Antiviral Agents|antiviral agents|mesh-ancestor
6188721|NCT01853228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6188722|NCT01853228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6188723|NCT01853228|Immunologic Factors|immunologic factors|mesh-ancestor
6188724|NCT01853228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188725|NCT01853228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6188726|NCT01853254|Ribavirin|ribavirin|mesh-list
5581639|NCT03843645|Anesthetics|anesthetics|mesh-list
6188727|NCT01853254|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6188728|NCT01853254|Antimetabolites|antimetabolites|mesh-ancestor
6188729|NCT01853254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188730|NCT01853254|Antiviral Agents|antiviral agents|mesh-ancestor
6188731|NCT01853254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6188732|NCT01853280|Methylphenidate|methylphenidate|mesh-list
5581640|NCT03843645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5581641|NCT03843645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581642|NCT03843541|Acetylcysteine|acetylcysteine|mesh-list
5581643|NCT03843541|Ambroxol|ambroxol|mesh-list
6188733|NCT01853280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6672033|NCT01553019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6672034|NCT01553019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6672035|NCT01553019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6672036|NCT01553019|Immunologic Factors|immunologic factors|mesh-ancestor
6672037|NCT01553019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672038|NCT01553032|Cetuximab|cetuximab|mesh-list
6672039|NCT01553032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6672040|NCT01553032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6672041|NCT01553071|Fenretinide|fenretinide|mesh-list
6672042|NCT01553071|Safingol|safingol|mesh-list
5581644|NCT03843541|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5581645|NCT03843541|Antiviral Agents|antiviral agents|mesh-ancestor
5581646|NCT03843541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5581647|NCT03843541|Expectorants|expectorants|mesh-ancestor
5581648|NCT03843541|Respiratory System Agents|respiratory system agents|mesh-ancestor
5581649|NCT03843541|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5581650|NCT03843541|Antioxidants|antioxidants|mesh-ancestor
5581651|NCT03843541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581652|NCT03843541|Protective Agents|protective agents|mesh-ancestor
5581653|NCT03843541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581654|NCT03843541|Antidotes|antidotes|mesh-ancestor
6672043|NCT01553071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6188734|NCT01853280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188735|NCT01853280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6188736|NCT01853280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6188737|NCT01853280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6188738|NCT01853280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188739|NCT01853280|Dopamine Agents|dopamine agents|mesh-ancestor
6188740|NCT01853280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5581655|NCT03843528|Azacitidine|azacitidine|mesh-list
5581656|NCT03843528|Vorinostat|vorinostat|mesh-list
5581657|NCT03843528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5581658|NCT03843528|Antimetabolites|antimetabolites|mesh-ancestor
5581659|NCT03843528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581660|NCT03843528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5581661|NCT03843528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5581662|NCT03843528|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5581663|NCT03843463|Dexetimide|dexetimide|mesh-list
6188741|NCT01853475|Artefenomel|artefenomel|mesh-list
6188742|NCT01853475|Antimalarials|antimalarials|mesh-ancestor
6188743|NCT01853475|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6188744|NCT01853475|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6188745|NCT01853475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6188746|NCT01853553|Spironolactone|spironolactone|mesh-list
6188747|NCT01853553|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6188748|NCT01853553|Hormone Antagonists|hormone antagonists|mesh-ancestor
6188749|NCT01853553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6188750|NCT01853553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188751|NCT01853553|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6188752|NCT01853553|Diuretics|diuretics|mesh-ancestor
6188753|NCT01853553|Natriuretic Agents|natriuretic agents|mesh-ancestor
6188754|NCT01853618|Tremelimumab|tremelimumab|mesh-list
6188755|NCT01853618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6188756|NCT01853696|Loteprednol Etabonate|loteprednol etabonate|mesh-list
6188757|NCT01853696|Prednisolone|prednisolone|mesh-list
6188758|NCT01853696|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6188759|NCT01853696|Methylprednisolone|methylprednisolone|mesh-list
6188760|NCT01853696|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6188761|NCT01853696|Prednisolone acetate|prednisolone acetate|mesh-list
6188762|NCT01853696|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6188763|NCT01853696|Prednisolone phosphate|prednisolone phosphate|mesh-list
6188764|NCT01853696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5581664|NCT03843463|Citalopram|citalopram|mesh-list
5581665|NCT03843463|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5581666|NCT03843463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5581667|NCT03843463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5581668|NCT03843463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672044|NCT01553071|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5581669|NCT03843463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5581670|NCT03843463|Serotonin Agents|serotonin agents|mesh-ancestor
6188765|NCT01853696|Glucocorticoids|glucocorticoids|mesh-ancestor
6188766|NCT01853696|Hormones|hormones|mesh-ancestor
6188767|NCT01853696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6188768|NCT01853696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188769|NCT01853696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6188770|NCT01853696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6188771|NCT01853696|Antiemetics|antiemetics|mesh-ancestor
6188772|NCT01853696|Autonomic Agents|autonomic agents|mesh-ancestor
6188773|NCT01853696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6188774|NCT01853696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6188775|NCT01853696|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6188776|NCT01853696|Protective Agents|protective agents|mesh-ancestor
6188777|NCT01853696|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6188778|NCT01854047|Albuterol|albuterol|mesh-list
6188779|NCT01854047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6188780|NCT01854047|Autonomic Agents|autonomic agents|mesh-ancestor
6188781|NCT01854047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6188782|NCT01854047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188783|NCT01854047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5581671|NCT03843463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581672|NCT03843463|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5581673|NCT03843463|Antidepressive Agents|antidepressive agents|mesh-ancestor
5581674|NCT03843463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5581675|NCT03843463|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5581676|NCT03843463|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5581677|NCT03843463|Parasympatholytics|parasympatholytics|mesh-ancestor
5581678|NCT03843463|Autonomic Agents|autonomic agents|mesh-ancestor
5581679|NCT03843463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5581680|NCT03843463|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5581681|NCT03843463|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5581682|NCT03843463|Cholinergic Agents|cholinergic agents|mesh-ancestor
5581683|NCT03843281|Acetaminophen|acetaminophen|mesh-list
5581684|NCT03843281|Morphine|morphine|mesh-list
5581685|NCT03843281|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5581686|NCT03843281|Narcotics|narcotics|mesh-ancestor
5581687|NCT03843281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5581688|NCT03843281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581689|NCT03843281|Analgesics|analgesics|mesh-ancestor
5581690|NCT03843281|Sensory System Agents|sensory system agents|mesh-ancestor
5581691|NCT03843281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5581692|NCT03843281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5581693|NCT03843281|Antipyretics|antipyretics|mesh-ancestor
5581694|NCT03843294|Nivolumab|nivolumab|mesh-list
5581695|NCT03843294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5581696|NCT03843294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5581697|NCT03843294|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6188784|NCT01854047|Respiratory System Agents|respiratory system agents|mesh-ancestor
6188785|NCT01854047|Tocolytic Agents|tocolytic agents|mesh-ancestor
6188786|NCT01854047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6188787|NCT01854047|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6188788|NCT01854047|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6188789|NCT01854047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6188790|NCT01854047|Adrenergic Agents|adrenergic agents|mesh-ancestor
6188791|NCT01854047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6188792|NCT01854047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188793|NCT01854177|Aprepitant|aprepitant|mesh-list
6188794|NCT01854177|Fosaprepitant|fosaprepitant|mesh-list
6188795|NCT01854177|Antiemetics|antiemetics|mesh-ancestor
6188796|NCT01854177|Autonomic Agents|autonomic agents|mesh-ancestor
6188797|NCT01854177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6188798|NCT01854177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188799|NCT01854177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6188800|NCT01854177|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6188801|NCT01854177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6188802|NCT01854177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581698|NCT03843294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581699|NCT03843229|Bufanolides|bufanolides|mesh-list
5581700|NCT03843229|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5581701|NCT03843229|Protective Agents|protective agents|mesh-ancestor
5581702|NCT03843229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581703|NCT03843515|Nivolumab|nivolumab|mesh-list
5581704|NCT03843515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5581705|NCT03843515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5581706|NCT03843515|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5604926|NCT03962465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5581707|NCT03843515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581708|NCT03843307|Immunologic Factors|immunologic factors|mesh-list
5581709|NCT03843307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581710|NCT03843060|Itraconazole|itraconazole|mesh-list
5581711|NCT03843060|Antifungal Agents|antifungal agents|mesh-ancestor
5581712|NCT03843060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5581713|NCT03843060|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6188803|NCT01854359|Idebenone|idebenone|mesh-list
6188804|NCT01854359|Antioxidants|antioxidants|mesh-ancestor
6188805|NCT01854359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188806|NCT01854359|Protective Agents|protective agents|mesh-ancestor
6188807|NCT01854359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188808|NCT01854528|Interferons|interferons|mesh-list
6188809|NCT01854528|Ribavirin|ribavirin|mesh-list
5581714|NCT03843060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5581715|NCT03843060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5581716|NCT03843060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581717|NCT03843060|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5581718|NCT03843060|Hormone Antagonists|hormone antagonists|mesh-ancestor
5581719|NCT03843060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5581720|NCT03843060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581721|NCT03843060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5581722|NCT03842943|Pembrolizumab|pembrolizumab|mesh-list
5581723|NCT03842943|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
5581724|NCT03842943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5581725|NCT03842943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5581726|NCT03843047|Nicotine|nicotine|mesh-list
5581727|NCT03843047|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5581728|NCT03843047|Autonomic Agents|autonomic agents|mesh-ancestor
5581729|NCT03843047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5581730|NCT03843047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581731|NCT03843047|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5581732|NCT03843047|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5581733|NCT03843047|Cholinergic Agents|cholinergic agents|mesh-ancestor
5581734|NCT03843047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5581735|NCT03843047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188810|NCT01854528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6188811|NCT01854528|Antiviral Agents|antiviral agents|mesh-ancestor
6188812|NCT01854528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6188813|NCT01854528|Antimetabolites|antimetabolites|mesh-ancestor
6188814|NCT01854528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188815|NCT01854593|Bevacizumab|bevacizumab|mesh-list
6188816|NCT01854593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6188817|NCT01854593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6188818|NCT01854593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6188819|NCT01854593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5581736|NCT03842722|Protoporphyrin IX|protoporphyrin ix|mesh-list
5581737|NCT03842722|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5581738|NCT03842722|Dermatologic Agents|dermatologic agents|mesh-ancestor
5581739|NCT03842800|Ketamine|ketamine|mesh-list
5581740|NCT03842800|Analgesics|analgesics|mesh-ancestor
5581741|NCT03842800|Sensory System Agents|sensory system agents|mesh-ancestor
5581742|NCT03842800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5581743|NCT03842800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581744|NCT03842800|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5581745|NCT03842800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5581746|NCT03842800|Anesthetics, General|anesthetics, general|mesh-ancestor
5581747|NCT03842800|Anesthetics|anesthetics|mesh-ancestor
5581748|NCT03842800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5581749|NCT03842800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5581750|NCT03842800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5581751|NCT03842800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5581752|NCT03842800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581753|NCT03842839|Tiotropium Bromide|tiotropium bromide|mesh-list
5581754|NCT03842839|Olodaterol|olodaterol|mesh-list
5581755|NCT03842839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5581756|NCT03842839|Autonomic Agents|autonomic agents|mesh-ancestor
5581757|NCT03842839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5581758|NCT03842839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581759|NCT03842839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5581760|NCT03842839|Respiratory System Agents|respiratory system agents|mesh-ancestor
5581761|NCT03842839|Parasympatholytics|parasympatholytics|mesh-ancestor
6188820|NCT01854593|Growth Substances|growth substances|mesh-ancestor
6188821|NCT01854593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188822|NCT01854593|Growth Inhibitors|growth inhibitors|mesh-ancestor
6188823|NCT01854645|Bromides|bromides|mesh-list
6188824|NCT01854645|Tiotropium Bromide|tiotropium bromide|mesh-list
6188825|NCT01854645|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6188826|NCT01854645|Autonomic Agents|autonomic agents|mesh-ancestor
6188827|NCT01854645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5581762|NCT03842839|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5581763|NCT03842839|Cholinergic Agents|cholinergic agents|mesh-ancestor
5581764|NCT03842839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5581765|NCT03842839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581766|NCT03842709|Pramipexole|pramipexole|mesh-list
6188828|NCT01854645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188829|NCT01854645|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6188830|NCT01854645|Respiratory System Agents|respiratory system agents|mesh-ancestor
6188831|NCT01854645|Parasympatholytics|parasympatholytics|mesh-ancestor
6188832|NCT01854645|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6188833|NCT01854645|Cholinergic Agents|cholinergic agents|mesh-ancestor
6188834|NCT01854645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6188835|NCT01854645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188836|NCT01854645|Anticonvulsants|anticonvulsants|mesh-ancestor
6188837|NCT01854658|Glycopyrrolate|glycopyrrolate|mesh-list
6188838|NCT01854658|Formoterol Fumarate|formoterol fumarate|mesh-list
6188839|NCT01854658|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6188840|NCT01854658|Autonomic Agents|autonomic agents|mesh-ancestor
6188841|NCT01854658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5581767|NCT03842709|Antioxidants|antioxidants|mesh-ancestor
5581768|NCT03842709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581769|NCT03842709|Protective Agents|protective agents|mesh-ancestor
5581770|NCT03842709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581771|NCT03842709|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6188842|NCT01854658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188843|NCT01854658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6188844|NCT01854658|Respiratory System Agents|respiratory system agents|mesh-ancestor
6188845|NCT01854658|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6188846|NCT01854658|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6188847|NCT01854658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6188848|NCT01854658|Adrenergic Agents|adrenergic agents|mesh-ancestor
6188849|NCT01854658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6188850|NCT01854658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188851|NCT01854658|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6188852|NCT01854658|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6188853|NCT01854658|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6188854|NCT01854658|Cholinergic Agents|cholinergic agents|mesh-ancestor
6188855|NCT01854697|Interferons|interferons|mesh-list
6188856|NCT01854697|Ribavirin|ribavirin|mesh-list
6188857|NCT01854697|Interferon-alpha|interferon-alpha|mesh-list
6188858|NCT01854697|Interferon alpha-2|interferon alpha-2|mesh-list
6188859|NCT01854697|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6188860|NCT01854697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6188861|NCT01854697|Antiviral Agents|antiviral agents|mesh-ancestor
6188862|NCT01854697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6188863|NCT01854697|Antimetabolites|antimetabolites|mesh-ancestor
6188864|NCT01854697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581772|NCT03842709|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5581773|NCT03842709|Dopamine Agonists|dopamine agonists|mesh-ancestor
5581774|NCT03842709|Dopamine Agents|dopamine agents|mesh-ancestor
6188865|NCT01854697|Immunologic Factors|immunologic factors|mesh-ancestor
6188866|NCT01854697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188867|NCT01854710|Moxifloxacin|moxifloxacin|mesh-list
6188868|NCT01854710|Loxapine|loxapine|mesh-list
6188869|NCT01854710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6188870|NCT01854710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6188871|NCT01854710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6188872|NCT01854710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6188873|NCT01854710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6188874|NCT01854710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188875|NCT01854710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6188876|NCT01854710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188877|NCT01854710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6188878|NCT01854710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6188879|NCT01854710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6188880|NCT01854710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6188881|NCT01854710|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6188882|NCT01854710|Dopamine Agents|dopamine agents|mesh-ancestor
6188883|NCT01854710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6188884|NCT01854775|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6188885|NCT01854775|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6188886|NCT01854775|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6188887|NCT01854775|Antiviral Agents|antiviral agents|mesh-ancestor
6188888|NCT01854775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6188889|NCT01854827|Immunoglobulins|immunoglobulins|mesh-list
6188890|NCT01854827|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6188891|NCT01854827|Antibodies|antibodies|mesh-list
6188892|NCT01854827|gamma-Globulins|gamma-globulins|mesh-list
6188893|NCT01854827|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6188894|NCT01854827|Immunologic Factors|immunologic factors|mesh-ancestor
6188895|NCT01854827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188896|NCT01854918|Evolocumab|evolocumab|mesh-list
6188897|NCT01854918|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6188898|NCT01854918|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6188899|NCT01854918|Antimetabolites|antimetabolites|mesh-ancestor
6188900|NCT01854918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188901|NCT01854918|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6188902|NCT01854944|Brexpiprazole|brexpiprazole|mesh-list
6188903|NCT01854944|Serotonin Agents|serotonin agents|mesh-ancestor
6188904|NCT01854944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6188905|NCT01854944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188906|NCT01854944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188907|NCT01854944|Dopamine Agonists|dopamine agonists|mesh-ancestor
6188908|NCT01854944|Dopamine Agents|dopamine agents|mesh-ancestor
6188909|NCT01855074|Risperidone|risperidone|mesh-list
6188910|NCT01855074|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6188911|NCT01855074|Serotonin Agents|serotonin agents|mesh-ancestor
6188912|NCT01855074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6188913|NCT01855074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188914|NCT01855074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188915|NCT01855074|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6188916|NCT01855074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6188917|NCT01855074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6188918|NCT01855074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6188919|NCT01855074|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6188920|NCT01855074|Dopamine Agents|dopamine agents|mesh-ancestor
6188921|NCT01855243|Insulin|insulin|mesh-list
6188922|NCT01855243|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6188923|NCT01855243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6188924|NCT01855243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188925|NCT01855360|Doxycycline|doxycycline|mesh-list
6188926|NCT01855360|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
6188927|NCT01855360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6188928|NCT01855360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6188929|NCT01855360|Antimalarials|antimalarials|mesh-ancestor
5581775|NCT03842709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5581776|NCT03842631|Timolol|timolol|mesh-list
5581777|NCT03842631|Maleic acid|maleic acid|mesh-list
5581778|NCT03842631|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5581779|NCT03842631|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5581780|NCT03842631|Adrenergic Agents|adrenergic agents|mesh-ancestor
5581781|NCT03842631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5581782|NCT03842631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188930|NCT01855360|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6188931|NCT01855360|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5581783|NCT03842631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581784|NCT03842631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5581785|NCT03842631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5581786|NCT03842631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5581787|NCT03842488|Raltegravir Potassium|raltegravir potassium|mesh-list
5581788|NCT03842488|Darunavir|darunavir|mesh-list
5581789|NCT03842488|Cobicistat|cobicistat|mesh-list
5581790|NCT03842488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5581791|NCT03842488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6188932|NCT01855360|Antiviral Agents|antiviral agents|mesh-ancestor
6188933|NCT01855360|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6188934|NCT01855360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6188935|NCT01855750|Prednisone|prednisone|mesh-list
6188936|NCT01855750|Cyclophosphamide|cyclophosphamide|mesh-list
6188937|NCT01855750|Rituximab|rituximab|mesh-list
6188938|NCT01855750|Doxorubicin|doxorubicin|mesh-list
6188939|NCT01855750|Vincristine|vincristine|mesh-list
6188940|NCT01855750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5581792|NCT03842488|Antiviral Agents|antiviral agents|mesh-ancestor
6188941|NCT01855750|Immunologic Factors|immunologic factors|mesh-ancestor
6188942|NCT01855750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188943|NCT01855750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6188944|NCT01855750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6188945|NCT01855750|Alkylating Agents|alkylating agents|mesh-ancestor
6188946|NCT01855750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581793|NCT03842488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5581794|NCT03842488|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5581795|NCT03842488|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5581796|NCT03842488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5581797|NCT03842488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581798|NCT03842488|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5581799|NCT03842488|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5581800|NCT03842488|Protease Inhibitors|protease inhibitors|mesh-ancestor
5581801|NCT03842488|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5581802|NCT03842488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5581803|NCT03842423|Anesthetics|anesthetics|mesh-list
5581804|NCT03842423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5581805|NCT03842423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581806|NCT03842254|Epoetin Alfa|epoetin alfa|mesh-list
5581807|NCT03842254|Hematinics|hematinics|mesh-ancestor
5581808|NCT03842085|Antibodies|antibodies|mesh-list
5581809|NCT03842085|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5581810|NCT03842085|Antibodies, Bispecific|antibodies, bispecific|mesh-list
5581811|NCT03842085|Immunologic Factors|immunologic factors|mesh-ancestor
5581812|NCT03842085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581813|NCT03842046|Phenylephrine|phenylephrine|mesh-list
5581814|NCT03842046|Oxymetazoline|oxymetazoline|mesh-list
5581815|NCT03842046|Norepinephrine|norepinephrine|mesh-list
5581816|NCT03842046|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5581817|NCT03842046|Mydriatics|mydriatics|mesh-ancestor
5581818|NCT03842046|Autonomic Agents|autonomic agents|mesh-ancestor
5581819|NCT03842046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5581820|NCT03842046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581821|NCT03842046|Sympathomimetics|sympathomimetics|mesh-ancestor
5581822|NCT03842046|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5581823|NCT03842046|Nasal Decongestants|nasal decongestants|mesh-ancestor
5581824|NCT03842046|Respiratory System Agents|respiratory system agents|mesh-ancestor
5581825|NCT03842046|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5581826|NCT03842046|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6188947|NCT01855750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6188948|NCT01855750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6188949|NCT01855750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6188950|NCT01855750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6188951|NCT01855750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6188952|NCT01855750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6188953|NCT01855750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6188954|NCT01855750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6188955|NCT01855750|Glucocorticoids|glucocorticoids|mesh-ancestor
6188956|NCT01855750|Hormones|hormones|mesh-ancestor
6188957|NCT01855750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6188958|NCT01855750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6188959|NCT01855750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6188960|NCT01855750|Tubulin Modulators|tubulin modulators|mesh-ancestor
6188961|NCT01855750|Antimitotic Agents|antimitotic agents|mesh-ancestor
6188962|NCT01855750|Mitosis Modulators|mitosis modulators|mesh-ancestor
6188963|NCT01855789|Methotrexate|methotrexate|mesh-list
6188964|NCT01855789|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6188965|NCT01855789|Abortifacient Agents|abortifacient agents|mesh-ancestor
6188966|NCT01855789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6188967|NCT01855789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188968|NCT01855789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6188969|NCT01855789|Antimetabolites|antimetabolites|mesh-ancestor
6188970|NCT01855789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188971|NCT01855789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6188972|NCT01855789|Dermatologic Agents|dermatologic agents|mesh-ancestor
6188973|NCT01855789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6188974|NCT01855789|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6188975|NCT01855789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6188976|NCT01855789|Immunologic Factors|immunologic factors|mesh-ancestor
6188977|NCT01855789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6188978|NCT01855789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6188979|NCT01855828|Paclitaxel|paclitaxel|mesh-list
6188980|NCT01855828|Cyclophosphamide|cyclophosphamide|mesh-list
5581827|NCT03842046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5581828|NCT03842046|Adrenergic Agents|adrenergic agents|mesh-ancestor
5581829|NCT03842046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6188981|NCT01855828|Fluorouracil|fluorouracil|mesh-list
6188982|NCT01855828|Trastuzumab|trastuzumab|mesh-list
6188983|NCT01855828|Epirubicin|epirubicin|mesh-list
6188984|NCT01855828|Pertuzumab|pertuzumab|mesh-list
6188985|NCT01855828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5581830|NCT03842046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581831|NCT03842046|Protective Agents|protective agents|mesh-ancestor
5581832|NCT03842020|Amiodarone|amiodarone|mesh-list
5581833|NCT03842020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5581834|NCT03842020|Vasodilator Agents|vasodilator agents|mesh-ancestor
5581835|NCT03842020|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5581836|NCT03842020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5581837|NCT03842020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581838|NCT03842020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5581839|NCT03842020|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5581840|NCT03842020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5581841|NCT03842020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5581842|NCT03842020|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5581843|NCT03842020|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5581844|NCT03842020|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5604927|NCT03962465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5604928|NCT03962465|Abortifacient Agents|abortifacient agents|mesh-ancestor
5604929|NCT03962465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5604930|NCT03962465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5604931|NCT03962465|Antimetabolites|antimetabolites|mesh-ancestor
5604932|NCT03962465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604933|NCT03962465|Dermatologic Agents|dermatologic agents|mesh-ancestor
5604934|NCT03962465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5604935|NCT03962465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5604936|NCT03962465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5604937|NCT03962465|Immunologic Factors|immunologic factors|mesh-ancestor
5604938|NCT03962465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5604939|NCT03962465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5604940|NCT03962465|Antiviral Agents|antiviral agents|mesh-ancestor
5604941|NCT03962465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5604942|NCT03962465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5604943|NCT03962465|Tubulin Modulators|tubulin modulators|mesh-ancestor
5604944|NCT03962465|Antimitotic Agents|antimitotic agents|mesh-ancestor
5604945|NCT03962465|Mitosis Modulators|mitosis modulators|mesh-ancestor
5604946|NCT03962465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5604947|NCT03962465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5604948|NCT03962465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5604949|NCT03962465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5604950|NCT03953898|Olaparib|olaparib|mesh-list
5604951|NCT03953898|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
5604952|NCT03953898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6188986|NCT01855828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6188987|NCT01855828|Tubulin Modulators|tubulin modulators|mesh-ancestor
6188988|NCT01855828|Antimitotic Agents|antimitotic agents|mesh-ancestor
6188989|NCT01855828|Mitosis Modulators|mitosis modulators|mesh-ancestor
6188990|NCT01855828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6188991|NCT01855828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6188992|NCT01855828|Immunologic Factors|immunologic factors|mesh-ancestor
6188993|NCT01855828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6188994|NCT01855828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6188995|NCT01855828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5604953|NCT03953898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604954|NCT03953898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5604955|NCT03948035|Dexamethasone|dexamethasone|mesh-list
5604956|NCT03948035|Dexamethasone acetate|dexamethasone acetate|mesh-list
5604957|NCT03948035|Lenalidomide|lenalidomide|mesh-list
5604958|NCT03948035|Elotuzumab|elotuzumab|mesh-list
5604959|NCT03948035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6188996|NCT01855828|Alkylating Agents|alkylating agents|mesh-ancestor
6188997|NCT01855828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6188998|NCT01855828|Antimetabolites|antimetabolites|mesh-ancestor
6188999|NCT01855828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6189000|NCT01855828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6189001|NCT01855828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6189002|NCT01855828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6189003|NCT01855828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6189004|NCT01855828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6189005|NCT01855919|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6189006|NCT01855919|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6189007|NCT01855919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6189008|NCT01855919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6189009|NCT01855919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189010|NCT01855919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6189011|NCT01855919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189012|NCT01855919|Analgesics|analgesics|mesh-ancestor
6189013|NCT01855919|Sensory System Agents|sensory system agents|mesh-ancestor
5581845|NCT03841773|Cyclobenzaprine|cyclobenzaprine|mesh-list
5581846|NCT03841773|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5581847|NCT03841773|Antidepressive Agents|antidepressive agents|mesh-ancestor
5581848|NCT03841773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5581849|NCT03841773|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5581850|NCT03841773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581851|NCT03841773|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5581852|NCT03841773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5581853|NCT03841773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5581854|NCT03841773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5581855|NCT03841890|Tolnaftate|tolnaftate|mesh-list
5581856|NCT03841890|Antifungal Agents|antifungal agents|mesh-ancestor
5581857|NCT03841890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6189014|NCT01855919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6189015|NCT01855919|Antidepressive Agents|antidepressive agents|mesh-ancestor
6189016|NCT01855919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6189017|NCT01855919|Dopamine Agents|dopamine agents|mesh-ancestor
6189018|NCT01855997|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6189019|NCT01855997|Interferon alpha-2|interferon alpha-2|mesh-list
6189020|NCT01855997|Antiviral Agents|antiviral agents|mesh-ancestor
6189021|NCT01855997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6189022|NCT01855997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6189023|NCT01856114|Fentanyl|fentanyl|mesh-list
6189024|NCT01856114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6189025|NCT01856114|Narcotics|narcotics|mesh-ancestor
6189026|NCT01856114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6189027|NCT01856114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189028|NCT01856114|Analgesics|analgesics|mesh-ancestor
6189029|NCT01856114|Sensory System Agents|sensory system agents|mesh-ancestor
6189030|NCT01856114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6189031|NCT01856114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6189032|NCT01856114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6189033|NCT01856114|Anesthetics, General|anesthetics, general|mesh-ancestor
6189034|NCT01856114|Anesthetics|anesthetics|mesh-ancestor
6189035|NCT01856257|Mycophenolic Acid|mycophenolic acid|mesh-list
6189036|NCT01856257|Methylprednisolone|methylprednisolone|mesh-list
6189037|NCT01856257|Abatacept|abatacept|mesh-list
6189038|NCT01856257|Tacrolimus|tacrolimus|mesh-list
6189039|NCT01856257|Thymoglobulin|thymoglobulin|mesh-list
6189040|NCT01856257|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6189041|NCT01856257|Basiliximab|basiliximab|mesh-list
6189042|NCT01856257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6189043|NCT01856257|Immunologic Factors|immunologic factors|mesh-ancestor
6189044|NCT01856257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189045|NCT01856257|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6189046|NCT01856257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6189047|NCT01856257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189048|NCT01856257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6189049|NCT01856257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6189050|NCT01856257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6189051|NCT01856257|Antitubercular Agents|antitubercular agents|mesh-ancestor
5581858|NCT03841721|Linezolid|linezolid|mesh-list
5581859|NCT03841721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5581860|NCT03841721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5581861|NCT03841721|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5581862|NCT03841721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5581863|NCT03841721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581864|NCT03841747|Paclitaxel|paclitaxel|mesh-list
5581865|NCT03841747|Pembrolizumab|pembrolizumab|mesh-list
5581866|NCT03841747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5581867|NCT03841747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5581868|NCT03841747|Tubulin Modulators|tubulin modulators|mesh-ancestor
5581869|NCT03841747|Antimitotic Agents|antimitotic agents|mesh-ancestor
5581870|NCT03841747|Mitosis Modulators|mitosis modulators|mesh-ancestor
5604960|NCT03948035|Antiemetics|antiemetics|mesh-ancestor
6189052|NCT01856257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6189053|NCT01856257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6189054|NCT01856257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6189055|NCT01856257|Antiemetics|antiemetics|mesh-ancestor
6189056|NCT01856257|Autonomic Agents|autonomic agents|mesh-ancestor
6189057|NCT01856257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6189058|NCT01856257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6189059|NCT01856257|Glucocorticoids|glucocorticoids|mesh-ancestor
6189060|NCT01856257|Hormones|hormones|mesh-ancestor
6189061|NCT01856257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6189062|NCT01856257|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6189063|NCT01856257|Protective Agents|protective agents|mesh-ancestor
5581871|NCT03841747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581872|NCT03841747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5581873|NCT03841526|Glucagon|glucagon|mesh-list
5581874|NCT03841526|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5581875|NCT03841526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5581876|NCT03841526|Hormones|hormones|mesh-ancestor
5581877|NCT03841526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5581878|NCT03841526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581879|NCT03841526|Incretins|incretins|mesh-ancestor
5581880|NCT03841812|Propofol|propofol|mesh-list
5581881|NCT03841812|Sevoflurane|sevoflurane|mesh-list
5581882|NCT03841812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5581883|NCT03841812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5581884|NCT03841812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581885|NCT03841812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5581886|NCT03841812|Anesthetics, General|anesthetics, general|mesh-ancestor
5581887|NCT03841812|Anesthetics|anesthetics|mesh-ancestor
5581888|NCT03841812|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5581889|NCT03841812|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5581890|NCT03841591|Metformin|metformin|mesh-list
5581891|NCT03841591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5581892|NCT03841591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581893|NCT03841292|Varenicline|varenicline|mesh-list
5581894|NCT03841292|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5581895|NCT03841292|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5581896|NCT03841292|Cholinergic Agents|cholinergic agents|mesh-ancestor
5581897|NCT03841292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5581898|NCT03841292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581899|NCT03841292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581900|NCT03841383|Dipyridamole|dipyridamole|mesh-list
5581901|NCT03841383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5581902|NCT03841383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5581903|NCT03841383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581904|NCT03841383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5581905|NCT03841383|Vasodilator Agents|vasodilator agents|mesh-ancestor
5581906|NCT03841305|Liver Extracts|liver extracts|mesh-list
5581907|NCT03841305|Hematinics|hematinics|mesh-ancestor
5581908|NCT03841357|Abatacept|abatacept|mesh-list
5581909|NCT03841357|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5581910|NCT03841357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581911|NCT03841357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5581912|NCT03841357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5581913|NCT03841357|Immunologic Factors|immunologic factors|mesh-ancestor
5581914|NCT03841357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581915|NCT03841357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5581916|NCT03841474|Citalopram|citalopram|mesh-list
5581917|NCT03841474|Sertraline|sertraline|mesh-list
5581918|NCT03841474|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5581919|NCT03841474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5581920|NCT03841474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5581921|NCT03841474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581922|NCT03841474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5581923|NCT03841474|Serotonin Agents|serotonin agents|mesh-ancestor
5581924|NCT03841474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581925|NCT03841474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5581926|NCT03841474|Antidepressive Agents|antidepressive agents|mesh-ancestor
5581927|NCT03841474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5581928|NCT03841136|Etoposide|etoposide|mesh-list
5581929|NCT03841136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5581930|NCT03841136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5581931|NCT03841136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5581932|NCT03841136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5581933|NCT03841136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5581934|NCT03841136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189064|NCT01856257|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6189065|NCT01856257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5581935|NCT03841201|Nivolumab|nivolumab|mesh-list
5581936|NCT03841201|Lenvatinib|lenvatinib|mesh-list
5581937|NCT03841201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6189066|NCT01856309|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6189067|NCT01856309|Immunologic Factors|immunologic factors|mesh-ancestor
6189068|NCT01856309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189069|NCT01856530|Oxytocin|oxytocin|mesh-list
6189070|NCT01856530|Oxytocics|oxytocics|mesh-ancestor
6189071|NCT01856530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6189072|NCT01856530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189073|NCT01856543|Mometasone Furoate|mometasone furoate|mesh-list
5581938|NCT03841201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5581939|NCT03841201|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5581940|NCT03841201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581941|NCT03841201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5581942|NCT03841201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5581943|NCT03841058|Abaloparatide|abaloparatide|mesh-list
5581944|NCT03841058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5581945|NCT03841058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581946|NCT03840421|Gemcitabine|gemcitabine|mesh-list
5581947|NCT03840421|Cisplatin|cisplatin|mesh-list
5581948|NCT03840421|Fluorouracil|fluorouracil|mesh-list
5581949|NCT03840421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5581950|NCT03840421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5581951|NCT03840421|Antimetabolites|antimetabolites|mesh-ancestor
5581952|NCT03840421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581953|NCT03840421|Antiviral Agents|antiviral agents|mesh-ancestor
5581954|NCT03840421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5581955|NCT03840421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5581956|NCT03840421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5581957|NCT03840421|Immunologic Factors|immunologic factors|mesh-ancestor
6189074|NCT01856543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6189075|NCT01856543|Dermatologic Agents|dermatologic agents|mesh-ancestor
6189076|NCT01856543|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6189077|NCT01856712|Naltrexone|naltrexone|mesh-list
6189078|NCT01856712|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6189079|NCT01856712|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6189080|NCT01856712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189081|NCT01856712|Sensory System Agents|sensory system agents|mesh-ancestor
6189082|NCT01856712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6189083|NCT01856790|Liraglutide|liraglutide|mesh-list
6189084|NCT01856790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6189085|NCT01856790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189086|NCT01856790|Incretins|incretins|mesh-ancestor
6189087|NCT01856790|Hormones|hormones|mesh-ancestor
6189088|NCT01856790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6189089|NCT01856907|Metformin|metformin|mesh-list
6189090|NCT01856907|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6189091|NCT01856907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6189092|NCT01856907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581958|NCT03840421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581959|NCT03840291|Edoxaban|edoxaban|mesh-list
5581960|NCT03840291|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5581961|NCT03840291|Antithrombins|antithrombins|mesh-ancestor
5581962|NCT03840291|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5581963|NCT03840291|Protease Inhibitors|protease inhibitors|mesh-ancestor
5581964|NCT03840291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5581965|NCT03840291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581966|NCT03840291|Anticoagulants|anticoagulants|mesh-ancestor
5604961|NCT03948035|Autonomic Agents|autonomic agents|mesh-ancestor
5604962|NCT03948035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5604963|NCT03948035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604964|NCT03948035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5604965|NCT03948035|Glucocorticoids|glucocorticoids|mesh-ancestor
5604966|NCT03948035|Hormones|hormones|mesh-ancestor
5604967|NCT03948035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5604968|NCT03948035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5604969|NCT03948035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5604970|NCT03948035|Immunologic Factors|immunologic factors|mesh-ancestor
6189093|NCT01856907|Incretins|incretins|mesh-ancestor
6189094|NCT01856907|Hormones|hormones|mesh-ancestor
6189095|NCT01856907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5604971|NCT03948035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5604972|NCT03948035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6189096|NCT01856907|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6189097|NCT01856907|Protease Inhibitors|protease inhibitors|mesh-ancestor
6189098|NCT01856907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6189099|NCT01856907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189100|NCT01857206|Vaccines|vaccines|mesh-list
6189101|NCT01857206|Immunologic Factors|immunologic factors|mesh-ancestor
6189102|NCT01857206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207063|NCT02109445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6207064|NCT02109445|Antimetabolites|antimetabolites|mesh-ancestor
6207065|NCT02109445|Antiviral Agents|antiviral agents|mesh-ancestor
6207066|NCT02109445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6207067|NCT02109445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6207068|NCT02109445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6207069|NCT02109445|Immunologic Factors|immunologic factors|mesh-ancestor
6207070|NCT02109445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207071|NCT02109484|Vaccines|vaccines|mesh-list
6207072|NCT02109484|Immunologic Factors|immunologic factors|mesh-ancestor
6207073|NCT02109484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207074|NCT02109562|Risperidone|risperidone|mesh-list
6207075|NCT02109562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5581967|NCT03840122|Anesthetics|anesthetics|mesh-list
5581968|NCT03840122|Anesthetics, Local|anesthetics, local|mesh-list
5581969|NCT03840122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6207076|NCT02109562|Serotonin Agents|serotonin agents|mesh-ancestor
6207077|NCT02109562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6207078|NCT02109562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207079|NCT02109562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207080|NCT02109562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6207081|NCT02109562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6207082|NCT02109562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6207083|NCT02109562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6207084|NCT02109562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6207085|NCT02109562|Dopamine Agents|dopamine agents|mesh-ancestor
6207086|NCT02109640|Oxycodone|oxycodone|mesh-list
6207087|NCT02109640|Naloxone|naloxone|mesh-list
6207088|NCT02109640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6207089|NCT02109640|Narcotics|narcotics|mesh-ancestor
6207090|NCT02109640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6207091|NCT02109640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207092|NCT02109640|Analgesics|analgesics|mesh-ancestor
6207093|NCT02109640|Sensory System Agents|sensory system agents|mesh-ancestor
6207094|NCT02109640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6207095|NCT02109640|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5581970|NCT03840122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581971|NCT03840122|Sensory System Agents|sensory system agents|mesh-ancestor
5581972|NCT03840122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5581973|NCT03839888|Atropine|atropine|mesh-list
6207096|NCT02109939|Psychotropic Drugs|psychotropic drugs|mesh-list
6207097|NCT02110225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6207098|NCT02110225|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6207099|NCT02110225|Mitogens|mitogens|mesh-list
6207100|NCT02110225|Mitosis Modulators|mitosis modulators|mesh-ancestor
6207101|NCT02110225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207102|NCT02110238|Hyaluronic Acid|hyaluronic acid|mesh-list
6207103|NCT02110238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6207104|NCT02110238|Immunologic Factors|immunologic factors|mesh-ancestor
6207105|NCT02110238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207106|NCT02110238|Viscosupplements|viscosupplements|mesh-ancestor
6207107|NCT02110238|Protective Agents|protective agents|mesh-ancestor
6207108|NCT02110264|Naltrexone|naltrexone|mesh-list
6207109|NCT02110264|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6207110|NCT02110264|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6207111|NCT02110264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207112|NCT02110264|Sensory System Agents|sensory system agents|mesh-ancestor
6207113|NCT02110264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6207114|NCT02110706|Rituximab|rituximab|mesh-list
6207115|NCT02110706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6207116|NCT02110706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6207117|NCT02110706|Immunologic Factors|immunologic factors|mesh-ancestor
6207118|NCT02110706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207119|NCT02110706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6207120|NCT02111083|Insulin Lispro|insulin lispro|mesh-list
6207121|NCT02111083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6207122|NCT02111083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207123|NCT02111096|Metformin|metformin|mesh-list
6207124|NCT02111096|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6207125|NCT02111096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6207126|NCT02111096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581974|NCT03839888|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6189103|NCT01857232|Dexamethasone|dexamethasone|mesh-list
6189104|NCT01857232|Ondansetron|ondansetron|mesh-list
6189105|NCT01857232|Fosaprepitant|fosaprepitant|mesh-list
6189106|NCT01857232|Aprepitant|aprepitant|mesh-list
6189107|NCT01857232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6189108|NCT01857232|Antiemetics|antiemetics|mesh-ancestor
6189109|NCT01857232|Autonomic Agents|autonomic agents|mesh-ancestor
6189110|NCT01857232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6189111|NCT01857232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189112|NCT01857232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6189113|NCT01857232|Glucocorticoids|glucocorticoids|mesh-ancestor
6189114|NCT01857232|Hormones|hormones|mesh-ancestor
6189115|NCT01857232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6189116|NCT01857232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6189117|NCT01857232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6189118|NCT01857232|Antipruritics|antipruritics|mesh-ancestor
6189119|NCT01857232|Dermatologic Agents|dermatologic agents|mesh-ancestor
6189120|NCT01857232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6189121|NCT01857232|Serotonin Agents|serotonin agents|mesh-ancestor
6189122|NCT01857232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6189123|NCT01857232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189124|NCT01857232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6189125|NCT01857232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6672045|NCT01553071|Protective Agents|protective agents|mesh-ancestor
6672046|NCT01553071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672047|NCT01553071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6672048|NCT01553071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672049|NCT01553123|Ulipristal acetate|ulipristal acetate|mesh-list
6672050|NCT01553123|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6672051|NCT01553123|Contraceptive Agents|contraceptive agents|mesh-ancestor
6672052|NCT01553123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6672053|NCT01553123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672054|NCT01553123|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6672055|NCT01553357|Dexamethasone|dexamethasone|mesh-list
6672056|NCT01553357|Lenalidomide|lenalidomide|mesh-list
6672057|NCT01553357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6672058|NCT01553357|Antiemetics|antiemetics|mesh-ancestor
6672059|NCT01553357|Autonomic Agents|autonomic agents|mesh-ancestor
6672060|NCT01553357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6672061|NCT01553357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581975|NCT03839888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6189126|NCT01857232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6189127|NCT01857232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6189128|NCT01857232|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6189129|NCT01857232|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6189130|NCT01857297|Vaccines|vaccines|mesh-list
6189131|NCT01857297|Immunologic Factors|immunologic factors|mesh-ancestor
6189132|NCT01857297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189133|NCT01857310|Folic Acid|folic acid|mesh-list
6189134|NCT01857310|Hematinics|hematinics|mesh-ancestor
6189135|NCT01857310|Vitamin B Complex|vitamin b complex|mesh-ancestor
6189136|NCT01857310|Vitamins|vitamins|mesh-ancestor
6189137|NCT01857310|Micronutrients|micronutrients|mesh-ancestor
6189138|NCT01857310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189139|NCT01857323|Albuterol|albuterol|mesh-list
6189140|NCT01857323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6189141|NCT01857323|Autonomic Agents|autonomic agents|mesh-ancestor
5581976|NCT03839888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5581977|NCT03839888|Autonomic Agents|autonomic agents|mesh-ancestor
5581978|NCT03839888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5581979|NCT03839888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581980|NCT03839888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5581981|NCT03839888|Respiratory System Agents|respiratory system agents|mesh-ancestor
5581982|NCT03839888|Mydriatics|mydriatics|mesh-ancestor
6189142|NCT01857323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6189143|NCT01857323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189144|NCT01857323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6189145|NCT01857323|Respiratory System Agents|respiratory system agents|mesh-ancestor
6189146|NCT01857323|Tocolytic Agents|tocolytic agents|mesh-ancestor
6189147|NCT01857323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6189148|NCT01857323|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6189149|NCT01857323|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6189150|NCT01857323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5581983|NCT03839888|Parasympatholytics|parasympatholytics|mesh-ancestor
5581984|NCT03839888|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6189151|NCT01857323|Adrenergic Agents|adrenergic agents|mesh-ancestor
6189152|NCT01857323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5581985|NCT03839888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6189153|NCT01857323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189154|NCT01857362|Nitisinone|nitisinone|mesh-list
6189155|NCT01857362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6189156|NCT01857362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189157|NCT01857531|Nicotine|nicotine|mesh-list
6189158|NCT01857531|Ganaxolone|ganaxolone|mesh-list
6189159|NCT01857531|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6189160|NCT01857531|Autonomic Agents|autonomic agents|mesh-ancestor
6189161|NCT01857531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6189162|NCT01857531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5581986|NCT03839888|Cholinergic Agents|cholinergic agents|mesh-ancestor
5581987|NCT03839888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5581988|NCT03839888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581989|NCT03840226|Magnesium Oxide|magnesium oxide|mesh-list
5581990|NCT03840226|Antacids|antacids|mesh-ancestor
5581991|NCT03840226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5581992|NCT03840226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5581993|NCT03840057|Azithromycin|azithromycin|mesh-list
5581994|NCT03840057|Metoclopramide|metoclopramide|mesh-list
5581995|NCT03840057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5581996|NCT03840057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5581997|NCT03840057|Antiemetics|antiemetics|mesh-ancestor
5581998|NCT03840057|Autonomic Agents|autonomic agents|mesh-ancestor
5581999|NCT03840057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5582000|NCT03840057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582001|NCT03840057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5582002|NCT03840057|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5582003|NCT03840057|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5582004|NCT03840057|Dopamine Agents|dopamine agents|mesh-ancestor
6189163|NCT01857531|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6189164|NCT01857531|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6189165|NCT01857531|Cholinergic Agents|cholinergic agents|mesh-ancestor
6189166|NCT01857531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5582005|NCT03840057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5582006|NCT03840057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582007|NCT03839914|Vancomycin|vancomycin|mesh-list
5582008|NCT03839914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5582009|NCT03839914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5582010|NCT03840070|Hyaluronic Acid|hyaluronic acid|mesh-list
5582011|NCT03840070|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5582012|NCT03840070|Immunologic Factors|immunologic factors|mesh-ancestor
5582013|NCT03840070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582014|NCT03840070|Viscosupplements|viscosupplements|mesh-ancestor
5582015|NCT03840070|Protective Agents|protective agents|mesh-ancestor
5582016|NCT03839771|Ivosidenib|ivosidenib|mesh-list
5582017|NCT03839771|Glycine|glycine|mesh-list
5582018|NCT03839771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5582019|NCT03839771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5582020|NCT03839771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582021|NCT03839771|Glycine Agents|glycine agents|mesh-ancestor
5582022|NCT03839771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5582023|NCT03839771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582024|NCT03839940|Dexamethasone|dexamethasone|mesh-list
5582025|NCT03839940|Everolimus|everolimus|mesh-list
6189167|NCT01857531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189168|NCT01857531|Neurosteroids|neurosteroids|mesh-ancestor
6189169|NCT01857531|GABA Modulators|gaba modulators|mesh-ancestor
6189170|NCT01857531|GABA Agents|gaba agents|mesh-ancestor
6189171|NCT01857583|PENTA|penta|mesh-list
5582026|NCT03839940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5582027|NCT03839940|Antiemetics|antiemetics|mesh-ancestor
5582028|NCT03839940|Autonomic Agents|autonomic agents|mesh-ancestor
5582029|NCT03839940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5582030|NCT03839940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582031|NCT03839940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5582032|NCT03839940|Glucocorticoids|glucocorticoids|mesh-ancestor
5582033|NCT03839940|Hormones|hormones|mesh-ancestor
5582034|NCT03839940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5582035|NCT03839940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5582036|NCT03839940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5582037|NCT03839940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5582038|NCT03839940|Immunologic Factors|immunologic factors|mesh-ancestor
5582039|NCT03839550|Apatinib|apatinib|mesh-list
5582040|NCT03839550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5582041|NCT03839550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5582042|NCT03839550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5582043|NCT03839550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582044|NCT03839537|Nitric Oxide|nitric oxide|mesh-list
6189172|NCT01857583|Edoxaban|edoxaban|mesh-list
6189173|NCT01857583|Fondaparinux|fondaparinux|mesh-list
6189174|NCT01857583|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6189175|NCT01857583|Antithrombins|antithrombins|mesh-ancestor
5582045|NCT03839537|Carbon Monoxide|carbon monoxide|mesh-list
5582046|NCT03839537|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5582047|NCT03839537|Autonomic Agents|autonomic agents|mesh-ancestor
5582048|NCT03839537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5582049|NCT03839537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582050|NCT03839537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5582051|NCT03839537|Respiratory System Agents|respiratory system agents|mesh-ancestor
5582052|NCT03839537|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5582053|NCT03839537|Antioxidants|antioxidants|mesh-ancestor
5582054|NCT03839537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582055|NCT03839537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5582056|NCT03839537|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5582057|NCT03839537|Vasodilator Agents|vasodilator agents|mesh-ancestor
5582058|NCT03839537|Gasotransmitters|gasotransmitters|mesh-ancestor
5582059|NCT03839537|Protective Agents|protective agents|mesh-ancestor
5582060|NCT03839537|Antimetabolites|antimetabolites|mesh-ancestor
5582061|NCT03839498|Axitinib|axitinib|mesh-list
5582062|NCT03839498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5582063|NCT03839498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5582064|NCT03839498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5582065|NCT03839498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582066|NCT03839485|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5582067|NCT03839485|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5582068|NCT03839485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5582069|NCT03839485|Antitubercular Agents|antitubercular agents|mesh-ancestor
5582070|NCT03839251|Aripiprazole|aripiprazole|mesh-list
5582071|NCT03839251|Antidepressive Agents|antidepressive agents|mesh-ancestor
5582072|NCT03839251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5582073|NCT03839251|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5582074|NCT03839251|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5582075|NCT03839251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6189176|NCT01857583|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6189177|NCT01857583|Protease Inhibitors|protease inhibitors|mesh-ancestor
6189178|NCT01857583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6189179|NCT01857583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189180|NCT01857583|Anticoagulants|anticoagulants|mesh-ancestor
6189181|NCT01857583|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6189182|NCT01857583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6189183|NCT01857622|Edoxaban|edoxaban|mesh-list
6189184|NCT01857622|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6189185|NCT01857622|Antithrombins|antithrombins|mesh-ancestor
6189186|NCT01857622|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6189187|NCT01857622|Protease Inhibitors|protease inhibitors|mesh-ancestor
6189188|NCT01857622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6189189|NCT01857622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189190|NCT01857622|Anticoagulants|anticoagulants|mesh-ancestor
6189191|NCT01858363|Paclitaxel|paclitaxel|mesh-list
5582076|NCT03839251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189192|NCT01858363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6189193|NCT01858363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6189194|NCT01858363|Tubulin Modulators|tubulin modulators|mesh-ancestor
6189195|NCT01858363|Antimitotic Agents|antimitotic agents|mesh-ancestor
6189196|NCT01858363|Mitosis Modulators|mitosis modulators|mesh-ancestor
5582077|NCT03839251|Dopamine Agonists|dopamine agonists|mesh-ancestor
5582078|NCT03839251|Dopamine Agents|dopamine agents|mesh-ancestor
5582079|NCT03839251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6189197|NCT01858363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189198|NCT01858428|Paclitaxel|paclitaxel|mesh-list
6189199|NCT01858428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6189200|NCT01858428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6189201|NCT01858428|Tubulin Modulators|tubulin modulators|mesh-ancestor
6189202|NCT01858428|Antimitotic Agents|antimitotic agents|mesh-ancestor
6189203|NCT01858428|Mitosis Modulators|mitosis modulators|mesh-ancestor
6189204|NCT01858428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189205|NCT01858532|Atrasentan|atrasentan|mesh-list
6189206|NCT01858532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6189207|NCT01858532|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
5582080|NCT03839251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582081|NCT03839251|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5582082|NCT03839251|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5582083|NCT03839251|Serotonin Agents|serotonin agents|mesh-ancestor
5582084|NCT03839251|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5582085|NCT03839251|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5582086|NCT03839251|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5582087|NCT03839251|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5582088|NCT03839459|Denosumab|denosumab|mesh-list
5582089|NCT03839459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5582090|NCT03839459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582091|NCT03839160|Morphine|morphine|mesh-list
5582092|NCT03839160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5582093|NCT03839160|Narcotics|narcotics|mesh-ancestor
5582094|NCT03839160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5582095|NCT03839160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582096|NCT03839160|Analgesics|analgesics|mesh-ancestor
5582097|NCT03839160|Sensory System Agents|sensory system agents|mesh-ancestor
5582098|NCT03839160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5582099|NCT03839134|Lidocaine|lidocaine|mesh-list
5582100|NCT03839134|Epinephrine|epinephrine|mesh-list
6189208|NCT01858532|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6189209|NCT01858532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189210|NCT01858766|Ribavirin|ribavirin|mesh-list
6189211|NCT01858766|Antiviral Agents|antiviral agents|mesh-ancestor
6189212|NCT01858766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6189213|NCT01858766|Antimetabolites|antimetabolites|mesh-ancestor
5582101|NCT03839134|Racepinephrine|racepinephrine|mesh-list
5582102|NCT03839134|Epinephryl borate|epinephryl borate|mesh-list
5582103|NCT03839134|Anesthetics, Local|anesthetics, local|mesh-ancestor
5582104|NCT03839134|Anesthetics|anesthetics|mesh-ancestor
5582105|NCT03839134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5582106|NCT03839134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582107|NCT03839134|Sensory System Agents|sensory system agents|mesh-ancestor
5582108|NCT03839134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5582109|NCT03839134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5582110|NCT03839134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5582111|NCT03839134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5582112|NCT03839134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5582113|NCT03839134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582114|NCT03839134|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5582115|NCT03839134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5582116|NCT03839134|Adrenergic Agents|adrenergic agents|mesh-ancestor
5582117|NCT03839134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6189214|NCT01858766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189215|NCT01859013|Topiramate|topiramate|mesh-list
6189216|NCT01859013|Anticonvulsants|anticonvulsants|mesh-ancestor
6189217|NCT01859013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6672062|NCT01553357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6672063|NCT01553357|Glucocorticoids|glucocorticoids|mesh-ancestor
6672064|NCT01553357|Hormones|hormones|mesh-ancestor
6672065|NCT01553357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6672066|NCT01553357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6672067|NCT01553357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6672068|NCT01553357|Immunologic Factors|immunologic factors|mesh-ancestor
6672069|NCT01553357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6672070|NCT01553357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6672071|NCT01553357|Growth Substances|growth substances|mesh-ancestor
5582118|NCT03839134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5582119|NCT03839134|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5582120|NCT03839134|Autonomic Agents|autonomic agents|mesh-ancestor
5582121|NCT03839134|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5582122|NCT03839134|Respiratory System Agents|respiratory system agents|mesh-ancestor
5582123|NCT03839134|Mydriatics|mydriatics|mesh-ancestor
5582124|NCT03839134|Sympathomimetics|sympathomimetics|mesh-ancestor
5582125|NCT03839134|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5582126|NCT03839433|Ciclesonide|ciclesonide|mesh-list
5582127|NCT03839433|Glucocorticoids|glucocorticoids|mesh-ancestor
5582128|NCT03839433|Hormones|hormones|mesh-ancestor
5582129|NCT03839433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6189218|NCT01859013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189219|NCT01859078|Digoxin|digoxin|mesh-list
6189220|NCT01859078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6189221|NCT01859078|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6189222|NCT01859078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6189223|NCT01859078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189224|NCT01859078|Protective Agents|protective agents|mesh-ancestor
6189225|NCT01859078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189226|NCT01859312|Hydrocortisone|hydrocortisone|mesh-list
6189227|NCT01859312|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6189228|NCT01859312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6189229|NCT01859390|Antioxidants|antioxidants|mesh-list
6189230|NCT01859390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189231|NCT01859390|Protective Agents|protective agents|mesh-ancestor
6189232|NCT01859390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189233|NCT01859637|Lenograstim|lenograstim|mesh-list
6189234|NCT01859637|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6189235|NCT01859637|Immunologic Factors|immunologic factors|mesh-ancestor
6189236|NCT01859637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189237|NCT01859702|Moxifloxacin|moxifloxacin|mesh-list
6189238|NCT01859702|Dexamethasone|dexamethasone|mesh-list
6189239|NCT01859702|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6189240|NCT01859702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6189241|NCT01859702|Antiemetics|antiemetics|mesh-ancestor
6189242|NCT01859702|Autonomic Agents|autonomic agents|mesh-ancestor
6189243|NCT01859702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6189244|NCT01859702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189245|NCT01859702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6189246|NCT01859702|Glucocorticoids|glucocorticoids|mesh-ancestor
6189247|NCT01859702|Hormones|hormones|mesh-ancestor
6189248|NCT01859702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6189249|NCT01859702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6189250|NCT01859702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6189251|NCT01859702|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6189252|NCT01859702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6189253|NCT01859702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6488191|NCT00581165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6488192|NCT00581165|Immunologic Factors|immunologic factors|mesh-ancestor
6488193|NCT00581217|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6488194|NCT00581217|Laxatives|laxatives|mesh-ancestor
6488195|NCT00581217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6488196|NCT00581425|Interferons|interferons|mesh-list
6488197|NCT00581425|Interferon-alpha|interferon-alpha|mesh-list
6488198|NCT00581425|Imiquimod|imiquimod|mesh-list
6488199|NCT00581425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6488200|NCT00581425|Antiviral Agents|antiviral agents|mesh-ancestor
6488201|NCT00581425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6488202|NCT00581425|Immunologic Factors|immunologic factors|mesh-ancestor
6488203|NCT00581425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488204|NCT00581425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6488205|NCT00581425|Interferon Inducers|interferon inducers|mesh-ancestor
6488206|NCT00581477|Methyldopa|methyldopa|mesh-list
6488207|NCT00581477|Levodopa|levodopa|mesh-list
6488208|NCT00581477|Carbidopa|carbidopa|mesh-list
6488209|NCT00581477|Droxidopa|droxidopa|mesh-list
6488210|NCT00581477|Metoclopramide|metoclopramide|mesh-list
6488211|NCT00581477|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6488212|NCT00581477|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
6488213|NCT00581477|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6488214|NCT00581477|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6488215|NCT00581477|Dopamine Agents|dopamine agents|mesh-ancestor
6488216|NCT00581477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6488217|NCT00581477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488218|NCT00581477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488219|NCT00581477|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6189254|NCT01859702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6189255|NCT01859702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6189256|NCT01859702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6189257|NCT01859702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189258|NCT01859715|Oxycodone|oxycodone|mesh-list
6189259|NCT01859715|Hydrocodone|hydrocodone|mesh-list
6189260|NCT01859715|Ondansetron|ondansetron|mesh-list
5582130|NCT03839433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582131|NCT03839433|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5582132|NCT03838926|Trichostatin A|trichostatin a|mesh-list
5582133|NCT03838926|Antifungal Agents|antifungal agents|mesh-ancestor
5582134|NCT03838926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5582135|NCT03838926|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5582136|NCT03838926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5582137|NCT03838926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189261|NCT01859715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6189262|NCT01859715|Narcotics|narcotics|mesh-ancestor
6189263|NCT01859715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6189264|NCT01859715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189265|NCT01859715|Analgesics|analgesics|mesh-ancestor
6189266|NCT01859715|Sensory System Agents|sensory system agents|mesh-ancestor
6189267|NCT01859715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6189268|NCT01859715|Antiemetics|antiemetics|mesh-ancestor
6189269|NCT01859715|Autonomic Agents|autonomic agents|mesh-ancestor
6189270|NCT01859715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6189271|NCT01859715|Antipruritics|antipruritics|mesh-ancestor
6189272|NCT01859715|Dermatologic Agents|dermatologic agents|mesh-ancestor
6189273|NCT01859715|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6189274|NCT01859715|Serotonin Agents|serotonin agents|mesh-ancestor
6189275|NCT01859715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5582138|NCT03838926|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5582139|NCT03838783|Insulin|insulin|mesh-list
5582140|NCT03838783|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5582141|NCT03838783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582142|NCT03838796|Lenvatinib|lenvatinib|mesh-list
5582143|NCT03838796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5582144|NCT03838796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5582145|NCT03838796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5582146|NCT03838796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582147|NCT03838484|Nicotine|nicotine|mesh-list
5582148|NCT03838484|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5582149|NCT03838484|Autonomic Agents|autonomic agents|mesh-ancestor
5582150|NCT03838484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6189276|NCT01859715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189277|NCT01859715|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6189278|NCT01859715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6189279|NCT01859715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6189280|NCT01859715|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6189281|NCT01859715|Antitussive Agents|antitussive agents|mesh-ancestor
6189282|NCT01859715|Respiratory System Agents|respiratory system agents|mesh-ancestor
6189283|NCT01859741|Carboplatin|carboplatin|mesh-list
6189284|NCT01859741|Etoposide|etoposide|mesh-list
6189285|NCT01859741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6189286|NCT01859741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6189287|NCT01859741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6189288|NCT01859741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5582151|NCT03838484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582152|NCT03838484|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5582153|NCT03838484|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5582154|NCT03838484|Cholinergic Agents|cholinergic agents|mesh-ancestor
5582155|NCT03838484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5582156|NCT03838484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582157|NCT03838497|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5582158|NCT03838497|Immunologic Factors|immunologic factors|mesh-ancestor
5582159|NCT03838497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582160|NCT03838328|Tranexamic Acid|tranexamic acid|mesh-list
5582161|NCT03838328|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5582162|NCT03838328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5582163|NCT03838328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582164|NCT03838328|Hemostatics|hemostatics|mesh-ancestor
5582165|NCT03838328|Coagulants|coagulants|mesh-ancestor
5604973|NCT03948035|Growth Substances|growth substances|mesh-ancestor
6189289|NCT01859741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5604974|NCT03948035|Growth Inhibitors|growth inhibitors|mesh-ancestor
5604975|NCT03861390|Prednisone|prednisone|mesh-list
6189290|NCT01859741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189291|NCT01859793|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6189292|NCT01859793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6189293|NCT01859793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189294|NCT01859793|Incretins|incretins|mesh-ancestor
6189295|NCT01859793|Hormones|hormones|mesh-ancestor
6189296|NCT01859793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6189297|NCT01859793|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6189298|NCT01859793|Protease Inhibitors|protease inhibitors|mesh-ancestor
6189299|NCT01859793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6189300|NCT01859793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189301|NCT01860170|Cyclophosphamide|cyclophosphamide|mesh-list
6189302|NCT01860170|Bortezomib|bortezomib|mesh-list
6189303|NCT01860170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6189304|NCT01860170|Immunologic Factors|immunologic factors|mesh-ancestor
6189305|NCT01860170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189306|NCT01860170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6189307|NCT01860170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6189308|NCT01860170|Alkylating Agents|alkylating agents|mesh-ancestor
6189309|NCT01860170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189310|NCT01860170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6189311|NCT01860170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5582166|NCT03838263|Cisplatin|cisplatin|mesh-list
5582167|NCT03838263|Nivolumab|nivolumab|mesh-list
6189312|NCT01860287|Buprenorphine|buprenorphine|mesh-list
6189313|NCT01860287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6189314|NCT01860287|Narcotics|narcotics|mesh-ancestor
6189315|NCT01860287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6189316|NCT01860287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189317|NCT01860287|Analgesics|analgesics|mesh-ancestor
6189318|NCT01860287|Sensory System Agents|sensory system agents|mesh-ancestor
6189319|NCT01860287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6189320|NCT01860287|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6189321|NCT01860521|Sufentanil|sufentanil|mesh-list
6189322|NCT01860521|Levobupivacaine|levobupivacaine|mesh-list
6189323|NCT01860521|Gemeprost|gemeprost|mesh-list
6189324|NCT01860521|Anesthetics, Local|anesthetics, local|mesh-ancestor
6189325|NCT01860521|Anesthetics|anesthetics|mesh-ancestor
6189326|NCT01860521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6189327|NCT01860521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189328|NCT01860521|Sensory System Agents|sensory system agents|mesh-ancestor
6189329|NCT01860521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6189330|NCT01860521|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6189331|NCT01860521|Narcotics|narcotics|mesh-ancestor
6189332|NCT01860521|Analgesics|analgesics|mesh-ancestor
6189333|NCT01860521|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6189334|NCT01860521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6189335|NCT01860521|Anesthetics, General|anesthetics, general|mesh-ancestor
6189336|NCT01860521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6189337|NCT01860521|Abortifacient Agents|abortifacient agents|mesh-ancestor
6189338|NCT01860521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6189339|NCT01860586|Bevacizumab|bevacizumab|mesh-list
6189340|NCT01860586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6189341|NCT01860586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6189342|NCT01860586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6189343|NCT01860586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6189344|NCT01860586|Growth Substances|growth substances|mesh-ancestor
6189345|NCT01860586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189346|NCT01860586|Growth Inhibitors|growth inhibitors|mesh-ancestor
5582168|NCT03838263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5582169|NCT03838263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5582170|NCT03838263|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5582171|NCT03838263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582172|NCT03838575|Chlorhexidine|chlorhexidine|mesh-list
5582173|NCT03838575|Gentamicins|gentamicins|mesh-list
5582174|NCT03838575|Anti-Infective Agents|anti-infective agents|mesh-list
5582175|NCT03838575|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6189347|NCT01860703|Moxifloxacin|moxifloxacin|mesh-list
6189348|NCT01860703|Deferiprone|deferiprone|mesh-list
6189349|NCT01860703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6189350|NCT01860703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6189351|NCT01860703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6189352|NCT01860703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6189353|NCT01860703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5582176|NCT03838575|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5582177|NCT03838575|Disinfectants|disinfectants|mesh-ancestor
6189354|NCT01860703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582178|NCT03838575|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5582179|NCT03838575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5582180|NCT03838575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582181|NCT03838068|Anesthetics|anesthetics|mesh-list
5582182|NCT03838068|Procaine|procaine|mesh-list
5582183|NCT03838068|Anesthetics, Local|anesthetics, local|mesh-list
5582184|NCT03838068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582185|NCT03838068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6488220|NCT00581477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6189355|NCT01860703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6189356|NCT01860703|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6189357|NCT01860703|Chelating Agents|chelating agents|mesh-ancestor
6189358|NCT01860703|Sequestering Agents|sequestering agents|mesh-ancestor
6189359|NCT01860807|Ibudilast|ibudilast|mesh-list
6189360|NCT01860807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6189361|NCT01860807|Autonomic Agents|autonomic agents|mesh-ancestor
6189362|NCT01860807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6189363|NCT01860807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189364|NCT01860807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6189365|NCT01860807|Respiratory System Agents|respiratory system agents|mesh-ancestor
6189366|NCT01860807|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6189367|NCT01860807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6189368|NCT01860807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189369|NCT01860807|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6488221|NCT00581477|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6488222|NCT00581477|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6488223|NCT00581477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6488224|NCT00581477|Adrenergic Agents|adrenergic agents|mesh-ancestor
6488225|NCT00581477|Antiemetics|antiemetics|mesh-ancestor
6488226|NCT00581477|Autonomic Agents|autonomic agents|mesh-ancestor
6488227|NCT00581477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6488228|NCT00581477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6488229|NCT00581477|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5582186|NCT03838068|Sensory System Agents|sensory system agents|mesh-ancestor
5582187|NCT03838068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5582188|NCT03837886|Calcium Carbonate|calcium carbonate|mesh-list
5582189|NCT03837886|Calcium|calcium|mesh-list
6189370|NCT01860807|Vasodilator Agents|vasodilator agents|mesh-ancestor
6189371|NCT01860976|Abatacept|abatacept|mesh-list
6189372|NCT01860976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6189373|NCT01860976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189374|NCT01860976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6189375|NCT01860976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6189376|NCT01860976|Immunologic Factors|immunologic factors|mesh-ancestor
6189377|NCT01860976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189378|NCT01860976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6189379|NCT01861002|Vidarabine|vidarabine|mesh-list
6189380|NCT01861002|Cytarabine|cytarabine|mesh-list
6189381|NCT01861002|Methotrexate|methotrexate|mesh-list
6189382|NCT01861002|Fludarabine phosphate|fludarabine phosphate|mesh-list
6189383|NCT01861002|Azacitidine|azacitidine|mesh-list
6189384|NCT01861002|Fludarabine|fludarabine|mesh-list
6189385|NCT01861002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6189386|NCT01861002|Abortifacient Agents|abortifacient agents|mesh-ancestor
6189387|NCT01861002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6189388|NCT01861002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189389|NCT01861002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6189390|NCT01861002|Antimetabolites|antimetabolites|mesh-ancestor
6189391|NCT01861002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189392|NCT01861002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6189393|NCT01861002|Dermatologic Agents|dermatologic agents|mesh-ancestor
6189394|NCT01861002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6189395|NCT01861002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6189396|NCT01861002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6189397|NCT01861002|Immunologic Factors|immunologic factors|mesh-ancestor
5582190|NCT03837886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5582191|NCT03837886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582192|NCT03837886|Antacids|antacids|mesh-ancestor
5582193|NCT03837886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582194|NCT03837886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5582195|NCT03838094|Calcium|calcium|mesh-list
5582196|NCT03838094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5582197|NCT03838094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582198|NCT03838133|Bupivacaine|bupivacaine|mesh-list
6488230|NCT00581477|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6189398|NCT01861002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6189399|NCT01861002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6189400|NCT01861002|Antiviral Agents|antiviral agents|mesh-ancestor
6189401|NCT01861002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6189402|NCT01861457|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
6189403|NCT01861457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6189404|NCT01861522|Bepotastine besilate|bepotastine besilate|mesh-list
6189405|NCT01861522|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6189406|NCT01861665|Bupivacaine|bupivacaine|mesh-list
6189407|NCT01861665|Anesthetics, Local|anesthetics, local|mesh-ancestor
6189408|NCT01861665|Anesthetics|anesthetics|mesh-ancestor
6189409|NCT01861665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6189410|NCT01861665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189411|NCT01861665|Sensory System Agents|sensory system agents|mesh-ancestor
6189412|NCT01861665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6189413|NCT01862250|Clonidine|clonidine|mesh-list
6189414|NCT01862250|Analgesics|analgesics|mesh-ancestor
6189415|NCT01862250|Sensory System Agents|sensory system agents|mesh-ancestor
6189416|NCT01862250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6189417|NCT01862250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189418|NCT01862250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6189419|NCT01862250|Sympatholytics|sympatholytics|mesh-ancestor
6189420|NCT01862250|Autonomic Agents|autonomic agents|mesh-ancestor
6189421|NCT01862250|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6189422|NCT01862250|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6189423|NCT01862250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6189424|NCT01862250|Adrenergic Agents|adrenergic agents|mesh-ancestor
6189425|NCT01862250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6189426|NCT01862250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189427|NCT01862328|Gemcitabine|gemcitabine|mesh-list
6189428|NCT01862328|Paclitaxel|paclitaxel|mesh-list
6189429|NCT01862328|Docetaxel|docetaxel|mesh-list
6189430|NCT01862328|Carboplatin|carboplatin|mesh-list
6189431|NCT01862328|Pevonedistat|pevonedistat|mesh-list
6189432|NCT01862328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6189433|NCT01862328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6189434|NCT01862328|Tubulin Modulators|tubulin modulators|mesh-ancestor
6189435|NCT01862328|Antimitotic Agents|antimitotic agents|mesh-ancestor
6189436|NCT01862328|Mitosis Modulators|mitosis modulators|mesh-ancestor
6189437|NCT01862328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189438|NCT01862328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6189439|NCT01862328|Antimetabolites|antimetabolites|mesh-ancestor
6189440|NCT01862328|Antiviral Agents|antiviral agents|mesh-ancestor
6189441|NCT01862328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6189442|NCT01862328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6189443|NCT01862328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6189444|NCT01862328|Immunologic Factors|immunologic factors|mesh-ancestor
5582199|NCT03838133|Ropivacaine|ropivacaine|mesh-list
5582200|NCT03838133|Anesthetics, Local|anesthetics, local|mesh-ancestor
5582201|NCT03838133|Anesthetics|anesthetics|mesh-ancestor
5582202|NCT03838133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5582203|NCT03838133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582204|NCT03838133|Sensory System Agents|sensory system agents|mesh-ancestor
5582205|NCT03838133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6189445|NCT01862328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189446|NCT01862536|Tadalafil|tadalafil|mesh-list
6189447|NCT01862536|Vasodilator Agents|vasodilator agents|mesh-ancestor
5582206|NCT03838029|Etodolac|etodolac|mesh-list
5582207|NCT03838029|Propranolol|propranolol|mesh-list
5582208|NCT03838029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5582209|NCT03838029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6189448|NCT01862536|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6189449|NCT01862536|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6189450|NCT01862536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6189451|NCT01862536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189452|NCT01862536|Urological Agents|urological agents|mesh-ancestor
6189453|NCT01862614|Epinephrine|epinephrine|mesh-list
6189454|NCT01862614|Racepinephrine|racepinephrine|mesh-list
6189455|NCT01862614|Carticaine|carticaine|mesh-list
6189456|NCT01862614|Epinephryl borate|epinephryl borate|mesh-list
6189457|NCT01862614|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6189458|NCT01862614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6189459|NCT01862614|Adrenergic Agents|adrenergic agents|mesh-ancestor
6189460|NCT01862614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6189461|NCT01862614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582210|NCT03838029|Adrenergic Agents|adrenergic agents|mesh-ancestor
6189462|NCT01862614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189463|NCT01862614|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5582211|NCT03838029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5582212|NCT03838029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582213|NCT03838029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582214|NCT03838029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5582215|NCT03838029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5582216|NCT03838029|Vasodilator Agents|vasodilator agents|mesh-ancestor
5582217|NCT03838029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5582218|NCT03838029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5582219|NCT03838029|Analgesics|analgesics|mesh-ancestor
6189464|NCT01862614|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6189465|NCT01862614|Autonomic Agents|autonomic agents|mesh-ancestor
6189466|NCT01862614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6189467|NCT01862614|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6189468|NCT01862614|Respiratory System Agents|respiratory system agents|mesh-ancestor
6189469|NCT01862614|Mydriatics|mydriatics|mesh-ancestor
6189470|NCT01862614|Sympathomimetics|sympathomimetics|mesh-ancestor
6189471|NCT01862614|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6189472|NCT01862614|Anesthetics, Local|anesthetics, local|mesh-ancestor
6189473|NCT01862614|Anesthetics|anesthetics|mesh-ancestor
6189474|NCT01862614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6189475|NCT01862614|Sensory System Agents|sensory system agents|mesh-ancestor
6189476|NCT01862640|Brexpiprazole|brexpiprazole|mesh-list
6189477|NCT01862640|Serotonin Agents|serotonin agents|mesh-ancestor
6189478|NCT01862640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6189479|NCT01862640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189480|NCT01862640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189481|NCT01862640|Dopamine Agonists|dopamine agonists|mesh-ancestor
6189482|NCT01862640|Dopamine Agents|dopamine agents|mesh-ancestor
6189483|NCT01862874|Vaccines|vaccines|mesh-list
6189484|NCT01862874|Immunologic Factors|immunologic factors|mesh-ancestor
6189485|NCT01862874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582220|NCT03838029|Sensory System Agents|sensory system agents|mesh-ancestor
5582221|NCT03838029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5582222|NCT03838029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5582223|NCT03838029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5582224|NCT03838029|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5582225|NCT03838029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5582226|NCT03838029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5582227|NCT03837938|Dipropizine|dipropizine|mesh-list
5582228|NCT03837938|Antitussive Agents|antitussive agents|mesh-ancestor
5582229|NCT03837938|Respiratory System Agents|respiratory system agents|mesh-ancestor
5582230|NCT03837808|Nimotuzumab|nimotuzumab|mesh-list
5582231|NCT03837808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5582232|NCT03837808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5582233|NCT03837925|Atorvastatin|atorvastatin|mesh-list
5582234|NCT03837925|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5582235|NCT03837925|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5582236|NCT03837925|Antimetabolites|antimetabolites|mesh-ancestor
5582237|NCT03837925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582238|NCT03837925|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6189486|NCT01862991|Digoxin|digoxin|mesh-list
6189487|NCT01862991|Misoprostol|misoprostol|mesh-list
6189488|NCT01862991|Mifepristone|mifepristone|mesh-list
6189489|NCT01862991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6189490|NCT01862991|Abortifacient Agents|abortifacient agents|mesh-ancestor
6189491|NCT01862991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6189492|NCT01862991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189493|NCT01862991|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6189494|NCT01862991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6189495|NCT01862991|Oxytocics|oxytocics|mesh-ancestor
6189496|NCT01862991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6189497|NCT01862991|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6189498|NCT01862991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6189499|NCT01862991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189500|NCT01862991|Protective Agents|protective agents|mesh-ancestor
6189501|NCT01862991|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6189502|NCT01862991|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6189503|NCT01862991|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6189504|NCT01862991|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6189505|NCT01862991|Contraceptive Agents|contraceptive agents|mesh-ancestor
5582239|NCT03837925|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5582240|NCT03837925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5582241|NCT03837509|Daratumumab|daratumumab|mesh-list
5582242|NCT03837509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6189506|NCT01862991|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6189507|NCT01862991|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6189508|NCT01862991|Hormone Antagonists|hormone antagonists|mesh-ancestor
6189509|NCT01862991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6189510|NCT01862991|Luteolytic Agents|luteolytic agents|mesh-ancestor
6189511|NCT01862991|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6189512|NCT01862991|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5582243|NCT03837353|Docetaxel|docetaxel|mesh-list
5582244|NCT03837353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5582245|NCT03837353|Tubulin Modulators|tubulin modulators|mesh-ancestor
5582246|NCT03837353|Antimitotic Agents|antimitotic agents|mesh-ancestor
5582247|NCT03837353|Mitosis Modulators|mitosis modulators|mesh-ancestor
5582248|NCT03837353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582249|NCT03837626|Amiloride|amiloride|mesh-list
5582250|NCT03837626|Diuretics|diuretics|mesh-ancestor
5582251|NCT03837626|Natriuretic Agents|natriuretic agents|mesh-ancestor
5582252|NCT03837626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582253|NCT03837626|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
5582254|NCT03837626|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6189513|NCT01863134|Eptifibatide|eptifibatide|mesh-list
6189514|NCT01863134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6189515|NCT01863186|Lofexidine|lofexidine|mesh-list
6189516|NCT01863186|Clonidine|clonidine|mesh-list
6189517|NCT01863186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6189518|NCT01863186|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6189519|NCT01863186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189520|NCT01863186|Sensory System Agents|sensory system agents|mesh-ancestor
6189521|NCT01863186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6189522|NCT01863186|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6189523|NCT01863186|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6189524|NCT01863186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6189525|NCT01863186|Adrenergic Agents|adrenergic agents|mesh-ancestor
6189526|NCT01863186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6189527|NCT01863186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189528|NCT01863186|Analgesics|analgesics|mesh-ancestor
6189529|NCT01863186|Sympatholytics|sympatholytics|mesh-ancestor
6189530|NCT01863186|Autonomic Agents|autonomic agents|mesh-ancestor
6189531|NCT01863368|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6189532|NCT01863368|Lubricant Eye Drops|lubricant eye drops|mesh-list
6189533|NCT01863368|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6189534|NCT01863667|Glimepiride|glimepiride|mesh-list
6189535|NCT01863667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6189536|NCT01863667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6189537|NCT01863667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189538|NCT01863667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6189539|NCT01863667|Immunologic Factors|immunologic factors|mesh-ancestor
6189540|NCT01863680|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6189541|NCT01863680|Hormones|hormones|mesh-list
6189542|NCT01863680|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6189543|NCT01863680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5582255|NCT03837626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5582256|NCT03837626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582257|NCT03837626|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
5582258|NCT03837626|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5582259|NCT03837470|Furosemide|furosemide|mesh-list
5582260|NCT03837470|Diuretics|diuretics|mesh-ancestor
5582261|NCT03837470|Natriuretic Agents|natriuretic agents|mesh-ancestor
5582262|NCT03837470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582263|NCT03837470|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5582264|NCT03837470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5582265|NCT03837470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582266|NCT03836807|Ketoprofen|ketoprofen|mesh-list
5582267|NCT03836807|Ketoprofen lysine|ketoprofen lysine|mesh-list
5582268|NCT03836807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5582269|NCT03836807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5582270|NCT03836807|Analgesics|analgesics|mesh-ancestor
5582271|NCT03836807|Sensory System Agents|sensory system agents|mesh-ancestor
5582272|NCT03836807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5582273|NCT03836807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582274|NCT03836807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5582275|NCT03836807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5582276|NCT03836807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6189544|NCT01863680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189545|NCT01863680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6189546|NCT01863771|Golimumab|golimumab|mesh-list
6189547|NCT01863771|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6189548|NCT01863771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5582277|NCT03836807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5582278|NCT03836807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582279|NCT03836703|Iron|iron|mesh-list
5582280|NCT03836703|Trace Elements|trace elements|mesh-ancestor
5582281|NCT03836703|Micronutrients|micronutrients|mesh-ancestor
5582282|NCT03836703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582283|NCT03836885|Apremilast|apremilast|mesh-list
6189549|NCT01863771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6189550|NCT01863771|Immunologic Factors|immunologic factors|mesh-ancestor
6189551|NCT01863771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207127|NCT02111096|Incretins|incretins|mesh-ancestor
6207128|NCT02111096|Hormones|hormones|mesh-ancestor
6207129|NCT02111096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6207130|NCT02111096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6207131|NCT02111096|Protease Inhibitors|protease inhibitors|mesh-ancestor
6207132|NCT02111096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6207133|NCT02111096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207134|NCT02111200|Sodium Benzoate|sodium benzoate|mesh-list
6207135|NCT02111200|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
6207136|NCT02111200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6207137|NCT02111200|Antifungal Agents|antifungal agents|mesh-ancestor
6207138|NCT02111200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6207139|NCT02111369|Propranolol|propranolol|mesh-list
6207140|NCT02111369|Botulinum Toxins|botulinum toxins|mesh-list
6207141|NCT02111369|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6207142|NCT02111369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6207143|NCT02111369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207144|NCT02111369|Cholinergic Agents|cholinergic agents|mesh-ancestor
6207145|NCT02111369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6207146|NCT02111369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207147|NCT02111369|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6207148|NCT02111369|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6207149|NCT02111369|Adrenergic Agents|adrenergic agents|mesh-ancestor
6207150|NCT02111369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6207151|NCT02111369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6207152|NCT02111369|Vasodilator Agents|vasodilator agents|mesh-ancestor
6207153|NCT02111447|Propofol|propofol|mesh-list
6207154|NCT02111447|Sevoflurane|sevoflurane|mesh-list
6207155|NCT02111447|Isoflurane|isoflurane|mesh-list
6207156|NCT02111447|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6207157|NCT02111447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6207158|NCT02111447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207159|NCT02111447|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6207160|NCT02111447|Anesthetics, General|anesthetics, general|mesh-ancestor
6207161|NCT02111447|Anesthetics|anesthetics|mesh-ancestor
6207162|NCT02111447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6207163|NCT02111447|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6207164|NCT02111564|Rivaroxaban|rivaroxaban|mesh-list
6207165|NCT02111564|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6207166|NCT02111564|Antithrombins|antithrombins|mesh-ancestor
5582284|NCT03836885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5582285|NCT03836885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5582286|NCT03836885|Analgesics|analgesics|mesh-ancestor
5582287|NCT03836885|Sensory System Agents|sensory system agents|mesh-ancestor
5582288|NCT03836885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5582289|NCT03836885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207167|NCT02111564|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6207168|NCT02111564|Protease Inhibitors|protease inhibitors|mesh-ancestor
6207169|NCT02111564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6207170|NCT02111564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207171|NCT02111564|Anticoagulants|anticoagulants|mesh-ancestor
6207172|NCT02111603|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
6207173|NCT02111603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6207174|NCT02111603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6207175|NCT02111603|Antimetabolites|antimetabolites|mesh-ancestor
6207176|NCT02111603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207177|NCT02111603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6207178|NCT02111746|Bupivacaine|bupivacaine|mesh-list
6207179|NCT02111746|Anesthetics, Local|anesthetics, local|mesh-ancestor
6207180|NCT02111746|Anesthetics|anesthetics|mesh-ancestor
6207181|NCT02111746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6189552|NCT01863849|Vaccines|vaccines|mesh-list
6189553|NCT01863849|Immunologic Factors|immunologic factors|mesh-ancestor
6189554|NCT01863849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189555|NCT01863953|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6189556|NCT01863953|Bimatoprost|bimatoprost|mesh-list
6189557|NCT01863953|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6189558|NCT01863953|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6189559|NCT01863953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6189560|NCT01863953|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6189561|NCT01863953|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6189562|NCT01863953|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6189563|NCT01863953|Adrenergic Agents|adrenergic agents|mesh-ancestor
6189564|NCT01863953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6189565|NCT01863953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189566|NCT01863953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582290|NCT03836885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5582291|NCT03836885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5582292|NCT03836885|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6189567|NCT01864005|Clopidogrel|clopidogrel|mesh-list
6189568|NCT01864005|Ticagrelor|ticagrelor|mesh-list
6189569|NCT01864005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6189570|NCT01864005|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6189571|NCT01864005|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6189572|NCT01864005|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6189573|NCT01864005|Purinergic Agents|purinergic agents|mesh-ancestor
6189574|NCT01864005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6189575|NCT01864005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189576|NCT01864005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189577|NCT01864148|Interferons|interferons|mesh-list
6189578|NCT01864148|Interferon-beta|interferon-beta|mesh-list
6189579|NCT01864148|Interferon beta-1a|interferon beta-1a|mesh-list
6189580|NCT01864148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6189581|NCT01864148|Antiviral Agents|antiviral agents|mesh-ancestor
6189582|NCT01864148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6189583|NCT01864148|Immunologic Factors|immunologic factors|mesh-ancestor
6189584|NCT01864148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189585|NCT01864148|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6189586|NCT01864174|Metformin|metformin|mesh-list
6189587|NCT01864174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6189588|NCT01864174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189589|NCT01865084|Tadalafil|tadalafil|mesh-list
6189590|NCT01865084|Vasodilator Agents|vasodilator agents|mesh-ancestor
6189591|NCT01865084|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6189592|NCT01865084|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6189593|NCT01865084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5582293|NCT03836885|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5582294|NCT03836885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5582295|NCT03836885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582296|NCT03836833|Lamivudine|lamivudine|mesh-list
5582297|NCT03836833|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5582298|NCT03836833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5582299|NCT03836833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5582300|NCT03836833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582301|NCT03836833|Antiviral Agents|antiviral agents|mesh-ancestor
5582302|NCT03836833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5582303|NCT03836833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5582304|NCT03836833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6189594|NCT01865084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189595|NCT01865084|Urological Agents|urological agents|mesh-ancestor
6189596|NCT01865552|Etanercept|etanercept|mesh-list
6189597|NCT01865552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6189598|NCT01865552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6189599|NCT01865552|Analgesics|analgesics|mesh-ancestor
6189600|NCT01865552|Sensory System Agents|sensory system agents|mesh-ancestor
6189601|NCT01865552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6189602|NCT01865552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672072|NCT01553357|Growth Inhibitors|growth inhibitors|mesh-ancestor
6672073|NCT01553435|Dextromethorphan|dextromethorphan|mesh-list
6672074|NCT01553435|Antitussive Agents|antitussive agents|mesh-ancestor
6672075|NCT01553435|Respiratory System Agents|respiratory system agents|mesh-ancestor
6672076|NCT01553435|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6672077|NCT01553435|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5582305|NCT03836781|Chlorhexidine|chlorhexidine|mesh-list
6189603|NCT01865552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6672078|NCT01553435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6672079|NCT01553435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672080|NCT01553435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672081|NCT01553500|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
6189604|NCT01865552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6189605|NCT01865552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6189606|NCT01865552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6189607|NCT01865552|Immunologic Factors|immunologic factors|mesh-ancestor
6189608|NCT01865708|Ethanol|ethanol|mesh-list
6189609|NCT01865708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6189610|NCT01865708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6189611|NCT01865708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6189612|NCT01865708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189613|NCT01865747|Everolimus|everolimus|mesh-list
6189614|NCT01865747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6189615|NCT01865747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6189616|NCT01865747|Immunologic Factors|immunologic factors|mesh-ancestor
6189617|NCT01865747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189618|NCT01865812|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
6189619|NCT01865812|Cathartics|cathartics|mesh-ancestor
6189620|NCT01865812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6189621|NCT01866098|Naltrexone|naltrexone|mesh-list
6189622|NCT01866098|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6189623|NCT01866098|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6189624|NCT01866098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189625|NCT01866098|Sensory System Agents|sensory system agents|mesh-ancestor
6189626|NCT01866098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6189627|NCT01866319|Pembrolizumab|pembrolizumab|mesh-list
6189628|NCT01866319|Ipilimumab|ipilimumab|mesh-list
6189629|NCT01866319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6189630|NCT01866319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6189631|NCT01866319|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6189632|NCT01866319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189633|NCT01866410|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6189634|NCT01866410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6189635|NCT01866410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6189636|NCT01866410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6189637|NCT01866410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189638|NCT01866592|Adalimumab|adalimumab|mesh-list
6189639|NCT01866592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6189640|NCT01866592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6672082|NCT01553500|Cathartics|cathartics|mesh-ancestor
6672083|NCT01553500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6672084|NCT01553617|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
6672085|NCT01553617|Plasma Substitutes|plasma substitutes|mesh-ancestor
6672086|NCT01553617|Blood Substitutes|blood substitutes|mesh-ancestor
6672087|NCT01553721|Udenafil|udenafil|mesh-list
6672088|NCT01553721|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6672089|NCT01553721|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5582306|NCT03836781|Ketorolac|ketorolac|mesh-list
5582307|NCT03836781|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5582308|NCT03836781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5582309|NCT03836781|Disinfectants|disinfectants|mesh-ancestor
5582310|NCT03836781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5582311|NCT03836781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5582312|NCT03836781|Analgesics|analgesics|mesh-ancestor
5582313|NCT03836781|Sensory System Agents|sensory system agents|mesh-ancestor
5582314|NCT03836781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5582315|NCT03836781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582316|NCT03836781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5582317|NCT03836781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6672090|NCT01553721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6672091|NCT01553721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672092|NCT01553773|Estradiol|estradiol|mesh-list
6672093|NCT01553773|Estrogens|estrogens|mesh-ancestor
6672094|NCT01553773|Hormones|hormones|mesh-ancestor
6672095|NCT01553773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6672096|NCT01553773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672097|NCT01553786|Lenalidomide|lenalidomide|mesh-list
6672098|NCT01553786|Immunologic Factors|immunologic factors|mesh-ancestor
6672099|NCT01553786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672100|NCT01553786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6672101|NCT01553786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5582318|NCT03836781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6189641|NCT01866826|Rifaximin|rifaximin|mesh-list
6189642|NCT01866826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6189643|NCT01866826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6189644|NCT01866826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6189645|NCT01866917|Ropivacaine|ropivacaine|mesh-list
6189646|NCT01866917|Anesthetics, Local|anesthetics, local|mesh-ancestor
6189647|NCT01866917|Anesthetics|anesthetics|mesh-ancestor
6189648|NCT01866917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6189649|NCT01866917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189650|NCT01866917|Sensory System Agents|sensory system agents|mesh-ancestor
6189651|NCT01866917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6189652|NCT01866943|Tranexamic Acid|tranexamic acid|mesh-list
6189653|NCT01866943|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6189654|NCT01866943|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6189655|NCT01866943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189656|NCT01866943|Hemostatics|hemostatics|mesh-ancestor
6189657|NCT01866943|Coagulants|coagulants|mesh-ancestor
6189658|NCT01867021|Vaccines|vaccines|mesh-list
6189659|NCT01867021|Immunologic Factors|immunologic factors|mesh-ancestor
6189660|NCT01867021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189661|NCT01867047|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6189662|NCT01867047|Protease Inhibitors|protease inhibitors|mesh-ancestor
6189663|NCT01867047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6189664|NCT01867047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189665|NCT01867086|Carboplatin|carboplatin|mesh-list
5582319|NCT03836781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5582320|NCT03836781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189666|NCT01867086|Vaccines|vaccines|mesh-list
6189667|NCT01867086|Immunologic Factors|immunologic factors|mesh-ancestor
6189668|NCT01867086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189669|NCT01867086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6189670|NCT01867294|Doxycycline|doxycycline|mesh-list
6189671|NCT01867294|Hydrocortisone|hydrocortisone|mesh-list
6189672|NCT01867294|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6189673|NCT01867294|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6189674|NCT01867294|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6189675|NCT01867294|Spironolactone|spironolactone|mesh-list
6189676|NCT01867294|Sunscreening Agents|sunscreening agents|mesh-list
6189677|NCT01867294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6189678|NCT01867294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6189679|NCT01867294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6189680|NCT01867294|Antimalarials|antimalarials|mesh-ancestor
6189681|NCT01867294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6189682|NCT01867294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6189683|NCT01867294|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6189684|NCT01867294|Hormone Antagonists|hormone antagonists|mesh-ancestor
6189685|NCT01867294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6189686|NCT01867294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189687|NCT01867294|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6189688|NCT01867294|Diuretics|diuretics|mesh-ancestor
6189689|NCT01867294|Natriuretic Agents|natriuretic agents|mesh-ancestor
6189690|NCT01867294|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6189691|NCT01867294|Protective Agents|protective agents|mesh-ancestor
6189692|NCT01867294|Dermatologic Agents|dermatologic agents|mesh-ancestor
6189693|NCT01867307|Empagliflozin|empagliflozin|mesh-list
6189694|NCT01867307|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6189695|NCT01867307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189696|NCT01867307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6189697|NCT01867307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189698|NCT01867671|Immunologic Factors|immunologic factors|mesh-list
6189699|NCT01867671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189700|NCT01867710|Dexamethasone|dexamethasone|mesh-list
6189701|NCT01867710|Prednisone|prednisone|mesh-list
6189702|NCT01867710|Abiraterone Acetate|abiraterone acetate|mesh-list
6189703|NCT01867710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6189704|NCT01867710|Antiemetics|antiemetics|mesh-ancestor
6189705|NCT01867710|Autonomic Agents|autonomic agents|mesh-ancestor
6189706|NCT01867710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6189707|NCT01867710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189708|NCT01867710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6189709|NCT01867710|Glucocorticoids|glucocorticoids|mesh-ancestor
6189710|NCT01867710|Hormones|hormones|mesh-ancestor
6189711|NCT01867710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6189712|NCT01867710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6189713|NCT01867710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6672102|NCT01553786|Growth Substances|growth substances|mesh-ancestor
6189714|NCT01867710|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6189715|NCT01867710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6189716|NCT01867710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189717|NCT01867710|Hormone Antagonists|hormone antagonists|mesh-ancestor
6189718|NCT01867710|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6189719|NCT01868022|Paclitaxel|paclitaxel|mesh-list
5582321|NCT03836651|Antioxidants|antioxidants|mesh-list
5582322|NCT03836651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582323|NCT03836651|Protective Agents|protective agents|mesh-ancestor
5582324|NCT03836651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582325|NCT03836638|Botulinum Toxins|botulinum toxins|mesh-list
5582326|NCT03836638|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5582327|NCT03836638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5582328|NCT03836638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582329|NCT03836638|Cholinergic Agents|cholinergic agents|mesh-ancestor
5582330|NCT03836638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5582331|NCT03836638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604976|NCT03861390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5604977|NCT03861390|Glucocorticoids|glucocorticoids|mesh-ancestor
5604978|NCT03861390|Hormones|hormones|mesh-ancestor
5604979|NCT03861390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5604980|NCT03861390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604981|NCT03861390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5604982|NCT03861390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5604983|NCT03861078|Nicotine|nicotine|mesh-list
5604984|NCT03861078|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6189720|NCT01868022|Docetaxel|docetaxel|mesh-list
6189721|NCT01868022|Carboplatin|carboplatin|mesh-list
6189722|NCT01868022|Pemetrexed|pemetrexed|mesh-list
6189723|NCT01868022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6189724|NCT01868022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6189725|NCT01868022|Tubulin Modulators|tubulin modulators|mesh-ancestor
6189726|NCT01868022|Antimitotic Agents|antimitotic agents|mesh-ancestor
6189727|NCT01868022|Mitosis Modulators|mitosis modulators|mesh-ancestor
6189728|NCT01868022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189729|NCT01868022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6189730|NCT01868022|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6189731|NCT01868022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6189732|NCT01868035|Tositumomab I-131|tositumomab i-131|mesh-list
6189733|NCT01868035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6189734|NCT01868243|Warfarin|warfarin|mesh-list
6189735|NCT01868243|Dabigatran|dabigatran|mesh-list
6189736|NCT01868243|Anticoagulants|anticoagulants|mesh-ancestor
6189737|NCT01868243|Antithrombins|antithrombins|mesh-ancestor
6189738|NCT01868243|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6189739|NCT01868243|Protease Inhibitors|protease inhibitors|mesh-ancestor
6189740|NCT01868243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6189741|NCT01868243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189742|NCT01868334|Vaccines|vaccines|mesh-list
6189743|NCT01868334|Immunologic Factors|immunologic factors|mesh-ancestor
6189744|NCT01868334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189745|NCT01868425|Acetaminophen|acetaminophen|mesh-list
6189746|NCT01868425|Ketamine|ketamine|mesh-list
6189747|NCT01868425|Gabapentin|gabapentin|mesh-list
6189748|NCT01868425|Bupivacaine|bupivacaine|mesh-list
6189749|NCT01868425|Anesthetics, Local|anesthetics, local|mesh-ancestor
6189750|NCT01868425|Anesthetics|anesthetics|mesh-ancestor
6189751|NCT01868425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6189752|NCT01868425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189753|NCT01868425|Sensory System Agents|sensory system agents|mesh-ancestor
6189754|NCT01868425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6189755|NCT01868425|Analgesics|analgesics|mesh-ancestor
6189756|NCT01868425|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6189757|NCT01868425|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6189758|NCT01868425|Anesthetics, General|anesthetics, general|mesh-ancestor
6189759|NCT01868425|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6189760|NCT01868425|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6189761|NCT01868425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6189762|NCT01868425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189763|NCT01868425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6189764|NCT01868425|Antipyretics|antipyretics|mesh-ancestor
6189765|NCT01868425|Anticonvulsants|anticonvulsants|mesh-ancestor
6189766|NCT01868425|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6189767|NCT01868425|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6189768|NCT01868425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6672103|NCT01553786|Growth Inhibitors|growth inhibitors|mesh-ancestor
5582332|NCT03836599|Allopurinol|allopurinol|mesh-list
5582333|NCT03836599|Verinurad|verinurad|mesh-list
6189769|NCT01868425|Antimanic Agents|antimanic agents|mesh-ancestor
6189770|NCT01868477|Epoetin Alfa|epoetin alfa|mesh-list
6189771|NCT01868477|Deferasirox|deferasirox|mesh-list
6189772|NCT01868477|Hematinics|hematinics|mesh-ancestor
6189773|NCT01868477|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6189774|NCT01868477|Chelating Agents|chelating agents|mesh-ancestor
6189775|NCT01868477|Sequestering Agents|sequestering agents|mesh-ancestor
6189776|NCT01868477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189777|NCT01868503|Lapatinib|lapatinib|mesh-list
6189778|NCT01868503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6189779|NCT01868503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6189780|NCT01868503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6189781|NCT01868503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189782|NCT01868542|Insulin Detemir|insulin detemir|mesh-list
6189783|NCT01868542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6189784|NCT01868542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189785|NCT01868633|Dexamethasone|dexamethasone|mesh-list
5582334|NCT03836599|Antimetabolites|antimetabolites|mesh-ancestor
5582335|NCT03836599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582336|NCT03836599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5582337|NCT03836599|Gout Suppressants|gout suppressants|mesh-ancestor
5582338|NCT03836599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5582339|NCT03836599|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5582340|NCT03836599|Antioxidants|antioxidants|mesh-ancestor
5582341|NCT03836599|Protective Agents|protective agents|mesh-ancestor
5582342|NCT03836599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582343|NCT03836560|Nicotine|nicotine|mesh-list
5582344|NCT03836560|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5582345|NCT03836560|Autonomic Agents|autonomic agents|mesh-ancestor
5582346|NCT03836560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5582347|NCT03836560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582348|NCT03836560|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5582349|NCT03836560|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5582350|NCT03836560|Cholinergic Agents|cholinergic agents|mesh-ancestor
5582351|NCT03836560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5582352|NCT03836560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582353|NCT03836144|Potassium Citrate|potassium citrate|mesh-list
5582354|NCT03836144|Diuretics|diuretics|mesh-ancestor
5582355|NCT03836144|Natriuretic Agents|natriuretic agents|mesh-ancestor
5582356|NCT03836144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582357|NCT03836144|Expectorants|expectorants|mesh-ancestor
5582358|NCT03836144|Respiratory System Agents|respiratory system agents|mesh-ancestor
5582359|NCT03836352|Cyclophosphamide|cyclophosphamide|mesh-list
5582360|NCT03836352|Pembrolizumab|pembrolizumab|mesh-list
5582361|NCT03836352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5582362|NCT03836352|Immunologic Factors|immunologic factors|mesh-ancestor
5582363|NCT03836352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582364|NCT03836352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5582365|NCT03836352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5582366|NCT03836352|Alkylating Agents|alkylating agents|mesh-ancestor
6189786|NCT01868633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6189787|NCT01868633|Antiemetics|antiemetics|mesh-ancestor
6189788|NCT01868633|Autonomic Agents|autonomic agents|mesh-ancestor
6189789|NCT01868633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6189790|NCT01868633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189791|NCT01868633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6189792|NCT01868633|Glucocorticoids|glucocorticoids|mesh-ancestor
6189793|NCT01868633|Hormones|hormones|mesh-ancestor
5582367|NCT03836352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207182|NCT02111746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582368|NCT03836352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5582369|NCT03836352|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6189794|NCT01868633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6189795|NCT01868633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6189796|NCT01868633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6189797|NCT01868776|Lidocaine|lidocaine|mesh-list
6189798|NCT01868776|Anesthetics, Local|anesthetics, local|mesh-ancestor
6189799|NCT01868776|Anesthetics|anesthetics|mesh-ancestor
6189800|NCT01868776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6189801|NCT01868776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189802|NCT01868776|Sensory System Agents|sensory system agents|mesh-ancestor
6189803|NCT01868776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6189804|NCT01868776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6189805|NCT01868776|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6189806|NCT01868776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6189807|NCT01868776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6189808|NCT01868776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189809|NCT01868893|Obinutuzumab|obinutuzumab|mesh-list
6189810|NCT01868893|Chlorambucil|chlorambucil|mesh-list
6189811|NCT01868893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6189812|NCT01868893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6189813|NCT01868893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6189814|NCT01868893|Alkylating Agents|alkylating agents|mesh-ancestor
6189815|NCT01868893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189816|NCT01869192|Cyclophosphamide|cyclophosphamide|mesh-list
6189817|NCT01869192|Docetaxel|docetaxel|mesh-list
6189818|NCT01869192|Capecitabine|capecitabine|mesh-list
6189819|NCT01869192|Epirubicin|epirubicin|mesh-list
6189820|NCT01869192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5582370|NCT03836352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5582371|NCT03836222|Pentoxifylline|pentoxifylline|mesh-list
5582372|NCT03836222|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5582373|NCT03836222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5582374|NCT03836222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582375|NCT03836222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5582376|NCT03836222|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5582377|NCT03836222|Protective Agents|protective agents|mesh-ancestor
5582378|NCT03836222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582379|NCT03836222|Vasodilator Agents|vasodilator agents|mesh-ancestor
5582380|NCT03836222|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5582381|NCT03836222|Antioxidants|antioxidants|mesh-ancestor
5582382|NCT03836157|Bevacizumab|bevacizumab|mesh-list
5582383|NCT03836157|Maytansine|maytansine|mesh-list
5582384|NCT03836157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5582385|NCT03836157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5582386|NCT03836157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5582387|NCT03836157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5582388|NCT03836157|Growth Substances|growth substances|mesh-ancestor
5582389|NCT03836157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582390|NCT03836157|Growth Inhibitors|growth inhibitors|mesh-ancestor
5582391|NCT03836157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5582392|NCT03836157|Tubulin Modulators|tubulin modulators|mesh-ancestor
5582393|NCT03836157|Antimitotic Agents|antimitotic agents|mesh-ancestor
5582394|NCT03836157|Mitosis Modulators|mitosis modulators|mesh-ancestor
5582395|NCT03836157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582396|NCT03836001|Serlopitant|serlopitant|mesh-list
6189821|NCT01869192|Immunologic Factors|immunologic factors|mesh-ancestor
6189822|NCT01869192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189823|NCT01869192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6189824|NCT01869192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6189825|NCT01869192|Alkylating Agents|alkylating agents|mesh-ancestor
6189826|NCT01869192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189827|NCT01869192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6189828|NCT01869192|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6189829|NCT01869192|Tubulin Modulators|tubulin modulators|mesh-ancestor
6189830|NCT01869192|Antimitotic Agents|antimitotic agents|mesh-ancestor
6189831|NCT01869192|Mitosis Modulators|mitosis modulators|mesh-ancestor
6189832|NCT01869192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6189833|NCT01869192|Antimetabolites|antimetabolites|mesh-ancestor
6189834|NCT01869192|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6189835|NCT01869192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6189836|NCT01869192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5582397|NCT03836001|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5582398|NCT03836001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6189837|NCT01869192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6189838|NCT01869634|Ritonavir|ritonavir|mesh-list
6189839|NCT01869634|Darunavir|darunavir|mesh-list
6189840|NCT01869634|Emtricitabine|emtricitabine|mesh-list
6189841|NCT01869634|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6189842|NCT01869634|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6189843|NCT01869634|Protease Inhibitors|protease inhibitors|mesh-ancestor
6189844|NCT01869634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6189845|NCT01869634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189846|NCT01869634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6189847|NCT01869634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6189848|NCT01869634|Antiviral Agents|antiviral agents|mesh-ancestor
6189849|NCT01869634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6189850|NCT01869634|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5582399|NCT03836001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582400|NCT03836001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582401|NCT03836014|Dexamethasone|dexamethasone|mesh-list
5582402|NCT03836014|Dexamethasone acetate|dexamethasone acetate|mesh-list
5582403|NCT03836014|Lenalidomide|lenalidomide|mesh-list
6189851|NCT01869634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6189852|NCT01869634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6189853|NCT01869634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6189854|NCT01869686|Denosumab|denosumab|mesh-list
6189855|NCT01869686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6189856|NCT01869686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189857|NCT01869699|Acetaminophen|acetaminophen|mesh-list
6189858|NCT01869699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6189859|NCT01869699|Analgesics|analgesics|mesh-ancestor
6189860|NCT01869699|Sensory System Agents|sensory system agents|mesh-ancestor
6189861|NCT01869699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6189862|NCT01869699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189863|NCT01869699|Antipyretics|antipyretics|mesh-ancestor
6189864|NCT01869725|Octreotide|octreotide|mesh-list
6189865|NCT01869725|Edotreotide|edotreotide|mesh-list
6189866|NCT01869725|Indium-111-octreotide|indium-111-octreotide|mesh-list
6189867|NCT01869725|Somatostatin|somatostatin|mesh-list
6189868|NCT01869725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6189869|NCT01869725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6189870|NCT01869725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6189871|NCT01869725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189872|NCT01869725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189873|NCT01869725|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6189874|NCT01869725|Hormones|hormones|mesh-ancestor
6189875|NCT01869725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6189876|NCT01870297|Liraglutide|liraglutide|mesh-list
6189877|NCT01870297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6189878|NCT01870297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189879|NCT01870297|Incretins|incretins|mesh-ancestor
6189880|NCT01870297|Hormones|hormones|mesh-ancestor
6189881|NCT01870297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6189882|NCT01870583|Iodine|iodine|mesh-list
6189883|NCT01870583|Chlorhexidine|chlorhexidine|mesh-list
6189884|NCT01870583|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6189885|NCT01870583|Cadexomer iodine|cadexomer iodine|mesh-list
6189886|NCT01870583|Povidone|povidone|mesh-list
6189887|NCT01870583|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6189888|NCT01870583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5582404|NCT03836014|Daratumumab|daratumumab|mesh-list
5582405|NCT03836014|BB 1101|bb 1101|mesh-list
5582406|NCT03836014|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5582407|NCT03836014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5582408|NCT03836014|Antiemetics|antiemetics|mesh-ancestor
5582409|NCT03836014|Autonomic Agents|autonomic agents|mesh-ancestor
6189889|NCT01870583|Disinfectants|disinfectants|mesh-ancestor
6189890|NCT01870583|Dermatologic Agents|dermatologic agents|mesh-ancestor
6189891|NCT01870583|Trace Elements|trace elements|mesh-ancestor
6189892|NCT01870583|Micronutrients|micronutrients|mesh-ancestor
6189893|NCT01870583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189894|NCT01870583|Plasma Substitutes|plasma substitutes|mesh-ancestor
6189895|NCT01870583|Blood Substitutes|blood substitutes|mesh-ancestor
6189896|NCT01870596|Cytarabine|cytarabine|mesh-list
6189897|NCT01870596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6189898|NCT01870596|Antimetabolites|antimetabolites|mesh-ancestor
6189899|NCT01870596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189900|NCT01870596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6189901|NCT01870596|Antiviral Agents|antiviral agents|mesh-ancestor
5582410|NCT03836014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6189902|NCT01870596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6189903|NCT01870596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6189904|NCT01870596|Immunologic Factors|immunologic factors|mesh-ancestor
6189905|NCT01870596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189906|NCT01870739|Amlodipine|amlodipine|mesh-list
6189907|NCT01870739|Valsartan|valsartan|mesh-list
6189908|NCT01870739|Olmesartan|olmesartan|mesh-list
6189909|NCT01870739|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6189910|NCT01870739|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5582411|NCT03836014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582412|NCT03836014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5582413|NCT03836014|Glucocorticoids|glucocorticoids|mesh-ancestor
5582414|NCT03836014|Hormones|hormones|mesh-ancestor
5582415|NCT03836014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5582416|NCT03836014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5582417|NCT03836014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5582418|NCT03836014|Protease Inhibitors|protease inhibitors|mesh-ancestor
5582419|NCT03836014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5582420|NCT03836014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582421|NCT03836014|Immunologic Factors|immunologic factors|mesh-ancestor
5582422|NCT03836014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6189911|NCT01870739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6189912|NCT01870739|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6189913|NCT01870739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6189914|NCT01870739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189915|NCT01870739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6189916|NCT01870739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189917|NCT01870739|Vasodilator Agents|vasodilator agents|mesh-ancestor
6189918|NCT01870739|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5582423|NCT03836014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5582424|NCT03836014|Growth Substances|growth substances|mesh-ancestor
5582425|NCT03836014|Growth Inhibitors|growth inhibitors|mesh-ancestor
5582426|NCT03835676|Treprostinil|treprostinil|mesh-list
6189919|NCT01870739|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6189920|NCT01870843|Citalopram|citalopram|mesh-list
6189921|NCT01870843|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6189922|NCT01870843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6189923|NCT01870843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5582427|NCT03835676|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5582428|NCT03835715|Vortioxetine|vortioxetine|mesh-list
5582429|NCT03835715|Antidepressive Agents|antidepressive agents|mesh-ancestor
5582430|NCT03835715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5582431|NCT03835715|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5582432|NCT03835715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5582433|NCT03835715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5582434|NCT03835715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582435|NCT03835715|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5582436|NCT03835715|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5582437|NCT03835715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5582438|NCT03835715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582439|NCT03835715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5582440|NCT03835715|Serotonin Agents|serotonin agents|mesh-ancestor
5582441|NCT03835715|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6189924|NCT01870843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189925|NCT01870843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6189926|NCT01870843|Serotonin Agents|serotonin agents|mesh-ancestor
6189927|NCT01870843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189928|NCT01870843|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6189929|NCT01870843|Antidepressive Agents|antidepressive agents|mesh-ancestor
6189930|NCT01870843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6189931|NCT01870921|Ticagrelor|ticagrelor|mesh-list
6189932|NCT01870921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6189933|NCT01870921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6189934|NCT01870921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6189935|NCT01870921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6189936|NCT01870921|Purinergic Agents|purinergic agents|mesh-ancestor
6189937|NCT01870921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6189938|NCT01870921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189939|NCT01870921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189940|NCT01870973|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6189941|NCT01870973|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5582442|NCT03835715|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5582443|NCT03835715|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5582444|NCT03835715|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5582445|NCT03835442|Baclofen|baclofen|mesh-list
5582446|NCT03835442|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5582447|NCT03835442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582448|NCT03835442|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5582449|NCT03835442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6189942|NCT01870973|Analgesics|analgesics|mesh-list
6189943|NCT01870973|Anesthetics|anesthetics|mesh-list
6189944|NCT01870973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6189945|NCT01870973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189946|NCT01870973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6189947|NCT01870973|Antitubercular Agents|antitubercular agents|mesh-ancestor
6189948|NCT01870973|Sensory System Agents|sensory system agents|mesh-ancestor
6189949|NCT01870973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6189950|NCT01870999|Aripiprazole|aripiprazole|mesh-list
6189951|NCT01870999|Antidepressive Agents|antidepressive agents|mesh-ancestor
6189952|NCT01870999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6189953|NCT01870999|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6189954|NCT01870999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6189955|NCT01870999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6189956|NCT01870999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189957|NCT01870999|Dopamine Agonists|dopamine agonists|mesh-ancestor
6189958|NCT01870999|Dopamine Agents|dopamine agents|mesh-ancestor
6189959|NCT01870999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6189960|NCT01870999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189961|NCT01870999|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5582450|NCT03835442|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
5582451|NCT03835442|GABA Agonists|gaba agonists|mesh-ancestor
5582452|NCT03835442|GABA Agents|gaba agents|mesh-ancestor
5582453|NCT03835442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5582454|NCT03835442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582455|NCT03835871|Beclomethasone|beclomethasone|mesh-list
5582456|NCT03835871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6189962|NCT01870999|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6189963|NCT01870999|Serotonin Agents|serotonin agents|mesh-ancestor
6189964|NCT01870999|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6189965|NCT01870999|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6189966|NCT01870999|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6189967|NCT01870999|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6189968|NCT01871077|Ketorolac|ketorolac|mesh-list
6189969|NCT01871077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6189970|NCT01871077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6189971|NCT01871077|Analgesics|analgesics|mesh-ancestor
6189972|NCT01871077|Sensory System Agents|sensory system agents|mesh-ancestor
6189973|NCT01871077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6189974|NCT01871077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189975|NCT01871077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6189976|NCT01871077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6189977|NCT01871077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6189978|NCT01871077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6189979|NCT01871077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6189980|NCT01871285|Morphine|morphine|mesh-list
6189981|NCT01871285|Oxycodone|oxycodone|mesh-list
6189982|NCT01871285|Buprenorphine|buprenorphine|mesh-list
6189983|NCT01871285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6189984|NCT01871285|Narcotics|narcotics|mesh-ancestor
6189985|NCT01871285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6189986|NCT01871285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189987|NCT01871285|Analgesics|analgesics|mesh-ancestor
6189988|NCT01871285|Sensory System Agents|sensory system agents|mesh-ancestor
6189989|NCT01871285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6189990|NCT01871285|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6189991|NCT01871441|Mycophenolic Acid|mycophenolic acid|mesh-list
6189992|NCT01871441|Cyclophosphamide|cyclophosphamide|mesh-list
6189993|NCT01871441|Tacrolimus|tacrolimus|mesh-list
6189994|NCT01871441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6189995|NCT01871441|Immunologic Factors|immunologic factors|mesh-ancestor
6189996|NCT01871441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6189997|NCT01871441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6189998|NCT01871441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6189999|NCT01871441|Alkylating Agents|alkylating agents|mesh-ancestor
6190000|NCT01871441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190001|NCT01871441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5582457|NCT03835871|Glucocorticoids|glucocorticoids|mesh-ancestor
6190002|NCT01871441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6190003|NCT01871441|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6190004|NCT01871441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6190005|NCT01871441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6190006|NCT01871441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6190007|NCT01871441|Antitubercular Agents|antitubercular agents|mesh-ancestor
6190008|NCT01871441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6190009|NCT01871441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6190010|NCT01871532|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6190011|NCT01871532|Hormones|hormones|mesh-ancestor
6190012|NCT01871532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6190013|NCT01871532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207183|NCT02111746|Sensory System Agents|sensory system agents|mesh-ancestor
6207184|NCT02111746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6207939|NCT02121795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207940|NCT02121795|Antiviral Agents|antiviral agents|mesh-ancestor
6207941|NCT02121795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6207942|NCT02121795|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6207943|NCT02121847|Cyclosporine|cyclosporine|mesh-list
6207944|NCT02121847|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6207945|NCT02121847|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6207946|NCT02121847|Lubricant Eye Drops|lubricant eye drops|mesh-list
6207947|NCT02121847|Cyclosporins|cyclosporins|mesh-list
6207948|NCT02121847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6207949|NCT02121847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207950|NCT02121847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6207951|NCT02121847|Immunologic Factors|immunologic factors|mesh-ancestor
6207952|NCT02121847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207953|NCT02121847|Antifungal Agents|antifungal agents|mesh-ancestor
6207954|NCT02121847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6207955|NCT02121847|Dermatologic Agents|dermatologic agents|mesh-ancestor
6207956|NCT02121847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5582458|NCT03835871|Hormones|hormones|mesh-ancestor
5582459|NCT03835871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5582460|NCT03835871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582461|NCT03835871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5582462|NCT03835871|Respiratory System Agents|respiratory system agents|mesh-ancestor
5582463|NCT03835507|Epoetin Alfa|epoetin alfa|mesh-list
5582464|NCT03835507|Hematinics|hematinics|mesh-ancestor
5582465|NCT03835533|Nivolumab|nivolumab|mesh-list
5582466|NCT03835533|Poly ICLC|poly iclc|mesh-list
5582467|NCT03835533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5582468|NCT03835533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5582469|NCT03835533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5582470|NCT03835533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207957|NCT02121847|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6207958|NCT02121847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6207959|NCT02121847|Laxatives|laxatives|mesh-ancestor
6207960|NCT02121847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6207961|NCT02122380|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6207962|NCT02122380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6207963|NCT02122380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207964|NCT02122380|Incretins|incretins|mesh-ancestor
6207965|NCT02122380|Hormones|hormones|mesh-ancestor
6207966|NCT02122380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6207967|NCT02122380|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6207968|NCT02122380|Protease Inhibitors|protease inhibitors|mesh-ancestor
6207969|NCT02122380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6207970|NCT02122380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207971|NCT02122471|Plecanatide|plecanatide|mesh-list
6207972|NCT02122471|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
6207973|NCT02122471|Enzyme Activators|enzyme activators|mesh-ancestor
6207974|NCT02122471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207975|NCT02122471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6207976|NCT02122770|Itraconazole|itraconazole|mesh-list
6207977|NCT02122770|Fluconazole|fluconazole|mesh-list
6207978|NCT02122770|Paclitaxel|paclitaxel|mesh-list
6207979|NCT02122770|Docetaxel|docetaxel|mesh-list
6207980|NCT02122770|Carboplatin|carboplatin|mesh-list
6207981|NCT02122770|Pevonedistat|pevonedistat|mesh-list
6207982|NCT02122770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6207983|NCT02122770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6207984|NCT02122770|Tubulin Modulators|tubulin modulators|mesh-ancestor
5582471|NCT03835533|Interferon Inducers|interferon inducers|mesh-ancestor
5582472|NCT03835533|Immunologic Factors|immunologic factors|mesh-ancestor
5582473|NCT03835533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582474|NCT03835286|Ascorbic Acid|ascorbic acid|mesh-list
5582475|NCT03835286|Vitamins|vitamins|mesh-ancestor
5582476|NCT03835286|Micronutrients|micronutrients|mesh-ancestor
5582477|NCT03835286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582478|NCT03835286|Antioxidants|antioxidants|mesh-ancestor
5582479|NCT03835286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582480|NCT03835286|Protective Agents|protective agents|mesh-ancestor
5582481|NCT03834766|Amphetamine|amphetamine|mesh-list
5582482|NCT03834766|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5582483|NCT03834766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582484|NCT03834766|Sympathomimetics|sympathomimetics|mesh-ancestor
5582485|NCT03834766|Autonomic Agents|autonomic agents|mesh-ancestor
5582486|NCT03834766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5582487|NCT03834766|Dopamine Agents|dopamine agents|mesh-ancestor
5582488|NCT03834766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5582489|NCT03834766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582490|NCT03834766|Adrenergic Agents|adrenergic agents|mesh-ancestor
5582491|NCT03834766|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5582492|NCT03834766|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5582493|NCT03834766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5582494|NCT03834766|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5582495|NCT03834831|Selenium|selenium|mesh-list
5582496|NCT03834831|Ubiquinone|ubiquinone|mesh-list
5582497|NCT03834831|Coenzyme Q10|coenzyme q10|mesh-list
5582498|NCT03834831|Antioxidants|antioxidants|mesh-ancestor
5582499|NCT03834831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190014|NCT01871558|Metformin|metformin|mesh-list
6190015|NCT01871558|Vildagliptin|vildagliptin|mesh-list
6190016|NCT01871558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6190017|NCT01871558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190018|NCT01871558|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6190019|NCT01871558|Protease Inhibitors|protease inhibitors|mesh-ancestor
6190020|NCT01871558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6190021|NCT01871558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190022|NCT01871870|Pancrelipase|pancrelipase|mesh-list
6190023|NCT01871870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6190024|NCT01872611|Prednisolone|prednisolone|mesh-list
6190025|NCT01872611|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6190026|NCT01872611|Methylprednisolone|methylprednisolone|mesh-list
6190027|NCT01872611|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6190028|NCT01872611|Prednisolone acetate|prednisolone acetate|mesh-list
6190029|NCT01872611|Nepafenac|nepafenac|mesh-list
6190030|NCT01872611|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6190031|NCT01872611|Prednisolone phosphate|prednisolone phosphate|mesh-list
6190032|NCT01872611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6190033|NCT01872611|Glucocorticoids|glucocorticoids|mesh-ancestor
5582500|NCT03834831|Protective Agents|protective agents|mesh-ancestor
5582501|NCT03834831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582502|NCT03834831|Trace Elements|trace elements|mesh-ancestor
5582503|NCT03834831|Micronutrients|micronutrients|mesh-ancestor
5582504|NCT03834831|Vitamins|vitamins|mesh-ancestor
5582505|NCT03834740|Everolimus|everolimus|mesh-list
5582506|NCT03834740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5582507|NCT03834740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5582508|NCT03834740|Immunologic Factors|immunologic factors|mesh-ancestor
5582509|NCT03834740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582510|NCT03834935|Pimecrolimus|pimecrolimus|mesh-list
5582511|NCT03834935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5582512|NCT03834935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5582513|NCT03834935|Analgesics|analgesics|mesh-ancestor
5582514|NCT03834935|Sensory System Agents|sensory system agents|mesh-ancestor
6190034|NCT01872611|Hormones|hormones|mesh-ancestor
6190035|NCT01872611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6190036|NCT01872611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190037|NCT01872611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5582515|NCT03834935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5582516|NCT03834935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582517|NCT03834935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5582518|NCT03834935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6190038|NCT01872611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5582519|NCT03834935|Dermatologic Agents|dermatologic agents|mesh-ancestor
6190039|NCT01872611|Antiemetics|antiemetics|mesh-ancestor
6190040|NCT01872611|Autonomic Agents|autonomic agents|mesh-ancestor
5582520|NCT03834935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5582521|NCT03834935|Immunologic Factors|immunologic factors|mesh-ancestor
6190041|NCT01872611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6190042|NCT01872611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5582522|NCT03834935|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5582523|NCT03834935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5582524|NCT03834935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582525|NCT03834883|Ibutilide|ibutilide|mesh-list
5582526|NCT03834883|Progesterone|progesterone|mesh-list
5582527|NCT03834883|Progestins|progestins|mesh-ancestor
5582528|NCT03834883|Hormones|hormones|mesh-ancestor
5582529|NCT03834883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5582530|NCT03834883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190043|NCT01872611|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6190044|NCT01872611|Protective Agents|protective agents|mesh-ancestor
6190045|NCT01872611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6190046|NCT01872611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6190047|NCT01872611|Analgesics|analgesics|mesh-ancestor
6190048|NCT01872611|Sensory System Agents|sensory system agents|mesh-ancestor
6190049|NCT01872611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6190050|NCT01872689|Pirfenidone|pirfenidone|mesh-list
6190051|NCT01872689|Analgesics|analgesics|mesh-ancestor
6190052|NCT01872689|Sensory System Agents|sensory system agents|mesh-ancestor
6190053|NCT01872689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6190054|NCT01872689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190055|NCT01872689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6190056|NCT01872689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6190057|NCT01872689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6190058|NCT01872689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6190059|NCT01872689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6190060|NCT01872715|Doxycycline|doxycycline|mesh-list
6190061|NCT01872715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6190062|NCT01872715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6190063|NCT01872715|Antimalarials|antimalarials|mesh-ancestor
6190064|NCT01872715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6190065|NCT01872715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6190066|NCT01872819|Antineoplastic Agents|antineoplastic agents|mesh-list
6190067|NCT01872910|Celecoxib|celecoxib|mesh-list
6190068|NCT01872910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5582531|NCT03834883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5582532|NCT03834909|Tenofovir|tenofovir|mesh-list
5582533|NCT03834909|Emtricitabine|emtricitabine|mesh-list
6190069|NCT01872910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6190070|NCT01872910|Analgesics|analgesics|mesh-ancestor
6190071|NCT01872910|Sensory System Agents|sensory system agents|mesh-ancestor
6190072|NCT01872910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6190073|NCT01872910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190074|NCT01872910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6190075|NCT01872910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6190076|NCT01872910|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6190077|NCT01872910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6190078|NCT01872910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6190079|NCT01872910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190080|NCT01873417|Dimethyl Fumarate|dimethyl fumarate|mesh-list
6190081|NCT01873417|Dermatologic Agents|dermatologic agents|mesh-ancestor
5582534|NCT03834909|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5582535|NCT03834909|Antiviral Agents|antiviral agents|mesh-ancestor
5582536|NCT03834909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5582537|NCT03834909|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5582538|NCT03834909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5582539|NCT03834909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5582540|NCT03834909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582541|NCT03834909|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5582542|NCT03834909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5582543|NCT03835065|Calpastatin|calpastatin|mesh-list
5582544|NCT03835065|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
5582545|NCT03835065|Protease Inhibitors|protease inhibitors|mesh-ancestor
5582546|NCT03835065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5582547|NCT03835065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604985|NCT03861078|Autonomic Agents|autonomic agents|mesh-ancestor
6190082|NCT01873417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6190083|NCT01873417|Immunologic Factors|immunologic factors|mesh-ancestor
6190084|NCT01873417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190085|NCT01873495|Homoharringtonine|homoharringtonine|mesh-list
6190086|NCT01873495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6190087|NCT01873495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6190088|NCT01873495|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6190089|NCT01873495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6190090|NCT01873495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582548|NCT03834610|Tadalafil|tadalafil|mesh-list
5582549|NCT03834610|Testosterone|testosterone|mesh-list
5582550|NCT03834610|Androgens|androgens|mesh-ancestor
5582551|NCT03834610|Hormones|hormones|mesh-ancestor
5582552|NCT03834610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5582553|NCT03834610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582554|NCT03834610|Vasodilator Agents|vasodilator agents|mesh-ancestor
5582555|NCT03834610|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6190091|NCT01873729|Naltrexone|naltrexone|mesh-list
6190092|NCT01873729|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6190093|NCT01873729|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6190094|NCT01873729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190095|NCT01873729|Sensory System Agents|sensory system agents|mesh-ancestor
6190096|NCT01873729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6190097|NCT01873859|Metformin|metformin|mesh-list
6190098|NCT01873859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6190099|NCT01873859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582556|NCT03834610|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5582557|NCT03834610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5582558|NCT03834610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582559|NCT03834610|Urological Agents|urological agents|mesh-ancestor
5582560|NCT03834623|Nivolumab|nivolumab|mesh-list
5582561|NCT03834623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6190100|NCT01873950|Quinidine|quinidine|mesh-list
6190101|NCT01873950|Quinidine gluconate|quinidine gluconate|mesh-list
6190102|NCT01873950|Verapamil|verapamil|mesh-list
6190103|NCT01873950|Dofetilide|dofetilide|mesh-list
5582562|NCT03834623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5582563|NCT03834623|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5582564|NCT03834623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582565|NCT03834454|Bupivacaine|bupivacaine|mesh-list
5582566|NCT03834454|Anesthetics, Local|anesthetics, local|mesh-ancestor
6190104|NCT01873950|Ranolazine|ranolazine|mesh-list
6190105|NCT01873950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6190106|NCT01873950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6190107|NCT01873950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6190108|NCT01873950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190109|NCT01873950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6190110|NCT01873950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190111|NCT01873950|Vasodilator Agents|vasodilator agents|mesh-ancestor
6190112|NCT01873950|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6190113|NCT01873950|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6190114|NCT01873950|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6190115|NCT01873950|Adrenergic Agents|adrenergic agents|mesh-ancestor
6190116|NCT01873950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6190117|NCT01873950|Antimalarials|antimalarials|mesh-ancestor
5582567|NCT03834454|Anesthetics|anesthetics|mesh-ancestor
5582568|NCT03834454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6190118|NCT01873950|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6190119|NCT01873950|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6190120|NCT01873950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6190121|NCT01873950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6190122|NCT01873950|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6190123|NCT01873950|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6190124|NCT01873950|Cholinergic Agents|cholinergic agents|mesh-ancestor
6190125|NCT01873950|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6190126|NCT01873950|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6190127|NCT01873950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6190128|NCT01873950|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6190129|NCT01873989|Testosterone|testosterone|mesh-list
6190130|NCT01873989|Androgens|androgens|mesh-ancestor
6190131|NCT01873989|Hormones|hormones|mesh-ancestor
6190132|NCT01873989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6190133|NCT01873989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190134|NCT01874054|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5582569|NCT03834454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582570|NCT03834454|Sensory System Agents|sensory system agents|mesh-ancestor
6190135|NCT01874054|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6190136|NCT01874054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6190137|NCT01874054|Alkylating Agents|alkylating agents|mesh-ancestor
6190138|NCT01874054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190139|NCT01874054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6190140|NCT01874054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6190141|NCT01874119|Fosaprepitant|fosaprepitant|mesh-list
6190142|NCT01874119|Aprepitant|aprepitant|mesh-list
6190143|NCT01874119|Antiemetics|antiemetics|mesh-ancestor
6190144|NCT01874119|Autonomic Agents|autonomic agents|mesh-ancestor
5582571|NCT03834454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5582572|NCT03834519|Prednisone|prednisone|mesh-list
5582573|NCT03834519|Pembrolizumab|pembrolizumab|mesh-list
5582574|NCT03834519|Olaparib|olaparib|mesh-list
5582575|NCT03834519|Abiraterone Acetate|abiraterone acetate|mesh-list
5582576|NCT03834519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5582577|NCT03834519|Glucocorticoids|glucocorticoids|mesh-ancestor
5582578|NCT03834519|Hormones|hormones|mesh-ancestor
5582579|NCT03834519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6190145|NCT01874119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6190146|NCT01874119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190147|NCT01874119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6190148|NCT01874119|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6190149|NCT01874119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6190150|NCT01874119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190151|NCT01874145|Glatiramer Acetate|glatiramer acetate|mesh-list
6190152|NCT01874145|(T,G)-A-L|(t,g)-a-l|mesh-list
6190153|NCT01874145|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6190154|NCT01874145|Immunologic Factors|immunologic factors|mesh-ancestor
6190155|NCT01874145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190156|NCT01874145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6190157|NCT01874145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6190158|NCT01874392|Insulin|insulin|mesh-list
6190159|NCT01874392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6190160|NCT01874392|Pancrelipase|pancrelipase|mesh-list
6190161|NCT01874392|Pancreatin|pancreatin|mesh-list
6190162|NCT01874392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6190163|NCT01874392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190164|NCT01874392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6190165|NCT01874535|Esomeprazole|esomeprazole|mesh-list
6190166|NCT01874535|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6190167|NCT01874535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6190168|NCT01874535|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6190169|NCT01874535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5582580|NCT03834519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582581|NCT03834519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5582582|NCT03834519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5582583|NCT03834519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5582584|NCT03834519|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5582585|NCT03834519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6190170|NCT01874535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190171|NCT01874665|Ponatinib|ponatinib|mesh-list
6190172|NCT01874665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6190173|NCT01874665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6190174|NCT01874665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6190175|NCT01874665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190176|NCT01874951|Naltrexone|naltrexone|mesh-list
6190177|NCT01874951|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6190178|NCT01874951|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6190179|NCT01874951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190180|NCT01874951|Sensory System Agents|sensory system agents|mesh-ancestor
6190181|NCT01874951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6190182|NCT01875159|Caffeine|caffeine|mesh-list
6190183|NCT01875159|Caffeine citrate|caffeine citrate|mesh-list
6190184|NCT01875159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190185|NCT01875159|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6190186|NCT01875159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582586|NCT03834519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582587|NCT03834519|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5582588|NCT03834519|Hormone Antagonists|hormone antagonists|mesh-ancestor
5582589|NCT03834519|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5582590|NCT03834506|Dexamethasone|dexamethasone|mesh-list
5582591|NCT03834506|Prednisone|prednisone|mesh-list
5582592|NCT03834506|Docetaxel|docetaxel|mesh-list
5582593|NCT03834506|Pembrolizumab|pembrolizumab|mesh-list
5582594|NCT03834506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5582595|NCT03834506|Antiemetics|antiemetics|mesh-ancestor
5582596|NCT03834506|Autonomic Agents|autonomic agents|mesh-ancestor
5582597|NCT03834506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5582598|NCT03834506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582599|NCT03834506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5582600|NCT03834506|Glucocorticoids|glucocorticoids|mesh-ancestor
5582601|NCT03834506|Hormones|hormones|mesh-ancestor
5582602|NCT03834506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5582603|NCT03834506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5582604|NCT03834506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5582605|NCT03834506|Tubulin Modulators|tubulin modulators|mesh-ancestor
5582606|NCT03834506|Antimitotic Agents|antimitotic agents|mesh-ancestor
6190187|NCT01875159|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6190188|NCT01875159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6190189|NCT01875159|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6190190|NCT01875159|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6190191|NCT01875159|Purinergic Agents|purinergic agents|mesh-ancestor
6190192|NCT01875159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6190193|NCT01875237|Methylprednisolone|methylprednisolone|mesh-list
6190194|NCT01875237|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6190195|NCT01875237|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6190196|NCT01875237|Prednisolone|prednisolone|mesh-list
6190197|NCT01875237|Prednisolone acetate|prednisolone acetate|mesh-list
5582607|NCT03834506|Mitosis Modulators|mitosis modulators|mesh-ancestor
5582608|NCT03834506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582609|NCT03834506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5582610|NCT03834571|Paclitaxel|paclitaxel|mesh-list
5582611|NCT03834571|Cisplatin|cisplatin|mesh-list
5582612|NCT03834571|Carboplatin|carboplatin|mesh-list
5582613|NCT03834571|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5582614|NCT03834571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5582615|NCT03834571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5582616|NCT03834571|Tubulin Modulators|tubulin modulators|mesh-ancestor
5582617|NCT03834571|Antimitotic Agents|antimitotic agents|mesh-ancestor
5582618|NCT03834571|Mitosis Modulators|mitosis modulators|mesh-ancestor
6190198|NCT01875237|Methotrexate|methotrexate|mesh-list
6190199|NCT01875237|Fludarabine phosphate|fludarabine phosphate|mesh-list
6190200|NCT01875237|Fludarabine|fludarabine|mesh-list
6190201|NCT01875237|Melphalan|melphalan|mesh-list
6190202|NCT01875237|Alemtuzumab|alemtuzumab|mesh-list
6190203|NCT01875237|Tacrolimus|tacrolimus|mesh-list
6190204|NCT01875237|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6190205|NCT01875237|Prednisolone phosphate|prednisolone phosphate|mesh-list
6190206|NCT01875237|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6190207|NCT01875237|Abortifacient Agents|abortifacient agents|mesh-ancestor
6190208|NCT01875237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6190209|NCT01875237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190210|NCT01875237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6190211|NCT01875237|Antimetabolites|antimetabolites|mesh-ancestor
6190212|NCT01875237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190213|NCT01875237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6190214|NCT01875237|Dermatologic Agents|dermatologic agents|mesh-ancestor
6190215|NCT01875237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6190216|NCT01875237|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6190217|NCT01875237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6190218|NCT01875237|Immunologic Factors|immunologic factors|mesh-ancestor
5582619|NCT03834571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582620|NCT03834233|Nivolumab|nivolumab|mesh-list
5582621|NCT03834233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5582622|NCT03834233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5582623|NCT03834233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5582624|NCT03834233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582625|NCT03833999|Ondansetron|ondansetron|mesh-list
5582626|NCT03833999|Lactulose|lactulose|mesh-list
5582627|NCT03833999|Antiemetics|antiemetics|mesh-ancestor
5582628|NCT03833999|Autonomic Agents|autonomic agents|mesh-ancestor
5582629|NCT03833999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5582630|NCT03833999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190219|NCT01875237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5582631|NCT03833999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5582632|NCT03833999|Antipruritics|antipruritics|mesh-ancestor
5582633|NCT03833999|Dermatologic Agents|dermatologic agents|mesh-ancestor
6190220|NCT01875237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6190221|NCT01875237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6190222|NCT01875237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6190223|NCT01875237|Alkylating Agents|alkylating agents|mesh-ancestor
6190224|NCT01875237|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6190225|NCT01875237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5582634|NCT03833999|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5582635|NCT03833999|Serotonin Agents|serotonin agents|mesh-ancestor
5582636|NCT03833999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5582637|NCT03833999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582638|NCT03833999|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5582639|NCT03833999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5582640|NCT03833999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5582641|NCT03833999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5582642|NCT03833999|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5582643|NCT03834012|Beclomethasone|beclomethasone|mesh-list
5582644|NCT03834012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5582645|NCT03834012|Glucocorticoids|glucocorticoids|mesh-ancestor
5582646|NCT03834012|Hormones|hormones|mesh-ancestor
5582647|NCT03834012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5582648|NCT03834012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582649|NCT03834012|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5582650|NCT03834012|Respiratory System Agents|respiratory system agents|mesh-ancestor
5582651|NCT03833921|Prednisone|prednisone|mesh-list
6190226|NCT01875237|Antiemetics|antiemetics|mesh-ancestor
6190227|NCT01875237|Autonomic Agents|autonomic agents|mesh-ancestor
6190228|NCT01875237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6190229|NCT01875237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6190230|NCT01875237|Glucocorticoids|glucocorticoids|mesh-ancestor
6190231|NCT01875237|Hormones|hormones|mesh-ancestor
6190232|NCT01875237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6190233|NCT01875237|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6190234|NCT01875237|Protective Agents|protective agents|mesh-ancestor
6190235|NCT01875237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6190236|NCT01875237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6190237|NCT01875250|Metronidazole|metronidazole|mesh-list
6190238|NCT01875250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6190239|NCT01875250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6190240|NCT01875250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6190241|NCT01875250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6190242|NCT01875367|Trastuzumab|trastuzumab|mesh-list
6190243|NCT01875367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6190244|NCT01875367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6190245|NCT01875445|Inositol|inositol|mesh-list
6190246|NCT01875445|Vitamin B Complex|vitamin b complex|mesh-ancestor
6190247|NCT01875445|Vitamins|vitamins|mesh-ancestor
6190248|NCT01875445|Micronutrients|micronutrients|mesh-ancestor
6190249|NCT01875445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190250|NCT01875510|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6190251|NCT01875510|SMOFlipid|smoflipid|mesh-list
6190252|NCT01875510|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6190253|NCT01875510|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6190254|NCT01875510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6190255|NCT01875848|Buprenorphine|buprenorphine|mesh-list
6190256|NCT01875848|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6190257|NCT01875848|Naloxone|naloxone|mesh-list
6190258|NCT01875848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6190259|NCT01875848|Narcotics|narcotics|mesh-ancestor
6190260|NCT01875848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6190261|NCT01875848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190262|NCT01875848|Analgesics|analgesics|mesh-ancestor
6190263|NCT01875848|Sensory System Agents|sensory system agents|mesh-ancestor
6190264|NCT01875848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6190265|NCT01875848|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6190266|NCT01875991|Etanercept|etanercept|mesh-list
6190267|NCT01875991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6190268|NCT01875991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6190269|NCT01875991|Analgesics|analgesics|mesh-ancestor
6190270|NCT01875991|Sensory System Agents|sensory system agents|mesh-ancestor
6190271|NCT01875991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6190272|NCT01875991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190273|NCT01875991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5582652|NCT03833921|Abiraterone Acetate|abiraterone acetate|mesh-list
6190274|NCT01875991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6190275|NCT01875991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6190276|NCT01875991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6190277|NCT01875991|Immunologic Factors|immunologic factors|mesh-ancestor
6190278|NCT01876082|Methotrexate|methotrexate|mesh-list
6190279|NCT01876082|Vinblastine|vinblastine|mesh-list
6190280|NCT01876082|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6190281|NCT01876082|Abortifacient Agents|abortifacient agents|mesh-ancestor
6190282|NCT01876082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6190283|NCT01876082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190284|NCT01876082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6190285|NCT01876082|Antimetabolites|antimetabolites|mesh-ancestor
6190286|NCT01876082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190287|NCT01876082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6190288|NCT01876082|Dermatologic Agents|dermatologic agents|mesh-ancestor
6190289|NCT01876082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6190290|NCT01876082|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6190291|NCT01876082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6190292|NCT01876082|Immunologic Factors|immunologic factors|mesh-ancestor
6190293|NCT01876082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6190294|NCT01876082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6190295|NCT01876082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6190296|NCT01876082|Tubulin Modulators|tubulin modulators|mesh-ancestor
6190297|NCT01876082|Antimitotic Agents|antimitotic agents|mesh-ancestor
5582653|NCT03833921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5582654|NCT03833921|Glucocorticoids|glucocorticoids|mesh-ancestor
5582655|NCT03833921|Hormones|hormones|mesh-ancestor
6190298|NCT01876082|Mitosis Modulators|mitosis modulators|mesh-ancestor
6190299|NCT01876212|Dasatinib|dasatinib|mesh-list
6190300|NCT01876212|Vaccines|vaccines|mesh-list
6190301|NCT01876212|Immunologic Factors|immunologic factors|mesh-ancestor
6190302|NCT01876212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190303|NCT01876212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6190304|NCT01876212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6190305|NCT01876212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6190306|NCT01876212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190307|NCT01876251|Docetaxel|docetaxel|mesh-list
6190308|NCT01876251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6190309|NCT01876251|Tubulin Modulators|tubulin modulators|mesh-ancestor
6190310|NCT01876251|Antimitotic Agents|antimitotic agents|mesh-ancestor
6190311|NCT01876251|Mitosis Modulators|mitosis modulators|mesh-ancestor
6190312|NCT01876251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190313|NCT01876368|Olmesartan|olmesartan|mesh-list
6190314|NCT01876368|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6190315|NCT01876368|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
6190316|NCT01876368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6190317|NCT01876368|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6190318|NCT01876368|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6190319|NCT01876368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190320|NCT01876381|Tolvaptan|tolvaptan|mesh-list
6190321|NCT01876381|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6190322|NCT01876381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190323|NCT01876381|Natriuretic Agents|natriuretic agents|mesh-ancestor
6190324|NCT01876381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190325|NCT01876446|Irinotecan|irinotecan|mesh-list
6190326|NCT01876446|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6190327|NCT01876446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6190328|NCT01876446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6190329|NCT01876446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190330|NCT01876446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6190331|NCT01876511|Pembrolizumab|pembrolizumab|mesh-list
6190332|NCT01876511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5582656|NCT03833921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5582657|NCT03833921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582658|NCT03833921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5582659|NCT03833921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5582660|NCT03833921|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5582661|NCT03833921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5582662|NCT03833921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582663|NCT03833921|Hormone Antagonists|hormone antagonists|mesh-ancestor
5582664|NCT03833921|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5582665|NCT03834129|Dexmedetomidine|dexmedetomidine|mesh-list
6190333|NCT01876511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6190334|NCT01876732|Vitamin B 12|vitamin b 12|mesh-list
6190335|NCT01876732|Hydroxocobalamin|hydroxocobalamin|mesh-list
6190336|NCT01876732|Vitamins|vitamins|mesh-ancestor
6190337|NCT01876732|Micronutrients|micronutrients|mesh-ancestor
6190338|NCT01876732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190339|NCT01876732|Vitamin B Complex|vitamin b complex|mesh-ancestor
6190340|NCT01876732|Hematinics|hematinics|mesh-ancestor
6190341|NCT01876810|Gemfibrozil|gemfibrozil|mesh-list
6190342|NCT01876810|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6190343|NCT01876810|Antimetabolites|antimetabolites|mesh-ancestor
6190344|NCT01876810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190345|NCT01876810|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6190346|NCT01876810|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6190347|NCT01876810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6190348|NCT01876810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6190349|NCT01876823|Memantine|memantine|mesh-list
6190350|NCT01876823|Citalopram|citalopram|mesh-list
6190351|NCT01876823|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6190352|NCT01876823|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6190353|NCT01876823|Dopamine Agents|dopamine agents|mesh-ancestor
6190354|NCT01876823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6190355|NCT01876823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582666|NCT03834129|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5582667|NCT03834129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5582668|NCT03834129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582669|NCT03834129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5582670|NCT03834129|Analgesics|analgesics|mesh-ancestor
5582671|NCT03834129|Sensory System Agents|sensory system agents|mesh-ancestor
5582672|NCT03834129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5582673|NCT03834129|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5582674|NCT03834129|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5582675|NCT03834129|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5582676|NCT03834129|Adrenergic Agents|adrenergic agents|mesh-ancestor
5582677|NCT03834129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5582678|NCT03834129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582679|NCT03833895|Phenylephrine|phenylephrine|mesh-list
5582680|NCT03833895|Oxymetazoline|oxymetazoline|mesh-list
5582681|NCT03833895|Norepinephrine|norepinephrine|mesh-list
5582682|NCT03833895|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5582683|NCT03833895|Mydriatics|mydriatics|mesh-ancestor
5582684|NCT03833895|Autonomic Agents|autonomic agents|mesh-ancestor
5582685|NCT03833895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5582686|NCT03833895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582687|NCT03833895|Sympathomimetics|sympathomimetics|mesh-ancestor
5582688|NCT03833895|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5582689|NCT03833895|Nasal Decongestants|nasal decongestants|mesh-ancestor
5582690|NCT03833895|Respiratory System Agents|respiratory system agents|mesh-ancestor
5582691|NCT03833895|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5582692|NCT03833895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6190356|NCT01876823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190357|NCT01876823|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6190358|NCT01876823|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6190359|NCT01876823|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5582693|NCT03833895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5582694|NCT03833895|Adrenergic Agents|adrenergic agents|mesh-ancestor
5582695|NCT03833895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6190360|NCT01876823|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6190361|NCT01876823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6190362|NCT01876823|Serotonin Agents|serotonin agents|mesh-ancestor
6190363|NCT01876823|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6190364|NCT01876823|Antidepressive Agents|antidepressive agents|mesh-ancestor
6190365|NCT01876823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6190366|NCT01876953|Cytarabine|cytarabine|mesh-list
6190367|NCT01876953|Dasatinib|dasatinib|mesh-list
6190368|NCT01876953|Idarubicin|idarubicin|mesh-list
6190369|NCT01876953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6190370|NCT01876953|Antimetabolites|antimetabolites|mesh-ancestor
6190371|NCT01876953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190372|NCT01876953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6190373|NCT01876953|Antiviral Agents|antiviral agents|mesh-ancestor
6190374|NCT01876953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6190375|NCT01876953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6190376|NCT01876953|Immunologic Factors|immunologic factors|mesh-ancestor
6190377|NCT01876953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582696|NCT03833895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582697|NCT03833895|Protective Agents|protective agents|mesh-ancestor
5582698|NCT03833947|Dexamethasone|dexamethasone|mesh-list
5582699|NCT03833947|Lidocaine|lidocaine|mesh-list
5582700|NCT03833947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5582701|NCT03833947|Antiemetics|antiemetics|mesh-ancestor
5582702|NCT03833947|Autonomic Agents|autonomic agents|mesh-ancestor
5582703|NCT03833947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5582704|NCT03833947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582705|NCT03833947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5582706|NCT03833947|Glucocorticoids|glucocorticoids|mesh-ancestor
5582707|NCT03833947|Hormones|hormones|mesh-ancestor
5582708|NCT03833947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5582709|NCT03833947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5582710|NCT03833947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5582711|NCT03833947|Anesthetics, Local|anesthetics, local|mesh-ancestor
6190378|NCT01876953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6190379|NCT01876953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6190380|NCT01876953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6190381|NCT01876953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6190382|NCT01876953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6190383|NCT01876992|Metformin|metformin|mesh-list
6190384|NCT01876992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5582712|NCT03833947|Anesthetics|anesthetics|mesh-ancestor
5582713|NCT03833947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5582714|NCT03833947|Sensory System Agents|sensory system agents|mesh-ancestor
5582715|NCT03833947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5582716|NCT03833947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5582717|NCT03833947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6190385|NCT01876992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190386|NCT01877083|Lenvatinib|lenvatinib|mesh-list
5582718|NCT03833947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5582719|NCT03833947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582720|NCT03833596|Prednisone|prednisone|mesh-list
5582721|NCT03833596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5582722|NCT03833596|Glucocorticoids|glucocorticoids|mesh-ancestor
5582723|NCT03833596|Hormones|hormones|mesh-ancestor
5582724|NCT03833596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5582725|NCT03833596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582726|NCT03833596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5582727|NCT03833596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5582728|NCT03833466|Metformin|metformin|mesh-list
5582729|NCT03833466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5582730|NCT03833466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582731|NCT03833570|Melatonin|melatonin|mesh-list
5582732|NCT03833570|Antioxidants|antioxidants|mesh-ancestor
5582733|NCT03833570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582734|NCT03833570|Protective Agents|protective agents|mesh-ancestor
5582735|NCT03833570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582736|NCT03833570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5582737|NCT03833362|Interferons|interferons|mesh-list
5582738|NCT03833362|Ritonavir|ritonavir|mesh-list
5582739|NCT03833362|Ribavirin|ribavirin|mesh-list
5582740|NCT03833362|Interferon-alpha|interferon-alpha|mesh-list
5582741|NCT03833362|Interferon alpha-2|interferon alpha-2|mesh-list
5582742|NCT03833362|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5582743|NCT03833362|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6190387|NCT01877083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6190388|NCT01877083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6190389|NCT01877083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6190390|NCT01877083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190391|NCT01877187|Ethiodized Oil|ethiodized oil|mesh-list
6190392|NCT01877187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6190393|NCT01877538|Donepezil|donepezil|mesh-list
6190394|NCT01877538|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6190395|NCT01877538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5582744|NCT03833362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5582745|NCT03833362|Antiviral Agents|antiviral agents|mesh-ancestor
5582746|NCT03833362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5582747|NCT03833362|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5582748|NCT03833362|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5582749|NCT03833362|Protease Inhibitors|protease inhibitors|mesh-ancestor
5582750|NCT03833362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5582751|NCT03833362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190396|NCT01877538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190397|NCT01877538|Cholinergic Agents|cholinergic agents|mesh-ancestor
6190398|NCT01877538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5582752|NCT03833362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5582753|NCT03833362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5582754|NCT03833362|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5582755|NCT03833362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5582756|NCT03833362|Antimetabolites|antimetabolites|mesh-ancestor
5582757|NCT03833362|Immunologic Factors|immunologic factors|mesh-ancestor
5582758|NCT03833362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582759|NCT03833440|Docetaxel|docetaxel|mesh-list
5582760|NCT03833440|Durvalumab|durvalumab|mesh-list
5582761|NCT03833440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5582762|NCT03833440|Tubulin Modulators|tubulin modulators|mesh-ancestor
5582763|NCT03833440|Antimitotic Agents|antimitotic agents|mesh-ancestor
5582764|NCT03833440|Mitosis Modulators|mitosis modulators|mesh-ancestor
5582765|NCT03833440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582766|NCT03833440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5582767|NCT03833388|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5582768|NCT03833388|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5582769|NCT03832972|Estrogens|estrogens|mesh-list
5582770|NCT03832972|Hormones|hormones|mesh-ancestor
5582771|NCT03832972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5582772|NCT03832972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582773|NCT03833154|Durvalumab|durvalumab|mesh-list
5582774|NCT03833154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5582775|NCT03833154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5582776|NCT03833063|Botulinum Toxins|botulinum toxins|mesh-list
5582777|NCT03833063|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5582778|NCT03833063|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5582779|NCT03833063|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5582780|NCT03833063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5582781|NCT03833063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582782|NCT03833063|Cholinergic Agents|cholinergic agents|mesh-ancestor
5582783|NCT03833063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5582784|NCT03833063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582785|NCT03833063|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5582786|NCT03833063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5604986|NCT03861078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5604987|NCT03861078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190399|NCT01877538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190400|NCT01877538|Nootropic Agents|nootropic agents|mesh-ancestor
6190401|NCT01877551|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
6190402|NCT01877551|Antiviral Agents|antiviral agents|mesh-ancestor
6190403|NCT01877551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6190404|NCT01877551|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5604988|NCT03861078|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5604989|NCT03861078|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5604990|NCT03861078|Cholinergic Agents|cholinergic agents|mesh-ancestor
5604991|NCT03861078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5604992|NCT03861078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5604993|NCT03849443|Ascorbic Acid|ascorbic acid|mesh-list
5604994|NCT03849443|Tranexamic Acid|tranexamic acid|mesh-list
5604995|NCT03849443|Vitamins|vitamins|mesh-ancestor
5604996|NCT03849443|Micronutrients|micronutrients|mesh-ancestor
5604997|NCT03849443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5604998|NCT03849443|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5604999|NCT03849443|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6190405|NCT01877551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6190406|NCT01877642|Lorazepam|lorazepam|mesh-list
6190407|NCT01877642|Loxapine|loxapine|mesh-list
5605000|NCT03849443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605001|NCT03849443|Hemostatics|hemostatics|mesh-ancestor
5605002|NCT03849443|Coagulants|coagulants|mesh-ancestor
5605003|NCT03849443|Antioxidants|antioxidants|mesh-ancestor
5605004|NCT03849443|Protective Agents|protective agents|mesh-ancestor
5605005|NCT03842228|Durvalumab|durvalumab|mesh-list
5605006|NCT03842228|Olaparib|olaparib|mesh-list
5605007|NCT03842228|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
6190408|NCT01877642|Anticonvulsants|anticonvulsants|mesh-ancestor
6190409|NCT01877642|Antiemetics|antiemetics|mesh-ancestor
6190410|NCT01877642|Autonomic Agents|autonomic agents|mesh-ancestor
6190411|NCT01877642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6190412|NCT01877642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190413|NCT01877642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5605008|NCT03842228|Immunoglobulins|immunoglobulins|mesh-list
6190414|NCT01877642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6207185|NCT02111785|Dexamethasone|dexamethasone|mesh-list
5582787|NCT03832894|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5582788|NCT03832894|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5582789|NCT03832894|Estradiol|estradiol|mesh-list
5582790|NCT03832894|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5582791|NCT03832894|Progesterone|progesterone|mesh-list
5582792|NCT03832894|Estrogens|estrogens|mesh-ancestor
5582793|NCT03832894|Hormones|hormones|mesh-ancestor
5582794|NCT03832894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5582795|NCT03832894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582796|NCT03832894|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6190415|NCT01877642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6190416|NCT01877642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6190417|NCT01877642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6190418|NCT01877642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6190419|NCT01877642|GABA Modulators|gaba modulators|mesh-ancestor
6190420|NCT01877642|GABA Agents|gaba agents|mesh-ancestor
6190421|NCT01877642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6190422|NCT01877642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190423|NCT01877642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6190424|NCT01877642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6190425|NCT01877642|Dopamine Agents|dopamine agents|mesh-ancestor
6190426|NCT01877668|Adalimumab|adalimumab|mesh-list
6190427|NCT01877668|Tofacitinib|tofacitinib|mesh-list
6190428|NCT01877668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6190429|NCT01877668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6190430|NCT01877668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6190431|NCT01877668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6190432|NCT01877668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190433|NCT01877915|Rivaroxaban|rivaroxaban|mesh-list
6190434|NCT01877915|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6190435|NCT01877915|Antithrombins|antithrombins|mesh-ancestor
6190436|NCT01877915|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6190437|NCT01877915|Protease Inhibitors|protease inhibitors|mesh-ancestor
6190438|NCT01877915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6190439|NCT01877915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190440|NCT01877915|Anticoagulants|anticoagulants|mesh-ancestor
6190441|NCT01878006|Morphine|morphine|mesh-list
6190442|NCT01878006|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6190443|NCT01878006|Narcotics|narcotics|mesh-ancestor
6190444|NCT01878006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6190445|NCT01878006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190446|NCT01878006|Analgesics|analgesics|mesh-ancestor
6190447|NCT01878006|Sensory System Agents|sensory system agents|mesh-ancestor
6190448|NCT01878006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6190449|NCT01878292|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
6190450|NCT01878292|Antidepressive Agents|antidepressive agents|mesh-ancestor
6190451|NCT01878292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6190452|NCT01878292|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6190453|NCT01878292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6190454|NCT01878292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6190455|NCT01878292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190456|NCT01878292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6190457|NCT01878292|Serotonin Agents|serotonin agents|mesh-ancestor
6190458|NCT01878292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190459|NCT01878292|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6190460|NCT01878292|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6190461|NCT01878526|Domperidone|domperidone|mesh-list
6190462|NCT01878526|Antiemetics|antiemetics|mesh-ancestor
6190463|NCT01878526|Autonomic Agents|autonomic agents|mesh-ancestor
6190464|NCT01878526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6190465|NCT01878526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190466|NCT01878526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6190467|NCT01878526|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6190468|NCT01878526|Dopamine Agents|dopamine agents|mesh-ancestor
6190469|NCT01878526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6190470|NCT01878526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190471|NCT01878604|Hypolipidemic Agents|hypolipidemic agents|mesh-list
6190472|NCT01878604|Antimetabolites|antimetabolites|mesh-ancestor
6190473|NCT01878604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190474|NCT01878604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5582797|NCT03832894|Contraceptive Agents|contraceptive agents|mesh-ancestor
6190475|NCT01878656|Sevoflurane|sevoflurane|mesh-list
6190476|NCT01878656|Desflurane|desflurane|mesh-list
6207985|NCT02122770|Antimitotic Agents|antimitotic agents|mesh-ancestor
5582798|NCT03832894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5605009|NCT03842228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5582799|NCT03832894|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5582800|NCT03832894|Progestins|progestins|mesh-ancestor
6190477|NCT01878656|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6190478|NCT01878656|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6190479|NCT01878656|Anesthetics, General|anesthetics, general|mesh-ancestor
6190480|NCT01878656|Anesthetics|anesthetics|mesh-ancestor
5582801|NCT03832569|Pembrolizumab|pembrolizumab|mesh-list
5582802|NCT03832569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5582803|NCT03832569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5582804|NCT03832660|Valsartan|valsartan|mesh-list
5582805|NCT03832660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5582806|NCT03832660|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5582807|NCT03832660|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5582808|NCT03832660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190481|NCT01878656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6190482|NCT01878656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190483|NCT01878799|Sofosbuvir|sofosbuvir|mesh-list
6190484|NCT01878799|Ledipasvir|ledipasvir|mesh-list
6190485|NCT01878799|Antiviral Agents|antiviral agents|mesh-ancestor
6190486|NCT01878799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6207186|NCT02111785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6207187|NCT02111785|Antiemetics|antiemetics|mesh-ancestor
6207188|NCT02111785|Autonomic Agents|autonomic agents|mesh-ancestor
6207189|NCT02111785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6207190|NCT02111785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207191|NCT02111785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6207192|NCT02111785|Glucocorticoids|glucocorticoids|mesh-ancestor
6207193|NCT02111785|Hormones|hormones|mesh-ancestor
5582809|NCT03832816|Dronabinol|dronabinol|mesh-list
5582810|NCT03832816|Hallucinogens|hallucinogens|mesh-ancestor
5582811|NCT03832816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582812|NCT03832816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5582813|NCT03832816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5582814|NCT03832816|Analgesics|analgesics|mesh-ancestor
5582815|NCT03832816|Sensory System Agents|sensory system agents|mesh-ancestor
5582816|NCT03832816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6207194|NCT02111785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6207195|NCT02111785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6207196|NCT02111785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6207197|NCT02111798|Bupropion|bupropion|mesh-list
6207198|NCT02111798|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6207199|NCT02111798|Antidepressive Agents|antidepressive agents|mesh-ancestor
5582817|NCT03832816|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5582818|NCT03832816|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5582819|NCT03832816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6207200|NCT02111798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6207201|NCT02111798|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6207202|NCT02111798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6207203|NCT02111798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6207204|NCT02111798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207205|NCT02111798|Dopamine Agents|dopamine agents|mesh-ancestor
6207206|NCT02111798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6207207|NCT02111798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207208|NCT02111798|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5582820|NCT03832816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582821|NCT03832816|Hormones|hormones|mesh-ancestor
5582822|NCT03832816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5582823|NCT03832621|Nivolumab|nivolumab|mesh-list
5582824|NCT03832621|Ipilimumab|ipilimumab|mesh-list
5582825|NCT03832621|Temozolomide|temozolomide|mesh-list
5582826|NCT03832621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5582827|NCT03832621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5582828|NCT03832621|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5582829|NCT03832621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582830|NCT03832621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5582831|NCT03832621|Alkylating Agents|alkylating agents|mesh-ancestor
5582832|NCT03832673|Pembrolizumab|pembrolizumab|mesh-list
6207209|NCT02111798|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6207210|NCT02111798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6207211|NCT02111863|Aldesleukin|aldesleukin|mesh-list
6207212|NCT02111863|Cyclophosphamide|cyclophosphamide|mesh-list
6207213|NCT02111863|Fludarabine|fludarabine|mesh-list
6207214|NCT02111863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6207215|NCT02111863|Immunologic Factors|immunologic factors|mesh-ancestor
6190487|NCT01878890|Efavirenz|efavirenz|mesh-list
6190488|NCT01878890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6190489|NCT01878890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6190490|NCT01878890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6190491|NCT01878890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190492|NCT01878890|Antiviral Agents|antiviral agents|mesh-ancestor
6190493|NCT01878890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6190494|NCT01878890|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6190495|NCT01878890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6190496|NCT01878890|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6190497|NCT01878890|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6190498|NCT01878890|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6190499|NCT01878890|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6190500|NCT01879319|Evolocumab|evolocumab|mesh-list
6190501|NCT01879319|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6190502|NCT01879319|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6190503|NCT01879319|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6190504|NCT01879319|Antimetabolites|antimetabolites|mesh-ancestor
6190505|NCT01879319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190506|NCT01879319|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6190507|NCT01879319|Immunologic Factors|immunologic factors|mesh-ancestor
6190508|NCT01879319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190509|NCT01879332|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
6190510|NCT01879332|Anticonvulsants|anticonvulsants|mesh-ancestor
6190511|NCT01879332|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6190512|NCT01879332|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6190513|NCT01879332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6190514|NCT01879332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190515|NCT01879345|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
6190516|NCT01879345|Anticonvulsants|anticonvulsants|mesh-ancestor
6190517|NCT01879345|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6190518|NCT01879345|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6190519|NCT01879345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6190520|NCT01879345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190521|NCT01879371|Ibuprofen|ibuprofen|mesh-list
6190522|NCT01879371|Caffeine|caffeine|mesh-list
6190523|NCT01879371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6190524|NCT01879371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6190525|NCT01879371|Analgesics|analgesics|mesh-ancestor
6190526|NCT01879371|Sensory System Agents|sensory system agents|mesh-ancestor
6190527|NCT01879371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6190528|NCT01879371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190529|NCT01879371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6190530|NCT01879371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6190531|NCT01879371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6190532|NCT01879371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6190533|NCT01879371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190534|NCT01879371|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6190535|NCT01879371|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6190536|NCT01879371|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6190537|NCT01879371|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6190538|NCT01879371|Purinergic Agents|purinergic agents|mesh-ancestor
6190539|NCT01879371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6190540|NCT01879579|Insulin|insulin|mesh-list
6190541|NCT01879579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6190542|NCT01879579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190543|NCT01879618|Dalteparin|dalteparin|mesh-list
6190544|NCT01879618|Anticoagulants|anticoagulants|mesh-ancestor
5582833|NCT03832673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5582834|NCT03832673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5582835|NCT03832699|Dydrogesterone|dydrogesterone|mesh-list
5582836|NCT03832699|Progesterone|progesterone|mesh-list
5582837|NCT03832699|Progestins|progestins|mesh-ancestor
5582838|NCT03832699|Hormones|hormones|mesh-ancestor
5582839|NCT03832699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5582840|NCT03832699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582841|NCT03832465|Levofloxacin|levofloxacin|mesh-list
5582842|NCT03832465|Ofloxacin|ofloxacin|mesh-list
5582843|NCT03832465|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5582844|NCT03832465|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5582845|NCT03832465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6190545|NCT01879618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6190546|NCT01879618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6190547|NCT01879618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190548|NCT01879735|Cholylsarcosine|cholylsarcosine|mesh-list
6190549|NCT01879735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5582846|NCT03832465|Renal Agents|renal agents|mesh-ancestor
5582847|NCT03832465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5582848|NCT03832465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5582849|NCT03832465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5582850|NCT03832465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5582851|NCT03832465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582852|NCT03832465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5582853|NCT03832465|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5582854|NCT03832465|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5582855|NCT03832361|Maytansine|maytansine|mesh-list
5582856|NCT03832361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5582857|NCT03832361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5582858|NCT03832361|Tubulin Modulators|tubulin modulators|mesh-ancestor
5582859|NCT03832361|Antimitotic Agents|antimitotic agents|mesh-ancestor
5582860|NCT03832361|Mitosis Modulators|mitosis modulators|mesh-ancestor
5582861|NCT03832361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582862|NCT03832049|Vaccines|vaccines|mesh-list
5582863|NCT03832049|Immunologic Factors|immunologic factors|mesh-ancestor
5582864|NCT03832049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582865|NCT03832452|Moxifloxacin|moxifloxacin|mesh-list
6190550|NCT01880086|Clomiphene|clomiphene|mesh-list
6190551|NCT01880086|Enclomiphene|enclomiphene|mesh-list
6190552|NCT01880086|Zuclomiphene|zuclomiphene|mesh-list
6190553|NCT01880086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6190554|NCT01880086|Hormone Antagonists|hormone antagonists|mesh-ancestor
6190555|NCT01880086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6190556|NCT01880086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190557|NCT01880086|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6190558|NCT01880086|Fertility Agents|fertility agents|mesh-ancestor
6190559|NCT01880086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5582866|NCT03832452|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
5582867|NCT03832452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5582868|NCT03832452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5582869|NCT03832452|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5582870|NCT03832452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5582871|NCT03832452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5582872|NCT03832452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582873|NCT03832452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5582874|NCT03832452|Antiviral Agents|antiviral agents|mesh-ancestor
5582875|NCT03832179|Dexamethasone|dexamethasone|mesh-list
5582876|NCT03832179|Bevacizumab|bevacizumab|mesh-list
5582877|NCT03832179|Ranibizumab|ranibizumab|mesh-list
5582878|NCT03832179|Aflibercept|aflibercept|mesh-list
5582879|NCT03832179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5582880|NCT03832179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5582881|NCT03832179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5582882|NCT03832179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5582883|NCT03832179|Growth Substances|growth substances|mesh-ancestor
5582884|NCT03832179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582885|NCT03832179|Growth Inhibitors|growth inhibitors|mesh-ancestor
5582886|NCT03832179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5582887|NCT03832179|Antiemetics|antiemetics|mesh-ancestor
5582888|NCT03832179|Autonomic Agents|autonomic agents|mesh-ancestor
5582889|NCT03832179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5582890|NCT03832179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5582891|NCT03832179|Glucocorticoids|glucocorticoids|mesh-ancestor
5582892|NCT03832179|Hormones|hormones|mesh-ancestor
5582893|NCT03832179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6190560|NCT01880086|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6190561|NCT01880086|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6190562|NCT01880099|Galantamine|galantamine|mesh-list
6190563|NCT01880099|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
6190564|NCT01880099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6190565|NCT01880099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190566|NCT01880099|Cholinergic Agents|cholinergic agents|mesh-ancestor
5582894|NCT03832179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5582895|NCT03832426|Ritonavir|ritonavir|mesh-list
5582896|NCT03832426|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5582897|NCT03832426|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5582898|NCT03832426|Protease Inhibitors|protease inhibitors|mesh-ancestor
5582899|NCT03832426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5605010|NCT03842228|Immunoglobulin G|immunoglobulin g|mesh-list
6190567|NCT01880099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6190568|NCT01880099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190569|NCT01880099|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6190570|NCT01880099|Autonomic Agents|autonomic agents|mesh-ancestor
6190571|NCT01880099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6190572|NCT01880099|Nootropic Agents|nootropic agents|mesh-ancestor
6190573|NCT01880424|Linaclotide|linaclotide|mesh-list
6190574|NCT01880424|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
6190575|NCT01880424|Enzyme Activators|enzyme activators|mesh-ancestor
6190576|NCT01880424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190577|NCT01880424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6190578|NCT01880437|Cytarabine|cytarabine|mesh-list
6190579|NCT01880437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6190580|NCT01880437|Antimetabolites|antimetabolites|mesh-ancestor
6190581|NCT01880437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190582|NCT01880437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6190583|NCT01880437|Antiviral Agents|antiviral agents|mesh-ancestor
6190584|NCT01880437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6190585|NCT01880437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6190586|NCT01880437|Immunologic Factors|immunologic factors|mesh-ancestor
6190587|NCT01880437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190588|NCT01880515|Tetracycline|tetracycline|mesh-list
6190589|NCT01880515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6190590|NCT01880515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6190591|NCT01880515|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6190592|NCT01880515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6190593|NCT01880515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190594|NCT01880528|Lisinopril|lisinopril|mesh-list
6190595|NCT01880528|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6190596|NCT01880528|Protease Inhibitors|protease inhibitors|mesh-ancestor
6190597|NCT01880528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6190598|NCT01880528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190599|NCT01880528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6190600|NCT01880528|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6190601|NCT01880528|Protective Agents|protective agents|mesh-ancestor
6190602|NCT01880528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190603|NCT01880593|Ketamine|ketamine|mesh-list
6190604|NCT01880593|Lithium Carbonate|lithium carbonate|mesh-list
6190605|NCT01880593|Analgesics|analgesics|mesh-ancestor
6190606|NCT01880593|Sensory System Agents|sensory system agents|mesh-ancestor
6190607|NCT01880593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6190608|NCT01880593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190609|NCT01880593|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6190610|NCT01880593|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6190611|NCT01880593|Anesthetics, General|anesthetics, general|mesh-ancestor
6190612|NCT01880593|Anesthetics|anesthetics|mesh-ancestor
6190613|NCT01880593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6190614|NCT01880593|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6190615|NCT01880593|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6190616|NCT01880593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6190617|NCT01880593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190618|NCT01880593|Antidepressive Agents|antidepressive agents|mesh-ancestor
6190619|NCT01880593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6190620|NCT01880593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6190621|NCT01880593|Antimanic Agents|antimanic agents|mesh-ancestor
6190622|NCT01880593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6190623|NCT01880723|Albuterol|albuterol|mesh-list
6190624|NCT01880723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6190625|NCT01880723|Autonomic Agents|autonomic agents|mesh-ancestor
6190626|NCT01880723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6190627|NCT01880723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190628|NCT01880723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6190629|NCT01880723|Respiratory System Agents|respiratory system agents|mesh-ancestor
6190630|NCT01880723|Tocolytic Agents|tocolytic agents|mesh-ancestor
6190631|NCT01880723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6190632|NCT01880723|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6190633|NCT01880723|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6190634|NCT01880723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6190635|NCT01880723|Adrenergic Agents|adrenergic agents|mesh-ancestor
6190636|NCT01880723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6190637|NCT01880723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190638|NCT01880736|Insulin|insulin|mesh-list
5582900|NCT03832426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582901|NCT03832426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5582902|NCT03832426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5582903|NCT03832426|Antiviral Agents|antiviral agents|mesh-ancestor
5582904|NCT03832426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5582905|NCT03832426|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5582906|NCT03832426|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5582907|NCT03831984|Bromfenac|bromfenac|mesh-list
5582908|NCT03831984|Hyaluronic Acid|hyaluronic acid|mesh-list
5582909|NCT03831984|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5582910|NCT03831984|Immunologic Factors|immunologic factors|mesh-ancestor
5582911|NCT03831984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582912|NCT03831984|Viscosupplements|viscosupplements|mesh-ancestor
5582913|NCT03831984|Protective Agents|protective agents|mesh-ancestor
5582914|NCT03831984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5582915|NCT03831984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5582916|NCT03831984|Analgesics|analgesics|mesh-ancestor
5582917|NCT03831984|Sensory System Agents|sensory system agents|mesh-ancestor
6190639|NCT01880736|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6190640|NCT01880736|Insulin, Long-Acting|insulin, long-acting|mesh-list
6190641|NCT01880736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6190642|NCT01880736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190643|NCT01880840|Azelastine|azelastine|mesh-list
6190644|NCT01880840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6190645|NCT01880840|Autonomic Agents|autonomic agents|mesh-ancestor
6190646|NCT01880840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6190647|NCT01880840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190648|NCT01880840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6190649|NCT01880840|Respiratory System Agents|respiratory system agents|mesh-ancestor
6190650|NCT01880840|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6190651|NCT01880840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6190652|NCT01880840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190653|NCT01880840|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6190654|NCT01880840|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6190655|NCT01880840|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6190656|NCT01880840|Histamine Antagonists|histamine antagonists|mesh-ancestor
6190657|NCT01880840|Histamine Agents|histamine agents|mesh-ancestor
6190658|NCT01880840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6190659|NCT01881087|Levobupivacaine|levobupivacaine|mesh-list
5582918|NCT03831984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5582919|NCT03831984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5582920|NCT03831984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5582921|NCT03831815|Rocuronium|rocuronium|mesh-list
5582922|NCT03831815|Cisatracurium|cisatracurium|mesh-list
6190660|NCT01881087|Anesthetics, Local|anesthetics, local|mesh-ancestor
6190661|NCT01881087|Anesthetics|anesthetics|mesh-ancestor
6190662|NCT01881087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6190663|NCT01881087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672104|NCT01553786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6672105|NCT01553903|Tamoxifen|tamoxifen|mesh-list
6672106|NCT01553903|Letrozole|letrozole|mesh-list
6672107|NCT01553903|Anastrozole|anastrozole|mesh-list
6672108|NCT01553903|Exemestane|exemestane|mesh-list
6672109|NCT01553903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6672110|NCT01553903|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6672111|NCT01553903|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6672112|NCT01553903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6672113|NCT01553903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672114|NCT01553903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6672115|NCT01553903|Hormone Antagonists|hormone antagonists|mesh-ancestor
6190664|NCT01881087|Sensory System Agents|sensory system agents|mesh-ancestor
6190665|NCT01881087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6190666|NCT01881113|Cetirizine|cetirizine|mesh-list
6190667|NCT01881113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6190668|NCT01881113|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6190669|NCT01881113|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6190670|NCT01881113|Histamine Antagonists|histamine antagonists|mesh-ancestor
6190671|NCT01881113|Histamine Agents|histamine agents|mesh-ancestor
6190672|NCT01881113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6190673|NCT01881113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190674|NCT01881113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190675|NCT01881126|Timolol|timolol|mesh-list
6190676|NCT01881126|Bimatoprost|bimatoprost|mesh-list
6190677|NCT01881126|Travoprost|travoprost|mesh-list
6190678|NCT01881126|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6190679|NCT01881126|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5582923|NCT03831815|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6672116|NCT01553903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6190680|NCT01881126|Adrenergic Agents|adrenergic agents|mesh-ancestor
6190681|NCT01881126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6190682|NCT01881126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190683|NCT01881126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190684|NCT01881126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6190685|NCT01881126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6190686|NCT01881230|Gemcitabine|gemcitabine|mesh-list
5582924|NCT03831815|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5582925|NCT03831815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5582926|NCT03831815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5582927|NCT03831815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582928|NCT03831334|Minoxidil|minoxidil|mesh-list
5582929|NCT03831334|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5582930|NCT03831334|Vasodilator Agents|vasodilator agents|mesh-ancestor
5582931|NCT03831321|Diclofenac|diclofenac|mesh-list
5582932|NCT03831321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5582933|NCT03831321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5582934|NCT03831321|Analgesics|analgesics|mesh-ancestor
5582935|NCT03831321|Sensory System Agents|sensory system agents|mesh-ancestor
5582936|NCT03831321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5582937|NCT03831321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582938|NCT03831321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5582939|NCT03831321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5582940|NCT03831321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5582941|NCT03831321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5582942|NCT03831321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582943|NCT03831464|Metformin|metformin|mesh-list
5582944|NCT03831464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5582945|NCT03831464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582946|NCT03831269|Azithromycin|azithromycin|mesh-list
5582947|NCT03831269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5582948|NCT03831269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5582949|NCT03831113|Buprenorphine|buprenorphine|mesh-list
5582950|NCT03831113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5582951|NCT03831113|Narcotics|narcotics|mesh-ancestor
5582952|NCT03831113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5582953|NCT03831113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190687|NCT01881230|Paclitaxel|paclitaxel|mesh-list
6190688|NCT01881230|Carboplatin|carboplatin|mesh-list
6190689|NCT01881230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6190690|NCT01881230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6190691|NCT01881230|Tubulin Modulators|tubulin modulators|mesh-ancestor
5582954|NCT03831113|Analgesics|analgesics|mesh-ancestor
5582955|NCT03831113|Sensory System Agents|sensory system agents|mesh-ancestor
5582956|NCT03831113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5582957|NCT03831113|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5605011|NCT03842228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5605012|NCT03842228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605013|NCT03842228|Immunologic Factors|immunologic factors|mesh-ancestor
5605014|NCT03842228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605015|NCT03842228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5605016|NCT03842228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605017|NCT03810417|Digoxin|digoxin|mesh-list
5605018|NCT03810417|Antibodies|antibodies|mesh-list
5605019|NCT03810417|Immunoglobulin Fab Fragments|immunoglobulin fab fragments|mesh-list
6190692|NCT01881230|Antimitotic Agents|antimitotic agents|mesh-ancestor
6190693|NCT01881230|Mitosis Modulators|mitosis modulators|mesh-ancestor
6190694|NCT01881230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190695|NCT01881230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6190696|NCT01881230|Antimetabolites|antimetabolites|mesh-ancestor
6190697|NCT01881230|Antiviral Agents|antiviral agents|mesh-ancestor
6190698|NCT01881230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6190699|NCT01881230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6190700|NCT01881230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6190701|NCT01881230|Immunologic Factors|immunologic factors|mesh-ancestor
6190702|NCT01881230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190703|NCT01881412|Fluticasone|fluticasone|mesh-list
6190704|NCT01881412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6190705|NCT01881412|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6190706|NCT01881412|Autonomic Agents|autonomic agents|mesh-ancestor
6190707|NCT01881412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6190708|NCT01881412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190709|NCT01881412|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6190710|NCT01881412|Respiratory System Agents|respiratory system agents|mesh-ancestor
5605020|NCT03810417|Immunologic Factors|immunologic factors|mesh-ancestor
5582958|NCT03831126|Betamethasone|betamethasone|mesh-list
5582959|NCT03831126|Betamethasone Valerate|betamethasone valerate|mesh-list
5582960|NCT03831126|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5582961|NCT03831126|Betamethasone benzoate|betamethasone benzoate|mesh-list
5582962|NCT03831126|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
6190711|NCT01881412|Dermatologic Agents|dermatologic agents|mesh-ancestor
6190712|NCT01881412|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6190713|NCT01881789|Dexamethasone|dexamethasone|mesh-list
6190714|NCT01881789|Cyclophosphamide|cyclophosphamide|mesh-list
6190715|NCT01881789|Lenalidomide|lenalidomide|mesh-list
5582963|NCT03831126|Glucocorticoids|glucocorticoids|mesh-ancestor
5582964|NCT03831126|Hormones|hormones|mesh-ancestor
6190716|NCT01881789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6190717|NCT01881789|Immunologic Factors|immunologic factors|mesh-ancestor
6190718|NCT01881789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190719|NCT01881789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6190720|NCT01881789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6190721|NCT01881789|Alkylating Agents|alkylating agents|mesh-ancestor
6190722|NCT01881789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190723|NCT01881789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6190724|NCT01881789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6190725|NCT01881789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6190726|NCT01881789|Antiemetics|antiemetics|mesh-ancestor
6190727|NCT01881789|Autonomic Agents|autonomic agents|mesh-ancestor
6190728|NCT01881789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6190729|NCT01881789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6190730|NCT01881789|Glucocorticoids|glucocorticoids|mesh-ancestor
6190731|NCT01881789|Hormones|hormones|mesh-ancestor
6190732|NCT01881789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6190733|NCT01881789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6190734|NCT01881789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6190735|NCT01881789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6190736|NCT01881789|Growth Substances|growth substances|mesh-ancestor
6190737|NCT01881789|Growth Inhibitors|growth inhibitors|mesh-ancestor
6190738|NCT01881828|Metformin|metformin|mesh-list
6190739|NCT01881828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6190740|NCT01881828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190741|NCT01882088|Psyllium|psyllium|mesh-list
6190742|NCT01882088|Cathartics|cathartics|mesh-ancestor
6190743|NCT01882088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6190744|NCT01882439|Tofacitinib|tofacitinib|mesh-list
6190745|NCT01882439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6190746|NCT01882439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6190747|NCT01882439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190748|NCT01882829|Quinidine|quinidine|mesh-list
6190749|NCT01882829|Dextromethorphan|dextromethorphan|mesh-list
6190750|NCT01882829|Antitussive Agents|antitussive agents|mesh-ancestor
6190751|NCT01882829|Respiratory System Agents|respiratory system agents|mesh-ancestor
6190752|NCT01882829|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6190753|NCT01882829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6190754|NCT01882829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6190755|NCT01882829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190756|NCT01882829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190757|NCT01882829|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6190758|NCT01882829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6190759|NCT01882829|Adrenergic Agents|adrenergic agents|mesh-ancestor
6190760|NCT01882829|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6190761|NCT01882829|Antimalarials|antimalarials|mesh-ancestor
6190762|NCT01882829|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6190763|NCT01882829|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6190764|NCT01882829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6190765|NCT01882829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6190766|NCT01882829|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6207986|NCT02122770|Mitosis Modulators|mitosis modulators|mesh-ancestor
6190767|NCT01882829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6190768|NCT01882829|Cholinergic Agents|cholinergic agents|mesh-ancestor
6190769|NCT01882829|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6190770|NCT01882829|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6190771|NCT01882829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6190772|NCT01882829|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6190773|NCT01882829|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6190774|NCT01882868|Leucovorin|leucovorin|mesh-list
5582965|NCT03831126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5582966|NCT03831126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582967|NCT03831126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6190775|NCT01882868|Irinotecan|irinotecan|mesh-list
6190776|NCT01882868|Aflibercept|aflibercept|mesh-list
6190777|NCT01882868|Levoleucovorin|levoleucovorin|mesh-list
6190778|NCT01882868|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6190779|NCT01882868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6190780|NCT01882868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6190781|NCT01882868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190782|NCT01882868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6190783|NCT01882868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6190784|NCT01882868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6190785|NCT01882868|Growth Substances|growth substances|mesh-ancestor
6190786|NCT01882868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190787|NCT01882868|Growth Inhibitors|growth inhibitors|mesh-ancestor
6190788|NCT01882868|Antidotes|antidotes|mesh-ancestor
6190789|NCT01882868|Protective Agents|protective agents|mesh-ancestor
6190790|NCT01882868|Vitamin B Complex|vitamin b complex|mesh-ancestor
6190791|NCT01882868|Vitamins|vitamins|mesh-ancestor
6190792|NCT01882868|Micronutrients|micronutrients|mesh-ancestor
6190793|NCT01882907|Pioglitazone|pioglitazone|mesh-list
6190794|NCT01882907|Vildagliptin|vildagliptin|mesh-list
6190795|NCT01882907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6190796|NCT01882907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190797|NCT01882907|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6190798|NCT01882907|Protease Inhibitors|protease inhibitors|mesh-ancestor
6190799|NCT01882907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6190800|NCT01882907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190801|NCT01882985|Lycopene|lycopene|mesh-list
6190802|NCT01882985|Docetaxel|docetaxel|mesh-list
6190803|NCT01882985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6190804|NCT01882985|Tubulin Modulators|tubulin modulators|mesh-ancestor
6190805|NCT01882985|Antimitotic Agents|antimitotic agents|mesh-ancestor
6190806|NCT01882985|Mitosis Modulators|mitosis modulators|mesh-ancestor
6190807|NCT01882985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582968|NCT03831126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5582969|NCT03831126|Respiratory System Agents|respiratory system agents|mesh-ancestor
5582970|NCT03831425|Ubiquinone|ubiquinone|mesh-list
5582971|NCT03831425|Coenzyme Q10|coenzyme q10|mesh-list
5582972|NCT03831425|Micronutrients|micronutrients|mesh-ancestor
5582973|NCT03831425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582974|NCT03831425|Vitamins|vitamins|mesh-ancestor
5582975|NCT03831295|Antibodies|antibodies|mesh-list
6190808|NCT01882985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6190809|NCT01882985|Antioxidants|antioxidants|mesh-ancestor
6190810|NCT01882985|Protective Agents|protective agents|mesh-ancestor
6190811|NCT01882985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190812|NCT01882985|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6190813|NCT01882985|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6190814|NCT01883362|Midostaurin|midostaurin|mesh-list
6190815|NCT01883362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6190816|NCT01883362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6190817|NCT01883362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6190818|NCT01883362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190819|NCT01884337|Apixaban|apixaban|mesh-list
6190820|NCT01884337|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6190821|NCT01884337|Antithrombins|antithrombins|mesh-ancestor
6190822|NCT01884337|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6190823|NCT01884337|Protease Inhibitors|protease inhibitors|mesh-ancestor
6190824|NCT01884337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6207216|NCT02111863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582976|NCT03831295|Immunologic Factors|immunologic factors|mesh-ancestor
5582977|NCT03831295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582978|NCT03830827|Vortioxetine|vortioxetine|mesh-list
5582979|NCT03830827|Antidepressive Agents|antidepressive agents|mesh-ancestor
5582980|NCT03830827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5582981|NCT03830827|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5582982|NCT03830827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5582983|NCT03830827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6190825|NCT01884337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190826|NCT01884337|Anticoagulants|anticoagulants|mesh-ancestor
6190827|NCT01884350|Apixaban|apixaban|mesh-list
6190828|NCT01884350|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6190829|NCT01884350|Antithrombins|antithrombins|mesh-ancestor
6190830|NCT01884350|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6190831|NCT01884350|Protease Inhibitors|protease inhibitors|mesh-ancestor
6190832|NCT01884350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6190833|NCT01884350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190834|NCT01884350|Anticoagulants|anticoagulants|mesh-ancestor
6190835|NCT01884571|Mycophenolic Acid|mycophenolic acid|mesh-list
6190836|NCT01884571|Prednisone|prednisone|mesh-list
6190837|NCT01884571|Methylprednisolone|methylprednisolone|mesh-list
6190838|NCT01884571|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6190839|NCT01884571|Tacrolimus|tacrolimus|mesh-list
6190840|NCT01884571|Basiliximab|basiliximab|mesh-list
6190841|NCT01884571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6190842|NCT01884571|Glucocorticoids|glucocorticoids|mesh-ancestor
6190843|NCT01884571|Hormones|hormones|mesh-ancestor
6190844|NCT01884571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6190845|NCT01884571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190846|NCT01884571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6190847|NCT01884571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6190848|NCT01884571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6190849|NCT01884571|Immunologic Factors|immunologic factors|mesh-ancestor
6190850|NCT01884571|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6190851|NCT01884571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6190852|NCT01884571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190853|NCT01884571|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6190854|NCT01884571|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6190855|NCT01884571|Antitubercular Agents|antitubercular agents|mesh-ancestor
6190856|NCT01884571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6190857|NCT01884571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6190858|NCT01884571|Antiemetics|antiemetics|mesh-ancestor
6190859|NCT01884571|Autonomic Agents|autonomic agents|mesh-ancestor
6190860|NCT01884571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6190861|NCT01884571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6190862|NCT01884571|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5582984|NCT03830827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5582985|NCT03830827|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6190863|NCT01884571|Protective Agents|protective agents|mesh-ancestor
6190864|NCT01884597|Ranibizumab|ranibizumab|mesh-list
6190865|NCT01884597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6190866|NCT01884597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6190867|NCT01884597|Growth Substances|growth substances|mesh-ancestor
6190868|NCT01884597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190869|NCT01884597|Growth Inhibitors|growth inhibitors|mesh-ancestor
6190870|NCT01884597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6190871|NCT01884675|Ambrisentan|ambrisentan|mesh-list
6190872|NCT01884675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6190873|NCT01884844|Vitamin D|vitamin d|mesh-list
6190874|NCT01884844|Cholecalciferol|cholecalciferol|mesh-list
6190875|NCT01884844|Vitamins|vitamins|mesh-ancestor
6190876|NCT01884844|Micronutrients|micronutrients|mesh-ancestor
5582986|NCT03830827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5582987|NCT03830827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5582988|NCT03830827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5582989|NCT03830827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5582990|NCT03830827|Serotonin Agents|serotonin agents|mesh-ancestor
5582991|NCT03830827|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5582992|NCT03830827|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5582993|NCT03830827|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5582994|NCT03830827|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5582995|NCT03830957|Metoprolol|metoprolol|mesh-list
5582996|NCT03830957|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5582997|NCT03830957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5582998|NCT03830957|Sympatholytics|sympatholytics|mesh-ancestor
5582999|NCT03830957|Autonomic Agents|autonomic agents|mesh-ancestor
5583000|NCT03830957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5583001|NCT03830957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583002|NCT03830957|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6190877|NCT01884844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190878|NCT01884844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6207217|NCT02111863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5583003|NCT03830957|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5583004|NCT03830957|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5583005|NCT03830957|Adrenergic Agents|adrenergic agents|mesh-ancestor
5583006|NCT03830957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5583007|NCT03830957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583008|NCT03830489|Ascorbic Acid|ascorbic acid|mesh-list
5583009|NCT03830489|Antioxidants|antioxidants|mesh-ancestor
5583010|NCT03830489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583011|NCT03830489|Protective Agents|protective agents|mesh-ancestor
5583012|NCT03830489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583013|NCT03830489|Vitamins|vitamins|mesh-ancestor
5583014|NCT03830489|Micronutrients|micronutrients|mesh-ancestor
5583015|NCT03830684|Baicalein|baicalein|mesh-list
5583016|NCT03830684|Antioxidants|antioxidants|mesh-ancestor
5583017|NCT03830684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583018|NCT03830684|Protective Agents|protective agents|mesh-ancestor
5583019|NCT03830684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583020|NCT03830684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5583021|NCT03830684|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
5583022|NCT03830684|Hormone Antagonists|hormone antagonists|mesh-ancestor
5583023|NCT03830684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5583024|NCT03830606|Paclitaxel|paclitaxel|mesh-list
5583025|NCT03830606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5583026|NCT03830606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5583027|NCT03830606|Tubulin Modulators|tubulin modulators|mesh-ancestor
5583028|NCT03830606|Antimitotic Agents|antimitotic agents|mesh-ancestor
5583029|NCT03830606|Mitosis Modulators|mitosis modulators|mesh-ancestor
5583030|NCT03830606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583031|NCT03830398|Acetaminophen|acetaminophen|mesh-list
5583032|NCT03830398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5583033|NCT03830398|Analgesics|analgesics|mesh-ancestor
5583034|NCT03830398|Sensory System Agents|sensory system agents|mesh-ancestor
5583035|NCT03830398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5583036|NCT03830398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583037|NCT03830398|Antipyretics|antipyretics|mesh-ancestor
5583038|NCT03830164|Vitamins|vitamins|mesh-list
5583039|NCT03830164|Vitamin E|vitamin e|mesh-list
5583040|NCT03830164|Tocopherols|tocopherols|mesh-list
5583041|NCT03830164|Tocotrienols|tocotrienols|mesh-list
5583042|NCT03830164|alpha-Tocopherol|alpha-tocopherol|mesh-list
5583043|NCT03830164|Pentoxifylline|pentoxifylline|mesh-list
5583044|NCT03830164|Atorvastatin|atorvastatin|mesh-list
5583045|NCT03830164|Micronutrients|micronutrients|mesh-ancestor
5583046|NCT03830164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583047|NCT03830164|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5583048|NCT03830164|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5583049|NCT03830164|Antimetabolites|antimetabolites|mesh-ancestor
5583050|NCT03830164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583051|NCT03830164|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5583052|NCT03830164|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5583053|NCT03830164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5583054|NCT03830164|Antioxidants|antioxidants|mesh-ancestor
5583055|NCT03830164|Protective Agents|protective agents|mesh-ancestor
5583056|NCT03830164|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5583057|NCT03830164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5583058|NCT03830164|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5583059|NCT03830164|Vasodilator Agents|vasodilator agents|mesh-ancestor
5583060|NCT03830164|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5583061|NCT03830359|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5583062|NCT03830359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5583063|NCT03830385|Carboplatin|carboplatin|mesh-list
5583064|NCT03830385|Bleomycin|bleomycin|mesh-list
5583065|NCT03830385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5583066|NCT03830385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5583067|NCT03830086|Midazolam|midazolam|mesh-list
5583068|NCT03830086|Sufentanil|sufentanil|mesh-list
5583069|NCT03830086|Bupivacaine|bupivacaine|mesh-list
5583070|NCT03830086|Propofol|propofol|mesh-list
5583071|NCT03830086|Sevoflurane|sevoflurane|mesh-list
5583072|NCT03830086|Rocuronium|rocuronium|mesh-list
5583073|NCT03830086|Anesthetics, Local|anesthetics, local|mesh-ancestor
5583074|NCT03830086|Anesthetics|anesthetics|mesh-ancestor
5583075|NCT03830086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5583076|NCT03830086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583077|NCT03830086|Sensory System Agents|sensory system agents|mesh-ancestor
5583078|NCT03830086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5583079|NCT03830086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5583080|NCT03830086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6190879|NCT01884844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6190880|NCT01885000|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6190881|NCT01885000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6190882|NCT01885000|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6190883|NCT01885000|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6190884|NCT01885000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6190885|NCT01885000|Adrenergic Agents|adrenergic agents|mesh-ancestor
6190886|NCT01885000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6190887|NCT01885000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190888|NCT01885000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190889|NCT01885104|Bisacodyl|bisacodyl|mesh-list
6190890|NCT01885104|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
6190891|NCT01885104|Laxatives|laxatives|mesh-list
5583081|NCT03830086|Anesthetics, General|anesthetics, general|mesh-ancestor
5583082|NCT03830086|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5583083|NCT03830086|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5583084|NCT03830086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5583085|NCT03830086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5583086|NCT03830086|GABA Modulators|gaba modulators|mesh-ancestor
6190892|NCT01885104|Cathartics|cathartics|mesh-ancestor
6190893|NCT01885104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6190894|NCT01885182|Oxycodone|oxycodone|mesh-list
6190895|NCT01885182|Naloxone|naloxone|mesh-list
6190896|NCT01885182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6190897|NCT01885182|Narcotics|narcotics|mesh-ancestor
6190898|NCT01885182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6190899|NCT01885182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190900|NCT01885182|Analgesics|analgesics|mesh-ancestor
6190901|NCT01885182|Sensory System Agents|sensory system agents|mesh-ancestor
6190902|NCT01885182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6190903|NCT01885182|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6190904|NCT01885208|Exenatide|exenatide|mesh-list
6190905|NCT01885208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6190906|NCT01885208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190907|NCT01885208|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6190908|NCT01885208|Incretins|incretins|mesh-ancestor
6190909|NCT01885208|Hormones|hormones|mesh-ancestor
6190910|NCT01885208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6190911|NCT01885559|Telmisartan|telmisartan|mesh-list
5583087|NCT03830086|GABA Agents|gaba agents|mesh-ancestor
5583088|NCT03830086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5583089|NCT03830086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583090|NCT03830086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5583091|NCT03830086|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5583092|NCT03830086|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5583093|NCT03830086|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5583094|NCT03830086|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5583095|NCT03830086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5583096|NCT03830086|Narcotics|narcotics|mesh-ancestor
5583097|NCT03830086|Analgesics|analgesics|mesh-ancestor
5583098|NCT03830216|Insulin|insulin|mesh-list
5583099|NCT03830216|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5583100|NCT03830216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5583101|NCT03830216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583102|NCT03830034|Iron|iron|mesh-list
5583103|NCT03830034|Ferrous fumarate|ferrous fumarate|mesh-list
5583104|NCT03830034|Iron Chelating Agents|iron chelating agents|mesh-list
5583105|NCT03830034|Trace Elements|trace elements|mesh-ancestor
5583106|NCT03830034|Micronutrients|micronutrients|mesh-ancestor
5583107|NCT03830034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583108|NCT03830034|Chelating Agents|chelating agents|mesh-ancestor
5583109|NCT03830034|Sequestering Agents|sequestering agents|mesh-ancestor
5583110|NCT03830034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190912|NCT01885559|Lisinopril|lisinopril|mesh-list
6190913|NCT01885559|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6190914|NCT01885559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6190915|NCT01885559|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6190916|NCT01885559|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5583111|NCT03829696|Misoprostol|misoprostol|mesh-list
5583112|NCT03829696|Mifepristone|mifepristone|mesh-list
5583113|NCT03829696|Ulipristal acetate|ulipristal acetate|mesh-list
6190917|NCT01885559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583114|NCT03829696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5583115|NCT03829696|Abortifacient Agents|abortifacient agents|mesh-ancestor
5583116|NCT03829696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6190918|NCT01885559|Protease Inhibitors|protease inhibitors|mesh-ancestor
6190919|NCT01885559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6190920|NCT01885559|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6190921|NCT01885559|Protective Agents|protective agents|mesh-ancestor
6190922|NCT01885559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190923|NCT01885910|Doxycycline|doxycycline|mesh-list
6190924|NCT01885910|Dapsone|dapsone|mesh-list
6190925|NCT01885910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6190926|NCT01885910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6190927|NCT01885910|Antimalarials|antimalarials|mesh-ancestor
6190928|NCT01885910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6190929|NCT01885910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6190930|NCT01885910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6190931|NCT01885910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6190932|NCT01885910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190933|NCT01885910|Leprostatic Agents|leprostatic agents|mesh-ancestor
6190934|NCT01885936|Albuterol|albuterol|mesh-list
6190935|NCT01885936|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5583117|NCT03829696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583118|NCT03829696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5583119|NCT03829696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5583120|NCT03829696|Oxytocics|oxytocics|mesh-ancestor
5583121|NCT03829696|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5583122|NCT03829696|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5583123|NCT03829696|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5583124|NCT03829696|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5583125|NCT03829696|Contraceptive Agents|contraceptive agents|mesh-ancestor
5583126|NCT03829696|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5583127|NCT03829696|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5583128|NCT03829696|Hormone Antagonists|hormone antagonists|mesh-ancestor
5583129|NCT03829696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5583130|NCT03829696|Luteolytic Agents|luteolytic agents|mesh-ancestor
5583131|NCT03829696|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5583132|NCT03829696|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5583133|NCT03829839|Lorazepam|lorazepam|mesh-list
5583134|NCT03829839|Oxytocin|oxytocin|mesh-list
5583135|NCT03829839|Oxytocics|oxytocics|mesh-ancestor
5583136|NCT03829839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5583137|NCT03829839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583138|NCT03829839|Anticonvulsants|anticonvulsants|mesh-ancestor
5583139|NCT03829839|Antiemetics|antiemetics|mesh-ancestor
5583140|NCT03829839|Autonomic Agents|autonomic agents|mesh-ancestor
5583141|NCT03829839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5583142|NCT03829839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5583143|NCT03829839|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5583144|NCT03829839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5583145|NCT03829839|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5583146|NCT03829839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5583147|NCT03829839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6190936|NCT01885936|Autonomic Agents|autonomic agents|mesh-ancestor
6190937|NCT01885936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6190938|NCT01885936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190939|NCT01885936|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6190940|NCT01885936|Respiratory System Agents|respiratory system agents|mesh-ancestor
6190941|NCT01885936|Tocolytic Agents|tocolytic agents|mesh-ancestor
6190942|NCT01885936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6190943|NCT01885936|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6190944|NCT01885936|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6190945|NCT01885936|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6190946|NCT01885936|Adrenergic Agents|adrenergic agents|mesh-ancestor
6190947|NCT01885936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6190948|NCT01885936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190949|NCT01886105|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
6190950|NCT01886105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6190951|NCT01886105|Analgesics|analgesics|mesh-ancestor
6190952|NCT01886105|Sensory System Agents|sensory system agents|mesh-ancestor
6190953|NCT01886105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6190954|NCT01886105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207218|NCT02111863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6207219|NCT02111863|Alkylating Agents|alkylating agents|mesh-ancestor
6207220|NCT02111863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207221|NCT02111863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6207222|NCT02111863|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6207223|NCT02111863|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6207224|NCT02111863|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6207225|NCT02111863|Antiviral Agents|antiviral agents|mesh-ancestor
6207226|NCT02111863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6190955|NCT01886287|Octreotide|octreotide|mesh-list
6190956|NCT01886287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6190957|NCT01886287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6190958|NCT01886287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6190959|NCT01886690|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6190960|NCT01886690|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6190961|NCT01886690|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6190962|NCT01886690|Laxatives|laxatives|mesh-ancestor
6190963|NCT01886690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6190964|NCT01886937|Phentermine|phentermine|mesh-list
6190965|NCT01886937|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6190966|NCT01886937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190967|NCT01886937|Appetite Depressants|appetite depressants|mesh-ancestor
6190968|NCT01886937|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6190969|NCT01886937|Sympathomimetics|sympathomimetics|mesh-ancestor
6190970|NCT01886937|Autonomic Agents|autonomic agents|mesh-ancestor
6190971|NCT01886937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6190972|NCT01886937|Adrenergic Agents|adrenergic agents|mesh-ancestor
6190973|NCT01886937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6190974|NCT01886937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190975|NCT01887132|Donepezil|donepezil|mesh-list
6190976|NCT01887132|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6190977|NCT01887132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6190978|NCT01887132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583148|NCT03829839|GABA Modulators|gaba modulators|mesh-ancestor
5583149|NCT03829839|GABA Agents|gaba agents|mesh-ancestor
5583150|NCT03829839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5583151|NCT03829839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583152|NCT03829943|Vitamin D|vitamin d|mesh-list
5583153|NCT03829943|Vitamins|vitamins|mesh-ancestor
5583154|NCT03829943|Micronutrients|micronutrients|mesh-ancestor
5583155|NCT03829943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190979|NCT01887132|Cholinergic Agents|cholinergic agents|mesh-ancestor
6190980|NCT01887132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6190981|NCT01887132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190982|NCT01887132|Nootropic Agents|nootropic agents|mesh-ancestor
6190983|NCT01887171|Tacrolimus|tacrolimus|mesh-list
6190984|NCT01887171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6190985|NCT01887171|Immunologic Factors|immunologic factors|mesh-ancestor
6190986|NCT01887171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6190987|NCT01887171|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6190988|NCT01887171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5583156|NCT03829943|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5583157|NCT03829774|Acetaminophen|acetaminophen|mesh-list
5583158|NCT03829774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5583159|NCT03829774|Analgesics|analgesics|mesh-ancestor
5583160|NCT03829774|Sensory System Agents|sensory system agents|mesh-ancestor
5583161|NCT03829774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5583162|NCT03829774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583163|NCT03829774|Antipyretics|antipyretics|mesh-ancestor
5583164|NCT03830060|Hydrocortisone|hydrocortisone|mesh-list
6190989|NCT01887171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190990|NCT01887327|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
6190991|NCT01887327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6190992|NCT01887327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190993|NCT01887353|Ranolazine|ranolazine|mesh-list
6190994|NCT01887353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6190995|NCT01887353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6190996|NCT01887353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6190997|NCT01887418|Methyltestosterone|methyltestosterone|mesh-list
6190998|NCT01887418|Testosterone|testosterone|mesh-list
6190999|NCT01887418|Testosterone undecanoate|testosterone undecanoate|mesh-list
6191000|NCT01887418|Testosterone enanthate|testosterone enanthate|mesh-list
6191001|NCT01887418|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6191002|NCT01887418|Androgens|androgens|mesh-ancestor
6191003|NCT01887418|Hormones|hormones|mesh-ancestor
5583165|NCT03830060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5583166|NCT03829917|Paromomycin|paromomycin|mesh-list
5583167|NCT03829917|Miltefosine|miltefosine|mesh-list
5583168|NCT03829917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5583169|NCT03829917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5583170|NCT03829917|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5583171|NCT03829917|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5583172|NCT03829917|Antifungal Agents|antifungal agents|mesh-ancestor
6191004|NCT01887418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6191005|NCT01887418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191006|NCT01887418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6191007|NCT01887418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6191008|NCT01887418|Anabolic Agents|anabolic agents|mesh-ancestor
6191009|NCT01887587|Dexamethasone|dexamethasone|mesh-list
6191010|NCT01887587|Doxorubicin|doxorubicin|mesh-list
6191011|NCT01887587|Vincristine|vincristine|mesh-list
6191012|NCT01887587|Ixazomib|ixazomib|mesh-list
6191013|NCT01887587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5583173|NCT03829917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5583174|NCT03829930|Entinostat|entinostat|mesh-list
5583175|NCT03829930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5583176|NCT03829930|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5583177|NCT03829930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5583178|NCT03829930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583179|NCT03829371|Dexamethasone|dexamethasone|mesh-list
5583180|NCT03829371|Prednisone|prednisone|mesh-list
5583181|NCT03829371|Lenalidomide|lenalidomide|mesh-list
5583182|NCT03829371|Melphalan|melphalan|mesh-list
5583183|NCT03829371|Bortezomib|bortezomib|mesh-list
5583184|NCT03829371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5583185|NCT03829371|Antiemetics|antiemetics|mesh-ancestor
5583186|NCT03829371|Autonomic Agents|autonomic agents|mesh-ancestor
6191014|NCT01887587|Antiemetics|antiemetics|mesh-ancestor
6191015|NCT01887587|Autonomic Agents|autonomic agents|mesh-ancestor
6191016|NCT01887587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6191017|NCT01887587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191018|NCT01887587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6191019|NCT01887587|Glucocorticoids|glucocorticoids|mesh-ancestor
6191020|NCT01887587|Hormones|hormones|mesh-ancestor
5583187|NCT03829371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5583188|NCT03829371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583189|NCT03829371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5583190|NCT03829371|Glucocorticoids|glucocorticoids|mesh-ancestor
5583191|NCT03829371|Hormones|hormones|mesh-ancestor
5583192|NCT03829371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5583193|NCT03829371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5583194|NCT03829371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5583195|NCT03829371|Immunologic Factors|immunologic factors|mesh-ancestor
5583196|NCT03829371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6191021|NCT01887587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6191022|NCT01887587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6191023|NCT01887587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6191024|NCT01887587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6191025|NCT01887587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6191026|NCT01887587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6191027|NCT01887587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6191028|NCT01887587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191029|NCT01887587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6191030|NCT01887587|Tubulin Modulators|tubulin modulators|mesh-ancestor
6191031|NCT01887587|Antimitotic Agents|antimitotic agents|mesh-ancestor
6191032|NCT01887587|Mitosis Modulators|mitosis modulators|mesh-ancestor
6191033|NCT01887587|Protease Inhibitors|protease inhibitors|mesh-ancestor
6191034|NCT01887717|Sorafenib|sorafenib|mesh-list
6191035|NCT01887717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6191036|NCT01887717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6191037|NCT01887717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6191038|NCT01887717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191039|NCT01887990|Ketamine|ketamine|mesh-list
6191040|NCT01887990|Analgesics|analgesics|mesh-ancestor
6191041|NCT01887990|Sensory System Agents|sensory system agents|mesh-ancestor
6191042|NCT01887990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6191043|NCT01887990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191044|NCT01887990|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6191045|NCT01887990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6191046|NCT01887990|Anesthetics, General|anesthetics, general|mesh-ancestor
6191047|NCT01887990|Anesthetics|anesthetics|mesh-ancestor
6191048|NCT01887990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6207227|NCT02112045|Melphalan|melphalan|mesh-list
5583197|NCT03829371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6191049|NCT01887990|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6191050|NCT01887990|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6191051|NCT01887990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6191052|NCT01887990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191053|NCT01888003|Epoetin Alfa|epoetin alfa|mesh-list
6191054|NCT01888003|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6191055|NCT01888003|Hematinics|hematinics|mesh-ancestor
6191056|NCT01888367|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6191057|NCT01888367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6191058|NCT01888432|Everolimus|everolimus|mesh-list
6191059|NCT01888432|Tacrolimus|tacrolimus|mesh-list
6191060|NCT01888432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6191061|NCT01888432|Immunologic Factors|immunologic factors|mesh-ancestor
6191062|NCT01888432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191063|NCT01888432|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6191064|NCT01888432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6191065|NCT01888432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191066|NCT01888432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5583198|NCT03829371|Growth Substances|growth substances|mesh-ancestor
5583199|NCT03829371|Growth Inhibitors|growth inhibitors|mesh-ancestor
5583200|NCT03829371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5583201|NCT03829371|Alkylating Agents|alkylating agents|mesh-ancestor
5583202|NCT03829371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583203|NCT03829371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5583204|NCT03829371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5583205|NCT03829566|Methylprednisolone|methylprednisolone|mesh-list
5583206|NCT03829566|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5583207|NCT03829566|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5583208|NCT03829566|Prednisolone|prednisolone|mesh-list
5583209|NCT03829566|Prednisolone acetate|prednisolone acetate|mesh-list
5583210|NCT03829566|Cyclophosphamide|cyclophosphamide|mesh-list
5583211|NCT03829566|Rituximab|rituximab|mesh-list
5583212|NCT03829566|Thymoglobulin|thymoglobulin|mesh-list
5583213|NCT03829566|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5583214|NCT03829566|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5583215|NCT03829566|Prednisolone phosphate|prednisolone phosphate|mesh-list
5583216|NCT03829566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5583217|NCT03829566|Immunologic Factors|immunologic factors|mesh-ancestor
5583218|NCT03829566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191067|NCT01888497|Diphenhydramine|diphenhydramine|mesh-list
6191068|NCT01888497|Promethazine|promethazine|mesh-list
6191069|NCT01888497|Triazolam|triazolam|mesh-list
6191070|NCT01888497|Gabapentin|gabapentin|mesh-list
6191071|NCT01888497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191072|NCT01888497|Analgesics|analgesics|mesh-ancestor
6191073|NCT01888497|Sensory System Agents|sensory system agents|mesh-ancestor
6191074|NCT01888497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6191075|NCT01888497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191076|NCT01888497|Anticonvulsants|anticonvulsants|mesh-ancestor
6191077|NCT01888497|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6191078|NCT01888497|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6191079|NCT01888497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6191080|NCT01888497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6191081|NCT01888497|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6191082|NCT01888497|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6191083|NCT01888497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6191084|NCT01888497|Antimanic Agents|antimanic agents|mesh-ancestor
6191085|NCT01888497|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6191086|NCT01888497|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6191087|NCT01888497|Anesthetics, Local|anesthetics, local|mesh-ancestor
6191088|NCT01888497|Anesthetics|anesthetics|mesh-ancestor
6191089|NCT01888497|Antiemetics|antiemetics|mesh-ancestor
6191090|NCT01888497|Autonomic Agents|autonomic agents|mesh-ancestor
6191091|NCT01888497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6191092|NCT01888497|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6191093|NCT01888497|Histamine Antagonists|histamine antagonists|mesh-ancestor
6191094|NCT01888497|Histamine Agents|histamine agents|mesh-ancestor
6191095|NCT01888497|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6191096|NCT01888497|Antipruritics|antipruritics|mesh-ancestor
6191097|NCT01888497|Dermatologic Agents|dermatologic agents|mesh-ancestor
6191098|NCT01888497|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6191099|NCT01888497|GABA Modulators|gaba modulators|mesh-ancestor
5583219|NCT03829566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5583220|NCT03829566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6191100|NCT01888497|GABA Agents|gaba agents|mesh-ancestor
6191101|NCT01888952|Prednisone|prednisone|mesh-list
6191102|NCT01888952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6191103|NCT01888952|Glucocorticoids|glucocorticoids|mesh-ancestor
5583221|NCT03829566|Alkylating Agents|alkylating agents|mesh-ancestor
5583222|NCT03829566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583223|NCT03829566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5583224|NCT03829566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5583225|NCT03829566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5583226|NCT03829566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5583227|NCT03829566|Antiemetics|antiemetics|mesh-ancestor
6191104|NCT01888952|Hormones|hormones|mesh-ancestor
6191105|NCT01888952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6191106|NCT01888952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191107|NCT01888952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6191108|NCT01888952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6191109|NCT01889069|Prednisone|prednisone|mesh-list
6191110|NCT01889069|Cyclophosphamide|cyclophosphamide|mesh-list
6191111|NCT01889069|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6191112|NCT01889069|Rituximab|rituximab|mesh-list
6191113|NCT01889069|Doxorubicin|doxorubicin|mesh-list
6191114|NCT01889069|Vincristine|vincristine|mesh-list
6191115|NCT01889069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6191116|NCT01889069|Immunologic Factors|immunologic factors|mesh-ancestor
6191117|NCT01889069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191118|NCT01889069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6191119|NCT01889069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6191120|NCT01889069|Alkylating Agents|alkylating agents|mesh-ancestor
6191121|NCT01889069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191122|NCT01889069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6191123|NCT01889069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6191124|NCT01889069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6191125|NCT01889069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6191126|NCT01889069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6191127|NCT01889069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6191128|NCT01889069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6191129|NCT01889069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6191130|NCT01889069|Glucocorticoids|glucocorticoids|mesh-ancestor
6191131|NCT01889069|Hormones|hormones|mesh-ancestor
6191132|NCT01889069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6191133|NCT01889069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6191134|NCT01889069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6191135|NCT01889069|Tubulin Modulators|tubulin modulators|mesh-ancestor
6191136|NCT01889069|Antimitotic Agents|antimitotic agents|mesh-ancestor
6191137|NCT01889069|Mitosis Modulators|mitosis modulators|mesh-ancestor
6191138|NCT01889602|Topiramate|topiramate|mesh-list
6191139|NCT01889602|Lorazepam|lorazepam|mesh-list
6191140|NCT01889602|Anticonvulsants|anticonvulsants|mesh-ancestor
6191141|NCT01889602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6191142|NCT01889602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191143|NCT01889602|Antiemetics|antiemetics|mesh-ancestor
6191144|NCT01889602|Autonomic Agents|autonomic agents|mesh-ancestor
6191145|NCT01889602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6191146|NCT01889602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6191147|NCT01889602|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6191148|NCT01889602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6191149|NCT01889602|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6191150|NCT01889602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6191151|NCT01889602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6191152|NCT01889602|GABA Modulators|gaba modulators|mesh-ancestor
6191153|NCT01889602|GABA Agents|gaba agents|mesh-ancestor
6191154|NCT01889602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6191155|NCT01889602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191156|NCT01889667|Insulin|insulin|mesh-list
6191157|NCT01889667|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6191158|NCT01889667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6191159|NCT01889667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191160|NCT01889797|Rituximab|rituximab|mesh-list
6191161|NCT01889797|Obinutuzumab|obinutuzumab|mesh-list
6191162|NCT01889797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6191163|NCT01889797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6191164|NCT01889797|Immunologic Factors|immunologic factors|mesh-ancestor
6191165|NCT01889797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191166|NCT01889797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6191167|NCT01889862|Dextrans|dextrans|mesh-list
6191168|NCT01889862|Anticoagulants|anticoagulants|mesh-ancestor
5583228|NCT03829566|Autonomic Agents|autonomic agents|mesh-ancestor
6191169|NCT01889862|Plasma Substitutes|plasma substitutes|mesh-ancestor
6191170|NCT01889862|Blood Substitutes|blood substitutes|mesh-ancestor
6191171|NCT01890109|Erenumab|erenumab|mesh-list
6207228|NCT02112045|Immunologic Factors|immunologic factors|mesh-ancestor
6191172|NCT01890109|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
6191173|NCT01890109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191174|NCT01890109|Analgesics|analgesics|mesh-ancestor
6191175|NCT01890109|Sensory System Agents|sensory system agents|mesh-ancestor
6191176|NCT01890109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6191177|NCT01890109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191178|NCT01890122|Metformin|metformin|mesh-list
6191179|NCT01890122|Alogliptin|alogliptin|mesh-list
6191180|NCT01890122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6191181|NCT01890122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583229|NCT03829566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5583230|NCT03829566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5583231|NCT03829566|Glucocorticoids|glucocorticoids|mesh-ancestor
5583232|NCT03829566|Hormones|hormones|mesh-ancestor
5583233|NCT03829566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5583234|NCT03829566|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5583235|NCT03829566|Protective Agents|protective agents|mesh-ancestor
5583236|NCT03829566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6191182|NCT01890122|Incretins|incretins|mesh-ancestor
6191183|NCT01890122|Hormones|hormones|mesh-ancestor
6191184|NCT01890122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6191185|NCT01890122|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6191186|NCT01890122|Protease Inhibitors|protease inhibitors|mesh-ancestor
6191187|NCT01890122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6191188|NCT01890122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191189|NCT01890265|Pirfenidone|pirfenidone|mesh-list
5583237|NCT03829592|Misoprostol|misoprostol|mesh-list
5583238|NCT03829592|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5583239|NCT03829592|Abortifacient Agents|abortifacient agents|mesh-ancestor
5583240|NCT03829592|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5583241|NCT03829592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583242|NCT03829592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5583243|NCT03829592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5583244|NCT03829592|Oxytocics|oxytocics|mesh-ancestor
5605021|NCT03810417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191190|NCT01890265|Nintedanib|nintedanib|mesh-list
6191191|NCT01890265|Immunoglobulins|immunoglobulins|mesh-list
6191192|NCT01890265|Antibodies|antibodies|mesh-list
6191193|NCT01890265|Immunoglobulin G|immunoglobulin g|mesh-list
6191194|NCT01890265|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6191195|NCT01890265|Immunologic Factors|immunologic factors|mesh-ancestor
6191196|NCT01890265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191197|NCT01890265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6191198|NCT01890265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6191199|NCT01890265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6191200|NCT01890265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191201|NCT01890265|Analgesics|analgesics|mesh-ancestor
5605022|NCT03810417|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5605023|NCT03810417|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5605024|NCT03810417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5605025|NCT03810417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605026|NCT03810417|Protective Agents|protective agents|mesh-ancestor
5605027|NCT03781362|Capecitabine|capecitabine|mesh-list
5605028|NCT03781362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5605029|NCT03781362|Antimetabolites|antimetabolites|mesh-ancestor
5605030|NCT03781362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605031|NCT03781362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605032|NCT03746041|Abaloparatide|abaloparatide|mesh-list
5605033|NCT03746041|Bevacizumab|bevacizumab|mesh-list
6191202|NCT01890265|Sensory System Agents|sensory system agents|mesh-ancestor
6191203|NCT01890265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6191204|NCT01890265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6191205|NCT01890265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6191206|NCT01890265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6191207|NCT01890265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6191208|NCT01890343|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6191209|NCT01890343|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6191210|NCT01890343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191211|NCT01890473|Abatacept|abatacept|mesh-list
6191212|NCT01890473|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6191213|NCT01890473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191214|NCT01890473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605034|NCT03746041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5583245|NCT03829345|Olaparib|olaparib|mesh-list
5583246|NCT03829345|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5583247|NCT03829345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5583248|NCT03829345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583249|NCT03829345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6191215|NCT01890473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6191216|NCT01890473|Immunologic Factors|immunologic factors|mesh-ancestor
6191217|NCT01890473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191218|NCT01890473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6191219|NCT01890642|Lidocaine|lidocaine|mesh-list
6191220|NCT01890642|Anesthetics, Local|anesthetics, local|mesh-ancestor
6191221|NCT01890642|Anesthetics|anesthetics|mesh-ancestor
6191222|NCT01890642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6191223|NCT01890642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191224|NCT01890642|Sensory System Agents|sensory system agents|mesh-ancestor
6191225|NCT01890642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6191226|NCT01890642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6191227|NCT01890642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6191228|NCT01890642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6191229|NCT01890642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6191230|NCT01890642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191231|NCT01890707|Anesthetics|anesthetics|mesh-list
6191232|NCT01890707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6191233|NCT01890707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191234|NCT01890746|Cytarabine|cytarabine|mesh-list
6191235|NCT01890746|Daunorubicin|daunorubicin|mesh-list
6191236|NCT01890746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6191237|NCT01890746|Antimetabolites|antimetabolites|mesh-ancestor
6191238|NCT01890746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191239|NCT01890746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6191240|NCT01890746|Antiviral Agents|antiviral agents|mesh-ancestor
6191241|NCT01890746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6191242|NCT01890746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6191243|NCT01890746|Immunologic Factors|immunologic factors|mesh-ancestor
6191244|NCT01890746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191245|NCT01890746|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6191246|NCT01890746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6191247|NCT01890746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6191248|NCT01890746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6191249|NCT01890785|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6191250|NCT01890785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6191251|NCT01890785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583250|NCT03829488|Plasma-lyte 148|plasma-lyte 148|mesh-list
5583251|NCT03829488|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5583252|NCT03829488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5583253|NCT03829605|Hydrogen Sulfide|hydrogen sulfide|mesh-list
5583254|NCT03829605|Gasotransmitters|gasotransmitters|mesh-ancestor
5583255|NCT03829605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5583256|NCT03829605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191252|NCT01890785|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6191253|NCT01890785|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6191254|NCT01890785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6191255|NCT01890785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191256|NCT01890785|Dopamine Agents|dopamine agents|mesh-ancestor
6191257|NCT01890785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6191258|NCT01890967|Atorvastatin|atorvastatin|mesh-list
6191259|NCT01890967|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6191260|NCT01890967|Simvastatin|simvastatin|mesh-list
6191261|NCT01890967|Ezetimibe|ezetimibe|mesh-list
6191262|NCT01890967|Pravastatin|pravastatin|mesh-list
6191263|NCT01890967|Pitavastatin|pitavastatin|mesh-list
6191264|NCT01890967|Lovastatin|lovastatin|mesh-list
6191265|NCT01890967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6191266|NCT01890967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6191267|NCT01890967|Antimetabolites|antimetabolites|mesh-ancestor
6191268|NCT01890967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191269|NCT01890967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6191270|NCT01890967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6191271|NCT01890967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6191272|NCT01891331|Fluconazole|fluconazole|mesh-list
6191273|NCT01891331|Antifungal Agents|antifungal agents|mesh-ancestor
6191274|NCT01891331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6191275|NCT01891331|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6191276|NCT01891331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6191277|NCT01891331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5583257|NCT03829605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583258|NCT03829319|Carboplatin|carboplatin|mesh-list
5583259|NCT03829319|Pembrolizumab|pembrolizumab|mesh-list
5583260|NCT03829319|Pemetrexed|pemetrexed|mesh-list
5583261|NCT03829319|Lenvatinib|lenvatinib|mesh-list
5583262|NCT03829319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5583263|NCT03829319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5583264|NCT03829319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5583265|NCT03829319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583266|NCT03829319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5583267|NCT03829319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5583268|NCT03829319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5583269|NCT03829436|Nivolumab|nivolumab|mesh-list
6191278|NCT01891331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672117|NCT01553903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672118|NCT01553903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6672119|NCT01553903|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6672120|NCT01553903|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6672121|NCT01553903|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6672122|NCT01553942|Pemetrexed|pemetrexed|mesh-list
6672123|NCT01553942|Afatinib|afatinib|mesh-list
6672124|NCT01553942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6672125|NCT01553942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6672126|NCT01553942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672127|NCT01553942|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6672128|NCT01553942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6672129|NCT01553942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6672130|NCT01553981|Tadalafil|tadalafil|mesh-list
5583270|NCT03829436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6191279|NCT01891331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6191280|NCT01891331|Hormone Antagonists|hormone antagonists|mesh-ancestor
6191281|NCT01891331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6191282|NCT01891331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191283|NCT01891331|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6191284|NCT01891331|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6191285|NCT01891357|Paclitaxel|paclitaxel|mesh-list
6191286|NCT01891357|Trastuzumab|trastuzumab|mesh-list
6191287|NCT01891357|Lapatinib|lapatinib|mesh-list
6191288|NCT01891357|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6191289|NCT01891357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6191290|NCT01891357|Tubulin Modulators|tubulin modulators|mesh-ancestor
6191291|NCT01891357|Antimitotic Agents|antimitotic agents|mesh-ancestor
6191292|NCT01891357|Mitosis Modulators|mitosis modulators|mesh-ancestor
6191293|NCT01891357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191294|NCT01891357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6191295|NCT01891357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6191296|NCT01891357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6191297|NCT01891669|PF-06263507|pf-06263507|mesh-list
6191298|NCT01891669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6191299|NCT01891669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6191300|NCT01891669|Antimitotic Agents|antimitotic agents|mesh-ancestor
6191301|NCT01891669|Mitosis Modulators|mitosis modulators|mesh-ancestor
6191302|NCT01891669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191303|NCT01891864|Etanercept|etanercept|mesh-list
6191304|NCT01891864|GP2015|gp2015|mesh-list
6191305|NCT01891864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6191306|NCT01891864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6191307|NCT01891864|Analgesics|analgesics|mesh-ancestor
6672131|NCT01553981|Vasodilator Agents|vasodilator agents|mesh-ancestor
5583271|NCT03829436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6191308|NCT01891864|Sensory System Agents|sensory system agents|mesh-ancestor
6191309|NCT01891864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5583272|NCT03829436|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5583273|NCT03829436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583274|NCT03829124|Ketamine|ketamine|mesh-list
5583275|NCT03829124|Propofol|propofol|mesh-list
5583276|NCT03829124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5583277|NCT03829124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5583278|NCT03829124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583279|NCT03829124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5583280|NCT03829124|Anesthetics, General|anesthetics, general|mesh-ancestor
5583281|NCT03829124|Anesthetics|anesthetics|mesh-ancestor
5583282|NCT03829124|Analgesics|analgesics|mesh-ancestor
5583283|NCT03829124|Sensory System Agents|sensory system agents|mesh-ancestor
5583284|NCT03829124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5583285|NCT03829124|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5583286|NCT03829124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5583287|NCT03829124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5583288|NCT03829124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5583289|NCT03829124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583290|NCT03829150|Amoxicillin|amoxicillin|mesh-list
5583291|NCT03829150|Metronidazole|metronidazole|mesh-list
5583292|NCT03829150|Clarithromycin|clarithromycin|mesh-list
5583293|NCT03829150|Dexlansoprazole|dexlansoprazole|mesh-list
5583294|NCT03829150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5583295|NCT03829150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5583296|NCT03829150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5583297|NCT03829150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5583298|NCT03829150|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5583299|NCT03829150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5583300|NCT03829150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583301|NCT03829150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6191310|NCT01891864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191311|NCT01891864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6191312|NCT01891864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6191313|NCT01891864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6191314|NCT01891864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6191315|NCT01891864|Immunologic Factors|immunologic factors|mesh-ancestor
6191316|NCT01891864|Dermatologic Agents|dermatologic agents|mesh-ancestor
6191317|NCT01891890|Lamotrigine|lamotrigine|mesh-list
6191318|NCT01891890|Oxcarbazepine|oxcarbazepine|mesh-list
6191319|NCT01891890|Levetiracetam|levetiracetam|mesh-list
6191320|NCT01891890|Anticonvulsants|anticonvulsants|mesh-ancestor
6191321|NCT01891890|Nootropic Agents|nootropic agents|mesh-ancestor
6191322|NCT01891890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6191323|NCT01891890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6191324|NCT01891890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191325|NCT01891890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6191326|NCT01891890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583302|NCT03829150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5583303|NCT03829150|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5583304|NCT03829150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5583305|NCT03829150|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5583306|NCT03829020|Metformin|metformin|mesh-list
6191327|NCT01891890|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6191328|NCT01891890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6191329|NCT01891890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6191330|NCT01891890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6191331|NCT01891890|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6191332|NCT01891890|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6191333|NCT01891890|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6191334|NCT01891890|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6191335|NCT01891968|Bortezomib|bortezomib|mesh-list
6191336|NCT01891968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6191337|NCT01892020|Insulin|insulin|mesh-list
6191338|NCT01892020|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6191339|NCT01892020|Insulin Aspart|insulin aspart|mesh-list
6191340|NCT01892020|Biphasic Insulins|biphasic insulins|mesh-list
6191341|NCT01892020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6191342|NCT01892020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191343|NCT01892163|Dexamethasone|dexamethasone|mesh-list
6191344|NCT01892163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6191345|NCT01892163|Antiemetics|antiemetics|mesh-ancestor
6191346|NCT01892163|Autonomic Agents|autonomic agents|mesh-ancestor
6191347|NCT01892163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6191348|NCT01892163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191349|NCT01892163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6191350|NCT01892163|Glucocorticoids|glucocorticoids|mesh-ancestor
6191351|NCT01892163|Hormones|hormones|mesh-ancestor
6191352|NCT01892163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5583307|NCT03829020|Nelfinavir|nelfinavir|mesh-list
5583308|NCT03829020|Bortezomib|bortezomib|mesh-list
5583309|NCT03829020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5583310|NCT03829020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583311|NCT03829020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5583312|NCT03829020|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5583313|NCT03829020|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5583314|NCT03829020|Protease Inhibitors|protease inhibitors|mesh-ancestor
5583315|NCT03829020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5583316|NCT03829020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583317|NCT03829020|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5583318|NCT03829020|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5583319|NCT03829020|Antiviral Agents|antiviral agents|mesh-ancestor
5583320|NCT03829020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5583321|NCT03829111|Nivolumab|nivolumab|mesh-list
5583322|NCT03829111|Ipilimumab|ipilimumab|mesh-list
5583323|NCT03829111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5583324|NCT03829111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5583325|NCT03829111|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5583326|NCT03829111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583327|NCT03828929|Ascorbic Acid|ascorbic acid|mesh-list
5583328|NCT03828929|Thiamine|thiamine|mesh-list
5583329|NCT03828929|Vitamins|vitamins|mesh-ancestor
5583330|NCT03828929|Micronutrients|micronutrients|mesh-ancestor
5583331|NCT03828929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583332|NCT03828929|Antioxidants|antioxidants|mesh-ancestor
5583333|NCT03828929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583334|NCT03828929|Protective Agents|protective agents|mesh-ancestor
5583335|NCT03828929|Vitamin B Complex|vitamin b complex|mesh-ancestor
5583336|NCT03829046|Evolocumab|evolocumab|mesh-list
5583337|NCT03829046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5583338|NCT03829046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5583339|NCT03829046|Antimetabolites|antimetabolites|mesh-ancestor
5583340|NCT03829046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583341|NCT03829046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5583342|NCT03828838|177Lu-PSMA-617|177lu-psma-617|mesh-list
5583343|NCT03828838|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5583344|NCT03828838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583345|NCT03828643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5583346|NCT03828643|Immunologic Factors|immunologic factors|mesh-ancestor
6191353|NCT01892163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6191354|NCT01892163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6191355|NCT01892189|Ketamine|ketamine|mesh-list
6191356|NCT01892189|Analgesics|analgesics|mesh-ancestor
6191357|NCT01892189|Sensory System Agents|sensory system agents|mesh-ancestor
5583347|NCT03828643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583348|NCT03828682|Mycophenolic Acid|mycophenolic acid|mesh-list
5583349|NCT03828682|Prednisone|prednisone|mesh-list
5583350|NCT03828682|Methylprednisolone|methylprednisolone|mesh-list
5583351|NCT03828682|Tacrolimus|tacrolimus|mesh-list
5583352|NCT03828682|Thymoglobulin|thymoglobulin|mesh-list
5583353|NCT03828682|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5583354|NCT03828682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5583355|NCT03828682|Glucocorticoids|glucocorticoids|mesh-ancestor
5583356|NCT03828682|Hormones|hormones|mesh-ancestor
6191358|NCT01892189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6191359|NCT01892189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191360|NCT01892189|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6191361|NCT01892189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6191362|NCT01892189|Anesthetics, General|anesthetics, general|mesh-ancestor
6191363|NCT01892189|Anesthetics|anesthetics|mesh-ancestor
6191364|NCT01892189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6191365|NCT01892189|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6191366|NCT01892189|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6191367|NCT01892189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6191368|NCT01892189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191369|NCT01892345|Eculizumab|eculizumab|mesh-list
6191370|NCT01892345|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6191371|NCT01892345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5583357|NCT03828682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5583358|NCT03828682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583359|NCT03828682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5583360|NCT03828682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5583361|NCT03828682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5583362|NCT03828682|Immunologic Factors|immunologic factors|mesh-ancestor
5583363|NCT03828682|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5583364|NCT03828682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5583365|NCT03828682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583366|NCT03828682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5583367|NCT03828682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5583368|NCT03828682|Antitubercular Agents|antitubercular agents|mesh-ancestor
5583369|NCT03828682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5583370|NCT03828682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5583371|NCT03828682|Antiemetics|antiemetics|mesh-ancestor
5583372|NCT03828682|Autonomic Agents|autonomic agents|mesh-ancestor
5583373|NCT03828682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5583374|NCT03828682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5583375|NCT03828682|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5583376|NCT03828682|Protective Agents|protective agents|mesh-ancestor
5583377|NCT03828773|Fluconazole|fluconazole|mesh-list
5583378|NCT03828773|Posaconazole|posaconazole|mesh-list
5583379|NCT03828773|Antifungal Agents|antifungal agents|mesh-ancestor
5583380|NCT03828773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5583381|NCT03828773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5583382|NCT03828773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5583383|NCT03828773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5583384|NCT03828773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583385|NCT03828773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5583386|NCT03828773|Hormone Antagonists|hormone antagonists|mesh-ancestor
5583387|NCT03828773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5583388|NCT03828773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583389|NCT03828773|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5583390|NCT03828773|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5583391|NCT03828773|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5583392|NCT03828773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5583393|NCT03828773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5583394|NCT03828474|Acetazolamide|acetazolamide|mesh-list
5583395|NCT03828474|Anticonvulsants|anticonvulsants|mesh-ancestor
5583396|NCT03828474|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5583397|NCT03828474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5583398|NCT03828474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583399|NCT03828474|Diuretics|diuretics|mesh-ancestor
6191372|NCT01892345|Immunologic Factors|immunologic factors|mesh-ancestor
6191373|NCT01892345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191374|NCT01892709|Hydromorphone|hydromorphone|mesh-list
5583400|NCT03828474|Natriuretic Agents|natriuretic agents|mesh-ancestor
5583401|NCT03828474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583402|NCT03828175|Anesthetics|anesthetics|mesh-list
5583403|NCT03828175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5583404|NCT03828175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583405|NCT03828227|Bevacizumab|bevacizumab|mesh-list
5583406|NCT03828227|Capecitabine|capecitabine|mesh-list
5583407|NCT03828227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5583408|NCT03828227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5583409|NCT03828227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5583410|NCT03828227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5583411|NCT03828227|Growth Substances|growth substances|mesh-ancestor
5583412|NCT03828227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583413|NCT03828227|Growth Inhibitors|growth inhibitors|mesh-ancestor
6191375|NCT01892709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6191376|NCT01892709|Narcotics|narcotics|mesh-ancestor
6191377|NCT01892709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6191378|NCT01892709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191379|NCT01892709|Analgesics|analgesics|mesh-ancestor
6191380|NCT01892709|Sensory System Agents|sensory system agents|mesh-ancestor
6191381|NCT01892709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6191382|NCT01893203|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6191383|NCT01893203|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5583414|NCT03828227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5583415|NCT03828227|Antimetabolites|antimetabolites|mesh-ancestor
5583416|NCT03828227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583417|NCT03828006|Red yeast rice|red yeast rice|mesh-list
5583418|NCT03828006|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6191384|NCT01893203|Dermatologic Agents|dermatologic agents|mesh-ancestor
5583419|NCT03828006|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5583420|NCT03828006|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5583421|NCT03828006|Antimetabolites|antimetabolites|mesh-ancestor
5583422|NCT03828006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583423|NCT03828006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5583424|NCT03828006|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6191385|NCT01893281|Methyltestosterone|methyltestosterone|mesh-list
6191386|NCT01893281|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6191387|NCT01893281|Testosterone|testosterone|mesh-list
6191388|NCT01893281|Testosterone undecanoate|testosterone undecanoate|mesh-list
6191389|NCT01893281|Testosterone enanthate|testosterone enanthate|mesh-list
6191390|NCT01893281|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5583425|NCT03828032|Mannitol|mannitol|mesh-list
5583426|NCT03828032|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5583427|NCT03828032|Diuretics|diuretics|mesh-ancestor
5583428|NCT03828032|Natriuretic Agents|natriuretic agents|mesh-ancestor
5583429|NCT03828032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583430|NCT03828019|Cyclosporine|cyclosporine|mesh-list
5583431|NCT03828019|Adalimumab|adalimumab|mesh-list
5583432|NCT03828019|Methotrexate|methotrexate|mesh-list
5583433|NCT03828019|Azathioprine|azathioprine|mesh-list
5583434|NCT03828019|Tacrolimus|tacrolimus|mesh-list
5583435|NCT03828019|Cyclosporins|cyclosporins|mesh-list
5583436|NCT03828019|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5583437|NCT03828019|Abortifacient Agents|abortifacient agents|mesh-ancestor
6191391|NCT01893281|Androgens|androgens|mesh-ancestor
6191392|NCT01893281|Hormones|hormones|mesh-ancestor
6191393|NCT01893281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6191394|NCT01893281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191395|NCT01893281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6191396|NCT01893281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6191397|NCT01893281|Anabolic Agents|anabolic agents|mesh-ancestor
6191398|NCT01893411|Botulinum Toxins|botulinum toxins|mesh-list
6191399|NCT01893411|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6191400|NCT01893411|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6191401|NCT01893411|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
6191402|NCT01893411|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6191403|NCT01893411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6191404|NCT01893411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191405|NCT01893411|Cholinergic Agents|cholinergic agents|mesh-ancestor
6191406|NCT01893411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6191407|NCT01893411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191408|NCT01893411|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6191409|NCT01893411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6191410|NCT01893567|Clobetasol|clobetasol|mesh-list
6191411|NCT01893567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6191412|NCT01893567|Glucocorticoids|glucocorticoids|mesh-ancestor
6191413|NCT01893567|Hormones|hormones|mesh-ancestor
6191414|NCT01893567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6191415|NCT01893567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191416|NCT01893632|Gabapentin|gabapentin|mesh-list
6191417|NCT01893632|Analgesics|analgesics|mesh-ancestor
6191418|NCT01893632|Sensory System Agents|sensory system agents|mesh-ancestor
6191419|NCT01893632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6191420|NCT01893632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191421|NCT01893632|Anticonvulsants|anticonvulsants|mesh-ancestor
6191422|NCT01893632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6191423|NCT01893632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6191424|NCT01893632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6191425|NCT01893632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6191426|NCT01893632|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5583438|NCT03828019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5583439|NCT03828019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191427|NCT01893632|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6191428|NCT01893632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6191429|NCT01893632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191430|NCT01893632|Antimanic Agents|antimanic agents|mesh-ancestor
6191431|NCT01893801|Gemcitabine|gemcitabine|mesh-list
6191432|NCT01893801|Paclitaxel|paclitaxel|mesh-list
6191433|NCT01893801|Cisplatin|cisplatin|mesh-list
5583440|NCT03828019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5583441|NCT03828019|Antimetabolites|antimetabolites|mesh-ancestor
5583442|NCT03828019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583443|NCT03828019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5583444|NCT03828019|Dermatologic Agents|dermatologic agents|mesh-ancestor
5583445|NCT03828019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5583446|NCT03828019|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5583447|NCT03828019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5583448|NCT03828019|Immunologic Factors|immunologic factors|mesh-ancestor
5583449|NCT03828019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5583450|NCT03828019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5583451|NCT03828019|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5583452|NCT03828019|Antifungal Agents|antifungal agents|mesh-ancestor
5583453|NCT03828019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6191434|NCT01893801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6191435|NCT01893801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6191436|NCT01893801|Tubulin Modulators|tubulin modulators|mesh-ancestor
6191437|NCT01893801|Antimitotic Agents|antimitotic agents|mesh-ancestor
6191438|NCT01893801|Mitosis Modulators|mitosis modulators|mesh-ancestor
6191439|NCT01893801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191440|NCT01893801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6191441|NCT01893801|Antimetabolites|antimetabolites|mesh-ancestor
6191442|NCT01893801|Antiviral Agents|antiviral agents|mesh-ancestor
6191443|NCT01893801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6191444|NCT01893801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6191445|NCT01893801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6191446|NCT01893801|Immunologic Factors|immunologic factors|mesh-ancestor
6191447|NCT01893801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191448|NCT01893827|Naltrexone|naltrexone|mesh-list
6191449|NCT01893827|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6191450|NCT01893827|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6191451|NCT01893827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191452|NCT01893827|Sensory System Agents|sensory system agents|mesh-ancestor
6191453|NCT01893827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6191454|NCT01893879|Ketoprofen|ketoprofen|mesh-list
6191455|NCT01893879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6191456|NCT01893879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6191457|NCT01893879|Analgesics|analgesics|mesh-ancestor
6191458|NCT01893879|Sensory System Agents|sensory system agents|mesh-ancestor
6191459|NCT01893879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6191460|NCT01893879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191461|NCT01893879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6191462|NCT01893879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6191463|NCT01893879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6191464|NCT01893879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6191465|NCT01893879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191466|NCT01894022|Ambrisentan|ambrisentan|mesh-list
6191467|NCT01894022|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6207229|NCT02112045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207230|NCT02112045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6207231|NCT02112045|Alkylating Agents|alkylating agents|mesh-ancestor
6207232|NCT02112045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207233|NCT02112045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6207234|NCT02112045|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6207235|NCT02112045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6207236|NCT02112370|Epinephrine|epinephrine|mesh-list
6207237|NCT02112370|Racepinephrine|racepinephrine|mesh-list
6207238|NCT02112370|Ropivacaine|ropivacaine|mesh-list
6207239|NCT02112370|Epinephryl borate|epinephryl borate|mesh-list
6207240|NCT02112370|Anesthetics, Local|anesthetics, local|mesh-ancestor
6207241|NCT02112370|Anesthetics|anesthetics|mesh-ancestor
6207242|NCT02112370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6207243|NCT02112370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207244|NCT02112370|Sensory System Agents|sensory system agents|mesh-ancestor
6207245|NCT02112370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6207246|NCT02112370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6207247|NCT02112370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5583454|NCT03828019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5583455|NCT03827876|Calcitriol|calcitriol|mesh-list
6191468|NCT01894152|Everolimus|everolimus|mesh-list
6191469|NCT01894152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6191470|NCT01894152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6191471|NCT01894152|Immunologic Factors|immunologic factors|mesh-ancestor
6191472|NCT01894152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191473|NCT01894243|Olaparib|olaparib|mesh-list
6191474|NCT01894243|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6191475|NCT01894243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6191476|NCT01894243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191477|NCT01894243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6191478|NCT01894256|Olaparib|olaparib|mesh-list
6191479|NCT01894256|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6191480|NCT01894256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6191481|NCT01894256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191482|NCT01894256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6191483|NCT01894477|Fludarabine|fludarabine|mesh-list
6191484|NCT01894477|Fludarabine phosphate|fludarabine phosphate|mesh-list
6191485|NCT01894477|Treosulfan|treosulfan|mesh-list
6191486|NCT01894477|Busulfan|busulfan|mesh-list
6191487|NCT01894477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6191488|NCT01894477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6191489|NCT01894477|Antimetabolites|antimetabolites|mesh-ancestor
6191490|NCT01894477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583456|NCT03827876|Betamethasone|betamethasone|mesh-list
5583457|NCT03827876|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5583458|NCT03827876|Calcipotriene|calcipotriene|mesh-list
5583459|NCT03827876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5583460|NCT03827876|Glucocorticoids|glucocorticoids|mesh-ancestor
5583461|NCT03827876|Hormones|hormones|mesh-ancestor
5583462|NCT03827876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5583463|NCT03827876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583464|NCT03827876|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5583465|NCT03827876|Respiratory System Agents|respiratory system agents|mesh-ancestor
5583466|NCT03827876|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5583467|NCT03827876|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
5583468|NCT03827876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5583469|NCT03827876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583470|NCT03827876|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5583471|NCT03827876|Vitamins|vitamins|mesh-ancestor
5583472|NCT03827876|Micronutrients|micronutrients|mesh-ancestor
5583473|NCT03827876|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5583474|NCT03827876|Dermatologic Agents|dermatologic agents|mesh-ancestor
5583475|NCT03828084|Decitabine|decitabine|mesh-list
5583476|NCT03828084|Tetrahydrouridine|tetrahydrouridine|mesh-list
5583477|NCT03828084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5583478|NCT03828084|Antimetabolites|antimetabolites|mesh-ancestor
5583479|NCT03828084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583480|NCT03828084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5583481|NCT03828084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5583482|NCT03828058|Tacrolimus|tacrolimus|mesh-list
6191491|NCT01894477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6191492|NCT01894477|Immunologic Factors|immunologic factors|mesh-ancestor
6191493|NCT01894477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191494|NCT01894477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6191495|NCT01894477|Alkylating Agents|alkylating agents|mesh-ancestor
6191496|NCT01894477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6191497|NCT01894503|Mometasone Furoate|mometasone furoate|mesh-list
6191498|NCT01894503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6191499|NCT01894503|Dermatologic Agents|dermatologic agents|mesh-ancestor
6191500|NCT01894503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6191501|NCT01894555|Aspirin|aspirin|mesh-list
6191502|NCT01894555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6191503|NCT01894555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6191504|NCT01894555|Analgesics|analgesics|mesh-ancestor
6191505|NCT01894555|Sensory System Agents|sensory system agents|mesh-ancestor
6191506|NCT01894555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5583483|NCT03828058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5583484|NCT03828058|Immunologic Factors|immunologic factors|mesh-ancestor
5583485|NCT03828058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583486|NCT03828058|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5583487|NCT03828058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5583488|NCT03828058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583489|NCT03827889|Fluorides|fluorides|mesh-list
5583490|NCT03827889|Fluorides, Topical|fluorides, topical|mesh-list
5583491|NCT03827889|Cariostatic Agents|cariostatic agents|mesh-ancestor
5583492|NCT03827889|Protective Agents|protective agents|mesh-ancestor
5583493|NCT03827889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605035|NCT03746041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605036|NCT03746041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5605037|NCT03746041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6191507|NCT01894555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191508|NCT01894555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6191509|NCT01894555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6191510|NCT01894555|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6191511|NCT01894555|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6191512|NCT01894555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191513|NCT01894555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6191514|NCT01894555|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6191515|NCT01894555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6191516|NCT01894555|Antipyretics|antipyretics|mesh-ancestor
6191517|NCT01894568|Insulin|insulin|mesh-list
6191518|NCT01894568|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6191519|NCT01894568|Insulin Glargine|insulin glargine|mesh-list
6191520|NCT01894568|Pioglitazone|pioglitazone|mesh-list
6191521|NCT01894568|Biguanides|biguanides|mesh-list
6191522|NCT01894568|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6191523|NCT01894568|Meglitinide|meglitinide|mesh-list
6191524|NCT01894568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191525|NCT01894581|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
6191526|NCT01894581|Hormones|hormones|mesh-ancestor
6191527|NCT01894581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6191528|NCT01894581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191529|NCT01894776|Maraviroc|maraviroc|mesh-list
6191530|NCT01894776|Rifabutin|rifabutin|mesh-list
6191531|NCT01894776|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6191532|NCT01894776|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6191533|NCT01894776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191534|NCT01894776|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6191535|NCT01894776|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6191536|NCT01894776|Antiviral Agents|antiviral agents|mesh-ancestor
5605038|NCT03746041|Growth Substances|growth substances|mesh-ancestor
5605039|NCT03746041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605040|NCT03746041|Growth Inhibitors|growth inhibitors|mesh-ancestor
5605041|NCT03746041|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5605042|NCT03689582|Edetic Acid|edetic acid|mesh-list
5605043|NCT03689582|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5605044|NCT03689582|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5605045|NCT03689582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605046|NCT03689582|Anticoagulants|anticoagulants|mesh-ancestor
5605047|NCT03689582|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6191537|NCT01894776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6191538|NCT01894776|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6191539|NCT01894776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6191540|NCT01894776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6191541|NCT01894776|Antitubercular Agents|antitubercular agents|mesh-ancestor
6191542|NCT01894919|Vaccines|vaccines|mesh-list
6191543|NCT01894919|Immunologic Factors|immunologic factors|mesh-ancestor
5605048|NCT03689582|Chelating Agents|chelating agents|mesh-ancestor
5605049|NCT03689582|Sequestering Agents|sequestering agents|mesh-ancestor
5605050|NCT03668119|Nivolumab|nivolumab|mesh-list
5605051|NCT03668119|Ipilimumab|ipilimumab|mesh-list
5605052|NCT03668119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5605053|NCT03668119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605054|NCT03668119|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6191544|NCT01894919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191545|NCT01894984|Risperidone|risperidone|mesh-list
6191546|NCT01894984|Antipsychotic Agents|antipsychotic agents|mesh-list
6191547|NCT01894984|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6191548|NCT01894984|Serotonin Agents|serotonin agents|mesh-ancestor
6191549|NCT01894984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6191550|NCT01894984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191551|NCT01894984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191552|NCT01894984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6191553|NCT01894984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6191554|NCT01894984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6191555|NCT01894984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5605055|NCT03668119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605056|NCT03661320|Gemcitabine|gemcitabine|mesh-list
5605057|NCT03661320|Nivolumab|nivolumab|mesh-list
5605058|NCT03661320|Linrodostat|linrodostat|mesh-list
5605059|NCT03661320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6191556|NCT01894984|Dopamine Agents|dopamine agents|mesh-ancestor
5583494|NCT03827642|Naloxone|naloxone|mesh-list
5583495|NCT03827642|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5583496|NCT03827642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583497|NCT03827642|Sensory System Agents|sensory system agents|mesh-ancestor
5583498|NCT03827642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5583499|NCT03827629|Naloxone|naloxone|mesh-list
5583500|NCT03827629|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5583501|NCT03827629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583502|NCT03827629|Sensory System Agents|sensory system agents|mesh-ancestor
5583503|NCT03827629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5583504|NCT03827408|Midazolam|midazolam|mesh-list
5583505|NCT03827408|Dexmedetomidine|dexmedetomidine|mesh-list
5583506|NCT03827408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5583507|NCT03827408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5583508|NCT03827408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583509|NCT03827408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5583510|NCT03827408|Analgesics|analgesics|mesh-ancestor
5583511|NCT03827408|Sensory System Agents|sensory system agents|mesh-ancestor
5583512|NCT03827408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5583513|NCT03827408|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5583514|NCT03827408|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5583515|NCT03827408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5583516|NCT03827408|Adrenergic Agents|adrenergic agents|mesh-ancestor
5583517|NCT03827408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5583518|NCT03827408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583519|NCT03827408|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5583520|NCT03827408|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5583521|NCT03827408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5583522|NCT03827408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5583523|NCT03827408|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5583524|NCT03827408|Anesthetics, General|anesthetics, general|mesh-ancestor
6191557|NCT01895036|Naltrexone|naltrexone|mesh-list
6191558|NCT01895036|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6191559|NCT01895036|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6191560|NCT01895036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191561|NCT01895036|Sensory System Agents|sensory system agents|mesh-ancestor
6191562|NCT01895036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6191563|NCT01895101|Tranexamic Acid|tranexamic acid|mesh-list
6191564|NCT01895101|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6191565|NCT01895101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6191566|NCT01895101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191567|NCT01895101|Hemostatics|hemostatics|mesh-ancestor
6191568|NCT01895101|Coagulants|coagulants|mesh-ancestor
6191569|NCT01895127|Immunoglobulins|immunoglobulins|mesh-list
6191570|NCT01895127|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6191571|NCT01895127|Antibodies|antibodies|mesh-list
6191572|NCT01895127|Eculizumab|eculizumab|mesh-list
6191573|NCT01895127|Immunologic Factors|immunologic factors|mesh-ancestor
5583525|NCT03827408|Anesthetics|anesthetics|mesh-ancestor
5583526|NCT03827408|GABA Modulators|gaba modulators|mesh-ancestor
5583527|NCT03827408|GABA Agents|gaba agents|mesh-ancestor
5583528|NCT03827070|Afatinib|afatinib|mesh-list
5583529|NCT03827070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5583530|NCT03827070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5583531|NCT03827070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5583532|NCT03827070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583533|NCT03827122|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5583534|NCT03827122|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5583535|NCT03827122|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5583536|NCT03827122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5583537|NCT03827122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191574|NCT01895127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191575|NCT01895127|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6191576|NCT01895127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6191577|NCT01895270|Isradipine|isradipine|mesh-list
6191578|NCT01895270|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6191579|NCT01895270|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6191580|NCT01895270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6191581|NCT01895270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191582|NCT01895270|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6191583|NCT01895270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191584|NCT01895270|Vasodilator Agents|vasodilator agents|mesh-ancestor
6191585|NCT01895309|Etanercept|etanercept|mesh-list
5583538|NCT03827122|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5583539|NCT03827122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5583540|NCT03827122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583541|NCT03827122|Cholinergic Agents|cholinergic agents|mesh-ancestor
5583542|NCT03827122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5583543|NCT03827044|Avelumab|avelumab|mesh-list
5583544|NCT03827044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5583545|NCT03827044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5583546|NCT03827200|Ambrisentan|ambrisentan|mesh-list
5583547|NCT03827200|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5583548|NCT03827278|Itraconazole|itraconazole|mesh-list
5583549|NCT03827278|Voriconazole|voriconazole|mesh-list
5583550|NCT03827278|Amphotericin B|amphotericin b|mesh-list
6191586|NCT01895309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6191587|NCT01895309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6191588|NCT01895309|Analgesics|analgesics|mesh-ancestor
6191589|NCT01895309|Sensory System Agents|sensory system agents|mesh-ancestor
6191590|NCT01895309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6191591|NCT01895309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191592|NCT01895309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6191593|NCT01895309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6191594|NCT01895309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6191595|NCT01895309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6191596|NCT01895309|Immunologic Factors|immunologic factors|mesh-ancestor
6191597|NCT01895322|Tolvaptan|tolvaptan|mesh-list
5583551|NCT03827278|Antifungal Agents|antifungal agents|mesh-ancestor
5583552|NCT03827278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5583553|NCT03827278|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5583554|NCT03827278|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5583555|NCT03827278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5583556|NCT03827278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583557|NCT03827278|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5583558|NCT03827278|Hormone Antagonists|hormone antagonists|mesh-ancestor
5583559|NCT03827278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5583560|NCT03827278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583561|NCT03827278|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5583562|NCT03827278|Amebicides|amebicides|mesh-ancestor
5583563|NCT03827278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5583564|NCT03827278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5583565|NCT03827278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5583566|NCT03826693|Nitrous Oxide|nitrous oxide|mesh-list
5583567|NCT03826693|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5583568|NCT03826693|Anesthetics, General|anesthetics, general|mesh-ancestor
5583569|NCT03826693|Anesthetics|anesthetics|mesh-ancestor
5583570|NCT03826693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6191598|NCT01895322|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6191599|NCT01895322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191600|NCT01895322|Natriuretic Agents|natriuretic agents|mesh-ancestor
6191601|NCT01895322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191602|NCT01895335|Teriflunomide|teriflunomide|mesh-list
6191603|NCT01895335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6191604|NCT01895335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6191605|NCT01895335|Analgesics|analgesics|mesh-ancestor
6191606|NCT01895335|Sensory System Agents|sensory system agents|mesh-ancestor
6191607|NCT01895335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6191608|NCT01895335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191609|NCT01895335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6191610|NCT01895335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5583571|NCT03826693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583572|NCT03826693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5583573|NCT03826693|Analgesics|analgesics|mesh-ancestor
6191611|NCT01895335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6191612|NCT01895335|Immunologic Factors|immunologic factors|mesh-ancestor
5583574|NCT03826693|Sensory System Agents|sensory system agents|mesh-ancestor
5583575|NCT03826693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5583576|NCT03826940|Lovastatin|lovastatin|mesh-list
5583577|NCT03826940|L 647318|l 647318|mesh-list
5583578|NCT03826940|Dihydromevinolin|dihydromevinolin|mesh-list
5583579|NCT03826940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5583580|NCT03826940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5583581|NCT03826940|Antimetabolites|antimetabolites|mesh-ancestor
5583582|NCT03826940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583583|NCT03826940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5583584|NCT03826940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5583585|NCT03826940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5583586|NCT03826875|Fluoxetine|fluoxetine|mesh-list
5583587|NCT03826875|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5583588|NCT03826875|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5583589|NCT03826875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6191613|NCT01895777|Dabigatran|dabigatran|mesh-list
6191614|NCT01895777|Antithrombins|antithrombins|mesh-ancestor
5583590|NCT03826875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583591|NCT03826875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5583592|NCT03826875|Serotonin Agents|serotonin agents|mesh-ancestor
5583593|NCT03826875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583594|NCT03826875|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6191615|NCT01895777|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6191616|NCT01895777|Protease Inhibitors|protease inhibitors|mesh-ancestor
6191617|NCT01895777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6191618|NCT01895777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191619|NCT01895777|Anticoagulants|anticoagulants|mesh-ancestor
6191620|NCT01896050|Tamoxifen|tamoxifen|mesh-list
6191621|NCT01896050|Letrozole|letrozole|mesh-list
6191622|NCT01896050|Anastrozole|anastrozole|mesh-list
6191623|NCT01896050|Exemestane|exemestane|mesh-list
6191624|NCT01896050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6191625|NCT01896050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6191626|NCT01896050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6191627|NCT01896050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6191628|NCT01896050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191629|NCT01896050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6191630|NCT01896050|Hormone Antagonists|hormone antagonists|mesh-ancestor
6191631|NCT01896050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6191632|NCT01896050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191633|NCT01896050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6191634|NCT01896050|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6191635|NCT01896050|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6191636|NCT01896050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6191637|NCT01896128|Modafinil|modafinil|mesh-list
6191638|NCT01896128|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6191639|NCT01896128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191640|NCT01896128|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6191641|NCT01896128|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5583595|NCT03826875|Antidepressive Agents|antidepressive agents|mesh-ancestor
5583596|NCT03826875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6191642|NCT01896128|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6191643|NCT01896128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191644|NCT01896193|Sofosbuvir|sofosbuvir|mesh-list
6191645|NCT01896193|Antiviral Agents|antiviral agents|mesh-ancestor
6191646|NCT01896193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6191647|NCT01896232|Cinacalcet|cinacalcet|mesh-list
6191648|NCT01896232|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6191649|NCT01896232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191650|NCT01896232|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6191651|NCT01896232|Hormone Antagonists|hormone antagonists|mesh-ancestor
6191652|NCT01896232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6191653|NCT01896297|Dabigatran|dabigatran|mesh-list
6191654|NCT01896297|Antithrombins|antithrombins|mesh-ancestor
6191655|NCT01896297|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6191656|NCT01896297|Protease Inhibitors|protease inhibitors|mesh-ancestor
6191657|NCT01896297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6191658|NCT01896297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191659|NCT01896297|Anticoagulants|anticoagulants|mesh-ancestor
6191660|NCT01896544|Cholecalciferol|cholecalciferol|mesh-list
6191661|NCT01896544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6191662|NCT01896544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191663|NCT01896544|Vitamins|vitamins|mesh-ancestor
6191664|NCT01896544|Micronutrients|micronutrients|mesh-ancestor
6191665|NCT01896544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6191666|NCT01896557|Omeprazole|omeprazole|mesh-list
6191667|NCT01896557|Ranitidine|ranitidine|mesh-list
6191668|NCT01896557|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
6191669|NCT01896557|Clopidogrel|clopidogrel|mesh-list
6191670|NCT01896557|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
6191671|NCT01896557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6191672|NCT01896557|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6191673|NCT01896557|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6191674|NCT01896557|Purinergic Agents|purinergic agents|mesh-ancestor
6191675|NCT01896557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5583597|NCT03826875|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5583598|NCT03826875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5583599|NCT03826875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5583600|NCT03826589|Avelumab|avelumab|mesh-list
5583601|NCT03826589|Axitinib|axitinib|mesh-list
5583602|NCT03826589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5583603|NCT03826589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5583604|NCT03826589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5583605|NCT03826589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5583606|NCT03826589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583607|NCT03826706|Pyrithione zinc|pyrithione zinc|mesh-list
5583608|NCT03826706|Keratolytic Agents|keratolytic agents|mesh-ancestor
5583609|NCT03826706|Dermatologic Agents|dermatologic agents|mesh-ancestor
5583610|NCT03826628|Sirolimus|sirolimus|mesh-list
6191676|NCT01896557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191677|NCT01896557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191678|NCT01896557|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6191679|NCT01896557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6191680|NCT01896557|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6191681|NCT01896557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6191682|NCT01896557|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6191683|NCT01896557|Histamine Antagonists|histamine antagonists|mesh-ancestor
6191684|NCT01896557|Histamine Agents|histamine agents|mesh-ancestor
6191685|NCT01896700|Methylphenidate|methylphenidate|mesh-list
5583611|NCT03826628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5583612|NCT03826628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5583613|NCT03826628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5583614|NCT03826628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5583615|NCT03826628|Antifungal Agents|antifungal agents|mesh-ancestor
5583616|NCT03826628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5583617|NCT03826628|Immunologic Factors|immunologic factors|mesh-ancestor
5583618|NCT03826628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583619|NCT03826615|Gabapentin|gabapentin|mesh-list
5583620|NCT03826615|Analgesics|analgesics|mesh-ancestor
5583621|NCT03826615|Sensory System Agents|sensory system agents|mesh-ancestor
5583622|NCT03826615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5583623|NCT03826615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583624|NCT03826615|Anticonvulsants|anticonvulsants|mesh-ancestor
5583625|NCT03826615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5583626|NCT03826615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5583627|NCT03826615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5583628|NCT03826615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5583629|NCT03826615|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5583630|NCT03826615|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5583631|NCT03826615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5583632|NCT03826615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583633|NCT03826615|Antimanic Agents|antimanic agents|mesh-ancestor
5583634|NCT03826602|Metformin|metformin|mesh-list
5583635|NCT03826602|Tucatinib|tucatinib|mesh-list
5583636|NCT03826602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5583637|NCT03826602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583638|NCT03826602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5583639|NCT03826602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5583640|NCT03826602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5583641|NCT03826602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583642|NCT03826563|Melatonin|melatonin|mesh-list
5583643|NCT03826563|Antioxidants|antioxidants|mesh-ancestor
5583644|NCT03826563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583645|NCT03826563|Protective Agents|protective agents|mesh-ancestor
5583646|NCT03826563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583647|NCT03826563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5583648|NCT03826550|Diclofenac|diclofenac|mesh-list
6191686|NCT01896700|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6191687|NCT01896700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191688|NCT01896700|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6191689|NCT01896700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6191690|NCT01896700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6191691|NCT01896700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191692|NCT01896700|Dopamine Agents|dopamine agents|mesh-ancestor
6191693|NCT01896700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6191694|NCT01896726|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
6191695|NCT01896726|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
6191696|NCT01896726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6191697|NCT01896726|Contraceptive Agents|contraceptive agents|mesh-ancestor
6191698|NCT01896726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6191699|NCT01896726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191700|NCT01896726|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6191701|NCT01896726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6191702|NCT01896726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6191703|NCT01896726|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6191704|NCT01896726|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6191705|NCT01896726|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
5583649|NCT03826550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5583650|NCT03826550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5583651|NCT03826550|Analgesics|analgesics|mesh-ancestor
6191706|NCT01896726|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6191707|NCT01896726|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6191708|NCT01896856|Trifluridine|trifluridine|mesh-list
6191709|NCT01896856|Irinotecan|irinotecan|mesh-list
6191710|NCT01896856|Guadecitabine|guadecitabine|mesh-list
6191711|NCT01896856|Azacitidine|azacitidine|mesh-list
6191712|NCT01896856|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6191713|NCT01896856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6191714|NCT01896856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6191715|NCT01896856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191716|NCT01896856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6191717|NCT01896856|Antimetabolites|antimetabolites|mesh-ancestor
6191718|NCT01896856|Antiviral Agents|antiviral agents|mesh-ancestor
6191719|NCT01896856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6191720|NCT01896856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6191721|NCT01896869|Ipilimumab|ipilimumab|mesh-list
6191722|NCT01896869|Folfirinox|folfirinox|mesh-list
6191723|NCT01896869|Vaccines|vaccines|mesh-list
6191724|NCT01896869|Immunologic Factors|immunologic factors|mesh-ancestor
6191725|NCT01896869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191726|NCT01896869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6191727|NCT01896869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6191728|NCT01896869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6191729|NCT01896869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191730|NCT01896895|Botulinum Toxins|botulinum toxins|mesh-list
6191731|NCT01896895|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6191732|NCT01896895|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6191733|NCT01896895|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
6191734|NCT01896895|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6191735|NCT01896895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6191736|NCT01896895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191737|NCT01896895|Cholinergic Agents|cholinergic agents|mesh-ancestor
6191738|NCT01896895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6191739|NCT01896895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191740|NCT01896895|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6191741|NCT01896895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6191742|NCT01896921|Raltegravir Potassium|raltegravir potassium|mesh-list
6191743|NCT01896921|Maraviroc|maraviroc|mesh-list
6191744|NCT01896921|Dolutegravir|dolutegravir|mesh-list
6191745|NCT01896921|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6191746|NCT01896921|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6191747|NCT01896921|Antiviral Agents|antiviral agents|mesh-ancestor
6191748|NCT01896921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6191749|NCT01896921|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6191750|NCT01896921|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6191751|NCT01896921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6191752|NCT01896921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191753|NCT01896921|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6191754|NCT01896921|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6191755|NCT01896921|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6191756|NCT01896934|Sertraline|sertraline|mesh-list
6191757|NCT01896934|Antidepressive Agents|antidepressive agents|mesh-ancestor
6191758|NCT01896934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6191759|NCT01896934|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6191760|NCT01896934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6191761|NCT01896934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6191762|NCT01896934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191763|NCT01896934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6191764|NCT01896934|Serotonin Agents|serotonin agents|mesh-ancestor
6191765|NCT01896934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191766|NCT01897233|Ivacaftor|ivacaftor|mesh-list
6191767|NCT01897233|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6191768|NCT01897233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6191769|NCT01897233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191770|NCT01897285|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6191771|NCT01897285|Laxatives|laxatives|mesh-ancestor
6191772|NCT01897285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6191773|NCT01897402|Vaccines|vaccines|mesh-list
6191774|NCT01897402|Immunologic Factors|immunologic factors|mesh-ancestor
6191775|NCT01897402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191776|NCT01897493|Digoxin|digoxin|mesh-list
6191777|NCT01897493|Evacetrapib|evacetrapib|mesh-list
6191778|NCT01897493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6191779|NCT01897493|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6191780|NCT01897493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6191781|NCT01897493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583652|NCT03826550|Sensory System Agents|sensory system agents|mesh-ancestor
5583653|NCT03826550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5583654|NCT03826550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583655|NCT03826550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5583656|NCT03826550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5583657|NCT03826550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5583658|NCT03826550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5583659|NCT03826550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583660|NCT03826485|Pranlukast|pranlukast|mesh-list
5583661|NCT03826485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5583662|NCT03826485|Respiratory System Agents|respiratory system agents|mesh-ancestor
5583663|NCT03826485|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5583664|NCT03826485|Hormone Antagonists|hormone antagonists|mesh-ancestor
5583665|NCT03826485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5583666|NCT03826485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583667|NCT03826524|Epinephrine|epinephrine|mesh-list
5583668|NCT03826524|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5583669|NCT03826524|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5583670|NCT03826524|Adrenergic Agents|adrenergic agents|mesh-ancestor
5583671|NCT03826524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5583672|NCT03826524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583673|NCT03826524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583674|NCT03826524|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5583675|NCT03826524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5583676|NCT03826524|Autonomic Agents|autonomic agents|mesh-ancestor
5583677|NCT03826524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5583678|NCT03826524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5583679|NCT03826524|Respiratory System Agents|respiratory system agents|mesh-ancestor
5583680|NCT03826524|Mydriatics|mydriatics|mesh-ancestor
5583681|NCT03826524|Sympathomimetics|sympathomimetics|mesh-ancestor
6191782|NCT01897493|Protective Agents|protective agents|mesh-ancestor
6191783|NCT01897493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191784|NCT01897493|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6191785|NCT01897493|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6191786|NCT01897493|Antimetabolites|antimetabolites|mesh-ancestor
6191787|NCT01897493|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6191788|NCT01897532|Linagliptin|linagliptin|mesh-list
6191789|NCT01897532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6191790|NCT01897532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191791|NCT01897532|Incretins|incretins|mesh-ancestor
6191792|NCT01897532|Hormones|hormones|mesh-ancestor
6191793|NCT01897532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6191794|NCT01897532|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6191795|NCT01897532|Protease Inhibitors|protease inhibitors|mesh-ancestor
6191796|NCT01897532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6191797|NCT01897532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191798|NCT01897714|Dexamethasone|dexamethasone|mesh-list
6191799|NCT01897714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6191800|NCT01897714|Antiemetics|antiemetics|mesh-ancestor
6191801|NCT01897714|Autonomic Agents|autonomic agents|mesh-ancestor
6191802|NCT01897714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6191803|NCT01897714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191804|NCT01897714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6191805|NCT01897714|Glucocorticoids|glucocorticoids|mesh-ancestor
6191806|NCT01897714|Hormones|hormones|mesh-ancestor
6191807|NCT01897714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6191808|NCT01897714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6191809|NCT01897714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5583682|NCT03826524|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6191810|NCT01897727|Spironolactone|spironolactone|mesh-list
6191811|NCT01897727|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6191812|NCT01897727|Hormone Antagonists|hormone antagonists|mesh-ancestor
6191813|NCT01897727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6191814|NCT01897727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191815|NCT01897727|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6191816|NCT01897727|Diuretics|diuretics|mesh-ancestor
6191817|NCT01897727|Natriuretic Agents|natriuretic agents|mesh-ancestor
6191818|NCT01897792|Vitamins|vitamins|mesh-list
6191819|NCT01897792|Ascorbic Acid|ascorbic acid|mesh-list
6191820|NCT01897792|Vitamin E|vitamin e|mesh-list
5583683|NCT03826368|Cannabidiol|cannabidiol|mesh-list
5583684|NCT03826368|Anticonvulsants|anticonvulsants|mesh-ancestor
5583685|NCT03826316|Nalbuphine|nalbuphine|mesh-list
5583686|NCT03826316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5583687|NCT03826316|Narcotics|narcotics|mesh-ancestor
5583688|NCT03826316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5583689|NCT03826316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583690|NCT03826316|Analgesics|analgesics|mesh-ancestor
5583691|NCT03826316|Sensory System Agents|sensory system agents|mesh-ancestor
5583692|NCT03826316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5583693|NCT03826303|Ethanol|ethanol|mesh-list
5583694|NCT03826303|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5583695|NCT03826303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5583696|NCT03826303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5583697|NCT03826303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583698|NCT03825965|Cannabidiol|cannabidiol|mesh-list
5583699|NCT03825965|Anticonvulsants|anticonvulsants|mesh-ancestor
5583700|NCT03825887|Morphine|morphine|mesh-list
5583701|NCT03825887|Nalbuphine|nalbuphine|mesh-list
5583702|NCT03825887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5583703|NCT03825887|Narcotics|narcotics|mesh-ancestor
5583704|NCT03825887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5583705|NCT03825887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583706|NCT03825887|Analgesics|analgesics|mesh-ancestor
5583707|NCT03825887|Sensory System Agents|sensory system agents|mesh-ancestor
6191821|NCT01897792|Tocopherols|tocopherols|mesh-list
6191822|NCT01897792|Tocotrienols|tocotrienols|mesh-list
6191823|NCT01897792|alpha-Tocopherol|alpha-tocopherol|mesh-list
6191824|NCT01897792|Micronutrients|micronutrients|mesh-ancestor
6191825|NCT01897792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191826|NCT01897792|Antioxidants|antioxidants|mesh-ancestor
6191827|NCT01897792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191828|NCT01897792|Protective Agents|protective agents|mesh-ancestor
6191829|NCT01898091|Ascorbic Acid|ascorbic acid|mesh-list
6191830|NCT01898091|Glycerol|glycerol|mesh-list
6191831|NCT01898091|Antioxidants|antioxidants|mesh-ancestor
6191832|NCT01898091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191833|NCT01898091|Protective Agents|protective agents|mesh-ancestor
6191834|NCT01898091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191835|NCT01898091|Vitamins|vitamins|mesh-ancestor
6191836|NCT01898091|Micronutrients|micronutrients|mesh-ancestor
5583708|NCT03825887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5583709|NCT03826199|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5583710|NCT03826199|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5583711|NCT03826199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6191837|NCT01898091|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6191838|NCT01898130|Bevacizumab|bevacizumab|mesh-list
6191839|NCT01898130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5583712|NCT03826199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5583713|NCT03826199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583714|NCT03826199|Antiviral Agents|antiviral agents|mesh-ancestor
5583715|NCT03826199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5583716|NCT03826199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5583717|NCT03826199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5605060|NCT03661320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5605061|NCT03661320|Antimetabolites|antimetabolites|mesh-ancestor
5605062|NCT03661320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605063|NCT03661320|Antiviral Agents|antiviral agents|mesh-ancestor
5605064|NCT03661320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5605065|NCT03661320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5605066|NCT03661320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5605067|NCT03661320|Immunologic Factors|immunologic factors|mesh-ancestor
5605068|NCT03661320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605069|NCT03661320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5605070|NCT03661320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6191840|NCT01898130|Antibodies|antibodies|mesh-list
6191841|NCT01898130|Immunoglobulins|immunoglobulins|mesh-list
6191842|NCT01898130|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6191843|NCT01898130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6191844|NCT01898130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6191845|NCT01898130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6191846|NCT01898130|Growth Substances|growth substances|mesh-ancestor
6191847|NCT01898130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191848|NCT01898130|Growth Inhibitors|growth inhibitors|mesh-ancestor
6191849|NCT01898130|Immunologic Factors|immunologic factors|mesh-ancestor
6191850|NCT01898195|Varenicline|varenicline|mesh-list
6191851|NCT01898195|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6191852|NCT01898195|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6191853|NCT01898195|Cholinergic Agents|cholinergic agents|mesh-ancestor
6191854|NCT01898195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6191855|NCT01898195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191856|NCT01898195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191857|NCT01898208|Anti-Infective Agents|anti-infective agents|mesh-list
6191858|NCT01898208|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6191859|NCT01898403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6191860|NCT01898442|Ticagrelor|ticagrelor|mesh-list
6191861|NCT01898442|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6191862|NCT01898442|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6191863|NCT01898442|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6191864|NCT01898442|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6191865|NCT01898442|Purinergic Agents|purinergic agents|mesh-ancestor
6191866|NCT01898442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6191867|NCT01898442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191868|NCT01898442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191869|NCT01898689|Ropivacaine|ropivacaine|mesh-list
6191870|NCT01898689|Anesthetics, Local|anesthetics, local|mesh-ancestor
6191871|NCT01898689|Anesthetics|anesthetics|mesh-ancestor
6191872|NCT01898689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5583718|NCT03826004|Clemastine|clemastine|mesh-list
5583719|NCT03826004|Antipruritics|antipruritics|mesh-ancestor
5583720|NCT03826004|Dermatologic Agents|dermatologic agents|mesh-ancestor
5583721|NCT03826004|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5583722|NCT03826004|Histamine Antagonists|histamine antagonists|mesh-ancestor
5583723|NCT03826004|Histamine Agents|histamine agents|mesh-ancestor
5583724|NCT03826004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5583725|NCT03826004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583726|NCT03826004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583727|NCT03826004|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5583728|NCT03825861|Folfirinox|folfirinox|mesh-list
5583729|NCT03825861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5583730|NCT03825809|Acetaminophen|acetaminophen|mesh-list
5583731|NCT03825809|Celecoxib|celecoxib|mesh-list
5583732|NCT03825809|Ketorolac|ketorolac|mesh-list
5583733|NCT03825809|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
5583734|NCT03825809|Diazepam|diazepam|mesh-list
5583735|NCT03825809|Gabapentin|gabapentin|mesh-list
5583736|NCT03825809|Hydrocodone|hydrocodone|mesh-list
5583737|NCT03825809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5583738|NCT03825809|Analgesics|analgesics|mesh-ancestor
5583739|NCT03825809|Sensory System Agents|sensory system agents|mesh-ancestor
5583740|NCT03825809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5583741|NCT03825809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583742|NCT03825809|Antipyretics|antipyretics|mesh-ancestor
5583743|NCT03825809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5583744|NCT03825809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5583745|NCT03825809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5583746|NCT03825809|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5583747|NCT03825809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5583748|NCT03825809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5583749|NCT03825809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583750|NCT03825809|Anticonvulsants|anticonvulsants|mesh-ancestor
6191873|NCT01898689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583751|NCT03825809|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5583752|NCT03825809|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6191874|NCT01898689|Sensory System Agents|sensory system agents|mesh-ancestor
6191875|NCT01898689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6191876|NCT01898806|Triamcinolone|triamcinolone|mesh-list
6191877|NCT01898806|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6191878|NCT01898806|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6191879|NCT01898806|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6191880|NCT01898806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6191881|NCT01898806|Glucocorticoids|glucocorticoids|mesh-ancestor
6191882|NCT01898806|Hormones|hormones|mesh-ancestor
6191883|NCT01898806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6191884|NCT01898806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191885|NCT01898806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6191886|NCT01898806|Immunologic Factors|immunologic factors|mesh-ancestor
6191887|NCT01898806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6191888|NCT01898806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191889|NCT01898923|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6191890|NCT01898923|Laxatives|laxatives|mesh-ancestor
6191891|NCT01898923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6191892|NCT01899053|Serabelisib|serabelisib|mesh-list
5583753|NCT03825809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5583754|NCT03825809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5583755|NCT03825809|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5583756|NCT03825809|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5583757|NCT03825809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5583758|NCT03825809|Antimanic Agents|antimanic agents|mesh-ancestor
5583759|NCT03825809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5583760|NCT03825809|Narcotics|narcotics|mesh-ancestor
5583761|NCT03825809|Antitussive Agents|antitussive agents|mesh-ancestor
5583762|NCT03825809|Respiratory System Agents|respiratory system agents|mesh-ancestor
5583763|NCT03825809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5583764|NCT03825809|Antiemetics|antiemetics|mesh-ancestor
5583765|NCT03825809|Autonomic Agents|autonomic agents|mesh-ancestor
5583766|NCT03825809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5583767|NCT03825809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5583768|NCT03825809|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5583769|NCT03825809|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5583770|NCT03825809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6191893|NCT01899053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6191894|NCT01899053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191895|NCT01899742|Tiotropium Bromide|tiotropium bromide|mesh-list
6191896|NCT01899742|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6191897|NCT01899742|Autonomic Agents|autonomic agents|mesh-ancestor
6191898|NCT01899742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6191899|NCT01899742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191900|NCT01899742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6191901|NCT01899742|Respiratory System Agents|respiratory system agents|mesh-ancestor
6191902|NCT01899742|Parasympatholytics|parasympatholytics|mesh-ancestor
6191903|NCT01899742|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6191904|NCT01899742|Cholinergic Agents|cholinergic agents|mesh-ancestor
6191905|NCT01899742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6191906|NCT01899742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191907|NCT01900054|Bepotastine besilate|bepotastine besilate|mesh-list
6191908|NCT01900054|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6191909|NCT01900249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6191910|NCT01900249|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6207248|NCT02112370|Adrenergic Agents|adrenergic agents|mesh-ancestor
5583771|NCT03825809|Anesthetics, General|anesthetics, general|mesh-ancestor
5583772|NCT03825809|Anesthetics|anesthetics|mesh-ancestor
5583773|NCT03825809|GABA Modulators|gaba modulators|mesh-ancestor
5583774|NCT03825809|GABA Agents|gaba agents|mesh-ancestor
5583775|NCT03825601|Flumazenil|flumazenil|mesh-list
5583776|NCT03825601|Antidotes|antidotes|mesh-ancestor
6207249|NCT02112370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6207250|NCT02112370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207251|NCT02112370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6207252|NCT02112370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6207253|NCT02112370|Autonomic Agents|autonomic agents|mesh-ancestor
6207254|NCT02112370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6207255|NCT02112370|Respiratory System Agents|respiratory system agents|mesh-ancestor
6207256|NCT02112370|Mydriatics|mydriatics|mesh-ancestor
6207257|NCT02112370|Sympathomimetics|sympathomimetics|mesh-ancestor
5583777|NCT03825601|Protective Agents|protective agents|mesh-ancestor
5583778|NCT03825601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583779|NCT03825601|GABA Modulators|gaba modulators|mesh-ancestor
5583780|NCT03825601|GABA Agents|gaba agents|mesh-ancestor
5583781|NCT03825601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6191911|NCT01900431|Leucovorin|leucovorin|mesh-list
6191912|NCT01900431|Folic Acid|folic acid|mesh-list
6191913|NCT01900431|Prednisone|prednisone|mesh-list
6191914|NCT01900431|Methotrexate|methotrexate|mesh-list
6191915|NCT01900431|Levoleucovorin|levoleucovorin|mesh-list
6191916|NCT01900431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6191917|NCT01900431|Glucocorticoids|glucocorticoids|mesh-ancestor
6191918|NCT01900431|Hormones|hormones|mesh-ancestor
6191919|NCT01900431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6191920|NCT01900431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191921|NCT01900431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6191922|NCT01900431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6191923|NCT01900431|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6191924|NCT01900431|Abortifacient Agents|abortifacient agents|mesh-ancestor
6191925|NCT01900431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6191926|NCT01900431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6191927|NCT01900431|Antimetabolites|antimetabolites|mesh-ancestor
5583782|NCT03825601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583783|NCT03825471|Analgesics, Opioid|analgesics, opioid|mesh-list
5583784|NCT03825471|Anesthetics|anesthetics|mesh-list
5583785|NCT03825471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5583786|NCT03825471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583787|NCT03825471|Narcotics|narcotics|mesh-ancestor
5583788|NCT03825471|Analgesics|analgesics|mesh-ancestor
5583789|NCT03825471|Sensory System Agents|sensory system agents|mesh-ancestor
5583790|NCT03825471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6191928|NCT01900431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191929|NCT01900431|Dermatologic Agents|dermatologic agents|mesh-ancestor
6191930|NCT01900431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6191931|NCT01900431|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6191932|NCT01900431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6191933|NCT01900431|Immunologic Factors|immunologic factors|mesh-ancestor
6191934|NCT01900431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6191935|NCT01900431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6191936|NCT01900431|Antidotes|antidotes|mesh-ancestor
6191937|NCT01900431|Protective Agents|protective agents|mesh-ancestor
6191938|NCT01900431|Vitamin B Complex|vitamin b complex|mesh-ancestor
6191939|NCT01900431|Vitamins|vitamins|mesh-ancestor
6191940|NCT01900431|Micronutrients|micronutrients|mesh-ancestor
6191941|NCT01900431|Hematinics|hematinics|mesh-ancestor
6191942|NCT01900444|Vaccines|vaccines|mesh-list
6191943|NCT01900444|Immunologic Factors|immunologic factors|mesh-ancestor
6191944|NCT01900444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191945|NCT01900652|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6191946|NCT01900652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6191947|NCT01900652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6191948|NCT01900652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6191949|NCT01900652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191950|NCT01901146|Paclitaxel|paclitaxel|mesh-list
6191951|NCT01901146|Trastuzumab|trastuzumab|mesh-list
6191952|NCT01901146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6191953|NCT01901146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6191954|NCT01901146|Tubulin Modulators|tubulin modulators|mesh-ancestor
5583791|NCT03825757|Aspirin|aspirin|mesh-list
5583792|NCT03825757|Salicylic Acid|salicylic acid|mesh-list
5583793|NCT03825757|Salicylates|salicylates|mesh-list
5583794|NCT03825757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5583795|NCT03825757|Antifungal Agents|antifungal agents|mesh-ancestor
5583796|NCT03825757|Keratolytic Agents|keratolytic agents|mesh-ancestor
5583797|NCT03825757|Dermatologic Agents|dermatologic agents|mesh-ancestor
5583798|NCT03825757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5583799|NCT03825757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5583800|NCT03825757|Analgesics|analgesics|mesh-ancestor
5583801|NCT03825757|Sensory System Agents|sensory system agents|mesh-ancestor
5583802|NCT03825757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5583803|NCT03825757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191955|NCT01901146|Antimitotic Agents|antimitotic agents|mesh-ancestor
6191956|NCT01901146|Mitosis Modulators|mitosis modulators|mesh-ancestor
6191957|NCT01901146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191958|NCT01901146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6191959|NCT01901185|Etanercept|etanercept|mesh-list
6191960|NCT01901185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6191961|NCT01901185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6191962|NCT01901185|Analgesics|analgesics|mesh-ancestor
6191963|NCT01901185|Sensory System Agents|sensory system agents|mesh-ancestor
6191964|NCT01901185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6191965|NCT01901185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191966|NCT01901185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6191967|NCT01901185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6191968|NCT01901185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6191969|NCT01901185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6191970|NCT01901185|Immunologic Factors|immunologic factors|mesh-ancestor
6191971|NCT01901250|Fluorides|fluorides|mesh-list
6191972|NCT01901250|Fluorides, Topical|fluorides, topical|mesh-list
6191973|NCT01901250|Cariostatic Agents|cariostatic agents|mesh-ancestor
6191974|NCT01901250|Protective Agents|protective agents|mesh-ancestor
6191975|NCT01901250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191976|NCT01901393|Ibuprofen|ibuprofen|mesh-list
6191977|NCT01901393|Ketorolac|ketorolac|mesh-list
6191978|NCT01901393|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6191979|NCT01901393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6191980|NCT01901393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6191981|NCT01901393|Analgesics|analgesics|mesh-ancestor
6191982|NCT01901393|Sensory System Agents|sensory system agents|mesh-ancestor
6191983|NCT01901393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6191984|NCT01901393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191985|NCT01901393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6191986|NCT01901393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6191987|NCT01901393|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6191988|NCT01901393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6191989|NCT01901393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6191990|NCT01901419|Nitroglycerin|nitroglycerin|mesh-list
6191991|NCT01901419|Vasodilator Agents|vasodilator agents|mesh-ancestor
6191992|NCT01901575|Remifentanil|remifentanil|mesh-list
6191993|NCT01901575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6191994|NCT01901575|Narcotics|narcotics|mesh-ancestor
6191995|NCT01901575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6191996|NCT01901575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6191997|NCT01901575|Analgesics|analgesics|mesh-ancestor
6191998|NCT01901575|Sensory System Agents|sensory system agents|mesh-ancestor
6191999|NCT01901575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6192000|NCT01901588|Dexmedetomidine|dexmedetomidine|mesh-list
6192001|NCT01901588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6192002|NCT01901588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6192003|NCT01901588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192004|NCT01901588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6192005|NCT01901588|Analgesics|analgesics|mesh-ancestor
6192006|NCT01901588|Sensory System Agents|sensory system agents|mesh-ancestor
6192007|NCT01901588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6192008|NCT01901588|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6192009|NCT01901588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6192010|NCT01901588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6192011|NCT01901588|Adrenergic Agents|adrenergic agents|mesh-ancestor
6192012|NCT01901588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6192013|NCT01901588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192014|NCT01901614|Anesthetics|anesthetics|mesh-list
6192015|NCT01901614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6192016|NCT01901614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192017|NCT01901809|Dopamine|dopamine|mesh-list
6192018|NCT01901809|Furosemide|furosemide|mesh-list
6192019|NCT01901809|Diuretics|diuretics|mesh-ancestor
6192020|NCT01901809|Natriuretic Agents|natriuretic agents|mesh-ancestor
6192021|NCT01901809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583804|NCT03825757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5583805|NCT03825757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5583806|NCT03825757|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5583807|NCT03825757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5583808|NCT03825757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192022|NCT01901809|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6192023|NCT01901809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6192024|NCT01901809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192025|NCT01901809|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6192026|NCT01901809|Sympathomimetics|sympathomimetics|mesh-ancestor
6192027|NCT01901809|Autonomic Agents|autonomic agents|mesh-ancestor
6192028|NCT01901809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6192029|NCT01901809|Dopamine Agents|dopamine agents|mesh-ancestor
6192030|NCT01901809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6192031|NCT01901809|Protective Agents|protective agents|mesh-ancestor
5583809|NCT03825757|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6192032|NCT01901848|Bupropion|bupropion|mesh-list
6192033|NCT01901848|Nicotine|nicotine|mesh-list
6192034|NCT01901848|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5583810|NCT03825757|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6192035|NCT01901848|Autonomic Agents|autonomic agents|mesh-ancestor
6192036|NCT01901848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6192037|NCT01901848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192038|NCT01901848|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6192039|NCT01901848|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6192040|NCT01901848|Cholinergic Agents|cholinergic agents|mesh-ancestor
6192041|NCT01901848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6192042|NCT01901848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192043|NCT01901848|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6192044|NCT01901848|Antidepressive Agents|antidepressive agents|mesh-ancestor
6192045|NCT01901848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6192046|NCT01901848|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6192047|NCT01901848|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6192048|NCT01901848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6192049|NCT01901848|Dopamine Agents|dopamine agents|mesh-ancestor
6192050|NCT01901848|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6192051|NCT01901848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6192052|NCT01901848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6192053|NCT01902004|Memantine|memantine|mesh-list
6192054|NCT01902004|Citalopram|citalopram|mesh-list
6192055|NCT01902004|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6192056|NCT01902004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6192057|NCT01902004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6192058|NCT01902004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192059|NCT01902004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6192060|NCT01902004|Serotonin Agents|serotonin agents|mesh-ancestor
6192061|NCT01902004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192062|NCT01902004|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5583811|NCT03825757|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5583812|NCT03825757|Antipyretics|antipyretics|mesh-ancestor
5583813|NCT03825380|Bimatoprost|bimatoprost|mesh-list
5583814|NCT03825380|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5583815|NCT03825341|Hydroxyurea|hydroxyurea|mesh-list
6192063|NCT01902004|Antidepressive Agents|antidepressive agents|mesh-ancestor
6192064|NCT01902004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6192065|NCT01902004|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6192066|NCT01902004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6192067|NCT01902004|Dopamine Agents|dopamine agents|mesh-ancestor
6192068|NCT01902004|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6192069|NCT01902004|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6192070|NCT01902134|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
6192071|NCT01902134|Tramadol|tramadol|mesh-list
6192072|NCT01902134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6192073|NCT01902134|Narcotics|narcotics|mesh-ancestor
6192074|NCT01902134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6192075|NCT01902134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192076|NCT01902134|Analgesics|analgesics|mesh-ancestor
6192077|NCT01902134|Sensory System Agents|sensory system agents|mesh-ancestor
6192078|NCT01902134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6192079|NCT01902134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6192080|NCT01902134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6192081|NCT01902134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6192082|NCT01902134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6192083|NCT01902173|Trametinib|trametinib|mesh-list
6192084|NCT01902173|Dabrafenib|dabrafenib|mesh-list
6192085|NCT01902173|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
6192086|NCT01902173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6192087|NCT01902173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6192088|NCT01902173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6192089|NCT01902173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192090|NCT01902173|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6192091|NCT01902173|Protective Agents|protective agents|mesh-ancestor
6192092|NCT01902173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192093|NCT01902173|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6192094|NCT01902173|Antioxidants|antioxidants|mesh-ancestor
6192095|NCT01902459|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6192096|NCT01902459|Hemostatics|hemostatics|mesh-ancestor
6192097|NCT01902459|Coagulants|coagulants|mesh-ancestor
6192098|NCT01902758|Ambrisentan|ambrisentan|mesh-list
6192099|NCT01902758|Theophylline|theophylline|mesh-list
5583816|NCT03825341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5583817|NCT03825341|Antisickling Agents|antisickling agents|mesh-ancestor
5583818|NCT03825341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5583819|NCT03825341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192100|NCT01902758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6192101|NCT01902758|Autonomic Agents|autonomic agents|mesh-ancestor
6192102|NCT01902758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6192103|NCT01902758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192104|NCT01902758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5583820|NCT03825341|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5583821|NCT03825302|Mannitol|mannitol|mesh-list
5583822|NCT03825302|Methacholine Chloride|methacholine chloride|mesh-list
5583823|NCT03825302|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5583824|NCT03825302|Diuretics|diuretics|mesh-ancestor
5583825|NCT03825302|Natriuretic Agents|natriuretic agents|mesh-ancestor
5583826|NCT03825302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583827|NCT03825302|Miotics|miotics|mesh-ancestor
5583828|NCT03825302|Autonomic Agents|autonomic agents|mesh-ancestor
5583829|NCT03825302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5583830|NCT03825302|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5583831|NCT03825302|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
5583832|NCT03825302|Respiratory System Agents|respiratory system agents|mesh-ancestor
6192105|NCT01902758|Respiratory System Agents|respiratory system agents|mesh-ancestor
6192106|NCT01902758|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6192107|NCT01902758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5583833|NCT03825302|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
5583834|NCT03825302|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5583835|NCT03825302|Cholinergic Agents|cholinergic agents|mesh-ancestor
5583836|NCT03825302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5583837|NCT03825302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583838|NCT03825250|Valproic Acid|valproic acid|mesh-list
5583839|NCT03825250|Anticonvulsants|anticonvulsants|mesh-ancestor
6192108|NCT01902758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192109|NCT01902758|Vasodilator Agents|vasodilator agents|mesh-ancestor
6192110|NCT01902758|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6192111|NCT01902758|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6192112|NCT01902758|Purinergic Agents|purinergic agents|mesh-ancestor
6192113|NCT01902758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6192114|NCT01902758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6192115|NCT01903005|Buprenorphine|buprenorphine|mesh-list
6192116|NCT01903005|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6192117|NCT01903005|Naloxone|naloxone|mesh-list
6192118|NCT01903005|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6192119|NCT01903005|Narcotics|narcotics|mesh-ancestor
6192120|NCT01903005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6192121|NCT01903005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192122|NCT01903005|Analgesics|analgesics|mesh-ancestor
6192123|NCT01903005|Sensory System Agents|sensory system agents|mesh-ancestor
6192124|NCT01903005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6192125|NCT01903005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6192126|NCT01903031|Ritonavir|ritonavir|mesh-list
6192127|NCT01903031|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6192128|NCT01903031|Tenofovir|tenofovir|mesh-list
6192129|NCT01903031|Efavirenz|efavirenz|mesh-list
6192130|NCT01903031|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
6192131|NCT01903031|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6192132|NCT01903031|Etonogestrel|etonogestrel|mesh-list
6192133|NCT01903031|NuvaRing|nuvaring|mesh-list
6192134|NCT01903031|Estradiol|estradiol|mesh-list
6192135|NCT01903031|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6192136|NCT01903031|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6192137|NCT01903031|Protease Inhibitors|protease inhibitors|mesh-ancestor
6192138|NCT01903031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6192139|NCT01903031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192140|NCT01903031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6192141|NCT01903031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6192142|NCT01903031|Antiviral Agents|antiviral agents|mesh-ancestor
6192143|NCT01903031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6192144|NCT01903031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6192145|NCT01903031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6192146|NCT01903031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6192147|NCT01903031|Estrogens|estrogens|mesh-ancestor
6192148|NCT01903031|Hormones|hormones|mesh-ancestor
6192149|NCT01903031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6192150|NCT01903031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192151|NCT01903031|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6192152|NCT01903031|Contraceptive Agents|contraceptive agents|mesh-ancestor
6192153|NCT01903031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5583840|NCT03825250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6192154|NCT01903031|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6192155|NCT01903031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6192156|NCT01903031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6192157|NCT01903031|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6192158|NCT01903031|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6192159|NCT01903031|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6192160|NCT01903031|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6192161|NCT01903031|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6192162|NCT01903252|Mesalamine|mesalamine|mesh-list
6192163|NCT01903252|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6192164|NCT01903252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6192165|NCT01903252|Analgesics|analgesics|mesh-ancestor
5583841|NCT03825250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583842|NCT03825250|GABA Agents|gaba agents|mesh-ancestor
5583843|NCT03825250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5583844|NCT03825250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583845|NCT03825250|Antimanic Agents|antimanic agents|mesh-ancestor
5583846|NCT03825250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5583847|NCT03825250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5583848|NCT03825250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5583849|NCT03825445|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5583850|NCT03825445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5583851|NCT03825445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583852|NCT03825198|Dexamethasone|dexamethasone|mesh-list
5583853|NCT03825198|Ketorolac|ketorolac|mesh-list
6192166|NCT01903252|Sensory System Agents|sensory system agents|mesh-ancestor
6192167|NCT01903252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6192168|NCT01903252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192169|NCT01903252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6192170|NCT01903252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6192171|NCT01903265|Cyclobenzaprine|cyclobenzaprine|mesh-list
6192172|NCT01903265|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6192173|NCT01903265|Antidepressive Agents|antidepressive agents|mesh-ancestor
6192174|NCT01903265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6192175|NCT01903265|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6192176|NCT01903265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192177|NCT01903265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6192178|NCT01903265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6192179|NCT01903265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6192180|NCT01903265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6192181|NCT01903356|Linagliptin|linagliptin|mesh-list
6192182|NCT01903356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6192183|NCT01903356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192184|NCT01903356|Incretins|incretins|mesh-ancestor
6192185|NCT01903356|Hormones|hormones|mesh-ancestor
6192186|NCT01903356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6192187|NCT01903356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6192188|NCT01903356|Protease Inhibitors|protease inhibitors|mesh-ancestor
6192189|NCT01903356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6192190|NCT01903356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192191|NCT01903434|Evacetrapib|evacetrapib|mesh-list
6192192|NCT01903434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6192193|NCT01903434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6192194|NCT01903434|Antimetabolites|antimetabolites|mesh-ancestor
6192195|NCT01903434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192196|NCT01903434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6192197|NCT01903720|Dexamethasone|dexamethasone|mesh-list
6192198|NCT01903720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6192199|NCT01903720|Antiemetics|antiemetics|mesh-ancestor
6192200|NCT01903720|Autonomic Agents|autonomic agents|mesh-ancestor
6192201|NCT01903720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6192202|NCT01903720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192203|NCT01903720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6192204|NCT01903720|Glucocorticoids|glucocorticoids|mesh-ancestor
6192205|NCT01903720|Hormones|hormones|mesh-ancestor
6192206|NCT01903720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6192207|NCT01903720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6192208|NCT01903720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6192209|NCT01903798|Mycophenolic Acid|mycophenolic acid|mesh-list
6192210|NCT01903798|Prednisolone|prednisolone|mesh-list
5583854|NCT03825198|Sufentanil|sufentanil|mesh-list
5583855|NCT03825198|Morphine|morphine|mesh-list
5583856|NCT03825198|Bromides|bromides|mesh-list
5583857|NCT03825198|Propofol|propofol|mesh-list
5583858|NCT03825198|Sevoflurane|sevoflurane|mesh-list
5583859|NCT03825198|Levobupivacaine|levobupivacaine|mesh-list
6192211|NCT01903798|Rilonacept|rilonacept|mesh-list
5583860|NCT03825198|Rocuronium|rocuronium|mesh-list
5583861|NCT03825198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5583862|NCT03825198|Antiemetics|antiemetics|mesh-ancestor
5583863|NCT03825198|Autonomic Agents|autonomic agents|mesh-ancestor
6192212|NCT01903798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6192213|NCT01903798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6192214|NCT01903798|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6192215|NCT01903798|Antitubercular Agents|antitubercular agents|mesh-ancestor
6192216|NCT01903798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6192217|NCT01903798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6192218|NCT01903798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6192219|NCT01903798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192220|NCT01903798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6192221|NCT01903798|Glucocorticoids|glucocorticoids|mesh-ancestor
6192222|NCT01903798|Hormones|hormones|mesh-ancestor
6192223|NCT01903798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6192224|NCT01903798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192225|NCT01903798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6192226|NCT01903811|Dexamethasone|dexamethasone|mesh-list
6192227|NCT01903811|Dexamethasone acetate|dexamethasone acetate|mesh-list
6192228|NCT01903811|Ichthammol|ichthammol|mesh-list
6192229|NCT01903811|BB 1101|bb 1101|mesh-list
6192230|NCT01903811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6192231|NCT01903811|Antiemetics|antiemetics|mesh-ancestor
6192232|NCT01903811|Autonomic Agents|autonomic agents|mesh-ancestor
6192233|NCT01903811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6192234|NCT01903811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192235|NCT01903811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6192236|NCT01903811|Glucocorticoids|glucocorticoids|mesh-ancestor
6192237|NCT01903811|Hormones|hormones|mesh-ancestor
6192238|NCT01903811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6192239|NCT01903811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6192240|NCT01903811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6192241|NCT01903811|Protease Inhibitors|protease inhibitors|mesh-ancestor
6192242|NCT01903811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6192243|NCT01903811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192244|NCT01903811|Dermatologic Agents|dermatologic agents|mesh-ancestor
6192245|NCT01903837|Naltrexone|naltrexone|mesh-list
6192246|NCT01903837|Olanzapine|olanzapine|mesh-list
6192247|NCT01903837|ALKS-33|alks-33|mesh-list
6192248|NCT01903837|Antiemetics|antiemetics|mesh-ancestor
6192249|NCT01903837|Autonomic Agents|autonomic agents|mesh-ancestor
6192250|NCT01903837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6192251|NCT01903837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192252|NCT01903837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6192253|NCT01903837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6192254|NCT01903837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6192255|NCT01903837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6192256|NCT01903837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6192257|NCT01903837|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6192258|NCT01903837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6192259|NCT01903837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6192260|NCT01903837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192261|NCT01903837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6192262|NCT01903837|Serotonin Agents|serotonin agents|mesh-ancestor
6192263|NCT01903837|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6192264|NCT01903837|Sensory System Agents|sensory system agents|mesh-ancestor
6192265|NCT01903837|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5583864|NCT03825198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5583865|NCT03825198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583866|NCT03825198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5583867|NCT03825198|Glucocorticoids|glucocorticoids|mesh-ancestor
5583868|NCT03825198|Hormones|hormones|mesh-ancestor
5583869|NCT03825198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5583870|NCT03825198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5583871|NCT03825198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6192266|NCT01903993|Docetaxel|docetaxel|mesh-list
6192267|NCT01903993|Atezolizumab|atezolizumab|mesh-list
6192268|NCT01903993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6192269|NCT01903993|Tubulin Modulators|tubulin modulators|mesh-ancestor
6192270|NCT01903993|Antimitotic Agents|antimitotic agents|mesh-ancestor
6192271|NCT01903993|Mitosis Modulators|mitosis modulators|mesh-ancestor
6192272|NCT01903993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192273|NCT01904058|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
6192274|NCT01904058|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5583872|NCT03825198|Anesthetics|anesthetics|mesh-ancestor
6192275|NCT01904058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6192276|NCT01904071|Morphine|morphine|mesh-list
6192277|NCT01904071|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6192278|NCT01904071|Narcotics|narcotics|mesh-ancestor
6192279|NCT01904071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6192280|NCT01904071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583873|NCT03825198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5583874|NCT03825198|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5583875|NCT03825198|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5583876|NCT03825198|Anesthetics, General|anesthetics, general|mesh-ancestor
5583877|NCT03825198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5583878|NCT03825198|Narcotics|narcotics|mesh-ancestor
6192281|NCT01904071|Analgesics|analgesics|mesh-ancestor
6192282|NCT01904071|Sensory System Agents|sensory system agents|mesh-ancestor
6192283|NCT01904071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6192284|NCT01904149|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
6192285|NCT01904149|Tramadol|tramadol|mesh-list
6192286|NCT01904149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6192287|NCT01904149|Narcotics|narcotics|mesh-ancestor
6192288|NCT01904149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5583879|NCT03825198|Analgesics|analgesics|mesh-ancestor
5583880|NCT03825198|Sensory System Agents|sensory system agents|mesh-ancestor
5583881|NCT03825198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5583882|NCT03825198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5583883|NCT03825198|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6192289|NCT01904149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192290|NCT01904149|Analgesics|analgesics|mesh-ancestor
6192291|NCT01904149|Sensory System Agents|sensory system agents|mesh-ancestor
6192292|NCT01904149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6192293|NCT01904149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6192294|NCT01904149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6192295|NCT01904149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6192296|NCT01904149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6192297|NCT01904526|Guanfacine|guanfacine|mesh-list
6192298|NCT01904526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6192299|NCT01904526|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6192300|NCT01904526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6192301|NCT01904526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6192302|NCT01904526|Adrenergic Agents|adrenergic agents|mesh-ancestor
6192303|NCT01904526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6192304|NCT01904526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192305|NCT01904526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192306|NCT01904721|Bimatoprost|bimatoprost|mesh-list
6192307|NCT01904721|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6192308|NCT01904721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6192309|NCT01904760|Dexmedetomidine|dexmedetomidine|mesh-list
6192310|NCT01904760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6192311|NCT01904760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6192312|NCT01904760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192313|NCT01904760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6192314|NCT01904760|Analgesics|analgesics|mesh-ancestor
6192315|NCT01904760|Sensory System Agents|sensory system agents|mesh-ancestor
6192316|NCT01904760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6192317|NCT01904760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6192318|NCT01904760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6192319|NCT01904760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6192320|NCT01904760|Adrenergic Agents|adrenergic agents|mesh-ancestor
6192321|NCT01904760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6192322|NCT01904760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192323|NCT01904864|Iron|iron|mesh-list
6192324|NCT01904864|Micronutrients|micronutrients|mesh-ancestor
6192325|NCT01904864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192326|NCT01904864|Trace Elements|trace elements|mesh-ancestor
6192327|NCT01904903|Trastuzumab|trastuzumab|mesh-list
6192328|NCT01904903|Pertuzumab|pertuzumab|mesh-list
6192329|NCT01904903|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
6192330|NCT01904903|Maytansine|maytansine|mesh-list
6192331|NCT01904903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6192332|NCT01904903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6192333|NCT01904903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6192334|NCT01904903|Tubulin Modulators|tubulin modulators|mesh-ancestor
6192335|NCT01904903|Antimitotic Agents|antimitotic agents|mesh-ancestor
6192336|NCT01904903|Mitosis Modulators|mitosis modulators|mesh-ancestor
5583884|NCT03825198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5583885|NCT03825198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6192337|NCT01904903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192338|NCT01905423|Albendazole|albendazole|mesh-list
6192339|NCT01905423|Diethylcarbamazine|diethylcarbamazine|mesh-list
6192340|NCT01905423|Piperazine|piperazine|mesh-list
6192341|NCT01905423|Mebendazole|mebendazole|mesh-list
5583886|NCT03825198|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5583887|NCT03825198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5583888|NCT03825198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583889|NCT03825198|Anticonvulsants|anticonvulsants|mesh-ancestor
5583890|NCT03825198|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5583891|NCT03825198|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5583892|NCT03825198|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5583893|NCT03825198|Anesthetics, Local|anesthetics, local|mesh-ancestor
5583894|NCT03825198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6192342|NCT01905423|Piperazine citrate|piperazine citrate|mesh-list
6192343|NCT01905423|Citric Acid|citric acid|mesh-list
6192344|NCT01905423|Sodium Citrate|sodium citrate|mesh-list
6192345|NCT01905423|DMP 777|dmp 777|mesh-list
6192346|NCT01905423|Anticoagulants|anticoagulants|mesh-ancestor
6192347|NCT01905423|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6192348|NCT01905423|Chelating Agents|chelating agents|mesh-ancestor
6192349|NCT01905423|Sequestering Agents|sequestering agents|mesh-ancestor
5583895|NCT03825367|Nivolumab|nivolumab|mesh-list
5583896|NCT03825367|Azacitidine|azacitidine|mesh-list
5583897|NCT03825367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6192350|NCT01905423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192351|NCT01905423|Anthelmintics|anthelmintics|mesh-ancestor
6192352|NCT01905423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6192353|NCT01905423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6192354|NCT01905423|Anticestodal Agents|anticestodal agents|mesh-ancestor
6192355|NCT01905423|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6192356|NCT01905423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6192357|NCT01905423|Tubulin Modulators|tubulin modulators|mesh-ancestor
6192358|NCT01905423|Antimitotic Agents|antimitotic agents|mesh-ancestor
6192359|NCT01905423|Mitosis Modulators|mitosis modulators|mesh-ancestor
6192360|NCT01905423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6192361|NCT01905423|Filaricides|filaricides|mesh-ancestor
6192362|NCT01905423|Antinematodal Agents|antinematodal agents|mesh-ancestor
6192363|NCT01905423|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6192364|NCT01905423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6192365|NCT01905592|Niraparib|niraparib|mesh-list
6192366|NCT01905592|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6192367|NCT01905592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6192368|NCT01905592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192369|NCT01905592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6192370|NCT01905657|Docetaxel|docetaxel|mesh-list
6192371|NCT01905657|Pembrolizumab|pembrolizumab|mesh-list
6192372|NCT01905657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6192373|NCT01905657|Tubulin Modulators|tubulin modulators|mesh-ancestor
6192374|NCT01905657|Antimitotic Agents|antimitotic agents|mesh-ancestor
6192375|NCT01905657|Mitosis Modulators|mitosis modulators|mesh-ancestor
6192376|NCT01905657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192377|NCT01905657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6192378|NCT01905683|Botulinum Toxins|botulinum toxins|mesh-list
6192379|NCT01905683|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6192380|NCT01905683|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6192381|NCT01905683|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
6192382|NCT01905683|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6192383|NCT01905683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6192384|NCT01905683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192385|NCT01905683|Cholinergic Agents|cholinergic agents|mesh-ancestor
6192386|NCT01905683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6192387|NCT01905683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192388|NCT01905683|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6192389|NCT01905683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6192390|NCT01905943|Cyclophosphamide|cyclophosphamide|mesh-list
6192391|NCT01905943|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6192392|NCT01905943|Chlorambucil|chlorambucil|mesh-list
6192393|NCT01905943|Fludarabine|fludarabine|mesh-list
6192394|NCT01905943|Obinutuzumab|obinutuzumab|mesh-list
6192395|NCT01905943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6192396|NCT01905943|Immunologic Factors|immunologic factors|mesh-ancestor
6192397|NCT01905943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192398|NCT01905943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6192399|NCT01905943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6192400|NCT01905943|Alkylating Agents|alkylating agents|mesh-ancestor
5583898|NCT03825367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5583899|NCT03825367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5583900|NCT03825367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583901|NCT03825367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5583902|NCT03825367|Antimetabolites|antimetabolites|mesh-ancestor
5583903|NCT03825367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5583904|NCT03825536|Methamphetamine|methamphetamine|mesh-list
5583905|NCT03825536|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5583906|NCT03825536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583907|NCT03825536|Sympathomimetics|sympathomimetics|mesh-ancestor
5583908|NCT03825536|Autonomic Agents|autonomic agents|mesh-ancestor
5583909|NCT03825536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5583910|NCT03825536|Dopamine Agents|dopamine agents|mesh-ancestor
5583911|NCT03825536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5583912|NCT03825536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583913|NCT03825536|Adrenergic Agents|adrenergic agents|mesh-ancestor
5583914|NCT03825536|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5583915|NCT03825536|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6192401|NCT01905943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192402|NCT01905943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6192403|NCT01905943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6192404|NCT01905943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6192405|NCT01906008|Minocycline|minocycline|mesh-list
6192406|NCT01906008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6192407|NCT01906008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6192408|NCT01906346|Cocaine|cocaine|mesh-list
6192409|NCT01906346|Anesthetics, Local|anesthetics, local|mesh-ancestor
6192410|NCT01906346|Anesthetics|anesthetics|mesh-ancestor
5583916|NCT03825536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5583917|NCT03825536|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5583918|NCT03825328|Gemcitabine|gemcitabine|mesh-list
5583919|NCT03825328|Paclitaxel|paclitaxel|mesh-list
5583920|NCT03825328|Oxaliplatin|oxaliplatin|mesh-list
5583921|NCT03825328|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5583922|NCT03825328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5583923|NCT03825328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5583924|NCT03825328|Tubulin Modulators|tubulin modulators|mesh-ancestor
5583925|NCT03825328|Antimitotic Agents|antimitotic agents|mesh-ancestor
5583926|NCT03825328|Mitosis Modulators|mitosis modulators|mesh-ancestor
5583927|NCT03825328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583928|NCT03825328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5583929|NCT03825328|Antimetabolites|antimetabolites|mesh-ancestor
5583930|NCT03825328|Antiviral Agents|antiviral agents|mesh-ancestor
5583931|NCT03825328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5583932|NCT03825328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5583933|NCT03825328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6192411|NCT01906346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6192412|NCT01906346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192413|NCT01906346|Sensory System Agents|sensory system agents|mesh-ancestor
6192414|NCT01906346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6192415|NCT01906346|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6192416|NCT01906346|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6192417|NCT01906346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6192418|NCT01906346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6192419|NCT01906346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192420|NCT01906346|Dopamine Agents|dopamine agents|mesh-ancestor
6192421|NCT01906346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6192422|NCT01906372|Hormones|hormones|mesh-list
6192423|NCT01906372|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6192424|NCT01906372|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
6192425|NCT01906372|beta-Endorphin|beta-endorphin|mesh-list
6192426|NCT01906372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6192427|NCT01906372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192428|NCT01906372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5583934|NCT03825328|Immunologic Factors|immunologic factors|mesh-ancestor
5583935|NCT03825328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583936|NCT03825133|Hyaluronic Acid|hyaluronic acid|mesh-list
5583937|NCT03825133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5583938|NCT03825133|Immunologic Factors|immunologic factors|mesh-ancestor
5583939|NCT03825133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583940|NCT03825133|Viscosupplements|viscosupplements|mesh-ancestor
5583941|NCT03825133|Protective Agents|protective agents|mesh-ancestor
5583942|NCT03824847|Clarithromycin|clarithromycin|mesh-list
5583943|NCT03824847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5583944|NCT03824847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5583945|NCT03824847|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5583946|NCT03824847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5583947|NCT03824847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583948|NCT03824847|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5583949|NCT03824847|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5583950|NCT03824743|Plasma-lyte 148|plasma-lyte 148|mesh-list
5583951|NCT03824743|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5583952|NCT03824743|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6192429|NCT01906372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192430|NCT01906658|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6192431|NCT01906658|Hormones|hormones|mesh-ancestor
6192432|NCT01906658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6192433|NCT01906658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192434|NCT01906866|Melatonin|melatonin|mesh-list
6192435|NCT01906866|Antioxidants|antioxidants|mesh-ancestor
6192436|NCT01906866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192437|NCT01906866|Protective Agents|protective agents|mesh-ancestor
6192438|NCT01906866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192439|NCT01906866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6192440|NCT01907100|Cisplatin|cisplatin|mesh-list
6192441|NCT01907100|Pemetrexed|pemetrexed|mesh-list
6192442|NCT01907100|Nintedanib|nintedanib|mesh-list
6192443|NCT01907100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6192444|NCT01907100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6192445|NCT01907100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192446|NCT01907100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6192447|NCT01907100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5583953|NCT03824925|Zinc|zinc|mesh-list
5583954|NCT03824925|Zinc Sulfate|zinc sulfate|mesh-list
5583955|NCT03824925|Trace Elements|trace elements|mesh-ancestor
5583956|NCT03824925|Micronutrients|micronutrients|mesh-ancestor
5583957|NCT03824925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583958|NCT03824925|Astringents|astringents|mesh-ancestor
5583959|NCT03824925|Dermatologic Agents|dermatologic agents|mesh-ancestor
5583960|NCT03825081|Brimonidine Tartrate|brimonidine tartrate|mesh-list
5583961|NCT03825081|Pilocarpine|pilocarpine|mesh-list
5583962|NCT03825081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5583963|NCT03825081|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5583964|NCT03825081|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5583965|NCT03825081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5583966|NCT03825081|Adrenergic Agents|adrenergic agents|mesh-ancestor
5583967|NCT03825081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5583968|NCT03825081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583969|NCT03825081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583970|NCT03825081|Miotics|miotics|mesh-ancestor
5583971|NCT03825081|Autonomic Agents|autonomic agents|mesh-ancestor
5583972|NCT03825081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5583973|NCT03825081|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
5583974|NCT03825081|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6192448|NCT01907100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6192449|NCT01907113|Empagliflozin|empagliflozin|mesh-list
6192450|NCT01907113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6192451|NCT01907113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192452|NCT01907113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6192453|NCT01907113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192454|NCT01907217|Methohexital|methohexital|mesh-list
6192455|NCT01907217|Succinylcholine|succinylcholine|mesh-list
6192456|NCT01907217|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
6192457|NCT01907217|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6192458|NCT01907217|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6192459|NCT01907217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6192460|NCT01907217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583975|NCT03825081|Cholinergic Agents|cholinergic agents|mesh-ancestor
6192461|NCT01907217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6192462|NCT01907217|Anesthetics, General|anesthetics, general|mesh-ancestor
6192463|NCT01907217|Anesthetics|anesthetics|mesh-ancestor
6192464|NCT01907217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6192465|NCT01907321|Capsaicin|capsaicin|mesh-list
6192466|NCT01907321|Antipruritics|antipruritics|mesh-ancestor
6192467|NCT01907321|Dermatologic Agents|dermatologic agents|mesh-ancestor
6192468|NCT01907321|Sensory System Agents|sensory system agents|mesh-ancestor
6192469|NCT01907321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6192470|NCT01907321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192471|NCT01907334|Fluticasone|fluticasone|mesh-list
6192472|NCT01907334|Xhance|xhance|mesh-list
6192473|NCT01907334|Albuterol|albuterol|mesh-list
6192474|NCT01907334|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6192475|NCT01907334|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6192476|NCT01907334|Methacholine Chloride|methacholine chloride|mesh-list
6192477|NCT01907334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6192478|NCT01907334|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6192479|NCT01907334|Autonomic Agents|autonomic agents|mesh-ancestor
6192480|NCT01907334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6192481|NCT01907334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192482|NCT01907334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5583976|NCT03825068|Anesthetics|anesthetics|mesh-list
5583977|NCT03825068|Anesthetics, General|anesthetics, general|mesh-list
5583978|NCT03825068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5583979|NCT03825068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583980|NCT03824665|Fentanyl|fentanyl|mesh-list
5583981|NCT03824665|Nalbuphine|nalbuphine|mesh-list
5583982|NCT03824665|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5583983|NCT03824665|Narcotics|narcotics|mesh-ancestor
5583984|NCT03824665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6192483|NCT01907334|Respiratory System Agents|respiratory system agents|mesh-ancestor
6192484|NCT01907334|Dermatologic Agents|dermatologic agents|mesh-ancestor
6192485|NCT01907334|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6192486|NCT01907334|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6192487|NCT01907334|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6192488|NCT01907334|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6192489|NCT01907334|Adrenergic Agents|adrenergic agents|mesh-ancestor
6192490|NCT01907334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6192491|NCT01907334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192492|NCT01907334|Tocolytic Agents|tocolytic agents|mesh-ancestor
6192493|NCT01907334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6192494|NCT01907334|Glucocorticoids|glucocorticoids|mesh-ancestor
6192495|NCT01907334|Hormones|hormones|mesh-ancestor
6192496|NCT01907334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6192497|NCT01907334|Sympathomimetics|sympathomimetics|mesh-ancestor
6192498|NCT01907334|Miotics|miotics|mesh-ancestor
6192499|NCT01907334|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6192500|NCT01907334|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
6192501|NCT01907334|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6192502|NCT01907334|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6192503|NCT01907334|Cholinergic Agents|cholinergic agents|mesh-ancestor
6192504|NCT01907490|Benzyl Alcohol|benzyl alcohol|mesh-list
6192505|NCT01907490|Anesthetics, Local|anesthetics, local|mesh-ancestor
6192506|NCT01907490|Anesthetics|anesthetics|mesh-ancestor
6192507|NCT01907490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6192508|NCT01907490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192509|NCT01907490|Sensory System Agents|sensory system agents|mesh-ancestor
6192510|NCT01907490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6192511|NCT01907607|Palbociclib|palbociclib|mesh-list
6192512|NCT01907607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6192513|NCT01907607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6192514|NCT01907607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6192515|NCT01907607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192516|NCT01907815|Trametinib|trametinib|mesh-list
6192517|NCT01907815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6192518|NCT01907815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6192519|NCT01907815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6192520|NCT01907815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5583985|NCT03824665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5583986|NCT03824665|Analgesics|analgesics|mesh-ancestor
5583987|NCT03824665|Sensory System Agents|sensory system agents|mesh-ancestor
5583988|NCT03824665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5583989|NCT03824665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5583990|NCT03824665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6192521|NCT01907854|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6192522|NCT01907854|Liraglutide|liraglutide|mesh-list
5583991|NCT03824665|Anesthetics, General|anesthetics, general|mesh-ancestor
5583992|NCT03824665|Anesthetics|anesthetics|mesh-ancestor
6192523|NCT01907854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6192524|NCT01907854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192525|NCT01907854|Incretins|incretins|mesh-ancestor
6192526|NCT01907854|Hormones|hormones|mesh-ancestor
6192527|NCT01907854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6192528|NCT01907854|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6192529|NCT01907854|Protease Inhibitors|protease inhibitors|mesh-ancestor
6192530|NCT01907854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6192531|NCT01907854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192532|NCT01908062|Naltrexone|naltrexone|mesh-list
6192533|NCT01908062|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6192534|NCT01908062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6192535|NCT01908062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192536|NCT01908062|Sensory System Agents|sensory system agents|mesh-ancestor
6192537|NCT01908062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6207258|NCT02112370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6207259|NCT02112448|Acetaminophen|acetaminophen|mesh-list
6207260|NCT02112448|Ketorolac|ketorolac|mesh-list
6207261|NCT02112448|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6207262|NCT02112448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6207263|NCT02112448|Analgesics|analgesics|mesh-ancestor
6207264|NCT02112448|Sensory System Agents|sensory system agents|mesh-ancestor
6207265|NCT02112448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5583993|NCT03824938|Aspirin|aspirin|mesh-list
5583994|NCT03824938|Acetaminophen|acetaminophen|mesh-list
5583995|NCT03824938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5583996|NCT03824938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5583997|NCT03824938|Analgesics|analgesics|mesh-ancestor
5583998|NCT03824938|Sensory System Agents|sensory system agents|mesh-ancestor
6207266|NCT02112448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207267|NCT02112448|Antipyretics|antipyretics|mesh-ancestor
6207268|NCT02112448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6207269|NCT02112448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6207270|NCT02112448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6207271|NCT02112448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6207272|NCT02112448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6207273|NCT02112448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207274|NCT02113007|Rituximab|rituximab|mesh-list
6207275|NCT02113007|Temozolomide|temozolomide|mesh-list
6207276|NCT02113007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6207277|NCT02113007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6207278|NCT02113007|Immunologic Factors|immunologic factors|mesh-ancestor
6207279|NCT02113007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207280|NCT02113007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6207281|NCT02113007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6207282|NCT02113007|Alkylating Agents|alkylating agents|mesh-ancestor
6207283|NCT02113007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207284|NCT02113241|Dapagliflozin|dapagliflozin|mesh-list
6207285|NCT02113241|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6207286|NCT02113241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207287|NCT02113241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5583999|NCT03824938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5584000|NCT03824938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584001|NCT03824938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6207288|NCT02113241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207289|NCT02113579|Fluorides|fluorides|mesh-list
6207290|NCT02113579|Cariostatic Agents|cariostatic agents|mesh-ancestor
6207291|NCT02113579|Protective Agents|protective agents|mesh-ancestor
6207292|NCT02113579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207293|NCT02114151|Sofosbuvir|sofosbuvir|mesh-list
6207294|NCT02114151|Simeprevir|simeprevir|mesh-list
6207295|NCT02114151|Antiviral Agents|antiviral agents|mesh-ancestor
6207296|NCT02114151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6207297|NCT02114151|Protease Inhibitors|protease inhibitors|mesh-ancestor
6207298|NCT02114151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6207299|NCT02114151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584002|NCT03824938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5584003|NCT03824938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5584004|NCT03824938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5584005|NCT03824938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584006|NCT03824938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5584007|NCT03824938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6207300|NCT02114177|Sofosbuvir|sofosbuvir|mesh-list
6192538|NCT01908101|Halichondrin B|halichondrin b|mesh-list
6192539|NCT01908101|Tubulin Modulators|tubulin modulators|mesh-ancestor
6192540|NCT01908101|Antimitotic Agents|antimitotic agents|mesh-ancestor
6192541|NCT01908101|Mitosis Modulators|mitosis modulators|mesh-ancestor
5584008|NCT03824938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5584009|NCT03824938|Antipyretics|antipyretics|mesh-ancestor
5584010|NCT03825016|Diclofenac|diclofenac|mesh-list
5584011|NCT03825016|Lidocaine|lidocaine|mesh-list
5584012|NCT03825016|Anesthetics, Local|anesthetics, local|mesh-ancestor
5584013|NCT03825016|Anesthetics|anesthetics|mesh-ancestor
5584014|NCT03825016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5584015|NCT03825016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584016|NCT03825016|Sensory System Agents|sensory system agents|mesh-ancestor
5584017|NCT03825016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5584018|NCT03825016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5584019|NCT03825016|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5584020|NCT03825016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5584021|NCT03825016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6192542|NCT01908101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192543|NCT01908101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6192544|NCT01908127|Salicylic Acid|salicylic acid|mesh-list
6192545|NCT01908127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6192546|NCT01908127|Antifungal Agents|antifungal agents|mesh-ancestor
6192547|NCT01908127|Keratolytic Agents|keratolytic agents|mesh-ancestor
6192548|NCT01908127|Dermatologic Agents|dermatologic agents|mesh-ancestor
6192549|NCT01908140|Fluticasone|fluticasone|mesh-list
6192550|NCT01908140|Bromides|bromides|mesh-list
6192551|NCT01908140|Formoterol Fumarate|formoterol fumarate|mesh-list
6192552|NCT01908140|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6192553|NCT01908140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6192554|NCT01908140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6192555|NCT01908140|Autonomic Agents|autonomic agents|mesh-ancestor
6192556|NCT01908140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6192557|NCT01908140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192558|NCT01908140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6192559|NCT01908140|Respiratory System Agents|respiratory system agents|mesh-ancestor
6192560|NCT01908140|Dermatologic Agents|dermatologic agents|mesh-ancestor
6192561|NCT01908140|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6192562|NCT01908140|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6192563|NCT01908140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6192564|NCT01908140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6192565|NCT01908140|Adrenergic Agents|adrenergic agents|mesh-ancestor
5584022|NCT03825016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584023|NCT03825016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5584024|NCT03825016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5584025|NCT03825016|Analgesics|analgesics|mesh-ancestor
6192566|NCT01908140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6192567|NCT01908140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192568|NCT01908140|Anticonvulsants|anticonvulsants|mesh-ancestor
6192569|NCT01908205|Oxytocin|oxytocin|mesh-list
6192570|NCT01908205|Oxytocics|oxytocics|mesh-ancestor
6192571|NCT01908205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6192572|NCT01908205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192573|NCT01908582|Rifampin|rifampin|mesh-list
6192574|NCT01908582|Evacetrapib|evacetrapib|mesh-list
6192575|NCT01908582|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5584026|NCT03825016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6192576|NCT01908582|Antitubercular Agents|antitubercular agents|mesh-ancestor
6192577|NCT01908582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6192578|NCT01908582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5584027|NCT03825016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5584028|NCT03825016|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5584029|NCT03825016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5584030|NCT03824717|Ropivacaine|ropivacaine|mesh-list
5584031|NCT03824717|Anesthetics, Local|anesthetics, local|mesh-ancestor
5584032|NCT03824717|Anesthetics|anesthetics|mesh-ancestor
5584033|NCT03824717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5584034|NCT03824717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584035|NCT03824717|Sensory System Agents|sensory system agents|mesh-ancestor
5584036|NCT03824717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5584037|NCT03824834|Morphine|morphine|mesh-list
5584038|NCT03824834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5584039|NCT03824834|Narcotics|narcotics|mesh-ancestor
6192579|NCT01908582|Leprostatic Agents|leprostatic agents|mesh-ancestor
6192580|NCT01908582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6192581|NCT01908582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6192582|NCT01908582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192583|NCT01908582|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6192584|NCT01908582|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6192585|NCT01908582|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6192586|NCT01908582|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6672132|NCT01553981|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6672133|NCT01553981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6672134|NCT01553981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6672135|NCT01553981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672136|NCT01553981|Urological Agents|urological agents|mesh-ancestor
6672610|NCT01557270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672611|NCT01557270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6672612|NCT01557270|Analgesics|analgesics|mesh-ancestor
6672613|NCT01557270|Sensory System Agents|sensory system agents|mesh-ancestor
6672614|NCT01557270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6672615|NCT01557270|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6672616|NCT01557270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6192587|NCT01908582|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6192588|NCT01908582|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5584040|NCT03824834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5584041|NCT03824834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584042|NCT03824834|Analgesics|analgesics|mesh-ancestor
5584043|NCT03824834|Sensory System Agents|sensory system agents|mesh-ancestor
5584044|NCT03824834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5584045|NCT03824691|Durvalumab|durvalumab|mesh-list
5584046|NCT03824691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5584047|NCT03824691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5584048|NCT03824483|Venetoclax|venetoclax|mesh-list
5584049|NCT03824483|Obinutuzumab|obinutuzumab|mesh-list
5584050|NCT03824483|Zanubrutinib|zanubrutinib|mesh-list
5584051|NCT03824483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5584052|NCT03824483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6192589|NCT01908582|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6192590|NCT01908582|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6192591|NCT01908582|Antimetabolites|antimetabolites|mesh-ancestor
6192592|NCT01908582|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6192593|NCT01908699|Beraprost|beraprost|mesh-list
6192594|NCT01908699|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6192595|NCT01908699|Vasodilator Agents|vasodilator agents|mesh-ancestor
6192596|NCT01908751|Vitamin D|vitamin d|mesh-list
5584053|NCT03824483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5584054|NCT03824483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5584055|NCT03824483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584056|NCT03824379|Hypoglycemic Agents|hypoglycemic agents|mesh-list
5584057|NCT03824379|Magnesium citrate|magnesium citrate|mesh-list
6192597|NCT01908751|Ergocalciferols|ergocalciferols|mesh-list
6192598|NCT01908751|Vitamins|vitamins|mesh-list
5584058|NCT03824379|Cathartics|cathartics|mesh-ancestor
5584059|NCT03824379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5584060|NCT03824379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192599|NCT01908751|Micronutrients|micronutrients|mesh-ancestor
6192600|NCT01908751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192601|NCT01908751|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6192602|NCT01908751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6192603|NCT01908803|Ciprofloxacin|ciprofloxacin|mesh-list
6192604|NCT01908803|Dexamethasone|dexamethasone|mesh-list
6192605|NCT01908803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6192606|NCT01908803|Antiemetics|antiemetics|mesh-ancestor
6192607|NCT01908803|Autonomic Agents|autonomic agents|mesh-ancestor
6192608|NCT01908803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6192609|NCT01908803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192610|NCT01908803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6192611|NCT01908803|Glucocorticoids|glucocorticoids|mesh-ancestor
6192612|NCT01908803|Hormones|hormones|mesh-ancestor
6192613|NCT01908803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6192614|NCT01908803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6192615|NCT01908803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6192616|NCT01908803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6192617|NCT01908803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6192618|NCT01908803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6192619|NCT01908803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6192620|NCT01908803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6192621|NCT01908803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584061|NCT03824535|Deoxyglucose|deoxyglucose|mesh-list
5584062|NCT03824535|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5584063|NCT03824535|Fluorides|fluorides|mesh-list
5584064|NCT03824535|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5584065|NCT03824535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584066|NCT03824535|Cariostatic Agents|cariostatic agents|mesh-ancestor
5584067|NCT03824535|Protective Agents|protective agents|mesh-ancestor
5584068|NCT03824535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192622|NCT01908803|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6192623|NCT01908803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6192624|NCT01908816|Ranibizumab|ranibizumab|mesh-list
6672137|NCT01554046|Methylphenidate|methylphenidate|mesh-list
5584069|NCT03824535|Antimetabolites|antimetabolites|mesh-ancestor
5584070|NCT03824535|Antiviral Agents|antiviral agents|mesh-ancestor
5584071|NCT03824535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5584072|NCT03824561|Vedolizumab|vedolizumab|mesh-list
5584073|NCT03824561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5584074|NCT03824327|Papaverine|papaverine|mesh-list
5584075|NCT03824327|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5584076|NCT03824327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5584077|NCT03824327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584078|NCT03824327|Vasodilator Agents|vasodilator agents|mesh-ancestor
5584079|NCT03824327|Urological Agents|urological agents|mesh-ancestor
5584080|NCT03824171|Cholecalciferol|cholecalciferol|mesh-list
5584081|NCT03824171|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
5584082|NCT03824171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5605071|NCT03658772|Pembrolizumab|pembrolizumab|mesh-list
5584083|NCT03824171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584084|NCT03824171|Vitamins|vitamins|mesh-ancestor
5584085|NCT03824171|Micronutrients|micronutrients|mesh-ancestor
5584086|NCT03824171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5584087|NCT03824171|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5584088|NCT03824171|Hormone Antagonists|hormone antagonists|mesh-ancestor
5584089|NCT03824171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5584090|NCT03824171|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5584091|NCT03824171|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5584092|NCT03824314|Fentanyl|fentanyl|mesh-list
5584093|NCT03824314|Midazolam|midazolam|mesh-list
5584094|NCT03824314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5584095|NCT03824314|Narcotics|narcotics|mesh-ancestor
5584096|NCT03824314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5584097|NCT03824314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584098|NCT03824314|Analgesics|analgesics|mesh-ancestor
5584099|NCT03824314|Sensory System Agents|sensory system agents|mesh-ancestor
6192625|NCT01908816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6192626|NCT01908816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6192627|NCT01908816|Growth Substances|growth substances|mesh-ancestor
6192628|NCT01908816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192629|NCT01908816|Growth Inhibitors|growth inhibitors|mesh-ancestor
6192630|NCT01908816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6192631|NCT01908829|Solifenacin Succinate|solifenacin succinate|mesh-list
6192632|NCT01908829|Mirabegron|mirabegron|mesh-list
5584100|NCT03824314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5584101|NCT03824314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5584102|NCT03824314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5584103|NCT03824314|Anesthetics, General|anesthetics, general|mesh-ancestor
5584104|NCT03824314|Anesthetics|anesthetics|mesh-ancestor
5584105|NCT03824314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5584106|NCT03824314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5584107|NCT03824314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5584108|NCT03824314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5584109|NCT03824314|GABA Modulators|gaba modulators|mesh-ancestor
5584110|NCT03824314|GABA Agents|gaba agents|mesh-ancestor
5584111|NCT03824314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6192633|NCT01908829|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6192634|NCT01908829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6192635|NCT01908829|Cholinergic Agents|cholinergic agents|mesh-ancestor
6192636|NCT01908829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6192637|NCT01908829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192638|NCT01908829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192639|NCT01908829|Urological Agents|urological agents|mesh-ancestor
6192640|NCT01908829|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6192641|NCT01908829|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6192642|NCT01908829|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6192643|NCT01908829|Adrenergic Agents|adrenergic agents|mesh-ancestor
6192644|NCT01908842|Buprenorphine|buprenorphine|mesh-list
6192645|NCT01908842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6192646|NCT01908842|Narcotics|narcotics|mesh-ancestor
6192647|NCT01908842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6192648|NCT01908842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192649|NCT01908842|Analgesics|analgesics|mesh-ancestor
6192650|NCT01908842|Sensory System Agents|sensory system agents|mesh-ancestor
6192651|NCT01908842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6192652|NCT01908842|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6192653|NCT01908972|Prednisolone|prednisolone|mesh-list
6192654|NCT01908972|Propranolol|propranolol|mesh-list
6192655|NCT01908972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6192656|NCT01908972|Glucocorticoids|glucocorticoids|mesh-ancestor
6192657|NCT01908972|Hormones|hormones|mesh-ancestor
6192658|NCT01908972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6192659|NCT01908972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192660|NCT01908972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6192661|NCT01908972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6192662|NCT01908972|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6192663|NCT01908972|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6192664|NCT01908972|Adrenergic Agents|adrenergic agents|mesh-ancestor
6192665|NCT01908972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6192666|NCT01908972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192667|NCT01908972|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6672138|NCT01554046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5584112|NCT03824314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584113|NCT03824119|Ibuprofen|ibuprofen|mesh-list
6192668|NCT01908972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6192669|NCT01908972|Vasodilator Agents|vasodilator agents|mesh-ancestor
6192670|NCT01909141|Metformin|metformin|mesh-list
6192671|NCT01909141|Pioglitazone|pioglitazone|mesh-list
6192672|NCT01909141|Carbamide Peroxide|carbamide peroxide|mesh-list
5584114|NCT03824119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5584115|NCT03824119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5584116|NCT03824119|Analgesics|analgesics|mesh-ancestor
5584117|NCT03824119|Sensory System Agents|sensory system agents|mesh-ancestor
5584118|NCT03824119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5584119|NCT03824119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584120|NCT03824119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5584121|NCT03824119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5584122|NCT03824119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5584123|NCT03824119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5584124|NCT03824119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605072|NCT03658772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5605073|NCT03658772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605074|NCT03597568|Resveratrol|resveratrol|mesh-list
5605075|NCT03597568|Antioxidants|antioxidants|mesh-ancestor
5605076|NCT03597568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605077|NCT03597568|Protective Agents|protective agents|mesh-ancestor
5605078|NCT03597568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192673|NCT01909141|Letrozole|letrozole|mesh-list
6192674|NCT01909141|Clomiphene|clomiphene|mesh-list
6192675|NCT01909141|Enclomiphene|enclomiphene|mesh-list
6192676|NCT01909141|Zuclomiphene|zuclomiphene|mesh-list
6192677|NCT01909141|Hormones|hormones|mesh-list
6192678|NCT01909141|Estradiol|estradiol|mesh-list
6192679|NCT01909141|Testosterone|testosterone|mesh-list
6192680|NCT01909141|Progesterone|progesterone|mesh-list
6192681|NCT01909141|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6192682|NCT01909141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6192683|NCT01909141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192684|NCT01909141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192685|NCT01909141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6192686|NCT01909141|Estrogens|estrogens|mesh-ancestor
6192687|NCT01909141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6192688|NCT01909141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6192689|NCT01909141|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6192690|NCT01909141|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6192691|NCT01909141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6192692|NCT01909141|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6192693|NCT01909141|Hormone Antagonists|hormone antagonists|mesh-ancestor
6192694|NCT01909141|Androgens|androgens|mesh-ancestor
6192695|NCT01909141|Progestins|progestins|mesh-ancestor
6192696|NCT01909141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6192697|NCT01909141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6192698|NCT01909141|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6192699|NCT01909141|Fertility Agents|fertility agents|mesh-ancestor
6192700|NCT01909141|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6192701|NCT01909141|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6192702|NCT01909336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6192703|NCT01909453|Vemurafenib|vemurafenib|mesh-list
6192704|NCT01909453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6192705|NCT01909453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6192706|NCT01909453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6192707|NCT01909453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192708|NCT01909466|Aripiprazole|aripiprazole|mesh-list
6192709|NCT01909466|Antidepressive Agents|antidepressive agents|mesh-ancestor
6192710|NCT01909466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6192711|NCT01909466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6192712|NCT01909466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6192713|NCT01909466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6192714|NCT01909466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192715|NCT01909466|Dopamine Agonists|dopamine agonists|mesh-ancestor
6192716|NCT01909466|Dopamine Agents|dopamine agents|mesh-ancestor
6192717|NCT01909466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6192718|NCT01909466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192719|NCT01909466|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6192720|NCT01909466|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6192721|NCT01909466|Serotonin Agents|serotonin agents|mesh-ancestor
6192722|NCT01909466|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6192723|NCT01909466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6192724|NCT01909466|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6192725|NCT01909466|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6192726|NCT01909791|Bevacizumab|bevacizumab|mesh-list
6192727|NCT01909791|Aflibercept|aflibercept|mesh-list
6192728|NCT01909791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6192729|NCT01909791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6192730|NCT01909791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5584125|NCT03824340|Doxycycline|doxycycline|mesh-list
5584126|NCT03824340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5584127|NCT03824340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5584128|NCT03824340|Antimalarials|antimalarials|mesh-ancestor
5584129|NCT03824340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5584130|NCT03824340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5584131|NCT03824002|Insulin|insulin|mesh-list
5584132|NCT03824002|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5584133|NCT03824002|Metformin|metformin|mesh-list
5584134|NCT03824002|Insulin Glargine|insulin glargine|mesh-list
5584135|NCT03824002|Insulin Aspart|insulin aspart|mesh-list
5584136|NCT03824002|Dulaglutide|dulaglutide|mesh-list
5584137|NCT03824002|Repaglinide|repaglinide|mesh-list
5584138|NCT03824002|Insulin, Long-Acting|insulin, long-acting|mesh-list
5584139|NCT03824002|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
5584140|NCT03824002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5584141|NCT03824002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584142|NCT03823911|Sofosbuvir|sofosbuvir|mesh-list
5584143|NCT03823911|Grazoprevir|grazoprevir|mesh-list
5584144|NCT03823911|Ledipasvir|ledipasvir|mesh-list
5584145|NCT03823911|Velpatasvir|velpatasvir|mesh-list
6192731|NCT01909791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6192732|NCT01909791|Growth Substances|growth substances|mesh-ancestor
6192733|NCT01909791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192734|NCT01909791|Growth Inhibitors|growth inhibitors|mesh-ancestor
6192735|NCT01909804|Ribavirin|ribavirin|mesh-list
6192736|NCT01909804|Antiviral Agents|antiviral agents|mesh-ancestor
6192737|NCT01909804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6192738|NCT01909804|Antimetabolites|antimetabolites|mesh-ancestor
6192739|NCT01909804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192740|NCT01910064|Adapalene|adapalene|mesh-list
5584146|NCT03823911|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
5584147|NCT03823911|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
5584148|NCT03823911|Antiviral Agents|antiviral agents|mesh-ancestor
5584149|NCT03823911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5584150|NCT03823846|Flurbiprofen|flurbiprofen|mesh-list
5584151|NCT03823846|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
5584152|NCT03823846|Parecoxib|parecoxib|mesh-list
5584153|NCT03823846|Dezocine|dezocine|mesh-list
6192741|NCT01910064|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6192742|NCT01910064|Dermatologic Agents|dermatologic agents|mesh-ancestor
6192743|NCT01910064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6192744|NCT01910064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6192745|NCT01910064|Analgesics|analgesics|mesh-ancestor
6192746|NCT01910064|Sensory System Agents|sensory system agents|mesh-ancestor
6192747|NCT01910064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6192748|NCT01910064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192749|NCT01910064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6192750|NCT01910064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6192751|NCT01910181|Vemurafenib|vemurafenib|mesh-list
6192752|NCT01910181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6192753|NCT01910181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5584154|NCT03823846|Analgesics|analgesics|mesh-ancestor
5584155|NCT03823846|Sensory System Agents|sensory system agents|mesh-ancestor
5584156|NCT03823846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5584157|NCT03823846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584158|NCT03823846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5584159|NCT03823846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5584160|NCT03823846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5584161|NCT03823846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5584162|NCT03823846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5584163|NCT03823846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5584164|NCT03823846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584165|NCT03823846|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5584166|NCT03823846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5584167|NCT03823846|Narcotics|narcotics|mesh-ancestor
5584168|NCT03823846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5584169|NCT03823703|Cortisone|cortisone|mesh-list
6192754|NCT01910181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6207301|NCT02114177|Simeprevir|simeprevir|mesh-list
5584170|NCT03823703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5584171|NCT03823976|Anesthetics|anesthetics|mesh-list
5605079|NCT03597568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6192755|NCT01910181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192756|NCT01910311|Rifampin|rifampin|mesh-list
6192757|NCT01910311|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6192758|NCT01910311|Antitubercular Agents|antitubercular agents|mesh-ancestor
6192759|NCT01910311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6192760|NCT01910311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6192761|NCT01910311|Leprostatic Agents|leprostatic agents|mesh-ancestor
6192762|NCT01910311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6192763|NCT01910311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5584172|NCT03823976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5584173|NCT03823976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584174|NCT03823768|Tacrolimus|tacrolimus|mesh-list
5584175|NCT03823768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5584176|NCT03823768|Immunologic Factors|immunologic factors|mesh-ancestor
5584177|NCT03823768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488231|NCT00581477|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6488232|NCT00581477|Sympatholytics|sympatholytics|mesh-ancestor
6488233|NCT00581477|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6488234|NCT00581477|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6488235|NCT00581477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6488236|NCT00581607|Bosentan|bosentan|mesh-list
6488237|NCT00581607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6488238|NCT00581607|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6488239|NCT00581607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488240|NCT00581685|Celecoxib|celecoxib|mesh-list
6488241|NCT00581685|Pregabalin|pregabalin|mesh-list
6488242|NCT00581685|Analgesics|analgesics|mesh-ancestor
6488243|NCT00581685|Sensory System Agents|sensory system agents|mesh-ancestor
5584178|NCT03823768|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5584179|NCT03823768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5584180|NCT03823768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584181|NCT03823950|Sargramostim|sargramostim|mesh-list
5584182|NCT03823950|Lenograstim|lenograstim|mesh-list
5584183|NCT03823950|Immunologic Factors|immunologic factors|mesh-ancestor
5584184|NCT03823950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192764|NCT01910311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192765|NCT01910311|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6192766|NCT01910311|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6192767|NCT01910311|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6192768|NCT01910311|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6192769|NCT01910311|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6192770|NCT01910311|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6192771|NCT01910519|Vaccines|vaccines|mesh-list
6192772|NCT01910519|Immunologic Factors|immunologic factors|mesh-ancestor
6192773|NCT01910519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192774|NCT01910636|Sofosbuvir|sofosbuvir|mesh-list
6192775|NCT01910636|Antiviral Agents|antiviral agents|mesh-ancestor
6192776|NCT01910636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6192777|NCT01911065|Vaccines|vaccines|mesh-list
6192778|NCT01911065|Immunologic Factors|immunologic factors|mesh-ancestor
6192779|NCT01911065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192780|NCT01911169|Vitamin D|vitamin d|mesh-list
6192781|NCT01911169|Cholecalciferol|cholecalciferol|mesh-list
6192782|NCT01911169|Vitamins|vitamins|mesh-list
6192783|NCT01911169|Micronutrients|micronutrients|mesh-ancestor
6192784|NCT01911169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192785|NCT01911169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6192786|NCT01911169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6192787|NCT01911260|Chelating Agents|chelating agents|mesh-list
6192788|NCT01911260|Sequestering Agents|sequestering agents|mesh-ancestor
6192789|NCT01911260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192790|NCT01911351|Nitrous Oxide|nitrous oxide|mesh-list
6488244|NCT00581685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6192791|NCT01911351|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6192792|NCT01911351|Anesthetics, General|anesthetics, general|mesh-ancestor
6192793|NCT01911351|Anesthetics|anesthetics|mesh-ancestor
6192794|NCT01911351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6192795|NCT01911351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192796|NCT01911351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6192797|NCT01911351|Analgesics|analgesics|mesh-ancestor
6192798|NCT01911351|Sensory System Agents|sensory system agents|mesh-ancestor
6192799|NCT01911351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6192800|NCT01911429|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
6192801|NCT01911429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6192802|NCT01911429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6192803|NCT01911429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6192804|NCT01911429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192805|NCT01911429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6192806|NCT01911429|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6192807|NCT01911429|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6192808|NCT01911429|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6192809|NCT01911429|Adrenergic Agents|adrenergic agents|mesh-ancestor
6192810|NCT01911429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6192811|NCT01911429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192812|NCT01911429|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6192813|NCT01911429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6192814|NCT01911429|Serotonin Agents|serotonin agents|mesh-ancestor
6192815|NCT01911429|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6192816|NCT01911429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6192817|NCT01911429|Dopamine Agents|dopamine agents|mesh-ancestor
6192818|NCT01911442|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
6192819|NCT01911442|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6192820|NCT01911442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6192821|NCT01911442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6192822|NCT01911442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192823|NCT01911442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6192824|NCT01911442|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5584185|NCT03823950|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5584186|NCT03823612|Calcium|calcium|mesh-list
5584187|NCT03823612|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5584188|NCT03823612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584189|NCT03823638|Mannitol|mannitol|mesh-list
5584190|NCT03823638|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5584191|NCT03823638|Diuretics|diuretics|mesh-ancestor
6192825|NCT01911442|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6192826|NCT01911442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6192827|NCT01911442|Adrenergic Agents|adrenergic agents|mesh-ancestor
6192828|NCT01911442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6192829|NCT01911442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192830|NCT01911442|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6192831|NCT01911442|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6192832|NCT01911442|Serotonin Agents|serotonin agents|mesh-ancestor
6192833|NCT01911442|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6192834|NCT01911442|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6192835|NCT01911442|Dopamine Agents|dopamine agents|mesh-ancestor
6192836|NCT01911546|Everolimus|everolimus|mesh-list
6192837|NCT01911546|Tacrolimus|tacrolimus|mesh-list
6192838|NCT01911546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6192839|NCT01911546|Immunologic Factors|immunologic factors|mesh-ancestor
6192840|NCT01911546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192841|NCT01911546|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6192842|NCT01911546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6192843|NCT01911546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192844|NCT01911546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6192845|NCT01911780|Amlodipine|amlodipine|mesh-list
6192846|NCT01911780|Telmisartan|telmisartan|mesh-list
6192847|NCT01911780|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6192848|NCT01911780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6192849|NCT01911780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6192850|NCT01911780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6192851|NCT01911780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192852|NCT01911780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6192853|NCT01911780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192854|NCT01911780|Vasodilator Agents|vasodilator agents|mesh-ancestor
6192855|NCT01911780|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5584192|NCT03823638|Natriuretic Agents|natriuretic agents|mesh-ancestor
6192856|NCT01911780|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6192857|NCT01911780|Diuretics|diuretics|mesh-ancestor
6192858|NCT01911780|Natriuretic Agents|natriuretic agents|mesh-ancestor
6192859|NCT01911780|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6192860|NCT01911845|Ribavirin|ribavirin|mesh-list
6192861|NCT01911845|Antimetabolites|antimetabolites|mesh-ancestor
6192862|NCT01911845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192863|NCT01911845|Antiviral Agents|antiviral agents|mesh-ancestor
6192864|NCT01911845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6192865|NCT01912222|Ixazomib|ixazomib|mesh-list
5584193|NCT03823638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584194|NCT03823625|Nivolumab|nivolumab|mesh-list
5584195|NCT03823625|Ipilimumab|ipilimumab|mesh-list
5584196|NCT03823625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5584197|NCT03823625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5584198|NCT03823625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5584199|NCT03823625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584200|NCT03823781|Milrinone|milrinone|mesh-list
5584201|NCT03823781|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5584202|NCT03823781|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5584203|NCT03823781|Vasodilator Agents|vasodilator agents|mesh-ancestor
5584204|NCT03823781|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5584205|NCT03823781|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5584206|NCT03823781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5584207|NCT03823781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584208|NCT03823781|Protective Agents|protective agents|mesh-ancestor
5584209|NCT03823781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584210|NCT03823339|Liraglutide|liraglutide|mesh-list
5584211|NCT03823339|Xultophy|xultophy|mesh-list
5584212|NCT03823339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5584213|NCT03823339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584214|NCT03823339|Incretins|incretins|mesh-ancestor
5584215|NCT03823339|Hormones|hormones|mesh-ancestor
5584216|NCT03823339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5584217|NCT03823417|Tranexamic Acid|tranexamic acid|mesh-list
5584218|NCT03823417|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5584219|NCT03823417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5584220|NCT03823417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192866|NCT01912222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6192867|NCT01912222|Protease Inhibitors|protease inhibitors|mesh-ancestor
6192868|NCT01912222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6192869|NCT01912222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192870|NCT01912274|Azacitidine|azacitidine|mesh-list
6192871|NCT01912274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6192872|NCT01912274|Antimetabolites|antimetabolites|mesh-ancestor
6192873|NCT01912274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192874|NCT01912274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6192875|NCT01912274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6192876|NCT01912352|Methylphenidate|methylphenidate|mesh-list
6192877|NCT01912352|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6192878|NCT01912352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192879|NCT01912352|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6192880|NCT01912352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6192881|NCT01912352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6192882|NCT01912352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192883|NCT01912352|Dopamine Agents|dopamine agents|mesh-ancestor
6192884|NCT01912352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6192885|NCT01912456|Complement C1s|complement c1s|mesh-list
5584221|NCT03823417|Hemostatics|hemostatics|mesh-ancestor
5584222|NCT03823417|Coagulants|coagulants|mesh-ancestor
5584223|NCT03823079|Irinotecan|irinotecan|mesh-list
5584224|NCT03823079|Raltitrexed|raltitrexed|mesh-list
5584225|NCT03823079|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5584226|NCT03823079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5584227|NCT03823079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5584228|NCT03823079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584229|NCT03823079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5584230|NCT03823079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5584231|NCT03823079|Antimetabolites|antimetabolites|mesh-ancestor
5584232|NCT03823079|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5584233|NCT03823274|Aspirin|aspirin|mesh-list
6192886|NCT01912456|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
6192887|NCT01912456|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
6192888|NCT01912456|Immunologic Factors|immunologic factors|mesh-ancestor
6192889|NCT01912456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192890|NCT01912456|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6192891|NCT01912456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6192892|NCT01912612|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6192893|NCT01912612|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6192894|NCT01912612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6192895|NCT01912612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6192896|NCT01912612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192897|NCT01912612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6192898|NCT01912612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192899|NCT01912612|Analgesics|analgesics|mesh-ancestor
6192900|NCT01912612|Sensory System Agents|sensory system agents|mesh-ancestor
6192901|NCT01912612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6192902|NCT01912612|Antidepressive Agents|antidepressive agents|mesh-ancestor
6192903|NCT01912612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6192904|NCT01912612|Dopamine Agents|dopamine agents|mesh-ancestor
6192905|NCT01912716|Indomethacin|indomethacin|mesh-list
6192906|NCT01912716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6192907|NCT01912716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6192908|NCT01912716|Analgesics|analgesics|mesh-ancestor
6192909|NCT01912716|Sensory System Agents|sensory system agents|mesh-ancestor
6192910|NCT01912716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6192911|NCT01912716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192912|NCT01912716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6192913|NCT01912716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6192914|NCT01912716|Gout Suppressants|gout suppressants|mesh-ancestor
6192915|NCT01912716|Tocolytic Agents|tocolytic agents|mesh-ancestor
6192916|NCT01912716|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6192917|NCT01912716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6192918|NCT01912716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6192919|NCT01912716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192920|NCT01912768|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6192921|NCT01912781|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6192922|NCT01912807|Ondansetron|ondansetron|mesh-list
6192923|NCT01912807|Antiemetics|antiemetics|mesh-ancestor
6192924|NCT01912807|Autonomic Agents|autonomic agents|mesh-ancestor
6192925|NCT01912807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6192926|NCT01912807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192927|NCT01912807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6192928|NCT01912807|Antipruritics|antipruritics|mesh-ancestor
6192929|NCT01912807|Dermatologic Agents|dermatologic agents|mesh-ancestor
6192930|NCT01912807|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6192931|NCT01912807|Serotonin Agents|serotonin agents|mesh-ancestor
5584234|NCT03823274|Clopidogrel|clopidogrel|mesh-list
5584235|NCT03823274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5584236|NCT03823274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5584237|NCT03823274|Analgesics|analgesics|mesh-ancestor
5584238|NCT03823274|Sensory System Agents|sensory system agents|mesh-ancestor
5584239|NCT03823274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6192932|NCT01912807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6192933|NCT01912807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192934|NCT01912807|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6192935|NCT01912807|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6192936|NCT01912807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5584240|NCT03823274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584241|NCT03823274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5584242|NCT03823274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5584243|NCT03823274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6192937|NCT01912807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6192938|NCT01912807|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6192939|NCT01912872|Omalizumab|omalizumab|mesh-list
6192940|NCT01912872|Budesonide|budesonide|mesh-list
6192941|NCT01912872|Formoterol Fumarate|formoterol fumarate|mesh-list
6192942|NCT01912872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6192943|NCT01912872|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6192944|NCT01912872|Autonomic Agents|autonomic agents|mesh-ancestor
6192945|NCT01912872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6192946|NCT01912872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192947|NCT01912872|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5584244|NCT03823274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5584245|NCT03823274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584246|NCT03823274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5584247|NCT03823274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5584248|NCT03823274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5584249|NCT03823274|Antipyretics|antipyretics|mesh-ancestor
5584250|NCT03823274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5584251|NCT03823274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5584252|NCT03823274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5584253|NCT03823274|Purinergic Agents|purinergic agents|mesh-ancestor
5584254|NCT03823274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5584255|NCT03823482|Lidocaine|lidocaine|mesh-list
5584256|NCT03823482|Anesthetics, Local|anesthetics, local|mesh-ancestor
5584257|NCT03823482|Anesthetics|anesthetics|mesh-ancestor
5584258|NCT03823482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5584259|NCT03823482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584260|NCT03823482|Sensory System Agents|sensory system agents|mesh-ancestor
5584261|NCT03823482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5584262|NCT03823482|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5584263|NCT03823482|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5584264|NCT03823482|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5584265|NCT03823482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5584266|NCT03823482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584267|NCT03823040|Oxiconazole|oxiconazole|mesh-list
5584268|NCT03823040|Antifungal Agents|antifungal agents|mesh-ancestor
5584269|NCT03823040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5584270|NCT03823248|Folic Acid|folic acid|mesh-list
6192948|NCT01912872|Respiratory System Agents|respiratory system agents|mesh-ancestor
6192949|NCT01912872|Glucocorticoids|glucocorticoids|mesh-ancestor
6192950|NCT01912872|Hormones|hormones|mesh-ancestor
6192951|NCT01912872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6192952|NCT01912872|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6192953|NCT01912872|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6192954|NCT01912872|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6192955|NCT01912872|Adrenergic Agents|adrenergic agents|mesh-ancestor
6192956|NCT01912872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6192957|NCT01912872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192958|NCT01912872|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6192959|NCT01912963|Trastuzumab|trastuzumab|mesh-list
6192960|NCT01912963|Pertuzumab|pertuzumab|mesh-list
6192961|NCT01912963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6192962|NCT01912963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6192963|NCT01913340|Epoetin Alfa|epoetin alfa|mesh-list
6192964|NCT01913340|Hematinics|hematinics|mesh-ancestor
6192965|NCT01913405|Factor VIII|factor viii|mesh-list
6192966|NCT01913405|BAX 855|bax 855|mesh-list
6192967|NCT01913405|Coagulants|coagulants|mesh-ancestor
6192968|NCT01913470|Losartan|losartan|mesh-list
6192969|NCT01913470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6192970|NCT01913470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6192971|NCT01913470|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6192972|NCT01913470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6192973|NCT01913470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192974|NCT01913483|Heparin|heparin|mesh-list
6192975|NCT01913483|Calcium heparin|calcium heparin|mesh-list
6192976|NCT01913483|Bivalirudin|bivalirudin|mesh-list
6192977|NCT01913483|Anticoagulants|anticoagulants|mesh-ancestor
6192978|NCT01913483|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6192979|NCT01913483|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6192980|NCT01913483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584271|NCT03823248|Vitamin B Complex|vitamin b complex|mesh-list
5584272|NCT03823248|Hematinics|hematinics|mesh-ancestor
5584273|NCT03823248|Vitamins|vitamins|mesh-ancestor
6192981|NCT01913483|Antithrombins|antithrombins|mesh-ancestor
6192982|NCT01913483|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6192983|NCT01913483|Protease Inhibitors|protease inhibitors|mesh-ancestor
6192984|NCT01913483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6192985|NCT01913535|Aticaprant|aticaprant|mesh-list
6192986|NCT01913535|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6192987|NCT01913535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6192988|NCT01913535|Sensory System Agents|sensory system agents|mesh-ancestor
5584274|NCT03823248|Micronutrients|micronutrients|mesh-ancestor
5584275|NCT03823248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584276|NCT03822975|Heparin|heparin|mesh-list
5584277|NCT03822975|Calcium heparin|calcium heparin|mesh-list
5584278|NCT03822975|Bivalirudin|bivalirudin|mesh-list
5584279|NCT03822975|Anticoagulants|anticoagulants|mesh-ancestor
5584280|NCT03822975|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5584281|NCT03822975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5584282|NCT03822975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584283|NCT03822975|Antithrombins|antithrombins|mesh-ancestor
5584284|NCT03822975|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5584285|NCT03822975|Protease Inhibitors|protease inhibitors|mesh-ancestor
5584286|NCT03822975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5584287|NCT03822871|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5584288|NCT03822871|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5584289|NCT03822871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584290|NCT03822936|Fluorouracil|fluorouracil|mesh-list
5584291|NCT03822936|Oxaliplatin|oxaliplatin|mesh-list
5584292|NCT03822936|Irinotecan|irinotecan|mesh-list
5584293|NCT03822936|Antimetabolites|antimetabolites|mesh-ancestor
5584294|NCT03822936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584295|NCT03822936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5584296|NCT03822936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5584297|NCT03822936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5584298|NCT03822936|Immunologic Factors|immunologic factors|mesh-ancestor
5584299|NCT03822936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584300|NCT03822936|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5584301|NCT03822936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5584302|NCT03822936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5584303|NCT03822780|Hydroxychloroquine|hydroxychloroquine|mesh-list
5584304|NCT03822780|Antimalarials|antimalarials|mesh-ancestor
5584305|NCT03822780|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5584306|NCT03822780|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5584307|NCT03822780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5584308|NCT03822780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5584309|NCT03822780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584310|NCT03822780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5584311|NCT03822962|Acetaminophen|acetaminophen|mesh-list
5584312|NCT03822962|Ibuprofen|ibuprofen|mesh-list
5584313|NCT03822962|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5584314|NCT03822962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5584315|NCT03822962|Analgesics|analgesics|mesh-ancestor
5584316|NCT03822962|Sensory System Agents|sensory system agents|mesh-ancestor
5584317|NCT03822962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5584318|NCT03822962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584319|NCT03822962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5584320|NCT03822962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5584321|NCT03822962|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5584322|NCT03822962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5584323|NCT03822962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584324|NCT03822962|Antipyretics|antipyretics|mesh-ancestor
5584325|NCT03822754|Vaccines|vaccines|mesh-list
5584326|NCT03822754|Immunologic Factors|immunologic factors|mesh-ancestor
5584327|NCT03822754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584328|NCT03822715|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5584329|NCT03822715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5584330|NCT03822715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5584331|NCT03822715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584332|NCT03822715|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5584333|NCT03822715|Hormone Antagonists|hormone antagonists|mesh-ancestor
5584334|NCT03822715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5584335|NCT03822715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584336|NCT03822663|Caffeine|caffeine|mesh-list
5584337|NCT03822663|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5584338|NCT03822663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584339|NCT03822663|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5584340|NCT03822663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5584341|NCT03822663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192989|NCT01913535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6192990|NCT01913639|Leucovorin|leucovorin|mesh-list
6192991|NCT01913639|Fluorouracil|fluorouracil|mesh-list
6192992|NCT01913639|Oxaliplatin|oxaliplatin|mesh-list
6192993|NCT01913639|Antimetabolites|antimetabolites|mesh-ancestor
6192994|NCT01913639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6192995|NCT01913639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6192996|NCT01913639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6192997|NCT01913639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6192998|NCT01913639|Immunologic Factors|immunologic factors|mesh-ancestor
6192999|NCT01913639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193000|NCT01913639|Antidotes|antidotes|mesh-ancestor
6193001|NCT01913639|Protective Agents|protective agents|mesh-ancestor
6193002|NCT01913639|Vitamin B Complex|vitamin b complex|mesh-ancestor
6193003|NCT01913639|Vitamins|vitamins|mesh-ancestor
6193004|NCT01913639|Micronutrients|micronutrients|mesh-ancestor
6193005|NCT01914159|Ranibizumab|ranibizumab|mesh-list
6193006|NCT01914159|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6193007|NCT01914159|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6193008|NCT01914159|Growth Substances|growth substances|mesh-ancestor
6193009|NCT01914159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193010|NCT01914159|Growth Inhibitors|growth inhibitors|mesh-ancestor
6193011|NCT01914159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6193012|NCT01914393|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
6193013|NCT01914393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6193014|NCT01914393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6193015|NCT01914393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6193016|NCT01914393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193017|NCT01914393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6193018|NCT01914393|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6193019|NCT01914393|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6193020|NCT01914393|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6193021|NCT01914393|Adrenergic Agents|adrenergic agents|mesh-ancestor
6193022|NCT01914393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6193023|NCT01914393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193024|NCT01914393|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6193025|NCT01914393|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6193026|NCT01914393|Serotonin Agents|serotonin agents|mesh-ancestor
6193027|NCT01914393|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6193028|NCT01914393|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6193029|NCT01914393|Dopamine Agents|dopamine agents|mesh-ancestor
6193030|NCT01914666|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6193031|NCT01914666|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6193032|NCT01914666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6193033|NCT01914666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6193034|NCT01914666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193035|NCT01914666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6193036|NCT01914666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193037|NCT01914666|Analgesics|analgesics|mesh-ancestor
6193038|NCT01914666|Sensory System Agents|sensory system agents|mesh-ancestor
6193039|NCT01914666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6193040|NCT01914666|Antidepressive Agents|antidepressive agents|mesh-ancestor
6193041|NCT01914666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6193042|NCT01914666|Dopamine Agents|dopamine agents|mesh-ancestor
6193043|NCT01914757|Benralizumab|benralizumab|mesh-list
6193044|NCT01914757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6193045|NCT01914757|Respiratory System Agents|respiratory system agents|mesh-ancestor
6193046|NCT01914926|Metoprolol|metoprolol|mesh-list
6193047|NCT01914926|Diltiazem|diltiazem|mesh-list
6193048|NCT01914926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6193049|NCT01914926|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5584342|NCT03822663|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5584343|NCT03822663|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5584344|NCT03822663|Purinergic Agents|purinergic agents|mesh-ancestor
5584345|NCT03822663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5584346|NCT03822767|Vaccines|vaccines|mesh-list
5584347|NCT03822767|Immunologic Factors|immunologic factors|mesh-ancestor
6193050|NCT01914926|Sympatholytics|sympatholytics|mesh-ancestor
6193051|NCT01914926|Autonomic Agents|autonomic agents|mesh-ancestor
6193052|NCT01914926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6193053|NCT01914926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193054|NCT01914926|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6193055|NCT01914926|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6193056|NCT01914926|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6193057|NCT01914926|Adrenergic Agents|adrenergic agents|mesh-ancestor
6193058|NCT01914926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5584348|NCT03822767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584349|NCT03822507|Cinacalcet|cinacalcet|mesh-list
5584350|NCT03822507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5584351|NCT03822507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584352|NCT03822507|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
5584353|NCT03822507|Hormone Antagonists|hormone antagonists|mesh-ancestor
5584354|NCT03822507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5584355|NCT03822559|Timolol|timolol|mesh-list
5584356|NCT03822559|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5584357|NCT03822559|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5584358|NCT03822559|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5584359|NCT03822559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5584360|NCT03822559|Adrenergic Agents|adrenergic agents|mesh-ancestor
5584361|NCT03822559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5584362|NCT03822559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584363|NCT03822559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584364|NCT03822559|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5584365|NCT03822559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5584366|NCT03822845|Edetic Acid|edetic acid|mesh-list
5584367|NCT03822845|Chelating Agents|chelating agents|mesh-ancestor
5584368|NCT03822845|Sequestering Agents|sequestering agents|mesh-ancestor
5584369|NCT03822845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584370|NCT03822845|Anticoagulants|anticoagulants|mesh-ancestor
5584371|NCT03822845|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5584372|NCT03822546|Nicotine|nicotine|mesh-list
5584373|NCT03822546|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5584374|NCT03822546|Autonomic Agents|autonomic agents|mesh-ancestor
6193059|NCT01914926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193060|NCT01914926|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6193061|NCT01914926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6193062|NCT01914926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6193063|NCT01914926|Vasodilator Agents|vasodilator agents|mesh-ancestor
6193064|NCT01915108|Remifentanil|remifentanil|mesh-list
6193065|NCT01915108|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6193066|NCT01915108|Narcotics|narcotics|mesh-ancestor
6193067|NCT01915108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6193068|NCT01915108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193069|NCT01915108|Analgesics|analgesics|mesh-ancestor
6193070|NCT01915108|Sensory System Agents|sensory system agents|mesh-ancestor
6193071|NCT01915108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6193072|NCT01915303|Cabergoline|cabergoline|mesh-list
6193073|NCT01915303|Pasireotide|pasireotide|mesh-list
6193074|NCT01915303|Hormones|hormones|mesh-ancestor
6193075|NCT01915303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6193076|NCT01915303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193077|NCT01915303|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6193078|NCT01915303|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6193079|NCT01915303|Dopamine Agonists|dopamine agonists|mesh-ancestor
6193080|NCT01915303|Dopamine Agents|dopamine agents|mesh-ancestor
6193081|NCT01915303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6193082|NCT01915303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193083|NCT01915732|Clindamycin|clindamycin|mesh-list
6193084|NCT01915732|Clindamycin palmitate|clindamycin palmitate|mesh-list
6193085|NCT01915732|Clindamycin phosphate|clindamycin phosphate|mesh-list
6193086|NCT01915732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6193087|NCT01915732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6193088|NCT01915732|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6193089|NCT01915732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6193090|NCT01915732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193091|NCT01915823|Fluticasone|fluticasone|mesh-list
6193092|NCT01915823|Xhance|xhance|mesh-list
6193093|NCT01915823|Azelastine|azelastine|mesh-list
6193094|NCT01915823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6193095|NCT01915823|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6193096|NCT01915823|Autonomic Agents|autonomic agents|mesh-ancestor
6193097|NCT01915823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6193098|NCT01915823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584375|NCT03822546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5584376|NCT03822546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584377|NCT03822546|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5584378|NCT03822546|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5584379|NCT03822546|Cholinergic Agents|cholinergic agents|mesh-ancestor
5584380|NCT03822546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5584381|NCT03822546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605080|NCT03597568|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5605081|NCT03591770|Vaccines|vaccines|mesh-list
5605082|NCT03591770|Immunologic Factors|immunologic factors|mesh-ancestor
6193099|NCT01915823|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6193100|NCT01915823|Respiratory System Agents|respiratory system agents|mesh-ancestor
6193101|NCT01915823|Dermatologic Agents|dermatologic agents|mesh-ancestor
6193102|NCT01915823|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6193103|NCT01915823|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6193104|NCT01915823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6193105|NCT01915823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193106|NCT01915823|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6193107|NCT01915823|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6193108|NCT01915823|Histamine Antagonists|histamine antagonists|mesh-ancestor
6193109|NCT01915823|Histamine Agents|histamine agents|mesh-ancestor
5584382|NCT03822520|Moxifloxacin|moxifloxacin|mesh-list
5584383|NCT03822520|Celecoxib|celecoxib|mesh-list
5584384|NCT03822520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5584385|NCT03822520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5584386|NCT03822520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5584387|NCT03822520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6193110|NCT01915823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6193111|NCT01915849|Licogliflozin|licogliflozin|mesh-list
6193112|NCT01915849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6193113|NCT01915849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193114|NCT01915849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6193115|NCT01915849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207302|NCT02114177|Antiviral Agents|antiviral agents|mesh-ancestor
6207303|NCT02114177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6207304|NCT02114177|Protease Inhibitors|protease inhibitors|mesh-ancestor
6207305|NCT02114177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6207306|NCT02114177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207307|NCT02114385|Vaccines|vaccines|mesh-list
6207308|NCT02114385|Immunologic Factors|immunologic factors|mesh-ancestor
5584388|NCT03822520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6488245|NCT00581685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488246|NCT00581685|Anticonvulsants|anticonvulsants|mesh-ancestor
6488247|NCT00581685|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6488248|NCT00581685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6488249|NCT00581685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488250|NCT00581685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6488251|NCT00581685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6488252|NCT00581685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6488253|NCT00581685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6488254|NCT00581685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6193116|NCT01915914|Fluticasone|fluticasone|mesh-list
6193117|NCT01915914|Xhance|xhance|mesh-list
6193118|NCT01915914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6193119|NCT01915914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6193120|NCT01915914|Autonomic Agents|autonomic agents|mesh-ancestor
6193121|NCT01915914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6193122|NCT01915914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193123|NCT01915914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6193124|NCT01915914|Respiratory System Agents|respiratory system agents|mesh-ancestor
6193125|NCT01915914|Dermatologic Agents|dermatologic agents|mesh-ancestor
6193126|NCT01915914|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6193127|NCT01915940|Timolol|timolol|mesh-list
6193128|NCT01915940|Bimatoprost|bimatoprost|mesh-list
6193129|NCT01915940|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6193130|NCT01915940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6193131|NCT01915940|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6193132|NCT01915940|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6193133|NCT01915940|Adrenergic Agents|adrenergic agents|mesh-ancestor
6193134|NCT01915940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6193135|NCT01915940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193136|NCT01915940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193137|NCT01915940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6193138|NCT01915940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6193139|NCT01916109|Gemcitabine|gemcitabine|mesh-list
6193140|NCT01916109|Carboplatin|carboplatin|mesh-list
6193141|NCT01916109|Panitumumab|panitumumab|mesh-list
6193142|NCT01916109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6672139|NCT01554046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672140|NCT01554046|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6672141|NCT01554046|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6672142|NCT01554046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6672143|NCT01554046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672144|NCT01554046|Dopamine Agents|dopamine agents|mesh-ancestor
6672145|NCT01554046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6672146|NCT01554059|Bevacizumab|bevacizumab|mesh-list
6672147|NCT01554059|Oxaliplatin|oxaliplatin|mesh-list
6672148|NCT01554059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6672149|NCT01554059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6672150|NCT01554059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6672151|NCT01554059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6672152|NCT01554059|Growth Substances|growth substances|mesh-ancestor
6672153|NCT01554059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672154|NCT01554059|Growth Inhibitors|growth inhibitors|mesh-ancestor
6672155|NCT01554111|Picosulfate sodium|picosulfate sodium|mesh-list
5584389|NCT03822520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193143|NCT01916109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6193144|NCT01916109|Antimetabolites|antimetabolites|mesh-ancestor
6193145|NCT01916109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193146|NCT01916109|Antiviral Agents|antiviral agents|mesh-ancestor
6193147|NCT01916109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6193148|NCT01916109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6193149|NCT01916109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6193150|NCT01916109|Immunologic Factors|immunologic factors|mesh-ancestor
6193151|NCT01916109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193152|NCT01916109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6193153|NCT01916226|Cetirizine|cetirizine|mesh-list
6193154|NCT01916226|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6193155|NCT01916226|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6193156|NCT01916226|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6193157|NCT01916226|Histamine Antagonists|histamine antagonists|mesh-ancestor
5584390|NCT03822520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5584391|NCT03822520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584392|NCT03822520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5584393|NCT03822520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5584394|NCT03822520|Analgesics|analgesics|mesh-ancestor
5584395|NCT03822520|Sensory System Agents|sensory system agents|mesh-ancestor
6193158|NCT01916226|Histamine Agents|histamine agents|mesh-ancestor
6193159|NCT01916226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5584396|NCT03822520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5584397|NCT03822520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5584398|NCT03822520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5584399|NCT03822520|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6193160|NCT01916226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193161|NCT01916226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584400|NCT03822520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5584401|NCT03822091|Terlipressin|terlipressin|mesh-list
5584402|NCT03822091|Norepinephrine|norepinephrine|mesh-list
5584403|NCT03822091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5584404|NCT03822091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6193162|NCT01916629|Sunscreening Agents|sunscreening agents|mesh-list
6193163|NCT01916629|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6193164|NCT01916629|Protective Agents|protective agents|mesh-ancestor
6193165|NCT01916629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193166|NCT01916629|Dermatologic Agents|dermatologic agents|mesh-ancestor
6193167|NCT01916681|Misoprostol|misoprostol|mesh-list
6193168|NCT01916681|Oxytocin|oxytocin|mesh-list
6193169|NCT01916681|Oxytocics|oxytocics|mesh-ancestor
6193170|NCT01916681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6193171|NCT01916681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193172|NCT01916681|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6193173|NCT01916681|Abortifacient Agents|abortifacient agents|mesh-ancestor
6193174|NCT01916681|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6193175|NCT01916681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6193176|NCT01916824|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6193177|NCT01916824|Mirtazapine|mirtazapine|mesh-list
6193178|NCT01916824|Citalopram|citalopram|mesh-list
6193179|NCT01916824|Bupropion|bupropion|mesh-list
6193180|NCT01916824|Fluoxetine|fluoxetine|mesh-list
6193181|NCT01916824|Paroxetine|paroxetine|mesh-list
6193182|NCT01916824|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6193183|NCT01916824|Sertraline|sertraline|mesh-list
6193184|NCT01916824|Antidepressive Agents|antidepressive agents|mesh-list
6193185|NCT01916824|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6193186|NCT01916824|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6193187|NCT01916824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6193188|NCT01916824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6193189|NCT01916824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193190|NCT01916824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6193191|NCT01916824|Serotonin Agents|serotonin agents|mesh-ancestor
6193192|NCT01916824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488255|NCT00581685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6488256|NCT00581685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6488257|NCT00581685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6488258|NCT00581685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6672156|NCT01554111|Cathartics|cathartics|mesh-ancestor
6193193|NCT01916824|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6193194|NCT01916824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5584405|NCT03822091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5584406|NCT03822091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5584407|NCT03822091|Adrenergic Agents|adrenergic agents|mesh-ancestor
5584408|NCT03822091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5584409|NCT03822091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584410|NCT03822091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584411|NCT03822091|Sympathomimetics|sympathomimetics|mesh-ancestor
5584412|NCT03822091|Autonomic Agents|autonomic agents|mesh-ancestor
5584413|NCT03822091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6193195|NCT01916824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6193196|NCT01916824|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6193197|NCT01916824|Dopamine Agents|dopamine agents|mesh-ancestor
6193198|NCT01916824|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6193199|NCT01916824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6193200|NCT01916824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6193201|NCT01916824|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6193202|NCT01916824|Analgesics|analgesics|mesh-ancestor
6193203|NCT01916824|Sensory System Agents|sensory system agents|mesh-ancestor
6193204|NCT01916824|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6193205|NCT01916824|Histamine Antagonists|histamine antagonists|mesh-ancestor
6193206|NCT01916824|Histamine Agents|histamine agents|mesh-ancestor
5584414|NCT03822065|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
5584415|NCT03822065|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6193207|NCT01916824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6193208|NCT01916824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6193209|NCT01916824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6193210|NCT01916824|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6193211|NCT01916824|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6193212|NCT01916824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6193213|NCT01916824|Adrenergic Agents|adrenergic agents|mesh-ancestor
6193214|NCT01916824|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6193215|NCT01916824|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6193216|NCT01916824|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6193217|NCT01916941|Prazosin|prazosin|mesh-list
6193218|NCT01916941|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6193219|NCT01916941|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6193220|NCT01916941|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6193221|NCT01916941|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6193222|NCT01916941|Adrenergic Agents|adrenergic agents|mesh-ancestor
6193223|NCT01916941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6193224|NCT01916941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193225|NCT01916941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193226|NCT01917006|Botulinum Toxins|botulinum toxins|mesh-list
6193227|NCT01917006|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6193228|NCT01917006|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6193229|NCT01917006|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6193230|NCT01917006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6193231|NCT01917006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193232|NCT01917006|Cholinergic Agents|cholinergic agents|mesh-ancestor
6193233|NCT01917006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6193234|NCT01917006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193235|NCT01917006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6193236|NCT01917006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6193237|NCT01917136|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6193238|NCT01917136|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6193239|NCT01917136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193240|NCT01917214|Sunitinib|sunitinib|mesh-list
6193241|NCT01917214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6193242|NCT01917214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6193243|NCT01917214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6193244|NCT01917214|Growth Substances|growth substances|mesh-ancestor
6193245|NCT01917214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193246|NCT01917214|Growth Inhibitors|growth inhibitors|mesh-ancestor
6193247|NCT01917214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6193248|NCT01917214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6193249|NCT01917214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584416|NCT03822065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5584417|NCT03822065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5584418|NCT03822065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193250|NCT01917656|Metformin|metformin|mesh-list
6193251|NCT01917656|Liraglutide|liraglutide|mesh-list
6193252|NCT01917656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6193253|NCT01917656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193254|NCT01917656|Incretins|incretins|mesh-ancestor
6193255|NCT01917656|Hormones|hormones|mesh-ancestor
6672617|NCT01557270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6193256|NCT01917656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5584419|NCT03822065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5584420|NCT03822065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584421|NCT03822065|Antidepressive Agents|antidepressive agents|mesh-ancestor
5584422|NCT03822065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5584423|NCT03822312|Tobramycin|tobramycin|mesh-list
5584424|NCT03822312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5584425|NCT03822312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5584426|NCT03822169|Choline|choline|mesh-list
5584427|NCT03822169|Lipotropic Agents|lipotropic agents|mesh-ancestor
5584428|NCT03822169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5584429|NCT03822169|Antimetabolites|antimetabolites|mesh-ancestor
5584430|NCT03822169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584431|NCT03822169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5584432|NCT03822169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5584433|NCT03822169|Nootropic Agents|nootropic agents|mesh-ancestor
5584434|NCT03821987|Cyclophosphamide|cyclophosphamide|mesh-list
5584435|NCT03821987|Busulfan|busulfan|mesh-list
5584436|NCT03821987|Fludarabine|fludarabine|mesh-list
5584437|NCT03821987|Thymoglobulin|thymoglobulin|mesh-list
5584438|NCT03821987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5584439|NCT03821987|Immunologic Factors|immunologic factors|mesh-ancestor
5584440|NCT03821987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584441|NCT03821987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5584442|NCT03821987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5584443|NCT03821987|Alkylating Agents|alkylating agents|mesh-ancestor
5584444|NCT03821987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584445|NCT03821987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5584446|NCT03821987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5584447|NCT03821792|Prednisone|prednisone|mesh-list
5584448|NCT03821792|Cortisone|cortisone|mesh-list
5584449|NCT03821792|Abiraterone Acetate|abiraterone acetate|mesh-list
5584450|NCT03821792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5584451|NCT03821792|Glucocorticoids|glucocorticoids|mesh-ancestor
5584452|NCT03821792|Hormones|hormones|mesh-ancestor
6193257|NCT01917773|Octreotide|octreotide|mesh-list
6193258|NCT01917773|Bisacodyl|bisacodyl|mesh-list
6193259|NCT01917773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6193260|NCT01917773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6193261|NCT01917773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6193262|NCT01917773|Cathartics|cathartics|mesh-ancestor
6193263|NCT01917773|Laxatives|laxatives|mesh-ancestor
6193264|NCT01918306|Cisplatin|cisplatin|mesh-list
6193265|NCT01918306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5584453|NCT03821792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5584454|NCT03821792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584455|NCT03821792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5584456|NCT03821792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5584457|NCT03821792|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5584458|NCT03821792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5584459|NCT03821792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584460|NCT03821792|Hormone Antagonists|hormone antagonists|mesh-ancestor
5584461|NCT03821792|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5584462|NCT03821649|Naloxone|naloxone|mesh-list
5584463|NCT03821649|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5584464|NCT03821649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584465|NCT03821649|Sensory System Agents|sensory system agents|mesh-ancestor
5584466|NCT03821649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5584467|NCT03821701|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5584468|NCT03821701|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5584469|NCT03821701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193266|NCT01918332|Valsartan|valsartan|mesh-list
6193267|NCT01918332|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6193268|NCT01918332|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6193269|NCT01918332|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6193270|NCT01918332|Antimetabolites|antimetabolites|mesh-ancestor
6193271|NCT01918332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193272|NCT01918332|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6193273|NCT01918332|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6193274|NCT01918332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6193275|NCT01918332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6193276|NCT01918332|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6193277|NCT01918332|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6193278|NCT01918371|Bevacizumab|bevacizumab|mesh-list
6672618|NCT01557270|Adrenergic Agents|adrenergic agents|mesh-ancestor
6193279|NCT01918371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6193280|NCT01918371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6193281|NCT01918371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6193282|NCT01918371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6193283|NCT01918371|Growth Substances|growth substances|mesh-ancestor
6193284|NCT01918371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193285|NCT01918371|Growth Inhibitors|growth inhibitors|mesh-ancestor
6193286|NCT01918761|Pemetrexed|pemetrexed|mesh-list
6193287|NCT01918761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6193288|NCT01918761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6193289|NCT01918761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193290|NCT01918761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6193291|NCT01918761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6193292|NCT01919164|Mitogens|mitogens|mesh-list
6193293|NCT01919164|Mitosis Modulators|mitosis modulators|mesh-ancestor
6193294|NCT01919164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193295|NCT01919190|Bupivacaine|bupivacaine|mesh-list
6193296|NCT01919190|Anesthetics, Local|anesthetics, local|mesh-ancestor
6193297|NCT01919190|Anesthetics|anesthetics|mesh-ancestor
6193298|NCT01919190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6193299|NCT01919190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193300|NCT01919190|Sensory System Agents|sensory system agents|mesh-ancestor
6193301|NCT01919190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6193302|NCT01919216|Citalopram|citalopram|mesh-list
6193303|NCT01919216|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6193304|NCT01919216|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6193305|NCT01919216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6193306|NCT01919216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193307|NCT01919216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6193308|NCT01919216|Serotonin Agents|serotonin agents|mesh-ancestor
6193309|NCT01919216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193310|NCT01919216|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6193311|NCT01919216|Antidepressive Agents|antidepressive agents|mesh-ancestor
6193312|NCT01919216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6193313|NCT01919229|Letrozole|letrozole|mesh-list
6193314|NCT01919229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6193315|NCT01919229|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6193316|NCT01919229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6193317|NCT01919229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6193318|NCT01919229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193319|NCT01919229|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6193320|NCT01919229|Hormone Antagonists|hormone antagonists|mesh-ancestor
6193321|NCT01919229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6193322|NCT01919229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193323|NCT01919411|Amoxicillin|amoxicillin|mesh-list
5584470|NCT03821623|Niacinamide|niacinamide|mesh-list
5584471|NCT03821623|Niacin|niacin|mesh-list
5584472|NCT03821623|Nicotinic Acids|nicotinic acids|mesh-list
5584473|NCT03821623|Vitamin B Complex|vitamin b complex|mesh-ancestor
5584474|NCT03821623|Vitamins|vitamins|mesh-ancestor
5584475|NCT03821623|Micronutrients|micronutrients|mesh-ancestor
5584476|NCT03821623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193324|NCT01919411|Clavulanic Acid|clavulanic acid|mesh-list
6193325|NCT01919411|Clavulanic Acids|clavulanic acids|mesh-list
6193326|NCT01919411|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6193327|NCT01919411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6193328|NCT01919411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6193329|NCT01919411|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6193330|NCT01919411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6193331|NCT01919411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193332|NCT01919450|Regadenoson|regadenoson|mesh-list
6193333|NCT01919450|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
6193334|NCT01919450|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6193335|NCT01919450|Purinergic Agonists|purinergic agonists|mesh-ancestor
6193336|NCT01919450|Purinergic Agents|purinergic agents|mesh-ancestor
6193337|NCT01919450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6193338|NCT01919450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193339|NCT01919450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193340|NCT01919489|Insulin Glargine|insulin glargine|mesh-list
6193341|NCT01919489|Liraglutide|liraglutide|mesh-list
6193342|NCT01919489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6193343|NCT01919489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584477|NCT03821623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5584478|NCT03821623|Antimetabolites|antimetabolites|mesh-ancestor
5584479|NCT03821623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584480|NCT03821623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5584481|NCT03821623|Vasodilator Agents|vasodilator agents|mesh-ancestor
5584482|NCT03821714|Vitamins|vitamins|mesh-list
6193344|NCT01919489|Incretins|incretins|mesh-ancestor
6193345|NCT01919489|Hormones|hormones|mesh-ancestor
6193346|NCT01919489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6193347|NCT01919606|Bupivacaine|bupivacaine|mesh-list
6193348|NCT01919606|Anesthetics, Local|anesthetics, local|mesh-ancestor
6193349|NCT01919606|Anesthetics|anesthetics|mesh-ancestor
6193350|NCT01919606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6193351|NCT01919606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193352|NCT01919606|Sensory System Agents|sensory system agents|mesh-ancestor
6193353|NCT01919606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6193354|NCT01919697|Plecanatide|plecanatide|mesh-list
6193355|NCT01919697|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
6193356|NCT01919697|Enzyme Activators|enzyme activators|mesh-ancestor
6193357|NCT01919697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193358|NCT01919697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6193359|NCT01919723|Ticagrelor|ticagrelor|mesh-list
6193360|NCT01919723|Eptifibatide|eptifibatide|mesh-list
6193361|NCT01919723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6193362|NCT01919723|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6193363|NCT01919723|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6193364|NCT01919723|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6193365|NCT01919723|Purinergic Agents|purinergic agents|mesh-ancestor
6193366|NCT01919723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6193367|NCT01919723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193368|NCT01919723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193369|NCT01919801|Icatibant|icatibant|mesh-list
6193370|NCT01919801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6193371|NCT01919801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6193372|NCT01919801|Analgesics|analgesics|mesh-ancestor
6193373|NCT01919801|Sensory System Agents|sensory system agents|mesh-ancestor
6193374|NCT01919801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6193375|NCT01919801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193376|NCT01919801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6193377|NCT01919801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6193378|NCT01919801|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
6193379|NCT01919801|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
6193380|NCT01919801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193381|NCT01919801|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6193382|NCT01919801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6193383|NCT01919801|Immunologic Factors|immunologic factors|mesh-ancestor
6193384|NCT01919996|Azithromycin|azithromycin|mesh-list
6193385|NCT01919996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6193386|NCT01919996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6193387|NCT01920061|Docetaxel|docetaxel|mesh-list
6193388|NCT01920061|Gedatolisib|gedatolisib|mesh-list
6193389|NCT01920061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6193390|NCT01920061|Tubulin Modulators|tubulin modulators|mesh-ancestor
6193391|NCT01920061|Antimitotic Agents|antimitotic agents|mesh-ancestor
6193392|NCT01920061|Mitosis Modulators|mitosis modulators|mesh-ancestor
6193393|NCT01920061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193394|NCT01920061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6193395|NCT01920061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6193396|NCT01920152|Hyaluronic Acid|hyaluronic acid|mesh-list
6193397|NCT01920152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5584483|NCT03821714|Hydrocortisone|hydrocortisone|mesh-list
5584484|NCT03821714|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
5584485|NCT03821714|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
5584486|NCT03821714|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
5584487|NCT03821714|Glucocorticoids|glucocorticoids|mesh-list
5584488|NCT03821714|Micronutrients|micronutrients|mesh-ancestor
5584489|NCT03821714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584490|NCT03821714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5584491|NCT03821714|Hormones|hormones|mesh-ancestor
6193398|NCT01920152|Immunologic Factors|immunologic factors|mesh-ancestor
6193399|NCT01920152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584492|NCT03821714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5584493|NCT03821480|Fluconazole|fluconazole|mesh-list
6193400|NCT01920152|Viscosupplements|viscosupplements|mesh-ancestor
6193401|NCT01920152|Protective Agents|protective agents|mesh-ancestor
6193402|NCT01920282|Nebivolol|nebivolol|mesh-list
6193403|NCT01920282|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6193404|NCT01920282|Vasodilator Agents|vasodilator agents|mesh-ancestor
6193405|NCT01920282|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6193406|NCT01920282|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6193407|NCT01920282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6193408|NCT01920282|Adrenergic Agents|adrenergic agents|mesh-ancestor
6193409|NCT01920282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6193410|NCT01920282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193411|NCT01920282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193412|NCT01920477|Ofatumumab|ofatumumab|mesh-list
6193413|NCT01920477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6193414|NCT01920555|Midazolam|midazolam|mesh-list
6193415|NCT01920555|Ketamine|ketamine|mesh-list
6193416|NCT01920555|Analgesics|analgesics|mesh-ancestor
5584494|NCT03821480|Antifungal Agents|antifungal agents|mesh-ancestor
5584495|NCT03821480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5584496|NCT03821480|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5584497|NCT03821480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5584498|NCT03821480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5584499|NCT03821480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584500|NCT03821480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5584501|NCT03821480|Hormone Antagonists|hormone antagonists|mesh-ancestor
5584502|NCT03821480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5584503|NCT03821480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584504|NCT03821480|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5584505|NCT03821480|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5584506|NCT03821415|Estradiol|estradiol|mesh-list
5584507|NCT03821415|Estrogens|estrogens|mesh-ancestor
5584508|NCT03821415|Hormones|hormones|mesh-ancestor
5584509|NCT03821415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5584510|NCT03821415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584511|NCT03821454|Capecitabine|capecitabine|mesh-list
5584512|NCT03821454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5584513|NCT03821454|Antimetabolites|antimetabolites|mesh-ancestor
6193417|NCT01920555|Sensory System Agents|sensory system agents|mesh-ancestor
6193418|NCT01920555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6193419|NCT01920555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193420|NCT01920555|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6193421|NCT01920555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6193422|NCT01920555|Anesthetics, General|anesthetics, general|mesh-ancestor
6193423|NCT01920555|Anesthetics|anesthetics|mesh-ancestor
6193424|NCT01920555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6193425|NCT01920555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6193426|NCT01920555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5584514|NCT03821454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584515|NCT03821454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6193427|NCT01920555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6207309|NCT02114385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584516|NCT03821493|Itraconazole|itraconazole|mesh-list
5584517|NCT03821493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5584518|NCT03821493|Antifungal Agents|antifungal agents|mesh-ancestor
5584519|NCT03821493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5584520|NCT03821493|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5584521|NCT03821493|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6193428|NCT01920555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193429|NCT01920555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6193430|NCT01920555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6193431|NCT01920555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6193432|NCT01920555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6193433|NCT01920555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6193434|NCT01920555|GABA Modulators|gaba modulators|mesh-ancestor
6193435|NCT01920555|GABA Agents|gaba agents|mesh-ancestor
6193436|NCT01920568|Vitamin D|vitamin d|mesh-list
6193437|NCT01920568|Zoledronic Acid|zoledronic acid|mesh-list
6193438|NCT01920568|Denosumab|denosumab|mesh-list
6193439|NCT01920568|Calcium|calcium|mesh-list
6193440|NCT01920568|Vitamins|vitamins|mesh-ancestor
6193441|NCT01920568|Micronutrients|micronutrients|mesh-ancestor
6193442|NCT01920568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193443|NCT01920568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6193444|NCT01920568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6193445|NCT01920711|Valsartan|valsartan|mesh-list
6193446|NCT01920711|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
6193447|NCT01920711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6193448|NCT01920711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6193449|NCT01920711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6193450|NCT01920711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193451|NCT01920802|Olanzapine|olanzapine|mesh-list
6193452|NCT01920802|Iloperidone|iloperidone|mesh-list
6193453|NCT01920802|Antiemetics|antiemetics|mesh-ancestor
6193454|NCT01920802|Autonomic Agents|autonomic agents|mesh-ancestor
6193455|NCT01920802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6193456|NCT01920802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193457|NCT01920802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6193458|NCT01920802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6193459|NCT01920802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6193460|NCT01920802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6193461|NCT01920802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6193462|NCT01920802|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6193463|NCT01920802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6193464|NCT01920802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6193465|NCT01920802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193466|NCT01920802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6193467|NCT01920802|Serotonin Agents|serotonin agents|mesh-ancestor
6193468|NCT01920893|Mometasone Furoate|mometasone furoate|mesh-list
6193469|NCT01920893|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6193470|NCT01920893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6193471|NCT01920893|Dermatologic Agents|dermatologic agents|mesh-ancestor
6193472|NCT01920893|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6193473|NCT01920893|Immunologic Factors|immunologic factors|mesh-ancestor
6193474|NCT01920893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193475|NCT01921166|Leuprolide|leuprolide|mesh-list
6193476|NCT01921166|Clomiphene|clomiphene|mesh-list
6193477|NCT01921166|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6193478|NCT01921166|Fertility Agents|fertility agents|mesh-ancestor
6193479|NCT01921166|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6488259|NCT00581685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5584522|NCT03821493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5584523|NCT03821493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584524|NCT03821493|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5584525|NCT03821493|Hormone Antagonists|hormone antagonists|mesh-ancestor
5584526|NCT03821493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5584527|NCT03821493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584528|NCT03821493|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6193480|NCT01921166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584529|NCT03821168|Bevacizumab|bevacizumab|mesh-list
5584530|NCT03821168|Epoetin Alfa|epoetin alfa|mesh-list
5584531|NCT03821168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5584532|NCT03821168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5584533|NCT03821168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5584534|NCT03821168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6193481|NCT01921166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6193482|NCT01921166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6193483|NCT01921166|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6193484|NCT01921166|Hormone Antagonists|hormone antagonists|mesh-ancestor
6193485|NCT01921166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6193486|NCT01921166|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6193487|NCT01921166|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6193488|NCT01921205|Lacosamide|lacosamide|mesh-list
6193489|NCT01921205|Anticonvulsants|anticonvulsants|mesh-ancestor
6193490|NCT01921205|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6193491|NCT01921205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6193492|NCT01921205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6193493|NCT01921205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193494|NCT01921270|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6193495|NCT01921270|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6193496|NCT01921270|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6193497|NCT01921270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6193498|NCT01921270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193499|NCT01921270|Cholinergic Agents|cholinergic agents|mesh-ancestor
6193500|NCT01921270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6193501|NCT01921270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193502|NCT01921270|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6193503|NCT01921270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6193504|NCT01921296|Cyclobenzaprine|cyclobenzaprine|mesh-list
5584535|NCT03821168|Growth Substances|growth substances|mesh-ancestor
5584536|NCT03821168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584537|NCT03821168|Growth Inhibitors|growth inhibitors|mesh-ancestor
5584538|NCT03821168|Hematinics|hematinics|mesh-ancestor
5584539|NCT03820830|Palbociclib|palbociclib|mesh-list
5584540|NCT03820830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5584541|NCT03820830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5584542|NCT03820830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5584543|NCT03820830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584544|NCT03820622|Paclitaxel|paclitaxel|mesh-list
5584545|NCT03820622|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5584546|NCT03820622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5584547|NCT03820622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5584548|NCT03820622|Tubulin Modulators|tubulin modulators|mesh-ancestor
5584549|NCT03820622|Antimitotic Agents|antimitotic agents|mesh-ancestor
5584550|NCT03820622|Mitosis Modulators|mitosis modulators|mesh-ancestor
5584551|NCT03820622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584552|NCT03820531|Pancrelipase|pancrelipase|mesh-list
5584553|NCT03820531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5584554|NCT03820518|Calcitriol|calcitriol|mesh-list
5584555|NCT03820518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5584556|NCT03820518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584557|NCT03820518|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6193505|NCT01921296|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6193506|NCT01921296|Antidepressive Agents|antidepressive agents|mesh-ancestor
6193507|NCT01921296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6193508|NCT01921296|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6193509|NCT01921296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193510|NCT01921296|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6193511|NCT01921296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6193512|NCT01921296|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6193513|NCT01921296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6193514|NCT01921387|Cytarabine|cytarabine|mesh-list
6193515|NCT01921387|Etoposide|etoposide|mesh-list
6193516|NCT01921387|Podophyllotoxin|podophyllotoxin|mesh-list
6193517|NCT01921387|Etoposide phosphate|etoposide phosphate|mesh-list
6193518|NCT01921387|Melphalan|melphalan|mesh-list
5584558|NCT03820518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5584559|NCT03820518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584560|NCT03820518|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5584561|NCT03820518|Vitamins|vitamins|mesh-ancestor
5584562|NCT03820518|Micronutrients|micronutrients|mesh-ancestor
5584563|NCT03820518|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5605083|NCT03591770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605084|NCT03535727|Gemcitabine|gemcitabine|mesh-list
5605085|NCT03535727|Paclitaxel|paclitaxel|mesh-list
5605086|NCT03535727|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5605087|NCT03535727|Cisplatin|cisplatin|mesh-list
6193519|NCT01921387|Mechlorethamine|mechlorethamine|mesh-list
6193520|NCT01921387|Carmustine|carmustine|mesh-list
6193521|NCT01921387|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
6193522|NCT01921387|Antibodies|antibodies|mesh-list
6193523|NCT01921387|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6193524|NCT01921387|Immunologic Factors|immunologic factors|mesh-ancestor
6193525|NCT01921387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193526|NCT01921387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5605088|NCT03535727|Capecitabine|capecitabine|mesh-list
5605089|NCT03535727|Irinotecan|irinotecan|mesh-list
5605090|NCT03535727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6193527|NCT01921387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6193528|NCT01921387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6193529|NCT01921387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5605091|NCT03535727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605092|NCT03535727|Tubulin Modulators|tubulin modulators|mesh-ancestor
6193530|NCT01921387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5605093|NCT03535727|Antimitotic Agents|antimitotic agents|mesh-ancestor
6193531|NCT01921387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193532|NCT01921387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6193533|NCT01921387|Antimetabolites|antimetabolites|mesh-ancestor
6193534|NCT01921387|Antiviral Agents|antiviral agents|mesh-ancestor
6193535|NCT01921387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6193536|NCT01921387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6193537|NCT01921387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6193538|NCT01921387|Alkylating Agents|alkylating agents|mesh-ancestor
6193539|NCT01921387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6193540|NCT01921387|Keratolytic Agents|keratolytic agents|mesh-ancestor
6193541|NCT01921387|Dermatologic Agents|dermatologic agents|mesh-ancestor
6193542|NCT01921387|Tubulin Modulators|tubulin modulators|mesh-ancestor
6193543|NCT01921387|Antimitotic Agents|antimitotic agents|mesh-ancestor
6193544|NCT01921387|Mitosis Modulators|mitosis modulators|mesh-ancestor
6193545|NCT01921751|Gemcitabine|gemcitabine|mesh-list
6193546|NCT01921751|Paclitaxel|paclitaxel|mesh-list
6193547|NCT01921751|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6193548|NCT01921751|Capecitabine|capecitabine|mesh-list
6193549|NCT01921751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6193550|NCT01921751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6193551|NCT01921751|Tubulin Modulators|tubulin modulators|mesh-ancestor
6193552|NCT01921751|Antimitotic Agents|antimitotic agents|mesh-ancestor
6193553|NCT01921751|Mitosis Modulators|mitosis modulators|mesh-ancestor
6193554|NCT01921751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193555|NCT01921751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6193556|NCT01921751|Antimetabolites|antimetabolites|mesh-ancestor
6193557|NCT01921751|Antiviral Agents|antiviral agents|mesh-ancestor
6193558|NCT01921751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6193559|NCT01921751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6193560|NCT01921751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6193561|NCT01921751|Immunologic Factors|immunologic factors|mesh-ancestor
6193562|NCT01921751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193563|NCT01921829|Diuretics|diuretics|mesh-list
6193564|NCT01921829|Natriuretic Agents|natriuretic agents|mesh-ancestor
6193565|NCT01921829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193566|NCT01921894|Vitamin D|vitamin d|mesh-list
6193567|NCT01921894|Cholecalciferol|cholecalciferol|mesh-list
5584564|NCT03820466|Aspirin|aspirin|mesh-list
5584565|NCT03820466|Atorvastatin|atorvastatin|mesh-list
5584566|NCT03820466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5584567|NCT03820466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5584568|NCT03820466|Analgesics|analgesics|mesh-ancestor
5584569|NCT03820466|Sensory System Agents|sensory system agents|mesh-ancestor
5584570|NCT03820466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6193568|NCT01921894|Vitamins|vitamins|mesh-ancestor
6193569|NCT01921894|Micronutrients|micronutrients|mesh-ancestor
6193570|NCT01921894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193571|NCT01921894|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6193572|NCT01921894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6193573|NCT01922011|Vancomycin|vancomycin|mesh-list
6193574|NCT01922011|Daptomycin|daptomycin|mesh-list
5584571|NCT03820466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584572|NCT03820466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5584573|NCT03820466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5584574|NCT03820466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5584575|NCT03820466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5584576|NCT03820466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584577|NCT03820466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5584578|NCT03820466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5584579|NCT03820466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5584580|NCT03820466|Antipyretics|antipyretics|mesh-ancestor
5584581|NCT03820466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5584582|NCT03820466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5584583|NCT03820466|Antimetabolites|antimetabolites|mesh-ancestor
5584584|NCT03820466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5584585|NCT03820466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5584586|NCT03820245|Lycopene|lycopene|mesh-list
5584587|NCT03820245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5584588|NCT03820245|Antioxidants|antioxidants|mesh-ancestor
5584589|NCT03820245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584590|NCT03820245|Protective Agents|protective agents|mesh-ancestor
5584591|NCT03820245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584592|NCT03820245|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5584593|NCT03820245|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5584594|NCT03820245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6193575|NCT01922011|Nafcillin|nafcillin|mesh-list
6193576|NCT01922011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6193577|NCT01922011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6193578|NCT01922037|Omalizumab|omalizumab|mesh-list
6193579|NCT01922037|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6193580|NCT01922037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6193581|NCT01922037|Respiratory System Agents|respiratory system agents|mesh-ancestor
6193582|NCT01922089|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
6193583|NCT01922089|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6193584|NCT01922089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193585|NCT01922102|Ranibizumab|ranibizumab|mesh-list
6193586|NCT01922102|Verteporfin|verteporfin|mesh-list
6193587|NCT01922102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6193588|NCT01922102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6193589|NCT01922102|Growth Substances|growth substances|mesh-ancestor
6193590|NCT01922102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193591|NCT01922102|Growth Inhibitors|growth inhibitors|mesh-ancestor
6193592|NCT01922102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6193593|NCT01922102|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6193594|NCT01922102|Dermatologic Agents|dermatologic agents|mesh-ancestor
6193595|NCT01922115|Trospium chloride|trospium chloride|mesh-list
6193596|NCT01922115|Parasympatholytics|parasympatholytics|mesh-ancestor
6193597|NCT01922115|Autonomic Agents|autonomic agents|mesh-ancestor
6193598|NCT01922115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6193599|NCT01922115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193600|NCT01922115|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6193601|NCT01922115|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6193602|NCT01922115|Cholinergic Agents|cholinergic agents|mesh-ancestor
6193603|NCT01922115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6193604|NCT01922115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193605|NCT01922115|Urological Agents|urological agents|mesh-ancestor
6193606|NCT01922258|Brexpiprazole|brexpiprazole|mesh-list
6193607|NCT01922258|Serotonin Agents|serotonin agents|mesh-ancestor
6193608|NCT01922258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6193609|NCT01922258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193610|NCT01922258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193611|NCT01922258|Dopamine Agonists|dopamine agonists|mesh-ancestor
6193612|NCT01922258|Dopamine Agents|dopamine agents|mesh-ancestor
6193613|NCT01922271|Glycopyrrolate|glycopyrrolate|mesh-list
6193614|NCT01922271|Albuterol|albuterol|mesh-list
6193615|NCT01922271|Tiotropium Bromide|tiotropium bromide|mesh-list
6193616|NCT01922271|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6193617|NCT01922271|Autonomic Agents|autonomic agents|mesh-ancestor
6193618|NCT01922271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6193619|NCT01922271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193620|NCT01922271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6193621|NCT01922271|Respiratory System Agents|respiratory system agents|mesh-ancestor
6193622|NCT01922271|Parasympatholytics|parasympatholytics|mesh-ancestor
6193623|NCT01922271|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6193624|NCT01922271|Cholinergic Agents|cholinergic agents|mesh-ancestor
5584595|NCT03820206|Tranexamic Acid|tranexamic acid|mesh-list
5584596|NCT03820206|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5584597|NCT03820206|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5584598|NCT03820206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584599|NCT03820206|Hemostatics|hemostatics|mesh-ancestor
5584600|NCT03820206|Coagulants|coagulants|mesh-ancestor
6193625|NCT01922271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6193626|NCT01922271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584601|NCT03820193|Acetaminophen|acetaminophen|mesh-list
6193627|NCT01922271|Tocolytic Agents|tocolytic agents|mesh-ancestor
5584602|NCT03820193|Celecoxib|celecoxib|mesh-list
5584603|NCT03820193|Ketorolac|ketorolac|mesh-list
5584604|NCT03820193|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
5584605|NCT03820193|Diazepam|diazepam|mesh-list
6193628|NCT01922271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5584606|NCT03820193|Gabapentin|gabapentin|mesh-list
5584607|NCT03820193|Hydrocodone|hydrocodone|mesh-list
6207310|NCT02114684|Moxifloxacin|moxifloxacin|mesh-list
6193629|NCT01922271|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6193630|NCT01922271|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6193631|NCT01922271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6193632|NCT01922271|Adrenergic Agents|adrenergic agents|mesh-ancestor
6193633|NCT01922271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6193634|NCT01922271|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6193635|NCT01922336|Infliximab|infliximab|mesh-list
6193636|NCT01922336|Dermatologic Agents|dermatologic agents|mesh-ancestor
6193637|NCT01922336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6193638|NCT01922336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6193639|NCT01922739|Hydrocodone|hydrocodone|mesh-list
6193640|NCT01922739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6193641|NCT01922739|Narcotics|narcotics|mesh-ancestor
6193642|NCT01922739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6193643|NCT01922739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193644|NCT01922739|Analgesics|analgesics|mesh-ancestor
6193645|NCT01922739|Sensory System Agents|sensory system agents|mesh-ancestor
6193646|NCT01922739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6193647|NCT01922739|Antitussive Agents|antitussive agents|mesh-ancestor
6193648|NCT01922739|Respiratory System Agents|respiratory system agents|mesh-ancestor
6193649|NCT01922934|Topiramate|topiramate|mesh-list
6193650|NCT01922934|Phentermine|phentermine|mesh-list
6193651|NCT01922934|Anticonvulsants|anticonvulsants|mesh-ancestor
6193652|NCT01922934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6193653|NCT01922934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193654|NCT01922934|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6193655|NCT01922934|Appetite Depressants|appetite depressants|mesh-ancestor
6193656|NCT01922934|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6193657|NCT01922934|Sympathomimetics|sympathomimetics|mesh-ancestor
5584608|NCT03820193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5584609|NCT03820193|Analgesics|analgesics|mesh-ancestor
5584610|NCT03820193|Sensory System Agents|sensory system agents|mesh-ancestor
5584611|NCT03820193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5584612|NCT03820193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584613|NCT03820193|Antipyretics|antipyretics|mesh-ancestor
5584614|NCT03820193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5584615|NCT03820193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5584616|NCT03820193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5584617|NCT03820193|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5584618|NCT03820193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5584619|NCT03820193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5584620|NCT03820193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193658|NCT01922934|Autonomic Agents|autonomic agents|mesh-ancestor
6193659|NCT01922934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6193660|NCT01922934|Adrenergic Agents|adrenergic agents|mesh-ancestor
6193661|NCT01922934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6193662|NCT01922934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193663|NCT01923129|Prazosin|prazosin|mesh-list
6193664|NCT01923129|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6193665|NCT01923129|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6193666|NCT01923129|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6193667|NCT01923129|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6193668|NCT01923129|Adrenergic Agents|adrenergic agents|mesh-ancestor
6193669|NCT01923129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6193670|NCT01923129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193671|NCT01923129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193672|NCT01923311|Elvitegravir|elvitegravir|mesh-list
6193673|NCT01923311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6193674|NCT01923311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6193675|NCT01923311|Antiviral Agents|antiviral agents|mesh-ancestor
6193676|NCT01923311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6193677|NCT01923311|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6193678|NCT01923311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6193679|NCT01923311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193680|NCT01923363|Tazobactam|tazobactam|mesh-list
6193681|NCT01923363|Piperacillin|piperacillin|mesh-list
6193682|NCT01923363|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
5584621|NCT03820193|Anticonvulsants|anticonvulsants|mesh-ancestor
5584622|NCT03820193|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5584623|NCT03820193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5584624|NCT03820193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5584625|NCT03820193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5584626|NCT03820193|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5584627|NCT03820193|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5584628|NCT03820193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5584629|NCT03820193|Antimanic Agents|antimanic agents|mesh-ancestor
5584630|NCT03820193|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6193683|NCT01923363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6193684|NCT01923363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6193685|NCT01923363|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6193686|NCT01923363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6193687|NCT01923363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207311|NCT02114684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6207312|NCT02114684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6207313|NCT02114684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6207314|NCT02114684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6207315|NCT02114684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6208009|NCT02123459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5584631|NCT03820193|Narcotics|narcotics|mesh-ancestor
5584632|NCT03820193|Antitussive Agents|antitussive agents|mesh-ancestor
5584633|NCT03820193|Respiratory System Agents|respiratory system agents|mesh-ancestor
5584634|NCT03820193|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5584635|NCT03820193|Antiemetics|antiemetics|mesh-ancestor
5584636|NCT03820193|Autonomic Agents|autonomic agents|mesh-ancestor
5584637|NCT03820193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5584638|NCT03820193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5584639|NCT03820193|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5584640|NCT03820193|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5584641|NCT03820193|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5584642|NCT03820193|Anesthetics, General|anesthetics, general|mesh-ancestor
5584643|NCT03820193|Anesthetics|anesthetics|mesh-ancestor
5584644|NCT03820193|GABA Modulators|gaba modulators|mesh-ancestor
5584645|NCT03820193|GABA Agents|gaba agents|mesh-ancestor
5584646|NCT03820141|Trastuzumab|trastuzumab|mesh-list
5584647|NCT03820141|Durvalumab|durvalumab|mesh-list
5584648|NCT03820141|Pertuzumab|pertuzumab|mesh-list
5584649|NCT03820141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5584650|NCT03820141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6193688|NCT01923467|Nicotine|nicotine|mesh-list
6193689|NCT01923467|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6193690|NCT01923467|Autonomic Agents|autonomic agents|mesh-ancestor
6193691|NCT01923467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6193692|NCT01923467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193693|NCT01923467|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6193694|NCT01923467|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6193695|NCT01923467|Cholinergic Agents|cholinergic agents|mesh-ancestor
6193696|NCT01923467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6193697|NCT01923467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193698|NCT01923896|Cycloserine|cycloserine|mesh-list
6193699|NCT01923896|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6193700|NCT01923896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6193701|NCT01923896|Renal Agents|renal agents|mesh-ancestor
6193702|NCT01923896|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6193703|NCT01923896|Antitubercular Agents|antitubercular agents|mesh-ancestor
6193704|NCT01923896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6193705|NCT01923896|Antimetabolites|antimetabolites|mesh-ancestor
6193706|NCT01923896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193707|NCT01924169|Lenalidomide|lenalidomide|mesh-list
6193708|NCT01924169|Vaccines|vaccines|mesh-list
6193709|NCT01924169|Immunologic Factors|immunologic factors|mesh-ancestor
6193710|NCT01924169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193711|NCT01924169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6193712|NCT01924169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6193713|NCT01924169|Growth Substances|growth substances|mesh-ancestor
6193714|NCT01924169|Growth Inhibitors|growth inhibitors|mesh-ancestor
6193715|NCT01924169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6193716|NCT01924182|Morphine|morphine|mesh-list
6193717|NCT01924182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5584651|NCT03820180|Fluticasone|fluticasone|mesh-list
5584652|NCT03820180|Xhance|xhance|mesh-list
5584653|NCT03820180|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5584654|NCT03820180|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
5584655|NCT03820180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5584656|NCT03820180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5584657|NCT03820180|Autonomic Agents|autonomic agents|mesh-ancestor
5584658|NCT03820180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6193718|NCT01924182|Narcotics|narcotics|mesh-ancestor
6193719|NCT01924182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6193720|NCT01924182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193721|NCT01924182|Analgesics|analgesics|mesh-ancestor
6193722|NCT01924182|Sensory System Agents|sensory system agents|mesh-ancestor
6193723|NCT01924182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6193724|NCT01924299|Fluconazole|fluconazole|mesh-list
6193725|NCT01924299|Ketoconazole|ketoconazole|mesh-list
6193726|NCT01924299|Antifungal Agents|antifungal agents|mesh-ancestor
6193727|NCT01924299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6193728|NCT01924299|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6193729|NCT01924299|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6193730|NCT01924299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6193731|NCT01924299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193732|NCT01924299|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6193733|NCT01924299|Hormone Antagonists|hormone antagonists|mesh-ancestor
6193734|NCT01924299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6193735|NCT01924299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193736|NCT01924299|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6193737|NCT01924299|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5584659|NCT03820180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584660|NCT03820180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5584661|NCT03820180|Respiratory System Agents|respiratory system agents|mesh-ancestor
5584662|NCT03820180|Dermatologic Agents|dermatologic agents|mesh-ancestor
5584663|NCT03820180|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5584664|NCT03820180|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5584665|NCT03820180|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5584666|NCT03820180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5584667|NCT03820180|Adrenergic Agents|adrenergic agents|mesh-ancestor
5584668|NCT03820180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5584669|NCT03820180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584670|NCT03820180|Glucocorticoids|glucocorticoids|mesh-ancestor
6193738|NCT01924299|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6193739|NCT01924429|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6193740|NCT01924429|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6193741|NCT01924429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584671|NCT03820180|Hormones|hormones|mesh-ancestor
5584672|NCT03820180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5584673|NCT03820180|Sympathomimetics|sympathomimetics|mesh-ancestor
5584674|NCT03820037|Opicapone|opicapone|mesh-list
5605094|NCT03535727|Mitosis Modulators|mitosis modulators|mesh-ancestor
6193742|NCT01924429|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6193743|NCT01924429|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6193744|NCT01924429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6193745|NCT01924429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193746|NCT01924429|Dopamine Agents|dopamine agents|mesh-ancestor
6193747|NCT01924429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6193748|NCT01924533|Paclitaxel|paclitaxel|mesh-list
6193749|NCT01924533|Olaparib|olaparib|mesh-list
6193750|NCT01924533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6193751|NCT01924533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6193752|NCT01924533|Tubulin Modulators|tubulin modulators|mesh-ancestor
6193753|NCT01924533|Antimitotic Agents|antimitotic agents|mesh-ancestor
6193754|NCT01924533|Mitosis Modulators|mitosis modulators|mesh-ancestor
6193755|NCT01924533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584675|NCT03820037|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
5584676|NCT03820037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5584677|NCT03820037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584678|NCT03820037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5584679|NCT03820037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5584680|NCT03819790|Insulin|insulin|mesh-list
5584681|NCT03819790|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6193756|NCT01924533|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6193757|NCT01924533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6193758|NCT01924767|Empagliflozin|empagliflozin|mesh-list
6193759|NCT01924767|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6193760|NCT01924767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193761|NCT01924767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6193762|NCT01924767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193763|NCT01924871|Remifentanil|remifentanil|mesh-list
6193764|NCT01924871|Desflurane|desflurane|mesh-list
6193765|NCT01924871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6193766|NCT01924871|Narcotics|narcotics|mesh-ancestor
5584682|NCT03819790|Metformin|metformin|mesh-list
5584683|NCT03819790|Insulin Glargine|insulin glargine|mesh-list
5584684|NCT03819790|Lixisenatide|lixisenatide|mesh-list
5584685|NCT03819790|Gliclazide|gliclazide|mesh-list
5584686|NCT03819790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5584687|NCT03819790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584688|NCT03819660|Amifampridine|amifampridine|mesh-list
5584689|NCT03819660|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5584690|NCT03819660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5584691|NCT03819660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584692|NCT03819660|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5584693|NCT03819660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5584694|NCT03819660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584695|NCT03819647|Stiripentol|stiripentol|mesh-list
5584696|NCT03819647|Anticonvulsants|anticonvulsants|mesh-ancestor
5584697|NCT03819556|Caseins|caseins|mesh-list
5584698|NCT03819556|Chelating Agents|chelating agents|mesh-ancestor
5584699|NCT03819556|Sequestering Agents|sequestering agents|mesh-ancestor
5584700|NCT03819556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584701|NCT03821545|Lidocaine|lidocaine|mesh-list
5584702|NCT03821545|Ketamine|ketamine|mesh-list
5584703|NCT03821545|Anesthetics, Local|anesthetics, local|mesh-ancestor
5584704|NCT03821545|Anesthetics|anesthetics|mesh-ancestor
5584705|NCT03821545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5584706|NCT03821545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584707|NCT03821545|Sensory System Agents|sensory system agents|mesh-ancestor
5584708|NCT03821545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5584709|NCT03821545|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5584710|NCT03821545|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5584711|NCT03821545|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6193767|NCT01924871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6193768|NCT01924871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193769|NCT01924871|Analgesics|analgesics|mesh-ancestor
6193770|NCT01924871|Sensory System Agents|sensory system agents|mesh-ancestor
6193771|NCT01924871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6193772|NCT01924871|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6193773|NCT01924871|Anesthetics, General|anesthetics, general|mesh-ancestor
6193774|NCT01924871|Anesthetics|anesthetics|mesh-ancestor
6672157|NCT01554111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6672158|NCT01554124|Meropenem|meropenem|mesh-list
6672159|NCT01554124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6488260|NCT00581685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6488261|NCT00581685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6489034|NCT00588913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6489035|NCT00588913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6489036|NCT00588913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489037|NCT00588926|Remifentanil|remifentanil|mesh-list
6489038|NCT00588926|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6489039|NCT00588926|Narcotics|narcotics|mesh-ancestor
5584712|NCT03821545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6193775|NCT01924949|Sofosbuvir|sofosbuvir|mesh-list
6193776|NCT01924949|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
6193777|NCT01924949|Ledipasvir|ledipasvir|mesh-list
6193778|NCT01924949|Antiviral Agents|antiviral agents|mesh-ancestor
6193779|NCT01924949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6193780|NCT01925144|Omeprazole|omeprazole|mesh-list
6193781|NCT01925144|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6193782|NCT01925144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6193783|NCT01925144|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6193784|NCT01925144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6193785|NCT01925144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193786|NCT01925170|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
6193787|NCT01925170|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6193788|NCT01925170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193789|NCT01925183|Interferons|interferons|mesh-list
6193790|NCT01925183|Ribavirin|ribavirin|mesh-list
6193791|NCT01925183|Interferon-alpha|interferon-alpha|mesh-list
6193792|NCT01925183|Interferon alpha-2|interferon alpha-2|mesh-list
6193793|NCT01925183|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6193794|NCT01925183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6193795|NCT01925183|Antiviral Agents|antiviral agents|mesh-ancestor
6193796|NCT01925183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6193797|NCT01925183|Antimetabolites|antimetabolites|mesh-ancestor
6193798|NCT01925183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193799|NCT01925183|Immunologic Factors|immunologic factors|mesh-ancestor
6193800|NCT01925183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193801|NCT01925274|Irinotecan|irinotecan|mesh-list
6193802|NCT01925274|Cetuximab|cetuximab|mesh-list
6193803|NCT01925274|Gedatolisib|gedatolisib|mesh-list
6193804|NCT01925274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6193805|NCT01925274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6193806|NCT01925274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6193807|NCT01925274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193808|NCT01925274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6193809|NCT01925274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6193810|NCT01925274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6193811|NCT01925469|Benzocaine|benzocaine|mesh-list
6193812|NCT01925469|Anesthetics, Local|anesthetics, local|mesh-ancestor
6193813|NCT01925469|Anesthetics|anesthetics|mesh-ancestor
6193814|NCT01925469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6193815|NCT01925469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193816|NCT01925469|Sensory System Agents|sensory system agents|mesh-ancestor
6193817|NCT01925469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6193818|NCT01925612|Prednisone|prednisone|mesh-list
6193819|NCT01925612|Cyclophosphamide|cyclophosphamide|mesh-list
6193820|NCT01925612|Rituximab|rituximab|mesh-list
6193821|NCT01925612|Doxorubicin|doxorubicin|mesh-list
6488262|NCT00581789|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6488263|NCT00581789|Sunitinib|sunitinib|mesh-list
6488264|NCT00581789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6672160|NCT01554124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6193822|NCT01925612|Vincristine|vincristine|mesh-list
6193823|NCT01925612|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6193824|NCT01925612|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6193825|NCT01925612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6193826|NCT01925612|Immunologic Factors|immunologic factors|mesh-ancestor
6193827|NCT01925612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193828|NCT01925612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6193829|NCT01925612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6193830|NCT01925612|Alkylating Agents|alkylating agents|mesh-ancestor
6193831|NCT01925612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193832|NCT01925612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6193833|NCT01925612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6193834|NCT01925612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6193835|NCT01925612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6193836|NCT01925612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6193837|NCT01925612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6193838|NCT01925612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6193839|NCT01925612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6193840|NCT01925612|Glucocorticoids|glucocorticoids|mesh-ancestor
6193841|NCT01925612|Hormones|hormones|mesh-ancestor
6193842|NCT01925612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6193843|NCT01925612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6193844|NCT01925612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6193845|NCT01925612|Tubulin Modulators|tubulin modulators|mesh-ancestor
6193846|NCT01925612|Antimitotic Agents|antimitotic agents|mesh-ancestor
6193847|NCT01925612|Mitosis Modulators|mitosis modulators|mesh-ancestor
6193848|NCT01925703|Ferric gluconate|ferric gluconate|mesh-list
6193849|NCT01925703|Hematinics|hematinics|mesh-ancestor
6193850|NCT01925768|Apremilast|apremilast|mesh-list
6193851|NCT01925768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6193852|NCT01925768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5725644|NCT03178994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5725645|NCT03178994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725646|NCT03178994|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5725647|NCT03179254|Metformin|metformin|mesh-list
5725648|NCT03179254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5725649|NCT03179254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193853|NCT01925768|Analgesics|analgesics|mesh-ancestor
6193854|NCT01925768|Sensory System Agents|sensory system agents|mesh-ancestor
6488265|NCT00581789|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6488266|NCT00581789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6488267|NCT00581789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488268|NCT00581789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6488269|NCT00581789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6488270|NCT00581789|Growth Substances|growth substances|mesh-ancestor
6672161|NCT01554254|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
6193855|NCT01925768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6193856|NCT01925768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193857|NCT01925768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6193858|NCT01925768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6193859|NCT01925768|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6193860|NCT01925768|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6193861|NCT01925768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6193862|NCT01925768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193863|NCT01925781|Nicotine|nicotine|mesh-list
6193864|NCT01925781|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6193865|NCT01925781|Autonomic Agents|autonomic agents|mesh-ancestor
6193866|NCT01925781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6193867|NCT01925781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193868|NCT01925781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6193869|NCT01925781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6193870|NCT01925781|Cholinergic Agents|cholinergic agents|mesh-ancestor
6193871|NCT01925781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6193872|NCT01925781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193873|NCT01925950|Beclomethasone|beclomethasone|mesh-list
6193874|NCT01925950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6193875|NCT01925950|Glucocorticoids|glucocorticoids|mesh-ancestor
6193876|NCT01925950|Hormones|hormones|mesh-ancestor
6193877|NCT01925950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6193878|NCT01925950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672162|NCT01554254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6672163|NCT01554254|Vasodilator Agents|vasodilator agents|mesh-ancestor
6672164|NCT01554345|Vitamin E|vitamin e|mesh-list
6672165|NCT01554345|Selenium|selenium|mesh-list
6672166|NCT01554345|Vitamins|vitamins|mesh-ancestor
6672167|NCT01554345|Micronutrients|micronutrients|mesh-ancestor
6193879|NCT01925950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6193880|NCT01925950|Respiratory System Agents|respiratory system agents|mesh-ancestor
6672168|NCT01554345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672169|NCT01554345|Antioxidants|antioxidants|mesh-ancestor
6193881|NCT01925989|Insulin Glargine|insulin glargine|mesh-list
6193882|NCT01925989|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6193883|NCT01925989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193884|NCT01926444|Trimebutine|trimebutine|mesh-list
6193885|NCT01926444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6193886|NCT01926444|Parasympatholytics|parasympatholytics|mesh-ancestor
6193887|NCT01926444|Autonomic Agents|autonomic agents|mesh-ancestor
6193888|NCT01926444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5584713|NCT03821545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584714|NCT03821545|Analgesics|analgesics|mesh-ancestor
5584715|NCT03821545|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5584716|NCT03821545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5584717|NCT03821545|Anesthetics, General|anesthetics, general|mesh-ancestor
6193889|NCT01926444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193890|NCT01926496|Imiquimod|imiquimod|mesh-list
6193891|NCT01926496|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6193892|NCT01926496|Immunologic Factors|immunologic factors|mesh-ancestor
6193893|NCT01926496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193894|NCT01926496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6193895|NCT01926496|Interferon Inducers|interferon inducers|mesh-ancestor
6193896|NCT01926626|Moclobemide|moclobemide|mesh-list
6193897|NCT01926626|Nicotine|nicotine|mesh-list
6193898|NCT01926626|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6193899|NCT01926626|Autonomic Agents|autonomic agents|mesh-ancestor
6193900|NCT01926626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6193901|NCT01926626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193902|NCT01926626|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6193903|NCT01926626|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6193904|NCT01926626|Cholinergic Agents|cholinergic agents|mesh-ancestor
6193905|NCT01926626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6193906|NCT01926626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193907|NCT01926626|Antidepressive Agents|antidepressive agents|mesh-ancestor
6193908|NCT01926626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6193909|NCT01926626|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6193910|NCT01926626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6193911|NCT01926782|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6193912|NCT01926782|Immunologic Factors|immunologic factors|mesh-ancestor
6193913|NCT01926782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193914|NCT01926886|Trastuzumab|trastuzumab|mesh-list
6193915|NCT01926886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6193916|NCT01926886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6193917|NCT01926977|Ranibizumab|ranibizumab|mesh-list
6193918|NCT01926977|Aflibercept|aflibercept|mesh-list
6193919|NCT01926977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6193920|NCT01926977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6193921|NCT01926977|Growth Substances|growth substances|mesh-ancestor
6488271|NCT00581789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488272|NCT00581789|Growth Inhibitors|growth inhibitors|mesh-ancestor
6488273|NCT00582582|Vitamin D|vitamin d|mesh-list
6488274|NCT00582582|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
6488275|NCT00582582|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
6488276|NCT00582582|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
6488277|NCT00582582|Docetaxel|docetaxel|mesh-list
6488278|NCT00582582|Vitamins|vitamins|mesh-ancestor
6488279|NCT00582582|Micronutrients|micronutrients|mesh-ancestor
6488280|NCT00582582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725650|NCT03178708|Amantadine|amantadine|mesh-list
6193922|NCT01926977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488281|NCT00582582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6193923|NCT01926977|Growth Inhibitors|growth inhibitors|mesh-ancestor
6193924|NCT01926977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6193925|NCT01927055|Mannitol|mannitol|mesh-list
5584718|NCT03821545|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5584719|NCT03821545|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5584720|NCT03821545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5584721|NCT03819530|Micronutrients|micronutrients|mesh-list
5584722|NCT03819530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584723|NCT03819517|Resveratrol|resveratrol|mesh-list
5584724|NCT03819517|Antioxidants|antioxidants|mesh-ancestor
5584725|NCT03819517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584726|NCT03819517|Protective Agents|protective agents|mesh-ancestor
5584727|NCT03819517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584728|NCT03819517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5584729|NCT03819517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5584730|NCT03819296|Prednisone|prednisone|mesh-list
5584731|NCT03819296|Cortisone|cortisone|mesh-list
5584732|NCT03819296|Infliximab|infliximab|mesh-list
6193926|NCT01927055|Droxidopa|droxidopa|mesh-list
5584733|NCT03819296|Vedolizumab|vedolizumab|mesh-list
6193927|NCT01927055|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6193928|NCT01927055|Diuretics|diuretics|mesh-ancestor
6193929|NCT01927055|Natriuretic Agents|natriuretic agents|mesh-ancestor
6193930|NCT01927055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488282|NCT00582582|Tubulin Modulators|tubulin modulators|mesh-ancestor
6488283|NCT00582582|Antimitotic Agents|antimitotic agents|mesh-ancestor
6488284|NCT00582582|Mitosis Modulators|mitosis modulators|mesh-ancestor
6488285|NCT00582582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488286|NCT00582582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6488287|NCT00582634|Docetaxel|docetaxel|mesh-list
6488288|NCT00582634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6488289|NCT00582634|Tubulin Modulators|tubulin modulators|mesh-ancestor
6488290|NCT00582634|Antimitotic Agents|antimitotic agents|mesh-ancestor
6488291|NCT00582634|Mitosis Modulators|mitosis modulators|mesh-ancestor
6488292|NCT00582634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193931|NCT01927055|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6193932|NCT01927055|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6193933|NCT01927120|Sirolimus|sirolimus|mesh-list
6193934|NCT01927120|Aldesleukin|aldesleukin|mesh-list
6193935|NCT01927120|Tacrolimus|tacrolimus|mesh-list
6193936|NCT01927120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6193937|NCT01927120|Immunologic Factors|immunologic factors|mesh-ancestor
6672619|NCT01557270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5584734|NCT03819296|Immunoglobulins|immunoglobulins|mesh-list
5584735|NCT03819296|Immunoglobulin G|immunoglobulin g|mesh-list
5584736|NCT03819296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5584737|NCT03819296|Glucocorticoids|glucocorticoids|mesh-ancestor
6193938|NCT01927120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193939|NCT01927120|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6193940|NCT01927120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6193941|NCT01927120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193942|NCT01927120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6193943|NCT01927120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6193944|NCT01927120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6193945|NCT01927120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6193946|NCT01927120|Antifungal Agents|antifungal agents|mesh-ancestor
6193947|NCT01927120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6193948|NCT01927120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6193949|NCT01927120|Antiviral Agents|antiviral agents|mesh-ancestor
6193950|NCT01927341|Panitumumab|panitumumab|mesh-list
6193951|NCT01927341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6193952|NCT01927341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6193953|NCT01927718|Thalidomide|thalidomide|mesh-list
6193954|NCT01927718|Lenalidomide|lenalidomide|mesh-list
6193955|NCT01927718|Immunologic Factors|immunologic factors|mesh-ancestor
6193956|NCT01927718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193957|NCT01927718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6193958|NCT01927718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6193959|NCT01927718|Growth Substances|growth substances|mesh-ancestor
6193960|NCT01927718|Growth Inhibitors|growth inhibitors|mesh-ancestor
6193961|NCT01927718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6193962|NCT01927718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6193963|NCT01927718|Leprostatic Agents|leprostatic agents|mesh-ancestor
6193964|NCT01927718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6193965|NCT01927718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6193966|NCT01927757|Etanercept|etanercept|mesh-list
6193967|NCT01927757|Methotrexate|methotrexate|mesh-list
6193968|NCT01927757|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6193969|NCT01927757|Abortifacient Agents|abortifacient agents|mesh-ancestor
6193970|NCT01927757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6193971|NCT01927757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6193972|NCT01927757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6193973|NCT01927757|Antimetabolites|antimetabolites|mesh-ancestor
6193974|NCT01927757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6193975|NCT01927757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6193976|NCT01927757|Dermatologic Agents|dermatologic agents|mesh-ancestor
6193977|NCT01927757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6193978|NCT01927757|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6193979|NCT01927757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6193980|NCT01927757|Immunologic Factors|immunologic factors|mesh-ancestor
6193981|NCT01927757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6193982|NCT01927757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6193983|NCT01927757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6193984|NCT01927757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6193985|NCT01927757|Analgesics|analgesics|mesh-ancestor
5725651|NCT03178708|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5725652|NCT03178708|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5725653|NCT03178708|Antiviral Agents|antiviral agents|mesh-ancestor
5725654|NCT03178708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5725655|NCT03178708|Dopamine Agents|dopamine agents|mesh-ancestor
5725656|NCT03178708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5725657|NCT03178708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725658|NCT03178708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725659|NCT03178708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5725660|NCT03178708|Analgesics|analgesics|mesh-ancestor
5725661|NCT03178708|Sensory System Agents|sensory system agents|mesh-ancestor
5725662|NCT03178708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5725663|NCT03178955|Etanercept|etanercept|mesh-list
5725664|NCT03178955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6193986|NCT01927757|Sensory System Agents|sensory system agents|mesh-ancestor
6193987|NCT01927757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6193988|NCT01927757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6193989|NCT01927757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6193990|NCT01927887|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
6193991|NCT01927887|Hematinics|hematinics|mesh-ancestor
6193992|NCT01927887|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6193993|NCT01927887|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6193994|NCT01928186|Alovudine|alovudine|mesh-list
6193995|NCT01928186|Antiviral Agents|antiviral agents|mesh-ancestor
6193996|NCT01928186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6193997|NCT01928199|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6193998|NCT01928199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6488293|NCT00582920|Zoledronic Acid|zoledronic acid|mesh-list
6193999|NCT01928199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194000|NCT01928199|Incretins|incretins|mesh-ancestor
6194001|NCT01928199|Hormones|hormones|mesh-ancestor
6194002|NCT01928199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6194003|NCT01928199|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6194004|NCT01928199|Protease Inhibitors|protease inhibitors|mesh-ancestor
6194005|NCT01928199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6194006|NCT01928199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194007|NCT01928225|Vaccines|vaccines|mesh-list
6194008|NCT01928225|Immunologic Factors|immunologic factors|mesh-ancestor
6194009|NCT01928225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194010|NCT01928290|Leucovorin|leucovorin|mesh-list
6194011|NCT01928290|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
5584738|NCT03819296|Hormones|hormones|mesh-ancestor
5584739|NCT03819296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5584740|NCT03819296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584741|NCT03819296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5584742|NCT03819296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5584743|NCT03819296|Immunologic Factors|immunologic factors|mesh-ancestor
6194012|NCT01928290|Tetrahydrofolates|tetrahydrofolates|mesh-list
6194013|NCT01928290|Fluorouracil|fluorouracil|mesh-list
6194014|NCT01928290|Oxaliplatin|oxaliplatin|mesh-list
6194015|NCT01928290|Trastuzumab|trastuzumab|mesh-list
6194016|NCT01928290|Irinotecan|irinotecan|mesh-list
6194017|NCT01928290|Levoleucovorin|levoleucovorin|mesh-list
6194018|NCT01928290|Antimetabolites|antimetabolites|mesh-ancestor
6194019|NCT01928290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194020|NCT01928290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6194021|NCT01928290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6194022|NCT01928290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6194023|NCT01928290|Immunologic Factors|immunologic factors|mesh-ancestor
6194024|NCT01928290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584744|NCT03819296|Dermatologic Agents|dermatologic agents|mesh-ancestor
5584745|NCT03819296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5584746|NCT03819296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5584747|NCT03819348|Antifungal Agents|antifungal agents|mesh-list
5584748|NCT03819348|Clotrimazole|clotrimazole|mesh-list
5584749|NCT03819348|Miconazole|miconazole|mesh-list
5584750|NCT03819348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5584751|NCT03819348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5584752|NCT03819348|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5584753|NCT03819348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5584754|NCT03819348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5584755|NCT03819348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584756|NCT03819348|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5584757|NCT03819348|Hormone Antagonists|hormone antagonists|mesh-ancestor
5584758|NCT03819348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5584759|NCT03819348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584760|NCT03819348|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5584761|NCT03819348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5584762|NCT03820986|Pembrolizumab|pembrolizumab|mesh-list
6194025|NCT01928290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6194026|NCT01928290|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6194027|NCT01928290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6194028|NCT01928290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6194029|NCT01928290|Antidotes|antidotes|mesh-ancestor
5584763|NCT03820986|Lenvatinib|lenvatinib|mesh-list
5584764|NCT03820986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5584765|NCT03820986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5584766|NCT03820986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5584767|NCT03820986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5584768|NCT03820986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584769|NCT03819231|Oxytocin|oxytocin|mesh-list
5584770|NCT03819231|Oxytocics|oxytocics|mesh-ancestor
5584771|NCT03819231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6194030|NCT01928290|Protective Agents|protective agents|mesh-ancestor
6194031|NCT01928290|Vitamin B Complex|vitamin b complex|mesh-ancestor
6194032|NCT01928290|Vitamins|vitamins|mesh-ancestor
6194033|NCT01928290|Micronutrients|micronutrients|mesh-ancestor
6194034|NCT01928329|Exenatide|exenatide|mesh-list
6194035|NCT01928329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6194036|NCT01928329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194037|NCT01928329|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6194038|NCT01928329|Incretins|incretins|mesh-ancestor
6194039|NCT01928329|Hormones|hormones|mesh-ancestor
6194040|NCT01928329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5584772|NCT03819231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584773|NCT03819322|Sofosbuvir|sofosbuvir|mesh-list
5584774|NCT03819322|Velpatasvir|velpatasvir|mesh-list
5584775|NCT03819322|Antiviral Agents|antiviral agents|mesh-ancestor
5584776|NCT03819322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5584777|NCT03820908|Bisantrene|bisantrene|mesh-list
5584778|NCT03820908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5584779|NCT03820908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5584780|NCT03819140|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
5584781|NCT03819140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5584782|NCT03819140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584783|NCT03819101|Aspirin|aspirin|mesh-list
5584784|NCT03819101|Atorvastatin|atorvastatin|mesh-list
5584785|NCT03819101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5584786|NCT03819101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5584787|NCT03819101|Antimetabolites|antimetabolites|mesh-ancestor
5584788|NCT03819101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584789|NCT03819101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5584790|NCT03819101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5584791|NCT03819101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5584792|NCT03819101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5584793|NCT03819101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5584794|NCT03819101|Analgesics|analgesics|mesh-ancestor
5584795|NCT03819101|Sensory System Agents|sensory system agents|mesh-ancestor
5584796|NCT03819101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5584797|NCT03819101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194041|NCT01928381|Pregabalin|pregabalin|mesh-list
6194042|NCT01928381|Analgesics|analgesics|mesh-ancestor
6194043|NCT01928381|Sensory System Agents|sensory system agents|mesh-ancestor
6194044|NCT01928381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6194045|NCT01928381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194046|NCT01928381|Anticonvulsants|anticonvulsants|mesh-ancestor
6194047|NCT01928381|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6194048|NCT01928381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6194049|NCT01928381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194050|NCT01928381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6194051|NCT01928381|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6194052|NCT01928381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6194053|NCT01928381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6194054|NCT01928381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6194055|NCT01928394|Nivolumab|nivolumab|mesh-list
6194056|NCT01928394|Ipilimumab|ipilimumab|mesh-list
6194057|NCT01928394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6194058|NCT01928394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6194059|NCT01928394|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6194060|NCT01928394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194061|NCT01928433|Ciprofloxacin|ciprofloxacin|mesh-list
6194062|NCT01928433|Finafloxacin|finafloxacin|mesh-list
6194063|NCT01928433|Fluoroquinolones|fluoroquinolones|mesh-list
6194064|NCT01928433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6194065|NCT01928433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6194066|NCT01928433|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6194067|NCT01928433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6194068|NCT01928433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6194069|NCT01928433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194070|NCT01928433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6194071|NCT01928433|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6194072|NCT01928433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6194073|NCT01928433|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6194074|NCT01928433|Renal Agents|renal agents|mesh-ancestor
6194075|NCT01928433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6194076|NCT01928446|Lithium Carbonate|lithium carbonate|mesh-list
6194077|NCT01928446|Antidepressive Agents|antidepressive agents|mesh-ancestor
6194078|NCT01928446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6194079|NCT01928446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6194080|NCT01928446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194081|NCT01928446|Antimanic Agents|antimanic agents|mesh-ancestor
6194082|NCT01928446|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6194083|NCT01928446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6194084|NCT01928446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194085|NCT01928680|Capecitabine|capecitabine|mesh-list
6194086|NCT01928680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6194087|NCT01928680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6194088|NCT01928680|Antimetabolites|antimetabolites|mesh-ancestor
6194089|NCT01928680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194090|NCT01928693|Moxifloxacin|moxifloxacin|mesh-list
6194091|NCT01928693|Gatifloxacin|gatifloxacin|mesh-list
6194092|NCT01928693|Besifloxacin|besifloxacin|mesh-list
6194093|NCT01928693|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6194094|NCT01928693|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6194095|NCT01928693|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6194096|NCT01928693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6194097|NCT01928693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6194098|NCT01928693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6194099|NCT01928693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6194100|NCT01928693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6194101|NCT01928693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194102|NCT01928693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6194103|NCT01928693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6194104|NCT01928693|Contraceptive Agents|contraceptive agents|mesh-ancestor
6194105|NCT01928693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6194106|NCT01928693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194107|NCT01928693|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6194108|NCT01928693|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6194109|NCT01928693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6194110|NCT01928719|Nicotine|nicotine|mesh-list
6194111|NCT01928719|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6194112|NCT01928719|Autonomic Agents|autonomic agents|mesh-ancestor
6194113|NCT01928719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6194114|NCT01928719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194115|NCT01928719|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6194116|NCT01928719|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6194117|NCT01928719|Cholinergic Agents|cholinergic agents|mesh-ancestor
6194118|NCT01928719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6194119|NCT01928719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194120|NCT01928758|Nicotine|nicotine|mesh-list
6194121|NCT01928758|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6194122|NCT01928758|Autonomic Agents|autonomic agents|mesh-ancestor
6194123|NCT01928758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6194124|NCT01928758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194125|NCT01928758|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6194126|NCT01928758|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6194127|NCT01928758|Cholinergic Agents|cholinergic agents|mesh-ancestor
6194128|NCT01928758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6194129|NCT01928758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194130|NCT01928771|Benralizumab|benralizumab|mesh-list
6194131|NCT01928771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6194132|NCT01928771|Respiratory System Agents|respiratory system agents|mesh-ancestor
6194133|NCT01928849|Valproic Acid|valproic acid|mesh-list
6194134|NCT01928849|Anticonvulsants|anticonvulsants|mesh-ancestor
6194135|NCT01928849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6194136|NCT01928849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194137|NCT01928849|GABA Agents|gaba agents|mesh-ancestor
6194138|NCT01928849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6194139|NCT01928849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194140|NCT01928849|Antimanic Agents|antimanic agents|mesh-ancestor
6194141|NCT01928849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6194142|NCT01928849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6194143|NCT01928849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6194144|NCT01928927|Telmisartan|telmisartan|mesh-list
5584798|NCT03819101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5584799|NCT03819101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5584800|NCT03819101|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5584801|NCT03819101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5584802|NCT03819101|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5584803|NCT03819101|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5584804|NCT03819101|Antipyretics|antipyretics|mesh-ancestor
5584805|NCT03819088|Zinc|zinc|mesh-list
5584806|NCT03819088|Zinc Sulfate|zinc sulfate|mesh-list
5584807|NCT03819088|Trace Elements|trace elements|mesh-ancestor
5584808|NCT03819088|Micronutrients|micronutrients|mesh-ancestor
5584809|NCT03819088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584810|NCT03819088|Astringents|astringents|mesh-ancestor
5584811|NCT03819088|Dermatologic Agents|dermatologic agents|mesh-ancestor
5584812|NCT03819127|Metformin|metformin|mesh-list
5584813|NCT03819127|Vildagliptin|vildagliptin|mesh-list
5584814|NCT03819127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5584815|NCT03819127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194145|NCT01928927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6194146|NCT01928927|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6194147|NCT01928927|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6194148|NCT01928927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194149|NCT01928940|Trametinib|trametinib|mesh-list
6194150|NCT01928940|Dabrafenib|dabrafenib|mesh-list
6194151|NCT01928940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6194152|NCT01928940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6194153|NCT01928940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6194154|NCT01928940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194155|NCT01929031|Ibuprofen|ibuprofen|mesh-list
6194156|NCT01929031|Caffeine|caffeine|mesh-list
6194157|NCT01929031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5584816|NCT03819127|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6194158|NCT01929031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6194159|NCT01929031|Analgesics|analgesics|mesh-ancestor
6194160|NCT01929031|Sensory System Agents|sensory system agents|mesh-ancestor
6194161|NCT01929031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5584817|NCT03819127|Protease Inhibitors|protease inhibitors|mesh-ancestor
5584818|NCT03819127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5584819|NCT03819127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605095|NCT03535727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194162|NCT01929031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194163|NCT01929031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6194164|NCT01929031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6194165|NCT01929031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6194166|NCT01929031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6194167|NCT01929031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194168|NCT01929031|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6194169|NCT01929031|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6194170|NCT01929031|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6194171|NCT01929031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6194172|NCT01929031|Purinergic Agents|purinergic agents|mesh-ancestor
6194173|NCT01929031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6194174|NCT01929044|Anisodamine|anisodamine|mesh-list
6194175|NCT01929044|Scopolamine|scopolamine|mesh-list
6194176|NCT01929044|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
6194177|NCT01929044|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6194178|NCT01929044|Antiemetics|antiemetics|mesh-ancestor
6194179|NCT01929044|Autonomic Agents|autonomic agents|mesh-ancestor
5605096|NCT03535727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5605097|NCT03535727|Antimetabolites|antimetabolites|mesh-ancestor
5605098|NCT03535727|Antiviral Agents|antiviral agents|mesh-ancestor
5605099|NCT03535727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5605100|NCT03535727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5605101|NCT03535727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5605102|NCT03535727|Immunologic Factors|immunologic factors|mesh-ancestor
5605103|NCT03535727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605104|NCT03535727|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5605105|NCT03535727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5605106|NCT03532555|Zinc|zinc|mesh-list
5605107|NCT03532555|Trace Elements|trace elements|mesh-ancestor
5605108|NCT03532555|Micronutrients|micronutrients|mesh-ancestor
5605109|NCT03532555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606884|NCT03517969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5606885|NCT03517969|Tubulin Modulators|tubulin modulators|mesh-ancestor
5606886|NCT03517969|Antimitotic Agents|antimitotic agents|mesh-ancestor
5606887|NCT03517969|Mitosis Modulators|mitosis modulators|mesh-ancestor
5606888|NCT03517969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606889|NCT03493425|Cisplatin|cisplatin|mesh-list
5606890|NCT03493425|Carboplatin|carboplatin|mesh-list
6194180|NCT01929044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6194181|NCT01929044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194182|NCT01929044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6194183|NCT01929044|Mydriatics|mydriatics|mesh-ancestor
6194184|NCT01929044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5606891|NCT03493425|Docetaxel|docetaxel|mesh-list
5606892|NCT03493425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5606893|NCT03493425|Tubulin Modulators|tubulin modulators|mesh-ancestor
5606894|NCT03493425|Antimitotic Agents|antimitotic agents|mesh-ancestor
6194185|NCT01929044|Cholinergic Agents|cholinergic agents|mesh-ancestor
6194186|NCT01929044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6194187|NCT01929044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606895|NCT03493425|Mitosis Modulators|mitosis modulators|mesh-ancestor
6194188|NCT01929044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6194189|NCT01929044|Parasympatholytics|parasympatholytics|mesh-ancestor
6194190|NCT01929044|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6194191|NCT01929044|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6194192|NCT01929044|Adrenergic Agents|adrenergic agents|mesh-ancestor
6194193|NCT01929044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6194194|NCT01929044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6194195|NCT01929044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6194196|NCT01929044|Analgesics|analgesics|mesh-ancestor
6194197|NCT01929044|Sensory System Agents|sensory system agents|mesh-ancestor
6194198|NCT01929044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6194199|NCT01929044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6194200|NCT01929044|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6194201|NCT01929044|Vasodilator Agents|vasodilator agents|mesh-ancestor
6194202|NCT01929044|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6194203|NCT01929044|Antioxidants|antioxidants|mesh-ancestor
6194204|NCT01929044|Protective Agents|protective agents|mesh-ancestor
6194205|NCT01929083|Ibutilide|ibutilide|mesh-list
6194206|NCT01929083|Progesterone|progesterone|mesh-list
6194207|NCT01929083|Progestins|progestins|mesh-ancestor
6194208|NCT01929083|Hormones|hormones|mesh-ancestor
6194209|NCT01929083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6194210|NCT01929083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194211|NCT01929083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6194212|NCT01929135|Atorvastatin|atorvastatin|mesh-list
6194213|NCT01929135|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6194214|NCT01929135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6194215|NCT01929135|Antimetabolites|antimetabolites|mesh-ancestor
6194216|NCT01929135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194217|NCT01929135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6194218|NCT01929135|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6194219|NCT01929135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6194220|NCT01929291|Vaccines|vaccines|mesh-list
5584820|NCT03819010|Letrozole|letrozole|mesh-list
5584821|NCT03819010|Palbociclib|palbociclib|mesh-list
5584822|NCT03819010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5584823|NCT03819010|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5584824|NCT03819010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5584825|NCT03819010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5584826|NCT03819010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584827|NCT03819010|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5584828|NCT03819010|Hormone Antagonists|hormone antagonists|mesh-ancestor
5584829|NCT03819010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5584830|NCT03819010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584831|NCT03819010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5584832|NCT03818997|Paclitaxel|paclitaxel|mesh-list
5584833|NCT03818997|Atezolizumab|atezolizumab|mesh-list
5584834|NCT03818997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5584835|NCT03818997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6194221|NCT01929291|Immunologic Factors|immunologic factors|mesh-ancestor
6194222|NCT01929291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194223|NCT01929317|Ropinirole|ropinirole|mesh-list
6194224|NCT01929317|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6194225|NCT01929317|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6194226|NCT01929317|Dopamine Agonists|dopamine agonists|mesh-ancestor
6194227|NCT01929317|Dopamine Agents|dopamine agents|mesh-ancestor
6194228|NCT01929317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6194229|NCT01929317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194230|NCT01929317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194231|NCT01929343|Lidocaine|lidocaine|mesh-list
6194232|NCT01929343|Anesthetics, Local|anesthetics, local|mesh-ancestor
6194233|NCT01929343|Anesthetics|anesthetics|mesh-ancestor
6194234|NCT01929343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6194235|NCT01929343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194236|NCT01929343|Sensory System Agents|sensory system agents|mesh-ancestor
6194237|NCT01929343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6194238|NCT01929343|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6194239|NCT01929343|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6194240|NCT01929343|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6194241|NCT01929343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6194242|NCT01929343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207316|NCT02114684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207317|NCT02114684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6207318|NCT02114892|Resveratrol|resveratrol|mesh-list
6207319|NCT02114892|Antioxidants|antioxidants|mesh-ancestor
6194243|NCT01929460|Ciprofloxacin|ciprofloxacin|mesh-list
6194244|NCT01929460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6194245|NCT01929460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6194246|NCT01929460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6194247|NCT01929460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6194248|NCT01929460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6194249|NCT01929460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194250|NCT01929460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6194251|NCT01929460|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6194252|NCT01929460|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6194253|NCT01929642|Sirolimus|sirolimus|mesh-list
6194254|NCT01929642|Everolimus|everolimus|mesh-list
6194255|NCT01929642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6194256|NCT01929642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6194257|NCT01929642|Immunologic Factors|immunologic factors|mesh-ancestor
6194258|NCT01929642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584836|NCT03818997|Tubulin Modulators|tubulin modulators|mesh-ancestor
5584837|NCT03818997|Antimitotic Agents|antimitotic agents|mesh-ancestor
5584838|NCT03818997|Mitosis Modulators|mitosis modulators|mesh-ancestor
5584839|NCT03818997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584840|NCT03818945|Listerine|listerine|mesh-list
6194259|NCT01929642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6194260|NCT01929642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6194261|NCT01929642|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6194262|NCT01929642|Antifungal Agents|antifungal agents|mesh-ancestor
6194263|NCT01929759|Tenofovir|tenofovir|mesh-list
6194264|NCT01929759|Emtricitabine|emtricitabine|mesh-list
6194265|NCT01929759|Cobicistat|cobicistat|mesh-list
6194266|NCT01929759|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6194267|NCT01929759|Elvitegravir|elvitegravir|mesh-list
6194268|NCT01929759|Antiviral Agents|antiviral agents|mesh-ancestor
6194269|NCT01929759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6194270|NCT01929759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6194271|NCT01929759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6194272|NCT01929759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6194273|NCT01929759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194274|NCT01929759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6194275|NCT01929759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6194276|NCT01929759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6194277|NCT01929759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6194278|NCT01929759|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6194279|NCT01929863|Metformin|metformin|mesh-list
6194280|NCT01929863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6194281|NCT01929863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194282|NCT01929876|Itraconazole|itraconazole|mesh-list
6194283|NCT01929876|Antifungal Agents|antifungal agents|mesh-ancestor
6194284|NCT01929876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6194285|NCT01929876|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6194286|NCT01929876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6194287|NCT01929876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6194288|NCT01929876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194289|NCT01929876|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6194290|NCT01929876|Hormone Antagonists|hormone antagonists|mesh-ancestor
6194291|NCT01929876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6194292|NCT01929876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194293|NCT01929876|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6194294|NCT01929889|Iloperidone|iloperidone|mesh-list
6194295|NCT01929889|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6194296|NCT01929889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6194297|NCT01929889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6194298|NCT01929889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194299|NCT01929889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6194300|NCT01929980|Bortezomib|bortezomib|mesh-list
6194301|NCT01929980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6194302|NCT01930045|Raltegravir Potassium|raltegravir potassium|mesh-list
6194303|NCT01930045|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
6194304|NCT01930045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6194305|NCT01930045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6194306|NCT01930045|Antiviral Agents|antiviral agents|mesh-ancestor
6194307|NCT01930045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6194308|NCT01930045|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6194309|NCT01930045|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6194310|NCT01930045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6194311|NCT01930045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194312|NCT01930045|Antacids|antacids|mesh-ancestor
6194313|NCT01930045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6194314|NCT01930188|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6194315|NCT01930188|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6194316|NCT01930188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194317|NCT01930188|Incretins|incretins|mesh-ancestor
6194318|NCT01930188|Hormones|hormones|mesh-ancestor
6194319|NCT01930188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6194320|NCT01930188|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6194321|NCT01930188|Protease Inhibitors|protease inhibitors|mesh-ancestor
6194322|NCT01930188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6194323|NCT01930188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194324|NCT01930487|Antioxidants|antioxidants|mesh-list
6194325|NCT01930487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194326|NCT01930487|Protective Agents|protective agents|mesh-ancestor
6194327|NCT01930487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194328|NCT01930747|Remifentanil|remifentanil|mesh-list
6194329|NCT01930747|Sevoflurane|sevoflurane|mesh-list
6194330|NCT01930747|Rocuronium|rocuronium|mesh-list
6194331|NCT01930747|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6194332|NCT01930747|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6194333|NCT01930747|Anesthetics, General|anesthetics, general|mesh-ancestor
6194334|NCT01930747|Anesthetics|anesthetics|mesh-ancestor
6194335|NCT01930747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6194336|NCT01930747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194337|NCT01930747|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6194338|NCT01930747|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6194339|NCT01930747|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6194340|NCT01930747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6194341|NCT01930747|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6194342|NCT01930747|Narcotics|narcotics|mesh-ancestor
6194343|NCT01930747|Analgesics|analgesics|mesh-ancestor
6194344|NCT01930747|Sensory System Agents|sensory system agents|mesh-ancestor
6194345|NCT01930890|Mycophenolic Acid|mycophenolic acid|mesh-list
6194346|NCT01930890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6194347|NCT01930890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6194348|NCT01930890|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6194349|NCT01930890|Antitubercular Agents|antitubercular agents|mesh-ancestor
6194350|NCT01930890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6194351|NCT01930890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6194352|NCT01930890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6194353|NCT01930890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194354|NCT01931059|Risperidone|risperidone|mesh-list
6194355|NCT01931059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6194356|NCT01931059|Serotonin Agents|serotonin agents|mesh-ancestor
6194357|NCT01931059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5584841|NCT03818945|Fluorides|fluorides|mesh-list
5584842|NCT03818945|Sodium Fluoride|sodium fluoride|mesh-list
5584843|NCT03818945|Fluorides, Topical|fluorides, topical|mesh-list
5584844|NCT03818945|Cariostatic Agents|cariostatic agents|mesh-ancestor
5584845|NCT03818945|Protective Agents|protective agents|mesh-ancestor
5584846|NCT03818945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584847|NCT03818945|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5584848|NCT03818945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5584849|NCT03818932|Acetaminophen|acetaminophen|mesh-list
5584850|NCT03818932|Celecoxib|celecoxib|mesh-list
5584851|NCT03818932|Ketorolac|ketorolac|mesh-list
6194358|NCT01931059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194359|NCT01931059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194360|NCT01931059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6194361|NCT01931059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6194362|NCT01931059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6194363|NCT01931059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6194364|NCT01931059|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6194365|NCT01931059|Dopamine Agents|dopamine agents|mesh-ancestor
6194366|NCT01931150|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6194367|NCT01931150|Dapsone|dapsone|mesh-list
6194368|NCT01931150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6194369|NCT01931150|Antimalarials|antimalarials|mesh-ancestor
6194370|NCT01931150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6194371|NCT01931150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6194372|NCT01931150|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6194373|NCT01931150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6208010|NCT02123459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5584852|NCT03818932|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
5584853|NCT03818932|Diazepam|diazepam|mesh-list
5584854|NCT03818932|Gabapentin|gabapentin|mesh-list
5584855|NCT03818932|Hydrocodone|hydrocodone|mesh-list
5584856|NCT03818932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5584857|NCT03818932|Analgesics|analgesics|mesh-ancestor
5584858|NCT03818932|Sensory System Agents|sensory system agents|mesh-ancestor
5584859|NCT03818932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5584860|NCT03818932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584861|NCT03818932|Antipyretics|antipyretics|mesh-ancestor
5584862|NCT03818932|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5584863|NCT03818932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5584864|NCT03818932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5584865|NCT03818932|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5584866|NCT03818932|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5584867|NCT03818932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5584868|NCT03818932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584869|NCT03818932|Anticonvulsants|anticonvulsants|mesh-ancestor
5584870|NCT03818932|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6194374|NCT01931150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194375|NCT01931150|Leprostatic Agents|leprostatic agents|mesh-ancestor
6194376|NCT01931163|Everolimus|everolimus|mesh-list
6194377|NCT01931163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6194378|NCT01931163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6194379|NCT01931163|Immunologic Factors|immunologic factors|mesh-ancestor
6194380|NCT01931163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194381|NCT01931202|Citalopram|citalopram|mesh-list
6194382|NCT01931202|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6194383|NCT01931202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6194384|NCT01931202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6194385|NCT01931202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194386|NCT01931202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6194387|NCT01931202|Serotonin Agents|serotonin agents|mesh-ancestor
6194388|NCT01931202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194389|NCT01931202|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6194390|NCT01931202|Antidepressive Agents|antidepressive agents|mesh-ancestor
6194391|NCT01931202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6672170|NCT01554345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672171|NCT01554345|Protective Agents|protective agents|mesh-ancestor
6672172|NCT01554345|Trace Elements|trace elements|mesh-ancestor
6194392|NCT01931475|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6194393|NCT01931475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6194394|NCT01931475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6194395|NCT01931475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6194396|NCT01931475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194397|NCT01931475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6194398|NCT01931475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194399|NCT01931475|Analgesics|analgesics|mesh-ancestor
6194400|NCT01931475|Sensory System Agents|sensory system agents|mesh-ancestor
6194401|NCT01931475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6194402|NCT01931475|Antidepressive Agents|antidepressive agents|mesh-ancestor
6194403|NCT01931475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6194404|NCT01931475|Dopamine Agents|dopamine agents|mesh-ancestor
6194405|NCT01931527|Rasburicase|rasburicase|mesh-list
6194406|NCT01931527|Gout Suppressants|gout suppressants|mesh-ancestor
6194407|NCT01931527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6194408|NCT01931566|Pioglitazone|pioglitazone|mesh-list
6194409|NCT01931566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6194410|NCT01931566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194411|NCT01931709|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6194412|NCT01931709|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6194413|NCT01931709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194414|NCT01931839|Ivacaftor|ivacaftor|mesh-list
6194415|NCT01931839|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6194416|NCT01931839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6194417|NCT01931839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194418|NCT01931865|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
6194419|NCT01931865|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6194420|NCT01931865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6672173|NCT01554397|Cisplatin|cisplatin|mesh-list
6672174|NCT01554397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5584871|NCT03818932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5584872|NCT03818932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5584873|NCT03818932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5584874|NCT03818932|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5584875|NCT03818932|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5584876|NCT03818932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5584877|NCT03818932|Antimanic Agents|antimanic agents|mesh-ancestor
5584878|NCT03818932|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5584879|NCT03818932|Narcotics|narcotics|mesh-ancestor
5584880|NCT03818932|Antitussive Agents|antitussive agents|mesh-ancestor
5584881|NCT03818932|Respiratory System Agents|respiratory system agents|mesh-ancestor
5584882|NCT03818932|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5584883|NCT03818932|Antiemetics|antiemetics|mesh-ancestor
5584884|NCT03818932|Autonomic Agents|autonomic agents|mesh-ancestor
5584885|NCT03818932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5584886|NCT03818932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5584887|NCT03818932|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6194421|NCT01931865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194422|NCT01931865|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6194423|NCT01931865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6194424|NCT01931865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194425|NCT01931865|Cholinergic Agents|cholinergic agents|mesh-ancestor
6194426|NCT01931865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6194427|NCT01931878|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
6194428|NCT01931878|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6194429|NCT01931878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6194430|NCT01931878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194431|NCT01931878|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6194432|NCT01931878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6194433|NCT01931878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194434|NCT01931878|Cholinergic Agents|cholinergic agents|mesh-ancestor
6194435|NCT01931878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6194436|NCT01932060|Oxytocin|oxytocin|mesh-list
6194437|NCT01932060|Oxytocics|oxytocics|mesh-ancestor
6194438|NCT01932060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6194439|NCT01932060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194440|NCT01932112|Adenosine|adenosine|mesh-list
5584888|NCT03818932|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5584889|NCT03818932|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5584890|NCT03818932|Anesthetics, General|anesthetics, general|mesh-ancestor
5584891|NCT03818932|Anesthetics|anesthetics|mesh-ancestor
5584892|NCT03818932|GABA Modulators|gaba modulators|mesh-ancestor
5584893|NCT03818932|GABA Agents|gaba agents|mesh-ancestor
5584894|NCT03818919|Acetaminophen|acetaminophen|mesh-list
5584895|NCT03818919|Celecoxib|celecoxib|mesh-list
5584896|NCT03818919|Ketorolac|ketorolac|mesh-list
5584897|NCT03818919|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
5584898|NCT03818919|Diazepam|diazepam|mesh-list
5584899|NCT03818919|Gabapentin|gabapentin|mesh-list
6194441|NCT01932112|Analgesics|analgesics|mesh-ancestor
6194442|NCT01932112|Sensory System Agents|sensory system agents|mesh-ancestor
6194443|NCT01932112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6194444|NCT01932112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194445|NCT01932112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6194446|NCT01932112|Vasodilator Agents|vasodilator agents|mesh-ancestor
6194447|NCT01932112|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6194448|NCT01932112|Purinergic Agonists|purinergic agonists|mesh-ancestor
6194449|NCT01932112|Purinergic Agents|purinergic agents|mesh-ancestor
6194450|NCT01932112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6194451|NCT01932112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194452|NCT01932697|Docetaxel|docetaxel|mesh-list
6194453|NCT01932697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6194454|NCT01932697|Tubulin Modulators|tubulin modulators|mesh-ancestor
6194455|NCT01932697|Antimitotic Agents|antimitotic agents|mesh-ancestor
6194456|NCT01932697|Mitosis Modulators|mitosis modulators|mesh-ancestor
6194457|NCT01932697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194458|NCT01932762|Ribavirin|ribavirin|mesh-list
6194459|NCT01932762|Grazoprevir|grazoprevir|mesh-list
6194460|NCT01932762|Antimetabolites|antimetabolites|mesh-ancestor
6194461|NCT01932762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194462|NCT01932762|Antiviral Agents|antiviral agents|mesh-ancestor
6194463|NCT01932762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6194464|NCT01932788|Vitamin D|vitamin d|mesh-list
6194465|NCT01932788|Cholecalciferol|cholecalciferol|mesh-list
6194466|NCT01932788|Vitamins|vitamins|mesh-list
6194467|NCT01932788|Micronutrients|micronutrients|mesh-ancestor
5584900|NCT03818919|Hydrocodone|hydrocodone|mesh-list
5584901|NCT03818919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5584902|NCT03818919|Analgesics|analgesics|mesh-ancestor
6194468|NCT01932788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194469|NCT01932788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6194470|NCT01932788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6194471|NCT01932996|Nicotine|nicotine|mesh-list
6194472|NCT01932996|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6194473|NCT01932996|Autonomic Agents|autonomic agents|mesh-ancestor
6194474|NCT01932996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6194475|NCT01932996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194476|NCT01932996|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6194477|NCT01932996|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6194478|NCT01932996|Cholinergic Agents|cholinergic agents|mesh-ancestor
6194479|NCT01932996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6194480|NCT01932996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194481|NCT01933048|Vaccines|vaccines|mesh-list
6194482|NCT01933048|Immunologic Factors|immunologic factors|mesh-ancestor
6194483|NCT01933048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194484|NCT01933217|Methylphenidate|methylphenidate|mesh-list
6194485|NCT01933217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6194486|NCT01933217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194487|NCT01933217|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6194488|NCT01933217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6194489|NCT01933217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6194490|NCT01933217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194491|NCT01933217|Dopamine Agents|dopamine agents|mesh-ancestor
6194492|NCT01933217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6194493|NCT01933334|Pirfenidone|pirfenidone|mesh-list
6194494|NCT01933334|Analgesics|analgesics|mesh-ancestor
6194495|NCT01933334|Sensory System Agents|sensory system agents|mesh-ancestor
6194496|NCT01933334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6194497|NCT01933334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194498|NCT01933334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6194499|NCT01933334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6194500|NCT01933334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6194501|NCT01933334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6194502|NCT01933334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6194503|NCT01933425|Rocuronium|rocuronium|mesh-list
6194504|NCT01933425|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6194505|NCT01933425|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6194506|NCT01933425|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6194507|NCT01933425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6194508|NCT01933425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194509|NCT01933464|Cromolyn Sodium|cromolyn sodium|mesh-list
6194510|NCT01933464|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
6194511|NCT01933464|Immunologic Factors|immunologic factors|mesh-ancestor
6194512|NCT01933464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194513|NCT01933464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6194514|NCT01933464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6194515|NCT01933464|Respiratory System Agents|respiratory system agents|mesh-ancestor
6194516|NCT01933594|Romidepsin|romidepsin|mesh-list
6194517|NCT01933594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5584903|NCT03818919|Sensory System Agents|sensory system agents|mesh-ancestor
5584904|NCT03818919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5605110|NCT03526354|Antipsychotic Agents|antipsychotic agents|mesh-list
6194518|NCT01933594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6194519|NCT01933672|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6194520|NCT01933672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6194521|NCT01933672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194522|NCT01933672|Incretins|incretins|mesh-ancestor
6194523|NCT01933672|Hormones|hormones|mesh-ancestor
6194524|NCT01933672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6194525|NCT01933672|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6194526|NCT01933672|Protease Inhibitors|protease inhibitors|mesh-ancestor
6194527|NCT01933672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6194528|NCT01933672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194529|NCT01933776|Vaccines|vaccines|mesh-list
6194530|NCT01933776|Immunologic Factors|immunologic factors|mesh-ancestor
6194531|NCT01933776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194532|NCT01933880|Methylphenidate|methylphenidate|mesh-list
6194533|NCT01933880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6194534|NCT01933880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194535|NCT01933880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6194536|NCT01933880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6194537|NCT01933880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5584905|NCT03818919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584906|NCT03818919|Antipyretics|antipyretics|mesh-ancestor
5584907|NCT03818919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5584908|NCT03818919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5584909|NCT03818919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5584910|NCT03818919|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5584911|NCT03818919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5584912|NCT03818919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5584913|NCT03818919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584914|NCT03818919|Anticonvulsants|anticonvulsants|mesh-ancestor
5584915|NCT03818919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5584916|NCT03818919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5584917|NCT03818919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5584918|NCT03818919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5584919|NCT03818919|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5584920|NCT03818919|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5584921|NCT03818919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5584922|NCT03818919|Antimanic Agents|antimanic agents|mesh-ancestor
5584923|NCT03818919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6194538|NCT01933880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194539|NCT01933880|Dopamine Agents|dopamine agents|mesh-ancestor
6194540|NCT01933880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6194541|NCT01933919|Fluvoxamine|fluvoxamine|mesh-list
6194542|NCT01933919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6194543|NCT01933919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194544|NCT01933919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6194545|NCT01933919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6194546|NCT01933919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6194547|NCT01933919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584924|NCT03818919|Narcotics|narcotics|mesh-ancestor
5584925|NCT03818919|Antitussive Agents|antitussive agents|mesh-ancestor
5584926|NCT03818919|Respiratory System Agents|respiratory system agents|mesh-ancestor
5584927|NCT03818919|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5584928|NCT03818919|Antiemetics|antiemetics|mesh-ancestor
5584929|NCT03818919|Autonomic Agents|autonomic agents|mesh-ancestor
5584930|NCT03818919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5584931|NCT03818919|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5584932|NCT03818919|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5584933|NCT03818919|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5584934|NCT03818919|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6194548|NCT01933919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6194549|NCT01933919|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6194550|NCT01933919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6194551|NCT01933919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6194552|NCT01933919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6194553|NCT01933919|Serotonin Agents|serotonin agents|mesh-ancestor
6194554|NCT01933919|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6194555|NCT01933919|Antidepressive Agents|antidepressive agents|mesh-ancestor
6194556|NCT01933919|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6194557|NCT01933919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6194558|NCT01933919|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6194559|NCT01933984|Fluticasone|fluticasone|mesh-list
6194560|NCT01933984|Fenoterol|fenoterol|mesh-list
6194561|NCT01933984|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6194562|NCT01933984|Bronchodilator Agents|bronchodilator agents|mesh-list
6194563|NCT01933984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6194564|NCT01933984|Autonomic Agents|autonomic agents|mesh-ancestor
6194565|NCT01933984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6194566|NCT01933984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194567|NCT01933984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6194568|NCT01933984|Respiratory System Agents|respiratory system agents|mesh-ancestor
6194569|NCT01933984|Dermatologic Agents|dermatologic agents|mesh-ancestor
6194570|NCT01933984|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6194571|NCT01933984|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6194572|NCT01933984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6194573|NCT01933984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5584935|NCT03818919|Anesthetics, General|anesthetics, general|mesh-ancestor
5584936|NCT03818919|Anesthetics|anesthetics|mesh-ancestor
5584937|NCT03818919|GABA Modulators|gaba modulators|mesh-ancestor
5584938|NCT03818919|GABA Agents|gaba agents|mesh-ancestor
5584939|NCT03818685|Capecitabine|capecitabine|mesh-list
5584940|NCT03818685|Nivolumab|nivolumab|mesh-list
5584941|NCT03818685|Ipilimumab|ipilimumab|mesh-list
5584942|NCT03818685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5584943|NCT03818685|Antimetabolites|antimetabolites|mesh-ancestor
6194574|NCT01933984|Adrenergic Agents|adrenergic agents|mesh-ancestor
6194575|NCT01933984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6194576|NCT01933984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194577|NCT01933984|Sympathomimetics|sympathomimetics|mesh-ancestor
6194578|NCT01933984|Tocolytic Agents|tocolytic agents|mesh-ancestor
6194579|NCT01933984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6194580|NCT01934192|Metoclopramide|metoclopramide|mesh-list
6194581|NCT01934192|Antiemetics|antiemetics|mesh-ancestor
6194582|NCT01934192|Autonomic Agents|autonomic agents|mesh-ancestor
6194583|NCT01934192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6194584|NCT01934192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194585|NCT01934192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6194586|NCT01934192|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6194587|NCT01934192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6194588|NCT01934192|Dopamine Agents|dopamine agents|mesh-ancestor
6194589|NCT01934192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6194590|NCT01934192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194591|NCT01934218|Hyaluronic Acid|hyaluronic acid|mesh-list
6194592|NCT01934218|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6194593|NCT01934218|Immunologic Factors|immunologic factors|mesh-ancestor
6194594|NCT01934218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194595|NCT01934218|Viscosupplements|viscosupplements|mesh-ancestor
6194596|NCT01934218|Protective Agents|protective agents|mesh-ancestor
6194597|NCT01934231|Amoxicillin|amoxicillin|mesh-list
6194598|NCT01934231|Clavulanic Acid|clavulanic acid|mesh-list
6194599|NCT01934231|Clavulanic Acids|clavulanic acids|mesh-list
6194600|NCT01934231|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6194601|NCT01934231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6194602|NCT01934231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6194603|NCT01934231|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6194604|NCT01934231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6194605|NCT01934231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194606|NCT01934556|Ranibizumab|ranibizumab|mesh-list
5584944|NCT03818685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584945|NCT03818685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5584946|NCT03818685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5584947|NCT03818685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5584948|NCT03818581|Suvorexant|suvorexant|mesh-list
5584949|NCT03818581|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5584950|NCT03818581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5584951|NCT03818581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5584952|NCT03818581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584953|NCT03818581|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
5584954|NCT03818581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5584955|NCT03818581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584956|NCT03818672|Rifaximin|rifaximin|mesh-list
5584957|NCT03818672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5584958|NCT03818672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5584959|NCT03818672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5584960|NCT03818282|Paclitaxel|paclitaxel|mesh-list
5584961|NCT03818282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5584962|NCT03818282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5584963|NCT03818282|Tubulin Modulators|tubulin modulators|mesh-ancestor
5584964|NCT03818282|Antimitotic Agents|antimitotic agents|mesh-ancestor
6194607|NCT01934556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6194608|NCT01934556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6194609|NCT01934556|Growth Substances|growth substances|mesh-ancestor
6194610|NCT01934556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194611|NCT01934556|Growth Inhibitors|growth inhibitors|mesh-ancestor
6194612|NCT01934556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6194613|NCT01934582|Treprostinil|treprostinil|mesh-list
6194614|NCT01934582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6194615|NCT01934790|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
6194616|NCT01934790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6194617|NCT01934894|Lapatinib|lapatinib|mesh-list
6194618|NCT01934894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6194619|NCT01934894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6194620|NCT01934894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6194621|NCT01934894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194622|NCT01934972|Cycloserine|cycloserine|mesh-list
6194623|NCT01934972|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6194624|NCT01934972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6194625|NCT01934972|Renal Agents|renal agents|mesh-ancestor
6194626|NCT01934972|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6194627|NCT01934972|Antitubercular Agents|antitubercular agents|mesh-ancestor
6194628|NCT01934972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6194629|NCT01934972|Antimetabolites|antimetabolites|mesh-ancestor
6194630|NCT01934972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194631|NCT01935622|Doxycycline|doxycycline|mesh-list
6194632|NCT01935622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6194633|NCT01935622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6194634|NCT01935622|Antimalarials|antimalarials|mesh-ancestor
5584965|NCT03818282|Mitosis Modulators|mitosis modulators|mesh-ancestor
5584966|NCT03818282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584967|NCT03818191|Acamprosate|acamprosate|mesh-list
5584968|NCT03818191|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5584969|NCT03818308|Sofosbuvir|sofosbuvir|mesh-list
5584970|NCT03818308|Velpatasvir|velpatasvir|mesh-list
5584971|NCT03818308|Antiviral Agents|antiviral agents|mesh-ancestor
5584972|NCT03818308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5584973|NCT03817970|Ondansetron|ondansetron|mesh-list
5584974|NCT03817970|Palonosetron|palonosetron|mesh-list
5584975|NCT03817970|Granisetron|granisetron|mesh-list
5584976|NCT03817970|Antiemetics|antiemetics|mesh-ancestor
5584977|NCT03817970|Autonomic Agents|autonomic agents|mesh-ancestor
5584978|NCT03817970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5584979|NCT03817970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5584980|NCT03817970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6194635|NCT01935622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6194636|NCT01935622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6194637|NCT01935700|Colchicine|colchicine|mesh-list
6194638|NCT01935700|Gout Suppressants|gout suppressants|mesh-ancestor
6194639|NCT01935700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6194640|NCT01935700|Tubulin Modulators|tubulin modulators|mesh-ancestor
6194641|NCT01935700|Antimitotic Agents|antimitotic agents|mesh-ancestor
6194642|NCT01935700|Mitosis Modulators|mitosis modulators|mesh-ancestor
6194643|NCT01935700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194644|NCT01935700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6194645|NCT01935791|Glucagon|glucagon|mesh-list
6194646|NCT01935791|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6194647|NCT01935791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6194648|NCT01935791|Hormones|hormones|mesh-ancestor
6194649|NCT01935791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6194650|NCT01935791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194651|NCT01935791|Incretins|incretins|mesh-ancestor
6194652|NCT01936181|Infliximab|infliximab|mesh-list
6194653|NCT01936181|Dermatologic Agents|dermatologic agents|mesh-ancestor
6194654|NCT01936181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6194655|NCT01936181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6194656|NCT01936363|Niacinamide|niacinamide|mesh-list
6194657|NCT01936363|Vitamin B Complex|vitamin b complex|mesh-ancestor
6194658|NCT01936363|Vitamins|vitamins|mesh-ancestor
5584981|NCT03817970|Antipruritics|antipruritics|mesh-ancestor
5584982|NCT03817970|Dermatologic Agents|dermatologic agents|mesh-ancestor
5584983|NCT03817970|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5584984|NCT03817970|Serotonin Agents|serotonin agents|mesh-ancestor
5584985|NCT03817970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5584986|NCT03817970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5584987|NCT03817970|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5584988|NCT03817970|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5584989|NCT03817970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6194659|NCT01936363|Micronutrients|micronutrients|mesh-ancestor
6194660|NCT01936363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194661|NCT01936519|Cyclosporine|cyclosporine|mesh-list
6194662|NCT01936519|Mycophenolic Acid|mycophenolic acid|mesh-list
6194663|NCT01936519|Everolimus|everolimus|mesh-list
6194664|NCT01936519|Tacrolimus|tacrolimus|mesh-list
6194665|NCT01936519|Cyclosporins|cyclosporins|mesh-list
6194666|NCT01936519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
6194667|NCT01936519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6194668|NCT01936519|Immunologic Factors|immunologic factors|mesh-ancestor
6194669|NCT01936519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194670|NCT01936519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6194671|NCT01936519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194672|NCT01936519|Antifungal Agents|antifungal agents|mesh-ancestor
6672175|NCT01554540|Treprostinil|treprostinil|mesh-list
5584990|NCT03817970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6672176|NCT01554540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6672177|NCT01554592|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
5584991|NCT03817970|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6194673|NCT01936519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5605111|NCT03526354|Brexpiprazole|brexpiprazole|mesh-list
6194674|NCT01936519|Dermatologic Agents|dermatologic agents|mesh-ancestor
5584992|NCT03817970|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5584993|NCT03818295|Praliciguat|praliciguat|mesh-list
5584994|NCT03818295|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
5584995|NCT03818295|Enzyme Activators|enzyme activators|mesh-ancestor
5584996|NCT03818295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672178|NCT01554592|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6672179|NCT01554592|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6194675|NCT01936519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6194676|NCT01936519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6194677|NCT01936519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6194678|NCT01936519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6194679|NCT01936519|Antitubercular Agents|antitubercular agents|mesh-ancestor
6194680|NCT01936519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6194681|NCT01936649|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
6194682|NCT01936649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6194683|NCT01936649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6194684|NCT01936649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194685|NCT01936649|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6194686|NCT01936844|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6194687|NCT01936844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6194688|NCT01936857|Buprenorphine|buprenorphine|mesh-list
6194689|NCT01936857|Methadone|methadone|mesh-list
6194690|NCT01936857|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6194691|NCT01936857|Naloxone|naloxone|mesh-list
6194692|NCT01936857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6194693|NCT01936857|Narcotics|narcotics|mesh-ancestor
6194694|NCT01936857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6194695|NCT01936857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194696|NCT01936857|Analgesics|analgesics|mesh-ancestor
6194697|NCT01936857|Sensory System Agents|sensory system agents|mesh-ancestor
6194698|NCT01936857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6194699|NCT01936857|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6194700|NCT01936857|Antitussive Agents|antitussive agents|mesh-ancestor
6194701|NCT01936857|Respiratory System Agents|respiratory system agents|mesh-ancestor
6194702|NCT01936870|Fesoterodine|fesoterodine|mesh-list
6194703|NCT01936870|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6194704|NCT01936870|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6194705|NCT01936870|Cholinergic Agents|cholinergic agents|mesh-ancestor
6194706|NCT01936870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6194707|NCT01936870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194708|NCT01936870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194709|NCT01936870|Urological Agents|urological agents|mesh-ancestor
6194710|NCT01936896|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
6194711|NCT01936896|Protein C Inhibitor|protein c inhibitor|mesh-list
6194712|NCT01936896|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6194713|NCT01936896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6194714|NCT01936896|Protease Inhibitors|protease inhibitors|mesh-ancestor
6194715|NCT01936896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6194716|NCT01936896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194717|NCT01936909|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6194718|NCT01936909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6207320|NCT02114892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207321|NCT02114892|Protective Agents|protective agents|mesh-ancestor
6207322|NCT02114892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207323|NCT02114892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5584997|NCT03818295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5584998|NCT03818113|Cardioplegic Solutions|cardioplegic solutions|mesh-list
5584999|NCT03818113|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5585000|NCT03817931|Solifenacin Succinate|solifenacin succinate|mesh-list
6207324|NCT02114892|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6207325|NCT02114931|Adalimumab|adalimumab|mesh-list
6207326|NCT02114931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6207327|NCT02114931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6207328|NCT02115048|Letrozole|letrozole|mesh-list
6207329|NCT02115048|Afatinib|afatinib|mesh-list
6207330|NCT02115048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5585001|NCT03817931|Mirabegron|mirabegron|mesh-list
5585002|NCT03817931|Cholinergic Antagonists|cholinergic antagonists|mesh-list
5585003|NCT03817931|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-list
5585004|NCT03817931|Adrenergic Agents|adrenergic agents|mesh-list
5585005|NCT03817931|Adrenergic Agonists|adrenergic agonists|mesh-list
5585006|NCT03817931|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5585007|NCT03817931|Cholinergic Agents|cholinergic agents|mesh-ancestor
6194719|NCT01937026|Probenecid|probenecid|mesh-list
6194720|NCT01937026|Uricosuric Agents|uricosuric agents|mesh-ancestor
6194721|NCT01937026|Gout Suppressants|gout suppressants|mesh-ancestor
6194722|NCT01937026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6194723|NCT01937026|Renal Agents|renal agents|mesh-ancestor
6194724|NCT01937117|Trastuzumab|trastuzumab|mesh-list
6194725|NCT01937117|Pertuzumab|pertuzumab|mesh-list
6194726|NCT01937117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6194727|NCT01937117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6194728|NCT01937260|Brodalumab|brodalumab|mesh-list
6194729|NCT01937260|Dermatologic Agents|dermatologic agents|mesh-ancestor
6194730|NCT01937299|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6194731|NCT01937299|Travoprost|travoprost|mesh-list
6194732|NCT01937299|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6194733|NCT01937299|Brinzolamide|brinzolamide|mesh-list
6194734|NCT01937299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6194735|NCT01937299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6194736|NCT01937299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6194737|NCT01937299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6194738|NCT01937299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6194739|NCT01937299|Adrenergic Agents|adrenergic agents|mesh-ancestor
6194740|NCT01937299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6194741|NCT01937299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194742|NCT01937299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194743|NCT01937299|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6194744|NCT01937299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6194745|NCT01937312|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6194746|NCT01937312|Travoprost|travoprost|mesh-list
6194747|NCT01937312|Brinzolamide|brinzolamide|mesh-list
6194748|NCT01937312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6194749|NCT01937312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6194750|NCT01937312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6194751|NCT01937312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6194752|NCT01937312|Adrenergic Agents|adrenergic agents|mesh-ancestor
6194753|NCT01937312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6194754|NCT01937312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194755|NCT01937312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194756|NCT01937312|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6194757|NCT01937312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6194758|NCT01937364|Baclofen|baclofen|mesh-list
6194759|NCT01937364|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6194760|NCT01937364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194761|NCT01937364|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6194762|NCT01937364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6194763|NCT01937364|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6194764|NCT01937364|GABA Agonists|gaba agonists|mesh-ancestor
6194765|NCT01937364|GABA Agents|gaba agents|mesh-ancestor
6194766|NCT01937364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6194767|NCT01937364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194768|NCT01937390|Bromides|bromides|mesh-list
6194769|NCT01937390|Tiotropium Bromide|tiotropium bromide|mesh-list
6194770|NCT01937390|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6194771|NCT01937390|Autonomic Agents|autonomic agents|mesh-ancestor
6194772|NCT01937390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6194773|NCT01937390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194774|NCT01937390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6194775|NCT01937390|Respiratory System Agents|respiratory system agents|mesh-ancestor
6194776|NCT01937390|Parasympatholytics|parasympatholytics|mesh-ancestor
6194777|NCT01937390|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6194778|NCT01937390|Cholinergic Agents|cholinergic agents|mesh-ancestor
6194779|NCT01937390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6194780|NCT01937390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585008|NCT03817931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5585009|NCT03817931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585010|NCT03817931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585011|NCT03817931|Urological Agents|urological agents|mesh-ancestor
5585012|NCT03817931|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5585013|NCT03818061|Bevacizumab|bevacizumab|mesh-list
6194781|NCT01937390|Anticonvulsants|anticonvulsants|mesh-ancestor
6194782|NCT01937559|Tranexamic Acid|tranexamic acid|mesh-list
6194783|NCT01937559|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6194784|NCT01937559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6194785|NCT01937559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194786|NCT01937559|Hemostatics|hemostatics|mesh-ancestor
6194787|NCT01937559|Coagulants|coagulants|mesh-ancestor
5585014|NCT03818061|Atezolizumab|atezolizumab|mesh-list
5585015|NCT03818061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5585016|NCT03818061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5585017|NCT03818061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5585018|NCT03818061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5585019|NCT03818061|Growth Substances|growth substances|mesh-ancestor
5585020|NCT03818061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585021|NCT03818061|Growth Inhibitors|growth inhibitors|mesh-ancestor
5585022|NCT03818178|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
5585023|NCT03818178|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
5585024|NCT03818178|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5585025|NCT03818178|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5585026|NCT03818048|Propofol|propofol|mesh-list
5585027|NCT03818048|Sevoflurane|sevoflurane|mesh-list
5585028|NCT03818048|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5585029|NCT03818048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5585030|NCT03818048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585031|NCT03818048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5585032|NCT03818048|Anesthetics, General|anesthetics, general|mesh-ancestor
5585033|NCT03818048|Anesthetics|anesthetics|mesh-ancestor
5585034|NCT03818048|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5585035|NCT03818048|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5585036|NCT03818334|Cyclophosphamide|cyclophosphamide|mesh-list
5585037|NCT03818334|Thymoglobulin|thymoglobulin|mesh-list
5585038|NCT03818334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5585039|NCT03818334|Immunologic Factors|immunologic factors|mesh-ancestor
5585040|NCT03818334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585041|NCT03818334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5585042|NCT03818334|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5585043|NCT03818334|Alkylating Agents|alkylating agents|mesh-ancestor
5585044|NCT03818334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585045|NCT03818334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5585046|NCT03818334|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5585047|NCT03818321|Methenamine|methenamine|mesh-list
6194788|NCT01937598|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6194789|NCT01937598|Liraglutide|liraglutide|mesh-list
6194790|NCT01937598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6194791|NCT01937598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194792|NCT01937598|Incretins|incretins|mesh-ancestor
6194793|NCT01937598|Hormones|hormones|mesh-ancestor
6194794|NCT01937598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6194795|NCT01937598|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6194796|NCT01937598|Protease Inhibitors|protease inhibitors|mesh-ancestor
6194797|NCT01937598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6194798|NCT01937598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194799|NCT01937715|Bevacizumab|bevacizumab|mesh-list
6194800|NCT01937715|Gedatolisib|gedatolisib|mesh-list
6194801|NCT01937715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6194802|NCT01937715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6194803|NCT01937715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6194804|NCT01937715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6194805|NCT01937715|Growth Substances|growth substances|mesh-ancestor
6194806|NCT01937715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194807|NCT01937715|Growth Inhibitors|growth inhibitors|mesh-ancestor
6194808|NCT01937715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6194809|NCT01937715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6194810|NCT01937715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194811|NCT01937871|Tadalafil|tadalafil|mesh-list
6194812|NCT01937871|Tamsulosin|tamsulosin|mesh-list
6194813|NCT01937871|Vasodilator Agents|vasodilator agents|mesh-ancestor
6194814|NCT01937871|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6194815|NCT01937871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6194816|NCT01937871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6194817|NCT01937871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194818|NCT01937871|Urological Agents|urological agents|mesh-ancestor
6194819|NCT01937871|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6194820|NCT01937871|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6194821|NCT01937871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6194822|NCT01937871|Adrenergic Agents|adrenergic agents|mesh-ancestor
6194823|NCT01937871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6194824|NCT01937871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194825|NCT01937975|Grazoprevir|grazoprevir|mesh-list
6194826|NCT01937975|Antiviral Agents|antiviral agents|mesh-ancestor
6194827|NCT01937975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6194828|NCT01938001|Rituximab|rituximab|mesh-list
6194829|NCT01938001|Lenalidomide|lenalidomide|mesh-list
6194830|NCT01938001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6194831|NCT01938001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6194832|NCT01938001|Immunologic Factors|immunologic factors|mesh-ancestor
6194833|NCT01938001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194834|NCT01938001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6194835|NCT01938001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6194836|NCT01938001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6194837|NCT01938001|Growth Substances|growth substances|mesh-ancestor
6194838|NCT01938001|Growth Inhibitors|growth inhibitors|mesh-ancestor
6194839|NCT01938040|Ibuprofen|ibuprofen|mesh-list
6194840|NCT01938040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6194841|NCT01938040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6194842|NCT01938040|Analgesics|analgesics|mesh-ancestor
6194843|NCT01938040|Sensory System Agents|sensory system agents|mesh-ancestor
6194844|NCT01938040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6194845|NCT01938040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194846|NCT01938040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6194847|NCT01938040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6194848|NCT01938040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6194849|NCT01938040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6194850|NCT01938040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194851|NCT01938079|Ketamine|ketamine|mesh-list
5585048|NCT03818321|Methenamine hippurate|methenamine hippurate|mesh-list
5585049|NCT03818321|Methenamine mandelate|methenamine mandelate|mesh-list
5585050|NCT03818321|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5585051|NCT03818321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5585052|NCT03818321|Renal Agents|renal agents|mesh-ancestor
5585053|NCT03818321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5585054|NCT03817541|Propofol|propofol|mesh-list
5585055|NCT03817541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5585056|NCT03817541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5585057|NCT03817541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585058|NCT03817541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5585059|NCT03817541|Anesthetics, General|anesthetics, general|mesh-ancestor
6194852|NCT01938079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
6194853|NCT01938079|Analgesics|analgesics|mesh-ancestor
6194854|NCT01938079|Sensory System Agents|sensory system agents|mesh-ancestor
6194855|NCT01938079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6194856|NCT01938079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194857|NCT01938079|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6194858|NCT01938079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6194859|NCT01938079|Anesthetics, General|anesthetics, general|mesh-ancestor
6194860|NCT01938079|Anesthetics|anesthetics|mesh-ancestor
6194861|NCT01938079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6194862|NCT01938079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6194863|NCT01938079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5585060|NCT03817541|Anesthetics|anesthetics|mesh-ancestor
5585061|NCT03817619|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
5585062|NCT03817619|Antiviral Agents|antiviral agents|mesh-ancestor
5585063|NCT03817619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5585064|NCT03817567|Cetuximab|cetuximab|mesh-list
5585065|NCT03817567|Antibodies|antibodies|mesh-list
5585066|NCT03817567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5585067|NCT03817567|Immunologic Factors|immunologic factors|mesh-ancestor
5585068|NCT03817567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585069|NCT03817567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5585070|NCT03817567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5585071|NCT03817502|Cariprazine|cariprazine|mesh-list
5585072|NCT03817502|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5585073|NCT03817502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5585074|NCT03817502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5585075|NCT03817502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585076|NCT03817502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5585077|NCT03817515|Sirolimus|sirolimus|mesh-list
5585078|NCT03817515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5585079|NCT03817515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6194864|NCT01938079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6194865|NCT01938079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585080|NCT03817515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5585081|NCT03817515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5585082|NCT03817515|Antifungal Agents|antifungal agents|mesh-ancestor
5585083|NCT03817515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6194866|NCT01938430|Sofosbuvir|sofosbuvir|mesh-list
6194867|NCT01938430|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
6194868|NCT01938430|Ledipasvir|ledipasvir|mesh-list
6194869|NCT01938430|Antiviral Agents|antiviral agents|mesh-ancestor
6194870|NCT01938430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6194871|NCT01938573|Gemcitabine|gemcitabine|mesh-list
6194872|NCT01938573|Sirolimus|sirolimus|mesh-list
6194873|NCT01938573|Cisplatin|cisplatin|mesh-list
6194874|NCT01938573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6194875|NCT01938573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6194876|NCT01938573|Antimetabolites|antimetabolites|mesh-ancestor
6194877|NCT01938573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194878|NCT01938573|Antiviral Agents|antiviral agents|mesh-ancestor
6194879|NCT01938573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6194880|NCT01938573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5585084|NCT03817515|Immunologic Factors|immunologic factors|mesh-ancestor
5585085|NCT03817515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585086|NCT03817411|Capecitabine|capecitabine|mesh-list
5585087|NCT03817411|Oxaliplatin|oxaliplatin|mesh-list
5585088|NCT03817411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5585089|NCT03817411|Antimetabolites|antimetabolites|mesh-ancestor
5585090|NCT03817411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585091|NCT03817411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5585092|NCT03817476|BI 425809|bi 425809|mesh-list
5585093|NCT03817476|Nootropic Agents|nootropic agents|mesh-ancestor
5585094|NCT03817736|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5585095|NCT03817736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585096|NCT03817736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5585097|NCT03817359|Remifentanil|remifentanil|mesh-list
6194881|NCT01938573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6194882|NCT01938573|Immunologic Factors|immunologic factors|mesh-ancestor
6194883|NCT01938573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194884|NCT01938573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6194885|NCT01938573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6194886|NCT01938573|Antifungal Agents|antifungal agents|mesh-ancestor
6194887|NCT01938625|Cyclosporine|cyclosporine|mesh-list
6194888|NCT01938625|Ribavirin|ribavirin|mesh-list
6194889|NCT01938625|Simeprevir|simeprevir|mesh-list
6194890|NCT01938625|Tacrolimus|tacrolimus|mesh-list
6194891|NCT01938625|Cyclosporins|cyclosporins|mesh-list
6194892|NCT01938625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6194893|NCT01938625|Immunologic Factors|immunologic factors|mesh-ancestor
6194894|NCT01938625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194895|NCT01938625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6194896|NCT01938625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6194897|NCT01938625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194898|NCT01938625|Antifungal Agents|antifungal agents|mesh-ancestor
6194899|NCT01938625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6194900|NCT01938625|Dermatologic Agents|dermatologic agents|mesh-ancestor
6194901|NCT01938625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6194902|NCT01938625|Antimetabolites|antimetabolites|mesh-ancestor
6194903|NCT01938625|Antiviral Agents|antiviral agents|mesh-ancestor
6194904|NCT01938625|Protease Inhibitors|protease inhibitors|mesh-ancestor
6194905|NCT01938664|Candesartan|candesartan|mesh-list
6194906|NCT01938664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6194907|NCT01938664|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6194908|NCT01938664|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6194909|NCT01938664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194910|NCT01938846|Paclitaxel|paclitaxel|mesh-list
6194911|NCT01938846|Exemestane|exemestane|mesh-list
6194912|NCT01938846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6194913|NCT01938846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6194914|NCT01938846|Tubulin Modulators|tubulin modulators|mesh-ancestor
5585098|NCT03817359|Propofol|propofol|mesh-list
5585099|NCT03817359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5585100|NCT03817359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5585101|NCT03817359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585102|NCT03817359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5585103|NCT03817359|Anesthetics, General|anesthetics, general|mesh-ancestor
6194915|NCT01938846|Antimitotic Agents|antimitotic agents|mesh-ancestor
5585104|NCT03817359|Anesthetics|anesthetics|mesh-ancestor
5585105|NCT03817359|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6194916|NCT01938846|Mitosis Modulators|mitosis modulators|mesh-ancestor
6207331|NCT02115048|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6194917|NCT01938846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194918|NCT01938846|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6194919|NCT01938846|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5585106|NCT03817359|Narcotics|narcotics|mesh-ancestor
5585107|NCT03817359|Analgesics|analgesics|mesh-ancestor
5585108|NCT03817359|Sensory System Agents|sensory system agents|mesh-ancestor
5585109|NCT03817359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5605112|NCT03526354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5605113|NCT03526354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5605114|NCT03526354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605115|NCT03526354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5605116|NCT03526354|Serotonin Agents|serotonin agents|mesh-ancestor
5605117|NCT03526354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5605118|NCT03526354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605119|NCT03526354|Dopamine Agonists|dopamine agonists|mesh-ancestor
5605120|NCT03526354|Dopamine Agents|dopamine agents|mesh-ancestor
5605121|NCT03511599|Cycloserine|cycloserine|mesh-list
6194920|NCT01938846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6194921|NCT01938846|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6194922|NCT01938846|Hormone Antagonists|hormone antagonists|mesh-ancestor
6194923|NCT01938846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6194924|NCT01938846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194925|NCT01938989|Methamphetamine|methamphetamine|mesh-list
6194926|NCT01938989|beta-Endorphin|beta-endorphin|mesh-list
6194927|NCT01938989|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6194928|NCT01938989|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
6194929|NCT01938989|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6194930|NCT01938989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194931|NCT01938989|Sympathomimetics|sympathomimetics|mesh-ancestor
6194932|NCT01938989|Autonomic Agents|autonomic agents|mesh-ancestor
6194933|NCT01938989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6194934|NCT01938989|Dopamine Agents|dopamine agents|mesh-ancestor
6194935|NCT01938989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6194936|NCT01938989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194937|NCT01938989|Adrenergic Agents|adrenergic agents|mesh-ancestor
6194938|NCT01938989|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6194939|NCT01938989|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6194940|NCT01938989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6194941|NCT01938989|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6194942|NCT01938989|Hormones|hormones|mesh-ancestor
6194943|NCT01938989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6194944|NCT01939002|Interferons|interferons|mesh-list
6194945|NCT01939002|Interferon-beta|interferon-beta|mesh-list
6194946|NCT01939002|Interferon beta-1a|interferon beta-1a|mesh-list
6194947|NCT01939002|Naproxen|naproxen|mesh-list
6194948|NCT01939002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
6194949|NCT01939002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
6194950|NCT01939002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6194951|NCT01939002|Antiviral Agents|antiviral agents|mesh-ancestor
6194952|NCT01939002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5605122|NCT03511599|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5605123|NCT03511599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5605124|NCT03511599|Renal Agents|renal agents|mesh-ancestor
5605125|NCT03511599|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6194953|NCT01939002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6194954|NCT01939002|Analgesics|analgesics|mesh-ancestor
6194955|NCT01939002|Sensory System Agents|sensory system agents|mesh-ancestor
6194956|NCT01939002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6194957|NCT01939002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194958|NCT01939002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6194959|NCT01939002|Gout Suppressants|gout suppressants|mesh-ancestor
6194960|NCT01939002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6194961|NCT01939002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6194962|NCT01939002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194963|NCT01939002|Immunologic Factors|immunologic factors|mesh-ancestor
6194964|NCT01939002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6194965|NCT01939028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6194966|NCT01939158|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6194967|NCT01939158|Immunologic Factors|immunologic factors|mesh-ancestor
6194968|NCT01939158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194969|NCT01939197|Ritonavir|ritonavir|mesh-list
6194970|NCT01939197|Ribavirin|ribavirin|mesh-list
6194971|NCT01939197|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5605126|NCT03511599|Antitubercular Agents|antitubercular agents|mesh-ancestor
6194972|NCT01939197|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6194973|NCT01939197|Protease Inhibitors|protease inhibitors|mesh-ancestor
6194974|NCT01939197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6194975|NCT01939197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6194976|NCT01939197|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6194977|NCT01939197|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6194978|NCT01939197|Antiviral Agents|antiviral agents|mesh-ancestor
6194979|NCT01939197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6194980|NCT01939197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6194981|NCT01939197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6194982|NCT01939197|Antimetabolites|antimetabolites|mesh-ancestor
6194983|NCT01939275|Copper|copper|mesh-list
6194984|NCT01939275|Trastuzumab|trastuzumab|mesh-list
6194985|NCT01939275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6194986|NCT01939275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6194987|NCT01939275|Trace Elements|trace elements|mesh-ancestor
6194988|NCT01939275|Micronutrients|micronutrients|mesh-ancestor
6194989|NCT01939275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194990|NCT01939301|Nitric Oxide|nitric oxide|mesh-list
6194991|NCT01939301|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6194992|NCT01939301|Autonomic Agents|autonomic agents|mesh-ancestor
6194993|NCT01939301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6194994|NCT01939301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6194995|NCT01939301|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6194996|NCT01939301|Respiratory System Agents|respiratory system agents|mesh-ancestor
6194997|NCT01939301|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6194998|NCT01939301|Antioxidants|antioxidants|mesh-ancestor
6194999|NCT01939301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585110|NCT03816982|Bupivacaine|bupivacaine|mesh-list
5585111|NCT03816982|Anesthetics, Local|anesthetics, local|mesh-ancestor
5585112|NCT03816982|Anesthetics|anesthetics|mesh-ancestor
5585113|NCT03816982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5585114|NCT03816982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585115|NCT03816982|Sensory System Agents|sensory system agents|mesh-ancestor
5585116|NCT03816982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5585117|NCT03817320|Dexamethasone|dexamethasone|mesh-list
5585118|NCT03817320|Doxorubicin|doxorubicin|mesh-list
5585119|NCT03817320|Vincristine|vincristine|mesh-list
5585120|NCT03817320|Asparaginase|asparaginase|mesh-list
5585121|NCT03817320|Ixazomib|ixazomib|mesh-list
5585122|NCT03817320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5585123|NCT03817320|Antiemetics|antiemetics|mesh-ancestor
5585124|NCT03817320|Autonomic Agents|autonomic agents|mesh-ancestor
5585125|NCT03817320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5585126|NCT03817320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585127|NCT03817320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5585128|NCT03817320|Glucocorticoids|glucocorticoids|mesh-ancestor
5585129|NCT03817320|Hormones|hormones|mesh-ancestor
5585130|NCT03817320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5585131|NCT03817320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5585132|NCT03817320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5585133|NCT03817320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5585134|NCT03817320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6195000|NCT01939301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6195001|NCT01939301|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6195002|NCT01939301|Vasodilator Agents|vasodilator agents|mesh-ancestor
6195003|NCT01939301|Gasotransmitters|gasotransmitters|mesh-ancestor
6195004|NCT01939301|Protective Agents|protective agents|mesh-ancestor
6195005|NCT01939314|Bupivacaine|bupivacaine|mesh-list
6195006|NCT01939314|Anesthetics, Local|anesthetics, local|mesh-ancestor
6195007|NCT01939314|Anesthetics|anesthetics|mesh-ancestor
6195008|NCT01939314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6195009|NCT01939314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195010|NCT01939314|Sensory System Agents|sensory system agents|mesh-ancestor
6195011|NCT01939314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6195012|NCT01939366|Pregabalin|pregabalin|mesh-list
5585135|NCT03817320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5585136|NCT03817320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6195013|NCT01939366|Analgesics|analgesics|mesh-ancestor
6195014|NCT01939366|Sensory System Agents|sensory system agents|mesh-ancestor
6195015|NCT01939366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6195016|NCT01939366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195017|NCT01939366|Anticonvulsants|anticonvulsants|mesh-ancestor
6195018|NCT01939366|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6195019|NCT01939366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6207332|NCT02115048|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6195020|NCT01939366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195021|NCT01939366|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6195022|NCT01939366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6195023|NCT01939366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6195024|NCT01939366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6195025|NCT01939366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6195026|NCT01939496|Canagliflozin|canagliflozin|mesh-list
5585137|NCT03817320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585138|NCT03817320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5585139|NCT03817320|Tubulin Modulators|tubulin modulators|mesh-ancestor
5585140|NCT03817320|Antimitotic Agents|antimitotic agents|mesh-ancestor
5585141|NCT03817320|Mitosis Modulators|mitosis modulators|mesh-ancestor
5585142|NCT03817320|Protease Inhibitors|protease inhibitors|mesh-ancestor
5585143|NCT03817268|Capecitabine|capecitabine|mesh-list
5585144|NCT03817268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5585145|NCT03817268|Antimetabolites|antimetabolites|mesh-ancestor
5585146|NCT03817268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585147|NCT03817268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5585148|NCT03817112|Dexmedetomidine|dexmedetomidine|mesh-list
5585149|NCT03817112|Propofol|propofol|mesh-list
5585150|NCT03817112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5585151|NCT03817112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5585152|NCT03817112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585153|NCT03817112|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5585154|NCT03817112|Anesthetics, General|anesthetics, general|mesh-ancestor
5585155|NCT03817112|Anesthetics|anesthetics|mesh-ancestor
5585156|NCT03817112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5585157|NCT03817112|Analgesics|analgesics|mesh-ancestor
5585158|NCT03817112|Sensory System Agents|sensory system agents|mesh-ancestor
5585159|NCT03817112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5585160|NCT03817112|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5585161|NCT03817112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5585162|NCT03817112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5585163|NCT03817112|Adrenergic Agents|adrenergic agents|mesh-ancestor
5585164|NCT03817112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5585165|NCT03817112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195027|NCT01939496|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6195028|NCT01939496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195029|NCT01939496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6195030|NCT01939496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195031|NCT01939899|Ixazomib|ixazomib|mesh-list
6195032|NCT01939899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6195033|NCT01939899|Protease Inhibitors|protease inhibitors|mesh-ancestor
6195034|NCT01939899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6195035|NCT01939899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195036|NCT01939977|Calcifediol|calcifediol|mesh-list
6195037|NCT01939977|Vitamins|vitamins|mesh-ancestor
6195038|NCT01939977|Micronutrients|micronutrients|mesh-ancestor
6195039|NCT01939977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195040|NCT01939977|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6195041|NCT01940276|Prednisone|prednisone|mesh-list
6195042|NCT01940276|Abiraterone Acetate|abiraterone acetate|mesh-list
6195043|NCT01940276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6195044|NCT01940276|Glucocorticoids|glucocorticoids|mesh-ancestor
6195045|NCT01940276|Hormones|hormones|mesh-ancestor
6195046|NCT01940276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6195047|NCT01940276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195048|NCT01940276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6195049|NCT01940276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6195050|NCT01940276|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6195051|NCT01940276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6195052|NCT01940276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195053|NCT01940276|Hormone Antagonists|hormone antagonists|mesh-ancestor
5585166|NCT03816774|Simethicone|simethicone|mesh-list
5585167|NCT03816774|Antifoaming Agents|antifoaming agents|mesh-ancestor
5585168|NCT03816774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585169|NCT03816774|Emollients|emollients|mesh-ancestor
5585170|NCT03816774|Dermatologic Agents|dermatologic agents|mesh-ancestor
5585171|NCT03816592|Analgesics, Opioid|analgesics, opioid|mesh-list
5585172|NCT03816592|Anesthetics|anesthetics|mesh-list
5585173|NCT03816592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5585174|NCT03816592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585175|NCT03816592|Narcotics|narcotics|mesh-ancestor
5585176|NCT03816592|Analgesics|analgesics|mesh-ancestor
5585177|NCT03816592|Sensory System Agents|sensory system agents|mesh-ancestor
5585178|NCT03816592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5585179|NCT03816488|Metformin|metformin|mesh-list
5585180|NCT03816488|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
5585181|NCT03816488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5585182|NCT03816488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585183|NCT03816488|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5585184|NCT03816488|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5585185|NCT03816488|Analgesics|analgesics|mesh-ancestor
5585186|NCT03816488|Sensory System Agents|sensory system agents|mesh-ancestor
5585187|NCT03816488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5585188|NCT03816488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5585189|NCT03816488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5585190|NCT03816553|Apatinib|apatinib|mesh-list
5585191|NCT03816553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5585192|NCT03816553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5585193|NCT03816553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5585194|NCT03816553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585195|NCT03816618|Fusidic Acid|fusidic acid|mesh-list
5585196|NCT03816618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5585197|NCT03816618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5585198|NCT03816618|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5585199|NCT03816618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5585200|NCT03816618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585201|NCT03816397|Adalimumab|adalimumab|mesh-list
5585202|NCT03816397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5585203|NCT03816397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5585204|NCT03816267|Albuterol|albuterol|mesh-list
6195054|NCT01940276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6195055|NCT01940484|Epoetin Alfa|epoetin alfa|mesh-list
6195056|NCT01940484|Hematinics|hematinics|mesh-ancestor
6195057|NCT01940497|Paclitaxel|paclitaxel|mesh-list
6195058|NCT01940497|Docetaxel|docetaxel|mesh-list
6195059|NCT01940497|Doxorubicin|doxorubicin|mesh-list
6195060|NCT01940497|Trastuzumab|trastuzumab|mesh-list
6195061|NCT01940497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6195062|NCT01940497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6195063|NCT01940497|Tubulin Modulators|tubulin modulators|mesh-ancestor
6195064|NCT01940497|Antimitotic Agents|antimitotic agents|mesh-ancestor
6195065|NCT01940497|Mitosis Modulators|mitosis modulators|mesh-ancestor
6195066|NCT01940497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195067|NCT01940497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6195068|NCT01940497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6195069|NCT01940497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6195070|NCT01940497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6195071|NCT01940497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6195072|NCT01940510|Rifampin|rifampin|mesh-list
6195073|NCT01940510|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6195074|NCT01940510|Antitubercular Agents|antitubercular agents|mesh-ancestor
6195075|NCT01940510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6195076|NCT01940510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6195077|NCT01940510|Leprostatic Agents|leprostatic agents|mesh-ancestor
6195078|NCT01940510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6195079|NCT01940510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6195080|NCT01940510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195081|NCT01940510|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6195082|NCT01940510|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6195083|NCT01940510|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6195084|NCT01940510|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6195085|NCT01940510|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5585205|NCT03816267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5585206|NCT03816267|Autonomic Agents|autonomic agents|mesh-ancestor
5585207|NCT03816267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5585208|NCT03816267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585209|NCT03816267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6195086|NCT01940510|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6195087|NCT01940523|Tranexamic Acid|tranexamic acid|mesh-list
5585210|NCT03816267|Respiratory System Agents|respiratory system agents|mesh-ancestor
5585211|NCT03816267|Tocolytic Agents|tocolytic agents|mesh-ancestor
5585212|NCT03816267|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5585213|NCT03816267|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5585214|NCT03816267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6195088|NCT01940523|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6195089|NCT01940523|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5585215|NCT03816267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5585216|NCT03816267|Adrenergic Agents|adrenergic agents|mesh-ancestor
5585217|NCT03816267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5585218|NCT03816267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585219|NCT03816306|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5585220|NCT03816306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5585221|NCT03816306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195090|NCT01940523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195091|NCT01940523|Hemostatics|hemostatics|mesh-ancestor
6195092|NCT01940523|Coagulants|coagulants|mesh-ancestor
6195093|NCT01940887|Bevacizumab|bevacizumab|mesh-list
6195094|NCT01940887|Aflibercept|aflibercept|mesh-list
6195095|NCT01940887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6195096|NCT01940887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6195097|NCT01940887|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6195098|NCT01940887|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6195099|NCT01940887|Growth Substances|growth substances|mesh-ancestor
6195100|NCT01940887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195101|NCT01940887|Growth Inhibitors|growth inhibitors|mesh-ancestor
6195102|NCT01940900|Ranibizumab|ranibizumab|mesh-list
6195103|NCT01940900|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6195104|NCT01940900|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6195105|NCT01940900|Growth Substances|growth substances|mesh-ancestor
6195106|NCT01940900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195107|NCT01940900|Growth Inhibitors|growth inhibitors|mesh-ancestor
5585222|NCT03816020|Niacinamide|niacinamide|mesh-list
5585223|NCT03816020|Niacin|niacin|mesh-list
5585224|NCT03816020|Nicotinic Acids|nicotinic acids|mesh-list
5585225|NCT03816020|Vitamin B Complex|vitamin b complex|mesh-ancestor
5585226|NCT03816020|Vitamins|vitamins|mesh-ancestor
5585227|NCT03816020|Micronutrients|micronutrients|mesh-ancestor
5585228|NCT03816020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195108|NCT01940900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6195109|NCT01941095|Hydroxychloroquine|hydroxychloroquine|mesh-list
6195110|NCT01941095|Chloroquine|chloroquine|mesh-list
6195111|NCT01941095|Sulfasalazine|sulfasalazine|mesh-list
6195112|NCT01941095|Methotrexate|methotrexate|mesh-list
6195113|NCT01941095|Azathioprine|azathioprine|mesh-list
6195114|NCT01941095|Leflunomide|leflunomide|mesh-list
6195115|NCT01941095|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6195116|NCT01941095|Abortifacient Agents|abortifacient agents|mesh-ancestor
6195117|NCT01941095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6195118|NCT01941095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585229|NCT03816020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5585230|NCT03816020|Antimetabolites|antimetabolites|mesh-ancestor
5585231|NCT03816020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585232|NCT03816020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5585233|NCT03816020|Vasodilator Agents|vasodilator agents|mesh-ancestor
5585234|NCT03816072|Phenylephrine|phenylephrine|mesh-list
5585235|NCT03816072|Oxymetazoline|oxymetazoline|mesh-list
5585236|NCT03816072|Propofol|propofol|mesh-list
5585237|NCT03816072|Sevoflurane|sevoflurane|mesh-list
6195119|NCT01941095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6195120|NCT01941095|Antimetabolites|antimetabolites|mesh-ancestor
6195121|NCT01941095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195122|NCT01941095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6195123|NCT01941095|Dermatologic Agents|dermatologic agents|mesh-ancestor
6195124|NCT01941095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6195125|NCT01941095|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6195126|NCT01941095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6195127|NCT01941095|Immunologic Factors|immunologic factors|mesh-ancestor
6195128|NCT01941095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6195129|NCT01941095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6195130|NCT01941095|Antimalarials|antimalarials|mesh-ancestor
6195131|NCT01941095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6195132|NCT01941095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5585238|NCT03816072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5585239|NCT03816072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5585240|NCT03816072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585241|NCT03816072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5585242|NCT03816072|Anesthetics, General|anesthetics, general|mesh-ancestor
5585243|NCT03816072|Anesthetics|anesthetics|mesh-ancestor
5585244|NCT03816072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5585245|NCT03816072|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6195133|NCT01941095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6195134|NCT01941095|Amebicides|amebicides|mesh-ancestor
6207333|NCT02115048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6195135|NCT01941095|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6195136|NCT01941095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6195137|NCT01941095|Analgesics|analgesics|mesh-ancestor
6195138|NCT01941095|Sensory System Agents|sensory system agents|mesh-ancestor
6195139|NCT01941095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6195140|NCT01941095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6195141|NCT01941095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6195142|NCT01941537|Fezakinumab|fezakinumab|mesh-list
6195143|NCT01941537|Dermatologic Agents|dermatologic agents|mesh-ancestor
6195144|NCT01941628|Rocuronium|rocuronium|mesh-list
6195145|NCT01941628|Succinylcholine|succinylcholine|mesh-list
6195146|NCT01941628|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6195147|NCT01941628|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6195148|NCT01941628|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6195149|NCT01941628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6195150|NCT01941628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195151|NCT01941628|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
6195152|NCT01941927|Trametinib|trametinib|mesh-list
5585246|NCT03816072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5585247|NCT03816072|Mydriatics|mydriatics|mesh-ancestor
5585248|NCT03816072|Autonomic Agents|autonomic agents|mesh-ancestor
5585249|NCT03816072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5585250|NCT03816072|Sympathomimetics|sympathomimetics|mesh-ancestor
5585251|NCT03816072|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5585252|NCT03816072|Nasal Decongestants|nasal decongestants|mesh-ancestor
5585253|NCT03816072|Respiratory System Agents|respiratory system agents|mesh-ancestor
5585254|NCT03816072|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5585255|NCT03816072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5585256|NCT03816072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5585257|NCT03816072|Adrenergic Agents|adrenergic agents|mesh-ancestor
5585258|NCT03816072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5585259|NCT03816072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585260|NCT03816072|Protective Agents|protective agents|mesh-ancestor
5585261|NCT03816046|Botulinum Toxins|botulinum toxins|mesh-list
5585262|NCT03816046|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5585263|NCT03816046|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5585264|NCT03816046|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5585265|NCT03816046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5585266|NCT03816046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585267|NCT03816046|Cholinergic Agents|cholinergic agents|mesh-ancestor
5585268|NCT03816046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5585269|NCT03816046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585270|NCT03816046|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5585271|NCT03816046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5585272|NCT03815864|Antibodies|antibodies|mesh-list
5585273|NCT03815864|Immunoglobulins|immunoglobulins|mesh-list
5585274|NCT03815864|Immunologic Factors|immunologic factors|mesh-ancestor
5585275|NCT03815864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585276|NCT03815942|Nivolumab|nivolumab|mesh-list
6195153|NCT01941927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6195154|NCT01941927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6195155|NCT01941927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6195156|NCT01941927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195157|NCT01942148|Aripiprazole|aripiprazole|mesh-list
6195158|NCT01942148|Antidepressive Agents|antidepressive agents|mesh-ancestor
6195159|NCT01942148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6195160|NCT01942148|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6195161|NCT01942148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6195162|NCT01942148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6195163|NCT01942148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195164|NCT01942148|Dopamine Agonists|dopamine agonists|mesh-ancestor
6195165|NCT01942148|Dopamine Agents|dopamine agents|mesh-ancestor
6195166|NCT01942148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6195167|NCT01942148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195168|NCT01942148|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6195169|NCT01942148|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6195170|NCT01942148|Serotonin Agents|serotonin agents|mesh-ancestor
6195171|NCT01942148|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6195172|NCT01942148|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6195173|NCT01942148|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6195174|NCT01942148|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6195175|NCT01942161|Aripiprazole|aripiprazole|mesh-list
6195176|NCT01942161|Antidepressive Agents|antidepressive agents|mesh-ancestor
6195177|NCT01942161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6195178|NCT01942161|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6195179|NCT01942161|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6195180|NCT01942161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6195181|NCT01942161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195182|NCT01942161|Dopamine Agonists|dopamine agonists|mesh-ancestor
6195183|NCT01942161|Dopamine Agents|dopamine agents|mesh-ancestor
6195184|NCT01942161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6195185|NCT01942161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195186|NCT01942161|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6195187|NCT01942161|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6195188|NCT01942161|Serotonin Agents|serotonin agents|mesh-ancestor
6195189|NCT01942161|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6195190|NCT01942161|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6195191|NCT01942161|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6195192|NCT01942161|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6195193|NCT01942590|Clenbuterol|clenbuterol|mesh-list
6195194|NCT01942590|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6195195|NCT01942590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5585277|NCT03815942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5585278|NCT03815942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5585279|NCT03815942|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5585280|NCT03815942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585281|NCT03815890|Nivolumab|nivolumab|mesh-list
5585282|NCT03815890|Ipilimumab|ipilimumab|mesh-list
5585283|NCT03815890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5585284|NCT03815890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5585285|NCT03815890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5585286|NCT03815890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585287|NCT03815838|Fallypride|fallypride|mesh-list
5585288|NCT03815838|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5585289|NCT03815838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5585290|NCT03815838|Dopamine Agents|dopamine agents|mesh-ancestor
5585291|NCT03815838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5585292|NCT03815838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585293|NCT03815838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585294|NCT03815539|Hyaluronic Acid|hyaluronic acid|mesh-list
5585295|NCT03815539|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5585296|NCT03815539|Immunologic Factors|immunologic factors|mesh-ancestor
6195196|NCT01942590|Adrenergic Agents|adrenergic agents|mesh-ancestor
6195197|NCT01942590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6195198|NCT01942590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195199|NCT01942590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195200|NCT01942590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6195201|NCT01942590|Autonomic Agents|autonomic agents|mesh-ancestor
6195202|NCT01942590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6195203|NCT01942590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6195204|NCT01942590|Respiratory System Agents|respiratory system agents|mesh-ancestor
6195205|NCT01942590|Sympathomimetics|sympathomimetics|mesh-ancestor
6195206|NCT01942668|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6195207|NCT01942668|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6195208|NCT01942668|Estradiol|estradiol|mesh-list
6195209|NCT01942668|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6195210|NCT01942668|Progesterone|progesterone|mesh-list
6195211|NCT01942668|Estrogens|estrogens|mesh-ancestor
6195212|NCT01942668|Hormones|hormones|mesh-ancestor
6195213|NCT01942668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6195214|NCT01942668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195215|NCT01942668|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6195216|NCT01942668|Contraceptive Agents|contraceptive agents|mesh-ancestor
6195217|NCT01942668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6195218|NCT01942668|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6195219|NCT01942668|Progestins|progestins|mesh-ancestor
6195220|NCT01942694|Vitamin D|vitamin d|mesh-list
6195221|NCT01942694|Cholecalciferol|cholecalciferol|mesh-list
6195222|NCT01942694|Vitamins|vitamins|mesh-ancestor
6195223|NCT01942694|Micronutrients|micronutrients|mesh-ancestor
6195224|NCT01942694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195225|NCT01942694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6195226|NCT01942694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6195227|NCT01942733|Brexpiprazole|brexpiprazole|mesh-list
5585297|NCT03815539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585298|NCT03815539|Viscosupplements|viscosupplements|mesh-ancestor
5585299|NCT03815539|Protective Agents|protective agents|mesh-ancestor
5585300|NCT03815487|Insulin|insulin|mesh-list
5585301|NCT03815487|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5585302|NCT03815487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5585303|NCT03815487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585304|NCT03815474|Epirubicin|epirubicin|mesh-list
6195228|NCT01942733|Serotonin Agents|serotonin agents|mesh-ancestor
6195229|NCT01942733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6195230|NCT01942733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195231|NCT01942733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195232|NCT01942733|Dopamine Agonists|dopamine agonists|mesh-ancestor
6195233|NCT01942733|Dopamine Agents|dopamine agents|mesh-ancestor
6195234|NCT01942785|Brexpiprazole|brexpiprazole|mesh-list
6195235|NCT01942785|Serotonin Agents|serotonin agents|mesh-ancestor
5585305|NCT03815474|Ifosfamide|ifosfamide|mesh-list
5585306|NCT03815474|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5585307|NCT03815474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5585308|NCT03815474|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5585309|NCT03815474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5585310|NCT03815474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5585311|NCT03815474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585312|NCT03815474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5585313|NCT03815474|Alkylating Agents|alkylating agents|mesh-ancestor
5585314|NCT03815461|Paclitaxel|paclitaxel|mesh-list
5585315|NCT03815461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5585316|NCT03815461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5585317|NCT03815461|Tubulin Modulators|tubulin modulators|mesh-ancestor
5585318|NCT03815461|Antimitotic Agents|antimitotic agents|mesh-ancestor
5585319|NCT03815461|Mitosis Modulators|mitosis modulators|mesh-ancestor
5585320|NCT03815461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585321|NCT03815448|Methotrexate|methotrexate|mesh-list
5585322|NCT03815448|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5585323|NCT03815448|Abortifacient Agents|abortifacient agents|mesh-ancestor
5585324|NCT03815448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5585325|NCT03815448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585326|NCT03815448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5585327|NCT03815448|Antimetabolites|antimetabolites|mesh-ancestor
5585328|NCT03815448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585329|NCT03815448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5585330|NCT03815448|Dermatologic Agents|dermatologic agents|mesh-ancestor
5585331|NCT03815448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5585332|NCT03815448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5585333|NCT03815448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5585334|NCT03815448|Immunologic Factors|immunologic factors|mesh-ancestor
5585335|NCT03815448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5585336|NCT03815448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5585337|NCT03815344|Misoprostol|misoprostol|mesh-list
5585338|NCT03815344|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5585339|NCT03815344|Abortifacient Agents|abortifacient agents|mesh-ancestor
5585340|NCT03815344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5585341|NCT03815344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585342|NCT03815344|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5585343|NCT03815344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5585344|NCT03815344|Oxytocics|oxytocics|mesh-ancestor
5605127|NCT03511599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5605128|NCT03511599|Antimetabolites|antimetabolites|mesh-ancestor
5605129|NCT03511599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195236|NCT01942785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6195237|NCT01942785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195238|NCT01942785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195239|NCT01942785|Dopamine Agonists|dopamine agonists|mesh-ancestor
6195240|NCT01942785|Dopamine Agents|dopamine agents|mesh-ancestor
5585345|NCT03815305|Petrolatum|petrolatum|mesh-list
5585346|NCT03815305|Emollients|emollients|mesh-ancestor
5585347|NCT03815305|Dermatologic Agents|dermatologic agents|mesh-ancestor
5585348|NCT03815435|Anesthetics|anesthetics|mesh-list
5585349|NCT03815435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5585350|NCT03815435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585351|NCT03815279|Dexamethasone|dexamethasone|mesh-list
5585352|NCT03815279|Lenalidomide|lenalidomide|mesh-list
5585353|NCT03815279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5585354|NCT03815279|Antiemetics|antiemetics|mesh-ancestor
5585355|NCT03815279|Autonomic Agents|autonomic agents|mesh-ancestor
5585356|NCT03815279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5585357|NCT03815279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585358|NCT03815279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5585359|NCT03815279|Glucocorticoids|glucocorticoids|mesh-ancestor
5585360|NCT03815279|Hormones|hormones|mesh-ancestor
6195241|NCT01942993|Vemurafenib|vemurafenib|mesh-list
6195242|NCT01942993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6195243|NCT01942993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6195244|NCT01942993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6195245|NCT01942993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195246|NCT01943435|Acetaminophen|acetaminophen|mesh-list
6195247|NCT01943435|Ibuprofen|ibuprofen|mesh-list
6195248|NCT01943435|Celecoxib|celecoxib|mesh-list
6195249|NCT01943435|Diclofenac|diclofenac|mesh-list
6195250|NCT01943435|Gabapentin|gabapentin|mesh-list
6195251|NCT01943435|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6195252|NCT01943435|Tramadol|tramadol|mesh-list
6195253|NCT01943435|Analgesics|analgesics|mesh-list
6195254|NCT01943435|Mirtazapine|mirtazapine|mesh-list
6195255|NCT01943435|Trazodone|trazodone|mesh-list
5585361|NCT03815279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5585362|NCT03815279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5585363|NCT03815279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6195256|NCT01943435|Sertraline|sertraline|mesh-list
6195257|NCT01943435|Nortriptyline|nortriptyline|mesh-list
6195258|NCT01943435|Antidepressive Agents|antidepressive agents|mesh-list
6195259|NCT01943435|Misoprostol|misoprostol|mesh-list
6195260|NCT01943435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6195261|NCT01943435|Sensory System Agents|sensory system agents|mesh-ancestor
6195262|NCT01943435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6195263|NCT01943435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195264|NCT01943435|Antipyretics|antipyretics|mesh-ancestor
6195265|NCT01943435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6195266|NCT01943435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6195267|NCT01943435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6195268|NCT01943435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6195269|NCT01943435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6195270|NCT01943435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195271|NCT01943435|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6195272|NCT01943435|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6195273|NCT01943435|Abortifacient Agents|abortifacient agents|mesh-ancestor
6195274|NCT01943435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6195275|NCT01943435|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6195276|NCT01943435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6195277|NCT01943435|Oxytocics|oxytocics|mesh-ancestor
6195278|NCT01943435|Anticonvulsants|anticonvulsants|mesh-ancestor
6195279|NCT01943435|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6195280|NCT01943435|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6195281|NCT01943435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6195282|NCT01943435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6195283|NCT01943435|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6195284|NCT01943435|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6195285|NCT01943435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6195286|NCT01943435|Antimanic Agents|antimanic agents|mesh-ancestor
6195287|NCT01943435|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5585364|NCT03815279|Immunologic Factors|immunologic factors|mesh-ancestor
5585365|NCT03815279|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5585366|NCT03815279|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5585367|NCT03815279|Growth Substances|growth substances|mesh-ancestor
5585368|NCT03815279|Growth Inhibitors|growth inhibitors|mesh-ancestor
5585369|NCT03815019|Megestrol|megestrol|mesh-list
5585370|NCT03815019|Megestrol Acetate|megestrol acetate|mesh-list
5585371|NCT03815019|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5585372|NCT03815019|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5585373|NCT03815019|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5585374|NCT03815019|Contraceptive Agents|contraceptive agents|mesh-ancestor
6195288|NCT01943435|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6195289|NCT01943435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6195290|NCT01943435|Dopamine Agents|dopamine agents|mesh-ancestor
6195291|NCT01943435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6195292|NCT01943435|Narcotics|narcotics|mesh-ancestor
6195293|NCT01943435|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6195294|NCT01943435|Serotonin Agents|serotonin agents|mesh-ancestor
6195295|NCT01943435|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6195296|NCT01943435|Histamine Antagonists|histamine antagonists|mesh-ancestor
6195297|NCT01943435|Histamine Agents|histamine agents|mesh-ancestor
6195298|NCT01943435|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6195299|NCT01943435|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6195300|NCT01943435|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6195301|NCT01943435|Adrenergic Agents|adrenergic agents|mesh-ancestor
6195302|NCT01943435|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6195303|NCT01943435|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6195304|NCT01943435|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6195305|NCT01943435|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6195306|NCT01943435|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6195307|NCT01943435|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6195308|NCT01943461|Avelumab|avelumab|mesh-list
5585375|NCT03815019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5585376|NCT03815019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585377|NCT03815019|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5585378|NCT03815019|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5585379|NCT03815019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5585380|NCT03815019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5585381|NCT03815019|Appetite Stimulants|appetite stimulants|mesh-ancestor
5585382|NCT03815019|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5585383|NCT03814954|Epinephrine|epinephrine|mesh-list
5585384|NCT03814954|Albuterol|albuterol|mesh-list
5585385|NCT03814954|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5585386|NCT03814954|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5585387|NCT03814954|Adrenergic Agents|adrenergic agents|mesh-ancestor
5585388|NCT03814954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5585389|NCT03814954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585390|NCT03814954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605130|NCT03503318|Risperidone|risperidone|mesh-list
6195309|NCT01943461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6195310|NCT01943461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6195311|NCT01943461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6195312|NCT01943461|Immunologic Factors|immunologic factors|mesh-ancestor
6195313|NCT01943461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195314|NCT01943552|Bromides|bromides|mesh-list
6195315|NCT01943552|Ipratropium|ipratropium|mesh-list
6195316|NCT01943552|Anticonvulsants|anticonvulsants|mesh-ancestor
6195317|NCT01943552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6195318|NCT01943552|Autonomic Agents|autonomic agents|mesh-ancestor
6195319|NCT01943552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6195320|NCT01943552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195321|NCT01943552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6195322|NCT01943552|Respiratory System Agents|respiratory system agents|mesh-ancestor
6195323|NCT01943552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6195324|NCT01943552|Cholinergic Agents|cholinergic agents|mesh-ancestor
6195325|NCT01943552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6195326|NCT01943552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195327|NCT01943565|Hydromorphone|hydromorphone|mesh-list
6195328|NCT01943565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6195329|NCT01943565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195330|NCT01943565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6195331|NCT01943565|Narcotics|narcotics|mesh-ancestor
6195332|NCT01943565|Analgesics|analgesics|mesh-ancestor
6195333|NCT01943565|Sensory System Agents|sensory system agents|mesh-ancestor
6195334|NCT01943565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6195335|NCT01943825|Vaccines|vaccines|mesh-list
6195336|NCT01943825|Immunologic Factors|immunologic factors|mesh-ancestor
6195337|NCT01943825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195338|NCT01943864|Trametinib|trametinib|mesh-list
6195339|NCT01943864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6195340|NCT01943864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6195341|NCT01943864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6195342|NCT01943864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207334|NCT02115048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207335|NCT02115048|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6207336|NCT02115048|Hormone Antagonists|hormone antagonists|mesh-ancestor
5585391|NCT03814954|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5585392|NCT03814954|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5585393|NCT03814954|Autonomic Agents|autonomic agents|mesh-ancestor
5585394|NCT03814954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5585395|NCT03814954|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5585396|NCT03814954|Respiratory System Agents|respiratory system agents|mesh-ancestor
5585397|NCT03814954|Mydriatics|mydriatics|mesh-ancestor
5585398|NCT03814954|Sympathomimetics|sympathomimetics|mesh-ancestor
5585399|NCT03814954|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5585400|NCT03814954|Tocolytic Agents|tocolytic agents|mesh-ancestor
5585401|NCT03814954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5585402|NCT03814954|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5585403|NCT03814941|Anesthetics|anesthetics|mesh-list
6195343|NCT01944046|Oxytocin|oxytocin|mesh-list
6195344|NCT01944046|Oxytocics|oxytocics|mesh-ancestor
6195345|NCT01944046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6195346|NCT01944046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195347|NCT01944098|Lidocaine|lidocaine|mesh-list
6195348|NCT01944098|Anesthetics, Local|anesthetics, local|mesh-ancestor
6195349|NCT01944098|Anesthetics|anesthetics|mesh-ancestor
6195350|NCT01944098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6195351|NCT01944098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195352|NCT01944098|Sensory System Agents|sensory system agents|mesh-ancestor
6195353|NCT01944098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6195354|NCT01944098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6672180|NCT01554592|Antimetabolites|antimetabolites|mesh-ancestor
6672181|NCT01554592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672182|NCT01554592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5585404|NCT03814941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5585405|NCT03814941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585406|NCT03814733|Ketamine|ketamine|mesh-list
5585407|NCT03814733|Alprazolam|alprazolam|mesh-list
5585408|NCT03814733|Analgesics|analgesics|mesh-ancestor
5585409|NCT03814733|Sensory System Agents|sensory system agents|mesh-ancestor
5585410|NCT03814733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5585411|NCT03814733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585412|NCT03814733|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5585413|NCT03814733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5585414|NCT03814733|Anesthetics, General|anesthetics, general|mesh-ancestor
5585415|NCT03814733|Anesthetics|anesthetics|mesh-ancestor
5585416|NCT03814733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5585417|NCT03814733|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5585418|NCT03814733|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5585419|NCT03814733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5585420|NCT03814733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585421|NCT03814733|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5585422|NCT03814733|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5585423|NCT03814733|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5585424|NCT03814733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5585425|NCT03814733|GABA Modulators|gaba modulators|mesh-ancestor
5585426|NCT03814733|GABA Agents|gaba agents|mesh-ancestor
5585427|NCT03814759|Cisplatin|cisplatin|mesh-list
5585428|NCT03814759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5585429|NCT03814577|Antioxidants|antioxidants|mesh-list
5585430|NCT03814577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585431|NCT03814577|Protective Agents|protective agents|mesh-ancestor
5585432|NCT03814577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585433|NCT03814629|Vitamins|vitamins|mesh-list
5585434|NCT03814629|Micronutrients|micronutrients|mesh-ancestor
5585435|NCT03814629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585436|NCT03814707|Hyaluronic Acid|hyaluronic acid|mesh-list
6195355|NCT01944098|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6195356|NCT01944098|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6195357|NCT01944098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6195358|NCT01944098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195359|NCT01944293|Midazolam|midazolam|mesh-list
6195360|NCT01944293|Ketamine|ketamine|mesh-list
6195361|NCT01944293|Analgesics|analgesics|mesh-ancestor
6195362|NCT01944293|Sensory System Agents|sensory system agents|mesh-ancestor
6195363|NCT01944293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6195364|NCT01944293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195365|NCT01944293|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6195366|NCT01944293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6195367|NCT01944293|Anesthetics, General|anesthetics, general|mesh-ancestor
6195368|NCT01944293|Anesthetics|anesthetics|mesh-ancestor
5585437|NCT03814707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5585438|NCT03814707|Immunologic Factors|immunologic factors|mesh-ancestor
5585439|NCT03814707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585440|NCT03814707|Viscosupplements|viscosupplements|mesh-ancestor
5585441|NCT03814707|Protective Agents|protective agents|mesh-ancestor
5585442|NCT03814447|Cyclophosphamide|cyclophosphamide|mesh-list
6672183|NCT01554592|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6672184|NCT01554631|Acarbose|acarbose|mesh-list
6672185|NCT01554631|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6672186|NCT01554631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6195369|NCT01944293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6195370|NCT01944293|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6195371|NCT01944293|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6195372|NCT01944293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6195373|NCT01944293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195374|NCT01944293|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5585443|NCT03814447|Fludarabine|fludarabine|mesh-list
5585444|NCT03814447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5585445|NCT03814447|Immunologic Factors|immunologic factors|mesh-ancestor
5585446|NCT03814447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585447|NCT03814447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5585448|NCT03814447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5585449|NCT03814447|Alkylating Agents|alkylating agents|mesh-ancestor
5585450|NCT03814447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585451|NCT03814447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5585452|NCT03814447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5585453|NCT03814616|Artesunate|artesunate|mesh-list
5585454|NCT03814616|Pyronaridine|pyronaridine|mesh-list
5585455|NCT03814616|Antimalarials|antimalarials|mesh-ancestor
5585456|NCT03814616|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5585457|NCT03814616|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5585458|NCT03814616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5585459|NCT03814616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5585460|NCT03814616|Antiviral Agents|antiviral agents|mesh-ancestor
5585461|NCT03814616|Schistosomicides|schistosomicides|mesh-ancestor
5585462|NCT03814616|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5585463|NCT03814616|Anthelmintics|anthelmintics|mesh-ancestor
5585464|NCT03814642|Esomeprazole|esomeprazole|mesh-list
5585465|NCT03814642|Clopidogrel|clopidogrel|mesh-list
6195375|NCT01944293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6195376|NCT01944293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6195377|NCT01944293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6195378|NCT01944293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6195379|NCT01944293|GABA Modulators|gaba modulators|mesh-ancestor
6195380|NCT01944293|GABA Agents|gaba agents|mesh-ancestor
6195381|NCT01944319|Meropenem|meropenem|mesh-list
6195382|NCT01944319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6195383|NCT01944319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6195384|NCT01944371|Disulfiram|disulfiram|mesh-list
6195385|NCT01944371|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6195386|NCT01944371|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
6195387|NCT01944371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6195388|NCT01944371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195389|NCT01944423|Cycloserine|cycloserine|mesh-list
6195390|NCT01944423|Nicotine|nicotine|mesh-list
6195391|NCT01944423|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6195392|NCT01944423|Autonomic Agents|autonomic agents|mesh-ancestor
6195393|NCT01944423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6195394|NCT01944423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195395|NCT01944423|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6195396|NCT01944423|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6195397|NCT01944423|Cholinergic Agents|cholinergic agents|mesh-ancestor
6195398|NCT01944423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6195399|NCT01944423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195400|NCT01944423|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6195401|NCT01944423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6195402|NCT01944423|Renal Agents|renal agents|mesh-ancestor
6195403|NCT01944423|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6195404|NCT01944423|Antitubercular Agents|antitubercular agents|mesh-ancestor
6195405|NCT01944423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6195406|NCT01944423|Antimetabolites|antimetabolites|mesh-ancestor
6195407|NCT01944462|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5585466|NCT03814642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5585467|NCT03814642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6195408|NCT01944462|Immunologic Factors|immunologic factors|mesh-ancestor
6672187|NCT01554631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585468|NCT03814642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5585469|NCT03814642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5585470|NCT03814642|Purinergic Agents|purinergic agents|mesh-ancestor
5585471|NCT03814642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5585472|NCT03814642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585473|NCT03814642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585474|NCT03814642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5585475|NCT03814642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5585476|NCT03814642|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5585477|NCT03814642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5585478|NCT03814291|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
5585479|NCT03814291|Immunologic Factors|immunologic factors|mesh-ancestor
5585480|NCT03814291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585481|NCT03814343|Amphotericin B|amphotericin b|mesh-list
5585482|NCT03814343|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6195409|NCT01944462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195410|NCT01944774|Moxifloxacin|moxifloxacin|mesh-list
6195411|NCT01944774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6195412|NCT01944774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6195413|NCT01944774|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6195414|NCT01944774|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6195415|NCT01944774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6195416|NCT01944774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195417|NCT01944774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6195418|NCT01944839|Ranibizumab|ranibizumab|mesh-list
6195419|NCT01944839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6195420|NCT01944839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6195421|NCT01944839|Growth Substances|growth substances|mesh-ancestor
6195422|NCT01944839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195423|NCT01944839|Growth Inhibitors|growth inhibitors|mesh-ancestor
6195424|NCT01944839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6195425|NCT01944969|Brexpiprazole|brexpiprazole|mesh-list
6195426|NCT01944969|Serotonin Agents|serotonin agents|mesh-ancestor
6195427|NCT01944969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6195428|NCT01944969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195429|NCT01944969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195430|NCT01944969|Dopamine Agonists|dopamine agonists|mesh-ancestor
6195431|NCT01944969|Dopamine Agents|dopamine agents|mesh-ancestor
6195432|NCT01945086|Ustekinumab|ustekinumab|mesh-list
6195433|NCT01945086|Dermatologic Agents|dermatologic agents|mesh-ancestor
6195434|NCT01945138|Insulin|insulin|mesh-list
6195435|NCT01945138|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6195436|NCT01945138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6195437|NCT01945138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195438|NCT01945216|Alogliptin|alogliptin|mesh-list
6195439|NCT01945216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6195440|NCT01945216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195441|NCT01945216|Incretins|incretins|mesh-ancestor
6195442|NCT01945216|Hormones|hormones|mesh-ancestor
6195443|NCT01945216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6195444|NCT01945216|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6195445|NCT01945216|Protease Inhibitors|protease inhibitors|mesh-ancestor
6195446|NCT01945216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6195447|NCT01945216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195448|NCT01945242|Alogliptin|alogliptin|mesh-list
6195449|NCT01945242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6195450|NCT01945242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195451|NCT01945242|Incretins|incretins|mesh-ancestor
6195452|NCT01945242|Hormones|hormones|mesh-ancestor
6195453|NCT01945242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6195454|NCT01945242|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6195455|NCT01945242|Protease Inhibitors|protease inhibitors|mesh-ancestor
6195456|NCT01945242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6195457|NCT01945242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195458|NCT01945281|Amphotericin B|amphotericin b|mesh-list
6195459|NCT01945281|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6195460|NCT01945281|Caspofungin|caspofungin|mesh-list
5585483|NCT03814343|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
5585484|NCT03814343|Amebicides|amebicides|mesh-ancestor
5585485|NCT03814343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5585486|NCT03814343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5585487|NCT03814343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5585488|NCT03814343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5585489|NCT03814343|Antifungal Agents|antifungal agents|mesh-ancestor
6195461|NCT01945281|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
5585490|NCT03814343|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
5585491|NCT03814343|Protective Agents|protective agents|mesh-ancestor
5585492|NCT03814343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195462|NCT01945281|Deoxycholic Acid|deoxycholic acid|mesh-list
6195463|NCT01945281|Amebicides|amebicides|mesh-ancestor
6195464|NCT01945281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6195465|NCT01945281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6195466|NCT01945281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6195467|NCT01945281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5585493|NCT03814343|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5585494|NCT03814343|Antioxidants|antioxidants|mesh-ancestor
5585495|NCT03814343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585496|NCT03814226|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
5585497|NCT03814226|Growth Substances|growth substances|mesh-ancestor
5585498|NCT03814226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585499|NCT03814226|Vasodilator Agents|vasodilator agents|mesh-ancestor
5585500|NCT03814226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5585501|NCT03814226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585502|NCT03813875|Fentanyl|fentanyl|mesh-list
5585503|NCT03813875|Midazolam|midazolam|mesh-list
5585504|NCT03813875|Alfentanil|alfentanil|mesh-list
5585505|NCT03813875|Propofol|propofol|mesh-list
5585506|NCT03813875|Sevoflurane|sevoflurane|mesh-list
5585507|NCT03813875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5585508|NCT03813875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5585509|NCT03813875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585510|NCT03813875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5585511|NCT03813875|Anesthetics, General|anesthetics, general|mesh-ancestor
5585512|NCT03813875|Anesthetics|anesthetics|mesh-ancestor
5585513|NCT03813875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5585514|NCT03813875|Narcotics|narcotics|mesh-ancestor
5585515|NCT03813875|Analgesics|analgesics|mesh-ancestor
5585516|NCT03813875|Sensory System Agents|sensory system agents|mesh-ancestor
5585517|NCT03813875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5585518|NCT03813875|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5585519|NCT03813875|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5585520|NCT03813875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5585521|NCT03813875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5585522|NCT03813875|GABA Modulators|gaba modulators|mesh-ancestor
5585523|NCT03813875|GABA Agents|gaba agents|mesh-ancestor
5585524|NCT03813875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5585525|NCT03813875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585526|NCT03813875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5585527|NCT03813875|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5585528|NCT03813784|Capecitabine|capecitabine|mesh-list
5585529|NCT03813784|Oxaliplatin|oxaliplatin|mesh-list
5585530|NCT03813784|Apatinib|apatinib|mesh-list
5585531|NCT03813784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5585532|NCT03813784|Antimetabolites|antimetabolites|mesh-ancestor
5585533|NCT03813784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585534|NCT03813784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5585535|NCT03813784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5585536|NCT03813784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5585537|NCT03813979|Dolutegravir|dolutegravir|mesh-list
5585538|NCT03813979|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5585539|NCT03813979|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5585540|NCT03813979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5585541|NCT03813979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585542|NCT03813979|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5585543|NCT03813979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5585544|NCT03813979|Antiviral Agents|antiviral agents|mesh-ancestor
5585545|NCT03813979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5585546|NCT03814148|Indapamide|indapamide|mesh-list
5585547|NCT03814148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5585548|NCT03814148|Diuretics|diuretics|mesh-ancestor
6195468|NCT01945281|Antifungal Agents|antifungal agents|mesh-ancestor
6195469|NCT01945281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6195470|NCT01945281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585549|NCT03814148|Natriuretic Agents|natriuretic agents|mesh-ancestor
6195471|NCT01945281|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6195472|NCT01945281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6195473|NCT01945294|Interferons|interferons|mesh-list
6195474|NCT01945294|Ribavirin|ribavirin|mesh-list
6195475|NCT01945294|Interferon-alpha|interferon-alpha|mesh-list
6195476|NCT01945294|Interferon alpha-2|interferon alpha-2|mesh-list
5585550|NCT03814148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585551|NCT03814148|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6195477|NCT01945294|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6195478|NCT01945294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6195479|NCT01945294|Antiviral Agents|antiviral agents|mesh-ancestor
5585552|NCT03814148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5585553|NCT03814148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585554|NCT03813992|Nitroglycerin|nitroglycerin|mesh-list
5585555|NCT03813992|Vasodilator Agents|vasodilator agents|mesh-ancestor
5585556|NCT03814109|Niacin|niacin|mesh-list
5585557|NCT03814109|Indapamide|indapamide|mesh-list
5585558|NCT03814109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5585559|NCT03814109|Diuretics|diuretics|mesh-ancestor
5585560|NCT03814109|Natriuretic Agents|natriuretic agents|mesh-ancestor
5585561|NCT03814109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585562|NCT03814109|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5585563|NCT03814109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5585564|NCT03814109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585565|NCT03814109|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5585566|NCT03814109|Antimetabolites|antimetabolites|mesh-ancestor
5585567|NCT03814109|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5585568|NCT03814109|Vasodilator Agents|vasodilator agents|mesh-ancestor
5585569|NCT03814109|Vitamin B Complex|vitamin b complex|mesh-ancestor
5585570|NCT03814109|Vitamins|vitamins|mesh-ancestor
5585571|NCT03814109|Micronutrients|micronutrients|mesh-ancestor
5585572|NCT03813927|Vitamin D|vitamin d|mesh-list
5585573|NCT03813927|Vitamins|vitamins|mesh-ancestor
5585574|NCT03813927|Micronutrients|micronutrients|mesh-ancestor
5585575|NCT03813927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585576|NCT03813927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5585577|NCT03813940|Vaccines|vaccines|mesh-list
5585578|NCT03813940|Immunologic Factors|immunologic factors|mesh-ancestor
5585579|NCT03813940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585580|NCT03813771|Hydroxychloroquine|hydroxychloroquine|mesh-list
5585581|NCT03813771|Sulfasalazine|sulfasalazine|mesh-list
5585582|NCT03813771|Etanercept|etanercept|mesh-list
5585583|NCT03813771|Methotrexate|methotrexate|mesh-list
5585584|NCT03813771|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5585585|NCT03813771|Abortifacient Agents|abortifacient agents|mesh-ancestor
5585586|NCT03813771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5585587|NCT03813771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585588|NCT03813771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5585589|NCT03813771|Antimetabolites|antimetabolites|mesh-ancestor
5585590|NCT03813771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585591|NCT03813771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5585592|NCT03813771|Dermatologic Agents|dermatologic agents|mesh-ancestor
5585593|NCT03813771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5585594|NCT03813771|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5585595|NCT03813771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5585596|NCT03813771|Immunologic Factors|immunologic factors|mesh-ancestor
5585597|NCT03813771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5585598|NCT03813771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5585599|NCT03813771|Antimalarials|antimalarials|mesh-ancestor
6195480|NCT01945294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6195481|NCT01945294|Antimetabolites|antimetabolites|mesh-ancestor
6195482|NCT01945294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195483|NCT01945294|Immunologic Factors|immunologic factors|mesh-ancestor
6195484|NCT01945294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195485|NCT01945489|Botulinum Toxins|botulinum toxins|mesh-list
6195486|NCT01945489|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6195487|NCT01945489|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6195488|NCT01945489|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6195489|NCT01945489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6195490|NCT01945489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195491|NCT01945489|Cholinergic Agents|cholinergic agents|mesh-ancestor
6195492|NCT01945489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6195493|NCT01945489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195494|NCT01945489|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6195495|NCT01945489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6195496|NCT01945593|Factor VIII|factor viii|mesh-list
6195497|NCT01945593|BAX 855|bax 855|mesh-list
6195498|NCT01945593|Coagulants|coagulants|mesh-ancestor
6195499|NCT01945866|Dexamethasone|dexamethasone|mesh-list
6195500|NCT01945866|Ranibizumab|ranibizumab|mesh-list
6195501|NCT01945866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6195502|NCT01945866|Antiemetics|antiemetics|mesh-ancestor
5585600|NCT03813771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5585601|NCT03813771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5585602|NCT03813771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6195503|NCT01945866|Autonomic Agents|autonomic agents|mesh-ancestor
6195504|NCT01945866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6195505|NCT01945866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585603|NCT03813771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5585604|NCT03813771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5585605|NCT03813771|Analgesics|analgesics|mesh-ancestor
5585606|NCT03813771|Sensory System Agents|sensory system agents|mesh-ancestor
5585607|NCT03813771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5585608|NCT03813771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5585609|NCT03813771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5605131|NCT03503318|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5605132|NCT03503318|Serotonin Agents|serotonin agents|mesh-ancestor
5605133|NCT03503318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5605134|NCT03503318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605135|NCT03503318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605136|NCT03503318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6195506|NCT01945866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6195507|NCT01945866|Glucocorticoids|glucocorticoids|mesh-ancestor
6195508|NCT01945866|Hormones|hormones|mesh-ancestor
6195509|NCT01945866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6195510|NCT01945866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6195511|NCT01945866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6195512|NCT01945866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6195513|NCT01945866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6195514|NCT01945866|Growth Substances|growth substances|mesh-ancestor
6195515|NCT01945866|Growth Inhibitors|growth inhibitors|mesh-ancestor
6195516|NCT01946152|Dexamethasone|dexamethasone|mesh-list
6195517|NCT01946152|Dexamethasone acetate|dexamethasone acetate|mesh-list
6195518|NCT01946152|Pomalidomide|pomalidomide|mesh-list
6195519|NCT01946152|Ichthammol|ichthammol|mesh-list
6195520|NCT01946152|Lenograstim|lenograstim|mesh-list
6195521|NCT01946152|BB 1101|bb 1101|mesh-list
6195522|NCT01946152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6195523|NCT01946152|Antiemetics|antiemetics|mesh-ancestor
6195524|NCT01946152|Autonomic Agents|autonomic agents|mesh-ancestor
6195525|NCT01946152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6195526|NCT01946152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195527|NCT01946152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6195528|NCT01946152|Glucocorticoids|glucocorticoids|mesh-ancestor
6195529|NCT01946152|Hormones|hormones|mesh-ancestor
6195530|NCT01946152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6195531|NCT01946152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6195532|NCT01946152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6195533|NCT01946152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6195534|NCT01946152|Immunologic Factors|immunologic factors|mesh-ancestor
6195535|NCT01946152|Protease Inhibitors|protease inhibitors|mesh-ancestor
6195536|NCT01946152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6195537|NCT01946152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195538|NCT01946152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6195539|NCT01946152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6195540|NCT01946152|Growth Substances|growth substances|mesh-ancestor
6195541|NCT01946152|Growth Inhibitors|growth inhibitors|mesh-ancestor
6195542|NCT01946152|Dermatologic Agents|dermatologic agents|mesh-ancestor
6195543|NCT01946165|Prednisone|prednisone|mesh-list
6195544|NCT01946165|Abiraterone Acetate|abiraterone acetate|mesh-list
6195545|NCT01946165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6195546|NCT01946165|Glucocorticoids|glucocorticoids|mesh-ancestor
6195547|NCT01946165|Hormones|hormones|mesh-ancestor
6195548|NCT01946165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6195549|NCT01946165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195550|NCT01946165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6195551|NCT01946165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605137|NCT03503318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5605138|NCT03503318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5605139|NCT03503318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5605140|NCT03503318|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5605141|NCT03503318|Dopamine Agents|dopamine agents|mesh-ancestor
6195552|NCT01946165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6195553|NCT01946165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6195554|NCT01946165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605142|NCT03498612|Pembrolizumab|pembrolizumab|mesh-list
5605143|NCT03498612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6195555|NCT01946165|Hormone Antagonists|hormone antagonists|mesh-ancestor
6195556|NCT01946165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6195557|NCT01946412|Ivacaftor|ivacaftor|mesh-list
6195558|NCT01946412|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6195559|NCT01946412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6195560|NCT01946412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195561|NCT01946425|Vaccines|vaccines|mesh-list
6195562|NCT01946425|Immunologic Factors|immunologic factors|mesh-ancestor
6195563|NCT01946425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195564|NCT01946438|Vaccines|vaccines|mesh-list
6195565|NCT01946438|Immunologic Factors|immunologic factors|mesh-ancestor
6195566|NCT01946438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195567|NCT01946529|Sirolimus|sirolimus|mesh-list
6195568|NCT01946529|Cyclophosphamide|cyclophosphamide|mesh-list
6195569|NCT01946529|Temozolomide|temozolomide|mesh-list
6195570|NCT01946529|Ifosfamide|ifosfamide|mesh-list
6195571|NCT01946529|Bevacizumab|bevacizumab|mesh-list
6195572|NCT01946529|Doxorubicin|doxorubicin|mesh-list
6195573|NCT01946529|Etoposide|etoposide|mesh-list
6195574|NCT01946529|Vincristine|vincristine|mesh-list
6195575|NCT01946529|Sorafenib|sorafenib|mesh-list
6195576|NCT01946529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6195577|NCT01946529|Immunologic Factors|immunologic factors|mesh-ancestor
6195578|NCT01946529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195579|NCT01946529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6195580|NCT01946529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6195581|NCT01946529|Alkylating Agents|alkylating agents|mesh-ancestor
6195582|NCT01946529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195583|NCT01946529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6195584|NCT01946529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6195585|NCT01946529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5585610|NCT03813641|Capecitabine|capecitabine|mesh-list
5585611|NCT03813641|Raltitrexed|raltitrexed|mesh-list
5585612|NCT03813641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5585613|NCT03813641|Antimetabolites|antimetabolites|mesh-ancestor
5585614|NCT03813641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195586|NCT01946529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6195587|NCT01946529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6195588|NCT01946529|Growth Substances|growth substances|mesh-ancestor
6195589|NCT01946529|Growth Inhibitors|growth inhibitors|mesh-ancestor
6195590|NCT01946529|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6195591|NCT01946529|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5585615|NCT03813641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5585616|NCT03813641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5585617|NCT03813641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5585618|NCT03813693|Chlorhexidine|chlorhexidine|mesh-list
5585619|NCT03813693|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5585620|NCT03813693|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5585621|NCT03813693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5585622|NCT03813693|Disinfectants|disinfectants|mesh-ancestor
5585623|NCT03813693|Dermatologic Agents|dermatologic agents|mesh-ancestor
5585624|NCT03813394|Bevacizumab|bevacizumab|mesh-list
5585625|NCT03813394|Pembrolizumab|pembrolizumab|mesh-list
5585626|NCT03813394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5585627|NCT03813394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5585628|NCT03813394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6195592|NCT01946529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6195593|NCT01946529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6195594|NCT01946529|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6195595|NCT01946529|Tubulin Modulators|tubulin modulators|mesh-ancestor
6195596|NCT01946529|Antimitotic Agents|antimitotic agents|mesh-ancestor
6195597|NCT01946529|Mitosis Modulators|mitosis modulators|mesh-ancestor
6195598|NCT01946529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6195599|NCT01946529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6195600|NCT01946529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6195601|NCT01946529|Antifungal Agents|antifungal agents|mesh-ancestor
6195602|NCT01946880|Mycophenolic Acid|mycophenolic acid|mesh-list
6195603|NCT01946880|Hydroxychloroquine|hydroxychloroquine|mesh-list
6195604|NCT01946880|Chloroquine|chloroquine|mesh-list
6195605|NCT01946880|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
6195606|NCT01946880|Prednisone|prednisone|mesh-list
6195607|NCT01946880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6195608|NCT01946880|Glucocorticoids|glucocorticoids|mesh-ancestor
6195609|NCT01946880|Hormones|hormones|mesh-ancestor
5585629|NCT03813394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5585630|NCT03813394|Growth Substances|growth substances|mesh-ancestor
5585631|NCT03813394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585632|NCT03813394|Growth Inhibitors|growth inhibitors|mesh-ancestor
5585633|NCT03813329|Calcium Carbonate|calcium carbonate|mesh-list
5585634|NCT03813329|Calcium|calcium|mesh-list
6195610|NCT01946880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6195611|NCT01946880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195612|NCT01946880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6195613|NCT01946880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6195614|NCT01946880|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6195615|NCT01946880|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6195616|NCT01946880|Antitubercular Agents|antitubercular agents|mesh-ancestor
6195617|NCT01946880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6195618|NCT01946880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6195619|NCT01946880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6195620|NCT01946880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585635|NCT03813329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5585636|NCT03813329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585637|NCT03813329|Antacids|antacids|mesh-ancestor
5585638|NCT03813329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585639|NCT03813329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5585640|NCT03813277|Dexmedetomidine|dexmedetomidine|mesh-list
5585641|NCT03813277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6195621|NCT01946880|Antimalarials|antimalarials|mesh-ancestor
6195622|NCT01946880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6195623|NCT01946880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6195624|NCT01946880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6195625|NCT01946880|Amebicides|amebicides|mesh-ancestor
6195626|NCT01946880|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6195627|NCT01946880|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6195628|NCT01946880|Analgesics|analgesics|mesh-ancestor
6195629|NCT01946880|Sensory System Agents|sensory system agents|mesh-ancestor
6195630|NCT01946880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6195631|NCT01946880|Filaricides|filaricides|mesh-ancestor
6195632|NCT01946880|Antinematodal Agents|antinematodal agents|mesh-ancestor
6195633|NCT01946880|Anthelmintics|anthelmintics|mesh-ancestor
6195634|NCT01947153|Metformin|metformin|mesh-list
6195635|NCT01947153|Linagliptin|linagliptin|mesh-list
6195636|NCT01947153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6195637|NCT01947153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195638|NCT01947153|Incretins|incretins|mesh-ancestor
6195639|NCT01947153|Hormones|hormones|mesh-ancestor
6195640|NCT01947153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6195641|NCT01947153|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6195642|NCT01947153|Protease Inhibitors|protease inhibitors|mesh-ancestor
6195643|NCT01947153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6195644|NCT01947153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195645|NCT01947855|Empagliflozin|empagliflozin|mesh-list
6195646|NCT01947855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6195647|NCT01947855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195648|NCT01947855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6195649|NCT01947855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195650|NCT01947907|Hormones|hormones|mesh-list
6195651|NCT01947907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5585642|NCT03813277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5585643|NCT03813277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585644|NCT03813277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5585645|NCT03813277|Analgesics|analgesics|mesh-ancestor
5585646|NCT03813277|Sensory System Agents|sensory system agents|mesh-ancestor
5585647|NCT03813277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5585648|NCT03813277|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5585649|NCT03813277|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5585650|NCT03813277|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5585651|NCT03813277|Adrenergic Agents|adrenergic agents|mesh-ancestor
5585652|NCT03813277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5585653|NCT03813277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585654|NCT03813316|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5585655|NCT03813316|Ertugliflozin|ertugliflozin|mesh-list
5585656|NCT03813316|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
5585657|NCT03813316|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
5585658|NCT03813316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5585659|NCT03813316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585660|NCT03813316|Incretins|incretins|mesh-ancestor
5585661|NCT03813316|Hormones|hormones|mesh-ancestor
5585662|NCT03813316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5585663|NCT03813316|Protease Inhibitors|protease inhibitors|mesh-ancestor
5585664|NCT03813316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5585665|NCT03813316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585666|NCT03813303|Fentanyl|fentanyl|mesh-list
5585667|NCT03813303|Midazolam|midazolam|mesh-list
6195652|NCT01947907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195653|NCT01947946|Benralizumab|benralizumab|mesh-list
6195654|NCT01947946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6195655|NCT01947946|Respiratory System Agents|respiratory system agents|mesh-ancestor
6195656|NCT01948141|Nintedanib|nintedanib|mesh-list
6195657|NCT01948141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6195658|NCT01948141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6195659|NCT01948141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6195660|NCT01948141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195661|NCT01948310|Ranolazine|ranolazine|mesh-list
6195662|NCT01948310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6195663|NCT01948310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6195664|NCT01948310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195665|NCT01948388|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6195666|NCT01948388|Hormones|hormones|mesh-ancestor
6195667|NCT01948388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6195668|NCT01948388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585668|NCT03813303|Propofol|propofol|mesh-list
5585669|NCT03813303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5585670|NCT03813303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5585671|NCT03813303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585672|NCT03813303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5585673|NCT03813303|Anesthetics, General|anesthetics, general|mesh-ancestor
5585674|NCT03813303|Anesthetics|anesthetics|mesh-ancestor
5585675|NCT03813303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5585676|NCT03813303|Narcotics|narcotics|mesh-ancestor
5585677|NCT03813303|Analgesics|analgesics|mesh-ancestor
5585678|NCT03813303|Sensory System Agents|sensory system agents|mesh-ancestor
5585679|NCT03813303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5585680|NCT03813303|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5585681|NCT03813303|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6195669|NCT01948518|Sildenafil Citrate|sildenafil citrate|mesh-list
6195670|NCT01948518|Vasodilator Agents|vasodilator agents|mesh-ancestor
5585682|NCT03813303|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5585683|NCT03813303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5585684|NCT03813303|GABA Modulators|gaba modulators|mesh-ancestor
5585685|NCT03813303|GABA Agents|gaba agents|mesh-ancestor
5585686|NCT03813303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6195671|NCT01948518|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6195672|NCT01948518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6195673|NCT01948518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6195674|NCT01948518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195675|NCT01948518|Urological Agents|urological agents|mesh-ancestor
6195676|NCT01948791|Rivastigmine|rivastigmine|mesh-list
6195677|NCT01948791|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6195678|NCT01948791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6195679|NCT01948791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195680|NCT01948791|Cholinergic Agents|cholinergic agents|mesh-ancestor
6195681|NCT01948791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6195682|NCT01948791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195683|NCT01948791|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6195684|NCT01948791|Protective Agents|protective agents|mesh-ancestor
6195685|NCT01948830|Ranibizumab|ranibizumab|mesh-list
6195686|NCT01948830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6195687|NCT01948830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6195688|NCT01948830|Growth Substances|growth substances|mesh-ancestor
6195689|NCT01948830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195690|NCT01948830|Growth Inhibitors|growth inhibitors|mesh-ancestor
6195691|NCT01948830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6195692|NCT01948908|Midazolam|midazolam|mesh-list
6195693|NCT01948908|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5585687|NCT03813303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585688|NCT03813043|Midazolam|midazolam|mesh-list
5585689|NCT03813043|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5585690|NCT03813043|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5585691|NCT03813043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5585692|NCT03813043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585693|NCT03813043|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5585694|NCT03813043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5585695|NCT03813043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5585696|NCT03813043|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6195694|NCT01948908|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5585697|NCT03813043|Anesthetics, General|anesthetics, general|mesh-ancestor
5585698|NCT03813043|Anesthetics|anesthetics|mesh-ancestor
5585699|NCT03813043|GABA Modulators|gaba modulators|mesh-ancestor
5585700|NCT03813043|GABA Agents|gaba agents|mesh-ancestor
5585701|NCT03813043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5585702|NCT03813043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585703|NCT03813199|Methotrexate|methotrexate|mesh-list
5585704|NCT03813199|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5585705|NCT03813199|Abortifacient Agents|abortifacient agents|mesh-ancestor
5585706|NCT03813199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5585707|NCT03813199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585708|NCT03813199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5585709|NCT03813199|Antimetabolites|antimetabolites|mesh-ancestor
5585710|NCT03813199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585711|NCT03813199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5585712|NCT03813199|Dermatologic Agents|dermatologic agents|mesh-ancestor
6195695|NCT01948908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6195696|NCT01948908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195697|NCT01948908|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6195698|NCT01948908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6195699|NCT01948908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6195700|NCT01948908|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6195701|NCT01948908|Anesthetics, General|anesthetics, general|mesh-ancestor
6195702|NCT01948908|Anesthetics|anesthetics|mesh-ancestor
6195703|NCT01948908|GABA Modulators|gaba modulators|mesh-ancestor
6195704|NCT01948908|GABA Agents|gaba agents|mesh-ancestor
6195705|NCT01948908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6195706|NCT01948908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195707|NCT01948986|Ertugliflozin|ertugliflozin|mesh-list
6195708|NCT01948986|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6195709|NCT01948986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195710|NCT01948986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6195711|NCT01948986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195712|NCT01949051|Levocabastine|levocabastine|mesh-list
6195713|NCT01949051|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6195714|NCT01949051|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6195715|NCT01949051|Histamine Antagonists|histamine antagonists|mesh-ancestor
6195716|NCT01949051|Histamine Agents|histamine agents|mesh-ancestor
6195717|NCT01949051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6195718|NCT01949051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195719|NCT01949051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195720|NCT01949116|Folic Acid|folic acid|mesh-list
6195721|NCT01949116|Methotrexate|methotrexate|mesh-list
6195722|NCT01949116|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6195723|NCT01949116|Abortifacient Agents|abortifacient agents|mesh-ancestor
6195724|NCT01949116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6195725|NCT01949116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195726|NCT01949116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6195727|NCT01949116|Antimetabolites|antimetabolites|mesh-ancestor
6208011|NCT02123472|Cephalexin|cephalexin|mesh-list
5585713|NCT03813199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5585714|NCT03813199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5585715|NCT03813199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5585716|NCT03813199|Immunologic Factors|immunologic factors|mesh-ancestor
5585717|NCT03813199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5585718|NCT03813199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5585719|NCT03813069|Permethrin|permethrin|mesh-list
5585720|NCT03813069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5585721|NCT03813069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585722|NCT03813108|Lumefantrine|lumefantrine|mesh-list
5585723|NCT03813108|Mefloquine|mefloquine|mesh-list
5585724|NCT03813108|Atovaquone|atovaquone|mesh-list
5585725|NCT03813108|Proguanil|proguanil|mesh-list
5585726|NCT03813108|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
5585727|NCT03813108|Vaccines|vaccines|mesh-list
5585728|NCT03813108|Antimalarials|antimalarials|mesh-ancestor
5585729|NCT03813108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5585730|NCT03813108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5585731|NCT03813108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5585732|NCT03813108|Immunologic Factors|immunologic factors|mesh-ancestor
5585733|NCT03813108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585734|NCT03813108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5585735|NCT03813108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585736|NCT03813108|Antimetabolites|antimetabolites|mesh-ancestor
5585737|NCT03813056|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5585738|NCT03813056|Lubricant Eye Drops|lubricant eye drops|mesh-list
5585739|NCT03813056|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5585740|NCT03812965|Botulinum Toxins|botulinum toxins|mesh-list
5585741|NCT03812965|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5585742|NCT03812965|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5585743|NCT03812965|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5585744|NCT03812965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5585745|NCT03812965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585746|NCT03812965|Cholinergic Agents|cholinergic agents|mesh-ancestor
5585747|NCT03812965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5585748|NCT03812965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585749|NCT03812965|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5585750|NCT03812965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5585751|NCT03813186|Decitabine|decitabine|mesh-list
5585752|NCT03813186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5585753|NCT03813186|Antimetabolites|antimetabolites|mesh-ancestor
5585754|NCT03813186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585755|NCT03813186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5585756|NCT03813186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5585757|NCT03812939|Octreotide|octreotide|mesh-list
5585758|NCT03812939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5585759|NCT03812939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5585760|NCT03812939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5585761|NCT03813030|Lidocaine|lidocaine|mesh-list
5585762|NCT03813030|Prilocaine|prilocaine|mesh-list
5585763|NCT03813030|Anesthetics, Local|anesthetics, local|mesh-ancestor
5585764|NCT03813030|Anesthetics|anesthetics|mesh-ancestor
5585765|NCT03813030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5585766|NCT03813030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585767|NCT03813030|Sensory System Agents|sensory system agents|mesh-ancestor
5585768|NCT03813030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5585769|NCT03813030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6195728|NCT01949116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195729|NCT01949116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6195730|NCT01949116|Dermatologic Agents|dermatologic agents|mesh-ancestor
6195731|NCT01949116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6195732|NCT01949116|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6195733|NCT01949116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6195734|NCT01949116|Immunologic Factors|immunologic factors|mesh-ancestor
6195735|NCT01949116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6195736|NCT01949116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6195737|NCT01949116|Hematinics|hematinics|mesh-ancestor
6195738|NCT01949116|Vitamin B Complex|vitamin b complex|mesh-ancestor
6195739|NCT01949116|Vitamins|vitamins|mesh-ancestor
6195740|NCT01949116|Micronutrients|micronutrients|mesh-ancestor
6195741|NCT01949337|Prednisone|prednisone|mesh-list
6195742|NCT01949337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6195743|NCT01949337|Glucocorticoids|glucocorticoids|mesh-ancestor
6195744|NCT01949337|Hormones|hormones|mesh-ancestor
6195745|NCT01949337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6195746|NCT01949337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195747|NCT01949337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6195748|NCT01949337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6195749|NCT01949662|Lorazepam|lorazepam|mesh-list
6195750|NCT01949662|Haloperidol|haloperidol|mesh-list
6195751|NCT01949662|Haloperidol decanoate|haloperidol decanoate|mesh-list
6195752|NCT01949662|Antiemetics|antiemetics|mesh-ancestor
6195753|NCT01949662|Autonomic Agents|autonomic agents|mesh-ancestor
6195754|NCT01949662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6195755|NCT01949662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195756|NCT01949662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6195757|NCT01949662|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6195758|NCT01949662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6195759|NCT01949662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6195760|NCT01949662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6195761|NCT01949662|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6195762|NCT01949662|Dopamine Agents|dopamine agents|mesh-ancestor
6195763|NCT01949662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6195764|NCT01949662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195765|NCT01949662|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6195766|NCT01949662|Anticonvulsants|anticonvulsants|mesh-ancestor
6195767|NCT01949662|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6195768|NCT01949662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6195769|NCT01949662|GABA Modulators|gaba modulators|mesh-ancestor
6195770|NCT01949662|GABA Agents|gaba agents|mesh-ancestor
6195771|NCT01949844|Regadenoson|regadenoson|mesh-list
6195772|NCT01949844|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
6195773|NCT01949844|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6195774|NCT01949844|Purinergic Agonists|purinergic agonists|mesh-ancestor
6195775|NCT01949844|Purinergic Agents|purinergic agents|mesh-ancestor
6195776|NCT01949844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6195777|NCT01949844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195778|NCT01949844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195779|NCT01949870|Gemcitabine|gemcitabine|mesh-list
6195780|NCT01949870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6195781|NCT01949870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6195782|NCT01949870|Antimetabolites|antimetabolites|mesh-ancestor
6195783|NCT01949870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195784|NCT01949870|Antiviral Agents|antiviral agents|mesh-ancestor
6195785|NCT01949870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6195786|NCT01949870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6195787|NCT01949870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6195788|NCT01949870|Immunologic Factors|immunologic factors|mesh-ancestor
6195789|NCT01949870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195790|NCT01950039|Betaine|betaine|mesh-list
6195791|NCT01950039|Glycine|glycine|mesh-list
6195792|NCT01950039|Glycine Agents|glycine agents|mesh-ancestor
6195793|NCT01950039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6195794|NCT01950039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195795|NCT01950039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195796|NCT01950039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6195797|NCT01950039|Lipotropic Agents|lipotropic agents|mesh-ancestor
6195798|NCT01950039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6195799|NCT01950039|Antimetabolites|antimetabolites|mesh-ancestor
6195800|NCT01950039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6195801|NCT01950169|Vitamin D|vitamin d|mesh-list
6195802|NCT01950169|Cholecalciferol|cholecalciferol|mesh-list
6195803|NCT01950169|Risedronic Acid|risedronic acid|mesh-list
6195804|NCT01950169|Diphosphonates|diphosphonates|mesh-list
6195805|NCT01950169|Calcium|calcium|mesh-list
6195806|NCT01950169|Vitamins|vitamins|mesh-ancestor
6195807|NCT01950169|Micronutrients|micronutrients|mesh-ancestor
6195808|NCT01950169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195809|NCT01950169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6195810|NCT01950169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6195811|NCT01950169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6195812|NCT01950169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6195813|NCT01950169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195814|NCT01950260|Hormones|hormones|mesh-list
6195815|NCT01950260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6195816|NCT01950260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195817|NCT01950273|Rituximab|rituximab|mesh-list
6195818|NCT01950273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6195819|NCT01950273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6195820|NCT01950273|Immunologic Factors|immunologic factors|mesh-ancestor
6195821|NCT01950273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195822|NCT01950273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6195823|NCT01950299|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6195824|NCT01950299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6195825|NCT01950364|Rifampin|rifampin|mesh-list
6195826|NCT01950364|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6195827|NCT01950364|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6195828|NCT01950364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6195829|NCT01950364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6195830|NCT01950364|Immunologic Factors|immunologic factors|mesh-ancestor
6195831|NCT01950364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195832|NCT01950364|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6195833|NCT01950364|Antitubercular Agents|antitubercular agents|mesh-ancestor
6195834|NCT01950364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6195835|NCT01950364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6195836|NCT01950364|Leprostatic Agents|leprostatic agents|mesh-ancestor
6195837|NCT01950364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6195838|NCT01950364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6195839|NCT01950364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195840|NCT01950364|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6195841|NCT01950364|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6195842|NCT01950364|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6195843|NCT01950364|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6195844|NCT01950364|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6195845|NCT01950364|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6195846|NCT01950741|Aflibercept|aflibercept|mesh-list
6195847|NCT01950741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6195848|NCT01950741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6195849|NCT01950741|Growth Substances|growth substances|mesh-ancestor
6195850|NCT01950741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195851|NCT01950741|Growth Inhibitors|growth inhibitors|mesh-ancestor
6195852|NCT01950741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6207337|NCT02115048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6207338|NCT02115048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207339|NCT02115048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6207340|NCT02115113|Everolimus|everolimus|mesh-list
6207341|NCT02115113|Tacrolimus|tacrolimus|mesh-list
6207342|NCT02115113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6207343|NCT02115113|Immunologic Factors|immunologic factors|mesh-ancestor
6207344|NCT02115113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207345|NCT02115113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6207346|NCT02115113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6207347|NCT02115113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207348|NCT02115113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6207349|NCT02115139|Ipilimumab|ipilimumab|mesh-list
6207350|NCT02115139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6207351|NCT02115139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6207352|NCT02115139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6207353|NCT02115139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207354|NCT02115256|Nitroglycerin|nitroglycerin|mesh-list
6672188|NCT01554631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5585770|NCT03813030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5585771|NCT03813030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5585772|NCT03813030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5585773|NCT03813030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585774|NCT03812783|Sorafenib|sorafenib|mesh-list
5585775|NCT03812783|Folfirinox|folfirinox|mesh-list
5585776|NCT03812783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5585777|NCT03812783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5585778|NCT03812783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5585779|NCT03812783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585780|NCT03812796|Avelumab|avelumab|mesh-list
5585781|NCT03812796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5585782|NCT03812796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5585783|NCT03812731|Fentanyl|fentanyl|mesh-list
5585784|NCT03812731|Ropivacaine|ropivacaine|mesh-list
5585785|NCT03812731|Anesthetics, Local|anesthetics, local|mesh-ancestor
5585786|NCT03812731|Anesthetics|anesthetics|mesh-ancestor
5585787|NCT03812731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5585788|NCT03812731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672189|NCT01554631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672190|NCT01554657|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6672191|NCT01554657|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6672192|NCT01554657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6672193|NCT01554657|Antitubercular Agents|antitubercular agents|mesh-ancestor
6672194|NCT01554813|Vaccines|vaccines|mesh-list
6672195|NCT01554813|Immunologic Factors|immunologic factors|mesh-ancestor
6672196|NCT01554813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207355|NCT02115256|Terbutaline|terbutaline|mesh-list
6207356|NCT02115256|Vasodilator Agents|vasodilator agents|mesh-ancestor
6207357|NCT02115256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6207358|NCT02115256|Autonomic Agents|autonomic agents|mesh-ancestor
6207359|NCT02115256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6207360|NCT02115256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207361|NCT02115256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6207362|NCT02115256|Respiratory System Agents|respiratory system agents|mesh-ancestor
6207363|NCT02115256|Sympathomimetics|sympathomimetics|mesh-ancestor
6207364|NCT02115256|Tocolytic Agents|tocolytic agents|mesh-ancestor
6207365|NCT02115256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6207366|NCT02115256|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6207367|NCT02115256|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6207368|NCT02115256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6207369|NCT02115256|Adrenergic Agents|adrenergic agents|mesh-ancestor
6207370|NCT02115256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6207371|NCT02115256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207372|NCT02115282|Exemestane|exemestane|mesh-list
6207373|NCT02115282|Goserelin|goserelin|mesh-list
6207374|NCT02115282|Entinostat|entinostat|mesh-list
6207375|NCT02115282|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
5585789|NCT03812731|Sensory System Agents|sensory system agents|mesh-ancestor
5585790|NCT03812731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6672197|NCT01554826|Vaccines|vaccines|mesh-list
5585791|NCT03812731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5585792|NCT03812731|Narcotics|narcotics|mesh-ancestor
5585793|NCT03812731|Analgesics|analgesics|mesh-ancestor
6195853|NCT01950819|Cyclosporine|cyclosporine|mesh-list
6195854|NCT01950819|Prednisone|prednisone|mesh-list
6195855|NCT01950819|Methylprednisolone|methylprednisolone|mesh-list
6195856|NCT01950819|Tacrolimus|tacrolimus|mesh-list
6195857|NCT01950819|Thymoglobulin|thymoglobulin|mesh-list
6195858|NCT01950819|Cyclosporins|cyclosporins|mesh-list
6195859|NCT01950819|Basiliximab|basiliximab|mesh-list
6195860|NCT01950819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6195861|NCT01950819|Glucocorticoids|glucocorticoids|mesh-ancestor
6195862|NCT01950819|Hormones|hormones|mesh-ancestor
6195863|NCT01950819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6195864|NCT01950819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195865|NCT01950819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6195866|NCT01950819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6195867|NCT01950819|Antiemetics|antiemetics|mesh-ancestor
6195868|NCT01950819|Autonomic Agents|autonomic agents|mesh-ancestor
6195869|NCT01950819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6195870|NCT01950819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6195871|NCT01950819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6195872|NCT01950819|Protective Agents|protective agents|mesh-ancestor
6195873|NCT01950819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6195874|NCT01950819|Immunologic Factors|immunologic factors|mesh-ancestor
6195875|NCT01950819|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6195876|NCT01950819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6195877|NCT01950819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195878|NCT01950819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6195879|NCT01950819|Antifungal Agents|antifungal agents|mesh-ancestor
6195880|NCT01950819|Dermatologic Agents|dermatologic agents|mesh-ancestor
6195881|NCT01950819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6195882|NCT01951066|Dexamethasone|dexamethasone|mesh-list
6195883|NCT01951066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6195884|NCT01951066|Antiemetics|antiemetics|mesh-ancestor
6195885|NCT01951066|Autonomic Agents|autonomic agents|mesh-ancestor
6195886|NCT01951066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6195887|NCT01951066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585794|NCT03812731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5585795|NCT03812731|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5585796|NCT03812731|Anesthetics, General|anesthetics, general|mesh-ancestor
5585797|NCT03812380|Magnesium citrate|magnesium citrate|mesh-list
5585798|NCT03812380|Cathartics|cathartics|mesh-ancestor
5585799|NCT03812380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5585800|NCT03812523|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5585801|NCT03812523|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5585802|NCT03812523|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5585803|NCT03812523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5585804|NCT03812523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585805|NCT03812523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5585806|NCT03812523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585807|NCT03812523|Analgesics|analgesics|mesh-ancestor
5585808|NCT03812523|Sensory System Agents|sensory system agents|mesh-ancestor
5585809|NCT03812523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5585810|NCT03812523|Antidepressive Agents|antidepressive agents|mesh-ancestor
5585811|NCT03812523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5585812|NCT03812523|Dopamine Agents|dopamine agents|mesh-ancestor
5585813|NCT03812562|Nivolumab|nivolumab|mesh-list
5585814|NCT03812562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5585815|NCT03812562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5585816|NCT03812562|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5585817|NCT03812562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585818|NCT03812419|Esomeprazole|esomeprazole|mesh-list
6195888|NCT01951066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6195889|NCT01951066|Glucocorticoids|glucocorticoids|mesh-ancestor
6195890|NCT01951066|Hormones|hormones|mesh-ancestor
6195891|NCT01951066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5585819|NCT03812419|Pantoprazole|pantoprazole|mesh-list
5585820|NCT03812419|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5585821|NCT03812419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5585822|NCT03812419|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5585823|NCT03812419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6195892|NCT01951066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6195893|NCT01951066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5585824|NCT03812419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195894|NCT01951105|Naproxen|naproxen|mesh-list
6195895|NCT01951105|Levodopa|levodopa|mesh-list
6195896|NCT01951105|Carbidopa|carbidopa|mesh-list
6195897|NCT01951105|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
6195898|NCT01951105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6195899|NCT01951105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6195900|NCT01951105|Analgesics|analgesics|mesh-ancestor
6195901|NCT01951105|Sensory System Agents|sensory system agents|mesh-ancestor
6195902|NCT01951105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6195903|NCT01951105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195904|NCT01951105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6195905|NCT01951105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6195906|NCT01951105|Gout Suppressants|gout suppressants|mesh-ancestor
6195907|NCT01951105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6195908|NCT01951105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6195909|NCT01951105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195910|NCT01951105|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6195911|NCT01951105|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6195912|NCT01951105|Dopamine Agents|dopamine agents|mesh-ancestor
6195913|NCT01951105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6195914|NCT01951105|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6195915|NCT01951105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6195916|NCT01951105|Immunologic Factors|immunologic factors|mesh-ancestor
6195917|NCT01951105|Dopamine Agonists|dopamine agonists|mesh-ancestor
6195918|NCT01951118|Donepezil|donepezil|mesh-list
6195919|NCT01951118|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6195920|NCT01951118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6195921|NCT01951118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195922|NCT01951118|Cholinergic Agents|cholinergic agents|mesh-ancestor
6195923|NCT01951118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6195924|NCT01951118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195925|NCT01951118|Nootropic Agents|nootropic agents|mesh-ancestor
6195926|NCT01951157|Gemcitabine|gemcitabine|mesh-list
6195927|NCT01951157|Docetaxel|docetaxel|mesh-list
6195928|NCT01951157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6195929|NCT01951157|Antimetabolites|antimetabolites|mesh-ancestor
6195930|NCT01951157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195931|NCT01951157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6195932|NCT01951157|Antiviral Agents|antiviral agents|mesh-ancestor
6195933|NCT01951157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6195934|NCT01951157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6195935|NCT01951157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5585825|NCT03812770|Leucovorin|leucovorin|mesh-list
5585826|NCT03812770|Fluorouracil|fluorouracil|mesh-list
5585827|NCT03812770|Oxaliplatin|oxaliplatin|mesh-list
5585828|NCT03812770|Sorafenib|sorafenib|mesh-list
5585829|NCT03812770|Antimetabolites|antimetabolites|mesh-ancestor
6195936|NCT01951157|Immunologic Factors|immunologic factors|mesh-ancestor
6195937|NCT01951157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195938|NCT01951157|Tubulin Modulators|tubulin modulators|mesh-ancestor
6195939|NCT01951157|Antimitotic Agents|antimitotic agents|mesh-ancestor
6195940|NCT01951157|Mitosis Modulators|mitosis modulators|mesh-ancestor
6195941|NCT01951339|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6195942|NCT01951339|Glimepiride|glimepiride|mesh-list
6195943|NCT01951339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6195944|NCT01951339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195945|NCT01951339|Incretins|incretins|mesh-ancestor
6195946|NCT01951339|Hormones|hormones|mesh-ancestor
6195947|NCT01951339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6195948|NCT01951339|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6195949|NCT01951339|Protease Inhibitors|protease inhibitors|mesh-ancestor
6195950|NCT01951339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6195951|NCT01951339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195952|NCT01951339|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6195953|NCT01951339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6195954|NCT01951339|Immunologic Factors|immunologic factors|mesh-ancestor
6195955|NCT01951391|Benzalkonium Compounds|benzalkonium compounds|mesh-list
6195956|NCT01951391|Triclocarban|triclocarban|mesh-list
6195957|NCT01951391|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6195958|NCT01951391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6195959|NCT01951417|Adapalene|adapalene|mesh-list
6195960|NCT01951417|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6195961|NCT01951417|Dermatologic Agents|dermatologic agents|mesh-ancestor
6195962|NCT01951417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6195963|NCT01951417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6195964|NCT01951417|Analgesics|analgesics|mesh-ancestor
6195965|NCT01951417|Sensory System Agents|sensory system agents|mesh-ancestor
5585830|NCT03812770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585831|NCT03812770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5585832|NCT03812770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5585833|NCT03812770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5585834|NCT03812770|Immunologic Factors|immunologic factors|mesh-ancestor
5585835|NCT03812770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585836|NCT03812770|Antidotes|antidotes|mesh-ancestor
5585837|NCT03812770|Protective Agents|protective agents|mesh-ancestor
5585838|NCT03812770|Vitamin B Complex|vitamin b complex|mesh-ancestor
5585839|NCT03812770|Vitamins|vitamins|mesh-ancestor
5585840|NCT03812770|Micronutrients|micronutrients|mesh-ancestor
5585841|NCT03812770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6195966|NCT01951417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6195967|NCT01951417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195968|NCT01951417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6195969|NCT01951417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6195970|NCT01951586|Zoledronic Acid|zoledronic acid|mesh-list
6195971|NCT01951586|Denosumab|denosumab|mesh-list
6195972|NCT01951586|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6195973|NCT01951586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195974|NCT01951651|Exenatide|exenatide|mesh-list
6195975|NCT01951651|Glipizide|glipizide|mesh-list
6195976|NCT01951651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6195977|NCT01951651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195978|NCT01951651|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6195979|NCT01951651|Incretins|incretins|mesh-ancestor
6195980|NCT01951651|Hormones|hormones|mesh-ancestor
6195981|NCT01951651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6195982|NCT01951768|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6195983|NCT01951768|Gentamicins|gentamicins|mesh-list
6195984|NCT01951768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6195985|NCT01951768|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5585842|NCT03812770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5585843|NCT03812588|Citalopram|citalopram|mesh-list
5585844|NCT03812588|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5585845|NCT03812588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5585846|NCT03812588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5585847|NCT03812588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585848|NCT03812588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5585849|NCT03812588|Serotonin Agents|serotonin agents|mesh-ancestor
6195986|NCT01951768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6195987|NCT01951768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6195988|NCT01951820|Lidocaine|lidocaine|mesh-list
6195989|NCT01951820|Tetracaine|tetracaine|mesh-list
6195990|NCT01951820|Carticaine|carticaine|mesh-list
6195991|NCT01951820|Benzocaine|benzocaine|mesh-list
6195992|NCT01951820|Anesthetics, Local|anesthetics, local|mesh-ancestor
6195993|NCT01951820|Anesthetics|anesthetics|mesh-ancestor
6195994|NCT01951820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6195995|NCT01951820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6195996|NCT01951820|Sensory System Agents|sensory system agents|mesh-ancestor
6195997|NCT01951820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6195998|NCT01951820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6195999|NCT01951820|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6196000|NCT01951820|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6196001|NCT01951820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6196002|NCT01951820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196003|NCT01951950|Nicardipine|nicardipine|mesh-list
6196004|NCT01951950|Esmolol|esmolol|mesh-list
6196005|NCT01951950|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6196006|NCT01951950|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6196007|NCT01951950|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5585850|NCT03812588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196008|NCT01951950|Adrenergic Agents|adrenergic agents|mesh-ancestor
6196009|NCT01951950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6196010|NCT01951950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196011|NCT01951950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196012|NCT01951950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6196013|NCT01951950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6196014|NCT01951950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6196015|NCT01951950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6196016|NCT01951950|Vasodilator Agents|vasodilator agents|mesh-ancestor
6196017|NCT01951963|Morphine|morphine|mesh-list
6196018|NCT01951963|Ketamine|ketamine|mesh-list
6196019|NCT01951963|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6196020|NCT01951963|Narcotics|narcotics|mesh-ancestor
6196021|NCT01951963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5585851|NCT03812588|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5585852|NCT03812588|Antidepressive Agents|antidepressive agents|mesh-ancestor
5585853|NCT03812588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5585854|NCT03812354|Nicotine|nicotine|mesh-list
5585855|NCT03812354|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5585856|NCT03812354|Autonomic Agents|autonomic agents|mesh-ancestor
5585857|NCT03812354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5585858|NCT03812354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585859|NCT03812354|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5585860|NCT03812354|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5585861|NCT03812354|Cholinergic Agents|cholinergic agents|mesh-ancestor
5585862|NCT03812354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5585863|NCT03812354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585864|NCT03812315|Propolis|propolis|mesh-list
5585865|NCT03812315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5585866|NCT03812120|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
5585867|NCT03812120|Hemostatics|hemostatics|mesh-ancestor
5585868|NCT03812120|Coagulants|coagulants|mesh-ancestor
5585869|NCT03812003|Remifentanil|remifentanil|mesh-list
5585870|NCT03812003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5585871|NCT03812003|Narcotics|narcotics|mesh-ancestor
5585872|NCT03812003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5585873|NCT03812003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585874|NCT03812003|Analgesics|analgesics|mesh-ancestor
5585875|NCT03812003|Sensory System Agents|sensory system agents|mesh-ancestor
5585876|NCT03812003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5585877|NCT03811860|Lithium Carbonate|lithium carbonate|mesh-list
5585878|NCT03811860|Antidepressive Agents|antidepressive agents|mesh-ancestor
5585879|NCT03811860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5585880|NCT03811860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5585881|NCT03811860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585882|NCT03811860|Antimanic Agents|antimanic agents|mesh-ancestor
5585883|NCT03811860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5585884|NCT03811860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5585885|NCT03811860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605144|NCT03498612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605145|NCT03441282|Fentanyl|fentanyl|mesh-list
5605146|NCT03441282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5605147|NCT03441282|Narcotics|narcotics|mesh-ancestor
5605148|NCT03441282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5605149|NCT03441282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605150|NCT03441282|Analgesics|analgesics|mesh-ancestor
5605151|NCT03441282|Sensory System Agents|sensory system agents|mesh-ancestor
6196022|NCT01951963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196023|NCT01951963|Analgesics|analgesics|mesh-ancestor
6196024|NCT01951963|Sensory System Agents|sensory system agents|mesh-ancestor
6196025|NCT01951963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6196026|NCT01951963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6196027|NCT01951963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6196028|NCT01951963|Anesthetics, General|anesthetics, general|mesh-ancestor
6196029|NCT01951963|Anesthetics|anesthetics|mesh-ancestor
6196030|NCT01951963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6196031|NCT01951963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6196032|NCT01951963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6196033|NCT01951963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196034|NCT01952054|Denosumab|denosumab|mesh-list
6196035|NCT01952054|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6196036|NCT01952054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196037|NCT01952080|Teduglutide|teduglutide|mesh-list
6196038|NCT01952080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6196039|NCT01952080|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6196040|NCT01952080|Protective Agents|protective agents|mesh-ancestor
6196041|NCT01952080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196042|NCT01952145|Insulin|insulin|mesh-list
6196043|NCT01952145|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6196044|NCT01952145|Insulin Glargine|insulin glargine|mesh-list
6196045|NCT01952145|Liraglutide|liraglutide|mesh-list
6196046|NCT01952145|Xultophy|xultophy|mesh-list
6196047|NCT01952145|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6196048|NCT01952145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196049|NCT01952145|Incretins|incretins|mesh-ancestor
6196050|NCT01952145|Hormones|hormones|mesh-ancestor
6196051|NCT01952145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5605152|NCT03441282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6196052|NCT01952444|Ciprofloxacin|ciprofloxacin|mesh-list
6196053|NCT01952444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6196054|NCT01952444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6196055|NCT01952444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6196056|NCT01952444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6196057|NCT01952444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6196058|NCT01952444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196059|NCT01952444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5585886|NCT03811418|Docetaxel|docetaxel|mesh-list
5585887|NCT03811418|Trastuzumab|trastuzumab|mesh-list
5585888|NCT03811418|Vinorelbine|vinorelbine|mesh-list
5585889|NCT03811418|Pertuzumab|pertuzumab|mesh-list
5585890|NCT03811418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5585891|NCT03811418|Tubulin Modulators|tubulin modulators|mesh-ancestor
5585892|NCT03811418|Antimitotic Agents|antimitotic agents|mesh-ancestor
6196060|NCT01952444|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6196061|NCT01952444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6196062|NCT01952574|Erenumab|erenumab|mesh-list
6196063|NCT01952574|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6196064|NCT01952574|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
6196065|NCT01952574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196066|NCT01952574|Analgesics|analgesics|mesh-ancestor
6196067|NCT01952574|Sensory System Agents|sensory system agents|mesh-ancestor
6196068|NCT01952574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6196069|NCT01952574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196070|NCT01952574|Immunologic Factors|immunologic factors|mesh-ancestor
6196071|NCT01952834|Vancomycin|vancomycin|mesh-list
6196072|NCT01952834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6196073|NCT01952834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6196074|NCT01953003|Capecitabine|capecitabine|mesh-list
6196075|NCT01953003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6196076|NCT01953003|Antimetabolites|antimetabolites|mesh-ancestor
6196077|NCT01953003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196078|NCT01953003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6196079|NCT01953081|Metoclopramide|metoclopramide|mesh-list
6196080|NCT01953081|Antiemetics|antiemetics|mesh-ancestor
6196081|NCT01953081|Autonomic Agents|autonomic agents|mesh-ancestor
6196082|NCT01953081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6196083|NCT01953081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196084|NCT01953081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6196085|NCT01953081|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6196086|NCT01953081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6196087|NCT01953081|Dopamine Agents|dopamine agents|mesh-ancestor
6196088|NCT01953081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6196089|NCT01953081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196090|NCT01953211|Contraceptive Agents|contraceptive agents|mesh-list
6196091|NCT01953211|Norinyl|norinyl|mesh-list
5585893|NCT03811418|Mitosis Modulators|mitosis modulators|mesh-ancestor
5585894|NCT03811418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196092|NCT01953211|Contraceptives, Oral|contraceptives, oral|mesh-list
6196093|NCT01953211|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
6196094|NCT01953211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6196095|NCT01953211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196096|NCT01953211|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6196097|NCT01953211|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6196098|NCT01953211|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6196099|NCT01953328|Atorvastatin|atorvastatin|mesh-list
5585895|NCT03811418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5585896|NCT03811418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5585897|NCT03811509|Denosumab|denosumab|mesh-list
5585898|NCT03811509|Diphosphonates|diphosphonates|mesh-list
5585899|NCT03811509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5585900|NCT03811509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585901|NCT03811262|Levobupivacaine|levobupivacaine|mesh-list
5585902|NCT03811262|Anesthetics, Local|anesthetics, local|mesh-ancestor
5585903|NCT03811262|Anesthetics|anesthetics|mesh-ancestor
5585904|NCT03811262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5585905|NCT03811262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585906|NCT03811262|Sensory System Agents|sensory system agents|mesh-ancestor
5585907|NCT03811262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5585908|NCT03810872|Paclitaxel|paclitaxel|mesh-list
5585909|NCT03810872|Afatinib|afatinib|mesh-list
5585910|NCT03810872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5585911|NCT03810872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5585912|NCT03810872|Tubulin Modulators|tubulin modulators|mesh-ancestor
5585913|NCT03810872|Antimitotic Agents|antimitotic agents|mesh-ancestor
5585914|NCT03810872|Mitosis Modulators|mitosis modulators|mesh-ancestor
5585915|NCT03810872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585916|NCT03810872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5585917|NCT03810872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5585918|NCT03811223|Evolocumab|evolocumab|mesh-list
5585919|NCT03811223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5585920|NCT03811223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5585921|NCT03811223|Antimetabolites|antimetabolites|mesh-ancestor
5585922|NCT03811223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585923|NCT03811223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6196100|NCT01953328|Evolocumab|evolocumab|mesh-list
6196101|NCT01953328|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6196102|NCT01953328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5585924|NCT03811054|Apatinib|apatinib|mesh-list
5585925|NCT03811054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5585926|NCT03811054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5585927|NCT03811054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5585928|NCT03811054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585929|NCT03811197|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
5585930|NCT03811197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5585931|NCT03811197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585932|NCT03810976|Gemcitabine|gemcitabine|mesh-list
5585933|NCT03810976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5585934|NCT03810976|Antimetabolites|antimetabolites|mesh-ancestor
5585935|NCT03810976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585936|NCT03810976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5585937|NCT03810976|Antiviral Agents|antiviral agents|mesh-ancestor
5585938|NCT03810976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5585939|NCT03810976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5585940|NCT03810976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5585941|NCT03810976|Immunologic Factors|immunologic factors|mesh-ancestor
5585942|NCT03810976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585943|NCT03810794|Donepezil|donepezil|mesh-list
5585944|NCT03810794|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5585945|NCT03810794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5585946|NCT03810794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585947|NCT03810794|Cholinergic Agents|cholinergic agents|mesh-ancestor
5585948|NCT03810794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5585949|NCT03810794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585950|NCT03810794|Nootropic Agents|nootropic agents|mesh-ancestor
6196103|NCT01953328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6196104|NCT01953328|Antimetabolites|antimetabolites|mesh-ancestor
6672198|NCT01554826|Immunologic Factors|immunologic factors|mesh-ancestor
6672199|NCT01554826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585951|NCT03810703|Amphetamine|amphetamine|mesh-list
5585952|NCT03810703|Dextroamphetamine|dextroamphetamine|mesh-list
6196105|NCT01953328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672200|NCT01554852|Thalidomide|thalidomide|mesh-list
5585953|NCT03810703|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5585954|NCT03810703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5585955|NCT03810703|Sympathomimetics|sympathomimetics|mesh-ancestor
5585956|NCT03810703|Autonomic Agents|autonomic agents|mesh-ancestor
5585957|NCT03810703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5585958|NCT03810703|Dopamine Agents|dopamine agents|mesh-ancestor
5585959|NCT03810703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5585960|NCT03810703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585961|NCT03810703|Adrenergic Agents|adrenergic agents|mesh-ancestor
5585962|NCT03810703|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5585963|NCT03810703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5585964|NCT03810703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5585965|NCT03810703|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5585966|NCT03810742|Irinotecan|irinotecan|mesh-list
5585967|NCT03810742|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5585968|NCT03810742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5585969|NCT03810742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6196106|NCT01953328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6196107|NCT01953328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6196108|NCT01953328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6196109|NCT01953328|Immunologic Factors|immunologic factors|mesh-ancestor
6196110|NCT01953328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196111|NCT01953432|Doxazosin|doxazosin|mesh-list
6196112|NCT01953432|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6196113|NCT01953432|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6196114|NCT01953432|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6196115|NCT01953432|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5585970|NCT03810742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585971|NCT03810742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5585972|NCT03810547|Ketamine|ketamine|mesh-list
5585973|NCT03810547|Propofol|propofol|mesh-list
5585974|NCT03810547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5585975|NCT03810547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5585976|NCT03810547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672201|NCT01554852|Dexamethasone|dexamethasone|mesh-list
6672202|NCT01554852|Dexamethasone acetate|dexamethasone acetate|mesh-list
6672203|NCT01554852|Cyclophosphamide|cyclophosphamide|mesh-list
6196116|NCT01953432|Adrenergic Agents|adrenergic agents|mesh-ancestor
6196117|NCT01953432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6196118|NCT01953432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196119|NCT01953432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196120|NCT01953692|Pembrolizumab|pembrolizumab|mesh-list
6196121|NCT01953692|Lenalidomide|lenalidomide|mesh-list
6196122|NCT01953692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6196123|NCT01953692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6196124|NCT01953692|Immunologic Factors|immunologic factors|mesh-ancestor
6196125|NCT01953692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196126|NCT01953692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6196127|NCT01953692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6196128|NCT01953692|Growth Substances|growth substances|mesh-ancestor
6196129|NCT01953692|Growth Inhibitors|growth inhibitors|mesh-ancestor
6196130|NCT01953783|Ixazomib|ixazomib|mesh-list
6196131|NCT01953783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6196132|NCT01953783|Protease Inhibitors|protease inhibitors|mesh-ancestor
6196133|NCT01953783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6196134|NCT01953783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196135|NCT01953913|Afatinib|afatinib|mesh-list
6196136|NCT01953913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6196137|NCT01953913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6196138|NCT01953913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6196139|NCT01953913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196140|NCT01954056|Hydrocortisone|hydrocortisone|mesh-list
6672204|NCT01554852|Melphalan|melphalan|mesh-list
6672205|NCT01554852|Lenalidomide|lenalidomide|mesh-list
6672206|NCT01554852|Bortezomib|bortezomib|mesh-list
6672207|NCT01554852|Vorinostat|vorinostat|mesh-list
6672208|NCT01554852|BB 1101|bb 1101|mesh-list
6672209|NCT01554852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6672210|NCT01554852|Immunologic Factors|immunologic factors|mesh-ancestor
6672211|NCT01554852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672212|NCT01554852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6672213|NCT01554852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5585977|NCT03810547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5585978|NCT03810547|Anesthetics, General|anesthetics, general|mesh-ancestor
5585979|NCT03810547|Anesthetics|anesthetics|mesh-ancestor
5585980|NCT03810547|Analgesics|analgesics|mesh-ancestor
6196141|NCT01954056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6196142|NCT01954082|Inositol|inositol|mesh-list
6196143|NCT01954082|Vitamin B Complex|vitamin b complex|mesh-ancestor
6196144|NCT01954082|Vitamins|vitamins|mesh-ancestor
6196145|NCT01954082|Micronutrients|micronutrients|mesh-ancestor
6196146|NCT01954082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196147|NCT01954121|Carbamazepine|carbamazepine|mesh-list
6196148|NCT01954121|Levetiracetam|levetiracetam|mesh-list
6196149|NCT01954121|Anticonvulsants|anticonvulsants|mesh-ancestor
6196150|NCT01954121|Nootropic Agents|nootropic agents|mesh-ancestor
6196151|NCT01954121|Antimanic Agents|antimanic agents|mesh-ancestor
6196152|NCT01954121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6196153|NCT01954121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6196154|NCT01954121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196155|NCT01954121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6196156|NCT01954121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6196157|NCT01954121|Analgesics|analgesics|mesh-ancestor
6196158|NCT01954121|Sensory System Agents|sensory system agents|mesh-ancestor
6196159|NCT01954121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6196160|NCT01954121|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6196161|NCT01954121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6196162|NCT01954121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196163|NCT01954121|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6196164|NCT01954121|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6196165|NCT01954251|Vaccines|vaccines|mesh-list
6196166|NCT01954251|Immunologic Factors|immunologic factors|mesh-ancestor
6196167|NCT01954251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196168|NCT01954927|Gabapentin|gabapentin|mesh-list
6196169|NCT01954927|Analgesics|analgesics|mesh-ancestor
6196170|NCT01954927|Sensory System Agents|sensory system agents|mesh-ancestor
6196171|NCT01954927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6196172|NCT01954927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196173|NCT01954927|Anticonvulsants|anticonvulsants|mesh-ancestor
6196174|NCT01954927|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6196175|NCT01954927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6196176|NCT01954927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6196177|NCT01954927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6196178|NCT01954927|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6196179|NCT01954927|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6196180|NCT01954927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6196181|NCT01954927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196182|NCT01954927|Antimanic Agents|antimanic agents|mesh-ancestor
6196183|NCT01955382|Artesunate|artesunate|mesh-list
6196184|NCT01955382|Amodiaquine|amodiaquine|mesh-list
6196185|NCT01955382|Charcoal|charcoal|mesh-list
6196186|NCT01955382|Antimalarials|antimalarials|mesh-ancestor
6196187|NCT01955382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6196188|NCT01955382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6196189|NCT01955382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6196190|NCT01955382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6196191|NCT01955382|Antiviral Agents|antiviral agents|mesh-ancestor
6196192|NCT01955382|Schistosomicides|schistosomicides|mesh-ancestor
6196193|NCT01955382|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6196194|NCT01955382|Anthelmintics|anthelmintics|mesh-ancestor
6196195|NCT01955382|Antidotes|antidotes|mesh-ancestor
6196196|NCT01955382|Protective Agents|protective agents|mesh-ancestor
6196197|NCT01955382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196198|NCT01955434|Cyclophosphamide|cyclophosphamide|mesh-list
6196199|NCT01955434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6196200|NCT01955434|Immunologic Factors|immunologic factors|mesh-ancestor
6196201|NCT01955434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196202|NCT01955434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6196203|NCT01955434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6672214|NCT01554852|Alkylating Agents|alkylating agents|mesh-ancestor
6672215|NCT01554852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672216|NCT01554852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6672217|NCT01554852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6196204|NCT01955434|Alkylating Agents|alkylating agents|mesh-ancestor
6196205|NCT01955434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196206|NCT01955434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6196207|NCT01955434|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6196208|NCT01955629|Capecitabine|capecitabine|mesh-list
6488294|NCT00582920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6196209|NCT01955629|Oxaliplatin|oxaliplatin|mesh-list
6196210|NCT01955629|Aflibercept|aflibercept|mesh-list
6196211|NCT01955629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6196212|NCT01955629|Antimetabolites|antimetabolites|mesh-ancestor
6672218|NCT01554852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6672219|NCT01554852|Antiemetics|antiemetics|mesh-ancestor
6672220|NCT01554852|Autonomic Agents|autonomic agents|mesh-ancestor
6672221|NCT01554852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6672222|NCT01554852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6672223|NCT01554852|Glucocorticoids|glucocorticoids|mesh-ancestor
6672224|NCT01554852|Hormones|hormones|mesh-ancestor
6672225|NCT01554852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6672226|NCT01554852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6672227|NCT01554852|Protease Inhibitors|protease inhibitors|mesh-ancestor
6672228|NCT01554852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6672229|NCT01554852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6672230|NCT01554852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6672231|NCT01554852|Growth Substances|growth substances|mesh-ancestor
6672232|NCT01554852|Growth Inhibitors|growth inhibitors|mesh-ancestor
6196213|NCT01955629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196214|NCT01955629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6672233|NCT01554852|Leprostatic Agents|leprostatic agents|mesh-ancestor
6672234|NCT01554852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6672235|NCT01554852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6672236|NCT01554852|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6672237|NCT01554930|Methylprednisolone|methylprednisolone|mesh-list
6672238|NCT01554930|Mannitol|mannitol|mesh-list
6672239|NCT01554930|Immunoglobulins|immunoglobulins|mesh-list
6672240|NCT01554930|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6672241|NCT01554930|Antibodies|antibodies|mesh-list
6672242|NCT01554930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6672243|NCT01554930|Antiemetics|antiemetics|mesh-ancestor
6672244|NCT01554930|Autonomic Agents|autonomic agents|mesh-ancestor
6672245|NCT01554930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6672246|NCT01554930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672247|NCT01554930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6672248|NCT01554930|Glucocorticoids|glucocorticoids|mesh-ancestor
6672249|NCT01554930|Hormones|hormones|mesh-ancestor
6672250|NCT01554930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6672251|NCT01554930|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6672252|NCT01554930|Protective Agents|protective agents|mesh-ancestor
6672253|NCT01554930|Immunologic Factors|immunologic factors|mesh-ancestor
6672254|NCT01554930|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6672255|NCT01554930|Diuretics|diuretics|mesh-ancestor
5585981|NCT03810547|Sensory System Agents|sensory system agents|mesh-ancestor
5585982|NCT03810547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5585983|NCT03810547|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5585984|NCT03810547|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5585985|NCT03810547|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5585986|NCT03810547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5585987|NCT03810547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585988|NCT03810287|Domperidone|domperidone|mesh-list
5585989|NCT03810287|Antiemetics|antiemetics|mesh-ancestor
5585990|NCT03810287|Autonomic Agents|autonomic agents|mesh-ancestor
5585991|NCT03810287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5585992|NCT03810287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672256|NCT01554930|Natriuretic Agents|natriuretic agents|mesh-ancestor
6196215|NCT01955629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6196216|NCT01955629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5585993|NCT03810287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5585994|NCT03810287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5585995|NCT03810287|Dopamine Agents|dopamine agents|mesh-ancestor
5585996|NCT03810287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5585997|NCT03810287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5585998|NCT03810105|Durvalumab|durvalumab|mesh-list
5585999|NCT03810105|Olaparib|olaparib|mesh-list
5586000|NCT03810105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5586001|NCT03810105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5586002|NCT03810105|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5586003|NCT03810105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5586004|NCT03810105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586005|NCT03810391|Butorphanol|butorphanol|mesh-list
5586006|NCT03810391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5586007|NCT03810391|Narcotics|narcotics|mesh-ancestor
5586008|NCT03810391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5586009|NCT03810391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586010|NCT03810391|Analgesics|analgesics|mesh-ancestor
5586011|NCT03810391|Sensory System Agents|sensory system agents|mesh-ancestor
5586012|NCT03810391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5586013|NCT03810391|Antitussive Agents|antitussive agents|mesh-ancestor
6196217|NCT01955629|Growth Substances|growth substances|mesh-ancestor
6196218|NCT01955629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196219|NCT01955629|Growth Inhibitors|growth inhibitors|mesh-ancestor
6196220|NCT01955707|Natalizumab|natalizumab|mesh-list
6196221|NCT01955707|Immunologic Factors|immunologic factors|mesh-ancestor
6196222|NCT01955707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196223|NCT01956123|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6196224|NCT01956123|Hormones|hormones|mesh-ancestor
6196225|NCT01956123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6196226|NCT01956123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586014|NCT03810391|Respiratory System Agents|respiratory system agents|mesh-ancestor
5586015|NCT03810391|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5605153|NCT03441282|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5605154|NCT03441282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5605155|NCT03441282|Anesthetics, General|anesthetics, general|mesh-ancestor
5605156|NCT03441282|Anesthetics|anesthetics|mesh-ancestor
5605157|NCT03432741|Gemcitabine|gemcitabine|mesh-list
5605158|NCT03432741|Deoxyglucose|deoxyglucose|mesh-list
5605159|NCT03432741|Rituximab|rituximab|mesh-list
5605160|NCT03432741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5605161|NCT03432741|Pembrolizumab|pembrolizumab|mesh-list
5605162|NCT03432741|Nivolumab|nivolumab|mesh-list
5605163|NCT03432741|Trastuzumab|trastuzumab|mesh-list
5605164|NCT03432741|Obinutuzumab|obinutuzumab|mesh-list
5605165|NCT03432741|Daratumumab|daratumumab|mesh-list
5605166|NCT03432741|Romidepsin|romidepsin|mesh-list
5605167|NCT03432741|Belinostat|belinostat|mesh-list
5605168|NCT03432741|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
5605169|NCT03432741|Antibodies|antibodies|mesh-list
5605170|NCT03432741|Immunoglobulins|immunoglobulins|mesh-list
5605171|NCT03432741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6196227|NCT01957150|Fluticasone|fluticasone|mesh-list
6196228|NCT01957150|Xhance|xhance|mesh-list
6196229|NCT01957150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6196230|NCT01957150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6196231|NCT01957150|Autonomic Agents|autonomic agents|mesh-ancestor
6196232|NCT01957150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6196233|NCT01957150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196234|NCT01957150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6196235|NCT01957150|Respiratory System Agents|respiratory system agents|mesh-ancestor
6196236|NCT01957150|Dermatologic Agents|dermatologic agents|mesh-ancestor
6196237|NCT01957150|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6196238|NCT01957202|Levocabastine|levocabastine|mesh-list
5605172|NCT03432741|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5605173|NCT03432741|Immunologic Factors|immunologic factors|mesh-ancestor
5605174|NCT03432741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672257|NCT01554956|Plasminogen|plasminogen|mesh-list
5586016|NCT03810209|Magnesium Sulfate|magnesium sulfate|mesh-list
5586017|NCT03810209|Analgesics|analgesics|mesh-ancestor
5586018|NCT03810209|Sensory System Agents|sensory system agents|mesh-ancestor
5586019|NCT03810209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5586020|NCT03810209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586021|NCT03810209|Anesthetics|anesthetics|mesh-ancestor
6196239|NCT01957202|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6196240|NCT01957202|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6196241|NCT01957202|Histamine Antagonists|histamine antagonists|mesh-ancestor
6196242|NCT01957202|Histamine Agents|histamine agents|mesh-ancestor
6196243|NCT01957202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6196244|NCT01957202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196245|NCT01957202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196246|NCT01957215|Indomethacin|indomethacin|mesh-list
6196247|NCT01957215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6196248|NCT01957215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6196249|NCT01957215|Analgesics|analgesics|mesh-ancestor
5586022|NCT03810209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5586023|NCT03810209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5586024|NCT03810209|Anticonvulsants|anticonvulsants|mesh-ancestor
5586025|NCT03810209|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5586026|NCT03810209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5586027|NCT03810209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196250|NCT01957215|Sensory System Agents|sensory system agents|mesh-ancestor
6196251|NCT01957215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6196252|NCT01957215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196253|NCT01957215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6196254|NCT01957215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6196255|NCT01957215|Gout Suppressants|gout suppressants|mesh-ancestor
5586028|NCT03810209|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5586029|NCT03810209|Tocolytic Agents|tocolytic agents|mesh-ancestor
5586030|NCT03810209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5586031|NCT03810066|Osimertinib|osimertinib|mesh-list
6196256|NCT01957215|Tocolytic Agents|tocolytic agents|mesh-ancestor
6196257|NCT01957215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6196258|NCT01957215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6196259|NCT01957215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6196260|NCT01957215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196261|NCT01957410|Ketamine|ketamine|mesh-list
6196262|NCT01957410|Analgesics|analgesics|mesh-ancestor
6196263|NCT01957410|Sensory System Agents|sensory system agents|mesh-ancestor
6196264|NCT01957410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6196265|NCT01957410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196266|NCT01957410|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6196267|NCT01957410|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5586032|NCT03810066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5586033|NCT03810066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5586034|NCT03810066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5586035|NCT03810066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586036|NCT03809949|Fentanyl|fentanyl|mesh-list
5586037|NCT03809949|Anesthetics|anesthetics|mesh-list
5586038|NCT03809949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5586039|NCT03809949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586040|NCT03809949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5586041|NCT03809949|Narcotics|narcotics|mesh-ancestor
5586042|NCT03809949|Analgesics|analgesics|mesh-ancestor
5586043|NCT03809949|Sensory System Agents|sensory system agents|mesh-ancestor
5586044|NCT03809949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6196268|NCT01957410|Anesthetics, General|anesthetics, general|mesh-ancestor
5586045|NCT03809949|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5586046|NCT03809949|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5586047|NCT03809949|Anesthetics, General|anesthetics, general|mesh-ancestor
5586048|NCT03809780|Dexamethasone|dexamethasone|mesh-list
5586049|NCT03809780|Lenalidomide|lenalidomide|mesh-list
5586050|NCT03809780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5586051|NCT03809780|Antiemetics|antiemetics|mesh-ancestor
5586052|NCT03809780|Autonomic Agents|autonomic agents|mesh-ancestor
5586053|NCT03809780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5586054|NCT03809780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586055|NCT03809780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5586056|NCT03809780|Glucocorticoids|glucocorticoids|mesh-ancestor
6196269|NCT01957410|Anesthetics|anesthetics|mesh-ancestor
6196270|NCT01957410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5586057|NCT03809780|Hormones|hormones|mesh-ancestor
6196271|NCT01957410|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6196272|NCT01957410|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6196273|NCT01957410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6196274|NCT01957410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207376|NCT02115282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6207377|NCT02115282|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6207378|NCT02115282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6207379|NCT02115282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6207380|NCT02115282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207381|NCT02115282|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6207382|NCT02115282|Hormone Antagonists|hormone antagonists|mesh-ancestor
6207383|NCT02115282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6207384|NCT02115282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207385|NCT02115282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6207386|NCT02115308|Regadenoson|regadenoson|mesh-list
6207387|NCT02115308|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
6207388|NCT02115308|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6207389|NCT02115308|Purinergic Agonists|purinergic agonists|mesh-ancestor
6207390|NCT02115308|Purinergic Agents|purinergic agents|mesh-ancestor
5586058|NCT03809780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5586059|NCT03809780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5586060|NCT03809780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5586061|NCT03809780|Immunologic Factors|immunologic factors|mesh-ancestor
5586062|NCT03809780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5586063|NCT03809780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5586064|NCT03809780|Growth Substances|growth substances|mesh-ancestor
5586065|NCT03809780|Growth Inhibitors|growth inhibitors|mesh-ancestor
5586066|NCT03809793|Acipimox|acipimox|mesh-list
5586067|NCT03809793|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5586068|NCT03809793|Antimetabolites|antimetabolites|mesh-ancestor
6207391|NCT02115308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6207392|NCT02115308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207393|NCT02115308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207394|NCT02115321|Grazoprevir|grazoprevir|mesh-list
6207395|NCT02115321|Antiviral Agents|antiviral agents|mesh-ancestor
6207396|NCT02115321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6207397|NCT02115347|Ertugliflozin|ertugliflozin|mesh-list
6207398|NCT02115347|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6207399|NCT02115347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207400|NCT02115347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6207401|NCT02115347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207402|NCT02115373|Tepotinib|tepotinib|mesh-list
6207403|NCT02115373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6207404|NCT02115581|Ubiquinone|ubiquinone|mesh-list
6207405|NCT02115581|Coenzyme Q10|coenzyme q10|mesh-list
6207406|NCT02115581|Micronutrients|micronutrients|mesh-ancestor
5586069|NCT03809793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586070|NCT03809793|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5586071|NCT03809702|Pregabalin|pregabalin|mesh-list
5586072|NCT03809702|Analgesics|analgesics|mesh-ancestor
5586073|NCT03809702|Sensory System Agents|sensory system agents|mesh-ancestor
5586074|NCT03809702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5586075|NCT03809702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586076|NCT03809702|Anticonvulsants|anticonvulsants|mesh-ancestor
6207407|NCT02115581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207408|NCT02115581|Vitamins|vitamins|mesh-ancestor
6207409|NCT02115750|Etanercept|etanercept|mesh-list
6207410|NCT02115750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6207411|NCT02115750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6207412|NCT02115750|Analgesics|analgesics|mesh-ancestor
6207413|NCT02115750|Sensory System Agents|sensory system agents|mesh-ancestor
6207414|NCT02115750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6207415|NCT02115750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207416|NCT02115750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6207417|NCT02115750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6207418|NCT02115750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6207419|NCT02115750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6207420|NCT02115750|Immunologic Factors|immunologic factors|mesh-ancestor
6207421|NCT02116205|Vaccines|vaccines|mesh-list
6207422|NCT02116205|Immunologic Factors|immunologic factors|mesh-ancestor
6207423|NCT02116205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207424|NCT02116309|Indomethacin|indomethacin|mesh-list
6207425|NCT02116309|Epinephrine|epinephrine|mesh-list
5586077|NCT03809702|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5586078|NCT03809702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6196275|NCT01957644|Azacitidine|azacitidine|mesh-list
6196276|NCT01957644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6196277|NCT01957644|Antimetabolites|antimetabolites|mesh-ancestor
6196278|NCT01957644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196279|NCT01957644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6196280|NCT01957644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6196281|NCT01957709|Interferons|interferons|mesh-list
6196282|NCT01957709|Interferon-gamma|interferon-gamma|mesh-list
6672258|NCT01554956|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6672259|NCT01554956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6672260|NCT01554956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672261|NCT01554969|Capecitabine|capecitabine|mesh-list
6672262|NCT01554969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6196283|NCT01957709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6196284|NCT01957709|Antiviral Agents|antiviral agents|mesh-ancestor
6196285|NCT01957709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5586079|NCT03809702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586080|NCT03809702|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5586081|NCT03809702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5586082|NCT03809702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5586083|NCT03809702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5586084|NCT03809702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5586085|NCT03810261|Vitamin D|vitamin d|mesh-list
5586086|NCT03810261|Ergocalciferols|ergocalciferols|mesh-list
5586087|NCT03810261|Vitamins|vitamins|mesh-list
5586088|NCT03810261|Micronutrients|micronutrients|mesh-ancestor
5586089|NCT03810261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586090|NCT03810261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5586091|NCT03810261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5586092|NCT03809897|Nicotine|nicotine|mesh-list
5586093|NCT03809897|Varenicline|varenicline|mesh-list
5586094|NCT03809897|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5586095|NCT03809897|Autonomic Agents|autonomic agents|mesh-ancestor
5586096|NCT03809897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5586097|NCT03809897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586098|NCT03809897|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5586099|NCT03809897|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6196286|NCT01957930|Insulin|insulin|mesh-list
6196287|NCT01957930|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6196288|NCT01957930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6196289|NCT01957930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586100|NCT03809897|Cholinergic Agents|cholinergic agents|mesh-ancestor
5586101|NCT03809897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5586102|NCT03809897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586103|NCT03809923|Lidocaine|lidocaine|mesh-list
5586104|NCT03809923|Dexmedetomidine|dexmedetomidine|mesh-list
5586105|NCT03809923|Anesthetics, Local|anesthetics, local|mesh-ancestor
5586106|NCT03809923|Anesthetics|anesthetics|mesh-ancestor
5586107|NCT03809923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5586108|NCT03809923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586109|NCT03809923|Sensory System Agents|sensory system agents|mesh-ancestor
5586110|NCT03809923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5586111|NCT03809923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5586112|NCT03809923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5586113|NCT03809923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5586114|NCT03809923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5586115|NCT03809923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586116|NCT03809923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5586117|NCT03809923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5586118|NCT03809923|Analgesics|analgesics|mesh-ancestor
5586119|NCT03809923|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5586120|NCT03809923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5586121|NCT03809923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5586122|NCT03809923|Adrenergic Agents|adrenergic agents|mesh-ancestor
6196290|NCT01958073|Estradiol|estradiol|mesh-list
6196291|NCT01958073|Estrogens|estrogens|mesh-list
6196292|NCT01958073|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6196293|NCT01958073|Hormones|hormones|mesh-ancestor
6196294|NCT01958073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6196295|NCT01958073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196296|NCT01958112|Trametinib|trametinib|mesh-list
6196297|NCT01958112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6196298|NCT01958112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6196299|NCT01958112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6207426|NCT02116309|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5586123|NCT03809923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5586124|NCT03809988|Letrozole|letrozole|mesh-list
5586125|NCT03809988|Fulvestrant|fulvestrant|mesh-list
5586126|NCT03809988|Palbociclib|palbociclib|mesh-list
5586127|NCT03809988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5586128|NCT03809988|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5586129|NCT03809988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5586130|NCT03809988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5586131|NCT03809988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586132|NCT03809988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5586133|NCT03809988|Hormone Antagonists|hormone antagonists|mesh-ancestor
5586134|NCT03809988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5586135|NCT03809988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586136|NCT03809988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5586137|NCT03809988|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5586138|NCT03809988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5586139|NCT03809637|Pemetrexed|pemetrexed|mesh-list
5586140|NCT03809637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5586141|NCT03809637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5586142|NCT03809637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586143|NCT03809637|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6196300|NCT01958112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196301|NCT01958164|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6196302|NCT01958164|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6196303|NCT01958164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6196304|NCT01958164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196305|NCT01958281|Sofosbuvir|sofosbuvir|mesh-list
6196306|NCT01958281|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
6196307|NCT01958281|Antiviral Agents|antiviral agents|mesh-ancestor
6196308|NCT01958281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6196309|NCT01958476|Morphine|morphine|mesh-list
6196310|NCT01958476|Methadone|methadone|mesh-list
6196311|NCT01958476|Phenobarbital|phenobarbital|mesh-list
6196312|NCT01958476|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6196313|NCT01958476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6196314|NCT01958476|Narcotics|narcotics|mesh-ancestor
6196315|NCT01958476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6196316|NCT01958476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196317|NCT01958476|Analgesics|analgesics|mesh-ancestor
6196318|NCT01958476|Sensory System Agents|sensory system agents|mesh-ancestor
6196319|NCT01958476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6196320|NCT01958476|Antitussive Agents|antitussive agents|mesh-ancestor
6196321|NCT01958476|Respiratory System Agents|respiratory system agents|mesh-ancestor
6196322|NCT01958476|Anticonvulsants|anticonvulsants|mesh-ancestor
5586144|NCT03809637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5586145|NCT03809650|Macitentan|macitentan|mesh-list
5586146|NCT03809650|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
5586147|NCT03809650|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5586148|NCT03809650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586149|NCT03809650|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
5586150|NCT03809546|Dronabinol|dronabinol|mesh-list
5586151|NCT03809546|Hallucinogens|hallucinogens|mesh-ancestor
5586152|NCT03809546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586153|NCT03809546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6196323|NCT01958476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6196324|NCT01958476|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6196325|NCT01958476|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6196326|NCT01958476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6196327|NCT01958476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196328|NCT01958476|GABA Modulators|gaba modulators|mesh-ancestor
6196329|NCT01958476|GABA Agents|gaba agents|mesh-ancestor
6196330|NCT01958476|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6196331|NCT01958476|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6196332|NCT01958476|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6196333|NCT01958489|Pravastatin|pravastatin|mesh-list
6196334|NCT01958489|Evacetrapib|evacetrapib|mesh-list
6196335|NCT01958489|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6196336|NCT01958489|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6196337|NCT01958489|Antimetabolites|antimetabolites|mesh-ancestor
6196338|NCT01958489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196339|NCT01958489|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6196340|NCT01958489|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6196341|NCT01958489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6196342|NCT01958619|Artefenomel|artefenomel|mesh-list
6196343|NCT01958619|Antimalarials|antimalarials|mesh-ancestor
6196344|NCT01958619|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6196345|NCT01958619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6196346|NCT01958619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6196347|NCT01958671|Metformin|metformin|mesh-list
6196348|NCT01958671|Glimepiride|glimepiride|mesh-list
6196349|NCT01958671|Ertugliflozin|ertugliflozin|mesh-list
6196350|NCT01958671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6196351|NCT01958671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196352|NCT01958671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6196353|NCT01958671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6196354|NCT01958671|Immunologic Factors|immunologic factors|mesh-ancestor
6196355|NCT01958671|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6196356|NCT01958671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196357|NCT01958827|Adalimumab|adalimumab|mesh-list
6196358|NCT01958827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6196359|NCT01958827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6196360|NCT01958918|Ranibizumab|ranibizumab|mesh-list
6196361|NCT01958918|Aflibercept|aflibercept|mesh-list
6196362|NCT01958918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6196363|NCT01958918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6196364|NCT01958918|Growth Substances|growth substances|mesh-ancestor
6196365|NCT01958918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196366|NCT01958918|Growth Inhibitors|growth inhibitors|mesh-ancestor
6196367|NCT01958918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6196368|NCT01959035|Aripiprazole|aripiprazole|mesh-list
6196369|NCT01959035|Antidepressive Agents|antidepressive agents|mesh-ancestor
5586154|NCT03809546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5586155|NCT03809546|Analgesics|analgesics|mesh-ancestor
5586156|NCT03809546|Sensory System Agents|sensory system agents|mesh-ancestor
5586157|NCT03809546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5586158|NCT03809546|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5586159|NCT03809546|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5586160|NCT03809546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5586161|NCT03809546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586162|NCT03809546|Hormones|hormones|mesh-ancestor
5586163|NCT03809546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5586164|NCT03809312|Amoxicillin|amoxicillin|mesh-list
5586165|NCT03809312|Clavulanic Acids|clavulanic acids|mesh-list
5586166|NCT03809312|Clavulanic Acid|clavulanic acid|mesh-list
5586167|NCT03809312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5586168|NCT03809312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5586169|NCT03809312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5586170|NCT03809312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586171|NCT03809312|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5586172|NCT03809442|Dexamethasone|dexamethasone|mesh-list
5586173|NCT03809442|Midazolam|midazolam|mesh-list
6196370|NCT01959035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6196371|NCT01959035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6196372|NCT01959035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6196373|NCT01959035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6196374|NCT01959035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586174|NCT03809442|Dexmedetomidine|dexmedetomidine|mesh-list
6196375|NCT01959035|Dopamine Agonists|dopamine agonists|mesh-ancestor
6196376|NCT01959035|Dopamine Agents|dopamine agents|mesh-ancestor
6196377|NCT01959035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6196378|NCT01959035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196379|NCT01959035|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6196380|NCT01959035|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6196381|NCT01959035|Serotonin Agents|serotonin agents|mesh-ancestor
6196382|NCT01959035|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6196383|NCT01959035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6196384|NCT01959035|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6196385|NCT01959035|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6196386|NCT01959230|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6196387|NCT01959230|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6196388|NCT01959230|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6196389|NCT01959230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6196390|NCT01959230|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6196391|NCT01959230|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6196392|NCT01959230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6196393|NCT01959230|Adrenergic Agents|adrenergic agents|mesh-ancestor
6196394|NCT01959230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6196395|NCT01959230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196396|NCT01959230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196397|NCT01959243|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6196398|NCT01959243|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6196399|NCT01959243|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6196400|NCT01959243|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6196401|NCT01959243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6196402|NCT01959243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6196403|NCT01959243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5586175|NCT03809442|Ketamine|ketamine|mesh-list
5586176|NCT03809442|Tramadol|tramadol|mesh-list
5586177|NCT03809442|Ropivacaine|ropivacaine|mesh-list
5586178|NCT03809442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5586179|NCT03809442|Antiemetics|antiemetics|mesh-ancestor
5586180|NCT03809442|Autonomic Agents|autonomic agents|mesh-ancestor
5586181|NCT03809442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6196404|NCT01959243|Adrenergic Agents|adrenergic agents|mesh-ancestor
6196405|NCT01959243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6196406|NCT01959243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196407|NCT01959243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196408|NCT01959334|Glucagon|glucagon|mesh-list
6196409|NCT01959334|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6196410|NCT01959334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6196411|NCT01959334|Hormones|hormones|mesh-ancestor
6196412|NCT01959334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6196413|NCT01959334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196414|NCT01959334|Incretins|incretins|mesh-ancestor
5586182|NCT03809442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586183|NCT03809442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6196415|NCT01959464|Progesterone|progesterone|mesh-list
6196416|NCT01959464|Progestins|progestins|mesh-ancestor
6196417|NCT01959464|Hormones|hormones|mesh-ancestor
6196418|NCT01959464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6196419|NCT01959464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196420|NCT01959490|Paclitaxel|paclitaxel|mesh-list
6196421|NCT01959490|Docetaxel|docetaxel|mesh-list
6196422|NCT01959490|Cyclophosphamide|cyclophosphamide|mesh-list
6196423|NCT01959490|Bevacizumab|bevacizumab|mesh-list
6196424|NCT01959490|Carboplatin|carboplatin|mesh-list
6196425|NCT01959490|Doxorubicin|doxorubicin|mesh-list
6196426|NCT01959490|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6196427|NCT01959490|Trastuzumab|trastuzumab|mesh-list
6196428|NCT01959490|Pertuzumab|pertuzumab|mesh-list
6488295|NCT00582920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586184|NCT03809442|Glucocorticoids|glucocorticoids|mesh-ancestor
5586185|NCT03809442|Hormones|hormones|mesh-ancestor
5586186|NCT03809442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5586187|NCT03809442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5586188|NCT03809442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5586189|NCT03809442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5586190|NCT03809442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5586191|NCT03809442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5586192|NCT03809442|Analgesics|analgesics|mesh-ancestor
5586193|NCT03809442|Sensory System Agents|sensory system agents|mesh-ancestor
5586194|NCT03809442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5586195|NCT03809442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6196429|NCT01959490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6196430|NCT01959490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6196431|NCT01959490|Tubulin Modulators|tubulin modulators|mesh-ancestor
6196432|NCT01959490|Antimitotic Agents|antimitotic agents|mesh-ancestor
6196433|NCT01959490|Mitosis Modulators|mitosis modulators|mesh-ancestor
6196434|NCT01959490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196435|NCT01959490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6196436|NCT01959490|Immunologic Factors|immunologic factors|mesh-ancestor
6196437|NCT01959490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196438|NCT01959490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6196439|NCT01959490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6196440|NCT01959490|Alkylating Agents|alkylating agents|mesh-ancestor
6196441|NCT01959490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6196442|NCT01959490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6196443|NCT01959490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6196444|NCT01959490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6196445|NCT01959490|Growth Substances|growth substances|mesh-ancestor
6196446|NCT01959490|Growth Inhibitors|growth inhibitors|mesh-ancestor
6196447|NCT01959490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6196448|NCT01959490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6196449|NCT01959490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6196450|NCT01959490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6196451|NCT01959503|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
5586196|NCT03809442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5586197|NCT03809442|Adrenergic Agents|adrenergic agents|mesh-ancestor
5586198|NCT03809442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5586199|NCT03809442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586200|NCT03809442|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5586201|NCT03809442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5586202|NCT03809442|Anesthetics, General|anesthetics, general|mesh-ancestor
5586203|NCT03809442|Anesthetics|anesthetics|mesh-ancestor
5586204|NCT03809442|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6196452|NCT01959503|Hemostatics|hemostatics|mesh-ancestor
6196453|NCT01959503|Coagulants|coagulants|mesh-ancestor
6196454|NCT01959516|Glycopyrrolate|glycopyrrolate|mesh-list
6196455|NCT01959516|Tiotropium Bromide|tiotropium bromide|mesh-list
6196456|NCT01959516|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6196457|NCT01959516|Autonomic Agents|autonomic agents|mesh-ancestor
6196458|NCT01959516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6196459|NCT01959516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196460|NCT01959516|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6196461|NCT01959516|Respiratory System Agents|respiratory system agents|mesh-ancestor
6196462|NCT01959516|Parasympatholytics|parasympatholytics|mesh-ancestor
6196463|NCT01959516|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6196464|NCT01959516|Cholinergic Agents|cholinergic agents|mesh-ancestor
6196465|NCT01959516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6196466|NCT01959516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196467|NCT01959516|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6196468|NCT01959516|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6196469|NCT01959529|Insulin|insulin|mesh-list
6196470|NCT01959529|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6196471|NCT01959529|Insulin Glargine|insulin glargine|mesh-list
6196472|NCT01959529|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6196473|NCT01959529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196474|NCT01959672|Calcium, Dietary|calcium, dietary|mesh-list
6196475|NCT01959672|Leucovorin|leucovorin|mesh-list
6196476|NCT01959672|Folic Acid|folic acid|mesh-list
6196477|NCT01959672|Gemcitabine|gemcitabine|mesh-list
6196478|NCT01959672|Nelfinavir|nelfinavir|mesh-list
6196479|NCT01959672|Fluorouracil|fluorouracil|mesh-list
6196480|NCT01959672|Oregovomab|oregovomab|mesh-list
5586205|NCT03809442|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5586206|NCT03809442|Anesthetics, Local|anesthetics, local|mesh-ancestor
5586207|NCT03809442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5586208|NCT03809442|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5586209|NCT03809442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5586210|NCT03809442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5586211|NCT03809442|GABA Modulators|gaba modulators|mesh-ancestor
5586212|NCT03809442|GABA Agents|gaba agents|mesh-ancestor
5586213|NCT03809442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5586214|NCT03809442|Narcotics|narcotics|mesh-ancestor
5586215|NCT03809455|Fentanyl|fentanyl|mesh-list
5586216|NCT03809455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5586217|NCT03809455|Narcotics|narcotics|mesh-ancestor
6196481|NCT01959672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6196482|NCT01959672|Antibodies|antibodies|mesh-list
5586218|NCT03809455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6196483|NCT01959672|Immunoglobulins|immunoglobulins|mesh-list
6196484|NCT01959672|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6196485|NCT01959672|Calcium|calcium|mesh-list
6196486|NCT01959672|Levoleucovorin|levoleucovorin|mesh-list
6196487|NCT01959672|Immunologic Factors|immunologic factors|mesh-ancestor
6196488|NCT01959672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196489|NCT01959672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6196490|NCT01959672|Antimetabolites|antimetabolites|mesh-ancestor
6196491|NCT01959672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196492|NCT01959672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6196493|NCT01959672|Antiviral Agents|antiviral agents|mesh-ancestor
6196494|NCT01959672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6196495|NCT01959672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6196496|NCT01959672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6196497|NCT01959672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6196498|NCT01959672|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6196499|NCT01959672|Antidotes|antidotes|mesh-ancestor
6196500|NCT01959672|Protective Agents|protective agents|mesh-ancestor
6196501|NCT01959672|Vitamin B Complex|vitamin b complex|mesh-ancestor
6196502|NCT01959672|Vitamins|vitamins|mesh-ancestor
6196503|NCT01959672|Micronutrients|micronutrients|mesh-ancestor
6196504|NCT01959672|Hematinics|hematinics|mesh-ancestor
6196505|NCT01959672|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6196506|NCT01959672|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6196507|NCT01959672|Protease Inhibitors|protease inhibitors|mesh-ancestor
5586219|NCT03809455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586220|NCT03809455|Analgesics|analgesics|mesh-ancestor
5586221|NCT03809455|Sensory System Agents|sensory system agents|mesh-ancestor
5586222|NCT03809455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5586223|NCT03809455|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5586224|NCT03809455|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5586225|NCT03809455|Anesthetics, General|anesthetics, general|mesh-ancestor
5586226|NCT03809455|Anesthetics|anesthetics|mesh-ancestor
5586227|NCT03809325|Paliperidone Palmitate|paliperidone palmitate|mesh-list
5586228|NCT03809325|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5586229|NCT03809325|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5586230|NCT03809325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5586231|NCT03809325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586232|NCT03809325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5586233|NCT03809325|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5586234|NCT03809325|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5586235|NCT03809325|Serotonin Agents|serotonin agents|mesh-ancestor
6196508|NCT01959672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6196509|NCT01959672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6196510|NCT01959685|Enclomiphene|enclomiphene|mesh-list
6196511|NCT01959685|Clomiphene|clomiphene|mesh-list
6196512|NCT01959685|Zuclomiphene|zuclomiphene|mesh-list
6196513|NCT01959685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6196514|NCT01959685|Hormone Antagonists|hormone antagonists|mesh-ancestor
6196515|NCT01959685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6196516|NCT01959685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196517|NCT01959685|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6196518|NCT01959685|Fertility Agents|fertility agents|mesh-ancestor
6196519|NCT01959685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6196520|NCT01959685|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6196521|NCT01959685|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6196522|NCT01959698|Rituximab|rituximab|mesh-list
6196523|NCT01959698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6196524|NCT01959698|Carboplatin|carboplatin|mesh-list
6196525|NCT01959698|Etoposide|etoposide|mesh-list
6196526|NCT01959698|Etoposide phosphate|etoposide phosphate|mesh-list
6196527|NCT01959698|Ifosfamide|ifosfamide|mesh-list
6196528|NCT01959698|Isophosphamide mustard|isophosphamide mustard|mesh-list
6196529|NCT01959698|Podophyllotoxin|podophyllotoxin|mesh-list
6196530|NCT01959698|Antibodies|antibodies|mesh-list
6196531|NCT01959698|Immunoglobulins|immunoglobulins|mesh-list
6196532|NCT01959698|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6196533|NCT01959698|Immunologic Factors|immunologic factors|mesh-ancestor
6196534|NCT01959698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196535|NCT01959698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6196536|NCT01959698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6196537|NCT01959698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6196538|NCT01959698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6196539|NCT01959698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6196540|NCT01959698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6196541|NCT01959698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196542|NCT01959698|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5586236|NCT03809325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6196543|NCT01959698|Alkylating Agents|alkylating agents|mesh-ancestor
6196544|NCT01959698|Keratolytic Agents|keratolytic agents|mesh-ancestor
6196545|NCT01959698|Dermatologic Agents|dermatologic agents|mesh-ancestor
5586237|NCT03809325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586238|NCT03809325|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5586239|NCT03809325|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5586240|NCT03809325|Dopamine Agents|dopamine agents|mesh-ancestor
5586241|NCT03809260|Metformin|metformin|mesh-list
5586242|NCT03809260|Vancomycin|vancomycin|mesh-list
5586243|NCT03809260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6196546|NCT01959698|Tubulin Modulators|tubulin modulators|mesh-ancestor
6196547|NCT01959698|Antimitotic Agents|antimitotic agents|mesh-ancestor
6196548|NCT01959698|Mitosis Modulators|mitosis modulators|mesh-ancestor
6196549|NCT01959841|Valacyclovir|valacyclovir|mesh-list
6196550|NCT01959841|Antiviral Agents|antiviral agents|mesh-ancestor
6196551|NCT01959841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6196552|NCT01959919|Factor VIII|factor viii|mesh-list
6196553|NCT01959919|Coagulants|coagulants|mesh-ancestor
6196554|NCT01959945|Vaccines|vaccines|mesh-list
6196555|NCT01959945|Hemagglutinins|hemagglutinins|mesh-list
6196556|NCT01959945|Immunologic Factors|immunologic factors|mesh-ancestor
6196557|NCT01959945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196558|NCT01959945|Agglutinins|agglutinins|mesh-ancestor
6196559|NCT01960075|Fosphenytoin|fosphenytoin|mesh-list
6196560|NCT01960075|Levetiracetam|levetiracetam|mesh-list
6196561|NCT01960075|Valproic Acid|valproic acid|mesh-list
5586244|NCT03809260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586245|NCT03809260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5586246|NCT03809260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5586247|NCT03809273|Trimetazidine|trimetazidine|mesh-list
5586248|NCT03809273|Vasodilator Agents|vasodilator agents|mesh-ancestor
5586249|NCT03809065|Labetalol|labetalol|mesh-list
5586250|NCT03809065|Nitroglycerin|nitroglycerin|mesh-list
5586251|NCT03809065|Vasodilator Agents|vasodilator agents|mesh-ancestor
5586252|NCT03809065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5586253|NCT03809065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5586254|NCT03809065|Adrenergic Agents|adrenergic agents|mesh-ancestor
5586255|NCT03809065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5586256|NCT03809065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586257|NCT03809065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586258|NCT03809065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5586259|NCT03809065|Sympathomimetics|sympathomimetics|mesh-ancestor
5586260|NCT03809065|Autonomic Agents|autonomic agents|mesh-ancestor
5586261|NCT03809065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5586262|NCT03809065|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5586263|NCT03809065|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6196562|NCT01960075|Anticonvulsants|anticonvulsants|mesh-ancestor
6196563|NCT01960075|Nootropic Agents|nootropic agents|mesh-ancestor
6196564|NCT01960075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6196565|NCT01960075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196566|NCT01960075|GABA Agents|gaba agents|mesh-ancestor
6196567|NCT01960075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6196568|NCT01960075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196569|NCT01960075|Antimanic Agents|antimanic agents|mesh-ancestor
6196570|NCT01960075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6196571|NCT01960075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6196572|NCT01960075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6196573|NCT01960075|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6196574|NCT01960075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6196575|NCT01960114|Acetaminophen|acetaminophen|mesh-list
6196576|NCT01960114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6196577|NCT01960114|Analgesics|analgesics|mesh-ancestor
6196578|NCT01960114|Sensory System Agents|sensory system agents|mesh-ancestor
6196579|NCT01960114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6196580|NCT01960114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196581|NCT01960114|Antipyretics|antipyretics|mesh-ancestor
6196582|NCT01960140|Simvastatin|simvastatin|mesh-list
6196583|NCT01960140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6196584|NCT01960140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6196585|NCT01960140|Antimetabolites|antimetabolites|mesh-ancestor
6196586|NCT01960140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196587|NCT01960140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6196588|NCT01960140|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6196589|NCT01960140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6196590|NCT01960296|Clopidogrel|clopidogrel|mesh-list
6196591|NCT01960296|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6196592|NCT01960296|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6196593|NCT01960296|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6207427|NCT02116309|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6196594|NCT01960296|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6196595|NCT01960296|Purinergic Agents|purinergic agents|mesh-ancestor
6196596|NCT01960296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6196597|NCT01960296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196598|NCT01960296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196599|NCT01960387|Cytarabine|cytarabine|mesh-list
6196600|NCT01960387|Clofarabine|clofarabine|mesh-list
6196601|NCT01960387|Antimetabolites|antimetabolites|mesh-list
6196602|NCT01960387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6196603|NCT01960387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196604|NCT01960387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6196605|NCT01960387|Antiviral Agents|antiviral agents|mesh-ancestor
6196606|NCT01960387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6196607|NCT01960387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6196608|NCT01960387|Immunologic Factors|immunologic factors|mesh-ancestor
6196609|NCT01960387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196610|NCT01960413|Hydroxyurea|hydroxyurea|mesh-list
6196611|NCT01960413|Montelukast|montelukast|mesh-list
6196612|NCT01960413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6196613|NCT01960413|Respiratory System Agents|respiratory system agents|mesh-ancestor
6196614|NCT01960413|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6196615|NCT01960413|Hormone Antagonists|hormone antagonists|mesh-ancestor
6196616|NCT01960413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6196617|NCT01960413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586264|NCT03808961|Vitamins|vitamins|mesh-list
5586265|NCT03808961|Niacin|niacin|mesh-list
5586266|NCT03808961|Niacinamide|niacinamide|mesh-list
5586267|NCT03808961|Nicotinic Acids|nicotinic acids|mesh-list
5586268|NCT03808961|Vitamin B Complex|vitamin b complex|mesh-list
5586269|NCT03808961|Micronutrients|micronutrients|mesh-ancestor
5586270|NCT03808961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586271|NCT03808961|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5586272|NCT03808961|Antimetabolites|antimetabolites|mesh-ancestor
5586273|NCT03808961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586274|NCT03808961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5586275|NCT03808961|Vasodilator Agents|vasodilator agents|mesh-ancestor
5586276|NCT03809143|Buprenorphine|buprenorphine|mesh-list
5586277|NCT03809143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5586278|NCT03809143|Narcotics|narcotics|mesh-ancestor
5586279|NCT03809143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5586280|NCT03809143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586281|NCT03809143|Analgesics|analgesics|mesh-ancestor
5586282|NCT03809143|Sensory System Agents|sensory system agents|mesh-ancestor
5586283|NCT03809143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5586284|NCT03809143|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5586285|NCT03809221|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5586286|NCT03809221|Hormones|hormones|mesh-list
5586287|NCT03809221|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5586288|NCT03809221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5586289|NCT03809221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586290|NCT03809221|Luteolytic Agents|luteolytic agents|mesh-ancestor
5586291|NCT03809221|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5586292|NCT03809221|Contraceptive Agents|contraceptive agents|mesh-ancestor
5586293|NCT03809221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5586294|NCT03809221|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6196618|NCT01960413|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6196619|NCT01960413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6196620|NCT01960413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196621|NCT01960413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6196622|NCT01960413|Antisickling Agents|antisickling agents|mesh-ancestor
6196623|NCT01960413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6196624|NCT01960413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6196625|NCT01960530|Dexamethasone|dexamethasone|mesh-list
6196626|NCT01960530|Hydrocortisone|hydrocortisone|mesh-list
6196627|NCT01960530|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
5586295|NCT03809221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5586296|NCT03809221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5586297|NCT03809156|Ambrisentan|ambrisentan|mesh-list
5586298|NCT03809156|Riociguat|riociguat|mesh-list
5586299|NCT03809156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5586300|NCT03809156|Enzyme Activators|enzyme activators|mesh-ancestor
5586301|NCT03809156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586302|NCT03808844|Propofol|propofol|mesh-list
5586303|NCT03808844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5586304|NCT03808844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6196628|NCT01960530|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6196629|NCT01960530|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6196630|NCT01960530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6196631|NCT01960530|Antiemetics|antiemetics|mesh-ancestor
6196632|NCT01960530|Autonomic Agents|autonomic agents|mesh-ancestor
6196633|NCT01960530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6196634|NCT01960530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196635|NCT01960530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6196636|NCT01960530|Glucocorticoids|glucocorticoids|mesh-ancestor
6196637|NCT01960530|Hormones|hormones|mesh-ancestor
6196638|NCT01960530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6196639|NCT01960530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6196640|NCT01960530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5586305|NCT03808844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586306|NCT03808844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5586307|NCT03808844|Anesthetics, General|anesthetics, general|mesh-ancestor
5586308|NCT03808844|Anesthetics|anesthetics|mesh-ancestor
5586309|NCT03809078|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5586310|NCT03809078|Bombesin|bombesin|mesh-list
5586311|NCT03809078|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5586312|NCT03809078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586313|NCT03809078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5586314|NCT03809078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586315|NCT03809234|Ondansetron|ondansetron|mesh-list
6196641|NCT01960842|Levodopa|levodopa|mesh-list
6196642|NCT01960842|Carbidopa|carbidopa|mesh-list
6196643|NCT01960842|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
6196644|NCT01960842|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6196645|NCT01960842|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6196646|NCT01960842|Dopamine Agents|dopamine agents|mesh-ancestor
6196647|NCT01960842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6196648|NCT01960842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196649|NCT01960842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196650|NCT01960842|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6196651|NCT01960842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6196652|NCT01960842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6196653|NCT01960842|Immunologic Factors|immunologic factors|mesh-ancestor
6196654|NCT01960842|Dopamine Agonists|dopamine agonists|mesh-ancestor
6196655|NCT01960855|Upadacitinib|upadacitinib|mesh-list
6196656|NCT01960855|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
6196657|NCT01960855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5586316|NCT03809234|Antiemetics|antiemetics|mesh-ancestor
5586317|NCT03809234|Autonomic Agents|autonomic agents|mesh-ancestor
6196658|NCT01960855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6196659|NCT01960855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196660|NCT01960855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6196661|NCT01961271|Buprenorphine|buprenorphine|mesh-list
6196662|NCT01961271|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6196663|NCT01961271|Narcotics|narcotics|mesh-ancestor
6196664|NCT01961271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6196665|NCT01961271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196666|NCT01961271|Analgesics|analgesics|mesh-ancestor
5586318|NCT03809234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5586319|NCT03809234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586320|NCT03809234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5586321|NCT03809234|Antipruritics|antipruritics|mesh-ancestor
5586322|NCT03809234|Dermatologic Agents|dermatologic agents|mesh-ancestor
5586323|NCT03809234|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5586324|NCT03809234|Serotonin Agents|serotonin agents|mesh-ancestor
5586325|NCT03809234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5586326|NCT03809234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586327|NCT03809234|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5586328|NCT03809234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5586329|NCT03809234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5586330|NCT03809234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5586331|NCT03809234|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5586332|NCT03808818|Nicotine|nicotine|mesh-list
5586333|NCT03808818|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5586334|NCT03808818|Autonomic Agents|autonomic agents|mesh-ancestor
5586335|NCT03808818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5586336|NCT03808818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586337|NCT03808818|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5586338|NCT03808818|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5586339|NCT03808818|Cholinergic Agents|cholinergic agents|mesh-ancestor
5586340|NCT03808818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5586341|NCT03808818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586342|NCT03808805|Aprepitant|aprepitant|mesh-list
5586343|NCT03808805|Fosaprepitant|fosaprepitant|mesh-list
5586344|NCT03808805|Hydroxyzine|hydroxyzine|mesh-list
5586345|NCT03808805|Antiemetics|antiemetics|mesh-ancestor
5586346|NCT03808805|Autonomic Agents|autonomic agents|mesh-ancestor
5586347|NCT03808805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5586348|NCT03808805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586349|NCT03808805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5586350|NCT03808805|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5586351|NCT03808805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5586352|NCT03808805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586353|NCT03808805|Antipruritics|antipruritics|mesh-ancestor
6196667|NCT01961271|Sensory System Agents|sensory system agents|mesh-ancestor
6196668|NCT01961271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6196669|NCT01961271|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6196670|NCT01961297|Sodium Oxybate|sodium oxybate|mesh-list
6196671|NCT01961297|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6196672|NCT01961297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6196673|NCT01961297|Anesthetics, General|anesthetics, general|mesh-ancestor
6196674|NCT01961297|Anesthetics|anesthetics|mesh-ancestor
6196675|NCT01961297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5586354|NCT03808805|Dermatologic Agents|dermatologic agents|mesh-ancestor
5586355|NCT03808805|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5586356|NCT03808805|Histamine Antagonists|histamine antagonists|mesh-ancestor
5586357|NCT03808805|Histamine Agents|histamine agents|mesh-ancestor
5586358|NCT03808740|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
5586359|NCT03808740|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5586360|NCT03808740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5586361|NCT03808740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5586362|NCT03808740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586363|NCT03808740|Adrenergic Agents|adrenergic agents|mesh-ancestor
5586364|NCT03808740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5586365|NCT03808740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586366|NCT03808649|Mannitol|mannitol|mesh-list
5586367|NCT03808649|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5586368|NCT03808649|Diuretics|diuretics|mesh-ancestor
5586369|NCT03808649|Natriuretic Agents|natriuretic agents|mesh-ancestor
5586370|NCT03808649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605175|NCT03432741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605176|NCT03432741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5605177|NCT03432741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5605178|NCT03432741|Antimetabolites|antimetabolites|mesh-ancestor
6196676|NCT01961297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586371|NCT03808480|Nivolumab|nivolumab|mesh-list
5586372|NCT03808480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5586373|NCT03808480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5586374|NCT03808480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5586375|NCT03808480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586376|NCT03808168|Nivolumab|nivolumab|mesh-list
5586377|NCT03808168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5586378|NCT03808168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5586379|NCT03808168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5586380|NCT03808168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586381|NCT03808142|Interferon beta-1b|interferon beta-1b|mesh-list
5586382|NCT03808142|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5586383|NCT03808142|Immunologic Factors|immunologic factors|mesh-ancestor
5586384|NCT03808142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586385|NCT03808259|Ketamine|ketamine|mesh-list
5586386|NCT03808259|Esketamine|esketamine|mesh-list
6196677|NCT01961323|Nebivolol|nebivolol|mesh-list
6196678|NCT01961323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6196679|NCT01961323|Vasodilator Agents|vasodilator agents|mesh-ancestor
6196680|NCT01961323|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5586387|NCT03808259|Analgesics|analgesics|mesh-ancestor
5586388|NCT03808259|Sensory System Agents|sensory system agents|mesh-ancestor
5586389|NCT03808259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5586390|NCT03808259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586391|NCT03808259|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5586392|NCT03808259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5586393|NCT03808259|Anesthetics, General|anesthetics, general|mesh-ancestor
5586394|NCT03808259|Anesthetics|anesthetics|mesh-ancestor
5586395|NCT03808259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5586396|NCT03808259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5586397|NCT03808259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5586398|NCT03808259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5586399|NCT03808259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586400|NCT03808259|Antidepressive Agents|antidepressive agents|mesh-ancestor
5586401|NCT03808259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5586402|NCT03808129|Lidocaine|lidocaine|mesh-list
5586403|NCT03808129|Bupivacaine|bupivacaine|mesh-list
5586404|NCT03808129|Anesthetics, Local|anesthetics, local|mesh-ancestor
5586405|NCT03808129|Anesthetics|anesthetics|mesh-ancestor
5586406|NCT03808129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5586407|NCT03808129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586408|NCT03808129|Sensory System Agents|sensory system agents|mesh-ancestor
5586409|NCT03808129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5586410|NCT03808129|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6196681|NCT01961323|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6196682|NCT01961323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6196683|NCT01961323|Adrenergic Agents|adrenergic agents|mesh-ancestor
6196684|NCT01961323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6196685|NCT01961323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196686|NCT01961323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196687|NCT01961349|Propofol|propofol|mesh-list
6196688|NCT01961349|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6196689|NCT01961349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6196690|NCT01961349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6196691|NCT01961349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196692|NCT01961349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6196693|NCT01961349|Anesthetics, General|anesthetics, general|mesh-ancestor
6196694|NCT01961349|Anesthetics|anesthetics|mesh-ancestor
6196695|NCT01961349|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6196696|NCT01961349|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6196697|NCT01961349|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6196698|NCT01962103|Paclitaxel|paclitaxel|mesh-list
6196699|NCT01962103|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6196700|NCT01962103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6196701|NCT01962103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6196702|NCT01962103|Tubulin Modulators|tubulin modulators|mesh-ancestor
6196703|NCT01962103|Antimitotic Agents|antimitotic agents|mesh-ancestor
6196704|NCT01962103|Mitosis Modulators|mitosis modulators|mesh-ancestor
6196705|NCT01962103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196706|NCT01962298|Rocuronium|rocuronium|mesh-list
6196707|NCT01962298|Neostigmine|neostigmine|mesh-list
6196708|NCT01962298|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6196709|NCT01962298|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6196710|NCT01962298|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6196711|NCT01962298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6196712|NCT01962298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196713|NCT01962298|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6196714|NCT01962298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6196715|NCT01962298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196716|NCT01962298|Cholinergic Agents|cholinergic agents|mesh-ancestor
6196717|NCT01962298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6196718|NCT01962298|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6196719|NCT01962298|Autonomic Agents|autonomic agents|mesh-ancestor
6196720|NCT01962428|Ticagrelor|ticagrelor|mesh-list
6196721|NCT01962428|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6196722|NCT01962428|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6196723|NCT01962428|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6196724|NCT01962428|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6196725|NCT01962428|Purinergic Agents|purinergic agents|mesh-ancestor
6196726|NCT01962428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6196727|NCT01962428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196728|NCT01962428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196729|NCT01962441|Sofosbuvir|sofosbuvir|mesh-list
6196730|NCT01962441|Antiviral Agents|antiviral agents|mesh-ancestor
6196731|NCT01962441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6196732|NCT01962493|Chlorhexidine|chlorhexidine|mesh-list
5586411|NCT03808129|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5586412|NCT03808129|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5586413|NCT03808129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5586414|NCT03808129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586415|NCT03808155|Tamsulosin|tamsulosin|mesh-list
5586416|NCT03808155|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5586417|NCT03808155|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5586418|NCT03808155|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6196733|NCT01962493|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6196734|NCT01962493|Listerine|listerine|mesh-list
6196735|NCT01962493|Fluorides|fluorides|mesh-list
6196736|NCT01962493|Sodium Fluoride|sodium fluoride|mesh-list
6196737|NCT01962493|Cariostatic Agents|cariostatic agents|mesh-ancestor
6196738|NCT01962493|Protective Agents|protective agents|mesh-ancestor
6196739|NCT01962493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196740|NCT01962493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6196741|NCT01962493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6196742|NCT01962493|Disinfectants|disinfectants|mesh-ancestor
6196743|NCT01962493|Dermatologic Agents|dermatologic agents|mesh-ancestor
6196744|NCT01962688|Diuretics|diuretics|mesh-list
6196745|NCT01962688|Natriuretic Agents|natriuretic agents|mesh-ancestor
6196746|NCT01962688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207428|NCT02116309|Adrenergic Agents|adrenergic agents|mesh-ancestor
6207429|NCT02116309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6207430|NCT02116309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207431|NCT02116309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207432|NCT02116309|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6207433|NCT02116309|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6207434|NCT02116309|Autonomic Agents|autonomic agents|mesh-ancestor
6207435|NCT02116309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6207436|NCT02116309|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6207437|NCT02116309|Respiratory System Agents|respiratory system agents|mesh-ancestor
6207438|NCT02116309|Mydriatics|mydriatics|mesh-ancestor
6207439|NCT02116309|Sympathomimetics|sympathomimetics|mesh-ancestor
6207440|NCT02116309|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6207441|NCT02116309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6207442|NCT02116309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6207443|NCT02116309|Analgesics|analgesics|mesh-ancestor
6207444|NCT02116309|Sensory System Agents|sensory system agents|mesh-ancestor
6207445|NCT02116309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6207446|NCT02116309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6207447|NCT02116309|Gout Suppressants|gout suppressants|mesh-ancestor
6207448|NCT02116309|Tocolytic Agents|tocolytic agents|mesh-ancestor
6488296|NCT00582985|Antibodies|antibodies|mesh-list
5586419|NCT03808155|Adrenergic Agents|adrenergic agents|mesh-ancestor
5586420|NCT03808155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5586421|NCT03808155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586422|NCT03808155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586423|NCT03808155|Urological Agents|urological agents|mesh-ancestor
5586424|NCT03807999|Gemcitabine|gemcitabine|mesh-list
5586425|NCT03807999|Paclitaxel|paclitaxel|mesh-list
5586426|NCT03807999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5586427|NCT03807999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6196747|NCT01962870|Vasopressins|vasopressins|mesh-list
6196748|NCT01962870|Arginine Vasopressin|arginine vasopressin|mesh-list
6196749|NCT01962870|Hemostatics|hemostatics|mesh-ancestor
6196750|NCT01962870|Coagulants|coagulants|mesh-ancestor
6196751|NCT01962870|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6196752|NCT01962870|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6196753|NCT01962870|Natriuretic Agents|natriuretic agents|mesh-ancestor
6196754|NCT01962870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196755|NCT01962896|Sirolimus|sirolimus|mesh-list
6196756|NCT01962896|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6196757|NCT01962896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6672263|NCT01554969|Antimetabolites|antimetabolites|mesh-ancestor
6672264|NCT01554969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672265|NCT01554969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6672266|NCT01554995|Linezolid|linezolid|mesh-list
6672267|NCT01554995|Delpazolid|delpazolid|mesh-list
6672268|NCT01554995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5586428|NCT03807999|Tubulin Modulators|tubulin modulators|mesh-ancestor
5586429|NCT03807999|Antimitotic Agents|antimitotic agents|mesh-ancestor
5586430|NCT03807999|Mitosis Modulators|mitosis modulators|mesh-ancestor
5586431|NCT03807999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586432|NCT03807999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5586433|NCT03807999|Antimetabolites|antimetabolites|mesh-ancestor
5586434|NCT03807999|Antiviral Agents|antiviral agents|mesh-ancestor
5586435|NCT03807999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5586436|NCT03807999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5586437|NCT03807999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5586438|NCT03807999|Immunologic Factors|immunologic factors|mesh-ancestor
5586439|NCT03807999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586440|NCT03807921|Aspirin|aspirin|mesh-list
5586441|NCT03807921|Warfarin|warfarin|mesh-list
5586442|NCT03807921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5586443|NCT03807921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5586444|NCT03807921|Analgesics|analgesics|mesh-ancestor
5586445|NCT03807921|Sensory System Agents|sensory system agents|mesh-ancestor
5586446|NCT03807921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5586447|NCT03807921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586448|NCT03807921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5586449|NCT03807921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5586450|NCT03807921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5586451|NCT03807921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5586452|NCT03807921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586453|NCT03807921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5586454|NCT03807921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5586455|NCT03807921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5586456|NCT03807921|Antipyretics|antipyretics|mesh-ancestor
5586457|NCT03807921|Anticoagulants|anticoagulants|mesh-ancestor
5586458|NCT03807596|Hyaluronic Acid|hyaluronic acid|mesh-list
5586459|NCT03807596|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5586460|NCT03807596|Immunologic Factors|immunologic factors|mesh-ancestor
6196758|NCT01962896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6196759|NCT01962896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6196760|NCT01962896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196761|NCT01962896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6196762|NCT01962896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6196763|NCT01962896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6196764|NCT01962896|Antifungal Agents|antifungal agents|mesh-ancestor
6196765|NCT01962896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6196766|NCT01962896|Immunologic Factors|immunologic factors|mesh-ancestor
5586461|NCT03807596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586462|NCT03807596|Viscosupplements|viscosupplements|mesh-ancestor
5586463|NCT03807596|Protective Agents|protective agents|mesh-ancestor
5586464|NCT03807856|Dabigatran|dabigatran|mesh-list
5586465|NCT03807856|Antithrombins|antithrombins|mesh-ancestor
5586466|NCT03807856|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5586467|NCT03807856|Protease Inhibitors|protease inhibitors|mesh-ancestor
5586468|NCT03807856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5586469|NCT03807856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586470|NCT03807856|Anticoagulants|anticoagulants|mesh-ancestor
5586471|NCT03807843|Vaccines|vaccines|mesh-list
5586472|NCT03807843|Immunologic Factors|immunologic factors|mesh-ancestor
5586473|NCT03807843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586474|NCT03807882|Clozapine|clozapine|mesh-list
5586475|NCT03807882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6196767|NCT01962896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672269|NCT01554995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6672270|NCT01554995|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5586476|NCT03807882|Serotonin Agents|serotonin agents|mesh-ancestor
5586477|NCT03807882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5586478|NCT03807882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586479|NCT03807882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586480|NCT03807882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5586481|NCT03807882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6196768|NCT01962922|Tacrolimus|tacrolimus|mesh-list
6196769|NCT01962922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6196770|NCT01962922|Immunologic Factors|immunologic factors|mesh-ancestor
6196771|NCT01962922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196772|NCT01962922|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6196773|NCT01962922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6196774|NCT01962922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196775|NCT01962961|Acetylcysteine|acetylcysteine|mesh-list
6196776|NCT01962961|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6196777|NCT01962961|Antiviral Agents|antiviral agents|mesh-ancestor
6196778|NCT01962961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6196779|NCT01962961|Expectorants|expectorants|mesh-ancestor
6196780|NCT01962961|Respiratory System Agents|respiratory system agents|mesh-ancestor
6196781|NCT01962961|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6196782|NCT01962961|Antioxidants|antioxidants|mesh-ancestor
6196783|NCT01962961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196784|NCT01962961|Protective Agents|protective agents|mesh-ancestor
6196785|NCT01962961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196786|NCT01962961|Antidotes|antidotes|mesh-ancestor
6196787|NCT01962987|Diclofenac|diclofenac|mesh-list
6196788|NCT01962987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6196789|NCT01962987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6196790|NCT01962987|Analgesics|analgesics|mesh-ancestor
5586482|NCT03807882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5586483|NCT03807882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5586484|NCT03807882|GABA Antagonists|gaba antagonists|mesh-ancestor
5586485|NCT03807882|GABA Agents|gaba agents|mesh-ancestor
5586486|NCT03807297|Dexmedetomidine|dexmedetomidine|mesh-list
5586487|NCT03807297|Nitrous Oxide|nitrous oxide|mesh-list
5586488|NCT03807297|Propofol|propofol|mesh-list
5586489|NCT03807297|Sevoflurane|sevoflurane|mesh-list
5586490|NCT03807297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5586491|NCT03807297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5586492|NCT03807297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196791|NCT01962987|Sensory System Agents|sensory system agents|mesh-ancestor
6196792|NCT01962987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6196793|NCT01962987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196794|NCT01962987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6196795|NCT01962987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6196796|NCT01962987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6196797|NCT01962987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6196798|NCT01962987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196799|NCT01963078|Oxytocin|oxytocin|mesh-list
6196800|NCT01963078|Oxytocics|oxytocics|mesh-ancestor
6196801|NCT01963078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6196802|NCT01963078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196803|NCT01963091|Oxytocin|oxytocin|mesh-list
6196804|NCT01963091|Oxytocics|oxytocics|mesh-ancestor
6196805|NCT01963091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6196806|NCT01963091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196807|NCT01963143|gamma-Globulins|gamma-globulins|mesh-list
6196808|NCT01963143|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6196809|NCT01963143|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6196810|NCT01963143|Immunologic Factors|immunologic factors|mesh-ancestor
6196811|NCT01963143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196812|NCT01963481|Cyclophosphamide|cyclophosphamide|mesh-list
6196813|NCT01963481|Exemestane|exemestane|mesh-list
6196814|NCT01963481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6196815|NCT01963481|Immunologic Factors|immunologic factors|mesh-ancestor
6196816|NCT01963481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196817|NCT01963481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6196818|NCT01963481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6196819|NCT01963481|Alkylating Agents|alkylating agents|mesh-ancestor
6196820|NCT01963481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196821|NCT01963481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6196822|NCT01963481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6196823|NCT01963481|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6196824|NCT01963481|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5586493|NCT03807297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5586494|NCT03807297|Anesthetics, General|anesthetics, general|mesh-ancestor
5586495|NCT03807297|Anesthetics|anesthetics|mesh-ancestor
5586496|NCT03807297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5586497|NCT03807297|Analgesics|analgesics|mesh-ancestor
5586498|NCT03807297|Sensory System Agents|sensory system agents|mesh-ancestor
5586499|NCT03807297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5586500|NCT03807297|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5586501|NCT03807297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5586502|NCT03807297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5586503|NCT03807297|Adrenergic Agents|adrenergic agents|mesh-ancestor
5586504|NCT03807297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5586505|NCT03807297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196825|NCT01963481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6196826|NCT01963481|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6196827|NCT01963481|Hormone Antagonists|hormone antagonists|mesh-ancestor
6196828|NCT01963481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6196829|NCT01963611|Glatiramer Acetate|glatiramer acetate|mesh-list
6196830|NCT01963611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6196831|NCT01963611|Immunologic Factors|immunologic factors|mesh-ancestor
6196832|NCT01963611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196833|NCT01963611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6196834|NCT01963611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6196835|NCT01963793|Aprepitant|aprepitant|mesh-list
6196836|NCT01963793|Fosaprepitant|fosaprepitant|mesh-list
6196837|NCT01963793|Antiemetics|antiemetics|mesh-ancestor
6196838|NCT01963793|Autonomic Agents|autonomic agents|mesh-ancestor
6196839|NCT01963793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6196840|NCT01963793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196841|NCT01963793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6196842|NCT01963793|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6196843|NCT01963793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6196844|NCT01963793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196845|NCT01963845|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6196846|NCT01963845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6196847|NCT01963845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196848|NCT01963845|Incretins|incretins|mesh-ancestor
6196849|NCT01963845|Hormones|hormones|mesh-ancestor
6196850|NCT01963845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6196851|NCT01963845|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6196852|NCT01963845|Protease Inhibitors|protease inhibitors|mesh-ancestor
6196853|NCT01963845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6196854|NCT01963845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196855|NCT01964300|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6196856|NCT01964300|Antiviral Agents|antiviral agents|mesh-ancestor
6196857|NCT01964300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6196858|NCT01964326|Atorvastatin|atorvastatin|mesh-list
6196859|NCT01964326|Calcium|calcium|mesh-list
6196860|NCT01964326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6196861|NCT01964326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196862|NCT01964326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6196863|NCT01964326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6196864|NCT01964326|Antimetabolites|antimetabolites|mesh-ancestor
5586506|NCT03807297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5586507|NCT03807297|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5586508|NCT03807271|Anesthetics|anesthetics|mesh-list
5586509|NCT03807271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5586510|NCT03807271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586511|NCT03807479|Ponatinib|ponatinib|mesh-list
5586512|NCT03807479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6196865|NCT01964326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196866|NCT01964326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6196867|NCT01964326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6196868|NCT01964326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6196869|NCT01964352|Tiotropium Bromide|tiotropium bromide|mesh-list
6196870|NCT01964352|Olodaterol|olodaterol|mesh-list
6196871|NCT01964352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6196872|NCT01964352|Autonomic Agents|autonomic agents|mesh-ancestor
6196873|NCT01964352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6196874|NCT01964352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196875|NCT01964352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6196876|NCT01964352|Respiratory System Agents|respiratory system agents|mesh-ancestor
6196877|NCT01964352|Parasympatholytics|parasympatholytics|mesh-ancestor
6196878|NCT01964352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5586513|NCT03807479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6196879|NCT01964352|Cholinergic Agents|cholinergic agents|mesh-ancestor
5586514|NCT03807479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5586515|NCT03807479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586516|NCT03806985|Psilocybin|psilocybin|mesh-list
5586517|NCT03806985|Hallucinogens|hallucinogens|mesh-ancestor
5586518|NCT03806985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196880|NCT01964352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6196881|NCT01964352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196882|NCT01964378|Morphine|morphine|mesh-list
6196883|NCT01964378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6196884|NCT01964378|Narcotics|narcotics|mesh-ancestor
6196885|NCT01964378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6196886|NCT01964378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196887|NCT01964378|Analgesics|analgesics|mesh-ancestor
6196888|NCT01964378|Sensory System Agents|sensory system agents|mesh-ancestor
6196889|NCT01964378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5586519|NCT03806985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5586520|NCT03806816|Melatonin|melatonin|mesh-list
5586521|NCT03806816|Antioxidants|antioxidants|mesh-ancestor
5586522|NCT03806816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586523|NCT03806816|Protective Agents|protective agents|mesh-ancestor
5586524|NCT03806816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196890|NCT01964430|Gemcitabine|gemcitabine|mesh-list
6196891|NCT01964430|Paclitaxel|paclitaxel|mesh-list
6196892|NCT01964430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6196893|NCT01964430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6196894|NCT01964430|Tubulin Modulators|tubulin modulators|mesh-ancestor
6196895|NCT01964430|Antimitotic Agents|antimitotic agents|mesh-ancestor
6196896|NCT01964430|Mitosis Modulators|mitosis modulators|mesh-ancestor
6196897|NCT01964430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196898|NCT01964430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6196899|NCT01964430|Antimetabolites|antimetabolites|mesh-ancestor
6196900|NCT01964430|Antiviral Agents|antiviral agents|mesh-ancestor
6196901|NCT01964430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6196902|NCT01964430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6196903|NCT01964430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6196904|NCT01964430|Immunologic Factors|immunologic factors|mesh-ancestor
6196905|NCT01964430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196906|NCT01964547|Nabiximols|nabiximols|mesh-list
6196907|NCT01964547|Analgesics|analgesics|mesh-ancestor
6196908|NCT01964547|Sensory System Agents|sensory system agents|mesh-ancestor
6196909|NCT01964547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6196910|NCT01964547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196911|NCT01964716|Vaccines|vaccines|mesh-list
6196912|NCT01964716|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6196913|NCT01964716|Immunologic Factors|immunologic factors|mesh-ancestor
6196914|NCT01964716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196915|NCT01964755|Leucovorin|leucovorin|mesh-list
6196916|NCT01964755|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
6196917|NCT01964755|Tetrahydrofolates|tetrahydrofolates|mesh-list
6196918|NCT01964755|Zidovudine|zidovudine|mesh-list
6196919|NCT01964755|Rituximab|rituximab|mesh-list
6196920|NCT01964755|Doxorubicin|doxorubicin|mesh-list
6196921|NCT01964755|Methotrexate|methotrexate|mesh-list
5586525|NCT03806816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5586526|NCT03807011|Fentanyl|fentanyl|mesh-list
5586527|NCT03807011|Remifentanil|remifentanil|mesh-list
5586528|NCT03807011|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5586529|NCT03807011|Narcotics|narcotics|mesh-ancestor
5586530|NCT03807011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6196922|NCT01964755|Hydroxyurea|hydroxyurea|mesh-list
6196923|NCT01964755|Levoleucovorin|levoleucovorin|mesh-list
6196924|NCT01964755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6196925|NCT01964755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6196926|NCT01964755|Immunologic Factors|immunologic factors|mesh-ancestor
6196927|NCT01964755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196928|NCT01964755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6196929|NCT01964755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6196930|NCT01964755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6196931|NCT01964755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6196932|NCT01964755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6196933|NCT01964755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196934|NCT01964755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6196935|NCT01964755|Abortifacient Agents|abortifacient agents|mesh-ancestor
5586531|NCT03807011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196936|NCT01964755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6196937|NCT01964755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6196938|NCT01964755|Antimetabolites|antimetabolites|mesh-ancestor
5586532|NCT03807011|Analgesics|analgesics|mesh-ancestor
6196939|NCT01964755|Dermatologic Agents|dermatologic agents|mesh-ancestor
6196940|NCT01964755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6196941|NCT01964755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6196942|NCT01964755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6196943|NCT01964755|Antidotes|antidotes|mesh-ancestor
6196944|NCT01964755|Protective Agents|protective agents|mesh-ancestor
6196945|NCT01964755|Vitamin B Complex|vitamin b complex|mesh-ancestor
6196946|NCT01964755|Vitamins|vitamins|mesh-ancestor
6196947|NCT01964755|Micronutrients|micronutrients|mesh-ancestor
6196948|NCT01964755|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6196949|NCT01964755|Antiviral Agents|antiviral agents|mesh-ancestor
6196950|NCT01964755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5586533|NCT03807011|Sensory System Agents|sensory system agents|mesh-ancestor
5586534|NCT03807011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5586535|NCT03807011|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6196951|NCT01964755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6196952|NCT01964755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6196953|NCT01964755|Antisickling Agents|antisickling agents|mesh-ancestor
6196954|NCT01964898|Nicotine|nicotine|mesh-list
6196955|NCT01964898|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6196956|NCT01964898|Autonomic Agents|autonomic agents|mesh-ancestor
6196957|NCT01964898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6196958|NCT01964898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196959|NCT01964898|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6196960|NCT01964898|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6196961|NCT01964898|Cholinergic Agents|cholinergic agents|mesh-ancestor
6196962|NCT01964898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6196963|NCT01964898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672271|NCT01554995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6196964|NCT01964924|Trametinib|trametinib|mesh-list
6196965|NCT01964924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6196966|NCT01964924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6196967|NCT01964924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6196968|NCT01964924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196969|NCT01964963|Alogliptin|alogliptin|mesh-list
6196970|NCT01964963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6196971|NCT01964963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196972|NCT01964963|Incretins|incretins|mesh-ancestor
6196973|NCT01964963|Hormones|hormones|mesh-ancestor
6196974|NCT01964963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6196975|NCT01964963|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6196976|NCT01964963|Protease Inhibitors|protease inhibitors|mesh-ancestor
6196977|NCT01964963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6196978|NCT01964963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196979|NCT01965002|Aspirin|aspirin|mesh-list
6196980|NCT01965002|Enoxaparin|enoxaparin|mesh-list
6196981|NCT01965002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6196982|NCT01965002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6196983|NCT01965002|Analgesics|analgesics|mesh-ancestor
5586536|NCT03807011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5586537|NCT03807011|Anesthetics, General|anesthetics, general|mesh-ancestor
5586538|NCT03807011|Anesthetics|anesthetics|mesh-ancestor
5586539|NCT03806673|Bupivacaine|bupivacaine|mesh-list
5586540|NCT03806673|Anesthetics, Local|anesthetics, local|mesh-ancestor
5586541|NCT03806673|Anesthetics|anesthetics|mesh-ancestor
5586542|NCT03806673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5586543|NCT03806673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586544|NCT03806673|Sensory System Agents|sensory system agents|mesh-ancestor
6488297|NCT00582985|Immunologic Factors|immunologic factors|mesh-ancestor
5586545|NCT03806673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6488298|NCT00582985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488299|NCT00583063|Sirolimus|sirolimus|mesh-list
6488300|NCT00583063|Sunitinib|sunitinib|mesh-list
6488301|NCT00583063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6488302|NCT00583063|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6488303|NCT00583063|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6488304|NCT00583063|Growth Substances|growth substances|mesh-ancestor
6488305|NCT00583063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488306|NCT00583063|Growth Inhibitors|growth inhibitors|mesh-ancestor
6488307|NCT00583063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6488308|NCT00583063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6488309|NCT00583063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488310|NCT00583063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6488311|NCT00583063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6196984|NCT01965002|Sensory System Agents|sensory system agents|mesh-ancestor
5586546|NCT03806751|Acetazolamide|acetazolamide|mesh-list
5586547|NCT03806751|Anticonvulsants|anticonvulsants|mesh-ancestor
5586548|NCT03806751|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5586549|NCT03806751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5586550|NCT03806751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196985|NCT01965002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6196986|NCT01965002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6196987|NCT01965002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6196988|NCT01965002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6196989|NCT01965002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6196990|NCT01965002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6196991|NCT01965002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6196992|NCT01965002|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6196993|NCT01965002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6196994|NCT01965002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6196995|NCT01965002|Antipyretics|antipyretics|mesh-ancestor
6196996|NCT01965002|Anticoagulants|anticoagulants|mesh-ancestor
6196997|NCT01965327|Interferons|interferons|mesh-list
6196998|NCT01965327|Interferon-gamma|interferon-gamma|mesh-list
6196999|NCT01965327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6197000|NCT01965327|Antiviral Agents|antiviral agents|mesh-ancestor
6197001|NCT01965327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6197002|NCT01965366|Dexamethasone|dexamethasone|mesh-list
6197003|NCT01965366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6197004|NCT01965366|Antiemetics|antiemetics|mesh-ancestor
6197005|NCT01965366|Autonomic Agents|autonomic agents|mesh-ancestor
6197006|NCT01965366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6197007|NCT01965366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197008|NCT01965366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6197009|NCT01965366|Glucocorticoids|glucocorticoids|mesh-ancestor
6197010|NCT01965366|Hormones|hormones|mesh-ancestor
5586551|NCT03806751|Diuretics|diuretics|mesh-ancestor
5586552|NCT03806751|Natriuretic Agents|natriuretic agents|mesh-ancestor
5586553|NCT03806751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605179|NCT03432741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605180|NCT03432741|Antiviral Agents|antiviral agents|mesh-ancestor
5605181|NCT03432741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5605182|NCT03432741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5605183|NCT03432741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5605184|NCT03432741|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5605185|NCT03432741|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5605186|NCT03432741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5605187|NCT03432741|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5605188|NCT03422822|Abrocitinib|abrocitinib|mesh-list
5605189|NCT03422822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5605190|NCT03422822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5605191|NCT03422822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605192|NCT03410706|Rivaroxaban|rivaroxaban|mesh-list
5605193|NCT03410706|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5605194|NCT03410706|Antithrombins|antithrombins|mesh-ancestor
5605195|NCT03410706|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5605196|NCT03410706|Protease Inhibitors|protease inhibitors|mesh-ancestor
5605197|NCT03410706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5605198|NCT03410706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605199|NCT03410706|Anticoagulants|anticoagulants|mesh-ancestor
5605200|NCT03406715|Nivolumab|nivolumab|mesh-list
5605201|NCT03406715|Ipilimumab|ipilimumab|mesh-list
5605202|NCT03406715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5605203|NCT03406715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605204|NCT03406715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5605205|NCT03406715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605206|NCT03399175|Immunosuppressive Agents|immunosuppressive agents|mesh-list
5605207|NCT03399175|Immunologic Factors|immunologic factors|mesh-ancestor
5605208|NCT03399175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605209|NCT03278925|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
5605210|NCT03278925|Antioxidants|antioxidants|mesh-ancestor
5605211|NCT03278925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605212|NCT03278925|Protective Agents|protective agents|mesh-ancestor
5605213|NCT03278925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197011|NCT01965366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6197012|NCT01965366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6197013|NCT01965366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605214|NCT03278925|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
6197014|NCT01965431|Moxifloxacin|moxifloxacin|mesh-list
6197015|NCT01965431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6197016|NCT01965431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6197017|NCT01965431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6197018|NCT01965431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6197019|NCT01965431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6197020|NCT01965431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197021|NCT01965431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6197022|NCT01965535|Sofosbuvir|sofosbuvir|mesh-list
6197023|NCT01965535|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
6197024|NCT01965535|Ledipasvir|ledipasvir|mesh-list
6197025|NCT01965535|Antiviral Agents|antiviral agents|mesh-ancestor
6197026|NCT01965535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6197027|NCT01965756|Metformin|metformin|mesh-list
6672272|NCT01554995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672273|NCT01555008|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
6672274|NCT01555008|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6672275|NCT01555008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672276|NCT01555008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6672277|NCT01555008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672278|NCT01555060|Ferrous gluconate|ferrous gluconate|mesh-list
6672279|NCT01555060|Hematinics|hematinics|mesh-ancestor
6672280|NCT01555099|Budesonide|budesonide|mesh-list
6672281|NCT01555099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6672282|NCT01555099|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6672283|NCT01555099|Autonomic Agents|autonomic agents|mesh-ancestor
6197028|NCT01965756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6197029|NCT01965756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197030|NCT01965834|Fenofibrate|fenofibrate|mesh-list
6197031|NCT01965834|Fenofibric acid|fenofibric acid|mesh-list
6197032|NCT01965834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6197033|NCT01965834|Antimetabolites|antimetabolites|mesh-ancestor
6197034|NCT01965834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197035|NCT01965834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6197036|NCT01965834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6197037|NCT01966003|Paclitaxel|paclitaxel|mesh-list
6197038|NCT01966003|Bevacizumab|bevacizumab|mesh-list
6197039|NCT01966003|Carboplatin|carboplatin|mesh-list
6197040|NCT01966003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6197041|NCT01966003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6197042|NCT01966003|Tubulin Modulators|tubulin modulators|mesh-ancestor
6197043|NCT01966003|Antimitotic Agents|antimitotic agents|mesh-ancestor
6197044|NCT01966003|Mitosis Modulators|mitosis modulators|mesh-ancestor
6197045|NCT01966003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197046|NCT01966003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6197047|NCT01966003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6197048|NCT01966003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6197049|NCT01966003|Growth Substances|growth substances|mesh-ancestor
6197050|NCT01966003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197051|NCT01966003|Growth Inhibitors|growth inhibitors|mesh-ancestor
6197052|NCT01966107|Bromides|bromides|mesh-list
6197053|NCT01966107|Anticonvulsants|anticonvulsants|mesh-ancestor
6197054|NCT01966120|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6197055|NCT01966120|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6197056|NCT01966120|Dermatologic Agents|dermatologic agents|mesh-ancestor
6197057|NCT01966419|Phenylacetic acid|phenylacetic acid|mesh-list
6197058|NCT01966419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6197059|NCT01966419|Antimetabolites|antimetabolites|mesh-ancestor
6197060|NCT01966419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197061|NCT01966419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6197062|NCT01966718|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6197063|NCT01966718|Hormones|hormones|mesh-ancestor
6197064|NCT01966718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6197065|NCT01966718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197066|NCT01966809|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
6197067|NCT01966809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6197068|NCT01966809|Dermatologic Agents|dermatologic agents|mesh-ancestor
6197069|NCT01966809|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6197070|NCT01966978|Insulin|insulin|mesh-list
6197071|NCT01966978|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6197072|NCT01966978|Metformin|metformin|mesh-list
6197073|NCT01966978|Insulin Aspart|insulin aspart|mesh-list
6197074|NCT01966978|Insulin, Long-Acting|insulin, long-acting|mesh-list
6197075|NCT01966978|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6197076|NCT01966978|Liraglutide|liraglutide|mesh-list
6197077|NCT01966978|Insulin Detemir|insulin detemir|mesh-list
6197078|NCT01966978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6197079|NCT01966978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197080|NCT01966978|Incretins|incretins|mesh-ancestor
6197081|NCT01966978|Hormones|hormones|mesh-ancestor
6197082|NCT01966978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6197083|NCT01967147|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6197084|NCT01967147|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6197085|NCT01967173|Fluticasone|fluticasone|mesh-list
6197086|NCT01967173|Xhance|xhance|mesh-list
6197087|NCT01967173|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6197088|NCT01967173|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6197089|NCT01967173|Autonomic Agents|autonomic agents|mesh-ancestor
6197090|NCT01967173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6197091|NCT01967173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197092|NCT01967173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6197093|NCT01967173|Respiratory System Agents|respiratory system agents|mesh-ancestor
5586554|NCT03806595|Lidocaine|lidocaine|mesh-list
5586555|NCT03806595|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5586556|NCT03806595|Anesthetics, Local|anesthetics, local|mesh-ancestor
5586557|NCT03806595|Anesthetics|anesthetics|mesh-ancestor
5586558|NCT03806595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6197094|NCT01967173|Glucocorticoids|glucocorticoids|mesh-ancestor
6197095|NCT01967173|Hormones|hormones|mesh-ancestor
6197096|NCT01967173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6197097|NCT01967173|Sympathomimetics|sympathomimetics|mesh-ancestor
5586559|NCT03806595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586560|NCT03806595|Sensory System Agents|sensory system agents|mesh-ancestor
5586561|NCT03806595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5586562|NCT03806595|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5586563|NCT03806595|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5586564|NCT03806595|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5586565|NCT03806595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5586566|NCT03806595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586567|NCT03806777|Dexmedetomidine|dexmedetomidine|mesh-list
5586568|NCT03806777|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5586569|NCT03806777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5586570|NCT03806777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586571|NCT03806777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5586572|NCT03806777|Analgesics|analgesics|mesh-ancestor
5586573|NCT03806777|Sensory System Agents|sensory system agents|mesh-ancestor
5586574|NCT03806777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5586575|NCT03806777|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5586576|NCT03806777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5586577|NCT03806777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5586578|NCT03806777|Adrenergic Agents|adrenergic agents|mesh-ancestor
5586579|NCT03806777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5586580|NCT03806777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586581|NCT03807037|Tocotrienols|tocotrienols|mesh-list
5586582|NCT03807037|Vitamin E|vitamin e|mesh-list
5586583|NCT03807037|Tocopherols|tocopherols|mesh-list
5586584|NCT03807037|Tocovid|tocovid|mesh-list
5586585|NCT03807037|Antioxidants|antioxidants|mesh-ancestor
5586586|NCT03807037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586587|NCT03807037|Protective Agents|protective agents|mesh-ancestor
5586588|NCT03807037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586589|NCT03807037|Vitamins|vitamins|mesh-ancestor
5586590|NCT03807037|Micronutrients|micronutrients|mesh-ancestor
5586591|NCT03806582|Norepinephrine|norepinephrine|mesh-list
5586592|NCT03806582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5586593|NCT03806582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5586594|NCT03806582|Adrenergic Agents|adrenergic agents|mesh-ancestor
5586595|NCT03806582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5586596|NCT03806582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586597|NCT03806582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586598|NCT03806582|Sympathomimetics|sympathomimetics|mesh-ancestor
5586599|NCT03806582|Autonomic Agents|autonomic agents|mesh-ancestor
5586600|NCT03806582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5586601|NCT03806582|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5586602|NCT03806530|Gabapentin|gabapentin|mesh-list
5586603|NCT03806530|Ropinirole|ropinirole|mesh-list
5586604|NCT03806530|Analgesics|analgesics|mesh-ancestor
5586605|NCT03806530|Sensory System Agents|sensory system agents|mesh-ancestor
6197098|NCT01967173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5586606|NCT03806530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6197099|NCT01967173|Dermatologic Agents|dermatologic agents|mesh-ancestor
6197100|NCT01967173|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6197101|NCT01967225|Linezolid|linezolid|mesh-list
6197102|NCT01967225|Tedizolid|tedizolid|mesh-list
6197103|NCT01967225|Tedizolid phosphate|tedizolid phosphate|mesh-list
6197104|NCT01967225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6197105|NCT01967225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6197106|NCT01967225|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6197107|NCT01967225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6197108|NCT01967225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197109|NCT01967433|Diphenhydramine|diphenhydramine|mesh-list
6197110|NCT01967433|Promethazine|promethazine|mesh-list
6197111|NCT01967433|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6197112|NCT01967433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6197113|NCT01967433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6197114|NCT01967433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197115|NCT01967433|Anesthetics, Local|anesthetics, local|mesh-ancestor
6197116|NCT01967433|Anesthetics|anesthetics|mesh-ancestor
6197117|NCT01967433|Sensory System Agents|sensory system agents|mesh-ancestor
6197118|NCT01967433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6197119|NCT01967433|Antiemetics|antiemetics|mesh-ancestor
6197120|NCT01967433|Autonomic Agents|autonomic agents|mesh-ancestor
6197121|NCT01967433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6197122|NCT01967433|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6197123|NCT01967433|Histamine Antagonists|histamine antagonists|mesh-ancestor
6197124|NCT01967433|Histamine Agents|histamine agents|mesh-ancestor
6197125|NCT01967433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6197126|NCT01967433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197127|NCT01967433|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6197128|NCT01967433|Antipruritics|antipruritics|mesh-ancestor
6197129|NCT01967433|Dermatologic Agents|dermatologic agents|mesh-ancestor
6197130|NCT01967550|Diclofenac|diclofenac|mesh-list
6197131|NCT01967550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6197132|NCT01967550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6197133|NCT01967550|Analgesics|analgesics|mesh-ancestor
6197134|NCT01967550|Sensory System Agents|sensory system agents|mesh-ancestor
6197135|NCT01967550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6197136|NCT01967550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197137|NCT01967550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6197138|NCT01967550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6197139|NCT01967550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6197140|NCT01967550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6197141|NCT01967550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197142|NCT01967576|Axitinib|axitinib|mesh-list
6197143|NCT01967576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6197144|NCT01967576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6197145|NCT01967576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6197146|NCT01967576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197147|NCT01967628|Vitamin D|vitamin d|mesh-list
6197148|NCT01967628|Cholecalciferol|cholecalciferol|mesh-list
5586607|NCT03806530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586608|NCT03806530|Anticonvulsants|anticonvulsants|mesh-ancestor
5586609|NCT03806530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5586610|NCT03806530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5586611|NCT03806530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5586612|NCT03806530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6197149|NCT01967628|Vitamins|vitamins|mesh-ancestor
6197150|NCT01967628|Micronutrients|micronutrients|mesh-ancestor
6197151|NCT01967628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197152|NCT01967628|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6197153|NCT01967628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6197154|NCT01967641|Buprenorphine|buprenorphine|mesh-list
6197155|NCT01967641|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6197156|NCT01967641|Naloxone|naloxone|mesh-list
6197157|NCT01967641|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6197158|NCT01967641|Narcotics|narcotics|mesh-ancestor
6197159|NCT01967641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6197160|NCT01967641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197161|NCT01967641|Analgesics|analgesics|mesh-ancestor
6197162|NCT01967641|Sensory System Agents|sensory system agents|mesh-ancestor
6197163|NCT01967641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6197164|NCT01967641|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6197165|NCT01967862|Listerine|listerine|mesh-list
6197166|NCT01967862|Fluorides|fluorides|mesh-list
6197167|NCT01967862|Sodium Fluoride|sodium fluoride|mesh-list
6197168|NCT01967862|Cariostatic Agents|cariostatic agents|mesh-ancestor
5586613|NCT03806530|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5586614|NCT03806530|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5586615|NCT03806530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5586616|NCT03806530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586617|NCT03806530|Antimanic Agents|antimanic agents|mesh-ancestor
5586618|NCT03806530|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5586619|NCT03806530|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5586620|NCT03806530|Dopamine Agonists|dopamine agonists|mesh-ancestor
6197169|NCT01967862|Protective Agents|protective agents|mesh-ancestor
6197170|NCT01967862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197171|NCT01967862|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6197172|NCT01967862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6197173|NCT01967940|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6197174|NCT01967940|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6197175|NCT01967940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6197176|NCT01967940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6197177|NCT01967940|Protease Inhibitors|protease inhibitors|mesh-ancestor
5586621|NCT03806530|Dopamine Agents|dopamine agents|mesh-ancestor
5586622|NCT03806387|Alemtuzumab|alemtuzumab|mesh-list
5586623|NCT03806387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5586624|NCT03806387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5586625|NCT03806062|Domperidone|domperidone|mesh-list
5586626|NCT03806062|Antiemetics|antiemetics|mesh-ancestor
5586627|NCT03806062|Autonomic Agents|autonomic agents|mesh-ancestor
5586628|NCT03806062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5586629|NCT03806062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586630|NCT03806062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5586631|NCT03806062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5586632|NCT03806062|Dopamine Agents|dopamine agents|mesh-ancestor
5586633|NCT03806062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5586634|NCT03806062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586635|NCT03806036|Vitamin D|vitamin d|mesh-list
5586636|NCT03806036|Clomiphene|clomiphene|mesh-list
6197178|NCT01967940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6197179|NCT01967940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197180|NCT01967940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6197181|NCT01967940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6197182|NCT01967940|Antiviral Agents|antiviral agents|mesh-ancestor
6197183|NCT01967940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6197184|NCT01968031|Istradefylline|istradefylline|mesh-list
6197185|NCT01968031|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
6197186|NCT01968031|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6197187|NCT01968031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6197188|NCT01968031|Purinergic Agents|purinergic agents|mesh-ancestor
6197189|NCT01968031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6197190|NCT01968031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197191|NCT01968031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197192|NCT01968057|Cyclosporine|cyclosporine|mesh-list
6197193|NCT01968057|Cyclosporins|cyclosporins|mesh-list
6197194|NCT01968057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6197195|NCT01968057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197196|NCT01968057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6197197|NCT01968057|Immunologic Factors|immunologic factors|mesh-ancestor
6197198|NCT01968057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197199|NCT01968057|Antifungal Agents|antifungal agents|mesh-ancestor
6197200|NCT01968057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6197201|NCT01968057|Dermatologic Agents|dermatologic agents|mesh-ancestor
5586637|NCT03806036|Enclomiphene|enclomiphene|mesh-list
5586638|NCT03806036|Zuclomiphene|zuclomiphene|mesh-list
5586639|NCT03806036|Vitamins|vitamins|mesh-ancestor
5586640|NCT03806036|Micronutrients|micronutrients|mesh-ancestor
5586641|NCT03806036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197202|NCT01968057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6197203|NCT01968057|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6197204|NCT01968070|Celecoxib|celecoxib|mesh-list
6197205|NCT01968070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6197206|NCT01968070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6197207|NCT01968070|Analgesics|analgesics|mesh-ancestor
6197208|NCT01968070|Sensory System Agents|sensory system agents|mesh-ancestor
6197209|NCT01968070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6197210|NCT01968070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586642|NCT03806036|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5586643|NCT03806036|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5586644|NCT03806036|Hormone Antagonists|hormone antagonists|mesh-ancestor
6197211|NCT01968070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6197212|NCT01968070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6197213|NCT01968070|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6197214|NCT01968070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6197215|NCT01968070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6197216|NCT01968070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207449|NCT02116309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6207450|NCT02116309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6207451|NCT02116309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6207452|NCT02116361|Botulinum Toxins|botulinum toxins|mesh-list
6207453|NCT02116361|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6207454|NCT02116361|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6207455|NCT02116361|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6207456|NCT02116361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6207457|NCT02116361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207458|NCT02116361|Cholinergic Agents|cholinergic agents|mesh-ancestor
6207459|NCT02116361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6207460|NCT02116361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207461|NCT02116361|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6207462|NCT02116361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5586645|NCT03806036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5586646|NCT03806036|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5586647|NCT03806036|Fertility Agents|fertility agents|mesh-ancestor
5586648|NCT03806036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5586649|NCT03806036|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5586650|NCT03806036|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5586651|NCT03805945|Dexmedetomidine|dexmedetomidine|mesh-list
5586652|NCT03805945|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5586653|NCT03805945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5586654|NCT03805945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586655|NCT03805945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5586656|NCT03805945|Analgesics|analgesics|mesh-ancestor
5586657|NCT03805945|Sensory System Agents|sensory system agents|mesh-ancestor
5586658|NCT03805945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6207463|NCT02116530|Dexamethasone|dexamethasone|mesh-list
6207464|NCT02116530|Cyclophosphamide|cyclophosphamide|mesh-list
6207465|NCT02116530|Doxorubicin|doxorubicin|mesh-list
6207466|NCT02116530|Ondansetron|ondansetron|mesh-list
6207467|NCT02116530|Olanzapine|olanzapine|mesh-list
6207468|NCT02116530|Aprepitant|aprepitant|mesh-list
6207469|NCT02116530|Fosaprepitant|fosaprepitant|mesh-list
6207470|NCT02116530|Palonosetron|palonosetron|mesh-list
6207471|NCT02116530|Granisetron|granisetron|mesh-list
6207472|NCT02116530|Antiemetics|antiemetics|mesh-list
6207473|NCT02116530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6207474|NCT02116530|Immunologic Factors|immunologic factors|mesh-ancestor
6207475|NCT02116530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207476|NCT02116530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6207477|NCT02116530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6207478|NCT02116530|Alkylating Agents|alkylating agents|mesh-ancestor
6207479|NCT02116530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207480|NCT02116530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6207481|NCT02116530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6207482|NCT02116530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6207483|NCT02116530|Autonomic Agents|autonomic agents|mesh-ancestor
6207484|NCT02116530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6207485|NCT02116530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6207486|NCT02116530|Glucocorticoids|glucocorticoids|mesh-ancestor
6207487|NCT02116530|Hormones|hormones|mesh-ancestor
5586659|NCT03805945|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5586660|NCT03805945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5586661|NCT03805945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5586662|NCT03805945|Adrenergic Agents|adrenergic agents|mesh-ancestor
5586663|NCT03805945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5586664|NCT03805945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586665|NCT03806374|Lidocaine|lidocaine|mesh-list
5586666|NCT03806374|Fentanyl|fentanyl|mesh-list
5586667|NCT03806374|Ketamine|ketamine|mesh-list
5586668|NCT03806374|Propofol|propofol|mesh-list
5586669|NCT03806374|Cisatracurium|cisatracurium|mesh-list
5586670|NCT03806374|Anesthetics, Local|anesthetics, local|mesh-ancestor
5586671|NCT03806374|Anesthetics|anesthetics|mesh-ancestor
5586672|NCT03806374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5586673|NCT03806374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207488|NCT02116530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6197217|NCT01968135|Contraceptive Agents|contraceptive agents|mesh-list
6197218|NCT01968135|Contraceptives, Oral|contraceptives, oral|mesh-list
6197219|NCT01968135|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
6197220|NCT01968135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6197221|NCT01968135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197222|NCT01968135|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6197223|NCT01968213|Rucaparib|rucaparib|mesh-list
6197224|NCT01968213|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6197225|NCT01968213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6197226|NCT01968213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197227|NCT01968213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5586674|NCT03806374|Sensory System Agents|sensory system agents|mesh-ancestor
5586675|NCT03806374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5586676|NCT03806374|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5586677|NCT03806374|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5586678|NCT03806374|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5586679|NCT03806374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5586680|NCT03806374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586681|NCT03806374|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5586682|NCT03806374|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5586683|NCT03806374|Anesthetics, General|anesthetics, general|mesh-ancestor
5586684|NCT03806374|Analgesics|analgesics|mesh-ancestor
5586685|NCT03806374|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5586686|NCT03806374|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5586687|NCT03806374|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5586688|NCT03806374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5586689|NCT03806374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5586690|NCT03806374|Narcotics|narcotics|mesh-ancestor
5586691|NCT03806374|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5586692|NCT03806374|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5586693|NCT03806374|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5586694|NCT03806101|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5586695|NCT03806101|Abrocitinib|abrocitinib|mesh-list
5586696|NCT03806101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5586697|NCT03806101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5586698|NCT03806101|Antimetabolites|antimetabolites|mesh-ancestor
5586699|NCT03806101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586700|NCT03806101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5586701|NCT03806101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5586702|NCT03806101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5586703|NCT03806101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5586704|NCT03806049|Paclitaxel|paclitaxel|mesh-list
5586705|NCT03806049|Bevacizumab|bevacizumab|mesh-list
5586706|NCT03806049|Carboplatin|carboplatin|mesh-list
5586707|NCT03806049|Niraparib|niraparib|mesh-list
5586708|NCT03806049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5586709|NCT03806049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5586710|NCT03806049|Tubulin Modulators|tubulin modulators|mesh-ancestor
6197228|NCT01968317|Metformin|metformin|mesh-list
6197229|NCT01968317|Megestrol|megestrol|mesh-list
6197230|NCT01968317|Megestrol Acetate|megestrol acetate|mesh-list
6197231|NCT01968317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6197232|NCT01968317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197233|NCT01968317|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6197234|NCT01968317|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6197235|NCT01968317|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6197236|NCT01968317|Contraceptive Agents|contraceptive agents|mesh-ancestor
6197237|NCT01968317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6197238|NCT01968317|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6197239|NCT01968317|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6197240|NCT01968317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5586711|NCT03806049|Antimitotic Agents|antimitotic agents|mesh-ancestor
5586712|NCT03806049|Mitosis Modulators|mitosis modulators|mesh-ancestor
5586713|NCT03806049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197241|NCT01968317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6197242|NCT01968317|Appetite Stimulants|appetite stimulants|mesh-ancestor
6197243|NCT01968317|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6197244|NCT01968356|Ethanol|ethanol|mesh-list
6197245|NCT01968356|Chlorhexidine|chlorhexidine|mesh-list
6197246|NCT01968356|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6197247|NCT01968356|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6197248|NCT01968356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6197249|NCT01968356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6197250|NCT01968356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197251|NCT01968356|Disinfectants|disinfectants|mesh-ancestor
6197252|NCT01968356|Dermatologic Agents|dermatologic agents|mesh-ancestor
6197253|NCT01968421|Broncho-Vaxom|broncho-vaxom|mesh-list
6197254|NCT01968421|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6197255|NCT01968421|Immunologic Factors|immunologic factors|mesh-ancestor
6197256|NCT01968421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197257|NCT01968434|Carbocysteine|carbocysteine|mesh-list
6197258|NCT01968434|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6197259|NCT01968434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6197260|NCT01968434|Expectorants|expectorants|mesh-ancestor
6197261|NCT01968434|Respiratory System Agents|respiratory system agents|mesh-ancestor
6197262|NCT01968551|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6197263|NCT01968551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6197264|NCT01968551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6197265|NCT01968551|Antiviral Agents|antiviral agents|mesh-ancestor
6197266|NCT01968551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6197267|NCT01968694|Diphenhydramine|diphenhydramine|mesh-list
6197268|NCT01968694|Promethazine|promethazine|mesh-list
6197269|NCT01968694|Lidocaine|lidocaine|mesh-list
6197270|NCT01968694|Anesthetics, Local|anesthetics, local|mesh-ancestor
6197271|NCT01968694|Anesthetics|anesthetics|mesh-ancestor
6197272|NCT01968694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6197273|NCT01968694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197274|NCT01968694|Sensory System Agents|sensory system agents|mesh-ancestor
6197275|NCT01968694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6197276|NCT01968694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6197277|NCT01968694|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6197278|NCT01968694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6197279|NCT01968694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5586714|NCT03806049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5586715|NCT03806049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5586716|NCT03806049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5586717|NCT03806049|Growth Substances|growth substances|mesh-ancestor
5586718|NCT03806049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586719|NCT03806049|Growth Inhibitors|growth inhibitors|mesh-ancestor
5586720|NCT03806049|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5586721|NCT03806049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5586722|NCT03805594|Pembrolizumab|pembrolizumab|mesh-list
5586723|NCT03805594|177Lu-PSMA-617|177lu-psma-617|mesh-list
5586724|NCT03805594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5586725|NCT03805594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5586726|NCT03805594|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5586727|NCT03805594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586728|NCT03805607|Ketorolac|ketorolac|mesh-list
5586729|NCT03805607|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
5586730|NCT03805607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5586731|NCT03805607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5586732|NCT03805607|Analgesics|analgesics|mesh-ancestor
5586733|NCT03805607|Sensory System Agents|sensory system agents|mesh-ancestor
5586734|NCT03805607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5586735|NCT03805607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586736|NCT03805607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5586737|NCT03805607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5586738|NCT03805607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6197280|NCT01968694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197281|NCT01968694|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6197282|NCT01968694|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6197283|NCT01968694|Antiemetics|antiemetics|mesh-ancestor
6197284|NCT01968694|Autonomic Agents|autonomic agents|mesh-ancestor
6197285|NCT01968694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6197286|NCT01968694|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6197287|NCT01968694|Histamine Antagonists|histamine antagonists|mesh-ancestor
6197288|NCT01968694|Histamine Agents|histamine agents|mesh-ancestor
6197289|NCT01968694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6197290|NCT01968694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6197291|NCT01968694|Antipruritics|antipruritics|mesh-ancestor
6197292|NCT01968694|Dermatologic Agents|dermatologic agents|mesh-ancestor
6197293|NCT01968707|Ethanol|ethanol|mesh-list
6197294|NCT01968707|Chlorhexidine|chlorhexidine|mesh-list
6197295|NCT01968707|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5586739|NCT03805607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5586740|NCT03805607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586741|NCT03805568|Dexmedetomidine|dexmedetomidine|mesh-list
5586742|NCT03805568|Remifentanil|remifentanil|mesh-list
6197296|NCT01968707|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6197297|NCT01968707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6197298|NCT01968707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6197299|NCT01968707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197300|NCT01968707|Disinfectants|disinfectants|mesh-ancestor
6197301|NCT01968707|Dermatologic Agents|dermatologic agents|mesh-ancestor
6197302|NCT01968954|Bococizumab|bococizumab|mesh-list
6197303|NCT01968954|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6197304|NCT01968954|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6197305|NCT01968954|Antimetabolites|antimetabolites|mesh-ancestor
6197306|NCT01968954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197307|NCT01968954|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6197308|NCT01968967|Bococizumab|bococizumab|mesh-list
5586743|NCT03805568|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5586744|NCT03805568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6197309|NCT01968967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6197310|NCT01968967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6672284|NCT01555099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6672285|NCT01555099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672286|NCT01555099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6197311|NCT01968967|Antimetabolites|antimetabolites|mesh-ancestor
6197312|NCT01968967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197313|NCT01968967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6197314|NCT01968980|Bococizumab|bococizumab|mesh-list
6197315|NCT01968980|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6197316|NCT01968980|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6197317|NCT01968980|Antimetabolites|antimetabolites|mesh-ancestor
6197318|NCT01968980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197319|NCT01968980|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6197320|NCT01969058|Isotretinoin|isotretinoin|mesh-list
6197321|NCT01969058|Dermatologic Agents|dermatologic agents|mesh-ancestor
6197322|NCT01969084|Linagliptin|linagliptin|mesh-list
6197323|NCT01969084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6197324|NCT01969084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197325|NCT01969084|Incretins|incretins|mesh-ancestor
6197326|NCT01969084|Hormones|hormones|mesh-ancestor
6197327|NCT01969084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6197328|NCT01969084|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6197329|NCT01969084|Protease Inhibitors|protease inhibitors|mesh-ancestor
6197330|NCT01969084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6197331|NCT01969084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197332|NCT01969201|Hormones|hormones|mesh-list
6197333|NCT01969201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6197334|NCT01969201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197335|NCT01969435|Cytarabine|cytarabine|mesh-list
6197336|NCT01969435|Etoposide|etoposide|mesh-list
6197337|NCT01969435|Melphalan|melphalan|mesh-list
6197338|NCT01969435|Carmustine|carmustine|mesh-list
6197339|NCT01969435|Etoposide phosphate|etoposide phosphate|mesh-list
6197340|NCT01969435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6197341|NCT01969435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6197342|NCT01969435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6197343|NCT01969435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5586745|NCT03805568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586746|NCT03805568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5586747|NCT03805568|Analgesics|analgesics|mesh-ancestor
5586748|NCT03805568|Sensory System Agents|sensory system agents|mesh-ancestor
5586749|NCT03805568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5586750|NCT03805568|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5586751|NCT03805568|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5586752|NCT03805568|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5586753|NCT03805568|Adrenergic Agents|adrenergic agents|mesh-ancestor
5586754|NCT03805568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5586755|NCT03805568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586756|NCT03805568|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6197344|NCT01969435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6197345|NCT01969435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197346|NCT01969435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6197347|NCT01969435|Antimetabolites|antimetabolites|mesh-ancestor
6197348|NCT01969435|Antiviral Agents|antiviral agents|mesh-ancestor
6197349|NCT01969435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6197350|NCT01969435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6197351|NCT01969435|Immunologic Factors|immunologic factors|mesh-ancestor
6197352|NCT01969435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197353|NCT01969435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6197354|NCT01969435|Alkylating Agents|alkylating agents|mesh-ancestor
6197355|NCT01969435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6197356|NCT01969708|Bevacizumab|bevacizumab|mesh-list
6197357|NCT01969708|Aflibercept|aflibercept|mesh-list
6197358|NCT01969708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5586757|NCT03805568|Narcotics|narcotics|mesh-ancestor
6197359|NCT01969708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6197360|NCT01969708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6197361|NCT01969708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6197362|NCT01969708|Growth Substances|growth substances|mesh-ancestor
6197363|NCT01969708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197364|NCT01969708|Growth Inhibitors|growth inhibitors|mesh-ancestor
6197365|NCT01969721|Fluticasone|fluticasone|mesh-list
6197366|NCT01969721|Xhance|xhance|mesh-list
6197367|NCT01969721|Tiotropium Bromide|tiotropium bromide|mesh-list
6197368|NCT01969721|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6197369|NCT01969721|Olodaterol|olodaterol|mesh-list
6197370|NCT01969721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6197371|NCT01969721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6197372|NCT01969721|Autonomic Agents|autonomic agents|mesh-ancestor
6197373|NCT01969721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6197374|NCT01969721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197375|NCT01969721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6197376|NCT01969721|Respiratory System Agents|respiratory system agents|mesh-ancestor
6197377|NCT01969721|Dermatologic Agents|dermatologic agents|mesh-ancestor
6197378|NCT01969721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6197379|NCT01969721|Parasympatholytics|parasympatholytics|mesh-ancestor
6197380|NCT01969721|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6197381|NCT01969721|Cholinergic Agents|cholinergic agents|mesh-ancestor
6197382|NCT01969721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6197383|NCT01969721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197384|NCT01969721|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6197385|NCT01969721|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6197386|NCT01969721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6197387|NCT01969721|Adrenergic Agents|adrenergic agents|mesh-ancestor
6197388|NCT01969747|Empagliflozin|empagliflozin|mesh-list
6197389|NCT01969747|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6197390|NCT01969747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197391|NCT01969747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6197392|NCT01969747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197393|NCT01969799|Amikacin|amikacin|mesh-list
6197394|NCT01969799|Fosfomycin|fosfomycin|mesh-list
6197395|NCT01969799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6197396|NCT01969799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6197397|NCT01969851|Lacosamide|lacosamide|mesh-list
6197398|NCT01969851|Anticonvulsants|anticonvulsants|mesh-ancestor
6197399|NCT01969851|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5586758|NCT03805633|Pancrelipase|pancrelipase|mesh-list
5586759|NCT03805633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5586760|NCT03805399|Sirolimus|sirolimus|mesh-list
5586761|NCT03805399|Paclitaxel|paclitaxel|mesh-list
5586762|NCT03805399|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5586763|NCT03805399|Capecitabine|capecitabine|mesh-list
5586764|NCT03805399|Everolimus|everolimus|mesh-list
5586765|NCT03805399|Apatinib|apatinib|mesh-list
5586766|NCT03805399|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
5586767|NCT03805399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6197400|NCT01969851|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6197401|NCT01969851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6197402|NCT01969851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197403|NCT01969916|Regadenoson|regadenoson|mesh-list
6197404|NCT01969916|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
6197405|NCT01969916|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6197406|NCT01969916|Purinergic Agonists|purinergic agonists|mesh-ancestor
6197407|NCT01969916|Purinergic Agents|purinergic agents|mesh-ancestor
6197408|NCT01969916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6197409|NCT01969916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197410|NCT01969916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197411|NCT01970176|Tadalafil|tadalafil|mesh-list
6197412|NCT01970176|Vasodilator Agents|vasodilator agents|mesh-ancestor
6197413|NCT01970176|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6197414|NCT01970176|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6197415|NCT01970176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5586768|NCT03805399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5586769|NCT03805399|Tubulin Modulators|tubulin modulators|mesh-ancestor
5586770|NCT03805399|Antimitotic Agents|antimitotic agents|mesh-ancestor
6197416|NCT01970176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197417|NCT01970176|Urological Agents|urological agents|mesh-ancestor
6197418|NCT01970241|Insulin|insulin|mesh-list
6197419|NCT01970241|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6197420|NCT01970241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6197421|NCT01970241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586771|NCT03805399|Mitosis Modulators|mitosis modulators|mesh-ancestor
5586772|NCT03805399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586773|NCT03805399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5586774|NCT03805399|Antimetabolites|antimetabolites|mesh-ancestor
6197422|NCT01970371|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6197423|NCT01970371|Meropenem|meropenem|mesh-list
6197424|NCT01970371|Colistin|colistin|mesh-list
6197425|NCT01970371|Tigecycline|tigecycline|mesh-list
6197426|NCT01970371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6197427|NCT01970371|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6197428|NCT01970371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6197429|NCT01970371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197430|NCT01970397|Hyaluronic Acid|hyaluronic acid|mesh-list
6197431|NCT01970397|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6197432|NCT01970397|Immunologic Factors|immunologic factors|mesh-ancestor
6197433|NCT01970397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197434|NCT01970397|Viscosupplements|viscosupplements|mesh-ancestor
6197435|NCT01970397|Protective Agents|protective agents|mesh-ancestor
6197436|NCT01970475|Adalimumab|adalimumab|mesh-list
6197437|NCT01970475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6197438|NCT01970475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6197439|NCT01970488|Adalimumab|adalimumab|mesh-list
6197440|NCT01970488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6197441|NCT01970488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6197442|NCT01970527|Ipilimumab|ipilimumab|mesh-list
6197443|NCT01970527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6197444|NCT01970527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6197445|NCT01970527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6197446|NCT01970527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197447|NCT01970540|Doxorubicin|doxorubicin|mesh-list
6197448|NCT01970540|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6197449|NCT01970540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6197450|NCT01970540|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6197451|NCT01970540|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6197452|NCT01970540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6197453|NCT01970540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197454|NCT01970878|Bromides|bromides|mesh-list
6197455|NCT01970878|Tiotropium Bromide|tiotropium bromide|mesh-list
6197456|NCT01970878|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6197457|NCT01970878|Autonomic Agents|autonomic agents|mesh-ancestor
6197458|NCT01970878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6197459|NCT01970878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197460|NCT01970878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6197461|NCT01970878|Respiratory System Agents|respiratory system agents|mesh-ancestor
6197462|NCT01970878|Parasympatholytics|parasympatholytics|mesh-ancestor
6197463|NCT01970878|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6197464|NCT01970878|Cholinergic Agents|cholinergic agents|mesh-ancestor
6197465|NCT01970878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6197466|NCT01970878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586775|NCT03805399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5586776|NCT03805399|Immunologic Factors|immunologic factors|mesh-ancestor
5586777|NCT03805399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586778|NCT03805399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5586779|NCT03805399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5586780|NCT03805399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5586781|NCT03805399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5586782|NCT03805399|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5586783|NCT03805399|Antifungal Agents|antifungal agents|mesh-ancestor
5586784|NCT03805282|Lidocaine|lidocaine|mesh-list
5586785|NCT03805282|Anesthetics, Local|anesthetics, local|mesh-ancestor
5586786|NCT03805282|Anesthetics|anesthetics|mesh-ancestor
5586787|NCT03805282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5586788|NCT03805282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586789|NCT03805282|Sensory System Agents|sensory system agents|mesh-ancestor
5586790|NCT03805282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6197467|NCT01970878|Anticonvulsants|anticonvulsants|mesh-ancestor
6197468|NCT01970995|Menthol|menthol|mesh-list
6197469|NCT01970995|Antipruritics|antipruritics|mesh-ancestor
6197470|NCT01970995|Dermatologic Agents|dermatologic agents|mesh-ancestor
6197471|NCT01971203|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6197472|NCT01971203|Antidepressive Agents|antidepressive agents|mesh-ancestor
6197473|NCT01971203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6197474|NCT01971203|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6197475|NCT01971203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6197476|NCT01971203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6197477|NCT01971203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197478|NCT01971346|Etanercept|etanercept|mesh-list
6197479|NCT01971346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6197480|NCT01971346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6197481|NCT01971346|Analgesics|analgesics|mesh-ancestor
6197482|NCT01971346|Sensory System Agents|sensory system agents|mesh-ancestor
6197483|NCT01971346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6197484|NCT01971346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197485|NCT01971346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6197486|NCT01971346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6197487|NCT01971346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6197488|NCT01971346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6197489|NCT01971346|Immunologic Factors|immunologic factors|mesh-ancestor
6197490|NCT01971385|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6197491|NCT01971385|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
6197492|NCT01971385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6197493|NCT01971385|Immunologic Factors|immunologic factors|mesh-ancestor
6197494|NCT01971385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197495|NCT01971580|Ambrisentan|ambrisentan|mesh-list
6197496|NCT01971580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6197497|NCT01971593|Eplerenone|eplerenone|mesh-list
6197498|NCT01971593|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6197499|NCT01971593|Hormone Antagonists|hormone antagonists|mesh-ancestor
6197500|NCT01971593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6197501|NCT01971593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197502|NCT01971593|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6197503|NCT01971593|Diuretics|diuretics|mesh-ancestor
6197504|NCT01971593|Natriuretic Agents|natriuretic agents|mesh-ancestor
6197505|NCT01971593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6197506|NCT01971645|Dexamethasone|dexamethasone|mesh-list
6197507|NCT01971645|Ropivacaine|ropivacaine|mesh-list
6197508|NCT01971645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6197509|NCT01971645|Antiemetics|antiemetics|mesh-ancestor
6197510|NCT01971645|Autonomic Agents|autonomic agents|mesh-ancestor
6197511|NCT01971645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6197512|NCT01971645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197513|NCT01971645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5586791|NCT03805282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5586792|NCT03805282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5586793|NCT03805282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5586794|NCT03805282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5605215|NCT03278925|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6197514|NCT01971645|Glucocorticoids|glucocorticoids|mesh-ancestor
6197515|NCT01971645|Hormones|hormones|mesh-ancestor
6197516|NCT01971645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6197517|NCT01971645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6197518|NCT01971645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6197519|NCT01971645|Anesthetics, Local|anesthetics, local|mesh-ancestor
6197520|NCT01971645|Anesthetics|anesthetics|mesh-ancestor
6197521|NCT01971645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6197522|NCT01971645|Sensory System Agents|sensory system agents|mesh-ancestor
6197523|NCT01972074|Memantine|memantine|mesh-list
6197524|NCT01972074|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6197525|NCT01972074|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6197526|NCT01972074|Dopamine Agents|dopamine agents|mesh-ancestor
6197527|NCT01972074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6197528|NCT01972074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197529|NCT01972074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197530|NCT01972074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6197531|NCT01972074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6197532|NCT01972152|Glucagon|glucagon|mesh-list
6197533|NCT01972152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6197534|NCT01972152|Hormones|hormones|mesh-ancestor
6197535|NCT01972152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6197536|NCT01972152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197537|NCT01972464|Progesterone|progesterone|mesh-list
6197538|NCT01972464|Progestins|progestins|mesh-ancestor
6197539|NCT01972464|Hormones|hormones|mesh-ancestor
6207489|NCT02116530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6197540|NCT01972464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6197541|NCT01972464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197542|NCT01972659|Magnesium Sulfate|magnesium sulfate|mesh-list
6197543|NCT01972659|Analgesics|analgesics|mesh-ancestor
6197544|NCT01972659|Sensory System Agents|sensory system agents|mesh-ancestor
6197545|NCT01972659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6197546|NCT01972659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197547|NCT01972659|Anesthetics|anesthetics|mesh-ancestor
6197548|NCT01972659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6197549|NCT01972659|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6197550|NCT01972659|Anticonvulsants|anticonvulsants|mesh-ancestor
6197551|NCT01972659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6197552|NCT01972659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6197553|NCT01972659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197554|NCT01972659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6197555|NCT01972659|Tocolytic Agents|tocolytic agents|mesh-ancestor
6197556|NCT01972659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6197557|NCT01972724|Metformin|metformin|mesh-list
6197558|NCT01972724|Pioglitazone|pioglitazone|mesh-list
6197559|NCT01972724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6197560|NCT01972724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197561|NCT01972789|Ranibizumab|ranibizumab|mesh-list
6197562|NCT01972789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6197563|NCT01972789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6197564|NCT01972789|Growth Substances|growth substances|mesh-ancestor
6197565|NCT01972789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672287|NCT01555099|Respiratory System Agents|respiratory system agents|mesh-ancestor
6672288|NCT01555099|Glucocorticoids|glucocorticoids|mesh-ancestor
6672289|NCT01555099|Hormones|hormones|mesh-ancestor
6197566|NCT01972789|Growth Inhibitors|growth inhibitors|mesh-ancestor
6197567|NCT01972789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6197568|NCT01972841|Solifenacin Succinate|solifenacin succinate|mesh-list
6197569|NCT01972841|Mirabegron|mirabegron|mesh-list
6197570|NCT01972841|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6197571|NCT01972841|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6197572|NCT01972841|Cholinergic Agents|cholinergic agents|mesh-ancestor
6197573|NCT01972841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5586795|NCT03805282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586796|NCT03805477|Nintedanib|nintedanib|mesh-list
5586797|NCT03805477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5586798|NCT03805477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5586799|NCT03805477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5586800|NCT03805477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586801|NCT03805360|Ropivacaine|ropivacaine|mesh-list
5586802|NCT03805360|Anesthetics, Local|anesthetics, local|mesh-list
5586803|NCT03805360|Anesthetics|anesthetics|mesh-list
5586804|NCT03805360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5586805|NCT03805360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586806|NCT03805360|Sensory System Agents|sensory system agents|mesh-ancestor
5586807|NCT03805360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5586808|NCT03805503|Chloroprocaine|chloroprocaine|mesh-list
6197574|NCT01972841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197575|NCT01972841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197576|NCT01972841|Urological Agents|urological agents|mesh-ancestor
6197577|NCT01972841|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6197578|NCT01972841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6197579|NCT01972841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6197580|NCT01972841|Adrenergic Agents|adrenergic agents|mesh-ancestor
5586809|NCT03805503|Procaine|procaine|mesh-list
5586810|NCT03805503|Anesthetics, Local|anesthetics, local|mesh-ancestor
5586811|NCT03805503|Anesthetics|anesthetics|mesh-ancestor
5586812|NCT03805503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6197581|NCT01973036|Oxytocin|oxytocin|mesh-list
6197582|NCT01973036|Oxytocics|oxytocics|mesh-ancestor
6197583|NCT01973036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6197584|NCT01973036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197585|NCT01973205|Aspirin|aspirin|mesh-list
6197586|NCT01973205|Acetaminophen|acetaminophen|mesh-list
6197587|NCT01973205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6197588|NCT01973205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6197589|NCT01973205|Analgesics|analgesics|mesh-ancestor
6672290|NCT01555099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6672291|NCT01555112|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
6672292|NCT01555112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6672293|NCT01555112|Immunologic Factors|immunologic factors|mesh-ancestor
6672294|NCT01555112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672295|NCT01555112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6672296|NCT01555112|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6672297|NCT01555112|Protective Agents|protective agents|mesh-ancestor
6672298|NCT01555112|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6197590|NCT01973205|Sensory System Agents|sensory system agents|mesh-ancestor
6197591|NCT01973205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6197592|NCT01973205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197593|NCT01973205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6197594|NCT01973205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6197595|NCT01973205|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6197596|NCT01973205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6197597|NCT01973205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197598|NCT01973205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6197599|NCT01973205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6197600|NCT01973205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6197601|NCT01973205|Antipyretics|antipyretics|mesh-ancestor
6197602|NCT01973218|Vaccines|vaccines|mesh-list
6197603|NCT01973218|Immunologic Factors|immunologic factors|mesh-ancestor
5586813|NCT03805503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586814|NCT03805503|Sensory System Agents|sensory system agents|mesh-ancestor
5586815|NCT03805503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5586816|NCT03805178|Abatacept|abatacept|mesh-list
5586817|NCT03805178|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5586818|NCT03805178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586819|NCT03805178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5586820|NCT03805178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5586821|NCT03805178|Immunologic Factors|immunologic factors|mesh-ancestor
5586822|NCT03805178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586823|NCT03805178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5586824|NCT03804931|Aminosalicylic Acid|aminosalicylic acid|mesh-list
5586825|NCT03804931|Prednisone|prednisone|mesh-list
5586826|NCT03804931|Mesalamine|mesalamine|mesh-list
5586827|NCT03804931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5586828|NCT03804931|Glucocorticoids|glucocorticoids|mesh-ancestor
5586829|NCT03804931|Hormones|hormones|mesh-ancestor
5586830|NCT03804931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5586831|NCT03804931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586832|NCT03804931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5586833|NCT03804931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5586834|NCT03804931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5586835|NCT03804931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5586836|NCT03804931|Analgesics|analgesics|mesh-ancestor
5586837|NCT03804931|Sensory System Agents|sensory system agents|mesh-ancestor
5586838|NCT03804931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5586839|NCT03804931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5586840|NCT03804931|Antitubercular Agents|antitubercular agents|mesh-ancestor
5586841|NCT03804931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5586842|NCT03804931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5586843|NCT03805100|Ranibizumab|ranibizumab|mesh-list
5586844|NCT03805100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5586845|NCT03805100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5586846|NCT03805100|Growth Substances|growth substances|mesh-ancestor
5586847|NCT03805100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586848|NCT03805100|Growth Inhibitors|growth inhibitors|mesh-ancestor
5586849|NCT03805100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5586850|NCT03805152|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6197604|NCT01973218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197605|NCT01973231|Liraglutide|liraglutide|mesh-list
6197606|NCT01973231|Lixisenatide|lixisenatide|mesh-list
6197607|NCT01973231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6197608|NCT01973231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586851|NCT03805152|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5586852|NCT03805152|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5586853|NCT03805152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5586854|NCT03805152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586855|NCT03805152|Cholinergic Agents|cholinergic agents|mesh-ancestor
5586856|NCT03805152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5586857|NCT03805152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197609|NCT01973231|Incretins|incretins|mesh-ancestor
6197610|NCT01973231|Hormones|hormones|mesh-ancestor
6197611|NCT01973231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6197612|NCT01973283|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5586858|NCT03805152|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5586859|NCT03805152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5586860|NCT03804944|Pembrolizumab|pembrolizumab|mesh-list
5586861|NCT03804944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5586862|NCT03804944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5586863|NCT03805035|Chlorpheniramine|chlorpheniramine|mesh-list
5586864|NCT03805035|Maleic acid|maleic acid|mesh-list
5586865|NCT03805035|Histamine Antagonists|histamine antagonists|mesh-list
5586866|NCT03805035|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
5586867|NCT03805035|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
5586868|NCT03805035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5586869|NCT03805035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586870|NCT03805035|Histamine Agents|histamine agents|mesh-ancestor
5586871|NCT03805035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5586872|NCT03805035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586873|NCT03805035|Antipruritics|antipruritics|mesh-ancestor
5586874|NCT03805035|Dermatologic Agents|dermatologic agents|mesh-ancestor
5586875|NCT03805035|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5586876|NCT03804866|Doxorubicin|doxorubicin|mesh-list
5586877|NCT03804866|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5586878|NCT03804866|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5586879|NCT03804866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5586880|NCT03804866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5586881|NCT03804866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5586882|NCT03804866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5586883|NCT03804866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586884|NCT03804840|Dronabinol|dronabinol|mesh-list
5586885|NCT03804840|Hallucinogens|hallucinogens|mesh-ancestor
5586886|NCT03804840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197613|NCT01973283|Citalopram|citalopram|mesh-list
6197614|NCT01973283|Antidepressive Agents|antidepressive agents|mesh-list
6197615|NCT01973283|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6197616|NCT01973283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6197617|NCT01973283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6197618|NCT01973283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197619|NCT01973283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6197620|NCT01973283|Serotonin Agents|serotonin agents|mesh-ancestor
6197621|NCT01973283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197622|NCT01973283|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6197623|NCT01973283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6197624|NCT01973283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6197625|NCT01973283|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6197626|NCT01973283|Analgesics|analgesics|mesh-ancestor
6197627|NCT01973283|Sensory System Agents|sensory system agents|mesh-ancestor
6197628|NCT01973283|Dopamine Agents|dopamine agents|mesh-ancestor
6197629|NCT01973335|Spironolactone|spironolactone|mesh-list
6197630|NCT01973335|Acetazolamide|acetazolamide|mesh-list
6197631|NCT01973335|Bumetanide|bumetanide|mesh-list
6197632|NCT01973335|Diuretics|diuretics|mesh-list
6197633|NCT01973335|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
6197634|NCT01973335|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6197635|NCT01973335|Hormone Antagonists|hormone antagonists|mesh-ancestor
6197636|NCT01973335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6197637|NCT01973335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197638|NCT01973335|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6197639|NCT01973335|Natriuretic Agents|natriuretic agents|mesh-ancestor
6197640|NCT01973335|Anticonvulsants|anticonvulsants|mesh-ancestor
6197641|NCT01973335|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6197642|NCT01973335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6197643|NCT01973335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197644|NCT01973335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6197645|NCT01973348|Methamphetamine|methamphetamine|mesh-list
6197646|NCT01973348|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6197647|NCT01973348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197648|NCT01973348|Sympathomimetics|sympathomimetics|mesh-ancestor
6197649|NCT01973348|Autonomic Agents|autonomic agents|mesh-ancestor
6197650|NCT01973348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6197651|NCT01973348|Dopamine Agents|dopamine agents|mesh-ancestor
6197652|NCT01973348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6197653|NCT01973348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197654|NCT01973348|Adrenergic Agents|adrenergic agents|mesh-ancestor
6197655|NCT01973348|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6197656|NCT01973348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6197657|NCT01973348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6197658|NCT01973348|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6197659|NCT01973387|Rituximab|rituximab|mesh-list
6197660|NCT01973387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6197661|NCT01973387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6197662|NCT01973387|Immunologic Factors|immunologic factors|mesh-ancestor
6197663|NCT01973387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197664|NCT01973387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6197665|NCT01973413|Insulin|insulin|mesh-list
6197666|NCT01973413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6197667|NCT01973413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197668|NCT01973439|Abacavir|abacavir|mesh-list
6197669|NCT01973439|Dideoxynucleosides|dideoxynucleosides|mesh-list
6197670|NCT01973439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6197671|NCT01973439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6197672|NCT01973439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6197673|NCT01973439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586887|NCT03804840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5586888|NCT03804840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5586889|NCT03804840|Analgesics|analgesics|mesh-ancestor
5586890|NCT03804840|Sensory System Agents|sensory system agents|mesh-ancestor
5586891|NCT03804840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5586892|NCT03804840|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5586893|NCT03804840|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5586894|NCT03804840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5586895|NCT03804840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197674|NCT01973439|Antiviral Agents|antiviral agents|mesh-ancestor
6197675|NCT01973439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6197676|NCT01973439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6197677|NCT01973439|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6197678|NCT01973439|Antimetabolites|antimetabolites|mesh-ancestor
6197679|NCT01973569|Denosumab|denosumab|mesh-list
6197680|NCT01973569|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6197681|NCT01973569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197682|NCT01974141|Dapsone|dapsone|mesh-list
6197683|NCT01974141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5586896|NCT03804840|Hormones|hormones|mesh-ancestor
5586897|NCT03804840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5605216|NCT03278925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605217|NCT03278925|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5605218|NCT03223883|Curcumin|curcumin|mesh-list
5605219|NCT03223883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5605220|NCT03223883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5605221|NCT03223883|Analgesics|analgesics|mesh-ancestor
5605222|NCT03223883|Sensory System Agents|sensory system agents|mesh-ancestor
5605223|NCT03223883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5605224|NCT03223883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605225|NCT03223883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5605226|NCT03223883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5605227|NCT03223883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605228|NCT03223883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5605229|NCT03223883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605230|NCT03153514|Obinutuzumab|obinutuzumab|mesh-list
5605231|NCT03153514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5605232|NCT03153514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605233|NCT03125642|Cytarabine|cytarabine|mesh-list
5605234|NCT03125642|Cyclophosphamide|cyclophosphamide|mesh-list
5605235|NCT03125642|Melphalan|melphalan|mesh-list
6197684|NCT01974141|Antimalarials|antimalarials|mesh-ancestor
5605236|NCT03125642|Carmustine|carmustine|mesh-list
5586898|NCT03804749|Suramin|suramin|mesh-list
5586899|NCT03804749|Antinematodal Agents|antinematodal agents|mesh-ancestor
5586900|NCT03804749|Anthelmintics|anthelmintics|mesh-ancestor
5586901|NCT03804749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5586902|NCT03804749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5586903|NCT03804749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5586904|NCT03804749|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5586905|NCT03804749|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5586906|NCT03804580|Osimertinib|osimertinib|mesh-list
5586907|NCT03804580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5586908|NCT03804580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5586909|NCT03804580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5586910|NCT03804580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586911|NCT03804372|Tenofovir|tenofovir|mesh-list
5586912|NCT03804372|Rituximab|rituximab|mesh-list
5586913|NCT03804372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6197685|NCT01974141|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6197686|NCT01974141|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6197687|NCT01974141|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6197688|NCT01974141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6197689|NCT01974141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197690|NCT01974141|Leprostatic Agents|leprostatic agents|mesh-ancestor
6197691|NCT01974141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6197692|NCT01974245|Cholecalciferol|cholecalciferol|mesh-list
6197693|NCT01974245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6197694|NCT01974245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197695|NCT01974245|Vitamins|vitamins|mesh-ancestor
6197696|NCT01974245|Micronutrients|micronutrients|mesh-ancestor
6197697|NCT01974245|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6197698|NCT01974323|Dapsone|dapsone|mesh-list
5586914|NCT03804372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5586915|NCT03804372|Immunologic Factors|immunologic factors|mesh-ancestor
5586916|NCT03804372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586917|NCT03804372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5586918|NCT03804372|Antiviral Agents|antiviral agents|mesh-ancestor
5586919|NCT03804372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5586920|NCT03804372|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5586921|NCT03804372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5586922|NCT03804372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5586923|NCT03804372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586924|NCT03804372|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5586925|NCT03804372|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5586926|NCT03804541|Ensartinib|ensartinib|mesh-list
5586927|NCT03804541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5586928|NCT03804541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5586929|NCT03804541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5586930|NCT03804541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586931|NCT03804723|Prednisone|prednisone|mesh-list
5586932|NCT03804723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5586933|NCT03804723|Glucocorticoids|glucocorticoids|mesh-ancestor
5586934|NCT03804723|Hormones|hormones|mesh-ancestor
5586935|NCT03804723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5586936|NCT03804723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586937|NCT03804723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5586938|NCT03804723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5586939|NCT03804359|Rituximab|rituximab|mesh-list
5586940|NCT03804359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5586941|NCT03804359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5586942|NCT03804359|Immunologic Factors|immunologic factors|mesh-ancestor
5586943|NCT03804359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586944|NCT03804359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5586945|NCT03804034|Molybdenum|molybdenum|mesh-list
5586946|NCT03804034|Trace Elements|trace elements|mesh-ancestor
5586947|NCT03804034|Micronutrients|micronutrients|mesh-ancestor
5586948|NCT03804034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586949|NCT03804177|Ascorbic Acid|ascorbic acid|mesh-list
5586950|NCT03804177|Melatonin|melatonin|mesh-list
5586951|NCT03804177|Hyaluronic Acid|hyaluronic acid|mesh-list
5586952|NCT03804177|Antioxidants|antioxidants|mesh-ancestor
5586953|NCT03804177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586954|NCT03804177|Protective Agents|protective agents|mesh-ancestor
5586955|NCT03804177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586956|NCT03804177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5586957|NCT03804177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5586958|NCT03804177|Immunologic Factors|immunologic factors|mesh-ancestor
5586959|NCT03804177|Viscosupplements|viscosupplements|mesh-ancestor
5586960|NCT03804177|Vitamins|vitamins|mesh-ancestor
5586961|NCT03804177|Micronutrients|micronutrients|mesh-ancestor
5586962|NCT03804229|3-n-butylphthalide|3-n-butylphthalide|mesh-list
5586963|NCT03804229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5586964|NCT03804229|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5586965|NCT03804229|Protective Agents|protective agents|mesh-ancestor
5586966|NCT03804229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197699|NCT01974323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6197700|NCT01974323|Antimalarials|antimalarials|mesh-ancestor
6197701|NCT01974323|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6197702|NCT01974323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6197703|NCT01974323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6197704|NCT01974323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6197705|NCT01974323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197706|NCT01974323|Leprostatic Agents|leprostatic agents|mesh-ancestor
6197707|NCT01974323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6197708|NCT01974687|Itraconazole|itraconazole|mesh-list
6197709|NCT01974687|Uprifosbuvir|uprifosbuvir|mesh-list
6197710|NCT01974687|Antifungal Agents|antifungal agents|mesh-ancestor
6197711|NCT01974687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6197712|NCT01974687|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6197713|NCT01974687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6197714|NCT01974687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6197715|NCT01974687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197716|NCT01974687|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6197717|NCT01974687|Hormone Antagonists|hormone antagonists|mesh-ancestor
6197718|NCT01974687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6197719|NCT01974687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197720|NCT01974687|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6197721|NCT01974687|Antiviral Agents|antiviral agents|mesh-ancestor
6207490|NCT02116530|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6207491|NCT02116530|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6207492|NCT02116530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6207493|NCT02116530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6207494|NCT02116530|Antipruritics|antipruritics|mesh-ancestor
6207495|NCT02116530|Dermatologic Agents|dermatologic agents|mesh-ancestor
6207496|NCT02116530|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6207497|NCT02116530|Serotonin Agents|serotonin agents|mesh-ancestor
6207498|NCT02116530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6207499|NCT02116530|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6207500|NCT02116530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6207501|NCT02116530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6207502|NCT02116530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6207503|NCT02116530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6207504|NCT02116530|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6207505|NCT02116530|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6207506|NCT02116530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6207507|NCT02116530|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6207508|NCT02116530|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6207509|NCT02116608|Povidone-Iodine|povidone-iodine|mesh-list
6207510|NCT02116608|Silver Nitrate|silver nitrate|mesh-list
6207511|NCT02116608|Hydrocortisone|hydrocortisone|mesh-list
6207512|NCT02116608|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
6207513|NCT02116608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6207514|NCT02116608|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6207515|NCT02116608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5586967|NCT03803553|Fluorouracil|fluorouracil|mesh-list
5586968|NCT03803553|Nivolumab|nivolumab|mesh-list
5586969|NCT03803553|Irinotecan|irinotecan|mesh-list
5586970|NCT03803553|Cetuximab|cetuximab|mesh-list
5586971|NCT03803553|Antimetabolites|antimetabolites|mesh-ancestor
5586972|NCT03803553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5586973|NCT03803553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5586974|NCT03803553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5586975|NCT03803553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5586976|NCT03803553|Immunologic Factors|immunologic factors|mesh-ancestor
5586977|NCT03803553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586978|NCT03803553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5586979|NCT03803553|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5586980|NCT03803553|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5586981|NCT03803553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5586982|NCT03803553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5586983|NCT03803787|Budesonide|budesonide|mesh-list
5586984|NCT03803787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5605237|NCT03125642|Etoposide|etoposide|mesh-list
6197722|NCT01974700|Levetiracetam|levetiracetam|mesh-list
6197723|NCT01974700|Anticonvulsants|anticonvulsants|mesh-ancestor
6197724|NCT01974700|Nootropic Agents|nootropic agents|mesh-ancestor
6197725|NCT01974752|Dacarbazine|dacarbazine|mesh-list
6197726|NCT01974752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6197727|NCT01974752|Alkylating Agents|alkylating agents|mesh-ancestor
6197728|NCT01974752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197729|NCT01974752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6197730|NCT01974817|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6197731|NCT01974817|Immunologic Factors|immunologic factors|mesh-ancestor
6197732|NCT01974817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197733|NCT01975220|Metformin|metformin|mesh-list
6197734|NCT01975220|Empagliflozin|empagliflozin|mesh-list
6197735|NCT01975220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6197736|NCT01975220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197737|NCT01975220|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5586985|NCT03803787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5586986|NCT03803787|Autonomic Agents|autonomic agents|mesh-ancestor
5586987|NCT03803787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5586988|NCT03803787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5586989|NCT03803787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5586990|NCT03803787|Respiratory System Agents|respiratory system agents|mesh-ancestor
5586991|NCT03803787|Glucocorticoids|glucocorticoids|mesh-ancestor
5586992|NCT03803787|Hormones|hormones|mesh-ancestor
5586993|NCT03803787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5586994|NCT03803514|Epoetin Alfa|epoetin alfa|mesh-list
5586995|NCT03803514|Hematinics|hematinics|mesh-ancestor
6197738|NCT01975220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197739|NCT01975246|Amlodipine|amlodipine|mesh-list
6197740|NCT01975246|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6197741|NCT01975246|Telmisartan|telmisartan|mesh-list
6197742|NCT01975246|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
6197743|NCT01975246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6197744|NCT01975246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6197745|NCT01975246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6197746|NCT01975246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197747|NCT01975246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6197748|NCT01975246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197749|NCT01975246|Vasodilator Agents|vasodilator agents|mesh-ancestor
6197750|NCT01975246|Diuretics|diuretics|mesh-ancestor
6197751|NCT01975246|Natriuretic Agents|natriuretic agents|mesh-ancestor
6197752|NCT01975246|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6197753|NCT01975246|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6197754|NCT01975246|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6197755|NCT01975285|Dexamethasone|dexamethasone|mesh-list
6197756|NCT01975285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6197757|NCT01975285|Antiemetics|antiemetics|mesh-ancestor
6197758|NCT01975285|Autonomic Agents|autonomic agents|mesh-ancestor
6197759|NCT01975285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6197760|NCT01975285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197761|NCT01975285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6197762|NCT01975285|Glucocorticoids|glucocorticoids|mesh-ancestor
6197763|NCT01975285|Hormones|hormones|mesh-ancestor
6197764|NCT01975285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6197765|NCT01975285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6197766|NCT01975285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6197767|NCT01975376|Bococizumab|bococizumab|mesh-list
6197768|NCT01975376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6197769|NCT01975376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6197770|NCT01975376|Antimetabolites|antimetabolites|mesh-ancestor
6197771|NCT01975376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197772|NCT01975376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6197773|NCT01975389|Bococizumab|bococizumab|mesh-list
6197774|NCT01975389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6197775|NCT01975389|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6197776|NCT01975389|Antimetabolites|antimetabolites|mesh-ancestor
6197777|NCT01975389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197778|NCT01975389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6197779|NCT01975519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6197780|NCT01975519|Immunologic Factors|immunologic factors|mesh-ancestor
6197781|NCT01975519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197782|NCT01975675|Sofosbuvir|sofosbuvir|mesh-list
5586996|NCT03803449|Fentanyl|fentanyl|mesh-list
5586997|NCT03803449|Midazolam|midazolam|mesh-list
6197783|NCT01975675|Ledipasvir|ledipasvir|mesh-list
5586998|NCT03803449|Propofol|propofol|mesh-list
5586999|NCT03803449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5587000|NCT03803449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5587001|NCT03803449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587002|NCT03803449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5587003|NCT03803449|Anesthetics, General|anesthetics, general|mesh-ancestor
5587004|NCT03803449|Anesthetics|anesthetics|mesh-ancestor
5587005|NCT03803449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5587006|NCT03803449|Narcotics|narcotics|mesh-ancestor
5587007|NCT03803449|Analgesics|analgesics|mesh-ancestor
5587008|NCT03803449|Sensory System Agents|sensory system agents|mesh-ancestor
5587009|NCT03803449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5587010|NCT03803449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5587011|NCT03803449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5587012|NCT03803449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5587013|NCT03803449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5587014|NCT03803449|GABA Modulators|gaba modulators|mesh-ancestor
5587015|NCT03803449|GABA Agents|gaba agents|mesh-ancestor
5587016|NCT03803449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5587017|NCT03803449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587018|NCT03803839|Clodronic Acid|clodronic acid|mesh-list
5587019|NCT03803839|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5587020|NCT03803839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587021|NCT03803371|Acetaminophen|acetaminophen|mesh-list
5587022|NCT03803371|Tramadol|tramadol|mesh-list
5587023|NCT03803371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5587024|NCT03803371|Analgesics|analgesics|mesh-ancestor
5587025|NCT03803371|Sensory System Agents|sensory system agents|mesh-ancestor
5587026|NCT03803371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5587027|NCT03803371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587028|NCT03803371|Antipyretics|antipyretics|mesh-ancestor
5587029|NCT03803371|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5587030|NCT03803371|Narcotics|narcotics|mesh-ancestor
5587031|NCT03803371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6197784|NCT01975675|Antiviral Agents|antiviral agents|mesh-ancestor
6197785|NCT01975675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6197786|NCT01975701|Infigratinib|infigratinib|mesh-list
6197787|NCT01975701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6197788|NCT01975831|Durvalumab|durvalumab|mesh-list
6197789|NCT01975831|Tremelimumab|tremelimumab|mesh-list
6197790|NCT01975831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6197791|NCT01975831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6197792|NCT01975935|Amlexanox|amlexanox|mesh-list
5587032|NCT03803254|Lenvatinib|lenvatinib|mesh-list
5587033|NCT03803254|Antibodies|antibodies|mesh-list
5587034|NCT03803254|Immunologic Factors|immunologic factors|mesh-ancestor
5587035|NCT03803254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587036|NCT03803254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5587037|NCT03803254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5587038|NCT03803254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5587039|NCT03803254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587040|NCT03803124|Tolvaptan|tolvaptan|mesh-list
5587041|NCT03803124|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
5587042|NCT03803124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587043|NCT03803124|Natriuretic Agents|natriuretic agents|mesh-ancestor
5587044|NCT03803124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587045|NCT03803267|Fentanyl|fentanyl|mesh-list
5587046|NCT03803267|Propofol|propofol|mesh-list
5587047|NCT03803267|Atracurium|atracurium|mesh-list
5587048|NCT03803267|Anesthetics|anesthetics|mesh-ancestor
5587049|NCT03803267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5587050|NCT03803267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587051|NCT03803267|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5587052|NCT03803267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5587053|NCT03803267|Anesthetics, General|anesthetics, general|mesh-ancestor
5587054|NCT03803267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5587055|NCT03803267|Narcotics|narcotics|mesh-ancestor
5587056|NCT03803267|Analgesics|analgesics|mesh-ancestor
5587057|NCT03803267|Sensory System Agents|sensory system agents|mesh-ancestor
5587058|NCT03803267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5587059|NCT03803267|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5587060|NCT03803267|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5587061|NCT03803267|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6197793|NCT01975935|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5587062|NCT03803267|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5587063|NCT03803267|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
5587064|NCT03803267|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6197794|NCT01976312|Ranibizumab|ranibizumab|mesh-list
6197795|NCT01976312|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6197796|NCT01976312|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6197797|NCT01976312|Growth Substances|growth substances|mesh-ancestor
6197798|NCT01976312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197799|NCT01976312|Growth Inhibitors|growth inhibitors|mesh-ancestor
6197800|NCT01976312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6197801|NCT01976338|Ranibizumab|ranibizumab|mesh-list
6197802|NCT01976338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6197803|NCT01976338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6197804|NCT01976338|Growth Substances|growth substances|mesh-ancestor
6197805|NCT01976338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197806|NCT01976338|Growth Inhibitors|growth inhibitors|mesh-ancestor
6197807|NCT01976338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6197808|NCT01976364|Methotrexate|methotrexate|mesh-list
6197809|NCT01976364|Tofacitinib|tofacitinib|mesh-list
6197810|NCT01976364|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6197811|NCT01976364|Abortifacient Agents|abortifacient agents|mesh-ancestor
6197812|NCT01976364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6197813|NCT01976364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197814|NCT01976364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6197815|NCT01976364|Antimetabolites|antimetabolites|mesh-ancestor
6197816|NCT01976364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197817|NCT01976364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6197818|NCT01976364|Dermatologic Agents|dermatologic agents|mesh-ancestor
6197819|NCT01976364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6197820|NCT01976364|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6197821|NCT01976364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6197822|NCT01976364|Immunologic Factors|immunologic factors|mesh-ancestor
6197823|NCT01976364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6197824|NCT01976364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6197825|NCT01976364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6197826|NCT01976390|Sirolimus|sirolimus|mesh-list
6197827|NCT01976390|Everolimus|everolimus|mesh-list
6197828|NCT01976390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6197829|NCT01976390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6197830|NCT01976390|Immunologic Factors|immunologic factors|mesh-ancestor
6197831|NCT01976390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197832|NCT01976390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5587065|NCT03803267|Cholinergic Agents|cholinergic agents|mesh-ancestor
5587066|NCT03803267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6197833|NCT01976390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6197834|NCT01976390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6197835|NCT01976390|Antifungal Agents|antifungal agents|mesh-ancestor
6197836|NCT01976416|Hydroxyurea|hydroxyurea|mesh-list
6197837|NCT01976416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6197838|NCT01976416|Antisickling Agents|antisickling agents|mesh-ancestor
6197839|NCT01976416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6197840|NCT01976416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197841|NCT01976416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6197842|NCT01976507|Dabigatran|dabigatran|mesh-list
6197843|NCT01976507|Antithrombins|antithrombins|mesh-ancestor
6197844|NCT01976507|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6197845|NCT01976507|Protease Inhibitors|protease inhibitors|mesh-ancestor
5587067|NCT03803267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587068|NCT03803007|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5587069|NCT03803007|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5587070|NCT03803007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5587071|NCT03803007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605238|NCT03125642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5605239|NCT03125642|Immunologic Factors|immunologic factors|mesh-ancestor
5605240|NCT03125642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605241|NCT03125642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5605242|NCT03125642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5605243|NCT03125642|Alkylating Agents|alkylating agents|mesh-ancestor
5605244|NCT03125642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605245|NCT03125642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605246|NCT03125642|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6197846|NCT01976507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6197847|NCT01976507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197848|NCT01976507|Anticoagulants|anticoagulants|mesh-ancestor
6197849|NCT01976572|Candesartan|candesartan|mesh-list
6197850|NCT01976572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6197851|NCT01976572|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6207516|NCT02116608|Dermatologic Agents|dermatologic agents|mesh-ancestor
6197852|NCT01976572|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6197853|NCT01976572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197854|NCT01976624|Timolol|timolol|mesh-list
6197855|NCT01976624|Bimatoprost|bimatoprost|mesh-list
6197856|NCT01976624|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6197857|NCT01976624|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6197858|NCT01976624|Adrenergic Agents|adrenergic agents|mesh-ancestor
6197859|NCT01976624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6197860|NCT01976624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197861|NCT01976624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197862|NCT01976624|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6197863|NCT01976624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6197864|NCT01976650|Dexamethasone|dexamethasone|mesh-list
5587072|NCT03803215|Theophylline|theophylline|mesh-list
5587073|NCT03803215|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5587074|NCT03803215|Autonomic Agents|autonomic agents|mesh-ancestor
5587075|NCT03803215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5587076|NCT03803215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587077|NCT03803215|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5587078|NCT03803215|Respiratory System Agents|respiratory system agents|mesh-ancestor
5587079|NCT03803215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5587080|NCT03803215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5587081|NCT03803215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587082|NCT03803215|Vasodilator Agents|vasodilator agents|mesh-ancestor
5587083|NCT03803215|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5587084|NCT03803215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5587085|NCT03803215|Purinergic Agents|purinergic agents|mesh-ancestor
5587086|NCT03803215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6197865|NCT01976650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5587087|NCT03803163|Treprostinil|treprostinil|mesh-list
5587088|NCT03803163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5587089|NCT03802747|Durvalumab|durvalumab|mesh-list
5587090|NCT03802747|Tremelimumab|tremelimumab|mesh-list
5587091|NCT03802747|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5587092|NCT03802747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6197866|NCT01976650|Antiemetics|antiemetics|mesh-ancestor
6197867|NCT01976650|Autonomic Agents|autonomic agents|mesh-ancestor
6197868|NCT01976650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6197869|NCT01976650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197870|NCT01976650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6197871|NCT01976650|Glucocorticoids|glucocorticoids|mesh-ancestor
6197872|NCT01976650|Hormones|hormones|mesh-ancestor
6197873|NCT01976650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6197874|NCT01976650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6197875|NCT01976650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6197876|NCT01976728|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
5587093|NCT03802747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5587094|NCT03802747|Immunologic Factors|immunologic factors|mesh-ancestor
6197877|NCT01976728|Hormones|hormones|mesh-ancestor
6197878|NCT01976728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6197879|NCT01976728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197880|NCT01976806|Aspirin|aspirin|mesh-list
6197881|NCT01976806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6197882|NCT01976806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6197883|NCT01976806|Analgesics|analgesics|mesh-ancestor
6197884|NCT01976806|Sensory System Agents|sensory system agents|mesh-ancestor
6197885|NCT01976806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6197886|NCT01976806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197887|NCT01976806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6197888|NCT01976806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6197889|NCT01976806|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6197890|NCT01976806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6197891|NCT01976806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197892|NCT01976806|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6197893|NCT01976806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6197894|NCT01976806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6197895|NCT01976806|Antipyretics|antipyretics|mesh-ancestor
6197896|NCT01976845|Midazolam|midazolam|mesh-list
6197897|NCT01976845|Propofol|propofol|mesh-list
6197898|NCT01976845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6197899|NCT01976845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6197900|NCT01976845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197901|NCT01976845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6197902|NCT01976845|Anesthetics, General|anesthetics, general|mesh-ancestor
6197903|NCT01976845|Anesthetics|anesthetics|mesh-ancestor
6197904|NCT01976845|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6197905|NCT01976845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6197906|NCT01976845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6197907|NCT01976845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6197908|NCT01976845|GABA Modulators|gaba modulators|mesh-ancestor
6197909|NCT01976845|GABA Agents|gaba agents|mesh-ancestor
6197910|NCT01976845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6197911|NCT01976845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197912|NCT01976871|Rotigotine|rotigotine|mesh-list
6197913|NCT01976871|Dopamine Agonists|dopamine agonists|mesh-ancestor
6197914|NCT01976871|Dopamine Agents|dopamine agents|mesh-ancestor
6197915|NCT01976871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6197916|NCT01976871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197917|NCT01976871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587095|NCT03802747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587096|NCT03802838|Amisulpride|amisulpride|mesh-list
5587097|NCT03802838|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5587098|NCT03802838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6197918|NCT01976988|Heparin|heparin|mesh-list
6197919|NCT01976988|Anticoagulants|anticoagulants|mesh-ancestor
6197920|NCT01976988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5587099|NCT03802838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6197921|NCT01976988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6197922|NCT01976988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197923|NCT01977352|Bupivacaine|bupivacaine|mesh-list
6197924|NCT01977352|Anesthetics, Local|anesthetics, local|mesh-ancestor
6197925|NCT01977352|Anesthetics|anesthetics|mesh-ancestor
6197926|NCT01977352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6197927|NCT01977352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197928|NCT01977352|Sensory System Agents|sensory system agents|mesh-ancestor
6197929|NCT01977352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6197930|NCT01977456|Eptifibatide|eptifibatide|mesh-list
6197931|NCT01977456|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6197932|NCT01977625|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6197933|NCT01977625|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6197934|NCT01977625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587100|NCT03802838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587101|NCT03802838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5587102|NCT03802838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5587103|NCT03802838|Dopamine Agents|dopamine agents|mesh-ancestor
5587104|NCT03802838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5587105|NCT03802838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587106|NCT03802838|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5587107|NCT03802838|Antidepressive Agents|antidepressive agents|mesh-ancestor
5587108|NCT03802773|Cyclophosphamide|cyclophosphamide|mesh-list
5587109|NCT03802773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5587110|NCT03802773|Immunologic Factors|immunologic factors|mesh-ancestor
5587111|NCT03802773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587112|NCT03802773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5587113|NCT03802773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5587114|NCT03802773|Alkylating Agents|alkylating agents|mesh-ancestor
5587115|NCT03802773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587116|NCT03802773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5587117|NCT03802773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5587118|NCT03802604|Atezolizumab|atezolizumab|mesh-list
5587119|NCT03802604|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
5587120|NCT03802604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5587121|NCT03802604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5605247|NCT03125642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6197935|NCT01977625|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6197936|NCT01977625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6197937|NCT01977625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6197938|NCT01977625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197939|NCT01977625|Dopamine Agents|dopamine agents|mesh-ancestor
5587122|NCT03802487|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
5587123|NCT03802487|Charcoal|charcoal|mesh-list
5587124|NCT03802487|Antidotes|antidotes|mesh-ancestor
6197940|NCT01977625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6197941|NCT01977677|Plerixafor|plerixafor|mesh-list
6197942|NCT01977677|Temozolomide|temozolomide|mesh-list
6197943|NCT01977677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6197944|NCT01977677|Alkylating Agents|alkylating agents|mesh-ancestor
6197945|NCT01977677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197946|NCT01977677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6197947|NCT01977677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6197948|NCT01977677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6197949|NCT01977677|Antiviral Agents|antiviral agents|mesh-ancestor
6197950|NCT01977677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6197951|NCT01977781|Methylprednisolone|methylprednisolone|mesh-list
5587125|NCT03802487|Protective Agents|protective agents|mesh-ancestor
5587126|NCT03802487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587127|NCT03802487|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5587128|NCT03802487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587129|NCT03802487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5587130|NCT03802552|Cephalexin|cephalexin|mesh-list
5587131|NCT03802552|Cefadroxil|cefadroxil|mesh-list
5587132|NCT03802552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5587133|NCT03802552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5587134|NCT03802318|Amoxicillin|amoxicillin|mesh-list
5587135|NCT03802318|Rabeprazole|rabeprazole|mesh-list
5587136|NCT03802318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5587137|NCT03802318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6197952|NCT01977781|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6197953|NCT01977781|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6197954|NCT01977781|Prednisolone|prednisolone|mesh-list
6197955|NCT01977781|Prednisolone acetate|prednisolone acetate|mesh-list
6197956|NCT01977781|Tacrolimus|tacrolimus|mesh-list
6197957|NCT01977781|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6197958|NCT01977781|Prednisolone phosphate|prednisolone phosphate|mesh-list
6197959|NCT01977781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6197960|NCT01977781|Immunologic Factors|immunologic factors|mesh-ancestor
6197961|NCT01977781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197962|NCT01977781|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6197963|NCT01977781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6197964|NCT01977781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197965|NCT01977781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6197966|NCT01977781|Antiemetics|antiemetics|mesh-ancestor
6197967|NCT01977781|Autonomic Agents|autonomic agents|mesh-ancestor
6197968|NCT01977781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5587138|NCT03802318|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6197969|NCT01977781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6197970|NCT01977781|Glucocorticoids|glucocorticoids|mesh-ancestor
6197971|NCT01977781|Hormones|hormones|mesh-ancestor
6197972|NCT01977781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6197973|NCT01977781|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6197974|NCT01977781|Protective Agents|protective agents|mesh-ancestor
6197975|NCT01977781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6197976|NCT01977781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6197977|NCT01977794|Amlodipine|amlodipine|mesh-list
6197978|NCT01977794|Bisoprolol|bisoprolol|mesh-list
6197979|NCT01977794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6197980|NCT01977794|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6197981|NCT01977794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6197982|NCT01977794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6197983|NCT01977794|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6197984|NCT01977794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197985|NCT01977794|Vasodilator Agents|vasodilator agents|mesh-ancestor
6197986|NCT01977794|Sympatholytics|sympatholytics|mesh-ancestor
6197987|NCT01977794|Autonomic Agents|autonomic agents|mesh-ancestor
6197988|NCT01977794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6197989|NCT01977794|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6197990|NCT01977794|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6197991|NCT01977794|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6197992|NCT01977794|Adrenergic Agents|adrenergic agents|mesh-ancestor
6197993|NCT01977794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6197994|NCT01977898|Morphine|morphine|mesh-list
6197995|NCT01977898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6197996|NCT01977898|Narcotics|narcotics|mesh-ancestor
6197997|NCT01977898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5587139|NCT03802318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5587140|NCT03802318|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5587141|NCT03802318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5587142|NCT03802318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587143|NCT03802422|Vitamin B 12|vitamin b 12|mesh-list
5587144|NCT03802422|Hydroxocobalamin|hydroxocobalamin|mesh-list
5587145|NCT03802422|Vitamins|vitamins|mesh-ancestor
5587146|NCT03802422|Micronutrients|micronutrients|mesh-ancestor
5587147|NCT03802422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197998|NCT01977898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6197999|NCT01977898|Analgesics|analgesics|mesh-ancestor
6198000|NCT01977898|Sensory System Agents|sensory system agents|mesh-ancestor
6198001|NCT01977898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5587148|NCT03802422|Vitamin B Complex|vitamin b complex|mesh-ancestor
5587149|NCT03802422|Hematinics|hematinics|mesh-ancestor
5587150|NCT03802071|Doxorubicin|doxorubicin|mesh-list
5587151|NCT03802071|Durvalumab|durvalumab|mesh-list
5587152|NCT03802071|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5587153|NCT03802071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5587154|NCT03802071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5587155|NCT03802071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5587156|NCT03802071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5587157|NCT03802071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587158|NCT03802071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5587159|NCT03802149|Ulipristal acetate|ulipristal acetate|mesh-list
5587160|NCT03802149|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5587161|NCT03802149|Contraceptive Agents|contraceptive agents|mesh-ancestor
5587162|NCT03802149|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5587163|NCT03802149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587164|NCT03802149|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5587165|NCT03802032|Lidocaine|lidocaine|mesh-list
5587166|NCT03802032|Anesthetics, Local|anesthetics, local|mesh-ancestor
5587167|NCT03802032|Anesthetics|anesthetics|mesh-ancestor
6198002|NCT01977937|Gabapentin|gabapentin|mesh-list
6198003|NCT01977937|Analgesics|analgesics|mesh-ancestor
6198004|NCT01977937|Sensory System Agents|sensory system agents|mesh-ancestor
6198005|NCT01977937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6198006|NCT01977937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198007|NCT01977937|Anticonvulsants|anticonvulsants|mesh-ancestor
6198008|NCT01977937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6198009|NCT01977937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6198010|NCT01977937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6198011|NCT01977937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6198012|NCT01977937|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6198013|NCT01977937|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6198014|NCT01977937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6198015|NCT01977937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198016|NCT01977937|Antimanic Agents|antimanic agents|mesh-ancestor
6198017|NCT01978093|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6198018|NCT01978093|Immunologic Factors|immunologic factors|mesh-ancestor
6198019|NCT01978093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198020|NCT01978184|Gemcitabine|gemcitabine|mesh-list
6198021|NCT01978184|Hydroxychloroquine|hydroxychloroquine|mesh-list
6198022|NCT01978184|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6198023|NCT01978184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6198024|NCT01978184|Antimetabolites|antimetabolites|mesh-ancestor
6198025|NCT01978184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198026|NCT01978184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6198027|NCT01978184|Antiviral Agents|antiviral agents|mesh-ancestor
6198028|NCT01978184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6198029|NCT01978184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6198030|NCT01978184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6198031|NCT01978184|Immunologic Factors|immunologic factors|mesh-ancestor
6198032|NCT01978184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198033|NCT01978184|Antimalarials|antimalarials|mesh-ancestor
6198034|NCT01978184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6198035|NCT01978184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6198036|NCT01978184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6198037|NCT01978236|Trametinib|trametinib|mesh-list
6198038|NCT01978236|Dabrafenib|dabrafenib|mesh-list
6198039|NCT01978236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6198040|NCT01978236|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6198041|NCT01978236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5587168|NCT03802032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6198042|NCT01978236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198043|NCT01978600|Timolol|timolol|mesh-list
5587169|NCT03802032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587170|NCT03802032|Sensory System Agents|sensory system agents|mesh-ancestor
5587171|NCT03802032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5587172|NCT03802032|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5587173|NCT03802032|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5587174|NCT03802032|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5587175|NCT03802032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5587176|NCT03802032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587177|NCT03802058|Paclitaxel|paclitaxel|mesh-list
5587178|NCT03802058|Carboplatin|carboplatin|mesh-list
5587179|NCT03802058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5587180|NCT03802058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5587181|NCT03802058|Tubulin Modulators|tubulin modulators|mesh-ancestor
5587182|NCT03802058|Antimitotic Agents|antimitotic agents|mesh-ancestor
5587183|NCT03802058|Mitosis Modulators|mitosis modulators|mesh-ancestor
5587184|NCT03802058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587185|NCT03802097|Anti-Infective Agents|anti-infective agents|mesh-list
5587186|NCT03802097|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5587187|NCT03802214|Vedolizumab|vedolizumab|mesh-list
5587188|NCT03802214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5587189|NCT03802084|Imatinib Mesylate|imatinib mesylate|mesh-list
5587190|NCT03802084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5587191|NCT03802084|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6198044|NCT01978600|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6198045|NCT01978600|Brinzolamide|brinzolamide|mesh-list
6198046|NCT01978600|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6198047|NCT01978600|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6198048|NCT01978600|Adrenergic Agents|adrenergic agents|mesh-ancestor
6198049|NCT01978600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6198050|NCT01978600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198051|NCT01978600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198052|NCT01978600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6198053|NCT01978600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6198054|NCT01978600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5587192|NCT03802084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5587193|NCT03802084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587194|NCT03802162|Memantine|memantine|mesh-list
5587195|NCT03802162|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5587196|NCT03802162|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5587197|NCT03802162|Dopamine Agents|dopamine agents|mesh-ancestor
5587198|NCT03802162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5587199|NCT03802162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587200|NCT03802162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587201|NCT03802162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5587202|NCT03802162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5587203|NCT03801603|Vaccines|vaccines|mesh-list
5587204|NCT03801603|Immunologic Factors|immunologic factors|mesh-ancestor
6198055|NCT01978600|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6198056|NCT01978600|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6198057|NCT01978600|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6198058|NCT01978600|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6198059|NCT01978743|Raltegravir Potassium|raltegravir potassium|mesh-list
6198060|NCT01978743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5587205|NCT03801603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587206|NCT03801642|Dapagliflozin|dapagliflozin|mesh-list
5587207|NCT03801642|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5587208|NCT03801642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587209|NCT03801642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5587210|NCT03801642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587211|NCT03801746|Cyclosporine|cyclosporine|mesh-list
5587212|NCT03801746|Rifampin|rifampin|mesh-list
5587213|NCT03801746|Probenecid|probenecid|mesh-list
5587214|NCT03801746|Cyclosporins|cyclosporins|mesh-list
5587215|NCT03801746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5587216|NCT03801746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587217|NCT03801746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6198061|NCT01978743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6198062|NCT01978743|Antiviral Agents|antiviral agents|mesh-ancestor
6198063|NCT01978743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6198064|NCT01978743|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6198065|NCT01978743|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6198066|NCT01978743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6198067|NCT01978743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198068|NCT01979016|Emollients|emollients|mesh-list
5587218|NCT03801746|Immunologic Factors|immunologic factors|mesh-ancestor
6198069|NCT01979016|Dermatologic Agents|dermatologic agents|mesh-ancestor
6198070|NCT01979185|Simvastatin|simvastatin|mesh-list
6198071|NCT01979185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6198072|NCT01979185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6198073|NCT01979185|Antimetabolites|antimetabolites|mesh-ancestor
6198074|NCT01979185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198075|NCT01979185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6198076|NCT01979185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5587219|NCT03801746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587220|NCT03801746|Antifungal Agents|antifungal agents|mesh-ancestor
5587221|NCT03801746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6198077|NCT01979185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6198078|NCT01979276|Dexamethasone|dexamethasone|mesh-list
6198079|NCT01979276|Pomalidomide|pomalidomide|mesh-list
5587222|NCT03801746|Dermatologic Agents|dermatologic agents|mesh-ancestor
5587223|NCT03801746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5587224|NCT03801746|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5587225|NCT03801746|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5587226|NCT03801746|Antitubercular Agents|antitubercular agents|mesh-ancestor
5587227|NCT03801746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5587228|NCT03801746|Leprostatic Agents|leprostatic agents|mesh-ancestor
5587229|NCT03801746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5587230|NCT03801746|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5587231|NCT03801746|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5587232|NCT03801746|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5587233|NCT03801746|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5587234|NCT03801746|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5587235|NCT03801746|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5587236|NCT03801746|Uricosuric Agents|uricosuric agents|mesh-ancestor
5587237|NCT03801746|Gout Suppressants|gout suppressants|mesh-ancestor
5587238|NCT03801746|Renal Agents|renal agents|mesh-ancestor
5587239|NCT03801733|Sulfasalazine|sulfasalazine|mesh-list
5587240|NCT03801733|Atorvastatin|atorvastatin|mesh-list
5587241|NCT03801733|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6198080|NCT01979276|Romidepsin|romidepsin|mesh-list
6198081|NCT01979276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6198082|NCT01979276|Antiemetics|antiemetics|mesh-ancestor
6198083|NCT01979276|Autonomic Agents|autonomic agents|mesh-ancestor
6198084|NCT01979276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6198085|NCT01979276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198086|NCT01979276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6198087|NCT01979276|Glucocorticoids|glucocorticoids|mesh-ancestor
6198088|NCT01979276|Hormones|hormones|mesh-ancestor
6198089|NCT01979276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6198090|NCT01979276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6198091|NCT01979276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6198092|NCT01979276|Immunologic Factors|immunologic factors|mesh-ancestor
6198093|NCT01979276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6198094|NCT01979276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6198095|NCT01979276|Growth Substances|growth substances|mesh-ancestor
6198096|NCT01979276|Growth Inhibitors|growth inhibitors|mesh-ancestor
6198097|NCT01979276|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6198098|NCT01979445|Clopidogrel|clopidogrel|mesh-list
6198099|NCT01979445|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6198100|NCT01979445|Cangrelor|cangrelor|mesh-list
6198101|NCT01979445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6198102|NCT01979445|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6198103|NCT01979445|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6198104|NCT01979445|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6198105|NCT01979445|Purinergic Agents|purinergic agents|mesh-ancestor
6198106|NCT01979445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6198107|NCT01979445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198108|NCT01979445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198109|NCT01979523|Trametinib|trametinib|mesh-list
6198110|NCT01979523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5725665|NCT03178955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5725666|NCT03178955|Analgesics|analgesics|mesh-ancestor
5725667|NCT03178955|Sensory System Agents|sensory system agents|mesh-ancestor
5725668|NCT03178955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5725669|NCT03178955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725670|NCT03178955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5587242|NCT03801733|Simvastatin|simvastatin|mesh-list
5587243|NCT03801733|Pravastatin|pravastatin|mesh-list
5587244|NCT03801733|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6198111|NCT01979523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6198112|NCT01979523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6198113|NCT01979523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198114|NCT01979952|Nintedanib|nintedanib|mesh-list
6198115|NCT01979952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6198116|NCT01979952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6198117|NCT01979952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6198118|NCT01979952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587245|NCT03801733|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5587246|NCT03801733|Antimetabolites|antimetabolites|mesh-ancestor
5587247|NCT03801733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587248|NCT03801733|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5587249|NCT03801733|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5587250|NCT03801733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5587251|NCT03801733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5587252|NCT03801733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5587253|NCT03801733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5587254|NCT03801733|Analgesics|analgesics|mesh-ancestor
5587255|NCT03801733|Sensory System Agents|sensory system agents|mesh-ancestor
5587256|NCT03801733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5587257|NCT03801733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587258|NCT03801733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6198119|NCT01980485|Carbon Monoxide|carbon monoxide|mesh-list
6198120|NCT01980485|Antimetabolites|antimetabolites|mesh-ancestor
6198121|NCT01980485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198122|NCT01980485|Gasotransmitters|gasotransmitters|mesh-ancestor
6198123|NCT01980485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6198124|NCT01980485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198125|NCT01980524|Acipimox|acipimox|mesh-list
6198126|NCT01980524|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6198127|NCT01980524|Antimetabolites|antimetabolites|mesh-ancestor
6198128|NCT01980524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198129|NCT01980524|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6198130|NCT01980589|Dexamethasone|dexamethasone|mesh-list
6198131|NCT01980589|Cyclophosphamide|cyclophosphamide|mesh-list
6198132|NCT01980589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6198133|NCT01980589|Immunologic Factors|immunologic factors|mesh-ancestor
6198134|NCT01980589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587259|NCT03801733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5587260|NCT03801733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5587261|NCT03801707|Sofosbuvir|sofosbuvir|mesh-list
5587262|NCT03801707|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
5587263|NCT03801707|Velpatasvir|velpatasvir|mesh-list
5587264|NCT03801707|Antiviral Agents|antiviral agents|mesh-ancestor
5587265|NCT03801707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5587266|NCT03801668|Paclitaxel|paclitaxel|mesh-list
5587267|NCT03801668|Oxaliplatin|oxaliplatin|mesh-list
5587268|NCT03801668|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5587269|NCT03801668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5587270|NCT03801668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5587271|NCT03801668|Tubulin Modulators|tubulin modulators|mesh-ancestor
5587272|NCT03801668|Antimitotic Agents|antimitotic agents|mesh-ancestor
5587273|NCT03801668|Mitosis Modulators|mitosis modulators|mesh-ancestor
6198135|NCT01980589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6198136|NCT01980589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6198137|NCT01980589|Alkylating Agents|alkylating agents|mesh-ancestor
6198138|NCT01980589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198139|NCT01980589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6198140|NCT01980589|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6198141|NCT01980589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6198142|NCT01980589|Antiemetics|antiemetics|mesh-ancestor
6198143|NCT01980589|Autonomic Agents|autonomic agents|mesh-ancestor
6198144|NCT01980589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6198145|NCT01980589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6198146|NCT01980589|Glucocorticoids|glucocorticoids|mesh-ancestor
6198147|NCT01980589|Hormones|hormones|mesh-ancestor
6198148|NCT01980589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6198149|NCT01980589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6198150|NCT01980654|Rituximab|rituximab|mesh-list
6198151|NCT01980654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6198152|NCT01980654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6198153|NCT01980654|Immunologic Factors|immunologic factors|mesh-ancestor
6198154|NCT01980654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198155|NCT01980654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6198156|NCT01980706|Baclofen|baclofen|mesh-list
6198157|NCT01980706|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6198158|NCT01980706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198159|NCT01980706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6198160|NCT01980706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6198161|NCT01980706|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6198162|NCT01980706|GABA Agonists|gaba agonists|mesh-ancestor
6198163|NCT01980706|GABA Agents|gaba agents|mesh-ancestor
6198164|NCT01980706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6198165|NCT01980706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198166|NCT01980888|Rituximab|rituximab|mesh-list
6198167|NCT01980888|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6198168|NCT01980888|Idelalisib|idelalisib|mesh-list
6198169|NCT01980888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6198170|NCT01980888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6198171|NCT01980888|Immunologic Factors|immunologic factors|mesh-ancestor
6198172|NCT01980888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198173|NCT01980888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6198174|NCT01980888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6198175|NCT01980888|Alkylating Agents|alkylating agents|mesh-ancestor
6198176|NCT01980888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198177|NCT01980888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6207517|NCT02116660|Ritonavir|ritonavir|mesh-list
6207518|NCT02116660|Lopinavir|lopinavir|mesh-list
6207519|NCT02116660|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6207520|NCT02116660|Darunavir|darunavir|mesh-list
6207521|NCT02116660|Tenofovir|tenofovir|mesh-list
6207522|NCT02116660|Lamivudine|lamivudine|mesh-list
6207523|NCT02116660|Emtricitabine|emtricitabine|mesh-list
6207524|NCT02116660|Raltegravir Potassium|raltegravir potassium|mesh-list
5587274|NCT03801668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587275|NCT03801629|Morphine|morphine|mesh-list
5587276|NCT03801629|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5587277|NCT03801629|Narcotics|narcotics|mesh-ancestor
5587278|NCT03801629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5587279|NCT03801629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587280|NCT03801629|Analgesics|analgesics|mesh-ancestor
5587281|NCT03801629|Sensory System Agents|sensory system agents|mesh-ancestor
5587282|NCT03801629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5587283|NCT03801564|Hyaluronic Acid|hyaluronic acid|mesh-list
5587284|NCT03801564|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5587285|NCT03801564|Immunologic Factors|immunologic factors|mesh-ancestor
5587286|NCT03801564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587287|NCT03801564|Viscosupplements|viscosupplements|mesh-ancestor
5587288|NCT03801564|Protective Agents|protective agents|mesh-ancestor
5587289|NCT03801590|Riboflavin|riboflavin|mesh-list
5587290|NCT03801590|Vitamin B Complex|vitamin b complex|mesh-ancestor
5587291|NCT03801590|Vitamins|vitamins|mesh-ancestor
5587292|NCT03801590|Micronutrients|micronutrients|mesh-ancestor
5587293|NCT03801590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587294|NCT03801590|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5587295|NCT03801590|Dermatologic Agents|dermatologic agents|mesh-ancestor
5587296|NCT03801759|Adefovir|adefovir|mesh-list
5587297|NCT03801759|Digoxin|digoxin|mesh-list
5587298|NCT03801759|Furosemide|furosemide|mesh-list
5587299|NCT03801759|Diuretics|diuretics|mesh-ancestor
5587300|NCT03801759|Natriuretic Agents|natriuretic agents|mesh-ancestor
5587301|NCT03801759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207525|NCT02116660|Nevirapine|nevirapine|mesh-list
6207526|NCT02116660|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6207527|NCT02116660|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6207528|NCT02116660|Protease Inhibitors|protease inhibitors|mesh-ancestor
6207529|NCT02116660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6207530|NCT02116660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207531|NCT02116660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6207532|NCT02116660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6207533|NCT02116660|Antiviral Agents|antiviral agents|mesh-ancestor
6207534|NCT02116660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6207535|NCT02116660|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6207536|NCT02116660|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6207537|NCT02116660|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6207538|NCT02116660|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6207539|NCT02116660|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6207540|NCT02116660|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6207541|NCT02116660|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5587302|NCT03801759|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5587303|NCT03801759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6198178|NCT01981473|Infliximab|infliximab|mesh-list
6198179|NCT01981473|Dermatologic Agents|dermatologic agents|mesh-ancestor
6198180|NCT01981473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6198181|NCT01981473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6198182|NCT01981616|Vedolizumab|vedolizumab|mesh-list
6198183|NCT01981616|Vaccines|vaccines|mesh-list
6198184|NCT01981616|Immunologic Factors|immunologic factors|mesh-ancestor
6198185|NCT01981616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198186|NCT01981616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5587304|NCT03801759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587305|NCT03801759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5587306|NCT03801759|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5587307|NCT03801759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5587308|NCT03801759|Protective Agents|protective agents|mesh-ancestor
5587309|NCT03801759|Antiviral Agents|antiviral agents|mesh-ancestor
5587310|NCT03801759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5587311|NCT03801759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5587312|NCT03801759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5587313|NCT03801499|Lenvatinib|lenvatinib|mesh-list
5587314|NCT03801499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5587315|NCT03801499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6198187|NCT01981759|Cycloserine|cycloserine|mesh-list
6198188|NCT01981759|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6198189|NCT01981759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6198190|NCT01981759|Renal Agents|renal agents|mesh-ancestor
6198191|NCT01981759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6198192|NCT01981759|Antitubercular Agents|antitubercular agents|mesh-ancestor
6198193|NCT01981759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6198194|NCT01981759|Antimetabolites|antimetabolites|mesh-ancestor
6198195|NCT01981759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198196|NCT01981772|Lidocaine|lidocaine|mesh-list
6198197|NCT01981772|Epinephrine|epinephrine|mesh-list
6198198|NCT01981772|Racepinephrine|racepinephrine|mesh-list
6198199|NCT01981772|Epinephryl borate|epinephryl borate|mesh-list
6198200|NCT01981772|Anesthetics, Local|anesthetics, local|mesh-ancestor
6198201|NCT01981772|Anesthetics|anesthetics|mesh-ancestor
6198202|NCT01981772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6198203|NCT01981772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198204|NCT01981772|Sensory System Agents|sensory system agents|mesh-ancestor
6198205|NCT01981772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6198206|NCT01981772|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6198207|NCT01981772|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6198208|NCT01981772|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6198209|NCT01981772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6198210|NCT01981772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198211|NCT01981772|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6198212|NCT01981772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6198213|NCT01981772|Adrenergic Agents|adrenergic agents|mesh-ancestor
6198214|NCT01981772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6198215|NCT01981772|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6198216|NCT01981772|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6198217|NCT01981772|Autonomic Agents|autonomic agents|mesh-ancestor
6198218|NCT01981772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6198219|NCT01981772|Respiratory System Agents|respiratory system agents|mesh-ancestor
6198220|NCT01981772|Mydriatics|mydriatics|mesh-ancestor
6198221|NCT01981772|Sympathomimetics|sympathomimetics|mesh-ancestor
6198222|NCT01981772|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6198223|NCT01981863|Aminocaproic Acid|aminocaproic acid|mesh-list
6198224|NCT01981863|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6198225|NCT01981863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6198226|NCT01981863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198227|NCT01981863|Hemostatics|hemostatics|mesh-ancestor
6198228|NCT01981863|Coagulants|coagulants|mesh-ancestor
5587316|NCT03801499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5587317|NCT03801499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587318|NCT03801304|Atezolizumab|atezolizumab|mesh-list
5587319|NCT03801304|Vinorelbine|vinorelbine|mesh-list
5587320|NCT03801304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5587321|NCT03801304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5587322|NCT03801304|Tubulin Modulators|tubulin modulators|mesh-ancestor
5587323|NCT03801304|Antimitotic Agents|antimitotic agents|mesh-ancestor
5587324|NCT03801304|Mitosis Modulators|mitosis modulators|mesh-ancestor
6198229|NCT01981954|Solifenacin Succinate|solifenacin succinate|mesh-list
6198230|NCT01981954|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6198231|NCT01981954|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6198232|NCT01981954|Cholinergic Agents|cholinergic agents|mesh-ancestor
5587325|NCT03801304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587326|NCT03801252|Azithromycin|azithromycin|mesh-list
5587327|NCT03801252|Cefazolin|cefazolin|mesh-list
5587328|NCT03801252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5587329|NCT03801252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5605248|NCT03125642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5605249|NCT03125642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5605250|NCT03125642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6198233|NCT01981954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6198234|NCT01981954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198235|NCT01981954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198236|NCT01981954|Urological Agents|urological agents|mesh-ancestor
6198237|NCT01981967|Vaccines|vaccines|mesh-list
6198238|NCT01981967|Immunologic Factors|immunologic factors|mesh-ancestor
6198239|NCT01981967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198240|NCT01982123|Edetic Acid|edetic acid|mesh-list
6198241|NCT01982123|Pentetic Acid|pentetic acid|mesh-list
6198242|NCT01982123|Technetium Tc 99m Pentetate|technetium tc 99m pentetate|mesh-list
6198243|NCT01982123|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
6198244|NCT01982123|Antidotes|antidotes|mesh-ancestor
5605251|NCT03125642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5605252|NCT03125642|Antimetabolites|antimetabolites|mesh-ancestor
5605253|NCT03125642|Antiviral Agents|antiviral agents|mesh-ancestor
5605254|NCT03125642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5605255|NCT03106415|Pembrolizumab|pembrolizumab|mesh-list
6198245|NCT01982123|Protective Agents|protective agents|mesh-ancestor
6198246|NCT01982123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198247|NCT01982123|Chelating Agents|chelating agents|mesh-ancestor
6198248|NCT01982123|Sequestering Agents|sequestering agents|mesh-ancestor
6198249|NCT01982123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198250|NCT01982123|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6198251|NCT01982123|Anticoagulants|anticoagulants|mesh-ancestor
6198252|NCT01982123|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6198253|NCT01982123|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6198254|NCT01982240|Bisacodyl|bisacodyl|mesh-list
6198255|NCT01982240|Plecanatide|plecanatide|mesh-list
6198256|NCT01982240|Cathartics|cathartics|mesh-ancestor
6198257|NCT01982240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6198258|NCT01982240|Laxatives|laxatives|mesh-ancestor
6198259|NCT01982240|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
6198260|NCT01982240|Enzyme Activators|enzyme activators|mesh-ancestor
6198261|NCT01982240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198262|NCT01982331|Vaccines|vaccines|mesh-list
6198263|NCT01982331|Immunologic Factors|immunologic factors|mesh-ancestor
5605256|NCT03106415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5605257|NCT03106415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605258|NCT03103971|Cyclophosphamide|cyclophosphamide|mesh-list
5605259|NCT03103971|Fludarabine|fludarabine|mesh-list
5605260|NCT03103971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5605261|NCT03103971|Immunologic Factors|immunologic factors|mesh-ancestor
5605262|NCT03103971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605263|NCT03103971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5605264|NCT03103971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6198264|NCT01982331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198265|NCT01982435|Ranibizumab|ranibizumab|mesh-list
6198266|NCT01982435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6198267|NCT01982435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6198268|NCT01982435|Growth Substances|growth substances|mesh-ancestor
6198269|NCT01982435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198270|NCT01982435|Growth Inhibitors|growth inhibitors|mesh-ancestor
6198271|NCT01982435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6198272|NCT01982448|Paclitaxel|paclitaxel|mesh-list
6198273|NCT01982448|Cisplatin|cisplatin|mesh-list
6198274|NCT01982448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6198275|NCT01982448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6198276|NCT01982448|Tubulin Modulators|tubulin modulators|mesh-ancestor
6198277|NCT01982448|Antimitotic Agents|antimitotic agents|mesh-ancestor
6198278|NCT01982448|Mitosis Modulators|mitosis modulators|mesh-ancestor
6198279|NCT01982448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198280|NCT01982539|Diclofenac|diclofenac|mesh-list
6198281|NCT01982539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6198282|NCT01982539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6198283|NCT01982539|Analgesics|analgesics|mesh-ancestor
6198284|NCT01982539|Sensory System Agents|sensory system agents|mesh-ancestor
6198285|NCT01982539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5605265|NCT03103971|Alkylating Agents|alkylating agents|mesh-ancestor
5607031|NCT03031730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6198286|NCT01982539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198287|NCT01982539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6198288|NCT01982539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6198289|NCT01982539|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6198290|NCT01982539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6198291|NCT01982539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198292|NCT01982643|Naltrexone|naltrexone|mesh-list
6198293|NCT01982643|Bupropion|bupropion|mesh-list
6198294|NCT01982643|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6198295|NCT01982643|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6198296|NCT01982643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198297|NCT01982643|Sensory System Agents|sensory system agents|mesh-ancestor
6198298|NCT01982643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5587330|NCT03801187|Chlorhexidine|chlorhexidine|mesh-list
5587331|NCT03801187|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5587332|NCT03801187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5587333|NCT03801187|Disinfectants|disinfectants|mesh-ancestor
5587334|NCT03801226|Calcium|calcium|mesh-list
5587335|NCT03801226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5587336|NCT03801226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198299|NCT01982643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6198300|NCT01982643|Antidepressive Agents|antidepressive agents|mesh-ancestor
6198301|NCT01982643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6198302|NCT01982643|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6198303|NCT01982643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6198304|NCT01982643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5587337|NCT03801031|Lidocaine|lidocaine|mesh-list
5587338|NCT03801031|Anesthetics, Local|anesthetics, local|mesh-ancestor
5587339|NCT03801031|Anesthetics|anesthetics|mesh-ancestor
5587340|NCT03801031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5587341|NCT03801031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587342|NCT03801031|Sensory System Agents|sensory system agents|mesh-ancestor
5587343|NCT03801031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5587344|NCT03801031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5587345|NCT03801031|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5587346|NCT03801031|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5587347|NCT03801031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5587348|NCT03801031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198305|NCT01982643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198306|NCT01982643|Dopamine Agents|dopamine agents|mesh-ancestor
6198307|NCT01982643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6198308|NCT01982643|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6198309|NCT01982643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6198310|NCT01982643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6198311|NCT01982682|Mycophenolic Acid|mycophenolic acid|mesh-list
6198312|NCT01982682|Cyclophosphamide|cyclophosphamide|mesh-list
6198313|NCT01982682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6198314|NCT01982682|Immunologic Factors|immunologic factors|mesh-ancestor
6198315|NCT01982682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198316|NCT01982682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6198317|NCT01982682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6198318|NCT01982682|Alkylating Agents|alkylating agents|mesh-ancestor
5587349|NCT03800979|Tofacitinib|tofacitinib|mesh-list
5587350|NCT03800979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5587351|NCT03800979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5587352|NCT03800979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198319|NCT01982682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198320|NCT01982682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6198321|NCT01982682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6198322|NCT01982682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6198323|NCT01982682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6198324|NCT01982682|Antitubercular Agents|antitubercular agents|mesh-ancestor
6198325|NCT01982682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6198326|NCT01982682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6198327|NCT01982682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6198328|NCT01982695|Losartan|losartan|mesh-list
6198329|NCT01982695|Lisinopril|lisinopril|mesh-list
6198330|NCT01982695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6198331|NCT01982695|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6198332|NCT01982695|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6198333|NCT01982695|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6198334|NCT01982695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587353|NCT03801317|Micronutrients|micronutrients|mesh-list
5587354|NCT03801317|Trace Elements|trace elements|mesh-list
5587355|NCT03801317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587356|NCT03800953|Avelumab|avelumab|mesh-list
5587357|NCT03800953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6198335|NCT01982695|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6198336|NCT01982695|Protease Inhibitors|protease inhibitors|mesh-ancestor
6198337|NCT01982695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6198338|NCT01982695|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6198339|NCT01982695|Protective Agents|protective agents|mesh-ancestor
6198340|NCT01982695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198341|NCT01982812|Levetiracetam|levetiracetam|mesh-list
5587358|NCT03800953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5587359|NCT03800810|Hyaluronic Acid|hyaluronic acid|mesh-list
5587360|NCT03800810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5587361|NCT03800810|Immunologic Factors|immunologic factors|mesh-ancestor
5587362|NCT03800810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198342|NCT01982812|Anticonvulsants|anticonvulsants|mesh-ancestor
6198343|NCT01982812|Nootropic Agents|nootropic agents|mesh-ancestor
6198344|NCT01982942|Ibudilast|ibudilast|mesh-list
6198345|NCT01982942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5725671|NCT03178955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5725672|NCT03178955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5725673|NCT03178955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5725674|NCT03178955|Immunologic Factors|immunologic factors|mesh-ancestor
5725675|NCT03178864|Heparin|heparin|mesh-list
5725676|NCT03178864|Rivaroxaban|rivaroxaban|mesh-list
5725677|NCT03178864|Anticoagulants|anticoagulants|mesh-ancestor
5725678|NCT03178864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5725679|NCT03178864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5725680|NCT03178864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198346|NCT01982942|Autonomic Agents|autonomic agents|mesh-ancestor
6198347|NCT01982942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6198348|NCT01982942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198349|NCT01982942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6198350|NCT01982942|Respiratory System Agents|respiratory system agents|mesh-ancestor
6198351|NCT01982942|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6198352|NCT01982942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6198353|NCT01982942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198354|NCT01982942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6198355|NCT01982942|Vasodilator Agents|vasodilator agents|mesh-ancestor
6198356|NCT01982955|Carboplatin|carboplatin|mesh-list
6198357|NCT01982955|Pemetrexed|pemetrexed|mesh-list
6198358|NCT01982955|Gefitinib|gefitinib|mesh-list
6198359|NCT01982955|Tepotinib|tepotinib|mesh-list
6198360|NCT01982955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6198361|NCT01982955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6198362|NCT01982955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198363|NCT01982955|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6198364|NCT01982955|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6198365|NCT01982955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6198366|NCT01983020|Lidocaine|lidocaine|mesh-list
6198367|NCT01983020|Ketamine|ketamine|mesh-list
5587363|NCT03800810|Viscosupplements|viscosupplements|mesh-ancestor
5587364|NCT03800810|Protective Agents|protective agents|mesh-ancestor
5587365|NCT03800667|Ascorbic Acid|ascorbic acid|mesh-list
5587366|NCT03800667|Antioxidants|antioxidants|mesh-ancestor
5587367|NCT03800667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587368|NCT03800667|Protective Agents|protective agents|mesh-ancestor
5587369|NCT03800667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587370|NCT03800667|Vitamins|vitamins|mesh-ancestor
5587371|NCT03800667|Micronutrients|micronutrients|mesh-ancestor
5587372|NCT03800745|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
5587373|NCT03800745|Laxatives|laxatives|mesh-ancestor
5587374|NCT03800745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5587375|NCT03800693|Leucovorin|leucovorin|mesh-list
5587376|NCT03800693|Fluorouracil|fluorouracil|mesh-list
5587377|NCT03800693|Oxaliplatin|oxaliplatin|mesh-list
5587378|NCT03800693|Antimetabolites|antimetabolites|mesh-ancestor
5587379|NCT03800693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587380|NCT03800693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5587381|NCT03800693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5587382|NCT03800693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5587383|NCT03800693|Immunologic Factors|immunologic factors|mesh-ancestor
5587384|NCT03800693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198368|NCT01983020|Anesthetics, Local|anesthetics, local|mesh-ancestor
6198369|NCT01983020|Anesthetics|anesthetics|mesh-ancestor
5725681|NCT03178864|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6198370|NCT01983020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6198371|NCT01983020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198372|NCT01983020|Sensory System Agents|sensory system agents|mesh-ancestor
6198373|NCT01983020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6198374|NCT01983020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6198375|NCT01983020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6198376|NCT01983020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6198377|NCT01983020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6198378|NCT01983020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198379|NCT01983020|Analgesics|analgesics|mesh-ancestor
6198380|NCT01983020|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5587385|NCT03800693|Antidotes|antidotes|mesh-ancestor
5587386|NCT03800693|Protective Agents|protective agents|mesh-ancestor
5587387|NCT03800693|Vitamin B Complex|vitamin b complex|mesh-ancestor
5587388|NCT03800693|Vitamins|vitamins|mesh-ancestor
5587389|NCT03800693|Micronutrients|micronutrients|mesh-ancestor
5587390|NCT03800381|Rifampin|rifampin|mesh-list
5587391|NCT03800381|Isoniazid|isoniazid|mesh-list
5587392|NCT03800381|Pyrazinamide|pyrazinamide|mesh-list
5587393|NCT03800381|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5587394|NCT03800381|Antitubercular Agents|antitubercular agents|mesh-ancestor
5587395|NCT03800381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5587396|NCT03800381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5587397|NCT03800381|Leprostatic Agents|leprostatic agents|mesh-ancestor
5587398|NCT03800381|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5587399|NCT03800381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5587400|NCT03800381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587401|NCT03800381|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5587402|NCT03800381|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5587403|NCT03800381|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5587404|NCT03800381|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5587405|NCT03800381|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5587406|NCT03800381|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5587407|NCT03800381|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5587408|NCT03800381|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6198381|NCT01983020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6198382|NCT01983020|Anesthetics, General|anesthetics, general|mesh-ancestor
6198383|NCT01983020|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6198384|NCT01983020|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6198385|NCT01983020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6198386|NCT01983111|Acetaminophen|acetaminophen|mesh-list
6198387|NCT01983111|Buprenorphine|buprenorphine|mesh-list
6198388|NCT01983111|Tramadol|tramadol|mesh-list
6198389|NCT01983111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6198390|NCT01983111|Analgesics|analgesics|mesh-ancestor
6198391|NCT01983111|Sensory System Agents|sensory system agents|mesh-ancestor
6198392|NCT01983111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6198393|NCT01983111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198394|NCT01983111|Antipyretics|antipyretics|mesh-ancestor
6198395|NCT01983111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6198396|NCT01983111|Narcotics|narcotics|mesh-ancestor
6198397|NCT01983111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6198398|NCT01983111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6198399|NCT01983566|Omeprazole|omeprazole|mesh-list
6198400|NCT01983566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6198401|NCT01983566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6198402|NCT01983566|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6198403|NCT01983566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6672299|NCT01555112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6672300|NCT01555112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6672301|NCT01555112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672302|NCT01555112|Antiviral Agents|antiviral agents|mesh-ancestor
6672303|NCT01555112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6672304|NCT01555190|Folic Acid|folic acid|mesh-list
6672305|NCT01555190|Inositol|inositol|mesh-list
6198404|NCT01983566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198405|NCT01983683|Vancomycin|vancomycin|mesh-list
5587409|NCT03800381|Antimetabolites|antimetabolites|mesh-ancestor
5587410|NCT03800381|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5587411|NCT03800550|Clarithromycin|clarithromycin|mesh-list
5587412|NCT03800550|Bedaquiline|bedaquiline|mesh-list
5587413|NCT03800550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5587414|NCT03800550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6198406|NCT01983683|Oxazolidinones|oxazolidinones|mesh-list
6198407|NCT01983683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6198408|NCT01983683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6198409|NCT01983683|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6198410|NCT01983683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6198411|NCT01983683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198412|NCT01983878|Ramucirumab|ramucirumab|mesh-list
6198413|NCT01983878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6198414|NCT01983969|Pyridoxine|pyridoxine|mesh-list
5587415|NCT03800550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5587416|NCT03800550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5587417|NCT03800550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587418|NCT03800550|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5587419|NCT03800550|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5587420|NCT03800550|Antitubercular Agents|antitubercular agents|mesh-ancestor
5587421|NCT03800264|Hydrocortisone|hydrocortisone|mesh-list
5587422|NCT03800264|Bisoprolol|bisoprolol|mesh-list
5587423|NCT03800264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5587424|NCT03800264|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5587425|NCT03800264|Sympatholytics|sympatholytics|mesh-ancestor
5587426|NCT03800264|Autonomic Agents|autonomic agents|mesh-ancestor
5587427|NCT03800264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5587428|NCT03800264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587429|NCT03800264|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6198415|NCT01983969|Gemcitabine|gemcitabine|mesh-list
6198416|NCT01983969|Dexamethasone|dexamethasone|mesh-list
6198417|NCT01983969|Rituximab|rituximab|mesh-list
6198418|NCT01983969|Azacitidine|azacitidine|mesh-list
6198419|NCT01983969|Melphalan|melphalan|mesh-list
6198420|NCT01983969|Busulfan|busulfan|mesh-list
6198421|NCT01983969|Vorinostat|vorinostat|mesh-list
5587430|NCT03800264|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5587431|NCT03800264|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5587432|NCT03800264|Adrenergic Agents|adrenergic agents|mesh-ancestor
5587433|NCT03800264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5587434|NCT03800264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587435|NCT03800797|Loxoprofen|loxoprofen|mesh-list
6198422|NCT01983969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6198423|NCT01983969|Antiemetics|antiemetics|mesh-ancestor
6198424|NCT01983969|Autonomic Agents|autonomic agents|mesh-ancestor
6198425|NCT01983969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6198426|NCT01983969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198427|NCT01983969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6198428|NCT01983969|Glucocorticoids|glucocorticoids|mesh-ancestor
6198429|NCT01983969|Hormones|hormones|mesh-ancestor
6198430|NCT01983969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6198431|NCT01983969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6198432|NCT01983969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6198433|NCT01983969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6198434|NCT01983969|Immunologic Factors|immunologic factors|mesh-ancestor
6198435|NCT01983969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6198436|NCT01983969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5587436|NCT03800797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5587437|NCT03800797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5587438|NCT03800797|Analgesics|analgesics|mesh-ancestor
5587439|NCT03800797|Sensory System Agents|sensory system agents|mesh-ancestor
5587440|NCT03800797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5587441|NCT03800797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587442|NCT03800797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5587443|NCT03800797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5587444|NCT03800290|Clenbuterol|clenbuterol|mesh-list
6198437|NCT01983969|Antimetabolites|antimetabolites|mesh-ancestor
6198438|NCT01983969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198439|NCT01983969|Antiviral Agents|antiviral agents|mesh-ancestor
6198440|NCT01983969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6198441|NCT01983969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6198442|NCT01983969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6198443|NCT01983969|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6198444|NCT01983969|Alkylating Agents|alkylating agents|mesh-ancestor
6198445|NCT01983969|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6198446|NCT01983969|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6198447|NCT01983969|Vitamin B Complex|vitamin b complex|mesh-ancestor
6198448|NCT01983969|Vitamins|vitamins|mesh-ancestor
6198449|NCT01983969|Micronutrients|micronutrients|mesh-ancestor
6198450|NCT01984164|Candesartan|candesartan|mesh-list
5587445|NCT03800290|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5587446|NCT03800290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6198451|NCT01984164|Lisinopril|lisinopril|mesh-list
6198452|NCT01984164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6198453|NCT01984164|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6198454|NCT01984164|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6198455|NCT01984164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198456|NCT01984164|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6198457|NCT01984164|Protease Inhibitors|protease inhibitors|mesh-ancestor
6198458|NCT01984164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6198459|NCT01984164|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6198460|NCT01984164|Protective Agents|protective agents|mesh-ancestor
6198461|NCT01984164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198462|NCT01984229|Posaconazole|posaconazole|mesh-list
6198463|NCT01984229|Antifungal Agents|antifungal agents|mesh-ancestor
6198464|NCT01984229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6198465|NCT01984229|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6198466|NCT01984229|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6198467|NCT01984229|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6198468|NCT01984229|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6198469|NCT01984229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6198470|NCT01984229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6198471|NCT01984229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198472|NCT01984229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6198473|NCT01984229|Hormone Antagonists|hormone antagonists|mesh-ancestor
6198474|NCT01984229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6198475|NCT01984229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198476|NCT01984242|Bevacizumab|bevacizumab|mesh-list
6198477|NCT01984242|Sunitinib|sunitinib|mesh-list
6198478|NCT01984242|Atezolizumab|atezolizumab|mesh-list
6198479|NCT01984242|Antibodies|antibodies|mesh-list
6198480|NCT01984242|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6198481|NCT01984242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6198482|NCT01984242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6198483|NCT01984242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6198484|NCT01984242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5587447|NCT03800290|Adrenergic Agents|adrenergic agents|mesh-ancestor
5587448|NCT03800290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5587449|NCT03800290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587450|NCT03800290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587451|NCT03800290|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5587452|NCT03800290|Autonomic Agents|autonomic agents|mesh-ancestor
5587453|NCT03800290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5587454|NCT03800290|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5587455|NCT03800290|Respiratory System Agents|respiratory system agents|mesh-ancestor
6198485|NCT01984242|Growth Substances|growth substances|mesh-ancestor
6198486|NCT01984242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198487|NCT01984242|Growth Inhibitors|growth inhibitors|mesh-ancestor
6198488|NCT01984242|Immunologic Factors|immunologic factors|mesh-ancestor
6198489|NCT01984242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6198490|NCT01984242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6198491|NCT01984242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198492|NCT01984294|Ribavirin|ribavirin|mesh-list
6198493|NCT01984294|Antiviral Agents|antiviral agents|mesh-ancestor
6198494|NCT01984294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6198495|NCT01984294|Antimetabolites|antimetabolites|mesh-ancestor
6198496|NCT01984294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198497|NCT01984398|Citric Acid|citric acid|mesh-list
6198498|NCT01984398|Sodium Citrate|sodium citrate|mesh-list
6198499|NCT01984398|Enclomiphene|enclomiphene|mesh-list
6198500|NCT01984398|Clomiphene|clomiphene|mesh-list
6198501|NCT01984398|Zuclomiphene|zuclomiphene|mesh-list
6198502|NCT01984398|Anticoagulants|anticoagulants|mesh-ancestor
6198503|NCT01984398|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6198504|NCT01984398|Chelating Agents|chelating agents|mesh-ancestor
5587456|NCT03800290|Sympathomimetics|sympathomimetics|mesh-ancestor
5587457|NCT03800524|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
5587458|NCT03800524|Antiviral Agents|antiviral agents|mesh-ancestor
5587459|NCT03800524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6198505|NCT01984398|Sequestering Agents|sequestering agents|mesh-ancestor
6198506|NCT01984398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198507|NCT01984398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6198508|NCT01984398|Hormone Antagonists|hormone antagonists|mesh-ancestor
6198509|NCT01984398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6198510|NCT01984398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587460|NCT03800524|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5587461|NCT03800524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5587462|NCT03800433|Pentoxifylline|pentoxifylline|mesh-list
5587463|NCT03800433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5587464|NCT03800433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5587465|NCT03800433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587466|NCT03800433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5587467|NCT03800433|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5587468|NCT03800433|Protective Agents|protective agents|mesh-ancestor
6198511|NCT01984398|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6198512|NCT01984398|Fertility Agents|fertility agents|mesh-ancestor
6198513|NCT01984398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6198514|NCT01984398|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6198515|NCT01984398|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6198516|NCT01984424|Atorvastatin|atorvastatin|mesh-list
6198517|NCT01984424|Ezetimibe|ezetimibe|mesh-list
5587469|NCT03800433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587470|NCT03800433|Vasodilator Agents|vasodilator agents|mesh-ancestor
5587471|NCT03800433|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5587472|NCT03800433|Antioxidants|antioxidants|mesh-ancestor
5587473|NCT03799835|Atezolizumab|atezolizumab|mesh-list
5587474|NCT03799835|BCG Vaccine|bcg vaccine|mesh-list
5587475|NCT03799835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5587476|NCT03799835|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5587477|NCT03799835|Immunologic Factors|immunologic factors|mesh-ancestor
5587478|NCT03799835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587479|NCT03799809|Voriconazole|voriconazole|mesh-list
5587480|NCT03799809|Antifungal Agents|antifungal agents|mesh-ancestor
5587481|NCT03799809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5587482|NCT03799809|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5587483|NCT03799809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5587484|NCT03799809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5587485|NCT03799809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587486|NCT03799809|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6198518|NCT01984424|Evolocumab|evolocumab|mesh-list
6198519|NCT01984424|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6198520|NCT01984424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6198521|NCT01984424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6198522|NCT01984424|Antimetabolites|antimetabolites|mesh-ancestor
6198523|NCT01984424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198524|NCT01984424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6198525|NCT01984424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6198526|NCT01984424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6198527|NCT01984424|Immunologic Factors|immunologic factors|mesh-ancestor
6198528|NCT01984424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198529|NCT01984684|Vancomycin|vancomycin|mesh-list
6198530|NCT01984684|Aztreonam|aztreonam|mesh-list
6198531|NCT01984684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5587487|NCT03799809|Hormone Antagonists|hormone antagonists|mesh-ancestor
5587488|NCT03799809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5587489|NCT03799809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587490|NCT03799809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5587491|NCT03799744|Durvalumab|durvalumab|mesh-list
5587492|NCT03799744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5587493|NCT03799744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5587494|NCT03799679|Antineoplastic Agents|antineoplastic agents|mesh-list
5587495|NCT03799731|Trifluridine|trifluridine|mesh-list
5587496|NCT03799731|Antibodies|antibodies|mesh-list
5587497|NCT03799731|Immunologic Factors|immunologic factors|mesh-ancestor
5587498|NCT03799731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587499|NCT03799731|Antimetabolites|antimetabolites|mesh-ancestor
5587500|NCT03799731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587501|NCT03799731|Antiviral Agents|antiviral agents|mesh-ancestor
5587502|NCT03799731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5587503|NCT03799536|Sotalol|sotalol|mesh-list
5587504|NCT03799536|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5587505|NCT03799536|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5587506|NCT03799536|Adrenergic Agents|adrenergic agents|mesh-ancestor
6198532|NCT01984684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6198533|NCT01984892|Poly ICLC|poly iclc|mesh-list
6198534|NCT01984892|Interferon Inducers|interferon inducers|mesh-ancestor
6198535|NCT01984892|Immunologic Factors|immunologic factors|mesh-ancestor
6198536|NCT01984892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198537|NCT01985126|Acetaminophen|acetaminophen|mesh-list
6198538|NCT01985126|Diphenhydramine|diphenhydramine|mesh-list
6198539|NCT01985126|Promethazine|promethazine|mesh-list
6198540|NCT01985126|Methylprednisolone|methylprednisolone|mesh-list
6198541|NCT01985126|Daratumumab|daratumumab|mesh-list
6198542|NCT01985126|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5587507|NCT03799536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5587508|NCT03799536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587509|NCT03799536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587510|NCT03799536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5587511|NCT03799536|Sympatholytics|sympatholytics|mesh-ancestor
5587512|NCT03799536|Autonomic Agents|autonomic agents|mesh-ancestor
5587513|NCT03799536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5587514|NCT03799406|Vitamin D|vitamin d|mesh-list
6198543|NCT01985126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6198544|NCT01985126|Analgesics|analgesics|mesh-ancestor
6198545|NCT01985126|Sensory System Agents|sensory system agents|mesh-ancestor
6198546|NCT01985126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6198547|NCT01985126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198548|NCT01985126|Antipyretics|antipyretics|mesh-ancestor
6198549|NCT01985126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6198550|NCT01985126|Antiemetics|antiemetics|mesh-ancestor
6198551|NCT01985126|Autonomic Agents|autonomic agents|mesh-ancestor
6198552|NCT01985126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6198553|NCT01985126|Glucocorticoids|glucocorticoids|mesh-ancestor
6198554|NCT01985126|Hormones|hormones|mesh-ancestor
6198555|NCT01985126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6198556|NCT01985126|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6198557|NCT01985126|Protective Agents|protective agents|mesh-ancestor
6198558|NCT01985126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6198559|NCT01985126|Immunologic Factors|immunologic factors|mesh-ancestor
6198560|NCT01985126|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6198561|NCT01985126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6198562|NCT01985126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6198563|NCT01985126|Anesthetics, Local|anesthetics, local|mesh-ancestor
5587515|NCT03799406|Cholecalciferol|cholecalciferol|mesh-list
5587516|NCT03799406|Vitamins|vitamins|mesh-ancestor
5587517|NCT03799406|Micronutrients|micronutrients|mesh-ancestor
5587518|NCT03799406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198564|NCT01985126|Anesthetics|anesthetics|mesh-ancestor
6198565|NCT01985126|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6198566|NCT01985126|Histamine Antagonists|histamine antagonists|mesh-ancestor
6198567|NCT01985126|Histamine Agents|histamine agents|mesh-ancestor
6198568|NCT01985126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6198569|NCT01985126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198570|NCT01985126|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6198571|NCT01985126|Antipruritics|antipruritics|mesh-ancestor
6198572|NCT01985126|Dermatologic Agents|dermatologic agents|mesh-ancestor
6198573|NCT01985321|Ethanol|ethanol|mesh-list
6198574|NCT01985321|Glycolic acid|glycolic acid|mesh-list
6198575|NCT01985321|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6198576|NCT01985321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6198577|NCT01985321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6198578|NCT01985321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198579|NCT01985321|Keratolytic Agents|keratolytic agents|mesh-ancestor
6198580|NCT01985321|Dermatologic Agents|dermatologic agents|mesh-ancestor
6198581|NCT01985334|Glycopyrrolate|glycopyrrolate|mesh-list
6198582|NCT01985334|Bromides|bromides|mesh-list
6198583|NCT01985334|Anticonvulsants|anticonvulsants|mesh-ancestor
6198584|NCT01985334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198585|NCT01985334|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5587519|NCT03799406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5587520|NCT03799406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5587521|NCT03799224|Decitabine|decitabine|mesh-list
5587522|NCT03799224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5587523|NCT03799224|Antimetabolites|antimetabolites|mesh-ancestor
5587524|NCT03799224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587525|NCT03799224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5587526|NCT03799224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5587527|NCT03799315|Nicotine|nicotine|mesh-list
5587528|NCT03799315|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5587529|NCT03799315|Autonomic Agents|autonomic agents|mesh-ancestor
5587530|NCT03799315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5587531|NCT03799315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198586|NCT01985334|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6198587|NCT01985334|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6198588|NCT01985334|Cholinergic Agents|cholinergic agents|mesh-ancestor
6198589|NCT01985334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6198590|NCT01985334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198591|NCT01985425|Colchicine|colchicine|mesh-list
6198592|NCT01985425|Gout Suppressants|gout suppressants|mesh-ancestor
6198593|NCT01985425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6198594|NCT01985425|Tubulin Modulators|tubulin modulators|mesh-ancestor
6198595|NCT01985425|Antimitotic Agents|antimitotic agents|mesh-ancestor
6198596|NCT01985425|Mitosis Modulators|mitosis modulators|mesh-ancestor
6198597|NCT01985425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198598|NCT01985425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6198599|NCT01985581|Guanfacine|guanfacine|mesh-list
6198600|NCT01985581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6198601|NCT01985581|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6198602|NCT01985581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6198603|NCT01985581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6198604|NCT01985581|Adrenergic Agents|adrenergic agents|mesh-ancestor
6198605|NCT01985581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6198606|NCT01985581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198607|NCT01985581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198608|NCT01985685|Thiamine|thiamine|mesh-list
6198609|NCT01985685|Vitamin B Complex|vitamin b complex|mesh-ancestor
6198610|NCT01985685|Vitamins|vitamins|mesh-ancestor
6198611|NCT01985685|Micronutrients|micronutrients|mesh-ancestor
6198612|NCT01985685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198613|NCT01985763|Genistein|genistein|mesh-list
6198614|NCT01985763|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6198615|NCT01985763|Protective Agents|protective agents|mesh-ancestor
6198616|NCT01985763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198617|NCT01985763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6198618|NCT01985763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6198619|NCT01985763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6198620|NCT01985763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198621|NCT01985763|Phytoestrogens|phytoestrogens|mesh-ancestor
6198622|NCT01985763|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6198623|NCT01985763|Estrogens|estrogens|mesh-ancestor
6198624|NCT01985763|Hormones|hormones|mesh-ancestor
6198625|NCT01985763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6198626|NCT01986010|Aluminum phosphate|aluminum phosphate|mesh-list
6198627|NCT01986010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6198628|NCT01986010|Immunologic Factors|immunologic factors|mesh-ancestor
6198629|NCT01986010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198630|NCT01986010|Antacids|antacids|mesh-ancestor
6198631|NCT01986010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198632|NCT01986010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6198633|NCT01986062|Amphetamine|amphetamine|mesh-list
6198634|NCT01986062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6198635|NCT01986062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198636|NCT01986062|Sympathomimetics|sympathomimetics|mesh-ancestor
5587532|NCT03799315|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5587533|NCT03799315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5587534|NCT03799315|Cholinergic Agents|cholinergic agents|mesh-ancestor
5587535|NCT03799315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5587536|NCT03799315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587537|NCT03799172|Echinocandins|echinocandins|mesh-list
5587538|NCT03799172|Antifungal Agents|antifungal agents|mesh-ancestor
5587539|NCT03799172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5587540|NCT03799120|Tamsulosin|tamsulosin|mesh-list
5587541|NCT03799120|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5587542|NCT03799120|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5587543|NCT03799120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6198637|NCT01986062|Autonomic Agents|autonomic agents|mesh-ancestor
6198638|NCT01986062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6198639|NCT01986062|Dopamine Agents|dopamine agents|mesh-ancestor
6198640|NCT01986062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6198641|NCT01986062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198642|NCT01986062|Adrenergic Agents|adrenergic agents|mesh-ancestor
6198643|NCT01986062|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6198644|NCT01986062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6198645|NCT01986062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6198646|NCT01986062|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6198647|NCT01986101|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
6198648|NCT01986101|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6198649|NCT01986101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6198650|NCT01986101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6198651|NCT01986101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198652|NCT01986101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6198653|NCT01986101|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6198654|NCT01986101|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5587544|NCT03799120|Adrenergic Agents|adrenergic agents|mesh-ancestor
5587545|NCT03799120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5587546|NCT03799120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587547|NCT03799120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587548|NCT03799120|Urological Agents|urological agents|mesh-ancestor
5587549|NCT03799094|Ascorbic Acid|ascorbic acid|mesh-list
5587550|NCT03799094|Vitamins|vitamins|mesh-ancestor
5587551|NCT03799094|Micronutrients|micronutrients|mesh-ancestor
6198655|NCT01986101|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6198656|NCT01986101|Adrenergic Agents|adrenergic agents|mesh-ancestor
6198657|NCT01986101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6198658|NCT01986101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198659|NCT01986101|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6198660|NCT01986101|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6198661|NCT01986101|Serotonin Agents|serotonin agents|mesh-ancestor
6198662|NCT01986101|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6198663|NCT01986101|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6198664|NCT01986101|Dopamine Agents|dopamine agents|mesh-ancestor
6198665|NCT01986114|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
6198666|NCT01986114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6198667|NCT01986114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6198668|NCT01986114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6198669|NCT01986114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198670|NCT01986114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6198671|NCT01986114|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6198672|NCT01986114|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6198673|NCT01986114|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6198674|NCT01986114|Adrenergic Agents|adrenergic agents|mesh-ancestor
6198675|NCT01986114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6198676|NCT01986114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198677|NCT01986114|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6198678|NCT01986114|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6198679|NCT01986114|Serotonin Agents|serotonin agents|mesh-ancestor
6198680|NCT01986114|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6198681|NCT01986114|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6198682|NCT01986114|Dopamine Agents|dopamine agents|mesh-ancestor
6198683|NCT01986231|Glucagon|glucagon|mesh-list
6198684|NCT01986231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6198685|NCT01986231|Hormones|hormones|mesh-ancestor
6198686|NCT01986231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6198687|NCT01986231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198688|NCT01986361|Flurbiprofen|flurbiprofen|mesh-list
6198689|NCT01986361|Analgesics|analgesics|mesh-ancestor
6198690|NCT01986361|Sensory System Agents|sensory system agents|mesh-ancestor
6198691|NCT01986361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6198692|NCT01986361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198693|NCT01986361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6198694|NCT01986361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6198695|NCT01986361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6198696|NCT01986361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6198697|NCT01986361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6198698|NCT01986361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6198699|NCT01986361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198700|NCT01986855|Ertugliflozin|ertugliflozin|mesh-list
6198701|NCT01986855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6198702|NCT01986855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198703|NCT01986855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5587552|NCT03799094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587553|NCT03799094|Antioxidants|antioxidants|mesh-ancestor
5587554|NCT03799094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587555|NCT03799094|Protective Agents|protective agents|mesh-ancestor
5605266|NCT03103971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605267|NCT03103971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605268|NCT03103971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5605269|NCT03086616|Irinotecan|irinotecan|mesh-list
5605270|NCT03086616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5605271|NCT03086616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5605272|NCT03086616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5605273|NCT03086616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605274|NCT03086616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5607032|NCT03031730|Glucocorticoids|glucocorticoids|mesh-ancestor
6198704|NCT01986855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198705|NCT01986881|Ertugliflozin|ertugliflozin|mesh-list
6198706|NCT01986881|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6198707|NCT01986881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198708|NCT01986881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6198709|NCT01986881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198710|NCT01986907|Ranibizumab|ranibizumab|mesh-list
6198711|NCT01986907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6198712|NCT01986907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6198713|NCT01986907|Growth Substances|growth substances|mesh-ancestor
6198714|NCT01986907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198715|NCT01986907|Growth Inhibitors|growth inhibitors|mesh-ancestor
6198716|NCT01986907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6198717|NCT01986946|Hydromorphone|hydromorphone|mesh-list
6198718|NCT01986946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6198719|NCT01986946|Narcotics|narcotics|mesh-ancestor
6198720|NCT01986946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6198721|NCT01986946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198722|NCT01986946|Analgesics|analgesics|mesh-ancestor
6198723|NCT01986946|Sensory System Agents|sensory system agents|mesh-ancestor
6198724|NCT01986946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6198725|NCT01987102|Leucovorin|leucovorin|mesh-list
6198726|NCT01987102|Calcium|calcium|mesh-list
6198727|NCT01987102|Levoleucovorin|levoleucovorin|mesh-list
6198728|NCT01987102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6198729|NCT01987102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198730|NCT01987102|Antidotes|antidotes|mesh-ancestor
6198731|NCT01987102|Protective Agents|protective agents|mesh-ancestor
6198732|NCT01987102|Vitamin B Complex|vitamin b complex|mesh-ancestor
6198733|NCT01987102|Vitamins|vitamins|mesh-ancestor
6198734|NCT01987102|Micronutrients|micronutrients|mesh-ancestor
6198735|NCT01987219|Bromides|bromides|mesh-list
6198736|NCT01987219|Albuterol|albuterol|mesh-list
6198737|NCT01987219|Ipratropium|ipratropium|mesh-list
5587556|NCT03798912|Octreotide|octreotide|mesh-list
5587557|NCT03798912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5587558|NCT03798912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5587559|NCT03798912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5587560|NCT03798899|Methoxyflurane|methoxyflurane|mesh-list
5587561|NCT03798899|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5587562|NCT03798899|Anesthetics, General|anesthetics, general|mesh-ancestor
5587563|NCT03798899|Anesthetics|anesthetics|mesh-ancestor
5587564|NCT03798899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5587565|NCT03798899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587566|NCT03798834|Anesthetics|anesthetics|mesh-list
5587567|NCT03798834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5587568|NCT03798834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587569|NCT03798821|Sulfalene|sulfalene|mesh-list
5587570|NCT03798821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5587571|NCT03798821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5587572|NCT03798821|Renal Agents|renal agents|mesh-ancestor
6198738|NCT01987219|Anticonvulsants|anticonvulsants|mesh-ancestor
6198739|NCT01987219|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6198740|NCT01987219|Autonomic Agents|autonomic agents|mesh-ancestor
6198741|NCT01987219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6198742|NCT01987219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198743|NCT01987219|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6198744|NCT01987219|Respiratory System Agents|respiratory system agents|mesh-ancestor
6198745|NCT01987219|Tocolytic Agents|tocolytic agents|mesh-ancestor
6198746|NCT01987219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6198747|NCT01987219|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6198748|NCT01987219|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6198749|NCT01987219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6198750|NCT01987219|Adrenergic Agents|adrenergic agents|mesh-ancestor
6198751|NCT01987219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6198752|NCT01987219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198753|NCT01987219|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6198754|NCT01987219|Cholinergic Agents|cholinergic agents|mesh-ancestor
5587573|NCT03798821|Antimalarials|antimalarials|mesh-ancestor
5587574|NCT03798821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5587575|NCT03798821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5587576|NCT03798743|Docetaxel|docetaxel|mesh-list
5587577|NCT03798743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5587578|NCT03798743|Tubulin Modulators|tubulin modulators|mesh-ancestor
5587579|NCT03798743|Antimitotic Agents|antimitotic agents|mesh-ancestor
5587580|NCT03798743|Mitosis Modulators|mitosis modulators|mesh-ancestor
5587581|NCT03798743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587582|NCT03798639|Nivolumab|nivolumab|mesh-list
6198755|NCT01987232|Carboplatin|carboplatin|mesh-list
5587583|NCT03798639|Ipilimumab|ipilimumab|mesh-list
5587584|NCT03798639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5587585|NCT03798639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5587586|NCT03798639|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5587587|NCT03798639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587588|NCT03798600|Caspofungin|caspofungin|mesh-list
5587589|NCT03798600|Antifungal Agents|antifungal agents|mesh-ancestor
6198756|NCT01987232|Etoposide|etoposide|mesh-list
6198757|NCT01987232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6198758|NCT01987232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6198759|NCT01987232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6198760|NCT01987232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6198761|NCT01987232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6198762|NCT01987232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198763|NCT01987427|Phentermine|phentermine|mesh-list
6198764|NCT01987427|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6198765|NCT01987427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198766|NCT01987427|Appetite Depressants|appetite depressants|mesh-ancestor
6198767|NCT01987427|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6198768|NCT01987427|Sympathomimetics|sympathomimetics|mesh-ancestor
6198769|NCT01987427|Autonomic Agents|autonomic agents|mesh-ancestor
6198770|NCT01987427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6198771|NCT01987427|Adrenergic Agents|adrenergic agents|mesh-ancestor
6198772|NCT01987427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6198773|NCT01987427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198774|NCT01987453|Sofosbuvir|sofosbuvir|mesh-list
6198775|NCT01987453|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
6198776|NCT01987453|Ledipasvir|ledipasvir|mesh-list
6198777|NCT01987453|Antiviral Agents|antiviral agents|mesh-ancestor
6198778|NCT01987453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6198779|NCT01987479|Methotrexate|methotrexate|mesh-list
6198780|NCT01987479|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6198781|NCT01987479|Abortifacient Agents|abortifacient agents|mesh-ancestor
6198782|NCT01987479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6198783|NCT01987479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198784|NCT01987479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6198785|NCT01987479|Antimetabolites|antimetabolites|mesh-ancestor
6198786|NCT01987479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198787|NCT01987479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6198788|NCT01987479|Dermatologic Agents|dermatologic agents|mesh-ancestor
6198789|NCT01987479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6198790|NCT01987479|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6198791|NCT01987479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6198792|NCT01987479|Immunologic Factors|immunologic factors|mesh-ancestor
6198793|NCT01987479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6198794|NCT01987479|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6198795|NCT01987505|Rituximab|rituximab|mesh-list
6198796|NCT01987505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6198797|NCT01987505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6198798|NCT01987505|Immunologic Factors|immunologic factors|mesh-ancestor
6198799|NCT01987505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198800|NCT01987505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6198801|NCT01987596|Lenograstim|lenograstim|mesh-list
6198802|NCT01987596|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6198803|NCT01987596|Immunologic Factors|immunologic factors|mesh-ancestor
6198804|NCT01987596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198805|NCT01987752|Timolol|timolol|mesh-list
6198806|NCT01987752|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6198807|NCT01987752|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6198808|NCT01987752|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
6198809|NCT01987752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6198810|NCT01987752|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6198811|NCT01987752|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6198812|NCT01987752|Adrenergic Agents|adrenergic agents|mesh-ancestor
6198813|NCT01987752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6198814|NCT01987752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198815|NCT01987752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198816|NCT01987752|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6198817|NCT01987752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6198818|NCT01987752|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6198819|NCT01987752|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6198820|NCT01987752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5587590|NCT03798600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5587591|NCT03798600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5587592|NCT03798600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587593|NCT03798522|Nalbuphine|nalbuphine|mesh-list
5587594|NCT03798522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5587595|NCT03798522|Narcotics|narcotics|mesh-ancestor
5587596|NCT03798522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5587597|NCT03798522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587598|NCT03798522|Analgesics|analgesics|mesh-ancestor
5587599|NCT03798522|Sensory System Agents|sensory system agents|mesh-ancestor
5587600|NCT03798522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6198821|NCT01987765|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6198822|NCT01987765|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6198823|NCT01987895|Vancomycin|vancomycin|mesh-list
6198824|NCT01987895|Oxazolidinones|oxazolidinones|mesh-list
6198825|NCT01987895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6198826|NCT01987895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6198827|NCT01987895|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6198828|NCT01987895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6198829|NCT01987895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207542|NCT02116660|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6207543|NCT02116777|Temozolomide|temozolomide|mesh-list
6207544|NCT02116777|Talazoparib|talazoparib|mesh-list
6207545|NCT02116777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6207546|NCT02116777|Alkylating Agents|alkylating agents|mesh-ancestor
5725682|NCT03178864|Antithrombins|antithrombins|mesh-ancestor
5725683|NCT03178864|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5725684|NCT03178864|Protease Inhibitors|protease inhibitors|mesh-ancestor
6207547|NCT02116777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207548|NCT02116777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6207549|NCT02116777|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6207550|NCT02116777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6207551|NCT02116803|Fulvestrant|fulvestrant|mesh-list
6207552|NCT02116803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6207553|NCT02116803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6207554|NCT02116803|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6207555|NCT02116803|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6207556|NCT02116803|Hormone Antagonists|hormone antagonists|mesh-ancestor
6207557|NCT02116803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6207558|NCT02116803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587601|NCT03798405|Analgesics|analgesics|mesh-list
5587602|NCT03798405|Narcotics|narcotics|mesh-list
5587603|NCT03798405|Sensory System Agents|sensory system agents|mesh-ancestor
5587604|NCT03798405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5587605|NCT03798405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587606|NCT03798405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5587607|NCT03798392|Anesthetics|anesthetics|mesh-list
5587608|NCT03798392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5725685|NCT03178864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6207559|NCT02116972|FX006|fx006|mesh-list
6207560|NCT02116972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6207561|NCT02116972|Glucocorticoids|glucocorticoids|mesh-ancestor
6207562|NCT02116972|Hormones|hormones|mesh-ancestor
6207563|NCT02116972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6207564|NCT02116972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207565|NCT02116972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6207566|NCT02116972|Immunologic Factors|immunologic factors|mesh-ancestor
6207567|NCT02117024|Gemcitabine|gemcitabine|mesh-list
6207568|NCT02117024|Paclitaxel|paclitaxel|mesh-list
6207569|NCT02117024|Vinorelbine|vinorelbine|mesh-list
6207570|NCT02117024|Docetaxel|docetaxel|mesh-list
6207571|NCT02117024|Cyclophosphamide|cyclophosphamide|mesh-list
6207572|NCT02117024|Pemetrexed|pemetrexed|mesh-list
6207573|NCT02117024|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6207574|NCT02117024|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6207575|NCT02117024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6207576|NCT02117024|Tubulin Modulators|tubulin modulators|mesh-ancestor
6207577|NCT02117024|Antimitotic Agents|antimitotic agents|mesh-ancestor
6207578|NCT02117024|Mitosis Modulators|mitosis modulators|mesh-ancestor
6672306|NCT01555190|Hematinics|hematinics|mesh-ancestor
6198830|NCT01987960|Brexpiprazole|brexpiprazole|mesh-list
6198831|NCT01987960|Serotonin Agents|serotonin agents|mesh-ancestor
6198832|NCT01987960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6198833|NCT01987960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198834|NCT01987960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198835|NCT01987960|Dopamine Agonists|dopamine agonists|mesh-ancestor
6198836|NCT01987960|Dopamine Agents|dopamine agents|mesh-ancestor
6198837|NCT01988090|Vitamin D|vitamin d|mesh-list
6198838|NCT01988090|Ergocalciferols|ergocalciferols|mesh-list
6198839|NCT01988090|Vitamins|vitamins|mesh-list
6198840|NCT01988090|Micronutrients|micronutrients|mesh-ancestor
6198841|NCT01988090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198842|NCT01988090|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6198843|NCT01988090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6198844|NCT01988103|Thalidomide|thalidomide|mesh-list
6198845|NCT01988103|Apremilast|apremilast|mesh-list
6198846|NCT01988103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6198847|NCT01988103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6198848|NCT01988103|Analgesics|analgesics|mesh-ancestor
5587609|NCT03798392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587610|NCT03798314|Nivolumab|nivolumab|mesh-list
5587611|NCT03798314|Pomalidomide|pomalidomide|mesh-list
5587612|NCT03798314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5587613|NCT03798314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5587614|NCT03798314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5587615|NCT03798314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587616|NCT03798314|Immunologic Factors|immunologic factors|mesh-ancestor
6198849|NCT01988103|Sensory System Agents|sensory system agents|mesh-ancestor
6198850|NCT01988103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6198851|NCT01988103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198852|NCT01988103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6198853|NCT01988103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6198854|NCT01988103|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6198855|NCT01988103|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6198856|NCT01988103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6198857|NCT01988103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198858|NCT01988103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6198859|NCT01988103|Immunologic Factors|immunologic factors|mesh-ancestor
6198860|NCT01988103|Leprostatic Agents|leprostatic agents|mesh-ancestor
6198861|NCT01988103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6198862|NCT01988103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6198863|NCT01988103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6198864|NCT01988103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6198865|NCT01988103|Growth Substances|growth substances|mesh-ancestor
6198866|NCT01988103|Growth Inhibitors|growth inhibitors|mesh-ancestor
6198867|NCT01988103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6198868|NCT01988246|Aflibercept|aflibercept|mesh-list
6198869|NCT01988246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6198870|NCT01988246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6198871|NCT01988246|Growth Substances|growth substances|mesh-ancestor
6198872|NCT01988246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198873|NCT01988246|Growth Inhibitors|growth inhibitors|mesh-ancestor
6198874|NCT01988246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6198875|NCT01988402|Allopurinol|allopurinol|mesh-list
6198876|NCT01988402|Antimetabolites|antimetabolites|mesh-ancestor
6198877|NCT01988402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198878|NCT01988402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6198879|NCT01988402|Gout Suppressants|gout suppressants|mesh-ancestor
6198880|NCT01988402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6198881|NCT01988402|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6198882|NCT01988402|Antioxidants|antioxidants|mesh-ancestor
6198883|NCT01988402|Protective Agents|protective agents|mesh-ancestor
6198884|NCT01988402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198885|NCT01988493|Sorafenib|sorafenib|mesh-list
6198886|NCT01988493|Tepotinib|tepotinib|mesh-list
6198887|NCT01988493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6198888|NCT01988493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6198889|NCT01988493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6198890|NCT01988493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198891|NCT01988662|Ranibizumab|ranibizumab|mesh-list
6198892|NCT01988662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6198893|NCT01988662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6198894|NCT01988662|Growth Substances|growth substances|mesh-ancestor
6198895|NCT01988662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488312|NCT00583063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6198896|NCT01988662|Growth Inhibitors|growth inhibitors|mesh-ancestor
6198897|NCT01988662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6198898|NCT01988779|Levofloxacin|levofloxacin|mesh-list
5587617|NCT03798314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587618|NCT03798314|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5587619|NCT03798314|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5587620|NCT03798314|Growth Substances|growth substances|mesh-ancestor
5587621|NCT03798314|Growth Inhibitors|growth inhibitors|mesh-ancestor
5587622|NCT03798106|Durvalumab|durvalumab|mesh-list
5587623|NCT03798106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5587624|NCT03798106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5587625|NCT03798119|Tenofovir|tenofovir|mesh-list
5587626|NCT03798119|Antiviral Agents|antiviral agents|mesh-ancestor
5587627|NCT03798119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5587628|NCT03798119|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5587629|NCT03798119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5587630|NCT03798119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5587631|NCT03798119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587632|NCT03798119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5587633|NCT03798119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5587634|NCT03798080|Insulin|insulin|mesh-list
5587635|NCT03798080|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5587636|NCT03798080|Metformin|metformin|mesh-list
5587637|NCT03798080|Insulin Glargine|insulin glargine|mesh-list
5587638|NCT03798080|Lixisenatide|lixisenatide|mesh-list
5587639|NCT03798080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5587640|NCT03798080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587641|NCT03798054|Insulin|insulin|mesh-list
5587642|NCT03798054|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5587643|NCT03798054|Metformin|metformin|mesh-list
5587644|NCT03798054|Insulin Glargine|insulin glargine|mesh-list
5587645|NCT03798054|Lixisenatide|lixisenatide|mesh-list
5587646|NCT03798054|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
5587647|NCT03798054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5587648|NCT03798054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587649|NCT03798054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587650|NCT03799822|Vitamin K|vitamin k|mesh-list
5587651|NCT03799822|Rivaroxaban|rivaroxaban|mesh-list
5587652|NCT03799822|Vitamins|vitamins|mesh-ancestor
5587653|NCT03799822|Micronutrients|micronutrients|mesh-ancestor
5587654|NCT03799822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587655|NCT03799822|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5587656|NCT03799822|Antithrombins|antithrombins|mesh-ancestor
5587657|NCT03799822|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5587658|NCT03799822|Protease Inhibitors|protease inhibitors|mesh-ancestor
5587659|NCT03799822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5587660|NCT03799822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587661|NCT03799822|Anticoagulants|anticoagulants|mesh-ancestor
5587662|NCT03799822|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6198899|NCT01988779|Ofloxacin|ofloxacin|mesh-list
6198900|NCT01988779|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6198901|NCT01988779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6198902|NCT01988779|Renal Agents|renal agents|mesh-ancestor
6198903|NCT01988779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6198904|NCT01988779|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6198905|NCT01988779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6198906|NCT01988779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6198907|NCT01988779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198908|NCT01988779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6198909|NCT01988779|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6198910|NCT01988779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6198911|NCT01988922|Ketamine|ketamine|mesh-list
6198912|NCT01988922|Analgesics|analgesics|mesh-ancestor
6198913|NCT01988922|Sensory System Agents|sensory system agents|mesh-ancestor
6198914|NCT01988922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6198915|NCT01988922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198916|NCT01988922|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5587663|NCT03799822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5587664|NCT03799822|Hemostatics|hemostatics|mesh-ancestor
5587665|NCT03799822|Coagulants|coagulants|mesh-ancestor
5587666|NCT03799900|Ketamine|ketamine|mesh-list
5587667|NCT03799900|Analgesics|analgesics|mesh-ancestor
5587668|NCT03799900|Sensory System Agents|sensory system agents|mesh-ancestor
5587669|NCT03799900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5587670|NCT03799900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587671|NCT03799900|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5607033|NCT03031730|Hormones|hormones|mesh-ancestor
6198917|NCT01988922|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6198918|NCT01988922|Anesthetics, General|anesthetics, general|mesh-ancestor
6198919|NCT01988922|Anesthetics|anesthetics|mesh-ancestor
6198920|NCT01988922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6198921|NCT01988922|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6198922|NCT01988922|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6198923|NCT01988922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6198924|NCT01988922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587672|NCT03799900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5587673|NCT03799900|Anesthetics, General|anesthetics, general|mesh-ancestor
5587674|NCT03799900|Anesthetics|anesthetics|mesh-ancestor
5587675|NCT03799900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5587676|NCT03799900|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5587677|NCT03799900|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6198925|NCT01989156|Menthol|menthol|mesh-list
6198926|NCT01989156|Antipruritics|antipruritics|mesh-ancestor
6198927|NCT01989156|Dermatologic Agents|dermatologic agents|mesh-ancestor
6198928|NCT01989169|Midazolam|midazolam|mesh-list
6198929|NCT01989169|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6198930|NCT01989169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6198931|NCT01989169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6198932|NCT01989169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198933|NCT01989169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6198934|NCT01989169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6198935|NCT01989169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6198936|NCT01989169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6198937|NCT01989169|Anesthetics, General|anesthetics, general|mesh-ancestor
6198938|NCT01989169|Anesthetics|anesthetics|mesh-ancestor
6198939|NCT01989169|GABA Modulators|gaba modulators|mesh-ancestor
6198940|NCT01989169|GABA Agents|gaba agents|mesh-ancestor
6198941|NCT01989169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6198942|NCT01989169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198943|NCT01989195|Manganese|manganese|mesh-list
6198944|NCT01989195|Trace Elements|trace elements|mesh-ancestor
6198945|NCT01989195|Micronutrients|micronutrients|mesh-ancestor
6198946|NCT01989195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198947|NCT01989208|Sodium sulfate|sodium sulfate|mesh-list
6198948|NCT01989208|Cathartics|cathartics|mesh-ancestor
6198949|NCT01989208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6198950|NCT01989221|Granisetron|granisetron|mesh-list
6198951|NCT01989221|Antiemetics|antiemetics|mesh-ancestor
6198952|NCT01989221|Autonomic Agents|autonomic agents|mesh-ancestor
6198953|NCT01989221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6198954|NCT01989221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198955|NCT01989221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6198956|NCT01989221|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6198957|NCT01989221|Serotonin Agents|serotonin agents|mesh-ancestor
6198958|NCT01989221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6198959|NCT01989221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198960|NCT01989455|Deferiprone|deferiprone|mesh-list
6198961|NCT01989455|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6198962|NCT01989455|Chelating Agents|chelating agents|mesh-ancestor
6198963|NCT01989455|Sequestering Agents|sequestering agents|mesh-ancestor
6198964|NCT01989455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198965|NCT01989468|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6198966|NCT01989468|Immunologic Factors|immunologic factors|mesh-ancestor
6198967|NCT01989468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198968|NCT01989546|Talazoparib|talazoparib|mesh-list
6198969|NCT01989546|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6198970|NCT01989546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6198971|NCT01989546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198972|NCT01989546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6198973|NCT01989572|Sargramostim|sargramostim|mesh-list
6198974|NCT01989572|Immunologic Factors|immunologic factors|mesh-ancestor
6198975|NCT01989572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198976|NCT01989689|Etanercept|etanercept|mesh-list
6198977|NCT01989689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6198978|NCT01989689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6198979|NCT01989689|Analgesics|analgesics|mesh-ancestor
6198980|NCT01989689|Sensory System Agents|sensory system agents|mesh-ancestor
6198981|NCT01989689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6198982|NCT01989689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198983|NCT01989689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6198984|NCT01989689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6198985|NCT01989689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6198986|NCT01989689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6198987|NCT01989689|Immunologic Factors|immunologic factors|mesh-ancestor
6198988|NCT01989754|Canagliflozin|canagliflozin|mesh-list
6198989|NCT01989754|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6198990|NCT01989754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198991|NCT01989754|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6198992|NCT01989754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6198993|NCT01989793|Losartan|losartan|mesh-list
6198994|NCT01989793|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6198995|NCT01989793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6198996|NCT01989793|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6198997|NCT01989793|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6198998|NCT01989793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6198999|NCT01989910|Efavirenz|efavirenz|mesh-list
6199000|NCT01989910|Raltegravir Potassium|raltegravir potassium|mesh-list
6199001|NCT01989910|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6199002|NCT01989910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6199003|NCT01989910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6199004|NCT01989910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199005|NCT01989910|Antiviral Agents|antiviral agents|mesh-ancestor
6199006|NCT01989910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6199007|NCT01989910|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6199008|NCT01989910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6199009|NCT01989910|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6199010|NCT01989910|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6199011|NCT01989910|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6199012|NCT01989910|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6199013|NCT01989910|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6199014|NCT01989910|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6199015|NCT01989910|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6199016|NCT01989910|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6199017|NCT01990261|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6199018|NCT01990261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6199019|NCT01990261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5587678|NCT03799900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5587679|NCT03799900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587680|NCT03799757|Bupivacaine|bupivacaine|mesh-list
5587681|NCT03799757|Anesthetics, Local|anesthetics, local|mesh-ancestor
5587682|NCT03799757|Anesthetics|anesthetics|mesh-ancestor
5587683|NCT03799757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5587684|NCT03799757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587685|NCT03799757|Sensory System Agents|sensory system agents|mesh-ancestor
6199020|NCT01990261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6199021|NCT01990261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199022|NCT01990300|Pioglitazone|pioglitazone|mesh-list
6199023|NCT01990300|Alogliptin|alogliptin|mesh-list
6199024|NCT01990300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6199025|NCT01990300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199026|NCT01990300|Incretins|incretins|mesh-ancestor
6199027|NCT01990300|Hormones|hormones|mesh-ancestor
6199028|NCT01990300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6199029|NCT01990300|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6199030|NCT01990300|Protease Inhibitors|protease inhibitors|mesh-ancestor
6199031|NCT01990300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6199032|NCT01990300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199033|NCT01990339|Lansoprazole|lansoprazole|mesh-list
6199034|NCT01990339|Dexlansoprazole|dexlansoprazole|mesh-list
6199035|NCT01990339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6199036|NCT01990339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5587686|NCT03799757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5587687|NCT03799913|Cyclophosphamide|cyclophosphamide|mesh-list
5587688|NCT03799913|Fludarabine|fludarabine|mesh-list
5587689|NCT03799913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5587690|NCT03799913|Immunologic Factors|immunologic factors|mesh-ancestor
6199037|NCT01990339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6199038|NCT01990339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6199039|NCT01990339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199040|NCT01990534|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6199041|NCT01990534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6199042|NCT01990534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6199043|NCT01990560|Mifepristone|mifepristone|mesh-list
6199044|NCT01990560|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6199045|NCT01990560|Abortifacient Agents|abortifacient agents|mesh-ancestor
6199046|NCT01990560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5587691|NCT03799913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587692|NCT03799913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5587693|NCT03799913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5587694|NCT03799913|Alkylating Agents|alkylating agents|mesh-ancestor
5587695|NCT03799913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587696|NCT03799913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5587697|NCT03799913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5587698|NCT03797833|Anesthetics|anesthetics|mesh-list
6199047|NCT01990560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199048|NCT01990560|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6199049|NCT01990560|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6199050|NCT01990560|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6199051|NCT01990560|Contraceptive Agents|contraceptive agents|mesh-ancestor
6199052|NCT01990560|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6199053|NCT01990560|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6199054|NCT01990560|Hormone Antagonists|hormone antagonists|mesh-ancestor
6199055|NCT01990560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6199056|NCT01990560|Luteolytic Agents|luteolytic agents|mesh-ancestor
6199057|NCT01990560|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6199058|NCT01990560|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6199059|NCT01990573|Methadone|methadone|mesh-list
6199060|NCT01990573|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6199061|NCT01990573|Narcotics|narcotics|mesh-ancestor
6199062|NCT01990573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6199063|NCT01990573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199064|NCT01990573|Analgesics|analgesics|mesh-ancestor
6199065|NCT01990573|Sensory System Agents|sensory system agents|mesh-ancestor
6199066|NCT01990573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5587699|NCT03797833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5587700|NCT03797833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587701|NCT03799601|Carboplatin|carboplatin|mesh-list
5587702|NCT03799601|Docetaxel|docetaxel|mesh-list
5587703|NCT03799601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6199067|NCT01990573|Antitussive Agents|antitussive agents|mesh-ancestor
6199068|NCT01990573|Respiratory System Agents|respiratory system agents|mesh-ancestor
6199069|NCT01990677|Eplerenone|eplerenone|mesh-list
6199070|NCT01990677|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6199071|NCT01990677|Hormone Antagonists|hormone antagonists|mesh-ancestor
6199072|NCT01990677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6199073|NCT01990677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587704|NCT03799601|Tubulin Modulators|tubulin modulators|mesh-ancestor
5587705|NCT03799601|Antimitotic Agents|antimitotic agents|mesh-ancestor
6199074|NCT01990677|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6199075|NCT01990677|Diuretics|diuretics|mesh-ancestor
6199076|NCT01990677|Natriuretic Agents|natriuretic agents|mesh-ancestor
6199077|NCT01990677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6199078|NCT01990703|Levonorgestrel|levonorgestrel|mesh-list
6199079|NCT01990703|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6199080|NCT01990703|Contraceptive Agents|contraceptive agents|mesh-ancestor
6199081|NCT01990703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6199082|NCT01990703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199083|NCT01990703|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6199084|NCT01990703|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6199085|NCT01990703|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6199086|NCT01990768|Tranexamic Acid|tranexamic acid|mesh-list
6199087|NCT01990768|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6199088|NCT01990768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6199089|NCT01990768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199090|NCT01990768|Hemostatics|hemostatics|mesh-ancestor
6199091|NCT01990768|Coagulants|coagulants|mesh-ancestor
6199092|NCT01990859|Ipilimumab|ipilimumab|mesh-list
6199093|NCT01990859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6199094|NCT01990859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6199095|NCT01990859|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6199096|NCT01990859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199097|NCT01990898|Cyclosporine|cyclosporine|mesh-list
6199098|NCT01990898|Cyclosporins|cyclosporins|mesh-list
6199099|NCT01990898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6199100|NCT01990898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199101|NCT01990898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6199102|NCT01990898|Immunologic Factors|immunologic factors|mesh-ancestor
6199103|NCT01990898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199104|NCT01990898|Antifungal Agents|antifungal agents|mesh-ancestor
5587706|NCT03799601|Mitosis Modulators|mitosis modulators|mesh-ancestor
5587707|NCT03799601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587708|NCT03797703|Lidocaine|lidocaine|mesh-list
5587709|NCT03797703|Anesthetics, Local|anesthetics, local|mesh-ancestor
5587710|NCT03797703|Anesthetics|anesthetics|mesh-ancestor
5587711|NCT03797703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5587712|NCT03797703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587713|NCT03797703|Sensory System Agents|sensory system agents|mesh-ancestor
6199105|NCT01990898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6199106|NCT01990898|Dermatologic Agents|dermatologic agents|mesh-ancestor
6199107|NCT01990898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6199108|NCT01990898|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5587714|NCT03797703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5587715|NCT03797703|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5587716|NCT03797703|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5587717|NCT03797703|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5587718|NCT03797703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5587719|NCT03797703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605275|NCT03007030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5605276|NCT03007030|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5605277|NCT03007030|Antibodies|antibodies|mesh-list
5605278|NCT03007030|Immunoglobulins|immunoglobulins|mesh-list
5605279|NCT03007030|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5605280|NCT03007030|Immunoconjugates|immunoconjugates|mesh-list
5605281|NCT03007030|Immunologic Factors|immunologic factors|mesh-ancestor
5605282|NCT03007030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605283|NCT03007030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605284|NCT02995252|Tenofovir|tenofovir|mesh-list
5605285|NCT02995252|Liver Extracts|liver extracts|mesh-list
5605286|NCT02995252|Antiviral Agents|antiviral agents|mesh-ancestor
5605287|NCT02995252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5605288|NCT02995252|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5605289|NCT02995252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5605290|NCT02995252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6199109|NCT01991197|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6199110|NCT01991197|Gliclazide|gliclazide|mesh-list
6199111|NCT01991197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6199112|NCT01991197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199113|NCT01991197|Incretins|incretins|mesh-ancestor
5605291|NCT02995252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605292|NCT02995252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5605293|NCT02995252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5605294|NCT02995252|Hematinics|hematinics|mesh-ancestor
5605295|NCT02993146|Ropidoxuridine|ropidoxuridine|mesh-list
5605296|NCT02993146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605297|NCT02991144|Prednisone|prednisone|mesh-list
5605298|NCT02991144|Prednisolone|prednisolone|mesh-list
5605299|NCT02991144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5605300|NCT02991144|Glucocorticoids|glucocorticoids|mesh-ancestor
5605301|NCT02991144|Hormones|hormones|mesh-ancestor
5605302|NCT02991144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5605303|NCT02991144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199114|NCT01991197|Hormones|hormones|mesh-ancestor
6199115|NCT01991197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6199116|NCT01991197|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6199117|NCT01991197|Protease Inhibitors|protease inhibitors|mesh-ancestor
6199118|NCT01991197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6199119|NCT01991197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199120|NCT01991548|Insulin|insulin|mesh-list
6199121|NCT01991548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6199122|NCT01991548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199123|NCT01991743|Bupivacaine|bupivacaine|mesh-list
6199124|NCT01991743|Anesthetics, Local|anesthetics, local|mesh-ancestor
6199125|NCT01991743|Anesthetics|anesthetics|mesh-ancestor
6199126|NCT01991743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6199127|NCT01991743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199128|NCT01991743|Sensory System Agents|sensory system agents|mesh-ancestor
6199129|NCT01991743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6199130|NCT01991795|Ticagrelor|ticagrelor|mesh-list
6199131|NCT01991795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6199132|NCT01991795|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6199133|NCT01991795|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6199134|NCT01991795|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6199135|NCT01991795|Purinergic Agents|purinergic agents|mesh-ancestor
6199136|NCT01991795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5587720|NCT03797729|Tirofiban|tirofiban|mesh-list
5587721|NCT03797729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5587722|NCT03797729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5587723|NCT03797729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587724|NCT03797729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5587725|NCT03797924|Ropivacaine|ropivacaine|mesh-list
5587726|NCT03797924|Anesthetics, Local|anesthetics, local|mesh-ancestor
5587727|NCT03797924|Anesthetics|anesthetics|mesh-ancestor
5587728|NCT03797924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5587729|NCT03797924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587730|NCT03797924|Sensory System Agents|sensory system agents|mesh-ancestor
5587731|NCT03797924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5587732|NCT03797625|Cisplatin|cisplatin|mesh-list
5587733|NCT03797625|Irinotecan|irinotecan|mesh-list
5587734|NCT03797625|Endostar protein|endostar protein|mesh-list
5587735|NCT03797625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5587736|NCT03797625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5587737|NCT03797625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5587738|NCT03797625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5587739|NCT03797625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199137|NCT01991795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199138|NCT01991795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199139|NCT01991860|Amisulpride|amisulpride|mesh-list
6199140|NCT01991860|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6199141|NCT01991860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6199142|NCT01991860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6199143|NCT01991860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199144|NCT01991860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6199145|NCT01991860|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6199146|NCT01991860|Dopamine Agents|dopamine agents|mesh-ancestor
6199147|NCT01991860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6199148|NCT01991860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199149|NCT01991860|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6199150|NCT01991860|Antidepressive Agents|antidepressive agents|mesh-ancestor
6199151|NCT01991977|Temozolomide|temozolomide|mesh-list
6199152|NCT01991977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6199153|NCT01991977|Alkylating Agents|alkylating agents|mesh-ancestor
6199154|NCT01991977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199155|NCT01991977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6199156|NCT01992016|Ranolazine|ranolazine|mesh-list
6199157|NCT01992016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6199158|NCT01992016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6199159|NCT01992016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199160|NCT01992172|Sunscreening Agents|sunscreening agents|mesh-list
5587740|NCT03797625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6199161|NCT01992172|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6199162|NCT01992172|Protective Agents|protective agents|mesh-ancestor
6199163|NCT01992172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199164|NCT01992172|Dermatologic Agents|dermatologic agents|mesh-ancestor
6199165|NCT01992185|Sunscreening Agents|sunscreening agents|mesh-list
6199166|NCT01992185|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6199167|NCT01992185|Protective Agents|protective agents|mesh-ancestor
6199168|NCT01992185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199169|NCT01992185|Dermatologic Agents|dermatologic agents|mesh-ancestor
6199170|NCT01992523|Ticagrelor|ticagrelor|mesh-list
5587741|NCT03797625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5587742|NCT03797625|Growth Substances|growth substances|mesh-ancestor
5587743|NCT03797625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587744|NCT03797625|Growth Inhibitors|growth inhibitors|mesh-ancestor
5587745|NCT03799445|Nivolumab|nivolumab|mesh-list
5587746|NCT03799445|Ipilimumab|ipilimumab|mesh-list
5587747|NCT03799445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5587748|NCT03799445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5587749|NCT03799445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5587750|NCT03799445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587751|NCT03797508|Progesterone|progesterone|mesh-list
5587752|NCT03797508|Progestins|progestins|mesh-ancestor
5587753|NCT03797508|Hormones|hormones|mesh-ancestor
5587754|NCT03797508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5587755|NCT03797508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587756|NCT03797196|Mycophenolic Acid|mycophenolic acid|mesh-list
5587757|NCT03797196|Everolimus|everolimus|mesh-list
5587758|NCT03797196|Tacrolimus|tacrolimus|mesh-list
5587759|NCT03797196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5587760|NCT03797196|Immunologic Factors|immunologic factors|mesh-ancestor
5587761|NCT03797196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587762|NCT03797196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5587763|NCT03797196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5587764|NCT03797196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587765|NCT03797196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5587766|NCT03797196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5587767|NCT03797196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5587768|NCT03797196|Antitubercular Agents|antitubercular agents|mesh-ancestor
6199171|NCT01992523|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6199172|NCT01992523|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6199173|NCT01992523|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6199174|NCT01992523|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6199175|NCT01992523|Purinergic Agents|purinergic agents|mesh-ancestor
6199176|NCT01992523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6199177|NCT01992523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199178|NCT01992523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199179|NCT01992874|Niacinamide|niacinamide|mesh-list
6199180|NCT01992874|Vitamin B Complex|vitamin b complex|mesh-ancestor
6199181|NCT01992874|Vitamins|vitamins|mesh-ancestor
6199182|NCT01992874|Micronutrients|micronutrients|mesh-ancestor
6199183|NCT01992874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199184|NCT01993017|Bupropion|bupropion|mesh-list
6199185|NCT01993017|Sertraline|sertraline|mesh-list
6199186|NCT01993017|Antidepressive Agents|antidepressive agents|mesh-list
6199187|NCT01993017|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6199188|NCT01993017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6199189|NCT01993017|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6199190|NCT01993017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6199191|NCT01993017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6199192|NCT01993017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199193|NCT01993017|Dopamine Agents|dopamine agents|mesh-ancestor
6199194|NCT01993017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6199195|NCT01993017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199196|NCT01993017|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6199197|NCT01993017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6199198|NCT01993017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6199199|NCT01993017|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6199200|NCT01993017|Serotonin Agents|serotonin agents|mesh-ancestor
6199201|NCT01993108|Naltrexone|naltrexone|mesh-list
6199202|NCT01993108|Methylphenidate|methylphenidate|mesh-list
6199203|NCT01993108|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6199204|NCT01993108|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6199205|NCT01993108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199206|NCT01993108|Sensory System Agents|sensory system agents|mesh-ancestor
6199207|NCT01993108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6199208|NCT01993108|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6199209|NCT01993108|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6199210|NCT01993108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6199211|NCT01993108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6199212|NCT01993108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199213|NCT01993108|Dopamine Agents|dopamine agents|mesh-ancestor
6199214|NCT01993108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6199215|NCT01993186|Glycerol|glycerol|mesh-list
6199216|NCT01993186|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6199217|NCT01993186|Protective Agents|protective agents|mesh-ancestor
6199218|NCT01993186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199219|NCT01993329|Mitomycin|mitomycin|mesh-list
6199220|NCT01993329|Cisplatin|cisplatin|mesh-list
6199221|NCT01993329|Ifosfamide|ifosfamide|mesh-list
6199222|NCT01993329|Mesna|mesna|mesh-list
6199223|NCT01993329|Protective Agents|protective agents|mesh-ancestor
6199224|NCT01993329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587769|NCT03797196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5587770|NCT03797196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5587771|NCT03797079|Bupivacaine|bupivacaine|mesh-list
5587772|NCT03797079|Anesthetics, Local|anesthetics, local|mesh-ancestor
5587773|NCT03797079|Anesthetics|anesthetics|mesh-ancestor
5587774|NCT03797079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5587775|NCT03797079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587776|NCT03797079|Sensory System Agents|sensory system agents|mesh-ancestor
5587777|NCT03797079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5587778|NCT03797066|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
5587779|NCT03797066|Antiviral Agents|antiviral agents|mesh-ancestor
5587780|NCT03797066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5587781|NCT03797443|Ascorbic Acid|ascorbic acid|mesh-list
5587782|NCT03797443|Gemcitabine|gemcitabine|mesh-list
5587783|NCT03797443|Paclitaxel|paclitaxel|mesh-list
5587784|NCT03797443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5587785|NCT03797443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5587786|NCT03797443|Tubulin Modulators|tubulin modulators|mesh-ancestor
5587787|NCT03797443|Antimitotic Agents|antimitotic agents|mesh-ancestor
5587788|NCT03797443|Mitosis Modulators|mitosis modulators|mesh-ancestor
6199225|NCT01993329|Alkylating Agents|alkylating agents|mesh-ancestor
6199226|NCT01993329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199227|NCT01993329|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6199228|NCT01993329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6199229|NCT01993329|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5587789|NCT03797443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587790|NCT03797443|Vitamins|vitamins|mesh-ancestor
5587791|NCT03797443|Micronutrients|micronutrients|mesh-ancestor
5587792|NCT03797443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587793|NCT03797443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5587794|NCT03797443|Antimetabolites|antimetabolites|mesh-ancestor
5587795|NCT03797443|Antiviral Agents|antiviral agents|mesh-ancestor
5587796|NCT03797443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6199230|NCT01993329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6199231|NCT01993329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6199232|NCT01993667|Acetazolamide|acetazolamide|mesh-list
6199233|NCT01993667|Anticonvulsants|anticonvulsants|mesh-ancestor
6199234|NCT01993667|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6199235|NCT01993667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6199236|NCT01993667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199237|NCT01993667|Diuretics|diuretics|mesh-ancestor
6199238|NCT01993667|Natriuretic Agents|natriuretic agents|mesh-ancestor
6199239|NCT01993667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199240|NCT01993823|Clotrimazole|clotrimazole|mesh-list
6199241|NCT01993823|Miconazole|miconazole|mesh-list
6199242|NCT01993823|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6199243|NCT01993823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6199244|NCT01993823|Antifungal Agents|antifungal agents|mesh-ancestor
6199245|NCT01993823|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6199246|NCT01993823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6199247|NCT01993823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6199248|NCT01993823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199249|NCT01993823|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6199250|NCT01993823|Hormone Antagonists|hormone antagonists|mesh-ancestor
6199251|NCT01993823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6199252|NCT01993823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199253|NCT01993823|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6199254|NCT01993823|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6199255|NCT01993836|Anesthetics|anesthetics|mesh-list
6199256|NCT01993836|Propofol|propofol|mesh-list
6199257|NCT01993836|Isoflurane|isoflurane|mesh-list
6199258|NCT01993836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6199259|NCT01993836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199260|NCT01993836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6199261|NCT01993836|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6199262|NCT01993836|Anesthetics, General|anesthetics, general|mesh-ancestor
6199263|NCT01993836|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6199264|NCT01993849|Acetylcysteine|acetylcysteine|mesh-list
6199265|NCT01993849|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6199266|NCT01993849|Antiviral Agents|antiviral agents|mesh-ancestor
6199267|NCT01993849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6199268|NCT01993849|Expectorants|expectorants|mesh-ancestor
6199269|NCT01993849|Respiratory System Agents|respiratory system agents|mesh-ancestor
6199270|NCT01993849|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5587797|NCT03797443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5587798|NCT03797443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5587799|NCT03797443|Immunologic Factors|immunologic factors|mesh-ancestor
5587800|NCT03797443|Antioxidants|antioxidants|mesh-ancestor
5587801|NCT03797443|Protective Agents|protective agents|mesh-ancestor
5587802|NCT03796884|Linaclotide|linaclotide|mesh-list
5587803|NCT03796884|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
5587804|NCT03796884|Enzyme Activators|enzyme activators|mesh-ancestor
5587805|NCT03796884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587806|NCT03796884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5587807|NCT03797222|Vitamin E|vitamin e|mesh-list
5587808|NCT03797222|Tocopherols|tocopherols|mesh-list
5587809|NCT03797222|alpha-Tocopherol|alpha-tocopherol|mesh-list
6199271|NCT01993849|Antioxidants|antioxidants|mesh-ancestor
6199272|NCT01993849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199273|NCT01993849|Protective Agents|protective agents|mesh-ancestor
6199274|NCT01993849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199275|NCT01993849|Antidotes|antidotes|mesh-ancestor
6199276|NCT01993875|Lubiprostone|lubiprostone|mesh-list
6199277|NCT01993875|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6199278|NCT01993875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6199279|NCT01993875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199280|NCT01993888|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6199281|NCT01993888|Hemostatics|hemostatics|mesh-ancestor
5587810|NCT03797222|Vitamins|vitamins|mesh-ancestor
5587811|NCT03797222|Micronutrients|micronutrients|mesh-ancestor
5587812|NCT03797222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199282|NCT01993888|Coagulants|coagulants|mesh-ancestor
6199283|NCT01993927|Voglibose|voglibose|mesh-list
6199284|NCT01993927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6199285|NCT01993927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199286|NCT01993927|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6199287|NCT01993927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6199288|NCT01993927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587813|NCT03797222|Antioxidants|antioxidants|mesh-ancestor
5587814|NCT03797222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587815|NCT03797222|Protective Agents|protective agents|mesh-ancestor
5587816|NCT03796975|Metformin|metformin|mesh-list
5587817|NCT03796975|Pioglitazone|pioglitazone|mesh-list
5587818|NCT03796975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5587819|NCT03796975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587820|NCT03797001|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5587821|NCT03797001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5587822|NCT03796650|Vancomycin|vancomycin|mesh-list
5587823|NCT03796650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6199289|NCT01994109|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
6199290|NCT01994109|Botulinum Toxins|botulinum toxins|mesh-list
6199291|NCT01994109|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6199292|NCT01994109|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5587824|NCT03796650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5587825|NCT03796572|Ropivacaine|ropivacaine|mesh-list
5587826|NCT03796572|Anesthetics, Local|anesthetics, local|mesh-ancestor
5587827|NCT03796572|Anesthetics|anesthetics|mesh-ancestor
5587828|NCT03796572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5587829|NCT03796572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587830|NCT03796572|Sensory System Agents|sensory system agents|mesh-ancestor
5587831|NCT03796572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5587832|NCT03796585|Vaccines|vaccines|mesh-list
5587833|NCT03796585|Immunologic Factors|immunologic factors|mesh-ancestor
5587834|NCT03796585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587835|NCT03796533|Posaconazole|posaconazole|mesh-list
5587836|NCT03796533|Antifungal Agents|antifungal agents|mesh-ancestor
6199293|NCT01994109|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6199294|NCT01994109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6199295|NCT01994109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199296|NCT01994109|Cholinergic Agents|cholinergic agents|mesh-ancestor
6199297|NCT01994109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6199298|NCT01994109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199299|NCT01994109|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6199300|NCT01994109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6199301|NCT01994109|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6199302|NCT01994226|Naproxen|naproxen|mesh-list
6199303|NCT01994226|Colchicine|colchicine|mesh-list
6199304|NCT01994226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6199305|NCT01994226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5587837|NCT03796533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5587838|NCT03796533|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5587839|NCT03796533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5587840|NCT03796533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6199306|NCT01994226|Analgesics|analgesics|mesh-ancestor
6199307|NCT01994226|Sensory System Agents|sensory system agents|mesh-ancestor
6199308|NCT01994226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6199309|NCT01994226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199310|NCT01994226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6199311|NCT01994226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6199312|NCT01994226|Gout Suppressants|gout suppressants|mesh-ancestor
6199313|NCT01994226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6199314|NCT01994226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6199315|NCT01994226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199316|NCT01994226|Tubulin Modulators|tubulin modulators|mesh-ancestor
6199317|NCT01994226|Antimitotic Agents|antimitotic agents|mesh-ancestor
6199318|NCT01994226|Mitosis Modulators|mitosis modulators|mesh-ancestor
6199319|NCT01994226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6199320|NCT01994291|Ranibizumab|ranibizumab|mesh-list
6199321|NCT01994291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6199322|NCT01994291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6199323|NCT01994291|Growth Substances|growth substances|mesh-ancestor
6199324|NCT01994291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199325|NCT01994291|Growth Inhibitors|growth inhibitors|mesh-ancestor
6199326|NCT01994291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6199327|NCT01994486|Sofosbuvir|sofosbuvir|mesh-list
6199328|NCT01994486|Antiviral Agents|antiviral agents|mesh-ancestor
6199329|NCT01994486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6199330|NCT01994538|Oxymetazoline|oxymetazoline|mesh-list
6199331|NCT01994538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6199332|NCT01994538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6199333|NCT01994538|Adrenergic Agents|adrenergic agents|mesh-ancestor
6199334|NCT01994538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6199335|NCT01994538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199336|NCT01994538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199337|NCT01994538|Sympathomimetics|sympathomimetics|mesh-ancestor
6199338|NCT01994538|Autonomic Agents|autonomic agents|mesh-ancestor
6199339|NCT01994538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6199340|NCT01994538|Nasal Decongestants|nasal decongestants|mesh-ancestor
6199341|NCT01994538|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6199342|NCT01994538|Respiratory System Agents|respiratory system agents|mesh-ancestor
6199343|NCT01994590|Prednisone|prednisone|mesh-list
6199344|NCT01994590|Abiraterone Acetate|abiraterone acetate|mesh-list
6199345|NCT01994590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6199346|NCT01994590|Glucocorticoids|glucocorticoids|mesh-ancestor
6199347|NCT01994590|Hormones|hormones|mesh-ancestor
6199348|NCT01994590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6199349|NCT01994590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199350|NCT01994590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6199351|NCT01994590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6199352|NCT01994590|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6199353|NCT01994590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6199354|NCT01994590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199355|NCT01994590|Hormone Antagonists|hormone antagonists|mesh-ancestor
6199356|NCT01994590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5587841|NCT03796533|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5587842|NCT03796533|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5587843|NCT03796533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5587844|NCT03796533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587845|NCT03796533|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5587846|NCT03796533|Hormone Antagonists|hormone antagonists|mesh-ancestor
5587847|NCT03796533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5587848|NCT03796533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587849|NCT03796403|Diclofenac|diclofenac|mesh-list
5587850|NCT03796403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6199357|NCT01994720|Aspirin|aspirin|mesh-list
6199358|NCT01994720|Ticagrelor|ticagrelor|mesh-list
6199359|NCT01994720|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6199360|NCT01994720|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6199361|NCT01994720|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6199362|NCT01994720|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6199363|NCT01994720|Purinergic Agents|purinergic agents|mesh-ancestor
6199364|NCT01994720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6199365|NCT01994720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199366|NCT01994720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199367|NCT01994720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5587851|NCT03796403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5587852|NCT03796403|Analgesics|analgesics|mesh-ancestor
5587853|NCT03796403|Sensory System Agents|sensory system agents|mesh-ancestor
5587854|NCT03796403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5587855|NCT03796403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587856|NCT03796403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5587857|NCT03796403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5587858|NCT03796403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5587859|NCT03796403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5587860|NCT03796403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587861|NCT03796507|Temozolomide|temozolomide|mesh-list
5587862|NCT03796507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5587863|NCT03796507|Alkylating Agents|alkylating agents|mesh-ancestor
5587864|NCT03796507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587865|NCT03796507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5587866|NCT03796416|Misoprostol|misoprostol|mesh-list
6199368|NCT01994720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6199369|NCT01994720|Analgesics|analgesics|mesh-ancestor
6199370|NCT01994720|Sensory System Agents|sensory system agents|mesh-ancestor
6199371|NCT01994720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6199372|NCT01994720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6199373|NCT01994720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6199374|NCT01994720|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6199375|NCT01994720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6199376|NCT01994720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6199377|NCT01994720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6199378|NCT01994720|Antipyretics|antipyretics|mesh-ancestor
6199379|NCT01994746|Glucagon|glucagon|mesh-list
6199380|NCT01994746|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6199381|NCT01994746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6199382|NCT01994746|Hormones|hormones|mesh-ancestor
6199383|NCT01994746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6199384|NCT01994746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199385|NCT01994746|Incretins|incretins|mesh-ancestor
6207579|NCT02117024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207580|NCT02117024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6207581|NCT02117024|Immunologic Factors|immunologic factors|mesh-ancestor
6207582|NCT02117024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207583|NCT02117024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6207584|NCT02117024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6207585|NCT02117024|Alkylating Agents|alkylating agents|mesh-ancestor
6207586|NCT02117024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6207587|NCT02117024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6207588|NCT02117024|Antimetabolites|antimetabolites|mesh-ancestor
6207589|NCT02117024|Antiviral Agents|antiviral agents|mesh-ancestor
6207590|NCT02117024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6207591|NCT02117024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5587867|NCT03796416|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5587868|NCT03796416|Abortifacient Agents|abortifacient agents|mesh-ancestor
5587869|NCT03796416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5587870|NCT03796416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587871|NCT03796416|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5587872|NCT03796416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5587873|NCT03796416|Oxytocics|oxytocics|mesh-ancestor
5587874|NCT03796377|Rivaroxaban|rivaroxaban|mesh-list
5587875|NCT03796377|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5587876|NCT03796377|Antithrombins|antithrombins|mesh-ancestor
5587877|NCT03796377|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5587878|NCT03796377|Protease Inhibitors|protease inhibitors|mesh-ancestor
5587879|NCT03796377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5587880|NCT03796377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587881|NCT03796377|Anticoagulants|anticoagulants|mesh-ancestor
5587882|NCT03796364|Endostar protein|endostar protein|mesh-list
5587883|NCT03796364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5587884|NCT03796364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6207592|NCT02117024|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6207593|NCT02117024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6207594|NCT02117024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6207595|NCT02117349|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6207596|NCT02117349|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
6207597|NCT02117349|Hemostatics|hemostatics|mesh-ancestor
6207598|NCT02117349|Coagulants|coagulants|mesh-ancestor
5587885|NCT03796364|Growth Substances|growth substances|mesh-ancestor
5587886|NCT03796364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587887|NCT03796364|Growth Inhibitors|growth inhibitors|mesh-ancestor
6199386|NCT01994837|Venetoclax|venetoclax|mesh-list
6199387|NCT01994837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6199388|NCT01994850|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6199389|NCT01994850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6199390|NCT01994850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5587888|NCT03796364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5587889|NCT03796195|Bupivacaine|bupivacaine|mesh-list
5587890|NCT03796195|Anesthetics, Local|anesthetics, local|mesh-ancestor
5587891|NCT03796195|Anesthetics|anesthetics|mesh-ancestor
5587892|NCT03796195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5587893|NCT03796195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587894|NCT03796195|Sensory System Agents|sensory system agents|mesh-ancestor
5587895|NCT03796195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5587896|NCT03795909|Dexamethasone|dexamethasone|mesh-list
5587897|NCT03795909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5587898|NCT03795909|Antiemetics|antiemetics|mesh-ancestor
5587899|NCT03795909|Autonomic Agents|autonomic agents|mesh-ancestor
5587900|NCT03795909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5587901|NCT03795909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199391|NCT01994993|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6199392|NCT01994993|Metronidazole|metronidazole|mesh-list
6199393|NCT01994993|Clindamycin|clindamycin|mesh-list
6199394|NCT01994993|Clindamycin palmitate|clindamycin palmitate|mesh-list
6199395|NCT01994993|Clindamycin phosphate|clindamycin phosphate|mesh-list
6199396|NCT01994993|Gentamicins|gentamicins|mesh-list
6199397|NCT01994993|Tazobactam|tazobactam|mesh-list
6199398|NCT01994993|Piperacillin|piperacillin|mesh-list
6199399|NCT01994993|Ampicillin|ampicillin|mesh-list
6199400|NCT01994993|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
6199401|NCT01994993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5587902|NCT03795909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5587903|NCT03795909|Glucocorticoids|glucocorticoids|mesh-ancestor
5587904|NCT03795909|Hormones|hormones|mesh-ancestor
5587905|NCT03795909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5587906|NCT03795909|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5587907|NCT03795909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5587908|NCT03795844|Liver Extracts|liver extracts|mesh-list
5587909|NCT03795844|Hematinics|hematinics|mesh-ancestor
5605304|NCT02991144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5605305|NCT02991144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605306|NCT02953509|Gemcitabine|gemcitabine|mesh-list
5605307|NCT02953509|Rituximab|rituximab|mesh-list
5605308|NCT02953509|Magrolimab|magrolimab|mesh-list
5605309|NCT02953509|Oxaliplatin|oxaliplatin|mesh-list
5605310|NCT02953509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5605311|NCT02953509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605312|NCT02953509|Immunologic Factors|immunologic factors|mesh-ancestor
5605313|NCT02953509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605314|NCT02953509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6199402|NCT01994993|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6199403|NCT01994993|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6199404|NCT01994993|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6199405|NCT01994993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6199406|NCT01994993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605315|NCT02953509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5605316|NCT02953509|Antimetabolites|antimetabolites|mesh-ancestor
5605317|NCT02953509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605318|NCT02953509|Antiviral Agents|antiviral agents|mesh-ancestor
5605319|NCT02953509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5605320|NCT02953509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5605321|NCT02953509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5605322|NCT02921789|Mycophenolic Acid|mycophenolic acid|mesh-list
5605323|NCT02921789|Prednisone|prednisone|mesh-list
6199407|NCT01994993|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6199408|NCT01995045|Triamcinolone|triamcinolone|mesh-list
6199409|NCT01995045|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6199410|NCT01995045|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6199411|NCT01995045|Bupivacaine|bupivacaine|mesh-list
6199412|NCT01995045|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6199413|NCT01995045|Anesthetics, Local|anesthetics, local|mesh-ancestor
5605324|NCT02921789|Tacrolimus|tacrolimus|mesh-list
5605325|NCT02921789|Basiliximab|basiliximab|mesh-list
5605326|NCT02921789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6199414|NCT01995045|Anesthetics|anesthetics|mesh-ancestor
5605327|NCT02921789|Glucocorticoids|glucocorticoids|mesh-ancestor
5605328|NCT02921789|Hormones|hormones|mesh-ancestor
5605329|NCT02921789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5605330|NCT02921789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207599|NCT02117479|Capecitabine|capecitabine|mesh-list
5587910|NCT03795792|Curcumin|curcumin|mesh-list
5587911|NCT03795792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5587912|NCT03795792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5587913|NCT03795792|Analgesics|analgesics|mesh-ancestor
5587914|NCT03795792|Sensory System Agents|sensory system agents|mesh-ancestor
5587915|NCT03795792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5587916|NCT03795792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587917|NCT03795792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5587918|NCT03795792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5587919|NCT03795792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6199415|NCT01995045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6199416|NCT01995045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199417|NCT01995045|Sensory System Agents|sensory system agents|mesh-ancestor
6199418|NCT01995045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6199419|NCT01995045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6199420|NCT01995045|Glucocorticoids|glucocorticoids|mesh-ancestor
6199421|NCT01995045|Hormones|hormones|mesh-ancestor
6199422|NCT01995045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6199423|NCT01995045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5587920|NCT03795792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5587921|NCT03795792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587922|NCT03795584|Hemostatics|hemostatics|mesh-list
5587923|NCT03795584|Coagulants|coagulants|mesh-ancestor
5587924|NCT03795571|Gemcitabine|gemcitabine|mesh-list
5587925|NCT03795571|Dexamethasone|dexamethasone|mesh-list
5587926|NCT03795571|Rituximab|rituximab|mesh-list
5587927|NCT03795571|Oxaliplatin|oxaliplatin|mesh-list
5587928|NCT03795571|Lenalidomide|lenalidomide|mesh-list
5587929|NCT03795571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6199424|NCT01995045|Immunologic Factors|immunologic factors|mesh-ancestor
6199425|NCT01995045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6199426|NCT01995045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199427|NCT01995071|Ribavirin|ribavirin|mesh-list
6199428|NCT01995071|Antimetabolites|antimetabolites|mesh-ancestor
5587930|NCT03795571|Antiemetics|antiemetics|mesh-ancestor
5587931|NCT03795571|Autonomic Agents|autonomic agents|mesh-ancestor
5587932|NCT03795571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5587933|NCT03795571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587934|NCT03795571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5587935|NCT03795571|Glucocorticoids|glucocorticoids|mesh-ancestor
5587936|NCT03795571|Hormones|hormones|mesh-ancestor
5587937|NCT03795571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5587938|NCT03795571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5587939|NCT03795571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6199429|NCT01995071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199430|NCT01995071|Antiviral Agents|antiviral agents|mesh-ancestor
6199431|NCT01995071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6199432|NCT01995136|Travoprost|travoprost|mesh-list
6199433|NCT01995136|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6199434|NCT01995136|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6199435|NCT01995136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6199436|NCT01995201|Methotrexate|methotrexate|mesh-list
5587940|NCT03795571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5587941|NCT03795571|Immunologic Factors|immunologic factors|mesh-ancestor
5587942|NCT03795571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5587943|NCT03795571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5587944|NCT03795571|Antimetabolites|antimetabolites|mesh-ancestor
5587945|NCT03795571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587946|NCT03795571|Antiviral Agents|antiviral agents|mesh-ancestor
5587947|NCT03795571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5587948|NCT03795571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5587949|NCT03795571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5587950|NCT03795571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5587951|NCT03795571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5587952|NCT03795571|Growth Substances|growth substances|mesh-ancestor
5587953|NCT03795571|Growth Inhibitors|growth inhibitors|mesh-ancestor
6199437|NCT01995201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6199438|NCT01995201|Abortifacient Agents|abortifacient agents|mesh-ancestor
6199439|NCT01995201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6199440|NCT01995201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199441|NCT01995201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6199442|NCT01995201|Antimetabolites|antimetabolites|mesh-ancestor
6199443|NCT01995201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587954|NCT03795649|Tranexamic Acid|tranexamic acid|mesh-list
5587955|NCT03795649|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6199444|NCT01995201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6199445|NCT01995201|Dermatologic Agents|dermatologic agents|mesh-ancestor
6199446|NCT01995201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6199447|NCT01995201|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6199448|NCT01995201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6199449|NCT01995201|Immunologic Factors|immunologic factors|mesh-ancestor
6199450|NCT01995201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6199451|NCT01995201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6199452|NCT01995266|Asunaprevir|asunaprevir|mesh-list
6199453|NCT01995266|Protease Inhibitors|protease inhibitors|mesh-ancestor
6199454|NCT01995266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6199455|NCT01995266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199456|NCT01995513|Prednisone|prednisone|mesh-list
6199457|NCT01995513|Prednisolone|prednisolone|mesh-list
6199458|NCT01995513|Abiraterone Acetate|abiraterone acetate|mesh-list
5587956|NCT03795649|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5587957|NCT03795649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587958|NCT03795649|Hemostatics|hemostatics|mesh-ancestor
5587959|NCT03795649|Coagulants|coagulants|mesh-ancestor
5587960|NCT03795597|Melphalan|melphalan|mesh-list
5587961|NCT03795597|Busulfan|busulfan|mesh-list
5587962|NCT03795597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5587963|NCT03795597|Alkylating Agents|alkylating agents|mesh-ancestor
6199459|NCT01995513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6199460|NCT01995513|Glucocorticoids|glucocorticoids|mesh-ancestor
6199461|NCT01995513|Hormones|hormones|mesh-ancestor
6199462|NCT01995513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6199463|NCT01995513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587964|NCT03795597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587965|NCT03795597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5587966|NCT03795597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5587967|NCT03795597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5587968|NCT03795597|Immunologic Factors|immunologic factors|mesh-ancestor
5587969|NCT03795597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587970|NCT03795805|Lidocaine|lidocaine|mesh-list
5587971|NCT03795805|Anesthetics, Local|anesthetics, local|mesh-ancestor
6199464|NCT01995513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6199465|NCT01995513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6199466|NCT01995513|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5587972|NCT03795805|Anesthetics|anesthetics|mesh-ancestor
5587973|NCT03795805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5587974|NCT03795805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5587975|NCT03795805|Sensory System Agents|sensory system agents|mesh-ancestor
5587976|NCT03795805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5587977|NCT03795805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5587978|NCT03795805|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5587979|NCT03795805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5587980|NCT03795805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5587981|NCT03795805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587982|NCT03795090|Anti-Infective Agents|anti-infective agents|mesh-list
5587983|NCT03795090|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5587984|NCT03795259|Rocuronium|rocuronium|mesh-list
5587985|NCT03795259|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5587986|NCT03795259|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5587987|NCT03795259|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5587988|NCT03795259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5587989|NCT03795259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199467|NCT01995513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6199468|NCT01995513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199469|NCT01995513|Hormone Antagonists|hormone antagonists|mesh-ancestor
6199470|NCT01995513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6199471|NCT01995526|Insulin|insulin|mesh-list
6199472|NCT01995526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6199473|NCT01995526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199474|NCT01995825|Lamotrigine|lamotrigine|mesh-list
6199475|NCT01995825|Anticonvulsants|anticonvulsants|mesh-list
6199476|NCT01995825|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6199477|NCT01995825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6199478|NCT01995825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199479|NCT01995825|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6199480|NCT01995825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199481|NCT01995825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6199482|NCT01995825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6199483|NCT01995825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5587990|NCT03795272|Rucaparib|rucaparib|mesh-list
5587991|NCT03795272|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5587992|NCT03795272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5587993|NCT03795272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5587994|NCT03795272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5587995|NCT03795194|Clavulanic Acid|clavulanic acid|mesh-list
5587996|NCT03795194|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5587997|NCT03795194|Clavulanic Acids|clavulanic acids|mesh-list
5587998|NCT03795194|Ampicillin|ampicillin|mesh-list
5587999|NCT03795194|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5588000|NCT03795194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5588001|NCT03795194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5588002|NCT03795194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5588003|NCT03795194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5588004|NCT03795311|Bevacizumab|bevacizumab|mesh-list
5588005|NCT03795311|Folfirinox|folfirinox|mesh-list
5588006|NCT03795311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5588007|NCT03795311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5588008|NCT03795311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5588009|NCT03795311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5588010|NCT03795311|Growth Substances|growth substances|mesh-ancestor
5588011|NCT03795311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588012|NCT03795311|Growth Inhibitors|growth inhibitors|mesh-ancestor
5588013|NCT03795207|Durvalumab|durvalumab|mesh-list
5588014|NCT03795207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5588015|NCT03795207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5588016|NCT03795350|Beclomethasone|beclomethasone|mesh-list
5588017|NCT03795350|Glycopyrrolate|glycopyrrolate|mesh-list
5588018|NCT03795350|Bromides|bromides|mesh-list
6199484|NCT01995825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6199485|NCT01995825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6199486|NCT01996332|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6199487|NCT01996332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6199488|NCT01996332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6199489|NCT01996332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6199490|NCT01996332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199491|NCT01996657|Warfarin|warfarin|mesh-list
6199492|NCT01996657|Anticoagulants|anticoagulants|mesh-ancestor
6199493|NCT01996709|Hydrogen Peroxide|hydrogen peroxide|mesh-list
6199494|NCT01996709|Contact Lens Solutions|contact lens solutions|mesh-list
6199495|NCT01996709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6199496|NCT01996709|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6199497|NCT01996709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6199498|NCT01996709|Disinfectants|disinfectants|mesh-ancestor
5588019|NCT03795350|Formoterol Fumarate|formoterol fumarate|mesh-list
5588020|NCT03795350|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5588021|NCT03795350|Autonomic Agents|autonomic agents|mesh-ancestor
5588022|NCT03795350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5588023|NCT03795350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588024|NCT03795350|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5588025|NCT03795350|Respiratory System Agents|respiratory system agents|mesh-ancestor
5588026|NCT03795350|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5588027|NCT03795350|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5588028|NCT03795350|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5588029|NCT03795350|Adrenergic Agents|adrenergic agents|mesh-ancestor
5588030|NCT03795350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6199499|NCT01996826|Bevacizumab|bevacizumab|mesh-list
6199500|NCT01996826|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6199501|NCT01996826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6199502|NCT01996826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6199503|NCT01996826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6199504|NCT01996826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6199505|NCT01996826|Growth Substances|growth substances|mesh-ancestor
6199506|NCT01996826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199507|NCT01996826|Growth Inhibitors|growth inhibitors|mesh-ancestor
6199508|NCT01996826|Laxatives|laxatives|mesh-ancestor
5588031|NCT03795350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5588032|NCT03795350|Anticonvulsants|anticonvulsants|mesh-ancestor
5588033|NCT03795350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5588034|NCT03795350|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5588035|NCT03795350|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5588036|NCT03795350|Cholinergic Agents|cholinergic agents|mesh-ancestor
5588037|NCT03795350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5588038|NCT03795350|Glucocorticoids|glucocorticoids|mesh-ancestor
5588039|NCT03795350|Hormones|hormones|mesh-ancestor
5588040|NCT03795350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5588041|NCT03794765|Metronidazole|metronidazole|mesh-list
5588042|NCT03794765|Ceftriaxone|ceftriaxone|mesh-list
5588043|NCT03794765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5588044|NCT03794765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5588045|NCT03794765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5588046|NCT03794765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5588047|NCT03794843|Nimodipine|nimodipine|mesh-list
5588048|NCT03794843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5588049|NCT03794843|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5588050|NCT03794843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5588051|NCT03794843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5588052|NCT03794843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5588053|NCT03794843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588054|NCT03794843|Vasodilator Agents|vasodilator agents|mesh-ancestor
5588055|NCT03794505|Methylprednisolone|methylprednisolone|mesh-list
5588056|NCT03794505|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5588057|NCT03794505|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5588058|NCT03794505|Prednisolone|prednisolone|mesh-list
5588059|NCT03794505|Prednisolone acetate|prednisolone acetate|mesh-list
5588060|NCT03794505|Lidocaine|lidocaine|mesh-list
5588061|NCT03794505|Ropivacaine|ropivacaine|mesh-list
5588062|NCT03794505|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6199509|NCT01996826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6199510|NCT01996839|Loteprednol Etabonate|loteprednol etabonate|mesh-list
6199511|NCT01996839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6199512|NCT01996943|Ethanol|ethanol|mesh-list
6199513|NCT01996943|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6199514|NCT01996943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6199515|NCT01996943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6199516|NCT01996943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199517|NCT01997229|Eculizumab|eculizumab|mesh-list
6199518|NCT01997229|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6199519|NCT01997229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6199520|NCT01997229|Immunologic Factors|immunologic factors|mesh-ancestor
6199521|NCT01997229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199522|NCT01997333|Capecitabine|capecitabine|mesh-list
6199523|NCT01997333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6199524|NCT01997333|Antimetabolites|antimetabolites|mesh-ancestor
6199525|NCT01997333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199526|NCT01997333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6199527|NCT01997411|Glucagon|glucagon|mesh-list
6199528|NCT01997411|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6199529|NCT01997411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6199530|NCT01997411|Hormones|hormones|mesh-ancestor
6199531|NCT01997411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6199532|NCT01997411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199533|NCT01997411|Incretins|incretins|mesh-ancestor
6199534|NCT01997515|Ketamine|ketamine|mesh-list
6199535|NCT01997515|Analgesics|analgesics|mesh-ancestor
6199536|NCT01997515|Sensory System Agents|sensory system agents|mesh-ancestor
6199537|NCT01997515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6199538|NCT01997515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199539|NCT01997515|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5588063|NCT03794505|Prednisolone phosphate|prednisolone phosphate|mesh-list
5588064|NCT03794505|Anesthetics, Local|anesthetics, local|mesh-ancestor
5588065|NCT03794505|Anesthetics|anesthetics|mesh-ancestor
5588066|NCT03794505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6199540|NCT01997515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6199541|NCT01997515|Anesthetics, General|anesthetics, general|mesh-ancestor
6199542|NCT01997515|Anesthetics|anesthetics|mesh-ancestor
6199543|NCT01997515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6199544|NCT01997515|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6199545|NCT01997515|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6199546|NCT01997515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6199547|NCT01997515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199548|NCT01997905|Protein S|protein s|mesh-list
6199549|NCT01997905|Anticoagulants|anticoagulants|mesh-ancestor
6199550|NCT01998399|Ticagrelor|ticagrelor|mesh-list
6199551|NCT01998399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6199552|NCT01998399|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6199553|NCT01998399|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6199554|NCT01998399|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6199555|NCT01998399|Purinergic Agents|purinergic agents|mesh-ancestor
5588067|NCT03794505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199556|NCT01998399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6199557|NCT01998399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199558|NCT01998399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199559|NCT01998438|Tranexamic Acid|tranexamic acid|mesh-list
6199560|NCT01998438|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6199561|NCT01998438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6199562|NCT01998438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199563|NCT01998438|Hemostatics|hemostatics|mesh-ancestor
6199564|NCT01998438|Coagulants|coagulants|mesh-ancestor
6199565|NCT01998880|Rituximab|rituximab|mesh-list
6199566|NCT01998880|Obinutuzumab|obinutuzumab|mesh-list
6199567|NCT01998880|Chlorambucil|chlorambucil|mesh-list
6199568|NCT01998880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6199569|NCT01998880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6199570|NCT01998880|Immunologic Factors|immunologic factors|mesh-ancestor
6199571|NCT01998880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588068|NCT03794505|Sensory System Agents|sensory system agents|mesh-ancestor
5588069|NCT03794505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5588070|NCT03794505|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5588071|NCT03794505|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5588072|NCT03794505|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5588073|NCT03794505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5588074|NCT03794505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5588075|NCT03794505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5588076|NCT03794505|Antiemetics|antiemetics|mesh-ancestor
5588077|NCT03794505|Autonomic Agents|autonomic agents|mesh-ancestor
6199572|NCT01998880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6199573|NCT01998880|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6199574|NCT01998880|Alkylating Agents|alkylating agents|mesh-ancestor
6199575|NCT01998880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199576|NCT01998893|Rituximab|rituximab|mesh-list
5588078|NCT03794505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5588079|NCT03794505|Glucocorticoids|glucocorticoids|mesh-ancestor
5588080|NCT03794505|Hormones|hormones|mesh-ancestor
5588081|NCT03794505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5588082|NCT03794505|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5588083|NCT03794505|Protective Agents|protective agents|mesh-ancestor
5588084|NCT03794505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5588085|NCT03794505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5588086|NCT03794544|Durvalumab|durvalumab|mesh-list
5588087|NCT03794544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5588088|NCT03794544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6199577|NCT01998893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6199578|NCT01998893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6199579|NCT01998893|Immunologic Factors|immunologic factors|mesh-ancestor
6199580|NCT01998893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199581|NCT01998893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6199582|NCT01998906|Paclitaxel|paclitaxel|mesh-list
6199583|NCT01998906|Doxorubicin|doxorubicin|mesh-list
6199584|NCT01998906|Trastuzumab|trastuzumab|mesh-list
6199585|NCT01998906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6199586|NCT01998906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6199587|NCT01998906|Tubulin Modulators|tubulin modulators|mesh-ancestor
6199588|NCT01998906|Antimitotic Agents|antimitotic agents|mesh-ancestor
6199589|NCT01998906|Mitosis Modulators|mitosis modulators|mesh-ancestor
6199590|NCT01998906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199591|NCT01998906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6199592|NCT01998906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6199593|NCT01998906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6199594|NCT01998906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6199595|NCT01998906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6199596|NCT01998919|Gemcitabine|gemcitabine|mesh-list
6199597|NCT01998919|Carboplatin|carboplatin|mesh-list
6199598|NCT01998919|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6199599|NCT01998919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6199600|NCT01998919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6199601|NCT01998919|Antimetabolites|antimetabolites|mesh-ancestor
6199602|NCT01998919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199603|NCT01998919|Antiviral Agents|antiviral agents|mesh-ancestor
6199604|NCT01998919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6199605|NCT01998919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6199606|NCT01998919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6199607|NCT01998919|Immunologic Factors|immunologic factors|mesh-ancestor
6199608|NCT01998919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588089|NCT03794778|Paclitaxel|paclitaxel|mesh-list
5588090|NCT03794778|Carboplatin|carboplatin|mesh-list
5588091|NCT03794778|Doxorubicin|doxorubicin|mesh-list
5588092|NCT03794778|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5588093|NCT03794778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5588094|NCT03794778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5588095|NCT03794778|Tubulin Modulators|tubulin modulators|mesh-ancestor
5588096|NCT03794778|Antimitotic Agents|antimitotic agents|mesh-ancestor
5588097|NCT03794778|Mitosis Modulators|mitosis modulators|mesh-ancestor
5588098|NCT03794778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5588099|NCT03794778|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5588100|NCT03794778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5588101|NCT03794778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5588102|NCT03794778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5588103|NCT03794518|Pioglitazone|pioglitazone|mesh-list
5588104|NCT03794518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5588105|NCT03794518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588106|NCT03794557|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
5588107|NCT03794557|Respiratory System Agents|respiratory system agents|mesh-ancestor
5588108|NCT03794492|Mycophenolic Acid|mycophenolic acid|mesh-list
5588109|NCT03794492|Methylprednisolone|methylprednisolone|mesh-list
5588110|NCT03794492|Prednisolone|prednisolone|mesh-list
5588111|NCT03794492|Tacrolimus|tacrolimus|mesh-list
5588112|NCT03794492|Basiliximab|basiliximab|mesh-list
5588113|NCT03794492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6199609|NCT01998919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6199610|NCT01998958|Esketamine|esketamine|mesh-list
6199611|NCT01998958|Antidepressive Agents|antidepressive agents|mesh-ancestor
6199612|NCT01998958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6199613|NCT01999114|Moxifloxacin|moxifloxacin|mesh-list
6199614|NCT01999114|Naltrexone|naltrexone|mesh-list
6199615|NCT01999114|Buprenorphine|buprenorphine|mesh-list
6199616|NCT01999114|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
5588114|NCT03794492|Immunologic Factors|immunologic factors|mesh-ancestor
6199617|NCT01999114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6199618|NCT01999114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6199619|NCT01999114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6199620|NCT01999114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6199621|NCT01999114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6199622|NCT01999114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199623|NCT01999114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6199624|NCT01999114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6199625|NCT01999114|Contraceptive Agents|contraceptive agents|mesh-ancestor
6199626|NCT01999114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6199627|NCT01999114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199628|NCT01999114|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6199629|NCT01999114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6199630|NCT01999114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6199631|NCT01999114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6199632|NCT01999114|Narcotics|narcotics|mesh-ancestor
6199633|NCT01999114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6199634|NCT01999114|Analgesics|analgesics|mesh-ancestor
6199635|NCT01999114|Sensory System Agents|sensory system agents|mesh-ancestor
6199636|NCT01999114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6199637|NCT01999114|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6199638|NCT01999114|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6199639|NCT01999218|Metformin|metformin|mesh-list
6199640|NCT01999218|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6199641|NCT01999218|Glimepiride|glimepiride|mesh-list
6199642|NCT01999218|Ertugliflozin|ertugliflozin|mesh-list
6199643|NCT01999218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6199644|NCT01999218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199645|NCT01999218|Incretins|incretins|mesh-ancestor
6199646|NCT01999218|Hormones|hormones|mesh-ancestor
6199647|NCT01999218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6199648|NCT01999218|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6199649|NCT01999218|Protease Inhibitors|protease inhibitors|mesh-ancestor
6199650|NCT01999218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5588115|NCT03794492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588116|NCT03794492|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6199651|NCT01999218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199652|NCT01999218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6199653|NCT01999218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6199654|NCT01999218|Immunologic Factors|immunologic factors|mesh-ancestor
6199655|NCT01999218|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6199656|NCT01999322|Insulin|insulin|mesh-list
6199657|NCT01999322|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6199658|NCT01999322|Insulin Aspart|insulin aspart|mesh-list
6199659|NCT01999322|Insulin, Long-Acting|insulin, long-acting|mesh-list
6199660|NCT01999322|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6199661|NCT01999322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6199662|NCT01999322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199663|NCT01999335|Dexamethasone|dexamethasone|mesh-list
6199664|NCT01999335|Pomalidomide|pomalidomide|mesh-list
6199665|NCT01999335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6199666|NCT01999335|Antiemetics|antiemetics|mesh-ancestor
6199667|NCT01999335|Autonomic Agents|autonomic agents|mesh-ancestor
6199668|NCT01999335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6199669|NCT01999335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199670|NCT01999335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6199671|NCT01999335|Glucocorticoids|glucocorticoids|mesh-ancestor
6199672|NCT01999335|Hormones|hormones|mesh-ancestor
6199673|NCT01999335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6199674|NCT01999335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6199675|NCT01999335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6199676|NCT01999335|Immunologic Factors|immunologic factors|mesh-ancestor
6199677|NCT01999335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6199678|NCT01999335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6199679|NCT01999335|Growth Substances|growth substances|mesh-ancestor
6199680|NCT01999335|Growth Inhibitors|growth inhibitors|mesh-ancestor
6199681|NCT01999348|Timolol|timolol|mesh-list
5588117|NCT03794492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5588118|NCT03794492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5588119|NCT03794492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5588120|NCT03794492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5588121|NCT03794492|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5588122|NCT03794492|Antitubercular Agents|antitubercular agents|mesh-ancestor
5588123|NCT03794492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5588124|NCT03794492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5588125|NCT03794492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5588126|NCT03794492|Antiemetics|antiemetics|mesh-ancestor
5588127|NCT03794492|Autonomic Agents|autonomic agents|mesh-ancestor
5588128|NCT03794492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5588129|NCT03794492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5588130|NCT03794492|Glucocorticoids|glucocorticoids|mesh-ancestor
5588131|NCT03794492|Hormones|hormones|mesh-ancestor
5588132|NCT03794492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5588133|NCT03794492|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5588134|NCT03794492|Protective Agents|protective agents|mesh-ancestor
5588135|NCT03794492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5588136|NCT03794596|Aspirin|aspirin|mesh-list
5588137|NCT03794596|Avelumab|avelumab|mesh-list
5588138|NCT03794596|Lansoprazole|lansoprazole|mesh-list
5588139|NCT03794596|Dexlansoprazole|dexlansoprazole|mesh-list
5588140|NCT03794596|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
5588141|NCT03794596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5588142|NCT03794596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5588143|NCT03794596|Analgesics|analgesics|mesh-ancestor
5588144|NCT03794596|Sensory System Agents|sensory system agents|mesh-ancestor
5588145|NCT03794596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5588146|NCT03794596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588147|NCT03794596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5588148|NCT03794596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5588149|NCT03794596|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5588150|NCT03794596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5588151|NCT03794596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5588152|NCT03794596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5588153|NCT03794596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5588154|NCT03794596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5588155|NCT03794596|Antipyretics|antipyretics|mesh-ancestor
5588156|NCT03794596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5588157|NCT03794596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6199682|NCT01999348|Bimatoprost|bimatoprost|mesh-list
5588158|NCT03794596|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5588159|NCT03794596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5588160|NCT03794219|Naproxen|naproxen|mesh-list
5588161|NCT03794219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5588162|NCT03794219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5588163|NCT03794219|Analgesics|analgesics|mesh-ancestor
6199683|NCT01999348|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6199684|NCT01999348|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6199685|NCT01999348|Adrenergic Agents|adrenergic agents|mesh-ancestor
6199686|NCT01999348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6199687|NCT01999348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199688|NCT01999348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199689|NCT01999348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6199690|NCT01999348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6199691|NCT01999400|Mesalamine|mesalamine|mesh-list
6199692|NCT01999400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6199693|NCT01999400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6199694|NCT01999400|Analgesics|analgesics|mesh-ancestor
6199695|NCT01999400|Sensory System Agents|sensory system agents|mesh-ancestor
6199696|NCT01999400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6199697|NCT01999400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199698|NCT01999400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6199699|NCT01999400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5588164|NCT03794219|Sensory System Agents|sensory system agents|mesh-ancestor
5588165|NCT03794219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5588166|NCT03794219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588167|NCT03794219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5588168|NCT03794219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5588169|NCT03794219|Gout Suppressants|gout suppressants|mesh-ancestor
5588170|NCT03794219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5588171|NCT03794219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5588172|NCT03794219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5588173|NCT03794076|Cromolyn Sodium|cromolyn sodium|mesh-list
5588174|NCT03794076|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
5588175|NCT03794076|Immunologic Factors|immunologic factors|mesh-ancestor
5588176|NCT03794076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588177|NCT03794076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5588178|NCT03794076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5588179|NCT03794076|Respiratory System Agents|respiratory system agents|mesh-ancestor
5588180|NCT03794440|Sorafenib|sorafenib|mesh-list
5588181|NCT03794440|Bevacizumab|bevacizumab|mesh-list
6199700|NCT01999517|Nitroglycerin|nitroglycerin|mesh-list
6199701|NCT01999517|Vasodilator Agents|vasodilator agents|mesh-ancestor
6199702|NCT01999530|Prazosin|prazosin|mesh-list
6199703|NCT01999530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6199704|NCT01999530|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6199705|NCT01999530|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6199706|NCT01999530|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6199707|NCT01999530|Adrenergic Agents|adrenergic agents|mesh-ancestor
6199708|NCT01999530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6199709|NCT01999530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199710|NCT01999530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588182|NCT03794440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5588183|NCT03794440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5588184|NCT03794440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5588185|NCT03794440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5588186|NCT03794440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5588187|NCT03794440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5588188|NCT03794440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5588189|NCT03794440|Growth Substances|growth substances|mesh-ancestor
5588190|NCT03794440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588191|NCT03794440|Growth Inhibitors|growth inhibitors|mesh-ancestor
5588192|NCT03794037|Montelukast|montelukast|mesh-list
5588193|NCT03794037|Progesterone|progesterone|mesh-list
5588194|NCT03794037|Progestins|progestins|mesh-ancestor
5588195|NCT03794037|Hormones|hormones|mesh-ancestor
5588196|NCT03794037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5588197|NCT03794037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588198|NCT03794037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6199711|NCT01999569|Letrozole|letrozole|mesh-list
6199712|NCT01999569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6199713|NCT01999569|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6199714|NCT01999569|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6199715|NCT01999569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5588199|NCT03794037|Respiratory System Agents|respiratory system agents|mesh-ancestor
5588200|NCT03794037|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5588201|NCT03794037|Hormone Antagonists|hormone antagonists|mesh-ancestor
6199716|NCT01999569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199717|NCT01999569|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6199718|NCT01999569|Hormone Antagonists|hormone antagonists|mesh-ancestor
6199719|NCT01999569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6199720|NCT01999569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199721|NCT01999868|Abatacept|abatacept|mesh-list
5588202|NCT03794037|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5588203|NCT03794037|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5588204|NCT03794037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5588205|NCT03794271|Anesthetics|anesthetics|mesh-list
5588206|NCT03794271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5588207|NCT03794271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605331|NCT02921789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5605332|NCT02921789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605333|NCT02921789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5605334|NCT02921789|Immunologic Factors|immunologic factors|mesh-ancestor
5605335|NCT02921789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5605336|NCT02921789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5605337|NCT02921789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605338|NCT02921789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5605339|NCT02921789|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5605340|NCT02921789|Antitubercular Agents|antitubercular agents|mesh-ancestor
5605341|NCT02921789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5605342|NCT02921789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5605343|NCT02918500|Nicotine|nicotine|mesh-list
5605344|NCT02918500|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5605345|NCT02918500|Autonomic Agents|autonomic agents|mesh-ancestor
5605346|NCT02918500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5605347|NCT02918500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605348|NCT02918500|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5605349|NCT02918500|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5605350|NCT02918500|Cholinergic Agents|cholinergic agents|mesh-ancestor
5605351|NCT02918500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5605352|NCT02918500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605353|NCT02903381|Dexamethasone|dexamethasone|mesh-list
6199722|NCT01999868|Ustekinumab|ustekinumab|mesh-list
6199723|NCT01999868|Immunoglobulins|immunoglobulins|mesh-list
6199724|NCT01999868|Immunologic Factors|immunologic factors|mesh-ancestor
6199725|NCT01999868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199726|NCT01999868|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6199727|NCT01999868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605354|NCT02903381|Nivolumab|nivolumab|mesh-list
5605355|NCT02903381|Lenalidomide|lenalidomide|mesh-list
5605356|NCT02903381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5605357|NCT02903381|Antiemetics|antiemetics|mesh-ancestor
5605358|NCT02903381|Autonomic Agents|autonomic agents|mesh-ancestor
5605359|NCT02903381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5605360|NCT02903381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199728|NCT01999868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6199729|NCT01999868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6199730|NCT01999868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6199731|NCT01999868|Dermatologic Agents|dermatologic agents|mesh-ancestor
6199732|NCT01999894|Memantine|memantine|mesh-list
6199733|NCT01999894|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6199734|NCT01999894|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6199735|NCT01999894|Dopamine Agents|dopamine agents|mesh-ancestor
6199736|NCT01999894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6199737|NCT01999894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199738|NCT01999894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199739|NCT01999894|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6199740|NCT01999894|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6199741|NCT01999920|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
6199742|NCT01999920|Antidepressive Agents|antidepressive agents|mesh-ancestor
6199743|NCT01999920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6199744|NCT01999920|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6199745|NCT01999920|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6199746|NCT01999920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6199747|NCT01999920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605361|NCT02903381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6199748|NCT01999920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6199749|NCT01999920|Serotonin Agents|serotonin agents|mesh-ancestor
6199750|NCT01999920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199751|NCT01999920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6199752|NCT01999920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6199753|NCT01999946|Naltrexone|naltrexone|mesh-list
6199754|NCT01999946|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6199755|NCT01999946|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6199756|NCT01999946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199757|NCT01999946|Sensory System Agents|sensory system agents|mesh-ancestor
6199758|NCT01999946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6199759|NCT01999972|Axitinib|axitinib|mesh-list
6199760|NCT01999972|Crizotinib|crizotinib|mesh-list
6199761|NCT01999972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6199762|NCT01999972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6199763|NCT01999972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6199764|NCT01999972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5588208|NCT03794154|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5588209|NCT03794154|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5588210|NCT03794154|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5588211|NCT03794154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5588212|NCT03794154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5588213|NCT03794154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5588214|NCT03794154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588215|NCT03794154|Analgesics|analgesics|mesh-ancestor
5588216|NCT03794154|Sensory System Agents|sensory system agents|mesh-ancestor
5588217|NCT03794154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5588218|NCT03794154|Antidepressive Agents|antidepressive agents|mesh-ancestor
5588219|NCT03794154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5588220|NCT03794154|Dopamine Agents|dopamine agents|mesh-ancestor
5588221|NCT03794167|Cyclophosphamide|cyclophosphamide|mesh-list
5588222|NCT03794167|Melphalan|melphalan|mesh-list
5588223|NCT03794167|Busulfan|busulfan|mesh-list
5588224|NCT03794167|Etoposide|etoposide|mesh-list
5588225|NCT03794167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5588226|NCT03794167|Immunologic Factors|immunologic factors|mesh-ancestor
5588227|NCT03794167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588228|NCT03794167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5588229|NCT03794167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5588230|NCT03794167|Alkylating Agents|alkylating agents|mesh-ancestor
5588231|NCT03794167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5588232|NCT03794167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5588233|NCT03794167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5588234|NCT03794167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5588235|NCT03794167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5588236|NCT03794167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6199765|NCT01999985|Dasatinib|dasatinib|mesh-list
6199766|NCT01999985|Afatinib|afatinib|mesh-list
6199767|NCT01999985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6199768|NCT01999985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6199769|NCT01999985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6199770|NCT01999985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199771|NCT02000531|Gemcitabine|gemcitabine|mesh-list
6199772|NCT02000531|Cisplatin|cisplatin|mesh-list
6199773|NCT02000531|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6199774|NCT02000531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6199775|NCT02000531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5588237|NCT03794167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5588238|NCT03794336|Aspirin|aspirin|mesh-list
5588239|NCT03794336|Metformin|metformin|mesh-list
5588240|NCT03794336|Alogliptin|alogliptin|mesh-list
5588241|NCT03794336|Acarbose|acarbose|mesh-list
5588242|NCT03794336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5588243|NCT03794336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588244|NCT03794336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5588245|NCT03794336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6199776|NCT02000531|Antimetabolites|antimetabolites|mesh-ancestor
6199777|NCT02000531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199778|NCT02000531|Antiviral Agents|antiviral agents|mesh-ancestor
6199779|NCT02000531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6199780|NCT02000531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6199781|NCT02000531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6199782|NCT02000531|Immunologic Factors|immunologic factors|mesh-ancestor
6199783|NCT02000531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488313|NCT00583063|Antifungal Agents|antifungal agents|mesh-ancestor
5588246|NCT03794336|Analgesics|analgesics|mesh-ancestor
6199784|NCT02000531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6199785|NCT02000622|Olaparib|olaparib|mesh-list
6199786|NCT02000622|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6199787|NCT02000622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6199788|NCT02000622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199789|NCT02000622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6199790|NCT02000921|Nicotine|nicotine|mesh-list
6199791|NCT02000921|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6199792|NCT02000921|Autonomic Agents|autonomic agents|mesh-ancestor
5588247|NCT03794336|Sensory System Agents|sensory system agents|mesh-ancestor
5588248|NCT03794336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5588249|NCT03794336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6199793|NCT02000921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6199794|NCT02000921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199795|NCT02000921|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6199796|NCT02000921|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6199797|NCT02000921|Cholinergic Agents|cholinergic agents|mesh-ancestor
6199798|NCT02000921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6199799|NCT02000921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199800|NCT02000973|Lidocaine|lidocaine|mesh-list
6199801|NCT02000973|Bupivacaine|bupivacaine|mesh-list
6199802|NCT02000973|Ropivacaine|ropivacaine|mesh-list
6199803|NCT02000973|Anesthetics, Local|anesthetics, local|mesh-ancestor
6199804|NCT02000973|Anesthetics|anesthetics|mesh-ancestor
6199805|NCT02000973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6199806|NCT02000973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199807|NCT02000973|Sensory System Agents|sensory system agents|mesh-ancestor
6199808|NCT02000973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6199809|NCT02000973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6199810|NCT02000973|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6199811|NCT02000973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6199812|NCT02000973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6199813|NCT02000973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207600|NCT02117479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6207601|NCT02117479|Antimetabolites|antimetabolites|mesh-ancestor
6207602|NCT02117479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207603|NCT02117479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6207604|NCT02117570|Vaccines|vaccines|mesh-list
6207605|NCT02117570|Immunologic Factors|immunologic factors|mesh-ancestor
6207606|NCT02117570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207607|NCT02117648|Clarithromycin|clarithromycin|mesh-list
6207608|NCT02117648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6207609|NCT02117648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6207610|NCT02117648|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6207611|NCT02117648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6207612|NCT02117648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207613|NCT02117648|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6207614|NCT02117648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6207615|NCT02117687|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6207616|NCT02117687|Hyaluronic Acid|hyaluronic acid|mesh-list
6207617|NCT02117687|Glycerol|glycerol|mesh-list
6207618|NCT02117687|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6207619|NCT02117687|Immunologic Factors|immunologic factors|mesh-ancestor
6207620|NCT02117687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207621|NCT02117687|Viscosupplements|viscosupplements|mesh-ancestor
5588250|NCT03794336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5588251|NCT03794336|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5588252|NCT03794336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5588253|NCT03794336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5588254|NCT03794336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5588255|NCT03794336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5588256|NCT03794336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6207622|NCT02117687|Protective Agents|protective agents|mesh-ancestor
6207623|NCT02117687|Laxatives|laxatives|mesh-ancestor
6207624|NCT02117687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6207625|NCT02117687|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6207626|NCT02117934|Vaccines|vaccines|mesh-list
6207627|NCT02117934|Immunologic Factors|immunologic factors|mesh-ancestor
6207628|NCT02117934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207629|NCT02118012|Ribavirin|ribavirin|mesh-list
6207630|NCT02118012|Antimetabolites|antimetabolites|mesh-ancestor
6207631|NCT02118012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207632|NCT02118012|Antiviral Agents|antiviral agents|mesh-ancestor
6207633|NCT02118012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5588257|NCT03794336|Antipyretics|antipyretics|mesh-ancestor
5588258|NCT03794336|Incretins|incretins|mesh-ancestor
6199814|NCT02001181|Tofacitinib|tofacitinib|mesh-list
6199815|NCT02001181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6199816|NCT02001181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6199817|NCT02001181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199818|NCT02001987|Methotrexate|methotrexate|mesh-list
6199819|NCT02001987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6199820|NCT02001987|Abortifacient Agents|abortifacient agents|mesh-ancestor
6199821|NCT02001987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6199822|NCT02001987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199823|NCT02001987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6199824|NCT02001987|Antimetabolites|antimetabolites|mesh-ancestor
6199825|NCT02001987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199826|NCT02001987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6199827|NCT02001987|Dermatologic Agents|dermatologic agents|mesh-ancestor
6199828|NCT02001987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6199829|NCT02001987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6199830|NCT02001987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6199831|NCT02001987|Immunologic Factors|immunologic factors|mesh-ancestor
6199832|NCT02001987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6199833|NCT02001987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6199834|NCT02002221|Metformin|metformin|mesh-list
6199835|NCT02002221|Vildagliptin|vildagliptin|mesh-list
6199836|NCT02002221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6199837|NCT02002221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199838|NCT02002221|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6199839|NCT02002221|Protease Inhibitors|protease inhibitors|mesh-ancestor
6199840|NCT02002221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6199841|NCT02002221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199842|NCT02002650|Indomethacin|indomethacin|mesh-list
6199843|NCT02002650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6199844|NCT02002650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6199845|NCT02002650|Analgesics|analgesics|mesh-ancestor
6199846|NCT02002650|Sensory System Agents|sensory system agents|mesh-ancestor
6199847|NCT02002650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6199848|NCT02002650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199849|NCT02002650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6199850|NCT02002650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6199851|NCT02002650|Gout Suppressants|gout suppressants|mesh-ancestor
5588259|NCT03794336|Hormones|hormones|mesh-ancestor
5588260|NCT03794336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5588261|NCT03794336|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5588262|NCT03794336|Protease Inhibitors|protease inhibitors|mesh-ancestor
5588263|NCT03794336|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
5588264|NCT03794297|Trametinib|trametinib|mesh-list
5588265|NCT03794297|Dabrafenib|dabrafenib|mesh-list
5588266|NCT03794297|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
5588267|NCT03794297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5588268|NCT03794297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5588269|NCT03794297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5588270|NCT03794297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199852|NCT02002650|Tocolytic Agents|tocolytic agents|mesh-ancestor
6199853|NCT02002650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6199854|NCT02002650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6199855|NCT02002650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6199856|NCT02002650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199857|NCT02002767|Velpatasvir|velpatasvir|mesh-list
6199858|NCT02002767|Antiviral Agents|antiviral agents|mesh-ancestor
5588271|NCT03794297|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
5588272|NCT03794297|Protective Agents|protective agents|mesh-ancestor
5588273|NCT03794297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588274|NCT03794297|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5588275|NCT03794297|Antioxidants|antioxidants|mesh-ancestor
5588276|NCT03793725|Apatinib|apatinib|mesh-list
5588277|NCT03793725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5588278|NCT03793725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5588279|NCT03793725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5588280|NCT03793725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5588281|NCT03793517|Decitabine|decitabine|mesh-list
5588282|NCT03793517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5588283|NCT03793517|Antimetabolites|antimetabolites|mesh-ancestor
5588284|NCT03793517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5588285|NCT03793517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6199859|NCT02002767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6199860|NCT02002832|Risperidone|risperidone|mesh-list
6199861|NCT02002832|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
6199862|NCT02002832|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6199863|NCT02002832|Serotonin Agents|serotonin agents|mesh-ancestor
6199864|NCT02002832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6199865|NCT02002832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199866|NCT02002832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199867|NCT02002832|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6199868|NCT02002832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6199869|NCT02002832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6199870|NCT02002832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6199871|NCT02002832|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6199872|NCT02002832|Dopamine Agents|dopamine agents|mesh-ancestor
6199873|NCT02002832|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6199874|NCT02002832|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6199875|NCT02002832|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6199876|NCT02002832|Adrenergic Agents|adrenergic agents|mesh-ancestor
5588286|NCT03793517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5588287|NCT03793309|Vitamin D|vitamin d|mesh-list
5588288|NCT03793309|Ergocalciferols|ergocalciferols|mesh-list
5588289|NCT03793309|Vitamins|vitamins|mesh-list
5588290|NCT03793309|Micronutrients|micronutrients|mesh-ancestor
5588291|NCT03793309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588292|NCT03793309|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5588293|NCT03793309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5588294|NCT03793283|Insulin|insulin|mesh-list
5588295|NCT03793283|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5588296|NCT03793283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5588297|NCT03793283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588298|NCT03793075|Ketamine|ketamine|mesh-list
5588299|NCT03793075|Propofol|propofol|mesh-list
5588300|NCT03793075|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5588301|NCT03793075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5588302|NCT03793075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588303|NCT03793075|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5588304|NCT03793075|Anesthetics, General|anesthetics, general|mesh-ancestor
6199877|NCT02002832|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6199878|NCT02002832|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6199879|NCT02002884|Botulinum Toxins|botulinum toxins|mesh-list
6199880|NCT02002884|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6199881|NCT02002884|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6199882|NCT02002884|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
6199883|NCT02002884|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6199884|NCT02002884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6199885|NCT02002884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199886|NCT02002884|Cholinergic Agents|cholinergic agents|mesh-ancestor
6199887|NCT02002884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6199888|NCT02002884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199889|NCT02002884|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6199890|NCT02002884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6199891|NCT02002975|Pioglitazone|pioglitazone|mesh-list
6199892|NCT02002975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6199893|NCT02002975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199894|NCT02003014|Pioglitazone|pioglitazone|mesh-list
6199895|NCT02003014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6199896|NCT02003014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199897|NCT02003365|Triamcinolone|triamcinolone|mesh-list
5588305|NCT03793075|Anesthetics|anesthetics|mesh-ancestor
5588306|NCT03793075|Analgesics|analgesics|mesh-ancestor
5588307|NCT03793075|Sensory System Agents|sensory system agents|mesh-ancestor
5588308|NCT03793075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5588309|NCT03793075|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5588310|NCT03793075|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5588311|NCT03793075|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5588312|NCT03793075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5588313|NCT03793075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5588314|NCT03793205|Lenograstim|lenograstim|mesh-list
5588315|NCT03793205|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6199898|NCT02003365|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6199899|NCT02003365|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6199900|NCT02003365|FX006|fx006|mesh-list
6199901|NCT02003365|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6199902|NCT02003365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6199903|NCT02003365|Glucocorticoids|glucocorticoids|mesh-ancestor
6199904|NCT02003365|Hormones|hormones|mesh-ancestor
6199905|NCT02003365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6199906|NCT02003365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199907|NCT02003365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5588316|NCT03793205|Immunologic Factors|immunologic factors|mesh-ancestor
5588317|NCT03793205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588318|NCT03793114|Cosyntropin|cosyntropin|mesh-list
5588319|NCT03793114|Hormones|hormones|mesh-ancestor
5588320|NCT03793114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5588321|NCT03793114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588322|NCT03792867|Doxorubicin|doxorubicin|mesh-list
5588323|NCT03792867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5588324|NCT03792867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5588325|NCT03792867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5588326|NCT03792867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6199908|NCT02003365|Immunologic Factors|immunologic factors|mesh-ancestor
6199909|NCT02003365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6199910|NCT02003365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5588327|NCT03792867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5588328|NCT03792867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5588329|NCT03792776|Lidocaine|lidocaine|mesh-list
5588330|NCT03792776|Anesthetics|anesthetics|mesh-list
5588331|NCT03792776|Anesthetics, Local|anesthetics, local|mesh-ancestor
5588332|NCT03792776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6199911|NCT02003391|Timolol|timolol|mesh-list
6199912|NCT02003391|Travoprost|travoprost|mesh-list
6199913|NCT02003391|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6199914|NCT02003391|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
6199915|NCT02003391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6199916|NCT02003391|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6199917|NCT02003391|Adrenergic Agents|adrenergic agents|mesh-ancestor
6199918|NCT02003391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6199919|NCT02003391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199920|NCT02003391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199921|NCT02003391|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6199922|NCT02003391|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6199923|NCT02003534|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6199924|NCT02003534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6199925|NCT02003534|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6199926|NCT02003534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6199927|NCT02003534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6199928|NCT02003534|Adrenergic Agents|adrenergic agents|mesh-ancestor
6199929|NCT02003534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6199930|NCT02003534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199931|NCT02003534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199932|NCT02003573|Decitabine|decitabine|mesh-list
6199933|NCT02003573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6488314|NCT00583063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5605362|NCT02903381|Glucocorticoids|glucocorticoids|mesh-ancestor
6199934|NCT02003573|Antimetabolites|antimetabolites|mesh-ancestor
6199935|NCT02003573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199936|NCT02003573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6199937|NCT02003573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6199938|NCT02003625|Meloxicam|meloxicam|mesh-list
6199939|NCT02003625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6199940|NCT02003625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6199941|NCT02003625|Analgesics|analgesics|mesh-ancestor
6199942|NCT02003625|Sensory System Agents|sensory system agents|mesh-ancestor
6199943|NCT02003625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6199944|NCT02003625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199945|NCT02003625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6199946|NCT02003625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6199947|NCT02003625|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6199948|NCT02003625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6199949|NCT02003625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6199950|NCT02003625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199951|NCT02003638|Niacin|niacin|mesh-list
6199952|NCT02003638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6199953|NCT02003638|Antimetabolites|antimetabolites|mesh-ancestor
6199954|NCT02003638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199955|NCT02003638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6199956|NCT02003638|Vasodilator Agents|vasodilator agents|mesh-ancestor
6199957|NCT02003638|Vitamin B Complex|vitamin b complex|mesh-ancestor
6199958|NCT02003638|Vitamins|vitamins|mesh-ancestor
6199959|NCT02003638|Micronutrients|micronutrients|mesh-ancestor
6199960|NCT02003638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199961|NCT02003898|Insulin|insulin|mesh-list
6199962|NCT02003898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6199963|NCT02003898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199964|NCT02003911|Azithromycin|azithromycin|mesh-list
6199965|NCT02003911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6199966|NCT02003911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6199967|NCT02004093|Gemcitabine|gemcitabine|mesh-list
6199968|NCT02004093|Paclitaxel|paclitaxel|mesh-list
6199969|NCT02004093|Carboplatin|carboplatin|mesh-list
6199970|NCT02004093|Pertuzumab|pertuzumab|mesh-list
6199971|NCT02004093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6199972|NCT02004093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6199973|NCT02004093|Tubulin Modulators|tubulin modulators|mesh-ancestor
6199974|NCT02004093|Antimitotic Agents|antimitotic agents|mesh-ancestor
6199975|NCT02004093|Mitosis Modulators|mitosis modulators|mesh-ancestor
6199976|NCT02004093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6199977|NCT02004093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6199978|NCT02004093|Antimetabolites|antimetabolites|mesh-ancestor
6199979|NCT02004093|Antiviral Agents|antiviral agents|mesh-ancestor
6199980|NCT02004093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6199981|NCT02004093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6199982|NCT02004093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6199983|NCT02004093|Immunologic Factors|immunologic factors|mesh-ancestor
5588333|NCT03792776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588334|NCT03792776|Sensory System Agents|sensory system agents|mesh-ancestor
5588335|NCT03792776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5588336|NCT03792776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5588337|NCT03792776|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5588338|NCT03792776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5588339|NCT03792776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6199984|NCT02004093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199985|NCT02004093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6199986|NCT02004132|Testosterone|testosterone|mesh-list
6199987|NCT02004132|Androgens|androgens|mesh-ancestor
6199988|NCT02004132|Hormones|hormones|mesh-ancestor
6199989|NCT02004132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6199990|NCT02004132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199991|NCT02004262|Cyclophosphamide|cyclophosphamide|mesh-list
6199992|NCT02004262|Pancrelipase|pancrelipase|mesh-list
6199993|NCT02004262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6199994|NCT02004262|Immunologic Factors|immunologic factors|mesh-ancestor
6199995|NCT02004262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6199996|NCT02004262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6199997|NCT02004262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6199998|NCT02004262|Alkylating Agents|alkylating agents|mesh-ancestor
6199999|NCT02004262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200000|NCT02004262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6200001|NCT02004262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6200002|NCT02004262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6200003|NCT02004366|Insulin Glargine|insulin glargine|mesh-list
6200004|NCT02004366|Linagliptin|linagliptin|mesh-list
6200005|NCT02004366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6200006|NCT02004366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200007|NCT02004366|Incretins|incretins|mesh-ancestor
6200008|NCT02004366|Hormones|hormones|mesh-ancestor
6200009|NCT02004366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6200010|NCT02004366|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5588340|NCT03792776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5588341|NCT03792828|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5588342|NCT03792828|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5588343|NCT03792828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5588344|NCT03792828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5588345|NCT03792828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200011|NCT02004366|Protease Inhibitors|protease inhibitors|mesh-ancestor
6200012|NCT02004366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6200013|NCT02004366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200014|NCT02004613|Dexmedetomidine|dexmedetomidine|mesh-list
6200015|NCT02004613|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6200016|NCT02004613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6200017|NCT02004613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200018|NCT02004613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6200019|NCT02004613|Analgesics|analgesics|mesh-ancestor
6200020|NCT02004613|Sensory System Agents|sensory system agents|mesh-ancestor
6200021|NCT02004613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6200022|NCT02004613|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6200023|NCT02004613|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6200024|NCT02004613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6200025|NCT02004613|Adrenergic Agents|adrenergic agents|mesh-ancestor
6200026|NCT02004613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6200027|NCT02004613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200028|NCT02004886|Metformin|metformin|mesh-list
6200029|NCT02004886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6200030|NCT02004886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200031|NCT02004990|Povidone-Iodine|povidone-iodine|mesh-list
6200032|NCT02004990|Povidone|povidone|mesh-list
6200033|NCT02004990|Plasma Substitutes|plasma substitutes|mesh-ancestor
6200034|NCT02004990|Blood Substitutes|blood substitutes|mesh-ancestor
6200035|NCT02004990|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6200036|NCT02004990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6200037|NCT02005029|Erythromycin|erythromycin|mesh-list
6200038|NCT02005029|Erythromycin Estolate|erythromycin estolate|mesh-list
6200039|NCT02005029|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
6200040|NCT02005029|Erythromycin stearate|erythromycin stearate|mesh-list
6200041|NCT02005029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6200042|NCT02005029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6200043|NCT02005029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6200044|NCT02005029|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6200045|NCT02005029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6200046|NCT02005029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200047|NCT02005354|Nitrous Oxide|nitrous oxide|mesh-list
6200048|NCT02005354|Anesthetics|anesthetics|mesh-list
6200049|NCT02005354|Anesthetics, Local|anesthetics, local|mesh-list
6200050|NCT02005354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6200051|NCT02005354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200052|NCT02005354|Sensory System Agents|sensory system agents|mesh-ancestor
6200053|NCT02005354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6200054|NCT02005354|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6200055|NCT02005354|Anesthetics, General|anesthetics, general|mesh-ancestor
6200056|NCT02005354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6200057|NCT02005354|Analgesics|analgesics|mesh-ancestor
6200058|NCT02005484|Trastuzumab|trastuzumab|mesh-list
6200059|NCT02005484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6200060|NCT02005484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6200061|NCT02005549|Bevacizumab|bevacizumab|mesh-list
6200062|NCT02005549|Docetaxel|docetaxel|mesh-list
6200063|NCT02005549|Capecitabine|capecitabine|mesh-list
6200064|NCT02005549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5588346|NCT03792828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5588347|NCT03792828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588348|NCT03792828|Analgesics|analgesics|mesh-ancestor
5588349|NCT03792828|Sensory System Agents|sensory system agents|mesh-ancestor
5588350|NCT03792828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5588351|NCT03792828|Antidepressive Agents|antidepressive agents|mesh-ancestor
5588352|NCT03792828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5588353|NCT03792828|Dopamine Agents|dopamine agents|mesh-ancestor
5588354|NCT03792724|Nivolumab|nivolumab|mesh-list
5588355|NCT03792724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6200065|NCT02005549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6200066|NCT02005549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6200067|NCT02005549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6200068|NCT02005549|Growth Substances|growth substances|mesh-ancestor
6200069|NCT02005549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200070|NCT02005549|Growth Inhibitors|growth inhibitors|mesh-ancestor
6200071|NCT02005549|Tubulin Modulators|tubulin modulators|mesh-ancestor
5588356|NCT03792724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5588357|NCT03792724|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5588358|NCT03792724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5588359|NCT03792971|Dextromethorphan|dextromethorphan|mesh-list
5588360|NCT03792971|Avasopasem manganese|avasopasem manganese|mesh-list
5588361|NCT03792971|Antitussive Agents|antitussive agents|mesh-ancestor
5588362|NCT03792971|Respiratory System Agents|respiratory system agents|mesh-ancestor
5588363|NCT03792971|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5588364|NCT03792971|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5588365|NCT03792971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5588366|NCT03792971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5588367|NCT03792971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588368|NCT03792971|Antioxidants|antioxidants|mesh-ancestor
5588369|NCT03792971|Protective Agents|protective agents|mesh-ancestor
5588370|NCT03792984|Vitamin D|vitamin d|mesh-list
5588371|NCT03792984|Cholecalciferol|cholecalciferol|mesh-list
5588372|NCT03792984|Metformin|metformin|mesh-list
5588373|NCT03792984|Calcium Carbonate|calcium carbonate|mesh-list
5588374|NCT03792984|Calcium|calcium|mesh-list
5588375|NCT03792984|Vitamins|vitamins|mesh-ancestor
5588376|NCT03792984|Micronutrients|micronutrients|mesh-ancestor
5588377|NCT03792984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588378|NCT03792984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5588379|NCT03792984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5588380|NCT03792984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5588381|NCT03792984|Antacids|antacids|mesh-ancestor
5588382|NCT03792984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200072|NCT02005549|Antimitotic Agents|antimitotic agents|mesh-ancestor
6200073|NCT02005549|Mitosis Modulators|mitosis modulators|mesh-ancestor
6200074|NCT02005549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200075|NCT02005549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6200076|NCT02005549|Antimetabolites|antimetabolites|mesh-ancestor
6200077|NCT02005562|Cyclosporine|cyclosporine|mesh-list
6200078|NCT02005562|Mycophenolic Acid|mycophenolic acid|mesh-list
6200079|NCT02005562|Methylprednisolone|methylprednisolone|mesh-list
5588383|NCT03792984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6200080|NCT02005562|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6200081|NCT02005562|Cyclosporins|cyclosporins|mesh-list
6200082|NCT02005562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6200083|NCT02005562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200084|NCT02005562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6200085|NCT02005562|Immunologic Factors|immunologic factors|mesh-ancestor
6200086|NCT02005562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200087|NCT02005562|Antifungal Agents|antifungal agents|mesh-ancestor
6200088|NCT02005562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6200089|NCT02005562|Dermatologic Agents|dermatologic agents|mesh-ancestor
6200090|NCT02005562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6200091|NCT02005562|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6200092|NCT02005562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6200093|NCT02005562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6200094|NCT02005562|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6200095|NCT02005562|Antitubercular Agents|antitubercular agents|mesh-ancestor
6200096|NCT02005562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6200097|NCT02005562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6200098|NCT02005562|Antiemetics|antiemetics|mesh-ancestor
6200099|NCT02005562|Autonomic Agents|autonomic agents|mesh-ancestor
6200100|NCT02005562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6200101|NCT02005562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6200102|NCT02005562|Glucocorticoids|glucocorticoids|mesh-ancestor
6200103|NCT02005562|Hormones|hormones|mesh-ancestor
6200104|NCT02005562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6200105|NCT02005562|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6200106|NCT02005562|Protective Agents|protective agents|mesh-ancestor
6200107|NCT02005562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6200108|NCT02005601|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6200109|NCT02005601|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6200110|NCT02005601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6200111|NCT02005601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6488315|NCT00583063|Immunologic Factors|immunologic factors|mesh-ancestor
6488316|NCT00583180|Capsaicin|capsaicin|mesh-list
5588384|NCT03792815|Etoposide|etoposide|mesh-list
5588385|NCT03792815|Melphalan|melphalan|mesh-list
5588386|NCT03792815|Busulfan|busulfan|mesh-list
5588387|NCT03792815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5588388|NCT03792815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5588389|NCT03792815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5588390|NCT03792815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5588391|NCT03792815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5588392|NCT03792815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5588393|NCT03792815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5588394|NCT03792815|Alkylating Agents|alkylating agents|mesh-ancestor
5588395|NCT03792815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5588396|NCT03792815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5588397|NCT03792815|Immunologic Factors|immunologic factors|mesh-ancestor
5588398|NCT03792815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588399|NCT03792906|Norepinephrine|norepinephrine|mesh-list
5588400|NCT03792906|Bupivacaine|bupivacaine|mesh-list
5588401|NCT03792906|Anesthetics, Local|anesthetics, local|mesh-ancestor
5588402|NCT03792906|Anesthetics|anesthetics|mesh-ancestor
5588403|NCT03792906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5588404|NCT03792906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588405|NCT03792906|Sensory System Agents|sensory system agents|mesh-ancestor
5588406|NCT03792906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5588407|NCT03792906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5588408|NCT03792906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5588409|NCT03792906|Adrenergic Agents|adrenergic agents|mesh-ancestor
5588410|NCT03792906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5588411|NCT03792906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200112|NCT02005601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200113|NCT02005601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6200114|NCT02005601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200115|NCT02005601|Analgesics|analgesics|mesh-ancestor
6200116|NCT02005601|Sensory System Agents|sensory system agents|mesh-ancestor
6200117|NCT02005601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6200118|NCT02005601|Antidepressive Agents|antidepressive agents|mesh-ancestor
6200119|NCT02005601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6200120|NCT02005601|Dopamine Agents|dopamine agents|mesh-ancestor
6200121|NCT02005627|Immunologic Factors|immunologic factors|mesh-list
6200122|NCT02005627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200123|NCT02005666|Clindamycin|clindamycin|mesh-list
6200124|NCT02005666|Clindamycin palmitate|clindamycin palmitate|mesh-list
6200125|NCT02005666|Clindamycin phosphate|clindamycin phosphate|mesh-list
6200126|NCT02005666|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6200127|NCT02005666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6200128|NCT02005666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6200129|NCT02005666|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6200130|NCT02005666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6200131|NCT02005666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200132|NCT02005666|Dermatologic Agents|dermatologic agents|mesh-ancestor
6200133|NCT02005887|Letrozole|letrozole|mesh-list
6200134|NCT02005887|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6200135|NCT02005887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6200136|NCT02005887|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6200137|NCT02005887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6200138|NCT02005887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6200139|NCT02005887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200140|NCT02005887|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6200141|NCT02005887|Hormone Antagonists|hormone antagonists|mesh-ancestor
6200142|NCT02005887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6200143|NCT02005887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588412|NCT03792906|Sympathomimetics|sympathomimetics|mesh-ancestor
5588413|NCT03792906|Autonomic Agents|autonomic agents|mesh-ancestor
5588414|NCT03792906|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5588415|NCT03792763|Denosumab|denosumab|mesh-list
5588416|NCT03792763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5588417|NCT03792763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5588418|NCT03792763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588419|NCT03792620|Daratumumab|daratumumab|mesh-list
6200144|NCT02005887|Luteolytic Agents|luteolytic agents|mesh-ancestor
6200145|NCT02005887|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6200146|NCT02005887|Contraceptive Agents|contraceptive agents|mesh-ancestor
6200147|NCT02005887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6200148|NCT02005887|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6200149|NCT02005887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6200150|NCT02006056|Ondansetron|ondansetron|mesh-list
5588420|NCT03792620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605363|NCT02903381|Hormones|hormones|mesh-ancestor
6200151|NCT02006056|Antiemetics|antiemetics|mesh-ancestor
6200152|NCT02006056|Autonomic Agents|autonomic agents|mesh-ancestor
6200153|NCT02006056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6200154|NCT02006056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200155|NCT02006056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6200156|NCT02006056|Antipruritics|antipruritics|mesh-ancestor
6200157|NCT02006056|Dermatologic Agents|dermatologic agents|mesh-ancestor
6200158|NCT02006056|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6200159|NCT02006056|Serotonin Agents|serotonin agents|mesh-ancestor
6200160|NCT02006056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5588421|NCT03792503|Pemetrexed|pemetrexed|mesh-list
5588422|NCT03792503|Apatinib|apatinib|mesh-list
5588423|NCT03792503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5588424|NCT03792503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5588425|NCT03792503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5588426|NCT03792503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6200161|NCT02006056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200162|NCT02006056|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6200163|NCT02006056|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6200164|NCT02006056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6200165|NCT02006056|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6200166|NCT02006056|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5588427|NCT03792503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5588428|NCT03792503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5588429|NCT03792490|Fasudil|fasudil|mesh-list
5588430|NCT03792490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5588431|NCT03792490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5588432|NCT03792490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5588433|NCT03792490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5588434|NCT03792490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588435|NCT03792490|Vasodilator Agents|vasodilator agents|mesh-ancestor
5588436|NCT03792490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5588437|NCT03792490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5588438|NCT03792217|Sodium Hypochlorite|sodium hypochlorite|mesh-list
5588439|NCT03792217|Eusol|eusol|mesh-list
5588440|NCT03792217|Disinfectants|disinfectants|mesh-ancestor
5588441|NCT03792217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6200167|NCT02006108|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
6200168|NCT02006108|Hematinics|hematinics|mesh-ancestor
6200169|NCT02006108|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6200170|NCT02006108|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6200171|NCT02006121|Apomorphine|apomorphine|mesh-list
5588442|NCT03792256|Cytarabine|cytarabine|mesh-list
5588443|NCT03792256|Prednisone|prednisone|mesh-list
5588444|NCT03792256|Prednisolone|prednisolone|mesh-list
5588445|NCT03792256|Hydrocortisone|hydrocortisone|mesh-list
6200172|NCT02006121|Emetics|emetics|mesh-ancestor
6200173|NCT02006121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200174|NCT02006121|Autonomic Agents|autonomic agents|mesh-ancestor
6200175|NCT02006121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6200176|NCT02006121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6200177|NCT02006121|Dopamine Agonists|dopamine agonists|mesh-ancestor
6200178|NCT02006121|Dopamine Agents|dopamine agents|mesh-ancestor
6200179|NCT02006121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6200180|NCT02006121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200181|NCT02006160|4-Aminopyridine|4-aminopyridine|mesh-list
6200182|NCT02006160|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5588446|NCT03792256|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
5588447|NCT03792256|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
5588448|NCT03792256|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
5588449|NCT03792256|Doxorubicin|doxorubicin|mesh-list
5588450|NCT03792256|Methotrexate|methotrexate|mesh-list
5588451|NCT03792256|Vincristine|vincristine|mesh-list
5588452|NCT03792256|Palbociclib|palbociclib|mesh-list
5588453|NCT03792256|Pegaspargase|pegaspargase|mesh-list
5588454|NCT03792256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5588455|NCT03792256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5588456|NCT03792256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6200183|NCT02006160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6200184|NCT02006160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200185|NCT02006342|Insulin|insulin|mesh-list
6200186|NCT02006342|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6200187|NCT02006342|Insulin Glargine|insulin glargine|mesh-list
6200188|NCT02006342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5588457|NCT03792256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5588458|NCT03792256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5588459|NCT03792256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200189|NCT02006342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200190|NCT02006576|Ibuprofen|ibuprofen|mesh-list
6200191|NCT02006576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6200192|NCT02006576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6200193|NCT02006576|Analgesics|analgesics|mesh-ancestor
6200194|NCT02006576|Sensory System Agents|sensory system agents|mesh-ancestor
6200195|NCT02006576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6200196|NCT02006576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200197|NCT02006576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6200198|NCT02006576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6200199|NCT02006576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6200200|NCT02006576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6200201|NCT02006576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200202|NCT02006628|Cannabidiol|cannabidiol|mesh-list
6200203|NCT02006628|Anticonvulsants|anticonvulsants|mesh-ancestor
6200204|NCT02006667|Gemcitabine|gemcitabine|mesh-list
6200205|NCT02006667|Trastuzumab|trastuzumab|mesh-list
6200206|NCT02006667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6200207|NCT02006667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6200208|NCT02006667|Antimetabolites|antimetabolites|mesh-ancestor
6200209|NCT02006667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200210|NCT02006667|Antiviral Agents|antiviral agents|mesh-ancestor
6200211|NCT02006667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6200212|NCT02006667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6200213|NCT02006667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6200214|NCT02006667|Immunologic Factors|immunologic factors|mesh-ancestor
6200215|NCT02006667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200216|NCT02006667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6200217|NCT02006706|Methylprednisolone|methylprednisolone|mesh-list
6200218|NCT02006706|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6200219|NCT02006706|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6200220|NCT02006706|Prednisolone|prednisolone|mesh-list
6200221|NCT02006706|Prednisolone acetate|prednisolone acetate|mesh-list
6200222|NCT02006706|Rituximab|rituximab|mesh-list
6200223|NCT02006706|Methotrexate|methotrexate|mesh-list
6200224|NCT02006706|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6200225|NCT02006706|Prednisolone phosphate|prednisolone phosphate|mesh-list
5588460|NCT03792256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5588461|NCT03792256|Glucocorticoids|glucocorticoids|mesh-ancestor
5588462|NCT03792256|Hormones|hormones|mesh-ancestor
5588463|NCT03792256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5588464|NCT03792256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588465|NCT03792256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5588466|NCT03792256|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5588467|NCT03792256|Abortifacient Agents|abortifacient agents|mesh-ancestor
5588468|NCT03792256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5588469|NCT03792256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5588470|NCT03792256|Antimetabolites|antimetabolites|mesh-ancestor
5588471|NCT03792256|Dermatologic Agents|dermatologic agents|mesh-ancestor
5588472|NCT03792256|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5588473|NCT03792256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5588474|NCT03792256|Immunologic Factors|immunologic factors|mesh-ancestor
5588475|NCT03792256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5588476|NCT03792256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5588477|NCT03792256|Antiviral Agents|antiviral agents|mesh-ancestor
5588478|NCT03792256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5588479|NCT03792256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6200226|NCT02006706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6200227|NCT02006706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6200228|NCT02006706|Immunologic Factors|immunologic factors|mesh-ancestor
6200229|NCT02006706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200230|NCT02006706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6200231|NCT02006706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6200232|NCT02006706|Abortifacient Agents|abortifacient agents|mesh-ancestor
6200233|NCT02006706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6200234|NCT02006706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5588480|NCT03792256|Tubulin Modulators|tubulin modulators|mesh-ancestor
5588481|NCT03792256|Antimitotic Agents|antimitotic agents|mesh-ancestor
5588482|NCT03792256|Mitosis Modulators|mitosis modulators|mesh-ancestor
5588483|NCT03792256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5588484|NCT03792139|Itraconazole|itraconazole|mesh-list
5588485|NCT03792139|Antifungal Agents|antifungal agents|mesh-ancestor
5588486|NCT03792139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5588487|NCT03792139|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6200235|NCT02006706|Antimetabolites|antimetabolites|mesh-ancestor
5588488|NCT03792139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5588489|NCT03792139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5588490|NCT03792139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5588491|NCT03792139|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5588492|NCT03792139|Hormone Antagonists|hormone antagonists|mesh-ancestor
5588493|NCT03792139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5588494|NCT03792139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588495|NCT03792139|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6200236|NCT02006706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200237|NCT02006706|Dermatologic Agents|dermatologic agents|mesh-ancestor
6200238|NCT02006706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6200239|NCT02006706|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6200240|NCT02006706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6200241|NCT02006706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6200242|NCT02006706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6200243|NCT02006706|Antiemetics|antiemetics|mesh-ancestor
6200244|NCT02006706|Autonomic Agents|autonomic agents|mesh-ancestor
6200245|NCT02006706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6200246|NCT02006706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6200247|NCT02006706|Glucocorticoids|glucocorticoids|mesh-ancestor
6200248|NCT02006706|Hormones|hormones|mesh-ancestor
6200249|NCT02006706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6200250|NCT02006706|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6200251|NCT02006706|Protective Agents|protective agents|mesh-ancestor
6200252|NCT02006706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6200253|NCT02006732|Tiotropium Bromide|tiotropium bromide|mesh-list
6200254|NCT02006732|Olodaterol|olodaterol|mesh-list
6200255|NCT02006732|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6200256|NCT02006732|Autonomic Agents|autonomic agents|mesh-ancestor
6200257|NCT02006732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6200258|NCT02006732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200259|NCT02006732|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6200260|NCT02006732|Respiratory System Agents|respiratory system agents|mesh-ancestor
6200261|NCT02006732|Parasympatholytics|parasympatholytics|mesh-ancestor
6200262|NCT02006732|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6200263|NCT02006732|Cholinergic Agents|cholinergic agents|mesh-ancestor
6200264|NCT02006732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6200265|NCT02006732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200266|NCT02006836|Insulin|insulin|mesh-list
6200267|NCT02006836|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6200268|NCT02006836|Metformin|metformin|mesh-list
6200269|NCT02006836|Insulin Aspart|insulin aspart|mesh-list
6200270|NCT02006836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6200271|NCT02006836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200272|NCT02007070|Pembrolizumab|pembrolizumab|mesh-list
5588496|NCT03792269|Capecitabine|capecitabine|mesh-list
5588497|NCT03792269|Oxaliplatin|oxaliplatin|mesh-list
5588498|NCT03792269|Irinotecan|irinotecan|mesh-list
5588499|NCT03792269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5588500|NCT03792269|Antimetabolites|antimetabolites|mesh-ancestor
5588501|NCT03792269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5588502|NCT03792269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5588503|NCT03792269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5588504|NCT03792269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5588505|NCT03792269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5588506|NCT03792295|Acetaminophen|acetaminophen|mesh-list
5588507|NCT03792295|Ibuprofen|ibuprofen|mesh-list
5588508|NCT03792295|Oxycodone|oxycodone|mesh-list
5588509|NCT03792295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5588510|NCT03792295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5588511|NCT03792295|Analgesics|analgesics|mesh-ancestor
5588512|NCT03792295|Sensory System Agents|sensory system agents|mesh-ancestor
6200273|NCT02007070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6200274|NCT02007070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6200275|NCT02007096|Bupivacaine|bupivacaine|mesh-list
6200276|NCT02007096|Anesthetics, Local|anesthetics, local|mesh-ancestor
6200277|NCT02007096|Anesthetics|anesthetics|mesh-ancestor
6200278|NCT02007096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6200279|NCT02007096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200280|NCT02007096|Sensory System Agents|sensory system agents|mesh-ancestor
6200281|NCT02007096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6200282|NCT02007278|Metformin|metformin|mesh-list
6200283|NCT02007278|Glimepiride|glimepiride|mesh-list
6200284|NCT02007278|Vildagliptin|vildagliptin|mesh-list
6200285|NCT02007278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6207634|NCT02118337|Nivolumab|nivolumab|mesh-list
6200286|NCT02007278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200287|NCT02007278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6200288|NCT02007278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6200289|NCT02007278|Immunologic Factors|immunologic factors|mesh-ancestor
6200290|NCT02007278|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6200291|NCT02007278|Protease Inhibitors|protease inhibitors|mesh-ancestor
6200292|NCT02007278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5588513|NCT03792295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5588514|NCT03792295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588515|NCT03792295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5588516|NCT03792295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5588517|NCT03792295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5588518|NCT03792295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5588519|NCT03792295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5588520|NCT03792295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6200293|NCT02007278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200294|NCT02007434|Loratadine|loratadine|mesh-list
6200295|NCT02007434|Ibuprofen|ibuprofen|mesh-list
6200296|NCT02007434|Lidocaine|lidocaine|mesh-list
6200297|NCT02007434|Epinephrine|epinephrine|mesh-list
6200298|NCT02007434|Deoxycholic Acid|deoxycholic acid|mesh-list
5588521|NCT03792295|Narcotics|narcotics|mesh-ancestor
5588522|NCT03792295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5588523|NCT03792295|Antipyretics|antipyretics|mesh-ancestor
5588524|NCT03792152|Warfarin|warfarin|mesh-list
5588525|NCT03792152|Rivaroxaban|rivaroxaban|mesh-list
5588526|NCT03792152|Anticoagulants|anticoagulants|mesh-ancestor
5588527|NCT03792152|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5588528|NCT03792152|Antithrombins|antithrombins|mesh-ancestor
5588529|NCT03792152|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5588530|NCT03792152|Protease Inhibitors|protease inhibitors|mesh-ancestor
5588531|NCT03792152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5588532|NCT03792152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5588533|NCT03792347|Pembrolizumab|pembrolizumab|mesh-list
5588534|NCT03792347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5588535|NCT03792347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5588536|NCT03792321|Methyltestosterone|methyltestosterone|mesh-list
5588537|NCT03792321|Testosterone|testosterone|mesh-list
5588538|NCT03792321|Testosterone undecanoate|testosterone undecanoate|mesh-list
5588539|NCT03792321|Testosterone enanthate|testosterone enanthate|mesh-list
6200299|NCT02007434|Anesthetics, Local|anesthetics, local|mesh-ancestor
6200300|NCT02007434|Anesthetics|anesthetics|mesh-ancestor
6200301|NCT02007434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6200302|NCT02007434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200303|NCT02007434|Sensory System Agents|sensory system agents|mesh-ancestor
6200304|NCT02007434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6200305|NCT02007434|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6200306|NCT02007434|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6200307|NCT02007434|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6200308|NCT02007434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6200309|NCT02007434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200310|NCT02007434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6200311|NCT02007434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6200312|NCT02007434|Analgesics|analgesics|mesh-ancestor
6200313|NCT02007434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6200314|NCT02007434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6200315|NCT02007434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6200316|NCT02007434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6200317|NCT02007434|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6200318|NCT02007434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6200319|NCT02007434|Adrenergic Agents|adrenergic agents|mesh-ancestor
6200320|NCT02007434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6200321|NCT02007434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6200322|NCT02007434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6200323|NCT02007434|Autonomic Agents|autonomic agents|mesh-ancestor
6200324|NCT02007434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6200325|NCT02007434|Respiratory System Agents|respiratory system agents|mesh-ancestor
6200326|NCT02007434|Mydriatics|mydriatics|mesh-ancestor
6200327|NCT02007434|Sympathomimetics|sympathomimetics|mesh-ancestor
6200328|NCT02007434|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6200329|NCT02007434|Antipruritics|antipruritics|mesh-ancestor
6200330|NCT02007434|Dermatologic Agents|dermatologic agents|mesh-ancestor
6200331|NCT02007434|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6200332|NCT02007434|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5588540|NCT03792321|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5588541|NCT03792321|Androgens|androgens|mesh-ancestor
6200333|NCT02007434|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6200334|NCT02007434|Histamine Antagonists|histamine antagonists|mesh-ancestor
6200335|NCT02007434|Histamine Agents|histamine agents|mesh-ancestor
6200336|NCT02007434|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6200337|NCT02007434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6200338|NCT02007512|Exemestane|exemestane|mesh-list
6200339|NCT02007512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6200340|NCT02007512|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6200341|NCT02007512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6200342|NCT02007512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6200343|NCT02007512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200344|NCT02007512|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6200345|NCT02007512|Hormone Antagonists|hormone antagonists|mesh-ancestor
6200346|NCT02007512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6200347|NCT02007512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200348|NCT02007577|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
6200349|NCT02007577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6200350|NCT02007577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6200351|NCT02007577|Analgesics|analgesics|mesh-ancestor
6200352|NCT02007577|Sensory System Agents|sensory system agents|mesh-ancestor
6200353|NCT02007577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6200354|NCT02007577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200355|NCT02007577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6200356|NCT02007577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6207635|NCT02118337|Durvalumab|durvalumab|mesh-list
6207636|NCT02118337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6207637|NCT02118337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6207638|NCT02118337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6207639|NCT02118337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207640|NCT02118597|Interferons|interferons|mesh-list
6207641|NCT02118597|Ribavirin|ribavirin|mesh-list
6207642|NCT02118597|Simeprevir|simeprevir|mesh-list
6207643|NCT02118597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6207644|NCT02118597|Antiviral Agents|antiviral agents|mesh-ancestor
6207645|NCT02118597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5588542|NCT03792321|Hormones|hormones|mesh-ancestor
5588543|NCT03792321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5588544|NCT03792321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588545|NCT03792321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5588546|NCT03792321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5588547|NCT03792321|Anabolic Agents|anabolic agents|mesh-ancestor
5588548|NCT03792009|Bupivacaine|bupivacaine|mesh-list
5588549|NCT03792009|Anesthetics, Local|anesthetics, local|mesh-ancestor
5588550|NCT03792009|Anesthetics|anesthetics|mesh-ancestor
5588551|NCT03792009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5588552|NCT03792009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588553|NCT03792009|Sensory System Agents|sensory system agents|mesh-ancestor
5588554|NCT03792009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5588555|NCT03792074|Paclitaxel|paclitaxel|mesh-list
5588556|NCT03792074|Bevacizumab|bevacizumab|mesh-list
5588557|NCT03792074|Carboplatin|carboplatin|mesh-list
5588558|NCT03792074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6207646|NCT02118597|Antimetabolites|antimetabolites|mesh-ancestor
6207647|NCT02118597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207648|NCT02118597|Protease Inhibitors|protease inhibitors|mesh-ancestor
6207649|NCT02118597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6207650|NCT02118714|Atrasentan|atrasentan|mesh-list
6207651|NCT02118714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6207652|NCT02118714|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
6207653|NCT02118714|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6207654|NCT02118714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207655|NCT02118831|Bevacizumab|bevacizumab|mesh-list
6207656|NCT02118831|Ranibizumab|ranibizumab|mesh-list
6207657|NCT02118831|Aflibercept|aflibercept|mesh-list
6207658|NCT02118831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6207659|NCT02118831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6207660|NCT02118831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6207661|NCT02118831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5588559|NCT03792074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5588560|NCT03792074|Tubulin Modulators|tubulin modulators|mesh-ancestor
5588561|NCT03792074|Antimitotic Agents|antimitotic agents|mesh-ancestor
6207662|NCT02118831|Growth Substances|growth substances|mesh-ancestor
6207663|NCT02118831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588562|NCT03792074|Mitosis Modulators|mitosis modulators|mesh-ancestor
5725686|NCT03178656|Sorafenib|sorafenib|mesh-list
6200357|NCT02007863|Fludarabine|fludarabine|mesh-list
6200358|NCT02007863|Melphalan|melphalan|mesh-list
6200359|NCT02007863|Busulfan|busulfan|mesh-list
5588563|NCT03792074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5588564|NCT03792074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5588565|NCT03792074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5588566|NCT03792074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5588567|NCT03792074|Growth Substances|growth substances|mesh-ancestor
5588568|NCT03792074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588569|NCT03792074|Growth Inhibitors|growth inhibitors|mesh-ancestor
5588570|NCT03792113|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
5588571|NCT03792113|Hemostatics|hemostatics|mesh-ancestor
5588572|NCT03792113|Coagulants|coagulants|mesh-ancestor
5588573|NCT03791905|Leucovorin|leucovorin|mesh-list
5588574|NCT03791905|Paclitaxel|paclitaxel|mesh-list
5588575|NCT03791905|Fluorouracil|fluorouracil|mesh-list
5588576|NCT03791905|Oxaliplatin|oxaliplatin|mesh-list
5588577|NCT03791905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5588578|NCT03791905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5588579|NCT03791905|Tubulin Modulators|tubulin modulators|mesh-ancestor
5588580|NCT03791905|Antimitotic Agents|antimitotic agents|mesh-ancestor
5588581|NCT03791905|Mitosis Modulators|mitosis modulators|mesh-ancestor
5588582|NCT03791905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5588583|NCT03791905|Antimetabolites|antimetabolites|mesh-ancestor
5588584|NCT03791905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5588585|NCT03791905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5588586|NCT03791905|Immunologic Factors|immunologic factors|mesh-ancestor
5588587|NCT03791905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588588|NCT03791905|Antidotes|antidotes|mesh-ancestor
5588589|NCT03791905|Protective Agents|protective agents|mesh-ancestor
5588590|NCT03791905|Vitamin B Complex|vitamin b complex|mesh-ancestor
5588591|NCT03791905|Vitamins|vitamins|mesh-ancestor
5588592|NCT03791905|Micronutrients|micronutrients|mesh-ancestor
5588593|NCT03791918|Chlorotrianisene|chlorotrianisene|mesh-list
5588594|NCT03791918|Lenvatinib|lenvatinib|mesh-list
5588595|NCT03791918|Antibodies|antibodies|mesh-list
5588596|NCT03791918|Immunoglobulins|immunoglobulins|mesh-list
5588597|NCT03791918|Immunologic Factors|immunologic factors|mesh-ancestor
5588598|NCT03791918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588599|NCT03791918|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
5588600|NCT03791918|Estrogens|estrogens|mesh-ancestor
5588601|NCT03791918|Hormones|hormones|mesh-ancestor
6200360|NCT02007863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6200361|NCT02007863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200362|NCT02007863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6200363|NCT02007863|Immunologic Factors|immunologic factors|mesh-ancestor
6200364|NCT02007863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200365|NCT02007863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6200366|NCT02007863|Alkylating Agents|alkylating agents|mesh-ancestor
6200367|NCT02007863|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6200368|NCT02008227|Docetaxel|docetaxel|mesh-list
6200369|NCT02008227|Atezolizumab|atezolizumab|mesh-list
6200370|NCT02008227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6200371|NCT02008227|Tubulin Modulators|tubulin modulators|mesh-ancestor
6200372|NCT02008227|Antimitotic Agents|antimitotic agents|mesh-ancestor
6200373|NCT02008227|Mitosis Modulators|mitosis modulators|mesh-ancestor
6200374|NCT02008227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200375|NCT02008565|Loperamide|loperamide|mesh-list
6200376|NCT02008565|Antidiarrheals|antidiarrheals|mesh-list
6200377|NCT02008565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6200378|NCT02008617|Bupivacaine|bupivacaine|mesh-list
6200379|NCT02008617|Anesthetics, Local|anesthetics, local|mesh-ancestor
6200380|NCT02008617|Anesthetics|anesthetics|mesh-ancestor
6200381|NCT02008617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6200382|NCT02008617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200383|NCT02008617|Sensory System Agents|sensory system agents|mesh-ancestor
6200384|NCT02008617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6200385|NCT02008682|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6200386|NCT02008682|Liraglutide|liraglutide|mesh-list
6200387|NCT02008682|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6200388|NCT02008682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200389|NCT02008682|Incretins|incretins|mesh-ancestor
6200390|NCT02008682|Hormones|hormones|mesh-ancestor
6200391|NCT02008682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5588602|NCT03791918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5588603|NCT03791918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6200392|NCT02008682|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6200393|NCT02008682|Protease Inhibitors|protease inhibitors|mesh-ancestor
6200394|NCT02008682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6200395|NCT02008682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200396|NCT02008773|Valacyclovir|valacyclovir|mesh-list
6200397|NCT02008773|Antiviral Agents|antiviral agents|mesh-ancestor
6200398|NCT02008773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6200399|NCT02008877|Sirolimus|sirolimus|mesh-list
6200400|NCT02008877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6200401|NCT02008877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6200402|NCT02008877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6200403|NCT02008877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6200404|NCT02008877|Antifungal Agents|antifungal agents|mesh-ancestor
6200405|NCT02008877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6200406|NCT02008877|Immunologic Factors|immunologic factors|mesh-ancestor
6200407|NCT02008877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200408|NCT02008890|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6200409|NCT02008890|Immunologic Factors|immunologic factors|mesh-ancestor
6200410|NCT02008890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200411|NCT02008916|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6200412|NCT02008916|Immunologic Factors|immunologic factors|mesh-ancestor
6200413|NCT02008916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200414|NCT02008942|Aspirin|aspirin|mesh-list
6200415|NCT02008942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6200416|NCT02008942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6200417|NCT02008942|Analgesics|analgesics|mesh-ancestor
6200418|NCT02008942|Sensory System Agents|sensory system agents|mesh-ancestor
6200419|NCT02008942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6200420|NCT02008942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200421|NCT02008942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6200422|NCT02008942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6200423|NCT02008942|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6200424|NCT02008942|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6200425|NCT02008942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200426|NCT02008942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6200427|NCT02008942|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6200428|NCT02008942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6200429|NCT02008942|Antipyretics|antipyretics|mesh-ancestor
6200430|NCT02009163|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6200431|NCT02009163|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6200432|NCT02009163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200433|NCT02009163|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5588604|NCT03791918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5588605|NCT03791918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5588606|NCT03791918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5588607|NCT03791918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5588608|NCT03791814|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
5588609|NCT03791814|Antiviral Agents|antiviral agents|mesh-ancestor
5588610|NCT03791814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5588611|NCT03791801|Glycopyrrolate|glycopyrrolate|mesh-list
6200434|NCT02009163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6200435|NCT02009163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6200436|NCT02009163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200437|NCT02009163|Dopamine Agents|dopamine agents|mesh-ancestor
6200438|NCT02009163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6200439|NCT02009332|Gemcitabine|gemcitabine|mesh-list
6200440|NCT02009332|Sirolimus|sirolimus|mesh-list
6200441|NCT02009332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6200442|NCT02009332|Antimetabolites|antimetabolites|mesh-ancestor
6200443|NCT02009332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200444|NCT02009332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6200445|NCT02009332|Antiviral Agents|antiviral agents|mesh-ancestor
6200446|NCT02009332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6200447|NCT02009332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6200448|NCT02009332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6200449|NCT02009332|Immunologic Factors|immunologic factors|mesh-ancestor
6200450|NCT02009332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200451|NCT02009332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6200452|NCT02009332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6200453|NCT02009332|Antifungal Agents|antifungal agents|mesh-ancestor
6200454|NCT02009397|Ipilimumab|ipilimumab|mesh-list
6200455|NCT02009397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6200456|NCT02009397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6200457|NCT02009397|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6200458|NCT02009397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200459|NCT02009722|Morphine|morphine|mesh-list
6200460|NCT02009722|Hydromorphone|hydromorphone|mesh-list
6200461|NCT02009722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6200462|NCT02009722|Narcotics|narcotics|mesh-ancestor
6200463|NCT02009722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6200464|NCT02009722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200465|NCT02009722|Analgesics|analgesics|mesh-ancestor
6200466|NCT02009722|Sensory System Agents|sensory system agents|mesh-ancestor
6200467|NCT02009722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6200468|NCT02009878|Tolvaptan|tolvaptan|mesh-list
6200469|NCT02009878|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
5588612|NCT03791801|Rocuronium|rocuronium|mesh-list
5588613|NCT03791801|Neostigmine|neostigmine|mesh-list
5588614|NCT03791801|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5588615|NCT03791801|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5588616|NCT03791801|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5588617|NCT03791801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5588618|NCT03791801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588619|NCT03791801|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5588620|NCT03791801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5588621|NCT03791801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5588622|NCT03791801|Cholinergic Agents|cholinergic agents|mesh-ancestor
5588623|NCT03791801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5588624|NCT03791801|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6200470|NCT02009878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200471|NCT02009878|Natriuretic Agents|natriuretic agents|mesh-ancestor
6200472|NCT02009878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200473|NCT02010021|Letrozole|letrozole|mesh-list
6200474|NCT02010021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6200475|NCT02010021|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6200476|NCT02010021|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6200477|NCT02010021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6200478|NCT02010021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200479|NCT02010021|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6200480|NCT02010021|Hormone Antagonists|hormone antagonists|mesh-ancestor
6200481|NCT02010021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6200482|NCT02010021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200483|NCT02010203|BCG Vaccine|bcg vaccine|mesh-list
6200484|NCT02010203|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6200485|NCT02010203|Immunologic Factors|immunologic factors|mesh-ancestor
6200486|NCT02010203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588625|NCT03791801|Autonomic Agents|autonomic agents|mesh-ancestor
5588626|NCT03791801|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5588627|NCT03791801|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5588628|NCT03791801|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5588629|NCT03791775|Polidocanol|polidocanol|mesh-list
5588630|NCT03791775|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
5588631|NCT03791775|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5588632|NCT03791827|Cyclosporine|cyclosporine|mesh-list
5588633|NCT03791827|Mycophenolic Acid|mycophenolic acid|mesh-list
5588634|NCT03791827|Hydroxychloroquine|hydroxychloroquine|mesh-list
5588635|NCT03791827|Prednisone|prednisone|mesh-list
5588636|NCT03791827|Prednisolone|prednisolone|mesh-list
5588637|NCT03791827|Cyclophosphamide|cyclophosphamide|mesh-list
5588638|NCT03791827|Rituximab|rituximab|mesh-list
5588639|NCT03791827|Azathioprine|azathioprine|mesh-list
5588640|NCT03791827|Tacrolimus|tacrolimus|mesh-list
5588641|NCT03791827|Cyclosporins|cyclosporins|mesh-list
5588642|NCT03791827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5588643|NCT03791827|Immunologic Factors|immunologic factors|mesh-ancestor
5588644|NCT03791827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200487|NCT02010255|Sofosbuvir|sofosbuvir|mesh-list
6200488|NCT02010255|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
6200489|NCT02010255|Ledipasvir|ledipasvir|mesh-list
6672307|NCT01555190|Vitamin B Complex|vitamin b complex|mesh-ancestor
6672308|NCT01555190|Vitamins|vitamins|mesh-ancestor
6672309|NCT01555190|Micronutrients|micronutrients|mesh-ancestor
6672310|NCT01555190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672311|NCT01555216|Ropivacaine|ropivacaine|mesh-list
6672312|NCT01555216|Anesthetics, Local|anesthetics, local|mesh-ancestor
6200490|NCT02010255|Antiviral Agents|antiviral agents|mesh-ancestor
6200491|NCT02010255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6200492|NCT02010567|Capecitabine|capecitabine|mesh-list
5588645|NCT03791827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6672313|NCT01555216|Anesthetics|anesthetics|mesh-ancestor
5588646|NCT03791827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5588647|NCT03791827|Alkylating Agents|alkylating agents|mesh-ancestor
5588648|NCT03791827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200493|NCT02010567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6200494|NCT02010567|Antimetabolites|antimetabolites|mesh-ancestor
6200495|NCT02010567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200496|NCT02010567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6200497|NCT02010632|Clopidogrel|clopidogrel|mesh-list
6200498|NCT02010632|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6200499|NCT02010632|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6200500|NCT02010632|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6200501|NCT02010632|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6200502|NCT02010632|Purinergic Agents|purinergic agents|mesh-ancestor
6200503|NCT02010632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6200504|NCT02010632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200505|NCT02010632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200506|NCT02010645|Decitabine|decitabine|mesh-list
5588649|NCT03791827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5588650|NCT03791827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5588651|NCT03791827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5588652|NCT03791827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5588653|NCT03791827|Glucocorticoids|glucocorticoids|mesh-ancestor
5588654|NCT03791827|Hormones|hormones|mesh-ancestor
5588655|NCT03791827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5588656|NCT03791827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5588657|NCT03791827|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5588658|NCT03791827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6200507|NCT02010645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6200508|NCT02010645|Antimetabolites|antimetabolites|mesh-ancestor
6200509|NCT02010645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200510|NCT02010645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6200511|NCT02010645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6200512|NCT02010775|Botulinum Toxins|botulinum toxins|mesh-list
6200513|NCT02010775|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6200514|NCT02010775|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6200515|NCT02010775|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6200516|NCT02010775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6200517|NCT02010775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200518|NCT02010775|Cholinergic Agents|cholinergic agents|mesh-ancestor
6200519|NCT02010775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6200520|NCT02010775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200521|NCT02010775|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6200522|NCT02010775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6200523|NCT02011113|Dexamethasone|dexamethasone|mesh-list
5588659|NCT03791827|Antifungal Agents|antifungal agents|mesh-ancestor
5588660|NCT03791827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5588661|NCT03791827|Dermatologic Agents|dermatologic agents|mesh-ancestor
5588662|NCT03791827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5588663|NCT03791827|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5588664|NCT03791827|Antitubercular Agents|antitubercular agents|mesh-ancestor
5588665|NCT03791827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5588666|NCT03791827|Antimalarials|antimalarials|mesh-ancestor
5588667|NCT03791827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5588668|NCT03791827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5588669|NCT03791827|Antimetabolites|antimetabolites|mesh-ancestor
5588670|NCT03791827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5588671|NCT03791736|Octreotide|octreotide|mesh-list
5588672|NCT03791736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5588673|NCT03791736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5588674|NCT03791736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5588675|NCT03791762|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
5588676|NCT03791762|Vasodilator Agents|vasodilator agents|mesh-ancestor
5588677|NCT03791762|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
5588678|NCT03791762|Protective Agents|protective agents|mesh-ancestor
5588679|NCT03791762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588680|NCT03791723|Valsartan|valsartan|mesh-list
5588681|NCT03791723|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5588682|NCT03791723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6200524|NCT02011113|Pomalidomide|pomalidomide|mesh-list
6200525|NCT02011113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6200526|NCT02011113|Antiemetics|antiemetics|mesh-ancestor
6200527|NCT02011113|Autonomic Agents|autonomic agents|mesh-ancestor
6200528|NCT02011113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6200529|NCT02011113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200530|NCT02011113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6200531|NCT02011113|Glucocorticoids|glucocorticoids|mesh-ancestor
6200532|NCT02011113|Hormones|hormones|mesh-ancestor
6200533|NCT02011113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6200534|NCT02011113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6200535|NCT02011113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6200536|NCT02011113|Immunologic Factors|immunologic factors|mesh-ancestor
6200537|NCT02011113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6200538|NCT02011113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6200539|NCT02011113|Growth Substances|growth substances|mesh-ancestor
6200540|NCT02011113|Growth Inhibitors|growth inhibitors|mesh-ancestor
6200541|NCT02011386|Golimumab|golimumab|mesh-list
6200542|NCT02011386|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6200543|NCT02011386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6200544|NCT02011386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6200545|NCT02011386|Immunologic Factors|immunologic factors|mesh-ancestor
6200546|NCT02011386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200547|NCT02011464|Bupivacaine|bupivacaine|mesh-list
6200548|NCT02011464|Anesthetics, Local|anesthetics, local|mesh-ancestor
6200549|NCT02011464|Anesthetics|anesthetics|mesh-ancestor
6200550|NCT02011464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6200551|NCT02011464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200552|NCT02011464|Sensory System Agents|sensory system agents|mesh-ancestor
6200553|NCT02011464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6200554|NCT02011516|Baclofen|baclofen|mesh-list
6200555|NCT02011516|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6200556|NCT02011516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200557|NCT02011516|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6200558|NCT02011516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6200559|NCT02011516|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6200560|NCT02011516|GABA Agonists|gaba agonists|mesh-ancestor
6200561|NCT02011516|GABA Agents|gaba agents|mesh-ancestor
6200562|NCT02011516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6200563|NCT02011516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200564|NCT02011945|Nivolumab|nivolumab|mesh-list
6200565|NCT02011945|Dasatinib|dasatinib|mesh-list
6200566|NCT02011945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6200567|NCT02011945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6200568|NCT02011945|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6200569|NCT02011945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200570|NCT02011945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6200571|NCT02011945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6200572|NCT02012192|Paclitaxel|paclitaxel|mesh-list
6200573|NCT02012192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6200574|NCT02012192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6200575|NCT02012192|Tubulin Modulators|tubulin modulators|mesh-ancestor
6200576|NCT02012192|Antimitotic Agents|antimitotic agents|mesh-ancestor
6200577|NCT02012192|Mitosis Modulators|mitosis modulators|mesh-ancestor
6200578|NCT02012192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200579|NCT02012218|Brexpiprazole|brexpiprazole|mesh-list
6200580|NCT02012218|Serotonin Agents|serotonin agents|mesh-ancestor
6200581|NCT02012218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6200582|NCT02012218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200583|NCT02012218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200584|NCT02012218|Dopamine Agonists|dopamine agonists|mesh-ancestor
6200585|NCT02012218|Dopamine Agents|dopamine agents|mesh-ancestor
6200586|NCT02012348|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6200587|NCT02012348|Benzalkonium Compounds|benzalkonium compounds|mesh-list
6200588|NCT02012348|Triclocarban|triclocarban|mesh-list
6200589|NCT02012348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6200590|NCT02012348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6200591|NCT02012491|Misoprostol|misoprostol|mesh-list
6200592|NCT02012491|Mifepristone|mifepristone|mesh-list
6200593|NCT02012491|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6200594|NCT02012491|Abortifacient Agents|abortifacient agents|mesh-ancestor
6200595|NCT02012491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6200596|NCT02012491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200597|NCT02012491|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6200598|NCT02012491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6200599|NCT02012491|Oxytocics|oxytocics|mesh-ancestor
6200600|NCT02012491|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6200601|NCT02012491|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6200602|NCT02012491|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6200603|NCT02012491|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6200604|NCT02012491|Contraceptive Agents|contraceptive agents|mesh-ancestor
6200605|NCT02012491|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6207664|NCT02118831|Growth Inhibitors|growth inhibitors|mesh-ancestor
6200606|NCT02012491|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6200607|NCT02012491|Hormone Antagonists|hormone antagonists|mesh-ancestor
6200608|NCT02012491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6200609|NCT02012491|Luteolytic Agents|luteolytic agents|mesh-ancestor
6200610|NCT02012491|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6200611|NCT02012491|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6200612|NCT02012959|Tolvaptan|tolvaptan|mesh-list
5588683|NCT03791723|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5588684|NCT03791723|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5588685|NCT03791723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5588686|NCT03791515|Calcitonin|calcitonin|mesh-list
5588687|NCT03791515|Salmon calcitonin|salmon calcitonin|mesh-list
5588688|NCT03791515|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
5588689|NCT03791515|Katacalcin|katacalcin|mesh-list
6200613|NCT02012959|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6200614|NCT02012959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200615|NCT02012959|Natriuretic Agents|natriuretic agents|mesh-ancestor
6200616|NCT02012959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200617|NCT02013037|Eculizumab|eculizumab|mesh-list
6200618|NCT02013037|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6200619|NCT02013037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6200620|NCT02013037|Immunologic Factors|immunologic factors|mesh-ancestor
6200621|NCT02013037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200622|NCT02013206|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6200623|NCT02013206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6200624|NCT02013206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6200625|NCT02013206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5588690|NCT03791515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5588691|NCT03791515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588692|NCT03791515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5588693|NCT03791515|Vasodilator Agents|vasodilator agents|mesh-ancestor
5588694|NCT03791463|Salvianolic acid A|salvianolic acid a|mesh-list
5588695|NCT03791463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5588696|NCT03791463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5588697|NCT03791463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5588698|NCT03791463|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5588699|NCT03791398|Nivolumab|nivolumab|mesh-list
5588700|NCT03791398|TIC10 compound|tic10 compound|mesh-list
5588701|NCT03791398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5588702|NCT03791398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5588703|NCT03791398|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5588704|NCT03791398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5588705|NCT03791424|Midazolam|midazolam|mesh-list
6200626|NCT02013206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200627|NCT02013245|Vaccines|vaccines|mesh-list
6200628|NCT02013245|Immunoglobulins|immunoglobulins|mesh-list
6200629|NCT02013245|Immunologic Factors|immunologic factors|mesh-ancestor
6200630|NCT02013245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200631|NCT02013375|Sirolimus|sirolimus|mesh-list
6200632|NCT02013375|Cyclophosphamide|cyclophosphamide|mesh-list
6200633|NCT02013375|Alemtuzumab|alemtuzumab|mesh-list
6200634|NCT02013375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6200635|NCT02013375|Immunologic Factors|immunologic factors|mesh-ancestor
6200636|NCT02013375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200637|NCT02013375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6200638|NCT02013375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6200639|NCT02013375|Alkylating Agents|alkylating agents|mesh-ancestor
6200640|NCT02013375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200641|NCT02013375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6200642|NCT02013375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6200643|NCT02013375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6200644|NCT02013375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6200645|NCT02013375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6200646|NCT02013375|Antifungal Agents|antifungal agents|mesh-ancestor
6200647|NCT02013375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6200648|NCT02013531|Brexpiprazole|brexpiprazole|mesh-list
6200649|NCT02013531|Serotonin Agents|serotonin agents|mesh-ancestor
6200650|NCT02013531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6200651|NCT02013531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200652|NCT02013531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200653|NCT02013531|Dopamine Agonists|dopamine agonists|mesh-ancestor
6200654|NCT02013531|Dopamine Agents|dopamine agents|mesh-ancestor
6200655|NCT02013544|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
5588706|NCT03791424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5588707|NCT03791424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5588708|NCT03791424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5588709|NCT03791424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588710|NCT03791424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5588711|NCT03791424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5588712|NCT03791424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5588713|NCT03791424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5588714|NCT03791424|Anesthetics, General|anesthetics, general|mesh-ancestor
5588715|NCT03791424|Anesthetics|anesthetics|mesh-ancestor
5588716|NCT03791424|GABA Modulators|gaba modulators|mesh-ancestor
5588717|NCT03791424|GABA Agents|gaba agents|mesh-ancestor
5588718|NCT03791424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5588719|NCT03791424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5588720|NCT03791294|Titanium dioxide|titanium dioxide|mesh-list
5588721|NCT03791294|Hyaluronic Acid|hyaluronic acid|mesh-list
5588722|NCT03791294|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5588723|NCT03791294|Immunologic Factors|immunologic factors|mesh-ancestor
5588724|NCT03791294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588725|NCT03791294|Viscosupplements|viscosupplements|mesh-ancestor
5588726|NCT03791294|Protective Agents|protective agents|mesh-ancestor
5588727|NCT03791294|Sunscreening Agents|sunscreening agents|mesh-ancestor
5588728|NCT03791294|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5588729|NCT03791294|Dermatologic Agents|dermatologic agents|mesh-ancestor
5588730|NCT03791294|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5588731|NCT03791099|Metronidazole|metronidazole|mesh-list
5588732|NCT03791099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5588733|NCT03791099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5588734|NCT03791099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5588735|NCT03791099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5588736|NCT03791255|Calcium, Dietary|calcium, dietary|mesh-list
5588737|NCT03791255|Calcium|calcium|mesh-list
5588738|NCT03791255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5588739|NCT03791255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588740|NCT03791255|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5588741|NCT03790839|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5588742|NCT03790839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6200656|NCT02013544|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6200657|NCT02013544|Immunologic Factors|immunologic factors|mesh-ancestor
6200658|NCT02013544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200659|NCT02013609|Brexpiprazole|brexpiprazole|mesh-list
6200660|NCT02013609|Serotonin Agents|serotonin agents|mesh-ancestor
6200661|NCT02013609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6200662|NCT02013609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200663|NCT02013609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200664|NCT02013609|Dopamine Agonists|dopamine agonists|mesh-ancestor
6200665|NCT02013609|Dopamine Agents|dopamine agents|mesh-ancestor
6200666|NCT02013622|Brexpiprazole|brexpiprazole|mesh-list
6200667|NCT02013622|Serotonin Agents|serotonin agents|mesh-ancestor
6200668|NCT02013622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6200669|NCT02013622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200670|NCT02013622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200671|NCT02013622|Dopamine Agonists|dopamine agonists|mesh-ancestor
6200672|NCT02013622|Dopamine Agents|dopamine agents|mesh-ancestor
6200673|NCT02013674|Remestemcel-l|remestemcel-l|mesh-list
6200674|NCT02013674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6200675|NCT02013674|Antiviral Agents|antiviral agents|mesh-ancestor
6200676|NCT02013674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5588743|NCT03790839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588744|NCT03790839|Incretins|incretins|mesh-ancestor
5588745|NCT03790839|Hormones|hormones|mesh-ancestor
6200677|NCT02013765|Trastuzumab|trastuzumab|mesh-list
6200678|NCT02013765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6200679|NCT02013765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6200680|NCT02013791|Cyclosporine|cyclosporine|mesh-list
6200681|NCT02013791|Cyclosporins|cyclosporins|mesh-list
6200682|NCT02013791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6200683|NCT02013791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200684|NCT02013791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6200685|NCT02013791|Immunologic Factors|immunologic factors|mesh-ancestor
6200686|NCT02013791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200687|NCT02013791|Antifungal Agents|antifungal agents|mesh-ancestor
6200688|NCT02013791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5588746|NCT03790839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5588747|NCT03790839|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5588748|NCT03790839|Protease Inhibitors|protease inhibitors|mesh-ancestor
6200689|NCT02013791|Dermatologic Agents|dermatologic agents|mesh-ancestor
6200690|NCT02013791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6200691|NCT02013791|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6200692|NCT02013817|Cyclophosphamide|cyclophosphamide|mesh-list
6200693|NCT02013817|Rituximab|rituximab|mesh-list
6200694|NCT02013817|Fludarabine|fludarabine|mesh-list
6200695|NCT02013817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6200696|NCT02013817|Immunologic Factors|immunologic factors|mesh-ancestor
6200697|NCT02013817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200698|NCT02013817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6200699|NCT02013817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6200700|NCT02013817|Alkylating Agents|alkylating agents|mesh-ancestor
6200701|NCT02013817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200702|NCT02013817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6200703|NCT02013817|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6200704|NCT02013817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6200705|NCT02013830|Bevacizumab|bevacizumab|mesh-list
6200706|NCT02013830|Capecitabine|capecitabine|mesh-list
6200707|NCT02013830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6200708|NCT02013830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6200709|NCT02013830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6200710|NCT02013830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6200711|NCT02013830|Growth Substances|growth substances|mesh-ancestor
6200712|NCT02013830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200713|NCT02013830|Growth Inhibitors|growth inhibitors|mesh-ancestor
6200714|NCT02013830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6200715|NCT02013830|Antimetabolites|antimetabolites|mesh-ancestor
6200716|NCT02013830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200717|NCT02014363|Amitriptyline|amitriptyline|mesh-list
6200718|NCT02014363|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6200719|NCT02014363|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6200720|NCT02014363|Antidepressive Agents|antidepressive agents|mesh-ancestor
6200721|NCT02014363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6200722|NCT02014363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6200723|NCT02014363|Analgesics|analgesics|mesh-ancestor
6200724|NCT02014363|Sensory System Agents|sensory system agents|mesh-ancestor
6200725|NCT02014363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6200726|NCT02014363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200727|NCT02014363|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6200728|NCT02014363|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6200729|NCT02014363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6200730|NCT02014363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200731|NCT02014363|Adrenergic Agents|adrenergic agents|mesh-ancestor
6200732|NCT02014363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6200733|NCT02014363|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6200734|NCT02014363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6200735|NCT02014363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6200736|NCT02014402|Thrombin|thrombin|mesh-list
6200737|NCT02014402|Hemostatics|hemostatics|mesh-ancestor
6200738|NCT02014402|Coagulants|coagulants|mesh-ancestor
6200739|NCT02014441|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
5588749|NCT03790839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5588750|NCT03790839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605364|NCT02903381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5605365|NCT02903381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5605366|NCT02903381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605367|NCT02903381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5605368|NCT02903381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5605369|NCT02903381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605370|NCT02903381|Immunologic Factors|immunologic factors|mesh-ancestor
5605371|NCT02903381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5605372|NCT02903381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5605373|NCT02903381|Growth Substances|growth substances|mesh-ancestor
5605374|NCT02903381|Growth Inhibitors|growth inhibitors|mesh-ancestor
5605375|NCT02866279|Contraceptive Agents|contraceptive agents|mesh-list
5605376|NCT02866279|Etonogestrel|etonogestrel|mesh-list
5605377|NCT02866279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6200740|NCT02014441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6200741|NCT02014441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6200742|NCT02014467|Vitamin D|vitamin d|mesh-list
6200743|NCT02014467|Denosumab|denosumab|mesh-list
6200744|NCT02014467|Calcium|calcium|mesh-list
6200745|NCT02014467|Vitamins|vitamins|mesh-ancestor
6200746|NCT02014467|Micronutrients|micronutrients|mesh-ancestor
6200747|NCT02014467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200748|NCT02014467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6200749|NCT02014467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6200750|NCT02014584|Dutasteride|dutasteride|mesh-list
6200751|NCT02014584|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6200752|NCT02014584|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5588751|NCT03791125|Salvianolic acid A|salvianolic acid a|mesh-list
5588752|NCT03791125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5588753|NCT03791125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6200753|NCT02014584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6200754|NCT02014584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200755|NCT02014584|Hormone Antagonists|hormone antagonists|mesh-ancestor
6200756|NCT02014584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6200757|NCT02014584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200758|NCT02014740|Metformin|metformin|mesh-list
6200759|NCT02014740|Liraglutide|liraglutide|mesh-list
6200760|NCT02014740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6200761|NCT02014740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200762|NCT02014740|Incretins|incretins|mesh-ancestor
6200763|NCT02014740|Hormones|hormones|mesh-ancestor
6200764|NCT02014740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6200765|NCT02015104|BCG Vaccine|bcg vaccine|mesh-list
6200766|NCT02015104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6200767|NCT02015104|Immunologic Factors|immunologic factors|mesh-ancestor
6200768|NCT02015104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588754|NCT03791125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5588755|NCT03791125|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5588756|NCT03790800|Urapidil|urapidil|mesh-list
5588757|NCT03790800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5588758|NCT03790800|Vasodilator Agents|vasodilator agents|mesh-ancestor
5588759|NCT03790800|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5588760|NCT03790800|Serotonin Agents|serotonin agents|mesh-ancestor
5588761|NCT03790800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5588762|NCT03790800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5588763|NCT03790800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588764|NCT03790800|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5588765|NCT03790800|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5588766|NCT03790800|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5588767|NCT03790800|Adrenergic Agents|adrenergic agents|mesh-ancestor
6200769|NCT02015195|Ethanol|ethanol|mesh-list
6200770|NCT02015195|Acetic Acid|acetic acid|mesh-list
6200771|NCT02015195|Retinol acetate|retinol acetate|mesh-list
6200772|NCT02015195|Lidocaine|lidocaine|mesh-list
6200773|NCT02015195|Anesthetics, Local|anesthetics, local|mesh-ancestor
6200774|NCT02015195|Anesthetics|anesthetics|mesh-ancestor
6200775|NCT02015195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6200776|NCT02015195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200777|NCT02015195|Sensory System Agents|sensory system agents|mesh-ancestor
6488317|NCT00583180|Antipruritics|antipruritics|mesh-ancestor
6488318|NCT00583180|Dermatologic Agents|dermatologic agents|mesh-ancestor
6488319|NCT00583180|Sensory System Agents|sensory system agents|mesh-ancestor
6488320|NCT00583180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6488321|NCT00583180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488322|NCT00583193|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6488323|NCT00583193|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5588768|NCT03790787|Empagliflozin|empagliflozin|mesh-list
5588769|NCT03790787|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5588770|NCT03790787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5588771|NCT03790787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5588772|NCT03790787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588773|NCT03790670|Sargramostim|sargramostim|mesh-list
5588774|NCT03790670|Immunologic Factors|immunologic factors|mesh-ancestor
5588775|NCT03790670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588776|NCT03790540|Benzocaine|benzocaine|mesh-list
5588777|NCT03790540|Anesthetics, Local|anesthetics, local|mesh-ancestor
5588778|NCT03790540|Anesthetics|anesthetics|mesh-ancestor
5588779|NCT03790540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5588780|NCT03790540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588781|NCT03790540|Sensory System Agents|sensory system agents|mesh-ancestor
6200778|NCT02015195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6200779|NCT02015195|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6200780|NCT02015195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6200781|NCT02015195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6672314|NCT01555216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5588782|NCT03790540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5588783|NCT03790605|Curcumin|curcumin|mesh-list
5588784|NCT03790605|Iproplatin|iproplatin|mesh-list
5588785|NCT03790605|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5588786|NCT03790605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5588787|NCT03790605|Analgesics|analgesics|mesh-ancestor
5588788|NCT03790605|Sensory System Agents|sensory system agents|mesh-ancestor
6672315|NCT01555216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672316|NCT01555216|Sensory System Agents|sensory system agents|mesh-ancestor
6672317|NCT01555216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6672318|NCT01555268|Cytarabine|cytarabine|mesh-list
6672319|NCT01555268|Trebananib|trebananib|mesh-list
6672320|NCT01555268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5588789|NCT03790605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5588790|NCT03790605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588791|NCT03790605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5588792|NCT03790605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6672321|NCT01555268|Antimetabolites|antimetabolites|mesh-ancestor
6672322|NCT01555268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672323|NCT01555268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6672324|NCT01555268|Antiviral Agents|antiviral agents|mesh-ancestor
6672325|NCT01555268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6672326|NCT01555268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6672327|NCT01555268|Immunologic Factors|immunologic factors|mesh-ancestor
6200782|NCT02015195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6200783|NCT02015195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200784|NCT02015195|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6200785|NCT02015195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6200786|NCT02015195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6200787|NCT02015195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6200788|NCT02015195|Immunologic Factors|immunologic factors|mesh-ancestor
6200789|NCT02015195|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6200790|NCT02015195|Protective Agents|protective agents|mesh-ancestor
6200791|NCT02015195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6200792|NCT02015234|Cyclobenzaprine|cyclobenzaprine|mesh-list
6200793|NCT02015234|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5588793|NCT03790605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5588794|NCT03790605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5588795|NCT03790605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5588796|NCT03790345|Vitamins|vitamins|mesh-list
5588797|NCT03790345|Vitamin B 12|vitamin b 12|mesh-list
5588798|NCT03790345|Pyridoxine|pyridoxine|mesh-list
5588799|NCT03790345|Vitamin B 6|vitamin b 6|mesh-list
5588800|NCT03790345|Vitamin B Complex|vitamin b complex|mesh-list
5588801|NCT03790345|Micronutrients|micronutrients|mesh-ancestor
5588802|NCT03790345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588803|NCT03790618|Methamphetamine|methamphetamine|mesh-list
5588804|NCT03790618|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
5588805|NCT03790618|Hallucinogens|hallucinogens|mesh-ancestor
5588806|NCT03790618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588807|NCT03790618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5588808|NCT03790618|Serotonin Agents|serotonin agents|mesh-ancestor
5588809|NCT03790618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5588810|NCT03790618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5588811|NCT03790618|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5588812|NCT03790618|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5588813|NCT03790618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5588814|NCT03790618|Adrenergic Agents|adrenergic agents|mesh-ancestor
5588815|NCT03790618|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5588816|NCT03790618|Sympathomimetics|sympathomimetics|mesh-ancestor
5588817|NCT03790618|Autonomic Agents|autonomic agents|mesh-ancestor
5588818|NCT03790618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5588819|NCT03790618|Dopamine Agents|dopamine agents|mesh-ancestor
6200794|NCT02015234|Antidepressive Agents|antidepressive agents|mesh-ancestor
6200795|NCT02015234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6200796|NCT02015234|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6200797|NCT02015234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200798|NCT02015234|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6200799|NCT02015234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6200800|NCT02015234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6200801|NCT02015234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6200802|NCT02015546|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
6200803|NCT02015546|Antidepressive Agents|antidepressive agents|mesh-ancestor
6200804|NCT02015546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6200805|NCT02015546|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6200806|NCT02015546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6200807|NCT02015546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6200808|NCT02015546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200809|NCT02015546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6200810|NCT02015546|Serotonin Agents|serotonin agents|mesh-ancestor
5588820|NCT03790618|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5588821|NCT03790566|Bupivacaine|bupivacaine|mesh-list
5588822|NCT03790566|Anesthetics, Local|anesthetics, local|mesh-ancestor
5588823|NCT03790566|Anesthetics|anesthetics|mesh-ancestor
5588824|NCT03790566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5588825|NCT03790566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200811|NCT02015546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200812|NCT02015546|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6200813|NCT02015546|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6200814|NCT02015637|Ceftriaxone|ceftriaxone|mesh-list
6200815|NCT02015637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6200816|NCT02015637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6200817|NCT02015676|Paclitaxel|paclitaxel|mesh-list
6200818|NCT02015676|Trastuzumab|trastuzumab|mesh-list
6200819|NCT02015676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6200820|NCT02015676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6200821|NCT02015676|Tubulin Modulators|tubulin modulators|mesh-ancestor
6200822|NCT02015676|Antimitotic Agents|antimitotic agents|mesh-ancestor
6200823|NCT02015676|Mitosis Modulators|mitosis modulators|mesh-ancestor
5588826|NCT03790566|Sensory System Agents|sensory system agents|mesh-ancestor
5588827|NCT03790566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5588828|NCT03790215|Dydrogesterone|dydrogesterone|mesh-list
5588829|NCT03790215|Progestins|progestins|mesh-ancestor
5588830|NCT03790215|Hormones|hormones|mesh-ancestor
5588831|NCT03790215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5588832|NCT03790215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588833|NCT03790228|Carboplatin|carboplatin|mesh-list
5588834|NCT03790228|Pemetrexed|pemetrexed|mesh-list
6200824|NCT02015676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200825|NCT02015676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6207665|NCT02118896|Tacrolimus|tacrolimus|mesh-list
6207666|NCT02118896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6207667|NCT02118896|Immunologic Factors|immunologic factors|mesh-ancestor
6207668|NCT02118896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207669|NCT02118896|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6207670|NCT02118896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6207671|NCT02118896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207672|NCT02118961|Vaccines|vaccines|mesh-list
6207673|NCT02118961|Immunologic Factors|immunologic factors|mesh-ancestor
6207674|NCT02118961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588835|NCT03790228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5588836|NCT03790228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5588837|NCT03790228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5588838|NCT03790228|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5588839|NCT03790228|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5588840|NCT03790371|Misoprostol|misoprostol|mesh-list
5588841|NCT03790371|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5588842|NCT03790371|Abortifacient Agents|abortifacient agents|mesh-ancestor
5588843|NCT03790371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6207675|NCT02119026|Bevacizumab|bevacizumab|mesh-list
6207676|NCT02119026|Capecitabine|capecitabine|mesh-list
6207677|NCT02119026|Oxaliplatin|oxaliplatin|mesh-list
6207678|NCT02119026|Irinotecan|irinotecan|mesh-list
6207679|NCT02119026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6207680|NCT02119026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6207681|NCT02119026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5588844|NCT03790371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200826|NCT02015793|Adalimumab|adalimumab|mesh-list
6200827|NCT02015793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6200828|NCT02015793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6200829|NCT02015819|Leucovorin|leucovorin|mesh-list
6200830|NCT02015819|Flucytosine|flucytosine|mesh-list
6200831|NCT02015819|Calcium|calcium|mesh-list
6200832|NCT02015819|Levoleucovorin|levoleucovorin|mesh-list
6200833|NCT02015819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6200834|NCT02015819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200835|NCT02015819|Antidotes|antidotes|mesh-ancestor
6200836|NCT02015819|Protective Agents|protective agents|mesh-ancestor
6200837|NCT02015819|Vitamin B Complex|vitamin b complex|mesh-ancestor
6200838|NCT02015819|Vitamins|vitamins|mesh-ancestor
6200839|NCT02015819|Micronutrients|micronutrients|mesh-ancestor
6200840|NCT02015819|Antifungal Agents|antifungal agents|mesh-ancestor
6200841|NCT02015819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6200842|NCT02015819|Antimetabolites|antimetabolites|mesh-ancestor
6200843|NCT02015819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200844|NCT02016105|Adalimumab|adalimumab|mesh-list
6200845|NCT02016105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6200846|NCT02016105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6200847|NCT02016170|Ticagrelor|ticagrelor|mesh-list
6200848|NCT02016170|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6200849|NCT02016170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5588845|NCT03790371|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5588846|NCT03790371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5588847|NCT03790371|Oxytocics|oxytocics|mesh-ancestor
5588848|NCT03790163|Levobupivacaine|levobupivacaine|mesh-list
5588849|NCT03790163|Anesthetics, Local|anesthetics, local|mesh-ancestor
5588850|NCT03790163|Anesthetics|anesthetics|mesh-ancestor
5588851|NCT03790163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5588852|NCT03790163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588853|NCT03790163|Sensory System Agents|sensory system agents|mesh-ancestor
6200850|NCT02016170|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6200851|NCT02016170|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6200852|NCT02016170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6200853|NCT02016170|Purinergic Agents|purinergic agents|mesh-ancestor
5588854|NCT03790163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5588855|NCT03790358|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
5588856|NCT03790358|Hallucinogens|hallucinogens|mesh-ancestor
5588857|NCT03790358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588858|NCT03790358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5588859|NCT03790358|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6200854|NCT02016170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6200855|NCT02016170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200856|NCT02016170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200857|NCT02016183|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6200858|NCT02016183|Candesartan|candesartan|mesh-list
6200859|NCT02016183|Candesartan cilexetil|candesartan cilexetil|mesh-list
6200860|NCT02016183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6200861|NCT02016183|Diuretics|diuretics|mesh-ancestor
6200862|NCT02016183|Natriuretic Agents|natriuretic agents|mesh-ancestor
6200863|NCT02016183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200864|NCT02016183|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6200865|NCT02016183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6200866|NCT02016183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200867|NCT02016183|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6200868|NCT02016183|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6200869|NCT02016482|Adalimumab|adalimumab|mesh-list
6200870|NCT02016482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6200871|NCT02016482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6200872|NCT02016625|Cyclosporine|cyclosporine|mesh-list
6200873|NCT02016625|Tacrolimus|tacrolimus|mesh-list
6200874|NCT02016625|Cyclosporins|cyclosporins|mesh-list
6200875|NCT02016625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6200876|NCT02016625|Immunologic Factors|immunologic factors|mesh-ancestor
6200877|NCT02016625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200878|NCT02016625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6200879|NCT02016625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6200880|NCT02016625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200881|NCT02016625|Antifungal Agents|antifungal agents|mesh-ancestor
6200882|NCT02016625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6200883|NCT02016625|Dermatologic Agents|dermatologic agents|mesh-ancestor
6200884|NCT02016625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6200885|NCT02016716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6200886|NCT02016716|Immunologic Factors|immunologic factors|mesh-ancestor
6200887|NCT02016716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588860|NCT03790358|Serotonin Agents|serotonin agents|mesh-ancestor
5588861|NCT03790358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5588862|NCT03790358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5588863|NCT03790358|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5588864|NCT03790488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
6200888|NCT02016885|Glycopyrrolate|glycopyrrolate|mesh-list
6200889|NCT02016885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6200890|NCT02016885|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6200891|NCT02016885|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6200892|NCT02016885|Cholinergic Agents|cholinergic agents|mesh-ancestor
6200893|NCT02016885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6200894|NCT02016885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200895|NCT02016885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588865|NCT03790488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5588866|NCT03790488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5588867|NCT03790384|Mitomycins|mitomycins|mesh-list
5588868|NCT03790384|Mitomycin|mitomycin|mesh-list
5588869|NCT03790384|BCG Vaccine|bcg vaccine|mesh-list
5588870|NCT03790384|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5588871|NCT03790384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5588872|NCT03790384|Alkylating Agents|alkylating agents|mesh-ancestor
5588873|NCT03790384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5588874|NCT03790384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6200896|NCT02016898|Mitomycins|mitomycins|mesh-list
6200897|NCT02016898|Mitomycin|mitomycin|mesh-list
6200898|NCT02016898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6200899|NCT02016898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6200900|NCT02016898|Alkylating Agents|alkylating agents|mesh-ancestor
6200901|NCT02016898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200902|NCT02016898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6200903|NCT02016898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6200904|NCT02017015|Gemcitabine|gemcitabine|mesh-list
6200905|NCT02017015|Paclitaxel|paclitaxel|mesh-list
6200906|NCT02017015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6200907|NCT02017015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6200908|NCT02017015|Tubulin Modulators|tubulin modulators|mesh-ancestor
5588875|NCT03790384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5588876|NCT03790384|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5588877|NCT03790384|Immunologic Factors|immunologic factors|mesh-ancestor
5588878|NCT03790384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588879|NCT03790397|Osimertinib|osimertinib|mesh-list
5588880|NCT03790397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5588881|NCT03790397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5588882|NCT03790397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5588883|NCT03790397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200909|NCT02017015|Antimitotic Agents|antimitotic agents|mesh-ancestor
6200910|NCT02017015|Mitosis Modulators|mitosis modulators|mesh-ancestor
6200911|NCT02017015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200912|NCT02017015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6200913|NCT02017015|Antimetabolites|antimetabolites|mesh-ancestor
6200914|NCT02017015|Antiviral Agents|antiviral agents|mesh-ancestor
5588884|NCT03790293|Rituximab|rituximab|mesh-list
5588885|NCT03790293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5588886|NCT03790293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5588887|NCT03790293|Immunologic Factors|immunologic factors|mesh-ancestor
5588888|NCT03790293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588889|NCT03790293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5588890|NCT03790020|Bupivacaine|bupivacaine|mesh-list
5588891|NCT03790020|Anesthetics, Local|anesthetics, local|mesh-ancestor
5588892|NCT03790020|Anesthetics|anesthetics|mesh-ancestor
5588893|NCT03790020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5588894|NCT03790020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588895|NCT03790020|Sensory System Agents|sensory system agents|mesh-ancestor
5588896|NCT03790020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5588897|NCT03790072|Cyclophosphamide|cyclophosphamide|mesh-list
5588898|NCT03790072|Fludarabine|fludarabine|mesh-list
5588899|NCT03790072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5588900|NCT03790072|Immunologic Factors|immunologic factors|mesh-ancestor
5588901|NCT03790072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588902|NCT03790072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5588903|NCT03790072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5588904|NCT03790072|Alkylating Agents|alkylating agents|mesh-ancestor
5588905|NCT03790072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5588906|NCT03790072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5588907|NCT03790072|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5588908|NCT03789890|Itraconazole|itraconazole|mesh-list
5588909|NCT03789890|Antifungal Agents|antifungal agents|mesh-ancestor
5588910|NCT03789890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5588911|NCT03789890|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5588912|NCT03789890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6200915|NCT02017015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6200916|NCT02017015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6200917|NCT02017015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6200918|NCT02017015|Immunologic Factors|immunologic factors|mesh-ancestor
6200919|NCT02017015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200920|NCT02017171|Allopurinol|allopurinol|mesh-list
6200921|NCT02017171|Antimetabolites|antimetabolites|mesh-ancestor
6200922|NCT02017171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5588913|NCT03789890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5588914|NCT03789890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5588915|NCT03789890|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5588916|NCT03789890|Hormone Antagonists|hormone antagonists|mesh-ancestor
5588917|NCT03789890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5588918|NCT03789890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588919|NCT03789890|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5588920|NCT03790085|Olanzapine|olanzapine|mesh-list
5588921|NCT03790085|Risperidone|risperidone|mesh-list
5588922|NCT03790085|Aripiprazole|aripiprazole|mesh-list
5588923|NCT03790085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5588924|NCT03790085|Serotonin Agents|serotonin agents|mesh-ancestor
5588925|NCT03790085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5588926|NCT03790085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5588927|NCT03790085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588928|NCT03790085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5588929|NCT03790085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5588930|NCT03790085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6200923|NCT02017171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6200924|NCT02017171|Gout Suppressants|gout suppressants|mesh-ancestor
6200925|NCT02017171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6200926|NCT02017171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6200927|NCT02017171|Antioxidants|antioxidants|mesh-ancestor
6200928|NCT02017171|Protective Agents|protective agents|mesh-ancestor
6200929|NCT02017171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588931|NCT03790085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5588932|NCT03790085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5588933|NCT03790085|Dopamine Agents|dopamine agents|mesh-ancestor
5588934|NCT03790085|Antiemetics|antiemetics|mesh-ancestor
5588935|NCT03790085|Autonomic Agents|autonomic agents|mesh-ancestor
5588936|NCT03790085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5588937|NCT03790085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5588938|NCT03790085|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5588939|NCT03790085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6200930|NCT02017327|Bimatoprost|bimatoprost|mesh-list
6200931|NCT02017327|Latanoprost|latanoprost|mesh-list
6200932|NCT02017327|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6200933|NCT02017327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6200934|NCT02017327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5588940|NCT03790085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5588941|NCT03790085|Antidepressive Agents|antidepressive agents|mesh-ancestor
5588942|NCT03790085|Dopamine Agonists|dopamine agonists|mesh-ancestor
5588943|NCT03790085|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5588944|NCT03790085|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5588945|NCT03790085|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5588946|NCT03790085|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5588947|NCT03789916|Aspirin|aspirin|mesh-list
5588948|NCT03789916|Ticagrelor|ticagrelor|mesh-list
5588949|NCT03789916|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5588950|NCT03789916|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5588951|NCT03789916|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5588952|NCT03789916|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5588953|NCT03789916|Purinergic Agents|purinergic agents|mesh-ancestor
5588954|NCT03789916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5588955|NCT03789916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5588956|NCT03789916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588957|NCT03789916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6200935|NCT02017535|Fluoxetine|fluoxetine|mesh-list
6200936|NCT02017535|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6200937|NCT02017535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6200938|NCT02017535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6200939|NCT02017535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200940|NCT02017535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6200941|NCT02017535|Serotonin Agents|serotonin agents|mesh-ancestor
6200942|NCT02017535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200943|NCT02017535|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6200944|NCT02017535|Antidepressive Agents|antidepressive agents|mesh-ancestor
6200945|NCT02017535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6200946|NCT02017535|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6200947|NCT02017535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6200948|NCT02017535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6200949|NCT02017860|Everolimus|everolimus|mesh-list
6200950|NCT02017860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6200951|NCT02017860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6200952|NCT02017860|Immunologic Factors|immunologic factors|mesh-ancestor
5588958|NCT03789916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5588959|NCT03789916|Analgesics|analgesics|mesh-ancestor
5588960|NCT03789916|Sensory System Agents|sensory system agents|mesh-ancestor
5588961|NCT03789916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5588962|NCT03789916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5588963|NCT03789916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5588964|NCT03789916|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5588965|NCT03789916|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5588966|NCT03789916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5588967|NCT03789916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5588968|NCT03789916|Antipyretics|antipyretics|mesh-ancestor
5588969|NCT03790137|Fenfluramine|fenfluramine|mesh-list
5588970|NCT03790137|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5588971|NCT03790137|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5588972|NCT03790137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5588973|NCT03790137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5588974|NCT03790137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5588975|NCT03790137|Serotonin Agents|serotonin agents|mesh-ancestor
5588976|NCT03790137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588977|NCT03790007|Bupivacaine|bupivacaine|mesh-list
5588978|NCT03790007|Anesthetics, Local|anesthetics, local|mesh-ancestor
5588979|NCT03790007|Anesthetics|anesthetics|mesh-ancestor
5588980|NCT03790007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5588981|NCT03790007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588982|NCT03790007|Sensory System Agents|sensory system agents|mesh-ancestor
5588983|NCT03790007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5588984|NCT03789695|Dabigatran|dabigatran|mesh-list
5588985|NCT03789695|Antithrombins|antithrombins|mesh-ancestor
5588986|NCT03789695|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5588987|NCT03789695|Protease Inhibitors|protease inhibitors|mesh-ancestor
5588988|NCT03789695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5588989|NCT03789695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5588990|NCT03789695|Anticoagulants|anticoagulants|mesh-ancestor
5588991|NCT03789799|Titanium dioxide|titanium dioxide|mesh-list
5588992|NCT03789799|Sunscreening Agents|sunscreening agents|mesh-ancestor
5588993|NCT03789799|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6200953|NCT02017860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200954|NCT02017899|Vaccines|vaccines|mesh-list
6200955|NCT02017899|Immunologic Factors|immunologic factors|mesh-ancestor
6200956|NCT02017899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200957|NCT02018042|Abatacept|abatacept|mesh-list
6200958|NCT02018042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6200959|NCT02018042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200960|NCT02018042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6200961|NCT02018042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6200962|NCT02018042|Immunologic Factors|immunologic factors|mesh-ancestor
6200963|NCT02018042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200964|NCT02018042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6200965|NCT02018107|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6200966|NCT02018107|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6200967|NCT02018107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200968|NCT02018458|Paclitaxel|paclitaxel|mesh-list
6200969|NCT02018458|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6200970|NCT02018458|Cyclophosphamide|cyclophosphamide|mesh-list
6200971|NCT02018458|Carboplatin|carboplatin|mesh-list
6200972|NCT02018458|Doxorubicin|doxorubicin|mesh-list
6200973|NCT02018458|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6200974|NCT02018458|Vaccines|vaccines|mesh-list
6200975|NCT02018458|Immunologic Factors|immunologic factors|mesh-ancestor
5588994|NCT03789799|Protective Agents|protective agents|mesh-ancestor
5588995|NCT03789799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5588996|NCT03789799|Dermatologic Agents|dermatologic agents|mesh-ancestor
5588997|NCT03789799|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6200976|NCT02018458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200977|NCT02018458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6200978|NCT02018458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6200979|NCT02018458|Tubulin Modulators|tubulin modulators|mesh-ancestor
6200980|NCT02018458|Antimitotic Agents|antimitotic agents|mesh-ancestor
6200981|NCT02018458|Mitosis Modulators|mitosis modulators|mesh-ancestor
6200982|NCT02018458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6200983|NCT02018458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6200984|NCT02018458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6200985|NCT02018458|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6200986|NCT02018458|Alkylating Agents|alkylating agents|mesh-ancestor
6200987|NCT02018458|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6200988|NCT02018458|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6200989|NCT02018458|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6200990|NCT02018458|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6200991|NCT02018458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6200992|NCT02018627|Glucagon|glucagon|mesh-list
6200993|NCT02018627|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6200994|NCT02018627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6200995|NCT02018627|Hormones|hormones|mesh-ancestor
6200996|NCT02018627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6672328|NCT01555268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672329|NCT01555268|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6672330|NCT01555268|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6672331|NCT01555268|Growth Substances|growth substances|mesh-ancestor
6672332|NCT01555268|Growth Inhibitors|growth inhibitors|mesh-ancestor
6672333|NCT01555398|Fenofibric acid|fenofibric acid|mesh-list
6672334|NCT01555398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6672335|NCT01555398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6200997|NCT02018627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6200998|NCT02018627|Incretins|incretins|mesh-ancestor
6200999|NCT02018653|Calcium, Dietary|calcium, dietary|mesh-list
6201000|NCT02018653|Antidiarrheals|antidiarrheals|mesh-list
6201001|NCT02018653|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
6201002|NCT02018653|Calcium|calcium|mesh-list
6201003|NCT02018653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6201004|NCT02018653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201005|NCT02018653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6201006|NCT02018653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6201007|NCT02018822|Urethane|urethane|mesh-list
6201008|NCT02018822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6201009|NCT02018822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6201010|NCT02018822|Anesthetics, General|anesthetics, general|mesh-ancestor
6201011|NCT02018822|Anesthetics|anesthetics|mesh-ancestor
6201012|NCT02018822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6201013|NCT02018822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201014|NCT02019069|Cytarabine|cytarabine|mesh-list
6201015|NCT02019069|Daunorubicin|daunorubicin|mesh-list
6201016|NCT02019069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6201017|NCT02019069|Antimetabolites|antimetabolites|mesh-ancestor
6201018|NCT02019069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201019|NCT02019069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6201020|NCT02019069|Antiviral Agents|antiviral agents|mesh-ancestor
6201021|NCT02019069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6201022|NCT02019069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6201023|NCT02019069|Immunologic Factors|immunologic factors|mesh-ancestor
6201024|NCT02019069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201025|NCT02019069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6201026|NCT02019069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6201027|NCT02019069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6201028|NCT02019069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6201029|NCT02019277|Paclitaxel|paclitaxel|mesh-list
6201030|NCT02019277|Docetaxel|docetaxel|mesh-list
6201031|NCT02019277|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6201032|NCT02019277|Trastuzumab|trastuzumab|mesh-list
6201033|NCT02019277|Pertuzumab|pertuzumab|mesh-list
6201034|NCT02019277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6672336|NCT01555398|Antimetabolites|antimetabolites|mesh-ancestor
5588998|NCT03789370|Propofol|propofol|mesh-list
5588999|NCT03789370|Sevoflurane|sevoflurane|mesh-list
6201035|NCT02019277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6201036|NCT02019277|Tubulin Modulators|tubulin modulators|mesh-ancestor
6201037|NCT02019277|Antimitotic Agents|antimitotic agents|mesh-ancestor
5589000|NCT03789370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5589001|NCT03789370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5589002|NCT03789370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589003|NCT03789370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6201038|NCT02019277|Mitosis Modulators|mitosis modulators|mesh-ancestor
6201039|NCT02019277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201040|NCT02019277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6201041|NCT02019420|Linezolid|linezolid|mesh-list
6201042|NCT02019420|Tedizolid|tedizolid|mesh-list
6201043|NCT02019420|Tedizolid phosphate|tedizolid phosphate|mesh-list
6201044|NCT02019420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6201045|NCT02019420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6201046|NCT02019420|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6201047|NCT02019420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6201048|NCT02019420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201049|NCT02019472|Adalimumab|adalimumab|mesh-list
6201050|NCT02019472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6201051|NCT02019472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6201052|NCT02019472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6201053|NCT02019472|Immunologic Factors|immunologic factors|mesh-ancestor
6201054|NCT02019472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201055|NCT02019602|Certolizumab Pegol|certolizumab pegol|mesh-list
6201056|NCT02019602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6201057|NCT02019602|Immunologic Factors|immunologic factors|mesh-ancestor
6201058|NCT02019602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201059|NCT02019602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6201060|NCT02019667|(3-aminopropyl)(n-butyl)phosphinic acid|(3-aminopropyl)(n-butyl)phosphinic acid|mesh-list
6201061|NCT02019667|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6201062|NCT02019667|Protective Agents|protective agents|mesh-ancestor
6201063|NCT02019667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201064|NCT02019667|GABA Antagonists|gaba antagonists|mesh-ancestor
6201065|NCT02019667|GABA Agents|gaba agents|mesh-ancestor
6201066|NCT02019667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6201067|NCT02019667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201068|NCT02019758|Fluticasone|fluticasone|mesh-list
5589004|NCT03789370|Anesthetics, General|anesthetics, general|mesh-ancestor
5589005|NCT03789370|Anesthetics|anesthetics|mesh-ancestor
5589006|NCT03789370|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5589007|NCT03789370|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5589008|NCT03789539|Vaccines|vaccines|mesh-list
5589009|NCT03789539|Immunologic Factors|immunologic factors|mesh-ancestor
5589010|NCT03789539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589011|NCT03789422|Cetirizine|cetirizine|mesh-list
5589012|NCT03789422|Tranexamic Acid|tranexamic acid|mesh-list
5589013|NCT03789422|Levocetirizine|levocetirizine|mesh-list
5589014|NCT03789422|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5589015|NCT03789422|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5589016|NCT03789422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589017|NCT03789422|Hemostatics|hemostatics|mesh-ancestor
5589018|NCT03789422|Coagulants|coagulants|mesh-ancestor
6201069|NCT02019758|Budesonide|budesonide|mesh-list
6201070|NCT02019758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6201071|NCT02019758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6201072|NCT02019758|Autonomic Agents|autonomic agents|mesh-ancestor
6201073|NCT02019758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6201074|NCT02019758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201075|NCT02019758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6201076|NCT02019758|Respiratory System Agents|respiratory system agents|mesh-ancestor
6201077|NCT02019758|Dermatologic Agents|dermatologic agents|mesh-ancestor
6201078|NCT02019758|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6201079|NCT02019758|Glucocorticoids|glucocorticoids|mesh-ancestor
6201080|NCT02019758|Hormones|hormones|mesh-ancestor
6201081|NCT02019758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5589019|NCT03789422|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5589020|NCT03789422|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5589021|NCT03789422|Histamine Antagonists|histamine antagonists|mesh-ancestor
5589022|NCT03789422|Histamine Agents|histamine agents|mesh-ancestor
5589023|NCT03789422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5589024|NCT03789422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589025|NCT03789422|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5605378|NCT02866279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605379|NCT02866279|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5605380|NCT02866279|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5605381|NCT02774265|Aspirin|aspirin|mesh-list
5605382|NCT02774265|Heparin|heparin|mesh-list
5605383|NCT02774265|Enoxaparin|enoxaparin|mesh-list
6201082|NCT02019940|Riluzole|riluzole|mesh-list
6201083|NCT02019940|Anticonvulsants|anticonvulsants|mesh-ancestor
6201084|NCT02019940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5589026|NCT03789123|Dienogest|dienogest|mesh-list
5589027|NCT03789123|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5589028|NCT03789123|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5589029|NCT03789123|Estradiol|estradiol|mesh-list
5589030|NCT03789123|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5589031|NCT03789123|Nandrolone|nandrolone|mesh-list
5589032|NCT03789123|Estrogens|estrogens|mesh-ancestor
5589033|NCT03789123|Hormones|hormones|mesh-ancestor
5589034|NCT03789123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5589035|NCT03789123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589036|NCT03789123|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5589037|NCT03789123|Contraceptive Agents|contraceptive agents|mesh-ancestor
5589038|NCT03789123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5589039|NCT03789123|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5589040|NCT03789123|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5589041|NCT03789123|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5589042|NCT03789123|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5589043|NCT03789123|Hormone Antagonists|hormone antagonists|mesh-ancestor
5589044|NCT03789123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5589045|NCT03789123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5589046|NCT03789123|Androgens|androgens|mesh-ancestor
5589047|NCT03789123|Anabolic Agents|anabolic agents|mesh-ancestor
5589048|NCT03789214|Suvorexant|suvorexant|mesh-list
5589049|NCT03789214|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5589050|NCT03789214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5589051|NCT03789214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5589052|NCT03789214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589053|NCT03789214|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
5589054|NCT03789214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5589055|NCT03789214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589056|NCT03789058|Ibuprofen|ibuprofen|mesh-list
5589057|NCT03789058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5589058|NCT03789058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5589059|NCT03789058|Analgesics|analgesics|mesh-ancestor
5589060|NCT03789058|Sensory System Agents|sensory system agents|mesh-ancestor
5589061|NCT03789058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5589062|NCT03789058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589063|NCT03789058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5589064|NCT03789058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6201085|NCT02019940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6201086|NCT02019940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6201087|NCT02019940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201088|NCT02019940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201089|NCT02019940|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6201090|NCT02019940|Protective Agents|protective agents|mesh-ancestor
6201091|NCT02019979|Metformin|metformin|mesh-list
6201092|NCT02019979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6201093|NCT02019979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201094|NCT02020031|Vancomycin|vancomycin|mesh-list
6201095|NCT02020031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6201096|NCT02020031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6201097|NCT02020278|Tolvaptan|tolvaptan|mesh-list
6201098|NCT02020278|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6201099|NCT02020278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201100|NCT02020278|Natriuretic Agents|natriuretic agents|mesh-ancestor
6201101|NCT02020278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201102|NCT02020408|Raclopride|raclopride|mesh-list
6201103|NCT02020408|Amphetamine|amphetamine|mesh-list
6201104|NCT02020408|Dextroamphetamine|dextroamphetamine|mesh-list
6201105|NCT02020408|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6201106|NCT02020408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201107|NCT02020408|Sympathomimetics|sympathomimetics|mesh-ancestor
6201108|NCT02020408|Autonomic Agents|autonomic agents|mesh-ancestor
6201109|NCT02020408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6201110|NCT02020408|Dopamine Agents|dopamine agents|mesh-ancestor
6201111|NCT02020408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6201112|NCT02020408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201113|NCT02020408|Adrenergic Agents|adrenergic agents|mesh-ancestor
6201114|NCT02020408|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5589065|NCT03789058|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5589066|NCT03789058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6201115|NCT02020408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6201116|NCT02020408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6201117|NCT02020408|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6201118|NCT02020408|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6201119|NCT02020408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6201120|NCT02020408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6201121|NCT02020408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6201122|NCT02020408|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6201123|NCT02020512|Bimatoprost|bimatoprost|mesh-list
6201124|NCT02020512|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6201125|NCT02020577|Cetuximab|cetuximab|mesh-list
6201126|NCT02020577|Afatinib|afatinib|mesh-list
6201127|NCT02020577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6201128|NCT02020577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6201129|NCT02020577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6201130|NCT02020577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6201131|NCT02020577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201132|NCT02020616|Metformin|metformin|mesh-list
6201133|NCT02020616|Exenatide|exenatide|mesh-list
6201134|NCT02020616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6201135|NCT02020616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201136|NCT02020616|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6201137|NCT02020616|Incretins|incretins|mesh-ancestor
6201138|NCT02020616|Hormones|hormones|mesh-ancestor
6201139|NCT02020616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6201140|NCT02020941|Dexamethasone|dexamethasone|mesh-list
6201141|NCT02020941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6201142|NCT02020941|Antiemetics|antiemetics|mesh-ancestor
6201143|NCT02020941|Autonomic Agents|autonomic agents|mesh-ancestor
6201144|NCT02020941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6201145|NCT02020941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201146|NCT02020941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6201147|NCT02020941|Glucocorticoids|glucocorticoids|mesh-ancestor
6201148|NCT02020941|Hormones|hormones|mesh-ancestor
6201149|NCT02020941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6201150|NCT02020941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6201151|NCT02020941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6201152|NCT02021292|Macitentan|macitentan|mesh-list
6201153|NCT02021292|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
6201154|NCT02021292|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6201155|NCT02021292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201156|NCT02021292|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
6201157|NCT02021318|Darbepoetin alfa|darbepoetin alfa|mesh-list
6201158|NCT02021318|Hematinics|hematinics|mesh-ancestor
6201159|NCT02021331|Ethanol|ethanol|mesh-list
6201160|NCT02021331|Povidone-Iodine|povidone-iodine|mesh-list
6201161|NCT02021331|Cimetidine|cimetidine|mesh-list
6201162|NCT02021331|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6201163|NCT02021331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6201164|NCT02021331|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6201165|NCT02021331|Histamine Antagonists|histamine antagonists|mesh-ancestor
5589067|NCT03789058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589068|NCT03788889|Ketamine|ketamine|mesh-list
5589069|NCT03788889|Lorazepam|lorazepam|mesh-list
5589070|NCT03788889|Phenobarbital|phenobarbital|mesh-list
5589071|NCT03788889|Analgesics|analgesics|mesh-ancestor
5589072|NCT03788889|Sensory System Agents|sensory system agents|mesh-ancestor
5589073|NCT03788889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5589074|NCT03788889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589075|NCT03788889|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5589076|NCT03788889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5589077|NCT03788889|Anesthetics, General|anesthetics, general|mesh-ancestor
5589078|NCT03788889|Anesthetics|anesthetics|mesh-ancestor
5589079|NCT03788889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5589080|NCT03788889|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5589081|NCT03788889|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5589082|NCT03788889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5589083|NCT03788889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589084|NCT03788889|Anticonvulsants|anticonvulsants|mesh-ancestor
5589085|NCT03788889|Antiemetics|antiemetics|mesh-ancestor
5589086|NCT03788889|Autonomic Agents|autonomic agents|mesh-ancestor
5589087|NCT03788889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5589088|NCT03788889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5589089|NCT03788889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5589090|NCT03788889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5589091|NCT03788889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6201166|NCT02021331|Histamine Agents|histamine agents|mesh-ancestor
6201167|NCT02021331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6201168|NCT02021331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201169|NCT02021331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201170|NCT02021331|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6201171|NCT02021331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6201172|NCT02021331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6201173|NCT02021331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6201174|NCT02021331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6201175|NCT02021331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6201176|NCT02021461|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
6201177|NCT02021461|Anticonvulsants|anticonvulsants|mesh-ancestor
6201178|NCT02021461|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6201179|NCT02021461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6201180|NCT02021461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6201181|NCT02021461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201182|NCT02021643|Sofosbuvir|sofosbuvir|mesh-list
6201183|NCT02021643|Ribavirin|ribavirin|mesh-list
6201184|NCT02021643|Antiviral Agents|antiviral agents|mesh-ancestor
6201185|NCT02021643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6201186|NCT02021643|Antimetabolites|antimetabolites|mesh-ancestor
6201187|NCT02021643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201188|NCT02021656|Sofosbuvir|sofosbuvir|mesh-list
6201189|NCT02021656|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
6201190|NCT02021656|Ledipasvir|ledipasvir|mesh-list
6201191|NCT02021656|Antiviral Agents|antiviral agents|mesh-ancestor
6201192|NCT02021656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6201193|NCT02021929|Sorafenib|sorafenib|mesh-list
6201194|NCT02021929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6201195|NCT02021929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6201196|NCT02021929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6201197|NCT02021929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201198|NCT02021942|Pasireotide|pasireotide|mesh-list
6201199|NCT02021942|Hormones|hormones|mesh-ancestor
6201200|NCT02021942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6201201|NCT02021942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201202|NCT02022007|Metformin|metformin|mesh-list
6201203|NCT02022007|Saxagliptin|saxagliptin|mesh-list
6201204|NCT02022007|Biguanides|biguanides|mesh-list
6201205|NCT02022007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
6201206|NCT02022007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6201207|NCT02022007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201208|NCT02022007|Incretins|incretins|mesh-ancestor
6201209|NCT02022007|Hormones|hormones|mesh-ancestor
6201210|NCT02022007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6201211|NCT02022007|Protease Inhibitors|protease inhibitors|mesh-ancestor
6201212|NCT02022007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6201213|NCT02022007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201214|NCT02022657|Tenofovir|tenofovir|mesh-list
6201215|NCT02022657|Emtricitabine|emtricitabine|mesh-list
6201216|NCT02022657|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6201217|NCT02022657|Antiviral Agents|antiviral agents|mesh-ancestor
6201218|NCT02022657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6201219|NCT02022657|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6201220|NCT02022657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6201221|NCT02022657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6201222|NCT02022657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201223|NCT02022657|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6201224|NCT02022657|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6201225|NCT02022748|Ticagrelor|ticagrelor|mesh-list
6201226|NCT02022748|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6201227|NCT02022748|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6201228|NCT02022748|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6201229|NCT02022748|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6201230|NCT02022748|Purinergic Agents|purinergic agents|mesh-ancestor
6201231|NCT02022748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6201232|NCT02022748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201233|NCT02022748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201234|NCT02023099|Ritonavir|ritonavir|mesh-list
6201235|NCT02023099|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6201236|NCT02023099|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6201237|NCT02023099|Protease Inhibitors|protease inhibitors|mesh-ancestor
6201238|NCT02023099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5589092|NCT03788889|GABA Modulators|gaba modulators|mesh-ancestor
5589093|NCT03788889|GABA Agents|gaba agents|mesh-ancestor
5589094|NCT03788889|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5589095|NCT03788889|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6201239|NCT02023099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201240|NCT02023099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6201241|NCT02023099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5589096|NCT03788889|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5589097|NCT03788902|Methylphenidate|methylphenidate|mesh-list
5589098|NCT03788902|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5589099|NCT03788902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589100|NCT03788902|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5589101|NCT03788902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5589102|NCT03788902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5589103|NCT03788902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589104|NCT03788902|Dopamine Agents|dopamine agents|mesh-ancestor
5589105|NCT03788902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5589106|NCT03788863|Diflucortolone valerate|diflucortolone valerate|mesh-list
5589107|NCT03788863|Diflucortolone|diflucortolone|mesh-list
5589108|NCT03788863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5589109|NCT03788863|Glucocorticoids|glucocorticoids|mesh-ancestor
5589110|NCT03788863|Hormones|hormones|mesh-ancestor
5589111|NCT03788863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5589112|NCT03788863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589113|NCT03789032|Rabeprazole|rabeprazole|mesh-list
5589114|NCT03789032|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5589115|NCT03789032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5589116|NCT03789032|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5589117|NCT03789032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5589118|NCT03789032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589119|NCT03788733|Melatonin|melatonin|mesh-list
5589120|NCT03788733|Antioxidants|antioxidants|mesh-ancestor
5589121|NCT03788733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589122|NCT03788733|Protective Agents|protective agents|mesh-ancestor
5589123|NCT03788733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589124|NCT03788733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5589125|NCT03788694|Ketamine|ketamine|mesh-list
5589126|NCT03788694|Analgesics|analgesics|mesh-ancestor
5589127|NCT03788694|Sensory System Agents|sensory system agents|mesh-ancestor
5589128|NCT03788694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5589129|NCT03788694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589130|NCT03788694|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5589131|NCT03788694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5589132|NCT03788694|Anesthetics, General|anesthetics, general|mesh-ancestor
5589133|NCT03788694|Anesthetics|anesthetics|mesh-ancestor
5589134|NCT03788694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5589135|NCT03788694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5589136|NCT03788694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5589137|NCT03788694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5589138|NCT03788694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589139|NCT03789006|Interleukin-2|interleukin-2|mesh-list
6201242|NCT02023099|Antiviral Agents|antiviral agents|mesh-ancestor
6201243|NCT02023099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6201244|NCT02023099|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6201245|NCT02023099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6201246|NCT02023112|Ritonavir|ritonavir|mesh-list
6201247|NCT02023112|Ribavirin|ribavirin|mesh-list
6201248|NCT02023112|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6201249|NCT02023112|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6201250|NCT02023112|Protease Inhibitors|protease inhibitors|mesh-ancestor
6201251|NCT02023112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6201252|NCT02023112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201253|NCT02023112|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6201254|NCT02023112|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6201255|NCT02023112|Antiviral Agents|antiviral agents|mesh-ancestor
6201256|NCT02023112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5589140|NCT03789006|Immunoglobulins|immunoglobulins|mesh-list
5589141|NCT03789006|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5589142|NCT03789006|Antibodies|antibodies|mesh-list
5589143|NCT03789006|Basiliximab|basiliximab|mesh-list
5589144|NCT03789006|Thymoglobulin|thymoglobulin|mesh-list
5589145|NCT03789006|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5589146|NCT03789006|Immunologic Factors|immunologic factors|mesh-ancestor
5589147|NCT03789006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201257|NCT02023112|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6201258|NCT02023112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6201259|NCT02023112|Antimetabolites|antimetabolites|mesh-ancestor
6201260|NCT02023125|Esomeprazole|esomeprazole|mesh-list
6201261|NCT02023125|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6201262|NCT02023125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6201263|NCT02023125|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6201264|NCT02023125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6201265|NCT02023125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201266|NCT02023151|Omalizumab|omalizumab|mesh-list
6201267|NCT02023151|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6201268|NCT02023151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6201269|NCT02023151|Respiratory System Agents|respiratory system agents|mesh-ancestor
6207682|NCT02119026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6207683|NCT02119026|Growth Substances|growth substances|mesh-ancestor
6207684|NCT02119026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207685|NCT02119026|Growth Inhibitors|growth inhibitors|mesh-ancestor
6207686|NCT02119026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6207687|NCT02119026|Antimetabolites|antimetabolites|mesh-ancestor
6207688|NCT02119026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207689|NCT02119026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6207690|NCT02119026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6207691|NCT02119026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6207692|NCT02119104|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6207693|NCT02119104|Immunologic Factors|immunologic factors|mesh-ancestor
6207694|NCT02119104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207695|NCT02119156|Belimumab|belimumab|mesh-list
6207696|NCT02119156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6207697|NCT02119156|Immunologic Factors|immunologic factors|mesh-ancestor
6207698|NCT02119156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207699|NCT02119260|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6207987|NCT02122770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207988|NCT02122770|Antifungal Agents|antifungal agents|mesh-ancestor
6207989|NCT02122770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5589148|NCT03789006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5589149|NCT03789006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5589150|NCT03789006|Analgesics|analgesics|mesh-ancestor
5589151|NCT03789006|Sensory System Agents|sensory system agents|mesh-ancestor
5589152|NCT03789006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5589153|NCT03789006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5589154|NCT03788759|Thioctic Acid|thioctic acid|mesh-list
5589155|NCT03788759|Antioxidants|antioxidants|mesh-ancestor
5589156|NCT03788759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207990|NCT02122770|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6207991|NCT02122770|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6207992|NCT02122770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6207993|NCT02122770|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6207994|NCT02122770|Hormone Antagonists|hormone antagonists|mesh-ancestor
6207995|NCT02122770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6207996|NCT02122770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6207997|NCT02122770|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5589157|NCT03788759|Protective Agents|protective agents|mesh-ancestor
5589158|NCT03788759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589159|NCT03788759|Vitamin B Complex|vitamin b complex|mesh-ancestor
5589160|NCT03788759|Vitamins|vitamins|mesh-ancestor
5589161|NCT03788759|Micronutrients|micronutrients|mesh-ancestor
5589162|NCT03788681|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5589163|NCT03788681|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5589164|NCT03788681|Estradiol|estradiol|mesh-list
5589165|NCT03788681|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5589166|NCT03788681|Estrogens|estrogens|mesh-ancestor
5589167|NCT03788681|Hormones|hormones|mesh-ancestor
5589168|NCT03788681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5589169|NCT03788681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589170|NCT03788681|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5589171|NCT03788681|Contraceptive Agents|contraceptive agents|mesh-ancestor
5589172|NCT03788681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5589173|NCT03788681|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5589174|NCT03788538|Dexmedetomidine|dexmedetomidine|mesh-list
5589175|NCT03788538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5589176|NCT03788538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5589177|NCT03788538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201270|NCT02023411|Teriparatide|teriparatide|mesh-list
6201271|NCT02023411|Hormones|hormones|mesh-list
6201272|NCT02023411|Parathyroid Hormone|parathyroid hormone|mesh-list
6201273|NCT02023411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6201274|NCT02023411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201275|NCT02023411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6201276|NCT02023411|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6201277|NCT02023697|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
6201278|NCT02023697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6201279|NCT02023866|Cysteamine|cysteamine|mesh-list
6201280|NCT02023866|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
6201281|NCT02023866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201282|NCT02023879|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6201283|NCT02023879|Immunologic Factors|immunologic factors|mesh-ancestor
6201284|NCT02023879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201285|NCT02024087|Sorafenib|sorafenib|mesh-list
6201286|NCT02024087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6201287|NCT02024087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6201288|NCT02024087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6201289|NCT02024087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201290|NCT02024204|Fluticasone|fluticasone|mesh-list
6201291|NCT02024204|Xhance|xhance|mesh-list
6201292|NCT02024204|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6201293|NCT02024204|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6201294|NCT02024204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6201295|NCT02024204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6201296|NCT02024204|Autonomic Agents|autonomic agents|mesh-ancestor
6201297|NCT02024204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6201298|NCT02024204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201299|NCT02024204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6201300|NCT02024204|Respiratory System Agents|respiratory system agents|mesh-ancestor
6201301|NCT02024204|Dermatologic Agents|dermatologic agents|mesh-ancestor
6201302|NCT02024204|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6201303|NCT02024204|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6201304|NCT02024204|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6201305|NCT02024204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6201306|NCT02024204|Adrenergic Agents|adrenergic agents|mesh-ancestor
6201307|NCT02024204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6201308|NCT02024204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201309|NCT02024204|Glucocorticoids|glucocorticoids|mesh-ancestor
6201310|NCT02024204|Hormones|hormones|mesh-ancestor
6201311|NCT02024204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6201312|NCT02024204|Sympathomimetics|sympathomimetics|mesh-ancestor
6201313|NCT02024386|Riociguat|riociguat|mesh-list
6672337|NCT01555398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672338|NCT01555398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6672339|NCT01555476|Ibuprofen|ibuprofen|mesh-list
6672340|NCT01555476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6672341|NCT01555476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6672342|NCT01555476|Analgesics|analgesics|mesh-ancestor
6672343|NCT01555476|Sensory System Agents|sensory system agents|mesh-ancestor
6672344|NCT01555476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5589178|NCT03788538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5589179|NCT03788538|Analgesics|analgesics|mesh-ancestor
5589180|NCT03788538|Sensory System Agents|sensory system agents|mesh-ancestor
5589181|NCT03788538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5589182|NCT03788538|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5589183|NCT03788538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5589184|NCT03788538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5589185|NCT03788538|Adrenergic Agents|adrenergic agents|mesh-ancestor
5589186|NCT03788538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5589187|NCT03788538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589188|NCT03788395|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
5589189|NCT03788395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5589190|NCT03788395|Respiratory System Agents|respiratory system agents|mesh-ancestor
5589191|NCT03788317|Botulinum Toxins|botulinum toxins|mesh-list
5589192|NCT03788317|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5589193|NCT03788317|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5589194|NCT03788317|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5589195|NCT03788317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5589196|NCT03788317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589197|NCT03788317|Cholinergic Agents|cholinergic agents|mesh-ancestor
6672345|NCT01555476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672346|NCT01555476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6672347|NCT01555476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6672348|NCT01555476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6672349|NCT01555476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6672350|NCT01555476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672351|NCT01555580|Molgramostim|molgramostim|mesh-list
6672352|NCT01555580|Sargramostim|sargramostim|mesh-list
6672353|NCT01555580|Immunologic Factors|immunologic factors|mesh-ancestor
6672354|NCT01555580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672355|NCT01555580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6672356|NCT01555632|Atorvastatin|atorvastatin|mesh-list
6672357|NCT01555632|Calcium|calcium|mesh-list
6672358|NCT01555632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6672359|NCT01555632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672360|NCT01555632|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6672361|NCT01555632|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6201314|NCT02024386|Enzyme Activators|enzyme activators|mesh-ancestor
6201315|NCT02024386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201316|NCT02024477|Saxagliptin|saxagliptin|mesh-list
6201317|NCT02024477|Incretins|incretins|mesh-ancestor
6201318|NCT02024477|Hormones|hormones|mesh-ancestor
6201319|NCT02024477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6201320|NCT02024477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201321|NCT02024477|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6201322|NCT02024477|Protease Inhibitors|protease inhibitors|mesh-ancestor
6201323|NCT02024477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6201324|NCT02024477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589198|NCT03788317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5589199|NCT03788317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589200|NCT03788317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5589201|NCT03788317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5589202|NCT03787992|Gefitinib|gefitinib|mesh-list
5589203|NCT03787992|Aflutinib|aflutinib|mesh-list
5589204|NCT03787992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5589205|NCT03787992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5589206|NCT03787992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5589207|NCT03787992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589208|NCT03787940|Isoniazid|isoniazid|mesh-list
5589209|NCT03787940|Antitubercular Agents|antitubercular agents|mesh-ancestor
5589210|NCT03787940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5589211|NCT03787940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5589212|NCT03787940|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5589213|NCT03787940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5589214|NCT03787940|Antimetabolites|antimetabolites|mesh-ancestor
6201325|NCT02024477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6201326|NCT02024607|Leucovorin|leucovorin|mesh-list
6201327|NCT02024607|Bevacizumab|bevacizumab|mesh-list
6201328|NCT02024607|Fluorouracil|fluorouracil|mesh-list
6201329|NCT02024607|Capecitabine|capecitabine|mesh-list
6201330|NCT02024607|Oxaliplatin|oxaliplatin|mesh-list
6201331|NCT02024607|Irinotecan|irinotecan|mesh-list
6201332|NCT02024607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6201333|NCT02024607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6201334|NCT02024607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6201335|NCT02024607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6201336|NCT02024607|Growth Substances|growth substances|mesh-ancestor
6672362|NCT01555632|Antimetabolites|antimetabolites|mesh-ancestor
5589215|NCT03787940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589216|NCT03787940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5589217|NCT03787953|Antibodies|antibodies|mesh-list
5589218|NCT03787953|Immunologic Factors|immunologic factors|mesh-ancestor
5589219|NCT03787953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589220|NCT03788018|Lidocaine|lidocaine|mesh-list
5589221|NCT03788018|Dexmedetomidine|dexmedetomidine|mesh-list
5589222|NCT03788018|Anesthetics, Local|anesthetics, local|mesh-ancestor
5589223|NCT03788018|Anesthetics|anesthetics|mesh-ancestor
5589224|NCT03788018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5589225|NCT03788018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589226|NCT03788018|Sensory System Agents|sensory system agents|mesh-ancestor
5589227|NCT03788018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5589228|NCT03788018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5589229|NCT03788018|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5589230|NCT03788018|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5589231|NCT03788018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5589232|NCT03788018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589233|NCT03788018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5589234|NCT03788018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5589235|NCT03788018|Analgesics|analgesics|mesh-ancestor
5589236|NCT03788018|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5589237|NCT03788018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5589238|NCT03788018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5589239|NCT03788018|Adrenergic Agents|adrenergic agents|mesh-ancestor
5589240|NCT03788018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5589241|NCT03788174|Apatinib|apatinib|mesh-list
5589242|NCT03788174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5589243|NCT03788174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5589244|NCT03788174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5589245|NCT03788174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589246|NCT03787927|Aspirin|aspirin|mesh-list
5589247|NCT03787927|Clopidogrel|clopidogrel|mesh-list
6201337|NCT02024607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201338|NCT02024607|Growth Inhibitors|growth inhibitors|mesh-ancestor
6201339|NCT02024607|Antimetabolites|antimetabolites|mesh-ancestor
6201340|NCT02024607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201341|NCT02024607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6201342|NCT02024607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6201343|NCT02024607|Immunologic Factors|immunologic factors|mesh-ancestor
6201344|NCT02024607|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6201345|NCT02024607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6201346|NCT02024607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6201347|NCT02024607|Antidotes|antidotes|mesh-ancestor
6201348|NCT02024607|Protective Agents|protective agents|mesh-ancestor
6201349|NCT02024607|Vitamin B Complex|vitamin b complex|mesh-ancestor
6201350|NCT02024607|Vitamins|vitamins|mesh-ancestor
6201351|NCT02024607|Micronutrients|micronutrients|mesh-ancestor
6201352|NCT02024646|Brodalumab|brodalumab|mesh-list
6201353|NCT02024646|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6201354|NCT02024646|Dermatologic Agents|dermatologic agents|mesh-ancestor
6201355|NCT02024646|Immunologic Factors|immunologic factors|mesh-ancestor
6201356|NCT02024646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589248|NCT03787927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5589249|NCT03787927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5589250|NCT03787927|Analgesics|analgesics|mesh-ancestor
5589251|NCT03787927|Sensory System Agents|sensory system agents|mesh-ancestor
5589252|NCT03787927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5589253|NCT03787927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589254|NCT03787927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5589255|NCT03787927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5589256|NCT03787927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5589257|NCT03787927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5589258|NCT03787927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589259|NCT03787927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5589260|NCT03787927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5589261|NCT03787927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5589262|NCT03787927|Antipyretics|antipyretics|mesh-ancestor
5589263|NCT03787927|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5589264|NCT03787927|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5589265|NCT03787927|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5589266|NCT03787927|Purinergic Agents|purinergic agents|mesh-ancestor
5589267|NCT03787927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5589268|NCT03787550|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5589269|NCT03787550|Analgesics|analgesics|mesh-list
5589270|NCT03787550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
5589271|NCT03787550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5589272|NCT03787550|Sensory System Agents|sensory system agents|mesh-ancestor
5589273|NCT03787550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5589274|NCT03787550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589275|NCT03787550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5589276|NCT03787641|Protamines|protamines|mesh-list
5589277|NCT03787641|Heparin Antagonists|heparin antagonists|mesh-ancestor
5589278|NCT03787641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589279|NCT03787641|Coagulants|coagulants|mesh-ancestor
5605384|NCT02774265|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5605385|NCT02774265|Tinzaparin|tinzaparin|mesh-list
5605386|NCT02774265|Dalteparin|dalteparin|mesh-list
5605387|NCT02774265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5605388|NCT02774265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5605389|NCT02774265|Analgesics|analgesics|mesh-ancestor
6201357|NCT02024711|Hyaluronic Acid|hyaluronic acid|mesh-list
6201358|NCT02024711|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6201359|NCT02024711|Immunologic Factors|immunologic factors|mesh-ancestor
6201360|NCT02024711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201361|NCT02024711|Viscosupplements|viscosupplements|mesh-ancestor
6201362|NCT02024711|Protective Agents|protective agents|mesh-ancestor
6201363|NCT02024724|Dexamethasone|dexamethasone|mesh-list
6201364|NCT02024724|Triamcinolone|triamcinolone|mesh-list
6201365|NCT02024724|Bupivacaine|bupivacaine|mesh-list
6201366|NCT02024724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6201367|NCT02024724|Antiemetics|antiemetics|mesh-ancestor
6201368|NCT02024724|Autonomic Agents|autonomic agents|mesh-ancestor
6201369|NCT02024724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6201370|NCT02024724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201371|NCT02024724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6201372|NCT02024724|Glucocorticoids|glucocorticoids|mesh-ancestor
5589280|NCT03787251|Apatinib|apatinib|mesh-list
5589281|NCT03787251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5589282|NCT03787251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5589283|NCT03787251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5589284|NCT03787251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589285|NCT03787264|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5589286|NCT03787264|Venetoclax|venetoclax|mesh-list
5589287|NCT03787264|Obinutuzumab|obinutuzumab|mesh-list
5589288|NCT03787264|Acalabrutinib|acalabrutinib|mesh-list
5589289|NCT03787264|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5589290|NCT03787264|Alkylating Agents|alkylating agents|mesh-ancestor
5589291|NCT03787264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589292|NCT03787264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5589293|NCT03787264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5589294|NCT03787147|Lidocaine|lidocaine|mesh-list
5589295|NCT03787147|Bupivacaine|bupivacaine|mesh-list
5589296|NCT03787147|Anesthetics, Local|anesthetics, local|mesh-ancestor
5589297|NCT03787147|Anesthetics|anesthetics|mesh-ancestor
5589298|NCT03787147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5589299|NCT03787147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589300|NCT03787147|Sensory System Agents|sensory system agents|mesh-ancestor
5589301|NCT03787147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5589302|NCT03787147|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5589303|NCT03787147|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5589304|NCT03787147|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5589305|NCT03787147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5589306|NCT03787147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589307|NCT03786887|Nalbuphine|nalbuphine|mesh-list
5589308|NCT03786887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5589309|NCT03786887|Narcotics|narcotics|mesh-ancestor
5589310|NCT03786887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5589311|NCT03786887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589312|NCT03786887|Analgesics|analgesics|mesh-ancestor
5589313|NCT03786887|Sensory System Agents|sensory system agents|mesh-ancestor
6201373|NCT02024724|Hormones|hormones|mesh-ancestor
6201374|NCT02024724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6201375|NCT02024724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6201376|NCT02024724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6201377|NCT02024724|Anesthetics, Local|anesthetics, local|mesh-ancestor
6201378|NCT02024724|Anesthetics|anesthetics|mesh-ancestor
6201379|NCT02024724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6201380|NCT02024724|Sensory System Agents|sensory system agents|mesh-ancestor
6201381|NCT02024867|Trimethoprim|trimethoprim|mesh-list
6201382|NCT02024867|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6201383|NCT02024867|Sulfamethoxazole|sulfamethoxazole|mesh-list
6201384|NCT02024867|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6201385|NCT02024867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6201386|NCT02024867|Renal Agents|renal agents|mesh-ancestor
6201387|NCT02024867|Antimalarials|antimalarials|mesh-ancestor
6201388|NCT02024867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6201389|NCT02024867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6201390|NCT02024867|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5589314|NCT03786887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5589315|NCT03786796|Olaparib|olaparib|mesh-list
5589316|NCT03786796|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5589317|NCT03786796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5589318|NCT03786796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201391|NCT02024867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5589319|NCT03786796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6201392|NCT02024867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201393|NCT02024867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6201394|NCT02024867|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6201395|NCT02024867|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6201396|NCT02024867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6201397|NCT02024971|Metformin|metformin|mesh-list
5589320|NCT03787043|Metformin|metformin|mesh-list
5589321|NCT03787043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5589322|NCT03787043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589323|NCT03787017|Metformin|metformin|mesh-list
5589324|NCT03787017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5589325|NCT03787017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589326|NCT03786757|Rivaroxaban|rivaroxaban|mesh-list
5589327|NCT03786757|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5589328|NCT03786757|Antithrombins|antithrombins|mesh-ancestor
5589329|NCT03786757|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5589330|NCT03786757|Protease Inhibitors|protease inhibitors|mesh-ancestor
5589331|NCT03786757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5589332|NCT03786757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589333|NCT03786757|Anticoagulants|anticoagulants|mesh-ancestor
5589334|NCT03787030|Vitamin E|vitamin e|mesh-list
5589335|NCT03787030|Tocopherols|tocopherols|mesh-list
5589336|NCT03787030|alpha-Tocopherol|alpha-tocopherol|mesh-list
5589337|NCT03787030|Nitroglycerin|nitroglycerin|mesh-list
5589338|NCT03787030|Vitamins|vitamins|mesh-ancestor
5589339|NCT03787030|Micronutrients|micronutrients|mesh-ancestor
5589340|NCT03787030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589341|NCT03787030|Antioxidants|antioxidants|mesh-ancestor
5589342|NCT03787030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589343|NCT03787030|Protective Agents|protective agents|mesh-ancestor
5589344|NCT03787030|Vasodilator Agents|vasodilator agents|mesh-ancestor
5589345|NCT03787069|Lidocaine|lidocaine|mesh-list
5589346|NCT03787069|Anesthetics, Local|anesthetics, local|mesh-ancestor
5589347|NCT03787069|Anesthetics|anesthetics|mesh-ancestor
5589348|NCT03787069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5589349|NCT03787069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589350|NCT03787069|Sensory System Agents|sensory system agents|mesh-ancestor
5589351|NCT03787069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5589352|NCT03787069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5589353|NCT03787069|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5589354|NCT03787069|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5589355|NCT03787069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5589356|NCT03787069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589357|NCT03786562|Morphine|morphine|mesh-list
5589358|NCT03786562|Nalbuphine|nalbuphine|mesh-list
5589359|NCT03786562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6201398|NCT02024971|Pioglitazone|pioglitazone|mesh-list
6201399|NCT02024971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6201400|NCT02024971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201401|NCT02025075|Rocuronium|rocuronium|mesh-list
6201402|NCT02025075|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6201403|NCT02025075|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6201404|NCT02025075|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6201405|NCT02025075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6201406|NCT02025075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201407|NCT02025179|Teriparatide|teriparatide|mesh-list
5589360|NCT03786562|Narcotics|narcotics|mesh-ancestor
5589361|NCT03786562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5589362|NCT03786562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589363|NCT03786562|Analgesics|analgesics|mesh-ancestor
5589364|NCT03786562|Sensory System Agents|sensory system agents|mesh-ancestor
5589365|NCT03786562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5589366|NCT03786614|Antidepressive Agents|antidepressive agents|mesh-list
5589367|NCT03786614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5589368|NCT03786289|Epoetin Alfa|epoetin alfa|mesh-list
5589369|NCT03786289|Hematinics|hematinics|mesh-ancestor
5589370|NCT03786419|Atezolizumab|atezolizumab|mesh-list
5589371|NCT03786419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5589372|NCT03786120|Zolpidem|zolpidem|mesh-list
5589373|NCT03786120|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5589374|NCT03786120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5589375|NCT03786120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5589376|NCT03786120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589377|NCT03786120|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
5589378|NCT03786120|GABA Agonists|gaba agonists|mesh-ancestor
5589379|NCT03786120|GABA Agents|gaba agents|mesh-ancestor
5589380|NCT03786120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5589381|NCT03786120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201408|NCT02025179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6201409|NCT02025179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589382|NCT03785873|Leucovorin|leucovorin|mesh-list
5589383|NCT03785873|Fluorouracil|fluorouracil|mesh-list
5589384|NCT03785873|Nivolumab|nivolumab|mesh-list
5589385|NCT03785873|Irinotecan|irinotecan|mesh-list
5589386|NCT03785873|Antimetabolites|antimetabolites|mesh-ancestor
5589387|NCT03785873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589388|NCT03785873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5589389|NCT03785873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5589390|NCT03785873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5589391|NCT03785873|Immunologic Factors|immunologic factors|mesh-ancestor
5589392|NCT03785873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589393|NCT03785873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5589394|NCT03785873|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5589395|NCT03785873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5589396|NCT03785873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5589397|NCT03785873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5589398|NCT03785873|Antidotes|antidotes|mesh-ancestor
5589399|NCT03785873|Protective Agents|protective agents|mesh-ancestor
5589400|NCT03785873|Vitamin B Complex|vitamin b complex|mesh-ancestor
5589401|NCT03785873|Vitamins|vitamins|mesh-ancestor
5589402|NCT03785873|Micronutrients|micronutrients|mesh-ancestor
5589403|NCT03786237|ON 01910|on 01910|mesh-list
5589404|NCT03786237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5589405|NCT03786237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5589406|NCT03786237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5589407|NCT03786237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589408|NCT03786029|Acetaminophen|acetaminophen|mesh-list
5589409|NCT03786029|Ibuprofen|ibuprofen|mesh-list
5589410|NCT03786029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5589411|NCT03786029|Analgesics|analgesics|mesh-ancestor
5589412|NCT03786029|Sensory System Agents|sensory system agents|mesh-ancestor
5589413|NCT03786029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5589414|NCT03786029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201410|NCT02025179|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6201411|NCT02025426|Phenylephrine|phenylephrine|mesh-list
6201412|NCT02025426|Oxymetazoline|oxymetazoline|mesh-list
6201413|NCT02025426|Ephedrine|ephedrine|mesh-list
6201414|NCT02025426|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6201415|NCT02025426|Mydriatics|mydriatics|mesh-ancestor
6201416|NCT02025426|Autonomic Agents|autonomic agents|mesh-ancestor
6201417|NCT02025426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6201418|NCT02025426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201419|NCT02025426|Sympathomimetics|sympathomimetics|mesh-ancestor
6201420|NCT02025426|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6201421|NCT02025426|Nasal Decongestants|nasal decongestants|mesh-ancestor
5589415|NCT03786029|Antipyretics|antipyretics|mesh-ancestor
5589416|NCT03786029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5589417|NCT03786029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5589418|NCT03786029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5589419|NCT03786029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5589420|NCT03786029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5589421|NCT03786029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589422|NCT03785756|Ibuprofen|ibuprofen|mesh-list
5589423|NCT03785756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5589424|NCT03785756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5589425|NCT03785756|Analgesics|analgesics|mesh-ancestor
5589426|NCT03785756|Sensory System Agents|sensory system agents|mesh-ancestor
5589427|NCT03785756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5589428|NCT03785756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589429|NCT03785756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5589430|NCT03785756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5589431|NCT03785756|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5589432|NCT03785756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5589433|NCT03785756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605390|NCT02774265|Sensory System Agents|sensory system agents|mesh-ancestor
5605391|NCT02774265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5605392|NCT02774265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605393|NCT02774265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5605394|NCT02774265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5605395|NCT02774265|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5605396|NCT02774265|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5605397|NCT02774265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605398|NCT02774265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6201422|NCT02025426|Respiratory System Agents|respiratory system agents|mesh-ancestor
6201423|NCT02025426|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5589434|NCT03785496|Spartalizumab|spartalizumab|mesh-list
5589435|NCT03785496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5589436|NCT03785496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589437|NCT03785496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5589438|NCT03785587|Bromides|bromides|mesh-list
6201424|NCT02025426|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6201425|NCT02025426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6201426|NCT02025426|Adrenergic Agents|adrenergic agents|mesh-ancestor
6201427|NCT02025426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6201428|NCT02025426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201429|NCT02025426|Protective Agents|protective agents|mesh-ancestor
6201430|NCT02025426|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6201431|NCT02025439|Amantadine|amantadine|mesh-list
6201432|NCT02025439|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6201433|NCT02025439|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6201434|NCT02025439|Antiviral Agents|antiviral agents|mesh-ancestor
6201435|NCT02025439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6201436|NCT02025439|Dopamine Agents|dopamine agents|mesh-ancestor
6201437|NCT02025439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6201438|NCT02025439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201439|NCT02025439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201440|NCT02025439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6201441|NCT02025439|Analgesics|analgesics|mesh-ancestor
6201442|NCT02025439|Sensory System Agents|sensory system agents|mesh-ancestor
6201443|NCT02025439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6201444|NCT02025621|Simendan|simendan|mesh-list
6201445|NCT02025621|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6201446|NCT02025621|Vasodilator Agents|vasodilator agents|mesh-ancestor
6201447|NCT02025621|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6201448|NCT02025621|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6201449|NCT02025621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5589439|NCT03785587|Anticonvulsants|anticonvulsants|mesh-ancestor
5589440|NCT03785691|Ondansetron|ondansetron|mesh-list
5589441|NCT03785691|Mirtazapine|mirtazapine|mesh-list
5589442|NCT03785691|Antiemetics|antiemetics|mesh-ancestor
5589443|NCT03785691|Autonomic Agents|autonomic agents|mesh-ancestor
5589444|NCT03785691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5589445|NCT03785691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589446|NCT03785691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5589447|NCT03785691|Antipruritics|antipruritics|mesh-ancestor
5589448|NCT03785691|Dermatologic Agents|dermatologic agents|mesh-ancestor
5589449|NCT03785691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5589450|NCT03785691|Serotonin Agents|serotonin agents|mesh-ancestor
5589451|NCT03785691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5589452|NCT03785691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589453|NCT03785691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5589454|NCT03785691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5589455|NCT03785691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5589456|NCT03785691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5589457|NCT03785691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5589458|NCT03785691|Antidepressive Agents|antidepressive agents|mesh-ancestor
5589459|NCT03785691|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5589460|NCT03785691|Histamine Antagonists|histamine antagonists|mesh-ancestor
5589461|NCT03785691|Histamine Agents|histamine agents|mesh-ancestor
5589462|NCT03785691|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5589463|NCT03785691|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5589464|NCT03785691|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5589465|NCT03785691|Adrenergic Agents|adrenergic agents|mesh-ancestor
5589466|NCT03785691|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5589467|NCT03785691|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5589468|NCT03785613|Buprenorphine|buprenorphine|mesh-list
5589469|NCT03785613|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5589470|NCT03785613|Narcotics|narcotics|mesh-ancestor
5589471|NCT03785613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5589472|NCT03785613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589473|NCT03785613|Analgesics|analgesics|mesh-ancestor
5589474|NCT03785613|Sensory System Agents|sensory system agents|mesh-ancestor
5589475|NCT03785613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5589476|NCT03785613|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5589477|NCT03785522|Insulin|insulin|mesh-list
5589478|NCT03785522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5589479|NCT03785522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589480|NCT03785340|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6201450|NCT02025621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201451|NCT02025621|Protective Agents|protective agents|mesh-ancestor
6201452|NCT02025621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201453|NCT02025634|Acetaminophen|acetaminophen|mesh-list
6201454|NCT02025634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6201455|NCT02025634|Analgesics|analgesics|mesh-ancestor
6201456|NCT02025634|Sensory System Agents|sensory system agents|mesh-ancestor
6201457|NCT02025634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6201458|NCT02025634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201459|NCT02025634|Antipyretics|antipyretics|mesh-ancestor
6201460|NCT02025725|Metoclopramide|metoclopramide|mesh-list
6201461|NCT02025725|Antiemetics|antiemetics|mesh-ancestor
6201462|NCT02025725|Autonomic Agents|autonomic agents|mesh-ancestor
6201463|NCT02025725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6201464|NCT02025725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201465|NCT02025725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6201466|NCT02025725|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5589481|NCT03785340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5589482|NCT03785340|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5589483|NCT03785340|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6201467|NCT02025725|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6201468|NCT02025725|Dopamine Agents|dopamine agents|mesh-ancestor
6201469|NCT02025725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6201470|NCT02025725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201471|NCT02025751|Metoclopramide|metoclopramide|mesh-list
6201472|NCT02025751|Antiemetics|antiemetics|mesh-ancestor
6201473|NCT02025751|Autonomic Agents|autonomic agents|mesh-ancestor
6201474|NCT02025751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6201475|NCT02025751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201476|NCT02025751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5589484|NCT03785340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5589485|NCT03785340|Adrenergic Agents|adrenergic agents|mesh-ancestor
5589486|NCT03785340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5589487|NCT03785340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589488|NCT03785340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589489|NCT03785158|Melatonin|melatonin|mesh-list
5589490|NCT03785158|Antioxidants|antioxidants|mesh-ancestor
5589491|NCT03785158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589492|NCT03785158|Protective Agents|protective agents|mesh-ancestor
5589493|NCT03785158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589494|NCT03785158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5589495|NCT03785223|Methylphenidate|methylphenidate|mesh-list
5589496|NCT03785223|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6201477|NCT02025751|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6201478|NCT02025751|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6201479|NCT02025751|Dopamine Agents|dopamine agents|mesh-ancestor
6201480|NCT02025751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6201481|NCT02025751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201482|NCT02025907|Canagliflozin|canagliflozin|mesh-list
6201483|NCT02025907|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6201484|NCT02025907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201485|NCT02025907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6201486|NCT02025907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589497|NCT03785223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589498|NCT03785223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5589499|NCT03785223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5589500|NCT03785223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5589501|NCT03785223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589502|NCT03785223|Dopamine Agents|dopamine agents|mesh-ancestor
5589503|NCT03785223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5589504|NCT03785106|Vitamins|vitamins|mesh-list
5589505|NCT03785106|Pyridoxine|pyridoxine|mesh-list
5589506|NCT03785106|Pyridoxal|pyridoxal|mesh-list
5589507|NCT03785106|Vitamin B 6|vitamin b 6|mesh-list
5589508|NCT03785106|Vitamin B Complex|vitamin b complex|mesh-list
5589509|NCT03785106|Isoniazid|isoniazid|mesh-list
5589510|NCT03785106|Rifapentine|rifapentine|mesh-list
5589511|NCT03785106|Rifampin|rifampin|mesh-list
5589512|NCT03785106|Micronutrients|micronutrients|mesh-ancestor
5589513|NCT03785106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589514|NCT03785106|Antitubercular Agents|antitubercular agents|mesh-ancestor
5589515|NCT03785106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5589516|NCT03785106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5589517|NCT03785106|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6201487|NCT02026011|Naltrexone|naltrexone|mesh-list
6201488|NCT02026011|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6201489|NCT02026011|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6201490|NCT02026011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201491|NCT02026011|Sensory System Agents|sensory system agents|mesh-ancestor
6201492|NCT02026011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5589518|NCT03785106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5589519|NCT03785106|Antimetabolites|antimetabolites|mesh-ancestor
5589520|NCT03785106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589521|NCT03785106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5589522|NCT03785106|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5589523|NCT03785106|Leprostatic Agents|leprostatic agents|mesh-ancestor
5589524|NCT03785106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5589525|NCT03785106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5589526|NCT03785106|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5589527|NCT03785106|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5589528|NCT03785106|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5589529|NCT03785106|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5589530|NCT03785106|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5589531|NCT03785106|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5589532|NCT03785015|Aspirin|aspirin|mesh-list
5589533|NCT03785015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5589534|NCT03785015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5589535|NCT03785015|Analgesics|analgesics|mesh-ancestor
5589536|NCT03785015|Sensory System Agents|sensory system agents|mesh-ancestor
5589537|NCT03785015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5589538|NCT03785015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589539|NCT03785015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5589540|NCT03785015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5589541|NCT03785015|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5589542|NCT03785015|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5589543|NCT03785015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589544|NCT03785015|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5589545|NCT03785015|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5589546|NCT03785015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5589547|NCT03785015|Antipyretics|antipyretics|mesh-ancestor
5589548|NCT03785184|Dexamethasone|dexamethasone|mesh-list
5589549|NCT03785184|Lenalidomide|lenalidomide|mesh-list
5589550|NCT03785184|Venetoclax|venetoclax|mesh-list
5589551|NCT03785184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5589552|NCT03785184|Antiemetics|antiemetics|mesh-ancestor
5589553|NCT03785184|Autonomic Agents|autonomic agents|mesh-ancestor
5589554|NCT03785184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5589555|NCT03785184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589556|NCT03785184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5589557|NCT03785184|Glucocorticoids|glucocorticoids|mesh-ancestor
5589558|NCT03785184|Hormones|hormones|mesh-ancestor
5589559|NCT03785184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5589560|NCT03785184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5589561|NCT03785184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5589562|NCT03785184|Immunologic Factors|immunologic factors|mesh-ancestor
5589563|NCT03785184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5589564|NCT03785184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5589565|NCT03785184|Growth Substances|growth substances|mesh-ancestor
5589566|NCT03785184|Growth Inhibitors|growth inhibitors|mesh-ancestor
5589567|NCT03785041|Tramadol|tramadol|mesh-list
5589568|NCT03785041|Levobupivacaine|levobupivacaine|mesh-list
5589569|NCT03785041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5589570|NCT03785041|Narcotics|narcotics|mesh-ancestor
5589571|NCT03785041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5589572|NCT03785041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589573|NCT03785041|Analgesics|analgesics|mesh-ancestor
5589574|NCT03785041|Sensory System Agents|sensory system agents|mesh-ancestor
5589575|NCT03785041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5589576|NCT03785041|Anesthetics, Local|anesthetics, local|mesh-ancestor
5589577|NCT03785041|Anesthetics|anesthetics|mesh-ancestor
5589578|NCT03784794|Thrombin|thrombin|mesh-list
5589579|NCT03784794|Hemostatics|hemostatics|mesh-ancestor
5589580|NCT03784794|Coagulants|coagulants|mesh-ancestor
5589581|NCT03785067|Amlodipine|amlodipine|mesh-list
5589582|NCT03785067|Telmisartan|telmisartan|mesh-list
5589583|NCT03785067|Indapamide|indapamide|mesh-list
5589584|NCT03785067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5589585|NCT03785067|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5589586|NCT03785067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6201493|NCT02026141|Dexmedetomidine|dexmedetomidine|mesh-list
6201494|NCT02026141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6201495|NCT02026141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6201496|NCT02026141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201497|NCT02026141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6201498|NCT02026141|Analgesics|analgesics|mesh-ancestor
5589587|NCT03785067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589588|NCT03785067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5589589|NCT03785067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589590|NCT03785067|Vasodilator Agents|vasodilator agents|mesh-ancestor
5589591|NCT03785067|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5589592|NCT03785067|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5589593|NCT03785067|Diuretics|diuretics|mesh-ancestor
5589594|NCT03785067|Natriuretic Agents|natriuretic agents|mesh-ancestor
5589595|NCT03785067|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5589596|NCT03784495|Melatonin|melatonin|mesh-list
5589597|NCT03784495|Antioxidants|antioxidants|mesh-ancestor
5589598|NCT03784495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589599|NCT03784495|Protective Agents|protective agents|mesh-ancestor
5589600|NCT03784495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589601|NCT03784495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5589602|NCT03784599|Trastuzumab|trastuzumab|mesh-list
5589603|NCT03784599|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
5589604|NCT03784599|Osimertinib|osimertinib|mesh-list
5589605|NCT03784599|Maytansine|maytansine|mesh-list
6201499|NCT02026141|Sensory System Agents|sensory system agents|mesh-ancestor
6201500|NCT02026141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6201501|NCT02026141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6201502|NCT02026141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6201503|NCT02026141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6201504|NCT02026141|Adrenergic Agents|adrenergic agents|mesh-ancestor
6201505|NCT02026141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5589606|NCT03784599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5589607|NCT03784599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5589608|NCT03784599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5589609|NCT03784599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5589610|NCT03784599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589611|NCT03784599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5589612|NCT03784599|Tubulin Modulators|tubulin modulators|mesh-ancestor
5589613|NCT03784599|Antimitotic Agents|antimitotic agents|mesh-ancestor
5589614|NCT03784599|Mitosis Modulators|mitosis modulators|mesh-ancestor
5589615|NCT03784703|Atorvastatin|atorvastatin|mesh-list
5589616|NCT03784703|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5589617|NCT03784703|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5589618|NCT03784703|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5589619|NCT03784703|Antimetabolites|antimetabolites|mesh-ancestor
5589620|NCT03784703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589621|NCT03784703|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5589622|NCT03784703|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5589623|NCT03784703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5589624|NCT03784677|SOR-C13|sor-c13|mesh-list
5589625|NCT03784677|Calcium|calcium|mesh-list
5589626|NCT03784677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5589627|NCT03784677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589628|NCT03784677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5589629|NCT03784677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5589630|NCT03784677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5589631|NCT03784677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589632|NCT03784443|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
5589633|NCT03784443|Ranibizumab|ranibizumab|mesh-list
5589634|NCT03784443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5589635|NCT03784443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5589636|NCT03784443|Growth Substances|growth substances|mesh-ancestor
5589637|NCT03784443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589638|NCT03784443|Growth Inhibitors|growth inhibitors|mesh-ancestor
5589639|NCT03784443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5589640|NCT03784443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5589641|NCT03784443|Glucocorticoids|glucocorticoids|mesh-ancestor
5589642|NCT03784443|Hormones|hormones|mesh-ancestor
5589643|NCT03784443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5589644|NCT03784378|Agerafenib|agerafenib|mesh-list
5589645|NCT03784378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5589646|NCT03784378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5589647|NCT03784378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201506|NCT02026141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201507|NCT02026297|Tranexamic Acid|tranexamic acid|mesh-list
6201508|NCT02026297|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6201509|NCT02026297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6201510|NCT02026297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201511|NCT02026297|Hemostatics|hemostatics|mesh-ancestor
6201512|NCT02026297|Coagulants|coagulants|mesh-ancestor
6201513|NCT02027311|Midazolam|midazolam|mesh-list
6201514|NCT02027311|Meperidine|meperidine|mesh-list
6201515|NCT02027311|Etomidate|etomidate|mesh-list
6201516|NCT02027311|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6201517|NCT02027311|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6201518|NCT02027311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6201519|NCT02027311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589648|NCT03784547|Ocrelizumab|ocrelizumab|mesh-list
5589649|NCT03784547|Immunologic Factors|immunologic factors|mesh-ancestor
5589650|NCT03784547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589651|NCT03784391|Nifurtimox|nifurtimox|mesh-list
5589652|NCT03784391|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6201520|NCT02027311|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6201521|NCT02027311|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6201522|NCT02027311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6201523|NCT02027311|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6201524|NCT02027311|Anesthetics, General|anesthetics, general|mesh-ancestor
6201525|NCT02027311|Anesthetics|anesthetics|mesh-ancestor
6201526|NCT02027311|GABA Modulators|gaba modulators|mesh-ancestor
6201527|NCT02027311|GABA Agents|gaba agents|mesh-ancestor
6201528|NCT02027311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6201529|NCT02027311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201530|NCT02027311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6201531|NCT02027311|Narcotics|narcotics|mesh-ancestor
6201532|NCT02027311|Analgesics|analgesics|mesh-ancestor
6201533|NCT02027311|Sensory System Agents|sensory system agents|mesh-ancestor
6201534|NCT02027311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6201535|NCT02027376|Docetaxel|docetaxel|mesh-list
6201536|NCT02027376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6201537|NCT02027376|Tubulin Modulators|tubulin modulators|mesh-ancestor
6201538|NCT02027376|Antimitotic Agents|antimitotic agents|mesh-ancestor
6201539|NCT02027376|Mitosis Modulators|mitosis modulators|mesh-ancestor
6201540|NCT02027376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201541|NCT02027428|Paclitaxel|paclitaxel|mesh-list
6201542|NCT02027428|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6201543|NCT02027428|Carboplatin|carboplatin|mesh-list
6201544|NCT02027428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6201545|NCT02027428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6201546|NCT02027428|Tubulin Modulators|tubulin modulators|mesh-ancestor
6201547|NCT02027428|Antimitotic Agents|antimitotic agents|mesh-ancestor
6201548|NCT02027428|Mitosis Modulators|mitosis modulators|mesh-ancestor
6201549|NCT02027428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201550|NCT02028221|Metformin|metformin|mesh-list
6201551|NCT02028221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6201552|NCT02028221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201553|NCT02028676|Lamivudine|lamivudine|mesh-list
6201554|NCT02028676|Zidovudine|zidovudine|mesh-list
6201555|NCT02028676|Efavirenz|efavirenz|mesh-list
6201556|NCT02028676|Nevirapine|nevirapine|mesh-list
5589653|NCT03784391|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5589654|NCT03784391|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5589655|NCT03784391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5589656|NCT03784105|Codeine|codeine|mesh-list
5589657|NCT03784105|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5589658|NCT03784105|Narcotics|narcotics|mesh-ancestor
5589659|NCT03784105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5589660|NCT03784105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589661|NCT03784105|Analgesics|analgesics|mesh-ancestor
5589662|NCT03784105|Sensory System Agents|sensory system agents|mesh-ancestor
5589663|NCT03784105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5589664|NCT03784105|Antitussive Agents|antitussive agents|mesh-ancestor
5589665|NCT03784105|Respiratory System Agents|respiratory system agents|mesh-ancestor
5589666|NCT03784014|Durvalumab|durvalumab|mesh-list
6201557|NCT02028676|Abacavir|abacavir|mesh-list
5589667|NCT03784014|Olaparib|olaparib|mesh-list
5589668|NCT03784014|Lapatinib|lapatinib|mesh-list
5589669|NCT03784014|Palbociclib|palbociclib|mesh-list
5589670|NCT03784014|Trametinib|trametinib|mesh-list
5589671|NCT03784014|Dabrafenib|dabrafenib|mesh-list
5589672|NCT03784014|Ceritinib|ceritinib|mesh-list
5589673|NCT03784014|Futibatinib|futibatinib|mesh-list
5589674|NCT03784014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6201558|NCT02028676|Dideoxynucleosides|dideoxynucleosides|mesh-list
6201559|NCT02028676|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6201560|NCT02028676|Trimethoprim|trimethoprim|mesh-list
6201561|NCT02028676|Sulfamethoxazole|sulfamethoxazole|mesh-list
6201562|NCT02028676|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6201563|NCT02028676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6201564|NCT02028676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6201565|NCT02028676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6201566|NCT02028676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201567|NCT02028676|Antiviral Agents|antiviral agents|mesh-ancestor
6201568|NCT02028676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6201569|NCT02028676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6201570|NCT02028676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6201571|NCT02028676|Antimetabolites|antimetabolites|mesh-ancestor
6201572|NCT02028676|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6201573|NCT02028676|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6201574|NCT02028676|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6201575|NCT02028676|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6201576|NCT02028676|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6201577|NCT02028676|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6201578|NCT02028676|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6201579|NCT02028676|Renal Agents|renal agents|mesh-ancestor
6201580|NCT02028676|Antimalarials|antimalarials|mesh-ancestor
6201581|NCT02028676|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6201582|NCT02028676|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6201583|NCT02028676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6201584|NCT02028676|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6201585|NCT02028676|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6201586|NCT02028676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6201587|NCT02028715|Acetaminophen|acetaminophen|mesh-list
6201588|NCT02028715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6201589|NCT02028715|Analgesics|analgesics|mesh-ancestor
6201590|NCT02028715|Sensory System Agents|sensory system agents|mesh-ancestor
6201591|NCT02028715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6201592|NCT02028715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201593|NCT02028715|Antipyretics|antipyretics|mesh-ancestor
6201594|NCT02028754|Levofloxacin|levofloxacin|mesh-list
6201595|NCT02028754|Ofloxacin|ofloxacin|mesh-list
6201596|NCT02028754|Prednisolone|prednisolone|mesh-list
6201597|NCT02028754|Prednisolone acetate|prednisolone acetate|mesh-list
6201598|NCT02028754|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6201599|NCT02028754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6201600|NCT02028754|Glucocorticoids|glucocorticoids|mesh-ancestor
6201601|NCT02028754|Hormones|hormones|mesh-ancestor
6201602|NCT02028754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6201603|NCT02028754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201604|NCT02028754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6201605|NCT02028754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6201606|NCT02028754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6201607|NCT02028754|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6201608|NCT02028754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6201609|NCT02028754|Renal Agents|renal agents|mesh-ancestor
6201610|NCT02028754|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6201611|NCT02028754|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6201612|NCT02028754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5589675|NCT03784014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5589676|NCT03784014|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5589677|NCT03784014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5589678|NCT03784014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589679|NCT03784014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5589680|NCT03784326|Fluorouracil|fluorouracil|mesh-list
5589681|NCT03784326|Oxaliplatin|oxaliplatin|mesh-list
5589682|NCT03784326|Atezolizumab|atezolizumab|mesh-list
5589683|NCT03784326|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5589684|NCT03784326|Antimetabolites|antimetabolites|mesh-ancestor
5589685|NCT03784326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589686|NCT03784326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5589687|NCT03784326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5589688|NCT03784326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5589689|NCT03784326|Immunologic Factors|immunologic factors|mesh-ancestor
5589690|NCT03784326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589691|NCT03784261|Abatacept|abatacept|mesh-list
5589692|NCT03784261|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5589693|NCT03784261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589694|NCT03784261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6201613|NCT02028754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6201614|NCT02028754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201615|NCT02028754|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6201616|NCT02028754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6201617|NCT02028754|Laxatives|laxatives|mesh-ancestor
6201618|NCT02028767|Metformin|metformin|mesh-list
6201619|NCT02028767|Empagliflozin|empagliflozin|mesh-list
6201620|NCT02028767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6201621|NCT02028767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201622|NCT02028767|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6201623|NCT02028767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201624|NCT02028780|Dabigatran|dabigatran|mesh-list
6201625|NCT02028780|Antithrombins|antithrombins|mesh-ancestor
6201626|NCT02028780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6201627|NCT02028780|Protease Inhibitors|protease inhibitors|mesh-ancestor
6201628|NCT02028780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6201629|NCT02028780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201630|NCT02028780|Anticoagulants|anticoagulants|mesh-ancestor
6201631|NCT02028871|Insulin|insulin|mesh-list
6201632|NCT02028871|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6201633|NCT02028871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201634|NCT02029235|Acetaminophen|acetaminophen|mesh-list
6201635|NCT02029235|Ibuprofen|ibuprofen|mesh-list
6201636|NCT02029235|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
6201637|NCT02029235|Hydrocodone|hydrocodone|mesh-list
6201638|NCT02029235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6201639|NCT02029235|Analgesics|analgesics|mesh-ancestor
6201640|NCT02029235|Sensory System Agents|sensory system agents|mesh-ancestor
6201641|NCT02029235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6201642|NCT02029235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201643|NCT02029235|Antipyretics|antipyretics|mesh-ancestor
6201644|NCT02029235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6201645|NCT02029235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6201646|NCT02029235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6201647|NCT02029235|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6201648|NCT02029235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6201649|NCT02029235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201650|NCT02029235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6201651|NCT02029235|Narcotics|narcotics|mesh-ancestor
6201652|NCT02029235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6201653|NCT02029235|Antitussive Agents|antitussive agents|mesh-ancestor
6201654|NCT02029235|Respiratory System Agents|respiratory system agents|mesh-ancestor
6201655|NCT02029274|Siponimod|siponimod|mesh-list
6201656|NCT02029274|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6201657|NCT02029274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201658|NCT02029274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6201659|NCT02029274|Immunologic Factors|immunologic factors|mesh-ancestor
6201660|NCT02029274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201661|NCT02029417|Cytarabine|cytarabine|mesh-list
6201662|NCT02029417|Decitabine|decitabine|mesh-list
6201663|NCT02029417|Azacitidine|azacitidine|mesh-list
6201664|NCT02029417|Homoharringtonine|homoharringtonine|mesh-list
6201665|NCT02029417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6201666|NCT02029417|Antimetabolites|antimetabolites|mesh-ancestor
6201667|NCT02029417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201668|NCT02029417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6201669|NCT02029417|Antiviral Agents|antiviral agents|mesh-ancestor
6201670|NCT02029417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6201671|NCT02029417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6201672|NCT02029417|Immunologic Factors|immunologic factors|mesh-ancestor
6201673|NCT02029417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201674|NCT02029417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6201675|NCT02029417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6201676|NCT02029417|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6201677|NCT02029495|Brodalumab|brodalumab|mesh-list
6201678|NCT02029495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6201679|NCT02029495|Dermatologic Agents|dermatologic agents|mesh-ancestor
6201680|NCT02029495|Immunologic Factors|immunologic factors|mesh-ancestor
5589695|NCT03784261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5589696|NCT03784261|Immunologic Factors|immunologic factors|mesh-ancestor
5589697|NCT03784261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589698|NCT03784261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5589699|NCT03783897|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5589700|NCT03783897|Norgestimate|norgestimate|mesh-list
5589701|NCT03783897|Contraceptive Agents|contraceptive agents|mesh-list
5589702|NCT03783897|Contraceptives, Oral|contraceptives, oral|mesh-list
6201681|NCT02029495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201682|NCT02029638|Acetaminophen|acetaminophen|mesh-list
6201683|NCT02029638|Diphenhydramine|diphenhydramine|mesh-list
6201684|NCT02029638|Promethazine|promethazine|mesh-list
6201685|NCT02029638|Mycophenolic Acid|mycophenolic acid|mesh-list
6201686|NCT02029638|Prednisone|prednisone|mesh-list
6201687|NCT02029638|Methylprednisolone|methylprednisolone|mesh-list
6201688|NCT02029638|Cyclophosphamide|cyclophosphamide|mesh-list
6201689|NCT02029638|Fludarabine|fludarabine|mesh-list
6201690|NCT02029638|Thymoglobulin|thymoglobulin|mesh-list
6201691|NCT02029638|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6201692|NCT02029638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6201693|NCT02029638|Immunologic Factors|immunologic factors|mesh-ancestor
6201694|NCT02029638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201695|NCT02029638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6201696|NCT02029638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5589703|NCT03783897|Estradiol|estradiol|mesh-list
5589704|NCT03783897|Estrogens|estrogens|mesh-ancestor
5589705|NCT03783897|Hormones|hormones|mesh-ancestor
5589706|NCT03783897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5589707|NCT03783897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589708|NCT03783897|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5589709|NCT03783897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5589710|NCT03783897|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5589711|NCT03783897|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5589712|NCT03783897|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5605399|NCT02774265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5605400|NCT02774265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5605401|NCT02774265|Antipyretics|antipyretics|mesh-ancestor
5605402|NCT02774265|Anticoagulants|anticoagulants|mesh-ancestor
5605403|NCT02736617|Obinutuzumab|obinutuzumab|mesh-list
5605404|NCT02736617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5605405|NCT02736617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605406|NCT02695992|Metoprolol|metoprolol|mesh-list
5605407|NCT02695992|Diltiazem|diltiazem|mesh-list
5605408|NCT02695992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5605409|NCT02695992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5605410|NCT02695992|Sympatholytics|sympatholytics|mesh-ancestor
5605411|NCT02695992|Autonomic Agents|autonomic agents|mesh-ancestor
5605412|NCT02695992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5605413|NCT02695992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605414|NCT02695992|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5605415|NCT02695992|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5605416|NCT02695992|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5605417|NCT02695992|Adrenergic Agents|adrenergic agents|mesh-ancestor
5605418|NCT02695992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5605419|NCT02695992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605420|NCT02695992|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5605421|NCT02695992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5605422|NCT02695992|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5605423|NCT02695992|Vasodilator Agents|vasodilator agents|mesh-ancestor
5605424|NCT02693535|Pembrolizumab|pembrolizumab|mesh-list
5605425|NCT02693535|Nivolumab|nivolumab|mesh-list
5605426|NCT02693535|Trastuzumab|trastuzumab|mesh-list
5605427|NCT02693535|Ipilimumab|ipilimumab|mesh-list
5605428|NCT02693535|Pertuzumab|pertuzumab|mesh-list
5605429|NCT02693535|Atezolizumab|atezolizumab|mesh-list
5605430|NCT02693535|Sunitinib|sunitinib|mesh-list
5605431|NCT02693535|Olaparib|olaparib|mesh-list
5605432|NCT02693535|Palbociclib|palbociclib|mesh-list
5605433|NCT02693535|Afatinib|afatinib|mesh-list
5605434|NCT02693535|Vemurafenib|vemurafenib|mesh-list
5605435|NCT02693535|Crizotinib|crizotinib|mesh-list
5605436|NCT02693535|Talazoparib|talazoparib|mesh-list
6201697|NCT02029638|Alkylating Agents|alkylating agents|mesh-ancestor
6201698|NCT02029638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201699|NCT02029638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605437|NCT02693535|Tucatinib|tucatinib|mesh-list
5605438|NCT02693535|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5605439|NCT02693535|Entrectinib|entrectinib|mesh-list
5605440|NCT02693535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5605441|NCT02693535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6201700|NCT02029638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6201701|NCT02029638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6201702|NCT02029638|Glucocorticoids|glucocorticoids|mesh-ancestor
6201703|NCT02029638|Hormones|hormones|mesh-ancestor
5589713|NCT03783949|Gemcitabine|gemcitabine|mesh-list
5589714|NCT03783949|Paclitaxel|paclitaxel|mesh-list
5589715|NCT03783949|Carboplatin|carboplatin|mesh-list
5589716|NCT03783949|Niraparib|niraparib|mesh-list
5589717|NCT03783949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5589718|NCT03783949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5589719|NCT03783949|Tubulin Modulators|tubulin modulators|mesh-ancestor
5589720|NCT03783949|Antimitotic Agents|antimitotic agents|mesh-ancestor
5589721|NCT03783949|Mitosis Modulators|mitosis modulators|mesh-ancestor
5589722|NCT03783949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589723|NCT03783949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5589724|NCT03783949|Antimetabolites|antimetabolites|mesh-ancestor
5589725|NCT03783949|Antiviral Agents|antiviral agents|mesh-ancestor
5589726|NCT03783949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5589727|NCT03783949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5589728|NCT03783949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5589729|NCT03783949|Immunologic Factors|immunologic factors|mesh-ancestor
5589730|NCT03783949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589731|NCT03783949|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5589732|NCT03783936|Leucovorin|leucovorin|mesh-list
5589733|NCT03783936|Fluorouracil|fluorouracil|mesh-list
5589734|NCT03783936|Oxaliplatin|oxaliplatin|mesh-list
5589735|NCT03783936|Trastuzumab|trastuzumab|mesh-list
5589736|NCT03783936|Avelumab|avelumab|mesh-list
5589737|NCT03783936|Antimetabolites|antimetabolites|mesh-ancestor
5589738|NCT03783936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589739|NCT03783936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5589740|NCT03783936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5589741|NCT03783936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5589742|NCT03783936|Immunologic Factors|immunologic factors|mesh-ancestor
5589743|NCT03783936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589744|NCT03783936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5589745|NCT03783936|Antidotes|antidotes|mesh-ancestor
5589746|NCT03783936|Protective Agents|protective agents|mesh-ancestor
5589747|NCT03783936|Vitamin B Complex|vitamin b complex|mesh-ancestor
5589748|NCT03783936|Vitamins|vitamins|mesh-ancestor
5589749|NCT03783936|Micronutrients|micronutrients|mesh-ancestor
5589750|NCT03784040|Nivolumab|nivolumab|mesh-list
5589751|NCT03784040|Ipilimumab|ipilimumab|mesh-list
5589752|NCT03784040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5589753|NCT03784040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5589754|NCT03784040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5589755|NCT03784040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589756|NCT03783845|Amoxicillin|amoxicillin|mesh-list
5589757|NCT03783845|Metronidazole|metronidazole|mesh-list
5589758|NCT03783845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5589759|NCT03783845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5589760|NCT03783845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5589761|NCT03783845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5589762|NCT03783728|Pyridoxine|pyridoxine|mesh-list
5589763|NCT03783728|Vitamin B 6|vitamin b 6|mesh-list
5589764|NCT03783728|Isoniazid|isoniazid|mesh-list
5589765|NCT03783728|Rifapentine|rifapentine|mesh-list
5589766|NCT03783728|Vitamins|vitamins|mesh-ancestor
5589767|NCT03783728|Micronutrients|micronutrients|mesh-ancestor
5589768|NCT03783728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589769|NCT03783728|Vitamin B Complex|vitamin b complex|mesh-ancestor
5589770|NCT03783728|Antitubercular Agents|antitubercular agents|mesh-ancestor
5589771|NCT03783728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5589772|NCT03783728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5589773|NCT03783728|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5589774|NCT03783728|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5589775|NCT03783728|Antimetabolites|antimetabolites|mesh-ancestor
5589776|NCT03783728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589777|NCT03783728|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5589778|NCT03783728|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5589779|NCT03783728|Leprostatic Agents|leprostatic agents|mesh-ancestor
5589780|NCT03783754|Amlodipine|amlodipine|mesh-list
5589781|NCT03783754|Telmisartan|telmisartan|mesh-list
5589782|NCT03783754|Indapamide|indapamide|mesh-list
5589783|NCT03783754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5589784|NCT03783754|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5589785|NCT03783754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5589786|NCT03783754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6207700|NCT02119468|Dexamethasone|dexamethasone|mesh-list
6207701|NCT02119468|Pomalidomide|pomalidomide|mesh-list
6201704|NCT02029638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6201705|NCT02029638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6201706|NCT02029638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5589787|NCT03783754|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5589788|NCT03783754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589789|NCT03783754|Vasodilator Agents|vasodilator agents|mesh-ancestor
5589790|NCT03783754|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5589791|NCT03783754|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5589792|NCT03783754|Diuretics|diuretics|mesh-ancestor
5589793|NCT03783754|Natriuretic Agents|natriuretic agents|mesh-ancestor
6201707|NCT02029638|Analgesics|analgesics|mesh-ancestor
6201708|NCT02029638|Sensory System Agents|sensory system agents|mesh-ancestor
6201709|NCT02029638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6201710|NCT02029638|Antipyretics|antipyretics|mesh-ancestor
6201711|NCT02029638|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6201712|NCT02029638|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6201713|NCT02029638|Antitubercular Agents|antitubercular agents|mesh-ancestor
6201714|NCT02029638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6201715|NCT02029638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6201716|NCT02029638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6201717|NCT02029638|Antiemetics|antiemetics|mesh-ancestor
6201718|NCT02029638|Autonomic Agents|autonomic agents|mesh-ancestor
6201719|NCT02029638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6201720|NCT02029638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6201721|NCT02029638|Protective Agents|protective agents|mesh-ancestor
6201722|NCT02029638|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6201723|NCT02029638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5589794|NCT03783754|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5589795|NCT03783715|Ketoprofen|ketoprofen|mesh-list
5589796|NCT03783715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5589797|NCT03783715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5589798|NCT03783715|Analgesics|analgesics|mesh-ancestor
5589799|NCT03783715|Sensory System Agents|sensory system agents|mesh-ancestor
5589800|NCT03783715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5589801|NCT03783715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589802|NCT03783715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5589803|NCT03783715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5589804|NCT03783715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5589805|NCT03783715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5589806|NCT03783715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589807|NCT03783494|Propofol|propofol|mesh-list
5589808|NCT03783494|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5589809|NCT03783494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5589810|NCT03783494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589811|NCT03783494|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5589812|NCT03783494|Anesthetics, General|anesthetics, general|mesh-ancestor
5589813|NCT03783494|Anesthetics|anesthetics|mesh-ancestor
5589814|NCT03783442|Paclitaxel|paclitaxel|mesh-list
5589815|NCT03783442|Fluorouracil|fluorouracil|mesh-list
5589816|NCT03783442|Capecitabine|capecitabine|mesh-list
5589817|NCT03783442|Oxaliplatin|oxaliplatin|mesh-list
5589818|NCT03783442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5589819|NCT03783442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5589820|NCT03783442|Tubulin Modulators|tubulin modulators|mesh-ancestor
5589821|NCT03783442|Antimitotic Agents|antimitotic agents|mesh-ancestor
5589822|NCT03783442|Mitosis Modulators|mitosis modulators|mesh-ancestor
5589823|NCT03783442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589824|NCT03783442|Antimetabolites|antimetabolites|mesh-ancestor
5589825|NCT03783442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5589826|NCT03783442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5589827|NCT03783442|Immunologic Factors|immunologic factors|mesh-ancestor
5589828|NCT03783442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589829|NCT03783676|Remifentanil|remifentanil|mesh-list
5589830|NCT03783676|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5589831|NCT03783676|Narcotics|narcotics|mesh-ancestor
5589832|NCT03783676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5589833|NCT03783676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589834|NCT03783676|Analgesics|analgesics|mesh-ancestor
5589835|NCT03783676|Sensory System Agents|sensory system agents|mesh-ancestor
5589836|NCT03783676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5589837|NCT03783455|Hyaluronic Acid|hyaluronic acid|mesh-list
5589838|NCT03783455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5589839|NCT03783455|Immunologic Factors|immunologic factors|mesh-ancestor
6201724|NCT02029638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6201725|NCT02029638|Anesthetics, Local|anesthetics, local|mesh-ancestor
5589840|NCT03783455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589841|NCT03783455|Viscosupplements|viscosupplements|mesh-ancestor
5589842|NCT03783455|Protective Agents|protective agents|mesh-ancestor
5589843|NCT03783520|Sodium Hypochlorite|sodium hypochlorite|mesh-list
5589844|NCT03783520|Eusol|eusol|mesh-list
5589845|NCT03783520|Disinfectants|disinfectants|mesh-ancestor
5589846|NCT03783520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5589847|NCT03783338|Vitamin D|vitamin d|mesh-list
5589848|NCT03783338|Vitamins|vitamins|mesh-ancestor
5589849|NCT03783338|Micronutrients|micronutrients|mesh-ancestor
5589850|NCT03783338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589851|NCT03783338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5589852|NCT03783416|Ixazomib|ixazomib|mesh-list
5589853|NCT03783416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5589854|NCT03783416|Protease Inhibitors|protease inhibitors|mesh-ancestor
5589855|NCT03783416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5589856|NCT03783416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589857|NCT03783312|Acetaminophen|acetaminophen|mesh-list
5589858|NCT03783312|Ibuprofen|ibuprofen|mesh-list
5589859|NCT03783312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5589860|NCT03783312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5589861|NCT03783312|Analgesics|analgesics|mesh-ancestor
5589862|NCT03783312|Sensory System Agents|sensory system agents|mesh-ancestor
5589863|NCT03783312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5589864|NCT03783312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589865|NCT03783312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5589866|NCT03783312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5589867|NCT03783312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5589868|NCT03783312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5589869|NCT03783312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589870|NCT03783312|Antipyretics|antipyretics|mesh-ancestor
5589871|NCT03783429|Digoxin|digoxin|mesh-list
5589872|NCT03783429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5589873|NCT03783429|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5589874|NCT03783429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5589875|NCT03783429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589876|NCT03783429|Protective Agents|protective agents|mesh-ancestor
5589877|NCT03783429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589878|NCT03783182|Betamethasone|betamethasone|mesh-list
5589879|NCT03783182|Betamethasone Valerate|betamethasone valerate|mesh-list
5589880|NCT03783182|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5589881|NCT03783182|Betamethasone benzoate|betamethasone benzoate|mesh-list
5589882|NCT03783182|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
5589883|NCT03783182|Glucocorticoids|glucocorticoids|mesh-ancestor
5589884|NCT03783182|Hormones|hormones|mesh-ancestor
5589885|NCT03783182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5589886|NCT03783182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589887|NCT03783182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5589888|NCT03783182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5589889|NCT03783182|Respiratory System Agents|respiratory system agents|mesh-ancestor
5589890|NCT03783299|Lumefantrine|lumefantrine|mesh-list
5589891|NCT03783299|Artemether|artemether|mesh-list
5589892|NCT03783299|Primaquine|primaquine|mesh-list
5589893|NCT03783299|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
5589894|NCT03783299|Antimalarials|antimalarials|mesh-ancestor
5589895|NCT03783299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5589896|NCT03783299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5589897|NCT03783299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5589898|NCT03783273|Vitamin D|vitamin d|mesh-list
5589899|NCT03783273|Cholecalciferol|cholecalciferol|mesh-list
5589900|NCT03783273|Vitamins|vitamins|mesh-ancestor
5589901|NCT03783273|Micronutrients|micronutrients|mesh-ancestor
5589902|NCT03783273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201726|NCT02029638|Anesthetics|anesthetics|mesh-ancestor
5589903|NCT03783273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5589904|NCT03783273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6201727|NCT02029638|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5589905|NCT03782987|Itraconazole|itraconazole|mesh-list
5589906|NCT03782987|Antifungal Agents|antifungal agents|mesh-ancestor
5589907|NCT03782987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5589908|NCT03782987|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5589909|NCT03782987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5589910|NCT03782987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5589911|NCT03782987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589912|NCT03782987|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5589913|NCT03782987|Hormone Antagonists|hormone antagonists|mesh-ancestor
5589914|NCT03782987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5589915|NCT03782987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589916|NCT03782987|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5589917|NCT03783065|Propranolol|propranolol|mesh-list
5589918|NCT03783065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5589919|NCT03783065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5589920|NCT03783065|Adrenergic Agents|adrenergic agents|mesh-ancestor
5589921|NCT03783065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5589922|NCT03783065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589923|NCT03783065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589924|NCT03783065|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5589925|NCT03783065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5589926|NCT03783065|Vasodilator Agents|vasodilator agents|mesh-ancestor
5589927|NCT03783078|Pembrolizumab|pembrolizumab|mesh-list
5589928|NCT03783078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5589929|NCT03783078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5589930|NCT03782935|Choline|choline|mesh-list
5589931|NCT03782935|Lipotropic Agents|lipotropic agents|mesh-ancestor
5589932|NCT03782935|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5589933|NCT03782935|Antimetabolites|antimetabolites|mesh-ancestor
5589934|NCT03782935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589935|NCT03782935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5589936|NCT03782935|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5589937|NCT03782935|Nootropic Agents|nootropic agents|mesh-ancestor
5589938|NCT03783013|Lycopene|lycopene|mesh-list
5589939|NCT03783013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5589940|NCT03783013|Antioxidants|antioxidants|mesh-ancestor
5589941|NCT03783013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589942|NCT03783013|Protective Agents|protective agents|mesh-ancestor
5589943|NCT03783013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589944|NCT03783013|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5589945|NCT03783013|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5589946|NCT03783013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5589947|NCT03782740|Melatonin|melatonin|mesh-list
5589948|NCT03782740|Antioxidants|antioxidants|mesh-ancestor
5589949|NCT03782740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589950|NCT03782740|Protective Agents|protective agents|mesh-ancestor
5589951|NCT03782740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589952|NCT03782740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5589953|NCT03782831|Antibodies|antibodies|mesh-list
5589954|NCT03782831|Immunologic Factors|immunologic factors|mesh-ancestor
5589955|NCT03782831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589956|NCT03783000|BI 425809|bi 425809|mesh-list
5589957|NCT03783000|Nootropic Agents|nootropic agents|mesh-ancestor
5589958|NCT03782805|Cholecalciferol|cholecalciferol|mesh-list
5589959|NCT03782805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5589960|NCT03782805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589961|NCT03782805|Vitamins|vitamins|mesh-ancestor
5589962|NCT03782805|Micronutrients|micronutrients|mesh-ancestor
5589963|NCT03782805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5589964|NCT03782818|Olaparib|olaparib|mesh-list
5589965|NCT03782818|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5589966|NCT03782818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5589967|NCT03782818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589968|NCT03782818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5589969|NCT03782662|Itraconazole|itraconazole|mesh-list
5589970|NCT03782662|Rifampin|rifampin|mesh-list
5589971|NCT03782662|Verapamil|verapamil|mesh-list
5589972|NCT03782662|Midazolam|midazolam|mesh-list
5589973|NCT03782662|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5589974|NCT03782662|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5589975|NCT03782662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5589976|NCT03782662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5589977|NCT03782662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6207702|NCT02119468|Ixazomib|ixazomib|mesh-list
5589978|NCT03782662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6201728|NCT02029638|Histamine Antagonists|histamine antagonists|mesh-ancestor
6201729|NCT02029638|Histamine Agents|histamine agents|mesh-ancestor
6201730|NCT02029638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6201731|NCT02029638|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6201732|NCT02029638|Antipruritics|antipruritics|mesh-ancestor
6201733|NCT02029638|Dermatologic Agents|dermatologic agents|mesh-ancestor
6201734|NCT02029703|Hylan|hylan|mesh-list
6201735|NCT02029703|Viscosupplements|viscosupplements|mesh-ancestor
6201736|NCT02029703|Protective Agents|protective agents|mesh-ancestor
6201737|NCT02029703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201738|NCT02029755|Anesthetics|anesthetics|mesh-list
6201739|NCT02029755|Anesthetics, Local|anesthetics, local|mesh-list
6201740|NCT02029755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5589979|NCT03782662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5589980|NCT03782662|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5589981|NCT03782662|Anesthetics, General|anesthetics, general|mesh-ancestor
5589982|NCT03782662|Anesthetics|anesthetics|mesh-ancestor
5589983|NCT03782662|GABA Modulators|gaba modulators|mesh-ancestor
5589984|NCT03782662|GABA Agents|gaba agents|mesh-ancestor
5589985|NCT03782662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5589986|NCT03782662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5589987|NCT03782662|Antifungal Agents|antifungal agents|mesh-ancestor
5589988|NCT03782662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5589989|NCT03782662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5589990|NCT03782662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5589991|NCT03782662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5589992|NCT03782662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5589993|NCT03782662|Hormone Antagonists|hormone antagonists|mesh-ancestor
5589994|NCT03782662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5589995|NCT03782662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5589996|NCT03782662|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5589997|NCT03782662|Antitubercular Agents|antitubercular agents|mesh-ancestor
5589998|NCT03782662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5589999|NCT03782662|Leprostatic Agents|leprostatic agents|mesh-ancestor
5590000|NCT03782662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5590001|NCT03782662|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5590002|NCT03782662|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5590003|NCT03782662|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5590004|NCT03782662|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5590005|NCT03782662|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5590006|NCT03782662|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5590007|NCT03782662|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5590008|NCT03782662|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5590009|NCT03782662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5590010|NCT03782662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5590011|NCT03782662|Vasodilator Agents|vasodilator agents|mesh-ancestor
5590012|NCT03782480|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
5590013|NCT03782480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5590014|NCT03782480|Immunologic Factors|immunologic factors|mesh-ancestor
5590015|NCT03782480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590016|NCT03782415|Temozolomide|temozolomide|mesh-list
5590017|NCT03782415|Ibudilast|ibudilast|mesh-list
5590018|NCT03782415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5590019|NCT03782415|Alkylating Agents|alkylating agents|mesh-ancestor
5590020|NCT03782415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5590021|NCT03782415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5590022|NCT03782415|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5590023|NCT03782415|Autonomic Agents|autonomic agents|mesh-ancestor
5590024|NCT03782415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5590025|NCT03782415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590026|NCT03782415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5590027|NCT03782415|Respiratory System Agents|respiratory system agents|mesh-ancestor
5590028|NCT03782415|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5590029|NCT03782415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5590030|NCT03782415|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5590031|NCT03782415|Vasodilator Agents|vasodilator agents|mesh-ancestor
5605442|NCT02693535|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5605443|NCT02693535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605444|NCT02693535|Immunologic Factors|immunologic factors|mesh-ancestor
5605445|NCT02693535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605446|NCT02693535|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6201741|NCT02029755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201742|NCT02029755|Sensory System Agents|sensory system agents|mesh-ancestor
5590032|NCT03782025|Vitamin K 1|vitamin k 1|mesh-list
5590033|NCT03782025|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5590034|NCT03782025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5590035|NCT03782025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5590036|NCT03782025|Hemostatics|hemostatics|mesh-ancestor
5590037|NCT03782025|Coagulants|coagulants|mesh-ancestor
6201743|NCT02029755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6201744|NCT02029872|Chlorhexidine|chlorhexidine|mesh-list
6201745|NCT02029872|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6201746|NCT02029872|Mupirocin|mupirocin|mesh-list
6201747|NCT02029872|Calcium|calcium|mesh-list
6201748|NCT02029872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6201749|NCT02029872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201750|NCT02029872|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5590038|NCT03782025|Vitamins|vitamins|mesh-ancestor
5590039|NCT03782025|Micronutrients|micronutrients|mesh-ancestor
5590040|NCT03782025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590041|NCT03781947|Antarelix|antarelix|mesh-list
5590042|NCT03781947|Hormone Antagonists|hormone antagonists|mesh-ancestor
5590043|NCT03781947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6488324|NCT00583193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6488325|NCT00583193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5590044|NCT03781947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590045|NCT03782064|Nivolumab|nivolumab|mesh-list
5590046|NCT03782064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5590047|NCT03782064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5590048|NCT03782064|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5590049|NCT03782064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5590050|NCT03781960|Nivolumab|nivolumab|mesh-list
5590051|NCT03781960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5590052|NCT03781960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5590053|NCT03781960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5590054|NCT03781960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5590055|NCT03781908|Silver Nitrate|silver nitrate|mesh-list
5590056|NCT03781908|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5590057|NCT03781908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5590058|NCT03782142|Tenofovir|tenofovir|mesh-list
5590059|NCT03782142|Dolutegravir|dolutegravir|mesh-list
5590060|NCT03782142|Rilpivirine|rilpivirine|mesh-list
5590061|NCT03782142|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
5590062|NCT03782142|Antiviral Agents|antiviral agents|mesh-ancestor
5590063|NCT03782142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5590064|NCT03782142|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5590065|NCT03782142|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5590066|NCT03782142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5590067|NCT03782142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5590068|NCT03782142|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5590069|NCT03782142|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5590070|NCT03782142|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5590071|NCT03782142|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5590072|NCT03782142|Protease Inhibitors|protease inhibitors|mesh-ancestor
5590073|NCT03782142|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5590074|NCT03782142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5590075|NCT03781895|Cholecalciferol|cholecalciferol|mesh-list
5590076|NCT03781895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5590077|NCT03781895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590078|NCT03781895|Vitamins|vitamins|mesh-ancestor
5590079|NCT03781895|Micronutrients|micronutrients|mesh-ancestor
5590080|NCT03781895|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5590081|NCT03781765|Methylphenidate|methylphenidate|mesh-list
5590082|NCT03781765|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
5590083|NCT03781765|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5590084|NCT03781765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590085|NCT03781765|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5590086|NCT03781765|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5590087|NCT03781765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5590088|NCT03781765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5590089|NCT03781765|Dopamine Agents|dopamine agents|mesh-ancestor
5590090|NCT03781765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5590091|NCT03781765|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5590092|NCT03781765|Adrenergic Agents|adrenergic agents|mesh-ancestor
5590093|NCT03781843|Lidocaine|lidocaine|mesh-list
5590094|NCT03781843|Anesthetics, Local|anesthetics, local|mesh-ancestor
6201751|NCT02029872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6201752|NCT02029872|Disinfectants|disinfectants|mesh-ancestor
6201753|NCT02029872|Dermatologic Agents|dermatologic agents|mesh-ancestor
6201754|NCT02029872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6201755|NCT02029872|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6201756|NCT02029872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6201757|NCT02029872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201758|NCT02030041|Vitamin D|vitamin d|mesh-list
6201759|NCT02030041|Cholecalciferol|cholecalciferol|mesh-list
6201760|NCT02030041|Simvastatin|simvastatin|mesh-list
6201761|NCT02030041|Vitamins|vitamins|mesh-ancestor
6201762|NCT02030041|Micronutrients|micronutrients|mesh-ancestor
6201763|NCT02030041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201764|NCT02030041|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6201765|NCT02030041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6201766|NCT02030041|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5590095|NCT03781843|Anesthetics|anesthetics|mesh-ancestor
5590096|NCT03781843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5590097|NCT03781843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590098|NCT03781843|Sensory System Agents|sensory system agents|mesh-ancestor
5590099|NCT03781843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5590100|NCT03781843|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5590101|NCT03781843|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5590102|NCT03781843|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5590103|NCT03781843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5590104|NCT03781843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5590105|NCT03781869|Cisplatin|cisplatin|mesh-list
5590106|NCT03781869|Etoposide|etoposide|mesh-list
5590107|NCT03781869|Etoposide phosphate|etoposide phosphate|mesh-list
5590108|NCT03781869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5590109|NCT03781869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5590110|NCT03781869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5590111|NCT03781869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5590112|NCT03781869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5590113|NCT03781869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5590114|NCT03781687|Morphine|morphine|mesh-list
5590115|NCT03781687|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5590116|NCT03781687|Narcotics|narcotics|mesh-ancestor
5590117|NCT03781687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6672363|NCT01555632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672364|NCT01555632|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6672365|NCT01555632|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6672366|NCT01555632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6672367|NCT01555658|Heparin|heparin|mesh-list
6672368|NCT01555658|Bivalirudin|bivalirudin|mesh-list
6672369|NCT01555658|Anticoagulants|anticoagulants|mesh-ancestor
6672370|NCT01555658|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6672371|NCT01555658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6672372|NCT01555658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672373|NCT01555658|Antithrombins|antithrombins|mesh-ancestor
6672374|NCT01555658|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6672375|NCT01555658|Protease Inhibitors|protease inhibitors|mesh-ancestor
6672376|NCT01555658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6672620|NCT01557270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672621|NCT01557335|Aspirin|aspirin|mesh-list
6672622|NCT01557335|Omeprazole|omeprazole|mesh-list
6672623|NCT01557335|Clopidogrel|clopidogrel|mesh-list
6672624|NCT01557335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6672625|NCT01557335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6672626|NCT01557335|Analgesics|analgesics|mesh-ancestor
6672627|NCT01557335|Sensory System Agents|sensory system agents|mesh-ancestor
6672628|NCT01557335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5590118|NCT03781687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590119|NCT03781687|Analgesics|analgesics|mesh-ancestor
5590120|NCT03781687|Sensory System Agents|sensory system agents|mesh-ancestor
5590121|NCT03781687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5590122|NCT03781596|Fluticasone|fluticasone|mesh-list
5590123|NCT03781596|Omeprazole|omeprazole|mesh-list
5590124|NCT03781596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5590125|NCT03781596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5590126|NCT03781596|Autonomic Agents|autonomic agents|mesh-ancestor
6672629|NCT01557335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672630|NCT01557335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6672631|NCT01557335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6201767|NCT02030041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6201768|NCT02030041|Antimetabolites|antimetabolites|mesh-ancestor
6672377|NCT01555710|Carboplatin|carboplatin|mesh-list
6672378|NCT01555710|Etoposide|etoposide|mesh-list
6672379|NCT01555710|Isophosphamide mustard|isophosphamide mustard|mesh-list
6672380|NCT01555710|Ifosfamide|ifosfamide|mesh-list
6672381|NCT01555710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6672382|NCT01555710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6672383|NCT01555710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6672384|NCT01555710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5590127|NCT03781596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5590128|NCT03781596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590129|NCT03781596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5590130|NCT03781596|Respiratory System Agents|respiratory system agents|mesh-ancestor
5590131|NCT03781596|Dermatologic Agents|dermatologic agents|mesh-ancestor
5590132|NCT03781596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5590133|NCT03781596|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5590134|NCT03781596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5590135|NCT03781596|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5590136|NCT03781596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5590137|NCT03781596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5590138|NCT03781674|Progesterone|progesterone|mesh-list
5590139|NCT03781674|Progestins|progestins|mesh-ancestor
5590140|NCT03781674|Hormones|hormones|mesh-ancestor
5590141|NCT03781674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5590142|NCT03781674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590143|NCT03781752|Methylphenidate|methylphenidate|mesh-list
5590144|NCT03781752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5590145|NCT03781752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590146|NCT03781752|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5590147|NCT03781752|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5590148|NCT03781752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5590149|NCT03781752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5590150|NCT03781752|Dopamine Agents|dopamine agents|mesh-ancestor
6672385|NCT01555710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6672386|NCT01555710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672387|NCT01555710|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6672388|NCT01555710|Alkylating Agents|alkylating agents|mesh-ancestor
6672389|NCT01555788|Pancrelipase|pancrelipase|mesh-list
6672390|NCT01555788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6672391|NCT01555814|Amisulpride|amisulpride|mesh-list
6672392|NCT01555814|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6672393|NCT01555814|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6672394|NCT01555814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5590151|NCT03781752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5590152|NCT03781635|Ketamine|ketamine|mesh-list
5590153|NCT03781635|Analgesics|analgesics|mesh-ancestor
5590154|NCT03781635|Sensory System Agents|sensory system agents|mesh-ancestor
5590155|NCT03781635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5590156|NCT03781635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590157|NCT03781635|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5590158|NCT03781635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5590159|NCT03781635|Anesthetics, General|anesthetics, general|mesh-ancestor
5590160|NCT03781635|Anesthetics|anesthetics|mesh-ancestor
5590161|NCT03781635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5590162|NCT03781635|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5590163|NCT03781635|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5590164|NCT03781635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5590165|NCT03781635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5590166|NCT03781544|Acetaminophen|acetaminophen|mesh-list
5590167|NCT03781544|Diclofenac|diclofenac|mesh-list
5590168|NCT03781544|Tramadol|tramadol|mesh-list
5590169|NCT03781544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5590170|NCT03781544|Analgesics|analgesics|mesh-ancestor
5590171|NCT03781544|Sensory System Agents|sensory system agents|mesh-ancestor
5590172|NCT03781544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5590173|NCT03781544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590174|NCT03781544|Antipyretics|antipyretics|mesh-ancestor
5590175|NCT03781544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5590176|NCT03781544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5590177|NCT03781544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5590178|NCT03781544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5590179|NCT03781544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6207703|NCT02119468|Glycine|glycine|mesh-list
6672395|NCT01555814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672396|NCT01555814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6201769|NCT02030041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201770|NCT02030041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6201771|NCT02030041|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6201772|NCT02030041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6201773|NCT02030405|Ixazomib|ixazomib|mesh-list
6201774|NCT02030405|Proteasome Inhibitors|proteasome inhibitors|mesh-list
6201775|NCT02030405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6201776|NCT02030405|Protease Inhibitors|protease inhibitors|mesh-ancestor
6201777|NCT02030405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6201778|NCT02030405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201779|NCT02030535|Tiotropium Bromide|tiotropium bromide|mesh-list
5590180|NCT03781544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5590181|NCT03781544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5590182|NCT03781544|Narcotics|narcotics|mesh-ancestor
5590183|NCT03781544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5590184|NCT03781713|Anti-Infective Agents|anti-infective agents|mesh-list
5590185|NCT03781713|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5590186|NCT03781505|Acetaminophen|acetaminophen|mesh-list
5590187|NCT03781505|Ropivacaine|ropivacaine|mesh-list
5590188|NCT03781505|Anesthetics, Local|anesthetics, local|mesh-ancestor
5590189|NCT03781505|Anesthetics|anesthetics|mesh-ancestor
5590190|NCT03781505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5590191|NCT03781505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590192|NCT03781505|Sensory System Agents|sensory system agents|mesh-ancestor
5590193|NCT03781505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5590194|NCT03781505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5590195|NCT03781505|Analgesics|analgesics|mesh-ancestor
5590196|NCT03781505|Antipyretics|antipyretics|mesh-ancestor
5590197|NCT03781700|Prednisolone|prednisolone|mesh-list
5590198|NCT03781700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5590199|NCT03781700|Glucocorticoids|glucocorticoids|mesh-ancestor
5590200|NCT03781700|Hormones|hormones|mesh-ancestor
5590201|NCT03781700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5590202|NCT03781700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590203|NCT03781700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5590204|NCT03781700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5590205|NCT03781466|Progesterone|progesterone|mesh-list
5590206|NCT03781466|Progestins|progestins|mesh-ancestor
5590207|NCT03781466|Hormones|hormones|mesh-ancestor
5590208|NCT03781466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5590209|NCT03781466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590210|NCT03781388|Bupivacaine|bupivacaine|mesh-list
5590211|NCT03781388|Anesthetics, Local|anesthetics, local|mesh-ancestor
5590212|NCT03781388|Anesthetics|anesthetics|mesh-ancestor
5590213|NCT03781388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5590214|NCT03781388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590215|NCT03781388|Sensory System Agents|sensory system agents|mesh-ancestor
5590216|NCT03781388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5590217|NCT03781258|Warfarin|warfarin|mesh-list
5590218|NCT03781258|Anticoagulants|anticoagulants|mesh-ancestor
5590219|NCT03781063|Fulvestrant|fulvestrant|mesh-list
5590220|NCT03781063|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5590221|NCT03781063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5590222|NCT03781063|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5590223|NCT03781063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5590224|NCT03781063|Hormone Antagonists|hormone antagonists|mesh-ancestor
5590225|NCT03781063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5590226|NCT03781063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590227|NCT03781128|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
5590228|NCT03781128|Hallucinogens|hallucinogens|mesh-ancestor
5590229|NCT03781128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590230|NCT03781128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5590231|NCT03781128|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5590232|NCT03781128|Serotonin Agents|serotonin agents|mesh-ancestor
5590233|NCT03781128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5590234|NCT03781128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5590235|NCT03781128|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5590236|NCT03781115|Olanzapine|olanzapine|mesh-list
5590237|NCT03781115|Ziprasidone|ziprasidone|mesh-list
5590238|NCT03781115|Antiemetics|antiemetics|mesh-ancestor
5590239|NCT03781115|Autonomic Agents|autonomic agents|mesh-ancestor
5590240|NCT03781115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5590241|NCT03781115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590242|NCT03781115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5590243|NCT03781115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6201780|NCT02030535|Olodaterol|olodaterol|mesh-list
6201781|NCT02030535|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6201782|NCT02030535|Autonomic Agents|autonomic agents|mesh-ancestor
5590244|NCT03781115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5590245|NCT03781115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5590246|NCT03781115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5590247|NCT03781115|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5590248|NCT03781115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5590249|NCT03781115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5590250|NCT03781115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5590251|NCT03781115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5590252|NCT03781115|Serotonin Agents|serotonin agents|mesh-ancestor
5590253|NCT03781115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5590254|NCT03781115|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5590255|NCT03781115|Dopamine Agents|dopamine agents|mesh-ancestor
5590256|NCT03781050|Sirolimus|sirolimus|mesh-list
5590257|NCT03781050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5590258|NCT03781050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5590259|NCT03781050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5590260|NCT03781050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5590261|NCT03781050|Antifungal Agents|antifungal agents|mesh-ancestor
5590262|NCT03781050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5590263|NCT03781050|Immunologic Factors|immunologic factors|mesh-ancestor
5590264|NCT03781050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590265|NCT03781011|Choline|choline|mesh-list
5590266|NCT03781011|Lipotropic Agents|lipotropic agents|mesh-ancestor
5590267|NCT03781011|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5590268|NCT03781011|Antimetabolites|antimetabolites|mesh-ancestor
5590269|NCT03781011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5590270|NCT03781011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5590271|NCT03781011|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5590272|NCT03781011|Nootropic Agents|nootropic agents|mesh-ancestor
5590273|NCT03780933|Ascorbic Acid|ascorbic acid|mesh-list
5590274|NCT03780933|Vitamins|vitamins|mesh-ancestor
5590275|NCT03780933|Micronutrients|micronutrients|mesh-ancestor
5590276|NCT03780933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590277|NCT03780933|Antioxidants|antioxidants|mesh-ancestor
5590278|NCT03780933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5590279|NCT03780933|Protective Agents|protective agents|mesh-ancestor
5590280|NCT03780894|Tranexamic Acid|tranexamic acid|mesh-list
5590281|NCT03780894|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5590282|NCT03780894|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5590283|NCT03780894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5590284|NCT03780894|Hemostatics|hemostatics|mesh-ancestor
5590285|NCT03780894|Coagulants|coagulants|mesh-ancestor
5590286|NCT03780673|Rifaximin|rifaximin|mesh-list
5590287|NCT03780673|Simvastatin|simvastatin|mesh-list
5590288|NCT03780673|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5590289|NCT03780673|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5590290|NCT03780673|Antimetabolites|antimetabolites|mesh-ancestor
5590291|NCT03780673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5590292|NCT03780673|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5590293|NCT03780673|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5590294|NCT03780673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5590295|NCT03780673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5590296|NCT03780673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5590297|NCT03780673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5590298|NCT03780686|Dopamine|dopamine|mesh-list
5590299|NCT03780686|Norepinephrine|norepinephrine|mesh-list
5590300|NCT03780686|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5590301|NCT03780686|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5590302|NCT03780686|Adrenergic Agents|adrenergic agents|mesh-ancestor
5590303|NCT03780686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5590304|NCT03780686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5590305|NCT03780686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590306|NCT03780686|Sympathomimetics|sympathomimetics|mesh-ancestor
5590307|NCT03780686|Autonomic Agents|autonomic agents|mesh-ancestor
5590308|NCT03780686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5590309|NCT03780686|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5590310|NCT03780686|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5590311|NCT03780686|Dopamine Agents|dopamine agents|mesh-ancestor
5590312|NCT03780686|Protective Agents|protective agents|mesh-ancestor
5590313|NCT03780556|Lornoxicam|lornoxicam|mesh-list
5590314|NCT03780556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5590315|NCT03780556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6201783|NCT02030535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5590316|NCT03780556|Analgesics|analgesics|mesh-ancestor
5590317|NCT03780556|Sensory System Agents|sensory system agents|mesh-ancestor
5590318|NCT03780556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5590319|NCT03780556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590320|NCT03780556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5590321|NCT03780556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5590322|NCT03780621|Andrographolide|andrographolide|mesh-list
5590323|NCT03780621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5590324|NCT03780621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5590325|NCT03780621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5590326|NCT03780621|Analgesics|analgesics|mesh-ancestor
5590327|NCT03780621|Sensory System Agents|sensory system agents|mesh-ancestor
5590328|NCT03780621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5590329|NCT03780621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590330|NCT03780621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5590331|NCT03780621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5590332|NCT03780621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5590333|NCT03780621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5590334|NCT03780621|Antiviral Agents|antiviral agents|mesh-ancestor
5590335|NCT03780621|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5590336|NCT03780634|Sorafenib|sorafenib|mesh-list
5590337|NCT03780634|Antibodies|antibodies|mesh-list
5590338|NCT03780634|Immunoglobulins|immunoglobulins|mesh-list
5590339|NCT03780634|Immunologic Factors|immunologic factors|mesh-ancestor
5590340|NCT03780634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590341|NCT03780634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5590342|NCT03780634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5590343|NCT03780634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5590344|NCT03780634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5590345|NCT03780829|Cycloserine|cycloserine|mesh-list
5590346|NCT03780829|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5590347|NCT03780829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5590348|NCT03780829|Renal Agents|renal agents|mesh-ancestor
5590349|NCT03780829|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5590350|NCT03780829|Antitubercular Agents|antitubercular agents|mesh-ancestor
5590351|NCT03780829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5590352|NCT03780829|Antimetabolites|antimetabolites|mesh-ancestor
5590353|NCT03780829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5590354|NCT03780790|Bupivacaine|bupivacaine|mesh-list
5590355|NCT03780790|Anesthetics, Local|anesthetics, local|mesh-ancestor
5590356|NCT03780790|Anesthetics|anesthetics|mesh-ancestor
5590357|NCT03780790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5590358|NCT03780790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590359|NCT03780790|Sensory System Agents|sensory system agents|mesh-ancestor
5590360|NCT03780790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5590361|NCT03780192|Sirolimus|sirolimus|mesh-list
5590362|NCT03780192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5590363|NCT03780192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5590364|NCT03780192|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5590365|NCT03780192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5590366|NCT03780192|Antifungal Agents|antifungal agents|mesh-ancestor
5590367|NCT03780192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5590368|NCT03780192|Immunologic Factors|immunologic factors|mesh-ancestor
5590369|NCT03780192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590370|NCT03780569|Temozolomide|temozolomide|mesh-list
5590371|NCT03780569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5590372|NCT03780569|Alkylating Agents|alkylating agents|mesh-ancestor
5590373|NCT03780569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5590374|NCT03780569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605447|NCT02693535|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5605448|NCT02693535|Growth Substances|growth substances|mesh-ancestor
5605449|NCT02693535|Growth Inhibitors|growth inhibitors|mesh-ancestor
5605450|NCT02693535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5605451|NCT02693535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5605452|NCT02693535|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5605453|NCT02667418|Vancomycin|vancomycin|mesh-list
5605454|NCT02667418|Fidaxomicin|fidaxomicin|mesh-list
5605455|NCT02667418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5605456|NCT02667418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5605457|NCT02652468|Mycophenolic Acid|mycophenolic acid|mesh-list
5605458|NCT02652468|Cyclophosphamide|cyclophosphamide|mesh-list
5605459|NCT02652468|Rituximab|rituximab|mesh-list
5605460|NCT02652468|Fludarabine|fludarabine|mesh-list
5605461|NCT02652468|Fludarabine phosphate|fludarabine phosphate|mesh-list
5605462|NCT02652468|Tacrolimus|tacrolimus|mesh-list
5605463|NCT02652468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5605464|NCT02652468|Immunologic Factors|immunologic factors|mesh-ancestor
6201784|NCT02030535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201785|NCT02030535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6201786|NCT02030535|Respiratory System Agents|respiratory system agents|mesh-ancestor
6201787|NCT02030535|Parasympatholytics|parasympatholytics|mesh-ancestor
6201788|NCT02030535|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6201789|NCT02030535|Cholinergic Agents|cholinergic agents|mesh-ancestor
6201790|NCT02030535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6201791|NCT02030535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201792|NCT02030574|Gemcitabine|gemcitabine|mesh-list
5590375|NCT03780205|Methamphetamine|methamphetamine|mesh-list
5590376|NCT03780205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5590377|NCT03780205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590378|NCT03780205|Sympathomimetics|sympathomimetics|mesh-ancestor
5590379|NCT03780205|Autonomic Agents|autonomic agents|mesh-ancestor
5590380|NCT03780205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5590381|NCT03780205|Dopamine Agents|dopamine agents|mesh-ancestor
5590382|NCT03780205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5590383|NCT03780205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5590384|NCT03780205|Adrenergic Agents|adrenergic agents|mesh-ancestor
5590385|NCT03780205|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5590386|NCT03780205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5590387|NCT03780205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5590388|NCT03780205|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5590389|NCT03780361|Aflibercept|aflibercept|mesh-list
5590390|NCT03780361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5590391|NCT03780361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5590392|NCT03780361|Growth Substances|growth substances|mesh-ancestor
5590393|NCT03780361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590394|NCT03780361|Growth Inhibitors|growth inhibitors|mesh-ancestor
5590395|NCT03780361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5590396|NCT03780270|Fluorides|fluorides|mesh-list
5590397|NCT03780270|Fluorides, Topical|fluorides, topical|mesh-list
5590398|NCT03780270|Cariostatic Agents|cariostatic agents|mesh-ancestor
5590399|NCT03780270|Protective Agents|protective agents|mesh-ancestor
5590400|NCT03780270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590401|NCT03780543|Tenofovir|tenofovir|mesh-list
5590402|NCT03780543|Entecavir|entecavir|mesh-list
5590403|NCT03780543|Antiviral Agents|antiviral agents|mesh-ancestor
5590404|NCT03780543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5590405|NCT03780543|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5590406|NCT03780543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5590407|NCT03780543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5590408|NCT03780543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5590409|NCT03780543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5590410|NCT03780543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5590411|NCT03780127|Fenfluramine|fenfluramine|mesh-list
5590412|NCT03780127|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5590413|NCT03780127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5590414|NCT03780127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5590415|NCT03780127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5590416|NCT03780127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5590417|NCT03780127|Serotonin Agents|serotonin agents|mesh-ancestor
5590418|NCT03780127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590419|NCT03780075|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
5590420|NCT03780075|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5590421|NCT03780075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5590422|NCT03779776|Vitamins|vitamins|mesh-list
5590423|NCT03779776|Micronutrients|micronutrients|mesh-ancestor
5590424|NCT03779776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590425|NCT03780049|Leucovorin|leucovorin|mesh-list
5590426|NCT03780049|Fluorouracil|fluorouracil|mesh-list
5590427|NCT03780049|Oxaliplatin|oxaliplatin|mesh-list
5590428|NCT03780049|Antimetabolites|antimetabolites|mesh-ancestor
5590429|NCT03780049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5590430|NCT03780049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5590431|NCT03780049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5590432|NCT03780049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5590433|NCT03780049|Immunologic Factors|immunologic factors|mesh-ancestor
5590434|NCT03780049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590435|NCT03780049|Antidotes|antidotes|mesh-ancestor
5590436|NCT03780049|Protective Agents|protective agents|mesh-ancestor
5590437|NCT03780049|Vitamin B Complex|vitamin b complex|mesh-ancestor
5590438|NCT03780049|Vitamins|vitamins|mesh-ancestor
5590439|NCT03780049|Micronutrients|micronutrients|mesh-ancestor
6201793|NCT02030574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5590440|NCT03780608|Durvalumab|durvalumab|mesh-list
5590441|NCT03780608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5590442|NCT03780608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5590472|NCT03779789|Vortioxetine|vortioxetine|mesh-list
5590473|NCT03779789|Fluvoxamine|fluvoxamine|mesh-list
5590474|NCT03779789|Citalopram|citalopram|mesh-list
5590475|NCT03779789|Fluoxetine|fluoxetine|mesh-list
5590476|NCT03779789|Paroxetine|paroxetine|mesh-list
5590477|NCT03779789|Sertraline|sertraline|mesh-list
5590478|NCT03779789|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5590479|NCT03779789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5590480|NCT03779789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5590481|NCT03779789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5590482|NCT03779789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5590483|NCT03779789|Serotonin Agents|serotonin agents|mesh-ancestor
5590484|NCT03779789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590485|NCT03779789|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5590486|NCT03779789|Antidepressive Agents|antidepressive agents|mesh-ancestor
5590487|NCT03779789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5590488|NCT03779789|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5590489|NCT03779789|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5590490|NCT03779789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5590491|NCT03779789|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5590492|NCT03779789|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5590493|NCT03779789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5590494|NCT03779789|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5590495|NCT03779789|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5590496|NCT03779789|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5590497|NCT03779789|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5590498|NCT03779789|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5590499|NCT03779789|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5590500|NCT03779685|Anesthetics|anesthetics|mesh-list
5590501|NCT03779685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5590502|NCT03779685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590503|NCT03779633|Estradiol|estradiol|mesh-list
5590504|NCT03779633|Estrogens|estrogens|mesh-ancestor
5590505|NCT03779633|Hormones|hormones|mesh-ancestor
5590506|NCT03779633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5590507|NCT03779633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590508|NCT03779516|Lidocaine|lidocaine|mesh-list
5590509|NCT03779516|Anesthetics, Local|anesthetics, local|mesh-ancestor
5590510|NCT03779516|Anesthetics|anesthetics|mesh-ancestor
5590511|NCT03779516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5590512|NCT03779516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590513|NCT03779516|Sensory System Agents|sensory system agents|mesh-ancestor
5590514|NCT03779516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6201794|NCT02030574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6201795|NCT02030574|Antimetabolites|antimetabolites|mesh-ancestor
6201796|NCT02030574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201797|NCT02030574|Antiviral Agents|antiviral agents|mesh-ancestor
6201798|NCT02030574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5590515|NCT03779516|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5590516|NCT03779516|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5590517|NCT03779516|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5590518|NCT03779516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5590519|NCT03779516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5590520|NCT03779451|Progesterone|progesterone|mesh-list
5590521|NCT03779451|Progestins|progestins|mesh-ancestor
5590522|NCT03779451|Hormones|hormones|mesh-ancestor
5590523|NCT03779451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5590524|NCT03779451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590525|NCT03779594|Acetazolamide|acetazolamide|mesh-list
5590526|NCT03779594|Anticonvulsants|anticonvulsants|mesh-ancestor
5590527|NCT03779594|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5590528|NCT03779594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5590529|NCT03779594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5590530|NCT03779594|Diuretics|diuretics|mesh-ancestor
5590531|NCT03779594|Natriuretic Agents|natriuretic agents|mesh-ancestor
5590532|NCT03779594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590533|NCT03779464|Gemcitabine|gemcitabine|mesh-list
5590534|NCT03779464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5590535|NCT03779464|Antimetabolites|antimetabolites|mesh-ancestor
5590536|NCT03779464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5590537|NCT03779464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5590538|NCT03779464|Antiviral Agents|antiviral agents|mesh-ancestor
5590539|NCT03779464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5590540|NCT03779464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5590541|NCT03779464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5590542|NCT03779464|Immunologic Factors|immunologic factors|mesh-ancestor
5590543|NCT03779464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590544|NCT03779568|Bupivacaine|bupivacaine|mesh-list
5590545|NCT03779568|Anesthetics, Local|anesthetics, local|mesh-ancestor
5590546|NCT03779568|Anesthetics|anesthetics|mesh-ancestor
5590547|NCT03779568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5590548|NCT03779568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590549|NCT03779568|Sensory System Agents|sensory system agents|mesh-ancestor
5590550|NCT03779568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5590551|NCT03779659|Anesthetics|anesthetics|mesh-list
5590552|NCT03779659|Benzocaine|benzocaine|mesh-list
5590553|NCT03779659|Anesthetics, Local|anesthetics, local|mesh-list
5590554|NCT03779659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5590555|NCT03779659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590556|NCT03779659|Sensory System Agents|sensory system agents|mesh-ancestor
5590557|NCT03779659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5590558|NCT03779646|Bisoprolol|bisoprolol|mesh-list
5590559|NCT03779646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5590560|NCT03779646|Sympatholytics|sympatholytics|mesh-ancestor
5590561|NCT03779646|Autonomic Agents|autonomic agents|mesh-ancestor
5590562|NCT03779646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5590563|NCT03779646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590564|NCT03779646|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5590565|NCT03779646|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5590566|NCT03779646|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5590567|NCT03779646|Adrenergic Agents|adrenergic agents|mesh-ancestor
5590568|NCT03779646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5590569|NCT03779646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5590570|NCT03779672|Memantine|memantine|mesh-list
5590571|NCT03779672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5590572|NCT03779672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5590573|NCT03779672|Dopamine Agents|dopamine agents|mesh-ancestor
5590574|NCT03779672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5590575|NCT03779672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5590576|NCT03779672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590577|NCT03779672|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5590578|NCT03779672|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5590579|NCT03779282|Dexmedetomidine|dexmedetomidine|mesh-list
5590580|NCT03779282|Ketamine|ketamine|mesh-list
5590581|NCT03779282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5590582|NCT03779282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5590583|NCT03779282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590584|NCT03779282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5590585|NCT03779282|Analgesics|analgesics|mesh-ancestor
5590586|NCT03779282|Sensory System Agents|sensory system agents|mesh-ancestor
5590587|NCT03779282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5590588|NCT03779282|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5590589|NCT03779282|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5590590|NCT03779282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5590591|NCT03779282|Adrenergic Agents|adrenergic agents|mesh-ancestor
5590592|NCT03779282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5590593|NCT03779282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5590594|NCT03779282|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5590595|NCT03779282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5590596|NCT03779282|Anesthetics, General|anesthetics, general|mesh-ancestor
5590597|NCT03779282|Anesthetics|anesthetics|mesh-ancestor
5590598|NCT03779282|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5590599|NCT03779282|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5590600|NCT03779295|Clindamycin|clindamycin|mesh-list
5590601|NCT03779295|Clindamycin palmitate|clindamycin palmitate|mesh-list
5590602|NCT03779295|Clindamycin phosphate|clindamycin phosphate|mesh-list
5590603|NCT03779295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5590604|NCT03779295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5590605|NCT03779295|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5590606|NCT03779295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5590607|NCT03779295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5590608|NCT03779360|Clindamycin|clindamycin|mesh-list
5590609|NCT03779360|Clindamycin palmitate|clindamycin palmitate|mesh-list
5590610|NCT03779360|Clindamycin phosphate|clindamycin phosphate|mesh-list
5590611|NCT03779360|Erythromycin|erythromycin|mesh-list
5590612|NCT03779360|Erythromycin Estolate|erythromycin estolate|mesh-list
5590613|NCT03779360|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
5590614|NCT03779360|Erythromycin stearate|erythromycin stearate|mesh-list
5590615|NCT03779360|Prednisolone|prednisolone|mesh-list
5590616|NCT03779360|Clobetasol|clobetasol|mesh-list
5590617|NCT03779360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5590618|NCT03779360|Glucocorticoids|glucocorticoids|mesh-ancestor
5590619|NCT03779360|Hormones|hormones|mesh-ancestor
5590620|NCT03779360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5590621|NCT03779360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590622|NCT03779360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5590623|NCT03779360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5590624|NCT03779360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5590625|NCT03779360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5590626|NCT03779360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5590627|NCT03779360|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5590628|NCT03779360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5590629|NCT03779360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5590630|NCT03779347|Praziquantel|praziquantel|mesh-list
5590631|NCT03779347|Anthelmintics|anthelmintics|mesh-ancestor
5590632|NCT03779347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5590633|NCT03779347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5590634|NCT03779178|Landiolol|landiolol|mesh-list
5590635|NCT03779178|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5590636|NCT03779178|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5590637|NCT03779178|Adrenergic Agents|adrenergic agents|mesh-ancestor
5590638|NCT03779178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5590639|NCT03779178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5590640|NCT03779178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590641|NCT03779178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5590642|NCT03779035|Gemcitabine|gemcitabine|mesh-list
5590643|NCT03779035|Capecitabine|capecitabine|mesh-list
5590644|NCT03779035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5590645|NCT03779035|Antimetabolites|antimetabolites|mesh-ancestor
5590646|NCT03779035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5590647|NCT03779035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5590648|NCT03779035|Antiviral Agents|antiviral agents|mesh-ancestor
5590649|NCT03779035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5590650|NCT03779035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5590651|NCT03779035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5590652|NCT03779035|Immunologic Factors|immunologic factors|mesh-ancestor
5590653|NCT03779035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590654|NCT03779191|Bevacizumab|bevacizumab|mesh-list
5590655|NCT03779191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5590656|NCT03779191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5590657|NCT03779191|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5590658|NCT03779191|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5590659|NCT03779191|Growth Substances|growth substances|mesh-ancestor
5590660|NCT03779191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590661|NCT03779191|Growth Inhibitors|growth inhibitors|mesh-ancestor
5590662|NCT03778931|Fulvestrant|fulvestrant|mesh-list
5590663|NCT03778931|Anastrozole|anastrozole|mesh-list
5590664|NCT03778931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5590665|NCT03778931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5590666|NCT03778931|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5590667|NCT03778931|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5590668|NCT03778931|Hormone Antagonists|hormone antagonists|mesh-ancestor
5590669|NCT03778931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5590670|NCT03778931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590671|NCT03778931|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5590672|NCT03778931|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5590673|NCT03778931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5590674|NCT03778931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5590675|NCT03779087|Amoxicillin|amoxicillin|mesh-list
5590676|NCT03779087|Levofloxacin|levofloxacin|mesh-list
5590677|NCT03779087|Ofloxacin|ofloxacin|mesh-list
5590678|NCT03779087|Tetracycline|tetracycline|mesh-list
5590679|NCT03779087|Esomeprazole|esomeprazole|mesh-list
5590680|NCT03779087|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5590681|NCT03779087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5590682|NCT03779087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5590683|NCT03779087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5590684|NCT03779087|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5590685|NCT03779087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5590686|NCT03779087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5590687|NCT03779087|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5590688|NCT03779087|Renal Agents|renal agents|mesh-ancestor
5590689|NCT03779087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5590690|NCT03779087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5590691|NCT03779087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5590692|NCT03779087|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5590693|NCT03779087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5590694|NCT03779087|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5590695|NCT03779100|Lenvatinib|lenvatinib|mesh-list
5590696|NCT03779100|Antibodies|antibodies|mesh-list
5590697|NCT03779100|Immunoglobulins|immunoglobulins|mesh-list
5590698|NCT03779100|Immunologic Factors|immunologic factors|mesh-ancestor
5590699|NCT03779100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590700|NCT03779100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5590701|NCT03779100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5590702|NCT03779100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5590703|NCT03779100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5590704|NCT03778944|Dopamine|dopamine|mesh-list
5590705|NCT03778944|Mannitol|mannitol|mesh-list
5590706|NCT03778944|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5590707|NCT03778944|Diuretics|diuretics|mesh-ancestor
5590708|NCT03778944|Natriuretic Agents|natriuretic agents|mesh-ancestor
5590709|NCT03778944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590710|NCT03778944|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5590711|NCT03778944|Sympathomimetics|sympathomimetics|mesh-ancestor
5590712|NCT03778944|Autonomic Agents|autonomic agents|mesh-ancestor
5590713|NCT03778944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5590714|NCT03778944|Dopamine Agents|dopamine agents|mesh-ancestor
5590715|NCT03778944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5590716|NCT03778944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5590717|NCT03778944|Protective Agents|protective agents|mesh-ancestor
5590718|NCT03778996|Sirolimus|sirolimus|mesh-list
5590719|NCT03778996|Phenytoin|phenytoin|mesh-list
5590720|NCT03778996|Methoxsalen|methoxsalen|mesh-list
5590721|NCT03778996|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
5590722|NCT03778996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5590723|NCT03778996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5590724|NCT03778996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5590725|NCT03778996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5590726|NCT03778996|Antifungal Agents|antifungal agents|mesh-ancestor
5590727|NCT03778996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5590728|NCT03778996|Immunologic Factors|immunologic factors|mesh-ancestor
5590729|NCT03778996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590730|NCT03778996|Anticonvulsants|anticonvulsants|mesh-ancestor
5590731|NCT03778996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5590732|NCT03778996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5590733|NCT03778996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5590734|NCT03778996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5590735|NCT03778996|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5590736|NCT03778996|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5590737|NCT03778996|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5590738|NCT03778996|Dermatologic Agents|dermatologic agents|mesh-ancestor
5590739|NCT03778996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5590740|NCT03779048|Phentermine|phentermine|mesh-list
5590741|NCT03779048|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5590742|NCT03779048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590743|NCT03779048|Appetite Depressants|appetite depressants|mesh-ancestor
5590744|NCT03779048|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5590745|NCT03779048|Sympathomimetics|sympathomimetics|mesh-ancestor
5590746|NCT03779048|Autonomic Agents|autonomic agents|mesh-ancestor
5590747|NCT03779048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5590748|NCT03779048|Adrenergic Agents|adrenergic agents|mesh-ancestor
5590749|NCT03779048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5590750|NCT03779048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5590751|NCT03778723|Fentanyl|fentanyl|mesh-list
5590752|NCT03778723|Anesthetics|anesthetics|mesh-list
5590753|NCT03778723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5590754|NCT03778723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590755|NCT03778723|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5590756|NCT03778723|Narcotics|narcotics|mesh-ancestor
5590757|NCT03778723|Analgesics|analgesics|mesh-ancestor
5590758|NCT03778723|Sensory System Agents|sensory system agents|mesh-ancestor
5590759|NCT03778723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5590760|NCT03778723|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5590761|NCT03778723|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5590762|NCT03778723|Anesthetics, General|anesthetics, general|mesh-ancestor
5605465|NCT02652468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605466|NCT02652468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5605467|NCT02652468|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5605468|NCT02652468|Alkylating Agents|alkylating agents|mesh-ancestor
5605469|NCT02652468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605470|NCT02652468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605471|NCT02652468|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5605472|NCT02652468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5605473|NCT02652468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5605474|NCT02652468|Antimetabolites|antimetabolites|mesh-ancestor
5605475|NCT02652468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5605476|NCT02652468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5605477|NCT02652468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5605478|NCT02652468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5605479|NCT02652468|Antitubercular Agents|antitubercular agents|mesh-ancestor
5605480|NCT02652468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5605481|NCT02652468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5605482|NCT02579265|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
5605483|NCT02579265|SMOFlipid|smoflipid|mesh-list
5605484|NCT02579265|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
5605485|NCT02579265|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5605486|NCT02579265|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5605487|NCT02525029|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5605488|NCT02525029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5605489|NCT02525029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605490|NCT02484391|Thioctic Acid|thioctic acid|mesh-list
5605491|NCT02484391|Cytarabine|cytarabine|mesh-list
5605492|NCT02484391|Mitoxantrone|mitoxantrone|mesh-list
5605493|NCT02484391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5605494|NCT02484391|Antimetabolites|antimetabolites|mesh-ancestor
5605495|NCT02484391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605496|NCT02484391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605497|NCT02484391|Antiviral Agents|antiviral agents|mesh-ancestor
5605498|NCT02484391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5605499|NCT02484391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5605500|NCT02484391|Immunologic Factors|immunologic factors|mesh-ancestor
5605501|NCT02484391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605502|NCT02484391|Analgesics|analgesics|mesh-ancestor
5605503|NCT02484391|Sensory System Agents|sensory system agents|mesh-ancestor
5605504|NCT02484391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5605505|NCT02484391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5605506|NCT02484391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5605507|NCT02484391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5605508|NCT02484391|Antioxidants|antioxidants|mesh-ancestor
5605509|NCT02484391|Protective Agents|protective agents|mesh-ancestor
5605510|NCT02484391|Vitamin B Complex|vitamin b complex|mesh-ancestor
5590763|NCT03779061|Propofol|propofol|mesh-list
5590764|NCT03779061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5590765|NCT03779061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5590766|NCT03779061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590767|NCT03779061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5590768|NCT03779061|Anesthetics, General|anesthetics, general|mesh-ancestor
5590769|NCT03779061|Anesthetics|anesthetics|mesh-ancestor
5590770|NCT03778619|Cyclophosphamide|cyclophosphamide|mesh-list
5590771|NCT03778619|Rituximab|rituximab|mesh-list
5590772|NCT03778619|Fludarabine|fludarabine|mesh-list
5590773|NCT03778619|Interleukin-2|interleukin-2|mesh-list
5590774|NCT03778619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5590775|NCT03778619|Immunologic Factors|immunologic factors|mesh-ancestor
5590776|NCT03778619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590777|NCT03778619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5590778|NCT03778619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5590779|NCT03778619|Alkylating Agents|alkylating agents|mesh-ancestor
5590780|NCT03778619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5590781|NCT03778619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5590782|NCT03778619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5590783|NCT03778619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5590784|NCT03778619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5590785|NCT03778619|Analgesics|analgesics|mesh-ancestor
5590786|NCT03778619|Sensory System Agents|sensory system agents|mesh-ancestor
5590787|NCT03778619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5590788|NCT03779074|Amoxicillin|amoxicillin|mesh-list
5590789|NCT03779074|Metronidazole|metronidazole|mesh-list
5590790|NCT03779074|Clarithromycin|clarithromycin|mesh-list
5590791|NCT03779074|Tetracycline|tetracycline|mesh-list
5590792|NCT03779074|Rabeprazole|rabeprazole|mesh-list
5590793|NCT03779074|Bismuth|bismuth|mesh-list
5590794|NCT03779074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5590795|NCT03779074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5590796|NCT03779074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5590797|NCT03779074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5590798|NCT03779074|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5590799|NCT03779074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5590800|NCT03779074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5590801|NCT03779074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5590802|NCT03779074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5590803|NCT03779074|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5590804|NCT03779074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5590805|NCT03779074|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5590806|NCT03779074|Antacids|antacids|mesh-ancestor
5590807|NCT03778645|Epinephrine|epinephrine|mesh-list
5590808|NCT03778645|Racepinephrine|racepinephrine|mesh-list
5590809|NCT03778645|Epinephryl borate|epinephryl borate|mesh-list
5590810|NCT03778645|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5590811|NCT03778645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5590812|NCT03778645|Adrenergic Agents|adrenergic agents|mesh-ancestor
5590813|NCT03778645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5590814|NCT03778645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5590815|NCT03778645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590816|NCT03778645|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5590817|NCT03778645|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5590818|NCT03778645|Autonomic Agents|autonomic agents|mesh-ancestor
5590819|NCT03778645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5590820|NCT03778645|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5590821|NCT03778645|Respiratory System Agents|respiratory system agents|mesh-ancestor
5590822|NCT03778645|Mydriatics|mydriatics|mesh-ancestor
5590823|NCT03778645|Sympathomimetics|sympathomimetics|mesh-ancestor
5590824|NCT03778645|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5590825|NCT03778450|Analgesics, Opioid|analgesics, opioid|mesh-list
5590826|NCT03778450|Analgesics|analgesics|mesh-list
5590827|NCT03778450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
5590828|NCT03778450|Narcotics|narcotics|mesh-ancestor
5590829|NCT03778450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5590830|NCT03778450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590831|NCT03778450|Sensory System Agents|sensory system agents|mesh-ancestor
5590832|NCT03778450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5590833|NCT03778359|Leuprolide|leuprolide|mesh-list
5590834|NCT03778359|Dienogest|dienogest|mesh-list
5590835|NCT03778359|Levonorgestrel|levonorgestrel|mesh-list
5590836|NCT03778359|Progestins|progestins|mesh-list
5590837|NCT03778359|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5590838|NCT03778359|Contraceptive Agents|contraceptive agents|mesh-ancestor
5590839|NCT03778359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5590840|NCT03778359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590841|NCT03778359|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5590842|NCT03778359|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5590843|NCT03778359|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5590844|NCT03778359|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5590845|NCT03778359|Fertility Agents|fertility agents|mesh-ancestor
5590846|NCT03778359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5590847|NCT03778359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5590848|NCT03778359|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5590849|NCT03778359|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5590850|NCT03778359|Hormone Antagonists|hormone antagonists|mesh-ancestor
5590851|NCT03778359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5590852|NCT03778359|Hormones|hormones|mesh-ancestor
5590853|NCT03778502|Rivaroxaban|rivaroxaban|mesh-list
5590854|NCT03778502|Apixaban|apixaban|mesh-list
5590855|NCT03778502|Edoxaban|edoxaban|mesh-list
5590856|NCT03778502|Dabigatran|dabigatran|mesh-list
5590857|NCT03778502|Anticoagulants|anticoagulants|mesh-list
5590858|NCT03778502|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5590859|NCT03778502|Antithrombins|antithrombins|mesh-ancestor
5590860|NCT03778502|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5590861|NCT03778502|Protease Inhibitors|protease inhibitors|mesh-ancestor
5590862|NCT03778502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5590863|NCT03778502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5590864|NCT03778281|Baclofen|baclofen|mesh-list
5590865|NCT03778281|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5590866|NCT03778281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590867|NCT03778281|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5590868|NCT03778281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5590869|NCT03778281|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
5590870|NCT03778281|GABA Agonists|gaba agonists|mesh-ancestor
5590871|NCT03778281|GABA Agents|gaba agents|mesh-ancestor
5590872|NCT03778281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5590873|NCT03778281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5590874|NCT03778567|Lamivudine|lamivudine|mesh-list
5590875|NCT03778567|Telbivudine|telbivudine|mesh-list
5590876|NCT03778567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5590877|NCT03778567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5590878|NCT03778567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5590879|NCT03778567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5590880|NCT03778567|Antiviral Agents|antiviral agents|mesh-ancestor
5590881|NCT03778567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5590882|NCT03778567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5590883|NCT03778567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5590884|NCT03778541|Temozolomide|temozolomide|mesh-list
5590885|NCT03778541|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5590886|NCT03778541|Alkylating Agents|alkylating agents|mesh-ancestor
5590887|NCT03778541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5590888|NCT03778541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5590889|NCT03778580|Pyridoxamine|pyridoxamine|mesh-list
5590890|NCT03778580|Vitamin B Complex|vitamin b complex|mesh-ancestor
5590891|NCT03778580|Vitamins|vitamins|mesh-ancestor
5590892|NCT03778580|Micronutrients|micronutrients|mesh-ancestor
5590893|NCT03778580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590894|NCT03778372|Methadone|methadone|mesh-list
5590895|NCT03778372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5590896|NCT03778372|Narcotics|narcotics|mesh-ancestor
5590897|NCT03778372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5590898|NCT03778372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590899|NCT03778372|Analgesics|analgesics|mesh-ancestor
5590900|NCT03778372|Sensory System Agents|sensory system agents|mesh-ancestor
5590901|NCT03778372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5590902|NCT03778372|Antitussive Agents|antitussive agents|mesh-ancestor
5590903|NCT03778372|Respiratory System Agents|respiratory system agents|mesh-ancestor
5590904|NCT03778593|Leucovorin|leucovorin|mesh-list
5590905|NCT03778593|Fluorouracil|fluorouracil|mesh-list
5590906|NCT03778593|Oxaliplatin|oxaliplatin|mesh-list
5590907|NCT03778593|Irinotecan|irinotecan|mesh-list
5590908|NCT03778593|Antimetabolites|antimetabolites|mesh-ancestor
5590909|NCT03778593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5590910|NCT03778593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5590911|NCT03778593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5590912|NCT03778593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5590913|NCT03778593|Immunologic Factors|immunologic factors|mesh-ancestor
5590914|NCT03778593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590915|NCT03778593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5590916|NCT03778593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5590917|NCT03778593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5590918|NCT03778593|Antidotes|antidotes|mesh-ancestor
5590919|NCT03778593|Protective Agents|protective agents|mesh-ancestor
5590920|NCT03778593|Vitamin B Complex|vitamin b complex|mesh-ancestor
5590921|NCT03778593|Vitamins|vitamins|mesh-ancestor
5590922|NCT03778593|Micronutrients|micronutrients|mesh-ancestor
5590923|NCT03778554|Metoprolol|metoprolol|mesh-list
5590924|NCT03778554|Carvedilol|carvedilol|mesh-list
5590925|NCT03778554|Nebivolol|nebivolol|mesh-list
5590926|NCT03778554|Bisoprolol|bisoprolol|mesh-list
5590927|NCT03778554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5590928|NCT03778554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5590929|NCT03778554|Sympatholytics|sympatholytics|mesh-ancestor
5590930|NCT03778554|Autonomic Agents|autonomic agents|mesh-ancestor
5590931|NCT03778554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5590932|NCT03778554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590933|NCT03778554|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5590934|NCT03778554|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5590935|NCT03778554|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5590936|NCT03778554|Adrenergic Agents|adrenergic agents|mesh-ancestor
5590937|NCT03778554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5590938|NCT03778554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5590939|NCT03778554|Antioxidants|antioxidants|mesh-ancestor
5590940|NCT03778554|Protective Agents|protective agents|mesh-ancestor
5590941|NCT03778554|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5590942|NCT03778554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5590943|NCT03778554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5590944|NCT03778554|Vasodilator Agents|vasodilator agents|mesh-ancestor
5590945|NCT03778554|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5590946|NCT03778554|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5590947|NCT03778554|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5590948|NCT03778554|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5590949|NCT03778554|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5590950|NCT03778008|Vitamin B 12|vitamin b 12|mesh-list
5590951|NCT03778008|Hydroxocobalamin|hydroxocobalamin|mesh-list
5590952|NCT03778008|Gentamicins|gentamicins|mesh-list
5590953|NCT03778008|Dexamethasone|dexamethasone|mesh-list
5590954|NCT03778008|Lidocaine|lidocaine|mesh-list
5590955|NCT03778008|Mitogens|mitogens|mesh-list
5590956|NCT03778008|Vitamins|vitamins|mesh-ancestor
5590957|NCT03778008|Micronutrients|micronutrients|mesh-ancestor
5590958|NCT03778008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590959|NCT03778008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5590960|NCT03778008|Antiemetics|antiemetics|mesh-ancestor
5590961|NCT03778008|Autonomic Agents|autonomic agents|mesh-ancestor
5590962|NCT03778008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5590963|NCT03778008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5590964|NCT03778008|Glucocorticoids|glucocorticoids|mesh-ancestor
5590965|NCT03778008|Hormones|hormones|mesh-ancestor
6672397|NCT01555814|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5590966|NCT03778008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5590967|NCT03778008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6672398|NCT01555814|Dopamine Agents|dopamine agents|mesh-ancestor
6672399|NCT01555814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6672400|NCT01555814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672401|NCT01555814|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6672402|NCT01555814|Antidepressive Agents|antidepressive agents|mesh-ancestor
6672403|NCT01555853|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6672404|NCT01555853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6672405|NCT01555866|Isavuconazole|isavuconazole|mesh-list
6672406|NCT01555866|Antifungal Agents|antifungal agents|mesh-ancestor
6672407|NCT01555866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5590968|NCT03778008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5590969|NCT03778008|Anesthetics, Local|anesthetics, local|mesh-ancestor
5590970|NCT03778008|Anesthetics|anesthetics|mesh-ancestor
5605511|NCT02484391|Vitamins|vitamins|mesh-ancestor
5590971|NCT03778008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5590972|NCT03778008|Sensory System Agents|sensory system agents|mesh-ancestor
5590973|NCT03778008|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5590974|NCT03778008|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5590975|NCT03778008|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5590976|NCT03778008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5590977|NCT03778008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5590978|NCT03778008|Mitosis Modulators|mitosis modulators|mesh-ancestor
5590979|NCT03778008|Vitamin B Complex|vitamin b complex|mesh-ancestor
5590980|NCT03778008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5590981|NCT03778008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5590982|NCT03778008|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5590983|NCT03778008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5590984|NCT03778008|Hematinics|hematinics|mesh-ancestor
5590985|NCT03778242|Oxytocin|oxytocin|mesh-list
5590986|NCT03778242|Oxytocics|oxytocics|mesh-ancestor
5590987|NCT03778242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5590988|NCT03778242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5590989|NCT03778138|Pemetrexed|pemetrexed|mesh-list
5590990|NCT03778138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5590991|NCT03778138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5590992|NCT03778138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5590993|NCT03778138|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5590994|NCT03778138|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5590995|NCT03777956|Lacosamide|lacosamide|mesh-list
5590996|NCT03777956|Anticonvulsants|anticonvulsants|mesh-ancestor
5590997|NCT03777956|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5590998|NCT03777956|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5590999|NCT03777956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6201799|NCT02030574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6201800|NCT02030574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6201801|NCT02030574|Immunologic Factors|immunologic factors|mesh-ancestor
6201802|NCT02030574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591000|NCT03777956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591001|NCT03777878|Oxytocin|oxytocin|mesh-list
5591002|NCT03777878|Carbetocin|carbetocin|mesh-list
5591003|NCT03777878|Oxytocics|oxytocics|mesh-ancestor
5591004|NCT03777878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5591005|NCT03777878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591006|NCT03777904|Iron|iron|mesh-list
5591007|NCT03777904|Trace Elements|trace elements|mesh-ancestor
5591008|NCT03777904|Micronutrients|micronutrients|mesh-ancestor
5591009|NCT03777904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591010|NCT03777813|Leucovorin|leucovorin|mesh-list
5591011|NCT03777813|Oxaliplatin|oxaliplatin|mesh-list
5591012|NCT03777813|Durvalumab|durvalumab|mesh-list
5591013|NCT03777813|Levoleucovorin|levoleucovorin|mesh-list
5591014|NCT03777813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5591015|NCT03777813|Antidotes|antidotes|mesh-ancestor
5591016|NCT03777813|Protective Agents|protective agents|mesh-ancestor
5591017|NCT03777813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591018|NCT03777813|Vitamin B Complex|vitamin b complex|mesh-ancestor
5591019|NCT03777813|Vitamins|vitamins|mesh-ancestor
5591020|NCT03777813|Micronutrients|micronutrients|mesh-ancestor
5591021|NCT03777813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5591022|NCT03777930|Thalidomide|thalidomide|mesh-list
5591023|NCT03777930|Megestrol|megestrol|mesh-list
5591024|NCT03777930|Megestrol Acetate|megestrol acetate|mesh-list
5591025|NCT03777930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5591026|NCT03777930|Immunologic Factors|immunologic factors|mesh-ancestor
5591027|NCT03777930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591028|NCT03777930|Leprostatic Agents|leprostatic agents|mesh-ancestor
5591029|NCT03777930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5591030|NCT03777930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5591031|NCT03777930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5591032|NCT03777930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5591033|NCT03777930|Growth Substances|growth substances|mesh-ancestor
5591034|NCT03777930|Growth Inhibitors|growth inhibitors|mesh-ancestor
5591035|NCT03777930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5591036|NCT03777930|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5591037|NCT03777930|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5591038|NCT03777930|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5591039|NCT03777930|Contraceptive Agents|contraceptive agents|mesh-ancestor
5591040|NCT03777930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5591041|NCT03777930|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5591042|NCT03777930|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5591043|NCT03777930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5591044|NCT03777930|Appetite Stimulants|appetite stimulants|mesh-ancestor
5591045|NCT03777930|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5591046|NCT03777579|Paclitaxel|paclitaxel|mesh-list
5591047|NCT03777579|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5591048|NCT03777579|Antibodies|antibodies|mesh-list
5591049|NCT03777579|Immunoglobulins|immunoglobulins|mesh-list
5591050|NCT03777579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5591051|NCT03777579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5591052|NCT03777579|Tubulin Modulators|tubulin modulators|mesh-ancestor
5591053|NCT03777579|Antimitotic Agents|antimitotic agents|mesh-ancestor
5591054|NCT03777579|Mitosis Modulators|mitosis modulators|mesh-ancestor
5591055|NCT03777579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591056|NCT03777579|Immunologic Factors|immunologic factors|mesh-ancestor
5591057|NCT03777579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591058|NCT03777696|Misoprostol|misoprostol|mesh-list
5591059|NCT03777696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5591060|NCT03777696|Abortifacient Agents|abortifacient agents|mesh-ancestor
5591061|NCT03777696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5591062|NCT03777696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591063|NCT03777696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5591064|NCT03777696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5591065|NCT03777696|Oxytocics|oxytocics|mesh-ancestor
5591066|NCT03777423|Cobalt|cobalt|mesh-list
5591067|NCT03777423|Chromium|chromium|mesh-list
5591068|NCT03777423|Trace Elements|trace elements|mesh-ancestor
5591069|NCT03777423|Micronutrients|micronutrients|mesh-ancestor
5591070|NCT03777423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591071|NCT03777787|Denatonium|denatonium|mesh-list
5591072|NCT03777787|Aversive Agents|aversive agents|mesh-ancestor
5591073|NCT03777787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591074|NCT03777787|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
5591075|NCT03777787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591076|NCT03777787|Sensory System Agents|sensory system agents|mesh-ancestor
5591077|NCT03777787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5591078|NCT03777462|Gemcitabine|gemcitabine|mesh-list
5591079|NCT03777462|Paclitaxel|paclitaxel|mesh-list
5591080|NCT03777462|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5591081|NCT03777462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5591082|NCT03777462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5591083|NCT03777462|Tubulin Modulators|tubulin modulators|mesh-ancestor
5591084|NCT03777462|Antimitotic Agents|antimitotic agents|mesh-ancestor
5591085|NCT03777462|Mitosis Modulators|mitosis modulators|mesh-ancestor
5591086|NCT03777462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591087|NCT03777462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5591088|NCT03777462|Antimetabolites|antimetabolites|mesh-ancestor
5591089|NCT03777462|Antiviral Agents|antiviral agents|mesh-ancestor
5591090|NCT03777462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5591091|NCT03777462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5591092|NCT03777462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5591093|NCT03777462|Immunologic Factors|immunologic factors|mesh-ancestor
5591094|NCT03777462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591095|NCT03777644|Morphine|morphine|mesh-list
5591096|NCT03777644|Ropivacaine|ropivacaine|mesh-list
5591097|NCT03777644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5591098|NCT03777644|Narcotics|narcotics|mesh-ancestor
5591099|NCT03777644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5591100|NCT03777644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591101|NCT03777644|Analgesics|analgesics|mesh-ancestor
5591102|NCT03777644|Sensory System Agents|sensory system agents|mesh-ancestor
5591103|NCT03777644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5591104|NCT03777644|Anesthetics, Local|anesthetics, local|mesh-ancestor
5591105|NCT03777644|Anesthetics|anesthetics|mesh-ancestor
5591106|NCT03777657|Capecitabine|capecitabine|mesh-list
5591107|NCT03777657|Oxaliplatin|oxaliplatin|mesh-list
5591108|NCT03777657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5591109|NCT03777657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5591110|NCT03777657|Antimetabolites|antimetabolites|mesh-ancestor
5591111|NCT03777657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591112|NCT03777605|Nitroglycerin|nitroglycerin|mesh-list
5591113|NCT03777605|Vasodilator Agents|vasodilator agents|mesh-ancestor
5591114|NCT03777761|Moxifloxacin|moxifloxacin|mesh-list
5591115|NCT03777761|Tucatinib|tucatinib|mesh-list
5591116|NCT03777761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5591117|NCT03777761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5591118|NCT03777761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5591119|NCT03777761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5591120|NCT03777761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5605512|NCT02484391|Micronutrients|micronutrients|mesh-ancestor
5591121|NCT03777761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591122|NCT03777761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5591123|NCT03777761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5591124|NCT03777488|Tranexamic Acid|tranexamic acid|mesh-list
5591125|NCT03777488|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5591126|NCT03777488|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5591127|NCT03777488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591128|NCT03777488|Hemostatics|hemostatics|mesh-ancestor
5591129|NCT03777488|Coagulants|coagulants|mesh-ancestor
5591130|NCT03777514|Ascorbic Acid|ascorbic acid|mesh-list
5591131|NCT03777514|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
5591132|NCT03777514|Vitamins|vitamins|mesh-ancestor
5591133|NCT03777514|Micronutrients|micronutrients|mesh-ancestor
5591134|NCT03777514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591135|NCT03777514|Antioxidants|antioxidants|mesh-ancestor
5591136|NCT03777514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591137|NCT03777514|Protective Agents|protective agents|mesh-ancestor
5591138|NCT03777514|Hematinics|hematinics|mesh-ancestor
5591139|NCT03777514|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5591140|NCT03777514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5591141|NCT03777085|Rituximab|rituximab|mesh-list
5591142|NCT03777085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5591143|NCT03777085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5591144|NCT03777085|Immunologic Factors|immunologic factors|mesh-ancestor
5591145|NCT03777085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591146|NCT03777085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5591147|NCT03777124|Carboplatin|carboplatin|mesh-list
5591148|NCT03777124|Pemetrexed|pemetrexed|mesh-list
5591149|NCT03777124|Apatinib|apatinib|mesh-list
5591150|NCT03777124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5591151|NCT03777124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5591152|NCT03777124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591153|NCT03777124|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5591154|NCT03777124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5591155|NCT03777124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5591156|NCT03777280|Cobalt|cobalt|mesh-list
5591157|NCT03777280|Chromium|chromium|mesh-list
5591158|NCT03777280|Trace Elements|trace elements|mesh-ancestor
5591159|NCT03777280|Micronutrients|micronutrients|mesh-ancestor
5591160|NCT03777280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605513|NCT02448095|Ponatinib|ponatinib|mesh-list
5605514|NCT02448095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605515|NCT02448095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5605516|NCT02448095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5605517|NCT02448095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605518|NCT02398825|Ponatinib|ponatinib|mesh-list
5605519|NCT02398825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605520|NCT02398825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5605521|NCT02398825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5605522|NCT02398825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605523|NCT02393248|Gemcitabine|gemcitabine|mesh-list
5605524|NCT02393248|Docetaxel|docetaxel|mesh-list
5605525|NCT02393248|Pembrolizumab|pembrolizumab|mesh-list
5605526|NCT02393248|Trastuzumab|trastuzumab|mesh-list
5605527|NCT02393248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605528|NCT02393248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5605529|NCT02393248|Antimetabolites|antimetabolites|mesh-ancestor
5605530|NCT02393248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605531|NCT02393248|Antiviral Agents|antiviral agents|mesh-ancestor
5605532|NCT02393248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5605533|NCT02393248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5605534|NCT02393248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5605535|NCT02393248|Immunologic Factors|immunologic factors|mesh-ancestor
5605536|NCT02393248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605537|NCT02393248|Tubulin Modulators|tubulin modulators|mesh-ancestor
5605538|NCT02393248|Antimitotic Agents|antimitotic agents|mesh-ancestor
5605539|NCT02393248|Mitosis Modulators|mitosis modulators|mesh-ancestor
5605540|NCT02393248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5605541|NCT02318654|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
5605542|NCT02318654|Anesthetics, Local|anesthetics, local|mesh-ancestor
5605543|NCT02318654|Anesthetics|anesthetics|mesh-ancestor
5605544|NCT02318654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5605545|NCT02318654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605546|NCT02318654|Sensory System Agents|sensory system agents|mesh-ancestor
5605547|NCT02318654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5605548|NCT02318654|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
5591161|NCT03777163|Vaccines|vaccines|mesh-list
5591162|NCT03777163|Immunologic Factors|immunologic factors|mesh-ancestor
5591163|NCT03777163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591164|NCT03777033|Alfacalcidol|alfacalcidol|mesh-list
5591165|NCT03777033|Calcium|calcium|mesh-list
5591166|NCT03777033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5591167|NCT03777033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591168|NCT03777033|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5591169|NCT03776851|Epoetin Alfa|epoetin alfa|mesh-list
5591170|NCT03776851|Hematinics|hematinics|mesh-ancestor
5591171|NCT03776916|Simethicone|simethicone|mesh-list
5591172|NCT03776916|Antifoaming Agents|antifoaming agents|mesh-ancestor
5591173|NCT03776916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591174|NCT03776916|Emollients|emollients|mesh-ancestor
5591175|NCT03776916|Dermatologic Agents|dermatologic agents|mesh-ancestor
5591176|NCT03776838|Fentanyl|fentanyl|mesh-list
5591177|NCT03776838|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5591178|NCT03776838|Narcotics|narcotics|mesh-ancestor
5591179|NCT03776838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5591180|NCT03776838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591181|NCT03776838|Analgesics|analgesics|mesh-ancestor
5591182|NCT03776838|Sensory System Agents|sensory system agents|mesh-ancestor
5591183|NCT03776838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5591184|NCT03776838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5591185|NCT03776838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5591186|NCT03776838|Anesthetics, General|anesthetics, general|mesh-ancestor
5591187|NCT03776838|Anesthetics|anesthetics|mesh-ancestor
5591188|NCT03777345|Cobalt|cobalt|mesh-list
5591189|NCT03777345|Chromium|chromium|mesh-list
5591190|NCT03777345|Trace Elements|trace elements|mesh-ancestor
5591191|NCT03777345|Micronutrients|micronutrients|mesh-ancestor
5591192|NCT03777345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591200|NCT03776955|Carvedilol|carvedilol|mesh-list
5591201|NCT03776955|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5591202|NCT03776955|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5591203|NCT03776955|Adrenergic Agents|adrenergic agents|mesh-ancestor
5591204|NCT03776955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5591205|NCT03776955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591206|NCT03776955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591207|NCT03776955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5591208|NCT03776955|Antioxidants|antioxidants|mesh-ancestor
5591209|NCT03776955|Protective Agents|protective agents|mesh-ancestor
5591210|NCT03776955|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5591211|NCT03776955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5591212|NCT03776955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5591213|NCT03776955|Vasodilator Agents|vasodilator agents|mesh-ancestor
5591214|NCT03776955|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5591215|NCT03776955|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5591216|NCT03776656|Allopurinol|allopurinol|mesh-list
5591217|NCT03776656|Antimetabolites|antimetabolites|mesh-ancestor
5591218|NCT03776656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591219|NCT03776656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5591220|NCT03776656|Gout Suppressants|gout suppressants|mesh-ancestor
5591221|NCT03776656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5591222|NCT03776656|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5591223|NCT03776656|Antioxidants|antioxidants|mesh-ancestor
5591224|NCT03776656|Protective Agents|protective agents|mesh-ancestor
5591225|NCT03776656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591226|NCT03776994|Vaccines|vaccines|mesh-list
5591227|NCT03776994|Immunologic Factors|immunologic factors|mesh-ancestor
5591228|NCT03776994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591229|NCT03776409|Vancomycin|vancomycin|mesh-list
5591230|NCT03776409|Tazobactam|tazobactam|mesh-list
5591231|NCT03776409|Piperacillin|piperacillin|mesh-list
5591232|NCT03776409|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
5591233|NCT03776409|Lactams|lactams|mesh-list
6201803|NCT02030600|Insulin|insulin|mesh-list
5591234|NCT03776409|beta-Lactams|beta-lactams|mesh-list
5591235|NCT03776409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5591236|NCT03776409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5591237|NCT03776409|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6201804|NCT02030600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5591238|NCT03776409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5591239|NCT03776409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591240|NCT03776448|Charcoal|charcoal|mesh-list
5591241|NCT03776448|Antidotes|antidotes|mesh-ancestor
5591242|NCT03776448|Protective Agents|protective agents|mesh-ancestor
5591243|NCT03776448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591244|NCT03776383|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5591245|NCT03776383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5591246|NCT03776487|Fluorouracil|fluorouracil|mesh-list
5591247|NCT03776487|Oxaliplatin|oxaliplatin|mesh-list
5591248|NCT03776487|Nivolumab|nivolumab|mesh-list
5591249|NCT03776487|Ipilimumab|ipilimumab|mesh-list
6201805|NCT02030600|Insulin Glargine|insulin glargine|mesh-list
6201806|NCT02030600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6201807|NCT02030600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201808|NCT02030821|Tranexamic Acid|tranexamic acid|mesh-list
6201809|NCT02030821|Aminocaproic Acid|aminocaproic acid|mesh-list
6201810|NCT02030821|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6201811|NCT02030821|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6201812|NCT02030821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201813|NCT02030821|Hemostatics|hemostatics|mesh-ancestor
6201814|NCT02030821|Coagulants|coagulants|mesh-ancestor
6207704|NCT02119468|Proteasome Inhibitors|proteasome inhibitors|mesh-list
6207705|NCT02119468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6207706|NCT02119468|Antiemetics|antiemetics|mesh-ancestor
6207707|NCT02119468|Autonomic Agents|autonomic agents|mesh-ancestor
5591250|NCT03776487|Antimetabolites|antimetabolites|mesh-ancestor
5591251|NCT03776487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591252|NCT03776487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5591253|NCT03776487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5591254|NCT03776487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5591255|NCT03776487|Immunologic Factors|immunologic factors|mesh-ancestor
5591256|NCT03776487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591257|NCT03776487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5591258|NCT03776487|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5591259|NCT03776500|Macozinone|macozinone|mesh-list
5591260|NCT03776500|Antitubercular Agents|antitubercular agents|mesh-ancestor
5591261|NCT03776500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5591262|NCT03776500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5591263|NCT03776812|Paclitaxel|paclitaxel|mesh-list
5591264|NCT03776812|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5591265|NCT03776812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5591266|NCT03776812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5591267|NCT03776812|Tubulin Modulators|tubulin modulators|mesh-ancestor
5591268|NCT03776812|Antimitotic Agents|antimitotic agents|mesh-ancestor
5591269|NCT03776812|Mitosis Modulators|mitosis modulators|mesh-ancestor
5591270|NCT03776812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591271|NCT03776227|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
5591272|NCT03776227|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5591273|NCT03776227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591274|NCT03776227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5591275|NCT03776227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591276|NCT03776279|Mitoxantrone|mitoxantrone|mesh-list
5591277|NCT03776279|Analgesics|analgesics|mesh-ancestor
5591278|NCT03776279|Sensory System Agents|sensory system agents|mesh-ancestor
5591279|NCT03776279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5591280|NCT03776279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591281|NCT03776279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5591282|NCT03776279|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5591283|NCT03776279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5591284|NCT03776279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5591285|NCT03776279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591286|NCT03776136|Pembrolizumab|pembrolizumab|mesh-list
5591287|NCT03776136|Lenvatinib|lenvatinib|mesh-list
5591288|NCT03776136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5591289|NCT03776136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5591290|NCT03776136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5591291|NCT03776136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5591292|NCT03776136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591293|NCT03776305|Imipenem|imipenem|mesh-list
5591294|NCT03776305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5591295|NCT03776305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5591296|NCT03776240|Trastuzumab|trastuzumab|mesh-list
6207708|NCT02119468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5591297|NCT03776240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5591298|NCT03776240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5591299|NCT03776058|Cinacalcet|cinacalcet|mesh-list
5591300|NCT03776058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5591301|NCT03776058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591302|NCT03776058|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
5591303|NCT03776058|Hormone Antagonists|hormone antagonists|mesh-ancestor
5591304|NCT03776058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5591305|NCT03776032|Darbepoetin alfa|darbepoetin alfa|mesh-list
5591306|NCT03776032|Hematinics|hematinics|mesh-ancestor
5591307|NCT03775798|Antiviral Agents|antiviral agents|mesh-list
5591308|NCT03775798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5591309|NCT03775993|Hormones|hormones|mesh-list
5591310|NCT03775993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5591311|NCT03775993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591312|NCT03775629|Tramadol|tramadol|mesh-list
5591313|NCT03775629|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5591314|NCT03775629|Narcotics|narcotics|mesh-ancestor
5591315|NCT03775629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5591316|NCT03775629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591317|NCT03775629|Analgesics|analgesics|mesh-ancestor
5591318|NCT03775629|Sensory System Agents|sensory system agents|mesh-ancestor
5591319|NCT03775629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5591320|NCT03775876|Dexmedetomidine|dexmedetomidine|mesh-list
5591321|NCT03775876|Propofol|propofol|mesh-list
5591322|NCT03775876|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5591323|NCT03775876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5591324|NCT03775876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591325|NCT03775876|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5591326|NCT03775876|Anesthetics, General|anesthetics, general|mesh-ancestor
5591327|NCT03775876|Anesthetics|anesthetics|mesh-ancestor
5591328|NCT03775876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5591329|NCT03775876|Analgesics|analgesics|mesh-ancestor
5591330|NCT03775876|Sensory System Agents|sensory system agents|mesh-ancestor
5591331|NCT03775876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5591332|NCT03775876|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5591333|NCT03775876|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5591334|NCT03775876|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5591335|NCT03775876|Adrenergic Agents|adrenergic agents|mesh-ancestor
5591336|NCT03775876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5591337|NCT03775876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591338|NCT03775668|Enmetazobactam|enmetazobactam|mesh-list
5591339|NCT03775668|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5591340|NCT03775668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5591341|NCT03775668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591342|NCT03775668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5591343|NCT03775668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5591344|NCT03775863|Liver Extracts|liver extracts|mesh-list
5591345|NCT03775863|Hematinics|hematinics|mesh-ancestor
5591346|NCT03775707|Lenvatinib|lenvatinib|mesh-list
5591347|NCT03775707|Antibodies|antibodies|mesh-list
5591348|NCT03775707|Immunologic Factors|immunologic factors|mesh-ancestor
5591349|NCT03775707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591350|NCT03775707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5591351|NCT03775707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5591352|NCT03775707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5591353|NCT03775707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591354|NCT03775902|Nicorandil|nicorandil|mesh-list
5591355|NCT03775902|Glimepiride|glimepiride|mesh-list
5591356|NCT03775902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5591357|NCT03775902|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5591358|NCT03775902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591359|NCT03775902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5591360|NCT03775902|Immunologic Factors|immunologic factors|mesh-ancestor
5591361|NCT03775902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5591362|NCT03775902|Vasodilator Agents|vasodilator agents|mesh-ancestor
5591363|NCT03775902|Vitamin B Complex|vitamin b complex|mesh-ancestor
5591364|NCT03775902|Vitamins|vitamins|mesh-ancestor
5591365|NCT03775902|Micronutrients|micronutrients|mesh-ancestor
5591366|NCT03775655|Dexmedetomidine|dexmedetomidine|mesh-list
5591367|NCT03775655|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5591368|NCT03775655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5591369|NCT03775655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591370|NCT03775655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5591371|NCT03775655|Analgesics|analgesics|mesh-ancestor
5591372|NCT03775655|Sensory System Agents|sensory system agents|mesh-ancestor
5591373|NCT03775655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5591374|NCT03775655|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5591375|NCT03775655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5591376|NCT03775655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5591377|NCT03775655|Adrenergic Agents|adrenergic agents|mesh-ancestor
5591378|NCT03775655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5591379|NCT03775655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591380|NCT03775590|Acetic Acid|acetic acid|mesh-list
5591381|NCT03775590|Retinol acetate|retinol acetate|mesh-list
5591382|NCT03775590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5591383|NCT03775590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5591384|NCT03775590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5591385|NCT03775590|Immunologic Factors|immunologic factors|mesh-ancestor
5591386|NCT03775590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591387|NCT03775590|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5591388|NCT03775590|Protective Agents|protective agents|mesh-ancestor
5591389|NCT03775590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5591390|NCT03775746|Rivaroxaban|rivaroxaban|mesh-list
5591391|NCT03775746|Clopidogrel|clopidogrel|mesh-list
5591392|NCT03775746|Ticagrelor|ticagrelor|mesh-list
5591393|NCT03775746|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5591394|NCT03775746|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5591395|NCT03775746|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5591396|NCT03775746|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5591397|NCT03775746|Purinergic Agents|purinergic agents|mesh-ancestor
5591398|NCT03775746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5591399|NCT03775746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591400|NCT03775746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591401|NCT03775746|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5591402|NCT03775746|Antithrombins|antithrombins|mesh-ancestor
5591403|NCT03775746|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5591404|NCT03775746|Protease Inhibitors|protease inhibitors|mesh-ancestor
5591405|NCT03775746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5591406|NCT03775746|Anticoagulants|anticoagulants|mesh-ancestor
5591407|NCT03775928|Capecitabine|capecitabine|mesh-list
5591408|NCT03775928|Apatinib|apatinib|mesh-list
5591409|NCT03775928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5591410|NCT03775928|Antimetabolites|antimetabolites|mesh-ancestor
5591411|NCT03775928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591412|NCT03775928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5591413|NCT03775928|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5591414|NCT03775928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5591415|NCT03775538|Dopamine|dopamine|mesh-list
5591416|NCT03775538|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5591417|NCT03775538|Sympathomimetics|sympathomimetics|mesh-ancestor
5591418|NCT03775538|Autonomic Agents|autonomic agents|mesh-ancestor
5591419|NCT03775538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5591420|NCT03775538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591421|NCT03775538|Dopamine Agents|dopamine agents|mesh-ancestor
5591422|NCT03775538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5591423|NCT03775538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591424|NCT03775538|Protective Agents|protective agents|mesh-ancestor
5591425|NCT03775460|Prednisolone|prednisolone|mesh-list
5591426|NCT03775460|Methotrexate|methotrexate|mesh-list
5591427|NCT03775460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5591428|NCT03775460|Abortifacient Agents|abortifacient agents|mesh-ancestor
5591429|NCT03775460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5591430|NCT03775460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591431|NCT03775460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5591432|NCT03775460|Antimetabolites|antimetabolites|mesh-ancestor
5591433|NCT03775460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591434|NCT03775460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5591435|NCT03775460|Dermatologic Agents|dermatologic agents|mesh-ancestor
5591436|NCT03775460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5591437|NCT03775460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5591438|NCT03775460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5591439|NCT03775460|Immunologic Factors|immunologic factors|mesh-ancestor
5591440|NCT03775460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5591441|NCT03775460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5591442|NCT03775460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5591443|NCT03775460|Glucocorticoids|glucocorticoids|mesh-ancestor
5591444|NCT03775460|Hormones|hormones|mesh-ancestor
5591445|NCT03775460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5591446|NCT03775460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5591447|NCT03775382|Ascorbic Acid|ascorbic acid|mesh-list
5591448|NCT03775382|Vitamins|vitamins|mesh-ancestor
5591449|NCT03775382|Micronutrients|micronutrients|mesh-ancestor
5591450|NCT03775382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591451|NCT03775382|Antioxidants|antioxidants|mesh-ancestor
5591452|NCT03775382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591453|NCT03775382|Protective Agents|protective agents|mesh-ancestor
5591454|NCT03775096|Carvedilol|carvedilol|mesh-list
5591455|NCT03775096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5591456|NCT03775096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5591457|NCT03775096|Adrenergic Agents|adrenergic agents|mesh-ancestor
5591458|NCT03775096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5591459|NCT03775096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591460|NCT03775096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591461|NCT03775096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5591462|NCT03775096|Antioxidants|antioxidants|mesh-ancestor
5591463|NCT03775096|Protective Agents|protective agents|mesh-ancestor
5591464|NCT03775096|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5591465|NCT03775096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5591466|NCT03775096|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5591467|NCT03775096|Vasodilator Agents|vasodilator agents|mesh-ancestor
5591468|NCT03775096|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5591469|NCT03775096|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5591470|NCT03775395|Sorafenib|sorafenib|mesh-list
5591471|NCT03775395|Lenvatinib|lenvatinib|mesh-list
5591472|NCT03775395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5591473|NCT03775395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5591474|NCT03775395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5591475|NCT03775395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591476|NCT03775356|Anesthetics|anesthetics|mesh-list
5591477|NCT03775356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5591478|NCT03775356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591479|NCT03775070|Simvastatin|simvastatin|mesh-list
5591480|NCT03775070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5591481|NCT03775070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5591482|NCT03775070|Antimetabolites|antimetabolites|mesh-ancestor
5591483|NCT03775070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591484|NCT03775070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5591485|NCT03775070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5591486|NCT03775070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5591487|NCT03774901|Avelumab|avelumab|mesh-list
5591488|NCT03774901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5591489|NCT03774901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5591490|NCT03774732|Paclitaxel|paclitaxel|mesh-list
5591491|NCT03774732|Cisplatin|cisplatin|mesh-list
5591492|NCT03774732|Carboplatin|carboplatin|mesh-list
5591493|NCT03774732|Pembrolizumab|pembrolizumab|mesh-list
5591494|NCT03774732|Pemetrexed|pemetrexed|mesh-list
5591495|NCT03774732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5591496|NCT03774732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5591497|NCT03774732|Tubulin Modulators|tubulin modulators|mesh-ancestor
5591498|NCT03774732|Antimitotic Agents|antimitotic agents|mesh-ancestor
5591499|NCT03774732|Mitosis Modulators|mitosis modulators|mesh-ancestor
5591500|NCT03774732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591501|NCT03774732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5591502|NCT03774732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5591503|NCT03774732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5591504|NCT03774732|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5591505|NCT03774654|Cyclophosphamide|cyclophosphamide|mesh-list
5591506|NCT03774654|Fludarabine|fludarabine|mesh-list
5591507|NCT03774654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5591508|NCT03774654|Immunologic Factors|immunologic factors|mesh-ancestor
5591509|NCT03774654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591510|NCT03774654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5591511|NCT03774654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5591512|NCT03774654|Alkylating Agents|alkylating agents|mesh-ancestor
5591513|NCT03774654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591514|NCT03774654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5591515|NCT03774654|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5591516|NCT03774953|Vitamins|vitamins|mesh-list
5591517|NCT03774953|Micronutrients|micronutrients|mesh-ancestor
5591518|NCT03774953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591519|NCT03774706|Misoprostol|misoprostol|mesh-list
5591520|NCT03774706|Tranexamic Acid|tranexamic acid|mesh-list
5591521|NCT03774706|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5591522|NCT03774706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5591523|NCT03774706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591524|NCT03774706|Hemostatics|hemostatics|mesh-ancestor
5591525|NCT03774706|Coagulants|coagulants|mesh-ancestor
5591526|NCT03774706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5591527|NCT03774706|Abortifacient Agents|abortifacient agents|mesh-ancestor
5591528|NCT03774706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5591529|NCT03774706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591530|NCT03774706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5591531|NCT03774706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5591532|NCT03774706|Oxytocics|oxytocics|mesh-ancestor
5591533|NCT03774771|Cinacalcet|cinacalcet|mesh-list
5591534|NCT03774771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5591535|NCT03774771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591536|NCT03774771|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
5591537|NCT03774771|Hormone Antagonists|hormone antagonists|mesh-ancestor
5591538|NCT03774771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5591539|NCT03774693|Fentanyl|fentanyl|mesh-list
5591540|NCT03774693|Anesthetics|anesthetics|mesh-ancestor
5591541|NCT03774693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5591542|NCT03774693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591543|NCT03774693|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5591544|NCT03774693|Narcotics|narcotics|mesh-ancestor
5591545|NCT03774693|Analgesics|analgesics|mesh-ancestor
5591546|NCT03774693|Sensory System Agents|sensory system agents|mesh-ancestor
5591547|NCT03774693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5591548|NCT03774693|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5591549|NCT03774693|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5591550|NCT03774693|Anesthetics, General|anesthetics, general|mesh-ancestor
5591551|NCT03774836|Morphine|morphine|mesh-list
5591552|NCT03774836|Tramadol|tramadol|mesh-list
5591553|NCT03774836|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5591554|NCT03774836|Narcotics|narcotics|mesh-ancestor
5591555|NCT03774836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5591556|NCT03774836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591557|NCT03774836|Analgesics|analgesics|mesh-ancestor
5591558|NCT03774836|Sensory System Agents|sensory system agents|mesh-ancestor
5591559|NCT03774836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5591560|NCT03774680|Cetuximab|cetuximab|mesh-list
5591561|NCT03774680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5591562|NCT03774680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5591563|NCT03774615|Ferric maltol|ferric maltol|mesh-list
5591564|NCT03774615|Hematinics|hematinics|mesh-ancestor
5591565|NCT03774810|Zolpidem|zolpidem|mesh-list
5591566|NCT03774810|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5591567|NCT03774810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5591568|NCT03774810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5591569|NCT03774810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591570|NCT03774810|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
5591571|NCT03774810|GABA Agonists|gaba agonists|mesh-ancestor
5591572|NCT03774810|GABA Agents|gaba agents|mesh-ancestor
5591573|NCT03774810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5591574|NCT03774810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591575|NCT03774524|Misoprostol|misoprostol|mesh-list
5591576|NCT03774524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5591577|NCT03774524|Abortifacient Agents|abortifacient agents|mesh-ancestor
5591578|NCT03774524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5591579|NCT03774524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591580|NCT03774524|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5591581|NCT03774524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5591582|NCT03774524|Oxytocics|oxytocics|mesh-ancestor
5591583|NCT03774472|Hydroxychloroquine|hydroxychloroquine|mesh-list
5591584|NCT03774472|Letrozole|letrozole|mesh-list
5591585|NCT03774472|Palbociclib|palbociclib|mesh-list
5591586|NCT03774472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5591587|NCT03774472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5591588|NCT03774472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5591589|NCT03774472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5591590|NCT03774472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591591|NCT03774472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5591592|NCT03774472|Hormone Antagonists|hormone antagonists|mesh-ancestor
5591593|NCT03774472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5591594|NCT03774472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591595|NCT03774472|Antimalarials|antimalarials|mesh-ancestor
5591596|NCT03774472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5591597|NCT03774472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5591598|NCT03774472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5591599|NCT03774472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5591600|NCT03774472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5591601|NCT03773991|Nitric Oxide|nitric oxide|mesh-list
5591602|NCT03773991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5591603|NCT03773991|Autonomic Agents|autonomic agents|mesh-ancestor
5591604|NCT03773991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5591605|NCT03773991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591606|NCT03773991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5591607|NCT03773991|Respiratory System Agents|respiratory system agents|mesh-ancestor
5591608|NCT03773991|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5591609|NCT03773991|Antioxidants|antioxidants|mesh-ancestor
5591610|NCT03773991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591611|NCT03773991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5591612|NCT03773991|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5591613|NCT03773991|Vasodilator Agents|vasodilator agents|mesh-ancestor
5591614|NCT03773991|Gasotransmitters|gasotransmitters|mesh-ancestor
5591615|NCT03773991|Protective Agents|protective agents|mesh-ancestor
5591616|NCT03774108|Metformin|metformin|mesh-list
5591617|NCT03774108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5591618|NCT03774108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591619|NCT03774446|Roscovitine|roscovitine|mesh-list
5591620|NCT03774446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5591621|NCT03774446|Antiviral Agents|antiviral agents|mesh-ancestor
5591622|NCT03774446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5591623|NCT03774446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5591624|NCT03774446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5591625|NCT03774446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591626|NCT03774095|Pycnogenols|pycnogenols|mesh-list
5591627|NCT03774095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5591628|NCT03774095|Immunologic Factors|immunologic factors|mesh-ancestor
5591629|NCT03774095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591630|NCT03774095|Antioxidants|antioxidants|mesh-ancestor
5591631|NCT03774095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591632|NCT03774095|Protective Agents|protective agents|mesh-ancestor
5591633|NCT03774095|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5591634|NCT03773822|Hydrocortisone|hydrocortisone|mesh-list
5591635|NCT03773822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5591636|NCT03773744|Cyclophosphamide|cyclophosphamide|mesh-list
5591637|NCT03773744|Pembrolizumab|pembrolizumab|mesh-list
5591638|NCT03773744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5591639|NCT03773744|Immunologic Factors|immunologic factors|mesh-ancestor
5591640|NCT03773744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591641|NCT03773744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5591642|NCT03773744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5591643|NCT03773744|Alkylating Agents|alkylating agents|mesh-ancestor
5591644|NCT03773744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591645|NCT03773744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5591646|NCT03773744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5591647|NCT03773744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5591648|NCT03773562|Erenumab|erenumab|mesh-list
5591649|NCT03773562|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
5591650|NCT03773562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591651|NCT03773562|Analgesics|analgesics|mesh-ancestor
5591652|NCT03773562|Sensory System Agents|sensory system agents|mesh-ancestor
5591653|NCT03773562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5591654|NCT03773562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591655|NCT03773536|Artesunate|artesunate|mesh-list
5591656|NCT03773536|Primaquine|primaquine|mesh-list
5591657|NCT03773536|Amodiaquine|amodiaquine|mesh-list
5591658|NCT03773536|Antimalarials|antimalarials|mesh-ancestor
5591659|NCT03773536|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5591660|NCT03773536|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5591661|NCT03773536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5591662|NCT03773536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5591663|NCT03773536|Antiviral Agents|antiviral agents|mesh-ancestor
5591664|NCT03773536|Schistosomicides|schistosomicides|mesh-ancestor
5591665|NCT03773536|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5591666|NCT03773536|Anthelmintics|anthelmintics|mesh-ancestor
5605549|NCT02307656|Atazanavir Sulfate|atazanavir sulfate|mesh-list
5605550|NCT02307656|Cobicistat|cobicistat|mesh-list
5605551|NCT02307656|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5605552|NCT02307656|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5605553|NCT02307656|Protease Inhibitors|protease inhibitors|mesh-ancestor
5605554|NCT02307656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5605555|NCT02307656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605556|NCT02307656|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5605557|NCT02307656|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5605558|NCT02307656|Antiviral Agents|antiviral agents|mesh-ancestor
5605559|NCT02307656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5605560|NCT02307656|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5605561|NCT02307656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5605562|NCT02216838|Botulinum Toxins|botulinum toxins|mesh-list
5605563|NCT02216838|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5605564|NCT02216838|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5605565|NCT02216838|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5605566|NCT02216838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5605567|NCT02216838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605568|NCT02216838|Cholinergic Agents|cholinergic agents|mesh-ancestor
5605569|NCT02216838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5605570|NCT02216838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605571|NCT02216838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5605572|NCT02216838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5606896|NCT03493425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606897|NCT03477396|Estrogens|estrogens|mesh-list
5606898|NCT03477396|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5606899|NCT03477396|Hormones|hormones|mesh-ancestor
5606900|NCT03477396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5606901|NCT03477396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606902|NCT03477396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5606903|NCT03477396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5606904|NCT03477396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606905|NCT03477396|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5606906|NCT03477396|Hormone Antagonists|hormone antagonists|mesh-ancestor
5606907|NCT03455439|Rivaroxaban|rivaroxaban|mesh-list
5606908|NCT03455439|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5606909|NCT03455439|Antithrombins|antithrombins|mesh-ancestor
5606910|NCT03455439|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5606911|NCT03455439|Protease Inhibitors|protease inhibitors|mesh-ancestor
5606912|NCT03455439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5606913|NCT03455439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606914|NCT03455439|Anticoagulants|anticoagulants|mesh-ancestor
5606915|NCT03420521|Nivolumab|nivolumab|mesh-list
5606916|NCT03420521|Ipilimumab|ipilimumab|mesh-list
5606917|NCT03420521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5606918|NCT03420521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5606919|NCT03420521|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5606920|NCT03420521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606921|NCT03386214|Pevonedistat|pevonedistat|mesh-list
5606922|NCT03386214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5606923|NCT03386214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606924|NCT03373188|Nivolumab|nivolumab|mesh-list
5606925|NCT03373188|Ipilimumab|ipilimumab|mesh-list
5606926|NCT03373188|Antibodies|antibodies|mesh-list
5606927|NCT03373188|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5606928|NCT03373188|Immunologic Factors|immunologic factors|mesh-ancestor
5606929|NCT03373188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591667|NCT03773809|Vitamin D|vitamin d|mesh-list
5591668|NCT03773809|Ergocalciferols|ergocalciferols|mesh-list
5591669|NCT03773809|Vitamins|vitamins|mesh-list
5591670|NCT03773809|Micronutrients|micronutrients|mesh-ancestor
5591671|NCT03773809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591672|NCT03773809|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5591673|NCT03773809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5591674|NCT03773588|Propofol|propofol|mesh-list
5591675|NCT03773588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5591676|NCT03773588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5591677|NCT03773588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591678|NCT03773588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5591679|NCT03773588|Anesthetics, General|anesthetics, general|mesh-ancestor
5591680|NCT03773588|Anesthetics|anesthetics|mesh-ancestor
5591681|NCT03773510|Trabectedin|trabectedin|mesh-list
5591682|NCT03773510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5591683|NCT03773510|Alkylating Agents|alkylating agents|mesh-ancestor
5591684|NCT03773510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591685|NCT03773510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5591686|NCT03773484|Analgesics, Opioid|analgesics, opioid|mesh-list
5591687|NCT03773484|Narcotics|narcotics|mesh-ancestor
5591688|NCT03773484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5591689|NCT03773484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591690|NCT03773484|Analgesics|analgesics|mesh-ancestor
5591691|NCT03773484|Sensory System Agents|sensory system agents|mesh-ancestor
5591692|NCT03773484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5591693|NCT03773445|Golimumab|golimumab|mesh-list
5591694|NCT03773445|Antibodies|antibodies|mesh-list
5591695|NCT03773445|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5591696|NCT03773445|Immunologic Factors|immunologic factors|mesh-ancestor
5591697|NCT03773445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591698|NCT03773445|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
5591699|NCT03773445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5591700|NCT03773445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5591701|NCT03773367|Fluorouracil|fluorouracil|mesh-list
5591702|NCT03773367|Oxaliplatin|oxaliplatin|mesh-list
5591703|NCT03773367|Irinotecan|irinotecan|mesh-list
5591704|NCT03773367|Antimetabolites|antimetabolites|mesh-ancestor
5591705|NCT03773367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591706|NCT03773367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5591707|NCT03773367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5591708|NCT03773367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5591709|NCT03773367|Immunologic Factors|immunologic factors|mesh-ancestor
5591710|NCT03773367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591711|NCT03773367|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5591712|NCT03773367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5591713|NCT03773367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5591726|NCT03773094|Chlorhexidine|chlorhexidine|mesh-list
5591727|NCT03773094|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5591728|NCT03773094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5591729|NCT03773094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5591730|NCT03773094|Disinfectants|disinfectants|mesh-ancestor
5591731|NCT03773094|Dermatologic Agents|dermatologic agents|mesh-ancestor
5591732|NCT03773042|Propofol|propofol|mesh-list
5591733|NCT03773042|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5591734|NCT03773042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5591735|NCT03773042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591736|NCT03773042|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5591737|NCT03773042|Anesthetics, General|anesthetics, general|mesh-ancestor
5591738|NCT03773042|Anesthetics|anesthetics|mesh-ancestor
5591739|NCT03772834|Methylphenidate|methylphenidate|mesh-list
5591740|NCT03772834|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5591741|NCT03772834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591742|NCT03772834|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5591743|NCT03772834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5591744|NCT03772834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5591745|NCT03772834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591746|NCT03772834|Dopamine Agents|dopamine agents|mesh-ancestor
5591747|NCT03772834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5591748|NCT03772613|Heparin|heparin|mesh-list
5591749|NCT03772613|Calcium heparin|calcium heparin|mesh-list
5591750|NCT03772613|Anticoagulants|anticoagulants|mesh-ancestor
5591751|NCT03772613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5591752|NCT03772613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5591753|NCT03772613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591754|NCT03772990|Calcium|calcium|mesh-list
5591755|NCT03772990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5591756|NCT03772990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591757|NCT03772574|Nicotine|nicotine|mesh-list
5591758|NCT03772574|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5591759|NCT03772574|Autonomic Agents|autonomic agents|mesh-ancestor
5591760|NCT03772574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5591761|NCT03772574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591762|NCT03772574|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5591763|NCT03772574|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5591764|NCT03772574|Cholinergic Agents|cholinergic agents|mesh-ancestor
5591765|NCT03772574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5591766|NCT03772574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591767|NCT03772483|Anesthetics|anesthetics|mesh-list
5591768|NCT03772483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5591769|NCT03772483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591770|NCT03772561|Durvalumab|durvalumab|mesh-list
5591771|NCT03772561|Olaparib|olaparib|mesh-list
5591772|NCT03772561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5591773|NCT03772561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5591774|NCT03772561|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5591775|NCT03772561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5591776|NCT03772561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591777|NCT03772457|Rivaroxaban|rivaroxaban|mesh-list
5591778|NCT03772457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5591779|NCT03772457|Antithrombins|antithrombins|mesh-ancestor
6201815|NCT02031276|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6201816|NCT02031276|Immunologic Factors|immunologic factors|mesh-ancestor
6201817|NCT02031276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201818|NCT02031458|Atezolizumab|atezolizumab|mesh-list
6201819|NCT02031458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6201820|NCT02031536|Everolimus|everolimus|mesh-list
5591780|NCT03772457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5591781|NCT03772457|Protease Inhibitors|protease inhibitors|mesh-ancestor
5591782|NCT03772457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5591783|NCT03772457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591784|NCT03772457|Anticoagulants|anticoagulants|mesh-ancestor
5591785|NCT03772314|Modafinil|modafinil|mesh-list
5591786|NCT03772314|Amphetamine|amphetamine|mesh-list
5591787|NCT03772314|Adderall|adderall|mesh-list
5591788|NCT03772314|Dextroamphetamine|dextroamphetamine|mesh-list
5591789|NCT03772314|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5591790|NCT03772314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591791|NCT03772314|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
5591792|NCT03772314|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5591793|NCT03772314|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5591794|NCT03772314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591795|NCT03772314|Sympathomimetics|sympathomimetics|mesh-ancestor
5591796|NCT03772314|Autonomic Agents|autonomic agents|mesh-ancestor
5591797|NCT03772314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5591798|NCT03772314|Dopamine Agents|dopamine agents|mesh-ancestor
5591799|NCT03772314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5591800|NCT03772314|Adrenergic Agents|adrenergic agents|mesh-ancestor
5591801|NCT03772314|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5591802|NCT03772314|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5591803|NCT03772314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5591804|NCT03772314|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5591805|NCT03772262|Metformin|metformin|mesh-list
5591806|NCT03772262|Furosemide|furosemide|mesh-list
5591807|NCT03772262|Midazolam|midazolam|mesh-list
5591808|NCT03772262|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5591809|NCT03772262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5591810|NCT03772262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201821|NCT02031536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5591811|NCT03772262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5591812|NCT03772262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5591813|NCT03772262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5591814|NCT03772262|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5591815|NCT03772262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5591816|NCT03772262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5591817|NCT03772262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5591818|NCT03772262|Anesthetics, General|anesthetics, general|mesh-ancestor
5591819|NCT03772262|Anesthetics|anesthetics|mesh-ancestor
5591820|NCT03772262|GABA Modulators|gaba modulators|mesh-ancestor
5591821|NCT03772262|GABA Agents|gaba agents|mesh-ancestor
5591822|NCT03772262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5591823|NCT03772262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591824|NCT03772262|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5591825|NCT03772262|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5591826|NCT03772262|Antimetabolites|antimetabolites|mesh-ancestor
5591827|NCT03772262|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5591828|NCT03772262|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5591829|NCT03772262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5591830|NCT03772262|Diuretics|diuretics|mesh-ancestor
5591831|NCT03772262|Natriuretic Agents|natriuretic agents|mesh-ancestor
5591832|NCT03772262|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5591833|NCT03772262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5591834|NCT03772223|Budesonide|budesonide|mesh-list
5591835|NCT03772223|Albuterol|albuterol|mesh-list
5591836|NCT03772223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5591837|NCT03772223|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5591838|NCT03772223|Autonomic Agents|autonomic agents|mesh-ancestor
5591839|NCT03772223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5591840|NCT03772223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591841|NCT03772223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5591842|NCT03772223|Respiratory System Agents|respiratory system agents|mesh-ancestor
5591843|NCT03772223|Glucocorticoids|glucocorticoids|mesh-ancestor
5591844|NCT03772223|Hormones|hormones|mesh-ancestor
5591845|NCT03772223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5591846|NCT03772223|Tocolytic Agents|tocolytic agents|mesh-ancestor
5591847|NCT03772223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5591848|NCT03772223|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5591849|NCT03772223|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5591850|NCT03772223|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5591851|NCT03772223|Adrenergic Agents|adrenergic agents|mesh-ancestor
5591852|NCT03772223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5591853|NCT03772223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591854|NCT03772106|Propofol|propofol|mesh-list
5591855|NCT03772106|Sevoflurane|sevoflurane|mesh-list
5591856|NCT03772106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5591857|NCT03772106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5591858|NCT03772106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591859|NCT03772106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5591860|NCT03772106|Anesthetics, General|anesthetics, general|mesh-ancestor
5591861|NCT03772106|Anesthetics|anesthetics|mesh-ancestor
5591862|NCT03772106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5591863|NCT03772106|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5591864|NCT03772054|Propofol|propofol|mesh-list
5591865|NCT03772054|Sevoflurane|sevoflurane|mesh-list
5591866|NCT03772054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5591867|NCT03772054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5591868|NCT03772054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591869|NCT03772054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5591870|NCT03772054|Anesthetics, General|anesthetics, general|mesh-ancestor
5591871|NCT03772054|Anesthetics|anesthetics|mesh-ancestor
5591872|NCT03772054|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5591873|NCT03772054|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5591874|NCT03771820|Pembrolizumab|pembrolizumab|mesh-list
5591875|NCT03771820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5591876|NCT03771820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5591877|NCT03771846|Leucovorin|leucovorin|mesh-list
5591878|NCT03771846|Gemcitabine|gemcitabine|mesh-list
5591879|NCT03771846|Fluorouracil|fluorouracil|mesh-list
5591880|NCT03771846|Oxaliplatin|oxaliplatin|mesh-list
5591881|NCT03771846|Irinotecan|irinotecan|mesh-list
5591882|NCT03771846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5591883|NCT03771846|Antimetabolites|antimetabolites|mesh-ancestor
5591884|NCT03771846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591885|NCT03771846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5591886|NCT03771846|Antiviral Agents|antiviral agents|mesh-ancestor
5591887|NCT03771846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5591888|NCT03771846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5591889|NCT03771846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5591890|NCT03771846|Immunologic Factors|immunologic factors|mesh-ancestor
5591891|NCT03771846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591892|NCT03771846|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5591893|NCT03771846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5591894|NCT03771846|Antidotes|antidotes|mesh-ancestor
5591895|NCT03771846|Protective Agents|protective agents|mesh-ancestor
5591896|NCT03771846|Vitamin B Complex|vitamin b complex|mesh-ancestor
5591897|NCT03771846|Vitamins|vitamins|mesh-ancestor
5591898|NCT03771846|Micronutrients|micronutrients|mesh-ancestor
5591899|NCT03771755|Acetaminophen|acetaminophen|mesh-list
5591900|NCT03771755|Ibuprofen|ibuprofen|mesh-list
5591901|NCT03771755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5591902|NCT03771755|Analgesics|analgesics|mesh-ancestor
5591903|NCT03771755|Sensory System Agents|sensory system agents|mesh-ancestor
5591904|NCT03771755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5591905|NCT03771755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591906|NCT03771755|Antipyretics|antipyretics|mesh-ancestor
5591907|NCT03771755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5591908|NCT03771755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5591909|NCT03771755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5591910|NCT03771755|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5591911|NCT03771755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5591912|NCT03771755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591913|NCT03771729|Valsartan|valsartan|mesh-list
5591914|NCT03771729|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5591915|NCT03771729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5591916|NCT03771729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5591917|NCT03771729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5591918|NCT03771729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591919|NCT03772067|Insulin|insulin|mesh-list
5591920|NCT03772067|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5591921|NCT03772067|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5591922|NCT03772067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5591923|NCT03772067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591924|NCT03772067|Incretins|incretins|mesh-ancestor
5591925|NCT03772067|Hormones|hormones|mesh-ancestor
5591926|NCT03772067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5605573|NCT02091141|Trastuzumab|trastuzumab|mesh-list
5605574|NCT02091141|Pertuzumab|pertuzumab|mesh-list
5605575|NCT02091141|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5605576|NCT02091141|Atezolizumab|atezolizumab|mesh-list
5605577|NCT02091141|Vemurafenib|vemurafenib|mesh-list
5605578|NCT02091141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5605579|NCT02091141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605580|NCT02091141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5605581|NCT02091141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5605582|NCT02091141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605583|NCT02090114|Methyltestosterone|methyltestosterone|mesh-list
5605584|NCT02090114|Abiraterone Acetate|abiraterone acetate|mesh-list
5605585|NCT02090114|Testosterone|testosterone|mesh-list
5605586|NCT02090114|Testosterone undecanoate|testosterone undecanoate|mesh-list
5605587|NCT02090114|Testosterone enanthate|testosterone enanthate|mesh-list
5605588|NCT02090114|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5605589|NCT02090114|Androgens|androgens|mesh-ancestor
5605590|NCT02090114|Hormones|hormones|mesh-ancestor
5605591|NCT02090114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5605592|NCT02090114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605593|NCT02090114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5605594|NCT02090114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605595|NCT02090114|Anabolic Agents|anabolic agents|mesh-ancestor
5605596|NCT02090114|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5605597|NCT02090114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5605598|NCT02090114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605599|NCT02090114|Hormone Antagonists|hormone antagonists|mesh-ancestor
5605600|NCT02090114|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5605601|NCT02031250|Carboplatin|carboplatin|mesh-list
5605602|NCT02031250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605603|NCT02015351|Bevacizumab|bevacizumab|mesh-list
5605604|NCT02015351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5605605|NCT02015351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605606|NCT02015351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5605607|NCT02015351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5591927|NCT03771677|Interferons|interferons|mesh-list
5591928|NCT03771677|Interferon-alpha|interferon-alpha|mesh-list
5591929|NCT03771677|Interferon alpha-2|interferon alpha-2|mesh-list
5591930|NCT03771677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5591931|NCT03771677|Antiviral Agents|antiviral agents|mesh-ancestor
5591932|NCT03771677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5591933|NCT03771677|Immunologic Factors|immunologic factors|mesh-ancestor
5591934|NCT03771677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591935|NCT03772028|Cisplatin|cisplatin|mesh-list
5591936|NCT03772028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5591937|NCT03771781|Empagliflozin|empagliflozin|mesh-list
5591938|NCT03771781|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5591939|NCT03771781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591940|NCT03771781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5591941|NCT03771781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591942|NCT03771768|Triamcinolone|triamcinolone|mesh-list
5591943|NCT03771768|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5591944|NCT03771768|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5591945|NCT03771768|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5591946|NCT03771768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5591947|NCT03771768|Glucocorticoids|glucocorticoids|mesh-ancestor
5591948|NCT03771768|Hormones|hormones|mesh-ancestor
5591949|NCT03771768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5591950|NCT03771768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591951|NCT03771768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5591952|NCT03771768|Immunologic Factors|immunologic factors|mesh-ancestor
5591953|NCT03771768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5591954|NCT03771768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591955|NCT03771638|Tenofovir|tenofovir|mesh-list
5591956|NCT03771638|Emtricitabine|emtricitabine|mesh-list
5591957|NCT03771638|Antiviral Agents|antiviral agents|mesh-ancestor
5591958|NCT03771638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5591959|NCT03771638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5591960|NCT03771638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5591961|NCT03771638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5591962|NCT03771638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591963|NCT03771638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5591964|NCT03771638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5591965|NCT03771222|Decitabine|decitabine|mesh-list
5591966|NCT03771222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5591967|NCT03771222|Antimetabolites|antimetabolites|mesh-ancestor
5591968|NCT03771222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591969|NCT03771222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5591970|NCT03771222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5591971|NCT03771066|Bisphenol A|bisphenol a|mesh-list
5591972|NCT03771066|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
5591973|NCT03771066|Estrogens|estrogens|mesh-ancestor
5591974|NCT03771066|Hormones|hormones|mesh-ancestor
5591975|NCT03771066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5591976|NCT03771066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591977|NCT03771066|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5591978|NCT03771066|Antioxidants|antioxidants|mesh-ancestor
5591979|NCT03771066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591980|NCT03771066|Protective Agents|protective agents|mesh-ancestor
5591981|NCT03771092|Ferric gluconate|ferric gluconate|mesh-list
5591982|NCT03771092|Hematinics|hematinics|mesh-ancestor
5591983|NCT03771651|Aspirin|aspirin|mesh-list
5591984|NCT03771651|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5591985|NCT03771651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5591986|NCT03771651|Analgesics|analgesics|mesh-ancestor
5591987|NCT03771651|Sensory System Agents|sensory system agents|mesh-ancestor
5591988|NCT03771651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5591989|NCT03771651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5591990|NCT03771651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5591991|NCT03771651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5591992|NCT03771651|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5591993|NCT03771651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5591994|NCT03771651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5591995|NCT03771651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5591996|NCT03771651|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5591997|NCT03771651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5591998|NCT03771651|Antipyretics|antipyretics|mesh-ancestor
5591999|NCT03770923|Montelukast|montelukast|mesh-list
5592000|NCT03770923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5592001|NCT03770923|Respiratory System Agents|respiratory system agents|mesh-ancestor
5592002|NCT03770923|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5592003|NCT03770923|Hormone Antagonists|hormone antagonists|mesh-ancestor
5592004|NCT03770923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5592005|NCT03770923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592006|NCT03770923|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5592007|NCT03770923|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5592008|NCT03770923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592009|NCT03770936|Candesartan|candesartan|mesh-list
5592010|NCT03770936|Ramipril|ramipril|mesh-list
5592011|NCT03770936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5592012|NCT03770936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5592013|NCT03770936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5592014|NCT03770936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592015|NCT03770936|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5592016|NCT03770936|Protease Inhibitors|protease inhibitors|mesh-ancestor
5592017|NCT03770936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5592018|NCT03770806|Acetaminophen|acetaminophen|mesh-list
5592019|NCT03770806|Celecoxib|celecoxib|mesh-list
5592020|NCT03770806|Oxycodone|oxycodone|mesh-list
5592021|NCT03770806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5592022|NCT03770806|Analgesics|analgesics|mesh-ancestor
5592023|NCT03770806|Sensory System Agents|sensory system agents|mesh-ancestor
5592024|NCT03770806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5592025|NCT03770806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592026|NCT03770806|Antipyretics|antipyretics|mesh-ancestor
5592027|NCT03770806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5592028|NCT03770806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5592029|NCT03770806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5592030|NCT03770806|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5592031|NCT03770806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5592032|NCT03770806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5592033|NCT03770806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592034|NCT03770806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5592035|NCT03770806|Narcotics|narcotics|mesh-ancestor
5592036|NCT03770806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5592037|NCT03771053|Simvastatin|simvastatin|mesh-list
5592038|NCT03771053|Ezetimibe|ezetimibe|mesh-list
5592039|NCT03771053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5592040|NCT03771053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5592041|NCT03771053|Antimetabolites|antimetabolites|mesh-ancestor
5592042|NCT03771053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592043|NCT03771053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5592044|NCT03771053|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5592045|NCT03771053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5592046|NCT03770416|Nivolumab|nivolumab|mesh-list
5592047|NCT03770416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5592048|NCT03770416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5592049|NCT03770416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5592050|NCT03770416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592051|NCT03770702|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
5592052|NCT03770702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592053|NCT03770663|Cyclophosphamide|cyclophosphamide|mesh-list
5592054|NCT03770663|Azathioprine|azathioprine|mesh-list
5592055|NCT03770663|Tacrolimus|tacrolimus|mesh-list
5592056|NCT03770663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5592057|NCT03770663|Immunologic Factors|immunologic factors|mesh-ancestor
5592058|NCT03770663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592059|NCT03770663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5592060|NCT03770663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5592061|NCT03770663|Alkylating Agents|alkylating agents|mesh-ancestor
5592062|NCT03770663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592063|NCT03770663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5592064|NCT03770663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5592065|NCT03770663|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5592066|NCT03770663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5592067|NCT03770663|Antimetabolites|antimetabolites|mesh-ancestor
5592068|NCT03770663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5592069|NCT03770637|Glucagon|glucagon|mesh-list
5592070|NCT03770637|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5592071|NCT03770637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5592072|NCT03770637|Hormones|hormones|mesh-ancestor
5592073|NCT03770637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5592074|NCT03770637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592075|NCT03770637|Incretins|incretins|mesh-ancestor
5592076|NCT03770767|Insulin|insulin|mesh-list
5592077|NCT03770767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5592078|NCT03770767|Insulin Aspart|insulin aspart|mesh-list
5592079|NCT03770767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5592080|NCT03770767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592081|NCT03770338|Teriparatide|teriparatide|mesh-list
5592082|NCT03770338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5592083|NCT03770338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592084|NCT03770338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5592085|NCT03770208|Lidocaine|lidocaine|mesh-list
5592086|NCT03770208|Anesthetics, Local|anesthetics, local|mesh-ancestor
5592087|NCT03770208|Anesthetics|anesthetics|mesh-ancestor
5592088|NCT03770208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5592089|NCT03770208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592090|NCT03770208|Sensory System Agents|sensory system agents|mesh-ancestor
5592091|NCT03770208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5592092|NCT03770208|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5592093|NCT03770208|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5592094|NCT03770208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5592095|NCT03770208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5592096|NCT03770208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592097|NCT03770000|Romidepsin|romidepsin|mesh-list
5592098|NCT03770000|Tenalisib|tenalisib|mesh-list
5592099|NCT03770000|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5592100|NCT03770000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5592101|NCT03770000|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
5592102|NCT03770000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5592103|NCT03770000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592104|NCT03770312|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
5592105|NCT03770312|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5592106|NCT03770312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5592107|NCT03770312|Antimetabolites|antimetabolites|mesh-ancestor
5592108|NCT03770312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592109|NCT03770312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5592110|NCT03770312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5592111|NCT03770299|Gemcitabine|gemcitabine|mesh-list
5592112|NCT03770299|Paclitaxel|paclitaxel|mesh-list
5592113|NCT03770299|Vinorelbine|vinorelbine|mesh-list
5592114|NCT03770299|Docetaxel|docetaxel|mesh-list
5592115|NCT03770299|Carboplatin|carboplatin|mesh-list
5592116|NCT03770299|Nivolumab|nivolumab|mesh-list
5592117|NCT03770299|Pemetrexed|pemetrexed|mesh-list
5592118|NCT03770299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5592119|NCT03770299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5592120|NCT03770299|Tubulin Modulators|tubulin modulators|mesh-ancestor
5592121|NCT03770299|Antimitotic Agents|antimitotic agents|mesh-ancestor
5592122|NCT03770299|Mitosis Modulators|mitosis modulators|mesh-ancestor
5592123|NCT03770299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592124|NCT03770299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5592125|NCT03770299|Antimetabolites|antimetabolites|mesh-ancestor
5592126|NCT03770299|Antiviral Agents|antiviral agents|mesh-ancestor
5592127|NCT03770299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5592128|NCT03770299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5592129|NCT03770299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5592130|NCT03770299|Immunologic Factors|immunologic factors|mesh-ancestor
5592131|NCT03770299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592132|NCT03770299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5592133|NCT03770299|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5592134|NCT03770299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5592135|NCT03770299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5592136|NCT03770039|PF-06700841|pf-06700841|mesh-list
5592137|NCT03770039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5592138|NCT03770039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5592139|NCT03770039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592140|NCT03770026|Clomiphene|clomiphene|mesh-list
5592141|NCT03770026|Enclomiphene|enclomiphene|mesh-list
5592142|NCT03770026|Zuclomiphene|zuclomiphene|mesh-list
5592143|NCT03770026|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5592144|NCT03770026|Hormone Antagonists|hormone antagonists|mesh-ancestor
5592145|NCT03770026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5592146|NCT03770026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592147|NCT03770026|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5592148|NCT03770026|Fertility Agents|fertility agents|mesh-ancestor
5592149|NCT03770026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5592150|NCT03770026|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5592151|NCT03770026|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5592152|NCT03770013|Clonidine|clonidine|mesh-list
5592153|NCT03770013|Dexmedetomidine|dexmedetomidine|mesh-list
5592154|NCT03770013|Bupivacaine|bupivacaine|mesh-list
5592155|NCT03770013|Anesthetics, Local|anesthetics, local|mesh-ancestor
5592156|NCT03770013|Anesthetics|anesthetics|mesh-ancestor
5592157|NCT03770013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5592158|NCT03770013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592159|NCT03770013|Sensory System Agents|sensory system agents|mesh-ancestor
5592160|NCT03770013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5592161|NCT03770013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5592162|NCT03770013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5592163|NCT03770013|Analgesics|analgesics|mesh-ancestor
5592164|NCT03770013|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5592165|NCT03770013|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5592166|NCT03770013|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5592167|NCT03770013|Adrenergic Agents|adrenergic agents|mesh-ancestor
5592168|NCT03770013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5592169|NCT03770013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592170|NCT03770013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5592171|NCT03770013|Sympatholytics|sympatholytics|mesh-ancestor
5592172|NCT03770013|Autonomic Agents|autonomic agents|mesh-ancestor
5592173|NCT03769935|Etoposide|etoposide|mesh-list
5592174|NCT03769935|Cisplatin|cisplatin|mesh-list
5592175|NCT03769935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5592176|NCT03769935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5592177|NCT03769935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5592178|NCT03769935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5592179|NCT03769935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5592180|NCT03769935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592181|NCT03769870|Atorvastatin|atorvastatin|mesh-list
5592182|NCT03769870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5592183|NCT03769870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5592184|NCT03769870|Antimetabolites|antimetabolites|mesh-ancestor
5592185|NCT03769870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592186|NCT03769870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5592187|NCT03769870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5592188|NCT03769870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6201822|NCT02031536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6201823|NCT02031536|Immunologic Factors|immunologic factors|mesh-ancestor
6201824|NCT02031536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201825|NCT02031640|Beclomethasone|beclomethasone|mesh-list
6201826|NCT02031640|Albuterol|albuterol|mesh-list
5592194|NCT03769818|Dexamethasone|dexamethasone|mesh-list
5592195|NCT03769818|Dexamethasone acetate|dexamethasone acetate|mesh-list
5592196|NCT03769818|Bupivacaine|bupivacaine|mesh-list
5592197|NCT03769818|BB 1101|bb 1101|mesh-list
5592198|NCT03769818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5592199|NCT03769818|Antiemetics|antiemetics|mesh-ancestor
5592200|NCT03769818|Autonomic Agents|autonomic agents|mesh-ancestor
5592201|NCT03769818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5592202|NCT03769818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592203|NCT03769818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5592204|NCT03769818|Glucocorticoids|glucocorticoids|mesh-ancestor
5592205|NCT03769818|Hormones|hormones|mesh-ancestor
5592206|NCT03769818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5592207|NCT03769818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5592208|NCT03769818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5592209|NCT03769818|Protease Inhibitors|protease inhibitors|mesh-ancestor
5592210|NCT03769818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5592211|NCT03769818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592212|NCT03769818|Anesthetics, Local|anesthetics, local|mesh-ancestor
5592213|NCT03769818|Anesthetics|anesthetics|mesh-ancestor
5592214|NCT03769818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5592215|NCT03769818|Sensory System Agents|sensory system agents|mesh-ancestor
5592216|NCT03769714|Bupivacaine|bupivacaine|mesh-list
5592217|NCT03769714|Anesthetics, Local|anesthetics, local|mesh-ancestor
5592218|NCT03769714|Anesthetics|anesthetics|mesh-ancestor
5592219|NCT03769714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5592220|NCT03769714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592221|NCT03769714|Sensory System Agents|sensory system agents|mesh-ancestor
5592222|NCT03769714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5592223|NCT03769532|Pembrolizumab|pembrolizumab|mesh-list
5592224|NCT03769532|Azacitidine|azacitidine|mesh-list
5592225|NCT03769532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5592226|NCT03769532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5592227|NCT03769532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5592228|NCT03769532|Antimetabolites|antimetabolites|mesh-ancestor
5592229|NCT03769532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592230|NCT03769532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5592231|NCT03769467|Pembrolizumab|pembrolizumab|mesh-list
5592232|NCT03769467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5592233|NCT03769467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5592234|NCT03769402|Citric Acid|citric acid|mesh-list
5592235|NCT03769402|Sodium Citrate|sodium citrate|mesh-list
5592236|NCT03769402|Anticoagulants|anticoagulants|mesh-ancestor
5592237|NCT03769402|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5592238|NCT03769402|Chelating Agents|chelating agents|mesh-ancestor
5592239|NCT03769402|Sequestering Agents|sequestering agents|mesh-ancestor
5592240|NCT03769402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592241|NCT03769311|Cetuximab|cetuximab|mesh-list
5592242|NCT03769311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5592243|NCT03769311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5592244|NCT03769298|Tacrolimus|tacrolimus|mesh-list
5592245|NCT03769298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5592246|NCT03769298|Immunologic Factors|immunologic factors|mesh-ancestor
5592247|NCT03769298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592248|NCT03769298|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5592249|NCT03769298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5592250|NCT03769298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592251|NCT03769129|Pembrolizumab|pembrolizumab|mesh-list
5592252|NCT03769129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5592253|NCT03769129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5592254|NCT03769103|Osimertinib|osimertinib|mesh-list
5592255|NCT03769103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5592256|NCT03769103|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5592257|NCT03769103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5592258|NCT03769103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592259|NCT03769090|Budesonide|budesonide|mesh-list
5592260|NCT03769090|Albuterol|albuterol|mesh-list
5592261|NCT03769090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5592262|NCT03769090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5592263|NCT03769090|Autonomic Agents|autonomic agents|mesh-ancestor
5592264|NCT03769090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5592265|NCT03769090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592266|NCT03769090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5592267|NCT03769090|Respiratory System Agents|respiratory system agents|mesh-ancestor
5592268|NCT03769090|Glucocorticoids|glucocorticoids|mesh-ancestor
5592269|NCT03769090|Hormones|hormones|mesh-ancestor
5592270|NCT03769090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5592271|NCT03769090|Tocolytic Agents|tocolytic agents|mesh-ancestor
5592272|NCT03769090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5592273|NCT03769090|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5592274|NCT03769090|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5592275|NCT03769090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5592276|NCT03769090|Adrenergic Agents|adrenergic agents|mesh-ancestor
5592277|NCT03769090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5592278|NCT03769090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592279|NCT03769064|Methylphenidate|methylphenidate|mesh-list
5592280|NCT03769064|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5592281|NCT03769064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592282|NCT03769064|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5592283|NCT03769064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5592284|NCT03769064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5592285|NCT03769064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592286|NCT03769064|Dopamine Agents|dopamine agents|mesh-ancestor
5592287|NCT03769064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5592288|NCT03769025|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
5592289|NCT03769025|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5592290|NCT03769025|Narcotics|narcotics|mesh-ancestor
5592291|NCT03769025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5592292|NCT03769025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592293|NCT03769025|Analgesics|analgesics|mesh-ancestor
5592294|NCT03769025|Sensory System Agents|sensory system agents|mesh-ancestor
5592295|NCT03769025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5592296|NCT03769025|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5592297|NCT03768908|Artesunate|artesunate|mesh-list
5592298|NCT03768908|Lumefantrine|lumefantrine|mesh-list
5592299|NCT03768908|Artemether|artemether|mesh-list
5592300|NCT03768908|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
5592301|NCT03768908|Amodiaquine|amodiaquine|mesh-list
5592302|NCT03768908|Antimalarials|antimalarials|mesh-ancestor
5592303|NCT03768908|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5592304|NCT03768908|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5592305|NCT03768908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5592306|NCT03768908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5592307|NCT03768908|Antiviral Agents|antiviral agents|mesh-ancestor
5592308|NCT03768908|Schistosomicides|schistosomicides|mesh-ancestor
5592309|NCT03768908|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5592310|NCT03768908|Anthelmintics|anthelmintics|mesh-ancestor
5592311|NCT03768882|Acetaminophen|acetaminophen|mesh-list
5592312|NCT03768882|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
5592313|NCT03768882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5592314|NCT03768882|Analgesics|analgesics|mesh-ancestor
5592315|NCT03768882|Sensory System Agents|sensory system agents|mesh-ancestor
5592316|NCT03768882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5592317|NCT03768882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592318|NCT03768882|Antipyretics|antipyretics|mesh-ancestor
5592319|NCT03768882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5592320|NCT03768882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5592321|NCT03768882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5592322|NCT03768869|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5592323|NCT03768869|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5592324|NCT03768869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5592325|NCT03768869|Antitubercular Agents|antitubercular agents|mesh-ancestor
5592326|NCT03768713|Suvorexant|suvorexant|mesh-list
5592327|NCT03768713|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5592328|NCT03768713|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5592329|NCT03768713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5592330|NCT03768713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592331|NCT03768713|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
5592332|NCT03768713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5592333|NCT03768713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592334|NCT03768609|Cyclosporine|cyclosporine|mesh-list
5592335|NCT03768609|Cyclosporins|cyclosporins|mesh-list
5592336|NCT03768609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5592337|NCT03768609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592338|NCT03768609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5592339|NCT03768609|Immunologic Factors|immunologic factors|mesh-ancestor
5592340|NCT03768609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592341|NCT03768609|Antifungal Agents|antifungal agents|mesh-ancestor
5592342|NCT03768609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5592343|NCT03768609|Dermatologic Agents|dermatologic agents|mesh-ancestor
5592344|NCT03768609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5592345|NCT03768609|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5592346|NCT03768596|Vaccines|vaccines|mesh-list
5592347|NCT03768596|Immunologic Factors|immunologic factors|mesh-ancestor
5592348|NCT03768596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592349|NCT03768557|Minocycline|minocycline|mesh-list
5592350|NCT03768557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5592351|NCT03768557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5592352|NCT03768531|Nivolumab|nivolumab|mesh-list
5592353|NCT03768531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5592354|NCT03768531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5592355|NCT03768531|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5592356|NCT03768531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592357|NCT03768518|Exenatide|exenatide|mesh-list
5592358|NCT03768518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5592359|NCT03768518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592360|NCT03768518|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5592361|NCT03768518|Incretins|incretins|mesh-ancestor
5592362|NCT03768518|Hormones|hormones|mesh-ancestor
5592363|NCT03768518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5592364|NCT03768440|Ropivacaine|ropivacaine|mesh-list
5592365|NCT03768440|Anesthetics, Local|anesthetics, local|mesh-ancestor
5592366|NCT03768440|Anesthetics|anesthetics|mesh-ancestor
5592367|NCT03768440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5592368|NCT03768440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592369|NCT03768440|Sensory System Agents|sensory system agents|mesh-ancestor
5592370|NCT03768440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5592371|NCT03768427|Atorvastatin|atorvastatin|mesh-list
5592372|NCT03768427|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5592373|NCT03768427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5592374|NCT03768427|Antimetabolites|antimetabolites|mesh-ancestor
5592375|NCT03768427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592376|NCT03768427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5592377|NCT03768427|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5592378|NCT03768427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5592379|NCT03768258|Methyltestosterone|methyltestosterone|mesh-list
5592380|NCT03768258|Anastrozole|anastrozole|mesh-list
5592381|NCT03768258|Testosterone|testosterone|mesh-list
5592382|NCT03768258|Testosterone undecanoate|testosterone undecanoate|mesh-list
5592383|NCT03768258|Testosterone enanthate|testosterone enanthate|mesh-list
5592384|NCT03768258|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5592385|NCT03768258|Androgens|androgens|mesh-ancestor
5592386|NCT03768258|Hormones|hormones|mesh-ancestor
5592387|NCT03768258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5592388|NCT03768258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592389|NCT03768258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5592390|NCT03768258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5592391|NCT03768258|Anabolic Agents|anabolic agents|mesh-ancestor
5592392|NCT03768258|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5592393|NCT03768258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5592394|NCT03768258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5592395|NCT03768258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592396|NCT03768258|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5592397|NCT03768258|Hormone Antagonists|hormone antagonists|mesh-ancestor
5605608|NCT02015351|Growth Substances|growth substances|mesh-ancestor
5605609|NCT02015351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605610|NCT02015351|Growth Inhibitors|growth inhibitors|mesh-ancestor
5605611|NCT02013167|Blinatumomab|blinatumomab|mesh-list
5605612|NCT02013167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605613|NCT02004522|Ofatumumab|ofatumumab|mesh-list
5605614|NCT02004522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605615|NCT02000427|Blinatumomab|blinatumomab|mesh-list
5605616|NCT02000427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605617|NCT01996436|Verapamil|verapamil|mesh-list
5605618|NCT01996436|Nicardipine|nicardipine|mesh-list
5605619|NCT01996436|Nitroglycerin|nitroglycerin|mesh-list
5605620|NCT01996436|Vasodilator Agents|vasodilator agents|mesh-ancestor
5605621|NCT01996436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5605622|NCT01996436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5605623|NCT01996436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5605624|NCT01996436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605625|NCT01996436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5605626|NCT01996436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605627|NCT01996436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5605628|NCT01957332|Trastuzumab|trastuzumab|mesh-list
5605629|NCT01957332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5605630|NCT01957332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605631|NCT01860456|Imatinib Mesylate|imatinib mesylate|mesh-list
5605632|NCT01860456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605633|NCT01860456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5605634|NCT01860456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5605635|NCT01860456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605636|NCT01807182|Aldesleukin|aldesleukin|mesh-list
5605637|NCT01807182|Cyclophosphamide|cyclophosphamide|mesh-list
5605638|NCT01807182|Fludarabine|fludarabine|mesh-list
5605639|NCT01807182|Fludarabine phosphate|fludarabine phosphate|mesh-list
5605640|NCT01807182|Interleukin-2|interleukin-2|mesh-list
5605641|NCT01807182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5605642|NCT01807182|Immunologic Factors|immunologic factors|mesh-ancestor
5605643|NCT01807182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605644|NCT01807182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5605645|NCT01807182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5605646|NCT01807182|Alkylating Agents|alkylating agents|mesh-ancestor
5605647|NCT01807182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605648|NCT01807182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605649|NCT01807182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5605650|NCT01807182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5592398|NCT03768037|Pemetrexed|pemetrexed|mesh-list
5592399|NCT03768037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5592400|NCT03768037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5592401|NCT03768037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592402|NCT03768037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5592403|NCT03768037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5592404|NCT03768024|Hydromorphone|hydromorphone|mesh-list
5592405|NCT03768024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5592406|NCT03768024|Narcotics|narcotics|mesh-ancestor
5592407|NCT03768024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5592408|NCT03768024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592409|NCT03768024|Analgesics|analgesics|mesh-ancestor
5592410|NCT03768024|Sensory System Agents|sensory system agents|mesh-ancestor
5592411|NCT03768024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5592412|NCT03767920|Dexamethasone|dexamethasone|mesh-list
5592413|NCT03767920|Dexamethasone acetate|dexamethasone acetate|mesh-list
5592414|NCT03767920|Bupivacaine|bupivacaine|mesh-list
5592415|NCT03767920|BB 1101|bb 1101|mesh-list
5592416|NCT03767920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5592417|NCT03767920|Antiemetics|antiemetics|mesh-ancestor
5592418|NCT03767920|Autonomic Agents|autonomic agents|mesh-ancestor
5592419|NCT03767920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5592420|NCT03767920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592421|NCT03767920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5592422|NCT03767920|Glucocorticoids|glucocorticoids|mesh-ancestor
5592423|NCT03767920|Hormones|hormones|mesh-ancestor
5592424|NCT03767920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5592425|NCT03767920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5592426|NCT03767920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5592427|NCT03767920|Protease Inhibitors|protease inhibitors|mesh-ancestor
5592428|NCT03767920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5592429|NCT03767920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592430|NCT03767920|Anesthetics, Local|anesthetics, local|mesh-ancestor
5592431|NCT03767920|Anesthetics|anesthetics|mesh-ancestor
5592432|NCT03767920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5592433|NCT03767920|Sensory System Agents|sensory system agents|mesh-ancestor
5592434|NCT03767660|Sirolimus|sirolimus|mesh-list
5592435|NCT03767660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5592436|NCT03767660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5592437|NCT03767660|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5592438|NCT03767660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5592439|NCT03767660|Antifungal Agents|antifungal agents|mesh-ancestor
5592440|NCT03767660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5592441|NCT03767660|Immunologic Factors|immunologic factors|mesh-ancestor
5592442|NCT03767660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592443|NCT03767569|Folic Acid|folic acid|mesh-list
5592444|NCT03767569|Inositol|inositol|mesh-list
5592445|NCT03767569|Hematinics|hematinics|mesh-ancestor
5592446|NCT03767569|Vitamin B Complex|vitamin b complex|mesh-ancestor
5592447|NCT03767569|Vitamins|vitamins|mesh-ancestor
5592448|NCT03767569|Micronutrients|micronutrients|mesh-ancestor
5592449|NCT03767569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592450|NCT03767543|Insulin Glargine|insulin glargine|mesh-list
5592451|NCT03767543|Lixisenatide|lixisenatide|mesh-list
5592452|NCT03767543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5592453|NCT03767543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592454|NCT03767504|Thymol|thymol|mesh-list
5592455|NCT03767504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5592456|NCT03767504|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5592457|NCT03767504|Antifungal Agents|antifungal agents|mesh-ancestor
5592458|NCT03767439|Nivolumab|nivolumab|mesh-list
5592459|NCT03767439|Ipilimumab|ipilimumab|mesh-list
5592460|NCT03767439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5592461|NCT03767439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5592462|NCT03767439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5592463|NCT03767439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592464|NCT03767335|Trastuzumab|trastuzumab|mesh-list
5592465|NCT03767335|Fulvestrant|fulvestrant|mesh-list
5592466|NCT03767335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5592467|NCT03767335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5592468|NCT03767335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5592469|NCT03767335|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5592470|NCT03767335|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5592471|NCT03767335|Hormone Antagonists|hormone antagonists|mesh-ancestor
5592472|NCT03767335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5592473|NCT03767335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592474|NCT03767322|Allopurinol|allopurinol|mesh-list
5592475|NCT03767322|Febuxostat|febuxostat|mesh-list
5592476|NCT03767322|Antimetabolites|antimetabolites|mesh-ancestor
5592477|NCT03767322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592478|NCT03767322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5592479|NCT03767322|Gout Suppressants|gout suppressants|mesh-ancestor
5592480|NCT03767322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5592481|NCT03767322|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5592482|NCT03767322|Antioxidants|antioxidants|mesh-ancestor
5592483|NCT03767322|Protective Agents|protective agents|mesh-ancestor
5592484|NCT03767322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592485|NCT03767296|Phenylephrine|phenylephrine|mesh-list
5592486|NCT03767296|Oxymetazoline|oxymetazoline|mesh-list
5592487|NCT03767296|Ephedrine|ephedrine|mesh-list
5592488|NCT03767296|Pseudoephedrine|pseudoephedrine|mesh-list
5592489|NCT03767296|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5592490|NCT03767296|Mydriatics|mydriatics|mesh-ancestor
5592491|NCT03767296|Autonomic Agents|autonomic agents|mesh-ancestor
5592492|NCT03767296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5592493|NCT03767296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592494|NCT03767296|Sympathomimetics|sympathomimetics|mesh-ancestor
5592495|NCT03767296|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5592496|NCT03767296|Nasal Decongestants|nasal decongestants|mesh-ancestor
5592497|NCT03767296|Respiratory System Agents|respiratory system agents|mesh-ancestor
5592498|NCT03767296|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5592499|NCT03767296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5592500|NCT03767296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5592501|NCT03767296|Adrenergic Agents|adrenergic agents|mesh-ancestor
5592502|NCT03767296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5592503|NCT03767296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592504|NCT03767296|Protective Agents|protective agents|mesh-ancestor
5592505|NCT03767296|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5592506|NCT03767296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5592507|NCT03767296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5592508|NCT03767257|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
5592509|NCT03767257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5592510|NCT03767257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5592511|NCT03767257|Antimetabolites|antimetabolites|mesh-ancestor
5592512|NCT03767257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592513|NCT03767257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5592514|NCT03767075|Atezolizumab|atezolizumab|mesh-list
5592515|NCT03767075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5592516|NCT03767036|Ketorolac|ketorolac|mesh-list
5592517|NCT03767036|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
5592518|NCT03767036|Tramadol|tramadol|mesh-list
5592519|NCT03767036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5592520|NCT03767036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5592521|NCT03767036|Analgesics|analgesics|mesh-ancestor
5592522|NCT03767036|Sensory System Agents|sensory system agents|mesh-ancestor
5592523|NCT03767036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5592524|NCT03767036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592525|NCT03767036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5592526|NCT03767036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5592527|NCT03767036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5592528|NCT03767036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5592529|NCT03767036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592530|NCT03767036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5592531|NCT03767036|Narcotics|narcotics|mesh-ancestor
5592532|NCT03767036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5592533|NCT03766997|Hydrocortisone|hydrocortisone|mesh-list
5592534|NCT03766997|Betamethasone|betamethasone|mesh-list
5592535|NCT03766997|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
5592536|NCT03766997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5592537|NCT03766997|Glucocorticoids|glucocorticoids|mesh-ancestor
5592538|NCT03766997|Hormones|hormones|mesh-ancestor
5592539|NCT03766997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5592540|NCT03766997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592541|NCT03766997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5592542|NCT03766997|Respiratory System Agents|respiratory system agents|mesh-ancestor
5592543|NCT03766997|Dermatologic Agents|dermatologic agents|mesh-ancestor
5592544|NCT03766984|Diclofenac|diclofenac|mesh-list
5592545|NCT03766984|Tramadol|tramadol|mesh-list
5592546|NCT03766984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5592547|NCT03766984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5592548|NCT03766984|Analgesics|analgesics|mesh-ancestor
5592549|NCT03766984|Sensory System Agents|sensory system agents|mesh-ancestor
5592550|NCT03766984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5605651|NCT01807182|Antimetabolites|antimetabolites|mesh-ancestor
5592551|NCT03766984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592552|NCT03766984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5592553|NCT03766984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5592554|NCT03766984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5592555|NCT03766984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5592556|NCT03766984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592557|NCT03766984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5592558|NCT03766984|Narcotics|narcotics|mesh-ancestor
5592559|NCT03766984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5592560|NCT03766893|Naltrexone|naltrexone|mesh-list
5592561|NCT03766893|Buprenorphine|buprenorphine|mesh-list
5592562|NCT03766893|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
5592563|NCT03766893|Naloxone|naloxone|mesh-list
5592564|NCT03766893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5592565|NCT03766893|Narcotics|narcotics|mesh-ancestor
5592566|NCT03766893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5592567|NCT03766893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592568|NCT03766893|Analgesics|analgesics|mesh-ancestor
5592569|NCT03766893|Sensory System Agents|sensory system agents|mesh-ancestor
5592570|NCT03766893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5592571|NCT03766893|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5592572|NCT03766893|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5592573|NCT03766867|Vortioxetine|vortioxetine|mesh-list
5592574|NCT03766867|Antidepressive Agents|antidepressive agents|mesh-ancestor
5592575|NCT03766867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5592576|NCT03766867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5592577|NCT03766867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5592578|NCT03766867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5592579|NCT03766867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592580|NCT03766867|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5592581|NCT03766867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5592582|NCT03766867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5592583|NCT03766867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592584|NCT03766867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5592585|NCT03766867|Serotonin Agents|serotonin agents|mesh-ancestor
5592586|NCT03766867|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5592587|NCT03766867|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5592588|NCT03766867|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5592589|NCT03766867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5592590|NCT03766854|Insulin|insulin|mesh-list
5592591|NCT03766854|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5592592|NCT03766854|Insulin Glargine|insulin glargine|mesh-list
5592593|NCT03766854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5592594|NCT03766854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592595|NCT03766763|Venetoclax|venetoclax|mesh-list
5592596|NCT03766763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5592597|NCT03766750|Dapagliflozin|dapagliflozin|mesh-list
5592598|NCT03766750|Linagliptin|linagliptin|mesh-list
5592599|NCT03766750|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5592600|NCT03766750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592601|NCT03766750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5592602|NCT03766750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592603|NCT03766750|Incretins|incretins|mesh-ancestor
5592604|NCT03766750|Hormones|hormones|mesh-ancestor
5592605|NCT03766750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5592606|NCT03766750|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5592607|NCT03766750|Protease Inhibitors|protease inhibitors|mesh-ancestor
5592608|NCT03766750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5592609|NCT03766724|Dapagliflozin|dapagliflozin|mesh-list
5592610|NCT03766724|Empagliflozin|empagliflozin|mesh-list
5592611|NCT03766724|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5592612|NCT03766724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592613|NCT03766724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5592614|NCT03766724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592615|NCT03766607|Paclitaxel|paclitaxel|mesh-list
5592616|NCT03766607|Trastuzumab|trastuzumab|mesh-list
5592617|NCT03766607|Ramucirumab|ramucirumab|mesh-list
5592618|NCT03766607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5592619|NCT03766607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5592620|NCT03766607|Tubulin Modulators|tubulin modulators|mesh-ancestor
5592621|NCT03766607|Antimitotic Agents|antimitotic agents|mesh-ancestor
5592622|NCT03766607|Mitosis Modulators|mitosis modulators|mesh-ancestor
5592623|NCT03766607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592624|NCT03766607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5592625|NCT03766594|Folic Acid|folic acid|mesh-list
5592626|NCT03766594|Sildenafil Citrate|sildenafil citrate|mesh-list
5592627|NCT03766594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592628|NCT03766594|Vasodilator Agents|vasodilator agents|mesh-ancestor
5592629|NCT03766594|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5592630|NCT03766594|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5592631|NCT03766594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5592632|NCT03766594|Urological Agents|urological agents|mesh-ancestor
5592633|NCT03766594|Hematinics|hematinics|mesh-ancestor
5592634|NCT03766594|Vitamin B Complex|vitamin b complex|mesh-ancestor
5592635|NCT03766594|Vitamins|vitamins|mesh-ancestor
5592636|NCT03766594|Micronutrients|micronutrients|mesh-ancestor
5592637|NCT03766594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592638|NCT03766581|Aspirin|aspirin|mesh-list
5592639|NCT03766581|Clopidogrel|clopidogrel|mesh-list
5592640|NCT03766581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5592641|NCT03766581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5592642|NCT03766581|Analgesics|analgesics|mesh-ancestor
5592643|NCT03766581|Sensory System Agents|sensory system agents|mesh-ancestor
5592644|NCT03766581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5592645|NCT03766581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592646|NCT03766581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5592647|NCT03766581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5592648|NCT03766581|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5592649|NCT03766581|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5592650|NCT03766581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592651|NCT03766581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5592652|NCT03766581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5592653|NCT03766581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5592654|NCT03766581|Antipyretics|antipyretics|mesh-ancestor
5592655|NCT03766581|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5592656|NCT03766581|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5592657|NCT03766581|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5592658|NCT03766581|Purinergic Agents|purinergic agents|mesh-ancestor
5592659|NCT03766581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5592660|NCT03766490|Gefitinib|gefitinib|mesh-list
5592661|NCT03766490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5592662|NCT03766490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5592663|NCT03766490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5592664|NCT03766490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605652|NCT01807182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5605653|NCT01807182|Analgesics|analgesics|mesh-ancestor
5605654|NCT01807182|Sensory System Agents|sensory system agents|mesh-ancestor
5605655|NCT01807182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5605656|NCT01807182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5605657|NCT01807182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5605658|NCT01807182|Antiviral Agents|antiviral agents|mesh-ancestor
5605659|NCT01807182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5605660|NCT01765140|Amifampridine|amifampridine|mesh-list
5605661|NCT01765140|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5605662|NCT01765140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5605663|NCT01765140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605664|NCT01765140|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5605665|NCT01765140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5605666|NCT01765140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605667|NCT01761890|Dasatinib|dasatinib|mesh-list
5605668|NCT01761890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605669|NCT01761890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5605670|NCT01761890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5605671|NCT01761890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605672|NCT01703949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5605673|NCT01703949|Nivolumab|nivolumab|mesh-list
5605674|NCT01703949|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5605675|NCT01703949|Antibodies|antibodies|mesh-list
5605676|NCT01703949|Immunoglobulins|immunoglobulins|mesh-list
5605677|NCT01703949|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5605678|NCT01703949|Immunoconjugates|immunoconjugates|mesh-list
5605679|NCT01703949|Immunologic Factors|immunologic factors|mesh-ancestor
5605680|NCT01703949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605681|NCT01703949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605682|NCT01703949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5605683|NCT01703949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605684|NCT01688076|Botulinum Toxins|botulinum toxins|mesh-list
5605685|NCT01688076|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5605686|NCT01688076|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5592665|NCT03766425|Aflibercept|aflibercept|mesh-list
5592666|NCT03766425|Mitomycins|mitomycins|mesh-list
5592667|NCT03766425|Mitomycin|mitomycin|mesh-list
5592668|NCT03766425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5592669|NCT03766425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5592670|NCT03766425|Growth Substances|growth substances|mesh-ancestor
5592671|NCT03766425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592672|NCT03766425|Growth Inhibitors|growth inhibitors|mesh-ancestor
5592673|NCT03766425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5592674|NCT03766425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5592675|NCT03766425|Alkylating Agents|alkylating agents|mesh-ancestor
5592676|NCT03766425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592677|NCT03766425|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5592678|NCT03766425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5592679|NCT03766269|Dronabinol|dronabinol|mesh-list
5592680|NCT03766269|Hallucinogens|hallucinogens|mesh-ancestor
5592681|NCT03766269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592682|NCT03766269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5592683|NCT03766269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5592684|NCT03766269|Analgesics|analgesics|mesh-ancestor
5592685|NCT03766269|Sensory System Agents|sensory system agents|mesh-ancestor
5592686|NCT03766269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5592687|NCT03766269|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5592688|NCT03766269|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5592689|NCT03766269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5592690|NCT03766269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592691|NCT03766269|Hormones|hormones|mesh-ancestor
5592692|NCT03766269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5592693|NCT03766178|Nimotuzumab|nimotuzumab|mesh-list
5592694|NCT03766178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5592695|NCT03766178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5592696|NCT03766074|Vitamin D|vitamin d|mesh-list
5592697|NCT03766074|Vitamins|vitamins|mesh-ancestor
5592698|NCT03766074|Micronutrients|micronutrients|mesh-ancestor
5592699|NCT03766074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592700|NCT03766074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5592701|NCT03765983|Trastuzumab|trastuzumab|mesh-list
5592702|NCT03765983|GDC-0084|gdc-0084|mesh-list
5592703|NCT03765983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5592704|NCT03765983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5592705|NCT03765983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5592706|NCT03765983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592707|NCT03765944|Sirolimus|sirolimus|mesh-list
5592708|NCT03765944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5592709|NCT03765944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5592710|NCT03765944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5592711|NCT03765944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5592712|NCT03765944|Antifungal Agents|antifungal agents|mesh-ancestor
5592713|NCT03765944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5592714|NCT03765944|Immunologic Factors|immunologic factors|mesh-ancestor
5592715|NCT03765944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592716|NCT03765931|Amoxicillin|amoxicillin|mesh-list
5592717|NCT03765931|Doxycycline|doxycycline|mesh-list
5592718|NCT03765931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5592719|NCT03765931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5592720|NCT03765931|Antimalarials|antimalarials|mesh-ancestor
5592721|NCT03765931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5592722|NCT03765931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5592723|NCT03765827|Vitamins|vitamins|mesh-list
5592724|NCT03765827|Vitamin E|vitamin e|mesh-list
5592725|NCT03765827|Tocopherols|tocopherols|mesh-list
5592726|NCT03765827|Tocotrienols|tocotrienols|mesh-list
5592727|NCT03765827|alpha-Tocopherol|alpha-tocopherol|mesh-list
5592728|NCT03765827|Micronutrients|micronutrients|mesh-ancestor
5592729|NCT03765827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592730|NCT03765827|Antioxidants|antioxidants|mesh-ancestor
5592731|NCT03765827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592732|NCT03765827|Protective Agents|protective agents|mesh-ancestor
5592733|NCT03765788|Prednisolone|prednisolone|mesh-list
5592734|NCT03765788|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5592735|NCT03765788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5592736|NCT03765788|Glucocorticoids|glucocorticoids|mesh-ancestor
5592737|NCT03765788|Hormones|hormones|mesh-ancestor
5592738|NCT03765788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5592739|NCT03765788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592740|NCT03765788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5592741|NCT03765788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5592742|NCT03765788|Immunologic Factors|immunologic factors|mesh-ancestor
5592743|NCT03765697|Lidocaine|lidocaine|mesh-list
5592744|NCT03765697|Anesthetics, Local|anesthetics, local|mesh-ancestor
5592745|NCT03765697|Anesthetics|anesthetics|mesh-ancestor
5592746|NCT03765697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5592747|NCT03765697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592748|NCT03765697|Sensory System Agents|sensory system agents|mesh-ancestor
5592749|NCT03765697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5592750|NCT03765697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5592751|NCT03765697|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5592752|NCT03765697|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5592753|NCT03765697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5592754|NCT03765697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592755|NCT03765645|Tazobactam|tazobactam|mesh-list
5592756|NCT03765645|Piperacillin|piperacillin|mesh-list
5592757|NCT03765645|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
5592758|NCT03765645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5592759|NCT03765645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5592760|NCT03765645|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5592761|NCT03765645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5592762|NCT03765645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592779|NCT03765554|PF-06700841|pf-06700841|mesh-list
5592780|NCT03765554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5592781|NCT03765554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5592782|NCT03765554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592783|NCT03765541|Cytarabine|cytarabine|mesh-list
5592784|NCT03765541|Dexamethasone|dexamethasone|mesh-list
5592785|NCT03765541|Azacitidine|azacitidine|mesh-list
5592786|NCT03765541|Amsacrine|amsacrine|mesh-list
5592787|NCT03765541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5592788|NCT03765541|Antiemetics|antiemetics|mesh-ancestor
5592789|NCT03765541|Autonomic Agents|autonomic agents|mesh-ancestor
5592790|NCT03765541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5592791|NCT03765541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592792|NCT03765541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5592793|NCT03765541|Glucocorticoids|glucocorticoids|mesh-ancestor
5592794|NCT03765541|Hormones|hormones|mesh-ancestor
5592795|NCT03765541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5592796|NCT03765541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5592797|NCT03765541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5592798|NCT03765541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5592799|NCT03765541|Antimetabolites|antimetabolites|mesh-ancestor
5592800|NCT03765541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592801|NCT03765541|Antiviral Agents|antiviral agents|mesh-ancestor
5592802|NCT03765541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5592803|NCT03765541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5592804|NCT03765541|Immunologic Factors|immunologic factors|mesh-ancestor
5592805|NCT03765541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5592806|NCT03765450|Infliximab|infliximab|mesh-list
5592807|NCT03765450|Dermatologic Agents|dermatologic agents|mesh-ancestor
5592808|NCT03765450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5592809|NCT03765450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5592810|NCT03765346|Oxycodone|oxycodone|mesh-list
5592811|NCT03765346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5592812|NCT03765346|Narcotics|narcotics|mesh-ancestor
5592813|NCT03765346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5592814|NCT03765346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592815|NCT03765346|Analgesics|analgesics|mesh-ancestor
5592816|NCT03765346|Sensory System Agents|sensory system agents|mesh-ancestor
5592817|NCT03765346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5592818|NCT03765229|Pembrolizumab|pembrolizumab|mesh-list
5592819|NCT03765229|Entinostat|entinostat|mesh-list
5592820|NCT03765229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5592821|NCT03765229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5592822|NCT03765229|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5592823|NCT03765229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5592824|NCT03765229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592825|NCT03765021|Tranexamic Acid|tranexamic acid|mesh-list
5592826|NCT03765021|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5592827|NCT03765021|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5592828|NCT03765021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592829|NCT03765021|Hemostatics|hemostatics|mesh-ancestor
5592830|NCT03765021|Coagulants|coagulants|mesh-ancestor
5605687|NCT01688076|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5605688|NCT01688076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5605689|NCT01688076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605690|NCT01688076|Cholinergic Agents|cholinergic agents|mesh-ancestor
5605691|NCT01688076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5605692|NCT01688076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605693|NCT01688076|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5605694|NCT01688076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5605695|NCT01595321|Leucovorin|leucovorin|mesh-list
5605696|NCT01595321|Cyclophosphamide|cyclophosphamide|mesh-list
5605697|NCT01595321|Fluorouracil|fluorouracil|mesh-list
5605698|NCT01595321|Oxaliplatin|oxaliplatin|mesh-list
5605699|NCT01595321|Irinotecan|irinotecan|mesh-list
5605700|NCT01595321|Folfirinox|folfirinox|mesh-list
5605701|NCT01595321|Vaccines|vaccines|mesh-list
5605702|NCT01595321|Immunologic Factors|immunologic factors|mesh-ancestor
5605703|NCT01595321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605704|NCT01595321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5605705|NCT01595321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5605706|NCT01595321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5605707|NCT01595321|Alkylating Agents|alkylating agents|mesh-ancestor
5605708|NCT01595321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605709|NCT01595321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605710|NCT01595321|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5605711|NCT01595321|Antimetabolites|antimetabolites|mesh-ancestor
5605712|NCT01595321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5605713|NCT01595321|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5605714|NCT01595321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5605715|NCT01595321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5605716|NCT01595321|Antidotes|antidotes|mesh-ancestor
5605717|NCT01595321|Protective Agents|protective agents|mesh-ancestor
5605718|NCT01595321|Vitamin B Complex|vitamin b complex|mesh-ancestor
5605719|NCT01595321|Vitamins|vitamins|mesh-ancestor
5605720|NCT01595321|Micronutrients|micronutrients|mesh-ancestor
5605721|NCT01556776|Lenalidomide|lenalidomide|mesh-list
5605722|NCT01556776|Immunologic Factors|immunologic factors|mesh-ancestor
5605723|NCT01556776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605724|NCT01556776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5605725|NCT01556776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5605726|NCT01556776|Growth Substances|growth substances|mesh-ancestor
5605727|NCT01556776|Growth Inhibitors|growth inhibitors|mesh-ancestor
5605728|NCT01556776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605729|NCT01519960|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5605730|NCT01519960|Interferon-alpha|interferon-alpha|mesh-list
5605731|NCT01519960|Antiviral Agents|antiviral agents|mesh-ancestor
5605732|NCT01519960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5605733|NCT01519960|Immunologic Factors|immunologic factors|mesh-ancestor
5605734|NCT01519960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605735|NCT01186640|Vidarabine|vidarabine|mesh-list
5605736|NCT01186640|Cyclophosphamide|cyclophosphamide|mesh-list
5605737|NCT01186640|Fludarabine|fludarabine|mesh-list
5605738|NCT01186640|Fludarabine phosphate|fludarabine phosphate|mesh-list
5605739|NCT01186640|Mitoxantrone|mitoxantrone|mesh-list
5605740|NCT01186640|Alemtuzumab|alemtuzumab|mesh-list
5605741|NCT01186640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5605742|NCT01186640|Immunologic Factors|immunologic factors|mesh-ancestor
5605743|NCT01186640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605744|NCT01186640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5605745|NCT01186640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5605746|NCT01186640|Alkylating Agents|alkylating agents|mesh-ancestor
5605747|NCT01186640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605748|NCT01186640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605749|NCT01186640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5592831|NCT03764722|Simendan|simendan|mesh-list
5592832|NCT03764722|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5592833|NCT03764722|Vasodilator Agents|vasodilator agents|mesh-ancestor
5592834|NCT03764722|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5592835|NCT03764722|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5592836|NCT03764722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5592837|NCT03764722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592838|NCT03764722|Protective Agents|protective agents|mesh-ancestor
5592839|NCT03764722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592840|NCT03764683|Suvorexant|suvorexant|mesh-list
5592841|NCT03764683|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5592842|NCT03764683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5592843|NCT03764683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5592844|NCT03764683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592845|NCT03764683|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
5592846|NCT03764683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5592847|NCT03764683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592848|NCT03764605|Metformin|metformin|mesh-list
5592849|NCT03764605|Tolvaptan|tolvaptan|mesh-list
5592850|NCT03764605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5592851|NCT03764605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592852|NCT03764605|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
5592853|NCT03764605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592854|NCT03764605|Natriuretic Agents|natriuretic agents|mesh-ancestor
5592855|NCT03764553|Leucovorin|leucovorin|mesh-list
5592856|NCT03764553|Carboplatin|carboplatin|mesh-list
5592857|NCT03764553|Fluorouracil|fluorouracil|mesh-list
5592858|NCT03764553|Capecitabine|capecitabine|mesh-list
5592859|NCT03764553|Oxaliplatin|oxaliplatin|mesh-list
5592860|NCT03764553|Irinotecan|irinotecan|mesh-list
5592861|NCT03764553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5592862|NCT03764553|Antimetabolites|antimetabolites|mesh-ancestor
5592863|NCT03764553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592864|NCT03764553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5592865|NCT03764553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5592866|NCT03764553|Immunologic Factors|immunologic factors|mesh-ancestor
5592867|NCT03764553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592868|NCT03764553|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5592869|NCT03764553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5592870|NCT03764553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5592871|NCT03764553|Antidotes|antidotes|mesh-ancestor
5592872|NCT03764553|Protective Agents|protective agents|mesh-ancestor
5592873|NCT03764553|Vitamin B Complex|vitamin b complex|mesh-ancestor
5592874|NCT03764553|Vitamins|vitamins|mesh-ancestor
5592875|NCT03764553|Micronutrients|micronutrients|mesh-ancestor
5592876|NCT03764540|Prednisone|prednisone|mesh-list
5592877|NCT03764540|Docetaxel|docetaxel|mesh-list
5592878|NCT03764540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5592879|NCT03764540|Tubulin Modulators|tubulin modulators|mesh-ancestor
5592880|NCT03764540|Antimitotic Agents|antimitotic agents|mesh-ancestor
5592881|NCT03764540|Mitosis Modulators|mitosis modulators|mesh-ancestor
5592882|NCT03764540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592883|NCT03764540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5592884|NCT03764540|Glucocorticoids|glucocorticoids|mesh-ancestor
5592885|NCT03764540|Hormones|hormones|mesh-ancestor
5592886|NCT03764540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5592887|NCT03764540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592888|NCT03764540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5592889|NCT03764527|Artesunate|artesunate|mesh-list
5592890|NCT03764527|Lumefantrine|lumefantrine|mesh-list
5592891|NCT03764527|Artemether|artemether|mesh-list
5592892|NCT03764527|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
5592893|NCT03764527|Amodiaquine|amodiaquine|mesh-list
5592894|NCT03764527|Antimalarials|antimalarials|mesh-ancestor
5592895|NCT03764527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5592896|NCT03764527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5592897|NCT03764527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5592898|NCT03764527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5592899|NCT03764527|Antiviral Agents|antiviral agents|mesh-ancestor
5592900|NCT03764527|Schistosomicides|schistosomicides|mesh-ancestor
5592901|NCT03764527|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5592902|NCT03764527|Anthelmintics|anthelmintics|mesh-ancestor
5592903|NCT03764488|Technetium Tc 99m Mertiatide|technetium tc 99m mertiatide|mesh-list
5592904|NCT03764488|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5592905|NCT03764488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592906|NCT03764462|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
5592907|NCT03764462|AD 101|ad 101|mesh-list
5592908|NCT03764462|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5592909|NCT03764462|Hormone Antagonists|hormone antagonists|mesh-ancestor
5592910|NCT03764462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5592911|NCT03764462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592912|NCT03764462|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5592913|NCT03764462|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5592914|NCT03764462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5592915|NCT03764462|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
5592916|NCT03764462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592917|NCT03764462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5592918|NCT03764462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5592919|NCT03764462|Antiviral Agents|antiviral agents|mesh-ancestor
5592920|NCT03764462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5592921|NCT03764293|Sorafenib|sorafenib|mesh-list
5592922|NCT03764293|Apatinib|apatinib|mesh-list
5592923|NCT03764293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5592924|NCT03764293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5592925|NCT03764293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5592926|NCT03764293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592927|NCT03764280|Insulin|insulin|mesh-list
5592928|NCT03764280|Insulin, Short-Acting|insulin, short-acting|mesh-list
5592929|NCT03764280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5592930|NCT03764280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592931|NCT03764267|Lidocaine|lidocaine|mesh-list
5592932|NCT03764267|Remifentanil|remifentanil|mesh-list
5592933|NCT03764267|Anesthetics|anesthetics|mesh-list
5592934|NCT03764267|Anesthetics, General|anesthetics, general|mesh-list
5592935|NCT03764267|Anesthetics, Local|anesthetics, local|mesh-ancestor
5592936|NCT03764267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5592937|NCT03764267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592938|NCT03764267|Sensory System Agents|sensory system agents|mesh-ancestor
5592939|NCT03764267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5592940|NCT03764267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5592941|NCT03764267|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5592942|NCT03764267|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5592943|NCT03764267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5592944|NCT03764267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592945|NCT03764267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5592946|NCT03764267|Narcotics|narcotics|mesh-ancestor
5592947|NCT03764267|Analgesics|analgesics|mesh-ancestor
5592948|NCT03764241|Vitamin K|vitamin k|mesh-list
5592949|NCT03764241|Rivaroxaban|rivaroxaban|mesh-list
5592950|NCT03764241|Vitamins|vitamins|mesh-ancestor
5592951|NCT03764241|Micronutrients|micronutrients|mesh-ancestor
5592952|NCT03764241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592953|NCT03764241|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5592954|NCT03764241|Antithrombins|antithrombins|mesh-ancestor
5592955|NCT03764241|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5592956|NCT03764241|Protease Inhibitors|protease inhibitors|mesh-ancestor
5592957|NCT03764241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5592958|NCT03764241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592959|NCT03764241|Anticoagulants|anticoagulants|mesh-ancestor
5592960|NCT03764241|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5592961|NCT03764241|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5592962|NCT03764241|Hemostatics|hemostatics|mesh-ancestor
5592963|NCT03764241|Coagulants|coagulants|mesh-ancestor
5592964|NCT03764202|Sufentanil|sufentanil|mesh-list
5592965|NCT03764202|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5592966|NCT03764202|Narcotics|narcotics|mesh-ancestor
5592967|NCT03764202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5592968|NCT03764202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592969|NCT03764202|Analgesics|analgesics|mesh-ancestor
5592970|NCT03764202|Sensory System Agents|sensory system agents|mesh-ancestor
5592971|NCT03764202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5592972|NCT03764202|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5592973|NCT03764202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5592974|NCT03764202|Anesthetics, General|anesthetics, general|mesh-ancestor
5592975|NCT03764202|Anesthetics|anesthetics|mesh-ancestor
5592976|NCT03764163|Xenon|xenon|mesh-list
5592977|NCT03764163|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5592978|NCT03764163|Anesthetics, General|anesthetics, general|mesh-ancestor
5592979|NCT03764163|Anesthetics|anesthetics|mesh-ancestor
5592980|NCT03764163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5592981|NCT03764163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592982|NCT03764059|Chlorhexidine|chlorhexidine|mesh-list
5592983|NCT03764059|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5592984|NCT03764059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5592985|NCT03764059|Disinfectants|disinfectants|mesh-ancestor
5592986|NCT03764020|Melatonin|melatonin|mesh-list
5592987|NCT03764020|Antioxidants|antioxidants|mesh-ancestor
5592988|NCT03764020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5592989|NCT03764020|Protective Agents|protective agents|mesh-ancestor
5592990|NCT03764020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592991|NCT03764020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5592992|NCT03763786|Cetrorelix|cetrorelix|mesh-list
5592993|NCT03763786|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5592994|NCT03763786|Fertility Agents|fertility agents|mesh-ancestor
5592995|NCT03763786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5592996|NCT03763786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5592997|NCT03763786|Hormone Antagonists|hormone antagonists|mesh-ancestor
5592998|NCT03763786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5592999|NCT03763760|Dexamethasone|dexamethasone|mesh-list
5593000|NCT03763760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5593001|NCT03763760|Antiemetics|antiemetics|mesh-ancestor
5593002|NCT03763760|Autonomic Agents|autonomic agents|mesh-ancestor
5593003|NCT03763760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5593004|NCT03763760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593005|NCT03763760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5593006|NCT03763760|Glucocorticoids|glucocorticoids|mesh-ancestor
5593007|NCT03763760|Hormones|hormones|mesh-ancestor
5593008|NCT03763760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5593009|NCT03763760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5593010|NCT03763760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5593011|NCT03763734|Dexamethasone|dexamethasone|mesh-list
5593012|NCT03763734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5593013|NCT03763734|Antiemetics|antiemetics|mesh-ancestor
5593014|NCT03763734|Autonomic Agents|autonomic agents|mesh-ancestor
5593015|NCT03763734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5593016|NCT03763734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593017|NCT03763734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5593018|NCT03763734|Glucocorticoids|glucocorticoids|mesh-ancestor
5593019|NCT03763734|Hormones|hormones|mesh-ancestor
5593020|NCT03763734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5593021|NCT03763734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5593022|NCT03763734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5593023|NCT03763669|Folic Acid|folic acid|mesh-list
5593024|NCT03763669|Vitamin B Complex|vitamin b complex|mesh-list
5593025|NCT03763669|Inositol|inositol|mesh-list
5593026|NCT03763669|Hematinics|hematinics|mesh-ancestor
5593027|NCT03763669|Vitamins|vitamins|mesh-ancestor
5593028|NCT03763669|Micronutrients|micronutrients|mesh-ancestor
5593029|NCT03763669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593030|NCT03763409|Losartan|losartan|mesh-list
5593031|NCT03763409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5593032|NCT03763409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5593033|NCT03763409|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5593034|NCT03763409|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5593035|NCT03763409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593036|NCT03763396|Ketoconazole|ketoconazole|mesh-list
5593037|NCT03763396|Posaconazole|posaconazole|mesh-list
5593038|NCT03763396|Antifungal Agents|antifungal agents|mesh-ancestor
5593039|NCT03763396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5593040|NCT03763396|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5593041|NCT03763396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5593042|NCT03763396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5593043|NCT03763396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593044|NCT03763396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5593045|NCT03763396|Hormone Antagonists|hormone antagonists|mesh-ancestor
5593046|NCT03763396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5593047|NCT03763396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593048|NCT03763396|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5593049|NCT03763396|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5593050|NCT03763396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5593051|NCT03763396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5593052|NCT03763305|Fentanyl|fentanyl|mesh-list
5593053|NCT03763305|Remifentanil|remifentanil|mesh-list
5593054|NCT03763305|Propofol|propofol|mesh-list
5593055|NCT03763305|Sevoflurane|sevoflurane|mesh-list
5593056|NCT03763305|Desflurane|desflurane|mesh-list
5593057|NCT03763305|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5593058|NCT03763305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5593059|NCT03763305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5593060|NCT03763305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593061|NCT03763305|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5593062|NCT03763305|Anesthetics, General|anesthetics, general|mesh-ancestor
5593063|NCT03763305|Anesthetics|anesthetics|mesh-ancestor
5593064|NCT03763305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5593065|NCT03763305|Narcotics|narcotics|mesh-ancestor
5593066|NCT03763305|Analgesics|analgesics|mesh-ancestor
5593067|NCT03763305|Sensory System Agents|sensory system agents|mesh-ancestor
5593068|NCT03763305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5593069|NCT03763305|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5593070|NCT03763305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5593071|NCT03763305|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5593072|NCT03763279|Triclosan|triclosan|mesh-list
5593073|NCT03763279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5593074|NCT03763279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5593075|NCT03763279|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5593076|NCT03763279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5593077|NCT03763279|Antimetabolites|antimetabolites|mesh-ancestor
5593078|NCT03763279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593079|NCT03763279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5593080|NCT03763227|Ranibizumab|ranibizumab|mesh-list
5593081|NCT03763227|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-list
5593082|NCT03763227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5593083|NCT03763227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5593084|NCT03763227|Growth Substances|growth substances|mesh-ancestor
5593085|NCT03763227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593086|NCT03763227|Growth Inhibitors|growth inhibitors|mesh-ancestor
5593087|NCT03763227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5593088|NCT03763227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5593089|NCT03763227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593090|NCT03763162|Dexamethasone|dexamethasone|mesh-list
5593091|NCT03763162|Dexamethasone acetate|dexamethasone acetate|mesh-list
5593092|NCT03763162|Bortezomib|bortezomib|mesh-list
5593093|NCT03763162|Daratumumab|daratumumab|mesh-list
5593094|NCT03763162|Ixazomib|ixazomib|mesh-list
5593095|NCT03763162|Ichthammol|ichthammol|mesh-list
5593096|NCT03763162|BB 1101|bb 1101|mesh-list
5593097|NCT03763162|Glycine|glycine|mesh-list
5593098|NCT03763162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5593099|NCT03763162|Antiemetics|antiemetics|mesh-ancestor
5593100|NCT03763162|Autonomic Agents|autonomic agents|mesh-ancestor
5593101|NCT03763162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5593102|NCT03763162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593103|NCT03763162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5593104|NCT03763162|Glucocorticoids|glucocorticoids|mesh-ancestor
5593105|NCT03763162|Hormones|hormones|mesh-ancestor
5593106|NCT03763162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5593107|NCT03763162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5593108|NCT03763162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5593109|NCT03763162|Protease Inhibitors|protease inhibitors|mesh-ancestor
5593110|NCT03763162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5593111|NCT03763162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593112|NCT03763162|Dermatologic Agents|dermatologic agents|mesh-ancestor
5593113|NCT03763162|Glycine Agents|glycine agents|mesh-ancestor
5593114|NCT03763162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5593115|NCT03763123|Paclitaxel|paclitaxel|mesh-list
5593116|NCT03763123|Topotecan|topotecan|mesh-list
5593117|NCT03763123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5593118|NCT03763123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6201827|NCT02031640|Bronchodilator Agents|bronchodilator agents|mesh-list
5593119|NCT03763123|Tubulin Modulators|tubulin modulators|mesh-ancestor
5593120|NCT03763123|Antimitotic Agents|antimitotic agents|mesh-ancestor
5593121|NCT03763123|Mitosis Modulators|mitosis modulators|mesh-ancestor
5605750|NCT01186640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5593122|NCT03763123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593123|NCT03763123|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5593124|NCT03763123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5593125|NCT03763123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5593126|NCT03763110|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5593127|NCT03763110|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5593128|NCT03763110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5593129|NCT03763110|Antitubercular Agents|antitubercular agents|mesh-ancestor
5593130|NCT03763084|Acetaminophen|acetaminophen|mesh-list
5593131|NCT03763084|Sufentanil|sufentanil|mesh-list
5593132|NCT03763084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5593133|NCT03763084|Analgesics|analgesics|mesh-ancestor
5593134|NCT03763084|Sensory System Agents|sensory system agents|mesh-ancestor
5593135|NCT03763084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5593136|NCT03763084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593137|NCT03763084|Antipyretics|antipyretics|mesh-ancestor
5593138|NCT03763084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5593139|NCT03763084|Narcotics|narcotics|mesh-ancestor
5593140|NCT03763084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5593141|NCT03763084|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5593142|NCT03763084|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5593143|NCT03763084|Anesthetics, General|anesthetics, general|mesh-ancestor
5593144|NCT03763084|Anesthetics|anesthetics|mesh-ancestor
5605751|NCT01186640|Antimetabolites|antimetabolites|mesh-ancestor
5605752|NCT01186640|Antiviral Agents|antiviral agents|mesh-ancestor
5605753|NCT01186640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5605754|NCT01186640|Analgesics|analgesics|mesh-ancestor
5605755|NCT01186640|Sensory System Agents|sensory system agents|mesh-ancestor
5605756|NCT01186640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5605757|NCT01186640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5605758|NCT01186640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5605759|NCT01186640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5605760|NCT01186640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5605761|NCT01112306|Selexipag|selexipag|mesh-list
5605762|NCT01112306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5605763|NCT01087619|Parathyroid Hormone|parathyroid hormone|mesh-list
5605764|NCT01087619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5605765|NCT01087619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605766|NCT00688376|Donepezil|donepezil|mesh-list
5605767|NCT00688376|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5605768|NCT00688376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5605769|NCT00688376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605770|NCT00688376|Cholinergic Agents|cholinergic agents|mesh-ancestor
5605771|NCT00688376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5605772|NCT00688376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605773|NCT00688376|Nootropic Agents|nootropic agents|mesh-ancestor
5605774|NCT00669734|Metronidazole|metronidazole|mesh-list
5605775|NCT00669734|Tricyclodecane-9-yl-xanthogenate|tricyclodecane-9-yl-xanthogenate|mesh-list
5605776|NCT00669734|Vaccines|vaccines|mesh-list
5605777|NCT00669734|Sargramostim|sargramostim|mesh-list
5605778|NCT00669734|Immunologic Factors|immunologic factors|mesh-ancestor
5605779|NCT00669734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605780|NCT00669734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605781|NCT00669734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5605782|NCT00669734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5605783|NCT00669734|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5605784|NCT00669734|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5605785|NCT00669734|Antioxidants|antioxidants|mesh-ancestor
5605786|NCT00669734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605787|NCT00669734|Protective Agents|protective agents|mesh-ancestor
5605788|NCT00669734|Antiviral Agents|antiviral agents|mesh-ancestor
5605789|NCT00669734|Growth Inhibitors|growth inhibitors|mesh-ancestor
5605790|NCT00669734|Growth Substances|growth substances|mesh-ancestor
5605791|NCT00669734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5605792|NCT00669734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5605793|NCT00492349|Varenicline|varenicline|mesh-list
5605794|NCT00492349|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5605795|NCT00492349|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5605796|NCT00492349|Cholinergic Agents|cholinergic agents|mesh-ancestor
5605797|NCT00492349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5605798|NCT00492349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605799|NCT00492349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605800|NCT00003102|Antibodies|antibodies|mesh-list
5605801|NCT00003102|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5605802|NCT00003102|Immunologic Factors|immunologic factors|mesh-ancestor
5605803|NCT00003102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605804|NCT05181852|Pregabalin|pregabalin|mesh-list
5593145|NCT03763045|Sildenafil Citrate|sildenafil citrate|mesh-list
5593146|NCT03763045|Vasodilator Agents|vasodilator agents|mesh-ancestor
5593147|NCT03763045|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5593148|NCT03763045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5593149|NCT03763045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5593150|NCT03763045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593151|NCT03763045|Urological Agents|urological agents|mesh-ancestor
5593152|NCT03762967|Hormones|hormones|mesh-list
5593153|NCT03762967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5593154|NCT03762967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593155|NCT03762928|Efavirenz|efavirenz|mesh-list
5593156|NCT03762928|Midazolam|midazolam|mesh-list
5593157|NCT03762928|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5593158|NCT03762928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5593159|NCT03762928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5593160|NCT03762928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593161|NCT03762928|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5593162|NCT03762928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5593163|NCT03762928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5593164|NCT03762928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5593165|NCT03762928|Anesthetics, General|anesthetics, general|mesh-ancestor
5593166|NCT03762928|Anesthetics|anesthetics|mesh-ancestor
5593167|NCT03762928|GABA Modulators|gaba modulators|mesh-ancestor
5593168|NCT03762928|GABA Agents|gaba agents|mesh-ancestor
5593169|NCT03762928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5593170|NCT03762928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593171|NCT03762928|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5593172|NCT03762928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5593173|NCT03762928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5593174|NCT03762928|Antiviral Agents|antiviral agents|mesh-ancestor
5593175|NCT03762928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5593176|NCT03762928|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5593177|NCT03762928|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5593178|NCT03762928|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5593179|NCT03762928|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5593180|NCT03762928|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5593181|NCT03762928|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5593182|NCT03762915|Minocycline|minocycline|mesh-list
5593183|NCT03762915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5593184|NCT03762915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5593185|NCT03762889|Anesthetics|anesthetics|mesh-list
5593186|NCT03762889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5593187|NCT03762889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593188|NCT03762850|Irbesartan|irbesartan|mesh-list
5593189|NCT03762850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5593190|NCT03762850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5593191|NCT03762850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5593192|NCT03762850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593193|NCT03762824|Vaccines|vaccines|mesh-list
5593194|NCT03762824|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5593195|NCT03762824|Immunologic Factors|immunologic factors|mesh-ancestor
5593196|NCT03762824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593197|NCT03762785|Dexmedetomidine|dexmedetomidine|mesh-list
5593198|NCT03762785|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5593199|NCT03762785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5593200|NCT03762785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593201|NCT03762785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5593202|NCT03762785|Analgesics|analgesics|mesh-ancestor
5593203|NCT03762785|Sensory System Agents|sensory system agents|mesh-ancestor
5593204|NCT03762785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5593205|NCT03762785|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5593206|NCT03762785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5593207|NCT03762785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5593208|NCT03762785|Adrenergic Agents|adrenergic agents|mesh-ancestor
5593209|NCT03762785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5593210|NCT03762785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593211|NCT03762759|Edetic Acid|edetic acid|mesh-list
5593212|NCT03762759|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5593213|NCT03762759|Anticoagulants|anticoagulants|mesh-ancestor
5593214|NCT03762759|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5593215|NCT03762759|Chelating Agents|chelating agents|mesh-ancestor
5593216|NCT03762759|Sequestering Agents|sequestering agents|mesh-ancestor
6201828|NCT02031640|Autonomic Agents|autonomic agents|mesh-ancestor
5593217|NCT03762759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593218|NCT03762759|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5593219|NCT03762564|Paclitaxel|paclitaxel|mesh-list
5593220|NCT03762564|Ramucirumab|ramucirumab|mesh-list
5593221|NCT03762564|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5593222|NCT03762564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5593223|NCT03762564|Tubulin Modulators|tubulin modulators|mesh-ancestor
5593224|NCT03762564|Antimitotic Agents|antimitotic agents|mesh-ancestor
5593225|NCT03762564|Mitosis Modulators|mitosis modulators|mesh-ancestor
5593226|NCT03762564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593227|NCT03762538|Propofol|propofol|mesh-list
5593228|NCT03762538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5593229|NCT03762538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5593230|NCT03762538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593231|NCT03762538|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5593232|NCT03762538|Anesthetics, General|anesthetics, general|mesh-ancestor
5593233|NCT03762538|Anesthetics|anesthetics|mesh-ancestor
5593234|NCT03762473|Tacrolimus|tacrolimus|mesh-list
5593235|NCT03762473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5593236|NCT03762473|Immunologic Factors|immunologic factors|mesh-ancestor
5593237|NCT03762473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593238|NCT03762473|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5593239|NCT03762473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5593240|NCT03762473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593241|NCT03762395|CXA-10|cxa-10|mesh-list
5593242|NCT03762395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5593243|NCT03762382|Tenofovir|tenofovir|mesh-list
5593244|NCT03762382|Levonorgestrel|levonorgestrel|mesh-list
5593245|NCT03762382|Antiviral Agents|antiviral agents|mesh-ancestor
5593246|NCT03762382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5593247|NCT03762382|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5593248|NCT03762382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5593249|NCT03762382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5593250|NCT03762382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593251|NCT03762382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5593252|NCT03762382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5593253|NCT03762382|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5593254|NCT03762382|Contraceptive Agents|contraceptive agents|mesh-ancestor
5593255|NCT03762382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5593256|NCT03762382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593257|NCT03762382|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5593258|NCT03762382|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5593259|NCT03762382|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5593260|NCT03762369|Latanoprost|latanoprost|mesh-list
5593261|NCT03762369|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5593262|NCT03762369|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5593263|NCT03762317|Clonidine|clonidine|mesh-list
5593264|NCT03762317|Analgesics|analgesics|mesh-ancestor
5593265|NCT03762317|Sensory System Agents|sensory system agents|mesh-ancestor
5593266|NCT03762317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5593267|NCT03762317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593268|NCT03762317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5593269|NCT03762317|Sympatholytics|sympatholytics|mesh-ancestor
5593270|NCT03762317|Autonomic Agents|autonomic agents|mesh-ancestor
5593271|NCT03762317|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5593272|NCT03762317|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5593273|NCT03762317|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5593274|NCT03762317|Adrenergic Agents|adrenergic agents|mesh-ancestor
5593275|NCT03762317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5593276|NCT03762317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593277|NCT03762226|Bevacizumab|bevacizumab|mesh-list
5593278|NCT03762226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5593279|NCT03762226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5593280|NCT03762226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5593281|NCT03762226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5593282|NCT03762226|Growth Substances|growth substances|mesh-ancestor
5593283|NCT03762226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593284|NCT03762226|Growth Inhibitors|growth inhibitors|mesh-ancestor
5593285|NCT03762148|Vitamins|vitamins|mesh-list
5593286|NCT03762148|Ascorbic Acid|ascorbic acid|mesh-list
5593287|NCT03762148|Ferrous fumarate|ferrous fumarate|mesh-list
5593288|NCT03762148|Iron|iron|mesh-list
5593289|NCT03762148|Micronutrients|micronutrients|mesh-ancestor
5593290|NCT03762148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593291|NCT03762148|Antioxidants|antioxidants|mesh-ancestor
5593292|NCT03762148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593293|NCT03762148|Protective Agents|protective agents|mesh-ancestor
5593294|NCT03762148|Trace Elements|trace elements|mesh-ancestor
5593295|NCT03762109|Dantrolene|dantrolene|mesh-list
5593296|NCT03762109|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5593297|NCT03762109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593298|NCT03762109|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5593299|NCT03762109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5593300|NCT03762096|Resveratrol|resveratrol|mesh-list
5593301|NCT03762096|Antioxidants|antioxidants|mesh-ancestor
5593302|NCT03762096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593303|NCT03762096|Protective Agents|protective agents|mesh-ancestor
5593304|NCT03762096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593305|NCT03762096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5593306|NCT03762096|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5593307|NCT03762018|Bevacizumab|bevacizumab|mesh-list
5593308|NCT03762018|Carboplatin|carboplatin|mesh-list
5593309|NCT03762018|Pemetrexed|pemetrexed|mesh-list
5593310|NCT03762018|Atezolizumab|atezolizumab|mesh-list
5593311|NCT03762018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5593312|NCT03762018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5593313|NCT03762018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5593314|NCT03762018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5593315|NCT03762018|Growth Substances|growth substances|mesh-ancestor
5593316|NCT03762018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593317|NCT03762018|Growth Inhibitors|growth inhibitors|mesh-ancestor
5593318|NCT03762018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5593319|NCT03762018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593320|NCT03762018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5593321|NCT03762018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5593322|NCT03761953|Oritavancin|oritavancin|mesh-list
5593323|NCT03761953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5593324|NCT03761953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5593325|NCT03761511|Niacinamide|niacinamide|mesh-list
5593326|NCT03761511|Niacin|niacin|mesh-list
5593327|NCT03761511|Nicotinic Acids|nicotinic acids|mesh-list
5593328|NCT03761511|Vitamin B Complex|vitamin b complex|mesh-ancestor
5593329|NCT03761511|Vitamins|vitamins|mesh-ancestor
5593330|NCT03761511|Micronutrients|micronutrients|mesh-ancestor
5593331|NCT03761511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593332|NCT03761511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5593333|NCT03761511|Antimetabolites|antimetabolites|mesh-ancestor
5593334|NCT03761511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593335|NCT03761511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5593336|NCT03761511|Vasodilator Agents|vasodilator agents|mesh-ancestor
5593337|NCT03761485|Fluorides|fluorides|mesh-list
5593338|NCT03761485|Cariostatic Agents|cariostatic agents|mesh-ancestor
5593339|NCT03761485|Protective Agents|protective agents|mesh-ancestor
5593340|NCT03761485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593341|NCT03761472|Hyaluronic Acid|hyaluronic acid|mesh-list
5593342|NCT03761472|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5593343|NCT03761472|Immunologic Factors|immunologic factors|mesh-ancestor
5593344|NCT03761472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593345|NCT03761472|Viscosupplements|viscosupplements|mesh-ancestor
5593346|NCT03761472|Protective Agents|protective agents|mesh-ancestor
5593347|NCT03761329|Lidocaine|lidocaine|mesh-list
5593348|NCT03761329|Anesthetics|anesthetics|mesh-list
5593349|NCT03761329|Anesthetics, Local|anesthetics, local|mesh-ancestor
5593350|NCT03761329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5593351|NCT03761329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593352|NCT03761329|Sensory System Agents|sensory system agents|mesh-ancestor
5593353|NCT03761329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5593354|NCT03761329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5593355|NCT03761329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5593356|NCT03761329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5593357|NCT03761329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5593358|NCT03761329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593359|NCT03761264|Amoxicillin|amoxicillin|mesh-list
5593360|NCT03761264|Zinc Oxide|zinc oxide|mesh-list
5593361|NCT03761264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593362|NCT03761264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5593363|NCT03761264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5593364|NCT03761264|Dermatologic Agents|dermatologic agents|mesh-ancestor
5593365|NCT03761264|Sunscreening Agents|sunscreening agents|mesh-ancestor
5593366|NCT03761264|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5593367|NCT03761264|Protective Agents|protective agents|mesh-ancestor
5593368|NCT03761134|Metformin|metformin|mesh-list
5593369|NCT03761134|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
5593370|NCT03761134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5593371|NCT03761134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593372|NCT03761134|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5593373|NCT03761134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593385|NCT03761004|Levodopa|levodopa|mesh-list
5593386|NCT03761004|Carbidopa|carbidopa|mesh-list
5593387|NCT03761004|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
5593388|NCT03761004|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5593389|NCT03761004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5593390|NCT03761004|Dopamine Agents|dopamine agents|mesh-ancestor
5593391|NCT03761004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5593392|NCT03761004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593393|NCT03761004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593394|NCT03761004|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5593395|NCT03761004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5593396|NCT03761004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5593397|NCT03761004|Immunologic Factors|immunologic factors|mesh-ancestor
5593398|NCT03761004|Dopamine Agonists|dopamine agonists|mesh-ancestor
5593399|NCT03760991|Insulin Glargine|insulin glargine|mesh-list
5593400|NCT03760991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5593401|NCT03760991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593402|NCT03760978|Dexmedetomidine|dexmedetomidine|mesh-list
5593403|NCT03760978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5593404|NCT03760978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5593405|NCT03760978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593406|NCT03760978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5593407|NCT03760978|Analgesics|analgesics|mesh-ancestor
5593408|NCT03760978|Sensory System Agents|sensory system agents|mesh-ancestor
5593409|NCT03760978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5593410|NCT03760978|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5593411|NCT03760978|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5593412|NCT03760978|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5593413|NCT03760978|Adrenergic Agents|adrenergic agents|mesh-ancestor
5593414|NCT03760978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5593415|NCT03760978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593416|NCT03760965|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
5593417|NCT03760965|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5593418|NCT03760965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593419|NCT03760965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5593420|NCT03760965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593421|NCT03760848|Midazolam|midazolam|mesh-list
5593422|NCT03760848|Atorvastatin|atorvastatin|mesh-list
5593423|NCT03760848|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5593424|NCT03760848|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5593425|NCT03760848|Antimetabolites|antimetabolites|mesh-ancestor
5593426|NCT03760848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593427|NCT03760848|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5593428|NCT03760848|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5593429|NCT03760848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5593430|NCT03760848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5593431|NCT03760848|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5593432|NCT03760848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5593433|NCT03760848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593434|NCT03760848|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5593435|NCT03760848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5593436|NCT03760848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5593437|NCT03760848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5593438|NCT03760848|Anesthetics, General|anesthetics, general|mesh-ancestor
5593439|NCT03760848|Anesthetics|anesthetics|mesh-ancestor
5593440|NCT03760848|GABA Modulators|gaba modulators|mesh-ancestor
5593441|NCT03760848|GABA Agents|gaba agents|mesh-ancestor
5593442|NCT03760848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5593443|NCT03760835|Dexamethasone|dexamethasone|mesh-list
5593444|NCT03760835|Prednisone|prednisone|mesh-list
5593445|NCT03760835|Prednisolone|prednisolone|mesh-list
5593446|NCT03760835|Hydrocortisone|hydrocortisone|mesh-list
5593447|NCT03760835|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
5593448|NCT03760835|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
5593449|NCT03760835|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
5593450|NCT03760835|Cortisone|cortisone|mesh-list
5593451|NCT03760835|Glucocorticoids|glucocorticoids|mesh-list
5593452|NCT03760835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5593453|NCT03760835|Antiemetics|antiemetics|mesh-ancestor
5593454|NCT03760835|Autonomic Agents|autonomic agents|mesh-ancestor
5593455|NCT03760835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5593456|NCT03760835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593457|NCT03760835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5593458|NCT03760835|Hormones|hormones|mesh-ancestor
5593459|NCT03760835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5593460|NCT03760835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5593461|NCT03760835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5593462|NCT03760822|Paclitaxel|paclitaxel|mesh-list
5593463|NCT03760822|Ramucirumab|ramucirumab|mesh-list
5593464|NCT03760822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5593465|NCT03760822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5593466|NCT03760822|Tubulin Modulators|tubulin modulators|mesh-ancestor
5593467|NCT03760822|Antimitotic Agents|antimitotic agents|mesh-ancestor
5593468|NCT03760822|Mitosis Modulators|mitosis modulators|mesh-ancestor
5593469|NCT03760822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593470|NCT03760809|Dexmedetomidine|dexmedetomidine|mesh-list
5593471|NCT03760809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5593472|NCT03760809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5593473|NCT03760809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593474|NCT03760809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5593475|NCT03760809|Analgesics|analgesics|mesh-ancestor
5593476|NCT03760809|Sensory System Agents|sensory system agents|mesh-ancestor
5593477|NCT03760809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5593478|NCT03760809|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5593479|NCT03760809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5593480|NCT03760809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5593481|NCT03760809|Adrenergic Agents|adrenergic agents|mesh-ancestor
5593482|NCT03760809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5593483|NCT03760809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593484|NCT03760770|Riboflavin|riboflavin|mesh-list
5593485|NCT03760770|Vitamin B Complex|vitamin b complex|mesh-ancestor
5593486|NCT03760770|Vitamins|vitamins|mesh-ancestor
5593487|NCT03760770|Micronutrients|micronutrients|mesh-ancestor
5593488|NCT03760770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593489|NCT03760770|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5593490|NCT03760770|Dermatologic Agents|dermatologic agents|mesh-ancestor
5593491|NCT03760679|Chlorhexidine|chlorhexidine|mesh-list
5593492|NCT03760679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5593493|NCT03760679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5593494|NCT03760679|Disinfectants|disinfectants|mesh-ancestor
5593495|NCT03760666|Ribavirin|ribavirin|mesh-list
5593496|NCT03760666|Brequinar|brequinar|mesh-list
5593497|NCT03760666|Antimetabolites|antimetabolites|mesh-ancestor
5593498|NCT03760666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593499|NCT03760666|Antiviral Agents|antiviral agents|mesh-ancestor
5593500|NCT03760666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5593501|NCT03760666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5593502|NCT03760666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5593503|NCT03760666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5593504|NCT03760666|Immunologic Factors|immunologic factors|mesh-ancestor
5593505|NCT03760666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593506|NCT03760614|Entinostat|entinostat|mesh-list
5593507|NCT03760614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5593508|NCT03760614|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5593509|NCT03760614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5593510|NCT03760614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593511|NCT03760588|Valsartan|valsartan|mesh-list
5593512|NCT03760588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5593513|NCT03760588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5593514|NCT03760588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5593515|NCT03760588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593516|NCT03760484|Fidaxomicin|fidaxomicin|mesh-list
5593517|NCT03760484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5593518|NCT03760484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5593519|NCT03760445|Cytarabine|cytarabine|mesh-list
5593520|NCT03760445|Posaconazole|posaconazole|mesh-list
5593521|NCT03760445|Daunorubicin|daunorubicin|mesh-list
5593522|NCT03760445|Idarubicin|idarubicin|mesh-list
5593523|NCT03760445|Midostaurin|midostaurin|mesh-list
5593524|NCT03760445|Midazolam|midazolam|mesh-list
5593525|NCT03760445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5593526|NCT03760445|Antimetabolites|antimetabolites|mesh-ancestor
5593527|NCT03760445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593528|NCT03760445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5593529|NCT03760445|Antiviral Agents|antiviral agents|mesh-ancestor
5593530|NCT03760445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5593531|NCT03760445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5593532|NCT03760445|Immunologic Factors|immunologic factors|mesh-ancestor
5593533|NCT03760445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593534|NCT03760445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5593535|NCT03760445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5593536|NCT03760445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5593537|NCT03760445|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5593538|NCT03760445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5593539|NCT03760445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5593540|NCT03760445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5593541|NCT03760445|Anesthetics, General|anesthetics, general|mesh-ancestor
5593542|NCT03760445|Anesthetics|anesthetics|mesh-ancestor
5593543|NCT03760445|GABA Modulators|gaba modulators|mesh-ancestor
5593544|NCT03760445|GABA Agents|gaba agents|mesh-ancestor
5593545|NCT03760445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5593546|NCT03760445|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5593547|NCT03760445|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5593548|NCT03760445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5593549|NCT03760445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5593550|NCT03760445|Antifungal Agents|antifungal agents|mesh-ancestor
5593551|NCT03760445|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5593552|NCT03760445|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5593553|NCT03760445|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5593554|NCT03760445|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5593555|NCT03760445|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5593556|NCT03760445|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5593557|NCT03760445|Hormone Antagonists|hormone antagonists|mesh-ancestor
5593558|NCT03760445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5593559|NCT03760445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5593560|NCT03760354|Methylprednisolone|methylprednisolone|mesh-list
5593561|NCT03760354|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5593562|NCT03760354|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5593563|NCT03760354|Prednisolone|prednisolone|mesh-list
5593564|NCT03760354|Prednisolone acetate|prednisolone acetate|mesh-list
5593565|NCT03760354|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5593566|NCT03760354|Prednisolone phosphate|prednisolone phosphate|mesh-list
5593567|NCT03760354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5593568|NCT03760354|Antiemetics|antiemetics|mesh-ancestor
5593569|NCT03760354|Autonomic Agents|autonomic agents|mesh-ancestor
5593570|NCT03760354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5593571|NCT03760354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593572|NCT03760354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5593573|NCT03760354|Glucocorticoids|glucocorticoids|mesh-ancestor
5593574|NCT03760354|Hormones|hormones|mesh-ancestor
5593575|NCT03760354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5593576|NCT03760354|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5593577|NCT03760354|Protective Agents|protective agents|mesh-ancestor
5593578|NCT03760354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5593579|NCT03760354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5593580|NCT03760302|Analgesics|analgesics|mesh-list
5593581|NCT03760302|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
5593582|NCT03760302|Sensory System Agents|sensory system agents|mesh-ancestor
5593583|NCT03760302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5593584|NCT03760302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593585|NCT03760302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5593586|NCT03760276|Voriconazole|voriconazole|mesh-list
5593587|NCT03760276|Antifungal Agents|antifungal agents|mesh-ancestor
5593588|NCT03760276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5593589|NCT03760276|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5593590|NCT03760276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5593591|NCT03760276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5593592|NCT03760276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593593|NCT03760276|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5593594|NCT03760276|Hormone Antagonists|hormone antagonists|mesh-ancestor
5593595|NCT03760276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5593596|NCT03760276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593597|NCT03760276|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5593598|NCT03760263|Tacrolimus|tacrolimus|mesh-list
5593599|NCT03760263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5593600|NCT03760263|Immunologic Factors|immunologic factors|mesh-ancestor
5593601|NCT03760263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593602|NCT03760263|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5593603|NCT03760263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5593604|NCT03760263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593605|NCT03760198|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5593606|NCT03760198|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5593607|NCT03760198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5593608|NCT03760198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593609|NCT03760198|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5593610|NCT03760198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5593611|NCT03760198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593612|NCT03760198|Cholinergic Agents|cholinergic agents|mesh-ancestor
5593613|NCT03760198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5593614|NCT03760185|Brimonidine Tartrate|brimonidine tartrate|mesh-list
5593615|NCT03760185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5593616|NCT03760185|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5593617|NCT03760185|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5593618|NCT03760185|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5593619|NCT03760185|Adrenergic Agents|adrenergic agents|mesh-ancestor
5593620|NCT03760185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5593621|NCT03760185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593622|NCT03760185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593623|NCT03759938|Rivaroxaban|rivaroxaban|mesh-list
5593624|NCT03759938|Apixaban|apixaban|mesh-list
5593625|NCT03759938|Edoxaban|edoxaban|mesh-list
5593626|NCT03759938|Dabigatran|dabigatran|mesh-list
5593627|NCT03759938|Anticoagulants|anticoagulants|mesh-list
5593628|NCT03759938|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5593629|NCT03759938|Antithrombins|antithrombins|mesh-ancestor
5593630|NCT03759938|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5593631|NCT03759938|Protease Inhibitors|protease inhibitors|mesh-ancestor
5593632|NCT03759938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5593633|NCT03759938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593634|NCT03759886|Metronidazole|metronidazole|mesh-list
5593635|NCT03759886|Paromomycin|paromomycin|mesh-list
5593636|NCT03759886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5593637|NCT03759886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5593638|NCT03759886|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5593639|NCT03759886|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5593640|NCT03759860|Ranibizumab|ranibizumab|mesh-list
5593641|NCT03759860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5593642|NCT03759860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5593643|NCT03759860|Growth Substances|growth substances|mesh-ancestor
5593644|NCT03759860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488326|NCT00583193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593645|NCT03759860|Growth Inhibitors|growth inhibitors|mesh-ancestor
5593646|NCT03759860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5593647|NCT03759782|Tenofovir|tenofovir|mesh-list
5593648|NCT03759782|Ribavirin|ribavirin|mesh-list
5593649|NCT03759782|Antiviral Agents|antiviral agents|mesh-ancestor
5593650|NCT03759782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5593651|NCT03759782|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5593652|NCT03759782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5593653|NCT03759782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5593654|NCT03759782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593655|NCT03759782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5593656|NCT03759782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5593657|NCT03759782|Antimetabolites|antimetabolites|mesh-ancestor
5605805|NCT05181852|Analgesics|analgesics|mesh-ancestor
5605806|NCT05181852|Sensory System Agents|sensory system agents|mesh-ancestor
5605807|NCT05181852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5605808|NCT05181852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605809|NCT05181852|Anticonvulsants|anticonvulsants|mesh-ancestor
5605810|NCT05181852|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5605811|NCT05181852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5605812|NCT05181852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605813|NCT05181852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5605814|NCT05181852|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5605815|NCT05181852|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5605816|NCT05181852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5605817|NCT05181852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5605818|NCT05181735|Luspatercept|luspatercept|mesh-list
5605819|NCT05181735|Hematinics|hematinics|mesh-ancestor
5605820|NCT05181605|Folfirinox|folfirinox|mesh-list
5605821|NCT05181605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605822|NCT05181592|Luspatercept|luspatercept|mesh-list
5605823|NCT05181592|Hematinics|hematinics|mesh-ancestor
5605824|NCT05181514|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
5605825|NCT05181514|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
5605826|NCT05181514|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5605827|NCT05181514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5605828|NCT05181462|Gemcitabine|gemcitabine|mesh-list
5605829|NCT05181462|Carboplatin|carboplatin|mesh-list
5605830|NCT05181462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605831|NCT05181462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5605832|NCT05181462|Antimetabolites|antimetabolites|mesh-ancestor
5605833|NCT05181462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605834|NCT05181462|Antiviral Agents|antiviral agents|mesh-ancestor
5605835|NCT05181462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5605836|NCT05181462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5605837|NCT05181462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5605838|NCT05181462|Immunologic Factors|immunologic factors|mesh-ancestor
5605839|NCT05181462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605840|NCT05181150|Glucagon|glucagon|mesh-list
5605841|NCT05181150|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5605842|NCT05181150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5605843|NCT05181150|Hormones|hormones|mesh-ancestor
5605844|NCT05181150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5605845|NCT05181150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605846|NCT05181150|Incretins|incretins|mesh-ancestor
5606930|NCT03373188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5606931|NCT03373188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5606932|NCT03373188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5606933|NCT03373188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606934|NCT03369665|Cladribine|cladribine|mesh-list
5606935|NCT03369665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5606936|NCT03369665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5606937|NCT03369665|Immunologic Factors|immunologic factors|mesh-ancestor
5606938|NCT03369665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607016|NCT03032510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607017|NCT03032510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5607018|NCT03032510|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5607019|NCT03032510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5607020|NCT03031730|Dexamethasone|dexamethasone|mesh-list
5593658|NCT03759496|Durvalumab|durvalumab|mesh-list
5593659|NCT03759496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5593660|NCT03759496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5593661|NCT03759353|Lactoferrin|lactoferrin|mesh-list
5593662|NCT03759353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5593663|NCT03759301|Cetrorelix|cetrorelix|mesh-list
5593664|NCT03759301|Hormones|hormones|mesh-list
5593665|NCT03759301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5593666|NCT03759301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593667|NCT03759301|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5593668|NCT03759301|Fertility Agents|fertility agents|mesh-ancestor
5593669|NCT03759301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5593670|NCT03759301|Hormone Antagonists|hormone antagonists|mesh-ancestor
5593671|NCT03759262|Vitamin D|vitamin d|mesh-list
5593672|NCT03759262|Cholecalciferol|cholecalciferol|mesh-list
5593673|NCT03759262|Vitamins|vitamins|mesh-ancestor
5593674|NCT03759262|Micronutrients|micronutrients|mesh-ancestor
5593675|NCT03759262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593676|NCT03759262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5593677|NCT03759262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5593678|NCT03759158|Acetylcysteine|acetylcysteine|mesh-list
5593679|NCT03759158|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5593680|NCT03759158|Antiviral Agents|antiviral agents|mesh-ancestor
5593681|NCT03759158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5593682|NCT03759158|Expectorants|expectorants|mesh-ancestor
5593683|NCT03759158|Respiratory System Agents|respiratory system agents|mesh-ancestor
5593684|NCT03759158|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5593685|NCT03759158|Antioxidants|antioxidants|mesh-ancestor
5593686|NCT03759158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593687|NCT03759158|Protective Agents|protective agents|mesh-ancestor
5593688|NCT03759158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593689|NCT03759158|Antidotes|antidotes|mesh-ancestor
5593690|NCT03759093|Thalidomide|thalidomide|mesh-list
5593691|NCT03759093|Dexamethasone|dexamethasone|mesh-list
5593692|NCT03759093|Dexamethasone acetate|dexamethasone acetate|mesh-list
5593693|NCT03759093|Cyclophosphamide|cyclophosphamide|mesh-list
5593694|NCT03759093|Bortezomib|bortezomib|mesh-list
5593695|NCT03759093|BB 1101|bb 1101|mesh-list
5593696|NCT03759093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5593697|NCT03759093|Immunologic Factors|immunologic factors|mesh-ancestor
5593698|NCT03759093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593699|NCT03759093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5593700|NCT03759093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5593701|NCT03759093|Alkylating Agents|alkylating agents|mesh-ancestor
5593702|NCT03759093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593703|NCT03759093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5593704|NCT03759093|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5593705|NCT03759093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5593706|NCT03759093|Antiemetics|antiemetics|mesh-ancestor
5593707|NCT03759093|Autonomic Agents|autonomic agents|mesh-ancestor
5593708|NCT03759093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5593709|NCT03759093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5593710|NCT03759093|Glucocorticoids|glucocorticoids|mesh-ancestor
5593711|NCT03759093|Hormones|hormones|mesh-ancestor
5593712|NCT03759093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5593713|NCT03759093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5593714|NCT03759093|Protease Inhibitors|protease inhibitors|mesh-ancestor
5593715|NCT03759093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5593716|NCT03759093|Leprostatic Agents|leprostatic agents|mesh-ancestor
5593717|NCT03759093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5593718|NCT03759093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5593719|NCT03759093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5593720|NCT03759093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5593721|NCT03759093|Growth Substances|growth substances|mesh-ancestor
5593722|NCT03759093|Growth Inhibitors|growth inhibitors|mesh-ancestor
5593723|NCT03759067|Clopidogrel|clopidogrel|mesh-list
5593724|NCT03759067|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5593725|NCT03759067|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5593726|NCT03759067|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5593727|NCT03759067|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5593728|NCT03759067|Purinergic Agents|purinergic agents|mesh-ancestor
5593729|NCT03759067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5593730|NCT03759067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593731|NCT03759067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593732|NCT03759028|Acetaminophen|acetaminophen|mesh-list
5593733|NCT03759028|Ibuprofen|ibuprofen|mesh-list
5593734|NCT03759028|Oxycodone|oxycodone|mesh-list
5593735|NCT03759028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5593736|NCT03759028|Analgesics|analgesics|mesh-ancestor
5593737|NCT03759028|Sensory System Agents|sensory system agents|mesh-ancestor
5593738|NCT03759028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5593739|NCT03759028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593740|NCT03759028|Antipyretics|antipyretics|mesh-ancestor
5593741|NCT03759028|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5593742|NCT03759028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5593743|NCT03759028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5593744|NCT03759028|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5593745|NCT03759028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5593746|NCT03759028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593747|NCT03759028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5593748|NCT03759028|Narcotics|narcotics|mesh-ancestor
5593749|NCT03759028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5593750|NCT03758989|Prednisone|prednisone|mesh-list
5593751|NCT03758989|Cyclophosphamide|cyclophosphamide|mesh-list
5593752|NCT03758989|Rituximab|rituximab|mesh-list
5593753|NCT03758989|Doxorubicin|doxorubicin|mesh-list
5593754|NCT03758989|Vincristine|vincristine|mesh-list
5593755|NCT03758989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5593756|NCT03758989|Immunologic Factors|immunologic factors|mesh-ancestor
5593757|NCT03758989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593758|NCT03758989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5593759|NCT03758989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5593760|NCT03758989|Alkylating Agents|alkylating agents|mesh-ancestor
5593761|NCT03758989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593762|NCT03758989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5593763|NCT03758989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5593764|NCT03758989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5593765|NCT03758989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5593766|NCT03758989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5593767|NCT03758989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5593768|NCT03758989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5593769|NCT03758989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5593770|NCT03758989|Glucocorticoids|glucocorticoids|mesh-ancestor
5593771|NCT03758989|Hormones|hormones|mesh-ancestor
5593772|NCT03758989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5593773|NCT03758989|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5593774|NCT03758989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5593775|NCT03758989|Tubulin Modulators|tubulin modulators|mesh-ancestor
5593776|NCT03758989|Antimitotic Agents|antimitotic agents|mesh-ancestor
5593777|NCT03758989|Mitosis Modulators|mitosis modulators|mesh-ancestor
5593778|NCT03758950|Mometasone Furoate|mometasone furoate|mesh-list
5593779|NCT03758950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5593780|NCT03758950|Dermatologic Agents|dermatologic agents|mesh-ancestor
5593781|NCT03758950|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5593782|NCT03758859|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5593783|NCT03758859|Hyaluronic Acid|hyaluronic acid|mesh-list
5593784|NCT03758859|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5593785|NCT03758859|Immunologic Factors|immunologic factors|mesh-ancestor
5593786|NCT03758859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593787|NCT03758859|Viscosupplements|viscosupplements|mesh-ancestor
5593788|NCT03758859|Protective Agents|protective agents|mesh-ancestor
5593789|NCT03758859|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5593790|NCT03758729|Nivolumab|nivolumab|mesh-list
5593791|NCT03758729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5593792|NCT03758729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5593793|NCT03758729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5593794|NCT03758729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593795|NCT03758677|Gemcitabine|gemcitabine|mesh-list
5593796|NCT03758677|Docetaxel|docetaxel|mesh-list
5593797|NCT03758677|Pemetrexed|pemetrexed|mesh-list
5593798|NCT03758677|Apatinib|apatinib|mesh-list
5593799|NCT03758677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5593800|NCT03758677|Antimetabolites|antimetabolites|mesh-ancestor
5593801|NCT03758677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593802|NCT03758677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5593803|NCT03758677|Antiviral Agents|antiviral agents|mesh-ancestor
5593804|NCT03758677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5593805|NCT03758677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5593806|NCT03758677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5593807|NCT03758677|Immunologic Factors|immunologic factors|mesh-ancestor
5593808|NCT03758677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593809|NCT03758677|Tubulin Modulators|tubulin modulators|mesh-ancestor
5593810|NCT03758677|Antimitotic Agents|antimitotic agents|mesh-ancestor
5593811|NCT03758677|Mitosis Modulators|mitosis modulators|mesh-ancestor
5593812|NCT03758677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5593813|NCT03758677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5593814|NCT03758677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5593815|NCT03758469|Rifampin|rifampin|mesh-list
5593816|NCT03758469|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5593817|NCT03758469|Antitubercular Agents|antitubercular agents|mesh-ancestor
5593818|NCT03758469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5593819|NCT03758469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5593820|NCT03758469|Leprostatic Agents|leprostatic agents|mesh-ancestor
5593821|NCT03758469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5593822|NCT03758469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5593823|NCT03758469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593824|NCT03758469|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5593825|NCT03758469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5593826|NCT03758469|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5593827|NCT03758469|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5593828|NCT03758469|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5593829|NCT03758469|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5593830|NCT03758339|Tucatinib|tucatinib|mesh-list
5593831|NCT03758339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5593832|NCT03758339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5593833|NCT03758339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5593834|NCT03758339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593835|NCT03758287|Gefitinib|gefitinib|mesh-list
5593836|NCT03758287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5593837|NCT03758287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5593838|NCT03758287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5593839|NCT03758287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593840|NCT03758235|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5593841|NCT03758235|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
5593842|NCT03758235|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5593843|NCT03758235|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5593844|NCT03758235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5593845|NCT03758235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593846|NCT03758235|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5593847|NCT03758235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5593848|NCT03758235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593849|NCT03758235|Cholinergic Agents|cholinergic agents|mesh-ancestor
5593850|NCT03758235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5593851|NCT03758170|Dexamethasone|dexamethasone|mesh-list
5593852|NCT03758170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5593853|NCT03758170|Antiemetics|antiemetics|mesh-ancestor
5593854|NCT03758170|Autonomic Agents|autonomic agents|mesh-ancestor
5593855|NCT03758170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5593856|NCT03758170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593857|NCT03758170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5593858|NCT03758170|Glucocorticoids|glucocorticoids|mesh-ancestor
5593859|NCT03758170|Hormones|hormones|mesh-ancestor
5593860|NCT03758170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5593861|NCT03758170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5593862|NCT03758170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5593863|NCT03758144|Rifaximin|rifaximin|mesh-list
5593864|NCT03758144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5593865|NCT03758144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5593866|NCT03758144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5593867|NCT03758118|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
5593868|NCT03758118|Nootropic Agents|nootropic agents|mesh-ancestor
5593869|NCT03758079|Gabapentin|gabapentin|mesh-list
5593870|NCT03758079|Doxepin|doxepin|mesh-list
5593871|NCT03758079|Analgesics|analgesics|mesh-ancestor
5593872|NCT03758079|Sensory System Agents|sensory system agents|mesh-ancestor
5593873|NCT03758079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5593874|NCT03758079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593875|NCT03758079|Anticonvulsants|anticonvulsants|mesh-ancestor
5593876|NCT03758079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5593877|NCT03758079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5593878|NCT03758079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5593879|NCT03758079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5593880|NCT03758079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5593881|NCT03758079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5593882|NCT03758079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5593883|NCT03758079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593884|NCT03758079|Antimanic Agents|antimanic agents|mesh-ancestor
5593885|NCT03758079|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5593886|NCT03758079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5593887|NCT03758079|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5593888|NCT03758079|Antidepressive Agents|antidepressive agents|mesh-ancestor
5593889|NCT03758079|Histamine Antagonists|histamine antagonists|mesh-ancestor
5593890|NCT03758079|Histamine Agents|histamine agents|mesh-ancestor
5593891|NCT03758014|Lomustine|lomustine|mesh-list
5593892|NCT03758014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5593893|NCT03758014|Alkylating Agents|alkylating agents|mesh-ancestor
5593894|NCT03758014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593895|NCT03758014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5593896|NCT03757923|Metformin|metformin|mesh-list
5593897|NCT03757923|Pioglitazone|pioglitazone|mesh-list
5593898|NCT03757923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5593899|NCT03757923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605847|NCT05181046|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5605848|NCT05181046|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5605849|NCT05181033|Letrozole|letrozole|mesh-list
5605850|NCT05181033|Fulvestrant|fulvestrant|mesh-list
5605851|NCT05181033|Lenvatinib|lenvatinib|mesh-list
5605852|NCT05181033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605853|NCT05181033|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5605854|NCT05181033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5605855|NCT05181033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5605856|NCT05181033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605857|NCT05181033|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5605858|NCT05181033|Hormone Antagonists|hormone antagonists|mesh-ancestor
5605859|NCT05181033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5605860|NCT05181033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605861|NCT05181033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5605862|NCT05181033|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5605863|NCT05181033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5605864|NCT05181007|Valproic Acid|valproic acid|mesh-list
5605865|NCT05181007|Anticonvulsants|anticonvulsants|mesh-ancestor
5605866|NCT05181007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5605867|NCT05181007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605868|NCT05181007|GABA Agents|gaba agents|mesh-ancestor
5605869|NCT05181007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5605870|NCT05181007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605871|NCT05181007|Antimanic Agents|antimanic agents|mesh-ancestor
5605872|NCT05181007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5605873|NCT05181007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5605874|NCT05181007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5605875|NCT05180994|Infliximab|infliximab|mesh-list
5605876|NCT05180994|Dermatologic Agents|dermatologic agents|mesh-ancestor
5605877|NCT05180994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5605878|NCT05180994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5605879|NCT05180968|Dronabinol|dronabinol|mesh-list
5605880|NCT05180968|Nabilone|nabilone|mesh-list
5605881|NCT05180968|Antiemetics|antiemetics|mesh-ancestor
5605882|NCT05180968|Autonomic Agents|autonomic agents|mesh-ancestor
5605883|NCT05180968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5605884|NCT05180968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605885|NCT05180968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5605886|NCT05180968|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5605887|NCT05180968|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5605888|NCT05180968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5605889|NCT05180968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5605890|NCT05180968|Hallucinogens|hallucinogens|mesh-ancestor
5605891|NCT05180968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5605892|NCT05180968|Analgesics|analgesics|mesh-ancestor
5605893|NCT05180968|Sensory System Agents|sensory system agents|mesh-ancestor
5605894|NCT05180968|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5605895|NCT05180968|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5605896|NCT05180968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5605897|NCT05180968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605898|NCT05180968|Hormones|hormones|mesh-ancestor
5605899|NCT05180968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5605900|NCT05180942|Atorvastatin|atorvastatin|mesh-list
5605901|NCT05180942|Calcium|calcium|mesh-list
5605902|NCT05180942|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5605903|NCT05180942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605904|NCT05180942|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5605905|NCT05180942|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5605906|NCT05180942|Antimetabolites|antimetabolites|mesh-ancestor
5593900|NCT03757910|Corticosterone|corticosterone|mesh-list
5593901|NCT03757910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5593902|NCT03757897|Dexmedetomidine|dexmedetomidine|mesh-list
5593903|NCT03757897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5593904|NCT03757897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5593905|NCT03757897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593906|NCT03757897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5593907|NCT03757897|Analgesics|analgesics|mesh-ancestor
5593908|NCT03757897|Sensory System Agents|sensory system agents|mesh-ancestor
5593909|NCT03757897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5593910|NCT03757897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5593911|NCT03757897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5593912|NCT03757897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5593913|NCT03757897|Adrenergic Agents|adrenergic agents|mesh-ancestor
5593914|NCT03757897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5593915|NCT03757897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593916|NCT03757858|Antibodies|antibodies|mesh-list
5593917|NCT03757858|Immunologic Factors|immunologic factors|mesh-ancestor
5593918|NCT03757858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593919|NCT03757650|Amoxicillin|amoxicillin|mesh-list
5593920|NCT03757650|Clarithromycin|clarithromycin|mesh-list
5593921|NCT03757650|Omeprazole|omeprazole|mesh-list
5593922|NCT03757650|Bismuth|bismuth|mesh-list
5593923|NCT03757650|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
5593924|NCT03757650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5593925|NCT03757650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5593926|NCT03757650|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5593927|NCT03757650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5593928|NCT03757650|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5593929|NCT03757650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5593930|NCT03757650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593931|NCT03757650|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5593932|NCT03757650|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5593933|NCT03757650|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5593934|NCT03757650|Antacids|antacids|mesh-ancestor
5593935|NCT03757650|Antidiarrheals|antidiarrheals|mesh-ancestor
5593936|NCT03757585|Inositol|inositol|mesh-list
5593937|NCT03757585|Acetylcysteine|acetylcysteine|mesh-list
5593938|NCT03757585|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5593939|NCT03757585|Antiviral Agents|antiviral agents|mesh-ancestor
5593940|NCT03757585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5593941|NCT03757585|Expectorants|expectorants|mesh-ancestor
5593942|NCT03757585|Respiratory System Agents|respiratory system agents|mesh-ancestor
5593943|NCT03757585|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5593944|NCT03757585|Antioxidants|antioxidants|mesh-ancestor
5593945|NCT03757585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593946|NCT03757585|Protective Agents|protective agents|mesh-ancestor
5593947|NCT03757585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593948|NCT03757585|Antidotes|antidotes|mesh-ancestor
5593949|NCT03757585|Vitamin B Complex|vitamin b complex|mesh-ancestor
5593950|NCT03757585|Vitamins|vitamins|mesh-ancestor
5593951|NCT03757585|Micronutrients|micronutrients|mesh-ancestor
5593952|NCT03757559|Hydromorphone|hydromorphone|mesh-list
5593953|NCT03757559|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5593954|NCT03757559|Narcotics|narcotics|mesh-ancestor
5593955|NCT03757559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5593956|NCT03757559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593957|NCT03757559|Analgesics|analgesics|mesh-ancestor
5593958|NCT03757559|Sensory System Agents|sensory system agents|mesh-ancestor
5593959|NCT03757559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5593960|NCT03757403|Mebendazole|mebendazole|mesh-list
5593961|NCT03757403|Piperazine|piperazine|mesh-list
5593962|NCT03757403|Piperazine citrate|piperazine citrate|mesh-list
5593963|NCT03757403|DMP 777|dmp 777|mesh-list
5593964|NCT03757403|Antinematodal Agents|antinematodal agents|mesh-ancestor
5593965|NCT03757403|Anthelmintics|anthelmintics|mesh-ancestor
5593966|NCT03757403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5593967|NCT03757403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5593968|NCT03757403|Tubulin Modulators|tubulin modulators|mesh-ancestor
5593969|NCT03757403|Antimitotic Agents|antimitotic agents|mesh-ancestor
5593970|NCT03757403|Mitosis Modulators|mitosis modulators|mesh-ancestor
5593971|NCT03757403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593972|NCT03757403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5593973|NCT03757403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5593974|NCT03757390|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
5593975|NCT03757390|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5593976|NCT03757390|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5593977|NCT03757390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5593978|NCT03757390|Antimetabolites|antimetabolites|mesh-ancestor
5593979|NCT03757390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593980|NCT03757390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5593981|NCT03757390|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5593982|NCT03757390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5593983|NCT03757390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5593984|NCT03757364|Methotrexate|methotrexate|mesh-list
5593985|NCT03757364|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5593986|NCT03757364|Abortifacient Agents|abortifacient agents|mesh-ancestor
5593987|NCT03757364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5593988|NCT03757364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5593989|NCT03757364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5593990|NCT03757364|Antimetabolites|antimetabolites|mesh-ancestor
5593991|NCT03757364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5593992|NCT03757364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5593993|NCT03757364|Dermatologic Agents|dermatologic agents|mesh-ancestor
5593994|NCT03757364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5593995|NCT03757364|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5593996|NCT03757364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5593997|NCT03757364|Immunologic Factors|immunologic factors|mesh-ancestor
5593998|NCT03757364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5593999|NCT03757364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5594000|NCT03757338|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
5594001|NCT03757338|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5594002|NCT03757338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594003|NCT03757338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5594004|NCT03757338|Immunologic Factors|immunologic factors|mesh-ancestor
5594005|NCT03757338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594006|NCT03757260|Anti-Infective Agents|anti-infective agents|mesh-list
5594007|NCT03757260|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5594008|NCT03757221|Daratumumab|daratumumab|mesh-list
5594009|NCT03757221|Ixazomib|ixazomib|mesh-list
5594010|NCT03757221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5594011|NCT03757221|Protease Inhibitors|protease inhibitors|mesh-ancestor
5594012|NCT03757221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5594013|NCT03757221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594014|NCT03757156|Aspirin|aspirin|mesh-list
5594015|NCT03757156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5594016|NCT03757156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5594017|NCT03757156|Analgesics|analgesics|mesh-ancestor
5594018|NCT03757156|Sensory System Agents|sensory system agents|mesh-ancestor
5594019|NCT03757156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5594020|NCT03757156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594021|NCT03757156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5594022|NCT03757156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5594023|NCT03757156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5594024|NCT03757156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5594025|NCT03757156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594026|NCT03757156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5594027|NCT03757156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5594028|NCT03757156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5594029|NCT03757156|Antipyretics|antipyretics|mesh-ancestor
5594030|NCT03757143|Ethanol|ethanol|mesh-list
5594031|NCT03757143|Chlorhexidine|chlorhexidine|mesh-list
5594032|NCT03757143|Povidone-Iodine|povidone-iodine|mesh-list
5594033|NCT03757143|Povidone|povidone|mesh-list
5594034|NCT03757143|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5594035|NCT03757143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5594036|NCT03757143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5594037|NCT03757143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594038|NCT03757143|Disinfectants|disinfectants|mesh-ancestor
5594039|NCT03757143|Plasma Substitutes|plasma substitutes|mesh-ancestor
5594040|NCT03757143|Blood Substitutes|blood substitutes|mesh-ancestor
5594041|NCT03757117|Hormones|hormones|mesh-list
5594042|NCT03757117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5594043|NCT03757117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594044|NCT03757052|Amoxicillin|amoxicillin|mesh-list
5594045|NCT03757052|Penicillins|penicillins|mesh-list
5594046|NCT03757052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5594047|NCT03757052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5594048|NCT03756987|Ropivacaine|ropivacaine|mesh-list
5594049|NCT03756987|Anesthetics, Local|anesthetics, local|mesh-ancestor
5594050|NCT03756987|Anesthetics|anesthetics|mesh-ancestor
5594051|NCT03756987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5594052|NCT03756987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594053|NCT03756987|Sensory System Agents|sensory system agents|mesh-ancestor
5594054|NCT03756987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5594055|NCT03756961|Lidocaine|lidocaine|mesh-list
5594056|NCT03756961|Dexmedetomidine|dexmedetomidine|mesh-list
5594057|NCT03756961|Remifentanil|remifentanil|mesh-list
5594058|NCT03756961|Oxycodone|oxycodone|mesh-list
5594059|NCT03756961|Propofol|propofol|mesh-list
5594060|NCT03756961|Desflurane|desflurane|mesh-list
5594061|NCT03756961|Esketamine|esketamine|mesh-list
5594062|NCT03756961|Anesthetics, Local|anesthetics, local|mesh-ancestor
5594063|NCT03756961|Anesthetics|anesthetics|mesh-ancestor
5594064|NCT03756961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5594065|NCT03756961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594066|NCT03756961|Sensory System Agents|sensory system agents|mesh-ancestor
5594067|NCT03756961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5594068|NCT03756961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5594069|NCT03756961|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5594070|NCT03756961|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5594071|NCT03756961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5594072|NCT03756961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594073|NCT03756961|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5594074|NCT03756961|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5594075|NCT03756961|Anesthetics, General|anesthetics, general|mesh-ancestor
5594076|NCT03756961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5594077|NCT03756961|Analgesics|analgesics|mesh-ancestor
5594078|NCT03756961|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5594079|NCT03756961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5594080|NCT03756961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5594081|NCT03756961|Adrenergic Agents|adrenergic agents|mesh-ancestor
5594082|NCT03756961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5594083|NCT03756961|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5594084|NCT03756961|Narcotics|narcotics|mesh-ancestor
5594085|NCT03756961|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5594086|NCT03756961|Antidepressive Agents|antidepressive agents|mesh-ancestor
5594087|NCT03756961|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5594088|NCT03756896|Dexamethasone|dexamethasone|mesh-list
5594089|NCT03756896|Pomalidomide|pomalidomide|mesh-list
5594090|NCT03756896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5594091|NCT03756896|Antiemetics|antiemetics|mesh-ancestor
5594092|NCT03756896|Autonomic Agents|autonomic agents|mesh-ancestor
5594093|NCT03756896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5594094|NCT03756896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594095|NCT03756896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5594096|NCT03756896|Glucocorticoids|glucocorticoids|mesh-ancestor
5594097|NCT03756896|Hormones|hormones|mesh-ancestor
5594098|NCT03756896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5594099|NCT03756896|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5594100|NCT03756896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5594101|NCT03756896|Immunologic Factors|immunologic factors|mesh-ancestor
5594102|NCT03756896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5594103|NCT03756896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5594104|NCT03756896|Growth Substances|growth substances|mesh-ancestor
5594105|NCT03756896|Growth Inhibitors|growth inhibitors|mesh-ancestor
5594106|NCT03756818|Paclitaxel|paclitaxel|mesh-list
5594107|NCT03756818|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5594108|NCT03756818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5594109|NCT03756818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5594110|NCT03756818|Tubulin Modulators|tubulin modulators|mesh-ancestor
5594111|NCT03756818|Antimitotic Agents|antimitotic agents|mesh-ancestor
5594112|NCT03756818|Mitosis Modulators|mitosis modulators|mesh-ancestor
5594113|NCT03756818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594114|NCT03756727|Ascorbic Acid|ascorbic acid|mesh-list
5594115|NCT03756727|Vitamins|vitamins|mesh-ancestor
5594116|NCT03756727|Micronutrients|micronutrients|mesh-ancestor
5594117|NCT03756727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594118|NCT03756727|Antioxidants|antioxidants|mesh-ancestor
5594119|NCT03756727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594120|NCT03756727|Protective Agents|protective agents|mesh-ancestor
5594121|NCT03756623|Metformin|metformin|mesh-list
5594122|NCT03756623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5594123|NCT03756623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594124|NCT03756324|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5594125|NCT03756324|Cefdinir|cefdinir|mesh-list
5594126|NCT03756324|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5594127|NCT03756324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5594128|NCT03756324|Antitubercular Agents|antitubercular agents|mesh-ancestor
5594129|NCT03756311|Paclitaxel|paclitaxel|mesh-list
5594130|NCT03756311|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5594131|NCT03756311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5594132|NCT03756311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5594133|NCT03756311|Tubulin Modulators|tubulin modulators|mesh-ancestor
5594134|NCT03756311|Antimitotic Agents|antimitotic agents|mesh-ancestor
5594135|NCT03756311|Mitosis Modulators|mitosis modulators|mesh-ancestor
5594136|NCT03756311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594137|NCT03756298|Capecitabine|capecitabine|mesh-list
5594138|NCT03756298|Atezolizumab|atezolizumab|mesh-list
5594139|NCT03756298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5594140|NCT03756298|Antimetabolites|antimetabolites|mesh-ancestor
5594141|NCT03756298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594142|NCT03756298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5594143|NCT03756272|Bupivacaine|bupivacaine|mesh-list
5594144|NCT03756272|Anesthetics, Local|anesthetics, local|mesh-ancestor
5594145|NCT03756272|Anesthetics|anesthetics|mesh-ancestor
5594146|NCT03756272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5594147|NCT03756272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594148|NCT03756272|Sensory System Agents|sensory system agents|mesh-ancestor
5594149|NCT03756272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5594150|NCT03756246|Vaccines|vaccines|mesh-list
5594151|NCT03756246|Immunologic Factors|immunologic factors|mesh-ancestor
5594152|NCT03756246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594153|NCT03756233|Remifentanil|remifentanil|mesh-list
5594154|NCT03756233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5594155|NCT03756233|Narcotics|narcotics|mesh-ancestor
5594156|NCT03756233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5594157|NCT03756233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594158|NCT03756233|Analgesics|analgesics|mesh-ancestor
5594159|NCT03756233|Sensory System Agents|sensory system agents|mesh-ancestor
5594160|NCT03756233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5594161|NCT03756220|Ascorbic Acid|ascorbic acid|mesh-list
5594162|NCT03756220|Thiamine|thiamine|mesh-list
5594163|NCT03756220|Vitamins|vitamins|mesh-ancestor
5594164|NCT03756220|Micronutrients|micronutrients|mesh-ancestor
5594165|NCT03756220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594166|NCT03756220|Antioxidants|antioxidants|mesh-ancestor
5594167|NCT03756220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594168|NCT03756220|Protective Agents|protective agents|mesh-ancestor
5594169|NCT03756220|Vitamin B Complex|vitamin b complex|mesh-ancestor
5594170|NCT03756194|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5605907|NCT05180942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605908|NCT05180942|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5605909|NCT05180942|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5605910|NCT05180942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5605911|NCT05180825|Trametinib|trametinib|mesh-list
5605912|NCT05180825|Vinblastine|vinblastine|mesh-list
5605913|NCT05180825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605914|NCT05180825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5605915|NCT05180825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5605916|NCT05180825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605917|NCT05180825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5605918|NCT05180825|Tubulin Modulators|tubulin modulators|mesh-ancestor
5605919|NCT05180825|Antimitotic Agents|antimitotic agents|mesh-ancestor
5605920|NCT05180825|Mitosis Modulators|mitosis modulators|mesh-ancestor
5605921|NCT05180799|Nivolumab|nivolumab|mesh-list
5605922|NCT05180799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5605923|NCT05180799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605924|NCT05180799|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5605925|NCT05180799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605926|NCT05180708|Sirolimus|sirolimus|mesh-list
5605927|NCT05180708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5605928|NCT05180708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5605929|NCT05180708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5605930|NCT05180708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605931|NCT05180708|Antifungal Agents|antifungal agents|mesh-ancestor
5605932|NCT05180708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5605933|NCT05180708|Immunologic Factors|immunologic factors|mesh-ancestor
5605934|NCT05180708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605935|NCT05180474|Antibodies|antibodies|mesh-list
5605936|NCT05180474|Antibodies, Bispecific|antibodies, bispecific|mesh-list
5605937|NCT05180474|Immunologic Factors|immunologic factors|mesh-ancestor
5605938|NCT05180474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605939|NCT05180461|Ivermectin|ivermectin|mesh-list
5605940|NCT05180461|Emodepside|emodepside|mesh-list
5594171|NCT03756116|Epinephrine|epinephrine|mesh-list
5594172|NCT03756116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5594173|NCT03756116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5594174|NCT03756116|Adrenergic Agents|adrenergic agents|mesh-ancestor
5594175|NCT03756116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5594176|NCT03756116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594177|NCT03756116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594178|NCT03756116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5594179|NCT03756116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5594180|NCT03756116|Autonomic Agents|autonomic agents|mesh-ancestor
5594181|NCT03756116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5594182|NCT03756116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5594183|NCT03756116|Respiratory System Agents|respiratory system agents|mesh-ancestor
5594184|NCT03756116|Mydriatics|mydriatics|mesh-ancestor
5594185|NCT03756116|Sympathomimetics|sympathomimetics|mesh-ancestor
5594186|NCT03756116|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5594187|NCT03756090|Paclitaxel|paclitaxel|mesh-list
5594188|NCT03756090|Cyclophosphamide|cyclophosphamide|mesh-list
5594189|NCT03756090|Epirubicin|epirubicin|mesh-list
5594190|NCT03756090|Palbociclib|palbociclib|mesh-list
5594191|NCT03756090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5594192|NCT03756090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5594193|NCT03756090|Tubulin Modulators|tubulin modulators|mesh-ancestor
5594194|NCT03756090|Antimitotic Agents|antimitotic agents|mesh-ancestor
5594195|NCT03756090|Mitosis Modulators|mitosis modulators|mesh-ancestor
5594196|NCT03756090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594197|NCT03756090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5594198|NCT03756090|Immunologic Factors|immunologic factors|mesh-ancestor
5594199|NCT03756090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594200|NCT03756090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5594201|NCT03756090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5594202|NCT03756090|Alkylating Agents|alkylating agents|mesh-ancestor
5594203|NCT03756090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5594204|NCT03756090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5594205|NCT03756090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5594206|NCT03756090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5594207|NCT03756090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5594208|NCT03756090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5594209|NCT03756077|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5594210|NCT03756077|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5594211|NCT03756077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594212|NCT03756064|Carboplatin|carboplatin|mesh-list
5594213|NCT03756064|Docetaxel|docetaxel|mesh-list
5594214|NCT03756064|Trastuzumab|trastuzumab|mesh-list
5594215|NCT03756064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5594216|NCT03756064|Tubulin Modulators|tubulin modulators|mesh-ancestor
5594217|NCT03756064|Antimitotic Agents|antimitotic agents|mesh-ancestor
5594218|NCT03756064|Mitosis Modulators|mitosis modulators|mesh-ancestor
5594219|NCT03756064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594220|NCT03756064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5594221|NCT03755973|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5594222|NCT03755973|Hormones|hormones|mesh-ancestor
5594223|NCT03755973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5594224|NCT03755973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594225|NCT03755947|Venetoclax|venetoclax|mesh-list
5594226|NCT03755947|Obinutuzumab|obinutuzumab|mesh-list
5594227|NCT03755947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5594228|NCT03755947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6201829|NCT02031640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6201830|NCT02031640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201831|NCT02031640|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6201832|NCT02031640|Respiratory System Agents|respiratory system agents|mesh-ancestor
6201833|NCT02031640|Tocolytic Agents|tocolytic agents|mesh-ancestor
6201834|NCT02031640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6201835|NCT02031640|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6201836|NCT02031640|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6201837|NCT02031640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6201838|NCT02031640|Adrenergic Agents|adrenergic agents|mesh-ancestor
6201839|NCT02031640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6201840|NCT02031640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201841|NCT02031640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6201842|NCT02031640|Glucocorticoids|glucocorticoids|mesh-ancestor
6201843|NCT02031640|Hormones|hormones|mesh-ancestor
6201844|NCT02031640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6201845|NCT02032173|Ranibizumab|ranibizumab|mesh-list
6201846|NCT02032173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6201847|NCT02032173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6201848|NCT02032173|Growth Substances|growth substances|mesh-ancestor
6201849|NCT02032173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201850|NCT02032173|Growth Inhibitors|growth inhibitors|mesh-ancestor
6201851|NCT02032173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6201852|NCT02032212|Nicotine|nicotine|mesh-list
6201853|NCT02032212|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6201854|NCT02032212|Autonomic Agents|autonomic agents|mesh-ancestor
6201855|NCT02032212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6201856|NCT02032212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201857|NCT02032212|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6201858|NCT02032212|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6201859|NCT02032212|Cholinergic Agents|cholinergic agents|mesh-ancestor
6201860|NCT02032212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5594264|NCT03755791|Sorafenib|sorafenib|mesh-list
5594265|NCT03755791|Atezolizumab|atezolizumab|mesh-list
5594266|NCT03755791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5594267|NCT03755791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5594268|NCT03755791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5594269|NCT03755791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594270|NCT03755778|Itraconazole|itraconazole|mesh-list
5594271|NCT03755778|Rifampin|rifampin|mesh-list
5594272|NCT03755778|Quinidine|quinidine|mesh-list
5594273|NCT03755778|Antifungal Agents|antifungal agents|mesh-ancestor
5594274|NCT03755778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5594275|NCT03755778|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5594276|NCT03755778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5594277|NCT03755778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5594278|NCT03755778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594279|NCT03755778|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5594280|NCT03755778|Hormone Antagonists|hormone antagonists|mesh-ancestor
5594281|NCT03755778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5594282|NCT03755778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594283|NCT03755778|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5594284|NCT03755778|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5594285|NCT03755778|Antitubercular Agents|antitubercular agents|mesh-ancestor
5594286|NCT03755778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5594287|NCT03755778|Leprostatic Agents|leprostatic agents|mesh-ancestor
5594288|NCT03755778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5594289|NCT03755778|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5594290|NCT03755778|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5594291|NCT03755778|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5594292|NCT03755778|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5594293|NCT03755778|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5594294|NCT03755778|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5594295|NCT03755778|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5594296|NCT03755778|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5594297|NCT03755778|Adrenergic Agents|adrenergic agents|mesh-ancestor
5594298|NCT03755778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5594299|NCT03755778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5594300|NCT03755778|Antimalarials|antimalarials|mesh-ancestor
5594301|NCT03755778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5594302|NCT03755778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5594303|NCT03755778|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5594304|NCT03755778|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5594305|NCT03755778|Cholinergic Agents|cholinergic agents|mesh-ancestor
5594306|NCT03755778|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5594307|NCT03755778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5594308|NCT03755778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5594309|NCT03755778|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5594310|NCT03755765|Amoxicillin|amoxicillin|mesh-list
5594311|NCT03755765|Clavulanic Acid|clavulanic acid|mesh-list
5594312|NCT03755765|Clavulanic Acids|clavulanic acids|mesh-list
5594313|NCT03755765|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5594314|NCT03755765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5594315|NCT03755765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5594316|NCT03755765|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5594317|NCT03755765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5594318|NCT03755765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594319|NCT03755752|Diminazene aceturate|diminazene aceturate|mesh-list
6207709|NCT02119468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594320|NCT03755752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5594321|NCT03755752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5594322|NCT03755752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5594323|NCT03755752|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5594324|NCT03755739|Pembrolizumab|pembrolizumab|mesh-list
5594325|NCT03755739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5594326|NCT03755739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5594327|NCT03755700|Vitamin E|vitamin e|mesh-list
5594328|NCT03755700|Acetylcysteine|acetylcysteine|mesh-list
5594329|NCT03755700|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5594330|NCT03755700|Vitamins|vitamins|mesh-ancestor
5594331|NCT03755700|Micronutrients|micronutrients|mesh-ancestor
5594332|NCT03755700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594333|NCT03755700|Antioxidants|antioxidants|mesh-ancestor
5594334|NCT03755700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594335|NCT03755700|Protective Agents|protective agents|mesh-ancestor
5594336|NCT03755700|Antiviral Agents|antiviral agents|mesh-ancestor
5594337|NCT03755700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5594338|NCT03755700|Expectorants|expectorants|mesh-ancestor
5594339|NCT03755700|Respiratory System Agents|respiratory system agents|mesh-ancestor
5594340|NCT03755700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5594341|NCT03755700|Antidotes|antidotes|mesh-ancestor
5594342|NCT03755609|Fentanyl|fentanyl|mesh-list
5594343|NCT03755609|Oxycodone|oxycodone|mesh-list
5594344|NCT03755609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5594345|NCT03755609|Narcotics|narcotics|mesh-ancestor
5594346|NCT03755609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5594347|NCT03755609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594348|NCT03755609|Analgesics|analgesics|mesh-ancestor
5594349|NCT03755609|Sensory System Agents|sensory system agents|mesh-ancestor
5594350|NCT03755609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5594351|NCT03755609|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5594352|NCT03755609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5594353|NCT03755609|Anesthetics, General|anesthetics, general|mesh-ancestor
5594354|NCT03755609|Anesthetics|anesthetics|mesh-ancestor
5594355|NCT03755557|Budesonide|budesonide|mesh-list
5594356|NCT03755557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5594357|NCT03755557|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5594358|NCT03755557|Autonomic Agents|autonomic agents|mesh-ancestor
5594359|NCT03755557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5594360|NCT03755557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594361|NCT03755557|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5594362|NCT03755557|Respiratory System Agents|respiratory system agents|mesh-ancestor
5594363|NCT03755557|Glucocorticoids|glucocorticoids|mesh-ancestor
5594364|NCT03755557|Hormones|hormones|mesh-ancestor
5594365|NCT03755557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5594366|NCT03755531|Oxytocin|oxytocin|mesh-list
5594367|NCT03755531|Carbetocin|carbetocin|mesh-list
5594368|NCT03755531|Oxytocics|oxytocics|mesh-ancestor
5594369|NCT03755531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5594370|NCT03755531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594371|NCT03755479|Insulin|insulin|mesh-list
5594372|NCT03755479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5594373|NCT03755479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594374|NCT03755466|Tofacitinib|tofacitinib|mesh-list
5594375|NCT03755466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5594376|NCT03755466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5594377|NCT03755466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594378|NCT03755440|Antibodies|antibodies|mesh-list
5594379|NCT03755440|Immunologic Factors|immunologic factors|mesh-ancestor
5594380|NCT03755440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594381|NCT03755427|Aluminum Hydroxide|aluminum hydroxide|mesh-list
5594382|NCT03755427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5594383|NCT03755427|Immunologic Factors|immunologic factors|mesh-ancestor
5594384|NCT03755427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594385|NCT03755427|Antacids|antacids|mesh-ancestor
5594386|NCT03755427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594387|NCT03755427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5594388|NCT03755310|Suvorexant|suvorexant|mesh-list
5594389|NCT03755310|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5594390|NCT03755310|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5594391|NCT03755310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5594392|NCT03755310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594393|NCT03755310|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
5594394|NCT03755310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5594395|NCT03755310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594396|NCT03755193|Diphosphonates|diphosphonates|mesh-list
5594397|NCT03755193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5594398|NCT03755193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594399|NCT03755115|Epirubicin|epirubicin|mesh-list
5594400|NCT03755115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5594401|NCT03755115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5594402|NCT03755115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5594403|NCT03755115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5594404|NCT03755115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5594405|NCT03755115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594406|NCT03755102|Osimertinib|osimertinib|mesh-list
5594407|NCT03755102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5594408|NCT03755102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5594409|NCT03755102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5594410|NCT03755102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594411|NCT03755089|Lidocaine|lidocaine|mesh-list
5594412|NCT03755089|Anesthetics, Local|anesthetics, local|mesh-ancestor
5594413|NCT03755089|Anesthetics|anesthetics|mesh-ancestor
5594414|NCT03755089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5594415|NCT03755089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594416|NCT03755089|Sensory System Agents|sensory system agents|mesh-ancestor
5594417|NCT03755089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5594418|NCT03755089|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5594419|NCT03755089|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5594420|NCT03755089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5594421|NCT03755089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5594422|NCT03755089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594423|NCT03755037|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5594424|NCT03755037|Estradiol|estradiol|mesh-list
5594425|NCT03755037|Estrogens|estrogens|mesh-ancestor
5594426|NCT03755037|Hormones|hormones|mesh-ancestor
5594427|NCT03755037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5594428|NCT03755037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594429|NCT03755037|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5594430|NCT03755037|Contraceptive Agents|contraceptive agents|mesh-ancestor
5594431|NCT03755037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5594432|NCT03755037|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5594433|NCT03755037|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5594434|NCT03755037|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5594435|NCT03754959|Midazolam|midazolam|mesh-list
5594436|NCT03754959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5594437|NCT03754959|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5594438|NCT03754959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5594439|NCT03754959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594440|NCT03754959|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5594441|NCT03754959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5594442|NCT03754959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5594443|NCT03754959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5594444|NCT03754959|Anesthetics, General|anesthetics, general|mesh-ancestor
5594445|NCT03754959|Anesthetics|anesthetics|mesh-ancestor
5594446|NCT03754959|GABA Modulators|gaba modulators|mesh-ancestor
5594447|NCT03754959|GABA Agents|gaba agents|mesh-ancestor
5594448|NCT03754959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5594449|NCT03754959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594450|NCT03754933|Fludarabine|fludarabine|mesh-list
5594451|NCT03754933|Fludarabine phosphate|fludarabine phosphate|mesh-list
5594452|NCT03754933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5594453|NCT03754933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5594454|NCT03754933|Antimetabolites|antimetabolites|mesh-ancestor
5594455|NCT03754933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594456|NCT03754933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5594457|NCT03754933|Immunologic Factors|immunologic factors|mesh-ancestor
5594458|NCT03754933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594459|NCT03754842|Niacinamide|niacinamide|mesh-list
5594460|NCT03754842|Niacin|niacin|mesh-list
5594461|NCT03754842|Nicotinic Acids|nicotinic acids|mesh-list
5594462|NCT03754842|Vitamin B Complex|vitamin b complex|mesh-ancestor
5594463|NCT03754842|Vitamins|vitamins|mesh-ancestor
5594464|NCT03754842|Micronutrients|micronutrients|mesh-ancestor
5594465|NCT03754842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594466|NCT03754842|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5594467|NCT03754842|Antimetabolites|antimetabolites|mesh-ancestor
5594468|NCT03754842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594469|NCT03754842|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5594470|NCT03754842|Vasodilator Agents|vasodilator agents|mesh-ancestor
5594471|NCT03754816|Anesthetics|anesthetics|mesh-list
5594472|NCT03754816|Levobupivacaine|levobupivacaine|mesh-list
5594473|NCT03754816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5594474|NCT03754816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594475|NCT03754816|Anesthetics, Local|anesthetics, local|mesh-ancestor
5594476|NCT03754816|Sensory System Agents|sensory system agents|mesh-ancestor
5594477|NCT03754816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5594478|NCT03754725|Deferiprone|deferiprone|mesh-list
5594479|NCT03754725|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5594480|NCT03754725|Chelating Agents|chelating agents|mesh-ancestor
5594481|NCT03754725|Sequestering Agents|sequestering agents|mesh-ancestor
5594482|NCT03754725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594483|NCT03754712|Vitamin D|vitamin d|mesh-list
5594484|NCT03754712|Cholecalciferol|cholecalciferol|mesh-list
5594485|NCT03754712|Vitamins|vitamins|mesh-ancestor
5594486|NCT03754712|Micronutrients|micronutrients|mesh-ancestor
5594487|NCT03754712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594488|NCT03754712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5594489|NCT03754712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5594490|NCT03754686|Acetaminophen|acetaminophen|mesh-list
5594491|NCT03754686|Oseltamivir|oseltamivir|mesh-list
5594492|NCT03754686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5594493|NCT03754686|Analgesics|analgesics|mesh-ancestor
5594494|NCT03754686|Sensory System Agents|sensory system agents|mesh-ancestor
5594495|NCT03754686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5594496|NCT03754686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594497|NCT03754686|Antipyretics|antipyretics|mesh-ancestor
5594498|NCT03754686|Antiviral Agents|antiviral agents|mesh-ancestor
5594499|NCT03754686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5594500|NCT03754686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5594501|NCT03754686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594502|NCT03754647|Ascorbic Acid|ascorbic acid|mesh-list
5594503|NCT03754647|Vitamins|vitamins|mesh-ancestor
5594504|NCT03754647|Micronutrients|micronutrients|mesh-ancestor
5594505|NCT03754647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594506|NCT03754647|Antioxidants|antioxidants|mesh-ancestor
5594507|NCT03754647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594508|NCT03754647|Protective Agents|protective agents|mesh-ancestor
5594509|NCT03754634|Diacetylrhein|diacetylrhein|mesh-list
5594510|NCT03754634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5605941|NCT05180461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5605942|NCT05180461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5605943|NCT05180318|Ketamine|ketamine|mesh-list
5605944|NCT05180318|Esketamine|esketamine|mesh-list
5605945|NCT05180318|Analgesics|analgesics|mesh-ancestor
5605946|NCT05180318|Sensory System Agents|sensory system agents|mesh-ancestor
5605947|NCT05180318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5605948|NCT05180318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605949|NCT05180318|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5605950|NCT05180318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5605951|NCT05180318|Anesthetics, General|anesthetics, general|mesh-ancestor
5605952|NCT05180318|Anesthetics|anesthetics|mesh-ancestor
5605953|NCT05180318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5605954|NCT05180318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5605955|NCT05180318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5605956|NCT05180318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5605957|NCT05180318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605958|NCT05180318|Antidepressive Agents|antidepressive agents|mesh-ancestor
5605959|NCT05180318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5605960|NCT05180240|Cannabidiol|cannabidiol|mesh-list
5605961|NCT05180240|Anticonvulsants|anticonvulsants|mesh-ancestor
5605962|NCT05180006|Bevacizumab|bevacizumab|mesh-list
5605963|NCT05180006|Trastuzumab|trastuzumab|mesh-list
5605964|NCT05180006|Pertuzumab|pertuzumab|mesh-list
5605965|NCT05180006|Atezolizumab|atezolizumab|mesh-list
5605966|NCT05180006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5605967|NCT05180006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605968|NCT05180006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5605969|NCT05180006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5605970|NCT05180006|Growth Substances|growth substances|mesh-ancestor
5605971|NCT05180006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605972|NCT05180006|Growth Inhibitors|growth inhibitors|mesh-ancestor
5605973|NCT05173298|Bevacizumab|bevacizumab|mesh-list
5605974|NCT05173298|Atezolizumab|atezolizumab|mesh-list
5605975|NCT05173298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5605976|NCT05173298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605977|NCT05173298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5605978|NCT05173298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5605979|NCT05173298|Growth Substances|growth substances|mesh-ancestor
5594511|NCT03754543|Iron|iron|mesh-list
5594512|NCT03754543|Trace Elements|trace elements|mesh-ancestor
5594513|NCT03754543|Micronutrients|micronutrients|mesh-ancestor
5594514|NCT03754543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594515|NCT03754387|Ceftazidime|ceftazidime|mesh-list
5594516|NCT03754387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5594517|NCT03754387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5594518|NCT03754179|Hydroxychloroquine|hydroxychloroquine|mesh-list
5594519|NCT03754179|Trametinib|trametinib|mesh-list
5594520|NCT03754179|Dabrafenib|dabrafenib|mesh-list
5594521|NCT03754179|Antimalarials|antimalarials|mesh-ancestor
5594522|NCT03754179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5594523|NCT03754179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5594524|NCT03754179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5594525|NCT03754179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5594526|NCT03754179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594527|NCT03754179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5594528|NCT03754179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5594529|NCT03754179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5594530|NCT03754140|Polidocanol|polidocanol|mesh-list
5594531|NCT03754140|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
5594532|NCT03754140|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5594533|NCT03754062|Haloperidol|haloperidol|mesh-list
5594534|NCT03754062|Haloperidol decanoate|haloperidol decanoate|mesh-list
5594535|NCT03754062|Antiemetics|antiemetics|mesh-ancestor
5594536|NCT03754062|Autonomic Agents|autonomic agents|mesh-ancestor
5594537|NCT03754062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5594538|NCT03754062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594539|NCT03754062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5594540|NCT03754062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5594541|NCT03754062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5594542|NCT03754062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5594543|NCT03754062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5594544|NCT03754062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5594545|NCT03754062|Dopamine Agents|dopamine agents|mesh-ancestor
5594546|NCT03754062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5594547|NCT03754062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594548|NCT03754062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5594549|NCT03754049|Dexamethasone|dexamethasone|mesh-list
5594550|NCT03754049|Dexamethasone acetate|dexamethasone acetate|mesh-list
5594551|NCT03754049|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
5594552|NCT03754049|BB 1101|bb 1101|mesh-list
5594553|NCT03754049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5594554|NCT03754049|Antiemetics|antiemetics|mesh-ancestor
5594555|NCT03754049|Autonomic Agents|autonomic agents|mesh-ancestor
5594556|NCT03754049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5594557|NCT03754049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594558|NCT03754049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5594559|NCT03754049|Glucocorticoids|glucocorticoids|mesh-ancestor
5594560|NCT03754049|Hormones|hormones|mesh-ancestor
5594561|NCT03754049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5594562|NCT03754049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5594563|NCT03754049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5594564|NCT03754049|Protease Inhibitors|protease inhibitors|mesh-ancestor
5594565|NCT03754049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5594566|NCT03754049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594567|NCT03754010|Hyaluronic Acid|hyaluronic acid|mesh-list
5594568|NCT03754010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5594569|NCT03754010|Immunologic Factors|immunologic factors|mesh-ancestor
5594570|NCT03754010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594571|NCT03754010|Viscosupplements|viscosupplements|mesh-ancestor
5594572|NCT03754010|Protective Agents|protective agents|mesh-ancestor
5594573|NCT03753867|Acitretin|acitretin|mesh-list
5594574|NCT03753867|Keratolytic Agents|keratolytic agents|mesh-ancestor
5594575|NCT03753867|Dermatologic Agents|dermatologic agents|mesh-ancestor
5594576|NCT03753685|Ensartinib|ensartinib|mesh-list
5594577|NCT03753685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5594578|NCT03753685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5594579|NCT03753685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5594580|NCT03753685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594581|NCT03753659|Pembrolizumab|pembrolizumab|mesh-list
5594582|NCT03753659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5594583|NCT03753659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5594584|NCT03753581|Cytarabine|cytarabine|mesh-list
5594585|NCT03753581|Methotrexate|methotrexate|mesh-list
5594586|NCT03753581|Etoposide|etoposide|mesh-list
5594587|NCT03753581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5594588|NCT03753581|Antimetabolites|antimetabolites|mesh-ancestor
5606939|NCT03303339|Cytarabine|cytarabine|mesh-list
5594589|NCT03753581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594590|NCT03753581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5594591|NCT03753581|Antiviral Agents|antiviral agents|mesh-ancestor
5594592|NCT03753581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5594593|NCT03753581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5594594|NCT03753581|Immunologic Factors|immunologic factors|mesh-ancestor
5594595|NCT03753581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594596|NCT03753581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5594597|NCT03753581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5594598|NCT03753581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5594599|NCT03753581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5594600|NCT03753581|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5594601|NCT03753581|Abortifacient Agents|abortifacient agents|mesh-ancestor
5594602|NCT03753581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5594603|NCT03753581|Dermatologic Agents|dermatologic agents|mesh-ancestor
5594604|NCT03753581|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5594605|NCT03753581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5594606|NCT03753581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5594607|NCT03753477|Amlodipine|amlodipine|mesh-list
5594608|NCT03753477|Olmesartan|olmesartan|mesh-list
5594609|NCT03753477|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
5594610|NCT03753477|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
5594611|NCT03753477|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5594612|NCT03753477|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5594613|NCT03753477|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5594614|NCT03753477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5594615|NCT03753477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594616|NCT03753477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5594617|NCT03753477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594618|NCT03753477|Vasodilator Agents|vasodilator agents|mesh-ancestor
5594619|NCT03753477|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5594620|NCT03753477|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5594621|NCT03753477|Antimetabolites|antimetabolites|mesh-ancestor
5594622|NCT03753477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5594623|NCT03753477|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5594624|NCT03753477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5594625|NCT03753477|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5594626|NCT03753477|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5594627|NCT03753269|Fasudil|fasudil|mesh-list
5594628|NCT03753269|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5594629|NCT03753269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5594630|NCT03753269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594631|NCT03753269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5594632|NCT03753269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594633|NCT03753269|Vasodilator Agents|vasodilator agents|mesh-ancestor
5594634|NCT03753269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5594635|NCT03753269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5594636|NCT03753243|Pembrolizumab|pembrolizumab|mesh-list
5594637|NCT03753243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5594638|NCT03753243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5605980|NCT05173298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605981|NCT05173298|Growth Inhibitors|growth inhibitors|mesh-ancestor
5605982|NCT05156814|Dydrogesterone|dydrogesterone|mesh-list
5605983|NCT05156814|Progestins|progestins|mesh-ancestor
5605984|NCT05156814|Hormones|hormones|mesh-ancestor
5605985|NCT05156814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5605986|NCT05156814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605987|NCT05154734|Belimumab|belimumab|mesh-list
5605988|NCT05154734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5605989|NCT05154734|Immunologic Factors|immunologic factors|mesh-ancestor
5605990|NCT05154734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5605991|NCT05152888|Evolocumab|evolocumab|mesh-list
5605992|NCT05152888|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5605993|NCT05152888|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5605994|NCT05152888|Antimetabolites|antimetabolites|mesh-ancestor
5605995|NCT05152888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5605996|NCT05152888|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5605997|NCT05152017|Vaccines|vaccines|mesh-list
5605998|NCT05152017|Immunologic Factors|immunologic factors|mesh-ancestor
5605999|NCT05152017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606000|NCT05142735|Acetylcysteine|acetylcysteine|mesh-list
5606001|NCT05142735|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5606002|NCT05142735|Antiviral Agents|antiviral agents|mesh-ancestor
5594639|NCT03752931|Celiprolol|celiprolol|mesh-list
5594640|NCT03752931|Diltiazem|diltiazem|mesh-list
5594641|NCT03752931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5594642|NCT03752931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5594643|NCT03752931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5594644|NCT03752931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594645|NCT03752931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5594646|NCT03752931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594647|NCT03752931|Vasodilator Agents|vasodilator agents|mesh-ancestor
5594648|NCT03752931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5594649|NCT03752931|Sympathomimetics|sympathomimetics|mesh-ancestor
5594650|NCT03752931|Autonomic Agents|autonomic agents|mesh-ancestor
5594651|NCT03752931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5594652|NCT03752931|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5594653|NCT03752931|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5594654|NCT03752931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5594655|NCT03752931|Adrenergic Agents|adrenergic agents|mesh-ancestor
5594656|NCT03752931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5594657|NCT03752749|Prednisolone|prednisolone|mesh-list
5594658|NCT03752749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5594659|NCT03752749|Glucocorticoids|glucocorticoids|mesh-ancestor
5594660|NCT03752749|Hormones|hormones|mesh-ancestor
5594661|NCT03752749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5594662|NCT03752749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594663|NCT03752749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5594664|NCT03752749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5594665|NCT03752736|Sunscreening Agents|sunscreening agents|mesh-list
5594666|NCT03752736|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5594667|NCT03752736|Protective Agents|protective agents|mesh-ancestor
5594668|NCT03752736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594669|NCT03752736|Dermatologic Agents|dermatologic agents|mesh-ancestor
5594670|NCT03752723|Cyclophosphamide|cyclophosphamide|mesh-list
5594671|NCT03752723|Pembrolizumab|pembrolizumab|mesh-list
5594672|NCT03752723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5594673|NCT03752723|Immunologic Factors|immunologic factors|mesh-ancestor
5594674|NCT03752723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594675|NCT03752723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5594676|NCT03752723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5594677|NCT03752723|Alkylating Agents|alkylating agents|mesh-ancestor
5594678|NCT03752723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594679|NCT03752723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5594680|NCT03752723|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5594681|NCT03752723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5594682|NCT03752658|Tenofovir|tenofovir|mesh-list
5594683|NCT03752658|Antiviral Agents|antiviral agents|mesh-ancestor
5594684|NCT03752658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5594685|NCT03752658|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5594686|NCT03752658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5594687|NCT03752658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5594688|NCT03752658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594689|NCT03752658|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5594690|NCT03752658|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5594691|NCT03752476|Lactams|lactams|mesh-list
5594692|NCT03752476|beta-Lactams|beta-lactams|mesh-list
5594693|NCT03752476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5594694|NCT03752476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5594695|NCT03752437|Heparin|heparin|mesh-list
5594696|NCT03752437|Anticoagulants|anticoagulants|mesh-ancestor
5594697|NCT03752437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5594698|NCT03752437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5594699|NCT03752437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594700|NCT03752424|Anti-Infective Agents|anti-infective agents|mesh-list
5594701|NCT03752424|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5594702|NCT03752398|Ipilimumab|ipilimumab|mesh-list
5594703|NCT03752398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5594704|NCT03752398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5594705|NCT03752398|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5594706|NCT03752398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594707|NCT03752333|Pembrolizumab|pembrolizumab|mesh-list
5594708|NCT03752333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5594709|NCT03752333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5594710|NCT03752294|Dabigatran|dabigatran|mesh-list
5594711|NCT03752294|Antithrombins|antithrombins|mesh-ancestor
5594712|NCT03752294|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5594713|NCT03752294|Protease Inhibitors|protease inhibitors|mesh-ancestor
5594714|NCT03752294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5594715|NCT03752294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594716|NCT03752294|Anticoagulants|anticoagulants|mesh-ancestor
5594717|NCT03752229|Diazepam|diazepam|mesh-list
5594718|NCT03752229|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5594719|NCT03752229|Anticonvulsants|anticonvulsants|mesh-ancestor
5594720|NCT03752229|Antiemetics|antiemetics|mesh-ancestor
5594721|NCT03752229|Autonomic Agents|autonomic agents|mesh-ancestor
5594722|NCT03752229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5594723|NCT03752229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594724|NCT03752229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5594725|NCT03752229|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5594726|NCT03752229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5594727|NCT03752229|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5594728|NCT03752229|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5594729|NCT03752229|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5594730|NCT03752229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5594731|NCT03752229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5594732|NCT03752229|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5594733|NCT03752229|Anesthetics, General|anesthetics, general|mesh-ancestor
5594734|NCT03752229|Anesthetics|anesthetics|mesh-ancestor
5594735|NCT03752229|GABA Modulators|gaba modulators|mesh-ancestor
5594736|NCT03752229|GABA Agents|gaba agents|mesh-ancestor
5594737|NCT03752229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5594738|NCT03752229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594739|NCT03752216|Niraparib|niraparib|mesh-list
5594740|NCT03752216|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5594741|NCT03752216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5594742|NCT03752216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594743|NCT03752216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5594744|NCT03752190|Cosyntropin|cosyntropin|mesh-list
5594745|NCT03752190|Hormones|hormones|mesh-ancestor
5594746|NCT03752190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5594747|NCT03752190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594748|NCT03752138|Decitabine|decitabine|mesh-list
5594749|NCT03752138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5594750|NCT03752138|Antimetabolites|antimetabolites|mesh-ancestor
5594751|NCT03752138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594752|NCT03752138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5594753|NCT03752138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5594754|NCT03752125|Caffeine|caffeine|mesh-list
5594755|NCT03752125|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5594756|NCT03752125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594757|NCT03752125|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5594758|NCT03752125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5594759|NCT03752125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594760|NCT03752125|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5594761|NCT03752125|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5594762|NCT03752125|Purinergic Agents|purinergic agents|mesh-ancestor
5594763|NCT03752125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5594764|NCT03752112|Penicillins|penicillins|mesh-list
5594765|NCT03752112|Cefixime|cefixime|mesh-list
5594766|NCT03752112|Penicillin G Benzathine|penicillin g benzathine|mesh-list
5594767|NCT03752112|Penicillin G|penicillin g|mesh-list
5594768|NCT03752112|Penicillin G Procaine|penicillin g procaine|mesh-list
5594769|NCT03752112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5594770|NCT03752112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5594771|NCT03751917|Arsenic Trioxide|arsenic trioxide|mesh-list
5594772|NCT03751917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5594773|NCT03751800|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
5594774|NCT03751800|Dienogest|dienogest|mesh-list
5594775|NCT03751800|Levonorgestrel|levonorgestrel|mesh-list
5594776|NCT03751800|Medroxyprogesterone|medroxyprogesterone|mesh-list
5594777|NCT03751800|Estradiol|estradiol|mesh-list
5594778|NCT03751800|Estrogens|estrogens|mesh-ancestor
5594779|NCT03751800|Hormones|hormones|mesh-ancestor
5594780|NCT03751800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5594781|NCT03751800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594782|NCT03751800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5594783|NCT03751800|Contraceptive Agents|contraceptive agents|mesh-ancestor
5594784|NCT03751800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5594785|NCT03751800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6672408|NCT01555879|Abatacept|abatacept|mesh-list
5594786|NCT03751800|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5594787|NCT03751800|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5594788|NCT03751800|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5594789|NCT03751800|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5594790|NCT03751800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5594791|NCT03751800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5594792|NCT03751800|Hormone Antagonists|hormone antagonists|mesh-ancestor
5594793|NCT03751761|Paclitaxel|paclitaxel|mesh-list
5594794|NCT03751761|Durvalumab|durvalumab|mesh-list
5594795|NCT03751761|Tremelimumab|tremelimumab|mesh-list
5594796|NCT03751761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5594797|NCT03751761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5594798|NCT03751761|Tubulin Modulators|tubulin modulators|mesh-ancestor
5594799|NCT03751761|Antimitotic Agents|antimitotic agents|mesh-ancestor
5594800|NCT03751761|Mitosis Modulators|mitosis modulators|mesh-ancestor
5594801|NCT03751761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594802|NCT03751761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5594803|NCT03751514|Azithromycin|azithromycin|mesh-list
5594804|NCT03751514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5594805|NCT03751514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5594806|NCT03751488|Paliperidone Palmitate|paliperidone palmitate|mesh-list
5594807|NCT03751488|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5594808|NCT03751488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5594809|NCT03751488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5594810|NCT03751488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594811|NCT03751488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5594812|NCT03751488|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5594813|NCT03751488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5594814|NCT03751488|Serotonin Agents|serotonin agents|mesh-ancestor
5594815|NCT03751488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5594816|NCT03751488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594817|NCT03751488|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5594818|NCT03751488|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5594819|NCT03751488|Dopamine Agents|dopamine agents|mesh-ancestor
5594820|NCT03751436|Venetoclax|venetoclax|mesh-list
5594821|NCT03751436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5594822|NCT03751423|Fentanyl|fentanyl|mesh-list
5594823|NCT03751423|Morphine|morphine|mesh-list
5594824|NCT03751423|Ketamine|ketamine|mesh-list
5594825|NCT03751423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5594826|NCT03751423|Narcotics|narcotics|mesh-ancestor
5594827|NCT03751423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5594828|NCT03751423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594829|NCT03751423|Analgesics|analgesics|mesh-ancestor
5594830|NCT03751423|Sensory System Agents|sensory system agents|mesh-ancestor
5594831|NCT03751423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5594832|NCT03751423|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5594833|NCT03751423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5594834|NCT03751423|Anesthetics, General|anesthetics, general|mesh-ancestor
5594835|NCT03751423|Anesthetics|anesthetics|mesh-ancestor
6201861|NCT02032212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201862|NCT02032407|Dapsone|dapsone|mesh-list
6201863|NCT02032407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6201864|NCT02032407|Antimalarials|antimalarials|mesh-ancestor
5594836|NCT03751423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5594837|NCT03751423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5594838|NCT03751423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5594839|NCT03751423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594840|NCT03751423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5594841|NCT03751358|Anesthetics|anesthetics|mesh-list
5594842|NCT03751358|Anesthetics, Local|anesthetics, local|mesh-list
5594843|NCT03751358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5594844|NCT03751358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594845|NCT03751358|Sensory System Agents|sensory system agents|mesh-ancestor
5594846|NCT03751358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5594847|NCT03751332|Tacrolimus|tacrolimus|mesh-list
5594848|NCT03751332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5594849|NCT03751332|Immunologic Factors|immunologic factors|mesh-ancestor
5594850|NCT03751332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594851|NCT03751332|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6201865|NCT02032407|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5594852|NCT03751332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5594853|NCT03751332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606003|NCT05142735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5606004|NCT05142735|Expectorants|expectorants|mesh-ancestor
5606005|NCT05142735|Respiratory System Agents|respiratory system agents|mesh-ancestor
5606006|NCT05142735|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5606007|NCT05142735|Antioxidants|antioxidants|mesh-ancestor
5606008|NCT05142735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606009|NCT05142735|Protective Agents|protective agents|mesh-ancestor
5606010|NCT05142735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606011|NCT05142735|Antidotes|antidotes|mesh-ancestor
5606940|NCT03303339|Decitabine|decitabine|mesh-list
5606941|NCT03303339|Onvansertib|onvansertib|mesh-list
5606942|NCT03303339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5606943|NCT03303339|Antimetabolites|antimetabolites|mesh-ancestor
5606944|NCT03303339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606945|NCT03303339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5606946|NCT03303339|Antiviral Agents|antiviral agents|mesh-ancestor
5606947|NCT03303339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5606948|NCT03303339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5606949|NCT03303339|Immunologic Factors|immunologic factors|mesh-ancestor
5606950|NCT03303339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606951|NCT03303339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5606952|NCT03303339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5606953|NCT03294954|Cyclophosphamide|cyclophosphamide|mesh-list
5606954|NCT03294954|Fludarabine|fludarabine|mesh-list
5606955|NCT03294954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5606956|NCT03294954|Immunologic Factors|immunologic factors|mesh-ancestor
6201866|NCT02032407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5606957|NCT03294954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606958|NCT03294954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5606959|NCT03294954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5606960|NCT03294954|Alkylating Agents|alkylating agents|mesh-ancestor
5606961|NCT03294954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606962|NCT03294954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5606963|NCT03294954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5606964|NCT03220178|Letrozole|letrozole|mesh-list
5606965|NCT03220178|Fulvestrant|fulvestrant|mesh-list
5606966|NCT03220178|Palbociclib|palbociclib|mesh-list
6201867|NCT02032407|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6201868|NCT02032407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6201869|NCT02032407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201870|NCT02032407|Leprostatic Agents|leprostatic agents|mesh-ancestor
6201871|NCT02032407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6201872|NCT02032433|Naltrexone|naltrexone|mesh-list
5606967|NCT03220178|Anastrozole|anastrozole|mesh-list
6201873|NCT02032433|Buprenorphine|buprenorphine|mesh-list
5594854|NCT03751228|BMS-986165|bms-986165|mesh-list
5594855|NCT03751228|Dermatologic Agents|dermatologic agents|mesh-ancestor
5594856|NCT03751228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5594857|NCT03751228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5594858|NCT03751228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594859|NCT03751202|Fluticasone|fluticasone|mesh-list
5594860|NCT03751202|Xhance|xhance|mesh-list
5594861|NCT03751202|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5594862|NCT03751202|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
5594863|NCT03751202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6488327|NCT00583193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6488328|NCT00583193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488329|NCT00583193|Analgesics|analgesics|mesh-ancestor
5594864|NCT03751202|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5594865|NCT03751202|Autonomic Agents|autonomic agents|mesh-ancestor
5594866|NCT03751202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5594867|NCT03751202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594868|NCT03751202|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5594869|NCT03751202|Respiratory System Agents|respiratory system agents|mesh-ancestor
5594870|NCT03751202|Dermatologic Agents|dermatologic agents|mesh-ancestor
5594871|NCT03751202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5594872|NCT03751202|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5594873|NCT03751202|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5594874|NCT03751202|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5594875|NCT03751202|Adrenergic Agents|adrenergic agents|mesh-ancestor
5594876|NCT03751202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5594877|NCT03751202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594878|NCT03751202|Glucocorticoids|glucocorticoids|mesh-ancestor
5594879|NCT03751202|Hormones|hormones|mesh-ancestor
5594880|NCT03751202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5594881|NCT03751202|Sympathomimetics|sympathomimetics|mesh-ancestor
5594882|NCT03751176|Leucovorin|leucovorin|mesh-list
5594883|NCT03751176|Folic Acid|folic acid|mesh-list
5594884|NCT03751176|Fluorouracil|fluorouracil|mesh-list
5594885|NCT03751176|Irinotecan|irinotecan|mesh-list
5594886|NCT03751176|Panitumumab|panitumumab|mesh-list
5594887|NCT03751176|Levoleucovorin|levoleucovorin|mesh-list
5594888|NCT03751176|Antimetabolites|antimetabolites|mesh-ancestor
5594889|NCT03751176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594890|NCT03751176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5594891|NCT03751176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5594892|NCT03751176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5594893|NCT03751176|Immunologic Factors|immunologic factors|mesh-ancestor
5594894|NCT03751176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594895|NCT03751176|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5594896|NCT03751176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5594897|NCT03751176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5594898|NCT03751176|Antidotes|antidotes|mesh-ancestor
5594899|NCT03751176|Protective Agents|protective agents|mesh-ancestor
5594900|NCT03751176|Vitamin B Complex|vitamin b complex|mesh-ancestor
5594901|NCT03751176|Vitamins|vitamins|mesh-ancestor
5594902|NCT03751176|Micronutrients|micronutrients|mesh-ancestor
5594903|NCT03751176|Hematinics|hematinics|mesh-ancestor
5594904|NCT03751176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5594905|NCT03751163|Sunscreening Agents|sunscreening agents|mesh-list
5594906|NCT03751163|Tranexamic Acid|tranexamic acid|mesh-list
5594907|NCT03751163|Hydroquinone|hydroquinone|mesh-list
5594908|NCT03751163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5594909|NCT03751163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5594910|NCT03751163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594911|NCT03751163|Hemostatics|hemostatics|mesh-ancestor
5594912|NCT03751163|Coagulants|coagulants|mesh-ancestor
5594913|NCT03751163|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5594914|NCT03751163|Protective Agents|protective agents|mesh-ancestor
5594915|NCT03751163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488330|NCT00583193|Sensory System Agents|sensory system agents|mesh-ancestor
5594916|NCT03751163|Dermatologic Agents|dermatologic agents|mesh-ancestor
5594917|NCT03751163|Antioxidants|antioxidants|mesh-ancestor
5594918|NCT03751111|Naloxone|naloxone|mesh-list
5594919|NCT03751111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5594920|NCT03751111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594921|NCT03751111|Sensory System Agents|sensory system agents|mesh-ancestor
5594922|NCT03751111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5594923|NCT03751059|Dexamethasone|dexamethasone|mesh-list
5594924|NCT03751059|Bromfenac|bromfenac|mesh-list
5594925|NCT03751059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5594926|NCT03751059|Antiemetics|antiemetics|mesh-ancestor
5594927|NCT03751059|Autonomic Agents|autonomic agents|mesh-ancestor
5594928|NCT03751059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5594929|NCT03751059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594930|NCT03751059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5594931|NCT03751059|Glucocorticoids|glucocorticoids|mesh-ancestor
5594932|NCT03751059|Hormones|hormones|mesh-ancestor
5594933|NCT03751059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5594934|NCT03751059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5594935|NCT03751059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5594936|NCT03751059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5594937|NCT03751059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5594938|NCT03751059|Analgesics|analgesics|mesh-ancestor
5594939|NCT03751059|Sensory System Agents|sensory system agents|mesh-ancestor
5594940|NCT03751059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5594941|NCT03750968|Carotenoids|carotenoids|mesh-list
5594942|NCT03750968|Antioxidants|antioxidants|mesh-ancestor
5594943|NCT03750968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594944|NCT03750968|Protective Agents|protective agents|mesh-ancestor
5594945|NCT03750968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594946|NCT03750916|Docetaxel|docetaxel|mesh-list
5594947|NCT03750916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5594948|NCT03750916|Tubulin Modulators|tubulin modulators|mesh-ancestor
5594949|NCT03750916|Antimitotic Agents|antimitotic agents|mesh-ancestor
5594950|NCT03750916|Mitosis Modulators|mitosis modulators|mesh-ancestor
5594951|NCT03750916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594952|NCT03750786|Leucovorin|leucovorin|mesh-list
5594953|NCT03750786|Antidotes|antidotes|mesh-ancestor
5594954|NCT03750786|Protective Agents|protective agents|mesh-ancestor
5594955|NCT03750786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594956|NCT03750786|Vitamin B Complex|vitamin b complex|mesh-ancestor
5594957|NCT03750786|Vitamins|vitamins|mesh-ancestor
5594958|NCT03750786|Micronutrients|micronutrients|mesh-ancestor
5594959|NCT03750773|Gabapentin|gabapentin|mesh-list
5594960|NCT03750773|Analgesics|analgesics|mesh-ancestor
5594961|NCT03750773|Sensory System Agents|sensory system agents|mesh-ancestor
5594962|NCT03750773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5594963|NCT03750773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5594964|NCT03750773|Anticonvulsants|anticonvulsants|mesh-ancestor
5594965|NCT03750773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5594966|NCT03750773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5594967|NCT03750773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5594968|NCT03750773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5594969|NCT03750773|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5594970|NCT03750773|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5594971|NCT03750773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5594972|NCT03750773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594973|NCT03750773|Antimanic Agents|antimanic agents|mesh-ancestor
5594974|NCT03750760|Atorvastatin|atorvastatin|mesh-list
5594975|NCT03750760|Ezetimibe|ezetimibe|mesh-list
5594976|NCT03750760|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5594977|NCT03750760|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5594978|NCT03750760|Antimetabolites|antimetabolites|mesh-ancestor
5594979|NCT03750760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594980|NCT03750760|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5594981|NCT03750760|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5594982|NCT03750760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5594983|NCT03750721|Rifampin|rifampin|mesh-list
5594984|NCT03750721|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5594985|NCT03750721|Antitubercular Agents|antitubercular agents|mesh-ancestor
5594986|NCT03750721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5594987|NCT03750721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5594988|NCT03750721|Leprostatic Agents|leprostatic agents|mesh-ancestor
5594989|NCT03750721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5594990|NCT03750721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5594991|NCT03750721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5594992|NCT03750721|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5594993|NCT03750721|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5594994|NCT03750721|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5594995|NCT03750721|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5594996|NCT03750721|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5594997|NCT03750721|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5594998|NCT03750669|Folic Acid|folic acid|mesh-list
5594999|NCT03750669|Gemcitabine|gemcitabine|mesh-list
5595000|NCT03750669|Paclitaxel|paclitaxel|mesh-list
5595001|NCT03750669|Fluorouracil|fluorouracil|mesh-list
5595002|NCT03750669|Oxaliplatin|oxaliplatin|mesh-list
5595003|NCT03750669|Irinotecan|irinotecan|mesh-list
5595004|NCT03750669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5595005|NCT03750669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5595006|NCT03750669|Tubulin Modulators|tubulin modulators|mesh-ancestor
5595007|NCT03750669|Antimitotic Agents|antimitotic agents|mesh-ancestor
5595008|NCT03750669|Mitosis Modulators|mitosis modulators|mesh-ancestor
5595009|NCT03750669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5595010|NCT03750669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5595011|NCT03750669|Antimetabolites|antimetabolites|mesh-ancestor
5595012|NCT03750669|Antiviral Agents|antiviral agents|mesh-ancestor
5595013|NCT03750669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5595014|NCT03750669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5595015|NCT03750669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5595016|NCT03750669|Immunologic Factors|immunologic factors|mesh-ancestor
5595017|NCT03750669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595018|NCT03750669|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5595019|NCT03750669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5595020|NCT03750669|Hematinics|hematinics|mesh-ancestor
5595021|NCT03750669|Vitamin B Complex|vitamin b complex|mesh-ancestor
5595022|NCT03750669|Vitamins|vitamins|mesh-ancestor
5595023|NCT03750669|Micronutrients|micronutrients|mesh-ancestor
5595024|NCT03750656|Hyoscyamine|hyoscyamine|mesh-list
5595025|NCT03750656|Tamsulosin|tamsulosin|mesh-list
5595026|NCT03750656|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5595027|NCT03750656|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5595028|NCT03750656|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5595029|NCT03750656|Adrenergic Agents|adrenergic agents|mesh-ancestor
5595030|NCT03750656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5595031|NCT03750656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5595032|NCT03750656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595033|NCT03750656|Urological Agents|urological agents|mesh-ancestor
5595034|NCT03750656|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5595035|NCT03750656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5595036|NCT03750656|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5595037|NCT03750656|Autonomic Agents|autonomic agents|mesh-ancestor
5595038|NCT03750656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5595039|NCT03750656|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5595040|NCT03750656|Respiratory System Agents|respiratory system agents|mesh-ancestor
5595041|NCT03750656|Mydriatics|mydriatics|mesh-ancestor
5595042|NCT03750656|Parasympatholytics|parasympatholytics|mesh-ancestor
5595043|NCT03750656|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5595044|NCT03750656|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5595045|NCT03750656|Cholinergic Agents|cholinergic agents|mesh-ancestor
5595046|NCT03750383|Cyclosporine|cyclosporine|mesh-list
5595047|NCT03750383|Prednisone|prednisone|mesh-list
5595048|NCT03750383|Cyclosporins|cyclosporins|mesh-list
5595049|NCT03750383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5595050|NCT03750383|Glucocorticoids|glucocorticoids|mesh-ancestor
5595051|NCT03750383|Hormones|hormones|mesh-ancestor
5595052|NCT03750383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5595053|NCT03750383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595054|NCT03750383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5595055|NCT03750383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5595056|NCT03750383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5595057|NCT03750383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5595058|NCT03750383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5595059|NCT03750383|Immunologic Factors|immunologic factors|mesh-ancestor
5595060|NCT03750383|Antifungal Agents|antifungal agents|mesh-ancestor
5606012|NCT05140694|Empagliflozin|empagliflozin|mesh-list
5595061|NCT03750383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5595062|NCT03750383|Dermatologic Agents|dermatologic agents|mesh-ancestor
5595063|NCT03750383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5595064|NCT03750383|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5595065|NCT03750136|Furosemide|furosemide|mesh-list
5595066|NCT03750136|Diuretics|diuretics|mesh-ancestor
5595067|NCT03750136|Natriuretic Agents|natriuretic agents|mesh-ancestor
5595068|NCT03750136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595069|NCT03750136|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5595070|NCT03750136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5595071|NCT03750136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5595072|NCT03750071|Avelumab|avelumab|mesh-list
5595073|NCT03750071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5595074|NCT03750071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5595075|NCT03749915|Tetracaine|tetracaine|mesh-list
5595076|NCT03749915|Anesthetics, Local|anesthetics, local|mesh-ancestor
5595077|NCT03749915|Anesthetics|anesthetics|mesh-ancestor
5595078|NCT03749915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5595079|NCT03749915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595080|NCT03749915|Sensory System Agents|sensory system agents|mesh-ancestor
5595081|NCT03749915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5595082|NCT03749902|Misoprostol|misoprostol|mesh-list
5595083|NCT03749902|Oxytocin|oxytocin|mesh-list
5595084|NCT03749902|Oxytocics|oxytocics|mesh-ancestor
5595085|NCT03749902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5595086|NCT03749902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595087|NCT03749902|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5595088|NCT03749902|Abortifacient Agents|abortifacient agents|mesh-ancestor
5595089|NCT03749902|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5595090|NCT03749902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5595091|NCT03749850|Cyclophosphamide|cyclophosphamide|mesh-list
5595092|NCT03749850|Doxorubicin|doxorubicin|mesh-list
5595093|NCT03749850|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5595094|NCT03749850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5595095|NCT03749850|Immunologic Factors|immunologic factors|mesh-ancestor
5595096|NCT03749850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595097|NCT03749850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5595098|NCT03749850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5595099|NCT03749850|Alkylating Agents|alkylating agents|mesh-ancestor
5595100|NCT03749850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5595101|NCT03749850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5595102|NCT03749850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5595103|NCT03749850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5595104|NCT03749850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5595105|NCT03749850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5595106|NCT03749850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5606013|NCT05140694|Dulaglutide|dulaglutide|mesh-list
5606014|NCT05140694|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
5606015|NCT05140694|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5606016|NCT05140694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606017|NCT05140694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5606018|NCT05140694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606019|NCT05140694|Immunologic Factors|immunologic factors|mesh-ancestor
5606020|NCT05135312|Etanercept|etanercept|mesh-list
5606021|NCT05135312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5606022|NCT05135312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5606023|NCT05135312|Analgesics|analgesics|mesh-ancestor
5606024|NCT05135312|Sensory System Agents|sensory system agents|mesh-ancestor
5606025|NCT05135312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5606026|NCT05135312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606027|NCT05135312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5606028|NCT05135312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5606029|NCT05135312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5606030|NCT05135312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5606031|NCT05135312|Immunologic Factors|immunologic factors|mesh-ancestor
5606032|NCT05116774|Eculizumab|eculizumab|mesh-list
5606033|NCT05116774|Ravulizumab|ravulizumab|mesh-list
5606034|NCT05116774|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5606035|NCT05116774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5606036|NCT05116774|Immunologic Factors|immunologic factors|mesh-ancestor
5606037|NCT05116774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606038|NCT05109104|Sunscreening Agents|sunscreening agents|mesh-list
5606039|NCT05109104|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5606040|NCT05109104|Protective Agents|protective agents|mesh-ancestor
5606041|NCT05109104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595107|NCT03749733|Megestrol|megestrol|mesh-list
5595108|NCT03749733|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5595109|NCT03749733|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5595110|NCT03749733|Estradiol|estradiol|mesh-list
5595111|NCT03749733|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5595112|NCT03749733|Estrogens|estrogens|mesh-ancestor
5595113|NCT03749733|Hormones|hormones|mesh-ancestor
5595114|NCT03749733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5595115|NCT03749733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595116|NCT03749733|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5595117|NCT03749733|Contraceptive Agents|contraceptive agents|mesh-ancestor
5595118|NCT03749733|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5595119|NCT03749733|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5595120|NCT03749733|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5595121|NCT03749733|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5595122|NCT03749733|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5595123|NCT03749733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5595124|NCT03749733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5595125|NCT03749642|Gabapentin|gabapentin|mesh-list
5595126|NCT03749642|Trazodone|trazodone|mesh-list
5595127|NCT03749642|Analgesics|analgesics|mesh-ancestor
5595128|NCT03749642|Sensory System Agents|sensory system agents|mesh-ancestor
5595129|NCT03749642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5595130|NCT03749642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595131|NCT03749642|Anticonvulsants|anticonvulsants|mesh-ancestor
5595132|NCT03749642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5595133|NCT03749642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5595134|NCT03749642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5595135|NCT03749642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5595136|NCT03749642|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5595137|NCT03749642|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5595138|NCT03749642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5595139|NCT03749642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5595140|NCT03749642|Antimanic Agents|antimanic agents|mesh-ancestor
5595141|NCT03749642|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5595142|NCT03749642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5595143|NCT03749642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5595144|NCT03749642|Serotonin Agents|serotonin agents|mesh-ancestor
5595145|NCT03749642|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5595146|NCT03749642|Antidepressive Agents|antidepressive agents|mesh-ancestor
5595147|NCT03749629|Psychotropic Drugs|psychotropic drugs|mesh-list
5595148|NCT03749590|Magnesium Sulfate|magnesium sulfate|mesh-list
5595149|NCT03749590|Analgesics|analgesics|mesh-ancestor
5595150|NCT03749590|Sensory System Agents|sensory system agents|mesh-ancestor
5595151|NCT03749590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5595152|NCT03749590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595153|NCT03749590|Anesthetics|anesthetics|mesh-ancestor
5595154|NCT03749590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5595155|NCT03749590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5595156|NCT03749590|Anticonvulsants|anticonvulsants|mesh-ancestor
5595157|NCT03749590|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5595158|NCT03749590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5595159|NCT03749590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5595160|NCT03749590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5595161|NCT03749590|Tocolytic Agents|tocolytic agents|mesh-ancestor
5595162|NCT03749590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5595163|NCT03749408|Mannitol|mannitol|mesh-list
5595164|NCT03749408|Bupivacaine|bupivacaine|mesh-list
5595165|NCT03749408|Anesthetics, Local|anesthetics, local|mesh-ancestor
5595166|NCT03749408|Anesthetics|anesthetics|mesh-ancestor
5595167|NCT03749408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5595168|NCT03749408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595169|NCT03749408|Sensory System Agents|sensory system agents|mesh-ancestor
5595170|NCT03749408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5595171|NCT03749408|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5595172|NCT03749408|Diuretics|diuretics|mesh-ancestor
5595173|NCT03749408|Natriuretic Agents|natriuretic agents|mesh-ancestor
5595174|NCT03749356|Tacrolimus|tacrolimus|mesh-list
5595175|NCT03749356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5595176|NCT03749356|Immunologic Factors|immunologic factors|mesh-ancestor
5595177|NCT03749356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595178|NCT03749356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5595179|NCT03749356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5595180|NCT03749356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5595181|NCT03749226|Aztreonam|aztreonam|mesh-list
5595182|NCT03749226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5595183|NCT03749226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5595184|NCT03749174|Anesthetics|anesthetics|mesh-list
5595185|NCT03749174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5595186|NCT03749174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595187|NCT03749109|Quinagolide|quinagolide|mesh-list
5595188|NCT03749109|Dopamine Agonists|dopamine agonists|mesh-ancestor
5595189|NCT03749109|Dopamine Agents|dopamine agents|mesh-ancestor
5595190|NCT03749109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5595191|NCT03749109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5595192|NCT03749109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595193|NCT03749096|Immunoglobulins|immunoglobulins|mesh-list
5595194|NCT03749096|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5595195|NCT03749096|Antibodies|antibodies|mesh-list
5595196|NCT03749096|gamma-Globulins|gamma-globulins|mesh-list
5595197|NCT03749096|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5595198|NCT03749096|Immunologic Factors|immunologic factors|mesh-ancestor
5595199|NCT03749096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595200|NCT03749018|Prednisone|prednisone|mesh-list
5595201|NCT03749018|Cortisone|cortisone|mesh-list
5595202|NCT03749018|Cyclophosphamide|cyclophosphamide|mesh-list
5595203|NCT03749018|Rituximab|rituximab|mesh-list
5595204|NCT03749018|Doxorubicin|doxorubicin|mesh-list
5595205|NCT03749018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5595206|NCT03749018|Nivolumab|nivolumab|mesh-list
5595207|NCT03749018|Etoposide|etoposide|mesh-list
5595208|NCT03749018|Vincristine|vincristine|mesh-list
5595209|NCT03749018|Etoposide phosphate|etoposide phosphate|mesh-list
5595210|NCT03749018|Podophyllotoxin|podophyllotoxin|mesh-list
5595211|NCT03749018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5595212|NCT03749018|Antibodies|antibodies|mesh-list
5595213|NCT03749018|Immunoglobulins|immunoglobulins|mesh-list
5595214|NCT03749018|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5595215|NCT03749018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5595216|NCT03749018|Immunologic Factors|immunologic factors|mesh-ancestor
5595217|NCT03749018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595218|NCT03749018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5595219|NCT03749018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5595220|NCT03749018|Alkylating Agents|alkylating agents|mesh-ancestor
5595221|NCT03749018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5595222|NCT03749018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5595223|NCT03749018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5595224|NCT03749018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5595225|NCT03749018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5595226|NCT03749018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5595227|NCT03749018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5595228|NCT03749018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5595229|NCT03749018|Glucocorticoids|glucocorticoids|mesh-ancestor
5595230|NCT03749018|Hormones|hormones|mesh-ancestor
5595231|NCT03749018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5595232|NCT03749018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5595233|NCT03749018|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5595234|NCT03749018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5595235|NCT03749018|Tubulin Modulators|tubulin modulators|mesh-ancestor
5595236|NCT03749018|Antimitotic Agents|antimitotic agents|mesh-ancestor
5595237|NCT03749018|Mitosis Modulators|mitosis modulators|mesh-ancestor
5595238|NCT03749018|Keratolytic Agents|keratolytic agents|mesh-ancestor
5595239|NCT03749018|Dermatologic Agents|dermatologic agents|mesh-ancestor
5595240|NCT03748966|Calcitriol|calcitriol|mesh-list
5595241|NCT03748966|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
5595242|NCT03748966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5595243|NCT03748966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595244|NCT03748966|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
5595245|NCT03748966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5595246|NCT03748966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5595247|NCT03748966|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5595248|NCT03748966|Vitamins|vitamins|mesh-ancestor
5595249|NCT03748966|Micronutrients|micronutrients|mesh-ancestor
5595250|NCT03748966|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5595251|NCT03748940|Mirikizumab|mirikizumab|mesh-list
5595252|NCT03748940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5595253|NCT03748940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5595254|NCT03748940|Analgesics|analgesics|mesh-ancestor
5595255|NCT03748940|Sensory System Agents|sensory system agents|mesh-ancestor
5595256|NCT03748940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5595257|NCT03748940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595258|NCT03748940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5595259|NCT03748940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5595260|NCT03748940|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5595261|NCT03748940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6201874|NCT02032433|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6201875|NCT02032433|Naloxone|naloxone|mesh-list
5595264|NCT03748537|Hydrocortisone|hydrocortisone|mesh-list
5595265|NCT03748537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5595266|NCT03748446|Xenon|xenon|mesh-list
5595267|NCT03748446|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5595268|NCT03748446|Anesthetics, General|anesthetics, general|mesh-ancestor
5595269|NCT03748446|Anesthetics|anesthetics|mesh-ancestor
5595270|NCT03748446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5595271|NCT03748446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595272|NCT03748433|Insulin|insulin|mesh-list
5595273|NCT03748433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5595274|NCT03748433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595275|NCT03748303|Pregnanolone|pregnanolone|mesh-list
5595276|NCT03748303|Anesthetics|anesthetics|mesh-ancestor
5595277|NCT03748303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5595278|NCT03748303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595279|NCT03748290|Pregabalin|pregabalin|mesh-list
5595280|NCT03748290|Analgesics|analgesics|mesh-ancestor
5595281|NCT03748290|Sensory System Agents|sensory system agents|mesh-ancestor
5595282|NCT03748290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5595283|NCT03748290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595284|NCT03748290|Anticonvulsants|anticonvulsants|mesh-ancestor
5595285|NCT03748290|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5595286|NCT03748290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5595287|NCT03748290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5595288|NCT03748290|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5595289|NCT03748290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5595290|NCT03748290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5595291|NCT03748290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5595292|NCT03748290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5595293|NCT03748173|Calfactant|calfactant|mesh-list
5595294|NCT03748173|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
5595295|NCT03748173|Respiratory System Agents|respiratory system agents|mesh-ancestor
5595296|NCT03748147|Misoprostol|misoprostol|mesh-list
5595297|NCT03748147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5595298|NCT03748147|Abortifacient Agents|abortifacient agents|mesh-ancestor
5595299|NCT03748147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5595300|NCT03748147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595301|NCT03748147|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5595302|NCT03748147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5595303|NCT03748147|Oxytocics|oxytocics|mesh-ancestor
5595304|NCT03748108|Lidocaine|lidocaine|mesh-list
5595305|NCT03748108|Anesthetics, Local|anesthetics, local|mesh-ancestor
5595306|NCT03748108|Anesthetics|anesthetics|mesh-ancestor
5595307|NCT03748108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5595308|NCT03748108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595309|NCT03748108|Sensory System Agents|sensory system agents|mesh-ancestor
5595310|NCT03748108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5595311|NCT03748108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5595312|NCT03748108|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5595313|NCT03748108|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5595314|NCT03748108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5595315|NCT03748108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5595316|NCT03748082|Nitric Oxide|nitric oxide|mesh-list
5595317|NCT03748082|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5595318|NCT03748082|Autonomic Agents|autonomic agents|mesh-ancestor
5595319|NCT03748082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5595320|NCT03748082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595321|NCT03748082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5595322|NCT03748082|Respiratory System Agents|respiratory system agents|mesh-ancestor
5595323|NCT03748082|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5595324|NCT03748082|Antioxidants|antioxidants|mesh-ancestor
5595325|NCT03748082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5595326|NCT03748082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5595327|NCT03748082|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5595328|NCT03748082|Vasodilator Agents|vasodilator agents|mesh-ancestor
5595329|NCT03748082|Gasotransmitters|gasotransmitters|mesh-ancestor
5595330|NCT03748082|Protective Agents|protective agents|mesh-ancestor
5595331|NCT03748043|Lactoferrin|lactoferrin|mesh-list
5595332|NCT03748043|Teferrol|teferrol|mesh-list
5595333|NCT03748043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5595334|NCT03748043|Hematinics|hematinics|mesh-ancestor
5595335|NCT03747978|Amlodipine|amlodipine|mesh-list
5595336|NCT03747978|Perindopril|perindopril|mesh-list
5595337|NCT03747978|Indapamide|indapamide|mesh-list
5595338|NCT03747978|Indapamide, perindopril drug combination|indapamide, perindopril drug combination|mesh-list
5595339|NCT03747978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5595340|NCT03747978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5595341|NCT03747978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5595342|NCT03747978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5595343|NCT03747978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5595344|NCT03747978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595345|NCT03747978|Vasodilator Agents|vasodilator agents|mesh-ancestor
5595346|NCT03747978|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5595347|NCT03747978|Protease Inhibitors|protease inhibitors|mesh-ancestor
5595348|NCT03747978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5595349|NCT03747978|Diuretics|diuretics|mesh-ancestor
5595350|NCT03747978|Natriuretic Agents|natriuretic agents|mesh-ancestor
5595351|NCT03747978|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5606042|NCT05109104|Dermatologic Agents|dermatologic agents|mesh-ancestor
5606043|NCT05089123|Vaccines|vaccines|mesh-list
5606044|NCT05089123|Immunologic Factors|immunologic factors|mesh-ancestor
5606045|NCT05089123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606046|NCT05081193|Methyltestosterone|methyltestosterone|mesh-list
5606047|NCT05081193|Testosterone|testosterone|mesh-list
5606048|NCT05081193|Testosterone undecanoate|testosterone undecanoate|mesh-list
5606049|NCT05081193|Testosterone enanthate|testosterone enanthate|mesh-list
5606050|NCT05081193|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5606051|NCT05081193|Androgens|androgens|mesh-ancestor
5606052|NCT05081193|Hormones|hormones|mesh-ancestor
5606053|NCT05081193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5606054|NCT05081193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606055|NCT05081193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5606056|NCT05081193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5606057|NCT05081193|Anabolic Agents|anabolic agents|mesh-ancestor
5606058|NCT05064332|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5606059|NCT05064332|Contraceptive Agents|contraceptive agents|mesh-list
5606060|NCT05064332|Contraceptives, Oral|contraceptives, oral|mesh-list
5606061|NCT05064332|Estradiol|estradiol|mesh-list
5606062|NCT05064332|Estrogens|estrogens|mesh-ancestor
5606063|NCT05064332|Hormones|hormones|mesh-ancestor
5606064|NCT05064332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5606065|NCT05064332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606066|NCT05064332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5606067|NCT05064332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5606068|NCT05064332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5606069|NCT05064332|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5606070|NCT05063656|Gabapentin|gabapentin|mesh-list
5606071|NCT05063656|Analgesics|analgesics|mesh-ancestor
5606072|NCT05063656|Sensory System Agents|sensory system agents|mesh-ancestor
5606073|NCT05063656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5606074|NCT05063656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606075|NCT05063656|Anticonvulsants|anticonvulsants|mesh-ancestor
5606076|NCT05063656|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5606077|NCT05063656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5606078|NCT05063656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5606079|NCT05063656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5606080|NCT05063656|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5606081|NCT05063656|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5606082|NCT05063656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5606083|NCT05063656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606084|NCT05063656|Antimanic Agents|antimanic agents|mesh-ancestor
5606085|NCT05041257|Maytansine|maytansine|mesh-list
5606086|NCT05041257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5606087|NCT05041257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5606088|NCT05041257|Tubulin Modulators|tubulin modulators|mesh-ancestor
5595352|NCT03747900|Botulinum Toxins|botulinum toxins|mesh-list
5595353|NCT03747900|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5595354|NCT03747900|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5595355|NCT03747900|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5595356|NCT03747900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5595357|NCT03747900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5595358|NCT03747900|Cholinergic Agents|cholinergic agents|mesh-ancestor
5595359|NCT03747900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5595360|NCT03747900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595361|NCT03747900|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5595362|NCT03747900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5595363|NCT03747744|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
5595364|NCT03747744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5595365|NCT03747744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5595366|NCT03747679|Mannitol|mannitol|mesh-list
5595367|NCT03747679|Sorbitol|sorbitol|mesh-list
5595368|NCT03747679|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5595369|NCT03747679|Diuretics|diuretics|mesh-ancestor
5595370|NCT03747679|Natriuretic Agents|natriuretic agents|mesh-ancestor
5595371|NCT03747679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595372|NCT03747679|Cathartics|cathartics|mesh-ancestor
5595373|NCT03747679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5595374|NCT03747614|Fluorometholone|fluorometholone|mesh-list
5595375|NCT03747614|Tacrolimus|tacrolimus|mesh-list
5595376|NCT03747614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5595377|NCT03747614|Immunologic Factors|immunologic factors|mesh-ancestor
5595378|NCT03747614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595379|NCT03747614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5595380|NCT03747614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5595381|NCT03747614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5595382|NCT03747614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5595383|NCT03747614|Glucocorticoids|glucocorticoids|mesh-ancestor
5595384|NCT03747614|Hormones|hormones|mesh-ancestor
5595385|NCT03747614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5595386|NCT03747614|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5595387|NCT03747562|Gabapentin|gabapentin|mesh-list
5595388|NCT03747562|Analgesics|analgesics|mesh-ancestor
5595389|NCT03747562|Sensory System Agents|sensory system agents|mesh-ancestor
5595390|NCT03747562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5595391|NCT03747562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595392|NCT03747562|Anticonvulsants|anticonvulsants|mesh-ancestor
5595393|NCT03747562|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5595394|NCT03747562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5595395|NCT03747562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5595396|NCT03747562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5595397|NCT03747562|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5595398|NCT03747562|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5595399|NCT03747562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5595400|NCT03747562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5595401|NCT03747562|Antimanic Agents|antimanic agents|mesh-ancestor
5595402|NCT03747536|Bromides|bromides|mesh-list
5595403|NCT03747536|Ipratropium|ipratropium|mesh-list
5595404|NCT03747536|Anticonvulsants|anticonvulsants|mesh-ancestor
5595405|NCT03747536|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5595406|NCT03747536|Autonomic Agents|autonomic agents|mesh-ancestor
5595407|NCT03747536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5595408|NCT03747536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595409|NCT03747536|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5595410|NCT03747536|Respiratory System Agents|respiratory system agents|mesh-ancestor
5595411|NCT03747536|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5595412|NCT03747536|Cholinergic Agents|cholinergic agents|mesh-ancestor
5595413|NCT03747536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5595414|NCT03747536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5595415|NCT03747523|Vitamin D|vitamin d|mesh-list
5595416|NCT03747523|Ergocalciferols|ergocalciferols|mesh-list
5595417|NCT03747523|Vitamins|vitamins|mesh-ancestor
5595418|NCT03747523|Micronutrients|micronutrients|mesh-ancestor
5595419|NCT03747523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595420|NCT03747523|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5595421|NCT03747523|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5595422|NCT03747432|Dexmedetomidine|dexmedetomidine|mesh-list
5595423|NCT03747432|Propofol|propofol|mesh-list
5595424|NCT03747432|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5595425|NCT03747432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5595426|NCT03747432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201876|NCT02032433|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5595427|NCT03747432|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5595428|NCT03747432|Anesthetics, General|anesthetics, general|mesh-ancestor
5595429|NCT03747432|Anesthetics|anesthetics|mesh-ancestor
5595430|NCT03747432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5595431|NCT03747432|Analgesics|analgesics|mesh-ancestor
5595432|NCT03747432|Sensory System Agents|sensory system agents|mesh-ancestor
5595433|NCT03747432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5595434|NCT03747432|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5595435|NCT03747432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5595436|NCT03747432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5595437|NCT03747432|Adrenergic Agents|adrenergic agents|mesh-ancestor
5595438|NCT03747432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5595439|NCT03747432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5595440|NCT03747419|Avelumab|avelumab|mesh-list
5595441|NCT03747419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5595442|NCT03747419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5595443|NCT03747341|Fentanyl|fentanyl|mesh-list
5595444|NCT03747341|Oxycodone|oxycodone|mesh-list
5595445|NCT03747341|Buprenorphine|buprenorphine|mesh-list
5595446|NCT03747341|Ondansetron|ondansetron|mesh-list
5595447|NCT03747341|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5595448|NCT03747341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5595449|NCT03747341|Narcotics|narcotics|mesh-ancestor
5595450|NCT03747341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5595451|NCT03747341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595452|NCT03747341|Analgesics|analgesics|mesh-ancestor
5595453|NCT03747341|Sensory System Agents|sensory system agents|mesh-ancestor
5595454|NCT03747341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5595455|NCT03747341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5595456|NCT03747341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5595457|NCT03747341|Anesthetics, General|anesthetics, general|mesh-ancestor
5595458|NCT03747341|Anesthetics|anesthetics|mesh-ancestor
5595459|NCT03747341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5595460|NCT03747341|Antiemetics|antiemetics|mesh-ancestor
5595461|NCT03747341|Autonomic Agents|autonomic agents|mesh-ancestor
5595462|NCT03747341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5595463|NCT03747341|Antipruritics|antipruritics|mesh-ancestor
5595464|NCT03747341|Dermatologic Agents|dermatologic agents|mesh-ancestor
5595465|NCT03747341|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5595466|NCT03747341|Serotonin Agents|serotonin agents|mesh-ancestor
5595467|NCT03747341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5595468|NCT03747341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5595469|NCT03747341|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5595470|NCT03747341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5595471|NCT03747341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5595472|NCT03747341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5595473|NCT03747198|Dimethyl sulfone|dimethyl sulfone|mesh-list
5595474|NCT03747198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5595475|NCT03747159|Belimumab|belimumab|mesh-list
5595476|NCT03747159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5595477|NCT03747159|Immunologic Factors|immunologic factors|mesh-ancestor
5595478|NCT03747159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595479|NCT03747094|Fentanyl|fentanyl|mesh-list
5595480|NCT03747094|Ketamine|ketamine|mesh-list
5595481|NCT03747094|Analgesics|analgesics|mesh-ancestor
5595482|NCT03747094|Sensory System Agents|sensory system agents|mesh-ancestor
5595483|NCT03747094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5595484|NCT03747094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595485|NCT03747094|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5595486|NCT03747094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5595487|NCT03747094|Anesthetics, General|anesthetics, general|mesh-ancestor
5595488|NCT03747094|Anesthetics|anesthetics|mesh-ancestor
5595489|NCT03747094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5595490|NCT03747094|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5595491|NCT03747094|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5595492|NCT03747094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5595493|NCT03747094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5595494|NCT03747094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5595495|NCT03747094|Narcotics|narcotics|mesh-ancestor
5595496|NCT03747094|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5595497|NCT03747081|Warfarin|warfarin|mesh-list
5595498|NCT03747081|Rivaroxaban|rivaroxaban|mesh-list
5595499|NCT03747081|Anticoagulants|anticoagulants|mesh-ancestor
5595500|NCT03747081|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5595501|NCT03747081|Antithrombins|antithrombins|mesh-ancestor
5595502|NCT03747081|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5595503|NCT03747081|Protease Inhibitors|protease inhibitors|mesh-ancestor
5595504|NCT03747081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5595505|NCT03747081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5595506|NCT03747042|Letrozole|letrozole|mesh-list
5595507|NCT03747042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5595508|NCT03747042|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5595509|NCT03747042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5595510|NCT03747042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5595511|NCT03747042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5595512|NCT03747042|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5595513|NCT03747042|Hormone Antagonists|hormone antagonists|mesh-ancestor
5595514|NCT03747042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5595515|NCT03747042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595516|NCT03746821|Biotin|biotin|mesh-list
5595517|NCT03746821|Vitamin B Complex|vitamin b complex|mesh-ancestor
5595518|NCT03746821|Vitamins|vitamins|mesh-ancestor
5595519|NCT03746821|Micronutrients|micronutrients|mesh-ancestor
5595520|NCT03746821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595521|NCT03746782|Thrombin|thrombin|mesh-list
5595522|NCT03746782|Hemostatics|hemostatics|mesh-ancestor
5595523|NCT03746782|Coagulants|coagulants|mesh-ancestor
5595524|NCT03746769|Gastrins|gastrins|mesh-list
5595525|NCT03746769|Hormones|hormones|mesh-ancestor
5595526|NCT03746769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5595527|NCT03746769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595528|NCT03746691|Citalopram|citalopram|mesh-list
5595529|NCT03746691|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5595530|NCT03746691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5595531|NCT03746691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5595532|NCT03746691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5595533|NCT03746691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5595534|NCT03746691|Serotonin Agents|serotonin agents|mesh-ancestor
5595535|NCT03746691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595536|NCT03746691|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5595537|NCT03746691|Antidepressive Agents|antidepressive agents|mesh-ancestor
5595538|NCT03746691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5595539|NCT03746652|Dexamethasone|dexamethasone|mesh-list
5595540|NCT03746652|Daratumumab|daratumumab|mesh-list
5595541|NCT03746652|Ixazomib|ixazomib|mesh-list
5595542|NCT03746652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5595543|NCT03746652|Antiemetics|antiemetics|mesh-ancestor
5595544|NCT03746652|Autonomic Agents|autonomic agents|mesh-ancestor
5595545|NCT03746652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5595546|NCT03746652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595547|NCT03746652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5595548|NCT03746652|Glucocorticoids|glucocorticoids|mesh-ancestor
5595549|NCT03746652|Hormones|hormones|mesh-ancestor
5595550|NCT03746652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5595551|NCT03746652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5595552|NCT03746652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5595553|NCT03746652|Protease Inhibitors|protease inhibitors|mesh-ancestor
5595554|NCT03746652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5595555|NCT03746652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5595556|NCT03746444|Anesthetics|anesthetics|mesh-list
5595557|NCT03746444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5595558|NCT03746444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595559|NCT03746366|Corticosterone|corticosterone|mesh-list
5595560|NCT03746366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5595561|NCT03746340|Propofol|propofol|mesh-list
5595562|NCT03746340|Sevoflurane|sevoflurane|mesh-list
5595563|NCT03746340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5595564|NCT03746340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5595565|NCT03746340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595566|NCT03746340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5595567|NCT03746340|Anesthetics, General|anesthetics, general|mesh-ancestor
5595568|NCT03746340|Anesthetics|anesthetics|mesh-ancestor
5595569|NCT03746340|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5595570|NCT03746340|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5595571|NCT03746327|Tedizolid phosphate|tedizolid phosphate|mesh-list
5595572|NCT03746327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5595573|NCT03746327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5606089|NCT05041257|Antimitotic Agents|antimitotic agents|mesh-ancestor
5606090|NCT05041257|Mitosis Modulators|mitosis modulators|mesh-ancestor
5606091|NCT05041257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606092|NCT05035927|Psilocybin|psilocybin|mesh-list
5606093|NCT05035927|Hallucinogens|hallucinogens|mesh-ancestor
5606094|NCT05035927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595574|NCT03746275|Aspirin|aspirin|mesh-list
5595575|NCT03746275|Rivaroxaban|rivaroxaban|mesh-list
5595576|NCT03746275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5595577|NCT03746275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5595578|NCT03746275|Analgesics|analgesics|mesh-ancestor
5595579|NCT03746275|Sensory System Agents|sensory system agents|mesh-ancestor
5595580|NCT03746275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5595581|NCT03746275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595582|NCT03746275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5595583|NCT03746275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5595584|NCT03746275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5595585|NCT03746275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5595586|NCT03746275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5595587|NCT03746275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5595588|NCT03746275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5595589|NCT03746275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5595590|NCT03746275|Antipyretics|antipyretics|mesh-ancestor
5595591|NCT03746275|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5595592|NCT03746275|Antithrombins|antithrombins|mesh-ancestor
5595593|NCT03746275|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5595594|NCT03746275|Protease Inhibitors|protease inhibitors|mesh-ancestor
5595595|NCT03746275|Anticoagulants|anticoagulants|mesh-ancestor
5595596|NCT03746249|Lenvatinib|lenvatinib|mesh-list
5595597|NCT03746249|Antibodies|antibodies|mesh-list
5595598|NCT03746249|Immunoglobulins|immunoglobulins|mesh-list
5595599|NCT03746249|Immunologic Factors|immunologic factors|mesh-ancestor
5595600|NCT03746249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595601|NCT03746249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5595602|NCT03746249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5595603|NCT03746249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5595604|NCT03746249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5595605|NCT03746223|Rituximab|rituximab|mesh-list
5595606|NCT03746223|Methotrexate|methotrexate|mesh-list
5595607|NCT03746223|Lenalidomide|lenalidomide|mesh-list
5595608|NCT03746223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5595609|NCT03746223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5595610|NCT03746223|Immunologic Factors|immunologic factors|mesh-ancestor
5595611|NCT03746223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595612|NCT03746223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5595613|NCT03746223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5595614|NCT03746223|Abortifacient Agents|abortifacient agents|mesh-ancestor
5595615|NCT03746223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5595616|NCT03746223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5595617|NCT03746223|Antimetabolites|antimetabolites|mesh-ancestor
5595618|NCT03746223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5595619|NCT03746223|Dermatologic Agents|dermatologic agents|mesh-ancestor
5595620|NCT03746223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5595621|NCT03746223|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5595622|NCT03746223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5595623|NCT03746223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5595624|NCT03746223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5595625|NCT03746223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5595626|NCT03746223|Growth Substances|growth substances|mesh-ancestor
5595627|NCT03746223|Growth Inhibitors|growth inhibitors|mesh-ancestor
5595628|NCT03746158|Curcumin|curcumin|mesh-list
5595629|NCT03746158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5595630|NCT03746158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5595631|NCT03746158|Analgesics|analgesics|mesh-ancestor
5595632|NCT03746158|Sensory System Agents|sensory system agents|mesh-ancestor
5595633|NCT03746158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5595634|NCT03746158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595635|NCT03746158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5595636|NCT03746158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5595637|NCT03746158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5595638|NCT03746158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5595639|NCT03746158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5595640|NCT03746119|Nicotine|nicotine|mesh-list
5595641|NCT03746119|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5595642|NCT03746119|Autonomic Agents|autonomic agents|mesh-ancestor
5595643|NCT03746119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5595644|NCT03746119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595645|NCT03746119|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5595646|NCT03746119|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5595647|NCT03746119|Cholinergic Agents|cholinergic agents|mesh-ancestor
5595648|NCT03746119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5595649|NCT03746119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5595650|NCT03746106|Thiamine|thiamine|mesh-list
5595651|NCT03746106|Metformin|metformin|mesh-list
5595652|NCT03746106|Trimethoprim|trimethoprim|mesh-list
5595653|NCT03746106|Vitamins|vitamins|mesh-ancestor
5595654|NCT03746106|Micronutrients|micronutrients|mesh-ancestor
5595655|NCT03746106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595656|NCT03746106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5595657|NCT03746106|Vitamin B Complex|vitamin b complex|mesh-ancestor
5595658|NCT03746106|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5595659|NCT03746106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5595660|NCT03746106|Renal Agents|renal agents|mesh-ancestor
5595661|NCT03746106|Antimalarials|antimalarials|mesh-ancestor
5595662|NCT03746106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5595663|NCT03746106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5595664|NCT03746106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5595665|NCT03746106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5595666|NCT03746106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5595667|NCT03746106|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5595668|NCT03746106|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
5595669|NCT03746106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5595670|NCT03745950|Olaparib|olaparib|mesh-list
5595671|NCT03745950|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5595672|NCT03745950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5595673|NCT03745950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5595674|NCT03745950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5595675|NCT03745911|Paclitaxel|paclitaxel|mesh-list
5595676|NCT03745911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5595677|NCT03745911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5595678|NCT03745911|Tubulin Modulators|tubulin modulators|mesh-ancestor
5595679|NCT03745911|Antimitotic Agents|antimitotic agents|mesh-ancestor
5595680|NCT03745911|Mitosis Modulators|mitosis modulators|mesh-ancestor
5595681|NCT03745911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5595682|NCT03745807|Nivolumab|nivolumab|mesh-list
5595683|NCT03745807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5595684|NCT03745807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5595685|NCT03745807|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5595686|NCT03745807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5595687|NCT03745716|Azacitidine|azacitidine|mesh-list
5595688|NCT03745716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5595689|NCT03745716|Antimetabolites|antimetabolites|mesh-ancestor
5595690|NCT03745716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5595691|NCT03745716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5595692|NCT03745716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5595693|NCT03745664|Methylprednisolone|methylprednisolone|mesh-list
5595694|NCT03745664|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5595695|NCT03745664|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5595696|NCT03745664|Prednisolone|prednisolone|mesh-list
5595697|NCT03745664|Prednisolone acetate|prednisolone acetate|mesh-list
5595698|NCT03745664|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5595699|NCT03745664|Prednisolone phosphate|prednisolone phosphate|mesh-list
5595700|NCT03745664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5595701|NCT03745664|Antiemetics|antiemetics|mesh-ancestor
5595702|NCT03745664|Autonomic Agents|autonomic agents|mesh-ancestor
5595703|NCT03745664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5595704|NCT03745664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595705|NCT03745664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5595706|NCT03745664|Glucocorticoids|glucocorticoids|mesh-ancestor
5595707|NCT03745664|Hormones|hormones|mesh-ancestor
5595708|NCT03745664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5595709|NCT03745664|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5595710|NCT03745664|Protective Agents|protective agents|mesh-ancestor
5595711|NCT03745664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5595712|NCT03745664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5595713|NCT03745625|Propofol|propofol|mesh-list
5595714|NCT03745625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5595715|NCT03745625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5595716|NCT03745625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595717|NCT03745625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5595718|NCT03745625|Anesthetics, General|anesthetics, general|mesh-ancestor
5595719|NCT03745625|Anesthetics|anesthetics|mesh-ancestor
5595720|NCT03745599|Diclofenac|diclofenac|mesh-list
5595721|NCT03745599|Flurbiprofen|flurbiprofen|mesh-list
5595722|NCT03745599|Benzydamine|benzydamine|mesh-list
5595723|NCT03745599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5595724|NCT03745599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5595725|NCT03745599|Analgesics|analgesics|mesh-ancestor
5595726|NCT03745599|Sensory System Agents|sensory system agents|mesh-ancestor
5595727|NCT03745599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5595728|NCT03745599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595729|NCT03745599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5595730|NCT03745599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5595731|NCT03745599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5595732|NCT03745599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5595733|NCT03745599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5595734|NCT03745586|Glucocorticoids|glucocorticoids|mesh-list
5595735|NCT03745586|Hormones|hormones|mesh-ancestor
5595736|NCT03745586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5595737|NCT03745586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595738|NCT03745404|Lidocaine|lidocaine|mesh-list
5595739|NCT03745404|Anesthetics, Local|anesthetics, local|mesh-ancestor
5595740|NCT03745404|Anesthetics|anesthetics|mesh-ancestor
5595741|NCT03745404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5595742|NCT03745404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595743|NCT03745404|Sensory System Agents|sensory system agents|mesh-ancestor
5595744|NCT03745404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5595745|NCT03745404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5595746|NCT03745404|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5595747|NCT03745404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5595748|NCT03745404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5595749|NCT03745404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5595750|NCT03745352|Azacitidine|azacitidine|mesh-list
5595751|NCT03745352|Enzyme Inhibitors|enzyme inhibitors|mesh-list
5595752|NCT03745352|Pevonedistat|pevonedistat|mesh-list
5595753|NCT03745352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5595754|NCT03745352|Antimetabolites|antimetabolites|mesh-ancestor
5595755|NCT03745352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5595756|NCT03745352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5595757|NCT03745300|Atorvastatin|atorvastatin|mesh-list
5595758|NCT03745300|Simvastatin|simvastatin|mesh-list
5595759|NCT03745300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5595760|NCT03745300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5595761|NCT03745300|Antimetabolites|antimetabolites|mesh-ancestor
5595762|NCT03745300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5595763|NCT03745300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5595764|NCT03745300|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5595765|NCT03745300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5595766|NCT03745261|Fluticasone|fluticasone|mesh-list
5595767|NCT03745261|Xhance|xhance|mesh-list
5595768|NCT03745261|Bromides|bromides|mesh-list
5595769|NCT03745261|Albuterol|albuterol|mesh-list
5595770|NCT03745261|Tiotropium Bromide|tiotropium bromide|mesh-list
5595771|NCT03745261|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5595772|NCT03745261|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
5595773|NCT03745261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5595774|NCT03745261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5595775|NCT03745261|Autonomic Agents|autonomic agents|mesh-ancestor
5595776|NCT03745261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5595777|NCT03745261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595778|NCT03745261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5595779|NCT03745261|Respiratory System Agents|respiratory system agents|mesh-ancestor
5595780|NCT03745261|Dermatologic Agents|dermatologic agents|mesh-ancestor
6488331|NCT00583193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6488332|NCT00583193|Antidepressive Agents|antidepressive agents|mesh-ancestor
6488333|NCT00583193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6488334|NCT00583193|Dopamine Agents|dopamine agents|mesh-ancestor
6488335|NCT00583258|Alfuzosin|alfuzosin|mesh-list
6488336|NCT00583258|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6488337|NCT00583258|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6488338|NCT00583258|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6488339|NCT00583258|Adrenergic Agents|adrenergic agents|mesh-ancestor
6488340|NCT00583258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6488341|NCT00583258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488342|NCT00583258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488343|NCT00583258|Urological Agents|urological agents|mesh-ancestor
6488344|NCT00583271|Triamcinolone|triamcinolone|mesh-list
6488345|NCT00583271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6488346|NCT00583271|Glucocorticoids|glucocorticoids|mesh-ancestor
6488347|NCT00583271|Hormones|hormones|mesh-ancestor
6488348|NCT00583271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6488349|NCT00583271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488350|NCT00583323|Atropine sulfate-diphenoxylate hydrochloride drug combination|atropine sulfate-diphenoxylate hydrochloride drug combination|mesh-list
6488351|NCT00583323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6488352|NCT00583349|Paclitaxel|paclitaxel|mesh-list
6488353|NCT00583349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6488354|NCT00583349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6488355|NCT00583349|Tubulin Modulators|tubulin modulators|mesh-ancestor
6488356|NCT00583349|Antimitotic Agents|antimitotic agents|mesh-ancestor
6488357|NCT00583349|Mitosis Modulators|mitosis modulators|mesh-ancestor
6488358|NCT00583349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488359|NCT00583427|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
6488360|NCT00583427|Anticoagulants|anticoagulants|mesh-ancestor
6488361|NCT00583427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6488362|NCT00583427|Antimetabolites|antimetabolites|mesh-ancestor
5595781|NCT03745261|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5595782|NCT03745261|Parasympatholytics|parasympatholytics|mesh-ancestor
5595783|NCT03745261|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5595784|NCT03745261|Cholinergic Agents|cholinergic agents|mesh-ancestor
5595785|NCT03745261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5595786|NCT03745261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5595787|NCT03745261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5595788|NCT03745261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5595789|NCT03745261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5595790|NCT03745261|Adrenergic Agents|adrenergic agents|mesh-ancestor
5595791|NCT03745261|Anticonvulsants|anticonvulsants|mesh-ancestor
5595792|NCT03745261|Tocolytic Agents|tocolytic agents|mesh-ancestor
5595793|NCT03745261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5595794|NCT03745261|Glucocorticoids|glucocorticoids|mesh-ancestor
5595795|NCT03745261|Hormones|hormones|mesh-ancestor
5595796|NCT03745261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5595797|NCT03745261|Sympathomimetics|sympathomimetics|mesh-ancestor
5595798|NCT03745170|Capecitabine|capecitabine|mesh-list
5595799|NCT03745170|Oxaliplatin|oxaliplatin|mesh-list
5595800|NCT03745170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5595801|NCT03745170|Antimetabolites|antimetabolites|mesh-ancestor
5595802|NCT03745170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5595803|NCT03745170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5595804|NCT03745157|Insulin|insulin|mesh-list
5595805|NCT03745157|Insulin Aspart|insulin aspart|mesh-list
5595806|NCT03745157|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5595807|NCT03745157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595808|NCT03745105|Dexamethasone|dexamethasone|mesh-list
5595809|NCT03745105|Dexamethasone acetate|dexamethasone acetate|mesh-list
5595810|NCT03745105|Piroxicam|piroxicam|mesh-list
5595811|NCT03745105|Mepivacaine|mepivacaine|mesh-list
5595812|NCT03745105|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
5595813|NCT03745105|BB 1101|bb 1101|mesh-list
5595814|NCT03745105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5595815|NCT03745105|Antiemetics|antiemetics|mesh-ancestor
5595816|NCT03745105|Autonomic Agents|autonomic agents|mesh-ancestor
5595817|NCT03745105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5595818|NCT03745105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595819|NCT03745105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5595820|NCT03745105|Glucocorticoids|glucocorticoids|mesh-ancestor
5595821|NCT03745105|Hormones|hormones|mesh-ancestor
5595822|NCT03745105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5595823|NCT03745105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5595824|NCT03745105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5595825|NCT03745105|Anesthetics, Local|anesthetics, local|mesh-ancestor
5595826|NCT03745105|Anesthetics|anesthetics|mesh-ancestor
5595827|NCT03745105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5595828|NCT03745105|Sensory System Agents|sensory system agents|mesh-ancestor
5595829|NCT03745105|Protease Inhibitors|protease inhibitors|mesh-ancestor
5595830|NCT03745105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5595831|NCT03745105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5595832|NCT03745105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5595833|NCT03745105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5595834|NCT03745105|Analgesics|analgesics|mesh-ancestor
5595835|NCT03745105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5595836|NCT03745105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5595837|NCT03745040|Bupivacaine|bupivacaine|mesh-list
5595838|NCT03745040|Anesthetics, Local|anesthetics, local|mesh-ancestor
5595839|NCT03745040|Anesthetics|anesthetics|mesh-ancestor
5595840|NCT03745040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5595841|NCT03745040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595842|NCT03745040|Sensory System Agents|sensory system agents|mesh-ancestor
5595843|NCT03745040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5595844|NCT03744988|Androgens|androgens|mesh-list
5595845|NCT03744988|Hormones|hormones|mesh-ancestor
5595846|NCT03744988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5595847|NCT03744988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595848|NCT03744949|Remifentanil|remifentanil|mesh-list
5595849|NCT03744949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5595850|NCT03744949|Narcotics|narcotics|mesh-ancestor
5595851|NCT03744949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5595852|NCT03744949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595853|NCT03744949|Analgesics|analgesics|mesh-ancestor
5595854|NCT03744949|Sensory System Agents|sensory system agents|mesh-ancestor
5595855|NCT03744949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5595856|NCT03744897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
5595857|NCT03744897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5595858|NCT03744897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595859|NCT03744806|Bevacizumab|bevacizumab|mesh-list
5595860|NCT03744806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5595861|NCT03744806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5595862|NCT03744806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5595863|NCT03744806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5595864|NCT03744806|Growth Substances|growth substances|mesh-ancestor
5595865|NCT03744806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595866|NCT03744806|Growth Inhibitors|growth inhibitors|mesh-ancestor
5595867|NCT03744767|Spironolactone|spironolactone|mesh-list
5595868|NCT03744767|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5595869|NCT03744767|Hormone Antagonists|hormone antagonists|mesh-ancestor
5595870|NCT03744767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5595871|NCT03744767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595872|NCT03744767|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5595873|NCT03744767|Diuretics|diuretics|mesh-ancestor
5595874|NCT03744767|Natriuretic Agents|natriuretic agents|mesh-ancestor
5595875|NCT03744702|Ascorbic Acid|ascorbic acid|mesh-list
5595876|NCT03744702|Antioxidants|antioxidants|mesh-ancestor
5595877|NCT03744702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5595878|NCT03744702|Protective Agents|protective agents|mesh-ancestor
5595879|NCT03744702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595880|NCT03744702|Vitamins|vitamins|mesh-ancestor
5595881|NCT03744702|Micronutrients|micronutrients|mesh-ancestor
5595882|NCT03744689|Bupivacaine|bupivacaine|mesh-list
5595883|NCT03744689|Anesthetics, Local|anesthetics, local|mesh-ancestor
5595884|NCT03744689|Anesthetics|anesthetics|mesh-ancestor
5595885|NCT03744689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5595886|NCT03744689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595887|NCT03744689|Sensory System Agents|sensory system agents|mesh-ancestor
5595888|NCT03744689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5595889|NCT03744663|Buprenorphine|buprenorphine|mesh-list
5595890|NCT03744663|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
5595891|NCT03744663|Naloxone|naloxone|mesh-list
5595892|NCT03744663|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5595893|NCT03744663|Narcotics|narcotics|mesh-ancestor
5595894|NCT03744663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5595895|NCT03744663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595896|NCT03744663|Analgesics|analgesics|mesh-ancestor
5595897|NCT03744663|Sensory System Agents|sensory system agents|mesh-ancestor
5595898|NCT03744663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5595899|NCT03744663|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5606095|NCT05035927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5606096|NCT05034029|Metformin|metformin|mesh-list
5606097|NCT05034029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5606098|NCT05034029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606099|NCT05013216|Poly ICLC|poly iclc|mesh-list
5606100|NCT05013216|Interferon Inducers|interferon inducers|mesh-ancestor
5606101|NCT05013216|Immunologic Factors|immunologic factors|mesh-ancestor
5606102|NCT05013216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606103|NCT05002816|Elotuzumab|elotuzumab|mesh-list
5606104|NCT05002816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5606105|NCT04966325|Moxifloxacin|moxifloxacin|mesh-list
5606106|NCT04966325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5606107|NCT04966325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5606108|NCT04966325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5606109|NCT04966325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5606110|NCT04966325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5606111|NCT04966325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606112|NCT04966325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5606113|NCT04949425|Adavosertib|adavosertib|mesh-list
5606114|NCT04949425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5606115|NCT04949425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606116|NCT04944888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5606117|NCT04944888|Eliglustat|eliglustat|mesh-list
5606118|NCT04944888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606119|NCT04944888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5606120|NCT04944888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5606121|NCT04938024|Ascorbic Acid|ascorbic acid|mesh-list
5606122|NCT04938024|Vitamins|vitamins|mesh-ancestor
5606123|NCT04938024|Micronutrients|micronutrients|mesh-ancestor
5606124|NCT04938024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606125|NCT04938024|Antioxidants|antioxidants|mesh-ancestor
5606126|NCT04938024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606127|NCT04938024|Protective Agents|protective agents|mesh-ancestor
5606128|NCT04936984|Abaloparatide|abaloparatide|mesh-list
5606129|NCT04936984|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
5606130|NCT04936984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5606131|NCT04936984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606132|NCT04936984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5606133|NCT04929808|Emollients|emollients|mesh-list
5606134|NCT04929808|Dermatologic Agents|dermatologic agents|mesh-ancestor
5606135|NCT04914234|Metoprolol|metoprolol|mesh-list
5606136|NCT04914234|Atenolol|atenolol|mesh-list
5606137|NCT04914234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5606138|NCT04914234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5606139|NCT04914234|Sympatholytics|sympatholytics|mesh-ancestor
5606140|NCT04914234|Autonomic Agents|autonomic agents|mesh-ancestor
5606141|NCT04914234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5606142|NCT04914234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606143|NCT04914234|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5606144|NCT04914234|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5606145|NCT04914234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5606146|NCT04914234|Adrenergic Agents|adrenergic agents|mesh-ancestor
5595900|NCT03744364|Misoprostol|misoprostol|mesh-list
5595901|NCT03744364|Dinoprostone|dinoprostone|mesh-list
5595902|NCT03744364|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5595903|NCT03744364|Abortifacient Agents|abortifacient agents|mesh-ancestor
5595904|NCT03744364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5595905|NCT03744364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595906|NCT03744364|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5595907|NCT03744364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5595908|NCT03744364|Oxytocics|oxytocics|mesh-ancestor
5595909|NCT03744247|Lenvatinib|lenvatinib|mesh-list
5595910|NCT03744247|Antibodies|antibodies|mesh-list
5595911|NCT03744247|Immunoglobulins|immunoglobulins|mesh-list
5595912|NCT03744247|Immunologic Factors|immunologic factors|mesh-ancestor
5595913|NCT03744247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595914|NCT03744247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5595915|NCT03744247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5595916|NCT03744247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5595917|NCT03744247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5595918|NCT03744208|Cetuximab|cetuximab|mesh-list
5595919|NCT03744208|Antibodies|antibodies|mesh-list
5595920|NCT03744208|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5595921|NCT03744208|Immunologic Factors|immunologic factors|mesh-ancestor
5595922|NCT03744208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595923|NCT03744208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5595924|NCT03744208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5595925|NCT03744104|Vaccines|vaccines|mesh-list
5595926|NCT03744104|Immunologic Factors|immunologic factors|mesh-ancestor
5595927|NCT03744104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595928|NCT03744091|Dronabinol|dronabinol|mesh-list
5595929|NCT03744091|Hallucinogens|hallucinogens|mesh-ancestor
5595930|NCT03744091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595931|NCT03744091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5595932|NCT03744091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5595933|NCT03744091|Analgesics|analgesics|mesh-ancestor
5595934|NCT03744091|Sensory System Agents|sensory system agents|mesh-ancestor
5595935|NCT03744091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5595936|NCT03744091|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5595937|NCT03744091|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5595938|NCT03744091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5595939|NCT03744091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5595940|NCT03744091|Hormones|hormones|mesh-ancestor
5595941|NCT03744091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5595942|NCT03743987|Pemetrexed|pemetrexed|mesh-list
5595943|NCT03743987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5595944|NCT03743987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5595945|NCT03743987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5595946|NCT03743987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5595947|NCT03743987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5595948|NCT03743922|Ergocalciferols|ergocalciferols|mesh-list
5595949|NCT03743922|Cholecalciferol|cholecalciferol|mesh-list
5595950|NCT03743922|Vitamin D|vitamin d|mesh-list
5595951|NCT03743922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5595952|NCT03743922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595953|NCT03743922|Vitamins|vitamins|mesh-ancestor
5595954|NCT03743922|Micronutrients|micronutrients|mesh-ancestor
5595955|NCT03743922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5595956|NCT03743896|Capsaicin|capsaicin|mesh-list
5595957|NCT03743896|Antipruritics|antipruritics|mesh-ancestor
5595958|NCT03743896|Dermatologic Agents|dermatologic agents|mesh-ancestor
5595959|NCT03743896|Sensory System Agents|sensory system agents|mesh-ancestor
5595960|NCT03743896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5595961|NCT03743896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595962|NCT03743883|Aspirin|aspirin|mesh-list
5595963|NCT03743883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5595964|NCT03743883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5595965|NCT03743883|Analgesics|analgesics|mesh-ancestor
5595966|NCT03743883|Sensory System Agents|sensory system agents|mesh-ancestor
5595967|NCT03743883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5595968|NCT03743883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595969|NCT03743883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5595970|NCT03743883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5595971|NCT03743883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5595972|NCT03743883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5595973|NCT03743883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5595974|NCT03743883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5606968|NCT03220178|Exemestane|exemestane|mesh-list
5595975|NCT03743883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5595976|NCT03743883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5595977|NCT03743883|Antipyretics|antipyretics|mesh-ancestor
5595978|NCT03743870|Bupivacaine|bupivacaine|mesh-list
5595979|NCT03743870|Levobupivacaine|levobupivacaine|mesh-list
5595980|NCT03743870|Anesthetics, Local|anesthetics, local|mesh-ancestor
5595981|NCT03743870|Anesthetics|anesthetics|mesh-ancestor
5595982|NCT03743870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5595983|NCT03743870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595984|NCT03743870|Sensory System Agents|sensory system agents|mesh-ancestor
5595985|NCT03743870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5595986|NCT03743805|Naloxone|naloxone|mesh-list
5595987|NCT03743805|Flumazenil|flumazenil|mesh-list
5595988|NCT03743805|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5595989|NCT03743805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5595990|NCT03743805|Sensory System Agents|sensory system agents|mesh-ancestor
5595991|NCT03743805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5595992|NCT03743805|Antidotes|antidotes|mesh-ancestor
5595993|NCT03743805|Protective Agents|protective agents|mesh-ancestor
5595994|NCT03743805|GABA Modulators|gaba modulators|mesh-ancestor
5595995|NCT03743805|GABA Agents|gaba agents|mesh-ancestor
5595996|NCT03743805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5595997|NCT03743805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5595998|NCT03743766|Nivolumab|nivolumab|mesh-list
5595999|NCT03743766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5596000|NCT03743766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5596001|NCT03743766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5596002|NCT03743766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596003|NCT03743727|Sofosbuvir|sofosbuvir|mesh-list
5596004|NCT03743727|Ledipasvir|ledipasvir|mesh-list
6488363|NCT00583427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596005|NCT03743727|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
5596006|NCT03743727|Antiviral Agents|antiviral agents|mesh-ancestor
5596007|NCT03743727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5596008|NCT03743649|Lorazepam|lorazepam|mesh-list
5596009|NCT03743649|Haloperidol|haloperidol|mesh-list
5596010|NCT03743649|Haloperidol decanoate|haloperidol decanoate|mesh-list
5596011|NCT03743649|Antiemetics|antiemetics|mesh-ancestor
5596012|NCT03743649|Autonomic Agents|autonomic agents|mesh-ancestor
5596013|NCT03743649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5596014|NCT03743649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596015|NCT03743649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5596016|NCT03743649|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5596017|NCT03743649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5596018|NCT03743649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5596019|NCT03743649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5596020|NCT03743649|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5596021|NCT03743649|Dopamine Agents|dopamine agents|mesh-ancestor
5596022|NCT03743649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5596023|NCT03743649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596024|NCT03743649|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5596025|NCT03743649|Anticonvulsants|anticonvulsants|mesh-ancestor
5596026|NCT03743649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5596027|NCT03743649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5596028|NCT03743649|GABA Modulators|gaba modulators|mesh-ancestor
5596029|NCT03743649|GABA Agents|gaba agents|mesh-ancestor
5596030|NCT03743636|Niacinamide|niacinamide|mesh-list
5596031|NCT03743636|Niacin|niacin|mesh-list
5596032|NCT03743636|Nicotinic Acids|nicotinic acids|mesh-list
5596033|NCT03743636|Resveratrol|resveratrol|mesh-list
5596034|NCT03743636|Antioxidants|antioxidants|mesh-ancestor
5596035|NCT03743636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596036|NCT03743636|Protective Agents|protective agents|mesh-ancestor
5596037|NCT03743636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596038|NCT03743636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5596039|NCT03743636|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5596040|NCT03743636|Vitamin B Complex|vitamin b complex|mesh-ancestor
5596041|NCT03743636|Vitamins|vitamins|mesh-ancestor
5596042|NCT03743636|Micronutrients|micronutrients|mesh-ancestor
5596043|NCT03743636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5596044|NCT03743636|Antimetabolites|antimetabolites|mesh-ancestor
5596045|NCT03743636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5596046|NCT03743636|Vasodilator Agents|vasodilator agents|mesh-ancestor
5596047|NCT03743428|Bevacizumab|bevacizumab|mesh-list
5596048|NCT03743428|Apatinib|apatinib|mesh-list
5596049|NCT03743428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5596050|NCT03743428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5596051|NCT03743428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5596052|NCT03743428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5596053|NCT03743428|Growth Substances|growth substances|mesh-ancestor
5596054|NCT03743428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596055|NCT03743428|Growth Inhibitors|growth inhibitors|mesh-ancestor
5596056|NCT03743428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5596057|NCT03743428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5596058|NCT03743428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596059|NCT03743376|UB-421|ub-421|mesh-list
5596060|NCT03743376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5596061|NCT03743376|Antiviral Agents|antiviral agents|mesh-ancestor
5596062|NCT03743376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5596063|NCT03743285|Insulin Lispro|insulin lispro|mesh-list
5596064|NCT03743285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5596065|NCT03743285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596066|NCT03743259|Charcoal|charcoal|mesh-list
5596067|NCT03743259|Antidotes|antidotes|mesh-ancestor
5596068|NCT03743259|Protective Agents|protective agents|mesh-ancestor
5596069|NCT03743259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596070|NCT03743246|Cyclophosphamide|cyclophosphamide|mesh-list
5596071|NCT03743246|Fludarabine|fludarabine|mesh-list
5596072|NCT03743246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5596073|NCT03743246|Immunologic Factors|immunologic factors|mesh-ancestor
5596074|NCT03743246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596075|NCT03743246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5596076|NCT03743246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5596077|NCT03743246|Alkylating Agents|alkylating agents|mesh-ancestor
5596078|NCT03743246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596079|NCT03743246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5596080|NCT03743246|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5596081|NCT03743103|Nitroprusside|nitroprusside|mesh-list
5596082|NCT03743103|Esmolol|esmolol|mesh-list
5596083|NCT03743103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5596084|NCT03743103|Vasodilator Agents|vasodilator agents|mesh-ancestor
5596085|NCT03743103|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5596086|NCT03743103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596087|NCT03743103|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5596088|NCT03743103|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5596089|NCT03743103|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5596090|NCT03743103|Adrenergic Agents|adrenergic agents|mesh-ancestor
5596091|NCT03743103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5596092|NCT03743103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596093|NCT03743025|Dulaglutide|dulaglutide|mesh-list
5596094|NCT03743025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5596095|NCT03743025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201877|NCT02032433|Narcotics|narcotics|mesh-ancestor
6201878|NCT02032433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6201879|NCT02032433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201880|NCT02032433|Analgesics|analgesics|mesh-ancestor
6201881|NCT02032433|Sensory System Agents|sensory system agents|mesh-ancestor
6201882|NCT02032433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6201883|NCT02032433|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6201884|NCT02032433|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6201885|NCT02032758|Propranolol|propranolol|mesh-list
6201886|NCT02032758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6201887|NCT02032758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6201888|NCT02032758|Adrenergic Agents|adrenergic agents|mesh-ancestor
6201889|NCT02032758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6201890|NCT02032758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201891|NCT02032758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201892|NCT02032758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6201893|NCT02032758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6201894|NCT02032758|Vasodilator Agents|vasodilator agents|mesh-ancestor
6201895|NCT02032810|Ipilimumab|ipilimumab|mesh-list
6488364|NCT00583427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6201896|NCT02032810|Panobinostat|panobinostat|mesh-list
6201897|NCT02032810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6201898|NCT02032810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6201899|NCT02032810|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6201900|NCT02032810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201901|NCT02032810|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5596123|NCT03742947|Hemostatics|hemostatics|mesh-list
5596124|NCT03742947|Coagulants|coagulants|mesh-ancestor
5596125|NCT03742921|Romidepsin|romidepsin|mesh-list
5596126|NCT03742921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5596127|NCT03742921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5596128|NCT03742908|Clindamycin|clindamycin|mesh-list
5596129|NCT03742908|Clindamycin palmitate|clindamycin palmitate|mesh-list
5596130|NCT03742908|Clindamycin phosphate|clindamycin phosphate|mesh-list
5596131|NCT03742908|Cefazolin|cefazolin|mesh-list
5596132|NCT03742908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5596133|NCT03742908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5596134|NCT03742908|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5596135|NCT03742908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5596136|NCT03742908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606147|NCT04914234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5606148|NCT04914234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606149|NCT04911062|Epinephrine|epinephrine|mesh-list
5606150|NCT04911062|Bupivacaine|bupivacaine|mesh-list
5606151|NCT04911062|Anesthetics, Local|anesthetics, local|mesh-ancestor
5606152|NCT04911062|Anesthetics|anesthetics|mesh-ancestor
5606153|NCT04911062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5606154|NCT04911062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606155|NCT04911062|Sensory System Agents|sensory system agents|mesh-ancestor
5606156|NCT04911062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5606157|NCT04911062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5606158|NCT04911062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5606159|NCT04911062|Adrenergic Agents|adrenergic agents|mesh-ancestor
5606160|NCT04911062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5606161|NCT04911062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606162|NCT04911062|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5606163|NCT04911062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5606164|NCT04911062|Autonomic Agents|autonomic agents|mesh-ancestor
5606165|NCT04911062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5606166|NCT04911062|Respiratory System Agents|respiratory system agents|mesh-ancestor
5606167|NCT04911062|Mydriatics|mydriatics|mesh-ancestor
5606168|NCT04911062|Sympathomimetics|sympathomimetics|mesh-ancestor
5606169|NCT04911062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5606170|NCT04896697|Pembrolizumab|pembrolizumab|mesh-list
5606171|NCT04896697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5606172|NCT04896697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5606173|NCT04857307|Alprazolam|alprazolam|mesh-list
5606174|NCT04857307|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5606175|NCT04857307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5606176|NCT04857307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606177|NCT04857307|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5606178|NCT04857307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5606179|NCT04857307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5606180|NCT04857307|GABA Modulators|gaba modulators|mesh-ancestor
5606181|NCT04857307|GABA Agents|gaba agents|mesh-ancestor
5606182|NCT04857307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5606183|NCT04857307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606184|NCT04855526|Dronabinol|dronabinol|mesh-list
5606185|NCT04855526|Hallucinogens|hallucinogens|mesh-ancestor
5606186|NCT04855526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606187|NCT04855526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5606188|NCT04855526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5606189|NCT04855526|Analgesics|analgesics|mesh-ancestor
5606190|NCT04855526|Sensory System Agents|sensory system agents|mesh-ancestor
5606191|NCT04855526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5606192|NCT04855526|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5606193|NCT04855526|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5606194|NCT04855526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5606195|NCT04855526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606196|NCT04855526|Hormones|hormones|mesh-ancestor
5606197|NCT04855526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5606198|NCT04842552|Hydralazine|hydralazine|mesh-list
5606199|NCT04842552|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5606200|NCT04842552|Vasodilator Agents|vasodilator agents|mesh-ancestor
5606201|NCT04825652|177Lu-PSMA-617|177lu-psma-617|mesh-list
5606202|NCT04825652|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5606203|NCT04825652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606204|NCT04818944|Tirofiban|tirofiban|mesh-list
5606205|NCT04818944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5606206|NCT04818944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5606207|NCT04818944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606208|NCT04818944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5606209|NCT04812951|Cyclosporine|cyclosporine|mesh-list
5606210|NCT04812951|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5606211|NCT04812951|Cyclosporins|cyclosporins|mesh-list
5606212|NCT04812951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5596137|NCT03742713|Docetaxel|docetaxel|mesh-list
5596138|NCT03742713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5596139|NCT03742713|Tubulin Modulators|tubulin modulators|mesh-ancestor
5596140|NCT03742713|Antimitotic Agents|antimitotic agents|mesh-ancestor
5596141|NCT03742713|Mitosis Modulators|mitosis modulators|mesh-ancestor
5596142|NCT03742713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596143|NCT03742557|Ketamine|ketamine|mesh-list
5596144|NCT03742557|Analgesics|analgesics|mesh-ancestor
5596145|NCT03742557|Sensory System Agents|sensory system agents|mesh-ancestor
5596146|NCT03742557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5596147|NCT03742557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596148|NCT03742557|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5596149|NCT03742557|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5596150|NCT03742557|Anesthetics, General|anesthetics, general|mesh-ancestor
5596151|NCT03742557|Anesthetics|anesthetics|mesh-ancestor
5596152|NCT03742557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5596153|NCT03742557|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5596154|NCT03742557|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5596155|NCT03742557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5596156|NCT03742557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596157|NCT03742531|Oxytocin|oxytocin|mesh-list
5596158|NCT03742531|Oxytocics|oxytocics|mesh-ancestor
5596159|NCT03742531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5596160|NCT03742531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596161|NCT03742466|Methylprednisolone|methylprednisolone|mesh-list
5596162|NCT03742466|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5596163|NCT03742466|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5596164|NCT03742466|Prednisolone|prednisolone|mesh-list
5596165|NCT03742466|Prednisolone acetate|prednisolone acetate|mesh-list
5596166|NCT03742466|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5596167|NCT03742466|Prednisolone phosphate|prednisolone phosphate|mesh-list
5596168|NCT03742466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5596169|NCT03742466|Antiemetics|antiemetics|mesh-ancestor
5596170|NCT03742466|Autonomic Agents|autonomic agents|mesh-ancestor
5596171|NCT03742466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5596172|NCT03742466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596173|NCT03742466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5596174|NCT03742466|Glucocorticoids|glucocorticoids|mesh-ancestor
5596175|NCT03742466|Hormones|hormones|mesh-ancestor
5596176|NCT03742466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5596177|NCT03742466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5596178|NCT03742466|Protective Agents|protective agents|mesh-ancestor
5596179|NCT03742466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5596180|NCT03742466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5596181|NCT03742336|Dabigatran|dabigatran|mesh-list
5596182|NCT03742336|Abrocitinib|abrocitinib|mesh-list
5596183|NCT03742336|Antithrombins|antithrombins|mesh-ancestor
5596184|NCT03742336|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5596185|NCT03742336|Protease Inhibitors|protease inhibitors|mesh-ancestor
5596186|NCT03742336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5596187|NCT03742336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596188|NCT03742336|Anticoagulants|anticoagulants|mesh-ancestor
5596189|NCT03742336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5596190|NCT03742323|Idelalisib|idelalisib|mesh-list
5596191|NCT03742323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5596192|NCT03742323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5596193|NCT03742323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596194|NCT03742310|Vitamin D|vitamin d|mesh-list
5596195|NCT03742310|Calcitriol|calcitriol|mesh-list
5596196|NCT03742310|Vitamins|vitamins|mesh-ancestor
5596197|NCT03742310|Micronutrients|micronutrients|mesh-ancestor
5596198|NCT03742310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596199|NCT03742310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5596200|NCT03742310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5596201|NCT03742310|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
5596202|NCT03742310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5596203|NCT03742310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596204|NCT03742310|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5596205|NCT03742297|Dexamethasone|dexamethasone|mesh-list
5596206|NCT03742297|Prednisone|prednisone|mesh-list
5596207|NCT03742297|Lenalidomide|lenalidomide|mesh-list
5596208|NCT03742297|Bortezomib|bortezomib|mesh-list
5596209|NCT03742297|Melphalan|melphalan|mesh-list
5596210|NCT03742297|Daratumumab|daratumumab|mesh-list
5596211|NCT03742297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5596212|NCT03742297|Antiemetics|antiemetics|mesh-ancestor
5596213|NCT03742297|Autonomic Agents|autonomic agents|mesh-ancestor
5596214|NCT03742297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5596215|NCT03742297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596216|NCT03742297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5596217|NCT03742297|Glucocorticoids|glucocorticoids|mesh-ancestor
5596218|NCT03742297|Hormones|hormones|mesh-ancestor
5596219|NCT03742297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5596220|NCT03742297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5596221|NCT03742297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5596222|NCT03742297|Immunologic Factors|immunologic factors|mesh-ancestor
5596223|NCT03742297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5596224|NCT03742297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5596225|NCT03742297|Growth Substances|growth substances|mesh-ancestor
5596226|NCT03742297|Growth Inhibitors|growth inhibitors|mesh-ancestor
5596227|NCT03742297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5596228|NCT03742297|Alkylating Agents|alkylating agents|mesh-ancestor
5596229|NCT03742297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596230|NCT03742297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5596231|NCT03742297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5596232|NCT03742258|Prednisone|prednisone|mesh-list
5596233|NCT03742258|Cortisone|cortisone|mesh-list
5596234|NCT03742258|Cyclophosphamide|cyclophosphamide|mesh-list
5596235|NCT03742258|Rituximab|rituximab|mesh-list
5596236|NCT03742258|Doxorubicin|doxorubicin|mesh-list
5596237|NCT03742258|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5596238|NCT03742258|Vincristine|vincristine|mesh-list
5596239|NCT03742258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5596240|NCT03742258|Antibodies|antibodies|mesh-list
5596241|NCT03742258|Immunoglobulins|immunoglobulins|mesh-list
5596242|NCT03742258|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5596243|NCT03742258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5596244|NCT03742258|Immunologic Factors|immunologic factors|mesh-ancestor
5596245|NCT03742258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596246|NCT03742258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5596247|NCT03742258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5596248|NCT03742258|Alkylating Agents|alkylating agents|mesh-ancestor
5596249|NCT03742258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596250|NCT03742258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5596251|NCT03742258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5596252|NCT03742258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5596253|NCT03742258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5596254|NCT03742258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5596255|NCT03742258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5596256|NCT03742258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5596257|NCT03742258|Glucocorticoids|glucocorticoids|mesh-ancestor
5596258|NCT03742258|Hormones|hormones|mesh-ancestor
5596259|NCT03742258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5596260|NCT03742258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5596261|NCT03742258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5596262|NCT03742258|Tubulin Modulators|tubulin modulators|mesh-ancestor
5596263|NCT03742258|Antimitotic Agents|antimitotic agents|mesh-ancestor
5596264|NCT03742258|Mitosis Modulators|mitosis modulators|mesh-ancestor
5596265|NCT03742245|Olaparib|olaparib|mesh-list
5596266|NCT03742245|Vorinostat|vorinostat|mesh-list
5596267|NCT03742245|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5596268|NCT03742245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5596269|NCT03742245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596270|NCT03742245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5596271|NCT03742245|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5596272|NCT03742232|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
5596273|NCT03742232|Laxatives|laxatives|mesh-ancestor
5596274|NCT03742232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5596275|NCT03742193|Apatinib|apatinib|mesh-list
5596276|NCT03742193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5596277|NCT03742193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5596278|NCT03742193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5596279|NCT03742193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596280|NCT03742180|Ketorolac|ketorolac|mesh-list
5596281|NCT03742180|Dexmedetomidine|dexmedetomidine|mesh-list
5596282|NCT03742180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5596283|NCT03742180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5596284|NCT03742180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596285|NCT03742180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5596286|NCT03742180|Analgesics|analgesics|mesh-ancestor
5596287|NCT03742180|Sensory System Agents|sensory system agents|mesh-ancestor
5596288|NCT03742180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5596289|NCT03742180|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5596290|NCT03742180|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5596291|NCT03742180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5596292|NCT03742180|Adrenergic Agents|adrenergic agents|mesh-ancestor
5596293|NCT03742180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5596294|NCT03742180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596295|NCT03742180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5596296|NCT03742180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5596297|NCT03742180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5596298|NCT03742180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5596299|NCT03742180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5596300|NCT03742115|Dexamethasone|dexamethasone|mesh-list
5596301|NCT03742115|Etoposide|etoposide|mesh-list
5596302|NCT03742115|Etoposide phosphate|etoposide phosphate|mesh-list
5596303|NCT03742115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5596304|NCT03742115|Antiemetics|antiemetics|mesh-ancestor
5596305|NCT03742115|Autonomic Agents|autonomic agents|mesh-ancestor
5596306|NCT03742115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5596307|NCT03742115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596308|NCT03742115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5596309|NCT03742115|Glucocorticoids|glucocorticoids|mesh-ancestor
5596310|NCT03742115|Hormones|hormones|mesh-ancestor
5596311|NCT03742115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5596312|NCT03742115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5596313|NCT03742115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5596314|NCT03742115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5596315|NCT03742115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5596316|NCT03742115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5596317|NCT03742115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5596318|NCT03742115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596319|NCT03741933|Apremilast|apremilast|mesh-list
5596320|NCT03741933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5596321|NCT03741933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5596322|NCT03741933|Analgesics|analgesics|mesh-ancestor
5596323|NCT03741933|Sensory System Agents|sensory system agents|mesh-ancestor
5596324|NCT03741933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5596325|NCT03741933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596326|NCT03741933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5596327|NCT03741933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5596328|NCT03741933|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5596329|NCT03741933|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5596330|NCT03741933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5596331|NCT03741933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596332|NCT03741894|Chlorhexidine|chlorhexidine|mesh-list
5596333|NCT03741894|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5596334|NCT03741894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5596335|NCT03741894|Disinfectants|disinfectants|mesh-ancestor
5596336|NCT03741686|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
5596337|NCT03741686|Cathartics|cathartics|mesh-ancestor
5596338|NCT03741686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5596339|NCT03741660|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
5596340|NCT03741660|Cathartics|cathartics|mesh-ancestor
5596341|NCT03741660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5596342|NCT03741621|Psyllium|psyllium|mesh-list
5596343|NCT03741621|Cathartics|cathartics|mesh-ancestor
5596344|NCT03741621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5596345|NCT03741517|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5596346|NCT03741517|Edotreotide|edotreotide|mesh-list
5596347|NCT03741517|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5596348|NCT03741517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596349|NCT03741478|Insulin|insulin|mesh-list
5596350|NCT03741478|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5596351|NCT03741478|Insulin Lispro|insulin lispro|mesh-list
5596352|NCT03741478|Olanzapine|olanzapine|mesh-list
5596353|NCT03741478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5596354|NCT03741478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596355|NCT03741478|Antiemetics|antiemetics|mesh-ancestor
5596356|NCT03741478|Autonomic Agents|autonomic agents|mesh-ancestor
5596357|NCT03741478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5596358|NCT03741478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5596359|NCT03741478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5596360|NCT03741478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5596361|NCT03741478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5596362|NCT03741478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5596363|NCT03741478|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5607021|NCT03031730|Dexamethasone acetate|dexamethasone acetate|mesh-list
5596364|NCT03741478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5596365|NCT03741478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5596366|NCT03741478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596367|NCT03741478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5596368|NCT03741478|Serotonin Agents|serotonin agents|mesh-ancestor
5596369|NCT03741426|Durvalumab|durvalumab|mesh-list
5596370|NCT03741426|Olaparib|olaparib|mesh-list
5596371|NCT03741426|Cediranib|cediranib|mesh-list
5596372|NCT03741426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5596373|NCT03741426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5596374|NCT03741426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5596375|NCT03741426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5596376|NCT03741426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596377|NCT03741426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5596378|NCT03741309|Calcium|calcium|mesh-list
5596379|NCT03741309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5596380|NCT03741309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596381|NCT03741244|Temozolomide|temozolomide|mesh-list
5596382|NCT03741244|Apatinib|apatinib|mesh-list
5596383|NCT03741244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5596384|NCT03741244|Alkylating Agents|alkylating agents|mesh-ancestor
5596385|NCT03741244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596386|NCT03741244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5596387|NCT03741244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5596388|NCT03741244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5596389|NCT03741101|Trametinib|trametinib|mesh-list
5596390|NCT03741101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5596391|NCT03741101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5596392|NCT03741101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5596393|NCT03741101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606213|NCT04812951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606214|NCT04812951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5606215|NCT04812951|Immunologic Factors|immunologic factors|mesh-ancestor
5606216|NCT04812951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606217|NCT04812951|Antifungal Agents|antifungal agents|mesh-ancestor
5606218|NCT04812951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5606219|NCT04812951|Dermatologic Agents|dermatologic agents|mesh-ancestor
5606220|NCT04812951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5606221|NCT04812951|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5606222|NCT04812951|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5606223|NCT04772313|Methotrexate|methotrexate|mesh-list
5606224|NCT04772313|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5606225|NCT04772313|Abortifacient Agents|abortifacient agents|mesh-ancestor
5606226|NCT04772313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5606227|NCT04772313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606228|NCT04772313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5606229|NCT04772313|Antimetabolites|antimetabolites|mesh-ancestor
5606230|NCT04772313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606231|NCT04772313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5606232|NCT04772313|Dermatologic Agents|dermatologic agents|mesh-ancestor
5606233|NCT04772313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5606234|NCT04772313|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5606235|NCT04772313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5606236|NCT04772313|Immunologic Factors|immunologic factors|mesh-ancestor
5606237|NCT04772313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5606238|NCT04772313|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5606239|NCT04756401|Dexamethasone|dexamethasone|mesh-list
5606240|NCT04756401|Dexamethasone acetate|dexamethasone acetate|mesh-list
5606241|NCT04756401|Daratumumab|daratumumab|mesh-list
5606242|NCT04756401|Ichthammol|ichthammol|mesh-list
5606243|NCT04756401|BB 1101|bb 1101|mesh-list
5596394|NCT03741075|Tranexamic Acid|tranexamic acid|mesh-list
5596395|NCT03741075|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5596396|NCT03741075|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5596397|NCT03741075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596398|NCT03741075|Hemostatics|hemostatics|mesh-ancestor
5596399|NCT03741075|Coagulants|coagulants|mesh-ancestor
5596400|NCT03740945|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
5596401|NCT03740945|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5596402|NCT03740945|Immunologic Factors|immunologic factors|mesh-ancestor
5596403|NCT03740945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596404|NCT03740893|Durvalumab|durvalumab|mesh-list
5596405|NCT03740893|Olaparib|olaparib|mesh-list
5596406|NCT03740893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5596407|NCT03740893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5596408|NCT03740893|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5596409|NCT03740893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5596410|NCT03740893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596411|NCT03740581|Insulin|insulin|mesh-list
5596412|NCT03740581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5596413|NCT03740581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596414|NCT03740568|Progesterone|progesterone|mesh-list
5596415|NCT03740568|Progestins|progestins|mesh-ancestor
5596416|NCT03740568|Hormones|hormones|mesh-ancestor
5596417|NCT03740568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5596418|NCT03740568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596419|NCT03740516|Apremilast|apremilast|mesh-list
5596420|NCT03740516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5596421|NCT03740516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5596422|NCT03740516|Analgesics|analgesics|mesh-ancestor
5596423|NCT03740516|Sensory System Agents|sensory system agents|mesh-ancestor
5596424|NCT03740516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5596425|NCT03740516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596426|NCT03740516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5596427|NCT03740516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5596428|NCT03740516|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5596429|NCT03740516|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5596430|NCT03740516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5596431|NCT03740516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596432|NCT03740464|Sargramostim|sargramostim|mesh-list
5596433|NCT03740464|Lenograstim|lenograstim|mesh-list
5596434|NCT03740464|Immunologic Factors|immunologic factors|mesh-ancestor
5596435|NCT03740464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596436|NCT03740464|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5596437|NCT03740399|Anesthetics|anesthetics|mesh-list
5596438|NCT03740399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5596439|NCT03740399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596440|NCT03740386|Phentolamine|phentolamine|mesh-list
5596441|NCT03740386|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5596442|NCT03740386|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5596443|NCT03740386|Adrenergic Agents|adrenergic agents|mesh-ancestor
5596444|NCT03740386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5596445|NCT03740386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596446|NCT03740386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596447|NCT03740386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5596448|NCT03740373|Budesonide|budesonide|mesh-list
5596449|NCT03740373|Glycopyrrolate|glycopyrrolate|mesh-list
5596450|NCT03740373|Formoterol Fumarate|formoterol fumarate|mesh-list
5596451|NCT03740373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5596452|NCT03740373|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5596453|NCT03740373|Autonomic Agents|autonomic agents|mesh-ancestor
5596454|NCT03740373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5596455|NCT03740373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596456|NCT03740373|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5596457|NCT03740373|Respiratory System Agents|respiratory system agents|mesh-ancestor
5596458|NCT03740373|Glucocorticoids|glucocorticoids|mesh-ancestor
5596459|NCT03740373|Hormones|hormones|mesh-ancestor
5596460|NCT03740373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5596461|NCT03740373|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5596462|NCT03740373|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5596463|NCT03740373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5596464|NCT03740373|Adrenergic Agents|adrenergic agents|mesh-ancestor
5596465|NCT03740373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5596466|NCT03740373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596467|NCT03740373|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5596468|NCT03740373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5596469|NCT03740373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5596470|NCT03740373|Cholinergic Agents|cholinergic agents|mesh-ancestor
5596471|NCT03740295|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
5596472|NCT03740295|Antioxidants|antioxidants|mesh-ancestor
5596473|NCT03740295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596474|NCT03740295|Protective Agents|protective agents|mesh-ancestor
5596475|NCT03740295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596476|NCT03740295|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
5596477|NCT03740295|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5596478|NCT03740295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5596479|NCT03740295|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5596480|NCT03740243|Buprenorphine|buprenorphine|mesh-list
5596481|NCT03740243|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
5596482|NCT03740243|Naloxone|naloxone|mesh-list
5596483|NCT03740243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5596484|NCT03740243|Narcotics|narcotics|mesh-ancestor
5596485|NCT03740243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5596486|NCT03740243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596487|NCT03740243|Analgesics|analgesics|mesh-ancestor
5596488|NCT03740243|Sensory System Agents|sensory system agents|mesh-ancestor
5596489|NCT03740243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5596490|NCT03740243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5596491|NCT03740178|Donepezil|donepezil|mesh-list
5596492|NCT03740178|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5596493|NCT03740178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5596494|NCT03740178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596495|NCT03740178|Cholinergic Agents|cholinergic agents|mesh-ancestor
5596496|NCT03740178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5596497|NCT03740178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596498|NCT03740178|Nootropic Agents|nootropic agents|mesh-ancestor
5596499|NCT03740165|Paclitaxel|paclitaxel|mesh-list
5596500|NCT03740165|Docetaxel|docetaxel|mesh-list
5596501|NCT03740165|Bevacizumab|bevacizumab|mesh-list
5596502|NCT03740165|Carboplatin|carboplatin|mesh-list
5596503|NCT03740165|Pembrolizumab|pembrolizumab|mesh-list
5596504|NCT03740165|Olaparib|olaparib|mesh-list
5596505|NCT03740165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5596506|NCT03740165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5596507|NCT03740165|Tubulin Modulators|tubulin modulators|mesh-ancestor
5596508|NCT03740165|Antimitotic Agents|antimitotic agents|mesh-ancestor
5596509|NCT03740165|Mitosis Modulators|mitosis modulators|mesh-ancestor
5596510|NCT03740165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596511|NCT03740165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5596512|NCT03740165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5596513|NCT03740165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5596514|NCT03740165|Growth Substances|growth substances|mesh-ancestor
5596515|NCT03740165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596516|NCT03740165|Growth Inhibitors|growth inhibitors|mesh-ancestor
5596517|NCT03740165|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5596518|NCT03740165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5596519|NCT03740126|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5596520|NCT03740126|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5596521|NCT03740126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596522|NCT03739853|Sulfasalazine|sulfasalazine|mesh-list
5596523|NCT03739853|Adalimumab|adalimumab|mesh-list
5596524|NCT03739853|Methotrexate|methotrexate|mesh-list
5596525|NCT03739853|Leflunomide|leflunomide|mesh-list
5596526|NCT03739853|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5596527|NCT03739853|Abortifacient Agents|abortifacient agents|mesh-ancestor
5596528|NCT03739853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5596529|NCT03739853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596530|NCT03739853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5596531|NCT03739853|Antimetabolites|antimetabolites|mesh-ancestor
5607022|NCT03031730|Lenalidomide|lenalidomide|mesh-list
5596532|NCT03739853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596533|NCT03739853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5596534|NCT03739853|Dermatologic Agents|dermatologic agents|mesh-ancestor
5596535|NCT03739853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5596536|NCT03739853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5596537|NCT03739853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5596538|NCT03739853|Immunologic Factors|immunologic factors|mesh-ancestor
5596539|NCT03739853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5596540|NCT03739853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5596541|NCT03739853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5596542|NCT03739853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5596543|NCT03739853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5596544|NCT03739853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5596545|NCT03739853|Analgesics|analgesics|mesh-ancestor
5596546|NCT03739853|Sensory System Agents|sensory system agents|mesh-ancestor
5596547|NCT03739853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5596548|NCT03739853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5596549|NCT03739801|Irinotecan|irinotecan|mesh-list
5596550|NCT03739801|Ramucirumab|ramucirumab|mesh-list
5596551|NCT03739801|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5596552|NCT03739801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5596553|NCT03739801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5596554|NCT03739801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596555|NCT03739801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5596556|NCT03739788|BMS-986165|bms-986165|mesh-list
5596557|NCT03739788|Dermatologic Agents|dermatologic agents|mesh-ancestor
5596558|NCT03739788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5596559|NCT03739788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5596560|NCT03739788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596561|NCT03739671|Vitamin D|vitamin d|mesh-list
5596562|NCT03739671|Ergocalciferols|ergocalciferols|mesh-list
5596563|NCT03739671|Vitamins|vitamins|mesh-list
5596564|NCT03739671|Micronutrients|micronutrients|mesh-ancestor
5596565|NCT03739671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596566|NCT03739671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5596567|NCT03739671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5596568|NCT03739619|Gemcitabine|gemcitabine|mesh-list
5596569|NCT03739619|Nivolumab|nivolumab|mesh-list
5596570|NCT03739619|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5596571|NCT03739619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5596572|NCT03739619|Antimetabolites|antimetabolites|mesh-ancestor
5596573|NCT03739619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596574|NCT03739619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5596575|NCT03739619|Antiviral Agents|antiviral agents|mesh-ancestor
5596576|NCT03739619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5596577|NCT03739619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5596578|NCT03739619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5596579|NCT03739619|Immunologic Factors|immunologic factors|mesh-ancestor
5596580|NCT03739619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596581|NCT03739619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5596582|NCT03739619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5596583|NCT03739619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5596584|NCT03739619|Alkylating Agents|alkylating agents|mesh-ancestor
5596585|NCT03739606|Antibodies|antibodies|mesh-list
5596586|NCT03739606|Immunoglobulins|immunoglobulins|mesh-list
5596587|NCT03739606|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5596588|NCT03739606|Antibodies, Bispecific|antibodies, bispecific|mesh-list
5596589|NCT03739606|Immunologic Factors|immunologic factors|mesh-ancestor
5596590|NCT03739606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596591|NCT03739554|Venetoclax|venetoclax|mesh-list
5596592|NCT03739554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5596593|NCT03739541|Benzonidazole|benzonidazole|mesh-list
5596594|NCT03739541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5596595|NCT03739541|Immunologic Factors|immunologic factors|mesh-ancestor
5596596|NCT03739541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596597|NCT03739541|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5596598|NCT03739541|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5596599|NCT03739541|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5596600|NCT03739541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5596601|NCT03739476|Quetiapine Fumarate|quetiapine fumarate|mesh-list
5596602|NCT03739476|Antidepressive Agents|antidepressive agents|mesh-ancestor
5596603|NCT03739476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5596604|NCT03739476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5596605|NCT03739476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5596606|NCT03739476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5596607|NCT03739476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596608|NCT03739411|Temozolomide|temozolomide|mesh-list
5596609|NCT03739411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5596610|NCT03739411|Alkylating Agents|alkylating agents|mesh-ancestor
5596611|NCT03739411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596612|NCT03739411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5596613|NCT03739333|Carbon-11 methionine|carbon-11 methionine|mesh-list
5596614|NCT03739333|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5596615|NCT03739333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596616|NCT03739294|Fluticasone|fluticasone|mesh-list
5596617|NCT03739294|Xhance|xhance|mesh-list
5596618|NCT03739294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5596619|NCT03739294|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5596620|NCT03739294|Autonomic Agents|autonomic agents|mesh-ancestor
5596621|NCT03739294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5596622|NCT03739294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596623|NCT03739294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5596624|NCT03739294|Respiratory System Agents|respiratory system agents|mesh-ancestor
5596625|NCT03739294|Dermatologic Agents|dermatologic agents|mesh-ancestor
5596626|NCT03739294|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5606244|NCT04756401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5606245|NCT04756401|Antiemetics|antiemetics|mesh-ancestor
5606246|NCT04756401|Autonomic Agents|autonomic agents|mesh-ancestor
5606247|NCT04756401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5606248|NCT04756401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606249|NCT04756401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5606250|NCT04756401|Glucocorticoids|glucocorticoids|mesh-ancestor
5606251|NCT04756401|Hormones|hormones|mesh-ancestor
5606252|NCT04756401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5606253|NCT04756401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5606254|NCT04756401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5606255|NCT04756401|Protease Inhibitors|protease inhibitors|mesh-ancestor
5606256|NCT04756401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5606257|NCT04756401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606258|NCT04756401|Dermatologic Agents|dermatologic agents|mesh-ancestor
5606259|NCT04754321|Pembrolizumab|pembrolizumab|mesh-list
5606260|NCT04754321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5606261|NCT04754321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5606969|NCT03220178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5606970|NCT03220178|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5606971|NCT03220178|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5606972|NCT03220178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5606973|NCT03220178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606974|NCT03220178|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5606975|NCT03220178|Hormone Antagonists|hormone antagonists|mesh-ancestor
5606976|NCT03220178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5606977|NCT03220178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606978|NCT03220178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5606979|NCT03220178|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5606980|NCT03220178|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5606981|NCT03122301|Bupivacaine|bupivacaine|mesh-list
5606982|NCT03122301|Anesthetics, Local|anesthetics, local|mesh-ancestor
5606983|NCT03122301|Anesthetics|anesthetics|mesh-ancestor
5606984|NCT03122301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5606985|NCT03122301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606986|NCT03122301|Sensory System Agents|sensory system agents|mesh-ancestor
5606987|NCT03122301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5606988|NCT03085147|Olaparib|olaparib|mesh-list
5606989|NCT03085147|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5606990|NCT03085147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5606991|NCT03085147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606992|NCT03085147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5606993|NCT03038672|Nivolumab|nivolumab|mesh-list
5606994|NCT03038672|Immunoglobulins|immunoglobulins|mesh-list
5606995|NCT03038672|Immunoglobulin G|immunoglobulin g|mesh-list
5606996|NCT03038672|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5606997|NCT03038672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5606998|NCT03038672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5606999|NCT03038672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5607000|NCT03038672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607001|NCT03038672|Immunologic Factors|immunologic factors|mesh-ancestor
5607002|NCT03038672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607003|NCT03034356|Levetiracetam|levetiracetam|mesh-list
5607004|NCT03034356|Anticonvulsants|anticonvulsants|mesh-ancestor
5596630|NCT03739112|Vaccines|vaccines|mesh-list
5596631|NCT03739112|Immunologic Factors|immunologic factors|mesh-ancestor
5596632|NCT03739112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596633|NCT03739021|Ropivacaine|ropivacaine|mesh-list
5596634|NCT03739021|Anesthetics, Local|anesthetics, local|mesh-ancestor
5596635|NCT03739021|Anesthetics|anesthetics|mesh-ancestor
5596636|NCT03739021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5596637|NCT03739021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596638|NCT03739021|Sensory System Agents|sensory system agents|mesh-ancestor
5596639|NCT03739021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5596640|NCT03738956|Tofacitinib|tofacitinib|mesh-list
5596641|NCT03738956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5596642|NCT03738956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5596643|NCT03738956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596644|NCT03738943|Pyridoxine|pyridoxine|mesh-list
5596645|NCT03738943|Pyridoxal|pyridoxal|mesh-list
5596646|NCT03738943|Vitamin B 6|vitamin b 6|mesh-list
5596647|NCT03738943|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
5596648|NCT03738943|Adenosine|adenosine|mesh-list
5596649|NCT03738943|Nitroprusside|nitroprusside|mesh-list
5596650|NCT03738943|Acetylcholine|acetylcholine|mesh-list
5596651|NCT03738943|Vitamins|vitamins|mesh-ancestor
5596652|NCT03738943|Micronutrients|micronutrients|mesh-ancestor
5596653|NCT03738943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596654|NCT03738943|Vitamin B Complex|vitamin b complex|mesh-ancestor
5596655|NCT03738943|Analgesics|analgesics|mesh-ancestor
5596656|NCT03738943|Sensory System Agents|sensory system agents|mesh-ancestor
5596657|NCT03738943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5596658|NCT03738943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5596659|NCT03738943|Vasodilator Agents|vasodilator agents|mesh-ancestor
5596660|NCT03738943|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5596661|NCT03738943|Purinergic Agonists|purinergic agonists|mesh-ancestor
5596662|NCT03738943|Purinergic Agents|purinergic agents|mesh-ancestor
5596663|NCT03738943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5596664|NCT03738943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596665|NCT03738943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5596666|NCT03738943|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5596667|NCT03738943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5596668|NCT03738943|Cholinergic Agents|cholinergic agents|mesh-ancestor
5596669|NCT03738917|Bromides|bromides|mesh-list
5596670|NCT03738917|Dextromethorphan|dextromethorphan|mesh-list
5596671|NCT03738917|Ipratropium|ipratropium|mesh-list
5596672|NCT03738917|Cholinergic Antagonists|cholinergic antagonists|mesh-list
5596673|NCT03738917|Anticonvulsants|anticonvulsants|mesh-ancestor
5596674|NCT03738917|Antitussive Agents|antitussive agents|mesh-ancestor
5596675|NCT03738917|Respiratory System Agents|respiratory system agents|mesh-ancestor
5596676|NCT03738917|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5596677|NCT03738917|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5596678|NCT03738917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5596679|NCT03738917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596680|NCT03738917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596681|NCT03738917|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5596682|NCT03738917|Autonomic Agents|autonomic agents|mesh-ancestor
5596683|NCT03738917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5596684|NCT03738917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5596685|NCT03738917|Cholinergic Agents|cholinergic agents|mesh-ancestor
5596686|NCT03738878|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5596687|NCT03738878|Valsartan|valsartan|mesh-list
5596688|NCT03738878|Bradykinin|bradykinin|mesh-list
5596689|NCT03738878|Kininogens|kininogens|mesh-list
5596690|NCT03738878|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5596691|NCT03738878|Substance P|substance p|mesh-list
5596692|NCT03738878|Neurokinin A|neurokinin a|mesh-list
5596693|NCT03738878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5596694|NCT03738878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596695|NCT03738878|Incretins|incretins|mesh-ancestor
5596696|NCT03738878|Hormones|hormones|mesh-ancestor
5596697|NCT03738878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5596698|NCT03738878|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5596699|NCT03738878|Protease Inhibitors|protease inhibitors|mesh-ancestor
5596700|NCT03738878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5596701|NCT03738878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596702|NCT03738878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5596703|NCT03738878|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5596704|NCT03738878|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5596705|NCT03738878|Vasodilator Agents|vasodilator agents|mesh-ancestor
5596706|NCT03738878|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
5596707|NCT03738878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5596708|NCT03738800|Trifarotene|trifarotene|mesh-list
5596709|NCT03738800|Dermatologic Agents|dermatologic agents|mesh-ancestor
5596710|NCT03738579|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5596711|NCT03738579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5596712|NCT03738527|Tranexamic Acid|tranexamic acid|mesh-list
5596713|NCT03738527|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5596714|NCT03738527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5596715|NCT03738527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596716|NCT03738527|Hemostatics|hemostatics|mesh-ancestor
5596717|NCT03738527|Coagulants|coagulants|mesh-ancestor
5596718|NCT03738176|Triamcinolone|triamcinolone|mesh-list
5596719|NCT03738176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5596720|NCT03738176|Glucocorticoids|glucocorticoids|mesh-ancestor
5596721|NCT03738176|Hormones|hormones|mesh-ancestor
5596722|NCT03738176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5596723|NCT03738176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596724|NCT03738137|Lidocaine|lidocaine|mesh-list
5596725|NCT03738137|Midazolam|midazolam|mesh-list
5596726|NCT03738137|Sufentanil|sufentanil|mesh-list
5596727|NCT03738137|Anesthetics, Local|anesthetics, local|mesh-ancestor
5596728|NCT03738137|Anesthetics|anesthetics|mesh-ancestor
5596729|NCT03738137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5596730|NCT03738137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596731|NCT03738137|Sensory System Agents|sensory system agents|mesh-ancestor
5596732|NCT03738137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5596733|NCT03738137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5596734|NCT03738137|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5596735|NCT03738137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5596736|NCT03738137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5596737|NCT03738137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596738|NCT03738137|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5596739|NCT03738137|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5596740|NCT03738137|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5596741|NCT03738137|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5596742|NCT03738137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5596743|NCT03738137|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5596744|NCT03738137|Anesthetics, General|anesthetics, general|mesh-ancestor
5596745|NCT03738137|GABA Modulators|gaba modulators|mesh-ancestor
5596746|NCT03738137|GABA Agents|gaba agents|mesh-ancestor
5596747|NCT03738137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5596748|NCT03738137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5596749|NCT03738137|Narcotics|narcotics|mesh-ancestor
5596750|NCT03738137|Analgesics|analgesics|mesh-ancestor
5596751|NCT03738059|Dexmedetomidine|dexmedetomidine|mesh-list
5596752|NCT03738059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5596753|NCT03738059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5596754|NCT03738059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596755|NCT03738059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5596756|NCT03738059|Analgesics|analgesics|mesh-ancestor
5596757|NCT03738059|Sensory System Agents|sensory system agents|mesh-ancestor
5596758|NCT03738059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5596759|NCT03738059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5596760|NCT03738059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5596761|NCT03738059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5596762|NCT03738059|Adrenergic Agents|adrenergic agents|mesh-ancestor
5596763|NCT03738059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5596764|NCT03738059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596765|NCT03737968|Durvalumab|durvalumab|mesh-list
5596766|NCT03737968|Tremelimumab|tremelimumab|mesh-list
5596767|NCT03737968|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5596768|NCT03737968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5596769|NCT03737968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5596770|NCT03737968|Immunologic Factors|immunologic factors|mesh-ancestor
5596771|NCT03737968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596772|NCT03737773|Methamphetamine|methamphetamine|mesh-list
5596773|NCT03737773|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5596774|NCT03737773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596775|NCT03737773|Sympathomimetics|sympathomimetics|mesh-ancestor
5596776|NCT03737773|Autonomic Agents|autonomic agents|mesh-ancestor
5596777|NCT03737773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5596778|NCT03737773|Dopamine Agents|dopamine agents|mesh-ancestor
5596779|NCT03737773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5596780|NCT03737773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596781|NCT03737773|Adrenergic Agents|adrenergic agents|mesh-ancestor
5596782|NCT03737773|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5596783|NCT03737773|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5596784|NCT03737773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5596785|NCT03737773|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5596786|NCT03737721|Avelumab|avelumab|mesh-list
5596787|NCT03737721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5596788|NCT03737721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5596789|NCT03737708|Adalimumab|adalimumab|mesh-list
5596790|NCT03737708|Methotrexate|methotrexate|mesh-list
5596791|NCT03737708|Abatacept|abatacept|mesh-list
5596792|NCT03737708|Tacrolimus|tacrolimus|mesh-list
5596793|NCT03737708|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5596794|NCT03737708|Abortifacient Agents|abortifacient agents|mesh-ancestor
5596795|NCT03737708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5596796|NCT03737708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596797|NCT03737708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5596798|NCT03737708|Antimetabolites|antimetabolites|mesh-ancestor
5596799|NCT03737708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596800|NCT03737708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5596801|NCT03737708|Dermatologic Agents|dermatologic agents|mesh-ancestor
5596802|NCT03737708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5596803|NCT03737708|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5596804|NCT03737708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5596805|NCT03737708|Immunologic Factors|immunologic factors|mesh-ancestor
5596806|NCT03737708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5596807|NCT03737708|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5596808|NCT03737708|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5596809|NCT03737708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5596810|NCT03737708|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5596811|NCT03737656|Progesterone|progesterone|mesh-list
5596812|NCT03737656|Progestins|progestins|mesh-ancestor
5596813|NCT03737656|Hormones|hormones|mesh-ancestor
5596814|NCT03737656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5596815|NCT03737656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596816|NCT03737474|Brexpiprazole|brexpiprazole|mesh-list
5596817|NCT03737474|Serotonin Agents|serotonin agents|mesh-ancestor
5596818|NCT03737474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5596819|NCT03737474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596820|NCT03737474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596821|NCT03737474|Dopamine Agonists|dopamine agonists|mesh-ancestor
5596822|NCT03737474|Dopamine Agents|dopamine agents|mesh-ancestor
5596823|NCT03737448|Trimetazidine|trimetazidine|mesh-list
5596824|NCT03737448|Vasodilator Agents|vasodilator agents|mesh-ancestor
5596825|NCT03737344|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5596826|NCT03737344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5596827|NCT03737292|Bupivacaine|bupivacaine|mesh-list
5596828|NCT03737292|Anesthetics, Local|anesthetics, local|mesh-ancestor
5596829|NCT03737292|Anesthetics|anesthetics|mesh-ancestor
5596830|NCT03737292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5596831|NCT03737292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596832|NCT03737292|Sensory System Agents|sensory system agents|mesh-ancestor
5596833|NCT03737292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5596834|NCT03737253|Menotropins|menotropins|mesh-list
5596835|NCT03737253|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5596836|NCT03737253|Hormones|hormones|mesh-ancestor
5596837|NCT03737253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5596838|NCT03737253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596839|NCT03737253|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5596840|NCT03737253|Fertility Agents|fertility agents|mesh-ancestor
5596841|NCT03737253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5596842|NCT03737240|Insulin|insulin|mesh-list
5596843|NCT03737240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5596844|NCT03737240|Insulin Aspart|insulin aspart|mesh-list
5596845|NCT03737240|Liraglutide|liraglutide|mesh-list
5596846|NCT03737240|Insulin, Long-Acting|insulin, long-acting|mesh-list
5596847|NCT03737240|Xultophy|xultophy|mesh-list
5596848|NCT03737240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5596849|NCT03737240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596850|NCT03737240|Incretins|incretins|mesh-ancestor
5596851|NCT03737240|Hormones|hormones|mesh-ancestor
5596852|NCT03737240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5606262|NCT04742751|Metformin|metformin|mesh-list
5606263|NCT04742751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5606264|NCT04742751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596853|NCT03737201|Chlorhexidine|chlorhexidine|mesh-list
5596854|NCT03737201|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5596855|NCT03737201|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5596856|NCT03737201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5596857|NCT03737201|Disinfectants|disinfectants|mesh-ancestor
5596858|NCT03737201|Dermatologic Agents|dermatologic agents|mesh-ancestor
5596859|NCT03737123|Gemcitabine|gemcitabine|mesh-list
5596860|NCT03737123|Carboplatin|carboplatin|mesh-list
5596861|NCT03737123|Docetaxel|docetaxel|mesh-list
5596862|NCT03737123|Atezolizumab|atezolizumab|mesh-list
5596863|NCT03737123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5596864|NCT03737123|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5596865|NCT03737123|Antimetabolites|antimetabolites|mesh-ancestor
5596866|NCT03737123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596867|NCT03737123|Antiviral Agents|antiviral agents|mesh-ancestor
5596868|NCT03737123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5596869|NCT03737123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5596870|NCT03737123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5596871|NCT03737123|Immunologic Factors|immunologic factors|mesh-ancestor
5596872|NCT03737123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596873|NCT03737123|Tubulin Modulators|tubulin modulators|mesh-ancestor
5596874|NCT03737123|Antimitotic Agents|antimitotic agents|mesh-ancestor
5596875|NCT03737123|Mitosis Modulators|mitosis modulators|mesh-ancestor
5596876|NCT03736980|Psilocybin|psilocybin|mesh-list
5596877|NCT03736980|Hallucinogens|hallucinogens|mesh-ancestor
5596878|NCT03736980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596879|NCT03736980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5596880|NCT03736863|Apatinib|apatinib|mesh-list
5596881|NCT03736863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5596882|NCT03736863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5596883|NCT03736863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5596884|NCT03736863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596885|NCT03736616|Cytarabine|cytarabine|mesh-list
5596886|NCT03736616|Rituximab|rituximab|mesh-list
5596887|NCT03736616|Carboplatin|carboplatin|mesh-list
5596888|NCT03736616|Etoposide|etoposide|mesh-list
5596889|NCT03736616|Melphalan|melphalan|mesh-list
5596890|NCT03736616|Ifosfamide|ifosfamide|mesh-list
5596891|NCT03736616|Carmustine|carmustine|mesh-list
5596892|NCT03736616|Acalabrutinib|acalabrutinib|mesh-list
5596893|NCT03736616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5596894|NCT03736616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5596895|NCT03736616|Immunologic Factors|immunologic factors|mesh-ancestor
5596896|NCT03736616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596897|NCT03736616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5596898|NCT03736616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5596899|NCT03736616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5596900|NCT03736616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5596901|NCT03736616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5596902|NCT03736616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596903|NCT03736616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5596904|NCT03736616|Antimetabolites|antimetabolites|mesh-ancestor
5596905|NCT03736616|Antiviral Agents|antiviral agents|mesh-ancestor
5596906|NCT03736616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5596907|NCT03736616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5596908|NCT03736616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5596909|NCT03736616|Alkylating Agents|alkylating agents|mesh-ancestor
5596910|NCT03736616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5596911|NCT03736369|Esomeprazole|esomeprazole|mesh-list
5596912|NCT03736369|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5596913|NCT03736369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5596914|NCT03736369|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5596915|NCT03736369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5596916|NCT03736369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596917|NCT03736330|Pembrolizumab|pembrolizumab|mesh-list
5606265|NCT04707625|Aflibercept|aflibercept|mesh-list
5596918|NCT03736330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5596919|NCT03736330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5596920|NCT03736187|Metronidazole|metronidazole|mesh-list
5596921|NCT03736187|Cephalexin|cephalexin|mesh-list
5596922|NCT03736187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5596923|NCT03736187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5596924|NCT03736187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5596925|NCT03736187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5596926|NCT03736161|Methotrexate|methotrexate|mesh-list
5596927|NCT03736161|Tofacitinib|tofacitinib|mesh-list
5596928|NCT03736161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5596929|NCT03736161|Abortifacient Agents|abortifacient agents|mesh-ancestor
5596930|NCT03736161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5596931|NCT03736161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596932|NCT03736161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5596933|NCT03736161|Antimetabolites|antimetabolites|mesh-ancestor
5596934|NCT03736161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596935|NCT03736161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5596936|NCT03736161|Dermatologic Agents|dermatologic agents|mesh-ancestor
5596937|NCT03736161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5596938|NCT03736161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5596939|NCT03736161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5596940|NCT03736161|Immunologic Factors|immunologic factors|mesh-ancestor
5596941|NCT03736161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5596942|NCT03736161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5596943|NCT03736161|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5596944|NCT03736044|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
5596945|NCT03736044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5596946|NCT03735979|Argatroban|argatroban|mesh-list
5596947|NCT03735979|Eptifibatide|eptifibatide|mesh-list
5596948|NCT03735979|Antithrombins|antithrombins|mesh-ancestor
5596949|NCT03735979|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5596950|NCT03735979|Protease Inhibitors|protease inhibitors|mesh-ancestor
5596951|NCT03735979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5596952|NCT03735979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596953|NCT03735979|Anticoagulants|anticoagulants|mesh-ancestor
5596954|NCT03735979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5596955|NCT03735966|Carboplatin|carboplatin|mesh-list
5596956|NCT03735966|Docetaxel|docetaxel|mesh-list
5596957|NCT03735966|Trastuzumab|trastuzumab|mesh-list
5596958|NCT03735966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5596959|NCT03735966|Tubulin Modulators|tubulin modulators|mesh-ancestor
5596960|NCT03735966|Antimitotic Agents|antimitotic agents|mesh-ancestor
5596961|NCT03735966|Mitosis Modulators|mitosis modulators|mesh-ancestor
5596962|NCT03735966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596963|NCT03735966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5596964|NCT03735901|Levodopa|levodopa|mesh-list
5596965|NCT03735901|Carbidopa|carbidopa|mesh-list
5596966|NCT03735901|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5596967|NCT03735901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5596968|NCT03735901|Dopamine Agents|dopamine agents|mesh-ancestor
5596969|NCT03735901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5596970|NCT03735901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596971|NCT03735901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596972|NCT03735901|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5596973|NCT03735901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5596974|NCT03735875|Venetoclax|venetoclax|mesh-list
5596975|NCT03735875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5596976|NCT03735771|Bupivacaine|bupivacaine|mesh-list
5596977|NCT03735771|Anesthetics, Local|anesthetics, local|mesh-ancestor
5596978|NCT03735771|Anesthetics|anesthetics|mesh-ancestor
5596979|NCT03735771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5596980|NCT03735771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596981|NCT03735771|Sensory System Agents|sensory system agents|mesh-ancestor
5596982|NCT03735771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5596983|NCT03735563|Fentanyl|fentanyl|mesh-list
5596984|NCT03735563|Ketamine|ketamine|mesh-list
5596985|NCT03735563|Analgesics|analgesics|mesh-ancestor
5596986|NCT03735563|Sensory System Agents|sensory system agents|mesh-ancestor
5596987|NCT03735563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5596988|NCT03735563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5596989|NCT03735563|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5596990|NCT03735563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5596991|NCT03735563|Anesthetics, General|anesthetics, general|mesh-ancestor
5596992|NCT03735563|Anesthetics|anesthetics|mesh-ancestor
5596993|NCT03735563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5596994|NCT03735563|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5596995|NCT03735563|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5596996|NCT03735563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5596997|NCT03735563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5596998|NCT03735563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5596999|NCT03735563|Narcotics|narcotics|mesh-ancestor
5597000|NCT03735563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5597001|NCT03735537|Zoledronic Acid|zoledronic acid|mesh-list
5597002|NCT03735537|Teriparatide|teriparatide|mesh-list
5597003|NCT03735537|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5597004|NCT03735537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5597005|NCT03735537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597006|NCT03735537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5597007|NCT03735446|Cytarabine|cytarabine|mesh-list
5597008|NCT03735446|Etoposide|etoposide|mesh-list
5597009|NCT03735446|Mitoxantrone|mitoxantrone|mesh-list
5597010|NCT03735446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5597011|NCT03735446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5597012|NCT03735446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5597013|NCT03735446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5597014|NCT03735446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5597015|NCT03735446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5597016|NCT03735446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5597017|NCT03735446|Antimetabolites|antimetabolites|mesh-ancestor
5597018|NCT03735446|Antiviral Agents|antiviral agents|mesh-ancestor
5597019|NCT03735446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5597020|NCT03735446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5597021|NCT03735446|Immunologic Factors|immunologic factors|mesh-ancestor
5597022|NCT03735446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597023|NCT03735446|Analgesics|analgesics|mesh-ancestor
5597024|NCT03735446|Sensory System Agents|sensory system agents|mesh-ancestor
5597025|NCT03735446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5597026|NCT03735433|Aspirin|aspirin|mesh-list
5597027|NCT03735433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5597028|NCT03735433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5597029|NCT03735433|Analgesics|analgesics|mesh-ancestor
5597030|NCT03735433|Sensory System Agents|sensory system agents|mesh-ancestor
5597031|NCT03735433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5597032|NCT03735433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597033|NCT03735433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5597034|NCT03735433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5597035|NCT03735433|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5597036|NCT03735433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5597037|NCT03735433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5597038|NCT03735433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5597039|NCT03735433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5597040|NCT03735433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5597041|NCT03735433|Antipyretics|antipyretics|mesh-ancestor
5597042|NCT03735368|Pregabalin|pregabalin|mesh-list
5597043|NCT03735368|Dexmedetomidine|dexmedetomidine|mesh-list
5597044|NCT03735368|Benoxinate|benoxinate|mesh-list
5597045|NCT03735368|Anesthetics|anesthetics|mesh-ancestor
5597046|NCT03735368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5597047|NCT03735368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597048|NCT03735368|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5597049|NCT03735368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5597050|NCT03735368|Analgesics|analgesics|mesh-ancestor
5597051|NCT03735368|Sensory System Agents|sensory system agents|mesh-ancestor
5597052|NCT03735368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5597053|NCT03735368|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5597054|NCT03735368|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5597055|NCT03735368|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5597056|NCT03735368|Adrenergic Agents|adrenergic agents|mesh-ancestor
5597057|NCT03735368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5597058|NCT03735368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5597059|NCT03735368|Anticonvulsants|anticonvulsants|mesh-ancestor
5597060|NCT03735368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5597061|NCT03735368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5597062|NCT03735368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5597063|NCT03735368|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5597064|NCT03735368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5597065|NCT03735368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5597066|NCT03735368|Anesthetics, Local|anesthetics, local|mesh-ancestor
5606266|NCT04707625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5607005|NCT03034356|Nootropic Agents|nootropic agents|mesh-ancestor
5597067|NCT03735316|Vitamin B 12|vitamin b 12|mesh-list
5597068|NCT03735316|Hydroxocobalamin|hydroxocobalamin|mesh-list
5597069|NCT03735316|Vitamins|vitamins|mesh-ancestor
5597070|NCT03735316|Micronutrients|micronutrients|mesh-ancestor
5597071|NCT03735316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597072|NCT03735316|Vitamin B Complex|vitamin b complex|mesh-ancestor
5597073|NCT03735316|Hematinics|hematinics|mesh-ancestor
5597074|NCT03735290|Pembrolizumab|pembrolizumab|mesh-list
5597075|NCT03735290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5597076|NCT03735290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5597077|NCT03735264|Docetaxel|docetaxel|mesh-list
5597078|NCT03735264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5597079|NCT03735264|Tubulin Modulators|tubulin modulators|mesh-ancestor
5597080|NCT03735264|Antimitotic Agents|antimitotic agents|mesh-ancestor
5597081|NCT03735264|Mitosis Modulators|mitosis modulators|mesh-ancestor
5597082|NCT03735264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5597083|NCT03735251|Metoprolol|metoprolol|mesh-list
5597084|NCT03735251|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
5597085|NCT03735251|Diuretics|diuretics|mesh-list
5597086|NCT03735251|Natriuretic Agents|natriuretic agents|mesh-ancestor
5597087|NCT03735251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597088|NCT03735251|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5597089|NCT03735251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5597090|NCT03735251|Sympatholytics|sympatholytics|mesh-ancestor
5597091|NCT03735251|Autonomic Agents|autonomic agents|mesh-ancestor
5597092|NCT03735251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5597093|NCT03735251|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5597094|NCT03735251|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5597095|NCT03735251|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5597096|NCT03735251|Adrenergic Agents|adrenergic agents|mesh-ancestor
5597097|NCT03735251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5597098|NCT03735251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5597099|NCT03735134|Colchicine|colchicine|mesh-list
5597100|NCT03735134|Gout Suppressants|gout suppressants|mesh-ancestor
5597101|NCT03735134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5597102|NCT03735134|Tubulin Modulators|tubulin modulators|mesh-ancestor
5597103|NCT03735134|Antimitotic Agents|antimitotic agents|mesh-ancestor
5597104|NCT03735134|Mitosis Modulators|mitosis modulators|mesh-ancestor
5597105|NCT03735134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5597106|NCT03735134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5597107|NCT03735095|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
5597108|NCT03735095|Trioxsalen|trioxsalen|mesh-list
5597109|NCT03735095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5597110|NCT03735095|Dermatologic Agents|dermatologic agents|mesh-ancestor
5597111|NCT03735095|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5597112|NCT03735082|Paclitaxel|paclitaxel|mesh-list
5597113|NCT03735082|Carboplatin|carboplatin|mesh-list
5597114|NCT03735082|Apatinib|apatinib|mesh-list
5597115|NCT03735082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5597116|NCT03735082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5597117|NCT03735082|Tubulin Modulators|tubulin modulators|mesh-ancestor
5597118|NCT03735082|Antimitotic Agents|antimitotic agents|mesh-ancestor
5597119|NCT03735082|Mitosis Modulators|mitosis modulators|mesh-ancestor
5597120|NCT03735082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5597121|NCT03735082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5597122|NCT03735082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5597123|NCT03734809|Pembrolizumab|pembrolizumab|mesh-list
5597124|NCT03734809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5597125|NCT03734809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5597126|NCT03734770|Progesterone|progesterone|mesh-list
5597127|NCT03734770|Progestins|progestins|mesh-ancestor
5597128|NCT03734770|Hormones|hormones|mesh-ancestor
5597129|NCT03734770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5597130|NCT03734770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597131|NCT03734744|Vitamin D|vitamin d|mesh-list
5597132|NCT03734744|Cholecalciferol|cholecalciferol|mesh-list
5597133|NCT03734744|Vitamins|vitamins|mesh-ancestor
5597134|NCT03734744|Micronutrients|micronutrients|mesh-ancestor
5597135|NCT03734744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597136|NCT03734744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5597137|NCT03734744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5597138|NCT03734692|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
5597139|NCT03734692|Pembrolizumab|pembrolizumab|mesh-list
5597140|NCT03734692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5597141|NCT03734692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5597142|NCT03734692|Antiviral Agents|antiviral agents|mesh-ancestor
5597143|NCT03734692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5597144|NCT03734627|Acetaminophen|acetaminophen|mesh-list
5597145|NCT03734627|Sulfasalazine|sulfasalazine|mesh-list
5597146|NCT03734627|Octreotide|octreotide|mesh-list
5597147|NCT03734627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5597148|NCT03734627|Analgesics|analgesics|mesh-ancestor
5597149|NCT03734627|Sensory System Agents|sensory system agents|mesh-ancestor
5597150|NCT03734627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5597151|NCT03734627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597152|NCT03734627|Antipyretics|antipyretics|mesh-ancestor
5597153|NCT03734627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5597154|NCT03734627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5597155|NCT03734627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5597156|NCT03734627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5597157|NCT03734627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5597158|NCT03734627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5597159|NCT03734627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5597160|NCT03734614|Aspirin|aspirin|mesh-list
5597161|NCT03734614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5597162|NCT03734614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5597163|NCT03734614|Analgesics|analgesics|mesh-ancestor
5597164|NCT03734614|Sensory System Agents|sensory system agents|mesh-ancestor
5597165|NCT03734614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5597166|NCT03734614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597167|NCT03734614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5597168|NCT03734614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5597169|NCT03734614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5597170|NCT03734614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5597171|NCT03734614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5597172|NCT03734614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5597173|NCT03734614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5597174|NCT03734614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5597175|NCT03734614|Antipyretics|antipyretics|mesh-ancestor
5597176|NCT03734562|Amiodarone|amiodarone|mesh-list
5597177|NCT03734562|Sotalol|sotalol|mesh-list
5597178|NCT03734562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
5597179|NCT03734562|Vasodilator Agents|vasodilator agents|mesh-ancestor
5597180|NCT03734562|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5597181|NCT03734562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5597182|NCT03734562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5597183|NCT03734562|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5597184|NCT03734562|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5597185|NCT03734562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5597186|NCT03734562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5597187|NCT03734562|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5597188|NCT03734562|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5597189|NCT03734562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5597190|NCT03734562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5597191|NCT03734562|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5597192|NCT03734562|Adrenergic Agents|adrenergic agents|mesh-ancestor
5597193|NCT03734562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5597194|NCT03734562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597195|NCT03734562|Sympatholytics|sympatholytics|mesh-ancestor
5597196|NCT03734562|Autonomic Agents|autonomic agents|mesh-ancestor
5597197|NCT03734562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5597198|NCT03734445|Vitamins|vitamins|mesh-list
5597199|NCT03734445|Micronutrients|micronutrients|mesh-ancestor
5597200|NCT03734445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597201|NCT03734354|Brexpiprazole|brexpiprazole|mesh-list
5597202|NCT03734354|Serotonin Agents|serotonin agents|mesh-ancestor
5597203|NCT03734354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5597204|NCT03734354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5597205|NCT03734354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597206|NCT03734354|Dopamine Agonists|dopamine agonists|mesh-ancestor
5597207|NCT03734354|Dopamine Agents|dopamine agents|mesh-ancestor
5597208|NCT03734302|Brexpiprazole|brexpiprazole|mesh-list
5597209|NCT03734302|Serotonin Agents|serotonin agents|mesh-ancestor
5597210|NCT03734302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5597211|NCT03734302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5597212|NCT03734302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597213|NCT03734302|Dopamine Agonists|dopamine agonists|mesh-ancestor
5597214|NCT03734302|Dopamine Agents|dopamine agents|mesh-ancestor
5597215|NCT03734211|Evolocumab|evolocumab|mesh-list
5597216|NCT03734211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5597217|NCT03734211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5597218|NCT03734211|Antimetabolites|antimetabolites|mesh-ancestor
5597219|NCT03734211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5597220|NCT03734211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5597221|NCT03734198|Daratumumab|daratumumab|mesh-list
5597222|NCT03734198|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5597223|NCT03734198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5597224|NCT03734198|Immunologic Factors|immunologic factors|mesh-ancestor
5597225|NCT03734198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597226|NCT03734159|Ropivacaine|ropivacaine|mesh-list
5597227|NCT03734159|Anesthetics, Local|anesthetics, local|mesh-ancestor
5597228|NCT03734159|Anesthetics|anesthetics|mesh-ancestor
5597229|NCT03734159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5597230|NCT03734159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597231|NCT03734159|Sensory System Agents|sensory system agents|mesh-ancestor
5597232|NCT03734159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5597233|NCT03734068|Doxorubicin|doxorubicin|mesh-list
5597234|NCT03734068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5597235|NCT03734068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5597236|NCT03734068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5597237|NCT03734068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5597238|NCT03734068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5597239|NCT03734068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5597240|NCT03733873|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
5597241|NCT03733873|Hemostatics|hemostatics|mesh-ancestor
5597242|NCT03733873|Coagulants|coagulants|mesh-ancestor
5597243|NCT03733873|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5597244|NCT03733873|Natriuretic Agents|natriuretic agents|mesh-ancestor
5597245|NCT03733873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597246|NCT03733860|Alprostadil|alprostadil|mesh-list
5597247|NCT03733860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5597248|NCT03733860|Vasodilator Agents|vasodilator agents|mesh-ancestor
5597249|NCT03733860|Urological Agents|urological agents|mesh-ancestor
5597250|NCT03733691|Lenalidomide|lenalidomide|mesh-list
5597251|NCT03733691|Ixazomib|ixazomib|mesh-list
5597252|NCT03733691|Immunologic Factors|immunologic factors|mesh-ancestor
5597253|NCT03733691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597254|NCT03733691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5597255|NCT03733691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5597256|NCT03733691|Growth Substances|growth substances|mesh-ancestor
5597257|NCT03733691|Growth Inhibitors|growth inhibitors|mesh-ancestor
5597258|NCT03733691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5597259|NCT03733691|Protease Inhibitors|protease inhibitors|mesh-ancestor
5597260|NCT03733691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5597261|NCT03733691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606267|NCT04707625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5606268|NCT04707625|Growth Substances|growth substances|mesh-ancestor
5606269|NCT04707625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606270|NCT04707625|Growth Inhibitors|growth inhibitors|mesh-ancestor
5606271|NCT04707625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5606272|NCT04698525|Valproic Acid|valproic acid|mesh-list
5606273|NCT04698525|Memantine|memantine|mesh-list
5606274|NCT04698525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5606275|NCT04698525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5606276|NCT04698525|Dopamine Agents|dopamine agents|mesh-ancestor
5606277|NCT04698525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5597262|NCT03733652|Interferons|interferons|mesh-list
5597263|NCT03733652|Interferon-alpha|interferon-alpha|mesh-list
5597264|NCT03733652|Interferon alpha-2|interferon alpha-2|mesh-list
5597265|NCT03733652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5597266|NCT03733652|Antiviral Agents|antiviral agents|mesh-ancestor
5597267|NCT03733652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5597268|NCT03733652|Immunologic Factors|immunologic factors|mesh-ancestor
5597269|NCT03733652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597270|NCT03733639|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
5597271|NCT03733639|Hemostatics|hemostatics|mesh-ancestor
5597272|NCT03733639|Coagulants|coagulants|mesh-ancestor
5597273|NCT03733587|Cyclophosphamide|cyclophosphamide|mesh-list
5597274|NCT03733587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5597275|NCT03733587|Immunologic Factors|immunologic factors|mesh-ancestor
5597276|NCT03733587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597277|NCT03733587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5597278|NCT03733587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5597279|NCT03733587|Alkylating Agents|alkylating agents|mesh-ancestor
5597280|NCT03733587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5597281|NCT03733587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5597282|NCT03733587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5597283|NCT03733574|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
5597284|NCT03733574|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5597285|NCT03733574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5597286|NCT03733574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5597287|NCT03733574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5597288|NCT03733574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5597289|NCT03733574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597290|NCT03733574|Antidepressive Agents|antidepressive agents|mesh-ancestor
5597291|NCT03733574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5597292|NCT03733561|Rotigotine|rotigotine|mesh-list
5597293|NCT03733561|Dopamine Agonists|dopamine agonists|mesh-ancestor
5597294|NCT03733561|Dopamine Agents|dopamine agents|mesh-ancestor
5597295|NCT03733561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5597296|NCT03733561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5597297|NCT03733561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597298|NCT03733535|Benralizumab|benralizumab|mesh-list
5597299|NCT03733535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5597300|NCT03733535|Respiratory System Agents|respiratory system agents|mesh-ancestor
5597301|NCT03733379|Amoxicillin|amoxicillin|mesh-list
5597302|NCT03733379|Metronidazole|metronidazole|mesh-list
5597303|NCT03733379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5597304|NCT03733379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5597305|NCT03733379|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5597306|NCT03733379|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5597307|NCT03733340|Imipenem|imipenem|mesh-list
5597308|NCT03733340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5597309|NCT03733340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5597310|NCT03733327|Cyclophosphamide|cyclophosphamide|mesh-list
5597311|NCT03733327|Busulfan|busulfan|mesh-list
5597312|NCT03733327|Etoposide|etoposide|mesh-list
5597313|NCT03733327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5597314|NCT03733327|Immunologic Factors|immunologic factors|mesh-ancestor
5597315|NCT03733327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597316|NCT03733327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5597317|NCT03733327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5597318|NCT03733327|Alkylating Agents|alkylating agents|mesh-ancestor
5597319|NCT03733327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5597320|NCT03733327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5597321|NCT03733327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5597322|NCT03733327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5597323|NCT03733327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5597324|NCT03733327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5597325|NCT03733327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5597326|NCT03733275|Lidocaine|lidocaine|mesh-list
5597327|NCT03733275|Bupivacaine|bupivacaine|mesh-list
5597328|NCT03733275|Anesthetics, Local|anesthetics, local|mesh-ancestor
5597329|NCT03733275|Anesthetics|anesthetics|mesh-ancestor
5597330|NCT03733275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5597331|NCT03733275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597332|NCT03733275|Sensory System Agents|sensory system agents|mesh-ancestor
5597333|NCT03733275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5597334|NCT03733275|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5597335|NCT03733275|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5597336|NCT03733275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5597337|NCT03733275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5597338|NCT03733275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5597339|NCT03733210|Panitumumab|panitumumab|mesh-list
5597340|NCT03733210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5597341|NCT03733210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5597342|NCT03733171|Epinephrine|epinephrine|mesh-list
5597343|NCT03733171|Hemostatics|hemostatics|mesh-list
5597344|NCT03733171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5597345|NCT03733171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5597346|NCT03733171|Adrenergic Agents|adrenergic agents|mesh-ancestor
5597347|NCT03733171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5597348|NCT03733171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5597349|NCT03733171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597350|NCT03733171|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5597351|NCT03733171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5597352|NCT03733171|Autonomic Agents|autonomic agents|mesh-ancestor
5597353|NCT03733171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5597354|NCT03733171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5597355|NCT03733171|Respiratory System Agents|respiratory system agents|mesh-ancestor
5597356|NCT03733171|Mydriatics|mydriatics|mesh-ancestor
5597357|NCT03733171|Sympathomimetics|sympathomimetics|mesh-ancestor
5597358|NCT03733171|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5597359|NCT03733171|Coagulants|coagulants|mesh-ancestor
5597360|NCT03733145|Angiotensin II|angiotensin ii|mesh-list
5597361|NCT03733145|Giapreza|giapreza|mesh-list
5597362|NCT03733145|Angiotensinogen|angiotensinogen|mesh-list
5597363|NCT03733145|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5597364|NCT03733145|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5597365|NCT03733145|Protease Inhibitors|protease inhibitors|mesh-ancestor
5597366|NCT03733145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5597367|NCT03733145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5597368|NCT03732963|Melatonin|melatonin|mesh-list
5597369|NCT03732963|Antioxidants|antioxidants|mesh-ancestor
5597370|NCT03732963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5597371|NCT03732963|Protective Agents|protective agents|mesh-ancestor
5597372|NCT03732963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597373|NCT03732963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5597374|NCT03732703|Thalidomide|thalidomide|mesh-list
5597375|NCT03732703|Dexamethasone|dexamethasone|mesh-list
5597376|NCT03732703|Dexamethasone acetate|dexamethasone acetate|mesh-list
5597377|NCT03732703|Venetoclax|venetoclax|mesh-list
5597378|NCT03732703|Daratumumab|daratumumab|mesh-list
5597379|NCT03732703|Pomalidomide|pomalidomide|mesh-list
5597380|NCT03732703|Ixazomib|ixazomib|mesh-list
5597381|NCT03732703|BB 1101|bb 1101|mesh-list
5597382|NCT03732703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5597383|NCT03732703|Glycine|glycine|mesh-list
5597384|NCT03732703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5597385|NCT03732703|Antiemetics|antiemetics|mesh-ancestor
5597386|NCT03732703|Autonomic Agents|autonomic agents|mesh-ancestor
5597387|NCT03732703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5597388|NCT03732703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597389|NCT03732703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5597390|NCT03732703|Glucocorticoids|glucocorticoids|mesh-ancestor
5597391|NCT03732703|Hormones|hormones|mesh-ancestor
5597392|NCT03732703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5597393|NCT03732703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5597394|NCT03732703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5597395|NCT03732703|Protease Inhibitors|protease inhibitors|mesh-ancestor
5597396|NCT03732703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5597397|NCT03732703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5597398|NCT03732703|Immunologic Factors|immunologic factors|mesh-ancestor
5597399|NCT03732703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5597400|NCT03732703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5597401|NCT03732703|Growth Substances|growth substances|mesh-ancestor
5597402|NCT03732703|Growth Inhibitors|growth inhibitors|mesh-ancestor
5597403|NCT03732703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5597404|NCT03732703|Leprostatic Agents|leprostatic agents|mesh-ancestor
5597405|NCT03732703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5597406|NCT03732703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5597407|NCT03732703|Glycine Agents|glycine agents|mesh-ancestor
5597408|NCT03732703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5597409|NCT03732625|Raltegravir Potassium|raltegravir potassium|mesh-list
5597410|NCT03732625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5597411|NCT03732625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5597412|NCT03732625|Antiviral Agents|antiviral agents|mesh-ancestor
5597413|NCT03732625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5607006|NCT03032510|Levofloxacin|levofloxacin|mesh-list
5597414|NCT03732625|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5597415|NCT03732625|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5597416|NCT03732625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5597417|NCT03732625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5597418|NCT03732547|Poly I-C|poly i-c|mesh-list
5597419|NCT03732547|Antiviral Agents|antiviral agents|mesh-ancestor
5597420|NCT03732547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5597421|NCT03732547|Interferon Inducers|interferon inducers|mesh-ancestor
5597422|NCT03732547|Immunologic Factors|immunologic factors|mesh-ancestor
5597423|NCT03732547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597424|NCT03732508|Fluorouracil|fluorouracil|mesh-list
5597425|NCT03732508|Irinotecan|irinotecan|mesh-list
5597426|NCT03732508|Antimetabolites|antimetabolites|mesh-ancestor
5597427|NCT03732508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5597428|NCT03732508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5597429|NCT03732508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5597430|NCT03732508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5597431|NCT03732508|Immunologic Factors|immunologic factors|mesh-ancestor
5597432|NCT03732508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597433|NCT03732508|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5597434|NCT03732508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5597435|NCT03732508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5597436|NCT03732495|Denosumab|denosumab|mesh-list
5597437|NCT03732495|Lenvatinib|lenvatinib|mesh-list
5597438|NCT03732495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5597439|NCT03732495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5597440|NCT03732495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5597441|NCT03732495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5597442|NCT03732495|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5597443|NCT03732495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597444|NCT03732482|Temozolomide|temozolomide|mesh-list
5597445|NCT03732482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5597446|NCT03732482|Alkylating Agents|alkylating agents|mesh-ancestor
5597447|NCT03732482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5597448|NCT03732482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5597449|NCT03732469|Acetaminophen|acetaminophen|mesh-list
5597450|NCT03732469|Fentanyl|fentanyl|mesh-list
5597451|NCT03732469|Propofol|propofol|mesh-list
5597452|NCT03732469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5597453|NCT03732469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5597454|NCT03732469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597455|NCT03732469|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5597456|NCT03732469|Anesthetics, General|anesthetics, general|mesh-ancestor
5597457|NCT03732469|Anesthetics|anesthetics|mesh-ancestor
5597458|NCT03732469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5597459|NCT03732469|Narcotics|narcotics|mesh-ancestor
5597460|NCT03732469|Analgesics|analgesics|mesh-ancestor
5597461|NCT03732469|Sensory System Agents|sensory system agents|mesh-ancestor
5597462|NCT03732469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5597463|NCT03732469|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5597464|NCT03732469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5597465|NCT03732469|Antipyretics|antipyretics|mesh-ancestor
5597466|NCT03732391|Carboplatin|carboplatin|mesh-list
5597467|NCT03732391|Pembrolizumab|pembrolizumab|mesh-list
5597468|NCT03732391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5597469|NCT03732391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5597470|NCT03732365|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5597471|NCT03732365|Cefazolin|cefazolin|mesh-list
5597472|NCT03732365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5597473|NCT03732287|Anesthetics|anesthetics|mesh-list
5597474|NCT03732287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5597475|NCT03732287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597476|NCT03732235|Bevacizumab|bevacizumab|mesh-list
5597477|NCT03732235|Chlorotrianisene|chlorotrianisene|mesh-list
5597478|NCT03732235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5597479|NCT03732235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5597480|NCT03732235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5597481|NCT03732235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5597482|NCT03732235|Growth Substances|growth substances|mesh-ancestor
5597483|NCT03732235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597484|NCT03732235|Growth Inhibitors|growth inhibitors|mesh-ancestor
5597485|NCT03732235|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
5597486|NCT03732235|Estrogens|estrogens|mesh-ancestor
5597487|NCT03732235|Hormones|hormones|mesh-ancestor
5597488|NCT03732235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5597489|NCT03732235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5597490|NCT03732105|Apatinib|apatinib|mesh-list
5597491|NCT03732105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
5597492|NCT03732105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5597493|NCT03732105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5597494|NCT03732105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5597495|NCT03732105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5597496|NCT03732105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5597497|NCT03732105|Growth Substances|growth substances|mesh-ancestor
5597498|NCT03732105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597499|NCT03732105|Growth Inhibitors|growth inhibitors|mesh-ancestor
5597500|NCT03732040|Fluorides|fluorides|mesh-list
5597501|NCT03732040|Cariostatic Agents|cariostatic agents|mesh-ancestor
5597502|NCT03732040|Protective Agents|protective agents|mesh-ancestor
5597503|NCT03732040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597504|NCT03732001|Docetaxel|docetaxel|mesh-list
5597505|NCT03732001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5597506|NCT03732001|Tubulin Modulators|tubulin modulators|mesh-ancestor
5597507|NCT03732001|Antimitotic Agents|antimitotic agents|mesh-ancestor
5597508|NCT03732001|Mitosis Modulators|mitosis modulators|mesh-ancestor
5597509|NCT03732001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606278|NCT04698525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606279|NCT04698525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606280|NCT04698525|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5606281|NCT04698525|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5606282|NCT04698525|Anticonvulsants|anticonvulsants|mesh-ancestor
5606283|NCT04698525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5606284|NCT04698525|GABA Agents|gaba agents|mesh-ancestor
5606285|NCT04698525|Antimanic Agents|antimanic agents|mesh-ancestor
5606286|NCT04698525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5606287|NCT04698525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5606288|NCT04698525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5606289|NCT04698031|Aspirin|aspirin|mesh-list
5606290|NCT04698031|Clopidogrel|clopidogrel|mesh-list
5606291|NCT04698031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5606292|NCT04698031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5606293|NCT04698031|Analgesics|analgesics|mesh-ancestor
5606294|NCT04698031|Sensory System Agents|sensory system agents|mesh-ancestor
5606295|NCT04698031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5606296|NCT04698031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606297|NCT04698031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5606298|NCT04698031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5606299|NCT04698031|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5606300|NCT04698031|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5606301|NCT04698031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606302|NCT04698031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5606303|NCT04698031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5606304|NCT04698031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5606305|NCT04698031|Antipyretics|antipyretics|mesh-ancestor
5606306|NCT04698031|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5606307|NCT04698031|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5606308|NCT04698031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5606309|NCT04698031|Purinergic Agents|purinergic agents|mesh-ancestor
5606310|NCT04698031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5606311|NCT04696146|Complement C1s|complement c1s|mesh-list
5606312|NCT04696146|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
5606313|NCT04696146|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
5606314|NCT04696146|Immunologic Factors|immunologic factors|mesh-ancestor
5606315|NCT04696146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606316|NCT04696146|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5606317|NCT04696146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5606318|NCT04695054|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
5606319|NCT04695054|Anesthetics, Local|anesthetics, local|mesh-ancestor
5606320|NCT04695054|Anesthetics|anesthetics|mesh-ancestor
5606321|NCT04695054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5606322|NCT04695054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606323|NCT04695054|Sensory System Agents|sensory system agents|mesh-ancestor
5606324|NCT04695054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5606325|NCT04695054|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
5606326|NCT04663464|Abaloparatide|abaloparatide|mesh-list
5606327|NCT04663464|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
5606328|NCT04663464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5606329|NCT04663464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606330|NCT04663464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5606331|NCT04650282|Lidocaine|lidocaine|mesh-list
5597510|NCT03731988|Lidocaine|lidocaine|mesh-list
5597511|NCT03731988|Prilocaine|prilocaine|mesh-list
5597512|NCT03731988|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
5597513|NCT03731988|Anesthetics, Local|anesthetics, local|mesh-ancestor
5597514|NCT03731988|Anesthetics|anesthetics|mesh-ancestor
5597515|NCT03731988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5597516|NCT03731988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597517|NCT03731988|Sensory System Agents|sensory system agents|mesh-ancestor
5597518|NCT03731988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5597519|NCT03731988|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5597520|NCT03731988|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5597521|NCT03731988|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5597522|NCT03731988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5597523|NCT03731988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5597524|NCT03731988|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
5597525|NCT03731897|Lidocaine|lidocaine|mesh-list
5597526|NCT03731897|Anesthetics, Local|anesthetics, local|mesh-ancestor
5597527|NCT03731897|Anesthetics|anesthetics|mesh-ancestor
5597528|NCT03731897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5597529|NCT03731897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597530|NCT03731897|Sensory System Agents|sensory system agents|mesh-ancestor
5597531|NCT03731897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5597532|NCT03731897|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5597533|NCT03731897|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5597534|NCT03731897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5597535|NCT03731897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5597536|NCT03731897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5597537|NCT03731832|Dexamethasone|dexamethasone|mesh-list
5597538|NCT03731832|Cyclophosphamide|cyclophosphamide|mesh-list
5597539|NCT03731832|Pomalidomide|pomalidomide|mesh-list
5597540|NCT03731832|Ixazomib|ixazomib|mesh-list
5597541|NCT03731832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5597542|NCT03731832|Immunologic Factors|immunologic factors|mesh-ancestor
5597543|NCT03731832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597544|NCT03731832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5597545|NCT03731832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5597546|NCT03731832|Alkylating Agents|alkylating agents|mesh-ancestor
5597547|NCT03731832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5597548|NCT03731832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5597549|NCT03731832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5597550|NCT03731832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5597551|NCT03731832|Antiemetics|antiemetics|mesh-ancestor
5597552|NCT03731832|Autonomic Agents|autonomic agents|mesh-ancestor
5597553|NCT03731832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5597554|NCT03731832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5597555|NCT03731832|Glucocorticoids|glucocorticoids|mesh-ancestor
5597556|NCT03731832|Hormones|hormones|mesh-ancestor
5597557|NCT03731832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5597558|NCT03731832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5597559|NCT03731832|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5597560|NCT03731832|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5597561|NCT03731832|Growth Substances|growth substances|mesh-ancestor
5597562|NCT03731832|Growth Inhibitors|growth inhibitors|mesh-ancestor
5597563|NCT03731832|Protease Inhibitors|protease inhibitors|mesh-ancestor
5597564|NCT03731832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5597565|NCT03731780|Chlorhexidine|chlorhexidine|mesh-list
5597566|NCT03731780|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5597567|NCT03731780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5597568|NCT03731780|Disinfectants|disinfectants|mesh-ancestor
5597569|NCT03731741|Pentoxifylline|pentoxifylline|mesh-list
5597570|NCT03731741|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5597571|NCT03731741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5597572|NCT03731741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5597573|NCT03731741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5597574|NCT03731741|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5597575|NCT03731741|Protective Agents|protective agents|mesh-ancestor
5597576|NCT03731741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597577|NCT03731741|Vasodilator Agents|vasodilator agents|mesh-ancestor
5597578|NCT03731741|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5597579|NCT03731741|Antioxidants|antioxidants|mesh-ancestor
5597580|NCT03731494|Nickel|nickel|mesh-list
5597581|NCT03731494|Trace Elements|trace elements|mesh-ancestor
5597582|NCT03731494|Micronutrients|micronutrients|mesh-ancestor
5597583|NCT03731494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597584|NCT03731468|Dexamethasone|dexamethasone|mesh-list
5597585|NCT03731468|Anesthetics|anesthetics|mesh-list
5597586|NCT03731468|Anesthetics, Local|anesthetics, local|mesh-list
5597587|NCT03731468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5597588|NCT03731468|Antiemetics|antiemetics|mesh-ancestor
5597589|NCT03731468|Autonomic Agents|autonomic agents|mesh-ancestor
5597590|NCT03731468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5597591|NCT03731468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597592|NCT03731468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5597593|NCT03731468|Glucocorticoids|glucocorticoids|mesh-ancestor
5597594|NCT03731468|Hormones|hormones|mesh-ancestor
5597595|NCT03731468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5597596|NCT03731468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5597597|NCT03731468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5597598|NCT03731468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5597599|NCT03731468|Sensory System Agents|sensory system agents|mesh-ancestor
5597600|NCT03731442|Paclitaxel|paclitaxel|mesh-list
5597601|NCT03731442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5597602|NCT03731442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5597603|NCT03731442|Tubulin Modulators|tubulin modulators|mesh-ancestor
5597604|NCT03731442|Antimitotic Agents|antimitotic agents|mesh-ancestor
5597605|NCT03731442|Mitosis Modulators|mitosis modulators|mesh-ancestor
5597606|NCT03731442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5597607|NCT03731429|Lidocaine|lidocaine|mesh-list
5597608|NCT03731429|Anesthetics, Local|anesthetics, local|mesh-ancestor
5597609|NCT03731429|Anesthetics|anesthetics|mesh-ancestor
5597610|NCT03731429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5597611|NCT03731429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597612|NCT03731429|Sensory System Agents|sensory system agents|mesh-ancestor
5597613|NCT03731429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5597614|NCT03731429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5597615|NCT03731429|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5597616|NCT03731429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5597617|NCT03731429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5597618|NCT03731429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5597619|NCT03731403|Fluorides|fluorides|mesh-list
5597620|NCT03731403|Cariostatic Agents|cariostatic agents|mesh-ancestor
5597621|NCT03731403|Protective Agents|protective agents|mesh-ancestor
5597622|NCT03731403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597623|NCT03731286|Caffeine|caffeine|mesh-list
5597624|NCT03731286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5597625|NCT03731286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597626|NCT03731286|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5597627|NCT03731286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5597628|NCT03731286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5597629|NCT03731286|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5597630|NCT03731286|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5597631|NCT03731286|Purinergic Agents|purinergic agents|mesh-ancestor
5597632|NCT03731286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5597633|NCT03731169|Voriconazole|voriconazole|mesh-list
5597634|NCT03731169|Antifungal Agents|antifungal agents|mesh-ancestor
5597635|NCT03731169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5597636|NCT03731169|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5597637|NCT03731169|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5597638|NCT03731169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5597639|NCT03731169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5597640|NCT03731169|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5597641|NCT03731169|Hormone Antagonists|hormone antagonists|mesh-ancestor
5597642|NCT03731169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5597643|NCT03731169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597644|NCT03731169|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5597645|NCT03731117|Furosemide|furosemide|mesh-list
5597646|NCT03731117|Diuretics|diuretics|mesh-ancestor
5597647|NCT03731117|Natriuretic Agents|natriuretic agents|mesh-ancestor
5597648|NCT03731117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597649|NCT03731117|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5597650|NCT03731117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5597651|NCT03731117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5597652|NCT03731091|Calcitriol|calcitriol|mesh-list
5597653|NCT03731091|Betamethasone|betamethasone|mesh-list
5597654|NCT03731091|Betamethasone Valerate|betamethasone valerate|mesh-list
5597655|NCT03731091|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5597656|NCT03731091|Betamethasone benzoate|betamethasone benzoate|mesh-list
5597657|NCT03731091|Calcipotriene|calcipotriene|mesh-list
5597658|NCT03731091|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
5597659|NCT03731091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5597660|NCT03731091|Glucocorticoids|glucocorticoids|mesh-ancestor
5597661|NCT03731091|Hormones|hormones|mesh-ancestor
5597662|NCT03731091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5597663|NCT03731091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597664|NCT03731091|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5597665|NCT03731091|Respiratory System Agents|respiratory system agents|mesh-ancestor
5597666|NCT03731091|Dermatologic Agents|dermatologic agents|mesh-ancestor
5597667|NCT03731091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5597668|NCT03731091|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
5597669|NCT03731091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5597670|NCT03731091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5597671|NCT03731091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5597672|NCT03731091|Vitamins|vitamins|mesh-ancestor
5597673|NCT03731091|Micronutrients|micronutrients|mesh-ancestor
5597674|NCT03731091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5597675|NCT03730857|Olanzapine|olanzapine|mesh-list
5597676|NCT03730857|Risperidone|risperidone|mesh-list
5597677|NCT03730857|Paliperidone Palmitate|paliperidone palmitate|mesh-list
5597678|NCT03730857|Antipsychotic Agents|antipsychotic agents|mesh-list
5597679|NCT03730857|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5597680|NCT03730857|Serotonin Agents|serotonin agents|mesh-ancestor
5597681|NCT03730857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5597682|NCT03730857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5597683|NCT03730857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597684|NCT03730857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5597685|NCT03730857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5597686|NCT03730857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5597687|NCT03730857|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5597688|NCT03730857|Dopamine Agents|dopamine agents|mesh-ancestor
5597689|NCT03730857|Antiemetics|antiemetics|mesh-ancestor
5597690|NCT03730857|Autonomic Agents|autonomic agents|mesh-ancestor
5597691|NCT03730857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5597692|NCT03730857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5597693|NCT03730857|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5597694|NCT03730857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5597695|NCT03730857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5597696|NCT03730857|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5597697|NCT03730857|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5597698|NCT03730766|Amoxicillin|amoxicillin|mesh-list
5597699|NCT03730766|Metronidazole|metronidazole|mesh-list
5597700|NCT03730766|Potassium Citrate|potassium citrate|mesh-list
5597701|NCT03730766|Esomeprazole|esomeprazole|mesh-list
5597702|NCT03730766|Bismuth|bismuth|mesh-list
5597703|NCT03730766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5597704|NCT03730766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5597705|NCT03730766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5597706|NCT03730766|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5597707|NCT03730766|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5597708|NCT03730766|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5597709|NCT03730766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5597710|NCT03730766|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5597711|NCT03730766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5597712|NCT03730766|Antacids|antacids|mesh-ancestor
5597713|NCT03730766|Diuretics|diuretics|mesh-ancestor
5597714|NCT03730766|Natriuretic Agents|natriuretic agents|mesh-ancestor
5597715|NCT03730766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597716|NCT03730766|Expectorants|expectorants|mesh-ancestor
5597717|NCT03730766|Respiratory System Agents|respiratory system agents|mesh-ancestor
5597718|NCT03730740|Lenalidomide|lenalidomide|mesh-list
5597719|NCT03730740|Immunologic Factors|immunologic factors|mesh-ancestor
5597720|NCT03730740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597721|NCT03730740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5597722|NCT03730740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5597723|NCT03730740|Growth Substances|growth substances|mesh-ancestor
5597724|NCT03730740|Growth Inhibitors|growth inhibitors|mesh-ancestor
5597725|NCT03730740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5597726|NCT03730714|Epinephrine|epinephrine|mesh-list
5597727|NCT03730714|Racepinephrine|racepinephrine|mesh-list
5597728|NCT03730714|Morphine|morphine|mesh-list
5597729|NCT03730714|Anesthetics|anesthetics|mesh-list
5597730|NCT03730714|Anesthetics, Local|anesthetics, local|mesh-list
5597731|NCT03730714|Epinephryl borate|epinephryl borate|mesh-list
5597732|NCT03730714|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5597733|NCT03730714|Narcotics|narcotics|mesh-ancestor
5606332|NCT04650282|Anesthetics, Local|anesthetics, local|mesh-ancestor
5597734|NCT03730714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5597735|NCT03730714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597736|NCT03730714|Analgesics|analgesics|mesh-ancestor
5597737|NCT03730714|Sensory System Agents|sensory system agents|mesh-ancestor
5597738|NCT03730714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5597739|NCT03730714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5597740|NCT03730714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5597741|NCT03730714|Adrenergic Agents|adrenergic agents|mesh-ancestor
5597742|NCT03730714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5597743|NCT03730714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5597744|NCT03730714|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5597745|NCT03730714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5597746|NCT03730714|Autonomic Agents|autonomic agents|mesh-ancestor
5597747|NCT03730714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5597748|NCT03730714|Respiratory System Agents|respiratory system agents|mesh-ancestor
5597749|NCT03730714|Mydriatics|mydriatics|mesh-ancestor
5597750|NCT03730714|Sympathomimetics|sympathomimetics|mesh-ancestor
5597751|NCT03730714|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5597752|NCT03730675|Sorafenib|sorafenib|mesh-list
5597753|NCT03730675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5597754|NCT03730675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5597755|NCT03730675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5597756|NCT03730675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5597757|NCT03730649|Sulforaphane|sulforaphane|mesh-list
5597758|NCT03730649|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5597759|NCT03730649|Protective Agents|protective agents|mesh-ancestor
5597760|NCT03730649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597761|NCT03730649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5597762|NCT03730584|Ropivacaine|ropivacaine|mesh-list
5597763|NCT03730584|Anesthetics, Local|anesthetics, local|mesh-ancestor
5597764|NCT03730584|Anesthetics|anesthetics|mesh-ancestor
5597765|NCT03730584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5597766|NCT03730584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597767|NCT03730584|Sensory System Agents|sensory system agents|mesh-ancestor
5597768|NCT03730584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5597769|NCT03730558|Aflibercept|aflibercept|mesh-list
5597770|NCT03730558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5597771|NCT03730558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5597772|NCT03730558|Growth Substances|growth substances|mesh-ancestor
5597773|NCT03730558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597774|NCT03730558|Growth Inhibitors|growth inhibitors|mesh-ancestor
5597775|NCT03730558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5597776|NCT03730402|Bupivacaine|bupivacaine|mesh-list
5597777|NCT03730402|Anesthetics, Local|anesthetics, local|mesh-ancestor
5597778|NCT03730402|Anesthetics|anesthetics|mesh-ancestor
5597779|NCT03730402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5597780|NCT03730402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597781|NCT03730402|Sensory System Agents|sensory system agents|mesh-ancestor
5597782|NCT03730402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5597783|NCT03730363|Pentamidine|pentamidine|mesh-list
5597784|NCT03730363|Antifungal Agents|antifungal agents|mesh-ancestor
5597785|NCT03730363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5597786|NCT03730363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5597787|NCT03730363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5597788|NCT03730363|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5597789|NCT03730311|Elsulfavirine|elsulfavirine|mesh-list
5597790|NCT03730311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5597791|NCT03730311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5597792|NCT03730311|Antiviral Agents|antiviral agents|mesh-ancestor
5597793|NCT03730311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5606333|NCT04650282|Anesthetics|anesthetics|mesh-ancestor
5606334|NCT04650282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5606335|NCT04650282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606336|NCT04650282|Sensory System Agents|sensory system agents|mesh-ancestor
5606337|NCT04650282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5606338|NCT04650282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5606339|NCT04650282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5606340|NCT04650282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5606341|NCT04650282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5606342|NCT04650282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606343|NCT04639466|Vaccines|vaccines|mesh-list
5606344|NCT04639466|Immunologic Factors|immunologic factors|mesh-ancestor
5606345|NCT04639466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606346|NCT04624945|Thromboplastin|thromboplastin|mesh-list
5606347|NCT04624945|Hemostatics|hemostatics|mesh-ancestor
5606348|NCT04624945|Coagulants|coagulants|mesh-ancestor
5597794|NCT03730272|Analgesics|analgesics|mesh-list
5597795|NCT03730272|Sensory System Agents|sensory system agents|mesh-ancestor
5597796|NCT03730272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5597797|NCT03730272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597798|NCT03730194|Melatonin|melatonin|mesh-list
5597799|NCT03730194|Antioxidants|antioxidants|mesh-ancestor
5597800|NCT03730194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5597801|NCT03730194|Protective Agents|protective agents|mesh-ancestor
5597802|NCT03730194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597803|NCT03730194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5597804|NCT03730181|Isoniazid|isoniazid|mesh-list
5597805|NCT03730181|Rifapentine|rifapentine|mesh-list
5597806|NCT03730181|Antitubercular Agents|antitubercular agents|mesh-ancestor
5597807|NCT03730181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5597808|NCT03730181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5597809|NCT03730181|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5597810|NCT03730181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5597811|NCT03730181|Antimetabolites|antimetabolites|mesh-ancestor
5597812|NCT03730181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5597813|NCT03730181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5597814|NCT03730181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5597815|NCT03730181|Leprostatic Agents|leprostatic agents|mesh-ancestor
5597816|NCT03730064|Acetylcysteine|acetylcysteine|mesh-list
5597817|NCT03730064|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5597818|NCT03730064|Antiviral Agents|antiviral agents|mesh-ancestor
5597819|NCT03730064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5597820|NCT03730064|Expectorants|expectorants|mesh-ancestor
5597821|NCT03730064|Respiratory System Agents|respiratory system agents|mesh-ancestor
5597822|NCT03730064|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5597823|NCT03730064|Antioxidants|antioxidants|mesh-ancestor
5597824|NCT03730064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5597825|NCT03730064|Protective Agents|protective agents|mesh-ancestor
5597826|NCT03730064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597827|NCT03730064|Antidotes|antidotes|mesh-ancestor
5597828|NCT03730038|Pitavastatin|pitavastatin|mesh-list
5597829|NCT03730038|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5597830|NCT03730038|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5597831|NCT03730038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5597832|NCT03730038|Antimetabolites|antimetabolites|mesh-ancestor
5597833|NCT03730038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5597834|NCT03730038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5597835|NCT03730038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5597836|NCT03730012|Atezolizumab|atezolizumab|mesh-list
5597837|NCT03730012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5597838|NCT03729973|Lidocaine|lidocaine|mesh-list
5597839|NCT03729973|Magnesium Sulfate|magnesium sulfate|mesh-list
5597840|NCT03729973|Ketamine|ketamine|mesh-list
5597841|NCT03729973|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5597842|NCT03729973|Anesthetics, Local|anesthetics, local|mesh-ancestor
5597843|NCT03729973|Anesthetics|anesthetics|mesh-ancestor
5597844|NCT03729973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5597845|NCT03729973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597846|NCT03729973|Sensory System Agents|sensory system agents|mesh-ancestor
5597847|NCT03729973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5597848|NCT03729973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5597849|NCT03729973|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5597850|NCT03729973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5597851|NCT03729973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5597852|NCT03729973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5597853|NCT03729973|Analgesics|analgesics|mesh-ancestor
5597854|NCT03729973|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5597855|NCT03729973|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5597856|NCT03729973|Anesthetics, General|anesthetics, general|mesh-ancestor
5597857|NCT03729973|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5597858|NCT03729973|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5597859|NCT03729973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5597860|NCT03729973|Anticonvulsants|anticonvulsants|mesh-ancestor
5597861|NCT03729973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5597862|NCT03729973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5597863|NCT03729973|Tocolytic Agents|tocolytic agents|mesh-ancestor
5597864|NCT03729973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5597865|NCT03729869|Progesterone|progesterone|mesh-list
5597866|NCT03729869|Progestins|progestins|mesh-ancestor
5597867|NCT03729869|Hormones|hormones|mesh-ancestor
5597868|NCT03729869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5597869|NCT03729869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597870|NCT03729804|Dexamethasone|dexamethasone|mesh-list
5597871|NCT03729804|Lenalidomide|lenalidomide|mesh-list
5597872|NCT03729804|Bortezomib|bortezomib|mesh-list
5597873|NCT03729804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5597874|NCT03729804|Antiemetics|antiemetics|mesh-ancestor
5597875|NCT03729804|Autonomic Agents|autonomic agents|mesh-ancestor
5597876|NCT03729804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5597877|NCT03729804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597878|NCT03729804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5597879|NCT03729804|Glucocorticoids|glucocorticoids|mesh-ancestor
5597880|NCT03729804|Hormones|hormones|mesh-ancestor
5597881|NCT03729804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5597882|NCT03729804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5597883|NCT03729804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5597884|NCT03729804|Immunologic Factors|immunologic factors|mesh-ancestor
5597885|NCT03729804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5597886|NCT03729804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5597887|NCT03729804|Growth Substances|growth substances|mesh-ancestor
5597888|NCT03729804|Growth Inhibitors|growth inhibitors|mesh-ancestor
5597889|NCT03729778|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5597890|NCT03729778|Immunologic Factors|immunologic factors|mesh-ancestor
5597891|NCT03729778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597892|NCT03729687|Capecitabine|capecitabine|mesh-list
5597893|NCT03729687|Oxaliplatin|oxaliplatin|mesh-list
5597894|NCT03729687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5597895|NCT03729687|Antimetabolites|antimetabolites|mesh-ancestor
5597896|NCT03729687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5597897|NCT03729687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5597898|NCT03729674|Infliximab|infliximab|mesh-list
5597899|NCT03729674|Dermatologic Agents|dermatologic agents|mesh-ancestor
5597900|NCT03729674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5597901|NCT03729674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5597902|NCT03729609|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5597903|NCT03729609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5597904|NCT03729609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5597905|NCT03729505|Lidocaine|lidocaine|mesh-list
5597906|NCT03729505|Magnesium Sulfate|magnesium sulfate|mesh-list
5597907|NCT03729505|Anesthetics, Local|anesthetics, local|mesh-ancestor
5597908|NCT03729505|Anesthetics|anesthetics|mesh-ancestor
5597909|NCT03729505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5597910|NCT03729505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597911|NCT03729505|Sensory System Agents|sensory system agents|mesh-ancestor
5597912|NCT03729505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5597913|NCT03729505|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5597914|NCT03729505|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5597915|NCT03729505|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5597916|NCT03729505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5597917|NCT03729505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5597918|NCT03729505|Analgesics|analgesics|mesh-ancestor
5597919|NCT03729505|Anticonvulsants|anticonvulsants|mesh-ancestor
5597920|NCT03729505|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5597921|NCT03729505|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5597922|NCT03729505|Tocolytic Agents|tocolytic agents|mesh-ancestor
5597923|NCT03729505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5597924|NCT03729375|Bupivacaine|bupivacaine|mesh-list
5597925|NCT03729375|Anesthetics, Local|anesthetics, local|mesh-ancestor
5597926|NCT03729375|Anesthetics|anesthetics|mesh-ancestor
5597927|NCT03729375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5597928|NCT03729375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597929|NCT03729375|Sensory System Agents|sensory system agents|mesh-ancestor
5597930|NCT03729375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5597931|NCT03729310|Triamcinolone|triamcinolone|mesh-list
5597932|NCT03729310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5597933|NCT03729310|Glucocorticoids|glucocorticoids|mesh-ancestor
5597934|NCT03729310|Hormones|hormones|mesh-ancestor
5597935|NCT03729310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5597936|NCT03729310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597937|NCT03729284|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5597938|NCT03729284|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5597939|NCT03729284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5597940|NCT03729284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5597941|NCT03729284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5597942|NCT03729284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5597943|NCT03729284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597944|NCT03729284|Analgesics|analgesics|mesh-ancestor
5597945|NCT03729284|Sensory System Agents|sensory system agents|mesh-ancestor
5597946|NCT03729284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5597947|NCT03729284|Antidepressive Agents|antidepressive agents|mesh-ancestor
5597948|NCT03729284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5597949|NCT03729284|Dopamine Agents|dopamine agents|mesh-ancestor
5597950|NCT03729128|Memantine|memantine|mesh-list
5597951|NCT03729128|Dextromethorphan|dextromethorphan|mesh-list
5597952|NCT03729128|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5597953|NCT03729128|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5597954|NCT03729128|Dopamine Agents|dopamine agents|mesh-ancestor
5597955|NCT03729128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5597956|NCT03729128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5597957|NCT03729128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597958|NCT03729128|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5597959|NCT03729128|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5597960|NCT03729128|Antitussive Agents|antitussive agents|mesh-ancestor
5597961|NCT03729128|Respiratory System Agents|respiratory system agents|mesh-ancestor
5597962|NCT03729102|Vaccines|vaccines|mesh-list
5597963|NCT03729102|Immunologic Factors|immunologic factors|mesh-ancestor
5597964|NCT03729102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597965|NCT03729063|Carbon Monoxide|carbon monoxide|mesh-list
5597966|NCT03729063|Antimetabolites|antimetabolites|mesh-ancestor
5597967|NCT03729063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5597968|NCT03729063|Gasotransmitters|gasotransmitters|mesh-ancestor
5597969|NCT03729063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5597970|NCT03729063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597971|NCT03729011|Propofol|propofol|mesh-list
5597972|NCT03729011|Sevoflurane|sevoflurane|mesh-list
5597973|NCT03729011|Desflurane|desflurane|mesh-list
5597974|NCT03729011|Isoflurane|isoflurane|mesh-list
5597975|NCT03729011|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5597976|NCT03729011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5597977|NCT03729011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597978|NCT03729011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5597979|NCT03729011|Anesthetics, General|anesthetics, general|mesh-ancestor
5597980|NCT03729011|Anesthetics|anesthetics|mesh-ancestor
5597981|NCT03729011|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5597982|NCT03729011|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5597983|NCT03728946|Bupivacaine|bupivacaine|mesh-list
5597984|NCT03728946|Anesthetics, Local|anesthetics, local|mesh-ancestor
5597985|NCT03728946|Anesthetics|anesthetics|mesh-ancestor
5597986|NCT03728946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5597987|NCT03728946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597988|NCT03728946|Sensory System Agents|sensory system agents|mesh-ancestor
5597989|NCT03728946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5597990|NCT03728933|Rotigotine|rotigotine|mesh-list
5597991|NCT03728933|Dopamine Agonists|dopamine agonists|mesh-ancestor
5597992|NCT03728933|Dopamine Agents|dopamine agents|mesh-ancestor
5597993|NCT03728933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5597994|NCT03728933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5597995|NCT03728933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5597996|NCT03728894|Midazolam|midazolam|mesh-list
5597997|NCT03728894|Hydroxyzine|hydroxyzine|mesh-list
5597998|NCT03728894|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5597999|NCT03728894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5598000|NCT03728894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5598001|NCT03728894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598002|NCT03728894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5598003|NCT03728894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5598004|NCT03728894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5598005|NCT03728894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5598006|NCT03728894|Anesthetics, General|anesthetics, general|mesh-ancestor
5598007|NCT03728894|Anesthetics|anesthetics|mesh-ancestor
5598008|NCT03728894|GABA Modulators|gaba modulators|mesh-ancestor
5598009|NCT03728894|GABA Agents|gaba agents|mesh-ancestor
5598010|NCT03728894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5598011|NCT03728894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598012|NCT03728894|Antipruritics|antipruritics|mesh-ancestor
5598013|NCT03728894|Dermatologic Agents|dermatologic agents|mesh-ancestor
5598014|NCT03728894|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5598015|NCT03728894|Histamine Antagonists|histamine antagonists|mesh-ancestor
5598016|NCT03728894|Histamine Agents|histamine agents|mesh-ancestor
5598017|NCT03728829|Carboplatin|carboplatin|mesh-list
5598018|NCT03728829|Docetaxel|docetaxel|mesh-list
5598019|NCT03728829|Trastuzumab|trastuzumab|mesh-list
5598020|NCT03728829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5598021|NCT03728829|Tubulin Modulators|tubulin modulators|mesh-ancestor
5598022|NCT03728829|Antimitotic Agents|antimitotic agents|mesh-ancestor
5598023|NCT03728829|Mitosis Modulators|mitosis modulators|mesh-ancestor
5598024|NCT03728829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598025|NCT03728829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5598026|NCT03728777|Resveratrol|resveratrol|mesh-list
5598027|NCT03728777|Antioxidants|antioxidants|mesh-ancestor
5598028|NCT03728777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598029|NCT03728777|Protective Agents|protective agents|mesh-ancestor
5598030|NCT03728777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598031|NCT03728777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5598032|NCT03728777|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5598033|NCT03728673|Dexetimide|dexetimide|mesh-list
5598034|NCT03728673|Citalopram|citalopram|mesh-list
5598035|NCT03728673|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5598036|NCT03728673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5598037|NCT03728673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5598038|NCT03728673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598039|NCT03728673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5598040|NCT03728673|Serotonin Agents|serotonin agents|mesh-ancestor
5598041|NCT03728673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598042|NCT03728673|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5598043|NCT03728673|Antidepressive Agents|antidepressive agents|mesh-ancestor
5598044|NCT03728673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5598045|NCT03728673|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5598046|NCT03728673|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5598047|NCT03728673|Parasympatholytics|parasympatholytics|mesh-ancestor
5598048|NCT03728673|Autonomic Agents|autonomic agents|mesh-ancestor
5598049|NCT03728673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5598050|NCT03728673|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5598051|NCT03728673|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5598052|NCT03728673|Cholinergic Agents|cholinergic agents|mesh-ancestor
5606349|NCT04623398|Lithium Carbonate|lithium carbonate|mesh-list
5606350|NCT04623398|Antidepressive Agents|antidepressive agents|mesh-ancestor
5606351|NCT04623398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5606352|NCT04623398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5606353|NCT04623398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606354|NCT04623398|Antimanic Agents|antimanic agents|mesh-ancestor
5606355|NCT04623398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5606356|NCT04623398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5606357|NCT04623398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606358|NCT04596657|Vitamin D|vitamin d|mesh-list
5606359|NCT04596657|Vitamins|vitamins|mesh-ancestor
5606360|NCT04596657|Micronutrients|micronutrients|mesh-ancestor
5606361|NCT04596657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606362|NCT04596657|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5606363|NCT04550546|Nystatin|nystatin|mesh-list
5606364|NCT04550546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5606365|NCT04550546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5606366|NCT04550546|Antifungal Agents|antifungal agents|mesh-ancestor
5606367|NCT04550546|Ionophores|ionophores|mesh-ancestor
5606368|NCT04550546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5606369|NCT04550546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606370|NCT04540380|Cyclophosphamide|cyclophosphamide|mesh-list
5606371|NCT04540380|Rituximab|rituximab|mesh-list
5598053|NCT03728478|Etanercept|etanercept|mesh-list
5598054|NCT03728478|Methotrexate|methotrexate|mesh-list
5598055|NCT03728478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5598056|NCT03728478|Abortifacient Agents|abortifacient agents|mesh-ancestor
5598057|NCT03728478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5598058|NCT03728478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598059|NCT03728478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5598060|NCT03728478|Antimetabolites|antimetabolites|mesh-ancestor
5598061|NCT03728478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598062|NCT03728478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5598063|NCT03728478|Dermatologic Agents|dermatologic agents|mesh-ancestor
5598064|NCT03728478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5598065|NCT03728478|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5598066|NCT03728478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5598067|NCT03728478|Immunologic Factors|immunologic factors|mesh-ancestor
5598068|NCT03728478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5598069|NCT03728478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5598070|NCT03728478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5598071|NCT03728478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5598072|NCT03728478|Analgesics|analgesics|mesh-ancestor
5598073|NCT03728478|Sensory System Agents|sensory system agents|mesh-ancestor
5598074|NCT03728478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5598075|NCT03728478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5598076|NCT03728478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5598077|NCT03728465|Nivolumab|nivolumab|mesh-list
5598078|NCT03728465|Ipilimumab|ipilimumab|mesh-list
5598079|NCT03728465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5598080|NCT03728465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5598081|NCT03728465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5598082|NCT03728465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598083|NCT03728361|Nivolumab|nivolumab|mesh-list
5598084|NCT03728361|Temozolomide|temozolomide|mesh-list
5598085|NCT03728361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5598086|NCT03728361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5598087|NCT03728361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5598088|NCT03728361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598089|NCT03728361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5598090|NCT03728361|Alkylating Agents|alkylating agents|mesh-ancestor
5598091|NCT03728244|Hyaluronic Acid|hyaluronic acid|mesh-list
5598092|NCT03728244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5598093|NCT03728244|Immunologic Factors|immunologic factors|mesh-ancestor
5598094|NCT03728244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598095|NCT03728244|Viscosupplements|viscosupplements|mesh-ancestor
5598096|NCT03728244|Protective Agents|protective agents|mesh-ancestor
5598097|NCT03728192|Camptothecin|camptothecin|mesh-list
5598098|NCT03728192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5598099|NCT03728192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5598100|NCT03728192|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5598101|NCT03728192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5598102|NCT03728192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5598103|NCT03728192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598104|NCT03728153|Fluoxetine|fluoxetine|mesh-list
5598105|NCT03728153|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5598106|NCT03728153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5598107|NCT03728153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5598108|NCT03728153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598109|NCT03728153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5598110|NCT03728153|Serotonin Agents|serotonin agents|mesh-ancestor
5598111|NCT03728153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598112|NCT03728153|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5598113|NCT03728153|Antidepressive Agents|antidepressive agents|mesh-ancestor
5598114|NCT03728153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5598115|NCT03728153|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5598116|NCT03728153|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5598117|NCT03728153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5598118|NCT03728101|Dabigatran|dabigatran|mesh-list
5598119|NCT03728101|Simvastatin|simvastatin|mesh-list
5598120|NCT03728101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5598121|NCT03728101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5598122|NCT03728101|Antimetabolites|antimetabolites|mesh-ancestor
5598123|NCT03728101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598124|NCT03728101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5598125|NCT03728101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5598126|NCT03728101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5598127|NCT03728101|Antithrombins|antithrombins|mesh-ancestor
5598128|NCT03728101|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5598129|NCT03728101|Protease Inhibitors|protease inhibitors|mesh-ancestor
5598130|NCT03728101|Anticoagulants|anticoagulants|mesh-ancestor
5598131|NCT03727880|Pembrolizumab|pembrolizumab|mesh-list
5598132|NCT03727880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5598133|NCT03727880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5598134|NCT03727867|Mitogens|mitogens|mesh-list
5598135|NCT03727867|Mitosis Modulators|mitosis modulators|mesh-ancestor
5598136|NCT03727867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598137|NCT03727763|Cetuximab|cetuximab|mesh-list
5598138|NCT03727763|Vemurafenib|vemurafenib|mesh-list
5598139|NCT03727763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5598140|NCT03727763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5598141|NCT03727763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5598142|NCT03727763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5598143|NCT03727763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598144|NCT03727750|Gemtuzumab|gemtuzumab|mesh-list
5598145|NCT03727750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5598146|NCT03727750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5598147|NCT03727646|Niacinamide|niacinamide|mesh-list
5598148|NCT03727646|Niacin|niacin|mesh-list
5598149|NCT03727646|Nicotinic Acids|nicotinic acids|mesh-list
5598150|NCT03727646|Vitamin B Complex|vitamin b complex|mesh-ancestor
5598151|NCT03727646|Vitamins|vitamins|mesh-ancestor
5598152|NCT03727646|Micronutrients|micronutrients|mesh-ancestor
5598153|NCT03727646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598154|NCT03727646|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5598155|NCT03727646|Antimetabolites|antimetabolites|mesh-ancestor
5598156|NCT03727646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598157|NCT03727646|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5598158|NCT03727646|Vasodilator Agents|vasodilator agents|mesh-ancestor
5598159|NCT03727620|Amoxicillin|amoxicillin|mesh-list
5598160|NCT03727620|Metronidazole|metronidazole|mesh-list
5598161|NCT03727620|Doxycycline|doxycycline|mesh-list
5598162|NCT03727620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5598163|NCT03727620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5598164|NCT03727620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5598165|NCT03727620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5598166|NCT03727620|Antimalarials|antimalarials|mesh-ancestor
5598167|NCT03727607|Propofol|propofol|mesh-list
5598168|NCT03727607|Desflurane|desflurane|mesh-list
5598169|NCT03727607|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5598170|NCT03727607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5598171|NCT03727607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598172|NCT03727607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5598173|NCT03727607|Anesthetics, General|anesthetics, general|mesh-ancestor
5598174|NCT03727607|Anesthetics|anesthetics|mesh-ancestor
5598175|NCT03727607|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5598176|NCT03727464|Propofol|propofol|mesh-list
5598177|NCT03727464|Sevoflurane|sevoflurane|mesh-list
5598178|NCT03727464|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5598179|NCT03727464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5598180|NCT03727464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598181|NCT03727464|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5598182|NCT03727464|Anesthetics, General|anesthetics, general|mesh-ancestor
5598183|NCT03727464|Anesthetics|anesthetics|mesh-ancestor
5598184|NCT03727464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5598185|NCT03727464|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5598186|NCT03727412|Naproxen|naproxen|mesh-list
5598187|NCT03727412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5598188|NCT03727412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5598189|NCT03727412|Analgesics|analgesics|mesh-ancestor
5598190|NCT03727412|Sensory System Agents|sensory system agents|mesh-ancestor
5598191|NCT03727412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5598192|NCT03727412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598193|NCT03727412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5598194|NCT03727412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5598195|NCT03727412|Gout Suppressants|gout suppressants|mesh-ancestor
5598196|NCT03727412|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5598197|NCT03727412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5598198|NCT03727412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598199|NCT03727295|Idebenone|idebenone|mesh-list
5598200|NCT03727295|Antioxidants|antioxidants|mesh-ancestor
5598201|NCT03727295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598202|NCT03727295|Protective Agents|protective agents|mesh-ancestor
5598203|NCT03727295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598204|NCT03727282|Dobutamine|dobutamine|mesh-list
5598205|NCT03727282|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5598206|NCT03727282|Sympathomimetics|sympathomimetics|mesh-ancestor
5598207|NCT03727282|Autonomic Agents|autonomic agents|mesh-ancestor
5598208|NCT03727282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5598209|NCT03727282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598210|NCT03727282|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5598211|NCT03727282|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5598212|NCT03727282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5598213|NCT03727282|Adrenergic Agents|adrenergic agents|mesh-ancestor
5598214|NCT03727282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5598215|NCT03727282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598216|NCT03727282|Protective Agents|protective agents|mesh-ancestor
5598217|NCT03727100|Clonidine|clonidine|mesh-list
5598218|NCT03727100|Analgesics|analgesics|mesh-ancestor
5598219|NCT03727100|Sensory System Agents|sensory system agents|mesh-ancestor
5598220|NCT03727100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5598221|NCT03727100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598222|NCT03727100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5598223|NCT03727100|Sympatholytics|sympatholytics|mesh-ancestor
5598224|NCT03727100|Autonomic Agents|autonomic agents|mesh-ancestor
5598225|NCT03727100|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5598226|NCT03727100|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5598227|NCT03727100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5598228|NCT03727100|Adrenergic Agents|adrenergic agents|mesh-ancestor
5598229|NCT03727100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5598230|NCT03727100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598231|NCT03727048|Ketorolac|ketorolac|mesh-list
5598232|NCT03727048|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
5598233|NCT03727048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5598234|NCT03727048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5598235|NCT03727048|Analgesics|analgesics|mesh-ancestor
5598236|NCT03727048|Sensory System Agents|sensory system agents|mesh-ancestor
5598237|NCT03727048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5598238|NCT03727048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598239|NCT03727048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5598240|NCT03727048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5598241|NCT03727048|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5598242|NCT03727048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5598243|NCT03727048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598244|NCT03726788|Triamcinolone|triamcinolone|mesh-list
5598245|NCT03726788|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5598246|NCT03726788|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5598247|NCT03726788|Botulinum Toxins|botulinum toxins|mesh-list
5598248|NCT03726788|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5598249|NCT03726788|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5598250|NCT03726788|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5598251|NCT03726788|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5598252|NCT03726788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5598253|NCT03726788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598254|NCT03726788|Cholinergic Agents|cholinergic agents|mesh-ancestor
5598255|NCT03726788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5598256|NCT03726788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598257|NCT03726788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5598258|NCT03726788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5598259|NCT03726788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5598260|NCT03726788|Glucocorticoids|glucocorticoids|mesh-ancestor
5598261|NCT03726788|Hormones|hormones|mesh-ancestor
5598262|NCT03726788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5598263|NCT03726788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5598264|NCT03726788|Immunologic Factors|immunologic factors|mesh-ancestor
5598265|NCT03726788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5598266|NCT03726775|Durvalumab|durvalumab|mesh-list
5598267|NCT03726775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5598268|NCT03726775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5606372|NCT04540380|Fludarabine|fludarabine|mesh-list
5606373|NCT04540380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5606374|NCT04540380|Immunologic Factors|immunologic factors|mesh-ancestor
5606375|NCT04540380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606376|NCT04540380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5606377|NCT04540380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5606378|NCT04540380|Alkylating Agents|alkylating agents|mesh-ancestor
5606379|NCT04540380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606380|NCT04540380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5606381|NCT04540380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5606382|NCT04540380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5606383|NCT04537715|Itraconazole|itraconazole|mesh-list
5606384|NCT04537715|Rifampin|rifampin|mesh-list
5606385|NCT04537715|Antifungal Agents|antifungal agents|mesh-ancestor
5606386|NCT04537715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5606387|NCT04537715|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5606388|NCT04537715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5606389|NCT04537715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5606390|NCT04537715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606391|NCT04537715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5606392|NCT04537715|Hormone Antagonists|hormone antagonists|mesh-ancestor
5606393|NCT04537715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5606394|NCT04537715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606395|NCT04537715|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5606396|NCT04537715|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5606397|NCT04537715|Antitubercular Agents|antitubercular agents|mesh-ancestor
5606398|NCT04537715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5606399|NCT04537715|Leprostatic Agents|leprostatic agents|mesh-ancestor
5606400|NCT04537715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5606401|NCT04537715|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5606402|NCT04537715|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5606403|NCT04537715|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5606404|NCT04537715|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5606405|NCT04537715|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5606406|NCT04537715|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5606407|NCT04523129|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5606408|NCT04523129|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5606409|NCT04520607|Lorecivivint|lorecivivint|mesh-list
5606410|NCT04520607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5606411|NCT04499131|Progesterone|progesterone|mesh-list
5606412|NCT04499131|Progestins|progestins|mesh-ancestor
5606413|NCT04499131|Hormones|hormones|mesh-ancestor
5606414|NCT04499131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5606415|NCT04499131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606416|NCT04469595|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
5606417|NCT04469595|Aflibercept|aflibercept|mesh-list
5606418|NCT04469595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5606419|NCT04469595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5606420|NCT04469595|Growth Substances|growth substances|mesh-ancestor
5606421|NCT04469595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606422|NCT04469595|Growth Inhibitors|growth inhibitors|mesh-ancestor
5606423|NCT04469595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5606424|NCT04469595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5606425|NCT04469595|Glucocorticoids|glucocorticoids|mesh-ancestor
5606426|NCT04469595|Hormones|hormones|mesh-ancestor
5606427|NCT04469595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5606428|NCT04454684|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
5606429|NCT04454684|Hallucinogens|hallucinogens|mesh-ancestor
5606430|NCT04454684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606431|NCT04454684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5606432|NCT04454684|Serotonin Agents|serotonin agents|mesh-ancestor
5606433|NCT04454684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5606434|NCT04454684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606435|NCT04454684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5606436|NCT04454684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5606437|NCT04454684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5606438|NCT04454684|Adrenergic Agents|adrenergic agents|mesh-ancestor
5606439|NCT04454424|Midazolam|midazolam|mesh-list
5606440|NCT04454424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5606441|NCT04454424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5607007|NCT03032510|Ofloxacin|ofloxacin|mesh-list
5598269|NCT03726749|Prednisone|prednisone|mesh-list
5598270|NCT03726749|Glucocorticoids|glucocorticoids|mesh-list
5598271|NCT03726749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5598272|NCT03726749|Hormones|hormones|mesh-ancestor
5598273|NCT03726749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5598274|NCT03726749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598275|NCT03726749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5598276|NCT03726749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5598277|NCT03726736|Docetaxel|docetaxel|mesh-list
5598278|NCT03726736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5598279|NCT03726736|Tubulin Modulators|tubulin modulators|mesh-ancestor
5598280|NCT03726736|Antimitotic Agents|antimitotic agents|mesh-ancestor
5598281|NCT03726736|Mitosis Modulators|mitosis modulators|mesh-ancestor
5598282|NCT03726736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598283|NCT03726593|Artesunate|artesunate|mesh-list
5598284|NCT03726593|Mefloquine|mefloquine|mesh-list
5598285|NCT03726593|Atovaquone|atovaquone|mesh-list
5598286|NCT03726593|Proguanil|proguanil|mesh-list
5598287|NCT03726593|Pyronaridine|pyronaridine|mesh-list
5598288|NCT03726593|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
5598289|NCT03726593|Antimalarials|antimalarials|mesh-ancestor
5598290|NCT03726593|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5598291|NCT03726593|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5598292|NCT03726593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5598293|NCT03726593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5598294|NCT03726593|Antiviral Agents|antiviral agents|mesh-ancestor
5598295|NCT03726593|Schistosomicides|schistosomicides|mesh-ancestor
5598296|NCT03726593|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5598297|NCT03726593|Anthelmintics|anthelmintics|mesh-ancestor
5598298|NCT03726593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5598299|NCT03726593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598300|NCT03726593|Antimetabolites|antimetabolites|mesh-ancestor
5598301|NCT03726580|Propofol|propofol|mesh-list
5598302|NCT03726580|Sevoflurane|sevoflurane|mesh-list
5598303|NCT03726580|Isoflurane|isoflurane|mesh-list
5598304|NCT03726580|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5598305|NCT03726580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5598306|NCT03726580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598307|NCT03726580|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5598308|NCT03726580|Anesthetics, General|anesthetics, general|mesh-ancestor
5598309|NCT03726580|Anesthetics|anesthetics|mesh-ancestor
5598310|NCT03726580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5598311|NCT03726580|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5598312|NCT03726515|Pembrolizumab|pembrolizumab|mesh-list
5598313|NCT03726515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5598314|NCT03726515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5598315|NCT03726398|Macitentan|macitentan|mesh-list
5598316|NCT03726398|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
5598317|NCT03726398|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5598318|NCT03726398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598319|NCT03726398|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
5598320|NCT03726372|Bromides|bromides|mesh-list
5598321|NCT03726372|Rocuronium|rocuronium|mesh-list
5598322|NCT03726372|Anticonvulsants|anticonvulsants|mesh-ancestor
5598323|NCT03726372|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5598324|NCT03726372|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5598325|NCT03726372|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5598326|NCT03726372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5598327|NCT03726372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598328|NCT03726281|Nivolumab|nivolumab|mesh-list
5598329|NCT03726281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5598330|NCT03726281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5598331|NCT03726281|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5598332|NCT03726281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598333|NCT03726268|Fentanyl|fentanyl|mesh-list
5598334|NCT03726268|Sufentanil|sufentanil|mesh-list
5598335|NCT03726268|Morphine|morphine|mesh-list
5598336|NCT03726268|Methadone|methadone|mesh-list
5598337|NCT03726268|Hydromorphone|hydromorphone|mesh-list
5598338|NCT03726268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5598339|NCT03726268|Narcotics|narcotics|mesh-ancestor
5598340|NCT03726268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5598341|NCT03726268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598342|NCT03726268|Analgesics|analgesics|mesh-ancestor
5598343|NCT03726268|Sensory System Agents|sensory system agents|mesh-ancestor
5598344|NCT03726268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5598345|NCT03726268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5598346|NCT03726268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5598347|NCT03726268|Anesthetics, General|anesthetics, general|mesh-ancestor
5598348|NCT03726268|Anesthetics|anesthetics|mesh-ancestor
5598349|NCT03726268|Antitussive Agents|antitussive agents|mesh-ancestor
5598350|NCT03726268|Respiratory System Agents|respiratory system agents|mesh-ancestor
5598351|NCT03726242|Cromakalim|cromakalim|mesh-list
5598352|NCT03726242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5598353|NCT03726242|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5598354|NCT03726242|Autonomic Agents|autonomic agents|mesh-ancestor
5598355|NCT03726242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5598356|NCT03726242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598357|NCT03726242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5598358|NCT03726242|Respiratory System Agents|respiratory system agents|mesh-ancestor
5598359|NCT03726242|Parasympatholytics|parasympatholytics|mesh-ancestor
5598360|NCT03726242|Vasodilator Agents|vasodilator agents|mesh-ancestor
5598361|NCT03726216|Dalbavancin|dalbavancin|mesh-list
5598362|NCT03726216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5598363|NCT03726216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5598364|NCT03726177|Aspirin|aspirin|mesh-list
5598365|NCT03726177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5598366|NCT03726177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5598367|NCT03726177|Analgesics|analgesics|mesh-ancestor
5598368|NCT03726177|Sensory System Agents|sensory system agents|mesh-ancestor
5598369|NCT03726177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5598370|NCT03726177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598371|NCT03726177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5598372|NCT03726177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5598373|NCT03726177|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5598374|NCT03726177|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5598375|NCT03726177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598376|NCT03726177|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5598377|NCT03726177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5598378|NCT03726177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5598379|NCT03726177|Antipyretics|antipyretics|mesh-ancestor
5598380|NCT03726125|Insulin|insulin|mesh-list
5598381|NCT03726125|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5598382|NCT03726125|Insulin, Long-Acting|insulin, long-acting|mesh-list
5598383|NCT03726125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5598384|NCT03726125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598385|NCT03726099|Amoxicillin|amoxicillin|mesh-list
5598386|NCT03726099|Tetracycline|tetracycline|mesh-list
5598387|NCT03726099|Furazolidone|furazolidone|mesh-list
5598388|NCT03726099|Esomeprazole|esomeprazole|mesh-list
5598389|NCT03726099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5598390|NCT03726099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5598391|NCT03726099|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5598392|NCT03726099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5598393|NCT03726099|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5598394|NCT03726099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5598395|NCT03726099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598396|NCT03726099|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5598397|NCT03726099|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5598398|NCT03726099|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5598399|NCT03726099|Renal Agents|renal agents|mesh-ancestor
5598400|NCT03726099|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
5598401|NCT03726099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5598402|NCT03726099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5598403|NCT03726099|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
5598404|NCT03726021|Oxaliplatin|oxaliplatin|mesh-list
5598405|NCT03726021|Irinotecan|irinotecan|mesh-list
5598406|NCT03726021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5598407|NCT03726021|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5598408|NCT03726021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5598409|NCT03726021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5598410|NCT03726021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598411|NCT03725995|Lidocaine|lidocaine|mesh-list
5598412|NCT03725995|Midazolam|midazolam|mesh-list
5598413|NCT03725995|Anesthetics, Local|anesthetics, local|mesh-ancestor
5598414|NCT03725995|Anesthetics|anesthetics|mesh-ancestor
5598415|NCT03725995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5598416|NCT03725995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598417|NCT03725995|Sensory System Agents|sensory system agents|mesh-ancestor
5598418|NCT03725995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5598419|NCT03725995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5598420|NCT03725995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5598421|NCT03725995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5598422|NCT03725995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5607008|NCT03032510|Ertapenem|ertapenem|mesh-list
5598423|NCT03725995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598424|NCT03725995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5598425|NCT03725995|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5598426|NCT03725995|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5598427|NCT03725995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5598428|NCT03725995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5598429|NCT03725995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5598430|NCT03725995|Anesthetics, General|anesthetics, general|mesh-ancestor
5598431|NCT03725995|GABA Modulators|gaba modulators|mesh-ancestor
5598432|NCT03725995|GABA Agents|gaba agents|mesh-ancestor
5598433|NCT03725995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5598434|NCT03725930|Clonidine|clonidine|mesh-list
5598435|NCT03725930|Analgesics|analgesics|mesh-ancestor
5598436|NCT03725930|Sensory System Agents|sensory system agents|mesh-ancestor
5598437|NCT03725930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5598438|NCT03725930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598439|NCT03725930|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5598440|NCT03725930|Sympatholytics|sympatholytics|mesh-ancestor
5598441|NCT03725930|Autonomic Agents|autonomic agents|mesh-ancestor
5598442|NCT03725930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5598443|NCT03725930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5598444|NCT03725930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5598445|NCT03725930|Adrenergic Agents|adrenergic agents|mesh-ancestor
5598446|NCT03725930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5598447|NCT03725930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598448|NCT03725904|Progesterone|progesterone|mesh-list
5598449|NCT03725904|Progestins|progestins|mesh-ancestor
5598450|NCT03725904|Hormones|hormones|mesh-ancestor
5598451|NCT03725904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5598452|NCT03725904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598453|NCT03725891|Aspirin|aspirin|mesh-list
5598454|NCT03725891|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5598455|NCT03725891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5598456|NCT03725891|Analgesics|analgesics|mesh-ancestor
5598457|NCT03725891|Sensory System Agents|sensory system agents|mesh-ancestor
5598458|NCT03725891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5598459|NCT03725891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598460|NCT03725891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5598461|NCT03725891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5598462|NCT03725891|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5598463|NCT03725891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5598464|NCT03725891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598465|NCT03725891|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5598466|NCT03725891|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5598467|NCT03725891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5598468|NCT03725891|Antipyretics|antipyretics|mesh-ancestor
5598469|NCT03725878|Folic Acid|folic acid|mesh-list
5598470|NCT03725878|Hematinics|hematinics|mesh-ancestor
5598471|NCT03725878|Vitamin B Complex|vitamin b complex|mesh-ancestor
5598472|NCT03725878|Vitamins|vitamins|mesh-ancestor
5598473|NCT03725878|Micronutrients|micronutrients|mesh-ancestor
5598474|NCT03725878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598475|NCT03725709|Anesthetics|anesthetics|mesh-list
5598476|NCT03725709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5598477|NCT03725709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598478|NCT03725553|Vasopressins|vasopressins|mesh-list
5598479|NCT03725553|Arginine Vasopressin|arginine vasopressin|mesh-list
5598480|NCT03725553|Hemostatics|hemostatics|mesh-ancestor
5598481|NCT03725553|Coagulants|coagulants|mesh-ancestor
5598482|NCT03725553|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5598483|NCT03725553|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5598484|NCT03725553|Natriuretic Agents|natriuretic agents|mesh-ancestor
5598485|NCT03725553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598486|NCT03725501|Ranibizumab|ranibizumab|mesh-list
5598487|NCT03725501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5598488|NCT03725501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5598489|NCT03725501|Growth Substances|growth substances|mesh-ancestor
5598490|NCT03725501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598491|NCT03725501|Growth Inhibitors|growth inhibitors|mesh-ancestor
5598492|NCT03725501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5598493|NCT03725423|Apatinib|apatinib|mesh-list
5598494|NCT03725423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5598495|NCT03725423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5598496|NCT03725423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5598497|NCT03725423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598498|NCT03725267|Melatonin|melatonin|mesh-list
5598499|NCT03725267|Antioxidants|antioxidants|mesh-ancestor
5598500|NCT03725267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598501|NCT03725267|Protective Agents|protective agents|mesh-ancestor
5598502|NCT03725267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598503|NCT03725267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5598504|NCT03725228|Lidocaine|lidocaine|mesh-list
5598505|NCT03725228|Magnesium Sulfate|magnesium sulfate|mesh-list
5598506|NCT03725228|Anesthetics, Local|anesthetics, local|mesh-ancestor
5598507|NCT03725228|Anesthetics|anesthetics|mesh-ancestor
5598508|NCT03725228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5598509|NCT03725228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598510|NCT03725228|Sensory System Agents|sensory system agents|mesh-ancestor
5598511|NCT03725228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5598512|NCT03725228|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5598513|NCT03725228|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5598514|NCT03725228|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5598515|NCT03725228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5598516|NCT03725228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598517|NCT03725228|Analgesics|analgesics|mesh-ancestor
5598518|NCT03725228|Anticonvulsants|anticonvulsants|mesh-ancestor
5598519|NCT03725228|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5598520|NCT03725228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5598521|NCT03725228|Tocolytic Agents|tocolytic agents|mesh-ancestor
5598522|NCT03725228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5598523|NCT03725020|Fluorides|fluorides|mesh-list
5598524|NCT03725020|Fluorides, Topical|fluorides, topical|mesh-list
5598525|NCT03725020|Cariostatic Agents|cariostatic agents|mesh-ancestor
5598526|NCT03725020|Protective Agents|protective agents|mesh-ancestor
5598527|NCT03725020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598528|NCT03724994|Gemcitabine|gemcitabine|mesh-list
5598529|NCT03724994|Paclitaxel|paclitaxel|mesh-list
5598530|NCT03724994|Fluorouracil|fluorouracil|mesh-list
5598531|NCT03724994|Folfirinox|folfirinox|mesh-list
5598532|NCT03724994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5598533|NCT03724994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5598534|NCT03724994|Tubulin Modulators|tubulin modulators|mesh-ancestor
5598535|NCT03724994|Antimitotic Agents|antimitotic agents|mesh-ancestor
5598536|NCT03724994|Mitosis Modulators|mitosis modulators|mesh-ancestor
5598537|NCT03724994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598538|NCT03724994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5598539|NCT03724994|Antimetabolites|antimetabolites|mesh-ancestor
5598540|NCT03724994|Antiviral Agents|antiviral agents|mesh-ancestor
5598541|NCT03724994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5598542|NCT03724994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5598543|NCT03724994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5598544|NCT03724994|Immunologic Factors|immunologic factors|mesh-ancestor
5598545|NCT03724994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606442|NCT04454424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5606443|NCT04454424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606444|NCT04454424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5606445|NCT04454424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5606446|NCT04454424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5606447|NCT04454424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5606448|NCT04454424|Anesthetics, General|anesthetics, general|mesh-ancestor
5606449|NCT04454424|Anesthetics|anesthetics|mesh-ancestor
5606450|NCT04454424|GABA Modulators|gaba modulators|mesh-ancestor
5606451|NCT04454424|GABA Agents|gaba agents|mesh-ancestor
5606452|NCT04454424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5606453|NCT04454424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606454|NCT04395469|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
5606455|NCT04395469|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5606456|NCT04395469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606457|NCT04367090|Docetaxel|docetaxel|mesh-list
5606458|NCT04367090|Trastuzumab|trastuzumab|mesh-list
5606459|NCT04367090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5606460|NCT04367090|Tubulin Modulators|tubulin modulators|mesh-ancestor
5606461|NCT04367090|Antimitotic Agents|antimitotic agents|mesh-ancestor
5606462|NCT04367090|Mitosis Modulators|mitosis modulators|mesh-ancestor
5606463|NCT04367090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606464|NCT04367090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5606465|NCT04338828|Nitric Oxide|nitric oxide|mesh-list
5606466|NCT04338828|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5606467|NCT04338828|Autonomic Agents|autonomic agents|mesh-ancestor
5606468|NCT04338828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5606469|NCT04338828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606470|NCT04338828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5598546|NCT03724955|Estradiol|estradiol|mesh-list
5598547|NCT03724955|Estrogens|estrogens|mesh-ancestor
5598548|NCT03724955|Hormones|hormones|mesh-ancestor
5598549|NCT03724955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5598550|NCT03724955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598551|NCT03724838|Sildenafil Citrate|sildenafil citrate|mesh-list
5598552|NCT03724838|Esomeprazole|esomeprazole|mesh-list
5598553|NCT03724838|Citric Acid|citric acid|mesh-list
5598554|NCT03724838|Sodium Citrate|sodium citrate|mesh-list
5598555|NCT03724838|Anticoagulants|anticoagulants|mesh-ancestor
5598556|NCT03724838|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5598557|NCT03724838|Chelating Agents|chelating agents|mesh-ancestor
5598558|NCT03724838|Sequestering Agents|sequestering agents|mesh-ancestor
5598559|NCT03724838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598560|NCT03724838|Vasodilator Agents|vasodilator agents|mesh-ancestor
5598561|NCT03724838|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5598562|NCT03724838|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5598563|NCT03724838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5598564|NCT03724838|Urological Agents|urological agents|mesh-ancestor
5598565|NCT03724838|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5598566|NCT03724838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5598567|NCT03724838|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5598568|NCT03724825|Testosterone|testosterone|mesh-list
5598569|NCT03724825|Androgens|androgens|mesh-ancestor
5598570|NCT03724825|Hormones|hormones|mesh-ancestor
5598571|NCT03724825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5598572|NCT03724825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598573|NCT03724578|Anti-Infective Agents|anti-infective agents|mesh-list
5598574|NCT03724578|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5598575|NCT03724578|Grape Seed Extract|grape seed extract|mesh-list
5598576|NCT03724578|Fluorides|fluorides|mesh-list
5598577|NCT03724578|Cariostatic Agents|cariostatic agents|mesh-ancestor
5598578|NCT03724578|Protective Agents|protective agents|mesh-ancestor
5598579|NCT03724578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598580|NCT03724578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5598581|NCT03724578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5598582|NCT03724578|Antioxidants|antioxidants|mesh-ancestor
5598583|NCT03724578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598584|NCT03724409|Octreotide|octreotide|mesh-list
5598585|NCT03724409|Edotreotide|edotreotide|mesh-list
5598586|NCT03724409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5598587|NCT03724409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5598588|NCT03724409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5598589|NCT03724409|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5598590|NCT03724409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598591|NCT03724266|Chitosan|chitosan|mesh-list
5598592|NCT03724266|Calcium|calcium|mesh-list
5598593|NCT03724266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5598594|NCT03724266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598595|NCT03724266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5598596|NCT03724266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5598597|NCT03724266|Antimetabolites|antimetabolites|mesh-ancestor
5598598|NCT03724266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598599|NCT03724266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5598600|NCT03724266|Chelating Agents|chelating agents|mesh-ancestor
5598601|NCT03724266|Sequestering Agents|sequestering agents|mesh-ancestor
5598602|NCT03724266|Hemostatics|hemostatics|mesh-ancestor
5598603|NCT03724266|Coagulants|coagulants|mesh-ancestor
5598604|NCT03724175|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
5598605|NCT03724175|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5598606|NCT03724175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5598607|NCT03724084|Cytarabine|cytarabine|mesh-list
5598608|NCT03724084|Daunorubicin|daunorubicin|mesh-list
5598609|NCT03724084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5598610|NCT03724084|Antimetabolites|antimetabolites|mesh-ancestor
5598611|NCT03724084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598612|NCT03724084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5598613|NCT03724084|Antiviral Agents|antiviral agents|mesh-ancestor
5598614|NCT03724084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5598615|NCT03724084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5598616|NCT03724084|Immunologic Factors|immunologic factors|mesh-ancestor
5598617|NCT03724084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598618|NCT03724084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5598619|NCT03724084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5598620|NCT03724084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5598621|NCT03724084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5598622|NCT03724071|Flucytosine|flucytosine|mesh-list
5598623|NCT03724071|Antifungal Agents|antifungal agents|mesh-ancestor
5598624|NCT03724071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5598625|NCT03724071|Antimetabolites|antimetabolites|mesh-ancestor
5598626|NCT03724071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598641|NCT03723967|Paclitaxel|paclitaxel|mesh-list
5598642|NCT03723967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5598643|NCT03723967|Carboplatin|carboplatin|mesh-list
5598644|NCT03723967|Durvalumab|durvalumab|mesh-list
5598645|NCT03723967|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5598646|NCT03723967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5598647|NCT03723967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5598648|NCT03723967|Tubulin Modulators|tubulin modulators|mesh-ancestor
5598649|NCT03723967|Antimitotic Agents|antimitotic agents|mesh-ancestor
5598650|NCT03723967|Mitosis Modulators|mitosis modulators|mesh-ancestor
5598651|NCT03723967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598652|NCT03723967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5598653|NCT03723967|Immunologic Factors|immunologic factors|mesh-ancestor
5598654|NCT03723967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598655|NCT03723941|Etoposide|etoposide|mesh-list
5598656|NCT03723941|Mitotane|mitotane|mesh-list
5598657|NCT03723941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5598658|NCT03723941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5598659|NCT03723941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5598660|NCT03723941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5598661|NCT03723941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5598662|NCT03723941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598663|NCT03723941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5598664|NCT03723824|Grazoprevir|grazoprevir|mesh-list
5598665|NCT03723824|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
5598666|NCT03723824|Antiviral Agents|antiviral agents|mesh-ancestor
5598667|NCT03723824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6488365|NCT00583427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6488366|NCT00583427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6488367|NCT00583427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6488368|NCT00583427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488369|NCT00583518|Hormones|hormones|mesh-list
6488370|NCT00583518|Parathyroid Hormone|parathyroid hormone|mesh-list
6488371|NCT00583518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6488372|NCT00583518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488373|NCT00583518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6488374|NCT00583778|Ipratropium|ipratropium|mesh-list
6488375|NCT00583778|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6488376|NCT00583778|Autonomic Agents|autonomic agents|mesh-ancestor
6488377|NCT00583778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6488378|NCT00583778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6488379|NCT00583778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6488380|NCT00583778|Respiratory System Agents|respiratory system agents|mesh-ancestor
6488381|NCT00583778|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6488382|NCT00583778|Cholinergic Agents|cholinergic agents|mesh-ancestor
6488383|NCT00583778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6488384|NCT00583778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6488385|NCT00583869|Pregabalin|pregabalin|mesh-list
6488386|NCT00583869|Analgesics|analgesics|mesh-ancestor
6488387|NCT00583869|Sensory System Agents|sensory system agents|mesh-ancestor
5598668|NCT03723785|Insulin|insulin|mesh-list
5598669|NCT03723785|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5598670|NCT03723785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6488388|NCT00583869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6488389|NCT00583869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598671|NCT03723785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598672|NCT03723759|Insulin Aspart|insulin aspart|mesh-list
5598673|NCT03723759|Insulin, Long-Acting|insulin, long-acting|mesh-list
5598674|NCT03723759|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
5598675|NCT03723759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5598676|NCT03723759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598677|NCT03723564|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5598678|NCT03723395|Repaglinide|repaglinide|mesh-list
5598679|NCT03723395|Tolbutamide|tolbutamide|mesh-list
5598680|NCT03723395|Itraconazole|itraconazole|mesh-list
5598681|NCT03723395|Rifampin|rifampin|mesh-list
5598682|NCT03723395|Tucatinib|tucatinib|mesh-list
5598683|NCT03723395|Digoxin|digoxin|mesh-list
5598684|NCT03723395|Midazolam|midazolam|mesh-list
5598685|NCT03723395|Gemfibrozil|gemfibrozil|mesh-list
5598686|NCT03723395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5598687|NCT03723395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5598688|NCT03723395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5598689|NCT03723395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598690|NCT03723395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5598691|NCT03723395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5598692|NCT03723395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5598693|NCT03723395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5598694|NCT03723395|Anesthetics, General|anesthetics, general|mesh-ancestor
5598695|NCT03723395|Anesthetics|anesthetics|mesh-ancestor
5598696|NCT03723395|GABA Modulators|gaba modulators|mesh-ancestor
5598697|NCT03723395|GABA Agents|gaba agents|mesh-ancestor
5598698|NCT03723395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5598699|NCT03723395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598700|NCT03723395|Antifungal Agents|antifungal agents|mesh-ancestor
5598701|NCT03723395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5598702|NCT03723395|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5598703|NCT03723395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5598704|NCT03723395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5598705|NCT03723395|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5598706|NCT03723395|Hormone Antagonists|hormone antagonists|mesh-ancestor
5598707|NCT03723395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5598708|NCT03723395|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5598709|NCT03723395|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5598710|NCT03723395|Antitubercular Agents|antitubercular agents|mesh-ancestor
5598711|NCT03723395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5598712|NCT03723395|Leprostatic Agents|leprostatic agents|mesh-ancestor
5598713|NCT03723395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5598714|NCT03723395|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5598715|NCT03723395|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5598716|NCT03723395|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5598717|NCT03723395|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5598718|NCT03723395|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5598719|NCT03723395|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5598720|NCT03723395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5598721|NCT03723395|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5598722|NCT03723395|Protective Agents|protective agents|mesh-ancestor
5598723|NCT03723395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5598724|NCT03723395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5598725|NCT03723395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5598726|NCT03723395|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5598727|NCT03723395|Antimetabolites|antimetabolites|mesh-ancestor
5598728|NCT03723395|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5598729|NCT03723395|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
5598730|NCT03723291|Tocopherols|tocopherols|mesh-list
5598731|NCT03723291|Vitamin E|vitamin e|mesh-list
5598732|NCT03723291|Tocotrienols|tocotrienols|mesh-list
5598733|NCT03723291|alpha-Tocopherol|alpha-tocopherol|mesh-list
5598734|NCT03723291|Pentoxifylline|pentoxifylline|mesh-list
5598735|NCT03723291|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5598736|NCT03723291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5598737|NCT03723291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598738|NCT03723291|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5598739|NCT03723291|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5598740|NCT03723291|Protective Agents|protective agents|mesh-ancestor
5598741|NCT03723291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598742|NCT03723291|Vasodilator Agents|vasodilator agents|mesh-ancestor
5598743|NCT03723291|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5598744|NCT03723291|Antioxidants|antioxidants|mesh-ancestor
5598745|NCT03723291|Vitamins|vitamins|mesh-ancestor
5598746|NCT03723291|Micronutrients|micronutrients|mesh-ancestor
5598747|NCT03723252|Dapagliflozin|dapagliflozin|mesh-list
5598748|NCT03723252|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5598749|NCT03723252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598750|NCT03723252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5598751|NCT03723252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598752|NCT03723187|Heparin|heparin|mesh-list
5598753|NCT03723187|Anticoagulants|anticoagulants|mesh-ancestor
5598754|NCT03723187|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5598755|NCT03723187|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5598756|NCT03723187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606471|NCT04338828|Respiratory System Agents|respiratory system agents|mesh-ancestor
5606472|NCT04338828|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5606473|NCT04338828|Antioxidants|antioxidants|mesh-ancestor
5606474|NCT04338828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606475|NCT04338828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5606476|NCT04338828|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5606477|NCT04338828|Vasodilator Agents|vasodilator agents|mesh-ancestor
5606478|NCT04338828|Gasotransmitters|gasotransmitters|mesh-ancestor
5606479|NCT04338828|Protective Agents|protective agents|mesh-ancestor
5606480|NCT04338321|Quetiapine Fumarate|quetiapine fumarate|mesh-list
5606481|NCT04338321|Esketamine|esketamine|mesh-list
5606482|NCT04338321|Antidepressive Agents|antidepressive agents|mesh-ancestor
5606483|NCT04338321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5606484|NCT04338321|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5606485|NCT04338321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5606486|NCT04338321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5606487|NCT04338321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606488|NCT04331288|Ethanol|ethanol|mesh-list
5606489|NCT04331288|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5606490|NCT04331288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5606491|NCT04331288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5606492|NCT04331288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606493|NCT04320628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
5606494|NCT04320628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5606495|NCT04299113|Vinorelbine|vinorelbine|mesh-list
5606496|NCT04299113|Mocetinostat|mocetinostat|mesh-list
5606497|NCT04299113|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5606498|NCT04299113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5606499|NCT04299113|Tubulin Modulators|tubulin modulators|mesh-ancestor
5606500|NCT04299113|Antimitotic Agents|antimitotic agents|mesh-ancestor
5606501|NCT04299113|Mitosis Modulators|mitosis modulators|mesh-ancestor
5606502|NCT04299113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606503|NCT04299113|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5606504|NCT04299113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5606505|NCT04283500|Buprenorphine|buprenorphine|mesh-list
5606506|NCT04283500|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
5606507|NCT04283500|Naloxone|naloxone|mesh-list
5606508|NCT04283500|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5606509|NCT04283500|Narcotics|narcotics|mesh-ancestor
5606510|NCT04283500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5606511|NCT04283500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606512|NCT04283500|Analgesics|analgesics|mesh-ancestor
5606513|NCT04283500|Sensory System Agents|sensory system agents|mesh-ancestor
5606514|NCT04283500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5606515|NCT04283500|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5606516|NCT04241549|Azacitidine|azacitidine|mesh-list
5606517|NCT04241549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5606518|NCT04241549|Antimetabolites|antimetabolites|mesh-ancestor
5606519|NCT04241549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606520|NCT04241549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5606521|NCT04241549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5606522|NCT04225026|Avasopasem manganese|avasopasem manganese|mesh-list
5606523|NCT04225026|Antioxidants|antioxidants|mesh-ancestor
5606524|NCT04225026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606525|NCT04225026|Protective Agents|protective agents|mesh-ancestor
5606526|NCT04225026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606527|NCT04217135|Hydralazine|hydralazine|mesh-list
5606528|NCT04217135|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5606529|NCT04217135|Vasodilator Agents|vasodilator agents|mesh-ancestor
5606530|NCT04205838|Vidarabine|vidarabine|mesh-list
5606531|NCT04205838|Cyclophosphamide|cyclophosphamide|mesh-list
5606532|NCT04205838|Fludarabine|fludarabine|mesh-list
5606533|NCT04205838|Fludarabine phosphate|fludarabine phosphate|mesh-list
5606534|NCT04205838|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5606535|NCT04205838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5606536|NCT04205838|Immunologic Factors|immunologic factors|mesh-ancestor
5598757|NCT03723135|Azacitidine|azacitidine|mesh-list
5598758|NCT03723135|Cc-486|cc-486|mesh-list
5598759|NCT03723135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5598760|NCT03723135|Antimetabolites|antimetabolites|mesh-ancestor
5598761|NCT03723135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598762|NCT03723135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5598763|NCT03723135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5598764|NCT03723109|Anesthetics|anesthetics|mesh-list
5598765|NCT03723109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5598766|NCT03723109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598767|NCT03723096|Pomalidomide|pomalidomide|mesh-list
5598768|NCT03723096|Immunologic Factors|immunologic factors|mesh-ancestor
5598769|NCT03723096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598770|NCT03723096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5598771|NCT03723096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5598772|NCT03723096|Growth Substances|growth substances|mesh-ancestor
5598773|NCT03723096|Growth Inhibitors|growth inhibitors|mesh-ancestor
5598774|NCT03723096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5598775|NCT03723083|Thalidomide|thalidomide|mesh-list
5598776|NCT03723083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5598777|NCT03723083|Immunologic Factors|immunologic factors|mesh-ancestor
5598778|NCT03723083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598779|NCT03723083|Leprostatic Agents|leprostatic agents|mesh-ancestor
5598780|NCT03723083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5598781|NCT03723083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5598782|NCT03723083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5598783|NCT03723083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5598784|NCT03723083|Growth Substances|growth substances|mesh-ancestor
5598785|NCT03723083|Growth Inhibitors|growth inhibitors|mesh-ancestor
5598786|NCT03723083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5598787|NCT03723031|Misoprostol|misoprostol|mesh-list
5598788|NCT03723031|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5598789|NCT03723031|Abortifacient Agents|abortifacient agents|mesh-ancestor
5598790|NCT03723031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5598791|NCT03723031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598792|NCT03723031|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5598793|NCT03723031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5598794|NCT03723031|Oxytocics|oxytocics|mesh-ancestor
5598795|NCT03722940|Magnesium Sulfate|magnesium sulfate|mesh-list
5598796|NCT03722940|Analgesics|analgesics|mesh-ancestor
5598797|NCT03722940|Sensory System Agents|sensory system agents|mesh-ancestor
5598798|NCT03722940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5598799|NCT03722940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598800|NCT03722940|Anesthetics|anesthetics|mesh-ancestor
5598801|NCT03722940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5598802|NCT03722940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5598803|NCT03722940|Anticonvulsants|anticonvulsants|mesh-ancestor
5598804|NCT03722940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5598805|NCT03722940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5598806|NCT03722940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598807|NCT03722940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5598808|NCT03722940|Tocolytic Agents|tocolytic agents|mesh-ancestor
5598809|NCT03722940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5598810|NCT03722927|Bupivacaine|bupivacaine|mesh-list
5598811|NCT03722927|Anesthetics, Local|anesthetics, local|mesh-ancestor
5598812|NCT03722927|Anesthetics|anesthetics|mesh-ancestor
5598813|NCT03722927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5598814|NCT03722927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598815|NCT03722927|Sensory System Agents|sensory system agents|mesh-ancestor
5598816|NCT03722927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5598817|NCT03722914|Benzonatate|benzonatate|mesh-list
5598818|NCT03722914|Antitussive Agents|antitussive agents|mesh-ancestor
5598819|NCT03722914|Respiratory System Agents|respiratory system agents|mesh-ancestor
5598820|NCT03722875|Apatinib|apatinib|mesh-list
5598821|NCT03722875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5598822|NCT03722875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5598823|NCT03722875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5598824|NCT03722875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598825|NCT03722849|Adenosine|adenosine|mesh-list
5598826|NCT03722849|Capsaicin|capsaicin|mesh-list
5598827|NCT03722849|Antipruritics|antipruritics|mesh-ancestor
5598828|NCT03722849|Dermatologic Agents|dermatologic agents|mesh-ancestor
5598829|NCT03722849|Sensory System Agents|sensory system agents|mesh-ancestor
5598830|NCT03722849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5598831|NCT03722849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598832|NCT03722849|Analgesics|analgesics|mesh-ancestor
5598833|NCT03722849|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5598834|NCT03722849|Vasodilator Agents|vasodilator agents|mesh-ancestor
5598835|NCT03722849|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5598836|NCT03722849|Purinergic Agonists|purinergic agonists|mesh-ancestor
5598837|NCT03722849|Purinergic Agents|purinergic agents|mesh-ancestor
5598838|NCT03722849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5598839|NCT03722849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598840|NCT03722823|Tucatinib|tucatinib|mesh-list
5598841|NCT03722823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5598842|NCT03722823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5598843|NCT03722823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5598844|NCT03722823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598845|NCT03722680|Riluzole|riluzole|mesh-list
5598846|NCT03722680|Anticonvulsants|anticonvulsants|mesh-ancestor
5598847|NCT03722680|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5598848|NCT03722680|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5598849|NCT03722680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5598850|NCT03722680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598851|NCT03722680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598852|NCT03722680|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5598853|NCT03722680|Protective Agents|protective agents|mesh-ancestor
5598854|NCT03722498|Leucovorin|leucovorin|mesh-list
5598855|NCT03722498|Fluorouracil|fluorouracil|mesh-list
5598856|NCT03722498|Oxaliplatin|oxaliplatin|mesh-list
5598857|NCT03722498|Sorafenib|sorafenib|mesh-list
5598858|NCT03722498|Antimetabolites|antimetabolites|mesh-ancestor
5598859|NCT03722498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598860|NCT03722498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5598861|NCT03722498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5598862|NCT03722498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5598863|NCT03722498|Immunologic Factors|immunologic factors|mesh-ancestor
5598864|NCT03722498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598865|NCT03722498|Antidotes|antidotes|mesh-ancestor
5598866|NCT03722498|Protective Agents|protective agents|mesh-ancestor
5598867|NCT03722498|Vitamin B Complex|vitamin b complex|mesh-ancestor
5598868|NCT03722498|Vitamins|vitamins|mesh-ancestor
5598869|NCT03722498|Micronutrients|micronutrients|mesh-ancestor
5598870|NCT03722498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5598871|NCT03722498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5598872|NCT03722420|Imatinib Mesylate|imatinib mesylate|mesh-list
5598873|NCT03722420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5598874|NCT03722420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5598875|NCT03722420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5598876|NCT03722420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598877|NCT03722381|Amlodipine|amlodipine|mesh-list
5598878|NCT03722381|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5598879|NCT03722381|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5598880|NCT03722381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5598881|NCT03722381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598882|NCT03722381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5598883|NCT03722381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598884|NCT03722381|Vasodilator Agents|vasodilator agents|mesh-ancestor
5598885|NCT03722355|Carmustine|carmustine|mesh-list
5598886|NCT03722355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5598887|NCT03722355|Alkylating Agents|alkylating agents|mesh-ancestor
5598888|NCT03722355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598889|NCT03722355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5598890|NCT03722342|Pembrolizumab|pembrolizumab|mesh-list
5598891|NCT03722342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5598892|NCT03722342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5598893|NCT03722329|Eculizumab|eculizumab|mesh-list
5598894|NCT03722329|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5598895|NCT03722329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5598896|NCT03722329|Immunologic Factors|immunologic factors|mesh-ancestor
5598897|NCT03722329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598898|NCT03722303|Cortisone|cortisone|mesh-list
5598899|NCT03722303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5598900|NCT03722290|Metformin|metformin|mesh-list
5598901|NCT03722290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5598902|NCT03722290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598903|NCT03722173|Itraconazole|itraconazole|mesh-list
5598904|NCT03722173|Antifungal Agents|antifungal agents|mesh-ancestor
5598905|NCT03722173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5598906|NCT03722173|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5598907|NCT03722173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5598908|NCT03722173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5598909|NCT03722173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598910|NCT03722173|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5598911|NCT03722173|Hormone Antagonists|hormone antagonists|mesh-ancestor
5598912|NCT03722173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5598913|NCT03722173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598914|NCT03722173|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5598915|NCT03721991|Butyric Acid|butyric acid|mesh-list
5598916|NCT03721991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5598917|NCT03721991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598918|NCT03721991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598919|NCT03721991|Histamine Antagonists|histamine antagonists|mesh-ancestor
5598920|NCT03721991|Histamine Agents|histamine agents|mesh-ancestor
5598921|NCT03721900|Ketamine|ketamine|mesh-list
5598922|NCT03721900|Analgesics|analgesics|mesh-ancestor
5598923|NCT03721900|Sensory System Agents|sensory system agents|mesh-ancestor
5598924|NCT03721900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5598925|NCT03721900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598926|NCT03721900|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5598927|NCT03721900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5598928|NCT03721900|Anesthetics, General|anesthetics, general|mesh-ancestor
5598929|NCT03721900|Anesthetics|anesthetics|mesh-ancestor
5598930|NCT03721900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5598931|NCT03721900|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5598932|NCT03721900|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5598933|NCT03721900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5598934|NCT03721900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598935|NCT03721874|Dapagliflozin|dapagliflozin|mesh-list
5598936|NCT03721874|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5598937|NCT03721874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598938|NCT03721874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5598939|NCT03721874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598940|NCT03721757|Nivolumab|nivolumab|mesh-list
5598941|NCT03721757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5598942|NCT03721757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5598943|NCT03721757|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5598944|NCT03721757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598945|NCT03721744|Gemcitabine|gemcitabine|mesh-list
5598946|NCT03721744|Paclitaxel|paclitaxel|mesh-list
5598947|NCT03721744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5598948|NCT03721744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5598949|NCT03721744|Tubulin Modulators|tubulin modulators|mesh-ancestor
5598950|NCT03721744|Antimitotic Agents|antimitotic agents|mesh-ancestor
5598951|NCT03721744|Mitosis Modulators|mitosis modulators|mesh-ancestor
5598952|NCT03721744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598953|NCT03721744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5598954|NCT03721744|Antimetabolites|antimetabolites|mesh-ancestor
5598955|NCT03721744|Antiviral Agents|antiviral agents|mesh-ancestor
5598956|NCT03721744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5598957|NCT03721744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5598958|NCT03721744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5598959|NCT03721744|Immunologic Factors|immunologic factors|mesh-ancestor
5598960|NCT03721744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598961|NCT03721679|Pembrolizumab|pembrolizumab|mesh-list
5598962|NCT03721679|Nivolumab|nivolumab|mesh-list
5598963|NCT03721679|Durvalumab|durvalumab|mesh-list
5598964|NCT03721679|Atezolizumab|atezolizumab|mesh-list
5598965|NCT03721679|Poly ICLC|poly iclc|mesh-list
5598966|NCT03721679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5598967|NCT03721679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5598968|NCT03721679|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5598969|NCT03721679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598970|NCT03721679|Interferon Inducers|interferon inducers|mesh-ancestor
5598971|NCT03721679|Immunologic Factors|immunologic factors|mesh-ancestor
5598972|NCT03721679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598973|NCT03721653|Leucovorin|leucovorin|mesh-list
5598974|NCT03721653|Bevacizumab|bevacizumab|mesh-list
5598975|NCT03721653|Fluorouracil|fluorouracil|mesh-list
5598976|NCT03721653|Oxaliplatin|oxaliplatin|mesh-list
5598977|NCT03721653|Irinotecan|irinotecan|mesh-list
5598978|NCT03721653|Atezolizumab|atezolizumab|mesh-list
5598979|NCT03721653|Levoleucovorin|levoleucovorin|mesh-list
5598980|NCT03721653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5598981|NCT03721653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5598982|NCT03721653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5598983|NCT03721653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5598984|NCT03721653|Growth Substances|growth substances|mesh-ancestor
5598985|NCT03721653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5598986|NCT03721653|Growth Inhibitors|growth inhibitors|mesh-ancestor
5598987|NCT03721653|Antimetabolites|antimetabolites|mesh-ancestor
5598988|NCT03721653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5598989|NCT03721653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5598990|NCT03721653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5598991|NCT03721653|Immunologic Factors|immunologic factors|mesh-ancestor
5598992|NCT03721653|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5598993|NCT03721653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5598994|NCT03721653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5598995|NCT03721653|Antidotes|antidotes|mesh-ancestor
5598996|NCT03721653|Protective Agents|protective agents|mesh-ancestor
5598997|NCT03721653|Vitamin B Complex|vitamin b complex|mesh-ancestor
5598998|NCT03721653|Vitamins|vitamins|mesh-ancestor
5598999|NCT03721653|Micronutrients|micronutrients|mesh-ancestor
5599000|NCT03721627|Sofosbuvir|sofosbuvir|mesh-list
5599001|NCT03721627|Ledipasvir|ledipasvir|mesh-list
5599002|NCT03721627|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
5599003|NCT03721627|Antiviral Agents|antiviral agents|mesh-ancestor
5599004|NCT03721627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5599005|NCT03721614|Sirolimus|sirolimus|mesh-list
5599006|NCT03721614|Everolimus|everolimus|mesh-list
5599007|NCT03721614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5599008|NCT03721614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5599009|NCT03721614|Immunologic Factors|immunologic factors|mesh-ancestor
5599010|NCT03721614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599011|NCT03721614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5599012|NCT03721614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5599013|NCT03721614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5599014|NCT03721614|Antifungal Agents|antifungal agents|mesh-ancestor
5606537|NCT04205838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606538|NCT04205838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5606539|NCT04205838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5606540|NCT04205838|Alkylating Agents|alkylating agents|mesh-ancestor
5606541|NCT04205838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606542|NCT04205838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5606543|NCT04205838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5606544|NCT04205838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5606545|NCT04205838|Antimetabolites|antimetabolites|mesh-ancestor
5606546|NCT04205838|Antiviral Agents|antiviral agents|mesh-ancestor
5606547|NCT04205838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5606548|NCT04195633|Cyclosporine|cyclosporine|mesh-list
5606549|NCT04195633|Mycophenolic Acid|mycophenolic acid|mesh-list
5606550|NCT04195633|Cyclophosphamide|cyclophosphamide|mesh-list
5606551|NCT04195633|Treosulfan|treosulfan|mesh-list
5606552|NCT04195633|Busulfan|busulfan|mesh-list
5606553|NCT04195633|Fludarabine|fludarabine|mesh-list
5606554|NCT04195633|Cyclosporins|cyclosporins|mesh-list
5606555|NCT04195633|Lenograstim|lenograstim|mesh-list
5606556|NCT04195633|Sargramostim|sargramostim|mesh-list
5606557|NCT04195633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5606558|NCT04195633|Immunologic Factors|immunologic factors|mesh-ancestor
5606559|NCT04195633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606560|NCT04195633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5606561|NCT04195633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5606562|NCT04195633|Alkylating Agents|alkylating agents|mesh-ancestor
5606563|NCT04195633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606564|NCT04195633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5606565|NCT04195633|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5606566|NCT04195633|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5606567|NCT04195633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5606568|NCT04195633|Antifungal Agents|antifungal agents|mesh-ancestor
5606569|NCT04195633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5606570|NCT04195633|Dermatologic Agents|dermatologic agents|mesh-ancestor
5606571|NCT04195633|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5606572|NCT04195633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5606573|NCT04195633|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5606574|NCT04195633|Antitubercular Agents|antitubercular agents|mesh-ancestor
5606575|NCT04195633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5607009|NCT03032510|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5607010|NCT03032510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5607011|NCT03032510|Renal Agents|renal agents|mesh-ancestor
5607012|NCT03032510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5607013|NCT03032510|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5599015|NCT03721497|Methyltestosterone|methyltestosterone|mesh-list
5599016|NCT03721497|Testosterone|testosterone|mesh-list
5599017|NCT03721497|Testosterone undecanoate|testosterone undecanoate|mesh-list
5599018|NCT03721497|Testosterone enanthate|testosterone enanthate|mesh-list
5599019|NCT03721497|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5599020|NCT03721497|Androgens|androgens|mesh-ancestor
5599021|NCT03721497|Hormones|hormones|mesh-ancestor
5599022|NCT03721497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5599023|NCT03721497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599024|NCT03721497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5599025|NCT03721497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5599026|NCT03721497|Anabolic Agents|anabolic agents|mesh-ancestor
5599027|NCT03721432|Pregabalin|pregabalin|mesh-list
5599028|NCT03721432|Analgesics|analgesics|mesh-ancestor
5599029|NCT03721432|Sensory System Agents|sensory system agents|mesh-ancestor
5599030|NCT03721432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5599031|NCT03721432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599032|NCT03721432|Anticonvulsants|anticonvulsants|mesh-ancestor
5599033|NCT03721432|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5599034|NCT03721432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5599035|NCT03721432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599036|NCT03721432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5599037|NCT03721432|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5599038|NCT03721432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5599039|NCT03721432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5599040|NCT03721432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5599041|NCT03721380|Methadone|methadone|mesh-list
5599042|NCT03721380|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5599043|NCT03721380|Narcotics|narcotics|mesh-ancestor
5599044|NCT03721380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5599045|NCT03721380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599046|NCT03721380|Analgesics|analgesics|mesh-ancestor
5599047|NCT03721380|Sensory System Agents|sensory system agents|mesh-ancestor
5599048|NCT03721380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5599049|NCT03721380|Antitussive Agents|antitussive agents|mesh-ancestor
5599050|NCT03721380|Respiratory System Agents|respiratory system agents|mesh-ancestor
5599051|NCT03721081|Lidocaine|lidocaine|mesh-list
5599052|NCT03721081|Anesthetics, Local|anesthetics, local|mesh-ancestor
5599053|NCT03721081|Anesthetics|anesthetics|mesh-ancestor
5599054|NCT03721081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5599055|NCT03721081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599056|NCT03721081|Sensory System Agents|sensory system agents|mesh-ancestor
5599057|NCT03721081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5599058|NCT03721081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5599059|NCT03721081|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5599060|NCT03721081|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5599061|NCT03721081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5599062|NCT03721081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599063|NCT03720990|Cholic Acids|cholic acids|mesh-list
5599064|NCT03720990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5599065|NCT03720899|Nicotine|nicotine|mesh-list
5599066|NCT03720899|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5599067|NCT03720899|Autonomic Agents|autonomic agents|mesh-ancestor
5599068|NCT03720899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5599069|NCT03720899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599070|NCT03720899|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5599071|NCT03720899|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5599072|NCT03720899|Cholinergic Agents|cholinergic agents|mesh-ancestor
5599073|NCT03720899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5599074|NCT03720899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599075|NCT03720886|Teriparatide|teriparatide|mesh-list
5599076|NCT03720886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5599077|NCT03720886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599078|NCT03720886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5599079|NCT03720873|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5599080|NCT03720873|Gefitinib|gefitinib|mesh-list
5599081|NCT03720873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5599082|NCT03720873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5599083|NCT03720873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5599084|NCT03720873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599085|NCT03720756|Nickel|nickel|mesh-list
5599086|NCT03720756|Trace Elements|trace elements|mesh-ancestor
5599087|NCT03720756|Micronutrients|micronutrients|mesh-ancestor
5599088|NCT03720756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599089|NCT03720717|Baclofen|baclofen|mesh-list
5599090|NCT03720717|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5599091|NCT03720717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599092|NCT03720717|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5599093|NCT03720717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5599094|NCT03720717|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
5599095|NCT03720717|GABA Agonists|gaba agonists|mesh-ancestor
5599096|NCT03720717|GABA Agents|gaba agents|mesh-ancestor
5599097|NCT03720717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5599098|NCT03720717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599099|NCT03720665|Caffeine|caffeine|mesh-list
5599100|NCT03720665|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5599101|NCT03720665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599102|NCT03720665|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5599103|NCT03720665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5599104|NCT03720665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599105|NCT03720665|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5599106|NCT03720665|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5599107|NCT03720665|Purinergic Agents|purinergic agents|mesh-ancestor
5599108|NCT03720665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5599109|NCT03720613|Naloxegol|naloxegol|mesh-list
5599110|NCT03720613|Lubiprostone|lubiprostone|mesh-list
5599111|NCT03720613|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
5599112|NCT03720613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5599113|NCT03720613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599114|NCT03720613|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5599115|NCT03720613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599116|NCT03720613|Sensory System Agents|sensory system agents|mesh-ancestor
5599117|NCT03720613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5599118|NCT03720522|Adenosine|adenosine|mesh-list
5599119|NCT03720522|Analgesics|analgesics|mesh-ancestor
5599120|NCT03720522|Sensory System Agents|sensory system agents|mesh-ancestor
5599121|NCT03720522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5599122|NCT03720522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599123|NCT03720522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5599124|NCT03720522|Vasodilator Agents|vasodilator agents|mesh-ancestor
5599125|NCT03720522|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5599126|NCT03720522|Purinergic Agonists|purinergic agonists|mesh-ancestor
5599127|NCT03720522|Purinergic Agents|purinergic agents|mesh-ancestor
5599128|NCT03720522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5599129|NCT03720522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599130|NCT03720483|Acetylcysteine|acetylcysteine|mesh-list
5599131|NCT03720483|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5599132|NCT03720483|Antiviral Agents|antiviral agents|mesh-ancestor
5599133|NCT03720483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5599134|NCT03720483|Expectorants|expectorants|mesh-ancestor
5599135|NCT03720483|Respiratory System Agents|respiratory system agents|mesh-ancestor
5599136|NCT03720483|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5599137|NCT03720483|Antioxidants|antioxidants|mesh-ancestor
5599138|NCT03720483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599139|NCT03720483|Protective Agents|protective agents|mesh-ancestor
5599140|NCT03720483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599141|NCT03720483|Antidotes|antidotes|mesh-ancestor
5599142|NCT03720431|Pembrolizumab|pembrolizumab|mesh-list
5599143|NCT03720431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5599144|NCT03720431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5599145|NCT03720340|Oprelvekin|oprelvekin|mesh-list
5599146|NCT03720340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5599147|NCT03720288|Acetazolamide|acetazolamide|mesh-list
5599148|NCT03720288|Anticonvulsants|anticonvulsants|mesh-ancestor
5599149|NCT03720288|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5599150|NCT03720288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5599151|NCT03720288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599152|NCT03720288|Diuretics|diuretics|mesh-ancestor
5599153|NCT03720288|Natriuretic Agents|natriuretic agents|mesh-ancestor
5599154|NCT03720288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599155|NCT03720249|Vitamins|vitamins|mesh-list
5599156|NCT03720249|Vitamin B 12|vitamin b 12|mesh-list
5599157|NCT03720249|Vitamin B 6|vitamin b 6|mesh-list
5599158|NCT03720249|Vitamin B Complex|vitamin b complex|mesh-list
5599159|NCT03720249|Betaine|betaine|mesh-list
5599160|NCT03720249|Micronutrients|micronutrients|mesh-ancestor
5599161|NCT03720249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599162|NCT03720249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5599163|NCT03720249|Lipotropic Agents|lipotropic agents|mesh-ancestor
5599164|NCT03720249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5599165|NCT03720249|Antimetabolites|antimetabolites|mesh-ancestor
5599166|NCT03720249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599167|NCT03720249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5599168|NCT03720223|Bupivacaine|bupivacaine|mesh-list
5599169|NCT03720223|Anesthetics, Local|anesthetics, local|mesh-ancestor
5599170|NCT03720223|Anesthetics|anesthetics|mesh-ancestor
5599171|NCT03720223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5599172|NCT03720223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599173|NCT03720223|Sensory System Agents|sensory system agents|mesh-ancestor
5599174|NCT03720223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5599175|NCT03720067|Propranolol|propranolol|mesh-list
5599176|NCT03720067|Carvedilol|carvedilol|mesh-list
5599177|NCT03720067|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5599178|NCT03720067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5599179|NCT03720067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5599180|NCT03720067|Antimetabolites|antimetabolites|mesh-ancestor
5599181|NCT03720067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599182|NCT03720067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5599183|NCT03720067|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5599184|NCT03720067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5599185|NCT03720067|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5599186|NCT03720067|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5599187|NCT03720067|Adrenergic Agents|adrenergic agents|mesh-ancestor
5599188|NCT03720067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5599189|NCT03720067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599190|NCT03720067|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5599191|NCT03720067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5599192|NCT03720067|Vasodilator Agents|vasodilator agents|mesh-ancestor
5599193|NCT03720067|Antioxidants|antioxidants|mesh-ancestor
5599194|NCT03720067|Protective Agents|protective agents|mesh-ancestor
5599195|NCT03720067|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5599196|NCT03720067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5599197|NCT03720067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5599198|NCT03720067|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5599199|NCT03720067|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5599200|NCT03720041|Dexamethasone|dexamethasone|mesh-list
5599201|NCT03720041|Dexamethasone acetate|dexamethasone acetate|mesh-list
5599202|NCT03720041|Lenalidomide|lenalidomide|mesh-list
5599203|NCT03720041|Ixazomib|ixazomib|mesh-list
5599204|NCT03720041|BB 1101|bb 1101|mesh-list
5599205|NCT03720041|Glycine|glycine|mesh-list
5599206|NCT03720041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5599207|NCT03720041|Antiemetics|antiemetics|mesh-ancestor
5599208|NCT03720041|Autonomic Agents|autonomic agents|mesh-ancestor
5599209|NCT03720041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5599210|NCT03720041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599211|NCT03720041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5599212|NCT03720041|Glucocorticoids|glucocorticoids|mesh-ancestor
5599213|NCT03720041|Hormones|hormones|mesh-ancestor
5599214|NCT03720041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5599215|NCT03720041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5599216|NCT03720041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5599217|NCT03720041|Protease Inhibitors|protease inhibitors|mesh-ancestor
5599218|NCT03720041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5599219|NCT03720041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599220|NCT03720041|Immunologic Factors|immunologic factors|mesh-ancestor
5599221|NCT03720041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5599222|NCT03720041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5599223|NCT03720041|Growth Substances|growth substances|mesh-ancestor
6488390|NCT00583869|Anticonvulsants|anticonvulsants|mesh-ancestor
5599224|NCT03720041|Growth Inhibitors|growth inhibitors|mesh-ancestor
5599225|NCT03720041|Glycine Agents|glycine agents|mesh-ancestor
5599226|NCT03720041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5599227|NCT03719989|Azacitidine|azacitidine|mesh-list
5599228|NCT03719989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5599229|NCT03719989|Antimetabolites|antimetabolites|mesh-ancestor
5599230|NCT03719989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599231|NCT03719989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5599232|NCT03719989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5606576|NCT04178603|Insulin|insulin|mesh-list
5606577|NCT04178603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5606578|NCT04178603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606579|NCT04170972|Insulin|insulin|mesh-list
5606580|NCT04170972|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5606581|NCT04170972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606582|NCT04133623|Ibuprofen|ibuprofen|mesh-list
5606583|NCT04133623|Ketorolac|ketorolac|mesh-list
5599233|NCT03719820|Aspirin|aspirin|mesh-list
5599234|NCT03719820|Clopidogrel|clopidogrel|mesh-list
5599235|NCT03719820|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5599236|NCT03719820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5599237|NCT03719820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5599238|NCT03719820|Analgesics|analgesics|mesh-ancestor
5599239|NCT03719820|Sensory System Agents|sensory system agents|mesh-ancestor
5599240|NCT03719820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5599241|NCT03719820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599242|NCT03719820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5599243|NCT03719820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5599244|NCT03719820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5599245|NCT03719820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5599246|NCT03719820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599247|NCT03719820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5599248|NCT03719820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5599249|NCT03719820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5599250|NCT03719820|Antipyretics|antipyretics|mesh-ancestor
5599251|NCT03719820|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5599252|NCT03719820|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5599253|NCT03719820|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5599254|NCT03719820|Purinergic Agents|purinergic agents|mesh-ancestor
5599255|NCT03719820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5599256|NCT03719820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5599257|NCT03719820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5599258|NCT03719820|Antimetabolites|antimetabolites|mesh-ancestor
5599259|NCT03719820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5599260|NCT03719820|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5599261|NCT03719729|Rifaximin|rifaximin|mesh-list
5599262|NCT03719729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5599263|NCT03719729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5599264|NCT03719729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5599265|NCT03719690|Tipifarnib|tipifarnib|mesh-list
5599266|NCT03719690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5599267|NCT03719625|Norepinephrine|norepinephrine|mesh-list
5599268|NCT03719625|Ephedrine|ephedrine|mesh-list
5599269|NCT03719625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5599270|NCT03719625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5599271|NCT03719625|Adrenergic Agents|adrenergic agents|mesh-ancestor
5599272|NCT03719625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5599273|NCT03719625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599274|NCT03719625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599275|NCT03719625|Sympathomimetics|sympathomimetics|mesh-ancestor
5599276|NCT03719625|Autonomic Agents|autonomic agents|mesh-ancestor
5599277|NCT03719625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5599278|NCT03719625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5599279|NCT03719625|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5599280|NCT03719560|Cytarabine|cytarabine|mesh-list
5599281|NCT03719560|Methotrexate|methotrexate|mesh-list
5599282|NCT03719560|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5599283|NCT03719560|Abortifacient Agents|abortifacient agents|mesh-ancestor
5599284|NCT03719560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5599285|NCT03719560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599286|NCT03719560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5599287|NCT03719560|Antimetabolites|antimetabolites|mesh-ancestor
5599288|NCT03719560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599289|NCT03719560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5599290|NCT03719560|Dermatologic Agents|dermatologic agents|mesh-ancestor
5599291|NCT03719560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5599292|NCT03719560|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5599293|NCT03719560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5599294|NCT03719560|Immunologic Factors|immunologic factors|mesh-ancestor
5599295|NCT03719560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5599296|NCT03719560|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5599297|NCT03719560|Antiviral Agents|antiviral agents|mesh-ancestor
5599298|NCT03719560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5599299|NCT03719404|Chlorhexidine|chlorhexidine|mesh-list
5599300|NCT03719404|Sodium Hypochlorite|sodium hypochlorite|mesh-list
5599301|NCT03719404|Eusol|eusol|mesh-list
5599302|NCT03719404|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5599303|NCT03719404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5599304|NCT03719404|Disinfectants|disinfectants|mesh-ancestor
5599305|NCT03719391|Nicotine|nicotine|mesh-list
5599306|NCT03719391|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5599307|NCT03719391|Autonomic Agents|autonomic agents|mesh-ancestor
5599308|NCT03719391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5599309|NCT03719391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599310|NCT03719391|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5599311|NCT03719391|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5599312|NCT03719391|Cholinergic Agents|cholinergic agents|mesh-ancestor
5599313|NCT03719391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5599314|NCT03719391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599315|NCT03719326|Paclitaxel|paclitaxel|mesh-list
5599316|NCT03719326|Doxorubicin|doxorubicin|mesh-list
5599317|NCT03719326|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5599318|NCT03719326|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5599319|NCT03719326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5599320|NCT03719326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5599321|NCT03719326|Tubulin Modulators|tubulin modulators|mesh-ancestor
5599322|NCT03719326|Antimitotic Agents|antimitotic agents|mesh-ancestor
5599323|NCT03719326|Mitosis Modulators|mitosis modulators|mesh-ancestor
5599324|NCT03719326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599325|NCT03719326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5599326|NCT03719326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5599327|NCT03719326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5599328|NCT03719326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5599329|NCT03719313|Interferons|interferons|mesh-list
5599330|NCT03719313|Ritonavir|ritonavir|mesh-list
5599331|NCT03719313|Interferon-alpha|interferon-alpha|mesh-list
5599332|NCT03719313|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5599333|NCT03719313|Interferon alpha-2|interferon alpha-2|mesh-list
5599334|NCT03719313|Lonafarnib|lonafarnib|mesh-list
5599335|NCT03719313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5599336|NCT03719313|Antiviral Agents|antiviral agents|mesh-ancestor
5599337|NCT03719313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5599338|NCT03719313|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5599339|NCT03719313|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5599340|NCT03719313|Protease Inhibitors|protease inhibitors|mesh-ancestor
5599341|NCT03719313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5599342|NCT03719313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599343|NCT03719313|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5599344|NCT03719313|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5599345|NCT03719313|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5599346|NCT03719313|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5599347|NCT03719313|Immunologic Factors|immunologic factors|mesh-ancestor
5599348|NCT03719313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599349|NCT03719274|Ascorbic Acid|ascorbic acid|mesh-list
5599350|NCT03719274|Vitamins|vitamins|mesh-ancestor
5599351|NCT03719274|Micronutrients|micronutrients|mesh-ancestor
5599352|NCT03719274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599353|NCT03719274|Antioxidants|antioxidants|mesh-ancestor
5599354|NCT03719274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599355|NCT03719274|Protective Agents|protective agents|mesh-ancestor
5599356|NCT03719261|Sodium Hypochlorite|sodium hypochlorite|mesh-list
5599357|NCT03719261|Eusol|eusol|mesh-list
5599358|NCT03719261|Chitosan|chitosan|mesh-list
5599359|NCT03719261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5599360|NCT03719261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5599361|NCT03719261|Antimetabolites|antimetabolites|mesh-ancestor
5599362|NCT03719261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599363|NCT03719261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5599364|NCT03719261|Chelating Agents|chelating agents|mesh-ancestor
5599365|NCT03719261|Sequestering Agents|sequestering agents|mesh-ancestor
5599366|NCT03719261|Hemostatics|hemostatics|mesh-ancestor
5599367|NCT03719261|Coagulants|coagulants|mesh-ancestor
5599368|NCT03719261|Disinfectants|disinfectants|mesh-ancestor
5599369|NCT03719261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5599370|NCT03719157|Anesthetics|anesthetics|mesh-list
5599371|NCT03719157|Anesthetics, Local|anesthetics, local|mesh-list
5599372|NCT03719157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5599373|NCT03719157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599374|NCT03719157|Sensory System Agents|sensory system agents|mesh-ancestor
5599375|NCT03719157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5599376|NCT03719131|Rituximab|rituximab|mesh-list
5599377|NCT03719131|Nivolumab|nivolumab|mesh-list
5599378|NCT03719131|Ipilimumab|ipilimumab|mesh-list
5599379|NCT03719131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5599380|NCT03719131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5599381|NCT03719131|Immunologic Factors|immunologic factors|mesh-ancestor
5599382|NCT03719131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599383|NCT03719131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5599384|NCT03719131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5599385|NCT03719131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599386|NCT03719105|Dexamethasone|dexamethasone|mesh-list
5599387|NCT03719105|Prednisone|prednisone|mesh-list
5599388|NCT03719105|Cyclophosphamide|cyclophosphamide|mesh-list
5599389|NCT03719105|Ifosfamide|ifosfamide|mesh-list
5599390|NCT03719105|Doxorubicin|doxorubicin|mesh-list
5599391|NCT03719105|Methotrexate|methotrexate|mesh-list
5599392|NCT03719105|Etoposide|etoposide|mesh-list
5599393|NCT03719105|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5599394|NCT03719105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5599395|NCT03719105|Immunologic Factors|immunologic factors|mesh-ancestor
5599396|NCT03719105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599397|NCT03719105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5599398|NCT03719105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5599399|NCT03719105|Alkylating Agents|alkylating agents|mesh-ancestor
5599400|NCT03719105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599401|NCT03719105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5599402|NCT03719105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5599403|NCT03719105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5599404|NCT03719105|Antiemetics|antiemetics|mesh-ancestor
5599405|NCT03719105|Autonomic Agents|autonomic agents|mesh-ancestor
5599406|NCT03719105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5599407|NCT03719105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5599408|NCT03719105|Glucocorticoids|glucocorticoids|mesh-ancestor
5599409|NCT03719105|Hormones|hormones|mesh-ancestor
5599410|NCT03719105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5599411|NCT03719105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5599412|NCT03719105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5599413|NCT03719105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5599414|NCT03719105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5599415|NCT03719105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5599416|NCT03719105|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5599417|NCT03719105|Abortifacient Agents|abortifacient agents|mesh-ancestor
5599418|NCT03719105|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5599419|NCT03719105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5599420|NCT03719105|Antimetabolites|antimetabolites|mesh-ancestor
5599421|NCT03719105|Dermatologic Agents|dermatologic agents|mesh-ancestor
5599422|NCT03719105|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5599423|NCT03719105|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5599424|NCT03719105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5599425|NCT03719105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5599426|NCT03719092|Vitamins|vitamins|mesh-list
5599427|NCT03719092|Vitamin A|vitamin a|mesh-list
5599428|NCT03719092|Retinol palmitate|retinol palmitate|mesh-list
5599429|NCT03719092|Micronutrients|micronutrients|mesh-ancestor
5599430|NCT03719092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599431|NCT03719092|Antioxidants|antioxidants|mesh-ancestor
5599432|NCT03719092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599433|NCT03719092|Protective Agents|protective agents|mesh-ancestor
5599434|NCT03719092|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5599435|NCT03719092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5599436|NCT03719053|Tenofovir|tenofovir|mesh-list
5599437|NCT03719053|Antiviral Agents|antiviral agents|mesh-ancestor
5599438|NCT03719053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5599439|NCT03719053|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5599440|NCT03719053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5599441|NCT03719053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5599442|NCT03719053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599443|NCT03719053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5599444|NCT03719053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5599445|NCT03719001|Clevidipine|clevidipine|mesh-list
5599446|NCT03719001|Phenylephrine|phenylephrine|mesh-list
5599447|NCT03719001|Oxymetazoline|oxymetazoline|mesh-list
5599448|NCT03719001|Dexmedetomidine|dexmedetomidine|mesh-list
5599449|NCT03719001|Calcium|calcium|mesh-list
5599450|NCT03719001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5599451|NCT03719001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599452|NCT03719001|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5599453|NCT03719001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5599454|NCT03719001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5599455|NCT03719001|Analgesics|analgesics|mesh-ancestor
5599456|NCT03719001|Sensory System Agents|sensory system agents|mesh-ancestor
5599457|NCT03719001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5599458|NCT03719001|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5599459|NCT03719001|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5599460|NCT03719001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5599461|NCT03719001|Adrenergic Agents|adrenergic agents|mesh-ancestor
5599462|NCT03719001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5599463|NCT03719001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599464|NCT03719001|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5599465|NCT03719001|Mydriatics|mydriatics|mesh-ancestor
5599466|NCT03719001|Autonomic Agents|autonomic agents|mesh-ancestor
5599467|NCT03719001|Sympathomimetics|sympathomimetics|mesh-ancestor
5599468|NCT03719001|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5599469|NCT03719001|Nasal Decongestants|nasal decongestants|mesh-ancestor
5599470|NCT03719001|Respiratory System Agents|respiratory system agents|mesh-ancestor
5599471|NCT03719001|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5599472|NCT03719001|Protective Agents|protective agents|mesh-ancestor
5599473|NCT03719001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5599474|NCT03719001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5599475|NCT03718884|Mirikizumab|mirikizumab|mesh-list
5599476|NCT03718884|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5599477|NCT03718884|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5599478|NCT03718884|Analgesics|analgesics|mesh-ancestor
5599479|NCT03718884|Sensory System Agents|sensory system agents|mesh-ancestor
5599480|NCT03718884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5599481|NCT03718884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599482|NCT03718884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5599483|NCT03718884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5599484|NCT03718884|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5599485|NCT03718884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5599486|NCT03718715|Metformin|metformin|mesh-list
5599487|NCT03718715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5599488|NCT03718715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599489|NCT03718676|Pemetrexed|pemetrexed|mesh-list
5599490|NCT03718676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5599491|NCT03718676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5599492|NCT03718676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599493|NCT03718676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5599494|NCT03718676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5599495|NCT03718624|Paclitaxel|paclitaxel|mesh-list
5599496|NCT03718624|Apatinib|apatinib|mesh-list
5599497|NCT03718624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5599498|NCT03718624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5599499|NCT03718624|Tubulin Modulators|tubulin modulators|mesh-ancestor
5599500|NCT03718624|Antimitotic Agents|antimitotic agents|mesh-ancestor
5599501|NCT03718624|Mitosis Modulators|mitosis modulators|mesh-ancestor
5599502|NCT03718624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599503|NCT03718624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5599504|NCT03718624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5599505|NCT03718559|Edoxaban|edoxaban|mesh-list
5599506|NCT03718559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
5599507|NCT03718559|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5599508|NCT03718559|Antithrombins|antithrombins|mesh-ancestor
5599509|NCT03718559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5599510|NCT03718559|Protease Inhibitors|protease inhibitors|mesh-ancestor
5599511|NCT03718559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5599512|NCT03718559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599513|NCT03718559|Anticoagulants|anticoagulants|mesh-ancestor
5599514|NCT03718507|Atropine|atropine|mesh-list
5599515|NCT03718507|Fentanyl|fentanyl|mesh-list
5599516|NCT03718507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5599517|NCT03718507|Narcotics|narcotics|mesh-ancestor
5599518|NCT03718507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5599519|NCT03718507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599520|NCT03718507|Analgesics|analgesics|mesh-ancestor
5599521|NCT03718507|Sensory System Agents|sensory system agents|mesh-ancestor
5599522|NCT03718507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5599523|NCT03718507|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5599524|NCT03718507|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5599525|NCT03718507|Anesthetics, General|anesthetics, general|mesh-ancestor
5599526|NCT03718507|Anesthetics|anesthetics|mesh-ancestor
5599527|NCT03718507|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5599528|NCT03718507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5599529|NCT03718507|Autonomic Agents|autonomic agents|mesh-ancestor
5599530|NCT03718507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5599531|NCT03718507|Respiratory System Agents|respiratory system agents|mesh-ancestor
5599532|NCT03718507|Mydriatics|mydriatics|mesh-ancestor
5599533|NCT03718507|Parasympatholytics|parasympatholytics|mesh-ancestor
5599534|NCT03718507|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5599535|NCT03718507|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5599536|NCT03718507|Cholinergic Agents|cholinergic agents|mesh-ancestor
5599537|NCT03718507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5607023|NCT03031730|Ichthammol|ichthammol|mesh-list
5599538|NCT03718507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599539|NCT03718429|Rivaroxaban|rivaroxaban|mesh-list
5599540|NCT03718429|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5599541|NCT03718429|Antithrombins|antithrombins|mesh-ancestor
5599542|NCT03718429|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5599543|NCT03718429|Protease Inhibitors|protease inhibitors|mesh-ancestor
5599544|NCT03718429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5599545|NCT03718429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599546|NCT03718429|Anticoagulants|anticoagulants|mesh-ancestor
5599547|NCT03718403|Theophylline|theophylline|mesh-list
5599548|NCT03718403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5599549|NCT03718403|Autonomic Agents|autonomic agents|mesh-ancestor
5599550|NCT03718403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5599551|NCT03718403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599552|NCT03718403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5599553|NCT03718403|Respiratory System Agents|respiratory system agents|mesh-ancestor
5599554|NCT03718403|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5599555|NCT03718403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5599556|NCT03718403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599557|NCT03718403|Vasodilator Agents|vasodilator agents|mesh-ancestor
5599558|NCT03718403|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5599559|NCT03718403|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5599560|NCT03718403|Purinergic Agents|purinergic agents|mesh-ancestor
5599561|NCT03718403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5599562|NCT03718377|Anesthetics|anesthetics|mesh-list
5599563|NCT03718377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5599564|NCT03718377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606584|NCT04133623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5606585|NCT04133623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5606586|NCT04133623|Analgesics|analgesics|mesh-ancestor
5606587|NCT04133623|Sensory System Agents|sensory system agents|mesh-ancestor
5606588|NCT04133623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5606589|NCT04133623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606590|NCT04133623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5606591|NCT04133623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5606592|NCT04133623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5606593|NCT04133623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5606594|NCT04133623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606595|NCT04091217|Bevacizumab|bevacizumab|mesh-list
5606596|NCT04091217|Atezolizumab|atezolizumab|mesh-list
5606597|NCT04091217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5606598|NCT04091217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5606599|NCT04091217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5606600|NCT04091217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5606601|NCT04091217|Growth Substances|growth substances|mesh-ancestor
5606602|NCT04091217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606603|NCT04091217|Growth Inhibitors|growth inhibitors|mesh-ancestor
5606604|NCT04064411|Abaloparatide|abaloparatide|mesh-list
5606605|NCT04064411|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
5606606|NCT04064411|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5606607|NCT04064411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606608|NCT04064411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5606609|NCT04057937|Apremilast|apremilast|mesh-list
5606610|NCT04057937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5606611|NCT04057937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5606612|NCT04057937|Analgesics|analgesics|mesh-ancestor
5606613|NCT04057937|Sensory System Agents|sensory system agents|mesh-ancestor
5606614|NCT04057937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5606615|NCT04057937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606616|NCT04057937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5606617|NCT04057937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5606618|NCT04057937|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5606619|NCT04057937|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5606620|NCT04057937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5606621|NCT04057937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606622|NCT04042831|Olaparib|olaparib|mesh-list
5606623|NCT04042831|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
5606624|NCT04042831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5606625|NCT04042831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606626|NCT04042831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5606627|NCT04017962|Letermovir|letermovir|mesh-list
5606628|NCT04017962|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5599565|NCT03718273|Digoxin|digoxin|mesh-list
5599566|NCT03718273|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5599567|NCT03718273|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5599568|NCT03718273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5599569|NCT03718273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599570|NCT03718273|Protective Agents|protective agents|mesh-ancestor
5599571|NCT03718273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599572|NCT03718234|Hydrocortisone|hydrocortisone|mesh-list
5599573|NCT03718234|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
5599574|NCT03718234|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
5599575|NCT03718234|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
5599576|NCT03718234|Glucocorticoids|glucocorticoids|mesh-list
5599577|NCT03718234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5599578|NCT03718234|Hormones|hormones|mesh-ancestor
5599579|NCT03718234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5599580|NCT03718234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599581|NCT03718182|Cholecalciferol|cholecalciferol|mesh-list
5599582|NCT03718182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5599583|NCT03718182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599584|NCT03718182|Vitamins|vitamins|mesh-ancestor
5599585|NCT03718182|Micronutrients|micronutrients|mesh-ancestor
5599586|NCT03718182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5599587|NCT03718130|Vaccines|vaccines|mesh-list
5599588|NCT03718130|Immunologic Factors|immunologic factors|mesh-ancestor
5599589|NCT03718130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599590|NCT03718065|Lofexidine|lofexidine|mesh-list
5599591|NCT03718065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5599592|NCT03718065|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5599593|NCT03718065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599594|NCT03718065|Sensory System Agents|sensory system agents|mesh-ancestor
5599595|NCT03718065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5599596|NCT03718065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5599597|NCT03718065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5599598|NCT03718065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5599599|NCT03718065|Adrenergic Agents|adrenergic agents|mesh-ancestor
5599600|NCT03718065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5599601|NCT03718065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599602|NCT03718039|Aprepitant|aprepitant|mesh-list
5599603|NCT03718039|Antiemetics|antiemetics|mesh-ancestor
5599604|NCT03718039|Autonomic Agents|autonomic agents|mesh-ancestor
5599605|NCT03718039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5599606|NCT03718039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599607|NCT03718039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5599608|NCT03718039|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5599609|NCT03718039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5599610|NCT03718039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599611|NCT03717987|Botulinum Toxins|botulinum toxins|mesh-list
5599612|NCT03717987|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5599613|NCT03717987|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5599614|NCT03717987|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5599615|NCT03717987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5599616|NCT03717987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599617|NCT03717987|Cholinergic Agents|cholinergic agents|mesh-ancestor
5599618|NCT03717987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5599619|NCT03717987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599620|NCT03717987|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5599621|NCT03717987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5599622|NCT03717909|Valproic Acid|valproic acid|mesh-list
5599623|NCT03717909|Anticonvulsants|anticonvulsants|mesh-ancestor
5599624|NCT03717909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5599625|NCT03717909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599626|NCT03717909|GABA Agents|gaba agents|mesh-ancestor
5599627|NCT03717909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5599628|NCT03717909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599629|NCT03717909|Antimanic Agents|antimanic agents|mesh-ancestor
5599630|NCT03717909|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5599631|NCT03717909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5599632|NCT03717909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5599633|NCT03717740|Esomeprazole|esomeprazole|mesh-list
5599634|NCT03717740|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5599635|NCT03717740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5599636|NCT03717740|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5599637|NCT03717740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5606629|NCT04017962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5599638|NCT03717740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599639|NCT03717701|Metformin|metformin|mesh-list
5599640|NCT03717701|Esomeprazole|esomeprazole|mesh-list
5599641|NCT03717701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5599642|NCT03717701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599643|NCT03717701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5599644|NCT03717701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5599645|NCT03717701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5599646|NCT03717701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5599647|NCT03717701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599648|NCT03717688|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5599649|NCT03717688|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
5599650|NCT03717688|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5599651|NCT03717688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5599652|NCT03717688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599653|NCT03717688|Incretins|incretins|mesh-ancestor
5599654|NCT03717688|Hormones|hormones|mesh-ancestor
5599655|NCT03717688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5599656|NCT03717688|Protease Inhibitors|protease inhibitors|mesh-ancestor
5599657|NCT03717688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5599658|NCT03717688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599659|NCT03717688|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5599660|NCT03717662|Nicotine|nicotine|mesh-list
5599661|NCT03717662|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5599662|NCT03717662|Autonomic Agents|autonomic agents|mesh-ancestor
5599663|NCT03717662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5599664|NCT03717662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599665|NCT03717662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5599666|NCT03717662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5599667|NCT03717662|Cholinergic Agents|cholinergic agents|mesh-ancestor
5599668|NCT03717662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5599669|NCT03717662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599670|NCT03717558|Ivermectin|ivermectin|mesh-list
5599671|NCT03717558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5599672|NCT03717558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5599673|NCT03717467|Magnesium Sulfate|magnesium sulfate|mesh-list
5599674|NCT03717467|Analgesics|analgesics|mesh-ancestor
5599675|NCT03717467|Sensory System Agents|sensory system agents|mesh-ancestor
5599676|NCT03717467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5599677|NCT03717467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599678|NCT03717467|Anesthetics|anesthetics|mesh-ancestor
5599679|NCT03717467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5599680|NCT03717467|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5599681|NCT03717467|Anticonvulsants|anticonvulsants|mesh-ancestor
5599682|NCT03717467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5599683|NCT03717467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5599684|NCT03717467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599685|NCT03717467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5599686|NCT03717467|Tocolytic Agents|tocolytic agents|mesh-ancestor
5599687|NCT03717467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5599688|NCT03717415|Carboplatin|carboplatin|mesh-list
5599689|NCT03717415|Rebastinib|rebastinib|mesh-list
5599690|NCT03717415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5599691|NCT03717415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5599692|NCT03717415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5599693|NCT03717415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599694|NCT03717350|Meropenem|meropenem|mesh-list
5599695|NCT03717350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5599696|NCT03717350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5599697|NCT03717194|Ertugliflozin|ertugliflozin|mesh-list
5599698|NCT03717194|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5599699|NCT03717194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599700|NCT03717194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5599701|NCT03717194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599702|NCT03717168|Hormones|hormones|mesh-list
5599703|NCT03717168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5599704|NCT03717168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599705|NCT03717116|Parathyroid Hormone|parathyroid hormone|mesh-list
5599706|NCT03717116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5599707|NCT03717116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599708|NCT03717103|Rituximab|rituximab|mesh-list
5599709|NCT03717103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5599710|NCT03717103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5599711|NCT03717103|Immunologic Factors|immunologic factors|mesh-ancestor
5599712|NCT03717103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599713|NCT03717103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5599714|NCT03717038|Trifluridine|trifluridine|mesh-list
5599715|NCT03717038|Antimetabolites|antimetabolites|mesh-ancestor
5599716|NCT03717038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599717|NCT03717038|Antiviral Agents|antiviral agents|mesh-ancestor
5599718|NCT03717038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5599719|NCT03716921|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5599720|NCT03716921|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5599721|NCT03716921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5599722|NCT03716921|Antitubercular Agents|antitubercular agents|mesh-ancestor
5599723|NCT03716856|Cyclophosphamide|cyclophosphamide|mesh-list
5599724|NCT03716856|Fludarabine|fludarabine|mesh-list
5599725|NCT03716856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5599726|NCT03716856|Immunologic Factors|immunologic factors|mesh-ancestor
5599727|NCT03716856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599728|NCT03716856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5599729|NCT03716856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5599730|NCT03716856|Alkylating Agents|alkylating agents|mesh-ancestor
5599731|NCT03716856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599732|NCT03716856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5599733|NCT03716856|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5599734|NCT03716804|Ciprofloxacin|ciprofloxacin|mesh-list
5599735|NCT03716804|Cefuroxime|cefuroxime|mesh-list
5599736|NCT03716804|Cefuroxime axetil|cefuroxime axetil|mesh-list
5599737|NCT03716804|Nitrofurantoin|nitrofurantoin|mesh-list
5599738|NCT03716804|Cefixime|cefixime|mesh-list
5599739|NCT03716804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5599740|NCT03716804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5599741|NCT03716804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5599742|NCT03716804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5599743|NCT03716804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5599744|NCT03716804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599745|NCT03716804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5599746|NCT03716804|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5599747|NCT03716804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5599748|NCT03716804|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5599749|NCT03716804|Renal Agents|renal agents|mesh-ancestor
5599750|NCT03716791|Dimethyl sulfone|dimethyl sulfone|mesh-list
5599751|NCT03716791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5599752|NCT03716765|Vitamin D|vitamin d|mesh-list
5599753|NCT03716765|Vitamins|vitamins|mesh-ancestor
5599754|NCT03716765|Micronutrients|micronutrients|mesh-ancestor
5599755|NCT03716765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599756|NCT03716765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5599757|NCT03716739|Methyltestosterone|methyltestosterone|mesh-list
5599758|NCT03716739|Testosterone|testosterone|mesh-list
5599759|NCT03716739|Testosterone undecanoate|testosterone undecanoate|mesh-list
5599760|NCT03716739|Testosterone enanthate|testosterone enanthate|mesh-list
5599761|NCT03716739|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5599762|NCT03716739|Androgens|androgens|mesh-ancestor
5599763|NCT03716739|Hormones|hormones|mesh-ancestor
5599764|NCT03716739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5599765|NCT03716739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599766|NCT03716739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5599767|NCT03716739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5599768|NCT03716739|Anabolic Agents|anabolic agents|mesh-ancestor
5599769|NCT03716700|Immunoglobulins|immunoglobulins|mesh-list
5599770|NCT03716700|gamma-Globulins|gamma-globulins|mesh-list
5599771|NCT03716700|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5599772|NCT03716700|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5599773|NCT03716700|Immunologic Factors|immunologic factors|mesh-ancestor
5599774|NCT03716700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606630|NCT04017962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606631|NCT04017962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5606632|NCT04017962|Antiviral Agents|antiviral agents|mesh-ancestor
5606633|NCT04017962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5606634|NCT03983824|Cytarabine|cytarabine|mesh-list
5606635|NCT03983824|Etoposide|etoposide|mesh-list
5606636|NCT03983824|Mitoxantrone|mitoxantrone|mesh-list
5606637|NCT03983824|Etoposide phosphate|etoposide phosphate|mesh-list
5606638|NCT03983824|Peposertib|peposertib|mesh-list
5606639|NCT03983824|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5606640|NCT03983824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5606641|NCT03983824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5599775|NCT03716622|Clarithromycin|clarithromycin|mesh-list
5599776|NCT03716622|Furazolidone|furazolidone|mesh-list
5599777|NCT03716622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5599778|NCT03716622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5599779|NCT03716622|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5599780|NCT03716622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5599781|NCT03716622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599782|NCT03716622|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5599783|NCT03716622|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5599784|NCT03716622|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5599785|NCT03716622|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5599786|NCT03716622|Renal Agents|renal agents|mesh-ancestor
5599787|NCT03716622|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
5599788|NCT03716622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5599789|NCT03716622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5599790|NCT03716622|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
5599791|NCT03716596|Antibodies|antibodies|mesh-list
5599792|NCT03716596|Immunologic Factors|immunologic factors|mesh-ancestor
5599793|NCT03716596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599794|NCT03716583|Melatonin|melatonin|mesh-list
5599795|NCT03716583|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
5599796|NCT03716583|Antioxidants|antioxidants|mesh-ancestor
5599797|NCT03716583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599798|NCT03716583|Protective Agents|protective agents|mesh-ancestor
5599799|NCT03716583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599800|NCT03716583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5599801|NCT03716583|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
5599802|NCT03716583|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5599803|NCT03716427|Tolbutamide|tolbutamide|mesh-list
5599804|NCT03716427|Midazolam|midazolam|mesh-list
5599805|NCT03716427|Dextromethorphan|dextromethorphan|mesh-list
5599806|NCT03716427|Omeprazole|omeprazole|mesh-list
5599807|NCT03716427|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5599808|NCT03716427|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5599809|NCT03716427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5599810|NCT03716427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599811|NCT03716427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5599812|NCT03716427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5599813|NCT03716427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5599814|NCT03716427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5599815|NCT03716427|Anesthetics, General|anesthetics, general|mesh-ancestor
5599816|NCT03716427|Anesthetics|anesthetics|mesh-ancestor
5599817|NCT03716427|GABA Modulators|gaba modulators|mesh-ancestor
5599818|NCT03716427|GABA Agents|gaba agents|mesh-ancestor
5599819|NCT03716427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5599820|NCT03716427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599821|NCT03716427|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5599822|NCT03716427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5599823|NCT03716427|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5599824|NCT03716427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5599825|NCT03716427|Antitussive Agents|antitussive agents|mesh-ancestor
5599826|NCT03716427|Respiratory System Agents|respiratory system agents|mesh-ancestor
5599827|NCT03716427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5599828|NCT03716427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5599829|NCT03716427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5599830|NCT03716388|Mesalamine|mesalamine|mesh-list
5599831|NCT03716388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5599832|NCT03716388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5599833|NCT03716388|Analgesics|analgesics|mesh-ancestor
5599834|NCT03716388|Sensory System Agents|sensory system agents|mesh-ancestor
5599835|NCT03716388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5599836|NCT03716388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599837|NCT03716388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5599838|NCT03716388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5599839|NCT03716115|Budesonide|budesonide|mesh-list
5599840|NCT03716115|Teduglutide|teduglutide|mesh-list
5599841|NCT03716115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5599842|NCT03716115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5599843|NCT03716115|Autonomic Agents|autonomic agents|mesh-ancestor
5599844|NCT03716115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5599845|NCT03716115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599846|NCT03716115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5599847|NCT03716115|Respiratory System Agents|respiratory system agents|mesh-ancestor
5599848|NCT03716115|Glucocorticoids|glucocorticoids|mesh-ancestor
5599849|NCT03716115|Hormones|hormones|mesh-ancestor
5599850|NCT03716115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5599851|NCT03716115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5599852|NCT03716115|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5599853|NCT03716115|Protective Agents|protective agents|mesh-ancestor
5599854|NCT03715998|Ramipril|ramipril|mesh-list
5599855|NCT03715998|Firibastat|firibastat|mesh-list
5599856|NCT03715998|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5599857|NCT03715998|Protease Inhibitors|protease inhibitors|mesh-ancestor
5599858|NCT03715998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5599859|NCT03715998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599860|NCT03715998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5599861|NCT03715972|Hydroxyurea|hydroxyurea|mesh-list
5599862|NCT03715972|Acetazolamide|acetazolamide|mesh-list
5599863|NCT03715972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5599864|NCT03715972|Antisickling Agents|antisickling agents|mesh-ancestor
5599865|NCT03715972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5599866|NCT03715972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599867|NCT03715972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5599868|NCT03715972|Anticonvulsants|anticonvulsants|mesh-ancestor
5599869|NCT03715972|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5599870|NCT03715972|Diuretics|diuretics|mesh-ancestor
5599871|NCT03715972|Natriuretic Agents|natriuretic agents|mesh-ancestor
5599872|NCT03715972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599873|NCT03715946|Nivolumab|nivolumab|mesh-list
5599874|NCT03715946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5599875|NCT03715946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5599876|NCT03715946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5599877|NCT03715946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599878|NCT03715881|Prednisolone|prednisolone|mesh-list
5599879|NCT03715881|Epoetin Alfa|epoetin alfa|mesh-list
5599880|NCT03715881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5599881|NCT03715881|Glucocorticoids|glucocorticoids|mesh-ancestor
5599882|NCT03715881|Hormones|hormones|mesh-ancestor
5599883|NCT03715881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5599884|NCT03715881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599885|NCT03715881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5599886|NCT03715881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5599887|NCT03715881|Hematinics|hematinics|mesh-ancestor
5599888|NCT03715829|PF-06700841|pf-06700841|mesh-list
5599889|NCT03715829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5599890|NCT03715829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5599891|NCT03715829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599892|NCT03715777|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
5599893|NCT03715777|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5599894|NCT03715777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5599895|NCT03715777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599896|NCT03715777|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5599897|NCT03715777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5599898|NCT03715777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599899|NCT03715777|Cholinergic Agents|cholinergic agents|mesh-ancestor
5599900|NCT03715777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5599901|NCT03715725|Warfarin|warfarin|mesh-list
5599902|NCT03715725|Rivaroxaban|rivaroxaban|mesh-list
5599903|NCT03715725|Dabigatran|dabigatran|mesh-list
5599904|NCT03715725|Apixaban|apixaban|mesh-list
5599905|NCT03715725|Anticoagulants|anticoagulants|mesh-ancestor
5599906|NCT03715725|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5599907|NCT03715725|Antithrombins|antithrombins|mesh-ancestor
5599908|NCT03715725|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5599909|NCT03715725|Protease Inhibitors|protease inhibitors|mesh-ancestor
5599910|NCT03715725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5599911|NCT03715725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599912|NCT03715699|Prednisone|prednisone|mesh-list
5599913|NCT03715699|Leflunomide|leflunomide|mesh-list
5599914|NCT03715699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5599915|NCT03715699|Glucocorticoids|glucocorticoids|mesh-ancestor
5599916|NCT03715699|Hormones|hormones|mesh-ancestor
5599917|NCT03715699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5599918|NCT03715699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599919|NCT03715699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5599920|NCT03715699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5599921|NCT03715699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5599922|NCT03715699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599923|NCT03715699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5599924|NCT03715699|Immunologic Factors|immunologic factors|mesh-ancestor
5599925|NCT03715634|Buprenorphine|buprenorphine|mesh-list
5599926|NCT03715634|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5599927|NCT03715634|Narcotics|narcotics|mesh-ancestor
5599928|NCT03715634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5599929|NCT03715634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599930|NCT03715634|Analgesics|analgesics|mesh-ancestor
5599931|NCT03715634|Sensory System Agents|sensory system agents|mesh-ancestor
5599932|NCT03715634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5599933|NCT03715634|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5599934|NCT03715582|Trimetazidine|trimetazidine|mesh-list
5599935|NCT03715582|Vasodilator Agents|vasodilator agents|mesh-ancestor
5599936|NCT03715556|Amiodarone|amiodarone|mesh-list
5599937|NCT03715556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5599938|NCT03715556|Vasodilator Agents|vasodilator agents|mesh-ancestor
5599939|NCT03715556|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5599940|NCT03715556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5599941|NCT03715556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599942|NCT03715556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5599943|NCT03715556|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5599944|NCT03715556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5599945|NCT03715556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5599946|NCT03715556|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5599947|NCT03715556|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5599948|NCT03715556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5599949|NCT03715517|Morphine|morphine|mesh-list
5599950|NCT03715517|Hydromorphone|hydromorphone|mesh-list
5599951|NCT03715517|Bupivacaine|bupivacaine|mesh-list
5599952|NCT03715517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5599953|NCT03715517|Anesthetics, Local|anesthetics, local|mesh-ancestor
5599954|NCT03715517|Anesthetics|anesthetics|mesh-ancestor
5599955|NCT03715517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5599956|NCT03715517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599957|NCT03715517|Sensory System Agents|sensory system agents|mesh-ancestor
5599958|NCT03715517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5599959|NCT03715517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5599960|NCT03715517|Narcotics|narcotics|mesh-ancestor
5599961|NCT03715517|Analgesics|analgesics|mesh-ancestor
5599962|NCT03715478|Dexamethasone|dexamethasone|mesh-list
5599963|NCT03715478|Pomalidomide|pomalidomide|mesh-list
5599964|NCT03715478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5599965|NCT03715478|Antiemetics|antiemetics|mesh-ancestor
5599966|NCT03715478|Autonomic Agents|autonomic agents|mesh-ancestor
5599967|NCT03715478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5599968|NCT03715478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599969|NCT03715478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5599970|NCT03715478|Glucocorticoids|glucocorticoids|mesh-ancestor
5599971|NCT03715478|Hormones|hormones|mesh-ancestor
5599972|NCT03715478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5599973|NCT03715478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5599974|NCT03715478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5599975|NCT03715478|Immunologic Factors|immunologic factors|mesh-ancestor
5599976|NCT03715478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5599977|NCT03715478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5599978|NCT03715478|Growth Substances|growth substances|mesh-ancestor
5599979|NCT03715478|Growth Inhibitors|growth inhibitors|mesh-ancestor
5599980|NCT03715413|Tamoxifen|tamoxifen|mesh-list
5599981|NCT03715413|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5599982|NCT03715413|Hormone Antagonists|hormone antagonists|mesh-ancestor
5599983|NCT03715413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5599984|NCT03715413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599985|NCT03715413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5599986|NCT03715413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5599987|NCT03715413|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5599988|NCT03715413|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5599989|NCT03715413|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5599990|NCT03715387|Bacitracin|bacitracin|mesh-list
5599991|NCT03715387|Polymyxin B|polymyxin b|mesh-list
5599992|NCT03715387|Tacrolimus|tacrolimus|mesh-list
5599993|NCT03715387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5599994|NCT03715387|Immunologic Factors|immunologic factors|mesh-ancestor
5599995|NCT03715387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5599996|NCT03715387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5599997|NCT03715387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5599998|NCT03715387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5599999|NCT03715387|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5600000|NCT03715387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5600001|NCT03715387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5600002|NCT03715348|Thrombin|thrombin|mesh-list
5600003|NCT03715348|Hemostatics|hemostatics|mesh-ancestor
5600004|NCT03715348|Coagulants|coagulants|mesh-ancestor
5600005|NCT03715322|Tobramycin|tobramycin|mesh-list
5600006|NCT03715322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5600007|NCT03715322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5600008|NCT03715309|Lenalidomide|lenalidomide|mesh-list
5600009|NCT03715309|Immunologic Factors|immunologic factors|mesh-ancestor
5600010|NCT03715309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600011|NCT03715309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5600012|NCT03715309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5600013|NCT03715309|Growth Substances|growth substances|mesh-ancestor
5600014|NCT03715309|Growth Inhibitors|growth inhibitors|mesh-ancestor
5600015|NCT03715309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5600016|NCT03715296|Lenalidomide|lenalidomide|mesh-list
5600017|NCT03715296|Immunologic Factors|immunologic factors|mesh-ancestor
5600018|NCT03715296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600019|NCT03715296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5600020|NCT03715296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5600021|NCT03715296|Growth Substances|growth substances|mesh-ancestor
5600022|NCT03715296|Growth Inhibitors|growth inhibitors|mesh-ancestor
5600023|NCT03715296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5600024|NCT03715244|Anesthetics|anesthetics|mesh-list
5600025|NCT03715244|Anesthetics, Local|anesthetics, local|mesh-list
5600026|NCT03715244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5600027|NCT03715244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600028|NCT03715244|Sensory System Agents|sensory system agents|mesh-ancestor
5600029|NCT03715244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5600030|NCT03715205|Pembrolizumab|pembrolizumab|mesh-list
5600031|NCT03715205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5600032|NCT03715205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5600033|NCT03715127|Psilocybin|psilocybin|mesh-list
5600034|NCT03715127|Hallucinogens|hallucinogens|mesh-ancestor
5600035|NCT03715127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5600036|NCT03715127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5600037|NCT03715101|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5600038|NCT03715101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5600039|NCT03715101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5600040|NCT03715101|Antimetabolites|antimetabolites|mesh-ancestor
5600041|NCT03715101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5600042|NCT03715101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5600043|NCT03715101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5600044|NCT03715101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5606642|NCT03983824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5606643|NCT03983824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5606644|NCT03983824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5606645|NCT03983824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5606646|NCT03983824|Antimetabolites|antimetabolites|mesh-ancestor
5606647|NCT03983824|Antiviral Agents|antiviral agents|mesh-ancestor
5606648|NCT03983824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5606649|NCT03983824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5606650|NCT03983824|Immunologic Factors|immunologic factors|mesh-ancestor
5606651|NCT03983824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5606652|NCT03983824|Analgesics|analgesics|mesh-ancestor
5606653|NCT03983824|Sensory System Agents|sensory system agents|mesh-ancestor
5606654|NCT03983824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5606655|NCT03983824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6201902|NCT02032810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6201903|NCT02032875|Ribavirin|ribavirin|mesh-list
6201904|NCT02032875|Sofosbuvir|sofosbuvir|mesh-list
6201905|NCT02032875|Antimetabolites|antimetabolites|mesh-ancestor
6201906|NCT02032875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201907|NCT02032875|Antiviral Agents|antiviral agents|mesh-ancestor
6201908|NCT02032875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6201909|NCT02032888|Sofosbuvir|sofosbuvir|mesh-list
6201910|NCT02032888|Antiviral Agents|antiviral agents|mesh-ancestor
6201911|NCT02032888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6201912|NCT02032901|Sofosbuvir|sofosbuvir|mesh-list
6201913|NCT02032901|Antiviral Agents|antiviral agents|mesh-ancestor
6201914|NCT02032901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6201915|NCT02033369|Pramipexole|pramipexole|mesh-list
6201916|NCT02033369|Antioxidants|antioxidants|mesh-ancestor
6201917|NCT02033369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6201918|NCT02033369|Protective Agents|protective agents|mesh-ancestor
6201919|NCT02033369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6201920|NCT02033369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5607034|NCT03031730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5607035|NCT03031730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5607036|NCT03031730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5607037|NCT03031730|Protease Inhibitors|protease inhibitors|mesh-ancestor
5607038|NCT03031730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5607039|NCT03031730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607040|NCT03031730|Immunologic Factors|immunologic factors|mesh-ancestor
5607041|NCT03031730|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5607042|NCT03031730|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5607043|NCT03031730|Growth Substances|growth substances|mesh-ancestor
5607044|NCT03031730|Growth Inhibitors|growth inhibitors|mesh-ancestor
5607045|NCT03031730|Dermatologic Agents|dermatologic agents|mesh-ancestor
5607046|NCT03029000|Lenograstim|lenograstim|mesh-list
5607047|NCT03029000|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5607048|NCT03029000|Immunologic Factors|immunologic factors|mesh-ancestor
5607049|NCT03029000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607050|NCT03022292|Aflibercept|aflibercept|mesh-list
5607051|NCT03022292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5607052|NCT03022292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5607053|NCT03022292|Growth Substances|growth substances|mesh-ancestor
5607054|NCT03022292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607055|NCT03022292|Growth Inhibitors|growth inhibitors|mesh-ancestor
5607056|NCT03022292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5607057|NCT03012100|Cyclophosphamide|cyclophosphamide|mesh-list
5607058|NCT03012100|Vaccines|vaccines|mesh-list
5607059|NCT03012100|Sargramostim|sargramostim|mesh-list
5607060|NCT03012100|Immunologic Factors|immunologic factors|mesh-ancestor
5607061|NCT03012100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607062|NCT03012100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5607063|NCT03012100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5607064|NCT03012100|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5607065|NCT03012100|Alkylating Agents|alkylating agents|mesh-ancestor
5607066|NCT03012100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607067|NCT03012100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5607068|NCT03012100|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5607069|NCT02973997|Pembrolizumab|pembrolizumab|mesh-list
5607070|NCT02973997|Lenvatinib|lenvatinib|mesh-list
5607071|NCT02973997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5607072|NCT02973997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5607073|NCT02973997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5607074|NCT02973997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5607075|NCT02973997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607076|NCT02968602|Minocycline|minocycline|mesh-list
5607077|NCT02968602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5607078|NCT02968602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5607079|NCT02946047|Ixazomib|ixazomib|mesh-list
5607080|NCT02946047|Glycine|glycine|mesh-list
5607081|NCT02946047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5607082|NCT02946047|Protease Inhibitors|protease inhibitors|mesh-ancestor
5607083|NCT02946047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5607084|NCT02946047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607085|NCT02946047|Glycine Agents|glycine agents|mesh-ancestor
5607086|NCT02946047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5607087|NCT02946047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607088|NCT02888743|Durvalumab|durvalumab|mesh-list
5607089|NCT02888743|Ipilimumab|ipilimumab|mesh-list
5607090|NCT02888743|Tremelimumab|tremelimumab|mesh-list
5607091|NCT02888743|Immunoglobulins|immunoglobulins|mesh-list
5607092|NCT02888743|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5607093|NCT02888743|Immunoglobulin G|immunoglobulin g|mesh-list
5607094|NCT02888743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5607095|NCT02888743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5607096|NCT02888743|Immunologic Factors|immunologic factors|mesh-ancestor
5607097|NCT02888743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607098|NCT02888743|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5607099|NCT02888743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607100|NCT02860000|Fulvestrant|fulvestrant|mesh-list
5607101|NCT02860000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5607102|NCT02860000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5607103|NCT02860000|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5607104|NCT02860000|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5607105|NCT02860000|Hormone Antagonists|hormone antagonists|mesh-ancestor
5607106|NCT02860000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5607107|NCT02860000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607108|NCT02832648|Selenium|selenium|mesh-list
5607109|NCT02832648|Antioxidants|antioxidants|mesh-ancestor
5607110|NCT02832648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607111|NCT02832648|Protective Agents|protective agents|mesh-ancestor
5607112|NCT02832648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607113|NCT02832648|Trace Elements|trace elements|mesh-ancestor
5607114|NCT02832648|Micronutrients|micronutrients|mesh-ancestor
5607115|NCT02821013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5607116|NCT02821013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607117|NCT02821013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5607118|NCT02784704|Meropenem|meropenem|mesh-list
5607119|NCT02784704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5607120|NCT02784704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5607121|NCT05241535|Moxifloxacin|moxifloxacin|mesh-list
5607122|NCT05241535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5607123|NCT05241535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5607124|NCT05241535|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5607125|NCT05241535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5607126|NCT05241535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5607127|NCT05241535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607128|NCT05241535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5607129|NCT05241496|Lidocaine|lidocaine|mesh-list
5607130|NCT05241496|Anesthetics, Local|anesthetics, local|mesh-ancestor
5607131|NCT05241496|Anesthetics|anesthetics|mesh-ancestor
5607132|NCT05241496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5607133|NCT05241496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607134|NCT05241496|Sensory System Agents|sensory system agents|mesh-ancestor
5607135|NCT05241496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5607136|NCT05241496|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5607137|NCT05241496|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5607138|NCT05241496|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5607139|NCT05241496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5607140|NCT05241496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607141|NCT05241470|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5607142|NCT05241470|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5607143|NCT05241431|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
5607144|NCT05241431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607145|NCT05241431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5607146|NCT05241431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607147|NCT05241340|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5607148|NCT05241340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607149|NCT05241340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5607150|NCT05241288|Albuterol|albuterol|mesh-list
5607151|NCT05241288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5607152|NCT05241288|Autonomic Agents|autonomic agents|mesh-ancestor
5607153|NCT05241288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5607154|NCT05241288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607155|NCT05241288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5607156|NCT05241288|Respiratory System Agents|respiratory system agents|mesh-ancestor
5607157|NCT05241288|Tocolytic Agents|tocolytic agents|mesh-ancestor
5607158|NCT05241288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5607159|NCT05241288|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5607160|NCT05241288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5607161|NCT05241288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5607162|NCT05241288|Adrenergic Agents|adrenergic agents|mesh-ancestor
5607163|NCT05241288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5607164|NCT05241288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607165|NCT05241275|Xenon|xenon|mesh-list
5607166|NCT05241275|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5607167|NCT05241275|Anesthetics, General|anesthetics, general|mesh-ancestor
5607168|NCT05241275|Anesthetics|anesthetics|mesh-ancestor
5607169|NCT05241275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5607170|NCT05241275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607171|NCT05241262|Acetylcysteine|acetylcysteine|mesh-list
5607172|NCT05241262|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5607173|NCT05241262|Antiviral Agents|antiviral agents|mesh-ancestor
5607174|NCT05241262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5607175|NCT05241262|Expectorants|expectorants|mesh-ancestor
5607176|NCT05241262|Respiratory System Agents|respiratory system agents|mesh-ancestor
5607177|NCT05241262|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5607178|NCT05241262|Antioxidants|antioxidants|mesh-ancestor
5607179|NCT05241262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607180|NCT05241262|Protective Agents|protective agents|mesh-ancestor
5607181|NCT05241262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607182|NCT05241262|Antidotes|antidotes|mesh-ancestor
5607183|NCT05241249|Gemcitabine|gemcitabine|mesh-list
5607184|NCT05241249|Paclitaxel|paclitaxel|mesh-list
5607185|NCT05241249|Bethanechol|bethanechol|mesh-list
5607186|NCT05241249|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5607187|NCT05241249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5607188|NCT05241249|Tubulin Modulators|tubulin modulators|mesh-ancestor
5607189|NCT05241249|Antimitotic Agents|antimitotic agents|mesh-ancestor
5607190|NCT05241249|Mitosis Modulators|mitosis modulators|mesh-ancestor
5607191|NCT05241249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607192|NCT05241249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5607193|NCT05241249|Antimetabolites|antimetabolites|mesh-ancestor
5607194|NCT05241249|Antiviral Agents|antiviral agents|mesh-ancestor
5607195|NCT05241249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5607196|NCT05241249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5607197|NCT05241249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5607198|NCT05241249|Immunologic Factors|immunologic factors|mesh-ancestor
5607199|NCT05241249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607200|NCT05241249|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5607201|NCT05241249|Autonomic Agents|autonomic agents|mesh-ancestor
5607202|NCT05241249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5607203|NCT05241249|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
5607204|NCT05241249|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5607205|NCT05241249|Cholinergic Agents|cholinergic agents|mesh-ancestor
5607206|NCT05241249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5607207|NCT05241132|Paclitaxel|paclitaxel|mesh-list
5607208|NCT05241132|Cisplatin|cisplatin|mesh-list
5607209|NCT05241132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5607210|NCT05241132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5607211|NCT05241132|Tubulin Modulators|tubulin modulators|mesh-ancestor
5607212|NCT05241132|Antimitotic Agents|antimitotic agents|mesh-ancestor
5607213|NCT05241132|Mitosis Modulators|mitosis modulators|mesh-ancestor
5607214|NCT05241132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607215|NCT05241093|Cytarabine|cytarabine|mesh-list
5607216|NCT05241093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5607217|NCT05241093|Antimetabolites|antimetabolites|mesh-ancestor
5607218|NCT05241093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607219|NCT05241093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5607220|NCT05241093|Antiviral Agents|antiviral agents|mesh-ancestor
5607221|NCT05241093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5607222|NCT05241093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5607223|NCT05241093|Immunologic Factors|immunologic factors|mesh-ancestor
5607224|NCT05241093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607225|NCT05241054|Acetaminophen|acetaminophen|mesh-list
5607226|NCT05241054|Nitroglycerin|nitroglycerin|mesh-list
5607227|NCT05241054|Fentanyl|fentanyl|mesh-list
5607228|NCT05241054|Bupivacaine|bupivacaine|mesh-list
5607229|NCT05241054|Propofol|propofol|mesh-list
5607230|NCT05241054|Sevoflurane|sevoflurane|mesh-list
5607231|NCT05241054|Atracurium|atracurium|mesh-list
5607232|NCT05241054|Anesthetics, Local|anesthetics, local|mesh-ancestor
5607233|NCT05241054|Anesthetics|anesthetics|mesh-ancestor
5607234|NCT05241054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5607235|NCT05241054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607236|NCT05241054|Sensory System Agents|sensory system agents|mesh-ancestor
5607237|NCT05241054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5607238|NCT05241054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5607239|NCT05241054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5607240|NCT05241054|Anesthetics, General|anesthetics, general|mesh-ancestor
5607241|NCT05241054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5607242|NCT05241054|Narcotics|narcotics|mesh-ancestor
5607243|NCT05241054|Analgesics|analgesics|mesh-ancestor
5607244|NCT05241054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5607245|NCT05241054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5607246|NCT05241054|Antipyretics|antipyretics|mesh-ancestor
5607247|NCT05241054|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5607248|NCT05241054|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5607249|NCT05241054|Vasodilator Agents|vasodilator agents|mesh-ancestor
5607250|NCT05241054|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5607251|NCT05241054|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5607252|NCT05241054|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5607253|NCT05241054|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
5607254|NCT05241054|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5607255|NCT05241054|Cholinergic Agents|cholinergic agents|mesh-ancestor
5607256|NCT05241054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5607257|NCT05241054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607258|NCT05241028|Ensartinib|ensartinib|mesh-list
5607259|NCT05241028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5607260|NCT05241028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5607261|NCT05241028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5607262|NCT05241028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607263|NCT05240898|Adenosine|adenosine|mesh-list
5607264|NCT05240898|Analgesics|analgesics|mesh-ancestor
5607265|NCT05240898|Sensory System Agents|sensory system agents|mesh-ancestor
5607266|NCT05240898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5607267|NCT05240898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607268|NCT05240898|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5607269|NCT05240898|Vasodilator Agents|vasodilator agents|mesh-ancestor
5607270|NCT05240898|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5725724|NCT03178292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5607271|NCT05240898|Purinergic Agonists|purinergic agonists|mesh-ancestor
5607272|NCT05240898|Purinergic Agents|purinergic agents|mesh-ancestor
5607273|NCT05240898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5607274|NCT05240898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691415|NCT03417388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5691416|NCT03417388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5691417|NCT03417388|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5691418|NCT03417388|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5691419|NCT03417388|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5691420|NCT03417388|Protease Inhibitors|protease inhibitors|mesh-ancestor
5691421|NCT03417388|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5691422|NCT03417388|Protective Agents|protective agents|mesh-ancestor
5691423|NCT03417284|Melphalan|melphalan|mesh-list
5691424|NCT03417284|Lenograstim|lenograstim|mesh-list
5691425|NCT03417284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5691426|NCT03417284|Immunologic Factors|immunologic factors|mesh-ancestor
5691427|NCT03417284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691428|NCT03417284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5691429|NCT03417284|Alkylating Agents|alkylating agents|mesh-ancestor
5691430|NCT03417284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691431|NCT03417284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5691432|NCT03417284|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5691433|NCT03417284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5691434|NCT03417206|Remifentanil|remifentanil|mesh-list
5691435|NCT03417206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5691436|NCT03417206|Narcotics|narcotics|mesh-ancestor
5691437|NCT03417206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5691438|NCT03417206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691439|NCT03417206|Analgesics|analgesics|mesh-ancestor
5607275|NCT05240781|Sirolimus|sirolimus|mesh-list
5607276|NCT05240781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5607277|NCT05240781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5607278|NCT05240781|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5607279|NCT05240781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5607280|NCT05240781|Antifungal Agents|antifungal agents|mesh-ancestor
5607281|NCT05240781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5607282|NCT05240781|Immunologic Factors|immunologic factors|mesh-ancestor
5607283|NCT05240781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607284|NCT05240755|Cannabidiol|cannabidiol|mesh-list
5607285|NCT05240755|Anticonvulsants|anticonvulsants|mesh-ancestor
5607286|NCT05240456|Solifenacin Succinate|solifenacin succinate|mesh-list
5607287|NCT05240456|Cholinergic Antagonists|cholinergic antagonists|mesh-list
5607288|NCT05240456|Adrenergic Agents|adrenergic agents|mesh-list
5607289|NCT05240456|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-list
5607290|NCT05240456|Adrenergic Agonists|adrenergic agonists|mesh-list
5607291|NCT05240456|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5607292|NCT05240456|Cholinergic Agents|cholinergic agents|mesh-ancestor
5607293|NCT05240456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5607294|NCT05240456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607295|NCT05240456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607296|NCT05240456|Urological Agents|urological agents|mesh-ancestor
5607297|NCT05240456|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5607298|NCT05240391|Midodrine|midodrine|mesh-list
5607299|NCT05240391|Sympathomimetics|sympathomimetics|mesh-ancestor
5607300|NCT05240391|Autonomic Agents|autonomic agents|mesh-ancestor
5607301|NCT05240391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5607302|NCT05240391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607303|NCT05240391|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5607304|NCT05240391|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5607305|NCT05240391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5725725|NCT03178292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5725726|NCT03178292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5725727|NCT03178292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5725728|NCT03178292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725729|NCT03178292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5725730|NCT03178292|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5725731|NCT03178292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5725732|NCT03178422|Nicotine|nicotine|mesh-list
5725733|NCT03178422|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5725734|NCT03178422|Autonomic Agents|autonomic agents|mesh-ancestor
5725735|NCT03178422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5725736|NCT03178422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725737|NCT03178422|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5725738|NCT03178422|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5725739|NCT03178422|Cholinergic Agents|cholinergic agents|mesh-ancestor
5725740|NCT03178422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5725741|NCT03178422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725742|NCT03178396|Melatonin|melatonin|mesh-list
5725743|NCT03178396|Antioxidants|antioxidants|mesh-ancestor
5725744|NCT03178396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725745|NCT03178396|Protective Agents|protective agents|mesh-ancestor
5725746|NCT03178396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725747|NCT03178396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5725748|NCT03178409|Liver Extracts|liver extracts|mesh-list
5725749|NCT03178409|Hematinics|hematinics|mesh-ancestor
5725750|NCT03178539|Diclofenac|diclofenac|mesh-list
5725751|NCT03178539|Ketorolac|ketorolac|mesh-list
5725752|NCT03178539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5725753|NCT03178539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5725754|NCT03178539|Analgesics|analgesics|mesh-ancestor
5725755|NCT03178539|Sensory System Agents|sensory system agents|mesh-ancestor
5725756|NCT03178539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5725757|NCT03178539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725758|NCT03178539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5725759|NCT03178539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5725760|NCT03178539|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5725761|NCT03178539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5725762|NCT03178539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496358|NCT00627731|Protective Agents|protective agents|mesh-ancestor
5607306|NCT05240391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5607307|NCT05240391|Adrenergic Agents|adrenergic agents|mesh-ancestor
5607308|NCT05240391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5607309|NCT05240391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607310|NCT05240274|Metformin|metformin|mesh-list
5607311|NCT05240274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5607312|NCT05240274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607313|NCT05240261|Quetiapine Fumarate|quetiapine fumarate|mesh-list
5607314|NCT05240261|Antidepressive Agents|antidepressive agents|mesh-ancestor
5607315|NCT05240261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5607316|NCT05240261|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5607317|NCT05240261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5607318|NCT05240261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5607319|NCT05240261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607320|NCT05240157|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5607321|NCT05240157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6208012|NCT02123472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6208013|NCT02123472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6208014|NCT02123511|Acetylcysteine|acetylcysteine|mesh-list
6208015|NCT02123511|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6208016|NCT02123511|Antiviral Agents|antiviral agents|mesh-ancestor
6208017|NCT02123511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6208018|NCT02123511|Expectorants|expectorants|mesh-ancestor
6208019|NCT02123511|Respiratory System Agents|respiratory system agents|mesh-ancestor
6208020|NCT02123511|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6208021|NCT02123511|Antioxidants|antioxidants|mesh-ancestor
6208022|NCT02123511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208023|NCT02123511|Protective Agents|protective agents|mesh-ancestor
5607322|NCT05240131|Atezolizumab|atezolizumab|mesh-list
5607323|NCT05240131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5725763|NCT03178500|Clomiphene|clomiphene|mesh-list
5725764|NCT03178500|Enclomiphene|enclomiphene|mesh-list
5725765|NCT03178500|Zuclomiphene|zuclomiphene|mesh-list
5725766|NCT03178500|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5725767|NCT03178500|Hormone Antagonists|hormone antagonists|mesh-ancestor
5725768|NCT03178500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5725769|NCT03178500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725770|NCT03178500|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5725771|NCT03178500|Fertility Agents|fertility agents|mesh-ancestor
5725772|NCT03178500|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5725773|NCT03178500|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5725774|NCT03178500|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5725775|NCT03178526|Lovastatin|lovastatin|mesh-list
5725776|NCT03178526|L 647318|l 647318|mesh-list
5725777|NCT03178526|Dihydromevinolin|dihydromevinolin|mesh-list
5725778|NCT03178526|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5725779|NCT03178526|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5725780|NCT03178526|Antimetabolites|antimetabolites|mesh-ancestor
5725781|NCT03178526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725782|NCT03178526|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5725783|NCT03178526|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5725784|NCT03178526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5892553|NCT05002530|Vitamin D|vitamin d|mesh-list
5892554|NCT05002530|Ergocalciferols|ergocalciferols|mesh-list
5892555|NCT05002530|Vitamins|vitamins|mesh-list
5892556|NCT05002530|Tretinoin|tretinoin|mesh-list
5892557|NCT05002530|Isotretinoin|isotretinoin|mesh-list
5892558|NCT05002530|Micronutrients|micronutrients|mesh-ancestor
5892559|NCT05002530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907678|NCT05231382|Raltitrexed|raltitrexed|mesh-list
6208024|NCT02123511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607324|NCT05239910|Tenalisib|tenalisib|mesh-list
5607325|NCT05239910|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
5607326|NCT05239910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5607327|NCT05239910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607328|NCT05239884|Nicotine|nicotine|mesh-list
5607329|NCT05239884|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5607330|NCT05239884|Autonomic Agents|autonomic agents|mesh-ancestor
5607331|NCT05239884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5607332|NCT05239884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607333|NCT05239884|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5607334|NCT05239884|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5607335|NCT05239884|Cholinergic Agents|cholinergic agents|mesh-ancestor
5607336|NCT05239884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5607337|NCT05239884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607338|NCT05239741|Leucovorin|leucovorin|mesh-list
5607339|NCT05239741|Bevacizumab|bevacizumab|mesh-list
5607340|NCT05239741|Pembrolizumab|pembrolizumab|mesh-list
5607341|NCT05239741|Cetuximab|cetuximab|mesh-list
5607342|NCT05239741|Fluorouracil|fluorouracil|mesh-list
5607343|NCT05239741|Oxaliplatin|oxaliplatin|mesh-list
5607344|NCT05239741|Irinotecan|irinotecan|mesh-list
6208025|NCT02123511|Antidotes|antidotes|mesh-ancestor
5607345|NCT05239741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5607346|NCT05239741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5607347|NCT05239741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5607348|NCT05239741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5607349|NCT05239741|Growth Substances|growth substances|mesh-ancestor
5607350|NCT05239741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607351|NCT05239741|Growth Inhibitors|growth inhibitors|mesh-ancestor
5607352|NCT05239741|Antimetabolites|antimetabolites|mesh-ancestor
5607353|NCT05239741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607354|NCT05239741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5607355|NCT05239741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5607356|NCT05239741|Immunologic Factors|immunologic factors|mesh-ancestor
5607357|NCT05239741|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5607358|NCT05239741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5607359|NCT05239741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5607360|NCT05239741|Antidotes|antidotes|mesh-ancestor
5607361|NCT05239741|Protective Agents|protective agents|mesh-ancestor
5607362|NCT05239741|Vitamin B Complex|vitamin b complex|mesh-ancestor
5607363|NCT05239741|Vitamins|vitamins|mesh-ancestor
5607364|NCT05239741|Micronutrients|micronutrients|mesh-ancestor
5607365|NCT05239728|Pembrolizumab|pembrolizumab|mesh-list
5607366|NCT05239728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5607367|NCT05239728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5607368|NCT05239637|Heparin|heparin|mesh-list
5607369|NCT05239637|Calcium heparin|calcium heparin|mesh-list
5607370|NCT05239637|Anticoagulants|anticoagulants|mesh-ancestor
5607371|NCT05239637|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5607372|NCT05239637|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5607373|NCT05239637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725785|NCT03178123|Interferons|interferons|mesh-list
5725786|NCT03178123|Antibodies|antibodies|mesh-list
5725787|NCT03178123|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5725788|NCT03178123|Immunologic Factors|immunologic factors|mesh-ancestor
5725789|NCT03178123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725790|NCT03178123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5725791|NCT03178123|Antiviral Agents|antiviral agents|mesh-ancestor
5725792|NCT03178123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5725793|NCT03177993|Ivermectin|ivermectin|mesh-list
5725794|NCT03177993|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5725795|NCT03177993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5725796|NCT03178084|Lamivudine|lamivudine|mesh-list
5725797|NCT03178084|Zidovudine|zidovudine|mesh-list
5725798|NCT03178084|Efavirenz|efavirenz|mesh-list
5725799|NCT03178084|Maraviroc|maraviroc|mesh-list
5725800|NCT03178084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5725801|NCT03178084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5725802|NCT03178084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5725803|NCT03178084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607374|NCT05239624|Pembrolizumab|pembrolizumab|mesh-list
5607375|NCT05239624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5607376|NCT05239624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5691440|NCT03417206|Sensory System Agents|sensory system agents|mesh-ancestor
5691441|NCT03417206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5691442|NCT03417154|Cyclophosphamide|cyclophosphamide|mesh-list
5725804|NCT03178084|Antiviral Agents|antiviral agents|mesh-ancestor
5725805|NCT03178084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5725806|NCT03178084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5725807|NCT03178084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5725808|NCT03178084|Antimetabolites|antimetabolites|mesh-ancestor
5725809|NCT03178084|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5725810|NCT03178084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5725811|NCT03178084|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5725812|NCT03178084|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5725813|NCT03178084|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5725814|NCT03178084|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5725815|NCT03178084|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5691443|NCT03417154|Nivolumab|nivolumab|mesh-list
5691444|NCT03417154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5691445|NCT03417154|Immunologic Factors|immunologic factors|mesh-ancestor
5691446|NCT03417154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691447|NCT03417154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5691448|NCT03417154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5691449|NCT03417154|Alkylating Agents|alkylating agents|mesh-ancestor
5691450|NCT03417154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691451|NCT03417154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5691452|NCT03417154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6208026|NCT02123576|Pentoxifylline|pentoxifylline|mesh-list
6208027|NCT02123576|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6208028|NCT02123576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5607380|NCT05224895|Anesthetics|anesthetics|mesh-list
5607381|NCT05224895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5607382|NCT05224895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607383|NCT05223478|Phentolamine|phentolamine|mesh-list
5607384|NCT05223478|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5607385|NCT05223478|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5607386|NCT05223478|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5607387|NCT05223478|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5607388|NCT05223478|Adrenergic Agents|adrenergic agents|mesh-ancestor
5607389|NCT05223478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5607390|NCT05223478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607391|NCT05223478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607392|NCT05223478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5607393|NCT05209867|Cannabidiol|cannabidiol|mesh-list
5607394|NCT05209867|Anticonvulsants|anticonvulsants|mesh-ancestor
5607395|NCT05209360|Carbon Fiber|carbon fiber|mesh-list
5607396|NCT05209360|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5607397|NCT05209360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5607398|NCT05208619|Anesthetics|anesthetics|mesh-list
5607399|NCT05208619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5607400|NCT05208619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607401|NCT05199285|Nivolumab|nivolumab|mesh-list
5607402|NCT05199285|Ipilimumab|ipilimumab|mesh-list
5607403|NCT05199285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5607404|NCT05199285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5607405|NCT05199285|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5607406|NCT05199285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607407|NCT05190770|Triamcinolone|triamcinolone|mesh-list
5607408|NCT05190770|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5607409|NCT05190770|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5607410|NCT05190770|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5607411|NCT05190770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5607412|NCT05190770|Glucocorticoids|glucocorticoids|mesh-ancestor
5607413|NCT05190770|Hormones|hormones|mesh-ancestor
5607414|NCT05190770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5607415|NCT05190770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607416|NCT05190770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5607417|NCT05190770|Immunologic Factors|immunologic factors|mesh-ancestor
5607418|NCT05190770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5607419|NCT05190770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607420|NCT05190315|Temozolomide|temozolomide|mesh-list
5607421|NCT05190315|Chlorpromazine|chlorpromazine|mesh-list
5607422|NCT05190315|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5607423|NCT05190315|Alkylating Agents|alkylating agents|mesh-ancestor
5607424|NCT05190315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607425|NCT05190315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5607426|NCT05190315|Antiemetics|antiemetics|mesh-ancestor
5607427|NCT05190315|Autonomic Agents|autonomic agents|mesh-ancestor
5607428|NCT05190315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5607429|NCT05190315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607430|NCT05190315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5607431|NCT05190315|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5607432|NCT05190315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5607433|NCT05190315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5607434|NCT05190315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5607435|NCT05190315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5607436|NCT05190315|Dopamine Agents|dopamine agents|mesh-ancestor
5607437|NCT05190315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5607438|NCT05186623|Ustekinumab|ustekinumab|mesh-list
5607439|NCT05186623|Vedolizumab|vedolizumab|mesh-list
5607440|NCT05186623|Tofacitinib|tofacitinib|mesh-list
5607441|NCT05186623|Dermatologic Agents|dermatologic agents|mesh-ancestor
5607442|NCT05186623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5607443|NCT05186623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5607444|NCT05186623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607445|NCT05186623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5607446|NCT05169372|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5607447|NCT05169372|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5607448|NCT05169372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607449|NCT05168163|Atezolizumab|atezolizumab|mesh-list
5607450|NCT05168163|Lenvatinib|lenvatinib|mesh-list
5607451|NCT05168163|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5607452|NCT05168163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5607453|NCT05168163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5607454|NCT05168163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5607455|NCT05168163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607456|NCT05168163|Immunologic Factors|immunologic factors|mesh-ancestor
5607457|NCT05168163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607458|NCT05167409|Pembrolizumab|pembrolizumab|mesh-list
5607459|NCT05167409|Cetuximab|cetuximab|mesh-list
5607460|NCT05167409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5607461|NCT05167409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5607462|NCT05165485|Tiotropium Bromide|tiotropium bromide|mesh-list
5607463|NCT05165485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5607464|NCT05165485|Autonomic Agents|autonomic agents|mesh-ancestor
5607465|NCT05165485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5607466|NCT05165485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607467|NCT05165485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5607468|NCT05165485|Respiratory System Agents|respiratory system agents|mesh-ancestor
5607469|NCT05165485|Parasympatholytics|parasympatholytics|mesh-ancestor
5607470|NCT05165485|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5607471|NCT05165485|Cholinergic Agents|cholinergic agents|mesh-ancestor
5607472|NCT05165485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5607473|NCT05165485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607474|NCT05153317|Ivacaftor|ivacaftor|mesh-list
5607475|NCT05153317|Elexacaftor|elexacaftor|mesh-list
5607476|NCT05153317|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
5607477|NCT05153317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5607478|NCT05153317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607479|NCT05150587|Rifaximin|rifaximin|mesh-list
5607480|NCT05150587|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5607481|NCT05150587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5607482|NCT05150587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5607483|NCT05145413|Xanomeline|xanomeline|mesh-list
5607484|NCT05145413|Trospium chloride|trospium chloride|mesh-list
5607485|NCT05145413|Parasympatholytics|parasympatholytics|mesh-ancestor
5607486|NCT05145413|Autonomic Agents|autonomic agents|mesh-ancestor
5607487|NCT05145413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5607488|NCT05145413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607489|NCT05145413|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5607490|NCT05145413|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5607491|NCT05145413|Cholinergic Agents|cholinergic agents|mesh-ancestor
5607492|NCT05145413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5607493|NCT05145413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607494|NCT05145413|Urological Agents|urological agents|mesh-ancestor
5607495|NCT05145413|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5607496|NCT05145413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5607497|NCT05145413|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
5607498|NCT05145413|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5607499|NCT05132582|Trastuzumab|trastuzumab|mesh-list
5607500|NCT05132582|Pertuzumab|pertuzumab|mesh-list
5607501|NCT05132582|Tucatinib|tucatinib|mesh-list
5607502|NCT05132582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5607503|NCT05132582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5607504|NCT05132582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5607505|NCT05132582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5607506|NCT05132582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691453|NCT03417154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5691454|NCT03417154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5691455|NCT03417076|Bexagliflozin|bexagliflozin|mesh-list
5691456|NCT03417076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5691457|NCT03417076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691458|NCT03417037|Nivolumab|nivolumab|mesh-list
5691459|NCT03417037|Linrodostat|linrodostat|mesh-list
5691460|NCT03417037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5691461|NCT03417037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5691462|NCT03417037|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5691463|NCT03417037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691464|NCT03417037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5691465|NCT03416777|Tocopherols|tocopherols|mesh-list
5691466|NCT03416777|Vitamin E|vitamin e|mesh-list
5691467|NCT03416777|Tocotrienols|tocotrienols|mesh-list
5691468|NCT03416777|alpha-Tocopherol|alpha-tocopherol|mesh-list
5691469|NCT03416777|Antioxidants|antioxidants|mesh-ancestor
5691470|NCT03416777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691471|NCT03416777|Protective Agents|protective agents|mesh-ancestor
5691472|NCT03416777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691473|NCT03416777|Vitamins|vitamins|mesh-ancestor
5691474|NCT03416777|Micronutrients|micronutrients|mesh-ancestor
5607507|NCT05126966|Ranibizumab|ranibizumab|mesh-list
5607508|NCT05126966|Aflibercept|aflibercept|mesh-list
5607509|NCT05126966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5607510|NCT05126966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5607511|NCT05126966|Growth Substances|growth substances|mesh-ancestor
5607512|NCT05126966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607513|NCT05126966|Growth Inhibitors|growth inhibitors|mesh-ancestor
5607514|NCT05126966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5607515|NCT05118724|Atezolizumab|atezolizumab|mesh-list
5607516|NCT05118724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5607517|NCT05103332|Amlodipine|amlodipine|mesh-list
5607518|NCT05103332|Olmesartan|olmesartan|mesh-list
5607519|NCT05103332|Indapamide|indapamide|mesh-list
5607520|NCT05103332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5607521|NCT05103332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5607522|NCT05103332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5607523|NCT05103332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607524|NCT05103332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5607525|NCT05103332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607526|NCT05103332|Vasodilator Agents|vasodilator agents|mesh-ancestor
5607527|NCT05103332|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5607528|NCT05103332|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5607529|NCT05103332|Diuretics|diuretics|mesh-ancestor
5607530|NCT05103332|Natriuretic Agents|natriuretic agents|mesh-ancestor
5607531|NCT05103332|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5607532|NCT05099666|Doxorubicin|doxorubicin|mesh-list
5607533|NCT05099666|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5607534|NCT05099666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5607535|NCT05099666|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5607536|NCT05099666|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5607537|NCT05099666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5607538|NCT05099666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607539|NCT05095064|Irinotecan|irinotecan|mesh-list
5607540|NCT05095064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5607541|NCT05095064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5607542|NCT05095064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5607543|NCT05095064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607544|NCT05095064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5607545|NCT05093959|Metformin|metformin|mesh-list
5607546|NCT05093959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5607547|NCT05093959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607548|NCT05050500|Dapagliflozin|dapagliflozin|mesh-list
5607549|NCT05050500|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5607550|NCT05050500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607551|NCT05050500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5607552|NCT05050500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607553|NCT05045794|Liver Extracts|liver extracts|mesh-list
5607554|NCT05045794|Hematinics|hematinics|mesh-ancestor
5607555|NCT05045612|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5607556|NCT05045612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5607557|NCT05039593|Chlorhexidine|chlorhexidine|mesh-list
5725816|NCT03178084|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5725817|NCT03178084|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
5725818|NCT03177824|Sildenafil Citrate|sildenafil citrate|mesh-list
5725819|NCT03177824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725820|NCT03177824|Vasodilator Agents|vasodilator agents|mesh-ancestor
5725821|NCT03177824|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5725822|NCT03177824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5725823|NCT03177824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5725824|NCT03177824|Urological Agents|urological agents|mesh-ancestor
5725825|NCT03177837|Acetazolamide|acetazolamide|mesh-list
5725826|NCT03177837|Anticonvulsants|anticonvulsants|mesh-ancestor
5725827|NCT03177837|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5725828|NCT03177837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5725829|NCT03177837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725830|NCT03177837|Diuretics|diuretics|mesh-ancestor
5725831|NCT03177837|Natriuretic Agents|natriuretic agents|mesh-ancestor
5725832|NCT03177837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725833|NCT03177811|Acetazolamide|acetazolamide|mesh-list
5725834|NCT03177811|Anticonvulsants|anticonvulsants|mesh-ancestor
5725835|NCT03177811|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5725836|NCT03177811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5607558|NCT05039593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5607559|NCT05039593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5607560|NCT05039593|Disinfectants|disinfectants|mesh-ancestor
5607561|NCT05011058|Valganciclovir|valganciclovir|mesh-list
5607562|NCT05011058|Antiviral Agents|antiviral agents|mesh-ancestor
5607563|NCT05011058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5607564|NCT05004025|Nivolumab|nivolumab|mesh-list
5607565|NCT05004025|Ipilimumab|ipilimumab|mesh-list
5607566|NCT05004025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5607567|NCT05004025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5607568|NCT05004025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5607569|NCT05004025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607570|NCT05002946|Naltrexone|naltrexone|mesh-list
5607571|NCT05002946|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5607572|NCT05002946|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5607573|NCT05002946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607574|NCT05002946|Sensory System Agents|sensory system agents|mesh-ancestor
5607575|NCT05002946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5607576|NCT04998851|Ocrelizumab|ocrelizumab|mesh-list
5607577|NCT04998851|Immunologic Factors|immunologic factors|mesh-ancestor
5607578|NCT04998851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607579|NCT04994132|Dactinomycin|dactinomycin|mesh-list
5607580|NCT04994132|Cactinomycin|cactinomycin|mesh-list
5607581|NCT04994132|Cyclophosphamide|cyclophosphamide|mesh-list
5607582|NCT04994132|Vincristine|vincristine|mesh-list
5607583|NCT04994132|Vinorelbine|vinorelbine|mesh-list
5607584|NCT04994132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5607585|NCT04994132|Immunologic Factors|immunologic factors|mesh-ancestor
5607586|NCT04994132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607587|NCT04994132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5607588|NCT04994132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5607589|NCT04994132|Alkylating Agents|alkylating agents|mesh-ancestor
5607590|NCT04994132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607591|NCT04994132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5607592|NCT04994132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5607593|NCT04994132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5607594|NCT04994132|Tubulin Modulators|tubulin modulators|mesh-ancestor
5607595|NCT04994132|Antimitotic Agents|antimitotic agents|mesh-ancestor
5607596|NCT04994132|Mitosis Modulators|mitosis modulators|mesh-ancestor
5607597|NCT04994132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5607598|NCT04994132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5607599|NCT04994132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5607600|NCT04994132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5607601|NCT04994132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5607602|NCT04994132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5607603|NCT04984083|Vitamin K|vitamin k|mesh-list
5607604|NCT04984083|Vitamins|vitamins|mesh-ancestor
5607605|NCT04984083|Micronutrients|micronutrients|mesh-ancestor
5607606|NCT04984083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607607|NCT04984083|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5607608|NCT04984083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5607609|NCT04984083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607610|NCT04984083|Hemostatics|hemostatics|mesh-ancestor
5607611|NCT04984083|Coagulants|coagulants|mesh-ancestor
5607612|NCT04976777|Dexamethasone|dexamethasone|mesh-list
5607613|NCT04976777|Dexamethasone acetate|dexamethasone acetate|mesh-list
5607614|NCT04976777|BB 1101|bb 1101|mesh-list
5607615|NCT04976777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5607616|NCT04976777|Antiemetics|antiemetics|mesh-ancestor
5607617|NCT04976777|Autonomic Agents|autonomic agents|mesh-ancestor
5607618|NCT04976777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5607619|NCT04976777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607620|NCT04976777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5607621|NCT04976777|Glucocorticoids|glucocorticoids|mesh-ancestor
5607622|NCT04976777|Hormones|hormones|mesh-ancestor
5607623|NCT04976777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5607624|NCT04976777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5607625|NCT04976777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5607626|NCT04976777|Protease Inhibitors|protease inhibitors|mesh-ancestor
5607627|NCT04976777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5607628|NCT04976777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607629|NCT04973163|Midazolam|midazolam|mesh-list
5607630|NCT04973163|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5607631|NCT04973163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5607632|NCT04973163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5607633|NCT04973163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607634|NCT04973163|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5607635|NCT04973163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5607636|NCT04973163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5607637|NCT04973163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5607638|NCT04973163|Anesthetics, General|anesthetics, general|mesh-ancestor
5607639|NCT04973163|Anesthetics|anesthetics|mesh-ancestor
5607640|NCT04973163|GABA Modulators|gaba modulators|mesh-ancestor
5607641|NCT04973163|GABA Agents|gaba agents|mesh-ancestor
5607642|NCT04973163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5607643|NCT04973163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607644|NCT04971954|Nicotine|nicotine|mesh-list
5607645|NCT04971954|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5607646|NCT04971954|Autonomic Agents|autonomic agents|mesh-ancestor
5607647|NCT04971954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5607648|NCT04971954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607649|NCT04971954|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5607650|NCT04971954|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5607651|NCT04971954|Cholinergic Agents|cholinergic agents|mesh-ancestor
5607652|NCT04971954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5607653|NCT04971954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607654|NCT04965077|Antibodies|antibodies|mesh-list
5607655|NCT04965077|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5607656|NCT04965077|Immunologic Factors|immunologic factors|mesh-ancestor
5607657|NCT04965077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607658|NCT04959006|Antioxidants|antioxidants|mesh-list
5607659|NCT04959006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607660|NCT04959006|Protective Agents|protective agents|mesh-ancestor
5725837|NCT03177811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725838|NCT03177811|Diuretics|diuretics|mesh-ancestor
5725839|NCT03177811|Natriuretic Agents|natriuretic agents|mesh-ancestor
5725840|NCT03177811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725841|NCT03177980|Clonidine|clonidine|mesh-list
5725842|NCT03177980|Fentanyl|fentanyl|mesh-list
5725843|NCT03177980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5725844|NCT03177980|Narcotics|narcotics|mesh-ancestor
5725845|NCT03177980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5725846|NCT03177980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725847|NCT03177980|Analgesics|analgesics|mesh-ancestor
5725848|NCT03177980|Sensory System Agents|sensory system agents|mesh-ancestor
5725849|NCT03177980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5725850|NCT03177980|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5725851|NCT03177980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5725852|NCT03177980|Anesthetics, General|anesthetics, general|mesh-ancestor
5725853|NCT03177980|Anesthetics|anesthetics|mesh-ancestor
5725854|NCT03177980|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5725855|NCT03177980|Sympatholytics|sympatholytics|mesh-ancestor
5725856|NCT03177980|Autonomic Agents|autonomic agents|mesh-ancestor
5725857|NCT03177980|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5725858|NCT03177980|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5725859|NCT03177980|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5725860|NCT03177980|Adrenergic Agents|adrenergic agents|mesh-ancestor
5725861|NCT03177980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5725862|NCT03177980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725863|NCT03177850|Acetazolamide|acetazolamide|mesh-list
5725864|NCT03177850|Anticonvulsants|anticonvulsants|mesh-ancestor
5725865|NCT03177850|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5725866|NCT03177850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5725867|NCT03177850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725868|NCT03177850|Diuretics|diuretics|mesh-ancestor
5725869|NCT03177850|Natriuretic Agents|natriuretic agents|mesh-ancestor
5725870|NCT03177850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725871|NCT03177720|Ciprofloxacin|ciprofloxacin|mesh-list
5725872|NCT03177720|Imipenem|imipenem|mesh-list
5607661|NCT04959006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607662|NCT04958785|Paclitaxel|paclitaxel|mesh-list
5607663|NCT04958785|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5607664|NCT04958785|Magrolimab|magrolimab|mesh-list
5607665|NCT04958785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5607666|NCT04958785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5607667|NCT04958785|Tubulin Modulators|tubulin modulators|mesh-ancestor
5607668|NCT04958785|Antimitotic Agents|antimitotic agents|mesh-ancestor
5607669|NCT04958785|Mitosis Modulators|mitosis modulators|mesh-ancestor
5607670|NCT04958785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607671|NCT04958785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5607672|NCT04942470|Propolis|propolis|mesh-list
5607673|NCT04942470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5607674|NCT04941287|Atezolizumab|atezolizumab|mesh-list
5607675|NCT04941287|Immunoglobulins|immunoglobulins|mesh-list
5607676|NCT04941287|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5607677|NCT04941287|Immunoglobulin G|immunoglobulin g|mesh-list
5725873|NCT03177720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5607678|NCT04941287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5607679|NCT04941287|Immunologic Factors|immunologic factors|mesh-ancestor
5607680|NCT04941287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607681|NCT04940767|Minocycline|minocycline|mesh-list
5607682|NCT04940767|Isotretinoin|isotretinoin|mesh-list
5607683|NCT04940767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5607684|NCT04940767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5607685|NCT04940767|Dermatologic Agents|dermatologic agents|mesh-ancestor
6208029|NCT02123576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208030|NCT02123576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6208031|NCT02123576|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6208032|NCT02123576|Protective Agents|protective agents|mesh-ancestor
6208033|NCT02123576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208034|NCT02123576|Vasodilator Agents|vasodilator agents|mesh-ancestor
6208035|NCT02123576|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6208036|NCT02123576|Antioxidants|antioxidants|mesh-ancestor
6208037|NCT02123849|Aspirin|aspirin|mesh-list
6208038|NCT02123849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6208039|NCT02123849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5691475|NCT03416569|Prazosin|prazosin|mesh-list
5691476|NCT03416569|Nicotine|nicotine|mesh-list
5691477|NCT03416569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5691478|NCT03416569|Autonomic Agents|autonomic agents|mesh-ancestor
5691479|NCT03416569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5691480|NCT03416569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691481|NCT03416569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5691482|NCT03416569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5691483|NCT03416569|Cholinergic Agents|cholinergic agents|mesh-ancestor
5691484|NCT03416569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5691485|NCT03416569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691486|NCT03416569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5691487|NCT03416569|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5691488|NCT03416569|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5691489|NCT03416569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5691490|NCT03416569|Adrenergic Agents|adrenergic agents|mesh-ancestor
5691491|NCT03416530|TIC10 compound|tic10 compound|mesh-list
5691492|NCT03416530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5691493|NCT03416517|Irinotecan|irinotecan|mesh-list
5691494|NCT03416517|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5691495|NCT03416517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5691496|NCT03416517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5691497|NCT03416517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691498|NCT03416517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5691499|NCT03416491|Sofosbuvir|sofosbuvir|mesh-list
5691500|NCT03416491|Antiviral Agents|antiviral agents|mesh-ancestor
5691501|NCT03416491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5691502|NCT03416374|Dexamethasone|dexamethasone|mesh-list
5691503|NCT03416374|Lenalidomide|lenalidomide|mesh-list
5691504|NCT03416374|Bortezomib|bortezomib|mesh-list
5691505|NCT03416374|Ixazomib|ixazomib|mesh-list
5691506|NCT03416374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5691507|NCT03416374|Antiemetics|antiemetics|mesh-ancestor
5691508|NCT03416374|Autonomic Agents|autonomic agents|mesh-ancestor
5691509|NCT03416374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5691510|NCT03416374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691511|NCT03416374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5691512|NCT03416374|Glucocorticoids|glucocorticoids|mesh-ancestor
5691513|NCT03416374|Hormones|hormones|mesh-ancestor
5691514|NCT03416374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5691515|NCT03416374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5691516|NCT03416374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5691517|NCT03416374|Immunologic Factors|immunologic factors|mesh-ancestor
5691518|NCT03416374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5691519|NCT03416374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5691520|NCT03416374|Growth Substances|growth substances|mesh-ancestor
5691521|NCT03416374|Growth Inhibitors|growth inhibitors|mesh-ancestor
5691522|NCT03416374|Protease Inhibitors|protease inhibitors|mesh-ancestor
5691523|NCT03416374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5691524|NCT03416374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691525|NCT03416361|Vitamin D|vitamin d|mesh-list
5691526|NCT03416361|Cholecalciferol|cholecalciferol|mesh-list
5691527|NCT03416361|Vitamins|vitamins|mesh-ancestor
5691528|NCT03416361|Micronutrients|micronutrients|mesh-ancestor
5691529|NCT03416361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691530|NCT03416361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5691531|NCT03416361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5691532|NCT03416348|Ethanol|ethanol|mesh-list
5607697|NCT04933383|Budesonide|budesonide|mesh-list
5607698|NCT04933383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5607699|NCT04933383|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5607700|NCT04933383|Autonomic Agents|autonomic agents|mesh-ancestor
5607701|NCT04933383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5607702|NCT04933383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607703|NCT04933383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5607704|NCT04933383|Respiratory System Agents|respiratory system agents|mesh-ancestor
5607705|NCT04933383|Glucocorticoids|glucocorticoids|mesh-ancestor
5607706|NCT04933383|Hormones|hormones|mesh-ancestor
5607707|NCT04933383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5607708|NCT04929223|Bevacizumab|bevacizumab|mesh-list
5607709|NCT04929223|Cetuximab|cetuximab|mesh-list
5607710|NCT04929223|Atezolizumab|atezolizumab|mesh-list
5607711|NCT04929223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5607712|NCT04929223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5607713|NCT04929223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5607714|NCT04929223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5607715|NCT04929223|Growth Substances|growth substances|mesh-ancestor
5607716|NCT04929223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607717|NCT04929223|Growth Inhibitors|growth inhibitors|mesh-ancestor
5607718|NCT04926571|Dexamethasone|dexamethasone|mesh-list
5607719|NCT04926571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5607720|NCT04926571|Antiemetics|antiemetics|mesh-ancestor
5607721|NCT04926571|Autonomic Agents|autonomic agents|mesh-ancestor
5607722|NCT04926571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5607723|NCT04926571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607724|NCT04926571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5607725|NCT04926571|Glucocorticoids|glucocorticoids|mesh-ancestor
5607726|NCT04926571|Hormones|hormones|mesh-ancestor
5607727|NCT04926571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5607728|NCT04926571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5607729|NCT04926571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5607730|NCT04925479|Niacinamide|niacinamide|mesh-list
5607731|NCT04925479|Vitamin B Complex|vitamin b complex|mesh-ancestor
5607732|NCT04925479|Vitamins|vitamins|mesh-ancestor
5607733|NCT04925479|Micronutrients|micronutrients|mesh-ancestor
5607734|NCT04925479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607735|NCT04904562|Angiotensin II|angiotensin ii|mesh-list
5607736|NCT04904562|Giapreza|giapreza|mesh-list
5607737|NCT04904562|Angiotensinogen|angiotensinogen|mesh-list
5607738|NCT04904562|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5607739|NCT04904562|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5607740|NCT04904562|Protease Inhibitors|protease inhibitors|mesh-ancestor
5607741|NCT04904562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5607742|NCT04904562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607743|NCT04884815|Prednisolone|prednisolone|mesh-list
5607744|NCT04884815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5607745|NCT04884815|Glucocorticoids|glucocorticoids|mesh-ancestor
5607746|NCT04884815|Hormones|hormones|mesh-ancestor
5607747|NCT04884815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5607748|NCT04884815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607749|NCT04884815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5607750|NCT04884815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5607751|NCT04877990|BMS-986165|bms-986165|mesh-list
5607752|NCT04877990|Dermatologic Agents|dermatologic agents|mesh-ancestor
5725874|NCT03177720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5725875|NCT03177720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5725876|NCT03177720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5725877|NCT03177720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5725878|NCT03177720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725879|NCT03177720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5907679|NCT05231382|Oxaliplatin|oxaliplatin|mesh-list
5607753|NCT04877990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5607754|NCT04877990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5607755|NCT04877990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607756|NCT04862780|Osimertinib|osimertinib|mesh-list
5607757|NCT04862780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5607758|NCT04862780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5607759|NCT04862780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5607760|NCT04862780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607761|NCT04862663|Fulvestrant|fulvestrant|mesh-list
5607762|NCT04862663|Palbociclib|palbociclib|mesh-list
5607763|NCT04862663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5607764|NCT04862663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5607765|NCT04862663|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5607766|NCT04862663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5607767|NCT04862663|Hormone Antagonists|hormone antagonists|mesh-ancestor
5607768|NCT04862663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5607769|NCT04862663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607770|NCT04862663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5607771|NCT04862663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5607772|NCT04862663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607773|NCT04851522|Sodium Hypochlorite|sodium hypochlorite|mesh-list
5607774|NCT04851522|Eusol|eusol|mesh-list
5607775|NCT04851522|Petrolatum|petrolatum|mesh-list
5607776|NCT04851522|Disinfectants|disinfectants|mesh-ancestor
5607777|NCT04851522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5607778|NCT04851522|Emollients|emollients|mesh-ancestor
5607779|NCT04851522|Dermatologic Agents|dermatologic agents|mesh-ancestor
5607780|NCT04847440|Tenofovir|tenofovir|mesh-list
5607781|NCT04847440|Antiviral Agents|antiviral agents|mesh-ancestor
5607782|NCT04847440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5607783|NCT04847440|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5607784|NCT04847440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5607785|NCT04847440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5607786|NCT04847440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607787|NCT04847440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5607788|NCT04847440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5607789|NCT04834024|Antibodies|antibodies|mesh-list
5607790|NCT04834024|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5607791|NCT04834024|Immunologic Factors|immunologic factors|mesh-ancestor
5607792|NCT04834024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607793|NCT04828343|Rozanolixizumab|rozanolixizumab|mesh-list
5607794|NCT04828343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5607795|NCT04828343|Immunologic Factors|immunologic factors|mesh-ancestor
5607796|NCT04828343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607797|NCT04821141|Bazedoxifene|bazedoxifene|mesh-list
5607798|NCT04821141|Estrogens|estrogens|mesh-list
5607799|NCT04821141|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
5607800|NCT04821141|Hormones|hormones|mesh-ancestor
5607801|NCT04821141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5607802|NCT04821141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607803|NCT04821141|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5607804|NCT04821141|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5607805|NCT04821141|Hormone Antagonists|hormone antagonists|mesh-ancestor
5607806|NCT04821141|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5607807|NCT04817345|Plerixafor|plerixafor|mesh-list
5607808|NCT04817345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5607809|NCT04817345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5607810|NCT04817345|Antiviral Agents|antiviral agents|mesh-ancestor
5607811|NCT04817345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5607812|NCT04788017|Ziresovir|ziresovir|mesh-list
5607813|NCT04788017|Antiviral Agents|antiviral agents|mesh-ancestor
5607814|NCT04788017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5607815|NCT04775082|Liraglutide|liraglutide|mesh-list
5607816|NCT04775082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5607817|NCT04775082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607818|NCT04775082|Incretins|incretins|mesh-ancestor
5607819|NCT04775082|Hormones|hormones|mesh-ancestor
5607820|NCT04775082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5607821|NCT04770896|Sorafenib|sorafenib|mesh-list
5607822|NCT04770896|Atezolizumab|atezolizumab|mesh-list
5607823|NCT04770896|Lenvatinib|lenvatinib|mesh-list
5607824|NCT04770896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5607825|NCT04770896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5607826|NCT04770896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5607827|NCT04770896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607828|NCT04767776|Rivaroxaban|rivaroxaban|mesh-list
5607829|NCT04767776|Charcoal|charcoal|mesh-list
5607830|NCT04767776|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5607831|NCT04767776|Antithrombins|antithrombins|mesh-ancestor
5607832|NCT04767776|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5607833|NCT04767776|Protease Inhibitors|protease inhibitors|mesh-ancestor
5607834|NCT04767776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5607835|NCT04767776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725880|NCT03177720|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5607836|NCT04767776|Anticoagulants|anticoagulants|mesh-ancestor
5607837|NCT04767776|Antidotes|antidotes|mesh-ancestor
5607838|NCT04767776|Protective Agents|protective agents|mesh-ancestor
5607839|NCT04767776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607840|NCT04766437|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
5607841|NCT04766437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5607842|NCT04760288|Pralsetinib|pralsetinib|mesh-list
5607843|NCT04760288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5607844|NCT04756765|Talazoparib|talazoparib|mesh-list
5607845|NCT04756765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5607846|NCT04756765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5607847|NCT04756765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607848|NCT04756765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5607849|NCT04753970|Cilostazol|cilostazol|mesh-list
5607850|NCT04753970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5607851|NCT04753970|Autonomic Agents|autonomic agents|mesh-ancestor
5607852|NCT04753970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5607853|NCT04753970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607854|NCT04753970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5607855|NCT04753970|Respiratory System Agents|respiratory system agents|mesh-ancestor
5607856|NCT04753970|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5607857|NCT04753970|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5607858|NCT04753970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607859|NCT04753970|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5607860|NCT04753970|Vasodilator Agents|vasodilator agents|mesh-ancestor
5607861|NCT04753970|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5607862|NCT04753970|Protective Agents|protective agents|mesh-ancestor
5607863|NCT04753970|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5607864|NCT04753970|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5607865|NCT04753970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5607866|NCT04738643|Varenicline|varenicline|mesh-list
5607867|NCT04738643|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5607868|NCT04738643|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5607869|NCT04738643|Cholinergic Agents|cholinergic agents|mesh-ancestor
5607870|NCT04738643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5607871|NCT04738643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607872|NCT04738643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607873|NCT04732286|Bevacizumab|bevacizumab|mesh-list
6672634|NCT01557335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672635|NCT01557335|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6672636|NCT01557335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6672637|NCT01557335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6672638|NCT01557335|Antipyretics|antipyretics|mesh-ancestor
6672639|NCT01557335|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6672640|NCT01557335|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6672641|NCT01557335|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5607874|NCT04732286|Atezolizumab|atezolizumab|mesh-list
5607875|NCT04732286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5607876|NCT04732286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5607877|NCT04732286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5607878|NCT04732286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5607879|NCT04732286|Growth Substances|growth substances|mesh-ancestor
5607880|NCT04732286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607881|NCT04732286|Growth Inhibitors|growth inhibitors|mesh-ancestor
5607882|NCT04727242|Gemcitabine|gemcitabine|mesh-list
5607883|NCT04727242|Dacarbazine|dacarbazine|mesh-list
5725881|NCT03177720|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5725882|NCT03177538|Menotropins|menotropins|mesh-list
5725883|NCT03177538|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5725884|NCT03177538|Hormones|hormones|mesh-ancestor
5725885|NCT03177538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5607884|NCT04727242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5607885|NCT04727242|Antimetabolites|antimetabolites|mesh-ancestor
5607886|NCT04727242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607887|NCT04727242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5607888|NCT04727242|Antiviral Agents|antiviral agents|mesh-ancestor
5607889|NCT04727242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5607890|NCT04727242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5607891|NCT04727242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5607892|NCT04727242|Immunologic Factors|immunologic factors|mesh-ancestor
5607893|NCT04727242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607894|NCT04727242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5607895|NCT04727242|Alkylating Agents|alkylating agents|mesh-ancestor
5607896|NCT04724447|Valganciclovir|valganciclovir|mesh-list
5607897|NCT04724447|Antiviral Agents|antiviral agents|mesh-ancestor
5725886|NCT03177538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725887|NCT03177538|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5725888|NCT03177538|Fertility Agents|fertility agents|mesh-ancestor
5725889|NCT03177538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5607898|NCT04724447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5607899|NCT04718922|Chlorhexidine|chlorhexidine|mesh-list
5607900|NCT04718922|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5607901|NCT04718922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5607902|NCT04718922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5607903|NCT04718922|Disinfectants|disinfectants|mesh-ancestor
5607904|NCT04718922|Dermatologic Agents|dermatologic agents|mesh-ancestor
5607905|NCT04712643|Atezolizumab|atezolizumab|mesh-list
5607906|NCT04712643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5607907|NCT04710732|Enoxaparin|enoxaparin|mesh-list
5607908|NCT04710732|Enoxaparin sodium|enoxaparin sodium|mesh-list
5607909|NCT04710732|Anticoagulants|anticoagulants|mesh-ancestor
5607910|NCT04710732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5607911|NCT04710732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5607912|NCT04710732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607913|NCT04697628|Gemcitabine|gemcitabine|mesh-list
5607914|NCT04697628|Irinotecan|irinotecan|mesh-list
5607915|NCT04697628|Pemetrexed|pemetrexed|mesh-list
5607916|NCT04697628|Topotecan|topotecan|mesh-list
5607917|NCT04697628|Vinorelbine|vinorelbine|mesh-list
5607918|NCT04697628|Tisotumab vedotin|tisotumab vedotin|mesh-list
5607919|NCT04697628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5607920|NCT04697628|Antimetabolites|antimetabolites|mesh-ancestor
5607921|NCT04697628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607922|NCT04697628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5607923|NCT04697628|Antiviral Agents|antiviral agents|mesh-ancestor
5607924|NCT04697628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5607925|NCT04697628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5607926|NCT04697628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5607927|NCT04697628|Immunologic Factors|immunologic factors|mesh-ancestor
5607928|NCT04697628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607929|NCT04697628|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5607930|NCT04697628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5607931|NCT04697628|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5607932|NCT04697628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5607933|NCT04697628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5607934|NCT04697628|Tubulin Modulators|tubulin modulators|mesh-ancestor
5607935|NCT04697628|Antimitotic Agents|antimitotic agents|mesh-ancestor
5607936|NCT04697628|Mitosis Modulators|mitosis modulators|mesh-ancestor
5607937|NCT04697628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5607938|NCT04688294|Valsartan|valsartan|mesh-list
5607939|NCT04688294|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5607940|NCT04688294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5725890|NCT03177434|Lactulose|lactulose|mesh-list
5725891|NCT03177434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5725892|NCT03177174|Docetaxel|docetaxel|mesh-list
5725893|NCT03177174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5725894|NCT03177174|Tubulin Modulators|tubulin modulators|mesh-ancestor
5725895|NCT03177174|Antimitotic Agents|antimitotic agents|mesh-ancestor
5725896|NCT03177174|Mitosis Modulators|mitosis modulators|mesh-ancestor
5725897|NCT03177174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725898|NCT03177252|Lidocaine|lidocaine|mesh-list
5725899|NCT03177252|Bupivacaine|bupivacaine|mesh-list
5725900|NCT03177252|Anesthetics, Local|anesthetics, local|mesh-ancestor
5725901|NCT03177252|Anesthetics|anesthetics|mesh-ancestor
5725902|NCT03177252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5725903|NCT03177252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725904|NCT03177252|Sensory System Agents|sensory system agents|mesh-ancestor
5725905|NCT03177252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5725906|NCT03177252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5725907|NCT03177252|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5725908|NCT03177252|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5725909|NCT03177252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5725910|NCT03177252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725911|NCT03177317|Dexamethasone|dexamethasone|mesh-list
5725912|NCT03177317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5725913|NCT03177317|Antiemetics|antiemetics|mesh-ancestor
5725914|NCT03177317|Autonomic Agents|autonomic agents|mesh-ancestor
5725915|NCT03177317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5725916|NCT03177317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725917|NCT03177317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5725918|NCT03177317|Glucocorticoids|glucocorticoids|mesh-ancestor
5725919|NCT03177317|Hormones|hormones|mesh-ancestor
5725920|NCT03177317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5607941|NCT04688294|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5607942|NCT04688294|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5607943|NCT04688294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607944|NCT04683939|Gemcitabine|gemcitabine|mesh-list
5607945|NCT04683939|Paclitaxel|paclitaxel|mesh-list
5607946|NCT04683939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5607947|NCT04683939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5607948|NCT04683939|Tubulin Modulators|tubulin modulators|mesh-ancestor
5607949|NCT04683939|Antimitotic Agents|antimitotic agents|mesh-ancestor
5607950|NCT04683939|Mitosis Modulators|mitosis modulators|mesh-ancestor
5607951|NCT04683939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607952|NCT04683939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5607953|NCT04683939|Antimetabolites|antimetabolites|mesh-ancestor
5607954|NCT04683939|Antiviral Agents|antiviral agents|mesh-ancestor
5607955|NCT04683939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5607956|NCT04683939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5607957|NCT04683939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5607958|NCT04683939|Immunologic Factors|immunologic factors|mesh-ancestor
5607959|NCT04683939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691533|NCT03416348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5691534|NCT03416348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5691535|NCT03416348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5691536|NCT03416348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691537|NCT03416270|Ertugliflozin|ertugliflozin|mesh-list
5691538|NCT03416270|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5691539|NCT03416270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691540|NCT03416270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5691541|NCT03416270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691542|NCT03416231|Docetaxel|docetaxel|mesh-list
5691543|NCT03416231|Apatinib|apatinib|mesh-list
5691544|NCT03416231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5691545|NCT03416231|Tubulin Modulators|tubulin modulators|mesh-ancestor
5691546|NCT03416231|Antimitotic Agents|antimitotic agents|mesh-ancestor
5691547|NCT03416231|Mitosis Modulators|mitosis modulators|mesh-ancestor
5691548|NCT03416231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691549|NCT03416231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5691550|NCT03416231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5691551|NCT03416062|Niacinamide|niacinamide|mesh-list
5691552|NCT03416062|Vitamin B Complex|vitamin b complex|mesh-ancestor
5691553|NCT03416062|Vitamins|vitamins|mesh-ancestor
5691554|NCT03416062|Micronutrients|micronutrients|mesh-ancestor
5691555|NCT03416062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697569|NCT03375242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697570|NCT03375138|Abatacept|abatacept|mesh-list
5697571|NCT03375138|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5697572|NCT03375138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697573|NCT03375138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5697574|NCT03375138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5697575|NCT03375138|Immunologic Factors|immunologic factors|mesh-ancestor
5697576|NCT03375138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697577|NCT03375138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5697578|NCT03375112|Bupivacaine|bupivacaine|mesh-list
6208040|NCT02123849|Analgesics|analgesics|mesh-ancestor
6208041|NCT02123849|Sensory System Agents|sensory system agents|mesh-ancestor
6208042|NCT02123849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6208043|NCT02123849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697579|NCT03375112|Anesthetics, Local|anesthetics, local|mesh-ancestor
5697580|NCT03375112|Anesthetics|anesthetics|mesh-ancestor
5697581|NCT03375112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5697582|NCT03375112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697583|NCT03375112|Sensory System Agents|sensory system agents|mesh-ancestor
5697584|NCT03375112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5697585|NCT03375034|Clonazepam|clonazepam|mesh-list
5697586|NCT03375034|Anticonvulsants|anticonvulsants|mesh-ancestor
5697587|NCT03375034|GABA Modulators|gaba modulators|mesh-ancestor
5697588|NCT03375034|GABA Agents|gaba agents|mesh-ancestor
5697589|NCT03375034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5697590|NCT03375034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607960|NCT04679402|Carbon Monoxide|carbon monoxide|mesh-list
5607961|NCT04679402|Antimetabolites|antimetabolites|mesh-ancestor
5607962|NCT04679402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607963|NCT04679402|Gasotransmitters|gasotransmitters|mesh-ancestor
5607964|NCT04679402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6672642|NCT01557335|Purinergic Agents|purinergic agents|mesh-ancestor
5607965|NCT04679402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607966|NCT04672460|Talazoparib|talazoparib|mesh-list
5607967|NCT04672460|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5607968|NCT04672460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5607969|NCT04672460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607970|NCT04672460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5607971|NCT04671875|Antibodies|antibodies|mesh-list
5607972|NCT04671875|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5607973|NCT04671875|Immunologic Factors|immunologic factors|mesh-ancestor
5607974|NCT04671875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607975|NCT04663997|Docetaxel|docetaxel|mesh-list
5607976|NCT04663997|177Lu-PSMA-617|177lu-psma-617|mesh-list
5607977|NCT04663997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5607978|NCT04663997|Tubulin Modulators|tubulin modulators|mesh-ancestor
5607979|NCT04663997|Antimitotic Agents|antimitotic agents|mesh-ancestor
5607980|NCT04663997|Mitosis Modulators|mitosis modulators|mesh-ancestor
5607981|NCT04663997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5607982|NCT04663997|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5607983|NCT04651348|Antibodies|antibodies|mesh-list
5607984|NCT04651348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5607985|NCT04651348|Immunologic Factors|immunologic factors|mesh-ancestor
5607986|NCT04651348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607987|NCT04650581|Fulvestrant|fulvestrant|mesh-list
5725921|NCT03177317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5725922|NCT03177317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5725923|NCT03177239|Nivolumab|nivolumab|mesh-list
5725924|NCT03177239|Ipilimumab|ipilimumab|mesh-list
5725925|NCT03177239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5725926|NCT03177239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5725927|NCT03177239|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5725928|NCT03177239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725931|NCT03176849|Vitamin D|vitamin d|mesh-list
5725932|NCT03176849|Ergocalciferols|ergocalciferols|mesh-list
5725933|NCT03176849|Cholecalciferol|cholecalciferol|mesh-list
5725934|NCT03176849|Vitamins|vitamins|mesh-list
5725935|NCT03176849|Micronutrients|micronutrients|mesh-ancestor
5725936|NCT03176849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725937|NCT03176849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5725938|NCT03176849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5725939|NCT03177109|Fluorides|fluorides|mesh-list
5725940|NCT03177109|Fluorides, Topical|fluorides, topical|mesh-list
5725941|NCT03177109|Cariostatic Agents|cariostatic agents|mesh-ancestor
5725942|NCT03177109|Protective Agents|protective agents|mesh-ancestor
5725943|NCT03177109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725944|NCT03176966|Vitamin E|vitamin e|mesh-list
5725945|NCT03176966|Ropinirole|ropinirole|mesh-list
5725946|NCT03176966|Vitamins|vitamins|mesh-ancestor
5725947|NCT03176966|Micronutrients|micronutrients|mesh-ancestor
5725948|NCT03176966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725949|NCT03176966|Antioxidants|antioxidants|mesh-ancestor
5725950|NCT03176966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725951|NCT03176966|Protective Agents|protective agents|mesh-ancestor
5725952|NCT03176966|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5725953|NCT03176966|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5725954|NCT03176966|Dopamine Agonists|dopamine agonists|mesh-ancestor
5725955|NCT03176966|Dopamine Agents|dopamine agents|mesh-ancestor
5725956|NCT03176966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5725957|NCT03176953|Topiramate|topiramate|mesh-list
5725958|NCT03176953|Anticonvulsants|anticonvulsants|mesh-ancestor
5725959|NCT03176953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5725960|NCT03176953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725961|NCT03177083|Interferons|interferons|mesh-list
5725962|NCT03177083|Interferon-beta|interferon-beta|mesh-list
5725963|NCT03177083|Interferon beta-1a|interferon beta-1a|mesh-list
5725964|NCT03177083|Interferon beta-1b|interferon beta-1b|mesh-list
5607988|NCT04650581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5607989|NCT04650581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5725965|NCT03177083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5725966|NCT03177083|Antiviral Agents|antiviral agents|mesh-ancestor
5725967|NCT03177083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5725968|NCT03177083|Immunologic Factors|immunologic factors|mesh-ancestor
5607990|NCT04650581|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5607991|NCT04650581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5607992|NCT04650581|Hormone Antagonists|hormone antagonists|mesh-ancestor
5607993|NCT04650581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5607994|NCT04650581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5607995|NCT04650087|Apixaban|apixaban|mesh-list
5607996|NCT04650087|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5607997|NCT04650087|Antithrombins|antithrombins|mesh-ancestor
5607998|NCT04650087|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5607999|NCT04650087|Protease Inhibitors|protease inhibitors|mesh-ancestor
5608000|NCT04650087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5608001|NCT04650087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5608002|NCT04650087|Anticoagulants|anticoagulants|mesh-ancestor
5608003|NCT04636086|Cholecalciferol|cholecalciferol|mesh-list
5608004|NCT04636086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5608005|NCT04636086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608006|NCT04636086|Vitamins|vitamins|mesh-ancestor
5608007|NCT04636086|Micronutrients|micronutrients|mesh-ancestor
5608008|NCT04636086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5608009|NCT04626791|Cytarabine|cytarabine|mesh-list
5608010|NCT04626791|Prednisone|prednisone|mesh-list
5608011|NCT04626791|Cortisone|cortisone|mesh-list
5608012|NCT04626791|Cyclophosphamide|cyclophosphamide|mesh-list
5608013|NCT04626791|Rituximab|rituximab|mesh-list
5608014|NCT04626791|Doxorubicin|doxorubicin|mesh-list
5608015|NCT04626791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5608016|NCT04626791|Bortezomib|bortezomib|mesh-list
5608017|NCT04626791|Acalabrutinib|acalabrutinib|mesh-list
5608018|NCT04626791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5608019|NCT04626791|Antibodies|antibodies|mesh-list
5608020|NCT04626791|Immunoglobulins|immunoglobulins|mesh-list
5608021|NCT04626791|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5608022|NCT04626791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5608023|NCT04626791|Immunologic Factors|immunologic factors|mesh-ancestor
5608024|NCT04626791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608025|NCT04626791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5608026|NCT04626791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5608027|NCT04626791|Alkylating Agents|alkylating agents|mesh-ancestor
5608028|NCT04626791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5608029|NCT04626791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5608030|NCT04626791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5608031|NCT04626791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5608032|NCT04626791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5608033|NCT04626791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5608034|NCT04626791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5608035|NCT04626791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5608036|NCT04626791|Glucocorticoids|glucocorticoids|mesh-ancestor
5608037|NCT04626791|Hormones|hormones|mesh-ancestor
5608038|NCT04626791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5608039|NCT04626791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5608040|NCT04626791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5608041|NCT04626791|Antimetabolites|antimetabolites|mesh-ancestor
5608042|NCT04626791|Antiviral Agents|antiviral agents|mesh-ancestor
5608043|NCT04626791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5608044|NCT04623099|Citalopram|citalopram|mesh-list
5608045|NCT04623099|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5608046|NCT04623099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5608047|NCT04623099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5608048|NCT04623099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5608049|NCT04623099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5608050|NCT04623099|Serotonin Agents|serotonin agents|mesh-ancestor
5608051|NCT04623099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608052|NCT04623099|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5608053|NCT04623099|Antidepressive Agents|antidepressive agents|mesh-ancestor
5608054|NCT04623099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5608055|NCT04622228|Carboplatin|carboplatin|mesh-list
5608056|NCT04622228|Etoposide|etoposide|mesh-list
5608057|NCT04622228|Atezolizumab|atezolizumab|mesh-list
5608058|NCT04622228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5608059|NCT04622228|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5608060|NCT04622228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5608061|NCT04622228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5608062|NCT04622228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5907680|NCT05231382|Antimetabolites|antimetabolites|mesh-ancestor
5608063|NCT04622228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5608064|NCT04609566|Pembrolizumab|pembrolizumab|mesh-list
5608065|NCT04609566|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5608066|NCT04609566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5608067|NCT04609566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5608068|NCT04579380|Trastuzumab|trastuzumab|mesh-list
5608069|NCT04579380|Fulvestrant|fulvestrant|mesh-list
5608070|NCT04579380|Tucatinib|tucatinib|mesh-list
5608071|NCT04579380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5608072|NCT04579380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5608073|NCT04579380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5608074|NCT04579380|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5608075|NCT04579380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5608076|NCT04579380|Hormone Antagonists|hormone antagonists|mesh-ancestor
5608077|NCT04579380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5608078|NCT04579380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608079|NCT04579380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5608080|NCT04579380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5608081|NCT04579380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5608082|NCT04563247|Antibodies|antibodies|mesh-list
5725969|NCT03177083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725970|NCT03177083|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5725971|NCT03176758|Anesthetics|anesthetics|mesh-list
5725972|NCT03176758|Anesthetics, General|anesthetics, general|mesh-list
5725973|NCT03176758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5725974|NCT03176758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725975|NCT03176693|Doxazosin|doxazosin|mesh-list
5725976|NCT03176693|Phenoxybenzamine|phenoxybenzamine|mesh-list
5725977|NCT03176693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5725978|NCT03176693|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5725979|NCT03176693|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5725980|NCT03176693|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5725981|NCT03176693|Adrenergic Agents|adrenergic agents|mesh-ancestor
5725982|NCT03176693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5725983|NCT03176693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5725984|NCT03176693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725985|NCT03176693|Vasodilator Agents|vasodilator agents|mesh-ancestor
5725986|NCT03177070|Methylene Blue|methylene blue|mesh-list
5725987|NCT03177070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5725988|NCT03177070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892560|NCT05002530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5608083|NCT04563247|Immunologic Factors|immunologic factors|mesh-ancestor
5608084|NCT04563247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608085|NCT04559529|Levetiracetam|levetiracetam|mesh-list
5608086|NCT04559529|Anticonvulsants|anticonvulsants|mesh-ancestor
5608087|NCT04559529|Nootropic Agents|nootropic agents|mesh-ancestor
5608088|NCT04552080|Amoxicillin|amoxicillin|mesh-list
5608089|NCT04552080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5608090|NCT04552080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5608091|NCT04551131|Dexamethasone|dexamethasone|mesh-list
5608092|NCT04551131|Etoposide|etoposide|mesh-list
5608093|NCT04551131|Etoposide phosphate|etoposide phosphate|mesh-list
5608094|NCT04551131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5608095|NCT04551131|Antiemetics|antiemetics|mesh-ancestor
5892561|NCT05002530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5892562|NCT05002530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5892563|NCT05002530|Keratolytic Agents|keratolytic agents|mesh-ancestor
5892564|NCT05002530|Dermatologic Agents|dermatologic agents|mesh-ancestor
5892565|NCT04940286|Gemcitabine|gemcitabine|mesh-list
5892566|NCT04940286|Paclitaxel|paclitaxel|mesh-list
5892567|NCT04940286|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5892568|NCT04940286|Durvalumab|durvalumab|mesh-list
5892569|NCT04940286|Immunoglobulins|immunoglobulins|mesh-list
5892570|NCT04940286|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5892571|NCT04940286|Immunoglobulin G|immunoglobulin g|mesh-list
5892572|NCT04940286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5892573|NCT04940286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5892574|NCT04940286|Tubulin Modulators|tubulin modulators|mesh-ancestor
6672643|NCT01557335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6672644|NCT01557335|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5608096|NCT04551131|Autonomic Agents|autonomic agents|mesh-ancestor
5608097|NCT04551131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5608098|NCT04551131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672645|NCT01557335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5608099|NCT04551131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5608100|NCT04551131|Glucocorticoids|glucocorticoids|mesh-ancestor
5892575|NCT04940286|Antimitotic Agents|antimitotic agents|mesh-ancestor
5892576|NCT04940286|Mitosis Modulators|mitosis modulators|mesh-ancestor
5608101|NCT04551131|Hormones|hormones|mesh-ancestor
5608102|NCT04551131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5608103|NCT04551131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5608104|NCT04551131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5608105|NCT04551131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5608106|NCT04551131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5608107|NCT04551131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5608108|NCT04551131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5608109|NCT04551131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5608110|NCT04544436|Methylprednisolone|methylprednisolone|mesh-list
5608111|NCT04544436|Ocrelizumab|ocrelizumab|mesh-list
5608112|NCT04544436|Histamine Antagonists|histamine antagonists|mesh-list
5608113|NCT04544436|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
5608114|NCT04544436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5608115|NCT04544436|Antiemetics|antiemetics|mesh-ancestor
5608116|NCT04544436|Autonomic Agents|autonomic agents|mesh-ancestor
5608117|NCT04544436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5608118|NCT04544436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608119|NCT04544436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5608120|NCT04544436|Glucocorticoids|glucocorticoids|mesh-ancestor
5608121|NCT04544436|Hormones|hormones|mesh-ancestor
5608122|NCT04544436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5608123|NCT04544436|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5608124|NCT04544436|Protective Agents|protective agents|mesh-ancestor
5608125|NCT04544436|Immunologic Factors|immunologic factors|mesh-ancestor
5608126|NCT04544436|Histamine Agents|histamine agents|mesh-ancestor
5608127|NCT04544436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5608128|NCT04544436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5608129|NCT04535401|Calcium, Dietary|calcium, dietary|mesh-list
5608130|NCT04535401|Leucovorin|leucovorin|mesh-list
5608131|NCT04535401|Folic Acid|folic acid|mesh-list
5608132|NCT04535401|Fluorouracil|fluorouracil|mesh-list
5608133|NCT04535401|Irinotecan|irinotecan|mesh-list
5608134|NCT04535401|Camptothecin|camptothecin|mesh-list
5608135|NCT04535401|Calcium|calcium|mesh-list
5608136|NCT04535401|Levoleucovorin|levoleucovorin|mesh-list
5608137|NCT04535401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5608138|NCT04535401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608139|NCT04535401|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5608140|NCT04535401|Antimetabolites|antimetabolites|mesh-ancestor
5608141|NCT04535401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5608142|NCT04535401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5608143|NCT04535401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5608144|NCT04535401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5608145|NCT04535401|Immunologic Factors|immunologic factors|mesh-ancestor
5608146|NCT04535401|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5608147|NCT04535401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5608148|NCT04535401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5608149|NCT04535401|Antidotes|antidotes|mesh-ancestor
5608150|NCT04535401|Protective Agents|protective agents|mesh-ancestor
5608151|NCT04535401|Vitamin B Complex|vitamin b complex|mesh-ancestor
5608152|NCT04535401|Vitamins|vitamins|mesh-ancestor
5608153|NCT04535401|Micronutrients|micronutrients|mesh-ancestor
5608154|NCT04535401|Hematinics|hematinics|mesh-ancestor
5608155|NCT04535401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5608156|NCT04524871|Bevacizumab|bevacizumab|mesh-list
5608157|NCT04524871|Atezolizumab|atezolizumab|mesh-list
5608158|NCT04524871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5608159|NCT04524871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5608160|NCT04524871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5608161|NCT04524871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5608162|NCT04524871|Growth Substances|growth substances|mesh-ancestor
5608163|NCT04524871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608164|NCT04524871|Growth Inhibitors|growth inhibitors|mesh-ancestor
5608165|NCT04514692|Lenograstim|lenograstim|mesh-list
5608166|NCT04514692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5608167|NCT04514692|Immunologic Factors|immunologic factors|mesh-ancestor
5608168|NCT04514692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608169|NCT04508855|Heparin|heparin|mesh-list
5608170|NCT04508855|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5608171|NCT04508855|Tinzaparin|tinzaparin|mesh-list
5608172|NCT04508855|Dalteparin|dalteparin|mesh-list
5608173|NCT04508855|Anticoagulants|anticoagulants|mesh-ancestor
5608174|NCT04508855|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5608175|NCT04508855|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5608176|NCT04508855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5608177|NCT04499950|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
5608178|NCT04499950|Naltrexone|naltrexone|mesh-list
5608179|NCT04499950|Bupropion|bupropion|mesh-list
5725989|NCT03176628|Niacinamide|niacinamide|mesh-list
5725990|NCT03176628|Vitamin B Complex|vitamin b complex|mesh-ancestor
5725991|NCT03176628|Vitamins|vitamins|mesh-ancestor
5725992|NCT03176628|Micronutrients|micronutrients|mesh-ancestor
5725993|NCT03176628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5725994|NCT03176524|Glucagon|glucagon|mesh-list
5725995|NCT03176524|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5725996|NCT03176524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5725997|NCT03176524|Hormones|hormones|mesh-ancestor
5725998|NCT03176524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5725999|NCT03176524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726000|NCT03176524|Incretins|incretins|mesh-ancestor
5726001|NCT03176264|Bevacizumab|bevacizumab|mesh-list
5726002|NCT03176264|Spartalizumab|spartalizumab|mesh-list
5726003|NCT03176264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5726004|NCT03176264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5726005|NCT03176264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5608180|NCT04499950|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5608181|NCT04499950|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5608182|NCT04499950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608183|NCT04499950|Sensory System Agents|sensory system agents|mesh-ancestor
5608184|NCT04499950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5608185|NCT04499950|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5608186|NCT04499950|Antidepressive Agents|antidepressive agents|mesh-ancestor
5608187|NCT04499950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5608188|NCT04499950|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5608189|NCT04499950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5608190|NCT04499950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5608191|NCT04499950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5608192|NCT04499950|Dopamine Agents|dopamine agents|mesh-ancestor
5608193|NCT04499950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5608194|NCT04499950|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5726006|NCT03176264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5726007|NCT03176264|Growth Substances|growth substances|mesh-ancestor
5726008|NCT03176264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726009|NCT03176264|Growth Inhibitors|growth inhibitors|mesh-ancestor
5726010|NCT03176264|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5726011|NCT03176264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726012|NCT03176563|Fosfomycin|fosfomycin|mesh-list
5726013|NCT03176563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5726014|NCT03176563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5726015|NCT03176316|Naloxone|naloxone|mesh-list
5726016|NCT03176316|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5726017|NCT03176316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726018|NCT03176316|Sensory System Agents|sensory system agents|mesh-ancestor
5726019|NCT03176316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5726020|NCT03176472|Ricolinostat|ricolinostat|mesh-list
5726021|NCT03176472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5726022|NCT03176472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5726023|NCT03176472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5726024|NCT03176472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726025|NCT03176446|Anesthetics|anesthetics|mesh-list
5726026|NCT03176446|Anesthetics, Local|anesthetics, local|mesh-list
5726027|NCT03176446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5726028|NCT03176446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726029|NCT03176446|Sensory System Agents|sensory system agents|mesh-ancestor
5726030|NCT03176446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5726031|NCT03176537|Testosterone|testosterone|mesh-list
5726032|NCT03176537|Androgens|androgens|mesh-ancestor
5726033|NCT03176537|Hormones|hormones|mesh-ancestor
5726034|NCT03176537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5726035|NCT03176537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726036|NCT03176212|Milk fat globule|milk fat globule|mesh-list
5726037|NCT03176212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5726038|NCT03176121|Oxycodone|oxycodone|mesh-list
5726039|NCT03176121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5726040|NCT03176121|Narcotics|narcotics|mesh-ancestor
6672646|NCT01557335|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6675618|NCT01576679|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5726041|NCT03176121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5608195|NCT04499950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5608196|NCT04499950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5608197|NCT04499950|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5608198|NCT04499924|Paclitaxel|paclitaxel|mesh-list
5608199|NCT04499924|Trastuzumab|trastuzumab|mesh-list
5608200|NCT04499924|Ramucirumab|ramucirumab|mesh-list
5608201|NCT04499924|Tucatinib|tucatinib|mesh-list
5608202|NCT04499924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5608203|NCT04499924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5608204|NCT04499924|Tubulin Modulators|tubulin modulators|mesh-ancestor
5608205|NCT04499924|Antimitotic Agents|antimitotic agents|mesh-ancestor
5608206|NCT04499924|Mitosis Modulators|mitosis modulators|mesh-ancestor
5608207|NCT04499924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5608208|NCT04499924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5608209|NCT04499924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5608210|NCT04499924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5608211|NCT04495621|Cetuximab|cetuximab|mesh-list
5608212|NCT04495621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5608213|NCT04495621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5608214|NCT04489732|Interferons|interferons|mesh-list
5608215|NCT04489732|Interferon-gamma|interferon-gamma|mesh-list
5608216|NCT04489732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5608217|NCT04489732|Antiviral Agents|antiviral agents|mesh-ancestor
5608218|NCT04489732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5608219|NCT04463394|Vasopressins|vasopressins|mesh-list
5608220|NCT04463394|Arginine Vasopressin|arginine vasopressin|mesh-list
5608221|NCT04463394|Hemostatics|hemostatics|mesh-ancestor
5608222|NCT04463394|Coagulants|coagulants|mesh-ancestor
5608223|NCT04463394|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5608224|NCT04463394|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5608225|NCT04463394|Natriuretic Agents|natriuretic agents|mesh-ancestor
5608226|NCT04463394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608227|NCT04454476|Trametinib|trametinib|mesh-list
5608228|NCT04454476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5608229|NCT04454476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5608230|NCT04454476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5608231|NCT04454476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5608232|NCT04454411|Naltrexone|naltrexone|mesh-list
5608233|NCT04454411|Buprenorphine|buprenorphine|mesh-list
5608234|NCT04454411|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5608235|NCT04454411|Narcotics|narcotics|mesh-ancestor
5608236|NCT04454411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5608237|NCT04454411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608238|NCT04454411|Analgesics|analgesics|mesh-ancestor
5608239|NCT04454411|Sensory System Agents|sensory system agents|mesh-ancestor
5608240|NCT04454411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5608241|NCT04454411|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5608242|NCT04454411|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5608243|NCT04447846|Cannabidiol|cannabidiol|mesh-list
5608244|NCT04447846|Anticonvulsants|anticonvulsants|mesh-ancestor
5608245|NCT04436133|Vaccines|vaccines|mesh-list
5608246|NCT04436133|Immunologic Factors|immunologic factors|mesh-ancestor
5608247|NCT04436133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691556|NCT03415906|Valsartan|valsartan|mesh-list
5691557|NCT03415906|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
5691558|NCT03415906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5691559|NCT03415906|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5691560|NCT03415906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691561|NCT03415828|Ethanol|ethanol|mesh-list
5691562|NCT03415828|Prednisolone|prednisolone|mesh-list
5691563|NCT03415828|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5691564|NCT03415828|Methylprednisolone|methylprednisolone|mesh-list
5691565|NCT03415828|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5691566|NCT03415828|Prednisolone acetate|prednisolone acetate|mesh-list
5691567|NCT03415828|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5691568|NCT03415828|Prednisolone phosphate|prednisolone phosphate|mesh-list
5691569|NCT03415828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5691570|NCT03415828|Glucocorticoids|glucocorticoids|mesh-ancestor
5691571|NCT03415828|Hormones|hormones|mesh-ancestor
5691572|NCT03415828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5691573|NCT03415828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691574|NCT03415828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5691575|NCT03415828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5691576|NCT03415828|Antiemetics|antiemetics|mesh-ancestor
5691577|NCT03415828|Autonomic Agents|autonomic agents|mesh-ancestor
5691578|NCT03415828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5691579|NCT03415828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5691580|NCT03415828|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5608248|NCT04424602|Cyclophosphamide|cyclophosphamide|mesh-list
5608249|NCT04424602|Dimethoate|dimethoate|mesh-list
5608250|NCT04424602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5608251|NCT04424602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5608252|NCT04424602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5608253|NCT04424602|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5608254|NCT04424602|Cholinergic Agents|cholinergic agents|mesh-ancestor
5608255|NCT04424602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5608256|NCT04424602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608257|NCT04424602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5608258|NCT04424602|Immunologic Factors|immunologic factors|mesh-ancestor
5608259|NCT04424602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5608260|NCT04424602|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5608261|NCT04424602|Alkylating Agents|alkylating agents|mesh-ancestor
5608262|NCT04424602|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5608263|NCT04398706|Vaccines|vaccines|mesh-list
5608264|NCT04398706|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5608265|NCT04398706|Immunoglobulins|immunoglobulins|mesh-list
5608266|NCT04398706|Immunologic Factors|immunologic factors|mesh-ancestor
5608267|NCT04398706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608268|NCT04398329|Bupivacaine|bupivacaine|mesh-list
5608269|NCT04398329|Anesthetics, Local|anesthetics, local|mesh-ancestor
5608270|NCT04398329|Anesthetics|anesthetics|mesh-ancestor
5608271|NCT04398329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5608272|NCT04398329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608273|NCT04398329|Sensory System Agents|sensory system agents|mesh-ancestor
5608274|NCT04398329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5608275|NCT04391855|Dexmedetomidine|dexmedetomidine|mesh-list
5726042|NCT03176121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726043|NCT03176121|Analgesics|analgesics|mesh-ancestor
5726044|NCT03176121|Sensory System Agents|sensory system agents|mesh-ancestor
5726045|NCT03176121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5726046|NCT03176199|Oxycodone|oxycodone|mesh-list
5726047|NCT03176199|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5726048|NCT03176199|Narcotics|narcotics|mesh-ancestor
5726049|NCT03176199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5726050|NCT03176199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726051|NCT03176199|Analgesics|analgesics|mesh-ancestor
5726052|NCT03176199|Sensory System Agents|sensory system agents|mesh-ancestor
5726053|NCT03176199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5726054|NCT03176186|Xenon|xenon|mesh-list
5726055|NCT03176186|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5726056|NCT03176186|Anesthetics, General|anesthetics, general|mesh-ancestor
6672647|NCT01557374|Abatacept|abatacept|mesh-list
6672648|NCT01557374|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6672649|NCT01557374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672650|NCT01557374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6672651|NCT01557374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6672652|NCT01557374|Immunologic Factors|immunologic factors|mesh-ancestor
6672653|NCT01557374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672654|NCT01557374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6672655|NCT01557439|Levocetirizine|levocetirizine|mesh-list
6672656|NCT01557439|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6672657|NCT01557439|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5726057|NCT03176186|Anesthetics|anesthetics|mesh-ancestor
5726058|NCT03176186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5726059|NCT03176186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726060|NCT03175978|Methotrexate|methotrexate|mesh-list
5726061|NCT03175978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726062|NCT03175978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5726063|NCT03175978|Abortifacient Agents|abortifacient agents|mesh-ancestor
5726064|NCT03175978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5726065|NCT03175978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5726066|NCT03175978|Antimetabolites|antimetabolites|mesh-ancestor
5726067|NCT03175978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726068|NCT03175978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5726069|NCT03175978|Dermatologic Agents|dermatologic agents|mesh-ancestor
5726070|NCT03175978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5726071|NCT03175978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5726072|NCT03175978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5726073|NCT03175978|Immunologic Factors|immunologic factors|mesh-ancestor
5726074|NCT03175978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6675619|NCT01576679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5608276|NCT04391855|Tramadol|tramadol|mesh-list
5608277|NCT04391855|Ropivacaine|ropivacaine|mesh-list
5726075|NCT03175978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5608278|NCT04391855|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5608279|NCT04391855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5608280|NCT04391855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608281|NCT04391855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5608282|NCT04391855|Analgesics|analgesics|mesh-ancestor
5608283|NCT04391855|Sensory System Agents|sensory system agents|mesh-ancestor
5608284|NCT04391855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5608285|NCT04391855|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5608286|NCT04391855|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5608287|NCT04391855|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5608288|NCT04391855|Adrenergic Agents|adrenergic agents|mesh-ancestor
5726076|NCT03175939|Fluorouracil|fluorouracil|mesh-list
5726077|NCT03175939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5726078|NCT03175939|Antimetabolites|antimetabolites|mesh-ancestor
5726079|NCT03175939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726080|NCT03175939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5726081|NCT03175939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5726082|NCT03175939|Immunologic Factors|immunologic factors|mesh-ancestor
5726083|NCT03175939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726084|NCT03175926|Budesonide|budesonide|mesh-list
5726085|NCT03175926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5726086|NCT03175926|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5726087|NCT03175926|Autonomic Agents|autonomic agents|mesh-ancestor
5726088|NCT03175926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5726089|NCT03175926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726090|NCT03175926|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5726091|NCT03175926|Respiratory System Agents|respiratory system agents|mesh-ancestor
5726092|NCT03175926|Glucocorticoids|glucocorticoids|mesh-ancestor
5726093|NCT03175926|Hormones|hormones|mesh-ancestor
5726094|NCT03175926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5726095|NCT03175679|Interleukin-2|interleukin-2|mesh-list
5726096|NCT03175679|Tegafur|tegafur|mesh-list
5726097|NCT03175679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5726098|NCT03175679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5726099|NCT03175679|Analgesics|analgesics|mesh-ancestor
5726100|NCT03175679|Sensory System Agents|sensory system agents|mesh-ancestor
5726101|NCT03175679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5726102|NCT03175679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726103|NCT03175679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5726104|NCT03175679|Antimetabolites|antimetabolites|mesh-ancestor
5726105|NCT03175679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726106|NCT03175666|Leucovorin|leucovorin|mesh-list
5726107|NCT03175666|Paclitaxel|paclitaxel|mesh-list
5726108|NCT03175666|Cyclophosphamide|cyclophosphamide|mesh-list
5726109|NCT03175666|Bevacizumab|bevacizumab|mesh-list
5726110|NCT03175666|Fluorouracil|fluorouracil|mesh-list
5726111|NCT03175666|Capecitabine|capecitabine|mesh-list
5726112|NCT03175666|Avelumab|avelumab|mesh-list
5726113|NCT03175666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5726114|NCT03175666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5726115|NCT03175666|Tubulin Modulators|tubulin modulators|mesh-ancestor
5726116|NCT03175666|Antimitotic Agents|antimitotic agents|mesh-ancestor
5726117|NCT03175666|Mitosis Modulators|mitosis modulators|mesh-ancestor
5726118|NCT03175666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726119|NCT03175666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5726120|NCT03175666|Immunologic Factors|immunologic factors|mesh-ancestor
5726121|NCT03175666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726122|NCT03175666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5726123|NCT03175666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5726124|NCT03175666|Alkylating Agents|alkylating agents|mesh-ancestor
5726125|NCT03175666|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5726126|NCT03175666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5726127|NCT03175666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5726128|NCT03175666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5726129|NCT03175666|Growth Substances|growth substances|mesh-ancestor
5726130|NCT03175666|Growth Inhibitors|growth inhibitors|mesh-ancestor
5726131|NCT03175666|Antimetabolites|antimetabolites|mesh-ancestor
5726132|NCT03175666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5726133|NCT03175666|Antidotes|antidotes|mesh-ancestor
5726134|NCT03175666|Protective Agents|protective agents|mesh-ancestor
5726135|NCT03175666|Vitamin B Complex|vitamin b complex|mesh-ancestor
5726136|NCT03175666|Vitamins|vitamins|mesh-ancestor
5726137|NCT03175666|Micronutrients|micronutrients|mesh-ancestor
5726138|NCT03175705|Interleukin-2|interleukin-2|mesh-list
5726139|NCT03175705|Tegafur|tegafur|mesh-list
5726140|NCT03175705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5608289|NCT04391855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5608290|NCT04391855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5608291|NCT04391855|Anesthetics, Local|anesthetics, local|mesh-ancestor
5608292|NCT04391855|Anesthetics|anesthetics|mesh-ancestor
5608293|NCT04391855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5608294|NCT04391855|Narcotics|narcotics|mesh-ancestor
5608295|NCT04385277|Vitamin A|vitamin a|mesh-list
5608296|NCT04385277|Irinotecan|irinotecan|mesh-list
5608297|NCT04385277|Temozolomide|temozolomide|mesh-list
5608298|NCT04385277|Tretinoin|tretinoin|mesh-list
5608299|NCT04385277|Dinutuximab|dinutuximab|mesh-list
5608300|NCT04385277|Isotretinoin|isotretinoin|mesh-list
5608301|NCT04385277|Sargramostim|sargramostim|mesh-list
5608302|NCT04385277|Vitamins|vitamins|mesh-ancestor
5608303|NCT04385277|Micronutrients|micronutrients|mesh-ancestor
5608304|NCT04385277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608305|NCT04385277|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5608306|NCT04385277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5608307|NCT04385277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5608308|NCT04385277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5608309|NCT04385277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5608310|NCT04385277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5608311|NCT04385277|Alkylating Agents|alkylating agents|mesh-ancestor
5608312|NCT04385277|Immunologic Factors|immunologic factors|mesh-ancestor
5608313|NCT04385277|Keratolytic Agents|keratolytic agents|mesh-ancestor
5608314|NCT04385277|Dermatologic Agents|dermatologic agents|mesh-ancestor
5608315|NCT04381897|Acetylcysteine|acetylcysteine|mesh-list
5608316|NCT04381897|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5608317|NCT04381897|Antiviral Agents|antiviral agents|mesh-ancestor
5608318|NCT04381897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5608319|NCT04381897|Expectorants|expectorants|mesh-ancestor
5608320|NCT04381897|Respiratory System Agents|respiratory system agents|mesh-ancestor
5608321|NCT04381897|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5608322|NCT04381897|Antioxidants|antioxidants|mesh-ancestor
5608323|NCT04381897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5608324|NCT04381897|Protective Agents|protective agents|mesh-ancestor
5608325|NCT04381897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608326|NCT04381897|Antidotes|antidotes|mesh-ancestor
5608327|NCT04371380|Rilpivirine|rilpivirine|mesh-list
5608328|NCT04371380|Cabotegravir|cabotegravir|mesh-list
5608329|NCT04371380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5608330|NCT04371380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5608331|NCT04371380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5608332|NCT04371380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726141|NCT03175705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5726142|NCT03175705|Analgesics|analgesics|mesh-ancestor
5726143|NCT03175705|Sensory System Agents|sensory system agents|mesh-ancestor
5726144|NCT03175705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5726145|NCT03175705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726146|NCT03175705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5726147|NCT03175705|Antimetabolites|antimetabolites|mesh-ancestor
5726148|NCT03175705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726149|NCT03175835|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5726150|NCT03175835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5726151|NCT03175835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5726152|NCT03175835|Antimetabolites|antimetabolites|mesh-ancestor
5726153|NCT03175835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726154|NCT03175835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5726155|NCT03175835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5726156|NCT03175835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5608333|NCT04371380|Antiviral Agents|antiviral agents|mesh-ancestor
5608334|NCT04371380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5608335|NCT04371380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5608336|NCT04371380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5608337|NCT04371380|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5608338|NCT04371380|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5608339|NCT04353661|Azithromycin|azithromycin|mesh-list
5608340|NCT04353661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5608341|NCT04353661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5608342|NCT04333576|Contraceptive Agents|contraceptive agents|mesh-list
5608343|NCT04333576|Contraceptives, Oral|contraceptives, oral|mesh-list
5608344|NCT04333576|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
5726157|NCT03175653|Oxycodone|oxycodone|mesh-list
5726158|NCT03175653|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5608345|NCT04333576|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5608346|NCT04333576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608347|NCT04333576|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5608348|NCT04323046|Nivolumab|nivolumab|mesh-list
5608349|NCT04323046|Ipilimumab|ipilimumab|mesh-list
5608350|NCT04323046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5608351|NCT04323046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5608352|NCT04323046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5608353|NCT04323046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5608354|NCT04322318|Cyclophosphamide|cyclophosphamide|mesh-list
5608355|NCT04322318|Ifosfamide|ifosfamide|mesh-list
5608356|NCT04322318|Isophosphamide mustard|isophosphamide mustard|mesh-list
5608357|NCT04322318|Carboplatin|carboplatin|mesh-list
5608358|NCT04322318|Doxorubicin|doxorubicin|mesh-list
5608359|NCT04322318|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5608360|NCT04322318|Irinotecan|irinotecan|mesh-list
5608361|NCT04322318|Etoposide|etoposide|mesh-list
5608362|NCT04322318|Vincristine|vincristine|mesh-list
5608363|NCT04322318|Etoposide phosphate|etoposide phosphate|mesh-list
5608364|NCT04322318|Topotecan|topotecan|mesh-list
5608365|NCT04322318|Daunorubicin|daunorubicin|mesh-list
5608366|NCT04322318|Podophyllotoxin|podophyllotoxin|mesh-list
5608367|NCT04322318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5608368|NCT04322318|Immunologic Factors|immunologic factors|mesh-ancestor
5608369|NCT04322318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608370|NCT04322318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5608371|NCT04322318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5608372|NCT04322318|Alkylating Agents|alkylating agents|mesh-ancestor
5608373|NCT04322318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5608374|NCT04322318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5608375|NCT04322318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5608376|NCT04322318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5608377|NCT04322318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5608378|NCT04322318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5608379|NCT04322318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5608380|NCT04322318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5608381|NCT04322318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5608382|NCT04322318|Tubulin Modulators|tubulin modulators|mesh-ancestor
5608383|NCT04322318|Antimitotic Agents|antimitotic agents|mesh-ancestor
5608384|NCT04322318|Mitosis Modulators|mitosis modulators|mesh-ancestor
5608385|NCT04322318|Keratolytic Agents|keratolytic agents|mesh-ancestor
5608386|NCT04322318|Dermatologic Agents|dermatologic agents|mesh-ancestor
5608387|NCT04297618|Lifitegrast|lifitegrast|mesh-list
5608388|NCT04297618|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5608389|NCT04297618|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5608390|NCT04266665|Dexmedetomidine|dexmedetomidine|mesh-list
5608391|NCT04266665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5608392|NCT04266665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5608393|NCT04266665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608394|NCT04266665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5608395|NCT04266665|Analgesics|analgesics|mesh-ancestor
5608396|NCT04266665|Sensory System Agents|sensory system agents|mesh-ancestor
5608397|NCT04266665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5608398|NCT04266665|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5608399|NCT04266665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5608400|NCT04266665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5608401|NCT04266665|Adrenergic Agents|adrenergic agents|mesh-ancestor
5608402|NCT04266665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5608403|NCT04266665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5608404|NCT04259749|Menthol|menthol|mesh-list
5608405|NCT04259749|Antipruritics|antipruritics|mesh-ancestor
5608406|NCT04259749|Dermatologic Agents|dermatologic agents|mesh-ancestor
5608407|NCT04250636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5608408|NCT04250636|Antibodies|antibodies|mesh-list
5608409|NCT04250636|Immunoglobulins|immunoglobulins|mesh-list
5608410|NCT04250636|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5608411|NCT04250636|Immunologic Factors|immunologic factors|mesh-ancestor
5608412|NCT04250636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608413|NCT04250636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5608414|NCT04246996|Gentamicins|gentamicins|mesh-list
5608415|NCT04246996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5608416|NCT04246996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5608417|NCT04246996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5608418|NCT04246996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5608419|NCT04246996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5608420|NCT04245748|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5608421|NCT04245748|Citalopram|citalopram|mesh-list
5608422|NCT04245748|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5608423|NCT04245748|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5608424|NCT04245748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5608425|NCT04245748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5608426|NCT04245748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5608427|NCT04245748|Serotonin Agents|serotonin agents|mesh-ancestor
5608428|NCT04245748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608429|NCT04245748|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5608430|NCT04245748|Antidepressive Agents|antidepressive agents|mesh-ancestor
5608431|NCT04245748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5608432|NCT04245748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5608433|NCT04245748|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5608434|NCT04245748|Analgesics|analgesics|mesh-ancestor
5608435|NCT04245748|Sensory System Agents|sensory system agents|mesh-ancestor
5608436|NCT04245748|Dopamine Agents|dopamine agents|mesh-ancestor
5608437|NCT04245436|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5608438|NCT04245436|Citalopram|citalopram|mesh-list
5608439|NCT04245436|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5608440|NCT04245436|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5608441|NCT04245436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5608442|NCT04245436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5608443|NCT04245436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5608444|NCT04245436|Serotonin Agents|serotonin agents|mesh-ancestor
5608445|NCT04245436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608446|NCT04245436|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5608447|NCT04245436|Antidepressive Agents|antidepressive agents|mesh-ancestor
5608448|NCT04245436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5608449|NCT04245436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5608450|NCT04245436|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5608451|NCT04245436|Analgesics|analgesics|mesh-ancestor
5608452|NCT04245436|Sensory System Agents|sensory system agents|mesh-ancestor
5608453|NCT04245436|Dopamine Agents|dopamine agents|mesh-ancestor
5608454|NCT04224766|Bupivacaine|bupivacaine|mesh-list
5608455|NCT04224766|Anesthetics, Local|anesthetics, local|mesh-ancestor
5608456|NCT04224766|Anesthetics|anesthetics|mesh-ancestor
5608457|NCT04224766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5608458|NCT04224766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608459|NCT04224766|Sensory System Agents|sensory system agents|mesh-ancestor
5608460|NCT04224766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5608461|NCT04221997|Sertraline|sertraline|mesh-list
5608462|NCT04221997|Antidepressive Agents|antidepressive agents|mesh-ancestor
5608463|NCT04221997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5608464|NCT04221997|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5608465|NCT04221997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5608466|NCT04221997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5608467|NCT04221997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5608468|NCT04221997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5608469|NCT04221997|Serotonin Agents|serotonin agents|mesh-ancestor
5608470|NCT04221997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608471|NCT04195399|Imidazole|imidazole|mesh-list
5608472|NCT04195399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5608473|NCT04195399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5608474|NCT04190550|Cytarabine|cytarabine|mesh-list
5608475|NCT04190550|Idarubicin|idarubicin|mesh-list
5608476|NCT04190550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5608477|NCT04190550|Antimetabolites|antimetabolites|mesh-ancestor
5608478|NCT04190550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5608479|NCT04190550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5608480|NCT04190550|Antiviral Agents|antiviral agents|mesh-ancestor
5608481|NCT04190550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5608482|NCT04190550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5608483|NCT04190550|Immunologic Factors|immunologic factors|mesh-ancestor
5608484|NCT04190550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608485|NCT04190550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5608486|NCT04190550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5608487|NCT04190550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5608488|NCT04190550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5608489|NCT04161989|Progesterone|progesterone|mesh-list
5608490|NCT04161989|Progestins|progestins|mesh-ancestor
5608491|NCT04161989|Hormones|hormones|mesh-ancestor
5608492|NCT04161989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5608493|NCT04161989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608494|NCT04157335|Benralizumab|benralizumab|mesh-list
5608495|NCT04157335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5608496|NCT04157335|Respiratory System Agents|respiratory system agents|mesh-ancestor
5608497|NCT04137120|Aflibercept|aflibercept|mesh-list
5608498|NCT04137120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5608499|NCT04137120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5608500|NCT04137120|Growth Substances|growth substances|mesh-ancestor
5608501|NCT04137120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608502|NCT04137120|Growth Inhibitors|growth inhibitors|mesh-ancestor
5608503|NCT04137120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5608504|NCT04130828|Ferrous fumarate|ferrous fumarate|mesh-list
5608505|NCT04130828|Trace Elements|trace elements|mesh-ancestor
5608506|NCT04130828|Micronutrients|micronutrients|mesh-ancestor
5726159|NCT03175653|Narcotics|narcotics|mesh-ancestor
5726160|NCT03175653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5726161|NCT03175653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726162|NCT03175653|Analgesics|analgesics|mesh-ancestor
5726163|NCT03175653|Sensory System Agents|sensory system agents|mesh-ancestor
5726164|NCT03175653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5726165|NCT03175341|Ascorbic Acid|ascorbic acid|mesh-list
5726166|NCT03175341|Vitamins|vitamins|mesh-ancestor
5726167|NCT03175341|Micronutrients|micronutrients|mesh-ancestor
5726168|NCT03175341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726169|NCT03175341|Antioxidants|antioxidants|mesh-ancestor
5726170|NCT03175341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726171|NCT03175341|Protective Agents|protective agents|mesh-ancestor
5726172|NCT03175549|Apremilast|apremilast|mesh-list
5726173|NCT03175549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5726174|NCT03175549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5726175|NCT03175549|Analgesics|analgesics|mesh-ancestor
5726176|NCT03175549|Sensory System Agents|sensory system agents|mesh-ancestor
5726177|NCT03175549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5726178|NCT03175549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726179|NCT03175549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5726180|NCT03175549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5726181|NCT03175549|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5726182|NCT03175549|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5726183|NCT03175549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5726184|NCT03175549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726185|NCT03175380|BCG Vaccine|bcg vaccine|mesh-list
5726186|NCT03175380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5726187|NCT03175380|Immunologic Factors|immunologic factors|mesh-ancestor
5726188|NCT03175380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726189|NCT03175081|Ropivacaine|ropivacaine|mesh-list
5726190|NCT03175081|Anesthetics, Local|anesthetics, local|mesh-ancestor
5726191|NCT03175081|Anesthetics|anesthetics|mesh-ancestor
5726192|NCT03175081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5726193|NCT03175081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726194|NCT03175081|Sensory System Agents|sensory system agents|mesh-ancestor
5726195|NCT03175081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5726196|NCT03174977|Raltegravir Potassium|raltegravir potassium|mesh-list
5726197|NCT03174977|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5726198|NCT03174977|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5726199|NCT03174977|Antiviral Agents|antiviral agents|mesh-ancestor
5726200|NCT03174977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5726201|NCT03174977|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5726202|NCT03174977|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5726203|NCT03174977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5726204|NCT03174977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726205|NCT03175016|Irinotecan|irinotecan|mesh-list
5608507|NCT04130828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608512|NCT04123366|Pembrolizumab|pembrolizumab|mesh-list
5608513|NCT04123366|Olaparib|olaparib|mesh-list
5608514|NCT04123366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5608515|NCT04123366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5608516|NCT04123366|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5726206|NCT03175016|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5726207|NCT03175016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5726208|NCT03175016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5726209|NCT03175016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726210|NCT03175016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5892577|NCT04940286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892578|NCT04940286|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5608517|NCT04123366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5892579|NCT04940286|Antimetabolites|antimetabolites|mesh-ancestor
5608518|NCT04123366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5608519|NCT04115956|Dexamethasone|dexamethasone|mesh-list
5608520|NCT04115956|Melphalan|melphalan|mesh-list
5608521|NCT04115956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5608522|NCT04115956|Antiemetics|antiemetics|mesh-ancestor
5608523|NCT04115956|Autonomic Agents|autonomic agents|mesh-ancestor
5608524|NCT04115956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5726211|NCT03174938|Flutemetamol|flutemetamol|mesh-list
5726212|NCT03174938|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5726213|NCT03174938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726214|NCT03174860|Diclofenac|diclofenac|mesh-list
5726215|NCT03174860|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5726216|NCT03174860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5726217|NCT03174860|Analgesics|analgesics|mesh-ancestor
5726218|NCT03174860|Sensory System Agents|sensory system agents|mesh-ancestor
5726219|NCT03174860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5726220|NCT03174860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726221|NCT03174860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5726222|NCT03174860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5726223|NCT03174860|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5726224|NCT03174860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5726225|NCT03174860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726226|NCT03174847|Eplerenone|eplerenone|mesh-list
5726227|NCT03174847|Amiloride|amiloride|mesh-list
5726228|NCT03174847|Spironolactone|spironolactone|mesh-list
5726229|NCT03174847|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
5726230|NCT03174847|Mineralocorticoids|mineralocorticoids|mesh-list
5608525|NCT04115956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608526|NCT04115956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5608527|NCT04115956|Glucocorticoids|glucocorticoids|mesh-ancestor
5608528|NCT04115956|Hormones|hormones|mesh-ancestor
5608529|NCT04115956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5608530|NCT04115956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5608531|NCT04115956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5608532|NCT04115956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5608533|NCT04115956|Alkylating Agents|alkylating agents|mesh-ancestor
5608534|NCT04115956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726231|NCT03174847|Hormone Antagonists|hormone antagonists|mesh-ancestor
5726232|NCT03174847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5726233|NCT03174847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726234|NCT03174847|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5726235|NCT03174847|Diuretics|diuretics|mesh-ancestor
5726236|NCT03174847|Natriuretic Agents|natriuretic agents|mesh-ancestor
5726237|NCT03174847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5726238|NCT03174847|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
5726239|NCT03174847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5726240|NCT03174847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5608535|NCT04115956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5608536|NCT04115956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5608537|NCT04115956|Immunologic Factors|immunologic factors|mesh-ancestor
6208044|NCT02123849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6208045|NCT02123849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6208046|NCT02123849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5726241|NCT03174847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726242|NCT03174847|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
5726243|NCT03174847|Hormones|hormones|mesh-ancestor
5726244|NCT03175432|Bevacizumab|bevacizumab|mesh-list
5726245|NCT03175432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5726246|NCT03175432|Atezolizumab|atezolizumab|mesh-list
5726247|NCT03175432|Endothelial Growth Factors|endothelial growth factors|mesh-list
5726248|NCT03175432|Antibodies|antibodies|mesh-list
6208047|NCT02123849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6208048|NCT02123849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208049|NCT02123849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5608545|NCT03881059|Ustekinumab|ustekinumab|mesh-list
5608546|NCT03881059|BMS-986165|bms-986165|mesh-list
5608547|NCT03881059|Dermatologic Agents|dermatologic agents|mesh-ancestor
5608548|NCT03881059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5608549|NCT03881059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5726249|NCT03175432|Immunoglobulins|immunoglobulins|mesh-list
5726250|NCT03175432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5608550|NCT03881059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726251|NCT03175432|Immunoglobulin G|immunoglobulin g|mesh-list
5608551|NCT03847649|Prednisone|prednisone|mesh-list
5608552|NCT03847649|Durvalumab|durvalumab|mesh-list
5608553|NCT03847649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5608554|NCT03847649|Glucocorticoids|glucocorticoids|mesh-ancestor
5608555|NCT03847649|Hormones|hormones|mesh-ancestor
5608556|NCT03847649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5608557|NCT03847649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608558|NCT03847649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5608559|NCT03847649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5608560|NCT03847649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5608561|NCT03840967|Niraparib|niraparib|mesh-list
5608562|NCT03840967|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5608563|NCT03840967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5608564|NCT03840967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5608565|NCT03840967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5608566|NCT03837860|Oxycodone|oxycodone|mesh-list
5726252|NCT03175432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5726253|NCT03175432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5726254|NCT03175432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5726255|NCT03175432|Growth Substances|growth substances|mesh-ancestor
5726256|NCT03175432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726257|NCT03175432|Growth Inhibitors|growth inhibitors|mesh-ancestor
5726258|NCT03175432|Immunologic Factors|immunologic factors|mesh-ancestor
5726259|NCT03174821|Insulin|insulin|mesh-list
5726260|NCT03174821|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5726261|NCT03174821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5726262|NCT03174821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726263|NCT03174795|Meropenem|meropenem|mesh-list
5726264|NCT03174795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5726265|NCT03174795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5726266|NCT03174548|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
5726267|NCT03174548|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5726268|NCT03174548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726269|NCT03174548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5726270|NCT03174548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726271|NCT03174561|Choline|choline|mesh-list
5726272|NCT03174561|Silymarin|silymarin|mesh-list
5726273|NCT03174561|Lipotropic Agents|lipotropic agents|mesh-ancestor
5726274|NCT03174561|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5726275|NCT03174561|Antimetabolites|antimetabolites|mesh-ancestor
5726276|NCT03174561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726277|NCT03174561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5726278|NCT03174561|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5726279|NCT03174561|Nootropic Agents|nootropic agents|mesh-ancestor
5726280|NCT03174561|Antioxidants|antioxidants|mesh-ancestor
5726281|NCT03174561|Protective Agents|protective agents|mesh-ancestor
5726282|NCT03174561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726283|NCT03174782|Bupivacaine|bupivacaine|mesh-list
5726284|NCT03174782|Anesthetics, Local|anesthetics, local|mesh-ancestor
5726285|NCT03174782|Anesthetics|anesthetics|mesh-ancestor
5726286|NCT03174782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5726287|NCT03174782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726288|NCT03174782|Sensory System Agents|sensory system agents|mesh-ancestor
5726289|NCT03174782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5726290|NCT03174756|Chlorhexidine|chlorhexidine|mesh-list
5726291|NCT03174756|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5726292|NCT03174756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5726293|NCT03174756|Disinfectants|disinfectants|mesh-ancestor
5726294|NCT03174483|Fluticasone|fluticasone|mesh-list
5726295|NCT03174483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5726296|NCT03174483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5726297|NCT03174483|Autonomic Agents|autonomic agents|mesh-ancestor
5726298|NCT03174483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5726299|NCT03174483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608567|NCT03837860|Risperidone|risperidone|mesh-list
5608568|NCT03837860|Ziprasidone|ziprasidone|mesh-list
5608569|NCT03837860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5608570|NCT03837860|Narcotics|narcotics|mesh-ancestor
5608571|NCT03837860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5608572|NCT03837860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608573|NCT03837860|Analgesics|analgesics|mesh-ancestor
5608574|NCT03837860|Sensory System Agents|sensory system agents|mesh-ancestor
5726300|NCT03174483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5726301|NCT03174483|Respiratory System Agents|respiratory system agents|mesh-ancestor
5608575|NCT03837860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5608576|NCT03837860|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5608577|NCT03837860|Serotonin Agents|serotonin agents|mesh-ancestor
5608578|NCT03837860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5608579|NCT03837860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5608580|NCT03837860|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5608581|NCT03837860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5608582|NCT03837860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5608583|NCT03837860|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5608584|NCT03837860|Dopamine Agents|dopamine agents|mesh-ancestor
5608585|NCT03817853|Prednisone|prednisone|mesh-list
5608586|NCT03817853|Methylprednisolone|methylprednisolone|mesh-list
5608587|NCT03817853|Prednisolone|prednisolone|mesh-list
5608588|NCT03817853|Cyclophosphamide|cyclophosphamide|mesh-list
5608589|NCT03817853|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5608590|NCT03817853|Doxorubicin|doxorubicin|mesh-list
5608591|NCT03817853|Vincristine|vincristine|mesh-list
5608592|NCT03817853|Obinutuzumab|obinutuzumab|mesh-list
5608593|NCT03817853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5608594|NCT03817853|Immunologic Factors|immunologic factors|mesh-ancestor
5608595|NCT03817853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608596|NCT03817853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5726302|NCT03174483|Dermatologic Agents|dermatologic agents|mesh-ancestor
5726303|NCT03174483|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5726304|NCT03174457|Micafungin|micafungin|mesh-list
5726305|NCT03174457|Antifungal Agents|antifungal agents|mesh-ancestor
5726306|NCT03174457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5726307|NCT03174678|Dexmedetomidine|dexmedetomidine|mesh-list
5726308|NCT03174678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5726309|NCT03174678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5726310|NCT03174678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726311|NCT03174678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5726312|NCT03174678|Analgesics|analgesics|mesh-ancestor
5726313|NCT03174678|Sensory System Agents|sensory system agents|mesh-ancestor
5726314|NCT03174678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5726315|NCT03174678|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5726316|NCT03174678|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5726317|NCT03174678|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5726318|NCT03174678|Adrenergic Agents|adrenergic agents|mesh-ancestor
5726319|NCT03174678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5726320|NCT03174678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726321|NCT03174171|Everolimus|everolimus|mesh-list
5726322|NCT03174171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5726323|NCT03174171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5726324|NCT03174171|Immunologic Factors|immunologic factors|mesh-ancestor
5726325|NCT03174171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726326|NCT03174080|Fluorides|fluorides|mesh-list
5726327|NCT03174080|Cariostatic Agents|cariostatic agents|mesh-ancestor
5726328|NCT03174080|Protective Agents|protective agents|mesh-ancestor
5726329|NCT03174080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726330|NCT03174236|Metronidazole|metronidazole|mesh-list
5726331|NCT03174236|Gentamicins|gentamicins|mesh-list
5726332|NCT03174236|Ceftriaxone|ceftriaxone|mesh-list
5726333|NCT03174236|Penicillins|penicillins|mesh-list
5726334|NCT03174236|Penicillin G|penicillin g|mesh-list
5726335|NCT03174236|Penicillin G Benzathine|penicillin g benzathine|mesh-list
5726336|NCT03174236|Penicillin G Procaine|penicillin g procaine|mesh-list
5726337|NCT03174236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5726338|NCT03174236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5726339|NCT03174236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5726340|NCT03174236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5726341|NCT03174236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5608597|NCT03817853|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5608598|NCT03817853|Alkylating Agents|alkylating agents|mesh-ancestor
5608599|NCT03817853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5608600|NCT03817853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5608601|NCT03817853|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5608602|NCT03817853|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5608603|NCT03817853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5608604|NCT03817853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5608605|NCT03817853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5608606|NCT03817853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5608607|NCT03817853|Glucocorticoids|glucocorticoids|mesh-ancestor
5608608|NCT03817853|Hormones|hormones|mesh-ancestor
5608609|NCT03817853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5608610|NCT03817853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5726342|NCT03174236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5892580|NCT04940286|Antiviral Agents|antiviral agents|mesh-ancestor
5608611|NCT03817853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5608612|NCT03817853|Tubulin Modulators|tubulin modulators|mesh-ancestor
5608613|NCT03817853|Antimitotic Agents|antimitotic agents|mesh-ancestor
5608614|NCT03817853|Mitosis Modulators|mitosis modulators|mesh-ancestor
5608615|NCT03817853|Antiemetics|antiemetics|mesh-ancestor
5608616|NCT03817853|Autonomic Agents|autonomic agents|mesh-ancestor
5608617|NCT03817853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5608618|NCT03817853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5608619|NCT03817853|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5608620|NCT03817853|Protective Agents|protective agents|mesh-ancestor
5608621|NCT03817853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5608622|NCT03816163|Gemcitabine|gemcitabine|mesh-list
5608623|NCT03816163|Paclitaxel|paclitaxel|mesh-list
5608624|NCT03816163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5608625|NCT03816163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5608626|NCT03816163|Tubulin Modulators|tubulin modulators|mesh-ancestor
5608627|NCT03816163|Antimitotic Agents|antimitotic agents|mesh-ancestor
5608628|NCT03816163|Mitosis Modulators|mitosis modulators|mesh-ancestor
5608629|NCT03816163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5608630|NCT03816163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5608631|NCT03816163|Antimetabolites|antimetabolites|mesh-ancestor
5608632|NCT03816163|Antiviral Agents|antiviral agents|mesh-ancestor
5608633|NCT03816163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5608634|NCT03816163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5608635|NCT03816163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5608636|NCT03816163|Immunologic Factors|immunologic factors|mesh-ancestor
5608637|NCT03816163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608638|NCT03794349|Eflornithine|eflornithine|mesh-list
5608639|NCT03794349|Irinotecan|irinotecan|mesh-list
5608640|NCT03794349|Camptothecin|camptothecin|mesh-list
5608641|NCT03794349|Temozolomide|temozolomide|mesh-list
5608642|NCT03794349|Dinutuximab|dinutuximab|mesh-list
5608643|NCT03794349|Sargramostim|sargramostim|mesh-list
5608644|NCT03794349|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5608645|NCT03794349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5608646|NCT03794349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5608647|NCT03794349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5608648|NCT03794349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5608649|NCT03794349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5608650|NCT03794349|Alkylating Agents|alkylating agents|mesh-ancestor
5608651|NCT03794349|Immunologic Factors|immunologic factors|mesh-ancestor
5608652|NCT03794349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608653|NCT03794349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5608654|NCT03794349|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5608655|NCT03794349|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5608656|NCT03794349|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5608657|NCT03794349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5608658|NCT03794349|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
5608659|NCT03782207|Atezolizumab|atezolizumab|mesh-list
5608660|NCT03782207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5608661|NCT03768570|Durvalumab|durvalumab|mesh-list
5608662|NCT03768570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5608663|NCT03768570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5608664|NCT03768063|Atezolizumab|atezolizumab|mesh-list
5608665|NCT03768063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5608666|NCT03735121|Atezolizumab|atezolizumab|mesh-list
5608667|NCT03735121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5691581|NCT03415828|Protective Agents|protective agents|mesh-ancestor
5691582|NCT03415828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5691583|NCT03415828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5691584|NCT03415828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5691585|NCT03415802|Paclitaxel|paclitaxel|mesh-list
5691586|NCT03415802|Tegafur|tegafur|mesh-list
5691587|NCT03415802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5892581|NCT04940286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5691588|NCT03415802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5691589|NCT03415802|Tubulin Modulators|tubulin modulators|mesh-ancestor
5691590|NCT03415802|Antimitotic Agents|antimitotic agents|mesh-ancestor
5691591|NCT03415802|Mitosis Modulators|mitosis modulators|mesh-ancestor
5691592|NCT03415802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691593|NCT03415802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5691594|NCT03415802|Antimetabolites|antimetabolites|mesh-ancestor
5691595|NCT03415763|Leucovorin|leucovorin|mesh-list
5691596|NCT03415763|Capecitabine|capecitabine|mesh-list
5691597|NCT03415763|Oxaliplatin|oxaliplatin|mesh-list
5691598|NCT03415763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5691599|NCT03415763|Antimetabolites|antimetabolites|mesh-ancestor
5608668|NCT03697629|Daratumumab|daratumumab|mesh-list
5608669|NCT03697629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5608670|NCT03677830|Acetaminophen|acetaminophen|mesh-list
5608671|NCT03677830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5608672|NCT03677830|Analgesics|analgesics|mesh-ancestor
5608673|NCT03677830|Sensory System Agents|sensory system agents|mesh-ancestor
5608674|NCT03677830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5608675|NCT03677830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608676|NCT03677830|Antipyretics|antipyretics|mesh-ancestor
5608677|NCT03657043|Tisotumab vedotin|tisotumab vedotin|mesh-list
5608678|NCT03657043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5608679|NCT03657043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5608680|NCT03656562|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5608681|NCT03656562|Immunologic Factors|immunologic factors|mesh-ancestor
5608682|NCT03656562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608683|NCT03646123|Doxorubicin|doxorubicin|mesh-list
5608684|NCT03646123|Nivolumab|nivolumab|mesh-list
5608685|NCT03646123|Dacarbazine|dacarbazine|mesh-list
5608686|NCT03646123|Vinblastine|vinblastine|mesh-list
5608687|NCT03646123|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5608688|NCT03646123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5608689|NCT03646123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5608690|NCT03646123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5608691|NCT03646123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5608692|NCT03646123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5608693|NCT03646123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5608694|NCT03646123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5608695|NCT03646123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5608696|NCT03646123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5608697|NCT03646123|Alkylating Agents|alkylating agents|mesh-ancestor
5608698|NCT03646123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5608699|NCT03646123|Tubulin Modulators|tubulin modulators|mesh-ancestor
5608700|NCT03646123|Antimitotic Agents|antimitotic agents|mesh-ancestor
5608701|NCT03646123|Mitosis Modulators|mitosis modulators|mesh-ancestor
5608702|NCT03613181|Paclitaxel|paclitaxel|mesh-list
5608703|NCT03613181|Capecitabine|capecitabine|mesh-list
5608704|NCT03613181|Methotrexate|methotrexate|mesh-list
5608705|NCT03613181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5608706|NCT03613181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5608707|NCT03613181|Tubulin Modulators|tubulin modulators|mesh-ancestor
5608708|NCT03613181|Antimitotic Agents|antimitotic agents|mesh-ancestor
5608709|NCT03613181|Mitosis Modulators|mitosis modulators|mesh-ancestor
5608710|NCT03613181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5608711|NCT03613181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5608712|NCT03613181|Antimetabolites|antimetabolites|mesh-ancestor
5608713|NCT03613181|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5608714|NCT03613181|Abortifacient Agents|abortifacient agents|mesh-ancestor
5608715|NCT03613181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5608716|NCT03613181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608717|NCT03613181|Dermatologic Agents|dermatologic agents|mesh-ancestor
5608718|NCT03613181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5608719|NCT03613181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5608720|NCT03613181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5608721|NCT03613181|Immunologic Factors|immunologic factors|mesh-ancestor
5608722|NCT03613181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5608723|NCT03613181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5608724|NCT03583697|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
5608725|NCT03583697|Natriuretic Agents|natriuretic agents|mesh-ancestor
5608726|NCT03583697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608727|NCT03582137|Cannabidiol|cannabidiol|mesh-list
5608728|NCT03582137|Anticonvulsants|anticonvulsants|mesh-ancestor
5608729|NCT03582033|Dexamethasone|dexamethasone|mesh-list
5608730|NCT03582033|Pomalidomide|pomalidomide|mesh-list
5608731|NCT03582033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5608732|NCT03582033|Antiemetics|antiemetics|mesh-ancestor
5608733|NCT03582033|Autonomic Agents|autonomic agents|mesh-ancestor
5608734|NCT03582033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5608735|NCT03582033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608736|NCT03582033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5608737|NCT03582033|Glucocorticoids|glucocorticoids|mesh-ancestor
5726343|NCT03174236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726344|NCT03174288|Spironolactone|spironolactone|mesh-list
5726345|NCT03174288|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5726346|NCT03174288|Hormone Antagonists|hormone antagonists|mesh-ancestor
5608738|NCT03582033|Hormones|hormones|mesh-ancestor
5697591|NCT03375034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608739|NCT03582033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5608740|NCT03582033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5608741|NCT03582033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5608742|NCT03582033|Immunologic Factors|immunologic factors|mesh-ancestor
5608743|NCT03582033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5608744|NCT03582033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5608745|NCT03582033|Growth Substances|growth substances|mesh-ancestor
5608746|NCT03582033|Growth Inhibitors|growth inhibitors|mesh-ancestor
5608747|NCT03567720|Paclitaxel|paclitaxel|mesh-list
5608748|NCT03567720|Pembrolizumab|pembrolizumab|mesh-list
5608749|NCT03567720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5608750|NCT03567720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5608751|NCT03567720|Tubulin Modulators|tubulin modulators|mesh-ancestor
5608752|NCT03567720|Antimitotic Agents|antimitotic agents|mesh-ancestor
5608753|NCT03567720|Mitosis Modulators|mitosis modulators|mesh-ancestor
5608754|NCT03567720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5608755|NCT03567720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5608756|NCT03550391|Memantine|memantine|mesh-list
5608757|NCT03550391|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5608758|NCT03550391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5608759|NCT03550391|Dopamine Agents|dopamine agents|mesh-ancestor
5608760|NCT03550391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5608761|NCT03550391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5608762|NCT03550391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608763|NCT03550391|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5608764|NCT03550391|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5608765|NCT03547999|Nivolumab|nivolumab|mesh-list
5608766|NCT03547999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5608767|NCT03547999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5608768|NCT03547999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5608769|NCT03547999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5608770|NCT03533582|Gemcitabine|gemcitabine|mesh-list
5608771|NCT03533582|Cisplatin|cisplatin|mesh-list
5608772|NCT03533582|Carboplatin|carboplatin|mesh-list
5608773|NCT03533582|Doxorubicin|doxorubicin|mesh-list
5608774|NCT03533582|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5608775|NCT03533582|Fluorouracil|fluorouracil|mesh-list
5608776|NCT03533582|Oxaliplatin|oxaliplatin|mesh-list
5608777|NCT03533582|Irinotecan|irinotecan|mesh-list
5608778|NCT03533582|Etoposide|etoposide|mesh-list
5608779|NCT03533582|Vincristine|vincristine|mesh-list
5608780|NCT03533582|Etoposide phosphate|etoposide phosphate|mesh-list
5608781|NCT03533582|Sorafenib|sorafenib|mesh-list
5608782|NCT03533582|Daunorubicin|daunorubicin|mesh-list
5608783|NCT03533582|Podophyllotoxin|podophyllotoxin|mesh-list
5608784|NCT03533582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5608785|NCT03533582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5608786|NCT03533582|Antimetabolites|antimetabolites|mesh-ancestor
5608787|NCT03533582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5608788|NCT03533582|Antiviral Agents|antiviral agents|mesh-ancestor
5608789|NCT03533582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5608790|NCT03533582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5608791|NCT03533582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5608792|NCT03533582|Immunologic Factors|immunologic factors|mesh-ancestor
5608793|NCT03533582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608794|NCT03533582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5608795|NCT03533582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5608796|NCT03533582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5608797|NCT03533582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5608798|NCT03533582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5608799|NCT03533582|Tubulin Modulators|tubulin modulators|mesh-ancestor
5608800|NCT03533582|Antimitotic Agents|antimitotic agents|mesh-ancestor
5608801|NCT03533582|Mitosis Modulators|mitosis modulators|mesh-ancestor
5608802|NCT03533582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5608803|NCT03533582|Keratolytic Agents|keratolytic agents|mesh-ancestor
5608804|NCT03533582|Dermatologic Agents|dermatologic agents|mesh-ancestor
5608805|NCT03528694|Durvalumab|durvalumab|mesh-list
5608806|NCT03528694|BCG Vaccine|bcg vaccine|mesh-list
5608807|NCT03528694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5608808|NCT03528694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5608809|NCT03528694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5608810|NCT03528694|Immunologic Factors|immunologic factors|mesh-ancestor
5608811|NCT03528694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608812|NCT03526848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5608813|NCT03526848|Antibodies|antibodies|mesh-list
5608814|NCT03526848|Immunoglobulins|immunoglobulins|mesh-list
5608815|NCT03526848|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5608816|NCT03526848|Immunologic Factors|immunologic factors|mesh-ancestor
5608817|NCT03526848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608818|NCT03526848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5608819|NCT03501381|Aldesleukin|aldesleukin|mesh-list
5608820|NCT03501381|Interleukin-2|interleukin-2|mesh-list
5608821|NCT03501381|Entinostat|entinostat|mesh-list
5608822|NCT03501381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5608823|NCT03501381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5608824|NCT03501381|Analgesics|analgesics|mesh-ancestor
5608825|NCT03501381|Sensory System Agents|sensory system agents|mesh-ancestor
5608826|NCT03501381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5608827|NCT03501381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608828|NCT03501381|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5608829|NCT03501381|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5608830|NCT03501381|Antiviral Agents|antiviral agents|mesh-ancestor
5726347|NCT03174288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5726348|NCT03174288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726349|NCT03174288|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5726350|NCT03174288|Diuretics|diuretics|mesh-ancestor
5726351|NCT03174288|Natriuretic Agents|natriuretic agents|mesh-ancestor
5726352|NCT03174197|Temozolomide|temozolomide|mesh-list
5726353|NCT03174197|Atezolizumab|atezolizumab|mesh-list
5726354|NCT03174197|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5726355|NCT03174197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5726356|NCT03174197|Alkylating Agents|alkylating agents|mesh-ancestor
5726357|NCT03174197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726358|NCT03174197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5726359|NCT03174197|Immunologic Factors|immunologic factors|mesh-ancestor
5726360|NCT03174197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726361|NCT03174353|Lanreotide|lanreotide|mesh-list
5726362|NCT03174353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5726363|NCT03174067|Clonidine|clonidine|mesh-list
5726364|NCT03174067|Buprenorphine|buprenorphine|mesh-list
5726365|NCT03174067|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5726366|NCT03174067|Narcotics|narcotics|mesh-ancestor
5726367|NCT03174067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5726368|NCT03174067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726369|NCT03174067|Analgesics|analgesics|mesh-ancestor
5726370|NCT03174067|Sensory System Agents|sensory system agents|mesh-ancestor
5726371|NCT03174067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5726372|NCT03174067|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5726373|NCT03174067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5726374|NCT03174067|Sympatholytics|sympatholytics|mesh-ancestor
5726375|NCT03174067|Autonomic Agents|autonomic agents|mesh-ancestor
5726376|NCT03174067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5726377|NCT03174067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5726378|NCT03174067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5726379|NCT03174067|Adrenergic Agents|adrenergic agents|mesh-ancestor
5726380|NCT03174067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5726381|NCT03174067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726382|NCT03174041|Itraconazole|itraconazole|mesh-list
5726383|NCT03174041|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
5726384|NCT03174041|Midazolam|midazolam|mesh-list
5726385|NCT03174041|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5726386|NCT03174041|Simvastatin|simvastatin|mesh-list
5726387|NCT03174041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5726388|NCT03174041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5726389|NCT03174041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5726390|NCT03174041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726391|NCT03174041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5608831|NCT03501381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5608832|NCT03501381|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5726392|NCT03174041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5726393|NCT03174041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5726394|NCT03174041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5726395|NCT03174041|Anesthetics, General|anesthetics, general|mesh-ancestor
5726396|NCT03174041|Anesthetics|anesthetics|mesh-ancestor
5726397|NCT03174041|GABA Modulators|gaba modulators|mesh-ancestor
5726398|NCT03174041|GABA Agents|gaba agents|mesh-ancestor
5726399|NCT03174041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5726400|NCT03174041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726401|NCT03174041|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5608833|NCT03501381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5608834|NCT03501381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726402|NCT03174041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5726403|NCT03174041|Antimetabolites|antimetabolites|mesh-ancestor
5726404|NCT03174041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5608835|NCT03498716|Paclitaxel|paclitaxel|mesh-list
5608836|NCT03498716|Cyclophosphamide|cyclophosphamide|mesh-list
5608837|NCT03498716|Doxorubicin|doxorubicin|mesh-list
5608838|NCT03498716|Atezolizumab|atezolizumab|mesh-list
5608839|NCT03498716|Epirubicin|epirubicin|mesh-list
5608840|NCT03498716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5608841|NCT03498716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5608842|NCT03498716|Tubulin Modulators|tubulin modulators|mesh-ancestor
5608843|NCT03498716|Antimitotic Agents|antimitotic agents|mesh-ancestor
5608844|NCT03498716|Mitosis Modulators|mitosis modulators|mesh-ancestor
5608845|NCT03498716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5608846|NCT03498716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5608847|NCT03498716|Immunologic Factors|immunologic factors|mesh-ancestor
5608848|NCT03498716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608849|NCT03498716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5608850|NCT03498716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5608851|NCT03498716|Alkylating Agents|alkylating agents|mesh-ancestor
5608852|NCT03498716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5608853|NCT03498716|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5608854|NCT03498716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5608855|NCT03498716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5608856|NCT03498716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5608857|NCT03495973|Ustekinumab|ustekinumab|mesh-list
5608858|NCT03495973|Dermatologic Agents|dermatologic agents|mesh-ancestor
5608859|NCT03485209|Carboplatin|carboplatin|mesh-list
5608860|NCT03485209|Pembrolizumab|pembrolizumab|mesh-list
5608861|NCT03485209|Tisotumab vedotin|tisotumab vedotin|mesh-list
5608862|NCT03485209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5608863|NCT03485209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6208050|NCT02123849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6208051|NCT02123849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6208052|NCT02123849|Antipyretics|antipyretics|mesh-ancestor
6208053|NCT02123966|Sirolimus|sirolimus|mesh-list
6208054|NCT02123966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6208055|NCT02123966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6208056|NCT02123966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6208057|NCT02123966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6208058|NCT02123966|Antifungal Agents|antifungal agents|mesh-ancestor
6208059|NCT02123966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6208060|NCT02123966|Immunologic Factors|immunologic factors|mesh-ancestor
6208061|NCT02123966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208062|NCT02124044|Asunaprevir|asunaprevir|mesh-list
6208063|NCT02124044|Protease Inhibitors|protease inhibitors|mesh-ancestor
6208064|NCT02124044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6208065|NCT02124044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208066|NCT02124083|Vorinostat|vorinostat|mesh-list
6208067|NCT02124083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6208068|NCT02124083|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6208069|NCT02124083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6208070|NCT02124083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5608886|NCT03450629|Brimonidine Tartrate|brimonidine tartrate|mesh-list
5608887|NCT03450629|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5608888|NCT03450629|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5608889|NCT03450629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5608890|NCT03450629|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5608891|NCT03450629|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5608892|NCT03450629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5608893|NCT03450629|Adrenergic Agents|adrenergic agents|mesh-ancestor
5608894|NCT03450629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5608895|NCT03450629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5608896|NCT03450629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608897|NCT03448718|Olaparib|olaparib|mesh-list
5608898|NCT03448718|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5608899|NCT03448718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5608900|NCT03448718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5608901|NCT03448718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5608902|NCT03445858|Pembrolizumab|pembrolizumab|mesh-list
5608903|NCT03445858|Decitabine|decitabine|mesh-list
5608904|NCT03445858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5608905|NCT03445858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5608906|NCT03445858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5608907|NCT03445858|Antimetabolites|antimetabolites|mesh-ancestor
5608908|NCT03445858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892582|NCT04940286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5608909|NCT03445858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5608910|NCT03442413|Nicotine|nicotine|mesh-list
5608911|NCT03442413|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5608912|NCT03442413|Autonomic Agents|autonomic agents|mesh-ancestor
5608913|NCT03442413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5608914|NCT03442413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608915|NCT03442413|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5608916|NCT03442413|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5608917|NCT03442413|Cholinergic Agents|cholinergic agents|mesh-ancestor
6672658|NCT01557439|Histamine Antagonists|histamine antagonists|mesh-ancestor
6672659|NCT01557439|Histamine Agents|histamine agents|mesh-ancestor
6672660|NCT01557439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6672661|NCT01557439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672662|NCT01557439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608918|NCT03442413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5608919|NCT03442413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5608920|NCT03441113|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
5608921|NCT03441113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5608922|NCT03441113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5608923|NCT03441113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5608924|NCT03439462|Sirolimus|sirolimus|mesh-list
5608925|NCT03439462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5608926|NCT03439462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5608927|NCT03439462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5608928|NCT03439462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5608929|NCT03439462|Antifungal Agents|antifungal agents|mesh-ancestor
5608930|NCT03439462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5608931|NCT03439462|Immunologic Factors|immunologic factors|mesh-ancestor
5608932|NCT03439462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608933|NCT03410615|Durvalumab|durvalumab|mesh-list
5608934|NCT03410615|Tremelimumab|tremelimumab|mesh-list
5608935|NCT03410615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6672663|NCT01557478|Melatonin|melatonin|mesh-list
6672664|NCT01557478|Antioxidants|antioxidants|mesh-ancestor
6672665|NCT01557478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672666|NCT01557478|Protective Agents|protective agents|mesh-ancestor
5608936|NCT03410615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5608937|NCT03386500|Manganese|manganese|mesh-list
5608938|NCT03386500|Trace Elements|trace elements|mesh-ancestor
5726405|NCT03174041|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5726406|NCT03174041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5608939|NCT03386500|Micronutrients|micronutrients|mesh-ancestor
5608940|NCT03386500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608941|NCT03385655|Carboplatin|carboplatin|mesh-list
5608942|NCT03385655|Durvalumab|durvalumab|mesh-list
5608943|NCT03385655|Tremelimumab|tremelimumab|mesh-list
5608944|NCT03385655|Adavosertib|adavosertib|mesh-list
5608945|NCT03385655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5608946|NCT03385655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5608947|NCT03385655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5608948|NCT03385655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5608949|NCT03379727|Midostaurin|midostaurin|mesh-list
5608950|NCT03379727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5726407|NCT03174041|Antifungal Agents|antifungal agents|mesh-ancestor
5726408|NCT03174041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5726409|NCT03174041|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5726410|NCT03174041|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5726411|NCT03174041|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5726412|NCT03174041|Hormone Antagonists|hormone antagonists|mesh-ancestor
5726413|NCT03174041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5726414|NCT03174041|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5726415|NCT03173898|Anesthetics|anesthetics|mesh-list
5726416|NCT03173898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5726417|NCT03173898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726418|NCT03173781|Droxidopa|droxidopa|mesh-list
5726419|NCT03173781|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5726420|NCT03173781|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5726421|NCT03173963|Empagliflozin|empagliflozin|mesh-list
5726422|NCT03173963|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5726423|NCT03173963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5608951|NCT03379727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5608952|NCT03379727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5608953|NCT03379727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5608954|NCT03371017|Gemcitabine|gemcitabine|mesh-list
5608955|NCT03371017|Carboplatin|carboplatin|mesh-list
5608956|NCT03371017|Capecitabine|capecitabine|mesh-list
5608957|NCT03371017|Atezolizumab|atezolizumab|mesh-list
5608958|NCT03371017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5608959|NCT03371017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5608960|NCT03371017|Antimetabolites|antimetabolites|mesh-ancestor
5608961|NCT03371017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5608962|NCT03371017|Antiviral Agents|antiviral agents|mesh-ancestor
5608963|NCT03371017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5608964|NCT03371017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5608965|NCT03371017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5608966|NCT03371017|Immunologic Factors|immunologic factors|mesh-ancestor
5608967|NCT03371017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608968|NCT03342937|Pembrolizumab|pembrolizumab|mesh-list
5608969|NCT03342937|Capecitabine|capecitabine|mesh-list
5608970|NCT03342937|Oxaliplatin|oxaliplatin|mesh-list
5608971|NCT03342937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5608972|NCT03342937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5608973|NCT03342937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5608974|NCT03342937|Antimetabolites|antimetabolites|mesh-ancestor
5608975|NCT03342937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5608976|NCT03326492|Antivenins|antivenins|mesh-list
5608977|NCT03326492|Immunologic Factors|immunologic factors|mesh-ancestor
5608978|NCT03326492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5608979|NCT03310957|Pembrolizumab|pembrolizumab|mesh-list
5608980|NCT03310957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5608981|NCT03310957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5608982|NCT03281369|Leucovorin|leucovorin|mesh-list
5608983|NCT03281369|Linagliptin|linagliptin|mesh-list
5608984|NCT03281369|Paclitaxel|paclitaxel|mesh-list
5608985|NCT03281369|Fluorouracil|fluorouracil|mesh-list
5726424|NCT03173963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5726425|NCT03173963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726426|NCT03173612|Cytarabine|cytarabine|mesh-list
5726427|NCT03173612|Etoposide|etoposide|mesh-list
5726428|NCT03173612|Mitoxantrone|mitoxantrone|mesh-list
5726429|NCT03173612|Idarubicin|idarubicin|mesh-list
5726430|NCT03173612|Dasatinib|dasatinib|mesh-list
5726431|NCT03173612|Aclacinomycins|aclacinomycins|mesh-list
5726432|NCT03173612|Sargramostim|sargramostim|mesh-list
5726433|NCT03173612|Lenograstim|lenograstim|mesh-list
5726434|NCT03173612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5726435|NCT03173612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5726436|NCT03173612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5726437|NCT03173612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5726438|NCT03173612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5608986|NCT03281369|Oxaliplatin|oxaliplatin|mesh-list
5608987|NCT03281369|Atezolizumab|atezolizumab|mesh-list
5608988|NCT03281369|Ramucirumab|ramucirumab|mesh-list
5608989|NCT03281369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5726439|NCT03173612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726440|NCT03173612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5726441|NCT03173612|Antimetabolites|antimetabolites|mesh-ancestor
5726442|NCT03173612|Antiviral Agents|antiviral agents|mesh-ancestor
5726443|NCT03173612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6489079|NCT00589238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489080|NCT00589238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5608990|NCT03281369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5726444|NCT03173612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5726445|NCT03173612|Immunologic Factors|immunologic factors|mesh-ancestor
5726446|NCT03173612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726447|NCT03173612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5726448|NCT03173612|Analgesics|analgesics|mesh-ancestor
5726449|NCT03173612|Sensory System Agents|sensory system agents|mesh-ancestor
5726450|NCT03173612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5726451|NCT03173612|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5726452|NCT03173612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5892583|NCT04940286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5892584|NCT04940286|Immunologic Factors|immunologic factors|mesh-ancestor
5892585|NCT04940286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892586|NCT04940286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5892587|NCT04930237|Methylnaltrexone|methylnaltrexone|mesh-list
5608991|NCT03281369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5892588|NCT04930237|Bisacodyl|bisacodyl|mesh-list
5892589|NCT04930237|Magnesium citrate|magnesium citrate|mesh-list
5608992|NCT03281369|Tubulin Modulators|tubulin modulators|mesh-ancestor
5892590|NCT04930237|Magnesium Oxide|magnesium oxide|mesh-list
5892591|NCT04930237|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
5892592|NCT04930237|Magnesium Hydroxide|magnesium hydroxide|mesh-list
5608993|NCT03281369|Antimitotic Agents|antimitotic agents|mesh-ancestor
5608994|NCT03281369|Mitosis Modulators|mitosis modulators|mesh-ancestor
5608995|NCT03281369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5608996|NCT03281369|Antimetabolites|antimetabolites|mesh-ancestor
5608997|NCT03281369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5608998|NCT03281369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5608999|NCT03281369|Immunologic Factors|immunologic factors|mesh-ancestor
5609000|NCT03281369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5609001|NCT03281369|Antidotes|antidotes|mesh-ancestor
5609002|NCT03281369|Protective Agents|protective agents|mesh-ancestor
5609003|NCT03281369|Vitamin B Complex|vitamin b complex|mesh-ancestor
5609004|NCT03281369|Vitamins|vitamins|mesh-ancestor
5609005|NCT03281369|Micronutrients|micronutrients|mesh-ancestor
5609006|NCT03281369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5609007|NCT03281369|Incretins|incretins|mesh-ancestor
5609008|NCT03281369|Hormones|hormones|mesh-ancestor
5609009|NCT03281369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5609010|NCT03281369|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5609011|NCT03281369|Protease Inhibitors|protease inhibitors|mesh-ancestor
5609012|NCT03281369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5609013|NCT03280563|Tamoxifen|tamoxifen|mesh-list
5609014|NCT03280563|Bevacizumab|bevacizumab|mesh-list
5609015|NCT03280563|Atezolizumab|atezolizumab|mesh-list
5609016|NCT03280563|Fulvestrant|fulvestrant|mesh-list
5609017|NCT03280563|Exemestane|exemestane|mesh-list
5609018|NCT03280563|Entinostat|entinostat|mesh-list
5609019|NCT03280563|Antibodies|antibodies|mesh-list
5609020|NCT03280563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5609021|NCT03280563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5609022|NCT03280563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5609023|NCT03280563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5609024|NCT03280563|Growth Substances|growth substances|mesh-ancestor
5609025|NCT03280563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5609026|NCT03280563|Growth Inhibitors|growth inhibitors|mesh-ancestor
5609027|NCT03280563|Immunologic Factors|immunologic factors|mesh-ancestor
5609028|NCT03280563|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5609029|NCT03280563|Hormone Antagonists|hormone antagonists|mesh-ancestor
5609030|NCT03280563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5609031|NCT03280563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5609032|NCT03280563|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5609033|NCT03280563|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5609034|NCT03280563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5609035|NCT03280563|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5609036|NCT03280563|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5609037|NCT03280563|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5609038|NCT03280563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5609039|NCT03280563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609040|NCT03280563|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5609041|NCT03272217|Bevacizumab|bevacizumab|mesh-list
5609042|NCT03272217|Atezolizumab|atezolizumab|mesh-list
5609043|NCT03272217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5609044|NCT03272217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5609045|NCT03272217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5609046|NCT03272217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5609047|NCT03272217|Growth Substances|growth substances|mesh-ancestor
5609048|NCT03272217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5609049|NCT03272217|Growth Inhibitors|growth inhibitors|mesh-ancestor
5609050|NCT03260023|Avelumab|avelumab|mesh-list
5609051|NCT03260023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5609052|NCT03260023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5609053|NCT03232593|Atezolizumab|atezolizumab|mesh-list
5609054|NCT03232593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5609055|NCT03227458|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
5609056|NCT03227458|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5609057|NCT03227458|Immunologic Factors|immunologic factors|mesh-ancestor
5609058|NCT03227458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5609059|NCT03215524|Thalidomide|thalidomide|mesh-list
5609060|NCT03215524|Dexamethasone|dexamethasone|mesh-list
5609061|NCT03215524|Dexamethasone acetate|dexamethasone acetate|mesh-list
5609062|NCT03215524|Cyclophosphamide|cyclophosphamide|mesh-list
5609063|NCT03215524|Daratumumab|daratumumab|mesh-list
5609064|NCT03215524|Pomalidomide|pomalidomide|mesh-list
5609065|NCT03215524|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5609066|NCT03215524|BB 1101|bb 1101|mesh-list
5609067|NCT03215524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5609068|NCT03215524|Immunologic Factors|immunologic factors|mesh-ancestor
5609069|NCT03215524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5609070|NCT03215524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5609071|NCT03215524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5609072|NCT03215524|Alkylating Agents|alkylating agents|mesh-ancestor
5609073|NCT03215524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609074|NCT03215524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5609075|NCT03215524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5609076|NCT03215524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5609077|NCT03215524|Antiemetics|antiemetics|mesh-ancestor
5609078|NCT03215524|Autonomic Agents|autonomic agents|mesh-ancestor
5609079|NCT03215524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5609080|NCT03215524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5609081|NCT03215524|Glucocorticoids|glucocorticoids|mesh-ancestor
5609082|NCT03215524|Hormones|hormones|mesh-ancestor
5609083|NCT03215524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5609084|NCT03215524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5609085|NCT03215524|Protease Inhibitors|protease inhibitors|mesh-ancestor
5609086|NCT03215524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5609087|NCT03215524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5609088|NCT03215524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5609089|NCT03215524|Growth Substances|growth substances|mesh-ancestor
5609090|NCT03215524|Growth Inhibitors|growth inhibitors|mesh-ancestor
5609091|NCT03215524|Leprostatic Agents|leprostatic agents|mesh-ancestor
5609092|NCT03215524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5609093|NCT03215524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5609094|NCT03135249|Alemtuzumab|alemtuzumab|mesh-list
5609095|NCT03135249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5609096|NCT03135249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5609097|NCT03132675|Pembrolizumab|pembrolizumab|mesh-list
5609098|NCT03132675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5609099|NCT03132675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5609100|NCT03117309|Nivolumab|nivolumab|mesh-list
5609101|NCT03117309|Ipilimumab|ipilimumab|mesh-list
5609102|NCT03117309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5609103|NCT03117309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5609104|NCT03117309|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5609105|NCT03117309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691600|NCT03415763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691601|NCT03415763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5691602|NCT03415763|Antidotes|antidotes|mesh-ancestor
5691603|NCT03415763|Protective Agents|protective agents|mesh-ancestor
5691604|NCT03415763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691605|NCT03415763|Vitamin B Complex|vitamin b complex|mesh-ancestor
5691606|NCT03415763|Vitamins|vitamins|mesh-ancestor
5691607|NCT03415763|Micronutrients|micronutrients|mesh-ancestor
5691608|NCT03415750|Mycophenolic Acid|mycophenolic acid|mesh-list
5691609|NCT03415750|Everolimus|everolimus|mesh-list
5691610|NCT03415750|Tacrolimus|tacrolimus|mesh-list
5691611|NCT03415750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5691612|NCT03415750|Immunologic Factors|immunologic factors|mesh-ancestor
5691613|NCT03415750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691614|NCT03415750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5691615|NCT03415750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5691616|NCT03415750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691617|NCT03415750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5691618|NCT03415750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5691619|NCT03415750|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5691620|NCT03415750|Antitubercular Agents|antitubercular agents|mesh-ancestor
5691621|NCT03415750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5691622|NCT03415750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5691623|NCT03415711|Mesalamine|mesalamine|mesh-list
5691624|NCT03415711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5691625|NCT03415711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5691626|NCT03415711|Analgesics|analgesics|mesh-ancestor
5726453|NCT03173417|Cyclophosphamide|cyclophosphamide|mesh-list
5726454|NCT03173417|Fludarabine|fludarabine|mesh-list
5726455|NCT03173417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5726456|NCT03173417|Immunologic Factors|immunologic factors|mesh-ancestor
5726457|NCT03173417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726458|NCT03173417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5726459|NCT03173417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5726460|NCT03173417|Alkylating Agents|alkylating agents|mesh-ancestor
5726461|NCT03173417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726462|NCT03173417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5726463|NCT03173417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5726464|NCT03173248|Azacitidine|azacitidine|mesh-list
5609106|NCT03085810|Ocrelizumab|ocrelizumab|mesh-list
5609107|NCT03085810|Immunologic Factors|immunologic factors|mesh-ancestor
5609108|NCT03085810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5609109|NCT03073785|Zoledronic Acid|zoledronic acid|mesh-list
5609110|NCT03073785|Fluorouracil|fluorouracil|mesh-list
5609111|NCT03073785|Capecitabine|capecitabine|mesh-list
5609112|NCT03073785|Imidazole|imidazole|mesh-list
6489081|NCT00589238|Immunologic Factors|immunologic factors|mesh-ancestor
6489082|NCT00589238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489083|NCT00589238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6489084|NCT00589238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5609113|NCT03073785|Antimetabolites|antimetabolites|mesh-ancestor
5609114|NCT03073785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609115|NCT03073785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5609116|NCT03073785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5609117|NCT03073785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5609118|NCT03073785|Immunologic Factors|immunologic factors|mesh-ancestor
5609119|NCT03073785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5609120|NCT03073785|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5609121|NCT03073785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5609122|NCT03067181|Cisplatin|cisplatin|mesh-list
5609123|NCT03067181|Carboplatin|carboplatin|mesh-list
5609124|NCT03067181|Etoposide|etoposide|mesh-list
5609125|NCT03067181|Etoposide phosphate|etoposide phosphate|mesh-list
5609126|NCT03067181|Bleomycin|bleomycin|mesh-list
5609127|NCT03067181|Podophyllotoxin|podophyllotoxin|mesh-list
5609128|NCT03067181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5609129|NCT03067181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5609130|NCT03067181|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5609131|NCT03067181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5609132|NCT03067181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5609133|NCT03067181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609134|NCT03067181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5609135|NCT03067181|Keratolytic Agents|keratolytic agents|mesh-ancestor
5609136|NCT03067181|Dermatologic Agents|dermatologic agents|mesh-ancestor
5609137|NCT03067181|Tubulin Modulators|tubulin modulators|mesh-ancestor
5609138|NCT03067181|Antimitotic Agents|antimitotic agents|mesh-ancestor
5609139|NCT03067181|Mitosis Modulators|mitosis modulators|mesh-ancestor
5609140|NCT03047135|Olaparib|olaparib|mesh-list
5609141|NCT03047135|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5609142|NCT03047135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5609143|NCT03047135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609144|NCT03047135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5609145|NCT03043313|Trastuzumab|trastuzumab|mesh-list
5609146|NCT03043313|Tucatinib|tucatinib|mesh-list
5609147|NCT03043313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5609148|NCT03043313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5726465|NCT03173248|Ivosidenib|ivosidenib|mesh-list
5726466|NCT03173248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5726467|NCT03173248|Antimetabolites|antimetabolites|mesh-ancestor
5726468|NCT03173248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726469|NCT03173248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5726470|NCT03173248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5726471|NCT03173235|Vitamin D|vitamin d|mesh-list
5726472|NCT03173235|Vitamins|vitamins|mesh-ancestor
5726473|NCT03173235|Micronutrients|micronutrients|mesh-ancestor
5726474|NCT03173235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726475|NCT03173235|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5726476|NCT03173365|Brimonidine Tartrate|brimonidine tartrate|mesh-list
5726477|NCT03173365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5726478|NCT03173365|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5726479|NCT03173365|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5726480|NCT03173365|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5609149|NCT03043313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5609150|NCT03043313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5609151|NCT03043313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726481|NCT03173365|Adrenergic Agents|adrenergic agents|mesh-ancestor
5726482|NCT03173365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5726483|NCT03173365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726484|NCT03173365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726485|NCT03173339|Remifentanil|remifentanil|mesh-list
5726486|NCT03173339|Sevoflurane|sevoflurane|mesh-list
5609152|NCT03035630|Sunitinib|sunitinib|mesh-list
5609153|NCT03035630|Avelumab|avelumab|mesh-list
5609154|NCT03035630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5726487|NCT03173339|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5726488|NCT03173339|Narcotics|narcotics|mesh-ancestor
5609155|NCT03035630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5609156|NCT03035630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5609157|NCT03035630|Growth Substances|growth substances|mesh-ancestor
5609158|NCT03035630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5609159|NCT03035630|Growth Inhibitors|growth inhibitors|mesh-ancestor
5609160|NCT03035630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5609161|NCT03035630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5609162|NCT03035630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609163|NCT03035630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5609164|NCT02962297|Vitamin E|vitamin e|mesh-list
5609165|NCT02962297|Vitamins|vitamins|mesh-ancestor
5609166|NCT02962297|Micronutrients|micronutrients|mesh-ancestor
5609167|NCT02962297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5609168|NCT02962297|Antioxidants|antioxidants|mesh-ancestor
5609169|NCT02962297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609170|NCT02962297|Protective Agents|protective agents|mesh-ancestor
5609171|NCT02913664|Losartan|losartan|mesh-list
5609172|NCT02913664|Amlodipine|amlodipine|mesh-list
5609173|NCT02913664|Calcium Channel Blockers|calcium channel blockers|mesh-list
5609174|NCT02913664|Angiotensin II|angiotensin ii|mesh-list
5609175|NCT02913664|Giapreza|giapreza|mesh-list
5609176|NCT02913664|Calcium|calcium|mesh-list
5609177|NCT02913664|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
5609178|NCT02913664|Angiotensinogen|angiotensinogen|mesh-list
5609179|NCT02913664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5609180|NCT02913664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5609181|NCT02913664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5609182|NCT02913664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5609183|NCT02913664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609184|NCT02913664|Vasodilator Agents|vasodilator agents|mesh-ancestor
5609185|NCT02913664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5609186|NCT02913664|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5609187|NCT02913664|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5609188|NCT02913664|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5609189|NCT02913664|Protease Inhibitors|protease inhibitors|mesh-ancestor
5609190|NCT02913664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5609191|NCT02889133|Iron|iron|mesh-list
5609192|NCT02889133|Dextrans|dextrans|mesh-list
5609193|NCT02889133|Iron-Dextran Complex|iron-dextran complex|mesh-list
5609194|NCT02889133|Trace Elements|trace elements|mesh-ancestor
5609195|NCT02889133|Micronutrients|micronutrients|mesh-ancestor
5609196|NCT02889133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5609197|NCT02889133|Anticoagulants|anticoagulants|mesh-ancestor
5609198|NCT02889133|Plasma Substitutes|plasma substitutes|mesh-ancestor
5609199|NCT02889133|Blood Substitutes|blood substitutes|mesh-ancestor
5609200|NCT02889133|Hematinics|hematinics|mesh-ancestor
5609201|NCT02871297|Vortioxetine|vortioxetine|mesh-list
5609202|NCT02871297|Antidepressive Agents|antidepressive agents|mesh-ancestor
5609203|NCT02871297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5609204|NCT02871297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5609205|NCT02871297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5609206|NCT02871297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5609207|NCT02871297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5609208|NCT02871297|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5609209|NCT02871297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5609210|NCT02871297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5609211|NCT02871297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609212|NCT02871297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5609213|NCT02871297|Serotonin Agents|serotonin agents|mesh-ancestor
5609214|NCT02871297|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5609215|NCT02871297|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5609216|NCT02871297|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5609217|NCT02871297|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5609218|NCT02818582|Remdesivir|remdesivir|mesh-list
5609219|NCT02818582|Antimetabolites|antimetabolites|mesh-ancestor
5609220|NCT02818582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609221|NCT02818582|Antiviral Agents|antiviral agents|mesh-ancestor
5609222|NCT02818582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5609223|NCT02740985|Docetaxel|docetaxel|mesh-list
5609224|NCT02740985|Durvalumab|durvalumab|mesh-list
5609225|NCT02740985|Abiraterone Acetate|abiraterone acetate|mesh-list
5609226|NCT02740985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5609227|NCT02740985|Tubulin Modulators|tubulin modulators|mesh-ancestor
5609228|NCT02740985|Antimitotic Agents|antimitotic agents|mesh-ancestor
5609229|NCT02740985|Mitosis Modulators|mitosis modulators|mesh-ancestor
5609230|NCT02740985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609231|NCT02740985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5609232|NCT02740985|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5609233|NCT02740985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5609234|NCT02740985|Hormone Antagonists|hormone antagonists|mesh-ancestor
5609235|NCT02740985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5609236|NCT02740985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5609237|NCT02740985|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5609238|NCT02703623|Prednisone|prednisone|mesh-list
5609239|NCT02703623|Cortisone|cortisone|mesh-list
5609240|NCT02703623|Carboplatin|carboplatin|mesh-list
5609241|NCT02703623|Ipilimumab|ipilimumab|mesh-list
5609242|NCT02703623|Abiraterone Acetate|abiraterone acetate|mesh-list
5609243|NCT02703623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5609244|NCT02703623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5609245|NCT02703623|Glucocorticoids|glucocorticoids|mesh-ancestor
5609246|NCT02703623|Hormones|hormones|mesh-ancestor
5609247|NCT02703623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5609248|NCT02703623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5609249|NCT02703623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5609250|NCT02703623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5609251|NCT02703623|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5609252|NCT02703623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609253|NCT02703623|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5609254|NCT02703623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5609255|NCT02703623|Hormone Antagonists|hormone antagonists|mesh-ancestor
5609256|NCT02703623|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5609257|NCT02684032|Letrozole|letrozole|mesh-list
5609258|NCT02684032|Fulvestrant|fulvestrant|mesh-list
5609259|NCT02684032|Palbociclib|palbociclib|mesh-list
5609260|NCT02684032|Gedatolisib|gedatolisib|mesh-list
5609261|NCT02684032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5609262|NCT02684032|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5609263|NCT02684032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5609264|NCT02684032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5609265|NCT02684032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609266|NCT02684032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5609267|NCT02684032|Hormone Antagonists|hormone antagonists|mesh-ancestor
5609268|NCT02684032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5609269|NCT02684032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726489|NCT03173339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5726490|NCT03173339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726491|NCT03173339|Analgesics|analgesics|mesh-ancestor
5726492|NCT03173339|Sensory System Agents|sensory system agents|mesh-ancestor
5726493|NCT03173339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5726494|NCT03173339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5726495|NCT03173339|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5726496|NCT03173339|Anesthetics, General|anesthetics, general|mesh-ancestor
5726497|NCT03173339|Anesthetics|anesthetics|mesh-ancestor
5726498|NCT03173326|Anesthetics|anesthetics|mesh-list
5726499|NCT03173326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5726500|NCT03173326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726501|NCT03173508|Acetazolamide|acetazolamide|mesh-list
5726502|NCT03173508|Anticonvulsants|anticonvulsants|mesh-ancestor
5726503|NCT03173508|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5726504|NCT03173508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5726505|NCT03173508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726506|NCT03173508|Diuretics|diuretics|mesh-ancestor
5726507|NCT03173508|Natriuretic Agents|natriuretic agents|mesh-ancestor
5726508|NCT03173508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726509|NCT03173430|Blinatumomab|blinatumomab|mesh-list
5726510|NCT03173430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5726511|NCT03172858|Oxytocin|oxytocin|mesh-list
5726512|NCT03172858|Oxytocics|oxytocics|mesh-ancestor
5726513|NCT03172858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5726514|NCT03172858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5609270|NCT02684032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5609271|NCT02684032|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5609272|NCT02684032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5609273|NCT02677038|Olaparib|olaparib|mesh-list
5609274|NCT02677038|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
5609275|NCT02677038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5609276|NCT02677038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609277|NCT02677038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5609278|NCT02668770|Ipilimumab|ipilimumab|mesh-list
5609279|NCT02668770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5609280|NCT02668770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5609281|NCT02668770|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5609282|NCT02668770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609283|NCT02652429|Nitric Oxide|nitric oxide|mesh-list
5609284|NCT02652429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5609285|NCT02652429|Autonomic Agents|autonomic agents|mesh-ancestor
5609286|NCT02652429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5609287|NCT02652429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5609288|NCT02652429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5609289|NCT02652429|Respiratory System Agents|respiratory system agents|mesh-ancestor
5609290|NCT02652429|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5609291|NCT02652429|Antioxidants|antioxidants|mesh-ancestor
5609292|NCT02652429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609293|NCT02652429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5609294|NCT02652429|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5609295|NCT02652429|Vasodilator Agents|vasodilator agents|mesh-ancestor
5609296|NCT02652429|Gasotransmitters|gasotransmitters|mesh-ancestor
5609297|NCT02652429|Protective Agents|protective agents|mesh-ancestor
5609298|NCT02650648|Cyclophosphamide|cyclophosphamide|mesh-list
5609299|NCT02650648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5609300|NCT02650648|Immunologic Factors|immunologic factors|mesh-ancestor
5609301|NCT02650648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5609302|NCT02650648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5609303|NCT02650648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5609304|NCT02650648|Alkylating Agents|alkylating agents|mesh-ancestor
5609305|NCT02650648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609306|NCT02650648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5609307|NCT02650648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5609308|NCT02649764|Cytarabine|cytarabine|mesh-list
5609309|NCT02649764|Fludarabine|fludarabine|mesh-list
5609310|NCT02649764|Fludarabine phosphate|fludarabine phosphate|mesh-list
5609311|NCT02649764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5609312|NCT02649764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5609313|NCT02649764|Antimetabolites|antimetabolites|mesh-ancestor
5609314|NCT02649764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609315|NCT02649764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5609316|NCT02649764|Immunologic Factors|immunologic factors|mesh-ancestor
5609317|NCT02649764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5609318|NCT02649764|Antiviral Agents|antiviral agents|mesh-ancestor
5609319|NCT02649764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5609320|NCT02629419|Amphotericin B|amphotericin b|mesh-list
5609321|NCT02629419|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
5609322|NCT02629419|Amebicides|amebicides|mesh-ancestor
5609323|NCT02629419|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5609324|NCT02629419|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5609325|NCT02629419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5609326|NCT02629419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5609327|NCT02629419|Antifungal Agents|antifungal agents|mesh-ancestor
5609328|NCT02596503|Cefixime|cefixime|mesh-list
5609329|NCT02596503|Irinotecan|irinotecan|mesh-list
5609330|NCT02596503|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5609331|NCT02596503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5609332|NCT02596503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5609333|NCT02596503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609334|NCT02596503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5609335|NCT02596503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5609336|NCT02596503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5609337|NCT02584478|Paclitaxel|paclitaxel|mesh-list
5609338|NCT02584478|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5609339|NCT02584478|Carboplatin|carboplatin|mesh-list
5609340|NCT02584478|Doxorubicin|doxorubicin|mesh-list
5609341|NCT02584478|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5609342|NCT02584478|Topotecan|topotecan|mesh-list
5609343|NCT02584478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5609344|NCT02584478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5609345|NCT02584478|Tubulin Modulators|tubulin modulators|mesh-ancestor
5609346|NCT02584478|Antimitotic Agents|antimitotic agents|mesh-ancestor
5609347|NCT02584478|Mitosis Modulators|mitosis modulators|mesh-ancestor
5609348|NCT02584478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609349|NCT02584478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5609350|NCT02584478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5609351|NCT02584478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5609352|NCT02584478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5609353|NCT02584478|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5609354|NCT02581215|Ramucirumab|ramucirumab|mesh-list
5609355|NCT02581215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5609356|NCT02554253|Ketamine|ketamine|mesh-list
5609357|NCT02554253|Propofol|propofol|mesh-list
5609358|NCT02554253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5609359|NCT02554253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5609360|NCT02554253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5609361|NCT02554253|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5609362|NCT02554253|Anesthetics, General|anesthetics, general|mesh-ancestor
5609363|NCT02554253|Anesthetics|anesthetics|mesh-ancestor
5609364|NCT02554253|Analgesics|analgesics|mesh-ancestor
5609365|NCT02554253|Sensory System Agents|sensory system agents|mesh-ancestor
5609366|NCT02554253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5609367|NCT02554253|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5609368|NCT02554253|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5609369|NCT02554253|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5609370|NCT02554253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5609371|NCT02554253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609372|NCT02535091|Cenobamate|cenobamate|mesh-list
5609373|NCT02535091|Anticonvulsants|anticonvulsants|mesh-ancestor
5609374|NCT02513563|Paclitaxel|paclitaxel|mesh-list
5609375|NCT02513563|Carboplatin|carboplatin|mesh-list
5609376|NCT02513563|Adavosertib|adavosertib|mesh-list
5609377|NCT02513563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5609378|NCT02513563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5609379|NCT02513563|Tubulin Modulators|tubulin modulators|mesh-ancestor
5609380|NCT02513563|Antimitotic Agents|antimitotic agents|mesh-ancestor
5609381|NCT02513563|Mitosis Modulators|mitosis modulators|mesh-ancestor
5609382|NCT02513563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609383|NCT02513563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5609384|NCT02509507|Pembrolizumab|pembrolizumab|mesh-list
5609385|NCT02509507|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
5609386|NCT02509507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5609387|NCT02509507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5609388|NCT02498600|Nivolumab|nivolumab|mesh-list
5609389|NCT02498600|Ipilimumab|ipilimumab|mesh-list
5609390|NCT02498600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5609391|NCT02498600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5609392|NCT02498600|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5609393|NCT02498600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609394|NCT02441686|Dexamethasone|dexamethasone|mesh-list
5609395|NCT02441686|Lenalidomide|lenalidomide|mesh-list
5609396|NCT02441686|Bortezomib|bortezomib|mesh-list
5609397|NCT02441686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5609398|NCT02441686|Antiemetics|antiemetics|mesh-ancestor
5609399|NCT02441686|Autonomic Agents|autonomic agents|mesh-ancestor
5609400|NCT02441686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5609401|NCT02441686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5609402|NCT02441686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5609403|NCT02441686|Glucocorticoids|glucocorticoids|mesh-ancestor
5609404|NCT02441686|Hormones|hormones|mesh-ancestor
5609405|NCT02441686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5609406|NCT02441686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5609407|NCT02441686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5609408|NCT02441686|Immunologic Factors|immunologic factors|mesh-ancestor
5609409|NCT02441686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5609410|NCT02441686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5609411|NCT02441686|Growth Substances|growth substances|mesh-ancestor
5609412|NCT02441686|Growth Inhibitors|growth inhibitors|mesh-ancestor
5609413|NCT02382406|Paclitaxel|paclitaxel|mesh-list
5609414|NCT02382406|Carboplatin|carboplatin|mesh-list
5609415|NCT02382406|Pembrolizumab|pembrolizumab|mesh-list
5609416|NCT02382406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5609417|NCT02382406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5609418|NCT02382406|Tubulin Modulators|tubulin modulators|mesh-ancestor
5726515|NCT03172936|Spartalizumab|spartalizumab|mesh-list
5609419|NCT02382406|Antimitotic Agents|antimitotic agents|mesh-ancestor
5609420|NCT02382406|Mitosis Modulators|mitosis modulators|mesh-ancestor
5609421|NCT02382406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609422|NCT02382406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5609423|NCT02308527|Cyclophosphamide|cyclophosphamide|mesh-list
5609424|NCT02308527|Temozolomide|temozolomide|mesh-list
5609425|NCT02308527|Bevacizumab|bevacizumab|mesh-list
5609426|NCT02308527|Irinotecan|irinotecan|mesh-list
5609427|NCT02308527|Topotecan|topotecan|mesh-list
5609428|NCT02308527|Dinutuximab|dinutuximab|mesh-list
5609429|NCT02308527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5609430|NCT02308527|Immunologic Factors|immunologic factors|mesh-ancestor
5609431|NCT02308527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5609432|NCT02308527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5609433|NCT02308527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5609434|NCT02308527|Alkylating Agents|alkylating agents|mesh-ancestor
5609435|NCT02308527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609436|NCT02308527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5609437|NCT02308527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5609438|NCT02308527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5609439|NCT02308527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5609440|NCT02308527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5609441|NCT02308527|Growth Substances|growth substances|mesh-ancestor
5609442|NCT02308527|Growth Inhibitors|growth inhibitors|mesh-ancestor
5609443|NCT02308527|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5609444|NCT02308527|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5609445|NCT02308527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5609446|NCT02176967|Cyclophosphamide|cyclophosphamide|mesh-list
5609447|NCT02176967|Carboplatin|carboplatin|mesh-list
5609448|NCT02176967|Doxorubicin|doxorubicin|mesh-list
5609449|NCT02176967|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5609450|NCT02176967|Etoposide|etoposide|mesh-list
5609451|NCT02176967|Etoposide phosphate|etoposide phosphate|mesh-list
5609452|NCT02176967|Podophyllotoxin|podophyllotoxin|mesh-list
5609453|NCT02176967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5609454|NCT02176967|Immunologic Factors|immunologic factors|mesh-ancestor
5609455|NCT02176967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5609456|NCT02176967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5609457|NCT02176967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5609458|NCT02176967|Alkylating Agents|alkylating agents|mesh-ancestor
5609459|NCT02176967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609460|NCT02176967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5609461|NCT02176967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5609462|NCT02176967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5609463|NCT02176967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5609464|NCT02176967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5609465|NCT02176967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5609466|NCT02176967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5609467|NCT02176967|Keratolytic Agents|keratolytic agents|mesh-ancestor
5609468|NCT02176967|Dermatologic Agents|dermatologic agents|mesh-ancestor
5609469|NCT02176967|Tubulin Modulators|tubulin modulators|mesh-ancestor
5609470|NCT02176967|Antimitotic Agents|antimitotic agents|mesh-ancestor
5609471|NCT02176967|Mitosis Modulators|mitosis modulators|mesh-ancestor
5609472|NCT02159755|Palbociclib|palbociclib|mesh-list
5609473|NCT02159755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5609474|NCT02159755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5609475|NCT02159755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5609476|NCT02159755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609477|NCT02121184|Oxytocin|oxytocin|mesh-list
5609478|NCT02121184|Oxytocics|oxytocics|mesh-ancestor
5609479|NCT02121184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5609480|NCT02121184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5609481|NCT02117791|Riociguat|riociguat|mesh-list
5609482|NCT02117791|Enzyme Activators|enzyme activators|mesh-ancestor
5609483|NCT02117791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609484|NCT02078427|BAX 855|bax 855|mesh-list
5609485|NCT02078427|Coagulants|coagulants|mesh-ancestor
5609486|NCT01972919|Gemcitabine|gemcitabine|mesh-list
5726516|NCT03172936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5726517|NCT03172936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726518|NCT03172936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5726519|NCT03172871|Aripiprazole|aripiprazole|mesh-list
5726520|NCT03172871|Antidepressive Agents|antidepressive agents|mesh-ancestor
5726521|NCT03172871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5726522|NCT03172871|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5726523|NCT03172871|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5609487|NCT01972919|Capecitabine|capecitabine|mesh-list
5609488|NCT01972919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5609489|NCT01972919|Antimetabolites|antimetabolites|mesh-ancestor
5609490|NCT01972919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609491|NCT01972919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5609492|NCT01972919|Antiviral Agents|antiviral agents|mesh-ancestor
5609493|NCT01972919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5609494|NCT01972919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5609495|NCT01972919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5609496|NCT01972919|Immunologic Factors|immunologic factors|mesh-ancestor
5609497|NCT01972919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5609498|NCT01716806|Nivolumab|nivolumab|mesh-list
5609499|NCT01716806|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5609500|NCT01716806|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5609501|NCT01716806|Dacarbazine|dacarbazine|mesh-list
5609502|NCT01716806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5609503|NCT01716806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5609504|NCT01716806|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5609505|NCT01716806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609506|NCT01716806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5609507|NCT01716806|Alkylating Agents|alkylating agents|mesh-ancestor
5609508|NCT01524536|Prednisone|prednisone|mesh-list
5609509|NCT01524536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5609510|NCT01524536|Glucocorticoids|glucocorticoids|mesh-ancestor
5609511|NCT01524536|Hormones|hormones|mesh-ancestor
5609512|NCT01524536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5609513|NCT01524536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5609514|NCT01524536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5609515|NCT01524536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5609516|NCT01485874|Doxorubicin|doxorubicin|mesh-list
5609517|NCT01485874|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5609518|NCT01485874|Nintedanib|nintedanib|mesh-list
5609519|NCT01485874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5609520|NCT01485874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5609521|NCT01485874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5609522|NCT01485874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5609523|NCT01485874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5609524|NCT01485874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609525|NCT01485874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5691627|NCT03415711|Sensory System Agents|sensory system agents|mesh-ancestor
5691628|NCT03415711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5691629|NCT03415711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691630|NCT03415711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5691631|NCT03415711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5691632|NCT03415646|Morphine|morphine|mesh-list
5691633|NCT03415646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5691634|NCT03415646|Narcotics|narcotics|mesh-ancestor
5691635|NCT03415646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5691636|NCT03415646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691637|NCT03415646|Analgesics|analgesics|mesh-ancestor
5691638|NCT03415646|Sensory System Agents|sensory system agents|mesh-ancestor
5691639|NCT03415646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5691640|NCT03415594|Glucagon|glucagon|mesh-list
5691641|NCT03415594|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5691642|NCT03415594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5691643|NCT03415594|Hormones|hormones|mesh-ancestor
5691644|NCT03415594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5691645|NCT03415594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691646|NCT03415594|Incretins|incretins|mesh-ancestor
5691647|NCT03415555|Acetaminophen|acetaminophen|mesh-list
5691648|NCT03415555|Oxycodone|oxycodone|mesh-list
5691649|NCT03415555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5691650|NCT03415555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691651|NCT03415555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5691652|NCT03415555|Analgesics|analgesics|mesh-ancestor
5691653|NCT03415555|Sensory System Agents|sensory system agents|mesh-ancestor
5691654|NCT03415555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5691655|NCT03415555|Antipyretics|antipyretics|mesh-ancestor
5691656|NCT03415555|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5691657|NCT03415555|Narcotics|narcotics|mesh-ancestor
5691658|NCT03415477|Denosumab|denosumab|mesh-list
5691659|NCT03415477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5691660|NCT03415477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691661|NCT03415386|Anticoagulants|anticoagulants|mesh-list
5691662|NCT03415386|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
5691663|NCT03415269|Ambroxol|ambroxol|mesh-list
5691664|NCT03415269|Expectorants|expectorants|mesh-ancestor
5691665|NCT03415269|Respiratory System Agents|respiratory system agents|mesh-ancestor
5609526|NCT01424982|Cytarabine|cytarabine|mesh-list
5609527|NCT01424982|Dexamethasone|dexamethasone|mesh-list
5609528|NCT01424982|Prednisone|prednisone|mesh-list
5609529|NCT01424982|Dexamethasone acetate|dexamethasone acetate|mesh-list
5609530|NCT01424982|Cortisone|cortisone|mesh-list
5609531|NCT01424982|Cyclophosphamide|cyclophosphamide|mesh-list
5609532|NCT01424982|Rituximab|rituximab|mesh-list
5609533|NCT01424982|Doxorubicin|doxorubicin|mesh-list
5609534|NCT01424982|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5609535|NCT01424982|Methotrexate|methotrexate|mesh-list
5609536|NCT01424982|Vincristine|vincristine|mesh-list
5609537|NCT01424982|Daunorubicin|daunorubicin|mesh-list
5609538|NCT01424982|Ponatinib|ponatinib|mesh-list
5609539|NCT01424982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5609540|NCT01424982|Antibodies|antibodies|mesh-list
5609541|NCT01424982|Immunoglobulins|immunoglobulins|mesh-list
5609542|NCT01424982|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5609543|NCT01424982|BB 1101|bb 1101|mesh-list
5609544|NCT01424982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5609545|NCT01424982|Immunologic Factors|immunologic factors|mesh-ancestor
5609546|NCT01424982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5609547|NCT01424982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5609548|NCT01424982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5609549|NCT01424982|Alkylating Agents|alkylating agents|mesh-ancestor
5609550|NCT01424982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609551|NCT01424982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5609552|NCT01424982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5609553|NCT01424982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5609554|NCT01424982|Antiemetics|antiemetics|mesh-ancestor
5609555|NCT01424982|Autonomic Agents|autonomic agents|mesh-ancestor
5609556|NCT01424982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5609557|NCT01424982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5609558|NCT01424982|Glucocorticoids|glucocorticoids|mesh-ancestor
5609559|NCT01424982|Hormones|hormones|mesh-ancestor
5609560|NCT01424982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5609561|NCT01424982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5609562|NCT01424982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5609563|NCT01424982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5609564|NCT01424982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5609565|NCT01424982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5609566|NCT01424982|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5609567|NCT01424982|Abortifacient Agents|abortifacient agents|mesh-ancestor
5609568|NCT01424982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5609569|NCT01424982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5609570|NCT01424982|Antimetabolites|antimetabolites|mesh-ancestor
5609571|NCT01424982|Dermatologic Agents|dermatologic agents|mesh-ancestor
5609572|NCT01424982|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5609573|NCT01424982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5609574|NCT01424982|Antiviral Agents|antiviral agents|mesh-ancestor
5609575|NCT01424982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5609576|NCT01424982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5609577|NCT01424982|Tubulin Modulators|tubulin modulators|mesh-ancestor
5609578|NCT01424982|Antimitotic Agents|antimitotic agents|mesh-ancestor
5609579|NCT01424982|Mitosis Modulators|mitosis modulators|mesh-ancestor
5609580|NCT01424982|Protease Inhibitors|protease inhibitors|mesh-ancestor
5609581|NCT01424982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5609582|NCT01307046|Losartan|losartan|mesh-list
5609583|NCT01307046|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5609584|NCT01307046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5609585|NCT01307046|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5609586|NCT01307046|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5609587|NCT01307046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609588|NCT01307033|Losartan|losartan|mesh-list
5609589|NCT01307033|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5609590|NCT01307033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5609591|NCT01307033|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5609592|NCT01307033|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5609593|NCT01307033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609594|NCT01041807|Losartan|losartan|mesh-list
5609595|NCT01041807|Amlodipine|amlodipine|mesh-list
5609596|NCT01041807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5609597|NCT01041807|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5609598|NCT01041807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5609599|NCT01041807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609600|NCT01041807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5609601|NCT01041807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5609602|NCT01041807|Vasodilator Agents|vasodilator agents|mesh-ancestor
5609603|NCT01041807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5609604|NCT01041807|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5609605|NCT01041807|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5609606|NCT00954226|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5609607|NCT00954226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5609608|NCT00954226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5609609|NCT00954226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5609610|NCT00954226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609611|NCT00942331|Gemcitabine|gemcitabine|mesh-list
5609612|NCT00942331|Bevacizumab|bevacizumab|mesh-list
5609613|NCT00942331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5609614|NCT00942331|Cisplatin|cisplatin|mesh-list
5609615|NCT00942331|Endothelial Growth Factors|endothelial growth factors|mesh-list
5609616|NCT00942331|Antibodies|antibodies|mesh-list
5609617|NCT00942331|Immunoglobulins|immunoglobulins|mesh-list
5609618|NCT00942331|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5609619|NCT00942331|Immunoglobulin G|immunoglobulin g|mesh-list
5609620|NCT00942331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5609621|NCT00942331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5609622|NCT00942331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5609623|NCT00942331|Growth Substances|growth substances|mesh-ancestor
5609624|NCT00942331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726524|NCT03172871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5726525|NCT03172871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726526|NCT03172871|Dopamine Agonists|dopamine agonists|mesh-ancestor
5726527|NCT03172871|Dopamine Agents|dopamine agents|mesh-ancestor
5726528|NCT03172871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5726529|NCT03172871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726530|NCT03172871|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5726531|NCT03172871|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5726532|NCT03172871|Serotonin Agents|serotonin agents|mesh-ancestor
5726533|NCT03172871|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5726534|NCT03172871|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5726535|NCT03172871|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5726536|NCT03172871|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5726537|NCT03172988|Dexamethasone|dexamethasone|mesh-list
5726538|NCT03172988|Dexamethasone acetate|dexamethasone acetate|mesh-list
5726539|NCT03172988|Flurbiprofen|flurbiprofen|mesh-list
5726540|NCT03172988|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
5726541|NCT03172988|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
5726542|NCT03172988|BB 1101|bb 1101|mesh-list
5609625|NCT00942331|Growth Inhibitors|growth inhibitors|mesh-ancestor
5609626|NCT00942331|Immunologic Factors|immunologic factors|mesh-ancestor
5609627|NCT00942331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5609628|NCT00942331|Antimetabolites|antimetabolites|mesh-ancestor
5609629|NCT00942331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726543|NCT03172988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5726544|NCT03172988|Antiemetics|antiemetics|mesh-ancestor
5726545|NCT03172988|Autonomic Agents|autonomic agents|mesh-ancestor
5726546|NCT03172988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5726547|NCT03172988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726548|NCT03172988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5726549|NCT03172988|Glucocorticoids|glucocorticoids|mesh-ancestor
5726550|NCT03172988|Hormones|hormones|mesh-ancestor
5726551|NCT03172988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5726552|NCT03172988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5726553|NCT03172988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5726554|NCT03172988|Protease Inhibitors|protease inhibitors|mesh-ancestor
5726555|NCT03172988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5726556|NCT03172988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726557|NCT03172988|Analgesics|analgesics|mesh-ancestor
5726558|NCT03172988|Sensory System Agents|sensory system agents|mesh-ancestor
5726559|NCT03172988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5726560|NCT03172988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5726561|NCT03172988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5726562|NCT03172988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5726563|NCT03172897|Dexmedetomidine|dexmedetomidine|mesh-list
5726564|NCT03172897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5726565|NCT03172897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5726566|NCT03172897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726567|NCT03172897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5726568|NCT03172897|Analgesics|analgesics|mesh-ancestor
5609630|NCT00942331|Antiviral Agents|antiviral agents|mesh-ancestor
5609631|NCT00942331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5609632|NCT00942331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5609633|NCT00942331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5609634|NCT00739674|Losartan|losartan|mesh-list
5609635|NCT00739674|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5609636|NCT00739674|Calcium Channel Blockers|calcium channel blockers|mesh-list
5609637|NCT00739674|Calcium|calcium|mesh-list
5609638|NCT00739674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5609639|NCT00739674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5609640|NCT00739674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5609641|NCT00739674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5609642|NCT00739674|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5609643|NCT00739674|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5609644|NCT00739674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609645|NCT00739674|Diuretics|diuretics|mesh-ancestor
5609646|NCT00739674|Natriuretic Agents|natriuretic agents|mesh-ancestor
5609647|NCT00739674|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5609648|NCT00739674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5609649|NCT00731757|Adalimumab|adalimumab|mesh-list
5609650|NCT00731757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5609651|NCT00731757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5609652|NCT00730717|Adalimumab|adalimumab|mesh-list
5609653|NCT00730717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5609654|NCT00730717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5609655|NCT00546754|Losartan|losartan|mesh-list
5609656|NCT00546754|Valsartan|valsartan|mesh-list
5609657|NCT00546754|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5609658|NCT00546754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5609659|NCT00546754|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5609660|NCT00546754|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5609661|NCT00546754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609662|NCT00546754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5609663|NCT00546754|Diuretics|diuretics|mesh-ancestor
5609664|NCT00546754|Natriuretic Agents|natriuretic agents|mesh-ancestor
5609665|NCT00546754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5609666|NCT00546754|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5609667|NCT00546754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5609668|NCT00482157|Vitamin D|vitamin d|mesh-list
5609669|NCT00482157|Calcitriol|calcitriol|mesh-list
5609670|NCT00482157|Vitamins|vitamins|mesh-ancestor
5609671|NCT00482157|Micronutrients|micronutrients|mesh-ancestor
5609672|NCT00482157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5609673|NCT00482157|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5609674|NCT00482157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5609675|NCT00482157|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
5609676|NCT00482157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5609677|NCT00482157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609678|NCT00482157|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5609679|NCT00480805|Losartan|losartan|mesh-list
5609680|NCT00480805|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5609681|NCT00480805|Ramipril|ramipril|mesh-list
5609682|NCT00480805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5609683|NCT00480805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5609684|NCT00480805|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5609685|NCT00480805|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5609686|NCT00480805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609687|NCT00480805|Diuretics|diuretics|mesh-ancestor
5609688|NCT00480805|Natriuretic Agents|natriuretic agents|mesh-ancestor
5609689|NCT00480805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5609690|NCT00480805|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5609691|NCT00480805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5609692|NCT00480805|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5609693|NCT00480805|Protease Inhibitors|protease inhibitors|mesh-ancestor
5609694|NCT00480805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5609695|NCT00479713|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5609696|NCT00479713|Simvastatin|simvastatin|mesh-list
5609697|NCT00479713|Ezetimibe|ezetimibe|mesh-list
5609698|NCT00479713|Calcium|calcium|mesh-list
5609699|NCT00479713|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5609700|NCT00479713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5609701|NCT00479713|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5609702|NCT00479713|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5609703|NCT00479713|Antimetabolites|antimetabolites|mesh-ancestor
5609704|NCT00479713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609705|NCT00479713|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5609706|NCT00479713|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5609707|NCT00479713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5609708|NCT00457275|Ezetimibe|ezetimibe|mesh-list
5609709|NCT00457275|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5609710|NCT00457275|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5609711|NCT00457275|Antimetabolites|antimetabolites|mesh-ancestor
5609712|NCT00457275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609713|NCT00457275|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5609714|NCT00449111|Losartan|losartan|mesh-list
5609715|NCT00449111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5609716|NCT00449111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5609717|NCT00449111|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5609718|NCT00449111|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5609719|NCT00449111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609720|NCT00406783|Desloratadine|desloratadine|mesh-list
5609721|NCT00406783|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5609722|NCT00406783|Cholinergic Agents|cholinergic agents|mesh-ancestor
5609723|NCT00406783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5609724|NCT00406783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609725|NCT00406783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5609726|NCT00406783|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5609727|NCT00406783|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5609728|NCT00406783|Histamine Antagonists|histamine antagonists|mesh-ancestor
5609729|NCT00406783|Histamine Agents|histamine agents|mesh-ancestor
5609730|NCT00405964|Desloratadine|desloratadine|mesh-list
5609731|NCT00405964|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5609732|NCT00405964|Cholinergic Agents|cholinergic agents|mesh-ancestor
5609733|NCT00405964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5609734|NCT00405964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609735|NCT00405964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5609736|NCT00405964|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5609737|NCT00405964|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5609738|NCT00405964|Histamine Antagonists|histamine antagonists|mesh-ancestor
5609739|NCT00405964|Histamine Agents|histamine agents|mesh-ancestor
5609740|NCT00400218|Losartan|losartan|mesh-list
5609741|NCT00400218|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5609742|NCT00400218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5609743|NCT00400218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5609744|NCT00400218|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5609745|NCT00400218|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5609746|NCT00400218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609747|NCT00400218|Diuretics|diuretics|mesh-ancestor
5609748|NCT00400218|Natriuretic Agents|natriuretic agents|mesh-ancestor
5609749|NCT00400218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5609750|NCT00400218|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5609751|NCT00400218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5609752|NCT00398541|Losartan|losartan|mesh-list
5609753|NCT00398541|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5609754|NCT00398541|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5609755|NCT00398541|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5609756|NCT00398541|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5609757|NCT00398541|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5609758|NCT00398541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609759|NCT00398541|Diuretics|diuretics|mesh-ancestor
5609760|NCT00398541|Natriuretic Agents|natriuretic agents|mesh-ancestor
5609761|NCT00398541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5609762|NCT00398541|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5609763|NCT00398541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5726569|NCT03172897|Sensory System Agents|sensory system agents|mesh-ancestor
5726570|NCT03172897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5726571|NCT03172897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5726572|NCT03172897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5726573|NCT03172897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5726574|NCT03172897|Adrenergic Agents|adrenergic agents|mesh-ancestor
5726575|NCT03172897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5726576|NCT03172897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726577|NCT03173053|Chlorhexidine|chlorhexidine|mesh-list
5726578|NCT03173053|Povidone-Iodine|povidone-iodine|mesh-list
5726579|NCT03173053|Clarithromycin|clarithromycin|mesh-list
5726580|NCT03173053|Doxycycline|doxycycline|mesh-list
5726581|NCT03173053|Ciprofloxacin|ciprofloxacin|mesh-list
5609764|NCT00383721|Mometasone Furoate|mometasone furoate|mesh-list
5609765|NCT00383721|Formoterol Fumarate|formoterol fumarate|mesh-list
5609766|NCT00383721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5609767|NCT00383721|Autonomic Agents|autonomic agents|mesh-ancestor
5609768|NCT00383721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5609769|NCT00383721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5609770|NCT00383721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5609771|NCT00383721|Respiratory System Agents|respiratory system agents|mesh-ancestor
5609772|NCT00383721|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5609773|NCT00383721|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5609774|NCT00383721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5609775|NCT00383721|Adrenergic Agents|adrenergic agents|mesh-ancestor
5609776|NCT00383721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5609777|NCT00383721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609778|NCT00383721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5609779|NCT00383721|Dermatologic Agents|dermatologic agents|mesh-ancestor
5609780|NCT00383721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5609781|NCT00383552|Mometasone Furoate|mometasone furoate|mesh-list
5609782|NCT00383552|Formoterol Fumarate|formoterol fumarate|mesh-list
5726582|NCT03173053|Rifampin|rifampin|mesh-list
5726583|NCT03173053|Clindamycin|clindamycin|mesh-list
5726584|NCT03173053|Trimethoprim|trimethoprim|mesh-list
5726585|NCT03173053|Sulfamethoxazole|sulfamethoxazole|mesh-list
5726586|NCT03173053|Mupirocin|mupirocin|mesh-list
5726587|NCT03173053|Fusidic Acid|fusidic acid|mesh-list
5726588|NCT03173053|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
5726589|NCT03173053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5726590|NCT03173053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5726591|NCT03173053|Disinfectants|disinfectants|mesh-ancestor
5726592|NCT03173053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5726593|NCT03173053|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5726594|NCT03173053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5726595|NCT03173053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726596|NCT03173053|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5726597|NCT03173053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5726598|NCT03173053|Antimalarials|antimalarials|mesh-ancestor
5726599|NCT03173053|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5726600|NCT03173053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5726601|NCT03173053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5726602|NCT03173053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5726603|NCT03173053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5726604|NCT03173053|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5726605|NCT03173053|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5726606|NCT03173053|Antitubercular Agents|antitubercular agents|mesh-ancestor
5726607|NCT03173053|Leprostatic Agents|leprostatic agents|mesh-ancestor
5726608|NCT03173053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5726609|NCT03173053|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5726610|NCT03173053|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5726611|NCT03173053|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5726612|NCT03173053|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5726613|NCT03173053|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5726614|NCT03173053|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5726615|NCT03173053|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5726616|NCT03173053|Renal Agents|renal agents|mesh-ancestor
5726617|NCT03173053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5726618|NCT03173053|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5726619|NCT03173053|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
5609783|NCT00383552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5609784|NCT00383552|Autonomic Agents|autonomic agents|mesh-ancestor
5609785|NCT00383552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5691666|NCT03415191|Ketamine|ketamine|mesh-list
5691667|NCT03415191|Analgesics|analgesics|mesh-ancestor
5691668|NCT03415191|Sensory System Agents|sensory system agents|mesh-ancestor
5691669|NCT03415191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5691670|NCT03415191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691671|NCT03415191|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5691672|NCT03415191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5691673|NCT03415191|Anesthetics, General|anesthetics, general|mesh-ancestor
5691674|NCT03415191|Anesthetics|anesthetics|mesh-ancestor
5691675|NCT03415191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5691676|NCT03415191|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5691677|NCT03415191|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5697592|NCT03374878|Contraceptive Agents|contraceptive agents|mesh-list
5726620|NCT03173066|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
5726621|NCT03173066|Hematinics|hematinics|mesh-ancestor
5726622|NCT03173066|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5726623|NCT03173066|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5726624|NCT03173092|Dexamethasone|dexamethasone|mesh-list
5726625|NCT03173092|Lenalidomide|lenalidomide|mesh-list
5726626|NCT03173092|Ixazomib|ixazomib|mesh-list
5726627|NCT03173092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5726628|NCT03173092|Antiemetics|antiemetics|mesh-ancestor
5726629|NCT03173092|Autonomic Agents|autonomic agents|mesh-ancestor
5726630|NCT03173092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5609786|NCT00383552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5609787|NCT00383552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5609788|NCT00383552|Respiratory System Agents|respiratory system agents|mesh-ancestor
5609789|NCT00383552|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5609790|NCT00383552|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5609791|NCT00383552|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5609792|NCT00383552|Adrenergic Agents|adrenergic agents|mesh-ancestor
5726631|NCT03173092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726632|NCT03173092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5726633|NCT03173092|Glucocorticoids|glucocorticoids|mesh-ancestor
5726634|NCT03173092|Hormones|hormones|mesh-ancestor
5726635|NCT03173092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5726636|NCT03173092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5726637|NCT03173092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5726638|NCT03173092|Immunologic Factors|immunologic factors|mesh-ancestor
5726639|NCT03173092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5726640|NCT03173092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5726641|NCT03173092|Growth Substances|growth substances|mesh-ancestor
5726642|NCT03173092|Growth Inhibitors|growth inhibitors|mesh-ancestor
5726643|NCT03173092|Protease Inhibitors|protease inhibitors|mesh-ancestor
5726644|NCT03173092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5726645|NCT03173092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726646|NCT03173131|Analgesics, Opioid|analgesics, opioid|mesh-list
5726647|NCT03173131|Narcotics|narcotics|mesh-ancestor
5726648|NCT03173131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5726649|NCT03173131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726650|NCT03173131|Analgesics|analgesics|mesh-ancestor
5726651|NCT03173131|Sensory System Agents|sensory system agents|mesh-ancestor
5726652|NCT03173131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5726653|NCT03172819|Pembrolizumab|pembrolizumab|mesh-list
5726654|NCT03172819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5726655|NCT03172819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5726656|NCT03172676|Amoxicillin|amoxicillin|mesh-list
5726657|NCT03172676|Clarithromycin|clarithromycin|mesh-list
5726658|NCT03172676|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
5726659|NCT03172676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5726660|NCT03172676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5726661|NCT03172676|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5726662|NCT03172676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5726663|NCT03172676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726664|NCT03172676|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5726665|NCT03172676|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5726666|NCT03172793|Telavancin|telavancin|mesh-list
5726667|NCT03172793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5726668|NCT03172793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5726669|NCT03172741|Dronabinol|dronabinol|mesh-list
5726670|NCT03172741|Cannabidiol|cannabidiol|mesh-list
5726671|NCT03172741|Anticonvulsants|anticonvulsants|mesh-ancestor
5726672|NCT03172741|Hallucinogens|hallucinogens|mesh-ancestor
5726673|NCT03172741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726674|NCT03172741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5609793|NCT00383552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5609794|NCT00383552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609795|NCT00383552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5609796|NCT00383552|Dermatologic Agents|dermatologic agents|mesh-ancestor
5609797|NCT00383552|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5609798|NCT00383435|Mometasone Furoate|mometasone furoate|mesh-list
5609799|NCT00383435|Formoterol Fumarate|formoterol fumarate|mesh-list
5609800|NCT00383435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5609801|NCT00383435|Autonomic Agents|autonomic agents|mesh-ancestor
5609802|NCT00383435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5609803|NCT00383435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726675|NCT03172741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5726676|NCT03172741|Analgesics|analgesics|mesh-ancestor
5726677|NCT03172741|Sensory System Agents|sensory system agents|mesh-ancestor
5726678|NCT03172741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5726679|NCT03172741|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5726680|NCT03172741|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5726681|NCT03172741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5726682|NCT03172741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726683|NCT03172741|Hormones|hormones|mesh-ancestor
5726684|NCT03172741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5726685|NCT03172455|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
5726686|NCT03172455|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5726687|NCT03172455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5726688|NCT03172455|Protease Inhibitors|protease inhibitors|mesh-ancestor
5726689|NCT03172455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5609804|NCT00383435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5609805|NCT00383435|Respiratory System Agents|respiratory system agents|mesh-ancestor
5609806|NCT00383435|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5609807|NCT00383435|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5609808|NCT00383435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5609809|NCT00383435|Adrenergic Agents|adrenergic agents|mesh-ancestor
5609810|NCT00383435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5609811|NCT00383435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609812|NCT00383435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5726690|NCT03172455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726691|NCT03172624|Nivolumab|nivolumab|mesh-list
5726692|NCT03172624|Ipilimumab|ipilimumab|mesh-list
5726693|NCT03172624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5726694|NCT03172624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5726695|NCT03172624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5726696|NCT03172624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726697|NCT03172377|Adalimumab|adalimumab|mesh-list
5726698|NCT03172377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5726699|NCT03172377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5726700|NCT03172416|Oxaliplatin|oxaliplatin|mesh-list
5726701|NCT03172416|Nivolumab|nivolumab|mesh-list
5726702|NCT03172416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5726703|NCT03172416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5726704|NCT03172416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5726705|NCT03172416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726706|NCT03172299|Aflibercept|aflibercept|mesh-list
5726707|NCT03172299|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5726708|NCT03172299|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5726709|NCT03172299|Growth Substances|growth substances|mesh-ancestor
5609813|NCT00383435|Dermatologic Agents|dermatologic agents|mesh-ancestor
5609814|NCT00383435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5609815|NCT00381485|Mometasone Furoate|mometasone furoate|mesh-list
5726710|NCT03172299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726711|NCT03172299|Growth Inhibitors|growth inhibitors|mesh-ancestor
5726712|NCT03172299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5726713|NCT03172533|Dienogest|dienogest|mesh-list
5726714|NCT03172533|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5726715|NCT03172533|Estradiol|estradiol|mesh-list
5726716|NCT03172533|Estrogens|estrogens|mesh-ancestor
5726717|NCT03172533|Hormones|hormones|mesh-ancestor
5726718|NCT03172533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5726719|NCT03172533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726720|NCT03172533|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5726721|NCT03172533|Contraceptive Agents|contraceptive agents|mesh-ancestor
5726722|NCT03172533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5726723|NCT03172533|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5726724|NCT03172533|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5726725|NCT03172533|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5726726|NCT03172533|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5726727|NCT03172533|Hormone Antagonists|hormone antagonists|mesh-ancestor
5726728|NCT03172533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5726729|NCT03172533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5726730|NCT03172234|Amantadine|amantadine|mesh-list
5726731|NCT03172234|Gabapentin|gabapentin|mesh-list
5726732|NCT03172234|Analgesics|analgesics|mesh-ancestor
5726733|NCT03172234|Sensory System Agents|sensory system agents|mesh-ancestor
5726734|NCT03172234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5726735|NCT03172234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726736|NCT03172234|Anticonvulsants|anticonvulsants|mesh-ancestor
5726737|NCT03172234|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5726738|NCT03172234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5609816|NCT00381485|Formoterol Fumarate|formoterol fumarate|mesh-list
5609817|NCT00381485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5726739|NCT03172234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5726740|NCT03172234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5726741|NCT03172234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5726742|NCT03172234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5726743|NCT03172234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5726744|NCT03172234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726745|NCT03172234|Antimanic Agents|antimanic agents|mesh-ancestor
5726746|NCT03172234|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5726747|NCT03172234|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5726748|NCT03172234|Antiviral Agents|antiviral agents|mesh-ancestor
5726749|NCT03172234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5726750|NCT03172234|Dopamine Agents|dopamine agents|mesh-ancestor
5726751|NCT03172234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5609818|NCT00381485|Autonomic Agents|autonomic agents|mesh-ancestor
5609819|NCT00381485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5609820|NCT00381485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5609821|NCT00381485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5609822|NCT00381485|Respiratory System Agents|respiratory system agents|mesh-ancestor
5609823|NCT00381485|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5609824|NCT00381485|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5609825|NCT00381485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5609826|NCT00381485|Adrenergic Agents|adrenergic agents|mesh-ancestor
5609827|NCT00381485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5609828|NCT00381485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609829|NCT00381485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5609830|NCT00381485|Dermatologic Agents|dermatologic agents|mesh-ancestor
5609831|NCT00381485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5609832|NCT00379288|Fluticasone|fluticasone|mesh-list
5609833|NCT00379288|Xhance|xhance|mesh-list
5609834|NCT00379288|Mometasone Furoate|mometasone furoate|mesh-list
5609835|NCT00379288|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5609836|NCT00379288|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
5609837|NCT00379288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5726752|NCT03171974|Dexamethasone|dexamethasone|mesh-list
5726753|NCT03171974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5726754|NCT03171974|Antiemetics|antiemetics|mesh-ancestor
5726755|NCT03171974|Autonomic Agents|autonomic agents|mesh-ancestor
5726756|NCT03171974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5726757|NCT03171974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726758|NCT03171974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5726759|NCT03171974|Glucocorticoids|glucocorticoids|mesh-ancestor
5726760|NCT03171974|Hormones|hormones|mesh-ancestor
5726761|NCT03171974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5726762|NCT03171974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5726763|NCT03171974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5726764|NCT03171987|Flurbiprofen|flurbiprofen|mesh-list
5726765|NCT03171987|Lidocaine|lidocaine|mesh-list
5609838|NCT00379288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5609839|NCT00379288|Autonomic Agents|autonomic agents|mesh-ancestor
5609840|NCT00379288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5609841|NCT00379288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5609842|NCT00379288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5609843|NCT00379288|Respiratory System Agents|respiratory system agents|mesh-ancestor
5609844|NCT00379288|Dermatologic Agents|dermatologic agents|mesh-ancestor
5609845|NCT00379288|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5726766|NCT03171987|Anesthetics, Local|anesthetics, local|mesh-ancestor
5726767|NCT03171987|Anesthetics|anesthetics|mesh-ancestor
5726768|NCT03171987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5726769|NCT03171987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726770|NCT03171987|Sensory System Agents|sensory system agents|mesh-ancestor
5726771|NCT03171987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5726772|NCT03171987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5726773|NCT03171987|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5726774|NCT03171987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5726775|NCT03171987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5726776|NCT03171987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726777|NCT03171987|Analgesics|analgesics|mesh-ancestor
5609846|NCT00379288|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5609847|NCT00379288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5609848|NCT00379288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5609849|NCT00379288|Adrenergic Agents|adrenergic agents|mesh-ancestor
5609850|NCT00379288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5697593|NCT03374878|Contraceptives, Oral|contraceptives, oral|mesh-list
5609851|NCT00379288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609852|NCT00379288|Glucocorticoids|glucocorticoids|mesh-ancestor
5609853|NCT00379288|Hormones|hormones|mesh-ancestor
5609854|NCT00379288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5609855|NCT00379288|Sympathomimetics|sympathomimetics|mesh-ancestor
5609856|NCT00378378|Mometasone Furoate|mometasone furoate|mesh-list
5609857|NCT00378378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5609858|NCT00378378|Dermatologic Agents|dermatologic agents|mesh-ancestor
5609859|NCT00378378|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5609860|NCT00338260|Atenolol|atenolol|mesh-list
5609861|NCT00338260|Adrenergic Agents|adrenergic agents|mesh-ancestor
5609862|NCT00338260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5609863|NCT00338260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609864|NCT00338260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5609865|NCT00338260|Autonomic Agents|autonomic agents|mesh-ancestor
5609866|NCT00338260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5609867|NCT00338260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5609868|NCT00338260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5609869|NCT00338260|Sympatholytics|sympatholytics|mesh-ancestor
5609870|NCT00338260|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5609871|NCT00338260|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5609872|NCT00338260|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5609873|NCT00308347|Losartan|losartan|mesh-list
5609874|NCT00308347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5609875|NCT00308347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5726778|NCT03171987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5726779|NCT03171987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5726780|NCT03171987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5726781|NCT03171987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5726782|NCT03171987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5726783|NCT03171987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5726784|NCT03172052|Streptokinase|streptokinase|mesh-list
5726785|NCT03172052|Mesna|mesna|mesh-list
5726786|NCT03172052|Protective Agents|protective agents|mesh-ancestor
5726787|NCT03172052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726788|NCT03172052|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5726789|NCT03172052|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5726790|NCT03172052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892593|NCT04930237|Calcium|calcium|mesh-list
5892594|NCT04930237|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6672667|NCT01557478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672668|NCT01557478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5892595|NCT04930237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892596|NCT04930237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892597|NCT04930237|Cathartics|cathartics|mesh-ancestor
5892598|NCT04930237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5892599|NCT04930237|Laxatives|laxatives|mesh-ancestor
5892600|NCT04930237|Antacids|antacids|mesh-ancestor
5892601|NCT04930237|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5892602|NCT04930237|Sensory System Agents|sensory system agents|mesh-ancestor
5892603|NCT04930237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5892604|NCT04930237|Antidiarrheals|antidiarrheals|mesh-ancestor
5892605|NCT04836429|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
5892606|NCT04836429|Trioxsalen|trioxsalen|mesh-list
5892607|NCT04836429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5892608|NCT04836429|Dermatologic Agents|dermatologic agents|mesh-ancestor
5892609|NCT04836429|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5892610|NCT04768504|Tofacitinib|tofacitinib|mesh-list
5892611|NCT04768504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5892612|NCT04768504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5892613|NCT04768504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892614|NCT04753437|Amoxicillin|amoxicillin|mesh-list
5892615|NCT04753437|Clarithromycin|clarithromycin|mesh-list
5892616|NCT04753437|Potassium Citrate|potassium citrate|mesh-list
5892617|NCT04753437|Esomeprazole|esomeprazole|mesh-list
5892618|NCT04753437|Bismuth|bismuth|mesh-list
5892619|NCT04753437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892620|NCT04753437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5892621|NCT04753437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5892622|NCT04753437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5892623|NCT04753437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5892624|NCT04753437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5892625|NCT04753437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5892626|NCT04753437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5726791|NCT03172065|Dexmedetomidine|dexmedetomidine|mesh-list
5726792|NCT03172065|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5726793|NCT03172065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5726794|NCT03172065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726795|NCT03172065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5726796|NCT03172065|Analgesics|analgesics|mesh-ancestor
5726797|NCT03172065|Sensory System Agents|sensory system agents|mesh-ancestor
5726798|NCT03172065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5609876|NCT00308347|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5609877|NCT00308347|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5609878|NCT00308347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609879|NCT00307060|Losartan|losartan|mesh-list
5609880|NCT00307060|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5609881|NCT00307060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5609882|NCT00307060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5609883|NCT00307060|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5609884|NCT00307060|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5609885|NCT00307060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609886|NCT00307060|Diuretics|diuretics|mesh-ancestor
5609887|NCT00307060|Natriuretic Agents|natriuretic agents|mesh-ancestor
5609888|NCT00307060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5609889|NCT00307060|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5609890|NCT00307060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5609891|NCT00157963|Losartan|losartan|mesh-list
5609892|NCT00157963|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5609893|NCT00157963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5609894|NCT00157963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5609895|NCT00157963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5609896|NCT00157963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5609897|NCT00157963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609898|NCT00157963|Diuretics|diuretics|mesh-ancestor
5609899|NCT00157963|Natriuretic Agents|natriuretic agents|mesh-ancestor
5609900|NCT00157963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726799|NCT03172065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5726800|NCT03172065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5726801|NCT03172065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5726802|NCT03172065|Adrenergic Agents|adrenergic agents|mesh-ancestor
5726803|NCT03172065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5726804|NCT03172065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726805|NCT03171818|Darbepoetin alfa|darbepoetin alfa|mesh-list
5726806|NCT03171818|Hematinics|hematinics|mesh-ancestor
5726807|NCT03171831|Mycophenolic Acid|mycophenolic acid|mesh-list
5726808|NCT03171831|Cyclophosphamide|cyclophosphamide|mesh-list
5609901|NCT00157963|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5609902|NCT00157963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5609903|NCT00151424|Olanzapine|olanzapine|mesh-list
5726809|NCT03171831|Busulfan|busulfan|mesh-list
5726810|NCT03171831|Methotrexate|methotrexate|mesh-list
5726811|NCT03171831|Fludarabine|fludarabine|mesh-list
5726812|NCT03171831|Tacrolimus|tacrolimus|mesh-list
5726813|NCT03171831|Thymoglobulin|thymoglobulin|mesh-list
5726814|NCT03171831|Basiliximab|basiliximab|mesh-list
5726815|NCT03171831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5726816|NCT03171831|Immunologic Factors|immunologic factors|mesh-ancestor
5726817|NCT03171831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5609904|NCT00151424|Asenapine|asenapine|mesh-list
5609905|NCT00151424|Antiemetics|antiemetics|mesh-ancestor
5609906|NCT00151424|Autonomic Agents|autonomic agents|mesh-ancestor
5609907|NCT00151424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5609908|NCT00151424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5609909|NCT00151424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5609910|NCT00151424|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5609911|NCT00151424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5609912|NCT00151424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5609913|NCT00151424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5609914|NCT00151424|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5609915|NCT00151424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5609916|NCT00151424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5726818|NCT03171831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5726819|NCT03171831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5726820|NCT03171831|Alkylating Agents|alkylating agents|mesh-ancestor
5609917|NCT00151424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726821|NCT03171831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726822|NCT03171831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5726823|NCT03171831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5726824|NCT03171831|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5726825|NCT03171831|Abortifacient Agents|abortifacient agents|mesh-ancestor
5726826|NCT03171831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5726827|NCT03171831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5726828|NCT03171831|Antimetabolites|antimetabolites|mesh-ancestor
5726829|NCT03171831|Dermatologic Agents|dermatologic agents|mesh-ancestor
5726830|NCT03171831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5726831|NCT03171831|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5726832|NCT03171831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5726833|NCT03171831|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5726834|NCT03171831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5726835|NCT03171831|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5726836|NCT03171831|Antitubercular Agents|antitubercular agents|mesh-ancestor
5726837|NCT03171831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5726838|NCT03171831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5609918|NCT00151424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5609919|NCT00151424|Serotonin Agents|serotonin agents|mesh-ancestor
5609920|NCT00092690|Atorvastatin|atorvastatin|mesh-list
5726839|NCT03171727|Heparin|heparin|mesh-list
5726840|NCT03171727|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5726841|NCT03171727|Tinzaparin|tinzaparin|mesh-list
5726842|NCT03171727|Dalteparin|dalteparin|mesh-list
5726843|NCT03171727|Anticoagulants|anticoagulants|mesh-ancestor
5726844|NCT03171727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5726845|NCT03171727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5726846|NCT03171727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726847|NCT03171740|Midazolam|midazolam|mesh-list
5726848|NCT03171740|Dexmedetomidine|dexmedetomidine|mesh-list
5726849|NCT03171740|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5726850|NCT03171740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5726851|NCT03171740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5726852|NCT03171740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726853|NCT03171740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5609921|NCT00092690|Simvastatin|simvastatin|mesh-list
5609922|NCT00092690|Ezetimibe|ezetimibe|mesh-list
6208071|NCT02124161|Vaccines|vaccines|mesh-list
6208072|NCT02124161|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6208073|NCT02124161|Immunologic Factors|immunologic factors|mesh-ancestor
6208074|NCT02124161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208075|NCT02124512|Rifaximin|rifaximin|mesh-list
6208076|NCT02124512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6208077|NCT02124512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6208078|NCT02124512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6208079|NCT02124564|Lacosamide|lacosamide|mesh-list
6208080|NCT02124564|Anticonvulsants|anticonvulsants|mesh-ancestor
6208081|NCT02124564|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6208082|NCT02124564|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6208083|NCT02124564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6208084|NCT02124564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208085|NCT02124707|Paclitaxel|paclitaxel|mesh-list
5726854|NCT03171740|Analgesics|analgesics|mesh-ancestor
5726855|NCT03171740|Sensory System Agents|sensory system agents|mesh-ancestor
5726856|NCT03171740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6208086|NCT02124707|Carboplatin|carboplatin|mesh-list
6208087|NCT02124707|Cetuximab|cetuximab|mesh-list
6208088|NCT02124707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6208089|NCT02124707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5609923|NCT00092690|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5609924|NCT00092690|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5609925|NCT00092690|Antimetabolites|antimetabolites|mesh-ancestor
5609926|NCT00092690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609927|NCT00092690|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5609928|NCT00092690|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5609929|NCT00092690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5609930|NCT00092664|Simvastatin|simvastatin|mesh-list
5609931|NCT00092664|Ezetimibe|ezetimibe|mesh-list
5609932|NCT00092664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5726857|NCT03171740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5726858|NCT03171740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5726859|NCT03171740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5726860|NCT03171740|Adrenergic Agents|adrenergic agents|mesh-ancestor
5726861|NCT03171740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6208090|NCT02124707|Tubulin Modulators|tubulin modulators|mesh-ancestor
6208091|NCT02124707|Antimitotic Agents|antimitotic agents|mesh-ancestor
5609933|NCT00092664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5726862|NCT03171740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726863|NCT03171740|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5726864|NCT03171740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5726865|NCT03171740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5726866|NCT03171740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5609934|NCT00092664|Antimetabolites|antimetabolites|mesh-ancestor
5609935|NCT00092664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609936|NCT00092664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5609937|NCT00092664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5609938|NCT00092664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5609939|NCT00092651|Simvastatin|simvastatin|mesh-list
5609940|NCT00092651|Ezetimibe|ezetimibe|mesh-list
5609941|NCT00092651|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
5609942|NCT00092651|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5609943|NCT00092651|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5609944|NCT00092651|Antimetabolites|antimetabolites|mesh-ancestor
5609945|NCT00092651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609946|NCT00092651|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5609947|NCT00092651|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5609948|NCT00092651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5609949|NCT00092638|Ezetimibe|ezetimibe|mesh-list
5609950|NCT00092638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5609951|NCT00092638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5609952|NCT00092638|Antimetabolites|antimetabolites|mesh-ancestor
5609953|NCT00092638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609954|NCT00092638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5609955|NCT00092625|Ezetimibe|ezetimibe|mesh-list
5609956|NCT00092625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5609957|NCT00092625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5609958|NCT00092625|Antimetabolites|antimetabolites|mesh-ancestor
5726867|NCT03171740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5726868|NCT03171740|Anesthetics, General|anesthetics, general|mesh-ancestor
5726869|NCT03171740|Anesthetics|anesthetics|mesh-ancestor
5726870|NCT03171740|GABA Modulators|gaba modulators|mesh-ancestor
5726871|NCT03171740|GABA Agents|gaba agents|mesh-ancestor
5726872|NCT03171584|Itraconazole|itraconazole|mesh-list
5726873|NCT03171584|Fluconazole|fluconazole|mesh-list
5726874|NCT03171584|Terbinafine|terbinafine|mesh-list
5726875|NCT03171584|Antifungal Agents|antifungal agents|mesh-ancestor
5726876|NCT03171584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5726877|NCT03171584|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5726878|NCT03171584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5726879|NCT03171584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5726880|NCT03171584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726881|NCT03171584|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5726882|NCT03171584|Hormone Antagonists|hormone antagonists|mesh-ancestor
5726883|NCT03171584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5726884|NCT03171584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726885|NCT03171584|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5726886|NCT03171584|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5726887|NCT03171584|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5726888|NCT03171610|Fentanyl|fentanyl|mesh-list
5726889|NCT03171610|Sufentanil|sufentanil|mesh-list
5726890|NCT03171610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5726891|NCT03171610|Narcotics|narcotics|mesh-ancestor
5726892|NCT03171610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5726893|NCT03171610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726894|NCT03171610|Analgesics|analgesics|mesh-ancestor
5726895|NCT03171610|Sensory System Agents|sensory system agents|mesh-ancestor
5726896|NCT03171610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5726897|NCT03171610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5726898|NCT03171610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5726899|NCT03171610|Anesthetics, General|anesthetics, general|mesh-ancestor
5726900|NCT03171610|Anesthetics|anesthetics|mesh-ancestor
5726901|NCT03171597|Vasodilator Agents|vasodilator agents|mesh-list
5726902|NCT03171597|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
5726903|NCT03171597|Lipid Regulating Agents|lipid regulating agents|mesh-list
5726904|NCT03171389|Ponatinib|ponatinib|mesh-list
5726905|NCT03171389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5726906|NCT03171389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5726907|NCT03171389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5726908|NCT03171389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726909|NCT03171090|Anesthetics|anesthetics|mesh-list
5726910|NCT03171090|Anesthetics, Local|anesthetics, local|mesh-list
5726911|NCT03171090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5609959|NCT00092625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609960|NCT00092625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5726912|NCT03171090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726913|NCT03171090|Sensory System Agents|sensory system agents|mesh-ancestor
5726914|NCT03171090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5726915|NCT03170960|Atezolizumab|atezolizumab|mesh-list
5726916|NCT03170960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5726917|NCT03170895|Sorafenib|sorafenib|mesh-list
5726918|NCT03170895|Homoharringtonine|homoharringtonine|mesh-list
5726919|NCT03170895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5726920|NCT03170895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5726921|NCT03170895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5726922|NCT03170895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726923|NCT03170895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6489085|NCT00589238|Alkylating Agents|alkylating agents|mesh-ancestor
6489086|NCT00589238|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6489087|NCT00589238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6489088|NCT00589238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6489089|NCT00589238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6489090|NCT00589238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5726924|NCT03170895|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5609961|NCT00092612|Ezetimibe|ezetimibe|mesh-list
5609962|NCT00092612|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5609963|NCT00092612|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5609964|NCT00092612|Antimetabolites|antimetabolites|mesh-ancestor
5609965|NCT00092612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726925|NCT03171220|Cyclophosphamide|cyclophosphamide|mesh-list
5726926|NCT03171220|Fludarabine|fludarabine|mesh-list
5726927|NCT03171220|Interleukin-2|interleukin-2|mesh-list
5726928|NCT03171220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5726929|NCT03171220|Immunologic Factors|immunologic factors|mesh-ancestor
5726930|NCT03171220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726931|NCT03171220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5726932|NCT03171220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5726933|NCT03171220|Alkylating Agents|alkylating agents|mesh-ancestor
5726934|NCT03171220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726935|NCT03171220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5726936|NCT03171220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5726937|NCT03171220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5726938|NCT03171220|Analgesics|analgesics|mesh-ancestor
5726939|NCT03171220|Sensory System Agents|sensory system agents|mesh-ancestor
5726940|NCT03171220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5726941|NCT03170713|Ibuprofen|ibuprofen|mesh-list
5726942|NCT03170713|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
5726943|NCT03170713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5726944|NCT03170713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5726945|NCT03170713|Analgesics|analgesics|mesh-ancestor
5726946|NCT03170713|Sensory System Agents|sensory system agents|mesh-ancestor
5726947|NCT03170713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5726948|NCT03170713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726949|NCT03170713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5726950|NCT03170713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5726951|NCT03170713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5609966|NCT00092612|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5609967|NCT00092599|Ezetimibe|ezetimibe|mesh-list
5609968|NCT00092599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5609969|NCT00092599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5609970|NCT00092599|Antimetabolites|antimetabolites|mesh-ancestor
5609971|NCT00092599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609972|NCT00092599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5609973|NCT00092586|Ezetimibe|ezetimibe|mesh-list
5609974|NCT00092586|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5609975|NCT00092586|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5609976|NCT00092586|Antimetabolites|antimetabolites|mesh-ancestor
5609977|NCT00092586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609978|NCT00092586|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5609979|NCT00092573|Ezetimibe|ezetimibe|mesh-list
5609980|NCT00092573|Fenofibrate|fenofibrate|mesh-list
5609981|NCT00092573|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5609982|NCT00092573|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5609983|NCT00092573|Antimetabolites|antimetabolites|mesh-ancestor
5726952|NCT03170713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5726953|NCT03170713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726954|NCT03170596|Tazarotene|tazarotene|mesh-list
6489091|NCT00589251|Penicillins|penicillins|mesh-list
5726955|NCT03170596|Dermatologic Agents|dermatologic agents|mesh-ancestor
5726956|NCT03170596|Keratolytic Agents|keratolytic agents|mesh-ancestor
5726957|NCT03170687|Calpastatin|calpastatin|mesh-list
5726958|NCT03170687|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
5726959|NCT03170687|Protease Inhibitors|protease inhibitors|mesh-ancestor
5726960|NCT03170687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5726961|NCT03170687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726962|NCT03170726|Ibuprofen|ibuprofen|mesh-list
5726963|NCT03170726|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
5726964|NCT03170726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5726965|NCT03170726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5726966|NCT03170726|Analgesics|analgesics|mesh-ancestor
5726967|NCT03170726|Sensory System Agents|sensory system agents|mesh-ancestor
5726968|NCT03170726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5726969|NCT03170726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726970|NCT03170726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5726971|NCT03170726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5726972|NCT03170726|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5726973|NCT03170726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5609984|NCT00092573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609985|NCT00092573|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5609986|NCT00092560|Ezetimibe|ezetimibe|mesh-list
5609987|NCT00092560|Fenofibrate|fenofibrate|mesh-list
5609988|NCT00092560|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5609989|NCT00092560|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5609990|NCT00092560|Antimetabolites|antimetabolites|mesh-ancestor
5609991|NCT00092560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5609992|NCT00092560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5609993|NCT00092209|Losartan|losartan|mesh-list
5609994|NCT00092209|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5609995|NCT00092209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5609996|NCT00092209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5609997|NCT00092209|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5726974|NCT03170726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726975|NCT03170739|Dopamine|dopamine|mesh-list
5726976|NCT03170739|Dexmedetomidine|dexmedetomidine|mesh-list
5726977|NCT03170739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5726978|NCT03170739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5726979|NCT03170739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5726980|NCT03170739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5726981|NCT03170739|Analgesics|analgesics|mesh-ancestor
5726982|NCT03170739|Sensory System Agents|sensory system agents|mesh-ancestor
5726983|NCT03170739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5726984|NCT03170739|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5726985|NCT03170739|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5726986|NCT03170739|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5726987|NCT03170739|Adrenergic Agents|adrenergic agents|mesh-ancestor
5726988|NCT03170739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5726989|NCT03170739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726990|NCT03170739|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5726991|NCT03170739|Sympathomimetics|sympathomimetics|mesh-ancestor
5726992|NCT03170739|Autonomic Agents|autonomic agents|mesh-ancestor
5726993|NCT03170739|Dopamine Agents|dopamine agents|mesh-ancestor
5726994|NCT03170739|Protective Agents|protective agents|mesh-ancestor
5609998|NCT00092209|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5609999|NCT00092209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610000|NCT00092209|Diuretics|diuretics|mesh-ancestor
5610001|NCT00092209|Natriuretic Agents|natriuretic agents|mesh-ancestor
5610002|NCT00092209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610003|NCT00092209|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5610004|NCT00092209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5610005|NCT00092157|Simvastatin|simvastatin|mesh-list
5610006|NCT00092157|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5610007|NCT00092157|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5610008|NCT00092157|Antimetabolites|antimetabolites|mesh-ancestor
5610009|NCT00092157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5726995|NCT03170310|Apatinib|apatinib|mesh-list
5726996|NCT03170310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5726997|NCT03170310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5726998|NCT03170310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5726999|NCT03170310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892627|NCT04753437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5892628|NCT04753437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5727000|NCT03170323|Cyclosporine|cyclosporine|mesh-list
5727001|NCT03170323|Mycophenolic Acid|mycophenolic acid|mesh-list
5727002|NCT03170323|Cyclosporins|cyclosporins|mesh-list
5727003|NCT03170323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5727004|NCT03170323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5727005|NCT03170323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5727006|NCT03170323|Immunologic Factors|immunologic factors|mesh-ancestor
5610010|NCT00092157|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5610011|NCT00092157|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5610012|NCT00092157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5610013|NCT00090298|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5610014|NCT00090298|Simvastatin|simvastatin|mesh-list
5610015|NCT00090298|Ezetimibe|ezetimibe|mesh-list
5610016|NCT00090298|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5610017|NCT00090298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5610018|NCT00090298|Antimetabolites|antimetabolites|mesh-ancestor
5610019|NCT00090298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610020|NCT00090298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5610021|NCT00090298|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5610022|NCT00090298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5610023|NCT00090181|Diclofenac|diclofenac|mesh-list
5610024|NCT00090181|Etoricoxib|etoricoxib|mesh-list
5610025|NCT00090181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5610026|NCT00090181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5610027|NCT00090181|Analgesics|analgesics|mesh-ancestor
5610028|NCT00090181|Sensory System Agents|sensory system agents|mesh-ancestor
5610029|NCT00090181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5610030|NCT00090181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610031|NCT00090181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5610032|NCT00090181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5610033|NCT00090181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5610034|NCT00090181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5610035|NCT00090181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610036|NCT00090181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5610037|NCT00090168|Atorvastatin|atorvastatin|mesh-list
5610038|NCT00090168|Simvastatin|simvastatin|mesh-list
5610039|NCT00090168|Ezetimibe|ezetimibe|mesh-list
5610040|NCT00090168|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5610041|NCT00090168|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5610042|NCT00090168|Antimetabolites|antimetabolites|mesh-ancestor
5610043|NCT00090168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610044|NCT00090168|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5610045|NCT00090168|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5727007|NCT03170323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727008|NCT03170323|Antifungal Agents|antifungal agents|mesh-ancestor
5727009|NCT03170323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5727010|NCT03170323|Dermatologic Agents|dermatologic agents|mesh-ancestor
5727011|NCT03170323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5727012|NCT03170323|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5727013|NCT03170323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5727014|NCT03170323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5727015|NCT03170323|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5727016|NCT03170323|Antitubercular Agents|antitubercular agents|mesh-ancestor
5727017|NCT03170323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5610046|NCT00090168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5727018|NCT03170336|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5727019|NCT03170336|Amiloride|amiloride|mesh-list
5727020|NCT03170336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5727021|NCT03170336|Diuretics|diuretics|mesh-ancestor
5727022|NCT03170336|Natriuretic Agents|natriuretic agents|mesh-ancestor
5727023|NCT03170336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727024|NCT03170336|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5727025|NCT03170336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5727026|NCT03170336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5727027|NCT03170336|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
5727028|NCT03170336|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5727029|NCT03170336|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
5727030|NCT03170336|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5727031|NCT03170284|Bevacizumab|bevacizumab|mesh-list
5727032|NCT03170284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5727033|NCT03170284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5727034|NCT03170284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5727035|NCT03170284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5610047|NCT00089895|Eptifibatide|eptifibatide|mesh-list
5727036|NCT03170284|Growth Substances|growth substances|mesh-ancestor
5727037|NCT03170284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727038|NCT03170284|Growth Inhibitors|growth inhibitors|mesh-ancestor
5727039|NCT03170050|Lidocaine|lidocaine|mesh-list
5727040|NCT03170050|Anesthetics, Local|anesthetics, local|mesh-ancestor
5727041|NCT03170050|Anesthetics|anesthetics|mesh-ancestor
5727042|NCT03170050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5727043|NCT03170050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727044|NCT03170050|Sensory System Agents|sensory system agents|mesh-ancestor
5727045|NCT03170050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5727046|NCT03170050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5727047|NCT03170050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5727048|NCT03170050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5727049|NCT03170050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5727050|NCT03170050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5727051|NCT03170115|Aspirin|aspirin|mesh-list
5727052|NCT03170115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5727053|NCT03170115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5727054|NCT03170115|Analgesics|analgesics|mesh-ancestor
5727055|NCT03170115|Sensory System Agents|sensory system agents|mesh-ancestor
5727056|NCT03170115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5727057|NCT03170115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727058|NCT03170115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5727059|NCT03170115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5727060|NCT03170115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5610048|NCT00089895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5610049|NCT02765854|Dexamethasone|dexamethasone|mesh-list
5727061|NCT03170115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5727062|NCT03170115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5727063|NCT03170115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5727064|NCT03170115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5727065|NCT03170115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5727066|NCT03170115|Antipyretics|antipyretics|mesh-ancestor
5727067|NCT03169959|Metformin|metformin|mesh-list
5727068|NCT03169959|Dapagliflozin|dapagliflozin|mesh-list
5727069|NCT03169959|Saxagliptin|saxagliptin|mesh-list
5727070|NCT03169959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5727071|NCT03169959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727072|NCT03169959|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5727073|NCT03169959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5727074|NCT03169959|Incretins|incretins|mesh-ancestor
5727075|NCT03169959|Hormones|hormones|mesh-ancestor
5727076|NCT03169959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5727077|NCT03169959|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5727078|NCT03169959|Protease Inhibitors|protease inhibitors|mesh-ancestor
5727079|NCT03169959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5727080|NCT03169881|Darbepoetin alfa|darbepoetin alfa|mesh-list
5727081|NCT03169881|Hematinics|hematinics|mesh-ancestor
5727082|NCT03169751|Caffeine|caffeine|mesh-list
5727083|NCT03169751|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5727084|NCT03169751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727085|NCT03169751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5727086|NCT03169751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5727087|NCT03169751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5727088|NCT03169751|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5727089|NCT03169751|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5727090|NCT03169751|Purinergic Agents|purinergic agents|mesh-ancestor
5727091|NCT03169751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5727092|NCT03169764|Leucovorin|leucovorin|mesh-list
5727093|NCT03169764|Cyclophosphamide|cyclophosphamide|mesh-list
5727094|NCT03169764|Bevacizumab|bevacizumab|mesh-list
5727095|NCT03169764|Fluorouracil|fluorouracil|mesh-list
5727096|NCT03169764|Capecitabine|capecitabine|mesh-list
5727097|NCT03169764|Nivolumab|nivolumab|mesh-list
5727098|NCT03169764|Cetuximab|cetuximab|mesh-list
5727099|NCT03169764|Fulvestrant|fulvestrant|mesh-list
5727100|NCT03169764|Avelumab|avelumab|mesh-list
5727101|NCT03169764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5727102|NCT03169764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610050|NCT02765854|Lenalidomide|lenalidomide|mesh-list
5610051|NCT02765854|Ixazomib|ixazomib|mesh-list
5610052|NCT02765854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5610053|NCT02765854|Antiemetics|antiemetics|mesh-ancestor
5610054|NCT02765854|Autonomic Agents|autonomic agents|mesh-ancestor
5610055|NCT02765854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5727103|NCT03169764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5610056|NCT02765854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610057|NCT02765854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5610058|NCT02765854|Glucocorticoids|glucocorticoids|mesh-ancestor
5610059|NCT02765854|Hormones|hormones|mesh-ancestor
5610060|NCT02765854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5610061|NCT02765854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5610062|NCT02765854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5610063|NCT02765854|Immunologic Factors|immunologic factors|mesh-ancestor
5610064|NCT02765854|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5610065|NCT02765854|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5610066|NCT02765854|Growth Substances|growth substances|mesh-ancestor
5610067|NCT02765854|Growth Inhibitors|growth inhibitors|mesh-ancestor
5610068|NCT02765854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5727104|NCT03169764|Immunologic Factors|immunologic factors|mesh-ancestor
5727105|NCT03169764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727106|NCT03169764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5727107|NCT03169764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5727108|NCT03169764|Alkylating Agents|alkylating agents|mesh-ancestor
5727109|NCT03169764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5727110|NCT03169764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5727111|NCT03169764|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5727112|NCT03169764|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5727113|NCT03169764|Growth Substances|growth substances|mesh-ancestor
5727114|NCT03169764|Growth Inhibitors|growth inhibitors|mesh-ancestor
5727115|NCT03169764|Antimetabolites|antimetabolites|mesh-ancestor
5727116|NCT03169764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5727117|NCT03169764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5727118|NCT03169764|Antidotes|antidotes|mesh-ancestor
5727119|NCT03169764|Protective Agents|protective agents|mesh-ancestor
5727120|NCT03169764|Vitamin B Complex|vitamin b complex|mesh-ancestor
5727121|NCT03169764|Vitamins|vitamins|mesh-ancestor
5610069|NCT02765854|Protease Inhibitors|protease inhibitors|mesh-ancestor
5610070|NCT02765854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5610071|NCT02761057|Sunitinib|sunitinib|mesh-list
5610072|NCT02761057|Crizotinib|crizotinib|mesh-list
5610073|NCT02761057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5610074|NCT02761057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5610075|NCT02761057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5610076|NCT02761057|Growth Substances|growth substances|mesh-ancestor
5610077|NCT02761057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610078|NCT02761057|Growth Inhibitors|growth inhibitors|mesh-ancestor
5610079|NCT02761057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5610080|NCT02761057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5610081|NCT02761057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610082|NCT02750540|Tenofovir|tenofovir|mesh-list
5610083|NCT02750540|Antiviral Agents|antiviral agents|mesh-ancestor
5610084|NCT02750540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5610085|NCT02750540|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5610086|NCT02750540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5610087|NCT02750540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5610088|NCT02750540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610089|NCT02750540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5610090|NCT02750540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5610091|NCT02614066|Cyclophosphamide|cyclophosphamide|mesh-list
5610092|NCT02614066|Fludarabine|fludarabine|mesh-list
5610093|NCT02614066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5610094|NCT02614066|Immunologic Factors|immunologic factors|mesh-ancestor
5610095|NCT02614066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610096|NCT02614066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5610097|NCT02614066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5610098|NCT02614066|Alkylating Agents|alkylating agents|mesh-ancestor
5610099|NCT02614066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610100|NCT02614066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5610101|NCT02614066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5610102|NCT02595879|Cisplatin|cisplatin|mesh-list
5610103|NCT02595879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5610104|NCT02520791|Antibodies|antibodies|mesh-list
5610105|NCT02520791|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5727122|NCT03169764|Micronutrients|micronutrients|mesh-ancestor
5727123|NCT03169764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5727124|NCT03169764|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5727125|NCT03169764|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5727126|NCT03169764|Hormone Antagonists|hormone antagonists|mesh-ancestor
5610106|NCT02520791|Immunologic Factors|immunologic factors|mesh-ancestor
5610107|NCT02520791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727127|NCT03169764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5727128|NCT03169738|Leucovorin|leucovorin|mesh-list
5727129|NCT03169738|Cyclophosphamide|cyclophosphamide|mesh-list
5727130|NCT03169738|Bevacizumab|bevacizumab|mesh-list
5727131|NCT03169738|Fluorouracil|fluorouracil|mesh-list
5727132|NCT03169738|Capecitabine|capecitabine|mesh-list
5727133|NCT03169738|Oxaliplatin|oxaliplatin|mesh-list
5727134|NCT03169738|Nivolumab|nivolumab|mesh-list
5727135|NCT03169738|Fulvestrant|fulvestrant|mesh-list
5727136|NCT03169738|Avelumab|avelumab|mesh-list
5727137|NCT03169738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5727138|NCT03169738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5727139|NCT03169738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5727140|NCT03169738|Immunologic Factors|immunologic factors|mesh-ancestor
5727141|NCT03169738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727142|NCT03169738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5727143|NCT03169738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5727144|NCT03169738|Alkylating Agents|alkylating agents|mesh-ancestor
5727145|NCT03169738|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5727146|NCT03169738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5727147|NCT03169738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5727148|NCT03169738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5727149|NCT03169738|Growth Substances|growth substances|mesh-ancestor
5727150|NCT03169738|Growth Inhibitors|growth inhibitors|mesh-ancestor
5727151|NCT03169738|Antimetabolites|antimetabolites|mesh-ancestor
5727152|NCT03169738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5727153|NCT03169738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5727154|NCT03169738|Antidotes|antidotes|mesh-ancestor
5727155|NCT03169738|Protective Agents|protective agents|mesh-ancestor
5727156|NCT03169738|Vitamin B Complex|vitamin b complex|mesh-ancestor
5727157|NCT03169738|Vitamins|vitamins|mesh-ancestor
5727158|NCT03169738|Micronutrients|micronutrients|mesh-ancestor
5727159|NCT03169738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5727160|NCT03169738|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5727161|NCT03169738|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5727162|NCT03169738|Hormone Antagonists|hormone antagonists|mesh-ancestor
5727163|NCT03169738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5727164|NCT03169725|Vaccines|vaccines|mesh-list
5727165|NCT03169725|Immunologic Factors|immunologic factors|mesh-ancestor
5727166|NCT03169725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727167|NCT03170479|Vitamin D|vitamin d|mesh-list
5727168|NCT03170479|Vitamins|vitamins|mesh-ancestor
5727169|NCT03170479|Micronutrients|micronutrients|mesh-ancestor
5727170|NCT03170479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727171|NCT03170479|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5610108|NCT02474173|Paclitaxel|paclitaxel|mesh-list
5610109|NCT02474173|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5610110|NCT02474173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5610111|NCT02474173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5610112|NCT02474173|Tubulin Modulators|tubulin modulators|mesh-ancestor
5610113|NCT02474173|Antimitotic Agents|antimitotic agents|mesh-ancestor
5610114|NCT02474173|Mitosis Modulators|mitosis modulators|mesh-ancestor
5610115|NCT02474173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5727172|NCT03169933|Androgens|androgens|mesh-list
5727173|NCT03169933|Hormones|hormones|mesh-ancestor
5727174|NCT03169933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5727175|NCT03169933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727176|NCT03170180|Sunitinib|sunitinib|mesh-list
5727177|NCT03170180|Imatinib Mesylate|imatinib mesylate|mesh-list
5727178|NCT03170180|Gefitinib|gefitinib|mesh-list
5610116|NCT02453620|Nivolumab|nivolumab|mesh-list
5610117|NCT02453620|Ipilimumab|ipilimumab|mesh-list
5610118|NCT02453620|Entinostat|entinostat|mesh-list
5727179|NCT03170180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5727180|NCT03170180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5727181|NCT03170180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5727182|NCT03170180|Growth Substances|growth substances|mesh-ancestor
5610119|NCT02453620|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
5610120|NCT02453620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5610121|NCT02453620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5610122|NCT02453620|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5610123|NCT02453620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610124|NCT02453620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5610125|NCT02298959|Pembrolizumab|pembrolizumab|mesh-list
5727183|NCT03170180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727184|NCT03170180|Growth Inhibitors|growth inhibitors|mesh-ancestor
5727185|NCT03170180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5727186|NCT03170180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5727187|NCT03170180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5727188|NCT03169790|Leucovorin|leucovorin|mesh-list
5727189|NCT03169790|Paclitaxel|paclitaxel|mesh-list
5727190|NCT03169790|Cyclophosphamide|cyclophosphamide|mesh-list
5727191|NCT03169790|Bevacizumab|bevacizumab|mesh-list
5727192|NCT03169790|Rituximab|rituximab|mesh-list
5727193|NCT03169790|Fluorouracil|fluorouracil|mesh-list
5727194|NCT03169790|Capecitabine|capecitabine|mesh-list
5727195|NCT03169790|Oxaliplatin|oxaliplatin|mesh-list
5610126|NCT02298959|Aflibercept|aflibercept|mesh-list
5610127|NCT02298959|Endothelial Growth Factors|endothelial growth factors|mesh-list
5610128|NCT02298959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5610129|NCT02298959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5610130|NCT02298959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5610131|NCT02298959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5610132|NCT02298959|Growth Substances|growth substances|mesh-ancestor
5610133|NCT02298959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610134|NCT02298959|Growth Inhibitors|growth inhibitors|mesh-ancestor
5610135|NCT02207504|Crizotinib|crizotinib|mesh-list
5610136|NCT02207504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5610137|NCT02207504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5727196|NCT03169790|Avelumab|avelumab|mesh-list
5727197|NCT03169790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5727198|NCT03169790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5727199|NCT03169790|Tubulin Modulators|tubulin modulators|mesh-ancestor
5727200|NCT03169790|Antimitotic Agents|antimitotic agents|mesh-ancestor
5727201|NCT03169790|Mitosis Modulators|mitosis modulators|mesh-ancestor
5727202|NCT03169790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5727203|NCT03169790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5727204|NCT03169790|Immunologic Factors|immunologic factors|mesh-ancestor
5727205|NCT03169790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727206|NCT03169790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5727207|NCT03169790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5727208|NCT03169790|Alkylating Agents|alkylating agents|mesh-ancestor
5727209|NCT03169790|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5727210|NCT03169790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5727211|NCT03169790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5727212|NCT03169790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5727213|NCT03169790|Growth Substances|growth substances|mesh-ancestor
5610138|NCT02207504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5610139|NCT02207504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610140|NCT02196961|Nivolumab|nivolumab|mesh-list
5610141|NCT02196961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5610142|NCT02196961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5610143|NCT02196961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5610144|NCT02196961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610145|NCT02118610|Tetrahydropalmatine|tetrahydropalmatine|mesh-list
5610146|NCT02118610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5610147|NCT02118610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5610148|NCT02118610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5610149|NCT02118610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5610150|NCT02118610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610151|NCT02118610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5610152|NCT02118610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610153|NCT02118610|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5610154|NCT02118610|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5610155|NCT02118610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5610156|NCT02118610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5610157|NCT02118610|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5610158|NCT02118610|Dopamine Agents|dopamine agents|mesh-ancestor
5610159|NCT02118610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5610160|NCT02118610|Adrenergic Agents|adrenergic agents|mesh-ancestor
5610161|NCT02118610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5610162|NCT02118610|Analgesics|analgesics|mesh-ancestor
5610163|NCT02118610|Sensory System Agents|sensory system agents|mesh-ancestor
5610164|NCT02118610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5610165|NCT02083250|Fludarabine|fludarabine|mesh-list
5610166|NCT02083250|Fludarabine phosphate|fludarabine phosphate|mesh-list
5610167|NCT02083250|Busulfan|busulfan|mesh-list
5727214|NCT03169790|Growth Inhibitors|growth inhibitors|mesh-ancestor
5727215|NCT03169790|Antimetabolites|antimetabolites|mesh-ancestor
5727216|NCT03169790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5727217|NCT03169790|Antidotes|antidotes|mesh-ancestor
5727218|NCT03169790|Protective Agents|protective agents|mesh-ancestor
5727219|NCT03169790|Vitamin B Complex|vitamin b complex|mesh-ancestor
5727220|NCT03169790|Vitamins|vitamins|mesh-ancestor
5727221|NCT03169790|Micronutrients|micronutrients|mesh-ancestor
5727222|NCT03169660|Aflibercept|aflibercept|mesh-list
5727223|NCT03169660|Mitogens|mitogens|mesh-list
5727224|NCT03169660|Endothelial Growth Factors|endothelial growth factors|mesh-list
5727225|NCT03169660|Mitosis Modulators|mitosis modulators|mesh-ancestor
5727226|NCT03169660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5727227|NCT03169660|Growth Substances|growth substances|mesh-ancestor
5727228|NCT03169660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727229|NCT03169660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5727230|NCT03169660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5727231|NCT03169660|Growth Inhibitors|growth inhibitors|mesh-ancestor
5727232|NCT03169660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5727233|NCT03169777|Leucovorin|leucovorin|mesh-list
5727234|NCT03169777|Cyclophosphamide|cyclophosphamide|mesh-list
5727235|NCT03169777|Bevacizumab|bevacizumab|mesh-list
5727236|NCT03169777|Fluorouracil|fluorouracil|mesh-list
5727237|NCT03169777|Capecitabine|capecitabine|mesh-list
5727238|NCT03169777|Oxaliplatin|oxaliplatin|mesh-list
5727239|NCT03169777|Nivolumab|nivolumab|mesh-list
5727240|NCT03169777|Cetuximab|cetuximab|mesh-list
5727241|NCT03169777|Fulvestrant|fulvestrant|mesh-list
5727242|NCT03169777|Avelumab|avelumab|mesh-list
5727243|NCT03169777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5727244|NCT03169777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5727245|NCT03169777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5727246|NCT03169777|Immunologic Factors|immunologic factors|mesh-ancestor
5727247|NCT03169777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727248|NCT03169777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5727249|NCT03169777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5727250|NCT03169777|Alkylating Agents|alkylating agents|mesh-ancestor
5610168|NCT02083250|Vorinostat|vorinostat|mesh-list
5610169|NCT02083250|Clofarabine|clofarabine|mesh-list
5610170|NCT02083250|Thymoglobulin|thymoglobulin|mesh-list
5610171|NCT02083250|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5610172|NCT02083250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5610173|NCT02083250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5610174|NCT02083250|Antimetabolites|antimetabolites|mesh-ancestor
5727251|NCT03169777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5727252|NCT03169777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5727253|NCT03169777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5727254|NCT03169777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5727255|NCT03169777|Growth Substances|growth substances|mesh-ancestor
5727256|NCT03169777|Growth Inhibitors|growth inhibitors|mesh-ancestor
5610175|NCT02083250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610176|NCT02083250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5610177|NCT02083250|Immunologic Factors|immunologic factors|mesh-ancestor
5610178|NCT02083250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610179|NCT02083250|Alkylating Agents|alkylating agents|mesh-ancestor
5610180|NCT02083250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5610181|NCT02083250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5610182|NCT02083250|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5610183|NCT02083250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5610184|NCT01857934|Aldesleukin|aldesleukin|mesh-list
5610185|NCT01857934|Cyclophosphamide|cyclophosphamide|mesh-list
5610186|NCT01857934|Melphalan|melphalan|mesh-list
5610187|NCT01857934|Busulfan|busulfan|mesh-list
5727257|NCT03169777|Antimetabolites|antimetabolites|mesh-ancestor
5727258|NCT03169777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5610188|NCT01857934|Mechlorethamine|mechlorethamine|mesh-list
5610189|NCT01857934|Doxorubicin|doxorubicin|mesh-list
5610190|NCT01857934|Etoposide|etoposide|mesh-list
5610191|NCT01857934|Vincristine|vincristine|mesh-list
5610192|NCT01857934|Topotecan|topotecan|mesh-list
5727259|NCT03169777|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5727260|NCT03169777|Antidotes|antidotes|mesh-ancestor
5727261|NCT03169777|Protective Agents|protective agents|mesh-ancestor
5727262|NCT03169777|Vitamin B Complex|vitamin b complex|mesh-ancestor
5727263|NCT03169777|Vitamins|vitamins|mesh-ancestor
5727264|NCT03169777|Micronutrients|micronutrients|mesh-ancestor
5727265|NCT03169777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5727266|NCT03169777|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5727267|NCT03169777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5727268|NCT03169777|Hormone Antagonists|hormone antagonists|mesh-ancestor
5610193|NCT01857934|Interleukin-2|interleukin-2|mesh-list
5610194|NCT01857934|Molgramostim|molgramostim|mesh-list
5610195|NCT01857934|Dinutuximab|dinutuximab|mesh-list
5610196|NCT01857934|Levetiracetam|levetiracetam|mesh-list
5727269|NCT03169777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5727270|NCT03169582|Sildenafil Citrate|sildenafil citrate|mesh-list
5727271|NCT03169582|Vasodilator Agents|vasodilator agents|mesh-ancestor
5727272|NCT03169582|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5727273|NCT03169582|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5610197|NCT01857934|Isotretinoin|isotretinoin|mesh-list
5610198|NCT01857934|Antibodies|antibodies|mesh-list
5610199|NCT01857934|Immunoglobulins|immunoglobulins|mesh-list
5610200|NCT01857934|Lenograstim|lenograstim|mesh-list
5610201|NCT01857934|Sargramostim|sargramostim|mesh-list
5610202|NCT01857934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5610203|NCT01857934|Immunologic Factors|immunologic factors|mesh-ancestor
5610204|NCT01857934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610205|NCT01857934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5610206|NCT01857934|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5610207|NCT01857934|Alkylating Agents|alkylating agents|mesh-ancestor
5610208|NCT01857934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610209|NCT01857934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5610210|NCT01857934|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5610211|NCT01857934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5610212|NCT01857934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5610213|NCT01857934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5610214|NCT01857934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5610215|NCT01857934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5610216|NCT01857934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5727274|NCT03169582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5727275|NCT03169582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5727276|NCT03169582|Urological Agents|urological agents|mesh-ancestor
5727277|NCT03169348|Sofosbuvir|sofosbuvir|mesh-list
5727278|NCT03169348|Ledipasvir|ledipasvir|mesh-list
5727279|NCT03169348|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
5727280|NCT03169348|Antiviral Agents|antiviral agents|mesh-ancestor
5727281|NCT03169348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5727282|NCT03169504|Fluticasone|fluticasone|mesh-list
5727283|NCT03169504|Xhance|xhance|mesh-list
5727284|NCT03169504|Bromides|bromides|mesh-list
5610217|NCT01857934|Tubulin Modulators|tubulin modulators|mesh-ancestor
5610218|NCT01857934|Antimitotic Agents|antimitotic agents|mesh-ancestor
5610219|NCT01857934|Mitosis Modulators|mitosis modulators|mesh-ancestor
5610220|NCT01857934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5610221|NCT01857934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5727285|NCT03169504|Tiotropium Bromide|tiotropium bromide|mesh-list
5727286|NCT03169504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5727287|NCT03169504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5727288|NCT03169504|Autonomic Agents|autonomic agents|mesh-ancestor
5727289|NCT03169504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5727290|NCT03169504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727291|NCT03169504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5727292|NCT03169504|Respiratory System Agents|respiratory system agents|mesh-ancestor
5727293|NCT03169504|Dermatologic Agents|dermatologic agents|mesh-ancestor
5727294|NCT03169504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5727295|NCT03169504|Parasympatholytics|parasympatholytics|mesh-ancestor
5727296|NCT03169504|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5727297|NCT03169504|Cholinergic Agents|cholinergic agents|mesh-ancestor
5727298|NCT03169504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5727299|NCT03169504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5727300|NCT03169504|Anticonvulsants|anticonvulsants|mesh-ancestor
5727301|NCT03169426|Carvedilol|carvedilol|mesh-list
5727302|NCT03169426|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
5727303|NCT03169426|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5727304|NCT03169426|Adrenergic Agents|adrenergic agents|mesh-ancestor
5727305|NCT03169426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5610222|NCT01857934|Analgesics|analgesics|mesh-ancestor
5610223|NCT01857934|Sensory System Agents|sensory system agents|mesh-ancestor
5610224|NCT01857934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5610225|NCT01857934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5610226|NCT01857934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5610227|NCT01857934|Antiviral Agents|antiviral agents|mesh-ancestor
5610228|NCT01857934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5610229|NCT01857934|Anticonvulsants|anticonvulsants|mesh-ancestor
5610230|NCT01857934|Nootropic Agents|nootropic agents|mesh-ancestor
5610231|NCT01857934|Dermatologic Agents|dermatologic agents|mesh-ancestor
5610232|NCT01841177|Milrinone|milrinone|mesh-list
5610233|NCT01841177|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5727306|NCT03169426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5727307|NCT03169426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727308|NCT03169426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5610234|NCT01841177|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5610235|NCT01841177|Vasodilator Agents|vasodilator agents|mesh-ancestor
5610236|NCT01841177|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5727309|NCT03169426|Antioxidants|antioxidants|mesh-ancestor
5727310|NCT03169426|Protective Agents|protective agents|mesh-ancestor
5727311|NCT03169426|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5727312|NCT03169426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5727313|NCT03169426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5727314|NCT03169426|Vasodilator Agents|vasodilator agents|mesh-ancestor
5727315|NCT03169426|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5727316|NCT03169426|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5727317|NCT03169569|Hemostatics|hemostatics|mesh-list
5727318|NCT03169569|Coagulants|coagulants|mesh-ancestor
5727319|NCT03169413|Adenosine|adenosine|mesh-list
5727320|NCT03169413|Analgesics|analgesics|mesh-ancestor
5727321|NCT03169413|Sensory System Agents|sensory system agents|mesh-ancestor
5727322|NCT03169413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5727323|NCT03169413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727324|NCT03169413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5727325|NCT03169413|Vasodilator Agents|vasodilator agents|mesh-ancestor
5727326|NCT03169413|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5727327|NCT03169413|Purinergic Agonists|purinergic agonists|mesh-ancestor
5727328|NCT03169413|Purinergic Agents|purinergic agents|mesh-ancestor
5727329|NCT03169413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5727330|NCT03169413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5727331|NCT03169335|Paclitaxel|paclitaxel|mesh-list
5727332|NCT03169335|Bevacizumab|bevacizumab|mesh-list
5727333|NCT03169335|Carboplatin|carboplatin|mesh-list
5727334|NCT03169335|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5727335|NCT03169335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5727336|NCT03169335|Tubulin Modulators|tubulin modulators|mesh-ancestor
5727337|NCT03169335|Antimitotic Agents|antimitotic agents|mesh-ancestor
5727338|NCT03169335|Mitosis Modulators|mitosis modulators|mesh-ancestor
5727339|NCT03169335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5727340|NCT03169335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5727341|NCT03169335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5610237|NCT01841177|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5610238|NCT01841177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5610239|NCT01841177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610240|NCT01841177|Protective Agents|protective agents|mesh-ancestor
5610241|NCT01841177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610242|NCT01697527|Aldesleukin|aldesleukin|mesh-list
5727342|NCT03169335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5727343|NCT03169335|Growth Substances|growth substances|mesh-ancestor
5727344|NCT03169335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727345|NCT03169335|Growth Inhibitors|growth inhibitors|mesh-ancestor
5727346|NCT03169192|Zoledronic Acid|zoledronic acid|mesh-list
5727347|NCT03169192|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5727348|NCT03169192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727349|NCT03168997|Memantine|memantine|mesh-list
5727350|NCT03168997|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5727351|NCT03168997|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5727352|NCT03168997|Dopamine Agents|dopamine agents|mesh-ancestor
5727353|NCT03168997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5727354|NCT03168997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5727355|NCT03168997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610243|NCT01697527|Cyclophosphamide|cyclophosphamide|mesh-list
5610244|NCT01697527|Fludarabine|fludarabine|mesh-list
5610245|NCT01697527|Fludarabine phosphate|fludarabine phosphate|mesh-list
5610246|NCT01697527|Interleukin-2|interleukin-2|mesh-list
5610247|NCT01697527|Vaccines|vaccines|mesh-list
5610248|NCT01697527|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5610249|NCT01697527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5610250|NCT01697527|Immunologic Factors|immunologic factors|mesh-ancestor
5610251|NCT01697527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610252|NCT01697527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5610253|NCT01697527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5727356|NCT03168997|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5727357|NCT03168997|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5727358|NCT03169114|Amikacin|amikacin|mesh-list
5727359|NCT03169114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5727360|NCT03169114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5727361|NCT03169127|Ibuprofen|ibuprofen|mesh-list
5727362|NCT03169127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5727363|NCT03169127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5610254|NCT01697527|Alkylating Agents|alkylating agents|mesh-ancestor
5727364|NCT03169127|Analgesics|analgesics|mesh-ancestor
5727365|NCT03169127|Sensory System Agents|sensory system agents|mesh-ancestor
5892629|NCT04753437|Antacids|antacids|mesh-ancestor
5727366|NCT03169127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5727367|NCT03169127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727368|NCT03169127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5727369|NCT03169127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5727370|NCT03169127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5727371|NCT03169127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5727372|NCT03169127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5727373|NCT03168958|Methadone|methadone|mesh-list
5727374|NCT03168958|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5727375|NCT03168958|Narcotics|narcotics|mesh-ancestor
5727376|NCT03168958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5727377|NCT03168958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727378|NCT03168958|Analgesics|analgesics|mesh-ancestor
5727379|NCT03168958|Sensory System Agents|sensory system agents|mesh-ancestor
5727380|NCT03168958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5727381|NCT03168958|Antitussive Agents|antitussive agents|mesh-ancestor
5727382|NCT03168958|Respiratory System Agents|respiratory system agents|mesh-ancestor
5727383|NCT03168737|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
5727384|NCT03168737|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5610255|NCT01697527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610256|NCT01697527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5610257|NCT01697527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5610258|NCT01697527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5610259|NCT01697527|Antimetabolites|antimetabolites|mesh-ancestor
5610260|NCT01697527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5610261|NCT01697527|Analgesics|analgesics|mesh-ancestor
5610262|NCT01697527|Sensory System Agents|sensory system agents|mesh-ancestor
5610263|NCT01697527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5610264|NCT01697527|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5610265|NCT01697527|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5610266|NCT01697527|Antiviral Agents|antiviral agents|mesh-ancestor
5610267|NCT01697527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5610268|NCT01697527|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5610269|NCT01655225|Pemetrexed|pemetrexed|mesh-list
5610270|NCT01655225|Letrozole|letrozole|mesh-list
5610271|NCT01655225|Fulvestrant|fulvestrant|mesh-list
5727385|NCT03168737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892630|NCT04753437|Diuretics|diuretics|mesh-ancestor
5892631|NCT04753437|Natriuretic Agents|natriuretic agents|mesh-ancestor
5892632|NCT04753437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892633|NCT04753437|Expectorants|expectorants|mesh-ancestor
5892634|NCT04753437|Respiratory System Agents|respiratory system agents|mesh-ancestor
5892635|NCT04690504|Melatonin|melatonin|mesh-list
5892636|NCT04690504|Antioxidants|antioxidants|mesh-ancestor
5892637|NCT04690504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892638|NCT04690504|Protective Agents|protective agents|mesh-ancestor
5892639|NCT04690504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892640|NCT04690504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5892641|NCT04683575|Selenium|selenium|mesh-list
5892642|NCT04683575|Antioxidants|antioxidants|mesh-ancestor
5892643|NCT04683575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892644|NCT04683575|Protective Agents|protective agents|mesh-ancestor
5892645|NCT04683575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892646|NCT04683575|Trace Elements|trace elements|mesh-ancestor
5892647|NCT04683575|Micronutrients|micronutrients|mesh-ancestor
5892648|NCT04675333|Carboplatin|carboplatin|mesh-list
5892649|NCT04675333|Pembrolizumab|pembrolizumab|mesh-list
5892650|NCT04675333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5892651|NCT04675333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5892652|NCT04675294|Pembrolizumab|pembrolizumab|mesh-list
5892653|NCT04675294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5892654|NCT04675294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5892655|NCT04671953|Metformin|metformin|mesh-list
5892656|NCT04671953|BMS-986165|bms-986165|mesh-list
5892657|NCT04671953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5892658|NCT04671953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892659|NCT04671953|Dermatologic Agents|dermatologic agents|mesh-ancestor
5892660|NCT04671953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5892661|NCT04671953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5892662|NCT04671953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892663|NCT04630964|Niacin|niacin|mesh-list
5892664|NCT04630964|Psilocybin|psilocybin|mesh-list
5892665|NCT04630964|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5892666|NCT04630964|Antimetabolites|antimetabolites|mesh-ancestor
5610272|NCT01655225|Midazolam|midazolam|mesh-list
5610273|NCT01655225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5892667|NCT04630964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610274|NCT01655225|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5610275|NCT01655225|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5610276|NCT01655225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5727386|NCT03168828|Trospium chloride|trospium chloride|mesh-list
5727387|NCT03168828|Parasympatholytics|parasympatholytics|mesh-ancestor
5727388|NCT03168828|Autonomic Agents|autonomic agents|mesh-ancestor
5727389|NCT03168828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5727390|NCT03168828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727391|NCT03168828|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5727392|NCT03168828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5727393|NCT03168828|Cholinergic Agents|cholinergic agents|mesh-ancestor
5727394|NCT03168828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5727395|NCT03168828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5727396|NCT03168828|Urological Agents|urological agents|mesh-ancestor
5727397|NCT03168880|Paclitaxel|paclitaxel|mesh-list
5727398|NCT03168880|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5727399|NCT03168880|Carboplatin|carboplatin|mesh-list
5727400|NCT03168880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5727401|NCT03168880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5727402|NCT03168880|Tubulin Modulators|tubulin modulators|mesh-ancestor
5727403|NCT03168880|Antimitotic Agents|antimitotic agents|mesh-ancestor
5727404|NCT03168880|Mitosis Modulators|mitosis modulators|mesh-ancestor
5727405|NCT03168880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5727406|NCT03168698|Oxytocin|oxytocin|mesh-list
5727407|NCT03168698|Carbetocin|carbetocin|mesh-list
5727408|NCT03168698|Oxytocics|oxytocics|mesh-ancestor
5727409|NCT03168698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5610277|NCT01655225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610278|NCT01655225|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5610279|NCT01655225|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5610280|NCT01655225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5610281|NCT01655225|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5610282|NCT01655225|Anesthetics, General|anesthetics, general|mesh-ancestor
5610283|NCT01655225|Anesthetics|anesthetics|mesh-ancestor
5610284|NCT01655225|GABA Modulators|gaba modulators|mesh-ancestor
5610285|NCT01655225|GABA Agents|gaba agents|mesh-ancestor
5610286|NCT01655225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5610287|NCT01655225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610288|NCT01655225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5610289|NCT01655225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5610290|NCT01655225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5610291|NCT01655225|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5727410|NCT03168698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727411|NCT03168594|Cisplatin|cisplatin|mesh-list
5727412|NCT03168594|Irinotecan|irinotecan|mesh-list
5727413|NCT03168594|Etoposide|etoposide|mesh-list
5727414|NCT03168594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5727415|NCT03168594|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5727416|NCT03168594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5610292|NCT01655225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5610293|NCT01655225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5610294|NCT01655225|Hormone Antagonists|hormone antagonists|mesh-ancestor
5727417|NCT03168594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5727418|NCT03168594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5727419|NCT03168594|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5727420|NCT03168594|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5727421|NCT03168568|Valsartan|valsartan|mesh-list
5727422|NCT03168568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5727423|NCT03168568|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5727424|NCT03168568|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5727425|NCT03168568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610295|NCT01655225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5610296|NCT01655225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5610297|NCT01655225|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5691678|NCT03415191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5691679|NCT03415191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691680|NCT03415087|Fentanyl|fentanyl|mesh-list
5691681|NCT03415087|Bupivacaine|bupivacaine|mesh-list
5691682|NCT03415087|Anesthetics, Local|anesthetics, local|mesh-ancestor
5691683|NCT03415087|Anesthetics|anesthetics|mesh-ancestor
5691684|NCT03415087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5691685|NCT03415087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691686|NCT03415087|Sensory System Agents|sensory system agents|mesh-ancestor
5691687|NCT03415087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5610298|NCT01591577|Temozolomide|temozolomide|mesh-list
5610299|NCT01591577|Lapatinib|lapatinib|mesh-list
5610300|NCT01591577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5610301|NCT01591577|Alkylating Agents|alkylating agents|mesh-ancestor
5610302|NCT01591577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5727426|NCT03168256|Apremilast|apremilast|mesh-list
5727427|NCT03168256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5727428|NCT03168256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5727429|NCT03168256|Analgesics|analgesics|mesh-ancestor
5727430|NCT03168256|Sensory System Agents|sensory system agents|mesh-ancestor
5727431|NCT03168256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5727432|NCT03168256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727433|NCT03168256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5727434|NCT03168256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5727435|NCT03168256|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5727436|NCT03168256|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5727437|NCT03168256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5727438|NCT03168256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5727439|NCT03168464|Nivolumab|nivolumab|mesh-list
5727440|NCT03168464|Ipilimumab|ipilimumab|mesh-list
5727441|NCT03168464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5727442|NCT03168464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5727443|NCT03168464|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5727444|NCT03168464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5727445|NCT03168191|Menthol|menthol|mesh-list
5727446|NCT03168191|Nicotine|nicotine|mesh-list
5727447|NCT03168191|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5610303|NCT01591577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5610304|NCT01591577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5610305|NCT01591577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5610306|NCT01512888|Busulfan|busulfan|mesh-list
5610307|NCT01512888|Alkylating Agents|alkylating agents|mesh-ancestor
5610308|NCT01512888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610309|NCT01512888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5610310|NCT01512888|Immunologic Factors|immunologic factors|mesh-ancestor
5610311|NCT01512888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610312|NCT01512888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5610313|NCT01512888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5610314|NCT01512888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5610315|NCT01453946|Budesonide|budesonide|mesh-list
5610316|NCT01453946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5610317|NCT01453946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5610318|NCT01453946|Autonomic Agents|autonomic agents|mesh-ancestor
5610319|NCT01453946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5610320|NCT01453946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727448|NCT03168191|Autonomic Agents|autonomic agents|mesh-ancestor
5727449|NCT03168191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5727450|NCT03168191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727451|NCT03168191|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5727452|NCT03168191|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5727453|NCT03168191|Cholinergic Agents|cholinergic agents|mesh-ancestor
5727454|NCT03168191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5727455|NCT03168191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5727456|NCT03168191|Antipruritics|antipruritics|mesh-ancestor
5727457|NCT03168191|Dermatologic Agents|dermatologic agents|mesh-ancestor
5727458|NCT03168178|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5727459|NCT03168178|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5727460|NCT03168178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5727461|NCT03168178|Antitubercular Agents|antitubercular agents|mesh-ancestor
5727462|NCT03168555|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
5727463|NCT03168555|Cathartics|cathartics|mesh-ancestor
5727464|NCT03168555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5727465|NCT03168412|Vaccines|vaccines|mesh-list
5727466|NCT03168412|Immunologic Factors|immunologic factors|mesh-ancestor
5727467|NCT03168412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727468|NCT03168139|Pembrolizumab|pembrolizumab|mesh-list
5727469|NCT03168139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5727470|NCT03168139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5610321|NCT01453946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5610322|NCT01453946|Respiratory System Agents|respiratory system agents|mesh-ancestor
5610323|NCT01453946|Glucocorticoids|glucocorticoids|mesh-ancestor
5610324|NCT01453946|Hormones|hormones|mesh-ancestor
5610325|NCT01453946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5727471|NCT03168074|Lenvatinib|lenvatinib|mesh-list
5727472|NCT03168074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5727473|NCT03168074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5727474|NCT03168074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5727475|NCT03168074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5727476|NCT03168087|Plasma-lyte 148|plasma-lyte 148|mesh-list
5727477|NCT03168087|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5727478|NCT03168087|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5727479|NCT03168035|NC-4016|nc-4016|mesh-list
5610326|NCT01444092|Budesonide|budesonide|mesh-list
5610327|NCT01444092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5610328|NCT01444092|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5727480|NCT03168035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5727481|NCT03168100|Dexamethasone|dexamethasone|mesh-list
5727482|NCT03168100|Lenalidomide|lenalidomide|mesh-list
5727483|NCT03168100|Bortezomib|bortezomib|mesh-list
5727484|NCT03168100|Elotuzumab|elotuzumab|mesh-list
5727485|NCT03168100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5727486|NCT03168100|Antiemetics|antiemetics|mesh-ancestor
5727487|NCT03168100|Autonomic Agents|autonomic agents|mesh-ancestor
5727488|NCT03168100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5727489|NCT03168100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727490|NCT03168100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5727491|NCT03168100|Glucocorticoids|glucocorticoids|mesh-ancestor
5727492|NCT03168100|Hormones|hormones|mesh-ancestor
5727493|NCT03168100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5727494|NCT03168100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5727495|NCT03168100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5727496|NCT03168100|Immunologic Factors|immunologic factors|mesh-ancestor
5727497|NCT03168100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5727498|NCT03168100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5727499|NCT03168100|Growth Substances|growth substances|mesh-ancestor
5727500|NCT03168100|Growth Inhibitors|growth inhibitors|mesh-ancestor
5727501|NCT03167918|Calcium, Dietary|calcium, dietary|mesh-list
5727502|NCT03167918|Metformin|metformin|mesh-list
5727503|NCT03167918|Calcium Dobesilate|calcium dobesilate|mesh-list
5727504|NCT03167918|Calcium|calcium|mesh-list
5727505|NCT03167918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5727506|NCT03167918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610329|NCT01444092|Autonomic Agents|autonomic agents|mesh-ancestor
5610330|NCT01444092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5610331|NCT01444092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610332|NCT01444092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5610333|NCT01444092|Respiratory System Agents|respiratory system agents|mesh-ancestor
5727507|NCT03167918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5727508|NCT03167918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5727509|NCT03167918|Hemostatics|hemostatics|mesh-ancestor
5727510|NCT03167918|Coagulants|coagulants|mesh-ancestor
5727511|NCT03167905|Fentanyl|fentanyl|mesh-list
5727512|NCT03167905|Meperidine|meperidine|mesh-list
5727513|NCT03167905|Remifentanil|remifentanil|mesh-list
5727514|NCT03167905|Ropivacaine|ropivacaine|mesh-list
5727515|NCT03167905|Entonox|entonox|mesh-list
5727516|NCT03167905|Anesthetics, Local|anesthetics, local|mesh-ancestor
5727517|NCT03167905|Anesthetics|anesthetics|mesh-ancestor
5727518|NCT03167905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5727519|NCT03167905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727520|NCT03167905|Sensory System Agents|sensory system agents|mesh-ancestor
5727521|NCT03167905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5727522|NCT03167905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5727523|NCT03167905|Narcotics|narcotics|mesh-ancestor
5727524|NCT03167905|Analgesics|analgesics|mesh-ancestor
5610334|NCT01444092|Glucocorticoids|glucocorticoids|mesh-ancestor
5610335|NCT01444092|Hormones|hormones|mesh-ancestor
5610336|NCT01444092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5610337|NCT01419067|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5610338|NCT01419067|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5610339|NCT01419067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610340|NCT01332968|Prednisone|prednisone|mesh-list
5610341|NCT01332968|Cyclophosphamide|cyclophosphamide|mesh-list
5610342|NCT01332968|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5610343|NCT01332968|Rituximab|rituximab|mesh-list
5610344|NCT01332968|Doxorubicin|doxorubicin|mesh-list
5610345|NCT01332968|Vincristine|vincristine|mesh-list
5610346|NCT01332968|Obinutuzumab|obinutuzumab|mesh-list
5610347|NCT01332968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5727525|NCT03167905|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5727526|NCT03167905|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5610348|NCT01332968|Immunologic Factors|immunologic factors|mesh-ancestor
5727527|NCT03167905|Anesthetics, General|anesthetics, general|mesh-ancestor
5727528|NCT03167905|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
5727529|NCT03167957|Amphotericin B|amphotericin b|mesh-list
5727530|NCT03167957|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
5727531|NCT03167957|Amebicides|amebicides|mesh-ancestor
5727532|NCT03167957|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5727533|NCT03167957|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5727534|NCT03167957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5727535|NCT03167957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5727536|NCT03167957|Antifungal Agents|antifungal agents|mesh-ancestor
5727537|NCT03167853|Antibodies|antibodies|mesh-list
5727538|NCT03167853|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5727539|NCT03167853|Immunologic Factors|immunologic factors|mesh-ancestor
5727540|NCT03167853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727541|NCT03167619|Durvalumab|durvalumab|mesh-list
5727542|NCT03167619|Olaparib|olaparib|mesh-list
5727543|NCT03167619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5727544|NCT03167619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5727545|NCT03167619|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5727546|NCT03167619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5727547|NCT03167619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5727548|NCT03167333|Hyaluronic Acid|hyaluronic acid|mesh-list
5727549|NCT03167333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5727550|NCT03167333|Immunologic Factors|immunologic factors|mesh-ancestor
5727551|NCT03167333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489092|NCT00589251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5610349|NCT01332968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727552|NCT03167333|Viscosupplements|viscosupplements|mesh-ancestor
5727553|NCT03167333|Protective Agents|protective agents|mesh-ancestor
5727554|NCT03167372|Imidacloprid|imidacloprid|mesh-list
5727555|NCT03167372|Cholinergic Agents|cholinergic agents|mesh-ancestor
5727556|NCT03167372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5727557|NCT03167372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5727558|NCT03167372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727559|NCT03167385|Apatinib|apatinib|mesh-list
5727560|NCT03167385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5727561|NCT03167385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5727562|NCT03167385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5727563|NCT03167385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5727564|NCT03167268|Lycopene|lycopene|mesh-list
5727565|NCT03167268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5727566|NCT03167268|Antioxidants|antioxidants|mesh-ancestor
5727567|NCT03167268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5727568|NCT03167268|Protective Agents|protective agents|mesh-ancestor
5727569|NCT03167268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727570|NCT03167268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5727571|NCT03167268|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5727572|NCT03167268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5892668|NCT04630964|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5892669|NCT04630964|Vasodilator Agents|vasodilator agents|mesh-ancestor
5892670|NCT04630964|Vitamin B Complex|vitamin b complex|mesh-ancestor
5892671|NCT04630964|Vitamins|vitamins|mesh-ancestor
5892672|NCT04630964|Micronutrients|micronutrients|mesh-ancestor
5892673|NCT04630964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892674|NCT04630964|Hallucinogens|hallucinogens|mesh-ancestor
5892675|NCT04630964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5892676|NCT04585061|Lidocaine|lidocaine|mesh-list
5892677|NCT04585061|Anesthetics, Local|anesthetics, local|mesh-ancestor
5892678|NCT04585061|Anesthetics|anesthetics|mesh-ancestor
5892679|NCT04585061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5892680|NCT04585061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892681|NCT04585061|Sensory System Agents|sensory system agents|mesh-ancestor
5892682|NCT04585061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5892683|NCT04585061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5892684|NCT04585061|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5892685|NCT04585061|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5892686|NCT04585061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5892687|NCT04585061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892688|NCT04564365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
5610350|NCT01332968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5610351|NCT01332968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5610352|NCT01332968|Alkylating Agents|alkylating agents|mesh-ancestor
5610353|NCT01332968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610354|NCT01332968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5610355|NCT01332968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5610356|NCT01332968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5892689|NCT04564365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5727573|NCT03167216|Cetirizine|cetirizine|mesh-list
5610357|NCT01332968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5610358|NCT01332968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5610359|NCT01332968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5610360|NCT01332968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5610361|NCT01332968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5610362|NCT01332968|Glucocorticoids|glucocorticoids|mesh-ancestor
5610363|NCT01332968|Hormones|hormones|mesh-ancestor
5610364|NCT01332968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5610365|NCT01332968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5727574|NCT03167216|Cromolyn Sodium|cromolyn sodium|mesh-list
5727575|NCT03167216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5727576|NCT03167216|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5727577|NCT03167216|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5727578|NCT03167216|Histamine Antagonists|histamine antagonists|mesh-ancestor
5727579|NCT03167216|Histamine Agents|histamine agents|mesh-ancestor
5610366|NCT01332968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5610367|NCT01332968|Tubulin Modulators|tubulin modulators|mesh-ancestor
5610368|NCT01332968|Antimitotic Agents|antimitotic agents|mesh-ancestor
5610369|NCT01332968|Mitosis Modulators|mitosis modulators|mesh-ancestor
5727580|NCT03167216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5727581|NCT03167216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5727582|NCT03167216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727583|NCT03167216|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
5727584|NCT03167216|Immunologic Factors|immunologic factors|mesh-ancestor
5727585|NCT03167216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5727586|NCT03167216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5727587|NCT03167216|Respiratory System Agents|respiratory system agents|mesh-ancestor
5727588|NCT03166956|Ascorbic Acid|ascorbic acid|mesh-list
5727589|NCT03166956|Vitamins|vitamins|mesh-ancestor
5727590|NCT03166956|Micronutrients|micronutrients|mesh-ancestor
5727591|NCT03166956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727592|NCT03166956|Antioxidants|antioxidants|mesh-ancestor
5727593|NCT03166956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5727594|NCT03166956|Protective Agents|protective agents|mesh-ancestor
5727595|NCT03167164|Leucovorin|leucovorin|mesh-list
5727596|NCT03167164|Paclitaxel|paclitaxel|mesh-list
5727597|NCT03167164|Cyclophosphamide|cyclophosphamide|mesh-list
5727598|NCT03167164|Bevacizumab|bevacizumab|mesh-list
5727599|NCT03167164|Fluorouracil|fluorouracil|mesh-list
5727600|NCT03167164|Capecitabine|capecitabine|mesh-list
5727601|NCT03167164|Avelumab|avelumab|mesh-list
5727602|NCT03167164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5727603|NCT03167164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6672669|NCT01557634|Insulin|insulin|mesh-list
6672670|NCT01557634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6672671|NCT01557634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672672|NCT01557647|Treprostinil|treprostinil|mesh-list
6672673|NCT01557647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6672674|NCT01557660|Treprostinil|treprostinil|mesh-list
5727604|NCT03167164|Tubulin Modulators|tubulin modulators|mesh-ancestor
5727605|NCT03167164|Antimitotic Agents|antimitotic agents|mesh-ancestor
5727606|NCT03167164|Mitosis Modulators|mitosis modulators|mesh-ancestor
5727607|NCT03167164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5727608|NCT03167164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5610370|NCT01265784|Ertapenem|ertapenem|mesh-list
5610371|NCT01265784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5610372|NCT01265784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5610373|NCT01176474|Nivolumab|nivolumab|mesh-list
5610374|NCT01176474|Ipilimumab|ipilimumab|mesh-list
5610375|NCT01176474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5610376|NCT01176474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5610377|NCT01176474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5610378|NCT01176474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610379|NCT00719966|Letrozole|letrozole|mesh-list
5610380|NCT00719966|Anastrozole|anastrozole|mesh-list
5610381|NCT00719966|Exemestane|exemestane|mesh-list
5610382|NCT00719966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5610383|NCT00719966|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5610384|NCT00719966|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5610385|NCT00719966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5610386|NCT00719966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610387|NCT00719966|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5727609|NCT03167164|Immunologic Factors|immunologic factors|mesh-ancestor
5610388|NCT00719966|Hormone Antagonists|hormone antagonists|mesh-ancestor
5691688|NCT03415087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5727610|NCT03167164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672675|NCT01557660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5610389|NCT00719966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5610390|NCT00719966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610391|NCT00719966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5610392|NCT00637832|Prednisolone|prednisolone|mesh-list
5610393|NCT00637832|Cyclophosphamide|cyclophosphamide|mesh-list
5610394|NCT00637832|Rituximab|rituximab|mesh-list
5610395|NCT00637832|Doxorubicin|doxorubicin|mesh-list
5610396|NCT00637832|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5610397|NCT00637832|Vincristine|vincristine|mesh-list
5610398|NCT00637832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5610399|NCT00637832|Immunologic Factors|immunologic factors|mesh-ancestor
5610400|NCT00637832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610401|NCT00637832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5610402|NCT00637832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5610403|NCT00637832|Alkylating Agents|alkylating agents|mesh-ancestor
5727611|NCT03167164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5727612|NCT03167164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5727613|NCT03167164|Alkylating Agents|alkylating agents|mesh-ancestor
5727614|NCT03167164|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5727615|NCT03167164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5727616|NCT03167164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5727617|NCT03167164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5727618|NCT03167164|Growth Substances|growth substances|mesh-ancestor
5727619|NCT03167164|Growth Inhibitors|growth inhibitors|mesh-ancestor
5727620|NCT03167164|Antimetabolites|antimetabolites|mesh-ancestor
5727621|NCT03167164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5727622|NCT03167164|Antidotes|antidotes|mesh-ancestor
5727623|NCT03167164|Protective Agents|protective agents|mesh-ancestor
5727624|NCT03167164|Vitamin B Complex|vitamin b complex|mesh-ancestor
5727625|NCT03167164|Vitamins|vitamins|mesh-ancestor
5727626|NCT03167164|Micronutrients|micronutrients|mesh-ancestor
5727627|NCT03166891|Chiauranib|chiauranib|mesh-list
5727628|NCT03166891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5727629|NCT03166891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5727630|NCT03166891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5727631|NCT03166891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5727632|NCT03167112|Leucovorin|leucovorin|mesh-list
5727633|NCT03167112|Fluorouracil|fluorouracil|mesh-list
5727634|NCT03167112|Oxaliplatin|oxaliplatin|mesh-list
5727635|NCT03167112|Irinotecan|irinotecan|mesh-list
5727636|NCT03167112|Antimetabolites|antimetabolites|mesh-ancestor
5727637|NCT03167112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5727638|NCT03167112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5727639|NCT03167112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5727640|NCT03167112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5727641|NCT03167112|Immunologic Factors|immunologic factors|mesh-ancestor
5727642|NCT03167112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727643|NCT03167112|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5727644|NCT03167112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5727645|NCT03167112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5727646|NCT03167112|Antidotes|antidotes|mesh-ancestor
5727647|NCT03167112|Protective Agents|protective agents|mesh-ancestor
5727648|NCT03167112|Vitamin B Complex|vitamin b complex|mesh-ancestor
5727649|NCT03167112|Vitamins|vitamins|mesh-ancestor
5727650|NCT03167112|Micronutrients|micronutrients|mesh-ancestor
5727651|NCT03167034|Acetazolamide|acetazolamide|mesh-list
5727652|NCT03167034|Anticonvulsants|anticonvulsants|mesh-ancestor
5727653|NCT03167034|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5727654|NCT03167034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5727655|NCT03167034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5727656|NCT03167034|Diuretics|diuretics|mesh-ancestor
5727657|NCT03167034|Natriuretic Agents|natriuretic agents|mesh-ancestor
5727658|NCT03167034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727659|NCT03167177|Leucovorin|leucovorin|mesh-list
5727660|NCT03167177|Paclitaxel|paclitaxel|mesh-list
5727661|NCT03167177|Cyclophosphamide|cyclophosphamide|mesh-list
5727662|NCT03167177|Bevacizumab|bevacizumab|mesh-list
5727663|NCT03167177|Fluorouracil|fluorouracil|mesh-list
5727664|NCT03167177|Capecitabine|capecitabine|mesh-list
5727665|NCT03167177|Nivolumab|nivolumab|mesh-list
5727666|NCT03167177|Avelumab|avelumab|mesh-list
5727667|NCT03167177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5610404|NCT00637832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610405|NCT00637832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5727668|NCT03167177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5727669|NCT03167177|Tubulin Modulators|tubulin modulators|mesh-ancestor
5727670|NCT03167177|Antimitotic Agents|antimitotic agents|mesh-ancestor
5727671|NCT03167177|Mitosis Modulators|mitosis modulators|mesh-ancestor
5892690|NCT04564365|Adrenergic Agents|adrenergic agents|mesh-ancestor
5727672|NCT03167177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5727673|NCT03167177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5727674|NCT03167177|Immunologic Factors|immunologic factors|mesh-ancestor
5727675|NCT03167177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727676|NCT03167177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5727677|NCT03167177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5727678|NCT03167177|Alkylating Agents|alkylating agents|mesh-ancestor
5727679|NCT03167177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5727680|NCT03167177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5727681|NCT03167177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5610406|NCT00637832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5610407|NCT00637832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5610408|NCT00637832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5610409|NCT00637832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5610410|NCT00637832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5610411|NCT00637832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5610412|NCT00637832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5610413|NCT00637832|Tubulin Modulators|tubulin modulators|mesh-ancestor
5610414|NCT00637832|Antimitotic Agents|antimitotic agents|mesh-ancestor
5610415|NCT00637832|Mitosis Modulators|mitosis modulators|mesh-ancestor
5610416|NCT00637832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5610417|NCT00637832|Glucocorticoids|glucocorticoids|mesh-ancestor
5610418|NCT00637832|Hormones|hormones|mesh-ancestor
5610419|NCT00637832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5610420|NCT00637832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5610421|NCT00392327|Vitamin A|vitamin a|mesh-list
5610422|NCT00392327|Cyclophosphamide|cyclophosphamide|mesh-list
5727682|NCT03167177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5727683|NCT03167177|Growth Substances|growth substances|mesh-ancestor
5727684|NCT03167177|Growth Inhibitors|growth inhibitors|mesh-ancestor
5727685|NCT03167177|Antimetabolites|antimetabolites|mesh-ancestor
5727686|NCT03167177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5727687|NCT03167177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5727688|NCT03167177|Antidotes|antidotes|mesh-ancestor
5727689|NCT03167177|Protective Agents|protective agents|mesh-ancestor
5727690|NCT03167177|Vitamin B Complex|vitamin b complex|mesh-ancestor
5727691|NCT03167177|Vitamins|vitamins|mesh-ancestor
5727692|NCT03167177|Micronutrients|micronutrients|mesh-ancestor
5727693|NCT03166644|Sufentanil|sufentanil|mesh-list
5610423|NCT00392327|Cisplatin|cisplatin|mesh-list
5610424|NCT00392327|Carboplatin|carboplatin|mesh-list
5610425|NCT00392327|Vincristine|vincristine|mesh-list
5610426|NCT00392327|Tretinoin|tretinoin|mesh-list
5610427|NCT00392327|Isotretinoin|isotretinoin|mesh-list
5610428|NCT00392327|Lenograstim|lenograstim|mesh-list
5610429|NCT00392327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5610430|NCT00392327|Immunologic Factors|immunologic factors|mesh-ancestor
5610431|NCT00392327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610432|NCT00392327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5610433|NCT00392327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5610434|NCT00392327|Alkylating Agents|alkylating agents|mesh-ancestor
5610435|NCT00392327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610436|NCT00392327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5610437|NCT00392327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5610438|NCT00392327|Vitamins|vitamins|mesh-ancestor
5727694|NCT03166644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5727695|NCT03166644|Narcotics|narcotics|mesh-ancestor
5727696|NCT03166644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5727697|NCT03166644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727698|NCT03166644|Analgesics|analgesics|mesh-ancestor
5727699|NCT03166644|Sensory System Agents|sensory system agents|mesh-ancestor
5727700|NCT03166644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5727701|NCT03166644|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5727702|NCT03166644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5727703|NCT03166644|Anesthetics, General|anesthetics, general|mesh-ancestor
5727704|NCT03166644|Anesthetics|anesthetics|mesh-ancestor
5727705|NCT03166865|Hyaluronic Acid|hyaluronic acid|mesh-list
5727706|NCT03166865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5727707|NCT03166865|Immunologic Factors|immunologic factors|mesh-ancestor
5727708|NCT03166865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727709|NCT03166865|Viscosupplements|viscosupplements|mesh-ancestor
5727710|NCT03166865|Protective Agents|protective agents|mesh-ancestor
5727711|NCT03166787|Ascorbic Acid|ascorbic acid|mesh-list
5727712|NCT03166787|Tadalafil|tadalafil|mesh-list
5727713|NCT03166787|Charcoal|charcoal|mesh-list
5727714|NCT03166787|Carbon Monoxide|carbon monoxide|mesh-list
5610439|NCT00392327|Micronutrients|micronutrients|mesh-ancestor
5727715|NCT03166787|Vitamins|vitamins|mesh-ancestor
5727716|NCT03166787|Micronutrients|micronutrients|mesh-ancestor
5727717|NCT03166787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727718|NCT03166787|Antioxidants|antioxidants|mesh-ancestor
5727719|NCT03166787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5727720|NCT03166787|Protective Agents|protective agents|mesh-ancestor
5727721|NCT03166787|Vasodilator Agents|vasodilator agents|mesh-ancestor
5727722|NCT03166787|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5727723|NCT03166787|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5727724|NCT03166787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5727725|NCT03166787|Urological Agents|urological agents|mesh-ancestor
5727726|NCT03166787|Antidotes|antidotes|mesh-ancestor
5727727|NCT03166787|Antimetabolites|antimetabolites|mesh-ancestor
5727728|NCT03166787|Gasotransmitters|gasotransmitters|mesh-ancestor
5610440|NCT00392327|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5610441|NCT00392327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5610442|NCT00392327|Tubulin Modulators|tubulin modulators|mesh-ancestor
5610443|NCT00392327|Antimitotic Agents|antimitotic agents|mesh-ancestor
5610444|NCT00392327|Mitosis Modulators|mitosis modulators|mesh-ancestor
5610445|NCT00392327|Keratolytic Agents|keratolytic agents|mesh-ancestor
5610446|NCT00392327|Dermatologic Agents|dermatologic agents|mesh-ancestor
5610447|NCT00116220|Goserelin|goserelin|mesh-list
5610448|NCT00116220|Flutamide|flutamide|mesh-list
5610449|NCT00116220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610450|NCT00116220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5610451|NCT00116220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5610452|NCT00116220|Androgen Antagonists|androgen antagonists|mesh-ancestor
5610453|NCT00116220|Hormone Antagonists|hormone antagonists|mesh-ancestor
5610454|NCT00116220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5610455|NCT00099086|Docetaxel|docetaxel|mesh-list
5610456|NCT00099086|Leuprolide|leuprolide|mesh-list
5610457|NCT00099086|Goserelin|goserelin|mesh-list
5610458|NCT00099086|Bicalutamide|bicalutamide|mesh-list
5610459|NCT00099086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5610460|NCT00099086|Tubulin Modulators|tubulin modulators|mesh-ancestor
5610461|NCT00099086|Antimitotic Agents|antimitotic agents|mesh-ancestor
5610462|NCT00099086|Mitosis Modulators|mitosis modulators|mesh-ancestor
5610463|NCT00099086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610464|NCT00099086|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5610465|NCT00099086|Fertility Agents|fertility agents|mesh-ancestor
5610466|NCT00099086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5727729|NCT03166787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5727730|NCT03166254|Pembrolizumab|pembrolizumab|mesh-list
5727731|NCT03166254|Vaccines|vaccines|mesh-list
5727732|NCT03166254|Poly ICLC|poly iclc|mesh-list
5727733|NCT03166254|Immunologic Factors|immunologic factors|mesh-ancestor
5727734|NCT03166254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727735|NCT03166254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5727736|NCT03166254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5727737|NCT03166254|Interferon Inducers|interferon inducers|mesh-ancestor
5727738|NCT03166306|Bevacizumab|bevacizumab|mesh-list
5727739|NCT03166306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5727740|NCT03166306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5727741|NCT03166306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5727742|NCT03166306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5727743|NCT03166306|Growth Substances|growth substances|mesh-ancestor
5727744|NCT03166306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727745|NCT03166306|Growth Inhibitors|growth inhibitors|mesh-ancestor
5727746|NCT03166228|Glycine|glycine|mesh-list
5727747|NCT03166228|Glycine Agents|glycine agents|mesh-ancestor
5727748|NCT03166228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5727749|NCT03166228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5727750|NCT03166228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727751|NCT03166605|Simethicone|simethicone|mesh-list
5727752|NCT03166605|Antifoaming Agents|antifoaming agents|mesh-ancestor
5727753|NCT03166605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5727754|NCT03166605|Emollients|emollients|mesh-ancestor
5727755|NCT03166605|Dermatologic Agents|dermatologic agents|mesh-ancestor
5727756|NCT03166553|Oxaliplatin|oxaliplatin|mesh-list
5727757|NCT03166553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5727758|NCT03166280|Sofosbuvir|sofosbuvir|mesh-list
5727759|NCT03166280|Antiviral Agents|antiviral agents|mesh-ancestor
5727760|NCT03166280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5727761|NCT03166397|Cyclophosphamide|cyclophosphamide|mesh-list
5727762|NCT03166397|Fludarabine|fludarabine|mesh-list
5727763|NCT03166397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5727764|NCT03166397|Immunologic Factors|immunologic factors|mesh-ancestor
5610467|NCT00099086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727765|NCT03166397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727766|NCT03166397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5610468|NCT00099086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5610469|NCT00099086|Androgen Antagonists|androgen antagonists|mesh-ancestor
5610470|NCT00099086|Hormone Antagonists|hormone antagonists|mesh-ancestor
5610471|NCT00099086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5610472|NCT00092222|Interferons|interferons|mesh-list
5610473|NCT00092222|Interferon-alpha|interferon-alpha|mesh-list
5610474|NCT00092222|Zidovudine|zidovudine|mesh-list
5610475|NCT00092222|Valganciclovir|valganciclovir|mesh-list
5610476|NCT00092222|Sirolimus|sirolimus|mesh-list
5610477|NCT00092222|Prednisone|prednisone|mesh-list
5610478|NCT00092222|Cyclophosphamide|cyclophosphamide|mesh-list
5610479|NCT00092222|Rituximab|rituximab|mesh-list
5610480|NCT00092222|Doxorubicin|doxorubicin|mesh-list
5610481|NCT00092222|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5610482|NCT00092222|Etoposide|etoposide|mesh-list
5610483|NCT00092222|Vincristine|vincristine|mesh-list
5610484|NCT00092222|Bortezomib|bortezomib|mesh-list
5727767|NCT03166397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5727768|NCT03166397|Alkylating Agents|alkylating agents|mesh-ancestor
5727769|NCT03166397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5727770|NCT03166397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5727771|NCT03166397|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5727772|NCT03166527|Immunoglobulins|immunoglobulins|mesh-list
5727773|NCT03166527|Antibodies|antibodies|mesh-list
5727774|NCT03166527|gamma-Globulins|gamma-globulins|mesh-list
5727775|NCT03166527|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5727776|NCT03166527|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5727777|NCT03166527|Immunologic Factors|immunologic factors|mesh-ancestor
5727778|NCT03166527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727779|NCT03166111|Lidocaine|lidocaine|mesh-list
5727780|NCT03166111|Anesthetics, Local|anesthetics, local|mesh-ancestor
5727781|NCT03166111|Anesthetics|anesthetics|mesh-ancestor
5727782|NCT03166111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5727783|NCT03166111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727784|NCT03166111|Sensory System Agents|sensory system agents|mesh-ancestor
5727785|NCT03166111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5727786|NCT03166111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5727787|NCT03166111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5727788|NCT03166111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5727789|NCT03166111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5727790|NCT03166111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5727791|NCT03165890|Acetazolamide|acetazolamide|mesh-list
5727792|NCT03165890|Anticonvulsants|anticonvulsants|mesh-ancestor
5727793|NCT03165890|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5727794|NCT03165890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5727795|NCT03165890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5727796|NCT03165890|Diuretics|diuretics|mesh-ancestor
5727797|NCT03165890|Natriuretic Agents|natriuretic agents|mesh-ancestor
5727798|NCT03165890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610485|NCT00092222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5610486|NCT00092222|Immunologic Factors|immunologic factors|mesh-ancestor
5610487|NCT00092222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610488|NCT00092222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5610489|NCT00092222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5610490|NCT00092222|Alkylating Agents|alkylating agents|mesh-ancestor
5610491|NCT00092222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610492|NCT00092222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5610493|NCT00092222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5610494|NCT00092222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5727799|NCT03165942|Ethanol|ethanol|mesh-list
5727800|NCT03165942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5727801|NCT03165942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5727802|NCT03165942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5727803|NCT03165942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727804|NCT03166163|Chlorhexidine|chlorhexidine|mesh-list
5727805|NCT03166163|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5727806|NCT03166163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5727807|NCT03166163|Disinfectants|disinfectants|mesh-ancestor
5610495|NCT00092222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5610496|NCT00092222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5610497|NCT00092222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5610498|NCT00092222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5610499|NCT00092222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5610500|NCT00092222|Glucocorticoids|glucocorticoids|mesh-ancestor
5610501|NCT00092222|Hormones|hormones|mesh-ancestor
5610502|NCT00092222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5727808|NCT03165929|Flurbiprofen|flurbiprofen|mesh-list
5727809|NCT03165929|Analgesics|analgesics|mesh-ancestor
5727810|NCT03165929|Sensory System Agents|sensory system agents|mesh-ancestor
5727811|NCT03165929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5727812|NCT03165929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727813|NCT03165929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5727814|NCT03165929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5727815|NCT03165929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5727816|NCT03165929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5727817|NCT03165929|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5727818|NCT03165929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5727819|NCT03165929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5727820|NCT03165825|Dexamethasone|dexamethasone|mesh-list
5727821|NCT03165825|Betamethasone|betamethasone|mesh-list
5727822|NCT03165825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5727823|NCT03165825|Antiemetics|antiemetics|mesh-ancestor
5727824|NCT03165825|Autonomic Agents|autonomic agents|mesh-ancestor
5727825|NCT03165825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5727826|NCT03165825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727827|NCT03165825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5727828|NCT03165825|Glucocorticoids|glucocorticoids|mesh-ancestor
5727829|NCT03165825|Hormones|hormones|mesh-ancestor
5727830|NCT03165825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5727831|NCT03165825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5727832|NCT03165825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5727833|NCT03165825|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5727834|NCT03165825|Respiratory System Agents|respiratory system agents|mesh-ancestor
5892691|NCT04564365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5892692|NCT04564365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892693|NCT04564365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610503|NCT00092222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5610504|NCT00092222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5610505|NCT00092222|Antiviral Agents|antiviral agents|mesh-ancestor
5610506|NCT00092222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6489093|NCT00589251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6489094|NCT00589264|Copper|copper|mesh-list
6489095|NCT00589264|Trace Elements|trace elements|mesh-ancestor
6489096|NCT00589264|Micronutrients|micronutrients|mesh-ancestor
6489097|NCT00589264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610507|NCT00092222|Tubulin Modulators|tubulin modulators|mesh-ancestor
5610508|NCT00092222|Antimitotic Agents|antimitotic agents|mesh-ancestor
5610509|NCT00092222|Mitosis Modulators|mitosis modulators|mesh-ancestor
5610510|NCT00092222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5610511|NCT00092222|Antifungal Agents|antifungal agents|mesh-ancestor
6489098|NCT00589316|Iodine|iodine|mesh-list
5892694|NCT04564157|Paclitaxel|paclitaxel|mesh-list
5892695|NCT04564157|Carboplatin|carboplatin|mesh-list
5892696|NCT04564157|Nivolumab|nivolumab|mesh-list
5892697|NCT04564157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5610512|NCT00092222|Antimetabolites|antimetabolites|mesh-ancestor
5610513|NCT00092222|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5610514|NCT00092222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5610515|NCT00092222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5610516|NCT00092222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5610517|NCT00085202|Cyclophosphamide|cyclophosphamide|mesh-list
5892698|NCT04564157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5892699|NCT04564157|Tubulin Modulators|tubulin modulators|mesh-ancestor
5892700|NCT04564157|Antimitotic Agents|antimitotic agents|mesh-ancestor
5892701|NCT04564157|Mitosis Modulators|mitosis modulators|mesh-ancestor
5892702|NCT04564157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892703|NCT04564157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5892704|NCT04564157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5892705|NCT04539236|Lenalidomide|lenalidomide|mesh-list
5892706|NCT04539236|Luspatercept|luspatercept|mesh-list
5892707|NCT04539236|Immunologic Factors|immunologic factors|mesh-ancestor
5892708|NCT04539236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892709|NCT04539236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5892710|NCT04539236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5892711|NCT04539236|Growth Substances|growth substances|mesh-ancestor
5892712|NCT04539236|Growth Inhibitors|growth inhibitors|mesh-ancestor
5892713|NCT04539236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5892714|NCT04539236|Hematinics|hematinics|mesh-ancestor
6489099|NCT00589316|Mycophenolic Acid|mycophenolic acid|mesh-list
6489100|NCT00589316|Cadexomer iodine|cadexomer iodine|mesh-list
5892715|NCT04530838|Vaccines|vaccines|mesh-list
6208092|NCT02124707|Mitosis Modulators|mitosis modulators|mesh-ancestor
6489101|NCT00589316|Cyclophosphamide|cyclophosphamide|mesh-list
5727835|NCT03165344|Prednisone|prednisone|mesh-list
5727836|NCT03165344|Triamcinolone|triamcinolone|mesh-list
5727837|NCT03165344|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5727838|NCT03165344|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5727839|NCT03165344|Hydrocortisone|hydrocortisone|mesh-list
5727840|NCT03165344|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
5727841|NCT03165344|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
5727842|NCT03165344|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
5727843|NCT03165344|Aluminum phosphate|aluminum phosphate|mesh-list
5610518|NCT00085202|Vincristine|vincristine|mesh-list
5610519|NCT00085202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5610520|NCT00085202|Immunologic Factors|immunologic factors|mesh-ancestor
5610521|NCT00085202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610522|NCT00085202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5610523|NCT00085202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5727844|NCT03165344|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5727845|NCT03165344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5727846|NCT03165344|Glucocorticoids|glucocorticoids|mesh-ancestor
5727847|NCT03165344|Hormones|hormones|mesh-ancestor
5727848|NCT03165344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5727849|NCT03165344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727850|NCT03165344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5727851|NCT03165344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5610524|NCT00085202|Alkylating Agents|alkylating agents|mesh-ancestor
5610525|NCT00085202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610526|NCT00085202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5610527|NCT00085202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5610528|NCT00085202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5610529|NCT00085202|Tubulin Modulators|tubulin modulators|mesh-ancestor
5610530|NCT00085202|Antimitotic Agents|antimitotic agents|mesh-ancestor
5610531|NCT00085202|Mitosis Modulators|mitosis modulators|mesh-ancestor
5610532|NCT05187507|Theobromine|theobromine|mesh-list
5610533|NCT05187507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5610534|NCT05187507|Autonomic Agents|autonomic agents|mesh-ancestor
5610535|NCT05187507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5610536|NCT05187507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610537|NCT05187507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5610538|NCT05187507|Respiratory System Agents|respiratory system agents|mesh-ancestor
5610539|NCT05187507|Vasodilator Agents|vasodilator agents|mesh-ancestor
5610540|NCT05187494|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
5610541|NCT05187494|Anesthetics, Local|anesthetics, local|mesh-ancestor
5610542|NCT05187494|Anesthetics|anesthetics|mesh-ancestor
5610543|NCT05187494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5610544|NCT05187494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610545|NCT05187494|Sensory System Agents|sensory system agents|mesh-ancestor
5610546|NCT05187494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5610547|NCT05187494|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
5610548|NCT05187429|Nivolumab|nivolumab|mesh-list
5610549|NCT05187429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5610550|NCT05187429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5610551|NCT05187429|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5610552|NCT05187429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610553|NCT05187286|Apixaban|apixaban|mesh-list
5610554|NCT05187286|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5610555|NCT05187286|Antithrombins|antithrombins|mesh-ancestor
5610556|NCT05187286|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5727852|NCT03165344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5727853|NCT03165344|Immunologic Factors|immunologic factors|mesh-ancestor
5727854|NCT03165344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5727855|NCT03165344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5727856|NCT03165344|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5727857|NCT03165344|Antacids|antacids|mesh-ancestor
5727858|NCT03165344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5727859|NCT03165383|Morphine|morphine|mesh-list
5727860|NCT03165383|Bupivacaine|bupivacaine|mesh-list
5727861|NCT03165383|Anesthetics, Local|anesthetics, local|mesh-ancestor
5727862|NCT03165383|Anesthetics|anesthetics|mesh-ancestor
5727863|NCT03165383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5727864|NCT03165383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727865|NCT03165383|Sensory System Agents|sensory system agents|mesh-ancestor
5727866|NCT03165383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5727867|NCT03165383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5727868|NCT03165383|Narcotics|narcotics|mesh-ancestor
5727869|NCT03165383|Analgesics|analgesics|mesh-ancestor
5727870|NCT03165591|Vaccines|vaccines|mesh-list
5727871|NCT03165591|Immunologic Factors|immunologic factors|mesh-ancestor
5727872|NCT03165591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727873|NCT03165500|Midazolam|midazolam|mesh-list
5727874|NCT03165500|Diazepam|diazepam|mesh-list
5727875|NCT03165500|Nitrous Oxide|nitrous oxide|mesh-list
5727876|NCT03165500|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5727877|NCT03165500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5727878|NCT03165500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5727879|NCT03165500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727880|NCT03165500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5727881|NCT03165500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5727882|NCT03165500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5727883|NCT03165500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5727884|NCT03165500|Anesthetics, General|anesthetics, general|mesh-ancestor
5727885|NCT03165500|Anesthetics|anesthetics|mesh-ancestor
5727886|NCT03165500|GABA Modulators|gaba modulators|mesh-ancestor
5727887|NCT03165500|GABA Agents|gaba agents|mesh-ancestor
5727888|NCT03165500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5727889|NCT03165500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5727890|NCT03165500|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5727891|NCT03165500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5727892|NCT03165500|Analgesics|analgesics|mesh-ancestor
5727893|NCT03165500|Sensory System Agents|sensory system agents|mesh-ancestor
5727894|NCT03165500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5727895|NCT03165500|Anticonvulsants|anticonvulsants|mesh-ancestor
5727896|NCT03165500|Antiemetics|antiemetics|mesh-ancestor
5727897|NCT03165500|Autonomic Agents|autonomic agents|mesh-ancestor
5727898|NCT03165500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5727899|NCT03165500|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5727900|NCT03165500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5727901|NCT03165396|Propofol|propofol|mesh-list
5727902|NCT03165396|Sevoflurane|sevoflurane|mesh-list
5727903|NCT03165396|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5727904|NCT03165396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5727905|NCT03165396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727906|NCT03165396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5727907|NCT03165396|Anesthetics, General|anesthetics, general|mesh-ancestor
5727908|NCT03165396|Anesthetics|anesthetics|mesh-ancestor
5727909|NCT03165396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5727910|NCT03165396|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5727911|NCT03165253|Amoxicillin|amoxicillin|mesh-list
5727912|NCT03165253|Clarithromycin|clarithromycin|mesh-list
5727913|NCT03165253|Omeprazole|omeprazole|mesh-list
5727914|NCT03165253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5727915|NCT03165253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5727916|NCT03165253|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5727917|NCT03165253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5727918|NCT03165253|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5727919|NCT03165253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5727920|NCT03165253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5727921|NCT03165253|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5727922|NCT03165253|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5727923|NCT03165253|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5610557|NCT05187286|Protease Inhibitors|protease inhibitors|mesh-ancestor
5610558|NCT05187286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5610559|NCT05187286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610560|NCT05187286|Anticoagulants|anticoagulants|mesh-ancestor
5610561|NCT05187182|Leucovorin|leucovorin|mesh-list
5610562|NCT05187182|Pembrolizumab|pembrolizumab|mesh-list
5610563|NCT05187182|Nivolumab|nivolumab|mesh-list
5610564|NCT05187182|Trastuzumab|trastuzumab|mesh-list
5610565|NCT05187182|Oxaliplatin|oxaliplatin|mesh-list
5610566|NCT05187182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5610567|NCT05187182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5610568|NCT05187182|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5610569|NCT05187182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610570|NCT05187182|Antidotes|antidotes|mesh-ancestor
5610571|NCT05187182|Protective Agents|protective agents|mesh-ancestor
5610572|NCT05187182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610573|NCT05187182|Vitamin B Complex|vitamin b complex|mesh-ancestor
5727924|NCT03165123|Azithromycin|azithromycin|mesh-list
5727925|NCT03165123|Dexamethasone|dexamethasone|mesh-list
5727926|NCT03165123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5727927|NCT03165123|Antiemetics|antiemetics|mesh-ancestor
5727928|NCT03165123|Autonomic Agents|autonomic agents|mesh-ancestor
5610574|NCT05187182|Vitamins|vitamins|mesh-ancestor
5610575|NCT05187182|Micronutrients|micronutrients|mesh-ancestor
5727929|NCT03165123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5727930|NCT03165123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727931|NCT03165123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5727932|NCT03165123|Glucocorticoids|glucocorticoids|mesh-ancestor
5727933|NCT03165123|Hormones|hormones|mesh-ancestor
5727934|NCT03165123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5727935|NCT03165123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5727936|NCT03165123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5727937|NCT03165123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5610576|NCT05186675|Epinephrine|epinephrine|mesh-list
5610577|NCT05186675|Racepinephrine|racepinephrine|mesh-list
5727938|NCT03165123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5727939|NCT03165240|Eplerenone|eplerenone|mesh-list
5727940|NCT03165240|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5727941|NCT03165240|Hormone Antagonists|hormone antagonists|mesh-ancestor
5727942|NCT03165240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6489102|NCT00589316|Fludarabine|fludarabine|mesh-list
5610578|NCT05186675|Epinephryl borate|epinephryl borate|mesh-list
5610579|NCT05186675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5610580|NCT05186675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5610581|NCT05186675|Adrenergic Agents|adrenergic agents|mesh-ancestor
5610582|NCT05186675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5610583|NCT05186675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610584|NCT05186675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610585|NCT05186675|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5610586|NCT05186675|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5610587|NCT05186675|Autonomic Agents|autonomic agents|mesh-ancestor
5610588|NCT05186675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5610589|NCT05186675|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5691689|NCT03415087|Narcotics|narcotics|mesh-ancestor
5691690|NCT03415087|Analgesics|analgesics|mesh-ancestor
5691691|NCT03415087|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5691692|NCT03415087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5691693|NCT03415087|Anesthetics, General|anesthetics, general|mesh-ancestor
5691694|NCT03414931|Sertraline|sertraline|mesh-list
5691695|NCT03414931|Antidepressive Agents|antidepressive agents|mesh-ancestor
5691696|NCT03414931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5691697|NCT03414931|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5691698|NCT03414931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5691699|NCT03414931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5691700|NCT03414931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691701|NCT03414931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5691702|NCT03414931|Serotonin Agents|serotonin agents|mesh-ancestor
5691703|NCT03414931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691704|NCT03414918|Clarithromycin|clarithromycin|mesh-list
5691705|NCT03414918|Roxithromycin|roxithromycin|mesh-list
5691706|NCT03414918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5691707|NCT03414918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5691708|NCT03414918|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5691709|NCT03414918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5691710|NCT03414918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691711|NCT03414918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5691712|NCT03414918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5691713|NCT03414879|Lidocaine|lidocaine|mesh-list
5691714|NCT03414879|Ketamine|ketamine|mesh-list
5691715|NCT03414879|Anesthetics, Local|anesthetics, local|mesh-ancestor
5691716|NCT03414879|Anesthetics|anesthetics|mesh-ancestor
5691717|NCT03414879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5691718|NCT03414879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691719|NCT03414879|Sensory System Agents|sensory system agents|mesh-ancestor
5691720|NCT03414879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5727943|NCT03165240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727944|NCT03165240|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5610590|NCT05186675|Respiratory System Agents|respiratory system agents|mesh-ancestor
5610591|NCT05186675|Mydriatics|mydriatics|mesh-ancestor
5610592|NCT05186675|Sympathomimetics|sympathomimetics|mesh-ancestor
5610593|NCT05186675|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5610594|NCT05186649|Warfarin|warfarin|mesh-list
5610595|NCT05186649|Anticoagulants|anticoagulants|mesh-ancestor
5610596|NCT05186558|Gemcitabine|gemcitabine|mesh-list
5610597|NCT05186558|Rituximab|rituximab|mesh-list
5610598|NCT05186558|Oxaliplatin|oxaliplatin|mesh-list
5610599|NCT05186558|Lenalidomide|lenalidomide|mesh-list
5610600|NCT05186558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5610601|NCT05186558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5610602|NCT05186558|Immunologic Factors|immunologic factors|mesh-ancestor
5610603|NCT05186558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610604|NCT05186558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5610605|NCT05186558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5610606|NCT05186558|Antimetabolites|antimetabolites|mesh-ancestor
5610607|NCT05186558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610608|NCT05186558|Antiviral Agents|antiviral agents|mesh-ancestor
5610609|NCT05186558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5610610|NCT05186558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5610611|NCT05186558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5610612|NCT05186558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5727945|NCT03165240|Diuretics|diuretics|mesh-ancestor
5727946|NCT03165240|Natriuretic Agents|natriuretic agents|mesh-ancestor
5727947|NCT03165240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5727948|NCT03165097|ACT-709478|act-709478|mesh-list
5727949|NCT03165097|Midazolam|midazolam|mesh-list
5727950|NCT03165097|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5727951|NCT03165097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5727952|NCT03165097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5727953|NCT03165097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727954|NCT03165097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5727955|NCT03165097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5727956|NCT03165097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5610613|NCT05186558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5610614|NCT05186558|Growth Substances|growth substances|mesh-ancestor
5727957|NCT03165097|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5727958|NCT03165097|Anesthetics, General|anesthetics, general|mesh-ancestor
5727959|NCT03165097|Anesthetics|anesthetics|mesh-ancestor
5727960|NCT03165097|GABA Modulators|gaba modulators|mesh-ancestor
5727961|NCT03165097|GABA Agents|gaba agents|mesh-ancestor
5727962|NCT03165097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5727963|NCT03165097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5727964|NCT03165097|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5727965|NCT03165097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5727966|NCT03165097|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5727967|NCT03165292|Topotecan|topotecan|mesh-list
5727968|NCT03165292|Thiotepa|thiotepa|mesh-list
5727969|NCT03165292|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5727970|NCT03165292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5727971|NCT03165292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5727972|NCT03165292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5727973|NCT03165292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5727974|NCT03165292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5727975|NCT03165292|Alkylating Agents|alkylating agents|mesh-ancestor
5727976|NCT03165292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5727977|NCT03165292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5727978|NCT03165292|Immunologic Factors|immunologic factors|mesh-ancestor
5727979|NCT03165292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727980|NCT03164993|Cyclophosphamide|cyclophosphamide|mesh-list
5727981|NCT03164993|Doxorubicin|doxorubicin|mesh-list
5727982|NCT03164993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5727983|NCT03164993|Atezolizumab|atezolizumab|mesh-list
5727984|NCT03164993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5727985|NCT03164993|Immunologic Factors|immunologic factors|mesh-ancestor
5727986|NCT03164993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5727987|NCT03164993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5727988|NCT03164993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5727989|NCT03164993|Alkylating Agents|alkylating agents|mesh-ancestor
5727990|NCT03164993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5727991|NCT03164993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5610615|NCT05186558|Growth Inhibitors|growth inhibitors|mesh-ancestor
5610616|NCT05186545|Fulvestrant|fulvestrant|mesh-list
5610617|NCT05186545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5727992|NCT03164993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5727993|NCT03164993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5727994|NCT03164993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5727995|NCT03164993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5727996|NCT03164993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5727997|NCT03165409|Nivolumab|nivolumab|mesh-list
5727998|NCT03165409|Ipilimumab|ipilimumab|mesh-list
5727999|NCT03165409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5728000|NCT03165409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5728001|NCT03165409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5728002|NCT03165409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728003|NCT03164837|68Ga-NOTA-RM26|68ga-nota-rm26|mesh-list
5728004|NCT03164837|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5728005|NCT03164837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728006|NCT03164889|Entecavir|entecavir|mesh-list
5728007|NCT03164889|Molgramostim|molgramostim|mesh-list
5728008|NCT03164889|Sargramostim|sargramostim|mesh-list
5728009|NCT03164889|Immunologic Factors|immunologic factors|mesh-ancestor
5728010|NCT03164889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728011|NCT03164889|Antiviral Agents|antiviral agents|mesh-ancestor
5728012|NCT03164889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5728013|NCT03164889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5728014|NCT03164967|Immunoglobulin G|immunoglobulin g|mesh-list
5728015|NCT03164967|Immunologic Factors|immunologic factors|mesh-ancestor
5728016|NCT03164967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728017|NCT03164980|Trabectedin|trabectedin|mesh-list
5728018|NCT03164980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5728019|NCT03164980|Alkylating Agents|alkylating agents|mesh-ancestor
5728020|NCT03164980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728021|NCT03164980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5728022|NCT03164694|Carboplatin|carboplatin|mesh-list
5728023|NCT03164694|Pemetrexed|pemetrexed|mesh-list
5728024|NCT03164694|Apatinib|apatinib|mesh-list
5728025|NCT03164694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5728026|NCT03164694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5728027|NCT03164694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728028|NCT03164694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5728029|NCT03164694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5728030|NCT03164694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5728031|NCT03164590|Dexmedetomidine|dexmedetomidine|mesh-list
5728032|NCT03164590|Ketamine|ketamine|mesh-list
5728033|NCT03164590|Bupivacaine|bupivacaine|mesh-list
5728034|NCT03164590|Anesthetics, Local|anesthetics, local|mesh-ancestor
5728035|NCT03164590|Anesthetics|anesthetics|mesh-ancestor
5728036|NCT03164590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5728037|NCT03164590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728038|NCT03164590|Sensory System Agents|sensory system agents|mesh-ancestor
5728039|NCT03164590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5728040|NCT03164590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5728041|NCT03164590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5728042|NCT03164590|Analgesics|analgesics|mesh-ancestor
5728043|NCT03164590|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5728044|NCT03164590|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5728045|NCT03164590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5728046|NCT03164590|Adrenergic Agents|adrenergic agents|mesh-ancestor
5728047|NCT03164590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5728048|NCT03164590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728049|NCT03164590|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5728050|NCT03164590|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5728051|NCT03164590|Anesthetics, General|anesthetics, general|mesh-ancestor
5728052|NCT03164590|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5728053|NCT03164590|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5728054|NCT03164668|Menthol|menthol|mesh-list
5728055|NCT03164668|Antipruritics|antipruritics|mesh-ancestor
5728056|NCT03164668|Dermatologic Agents|dermatologic agents|mesh-ancestor
5728057|NCT03164512|Cannabidiol|cannabidiol|mesh-list
5728058|NCT03164512|Anticonvulsants|anticonvulsants|mesh-ancestor
5728059|NCT03164421|Acetylcysteine|acetylcysteine|mesh-list
5728060|NCT03164421|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5728061|NCT03164421|Antiviral Agents|antiviral agents|mesh-ancestor
5728062|NCT03164421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5728063|NCT03164421|Expectorants|expectorants|mesh-ancestor
5728064|NCT03164421|Respiratory System Agents|respiratory system agents|mesh-ancestor
5728065|NCT03164421|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5728066|NCT03164421|Antioxidants|antioxidants|mesh-ancestor
5728067|NCT03164421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728068|NCT03164421|Protective Agents|protective agents|mesh-ancestor
5610618|NCT05186545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5610619|NCT05186545|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5610620|NCT05186545|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5610621|NCT05186545|Hormone Antagonists|hormone antagonists|mesh-ancestor
5610622|NCT05186545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5610623|NCT05186545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610624|NCT05186363|Pyrimethamine|pyrimethamine|mesh-list
5610625|NCT05186363|Sulfadoxine|sulfadoxine|mesh-list
5610626|NCT05186363|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
5610627|NCT05186363|Amodiaquine|amodiaquine|mesh-list
5610628|NCT05186363|Antimalarials|antimalarials|mesh-ancestor
5610629|NCT05186363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5610630|NCT05186363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5610631|NCT05186363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5610632|NCT05186363|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5610633|NCT05186363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5610634|NCT05186363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610635|NCT05186363|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5610636|NCT05186363|Renal Agents|renal agents|mesh-ancestor
5610637|NCT05186194|Vitamin D|vitamin d|mesh-list
5728069|NCT03164421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728070|NCT03164421|Antidotes|antidotes|mesh-ancestor
5728071|NCT03164304|Magnesium Sulfate|magnesium sulfate|mesh-list
5728072|NCT03164304|Analgesics|analgesics|mesh-ancestor
5728073|NCT03164304|Sensory System Agents|sensory system agents|mesh-ancestor
5728074|NCT03164304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5728075|NCT03164304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728076|NCT03164304|Anesthetics|anesthetics|mesh-ancestor
5728077|NCT03164304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5728078|NCT03164304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5728079|NCT03164304|Anticonvulsants|anticonvulsants|mesh-ancestor
5728080|NCT03164304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5728081|NCT03164304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5728082|NCT03164304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728083|NCT03164304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5728084|NCT03164304|Tocolytic Agents|tocolytic agents|mesh-ancestor
5728085|NCT03164304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5728086|NCT03164447|UB-421|ub-421|mesh-list
5728087|NCT03164447|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5728088|NCT03164447|Antiviral Agents|antiviral agents|mesh-ancestor
5728089|NCT03164447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5728090|NCT03164382|Sorafenib|sorafenib|mesh-list
5728091|NCT03164382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5728092|NCT03164382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5728093|NCT03164382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5728094|NCT03164382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728095|NCT03164291|Rifabutin|rifabutin|mesh-list
5728096|NCT03164291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5728097|NCT03164291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5728098|NCT03164291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5728099|NCT03164291|Antitubercular Agents|antitubercular agents|mesh-ancestor
5892716|NCT04530838|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5892717|NCT04530838|Immunologic Factors|immunologic factors|mesh-ancestor
5892718|NCT04530838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892719|NCT04521803|Rifampin|rifampin|mesh-list
5892720|NCT04521803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5892721|NCT04521803|Antitubercular Agents|antitubercular agents|mesh-ancestor
5892722|NCT04521803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5892723|NCT04521803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5892724|NCT04521803|Leprostatic Agents|leprostatic agents|mesh-ancestor
5892725|NCT04521803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5892726|NCT04521803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5892727|NCT04521803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892728|NCT04521803|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5892729|NCT04521803|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5892730|NCT04521803|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5892731|NCT04521803|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5892732|NCT04521803|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5892733|NCT04521803|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5892734|NCT04514653|Ranibizumab|ranibizumab|mesh-list
5892735|NCT04514653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5892736|NCT04514653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5610638|NCT05186194|Calcium|calcium|mesh-list
5610639|NCT05186194|Vitamins|vitamins|mesh-ancestor
5728100|NCT03164096|Bupivacaine|bupivacaine|mesh-list
5728101|NCT03164096|Anesthetics, Local|anesthetics, local|mesh-ancestor
6489103|NCT00589316|Fludarabine phosphate|fludarabine phosphate|mesh-list
6489104|NCT00589316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6489105|NCT00589316|Tacrolimus|tacrolimus|mesh-list
6489106|NCT00589316|Antibodies|antibodies|mesh-list
6489107|NCT00589316|Immunoglobulins|immunoglobulins|mesh-list
5728102|NCT03164096|Anesthetics|anesthetics|mesh-ancestor
5728103|NCT03164096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5728104|NCT03164096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728105|NCT03164096|Sensory System Agents|sensory system agents|mesh-ancestor
5728106|NCT03164096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5728107|NCT03164109|Moxifloxacin|moxifloxacin|mesh-list
5728108|NCT03164109|Avasopasem manganese|avasopasem manganese|mesh-list
5728109|NCT03164109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5728110|NCT03164109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5728111|NCT03164109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5728112|NCT03164109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5728113|NCT03164109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5728114|NCT03164109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728115|NCT03164109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5728116|NCT03164109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728117|NCT03164109|Antioxidants|antioxidants|mesh-ancestor
5728118|NCT03164109|Protective Agents|protective agents|mesh-ancestor
5728119|NCT03164018|4-Aminopyridine|4-aminopyridine|mesh-list
5728120|NCT03164018|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5728121|NCT03164018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5728122|NCT03164018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728123|NCT03163914|Phenylephrine|phenylephrine|mesh-list
5728124|NCT03163914|Epinephrine|epinephrine|mesh-list
5728125|NCT03163914|Oxymetazoline|oxymetazoline|mesh-list
5728126|NCT03163914|Norepinephrine|norepinephrine|mesh-list
5728127|NCT03163914|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5728128|NCT03163914|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5728129|NCT03163914|Adrenergic Agents|adrenergic agents|mesh-ancestor
5728130|NCT03163914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5728131|NCT03163914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728132|NCT03163914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728133|NCT03163914|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5728134|NCT03163914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5728135|NCT03163914|Autonomic Agents|autonomic agents|mesh-ancestor
5728136|NCT03163914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5728137|NCT03163914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5728138|NCT03163914|Respiratory System Agents|respiratory system agents|mesh-ancestor
5728139|NCT03163914|Mydriatics|mydriatics|mesh-ancestor
5728140|NCT03163914|Sympathomimetics|sympathomimetics|mesh-ancestor
5728141|NCT03163914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5728142|NCT03163914|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5728143|NCT03163914|Nasal Decongestants|nasal decongestants|mesh-ancestor
5728144|NCT03163914|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5728145|NCT03163914|Protective Agents|protective agents|mesh-ancestor
5728146|NCT03163693|Dexmedetomidine|dexmedetomidine|mesh-list
5728147|NCT03163693|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5728148|NCT03163693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5728149|NCT03163693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728150|NCT03163693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5728151|NCT03163693|Analgesics|analgesics|mesh-ancestor
5728152|NCT03163693|Sensory System Agents|sensory system agents|mesh-ancestor
5728153|NCT03163693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5728154|NCT03163693|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5728155|NCT03163693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5728156|NCT03163693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5728157|NCT03163693|Adrenergic Agents|adrenergic agents|mesh-ancestor
5610640|NCT05186194|Micronutrients|micronutrients|mesh-ancestor
5610641|NCT05186194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610642|NCT05186194|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5610643|NCT05186194|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5610644|NCT05186129|Clopidogrel|clopidogrel|mesh-list
5610645|NCT05186129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5728158|NCT03163693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5610646|NCT05186129|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5610647|NCT05186129|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5728159|NCT03163693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728160|NCT03163680|Omeprazole|omeprazole|mesh-list
6489108|NCT00589316|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5610648|NCT05186129|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5610649|NCT05186129|Purinergic Agents|purinergic agents|mesh-ancestor
5610650|NCT05186129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5610651|NCT05186129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610652|NCT05186129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691721|NCT03414879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5691722|NCT03414879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5691723|NCT03414879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5691724|NCT03414879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5691725|NCT03414879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691726|NCT03414879|Analgesics|analgesics|mesh-ancestor
5728161|NCT03163680|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5728162|NCT03163680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5728163|NCT03163680|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5728164|NCT03163680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5728165|NCT03163680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728166|NCT03163784|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5728167|NCT03163784|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5728168|NCT03163784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5728169|NCT03163784|Antitubercular Agents|antitubercular agents|mesh-ancestor
5728170|NCT03163979|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5728171|NCT03163979|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5728172|NCT03163979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728173|NCT03164161|Endorphins|endorphins|mesh-list
5728174|NCT03164161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5728175|NCT03164161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728176|NCT03164161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728177|NCT03163849|Sofosbuvir|sofosbuvir|mesh-list
5728178|NCT03163849|Antiviral Agents|antiviral agents|mesh-ancestor
5728179|NCT03163849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5728180|NCT03163966|Methotrexate|methotrexate|mesh-list
5728181|NCT03163966|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5728182|NCT03163966|Abortifacient Agents|abortifacient agents|mesh-ancestor
5728183|NCT03163966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5728184|NCT03163966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672676|NCT01557712|Ketamine|ketamine|mesh-list
5691727|NCT03414879|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5691728|NCT03414879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5691729|NCT03414879|Anesthetics, General|anesthetics, general|mesh-ancestor
5691730|NCT03414879|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5691731|NCT03414879|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5691732|NCT03414879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5691733|NCT03414840|Atorvastatin|atorvastatin|mesh-list
5691734|NCT03414840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5691735|NCT03414840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5691736|NCT03414840|Antimetabolites|antimetabolites|mesh-ancestor
5691737|NCT03414840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691738|NCT03414840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5691739|NCT03414840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5691740|NCT03414840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5691741|NCT03414814|Osimertinib|osimertinib|mesh-list
5691742|NCT03414814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5691743|NCT03414814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5691744|NCT03414814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5691745|NCT03414814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691746|NCT03414723|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
5691747|NCT03414723|Ramipril|ramipril|mesh-list
5691748|NCT03414723|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5691749|NCT03414723|Protease Inhibitors|protease inhibitors|mesh-ancestor
5691750|NCT03414723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5691751|NCT03414723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691752|NCT03414723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5691753|NCT03414723|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5691754|NCT03414723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5691755|NCT03414723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691756|NCT03414658|Trastuzumab|trastuzumab|mesh-list
5691757|NCT03414658|Avelumab|avelumab|mesh-list
5691758|NCT03414658|Vinorelbine|vinorelbine|mesh-list
5691759|NCT03414658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5691760|NCT03414658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5728185|NCT03163966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5728186|NCT03163966|Antimetabolites|antimetabolites|mesh-ancestor
5728187|NCT03163966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728188|NCT03163966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5728189|NCT03163966|Dermatologic Agents|dermatologic agents|mesh-ancestor
5728190|NCT03163966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5728191|NCT03163966|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5610653|NCT05185999|Icodextrin|icodextrin|mesh-list
5610654|NCT05185999|Dialysis Solutions|dialysis solutions|mesh-ancestor
5610655|NCT05185999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5610656|NCT05185869|Gemcitabine|gemcitabine|mesh-list
5610657|NCT05185869|Paclitaxel|paclitaxel|mesh-list
5610658|NCT05185869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5610659|NCT05185869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5610660|NCT05185869|Tubulin Modulators|tubulin modulators|mesh-ancestor
5610661|NCT05185869|Antimitotic Agents|antimitotic agents|mesh-ancestor
5610662|NCT05185869|Mitosis Modulators|mitosis modulators|mesh-ancestor
5610663|NCT05185869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610664|NCT05185869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5610665|NCT05185869|Antimetabolites|antimetabolites|mesh-ancestor
5610666|NCT05185869|Antiviral Agents|antiviral agents|mesh-ancestor
5728192|NCT03163966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5728193|NCT03163966|Immunologic Factors|immunologic factors|mesh-ancestor
5728194|NCT03163966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5728195|NCT03163966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5728196|NCT03163589|Epoetin Alfa|epoetin alfa|mesh-list
5728197|NCT03163589|Hematinics|hematinics|mesh-ancestor
5728198|NCT03163277|Emtricitabine|emtricitabine|mesh-list
5728199|NCT03163277|Maraviroc|maraviroc|mesh-list
5728200|NCT03163277|Darunavir|darunavir|mesh-list
5728201|NCT03163277|Cobicistat|cobicistat|mesh-list
5728202|NCT03163277|Antiviral Agents|antiviral agents|mesh-ancestor
5728203|NCT03163277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5728204|NCT03163277|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5728205|NCT03163277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5728206|NCT03163277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5728207|NCT03163277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728208|NCT03163277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5728209|NCT03163277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5728210|NCT03163277|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5728211|NCT03163277|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5728212|NCT03163277|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
5728213|NCT03163277|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5728214|NCT03163277|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5728215|NCT03163277|Protease Inhibitors|protease inhibitors|mesh-ancestor
5728216|NCT03163277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5728217|NCT03163277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5728218|NCT03163238|Dexmedetomidine|dexmedetomidine|mesh-list
5728219|NCT03163238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5728220|NCT03163238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5728221|NCT03163238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728222|NCT03163238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5728223|NCT03163238|Analgesics|analgesics|mesh-ancestor
5728224|NCT03163238|Sensory System Agents|sensory system agents|mesh-ancestor
5728225|NCT03163238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6672677|NCT01557712|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6672678|NCT01557712|Analgesics|analgesics|mesh-ancestor
6672679|NCT01557712|Sensory System Agents|sensory system agents|mesh-ancestor
6672680|NCT01557712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6672681|NCT01557712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672682|NCT01557712|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6672683|NCT01557712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6672684|NCT01557712|Anesthetics, General|anesthetics, general|mesh-ancestor
5610667|NCT05185869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5610668|NCT05185869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5610669|NCT05185869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5610670|NCT05185869|Immunologic Factors|immunologic factors|mesh-ancestor
5610671|NCT05185869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610672|NCT05185804|Enoxaparin|enoxaparin|mesh-list
5610673|NCT05185804|Enoxaparin sodium|enoxaparin sodium|mesh-list
5610674|NCT05185804|Anticoagulants|anticoagulants|mesh-ancestor
5610675|NCT05185804|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5610676|NCT05185804|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5610677|NCT05185804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728226|NCT03163238|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6672685|NCT01557712|Anesthetics|anesthetics|mesh-ancestor
5728227|NCT03163238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5728228|NCT03163238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5728229|NCT03163238|Adrenergic Agents|adrenergic agents|mesh-ancestor
5728230|NCT03163238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5728231|NCT03163238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728232|NCT03163420|Diclofenac|diclofenac|mesh-list
5728233|NCT03163420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5728234|NCT03163420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5728235|NCT03163420|Analgesics|analgesics|mesh-ancestor
5728236|NCT03163420|Sensory System Agents|sensory system agents|mesh-ancestor
5610678|NCT05185583|Methylphenidate|methylphenidate|mesh-list
5610679|NCT05185583|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5610680|NCT05185583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610681|NCT05185583|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5610682|NCT05185583|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5610683|NCT05185583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5610684|NCT05185583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610685|NCT05185583|Dopamine Agents|dopamine agents|mesh-ancestor
5610686|NCT05185583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5610687|NCT05185544|Pemetrexed|pemetrexed|mesh-list
5610688|NCT05185544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5610689|NCT05185544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5610690|NCT05185544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610691|NCT05185544|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5610692|NCT05185544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5610693|NCT05185518|Insulin|insulin|mesh-list
5610694|NCT05185518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5728237|NCT03163420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5728238|NCT03163420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728239|NCT03163420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5728240|NCT03163420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5728241|NCT03163420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5728242|NCT03163420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5728243|NCT03163420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728244|NCT03163407|Norepinephrine|norepinephrine|mesh-list
5728245|NCT03163407|Ephedrine|ephedrine|mesh-list
5728246|NCT03163407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5728247|NCT03163407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5728248|NCT03163407|Adrenergic Agents|adrenergic agents|mesh-ancestor
5728249|NCT03163407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6672686|NCT01557712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6672687|NCT01557712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6672688|NCT01557712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6672689|NCT01557712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6672690|NCT01557712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728250|NCT03163407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728251|NCT03163407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728252|NCT03163407|Sympathomimetics|sympathomimetics|mesh-ancestor
5728253|NCT03163407|Autonomic Agents|autonomic agents|mesh-ancestor
5728254|NCT03163407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5728255|NCT03163407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5728256|NCT03163407|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5728257|NCT03163381|Apatinib|apatinib|mesh-list
5728258|NCT03163381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5728259|NCT03163381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5728260|NCT03163381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5728261|NCT03163381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728262|NCT03163576|Niacin|niacin|mesh-list
5728263|NCT03163576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5728264|NCT03163576|Antimetabolites|antimetabolites|mesh-ancestor
5728265|NCT03163576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728266|NCT03163576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5728267|NCT03163576|Vasodilator Agents|vasodilator agents|mesh-ancestor
5728268|NCT03163576|Vitamin B Complex|vitamin b complex|mesh-ancestor
5728269|NCT03163576|Vitamins|vitamins|mesh-ancestor
5728270|NCT03163576|Micronutrients|micronutrients|mesh-ancestor
5728271|NCT03163576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728272|NCT03163173|Avasopasem manganese|avasopasem manganese|mesh-list
5728273|NCT03163173|Antioxidants|antioxidants|mesh-ancestor
5728274|NCT03163173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728275|NCT03163173|Protective Agents|protective agents|mesh-ancestor
5728276|NCT03163173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610695|NCT05185518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610696|NCT05185505|Bevacizumab|bevacizumab|mesh-list
5610697|NCT05185505|Atezolizumab|atezolizumab|mesh-list
5610698|NCT05185505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5728277|NCT03163212|Lactoferrin|lactoferrin|mesh-list
5728278|NCT03163212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5728279|NCT03163121|Vaccines|vaccines|mesh-list
5728280|NCT03163121|Immunologic Factors|immunologic factors|mesh-ancestor
5728281|NCT03163121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728282|NCT03162861|Anesthetics|anesthetics|mesh-list
5610699|NCT05185505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5610700|NCT05185505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5610701|NCT05185505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5728283|NCT03162861|Propofol|propofol|mesh-list
5728284|NCT03162861|Sevoflurane|sevoflurane|mesh-list
5728285|NCT03162861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5728286|NCT03162861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728287|NCT03162861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5728288|NCT03162861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5728289|NCT03162861|Anesthetics, General|anesthetics, general|mesh-ancestor
5728290|NCT03162861|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5728291|NCT03162861|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5728292|NCT03162653|Allopurinol|allopurinol|mesh-list
5728293|NCT03162653|Mannitol|mannitol|mesh-list
5610702|NCT05185505|Growth Substances|growth substances|mesh-ancestor
5610703|NCT05185505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610704|NCT05185505|Growth Inhibitors|growth inhibitors|mesh-ancestor
5610705|NCT05185284|Remdesivir|remdesivir|mesh-list
5610706|NCT05185284|Favipiravir|favipiravir|mesh-list
5610707|NCT05185284|Antimetabolites|antimetabolites|mesh-ancestor
5610708|NCT05185284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610709|NCT05185284|Antiviral Agents|antiviral agents|mesh-ancestor
5610710|NCT05185284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5610711|NCT05185167|Propofol|propofol|mesh-list
5610712|NCT05185167|Anesthetics|anesthetics|mesh-list
5610713|NCT05185167|Desflurane|desflurane|mesh-list
5610714|NCT05185167|Anesthetics, General|anesthetics, general|mesh-list
5728294|NCT03162653|Antimetabolites|antimetabolites|mesh-ancestor
5728295|NCT03162653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728296|NCT03162653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5728297|NCT03162653|Gout Suppressants|gout suppressants|mesh-ancestor
5728298|NCT03162653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5728299|NCT03162653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5728300|NCT03162653|Antioxidants|antioxidants|mesh-ancestor
5728301|NCT03162653|Protective Agents|protective agents|mesh-ancestor
5728302|NCT03162653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728303|NCT03162653|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5728304|NCT03162653|Diuretics|diuretics|mesh-ancestor
5728305|NCT03162653|Natriuretic Agents|natriuretic agents|mesh-ancestor
5728306|NCT03162731|Nivolumab|nivolumab|mesh-list
5728307|NCT03162731|Ipilimumab|ipilimumab|mesh-list
5728308|NCT03162731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5728309|NCT03162731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5728310|NCT03162731|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5728311|NCT03162731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728312|NCT03162510|Paclitaxel|paclitaxel|mesh-list
5728313|NCT03162510|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5728314|NCT03162510|Oxaliplatin|oxaliplatin|mesh-list
5728315|NCT03162510|Tegafur|tegafur|mesh-list
5728316|NCT03162510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5728317|NCT03162510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5728318|NCT03162510|Tubulin Modulators|tubulin modulators|mesh-ancestor
5728319|NCT03162510|Antimitotic Agents|antimitotic agents|mesh-ancestor
5728320|NCT03162510|Mitosis Modulators|mitosis modulators|mesh-ancestor
5728321|NCT03162510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728322|NCT03162510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5610715|NCT05185167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5610716|NCT05185167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5728323|NCT03162510|Antimetabolites|antimetabolites|mesh-ancestor
5728324|NCT03162588|Epoetin Alfa|epoetin alfa|mesh-list
5728325|NCT03162588|Hematinics|hematinics|mesh-ancestor
5728326|NCT03162406|Vitamin D|vitamin d|mesh-list
5728327|NCT03162406|Cholecalciferol|cholecalciferol|mesh-list
5728328|NCT03162406|Vitamins|vitamins|mesh-ancestor
5728329|NCT03162406|Micronutrients|micronutrients|mesh-ancestor
5728330|NCT03162406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728331|NCT03162406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5728332|NCT03162406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5892737|NCT04514653|Growth Substances|growth substances|mesh-ancestor
5728333|NCT03162900|Moxifloxacin|moxifloxacin|mesh-list
5728334|NCT03162900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5728335|NCT03162900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5728336|NCT03162900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5728337|NCT03162900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5728338|NCT03162900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5610717|NCT05185167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610718|NCT05185167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5610719|NCT05185167|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5610720|NCT05184842|Decitabine|decitabine|mesh-list
5610721|NCT05184842|Venetoclax|venetoclax|mesh-list
5610722|NCT05184842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5610723|NCT05184842|Antimetabolites|antimetabolites|mesh-ancestor
5610724|NCT05184842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610725|NCT05184842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5610726|NCT05184842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5610727|NCT05184816|Deferoxamine|deferoxamine|mesh-list
5610728|NCT05184816|Siderophores|siderophores|mesh-ancestor
5610729|NCT05184816|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5610730|NCT05184816|Chelating Agents|chelating agents|mesh-ancestor
5610731|NCT05184816|Sequestering Agents|sequestering agents|mesh-ancestor
5610732|NCT05184816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610733|NCT05184803|Docetaxel|docetaxel|mesh-list
5610734|NCT05184803|Oxaliplatin|oxaliplatin|mesh-list
5610735|NCT05184803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5610736|NCT05184803|Tubulin Modulators|tubulin modulators|mesh-ancestor
5610737|NCT05184803|Antimitotic Agents|antimitotic agents|mesh-ancestor
5610738|NCT05184803|Mitosis Modulators|mitosis modulators|mesh-ancestor
5610739|NCT05184803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610740|NCT05184712|Carboplatin|carboplatin|mesh-list
5610741|NCT05184712|Pemetrexed|pemetrexed|mesh-list
5610742|NCT05184712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5610743|NCT05184712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5728339|NCT03162900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728340|NCT03162900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5728341|NCT03162497|Azithromycin|azithromycin|mesh-list
5728342|NCT03162497|Doxycycline|doxycycline|mesh-list
5728343|NCT03162497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5728344|NCT03162497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5728345|NCT03162497|Antimalarials|antimalarials|mesh-ancestor
5728346|NCT03162497|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5728347|NCT03162497|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5728348|NCT03162432|Vitamin D|vitamin d|mesh-list
5728349|NCT03162432|Cholecalciferol|cholecalciferol|mesh-list
5728350|NCT03162432|Vitamins|vitamins|mesh-ancestor
5728351|NCT03162432|Micronutrients|micronutrients|mesh-ancestor
5728352|NCT03162432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728353|NCT03162432|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5728354|NCT03162432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6672691|NCT01557712|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6672692|NCT01557712|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6672693|NCT01557712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6672694|NCT01557712|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5610744|NCT05184712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610745|NCT05184712|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5610746|NCT05184712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5610747|NCT05184530|Evolocumab|evolocumab|mesh-list
5610748|NCT05184530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5610749|NCT05184530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5610750|NCT05184530|Antimetabolites|antimetabolites|mesh-ancestor
5610751|NCT05184530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610752|NCT05184530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5610753|NCT05184517|Cyclosporine|cyclosporine|mesh-list
5610754|NCT05184517|Cyclosporins|cyclosporins|mesh-list
5610755|NCT05184517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6672695|NCT01557712|Antidepressive Agents|antidepressive agents|mesh-ancestor
6672696|NCT01557712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5728355|NCT03162562|Oregovomab|oregovomab|mesh-list
5728356|NCT03162562|Poly ICLC|poly iclc|mesh-list
5728357|NCT03162562|Interferon Inducers|interferon inducers|mesh-ancestor
5610756|NCT05184517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610757|NCT05184517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5610758|NCT05184517|Immunologic Factors|immunologic factors|mesh-ancestor
5728358|NCT03162562|Immunologic Factors|immunologic factors|mesh-ancestor
5728359|NCT03162562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728360|NCT03162562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5728361|NCT03162562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5728362|NCT03162367|Sulfadiazine|sulfadiazine|mesh-list
5728363|NCT03162367|Silver Sulfadiazine|silver sulfadiazine|mesh-list
5728364|NCT03162367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5728365|NCT03162367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5728366|NCT03162367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5728367|NCT03162367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5728368|NCT03162367|Coccidiostats|coccidiostats|mesh-ancestor
5728369|NCT03162367|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5728370|NCT03162224|Durvalumab|durvalumab|mesh-list
5728371|NCT03162224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5728372|NCT03162224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5728373|NCT03162185|Citalopram|citalopram|mesh-list
5728374|NCT03162185|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5728375|NCT03162185|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5728376|NCT03162185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5610759|NCT05184517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610760|NCT05184517|Antifungal Agents|antifungal agents|mesh-ancestor
5610761|NCT05184517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5610762|NCT05184517|Dermatologic Agents|dermatologic agents|mesh-ancestor
5610763|NCT05184517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5610764|NCT05184517|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5610765|NCT05184465|Anesthetics|anesthetics|mesh-list
5610766|NCT05184465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5728377|NCT03162185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728378|NCT03162185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5728379|NCT03162185|Serotonin Agents|serotonin agents|mesh-ancestor
5728380|NCT03162185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728381|NCT03162185|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5728382|NCT03162185|Antidepressive Agents|antidepressive agents|mesh-ancestor
5728383|NCT03162185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5610767|NCT05184465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610768|NCT05184374|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
5610769|NCT05184374|Hormones|hormones|mesh-ancestor
5610770|NCT05184374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6208093|NCT02124707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208094|NCT02124707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6212571|NCT02189837|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5610771|NCT05184374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728384|NCT03162120|Metoprolol|metoprolol|mesh-list
5728385|NCT03162120|Flecainide|flecainide|mesh-list
5728386|NCT03162120|Ranolazine|ranolazine|mesh-list
5728387|NCT03162120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5728388|NCT03162120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5728389|NCT03162120|Sympatholytics|sympatholytics|mesh-ancestor
5728390|NCT03162120|Autonomic Agents|autonomic agents|mesh-ancestor
5728391|NCT03162120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5728392|NCT03162120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728393|NCT03162120|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5728394|NCT03162120|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5691761|NCT03414658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5691762|NCT03414658|Tubulin Modulators|tubulin modulators|mesh-ancestor
5691763|NCT03414658|Antimitotic Agents|antimitotic agents|mesh-ancestor
5691764|NCT03414658|Mitosis Modulators|mitosis modulators|mesh-ancestor
5691765|NCT03414658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697594|NCT03374878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5697595|NCT03374878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697596|NCT03374878|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5697597|NCT03374839|Nivolumab|nivolumab|mesh-list
5697598|NCT03374839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5697599|NCT03374839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5697600|NCT03374839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5697601|NCT03374839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728395|NCT03162120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5728396|NCT03162120|Adrenergic Agents|adrenergic agents|mesh-ancestor
5728397|NCT03162120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5728398|NCT03162120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728399|NCT03162120|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5728400|NCT03162120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5728401|NCT03162120|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5728402|NCT03162094|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5728403|NCT03162094|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5728404|NCT03161977|Mannitol|mannitol|mesh-list
5728405|NCT03161977|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5728406|NCT03161977|Diuretics|diuretics|mesh-ancestor
5728407|NCT03161977|Natriuretic Agents|natriuretic agents|mesh-ancestor
5728408|NCT03161977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728409|NCT03161756|Denosumab|denosumab|mesh-list
5728410|NCT03161756|Nivolumab|nivolumab|mesh-list
5728411|NCT03161756|Ipilimumab|ipilimumab|mesh-list
5728412|NCT03161756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5728413|NCT03161756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5728414|NCT03161756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5610772|NCT05184179|Olmesartan|olmesartan|mesh-list
5610773|NCT05184179|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
5610774|NCT05184179|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5610775|NCT05184179|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5610776|NCT05184179|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5728415|NCT03161756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728416|NCT03161756|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5728417|NCT03161756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728418|NCT03161652|Ranibizumab|ranibizumab|mesh-list
5610777|NCT05184179|Antimetabolites|antimetabolites|mesh-ancestor
5610778|NCT05184179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610779|NCT05184179|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5610780|NCT05184179|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5610781|NCT05184179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5610782|NCT05184179|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5610783|NCT05184179|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5610784|NCT05184179|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5610785|NCT05184101|Heparin|heparin|mesh-list
5610786|NCT05184101|Calcium heparin|calcium heparin|mesh-list
5610787|NCT05184101|Anticoagulants|anticoagulants|mesh-ancestor
5610788|NCT05184101|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5610789|NCT05184101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5610790|NCT05184101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610791|NCT05184049|Vitamin B 12|vitamin b 12|mesh-list
6489109|NCT00589316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6489110|NCT00589316|Immunologic Factors|immunologic factors|mesh-ancestor
6489111|NCT00589316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728419|NCT03161652|Dopamine|dopamine|mesh-list
5728420|NCT03161652|Sulpiride|sulpiride|mesh-list
5728421|NCT03161652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5728422|NCT03161652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5728423|NCT03161652|Growth Substances|growth substances|mesh-ancestor
6489112|NCT00589316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6489113|NCT00589316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5610792|NCT05184049|Epalrestat|epalrestat|mesh-list
5610793|NCT05184049|Vitamin B Complex|vitamin b complex|mesh-ancestor
5610794|NCT05184049|Vitamins|vitamins|mesh-ancestor
5610795|NCT05184049|Micronutrients|micronutrients|mesh-ancestor
5610796|NCT05184049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610797|NCT05184049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5610798|NCT05184049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610799|NCT05183997|Verapamil|verapamil|mesh-list
5610800|NCT05183997|Thrombin|thrombin|mesh-list
5728424|NCT03161652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728425|NCT03161652|Growth Inhibitors|growth inhibitors|mesh-ancestor
5728426|NCT03161652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5728427|NCT03161652|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5728428|NCT03161652|Sympathomimetics|sympathomimetics|mesh-ancestor
5728429|NCT03161652|Autonomic Agents|autonomic agents|mesh-ancestor
5728430|NCT03161652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5728431|NCT03161652|Dopamine Agents|dopamine agents|mesh-ancestor
5728432|NCT03161652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5728433|NCT03161652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728434|NCT03161652|Protective Agents|protective agents|mesh-ancestor
5728435|NCT03161652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5728436|NCT03161652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5728437|NCT03161652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5728438|NCT03161652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5728439|NCT03161652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5728440|NCT03161652|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5728441|NCT03161652|Antidepressive Agents|antidepressive agents|mesh-ancestor
5728442|NCT03161353|Tamoxifen|tamoxifen|mesh-list
5728443|NCT03161353|Carboplatin|carboplatin|mesh-list
6489114|NCT00589316|Alkylating Agents|alkylating agents|mesh-ancestor
5610801|NCT05183997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5728444|NCT03161353|Docetaxel|docetaxel|mesh-list
5728445|NCT03161353|Trastuzumab|trastuzumab|mesh-list
5610802|NCT05183997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5610803|NCT05183997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5610804|NCT05183997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610805|NCT05183997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5610806|NCT05183997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610807|NCT05183997|Vasodilator Agents|vasodilator agents|mesh-ancestor
5610808|NCT05183997|Hemostatics|hemostatics|mesh-ancestor
5610809|NCT05183997|Coagulants|coagulants|mesh-ancestor
5610810|NCT05183880|Vitamins|vitamins|mesh-list
5610811|NCT05183880|Ascorbic Acid|ascorbic acid|mesh-list
5610812|NCT05183880|Micronutrients|micronutrients|mesh-ancestor
5728446|NCT03161353|Letrozole|letrozole|mesh-list
5728447|NCT03161353|Pertuzumab|pertuzumab|mesh-list
5728448|NCT03161353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5728449|NCT03161353|Tubulin Modulators|tubulin modulators|mesh-ancestor
5728450|NCT03161353|Antimitotic Agents|antimitotic agents|mesh-ancestor
5728451|NCT03161353|Mitosis Modulators|mitosis modulators|mesh-ancestor
5728452|NCT03161353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728453|NCT03161353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5728454|NCT03161353|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5728455|NCT03161353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5728456|NCT03161353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5728457|NCT03161353|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5728458|NCT03161353|Hormone Antagonists|hormone antagonists|mesh-ancestor
5728459|NCT03161353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5728460|NCT03161353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728461|NCT03161353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5728462|NCT03161353|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5728463|NCT03161353|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5728464|NCT03161353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5728465|NCT03161509|Acetaminophen|acetaminophen|mesh-list
5728466|NCT03161509|Lamotrigine|lamotrigine|mesh-list
5728467|NCT03161509|Carbamazepine|carbamazepine|mesh-list
5728468|NCT03161509|Phenytoin|phenytoin|mesh-list
5728469|NCT03161509|Valproic Acid|valproic acid|mesh-list
5728470|NCT03161509|Anticonvulsants|anticonvulsants|mesh-list
5728471|NCT03161509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5728472|NCT03161509|Analgesics|analgesics|mesh-ancestor
5728473|NCT03161509|Sensory System Agents|sensory system agents|mesh-ancestor
5728474|NCT03161509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5728475|NCT03161509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728476|NCT03161509|Antipyretics|antipyretics|mesh-ancestor
5728477|NCT03161509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5728478|NCT03161509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5728479|NCT03161509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728480|NCT03161509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5728481|NCT03161509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5728482|NCT03161509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5728483|NCT03161509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5728484|NCT03161509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5728485|NCT03161509|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5728486|NCT03161509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5728487|NCT03161509|GABA Agents|gaba agents|mesh-ancestor
5728488|NCT03161509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5728489|NCT03161509|Antimanic Agents|antimanic agents|mesh-ancestor
5728490|NCT03161509|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5728491|NCT03161509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5728492|NCT03161509|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5728493|NCT03161509|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5728494|NCT03161457|Rituximab|rituximab|mesh-list
5728495|NCT03161457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5728496|NCT03161457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5728497|NCT03161457|Immunologic Factors|immunologic factors|mesh-ancestor
5728498|NCT03161457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728499|NCT03161457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5728500|NCT03161522|Fluorouracil|fluorouracil|mesh-list
5728501|NCT03161522|Capecitabine|capecitabine|mesh-list
5728502|NCT03161522|Antimetabolites|antimetabolites|mesh-ancestor
5728503|NCT03161522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728504|NCT03161522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5728505|NCT03161522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5728506|NCT03161522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5728507|NCT03161522|Immunologic Factors|immunologic factors|mesh-ancestor
6672697|NCT01557764|Trastuzumab|trastuzumab|mesh-list
5610813|NCT05183880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610814|NCT05183880|Antioxidants|antioxidants|mesh-ancestor
5610815|NCT05183880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610816|NCT05183880|Protective Agents|protective agents|mesh-ancestor
5610817|NCT05183841|Fenoterol|fenoterol|mesh-list
5610818|NCT05183841|Ipratropium|ipratropium|mesh-list
5610819|NCT05183841|Bronchodilator Agents|bronchodilator agents|mesh-list
5610820|NCT05183841|Autonomic Agents|autonomic agents|mesh-ancestor
5610821|NCT05183841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5610822|NCT05183841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610823|NCT05183841|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5610824|NCT05183841|Respiratory System Agents|respiratory system agents|mesh-ancestor
5610825|NCT05183841|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5610826|NCT05183841|Cholinergic Agents|cholinergic agents|mesh-ancestor
5610827|NCT05183841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5610828|NCT05183841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610829|NCT05183841|Sympathomimetics|sympathomimetics|mesh-ancestor
5610830|NCT05183841|Tocolytic Agents|tocolytic agents|mesh-ancestor
5728508|NCT03161522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728509|NCT03161379|Cyclophosphamide|cyclophosphamide|mesh-list
5728510|NCT03161379|Nivolumab|nivolumab|mesh-list
5728511|NCT03161379|Pancrelipase|pancrelipase|mesh-list
5728512|NCT03161379|Vaccines|vaccines|mesh-list
5728513|NCT03161379|Immunologic Factors|immunologic factors|mesh-ancestor
5728514|NCT03161379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728515|NCT03161379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5728516|NCT03161379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5728517|NCT03161379|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5728518|NCT03161379|Alkylating Agents|alkylating agents|mesh-ancestor
5728519|NCT03161379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728520|NCT03161379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5728521|NCT03161379|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5728522|NCT03161379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5728523|NCT03161379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5728524|NCT03161379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5728525|NCT03161340|Sirolimus|sirolimus|mesh-list
5728526|NCT03161340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5728527|NCT03161340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5610831|NCT05183841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5610832|NCT05183841|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5610833|NCT05183841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5610834|NCT05183841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5610835|NCT05183841|Adrenergic Agents|adrenergic agents|mesh-ancestor
5610836|NCT05183737|Propolis|propolis|mesh-list
5610837|NCT05183737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5610838|NCT05183646|Proxigermanium|proxigermanium|mesh-list
5610839|NCT05183646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5610840|NCT05183646|Interferon Inducers|interferon inducers|mesh-ancestor
5610841|NCT05183646|Immunologic Factors|immunologic factors|mesh-ancestor
5610842|NCT05183646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610843|NCT05183555|Edotreotide|edotreotide|mesh-list
5610844|NCT05183555|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5728528|NCT03161340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5728529|NCT03161340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5610845|NCT05183555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610846|NCT05183334|Sildenafil Citrate|sildenafil citrate|mesh-list
5610847|NCT05183334|Tramadol|tramadol|mesh-list
5610848|NCT05183334|Vasodilator Agents|vasodilator agents|mesh-ancestor
5610849|NCT05183334|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5610850|NCT05183334|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5610851|NCT05183334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5610852|NCT05183334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610853|NCT05183334|Urological Agents|urological agents|mesh-ancestor
5610854|NCT05183334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5728530|NCT03161340|Antifungal Agents|antifungal agents|mesh-ancestor
5728531|NCT03161340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5728532|NCT03161340|Immunologic Factors|immunologic factors|mesh-ancestor
5728533|NCT03161340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728534|NCT03161223|Azacitidine|azacitidine|mesh-list
5728535|NCT03161223|Durvalumab|durvalumab|mesh-list
5728536|NCT03161223|Romidepsin|romidepsin|mesh-list
5728537|NCT03161223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5610855|NCT05183334|Narcotics|narcotics|mesh-ancestor
5610856|NCT05183334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5610857|NCT05183334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610858|NCT05183334|Analgesics|analgesics|mesh-ancestor
5610859|NCT05183334|Sensory System Agents|sensory system agents|mesh-ancestor
5691766|NCT03414450|Dasatinib|dasatinib|mesh-list
5610860|NCT05183334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5610861|NCT05183204|Metformin|metformin|mesh-list
5610862|NCT05183204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5610863|NCT05183204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610864|NCT05183191|Hypoglycemic Agents|hypoglycemic agents|mesh-list
5610865|NCT05183191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610866|NCT05183139|Dexamethasone|dexamethasone|mesh-list
5610867|NCT05183139|Lenalidomide|lenalidomide|mesh-list
5610868|NCT05183139|Pomalidomide|pomalidomide|mesh-list
5610869|NCT05183139|Ixazomib|ixazomib|mesh-list
5610870|NCT05183139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5610871|NCT05183139|Antiemetics|antiemetics|mesh-ancestor
5610872|NCT05183139|Autonomic Agents|autonomic agents|mesh-ancestor
6489115|NCT00589316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489116|NCT00589316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6489117|NCT00589316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5728538|NCT03161223|Antimetabolites|antimetabolites|mesh-ancestor
5728539|NCT03161223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728540|NCT03161223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5728541|NCT03161223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5728542|NCT03161223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5728543|NCT03161223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5728544|NCT03161210|Anesthetics|anesthetics|mesh-list
5728545|NCT03161210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5728546|NCT03161210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728547|NCT03161574|Fluorouracil|fluorouracil|mesh-list
5728548|NCT03161574|Oxaliplatin|oxaliplatin|mesh-list
5728549|NCT03161574|Irinotecan|irinotecan|mesh-list
5728550|NCT03161574|Antimetabolites|antimetabolites|mesh-ancestor
5728551|NCT03161574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728552|NCT03161574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6489118|NCT00589316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5610873|NCT05183139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5610874|NCT05183139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610875|NCT05183139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5610876|NCT05183139|Glucocorticoids|glucocorticoids|mesh-ancestor
5610877|NCT05183139|Hormones|hormones|mesh-ancestor
5610878|NCT05183139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5610879|NCT05183139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5610880|NCT05183139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5610881|NCT05183139|Immunologic Factors|immunologic factors|mesh-ancestor
5610882|NCT05183139|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5610883|NCT05183139|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5610884|NCT05183139|Growth Substances|growth substances|mesh-ancestor
5610885|NCT05183139|Growth Inhibitors|growth inhibitors|mesh-ancestor
5610886|NCT05183139|Protease Inhibitors|protease inhibitors|mesh-ancestor
5610887|NCT05183139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5610888|NCT05183139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610889|NCT05183048|Panitumumab|panitumumab|mesh-list
5610890|NCT05183048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5610891|NCT05183048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5610892|NCT05183035|Cytarabine|cytarabine|mesh-list
5610893|NCT05183035|Fludarabine|fludarabine|mesh-list
5610894|NCT05183035|Azacitidine|azacitidine|mesh-list
5610895|NCT05183035|Venetoclax|venetoclax|mesh-list
5610896|NCT05183035|Gemtuzumab|gemtuzumab|mesh-list
5610897|NCT05183035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5610898|NCT05183035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5610899|NCT05183035|Antimetabolites|antimetabolites|mesh-ancestor
5610900|NCT05183035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610901|NCT05183035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5610902|NCT05183035|Immunologic Factors|immunologic factors|mesh-ancestor
5610903|NCT05183035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610904|NCT05183035|Antiviral Agents|antiviral agents|mesh-ancestor
5610905|NCT05183035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5610906|NCT05183035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5610907|NCT05183035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5610908|NCT05182970|Metformin|metformin|mesh-list
5610909|NCT05182970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5610910|NCT05182970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610911|NCT05182957|Lenalidomide|lenalidomide|mesh-list
5610912|NCT05182957|Azacitidine|azacitidine|mesh-list
5610913|NCT05182957|Antibodies|antibodies|mesh-list
5610914|NCT05182957|Immunoglobulins|immunoglobulins|mesh-list
5610915|NCT05182957|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5610916|NCT05182957|Immunologic Factors|immunologic factors|mesh-list
5610917|NCT05182957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728553|NCT03161574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5728554|NCT03161574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5728555|NCT03161574|Immunologic Factors|immunologic factors|mesh-ancestor
5728556|NCT03161574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728557|NCT03161574|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5728558|NCT03161574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5728559|NCT03161574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5728560|NCT03160846|Milrinone|milrinone|mesh-list
5728561|NCT03160846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5728562|NCT03160846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5728563|NCT03160846|Vasodilator Agents|vasodilator agents|mesh-ancestor
5728564|NCT03160846|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5728565|NCT03160846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5728566|NCT03160846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5728567|NCT03160846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728568|NCT03160846|Protective Agents|protective agents|mesh-ancestor
5728569|NCT03160846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728570|NCT03160872|Hormones|hormones|mesh-list
5728571|NCT03160872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5728572|NCT03160872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610918|NCT05182957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5610919|NCT05182957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5610920|NCT05182957|Growth Substances|growth substances|mesh-ancestor
5610921|NCT05182957|Growth Inhibitors|growth inhibitors|mesh-ancestor
5610922|NCT05182957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5610923|NCT05182957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5610924|NCT05182957|Antimetabolites|antimetabolites|mesh-ancestor
5610925|NCT05182957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610926|NCT05182957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5610927|NCT05182710|Vaccines|vaccines|mesh-list
5610928|NCT05182710|Immunologic Factors|immunologic factors|mesh-ancestor
5610929|NCT05182710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610930|NCT05182658|Empagliflozin|empagliflozin|mesh-list
5610931|NCT05182658|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5610932|NCT05182658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610933|NCT05182658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5610934|NCT05182658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610935|NCT05182463|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
5610936|NCT05182463|Antiviral Agents|antiviral agents|mesh-ancestor
5610937|NCT05182463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5691767|NCT03414450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5691768|NCT03414450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5691769|NCT03414450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5691770|NCT03414450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691771|NCT03414333|Hormones|hormones|mesh-list
5691772|NCT03414333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5691773|NCT03414333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691774|NCT03414164|Procyanidin|procyanidin|mesh-list
5691775|NCT03414164|Antioxidants|antioxidants|mesh-ancestor
5691776|NCT03414164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691777|NCT03414164|Protective Agents|protective agents|mesh-ancestor
5691778|NCT03414164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691779|NCT03414034|Prednisone|prednisone|mesh-list
5691780|NCT03414034|Onvansertib|onvansertib|mesh-list
5691781|NCT03414034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5691782|NCT03414034|Glucocorticoids|glucocorticoids|mesh-ancestor
5691783|NCT03414034|Hormones|hormones|mesh-ancestor
5691784|NCT03414034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5691785|NCT03414034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691786|NCT03414034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5691787|NCT03414034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5728573|NCT03161080|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5728574|NCT03161080|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5728575|NCT03161028|Thioctic Acid|thioctic acid|mesh-list
5728576|NCT03161028|Antioxidants|antioxidants|mesh-ancestor
5728577|NCT03161028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728578|NCT03161028|Protective Agents|protective agents|mesh-ancestor
5728579|NCT03161028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728580|NCT03161028|Vitamin B Complex|vitamin b complex|mesh-ancestor
5728581|NCT03161028|Vitamins|vitamins|mesh-ancestor
5728582|NCT03161028|Micronutrients|micronutrients|mesh-ancestor
5728583|NCT03161132|Doxorubicin|doxorubicin|mesh-list
5728584|NCT03161132|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5728585|NCT03161132|Olaparib|olaparib|mesh-list
5610938|NCT05182385|Venetoclax|venetoclax|mesh-list
5610939|NCT05182385|Blinatumomab|blinatumomab|mesh-list
5610940|NCT05182385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5610941|NCT05182151|Istradefylline|istradefylline|mesh-list
5610942|NCT05182151|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
5610943|NCT05182151|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5610944|NCT05182151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5728586|NCT03161132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5728587|NCT03161132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5728588|NCT03161132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5728589|NCT03161132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5728590|NCT03161132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5728591|NCT03161132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728592|NCT03161132|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5892738|NCT04514653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892739|NCT04514653|Growth Inhibitors|growth inhibitors|mesh-ancestor
5892740|NCT04514653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5892741|NCT04512430|Bevacizumab|bevacizumab|mesh-list
5610945|NCT05182151|Purinergic Agents|purinergic agents|mesh-ancestor
5610946|NCT05182151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5610947|NCT05182151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610948|NCT05182151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610949|NCT05182138|Zinc|zinc|mesh-list
5610950|NCT05182138|Trace Elements|trace elements|mesh-ancestor
5610951|NCT05182138|Micronutrients|micronutrients|mesh-ancestor
5610952|NCT05182138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610953|NCT05182112|Gemcitabine|gemcitabine|mesh-list
5610954|NCT05182112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5610955|NCT05182112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5892742|NCT04512430|Carboplatin|carboplatin|mesh-list
5892743|NCT04512430|Pemetrexed|pemetrexed|mesh-list
5892744|NCT04512430|Atezolizumab|atezolizumab|mesh-list
5892745|NCT04512430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5892746|NCT04512430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5892747|NCT04512430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5892748|NCT04512430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5892749|NCT04512430|Growth Substances|growth substances|mesh-ancestor
5892750|NCT04512430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892751|NCT04512430|Growth Inhibitors|growth inhibitors|mesh-ancestor
5892752|NCT04512430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5892753|NCT04512430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892754|NCT04512430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5892755|NCT04512430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5892756|NCT04480424|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5892757|NCT04480424|Immunologic Factors|immunologic factors|mesh-ancestor
5892758|NCT04480424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907681|NCT05231382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907682|NCT05231382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5907683|NCT05231382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5907684|NCT05231382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5907685|NCT05231382|Immunologic Factors|immunologic factors|mesh-ancestor
5907686|NCT05231382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907687|NCT05231382|Antidotes|antidotes|mesh-ancestor
5907688|NCT05231382|Protective Agents|protective agents|mesh-ancestor
5907689|NCT05231382|Vitamin B Complex|vitamin b complex|mesh-ancestor
5907690|NCT05231382|Vitamins|vitamins|mesh-ancestor
5907691|NCT05231382|Micronutrients|micronutrients|mesh-ancestor
5907692|NCT05231382|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5907693|NCT05231382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5907694|NCT05221398|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5907695|NCT05221398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907696|NCT05221398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5907697|NCT05221320|Hydroxychloroquine|hydroxychloroquine|mesh-list
5907698|NCT05221320|Antimalarials|antimalarials|mesh-ancestor
5907699|NCT05221320|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5907700|NCT05221320|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5907701|NCT05221320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5907702|NCT05221320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5907703|NCT05221320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907704|NCT05221320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5907705|NCT05219981|Fluorides|fluorides|mesh-list
5907706|NCT05219981|Cariostatic Agents|cariostatic agents|mesh-ancestor
5907707|NCT05219981|Protective Agents|protective agents|mesh-ancestor
5907708|NCT05219981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907709|NCT05215691|Morphine|morphine|mesh-list
5610956|NCT05182112|Antimetabolites|antimetabolites|mesh-ancestor
5610957|NCT05182112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728593|NCT03161041|Bevacizumab|bevacizumab|mesh-list
5728594|NCT03161041|Oxaliplatin|oxaliplatin|mesh-list
5728595|NCT03161041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5610958|NCT05182112|Antiviral Agents|antiviral agents|mesh-ancestor
5610959|NCT05182112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5610960|NCT05182112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5610961|NCT05182112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5610962|NCT05182112|Immunologic Factors|immunologic factors|mesh-ancestor
5610963|NCT05182112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610964|NCT05182073|Cyclophosphamide|cyclophosphamide|mesh-list
5610965|NCT05182073|Fludarabine|fludarabine|mesh-list
5610966|NCT05182073|Daratumumab|daratumumab|mesh-list
5610967|NCT05182073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5610968|NCT05182073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5610969|NCT05182073|Immunologic Factors|immunologic factors|mesh-ancestor
5610970|NCT05182073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728596|NCT03161041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5728597|NCT03161041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5728598|NCT03161041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5728599|NCT03161041|Growth Substances|growth substances|mesh-ancestor
5728600|NCT03161041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728601|NCT03161041|Growth Inhibitors|growth inhibitors|mesh-ancestor
5728602|NCT03160911|Hemostatics|hemostatics|mesh-list
5728603|NCT03160911|Coagulants|coagulants|mesh-ancestor
5728604|NCT03161184|Sulfamethazine|sulfamethazine|mesh-list
5728605|NCT03161184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5728606|NCT03161106|Lactulose|lactulose|mesh-list
5728607|NCT03161106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6672698|NCT01557764|Lapatinib|lapatinib|mesh-list
6672699|NCT01557764|Antibodies|antibodies|mesh-list
6672700|NCT01557764|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6672701|NCT01557764|Immunologic Factors|immunologic factors|mesh-ancestor
6672702|NCT01557764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672703|NCT01557764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6672704|NCT01557764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6672705|NCT01557764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5728608|NCT03160807|Levofloxacin|levofloxacin|mesh-list
5728609|NCT03160807|Ofloxacin|ofloxacin|mesh-list
5728610|NCT03160807|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5610971|NCT05182073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5610972|NCT05182073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5610973|NCT05182073|Alkylating Agents|alkylating agents|mesh-ancestor
5610974|NCT05182073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610975|NCT05182073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5610976|NCT05182073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5610977|NCT05181969|Dextrans|dextrans|mesh-list
5610978|NCT05181969|Anticoagulants|anticoagulants|mesh-ancestor
5610979|NCT05181969|Plasma Substitutes|plasma substitutes|mesh-ancestor
5610980|NCT05181969|Blood Substitutes|blood substitutes|mesh-ancestor
5610981|NCT05180292|Carvedilol|carvedilol|mesh-list
5610982|NCT05180292|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5610983|NCT05180292|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5610984|NCT05180292|Adrenergic Agents|adrenergic agents|mesh-ancestor
5610985|NCT05180292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5610986|NCT05180292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5610987|NCT05180292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5610988|NCT05180292|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5610989|NCT05180292|Antioxidants|antioxidants|mesh-ancestor
5610990|NCT05180292|Protective Agents|protective agents|mesh-ancestor
5610991|NCT05180292|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5610992|NCT05180292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5610993|NCT05180292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5610994|NCT05180292|Vasodilator Agents|vasodilator agents|mesh-ancestor
5610995|NCT05180292|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5610996|NCT05180292|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5610997|NCT05177939|Methylprednisolone|methylprednisolone|mesh-list
5610998|NCT05177939|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5728611|NCT03160807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5728612|NCT03160807|Renal Agents|renal agents|mesh-ancestor
5728613|NCT03160807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5728614|NCT03160807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6672706|NCT01557764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5610999|NCT05177939|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5611000|NCT05177939|Prednisolone|prednisolone|mesh-list
5728615|NCT03160807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5611001|NCT05177939|Prednisolone acetate|prednisolone acetate|mesh-list
5611002|NCT05177939|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5611003|NCT05177939|Prednisolone phosphate|prednisolone phosphate|mesh-list
5611004|NCT05177939|Immunoglobulins|immunoglobulins|mesh-list
5611005|NCT05177939|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5611006|NCT05177939|gamma-Globulins|gamma-globulins|mesh-list
5728616|NCT03160807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5728617|NCT03160807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728618|NCT03160807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5728619|NCT03160807|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5728620|NCT03160807|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5728621|NCT03160729|Dexamethasone|dexamethasone|mesh-list
5728622|NCT03160729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5728623|NCT03160729|Antiemetics|antiemetics|mesh-ancestor
5728624|NCT03160729|Autonomic Agents|autonomic agents|mesh-ancestor
5728625|NCT03160729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5728626|NCT03160729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728627|NCT03160729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5728628|NCT03160729|Glucocorticoids|glucocorticoids|mesh-ancestor
5728629|NCT03160729|Hormones|hormones|mesh-ancestor
5611007|NCT05177939|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5611008|NCT05177939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5611009|NCT05177939|Antiemetics|antiemetics|mesh-ancestor
5728630|NCT03160729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5728631|NCT03160729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5728632|NCT03160729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5728633|NCT03160638|Azithromycin|azithromycin|mesh-list
5728634|NCT03160638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5728635|NCT03160638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5728636|NCT03160404|Zolpidem|zolpidem|mesh-list
5728637|NCT03160404|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5728638|NCT03160404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5728639|NCT03160404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5728640|NCT03160404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728641|NCT03160404|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
5728642|NCT03160404|GABA Agonists|gaba agonists|mesh-ancestor
5728643|NCT03160404|GABA Agents|gaba agents|mesh-ancestor
5728644|NCT03160404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5728645|NCT03160404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728646|NCT03160651|Methylprednisolone|methylprednisolone|mesh-list
5728647|NCT03160651|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5728648|NCT03160651|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5728649|NCT03160651|Prednisolone|prednisolone|mesh-list
5728650|NCT03160651|Prednisolone acetate|prednisolone acetate|mesh-list
5728651|NCT03160651|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5728652|NCT03160651|Prednisolone phosphate|prednisolone phosphate|mesh-list
5728653|NCT03160651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5728654|NCT03160651|Antiemetics|antiemetics|mesh-ancestor
5728655|NCT03160651|Autonomic Agents|autonomic agents|mesh-ancestor
5728656|NCT03160651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5728657|NCT03160651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728658|NCT03160651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5728659|NCT03160651|Glucocorticoids|glucocorticoids|mesh-ancestor
5728660|NCT03160651|Hormones|hormones|mesh-ancestor
5728661|NCT03160651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5728662|NCT03160651|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5728663|NCT03160651|Protective Agents|protective agents|mesh-ancestor
5728664|NCT03160651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5728665|NCT03160651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5728666|NCT03160339|Vaccines|vaccines|mesh-list
5728667|NCT03160339|Immunologic Factors|immunologic factors|mesh-ancestor
5728668|NCT03160339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728669|NCT03160248|Apremilast|apremilast|mesh-list
5728670|NCT03160248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5728671|NCT03160248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5728672|NCT03160248|Analgesics|analgesics|mesh-ancestor
5728673|NCT03160248|Sensory System Agents|sensory system agents|mesh-ancestor
5728674|NCT03160248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5728675|NCT03160248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728676|NCT03160248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5728677|NCT03160248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5728678|NCT03160248|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5728679|NCT03160248|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5611010|NCT05177939|Autonomic Agents|autonomic agents|mesh-ancestor
5728680|NCT03160248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5611011|NCT05177939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5611012|NCT05177939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611013|NCT05177939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5611014|NCT05177939|Glucocorticoids|glucocorticoids|mesh-ancestor
5728681|NCT03160248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728682|NCT03160001|Niclosamide|niclosamide|mesh-list
5728683|NCT03160001|Etanercept|etanercept|mesh-list
5728684|NCT03160001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5728685|NCT03160001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5728686|NCT03160001|Analgesics|analgesics|mesh-ancestor
5728687|NCT03160001|Sensory System Agents|sensory system agents|mesh-ancestor
5728688|NCT03160001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5728689|NCT03160001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728690|NCT03160001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5728691|NCT03160001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5728692|NCT03160001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5728693|NCT03160001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5728694|NCT03160001|Immunologic Factors|immunologic factors|mesh-ancestor
5728695|NCT03160001|Anticestodal Agents|anticestodal agents|mesh-ancestor
5728696|NCT03160001|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5728697|NCT03160001|Anthelmintics|anthelmintics|mesh-ancestor
5728698|NCT03160001|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5728699|NCT03160001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5728700|NCT03160001|Antinematodal Agents|antinematodal agents|mesh-ancestor
5728701|NCT03160040|Minocycline|minocycline|mesh-list
5728702|NCT03160040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5728703|NCT03160040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5728704|NCT03160261|Exenatide|exenatide|mesh-list
5728705|NCT03160261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5728706|NCT03160261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728707|NCT03160261|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5728708|NCT03160261|Incretins|incretins|mesh-ancestor
5728709|NCT03160261|Hormones|hormones|mesh-ancestor
5728710|NCT03160261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5728711|NCT03159988|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
5728712|NCT03159988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5728713|NCT03159988|Vasodilator Agents|vasodilator agents|mesh-ancestor
5728714|NCT03160079|Pembrolizumab|pembrolizumab|mesh-list
5611015|NCT05177939|Hormones|hormones|mesh-ancestor
5611016|NCT05177939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5611017|NCT05177939|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5611018|NCT05177939|Protective Agents|protective agents|mesh-ancestor
5728715|NCT03160079|Blinatumomab|blinatumomab|mesh-list
5728716|NCT03160079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5728717|NCT03160079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5728718|NCT03159741|Glucagon|glucagon|mesh-list
5728719|NCT03159741|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5728720|NCT03159741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5728721|NCT03159741|Hormones|hormones|mesh-ancestor
5728722|NCT03159741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5728723|NCT03159741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728724|NCT03159741|Incretins|incretins|mesh-ancestor
5728725|NCT03159845|Levofloxacin|levofloxacin|mesh-list
5728726|NCT03159845|Ofloxacin|ofloxacin|mesh-list
5728727|NCT03159845|Fluconazole|fluconazole|mesh-list
5728728|NCT03159845|Acyclovir|acyclovir|mesh-list
5728729|NCT03159845|Zinc Sulfate|zinc sulfate|mesh-list
5728730|NCT03159845|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5728731|NCT03159845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5728732|NCT03159845|Renal Agents|renal agents|mesh-ancestor
5728733|NCT03159845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5728734|NCT03159845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5728735|NCT03159845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5728736|NCT03159845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5728737|NCT03159845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728738|NCT03159845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5728739|NCT03159845|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5728740|NCT03159845|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5728741|NCT03159845|Antifungal Agents|antifungal agents|mesh-ancestor
5728742|NCT03159845|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5728743|NCT03159845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5728744|NCT03159845|Hormone Antagonists|hormone antagonists|mesh-ancestor
5728745|NCT03159845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5728746|NCT03159845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728747|NCT03159845|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5728748|NCT03159845|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5728749|NCT03159845|Antiviral Agents|antiviral agents|mesh-ancestor
5728750|NCT03159845|Astringents|astringents|mesh-ancestor
5728751|NCT03159845|Dermatologic Agents|dermatologic agents|mesh-ancestor
5728752|NCT03159598|Urethane|urethane|mesh-list
5728753|NCT03159598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5728754|NCT03159598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5728755|NCT03159598|Anesthetics, General|anesthetics, general|mesh-ancestor
5728756|NCT03159598|Anesthetics|anesthetics|mesh-ancestor
5728757|NCT03159598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5728758|NCT03159598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728759|NCT03159754|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5728760|NCT03159754|Metronidazole|metronidazole|mesh-list
5728761|NCT03159754|Ciprofloxacin|ciprofloxacin|mesh-list
5728762|NCT03159754|Tazobactam|tazobactam|mesh-list
5728763|NCT03159754|Piperacillin|piperacillin|mesh-list
5728764|NCT03159754|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
5728765|NCT03159754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5728766|NCT03159754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5728767|NCT03159754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5728768|NCT03159754|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5611019|NCT05177939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5611020|NCT05177939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5611021|NCT05177939|Immunologic Factors|immunologic factors|mesh-ancestor
5611022|NCT05177718|Natalizumab|natalizumab|mesh-list
5611023|NCT05177718|Immunologic Factors|immunologic factors|mesh-ancestor
5728769|NCT03159754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5728770|NCT03159754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5728771|NCT03159754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728772|NCT03159754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5728773|NCT03159754|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5728774|NCT03159754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5728775|NCT03159754|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5728776|NCT03159702|Fludarabine|fludarabine|mesh-list
5728777|NCT03159702|Melphalan|melphalan|mesh-list
5728778|NCT03159702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5728779|NCT03159702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728780|NCT03159702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5728781|NCT03159702|Immunologic Factors|immunologic factors|mesh-ancestor
5728782|NCT03159702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728783|NCT03159702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5728784|NCT03159702|Alkylating Agents|alkylating agents|mesh-ancestor
5728785|NCT03159702|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5611024|NCT05177718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611025|NCT05172908|Dexamethasone|dexamethasone|mesh-list
5611026|NCT05172908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5611027|NCT05172908|Antiemetics|antiemetics|mesh-ancestor
5611028|NCT05172908|Autonomic Agents|autonomic agents|mesh-ancestor
5611029|NCT05172908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5611030|NCT05172908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611031|NCT05172908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5611032|NCT05172908|Glucocorticoids|glucocorticoids|mesh-ancestor
5611033|NCT05172908|Hormones|hormones|mesh-ancestor
5611034|NCT05172908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5611035|NCT05172908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5611036|NCT05172908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5611037|NCT05171166|Leucovorin|leucovorin|mesh-list
5611038|NCT05171166|Fluorouracil|fluorouracil|mesh-list
5611039|NCT05171166|Oxaliplatin|oxaliplatin|mesh-list
5611040|NCT05171166|Chlorotrianisene|chlorotrianisene|mesh-list
5611041|NCT05171166|Antimetabolites|antimetabolites|mesh-ancestor
5611042|NCT05171166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5611043|NCT05171166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5611044|NCT05171166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5611045|NCT05171166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5611046|NCT05171166|Immunologic Factors|immunologic factors|mesh-ancestor
5611047|NCT05171166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611048|NCT05171166|Antidotes|antidotes|mesh-ancestor
5611049|NCT05171166|Protective Agents|protective agents|mesh-ancestor
5611050|NCT05171166|Vitamin B Complex|vitamin b complex|mesh-ancestor
5611051|NCT05171166|Vitamins|vitamins|mesh-ancestor
5728786|NCT03159559|Aspirin|aspirin|mesh-list
5611052|NCT05171166|Micronutrients|micronutrients|mesh-ancestor
5611053|NCT05171166|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
5611054|NCT05171166|Estrogens|estrogens|mesh-ancestor
5611055|NCT05171166|Hormones|hormones|mesh-ancestor
5691788|NCT03414034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5728787|NCT03159559|Hypoglycemic Agents|hypoglycemic agents|mesh-list
5728788|NCT03159559|Alprostadil|alprostadil|mesh-list
5728789|NCT03159559|Clopidogrel|clopidogrel|mesh-list
5611056|NCT05171166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5611057|NCT05171166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5611058|NCT05170711|Antihypertensive Agents|antihypertensive agents|mesh-list
5728790|NCT03159559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5728791|NCT03159559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5728792|NCT03159559|Analgesics|analgesics|mesh-ancestor
5728793|NCT03159559|Sensory System Agents|sensory system agents|mesh-ancestor
5728794|NCT03159559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5728795|NCT03159559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728796|NCT03159559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5728797|NCT03159559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5728798|NCT03159559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5728799|NCT03159559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5728800|NCT03159559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728801|NCT03159559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5728802|NCT03159559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5728803|NCT03159559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5728804|NCT03159559|Antipyretics|antipyretics|mesh-ancestor
5728805|NCT03159559|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5728806|NCT03159559|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5728807|NCT03159559|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5728808|NCT03159559|Purinergic Agents|purinergic agents|mesh-ancestor
5728809|NCT03159559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5728810|NCT03159559|Vasodilator Agents|vasodilator agents|mesh-ancestor
5728811|NCT03159559|Urological Agents|urological agents|mesh-ancestor
5728812|NCT03159403|Oritavancin|oritavancin|mesh-list
5728813|NCT03159403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5728814|NCT03159403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5892759|NCT04450498|Vaccines|vaccines|mesh-list
5892760|NCT04450498|Immunologic Factors|immunologic factors|mesh-ancestor
5892761|NCT04450498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892762|NCT04431700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
5892763|NCT04425174|Anesthetics|anesthetics|mesh-list
5892764|NCT04425174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5611059|NCT05170711|Anesthetics|anesthetics|mesh-list
5611060|NCT05170711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5611061|NCT05170711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611062|NCT05170139|Caffeine|caffeine|mesh-list
5611063|NCT05170139|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5611064|NCT05170139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611065|NCT05170139|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5611066|NCT05170139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5611067|NCT05170139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5611068|NCT05170139|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5611069|NCT05170139|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5611070|NCT05170139|Purinergic Agents|purinergic agents|mesh-ancestor
5691789|NCT03414034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5892765|NCT04425174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892766|NCT04423211|Leuprolide|leuprolide|mesh-list
5892767|NCT04423211|Goserelin|goserelin|mesh-list
5892768|NCT04423211|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5892769|NCT04423211|Fertility Agents|fertility agents|mesh-ancestor
5892770|NCT04423211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5892771|NCT04423211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892772|NCT04423211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5892773|NCT04423211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5892774|NCT04418479|Aspirin|aspirin|mesh-list
5892775|NCT04418479|Clopidogrel|clopidogrel|mesh-list
5892776|NCT04418479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5892777|NCT04418479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5892778|NCT04418479|Analgesics|analgesics|mesh-ancestor
5892779|NCT04418479|Sensory System Agents|sensory system agents|mesh-ancestor
5892780|NCT04418479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5892781|NCT04418479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892782|NCT04418479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5892783|NCT04418479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5892784|NCT04418479|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5892785|NCT04418479|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5892786|NCT04418479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892787|NCT04418479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5892788|NCT04418479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5728815|NCT03159390|Phenylacetic acid|phenylacetic acid|mesh-list
5728816|NCT03159390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5728817|NCT03159390|Antimetabolites|antimetabolites|mesh-ancestor
5728818|NCT03159390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728819|NCT03159390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5728820|NCT03159078|Imipenem|imipenem|mesh-list
5728821|NCT03159078|Polymyxins|polymyxins|mesh-list
5728822|NCT03159078|Polymyxin B|polymyxin b|mesh-list
5728823|NCT03159078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5728824|NCT03159078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5728825|NCT03159234|Epinephrine|epinephrine|mesh-list
5728826|NCT03159234|Racepinephrine|racepinephrine|mesh-list
5728827|NCT03159234|Epinephryl borate|epinephryl borate|mesh-list
5728828|NCT03159234|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5728829|NCT03159234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5728830|NCT03159234|Adrenergic Agents|adrenergic agents|mesh-ancestor
5728831|NCT03159234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5728832|NCT03159234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728833|NCT03159234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728834|NCT03159234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5728835|NCT03159234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5728836|NCT03159234|Autonomic Agents|autonomic agents|mesh-ancestor
5728837|NCT03159234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5728838|NCT03159234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5728839|NCT03159234|Respiratory System Agents|respiratory system agents|mesh-ancestor
5611071|NCT05170139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5611072|NCT05168423|Cyclophosphamide|cyclophosphamide|mesh-list
5611073|NCT05168423|Fludarabine|fludarabine|mesh-list
5611074|NCT05168423|Isotretinoin|isotretinoin|mesh-list
5611075|NCT05168423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5611076|NCT05168423|Immunologic Factors|immunologic factors|mesh-ancestor
5611077|NCT05168423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611078|NCT05168423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5611079|NCT05168423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5611080|NCT05168423|Alkylating Agents|alkylating agents|mesh-ancestor
5728840|NCT03159234|Mydriatics|mydriatics|mesh-ancestor
5728841|NCT03159234|Sympathomimetics|sympathomimetics|mesh-ancestor
5728842|NCT03159234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5728843|NCT03158935|Aldesleukin|aldesleukin|mesh-list
5728844|NCT03158935|Cyclophosphamide|cyclophosphamide|mesh-list
5728845|NCT03158935|Pembrolizumab|pembrolizumab|mesh-list
5728846|NCT03158935|Fludarabine|fludarabine|mesh-list
5728847|NCT03158935|Interleukin-2|interleukin-2|mesh-list
5728848|NCT03158935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5728849|NCT03158935|Immunologic Factors|immunologic factors|mesh-ancestor
5728850|NCT03158935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728851|NCT03158935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5728852|NCT03158935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5728853|NCT03158935|Alkylating Agents|alkylating agents|mesh-ancestor
5728854|NCT03158935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728855|NCT03158935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5728856|NCT03158935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5728857|NCT03158935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5728858|NCT03158935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5728859|NCT03158935|Analgesics|analgesics|mesh-ancestor
5728860|NCT03158935|Sensory System Agents|sensory system agents|mesh-ancestor
5728861|NCT03158935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5728862|NCT03158935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5728863|NCT03158935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5728864|NCT03158935|Antiviral Agents|antiviral agents|mesh-ancestor
5728865|NCT03158935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5728866|NCT03158532|Nitroglycerin|nitroglycerin|mesh-list
5728867|NCT03158532|Vasodilator Agents|vasodilator agents|mesh-ancestor
5611081|NCT05168423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5611082|NCT05168423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5611083|NCT05168423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5611084|NCT05168423|Dermatologic Agents|dermatologic agents|mesh-ancestor
5611085|NCT05166291|Anesthetics|anesthetics|mesh-list
5611086|NCT05166291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5611087|NCT05166291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611088|NCT05165550|Elsulfavirine|elsulfavirine|mesh-list
5611089|NCT05165550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5611090|NCT05165550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5728868|NCT03158584|Morphine|morphine|mesh-list
5728869|NCT03158584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5611091|NCT05165550|Antiviral Agents|antiviral agents|mesh-ancestor
5728870|NCT03158584|Narcotics|narcotics|mesh-ancestor
5728871|NCT03158584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5611092|NCT05165550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5611093|NCT05163561|Vaccines|vaccines|mesh-list
5611094|NCT05163561|Immunologic Factors|immunologic factors|mesh-ancestor
5611095|NCT05163561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611096|NCT05163496|Psilocybin|psilocybin|mesh-list
5611097|NCT05163496|Hallucinogens|hallucinogens|mesh-ancestor
5611098|NCT05163496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728872|NCT03158584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728873|NCT03158584|Analgesics|analgesics|mesh-ancestor
5728874|NCT03158584|Sensory System Agents|sensory system agents|mesh-ancestor
5611099|NCT05163496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5611100|NCT05162573|177Lu-PSMA-617|177lu-psma-617|mesh-list
5611101|NCT05162573|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5611102|NCT05162573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5611103|NCT05162118|Nivolumab|nivolumab|mesh-list
5611104|NCT05162118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5611105|NCT05162118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5611106|NCT05162118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5611107|NCT05162118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5611108|NCT05159752|Afamelanotide|afamelanotide|mesh-list
5611109|NCT05159752|Dermatologic Agents|dermatologic agents|mesh-ancestor
5611110|NCT05158998|Propofol|propofol|mesh-list
5611111|NCT05158998|Sevoflurane|sevoflurane|mesh-list
5728875|NCT03158584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5728876|NCT03158805|Liraglutide|liraglutide|mesh-list
5728877|NCT03158805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5728878|NCT03158805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728879|NCT03158805|Incretins|incretins|mesh-ancestor
5728880|NCT03158805|Hormones|hormones|mesh-ancestor
5728881|NCT03158805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5728882|NCT03158610|Capecitabine|capecitabine|mesh-list
5728883|NCT03158610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5728884|NCT03158610|Antimetabolites|antimetabolites|mesh-ancestor
5728885|NCT03158610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728886|NCT03158610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5728887|NCT03158792|Enoxaparin|enoxaparin|mesh-list
5728888|NCT03158792|Enoxaparin sodium|enoxaparin sodium|mesh-list
5728889|NCT03158792|Anticoagulants|anticoagulants|mesh-ancestor
5728890|NCT03158792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5728891|NCT03158792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5728892|NCT03158792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728893|NCT03158389|Sirolimus|sirolimus|mesh-list
5728894|NCT03158389|Atezolizumab|atezolizumab|mesh-list
5728895|NCT03158389|Palbociclib|palbociclib|mesh-list
5728896|NCT03158389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5728897|NCT03158389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5728898|NCT03158389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5728899|NCT03158389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728900|NCT03158389|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5728901|NCT03158389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5728902|NCT03158389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5728903|NCT03158389|Antifungal Agents|antifungal agents|mesh-ancestor
5728904|NCT03158389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5728905|NCT03158389|Immunologic Factors|immunologic factors|mesh-ancestor
5728906|NCT03158389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728907|NCT03158376|Gabapentin|gabapentin|mesh-list
5728908|NCT03158376|Analgesics|analgesics|mesh-ancestor
5728909|NCT03158376|Sensory System Agents|sensory system agents|mesh-ancestor
5728910|NCT03158376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5728911|NCT03158376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728912|NCT03158376|Anticonvulsants|anticonvulsants|mesh-ancestor
5728913|NCT03158376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5728914|NCT03158376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5728915|NCT03158376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5728916|NCT03158376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5728917|NCT03158376|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5611112|NCT05158998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5611113|NCT05158998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5611114|NCT05158998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611115|NCT05158998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5611116|NCT05158998|Anesthetics, General|anesthetics, general|mesh-ancestor
5611117|NCT05158998|Anesthetics|anesthetics|mesh-ancestor
5611118|NCT05158998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5611119|NCT05158998|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5611120|NCT05158608|Cyclophosphamide|cyclophosphamide|mesh-list
5611121|NCT05158608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5728918|NCT03158376|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5728919|NCT03158376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5728920|NCT03158376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728921|NCT03158376|Antimanic Agents|antimanic agents|mesh-ancestor
5728922|NCT03158090|Lanreotide|lanreotide|mesh-list
5728923|NCT03158090|Octreotide|octreotide|mesh-list
5728924|NCT03158090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5728925|NCT03158090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5728926|NCT03158090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5728927|NCT03158142|Atropine|atropine|mesh-list
5728928|NCT03158142|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5728929|NCT03158142|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5728930|NCT03158142|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5728931|NCT03158142|Autonomic Agents|autonomic agents|mesh-ancestor
5728932|NCT03158142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5728933|NCT03158142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728934|NCT03158142|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5728935|NCT03158142|Respiratory System Agents|respiratory system agents|mesh-ancestor
5728936|NCT03158142|Mydriatics|mydriatics|mesh-ancestor
5728937|NCT03158142|Parasympatholytics|parasympatholytics|mesh-ancestor
5728938|NCT03158142|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5728939|NCT03158142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5728940|NCT03158142|Cholinergic Agents|cholinergic agents|mesh-ancestor
5728941|NCT03158142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5728942|NCT03158142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728943|NCT03158168|Zinc Sulfate|zinc sulfate|mesh-list
5728944|NCT03158168|Astringents|astringents|mesh-ancestor
5728945|NCT03158168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728946|NCT03158168|Dermatologic Agents|dermatologic agents|mesh-ancestor
5728947|NCT03158129|Cisplatin|cisplatin|mesh-list
5728948|NCT03158129|Carboplatin|carboplatin|mesh-list
5728949|NCT03158129|Docetaxel|docetaxel|mesh-list
5728950|NCT03158129|Nivolumab|nivolumab|mesh-list
5728951|NCT03158129|Pemetrexed|pemetrexed|mesh-list
5728952|NCT03158129|Ipilimumab|ipilimumab|mesh-list
5611122|NCT05158608|Immunologic Factors|immunologic factors|mesh-ancestor
5611123|NCT05158608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611124|NCT05158608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5611125|NCT05158608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5611126|NCT05158608|Alkylating Agents|alkylating agents|mesh-ancestor
5611127|NCT05158608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5611128|NCT05158608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5611129|NCT05158608|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5611130|NCT05157971|Cytarabine|cytarabine|mesh-list
5611131|NCT05157971|Prednisone|prednisone|mesh-list
5611132|NCT05157971|Cortisone|cortisone|mesh-list
5611133|NCT05157971|Cyclophosphamide|cyclophosphamide|mesh-list
5611134|NCT05157971|Methotrexate|methotrexate|mesh-list
5611135|NCT05157971|Vincristine|vincristine|mesh-list
5611136|NCT05157971|Daunorubicin|daunorubicin|mesh-list
5611137|NCT05157971|Asparaginase|asparaginase|mesh-list
5611138|NCT05157971|Venetoclax|venetoclax|mesh-list
5611139|NCT05157971|Mercaptopurine|mercaptopurine|mesh-list
5611140|NCT05157971|Pegaspargase|pegaspargase|mesh-list
5611141|NCT05157971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5611142|NCT05157971|Immunologic Factors|immunologic factors|mesh-ancestor
5728953|NCT03158129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5728954|NCT03158129|Tubulin Modulators|tubulin modulators|mesh-ancestor
5728955|NCT03158129|Antimitotic Agents|antimitotic agents|mesh-ancestor
5728956|NCT03158129|Mitosis Modulators|mitosis modulators|mesh-ancestor
5728957|NCT03158129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728958|NCT03158129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5728959|NCT03158129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5728960|NCT03158129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5728961|NCT03158129|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5728962|NCT03158129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5728963|NCT03158246|Vitamin D|vitamin d|mesh-list
5728964|NCT03158246|Zoledronic Acid|zoledronic acid|mesh-list
5728965|NCT03158246|Calcium|calcium|mesh-list
5728966|NCT03158246|Vitamins|vitamins|mesh-ancestor
5728967|NCT03158246|Micronutrients|micronutrients|mesh-ancestor
5728968|NCT03158246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728969|NCT03158246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5728970|NCT03158246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5728971|NCT03158025|Zolpidem|zolpidem|mesh-list
5611143|NCT05157971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611144|NCT05157971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5611145|NCT05157971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5728972|NCT03158025|Suvorexant|suvorexant|mesh-list
5728973|NCT03158025|Lemborexant|lemborexant|mesh-list
5728974|NCT03158025|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5728975|NCT03158025|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5611146|NCT05157971|Alkylating Agents|alkylating agents|mesh-ancestor
5611147|NCT05157971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5611148|NCT05157971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5611149|NCT05157971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5611150|NCT05157971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5611151|NCT05157971|Glucocorticoids|glucocorticoids|mesh-ancestor
5611152|NCT05157971|Hormones|hormones|mesh-ancestor
5611153|NCT05157971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5611154|NCT05157971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5611155|NCT05157971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5611156|NCT05157971|Abortifacient Agents|abortifacient agents|mesh-ancestor
5611157|NCT05157971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5611158|NCT05157971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5611159|NCT05157971|Antimetabolites|antimetabolites|mesh-ancestor
5611160|NCT05157971|Dermatologic Agents|dermatologic agents|mesh-ancestor
5611161|NCT05157971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5728976|NCT03158025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5728977|NCT03158025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728978|NCT03158025|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
5728979|NCT03158025|GABA Agonists|gaba agonists|mesh-ancestor
5728980|NCT03158025|GABA Agents|gaba agents|mesh-ancestor
5728981|NCT03158025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5728982|NCT03158025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728983|NCT03158025|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
5728984|NCT03157843|Heparin|heparin|mesh-list
5728985|NCT03157843|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5728986|NCT03157843|Tinzaparin|tinzaparin|mesh-list
5728987|NCT03157843|Dalteparin|dalteparin|mesh-list
5728988|NCT03157843|Anticoagulants|anticoagulants|mesh-ancestor
5728989|NCT03157843|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5728990|NCT03157843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5728991|NCT03157843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5728992|NCT03157804|Plerixafor|plerixafor|mesh-list
5728993|NCT03157804|Lenograstim|lenograstim|mesh-list
5728994|NCT03157804|Sargramostim|sargramostim|mesh-list
5728995|NCT03157804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5728996|NCT03157804|Immunologic Factors|immunologic factors|mesh-ancestor
5728997|NCT03157804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5728998|NCT03157804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5728999|NCT03157804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5729000|NCT03157804|Antiviral Agents|antiviral agents|mesh-ancestor
5729001|NCT03157804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5729002|NCT03157791|Simethicone|simethicone|mesh-list
5729003|NCT03157791|Antifoaming Agents|antifoaming agents|mesh-ancestor
5729004|NCT03157791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729005|NCT03157791|Emollients|emollients|mesh-ancestor
5729006|NCT03157791|Dermatologic Agents|dermatologic agents|mesh-ancestor
5892789|NCT04418479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5892790|NCT04418479|Antipyretics|antipyretics|mesh-ancestor
5611162|NCT05157971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5611163|NCT05157971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5892791|NCT04418479|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5892792|NCT04418479|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5892793|NCT04418479|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5892794|NCT04418479|Purinergic Agents|purinergic agents|mesh-ancestor
5892795|NCT04418479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5892796|NCT04379713|Vaccines|vaccines|mesh-list
5892797|NCT04379713|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5892798|NCT04379713|Immunologic Factors|immunologic factors|mesh-ancestor
5892799|NCT04379713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892800|NCT04375735|Pulmonary Surfactants|pulmonary surfactants|mesh-list
5892801|NCT04375735|Respiratory System Agents|respiratory system agents|mesh-ancestor
5892802|NCT04370379|Aflibercept|aflibercept|mesh-list
5892803|NCT04370379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5892804|NCT04370379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5892805|NCT04370379|Growth Substances|growth substances|mesh-ancestor
5892806|NCT04370379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892807|NCT04370379|Growth Inhibitors|growth inhibitors|mesh-ancestor
5892808|NCT04370379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5892809|NCT04305899|BMS-986165|bms-986165|mesh-list
5892810|NCT04305899|Dermatologic Agents|dermatologic agents|mesh-ancestor
5892811|NCT04305899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5892812|NCT04305899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5907710|NCT05215691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5611164|NCT05157971|Antiviral Agents|antiviral agents|mesh-ancestor
5611165|NCT05157971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5611166|NCT05157971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5611167|NCT05157971|Tubulin Modulators|tubulin modulators|mesh-ancestor
5611168|NCT05157971|Antimitotic Agents|antimitotic agents|mesh-ancestor
5611169|NCT05157971|Mitosis Modulators|mitosis modulators|mesh-ancestor
5729007|NCT03157505|Immunologic Factors|immunologic factors|mesh-list
5729008|NCT03157505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729009|NCT03157479|Anesthetics|anesthetics|mesh-list
5729010|NCT03157479|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
5729011|NCT03157479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5729012|NCT03157479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729013|NCT03157479|Anesthetics, General|anesthetics, general|mesh-ancestor
5729014|NCT03157401|Tranexamic Acid|tranexamic acid|mesh-list
5611170|NCT05157971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5611171|NCT05157971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5611172|NCT05157971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5691790|NCT03414034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691791|NCT03413995|Rucaparib|rucaparib|mesh-list
5691792|NCT03413995|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5691793|NCT03413995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5691794|NCT03413995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691795|NCT03413995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5691796|NCT03413891|Tranexamic Acid|tranexamic acid|mesh-list
5729015|NCT03157401|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5729016|NCT03157401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5729017|NCT03157401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729018|NCT03157401|Hemostatics|hemostatics|mesh-ancestor
5729019|NCT03157401|Coagulants|coagulants|mesh-ancestor
5729020|NCT03157310|Gefitinib|gefitinib|mesh-list
5729021|NCT03157310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5729022|NCT03157310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5729023|NCT03157310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5729024|NCT03157310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729025|NCT03157414|Empagliflozin|empagliflozin|mesh-list
5729026|NCT03157414|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5729027|NCT03157414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729028|NCT03157414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5729029|NCT03157414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729030|NCT03157193|Hyaluronic Acid|hyaluronic acid|mesh-list
5729031|NCT03157193|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5729032|NCT03157193|Immunologic Factors|immunologic factors|mesh-ancestor
5729033|NCT03157193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729034|NCT03157193|Viscosupplements|viscosupplements|mesh-ancestor
5729035|NCT03157193|Protective Agents|protective agents|mesh-ancestor
5729036|NCT03157388|Vancomycin|vancomycin|mesh-list
5729037|NCT03157388|Gentamicins|gentamicins|mesh-list
5729038|NCT03157388|Meropenem|meropenem|mesh-list
5729039|NCT03157388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5729040|NCT03157388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5729041|NCT03157388|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5729042|NCT03157388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5729043|NCT03157388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729044|NCT03157037|Immunoglobulins|immunoglobulins|mesh-list
5729045|NCT03157037|Immunoglobulin G|immunoglobulin g|mesh-list
5729046|NCT03157037|Immunologic Factors|immunologic factors|mesh-ancestor
5729047|NCT03157037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729048|NCT03156855|Bismuth|bismuth|mesh-list
5729049|NCT03156855|Antacids|antacids|mesh-ancestor
5729050|NCT03156855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691797|NCT03413891|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5691798|NCT03413891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5691799|NCT03413891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691800|NCT03413891|Hemostatics|hemostatics|mesh-ancestor
5691801|NCT03413891|Coagulants|coagulants|mesh-ancestor
5691802|NCT03413800|Dexamethasone|dexamethasone|mesh-list
5691803|NCT03413800|Lenalidomide|lenalidomide|mesh-list
5729051|NCT03156855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5729052|NCT03156920|Sumatriptan|sumatriptan|mesh-list
5729053|NCT03156920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5729054|NCT03156920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5729055|NCT03156920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5691804|NCT03413800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5691805|NCT03413800|Antiemetics|antiemetics|mesh-ancestor
5729056|NCT03156920|Serotonin Agents|serotonin agents|mesh-ancestor
5907711|NCT05215691|Narcotics|narcotics|mesh-ancestor
5729057|NCT03156920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5729058|NCT03156920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729059|NCT03156920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729060|NCT03156842|Amlodipine|amlodipine|mesh-list
5729061|NCT03156842|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5729062|NCT03156842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5729063|NCT03156842|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5729064|NCT03156842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5611173|NCT05153772|Octreotide|octreotide|mesh-list
5611174|NCT05153772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5611175|NCT05153772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5611176|NCT05153772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5611177|NCT05152862|Bevacizumab|bevacizumab|mesh-list
5611178|NCT05152862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5611179|NCT05152862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5611180|NCT05152862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5611181|NCT05152862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5611182|NCT05152862|Growth Substances|growth substances|mesh-ancestor
5729065|NCT03156842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729066|NCT03156842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5729067|NCT03156842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729068|NCT03156842|Vasodilator Agents|vasodilator agents|mesh-ancestor
5729069|NCT03156842|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5729070|NCT03156842|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5729071|NCT03156842|Antimetabolites|antimetabolites|mesh-ancestor
5729072|NCT03156842|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5729073|NCT03156842|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5729074|NCT03156842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5729075|NCT03156907|Buprenorphine|buprenorphine|mesh-list
5729076|NCT03156907|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5729077|NCT03156907|Narcotics|narcotics|mesh-ancestor
5729078|NCT03156907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5729079|NCT03156907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729080|NCT03156907|Analgesics|analgesics|mesh-ancestor
5729081|NCT03156907|Sensory System Agents|sensory system agents|mesh-ancestor
5729082|NCT03156907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5729083|NCT03156907|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5729084|NCT03156790|Asparaginase|asparaginase|mesh-list
5729085|NCT03156790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5729086|NCT03156829|Betamethasone|betamethasone|mesh-list
5729087|NCT03156829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5729088|NCT03156829|Glucocorticoids|glucocorticoids|mesh-ancestor
5729089|NCT03156829|Hormones|hormones|mesh-ancestor
5729090|NCT03156829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5729091|NCT03156829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729092|NCT03156829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5729093|NCT03156829|Respiratory System Agents|respiratory system agents|mesh-ancestor
5729094|NCT03156439|Huperzine A|huperzine a|mesh-list
5729095|NCT03156439|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5611183|NCT05152862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611184|NCT05152862|Growth Inhibitors|growth inhibitors|mesh-ancestor
5611185|NCT05151484|Alendronate|alendronate|mesh-list
5611186|NCT05151484|Teriparatide|teriparatide|mesh-list
5611187|NCT05151484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5611188|NCT05151484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611189|NCT05151484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5611190|NCT05151159|Antibodies|antibodies|mesh-list
5611191|NCT05151159|Immunologic Factors|immunologic factors|mesh-ancestor
5611192|NCT05151159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611193|NCT05150782|Ascorbic Acid|ascorbic acid|mesh-list
5611194|NCT05150782|Curcumin|curcumin|mesh-list
5611195|NCT05150782|Antioxidants|antioxidants|mesh-ancestor
5611196|NCT05150782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5611197|NCT05150782|Protective Agents|protective agents|mesh-ancestor
5611198|NCT05150782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729096|NCT03156439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5729097|NCT03156439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729098|NCT03156439|Cholinergic Agents|cholinergic agents|mesh-ancestor
5729099|NCT03156439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5729100|NCT03156439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729101|NCT03156439|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5611199|NCT05150782|Vitamins|vitamins|mesh-ancestor
5611200|NCT05150782|Micronutrients|micronutrients|mesh-ancestor
5729102|NCT03156439|Protective Agents|protective agents|mesh-ancestor
5729103|NCT03156504|Ketamine|ketamine|mesh-list
5729104|NCT03156504|Analgesics|analgesics|mesh-ancestor
5729105|NCT03156504|Sensory System Agents|sensory system agents|mesh-ancestor
5729106|NCT03156504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5729107|NCT03156504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729108|NCT03156504|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5729109|NCT03156504|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5729110|NCT03156504|Anesthetics, General|anesthetics, general|mesh-ancestor
5729111|NCT03156504|Anesthetics|anesthetics|mesh-ancestor
5729112|NCT03156504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5729113|NCT03156504|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5729114|NCT03156504|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5729115|NCT03156504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5729116|NCT03156504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729117|NCT03156452|Mycophenolic Acid|mycophenolic acid|mesh-list
5729118|NCT03156452|Prednisolone|prednisolone|mesh-list
5729119|NCT03156452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5729120|NCT03156452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5729121|NCT03156452|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5729122|NCT03156452|Antitubercular Agents|antitubercular agents|mesh-ancestor
5729123|NCT03156452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5729124|NCT03156452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5729125|NCT03156452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5729126|NCT03156452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729127|NCT03156452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5611201|NCT05150782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5611202|NCT05150782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5611203|NCT05150782|Analgesics|analgesics|mesh-ancestor
5611204|NCT05150782|Sensory System Agents|sensory system agents|mesh-ancestor
5611205|NCT05150782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5611206|NCT05150782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5611207|NCT05150782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5611208|NCT05150782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5611209|NCT05150782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5611210|NCT05149560|Ticagrelor|ticagrelor|mesh-list
5611211|NCT05149560|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5611212|NCT05149560|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5611213|NCT05149560|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5729128|NCT03156452|Glucocorticoids|glucocorticoids|mesh-ancestor
5729129|NCT03156452|Hormones|hormones|mesh-ancestor
5729130|NCT03156452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5729131|NCT03156452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729132|NCT03156452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5729133|NCT03156361|Insulin|insulin|mesh-list
5729134|NCT03156361|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5729135|NCT03156361|Insulin Lispro|insulin lispro|mesh-list
5729136|NCT03156361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5729137|NCT03156361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729138|NCT03156296|Dexmedetomidine|dexmedetomidine|mesh-list
5729139|NCT03156296|Bupivacaine|bupivacaine|mesh-list
5729140|NCT03156296|Anesthetics, Local|anesthetics, local|mesh-ancestor
5729141|NCT03156296|Anesthetics|anesthetics|mesh-ancestor
5729142|NCT03156296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5729143|NCT03156296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611214|NCT05149560|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5611215|NCT05149560|Purinergic Agents|purinergic agents|mesh-ancestor
5611216|NCT05149560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5611217|NCT05149560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5611218|NCT05149560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611219|NCT05146674|Tadalafil|tadalafil|mesh-list
5611220|NCT05146674|Vasodilator Agents|vasodilator agents|mesh-ancestor
5611221|NCT05146674|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5729144|NCT03156296|Sensory System Agents|sensory system agents|mesh-ancestor
5729145|NCT03156296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5729146|NCT03156296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5729147|NCT03156296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5729148|NCT03156296|Analgesics|analgesics|mesh-ancestor
5729149|NCT03156296|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5729150|NCT03156296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5729151|NCT03156296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5729152|NCT03156296|Adrenergic Agents|adrenergic agents|mesh-ancestor
5729153|NCT03156296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5729154|NCT03156296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729155|NCT03156322|Fentanyl|fentanyl|mesh-list
5729156|NCT03156322|Bupivacaine|bupivacaine|mesh-list
5611222|NCT05146674|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5611223|NCT05146674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5611224|NCT05146674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5611225|NCT05146674|Urological Agents|urological agents|mesh-ancestor
5611226|NCT05146635|Epirubicin|epirubicin|mesh-list
5611227|NCT05146635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5611228|NCT05146635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5611229|NCT05146635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5611230|NCT05146635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5611231|NCT05146635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5611232|NCT05146635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5611233|NCT05145569|Paclitaxel|paclitaxel|mesh-list
5611234|NCT05145569|Carboplatin|carboplatin|mesh-list
5611235|NCT05145569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5611236|NCT05145569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5611237|NCT05145569|Tubulin Modulators|tubulin modulators|mesh-ancestor
5611238|NCT05145569|Antimitotic Agents|antimitotic agents|mesh-ancestor
5611239|NCT05145569|Mitosis Modulators|mitosis modulators|mesh-ancestor
5729157|NCT03156322|Anesthetics, Local|anesthetics, local|mesh-ancestor
5729158|NCT03156322|Anesthetics|anesthetics|mesh-ancestor
5729159|NCT03156322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5729160|NCT03156322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729161|NCT03156322|Sensory System Agents|sensory system agents|mesh-ancestor
5729162|NCT03156322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5729163|NCT03156322|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5611240|NCT05145569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5611241|NCT05137730|Parathyroid Hormone|parathyroid hormone|mesh-list
5611242|NCT05137730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611243|NCT05137730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5611244|NCT05133518|Midazolam|midazolam|mesh-list
5611245|NCT05133518|Ketamine|ketamine|mesh-list
5611246|NCT05133518|Analgesics|analgesics|mesh-ancestor
5611247|NCT05133518|Sensory System Agents|sensory system agents|mesh-ancestor
5611248|NCT05133518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5611249|NCT05133518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611250|NCT05133518|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5611251|NCT05133518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5611252|NCT05133518|Anesthetics, General|anesthetics, general|mesh-ancestor
5611253|NCT05133518|Anesthetics|anesthetics|mesh-ancestor
5611254|NCT05133518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5729164|NCT03156322|Narcotics|narcotics|mesh-ancestor
5729165|NCT03156322|Analgesics|analgesics|mesh-ancestor
5729166|NCT03156322|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5729167|NCT03156322|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5729168|NCT03156322|Anesthetics, General|anesthetics, general|mesh-ancestor
5729169|NCT03156088|Neurotransmitter Agents|neurotransmitter agents|mesh-list
5729170|NCT03156088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729171|NCT03156088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892813|NCT04305899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892814|NCT04298606|Vaccines|vaccines|mesh-list
5892815|NCT04298606|Mitogens|mitogens|mesh-list
5892816|NCT04298606|Immunologic Factors|immunologic factors|mesh-ancestor
5892817|NCT04298606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892818|NCT04298606|Mitosis Modulators|mitosis modulators|mesh-ancestor
5892819|NCT04298606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892820|NCT04279847|INCB057643|incb057643|mesh-list
5892821|NCT04279847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5892822|NCT04256941|Letrozole|letrozole|mesh-list
5892823|NCT04256941|Fulvestrant|fulvestrant|mesh-list
5892824|NCT04256941|Palbociclib|palbociclib|mesh-list
5892825|NCT04256941|Anastrozole|anastrozole|mesh-list
5892826|NCT04256941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5892827|NCT04256941|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5892828|NCT04256941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5892829|NCT04256941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5892830|NCT04256941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892831|NCT04256941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5892832|NCT04256941|Hormone Antagonists|hormone antagonists|mesh-ancestor
5892833|NCT04256941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5892834|NCT04256941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892835|NCT04256941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5892836|NCT04256941|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5892837|NCT04256941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5892838|NCT04250883|Iodine|iodine|mesh-list
6489119|NCT00589316|Antimetabolites|antimetabolites|mesh-ancestor
5611255|NCT05133518|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5611256|NCT05133518|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5611257|NCT05133518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5611258|NCT05133518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5611259|NCT05133518|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5611260|NCT05133518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5611261|NCT05133518|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5611262|NCT05133518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5611263|NCT05133518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5611264|NCT05133518|GABA Modulators|gaba modulators|mesh-ancestor
5611265|NCT05133518|GABA Agents|gaba agents|mesh-ancestor
5729172|NCT03156036|Capecitabine|capecitabine|mesh-list
5729173|NCT03156036|Temozolomide|temozolomide|mesh-list
5729174|NCT03156036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5729175|NCT03156036|Antimetabolites|antimetabolites|mesh-ancestor
5729176|NCT03156036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729177|NCT03156036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5729178|NCT03156036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5729179|NCT03156036|Alkylating Agents|alkylating agents|mesh-ancestor
5729180|NCT03156179|Calcium|calcium|mesh-list
5729181|NCT03156179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5729182|NCT03156179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729183|NCT03156153|Bumetanide|bumetanide|mesh-list
5729184|NCT03156153|Diuretics|diuretics|mesh-ancestor
5729185|NCT03156153|Natriuretic Agents|natriuretic agents|mesh-ancestor
5729186|NCT03156153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729187|NCT03156153|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5729188|NCT03156153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5729189|NCT03156153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729190|NCT03156062|Salicylic Acid|salicylic acid|mesh-list
5729191|NCT03156062|Salicylates|salicylates|mesh-list
5729192|NCT03156062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5729193|NCT03156062|Antifungal Agents|antifungal agents|mesh-ancestor
5729194|NCT03156062|Keratolytic Agents|keratolytic agents|mesh-ancestor
5729195|NCT03156062|Dermatologic Agents|dermatologic agents|mesh-ancestor
5611266|NCT05132439|Metformin|metformin|mesh-list
5611267|NCT05132439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5611268|NCT05132439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611269|NCT05132114|Lugol's solution|lugol's solution|mesh-list
5611270|NCT05132114|Hemostatics|hemostatics|mesh-ancestor
5611271|NCT05132114|Coagulants|coagulants|mesh-ancestor
5611272|NCT05130060|Trifluridine|trifluridine|mesh-list
5611273|NCT05130060|Vaccines|vaccines|mesh-list
5611274|NCT05130060|Immunologic Factors|immunologic factors|mesh-ancestor
5611275|NCT05130060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611276|NCT05130060|Antimetabolites|antimetabolites|mesh-ancestor
5611277|NCT05130060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5611278|NCT05130060|Antiviral Agents|antiviral agents|mesh-ancestor
5611279|NCT05130060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5611280|NCT05124899|Sunscreening Agents|sunscreening agents|mesh-list
5611281|NCT05124899|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5611282|NCT05124899|Protective Agents|protective agents|mesh-ancestor
5611283|NCT05124899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611284|NCT05124899|Dermatologic Agents|dermatologic agents|mesh-ancestor
5611285|NCT05119140|Hydroxychloroquine|hydroxychloroquine|mesh-list
5611286|NCT05119140|Mesalamine|mesalamine|mesh-list
5611287|NCT05119140|Antimalarials|antimalarials|mesh-ancestor
5611288|NCT05119140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5611289|NCT05119140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5611290|NCT05119140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5611291|NCT05119140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5611292|NCT05119140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729196|NCT03156062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5729197|NCT03156062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5729198|NCT03156062|Analgesics|analgesics|mesh-ancestor
5729199|NCT03156062|Sensory System Agents|sensory system agents|mesh-ancestor
5729200|NCT03156062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5729201|NCT03156062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729202|NCT03156062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5729203|NCT03156062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5729204|NCT03156062|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5729205|NCT03156062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5729206|NCT03156062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5611293|NCT05119140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5611294|NCT05119140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5611295|NCT05119140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5611296|NCT05119140|Analgesics|analgesics|mesh-ancestor
5611297|NCT05119140|Sensory System Agents|sensory system agents|mesh-ancestor
5611298|NCT05119140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5729207|NCT03156231|Acetazolamide|acetazolamide|mesh-list
5729208|NCT03156231|Anticonvulsants|anticonvulsants|mesh-ancestor
5729209|NCT03156231|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5729210|NCT03156231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5729211|NCT03156231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729212|NCT03156231|Diuretics|diuretics|mesh-ancestor
5729213|NCT03156231|Natriuretic Agents|natriuretic agents|mesh-ancestor
5611299|NCT05119140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611300|NCT05119140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5611301|NCT05119075|Dopamine|dopamine|mesh-list
5611302|NCT05119075|Dopamine Agonists|dopamine agonists|mesh-list
5611303|NCT05119075|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5611304|NCT05119075|Sympathomimetics|sympathomimetics|mesh-ancestor
5611305|NCT05119075|Autonomic Agents|autonomic agents|mesh-ancestor
5611306|NCT05119075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5611307|NCT05119075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611308|NCT05119075|Dopamine Agents|dopamine agents|mesh-ancestor
5729214|NCT03156231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729215|NCT03155971|Paclitaxel|paclitaxel|mesh-list
5729216|NCT03155971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5729217|NCT03155971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5729218|NCT03155971|Tubulin Modulators|tubulin modulators|mesh-ancestor
5729219|NCT03155971|Antimitotic Agents|antimitotic agents|mesh-ancestor
5729220|NCT03155971|Mitosis Modulators|mitosis modulators|mesh-ancestor
5729221|NCT03155971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729222|NCT03155893|Moxifloxacin|moxifloxacin|mesh-list
5729223|NCT03155893|Adafosbuvir|adafosbuvir|mesh-list
5611309|NCT05119075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5611310|NCT05119075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5611311|NCT05119075|Protective Agents|protective agents|mesh-ancestor
5611312|NCT05111626|Nivolumab|nivolumab|mesh-list
5611313|NCT05111626|Bemarituzumab|bemarituzumab|mesh-list
5729224|NCT03155893|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
5729225|NCT03155893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5729226|NCT03155893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5729227|NCT03155893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5729228|NCT03155893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5729229|NCT03155893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5729230|NCT03155893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729231|NCT03155893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5729232|NCT03155893|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5611314|NCT05111626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5611315|NCT05111626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5611316|NCT05111626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5611317|NCT05111626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5611318|NCT05111262|Budesonide|budesonide|mesh-list
5611319|NCT05111262|Formoterol Fumarate|formoterol fumarate|mesh-list
5611320|NCT05111262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5611321|NCT05111262|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5611322|NCT05111262|Autonomic Agents|autonomic agents|mesh-ancestor
5729233|NCT03155893|Contraceptive Agents|contraceptive agents|mesh-ancestor
5729234|NCT03155893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5729235|NCT03155893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729236|NCT03155893|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5729237|NCT03155893|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5729238|NCT03155893|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5729239|NCT03155893|Antiviral Agents|antiviral agents|mesh-ancestor
5729240|NCT03155984|Antibodies|antibodies|mesh-list
5729241|NCT03155984|Immunologic Factors|immunologic factors|mesh-ancestor
5729242|NCT03155984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729243|NCT03155568|Bupivacaine|bupivacaine|mesh-list
5729244|NCT03155568|Anesthetics, Local|anesthetics, local|mesh-ancestor
5729245|NCT03155568|Anesthetics|anesthetics|mesh-ancestor
5729246|NCT03155568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5611323|NCT05111262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5611324|NCT05111262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611325|NCT05111262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5611326|NCT05111262|Respiratory System Agents|respiratory system agents|mesh-ancestor
5611327|NCT05111262|Glucocorticoids|glucocorticoids|mesh-ancestor
5729247|NCT03155568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611328|NCT05111262|Hormones|hormones|mesh-ancestor
5729248|NCT03155568|Sensory System Agents|sensory system agents|mesh-ancestor
5729249|NCT03155568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5729250|NCT03155477|Cholecalciferol|cholecalciferol|mesh-list
5729251|NCT03155477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5729252|NCT03155477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729253|NCT03155477|Vitamins|vitamins|mesh-ancestor
5729254|NCT03155477|Micronutrients|micronutrients|mesh-ancestor
5729255|NCT03155477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5729256|NCT03155646|Clonidine|clonidine|mesh-list
5729257|NCT03155646|Dexmedetomidine|dexmedetomidine|mesh-list
5729258|NCT03155646|Levobupivacaine|levobupivacaine|mesh-list
5611329|NCT05111262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5611330|NCT05111262|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5611331|NCT05111262|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5611332|NCT05111262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5611333|NCT05111262|Adrenergic Agents|adrenergic agents|mesh-ancestor
5611334|NCT05111262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5611335|NCT05111262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5611336|NCT05105282|Anesthetics|anesthetics|mesh-list
5611337|NCT05105282|Anesthetics, Local|anesthetics, local|mesh-list
5611338|NCT05105282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5729259|NCT03155646|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5729260|NCT03155646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5611339|NCT05105282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611340|NCT05105282|Sensory System Agents|sensory system agents|mesh-ancestor
5611341|NCT05105282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5611342|NCT05099107|Albuterol|albuterol|mesh-list
5611343|NCT05099107|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5611344|NCT05099107|Autonomic Agents|autonomic agents|mesh-ancestor
5611345|NCT05099107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5611346|NCT05099107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611347|NCT05099107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5611348|NCT05099107|Respiratory System Agents|respiratory system agents|mesh-ancestor
5729261|NCT03155646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729262|NCT03155646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5729263|NCT03155646|Analgesics|analgesics|mesh-ancestor
5729264|NCT03155646|Sensory System Agents|sensory system agents|mesh-ancestor
5729265|NCT03155646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5729266|NCT03155646|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5729267|NCT03155646|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5729268|NCT03155646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5729269|NCT03155646|Adrenergic Agents|adrenergic agents|mesh-ancestor
5729270|NCT03155646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5729271|NCT03155646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729272|NCT03155646|Anesthetics, Local|anesthetics, local|mesh-ancestor
5729273|NCT03155646|Anesthetics|anesthetics|mesh-ancestor
5729274|NCT03155646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5729275|NCT03155646|Sympatholytics|sympatholytics|mesh-ancestor
5729276|NCT03155646|Autonomic Agents|autonomic agents|mesh-ancestor
5729277|NCT03155087|Metformin|metformin|mesh-list
5729278|NCT03155087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5729279|NCT03155087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729280|NCT03155100|Dexamethasone|dexamethasone|mesh-list
5729281|NCT03155100|Elotuzumab|elotuzumab|mesh-list
5729282|NCT03155100|Proteasome Inhibitors|proteasome inhibitors|mesh-list
5729283|NCT03155100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5729284|NCT03155100|Antiemetics|antiemetics|mesh-ancestor
5729285|NCT03155100|Autonomic Agents|autonomic agents|mesh-ancestor
5729286|NCT03155100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5729287|NCT03155100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729288|NCT03155100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5729289|NCT03155100|Glucocorticoids|glucocorticoids|mesh-ancestor
5729290|NCT03155100|Hormones|hormones|mesh-ancestor
5729291|NCT03155100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5729292|NCT03155100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5729293|NCT03155100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5729294|NCT03155100|Protease Inhibitors|protease inhibitors|mesh-ancestor
5729295|NCT03155100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5729296|NCT03155100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729297|NCT03155204|Tiotropium Bromide|tiotropium bromide|mesh-list
5729298|NCT03155204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5611349|NCT05099107|Tocolytic Agents|tocolytic agents|mesh-ancestor
5729299|NCT03155204|Autonomic Agents|autonomic agents|mesh-ancestor
5729300|NCT03155204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5611350|NCT05099107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5611351|NCT05099107|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5611352|NCT05099107|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5611353|NCT05099107|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5611354|NCT05099107|Adrenergic Agents|adrenergic agents|mesh-ancestor
5611355|NCT05099107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5611356|NCT05099107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5611357|NCT05089643|Capecitabine|capecitabine|mesh-list
5611358|NCT05089643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5611359|NCT05089643|Antimetabolites|antimetabolites|mesh-ancestor
5611360|NCT05089643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5611361|NCT05089643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5611362|NCT05087030|Denosumab|denosumab|mesh-list
5611363|NCT05087030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5611364|NCT05087030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729301|NCT03155204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729302|NCT03155204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5729303|NCT03155204|Respiratory System Agents|respiratory system agents|mesh-ancestor
5729304|NCT03155204|Parasympatholytics|parasympatholytics|mesh-ancestor
5729305|NCT03155204|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5729306|NCT03155204|Cholinergic Agents|cholinergic agents|mesh-ancestor
5729307|NCT03155204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5729308|NCT03155204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729309|NCT03155048|Estradiol|estradiol|mesh-list
5729310|NCT03155048|Estrogens|estrogens|mesh-list
5729311|NCT03155048|Hormones|hormones|mesh-ancestor
5729312|NCT03155048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5729313|NCT03155048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729314|NCT03154827|Atezolizumab|atezolizumab|mesh-list
5729315|NCT03154827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5729316|NCT03155035|Vitamin D|vitamin d|mesh-list
5729317|NCT03155035|Albendazole|albendazole|mesh-list
5729318|NCT03155035|Calcium|calcium|mesh-list
5729319|NCT03155035|Vitamins|vitamins|mesh-ancestor
5729320|NCT03155035|Micronutrients|micronutrients|mesh-ancestor
5729321|NCT03155035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729322|NCT03155035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5729323|NCT03155035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5729324|NCT03155035|Anthelmintics|anthelmintics|mesh-ancestor
5729325|NCT03155035|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5729326|NCT03155035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5729327|NCT03155035|Anticestodal Agents|anticestodal agents|mesh-ancestor
5729328|NCT03155035|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5729329|NCT03155035|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5729330|NCT03155035|Tubulin Modulators|tubulin modulators|mesh-ancestor
5729331|NCT03155035|Antimitotic Agents|antimitotic agents|mesh-ancestor
5729332|NCT03155035|Mitosis Modulators|mitosis modulators|mesh-ancestor
5729333|NCT03155035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729334|NCT03155035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5729335|NCT03154814|Urinastatin|urinastatin|mesh-list
5729336|NCT03154814|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5729337|NCT03154814|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5729338|NCT03154814|Protease Inhibitors|protease inhibitors|mesh-ancestor
5729339|NCT03154814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5729340|NCT03154814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729341|NCT03154723|Vitamin A|vitamin a|mesh-list
5729342|NCT03154723|Vitamins|vitamins|mesh-ancestor
5729343|NCT03154723|Micronutrients|micronutrients|mesh-ancestor
5729344|NCT03154723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691806|NCT03413800|Autonomic Agents|autonomic agents|mesh-ancestor
5691807|NCT03413800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5691808|NCT03413800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691809|NCT03413800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5691810|NCT03413800|Glucocorticoids|glucocorticoids|mesh-ancestor
5691811|NCT03413800|Hormones|hormones|mesh-ancestor
5691812|NCT03413800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5691813|NCT03413800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5691814|NCT03413800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5691815|NCT03413800|Immunologic Factors|immunologic factors|mesh-ancestor
5691816|NCT03413800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5691817|NCT03413800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5691818|NCT03413800|Growth Substances|growth substances|mesh-ancestor
5691819|NCT03413800|Growth Inhibitors|growth inhibitors|mesh-ancestor
5729345|NCT03154918|Gemcitabine|gemcitabine|mesh-list
5729346|NCT03154918|Dexamethasone|dexamethasone|mesh-list
5729347|NCT03154918|Etoposide|etoposide|mesh-list
5729348|NCT03154918|Ifosfamide|ifosfamide|mesh-list
5729349|NCT03154918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5729350|NCT03154918|Antiemetics|antiemetics|mesh-ancestor
5729351|NCT03154918|Autonomic Agents|autonomic agents|mesh-ancestor
5729352|NCT03154918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5729353|NCT03154918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729354|NCT03154918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5729355|NCT03154918|Glucocorticoids|glucocorticoids|mesh-ancestor
5729356|NCT03154918|Hormones|hormones|mesh-ancestor
5729357|NCT03154918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5729358|NCT03154918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5729359|NCT03154918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5729360|NCT03154918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5729361|NCT03154918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729362|NCT03154918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5729363|NCT03154918|Antimetabolites|antimetabolites|mesh-ancestor
5729364|NCT03154918|Antiviral Agents|antiviral agents|mesh-ancestor
5729365|NCT03154918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5729366|NCT03154918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5729367|NCT03154918|Immunologic Factors|immunologic factors|mesh-ancestor
5729368|NCT03154918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5729369|NCT03154918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5729370|NCT03154918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5729371|NCT03154918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5729372|NCT03154918|Alkylating Agents|alkylating agents|mesh-ancestor
5892839|NCT04250883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5892840|NCT04250883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5892841|NCT04250883|Trace Elements|trace elements|mesh-ancestor
5892842|NCT04250883|Micronutrients|micronutrients|mesh-ancestor
5892843|NCT04250883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892844|NCT04238624|Trametinib|trametinib|mesh-list
5892845|NCT04238624|Dabrafenib|dabrafenib|mesh-list
5892846|NCT04238624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5892847|NCT04238624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5892848|NCT04238624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5892849|NCT04238624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892850|NCT04153604|Doxycycline|doxycycline|mesh-list
5892851|NCT04153604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5892852|NCT04153604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5892853|NCT04153604|Antimalarials|antimalarials|mesh-ancestor
5892854|NCT04153604|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5892855|NCT04153604|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5892856|NCT04129398|Letermovir|letermovir|mesh-list
5892857|NCT04129398|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5892858|NCT04129398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5892859|NCT04129398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892860|NCT04129398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5892861|NCT04129398|Antiviral Agents|antiviral agents|mesh-ancestor
5892862|NCT04129398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5892863|NCT04126278|Dexamethasone|dexamethasone|mesh-list
5892864|NCT04126278|Cortisone|cortisone|mesh-list
5892865|NCT04126278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5892866|NCT04126278|Antiemetics|antiemetics|mesh-ancestor
5892867|NCT04126278|Autonomic Agents|autonomic agents|mesh-ancestor
5892868|NCT04126278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5892869|NCT04126278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892870|NCT04126278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5892871|NCT04126278|Glucocorticoids|glucocorticoids|mesh-ancestor
5892872|NCT04126278|Hormones|hormones|mesh-ancestor
5892873|NCT04126278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5892874|NCT04126278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5892875|NCT04126278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5892876|NCT04074161|Liraglutide|liraglutide|mesh-list
5892877|NCT04074161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5892878|NCT04074161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892879|NCT04074161|Incretins|incretins|mesh-ancestor
5892880|NCT04074161|Hormones|hormones|mesh-ancestor
5892881|NCT04074161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5892882|NCT04042935|Thioctic Acid|thioctic acid|mesh-list
5892883|NCT04042935|Antioxidants|antioxidants|mesh-ancestor
5892884|NCT04042935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892885|NCT04042935|Protective Agents|protective agents|mesh-ancestor
5892886|NCT04042935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892887|NCT04042935|Vitamin B Complex|vitamin b complex|mesh-ancestor
5892888|NCT04042935|Vitamins|vitamins|mesh-ancestor
5892889|NCT04042935|Micronutrients|micronutrients|mesh-ancestor
5729373|NCT03154983|Docetaxel|docetaxel|mesh-list
5729374|NCT03154983|Apatinib|apatinib|mesh-list
5611365|NCT05076617|Alprazolam|alprazolam|mesh-list
5611366|NCT05076617|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5611367|NCT05076617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5611368|NCT05076617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611369|NCT05076617|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5611370|NCT05076617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5611371|NCT05076617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5611372|NCT05076617|GABA Modulators|gaba modulators|mesh-ancestor
5611373|NCT05076617|GABA Agents|gaba agents|mesh-ancestor
5611374|NCT05076617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5611375|NCT05076617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5611376|NCT05073627|Dicloxacillin|dicloxacillin|mesh-list
5611377|NCT05073627|Dabigatran|dabigatran|mesh-list
5611378|NCT05073627|Antithrombins|antithrombins|mesh-ancestor
5611379|NCT05073627|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5611380|NCT05073627|Protease Inhibitors|protease inhibitors|mesh-ancestor
5611381|NCT05073627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5611382|NCT05073627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5611383|NCT05073627|Anticoagulants|anticoagulants|mesh-ancestor
5611384|NCT05073627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5611385|NCT05073627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5729375|NCT03154983|Tegafur|tegafur|mesh-list
5729376|NCT03154983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5729377|NCT03154983|Tubulin Modulators|tubulin modulators|mesh-ancestor
5729378|NCT03154983|Antimitotic Agents|antimitotic agents|mesh-ancestor
5729379|NCT03154983|Mitosis Modulators|mitosis modulators|mesh-ancestor
5729380|NCT03154983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729381|NCT03154983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5729382|NCT03154983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5729383|NCT03154983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5729384|NCT03154983|Antimetabolites|antimetabolites|mesh-ancestor
5729385|NCT03154567|Yohimbine|yohimbine|mesh-list
5729386|NCT03154567|Mydriatics|mydriatics|mesh-ancestor
5729387|NCT03154567|Autonomic Agents|autonomic agents|mesh-ancestor
5729388|NCT03154567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5729389|NCT03154567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729390|NCT03154567|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5729391|NCT03154567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5729392|NCT03154567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5729393|NCT03154567|Adrenergic Agents|adrenergic agents|mesh-ancestor
5729394|NCT03154567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5729395|NCT03154567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729396|NCT03154567|Urological Agents|urological agents|mesh-ancestor
6208095|NCT02124746|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
6208096|NCT02124746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6208097|NCT02124746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6208098|NCT02124746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208099|NCT02124759|Sevelamer|sevelamer|mesh-list
6208100|NCT02124759|Chelating Agents|chelating agents|mesh-ancestor
6208101|NCT02124759|Sequestering Agents|sequestering agents|mesh-ancestor
6208102|NCT02124759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208103|NCT02124772|Trametinib|trametinib|mesh-list
6208104|NCT02124772|Dabrafenib|dabrafenib|mesh-list
6208105|NCT02124772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5729409|NCT03154645|Ibuprofen|ibuprofen|mesh-list
5729410|NCT03154645|Acetazolamide|acetazolamide|mesh-list
5729411|NCT03154645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5729412|NCT03154645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5729413|NCT03154645|Analgesics|analgesics|mesh-ancestor
5729414|NCT03154645|Sensory System Agents|sensory system agents|mesh-ancestor
5729415|NCT03154645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5729416|NCT03154645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729417|NCT03154645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5729418|NCT03154645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5729419|NCT03154645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5729420|NCT03154645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5729421|NCT03154645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729422|NCT03154645|Anticonvulsants|anticonvulsants|mesh-ancestor
5729423|NCT03154645|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5729424|NCT03154645|Diuretics|diuretics|mesh-ancestor
5729425|NCT03154645|Natriuretic Agents|natriuretic agents|mesh-ancestor
5729426|NCT03154385|Rituximab|rituximab|mesh-list
5729427|NCT03154385|Belimumab|belimumab|mesh-list
5729428|NCT03154385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5611386|NCT05072600|Pembrolizumab|pembrolizumab|mesh-list
5611387|NCT05072600|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5611388|NCT05072600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5611389|NCT05072600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5611390|NCT05072600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5611391|NCT05068232|Carboplatin|carboplatin|mesh-list
5611392|NCT05068232|Etoposide|etoposide|mesh-list
5611393|NCT05068232|Durvalumab|durvalumab|mesh-list
5611394|NCT05068232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5611395|NCT05068232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5729429|NCT03154385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5729430|NCT03154385|Immunologic Factors|immunologic factors|mesh-ancestor
5729431|NCT03154385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729432|NCT03154385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5729433|NCT03154385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5729434|NCT03154489|Acenocoumarol|acenocoumarol|mesh-list
5729435|NCT03154489|Anticoagulants|anticoagulants|mesh-ancestor
5729436|NCT03154528|Vitamin D|vitamin d|mesh-list
5729437|NCT03154528|Vitamins|vitamins|mesh-ancestor
5611396|NCT05068232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5611397|NCT05068232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5611398|NCT05068232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5611399|NCT05068232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5611400|NCT05068232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5611401|NCT05067998|Vitamins|vitamins|mesh-list
5611402|NCT05067998|Micronutrients|micronutrients|mesh-ancestor
5611403|NCT05067998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611404|NCT05064488|Metformin|metformin|mesh-list
5611405|NCT05064488|Digoxin|digoxin|mesh-list
5611406|NCT05064488|Sumatriptan|sumatriptan|mesh-list
5611407|NCT05064488|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5611408|NCT05064488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5611409|NCT05064488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611410|NCT05064488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5729438|NCT03154528|Micronutrients|micronutrients|mesh-ancestor
5729439|NCT03154528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729440|NCT03154528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5729441|NCT03154515|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
5729442|NCT03154515|Antiviral Agents|antiviral agents|mesh-ancestor
5729443|NCT03154515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5729444|NCT03154359|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
5729445|NCT03154359|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5729446|NCT03154359|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5729447|NCT03154359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5729448|NCT03154359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729449|NCT03154359|Adrenergic Agents|adrenergic agents|mesh-ancestor
5729450|NCT03154359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5729451|NCT03154359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729452|NCT03154372|Metronidazole|metronidazole|mesh-list
5729453|NCT03154372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5729454|NCT03154372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5729455|NCT03154372|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5729456|NCT03154372|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5729457|NCT03154294|Paclitaxel|paclitaxel|mesh-list
5729458|NCT03154294|Serabelisib|serabelisib|mesh-list
5729459|NCT03154294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5729460|NCT03154294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5729461|NCT03154294|Tubulin Modulators|tubulin modulators|mesh-ancestor
5729462|NCT03154294|Antimitotic Agents|antimitotic agents|mesh-ancestor
5729463|NCT03154294|Mitosis Modulators|mitosis modulators|mesh-ancestor
5729464|NCT03154294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729465|NCT03154294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5729466|NCT03154606|Calcium|calcium|mesh-list
5729467|NCT03154606|Caseins|caseins|mesh-list
5729468|NCT03154606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5729469|NCT03154606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729470|NCT03154606|Chelating Agents|chelating agents|mesh-ancestor
5729471|NCT03154606|Sequestering Agents|sequestering agents|mesh-ancestor
5729472|NCT03154606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729473|NCT03154281|Everolimus|everolimus|mesh-list
5729474|NCT03154281|Niraparib|niraparib|mesh-list
5729475|NCT03154281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5729476|NCT03154281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5729477|NCT03154281|Immunologic Factors|immunologic factors|mesh-ancestor
5729478|NCT03154281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729479|NCT03154281|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5611411|NCT05064488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5611412|NCT05064488|Antimetabolites|antimetabolites|mesh-ancestor
5611413|NCT05064488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5611414|NCT05064488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5611415|NCT05064488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5611416|NCT05064488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5611417|NCT05064488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5611418|NCT05064488|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5611419|NCT05064488|Protective Agents|protective agents|mesh-ancestor
5611420|NCT05064488|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5611421|NCT05064488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5611422|NCT05064488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5611423|NCT05064488|Serotonin Agents|serotonin agents|mesh-ancestor
5611424|NCT05064488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5611425|NCT05061524|Omalizumab|omalizumab|mesh-list
5611426|NCT05061524|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5729480|NCT03154281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5729481|NCT03154281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729482|NCT03154125|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
5729483|NCT03154125|Medroxyprogesterone|medroxyprogesterone|mesh-list
5729484|NCT03154125|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5729485|NCT03154125|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5729486|NCT03154125|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5729487|NCT03154125|Contraceptive Agents|contraceptive agents|mesh-ancestor
5729488|NCT03154125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5611427|NCT05061524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5611428|NCT05061524|Respiratory System Agents|respiratory system agents|mesh-ancestor
5611429|NCT05061017|Cyclophosphamide|cyclophosphamide|mesh-list
5611430|NCT05061017|Nivolumab|nivolumab|mesh-list
5729489|NCT03154125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729490|NCT03154125|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5729491|NCT03154125|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5729492|NCT03154125|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5729493|NCT03154125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5729494|NCT03154125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5729495|NCT03153852|Glycolic acid|glycolic acid|mesh-list
5729496|NCT03153852|Keratolytic Agents|keratolytic agents|mesh-ancestor
5729497|NCT03153852|Dermatologic Agents|dermatologic agents|mesh-ancestor
5729498|NCT03153813|Capsaicin|capsaicin|mesh-list
5729499|NCT03153813|Antipruritics|antipruritics|mesh-ancestor
5729500|NCT03153813|Dermatologic Agents|dermatologic agents|mesh-ancestor
5611431|NCT05061017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5611432|NCT05061017|Immunologic Factors|immunologic factors|mesh-ancestor
5611433|NCT05061017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611434|NCT05061017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5611435|NCT05061017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5611436|NCT05061017|Alkylating Agents|alkylating agents|mesh-ancestor
5611437|NCT05061017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5611438|NCT05061017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5611439|NCT05061017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5611440|NCT05061017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5611441|NCT05061017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5611442|NCT05060627|Dexamethasone|dexamethasone|mesh-list
5611443|NCT05060627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5611444|NCT05060627|Antiemetics|antiemetics|mesh-ancestor
5611445|NCT05060627|Autonomic Agents|autonomic agents|mesh-ancestor
5611446|NCT05060627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5611447|NCT05060627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611448|NCT05060627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5611449|NCT05060627|Glucocorticoids|glucocorticoids|mesh-ancestor
5611450|NCT05060627|Hormones|hormones|mesh-ancestor
5611451|NCT05060627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5611452|NCT05060627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5611453|NCT05060627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5611454|NCT05054140|Calcium|calcium|mesh-list
5611455|NCT05054140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5611456|NCT05054140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611457|NCT05051527|Silymarin|silymarin|mesh-list
5611458|NCT05051527|Antioxidants|antioxidants|mesh-ancestor
5611459|NCT05051527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5611460|NCT05051527|Protective Agents|protective agents|mesh-ancestor
5611461|NCT05051527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611462|NCT05036681|Pembrolizumab|pembrolizumab|mesh-list
5611463|NCT05036681|Futibatinib|futibatinib|mesh-list
5611464|NCT05036681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5611465|NCT05036681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5611466|NCT05031494|Gemcitabine|gemcitabine|mesh-list
5611467|NCT05031494|Paclitaxel|paclitaxel|mesh-list
5611468|NCT05031494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5611469|NCT05031494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5611470|NCT05031494|Tubulin Modulators|tubulin modulators|mesh-ancestor
5611471|NCT05031494|Antimitotic Agents|antimitotic agents|mesh-ancestor
5611472|NCT05031494|Mitosis Modulators|mitosis modulators|mesh-ancestor
5611473|NCT05031494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5611474|NCT05031494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5611475|NCT05031494|Antimetabolites|antimetabolites|mesh-ancestor
5611476|NCT05031494|Antiviral Agents|antiviral agents|mesh-ancestor
5611477|NCT05031494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5611478|NCT05031494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5611479|NCT05031494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5611480|NCT05031494|Immunologic Factors|immunologic factors|mesh-ancestor
5611481|NCT05031494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611482|NCT05029622|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5611483|NCT05029622|Luteolytic Agents|luteolytic agents|mesh-ancestor
5611484|NCT05029622|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5611485|NCT05029622|Contraceptive Agents|contraceptive agents|mesh-ancestor
5611486|NCT05029622|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5611487|NCT05029622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611488|NCT05029622|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5611489|NCT05029622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5611490|NCT05029622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5611491|NCT05027633|Carboplatin|carboplatin|mesh-list
5611492|NCT05027633|Docetaxel|docetaxel|mesh-list
5611493|NCT05027633|Pembrolizumab|pembrolizumab|mesh-list
5611494|NCT05027633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5611495|NCT05027633|Tubulin Modulators|tubulin modulators|mesh-ancestor
5611496|NCT05027633|Antimitotic Agents|antimitotic agents|mesh-ancestor
5611497|NCT05027633|Mitosis Modulators|mitosis modulators|mesh-ancestor
5611498|NCT05027633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5611499|NCT05027633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5611500|NCT05014776|Pembrolizumab|pembrolizumab|mesh-list
5611501|NCT05014776|Ipilimumab|ipilimumab|mesh-list
5611502|NCT05014776|Tadalafil|tadalafil|mesh-list
5611503|NCT05014776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5611504|NCT05014776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5729501|NCT03153813|Sensory System Agents|sensory system agents|mesh-ancestor
5729502|NCT03153813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5729503|NCT03153813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611505|NCT05014776|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5611506|NCT05014776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5611507|NCT05014776|Vasodilator Agents|vasodilator agents|mesh-ancestor
5611508|NCT05014776|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5611509|NCT05014776|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5611510|NCT05014776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5611511|NCT05014776|Urological Agents|urological agents|mesh-ancestor
5611512|NCT05012943|Vaccines|vaccines|mesh-list
5611513|NCT05012943|Immunologic Factors|immunologic factors|mesh-ancestor
5611514|NCT05012943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611515|NCT05008484|Vitamin D|vitamin d|mesh-list
5611516|NCT05008484|Vitamins|vitamins|mesh-ancestor
5611517|NCT05008484|Micronutrients|micronutrients|mesh-ancestor
5611518|NCT05008484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611519|NCT05008484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5611520|NCT05000710|Durvalumab|durvalumab|mesh-list
5611521|NCT05000710|Tremelimumab|tremelimumab|mesh-list
5611522|NCT05000710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5611523|NCT05000710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5729504|NCT03153917|Hydrocortisone|hydrocortisone|mesh-list
5729505|NCT03153917|Melatonin|melatonin|mesh-list
5729506|NCT03153917|Antioxidants|antioxidants|mesh-ancestor
5729507|NCT03153917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729508|NCT03153917|Protective Agents|protective agents|mesh-ancestor
5729509|NCT03153917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729510|NCT03153917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5729511|NCT03153917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5729512|NCT03153657|Piroxicam|piroxicam|mesh-list
5729513|NCT03153657|Piroxicam-beta-cyclodextrin|piroxicam-beta-cyclodextrin|mesh-list
5729514|NCT03153657|Betadex|betadex|mesh-list
5611524|NCT04993677|Carboplatin|carboplatin|mesh-list
5611525|NCT04993677|Pembrolizumab|pembrolizumab|mesh-list
5611526|NCT04993677|Pemetrexed|pemetrexed|mesh-list
5729515|NCT03153657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5729516|NCT03153657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5729517|NCT03153657|Analgesics|analgesics|mesh-ancestor
5729518|NCT03153657|Sensory System Agents|sensory system agents|mesh-ancestor
5729519|NCT03153657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5729520|NCT03153657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729521|NCT03153657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5611527|NCT04993677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5611528|NCT04993677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5611529|NCT04993677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5611530|NCT04993677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5611531|NCT04993677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5611532|NCT04993677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5611533|NCT04987203|Nivolumab|nivolumab|mesh-list
5611534|NCT04987203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5611535|NCT04987203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5611536|NCT04987203|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5611537|NCT04987203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691820|NCT03413722|Everolimus|everolimus|mesh-list
5691821|NCT03413722|Tacrolimus|tacrolimus|mesh-list
5691822|NCT03413722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5691823|NCT03413722|Immunologic Factors|immunologic factors|mesh-ancestor
5691824|NCT03413722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691825|NCT03413722|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5691826|NCT03413722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5691827|NCT03413722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691828|NCT03413722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5691829|NCT03413579|Nimotuzumab|nimotuzumab|mesh-list
5691830|NCT03413579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5691831|NCT03413579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5691832|NCT03413436|Cisplatin|cisplatin|mesh-list
5691833|NCT03413436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5691834|NCT03413410|Metoprolol|metoprolol|mesh-list
5691835|NCT03413410|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5691836|NCT03413410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5691837|NCT03413410|Sympatholytics|sympatholytics|mesh-ancestor
5691838|NCT03413410|Autonomic Agents|autonomic agents|mesh-ancestor
5691839|NCT03413410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5691840|NCT03413410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691841|NCT03413410|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5691842|NCT03413410|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5691843|NCT03413410|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5691844|NCT03413410|Adrenergic Agents|adrenergic agents|mesh-ancestor
5691845|NCT03413410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5691846|NCT03413410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691847|NCT03413384|Ceftriaxone|ceftriaxone|mesh-list
5691848|NCT03413384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5691849|NCT03413384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5691850|NCT03413371|Acetaminophen|acetaminophen|mesh-list
5691851|NCT03413371|Lidocaine|lidocaine|mesh-list
5691852|NCT03413371|Bupivacaine|bupivacaine|mesh-list
5691853|NCT03413371|Ropivacaine|ropivacaine|mesh-list
5691854|NCT03413371|Anesthetics, Local|anesthetics, local|mesh-ancestor
5691855|NCT03413371|Anesthetics|anesthetics|mesh-ancestor
5691856|NCT03413371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5691857|NCT03413371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691858|NCT03413371|Sensory System Agents|sensory system agents|mesh-ancestor
5691859|NCT03413371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5691860|NCT03413371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5691861|NCT03413371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5691862|NCT03413371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5691863|NCT03413371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5691864|NCT03413371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691865|NCT03413371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5691866|NCT03413371|Analgesics|analgesics|mesh-ancestor
5691867|NCT03413371|Antipyretics|antipyretics|mesh-ancestor
5691868|NCT03413358|Carboplatin|carboplatin|mesh-list
5691869|NCT03413358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5691870|NCT03413319|Tilavonemab|tilavonemab|mesh-list
5691871|NCT03413319|Nootropic Agents|nootropic agents|mesh-ancestor
5691872|NCT03413202|3-n-butylphthalide|3-n-butylphthalide|mesh-list
5691873|NCT03413202|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5691874|NCT03413202|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5691875|NCT03413202|Protective Agents|protective agents|mesh-ancestor
5729522|NCT03153657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5729523|NCT03153657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5729524|NCT03153657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5729525|NCT03153657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729526|NCT03153657|Sequestering Agents|sequestering agents|mesh-ancestor
5729527|NCT03153527|Prednisone|prednisone|mesh-list
5729528|NCT03153527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5729529|NCT03153527|Glucocorticoids|glucocorticoids|mesh-ancestor
5729530|NCT03153527|Hormones|hormones|mesh-ancestor
5729531|NCT03153527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5729532|NCT03153527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729533|NCT03153527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5729534|NCT03153527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5729535|NCT03153267|Doxycycline|doxycycline|mesh-list
5729536|NCT03153267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5729537|NCT03153267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5729538|NCT03153267|Antimalarials|antimalarials|mesh-ancestor
5729539|NCT03153267|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5729540|NCT03153267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5729541|NCT03153436|Inositol|inositol|mesh-list
5729542|NCT03153436|Vitamin B Complex|vitamin b complex|mesh-ancestor
5729543|NCT03153436|Vitamins|vitamins|mesh-ancestor
5729544|NCT03153436|Micronutrients|micronutrients|mesh-ancestor
5729545|NCT03153436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729546|NCT03152942|Aminophylline|aminophylline|mesh-list
5729547|NCT03152942|Progesterone|progesterone|mesh-list
5729548|NCT03152942|Progestins|progestins|mesh-ancestor
5729549|NCT03152942|Hormones|hormones|mesh-ancestor
5729550|NCT03152942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5729551|NCT03152942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729552|NCT03152942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5729553|NCT03152942|Autonomic Agents|autonomic agents|mesh-ancestor
5729554|NCT03152942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5611538|NCT04967508|Ustekinumab|ustekinumab|mesh-list
5611539|NCT04967508|Dermatologic Agents|dermatologic agents|mesh-ancestor
5611540|NCT04967248|Fulvestrant|fulvestrant|mesh-list
5611541|NCT04967248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5611542|NCT04967248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5611543|NCT04967248|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5611544|NCT04967248|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5611545|NCT04967248|Hormone Antagonists|hormone antagonists|mesh-ancestor
5611546|NCT04967248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5611547|NCT04967248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611548|NCT04965519|Trastuzumab|trastuzumab|mesh-list
5729555|NCT03152942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5729556|NCT03152942|Respiratory System Agents|respiratory system agents|mesh-ancestor
5729557|NCT03152942|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5729558|NCT03152942|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5729559|NCT03152942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5729560|NCT03152942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729561|NCT03152942|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5729562|NCT03152942|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5729563|NCT03152942|Purinergic Agents|purinergic agents|mesh-ancestor
5729564|NCT03152942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5729565|NCT03152942|Protective Agents|protective agents|mesh-ancestor
5729566|NCT03153072|Amiodarone|amiodarone|mesh-list
5729567|NCT03153072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5729568|NCT03153072|Vasodilator Agents|vasodilator agents|mesh-ancestor
5729569|NCT03153072|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5729570|NCT03153072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5729571|NCT03153072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729572|NCT03153072|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5729573|NCT03153072|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5729574|NCT03153072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5729575|NCT03153072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5729576|NCT03153072|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5729577|NCT03153072|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5729578|NCT03153072|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5611549|NCT04965519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5611550|NCT04965519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5611551|NCT04952389|Budesonide|budesonide|mesh-list
5611552|NCT04952389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5611553|NCT04952389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5611554|NCT04952389|Autonomic Agents|autonomic agents|mesh-ancestor
5611555|NCT04952389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5729579|NCT03152981|Remifentanil|remifentanil|mesh-list
5729580|NCT03152981|Propofol|propofol|mesh-list
5729581|NCT03152981|Desflurane|desflurane|mesh-list
5611556|NCT04952389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611557|NCT04952389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5729582|NCT03152981|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5729583|NCT03152981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5729584|NCT03152981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729585|NCT03152981|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5729586|NCT03152981|Anesthetics, General|anesthetics, general|mesh-ancestor
5729587|NCT03152981|Anesthetics|anesthetics|mesh-ancestor
5729588|NCT03152981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5729589|NCT03152981|Narcotics|narcotics|mesh-ancestor
5729590|NCT03152981|Analgesics|analgesics|mesh-ancestor
5729591|NCT03152981|Sensory System Agents|sensory system agents|mesh-ancestor
5729592|NCT03152981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5729593|NCT03152981|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5729594|NCT03153150|Warfarin|warfarin|mesh-list
5729595|NCT03153150|Rivaroxaban|rivaroxaban|mesh-list
5729596|NCT03153150|Dabigatran|dabigatran|mesh-list
5729597|NCT03153150|Apixaban|apixaban|mesh-list
5729598|NCT03153150|Edoxaban|edoxaban|mesh-list
5729599|NCT03153150|Acenocoumarol|acenocoumarol|mesh-list
5729600|NCT03153150|Phenindione|phenindione|mesh-list
5729601|NCT03153150|Anticoagulants|anticoagulants|mesh-ancestor
5729602|NCT03153150|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5729603|NCT03153150|Antithrombins|antithrombins|mesh-ancestor
5729604|NCT03153150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5729605|NCT03153150|Protease Inhibitors|protease inhibitors|mesh-ancestor
5729606|NCT03153150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5611558|NCT04952389|Respiratory System Agents|respiratory system agents|mesh-ancestor
5611559|NCT04952389|Glucocorticoids|glucocorticoids|mesh-ancestor
5611560|NCT04952389|Hormones|hormones|mesh-ancestor
5611561|NCT04952389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5611562|NCT04943848|Iodine|iodine|mesh-list
5611563|NCT04943848|Vaccines|vaccines|mesh-list
5611564|NCT04943848|Immunologic Factors|immunologic factors|mesh-ancestor
5611565|NCT04943848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611566|NCT04943848|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5611567|NCT04943848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5611568|NCT04943848|Trace Elements|trace elements|mesh-ancestor
5611569|NCT04943848|Micronutrients|micronutrients|mesh-ancestor
5611570|NCT04943549|Bupivacaine|bupivacaine|mesh-list
5611571|NCT04943549|Anesthetics, Local|anesthetics, local|mesh-ancestor
5611572|NCT04943549|Anesthetics|anesthetics|mesh-ancestor
5611573|NCT04943549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5611574|NCT04943549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611575|NCT04943549|Sensory System Agents|sensory system agents|mesh-ancestor
5729607|NCT03153150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892890|NCT04036435|BMS-986165|bms-986165|mesh-list
5892891|NCT04036435|Dermatologic Agents|dermatologic agents|mesh-ancestor
5611576|NCT04943549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5611577|NCT04935229|Nivolumab|nivolumab|mesh-list
5611578|NCT04935229|Ipilimumab|ipilimumab|mesh-list
5611579|NCT04935229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5611580|NCT04935229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5611581|NCT04935229|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5611582|NCT04935229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5611583|NCT04931667|Lorecivivint|lorecivivint|mesh-list
5611584|NCT04931667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5892892|NCT04036435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5892893|NCT04036435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5892894|NCT04036435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892895|NCT04016714|Vaccines|vaccines|mesh-list
5892896|NCT04016714|Immunoglobulins|immunoglobulins|mesh-list
5892897|NCT04016714|Immunologic Factors|immunologic factors|mesh-ancestor
5892898|NCT04016714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611585|NCT04915248|Dexamethasone|dexamethasone|mesh-list
5611586|NCT04915248|Dexamethasone acetate|dexamethasone acetate|mesh-list
5611587|NCT04915248|Bortezomib|bortezomib|mesh-list
5611588|NCT04915248|Daratumumab|daratumumab|mesh-list
5611589|NCT04915248|BB 1101|bb 1101|mesh-list
5611590|NCT04915248|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5892899|NCT04014803|Aspirin|aspirin|mesh-list
5611591|NCT04915248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5611592|NCT04915248|Antiemetics|antiemetics|mesh-ancestor
5611593|NCT04915248|Autonomic Agents|autonomic agents|mesh-ancestor
5892900|NCT04014803|Clopidogrel|clopidogrel|mesh-list
5892901|NCT04014803|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
5892902|NCT04014803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5892903|NCT04014803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5611594|NCT04915248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5611595|NCT04915248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611596|NCT04915248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5611597|NCT04915248|Glucocorticoids|glucocorticoids|mesh-ancestor
5611598|NCT04915248|Hormones|hormones|mesh-ancestor
5611599|NCT04915248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5611600|NCT04915248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5611601|NCT04915248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5611602|NCT04915248|Protease Inhibitors|protease inhibitors|mesh-ancestor
5611603|NCT04915248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5611604|NCT04915248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5611605|NCT04915248|Immunologic Factors|immunologic factors|mesh-ancestor
5611606|NCT04905173|Amyl Nitrite|amyl nitrite|mesh-list
5611607|NCT04905173|Vasodilator Agents|vasodilator agents|mesh-ancestor
5611608|NCT04902131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5611609|NCT04902131|Menotropins|menotropins|mesh-list
5611610|NCT04902131|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5611611|NCT04902131|Fertility Agents|fertility agents|mesh-ancestor
5611612|NCT04902131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5611613|NCT04902131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611614|NCT04896866|Anti-Infective Agents|anti-infective agents|mesh-list
5611615|NCT04896866|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5611616|NCT04893291|Sirolimus|sirolimus|mesh-list
5611617|NCT04893291|Everolimus|everolimus|mesh-list
5729608|NCT03153163|Trastuzumab|trastuzumab|mesh-list
5729609|NCT03153163|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
5729610|NCT03153163|Maytansine|maytansine|mesh-list
5729611|NCT03153163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5729612|NCT03153163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5729613|NCT03153163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5729614|NCT03153163|Tubulin Modulators|tubulin modulators|mesh-ancestor
5729615|NCT03153163|Antimitotic Agents|antimitotic agents|mesh-ancestor
5729616|NCT03153163|Mitosis Modulators|mitosis modulators|mesh-ancestor
5729617|NCT03153163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729618|NCT03153085|Ipilimumab|ipilimumab|mesh-list
5729619|NCT03153085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5729620|NCT03153085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5729621|NCT03153085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5729622|NCT03153085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729623|NCT03153137|Macitentan|macitentan|mesh-list
5729624|NCT03153137|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
5729625|NCT03153137|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5729626|NCT03153137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729627|NCT03153137|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
5729628|NCT03153202|Pembrolizumab|pembrolizumab|mesh-list
5729629|NCT03153202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5729630|NCT03153202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5729631|NCT03153111|Macitentan|macitentan|mesh-list
5729632|NCT03153111|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
5729633|NCT03153111|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5729634|NCT03153111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729635|NCT03153111|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
5729636|NCT03152955|Sufentanil|sufentanil|mesh-list
5729637|NCT03152955|Ketamine|ketamine|mesh-list
5729638|NCT03152955|Ondansetron|ondansetron|mesh-list
5611618|NCT04893291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5611619|NCT04893291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5611620|NCT04893291|Immunologic Factors|immunologic factors|mesh-ancestor
5611621|NCT04893291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611622|NCT04893291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5611623|NCT04893291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5611624|NCT04893291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5611625|NCT04893291|Antifungal Agents|antifungal agents|mesh-ancestor
5611626|NCT04889599|Docetaxel|docetaxel|mesh-list
5611627|NCT04889599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5611628|NCT04889599|Tubulin Modulators|tubulin modulators|mesh-ancestor
5611629|NCT04889599|Antimitotic Agents|antimitotic agents|mesh-ancestor
5611630|NCT04889599|Mitosis Modulators|mitosis modulators|mesh-ancestor
5611631|NCT04889599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5611632|NCT04877587|Gemcitabine|gemcitabine|mesh-list
5611633|NCT04877587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611634|NCT04877587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5611635|NCT04877587|Antimetabolites|antimetabolites|mesh-ancestor
5611636|NCT04877587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729639|NCT03152955|Analgesics|analgesics|mesh-ancestor
5729640|NCT03152955|Sensory System Agents|sensory system agents|mesh-ancestor
5729641|NCT03152955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5729642|NCT03152955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729643|NCT03152955|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5729644|NCT03152955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5729645|NCT03152955|Anesthetics, General|anesthetics, general|mesh-ancestor
5729646|NCT03152955|Anesthetics|anesthetics|mesh-ancestor
5729647|NCT03152955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5729648|NCT03152955|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5729649|NCT03152955|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5729650|NCT03152955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5729651|NCT03152955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729652|NCT03152955|Antiemetics|antiemetics|mesh-ancestor
5611637|NCT04877587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5611638|NCT04877587|Antiviral Agents|antiviral agents|mesh-ancestor
5611639|NCT04877587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5611640|NCT04877587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5611641|NCT04877587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5611642|NCT04877587|Immunologic Factors|immunologic factors|mesh-ancestor
5611643|NCT04875975|Rozanolixizumab|rozanolixizumab|mesh-list
5611644|NCT04875975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5611645|NCT04875975|Immunologic Factors|immunologic factors|mesh-ancestor
5611646|NCT04875975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611647|NCT04851613|Fulvestrant|fulvestrant|mesh-list
5611648|NCT04851613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5611649|NCT04851613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5611650|NCT04851613|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5729653|NCT03152955|Autonomic Agents|autonomic agents|mesh-ancestor
5729654|NCT03152955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5729655|NCT03152955|Antipruritics|antipruritics|mesh-ancestor
5729656|NCT03152955|Dermatologic Agents|dermatologic agents|mesh-ancestor
5729657|NCT03152955|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5729658|NCT03152955|Serotonin Agents|serotonin agents|mesh-ancestor
5729659|NCT03152955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5729660|NCT03152955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5729661|NCT03152955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5729662|NCT03152955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5729663|NCT03152955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5729664|NCT03152955|Narcotics|narcotics|mesh-ancestor
5729665|NCT03152955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5729666|NCT03152903|BCG Vaccine|bcg vaccine|mesh-list
5729667|NCT03152903|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5729668|NCT03152903|Immunologic Factors|immunologic factors|mesh-ancestor
5729669|NCT03152903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729670|NCT03152565|Avelumab|avelumab|mesh-list
5729671|NCT03152565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5729672|NCT03152565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5729673|NCT03152890|Insulin|insulin|mesh-list
5729674|NCT03152890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5729675|NCT03152890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729676|NCT03152578|Capsaicin|capsaicin|mesh-list
5729677|NCT03152578|Antipruritics|antipruritics|mesh-ancestor
5729678|NCT03152578|Dermatologic Agents|dermatologic agents|mesh-ancestor
5729679|NCT03152578|Sensory System Agents|sensory system agents|mesh-ancestor
5611651|NCT04851613|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5611652|NCT04851613|Hormone Antagonists|hormone antagonists|mesh-ancestor
5611653|NCT04851613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5611654|NCT04851613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611655|NCT04842643|Immunoglobulins|immunoglobulins|mesh-list
5611656|NCT04842643|Immunologic Factors|immunologic factors|mesh-ancestor
5611657|NCT04842643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611658|NCT04842422|Imiquimod|imiquimod|mesh-list
5611659|NCT04842422|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5611660|NCT04842422|Immunologic Factors|immunologic factors|mesh-ancestor
5611661|NCT04842422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611662|NCT04842422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5611663|NCT04842422|Interferon Inducers|interferon inducers|mesh-ancestor
5611664|NCT04840641|Efavirenz|efavirenz|mesh-list
5611665|NCT04840641|Floxacillin|floxacillin|mesh-list
5611666|NCT04840641|Losartan|losartan|mesh-list
5611667|NCT04840641|Metoprolol|metoprolol|mesh-list
5611668|NCT04840641|Midazolam|midazolam|mesh-list
5729680|NCT03152578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5729681|NCT03152578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611669|NCT04840641|Caffeine|caffeine|mesh-list
5729682|NCT03152877|Bupivacaine|bupivacaine|mesh-list
5611670|NCT04840641|Omeprazole|omeprazole|mesh-list
5611671|NCT04840641|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5729683|NCT03152877|Anesthetics, Local|anesthetics, local|mesh-ancestor
5729684|NCT03152877|Anesthetics|anesthetics|mesh-ancestor
5729685|NCT03152877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5729686|NCT03152877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729687|NCT03152877|Sensory System Agents|sensory system agents|mesh-ancestor
5729688|NCT03152877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5729689|NCT03152370|Leucovorin|leucovorin|mesh-list
5729690|NCT03152370|Folic Acid|folic acid|mesh-list
5611672|NCT04840641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5611673|NCT04840641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5611674|NCT04840641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611675|NCT04840641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5611676|NCT04840641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5611677|NCT04840641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5611678|NCT04840641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5611679|NCT04840641|Anesthetics, General|anesthetics, general|mesh-ancestor
5611680|NCT04840641|Anesthetics|anesthetics|mesh-ancestor
5611681|NCT04840641|GABA Modulators|gaba modulators|mesh-ancestor
5611682|NCT04840641|GABA Agents|gaba agents|mesh-ancestor
5611683|NCT04840641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5611684|NCT04840641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5611685|NCT04840641|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5611686|NCT04840641|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5611687|NCT04840641|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5729691|NCT03152370|Capecitabine|capecitabine|mesh-list
5729692|NCT03152370|Oxaliplatin|oxaliplatin|mesh-list
5729693|NCT03152370|Levoleucovorin|levoleucovorin|mesh-list
5729694|NCT03152370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5729695|NCT03152370|Antimetabolites|antimetabolites|mesh-ancestor
5729696|NCT03152370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729697|NCT03152370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5611688|NCT04840641|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5611689|NCT04840641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5611690|NCT04840641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5611691|NCT04840641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5611692|NCT04840641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5611693|NCT04840641|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5611694|NCT04840641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5611695|NCT04840641|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5611696|NCT04840641|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5611697|NCT04840641|Purinergic Agents|purinergic agents|mesh-ancestor
5611698|NCT04840641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5611699|NCT04840641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5611700|NCT04840641|Antiviral Agents|antiviral agents|mesh-ancestor
5611701|NCT04840641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5611702|NCT04840641|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5611703|NCT04840641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5729698|NCT03152370|Antidotes|antidotes|mesh-ancestor
5729699|NCT03152370|Protective Agents|protective agents|mesh-ancestor
5729700|NCT03152370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729701|NCT03152370|Vitamin B Complex|vitamin b complex|mesh-ancestor
5729702|NCT03152370|Vitamins|vitamins|mesh-ancestor
5729703|NCT03152370|Micronutrients|micronutrients|mesh-ancestor
5729704|NCT03152370|Hematinics|hematinics|mesh-ancestor
5729705|NCT03152409|Aspirin|aspirin|mesh-list
5729706|NCT03152409|Salicylic Acid|salicylic acid|mesh-list
5729707|NCT03152409|Salicylates|salicylates|mesh-list
5729708|NCT03152409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5729709|NCT03152409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5729710|NCT03152409|Analgesics|analgesics|mesh-ancestor
5729711|NCT03152409|Sensory System Agents|sensory system agents|mesh-ancestor
5729712|NCT03152409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5729713|NCT03152409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729714|NCT03152409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5729715|NCT03152409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5729716|NCT03152409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5729717|NCT03152409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5729718|NCT03152409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729719|NCT03152409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5729720|NCT03152409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5729721|NCT03152409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5729722|NCT03152409|Antipyretics|antipyretics|mesh-ancestor
5729723|NCT03152409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5729724|NCT03152409|Antifungal Agents|antifungal agents|mesh-ancestor
5729725|NCT03152409|Keratolytic Agents|keratolytic agents|mesh-ancestor
5729726|NCT03152409|Dermatologic Agents|dermatologic agents|mesh-ancestor
5611704|NCT04840641|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5729727|NCT03152474|Vitamin A|vitamin a|mesh-list
5729728|NCT03152474|Methylprednisolone|methylprednisolone|mesh-list
5729729|NCT03152474|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5729730|NCT03152474|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5729731|NCT03152474|Prednisolone|prednisolone|mesh-list
5729732|NCT03152474|Prednisolone acetate|prednisolone acetate|mesh-list
5729733|NCT03152474|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5729734|NCT03152474|Prednisolone phosphate|prednisolone phosphate|mesh-list
5611705|NCT04840641|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5611706|NCT04840641|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5611707|NCT04840641|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5611708|NCT04840641|Sympatholytics|sympatholytics|mesh-ancestor
5611709|NCT04840641|Autonomic Agents|autonomic agents|mesh-ancestor
5611710|NCT04840641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5611711|NCT04840641|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5611712|NCT04840641|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5611713|NCT04840641|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5611714|NCT04840641|Adrenergic Agents|adrenergic agents|mesh-ancestor
5611715|NCT04840641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5729735|NCT03152474|Vitamins|vitamins|mesh-ancestor
5729736|NCT03152474|Micronutrients|micronutrients|mesh-ancestor
5729737|NCT03152474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729738|NCT03152474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5729739|NCT03152474|Antiemetics|antiemetics|mesh-ancestor
5729740|NCT03152474|Autonomic Agents|autonomic agents|mesh-ancestor
5729741|NCT03152474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5729742|NCT03152474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5729743|NCT03152474|Glucocorticoids|glucocorticoids|mesh-ancestor
5729744|NCT03152474|Hormones|hormones|mesh-ancestor
5729745|NCT03152474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5729746|NCT03152474|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5729747|NCT03152474|Protective Agents|protective agents|mesh-ancestor
5729748|NCT03152474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5729749|NCT03152474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5729750|NCT03152318|Cyclophosphamide|cyclophosphamide|mesh-list
5729751|NCT03152318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5729752|NCT03152318|Immunologic Factors|immunologic factors|mesh-ancestor
5729753|NCT03152318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729754|NCT03152318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5729755|NCT03152318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5729756|NCT03152318|Alkylating Agents|alkylating agents|mesh-ancestor
5729757|NCT03152318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729758|NCT03152318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5729759|NCT03152318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5729760|NCT03152175|Propranolol|propranolol|mesh-list
5729761|NCT03152175|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5729762|NCT03152175|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5729763|NCT03152175|Adrenergic Agents|adrenergic agents|mesh-ancestor
5729764|NCT03152175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5729765|NCT03152175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729766|NCT03152175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729767|NCT03152175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5729768|NCT03152175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5729769|NCT03152175|Vasodilator Agents|vasodilator agents|mesh-ancestor
5729770|NCT03152097|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
5729771|NCT03152097|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5729772|NCT03152097|Protective Agents|protective agents|mesh-ancestor
5729773|NCT03152097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729774|NCT03152097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5729775|NCT03152058|Certolizumab Pegol|certolizumab pegol|mesh-list
5729776|NCT03152058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5729777|NCT03152058|Immunologic Factors|immunologic factors|mesh-ancestor
5729778|NCT03152058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729779|NCT03152058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5729780|NCT03152149|Fluticasone|fluticasone|mesh-list
5729781|NCT03152149|Xhance|xhance|mesh-list
5729782|NCT03152149|Tiotropium Bromide|tiotropium bromide|mesh-list
5729783|NCT03152149|Olodaterol|olodaterol|mesh-list
5729784|NCT03152149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5729785|NCT03152149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5729786|NCT03152149|Autonomic Agents|autonomic agents|mesh-ancestor
5729787|NCT03152149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5729788|NCT03152149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729789|NCT03152149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5729790|NCT03152149|Respiratory System Agents|respiratory system agents|mesh-ancestor
5729791|NCT03152149|Dermatologic Agents|dermatologic agents|mesh-ancestor
5729792|NCT03152149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5729793|NCT03152149|Parasympatholytics|parasympatholytics|mesh-ancestor
5611716|NCT04838223|Proxymetacaine|proxymetacaine|mesh-list
5611717|NCT04838223|Anesthetics, Local|anesthetics, local|mesh-ancestor
5611718|NCT04838223|Anesthetics|anesthetics|mesh-ancestor
5611719|NCT04838223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5611720|NCT04838223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611721|NCT04838223|Sensory System Agents|sensory system agents|mesh-ancestor
5611722|NCT04838223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5611723|NCT04827992|Analgesics, Opioid|analgesics, opioid|mesh-list
5611724|NCT04827992|Narcotics|narcotics|mesh-ancestor
5611725|NCT04827992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5611726|NCT04827992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611727|NCT04827992|Analgesics|analgesics|mesh-ancestor
5611728|NCT04827992|Sensory System Agents|sensory system agents|mesh-ancestor
5611729|NCT04827992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5691876|NCT03413202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691877|NCT03413150|Amiodarone|amiodarone|mesh-list
5691878|NCT03413150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5691879|NCT03413150|Vasodilator Agents|vasodilator agents|mesh-ancestor
5691880|NCT03413150|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5691881|NCT03413150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5691882|NCT03413150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691883|NCT03413150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5691884|NCT03413150|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5691885|NCT03413150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5691886|NCT03413150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5691887|NCT03413150|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5691888|NCT03413150|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5691889|NCT03413150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5697602|NCT03374774|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
5697603|NCT03374774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5697604|NCT03374774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697605|NCT03374722|Analgesics, Opioid|analgesics, opioid|mesh-list
5697606|NCT03374722|Narcotics|narcotics|mesh-ancestor
5697607|NCT03374722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5697608|NCT03374722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697609|NCT03374722|Analgesics|analgesics|mesh-ancestor
5697610|NCT03374722|Sensory System Agents|sensory system agents|mesh-ancestor
5697611|NCT03374722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5697612|NCT03374709|Oxcarbazepine|oxcarbazepine|mesh-list
5729794|NCT03152149|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5729795|NCT03152149|Cholinergic Agents|cholinergic agents|mesh-ancestor
5729796|NCT03152149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5729797|NCT03152149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729798|NCT03152123|Phentermine|phentermine|mesh-list
5729799|NCT03152123|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5729800|NCT03152123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729801|NCT03152123|Appetite Depressants|appetite depressants|mesh-ancestor
5729802|NCT03152123|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5729803|NCT03152123|Sympathomimetics|sympathomimetics|mesh-ancestor
5729804|NCT03152123|Autonomic Agents|autonomic agents|mesh-ancestor
5729805|NCT03152123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5729806|NCT03152123|Adrenergic Agents|adrenergic agents|mesh-ancestor
5729807|NCT03152123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5729808|NCT03152123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729809|NCT03151863|Dexmedetomidine|dexmedetomidine|mesh-list
5729810|NCT03151863|Analgesics, Opioid|analgesics, opioid|mesh-list
5729811|NCT03151863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5729812|NCT03151863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5729813|NCT03151863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729814|NCT03151863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5729815|NCT03151863|Analgesics|analgesics|mesh-ancestor
5729816|NCT03151863|Sensory System Agents|sensory system agents|mesh-ancestor
5729817|NCT03151863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5729818|NCT03151863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5729819|NCT03151863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5729820|NCT03151863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5729821|NCT03151863|Adrenergic Agents|adrenergic agents|mesh-ancestor
5729822|NCT03151863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5729823|NCT03151863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729824|NCT03151863|Narcotics|narcotics|mesh-ancestor
5729825|NCT03151993|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5729826|NCT03151993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5729827|NCT03151993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5729828|NCT03151993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729829|NCT03151772|Metformin|metformin|mesh-list
5729830|NCT03151772|Disulfiram|disulfiram|mesh-list
5729831|NCT03151772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5729832|NCT03151772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729833|NCT03151772|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5729834|NCT03151772|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
5729835|NCT03151772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5729836|NCT03151772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729837|NCT03151876|Gemcitabine|gemcitabine|mesh-list
5729838|NCT03151876|Busulfan|busulfan|mesh-list
5729839|NCT03151876|Cladribine|cladribine|mesh-list
5729840|NCT03151876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5729841|NCT03151876|Antimetabolites|antimetabolites|mesh-ancestor
5729842|NCT03151876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5611730|NCT04808843|Dienogest|dienogest|mesh-list
5611731|NCT04808843|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5611732|NCT04808843|Contraceptive Agents|contraceptive agents|mesh-ancestor
5611733|NCT04808843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5611734|NCT04808843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611735|NCT04808843|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5611736|NCT04808843|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5611737|NCT04808843|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5611738|NCT04808843|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5611739|NCT04808843|Hormone Antagonists|hormone antagonists|mesh-ancestor
5611740|NCT04808843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5611741|NCT04808843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5611742|NCT04808843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5611743|NCT04803877|Nivolumab|nivolumab|mesh-list
5611744|NCT04803877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5611745|NCT04803877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5611746|NCT04803877|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5691890|NCT03413059|Triamcinolone|triamcinolone|mesh-list
5729843|NCT03151876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5729844|NCT03151876|Antiviral Agents|antiviral agents|mesh-ancestor
5729845|NCT03151876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5729846|NCT03151876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5729847|NCT03151876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5729848|NCT03151876|Immunologic Factors|immunologic factors|mesh-ancestor
5729849|NCT03151876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729850|NCT03151876|Alkylating Agents|alkylating agents|mesh-ancestor
5729851|NCT03151876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5729852|NCT03151876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5729853|NCT03151720|Loratadine|loratadine|mesh-list
5729854|NCT03151720|Antipruritics|antipruritics|mesh-ancestor
6672707|NCT01557764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672708|NCT01557816|Naproxen|naproxen|mesh-list
5729855|NCT03151720|Dermatologic Agents|dermatologic agents|mesh-ancestor
5729856|NCT03151720|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5729857|NCT03151720|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5729858|NCT03151720|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5729859|NCT03151720|Histamine Antagonists|histamine antagonists|mesh-ancestor
5729860|NCT03151720|Histamine Agents|histamine agents|mesh-ancestor
5729861|NCT03151720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5729862|NCT03151720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729863|NCT03151720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729864|NCT03151681|Propranolol|propranolol|mesh-list
5729865|NCT03151681|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5729866|NCT03151681|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5729867|NCT03151681|Adrenergic Agents|adrenergic agents|mesh-ancestor
5729868|NCT03151681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5729869|NCT03151681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729870|NCT03151681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729871|NCT03151681|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5729872|NCT03151681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5729873|NCT03151681|Vasodilator Agents|vasodilator agents|mesh-ancestor
5729874|NCT03151707|Niacinamide|niacinamide|mesh-list
5729875|NCT03151707|Niacin|niacin|mesh-list
5729876|NCT03151707|Nicotinic Acids|nicotinic acids|mesh-list
5729877|NCT03151707|Vitamin B Complex|vitamin b complex|mesh-ancestor
5729878|NCT03151707|Vitamins|vitamins|mesh-ancestor
5729879|NCT03151707|Micronutrients|micronutrients|mesh-ancestor
6489120|NCT00589316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6489121|NCT00589316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5611747|NCT04803877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729880|NCT03151707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729881|NCT03151707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5729882|NCT03151707|Antimetabolites|antimetabolites|mesh-ancestor
5729883|NCT03151707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729884|NCT03151707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5729885|NCT03151707|Vasodilator Agents|vasodilator agents|mesh-ancestor
5892904|NCT04014803|Analgesics|analgesics|mesh-ancestor
5892905|NCT04014803|Sensory System Agents|sensory system agents|mesh-ancestor
5892906|NCT04014803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5892907|NCT04014803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611748|NCT04802863|Imipenem|imipenem|mesh-list
5611749|NCT04802863|Cilastatin|cilastatin|mesh-list
5611750|NCT04802863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5611751|NCT04802863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5611752|NCT04802863|Protease Inhibitors|protease inhibitors|mesh-ancestor
5611753|NCT04802863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5611754|NCT04802863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5611755|NCT04802746|Alprazolam|alprazolam|mesh-list
5611756|NCT04802746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5611757|NCT04802746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5611758|NCT04802746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611759|NCT04802746|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5611760|NCT04802746|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5611761|NCT04802746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5611762|NCT04802746|GABA Modulators|gaba modulators|mesh-ancestor
5611763|NCT04802746|GABA Agents|gaba agents|mesh-ancestor
5611764|NCT04802746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5611765|NCT04802746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5611766|NCT04801043|Imipenem|imipenem|mesh-list
5611767|NCT04801043|Cilastatin|cilastatin|mesh-list
5892908|NCT04014803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5892909|NCT04014803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5892910|NCT04014803|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5892911|NCT04014803|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5892912|NCT04014803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892913|NCT04014803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5892914|NCT04014803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5892915|NCT04014803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5892916|NCT04014803|Antipyretics|antipyretics|mesh-ancestor
5611768|NCT04801043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5611769|NCT04801043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5611770|NCT04801043|Protease Inhibitors|protease inhibitors|mesh-ancestor
5611771|NCT04801043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5611772|NCT04801043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892917|NCT04014803|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5611773|NCT04794569|Tinzaparin|tinzaparin|mesh-list
5892918|NCT04014803|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5729886|NCT03151668|Dexmedetomidine|dexmedetomidine|mesh-list
5729887|NCT03151668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5729888|NCT03151668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5611774|NCT04794569|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5611775|NCT04794569|Dalteparin|dalteparin|mesh-list
5611776|NCT04794569|Rivaroxaban|rivaroxaban|mesh-list
5611777|NCT04794569|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5611778|NCT04794569|Antithrombins|antithrombins|mesh-ancestor
5611779|NCT04794569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5611780|NCT04794569|Protease Inhibitors|protease inhibitors|mesh-ancestor
5611781|NCT04794569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5611782|NCT04794569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5611783|NCT04794569|Anticoagulants|anticoagulants|mesh-ancestor
5611784|NCT04794569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5611785|NCT04794569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5611786|NCT04791176|Lenvatinib|lenvatinib|mesh-list
5611787|NCT04791176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5611788|NCT04791176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5611789|NCT04791176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5611790|NCT04791176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5611791|NCT04787562|Imipenem|imipenem|mesh-list
5611792|NCT04787562|Cilastatin|cilastatin|mesh-list
5611793|NCT04787562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5611794|NCT04787562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5611795|NCT04787562|Protease Inhibitors|protease inhibitors|mesh-ancestor
5611796|NCT04787562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5729889|NCT03151668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729890|NCT03151668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5729891|NCT03151668|Analgesics|analgesics|mesh-ancestor
5729892|NCT03151668|Sensory System Agents|sensory system agents|mesh-ancestor
5611797|NCT04787562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5611798|NCT04786756|Bupivacaine|bupivacaine|mesh-list
5611799|NCT04786756|Anesthetics, Local|anesthetics, local|mesh-ancestor
5729893|NCT03151668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5729894|NCT03151668|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5729895|NCT03151668|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5729896|NCT03151668|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5729897|NCT03151668|Adrenergic Agents|adrenergic agents|mesh-ancestor
5729898|NCT03151668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5729899|NCT03151668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729900|NCT03151525|Azathioprine|azathioprine|mesh-list
5729901|NCT03151525|Infliximab|infliximab|mesh-list
5729902|NCT03151525|Dermatologic Agents|dermatologic agents|mesh-ancestor
5729903|NCT03151525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5729904|NCT03151525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5729905|NCT03151525|Antimetabolites|antimetabolites|mesh-ancestor
5729906|NCT03151525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729907|NCT03151525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5729908|NCT03151525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5729909|NCT03151525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5729910|NCT03151525|Immunologic Factors|immunologic factors|mesh-ancestor
5729911|NCT03151525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729912|NCT03151499|Rifampin|rifampin|mesh-list
5729913|NCT03151499|BI 409306|bi 409306|mesh-list
5729914|NCT03151499|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5729915|NCT03151499|Antitubercular Agents|antitubercular agents|mesh-ancestor
5729916|NCT03151499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5729917|NCT03151499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5729918|NCT03151499|Leprostatic Agents|leprostatic agents|mesh-ancestor
5729919|NCT03151499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5611800|NCT04786756|Anesthetics|anesthetics|mesh-ancestor
5729920|NCT03151499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5729921|NCT03151499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729922|NCT03151499|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5729923|NCT03151499|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5729924|NCT03151499|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5729925|NCT03151499|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5729926|NCT03151499|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5729927|NCT03151499|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5729928|NCT03151499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5729929|NCT03151408|Azacitidine|azacitidine|mesh-list
5729930|NCT03151408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5611801|NCT04786756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5611802|NCT04786756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729931|NCT03151408|Antimetabolites|antimetabolites|mesh-ancestor
5729932|NCT03151408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729933|NCT03151408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5729934|NCT03151408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5729935|NCT03151616|Cholinergic Antagonists|cholinergic antagonists|mesh-list
5729936|NCT03151616|Cholinergic Agents|cholinergic agents|mesh-ancestor
5729937|NCT03151616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5729938|NCT03151616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729939|NCT03151616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729940|NCT03151460|Dopamine|dopamine|mesh-list
5729941|NCT03151460|Dopamine Agents|dopamine agents|mesh-list
5729942|NCT03151460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5729943|NCT03151460|Sympathomimetics|sympathomimetics|mesh-ancestor
5729944|NCT03151460|Autonomic Agents|autonomic agents|mesh-ancestor
5729945|NCT03151460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5729946|NCT03151460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729947|NCT03151460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5729948|NCT03151460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729949|NCT03151460|Protective Agents|protective agents|mesh-ancestor
5729950|NCT03151486|JNJ-55308942|jnj-55308942|mesh-list
5729951|NCT03151486|Purinergic P2X Receptor Antagonists|purinergic p2x receptor antagonists|mesh-ancestor
5729952|NCT03151486|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5729953|NCT03151486|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5729954|NCT03151486|Purinergic Agents|purinergic agents|mesh-ancestor
5729955|NCT03151486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5729956|NCT03151486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729957|NCT03151486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729958|NCT03151603|Fosfomycin|fosfomycin|mesh-list
5611803|NCT04786756|Sensory System Agents|sensory system agents|mesh-ancestor
5611804|NCT04786756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5611805|NCT04785300|Dasatinib|dasatinib|mesh-list
5611806|NCT04785300|Quercetin|quercetin|mesh-list
5611807|NCT04785300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5611808|NCT04785300|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5611809|NCT04785300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5611810|NCT04785300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5611811|NCT04785300|Antioxidants|antioxidants|mesh-ancestor
5611812|NCT04785300|Protective Agents|protective agents|mesh-ancestor
5611813|NCT04785300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611814|NCT04784715|Trastuzumab|trastuzumab|mesh-list
5611815|NCT04784715|Pertuzumab|pertuzumab|mesh-list
5611816|NCT04784715|Taxane|taxane|mesh-list
5611817|NCT04784715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5611818|NCT04784715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5611819|NCT04782791|Nivolumab|nivolumab|mesh-list
5611820|NCT04782791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5611821|NCT04782791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5729959|NCT03151603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5729960|NCT03151603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5729961|NCT03151343|Empagliflozin|empagliflozin|mesh-list
5729962|NCT03151343|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5729963|NCT03151343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729964|NCT03151343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5729965|NCT03151343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729966|NCT03151304|Azacitidine|azacitidine|mesh-list
5729967|NCT03151304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5729968|NCT03151304|Antimetabolites|antimetabolites|mesh-ancestor
5729969|NCT03151304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729970|NCT03151304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5729971|NCT03151304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5729972|NCT03151369|Morphine|morphine|mesh-list
5729973|NCT03151369|Analgesics|analgesics|mesh-list
5729974|NCT03151369|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5729975|NCT03151369|Narcotics|narcotics|mesh-ancestor
5729976|NCT03151369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5729977|NCT03151369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729978|NCT03151369|Sensory System Agents|sensory system agents|mesh-ancestor
5729979|NCT03151369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5729980|NCT03151213|Pregabalin|pregabalin|mesh-list
5729981|NCT03151213|Analgesics|analgesics|mesh-ancestor
5729982|NCT03151213|Sensory System Agents|sensory system agents|mesh-ancestor
5729983|NCT03151213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5611822|NCT04782791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5611823|NCT04782791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5611824|NCT04780698|Immunoglobulin G|immunoglobulin g|mesh-list
5611825|NCT04780698|Immunologic Factors|immunologic factors|mesh-ancestor
5611826|NCT04780698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611827|NCT04777643|Cannabidiol|cannabidiol|mesh-list
5611828|NCT04777643|Anticonvulsants|anticonvulsants|mesh-ancestor
5611829|NCT04776018|Daratumumab|daratumumab|mesh-list
5611830|NCT04776018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5611831|NCT04768426|Capecitabine|capecitabine|mesh-list
5611832|NCT04768426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5611833|NCT04768426|Antimetabolites|antimetabolites|mesh-ancestor
5611834|NCT04768426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5611835|NCT04768426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5611836|NCT04766086|Vaccines|vaccines|mesh-list
5611837|NCT04766086|Immunologic Factors|immunologic factors|mesh-ancestor
5611838|NCT04766086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611839|NCT04762836|Cycloserine|cycloserine|mesh-list
5611840|NCT04762836|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5611841|NCT04762836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5611842|NCT04762836|Renal Agents|renal agents|mesh-ancestor
5611843|NCT04762836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5611844|NCT04762836|Antitubercular Agents|antitubercular agents|mesh-ancestor
5611845|NCT04762836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5611846|NCT04762836|Antimetabolites|antimetabolites|mesh-ancestor
5611847|NCT04762836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5611848|NCT04758949|Nivolumab|nivolumab|mesh-list
5611849|NCT04758949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5611850|NCT04758949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5611851|NCT04758949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5611852|NCT04758949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5611853|NCT04750395|Haloperidol|haloperidol|mesh-list
5611854|NCT04750395|Olanzapine|olanzapine|mesh-list
5611855|NCT04750395|Haloperidol decanoate|haloperidol decanoate|mesh-list
5611856|NCT04750395|Antiemetics|antiemetics|mesh-ancestor
5611857|NCT04750395|Autonomic Agents|autonomic agents|mesh-ancestor
5611858|NCT04750395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5611859|NCT04750395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611860|NCT04750395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5611861|NCT04750395|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5611862|NCT04750395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5611863|NCT04750395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5611864|NCT04750395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5611865|NCT04750395|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5611866|NCT04750395|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5729984|NCT03151213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5729985|NCT03151213|Anticonvulsants|anticonvulsants|mesh-ancestor
5729986|NCT03151213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5729987|NCT03151213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5729988|NCT03151213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729989|NCT03151213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5729990|NCT03151213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5729991|NCT03151213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5729992|NCT03151213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5729993|NCT03151213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5729994|NCT03151382|Tandospirone|tandospirone|mesh-list
5729995|NCT03151382|Donepezil|donepezil|mesh-list
5729996|NCT03151382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5729997|NCT03151382|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5729998|NCT03151382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5729999|NCT03151382|Cholinergic Agents|cholinergic agents|mesh-ancestor
5730000|NCT03151382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5730001|NCT03151382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730002|NCT03151382|Nootropic Agents|nootropic agents|mesh-ancestor
5730003|NCT03151382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5730004|NCT03151382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5730005|NCT03151382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5730006|NCT03151382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5730007|NCT03151382|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5730008|NCT03151382|Serotonin Agents|serotonin agents|mesh-ancestor
5730009|NCT03151174|Vitamin D|vitamin d|mesh-list
5730010|NCT03151174|Ergocalciferols|ergocalciferols|mesh-list
5730011|NCT03151174|Vitamins|vitamins|mesh-list
5730012|NCT03151174|Micronutrients|micronutrients|mesh-ancestor
5730013|NCT03151174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611867|NCT04750395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5697613|NCT03374709|Anticonvulsants|anticonvulsants|mesh-ancestor
5730014|NCT03151174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5611868|NCT04750395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5611869|NCT04750395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5611870|NCT04750395|Serotonin Agents|serotonin agents|mesh-ancestor
5611871|NCT04750395|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5611872|NCT04750395|Dopamine Agents|dopamine agents|mesh-ancestor
5611873|NCT04750395|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5611874|NCT04743661|Antipyretics|antipyretics|mesh-list
5611875|NCT04743661|Dexamethasone|dexamethasone|mesh-list
5611876|NCT04743661|Bevacizumab|bevacizumab|mesh-list
5611877|NCT04743661|Irinotecan|irinotecan|mesh-list
5611878|NCT04743661|Temozolomide|temozolomide|mesh-list
5611879|NCT04743661|Antiemetics|antiemetics|mesh-list
5611880|NCT04743661|Emetics|emetics|mesh-list
5611881|NCT04743661|Histamine Antagonists|histamine antagonists|mesh-list
5611882|NCT04743661|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
5611883|NCT04743661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5611884|NCT04743661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5611885|NCT04743661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5611886|NCT04743661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5611887|NCT04743661|Growth Substances|growth substances|mesh-ancestor
5611888|NCT04743661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611889|NCT04743661|Growth Inhibitors|growth inhibitors|mesh-ancestor
5611890|NCT04743661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5611891|NCT04743661|Autonomic Agents|autonomic agents|mesh-ancestor
5611892|NCT04743661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5611893|NCT04743661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5611894|NCT04743661|Glucocorticoids|glucocorticoids|mesh-ancestor
5611895|NCT04743661|Hormones|hormones|mesh-ancestor
5611896|NCT04743661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5611897|NCT04743661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5611898|NCT04743661|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5611899|NCT04743661|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5611900|NCT04743661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5611901|NCT04743661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5611902|NCT04743661|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5611903|NCT04743661|Alkylating Agents|alkylating agents|mesh-ancestor
5611904|NCT04743661|Histamine Agents|histamine agents|mesh-ancestor
5611905|NCT04743661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5611906|NCT04739735|Anesthetics|anesthetics|mesh-list
5730015|NCT03151174|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5730016|NCT03151044|Rituximab|rituximab|mesh-list
5730017|NCT03151044|Epirubicin|epirubicin|mesh-list
5730018|NCT03151044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5730019|NCT03151044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5730020|NCT03151044|Immunologic Factors|immunologic factors|mesh-ancestor
5730021|NCT03151044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730022|NCT03151044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5730023|NCT03151044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5730024|NCT03151044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5730025|NCT03151044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5730026|NCT03151044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5730027|NCT03151044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5730028|NCT03151161|Carboplatin|carboplatin|mesh-list
5730029|NCT03151161|Pemetrexed|pemetrexed|mesh-list
5730030|NCT03151161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5730031|NCT03151161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5730032|NCT03151161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5730033|NCT03151161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5730034|NCT03151161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5730035|NCT03151096|Riboflavin|riboflavin|mesh-list
5730036|NCT03151096|Vitamin B Complex|vitamin b complex|mesh-ancestor
5730037|NCT03151096|Vitamins|vitamins|mesh-ancestor
5730038|NCT03151096|Micronutrients|micronutrients|mesh-ancestor
5730039|NCT03151096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730040|NCT03151096|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5730041|NCT03151096|Dermatologic Agents|dermatologic agents|mesh-ancestor
5730042|NCT03151005|Metformin|metformin|mesh-list
5730043|NCT03151005|Liraglutide|liraglutide|mesh-list
5730044|NCT03151005|Exenatide|exenatide|mesh-list
5730045|NCT03151005|Contraceptive Agents|contraceptive agents|mesh-list
5611907|NCT04739735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5730046|NCT03151005|Contraceptives, Oral|contraceptives, oral|mesh-list
5730047|NCT03151005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5611908|NCT04739735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611909|NCT04735965|Meperidine|meperidine|mesh-list
5611910|NCT04735965|Dexmedetomidine|dexmedetomidine|mesh-list
5730048|NCT03151005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730049|NCT03151005|Incretins|incretins|mesh-ancestor
5730050|NCT03151005|Hormones|hormones|mesh-ancestor
5730051|NCT03151005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5730052|NCT03151005|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5611911|NCT04735965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5611912|NCT04735965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5611913|NCT04735965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611914|NCT04735965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5611915|NCT04735965|Analgesics|analgesics|mesh-ancestor
5611916|NCT04735965|Sensory System Agents|sensory system agents|mesh-ancestor
5611917|NCT04735965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5611918|NCT04735965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5611919|NCT04735965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5611920|NCT04735965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5611921|NCT04735965|Adrenergic Agents|adrenergic agents|mesh-ancestor
5611922|NCT04735965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5730053|NCT03151005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5730054|NCT03151005|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5730055|NCT03151239|Niacinamide|niacinamide|mesh-list
5730056|NCT03151239|Vitamin B Complex|vitamin b complex|mesh-ancestor
5730057|NCT03151239|Vitamins|vitamins|mesh-ancestor
5730058|NCT03151239|Micronutrients|micronutrients|mesh-ancestor
5730059|NCT03151239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611923|NCT04735965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5611924|NCT04735965|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5611925|NCT04735965|Narcotics|narcotics|mesh-ancestor
5611926|NCT04735965|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5730060|NCT03150810|Temozolomide|temozolomide|mesh-list
5730061|NCT03150810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5730062|NCT03150810|Alkylating Agents|alkylating agents|mesh-ancestor
5730063|NCT03150810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5730064|NCT03150810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5730065|NCT03150680|Clopidogrel|clopidogrel|mesh-list
5730066|NCT03150680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5730067|NCT03150680|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5730068|NCT03150680|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5730069|NCT03150680|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5730070|NCT03150680|Purinergic Agents|purinergic agents|mesh-ancestor
5730071|NCT03150680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5611927|NCT04734535|Thrombin|thrombin|mesh-list
5611928|NCT04734535|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
5611929|NCT04734535|Hemostatics|hemostatics|mesh-ancestor
5611930|NCT04734535|Coagulants|coagulants|mesh-ancestor
5611931|NCT04734379|Fasudil|fasudil|mesh-list
5611932|NCT04734379|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5611933|NCT04734379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5611934|NCT04734379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5611935|NCT04734379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5611936|NCT04734379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611937|NCT04734379|Vasodilator Agents|vasodilator agents|mesh-ancestor
5611938|NCT04734379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5611939|NCT04734379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5611940|NCT04734197|Cyclosporine|cyclosporine|mesh-list
5611941|NCT04734197|Mycophenolic Acid|mycophenolic acid|mesh-list
5611942|NCT04734197|Betamethasone|betamethasone|mesh-list
5611943|NCT04734197|Betamethasone Valerate|betamethasone valerate|mesh-list
5611944|NCT04734197|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5611945|NCT04734197|Betamethasone benzoate|betamethasone benzoate|mesh-list
5611946|NCT04734197|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5611947|NCT04734197|Lifitegrast|lifitegrast|mesh-list
5730072|NCT03150680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5730073|NCT03150680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730082|NCT03150706|Avelumab|avelumab|mesh-list
5730083|NCT03150706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5730084|NCT03150706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5611948|NCT04734197|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5611949|NCT04734197|Cyclosporins|cyclosporins|mesh-list
5730085|NCT03150771|Aripiprazole|aripiprazole|mesh-list
5730086|NCT03150771|Antidepressive Agents|antidepressive agents|mesh-ancestor
5730087|NCT03150771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5730088|NCT03150771|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5730089|NCT03150771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5730090|NCT03150771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5730091|NCT03150771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730092|NCT03150771|Dopamine Agonists|dopamine agonists|mesh-ancestor
5730093|NCT03150771|Dopamine Agents|dopamine agents|mesh-ancestor
5730094|NCT03150771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5730095|NCT03150771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672709|NCT01557816|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6672710|NCT01557816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6672711|NCT01557816|Analgesics|analgesics|mesh-ancestor
6672712|NCT01557816|Sensory System Agents|sensory system agents|mesh-ancestor
6672713|NCT01557816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5611950|NCT04734197|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
5611951|NCT04734197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5611952|NCT04734197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5611953|NCT04734197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5611954|NCT04734197|Immunologic Factors|immunologic factors|mesh-ancestor
5611955|NCT04734197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611956|NCT04734197|Antifungal Agents|antifungal agents|mesh-ancestor
5611957|NCT04734197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5611958|NCT04734197|Dermatologic Agents|dermatologic agents|mesh-ancestor
5611959|NCT04734197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5611960|NCT04734197|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5611961|NCT04734197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5611962|NCT04734197|Glucocorticoids|glucocorticoids|mesh-ancestor
5611963|NCT04734197|Hormones|hormones|mesh-ancestor
5611964|NCT04734197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5611965|NCT04734197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5611966|NCT04734197|Respiratory System Agents|respiratory system agents|mesh-ancestor
5611967|NCT04734197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5611968|NCT04734197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5611969|NCT04734197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5611970|NCT04734197|Antitubercular Agents|antitubercular agents|mesh-ancestor
5611971|NCT04734197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5611972|NCT04731272|Dulaglutide|dulaglutide|mesh-list
5611973|NCT04731272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5611974|NCT04731272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5611975|NCT04730037|Warfarin|warfarin|mesh-list
5611976|NCT04730037|Edoxaban|edoxaban|mesh-list
5611977|NCT04730037|Anticoagulants|anticoagulants|mesh-ancestor
5611978|NCT04730037|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6672714|NCT01557816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672715|NCT01557816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6672716|NCT01557816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6672717|NCT01557816|Gout Suppressants|gout suppressants|mesh-ancestor
6672718|NCT01557816|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6672719|NCT01557816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5611979|NCT04730037|Antithrombins|antithrombins|mesh-ancestor
5730096|NCT03150771|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5730097|NCT03150771|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5730098|NCT03150771|Serotonin Agents|serotonin agents|mesh-ancestor
5730099|NCT03150771|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5730100|NCT03150771|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5730101|NCT03150771|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5730102|NCT03150771|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5730103|NCT03150576|Paclitaxel|paclitaxel|mesh-list
5730104|NCT03150576|Carboplatin|carboplatin|mesh-list
5611980|NCT04730037|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5611981|NCT04730037|Protease Inhibitors|protease inhibitors|mesh-ancestor
5611982|NCT04730037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5611983|NCT04730037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5611984|NCT04714190|Paclitaxel|paclitaxel|mesh-list
5611985|NCT04714190|Irinotecan|irinotecan|mesh-list
5730105|NCT03150576|Olaparib|olaparib|mesh-list
5730106|NCT03150576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5730107|NCT03150576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5730108|NCT03150576|Tubulin Modulators|tubulin modulators|mesh-ancestor
5730109|NCT03150576|Antimitotic Agents|antimitotic agents|mesh-ancestor
5730110|NCT03150576|Mitosis Modulators|mitosis modulators|mesh-ancestor
5730111|NCT03150576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672720|NCT01557816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5611986|NCT04714190|Apatinib|apatinib|mesh-list
5611987|NCT04714190|Trastuzumab|trastuzumab|mesh-list
5611988|NCT04714190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5611989|NCT04714190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5730112|NCT03150576|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5730113|NCT03150576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5730114|NCT03150667|Clopidogrel|clopidogrel|mesh-list
5730115|NCT03150667|Ticagrelor|ticagrelor|mesh-list
5730116|NCT03150667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5730117|NCT03150667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5730118|NCT03150667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5730119|NCT03150667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5611990|NCT04714190|Tubulin Modulators|tubulin modulators|mesh-ancestor
5611991|NCT04714190|Antimitotic Agents|antimitotic agents|mesh-ancestor
5611992|NCT04714190|Mitosis Modulators|mitosis modulators|mesh-ancestor
5611993|NCT04714190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5611994|NCT04714190|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5611995|NCT04714190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5611996|NCT04714190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5611997|NCT04714190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5611998|NCT04714190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5611999|NCT04704999|Chloroquine|chloroquine|mesh-list
5612000|NCT04704999|Lumefantrine|lumefantrine|mesh-list
5612001|NCT04704999|Artemether|artemether|mesh-list
5612002|NCT04704999|Tafenoquine|tafenoquine|mesh-list
5612003|NCT04704999|Amebicides|amebicides|mesh-ancestor
5612004|NCT04704999|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5612005|NCT04704999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5612006|NCT04704999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5612007|NCT04704999|Antimalarials|antimalarials|mesh-ancestor
5612008|NCT04704999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5612009|NCT04702802|Hyaluronic Acid|hyaluronic acid|mesh-list
5612010|NCT04702802|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5612011|NCT04702802|Immunologic Factors|immunologic factors|mesh-ancestor
5612012|NCT04702802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612013|NCT04702802|Viscosupplements|viscosupplements|mesh-ancestor
5730120|NCT03150667|Purinergic Agents|purinergic agents|mesh-ancestor
5730121|NCT03150667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5730122|NCT03150667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5730123|NCT03150667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730124|NCT03150888|Antihypertensive Agents|antihypertensive agents|mesh-list
5730125|NCT03150836|Durvalumab|durvalumab|mesh-list
5612014|NCT04702802|Protective Agents|protective agents|mesh-ancestor
5730126|NCT03150836|Tremelimumab|tremelimumab|mesh-list
5730127|NCT03150836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5730128|NCT03150836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5730129|NCT03150316|Dexamethasone|dexamethasone|mesh-list
5730130|NCT03150316|Lenalidomide|lenalidomide|mesh-list
5730131|NCT03150316|CKD-581|ckd-581|mesh-list
5730132|NCT03150316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5730133|NCT03150316|Antiemetics|antiemetics|mesh-ancestor
5730134|NCT03150316|Autonomic Agents|autonomic agents|mesh-ancestor
5730135|NCT03150316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5730136|NCT03150316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730137|NCT03150316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5730138|NCT03150316|Glucocorticoids|glucocorticoids|mesh-ancestor
5730139|NCT03150316|Hormones|hormones|mesh-ancestor
5730140|NCT03150316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5730141|NCT03150316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5730142|NCT03150316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5730143|NCT03150316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5730144|NCT03150316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5730145|NCT03150316|Immunologic Factors|immunologic factors|mesh-ancestor
5730146|NCT03150316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5730147|NCT03150316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5730148|NCT03150316|Growth Substances|growth substances|mesh-ancestor
5730149|NCT03150316|Growth Inhibitors|growth inhibitors|mesh-ancestor
5730150|NCT03150316|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5730151|NCT03150290|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5730152|NCT03150290|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5730153|NCT03150290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5730154|NCT03150459|Rifaximin|rifaximin|mesh-list
5730155|NCT03150459|Simvastatin|simvastatin|mesh-list
5730156|NCT03150459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5612015|NCT04702789|Timolol|timolol|mesh-list
5612016|NCT04702789|Brimonidine Tartrate|brimonidine tartrate|mesh-list
5612017|NCT04702789|Dorzolamide|dorzolamide|mesh-list
5612018|NCT04702789|Latanoprost|latanoprost|mesh-list
5612019|NCT04702789|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5612020|NCT04702789|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5612021|NCT04702789|Adrenergic Agents|adrenergic agents|mesh-ancestor
5612022|NCT04702789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5612023|NCT04702789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612024|NCT04702789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612025|NCT04702789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5612026|NCT04702789|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5612027|NCT04702789|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5612028|NCT04702789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5612029|NCT04702789|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5612030|NCT04702789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5612031|NCT04702789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5612032|NCT04702789|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5612033|NCT04702789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5612034|NCT04702776|Hyaluronic Acid|hyaluronic acid|mesh-list
5612035|NCT04702776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5612036|NCT04702776|Immunologic Factors|immunologic factors|mesh-ancestor
5730157|NCT03150459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5730158|NCT03150459|Antimetabolites|antimetabolites|mesh-ancestor
5730159|NCT03150459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5730160|NCT03150459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5730161|NCT03150459|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5730162|NCT03150459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5730163|NCT03150459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5612037|NCT04702776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612038|NCT04702776|Viscosupplements|viscosupplements|mesh-ancestor
5612039|NCT04702776|Protective Agents|protective agents|mesh-ancestor
5691891|NCT03413059|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5691892|NCT03413059|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5691893|NCT03413059|Morphine|morphine|mesh-list
5691894|NCT03413059|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5691895|NCT03413059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5730164|NCT03150459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5730165|NCT03150459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5730166|NCT03150524|Verapamil|verapamil|mesh-list
5730167|NCT03150524|Nimodipine|nimodipine|mesh-list
5730168|NCT03150524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5730169|NCT03150524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5730170|NCT03150524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5730171|NCT03150524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691896|NCT03413059|Narcotics|narcotics|mesh-ancestor
5691897|NCT03413059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5691898|NCT03413059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691899|NCT03413059|Analgesics|analgesics|mesh-ancestor
5691900|NCT03413059|Sensory System Agents|sensory system agents|mesh-ancestor
5691901|NCT03413059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5691902|NCT03413059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5691903|NCT03413059|Glucocorticoids|glucocorticoids|mesh-ancestor
5691904|NCT03413059|Hormones|hormones|mesh-ancestor
5691905|NCT03413059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5691906|NCT03413059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5730172|NCT03150524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5730173|NCT03150524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730174|NCT03150524|Vasodilator Agents|vasodilator agents|mesh-ancestor
5730175|NCT03150524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5730176|NCT03150420|Sodium thiosulfate|sodium thiosulfate|mesh-list
5730177|NCT03150420|Antidotes|antidotes|mesh-ancestor
5730178|NCT03150420|Protective Agents|protective agents|mesh-ancestor
5730179|NCT03150420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730180|NCT03150420|Antioxidants|antioxidants|mesh-ancestor
5730181|NCT03150420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5730182|NCT03150420|Antitubercular Agents|antitubercular agents|mesh-ancestor
5730183|NCT03150420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5730184|NCT03150420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5730185|NCT03150420|Chelating Agents|chelating agents|mesh-ancestor
5730186|NCT03150420|Sequestering Agents|sequestering agents|mesh-ancestor
5730187|NCT03150134|Cyclosporine|cyclosporine|mesh-list
5730188|NCT03150134|Cyclosporins|cyclosporins|mesh-list
5730189|NCT03150134|Immunosuppressive Agents|immunosuppressive agents|mesh-list
5730190|NCT03150134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5691907|NCT03413059|Immunologic Factors|immunologic factors|mesh-ancestor
5691908|NCT03413059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5892919|NCT04014803|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5612040|NCT04699422|Pirinitramide|pirinitramide|mesh-list
5612041|NCT04699422|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5612042|NCT04699422|Narcotics|narcotics|mesh-ancestor
5612043|NCT04699422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5612044|NCT04699422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612045|NCT04699422|Analgesics|analgesics|mesh-ancestor
5612046|NCT04699422|Sensory System Agents|sensory system agents|mesh-ancestor
5730191|NCT03150134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5730192|NCT03150134|Immunologic Factors|immunologic factors|mesh-ancestor
5730193|NCT03150134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730194|NCT03150134|Antifungal Agents|antifungal agents|mesh-ancestor
5730195|NCT03150134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5730196|NCT03150134|Dermatologic Agents|dermatologic agents|mesh-ancestor
5730197|NCT03150134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5730198|NCT03150134|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5730199|NCT03149939|Febuxostat|febuxostat|mesh-list
5730200|NCT03149939|Gout Suppressants|gout suppressants|mesh-ancestor
5730201|NCT03149939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5730202|NCT03149913|Paclitaxel|paclitaxel|mesh-list
5730203|NCT03149913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5730204|NCT03149913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5730205|NCT03149913|Tubulin Modulators|tubulin modulators|mesh-ancestor
5730206|NCT03149913|Antimitotic Agents|antimitotic agents|mesh-ancestor
5730207|NCT03149913|Mitosis Modulators|mitosis modulators|mesh-ancestor
5730208|NCT03149913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892920|NCT04014803|Purinergic Agents|purinergic agents|mesh-ancestor
5892921|NCT04014803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5892922|NCT04006119|Cemiplimab|cemiplimab|mesh-list
5892923|NCT04006119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5892924|NCT04006119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5892925|NCT03971500|Aspirin|aspirin|mesh-list
5892926|NCT03971500|Ticagrelor|ticagrelor|mesh-list
5892927|NCT03971500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5612047|NCT04699422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5612048|NCT04693429|Bepotastine besilate|bepotastine besilate|mesh-list
5612049|NCT04693429|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5612050|NCT04686773|Vaccines|vaccines|mesh-list
5612051|NCT04686773|Immunologic Factors|immunologic factors|mesh-ancestor
5612052|NCT04686773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612053|NCT04684953|Hormones|hormones|mesh-list
5612054|NCT04684953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5612055|NCT04684953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612056|NCT04683614|Norepinephrine|norepinephrine|mesh-list
5612057|NCT04683614|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5612058|NCT04683614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5612059|NCT04683614|Adrenergic Agents|adrenergic agents|mesh-ancestor
5612060|NCT04683614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5612061|NCT04683614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612062|NCT04683614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612063|NCT04683614|Sympathomimetics|sympathomimetics|mesh-ancestor
5612064|NCT04683614|Autonomic Agents|autonomic agents|mesh-ancestor
5612065|NCT04683614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5612066|NCT04683614|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5612067|NCT04682483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
5612068|NCT04674020|Erenumab|erenumab|mesh-list
5612069|NCT04674020|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
5612070|NCT04674020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612071|NCT04674020|Analgesics|analgesics|mesh-ancestor
5612072|NCT04674020|Sensory System Agents|sensory system agents|mesh-ancestor
5612073|NCT04674020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5612074|NCT04674020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612075|NCT04673786|Ustekinumab|ustekinumab|mesh-list
5612076|NCT04673786|Dermatologic Agents|dermatologic agents|mesh-ancestor
5612077|NCT04667637|Edaravone|edaravone|mesh-list
5612078|NCT04667637|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5612079|NCT04667637|Antioxidants|antioxidants|mesh-ancestor
5612080|NCT04667637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612081|NCT04667637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5612082|NCT04667637|Protective Agents|protective agents|mesh-ancestor
5612083|NCT04667637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612084|NCT04660799|Diphenhydramine|diphenhydramine|mesh-list
5612085|NCT04660799|Promethazine|promethazine|mesh-list
5612086|NCT04660799|Prednisone|prednisone|mesh-list
5612087|NCT04660799|Cyclophosphamide|cyclophosphamide|mesh-list
5612088|NCT04660799|Rituximab|rituximab|mesh-list
5892928|NCT03971500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5892929|NCT03971500|Analgesics|analgesics|mesh-ancestor
5730209|NCT03150030|Hypoglycemic Agents|hypoglycemic agents|mesh-list
5730210|NCT03150030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730211|NCT03149783|Ropivacaine|ropivacaine|mesh-list
5730212|NCT03149783|Anesthetics, Local|anesthetics, local|mesh-ancestor
5730213|NCT03149783|Anesthetics|anesthetics|mesh-ancestor
5730214|NCT03149783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5730215|NCT03149783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730216|NCT03149783|Sensory System Agents|sensory system agents|mesh-ancestor
5730217|NCT03149783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5730218|NCT03150004|Cytarabine|cytarabine|mesh-list
5730219|NCT03150004|Mitoxantrone|mitoxantrone|mesh-list
5730220|NCT03150004|Cladribine|cladribine|mesh-list
5730221|NCT03150004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5730222|NCT03150004|Antimetabolites|antimetabolites|mesh-ancestor
5730223|NCT03150004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5730224|NCT03150004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5730225|NCT03150004|Antiviral Agents|antiviral agents|mesh-ancestor
5730226|NCT03150004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5730227|NCT03150004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5730228|NCT03150004|Immunologic Factors|immunologic factors|mesh-ancestor
5612089|NCT04660799|Doxorubicin|doxorubicin|mesh-list
5612090|NCT04660799|Vincristine|vincristine|mesh-list
5612091|NCT04660799|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
5612092|NCT04660799|Histamine Antagonists|histamine antagonists|mesh-list
5612093|NCT04660799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5612094|NCT04660799|Immunologic Factors|immunologic factors|mesh-ancestor
5612095|NCT04660799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730229|NCT03150004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730230|NCT03150004|Analgesics|analgesics|mesh-ancestor
5612096|NCT04660799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5612097|NCT04660799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5612098|NCT04660799|Alkylating Agents|alkylating agents|mesh-ancestor
5612099|NCT04660799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612100|NCT04660799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5612101|NCT04660799|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5612102|NCT04660799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5612103|NCT04660799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5612104|NCT04660799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5612105|NCT04660799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5612106|NCT04660799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5612107|NCT04660799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5612108|NCT04660799|Glucocorticoids|glucocorticoids|mesh-ancestor
5612109|NCT04660799|Hormones|hormones|mesh-ancestor
5612110|NCT04660799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5612111|NCT04660799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5612112|NCT04660799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5612113|NCT04660799|Tubulin Modulators|tubulin modulators|mesh-ancestor
5612114|NCT04660799|Antimitotic Agents|antimitotic agents|mesh-ancestor
5612115|NCT04660799|Mitosis Modulators|mitosis modulators|mesh-ancestor
5612116|NCT04660799|Sensory System Agents|sensory system agents|mesh-ancestor
5612117|NCT04660799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5612118|NCT04660799|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5612119|NCT04660799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5612120|NCT04660799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5730231|NCT03150004|Sensory System Agents|sensory system agents|mesh-ancestor
5730232|NCT03150004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5730233|NCT03150004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5730234|NCT03150004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5612121|NCT04660799|Anesthetics, Local|anesthetics, local|mesh-ancestor
5612122|NCT04660799|Anesthetics|anesthetics|mesh-ancestor
5612123|NCT04660799|Antiemetics|antiemetics|mesh-ancestor
5612124|NCT04660799|Autonomic Agents|autonomic agents|mesh-ancestor
5612125|NCT04660799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5612126|NCT04660799|Histamine Agents|histamine agents|mesh-ancestor
5612127|NCT04660799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5612128|NCT04660799|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5612129|NCT04660799|Antipruritics|antipruritics|mesh-ancestor
5612130|NCT04660799|Dermatologic Agents|dermatologic agents|mesh-ancestor
5612131|NCT04659317|Oxycodone|oxycodone|mesh-list
5612132|NCT04659317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5612133|NCT04659317|Narcotics|narcotics|mesh-ancestor
5612134|NCT04659317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5612135|NCT04659317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730235|NCT03150004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5730236|NCT03149653|SMOFlipid|smoflipid|mesh-list
5730237|NCT03149653|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
5730238|NCT03149653|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5730239|NCT03149653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5730240|NCT03149432|Gabapentin|gabapentin|mesh-list
5730241|NCT03149432|Analgesics|analgesics|mesh-ancestor
5730242|NCT03149432|Sensory System Agents|sensory system agents|mesh-ancestor
5730243|NCT03149432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5730244|NCT03149432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730245|NCT03149432|Anticonvulsants|anticonvulsants|mesh-ancestor
5730246|NCT03149432|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5730247|NCT03149432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5730248|NCT03149432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5730249|NCT03149432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5730250|NCT03149432|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5730251|NCT03149432|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5730252|NCT03149432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5730253|NCT03149432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5730254|NCT03149432|Antimanic Agents|antimanic agents|mesh-ancestor
5730255|NCT03149419|Paroxetine|paroxetine|mesh-list
5730256|NCT03149419|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5730257|NCT03149419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5730258|NCT03149419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5730259|NCT03149419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5730260|NCT03149419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5730261|NCT03149419|Serotonin Agents|serotonin agents|mesh-ancestor
5730262|NCT03149419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730263|NCT03149419|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5730264|NCT03149419|Antidepressive Agents|antidepressive agents|mesh-ancestor
5730265|NCT03149419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5730266|NCT03149419|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5730267|NCT03149419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5730268|NCT03149419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5612136|NCT04659317|Analgesics|analgesics|mesh-ancestor
5612137|NCT04659317|Sensory System Agents|sensory system agents|mesh-ancestor
5612138|NCT04659317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6208106|NCT02124772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6208107|NCT02124772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6208108|NCT02124772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208109|NCT02124798|Belimumab|belimumab|mesh-list
5730269|NCT03149588|Propofol|propofol|mesh-list
5730270|NCT03149588|Sevoflurane|sevoflurane|mesh-list
5730271|NCT03149588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5730272|NCT03149588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5730273|NCT03149588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730274|NCT03149588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5730275|NCT03149588|Anesthetics, General|anesthetics, general|mesh-ancestor
5730276|NCT03149588|Anesthetics|anesthetics|mesh-ancestor
5730277|NCT03149588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5730278|NCT03149588|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5730279|NCT03149640|Amikacin|amikacin|mesh-list
5730280|NCT03149640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5730281|NCT03149640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5730282|NCT03149679|Cyclophosphamide|cyclophosphamide|mesh-list
5730283|NCT03149679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5730284|NCT03149679|Immunologic Factors|immunologic factors|mesh-ancestor
5730285|NCT03149679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730286|NCT03149679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6208110|NCT02124798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6208111|NCT02124798|Immunologic Factors|immunologic factors|mesh-ancestor
6208112|NCT02124798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612146|NCT04656652|Docetaxel|docetaxel|mesh-list
5612147|NCT04656652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5612148|NCT04656652|Tubulin Modulators|tubulin modulators|mesh-ancestor
5612149|NCT04656652|Antimitotic Agents|antimitotic agents|mesh-ancestor
5612150|NCT04656652|Mitosis Modulators|mitosis modulators|mesh-ancestor
5612151|NCT04656652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612152|NCT04655690|Insulin Aspart|insulin aspart|mesh-list
5612153|NCT04655690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5612154|NCT04655690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612155|NCT04655586|Heparin|heparin|mesh-list
5612156|NCT04655586|Protein C|protein c|mesh-list
5612157|NCT04655586|Anticoagulants|anticoagulants|mesh-list
5612158|NCT04655586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5612159|NCT04655586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5612160|NCT04655586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612161|NCT04641312|Dulaglutide|dulaglutide|mesh-list
5730287|NCT03149679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5730288|NCT03149679|Alkylating Agents|alkylating agents|mesh-ancestor
5730289|NCT03149679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5730290|NCT03149679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5612162|NCT04641312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5612163|NCT04641312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612164|NCT04637763|Cyclophosphamide|cyclophosphamide|mesh-list
5612165|NCT04637763|Fludarabine|fludarabine|mesh-list
5612166|NCT04637763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5612167|NCT04637763|Immunologic Factors|immunologic factors|mesh-ancestor
5612168|NCT04637763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612169|NCT04637763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5612170|NCT04637763|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5612171|NCT04637763|Alkylating Agents|alkylating agents|mesh-ancestor
5612172|NCT04637763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612173|NCT04637763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5612174|NCT04637763|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5612175|NCT04635423|Vaccines|vaccines|mesh-list
5730291|NCT03149679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5730292|NCT03149575|Carboplatin|carboplatin|mesh-list
5730293|NCT03149575|Temozolomide|temozolomide|mesh-list
5730294|NCT03149575|Lomustine|lomustine|mesh-list
5730295|NCT03149575|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
5730296|NCT03149575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5730297|NCT03149575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5730298|NCT03149575|Alkylating Agents|alkylating agents|mesh-ancestor
5730299|NCT03149575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5730300|NCT03149445|Metoprolol|metoprolol|mesh-list
5730301|NCT03149445|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5730302|NCT03149445|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5730303|NCT03149445|Sympatholytics|sympatholytics|mesh-ancestor
5730304|NCT03149445|Autonomic Agents|autonomic agents|mesh-ancestor
5730305|NCT03149445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5730306|NCT03149445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730307|NCT03149445|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5730308|NCT03149445|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5730309|NCT03149445|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5730310|NCT03149445|Adrenergic Agents|adrenergic agents|mesh-ancestor
5730311|NCT03149445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5730312|NCT03149445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5730313|NCT03149393|Mosapride|mosapride|mesh-list
5730314|NCT03149393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5730315|NCT03149393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5730316|NCT03149393|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5730317|NCT03149393|Serotonin Agents|serotonin agents|mesh-ancestor
5730318|NCT03149393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5730319|NCT03149393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730320|NCT03149211|UB-421|ub-421|mesh-list
5730321|NCT03149211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5730322|NCT03149211|Antiviral Agents|antiviral agents|mesh-ancestor
5730323|NCT03149211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5730324|NCT03149289|Antiviral Agents|antiviral agents|mesh-list
5730325|NCT03149289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5730326|NCT03148990|Vaccines|vaccines|mesh-list
5730327|NCT03148990|Immunologic Factors|immunologic factors|mesh-ancestor
5730328|NCT03148990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730329|NCT03149159|Nivolumab|nivolumab|mesh-list
5730330|NCT03149159|Ipilimumab|ipilimumab|mesh-list
5730331|NCT03149159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5730332|NCT03149159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5730333|NCT03149159|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5730334|NCT03149159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612176|NCT04635423|Immunologic Factors|immunologic factors|mesh-ancestor
5612177|NCT04635423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612178|NCT04622319|Trastuzumab|trastuzumab|mesh-list
5612179|NCT04622319|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
5612180|NCT04622319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5612181|NCT04622319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5730335|NCT03149120|Nivolumab|nivolumab|mesh-list
5730336|NCT03149120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5730337|NCT03149120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5730338|NCT03149120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5730339|NCT03149120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5730340|NCT03149250|Hemostatics|hemostatics|mesh-list
5612182|NCT04622319|Tubulin Modulators|tubulin modulators|mesh-ancestor
5612183|NCT04622319|Antimitotic Agents|antimitotic agents|mesh-ancestor
5730341|NCT03149250|Coagulants|coagulants|mesh-ancestor
5730342|NCT03149107|Acetylcysteine|acetylcysteine|mesh-list
5730343|NCT03149107|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5612184|NCT04622319|Mitosis Modulators|mitosis modulators|mesh-ancestor
5612185|NCT04622319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612186|NCT04616014|Insulin|insulin|mesh-list
5612187|NCT04616014|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5612188|NCT04616014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5612189|NCT04616014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612190|NCT04614363|Edetic Acid|edetic acid|mesh-list
5612191|NCT04614363|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5612192|NCT04614363|Anticoagulants|anticoagulants|mesh-ancestor
5612193|NCT04614363|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5612194|NCT04614363|Chelating Agents|chelating agents|mesh-ancestor
5730344|NCT03149107|Antiviral Agents|antiviral agents|mesh-ancestor
5730345|NCT03149107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5730346|NCT03149107|Expectorants|expectorants|mesh-ancestor
5730347|NCT03149107|Respiratory System Agents|respiratory system agents|mesh-ancestor
5730348|NCT03149107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5730349|NCT03149107|Antioxidants|antioxidants|mesh-ancestor
5730350|NCT03149107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5730351|NCT03149107|Protective Agents|protective agents|mesh-ancestor
5730352|NCT03149107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730353|NCT03149107|Antidotes|antidotes|mesh-ancestor
5730354|NCT03148717|Misoprostol|misoprostol|mesh-list
5730355|NCT03148717|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5730356|NCT03148717|Abortifacient Agents|abortifacient agents|mesh-ancestor
5730357|NCT03148717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5730358|NCT03148717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730359|NCT03148717|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5730360|NCT03148717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5730361|NCT03148717|Oxytocics|oxytocics|mesh-ancestor
5730362|NCT03148704|Palonosetron|palonosetron|mesh-list
5730363|NCT03148704|Antiemetics|antiemetics|mesh-ancestor
5730364|NCT03148704|Autonomic Agents|autonomic agents|mesh-ancestor
5730365|NCT03148704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5612195|NCT04614363|Sequestering Agents|sequestering agents|mesh-ancestor
5612196|NCT04614363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612197|NCT04614363|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5612198|NCT04611802|Vaccines|vaccines|mesh-list
5612199|NCT04611802|Immunologic Factors|immunologic factors|mesh-ancestor
5612200|NCT04611802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612201|NCT04611763|Flurbiprofen|flurbiprofen|mesh-list
5612202|NCT04611763|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
5612203|NCT04611763|Analgesics|analgesics|mesh-ancestor
5612204|NCT04611763|Sensory System Agents|sensory system agents|mesh-ancestor
5612205|NCT04611763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5730366|NCT03148704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730367|NCT03148704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5730368|NCT03148704|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5730369|NCT03148704|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5730370|NCT03148704|Serotonin Agents|serotonin agents|mesh-ancestor
5730371|NCT03148704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5730372|NCT03148704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5730373|NCT03148561|Misoprostol|misoprostol|mesh-list
5730374|NCT03148561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5730375|NCT03148561|Abortifacient Agents|abortifacient agents|mesh-ancestor
5730376|NCT03148561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5730377|NCT03148561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612206|NCT04611763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612207|NCT04611763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5612208|NCT04611763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5612209|NCT04611763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5612210|NCT04611763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5612211|NCT04611763|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5612212|NCT04611763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5730378|NCT03148561|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5730379|NCT03148561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5730380|NCT03148561|Oxytocics|oxytocics|mesh-ancestor
5730381|NCT03148574|Misoprostol|misoprostol|mesh-list
5730382|NCT03148574|Oxytocin|oxytocin|mesh-list
5730383|NCT03148574|Oxytocics|oxytocics|mesh-ancestor
5730384|NCT03148574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5730385|NCT03148574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730386|NCT03148574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5730387|NCT03148574|Abortifacient Agents|abortifacient agents|mesh-ancestor
5730388|NCT03148574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5730389|NCT03148574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5730390|NCT03148535|Lithium Carbonate|lithium carbonate|mesh-list
5730391|NCT03148535|Antidepressive Agents|antidepressive agents|mesh-list
5730392|NCT03148535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5730393|NCT03148535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5730394|NCT03148535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5730395|NCT03148535|Antimanic Agents|antimanic agents|mesh-ancestor
5730396|NCT03148535|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5730397|NCT03148535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5730398|NCT03148535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612213|NCT04611763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612214|NCT04608786|Capecitabine|capecitabine|mesh-list
5612215|NCT04608786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5612216|NCT04608786|Antimetabolites|antimetabolites|mesh-ancestor
5612217|NCT04608786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612218|NCT04608786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5612219|NCT04603911|Dexamethasone|dexamethasone|mesh-list
5612220|NCT04603911|Clonidine|clonidine|mesh-list
5612221|NCT04603911|Epinephrine|epinephrine|mesh-list
5612222|NCT04603911|Bupivacaine|bupivacaine|mesh-list
5730399|NCT03148509|Risperidone|risperidone|mesh-list
5730400|NCT03148509|Aripiprazole|aripiprazole|mesh-list
5730401|NCT03148509|Bupropion|bupropion|mesh-list
5730402|NCT03148509|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5730403|NCT03148509|Serotonin Agents|serotonin agents|mesh-ancestor
5730404|NCT03148509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6489122|NCT00589316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6489123|NCT00589316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6489124|NCT00589316|Antitubercular Agents|antitubercular agents|mesh-ancestor
6489125|NCT00589316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5612223|NCT04603911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5730405|NCT03148509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5730406|NCT03148509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730407|NCT03148509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5730408|NCT03148509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5730409|NCT03148509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5730410|NCT03148509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5730411|NCT03148509|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5730412|NCT03148509|Dopamine Agents|dopamine agents|mesh-ancestor
5730413|NCT03148509|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5730414|NCT03148509|Antidepressive Agents|antidepressive agents|mesh-ancestor
5730415|NCT03148509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5730416|NCT03148509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5730417|NCT03148509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5612224|NCT04603911|Antiemetics|antiemetics|mesh-ancestor
5612225|NCT04603911|Autonomic Agents|autonomic agents|mesh-ancestor
5612226|NCT04603911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5612227|NCT04603911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612228|NCT04603911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5612229|NCT04603911|Glucocorticoids|glucocorticoids|mesh-ancestor
5612230|NCT04603911|Hormones|hormones|mesh-ancestor
5612231|NCT04603911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5612232|NCT04603911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5612233|NCT04603911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5612234|NCT04603911|Anesthetics, Local|anesthetics, local|mesh-ancestor
5612235|NCT04603911|Anesthetics|anesthetics|mesh-ancestor
5612236|NCT04603911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5730418|NCT03148509|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5730419|NCT03148509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5730420|NCT03148509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5730421|NCT03148509|Dopamine Agonists|dopamine agonists|mesh-ancestor
5730422|NCT03148509|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5730423|NCT03148509|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5730424|NCT03148509|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5730425|NCT03148509|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5730426|NCT03148860|Methotrexate|methotrexate|mesh-list
5730427|NCT03148860|Ustekinumab|ustekinumab|mesh-list
5730428|NCT03148860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5730429|NCT03148860|Abortifacient Agents|abortifacient agents|mesh-ancestor
5730430|NCT03148860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5730431|NCT03148860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730432|NCT03148860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6489126|NCT00589316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5730433|NCT03148860|Antimetabolites|antimetabolites|mesh-ancestor
5730434|NCT03148860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5730435|NCT03148860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5730436|NCT03148860|Dermatologic Agents|dermatologic agents|mesh-ancestor
5730437|NCT03148860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5730438|NCT03148860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5730439|NCT03148860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5730440|NCT03148860|Immunologic Factors|immunologic factors|mesh-ancestor
5730441|NCT03148860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5730442|NCT03148860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5730443|NCT03148522|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5730444|NCT03148522|Mirtazapine|mirtazapine|mesh-list
5730445|NCT03148522|Citalopram|citalopram|mesh-list
5730446|NCT03148522|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5730447|NCT03148522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5730448|NCT03148522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5730449|NCT03148522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5730450|NCT03148522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5730451|NCT03148522|Serotonin Agents|serotonin agents|mesh-ancestor
5730452|NCT03148522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730453|NCT03148522|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5730454|NCT03148522|Antidepressive Agents|antidepressive agents|mesh-ancestor
5730455|NCT03148522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5730456|NCT03148522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5730457|NCT03148522|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5730458|NCT03148522|Analgesics|analgesics|mesh-ancestor
5730459|NCT03148522|Sensory System Agents|sensory system agents|mesh-ancestor
5730460|NCT03148522|Dopamine Agents|dopamine agents|mesh-ancestor
5730461|NCT03148522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5730462|NCT03148522|Histamine Antagonists|histamine antagonists|mesh-ancestor
5730463|NCT03148522|Histamine Agents|histamine agents|mesh-ancestor
5730464|NCT03148522|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5730465|NCT03148522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5730466|NCT03148522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5730467|NCT03148522|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5730468|NCT03148522|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5730469|NCT03148522|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5612237|NCT04603911|Sensory System Agents|sensory system agents|mesh-ancestor
5612238|NCT04603911|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5612239|NCT04603911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5612240|NCT04603911|Adrenergic Agents|adrenergic agents|mesh-ancestor
5612241|NCT04603911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5612242|NCT04603911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612243|NCT04603911|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5612244|NCT04603911|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5612245|NCT04603911|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5612246|NCT04603911|Respiratory System Agents|respiratory system agents|mesh-ancestor
5612247|NCT04603911|Mydriatics|mydriatics|mesh-ancestor
5612248|NCT04603911|Sympathomimetics|sympathomimetics|mesh-ancestor
5612249|NCT04603911|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5612250|NCT04603911|Analgesics|analgesics|mesh-ancestor
5612251|NCT04603911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5612252|NCT04603911|Sympatholytics|sympatholytics|mesh-ancestor
5612253|NCT04603911|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5612254|NCT04597268|Midazolam|midazolam|mesh-list
5612255|NCT04597268|Dexmedetomidine|dexmedetomidine|mesh-list
5612256|NCT04597268|Ketamine|ketamine|mesh-list
5612257|NCT04597268|Propofol|propofol|mesh-list
5612258|NCT04597268|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5612259|NCT04597268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5612260|NCT04597268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612261|NCT04597268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5612262|NCT04597268|Anesthetics, General|anesthetics, general|mesh-ancestor
5612263|NCT04597268|Anesthetics|anesthetics|mesh-ancestor
5730470|NCT03148522|Adrenergic Agents|adrenergic agents|mesh-ancestor
5730471|NCT03148522|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5730472|NCT03148522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5730473|NCT03148522|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5730474|NCT03148444|Cephalexin|cephalexin|mesh-list
5730475|NCT03148444|Roxithromycin|roxithromycin|mesh-list
5730476|NCT03148444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5730477|NCT03148444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5730478|NCT03148366|Levofloxacin|levofloxacin|mesh-list
5612264|NCT04597268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5612265|NCT04597268|Analgesics|analgesics|mesh-ancestor
5730479|NCT03148366|Ofloxacin|ofloxacin|mesh-list
5730480|NCT03148366|Bismuth|bismuth|mesh-list
5730481|NCT03148366|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5730482|NCT03148366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5730483|NCT03148366|Renal Agents|renal agents|mesh-ancestor
5730484|NCT03148366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5730485|NCT03148366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5730486|NCT03148366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5730487|NCT03148366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5730488|NCT03148366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5730489|NCT03148366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5730490|NCT03148366|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5730491|NCT03148366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5730492|NCT03148366|Antacids|antacids|mesh-ancestor
5730493|NCT03148366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5892930|NCT03971500|Sensory System Agents|sensory system agents|mesh-ancestor
5892931|NCT03971500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5892932|NCT03971500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892933|NCT03971500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5892934|NCT03971500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5892935|NCT03971500|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5892936|NCT03971500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5892937|NCT03971500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892938|NCT03971500|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5892939|NCT03971500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5892940|NCT03971500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5612266|NCT04597268|Sensory System Agents|sensory system agents|mesh-ancestor
5612267|NCT04597268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5612268|NCT04597268|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5892941|NCT03971500|Antipyretics|antipyretics|mesh-ancestor
5892942|NCT03971500|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5892943|NCT03971500|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5612269|NCT04597268|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5612270|NCT04597268|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5612271|NCT04597268|Adrenergic Agents|adrenergic agents|mesh-ancestor
5612272|NCT04597268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5612273|NCT04597268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612274|NCT04597268|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5612275|NCT04597268|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5612276|NCT04597268|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5612277|NCT04597268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5612278|NCT04597268|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5612279|NCT04597268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5892944|NCT03971500|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5892945|NCT03971500|Purinergic Agents|purinergic agents|mesh-ancestor
5892946|NCT03971500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5892947|NCT03954132|Cholinergic Agents|cholinergic agents|mesh-list
5892948|NCT03954132|Muscarinic Antagonists|muscarinic antagonists|mesh-list
5892949|NCT03954132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5892950|NCT03954132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892951|NCT03954132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892952|NCT03954132|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5892953|NCT03929029|Nivolumab|nivolumab|mesh-list
5892954|NCT03929029|Ipilimumab|ipilimumab|mesh-list
5892955|NCT03929029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5892956|NCT03929029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5892957|NCT03929029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5892958|NCT03929029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892959|NCT03901339|Gemcitabine|gemcitabine|mesh-list
5892960|NCT03901339|Capecitabine|capecitabine|mesh-list
5892961|NCT03901339|Vinorelbine|vinorelbine|mesh-list
5892962|NCT03901339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5892963|NCT03901339|Antimetabolites|antimetabolites|mesh-ancestor
5892964|NCT03901339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892965|NCT03901339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5892966|NCT03901339|Antiviral Agents|antiviral agents|mesh-ancestor
5892967|NCT03901339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5612280|NCT04597268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5612281|NCT04597268|GABA Modulators|gaba modulators|mesh-ancestor
5892968|NCT03901339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5892969|NCT03901339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5892970|NCT03901339|Immunologic Factors|immunologic factors|mesh-ancestor
5892971|NCT03901339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892972|NCT03901339|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5612282|NCT04597268|GABA Agents|gaba agents|mesh-ancestor
5612283|NCT04595266|Leucovorin|leucovorin|mesh-list
5612284|NCT04595266|Bevacizumab|bevacizumab|mesh-list
5612285|NCT04595266|Fluorouracil|fluorouracil|mesh-list
5730494|NCT03148132|Bevacizumab|bevacizumab|mesh-list
5730495|NCT03148132|Ranibizumab|ranibizumab|mesh-list
5730496|NCT03148132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5730497|NCT03148132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5730498|NCT03148132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5730499|NCT03148132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5730500|NCT03148132|Growth Substances|growth substances|mesh-ancestor
5730501|NCT03148132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730502|NCT03148132|Growth Inhibitors|growth inhibitors|mesh-ancestor
5730503|NCT03148314|Misoprostol|misoprostol|mesh-list
5612286|NCT04595266|Oxaliplatin|oxaliplatin|mesh-list
5612287|NCT04595266|Irinotecan|irinotecan|mesh-list
5612288|NCT04595266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5612289|NCT04595266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5612290|NCT04595266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5612291|NCT04595266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5612292|NCT04595266|Growth Substances|growth substances|mesh-ancestor
5612293|NCT04595266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612294|NCT04595266|Growth Inhibitors|growth inhibitors|mesh-ancestor
5612295|NCT04595266|Antimetabolites|antimetabolites|mesh-ancestor
5612296|NCT04595266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612297|NCT04595266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5612298|NCT04595266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5612299|NCT04595266|Immunologic Factors|immunologic factors|mesh-ancestor
5612300|NCT04595266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5612301|NCT04595266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5612302|NCT04595266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5612303|NCT04595266|Antidotes|antidotes|mesh-ancestor
5612304|NCT04595266|Protective Agents|protective agents|mesh-ancestor
5612305|NCT04595266|Vitamin B Complex|vitamin b complex|mesh-ancestor
5612306|NCT04595266|Vitamins|vitamins|mesh-ancestor
5730504|NCT03148314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5730505|NCT03148314|Abortifacient Agents|abortifacient agents|mesh-ancestor
5730506|NCT03148314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5730507|NCT03148314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730508|NCT03148314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5730509|NCT03148314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5730510|NCT03148314|Oxytocics|oxytocics|mesh-ancestor
5730511|NCT03148288|Vitamin D|vitamin d|mesh-list
5730512|NCT03148288|Vitamins|vitamins|mesh-ancestor
5730513|NCT03148288|Micronutrients|micronutrients|mesh-ancestor
5730514|NCT03148288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730515|NCT03148288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5730516|NCT03148002|Lactulose|lactulose|mesh-list
5730517|NCT03148002|Sennosides|sennosides|mesh-list
5730518|NCT03148002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5730519|NCT03148002|Laxatives|laxatives|mesh-ancestor
5730520|NCT03147963|Docetaxel|docetaxel|mesh-list
5730521|NCT03147963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5730522|NCT03147963|Tubulin Modulators|tubulin modulators|mesh-ancestor
5730523|NCT03147963|Antimitotic Agents|antimitotic agents|mesh-ancestor
5730524|NCT03147963|Mitosis Modulators|mitosis modulators|mesh-ancestor
5730525|NCT03147963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5730526|NCT03147638|Warfarin|warfarin|mesh-list
5730527|NCT03147638|Anticoagulants|anticoagulants|mesh-ancestor
5612307|NCT04595266|Micronutrients|micronutrients|mesh-ancestor
5612308|NCT04594798|Prednisone|prednisone|mesh-list
5612309|NCT04594798|Cyclophosphamide|cyclophosphamide|mesh-list
5730528|NCT03147859|Vedolizumab|vedolizumab|mesh-list
5730529|NCT03147859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5730530|NCT03147677|Alfacalcidol|alfacalcidol|mesh-list
5612310|NCT04594798|Rituximab|rituximab|mesh-list
5612311|NCT04594798|Doxorubicin|doxorubicin|mesh-list
5612312|NCT04594798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5612313|NCT04594798|Immunologic Factors|immunologic factors|mesh-ancestor
5612314|NCT04594798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612315|NCT04594798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5612316|NCT04594798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5612317|NCT04594798|Alkylating Agents|alkylating agents|mesh-ancestor
5612318|NCT04594798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612319|NCT04594798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5612320|NCT04594798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5730531|NCT03147677|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
5730532|NCT03147677|Irbesartan|irbesartan|mesh-list
5730533|NCT03147677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5730534|NCT03147677|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5730535|NCT03147677|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5730536|NCT03147677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5730537|NCT03147677|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5730538|NCT03147677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730539|NCT03147677|Vitamins|vitamins|mesh-ancestor
5730540|NCT03147677|Micronutrients|micronutrients|mesh-ancestor
5730541|NCT03147599|Mebeverine|mebeverine|mesh-list
5730542|NCT03147599|Anticonvulsants|anticonvulsants|mesh-ancestor
5730543|NCT03147599|Parasympatholytics|parasympatholytics|mesh-ancestor
5730544|NCT03147599|Autonomic Agents|autonomic agents|mesh-ancestor
5730545|NCT03147599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5730546|NCT03147599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730547|NCT03147287|Fulvestrant|fulvestrant|mesh-list
5730548|NCT03147287|Palbociclib|palbociclib|mesh-list
5730549|NCT03147287|Avelumab|avelumab|mesh-list
5730550|NCT03147287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5730551|NCT03147287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5730552|NCT03147287|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5730553|NCT03147287|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5730554|NCT03147287|Hormone Antagonists|hormone antagonists|mesh-ancestor
5730555|NCT03147287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5730556|NCT03147287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730557|NCT03147287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5730558|NCT03147287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5730559|NCT03147287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5730560|NCT03147287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5730561|NCT03147404|Avelumab|avelumab|mesh-list
5730562|NCT03147404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5730563|NCT03147404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5730564|NCT03147183|Thymoglobulin|thymoglobulin|mesh-list
5730565|NCT03147183|Immunologic Factors|immunologic factors|mesh-ancestor
5730566|NCT03147183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730567|NCT03147183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5730568|NCT03146962|Ascorbic Acid|ascorbic acid|mesh-list
5730569|NCT03146962|Vitamins|vitamins|mesh-ancestor
5730570|NCT03146962|Micronutrients|micronutrients|mesh-ancestor
5730571|NCT03146962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730572|NCT03146962|Antioxidants|antioxidants|mesh-ancestor
5730573|NCT03146962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5730574|NCT03146962|Protective Agents|protective agents|mesh-ancestor
5730575|NCT03147066|Flurbiprofen|flurbiprofen|mesh-list
5730576|NCT03147066|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
5730577|NCT03147066|Dezocine|dezocine|mesh-list
5730578|NCT03147066|Analgesics|analgesics|mesh-ancestor
5730579|NCT03147066|Sensory System Agents|sensory system agents|mesh-ancestor
5612321|NCT04594798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5612322|NCT04594798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5612323|NCT04594798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5612324|NCT04594798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5612325|NCT04594798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5612326|NCT04594798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5612327|NCT04594798|Glucocorticoids|glucocorticoids|mesh-ancestor
5612328|NCT04594798|Hormones|hormones|mesh-ancestor
5612329|NCT04594798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5612330|NCT04594798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5612331|NCT04592536|Alprazolam|alprazolam|mesh-list
5730580|NCT03147066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5730581|NCT03147066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730582|NCT03147066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5730583|NCT03147066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5730584|NCT03147066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5612332|NCT04592536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5612333|NCT04592536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5612334|NCT04592536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612335|NCT04592536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5612336|NCT04592536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5612337|NCT04592536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5730585|NCT03147066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5730586|NCT03147066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5730587|NCT03147066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5612338|NCT04592536|GABA Modulators|gaba modulators|mesh-ancestor
5730588|NCT03147066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5730589|NCT03147066|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5730590|NCT03147066|Narcotics|narcotics|mesh-ancestor
5892973|NCT03901339|Tubulin Modulators|tubulin modulators|mesh-ancestor
5730591|NCT03147066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5730592|NCT03147092|Losartan|losartan|mesh-list
5730593|NCT03147092|Atenolol|atenolol|mesh-list
5730594|NCT03147092|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5730595|NCT03147092|Clonidine|clonidine|mesh-list
5730596|NCT03147092|Captopril|captopril|mesh-list
5730597|NCT03147092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5730598|NCT03147092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5612339|NCT04592536|GABA Agents|gaba agents|mesh-ancestor
5612340|NCT04592536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5612341|NCT04592536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612342|NCT04569032|Prednisone|prednisone|mesh-list
5612343|NCT04569032|Cyclophosphamide|cyclophosphamide|mesh-list
5612344|NCT04569032|Doxorubicin|doxorubicin|mesh-list
5612345|NCT04569032|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5612346|NCT04569032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5730599|NCT03147092|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5730600|NCT03147092|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5730601|NCT03147092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5730602|NCT03147092|Diuretics|diuretics|mesh-ancestor
5730603|NCT03147092|Natriuretic Agents|natriuretic agents|mesh-ancestor
5730604|NCT03147092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730605|NCT03147092|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5730606|NCT03147092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5730607|NCT03147092|Analgesics|analgesics|mesh-ancestor
5730608|NCT03147092|Sensory System Agents|sensory system agents|mesh-ancestor
5730609|NCT03147092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5730610|NCT03147092|Sympatholytics|sympatholytics|mesh-ancestor
5730611|NCT03147092|Autonomic Agents|autonomic agents|mesh-ancestor
5730612|NCT03147092|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5730613|NCT03147092|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5730614|NCT03147092|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5730615|NCT03147092|Adrenergic Agents|adrenergic agents|mesh-ancestor
5730616|NCT03147092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5730617|NCT03147092|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5730618|NCT03147092|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5730619|NCT03147092|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5730620|NCT03147092|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5730621|NCT03147092|Protease Inhibitors|protease inhibitors|mesh-ancestor
5730622|NCT03147092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5730623|NCT03147196|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
5730624|NCT03147196|Bicalutamide|bicalutamide|mesh-list
5730625|NCT03147196|Androgen Antagonists|androgen antagonists|mesh-ancestor
5730626|NCT03147196|Hormone Antagonists|hormone antagonists|mesh-ancestor
5730627|NCT03147196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5730628|NCT03147196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730629|NCT03147196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5730630|NCT03147196|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5612347|NCT04569032|Immunologic Factors|immunologic factors|mesh-ancestor
5612348|NCT04569032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612349|NCT04569032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5612350|NCT04569032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5730631|NCT03147196|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5730632|NCT03147196|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5730633|NCT03147196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5730634|NCT03146858|Enoxaparin|enoxaparin|mesh-list
5730635|NCT03146858|Anticoagulants|anticoagulants|mesh-ancestor
5730636|NCT03146858|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5730637|NCT03146858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5730638|NCT03146858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892974|NCT03901339|Antimitotic Agents|antimitotic agents|mesh-ancestor
5892975|NCT03901339|Mitosis Modulators|mitosis modulators|mesh-ancestor
5892976|NCT03890887|Itraconazole|itraconazole|mesh-list
5892977|NCT03890887|Antifungal Agents|antifungal agents|mesh-ancestor
5892978|NCT03890887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5892979|NCT03890887|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5892980|NCT03890887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5892981|NCT03890887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5892982|NCT03890887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892983|NCT03890887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5892984|NCT03890887|Hormone Antagonists|hormone antagonists|mesh-ancestor
5892985|NCT03890887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5892986|NCT03890887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730639|NCT03146793|Sodium thiosulfate|sodium thiosulfate|mesh-list
5730640|NCT03146793|Antidotes|antidotes|mesh-ancestor
5730641|NCT03146793|Protective Agents|protective agents|mesh-ancestor
5730642|NCT03146793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730643|NCT03146793|Antioxidants|antioxidants|mesh-ancestor
5730644|NCT03146793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5730645|NCT03146793|Antitubercular Agents|antitubercular agents|mesh-ancestor
5730646|NCT03146793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5730647|NCT03146793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5730648|NCT03146793|Chelating Agents|chelating agents|mesh-ancestor
5730649|NCT03146793|Sequestering Agents|sequestering agents|mesh-ancestor
5730650|NCT03147157|Tacrolimus|tacrolimus|mesh-list
5730651|NCT03147157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5730652|NCT03147157|Immunologic Factors|immunologic factors|mesh-ancestor
5612351|NCT04569032|Alkylating Agents|alkylating agents|mesh-ancestor
5612352|NCT04569032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612353|NCT04569032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5612354|NCT04569032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5612355|NCT04569032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5612356|NCT04569032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5612357|NCT04569032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5612358|NCT04569032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5612359|NCT04569032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5612360|NCT04569032|Glucocorticoids|glucocorticoids|mesh-ancestor
5730653|NCT03147157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730654|NCT03147157|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5730655|NCT03147157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5730656|NCT03147157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5730657|NCT03146871|Azacitidine|azacitidine|mesh-list
5730658|NCT03146871|Decitabine|decitabine|mesh-list
5730659|NCT03146871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5730660|NCT03146871|Antimetabolites|antimetabolites|mesh-ancestor
5730661|NCT03146871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5730662|NCT03146871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5730663|NCT03146871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5730664|NCT03146650|Nivolumab|nivolumab|mesh-list
5730665|NCT03146650|Ipilimumab|ipilimumab|mesh-list
5730666|NCT03146650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5730667|NCT03146650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5730668|NCT03146650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5730669|NCT03146650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612361|NCT04569032|Hormones|hormones|mesh-ancestor
5612362|NCT04569032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5612363|NCT04569032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5612364|NCT04569032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5612365|NCT04555044|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
5612366|NCT04555044|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
5612367|NCT04555044|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5612368|NCT04555044|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5612369|NCT04552535|Afatinib|afatinib|mesh-list
5612370|NCT04552535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5612371|NCT04552535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5612372|NCT04552535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5612373|NCT04552535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691909|NCT03413059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691910|NCT03413020|Amoxicillin|amoxicillin|mesh-list
5691911|NCT03413020|Metronidazole|metronidazole|mesh-list
5691912|NCT03413020|Clarithromycin|clarithromycin|mesh-list
5691913|NCT03413020|Levofloxacin|levofloxacin|mesh-list
5691914|NCT03413020|Ofloxacin|ofloxacin|mesh-list
5691915|NCT03413020|Potassium Citrate|potassium citrate|mesh-list
5691916|NCT03413020|Esomeprazole|esomeprazole|mesh-list
5691917|NCT03413020|Bismuth|bismuth|mesh-list
5691918|NCT03413020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691919|NCT03413020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5691920|NCT03413020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5691921|NCT03413020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5691922|NCT03413020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5691923|NCT03413020|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5691924|NCT03413020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5691925|NCT03413020|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5691926|NCT03413020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5730670|NCT03146533|Cyclophosphamide|cyclophosphamide|mesh-list
5730671|NCT03146533|Fludarabine|fludarabine|mesh-list
5730672|NCT03146533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5730673|NCT03146533|Immunologic Factors|immunologic factors|mesh-ancestor
5730674|NCT03146533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730675|NCT03146533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5730676|NCT03146533|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5730677|NCT03146533|Alkylating Agents|alkylating agents|mesh-ancestor
5730678|NCT03146533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5730679|NCT03146533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5730680|NCT03146533|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5730681|NCT03146689|Ibuprofen|ibuprofen|mesh-list
5730682|NCT03146689|Capsaicin|capsaicin|mesh-list
5730683|NCT03146689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5730684|NCT03146689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5730685|NCT03146689|Analgesics|analgesics|mesh-ancestor
5730686|NCT03146689|Sensory System Agents|sensory system agents|mesh-ancestor
5730687|NCT03146689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5730688|NCT03146689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730689|NCT03146689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5730690|NCT03146689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5730691|NCT03146689|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5730692|NCT03146689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5730693|NCT03146689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5730694|NCT03146689|Antipruritics|antipruritics|mesh-ancestor
5730695|NCT03146689|Dermatologic Agents|dermatologic agents|mesh-ancestor
5730696|NCT03146481|Aceclofenac|aceclofenac|mesh-list
5730697|NCT03146481|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5730698|NCT03146481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5730699|NCT03146481|Analgesics|analgesics|mesh-ancestor
5730700|NCT03146481|Sensory System Agents|sensory system agents|mesh-ancestor
5730701|NCT03146481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5730702|NCT03146481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730703|NCT03146481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5730704|NCT03146481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5730705|NCT03146468|Nivolumab|nivolumab|mesh-list
5730706|NCT03146468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5730707|NCT03146468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5730708|NCT03146468|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5730709|NCT03146468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5730710|NCT03146377|Capecitabine|capecitabine|mesh-list
5730711|NCT03146377|Oxaliplatin|oxaliplatin|mesh-list
5730712|NCT03146377|Irinotecan|irinotecan|mesh-list
5730713|NCT03146377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5730714|NCT03146377|Antimetabolites|antimetabolites|mesh-ancestor
5730715|NCT03146377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5730716|NCT03146377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5730717|NCT03146377|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5730718|NCT03146377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5612374|NCT04541797|Empagliflozin|empagliflozin|mesh-list
5612375|NCT04541797|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5612376|NCT04541797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612377|NCT04541797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5612378|NCT04541797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612379|NCT04531553|Bupivacaine|bupivacaine|mesh-list
5612380|NCT04531553|Anesthetics, Local|anesthetics, local|mesh-ancestor
5612381|NCT04531553|Anesthetics|anesthetics|mesh-ancestor
5612382|NCT04531553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5612383|NCT04531553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612384|NCT04531553|Sensory System Agents|sensory system agents|mesh-ancestor
5612385|NCT04531553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5612386|NCT04529499|Favipiravir|favipiravir|mesh-list
5612387|NCT04529499|Antiviral Agents|antiviral agents|mesh-ancestor
5612388|NCT04529499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5612389|NCT04529265|Methylene Blue|methylene blue|mesh-list
5612390|NCT04529265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5612391|NCT04529265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612392|NCT04528680|Paclitaxel|paclitaxel|mesh-list
5612393|NCT04528680|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5612394|NCT04528680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5612395|NCT04528680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5612396|NCT04528680|Tubulin Modulators|tubulin modulators|mesh-ancestor
5612397|NCT04528680|Antimitotic Agents|antimitotic agents|mesh-ancestor
5612398|NCT04528680|Mitosis Modulators|mitosis modulators|mesh-ancestor
5612399|NCT04528680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612404|NCT04520685|Cannabidiol|cannabidiol|mesh-list
5730719|NCT03146377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5730720|NCT03146390|Listerine|listerine|mesh-list
5730721|NCT03146390|Sodium Fluoride|sodium fluoride|mesh-list
5730722|NCT03146390|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5730723|NCT03146390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5730724|NCT03146390|Cariostatic Agents|cariostatic agents|mesh-ancestor
5730725|NCT03146390|Protective Agents|protective agents|mesh-ancestor
5730726|NCT03146390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612405|NCT04520685|Anticonvulsants|anticonvulsants|mesh-ancestor
5612406|NCT04515329|Cyclosporine|cyclosporine|mesh-list
5612407|NCT04515329|Lubricant Eye Drops|lubricant eye drops|mesh-list
5612408|NCT04515329|Cyclosporins|cyclosporins|mesh-list
5612409|NCT04515329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5612410|NCT04515329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612411|NCT04515329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5612412|NCT04515329|Immunologic Factors|immunologic factors|mesh-ancestor
5612413|NCT04515329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612414|NCT04515329|Antifungal Agents|antifungal agents|mesh-ancestor
5612415|NCT04515329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5612416|NCT04515329|Dermatologic Agents|dermatologic agents|mesh-ancestor
5612417|NCT04515329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5612418|NCT04515329|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5612419|NCT04515329|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5612420|NCT04515329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5612421|NCT04508790|Dexamethasone|dexamethasone|mesh-list
5612422|NCT04508790|Dexamethasone acetate|dexamethasone acetate|mesh-list
5612423|NCT04508790|Pomalidomide|pomalidomide|mesh-list
5612424|NCT04508790|Ichthammol|ichthammol|mesh-list
5612425|NCT04508790|BB 1101|bb 1101|mesh-list
5612426|NCT04508790|Leflunomide|leflunomide|mesh-list
5612427|NCT04508790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5612428|NCT04508790|Antiemetics|antiemetics|mesh-ancestor
5612429|NCT04508790|Autonomic Agents|autonomic agents|mesh-ancestor
5612430|NCT04508790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5612431|NCT04508790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612432|NCT04508790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5612433|NCT04508790|Glucocorticoids|glucocorticoids|mesh-ancestor
5612434|NCT04508790|Hormones|hormones|mesh-ancestor
5612435|NCT04508790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5612436|NCT04508790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5612437|NCT04508790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5612438|NCT04508790|Protease Inhibitors|protease inhibitors|mesh-ancestor
5612439|NCT04508790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5612440|NCT04508790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612441|NCT04508790|Immunologic Factors|immunologic factors|mesh-ancestor
5612442|NCT04508790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5612443|NCT04508790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5612444|NCT04508790|Growth Substances|growth substances|mesh-ancestor
5612445|NCT04508790|Growth Inhibitors|growth inhibitors|mesh-ancestor
5612446|NCT04508790|Dermatologic Agents|dermatologic agents|mesh-ancestor
5612447|NCT04508790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5612448|NCT04506372|Enzyme Inhibitors|enzyme inhibitors|mesh-list
5612449|NCT04506372|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
5612450|NCT04506372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612451|NCT04506372|Protease Inhibitors|protease inhibitors|mesh-ancestor
5612452|NCT04505098|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
5612453|NCT04505098|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5612454|NCT04505098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5612455|NCT04503668|Dexamethasone|dexamethasone|mesh-list
5612456|NCT04503668|Ondansetron|ondansetron|mesh-list
5612457|NCT04503668|Olanzapine|olanzapine|mesh-list
5612458|NCT04503668|Fosaprepitant|fosaprepitant|mesh-list
5612459|NCT04503668|Prochlorperazine|prochlorperazine|mesh-list
5612460|NCT04503668|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-list
5612461|NCT04503668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5612462|NCT04503668|Antiemetics|antiemetics|mesh-ancestor
5612463|NCT04503668|Autonomic Agents|autonomic agents|mesh-ancestor
5612464|NCT04503668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5612465|NCT04503668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612466|NCT04503668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5612467|NCT04503668|Glucocorticoids|glucocorticoids|mesh-ancestor
5612468|NCT04503668|Hormones|hormones|mesh-ancestor
5612469|NCT04503668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5730727|NCT03146247|Apremilast|apremilast|mesh-list
6208113|NCT02124811|Minocycline|minocycline|mesh-list
5730728|NCT03146247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5730729|NCT03146247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5730730|NCT03146247|Analgesics|analgesics|mesh-ancestor
5730731|NCT03146247|Sensory System Agents|sensory system agents|mesh-ancestor
5730732|NCT03146247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5730733|NCT03146247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730734|NCT03146247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5730735|NCT03146247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5730736|NCT03146247|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5730737|NCT03146247|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5730738|NCT03146247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5730739|NCT03146247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5730740|NCT03146000|Meloxicam|meloxicam|mesh-list
5730741|NCT03146000|Lidocaine|lidocaine|mesh-list
5730742|NCT03146000|Prilocaine|prilocaine|mesh-list
5730743|NCT03146000|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
5730744|NCT03146000|Anesthetics, Local|anesthetics, local|mesh-ancestor
5730745|NCT03146000|Anesthetics|anesthetics|mesh-ancestor
5730746|NCT03146000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5730747|NCT03146000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612470|NCT04503668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5612471|NCT04503668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5612472|NCT04503668|Antipruritics|antipruritics|mesh-ancestor
5612473|NCT04503668|Dermatologic Agents|dermatologic agents|mesh-ancestor
5612474|NCT04503668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5612475|NCT04503668|Serotonin Agents|serotonin agents|mesh-ancestor
5612476|NCT04503668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5612477|NCT04503668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612478|NCT04503668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5612479|NCT04503668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5612480|NCT04503668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5730748|NCT03146000|Sensory System Agents|sensory system agents|mesh-ancestor
5730749|NCT03146000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5730750|NCT03146000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5730751|NCT03146000|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5730752|NCT03146000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5730753|NCT03146000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5730754|NCT03146000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5730755|NCT03146000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5730756|NCT03146000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5730757|NCT03146000|Analgesics|analgesics|mesh-ancestor
5730758|NCT03146000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5730759|NCT03146000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5730760|NCT03146000|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5730761|NCT03146000|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5730762|NCT03146000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5730763|NCT03146000|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
5730764|NCT03146325|Metronidazole|metronidazole|mesh-list
5730765|NCT03146325|Tetracycline|tetracycline|mesh-list
5730766|NCT03146325|Omeprazole|omeprazole|mesh-list
5730767|NCT03146325|Bismuth|bismuth|mesh-list
5730768|NCT03146325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5730769|NCT03146325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5730770|NCT03146325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5730771|NCT03146325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5730772|NCT03146325|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5730773|NCT03146325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5730774|NCT03146325|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5730775|NCT03146325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5730776|NCT03146325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5730777|NCT03146325|Antacids|antacids|mesh-ancestor
5612481|NCT04503668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5612482|NCT04503668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5612483|NCT04503668|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5612484|NCT04503668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5612485|NCT04503668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5612486|NCT04503668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5612487|NCT04503668|Dopamine Agents|dopamine agents|mesh-ancestor
5612488|NCT04502550|Propofol|propofol|mesh-list
5612489|NCT04502550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5612490|NCT04502550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5612491|NCT04502550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730778|NCT03146325|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5730779|NCT03146052|Simethicone|simethicone|mesh-list
5730780|NCT03146052|Bisacodyl|bisacodyl|mesh-list
5730781|NCT03146052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5730782|NCT03146052|Cathartics|cathartics|mesh-ancestor
5730783|NCT03146052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5730784|NCT03146052|Laxatives|laxatives|mesh-ancestor
5612492|NCT04502550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5612493|NCT04502550|Anesthetics, General|anesthetics, general|mesh-ancestor
5730785|NCT03146052|Antifoaming Agents|antifoaming agents|mesh-ancestor
5730786|NCT03146052|Emollients|emollients|mesh-ancestor
5730787|NCT03146052|Dermatologic Agents|dermatologic agents|mesh-ancestor
5730788|NCT03145649|Insulin|insulin|mesh-list
5730789|NCT03145649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5612494|NCT04502550|Anesthetics|anesthetics|mesh-ancestor
5612495|NCT04502407|Cisplatin|cisplatin|mesh-list
5612496|NCT04502407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5612497|NCT04485546|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5612498|NCT04485546|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5612507|NCT04481672|Magnesium Sulfate|magnesium sulfate|mesh-list
5730790|NCT03145649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730791|NCT03145714|Dexmedetomidine|dexmedetomidine|mesh-list
5730792|NCT03145714|Anesthetics|anesthetics|mesh-list
5730793|NCT03145714|Propofol|propofol|mesh-list
5730794|NCT03145714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5730795|NCT03145714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730796|NCT03145714|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5730797|NCT03145714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5730798|NCT03145714|Anesthetics, General|anesthetics, general|mesh-ancestor
5730799|NCT03145714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5730800|NCT03145714|Analgesics|analgesics|mesh-ancestor
5730801|NCT03145714|Sensory System Agents|sensory system agents|mesh-ancestor
5730802|NCT03145714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5730803|NCT03145714|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5730804|NCT03145714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5730805|NCT03145714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5730806|NCT03145714|Adrenergic Agents|adrenergic agents|mesh-ancestor
5730807|NCT03145714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5730808|NCT03145714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5730809|NCT03145610|Triclosan|triclosan|mesh-list
5730810|NCT03145610|Fluorides|fluorides|mesh-list
5730811|NCT03145610|Cariostatic Agents|cariostatic agents|mesh-ancestor
5730812|NCT03145610|Protective Agents|protective agents|mesh-ancestor
5612508|NCT04481672|Analgesics|analgesics|mesh-ancestor
5612509|NCT04481672|Sensory System Agents|sensory system agents|mesh-ancestor
5612510|NCT04481672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5612511|NCT04481672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612512|NCT04481672|Anesthetics|anesthetics|mesh-ancestor
5612513|NCT04481672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5612514|NCT04481672|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5612515|NCT04481672|Anticonvulsants|anticonvulsants|mesh-ancestor
5612516|NCT04481672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5612517|NCT04481672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5612518|NCT04481672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612519|NCT04481672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5612520|NCT04481672|Tocolytic Agents|tocolytic agents|mesh-ancestor
5612521|NCT04481672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5612522|NCT04470778|Famotidine|famotidine|mesh-list
5612523|NCT04470778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5612524|NCT04470778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5612525|NCT04470778|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5612526|NCT04470778|Histamine Antagonists|histamine antagonists|mesh-ancestor
5612527|NCT04470778|Histamine Agents|histamine agents|mesh-ancestor
5612528|NCT04470778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5612529|NCT04470778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612530|NCT04470778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612531|NCT04468061|Pembrolizumab|pembrolizumab|mesh-list
5612532|NCT04468061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5612533|NCT04468061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5612534|NCT04464798|Rituximab|rituximab|mesh-list
5730813|NCT03145610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612535|NCT04464798|Obinutuzumab|obinutuzumab|mesh-list
5612536|NCT04464798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5612537|NCT04464798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5612538|NCT04464798|Immunologic Factors|immunologic factors|mesh-ancestor
5612539|NCT04464798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612540|NCT04464798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5612541|NCT04458259|Axitinib|axitinib|mesh-list
5612542|NCT04458259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5612543|NCT04458259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5612544|NCT04458259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5612545|NCT04458259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691927|NCT03413020|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5691928|NCT03413020|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5691929|NCT03413020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5691930|NCT03413020|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5691931|NCT03413020|Renal Agents|renal agents|mesh-ancestor
5691932|NCT03413020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5691933|NCT03413020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5691934|NCT03413020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5691935|NCT03413020|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5691936|NCT03413020|Antacids|antacids|mesh-ancestor
5691937|NCT03413020|Diuretics|diuretics|mesh-ancestor
5691938|NCT03413020|Natriuretic Agents|natriuretic agents|mesh-ancestor
5691939|NCT03413020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691940|NCT03413020|Expectorants|expectorants|mesh-ancestor
5691941|NCT03413020|Respiratory System Agents|respiratory system agents|mesh-ancestor
5691942|NCT03413007|Antigen-Antibody Complex|antigen-antibody complex|mesh-list
5730814|NCT03145610|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5730815|NCT03145610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5730816|NCT03145610|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5730817|NCT03145610|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5730818|NCT03145610|Antimetabolites|antimetabolites|mesh-ancestor
5730819|NCT03145610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5730820|NCT03145610|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5730821|NCT03146091|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5691943|NCT03413007|Immunologic Factors|immunologic factors|mesh-ancestor
5691944|NCT03413007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691945|NCT03412994|Apatinib|apatinib|mesh-list
5691946|NCT03412994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5691947|NCT03412994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5691948|NCT03412994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5691949|NCT03412994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691950|NCT03412773|Sorafenib|sorafenib|mesh-list
5691951|NCT03412773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5691952|NCT03412773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5691953|NCT03412773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5691954|NCT03412773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691955|NCT03412721|Analgesics|analgesics|mesh-list
5691956|NCT03412721|Sensory System Agents|sensory system agents|mesh-ancestor
5691957|NCT03412721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5691958|NCT03412721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691959|NCT03412682|Budesonide|budesonide|mesh-list
5691960|NCT03412682|Mesalamine|mesalamine|mesh-list
5691961|NCT03412682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5691962|NCT03412682|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5691963|NCT03412682|Autonomic Agents|autonomic agents|mesh-ancestor
5691964|NCT03412682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5691965|NCT03412682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691966|NCT03412682|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5691967|NCT03412682|Respiratory System Agents|respiratory system agents|mesh-ancestor
5691968|NCT03412682|Glucocorticoids|glucocorticoids|mesh-ancestor
5691969|NCT03412682|Hormones|hormones|mesh-ancestor
5730822|NCT03146091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5730823|NCT03146104|Propofol|propofol|mesh-list
5730824|NCT03146104|Isoflurane|isoflurane|mesh-list
5730825|NCT03146104|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5730826|NCT03146104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5730827|NCT03146104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730828|NCT03146104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5730829|NCT03146104|Anesthetics, General|anesthetics, general|mesh-ancestor
5730830|NCT03146104|Anesthetics|anesthetics|mesh-ancestor
5730831|NCT03146104|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5730832|NCT03145623|Grazoprevir|grazoprevir|mesh-list
5730833|NCT03145623|Antiviral Agents|antiviral agents|mesh-ancestor
5691970|NCT03412682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5730834|NCT03145623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5730835|NCT03145961|Pembrolizumab|pembrolizumab|mesh-list
5730836|NCT03145961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5612546|NCT04418427|Aflibercept|aflibercept|mesh-list
5612547|NCT04418427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5612548|NCT04418427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5612549|NCT04418427|Growth Substances|growth substances|mesh-ancestor
5612550|NCT04418427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612551|NCT04418427|Growth Inhibitors|growth inhibitors|mesh-ancestor
5612552|NCT04418427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5612553|NCT04412863|Interferons|interferons|mesh-list
5612554|NCT04412863|Interferon-alpha|interferon-alpha|mesh-list
5612555|NCT04412863|Interferon alpha-2|interferon alpha-2|mesh-list
5612556|NCT04412863|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5612557|NCT04412863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5612558|NCT04412863|Antiviral Agents|antiviral agents|mesh-ancestor
5612559|NCT04412863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5612560|NCT04412863|Immunologic Factors|immunologic factors|mesh-ancestor
5612561|NCT04412863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612562|NCT04412785|Cyclosporine|cyclosporine|mesh-list
5612563|NCT04412785|Cyclosporins|cyclosporins|mesh-list
5612564|NCT04412785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5730837|NCT03145961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5730838|NCT03145896|Vitamin D|vitamin d|mesh-list
5730839|NCT03145896|Vitamins|vitamins|mesh-ancestor
5730840|NCT03145896|Micronutrients|micronutrients|mesh-ancestor
5730841|NCT03145896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730842|NCT03145896|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5730843|NCT03145675|Enoxaparin|enoxaparin|mesh-list
5730844|NCT03145675|Enoxaparin sodium|enoxaparin sodium|mesh-list
5730845|NCT03145675|Anticoagulants|anticoagulants|mesh-ancestor
5730846|NCT03145675|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5730847|NCT03145675|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5730848|NCT03145675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5730849|NCT03145558|Doxorubicin|doxorubicin|mesh-list
5730850|NCT03145558|Tirapazamine|tirapazamine|mesh-list
5612565|NCT04412785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612566|NCT04412785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5612567|NCT04412785|Immunologic Factors|immunologic factors|mesh-ancestor
5612568|NCT04412785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612569|NCT04412785|Antifungal Agents|antifungal agents|mesh-ancestor
5612570|NCT04412785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5612571|NCT04412785|Dermatologic Agents|dermatologic agents|mesh-ancestor
5612572|NCT04412785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5612573|NCT04412785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5612574|NCT04385433|Pravastatin|pravastatin|mesh-list
5612575|NCT04385433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5612576|NCT04385433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5612577|NCT04385433|Antimetabolites|antimetabolites|mesh-ancestor
5612578|NCT04385433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5730851|NCT03145558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5730852|NCT03145558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5730853|NCT03145558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5730854|NCT03145558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5730855|NCT03145558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5730856|NCT03145558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5730857|NCT03145480|Obinutuzumab|obinutuzumab|mesh-list
5730858|NCT03145480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5730859|NCT03145480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5730860|NCT03145272|Oxycodone|oxycodone|mesh-list
5730861|NCT03145272|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5730862|NCT03145272|Narcotics|narcotics|mesh-ancestor
5730863|NCT03145272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5730864|NCT03145272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730865|NCT03145272|Analgesics|analgesics|mesh-ancestor
5730866|NCT03145272|Sensory System Agents|sensory system agents|mesh-ancestor
5730867|NCT03145272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5892987|NCT03890887|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5892988|NCT03838159|Paclitaxel|paclitaxel|mesh-list
5892989|NCT03838159|Carboplatin|carboplatin|mesh-list
5892990|NCT03838159|Nivolumab|nivolumab|mesh-list
5892991|NCT03838159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5892992|NCT03838159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5892993|NCT03838159|Tubulin Modulators|tubulin modulators|mesh-ancestor
5612579|NCT04385433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5892994|NCT03838159|Antimitotic Agents|antimitotic agents|mesh-ancestor
5892995|NCT03838159|Mitosis Modulators|mitosis modulators|mesh-ancestor
5892996|NCT03838159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612580|NCT04385433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5612581|NCT04385433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5612582|NCT04377711|Ciclesonide|ciclesonide|mesh-list
5612583|NCT04377711|Glucocorticoids|glucocorticoids|mesh-ancestor
5730868|NCT05255666|Pembrolizumab|pembrolizumab|mesh-list
5730869|NCT05255666|Irinotecan|irinotecan|mesh-list
5730870|NCT05255666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5730871|NCT05255666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5730872|NCT05255666|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5730873|NCT05255666|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5730874|NCT05255666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5730875|NCT05255666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5730876|NCT05255653|Paclitaxel|paclitaxel|mesh-list
5730877|NCT05255653|Cisplatin|cisplatin|mesh-list
5730878|NCT05255653|Carboplatin|carboplatin|mesh-list
5612584|NCT04377711|Hormones|hormones|mesh-ancestor
5612585|NCT04377711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5612586|NCT04377711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612587|NCT04377711|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5612588|NCT04369560|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
5612589|NCT04369560|Hematinics|hematinics|mesh-ancestor
5612590|NCT04369560|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5612591|NCT04369560|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5612592|NCT04356690|Etoposide|etoposide|mesh-list
5612593|NCT04356690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5612594|NCT04356690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5612595|NCT04356690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5612596|NCT04356690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5612597|NCT04356690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5612598|NCT04356690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612599|NCT04356209|Pravastatin|pravastatin|mesh-list
5612600|NCT04356209|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5612601|NCT04356209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5612602|NCT04356209|Antimetabolites|antimetabolites|mesh-ancestor
5612603|NCT04356209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612604|NCT04356209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5612605|NCT04356209|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5612606|NCT04356209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5612607|NCT04354025|Cytarabine|cytarabine|mesh-list
5612608|NCT04354025|Fludarabine|fludarabine|mesh-list
5612609|NCT04354025|Interleukin-2|interleukin-2|mesh-list
5612610|NCT04354025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5612611|NCT04354025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5612612|NCT04354025|Antimetabolites|antimetabolites|mesh-ancestor
5730879|NCT05255653|Durvalumab|durvalumab|mesh-list
5730880|NCT05255653|Olaparib|olaparib|mesh-list
5730881|NCT05255653|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
5730882|NCT05255653|Megestrol|megestrol|mesh-list
5730883|NCT05255653|Megestrol Acetate|megestrol acetate|mesh-list
5730884|NCT05255653|Medroxyprogesterone|medroxyprogesterone|mesh-list
5730885|NCT05255653|Progestins|progestins|mesh-list
5730886|NCT05255653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5730887|NCT05255653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5730888|NCT05255653|Tubulin Modulators|tubulin modulators|mesh-ancestor
5730889|NCT05255653|Antimitotic Agents|antimitotic agents|mesh-ancestor
5730890|NCT05255653|Mitosis Modulators|mitosis modulators|mesh-ancestor
5730891|NCT05255653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5730892|NCT05255653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5730893|NCT05255653|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5730894|NCT05255653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5730895|NCT05255653|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5730896|NCT05255653|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5730897|NCT05255653|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5730898|NCT05255653|Contraceptive Agents|contraceptive agents|mesh-ancestor
5730899|NCT05255653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5730900|NCT05255653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730901|NCT05255653|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5730902|NCT05255653|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5730903|NCT05255653|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5730904|NCT05255653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5730905|NCT05255653|Appetite Stimulants|appetite stimulants|mesh-ancestor
5730906|NCT05255653|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5612613|NCT04354025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612614|NCT04354025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5730907|NCT05255653|Hormones|hormones|mesh-ancestor
5612615|NCT04354025|Immunologic Factors|immunologic factors|mesh-ancestor
5612616|NCT04354025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612617|NCT04354025|Antiviral Agents|antiviral agents|mesh-ancestor
5612618|NCT04354025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5612619|NCT04354025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5612620|NCT04354025|Analgesics|analgesics|mesh-ancestor
5612621|NCT04354025|Sensory System Agents|sensory system agents|mesh-ancestor
5612622|NCT04354025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5612623|NCT04352101|Citalopram|citalopram|mesh-list
5612624|NCT04352101|Bupropion|bupropion|mesh-list
5612625|NCT04352101|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5612626|NCT04352101|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5612627|NCT04352101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5612628|NCT04352101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612629|NCT04352101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5612630|NCT04352101|Serotonin Agents|serotonin agents|mesh-ancestor
5612631|NCT04352101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612632|NCT04352101|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5612633|NCT04352101|Antidepressive Agents|antidepressive agents|mesh-ancestor
5612634|NCT04352101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5730908|NCT05255653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5730909|NCT05255601|Nivolumab|nivolumab|mesh-list
5730910|NCT05255601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5730911|NCT05255601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5730912|NCT05255601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5730913|NCT05255601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5730914|NCT05255575|Ertapenem|ertapenem|mesh-list
5730915|NCT05255575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5730916|NCT05255575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5730917|NCT05255523|Capecitabine|capecitabine|mesh-list
5730918|NCT05255523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5730919|NCT05255523|Antimetabolites|antimetabolites|mesh-ancestor
5730920|NCT05255523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5730921|NCT05255523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5730922|NCT05255484|Antibodies|antibodies|mesh-list
5730923|NCT05255484|Immunologic Factors|immunologic factors|mesh-ancestor
5730924|NCT05255484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730925|NCT05255471|Olaparib|olaparib|mesh-list
5730926|NCT05255471|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5730927|NCT05255471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5730928|NCT05255471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5730929|NCT05255471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5612635|NCT04352101|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5612636|NCT04352101|Dopamine Agents|dopamine agents|mesh-ancestor
5612637|NCT04352101|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5612638|NCT04352101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5612639|NCT04352101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5612640|NCT04350463|Nivolumab|nivolumab|mesh-list
5730930|NCT05255406|Aflutinib|aflutinib|mesh-list
5730931|NCT05255406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5730932|NCT05255406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5730933|NCT05255406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5730934|NCT05255367|Phenol|phenol|mesh-list
5730935|NCT05255367|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5730936|NCT05255367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5730937|NCT05255367|Disinfectants|disinfectants|mesh-ancestor
5730938|NCT05255367|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
5730939|NCT05255367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5730940|NCT05255302|Pembrolizumab|pembrolizumab|mesh-list
5730941|NCT05255302|Pemetrexed|pemetrexed|mesh-list
5730942|NCT05255302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5730943|NCT05255302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5730944|NCT05255302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5730945|NCT05255302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5730946|NCT05255302|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5730947|NCT05255302|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5730948|NCT05255276|Itraconazole|itraconazole|mesh-list
5730949|NCT05255276|Rifampin|rifampin|mesh-list
5730950|NCT05255276|Antifungal Agents|antifungal agents|mesh-ancestor
5730951|NCT05255276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5730952|NCT05255276|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5730953|NCT05255276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5730954|NCT05255276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5892997|NCT03838159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5730955|NCT05255276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5730956|NCT05255276|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5730957|NCT05255276|Hormone Antagonists|hormone antagonists|mesh-ancestor
5730958|NCT05255276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5730959|NCT05255276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730960|NCT05255276|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5730961|NCT05255276|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5730962|NCT05255276|Antitubercular Agents|antitubercular agents|mesh-ancestor
5730963|NCT05255276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5730964|NCT05255276|Leprostatic Agents|leprostatic agents|mesh-ancestor
5730965|NCT05255276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5730966|NCT05255276|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5730967|NCT05255276|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5730968|NCT05255276|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5730969|NCT05255276|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5730970|NCT05255276|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5730971|NCT05255276|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5730972|NCT05255211|Propofol|propofol|mesh-list
5730973|NCT05255211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5730974|NCT05255211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5730975|NCT05255211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730976|NCT05255211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5730977|NCT05255211|Anesthetics, General|anesthetics, general|mesh-ancestor
5730978|NCT05255211|Anesthetics|anesthetics|mesh-ancestor
5730979|NCT05255159|Furosemide|furosemide|mesh-list
5730980|NCT05255159|Diuretics|diuretics|mesh-ancestor
5730981|NCT05255159|Natriuretic Agents|natriuretic agents|mesh-ancestor
5730982|NCT05255159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730983|NCT05255159|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5730984|NCT05255159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5730985|NCT05255159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612641|NCT04350463|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
5612642|NCT04350463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5612643|NCT04350463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6672721|NCT01557829|Silicon|silicon|mesh-list
6672722|NCT01557829|Trace Elements|trace elements|mesh-ancestor
6672723|NCT01557829|Micronutrients|micronutrients|mesh-ancestor
6672724|NCT01557829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730986|NCT05255146|Nitrous Oxide|nitrous oxide|mesh-list
5730987|NCT05255146|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5730988|NCT05255146|Anesthetics, General|anesthetics, general|mesh-ancestor
5730989|NCT05255146|Anesthetics|anesthetics|mesh-ancestor
5730990|NCT05255146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6672725|NCT01557907|Insulin|insulin|mesh-list
5612644|NCT04350463|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5612645|NCT04350463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612646|NCT04350463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5612647|NCT04349267|Nivolumab|nivolumab|mesh-list
5612648|NCT04349267|Cetuximab|cetuximab|mesh-list
5612649|NCT04349267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5612650|NCT04349267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5612651|NCT04349267|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5612652|NCT04349267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612653|NCT04347408|Antibodies|antibodies|mesh-list
5612654|NCT04347408|Immunologic Factors|immunologic factors|mesh-ancestor
5612655|NCT04347408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612656|NCT04338022|Teriflunomide|teriflunomide|mesh-list
5612657|NCT04338022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5612658|NCT04338022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5612659|NCT04338022|Analgesics|analgesics|mesh-ancestor
5612660|NCT04338022|Sensory System Agents|sensory system agents|mesh-ancestor
5612661|NCT04338022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5612662|NCT04338022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612663|NCT04338022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5612664|NCT04338022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5612665|NCT04338022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5612666|NCT04338022|Immunologic Factors|immunologic factors|mesh-ancestor
5612667|NCT04336943|Durvalumab|durvalumab|mesh-list
5612668|NCT04336943|Olaparib|olaparib|mesh-list
5612669|NCT04336943|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
5612670|NCT04336943|Immunoglobulins|immunoglobulins|mesh-list
5612671|NCT04336943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5612672|NCT04336943|Immunoglobulin G|immunoglobulin g|mesh-list
5730991|NCT05255146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5730992|NCT05255146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5730993|NCT05255146|Analgesics|analgesics|mesh-ancestor
5730994|NCT05255146|Sensory System Agents|sensory system agents|mesh-ancestor
5730995|NCT05255146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5730996|NCT05255107|Riboflavin|riboflavin|mesh-list
5730997|NCT05255107|Lubricant Eye Drops|lubricant eye drops|mesh-list
5730998|NCT05255107|Vitamin B Complex|vitamin b complex|mesh-ancestor
5730999|NCT05255107|Vitamins|vitamins|mesh-ancestor
5612673|NCT04336943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5612674|NCT04336943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5612675|NCT04336943|Immunologic Factors|immunologic factors|mesh-ancestor
5612676|NCT04336943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612677|NCT04336943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5612678|NCT04336943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612679|NCT04328727|Cyclosporine|cyclosporine|mesh-list
5612680|NCT04328727|Cyclosporins|cyclosporins|mesh-list
5612681|NCT04328727|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5612682|NCT04328727|Thymoglobulin|thymoglobulin|mesh-list
5731000|NCT05255107|Micronutrients|micronutrients|mesh-ancestor
5731001|NCT05255107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5731002|NCT05255107|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5731003|NCT05255107|Dermatologic Agents|dermatologic agents|mesh-ancestor
5731004|NCT05255107|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5731005|NCT05255107|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5731006|NCT05255016|Riboflavin|riboflavin|mesh-list
5731007|NCT05255016|Lubricant Eye Drops|lubricant eye drops|mesh-list
5731008|NCT05255016|Vitamin B Complex|vitamin b complex|mesh-ancestor
5731009|NCT05255016|Vitamins|vitamins|mesh-ancestor
5731010|NCT05255016|Micronutrients|micronutrients|mesh-ancestor
5612683|NCT04328727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5612684|NCT04328727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612685|NCT04328727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5612686|NCT04328727|Immunologic Factors|immunologic factors|mesh-ancestor
5612687|NCT04328727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612688|NCT04328727|Antifungal Agents|antifungal agents|mesh-ancestor
5612689|NCT04328727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5731011|NCT05255016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5731012|NCT05255016|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5731013|NCT05255016|Dermatologic Agents|dermatologic agents|mesh-ancestor
5731014|NCT05255016|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5731015|NCT05255016|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5731016|NCT05255003|Enoxaparin|enoxaparin|mesh-list
5731017|NCT05255003|Dalteparin|dalteparin|mesh-list
5731018|NCT05255003|Tinzaparin|tinzaparin|mesh-list
5731019|NCT05255003|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5731020|NCT05255003|Anticoagulants|anticoagulants|mesh-ancestor
5731021|NCT05255003|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5612690|NCT04328727|Dermatologic Agents|dermatologic agents|mesh-ancestor
5612691|NCT04328727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5612692|NCT04328727|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5612693|NCT04302896|Tenofovir|tenofovir|mesh-list
5612694|NCT04302896|Lamivudine|lamivudine|mesh-list
5612695|NCT04302896|Emtricitabine|emtricitabine|mesh-list
5612696|NCT04302896|Dolutegravir|dolutegravir|mesh-list
5612697|NCT04302896|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
5612698|NCT04302896|Antiviral Agents|antiviral agents|mesh-ancestor
5612699|NCT04302896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5612700|NCT04302896|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5612701|NCT04302896|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5612702|NCT04302896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5612703|NCT04302896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612704|NCT04302896|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5612705|NCT04302896|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5612706|NCT04302896|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5612707|NCT04302896|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5612708|NCT04302025|Vemurafenib|vemurafenib|mesh-list
5612709|NCT04302025|Pralsetinib|pralsetinib|mesh-list
5612710|NCT04302025|Entrectinib|entrectinib|mesh-list
5612711|NCT04302025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5612712|NCT04302025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5612713|NCT04302025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5612714|NCT04302025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5731022|NCT05255003|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5731023|NCT05255003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5731024|NCT05254925|Sunscreening Agents|sunscreening agents|mesh-list
5731025|NCT05254925|Petrolatum|petrolatum|mesh-list
5731026|NCT05254925|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5731027|NCT05254925|Protective Agents|protective agents|mesh-ancestor
5731028|NCT05254925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5731029|NCT05254925|Dermatologic Agents|dermatologic agents|mesh-ancestor
5731030|NCT05254925|Emollients|emollients|mesh-ancestor
5731031|NCT05254912|Sunscreening Agents|sunscreening agents|mesh-list
5731032|NCT05254912|Petrolatum|petrolatum|mesh-list
5731033|NCT05254912|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5731034|NCT05254912|Protective Agents|protective agents|mesh-ancestor
5731035|NCT05254912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5731036|NCT05254912|Dermatologic Agents|dermatologic agents|mesh-ancestor
5731037|NCT05254912|Emollients|emollients|mesh-ancestor
5731038|NCT05254899|Gemcitabine|gemcitabine|mesh-list
5731039|NCT05254899|Oxaliplatin|oxaliplatin|mesh-list
5731040|NCT05254899|Pegaspargase|pegaspargase|mesh-list
5731041|NCT05254899|Antibodies|antibodies|mesh-list
5731042|NCT05254899|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5731043|NCT05254899|Immunologic Factors|immunologic factors|mesh-ancestor
5731044|NCT05254899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612737|NCT04296942|Trastuzumab|trastuzumab|mesh-list
5612738|NCT04296942|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
5612739|NCT04296942|Maytansine|maytansine|mesh-list
5612740|NCT04296942|Entinostat|entinostat|mesh-list
5612741|NCT04296942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5612742|NCT04296942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5612743|NCT04296942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5612744|NCT04296942|Tubulin Modulators|tubulin modulators|mesh-ancestor
5612745|NCT04296942|Antimitotic Agents|antimitotic agents|mesh-ancestor
5612746|NCT04296942|Mitosis Modulators|mitosis modulators|mesh-ancestor
5612747|NCT04296942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612748|NCT04296942|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5612749|NCT04296942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5612750|NCT04294043|Gallium nitrate|gallium nitrate|mesh-list
5612751|NCT04294043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5612752|NCT04294043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612753|NCT04294043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5612754|NCT04291599|Ketorolac|ketorolac|mesh-list
5612755|NCT04291599|Morphine|morphine|mesh-list
5612756|NCT04291599|Hydromorphone|hydromorphone|mesh-list
5612757|NCT04291599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5612758|NCT04291599|Narcotics|narcotics|mesh-ancestor
5612759|NCT04291599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5612760|NCT04291599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612761|NCT04291599|Analgesics|analgesics|mesh-ancestor
5612762|NCT04291599|Sensory System Agents|sensory system agents|mesh-ancestor
5612763|NCT04291599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5612764|NCT04291599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5612765|NCT04291599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5612766|NCT04291599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5612767|NCT04291599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5612768|NCT04291599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5612769|NCT04291599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5612770|NCT04291599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612771|NCT04287049|Azithromycin|azithromycin|mesh-list
5731045|NCT05254899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5731046|NCT05254899|Antimetabolites|antimetabolites|mesh-ancestor
6672726|NCT01557907|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5731047|NCT05254899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5731048|NCT05254899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5731049|NCT05254899|Antiviral Agents|antiviral agents|mesh-ancestor
5731050|NCT05254899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5731051|NCT05254899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5731052|NCT05254899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5731053|NCT05254847|Capecitabine|capecitabine|mesh-list
5731054|NCT05254847|Lenvatinib|lenvatinib|mesh-list
5612772|NCT04287049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5612773|NCT04287049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5612774|NCT04269356|Magnesium Oxide|magnesium oxide|mesh-list
5612775|NCT04269356|Magnesium Hydroxide|magnesium hydroxide|mesh-list
5612776|NCT04269356|Antacids|antacids|mesh-ancestor
5612777|NCT04269356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612778|NCT04269356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5691971|NCT03412682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5691972|NCT03412682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5691973|NCT03412682|Analgesics|analgesics|mesh-ancestor
5691974|NCT03412682|Sensory System Agents|sensory system agents|mesh-ancestor
5691975|NCT03412682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5691976|NCT03412591|Suvorexant|suvorexant|mesh-list
5691977|NCT03412591|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5691978|NCT03412591|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5691979|NCT03412591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5691980|NCT03412591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691981|NCT03412591|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
5691982|NCT03412591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5691983|NCT03412591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691984|NCT03412552|Magnesium Sulfate|magnesium sulfate|mesh-list
5691985|NCT03412552|Analgesics|analgesics|mesh-ancestor
5691986|NCT03412552|Sensory System Agents|sensory system agents|mesh-ancestor
5691987|NCT03412552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5691988|NCT03412552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691989|NCT03412552|Anesthetics|anesthetics|mesh-ancestor
5691990|NCT03412552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5691991|NCT03412552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5691992|NCT03412552|Anticonvulsants|anticonvulsants|mesh-ancestor
5691993|NCT03412552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5691994|NCT03412552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5691995|NCT03412552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691996|NCT03412552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5691997|NCT03412552|Tocolytic Agents|tocolytic agents|mesh-ancestor
5691998|NCT03412552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5691999|NCT03412526|Fludarabine|fludarabine|mesh-list
5692000|NCT03412526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5692001|NCT03412513|Mirabegron|mirabegron|mesh-list
5692002|NCT03412513|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
5692003|NCT03412513|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5692004|NCT03412513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5692005|NCT03412513|Adrenergic Agents|adrenergic agents|mesh-ancestor
5692006|NCT03412513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5692007|NCT03412513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692008|NCT03412513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692009|NCT03412513|Urological Agents|urological agents|mesh-ancestor
5692010|NCT03412500|Vancomycin|vancomycin|mesh-list
5692011|NCT03412500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5692012|NCT03412500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5692013|NCT03412474|Acetaminophen|acetaminophen|mesh-list
5612779|NCT04266249|Paclitaxel|paclitaxel|mesh-list
5612780|NCT04266249|Maytansine|maytansine|mesh-list
5612781|NCT04266249|Docetaxel|docetaxel|mesh-list
5612782|NCT04266249|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
5612783|NCT04266249|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5612784|NCT04266249|Trastuzumab|trastuzumab|mesh-list
5612785|NCT04266249|Pertuzumab|pertuzumab|mesh-list
5612786|NCT04266249|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
5612787|NCT04266249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5612788|NCT04266249|Antibodies|antibodies|mesh-list
5612789|NCT04266249|Immunoglobulins|immunoglobulins|mesh-list
5612790|NCT04266249|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5612791|NCT04266249|Immunoconjugates|immunoconjugates|mesh-list
5612792|NCT04266249|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5612793|NCT04266249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5612794|NCT04266249|Tubulin Modulators|tubulin modulators|mesh-ancestor
5612795|NCT04266249|Antimitotic Agents|antimitotic agents|mesh-ancestor
5612796|NCT04266249|Mitosis Modulators|mitosis modulators|mesh-ancestor
5612797|NCT04266249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612798|NCT04266249|Immunologic Factors|immunologic factors|mesh-ancestor
5731055|NCT05254847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5731056|NCT05254847|Antimetabolites|antimetabolites|mesh-ancestor
5731057|NCT05254847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5731058|NCT05254847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5731059|NCT05254847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5731060|NCT05254847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5731061|NCT05254808|Fosfomycin|fosfomycin|mesh-list
5731062|NCT05254808|Nitrofurantoin|nitrofurantoin|mesh-list
5731063|NCT05254808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5731064|NCT05254808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5731065|NCT05254808|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5731066|NCT05254808|Renal Agents|renal agents|mesh-ancestor
5731067|NCT05254665|Docetaxel|docetaxel|mesh-list
5731068|NCT05254665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5731069|NCT05254665|Tubulin Modulators|tubulin modulators|mesh-ancestor
5731070|NCT05254665|Antimitotic Agents|antimitotic agents|mesh-ancestor
5731071|NCT05254665|Mitosis Modulators|mitosis modulators|mesh-ancestor
5731072|NCT05254665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5731073|NCT05254652|Pregabalin|pregabalin|mesh-list
5731074|NCT05254652|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5731075|NCT05254652|Analgesics|analgesics|mesh-ancestor
5731076|NCT05254652|Sensory System Agents|sensory system agents|mesh-ancestor
5731077|NCT05254652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5731078|NCT05254652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5731079|NCT05254652|Anticonvulsants|anticonvulsants|mesh-ancestor
5731080|NCT05254652|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5731081|NCT05254652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5731082|NCT05254652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5731083|NCT05254652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5731084|NCT05254652|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5731085|NCT05254652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5612799|NCT04266249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612800|NCT04222504|Tenofovir|tenofovir|mesh-list
5612801|NCT04222504|Emtricitabine|emtricitabine|mesh-list
5612802|NCT04222504|Antiviral Agents|antiviral agents|mesh-ancestor
5612803|NCT04222504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5612804|NCT04222504|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5612805|NCT04222504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5612806|NCT04222504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5612807|NCT04222504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612808|NCT04222504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5612809|NCT04222504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5612810|NCT04209946|Pulmonary Surfactants|pulmonary surfactants|mesh-list
5731086|NCT05254652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5731087|NCT05254652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5731088|NCT05254652|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5731089|NCT05254652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5731090|NCT05254652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5731091|NCT05254652|Antidepressive Agents|antidepressive agents|mesh-ancestor
5731092|NCT05254652|Dopamine Agents|dopamine agents|mesh-ancestor
5731093|NCT05254639|Donepezil|donepezil|mesh-list
5731094|NCT05254639|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5731095|NCT05254639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5731096|NCT05254639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612811|NCT04209946|Respiratory System Agents|respiratory system agents|mesh-ancestor
5612812|NCT04205136|Spironolactone|spironolactone|mesh-list
5612813|NCT04205136|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5612814|NCT04205136|Hormone Antagonists|hormone antagonists|mesh-ancestor
5612815|NCT04205136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5612816|NCT04205136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612817|NCT04205136|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5612818|NCT04205136|Diuretics|diuretics|mesh-ancestor
5612819|NCT04205136|Natriuretic Agents|natriuretic agents|mesh-ancestor
5612820|NCT04180488|Histamine Antagonists|histamine antagonists|mesh-list
5612821|NCT04180488|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
5612822|NCT04180488|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-list
5612823|NCT04180488|Histamine Agents|histamine agents|mesh-ancestor
5612824|NCT04180488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5612825|NCT04180488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612826|NCT04180488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612827|NCT04177706|Ketamine|ketamine|mesh-list
5612828|NCT04177706|Analgesics|analgesics|mesh-ancestor
5612829|NCT04177706|Sensory System Agents|sensory system agents|mesh-ancestor
5612830|NCT04177706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5612831|NCT04177706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612832|NCT04177706|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5612833|NCT04177706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5612834|NCT04177706|Anesthetics, General|anesthetics, general|mesh-ancestor
5612835|NCT04177706|Anesthetics|anesthetics|mesh-ancestor
5612836|NCT04177706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5612837|NCT04177706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5612838|NCT04177706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5612839|NCT04177706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5612840|NCT04177706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612841|NCT04173247|Mineral Oil|mineral oil|mesh-list
5612842|NCT04173247|Emollients|emollients|mesh-ancestor
5612843|NCT04173247|Dermatologic Agents|dermatologic agents|mesh-ancestor
5612844|NCT04172558|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5612845|NCT04172558|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5612846|NCT04172558|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5612847|NCT04172558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5612848|NCT04172558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612849|NCT04172558|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5612850|NCT04172558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5612851|NCT04172558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612852|NCT04172558|Cholinergic Agents|cholinergic agents|mesh-ancestor
5612853|NCT04172558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5612854|NCT04170738|Amphetamine|amphetamine|mesh-list
5612855|NCT04170738|Adderall|adderall|mesh-list
5612856|NCT04170738|Dextroamphetamine|dextroamphetamine|mesh-list
5612857|NCT04170738|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5612858|NCT04170738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612859|NCT04170738|Sympathomimetics|sympathomimetics|mesh-ancestor
5612860|NCT04170738|Autonomic Agents|autonomic agents|mesh-ancestor
5612861|NCT04170738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5612862|NCT04170738|Dopamine Agents|dopamine agents|mesh-ancestor
5612863|NCT04170738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5612864|NCT04170738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612865|NCT04170738|Adrenergic Agents|adrenergic agents|mesh-ancestor
5612866|NCT04170738|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5612867|NCT04170738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5612868|NCT04170738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5612869|NCT04170738|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5612870|NCT04166331|Dobutamine|dobutamine|mesh-list
5731097|NCT05254639|Cholinergic Agents|cholinergic agents|mesh-ancestor
5731098|NCT05254639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5731099|NCT05254639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612871|NCT04166331|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5612872|NCT04166331|Sympathomimetics|sympathomimetics|mesh-ancestor
5612873|NCT04166331|Autonomic Agents|autonomic agents|mesh-ancestor
5612874|NCT04166331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5612875|NCT04166331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612876|NCT04166331|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5612877|NCT04166331|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5612878|NCT04166331|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5612879|NCT04166331|Adrenergic Agents|adrenergic agents|mesh-ancestor
5612880|NCT04166331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5612881|NCT04166331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5731100|NCT05254639|Nootropic Agents|nootropic agents|mesh-ancestor
5731101|NCT05254626|Pioglitazone|pioglitazone|mesh-list
5731102|NCT05254626|Dapagliflozin|dapagliflozin|mesh-list
5731103|NCT05254626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5731104|NCT05254626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5731105|NCT05254626|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5731106|NCT05254626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5731107|NCT05254574|Diclofenac|diclofenac|mesh-list
5731108|NCT05254574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5731109|NCT05254574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5731110|NCT05254574|Analgesics|analgesics|mesh-ancestor
5731111|NCT05254574|Sensory System Agents|sensory system agents|mesh-ancestor
5731112|NCT05254574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5731113|NCT05254574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5731114|NCT05254574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5731115|NCT05254574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5731116|NCT05254574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5731117|NCT05254574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5731118|NCT05254574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612882|NCT04166331|Protective Agents|protective agents|mesh-ancestor
5612883|NCT04166071|Naltrexone|naltrexone|mesh-list
5612884|NCT04166071|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5612885|NCT04166071|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5612886|NCT04166071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612887|NCT04166071|Sensory System Agents|sensory system agents|mesh-ancestor
5612888|NCT04166071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5612889|NCT04163874|Pramlintide|pramlintide|mesh-list
5612890|NCT04163874|Pancrelipase|pancrelipase|mesh-list
5612891|NCT04163874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5612892|NCT04163874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5612893|NCT04163874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612894|NCT04153760|Aspirin|aspirin|mesh-list
5612895|NCT04153760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5612896|NCT04153760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5612897|NCT04153760|Analgesics|analgesics|mesh-ancestor
5612898|NCT04153760|Sensory System Agents|sensory system agents|mesh-ancestor
5612899|NCT04153760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5731119|NCT05254548|Flurbiprofen|flurbiprofen|mesh-list
5731120|NCT05254548|Midazolam|midazolam|mesh-list
5731121|NCT05254548|Omeprazole|omeprazole|mesh-list
5731122|NCT05254548|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5731123|NCT05254548|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5731124|NCT05254548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5731125|NCT05254548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5731126|NCT05254548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5731127|NCT05254548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5731128|NCT05254548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5731129|NCT05254548|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5731130|NCT05254548|Anesthetics, General|anesthetics, general|mesh-ancestor
5731131|NCT05254548|Anesthetics|anesthetics|mesh-ancestor
5731132|NCT05254548|GABA Modulators|gaba modulators|mesh-ancestor
5731133|NCT05254548|GABA Agents|gaba agents|mesh-ancestor
5731134|NCT05254548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5731135|NCT05254548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612900|NCT04153760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612901|NCT04153760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5612902|NCT04153760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5612903|NCT04153760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5612904|NCT04153760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5612905|NCT04153760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612906|NCT04153760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5612907|NCT04153760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5612908|NCT04153760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5612909|NCT04153760|Antipyretics|antipyretics|mesh-ancestor
5612910|NCT04140526|Pembrolizumab|pembrolizumab|mesh-list
5612911|NCT04140526|Osimertinib|osimertinib|mesh-list
5692014|NCT03412474|Dexmedetomidine|dexmedetomidine|mesh-list
5731136|NCT05254548|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5731137|NCT05254548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5731138|NCT05254548|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5731139|NCT05254548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5731140|NCT05254548|Analgesics|analgesics|mesh-ancestor
5731141|NCT05254548|Sensory System Agents|sensory system agents|mesh-ancestor
5731142|NCT05254548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5731143|NCT05254548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5731144|NCT05254548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5731145|NCT05254548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5731146|NCT05254548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5731147|NCT05254548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5731148|NCT05254418|Dulaglutide|dulaglutide|mesh-list
5731149|NCT05254418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5731150|NCT05254418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5731151|NCT05254405|Brexanolone|brexanolone|mesh-list
5731152|NCT05254405|Neurosteroids|neurosteroids|mesh-ancestor
5731153|NCT05254405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5731154|NCT05254405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5731155|NCT05254405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5731156|NCT05254405|GABA Modulators|gaba modulators|mesh-ancestor
5731157|NCT05254405|GABA Agents|gaba agents|mesh-ancestor
5731158|NCT05254288|Chlorhexidine|chlorhexidine|mesh-list
5731159|NCT05254288|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5731160|NCT05254288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5731161|NCT05254288|Disinfectants|disinfectants|mesh-ancestor
5731162|NCT05254275|Chlorhexidine|chlorhexidine|mesh-list
5731163|NCT05254275|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5731164|NCT05254275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5731165|NCT05254275|Disinfectants|disinfectants|mesh-ancestor
5731166|NCT05254236|Vaccines|vaccines|mesh-list
5731167|NCT05254236|Immunologic Factors|immunologic factors|mesh-ancestor
5731168|NCT05254236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5731169|NCT05254223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
5731170|NCT05254184|Nivolumab|nivolumab|mesh-list
5731171|NCT05254184|Ipilimumab|ipilimumab|mesh-list
5731172|NCT05254184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5731173|NCT05254184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5731174|NCT05254184|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5731175|NCT05254184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5731176|NCT05254171|Gemcitabine|gemcitabine|mesh-list
5731177|NCT05254171|Paclitaxel|paclitaxel|mesh-list
5731178|NCT05254171|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5731179|NCT05254171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5731180|NCT05254171|Tubulin Modulators|tubulin modulators|mesh-ancestor
5731181|NCT05254171|Antimitotic Agents|antimitotic agents|mesh-ancestor
5731182|NCT05254171|Mitosis Modulators|mitosis modulators|mesh-ancestor
5731183|NCT05254171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612912|NCT04140526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5612913|NCT04140526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5612914|NCT04140526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5612915|NCT04140526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5612916|NCT04140526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612917|NCT04140305|Ozanimod|ozanimod|mesh-list
5612918|NCT04140305|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5612919|NCT04140305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612920|NCT04140305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5612921|NCT04140305|Immunologic Factors|immunologic factors|mesh-ancestor
5612922|NCT04140305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612923|NCT04138706|Vancomycin|vancomycin|mesh-list
5612924|NCT04138706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5612925|NCT04138706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5612926|NCT04129996|Paclitaxel|paclitaxel|mesh-list
5612927|NCT04129996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5612928|NCT04129996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5612929|NCT04129996|Tubulin Modulators|tubulin modulators|mesh-ancestor
5612930|NCT04129996|Antimitotic Agents|antimitotic agents|mesh-ancestor
5612931|NCT04129996|Mitosis Modulators|mitosis modulators|mesh-ancestor
5612932|NCT04129996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612933|NCT04129619|Ether|ether|mesh-list
5612934|NCT04129619|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5612935|NCT04129619|Anesthetics, General|anesthetics, general|mesh-ancestor
5612936|NCT04129619|Anesthetics|anesthetics|mesh-ancestor
5612937|NCT04129619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5612938|NCT04129619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5731184|NCT05254171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5612939|NCT04125134|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5612940|NCT04125134|Lubricant Eye Drops|lubricant eye drops|mesh-list
5612941|NCT04125134|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5612942|NCT04120766|Nicorandil|nicorandil|mesh-list
5612943|NCT04120766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5612944|NCT04120766|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5612945|NCT04120766|Vasodilator Agents|vasodilator agents|mesh-ancestor
5612946|NCT04120766|Vitamin B Complex|vitamin b complex|mesh-ancestor
5612947|NCT04120766|Vitamins|vitamins|mesh-ancestor
5612948|NCT04120766|Micronutrients|micronutrients|mesh-ancestor
5612949|NCT04120766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612950|NCT04109391|Trastuzumab|trastuzumab|mesh-list
5612951|NCT04109391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5612952|NCT04109391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5612953|NCT04108156|Ranibizumab|ranibizumab|mesh-list
5612954|NCT04108156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5612955|NCT04108156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5612956|NCT04108156|Growth Substances|growth substances|mesh-ancestor
5612957|NCT04108156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612958|NCT04108156|Growth Inhibitors|growth inhibitors|mesh-ancestor
5612959|NCT04108156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5612963|NCT04106115|Durvalumab|durvalumab|mesh-list
5612964|NCT04106115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5612965|NCT04106115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5612966|NCT04105998|Oxytocin|oxytocin|mesh-list
5612967|NCT04105998|Oxytocics|oxytocics|mesh-ancestor
5612968|NCT04105998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5612969|NCT04105998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612970|NCT04100018|Prednisone|prednisone|mesh-list
5612971|NCT04100018|Docetaxel|docetaxel|mesh-list
5612972|NCT04100018|Nivolumab|nivolumab|mesh-list
5612973|NCT04100018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5612974|NCT04100018|Tubulin Modulators|tubulin modulators|mesh-ancestor
5612975|NCT04100018|Antimitotic Agents|antimitotic agents|mesh-ancestor
5612976|NCT04100018|Mitosis Modulators|mitosis modulators|mesh-ancestor
5612977|NCT04100018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5612978|NCT04100018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5612979|NCT04100018|Glucocorticoids|glucocorticoids|mesh-ancestor
5612980|NCT04100018|Hormones|hormones|mesh-ancestor
5612981|NCT04100018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5612982|NCT04100018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612983|NCT04100018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5612984|NCT04100018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5612985|NCT04100018|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5692015|NCT03412474|Bupivacaine|bupivacaine|mesh-list
5731185|NCT05254171|Antimetabolites|antimetabolites|mesh-ancestor
5731186|NCT05254171|Antiviral Agents|antiviral agents|mesh-ancestor
5731187|NCT05254171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5731188|NCT05254171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5731189|NCT05254171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5731190|NCT05254171|Immunologic Factors|immunologic factors|mesh-ancestor
5731191|NCT05254171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5731192|NCT05254002|Empagliflozin|empagliflozin|mesh-list
5731193|NCT05254002|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5692016|NCT03412474|Anesthetics, Local|anesthetics, local|mesh-ancestor
5731194|NCT05254002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5731195|NCT05254002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5731196|NCT05254002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5731197|NCT05253937|Epinephrine|epinephrine|mesh-list
5731198|NCT05253937|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5731199|NCT05253937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5731200|NCT05253937|Adrenergic Agents|adrenergic agents|mesh-ancestor
5731201|NCT05253937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5731202|NCT05253937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5731203|NCT05253937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5731204|NCT05253937|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5731205|NCT05253937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5731206|NCT05253937|Autonomic Agents|autonomic agents|mesh-ancestor
5731207|NCT05253937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5731208|NCT05253937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5692017|NCT03412474|Anesthetics|anesthetics|mesh-ancestor
5692018|NCT03412474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5692019|NCT03412474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5731209|NCT05253937|Respiratory System Agents|respiratory system agents|mesh-ancestor
5731210|NCT05253937|Mydriatics|mydriatics|mesh-ancestor
5731211|NCT05253937|Sympathomimetics|sympathomimetics|mesh-ancestor
5731212|NCT05253937|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5731213|NCT05253846|Fluorouracil|fluorouracil|mesh-list
5731214|NCT05253846|Oxaliplatin|oxaliplatin|mesh-list
5731215|NCT05253846|Irinotecan|irinotecan|mesh-list
5612986|NCT04075136|Triamcinolone|triamcinolone|mesh-list
5612987|NCT04075136|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5612988|NCT04075136|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5612989|NCT04075136|Ranibizumab|ranibizumab|mesh-list
5612990|NCT04075136|Verteporfin|verteporfin|mesh-list
5612991|NCT04075136|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5612992|NCT04075136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5612993|NCT04075136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5612994|NCT04075136|Growth Substances|growth substances|mesh-ancestor
5612995|NCT04075136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5612996|NCT04075136|Growth Inhibitors|growth inhibitors|mesh-ancestor
5731216|NCT05253846|Antimetabolites|antimetabolites|mesh-ancestor
5731217|NCT05253846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5731218|NCT05253846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5612997|NCT04075136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5612998|NCT04075136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5612999|NCT04075136|Glucocorticoids|glucocorticoids|mesh-ancestor
5613000|NCT04075136|Hormones|hormones|mesh-ancestor
5613001|NCT04075136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5731219|NCT05253846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5731220|NCT05253846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5731221|NCT05253846|Immunologic Factors|immunologic factors|mesh-ancestor
5731222|NCT05253846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5731223|NCT05253846|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5731224|NCT05253846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5731225|NCT05253846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5731226|NCT05253833|Allopurinol|allopurinol|mesh-list
5731227|NCT05253833|Antimetabolites|antimetabolites|mesh-ancestor
5731228|NCT05253833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5731229|NCT05253833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5731230|NCT05253833|Gout Suppressants|gout suppressants|mesh-ancestor
5731231|NCT05253833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5731232|NCT05253833|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5731233|NCT05253833|Antioxidants|antioxidants|mesh-ancestor
5731234|NCT05253833|Protective Agents|protective agents|mesh-ancestor
5613002|NCT04075136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5613003|NCT04075136|Immunologic Factors|immunologic factors|mesh-ancestor
5613004|NCT04075136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5613005|NCT04075136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613006|NCT04075136|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5613007|NCT04075136|Dermatologic Agents|dermatologic agents|mesh-ancestor
5613008|NCT04074967|Nivolumab|nivolumab|mesh-list
5613009|NCT04074967|Ipilimumab|ipilimumab|mesh-list
5613010|NCT04074967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5613011|NCT04074967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5731235|NCT05253833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5731236|NCT05253794|Colchicine|colchicine|mesh-list
5731237|NCT05253794|Gout Suppressants|gout suppressants|mesh-ancestor
5731238|NCT05253794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5731239|NCT05253794|Tubulin Modulators|tubulin modulators|mesh-ancestor
5731240|NCT05253794|Antimitotic Agents|antimitotic agents|mesh-ancestor
5731241|NCT05253794|Mitosis Modulators|mitosis modulators|mesh-ancestor
5731242|NCT05253794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5731243|NCT05253794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5731244|NCT05253781|Aspirin|aspirin|mesh-list
5731245|NCT05253781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5731246|NCT05253781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5731247|NCT05253781|Analgesics|analgesics|mesh-ancestor
5731248|NCT05253781|Sensory System Agents|sensory system agents|mesh-ancestor
5731249|NCT05253781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5731250|NCT05253781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5731251|NCT05253781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5731252|NCT05253781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5731253|NCT05253781|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5731254|NCT05253781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5731255|NCT05253781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613012|NCT04074967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5731256|NCT05253781|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5731257|NCT05253781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5731258|NCT05253781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5731259|NCT05253781|Antipyretics|antipyretics|mesh-ancestor
5731260|NCT05253768|Glycerol|glycerol|mesh-list
5613013|NCT04074967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613014|NCT04074759|Pembrolizumab|pembrolizumab|mesh-list
5613015|NCT04074759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5731261|NCT05253768|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
5731262|NCT05253768|Protective Agents|protective agents|mesh-ancestor
5731263|NCT05253768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5731264|NCT05253651|Leucovorin|leucovorin|mesh-list
5731265|NCT05253651|Bevacizumab|bevacizumab|mesh-list
5613016|NCT04074759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5613017|NCT04074174|Acetaminophen|acetaminophen|mesh-list
5613018|NCT04074174|Contraceptive Agents|contraceptive agents|mesh-list
5613019|NCT04074174|Contraceptives, Oral|contraceptives, oral|mesh-list
5613020|NCT04074174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5613021|NCT04074174|Analgesics|analgesics|mesh-ancestor
5613022|NCT04074174|Sensory System Agents|sensory system agents|mesh-ancestor
5613023|NCT04074174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5613024|NCT04074174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613025|NCT04074174|Antipyretics|antipyretics|mesh-ancestor
5613026|NCT04074174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5613027|NCT04074174|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5613028|NCT04068831|Avelumab|avelumab|mesh-list
5613029|NCT04068831|Talazoparib|talazoparib|mesh-list
5613030|NCT04068831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5613031|NCT04068831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5613032|NCT04068831|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5613033|NCT04068831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5613034|NCT04068831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5731266|NCT05253651|Trastuzumab|trastuzumab|mesh-list
5731267|NCT05253651|Cetuximab|cetuximab|mesh-list
5731268|NCT05253651|Fluorouracil|fluorouracil|mesh-list
5731269|NCT05253651|Oxaliplatin|oxaliplatin|mesh-list
5731270|NCT05253651|Tucatinib|tucatinib|mesh-list
5731271|NCT05253651|Levoleucovorin|levoleucovorin|mesh-list
5731272|NCT05253651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5731273|NCT05253651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5731274|NCT05253651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5731275|NCT05253651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5731276|NCT05253651|Growth Substances|growth substances|mesh-ancestor
5731277|NCT05253651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5731278|NCT05253651|Growth Inhibitors|growth inhibitors|mesh-ancestor
5731279|NCT05253651|Antimetabolites|antimetabolites|mesh-ancestor
5731280|NCT05253651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5731281|NCT05253651|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5731282|NCT05253651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5731283|NCT05253651|Immunologic Factors|immunologic factors|mesh-ancestor
5731284|NCT05253651|Antidotes|antidotes|mesh-ancestor
5731285|NCT05253651|Protective Agents|protective agents|mesh-ancestor
5731286|NCT05253651|Vitamin B Complex|vitamin b complex|mesh-ancestor
5731287|NCT05253651|Vitamins|vitamins|mesh-ancestor
5731288|NCT05253651|Micronutrients|micronutrients|mesh-ancestor
5731289|NCT05253651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5731290|NCT05253651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5731291|NCT05253573|Nicotine|nicotine|mesh-list
5731292|NCT05253573|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5731293|NCT05253573|Autonomic Agents|autonomic agents|mesh-ancestor
5613035|NCT04063579|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
5613036|NCT04063579|Natriuretic Agents|natriuretic agents|mesh-ancestor
5613037|NCT04063579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613038|NCT04061421|Decitabine|decitabine|mesh-list
5613039|NCT04061421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5613040|NCT04061421|Antimetabolites|antimetabolites|mesh-ancestor
5613041|NCT04061421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613042|NCT04061421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5613043|NCT04061421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5613044|NCT04054713|Acetic Acid|acetic acid|mesh-list
5613045|NCT04054713|Retinol acetate|retinol acetate|mesh-list
5613046|NCT04054713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5613047|NCT04054713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5613048|NCT04054713|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5613049|NCT04054713|Immunologic Factors|immunologic factors|mesh-ancestor
5613050|NCT04054713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5731294|NCT05253573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6672727|NCT01557907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5731295|NCT05253573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5731296|NCT05253573|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5731297|NCT05253573|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5731298|NCT05253573|Cholinergic Agents|cholinergic agents|mesh-ancestor
5731299|NCT05253573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5731300|NCT05253573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5731301|NCT05230810|Fulvestrant|fulvestrant|mesh-list
5731302|NCT05230810|Tucatinib|tucatinib|mesh-list
5731303|NCT05230810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5731304|NCT05230810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5731305|NCT05230810|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5731306|NCT05230810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5731307|NCT05230810|Hormone Antagonists|hormone antagonists|mesh-ancestor
5731308|NCT05230810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5731309|NCT05230810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5731310|NCT05230810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5731311|NCT05230810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5731312|NCT05230810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5731313|NCT05227937|Amikacin|amikacin|mesh-list
5731314|NCT05227937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5731315|NCT05227937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5731316|NCT05227677|Hypoglycemic Agents|hypoglycemic agents|mesh-list
5731317|NCT05227677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208114|NCT02124811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6208115|NCT02124811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6208116|NCT02125279|Calcitriol|calcitriol|mesh-list
6208117|NCT02125279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6208118|NCT02125279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208119|NCT02125279|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6208120|NCT02125279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6208121|NCT02125279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208122|NCT02125279|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6208123|NCT02125279|Vitamins|vitamins|mesh-ancestor
6208124|NCT02125279|Micronutrients|micronutrients|mesh-ancestor
6208125|NCT02125279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6208126|NCT02125292|Mesalamine|mesalamine|mesh-list
6208127|NCT02125292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6208128|NCT02125292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6208129|NCT02125292|Analgesics|analgesics|mesh-ancestor
6208130|NCT02125292|Sensory System Agents|sensory system agents|mesh-ancestor
6208131|NCT02125292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6208132|NCT02125292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208133|NCT02125292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6208134|NCT02125292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6208135|NCT02125604|Dimethyl Fumarate|dimethyl fumarate|mesh-list
6208136|NCT02125604|Dermatologic Agents|dermatologic agents|mesh-ancestor
6208137|NCT02125604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6208138|NCT02125604|Immunologic Factors|immunologic factors|mesh-ancestor
6208139|NCT02125604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208140|NCT02125721|Penicillamine|penicillamine|mesh-list
5731345|NCT05178823|Chlorhexidine|chlorhexidine|mesh-list
5731346|NCT05178823|Chlorine dioxide|chlorine dioxide|mesh-list
5731347|NCT05178823|Fluorides|fluorides|mesh-list
5731348|NCT05178823|Sodium Fluoride|sodium fluoride|mesh-list
5731349|NCT05178823|Cariostatic Agents|cariostatic agents|mesh-ancestor
5731350|NCT05178823|Protective Agents|protective agents|mesh-ancestor
5731351|NCT05178823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613051|NCT04054713|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5613052|NCT04054713|Protective Agents|protective agents|mesh-ancestor
5613053|NCT04054713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5613054|NCT04044469|Vaccines|vaccines|mesh-list
5613055|NCT04044469|Immunologic Factors|immunologic factors|mesh-ancestor
5613056|NCT04044469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613057|NCT04040959|Niacinamide|niacinamide|mesh-list
5613058|NCT04040959|Niacin|niacin|mesh-list
5613059|NCT04040959|Nicotinic Acids|nicotinic acids|mesh-list
5613060|NCT04040959|Vitamin B Complex|vitamin b complex|mesh-ancestor
5613061|NCT04040959|Vitamins|vitamins|mesh-ancestor
5731352|NCT05178823|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5731353|NCT05178823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5731354|NCT05178823|Disinfectants|disinfectants|mesh-ancestor
5731355|NCT05178823|Dental Disinfectants|dental disinfectants|mesh-ancestor
6208141|NCT02125721|Antidotes|antidotes|mesh-ancestor
5613062|NCT04040959|Micronutrients|micronutrients|mesh-ancestor
5613063|NCT04040959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208142|NCT02125721|Protective Agents|protective agents|mesh-ancestor
6208143|NCT02125721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5731359|NCT05168202|Azacitidine|azacitidine|mesh-list
5613064|NCT04040959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5613065|NCT04040959|Antimetabolites|antimetabolites|mesh-ancestor
5613066|NCT04040959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5731360|NCT05168202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5731361|NCT05168202|Antimetabolites|antimetabolites|mesh-ancestor
5731362|NCT05168202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5731363|NCT05168202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5731364|NCT05168202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5731365|NCT05166304|Rebamipide|rebamipide|mesh-list
5731366|NCT05166304|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5731367|NCT05166304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5731368|NCT05166304|Antioxidants|antioxidants|mesh-ancestor
5731369|NCT05166304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5731370|NCT05166304|Protective Agents|protective agents|mesh-ancestor
5731371|NCT05166304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5731372|NCT05166304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6208144|NCT02125721|Chelating Agents|chelating agents|mesh-ancestor
6208145|NCT02125721|Sequestering Agents|sequestering agents|mesh-ancestor
6208146|NCT02125721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208147|NCT02125721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6208148|NCT02125734|Bromides|bromides|mesh-list
6208149|NCT02125734|Tiotropium Bromide|tiotropium bromide|mesh-list
6208150|NCT02125734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6208151|NCT02125734|Autonomic Agents|autonomic agents|mesh-ancestor
6208152|NCT02125734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6208153|NCT02125734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208154|NCT02125734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5613067|NCT04040959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5613068|NCT04040959|Vasodilator Agents|vasodilator agents|mesh-ancestor
5613069|NCT04034056|Obinutuzumab|obinutuzumab|mesh-list
5613070|NCT04034056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5613071|NCT04034056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5613072|NCT04030169|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
5613073|NCT04030169|Hallucinogens|hallucinogens|mesh-ancestor
5613074|NCT04030169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613075|NCT04030169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5613076|NCT04030169|Serotonin Agents|serotonin agents|mesh-ancestor
5613077|NCT04030169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5613078|NCT04030169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613079|NCT04030169|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5613080|NCT04030169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5613081|NCT04030169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5613082|NCT04030169|Adrenergic Agents|adrenergic agents|mesh-ancestor
5613083|NCT04023071|Cyclophosphamide|cyclophosphamide|mesh-list
5613084|NCT04023071|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5613085|NCT04023071|Rituximab|rituximab|mesh-list
5613086|NCT04023071|Fludarabine|fludarabine|mesh-list
5613087|NCT04023071|Obinutuzumab|obinutuzumab|mesh-list
5613088|NCT04023071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5613089|NCT04023071|Immunologic Factors|immunologic factors|mesh-ancestor
5613090|NCT04023071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613091|NCT04023071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5613092|NCT04023071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5613093|NCT04023071|Alkylating Agents|alkylating agents|mesh-ancestor
6208155|NCT02125734|Respiratory System Agents|respiratory system agents|mesh-ancestor
6208156|NCT02125734|Parasympatholytics|parasympatholytics|mesh-ancestor
6208157|NCT02125734|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6208158|NCT02125734|Cholinergic Agents|cholinergic agents|mesh-ancestor
5731381|NCT05152927|Parathyroid Hormone|parathyroid hormone|mesh-list
5731382|NCT05152927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5731383|NCT05152927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5731384|NCT05149638|Cosyntropin|cosyntropin|mesh-list
5613094|NCT04023071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613095|NCT04023071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5613096|NCT04023071|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5613097|NCT04023071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5613098|NCT04019262|Temozolomide|temozolomide|mesh-list
5613099|NCT04019262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5613100|NCT04019262|Alkylating Agents|alkylating agents|mesh-ancestor
5613101|NCT04019262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613102|NCT04019262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5613103|NCT04008628|Nitrous Oxide|nitrous oxide|mesh-list
5613104|NCT04008628|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5731385|NCT05149638|Hormones|hormones|mesh-ancestor
5613105|NCT04008628|Anesthetics, General|anesthetics, general|mesh-ancestor
5613106|NCT04008628|Anesthetics|anesthetics|mesh-ancestor
5613107|NCT04008628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5613108|NCT04008628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613109|NCT04008628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5613110|NCT04008628|Analgesics|analgesics|mesh-ancestor
5613111|NCT04008628|Sensory System Agents|sensory system agents|mesh-ancestor
5613112|NCT04008628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5613113|NCT04001894|Clopidogrel|clopidogrel|mesh-list
5613114|NCT04001894|Ticagrelor|ticagrelor|mesh-list
5613115|NCT04001894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5613116|NCT04001894|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5613117|NCT04001894|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5613118|NCT04001894|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5613119|NCT04001894|Purinergic Agents|purinergic agents|mesh-ancestor
5613120|NCT04001894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5613121|NCT04001894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613122|NCT04001894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613123|NCT03988920|Sevelamer|sevelamer|mesh-list
5731386|NCT05149638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5731387|NCT05149638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208159|NCT02125734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6208160|NCT02125734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208161|NCT02125734|Anticonvulsants|anticonvulsants|mesh-ancestor
6212572|NCT02189837|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6212573|NCT02189837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6212574|NCT02189837|Immunologic Factors|immunologic factors|mesh-ancestor
5731394|NCT05145400|Dexamethasone|dexamethasone|mesh-list
5731395|NCT05145400|Lenalidomide|lenalidomide|mesh-list
5731396|NCT05145400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5731397|NCT05145400|Antiemetics|antiemetics|mesh-ancestor
5731398|NCT05145400|Autonomic Agents|autonomic agents|mesh-ancestor
5731399|NCT05145400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5731400|NCT05145400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5731401|NCT05145400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5731402|NCT05145400|Glucocorticoids|glucocorticoids|mesh-ancestor
5731403|NCT05145400|Hormones|hormones|mesh-ancestor
5731404|NCT05145400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5731405|NCT05145400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5731406|NCT05145400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5731407|NCT05145400|Immunologic Factors|immunologic factors|mesh-ancestor
5731408|NCT05145400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5731409|NCT05145400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5731410|NCT05145400|Growth Substances|growth substances|mesh-ancestor
5731411|NCT05145400|Growth Inhibitors|growth inhibitors|mesh-ancestor
5731412|NCT05143970|Trastuzumab|trastuzumab|mesh-list
5731413|NCT05143970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5731414|NCT05143970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6212575|NCT02189837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613124|NCT03988920|Chelating Agents|chelating agents|mesh-ancestor
5613125|NCT03988920|Sequestering Agents|sequestering agents|mesh-ancestor
5613126|NCT03988920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212576|NCT02189889|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
6212577|NCT02189889|Hematinics|hematinics|mesh-ancestor
6212578|NCT02189889|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5731419|NCT05096442|Paclitaxel|paclitaxel|mesh-list
5731420|NCT05096442|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5731421|NCT05096442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5731422|NCT05096442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5731423|NCT05096442|Tubulin Modulators|tubulin modulators|mesh-ancestor
5731424|NCT05096442|Antimitotic Agents|antimitotic agents|mesh-ancestor
5731425|NCT05096442|Mitosis Modulators|mitosis modulators|mesh-ancestor
5731426|NCT05096442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5731427|NCT05093322|Gemcitabine|gemcitabine|mesh-list
5731428|NCT05093322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5731429|NCT05093322|Antimetabolites|antimetabolites|mesh-ancestor
5731430|NCT05093322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613127|NCT03982485|Paclitaxel|paclitaxel|mesh-list
5613128|NCT03982485|Apatinib|apatinib|mesh-list
5613129|NCT03982485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5613130|NCT03982485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5613131|NCT03982485|Tubulin Modulators|tubulin modulators|mesh-ancestor
5613132|NCT03982485|Antimitotic Agents|antimitotic agents|mesh-ancestor
5613133|NCT03982485|Mitosis Modulators|mitosis modulators|mesh-ancestor
5731431|NCT05093322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5731432|NCT05093322|Antiviral Agents|antiviral agents|mesh-ancestor
5731433|NCT05093322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5731434|NCT05093322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5731435|NCT05093322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5731436|NCT05093322|Immunologic Factors|immunologic factors|mesh-ancestor
5731437|NCT05093322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5731438|NCT05084586|Epirubicin|epirubicin|mesh-list
5613134|NCT03982485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613135|NCT03982485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5613136|NCT03982485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5613137|NCT03969121|Palbociclib|palbociclib|mesh-list
5613138|NCT03969121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5613139|NCT03969121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5613140|NCT03969121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5613141|NCT03969121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613142|NCT03966339|Hormones|hormones|mesh-list
5613143|NCT03966339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5731439|NCT05084586|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5731440|NCT05084586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5731441|NCT05084586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5731442|NCT05084586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5731443|NCT05084586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5731444|NCT05084586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5731445|NCT05084586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5731446|NCT05074290|Taxane|taxane|mesh-list
5731447|NCT05074290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5731448|NCT05067634|Cenobamate|cenobamate|mesh-list
5731449|NCT05067634|Anticonvulsants|anticonvulsants|mesh-ancestor
5731450|NCT05063734|Aflibercept|aflibercept|mesh-list
5731451|NCT05063734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5731452|NCT05063734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5731453|NCT05063734|Growth Substances|growth substances|mesh-ancestor
5731454|NCT05063734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5731455|NCT05063734|Growth Inhibitors|growth inhibitors|mesh-ancestor
5731456|NCT05063734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6208162|NCT02125877|Deferasirox|deferasirox|mesh-list
6208163|NCT02125877|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6208164|NCT02125877|Chelating Agents|chelating agents|mesh-ancestor
6208165|NCT02125877|Sequestering Agents|sequestering agents|mesh-ancestor
6208166|NCT02125877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208167|NCT02126839|Albuterol|albuterol|mesh-list
6208168|NCT02126839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6208169|NCT02126839|Autonomic Agents|autonomic agents|mesh-ancestor
6208170|NCT02126839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6208171|NCT02126839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208172|NCT02126839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6208173|NCT02126839|Respiratory System Agents|respiratory system agents|mesh-ancestor
6208174|NCT02126839|Tocolytic Agents|tocolytic agents|mesh-ancestor
6208175|NCT02126839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6208176|NCT02126839|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6208177|NCT02126839|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6208178|NCT02126839|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6208179|NCT02126839|Adrenergic Agents|adrenergic agents|mesh-ancestor
6208180|NCT02126839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6208181|NCT02126839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208182|NCT02126969|Carboplatin|carboplatin|mesh-list
5613144|NCT03966339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613145|NCT03948022|Progesterone|progesterone|mesh-list
5613146|NCT03948022|Dydrogesterone|dydrogesterone|mesh-list
5613147|NCT03948022|Progestins|progestins|mesh-ancestor
5613148|NCT03948022|Hormones|hormones|mesh-ancestor
5613149|NCT03948022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5613150|NCT03948022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613151|NCT03946111|Naltrexone|naltrexone|mesh-list
5613152|NCT03946111|Bupropion|bupropion|mesh-list
5613153|NCT03946111|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5613154|NCT03946111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5613155|NCT03946111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613156|NCT03946111|Sensory System Agents|sensory system agents|mesh-ancestor
5613157|NCT03946111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5613158|NCT03946111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5613159|NCT03946111|Antidepressive Agents|antidepressive agents|mesh-ancestor
5613160|NCT03946111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6208183|NCT02126969|Docetaxel|docetaxel|mesh-list
5613161|NCT03946111|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6208184|NCT02126969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6208185|NCT02126969|Tubulin Modulators|tubulin modulators|mesh-ancestor
6208186|NCT02126969|Antimitotic Agents|antimitotic agents|mesh-ancestor
6208187|NCT02126969|Mitosis Modulators|mitosis modulators|mesh-ancestor
6208188|NCT02126969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208189|NCT02127125|Sevelamer|sevelamer|mesh-list
6208190|NCT02127125|Chelating Agents|chelating agents|mesh-ancestor
6208191|NCT02127125|Sequestering Agents|sequestering agents|mesh-ancestor
6208192|NCT02127125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208193|NCT02127372|Cisplatin|cisplatin|mesh-list
6208194|NCT02127372|Docetaxel|docetaxel|mesh-list
6208195|NCT02127372|Imatinib Mesylate|imatinib mesylate|mesh-list
6208196|NCT02127372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6208197|NCT02127372|Tubulin Modulators|tubulin modulators|mesh-ancestor
6208198|NCT02127372|Antimitotic Agents|antimitotic agents|mesh-ancestor
6208199|NCT02127372|Mitosis Modulators|mitosis modulators|mesh-ancestor
6208200|NCT02127372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208201|NCT02127372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6208202|NCT02127372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6208203|NCT02127723|Hyaluronic Acid|hyaluronic acid|mesh-list
6208204|NCT02127723|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6208205|NCT02127723|Immunologic Factors|immunologic factors|mesh-ancestor
6208206|NCT02127723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208207|NCT02127723|Viscosupplements|viscosupplements|mesh-ancestor
6208208|NCT02127723|Protective Agents|protective agents|mesh-ancestor
6208209|NCT02127970|Dalbavancin|dalbavancin|mesh-list
6208210|NCT02127970|Teicoplanin|teicoplanin|mesh-list
6208211|NCT02127970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6208212|NCT02127970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6208213|NCT02128217|Ribavirin|ribavirin|mesh-list
5731510|NCT05022004|Brinzolamide|brinzolamide|mesh-list
5731511|NCT05022004|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5731512|NCT05022004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5731513|NCT05022004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5731514|NCT05017610|Lomustine|lomustine|mesh-list
5613162|NCT03946111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5613163|NCT03946111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5613164|NCT03946111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613165|NCT03946111|Dopamine Agents|dopamine agents|mesh-ancestor
5613166|NCT03946111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5731515|NCT05017610|Methimazole|methimazole|mesh-list
5731516|NCT05017610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5731517|NCT05017610|Alkylating Agents|alkylating agents|mesh-ancestor
5731518|NCT05017610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5731519|NCT05017610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5731520|NCT05017610|Antithyroid Agents|antithyroid agents|mesh-ancestor
5731521|NCT05017610|Hormone Antagonists|hormone antagonists|mesh-ancestor
5731522|NCT05017610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5731523|NCT05017610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5731524|NCT05013801|Hydroquinone|hydroquinone|mesh-list
5731525|NCT05013801|Antioxidants|antioxidants|mesh-ancestor
5731526|NCT05013801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5731527|NCT05013801|Protective Agents|protective agents|mesh-ancestor
5731528|NCT05013801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5731529|NCT05013801|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5731530|NCT05012865|Avelumab|avelumab|mesh-list
5731531|NCT05012865|Axitinib|axitinib|mesh-list
5731532|NCT05012865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5731533|NCT05012865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5731534|NCT05012865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5731535|NCT05012865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5731536|NCT05012865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208214|NCT02128217|Sofosbuvir|sofosbuvir|mesh-list
6208215|NCT02128217|Ledipasvir|ledipasvir|mesh-list
5892998|NCT03838159|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5613167|NCT03946111|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5613168|NCT03946111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5613169|NCT03946111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5613170|NCT03937596|Cycloserine|cycloserine|mesh-list
5613171|NCT03937596|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5613172|NCT03937596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5613173|NCT03937596|Renal Agents|renal agents|mesh-ancestor
6208216|NCT02128217|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
6208217|NCT02128217|Antimetabolites|antimetabolites|mesh-ancestor
5613174|NCT03937596|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5613175|NCT03937596|Antitubercular Agents|antitubercular agents|mesh-ancestor
5613176|NCT03937596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5613177|NCT03937596|Antimetabolites|antimetabolites|mesh-ancestor
5613178|NCT03937596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613179|NCT03930745|TOL-463|tol-463|mesh-list
5613180|NCT03930745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6208218|NCT02128217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5731540|NCT05008224|Prednisone|prednisone|mesh-list
5731541|NCT05008224|Cyclophosphamide|cyclophosphamide|mesh-list
5731542|NCT05008224|Dacarbazine|dacarbazine|mesh-list
5731543|NCT05008224|Doxorubicin|doxorubicin|mesh-list
5731544|NCT05008224|Pembrolizumab|pembrolizumab|mesh-list
5731545|NCT05008224|Etoposide|etoposide|mesh-list
5731546|NCT05008224|Etoposide phosphate|etoposide phosphate|mesh-list
5613181|NCT03928158|Valsartan|valsartan|mesh-list
5613182|NCT03928158|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5613183|NCT03928158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5613184|NCT03928158|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5613185|NCT03928158|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5613186|NCT03928158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613187|NCT03926052|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
5613188|NCT03926052|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5613189|NCT03926052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613190|NCT03926052|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5613191|NCT03926052|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5613192|NCT03926052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5613193|NCT03926052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613194|NCT03926052|Dopamine Agents|dopamine agents|mesh-ancestor
5613195|NCT03926052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5613196|NCT03924193|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
5613197|NCT03924193|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5613198|NCT03924193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613199|NCT03924193|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5613200|NCT03924193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5613201|NCT03924193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5613202|NCT03924193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613203|NCT03924193|Dopamine Agents|dopamine agents|mesh-ancestor
5613204|NCT03924193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5613205|NCT03922880|Nivolumab|nivolumab|mesh-list
5731547|NCT05008224|Vincristine|vincristine|mesh-list
5731548|NCT05008224|Bleomycin|bleomycin|mesh-list
5731549|NCT05008224|Vinblastine|vinblastine|mesh-list
5731550|NCT05008224|Procarbazine|procarbazine|mesh-list
5731551|NCT05008224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5731552|NCT05008224|Immunologic Factors|immunologic factors|mesh-ancestor
5731553|NCT05008224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5731554|NCT05008224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5613206|NCT03922880|Ipilimumab|ipilimumab|mesh-list
5613207|NCT03922880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5613208|NCT03922880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5613209|NCT03922880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5613210|NCT03922880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613211|NCT03920722|Rituximab|rituximab|mesh-list
5613212|NCT03920722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5613213|NCT03920722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5613214|NCT03920722|Immunologic Factors|immunologic factors|mesh-ancestor
5613215|NCT03920722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613216|NCT03920722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5613217|NCT03916419|Paclitaxel|paclitaxel|mesh-list
5613218|NCT03916419|Carboplatin|carboplatin|mesh-list
5613219|NCT03916419|Durvalumab|durvalumab|mesh-list
5613220|NCT03916419|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5613221|NCT03916419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5613222|NCT03916419|Tubulin Modulators|tubulin modulators|mesh-ancestor
5613223|NCT03916419|Antimitotic Agents|antimitotic agents|mesh-ancestor
5613224|NCT03916419|Mitosis Modulators|mitosis modulators|mesh-ancestor
5613225|NCT03916419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5731555|NCT05008224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5731556|NCT05008224|Alkylating Agents|alkylating agents|mesh-ancestor
5731557|NCT05008224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5731558|NCT05008224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5731559|NCT05008224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5613226|NCT03916419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5613227|NCT03902314|Lidocaine|lidocaine|mesh-list
5613228|NCT03902314|Anesthetics, Local|anesthetics, local|mesh-ancestor
5613229|NCT03902314|Anesthetics|anesthetics|mesh-ancestor
5731560|NCT05008224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5731561|NCT05008224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5731562|NCT05008224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5731563|NCT05008224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5731564|NCT05008224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5731565|NCT05008224|Glucocorticoids|glucocorticoids|mesh-ancestor
5731566|NCT05008224|Hormones|hormones|mesh-ancestor
5731567|NCT05008224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5731568|NCT05008224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5731569|NCT05008224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5731570|NCT05008224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5731571|NCT05008224|Tubulin Modulators|tubulin modulators|mesh-ancestor
5731572|NCT05008224|Antimitotic Agents|antimitotic agents|mesh-ancestor
5731573|NCT05008224|Mitosis Modulators|mitosis modulators|mesh-ancestor
5731574|NCT05001880|Bevacizumab|bevacizumab|mesh-list
5731575|NCT05001880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5731576|NCT05001880|Carboplatin|carboplatin|mesh-list
5731577|NCT05001880|Pemetrexed|pemetrexed|mesh-list
5731578|NCT05001880|Atezolizumab|atezolizumab|mesh-list
5731579|NCT05001880|Endothelial Growth Factors|endothelial growth factors|mesh-list
5731580|NCT05001880|Antibodies|antibodies|mesh-list
5731581|NCT05001880|Immunoglobulins|immunoglobulins|mesh-list
5731582|NCT05001880|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5731583|NCT05001880|Immunoglobulin G|immunoglobulin g|mesh-list
5731584|NCT05001880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5731585|NCT05001880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5731586|NCT05001880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5731587|NCT05001880|Growth Substances|growth substances|mesh-ancestor
5613230|NCT03902314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5613231|NCT03902314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613232|NCT03902314|Sensory System Agents|sensory system agents|mesh-ancestor
5613233|NCT03902314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5613234|NCT03902314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5613235|NCT03902314|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5613236|NCT03902314|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5613237|NCT03902314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5613238|NCT03902314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692020|NCT03412474|Sensory System Agents|sensory system agents|mesh-ancestor
5692021|NCT03412474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5692022|NCT03412474|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5692023|NCT03412474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5692024|NCT03412474|Analgesics|analgesics|mesh-ancestor
5692025|NCT03412474|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5692026|NCT03412474|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5692027|NCT03412474|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5692028|NCT03412474|Adrenergic Agents|adrenergic agents|mesh-ancestor
5692029|NCT03412474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5692030|NCT03412474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692031|NCT03412474|Antipyretics|antipyretics|mesh-ancestor
5692032|NCT03412409|Cytarabine|cytarabine|mesh-list
5692033|NCT03412409|Cyclophosphamide|cyclophosphamide|mesh-list
5692034|NCT03412409|Busulfan|busulfan|mesh-list
5692035|NCT03412409|Semustine|semustine|mesh-list
5692036|NCT03412409|Fludarabine|fludarabine|mesh-list
5692037|NCT03412409|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5692038|NCT03412409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5692039|NCT03412409|Immunologic Factors|immunologic factors|mesh-ancestor
5692040|NCT03412409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692041|NCT03412409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5692042|NCT03412409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5692043|NCT03412409|Alkylating Agents|alkylating agents|mesh-ancestor
5692044|NCT03412409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692045|NCT03412409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5692046|NCT03412409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5692047|NCT03412409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5692048|NCT03412409|Antimetabolites|antimetabolites|mesh-ancestor
5692049|NCT03412409|Antiviral Agents|antiviral agents|mesh-ancestor
5692050|NCT03412409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5692051|NCT03412305|Amoxicillin|amoxicillin|mesh-list
5692052|NCT03412305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5692053|NCT03412305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5892999|NCT03836066|Bevacizumab|bevacizumab|mesh-list
5613239|NCT03900715|Luspatercept|luspatercept|mesh-list
5613240|NCT03900715|Hematinics|hematinics|mesh-ancestor
5613241|NCT03899467|Androgens|androgens|mesh-list
5613242|NCT03899467|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
5613243|NCT03899467|Hormones|hormones|mesh-ancestor
5613244|NCT03899467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5613245|NCT03899467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5731588|NCT05001880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5731589|NCT05001880|Growth Inhibitors|growth inhibitors|mesh-ancestor
5731590|NCT05001880|Immunologic Factors|immunologic factors|mesh-ancestor
5731591|NCT05001880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5731592|NCT05001880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5731593|NCT05001880|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5731594|NCT05001880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5731595|NCT04998669|Rituximab|rituximab|mesh-list
5731596|NCT04998669|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
5731597|NCT04998669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5731598|NCT04998669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5731599|NCT04998669|Immunologic Factors|immunologic factors|mesh-ancestor
5731600|NCT04998669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5731601|NCT04998669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5731602|NCT04996030|Arsenic Trioxide|arsenic trioxide|mesh-list
5731603|NCT04996030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5731604|NCT04995029|Buprenorphine|buprenorphine|mesh-list
5731605|NCT04995029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5731606|NCT04995029|Narcotics|narcotics|mesh-ancestor
5731607|NCT04995029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5731608|NCT04995029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5731609|NCT04995029|Analgesics|analgesics|mesh-ancestor
5731610|NCT04995029|Sensory System Agents|sensory system agents|mesh-ancestor
5731611|NCT04995029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5731612|NCT04995029|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5731613|NCT04949256|Calcium, Dietary|calcium, dietary|mesh-list
5731614|NCT04949256|Leucovorin|leucovorin|mesh-list
5731615|NCT04949256|Pembrolizumab|pembrolizumab|mesh-list
5731616|NCT04949256|Oxaliplatin|oxaliplatin|mesh-list
5731617|NCT04949256|Lenvatinib|lenvatinib|mesh-list
5731618|NCT04949256|Calcium|calcium|mesh-list
5731619|NCT04949256|Levoleucovorin|levoleucovorin|mesh-list
5731620|NCT04949256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5731621|NCT04949256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5731622|NCT04949256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5731623|NCT04949256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5731624|NCT04949256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5731625|NCT04949256|Antidotes|antidotes|mesh-ancestor
5731626|NCT04949256|Protective Agents|protective agents|mesh-ancestor
5731627|NCT04949256|Vitamin B Complex|vitamin b complex|mesh-ancestor
5731628|NCT04949256|Vitamins|vitamins|mesh-ancestor
5731629|NCT04949256|Micronutrients|micronutrients|mesh-ancestor
5731630|NCT04949256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5731631|NCT04949256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5731632|NCT04949256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5731633|NCT04935476|Dapsone|dapsone|mesh-list
5731634|NCT04935476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5731635|NCT04935476|Antimalarials|antimalarials|mesh-ancestor
5731636|NCT04935476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5731637|NCT04935476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5731638|NCT04935476|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5731639|NCT04935476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5731640|NCT04935476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5731641|NCT04935476|Leprostatic Agents|leprostatic agents|mesh-ancestor
5731642|NCT04935476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5731643|NCT04934722|Pembrolizumab|pembrolizumab|mesh-list
5731644|NCT04934722|Androgens|androgens|mesh-list
5731645|NCT04934722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5731646|NCT04934722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5731647|NCT04934722|Hormones|hormones|mesh-ancestor
5613246|NCT03899467|Androgen Antagonists|androgen antagonists|mesh-ancestor
5613247|NCT03899467|Hormone Antagonists|hormone antagonists|mesh-ancestor
5613248|NCT03898037|Metformin|metformin|mesh-list
5613249|NCT03898037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5613250|NCT03898037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613251|NCT03894501|Methadone|methadone|mesh-list
5613252|NCT03894501|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5613253|NCT03894501|Narcotics|narcotics|mesh-ancestor
5613254|NCT03894501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5613255|NCT03894501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893000|NCT03836066|Atezolizumab|atezolizumab|mesh-list
5731648|NCT04934722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5731649|NCT04934722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613256|NCT03894501|Analgesics|analgesics|mesh-ancestor
5613257|NCT03894501|Sensory System Agents|sensory system agents|mesh-ancestor
5613258|NCT03894501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5613259|NCT03894501|Antitussive Agents|antitussive agents|mesh-ancestor
5613260|NCT03894501|Respiratory System Agents|respiratory system agents|mesh-ancestor
5613261|NCT03879538|Nitrous Oxide|nitrous oxide|mesh-list
5613262|NCT03879538|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5613263|NCT03879538|Anesthetics, General|anesthetics, general|mesh-ancestor
5613264|NCT03879538|Anesthetics|anesthetics|mesh-ancestor
5613265|NCT03879538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5613266|NCT03879538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613267|NCT03879538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5613268|NCT03879538|Analgesics|analgesics|mesh-ancestor
5613269|NCT03879538|Sensory System Agents|sensory system agents|mesh-ancestor
5613270|NCT03879538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5613271|NCT03874325|Durvalumab|durvalumab|mesh-list
5613272|NCT03874325|Letrozole|letrozole|mesh-list
5613273|NCT03874325|Anastrozole|anastrozole|mesh-list
5613274|NCT03874325|Exemestane|exemestane|mesh-list
5613275|NCT03874325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5613276|NCT03874325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5613277|NCT03874325|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5613278|NCT03874325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5613279|NCT03874325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5613280|NCT03874325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613281|NCT03874325|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5613282|NCT03874325|Hormone Antagonists|hormone antagonists|mesh-ancestor
5613283|NCT03874325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5613284|NCT03874325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613285|NCT03874325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5613286|NCT03860987|Prednisone|prednisone|mesh-list
5613287|NCT03860987|Goserelin|goserelin|mesh-list
5613288|NCT03860987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5613289|NCT03860987|Glucocorticoids|glucocorticoids|mesh-ancestor
5613290|NCT03860987|Hormones|hormones|mesh-ancestor
5613291|NCT03860987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5613292|NCT03860987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613293|NCT03860987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5613294|NCT03860987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5613295|NCT03853317|Avelumab|avelumab|mesh-list
5613296|NCT03853317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5613297|NCT03853317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5613298|NCT03841565|Dexamethasone|dexamethasone|mesh-list
5613299|NCT03841565|Dexamethasone acetate|dexamethasone acetate|mesh-list
5613300|NCT03841565|Daratumumab|daratumumab|mesh-list
5613301|NCT03841565|Pomalidomide|pomalidomide|mesh-list
5613302|NCT03841565|Ichthammol|ichthammol|mesh-list
5613303|NCT03841565|BB 1101|bb 1101|mesh-list
5613304|NCT03841565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5613305|NCT03841565|Antiemetics|antiemetics|mesh-ancestor
5613306|NCT03841565|Autonomic Agents|autonomic agents|mesh-ancestor
5613307|NCT03841565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5613308|NCT03841565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613309|NCT03841565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5613310|NCT03841565|Glucocorticoids|glucocorticoids|mesh-ancestor
5613311|NCT03841565|Hormones|hormones|mesh-ancestor
5613312|NCT03841565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5613313|NCT03841565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5613314|NCT03841565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5613315|NCT03841565|Protease Inhibitors|protease inhibitors|mesh-ancestor
5613316|NCT03841565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5613317|NCT03841565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613318|NCT03841565|Immunologic Factors|immunologic factors|mesh-ancestor
5613319|NCT03841565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5613320|NCT03841565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5613321|NCT03841565|Growth Substances|growth substances|mesh-ancestor
5613322|NCT03841565|Growth Inhibitors|growth inhibitors|mesh-ancestor
5613323|NCT03841565|Dermatologic Agents|dermatologic agents|mesh-ancestor
5613324|NCT03834688|Rituximab|rituximab|mesh-list
5613325|NCT03834688|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5613326|NCT03834688|Venetoclax|venetoclax|mesh-list
5613327|NCT03834688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5613328|NCT03834688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5613329|NCT03834688|Immunologic Factors|immunologic factors|mesh-ancestor
6208219|NCT02128217|Antiviral Agents|antiviral agents|mesh-ancestor
6208220|NCT02128217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6208221|NCT02128230|Thalidomide|thalidomide|mesh-list
6208222|NCT02128230|Dexamethasone|dexamethasone|mesh-list
6208223|NCT02128230|Dexamethasone acetate|dexamethasone acetate|mesh-list
6208224|NCT02128230|Cyclophosphamide|cyclophosphamide|mesh-list
6208225|NCT02128230|Melphalan|melphalan|mesh-list
6208226|NCT02128230|Cisplatin|cisplatin|mesh-list
6208227|NCT02128230|Doxorubicin|doxorubicin|mesh-list
6208228|NCT02128230|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6208229|NCT02128230|Etoposide|etoposide|mesh-list
6208230|NCT02128230|Etoposide phosphate|etoposide phosphate|mesh-list
6208231|NCT02128230|Lenalidomide|lenalidomide|mesh-list
5613330|NCT03834688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613331|NCT03834688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5613332|NCT03834688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5613333|NCT03834688|Alkylating Agents|alkylating agents|mesh-ancestor
5613334|NCT03834688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613335|NCT03831165|Acyclovir|acyclovir|mesh-list
5613336|NCT03831165|Melatonin|melatonin|mesh-list
5613337|NCT03831165|Antioxidants|antioxidants|mesh-ancestor
5613338|NCT03831165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613339|NCT03831165|Protective Agents|protective agents|mesh-ancestor
5613340|NCT03831165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613341|NCT03831165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5613342|NCT03831165|Antiviral Agents|antiviral agents|mesh-ancestor
5613343|NCT03831165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5613344|NCT03830723|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5613345|NCT03830723|Hormones|hormones|mesh-ancestor
5613346|NCT03830723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5613347|NCT03830723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613348|NCT03829007|Durvalumab|durvalumab|mesh-list
5613349|NCT03829007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5613350|NCT03829007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5613351|NCT03829007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5613352|NCT03829007|Immunologic Factors|immunologic factors|mesh-ancestor
5613353|NCT03829007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613354|NCT03806166|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5613355|NCT03806166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5613356|NCT03801902|Durvalumab|durvalumab|mesh-list
5613357|NCT03801902|Immunoglobulins|immunoglobulins|mesh-list
6208232|NCT02128230|Lenograstim|lenograstim|mesh-list
6208233|NCT02128230|BB 1101|bb 1101|mesh-list
6208234|NCT02128230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6208235|NCT02128230|Immunologic Factors|immunologic factors|mesh-ancestor
6208236|NCT02128230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208237|NCT02128230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6208238|NCT02128230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6208239|NCT02128230|Alkylating Agents|alkylating agents|mesh-ancestor
6208240|NCT02128230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208241|NCT02128230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6208242|NCT02128230|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6208243|NCT02128230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6208244|NCT02128230|Antiemetics|antiemetics|mesh-ancestor
6208245|NCT02128230|Autonomic Agents|autonomic agents|mesh-ancestor
6208246|NCT02128230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6208247|NCT02128230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6208248|NCT02128230|Glucocorticoids|glucocorticoids|mesh-ancestor
6208249|NCT02128230|Hormones|hormones|mesh-ancestor
6208250|NCT02128230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5613358|NCT03801902|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5613359|NCT03801902|Immunoglobulin G|immunoglobulin g|mesh-list
5613360|NCT03801902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5613361|NCT03801902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5613362|NCT03801902|Immunologic Factors|immunologic factors|mesh-ancestor
5613363|NCT03801902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613364|NCT03801863|Ropivacaine|ropivacaine|mesh-list
6208251|NCT02128230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6208252|NCT02128230|Protease Inhibitors|protease inhibitors|mesh-ancestor
6208253|NCT02128230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6208254|NCT02128230|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6208255|NCT02128230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6208256|NCT02128230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6208257|NCT02128230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6208258|NCT02128230|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6208259|NCT02128230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6208260|NCT02128230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5613365|NCT03801863|Anesthetics, Local|anesthetics, local|mesh-ancestor
5613366|NCT03801863|Anesthetics|anesthetics|mesh-ancestor
5613367|NCT03801863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5613368|NCT03801863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613369|NCT03801863|Sensory System Agents|sensory system agents|mesh-ancestor
5613370|NCT03801863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5613371|NCT03800836|Paclitaxel|paclitaxel|mesh-list
5613372|NCT03800836|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6208261|NCT02128230|Growth Substances|growth substances|mesh-ancestor
6208262|NCT02128230|Growth Inhibitors|growth inhibitors|mesh-ancestor
5731692|NCT04930107|Fluconazole|fluconazole|mesh-list
5613373|NCT03800836|Atezolizumab|atezolizumab|mesh-list
5613374|NCT03800836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5613375|NCT03800836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5613376|NCT03800836|Tubulin Modulators|tubulin modulators|mesh-ancestor
5613377|NCT03800836|Antimitotic Agents|antimitotic agents|mesh-ancestor
5613378|NCT03800836|Mitosis Modulators|mitosis modulators|mesh-ancestor
5731693|NCT04930107|Antifungal Agents|antifungal agents|mesh-ancestor
5731694|NCT04930107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5731695|NCT04930107|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5731696|NCT04930107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5731697|NCT04930107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5731698|NCT04930107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5731699|NCT04930107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5731700|NCT04930107|Hormone Antagonists|hormone antagonists|mesh-ancestor
5731701|NCT04930107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5731702|NCT04930107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5731703|NCT04930107|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5731704|NCT04930107|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5731705|NCT04924101|Cisplatin|cisplatin|mesh-list
5731706|NCT04924101|Carboplatin|carboplatin|mesh-list
5731707|NCT04924101|Pembrolizumab|pembrolizumab|mesh-list
5731708|NCT04924101|Etoposide|etoposide|mesh-list
5731709|NCT04924101|Etoposide phosphate|etoposide phosphate|mesh-list
5731710|NCT04924101|Lenvatinib|lenvatinib|mesh-list
5731711|NCT04924101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6208263|NCT02128230|Leprostatic Agents|leprostatic agents|mesh-ancestor
5613379|NCT03800836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613380|NCT03800641|Dexmedetomidine|dexmedetomidine|mesh-list
5613381|NCT03800641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5613382|NCT03800641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5613383|NCT03800641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613384|NCT03800641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5613385|NCT03800641|Analgesics|analgesics|mesh-ancestor
5613386|NCT03800641|Sensory System Agents|sensory system agents|mesh-ancestor
5613387|NCT03800641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5613388|NCT03800641|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5613389|NCT03800641|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5613390|NCT03800641|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5613391|NCT03800641|Adrenergic Agents|adrenergic agents|mesh-ancestor
5613392|NCT03800641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5613393|NCT03800641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613394|NCT03787082|Chlorhexidine|chlorhexidine|mesh-list
5613395|NCT03787082|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5613396|NCT03787082|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5613397|NCT03787082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5613398|NCT03787082|Disinfectants|disinfectants|mesh-ancestor
5613399|NCT03787082|Dermatologic Agents|dermatologic agents|mesh-ancestor
5613400|NCT03774914|Alemtuzumab|alemtuzumab|mesh-list
5613401|NCT03774914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5613402|NCT03774914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5613403|NCT03772951|Clozapine|clozapine|mesh-list
5613404|NCT03772951|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5613405|NCT03772951|Serotonin Agents|serotonin agents|mesh-ancestor
5613406|NCT03772951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5613407|NCT03772951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613408|NCT03772951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613409|NCT03772951|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5613410|NCT03772951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5613411|NCT03772951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5613412|NCT03772951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5613413|NCT03772951|GABA Antagonists|gaba antagonists|mesh-ancestor
5613414|NCT03772951|GABA Agents|gaba agents|mesh-ancestor
5613415|NCT03771612|Naproxen|naproxen|mesh-list
5613416|NCT03771612|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5731712|NCT04924101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5731713|NCT04924101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5731714|NCT04924101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5731715|NCT04924101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5731716|NCT04924101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5731717|NCT04924101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5731718|NCT04924101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6208264|NCT02128230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6208265|NCT02128230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6208266|NCT02128490|Naproxen|naproxen|mesh-list
6208267|NCT02128490|Colchicine|colchicine|mesh-list
6208268|NCT02128490|Febuxostat|febuxostat|mesh-list
6208269|NCT02128490|Lansoprazole|lansoprazole|mesh-list
6208270|NCT02128490|Dexlansoprazole|dexlansoprazole|mesh-list
6208271|NCT02128490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5731727|NCT04909801|Adalimumab|adalimumab|mesh-list
5731728|NCT04909801|Methotrexate|methotrexate|mesh-list
5731729|NCT04909801|Abatacept|abatacept|mesh-list
5731730|NCT04909801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5731731|NCT04909801|Abortifacient Agents|abortifacient agents|mesh-ancestor
5731732|NCT04909801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5731733|NCT04909801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5731734|NCT04909801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5731735|NCT04909801|Antimetabolites|antimetabolites|mesh-ancestor
5731736|NCT04909801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613417|NCT03771612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5613418|NCT03771612|Analgesics|analgesics|mesh-ancestor
5613419|NCT03771612|Sensory System Agents|sensory system agents|mesh-ancestor
5613420|NCT03771612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5613421|NCT03771612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613422|NCT03771612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5613423|NCT03771612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5613424|NCT03771612|Gout Suppressants|gout suppressants|mesh-ancestor
5613425|NCT03771612|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5731737|NCT04909801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5731738|NCT04909801|Dermatologic Agents|dermatologic agents|mesh-ancestor
5731739|NCT04909801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5731740|NCT04909801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5731741|NCT04909801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5731742|NCT04909801|Immunologic Factors|immunologic factors|mesh-ancestor
5731743|NCT04909801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5731744|NCT04909801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5731745|NCT04909801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5731746|NCT04909801|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5731747|NCT04907227|Dexamethasone|dexamethasone|mesh-list
5731748|NCT04907227|Prednisone|prednisone|mesh-list
5731749|NCT04907227|Docetaxel|docetaxel|mesh-list
5731750|NCT04907227|Pembrolizumab|pembrolizumab|mesh-list
5731751|NCT04907227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5731752|NCT04907227|Antiemetics|antiemetics|mesh-ancestor
5731753|NCT04907227|Autonomic Agents|autonomic agents|mesh-ancestor
5731754|NCT04907227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5731755|NCT04907227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5731756|NCT04907227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5731757|NCT04907227|Glucocorticoids|glucocorticoids|mesh-ancestor
5731758|NCT04907227|Hormones|hormones|mesh-ancestor
5731759|NCT04907227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5731760|NCT04907227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5731761|NCT04907227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5731762|NCT04907227|Tubulin Modulators|tubulin modulators|mesh-ancestor
5613426|NCT03771612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6208272|NCT02128490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6208273|NCT02128490|Analgesics|analgesics|mesh-ancestor
5731763|NCT04907227|Antimitotic Agents|antimitotic agents|mesh-ancestor
5731764|NCT04907227|Mitosis Modulators|mitosis modulators|mesh-ancestor
5731765|NCT04907227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5731766|NCT04907227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5731767|NCT04906395|Tamoxifen|tamoxifen|mesh-list
5731768|NCT04906395|Letrozole|letrozole|mesh-list
5731769|NCT04906395|Anastrozole|anastrozole|mesh-list
5731770|NCT04906395|Exemestane|exemestane|mesh-list
5731771|NCT04906395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5731772|NCT04906395|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5731773|NCT04906395|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5731774|NCT04906395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5731775|NCT04906395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5731776|NCT04906395|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5731777|NCT04906395|Hormone Antagonists|hormone antagonists|mesh-ancestor
5731778|NCT04906395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5731779|NCT04906395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5731780|NCT04906395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5731781|NCT04906395|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5731782|NCT04906395|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5731783|NCT04906395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5613427|NCT03771612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613428|NCT03757689|Pembrolizumab|pembrolizumab|mesh-list
5613429|NCT03757689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5613430|NCT03757689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5613431|NCT03753087|Empagliflozin|empagliflozin|mesh-list
5613432|NCT03753087|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5613433|NCT03753087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613434|NCT03753087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5613435|NCT03753087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613436|NCT03735420|Xanthohumol|xanthohumol|mesh-list
5731806|NCT04903314|Cenobamate|cenobamate|mesh-list
5731807|NCT04903314|Anticonvulsants|anticonvulsants|mesh-ancestor
5731808|NCT04903197|Lenalidomide|lenalidomide|mesh-list
5731809|NCT04903197|Immunologic Factors|immunologic factors|mesh-ancestor
5731810|NCT04903197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5731811|NCT04903197|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5731812|NCT04903197|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5731813|NCT04903197|Growth Substances|growth substances|mesh-ancestor
5731814|NCT04903197|Growth Inhibitors|growth inhibitors|mesh-ancestor
5731815|NCT04903197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6208274|NCT02128490|Sensory System Agents|sensory system agents|mesh-ancestor
6208275|NCT02128490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6208276|NCT02128490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208277|NCT02128490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6208278|NCT02128490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5731821|NCT04895046|Niraparib|niraparib|mesh-list
5731822|NCT04895046|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5731823|NCT04895046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5731824|NCT04895046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5731825|NCT04895046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6208279|NCT02128490|Gout Suppressants|gout suppressants|mesh-ancestor
6208280|NCT02128490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6208281|NCT02128490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6208282|NCT02128490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208283|NCT02128490|Tubulin Modulators|tubulin modulators|mesh-ancestor
6208284|NCT02128490|Antimitotic Agents|antimitotic agents|mesh-ancestor
6208285|NCT02128490|Mitosis Modulators|mitosis modulators|mesh-ancestor
6208286|NCT02128490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6208287|NCT02128490|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6208288|NCT02128490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5613437|NCT03735420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5613438|NCT03735420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5613439|NCT03735420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5613440|NCT03735420|Growth Substances|growth substances|mesh-ancestor
5613441|NCT03735420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613442|NCT03735420|Growth Inhibitors|growth inhibitors|mesh-ancestor
5613443|NCT03734237|Vaccines|vaccines|mesh-list
5613444|NCT03734237|Immunologic Factors|immunologic factors|mesh-ancestor
5613445|NCT03734237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613446|NCT03730337|Nivolumab|nivolumab|mesh-list
5613447|NCT03730337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5613448|NCT03730337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5613449|NCT03730337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5613450|NCT03730337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613451|NCT03730051|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
5613452|NCT03730051|Chelating Agents|chelating agents|mesh-ancestor
5613453|NCT03730051|Sequestering Agents|sequestering agents|mesh-ancestor
5613454|NCT03730051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613455|NCT03727776|Hormones|hormones|mesh-list
5613456|NCT03727776|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
5613457|NCT03727776|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
5613458|NCT03727776|beta-Endorphin|beta-endorphin|mesh-list
5613459|NCT03727776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5613460|NCT03727776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613461|NCT03727776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5613462|NCT03727776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613463|NCT03721328|Vancomycin|vancomycin|mesh-list
5613464|NCT03721328|Tobramycin|tobramycin|mesh-list
5613465|NCT03721328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5613466|NCT03721328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5613467|NCT03715166|Bumetanide|bumetanide|mesh-list
5613468|NCT03715166|Diuretics|diuretics|mesh-ancestor
5613469|NCT03715166|Natriuretic Agents|natriuretic agents|mesh-ancestor
5613470|NCT03715166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692054|NCT03412266|Cytarabine|cytarabine|mesh-list
5692055|NCT03412266|Cyclophosphamide|cyclophosphamide|mesh-list
5692056|NCT03412266|Busulfan|busulfan|mesh-list
5692057|NCT03412266|Semustine|semustine|mesh-list
5692058|NCT03412266|Fludarabine|fludarabine|mesh-list
5692059|NCT03412266|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5692060|NCT03412266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5692061|NCT03412266|Immunologic Factors|immunologic factors|mesh-ancestor
5692062|NCT03412266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692063|NCT03412266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5692064|NCT03412266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5692065|NCT03412266|Alkylating Agents|alkylating agents|mesh-ancestor
5692066|NCT03412266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692067|NCT03412266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5692068|NCT03412266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5692069|NCT03412266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5692070|NCT03412266|Antimetabolites|antimetabolites|mesh-ancestor
5692071|NCT03412266|Antiviral Agents|antiviral agents|mesh-ancestor
5692072|NCT03412266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5692073|NCT03412071|Metronidazole|metronidazole|mesh-list
5613471|NCT03715166|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5613472|NCT03715166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5613473|NCT03715166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613474|NCT03715153|Bumetanide|bumetanide|mesh-list
5613475|NCT03715153|Diuretics|diuretics|mesh-ancestor
5613476|NCT03715153|Natriuretic Agents|natriuretic agents|mesh-ancestor
5613477|NCT03715153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613478|NCT03715153|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5613479|NCT03715153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5613480|NCT03715153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613481|NCT03711838|Acetylcysteine|acetylcysteine|mesh-list
5613482|NCT03711838|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5613483|NCT03711838|Antiviral Agents|antiviral agents|mesh-ancestor
5613484|NCT03711838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5731836|NCT04889547|Dexamethasone|dexamethasone|mesh-list
5731837|NCT04889547|Dexamethasone acetate|dexamethasone acetate|mesh-list
5613485|NCT03711838|Expectorants|expectorants|mesh-ancestor
5613486|NCT03711838|Respiratory System Agents|respiratory system agents|mesh-ancestor
5613487|NCT03711838|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5613488|NCT03711838|Antioxidants|antioxidants|mesh-ancestor
5613489|NCT03711838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613490|NCT03711838|Protective Agents|protective agents|mesh-ancestor
5613491|NCT03711838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613492|NCT03711838|Antidotes|antidotes|mesh-ancestor
5613493|NCT03706898|Sofosbuvir|sofosbuvir|mesh-list
5613494|NCT03706898|Dolutegravir|dolutegravir|mesh-list
5613495|NCT03706898|Elsulfavirine|elsulfavirine|mesh-list
5613496|NCT03706898|Antiviral Agents|antiviral agents|mesh-ancestor
5613497|NCT03706898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5613498|NCT03706898|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5613499|NCT03706898|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5613500|NCT03706898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5613501|NCT03706898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613502|NCT03706898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5613503|NCT03706898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5613504|NCT03706690|Durvalumab|durvalumab|mesh-list
5613505|NCT03706690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5613506|NCT03706690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5613507|NCT03701763|Apremilast|apremilast|mesh-list
5613508|NCT03701763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5613509|NCT03701763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5613510|NCT03701763|Analgesics|analgesics|mesh-ancestor
5613511|NCT03701763|Sensory System Agents|sensory system agents|mesh-ancestor
5731838|NCT04889547|BB 1101|bb 1101|mesh-list
5731839|NCT04889547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5731840|NCT04889547|Antiemetics|antiemetics|mesh-ancestor
5731841|NCT04889547|Autonomic Agents|autonomic agents|mesh-ancestor
5731842|NCT04889547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5731843|NCT04889547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5731844|NCT04889547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5731845|NCT04889547|Glucocorticoids|glucocorticoids|mesh-ancestor
5731846|NCT04889547|Hormones|hormones|mesh-ancestor
5613512|NCT03701763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5613513|NCT03701763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613514|NCT03701763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5731847|NCT04889547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5731848|NCT04889547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5731849|NCT04889547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5731850|NCT04889547|Protease Inhibitors|protease inhibitors|mesh-ancestor
5613515|NCT03701763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5731851|NCT04889547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5893001|NCT03836066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5613516|NCT03701763|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5613517|NCT03701763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5613518|NCT03701763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5613519|NCT03701763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692074|NCT03412071|Clindamycin|clindamycin|mesh-list
5692075|NCT03412071|Clindamycin palmitate|clindamycin palmitate|mesh-list
5692076|NCT03412071|Clindamycin phosphate|clindamycin phosphate|mesh-list
5692077|NCT03412071|Hydrogen Peroxide|hydrogen peroxide|mesh-list
5692078|NCT03412071|Tinidazole|tinidazole|mesh-list
5692079|NCT03412071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5692080|NCT03412071|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5692081|NCT03412071|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5692082|NCT03412071|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5692083|NCT03412071|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5731852|NCT04889547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5731853|NCT04875364|Eszopiclone|eszopiclone|mesh-list
5731854|NCT04875364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5731855|NCT04875364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5731856|NCT04875364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5731857|NCT04873453|Cannabidiol|cannabidiol|mesh-list
5731858|NCT04873453|Anticonvulsants|anticonvulsants|mesh-ancestor
5731859|NCT04862949|Bevacizumab|bevacizumab|mesh-list
5731860|NCT04862949|Atezolizumab|atezolizumab|mesh-list
5731861|NCT04862949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5731862|NCT04862949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5731863|NCT04862949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5731864|NCT04862949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5731865|NCT04862949|Growth Substances|growth substances|mesh-ancestor
5731866|NCT04862949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5731867|NCT04862949|Growth Inhibitors|growth inhibitors|mesh-ancestor
5731868|NCT04862286|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5731869|NCT04862286|Immunologic Factors|immunologic factors|mesh-ancestor
5731870|NCT04862286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5731871|NCT04861064|Sirolimus|sirolimus|mesh-list
5692084|NCT03412071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5692085|NCT03412071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692086|NCT03412071|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5692087|NCT03412071|Alkylating Agents|alkylating agents|mesh-ancestor
5692088|NCT03412071|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
5692089|NCT03412006|Fulacimstat|fulacimstat|mesh-list
5692090|NCT03412006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5692091|NCT03412006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692092|NCT03411967|Docetaxel|docetaxel|mesh-list
5692093|NCT03411967|Apatinib|apatinib|mesh-list
5692094|NCT03411967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5692095|NCT03411967|Tubulin Modulators|tubulin modulators|mesh-ancestor
5731872|NCT04861064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5731873|NCT04861064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5731874|NCT04861064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5731875|NCT04861064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5731876|NCT04861064|Antifungal Agents|antifungal agents|mesh-ancestor
5731877|NCT04861064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5731878|NCT04861064|Immunologic Factors|immunologic factors|mesh-ancestor
5731879|NCT04861064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5731880|NCT04860635|Celecoxib|celecoxib|mesh-list
5731881|NCT04860635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5731882|NCT04860635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5731883|NCT04860635|Analgesics|analgesics|mesh-ancestor
5731884|NCT04860635|Sensory System Agents|sensory system agents|mesh-ancestor
5731885|NCT04860635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5731886|NCT04860635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5731887|NCT04860635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5731888|NCT04860635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5731889|NCT04860635|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5731890|NCT04860635|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5731891|NCT04860635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5731892|NCT04860635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5731893|NCT04853355|Spironolactone|spironolactone|mesh-list
5731894|NCT04853355|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5731895|NCT04853355|Hormone Antagonists|hormone antagonists|mesh-ancestor
5731896|NCT04853355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5731897|NCT04853355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5731898|NCT04853355|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5731899|NCT04853355|Diuretics|diuretics|mesh-ancestor
5692096|NCT03411967|Antimitotic Agents|antimitotic agents|mesh-ancestor
5731900|NCT04853355|Natriuretic Agents|natriuretic agents|mesh-ancestor
5731901|NCT04852367|Doxorubicin|doxorubicin|mesh-list
5613520|NCT03699865|Nicotine|nicotine|mesh-list
5613521|NCT03699865|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5613522|NCT03699865|Autonomic Agents|autonomic agents|mesh-ancestor
5613523|NCT03699865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5613524|NCT03699865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613525|NCT03699865|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5613526|NCT03699865|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5613527|NCT03699865|Cholinergic Agents|cholinergic agents|mesh-ancestor
5613528|NCT03699865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5613529|NCT03699865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613530|NCT03694002|Paclitaxel|paclitaxel|mesh-list
5613531|NCT03694002|Carboplatin|carboplatin|mesh-list
5613532|NCT03694002|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5613533|NCT03694002|Ramucirumab|ramucirumab|mesh-list
5613534|NCT03694002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5613535|NCT03694002|Antibodies|antibodies|mesh-list
5613536|NCT03694002|Immunoglobulins|immunoglobulins|mesh-list
5613537|NCT03694002|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5731902|NCT04852367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5731903|NCT04852367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5731904|NCT04852367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5731905|NCT04852367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5731906|NCT04852367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5731907|NCT04852367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5731908|NCT04850495|Prednisone|prednisone|mesh-list
5731909|NCT04850495|Cortisone|cortisone|mesh-list
5731910|NCT04850495|Cyclophosphamide|cyclophosphamide|mesh-list
5731911|NCT04850495|Rituximab|rituximab|mesh-list
5731912|NCT04850495|Doxorubicin|doxorubicin|mesh-list
5731913|NCT04850495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5731914|NCT04850495|Vincristine|vincristine|mesh-list
5731915|NCT04850495|Zanubrutinib|zanubrutinib|mesh-list
5731916|NCT04850495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5731917|NCT04850495|Antibodies|antibodies|mesh-list
5731918|NCT04850495|Immunoglobulins|immunoglobulins|mesh-list
5731919|NCT04850495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5731920|NCT04850495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5731921|NCT04850495|Immunologic Factors|immunologic factors|mesh-ancestor
5731922|NCT04850495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5731923|NCT04850495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5731924|NCT04850495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5731925|NCT04850495|Alkylating Agents|alkylating agents|mesh-ancestor
5731926|NCT04850495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5731927|NCT04850495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5731928|NCT04850495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5731929|NCT04850495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5731930|NCT04850495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5731931|NCT04850495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5731932|NCT04850495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5731933|NCT04850495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5731934|NCT04850495|Glucocorticoids|glucocorticoids|mesh-ancestor
5731935|NCT04850495|Hormones|hormones|mesh-ancestor
5731936|NCT04850495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5731937|NCT04850495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5731938|NCT04850495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5731939|NCT04850495|Tubulin Modulators|tubulin modulators|mesh-ancestor
5731940|NCT04850495|Antimitotic Agents|antimitotic agents|mesh-ancestor
5731941|NCT04850495|Mitosis Modulators|mitosis modulators|mesh-ancestor
5731942|NCT04850495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5731943|NCT04846881|BI 425809|bi 425809|mesh-list
5731944|NCT04846881|Nootropic Agents|nootropic agents|mesh-ancestor
5731945|NCT04844905|Ivermectin|ivermectin|mesh-list
5731946|NCT04844905|Piperaquine|piperaquine|mesh-list
5613538|NCT03694002|Lexatumumab|lexatumumab|mesh-list
5613539|NCT03694002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5613540|NCT03694002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5613541|NCT03694002|Tubulin Modulators|tubulin modulators|mesh-ancestor
5613542|NCT03694002|Antimitotic Agents|antimitotic agents|mesh-ancestor
5613543|NCT03694002|Mitosis Modulators|mitosis modulators|mesh-ancestor
5613544|NCT03694002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613545|NCT03694002|Immunologic Factors|immunologic factors|mesh-ancestor
5613546|NCT03694002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613547|NCT03691727|Tirofiban|tirofiban|mesh-list
5731947|NCT04844905|Artenimol|artenimol|mesh-list
5731948|NCT04844905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5731949|NCT04844905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5731950|NCT04844905|Antimalarials|antimalarials|mesh-ancestor
5731951|NCT04844905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5731952|NCT04844606|Mirikizumab|mirikizumab|mesh-list
5731953|NCT04844606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5731954|NCT04844606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5731955|NCT04844606|Analgesics|analgesics|mesh-ancestor
5731956|NCT04844606|Sensory System Agents|sensory system agents|mesh-ancestor
5731957|NCT04844606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5731958|NCT04844606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613548|NCT03691727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5613549|NCT03691727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5613550|NCT03691727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613551|NCT03691727|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5613552|NCT03651271|Nivolumab|nivolumab|mesh-list
5613553|NCT03651271|Ipilimumab|ipilimumab|mesh-list
5613554|NCT03651271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5613555|NCT03651271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5613556|NCT03651271|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5613557|NCT03651271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613558|NCT03648385|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
5613559|NCT03648385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5613560|NCT03648385|Immunologic Factors|immunologic factors|mesh-ancestor
5613561|NCT03648385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613562|NCT03647852|Methylprednisolone|methylprednisolone|mesh-list
5613563|NCT03647852|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5613564|NCT03647852|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5613565|NCT03647852|Prednisolone|prednisolone|mesh-list
5613566|NCT03647852|Prednisolone acetate|prednisolone acetate|mesh-list
5613567|NCT03647852|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5613568|NCT03647852|Prednisolone phosphate|prednisolone phosphate|mesh-list
5731959|NCT04844606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5731960|NCT04844606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5731961|NCT04844606|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5731962|NCT04844606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5731963|NCT04824274|Fentanyl|fentanyl|mesh-list
5731964|NCT04824274|Morphine|morphine|mesh-list
5731965|NCT04824274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5731966|NCT04824274|Narcotics|narcotics|mesh-ancestor
5731967|NCT04824274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5731968|NCT04824274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5731969|NCT04824274|Analgesics|analgesics|mesh-ancestor
5731970|NCT04824274|Sensory System Agents|sensory system agents|mesh-ancestor
5731971|NCT04824274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5731972|NCT04824274|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5731973|NCT04824274|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5731974|NCT04824274|Anesthetics, General|anesthetics, general|mesh-ancestor
5731975|NCT04824274|Anesthetics|anesthetics|mesh-ancestor
5731976|NCT04818957|Vitamin D|vitamin d|mesh-list
5731977|NCT04818957|Cholecalciferol|cholecalciferol|mesh-list
5731978|NCT04818957|Vitamins|vitamins|mesh-ancestor
5731979|NCT04818957|Micronutrients|micronutrients|mesh-ancestor
5731980|NCT04818957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5731981|NCT04818957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5731982|NCT04818957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5613569|NCT03647852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5613570|NCT03647852|Antiemetics|antiemetics|mesh-ancestor
5613571|NCT03647852|Autonomic Agents|autonomic agents|mesh-ancestor
5613572|NCT03647852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5613573|NCT03647852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613574|NCT03647852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5613575|NCT03647852|Glucocorticoids|glucocorticoids|mesh-ancestor
5613576|NCT03647852|Hormones|hormones|mesh-ancestor
5613577|NCT03647852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5613578|NCT03647852|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5613579|NCT03647852|Protective Agents|protective agents|mesh-ancestor
5613580|NCT03647852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5613581|NCT03647852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5613582|NCT03640949|Methylprednisolone|methylprednisolone|mesh-list
5613583|NCT03640949|Vasopressins|vasopressins|mesh-list
5613584|NCT03640949|Arginine Vasopressin|arginine vasopressin|mesh-list
5613585|NCT03640949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5613586|NCT03640949|Antiemetics|antiemetics|mesh-ancestor
5613587|NCT03640949|Autonomic Agents|autonomic agents|mesh-ancestor
5613588|NCT03640949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5613589|NCT03640949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613590|NCT03640949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5731983|NCT04812548|Azacitidine|azacitidine|mesh-list
5613591|NCT03640949|Glucocorticoids|glucocorticoids|mesh-ancestor
5613592|NCT03640949|Hormones|hormones|mesh-ancestor
5613593|NCT03640949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5613594|NCT03640949|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5613595|NCT03640949|Protective Agents|protective agents|mesh-ancestor
5613596|NCT03640949|Hemostatics|hemostatics|mesh-ancestor
5613597|NCT03640949|Coagulants|coagulants|mesh-ancestor
5613598|NCT03640949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5613599|NCT03640949|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5613600|NCT03640949|Natriuretic Agents|natriuretic agents|mesh-ancestor
5613601|NCT03630211|Cyclophosphamide|cyclophosphamide|mesh-list
5613602|NCT03630211|Thiotepa|thiotepa|mesh-list
5731984|NCT04812548|Venetoclax|venetoclax|mesh-list
5731985|NCT04812548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5731986|NCT04812548|Antimetabolites|antimetabolites|mesh-ancestor
5731987|NCT04812548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208289|NCT02128490|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6208290|NCT02128542|Sofosbuvir|sofosbuvir|mesh-list
6208291|NCT02128542|Antiviral Agents|antiviral agents|mesh-ancestor
6208292|NCT02128542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6208293|NCT02128828|Cenicriviroc|cenicriviroc|mesh-list
6208294|NCT02128828|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6208295|NCT02128828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208296|NCT02128828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5613603|NCT03630211|Rituximab|rituximab|mesh-list
5613604|NCT03630211|Alemtuzumab|alemtuzumab|mesh-list
5613605|NCT03630211|Thymoglobulin|thymoglobulin|mesh-list
5613606|NCT03630211|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6672728|NCT01557907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672729|NCT01557985|Bupivacaine|bupivacaine|mesh-list
6672730|NCT01557985|Anesthetics, Local|anesthetics, local|mesh-ancestor
6672731|NCT01557985|Anesthetics|anesthetics|mesh-ancestor
6672732|NCT01557985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6672733|NCT01557985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672734|NCT01557985|Sensory System Agents|sensory system agents|mesh-ancestor
6672735|NCT01557985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6672736|NCT01558011|Docetaxel|docetaxel|mesh-list
6208297|NCT02128828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6208298|NCT02128828|Antiviral Agents|antiviral agents|mesh-ancestor
6208299|NCT02128828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6208300|NCT02128932|Insulin Glargine|insulin glargine|mesh-list
6208301|NCT02128932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6208302|NCT02128932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208303|NCT02129075|Poly I-C|poly i-c|mesh-list
6208304|NCT02129075|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6208305|NCT02129075|Poly ICLC|poly iclc|mesh-list
6208306|NCT02129075|Flt3 ligand protein|flt3 ligand protein|mesh-list
5731988|NCT04812548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6672737|NCT01558011|Capecitabine|capecitabine|mesh-list
5613607|NCT03630211|Immunoglobulins|immunoglobulins|mesh-list
5613608|NCT03630211|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5613609|NCT03630211|Antibodies|antibodies|mesh-list
5613610|NCT03630211|gamma-Globulins|gamma-globulins|mesh-list
5613611|NCT03630211|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5613612|NCT03630211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5731989|NCT04812548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5731990|NCT04810949|Vitamin D|vitamin d|mesh-list
5731991|NCT04810949|Cholecalciferol|cholecalciferol|mesh-list
5731992|NCT04810949|Vitamins|vitamins|mesh-ancestor
5731993|NCT04810949|Micronutrients|micronutrients|mesh-ancestor
5731994|NCT04810949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5731995|NCT04810949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5731996|NCT04810949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5731997|NCT04784559|Remdesivir|remdesivir|mesh-list
5731998|NCT04784559|Favipiravir|favipiravir|mesh-list
5731999|NCT04784559|Dexamethasone|dexamethasone|mesh-list
5732000|NCT04784559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5732001|NCT04784559|Antiemetics|antiemetics|mesh-ancestor
5732002|NCT04784559|Autonomic Agents|autonomic agents|mesh-ancestor
5732003|NCT04784559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5732004|NCT04784559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5732005|NCT04784559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5732006|NCT04784559|Glucocorticoids|glucocorticoids|mesh-ancestor
5732007|NCT04784559|Hormones|hormones|mesh-ancestor
5613613|NCT03630211|Immunologic Factors|immunologic factors|mesh-ancestor
5613614|NCT03630211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5732008|NCT04784559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5732009|NCT04784559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6208307|NCT02129075|Interferon Inducers|interferon inducers|mesh-ancestor
6208308|NCT02129075|Immunologic Factors|immunologic factors|mesh-ancestor
5732010|NCT04784559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5732011|NCT04784559|Antimetabolites|antimetabolites|mesh-ancestor
5732012|NCT04784559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5732013|NCT04784559|Antiviral Agents|antiviral agents|mesh-ancestor
5732014|NCT04784559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5732015|NCT04776252|Islatravir|islatravir|mesh-list
5732016|NCT04776252|Antiviral Agents|antiviral agents|mesh-ancestor
5732017|NCT04776252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5732018|NCT04776252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5732019|NCT04776252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5732020|NCT04776252|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5732021|NCT04776252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5732022|NCT04776252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5732023|NCT04774991|Azithromycin|azithromycin|mesh-list
5732024|NCT04774991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5732025|NCT04774991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5732026|NCT04774380|Carboplatin|carboplatin|mesh-list
5732027|NCT04774380|Etoposide|etoposide|mesh-list
5732028|NCT04774380|Durvalumab|durvalumab|mesh-list
5732029|NCT04774380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5732030|NCT04774380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5732031|NCT04774380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5732032|NCT04774380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5732033|NCT04774380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5732034|NCT04774380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5732035|NCT04774380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5732036|NCT04771923|Epinephrine|epinephrine|mesh-list
5732037|NCT04771923|Racepinephrine|racepinephrine|mesh-list
5732038|NCT04771923|Tranexamic Acid|tranexamic acid|mesh-list
5732039|NCT04771923|Epinephryl borate|epinephryl borate|mesh-list
5732040|NCT04771923|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5732041|NCT04771923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5613615|NCT03630211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5613616|NCT03630211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5613617|NCT03630211|Alkylating Agents|alkylating agents|mesh-ancestor
5732042|NCT04771923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5732043|NCT04771923|Hemostatics|hemostatics|mesh-ancestor
5732044|NCT04771923|Coagulants|coagulants|mesh-ancestor
5732045|NCT04771923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5732046|NCT04771923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5732047|NCT04771923|Adrenergic Agents|adrenergic agents|mesh-ancestor
5732048|NCT04771923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5732049|NCT04771923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5732050|NCT04771923|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5732051|NCT04771923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5732052|NCT04771923|Autonomic Agents|autonomic agents|mesh-ancestor
5732053|NCT04771923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5732054|NCT04771923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5732055|NCT04771923|Respiratory System Agents|respiratory system agents|mesh-ancestor
5732056|NCT04771923|Mydriatics|mydriatics|mesh-ancestor
5732057|NCT04771923|Sympathomimetics|sympathomimetics|mesh-ancestor
5732058|NCT04771923|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5732059|NCT04766723|Botulinum Toxins|botulinum toxins|mesh-list
5732060|NCT04766723|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5732061|NCT04766723|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5732062|NCT04766723|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
5732063|NCT04766723|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5732064|NCT04766723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5732065|NCT04766723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5732066|NCT04766723|Cholinergic Agents|cholinergic agents|mesh-ancestor
5732067|NCT04766723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5732068|NCT04766723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5732069|NCT04766723|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5732070|NCT04766723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5613618|NCT03630211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613619|NCT03630211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5613620|NCT03630211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5613621|NCT03630211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5613622|NCT03629327|Aspirin|aspirin|mesh-list
5613623|NCT03629327|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5613624|NCT03629327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5613625|NCT03629327|Analgesics|analgesics|mesh-ancestor
5613626|NCT03629327|Sensory System Agents|sensory system agents|mesh-ancestor
5613627|NCT03629327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5732071|NCT04762459|Pemetrexed|pemetrexed|mesh-list
5613628|NCT03629327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613629|NCT03629327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5613630|NCT03629327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5732072|NCT04762459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5732073|NCT04762459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5732074|NCT04762459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5732075|NCT04762459|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5732076|NCT04762459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5732077|NCT04754230|Tranexamic Acid|tranexamic acid|mesh-list
5732078|NCT04754230|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5732079|NCT04754230|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5732080|NCT04754230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613631|NCT03629327|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5613632|NCT03629327|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5613633|NCT03629327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613634|NCT03629327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5613635|NCT03629327|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5613636|NCT03629327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5613637|NCT03629327|Antipyretics|antipyretics|mesh-ancestor
5613638|NCT03616886|Paclitaxel|paclitaxel|mesh-list
5613639|NCT03616886|Carboplatin|carboplatin|mesh-list
5613640|NCT03616886|Durvalumab|durvalumab|mesh-list
5613641|NCT03616886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5613642|NCT03616886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5613643|NCT03616886|Tubulin Modulators|tubulin modulators|mesh-ancestor
5613644|NCT03616886|Antimitotic Agents|antimitotic agents|mesh-ancestor
5613645|NCT03616886|Mitosis Modulators|mitosis modulators|mesh-ancestor
5613646|NCT03616886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613647|NCT03616886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5613648|NCT03604159|Buprenorphine|buprenorphine|mesh-list
5613649|NCT03604159|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
5732081|NCT04754230|Hemostatics|hemostatics|mesh-ancestor
5732082|NCT04754230|Coagulants|coagulants|mesh-ancestor
5732089|NCT04745949|Prednisone|prednisone|mesh-list
5732090|NCT04745949|Cortisone|cortisone|mesh-list
5732091|NCT04745949|Cyclophosphamide|cyclophosphamide|mesh-list
5732092|NCT04745949|Rituximab|rituximab|mesh-list
5732093|NCT04745949|Doxorubicin|doxorubicin|mesh-list
5732094|NCT04745949|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5732095|NCT04745949|Nivolumab|nivolumab|mesh-list
5732096|NCT04745949|Daunorubicin|daunorubicin|mesh-list
5732097|NCT04745949|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5732098|NCT04745949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5732099|NCT04745949|Antibodies|antibodies|mesh-list
5732100|NCT04745949|Immunoglobulins|immunoglobulins|mesh-list
5732101|NCT04745949|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5613650|NCT03604159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5613651|NCT03604159|Narcotics|narcotics|mesh-ancestor
5613652|NCT03604159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5613653|NCT03604159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613654|NCT03604159|Analgesics|analgesics|mesh-ancestor
5613655|NCT03604159|Sensory System Agents|sensory system agents|mesh-ancestor
5613656|NCT03604159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5613657|NCT03604159|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5613658|NCT03593590|Ocrelizumab|ocrelizumab|mesh-list
5613659|NCT03593590|Immunologic Factors|immunologic factors|mesh-ancestor
5613660|NCT03593590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613661|NCT03592693|Vitamins|vitamins|mesh-list
5613662|NCT03592693|Ascorbic Acid|ascorbic acid|mesh-list
5613663|NCT03592693|Hydrocortisone|hydrocortisone|mesh-list
5613664|NCT03592693|Micronutrients|micronutrients|mesh-ancestor
5613665|NCT03592693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613666|NCT03592693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5613667|NCT03592693|Antioxidants|antioxidants|mesh-ancestor
5732102|NCT04745949|Immunoconjugates|immunoconjugates|mesh-list
5732103|NCT04745949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5732104|NCT04745949|Immunologic Factors|immunologic factors|mesh-ancestor
5732105|NCT04745949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5732106|NCT04745949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5613668|NCT03592693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613669|NCT03592693|Protective Agents|protective agents|mesh-ancestor
6672738|NCT01558011|Oxaliplatin|oxaliplatin|mesh-list
5613670|NCT03591380|Belimumab|belimumab|mesh-list
5613671|NCT03591380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5613672|NCT03591380|Immunologic Factors|immunologic factors|mesh-ancestor
5613673|NCT03591380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613674|NCT03589105|Ocrelizumab|ocrelizumab|mesh-list
5613675|NCT03589105|Immunologic Factors|immunologic factors|mesh-ancestor
5732107|NCT04745949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5732108|NCT04745949|Alkylating Agents|alkylating agents|mesh-ancestor
5732109|NCT04745949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5732110|NCT04745949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5732111|NCT04745949|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5732112|NCT04745949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5732113|NCT04745949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5732114|NCT04745949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5732115|NCT04745949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5732116|NCT04745949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5732117|NCT04745949|Glucocorticoids|glucocorticoids|mesh-ancestor
5732118|NCT04745949|Hormones|hormones|mesh-ancestor
5732119|NCT04745949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5732120|NCT04745949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5732121|NCT04745949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5732122|NCT04736706|Pembrolizumab|pembrolizumab|mesh-list
5732123|NCT04736706|Lenvatinib|lenvatinib|mesh-list
5732124|NCT04736706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5732125|NCT04736706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5732126|NCT04736706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5732127|NCT04736706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5732128|NCT04736706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208309|NCT02129075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208310|NCT02129075|Laxatives|laxatives|mesh-ancestor
6208311|NCT02129075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6208312|NCT02129075|Antiviral Agents|antiviral agents|mesh-ancestor
6208313|NCT02129075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6208314|NCT02129075|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6208315|NCT02129075|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5732136|NCT04718415|Paclitaxel|paclitaxel|mesh-list
5732137|NCT04718415|Carboplatin|carboplatin|mesh-list
5732138|NCT04718415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5732139|NCT04718415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5732140|NCT04718415|Tubulin Modulators|tubulin modulators|mesh-ancestor
5732141|NCT04718415|Antimitotic Agents|antimitotic agents|mesh-ancestor
5613676|NCT03589105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613677|NCT03587740|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
5613678|NCT03587740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5613679|NCT03587740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5613680|NCT03587740|Tubulin Modulators|tubulin modulators|mesh-ancestor
5613681|NCT03587740|Antimitotic Agents|antimitotic agents|mesh-ancestor
5613682|NCT03587740|Mitosis Modulators|mitosis modulators|mesh-ancestor
5613683|NCT03587740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613684|NCT03587311|Paclitaxel|paclitaxel|mesh-list
5613685|NCT03587311|Maytansine|maytansine|mesh-list
5613686|NCT03587311|Bevacizumab|bevacizumab|mesh-list
5613687|NCT03587311|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5732142|NCT04718415|Mitosis Modulators|mitosis modulators|mesh-ancestor
5732143|NCT04718415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5732144|NCT04718025|Aspirin|aspirin|mesh-list
5732145|NCT04718025|Ticagrelor|ticagrelor|mesh-list
5732146|NCT04718025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5732147|NCT04718025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5732148|NCT04718025|Analgesics|analgesics|mesh-ancestor
5732149|NCT04718025|Sensory System Agents|sensory system agents|mesh-ancestor
5732150|NCT04718025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5732151|NCT04718025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5732152|NCT04718025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5732153|NCT04718025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5732154|NCT04718025|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5732155|NCT04718025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5732156|NCT04718025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5732157|NCT04718025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5732158|NCT04718025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5732159|NCT04718025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5732160|NCT04718025|Antipyretics|antipyretics|mesh-ancestor
5732161|NCT04718025|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5613688|NCT03587311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5613689|NCT03587311|Endothelial Growth Factors|endothelial growth factors|mesh-list
5613690|NCT03587311|Antibodies|antibodies|mesh-list
5613691|NCT03587311|Immunoglobulins|immunoglobulins|mesh-list
5613692|NCT03587311|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5613693|NCT03587311|Immunoglobulin G|immunoglobulin g|mesh-list
5613694|NCT03587311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5613695|NCT03587311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5613696|NCT03587311|Tubulin Modulators|tubulin modulators|mesh-ancestor
5613697|NCT03587311|Antimitotic Agents|antimitotic agents|mesh-ancestor
5613698|NCT03587311|Mitosis Modulators|mitosis modulators|mesh-ancestor
5613699|NCT03587311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613700|NCT03587311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5613701|NCT03587311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5613702|NCT03587311|Growth Substances|growth substances|mesh-ancestor
5613703|NCT03587311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5732162|NCT04718025|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5732163|NCT04718025|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5732164|NCT04718025|Purinergic Agents|purinergic agents|mesh-ancestor
5732165|NCT04718025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5732166|NCT04713514|Pembrolizumab|pembrolizumab|mesh-list
5732167|NCT04713514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5613704|NCT03587311|Growth Inhibitors|growth inhibitors|mesh-ancestor
5613705|NCT03587311|Immunologic Factors|immunologic factors|mesh-ancestor
5613706|NCT03578172|Menotropins|menotropins|mesh-list
5613707|NCT03578172|Hormones|hormones|mesh-list
5613708|NCT03578172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5613709|NCT03578172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613710|NCT03578172|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5613711|NCT03578172|Fertility Agents|fertility agents|mesh-ancestor
5613712|NCT03578172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5732168|NCT04713514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5732169|NCT04710628|Pembrolizumab|pembrolizumab|mesh-list
5732170|NCT04710628|Lenvatinib|lenvatinib|mesh-list
5732171|NCT04710628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5732172|NCT04710628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5732173|NCT04710628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5732174|NCT04710628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5732175|NCT04710628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5732176|NCT04708067|Atezolizumab|atezolizumab|mesh-list
5732177|NCT04708067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5732178|NCT04688203|Magnesium Sulfate|magnesium sulfate|mesh-list
5732179|NCT04688203|Labetalol|labetalol|mesh-list
5732180|NCT04688203|Analgesics|analgesics|mesh-ancestor
5732181|NCT04688203|Sensory System Agents|sensory system agents|mesh-ancestor
5732182|NCT04688203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5732183|NCT04688203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5732184|NCT04688203|Anesthetics|anesthetics|mesh-ancestor
5732185|NCT04688203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5613713|NCT03578081|Dexamethasone|dexamethasone|mesh-list
5613714|NCT03578081|Ondansetron|ondansetron|mesh-list
5613715|NCT03578081|Olanzapine|olanzapine|mesh-list
5613716|NCT03578081|Palonosetron|palonosetron|mesh-list
5613717|NCT03578081|Fosaprepitant|fosaprepitant|mesh-list
5613718|NCT03578081|Aprepitant|aprepitant|mesh-list
5613719|NCT03578081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5613720|NCT03578081|Antiemetics|antiemetics|mesh-ancestor
5613721|NCT03578081|Autonomic Agents|autonomic agents|mesh-ancestor
5613722|NCT03578081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5613723|NCT03578081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613724|NCT03578081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5613725|NCT03578081|Glucocorticoids|glucocorticoids|mesh-ancestor
5613726|NCT03578081|Hormones|hormones|mesh-ancestor
5613727|NCT03578081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5613728|NCT03578081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5613729|NCT03578081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5613730|NCT03578081|Antipruritics|antipruritics|mesh-ancestor
5613731|NCT03578081|Dermatologic Agents|dermatologic agents|mesh-ancestor
5613732|NCT03578081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5613733|NCT03578081|Serotonin Agents|serotonin agents|mesh-ancestor
5613734|NCT03578081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5613735|NCT03578081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613736|NCT03578081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5613737|NCT03578081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5613738|NCT03578081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5732186|NCT04688203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5613739|NCT03578081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5613740|NCT03578081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5732187|NCT04688203|Anticonvulsants|anticonvulsants|mesh-ancestor
5732188|NCT04688203|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5732189|NCT04688203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5732190|NCT04688203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5732191|NCT04688203|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5732192|NCT04688203|Tocolytic Agents|tocolytic agents|mesh-ancestor
5732193|NCT04688203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5732194|NCT04688203|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5732195|NCT04688203|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5732196|NCT04688203|Adrenergic Agents|adrenergic agents|mesh-ancestor
5732197|NCT04688203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5732198|NCT04688203|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5732199|NCT04688203|Sympathomimetics|sympathomimetics|mesh-ancestor
5732200|NCT04688203|Autonomic Agents|autonomic agents|mesh-ancestor
5732201|NCT04688203|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5732202|NCT04688203|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5732203|NCT04672395|Vaccines|vaccines|mesh-list
5732204|NCT04672395|1018 oligonucleotide|1018 oligonucleotide|mesh-list
5732205|NCT04672395|Immunologic Factors|immunologic factors|mesh-ancestor
5732206|NCT04672395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613741|NCT03578081|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5613742|NCT03578081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5613743|NCT03578081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5613744|NCT03578081|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5613745|NCT03578081|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5613746|NCT03575052|Pimavanserin|pimavanserin|mesh-list
5613747|NCT03575052|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5613748|NCT03575052|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5613749|NCT03575052|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5613750|NCT03575052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5613751|NCT03575052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5613752|NCT03575052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613753|NCT03575052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5613754|NCT03575052|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5613755|NCT03575052|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5613756|NCT03575052|Serotonin Agents|serotonin agents|mesh-ancestor
5613757|NCT03575052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5613758|NCT03575052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613759|NCT03573648|Palbociclib|palbociclib|mesh-list
5613760|NCT03573648|Avelumab|avelumab|mesh-list
5613761|NCT03573648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5613762|NCT03573648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5613763|NCT03573648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5613764|NCT03573648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613765|NCT03573648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5613766|NCT03562832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
5732207|NCT04672395|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6208316|NCT02129075|Protective Agents|protective agents|mesh-ancestor
6208317|NCT02129192|Amlodipine|amlodipine|mesh-list
6208318|NCT02129192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6208319|NCT02129192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6208320|NCT02129192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5732213|NCT04662710|Leucovorin|leucovorin|mesh-list
5732214|NCT04662710|Pembrolizumab|pembrolizumab|mesh-list
5732215|NCT04662710|Capecitabine|capecitabine|mesh-list
5732216|NCT04662710|Oxaliplatin|oxaliplatin|mesh-list
5732217|NCT04662710|Lenvatinib|lenvatinib|mesh-list
5732218|NCT04662710|Levoleucovorin|levoleucovorin|mesh-list
5732219|NCT04662710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5732220|NCT04662710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5732221|NCT04662710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5732222|NCT04662710|Antimetabolites|antimetabolites|mesh-ancestor
5732223|NCT04662710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5732224|NCT04662710|Antidotes|antidotes|mesh-ancestor
5732225|NCT04662710|Protective Agents|protective agents|mesh-ancestor
5732226|NCT04662710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5732227|NCT04662710|Vitamin B Complex|vitamin b complex|mesh-ancestor
5732228|NCT04662710|Vitamins|vitamins|mesh-ancestor
5732229|NCT04662710|Micronutrients|micronutrients|mesh-ancestor
5732230|NCT04662710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5732231|NCT04662710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5613767|NCT03562832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5613768|NCT03562832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5732232|NCT04662255|Acalabrutinib|acalabrutinib|mesh-list
5732233|NCT04662255|Zanubrutinib|zanubrutinib|mesh-list
5732234|NCT04662255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5732235|NCT04662255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5732236|NCT04662255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5732237|NCT04662255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208321|NCT02129192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208322|NCT02129192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6208323|NCT02129192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208324|NCT02129192|Vasodilator Agents|vasodilator agents|mesh-ancestor
6208325|NCT02129348|Lithium Carbonate|lithium carbonate|mesh-list
6208326|NCT02129348|Antidepressive Agents|antidepressive agents|mesh-ancestor
6208327|NCT02129348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6208328|NCT02129348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6208329|NCT02129348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208330|NCT02129348|Antimanic Agents|antimanic agents|mesh-ancestor
6208331|NCT02129348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5732250|NCT04636437|Tenofovir|tenofovir|mesh-list
5732251|NCT04636437|Lamivudine|lamivudine|mesh-list
5732252|NCT04636437|Emtricitabine|emtricitabine|mesh-list
5732253|NCT04636437|Integrase Inhibitors|integrase inhibitors|mesh-list
5732254|NCT04636437|Antiviral Agents|antiviral agents|mesh-ancestor
5732255|NCT04636437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5732256|NCT04636437|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5732257|NCT04636437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5732258|NCT04636437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5732259|NCT04636437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5732260|NCT04636437|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5732261|NCT04636437|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5732262|NCT04630938|Lidocaine|lidocaine|mesh-list
5732263|NCT04630938|Morphine|morphine|mesh-list
5732264|NCT04630938|Anesthetics, Local|anesthetics, local|mesh-ancestor
5732265|NCT04630938|Anesthetics|anesthetics|mesh-ancestor
5732266|NCT04630938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5732267|NCT04630938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5732268|NCT04630938|Sensory System Agents|sensory system agents|mesh-ancestor
5732269|NCT04630938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5732270|NCT04630938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5732271|NCT04630938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5732272|NCT04630938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5732273|NCT04630938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5732274|NCT04630938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5732275|NCT04630938|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5732276|NCT04630938|Narcotics|narcotics|mesh-ancestor
5732277|NCT04630938|Analgesics|analgesics|mesh-ancestor
5732278|NCT04624451|Dalbavancin|dalbavancin|mesh-list
5732279|NCT04624451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5732280|NCT04624451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5732281|NCT04617002|TIC10 compound|tic10 compound|mesh-list
5732282|NCT04617002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5732283|NCT04603183|Paclitaxel|paclitaxel|mesh-list
5613769|NCT03562832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5613770|NCT03561259|Vorinostat|vorinostat|mesh-list
5613771|NCT03561259|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
5613772|NCT03561259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5613773|NCT03561259|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5613774|NCT03561259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5613775|NCT03561259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613776|NCT03561259|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5613777|NCT03557008|Metronidazole|metronidazole|mesh-list
5613778|NCT03557008|Vancomycin|vancomycin|mesh-list
5613779|NCT03557008|Neomycin|neomycin|mesh-list
5732284|NCT04603183|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5732285|NCT04603183|Letrozole|letrozole|mesh-list
5732286|NCT04603183|Fulvestrant|fulvestrant|mesh-list
5732287|NCT04603183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5732288|NCT04603183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5732289|NCT04603183|Tubulin Modulators|tubulin modulators|mesh-ancestor
5732290|NCT04603183|Antimitotic Agents|antimitotic agents|mesh-ancestor
5732291|NCT04603183|Mitosis Modulators|mitosis modulators|mesh-ancestor
5732292|NCT04603183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5732293|NCT04603183|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5732294|NCT04603183|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5732295|NCT04603183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5732296|NCT04603183|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5732297|NCT04603183|Hormone Antagonists|hormone antagonists|mesh-ancestor
5732298|NCT04603183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5613780|NCT03557008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5613781|NCT03557008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5613782|NCT03557008|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5613783|NCT03557008|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5613784|NCT03557008|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5613785|NCT03557008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5613786|NCT03557008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613787|NCT03551522|Seladelpar|seladelpar|mesh-list
5613788|NCT03551522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5613789|NCT03551522|Antimetabolites|antimetabolites|mesh-ancestor
5613790|NCT03551522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613791|NCT03551522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5613792|NCT03539601|Hydrocortisone|hydrocortisone|mesh-list
5613793|NCT03539601|Pimecrolimus|pimecrolimus|mesh-list
5613794|NCT03539601|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
5613795|NCT03539601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5613796|NCT03539601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5613797|NCT03539601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5613798|NCT03539601|Analgesics|analgesics|mesh-ancestor
5613799|NCT03539601|Sensory System Agents|sensory system agents|mesh-ancestor
5613800|NCT03539601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5613801|NCT03539601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613802|NCT03539601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5613803|NCT03539601|Dermatologic Agents|dermatologic agents|mesh-ancestor
5613804|NCT03539601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5732299|NCT04603183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5732300|NCT04603183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5732301|NCT04603183|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5732302|NCT04594746|Amiodarone|amiodarone|mesh-list
5732303|NCT04594746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5732304|NCT04594746|Vasodilator Agents|vasodilator agents|mesh-ancestor
5732305|NCT04594746|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5732306|NCT04594746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5732307|NCT04594746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5732308|NCT04594746|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5732309|NCT04594746|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5732310|NCT04594746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5732311|NCT04594746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5732312|NCT04594746|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5732313|NCT04594746|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5732314|NCT04594746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5613805|NCT03539601|Immunologic Factors|immunologic factors|mesh-ancestor
5613806|NCT03539601|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5613807|NCT03539601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5613808|NCT03539601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613809|NCT03535688|Cycloserine|cycloserine|mesh-list
5613810|NCT03535688|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5613811|NCT03535688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5613812|NCT03535688|Renal Agents|renal agents|mesh-ancestor
5613813|NCT03535688|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5732318|NCT04592237|Carboplatin|carboplatin|mesh-list
5732319|NCT04592237|Niraparib|niraparib|mesh-list
5732320|NCT04592237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5732321|NCT04592237|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5732322|NCT04592237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5732323|NCT04592237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5732324|NCT04586231|Lenvatinib|lenvatinib|mesh-list
5732325|NCT04586231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5732326|NCT04586231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5732327|NCT04586231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5732328|NCT04586231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5732329|NCT04581824|Pembrolizumab|pembrolizumab|mesh-list
5732330|NCT04581824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5732331|NCT04581824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5732332|NCT04564755|Abrocitinib|abrocitinib|mesh-list
5732333|NCT04564755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5732334|NCT04564755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5732335|NCT04564755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613814|NCT03535688|Antitubercular Agents|antitubercular agents|mesh-ancestor
5732343|NCT04548648|Isavuconazole|isavuconazole|mesh-list
5732344|NCT04548648|Acalabrutinib|acalabrutinib|mesh-list
5732345|NCT04548648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5732346|NCT04548648|Antifungal Agents|antifungal agents|mesh-ancestor
5732347|NCT04548648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5732348|NCT04542135|Sulindac|sulindac|mesh-list
5732349|NCT04542135|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5732350|NCT04542135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5732351|NCT04542135|Analgesics|analgesics|mesh-ancestor
5732352|NCT04542135|Sensory System Agents|sensory system agents|mesh-ancestor
5732353|NCT04542135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5613815|NCT03535688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5613816|NCT03535688|Antimetabolites|antimetabolites|mesh-ancestor
5613817|NCT03535688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613818|NCT03535350|Temozolomide|temozolomide|mesh-list
5613819|NCT03535350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5613820|NCT03535350|Alkylating Agents|alkylating agents|mesh-ancestor
5732354|NCT04542135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5732355|NCT04542135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5732356|NCT04542135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5732357|NCT04542135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5732358|NCT04542135|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5732359|NCT04542135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5732360|NCT04542135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5732361|NCT04527107|Aflibercept|aflibercept|mesh-list
5732362|NCT04527107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5732363|NCT04527107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5613821|NCT03535350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613822|NCT03535350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5613823|NCT03532451|Nivolumab|nivolumab|mesh-list
5613824|NCT03532451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5613825|NCT03532451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5613826|NCT03532451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5613827|NCT03532451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613828|NCT03532217|Nivolumab|nivolumab|mesh-list
5613829|NCT03532217|Ipilimumab|ipilimumab|mesh-list
5613830|NCT03532217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5613831|NCT03532217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5613832|NCT03532217|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5613833|NCT03532217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613834|NCT03529110|Trastuzumab|trastuzumab|mesh-list
5613835|NCT03529110|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
5613836|NCT03529110|Maytansine|maytansine|mesh-list
5732364|NCT04527107|Growth Substances|growth substances|mesh-ancestor
5732365|NCT04527107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5732366|NCT04527107|Growth Inhibitors|growth inhibitors|mesh-ancestor
5732367|NCT04527107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5732368|NCT04509973|Dexamethasone|dexamethasone|mesh-list
5732369|NCT04509973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5732370|NCT04509973|Antiemetics|antiemetics|mesh-ancestor
5732371|NCT04509973|Autonomic Agents|autonomic agents|mesh-ancestor
5732372|NCT04509973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5732373|NCT04509973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5732374|NCT04509973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5732375|NCT04509973|Glucocorticoids|glucocorticoids|mesh-ancestor
5732376|NCT04509973|Hormones|hormones|mesh-ancestor
5732377|NCT04509973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5732378|NCT04509973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5732379|NCT04509973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5732380|NCT04504669|Durvalumab|durvalumab|mesh-list
5732381|NCT04504669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5732382|NCT04504669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5732383|NCT04482621|Decitabine|decitabine|mesh-list
5732384|NCT04482621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5732385|NCT04482621|Antimetabolites|antimetabolites|mesh-ancestor
5732386|NCT04482621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613837|NCT03529110|Camptothecin|camptothecin|mesh-list
5613838|NCT03529110|Immunoconjugates|immunoconjugates|mesh-list
5732387|NCT04482621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5732388|NCT04482621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5732389|NCT04469959|Levodopa|levodopa|mesh-list
5732390|NCT04469959|Carbidopa|carbidopa|mesh-list
5732391|NCT04469959|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
5732392|NCT04469959|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5732393|NCT04469959|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5732394|NCT04469959|Dopamine Agents|dopamine agents|mesh-ancestor
5732395|NCT04469959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5732396|NCT04469959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5732397|NCT04469959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5732398|NCT04469959|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5732399|NCT04469959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5732400|NCT04469959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5732401|NCT04469959|Immunologic Factors|immunologic factors|mesh-ancestor
5732402|NCT04469959|Dopamine Agonists|dopamine agonists|mesh-ancestor
5732403|NCT04456699|Leucovorin|leucovorin|mesh-list
5732404|NCT04456699|Bevacizumab|bevacizumab|mesh-list
5732405|NCT04456699|Fluorouracil|fluorouracil|mesh-list
5732406|NCT04456699|Capecitabine|capecitabine|mesh-list
5732407|NCT04456699|Olaparib|olaparib|mesh-list
5732408|NCT04456699|Levoleucovorin|levoleucovorin|mesh-list
5732409|NCT04456699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5732410|NCT04456699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5732411|NCT04456699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5732412|NCT04456699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5732413|NCT04456699|Growth Substances|growth substances|mesh-ancestor
5732414|NCT04456699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613839|NCT03529110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5613840|NCT03529110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5613841|NCT03529110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5613842|NCT03529110|Tubulin Modulators|tubulin modulators|mesh-ancestor
5613843|NCT03529110|Antimitotic Agents|antimitotic agents|mesh-ancestor
5613844|NCT03529110|Mitosis Modulators|mitosis modulators|mesh-ancestor
5613845|NCT03529110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613846|NCT03529110|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5613847|NCT03529110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5613848|NCT03529110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5613849|NCT03529110|Immunologic Factors|immunologic factors|mesh-ancestor
5613850|NCT03529110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613851|NCT03522844|Citalopram|citalopram|mesh-list
5613852|NCT03522844|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5613853|NCT03522844|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5613854|NCT03522844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5613855|NCT03522844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613856|NCT03522844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5613857|NCT03522844|Serotonin Agents|serotonin agents|mesh-ancestor
5613858|NCT03522844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613859|NCT03522844|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5613860|NCT03522844|Antidepressive Agents|antidepressive agents|mesh-ancestor
5613861|NCT03522844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5613862|NCT03514719|Avelumab|avelumab|mesh-list
5613863|NCT03514719|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5613864|NCT03514719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5732415|NCT04456699|Growth Inhibitors|growth inhibitors|mesh-ancestor
5732416|NCT04456699|Antimetabolites|antimetabolites|mesh-ancestor
5732417|NCT04456699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5732418|NCT04456699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5732419|NCT04456699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5732420|NCT04456699|Immunologic Factors|immunologic factors|mesh-ancestor
5732421|NCT04456699|Antidotes|antidotes|mesh-ancestor
5732422|NCT04456699|Protective Agents|protective agents|mesh-ancestor
5732423|NCT04456699|Vitamin B Complex|vitamin b complex|mesh-ancestor
5732424|NCT04456699|Vitamins|vitamins|mesh-ancestor
5732425|NCT04456699|Micronutrients|micronutrients|mesh-ancestor
5893002|NCT03836066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5613865|NCT03514719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5613866|NCT03514719|Immunologic Factors|immunologic factors|mesh-ancestor
5613867|NCT03514719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613868|NCT03514121|Pembrolizumab|pembrolizumab|mesh-list
5613869|NCT03514121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5613870|NCT03514121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5613871|NCT03513770|Ketorolac|ketorolac|mesh-list
5613872|NCT03513770|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
5613873|NCT03513770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5732426|NCT04456699|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5732427|NCT04456699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5732428|NCT04443569|Lidocaine|lidocaine|mesh-list
5732429|NCT04443569|Anesthetics, Local|anesthetics, local|mesh-ancestor
5732430|NCT04443569|Anesthetics|anesthetics|mesh-ancestor
5732431|NCT04443569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5732432|NCT04443569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5732433|NCT04443569|Sensory System Agents|sensory system agents|mesh-ancestor
5613874|NCT03513770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5613875|NCT03513770|Analgesics|analgesics|mesh-ancestor
5613876|NCT03513770|Sensory System Agents|sensory system agents|mesh-ancestor
5613877|NCT03513770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5732434|NCT04443569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5732435|NCT04443569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5732436|NCT04443569|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5732437|NCT04443569|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5613878|NCT03513770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613879|NCT03513770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5613880|NCT03513770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5613881|NCT03513770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5613882|NCT03513770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5613883|NCT03513770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692097|NCT03411967|Mitosis Modulators|mitosis modulators|mesh-ancestor
5692098|NCT03411967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692099|NCT03411967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5692100|NCT03411967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5692101|NCT03411941|Aflibercept|aflibercept|mesh-list
5692102|NCT03411941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5692103|NCT03411941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5692104|NCT03411941|Growth Substances|growth substances|mesh-ancestor
5692105|NCT03411941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692106|NCT03411941|Growth Inhibitors|growth inhibitors|mesh-ancestor
5692107|NCT03411941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5692108|NCT03411850|Abatacept|abatacept|mesh-list
5692109|NCT03411850|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5692110|NCT03411850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692111|NCT03411850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5692112|NCT03411850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5692113|NCT03411850|Immunologic Factors|immunologic factors|mesh-ancestor
5692114|NCT03411850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692115|NCT03411850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5692116|NCT03411798|Hydroxychloroquine|hydroxychloroquine|mesh-list
5692117|NCT03411798|Sulfasalazine|sulfasalazine|mesh-list
5692118|NCT03411798|Methotrexate|methotrexate|mesh-list
5692119|NCT03411798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5692120|NCT03411798|Abortifacient Agents|abortifacient agents|mesh-ancestor
5692121|NCT03411798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5692122|NCT03411798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692123|NCT03411798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5692124|NCT03411798|Antimetabolites|antimetabolites|mesh-ancestor
5692125|NCT03411798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692126|NCT03411798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5692127|NCT03411798|Dermatologic Agents|dermatologic agents|mesh-ancestor
5692128|NCT03411798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5692129|NCT03411798|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5692130|NCT03411798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5692131|NCT03411798|Immunologic Factors|immunologic factors|mesh-ancestor
5692132|NCT03411798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5692133|NCT03411798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5692134|NCT03411798|Antimalarials|antimalarials|mesh-ancestor
5692135|NCT03411798|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5692136|NCT03411798|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5692137|NCT03411798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5732438|NCT04443569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5732439|NCT04443569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5732440|NCT04425538|Infliximab|infliximab|mesh-list
5732441|NCT04425538|Dermatologic Agents|dermatologic agents|mesh-ancestor
5732442|NCT04425538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5732443|NCT04425538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5732444|NCT04380636|Paclitaxel|paclitaxel|mesh-list
5613884|NCT03492112|Sofosbuvir|sofosbuvir|mesh-list
5613885|NCT03492112|Velpatasvir|velpatasvir|mesh-list
5613886|NCT03492112|Antiviral Agents|antiviral agents|mesh-ancestor
5613887|NCT03492112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5613888|NCT03491683|Temozolomide|temozolomide|mesh-list
5613889|NCT03491683|Cemiplimab|cemiplimab|mesh-list
5613890|NCT03491683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5613891|NCT03491683|Alkylating Agents|alkylating agents|mesh-ancestor
5613892|NCT03491683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613893|NCT03491683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5613894|NCT03491683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5613895|NCT03484520|Venetoclax|venetoclax|mesh-list
5613896|NCT03484520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5613897|NCT03479671|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
5613898|NCT03479671|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
5613899|NCT03479671|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5613900|NCT03479671|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5613901|NCT03478956|Etrolizumab|etrolizumab|mesh-list
5613902|NCT03478956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5613903|NCT03478956|Immunologic Factors|immunologic factors|mesh-ancestor
5613904|NCT03478956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613905|NCT03476642|Epinephrine|epinephrine|mesh-list
5613906|NCT03476642|Ropivacaine|ropivacaine|mesh-list
5613907|NCT03476642|Anesthetics, Local|anesthetics, local|mesh-ancestor
5613908|NCT03476642|Anesthetics|anesthetics|mesh-ancestor
5613909|NCT03476642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5613910|NCT03476642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613911|NCT03476642|Sensory System Agents|sensory system agents|mesh-ancestor
5613912|NCT03476642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5613913|NCT03476642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5613914|NCT03476642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5613915|NCT03476642|Adrenergic Agents|adrenergic agents|mesh-ancestor
5732445|NCT04380636|Etoposide|etoposide|mesh-list
5732446|NCT04380636|Carboplatin|carboplatin|mesh-list
5732447|NCT04380636|Pembrolizumab|pembrolizumab|mesh-list
5732448|NCT04380636|Pemetrexed|pemetrexed|mesh-list
5732449|NCT04380636|Durvalumab|durvalumab|mesh-list
5732450|NCT04380636|Olaparib|olaparib|mesh-list
5732451|NCT04380636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5732452|NCT04380636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5732453|NCT04380636|Tubulin Modulators|tubulin modulators|mesh-ancestor
5732454|NCT04380636|Antimitotic Agents|antimitotic agents|mesh-ancestor
5732455|NCT04380636|Mitosis Modulators|mitosis modulators|mesh-ancestor
5732456|NCT04380636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5732457|NCT04380636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5732458|NCT04380636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5732459|NCT04380636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5732460|NCT04380636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5732461|NCT04380636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5732462|NCT04380636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5732463|NCT04380636|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5732464|NCT04372628|Ritonavir|ritonavir|mesh-list
5732465|NCT04372628|Lopinavir|lopinavir|mesh-list
5732466|NCT04372628|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5732467|NCT04372628|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5732468|NCT04372628|Protease Inhibitors|protease inhibitors|mesh-ancestor
5732469|NCT04372628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5732470|NCT04372628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5732471|NCT04372628|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5732472|NCT04372628|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5732473|NCT04372628|Antiviral Agents|antiviral agents|mesh-ancestor
5732474|NCT04372628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5732475|NCT04372628|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5732476|NCT04372628|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6208332|NCT02129348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6208333|NCT02129348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613916|NCT03476642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5613917|NCT03476642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208334|NCT02129426|Midazolam|midazolam|mesh-list
5613918|NCT03476642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5613919|NCT03476642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5613920|NCT03476642|Autonomic Agents|autonomic agents|mesh-ancestor
5613921|NCT03476642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5613922|NCT03476642|Respiratory System Agents|respiratory system agents|mesh-ancestor
5613923|NCT03476642|Mydriatics|mydriatics|mesh-ancestor
5613924|NCT03476642|Sympathomimetics|sympathomimetics|mesh-ancestor
6208335|NCT02129426|Dexmedetomidine|dexmedetomidine|mesh-list
6208336|NCT02129426|Ketamine|ketamine|mesh-list
6208337|NCT02129426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6208338|NCT02129426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6208339|NCT02129426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208340|NCT02129426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6208341|NCT02129426|Analgesics|analgesics|mesh-ancestor
5613925|NCT03476642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5613926|NCT03465280|Interferons|interferons|mesh-list
5613927|NCT03465280|Acyclovir|acyclovir|mesh-list
5613928|NCT03465280|Cidofovir|cidofovir|mesh-list
5613929|NCT03465280|Interferon-alpha|interferon-alpha|mesh-list
5613930|NCT03465280|Artemisinins|artemisinins|mesh-list
6208342|NCT02129426|Sensory System Agents|sensory system agents|mesh-ancestor
6208343|NCT02129426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6208344|NCT02129426|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5732491|NCT04357795|Cyclosporine|cyclosporine|mesh-list
5732492|NCT04357795|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5613931|NCT03465280|Artemisinin|artemisinin|mesh-list
5613932|NCT03465280|Celecoxib|celecoxib|mesh-list
5613933|NCT03465280|Bevacizumab|bevacizumab|mesh-list
5613934|NCT03465280|Methotrexate|methotrexate|mesh-list
5613935|NCT03465280|Indole-3-carbinol|indole-3-carbinol|mesh-list
5613936|NCT03465280|Isotretinoin|isotretinoin|mesh-list
5613937|NCT03465280|Cimetidine|cimetidine|mesh-list
5613938|NCT03465280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5613939|NCT03465280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5613940|NCT03465280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5613941|NCT03465280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5613942|NCT03465280|Growth Substances|growth substances|mesh-ancestor
5613943|NCT03465280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5732493|NCT04357795|Cyclosporins|cyclosporins|mesh-list
5732494|NCT04357795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5732495|NCT04357795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5732496|NCT04357795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5732497|NCT04357795|Immunologic Factors|immunologic factors|mesh-ancestor
5732498|NCT04357795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5732499|NCT04357795|Antifungal Agents|antifungal agents|mesh-ancestor
5732500|NCT04357795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5732501|NCT04357795|Dermatologic Agents|dermatologic agents|mesh-ancestor
5732502|NCT04357795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5732503|NCT04357795|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5732504|NCT04357795|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6208345|NCT02129426|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6208346|NCT02129426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6208347|NCT02129426|Adrenergic Agents|adrenergic agents|mesh-ancestor
6208348|NCT02129426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6208349|NCT02129426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208350|NCT02129426|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5732512|NCT04356638|Midazolam|midazolam|mesh-list
5732513|NCT04356638|Dexmedetomidine|dexmedetomidine|mesh-list
5732514|NCT04356638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5732515|NCT04356638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5613944|NCT03465280|Growth Inhibitors|growth inhibitors|mesh-ancestor
5613945|NCT03465280|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5613946|NCT03465280|Abortifacient Agents|abortifacient agents|mesh-ancestor
5613947|NCT03465280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5613948|NCT03465280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5613949|NCT03465280|Antimetabolites|antimetabolites|mesh-ancestor
5613950|NCT03465280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613951|NCT03465280|Dermatologic Agents|dermatologic agents|mesh-ancestor
5613952|NCT03465280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5613953|NCT03465280|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5613954|NCT03465280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5613955|NCT03465280|Immunologic Factors|immunologic factors|mesh-ancestor
5613956|NCT03465280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5732516|NCT04356638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613957|NCT03465280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5732517|NCT04356638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5613958|NCT03465280|Antiviral Agents|antiviral agents|mesh-ancestor
5732518|NCT04356638|Analgesics|analgesics|mesh-ancestor
5732519|NCT04356638|Sensory System Agents|sensory system agents|mesh-ancestor
5732520|NCT04356638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5732521|NCT04356638|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5732522|NCT04356638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5732523|NCT04356638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5732524|NCT04356638|Adrenergic Agents|adrenergic agents|mesh-ancestor
5732525|NCT04356638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5732526|NCT04356638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5732527|NCT04356638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5732528|NCT04356638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5732529|NCT04356638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5732530|NCT04356638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5732531|NCT04356638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5732532|NCT04356638|Anesthetics, General|anesthetics, general|mesh-ancestor
5732533|NCT04356638|Anesthetics|anesthetics|mesh-ancestor
5732534|NCT04356638|GABA Modulators|gaba modulators|mesh-ancestor
5732535|NCT04356638|GABA Agents|gaba agents|mesh-ancestor
5732536|NCT04352608|Vaccines|vaccines|mesh-list
5732537|NCT04352608|Immunologic Factors|immunologic factors|mesh-ancestor
5732538|NCT04352608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5732539|NCT04346108|Immunoglobulins|immunoglobulins|mesh-list
5732540|NCT04346108|Antibodies|antibodies|mesh-list
5732541|NCT04346108|gamma-Globulins|gamma-globulins|mesh-list
5732542|NCT04346108|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5732543|NCT04346108|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5732544|NCT04346108|Immunoglobulin G|immunoglobulin g|mesh-list
5732545|NCT04346108|Immunologic Factors|immunologic factors|mesh-ancestor
5732546|NCT04346108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208351|NCT02129426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6208352|NCT02129426|Anesthetics, General|anesthetics, general|mesh-ancestor
6208353|NCT02129426|Anesthetics|anesthetics|mesh-ancestor
6208354|NCT02129426|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6208355|NCT02129426|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5732552|NCT04332653|Pembrolizumab|pembrolizumab|mesh-list
5732553|NCT04332653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5732554|NCT04332653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5732555|NCT04305405|Benralizumab|benralizumab|mesh-list
5613959|NCT03465280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5613960|NCT03465280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5613961|NCT03465280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5613962|NCT03465280|Analgesics|analgesics|mesh-ancestor
5613963|NCT03465280|Sensory System Agents|sensory system agents|mesh-ancestor
5613964|NCT03465280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5613965|NCT03465280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5613966|NCT03465280|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5613967|NCT03465280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5613968|NCT03465280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5613969|NCT03465280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5613970|NCT03465280|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5613971|NCT03465280|Histamine Antagonists|histamine antagonists|mesh-ancestor
5613972|NCT03465280|Histamine Agents|histamine agents|mesh-ancestor
5613973|NCT03465280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5613974|NCT03465280|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5613975|NCT03465280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5613976|NCT03465280|Antimalarials|antimalarials|mesh-ancestor
5732556|NCT04305405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5732557|NCT04305405|Respiratory System Agents|respiratory system agents|mesh-ancestor
5732558|NCT04300309|Lumefantrine|lumefantrine|mesh-list
5613977|NCT03465280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5613978|NCT03465280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5613979|NCT03465280|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5732559|NCT04300309|Artemether|artemether|mesh-list
5732560|NCT04300309|Antimalarials|antimalarials|mesh-ancestor
5732561|NCT04300309|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5732562|NCT04300309|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5732563|NCT04300309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5732564|NCT04281147|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
6672739|NCT01558011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5613980|NCT03465280|Protective Agents|protective agents|mesh-ancestor
5613981|NCT03464136|Adalimumab|adalimumab|mesh-list
5613982|NCT03464136|Ustekinumab|ustekinumab|mesh-list
5613983|NCT03464136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5613984|NCT03464136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5613985|NCT03464136|Dermatologic Agents|dermatologic agents|mesh-ancestor
5613986|NCT03454035|Palbociclib|palbociclib|mesh-list
5732565|NCT04281147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5732566|NCT04276792|Analgesics, Opioid|analgesics, opioid|mesh-list
5732567|NCT04276792|Narcotics|narcotics|mesh-ancestor
5732568|NCT04276792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5732569|NCT04276792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613987|NCT03454035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5613988|NCT03454035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5613989|NCT03454035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5613990|NCT03454035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5613991|NCT03439657|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5613992|NCT03439657|Immunologic Factors|immunologic factors|mesh-ancestor
5613993|NCT03439657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5613994|NCT03435003|Dexamethasone|dexamethasone|mesh-list
5613995|NCT03435003|Fentanyl|fentanyl|mesh-list
5613996|NCT03435003|Scopolamine|scopolamine|mesh-list
5613997|NCT03435003|Dexmedetomidine|dexmedetomidine|mesh-list
5613998|NCT03435003|Ondansetron|ondansetron|mesh-list
5613999|NCT03435003|Aprepitant|aprepitant|mesh-list
5732570|NCT04276792|Analgesics|analgesics|mesh-ancestor
5732571|NCT04276792|Sensory System Agents|sensory system agents|mesh-ancestor
5732572|NCT04276792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5732573|NCT04246177|Pembrolizumab|pembrolizumab|mesh-list
5732574|NCT04246177|Lenvatinib|lenvatinib|mesh-list
5732575|NCT04246177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5732576|NCT04246177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5732577|NCT04246177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5732578|NCT04246177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5732579|NCT04246177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5732580|NCT04237792|Dexmedetomidine|dexmedetomidine|mesh-list
5732581|NCT04237792|Propofol|propofol|mesh-list
5732582|NCT04237792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5732583|NCT04237792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5732584|NCT04237792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5732585|NCT04237792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5732586|NCT04237792|Anesthetics, General|anesthetics, general|mesh-ancestor
5732587|NCT04237792|Anesthetics|anesthetics|mesh-ancestor
5732588|NCT04237792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5732589|NCT04237792|Analgesics|analgesics|mesh-ancestor
5732590|NCT04237792|Sensory System Agents|sensory system agents|mesh-ancestor
5732591|NCT04237792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5732592|NCT04237792|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5732593|NCT04237792|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5732594|NCT04237792|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5732595|NCT04237792|Adrenergic Agents|adrenergic agents|mesh-ancestor
5732596|NCT04237792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5732597|NCT04237792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5732598|NCT04233749|Tranexamic Acid|tranexamic acid|mesh-list
5732599|NCT04233749|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5732600|NCT04233749|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5732601|NCT04233749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5732602|NCT04233749|Hemostatics|hemostatics|mesh-ancestor
5732603|NCT04233749|Coagulants|coagulants|mesh-ancestor
5732604|NCT04229095|Suvorexant|suvorexant|mesh-list
5732605|NCT04229095|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5732606|NCT04229095|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5732607|NCT04229095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5732608|NCT04229095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5732609|NCT04229095|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
5732610|NCT04229095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5732611|NCT04229095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5732612|NCT04224987|Azithromycin|azithromycin|mesh-list
5732613|NCT04224987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5732614|NCT04224987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5732615|NCT04214067|Pembrolizumab|pembrolizumab|mesh-list
5732616|NCT04214067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5732617|NCT04214067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5732618|NCT04210180|Varenicline|varenicline|mesh-list
5732619|NCT04210180|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5732620|NCT04210180|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5732621|NCT04210180|Cholinergic Agents|cholinergic agents|mesh-ancestor
5732622|NCT04210180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5732623|NCT04210180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5732624|NCT04210180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5732625|NCT04209114|Nivolumab|nivolumab|mesh-list
5732626|NCT04209114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5614000|NCT03435003|Metoclopramide|metoclopramide|mesh-list
5614001|NCT03435003|Prochlorperazine|prochlorperazine|mesh-list
5614002|NCT03435003|Propofol|propofol|mesh-list
5614003|NCT03435003|Sevoflurane|sevoflurane|mesh-list
5614004|NCT03435003|Desflurane|desflurane|mesh-list
5614005|NCT03435003|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
5614006|NCT03435003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5614007|NCT03435003|Antiemetics|antiemetics|mesh-ancestor
5614008|NCT03435003|Autonomic Agents|autonomic agents|mesh-ancestor
5614009|NCT03435003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5614010|NCT03435003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5614011|NCT03435003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5614012|NCT03435003|Glucocorticoids|glucocorticoids|mesh-ancestor
5614013|NCT03435003|Hormones|hormones|mesh-ancestor
5614014|NCT03435003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5614015|NCT03435003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5614016|NCT03435003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614017|NCT03435003|Anesthetics|anesthetics|mesh-ancestor
5614018|NCT03435003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5614019|NCT03435003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5614020|NCT03435003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5614021|NCT03435003|Anesthetics, General|anesthetics, general|mesh-ancestor
5614022|NCT03435003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5614023|NCT03435003|Analgesics|analgesics|mesh-ancestor
5614024|NCT03435003|Sensory System Agents|sensory system agents|mesh-ancestor
5614025|NCT03435003|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5614026|NCT03435003|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5614027|NCT03435003|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5614028|NCT03435003|Adrenergic Agents|adrenergic agents|mesh-ancestor
5614029|NCT03435003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5614030|NCT03435003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614031|NCT03435003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5614032|NCT03435003|Narcotics|narcotics|mesh-ancestor
5614033|NCT03435003|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5614034|NCT03435003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5614035|NCT03435003|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5614036|NCT03435003|Antipruritics|antipruritics|mesh-ancestor
5614037|NCT03435003|Dermatologic Agents|dermatologic agents|mesh-ancestor
5614038|NCT03435003|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5614039|NCT03435003|Serotonin Agents|serotonin agents|mesh-ancestor
5614040|NCT03435003|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5614041|NCT03435003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5614042|NCT03435003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5614043|NCT03435003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5732627|NCT04209114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5732628|NCT04209114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5732629|NCT04209114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5732630|NCT04205812|Paclitaxel|paclitaxel|mesh-list
5732631|NCT04205812|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5732632|NCT04205812|Carboplatin|carboplatin|mesh-list
5732633|NCT04205812|Pemetrexed|pemetrexed|mesh-list
5732634|NCT04205812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5732635|NCT04205812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5732636|NCT04205812|Tubulin Modulators|tubulin modulators|mesh-ancestor
5732637|NCT04205812|Antimitotic Agents|antimitotic agents|mesh-ancestor
5732638|NCT04205812|Mitosis Modulators|mitosis modulators|mesh-ancestor
5732639|NCT04205812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5732640|NCT04205812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5732641|NCT04205812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5732642|NCT04205812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5732643|NCT04199104|Pembrolizumab|pembrolizumab|mesh-list
5732644|NCT04199104|Lenvatinib|lenvatinib|mesh-list
5732645|NCT04199104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5732646|NCT04199104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5732647|NCT04199104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5732648|NCT04199104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5732649|NCT04199104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5732650|NCT04175886|Tofacitinib|tofacitinib|mesh-list
5732651|NCT04175886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5732652|NCT04175886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5732653|NCT04175886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5732654|NCT04169737|Venetoclax|venetoclax|mesh-list
5732655|NCT04169737|Obinutuzumab|obinutuzumab|mesh-list
5732656|NCT04169737|Acalabrutinib|acalabrutinib|mesh-list
5732657|NCT04169737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5732658|NCT04169737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5732659|NCT04167514|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
5614044|NCT03435003|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5614045|NCT03435003|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5614046|NCT03435003|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5614047|NCT03435003|Dopamine Agents|dopamine agents|mesh-ancestor
5614048|NCT03435003|Mydriatics|mydriatics|mesh-ancestor
5614049|NCT03435003|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5732660|NCT04167514|Protein C Inhibitor|protein c inhibitor|mesh-list
5732661|NCT04167514|Protease Inhibitors|protease inhibitors|mesh-list
5732662|NCT04167514|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5732663|NCT04167514|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5732664|NCT04167514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5732665|NCT04167514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5732666|NCT04166409|Carboplatin|carboplatin|mesh-list
5732667|NCT04166409|Vincristine|vincristine|mesh-list
5732668|NCT04166409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5732669|NCT04166409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5732670|NCT04166409|Tubulin Modulators|tubulin modulators|mesh-ancestor
5732671|NCT04166409|Antimitotic Agents|antimitotic agents|mesh-ancestor
5732672|NCT04166409|Mitosis Modulators|mitosis modulators|mesh-ancestor
5732673|NCT04166409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208356|NCT02129426|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6208357|NCT02129426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6208358|NCT02129426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6208359|NCT02129426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5614050|NCT03435003|Cholinergic Agents|cholinergic agents|mesh-ancestor
5614051|NCT03435003|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5614052|NCT03435003|Parasympatholytics|parasympatholytics|mesh-ancestor
5614053|NCT03421041|Dexamethasone|dexamethasone|mesh-list
5614054|NCT03421041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5614055|NCT03421041|Antiemetics|antiemetics|mesh-ancestor
5614056|NCT03421041|Autonomic Agents|autonomic agents|mesh-ancestor
5614057|NCT03421041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5614058|NCT03421041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5614059|NCT03421041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5614060|NCT03421041|Glucocorticoids|glucocorticoids|mesh-ancestor
5614061|NCT03421041|Hormones|hormones|mesh-ancestor
5614062|NCT03421041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5614063|NCT03421041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5614064|NCT03421041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614065|NCT03377790|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5614066|NCT03377790|Cantharidin|cantharidin|mesh-list
5614067|NCT03377790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5614068|NCT03377790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614069|NCT03376477|Lenalidomide|lenalidomide|mesh-list
5614070|NCT03376477|Molgramostim|molgramostim|mesh-list
5614071|NCT03376477|Vaccines|vaccines|mesh-list
5614072|NCT03376477|Sargramostim|sargramostim|mesh-list
5614073|NCT03376477|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5614074|NCT03376477|Immunologic Factors|immunologic factors|mesh-ancestor
5614075|NCT03376477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5614076|NCT03376477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5614077|NCT03376477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5614078|NCT03376477|Growth Substances|growth substances|mesh-ancestor
5614079|NCT03376477|Growth Inhibitors|growth inhibitors|mesh-ancestor
6208360|NCT02129426|GABA Modulators|gaba modulators|mesh-ancestor
6208361|NCT02129426|GABA Agents|gaba agents|mesh-ancestor
6208362|NCT02129478|Olanzapine|olanzapine|mesh-list
6208363|NCT02129478|Antiemetics|antiemetics|mesh-ancestor
6208364|NCT02129478|Autonomic Agents|autonomic agents|mesh-ancestor
6208365|NCT02129478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6208366|NCT02129478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208367|NCT02129478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6208368|NCT02129478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6208369|NCT02129478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6208370|NCT02129478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6208371|NCT02129478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6208372|NCT02129478|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6208373|NCT02129478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5614080|NCT03376477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614081|NCT03367871|Paclitaxel|paclitaxel|mesh-list
5614082|NCT03367871|Bevacizumab|bevacizumab|mesh-list
5614083|NCT03367871|Carboplatin|carboplatin|mesh-list
5614084|NCT03367871|Pembrolizumab|pembrolizumab|mesh-list
5614085|NCT03367871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5614086|NCT03367871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614087|NCT03367871|Tubulin Modulators|tubulin modulators|mesh-ancestor
5614088|NCT03367871|Antimitotic Agents|antimitotic agents|mesh-ancestor
5614089|NCT03367871|Mitosis Modulators|mitosis modulators|mesh-ancestor
5614090|NCT03367871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614091|NCT03367871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6208374|NCT02129478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6208375|NCT02129478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208376|NCT02129478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6208377|NCT02129478|Serotonin Agents|serotonin agents|mesh-ancestor
6208378|NCT02129556|Pembrolizumab|pembrolizumab|mesh-list
6208379|NCT02129556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6208380|NCT02129556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6208381|NCT02129660|Glycopyrrolate|glycopyrrolate|mesh-list
6208382|NCT02129660|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6208383|NCT02129660|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6208384|NCT02129660|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6208385|NCT02129660|Cholinergic Agents|cholinergic agents|mesh-ancestor
6208386|NCT02129660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6208387|NCT02129660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208388|NCT02129660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5614092|NCT03367871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5614093|NCT03367871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5614094|NCT03367871|Growth Substances|growth substances|mesh-ancestor
5614095|NCT03367871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5614096|NCT03367871|Growth Inhibitors|growth inhibitors|mesh-ancestor
5614097|NCT03365882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5614098|NCT03365882|Trastuzumab|trastuzumab|mesh-list
5614099|NCT03365882|Cetuximab|cetuximab|mesh-list
6208389|NCT02129725|Sildenafil Citrate|sildenafil citrate|mesh-list
5732710|NCT04044001|Isoniazid|isoniazid|mesh-list
5732711|NCT04044001|Pyrazinamide|pyrazinamide|mesh-list
5732712|NCT04044001|Ethambutol|ethambutol|mesh-list
5732713|NCT04044001|Dolutegravir|dolutegravir|mesh-list
5732714|NCT04044001|Antitubercular Agents|antitubercular agents|mesh-ancestor
5732715|NCT04044001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5614100|NCT03365882|Pertuzumab|pertuzumab|mesh-list
5614101|NCT03365882|Irinotecan|irinotecan|mesh-list
5614102|NCT03365882|Camptothecin|camptothecin|mesh-list
5732716|NCT04044001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5732717|NCT04044001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5732718|NCT04044001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5732719|NCT04044001|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5732720|NCT04044001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5732721|NCT04044001|Antimetabolites|antimetabolites|mesh-ancestor
5732722|NCT04044001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5732723|NCT04044001|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5732724|NCT04044001|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5732725|NCT04044001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5732726|NCT04044001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5732727|NCT04044001|Antiviral Agents|antiviral agents|mesh-ancestor
5732728|NCT04031729|Aspirin|aspirin|mesh-list
5732729|NCT04031729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5732730|NCT04031729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5732731|NCT04031729|Analgesics|analgesics|mesh-ancestor
5732732|NCT04031729|Sensory System Agents|sensory system agents|mesh-ancestor
5732733|NCT04031729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5732734|NCT04031729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5732735|NCT04031729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5732736|NCT04031729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5732737|NCT04031729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5732738|NCT04031729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5732739|NCT04031729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5732740|NCT04031729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5732741|NCT04031729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5732742|NCT04031729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5732743|NCT04031729|Antipyretics|antipyretics|mesh-ancestor
5614103|NCT03365882|Antibodies|antibodies|mesh-list
5614104|NCT03365882|Immunoglobulins|immunoglobulins|mesh-list
5614105|NCT03365882|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5614106|NCT03365882|Immunologic Factors|immunologic factors|mesh-ancestor
5614107|NCT03365882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5614108|NCT03365882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614109|NCT03365882|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5614110|NCT03365882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5614111|NCT03365882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5614112|NCT03365882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614113|NCT03365882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5732744|NCT03992729|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5732745|NCT03992729|Immunologic Factors|immunologic factors|mesh-ancestor
5614114|NCT03365609|Bismuth|bismuth|mesh-list
5614115|NCT03365609|Antacids|antacids|mesh-ancestor
5614116|NCT03365609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614117|NCT03365609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5614118|NCT03361852|Rituximab|rituximab|mesh-list
5614119|NCT03361852|Pembrolizumab|pembrolizumab|mesh-list
5614120|NCT03361852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5614121|NCT03361852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614122|NCT03361852|Immunologic Factors|immunologic factors|mesh-ancestor
5614123|NCT03361852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5614124|NCT03361852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5614125|NCT03353675|Nivolumab|nivolumab|mesh-list
5614126|NCT03353675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5732746|NCT03992729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5732747|NCT03984448|Prednisone|prednisone|mesh-list
5732748|NCT03984448|Cortisone|cortisone|mesh-list
5732749|NCT03984448|Cyclophosphamide|cyclophosphamide|mesh-list
5732750|NCT03984448|Rituximab|rituximab|mesh-list
5732751|NCT03984448|Doxorubicin|doxorubicin|mesh-list
5732752|NCT03984448|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5732753|NCT03984448|Etoposide|etoposide|mesh-list
5732754|NCT03984448|Vincristine|vincristine|mesh-list
5614127|NCT03353675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614128|NCT03353675|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5614129|NCT03353675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614130|NCT03341156|Thrombin|thrombin|mesh-list
5614131|NCT03341156|Hemostatics|hemostatics|mesh-ancestor
5614132|NCT03341156|Coagulants|coagulants|mesh-ancestor
5614133|NCT03341078|Ibudilast|ibudilast|mesh-list
5614134|NCT03341078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5614135|NCT03341078|Autonomic Agents|autonomic agents|mesh-ancestor
5614136|NCT03341078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5732755|NCT03984448|Etoposide phosphate|etoposide phosphate|mesh-list
5732756|NCT03984448|Venetoclax|venetoclax|mesh-list
5732757|NCT03984448|Podophyllotoxin|podophyllotoxin|mesh-list
5732758|NCT03984448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5732759|NCT03984448|Antibodies|antibodies|mesh-list
5732760|NCT03984448|Immunoglobulins|immunoglobulins|mesh-list
5732761|NCT03984448|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5732762|NCT03984448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5732763|NCT03984448|Immunologic Factors|immunologic factors|mesh-ancestor
5732764|NCT03984448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5732765|NCT03984448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5732766|NCT03984448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5732767|NCT03984448|Alkylating Agents|alkylating agents|mesh-ancestor
5732768|NCT03984448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5732769|NCT03984448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5732770|NCT03984448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5732771|NCT03984448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5732772|NCT03984448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5732773|NCT03984448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5732774|NCT03984448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5732775|NCT03984448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5732776|NCT03984448|Glucocorticoids|glucocorticoids|mesh-ancestor
5732777|NCT03984448|Hormones|hormones|mesh-ancestor
5732778|NCT03984448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5732779|NCT03984448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5732780|NCT03984448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5732781|NCT03984448|Tubulin Modulators|tubulin modulators|mesh-ancestor
5732782|NCT03984448|Antimitotic Agents|antimitotic agents|mesh-ancestor
5732783|NCT03984448|Mitosis Modulators|mitosis modulators|mesh-ancestor
5732784|NCT03984448|Keratolytic Agents|keratolytic agents|mesh-ancestor
5732785|NCT03984448|Dermatologic Agents|dermatologic agents|mesh-ancestor
5732786|NCT03982030|Dalbavancin|dalbavancin|mesh-list
5732787|NCT03982030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5732788|NCT03982030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5732789|NCT03977363|Anticoagulants|anticoagulants|mesh-list
5732790|NCT03973268|Complement Factor H|complement factor h|mesh-list
5732791|NCT03973268|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5732792|NCT03973268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5732793|NCT03973268|Immunologic Factors|immunologic factors|mesh-ancestor
5732794|NCT03973268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5732795|NCT03971110|Goserelin|goserelin|mesh-list
5732796|NCT03971110|Bicalutamide|bicalutamide|mesh-list
5614137|NCT03341078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5614138|NCT03341078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5732797|NCT03971110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5732798|NCT03971110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614139|NCT03341078|Respiratory System Agents|respiratory system agents|mesh-ancestor
5732799|NCT03971110|Androgen Antagonists|androgen antagonists|mesh-ancestor
5732800|NCT03971110|Hormone Antagonists|hormone antagonists|mesh-ancestor
5732801|NCT03971110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5732802|NCT03971110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5732803|NCT03942653|Pembrolizumab|pembrolizumab|mesh-list
5732804|NCT03942653|Goserelin|goserelin|mesh-list
5732805|NCT03942653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5732806|NCT03942653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5732807|NCT03942653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5732808|NCT03941860|Lenalidomide|lenalidomide|mesh-list
5732809|NCT03941860|Ixazomib|ixazomib|mesh-list
5732810|NCT03941860|Glycine|glycine|mesh-list
5732811|NCT03941860|Immunologic Factors|immunologic factors|mesh-ancestor
5732812|NCT03941860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5732813|NCT03941860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5732814|NCT03941860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5732815|NCT03941860|Growth Substances|growth substances|mesh-ancestor
5732816|NCT03941860|Growth Inhibitors|growth inhibitors|mesh-ancestor
5732817|NCT03941860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5732818|NCT03941860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5732819|NCT03941860|Protease Inhibitors|protease inhibitors|mesh-ancestor
5732820|NCT03941860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5732821|NCT03941860|Glycine Agents|glycine agents|mesh-ancestor
5732822|NCT03941860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6208390|NCT02129725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208391|NCT02129725|Vasodilator Agents|vasodilator agents|mesh-ancestor
5614140|NCT03341078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5614141|NCT03341078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5614142|NCT03341078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614143|NCT03341078|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5614144|NCT03341078|Vasodilator Agents|vasodilator agents|mesh-ancestor
5614145|NCT03337594|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
5614146|NCT03337594|Chelating Agents|chelating agents|mesh-ancestor
5614147|NCT03337594|Sequestering Agents|sequestering agents|mesh-ancestor
5614148|NCT03337594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208392|NCT02129725|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6208393|NCT02129725|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6208394|NCT02129725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6208395|NCT02129725|Urological Agents|urological agents|mesh-ancestor
6208396|NCT02130024|Ranibizumab|ranibizumab|mesh-list
6208397|NCT02130024|Aflibercept|aflibercept|mesh-list
6208398|NCT02130024|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6208399|NCT02130024|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6208400|NCT02130024|Growth Substances|growth substances|mesh-ancestor
5732834|NCT03899155|Nivolumab|nivolumab|mesh-list
5732835|NCT03899155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5732836|NCT03899155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5732837|NCT03899155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5732838|NCT03899155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5732839|NCT03867084|Pembrolizumab|pembrolizumab|mesh-list
5732840|NCT03867084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5732841|NCT03867084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6208401|NCT02130024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208402|NCT02130024|Growth Inhibitors|growth inhibitors|mesh-ancestor
6208403|NCT02130024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6208404|NCT02130063|Iron|iron|mesh-list
6208405|NCT02130063|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6208406|NCT02130063|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
5732848|NCT03845517|PF-06700841|pf-06700841|mesh-list
5732849|NCT03845517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5732850|NCT03845517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5732851|NCT03845517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5732852|NCT03829501|Atezolizumab|atezolizumab|mesh-list
5732853|NCT03829501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6208407|NCT02130063|Trace Elements|trace elements|mesh-ancestor
6208408|NCT02130063|Micronutrients|micronutrients|mesh-ancestor
6208409|NCT02130063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208410|NCT02130063|Hematinics|hematinics|mesh-ancestor
6208411|NCT02130284|Insulin|insulin|mesh-list
6208412|NCT02130284|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6208413|NCT02130284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6208414|NCT02130284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208415|NCT02130557|Imatinib Mesylate|imatinib mesylate|mesh-list
6208416|NCT02130557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6208417|NCT02130557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6208418|NCT02130557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6208419|NCT02130557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208420|NCT02130635|Nemiralisib|nemiralisib|mesh-list
6208421|NCT02130635|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6208422|NCT02130635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5614149|NCT03326245|Methylphenidate|methylphenidate|mesh-list
5614150|NCT03326245|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5614151|NCT03326245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5614152|NCT03326245|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5614153|NCT03326245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5614154|NCT03326245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5614155|NCT03326245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614156|NCT03326245|Dopamine Agents|dopamine agents|mesh-ancestor
5614157|NCT03326245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5614158|NCT03319316|Durvalumab|durvalumab|mesh-list
5614159|NCT03319316|Tremelimumab|tremelimumab|mesh-list
5614160|NCT03319316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6208423|NCT02130635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208424|NCT02130687|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6208425|NCT02130687|Aprepitant|aprepitant|mesh-list
6208426|NCT02130687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5732874|NCT03805789|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
5732875|NCT03805789|Protein C Inhibitor|protein c inhibitor|mesh-list
5732876|NCT03805789|Protease Inhibitors|protease inhibitors|mesh-list
5732877|NCT03805789|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5732878|NCT03805789|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5732879|NCT03805789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5732880|NCT03805789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208427|NCT02130687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208428|NCT02130687|Incretins|incretins|mesh-ancestor
6208429|NCT02130687|Hormones|hormones|mesh-ancestor
6208430|NCT02130687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6208431|NCT02130687|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6208432|NCT02130687|Protease Inhibitors|protease inhibitors|mesh-ancestor
6208433|NCT02130687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6208434|NCT02130687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208435|NCT02130687|Antiemetics|antiemetics|mesh-ancestor
6208436|NCT02130687|Autonomic Agents|autonomic agents|mesh-ancestor
6208437|NCT02130687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6208438|NCT02130687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6208439|NCT02130687|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6208440|NCT02130687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6208441|NCT02131064|Carboplatin|carboplatin|mesh-list
6208442|NCT02131064|Docetaxel|docetaxel|mesh-list
6208443|NCT02131064|Trastuzumab|trastuzumab|mesh-list
6208444|NCT02131064|Pertuzumab|pertuzumab|mesh-list
6208445|NCT02131064|Maytansine|maytansine|mesh-list
6208446|NCT02131064|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
6208447|NCT02131064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5732908|NCT03712605|Pembrolizumab|pembrolizumab|mesh-list
5732909|NCT03712605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5732910|NCT03712605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6208448|NCT02131064|Tubulin Modulators|tubulin modulators|mesh-ancestor
6208449|NCT02131064|Antimitotic Agents|antimitotic agents|mesh-ancestor
6208450|NCT02131064|Mitosis Modulators|mitosis modulators|mesh-ancestor
6208451|NCT02131064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208452|NCT02131064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6208453|NCT02131064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6208454|NCT02131233|Raltegravir Potassium|raltegravir potassium|mesh-list
6208455|NCT02131233|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6208456|NCT02131233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6208457|NCT02131233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6208458|NCT02131233|Antiviral Agents|antiviral agents|mesh-ancestor
6208459|NCT02131233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6208460|NCT02131233|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6208461|NCT02131233|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6208462|NCT02131233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6208463|NCT02131233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208464|NCT02131233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5732929|NCT03651206|Niraparib|niraparib|mesh-list
5732930|NCT03651206|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5732931|NCT03651206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5732932|NCT03651206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5732933|NCT03651206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5732934|NCT03599622|BMS-986165|bms-986165|mesh-list
5732935|NCT03599622|Dermatologic Agents|dermatologic agents|mesh-ancestor
5732936|NCT03599622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5732937|NCT03599622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5732938|NCT03599622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5732939|NCT03573817|Formoterol Fumarate|formoterol fumarate|mesh-list
5732940|NCT03573817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5732941|NCT03573817|Autonomic Agents|autonomic agents|mesh-ancestor
5732942|NCT03573817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5732943|NCT03573817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5732944|NCT03573817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5732945|NCT03573817|Respiratory System Agents|respiratory system agents|mesh-ancestor
5732946|NCT03573817|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5732947|NCT03573817|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5732948|NCT03573817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5732949|NCT03573817|Adrenergic Agents|adrenergic agents|mesh-ancestor
5732950|NCT03573817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5732951|NCT03573817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208465|NCT02131233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6208466|NCT02131259|Afatinib|afatinib|mesh-list
6208467|NCT02131259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6208468|NCT02131259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6208469|NCT02131259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6208470|NCT02131259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208471|NCT02131272|Insulin|insulin|mesh-list
6208472|NCT02131272|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6208473|NCT02131272|Insulin Detemir|insulin detemir|mesh-list
6208474|NCT02131272|Isophane Insulin, Human|isophane insulin, human|mesh-list
6208475|NCT02131272|Insulin, Isophane|insulin, isophane|mesh-list
6208476|NCT02131272|Isophane insulin, beef|isophane insulin, beef|mesh-list
6208477|NCT02131272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6208478|NCT02131272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208479|NCT02131324|Clobetasol|clobetasol|mesh-list
6208480|NCT02131324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5732968|NCT03374800|Pantoprazole|pantoprazole|mesh-list
5732969|NCT03374800|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5732970|NCT03374800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5732971|NCT03374800|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5732972|NCT03374800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5732973|NCT03374800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5732974|NCT03318861|Cyclophosphamide|cyclophosphamide|mesh-list
5732975|NCT03318861|Fludarabine|fludarabine|mesh-list
5614161|NCT03319316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614162|NCT03317496|Gemcitabine|gemcitabine|mesh-list
5614163|NCT03317496|Cisplatin|cisplatin|mesh-list
5614164|NCT03317496|Carboplatin|carboplatin|mesh-list
5614165|NCT03317496|Pemetrexed|pemetrexed|mesh-list
5614166|NCT03317496|Avelumab|avelumab|mesh-list
5614167|NCT03317496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5614168|NCT03317496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614169|NCT03317496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5614170|NCT03317496|Antimetabolites|antimetabolites|mesh-ancestor
5614171|NCT03317496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614172|NCT03317496|Antiviral Agents|antiviral agents|mesh-ancestor
5614173|NCT03317496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5614174|NCT03317496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5614175|NCT03317496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5614176|NCT03317496|Immunologic Factors|immunologic factors|mesh-ancestor
5614177|NCT03317496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5614178|NCT03317496|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5732976|NCT03318861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5732977|NCT03318861|Immunologic Factors|immunologic factors|mesh-ancestor
5732978|NCT03318861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5732979|NCT03318861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6208481|NCT02131324|Glucocorticoids|glucocorticoids|mesh-ancestor
5614179|NCT03317496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5614180|NCT03317496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5732980|NCT03318861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5732981|NCT03318861|Alkylating Agents|alkylating agents|mesh-ancestor
5732982|NCT03318861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5732983|NCT03318861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5732984|NCT03318861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5732985|NCT03317405|Tamoxifen|tamoxifen|mesh-list
5732986|NCT03317405|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5732987|NCT03317405|Hormone Antagonists|hormone antagonists|mesh-ancestor
5732988|NCT03317405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5732989|NCT03317405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5732990|NCT03317405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5732991|NCT03317405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5732992|NCT03317405|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5732993|NCT03317405|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5732994|NCT03317405|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5732995|NCT03295396|TIC10 compound|tic10 compound|mesh-list
5732996|NCT03295396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5732997|NCT03269669|Prednisone|prednisone|mesh-list
5732998|NCT03269669|Cortisone|cortisone|mesh-list
5732999|NCT03269669|Cyclophosphamide|cyclophosphamide|mesh-list
5733000|NCT03269669|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5733001|NCT03269669|Doxorubicin|doxorubicin|mesh-list
5614181|NCT03315832|Valsartan|valsartan|mesh-list
5614182|NCT03315832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5614183|NCT03315832|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5614184|NCT03315832|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5614185|NCT03315832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614186|NCT03300557|Exemestane|exemestane|mesh-list
5733002|NCT03269669|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5733003|NCT03269669|Vincristine|vincristine|mesh-list
5733004|NCT03269669|Lenalidomide|lenalidomide|mesh-list
5733005|NCT03269669|Obinutuzumab|obinutuzumab|mesh-list
5733006|NCT03269669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5733007|NCT03269669|Immunologic Factors|immunologic factors|mesh-ancestor
5733008|NCT03269669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5733009|NCT03269669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5733010|NCT03269669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5733011|NCT03269669|Alkylating Agents|alkylating agents|mesh-ancestor
5733012|NCT03269669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5733013|NCT03269669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5733014|NCT03269669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5733015|NCT03269669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5733016|NCT03269669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5733017|NCT03269669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5733018|NCT03269669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5733019|NCT03269669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5733020|NCT03269669|Glucocorticoids|glucocorticoids|mesh-ancestor
5733021|NCT03269669|Hormones|hormones|mesh-ancestor
5733022|NCT03269669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5733023|NCT03269669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5733024|NCT03269669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5733025|NCT03269669|Tubulin Modulators|tubulin modulators|mesh-ancestor
5733026|NCT03269669|Antimitotic Agents|antimitotic agents|mesh-ancestor
5733027|NCT03269669|Mitosis Modulators|mitosis modulators|mesh-ancestor
5733028|NCT03269669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5733029|NCT03269669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5733030|NCT03269669|Growth Substances|growth substances|mesh-ancestor
5733031|NCT03269669|Growth Inhibitors|growth inhibitors|mesh-ancestor
5733032|NCT03269669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5614187|NCT03300557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614188|NCT03300557|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5614189|NCT03300557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5614190|NCT03300557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5614191|NCT03300557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614192|NCT03300557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5614193|NCT03300557|Hormone Antagonists|hormone antagonists|mesh-ancestor
5614194|NCT03300557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5614195|NCT03300557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5614196|NCT03300518|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5614197|NCT03300518|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5614198|NCT03300518|Estradiol|estradiol|mesh-list
5614199|NCT03300518|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5614200|NCT03300518|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5614201|NCT03300518|Ganirelix|ganirelix|mesh-list
5614202|NCT03300518|Estrogens|estrogens|mesh-ancestor
5614203|NCT03300518|Hormones|hormones|mesh-ancestor
5733052|NCT03165734|Hydroxyurea|hydroxyurea|mesh-list
5733053|NCT03165734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5733054|NCT03165734|Antisickling Agents|antisickling agents|mesh-ancestor
5733055|NCT03165734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5733056|NCT03165734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5733057|NCT03165734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5733058|NCT03119064|Irinotecan|irinotecan|mesh-list
5614204|NCT03300518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5614205|NCT03300518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5614206|NCT03300518|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5733059|NCT03119064|Temozolomide|temozolomide|mesh-list
5733060|NCT03119064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5733061|NCT03119064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5733062|NCT03119064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5733063|NCT03119064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5733064|NCT03119064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614207|NCT03300518|Contraceptive Agents|contraceptive agents|mesh-ancestor
5614208|NCT03300518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5614209|NCT03300518|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5614210|NCT03300518|Hormone Antagonists|hormone antagonists|mesh-ancestor
5614211|NCT03299309|Vaccines|vaccines|mesh-list
5614212|NCT03299309|Immunologic Factors|immunologic factors|mesh-ancestor
5614213|NCT03299309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5614214|NCT03294109|Bupivacaine|bupivacaine|mesh-list
5614215|NCT03294109|Anesthetics, Local|anesthetics, local|mesh-ancestor
5614216|NCT03294109|Anesthetics|anesthetics|mesh-ancestor
5614217|NCT03294109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5614218|NCT03294109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5614219|NCT03294109|Sensory System Agents|sensory system agents|mesh-ancestor
5614220|NCT03294109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5614221|NCT03292458|Sodium Oxybate|sodium oxybate|mesh-list
5733065|NCT03119064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5733066|NCT03119064|Alkylating Agents|alkylating agents|mesh-ancestor
5733067|NCT03117933|Paclitaxel|paclitaxel|mesh-list
5733068|NCT03117933|Olaparib|olaparib|mesh-list
5733069|NCT03117933|Cediranib|cediranib|mesh-list
5733070|NCT03117933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5733071|NCT03117933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5733072|NCT03117933|Tubulin Modulators|tubulin modulators|mesh-ancestor
5733073|NCT03117933|Antimitotic Agents|antimitotic agents|mesh-ancestor
5733074|NCT03117933|Mitosis Modulators|mitosis modulators|mesh-ancestor
5733075|NCT03117933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5733076|NCT03117933|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5733077|NCT03117933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5733078|NCT03117933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5733079|NCT03107871|Valganciclovir|valganciclovir|mesh-list
5733080|NCT03107871|Antiviral Agents|antiviral agents|mesh-ancestor
5733081|NCT03107871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5733082|NCT03095456|Tiotropium Bromide|tiotropium bromide|mesh-list
5733083|NCT03095456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5733084|NCT03095456|Autonomic Agents|autonomic agents|mesh-ancestor
5733085|NCT03095456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5733086|NCT03095456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5614222|NCT03292458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5614223|NCT03292458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5614224|NCT03292458|Anesthetics, General|anesthetics, general|mesh-ancestor
5614225|NCT03292458|Anesthetics|anesthetics|mesh-ancestor
5614226|NCT03292458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5614227|NCT03292458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5614228|NCT03289039|Fulvestrant|fulvestrant|mesh-list
5614229|NCT03289039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5614230|NCT03289039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614231|NCT03289039|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5614232|NCT03289039|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6489127|NCT00589316|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6489128|NCT00589316|Trace Elements|trace elements|mesh-ancestor
6489129|NCT00589316|Micronutrients|micronutrients|mesh-ancestor
6489130|NCT00589381|Fenretinide|fenretinide|mesh-list
6489131|NCT00589381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6489132|NCT00589381|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6489133|NCT00589381|Protective Agents|protective agents|mesh-ancestor
6489134|NCT00589381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489135|NCT00589394|Vaccines|vaccines|mesh-list
6489136|NCT00589394|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6489137|NCT00589394|Immunologic Factors|immunologic factors|mesh-ancestor
6489138|NCT00589394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489139|NCT00589485|Cobalt|cobalt|mesh-list
6489140|NCT00589485|Trace Elements|trace elements|mesh-ancestor
6489141|NCT00589485|Micronutrients|micronutrients|mesh-ancestor
5733087|NCT03095456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5733088|NCT03095456|Respiratory System Agents|respiratory system agents|mesh-ancestor
5733089|NCT03095456|Parasympatholytics|parasympatholytics|mesh-ancestor
5733090|NCT03095456|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5733091|NCT03095456|Cholinergic Agents|cholinergic agents|mesh-ancestor
5733092|NCT03095456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5733093|NCT03095456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5733094|NCT03087448|Trametinib|trametinib|mesh-list
5733095|NCT03087448|Ceritinib|ceritinib|mesh-list
5733096|NCT03087448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5733097|NCT03087448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5733098|NCT03087448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5733099|NCT03087448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5733100|NCT03084523|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
5733101|NCT03084523|Hematinics|hematinics|mesh-ancestor
5733102|NCT03084523|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5733103|NCT03084523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5733104|NCT03070301|Everolimus|everolimus|mesh-list
5733105|NCT03070301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5733106|NCT03070301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5733107|NCT03070301|Immunologic Factors|immunologic factors|mesh-ancestor
5733108|NCT03070301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5733109|NCT03064113|Ipratropium|ipratropium|mesh-list
5733110|NCT03064113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5733111|NCT03064113|Autonomic Agents|autonomic agents|mesh-ancestor
5733112|NCT03064113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5733113|NCT03064113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5733114|NCT03064113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5733115|NCT03064113|Respiratory System Agents|respiratory system agents|mesh-ancestor
5733116|NCT03064113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5733117|NCT03064113|Cholinergic Agents|cholinergic agents|mesh-ancestor
5733118|NCT03064113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5733119|NCT03064113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5733120|NCT03049540|Tadalafil|tadalafil|mesh-list
5733121|NCT03049540|Vasodilator Agents|vasodilator agents|mesh-ancestor
5733122|NCT03049540|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5733123|NCT03049540|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5733124|NCT03049540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5733125|NCT03049540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5733126|NCT03049540|Urological Agents|urological agents|mesh-ancestor
5733127|NCT03003546|Paclitaxel|paclitaxel|mesh-list
5614233|NCT03289039|Hormone Antagonists|hormone antagonists|mesh-ancestor
5614234|NCT03289039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5614235|NCT03289039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5733128|NCT03003546|Rituximab|rituximab|mesh-list
5733129|NCT03003546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5733130|NCT03003546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5733131|NCT03003546|Tubulin Modulators|tubulin modulators|mesh-ancestor
5614236|NCT03283137|Pembrolizumab|pembrolizumab|mesh-list
5614237|NCT03283137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5733132|NCT03003546|Antimitotic Agents|antimitotic agents|mesh-ancestor
5614238|NCT03283137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614239|NCT03277196|Ivacaftor|ivacaftor|mesh-list
5614240|NCT03277196|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
5614241|NCT03277196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5614242|NCT03277196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614243|NCT03273413|Pravastatin|pravastatin|mesh-list
5614244|NCT03273413|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5614245|NCT03273413|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5614246|NCT03273413|Antimetabolites|antimetabolites|mesh-ancestor
5614247|NCT03273413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5733133|NCT03003546|Mitosis Modulators|mitosis modulators|mesh-ancestor
5733134|NCT03003546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5733135|NCT03003546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5733136|NCT03003546|Immunologic Factors|immunologic factors|mesh-ancestor
5733137|NCT03003546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5733138|NCT03003546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5614248|NCT03273413|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5614249|NCT03273413|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5614250|NCT03273413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5614251|NCT03269409|Coal Tar|coal tar|mesh-list
5614252|NCT03269409|Keratolytic Agents|keratolytic agents|mesh-ancestor
5614253|NCT03269409|Dermatologic Agents|dermatologic agents|mesh-ancestor
5614254|NCT03268005|Insulin|insulin|mesh-list
5614255|NCT03268005|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5614256|NCT03268005|Metformin|metformin|mesh-list
5614257|NCT03268005|Insulin Aspart|insulin aspart|mesh-list
5614258|NCT03268005|Insulin, Long-Acting|insulin, long-acting|mesh-list
5614259|NCT03268005|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
5614260|NCT03268005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5614261|NCT03268005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5614262|NCT03257618|Temozolomide|temozolomide|mesh-list
5614263|NCT03257618|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5614264|NCT03257618|Alkylating Agents|alkylating agents|mesh-ancestor
5614265|NCT03257618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614266|NCT03257618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5733166|NCT02949700|Metformin|metformin|mesh-list
5733167|NCT02949700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5733168|NCT02949700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5733169|NCT02940769|Methamphetamine|methamphetamine|mesh-list
5733170|NCT02940769|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5733171|NCT02940769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672740|NCT01558011|Tubulin Modulators|tubulin modulators|mesh-ancestor
5614267|NCT03228693|Triamcinolone|triamcinolone|mesh-list
5614268|NCT03228693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5614269|NCT03228693|Glucocorticoids|glucocorticoids|mesh-ancestor
5614270|NCT03228693|Hormones|hormones|mesh-ancestor
5614271|NCT03228693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5733172|NCT02940769|Sympathomimetics|sympathomimetics|mesh-ancestor
5733173|NCT02940769|Autonomic Agents|autonomic agents|mesh-ancestor
5733174|NCT02940769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5614272|NCT03228693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5614273|NCT03228186|Docetaxel|docetaxel|mesh-list
5614274|NCT03228186|Pevonedistat|pevonedistat|mesh-list
5614275|NCT03228186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614276|NCT03228186|Tubulin Modulators|tubulin modulators|mesh-ancestor
5614277|NCT03228186|Antimitotic Agents|antimitotic agents|mesh-ancestor
5614278|NCT03228186|Mitosis Modulators|mitosis modulators|mesh-ancestor
5614279|NCT03228186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614280|NCT03228186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5614281|NCT03226756|Nivolumab|nivolumab|mesh-list
5614282|NCT03226756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5614283|NCT03226756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614284|NCT03226756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5733175|NCT02940769|Dopamine Agents|dopamine agents|mesh-ancestor
5733176|NCT02940769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5733177|NCT02940769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5733178|NCT02940769|Adrenergic Agents|adrenergic agents|mesh-ancestor
5733179|NCT02940769|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5733180|NCT02940769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5733181|NCT02940769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5733182|NCT02940769|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5733183|NCT02938013|Sofosbuvir|sofosbuvir|mesh-list
5733184|NCT02938013|Velpatasvir|velpatasvir|mesh-list
5733185|NCT02938013|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
5733186|NCT02938013|Antiviral Agents|antiviral agents|mesh-ancestor
5733187|NCT02938013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5733188|NCT02919683|Nivolumab|nivolumab|mesh-list
5733189|NCT02919683|Ipilimumab|ipilimumab|mesh-list
5733190|NCT02919683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5733191|NCT02919683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5733192|NCT02919683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5733193|NCT02919683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208482|NCT02131324|Hormones|hormones|mesh-ancestor
6208483|NCT02131324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6208484|NCT02131324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208485|NCT02132117|Phenylephrine|phenylephrine|mesh-list
6208486|NCT02132117|Oxymetazoline|oxymetazoline|mesh-list
6208487|NCT02132117|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6208488|NCT02132117|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6208489|NCT02132117|Adrenergic Agents|adrenergic agents|mesh-ancestor
6208490|NCT02132117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6208491|NCT02132117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208492|NCT02132117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208493|NCT02132117|Sympathomimetics|sympathomimetics|mesh-ancestor
6208494|NCT02132117|Autonomic Agents|autonomic agents|mesh-ancestor
6208495|NCT02132117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6208496|NCT02132117|Nasal Decongestants|nasal decongestants|mesh-ancestor
6208497|NCT02132117|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6208498|NCT02132117|Respiratory System Agents|respiratory system agents|mesh-ancestor
6208499|NCT02132117|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5614285|NCT03226756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692138|NCT03411798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5692139|NCT03411798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5692140|NCT03411798|Analgesics|analgesics|mesh-ancestor
5692141|NCT03411798|Sensory System Agents|sensory system agents|mesh-ancestor
5692142|NCT03411798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5692143|NCT03411798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5692144|NCT03411798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5697614|NCT03374709|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5697615|NCT03374709|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5697616|NCT03374709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5697617|NCT03374709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697618|NCT03374709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5697619|NCT03374709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5697620|NCT03374670|Aflibercept|aflibercept|mesh-list
5697621|NCT03374670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5697622|NCT03374670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5697623|NCT03374670|Growth Substances|growth substances|mesh-ancestor
6208500|NCT02132117|Mydriatics|mydriatics|mesh-ancestor
6208501|NCT02132117|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6208502|NCT02132117|Protective Agents|protective agents|mesh-ancestor
6208503|NCT02132169|Cetirizine|cetirizine|mesh-list
6489142|NCT00589485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5733218|NCT02901548|Durvalumab|durvalumab|mesh-list
5733219|NCT02901548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5733220|NCT02901548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5733221|NCT02890459|Denatonium|denatonium|mesh-list
5733222|NCT02890459|Aversive Agents|aversive agents|mesh-ancestor
5733223|NCT02890459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5733224|NCT02890459|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
5733225|NCT02890459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5733226|NCT02890459|Sensory System Agents|sensory system agents|mesh-ancestor
5733227|NCT02890459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5733228|NCT02864953|Glyburide|glyburide|mesh-list
5733229|NCT02864953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5733230|NCT02864953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5733231|NCT02863991|TIC10 compound|tic10 compound|mesh-list
5733232|NCT02863991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5733233|NCT02820311|Moxifloxacin|moxifloxacin|mesh-list
5733234|NCT02820311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5733235|NCT02820311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5733236|NCT02820311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5733237|NCT02820311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5733238|NCT02820311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5733239|NCT02820311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5733240|NCT02820311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5733241|NCT02812667|Nivolumab|nivolumab|mesh-list
5733242|NCT02812667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5733243|NCT02812667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5733244|NCT02812667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5733245|NCT02812667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5733246|NCT02797275|Albuterol|albuterol|mesh-list
5733247|NCT02797275|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5733248|NCT02797275|Autonomic Agents|autonomic agents|mesh-ancestor
5733249|NCT02797275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5733250|NCT02797275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5733251|NCT02797275|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5733252|NCT02797275|Respiratory System Agents|respiratory system agents|mesh-ancestor
5733253|NCT02797275|Tocolytic Agents|tocolytic agents|mesh-ancestor
5614286|NCT03220854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5614287|NCT03220854|Antibodies|antibodies|mesh-list
5614288|NCT03220854|Immunoglobulins|immunoglobulins|mesh-list
5614289|NCT03220854|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5614290|NCT03220854|Immunologic Factors|immunologic factors|mesh-ancestor
5614291|NCT03220854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5733254|NCT02797275|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5733255|NCT02797275|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5733256|NCT02797275|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5733257|NCT02797275|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5733258|NCT02797275|Adrenergic Agents|adrenergic agents|mesh-ancestor
5733259|NCT02797275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5733260|NCT02797275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5733261|NCT02790138|Ciprofloxacin|ciprofloxacin|mesh-list
5733262|NCT02790138|Vedolizumab|vedolizumab|mesh-list
5733263|NCT02790138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5733264|NCT02790138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5733265|NCT02790138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5733266|NCT02790138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5733267|NCT02790138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5733268|NCT02790138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5733269|NCT02790138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5733270|NCT02790138|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5733271|NCT02790138|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5733272|NCT02790138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5733273|NCT02783625|Bortezomib|bortezomib|mesh-list
5733274|NCT02783625|Romidepsin|romidepsin|mesh-list
5733275|NCT02783625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5733276|NCT02783625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5733277|NCT02773030|Dexamethasone|dexamethasone|mesh-list
5614292|NCT03220854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614293|NCT03187769|Olanzapine|olanzapine|mesh-list
5614294|NCT03187769|Antiemetics|antiemetics|mesh-ancestor
5614295|NCT03187769|Autonomic Agents|autonomic agents|mesh-ancestor
5614296|NCT03187769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5614297|NCT03187769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5614298|NCT03187769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5614299|NCT03187769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5614300|NCT03187769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5733278|NCT02773030|Bortezomib|bortezomib|mesh-list
5733279|NCT02773030|Daratumumab|daratumumab|mesh-list
5733280|NCT02773030|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5733281|NCT02773030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5733282|NCT02773030|Antiemetics|antiemetics|mesh-ancestor
5733283|NCT02773030|Autonomic Agents|autonomic agents|mesh-ancestor
5733284|NCT02773030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5733285|NCT02773030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5733286|NCT02773030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5733287|NCT02773030|Glucocorticoids|glucocorticoids|mesh-ancestor
5733288|NCT02773030|Hormones|hormones|mesh-ancestor
5733289|NCT02773030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5733290|NCT02773030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5733291|NCT02773030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5733292|NCT02773030|Immunologic Factors|immunologic factors|mesh-ancestor
5733293|NCT02744053|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
5733294|NCT02744053|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5733295|NCT02744053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5733296|NCT02726997|Paclitaxel|paclitaxel|mesh-list
5733297|NCT02726997|Carboplatin|carboplatin|mesh-list
5733298|NCT02726997|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5733299|NCT02726997|Durvalumab|durvalumab|mesh-list
5733300|NCT02726997|Immunoglobulins|immunoglobulins|mesh-list
5733301|NCT02726997|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5733302|NCT02726997|Immunoglobulin G|immunoglobulin g|mesh-list
5733303|NCT02726997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5733304|NCT02726997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5733305|NCT02726997|Tubulin Modulators|tubulin modulators|mesh-ancestor
5614301|NCT03187769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5614302|NCT03187769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5614303|NCT03187769|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5614304|NCT03187769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5614305|NCT03187769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5614306|NCT03187769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614307|NCT03187769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5614308|NCT03187769|Serotonin Agents|serotonin agents|mesh-ancestor
5614309|NCT03182166|Golimumab|golimumab|mesh-list
5614310|NCT03182166|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
5614311|NCT03182166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5614312|NCT03182166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5614313|NCT03182166|Immunologic Factors|immunologic factors|mesh-ancestor
5614314|NCT03182166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5733306|NCT02726997|Antimitotic Agents|antimitotic agents|mesh-ancestor
5733307|NCT02726997|Mitosis Modulators|mitosis modulators|mesh-ancestor
5733308|NCT02726997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5733309|NCT02726997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5733310|NCT02726997|Immunologic Factors|immunologic factors|mesh-ancestor
5733311|NCT02726997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5733312|NCT02723994|Leucovorin|leucovorin|mesh-list
5733313|NCT02723994|Cytarabine|cytarabine|mesh-list
5614315|NCT03181789|Interleukin-12|interleukin-12|mesh-list
5614316|NCT03181789|Vaccines|vaccines|mesh-list
5614317|NCT03181789|Immunologic Factors|immunologic factors|mesh-ancestor
5614318|NCT03181789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5614319|NCT03181789|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5733314|NCT02723994|Dexamethasone|dexamethasone|mesh-list
5733315|NCT02723994|Prednisone|prednisone|mesh-list
5733316|NCT02723994|Cyclophosphamide|cyclophosphamide|mesh-list
5733317|NCT02723994|Doxorubicin|doxorubicin|mesh-list
5733318|NCT02723994|Methotrexate|methotrexate|mesh-list
5733319|NCT02723994|Vincristine|vincristine|mesh-list
5733320|NCT02723994|Asparaginase|asparaginase|mesh-list
5733321|NCT02723994|Mercaptopurine|mercaptopurine|mesh-list
5733322|NCT02723994|Pegaspargase|pegaspargase|mesh-list
5733323|NCT02723994|Thioguanine|thioguanine|mesh-list
5733324|NCT02723994|Levoleucovorin|levoleucovorin|mesh-list
5733325|NCT02723994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5733326|NCT02723994|Immunologic Factors|immunologic factors|mesh-ancestor
5733327|NCT02723994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5733328|NCT02723994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5733329|NCT02723994|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5733330|NCT02723994|Alkylating Agents|alkylating agents|mesh-ancestor
6489143|NCT00589732|Valsartan|valsartan|mesh-list
5614320|NCT03181789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5733331|NCT02723994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5733332|NCT02723994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5733333|NCT02723994|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5733334|NCT02723994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5733335|NCT02723994|Antiemetics|antiemetics|mesh-ancestor
5733336|NCT02723994|Autonomic Agents|autonomic agents|mesh-ancestor
5733337|NCT02723994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5733338|NCT02723994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5733339|NCT02723994|Glucocorticoids|glucocorticoids|mesh-ancestor
5733340|NCT02723994|Hormones|hormones|mesh-ancestor
5614321|NCT03181789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5614322|NCT03181789|Growth Substances|growth substances|mesh-ancestor
5733341|NCT02723994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5733342|NCT02723994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5733343|NCT02723994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5733344|NCT02723994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5733345|NCT02723994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5733346|NCT02723994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5733347|NCT02723994|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5733348|NCT02723994|Abortifacient Agents|abortifacient agents|mesh-ancestor
5733349|NCT02723994|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5733350|NCT02723994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5733351|NCT02723994|Antimetabolites|antimetabolites|mesh-ancestor
5733352|NCT02723994|Dermatologic Agents|dermatologic agents|mesh-ancestor
5733353|NCT02723994|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5733354|NCT02723994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5733355|NCT02723994|Antiviral Agents|antiviral agents|mesh-ancestor
5733356|NCT02723994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5733357|NCT02723994|Antidotes|antidotes|mesh-ancestor
5733358|NCT02723994|Protective Agents|protective agents|mesh-ancestor
5733359|NCT02723994|Vitamin B Complex|vitamin b complex|mesh-ancestor
5733360|NCT02723994|Vitamins|vitamins|mesh-ancestor
5733361|NCT02723994|Micronutrients|micronutrients|mesh-ancestor
5733362|NCT02723994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5733363|NCT02723994|Tubulin Modulators|tubulin modulators|mesh-ancestor
5733364|NCT02723994|Antimitotic Agents|antimitotic agents|mesh-ancestor
5733365|NCT02723994|Mitosis Modulators|mitosis modulators|mesh-ancestor
5733366|NCT02677922|Azacitidine|azacitidine|mesh-list
5733367|NCT02677922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5733368|NCT02677922|Antimetabolites|antimetabolites|mesh-ancestor
5733369|NCT02677922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5733370|NCT02677922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5733371|NCT02677922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5733372|NCT02669173|Bevacizumab|bevacizumab|mesh-list
5733373|NCT02669173|Capecitabine|capecitabine|mesh-list
5733374|NCT02669173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5733375|NCT02669173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5733376|NCT02669173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5733377|NCT02669173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5733378|NCT02669173|Growth Substances|growth substances|mesh-ancestor
5733379|NCT02669173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5733380|NCT02669173|Growth Inhibitors|growth inhibitors|mesh-ancestor
5733381|NCT02669173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5733382|NCT02669173|Antimetabolites|antimetabolites|mesh-ancestor
5733383|NCT02669173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5733384|NCT02661282|Temozolomide|temozolomide|mesh-list
5733385|NCT02661282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5733386|NCT02661282|Alkylating Agents|alkylating agents|mesh-ancestor
5733387|NCT02661282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5733388|NCT02661282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5733389|NCT02642315|Gabapentin|gabapentin|mesh-list
5733390|NCT02642315|Analgesics|analgesics|mesh-ancestor
5733391|NCT02642315|Sensory System Agents|sensory system agents|mesh-ancestor
5733392|NCT02642315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5733393|NCT02642315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5733394|NCT02642315|Anticonvulsants|anticonvulsants|mesh-ancestor
5733395|NCT02642315|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5614323|NCT03181789|Growth Inhibitors|growth inhibitors|mesh-ancestor
5614324|NCT03181789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614325|NCT03172975|Albendazole|albendazole|mesh-list
5614326|NCT03172975|Aluminum Hydroxide|aluminum hydroxide|mesh-list
5614327|NCT03172975|Anthelmintics|anthelmintics|mesh-ancestor
5614328|NCT03172975|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5614329|NCT03172975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5614330|NCT03172975|Anticestodal Agents|anticestodal agents|mesh-ancestor
5614331|NCT03172975|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5614332|NCT03172975|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5733396|NCT02642315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5733397|NCT02642315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5614333|NCT03172975|Tubulin Modulators|tubulin modulators|mesh-ancestor
5733398|NCT02642315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5733399|NCT02642315|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5733400|NCT02642315|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5733401|NCT02642315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5733402|NCT02642315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614334|NCT03172975|Antimitotic Agents|antimitotic agents|mesh-ancestor
5614335|NCT03172975|Mitosis Modulators|mitosis modulators|mesh-ancestor
5614336|NCT03172975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614337|NCT03172975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614338|NCT03172975|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5614339|NCT03172975|Immunologic Factors|immunologic factors|mesh-ancestor
5614340|NCT03172975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5614341|NCT03172975|Antacids|antacids|mesh-ancestor
5614342|NCT03172975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5614343|NCT03169361|Ixazomib|ixazomib|mesh-list
5614344|NCT03169361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614345|NCT03169361|Protease Inhibitors|protease inhibitors|mesh-ancestor
5614346|NCT03169361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5614347|NCT03169361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614348|NCT03168438|Cyclophosphamide|cyclophosphamide|mesh-list
5614349|NCT03168438|Pembrolizumab|pembrolizumab|mesh-list
5733403|NCT02642315|Antimanic Agents|antimanic agents|mesh-ancestor
5733404|NCT02631447|Nivolumab|nivolumab|mesh-list
5614350|NCT03168438|Fludarabine|fludarabine|mesh-list
5614351|NCT03168438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5614352|NCT03168438|Immunologic Factors|immunologic factors|mesh-ancestor
5614353|NCT03168438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5614354|NCT03168438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5614355|NCT03168438|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5614356|NCT03168438|Alkylating Agents|alkylating agents|mesh-ancestor
5614357|NCT03168438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614358|NCT03168438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614359|NCT03168438|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5614360|NCT03168438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5614361|NCT03154996|Topotecan|topotecan|mesh-list
5614362|NCT03154996|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5614363|NCT03154996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5614364|NCT03154996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5614365|NCT03154996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614366|NCT03154996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614367|NCT03149822|Pembrolizumab|pembrolizumab|mesh-list
5733405|NCT02631447|Ipilimumab|ipilimumab|mesh-list
5733406|NCT02631447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5733407|NCT02631447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5733408|NCT02631447|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5733409|NCT02631447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5733410|NCT02586831|Exenatide|exenatide|mesh-list
5733411|NCT02586831|Aldesleukin|aldesleukin|mesh-list
5733412|NCT02586831|Adalimumab|adalimumab|mesh-list
5733413|NCT02586831|Interleukin-2|interleukin-2|mesh-list
5733414|NCT02586831|Thymoglobulin|thymoglobulin|mesh-list
5733415|NCT02586831|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5733416|NCT02586831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5733417|NCT02586831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5733418|NCT02586831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5733419|NCT02586831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5733420|NCT02586831|Analgesics|analgesics|mesh-ancestor
5733421|NCT02586831|Sensory System Agents|sensory system agents|mesh-ancestor
5733422|NCT02586831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5733423|NCT02586831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5733424|NCT02586831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5733425|NCT02586831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5733426|NCT02586831|Antiviral Agents|antiviral agents|mesh-ancestor
5733427|NCT02586831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5733428|NCT02586831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5733429|NCT02586831|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5733430|NCT02586831|Incretins|incretins|mesh-ancestor
5733431|NCT02586831|Hormones|hormones|mesh-ancestor
5614368|NCT03149822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5733432|NCT02586831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5733433|NCT02586831|Immunologic Factors|immunologic factors|mesh-ancestor
5733434|NCT02586831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5733435|NCT02574910|Abiraterone Acetate|abiraterone acetate|mesh-list
5733436|NCT02574910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5733437|NCT02574910|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5733438|NCT02574910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5733439|NCT02574910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5733440|NCT02574910|Hormone Antagonists|hormone antagonists|mesh-ancestor
5733441|NCT02574910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5733442|NCT02574910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5733443|NCT02574910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5733444|NCT02525692|TIC10 compound|tic10 compound|mesh-list
5733445|NCT02525692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5733446|NCT02518139|Tiotropium Bromide|tiotropium bromide|mesh-list
5733447|NCT02518139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5733448|NCT02518139|Autonomic Agents|autonomic agents|mesh-ancestor
5733449|NCT02518139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5733450|NCT02518139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5733451|NCT02518139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5733452|NCT02518139|Respiratory System Agents|respiratory system agents|mesh-ancestor
5733453|NCT02518139|Parasympatholytics|parasympatholytics|mesh-ancestor
5733454|NCT02518139|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5733455|NCT02518139|Cholinergic Agents|cholinergic agents|mesh-ancestor
5733456|NCT02518139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5733457|NCT02518139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5733458|NCT02481830|Nivolumab|nivolumab|mesh-list
5733459|NCT02481830|Topotecan|topotecan|mesh-list
5733460|NCT02481830|Amrubicin|amrubicin|mesh-list
5733461|NCT02481830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5733462|NCT02481830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6672741|NCT01558011|Antimitotic Agents|antimitotic agents|mesh-ancestor
5614369|NCT03149822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614370|NCT03141034|Irinotecan|irinotecan|mesh-list
5614371|NCT03141034|Ramucirumab|ramucirumab|mesh-list
5614372|NCT03141034|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5614373|NCT03141034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5614374|NCT03141034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5614375|NCT03141034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614376|NCT03141034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614377|NCT03132038|Nivolumab|nivolumab|mesh-list
5614378|NCT03132038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5614379|NCT03132038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614380|NCT03132038|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5614381|NCT03132038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614382|NCT03128021|Milnacipran|milnacipran|mesh-list
5614383|NCT03128021|Citalopram|citalopram|mesh-list
5614384|NCT03128021|Levomilnacipran|levomilnacipran|mesh-list
5614385|NCT03128021|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6672742|NCT01558011|Mitosis Modulators|mitosis modulators|mesh-ancestor
6672743|NCT01558011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672744|NCT01558011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6672745|NCT01558011|Antimetabolites|antimetabolites|mesh-ancestor
6672746|NCT01558115|Denosumab|denosumab|mesh-list
5614386|NCT03128021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5614387|NCT03128021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5614388|NCT03128021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614389|NCT03128021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5614390|NCT03128021|Serotonin Agents|serotonin agents|mesh-ancestor
5614391|NCT03128021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5614392|NCT03128021|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5614393|NCT03128021|Antidepressive Agents|antidepressive agents|mesh-ancestor
5614394|NCT03128021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5614395|NCT03128021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5614396|NCT03128021|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5614397|NCT03128021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5614398|NCT03128021|Analgesics|analgesics|mesh-ancestor
5614399|NCT03128021|Sensory System Agents|sensory system agents|mesh-ancestor
5614400|NCT03120624|Iodine|iodine|mesh-list
5614401|NCT03120624|Interferons|interferons|mesh-list
5614402|NCT03120624|Interferon-beta|interferon-beta|mesh-list
5614403|NCT03120624|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
5614404|NCT03120624|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
5614405|NCT03120624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614406|NCT03120624|Antiviral Agents|antiviral agents|mesh-ancestor
5614407|NCT03120624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5614408|NCT03120624|Immunologic Factors|immunologic factors|mesh-ancestor
5614409|NCT03120624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5614410|NCT03120624|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6672747|NCT01558115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5733463|NCT02481830|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5733464|NCT02481830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5733465|NCT02481830|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5733466|NCT02481830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5733467|NCT02481830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6208504|NCT02132169|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6208505|NCT02132169|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6208506|NCT02132169|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6208507|NCT02132169|Histamine Antagonists|histamine antagonists|mesh-ancestor
6208508|NCT02132169|Histamine Agents|histamine agents|mesh-ancestor
6208509|NCT02132169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6208510|NCT02132169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208511|NCT02132169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208512|NCT02132195|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6208513|NCT02132195|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
6208514|NCT02132195|beta-Endorphin|beta-endorphin|mesh-list
6208515|NCT02132195|Hormones|hormones|mesh-ancestor
6208516|NCT02132195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6208517|NCT02132195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208518|NCT02132195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6208519|NCT02132195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208520|NCT02132247|Diclofenac|diclofenac|mesh-list
6208521|NCT02132247|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
6208522|NCT02132247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6208523|NCT02132247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6208524|NCT02132247|Analgesics|analgesics|mesh-ancestor
6208525|NCT02132247|Sensory System Agents|sensory system agents|mesh-ancestor
6208526|NCT02132247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6208527|NCT02132247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208528|NCT02132247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6208529|NCT02132247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6489144|NCT00589732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6489145|NCT00589732|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6489146|NCT00589732|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6489147|NCT00589732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489148|NCT00589862|Clopidogrel|clopidogrel|mesh-list
6489149|NCT00589862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6489150|NCT00589862|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6489151|NCT00589862|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6489152|NCT00589862|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6489153|NCT00589862|Purinergic Agents|purinergic agents|mesh-ancestor
6489154|NCT00589862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6672748|NCT01558115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672749|NCT01558167|Rituximab|rituximab|mesh-list
6672750|NCT01558167|Lenalidomide|lenalidomide|mesh-list
6672751|NCT01558167|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6672752|NCT01558167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6672753|NCT01558167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6672754|NCT01558167|Immunologic Factors|immunologic factors|mesh-ancestor
6672755|NCT01558167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672756|NCT01558167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6672757|NCT01558167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6672758|NCT01558167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6672759|NCT01558167|Growth Substances|growth substances|mesh-ancestor
6672760|NCT01558167|Growth Inhibitors|growth inhibitors|mesh-ancestor
6672761|NCT01558167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6672762|NCT01558167|Alkylating Agents|alkylating agents|mesh-ancestor
6208530|NCT02132247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6208531|NCT02132247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6208532|NCT02132247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208533|NCT02132312|Phenylephrine|phenylephrine|mesh-list
6208534|NCT02132312|Oxymetazoline|oxymetazoline|mesh-list
6208535|NCT02132312|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6208536|NCT02132312|Mydriatics|mydriatics|mesh-ancestor
5733507|NCT02419417|Nivolumab|nivolumab|mesh-list
5733508|NCT02419417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5733509|NCT02419417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5733510|NCT02419417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5733511|NCT02419417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5733512|NCT02411656|Pembrolizumab|pembrolizumab|mesh-list
5733513|NCT02411656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5614411|NCT03120624|Trace Elements|trace elements|mesh-ancestor
5614412|NCT03120624|Micronutrients|micronutrients|mesh-ancestor
5614413|NCT03120624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5614414|NCT03120624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5614415|NCT03120624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614416|NCT03120624|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5733514|NCT02411656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5733515|NCT02383251|Paclitaxel|paclitaxel|mesh-list
5733516|NCT02383251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5733517|NCT02383251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5733518|NCT02383251|Tubulin Modulators|tubulin modulators|mesh-ancestor
5733519|NCT02383251|Antimitotic Agents|antimitotic agents|mesh-ancestor
5733520|NCT02383251|Mitosis Modulators|mitosis modulators|mesh-ancestor
5733521|NCT02383251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5733522|NCT02248701|Methyltestosterone|methyltestosterone|mesh-list
5733523|NCT02248701|Finasteride|finasteride|mesh-list
5733524|NCT02248701|Testosterone|testosterone|mesh-list
5733525|NCT02248701|Testosterone undecanoate|testosterone undecanoate|mesh-list
5733526|NCT02248701|Testosterone enanthate|testosterone enanthate|mesh-list
5733527|NCT02248701|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5733528|NCT02248701|Androgens|androgens|mesh-ancestor
5733529|NCT02248701|Hormones|hormones|mesh-ancestor
5733530|NCT02248701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5733531|NCT02248701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5733532|NCT02248701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5733533|NCT02248701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5733534|NCT02248701|Anabolic Agents|anabolic agents|mesh-ancestor
5733535|NCT02248701|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
5733536|NCT02248701|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5733537|NCT02248701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5733538|NCT02248701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5733539|NCT02248701|Hormone Antagonists|hormone antagonists|mesh-ancestor
5733540|NCT02248701|Urological Agents|urological agents|mesh-ancestor
5733541|NCT02245672|Fluticasone|fluticasone|mesh-list
5733542|NCT02245672|Xhance|xhance|mesh-list
5733543|NCT02245672|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5733544|NCT02245672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5733545|NCT02245672|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5733546|NCT02245672|Autonomic Agents|autonomic agents|mesh-ancestor
5733547|NCT02245672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5733548|NCT02245672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5733549|NCT02245672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5614417|NCT03110380|Dolutegravir|dolutegravir|mesh-list
5614418|NCT03110380|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
5614419|NCT03110380|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5733550|NCT02245672|Respiratory System Agents|respiratory system agents|mesh-ancestor
5733551|NCT02245672|Dermatologic Agents|dermatologic agents|mesh-ancestor
5733552|NCT02245672|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5733553|NCT02245672|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5733554|NCT02245672|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5733555|NCT02245672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5733556|NCT02245672|Adrenergic Agents|adrenergic agents|mesh-ancestor
5733557|NCT02245672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5614420|NCT03110380|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5614421|NCT03110380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5614422|NCT03110380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614423|NCT03110380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5614424|NCT03110380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5614425|NCT03110380|Antiviral Agents|antiviral agents|mesh-ancestor
5614426|NCT03110380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5614427|NCT03110380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5614428|NCT03110380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5614429|NCT03096418|Paclitaxel|paclitaxel|mesh-list
5733558|NCT02245672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5733559|NCT02194738|Gemcitabine|gemcitabine|mesh-list
5733560|NCT02194738|Paclitaxel|paclitaxel|mesh-list
5733561|NCT02194738|Cisplatin|cisplatin|mesh-list
5733562|NCT02194738|Carboplatin|carboplatin|mesh-list
5733563|NCT02194738|Pembrolizumab|pembrolizumab|mesh-list
5733564|NCT02194738|Nivolumab|nivolumab|mesh-list
5733565|NCT02194738|Pemetrexed|pemetrexed|mesh-list
5733566|NCT02194738|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5733567|NCT02194738|Crizotinib|crizotinib|mesh-list
5733568|NCT02194738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5733569|NCT02194738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5733570|NCT02194738|Tubulin Modulators|tubulin modulators|mesh-ancestor
5733571|NCT02194738|Antimitotic Agents|antimitotic agents|mesh-ancestor
5733572|NCT02194738|Mitosis Modulators|mitosis modulators|mesh-ancestor
5733573|NCT02194738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5733574|NCT02194738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5733575|NCT02194738|Antimetabolites|antimetabolites|mesh-ancestor
5733576|NCT02194738|Antiviral Agents|antiviral agents|mesh-ancestor
5733577|NCT02194738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5733578|NCT02194738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5733579|NCT02194738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5733580|NCT02194738|Immunologic Factors|immunologic factors|mesh-ancestor
5733581|NCT02194738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5733582|NCT02194738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5733583|NCT02194738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5733584|NCT02194738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5733585|NCT02194738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5733586|NCT02194738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5733587|NCT02129751|Bupropion|bupropion|mesh-list
5733588|NCT02129751|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5733589|NCT02129751|Antidepressive Agents|antidepressive agents|mesh-ancestor
5733590|NCT02129751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5733591|NCT02129751|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5733592|NCT02129751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5733593|NCT02129751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5733594|NCT02129751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5733595|NCT02129751|Dopamine Agents|dopamine agents|mesh-ancestor
5733596|NCT02129751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5733597|NCT02129751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5733598|NCT02129751|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5733599|NCT02129751|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5614430|NCT03096418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5614431|NCT03096418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614432|NCT03096418|Tubulin Modulators|tubulin modulators|mesh-ancestor
5614433|NCT03096418|Antimitotic Agents|antimitotic agents|mesh-ancestor
5614434|NCT03096418|Mitosis Modulators|mitosis modulators|mesh-ancestor
5614435|NCT03096418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614436|NCT03078478|Insulin|insulin|mesh-list
5614437|NCT03078478|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5614438|NCT03078478|Insulin Glargine|insulin glargine|mesh-list
5614439|NCT03078478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5614440|NCT03078478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5614441|NCT03061539|Nivolumab|nivolumab|mesh-list
5614442|NCT03061539|Ipilimumab|ipilimumab|mesh-list
5733600|NCT02129751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5733601|NCT02070705|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
5733602|NCT02070705|Hematinics|hematinics|mesh-ancestor
5733603|NCT02070705|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5733604|NCT02070705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5733605|NCT01979536|Cytarabine|cytarabine|mesh-list
5733606|NCT01979536|Dexamethasone|dexamethasone|mesh-list
5733607|NCT01979536|Dexamethasone acetate|dexamethasone acetate|mesh-list
5733608|NCT01979536|Cyclophosphamide|cyclophosphamide|mesh-list
5733609|NCT01979536|Ifosfamide|ifosfamide|mesh-list
5733610|NCT01979536|Isophosphamide mustard|isophosphamide mustard|mesh-list
5733611|NCT01979536|Doxorubicin|doxorubicin|mesh-list
5733612|NCT01979536|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5733613|NCT01979536|Methotrexate|methotrexate|mesh-list
5733614|NCT01979536|Etoposide|etoposide|mesh-list
5733615|NCT01979536|Etoposide phosphate|etoposide phosphate|mesh-list
5733616|NCT01979536|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5733617|NCT01979536|Crizotinib|crizotinib|mesh-list
5733618|NCT01979536|Podophyllotoxin|podophyllotoxin|mesh-list
5733619|NCT01979536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5614443|NCT03061539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5733620|NCT01979536|Antibodies|antibodies|mesh-list
5692145|NCT03411551|Anesthetics|anesthetics|mesh-list
5733621|NCT01979536|Immunoglobulins|immunoglobulins|mesh-list
5733622|NCT01979536|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5733623|NCT01979536|Immunoconjugates|immunoconjugates|mesh-list
5614444|NCT03061539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614445|NCT03061539|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5733624|NCT01979536|BB 1101|bb 1101|mesh-list
5733625|NCT01979536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5733626|NCT01979536|Immunologic Factors|immunologic factors|mesh-ancestor
5733627|NCT01979536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5733628|NCT01979536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5733629|NCT01979536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5733630|NCT01979536|Alkylating Agents|alkylating agents|mesh-ancestor
5733631|NCT01979536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5733632|NCT01979536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5733633|NCT01979536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5733634|NCT01979536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5733635|NCT01979536|Antiemetics|antiemetics|mesh-ancestor
5733636|NCT01979536|Autonomic Agents|autonomic agents|mesh-ancestor
5733637|NCT01979536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5733638|NCT01979536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5733639|NCT01979536|Glucocorticoids|glucocorticoids|mesh-ancestor
5733640|NCT01979536|Hormones|hormones|mesh-ancestor
5733641|NCT01979536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5733642|NCT01979536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5733643|NCT01979536|Protease Inhibitors|protease inhibitors|mesh-ancestor
5733644|NCT01979536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5733645|NCT01979536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5733646|NCT01979536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5614446|NCT03061539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614447|NCT03046927|Vitamin D|vitamin d|mesh-list
5614448|NCT03046927|Ergocalciferols|ergocalciferols|mesh-list
5614449|NCT03046927|Vitamins|vitamins|mesh-ancestor
5614450|NCT03046927|Micronutrients|micronutrients|mesh-ancestor
5614451|NCT03046927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5614452|NCT03046927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5614453|NCT03046927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5614454|NCT03040726|Palonosetron|palonosetron|mesh-list
5614455|NCT03040726|Antiemetics|antiemetics|mesh-ancestor
5614456|NCT03040726|Autonomic Agents|autonomic agents|mesh-ancestor
5614457|NCT03040726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5614458|NCT03040726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5614459|NCT03040726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5614460|NCT03040726|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5614461|NCT03040726|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5614462|NCT03040726|Serotonin Agents|serotonin agents|mesh-ancestor
5614463|NCT03040726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5614464|NCT03040726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614465|NCT03016377|Cyclophosphamide|cyclophosphamide|mesh-list
5614466|NCT03016377|Fludarabine|fludarabine|mesh-list
5614467|NCT03016377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5733647|NCT01979536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5733648|NCT01979536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5733649|NCT01979536|Abortifacient Agents|abortifacient agents|mesh-ancestor
5733650|NCT01979536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5733651|NCT01979536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5733652|NCT01979536|Antimetabolites|antimetabolites|mesh-ancestor
5733653|NCT01979536|Dermatologic Agents|dermatologic agents|mesh-ancestor
5733654|NCT01979536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5733655|NCT01979536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5733656|NCT01979536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5733657|NCT01979536|Antiviral Agents|antiviral agents|mesh-ancestor
5733658|NCT01979536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5733659|NCT01979536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5733660|NCT01979536|Keratolytic Agents|keratolytic agents|mesh-ancestor
5733661|NCT01979536|Tubulin Modulators|tubulin modulators|mesh-ancestor
5733662|NCT01979536|Antimitotic Agents|antimitotic agents|mesh-ancestor
5733663|NCT01979536|Mitosis Modulators|mitosis modulators|mesh-ancestor
5733664|NCT01959633|Interferons|interferons|mesh-list
5733665|NCT01959633|Vemurafenib|vemurafenib|mesh-list
5733666|NCT01959633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5733667|NCT01959633|Antiviral Agents|antiviral agents|mesh-ancestor
5733668|NCT01959633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5733669|NCT01959633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5733670|NCT01959633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5733671|NCT01959633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614468|NCT03016377|Immunologic Factors|immunologic factors|mesh-ancestor
5733672|NCT01936688|Etanercept|etanercept|mesh-list
5733673|NCT01936688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5614469|NCT03016377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5614470|NCT03016377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5614471|NCT03016377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5614472|NCT03016377|Alkylating Agents|alkylating agents|mesh-ancestor
5614473|NCT03016377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614474|NCT03016377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614475|NCT03016377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5614476|NCT03009487|Amlodipine|amlodipine|mesh-list
5614477|NCT03009487|Olmesartan|olmesartan|mesh-list
5614478|NCT03009487|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
5614479|NCT03009487|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
5614480|NCT03009487|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5614481|NCT03009487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5614482|NCT03009487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5614483|NCT03009487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5614484|NCT03009487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614485|NCT03009487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5614486|NCT03009487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5614487|NCT03009487|Vasodilator Agents|vasodilator agents|mesh-ancestor
5614488|NCT03009487|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5614489|NCT03009487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5614490|NCT03009487|Antimetabolites|antimetabolites|mesh-ancestor
5614491|NCT03009487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5614492|NCT03009487|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5614493|NCT03009487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5614494|NCT03009487|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5614495|NCT03009487|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5614496|NCT02999022|Lithium Carbonate|lithium carbonate|mesh-list
5614497|NCT02999022|Antidepressive Agents|antidepressive agents|mesh-ancestor
5614498|NCT02999022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5733674|NCT01936688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5733675|NCT01936688|Analgesics|analgesics|mesh-ancestor
5733676|NCT01936688|Sensory System Agents|sensory system agents|mesh-ancestor
5733677|NCT01936688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5733678|NCT01936688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5733679|NCT01936688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5733680|NCT01936688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5733681|NCT01936688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5733682|NCT01936688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5733683|NCT01936688|Immunologic Factors|immunologic factors|mesh-ancestor
5733684|NCT01892722|Interferons|interferons|mesh-list
5733685|NCT01892722|Interferon-beta|interferon-beta|mesh-list
5733686|NCT01892722|Interferon beta-1a|interferon beta-1a|mesh-list
5733687|NCT01892722|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
5733688|NCT01892722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5733689|NCT01892722|Antiviral Agents|antiviral agents|mesh-ancestor
5733690|NCT01892722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5614499|NCT02999022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5614500|NCT02999022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614501|NCT02999022|Antimanic Agents|antimanic agents|mesh-ancestor
5614502|NCT02999022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5614503|NCT02999022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5614504|NCT02999022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5614505|NCT02966782|Azacitidine|azacitidine|mesh-list
5614506|NCT02966782|Venetoclax|venetoclax|mesh-list
5614507|NCT02966782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5614508|NCT02966782|Antimetabolites|antimetabolites|mesh-ancestor
5614509|NCT02966782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5733691|NCT01892722|Immunologic Factors|immunologic factors|mesh-ancestor
5733692|NCT01892722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5733693|NCT01892722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5733694|NCT01892722|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5733695|NCT01892722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5733696|NCT01892722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5733697|NCT01879228|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5733698|NCT01879228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5733699|NCT01879228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5733700|NCT01879228|Incretins|incretins|mesh-ancestor
5733701|NCT01879228|Hormones|hormones|mesh-ancestor
5733702|NCT01879228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5733703|NCT01879228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5733704|NCT01879228|Protease Inhibitors|protease inhibitors|mesh-ancestor
5733705|NCT01879228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5733706|NCT01879228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5733707|NCT01861496|Cisplatin|cisplatin|mesh-list
5733708|NCT01861496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6208537|NCT02132312|Autonomic Agents|autonomic agents|mesh-ancestor
6208538|NCT02132312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6208539|NCT02132312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208540|NCT02132312|Sympathomimetics|sympathomimetics|mesh-ancestor
6208541|NCT02132312|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6208542|NCT02132312|Nasal Decongestants|nasal decongestants|mesh-ancestor
5733715|NCT01826838|Dasatinib|dasatinib|mesh-list
5733716|NCT01826838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5733717|NCT01826838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5733718|NCT01826838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5733719|NCT01826838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5733720|NCT01767675|Carboplatin|carboplatin|mesh-list
5733721|NCT01767675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5733722|NCT01748149|Vemurafenib|vemurafenib|mesh-list
5733723|NCT01748149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5733724|NCT01748149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5733725|NCT01748149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5733726|NCT01748149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5733727|NCT01502917|Antibodies|antibodies|mesh-list
5733728|NCT01502917|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5733729|NCT01502917|Immunologic Factors|immunologic factors|mesh-ancestor
5733730|NCT01502917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5733731|NCT00970866|Folic Acid|folic acid|mesh-list
5733732|NCT00970866|Micronutrients|micronutrients|mesh-list
5733733|NCT00970866|Trace Elements|trace elements|mesh-list
5733734|NCT00970866|Hematinics|hematinics|mesh-ancestor
5733735|NCT00970866|Vitamin B Complex|vitamin b complex|mesh-ancestor
5733736|NCT00970866|Vitamins|vitamins|mesh-ancestor
5614510|NCT02966782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614511|NCT02966782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5614512|NCT02961881|Blinatumomab|blinatumomab|mesh-list
5614513|NCT02961881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614514|NCT02954523|Dasatinib|dasatinib|mesh-list
5614515|NCT02954523|Osimertinib|osimertinib|mesh-list
5614516|NCT02954523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5733737|NCT00970866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208543|NCT02132312|Respiratory System Agents|respiratory system agents|mesh-ancestor
6208544|NCT02132312|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6208545|NCT02132312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5733741|NCT00799396|Aspirin|aspirin|mesh-list
5733742|NCT00799396|Clopidogrel|clopidogrel|mesh-list
5733743|NCT00799396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5733744|NCT00799396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5733745|NCT00799396|Analgesics|analgesics|mesh-ancestor
5733746|NCT00799396|Sensory System Agents|sensory system agents|mesh-ancestor
5733747|NCT00799396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5733748|NCT00799396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5733749|NCT00799396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5733750|NCT00799396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5733751|NCT00799396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5733752|NCT00799396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5733753|NCT00799396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5733754|NCT00799396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5733755|NCT00799396|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5733756|NCT00799396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5733757|NCT00799396|Antipyretics|antipyretics|mesh-ancestor
5733758|NCT00799396|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5733759|NCT00799396|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5733760|NCT00799396|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5733761|NCT00799396|Purinergic Agents|purinergic agents|mesh-ancestor
5733762|NCT00799396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5733763|NCT00308685|Albuterol|albuterol|mesh-list
5733764|NCT00308685|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5733765|NCT00308685|Autonomic Agents|autonomic agents|mesh-ancestor
5614517|NCT02954523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5614518|NCT02954523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5614519|NCT02954523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614520|NCT02951052|Rilpivirine|rilpivirine|mesh-list
5614521|NCT02951052|Cabotegravir|cabotegravir|mesh-list
5614522|NCT02951052|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5614523|NCT02951052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5733766|NCT00308685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5733767|NCT00308685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5733768|NCT00308685|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5733769|NCT00308685|Respiratory System Agents|respiratory system agents|mesh-ancestor
5733770|NCT00308685|Tocolytic Agents|tocolytic agents|mesh-ancestor
5733771|NCT00308685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5733772|NCT00308685|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5733773|NCT00308685|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5733774|NCT00308685|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5733775|NCT00308685|Adrenergic Agents|adrenergic agents|mesh-ancestor
5733776|NCT00308685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5733777|NCT00308685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5733778|NCT00069238|Prednisone|prednisone|mesh-list
5733779|NCT00069238|Cyclophosphamide|cyclophosphamide|mesh-list
5733780|NCT00069238|Doxorubicin|doxorubicin|mesh-list
5733781|NCT00069238|Etoposide|etoposide|mesh-list
5733782|NCT00069238|Vincristine|vincristine|mesh-list
5733783|NCT00069238|Alemtuzumab|alemtuzumab|mesh-list
5733784|NCT00069238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5614524|NCT02951052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5614525|NCT02951052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614526|NCT02951052|Antiviral Agents|antiviral agents|mesh-ancestor
5614527|NCT02951052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5614528|NCT02951052|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5614529|NCT02951052|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5614530|NCT02951052|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5614531|NCT02951052|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5614532|NCT02936102|Spartalizumab|spartalizumab|mesh-list
5614533|NCT02936102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5614534|NCT02936102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614535|NCT02936102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614536|NCT02927249|Aspirin|aspirin|mesh-list
5614537|NCT02927249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5614538|NCT02927249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5614539|NCT02927249|Analgesics|analgesics|mesh-ancestor
5614540|NCT02927249|Sensory System Agents|sensory system agents|mesh-ancestor
5614541|NCT02927249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5614542|NCT02927249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5614543|NCT02927249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5614544|NCT02927249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5614545|NCT02927249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5614546|NCT02927249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5614547|NCT02927249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614548|NCT02927249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5614549|NCT02927249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5614550|NCT02927249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5614551|NCT02927249|Antipyretics|antipyretics|mesh-ancestor
5614552|NCT02924272|Ixazomib|ixazomib|mesh-list
5614553|NCT02924272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614554|NCT02924272|Protease Inhibitors|protease inhibitors|mesh-ancestor
5614555|NCT02924272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5614556|NCT02924272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614557|NCT02908087|Liraglutide|liraglutide|mesh-list
5614558|NCT02908087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5614559|NCT02908087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5733785|NCT00069238|Immunologic Factors|immunologic factors|mesh-ancestor
5733786|NCT00069238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5733787|NCT00069238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5733788|NCT00069238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5733789|NCT00069238|Alkylating Agents|alkylating agents|mesh-ancestor
5733790|NCT00069238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5733791|NCT00069238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5733792|NCT00069238|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5733793|NCT00069238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5733794|NCT00069238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5733795|NCT00069238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5733796|NCT00069238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5733797|NCT00069238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5733798|NCT00069238|Glucocorticoids|glucocorticoids|mesh-ancestor
5733799|NCT00069238|Hormones|hormones|mesh-ancestor
5733800|NCT00069238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5733801|NCT00069238|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5733802|NCT00069238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5733803|NCT00069238|Tubulin Modulators|tubulin modulators|mesh-ancestor
5733804|NCT00069238|Antimitotic Agents|antimitotic agents|mesh-ancestor
5733805|NCT00069238|Mitosis Modulators|mitosis modulators|mesh-ancestor
5733806|NCT00069238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5733807|NCT00018057|Fluoxetine|fluoxetine|mesh-list
5733808|NCT00018057|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5733809|NCT00018057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5733810|NCT00018057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5733811|NCT00018057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5733812|NCT00018057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5733813|NCT00018057|Serotonin Agents|serotonin agents|mesh-ancestor
5733814|NCT00018057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5733815|NCT00018057|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5733816|NCT00018057|Antidepressive Agents|antidepressive agents|mesh-ancestor
5733817|NCT00018057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5733818|NCT00018057|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5733819|NCT00018057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5733820|NCT00018057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5733821|NCT00001322|Leuprolide|leuprolide|mesh-list
5733822|NCT00001322|Estradiol|estradiol|mesh-list
5733823|NCT00001322|Progesterone|progesterone|mesh-list
5733824|NCT00001322|Estrogens|estrogens|mesh-ancestor
5733825|NCT00001322|Hormones|hormones|mesh-ancestor
5614560|NCT02908087|Incretins|incretins|mesh-ancestor
5614561|NCT02908087|Hormones|hormones|mesh-ancestor
5614562|NCT02908087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5614563|NCT02903914|Pembrolizumab|pembrolizumab|mesh-list
5614564|NCT02903914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5733826|NCT00001322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5733827|NCT00001322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5733828|NCT00001322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5733829|NCT00001322|Progestins|progestins|mesh-ancestor
5733830|NCT00001322|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5733831|NCT00001322|Fertility Agents|fertility agents|mesh-ancestor
5733832|NCT00001322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5733833|NCT00001322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5893003|NCT03836066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5893004|NCT03836066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5893005|NCT03836066|Growth Substances|growth substances|mesh-ancestor
5893006|NCT03836066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893007|NCT03836066|Growth Inhibitors|growth inhibitors|mesh-ancestor
5893008|NCT03830866|Carboplatin|carboplatin|mesh-list
5614565|NCT02903914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614566|NCT02901483|Cisplatin|cisplatin|mesh-list
5893009|NCT03830866|Durvalumab|durvalumab|mesh-list
5893010|NCT03830866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5893011|NCT03830866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5893012|NCT03827213|Bupivacaine|bupivacaine|mesh-list
5893013|NCT03827213|Anesthetics, Local|anesthetics, local|mesh-ancestor
5893014|NCT03827213|Anesthetics|anesthetics|mesh-ancestor
5893015|NCT03827213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5893016|NCT03827213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893017|NCT03827213|Sensory System Agents|sensory system agents|mesh-ancestor
5614567|NCT02901483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614568|NCT02881086|Cytarabine|cytarabine|mesh-list
5614569|NCT02881086|Dexamethasone|dexamethasone|mesh-list
5614570|NCT02881086|Prednisolone|prednisolone|mesh-list
5614571|NCT02881086|Cyclophosphamide|cyclophosphamide|mesh-list
5614572|NCT02881086|Rituximab|rituximab|mesh-list
5614573|NCT02881086|Methotrexate|methotrexate|mesh-list
5614574|NCT02881086|Fludarabine|fludarabine|mesh-list
5614575|NCT02881086|Vincristine|vincristine|mesh-list
5614576|NCT02881086|Doxorubicin|doxorubicin|mesh-list
5614577|NCT02881086|Daunorubicin|daunorubicin|mesh-list
5614578|NCT02881086|Asparaginase|asparaginase|mesh-list
5733834|NCT03145467|Acetaminophen|acetaminophen|mesh-list
5733835|NCT03145467|Zolmitriptan|zolmitriptan|mesh-list
5733836|NCT03145467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5733837|NCT03145467|Analgesics|analgesics|mesh-ancestor
5733838|NCT03145467|Sensory System Agents|sensory system agents|mesh-ancestor
5733839|NCT03145467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5733840|NCT03145467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5733841|NCT03145467|Antipyretics|antipyretics|mesh-ancestor
5733842|NCT03145467|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5733843|NCT03145467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5733844|NCT03145467|Serotonin Agents|serotonin agents|mesh-ancestor
5733845|NCT03145467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5733846|NCT03145467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5733847|NCT03145584|Bupivacaine|bupivacaine|mesh-list
5733848|NCT03145584|Anesthetics, Local|anesthetics, local|mesh-ancestor
5733849|NCT03145584|Anesthetics|anesthetics|mesh-ancestor
5733850|NCT03145584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5733851|NCT03145584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5614579|NCT02881086|Mercaptopurine|mercaptopurine|mesh-list
5614580|NCT02881086|Idarubicin|idarubicin|mesh-list
5614581|NCT02881086|Pegaspargase|pegaspargase|mesh-list
5614582|NCT02881086|Vindesine|vindesine|mesh-list
5614583|NCT02881086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5614584|NCT02881086|Immunologic Factors|immunologic factors|mesh-ancestor
5614585|NCT02881086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5614586|NCT02881086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5614587|NCT02881086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5614588|NCT02881086|Alkylating Agents|alkylating agents|mesh-ancestor
5614589|NCT02881086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5733852|NCT03145584|Sensory System Agents|sensory system agents|mesh-ancestor
5733853|NCT03145584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5733854|NCT03145194|Ticagrelor|ticagrelor|mesh-list
5733855|NCT03145194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5733856|NCT03145194|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5733857|NCT03145194|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5733858|NCT03145194|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5733859|NCT03145194|Purinergic Agents|purinergic agents|mesh-ancestor
5733860|NCT03145194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5733861|NCT03145194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5733862|NCT03145194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5733863|NCT03145285|Abiraterone Acetate|abiraterone acetate|mesh-list
5733864|NCT03145285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5733865|NCT03145285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5733866|NCT03145285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5733867|NCT03145285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614590|NCT02881086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614591|NCT02881086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5614592|NCT02881086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5733868|NCT03145285|Hormone Antagonists|hormone antagonists|mesh-ancestor
5733869|NCT03145285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5733870|NCT03145285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5733871|NCT03145285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5733872|NCT03145025|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
5733873|NCT03145025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5733874|NCT03145025|Glucocorticoids|glucocorticoids|mesh-ancestor
5733875|NCT03145025|Hormones|hormones|mesh-ancestor
5733876|NCT03145025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5733877|NCT03145025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5733878|NCT03144947|Docetaxel|docetaxel|mesh-list
5614593|NCT02881086|Antiemetics|antiemetics|mesh-ancestor
5614594|NCT02881086|Autonomic Agents|autonomic agents|mesh-ancestor
5614595|NCT02881086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5614596|NCT02881086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5614597|NCT02881086|Glucocorticoids|glucocorticoids|mesh-ancestor
5614598|NCT02881086|Hormones|hormones|mesh-ancestor
5614599|NCT02881086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5614600|NCT02881086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5614601|NCT02881086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5614602|NCT02881086|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5614603|NCT02881086|Abortifacient Agents|abortifacient agents|mesh-ancestor
5614604|NCT02881086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5614605|NCT02881086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5614606|NCT02881086|Antimetabolites|antimetabolites|mesh-ancestor
5733879|NCT03144947|Trastuzumab|trastuzumab|mesh-list
5733880|NCT03144947|Pertuzumab|pertuzumab|mesh-list
5733881|NCT03144947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5733882|NCT03144947|Tubulin Modulators|tubulin modulators|mesh-ancestor
5614607|NCT02881086|Dermatologic Agents|dermatologic agents|mesh-ancestor
5614608|NCT02881086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5614609|NCT02881086|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5614610|NCT02881086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5614611|NCT02881086|Antiviral Agents|antiviral agents|mesh-ancestor
5614612|NCT02881086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5614613|NCT02881086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5614614|NCT02881086|Tubulin Modulators|tubulin modulators|mesh-ancestor
5614615|NCT02881086|Antimitotic Agents|antimitotic agents|mesh-ancestor
5614616|NCT02881086|Mitosis Modulators|mitosis modulators|mesh-ancestor
5614617|NCT02881086|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5614618|NCT02881086|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5614619|NCT02881086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5614620|NCT02874651|Apatinib|apatinib|mesh-list
5614621|NCT02874651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614622|NCT02874651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5614623|NCT02874651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5614624|NCT02874651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5733883|NCT03144947|Antimitotic Agents|antimitotic agents|mesh-ancestor
5733884|NCT03144947|Mitosis Modulators|mitosis modulators|mesh-ancestor
5733885|NCT03144947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5733886|NCT03144947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5733887|NCT03144596|Tamsulosin|tamsulosin|mesh-list
5733888|NCT03144596|Alfuzosin|alfuzosin|mesh-list
5733889|NCT03144596|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5733890|NCT03144596|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5733891|NCT03144596|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5733892|NCT03144596|Adrenergic Agents|adrenergic agents|mesh-ancestor
5733893|NCT03144596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5733894|NCT03144596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5733895|NCT03144596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5733896|NCT03144596|Urological Agents|urological agents|mesh-ancestor
5733897|NCT03145012|Ranitidine|ranitidine|mesh-list
5733898|NCT03145012|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
5733899|NCT03145012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5733900|NCT03145012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5614625|NCT02873195|Bevacizumab|bevacizumab|mesh-list
5614626|NCT02873195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5614627|NCT02873195|Capecitabine|capecitabine|mesh-list
5614628|NCT02873195|Atezolizumab|atezolizumab|mesh-list
5614629|NCT02873195|Endothelial Growth Factors|endothelial growth factors|mesh-list
5614630|NCT02873195|Antibodies|antibodies|mesh-list
5614631|NCT02873195|Immunoglobulins|immunoglobulins|mesh-list
5614632|NCT02873195|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5614633|NCT02873195|Immunoglobulin G|immunoglobulin g|mesh-list
5614634|NCT02873195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614635|NCT02873195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5614636|NCT02873195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5614637|NCT02873195|Growth Substances|growth substances|mesh-ancestor
5614638|NCT02873195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5614639|NCT02873195|Growth Inhibitors|growth inhibitors|mesh-ancestor
5614640|NCT02873195|Immunologic Factors|immunologic factors|mesh-ancestor
5614641|NCT02873195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5614642|NCT02873195|Antimetabolites|antimetabolites|mesh-ancestor
5614643|NCT02873195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614644|NCT02851056|Sargramostim|sargramostim|mesh-list
5614645|NCT02851056|Lenograstim|lenograstim|mesh-list
5614646|NCT02851056|Immunologic Factors|immunologic factors|mesh-ancestor
5614647|NCT02851056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5614648|NCT02851056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5614649|NCT02841748|Pembrolizumab|pembrolizumab|mesh-list
5614650|NCT02841748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5614651|NCT02841748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5692146|NCT03411551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5692147|NCT03411551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692148|NCT03411473|Pembrolizumab|pembrolizumab|mesh-list
5692149|NCT03411473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5692150|NCT03411473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5692151|NCT03411434|Methylphenidate|methylphenidate|mesh-list
5692152|NCT03411434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5692153|NCT03411434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208546|NCT02132312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5614652|NCT02834975|Paclitaxel|paclitaxel|mesh-list
5614653|NCT02834975|Carboplatin|carboplatin|mesh-list
5614654|NCT02834975|Pembrolizumab|pembrolizumab|mesh-list
5614655|NCT02834975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5614656|NCT02834975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614657|NCT02834975|Tubulin Modulators|tubulin modulators|mesh-ancestor
5614658|NCT02834975|Antimitotic Agents|antimitotic agents|mesh-ancestor
5614659|NCT02834975|Mitosis Modulators|mitosis modulators|mesh-ancestor
5614660|NCT02834975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614661|NCT02834975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5614662|NCT02821000|Pembrolizumab|pembrolizumab|mesh-list
5614663|NCT02821000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5614664|NCT02821000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614665|NCT02818868|Apixaban|apixaban|mesh-list
5614666|NCT02818868|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5614667|NCT02818868|Antithrombins|antithrombins|mesh-ancestor
5614668|NCT02818868|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5614669|NCT02818868|Protease Inhibitors|protease inhibitors|mesh-ancestor
5614670|NCT02818868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5614671|NCT02818868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614672|NCT02818868|Anticoagulants|anticoagulants|mesh-ancestor
5614673|NCT02809131|Levofloxacin|levofloxacin|mesh-list
5614674|NCT02809131|Ofloxacin|ofloxacin|mesh-list
5614675|NCT02809131|Clindamycin|clindamycin|mesh-list
5614676|NCT02809131|Clindamycin palmitate|clindamycin palmitate|mesh-list
5614677|NCT02809131|Clindamycin phosphate|clindamycin phosphate|mesh-list
5614678|NCT02809131|Cephalexin|cephalexin|mesh-list
5614679|NCT02809131|Polymyxins|polymyxins|mesh-list
5614680|NCT02809131|Bacitracin|bacitracin|mesh-list
5614681|NCT02809131|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5614682|NCT02809131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5614683|NCT02809131|Renal Agents|renal agents|mesh-ancestor
5614684|NCT02809131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5614685|NCT02809131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5614686|NCT02809131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5614687|NCT02809131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5614688|NCT02809131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614689|NCT02809131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614690|NCT02809131|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5614691|NCT02809131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5614692|NCT02809131|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5614693|NCT02809131|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5614694|NCT02798471|Heparin|heparin|mesh-list
5614695|NCT02798471|Enoxaparin|enoxaparin|mesh-list
5614696|NCT02798471|Warfarin|warfarin|mesh-list
5614697|NCT02798471|Edoxaban|edoxaban|mesh-list
5614698|NCT02798471|Fondaparinux|fondaparinux|mesh-list
5614699|NCT02798471|Anticoagulants|anticoagulants|mesh-ancestor
5614700|NCT02798471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5614701|NCT02798471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5614702|NCT02798471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614703|NCT02798471|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5614704|NCT02798471|Antithrombins|antithrombins|mesh-ancestor
5614705|NCT02798471|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5733901|NCT03145012|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5733902|NCT03145012|Histamine Antagonists|histamine antagonists|mesh-ancestor
5733903|NCT03145012|Histamine Agents|histamine agents|mesh-ancestor
5733904|NCT03145012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5733905|NCT03145012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5733906|NCT03145012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5733907|NCT03144778|Durvalumab|durvalumab|mesh-list
5733908|NCT03144778|Ipilimumab|ipilimumab|mesh-list
5733909|NCT03144778|Tremelimumab|tremelimumab|mesh-list
5733910|NCT03144778|Immunoglobulins|immunoglobulins|mesh-list
5614706|NCT02798471|Protease Inhibitors|protease inhibitors|mesh-ancestor
5614707|NCT02798471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5614708|NCT02788773|Durvalumab|durvalumab|mesh-list
5614709|NCT02788773|Tremelimumab|tremelimumab|mesh-list
5614710|NCT02788773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5614711|NCT02788773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614712|NCT02785952|Nivolumab|nivolumab|mesh-list
5614713|NCT02785952|Ipilimumab|ipilimumab|mesh-list
5614714|NCT02785952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5614715|NCT02785952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614716|NCT02785952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5614717|NCT02785952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614718|NCT02784171|Pembrolizumab|pembrolizumab|mesh-list
5614719|NCT02784171|Pemetrexed|pemetrexed|mesh-list
5733911|NCT03144778|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5733912|NCT03144778|Immunoglobulin G|immunoglobulin g|mesh-list
5733913|NCT03144778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5733914|NCT03144778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5733915|NCT03144778|Immunologic Factors|immunologic factors|mesh-ancestor
5733916|NCT03144778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5733917|NCT03144778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5733918|NCT03144778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614720|NCT02784171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614721|NCT02784171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5614722|NCT02784171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5614723|NCT02784171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614724|NCT02784171|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5614725|NCT02784171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5733919|NCT03144843|Apatinib|apatinib|mesh-list
5733920|NCT03144843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5733921|NCT03144843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5733922|NCT03144843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5733923|NCT03144843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5733924|NCT03144713|Terlipressin|terlipressin|mesh-list
5733925|NCT03144713|Midodrine|midodrine|mesh-list
5733926|NCT03144713|Sympathomimetics|sympathomimetics|mesh-ancestor
5733927|NCT03144713|Autonomic Agents|autonomic agents|mesh-ancestor
5733928|NCT03144713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5733929|NCT03144713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5733930|NCT03144713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5733931|NCT03144713|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5733932|NCT03144713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5733933|NCT03144713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5733934|NCT03144713|Adrenergic Agents|adrenergic agents|mesh-ancestor
5733935|NCT03144713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5733936|NCT03144713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5733937|NCT03144713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5733938|NCT03144856|Apatinib|apatinib|mesh-list
5733939|NCT03144856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5733940|NCT03144856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5733941|NCT03144856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5733942|NCT03144856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5733943|NCT03144817|Dialysis Solutions|dialysis solutions|mesh-list
5733944|NCT03144817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5733945|NCT03144882|Curcumin|curcumin|mesh-list
5733946|NCT03144882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5733947|NCT03144882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5733948|NCT03144882|Analgesics|analgesics|mesh-ancestor
5614726|NCT02758717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5614727|NCT02758717|Nivolumab|nivolumab|mesh-list
5614728|NCT02758717|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5614729|NCT02758717|Antibodies|antibodies|mesh-list
5614730|NCT02758717|Immunoglobulins|immunoglobulins|mesh-list
5614731|NCT02758717|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5614732|NCT02758717|Immunoconjugates|immunoconjugates|mesh-list
5614733|NCT02758717|Immunologic Factors|immunologic factors|mesh-ancestor
5614734|NCT02758717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5614735|NCT02758717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614736|NCT02758717|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5614737|NCT02758717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614738|NCT02748616|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
5614739|NCT02748616|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5614740|NCT02748616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5614741|NCT02738866|Fulvestrant|fulvestrant|mesh-list
5614742|NCT02738866|Palbociclib|palbociclib|mesh-list
5614743|NCT02738866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5614744|NCT02738866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614745|NCT02738866|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5733949|NCT03144882|Sensory System Agents|sensory system agents|mesh-ancestor
5733950|NCT03144882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5733951|NCT03144882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5733952|NCT03144882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5733953|NCT03144882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5733954|NCT03144882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6208547|NCT02132312|Adrenergic Agents|adrenergic agents|mesh-ancestor
6208548|NCT02132312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6208549|NCT02132312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5733955|NCT03144882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5733956|NCT03144882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5733957|NCT03144466|Pembrolizumab|pembrolizumab|mesh-list
5733958|NCT03144466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5733959|NCT03144466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5733960|NCT03144453|Atropine|atropine|mesh-list
5733961|NCT03144453|Neostigmine|neostigmine|mesh-list
5733962|NCT03144453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5733963|NCT03144453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5733964|NCT03144453|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5733965|NCT03144453|Autonomic Agents|autonomic agents|mesh-ancestor
5733966|NCT03144453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5733967|NCT03144453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5733968|NCT03144453|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5733969|NCT03144453|Respiratory System Agents|respiratory system agents|mesh-ancestor
5733970|NCT03144453|Mydriatics|mydriatics|mesh-ancestor
5733971|NCT03144453|Parasympatholytics|parasympatholytics|mesh-ancestor
5733972|NCT03144453|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5733973|NCT03144453|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5733974|NCT03144453|Cholinergic Agents|cholinergic agents|mesh-ancestor
5733975|NCT03144453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5733976|NCT03144453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5733977|NCT03144453|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5733978|NCT03144453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5733979|NCT03144453|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5733980|NCT03144401|Misoprostol|misoprostol|mesh-list
5733981|NCT03144401|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5733982|NCT03144401|Abortifacient Agents|abortifacient agents|mesh-ancestor
5733983|NCT03144401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5733984|NCT03144401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5733985|NCT03144401|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5733986|NCT03144401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5733987|NCT03144401|Oxytocics|oxytocics|mesh-ancestor
5733988|NCT03144115|Oxytocin|oxytocin|mesh-list
5733989|NCT03144115|Oxytocics|oxytocics|mesh-ancestor
5733990|NCT03144115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5733991|NCT03144115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5733992|NCT03144128|Vitamin D|vitamin d|mesh-list
5733993|NCT03144128|Vitamins|vitamins|mesh-ancestor
5733994|NCT03144128|Micronutrients|micronutrients|mesh-ancestor
5733995|NCT03144128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5733996|NCT03144128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5733997|NCT03144245|Pembrolizumab|pembrolizumab|mesh-list
5733998|NCT03144245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5733999|NCT03144245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5734000|NCT03143946|Vitamins|vitamins|mesh-list
5734001|NCT03143946|Micronutrients|micronutrients|mesh-ancestor
5734002|NCT03143946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734003|NCT03143933|Fentanyl|fentanyl|mesh-list
5734004|NCT03143933|Propofol|propofol|mesh-list
5734005|NCT03143933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5734006|NCT03143933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5614746|NCT02738866|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5614747|NCT02738866|Hormone Antagonists|hormone antagonists|mesh-ancestor
5614748|NCT02738866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5614749|NCT02738866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5614750|NCT02738866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5614751|NCT02738866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5614752|NCT02738866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614753|NCT02730429|Letrozole|letrozole|mesh-list
5614754|NCT02730429|Palbociclib|palbociclib|mesh-list
5734007|NCT03143933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734008|NCT03143933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5734009|NCT03143933|Anesthetics, General|anesthetics, general|mesh-ancestor
5734010|NCT03143933|Anesthetics|anesthetics|mesh-ancestor
5734011|NCT03143933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5734012|NCT03143933|Narcotics|narcotics|mesh-ancestor
5734013|NCT03143933|Analgesics|analgesics|mesh-ancestor
5734014|NCT03143933|Sensory System Agents|sensory system agents|mesh-ancestor
5734015|NCT03143933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5734016|NCT03143933|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5734017|NCT03143998|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
5614755|NCT02730429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614756|NCT02730429|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5734018|NCT03143998|Grazoprevir|grazoprevir|mesh-list
5734019|NCT03143998|Antiviral Agents|antiviral agents|mesh-ancestor
5734020|NCT03143998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5734021|NCT03143972|Dexmedetomidine|dexmedetomidine|mesh-list
5734022|NCT03143972|Remifentanil|remifentanil|mesh-list
5734023|NCT03143972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5734024|NCT03143972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5734025|NCT03143972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734026|NCT03143972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5734027|NCT03143972|Analgesics|analgesics|mesh-ancestor
5734028|NCT03143972|Sensory System Agents|sensory system agents|mesh-ancestor
5734029|NCT03143972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5734030|NCT03143972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5734031|NCT03143972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5734032|NCT03143972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5734033|NCT03143972|Adrenergic Agents|adrenergic agents|mesh-ancestor
5734034|NCT03143972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5734035|NCT03143972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5734036|NCT03143972|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5614757|NCT02730429|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5614758|NCT02730429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5614759|NCT02730429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614760|NCT02730429|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5614761|NCT02730429|Hormone Antagonists|hormone antagonists|mesh-ancestor
5614762|NCT02730429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5614763|NCT02730429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5614764|NCT02730429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5614765|NCT02730416|Paclitaxel|paclitaxel|mesh-list
5614766|NCT02730416|Carboplatin|carboplatin|mesh-list
5614767|NCT02730416|Nintedanib|nintedanib|mesh-list
5614768|NCT02730416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5614769|NCT02730416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614770|NCT02730416|Tubulin Modulators|tubulin modulators|mesh-ancestor
5614771|NCT02730416|Antimitotic Agents|antimitotic agents|mesh-ancestor
5614772|NCT02730416|Mitosis Modulators|mitosis modulators|mesh-ancestor
5614773|NCT02730416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614774|NCT02730416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5614775|NCT02730416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5614776|NCT02693821|Gabapentin|gabapentin|mesh-list
5614777|NCT02693821|Analgesics|analgesics|mesh-ancestor
5734037|NCT03143972|Narcotics|narcotics|mesh-ancestor
5893018|NCT03827213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5893019|NCT03797469|Niacinamide|niacinamide|mesh-list
5893020|NCT03797469|Vitamins|vitamins|mesh-ancestor
5893021|NCT03797469|Micronutrients|micronutrients|mesh-ancestor
5893022|NCT03797469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893023|NCT03797469|Vitamin B Complex|vitamin b complex|mesh-ancestor
5907712|NCT05215691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5614778|NCT02693821|Sensory System Agents|sensory system agents|mesh-ancestor
5614779|NCT02693821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5614780|NCT02693821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5614781|NCT02693821|Anticonvulsants|anticonvulsants|mesh-ancestor
5614782|NCT02693821|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5614783|NCT02693821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5907713|NCT05215691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907714|NCT05215691|Analgesics|analgesics|mesh-ancestor
5907715|NCT05215691|Sensory System Agents|sensory system agents|mesh-ancestor
5907716|NCT05215691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5907717|NCT05213650|Methamphetamine|methamphetamine|mesh-list
5907718|NCT05213650|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5907719|NCT05213650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907720|NCT05213650|Sympathomimetics|sympathomimetics|mesh-ancestor
5907721|NCT05213650|Autonomic Agents|autonomic agents|mesh-ancestor
5907722|NCT05213650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5907723|NCT05213650|Dopamine Agents|dopamine agents|mesh-ancestor
5907724|NCT05213650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5907725|NCT05213650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907726|NCT05213650|Adrenergic Agents|adrenergic agents|mesh-ancestor
5907727|NCT05213650|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5907728|NCT05213650|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5907729|NCT05213650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5907730|NCT05213650|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5907731|NCT05213221|Lenvatinib|lenvatinib|mesh-list
5907732|NCT05213221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5907733|NCT05213221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5907734|NCT05213221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5907735|NCT05213221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614784|NCT02693821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5614785|NCT02693821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5614786|NCT02693821|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5614787|NCT02693821|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5614788|NCT02693821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5614789|NCT02693821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614790|NCT02693821|Antimanic Agents|antimanic agents|mesh-ancestor
5614791|NCT02671890|Gemcitabine|gemcitabine|mesh-list
5614792|NCT02671890|Disulfiram|disulfiram|mesh-list
5614793|NCT02671890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5614794|NCT02671890|Antimetabolites|antimetabolites|mesh-ancestor
5614795|NCT02671890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614796|NCT02671890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614797|NCT02671890|Antiviral Agents|antiviral agents|mesh-ancestor
5614798|NCT02671890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5614799|NCT02671890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5614800|NCT02671890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5614801|NCT02671890|Immunologic Factors|immunologic factors|mesh-ancestor
5614802|NCT02671890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5614803|NCT02671890|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5614804|NCT02671890|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
5614805|NCT02664181|Nivolumab|nivolumab|mesh-list
5614806|NCT02664181|Decitabine|decitabine|mesh-list
5614807|NCT02664181|Tetrahydrouridine|tetrahydrouridine|mesh-list
5614808|NCT02664181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5614809|NCT02664181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614810|NCT02664181|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5614811|NCT02664181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614812|NCT02664181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5614813|NCT02664181|Antimetabolites|antimetabolites|mesh-ancestor
5614814|NCT02664181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5614815|NCT02658812|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
5614816|NCT02658812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5614817|NCT02658812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614818|NCT02633397|Riociguat|riociguat|mesh-list
5614819|NCT02633397|Enzyme Activators|enzyme activators|mesh-ancestor
5734038|NCT03143530|Ropivacaine|ropivacaine|mesh-list
5734039|NCT03143530|Anesthetics, Local|anesthetics, local|mesh-ancestor
5734040|NCT03143530|Anesthetics|anesthetics|mesh-ancestor
5734041|NCT03143530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5734042|NCT03143530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734043|NCT03143530|Sensory System Agents|sensory system agents|mesh-ancestor
5734044|NCT03143530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5734045|NCT03143738|Anesthetics|anesthetics|mesh-list
5734046|NCT03143738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5734047|NCT03143738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734048|NCT03143452|Lidocaine|lidocaine|mesh-list
5734049|NCT03143452|Tetracaine|tetracaine|mesh-list
5734050|NCT03143452|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5734051|NCT03143452|Anesthetics, Local|anesthetics, local|mesh-ancestor
5734052|NCT03143452|Anesthetics|anesthetics|mesh-ancestor
5734053|NCT03143452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5734054|NCT03143452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734055|NCT03143452|Sensory System Agents|sensory system agents|mesh-ancestor
5734056|NCT03143452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5734057|NCT03143452|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5734058|NCT03143452|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5734059|NCT03143452|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5734060|NCT03143452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6489155|NCT00589862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489156|NCT00589862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489157|NCT00589901|Cyclophosphamide|cyclophosphamide|mesh-list
6489158|NCT00589901|Capecitabine|capecitabine|mesh-list
6489159|NCT00589901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6489160|NCT00589901|Immunologic Factors|immunologic factors|mesh-ancestor
6489161|NCT00589901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489162|NCT00589901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6489163|NCT00589901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6489164|NCT00589901|Alkylating Agents|alkylating agents|mesh-ancestor
6489165|NCT00589901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489166|NCT00589901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6489167|NCT00589901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6489168|NCT00589901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5614820|NCT02633397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614821|NCT02633241|Dexmedetomidine|dexmedetomidine|mesh-list
5614822|NCT02633241|Propofol|propofol|mesh-list
5614823|NCT02633241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5614824|NCT02633241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5614825|NCT02633241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5614826|NCT02633241|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5614827|NCT02633241|Anesthetics, General|anesthetics, general|mesh-ancestor
5614828|NCT02633241|Anesthetics|anesthetics|mesh-ancestor
5614829|NCT02633241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5614830|NCT02633241|Analgesics|analgesics|mesh-ancestor
5614831|NCT02633241|Sensory System Agents|sensory system agents|mesh-ancestor
5614832|NCT02633241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5614833|NCT02633241|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5614834|NCT02633241|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5614835|NCT02633241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5614836|NCT02633241|Adrenergic Agents|adrenergic agents|mesh-ancestor
5614837|NCT02633241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5614838|NCT02633241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614839|NCT02632721|Decitabine|decitabine|mesh-list
5614840|NCT02632721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5614841|NCT02632721|Antimetabolites|antimetabolites|mesh-ancestor
5614842|NCT02632721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489169|NCT00589901|Antimetabolites|antimetabolites|mesh-ancestor
6489170|NCT00589927|Cilostazol|cilostazol|mesh-list
5614843|NCT02632721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614844|NCT02632721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5614845|NCT02626715|Vidarabine|vidarabine|mesh-list
5614846|NCT02626715|Fludarabine phosphate|fludarabine phosphate|mesh-list
5614847|NCT02626715|Fludarabine|fludarabine|mesh-list
5614848|NCT02626715|Alemtuzumab|alemtuzumab|mesh-list
5614849|NCT02626715|Thiotepa|thiotepa|mesh-list
5614850|NCT02626715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5614851|NCT02626715|Antimetabolites|antimetabolites|mesh-ancestor
5614852|NCT02626715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489171|NCT00589927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6489172|NCT00589927|Autonomic Agents|autonomic agents|mesh-ancestor
6489173|NCT00589927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6489174|NCT00589927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489175|NCT00589927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6489176|NCT00589927|Respiratory System Agents|respiratory system agents|mesh-ancestor
6489177|NCT00589927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6489178|NCT00589927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5614853|NCT02626715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614854|NCT02626715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5614855|NCT02626715|Immunologic Factors|immunologic factors|mesh-ancestor
5614856|NCT02626715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5614857|NCT02626715|Antiviral Agents|antiviral agents|mesh-ancestor
5614858|NCT02626715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5614859|NCT02626715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5614860|NCT02626715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5614861|NCT02626715|Alkylating Agents|alkylating agents|mesh-ancestor
5614862|NCT02626715|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5614863|NCT02611323|Rituximab|rituximab|mesh-list
5614864|NCT02611323|Obinutuzumab|obinutuzumab|mesh-list
5614865|NCT02611323|Venetoclax|venetoclax|mesh-list
5614866|NCT02611323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5614867|NCT02611323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614868|NCT02611323|Immunologic Factors|immunologic factors|mesh-ancestor
5734061|NCT03143452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5734062|NCT03143452|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5734063|NCT03143465|Calcitonin|calcitonin|mesh-list
5734064|NCT03143465|Salmon calcitonin|salmon calcitonin|mesh-list
5734065|NCT03143465|Sildenafil Citrate|sildenafil citrate|mesh-list
5734066|NCT03143465|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
5614869|NCT02611323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5614870|NCT02611323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5614871|NCT02608385|Pembrolizumab|pembrolizumab|mesh-list
5614872|NCT02608385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5734067|NCT03143465|Katacalcin|katacalcin|mesh-list
5734068|NCT03143465|Vasodilator Agents|vasodilator agents|mesh-ancestor
5734069|NCT03143465|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5734070|NCT03143465|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5734071|NCT03143465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6489179|NCT00589927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893024|NCT03795701|Liraglutide|liraglutide|mesh-list
5734072|NCT03143465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5734073|NCT03143465|Urological Agents|urological agents|mesh-ancestor
5734074|NCT03143465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5734075|NCT03143465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734076|NCT03143465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5734077|NCT03143491|Paclitaxel|paclitaxel|mesh-list
5734078|NCT03143491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5734079|NCT03143491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5734080|NCT03143491|Tubulin Modulators|tubulin modulators|mesh-ancestor
5734081|NCT03143491|Antimitotic Agents|antimitotic agents|mesh-ancestor
5734082|NCT03143491|Mitosis Modulators|mitosis modulators|mesh-ancestor
5734083|NCT03143491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5734084|NCT03143244|Ketorolac|ketorolac|mesh-list
5734085|NCT03143244|Midazolam|midazolam|mesh-list
5734086|NCT03143244|Dexmedetomidine|dexmedetomidine|mesh-list
5734087|NCT03143244|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5734088|NCT03143244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5734089|NCT03143244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734090|NCT03143244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5734091|NCT03143244|Analgesics|analgesics|mesh-ancestor
5614873|NCT02608385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614874|NCT02589860|Melphalan|melphalan|mesh-list
5614875|NCT02589860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5614876|NCT02589860|Alkylating Agents|alkylating agents|mesh-ancestor
5614877|NCT02589860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614878|NCT02589860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614879|NCT02589860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5734092|NCT03143244|Sensory System Agents|sensory system agents|mesh-ancestor
5734093|NCT03143244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5734094|NCT03143244|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5734095|NCT03143244|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5734096|NCT03143244|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5734097|NCT03143244|Adrenergic Agents|adrenergic agents|mesh-ancestor
5734098|NCT03143244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5734099|NCT03143244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5734100|NCT03143244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5734101|NCT03143244|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5734102|NCT03143244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5734103|NCT03143244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5734104|NCT03143244|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5734105|NCT03143244|Anesthetics, General|anesthetics, general|mesh-ancestor
5734106|NCT03143244|Anesthetics|anesthetics|mesh-ancestor
5734107|NCT03143244|GABA Modulators|gaba modulators|mesh-ancestor
5734108|NCT03143244|GABA Agents|gaba agents|mesh-ancestor
5734109|NCT03143244|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5734110|NCT03143244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5734111|NCT03143244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5734112|NCT03143244|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5734113|NCT03143244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5734114|NCT03143153|Fluorouracil|fluorouracil|mesh-list
5734115|NCT03143153|Nivolumab|nivolumab|mesh-list
5734116|NCT03143153|Ipilimumab|ipilimumab|mesh-list
5734117|NCT03143153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5734118|NCT03143153|Antimetabolites|antimetabolites|mesh-ancestor
5734119|NCT03143153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5734120|NCT03143153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5614880|NCT02589860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5614881|NCT02589860|Immunologic Factors|immunologic factors|mesh-ancestor
5614882|NCT02589860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5614883|NCT02586025|Docetaxel|docetaxel|mesh-list
5614884|NCT02586025|Trastuzumab|trastuzumab|mesh-list
5734121|NCT03143153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5734122|NCT03143153|Immunologic Factors|immunologic factors|mesh-ancestor
5734123|NCT03143153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734124|NCT03143153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5734125|NCT03143153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5734126|NCT03143036|Thalidomide|thalidomide|mesh-list
5734127|NCT03143036|Dexamethasone|dexamethasone|mesh-list
5734128|NCT03143036|Daratumumab|daratumumab|mesh-list
5734129|NCT03143036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5734130|NCT03143036|Antiemetics|antiemetics|mesh-ancestor
5734131|NCT03143036|Autonomic Agents|autonomic agents|mesh-ancestor
5734132|NCT03143036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5734133|NCT03143036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734134|NCT03143036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5734135|NCT03143036|Glucocorticoids|glucocorticoids|mesh-ancestor
5734136|NCT03143036|Hormones|hormones|mesh-ancestor
5734137|NCT03143036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5734138|NCT03143036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5734139|NCT03143036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5734140|NCT03143036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5734141|NCT03143036|Immunologic Factors|immunologic factors|mesh-ancestor
5734142|NCT03143036|Leprostatic Agents|leprostatic agents|mesh-ancestor
5734143|NCT03143036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5734144|NCT03143036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5734145|NCT03143036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5734146|NCT03143036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5734147|NCT03143036|Growth Substances|growth substances|mesh-ancestor
5734148|NCT03143036|Growth Inhibitors|growth inhibitors|mesh-ancestor
5734149|NCT03143023|Fluorides|fluorides|mesh-list
5734150|NCT03143023|Cariostatic Agents|cariostatic agents|mesh-ancestor
5734151|NCT03143023|Protective Agents|protective agents|mesh-ancestor
5734152|NCT03143023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734153|NCT03142789|Cerivastatin|cerivastatin|mesh-list
5734154|NCT03142789|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5734155|NCT03142789|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5734156|NCT03142789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5734157|NCT03142789|Antimetabolites|antimetabolites|mesh-ancestor
5734158|NCT03142789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5734159|NCT03142789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5734160|NCT03142789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5734161|NCT03143010|Dexmedetomidine|dexmedetomidine|mesh-list
5734162|NCT03143010|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5734163|NCT03143010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5734164|NCT03143010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734165|NCT03143010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5734166|NCT03143010|Analgesics|analgesics|mesh-ancestor
5734167|NCT03143010|Sensory System Agents|sensory system agents|mesh-ancestor
5734168|NCT03143010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5734169|NCT03143010|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5734170|NCT03143010|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5734171|NCT03143010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5734172|NCT03143010|Adrenergic Agents|adrenergic agents|mesh-ancestor
5734173|NCT03143010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5734174|NCT03143010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5734175|NCT03142776|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5734176|NCT03142776|Clarithromycin|clarithromycin|mesh-list
5614885|NCT02586025|Pertuzumab|pertuzumab|mesh-list
5614886|NCT02586025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614887|NCT02586025|Tubulin Modulators|tubulin modulators|mesh-ancestor
5614888|NCT02586025|Antimitotic Agents|antimitotic agents|mesh-ancestor
5614889|NCT02586025|Mitosis Modulators|mitosis modulators|mesh-ancestor
5614890|NCT02586025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614891|NCT02586025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5734177|NCT03142776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5734178|NCT03142776|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5734179|NCT03142776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5734180|NCT03142776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5734181|NCT03142776|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5734182|NCT03142776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5734183|NCT03142880|Ropivacaine|ropivacaine|mesh-list
5614892|NCT02583789|Treprostinil|treprostinil|mesh-list
5614893|NCT02583789|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5614894|NCT02573324|Temozolomide|temozolomide|mesh-list
5614895|NCT02573324|Immunoconjugates|immunoconjugates|mesh-list
5734184|NCT03142880|Anesthetics, Local|anesthetics, local|mesh-ancestor
5734185|NCT03142880|Anesthetics|anesthetics|mesh-ancestor
5614896|NCT02573324|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5614897|NCT02573324|Alkylating Agents|alkylating agents|mesh-ancestor
5614898|NCT02573324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614899|NCT02573324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614900|NCT02573324|Immunologic Factors|immunologic factors|mesh-ancestor
5614901|NCT02573324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5614902|NCT02568267|Entrectinib|entrectinib|mesh-list
5614903|NCT02568267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5614904|NCT02568267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5614905|NCT02568267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614906|NCT02556606|Midazolam|midazolam|mesh-list
5614907|NCT02556606|Ketamine|ketamine|mesh-list
5614908|NCT02556606|Analgesics|analgesics|mesh-ancestor
5614909|NCT02556606|Sensory System Agents|sensory system agents|mesh-ancestor
5614910|NCT02556606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5614911|NCT02556606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5614912|NCT02556606|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5614913|NCT02556606|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5614914|NCT02556606|Anesthetics, General|anesthetics, general|mesh-ancestor
5614915|NCT02556606|Anesthetics|anesthetics|mesh-ancestor
5614916|NCT02556606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5614917|NCT02556606|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5614918|NCT02556606|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5734186|NCT03142880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5734187|NCT03142880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734188|NCT03142880|Sensory System Agents|sensory system agents|mesh-ancestor
5734189|NCT03142880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5734190|NCT03142646|Cyclophosphamide|cyclophosphamide|mesh-list
5614919|NCT02556606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5614920|NCT02556606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614921|NCT02556606|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5614922|NCT02556606|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5614923|NCT02556606|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5614924|NCT02556606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5614925|NCT02556606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5614926|NCT02556606|GABA Modulators|gaba modulators|mesh-ancestor
5614927|NCT02556606|GABA Agents|gaba agents|mesh-ancestor
5614928|NCT02546999|Botulinum Toxins|botulinum toxins|mesh-list
5614929|NCT02546999|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5614930|NCT02546999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5614931|NCT02546999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5614932|NCT02546999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614933|NCT02546999|Cholinergic Agents|cholinergic agents|mesh-ancestor
5614934|NCT02546999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5614935|NCT02546999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5614936|NCT02546999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5734191|NCT03142646|Fludarabine|fludarabine|mesh-list
5734192|NCT03142646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5734193|NCT03142646|Immunologic Factors|immunologic factors|mesh-ancestor
5734194|NCT03142646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734195|NCT03142646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5734196|NCT03142646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5734197|NCT03142646|Alkylating Agents|alkylating agents|mesh-ancestor
5734198|NCT03142646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5734199|NCT03142646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5734200|NCT03142646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5734201|NCT03142828|Chlorhexidine|chlorhexidine|mesh-list
5734202|NCT03142828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5734203|NCT03142828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5734204|NCT03142828|Disinfectants|disinfectants|mesh-ancestor
5734205|NCT03142763|Choline|choline|mesh-list
5734206|NCT03142763|Lipotropic Agents|lipotropic agents|mesh-ancestor
5734207|NCT03142763|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5734208|NCT03142763|Antimetabolites|antimetabolites|mesh-ancestor
5734209|NCT03142763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5734210|NCT03142763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5734211|NCT03142763|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5734212|NCT03142763|Nootropic Agents|nootropic agents|mesh-ancestor
5734213|NCT03142893|Ketoconazole|ketoconazole|mesh-list
5734214|NCT03142893|Dexamethasone|dexamethasone|mesh-list
5734215|NCT03142893|Dexamethasone acetate|dexamethasone acetate|mesh-list
5734216|NCT03142893|Hydrocortisone|hydrocortisone|mesh-list
5734217|NCT03142893|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
5614937|NCT02546999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5614938|NCT02545283|Cytarabine|cytarabine|mesh-list
5734218|NCT03142893|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5734219|NCT03142893|Hormones|hormones|mesh-list
5734220|NCT03142893|Cosyntropin|cosyntropin|mesh-list
5734221|NCT03142893|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
5614939|NCT02545283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5614940|NCT02545283|Antimetabolites|antimetabolites|mesh-ancestor
5614941|NCT02545283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614942|NCT02545283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614943|NCT02545283|Antiviral Agents|antiviral agents|mesh-ancestor
5614944|NCT02545283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5614945|NCT02545283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5614946|NCT02545283|Immunologic Factors|immunologic factors|mesh-ancestor
5614947|NCT02545283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734222|NCT03142893|BB 1101|bb 1101|mesh-list
5734223|NCT03142893|Ganirelix|ganirelix|mesh-list
5734224|NCT03142893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5734225|NCT03142893|Antiemetics|antiemetics|mesh-ancestor
5734226|NCT03142893|Autonomic Agents|autonomic agents|mesh-ancestor
5734227|NCT03142893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5734228|NCT03142893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734229|NCT03142893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5734230|NCT03142893|Glucocorticoids|glucocorticoids|mesh-ancestor
5734231|NCT03142893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5734232|NCT03142893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5734233|NCT03142893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5734234|NCT03142893|Protease Inhibitors|protease inhibitors|mesh-ancestor
5614948|NCT02532231|Nivolumab|nivolumab|mesh-list
5614949|NCT02532231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5614950|NCT02532231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614951|NCT02532231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5614952|NCT02532231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614953|NCT02531126|Ozanimod|ozanimod|mesh-list
5614954|NCT02531126|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5614955|NCT02531126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614956|NCT02531126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5614957|NCT02531126|Immunologic Factors|immunologic factors|mesh-ancestor
5614958|NCT02531126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5614959|NCT02510300|Sofosbuvir|sofosbuvir|mesh-list
5614960|NCT02510300|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
5734235|NCT03142893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5734236|NCT03142893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5734237|NCT03142893|Antifungal Agents|antifungal agents|mesh-ancestor
5734238|NCT03142893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5734239|NCT03142893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5734240|NCT03142893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5734241|NCT03142893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5734242|NCT03142893|Hormone Antagonists|hormone antagonists|mesh-ancestor
5734243|NCT03142893|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5734244|NCT03142620|Vitamin D|vitamin d|mesh-list
5734245|NCT03142620|Cholecalciferol|cholecalciferol|mesh-list
5734246|NCT03142620|Amoxicillin|amoxicillin|mesh-list
5734247|NCT03142620|Clarithromycin|clarithromycin|mesh-list
5734248|NCT03142620|Clavulanic Acid|clavulanic acid|mesh-list
5734249|NCT03142620|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5734250|NCT03142620|Esomeprazole|esomeprazole|mesh-list
5734251|NCT03142620|Vitamins|vitamins|mesh-ancestor
5734252|NCT03142620|Micronutrients|micronutrients|mesh-ancestor
5734253|NCT03142620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734254|NCT03142620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5734255|NCT03142620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5734256|NCT03142620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5734257|NCT03142620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5734258|NCT03142620|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5734259|NCT03142620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6208550|NCT02132312|Protective Agents|protective agents|mesh-ancestor
5614961|NCT02510300|Ledipasvir|ledipasvir|mesh-list
5614962|NCT02510300|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
5614963|NCT02510300|Velpatasvir|velpatasvir|mesh-list
5614964|NCT02510300|Antiviral Agents|antiviral agents|mesh-ancestor
5614965|NCT02510300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5614966|NCT02507505|Anesthetics|anesthetics|mesh-list
5614967|NCT02507505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5734260|NCT03142620|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5734261|NCT03142620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5734262|NCT03142620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5734263|NCT03142620|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5734264|NCT03142620|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5734265|NCT03142620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5734266|NCT03142620|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5734267|NCT03142607|Chlorhexidine|chlorhexidine|mesh-list
5614968|NCT02507505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5614969|NCT02476968|Olaparib|olaparib|mesh-list
5614970|NCT02476968|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5614971|NCT02476968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5614972|NCT02476968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614973|NCT02476968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614974|NCT02465593|Fluorouracil|fluorouracil|mesh-list
5614975|NCT02465593|Capecitabine|capecitabine|mesh-list
5614976|NCT02465593|Antimetabolites|antimetabolites|mesh-ancestor
5614977|NCT02465593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614978|NCT02465593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5614979|NCT02465593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614980|NCT02465593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5614981|NCT02465593|Immunologic Factors|immunologic factors|mesh-ancestor
5614982|NCT02465593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5614983|NCT02465268|Molgramostim|molgramostim|mesh-list
5614984|NCT02465268|Sargramostim|sargramostim|mesh-list
5734268|NCT03142607|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5734269|NCT03142607|Metronidazole|metronidazole|mesh-list
5734270|NCT03142607|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5734271|NCT03142607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5734272|NCT03142607|Disinfectants|disinfectants|mesh-ancestor
5734273|NCT03142607|Dermatologic Agents|dermatologic agents|mesh-ancestor
5734274|NCT03142607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5734275|NCT03142607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5734276|NCT03142607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5734277|NCT03142516|Leucovorin|leucovorin|mesh-list
5734278|NCT03142516|Folic Acid|folic acid|mesh-list
5734279|NCT03142516|Fluorouracil|fluorouracil|mesh-list
5734280|NCT03142516|Irinotecan|irinotecan|mesh-list
5734281|NCT03142516|Panitumumab|panitumumab|mesh-list
5734282|NCT03142516|Levoleucovorin|levoleucovorin|mesh-list
5734283|NCT03142516|Antimetabolites|antimetabolites|mesh-ancestor
5734284|NCT03142516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5734285|NCT03142516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5614985|NCT02465268|Immunologic Factors|immunologic factors|mesh-ancestor
5614986|NCT02465268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5614987|NCT02465268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614988|NCT02448381|Hypericin|hypericin|mesh-list
5614989|NCT02448381|Antidepressive Agents|antidepressive agents|mesh-ancestor
5614990|NCT02448381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5614991|NCT02448381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5614992|NCT02448381|Antiviral Agents|antiviral agents|mesh-ancestor
5614993|NCT02448381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5614994|NCT02448381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5614995|NCT02448381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5614996|NCT02448381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5614997|NCT02448381|Immunologic Factors|immunologic factors|mesh-ancestor
5614998|NCT02448381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5614999|NCT02436707|Gemcitabine|gemcitabine|mesh-list
5615000|NCT02436707|Dexamethasone|dexamethasone|mesh-list
5615001|NCT02436707|Cyclophosphamide|cyclophosphamide|mesh-list
5615002|NCT02436707|Rituximab|rituximab|mesh-list
5615003|NCT02436707|Etoposide|etoposide|mesh-list
5615004|NCT02436707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5615005|NCT02436707|Immunologic Factors|immunologic factors|mesh-ancestor
5734286|NCT03142516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5734287|NCT03142516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5734288|NCT03142516|Immunologic Factors|immunologic factors|mesh-ancestor
5734289|NCT03142516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734290|NCT03142516|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5734291|NCT03142516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5734292|NCT03142516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5734293|NCT03142516|Antidotes|antidotes|mesh-ancestor
5734294|NCT03142516|Protective Agents|protective agents|mesh-ancestor
5734295|NCT03142516|Vitamin B Complex|vitamin b complex|mesh-ancestor
5734296|NCT03142516|Vitamins|vitamins|mesh-ancestor
5734297|NCT03142516|Micronutrients|micronutrients|mesh-ancestor
5615006|NCT02436707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5615007|NCT02436707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5734298|NCT03142516|Hematinics|hematinics|mesh-ancestor
5734299|NCT03142516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5734300|NCT03142165|Diphenhydramine|diphenhydramine|mesh-list
5734301|NCT03142165|Promethazine|promethazine|mesh-list
5734302|NCT03142165|Famotidine|famotidine|mesh-list
5734303|NCT03142165|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5734304|NCT03142165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5734305|NCT03142165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5734306|NCT03142165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734307|NCT03142165|Anesthetics, Local|anesthetics, local|mesh-ancestor
5734308|NCT03142165|Anesthetics|anesthetics|mesh-ancestor
5734309|NCT03142165|Sensory System Agents|sensory system agents|mesh-ancestor
5734310|NCT03142165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5734311|NCT03142165|Antiemetics|antiemetics|mesh-ancestor
5734312|NCT03142165|Autonomic Agents|autonomic agents|mesh-ancestor
5734313|NCT03142165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5734314|NCT03142165|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5734315|NCT03142165|Histamine Antagonists|histamine antagonists|mesh-ancestor
5734316|NCT03142165|Histamine Agents|histamine agents|mesh-ancestor
5734317|NCT03142165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5734318|NCT03142165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5734319|NCT03142165|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5734320|NCT03142165|Antipruritics|antipruritics|mesh-ancestor
5734321|NCT03142165|Dermatologic Agents|dermatologic agents|mesh-ancestor
5734322|NCT03142165|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5734323|NCT03142165|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5734324|NCT03142321|Vedolizumab|vedolizumab|mesh-list
5734325|NCT03142321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5734326|NCT03142256|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5615008|NCT02436707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5615009|NCT02436707|Alkylating Agents|alkylating agents|mesh-ancestor
5615010|NCT02436707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5615011|NCT02436707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5615012|NCT02436707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5615013|NCT02436707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5615014|NCT02436707|Antiemetics|antiemetics|mesh-ancestor
5615015|NCT02436707|Autonomic Agents|autonomic agents|mesh-ancestor
5615016|NCT02436707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5615017|NCT02436707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5615018|NCT02436707|Glucocorticoids|glucocorticoids|mesh-ancestor
5615019|NCT02436707|Hormones|hormones|mesh-ancestor
5615020|NCT02436707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5615021|NCT02436707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5615022|NCT02436707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5615023|NCT02436707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5615024|NCT02436707|Antimetabolites|antimetabolites|mesh-ancestor
5615025|NCT02436707|Antiviral Agents|antiviral agents|mesh-ancestor
5615026|NCT02436707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5615027|NCT02436707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5615028|NCT02436707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5615029|NCT02436707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5615030|NCT02436707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5615031|NCT02424019|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
5615032|NCT02424019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5615033|NCT02424019|Glucocorticoids|glucocorticoids|mesh-ancestor
5615034|NCT02424019|Hormones|hormones|mesh-ancestor
5734327|NCT03142256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5734328|NCT03142256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5734329|NCT03142256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5734330|NCT03142256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5734331|NCT03142256|Antiviral Agents|antiviral agents|mesh-ancestor
5734332|NCT03142256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5734333|NCT03142256|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5734334|NCT03142256|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5734335|NCT03142139|Vaccines|vaccines|mesh-list
5734336|NCT03142139|Immunologic Factors|immunologic factors|mesh-ancestor
5734337|NCT03142139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893025|NCT03795701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5893026|NCT03795701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893027|NCT03795701|Incretins|incretins|mesh-ancestor
5893028|NCT03795701|Hormones|hormones|mesh-ancestor
5893029|NCT03795701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5893030|NCT03771313|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
5893031|NCT03771313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5893032|NCT03771313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5893033|NCT03722108|Irinotecan|irinotecan|mesh-list
5893034|NCT03722108|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5734338|NCT03142360|Beraprost|beraprost|mesh-list
5615035|NCT02424019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5615036|NCT02424019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5615037|NCT02422368|Methylprednisolone|methylprednisolone|mesh-list
5615038|NCT02422368|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5615039|NCT02422368|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5615040|NCT02422368|Prednisolone|prednisolone|mesh-list
5615041|NCT02422368|Prednisolone acetate|prednisolone acetate|mesh-list
5734339|NCT03142360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5734340|NCT03142360|Vasodilator Agents|vasodilator agents|mesh-ancestor
5734341|NCT03142542|Udenafil|udenafil|mesh-list
5734342|NCT03142542|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5734343|NCT03142542|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5615042|NCT02422368|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5615043|NCT02422368|Prednisolone phosphate|prednisolone phosphate|mesh-list
5615044|NCT02422368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5615045|NCT02422368|Antiemetics|antiemetics|mesh-ancestor
5615046|NCT02422368|Autonomic Agents|autonomic agents|mesh-ancestor
5615047|NCT02422368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5615048|NCT02422368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734344|NCT03142542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5734345|NCT03142542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5734346|NCT03141827|Insulin|insulin|mesh-list
5734347|NCT03141827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5734348|NCT03141827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734349|NCT03141970|Prednisone|prednisone|mesh-list
5734350|NCT03141970|Prednisolone|prednisolone|mesh-list
5734351|NCT03141970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5734352|NCT03141970|Glucocorticoids|glucocorticoids|mesh-ancestor
5734353|NCT03141970|Hormones|hormones|mesh-ancestor
5734354|NCT03141970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5734355|NCT03141970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734356|NCT03141970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5734357|NCT03141970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5734358|NCT03142035|Dienogest|dienogest|mesh-list
5734359|NCT03142035|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5734360|NCT03142035|Contraceptive Agents|contraceptive agents|mesh-ancestor
5734361|NCT03142035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5734362|NCT03142035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734363|NCT03142035|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5734364|NCT03142035|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5734365|NCT03142035|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5734366|NCT03142035|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5734367|NCT03142035|Hormone Antagonists|hormone antagonists|mesh-ancestor
5734368|NCT03142035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5734369|NCT03142035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5734370|NCT03142035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5734371|NCT03141658|Ketamine|ketamine|mesh-list
5734372|NCT03141658|Analgesics|analgesics|mesh-ancestor
5734373|NCT03141658|Sensory System Agents|sensory system agents|mesh-ancestor
5734374|NCT03141658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5734375|NCT03141658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734376|NCT03141658|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5734377|NCT03141658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5734378|NCT03141658|Anesthetics, General|anesthetics, general|mesh-ancestor
5734379|NCT03141658|Anesthetics|anesthetics|mesh-ancestor
5734380|NCT03141658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5734381|NCT03141658|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5734382|NCT03141658|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5734383|NCT03141658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5734384|NCT03141658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5734385|NCT03141645|Ondansetron|ondansetron|mesh-list
5734386|NCT03141645|Antiemetics|antiemetics|mesh-ancestor
5734387|NCT03141645|Autonomic Agents|autonomic agents|mesh-ancestor
5734388|NCT03141645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5615049|NCT02422368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5615050|NCT02422368|Glucocorticoids|glucocorticoids|mesh-ancestor
5615051|NCT02422368|Hormones|hormones|mesh-ancestor
5615052|NCT02422368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5615053|NCT02422368|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5615054|NCT02422368|Protective Agents|protective agents|mesh-ancestor
5615055|NCT02422368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5615056|NCT02422368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5734389|NCT03141645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734390|NCT03141645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5734391|NCT03141645|Antipruritics|antipruritics|mesh-ancestor
5615057|NCT02420847|Gemcitabine|gemcitabine|mesh-list
5615058|NCT02420847|Doxorubicin|doxorubicin|mesh-list
5615059|NCT02420847|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5615060|NCT02420847|Ixazomib|ixazomib|mesh-list
5615061|NCT02420847|Glycine|glycine|mesh-list
5615062|NCT02420847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5615063|NCT02420847|Antimetabolites|antimetabolites|mesh-ancestor
5615064|NCT02420847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5615065|NCT02420847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5615066|NCT02420847|Antiviral Agents|antiviral agents|mesh-ancestor
5615067|NCT02420847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5615068|NCT02420847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5615069|NCT02420847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5615070|NCT02420847|Immunologic Factors|immunologic factors|mesh-ancestor
5615071|NCT02420847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5615072|NCT02420847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5615073|NCT02420847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5615074|NCT02420847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5615075|NCT02420847|Protease Inhibitors|protease inhibitors|mesh-ancestor
5615076|NCT02420847|Glycine Agents|glycine agents|mesh-ancestor
5615077|NCT02420847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5615078|NCT02400242|Dexamethasone|dexamethasone|mesh-list
5615079|NCT02400242|Pomalidomide|pomalidomide|mesh-list
5615080|NCT02400242|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
5615081|NCT02400242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5615082|NCT02400242|Antiemetics|antiemetics|mesh-ancestor
5615083|NCT02400242|Autonomic Agents|autonomic agents|mesh-ancestor
5734392|NCT03141645|Dermatologic Agents|dermatologic agents|mesh-ancestor
5734393|NCT03141645|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5734394|NCT03141645|Serotonin Agents|serotonin agents|mesh-ancestor
5734395|NCT03141645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5734396|NCT03141645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5734397|NCT03141645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5734398|NCT03141645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5734399|NCT03141645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5734400|NCT03141645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5734401|NCT03141645|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5734402|NCT03141918|Curcumin|curcumin|mesh-list
5615084|NCT02400242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5615085|NCT02400242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5615086|NCT02400242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5615087|NCT02400242|Glucocorticoids|glucocorticoids|mesh-ancestor
5615088|NCT02400242|Hormones|hormones|mesh-ancestor
5615089|NCT02400242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5615090|NCT02400242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5615091|NCT02400242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5615092|NCT02400242|Immunologic Factors|immunologic factors|mesh-ancestor
5615093|NCT02400242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5615094|NCT02400242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5734403|NCT03141918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5734404|NCT03141918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5734405|NCT03141918|Analgesics|analgesics|mesh-ancestor
5734406|NCT03141918|Sensory System Agents|sensory system agents|mesh-ancestor
5734407|NCT03141918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5734408|NCT03141918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5615095|NCT02400242|Growth Substances|growth substances|mesh-ancestor
5615096|NCT02400242|Growth Inhibitors|growth inhibitors|mesh-ancestor
5615097|NCT02400242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5615098|NCT02400242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5615099|NCT02393183|Selenium|selenium|mesh-list
5615100|NCT02393183|Antioxidants|antioxidants|mesh-list
6675620|NCT01576679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5734409|NCT03141918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5734410|NCT03141918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5734411|NCT03141918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5734412|NCT03141918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5734413|NCT03141918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5734414|NCT03141632|Dulaglutide|dulaglutide|mesh-list
5615101|NCT02393183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5615102|NCT02393183|Protective Agents|protective agents|mesh-ancestor
5615103|NCT02393183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5615104|NCT02393183|Trace Elements|trace elements|mesh-ancestor
5615105|NCT02393183|Micronutrients|micronutrients|mesh-ancestor
5615106|NCT02379520|Cyclophosphamide|cyclophosphamide|mesh-list
5615107|NCT02379520|Nivolumab|nivolumab|mesh-list
5615108|NCT02379520|Fludarabine|fludarabine|mesh-list
5615109|NCT02379520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5615110|NCT02379520|Immunologic Factors|immunologic factors|mesh-ancestor
5615111|NCT02379520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5615112|NCT02379520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5615113|NCT02379520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5615114|NCT02379520|Alkylating Agents|alkylating agents|mesh-ancestor
5615115|NCT02379520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5615116|NCT02379520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5615117|NCT02379520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5615118|NCT02379520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5615119|NCT02379520|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5615120|NCT02367040|Rituximab|rituximab|mesh-list
5615121|NCT02367040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5615122|NCT02367040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5615123|NCT02367040|Immunologic Factors|immunologic factors|mesh-ancestor
5615124|NCT02367040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5615125|NCT02367040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5692154|NCT03411434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5692155|NCT03411434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5734415|NCT03141632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5734416|NCT03141632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734417|NCT03141671|Prednisone|prednisone|mesh-list
5734418|NCT03141671|Bicalutamide|bicalutamide|mesh-list
5734419|NCT03141671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5734420|NCT03141671|Glucocorticoids|glucocorticoids|mesh-ancestor
5734421|NCT03141671|Hormones|hormones|mesh-ancestor
5734422|NCT03141671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5734423|NCT03141671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734424|NCT03141671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5734425|NCT03141671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5734426|NCT03141671|Androgen Antagonists|androgen antagonists|mesh-ancestor
5734427|NCT03141671|Hormone Antagonists|hormone antagonists|mesh-ancestor
5734428|NCT03141593|Vitamin D|vitamin d|mesh-list
5692156|NCT03411434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5692157|NCT03411434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692158|NCT03411434|Dopamine Agents|dopamine agents|mesh-ancestor
5734429|NCT03141593|Ergocalciferols|ergocalciferols|mesh-list
5734430|NCT03141593|Vitamins|vitamins|mesh-list
5734431|NCT03141593|Micronutrients|micronutrients|mesh-ancestor
5692159|NCT03411434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5692160|NCT03411369|Vitamins|vitamins|mesh-list
5692161|NCT03411369|Micronutrients|micronutrients|mesh-ancestor
5692162|NCT03411369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692163|NCT03411330|Lidocaine|lidocaine|mesh-list
5692164|NCT03411330|Bupivacaine|bupivacaine|mesh-list
5692165|NCT03411330|Anesthetics, Local|anesthetics, local|mesh-ancestor
5692166|NCT03411330|Anesthetics|anesthetics|mesh-ancestor
5692167|NCT03411330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5692168|NCT03411330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692169|NCT03411330|Sensory System Agents|sensory system agents|mesh-ancestor
5692170|NCT03411330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5692171|NCT03411330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5692172|NCT03411330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5734432|NCT03141593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734433|NCT03141593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5734434|NCT03141593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5734435|NCT03141398|Pancrelipase|pancrelipase|mesh-list
5734436|NCT03141398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5734437|NCT03141268|Lactulose|lactulose|mesh-list
5734438|NCT03141268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5734439|NCT03141476|Cefuroxime|cefuroxime|mesh-list
5734440|NCT03141476|Cefuroxime axetil|cefuroxime axetil|mesh-list
5734441|NCT03141476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5734442|NCT03141476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5734443|NCT03141554|Chlorhexidine|chlorhexidine|mesh-list
5734444|NCT03141554|Povidone-Iodine|povidone-iodine|mesh-list
5734445|NCT03141554|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5734446|NCT03141554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5734447|NCT03141554|Disinfectants|disinfectants|mesh-ancestor
5734448|NCT03141203|Romidepsin|romidepsin|mesh-list
5734449|NCT03141203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5734450|NCT03141203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5734451|NCT03141125|Ethanol|ethanol|mesh-list
5734452|NCT03141125|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5734453|NCT03141125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5734454|NCT03141125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5734455|NCT03141125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734456|NCT03140982|Propofol|propofol|mesh-list
5734457|NCT03140982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5734458|NCT03140982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5734459|NCT03140982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734460|NCT03140982|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5734461|NCT03140982|Anesthetics, General|anesthetics, general|mesh-ancestor
5734462|NCT03140982|Anesthetics|anesthetics|mesh-ancestor
5734463|NCT03140956|Levodopa|levodopa|mesh-list
5734464|NCT03140956|Carbidopa|carbidopa|mesh-list
5734465|NCT03140956|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5734466|NCT03140956|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5734467|NCT03140956|Dopamine Agents|dopamine agents|mesh-ancestor
5734468|NCT03140956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5734469|NCT03140956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5734470|NCT03140956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734471|NCT03140956|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5734472|NCT03140956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5734473|NCT03140943|Thalidomide|thalidomide|mesh-list
6489180|NCT00589927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6489181|NCT00589927|Vasodilator Agents|vasodilator agents|mesh-ancestor
6489182|NCT00589927|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6489183|NCT00589927|Protective Agents|protective agents|mesh-ancestor
6489184|NCT00589927|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6489185|NCT00589927|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6489186|NCT00589927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6489187|NCT00589953|Epoetin Alfa|epoetin alfa|mesh-list
6489188|NCT00589953|Hematinics|hematinics|mesh-ancestor
6489189|NCT00589992|Ibutilide|ibutilide|mesh-list
6489190|NCT00589992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6489191|NCT00590070|Adenosine|adenosine|mesh-list
6489192|NCT00590070|Nitroprusside|nitroprusside|mesh-list
6489193|NCT00590070|Analgesics|analgesics|mesh-ancestor
6489194|NCT00590070|Sensory System Agents|sensory system agents|mesh-ancestor
6489195|NCT00590070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6489196|NCT00590070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489197|NCT00590070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6489198|NCT00590070|Vasodilator Agents|vasodilator agents|mesh-ancestor
6489199|NCT00590070|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6489200|NCT00590070|Purinergic Agonists|purinergic agonists|mesh-ancestor
6489201|NCT00590070|Purinergic Agents|purinergic agents|mesh-ancestor
6489202|NCT00590070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5615126|NCT02354131|Bevacizumab|bevacizumab|mesh-list
5615127|NCT02354131|Niraparib|niraparib|mesh-list
5615128|NCT02354131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5615129|NCT02354131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5615130|NCT02354131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5615131|NCT02354131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5615132|NCT02354131|Growth Substances|growth substances|mesh-ancestor
5615133|NCT02354131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5615134|NCT02354131|Growth Inhibitors|growth inhibitors|mesh-ancestor
5615135|NCT02354131|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5615136|NCT02354131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5615137|NCT02354131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5615138|NCT02335944|Nazartinib|nazartinib|mesh-list
5615139|NCT02335944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5615140|NCT02333162|Mycophenolic Acid|mycophenolic acid|mesh-list
5615141|NCT02333162|Fludarabine|fludarabine|mesh-list
5615142|NCT02333162|Fludarabine phosphate|fludarabine phosphate|mesh-list
5615143|NCT02333162|Melphalan|melphalan|mesh-list
5734474|NCT03140943|Dexamethasone|dexamethasone|mesh-list
5734475|NCT03140943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6489203|NCT00590070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5734476|NCT03140943|Antiemetics|antiemetics|mesh-ancestor
5734477|NCT03140943|Autonomic Agents|autonomic agents|mesh-ancestor
5734478|NCT03140943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5734479|NCT03140943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734480|NCT03140943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5734481|NCT03140943|Glucocorticoids|glucocorticoids|mesh-ancestor
5734482|NCT03140943|Hormones|hormones|mesh-ancestor
5734483|NCT03140943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5734484|NCT03140943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5734485|NCT03140943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5734486|NCT03140943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5734487|NCT03140943|Immunologic Factors|immunologic factors|mesh-ancestor
5734488|NCT03140943|Leprostatic Agents|leprostatic agents|mesh-ancestor
5734489|NCT03140943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5734490|NCT03140943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5734491|NCT03140943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5734492|NCT03140943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5734493|NCT03140943|Growth Substances|growth substances|mesh-ancestor
5734494|NCT03140943|Growth Inhibitors|growth inhibitors|mesh-ancestor
5734495|NCT03140553|Cyclophosphamide|cyclophosphamide|mesh-list
5734496|NCT03140553|Carboplatin|carboplatin|mesh-list
5734497|NCT03140553|Docetaxel|docetaxel|mesh-list
5734498|NCT03140553|Trastuzumab|trastuzumab|mesh-list
5734499|NCT03140553|Epirubicin|epirubicin|mesh-list
5734500|NCT03140553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5734501|NCT03140553|Immunologic Factors|immunologic factors|mesh-ancestor
5734502|NCT03140553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734503|NCT03140553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5734504|NCT03140553|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5734505|NCT03140553|Alkylating Agents|alkylating agents|mesh-ancestor
5734506|NCT03140553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5734507|NCT03140553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5734508|NCT03140553|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5734509|NCT03140553|Tubulin Modulators|tubulin modulators|mesh-ancestor
5734510|NCT03140553|Antimitotic Agents|antimitotic agents|mesh-ancestor
5734511|NCT03140553|Mitosis Modulators|mitosis modulators|mesh-ancestor
5615144|NCT02333162|Tacrolimus|tacrolimus|mesh-list
5615145|NCT02333162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5615146|NCT02333162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5734512|NCT03140553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5734513|NCT03140553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5734514|NCT03140553|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5734515|NCT03140553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5734516|NCT03140553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5734517|NCT03140826|Meropenem|meropenem|mesh-list
5734518|NCT03140826|Tazobactam|tazobactam|mesh-list
5734519|NCT03140826|Piperacillin|piperacillin|mesh-list
5734520|NCT03140826|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
5615147|NCT02333162|Antimetabolites|antimetabolites|mesh-ancestor
5615148|NCT02333162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5615149|NCT02333162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5615150|NCT02333162|Immunologic Factors|immunologic factors|mesh-ancestor
5615151|NCT02333162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5615152|NCT02333162|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5615153|NCT02333162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5615154|NCT02333162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5615155|NCT02333162|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5615156|NCT02333162|Antitubercular Agents|antitubercular agents|mesh-ancestor
5615157|NCT02333162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5734521|NCT03140826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5734522|NCT03140826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5734523|NCT03140826|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5734524|NCT03140826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5734525|NCT03140826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5734526|NCT03140787|Lidocaine|lidocaine|mesh-list
5734527|NCT03140787|Anesthetics, Local|anesthetics, local|mesh-ancestor
5734528|NCT03140787|Anesthetics|anesthetics|mesh-ancestor
5734529|NCT03140787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5734530|NCT03140787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734531|NCT03140787|Sensory System Agents|sensory system agents|mesh-ancestor
5734532|NCT03140787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5734533|NCT03140787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5734534|NCT03140787|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5734535|NCT03140787|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5734536|NCT03140787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5734537|NCT03140787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5734538|NCT03140384|Misoprostol|misoprostol|mesh-list
5734539|NCT03140384|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5734540|NCT03140384|Abortifacient Agents|abortifacient agents|mesh-ancestor
5734541|NCT03140384|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5734542|NCT03140384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734543|NCT03140384|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5734544|NCT03140384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5734545|NCT03140384|Oxytocics|oxytocics|mesh-ancestor
5734546|NCT03140449|Calcitriol|calcitriol|mesh-list
5734547|NCT03140449|Sirolimus|sirolimus|mesh-list
5734548|NCT03140449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5734549|NCT03140449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5734550|NCT03140449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5734551|NCT03140449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5734552|NCT03140449|Antifungal Agents|antifungal agents|mesh-ancestor
5734553|NCT03140449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5734554|NCT03140449|Immunologic Factors|immunologic factors|mesh-ancestor
5734555|NCT03140449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734556|NCT03140449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5734557|NCT03140449|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
5734558|NCT03140449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5734559|NCT03140449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5734560|NCT03140449|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5734561|NCT03140449|Vitamins|vitamins|mesh-ancestor
5734562|NCT03140449|Micronutrients|micronutrients|mesh-ancestor
5734563|NCT03140449|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5734564|NCT03140709|Oxytocin|oxytocin|mesh-list
5734565|NCT03140709|Oxytocics|oxytocics|mesh-ancestor
5734566|NCT03140709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5734567|NCT03140709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893035|NCT03722108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5893036|NCT03722108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5893037|NCT03722108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893038|NCT03722108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5893039|NCT03717129|Tenofovir|tenofovir|mesh-list
5893040|NCT03717129|Emtricitabine|emtricitabine|mesh-list
5615158|NCT02333162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5615159|NCT02333162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5615160|NCT02333162|Alkylating Agents|alkylating agents|mesh-ancestor
5615161|NCT02333162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5615162|NCT02318342|Warfarin|warfarin|mesh-list
5615163|NCT02318342|Anticoagulants|anticoagulants|mesh-ancestor
5615164|NCT02304991|Glycerol|glycerol|mesh-list
5615165|NCT02304991|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
5615166|NCT02304991|Protective Agents|protective agents|mesh-ancestor
5615167|NCT02304991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5615168|NCT02303821|Cytarabine|cytarabine|mesh-list
5615169|NCT02303821|Dexamethasone|dexamethasone|mesh-list
5615170|NCT02303821|Hydrocortisone|hydrocortisone|mesh-list
5615171|NCT02303821|Cyclophosphamide|cyclophosphamide|mesh-list
5615172|NCT02303821|Methotrexate|methotrexate|mesh-list
5615173|NCT02303821|Vincristine|vincristine|mesh-list
5615174|NCT02303821|Daunorubicin|daunorubicin|mesh-list
5615175|NCT02303821|Asparaginase|asparaginase|mesh-list
5615176|NCT02303821|Mercaptopurine|mercaptopurine|mesh-list
5615177|NCT02303821|Mitoxantrone|mitoxantrone|mesh-list
5615178|NCT02303821|Pegaspargase|pegaspargase|mesh-list
5615179|NCT02303821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5893041|NCT03717129|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5893042|NCT03717129|Cobicistat|cobicistat|mesh-list
5615180|NCT02303821|Immunologic Factors|immunologic factors|mesh-ancestor
5615181|NCT02303821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5615182|NCT02303821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5615183|NCT02303821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5615184|NCT02303821|Alkylating Agents|alkylating agents|mesh-ancestor
5615185|NCT02303821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5615186|NCT02303821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5615187|NCT02303821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5615188|NCT02303821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5615189|NCT02303821|Antiemetics|antiemetics|mesh-ancestor
5615190|NCT02303821|Autonomic Agents|autonomic agents|mesh-ancestor
5615191|NCT02303821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5615192|NCT02303821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5615193|NCT02303821|Glucocorticoids|glucocorticoids|mesh-ancestor
5615194|NCT02303821|Hormones|hormones|mesh-ancestor
5615195|NCT02303821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5615196|NCT02303821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5615197|NCT02303821|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5615198|NCT02303821|Abortifacient Agents|abortifacient agents|mesh-ancestor
5734568|NCT03140488|Oxytocin|oxytocin|mesh-list
5734569|NCT03140488|Oxytocics|oxytocics|mesh-ancestor
5734570|NCT03140488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5734571|NCT03140488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734572|NCT03140423|Mupirocin|mupirocin|mesh-list
5615199|NCT02303821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5615200|NCT02303821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5615201|NCT02303821|Antimetabolites|antimetabolites|mesh-ancestor
5615202|NCT02303821|Dermatologic Agents|dermatologic agents|mesh-ancestor
5615203|NCT02303821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5615204|NCT02303821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5615205|NCT02303821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5615206|NCT02303821|Antiviral Agents|antiviral agents|mesh-ancestor
5615207|NCT02303821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5615208|NCT02303821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5615209|NCT02303821|Tubulin Modulators|tubulin modulators|mesh-ancestor
5615210|NCT02303821|Antimitotic Agents|antimitotic agents|mesh-ancestor
5615211|NCT02303821|Mitosis Modulators|mitosis modulators|mesh-ancestor
5734573|NCT03140423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5734574|NCT03140423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5615212|NCT02303821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5615213|NCT02303821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5615214|NCT02303821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5615215|NCT02303821|Analgesics|analgesics|mesh-ancestor
5615216|NCT02303821|Sensory System Agents|sensory system agents|mesh-ancestor
5615217|NCT02287311|Cyclophosphamide|cyclophosphamide|mesh-list
5615218|NCT02287311|Fludarabine|fludarabine|mesh-list
5615219|NCT02287311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5615220|NCT02287311|Immunologic Factors|immunologic factors|mesh-ancestor
5734575|NCT03140423|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5734576|NCT03140423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5734577|NCT03140423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5734578|NCT03140410|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5734579|NCT03140410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5734580|NCT03140358|Atropine|atropine|mesh-list
5734581|NCT03140358|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5734582|NCT03140358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5734583|NCT03140358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5734584|NCT03140358|Autonomic Agents|autonomic agents|mesh-ancestor
5734585|NCT03140358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5734586|NCT03140358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734587|NCT03140358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5734588|NCT03140358|Respiratory System Agents|respiratory system agents|mesh-ancestor
5734589|NCT03140358|Mydriatics|mydriatics|mesh-ancestor
5734590|NCT03140358|Parasympatholytics|parasympatholytics|mesh-ancestor
5734591|NCT03140358|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5734592|NCT03140358|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5734593|NCT03140358|Cholinergic Agents|cholinergic agents|mesh-ancestor
5734594|NCT03140358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5734595|NCT03140358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5615221|NCT02287311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5615222|NCT02287311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5615223|NCT02287311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5615224|NCT02287311|Alkylating Agents|alkylating agents|mesh-ancestor
5734596|NCT03140293|Lidocaine|lidocaine|mesh-list
5734597|NCT03140293|Ethyl Chloride|ethyl chloride|mesh-list
5734598|NCT03140293|Anesthetics, Local|anesthetics, local|mesh-ancestor
5734599|NCT03140293|Anesthetics|anesthetics|mesh-ancestor
5734600|NCT03140293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5734601|NCT03140293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734602|NCT03140293|Sensory System Agents|sensory system agents|mesh-ancestor
5734603|NCT03140293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5615225|NCT02287311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5615226|NCT02287311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5615227|NCT02287311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5615228|NCT02271919|Nicotine|nicotine|mesh-list
5615229|NCT02271919|Varenicline|varenicline|mesh-list
5615230|NCT02271919|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5615231|NCT02271919|Autonomic Agents|autonomic agents|mesh-ancestor
5615232|NCT02271919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5615233|NCT02271919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5615234|NCT02271919|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5615235|NCT02271919|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5615236|NCT02271919|Cholinergic Agents|cholinergic agents|mesh-ancestor
5734604|NCT03140293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5734605|NCT03140293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5734606|NCT03140293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5615237|NCT02271919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5615238|NCT02271919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5615239|NCT02263729|Losartan|losartan|mesh-list
5615240|NCT02263729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5615241|NCT02263729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5615242|NCT02263729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5615243|NCT02263729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5615244|NCT02263729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5615245|NCT02261415|Tranexamic Acid|tranexamic acid|mesh-list
5615246|NCT02261415|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5615247|NCT02261415|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5615248|NCT02261415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5615249|NCT02261415|Hemostatics|hemostatics|mesh-ancestor
5615250|NCT02261415|Coagulants|coagulants|mesh-ancestor
5615251|NCT02256696|Rifampin|rifampin|mesh-list
5615252|NCT02256696|Rifabutin|rifabutin|mesh-list
5615253|NCT02256696|Isoniazid|isoniazid|mesh-list
5615254|NCT02256696|Pyrazinamide|pyrazinamide|mesh-list
5615255|NCT02256696|Ethambutol|ethambutol|mesh-list
5615256|NCT02256696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5615257|NCT02256696|Antitubercular Agents|antitubercular agents|mesh-ancestor
5615258|NCT02256696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5615259|NCT02256696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5615260|NCT02256696|Leprostatic Agents|leprostatic agents|mesh-ancestor
5615261|NCT02256696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5615262|NCT02256696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5734607|NCT03140293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5734608|NCT03140293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5734609|NCT03140332|Sorafenib|sorafenib|mesh-list
5734610|NCT03140332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5734611|NCT03140332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5734612|NCT03140332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5734613|NCT03140332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5734614|NCT03140397|8-prenylnaringenin|8-prenylnaringenin|mesh-list
5734615|NCT03140397|Phytoestrogens|phytoestrogens|mesh-ancestor
5734616|NCT03140397|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
5734617|NCT03140397|Estrogens|estrogens|mesh-ancestor
5734618|NCT03140397|Hormones|hormones|mesh-ancestor
5615263|NCT02256696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5615264|NCT02256696|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5615265|NCT02256696|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5615266|NCT02256696|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5615267|NCT02256696|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5734619|NCT03140397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5734620|NCT03140397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734621|NCT03140176|Sunitinib|sunitinib|mesh-list
5734622|NCT03140176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5615268|NCT02256696|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5615269|NCT02256696|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5615270|NCT02256696|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5615271|NCT02256696|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5615272|NCT02256696|Antimetabolites|antimetabolites|mesh-ancestor
5615273|NCT02256696|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5615274|NCT02225600|Oxytocin|oxytocin|mesh-list
5615275|NCT02225600|Oxytocics|oxytocics|mesh-ancestor
5615276|NCT02225600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5615277|NCT02225600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5615278|NCT02223520|Chlorhexidine|chlorhexidine|mesh-list
5734623|NCT03140176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5734624|NCT03140176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5734625|NCT03140176|Growth Substances|growth substances|mesh-ancestor
5734626|NCT03140176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734627|NCT03140176|Growth Inhibitors|growth inhibitors|mesh-ancestor
5734628|NCT03140176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5734629|NCT03140176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5734630|NCT03140176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5734631|NCT03139851|Cyclophosphamide|cyclophosphamide|mesh-list
5734632|NCT03139851|Pembrolizumab|pembrolizumab|mesh-list
5734633|NCT03139851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5734634|NCT03139851|Immunologic Factors|immunologic factors|mesh-ancestor
5734635|NCT03139851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734636|NCT03139851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5734637|NCT03139851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5734638|NCT03139851|Alkylating Agents|alkylating agents|mesh-ancestor
5615279|NCT02223520|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5615280|NCT02223520|Mupirocin|mupirocin|mesh-list
5615281|NCT02223520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5615282|NCT02223520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5615283|NCT02223520|Disinfectants|disinfectants|mesh-ancestor
5615284|NCT02223520|Dermatologic Agents|dermatologic agents|mesh-ancestor
5615285|NCT02223520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5615286|NCT02223520|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5615287|NCT02223520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5615288|NCT02223520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5615289|NCT02220309|Pramipexole|pramipexole|mesh-list
5615290|NCT02220309|Antioxidants|antioxidants|mesh-ancestor
5615291|NCT02220309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5615292|NCT02220309|Protective Agents|protective agents|mesh-ancestor
5615293|NCT02220309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5615294|NCT02220309|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5615295|NCT02220309|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5615296|NCT02220309|Dopamine Agonists|dopamine agonists|mesh-ancestor
5615297|NCT02220309|Dopamine Agents|dopamine agents|mesh-ancestor
5615298|NCT02220309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5615299|NCT02199665|Dexamethasone|dexamethasone|mesh-list
5734639|NCT03139851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5734640|NCT03139851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5734641|NCT03139851|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5734642|NCT03139851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5734643|NCT03140085|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5734644|NCT03140085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5734645|NCT03139708|Brimonidine Tartrate|brimonidine tartrate|mesh-list
5734646|NCT03139708|Phenylephrine|phenylephrine|mesh-list
5734647|NCT03139708|Oxymetazoline|oxymetazoline|mesh-list
5734648|NCT03139708|Tropicamide|tropicamide|mesh-list
5734649|NCT03139708|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5734650|NCT03139708|Mydriatics|mydriatics|mesh-ancestor
5734651|NCT03139708|Autonomic Agents|autonomic agents|mesh-ancestor
5734652|NCT03139708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5734653|NCT03139708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734654|NCT03139708|Sympathomimetics|sympathomimetics|mesh-ancestor
5734655|NCT03139708|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5734656|NCT03139708|Nasal Decongestants|nasal decongestants|mesh-ancestor
5734657|NCT03139708|Respiratory System Agents|respiratory system agents|mesh-ancestor
5734658|NCT03139708|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5734659|NCT03139708|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5734660|NCT03139708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5734661|NCT03139708|Adrenergic Agents|adrenergic agents|mesh-ancestor
5734662|NCT03139708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5734663|NCT03139708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5615300|NCT02199665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5615301|NCT02199665|Antiemetics|antiemetics|mesh-ancestor
5734664|NCT03139708|Protective Agents|protective agents|mesh-ancestor
5734665|NCT03139708|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5734666|NCT03139708|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5734667|NCT03139708|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5734668|NCT03139708|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5734669|NCT03139708|Cholinergic Agents|cholinergic agents|mesh-ancestor
5734670|NCT03140033|Misoprostol|misoprostol|mesh-list
5734671|NCT03140033|Ranitidine|ranitidine|mesh-list
5734672|NCT03140033|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
5734673|NCT03140033|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5734674|NCT03140033|Abortifacient Agents|abortifacient agents|mesh-ancestor
5734675|NCT03140033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5734676|NCT03140033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734677|NCT03140033|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5734678|NCT03140033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5734679|NCT03140033|Oxytocics|oxytocics|mesh-ancestor
5734680|NCT03140033|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5734681|NCT03140033|Histamine Antagonists|histamine antagonists|mesh-ancestor
5734682|NCT03140033|Histamine Agents|histamine agents|mesh-ancestor
5734683|NCT03140033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5734684|NCT03140033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893043|NCT03717129|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
5893044|NCT03717129|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5893045|NCT03717129|Elvitegravir|elvitegravir|mesh-list
5893046|NCT03717129|Antiviral Agents|antiviral agents|mesh-ancestor
5893047|NCT03717129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5893048|NCT03717129|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5893049|NCT03717129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5893050|NCT03717129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5893051|NCT03717129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893052|NCT03717129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5893053|NCT03717129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5893054|NCT03717129|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5893055|NCT03717129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5893056|NCT03717129|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5893057|NCT03651128|Dexamethasone|dexamethasone|mesh-list
5893058|NCT03651128|Lenalidomide|lenalidomide|mesh-list
5893059|NCT03651128|Bortezomib|bortezomib|mesh-list
5893060|NCT03651128|Daratumumab|daratumumab|mesh-list
5893061|NCT03651128|Pomalidomide|pomalidomide|mesh-list
5893062|NCT03651128|Ixazomib|ixazomib|mesh-list
5893063|NCT03651128|Elotuzumab|elotuzumab|mesh-list
5893064|NCT03651128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5893065|NCT03651128|Antiemetics|antiemetics|mesh-ancestor
5893066|NCT03651128|Autonomic Agents|autonomic agents|mesh-ancestor
5893067|NCT03651128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5893068|NCT03651128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893069|NCT03651128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5893070|NCT03651128|Glucocorticoids|glucocorticoids|mesh-ancestor
5893071|NCT03651128|Hormones|hormones|mesh-ancestor
5893072|NCT03651128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5893073|NCT03651128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5893074|NCT03651128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5615302|NCT02199665|Autonomic Agents|autonomic agents|mesh-ancestor
5615303|NCT02199665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5615304|NCT02199665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5615305|NCT02199665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5615306|NCT02199665|Glucocorticoids|glucocorticoids|mesh-ancestor
5893075|NCT03651128|Immunologic Factors|immunologic factors|mesh-ancestor
5893076|NCT03651128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5615307|NCT02199665|Hormones|hormones|mesh-ancestor
5615308|NCT02199665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5615309|NCT02199665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5615310|NCT02199665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5615311|NCT02178709|Leucovorin|leucovorin|mesh-list
5615312|NCT02178709|Oxaliplatin|oxaliplatin|mesh-list
5615313|NCT02178709|Irinotecan|irinotecan|mesh-list
5615314|NCT02178709|Folfirinox|folfirinox|mesh-list
5615315|NCT02178709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5615316|NCT02178709|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5615317|NCT02178709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5615318|NCT02178709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5615319|NCT02178709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5615320|NCT02178709|Antidotes|antidotes|mesh-ancestor
5615321|NCT02178709|Protective Agents|protective agents|mesh-ancestor
5615322|NCT02178709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5615323|NCT02178709|Vitamin B Complex|vitamin b complex|mesh-ancestor
5615324|NCT02178709|Vitamins|vitamins|mesh-ancestor
5615325|NCT02178709|Micronutrients|micronutrients|mesh-ancestor
5615326|NCT02143401|Sorafenib|sorafenib|mesh-list
5615327|NCT02143401|Navitoclax|navitoclax|mesh-list
5615328|NCT02143401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5615329|NCT02143401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5615330|NCT02143401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5615331|NCT02143401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5615332|NCT02141282|Venetoclax|venetoclax|mesh-list
5615333|NCT02141282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5615334|NCT02126553|Lenalidomide|lenalidomide|mesh-list
5615335|NCT02126553|Immunologic Factors|immunologic factors|mesh-ancestor
5615336|NCT02126553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5615337|NCT02126553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5615338|NCT02126553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5734685|NCT03139474|Hormones|hormones|mesh-list
5734686|NCT03139474|Hormone Antagonists|hormone antagonists|mesh-list
5734687|NCT03139474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5734688|NCT03139474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734689|NCT03139487|Dalteparin|dalteparin|mesh-list
5734690|NCT03139487|Tinzaparin|tinzaparin|mesh-list
5734691|NCT03139487|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5734692|NCT03139487|Rivaroxaban|rivaroxaban|mesh-list
5734693|NCT03139487|Apixaban|apixaban|mesh-list
5734694|NCT03139487|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5734695|NCT03139487|Antithrombins|antithrombins|mesh-ancestor
5734696|NCT03139487|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5734697|NCT03139487|Protease Inhibitors|protease inhibitors|mesh-ancestor
5734698|NCT03139487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5734699|NCT03139487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5734700|NCT03139487|Anticoagulants|anticoagulants|mesh-ancestor
5734701|NCT03139487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5734702|NCT03139487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5734703|NCT03139253|Amoxicillin|amoxicillin|mesh-list
5734704|NCT03139253|Clarithromycin|clarithromycin|mesh-list
5734705|NCT03139253|Levofloxacin|levofloxacin|mesh-list
5734706|NCT03139253|Ofloxacin|ofloxacin|mesh-list
5734707|NCT03139253|Tetracycline|tetracycline|mesh-list
5734708|NCT03139253|Tinidazole|tinidazole|mesh-list
5734709|NCT03139253|Furazolidone|furazolidone|mesh-list
5734710|NCT03139253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5734711|NCT03139253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5734712|NCT03139253|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5734713|NCT03139253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5734714|NCT03139253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5734715|NCT03139253|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5734716|NCT03139253|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5734717|NCT03139253|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5734718|NCT03139253|Renal Agents|renal agents|mesh-ancestor
5734719|NCT03139253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5734720|NCT03139253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5734721|NCT03139253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5734722|NCT03139253|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5734723|NCT03139253|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5734724|NCT03139253|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
5734725|NCT03139253|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5734726|NCT03139253|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5734727|NCT03139253|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
5734728|NCT03139253|Alkylating Agents|alkylating agents|mesh-ancestor
5734729|NCT03139591|Dexamethasone|dexamethasone|mesh-list
5734730|NCT03139591|Lidocaine|lidocaine|mesh-list
5734731|NCT03139591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5734732|NCT03139591|Antiemetics|antiemetics|mesh-ancestor
5734733|NCT03139591|Autonomic Agents|autonomic agents|mesh-ancestor
5734734|NCT03139591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5734735|NCT03139591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734736|NCT03139591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5734737|NCT03139591|Glucocorticoids|glucocorticoids|mesh-ancestor
5734738|NCT03139591|Hormones|hormones|mesh-ancestor
5615339|NCT02126553|Growth Substances|growth substances|mesh-ancestor
5615340|NCT02126553|Growth Inhibitors|growth inhibitors|mesh-ancestor
6208551|NCT02132468|Fosbretabulin|fosbretabulin|mesh-list
5615341|NCT02126553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5615342|NCT02122198|Leuprolide|leuprolide|mesh-list
5734739|NCT03139591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5734740|NCT03139591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5734741|NCT03139591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5615343|NCT02122198|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
5615344|NCT02122198|Medroxyprogesterone|medroxyprogesterone|mesh-list
5615345|NCT02122198|Estradiol|estradiol|mesh-list
5615346|NCT02122198|Estrogens|estrogens|mesh-ancestor
5615347|NCT02122198|Hormones|hormones|mesh-ancestor
5615348|NCT02122198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5615349|NCT02122198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5615350|NCT02122198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5615351|NCT02122198|Contraceptive Agents|contraceptive agents|mesh-ancestor
5615352|NCT02122198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5615353|NCT02122198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5615354|NCT02122198|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5615355|NCT02122198|Fertility Agents|fertility agents|mesh-ancestor
5615356|NCT02122198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5615357|NCT02122198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5615358|NCT02122198|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5734742|NCT03139591|Anesthetics, Local|anesthetics, local|mesh-ancestor
5734743|NCT03139591|Anesthetics|anesthetics|mesh-ancestor
5734744|NCT03139591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5734745|NCT03139591|Sensory System Agents|sensory system agents|mesh-ancestor
5734746|NCT03139591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5734747|NCT03139591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5734748|NCT03139591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5734749|NCT03139591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5734750|NCT03139591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5734751|NCT03139409|Chlorhexidine|chlorhexidine|mesh-list
5734752|NCT03139409|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5734753|NCT03139409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5734754|NCT03139409|Disinfectants|disinfectants|mesh-ancestor
5734755|NCT03139422|Tranexamic Acid|tranexamic acid|mesh-list
5734756|NCT03139422|Calcium Dobesilate|calcium dobesilate|mesh-list
5734757|NCT03139422|Calcium|calcium|mesh-list
5734758|NCT03139422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5734759|NCT03139422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734760|NCT03139422|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5734761|NCT03139422|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5734762|NCT03139422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5734763|NCT03139422|Hemostatics|hemostatics|mesh-ancestor
5734764|NCT03139422|Coagulants|coagulants|mesh-ancestor
5734765|NCT03139513|Vemurafenib|vemurafenib|mesh-list
5734766|NCT03139513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5734767|NCT03139513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5734768|NCT03139513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5734769|NCT03139513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5734770|NCT03139565|Vaccines|vaccines|mesh-list
5734771|NCT03139565|Immunologic Factors|immunologic factors|mesh-ancestor
6489204|NCT00590070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6489205|NCT00590070|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6489206|NCT00590122|Levodopa|levodopa|mesh-list
6489207|NCT00590122|Carbidopa|carbidopa|mesh-list
5734772|NCT03139565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734773|NCT03139305|Glucagon|glucagon|mesh-list
5734774|NCT03139305|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5734775|NCT03139305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5734776|NCT03139305|Hormones|hormones|mesh-ancestor
5734777|NCT03139305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5734778|NCT03139305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734779|NCT03139305|Incretins|incretins|mesh-ancestor
5734780|NCT03139500|Midazolam|midazolam|mesh-list
5734781|NCT03139500|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5734782|NCT03139500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5734783|NCT03139500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5734784|NCT03139500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489208|NCT00590122|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
5615359|NCT02122198|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5734785|NCT03139500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5734786|NCT03139500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6489209|NCT00590122|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5734787|NCT03139500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5734788|NCT03139500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5734789|NCT03139500|Anesthetics, General|anesthetics, general|mesh-ancestor
5734790|NCT03139500|Anesthetics|anesthetics|mesh-ancestor
5734791|NCT03139500|GABA Modulators|gaba modulators|mesh-ancestor
5734792|NCT03139500|GABA Agents|gaba agents|mesh-ancestor
5734793|NCT03139500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5615360|NCT02122198|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5615361|NCT02122198|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5615362|NCT02118584|Etrolizumab|etrolizumab|mesh-list
5615363|NCT02118584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5615364|NCT02118584|Immunologic Factors|immunologic factors|mesh-ancestor
5615365|NCT02118584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5615366|NCT02115997|Prednisone|prednisone|mesh-list
5615367|NCT02115997|Methylprednisolone|methylprednisolone|mesh-list
5615368|NCT02115997|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5615369|NCT02115997|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5615370|NCT02115997|Prednisolone|prednisolone|mesh-list
5615371|NCT02115997|Prednisolone acetate|prednisolone acetate|mesh-list
5615372|NCT02115997|Rituximab|rituximab|mesh-list
5734794|NCT03139500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5734795|NCT03139331|Irinotecan|irinotecan|mesh-list
5734796|NCT03139331|Temozolomide|temozolomide|mesh-list
5734797|NCT03139331|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5734798|NCT03139331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5734799|NCT03139331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5734800|NCT03139331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5734801|NCT03139331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5734802|NCT03139331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5734803|NCT03139331|Alkylating Agents|alkylating agents|mesh-ancestor
5734804|NCT03139383|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5893077|NCT03651128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5893078|NCT03651128|Growth Substances|growth substances|mesh-ancestor
5893079|NCT03651128|Growth Inhibitors|growth inhibitors|mesh-ancestor
5893080|NCT03651128|Protease Inhibitors|protease inhibitors|mesh-ancestor
5893081|NCT03651128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5893082|NCT03651128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893083|NCT03636295|Warfarin|warfarin|mesh-list
5893084|NCT03636295|Anticoagulants|anticoagulants|mesh-ancestor
5893085|NCT03579446|Oxymorphone|oxymorphone|mesh-list
5893086|NCT03579446|Morphine|morphine|mesh-list
5893087|NCT03579446|Oxycodone|oxycodone|mesh-list
5893088|NCT03579446|Hydromorphone|hydromorphone|mesh-list
5893089|NCT03579446|Hydrocodone|hydrocodone|mesh-list
5615373|NCT02115997|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5615374|NCT02115997|Prednisolone phosphate|prednisolone phosphate|mesh-list
5615375|NCT02115997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5615376|NCT02115997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5615377|NCT02115997|Immunologic Factors|immunologic factors|mesh-ancestor
5615378|NCT02115997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5615379|NCT02115997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5615380|NCT02115997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5615381|NCT02115997|Glucocorticoids|glucocorticoids|mesh-ancestor
5615382|NCT02115997|Hormones|hormones|mesh-ancestor
5615383|NCT02115997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5615384|NCT02115997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5615385|NCT02115997|Antiemetics|antiemetics|mesh-ancestor
5615386|NCT02115997|Autonomic Agents|autonomic agents|mesh-ancestor
5893090|NCT03579446|Levorphanol|levorphanol|mesh-list
5893091|NCT03579446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5893092|NCT03579446|Narcotics|narcotics|mesh-ancestor
5893093|NCT03579446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5893094|NCT03579446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893095|NCT03579446|Analgesics|analgesics|mesh-ancestor
5893096|NCT03579446|Sensory System Agents|sensory system agents|mesh-ancestor
5893097|NCT03579446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5893098|NCT03579446|Antitussive Agents|antitussive agents|mesh-ancestor
5893099|NCT03579446|Respiratory System Agents|respiratory system agents|mesh-ancestor
5893100|NCT03579446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5893101|NCT03573700|Cyclophosphamide|cyclophosphamide|mesh-list
5893102|NCT03573700|Fludarabine|fludarabine|mesh-list
5893103|NCT03573700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5893104|NCT03573700|Immunologic Factors|immunologic factors|mesh-ancestor
5615387|NCT02115997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5615388|NCT02115997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5615389|NCT02115997|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5615390|NCT02115997|Protective Agents|protective agents|mesh-ancestor
5893105|NCT03573700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5615391|NCT02079948|Folic Acid|folic acid|mesh-list
5615392|NCT02079948|Vitamin B Complex|vitamin b complex|mesh-list
5615393|NCT02079948|Methotrexate|methotrexate|mesh-list
5615394|NCT02079948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5615395|NCT02079948|Abortifacient Agents|abortifacient agents|mesh-ancestor
5615396|NCT02079948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5615397|NCT02079948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5615398|NCT02079948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5615399|NCT02079948|Antimetabolites|antimetabolites|mesh-ancestor
5615400|NCT02079948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5615401|NCT02079948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5615402|NCT02079948|Dermatologic Agents|dermatologic agents|mesh-ancestor
5615403|NCT02079948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5615404|NCT02079948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5615405|NCT02079948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5615406|NCT02079948|Immunologic Factors|immunologic factors|mesh-ancestor
5615407|NCT02079948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5615408|NCT02079948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5615409|NCT02079948|Hematinics|hematinics|mesh-ancestor
5615410|NCT02079948|Vitamins|vitamins|mesh-ancestor
5615411|NCT02079948|Micronutrients|micronutrients|mesh-ancestor
5734805|NCT03138759|Probenecid|probenecid|mesh-list
5734806|NCT03138759|Uricosuric Agents|uricosuric agents|mesh-ancestor
5734807|NCT03138759|Gout Suppressants|gout suppressants|mesh-ancestor
5734808|NCT03138759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5734809|NCT03138759|Renal Agents|renal agents|mesh-ancestor
5734810|NCT03138603|Metoprolol|metoprolol|mesh-list
5734811|NCT03138603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5734812|NCT03138603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5734813|NCT03138603|Sympatholytics|sympatholytics|mesh-ancestor
5734814|NCT03138603|Autonomic Agents|autonomic agents|mesh-ancestor
5734815|NCT03138603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5734816|NCT03138603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734817|NCT03138603|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5734818|NCT03138603|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5734819|NCT03138603|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5734820|NCT03138603|Adrenergic Agents|adrenergic agents|mesh-ancestor
5734821|NCT03138603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5734822|NCT03138603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5734823|NCT03138681|Phosphocreatine|phosphocreatine|mesh-list
5734824|NCT03138681|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5734825|NCT03138681|Protective Agents|protective agents|mesh-ancestor
5734826|NCT03138681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5615412|NCT02075840|Crizotinib|crizotinib|mesh-list
5615413|NCT02075840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5615414|NCT02075840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5615415|NCT02075840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5615416|NCT02075840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5734827|NCT03138668|Ropivacaine|ropivacaine|mesh-list
5734828|NCT03138668|Anesthetics, Local|anesthetics, local|mesh-ancestor
5734829|NCT03138668|Anesthetics|anesthetics|mesh-ancestor
5734830|NCT03138668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5734831|NCT03138668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734832|NCT03138668|Sensory System Agents|sensory system agents|mesh-ancestor
5734833|NCT03138668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5734834|NCT03138785|Itraconazole|itraconazole|mesh-list
6489210|NCT00590122|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6489211|NCT00590122|Dopamine Agents|dopamine agents|mesh-ancestor
6489212|NCT00590122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6489213|NCT00590122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489214|NCT00590122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489215|NCT00590122|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6489216|NCT00590122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6489217|NCT00590122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6489218|NCT00590122|Immunologic Factors|immunologic factors|mesh-ancestor
6489219|NCT00590122|Dopamine Agonists|dopamine agonists|mesh-ancestor
6489220|NCT00590174|Aspirin|aspirin|mesh-list
6489221|NCT00590174|Clopidogrel|clopidogrel|mesh-list
5615417|NCT02060188|Nivolumab|nivolumab|mesh-list
5615418|NCT02060188|Ipilimumab|ipilimumab|mesh-list
5734835|NCT03138785|Voriconazole|voriconazole|mesh-list
5734836|NCT03138785|Levofloxacin|levofloxacin|mesh-list
5734837|NCT03138785|Ofloxacin|ofloxacin|mesh-list
5734838|NCT03138785|Antifungal Agents|antifungal agents|mesh-ancestor
5734839|NCT03138785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5734840|NCT03138785|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5734841|NCT03138785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5734842|NCT03138785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5734843|NCT03138785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5734844|NCT03138785|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5734845|NCT03138785|Hormone Antagonists|hormone antagonists|mesh-ancestor
5734846|NCT03138785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5734847|NCT03138785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734848|NCT03138785|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5734849|NCT03138785|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5734850|NCT03138785|Renal Agents|renal agents|mesh-ancestor
5734851|NCT03138785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5734852|NCT03138785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5734853|NCT03138785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5734854|NCT03138785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5615419|NCT02060188|Daratumumab|daratumumab|mesh-list
5615420|NCT02060188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5615421|NCT02060188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5615422|NCT02060188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5615423|NCT02060188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5615424|NCT02055053|Bupivacaine|bupivacaine|mesh-list
5615425|NCT02055053|Anesthetics, Local|anesthetics, local|mesh-ancestor
5615426|NCT02055053|Anesthetics|anesthetics|mesh-ancestor
5615427|NCT02055053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5615428|NCT02055053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5615429|NCT02055053|Sensory System Agents|sensory system agents|mesh-ancestor
5615430|NCT02055053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5615431|NCT02034110|Trametinib|trametinib|mesh-list
5615432|NCT02034110|Dabrafenib|dabrafenib|mesh-list
5615433|NCT02034110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5734855|NCT03138785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5734856|NCT03138616|Vitamin D|vitamin d|mesh-list
6672763|NCT01558167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672764|NCT01558193|Vitamins|vitamins|mesh-list
6672765|NCT01558193|Evening primrose oil|evening primrose oil|mesh-list
6672766|NCT01558193|Micronutrients|micronutrients|mesh-ancestor
6672767|NCT01558193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672768|NCT01558193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6672769|NCT01558193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6672770|NCT01558193|Analgesics|analgesics|mesh-ancestor
6672771|NCT01558193|Sensory System Agents|sensory system agents|mesh-ancestor
6672772|NCT01558193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6672773|NCT01558193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6672774|NCT01558193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6672775|NCT01558193|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6672776|NCT01558193|Antimetabolites|antimetabolites|mesh-ancestor
6672777|NCT01558193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672778|NCT01558193|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6672779|NCT01558193|Dermatologic Agents|dermatologic agents|mesh-ancestor
6672780|NCT01558245|Kallikreins|kallikreins|mesh-list
6672781|NCT01558245|Coagulants|coagulants|mesh-ancestor
5734857|NCT03138616|Vitamins|vitamins|mesh-ancestor
5734858|NCT03138616|Micronutrients|micronutrients|mesh-ancestor
5734859|NCT03138616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734860|NCT03138616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5734861|NCT03138499|Nivolumab|nivolumab|mesh-list
5734862|NCT03138499|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5734863|NCT03138499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5734864|NCT03138499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5734865|NCT03138499|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5734866|NCT03138499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5734867|NCT03138447|Insulin|insulin|mesh-list
5734868|NCT03138447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5734869|NCT03138447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734870|NCT03138356|Metformin|metformin|mesh-list
5734871|NCT03138356|Dapagliflozin|dapagliflozin|mesh-list
5734872|NCT03138356|Saxagliptin|saxagliptin|mesh-list
5734873|NCT03138356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5615434|NCT02034110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5615435|NCT02034110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5615436|NCT02034110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5615437|NCT02020707|Paclitaxel|paclitaxel|mesh-list
5615438|NCT02020707|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5615439|NCT02020707|Bevacizumab|bevacizumab|mesh-list
5615440|NCT02020707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5615441|NCT02020707|Endothelial Growth Factors|endothelial growth factors|mesh-list
5615442|NCT02020707|Antibodies|antibodies|mesh-list
5615443|NCT02020707|Immunoglobulins|immunoglobulins|mesh-list
5615444|NCT02020707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5615445|NCT02020707|Immunoglobulin G|immunoglobulin g|mesh-list
5615446|NCT02020707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5615447|NCT02020707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5615448|NCT02020707|Tubulin Modulators|tubulin modulators|mesh-ancestor
5615449|NCT02020707|Antimitotic Agents|antimitotic agents|mesh-ancestor
5615450|NCT02020707|Mitosis Modulators|mitosis modulators|mesh-ancestor
5615451|NCT02020707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5615452|NCT02020707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5615453|NCT02020707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5615454|NCT02020707|Growth Substances|growth substances|mesh-ancestor
5615455|NCT02020707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5615456|NCT02020707|Growth Inhibitors|growth inhibitors|mesh-ancestor
5615457|NCT02020707|Immunologic Factors|immunologic factors|mesh-ancestor
5615458|NCT02004275|Dexamethasone|dexamethasone|mesh-list
5615459|NCT02004275|Pomalidomide|pomalidomide|mesh-list
5615460|NCT02004275|Ixazomib|ixazomib|mesh-list
5615461|NCT02004275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5615462|NCT02004275|Antiemetics|antiemetics|mesh-ancestor
5734874|NCT03138356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734875|NCT03138356|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5734876|NCT03138356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5734877|NCT03138356|Incretins|incretins|mesh-ancestor
5734878|NCT03138356|Hormones|hormones|mesh-ancestor
5734879|NCT03138356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5734880|NCT03138356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5734881|NCT03138356|Protease Inhibitors|protease inhibitors|mesh-ancestor
5734882|NCT03138356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5734883|NCT03138252|Oxytocin|oxytocin|mesh-list
5734884|NCT03138252|Oxytocics|oxytocics|mesh-ancestor
5734885|NCT03138252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5734886|NCT03138252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734887|NCT03138239|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5734888|NCT03138239|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5734889|NCT03138239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5734890|NCT03138161|Nivolumab|nivolumab|mesh-list
5734891|NCT03138161|Ipilimumab|ipilimumab|mesh-list
5734892|NCT03138161|Trabectedin|trabectedin|mesh-list
5734893|NCT03138161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5734894|NCT03138161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5615463|NCT02004275|Autonomic Agents|autonomic agents|mesh-ancestor
5615464|NCT02004275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5615465|NCT02004275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734895|NCT03138161|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5734896|NCT03138161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5734897|NCT03138161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5734898|NCT03138161|Alkylating Agents|alkylating agents|mesh-ancestor
5734899|NCT03138031|Ethanol|ethanol|mesh-list
5734900|NCT03138031|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5734901|NCT03138031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5615466|NCT02004275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5615467|NCT02004275|Glucocorticoids|glucocorticoids|mesh-ancestor
5615468|NCT02004275|Hormones|hormones|mesh-ancestor
5615469|NCT02004275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5615470|NCT02004275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5615471|NCT02004275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5615472|NCT02004275|Immunologic Factors|immunologic factors|mesh-ancestor
5615473|NCT02004275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5615474|NCT02004275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5734902|NCT03138031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5734903|NCT03138031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734904|NCT03137927|Vaccines|vaccines|mesh-list
5734905|NCT03137927|Immunologic Factors|immunologic factors|mesh-ancestor
5734906|NCT03137927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734907|NCT03137966|Deferoxamine|deferoxamine|mesh-list
5734908|NCT03137966|Siderophores|siderophores|mesh-ancestor
5734909|NCT03137966|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5734910|NCT03137966|Chelating Agents|chelating agents|mesh-ancestor
5734911|NCT03137966|Sequestering Agents|sequestering agents|mesh-ancestor
5615475|NCT02004275|Growth Substances|growth substances|mesh-ancestor
5615476|NCT02004275|Growth Inhibitors|growth inhibitors|mesh-ancestor
5615477|NCT02004275|Protease Inhibitors|protease inhibitors|mesh-ancestor
5615478|NCT02004275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5615479|NCT02004275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5615480|NCT01978938|Levofloxacin|levofloxacin|mesh-list
5615481|NCT01978938|Ofloxacin|ofloxacin|mesh-list
5615482|NCT01978938|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5615483|NCT01978938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5615484|NCT01978938|Renal Agents|renal agents|mesh-ancestor
5615485|NCT01978938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5615486|NCT01978938|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5615487|NCT01978938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5615488|NCT01978938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5615489|NCT01978938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5615490|NCT01978938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5615491|NCT01978938|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5615492|NCT01978938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5615493|NCT01976065|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5615494|NCT01976065|Metronidazole|metronidazole|mesh-list
5615495|NCT01976065|Ciprofloxacin|ciprofloxacin|mesh-list
5615496|NCT01976065|Minocycline|minocycline|mesh-list
5615497|NCT01976065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5615498|NCT01976065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5615499|NCT01976065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5615500|NCT01976065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5615501|NCT01976065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5615502|NCT01976065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5615503|NCT01976065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5615504|NCT01976065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5615505|NCT01976065|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5615506|NCT01976065|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5615507|NCT01878669|Acetylcysteine|acetylcysteine|mesh-list
5615508|NCT01878669|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5615509|NCT01878669|Antiviral Agents|antiviral agents|mesh-ancestor
5615510|NCT01878669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5615511|NCT01878669|Expectorants|expectorants|mesh-ancestor
5734912|NCT03137966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5734913|NCT03137667|Vaccines|vaccines|mesh-list
5734914|NCT03137667|Immunologic Factors|immunologic factors|mesh-ancestor
5734915|NCT03137667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734916|NCT03137615|Anesthetics|anesthetics|mesh-list
5734917|NCT03137615|Anesthetics, Local|anesthetics, local|mesh-list
5734918|NCT03137615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5734919|NCT03137615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734920|NCT03137615|Sensory System Agents|sensory system agents|mesh-ancestor
5734921|NCT03137615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5734922|NCT03137498|Ketorolac|ketorolac|mesh-list
5734923|NCT03137498|Lidocaine|lidocaine|mesh-list
5734924|NCT03137498|Prilocaine|prilocaine|mesh-list
5734925|NCT03137498|Anesthetics, Local|anesthetics, local|mesh-ancestor
6489222|NCT00590174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5734926|NCT03137498|Anesthetics|anesthetics|mesh-ancestor
5615512|NCT01878669|Respiratory System Agents|respiratory system agents|mesh-ancestor
5615513|NCT01878669|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5615514|NCT01878669|Antioxidants|antioxidants|mesh-ancestor
5615515|NCT01878669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5615516|NCT01878669|Protective Agents|protective agents|mesh-ancestor
5615517|NCT01878669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5615518|NCT01878669|Antidotes|antidotes|mesh-ancestor
5615519|NCT01878617|Gemcitabine|gemcitabine|mesh-list
5615520|NCT01878617|Cyclophosphamide|cyclophosphamide|mesh-list
5615521|NCT01878617|Vincristine|vincristine|mesh-list
5615522|NCT01878617|Pemetrexed|pemetrexed|mesh-list
5734927|NCT03137498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5734928|NCT03137498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734929|NCT03137498|Sensory System Agents|sensory system agents|mesh-ancestor
5734930|NCT03137498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5734931|NCT03137498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5734932|NCT03137498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5734933|NCT03137498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5734934|NCT03137498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5734935|NCT03137498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5734936|NCT03137498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5734937|NCT03137498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5734938|NCT03137498|Analgesics|analgesics|mesh-ancestor
5734939|NCT03137498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5615523|NCT01878617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5734940|NCT03137498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5734941|NCT03137498|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5734942|NCT03137498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5734943|NCT03137160|Ixekizumab|ixekizumab|mesh-list
5734944|NCT03137160|Dermatologic Agents|dermatologic agents|mesh-ancestor
5893106|NCT03573700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5893107|NCT03573700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5893108|NCT03573700|Alkylating Agents|alkylating agents|mesh-ancestor
5893109|NCT03573700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893110|NCT03573700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5893111|NCT03573700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5893112|NCT03534284|Trazodone|trazodone|mesh-list
5893113|NCT03534284|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5893114|NCT03534284|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5893115|NCT03534284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5893116|NCT03534284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893117|NCT03534284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5893118|NCT03534284|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5893119|NCT03534284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5893120|NCT03534284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5893121|NCT03534284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893122|NCT03534284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5893123|NCT03534284|Serotonin Agents|serotonin agents|mesh-ancestor
5893124|NCT03534284|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5893125|NCT03534284|Antidepressive Agents|antidepressive agents|mesh-ancestor
5893126|NCT03533257|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
5893127|NCT03533257|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
5893128|NCT03533257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5893129|NCT03533257|Antiviral Agents|antiviral agents|mesh-ancestor
5893130|NCT03533257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5893131|NCT03533257|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5893132|NCT03533257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5893133|NCT03525873|Methylphenidate|methylphenidate|mesh-list
5893134|NCT03525873|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5893135|NCT03525873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893136|NCT03525873|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5893137|NCT03525873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5893138|NCT03525873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5893139|NCT03525873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893140|NCT03525873|Dopamine Agents|dopamine agents|mesh-ancestor
5893141|NCT03525873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5893142|NCT03463408|Nivolumab|nivolumab|mesh-list
5893143|NCT03463408|Ipilimumab|ipilimumab|mesh-list
5893144|NCT03463408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5893145|NCT03463408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5893146|NCT03463408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5893147|NCT03463408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893148|NCT03460158|Hyaluronic Acid|hyaluronic acid|mesh-list
5893149|NCT03460158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5893150|NCT03460158|Immunologic Factors|immunologic factors|mesh-ancestor
5893151|NCT03460158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893152|NCT03460158|Viscosupplements|viscosupplements|mesh-ancestor
5893153|NCT03460158|Protective Agents|protective agents|mesh-ancestor
5893154|NCT03246347|Docetaxel|docetaxel|mesh-list
5893155|NCT03246347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5893156|NCT03246347|Tubulin Modulators|tubulin modulators|mesh-ancestor
5893157|NCT03246347|Antimitotic Agents|antimitotic agents|mesh-ancestor
5893158|NCT03246347|Mitosis Modulators|mitosis modulators|mesh-ancestor
5893159|NCT03246347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893160|NCT03178149|Tacrolimus|tacrolimus|mesh-list
5893161|NCT03178149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5893162|NCT03178149|Immunologic Factors|immunologic factors|mesh-ancestor
5907736|NCT05211323|Gemcitabine|gemcitabine|mesh-list
5615524|NCT01878617|Immunologic Factors|immunologic factors|mesh-ancestor
5615525|NCT01878617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5615526|NCT01878617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5615527|NCT01878617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5615528|NCT01878617|Alkylating Agents|alkylating agents|mesh-ancestor
5615529|NCT01878617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5615530|NCT01878617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5615531|NCT01878617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5615532|NCT01878617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5615533|NCT01878617|Antimetabolites|antimetabolites|mesh-ancestor
5615534|NCT01878617|Antiviral Agents|antiviral agents|mesh-ancestor
5615535|NCT01878617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5615536|NCT01878617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5734945|NCT03137316|Hormones|hormones|mesh-list
5734946|NCT03137316|Parathyroid Hormone|parathyroid hormone|mesh-list
5734947|NCT03137316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5734948|NCT03137316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734949|NCT03137316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5734950|NCT03137134|Crizotinib|crizotinib|mesh-list
5734951|NCT03137134|Esomeprazole|esomeprazole|mesh-list
5734952|NCT03137134|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5734953|NCT03137134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5734954|NCT03137134|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5734955|NCT03137134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5734956|NCT03137134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5734957|NCT03137134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5734958|NCT03137134|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5734959|NCT03137368|Tamoxifen|tamoxifen|mesh-list
5734960|NCT03137368|Exemestane|exemestane|mesh-list
5615537|NCT01878617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5615538|NCT01878617|Tubulin Modulators|tubulin modulators|mesh-ancestor
5615539|NCT01878617|Antimitotic Agents|antimitotic agents|mesh-ancestor
5615540|NCT01878617|Mitosis Modulators|mitosis modulators|mesh-ancestor
5615541|NCT01878617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5615542|NCT01878617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5615543|NCT01854385|Sumatriptan|sumatriptan|mesh-list
5615544|NCT01854385|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5615545|NCT01854385|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5615546|NCT01854385|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5615547|NCT01854385|Serotonin Agents|serotonin agents|mesh-ancestor
5615548|NCT01854385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5615549|NCT01854385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5615550|NCT01854385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5615551|NCT01844856|Ertapenem|ertapenem|mesh-list
5615552|NCT01844856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5615553|NCT01844856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5734961|NCT03137368|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5734962|NCT03137368|Hormone Antagonists|hormone antagonists|mesh-ancestor
5734963|NCT03137368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5734964|NCT03137368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734965|NCT03137368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5734966|NCT03137368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5734967|NCT03137368|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5734968|NCT03137368|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5734969|NCT03137368|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5734970|NCT03137368|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5734971|NCT03137368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5734972|NCT03137368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5734973|NCT03137368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5734974|NCT03137290|Neostigmine|neostigmine|mesh-list
5734975|NCT03137290|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5734976|NCT03137290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5734977|NCT03137290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5734978|NCT03137290|Cholinergic Agents|cholinergic agents|mesh-ancestor
5734979|NCT03137290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5734980|NCT03137290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734981|NCT03137290|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5734982|NCT03137290|Autonomic Agents|autonomic agents|mesh-ancestor
5734983|NCT03137290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5734984|NCT03137186|Metformin|metformin|mesh-list
5734985|NCT03137186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5734986|NCT03137186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734987|NCT03137030|Acetaminophen|acetaminophen|mesh-list
5734988|NCT03137030|Hydrocodone|hydrocodone|mesh-list
5734989|NCT03137030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5734990|NCT03137030|Analgesics|analgesics|mesh-ancestor
5734991|NCT03137030|Sensory System Agents|sensory system agents|mesh-ancestor
5734992|NCT03137030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5734993|NCT03137030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5734994|NCT03137030|Antipyretics|antipyretics|mesh-ancestor
5734995|NCT03137030|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5734996|NCT03137030|Narcotics|narcotics|mesh-ancestor
5734997|NCT03137030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5734998|NCT03137030|Antitussive Agents|antitussive agents|mesh-ancestor
5734999|NCT03137030|Respiratory System Agents|respiratory system agents|mesh-ancestor
5735000|NCT03137017|Acetaminophen|acetaminophen|mesh-list
5615554|NCT01817166|Vitamin D|vitamin d|mesh-list
5615555|NCT01817166|Cholecalciferol|cholecalciferol|mesh-list
5615556|NCT01817166|Vitamins|vitamins|mesh-ancestor
5615557|NCT01817166|Micronutrients|micronutrients|mesh-ancestor
5615558|NCT01817166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5615559|NCT01817166|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5615560|NCT01817166|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5735001|NCT03137017|Hydrocodone|hydrocodone|mesh-list
5735002|NCT03137017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5735003|NCT03137017|Analgesics|analgesics|mesh-ancestor
5735004|NCT03137017|Sensory System Agents|sensory system agents|mesh-ancestor
5735005|NCT03137017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5735006|NCT03137017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735007|NCT03137017|Antipyretics|antipyretics|mesh-ancestor
5735008|NCT03137017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5735009|NCT03137017|Narcotics|narcotics|mesh-ancestor
5735010|NCT03137017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5735011|NCT03137017|Antitussive Agents|antitussive agents|mesh-ancestor
5735012|NCT03137017|Respiratory System Agents|respiratory system agents|mesh-ancestor
5735013|NCT03137082|Guanfacine|guanfacine|mesh-list
5735014|NCT03137082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5735015|NCT03137082|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5735016|NCT03137082|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5735017|NCT03137082|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5735018|NCT03137082|Adrenergic Agents|adrenergic agents|mesh-ancestor
5735019|NCT03137082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5735020|NCT03137082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5735021|NCT03137082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735022|NCT03137004|Docetaxel|docetaxel|mesh-list
5735023|NCT03137004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5735024|NCT03137004|Tubulin Modulators|tubulin modulators|mesh-ancestor
5735025|NCT03137004|Antimitotic Agents|antimitotic agents|mesh-ancestor
5615561|NCT01783535|Cyclophosphamide|cyclophosphamide|mesh-list
5615562|NCT01783535|Carboplatin|carboplatin|mesh-list
5615563|NCT01783535|Doxorubicin|doxorubicin|mesh-list
5615564|NCT01783535|Etoposide|etoposide|mesh-list
5735026|NCT03137004|Mitosis Modulators|mitosis modulators|mesh-ancestor
5735027|NCT03137004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5735028|NCT03136666|Candesartan|candesartan|mesh-list
5735029|NCT03136666|Candesartan cilexetil|candesartan cilexetil|mesh-list
5735030|NCT03136666|Nifedipine|nifedipine|mesh-list
5735031|NCT03136666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5735032|NCT03136666|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5735033|NCT03136666|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5735034|NCT03136666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5735035|NCT03136666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5735036|NCT03136666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5735037|NCT03136666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5735038|NCT03136666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735039|NCT03136666|Vasodilator Agents|vasodilator agents|mesh-ancestor
5735040|NCT03136666|Tocolytic Agents|tocolytic agents|mesh-ancestor
5735041|NCT03136666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5735042|NCT03136705|Niacinamide|niacinamide|mesh-list
5735043|NCT03136705|Niacin|niacin|mesh-list
5735044|NCT03136705|Nicotinic Acids|nicotinic acids|mesh-list
5735045|NCT03136705|Vitamin B Complex|vitamin b complex|mesh-ancestor
5735046|NCT03136705|Vitamins|vitamins|mesh-ancestor
5735047|NCT03136705|Micronutrients|micronutrients|mesh-ancestor
5735048|NCT03136705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735049|NCT03136705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5735050|NCT03136705|Antimetabolites|antimetabolites|mesh-ancestor
5735051|NCT03136705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5735052|NCT03136705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5735053|NCT03136705|Vasodilator Agents|vasodilator agents|mesh-ancestor
5735054|NCT03136796|Meropenem|meropenem|mesh-list
5735055|NCT03136796|Piperacillin|piperacillin|mesh-list
5735056|NCT03136796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5735057|NCT03136796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5735058|NCT03136510|Apixaban|apixaban|mesh-list
5735059|NCT03136510|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5735060|NCT03136510|Antithrombins|antithrombins|mesh-ancestor
5735061|NCT03136510|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5735062|NCT03136510|Protease Inhibitors|protease inhibitors|mesh-ancestor
5735063|NCT03136510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5615565|NCT01783535|Vincristine|vincristine|mesh-list
5735064|NCT03136510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5735065|NCT03136510|Anticoagulants|anticoagulants|mesh-ancestor
5615566|NCT01783535|Topotecan|topotecan|mesh-list
5735066|NCT03136341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5735067|NCT03136341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5735068|NCT03136341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5735069|NCT03136341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5735070|NCT03136341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5735071|NCT03136341|Cholinergic Agents|cholinergic agents|mesh-ancestor
5735072|NCT03136341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5735073|NCT03136341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735074|NCT03136341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5735075|NCT03136341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5735076|NCT03136445|Tranexamic Acid|tranexamic acid|mesh-list
5735077|NCT03136445|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5735078|NCT03136445|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5735079|NCT03136445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5735080|NCT03136445|Hemostatics|hemostatics|mesh-ancestor
5735081|NCT03136445|Coagulants|coagulants|mesh-ancestor
5735082|NCT03136237|Cyclosporine|cyclosporine|mesh-list
5735083|NCT03136237|Digoxin|digoxin|mesh-list
5735084|NCT03136237|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5735085|NCT03136237|Cyclosporins|cyclosporins|mesh-list
5735086|NCT03136237|Berotralstat|berotralstat|mesh-list
5615567|NCT01783535|Lenograstim|lenograstim|mesh-list
5615568|NCT01783535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5735087|NCT03136237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6208552|NCT02132468|Combretastatin|combretastatin|mesh-list
6208553|NCT02132468|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6208554|NCT02132468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6208555|NCT02132468|Tubulin Modulators|tubulin modulators|mesh-ancestor
6208556|NCT02132468|Antimitotic Agents|antimitotic agents|mesh-ancestor
6208557|NCT02132468|Mitosis Modulators|mitosis modulators|mesh-ancestor
6208558|NCT02132468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208559|NCT02132533|Nifedipine|nifedipine|mesh-list
6208560|NCT02132533|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6208561|NCT02132533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6489223|NCT00590174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5735088|NCT03136237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5615569|NCT01783535|Immunologic Factors|immunologic factors|mesh-ancestor
5615570|NCT01783535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5615571|NCT01783535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5615572|NCT01783535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5615573|NCT01783535|Alkylating Agents|alkylating agents|mesh-ancestor
5615574|NCT01783535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5615575|NCT01783535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5735089|NCT03136237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5735090|NCT03136237|Immunologic Factors|immunologic factors|mesh-ancestor
5735091|NCT03136237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735092|NCT03136237|Antifungal Agents|antifungal agents|mesh-ancestor
5735093|NCT03136237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5735094|NCT03136237|Dermatologic Agents|dermatologic agents|mesh-ancestor
5735095|NCT03136237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6489224|NCT00590174|Analgesics|analgesics|mesh-ancestor
6489225|NCT00590174|Sensory System Agents|sensory system agents|mesh-ancestor
6489226|NCT00590174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6489227|NCT00590174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489228|NCT00590174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6489229|NCT00590174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6489230|NCT00590174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5615576|NCT01783535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6489231|NCT00590174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5735096|NCT03136237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5735097|NCT03136237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5735098|NCT03136237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5735099|NCT03136237|Antimetabolites|antimetabolites|mesh-ancestor
5735100|NCT03136237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5735101|NCT03136237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5735102|NCT03136237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5735103|NCT03136237|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5735104|NCT03136237|Protective Agents|protective agents|mesh-ancestor
5735105|NCT03136406|Leucovorin|leucovorin|mesh-list
5735106|NCT03136406|Paclitaxel|paclitaxel|mesh-list
5735107|NCT03136406|Cyclophosphamide|cyclophosphamide|mesh-list
5735108|NCT03136406|Bevacizumab|bevacizumab|mesh-list
5735109|NCT03136406|Fluorouracil|fluorouracil|mesh-list
5735110|NCT03136406|Capecitabine|capecitabine|mesh-list
5735111|NCT03136406|Oxaliplatin|oxaliplatin|mesh-list
5735112|NCT03136406|Avelumab|avelumab|mesh-list
5615577|NCT01783535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5615578|NCT01783535|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5615579|NCT01783535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5615580|NCT01783535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5615581|NCT01783535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5615582|NCT01783535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5615583|NCT01783535|Tubulin Modulators|tubulin modulators|mesh-ancestor
5615584|NCT01783535|Antimitotic Agents|antimitotic agents|mesh-ancestor
5615585|NCT01783535|Mitosis Modulators|mitosis modulators|mesh-ancestor
5615586|NCT01783535|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5615587|NCT01726452|Leucovorin|leucovorin|mesh-list
5615588|NCT01726452|Paclitaxel|paclitaxel|mesh-list
5615589|NCT01726452|Docetaxel|docetaxel|mesh-list
5615590|NCT01726452|Carboplatin|carboplatin|mesh-list
5615591|NCT01726452|Fluorouracil|fluorouracil|mesh-list
5735113|NCT03136406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5735114|NCT03136406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5735115|NCT03136406|Tubulin Modulators|tubulin modulators|mesh-ancestor
5735116|NCT03136406|Antimitotic Agents|antimitotic agents|mesh-ancestor
5735117|NCT03136406|Mitosis Modulators|mitosis modulators|mesh-ancestor
5735118|NCT03136406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5735119|NCT03136406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5735120|NCT03136406|Immunologic Factors|immunologic factors|mesh-ancestor
5735121|NCT03136406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735122|NCT03136406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5735123|NCT03136406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5615592|NCT01726452|Capecitabine|capecitabine|mesh-list
5615593|NCT01726452|Oxaliplatin|oxaliplatin|mesh-list
5615594|NCT01726452|Epirubicin|epirubicin|mesh-list
5615595|NCT01726452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5615596|NCT01726452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5615597|NCT01726452|Tubulin Modulators|tubulin modulators|mesh-ancestor
5615598|NCT01726452|Antimitotic Agents|antimitotic agents|mesh-ancestor
5615599|NCT01726452|Mitosis Modulators|mitosis modulators|mesh-ancestor
5615600|NCT01726452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5615601|NCT01726452|Antimetabolites|antimetabolites|mesh-ancestor
5615602|NCT01726452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5615603|NCT01726452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5735124|NCT03136406|Alkylating Agents|alkylating agents|mesh-ancestor
5735125|NCT03136406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5735126|NCT03136406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5735127|NCT03136406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5735128|NCT03136406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5735129|NCT03136406|Growth Substances|growth substances|mesh-ancestor
5735130|NCT03136406|Growth Inhibitors|growth inhibitors|mesh-ancestor
5735131|NCT03136406|Antimetabolites|antimetabolites|mesh-ancestor
5735132|NCT03136406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5735133|NCT03136406|Antidotes|antidotes|mesh-ancestor
5735134|NCT03136406|Protective Agents|protective agents|mesh-ancestor
5735135|NCT03136406|Vitamin B Complex|vitamin b complex|mesh-ancestor
5735136|NCT03136406|Vitamins|vitamins|mesh-ancestor
5735137|NCT03136406|Micronutrients|micronutrients|mesh-ancestor
5735138|NCT03136146|Dexamethasone|dexamethasone|mesh-list
5735139|NCT03136146|Dexamethasone acetate|dexamethasone acetate|mesh-list
5735140|NCT03136146|Cyclophosphamide|cyclophosphamide|mesh-list
5735141|NCT03136146|Rituximab|rituximab|mesh-list
5615604|NCT01726452|Immunologic Factors|immunologic factors|mesh-ancestor
5735142|NCT03136146|Etoposide|etoposide|mesh-list
5735143|NCT03136146|Vincristine|vincristine|mesh-list
5735144|NCT03136146|Bortezomib|bortezomib|mesh-list
5735145|NCT03136146|Etoposide phosphate|etoposide phosphate|mesh-list
5735146|NCT03136146|Clofarabine|clofarabine|mesh-list
5735147|NCT03136146|Ofatumumab|ofatumumab|mesh-list
5615605|NCT01726452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5615606|NCT01726452|Antidotes|antidotes|mesh-ancestor
5615607|NCT01726452|Protective Agents|protective agents|mesh-ancestor
5615608|NCT01726452|Vitamin B Complex|vitamin b complex|mesh-ancestor
5615609|NCT01726452|Vitamins|vitamins|mesh-ancestor
5615610|NCT01726452|Micronutrients|micronutrients|mesh-ancestor
5615611|NCT01726452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5615612|NCT01726452|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5615613|NCT01726452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5615614|NCT01726452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5615615|NCT01712789|Dexamethasone|dexamethasone|mesh-list
5615616|NCT01712789|Pomalidomide|pomalidomide|mesh-list
5615617|NCT01712789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5615618|NCT01712789|Antiemetics|antiemetics|mesh-ancestor
5615619|NCT01712789|Autonomic Agents|autonomic agents|mesh-ancestor
5615620|NCT01712789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5615621|NCT01712789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5615622|NCT01712789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5615623|NCT01712789|Glucocorticoids|glucocorticoids|mesh-ancestor
5615624|NCT01712789|Hormones|hormones|mesh-ancestor
5735148|NCT03136146|Podophyllotoxin|podophyllotoxin|mesh-list
5735149|NCT03136146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5735150|NCT03136146|Antibodies|antibodies|mesh-list
5735151|NCT03136146|Immunoglobulins|immunoglobulins|mesh-list
5735152|NCT03136146|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5735153|NCT03136146|Lenograstim|lenograstim|mesh-list
5735154|NCT03136146|BB 1101|bb 1101|mesh-list
5735155|NCT03136146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5735156|NCT03136146|Immunologic Factors|immunologic factors|mesh-ancestor
5735157|NCT03136146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735158|NCT03136146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5735159|NCT03136146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5735160|NCT03136146|Alkylating Agents|alkylating agents|mesh-ancestor
5735161|NCT03136146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5735162|NCT03136146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5735163|NCT03136146|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5735164|NCT03136146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5735165|NCT03136146|Antiemetics|antiemetics|mesh-ancestor
5735166|NCT03136146|Autonomic Agents|autonomic agents|mesh-ancestor
5615625|NCT01712789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5615626|NCT01712789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5615627|NCT01712789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5615628|NCT01712789|Immunologic Factors|immunologic factors|mesh-ancestor
5615629|NCT01712789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5615630|NCT01712789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5615631|NCT01712789|Growth Substances|growth substances|mesh-ancestor
5615632|NCT01712789|Growth Inhibitors|growth inhibitors|mesh-ancestor
5615633|NCT01665794|Dexamethasone|dexamethasone|mesh-list
5615634|NCT01665794|Daratumumab|daratumumab|mesh-list
5615635|NCT01665794|Pomalidomide|pomalidomide|mesh-list
5615636|NCT01665794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5615637|NCT01665794|Antiemetics|antiemetics|mesh-ancestor
5615638|NCT01665794|Autonomic Agents|autonomic agents|mesh-ancestor
5615639|NCT01665794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5615640|NCT01665794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5615641|NCT01665794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5735167|NCT03136146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5735168|NCT03136146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5735169|NCT03136146|Glucocorticoids|glucocorticoids|mesh-ancestor
5735170|NCT03136146|Hormones|hormones|mesh-ancestor
5735171|NCT03136146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5735172|NCT03136146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5735173|NCT03136146|Protease Inhibitors|protease inhibitors|mesh-ancestor
5735174|NCT03136146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5735175|NCT03136146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5735176|NCT03136146|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5735177|NCT03136146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5735178|NCT03136146|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5735179|NCT03136146|Tubulin Modulators|tubulin modulators|mesh-ancestor
5615642|NCT01665794|Glucocorticoids|glucocorticoids|mesh-ancestor
5615643|NCT01665794|Hormones|hormones|mesh-ancestor
5615644|NCT01665794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5615645|NCT01665794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5735180|NCT03136146|Antimitotic Agents|antimitotic agents|mesh-ancestor
5735181|NCT03136146|Mitosis Modulators|mitosis modulators|mesh-ancestor
5615646|NCT01665794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5615647|NCT01665794|Immunologic Factors|immunologic factors|mesh-ancestor
5735182|NCT03136146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5735183|NCT03136146|Antimetabolites|antimetabolites|mesh-ancestor
5735184|NCT03136146|Keratolytic Agents|keratolytic agents|mesh-ancestor
5735185|NCT03136146|Dermatologic Agents|dermatologic agents|mesh-ancestor
5735186|NCT03135977|Etoposide|etoposide|mesh-list
5735187|NCT03135977|Apatinib|apatinib|mesh-list
5615648|NCT01665794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5615649|NCT01665794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5615650|NCT01665794|Growth Substances|growth substances|mesh-ancestor
5615651|NCT01665794|Growth Inhibitors|growth inhibitors|mesh-ancestor
5615652|NCT01651403|Tenofovir|tenofovir|mesh-list
5615653|NCT01651403|Antiviral Agents|antiviral agents|mesh-ancestor
5615654|NCT01651403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5615655|NCT01651403|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5615656|NCT01651403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5615657|NCT01651403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5615658|NCT01651403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5615659|NCT01651403|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5615660|NCT01651403|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5615661|NCT01560572|Mycophenolic Acid|mycophenolic acid|mesh-list
5615662|NCT01560572|Prednisolone|prednisolone|mesh-list
5615663|NCT01560572|Tacrolimus|tacrolimus|mesh-list
5615664|NCT01560572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5615665|NCT01560572|Immunologic Factors|immunologic factors|mesh-ancestor
5615666|NCT01560572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5615667|NCT01560572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5615668|NCT01560572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5615669|NCT01560572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5615670|NCT01560572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5615671|NCT01560572|Glucocorticoids|glucocorticoids|mesh-ancestor
5615672|NCT01560572|Hormones|hormones|mesh-ancestor
5615673|NCT01560572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5615674|NCT01560572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5615675|NCT01560572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5615676|NCT01560572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5615677|NCT01560572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5615678|NCT01560572|Antitubercular Agents|antitubercular agents|mesh-ancestor
5615679|NCT01560572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5615680|NCT01560572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5615681|NCT01543633|Propofol|propofol|mesh-list
5615682|NCT01543633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5615683|NCT01543633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5615684|NCT01543633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5615685|NCT01543633|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5615686|NCT01543633|Anesthetics, General|anesthetics, general|mesh-ancestor
5615687|NCT01543633|Anesthetics|anesthetics|mesh-ancestor
5615688|NCT01542736|Carboplatin|carboplatin|mesh-list
5615689|NCT01542736|Vincristine|vincristine|mesh-list
5615690|NCT01542736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5615691|NCT01542736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5615692|NCT01542736|Tubulin Modulators|tubulin modulators|mesh-ancestor
5615693|NCT01542736|Antimitotic Agents|antimitotic agents|mesh-ancestor
5615694|NCT01542736|Mitosis Modulators|mitosis modulators|mesh-ancestor
5615695|NCT01542736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692173|NCT03411330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5692174|NCT03411330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5692175|NCT03411330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692176|NCT03411252|Mirabegron|mirabegron|mesh-list
5735188|NCT03135977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5735189|NCT03135977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5735190|NCT03135977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5735191|NCT03135977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5735192|NCT03135977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5735193|NCT03135977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5735194|NCT03135977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5735195|NCT03136029|Antioxidants|antioxidants|mesh-list
5735196|NCT03136029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5735197|NCT03136029|Protective Agents|protective agents|mesh-ancestor
5735198|NCT03136029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735199|NCT03135912|Terbinafine|terbinafine|mesh-list
5735200|NCT03135912|Antifungal Agents|antifungal agents|mesh-ancestor
5735201|NCT03135912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5735202|NCT03135912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5907737|NCT05211323|Bevacizumab|bevacizumab|mesh-list
5692177|NCT03411252|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
5615696|NCT01481974|Treprostinil|treprostinil|mesh-list
5615697|NCT01481974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5615698|NCT01465100|Liver Extracts|liver extracts|mesh-list
5615699|NCT01465100|Hematinics|hematinics|mesh-ancestor
5615700|NCT01442649|Leucovorin|leucovorin|mesh-list
5615701|NCT01442649|Folic Acid|folic acid|mesh-list
5615702|NCT01442649|Bevacizumab|bevacizumab|mesh-list
5615703|NCT01442649|Cetuximab|cetuximab|mesh-list
5615704|NCT01442649|Oxaliplatin|oxaliplatin|mesh-list
5615705|NCT01442649|Irinotecan|irinotecan|mesh-list
5615706|NCT01442649|Fluorouracil|fluorouracil|mesh-list
5615707|NCT01442649|Levoleucovorin|levoleucovorin|mesh-list
5615708|NCT01442649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5615709|NCT01442649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5615710|NCT01442649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5615711|NCT01442649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5615712|NCT01442649|Growth Substances|growth substances|mesh-ancestor
5615713|NCT01442649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5615714|NCT01442649|Growth Inhibitors|growth inhibitors|mesh-ancestor
5615715|NCT01442649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5615716|NCT01442649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5615717|NCT01442649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5615718|NCT01442649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5615719|NCT01442649|Antidotes|antidotes|mesh-ancestor
5615720|NCT01442649|Protective Agents|protective agents|mesh-ancestor
5615721|NCT01442649|Vitamin B Complex|vitamin b complex|mesh-ancestor
5615722|NCT01442649|Vitamins|vitamins|mesh-ancestor
5615723|NCT01442649|Micronutrients|micronutrients|mesh-ancestor
5615724|NCT01442649|Hematinics|hematinics|mesh-ancestor
5615725|NCT01442649|Antimetabolites|antimetabolites|mesh-ancestor
5615726|NCT01442649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5615727|NCT01442649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5615728|NCT01442649|Immunologic Factors|immunologic factors|mesh-ancestor
5615729|NCT01147666|Epoetin Alfa|epoetin alfa|mesh-list
5615730|NCT01147666|Hematinics|hematinics|mesh-ancestor
5615731|NCT01065454|Riociguat|riociguat|mesh-list
5615732|NCT01065454|Enzyme Activators|enzyme activators|mesh-ancestor
5615733|NCT01065454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5615734|NCT00982111|Pemetrexed|pemetrexed|mesh-list
5615735|NCT00982111|Necitumumab|necitumumab|mesh-list
5615736|NCT00982111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5615737|NCT00982111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5615738|NCT00982111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5615739|NCT00982111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5615740|NCT00982111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5615741|NCT00982111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5615742|NCT00773695|Paclitaxel|paclitaxel|mesh-list
5615743|NCT00773695|Docetaxel|docetaxel|mesh-list
5615744|NCT00773695|Cyclophosphamide|cyclophosphamide|mesh-list
5615745|NCT00773695|Bevacizumab|bevacizumab|mesh-list
5615746|NCT00773695|Fluorouracil|fluorouracil|mesh-list
5735203|NCT03135912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5735204|NCT03136003|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
5735205|NCT03136003|Hemostatics|hemostatics|mesh-ancestor
5735206|NCT03136003|Coagulants|coagulants|mesh-ancestor
5735207|NCT03136003|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5735208|NCT03136003|Natriuretic Agents|natriuretic agents|mesh-ancestor
5735209|NCT03136003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735210|NCT03135795|Parecoxib|parecoxib|mesh-list
5735211|NCT03135795|Sufentanil|sufentanil|mesh-list
5735212|NCT03135795|Dexmedetomidine|dexmedetomidine|mesh-list
5735213|NCT03135795|Remifentanil|remifentanil|mesh-list
5735214|NCT03135795|Dsuvia|dsuvia|mesh-list
5735215|NCT03135795|Bromides|bromides|mesh-list
5735216|NCT03135795|Propofol|propofol|mesh-list
5735217|NCT03135795|Sevoflurane|sevoflurane|mesh-list
5735218|NCT03135795|Citric Acid|citric acid|mesh-list
5735219|NCT03135795|Sodium Citrate|sodium citrate|mesh-list
5735220|NCT03135795|Rocuronium|rocuronium|mesh-list
5735221|NCT03135795|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5735222|NCT03135795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5735223|NCT03135795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735224|NCT03135795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5735225|NCT03135795|Anesthetics, General|anesthetics, general|mesh-ancestor
5615747|NCT00773695|Epirubicin|epirubicin|mesh-list
5615748|NCT00773695|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5615749|NCT00773695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5615750|NCT00773695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5615751|NCT00773695|Tubulin Modulators|tubulin modulators|mesh-ancestor
5615752|NCT00773695|Antimitotic Agents|antimitotic agents|mesh-ancestor
5735226|NCT03135795|Anesthetics|anesthetics|mesh-ancestor
5735227|NCT03135795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5735228|NCT03135795|Analgesics|analgesics|mesh-ancestor
5615753|NCT00773695|Mitosis Modulators|mitosis modulators|mesh-ancestor
5615754|NCT00773695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5615755|NCT00773695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5615756|NCT00773695|Immunologic Factors|immunologic factors|mesh-ancestor
5615757|NCT00773695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5615758|NCT00773695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5615759|NCT00773695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5615760|NCT00773695|Alkylating Agents|alkylating agents|mesh-ancestor
5615761|NCT00773695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5615762|NCT00773695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5735229|NCT03135795|Sensory System Agents|sensory system agents|mesh-ancestor
5735230|NCT03135795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5615763|NCT00773695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5615764|NCT00773695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5615765|NCT00773695|Growth Substances|growth substances|mesh-ancestor
5615766|NCT00773695|Growth Inhibitors|growth inhibitors|mesh-ancestor
5615767|NCT00773695|Antimetabolites|antimetabolites|mesh-ancestor
5615768|NCT00773695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5615769|NCT00773695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5615770|NCT00773695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5615771|NCT00773695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5615772|NCT00773695|Hormone Antagonists|hormone antagonists|mesh-ancestor
5615773|NCT00773695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5615774|NCT00773695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5615775|NCT00773695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5615776|NCT00773695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5615777|NCT00670358|Prednisone|prednisone|mesh-list
5735231|NCT03135795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5735232|NCT03135795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5735233|NCT03135795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5735234|NCT03135795|Adrenergic Agents|adrenergic agents|mesh-ancestor
5735235|NCT03135795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5735236|NCT03135795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5735237|NCT03135795|Anticoagulants|anticoagulants|mesh-ancestor
5735238|NCT03135795|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5735239|NCT03135795|Chelating Agents|chelating agents|mesh-ancestor
5735240|NCT03135795|Sequestering Agents|sequestering agents|mesh-ancestor
5735241|NCT03135795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5735242|NCT03135795|Narcotics|narcotics|mesh-ancestor
5735243|NCT03135795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5735244|NCT03135795|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5735245|NCT03135795|Anticonvulsants|anticonvulsants|mesh-ancestor
6208562|NCT02132533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5615778|NCT00670358|Cyclophosphamide|cyclophosphamide|mesh-list
5615779|NCT00670358|Rituximab|rituximab|mesh-list
5615780|NCT00670358|Doxorubicin|doxorubicin|mesh-list
5615781|NCT00670358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5615782|NCT00670358|Vincristine|vincristine|mesh-list
5615783|NCT00670358|Lenalidomide|lenalidomide|mesh-list
5615784|NCT00670358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5615785|NCT00670358|Immunologic Factors|immunologic factors|mesh-ancestor
5615786|NCT00670358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5615787|NCT00670358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5615788|NCT00670358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5615789|NCT00670358|Alkylating Agents|alkylating agents|mesh-ancestor
5615790|NCT00670358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5615791|NCT00670358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5615792|NCT00670358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5615793|NCT00670358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5615794|NCT00670358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5615795|NCT00670358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5615796|NCT00670358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5615797|NCT00670358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5615798|NCT00670358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5615799|NCT00670358|Glucocorticoids|glucocorticoids|mesh-ancestor
5615800|NCT00670358|Hormones|hormones|mesh-ancestor
5615801|NCT00670358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5615802|NCT00670358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5615803|NCT00670358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5615804|NCT00670358|Tubulin Modulators|tubulin modulators|mesh-ancestor
5615805|NCT00670358|Antimitotic Agents|antimitotic agents|mesh-ancestor
5735246|NCT03135795|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5735247|NCT03135795|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5735248|NCT03135795|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5615806|NCT00670358|Mitosis Modulators|mitosis modulators|mesh-ancestor
5615807|NCT00670358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5615808|NCT00670358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5615809|NCT00670358|Growth Substances|growth substances|mesh-ancestor
5615810|NCT00670358|Growth Inhibitors|growth inhibitors|mesh-ancestor
5615811|NCT00193219|Leucovorin|leucovorin|mesh-list
5615812|NCT00193219|Bevacizumab|bevacizumab|mesh-list
5615813|NCT00193219|Cetuximab|cetuximab|mesh-list
5615814|NCT00193219|Fluorouracil|fluorouracil|mesh-list
5615815|NCT00193219|Oxaliplatin|oxaliplatin|mesh-list
5615816|NCT00193219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5615817|NCT00193219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5615818|NCT00193219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5615819|NCT00193219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5615820|NCT00193219|Growth Substances|growth substances|mesh-ancestor
5615821|NCT00193219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5615822|NCT00193219|Growth Inhibitors|growth inhibitors|mesh-ancestor
5615823|NCT00193219|Antimetabolites|antimetabolites|mesh-ancestor
5615824|NCT00193219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5615825|NCT00193219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5615826|NCT00193219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5615827|NCT00193219|Immunologic Factors|immunologic factors|mesh-ancestor
5615828|NCT00193219|Antidotes|antidotes|mesh-ancestor
5615829|NCT00193219|Protective Agents|protective agents|mesh-ancestor
5615830|NCT00193219|Vitamin B Complex|vitamin b complex|mesh-ancestor
5615831|NCT00193219|Vitamins|vitamins|mesh-ancestor
5615832|NCT00193219|Micronutrients|micronutrients|mesh-ancestor
5615833|NCT00116142|Ascorbic Acid|ascorbic acid|mesh-list
5615834|NCT00116142|Docetaxel|docetaxel|mesh-list
5615835|NCT00116142|Methyltestosterone|methyltestosterone|mesh-list
5615836|NCT00116142|Androgens|androgens|mesh-list
5615837|NCT00116142|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
5615838|NCT00116142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5615839|NCT00116142|Tubulin Modulators|tubulin modulators|mesh-ancestor
5615840|NCT00116142|Antimitotic Agents|antimitotic agents|mesh-ancestor
5615841|NCT00116142|Mitosis Modulators|mitosis modulators|mesh-ancestor
5615842|NCT00116142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5615843|NCT00116142|Hormones|hormones|mesh-ancestor
5615844|NCT00116142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5615845|NCT00116142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5615846|NCT00116142|Antioxidants|antioxidants|mesh-ancestor
5735249|NCT03135795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5735250|NCT03135795|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5615847|NCT00116142|Protective Agents|protective agents|mesh-ancestor
5615848|NCT00116142|Vitamins|vitamins|mesh-ancestor
5615849|NCT00116142|Micronutrients|micronutrients|mesh-ancestor
5615850|NCT00116142|Estrogens|estrogens|mesh-ancestor
5615851|NCT00116142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5615852|NCT00116142|Anabolic Agents|anabolic agents|mesh-ancestor
5615853|NCT00070018|Prednisone|prednisone|mesh-list
5615854|NCT00070018|Cyclophosphamide|cyclophosphamide|mesh-list
5735251|NCT03135795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5735252|NCT03135795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5735253|NCT03135795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5735254|NCT03135795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5735255|NCT03135795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5735256|NCT03135860|Nitric Oxide|nitric oxide|mesh-list
5735257|NCT03135860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5735258|NCT03135860|Autonomic Agents|autonomic agents|mesh-ancestor
5615855|NCT00070018|Rituximab|rituximab|mesh-list
5615856|NCT00070018|Doxorubicin|doxorubicin|mesh-list
5615857|NCT00070018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5615858|NCT00070018|Vincristine|vincristine|mesh-list
5615859|NCT00070018|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5615860|NCT00070018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5615861|NCT00070018|Immunologic Factors|immunologic factors|mesh-ancestor
5615862|NCT00070018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5615863|NCT00070018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5615864|NCT00070018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5615865|NCT00070018|Alkylating Agents|alkylating agents|mesh-ancestor
5615866|NCT00070018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5615867|NCT00070018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5615868|NCT00070018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5735259|NCT03135860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5735260|NCT03135860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735261|NCT03135860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5735262|NCT03135860|Respiratory System Agents|respiratory system agents|mesh-ancestor
5735263|NCT03135860|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5735264|NCT03135860|Antioxidants|antioxidants|mesh-ancestor
5735265|NCT03135860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5735266|NCT03135860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5735267|NCT03135860|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5735268|NCT03135860|Vasodilator Agents|vasodilator agents|mesh-ancestor
5735269|NCT03135860|Gasotransmitters|gasotransmitters|mesh-ancestor
5615869|NCT00070018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5615870|NCT00070018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5615871|NCT00070018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5615872|NCT00070018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5615873|NCT00070018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5615874|NCT00070018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5615875|NCT00070018|Glucocorticoids|glucocorticoids|mesh-ancestor
5735270|NCT03135860|Protective Agents|protective agents|mesh-ancestor
5735271|NCT03136120|Bromides|bromides|mesh-list
5735272|NCT03136120|Ipratropium|ipratropium|mesh-list
5735273|NCT03136120|Anticonvulsants|anticonvulsants|mesh-ancestor
5735274|NCT03136120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5735275|NCT03136120|Autonomic Agents|autonomic agents|mesh-ancestor
5735276|NCT03136120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5735277|NCT03136120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735278|NCT03136120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5735279|NCT03136120|Respiratory System Agents|respiratory system agents|mesh-ancestor
5735280|NCT03136120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5735281|NCT03136120|Cholinergic Agents|cholinergic agents|mesh-ancestor
5735282|NCT03136120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5735283|NCT03136120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5735284|NCT03135769|Avelumab|avelumab|mesh-list
5735285|NCT03135769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5735286|NCT03135769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5893163|NCT03178149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893164|NCT03178149|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5893165|NCT03178149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5893166|NCT03178149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893167|NCT03169985|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5893168|NCT03169985|Ezetimibe|ezetimibe|mesh-list
5893169|NCT03169985|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5893170|NCT03169985|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5893171|NCT03169985|Antimetabolites|antimetabolites|mesh-ancestor
5893172|NCT03169985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893173|NCT03169985|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5615876|NCT00070018|Hormones|hormones|mesh-ancestor
5615877|NCT00070018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5735287|NCT03135340|Anesthetics|anesthetics|mesh-list
5735288|NCT03135340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5735289|NCT03135340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735290|NCT03135301|Metformin|metformin|mesh-list
5735291|NCT03135301|Letrozole|letrozole|mesh-list
5735292|NCT03135301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5615878|NCT00070018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5615879|NCT00070018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5615880|NCT00070018|Tubulin Modulators|tubulin modulators|mesh-ancestor
5615881|NCT00070018|Antimitotic Agents|antimitotic agents|mesh-ancestor
5615882|NCT00070018|Mitosis Modulators|mitosis modulators|mesh-ancestor
5615883|NCT05189756|Aprepitant|aprepitant|mesh-list
5615884|NCT05189756|Fosaprepitant|fosaprepitant|mesh-list
5615885|NCT05189756|Antiemetics|antiemetics|mesh-ancestor
5615886|NCT05189756|Autonomic Agents|autonomic agents|mesh-ancestor
5615887|NCT05189756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5615888|NCT05189756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5615889|NCT05189756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5615890|NCT05189756|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5615891|NCT05189756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5615892|NCT05189756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208563|NCT02132533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6208564|NCT02132533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208565|NCT02132533|Vasodilator Agents|vasodilator agents|mesh-ancestor
6208566|NCT02132533|Tocolytic Agents|tocolytic agents|mesh-ancestor
6208567|NCT02132533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6208568|NCT02132637|Insulin|insulin|mesh-list
6208569|NCT02132637|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6208570|NCT02132637|Insulin Glargine|insulin glargine|mesh-list
5615901|NCT05189717|Everolimus|everolimus|mesh-list
5615902|NCT05189717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5615903|NCT05189717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5615904|NCT05189717|Immunologic Factors|immunologic factors|mesh-ancestor
5615905|NCT05189717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5615906|NCT05189535|Paclitaxel|paclitaxel|mesh-list
5615907|NCT05189535|Pentoxifylline|pentoxifylline|mesh-list
5615908|NCT05189535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5615909|NCT05189535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5615910|NCT05189535|Tubulin Modulators|tubulin modulators|mesh-ancestor
5615911|NCT05189535|Antimitotic Agents|antimitotic agents|mesh-ancestor
5615912|NCT05189535|Mitosis Modulators|mitosis modulators|mesh-ancestor
5615913|NCT05189535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5615914|NCT05189535|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5615915|NCT05189535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5615916|NCT05189535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5615917|NCT05189535|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5615918|NCT05189535|Protective Agents|protective agents|mesh-ancestor
5735293|NCT03135301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735294|NCT03135301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5735295|NCT03135301|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5735296|NCT03135301|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5735297|NCT03135301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5735298|NCT03135301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5735299|NCT03135301|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5735300|NCT03135301|Hormone Antagonists|hormone antagonists|mesh-ancestor
5735301|NCT03135301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5735302|NCT03135171|Trastuzumab|trastuzumab|mesh-list
5735303|NCT03135171|Pertuzumab|pertuzumab|mesh-list
5735304|NCT03135171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5735305|NCT03135171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5735306|NCT03135184|Coal Tar|coal tar|mesh-list
5735307|NCT03135184|Keratolytic Agents|keratolytic agents|mesh-ancestor
5735308|NCT03135184|Dermatologic Agents|dermatologic agents|mesh-ancestor
5735309|NCT03135054|Homoharringtonine|homoharringtonine|mesh-list
5735310|NCT03135054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5735311|NCT03135054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5735312|NCT03135054|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5735313|NCT03135054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5735314|NCT03135054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5735315|NCT03135106|Itraconazole|itraconazole|mesh-list
5735316|NCT03135106|Fluconazole|fluconazole|mesh-list
5735317|NCT03135106|Antifungal Agents|antifungal agents|mesh-ancestor
5735318|NCT03135106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5735319|NCT03135106|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5615919|NCT05189535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735320|NCT03135106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5735321|NCT03135106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5735322|NCT03135106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5735323|NCT03135106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5735324|NCT03135106|Hormone Antagonists|hormone antagonists|mesh-ancestor
5735325|NCT03135106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5735326|NCT03135106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735327|NCT03135106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5735328|NCT03135106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5735329|NCT03135106|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5735330|NCT03134872|Carboplatin|carboplatin|mesh-list
5735331|NCT03134872|Pemetrexed|pemetrexed|mesh-list
5735332|NCT03134872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5735333|NCT03134872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5735334|NCT03134872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5735335|NCT03134872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5735336|NCT03134872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5615920|NCT05189535|Vasodilator Agents|vasodilator agents|mesh-ancestor
5615921|NCT05189535|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5615922|NCT05189535|Antioxidants|antioxidants|mesh-ancestor
5615923|NCT05189223|Buprenorphine|buprenorphine|mesh-list
5615924|NCT05189223|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5615925|NCT05189223|Narcotics|narcotics|mesh-ancestor
5615926|NCT05189223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5615927|NCT05189223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5615928|NCT05189223|Analgesics|analgesics|mesh-ancestor
5615929|NCT05189223|Sensory System Agents|sensory system agents|mesh-ancestor
5615930|NCT05189223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5735337|NCT03134677|Bupivacaine|bupivacaine|mesh-list
5735338|NCT03134677|Sevoflurane|sevoflurane|mesh-list
5735339|NCT03134677|Anesthetics, Local|anesthetics, local|mesh-ancestor
5735340|NCT03134677|Anesthetics|anesthetics|mesh-ancestor
5735341|NCT03134677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5735342|NCT03134677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735343|NCT03134677|Sensory System Agents|sensory system agents|mesh-ancestor
5735344|NCT03134677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5615931|NCT05189223|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5615932|NCT05189184|Paclitaxel|paclitaxel|mesh-list
5615933|NCT05189184|Apatinib|apatinib|mesh-list
5615934|NCT05189184|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5615935|NCT05189184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5615936|NCT05189184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5615937|NCT05189184|Tubulin Modulators|tubulin modulators|mesh-ancestor
5615938|NCT05189184|Antimitotic Agents|antimitotic agents|mesh-ancestor
5615939|NCT05189184|Mitosis Modulators|mitosis modulators|mesh-ancestor
5615940|NCT05189184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5615941|NCT05189184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5615942|NCT05189184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5615943|NCT05189093|Antibodies|antibodies|mesh-list
5615944|NCT05189093|Antibodies, Bispecific|antibodies, bispecific|mesh-list
5615945|NCT05189093|Immunologic Factors|immunologic factors|mesh-ancestor
5615946|NCT05189093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5615947|NCT05189067|Paclitaxel|paclitaxel|mesh-list
5615948|NCT05189067|Docetaxel|docetaxel|mesh-list
5615949|NCT05189067|Trastuzumab|trastuzumab|mesh-list
5735345|NCT03134677|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5735346|NCT03134677|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5735347|NCT03134677|Anesthetics, General|anesthetics, general|mesh-ancestor
5735348|NCT03134729|Ropivacaine|ropivacaine|mesh-list
5735349|NCT03134729|Anesthetics, Local|anesthetics, local|mesh-ancestor
5735350|NCT03134729|Anesthetics|anesthetics|mesh-ancestor
5735351|NCT03134729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5735352|NCT03134729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735353|NCT03134729|Sensory System Agents|sensory system agents|mesh-ancestor
5735354|NCT03134729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5735355|NCT03134651|Propofol|propofol|mesh-list
5735356|NCT03134651|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5735357|NCT03134651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5735358|NCT03134651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735359|NCT03134651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5735360|NCT03134651|Anesthetics, General|anesthetics, general|mesh-ancestor
5615950|NCT05189067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5615951|NCT05189067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5615952|NCT05189067|Tubulin Modulators|tubulin modulators|mesh-ancestor
5615953|NCT05189067|Antimitotic Agents|antimitotic agents|mesh-ancestor
5615954|NCT05189067|Mitosis Modulators|mitosis modulators|mesh-ancestor
5735361|NCT03134651|Anesthetics|anesthetics|mesh-ancestor
5735362|NCT03134638|Carboplatin|carboplatin|mesh-list
5735363|NCT03134638|Fulvestrant|fulvestrant|mesh-list
5615955|NCT05189067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5615956|NCT05189067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5615957|NCT05189015|Olmesartan|olmesartan|mesh-list
5615958|NCT05189015|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
5615959|NCT05189015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5615960|NCT05189015|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5615961|NCT05189015|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5615962|NCT05189015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5615963|NCT05189002|Dalteparin|dalteparin|mesh-list
5615964|NCT05189002|Anticoagulants|anticoagulants|mesh-ancestor
5615965|NCT05189002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5615966|NCT05189002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5615967|NCT05189002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5615968|NCT05188911|Prednisone|prednisone|mesh-list
5615969|NCT05188911|Androgens|androgens|mesh-list
5615970|NCT05188911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5615971|NCT05188911|Glucocorticoids|glucocorticoids|mesh-ancestor
5615972|NCT05188911|Hormones|hormones|mesh-ancestor
5615973|NCT05188911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5615974|NCT05188911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5615975|NCT05188911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5615976|NCT05188911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5615977|NCT05188859|Pemetrexed|pemetrexed|mesh-list
5615978|NCT05188859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5615979|NCT05188859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5615980|NCT05188859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5615981|NCT05188859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5615982|NCT05188859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5615983|NCT05188833|Paroxetine|paroxetine|mesh-list
5615984|NCT05188833|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5615985|NCT05188833|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5615986|NCT05188833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5615987|NCT05188833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5735364|NCT03134638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5735365|NCT03134638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5735366|NCT03134638|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5735367|NCT03134638|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5735368|NCT03134638|Hormone Antagonists|hormone antagonists|mesh-ancestor
5735369|NCT03134638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5735370|NCT03134638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735371|NCT03134547|Sevoflurane|sevoflurane|mesh-list
5615988|NCT05188833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5615989|NCT05188833|Serotonin Agents|serotonin agents|mesh-ancestor
5615990|NCT05188833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5615991|NCT05188833|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5615992|NCT05188833|Antidepressive Agents|antidepressive agents|mesh-ancestor
5615993|NCT05188833|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5735372|NCT03134547|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5735373|NCT03134547|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5735374|NCT03134547|Anesthetics, General|anesthetics, general|mesh-ancestor
5735375|NCT03134547|Anesthetics|anesthetics|mesh-ancestor
5735376|NCT03134547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5735377|NCT03134547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735378|NCT03134443|Andrographolide|andrographolide|mesh-list
6672782|NCT01558245|Fertility Agents, Male|fertility agents, male|mesh-ancestor
6672783|NCT01558245|Fertility Agents|fertility agents|mesh-ancestor
6672784|NCT01558245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6672785|NCT01558245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672786|NCT01558310|Ustekinumab|ustekinumab|mesh-list
6672787|NCT01558310|Dermatologic Agents|dermatologic agents|mesh-ancestor
6672788|NCT01558336|Praziquantel|praziquantel|mesh-list
6672789|NCT01558336|Anthelmintics|anthelmintics|mesh-ancestor
6672790|NCT01558336|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6672791|NCT01558336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6672792|NCT01558375|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6672793|NCT01558375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6672794|NCT01558453|Oxaliplatin|oxaliplatin|mesh-list
6672795|NCT01558453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6672796|NCT01558466|Sildenafil Citrate|sildenafil citrate|mesh-list
6672797|NCT01558466|Vasodilator Agents|vasodilator agents|mesh-ancestor
6672798|NCT01558466|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6672799|NCT01558466|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6672800|NCT01558466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6672801|NCT01558466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672802|NCT01558466|Urological Agents|urological agents|mesh-ancestor
5735379|NCT03134443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5735380|NCT03134443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5735381|NCT03134443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5735382|NCT03134443|Analgesics|analgesics|mesh-ancestor
5735383|NCT03134443|Sensory System Agents|sensory system agents|mesh-ancestor
5735384|NCT03134443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5735385|NCT03134443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735386|NCT03134443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5735387|NCT03134443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5735388|NCT03134443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5735389|NCT03134443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5735390|NCT03134443|Antiviral Agents|antiviral agents|mesh-ancestor
5735391|NCT03134443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5735392|NCT03134612|Lidocaine|lidocaine|mesh-list
5735393|NCT03134612|Ondansetron|ondansetron|mesh-list
5735394|NCT03134612|Anesthetics, Local|anesthetics, local|mesh-ancestor
5735395|NCT03134612|Anesthetics|anesthetics|mesh-ancestor
5735396|NCT03134612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5735397|NCT03134612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5615994|NCT05188833|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5615995|NCT05188833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5615996|NCT05188833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5615997|NCT05188781|Pembrolizumab|pembrolizumab|mesh-list
5615998|NCT05188781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5615999|NCT05188781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5616000|NCT05188768|Mitogens|mitogens|mesh-list
5616001|NCT05188768|Mitosis Modulators|mitosis modulators|mesh-ancestor
5616002|NCT05188768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616003|NCT05188742|Mirabegron|mirabegron|mesh-list
5616004|NCT05188742|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
5616005|NCT05188742|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5616006|NCT05188742|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5616007|NCT05188742|Adrenergic Agents|adrenergic agents|mesh-ancestor
5616008|NCT05188742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5616009|NCT05188742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616010|NCT05188742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616011|NCT05188742|Urological Agents|urological agents|mesh-ancestor
5692178|NCT03411252|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5692179|NCT03411252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5692180|NCT03411252|Adrenergic Agents|adrenergic agents|mesh-ancestor
5692181|NCT03411252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5692182|NCT03411252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692183|NCT03411252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692184|NCT03411252|Urological Agents|urological agents|mesh-ancestor
5692185|NCT03411161|Paclitaxel|paclitaxel|mesh-list
5692186|NCT03411161|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5692187|NCT03411161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5692188|NCT03411161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5692189|NCT03411161|Tubulin Modulators|tubulin modulators|mesh-ancestor
5692190|NCT03411161|Antimitotic Agents|antimitotic agents|mesh-ancestor
5692191|NCT03411161|Mitosis Modulators|mitosis modulators|mesh-ancestor
5692192|NCT03411161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692193|NCT03411109|Hydromorphone|hydromorphone|mesh-list
5692194|NCT03411109|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5692195|NCT03411109|Narcotics|narcotics|mesh-ancestor
5692196|NCT03411109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5692197|NCT03411109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692198|NCT03411109|Analgesics|analgesics|mesh-ancestor
5692199|NCT03411109|Sensory System Agents|sensory system agents|mesh-ancestor
5692200|NCT03411109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5692201|NCT03411096|Ropivacaine|ropivacaine|mesh-list
5692202|NCT03411096|Anesthetics, Local|anesthetics, local|mesh-ancestor
5692203|NCT03411096|Anesthetics|anesthetics|mesh-ancestor
5692204|NCT03411096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5692205|NCT03411096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692206|NCT03411096|Sensory System Agents|sensory system agents|mesh-ancestor
5692207|NCT03411096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5692208|NCT03410901|Antibodies|antibodies|mesh-list
5735398|NCT03134612|Sensory System Agents|sensory system agents|mesh-ancestor
5735399|NCT03134612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5735400|NCT03134612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5735401|NCT03134612|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5735402|NCT03134612|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5735403|NCT03134612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5735404|NCT03134612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5735405|NCT03134612|Antiemetics|antiemetics|mesh-ancestor
5735406|NCT03134612|Autonomic Agents|autonomic agents|mesh-ancestor
5735407|NCT03134612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5735408|NCT03134612|Antipruritics|antipruritics|mesh-ancestor
5735409|NCT03134612|Dermatologic Agents|dermatologic agents|mesh-ancestor
5735410|NCT03134612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5735411|NCT03134612|Serotonin Agents|serotonin agents|mesh-ancestor
5735412|NCT03134612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5735413|NCT03134612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5735414|NCT03134612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5735415|NCT03134612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5735416|NCT03134612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5735417|NCT03134573|Interferons|interferons|mesh-list
5735418|NCT03134573|Interferon-beta|interferon-beta|mesh-list
5735419|NCT03134573|Interferon beta-1b|interferon beta-1b|mesh-list
5735420|NCT03134573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5735421|NCT03134573|Antiviral Agents|antiviral agents|mesh-ancestor
5735422|NCT03134573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5735423|NCT03134573|Immunologic Factors|immunologic factors|mesh-ancestor
5735424|NCT03134573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735425|NCT03134573|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5616012|NCT05188495|Trastuzumab|trastuzumab|mesh-list
5616013|NCT05188495|Pertuzumab|pertuzumab|mesh-list
5616014|NCT05188495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5616015|NCT05188495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5616016|NCT05188339|Citric Acid|citric acid|mesh-list
5616017|NCT05188339|Sodium Citrate|sodium citrate|mesh-list
5616018|NCT05188339|Anticoagulants|anticoagulants|mesh-ancestor
5616019|NCT05188339|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5616020|NCT05188339|Chelating Agents|chelating agents|mesh-ancestor
5616021|NCT05188339|Sequestering Agents|sequestering agents|mesh-ancestor
5616022|NCT05188339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616023|NCT05188313|Paclitaxel|paclitaxel|mesh-list
5616024|NCT05188313|Carboplatin|carboplatin|mesh-list
5616025|NCT05188313|Trastuzumab|trastuzumab|mesh-list
5616026|NCT05188313|Pertuzumab|pertuzumab|mesh-list
5616027|NCT05188313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5616028|NCT05188313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5616029|NCT05188313|Tubulin Modulators|tubulin modulators|mesh-ancestor
5616030|NCT05188313|Antimitotic Agents|antimitotic agents|mesh-ancestor
5616031|NCT05188313|Mitosis Modulators|mitosis modulators|mesh-ancestor
5616032|NCT05188313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616033|NCT05188313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5616034|NCT05188131|Diclofenac|diclofenac|mesh-list
5735426|NCT03134456|Pembrolizumab|pembrolizumab|mesh-list
5735427|NCT03134456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5735428|NCT03134456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5735429|NCT03134417|Vitamin D|vitamin d|mesh-list
5735430|NCT03134417|Ergocalciferols|ergocalciferols|mesh-list
5735431|NCT03134417|Vitamins|vitamins|mesh-list
5735432|NCT03134417|Micronutrients|micronutrients|mesh-ancestor
5616035|NCT05188131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5616036|NCT05188131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5616037|NCT05188131|Analgesics|analgesics|mesh-ancestor
5616038|NCT05188131|Sensory System Agents|sensory system agents|mesh-ancestor
5616039|NCT05188131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5616040|NCT05188131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616041|NCT05188131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5616042|NCT05188131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5616043|NCT05188131|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5616044|NCT05188131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5616045|NCT05188131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616046|NCT05188118|Nivolumab|nivolumab|mesh-list
5616047|NCT05188118|Ipilimumab|ipilimumab|mesh-list
5616048|NCT05188118|Everolimus|everolimus|mesh-list
5616049|NCT05188118|Lenvatinib|lenvatinib|mesh-list
5735433|NCT03134417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616050|NCT05188118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5616051|NCT05188118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5616052|NCT05188118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5735434|NCT03134417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5616053|NCT05188118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5735435|NCT03134417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5735436|NCT03134378|Amoxicillin|amoxicillin|mesh-list
5735437|NCT03134378|Clarithromycin|clarithromycin|mesh-list
5735438|NCT03134378|Rabeprazole|rabeprazole|mesh-list
5735439|NCT03134378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5616054|NCT05188118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5616055|NCT05188118|Immunologic Factors|immunologic factors|mesh-ancestor
5616056|NCT05188118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616057|NCT05188118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5616058|NCT05188118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5616059|NCT05187715|Simvastatin|simvastatin|mesh-list
5616060|NCT05187715|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5616061|NCT05187715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5616062|NCT05187715|Antimetabolites|antimetabolites|mesh-ancestor
5616063|NCT05187715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616064|NCT05187715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5616065|NCT05187715|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5616066|NCT05187715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5616067|NCT05187663|Chlorhexidine|chlorhexidine|mesh-list
5616068|NCT05187663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5616069|NCT05187663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5616070|NCT05187663|Disinfectants|disinfectants|mesh-ancestor
5616071|NCT05169424|Fluticasone|fluticasone|mesh-list
5616072|NCT05169424|Xhance|xhance|mesh-list
5616073|NCT05169424|Tiotropium Bromide|tiotropium bromide|mesh-list
5616074|NCT05169424|Olodaterol|olodaterol|mesh-list
5616075|NCT05169424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5616076|NCT05169424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5616077|NCT05169424|Autonomic Agents|autonomic agents|mesh-ancestor
5616078|NCT05169424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5616079|NCT05169424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616080|NCT05169424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5735440|NCT03134378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5735441|NCT03134378|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5735442|NCT03134378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5735443|NCT03134378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5735444|NCT03134378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5735445|NCT03134378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5735446|NCT03134378|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5735447|NCT03134378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5735448|NCT03134378|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5735449|NCT03134846|Cetuximab|cetuximab|mesh-list
5616081|NCT05169424|Respiratory System Agents|respiratory system agents|mesh-ancestor
5616082|NCT05169424|Dermatologic Agents|dermatologic agents|mesh-ancestor
5616083|NCT05169424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5735450|NCT03134846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5735451|NCT03134846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5735452|NCT03134755|Mometasone Furoate|mometasone furoate|mesh-list
5735453|NCT03134755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5735454|NCT03134755|Dermatologic Agents|dermatologic agents|mesh-ancestor
5735455|NCT03134755|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5735456|NCT03134339|Nicotine|nicotine|mesh-list
5735457|NCT03134339|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5735458|NCT03134339|Autonomic Agents|autonomic agents|mesh-ancestor
5735459|NCT03134339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5735460|NCT03134339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616084|NCT05169424|Parasympatholytics|parasympatholytics|mesh-ancestor
5616085|NCT05169424|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5616086|NCT05169424|Cholinergic Agents|cholinergic agents|mesh-ancestor
5616087|NCT05169424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5616088|NCT05169424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616089|NCT05165875|Hydrocortisone|hydrocortisone|mesh-list
5616090|NCT05165875|Lidocaine|lidocaine|mesh-list
5616091|NCT05165875|Anesthetics, Local|anesthetics, local|mesh-ancestor
5616092|NCT05165875|Anesthetics|anesthetics|mesh-ancestor
5616093|NCT05165875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5616094|NCT05165875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616095|NCT05165875|Sensory System Agents|sensory system agents|mesh-ancestor
5616096|NCT05165875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5616097|NCT05165875|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5735461|NCT03134339|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5735462|NCT03134339|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5735463|NCT03134339|Cholinergic Agents|cholinergic agents|mesh-ancestor
5616098|NCT05165875|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6208571|NCT02132637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5735464|NCT03134339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5735465|NCT03134339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5735466|NCT03134196|Valacyclovir|valacyclovir|mesh-list
5735467|NCT03134196|Antiviral Agents|antiviral agents|mesh-ancestor
5735468|NCT03134196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5735469|NCT03134118|Nivolumab|nivolumab|mesh-list
5735470|NCT03134118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5735471|NCT03134118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5735472|NCT03134118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5735473|NCT03134118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5735474|NCT03133975|Vitamin D|vitamin d|mesh-list
5735475|NCT03133975|Cholecalciferol|cholecalciferol|mesh-list
5735476|NCT03133975|Vitamins|vitamins|mesh-ancestor
5735477|NCT03133975|Micronutrients|micronutrients|mesh-ancestor
5735478|NCT03133975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735479|NCT03133975|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5735480|NCT03133975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5616099|NCT05165875|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5616100|NCT05165875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5616101|NCT05165875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616102|NCT05165875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5616103|NCT05165225|Cyclophosphamide|cyclophosphamide|mesh-list
5616104|NCT05165225|Docetaxel|docetaxel|mesh-list
5616105|NCT05165225|Epirubicin|epirubicin|mesh-list
5616106|NCT05165225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5893174|NCT03169985|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5893175|NCT03169985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5893176|NCT03140670|Rucaparib|rucaparib|mesh-list
5893177|NCT03140670|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5893178|NCT03140670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5893179|NCT03140670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893180|NCT03140670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5893181|NCT03129360|Levetiracetam|levetiracetam|mesh-list
5893182|NCT03129360|Anticonvulsants|anticonvulsants|mesh-ancestor
5893183|NCT03129360|Nootropic Agents|nootropic agents|mesh-ancestor
5893184|NCT02968810|Simvastatin|simvastatin|mesh-list
5893185|NCT02968810|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5893186|NCT02968810|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5893187|NCT02968810|Antimetabolites|antimetabolites|mesh-ancestor
5893188|NCT02968810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893189|NCT02968810|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5893190|NCT02968810|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5893191|NCT02968810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5893192|NCT02934282|HBOC 201|hboc 201|mesh-list
5893193|NCT02934282|Blood Substitutes|blood substitutes|mesh-ancestor
5893194|NCT02774590|Timolol|timolol|mesh-list
5893195|NCT02774590|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5893196|NCT02774590|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5893197|NCT02774590|Adrenergic Agents|adrenergic agents|mesh-ancestor
5893198|NCT02774590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5893199|NCT02774590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893200|NCT02774590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893201|NCT02774590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5893202|NCT02774590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5893203|NCT02624596|Midazolam|midazolam|mesh-list
5893204|NCT02624596|Ketamine|ketamine|mesh-list
5616107|NCT05165225|Immunologic Factors|immunologic factors|mesh-ancestor
5616108|NCT05165225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616109|NCT05165225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5616110|NCT05165225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5616111|NCT05165225|Alkylating Agents|alkylating agents|mesh-ancestor
5616112|NCT05165225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616113|NCT05165225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5616114|NCT05165225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5616115|NCT05165225|Tubulin Modulators|tubulin modulators|mesh-ancestor
5616116|NCT05165225|Antimitotic Agents|antimitotic agents|mesh-ancestor
5616117|NCT05165225|Mitosis Modulators|mitosis modulators|mesh-ancestor
5616118|NCT05165225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5616119|NCT05165225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5616120|NCT05165225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5616121|NCT05165225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5616122|NCT05162222|Itraconazole|itraconazole|mesh-list
5893205|NCT02624596|Analgesics|analgesics|mesh-ancestor
5893206|NCT02624596|Sensory System Agents|sensory system agents|mesh-ancestor
5616123|NCT05162222|Diltiazem|diltiazem|mesh-list
5735481|NCT03133832|Praziquantel|praziquantel|mesh-list
5735482|NCT03133832|Anthelmintics|anthelmintics|mesh-ancestor
5735483|NCT03133832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5735484|NCT03133832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5735485|NCT03134131|TIC10 compound|tic10 compound|mesh-list
5735486|NCT03134131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5735487|NCT03133845|Fentanyl|fentanyl|mesh-list
5735488|NCT03133845|Midazolam|midazolam|mesh-list
5735489|NCT03133845|Morphine|morphine|mesh-list
5735490|NCT03133845|Anesthetics|anesthetics|mesh-list
5735491|NCT03133845|Propofol|propofol|mesh-list
5616124|NCT05162222|Antifungal Agents|antifungal agents|mesh-ancestor
5616125|NCT05162222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5616126|NCT05162222|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5616127|NCT05162222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5616128|NCT05162222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5616129|NCT05162222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616130|NCT05162222|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5616131|NCT05162222|Hormone Antagonists|hormone antagonists|mesh-ancestor
5616132|NCT05162222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5616133|NCT05162222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616134|NCT05162222|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5616135|NCT05162222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5616136|NCT05162222|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5616137|NCT05162222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5616138|NCT05162222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5616139|NCT05162222|Vasodilator Agents|vasodilator agents|mesh-ancestor
5616140|NCT05160896|Bevacizumab|bevacizumab|mesh-list
5616141|NCT05160896|Cetuximab|cetuximab|mesh-list
5616142|NCT05160896|Irinotecan|irinotecan|mesh-list
5616143|NCT05160896|Raltitrexed|raltitrexed|mesh-list
5616144|NCT05160896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5616145|NCT05160896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5616146|NCT05160896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5616147|NCT05160896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5616148|NCT05160896|Growth Substances|growth substances|mesh-ancestor
5616149|NCT05160896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616150|NCT05160896|Growth Inhibitors|growth inhibitors|mesh-ancestor
5616151|NCT05160896|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5616152|NCT05160896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5616153|NCT05160896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5616154|NCT05160896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5735492|NCT03133845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5735493|NCT03133845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735494|NCT03133845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5735495|NCT03133845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5735496|NCT03133845|Anesthetics, General|anesthetics, general|mesh-ancestor
5735497|NCT03133845|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5735498|NCT03133845|Narcotics|narcotics|mesh-ancestor
5735499|NCT03133845|Analgesics|analgesics|mesh-ancestor
5616155|NCT05160896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5616156|NCT05160896|Antimetabolites|antimetabolites|mesh-ancestor
5616157|NCT05160896|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5616158|NCT05152004|Amoxicillin|amoxicillin|mesh-list
5616159|NCT05152004|Metronidazole|metronidazole|mesh-list
5616160|NCT05152004|Clarithromycin|clarithromycin|mesh-list
5616161|NCT05152004|Rabeprazole|rabeprazole|mesh-list
5616162|NCT05152004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5616163|NCT05152004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5616164|NCT05152004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5616165|NCT05152004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5616166|NCT05152004|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5616167|NCT05152004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5616168|NCT05152004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616169|NCT05152004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5616170|NCT05152004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5616171|NCT05152004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5616172|NCT05152004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5616173|NCT05152004|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5616174|NCT05142254|Hydroxyurea|hydroxyurea|mesh-list
5616175|NCT05142254|Tadalafil|tadalafil|mesh-list
5616176|NCT05142254|Vasodilator Agents|vasodilator agents|mesh-ancestor
5616177|NCT05142254|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5616178|NCT05142254|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5735500|NCT03133845|Sensory System Agents|sensory system agents|mesh-ancestor
5735501|NCT03133845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5735502|NCT03133845|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5735503|NCT03133845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5735504|NCT03133845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5735505|NCT03133845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5735506|NCT03133845|GABA Modulators|gaba modulators|mesh-ancestor
6672803|NCT01558622|Ascorbic Acid|ascorbic acid|mesh-list
5616179|NCT05142254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5616180|NCT05142254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616181|NCT05142254|Urological Agents|urological agents|mesh-ancestor
5616182|NCT05142254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5616183|NCT05142254|Antisickling Agents|antisickling agents|mesh-ancestor
5616184|NCT05142254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5616185|NCT05124509|Vaccines|vaccines|mesh-list
5616186|NCT05124509|Immunologic Factors|immunologic factors|mesh-ancestor
5616187|NCT05124509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692209|NCT03410901|Immunologic Factors|immunologic factors|mesh-ancestor
5692210|NCT03410901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692211|NCT03410836|Lidocaine|lidocaine|mesh-list
5692212|NCT03410836|Anesthetics, Local|anesthetics, local|mesh-ancestor
5692213|NCT03410836|Anesthetics|anesthetics|mesh-ancestor
5692214|NCT03410836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5692215|NCT03410836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692216|NCT03410836|Sensory System Agents|sensory system agents|mesh-ancestor
5692217|NCT03410836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5692218|NCT03410836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5692219|NCT03410836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5692220|NCT03410836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5692221|NCT03410836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5692222|NCT03410836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692223|NCT03410784|Paclitaxel|paclitaxel|mesh-list
5692224|NCT03410784|Carboplatin|carboplatin|mesh-list
5692225|NCT03410784|Pembrolizumab|pembrolizumab|mesh-list
5692226|NCT03410784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5692227|NCT03410784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5692228|NCT03410784|Tubulin Modulators|tubulin modulators|mesh-ancestor
5692229|NCT03410784|Antimitotic Agents|antimitotic agents|mesh-ancestor
5692230|NCT03410784|Mitosis Modulators|mitosis modulators|mesh-ancestor
5692231|NCT03410784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692232|NCT03410784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5692233|NCT03410771|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5692234|NCT03410771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5692235|NCT03410654|Tacrolimus|tacrolimus|mesh-list
5692236|NCT03410654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5692237|NCT03410654|Immunologic Factors|immunologic factors|mesh-ancestor
5692238|NCT03410654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692239|NCT03410654|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5692240|NCT03410654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5692241|NCT03410654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692242|NCT03410524|Simethicone|simethicone|mesh-list
5692243|NCT03410524|Antifoaming Agents|antifoaming agents|mesh-ancestor
5692244|NCT03410524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692245|NCT03410524|Emollients|emollients|mesh-ancestor
5692246|NCT03410524|Dermatologic Agents|dermatologic agents|mesh-ancestor
5692247|NCT03410511|Nicotine|nicotine|mesh-list
5692248|NCT03410511|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5692249|NCT03410511|Autonomic Agents|autonomic agents|mesh-ancestor
5692250|NCT03410511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5692251|NCT03410511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692252|NCT03410511|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5692253|NCT03410511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5692254|NCT03410511|Cholinergic Agents|cholinergic agents|mesh-ancestor
5692255|NCT03410511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5692256|NCT03410511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692257|NCT03410446|Ketamine|ketamine|mesh-list
5692258|NCT03410446|Analgesics|analgesics|mesh-ancestor
5692259|NCT03410446|Sensory System Agents|sensory system agents|mesh-ancestor
5692260|NCT03410446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5692261|NCT03410446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692262|NCT03410446|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5692263|NCT03410446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5692264|NCT03410446|Anesthetics, General|anesthetics, general|mesh-ancestor
5692265|NCT03410446|Anesthetics|anesthetics|mesh-ancestor
5692266|NCT03410446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5735507|NCT03133845|GABA Agents|gaba agents|mesh-ancestor
5735508|NCT03133845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5735509|NCT03133845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5735510|NCT03133897|Dexamethasone|dexamethasone|mesh-list
5735511|NCT03133897|Prednisone|prednisone|mesh-list
5735512|NCT03133897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5735513|NCT03133897|Antiemetics|antiemetics|mesh-ancestor
5735514|NCT03133897|Autonomic Agents|autonomic agents|mesh-ancestor
5735515|NCT03133897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5735516|NCT03133897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735517|NCT03133897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5735518|NCT03133897|Glucocorticoids|glucocorticoids|mesh-ancestor
5735519|NCT03133897|Hormones|hormones|mesh-ancestor
5735520|NCT03133897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5735521|NCT03133897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5735522|NCT03133897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5735523|NCT03133923|Vaccines|vaccines|mesh-list
5735524|NCT03133923|Immunologic Factors|immunologic factors|mesh-ancestor
5735525|NCT03133923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735526|NCT03134001|Analgesics|analgesics|mesh-list
5735527|NCT03134001|Sensory System Agents|sensory system agents|mesh-ancestor
5735528|NCT03134001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5735529|NCT03134001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735530|NCT03133793|Coenzyme Q10|coenzyme q10|mesh-list
5735531|NCT03133793|Vitamins|vitamins|mesh-ancestor
5735532|NCT03133793|Micronutrients|micronutrients|mesh-ancestor
5735533|NCT03133793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735534|NCT03133780|Midazolam|midazolam|mesh-list
5616188|NCT05076409|Fluconazole|fluconazole|mesh-list
5616189|NCT05076409|BI 425809|bi 425809|mesh-list
5616190|NCT05076409|Antifungal Agents|antifungal agents|mesh-ancestor
5616191|NCT05076409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5616192|NCT05076409|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5616193|NCT05076409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5616194|NCT05076409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5616195|NCT05076409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616196|NCT05076409|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5616197|NCT05076409|Hormone Antagonists|hormone antagonists|mesh-ancestor
5616198|NCT05076409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5616199|NCT05076409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616200|NCT05076409|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5616201|NCT05076409|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5616202|NCT05076409|Nootropic Agents|nootropic agents|mesh-ancestor
5616203|NCT05070754|Cantharidin|cantharidin|mesh-list
5616204|NCT05070754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5616205|NCT05070754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616206|NCT05060068|Ketamine|ketamine|mesh-list
5616207|NCT05060068|Esketamine|esketamine|mesh-list
5616208|NCT05060068|Analgesics|analgesics|mesh-ancestor
5616209|NCT05060068|Sensory System Agents|sensory system agents|mesh-ancestor
5616210|NCT05060068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5616211|NCT05060068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616212|NCT05060068|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5616213|NCT05060068|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5616214|NCT05060068|Anesthetics, General|anesthetics, general|mesh-ancestor
5616215|NCT05060068|Anesthetics|anesthetics|mesh-ancestor
5616216|NCT05060068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5616217|NCT05060068|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5616218|NCT05060068|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5616219|NCT05060068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5616220|NCT05060068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616221|NCT05060068|Antidepressive Agents|antidepressive agents|mesh-ancestor
5616222|NCT05060068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5616223|NCT05038982|Abrocitinib|abrocitinib|mesh-list
5616224|NCT05038982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5616225|NCT05038982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5616226|NCT05038982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616227|NCT05028062|Naltrexone|naltrexone|mesh-list
5616228|NCT05028062|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5616229|NCT05028062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5616230|NCT05028062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735535|NCT03133780|Ketamine|ketamine|mesh-list
5735536|NCT03133780|Analgesics|analgesics|mesh-ancestor
5735537|NCT03133780|Sensory System Agents|sensory system agents|mesh-ancestor
5735538|NCT03133780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5616231|NCT05028062|Sensory System Agents|sensory system agents|mesh-ancestor
5616232|NCT05028062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5616233|NCT05022342|Fulvestrant|fulvestrant|mesh-list
5616234|NCT05022342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5616235|NCT05022342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5616236|NCT05022342|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5616237|NCT05022342|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5616238|NCT05022342|Hormone Antagonists|hormone antagonists|mesh-ancestor
5616239|NCT05022342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5616240|NCT05022342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616241|NCT05017545|Abatacept|abatacept|mesh-list
5616242|NCT05017545|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5616243|NCT05017545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616244|NCT05017545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5616245|NCT05017545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5616246|NCT05017545|Immunologic Factors|immunologic factors|mesh-ancestor
5616247|NCT05017545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616248|NCT05017545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5616249|NCT05008575|Fludarabine|fludarabine|mesh-list
5735539|NCT03133780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735540|NCT03133780|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5735541|NCT03133780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5735542|NCT03133780|Anesthetics, General|anesthetics, general|mesh-ancestor
5735543|NCT03133780|Anesthetics|anesthetics|mesh-ancestor
5735544|NCT03133780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5616250|NCT05008575|Cyclophosphamide|cyclophosphamide|mesh-list
5616251|NCT05008575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5616252|NCT05008575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616253|NCT05008575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5616254|NCT05008575|Immunologic Factors|immunologic factors|mesh-ancestor
5616255|NCT05008575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616256|NCT05008575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5616257|NCT05008575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5735545|NCT03133780|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5735546|NCT03133780|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5735547|NCT03133780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5735548|NCT03133780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5735549|NCT03133780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5735550|NCT03133780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5616258|NCT05008575|Alkylating Agents|alkylating agents|mesh-ancestor
5616259|NCT05008575|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5735551|NCT03133780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5735552|NCT03133780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5735553|NCT03133780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5735554|NCT03133780|GABA Modulators|gaba modulators|mesh-ancestor
5735555|NCT03133780|GABA Agents|gaba agents|mesh-ancestor
5735556|NCT03133637|Ceftriaxone|ceftriaxone|mesh-list
5735557|NCT03133637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5735558|NCT03133637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5735559|NCT03133260|Aspirin|aspirin|mesh-list
5735560|NCT03133260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5735561|NCT03133260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5735562|NCT03133260|Analgesics|analgesics|mesh-ancestor
5735563|NCT03133260|Sensory System Agents|sensory system agents|mesh-ancestor
5735564|NCT03133260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5735565|NCT03133260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735566|NCT03133260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5735567|NCT03133260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5735568|NCT03133260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5735569|NCT03133260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5735570|NCT03133260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5735571|NCT03133260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5616260|NCT04999020|Ravulizumab|ravulizumab|mesh-list
5616261|NCT04999020|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5616262|NCT04999020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5616263|NCT04999020|Immunologic Factors|immunologic factors|mesh-ancestor
5616264|NCT04999020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616265|NCT04988074|Cemiplimab|cemiplimab|mesh-list
5616266|NCT04988074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5616267|NCT04988074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5616268|NCT04984369|Cetuximab|cetuximab|mesh-list
5616269|NCT04984369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5735572|NCT03133260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5735573|NCT03133260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5735574|NCT03133260|Antipyretics|antipyretics|mesh-ancestor
5735575|NCT03133234|Osimertinib|osimertinib|mesh-list
5735576|NCT03133234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5735577|NCT03133234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5735578|NCT03133234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5735579|NCT03133234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5735580|NCT03133546|Bevacizumab|bevacizumab|mesh-list
5735581|NCT03133546|Osimertinib|osimertinib|mesh-list
5735582|NCT03133546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5616270|NCT04984369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5616271|NCT04975919|Decitabine|decitabine|mesh-list
5616272|NCT04975919|Venetoclax|venetoclax|mesh-list
5616273|NCT04975919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5616274|NCT04975919|Antimetabolites|antimetabolites|mesh-ancestor
5616275|NCT04975919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616276|NCT04975919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5616277|NCT04975919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5616278|NCT04971473|Hormones|hormones|mesh-list
5616279|NCT04971473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5616280|NCT04971473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616281|NCT04964284|Hormones|hormones|mesh-list
5735583|NCT03133546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5735584|NCT03133546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5616282|NCT04964284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5616283|NCT04964284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616284|NCT04946396|Dexmedetomidine|dexmedetomidine|mesh-list
5616285|NCT04946396|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5616286|NCT04946396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5616287|NCT04946396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616288|NCT04946396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5616289|NCT04946396|Analgesics|analgesics|mesh-ancestor
5616290|NCT04946396|Sensory System Agents|sensory system agents|mesh-ancestor
5616291|NCT04946396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5616292|NCT04946396|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5616293|NCT04946396|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5616294|NCT04946396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5616295|NCT04946396|Adrenergic Agents|adrenergic agents|mesh-ancestor
5616296|NCT04946396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5616297|NCT04946396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616298|NCT04944017|Ketamine|ketamine|mesh-list
5616299|NCT04944017|Analgesics|analgesics|mesh-ancestor
5616300|NCT04944017|Sensory System Agents|sensory system agents|mesh-ancestor
5616301|NCT04944017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5616302|NCT04944017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616303|NCT04944017|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5616304|NCT04944017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5616305|NCT04944017|Anesthetics, General|anesthetics, general|mesh-ancestor
5616306|NCT04944017|Anesthetics|anesthetics|mesh-ancestor
5616307|NCT04944017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5735585|NCT03133546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5735586|NCT03133546|Growth Substances|growth substances|mesh-ancestor
5735587|NCT03133546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735588|NCT03133546|Growth Inhibitors|growth inhibitors|mesh-ancestor
5735589|NCT03133546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5735590|NCT03133546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5735591|NCT03133546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5735592|NCT03133325|Lidocaine|lidocaine|mesh-list
5735593|NCT03133325|Anesthetics, Local|anesthetics, local|mesh-ancestor
5735594|NCT03133325|Anesthetics|anesthetics|mesh-ancestor
5735595|NCT03133325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5735596|NCT03133325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735597|NCT03133325|Sensory System Agents|sensory system agents|mesh-ancestor
5735598|NCT03133325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5735599|NCT03133325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5735600|NCT03133325|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5735601|NCT03133325|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5735602|NCT03133325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5735603|NCT03133325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5735604|NCT03133065|Antiviral Agents|antiviral agents|mesh-list
6489232|NCT00590174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616308|NCT04944017|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5735605|NCT03133065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5735606|NCT03133312|Chlorhexidine|chlorhexidine|mesh-list
5735607|NCT03133312|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5735608|NCT03133312|Povidone-Iodine|povidone-iodine|mesh-list
5735609|NCT03133312|Povidone|povidone|mesh-list
5735610|NCT03133312|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5735611|NCT03133312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5735612|NCT03133312|Disinfectants|disinfectants|mesh-ancestor
5735613|NCT03133312|Dermatologic Agents|dermatologic agents|mesh-ancestor
5735614|NCT03133312|Plasma Substitutes|plasma substitutes|mesh-ancestor
5735615|NCT03133312|Blood Substitutes|blood substitutes|mesh-ancestor
5735616|NCT03133195|Vitamin D|vitamin d|mesh-list
5735617|NCT03133195|Teriparatide|teriparatide|mesh-list
5735618|NCT03133195|Calcium|calcium|mesh-list
5735619|NCT03133195|Parathyroid Hormone|parathyroid hormone|mesh-list
5735620|NCT03133195|Vitamins|vitamins|mesh-ancestor
5735621|NCT03133195|Micronutrients|micronutrients|mesh-ancestor
5735622|NCT03133195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735623|NCT03133195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5735624|NCT03133195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5735625|NCT03133221|Idelalisib|idelalisib|mesh-list
5735626|NCT03133221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5735627|NCT03133221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5735628|NCT03133221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5735629|NCT03133299|Vitamin D|vitamin d|mesh-list
5735630|NCT03133299|Glucocorticoids|glucocorticoids|mesh-list
5735631|NCT03133299|Vitamins|vitamins|mesh-ancestor
5735632|NCT03133299|Micronutrients|micronutrients|mesh-ancestor
5735633|NCT03133299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735634|NCT03133299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5735635|NCT03133299|Hormones|hormones|mesh-ancestor
5735636|NCT03133299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5735637|NCT03132688|Propofol|propofol|mesh-list
5735638|NCT03132688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5735639|NCT03132688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5735640|NCT03132688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735641|NCT03132688|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5735642|NCT03132688|Anesthetics, General|anesthetics, general|mesh-ancestor
5735643|NCT03132688|Anesthetics|anesthetics|mesh-ancestor
5735644|NCT03132779|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
5735645|NCT03132779|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
5735646|NCT03132779|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5735647|NCT03132779|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5735648|NCT03132623|Andrographolide|andrographolide|mesh-list
5735649|NCT03132623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5735650|NCT03132623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5735651|NCT03132623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5735652|NCT03132623|Analgesics|analgesics|mesh-ancestor
5735653|NCT03132623|Sensory System Agents|sensory system agents|mesh-ancestor
5735654|NCT03132623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5735655|NCT03132623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735656|NCT03132623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5735657|NCT03132623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5735658|NCT03132623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5616309|NCT04944017|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5616310|NCT04944017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5616311|NCT04944017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616312|NCT04933344|Daptomycin|daptomycin|mesh-list
5616313|NCT04933344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5616314|NCT04933344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5616315|NCT04930783|Nivolumab|nivolumab|mesh-list
5616316|NCT04930783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5616317|NCT04930783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5616318|NCT04930783|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5616319|NCT04930783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616320|NCT04925193|Dexamethasone|dexamethasone|mesh-list
5735659|NCT03132623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5735660|NCT03132623|Antiviral Agents|antiviral agents|mesh-ancestor
5735661|NCT03132623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5735662|NCT03132714|Amoxicillin|amoxicillin|mesh-list
5735663|NCT03132714|Metronidazole|metronidazole|mesh-list
5735664|NCT03132714|Clarithromycin|clarithromycin|mesh-list
5735665|NCT03132714|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5735666|NCT03132714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5735667|NCT03132714|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5735668|NCT03132714|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5735669|NCT03132714|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5735670|NCT03132714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5735671|NCT03132714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5735672|NCT03132714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5735673|NCT03132714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5735674|NCT03132610|Andrographolide|andrographolide|mesh-list
5735675|NCT03132610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5735676|NCT03132610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5735677|NCT03132610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5735678|NCT03132610|Analgesics|analgesics|mesh-ancestor
5735679|NCT03132610|Sensory System Agents|sensory system agents|mesh-ancestor
5735680|NCT03132610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5735681|NCT03132610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735682|NCT03132610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5735683|NCT03132610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5735684|NCT03132610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5735685|NCT03132610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5735686|NCT03132610|Antiviral Agents|antiviral agents|mesh-ancestor
5735687|NCT03132610|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5735688|NCT03132701|Magnesium Sulfate|magnesium sulfate|mesh-list
5735689|NCT03132701|Analgesics|analgesics|mesh-ancestor
5735690|NCT03132701|Sensory System Agents|sensory system agents|mesh-ancestor
5735691|NCT03132701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5735692|NCT03132701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735693|NCT03132701|Anesthetics|anesthetics|mesh-ancestor
5735694|NCT03132701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5735695|NCT03132701|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5735696|NCT03132701|Anticonvulsants|anticonvulsants|mesh-ancestor
5735697|NCT03132701|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5735698|NCT03132701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5735699|NCT03132701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5735700|NCT03132701|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5735701|NCT03132701|Tocolytic Agents|tocolytic agents|mesh-ancestor
5735702|NCT03132701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5735703|NCT03132636|Cemiplimab|cemiplimab|mesh-list
5735704|NCT03132636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5616321|NCT04925193|Daratumumab|daratumumab|mesh-list
5616322|NCT04925193|Pomalidomide|pomalidomide|mesh-list
5616323|NCT04925193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5616324|NCT04925193|Antiemetics|antiemetics|mesh-ancestor
5616325|NCT04925193|Autonomic Agents|autonomic agents|mesh-ancestor
5735705|NCT03132636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5893207|NCT02624596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5893208|NCT02624596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893209|NCT02624596|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5893210|NCT02624596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5616326|NCT04925193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5616327|NCT04925193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616328|NCT04925193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5616329|NCT04925193|Glucocorticoids|glucocorticoids|mesh-ancestor
5616330|NCT04925193|Hormones|hormones|mesh-ancestor
5616331|NCT04925193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5616332|NCT04925193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5616333|NCT04925193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5616334|NCT04925193|Immunologic Factors|immunologic factors|mesh-ancestor
5616335|NCT04925193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5616336|NCT04925193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5616337|NCT04925193|Growth Substances|growth substances|mesh-ancestor
5616338|NCT04925193|Growth Inhibitors|growth inhibitors|mesh-ancestor
5616339|NCT04925180|Cyproterone Acetate|cyproterone acetate|mesh-list
5735706|NCT03132584|Cyclophosphamide|cyclophosphamide|mesh-list
5735707|NCT03132584|Alemtuzumab|alemtuzumab|mesh-list
5735708|NCT03132584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5735709|NCT03132584|Immunologic Factors|immunologic factors|mesh-ancestor
5735710|NCT03132584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735711|NCT03132584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5735712|NCT03132584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5735713|NCT03132584|Alkylating Agents|alkylating agents|mesh-ancestor
5735714|NCT03132584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5735715|NCT03132584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5616340|NCT04925180|Cyproterone|cyproterone|mesh-list
5616341|NCT04925180|Androgen Antagonists|androgen antagonists|mesh-ancestor
5616342|NCT04925180|Hormone Antagonists|hormone antagonists|mesh-ancestor
5616343|NCT04925180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5616344|NCT04925180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616345|NCT04925180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5616346|NCT04925180|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5616347|NCT04925180|Contraceptive Agents|contraceptive agents|mesh-ancestor
5616348|NCT04925180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5616349|NCT04886531|Trastuzumab|trastuzumab|mesh-list
5616350|NCT04886531|Letrozole|letrozole|mesh-list
5616351|NCT04886531|Anastrozole|anastrozole|mesh-list
5616352|NCT04886531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5616353|NCT04886531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5616354|NCT04886531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5616355|NCT04886531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5616356|NCT04886531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5616357|NCT04886531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616358|NCT04886531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5616359|NCT04886531|Hormone Antagonists|hormone antagonists|mesh-ancestor
5616360|NCT04886531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5616361|NCT04886531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616362|NCT04886531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5616379|NCT04786067|Abatacept|abatacept|mesh-list
5616380|NCT04786067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5616381|NCT04786067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616382|NCT04786067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5616383|NCT04786067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5616384|NCT04786067|Immunologic Factors|immunologic factors|mesh-ancestor
5616385|NCT04786067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616386|NCT04786067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5735716|NCT03132584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5735717|NCT03132584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5735718|NCT03132272|Autoantibodies|autoantibodies|mesh-list
5735719|NCT03132272|Immunologic Factors|immunologic factors|mesh-ancestor
5735720|NCT03132272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735721|NCT03132493|Nivolumab|nivolumab|mesh-list
5735722|NCT03132493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5735723|NCT03132493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5735724|NCT03132493|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5735725|NCT03132493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5735726|NCT03132519|Remifentanil|remifentanil|mesh-list
5735727|NCT03132519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5735728|NCT03132519|Narcotics|narcotics|mesh-ancestor
5735729|NCT03132519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5735730|NCT03132519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735731|NCT03132519|Analgesics|analgesics|mesh-ancestor
5616387|NCT04775680|Antibodies|antibodies|mesh-list
5735732|NCT03132519|Sensory System Agents|sensory system agents|mesh-ancestor
5735733|NCT03132519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5735734|NCT03132233|Calcium|calcium|mesh-list
5735735|NCT03132233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5735736|NCT03132233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735737|NCT03132142|Cinnamaldehyde|cinnamaldehyde|mesh-list
5735738|NCT03132142|Capsaicin|capsaicin|mesh-list
5735739|NCT03132142|Menthol|menthol|mesh-list
5735740|NCT03132142|Antipruritics|antipruritics|mesh-ancestor
5735741|NCT03132142|Dermatologic Agents|dermatologic agents|mesh-ancestor
5735742|NCT03132142|Sensory System Agents|sensory system agents|mesh-ancestor
5735743|NCT03132142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5735744|NCT03132142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735745|NCT03132142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5735746|NCT03132142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5735747|NCT03132142|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
5616388|NCT04775680|Immunologic Factors|immunologic factors|mesh-ancestor
5616389|NCT04775680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616390|NCT04772222|Dexmedetomidine|dexmedetomidine|mesh-list
5735748|NCT03132142|Protective Agents|protective agents|mesh-ancestor
5735749|NCT03132194|Dapsone|dapsone|mesh-list
5735750|NCT03132194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5735751|NCT03132194|Antimalarials|antimalarials|mesh-ancestor
5735752|NCT03132194|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5735753|NCT03132194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5735754|NCT03132194|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5735755|NCT03132194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5735756|NCT03132194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5735757|NCT03132194|Leprostatic Agents|leprostatic agents|mesh-ancestor
5735758|NCT03132194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5735759|NCT03132311|Vaccines|vaccines|mesh-list
5616391|NCT04772222|Morphine|morphine|mesh-list
5616392|NCT04772222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5616393|NCT04772222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5616394|NCT04772222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616395|NCT04772222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5616396|NCT04772222|Analgesics|analgesics|mesh-ancestor
5616397|NCT04772222|Sensory System Agents|sensory system agents|mesh-ancestor
5616398|NCT04772222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5616399|NCT04772222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5616400|NCT04772222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5616401|NCT04772222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5616402|NCT04772222|Adrenergic Agents|adrenergic agents|mesh-ancestor
5616403|NCT04772222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5616404|NCT04772222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616405|NCT04772222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5616406|NCT04772222|Narcotics|narcotics|mesh-ancestor
5616407|NCT04760613|Cannabidiol|cannabidiol|mesh-list
5616408|NCT04760613|Anticonvulsants|anticonvulsants|mesh-ancestor
5616409|NCT04757363|Oxaliplatin|oxaliplatin|mesh-list
5616410|NCT04757363|Nivolumab|nivolumab|mesh-list
5616411|NCT04757363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5616412|NCT04757363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5616413|NCT04757363|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5616414|NCT04757363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616415|NCT04738292|Fulvestrant|fulvestrant|mesh-list
5616416|NCT04738292|Onapristone|onapristone|mesh-list
5616417|NCT04738292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5616418|NCT04738292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5616419|NCT04738292|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5616420|NCT04738292|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5616421|NCT04738292|Hormone Antagonists|hormone antagonists|mesh-ancestor
5616422|NCT04738292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5616423|NCT04738292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616424|NCT04738292|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5616425|NCT04738292|Fertility Agents|fertility agents|mesh-ancestor
5616426|NCT04738292|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5616427|NCT04722679|Anticoagulants|anticoagulants|mesh-list
5616428|NCT04699630|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
5616429|NCT04699630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5616430|NCT04699630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5616431|NCT04681417|Carboplatin|carboplatin|mesh-list
5616432|NCT04681417|Etoposide|etoposide|mesh-list
5616433|NCT04681417|Etoposide phosphate|etoposide phosphate|mesh-list
5616434|NCT04681417|Vincristine|vincristine|mesh-list
5735760|NCT03132311|Immunologic Factors|immunologic factors|mesh-ancestor
5893211|NCT02624596|Anesthetics, General|anesthetics, general|mesh-ancestor
5735761|NCT03132311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735762|NCT03132376|Caseins|caseins|mesh-list
5735763|NCT03132376|Chelating Agents|chelating agents|mesh-ancestor
5735764|NCT03132376|Sequestering Agents|sequestering agents|mesh-ancestor
5735765|NCT03132376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5735766|NCT03132259|Dexmedetomidine|dexmedetomidine|mesh-list
5735767|NCT03132259|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5735768|NCT03132259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5735769|NCT03132259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735770|NCT03132259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5735771|NCT03132259|Analgesics|analgesics|mesh-ancestor
5735772|NCT03132259|Sensory System Agents|sensory system agents|mesh-ancestor
5735773|NCT03132259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5616435|NCT04681417|Melphalan|melphalan|mesh-list
5616436|NCT04681417|Topotecan|topotecan|mesh-list
5616437|NCT04681417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5735774|NCT03132259|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5735775|NCT03132259|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5735776|NCT03132259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5735777|NCT03132259|Adrenergic Agents|adrenergic agents|mesh-ancestor
5735778|NCT03132259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5735779|NCT03132259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5735780|NCT03132181|Empagliflozin|empagliflozin|mesh-list
5735781|NCT03132181|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5735782|NCT03132181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5735783|NCT03132181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5735784|NCT03132181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616438|NCT04681417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5616439|NCT04681417|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5616440|NCT04681417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5616441|NCT04681417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5616442|NCT04681417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5735785|NCT03132103|Vitamin D|vitamin d|mesh-list
5735786|NCT03132103|Ergocalciferols|ergocalciferols|mesh-list
5735787|NCT03132103|Cholecalciferol|cholecalciferol|mesh-list
5735788|NCT03132103|Vitamins|vitamins|mesh-list
5735789|NCT03132103|Micronutrients|micronutrients|mesh-ancestor
5735790|NCT03132103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735791|NCT03132103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5735792|NCT03132103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5735793|NCT03132116|Gentamicins|gentamicins|mesh-list
5735794|NCT03132116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5735795|NCT03132116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5735796|NCT03132116|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5735797|NCT03132116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5735798|NCT03132116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5735799|NCT03132168|Anesthetics|anesthetics|mesh-list
5735800|NCT03132168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5735801|NCT03132168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735802|NCT03132025|Capecitabine|capecitabine|mesh-list
5735803|NCT03132025|Apatinib|apatinib|mesh-list
5735804|NCT03132025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5735805|NCT03132025|Antimetabolites|antimetabolites|mesh-ancestor
5735806|NCT03132025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5735807|NCT03132025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5735808|NCT03132025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5735809|NCT03132025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5735810|NCT03132051|Triamcinolone|triamcinolone|mesh-list
5735811|NCT03132051|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5735812|NCT03132051|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5616443|NCT04681417|Tubulin Modulators|tubulin modulators|mesh-ancestor
5616444|NCT04681417|Antimitotic Agents|antimitotic agents|mesh-ancestor
5616445|NCT04681417|Mitosis Modulators|mitosis modulators|mesh-ancestor
5616446|NCT04681417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5616447|NCT04681417|Alkylating Agents|alkylating agents|mesh-ancestor
5616448|NCT04681417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5616449|NCT04681417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5616450|NCT04681417|Immunologic Factors|immunologic factors|mesh-ancestor
5616451|NCT04681417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616452|NCT04681417|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5616453|NCT04658849|Pioglitazone|pioglitazone|mesh-list
5735813|NCT03132051|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5616454|NCT04658849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5616455|NCT04658849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735814|NCT03132051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5616456|NCT04657640|Iron|iron|mesh-list
5616457|NCT04657640|Trace Elements|trace elements|mesh-list
5616458|NCT04657640|Folic Acid|folic acid|mesh-list
5616459|NCT04657640|Micronutrients|micronutrients|mesh-list
5616460|NCT04657640|Vitamin B Complex|vitamin b complex|mesh-list
5616461|NCT04657640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616462|NCT04657640|Hematinics|hematinics|mesh-ancestor
5616463|NCT04657640|Vitamins|vitamins|mesh-ancestor
5616464|NCT04651088|Potassium Citrate|potassium citrate|mesh-list
5616465|NCT04651088|Diuretics|diuretics|mesh-ancestor
5616466|NCT04651088|Natriuretic Agents|natriuretic agents|mesh-ancestor
5616467|NCT04651088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616468|NCT04651088|Expectorants|expectorants|mesh-ancestor
5616469|NCT04651088|Respiratory System Agents|respiratory system agents|mesh-ancestor
5692267|NCT03410446|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5692268|NCT03410446|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5692269|NCT03410446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5692270|NCT03410446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692271|NCT03410355|Cortisone|cortisone|mesh-list
5735815|NCT03132051|Glucocorticoids|glucocorticoids|mesh-ancestor
5735816|NCT03132051|Hormones|hormones|mesh-ancestor
5735817|NCT03132051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5735818|NCT03132051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735819|NCT03132051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5692272|NCT03410355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5692273|NCT03410212|Ketorolac|ketorolac|mesh-list
5692274|NCT03410212|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
5692275|NCT03410212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5692276|NCT03410212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5692277|NCT03410212|Analgesics|analgesics|mesh-ancestor
5692278|NCT03410212|Sensory System Agents|sensory system agents|mesh-ancestor
5692279|NCT03410212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5692280|NCT03410212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692281|NCT03410212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5692282|NCT03410212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5692283|NCT03410212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5692284|NCT03410212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5735820|NCT03132051|Immunologic Factors|immunologic factors|mesh-ancestor
5735821|NCT03132051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5735822|NCT03132051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5735823|NCT03131908|Pembrolizumab|pembrolizumab|mesh-list
5735824|NCT03131908|GSK2636771|gsk2636771|mesh-list
5735825|NCT03131908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5735826|NCT03131908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5692285|NCT03410212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692286|NCT03410043|Osimertinib|osimertinib|mesh-list
5692287|NCT03410043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5692288|NCT03410043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5692289|NCT03410043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5692290|NCT03410043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697624|NCT03374670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697625|NCT03374670|Growth Inhibitors|growth inhibitors|mesh-ancestor
5735827|NCT03131908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5735828|NCT03131908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5735829|NCT03131908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5735830|NCT03131700|Bevacizumab|bevacizumab|mesh-list
5735831|NCT03131700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5735832|NCT03131700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5697626|NCT03374670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5697627|NCT03374540|Vitamin K|vitamin k|mesh-list
5697628|NCT03374540|Rivaroxaban|rivaroxaban|mesh-list
5697629|NCT03374540|Vitamins|vitamins|mesh-ancestor
5697630|NCT03374540|Micronutrients|micronutrients|mesh-ancestor
5697631|NCT03374540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735833|NCT03131700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5735834|NCT03131700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5735835|NCT03131700|Growth Substances|growth substances|mesh-ancestor
5735836|NCT03131700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735837|NCT03131700|Growth Inhibitors|growth inhibitors|mesh-ancestor
5735838|NCT03131791|Botulinum Toxins|botulinum toxins|mesh-list
5735839|NCT03131791|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5735840|NCT03131791|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5735841|NCT03131791|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5697632|NCT03374540|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5697633|NCT03374540|Antithrombins|antithrombins|mesh-ancestor
5735842|NCT03131791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5735843|NCT03131791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5735844|NCT03131791|Cholinergic Agents|cholinergic agents|mesh-ancestor
5735845|NCT03131791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5735846|NCT03131791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735847|NCT03131791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5735848|NCT03131791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5735849|NCT03131843|Ethanol|ethanol|mesh-list
5735850|NCT03131843|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5735851|NCT03131843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5735852|NCT03131843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5735853|NCT03131843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735854|NCT03131973|Leucovorin|leucovorin|mesh-list
5735855|NCT03131973|Flurbiprofen|flurbiprofen|mesh-list
5735856|NCT03131973|Methotrexate|methotrexate|mesh-list
5735857|NCT03131973|Digoxin|digoxin|mesh-list
5735858|NCT03131973|Midazolam|midazolam|mesh-list
5735859|NCT03131973|Caffeine|caffeine|mesh-list
5735860|NCT03131973|Omeprazole|omeprazole|mesh-list
5735861|NCT03131973|Pravastatin|pravastatin|mesh-list
5735862|NCT03131973|Montelukast|montelukast|mesh-list
5735863|NCT03131973|Branebrutinib|branebrutinib|mesh-list
5616470|NCT04595513|Sirolimus|sirolimus|mesh-list
5616471|NCT04595513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5616472|NCT04595513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5735864|NCT03131973|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5735865|NCT03131973|Abortifacient Agents|abortifacient agents|mesh-ancestor
5735866|NCT03131973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5735867|NCT03131973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735868|NCT03131973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5735869|NCT03131973|Antimetabolites|antimetabolites|mesh-ancestor
5735870|NCT03131973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5735871|NCT03131973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5735872|NCT03131973|Dermatologic Agents|dermatologic agents|mesh-ancestor
5735873|NCT03131973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5735874|NCT03131973|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5735875|NCT03131973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5735876|NCT03131973|Immunologic Factors|immunologic factors|mesh-ancestor
5735877|NCT03131973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5735878|NCT03131973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5735879|NCT03131973|Antidotes|antidotes|mesh-ancestor
5735880|NCT03131973|Protective Agents|protective agents|mesh-ancestor
5735881|NCT03131973|Vitamin B Complex|vitamin b complex|mesh-ancestor
5735882|NCT03131973|Vitamins|vitamins|mesh-ancestor
5735883|NCT03131973|Micronutrients|micronutrients|mesh-ancestor
5735884|NCT03131973|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5735885|NCT03131973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5735886|NCT03131973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5735887|NCT03131973|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5735888|NCT03131973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5735889|NCT03131973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5735890|NCT03131973|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5735891|NCT03131973|Anesthetics, General|anesthetics, general|mesh-ancestor
5735892|NCT03131973|Anesthetics|anesthetics|mesh-ancestor
5735893|NCT03131973|GABA Modulators|gaba modulators|mesh-ancestor
5735894|NCT03131973|GABA Agents|gaba agents|mesh-ancestor
5735895|NCT03131973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5616473|NCT04595513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5616474|NCT04595513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5616475|NCT04595513|Antifungal Agents|antifungal agents|mesh-ancestor
5616476|NCT04595513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5616477|NCT04595513|Immunologic Factors|immunologic factors|mesh-ancestor
5616478|NCT04595513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616479|NCT04589832|Entrectinib|entrectinib|mesh-list
5616480|NCT04589832|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5616481|NCT04589832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5735896|NCT03131973|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5735897|NCT03131973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5735898|NCT03131973|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5735899|NCT03131973|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5735900|NCT03131973|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5735901|NCT03131973|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5735902|NCT03131973|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5735903|NCT03131973|Purinergic Agents|purinergic agents|mesh-ancestor
5616482|NCT04589832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5735904|NCT03131973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5735905|NCT03131973|Respiratory System Agents|respiratory system agents|mesh-ancestor
5735906|NCT03131973|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5735907|NCT03131973|Hormone Antagonists|hormone antagonists|mesh-ancestor
5735908|NCT03131973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5735909|NCT03131973|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5735910|NCT03131973|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5735911|NCT03131973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5735912|NCT03131973|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5735913|NCT03131973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5735914|NCT03131973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5735915|NCT03131973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5735916|NCT03131973|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5735917|NCT03131973|Analgesics|analgesics|mesh-ancestor
5735918|NCT03131973|Sensory System Agents|sensory system agents|mesh-ancestor
5735919|NCT03131973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5735920|NCT03131973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5735921|NCT03131973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5735922|NCT03131973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5735923|NCT03131973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5735924|NCT03131973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5735925|NCT03131882|Triamcinolone|triamcinolone|mesh-list
5735926|NCT03131882|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5735927|NCT03131882|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5735928|NCT03131882|Hyaluronic Acid|hyaluronic acid|mesh-list
5735929|NCT03131882|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5735930|NCT03131882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5735931|NCT03131882|Glucocorticoids|glucocorticoids|mesh-ancestor
5735932|NCT03131882|Hormones|hormones|mesh-ancestor
5735933|NCT03131882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5735934|NCT03131882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616483|NCT04575181|Insulin|insulin|mesh-list
5616484|NCT04575181|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5616485|NCT04575181|Insulin Glargine|insulin glargine|mesh-list
5616486|NCT04575181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5616487|NCT04575181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616488|NCT04560881|Vaccines|vaccines|mesh-list
5616489|NCT04560881|Immunologic Factors|immunologic factors|mesh-ancestor
5616490|NCT04560881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616491|NCT04501120|Azacitidine|azacitidine|mesh-list
5616492|NCT04501120|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5616493|NCT04501120|Antimetabolites|antimetabolites|mesh-ancestor
5616494|NCT04501120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616495|NCT04501120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5616496|NCT04501120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5616497|NCT04498715|Zoledronic Acid|zoledronic acid|mesh-list
5616498|NCT04498715|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5616499|NCT04498715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616500|NCT04497961|Lenalidomide|lenalidomide|mesh-list
5616501|NCT04497961|Daratumumab|daratumumab|mesh-list
5616502|NCT04497961|Immunologic Factors|immunologic factors|mesh-ancestor
5616503|NCT04497961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616504|NCT04497961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5616505|NCT04497961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5616506|NCT04497961|Growth Substances|growth substances|mesh-ancestor
5616507|NCT04497961|Growth Inhibitors|growth inhibitors|mesh-ancestor
5616508|NCT04497961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5616509|NCT04483583|Clopidogrel|clopidogrel|mesh-list
5616510|NCT04483583|Ticagrelor|ticagrelor|mesh-list
5616511|NCT04483583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5616512|NCT04483583|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5616513|NCT04483583|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5616514|NCT04483583|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5616515|NCT04483583|Purinergic Agents|purinergic agents|mesh-ancestor
5616516|NCT04483583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5616517|NCT04483583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616518|NCT04483583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616519|NCT04460183|Nitric Oxide|nitric oxide|mesh-list
5616520|NCT04460183|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5616521|NCT04460183|Autonomic Agents|autonomic agents|mesh-ancestor
5616522|NCT04460183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5616523|NCT04460183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616524|NCT04460183|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5616525|NCT04460183|Respiratory System Agents|respiratory system agents|mesh-ancestor
5616526|NCT04460183|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5616527|NCT04460183|Antioxidants|antioxidants|mesh-ancestor
5616528|NCT04460183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616529|NCT04460183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5616530|NCT04460183|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5616531|NCT04460183|Vasodilator Agents|vasodilator agents|mesh-ancestor
5616532|NCT04460183|Gasotransmitters|gasotransmitters|mesh-ancestor
5616533|NCT04460183|Protective Agents|protective agents|mesh-ancestor
5616534|NCT04447287|Buprenorphine|buprenorphine|mesh-list
5616535|NCT04447287|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
5616536|NCT04447287|Naloxone|naloxone|mesh-list
5616537|NCT04447287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5616538|NCT04447287|Narcotics|narcotics|mesh-ancestor
5616539|NCT04447287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5616540|NCT04447287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616541|NCT04447287|Analgesics|analgesics|mesh-ancestor
5616542|NCT04447287|Sensory System Agents|sensory system agents|mesh-ancestor
5616543|NCT04447287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5616544|NCT04447287|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5616545|NCT04416048|Rivaroxaban|rivaroxaban|mesh-list
5735935|NCT03131882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5735936|NCT03131882|Immunologic Factors|immunologic factors|mesh-ancestor
5735937|NCT03131882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5735938|NCT03131882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5735939|NCT03131882|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5735940|NCT03131882|Viscosupplements|viscosupplements|mesh-ancestor
5735941|NCT03131882|Protective Agents|protective agents|mesh-ancestor
5735942|NCT03131765|Poly I-C|poly i-c|mesh-list
5735943|NCT03131765|Antiviral Agents|antiviral agents|mesh-ancestor
5735944|NCT03131765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5735945|NCT03131765|Interferon Inducers|interferon inducers|mesh-ancestor
5735946|NCT03131765|Immunologic Factors|immunologic factors|mesh-ancestor
5735947|NCT03131765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735948|NCT03131622|Coal Tar|coal tar|mesh-list
5735949|NCT03131622|Keratolytic Agents|keratolytic agents|mesh-ancestor
5735950|NCT03131622|Dermatologic Agents|dermatologic agents|mesh-ancestor
5735951|NCT03131583|Colchicine|colchicine|mesh-list
5735952|NCT03131583|Febuxostat|febuxostat|mesh-list
5735953|NCT03131583|Gout Suppressants|gout suppressants|mesh-ancestor
5735954|NCT03131583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5735955|NCT03131583|Tubulin Modulators|tubulin modulators|mesh-ancestor
5735956|NCT03131583|Antimitotic Agents|antimitotic agents|mesh-ancestor
5735957|NCT03131583|Mitosis Modulators|mitosis modulators|mesh-ancestor
5735958|NCT03131583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5735959|NCT03131583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5735960|NCT03131336|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
5735961|NCT03131336|Fibrin Foam|fibrin foam|mesh-list
5735962|NCT03131336|Hemostatics|hemostatics|mesh-ancestor
5735963|NCT03131336|Coagulants|coagulants|mesh-ancestor
5735964|NCT03131375|Dexmedetomidine|dexmedetomidine|mesh-list
5735965|NCT03131375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5735966|NCT03131375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5735967|NCT03131375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735968|NCT03131375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5735969|NCT03131375|Analgesics|analgesics|mesh-ancestor
5735970|NCT03131375|Sensory System Agents|sensory system agents|mesh-ancestor
5735971|NCT03131375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5735972|NCT03131375|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5735973|NCT03131375|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5735974|NCT03131375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5735975|NCT03131375|Adrenergic Agents|adrenergic agents|mesh-ancestor
5735976|NCT03131375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5735977|NCT03131375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5735978|NCT03130933|Amoxicillin|amoxicillin|mesh-list
5735979|NCT03130933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5735980|NCT03130933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5735981|NCT03131050|Scopolamine|scopolamine|mesh-list
5735982|NCT03131050|Citalopram|citalopram|mesh-list
5735983|NCT03131050|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
5735984|NCT03131050|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5735985|NCT03131050|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5616546|NCT04416048|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5616547|NCT04416048|Antithrombins|antithrombins|mesh-ancestor
5616548|NCT04416048|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5616549|NCT04416048|Protease Inhibitors|protease inhibitors|mesh-ancestor
5735986|NCT03131050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5616550|NCT04416048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5735987|NCT03131050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5735988|NCT03131050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5735989|NCT03131050|Serotonin Agents|serotonin agents|mesh-ancestor
5735990|NCT03131050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5735991|NCT03131050|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5735992|NCT03131050|Antidepressive Agents|antidepressive agents|mesh-ancestor
5735993|NCT03131050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5616551|NCT04416048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616552|NCT04416048|Anticoagulants|anticoagulants|mesh-ancestor
5616553|NCT04410562|Hydroxychloroquine|hydroxychloroquine|mesh-list
5616554|NCT04410562|Antimalarials|antimalarials|mesh-ancestor
5616555|NCT04410562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5616556|NCT04410562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5616557|NCT04410562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5616558|NCT04410562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5616559|NCT04410562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616560|NCT04410562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5616561|NCT04393350|Pembrolizumab|pembrolizumab|mesh-list
5616562|NCT04393350|Lenvatinib|lenvatinib|mesh-list
5735994|NCT03131050|Parasympatholytics|parasympatholytics|mesh-ancestor
5735995|NCT03131050|Autonomic Agents|autonomic agents|mesh-ancestor
5735996|NCT03131050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5735997|NCT03131050|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5735998|NCT03131050|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5735999|NCT03131050|Cholinergic Agents|cholinergic agents|mesh-ancestor
5736000|NCT03131050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5736001|NCT03131050|Antiemetics|antiemetics|mesh-ancestor
5736002|NCT03131050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5736003|NCT03131050|Mydriatics|mydriatics|mesh-ancestor
5736004|NCT03131063|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5736005|NCT03131063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5736006|NCT03131037|Valacyclovir|valacyclovir|mesh-list
5616563|NCT04393350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5616564|NCT04393350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5616565|NCT04393350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5616566|NCT04393350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5616567|NCT04393350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616568|NCT04336735|Vaccines|vaccines|mesh-list
5616569|NCT04336735|Immunologic Factors|immunologic factors|mesh-ancestor
5616570|NCT04336735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616571|NCT04322006|Antibodies|antibodies|mesh-list
5616572|NCT04322006|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5736007|NCT03131037|Antiviral Agents|antiviral agents|mesh-ancestor
5736008|NCT03131037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5736009|NCT03131141|Lefamulin|lefamulin|mesh-list
5736010|NCT03131141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5736011|NCT03131141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5893212|NCT02624596|Anesthetics|anesthetics|mesh-ancestor
5893213|NCT02624596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5893214|NCT02624596|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6489233|NCT00590174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6489234|NCT00590174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5893215|NCT02624596|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5893216|NCT02624596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5893217|NCT02624596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893218|NCT02624596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5893219|NCT02624596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5893220|NCT02624596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5893221|NCT02624596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5893222|NCT02624596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5893223|NCT02624596|GABA Modulators|gaba modulators|mesh-ancestor
5893224|NCT02624596|GABA Agents|gaba agents|mesh-ancestor
5893225|NCT02582125|Nivolumab|nivolumab|mesh-list
5893226|NCT02582125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5893227|NCT02582125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5616573|NCT04322006|Immunologic Factors|immunologic factors|mesh-ancestor
5616574|NCT04322006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616575|NCT04300647|Atezolizumab|atezolizumab|mesh-list
5616576|NCT04300647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5616577|NCT04283669|Crizotinib|crizotinib|mesh-list
5616578|NCT04283669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5616579|NCT04283669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5616580|NCT04283669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5616581|NCT04283669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616582|NCT04262154|Prednisone|prednisone|mesh-list
5616583|NCT04262154|Atezolizumab|atezolizumab|mesh-list
5616584|NCT04262154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5616585|NCT04262154|Glucocorticoids|glucocorticoids|mesh-ancestor
5616586|NCT04262154|Hormones|hormones|mesh-ancestor
5616587|NCT04262154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5616588|NCT04262154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616589|NCT04262154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5616590|NCT04262154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5616591|NCT04226950|Interferons|interferons|mesh-list
5616592|NCT04226950|Interferon-alpha|interferon-alpha|mesh-list
5616593|NCT04226950|Interferon alpha-2|interferon alpha-2|mesh-list
5893228|NCT02582125|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5893229|NCT02582125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893230|NCT02356159|Rituximab|rituximab|mesh-list
5893231|NCT02356159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5893232|NCT02356159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5893233|NCT02356159|Immunologic Factors|immunologic factors|mesh-ancestor
5893234|NCT02356159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893235|NCT02356159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5893236|NCT02195947|Hormones|hormones|mesh-list
5893237|NCT02195947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5893238|NCT02195947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893239|NCT02175173|Rufinamide|rufinamide|mesh-list
5893240|NCT02175173|Anticonvulsants|anticonvulsants|mesh-ancestor
5893241|NCT02175173|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5893242|NCT02175173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5616594|NCT04226950|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
5616595|NCT04226950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5616596|NCT04226950|Antiviral Agents|antiviral agents|mesh-ancestor
5616597|NCT04226950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5616598|NCT04226950|Immunologic Factors|immunologic factors|mesh-ancestor
5616599|NCT04226950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616600|NCT04175964|Metformin|metformin|mesh-list
5616601|NCT04175964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5616602|NCT04175964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616603|NCT04175834|Cetirizine|cetirizine|mesh-list
5616604|NCT04175834|Histamine Antagonists|histamine antagonists|mesh-list
5616605|NCT04175834|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
5616606|NCT04175834|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5616607|NCT04175834|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5893243|NCT02175173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5893244|NCT02175173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893245|NCT02037048|Leucovorin|leucovorin|mesh-list
5893246|NCT02037048|Paclitaxel|paclitaxel|mesh-list
5893247|NCT02037048|Carboplatin|carboplatin|mesh-list
5616608|NCT04175834|Histamine Agents|histamine agents|mesh-ancestor
5736012|NCT03130855|Carticaine|carticaine|mesh-list
5616609|NCT04175834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5616610|NCT04175834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616611|NCT04175834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616612|NCT04171700|Rucaparib|rucaparib|mesh-list
5616613|NCT04171700|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5616614|NCT04171700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5616615|NCT04171700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616616|NCT04171700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5616617|NCT04157985|Pembrolizumab|pembrolizumab|mesh-list
5616618|NCT04157985|Nivolumab|nivolumab|mesh-list
5616619|NCT04157985|Ipilimumab|ipilimumab|mesh-list
5616620|NCT04157985|Cemiplimab|cemiplimab|mesh-list
5616621|NCT04157985|Atezolizumab|atezolizumab|mesh-list
5616622|NCT04157985|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5616623|NCT04157985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5616624|NCT04157985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5616625|NCT04157985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616626|NCT04125745|CXA-10|cxa-10|mesh-list
5616627|NCT04125745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5616628|NCT04074096|Pembrolizumab|pembrolizumab|mesh-list
5616629|NCT04074096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5616630|NCT04074096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5692291|NCT03409874|Diclofenac|diclofenac|mesh-list
5692292|NCT03409874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5692293|NCT03409874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5692294|NCT03409874|Analgesics|analgesics|mesh-ancestor
5692295|NCT03409874|Sensory System Agents|sensory system agents|mesh-ancestor
5692296|NCT03409874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5736013|NCT03130855|Anesthetics, Local|anesthetics, local|mesh-ancestor
5736014|NCT03130855|Anesthetics|anesthetics|mesh-ancestor
5736015|NCT03130855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5692297|NCT03409874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692298|NCT03409874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5692299|NCT03409874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5692300|NCT03409874|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5692301|NCT03409874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5692302|NCT03409874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692303|NCT03409848|Nivolumab|nivolumab|mesh-list
5692304|NCT03409848|Ipilimumab|ipilimumab|mesh-list
5692305|NCT03409848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5692306|NCT03409848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5692307|NCT03409848|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5692308|NCT03409848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736016|NCT03130855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736017|NCT03130855|Sensory System Agents|sensory system agents|mesh-ancestor
5736018|NCT03130855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5736019|NCT03130842|Midazolam|midazolam|mesh-list
5692309|NCT03409835|Ramosetron|ramosetron|mesh-list
5692310|NCT03409835|Antiemetics|antiemetics|mesh-ancestor
5692311|NCT03409835|Autonomic Agents|autonomic agents|mesh-ancestor
5692312|NCT03409835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5692313|NCT03409835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736020|NCT03130842|Alprazolam|alprazolam|mesh-list
5736021|NCT03130842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5736022|NCT03130842|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5736023|NCT03130842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5736024|NCT03130842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736025|NCT03130842|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5736026|NCT03130842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5736027|NCT03130842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5736028|NCT03130842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6672804|NCT01558622|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
6672805|NCT01558622|Ketoprofen|ketoprofen|mesh-list
6672806|NCT01558622|Meperidine|meperidine|mesh-list
6672807|NCT01558622|Tramadol|tramadol|mesh-list
6672808|NCT01558622|Vitamins|vitamins|mesh-ancestor
6672809|NCT01558622|Micronutrients|micronutrients|mesh-ancestor
6672810|NCT01558622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672811|NCT01558622|Antioxidants|antioxidants|mesh-ancestor
6672812|NCT01558622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736029|NCT03130842|Anesthetics, General|anesthetics, general|mesh-ancestor
5736030|NCT03130842|Anesthetics|anesthetics|mesh-ancestor
5736031|NCT03130842|GABA Modulators|gaba modulators|mesh-ancestor
5736032|NCT03130842|GABA Agents|gaba agents|mesh-ancestor
5736033|NCT03130842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6672813|NCT01558622|Protective Agents|protective agents|mesh-ancestor
5736034|NCT03130842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736035|NCT03130829|Fucoidan|fucoidan|mesh-list
5736036|NCT03130829|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5616631|NCT04070768|Venetoclax|venetoclax|mesh-list
5616632|NCT04070768|Gemtuzumab|gemtuzumab|mesh-list
5616633|NCT04070768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5616634|NCT04070768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5616635|NCT04060342|Gemcitabine|gemcitabine|mesh-list
5616636|NCT04060342|Paclitaxel|paclitaxel|mesh-list
5616637|NCT04060342|Pembrolizumab|pembrolizumab|mesh-list
5616638|NCT04060342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5616639|NCT04060342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5736037|NCT03130829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5736038|NCT03130829|Anticoagulants|anticoagulants|mesh-ancestor
5736039|NCT03130829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5736040|NCT03130764|Durvalumab|durvalumab|mesh-list
5736041|NCT03130764|Tremelimumab|tremelimumab|mesh-list
5736042|NCT03130764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5736043|NCT03130764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5736044|NCT03130504|Progesterone|progesterone|mesh-list
5736045|NCT03130504|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
5736046|NCT03130504|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
5736047|NCT03130504|Progestins|progestins|mesh-ancestor
5736048|NCT03130504|Hormones|hormones|mesh-ancestor
5736049|NCT03130504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5736050|NCT03130504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736051|NCT03130504|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5736052|NCT03130504|Hormone Antagonists|hormone antagonists|mesh-ancestor
5736053|NCT03130634|Silymarin|silymarin|mesh-list
5736054|NCT03130634|Antioxidants|antioxidants|mesh-ancestor
5736055|NCT03130634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736056|NCT03130634|Protective Agents|protective agents|mesh-ancestor
5736057|NCT03130634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616640|NCT04060342|Tubulin Modulators|tubulin modulators|mesh-ancestor
5616641|NCT04060342|Antimitotic Agents|antimitotic agents|mesh-ancestor
5736058|NCT03130556|Rabeprazole|rabeprazole|mesh-list
5736059|NCT03130556|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5736060|NCT03130556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5736061|NCT03130556|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5736062|NCT03130556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5736063|NCT03130556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736064|NCT03130452|Amoxicillin|amoxicillin|mesh-list
5736065|NCT03130452|Metronidazole|metronidazole|mesh-list
5736066|NCT03130452|Clarithromycin|clarithromycin|mesh-list
5736067|NCT03130452|Lansoprazole|lansoprazole|mesh-list
5736068|NCT03130452|Dexlansoprazole|dexlansoprazole|mesh-list
5736069|NCT03130452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5736070|NCT03130452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5736071|NCT03130452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5736072|NCT03130452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5736073|NCT03130452|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5736074|NCT03130452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5736075|NCT03130452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736076|NCT03130452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5736077|NCT03130452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5736078|NCT03130452|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5736079|NCT03130452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5736080|NCT03130452|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5616642|NCT04060342|Mitosis Modulators|mitosis modulators|mesh-ancestor
5616643|NCT04060342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616644|NCT04060342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5616645|NCT04060342|Antimetabolites|antimetabolites|mesh-ancestor
5616646|NCT04060342|Antiviral Agents|antiviral agents|mesh-ancestor
5616647|NCT04060342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5616648|NCT04060342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5736081|NCT03130426|Insulin|insulin|mesh-list
5736082|NCT03130426|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5736083|NCT03130426|Metformin|metformin|mesh-list
5736084|NCT03130426|Insulin Glargine|insulin glargine|mesh-list
5616649|NCT04060342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5616650|NCT04060342|Immunologic Factors|immunologic factors|mesh-ancestor
5616651|NCT04060342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616652|NCT04060342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5616653|NCT04058366|Ivacaftor|ivacaftor|mesh-list
5736085|NCT03130426|Lixisenatide|lixisenatide|mesh-list
5736086|NCT03130426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5736087|NCT03130426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736088|NCT03130582|Etoposide|etoposide|mesh-list
5736089|NCT03130582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5736090|NCT03130582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5736091|NCT03130582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5736092|NCT03130582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5736093|NCT03130582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5736094|NCT03130582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736095|NCT03130517|Immunoglobulins|immunoglobulins|mesh-list
5736096|NCT03130517|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5736097|NCT03130517|Antibodies|antibodies|mesh-list
5736098|NCT03130517|gamma-Globulins|gamma-globulins|mesh-list
5736099|NCT03130517|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5736100|NCT03130517|Immunologic Factors|immunologic factors|mesh-ancestor
5736101|NCT03130517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736102|NCT03130348|Dexamethasone|dexamethasone|mesh-list
5736103|NCT03130348|Dexamethasone acetate|dexamethasone acetate|mesh-list
5736104|NCT03130348|Bortezomib|bortezomib|mesh-list
5736105|NCT03130348|Ichthammol|ichthammol|mesh-list
5736106|NCT03130348|BB 1101|bb 1101|mesh-list
5736107|NCT03130348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5736108|NCT03130348|Antiemetics|antiemetics|mesh-ancestor
5736109|NCT03130348|Autonomic Agents|autonomic agents|mesh-ancestor
5736110|NCT03130348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5736111|NCT03130348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736112|NCT03130348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5736113|NCT03130348|Glucocorticoids|glucocorticoids|mesh-ancestor
5736114|NCT03130348|Hormones|hormones|mesh-ancestor
5736115|NCT03130348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5736116|NCT03130348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5736117|NCT03130348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5736118|NCT03130348|Protease Inhibitors|protease inhibitors|mesh-ancestor
5736119|NCT03130348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5736120|NCT03130348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736121|NCT03130348|Dermatologic Agents|dermatologic agents|mesh-ancestor
5736122|NCT03130179|Nicotine|nicotine|mesh-list
5736123|NCT03130179|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5736124|NCT03130179|Autonomic Agents|autonomic agents|mesh-ancestor
5736125|NCT03130179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5736126|NCT03130179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736127|NCT03130179|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5616654|NCT04058366|Elexacaftor|elexacaftor|mesh-list
5616655|NCT04058366|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
5616656|NCT04058366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5616657|NCT04058366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616658|NCT04042740|Ribavirin|ribavirin|mesh-list
5616659|NCT04042740|Antimetabolites|antimetabolites|mesh-ancestor
5616660|NCT04042740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616661|NCT04042740|Antiviral Agents|antiviral agents|mesh-ancestor
5616662|NCT04042740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5616663|NCT04039503|Tirzepatide|tirzepatide|mesh-list
5616664|NCT04039503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5616665|NCT04039503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616666|NCT04039503|Incretins|incretins|mesh-ancestor
5616667|NCT04039503|Hormones|hormones|mesh-ancestor
5736128|NCT03130179|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5736129|NCT03130179|Cholinergic Agents|cholinergic agents|mesh-ancestor
5736130|NCT03130179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5736131|NCT03130179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736132|NCT03130010|Nefopam|nefopam|mesh-list
5616668|NCT04039503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5616669|NCT04025879|Paclitaxel|paclitaxel|mesh-list
5616670|NCT04025879|Docetaxel|docetaxel|mesh-list
5736133|NCT03130010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5736134|NCT03130010|Analgesics|analgesics|mesh-ancestor
5736135|NCT03130010|Sensory System Agents|sensory system agents|mesh-ancestor
5736136|NCT03130010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5736137|NCT03130010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736138|NCT03130205|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5736139|NCT03130205|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5736140|NCT03130205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736141|NCT03130218|Peppermint oil|peppermint oil|mesh-list
5736142|NCT03130218|Antiemetics|antiemetics|mesh-ancestor
5736143|NCT03130218|Autonomic Agents|autonomic agents|mesh-ancestor
5736144|NCT03130218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5736145|NCT03130218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616671|NCT04025879|Carboplatin|carboplatin|mesh-list
5736146|NCT03130218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5616672|NCT04025879|Nivolumab|nivolumab|mesh-list
5616673|NCT04025879|Pemetrexed|pemetrexed|mesh-list
5616674|NCT04025879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5616675|NCT04025879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5616676|NCT04025879|Tubulin Modulators|tubulin modulators|mesh-ancestor
5616677|NCT04025879|Antimitotic Agents|antimitotic agents|mesh-ancestor
5736147|NCT03130218|Parasympatholytics|parasympatholytics|mesh-ancestor
5736148|NCT03130153|Aspirin|aspirin|mesh-list
5736149|NCT03130153|Salicylic Acid|salicylic acid|mesh-list
5736150|NCT03130153|Salicylates|salicylates|mesh-list
5736151|NCT03130153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5736152|NCT03130153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5616678|NCT04025879|Mitosis Modulators|mitosis modulators|mesh-ancestor
5616679|NCT04025879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616680|NCT04025879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5616681|NCT04025879|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5616682|NCT04025879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5616683|NCT04025879|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5616684|NCT04025879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5616685|NCT04004416|Lorazepam|lorazepam|mesh-list
5616686|NCT04004416|Anticonvulsants|anticonvulsants|mesh-ancestor
5616687|NCT04004416|Antiemetics|antiemetics|mesh-ancestor
5616688|NCT04004416|Autonomic Agents|autonomic agents|mesh-ancestor
5616689|NCT04004416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5616690|NCT04004416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616691|NCT04004416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5616692|NCT04004416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5616693|NCT04004416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5616694|NCT04004416|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5736153|NCT03130153|Analgesics|analgesics|mesh-ancestor
5736154|NCT03130153|Sensory System Agents|sensory system agents|mesh-ancestor
5736155|NCT03130153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5736156|NCT03130153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736157|NCT03130153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5736158|NCT03130153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5736159|NCT03130153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5736160|NCT03130153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5736161|NCT03130153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736162|NCT03130153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5736163|NCT03130153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5736164|NCT03130153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5736165|NCT03130153|Antipyretics|antipyretics|mesh-ancestor
5736166|NCT03130153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5736167|NCT03130153|Antifungal Agents|antifungal agents|mesh-ancestor
5736168|NCT03130153|Keratolytic Agents|keratolytic agents|mesh-ancestor
5736169|NCT03130153|Dermatologic Agents|dermatologic agents|mesh-ancestor
5736170|NCT03130114|Azithromycin|azithromycin|mesh-list
5736171|NCT03130114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5736172|NCT03130114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5736173|NCT03130127|Terlipressin|terlipressin|mesh-list
5736174|NCT03130127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5736175|NCT03130127|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5736176|NCT03130270|Apatinib|apatinib|mesh-list
5736177|NCT03130270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5736178|NCT03130270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5736179|NCT03130270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5736180|NCT03130270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736181|NCT03130101|Insulin|insulin|mesh-list
5736182|NCT03130101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5736183|NCT03130101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736184|NCT03129646|Paromomycin|paromomycin|mesh-list
5736185|NCT03129646|Miltefosine|miltefosine|mesh-list
5736186|NCT03129646|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
5736187|NCT03129646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5736188|NCT03129646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5736189|NCT03129646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5736190|NCT03129646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5736191|NCT03129646|Antifungal Agents|antifungal agents|mesh-ancestor
5736192|NCT03129646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5736193|NCT03129646|Schistosomicides|schistosomicides|mesh-ancestor
5736194|NCT03129646|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5736195|NCT03129646|Anthelmintics|anthelmintics|mesh-ancestor
5736196|NCT03129828|Bortezomib|bortezomib|mesh-list
5736197|NCT03129828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5616695|NCT04004416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5736198|NCT03129594|Glucagon|glucagon|mesh-list
5736199|NCT03129594|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5736200|NCT03129594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5736201|NCT03129594|Hormones|hormones|mesh-ancestor
5736202|NCT03129594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5736203|NCT03129594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736204|NCT03129594|Incretins|incretins|mesh-ancestor
5736205|NCT03129867|Ticagrelor|ticagrelor|mesh-list
5736206|NCT03129867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5736207|NCT03129867|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5736208|NCT03129867|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5736209|NCT03129867|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5736210|NCT03129867|Purinergic Agents|purinergic agents|mesh-ancestor
5736211|NCT03129867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5736212|NCT03129867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736213|NCT03129867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736214|NCT03129698|Apatinib|apatinib|mesh-list
5736215|NCT03129698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5736216|NCT03129698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5736217|NCT03129698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5736218|NCT03129698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736219|NCT03129347|Nalmefene|nalmefene|mesh-list
5736220|NCT03129347|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5736221|NCT03129347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736222|NCT03129347|Sensory System Agents|sensory system agents|mesh-ancestor
5736223|NCT03129347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5616696|NCT04004416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5616697|NCT04004416|GABA Modulators|gaba modulators|mesh-ancestor
5616698|NCT04004416|GABA Agents|gaba agents|mesh-ancestor
5616699|NCT04004416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5616700|NCT04004416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616701|NCT03913195|Ibalizumab|ibalizumab|mesh-list
5616702|NCT03913195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5616703|NCT03913195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5616704|NCT03913195|Antiviral Agents|antiviral agents|mesh-ancestor
5616705|NCT03913195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5616706|NCT03878199|Cytarabine|cytarabine|mesh-list
5616707|NCT03878199|Daunorubicin|daunorubicin|mesh-list
5616708|NCT03878199|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
5616709|NCT03878199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5616710|NCT03878199|Antimetabolites|antimetabolites|mesh-ancestor
5616711|NCT03878199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616712|NCT03878199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5616713|NCT03878199|Antiviral Agents|antiviral agents|mesh-ancestor
5616714|NCT03878199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5616715|NCT03878199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5616716|NCT03878199|Immunologic Factors|immunologic factors|mesh-ancestor
5616717|NCT03878199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893248|NCT02037048|Fluorouracil|fluorouracil|mesh-list
5893249|NCT02037048|Oxaliplatin|oxaliplatin|mesh-list
5893250|NCT02037048|Calcium|calcium|mesh-list
5893251|NCT02037048|Levoleucovorin|levoleucovorin|mesh-list
5616718|NCT03878199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5616719|NCT03878199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5616720|NCT03878199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5616721|NCT03878199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5616722|NCT03878199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5616723|NCT03818607|Eculizumab|eculizumab|mesh-list
5616724|NCT03818607|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5616725|NCT03818607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5616726|NCT03818607|Immunologic Factors|immunologic factors|mesh-ancestor
5616727|NCT03818607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616728|NCT03813121|Midazolam|midazolam|mesh-list
5893252|NCT02037048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5893253|NCT02037048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5893254|NCT02037048|Tubulin Modulators|tubulin modulators|mesh-ancestor
5893255|NCT02037048|Antimitotic Agents|antimitotic agents|mesh-ancestor
5893256|NCT02037048|Mitosis Modulators|mitosis modulators|mesh-ancestor
5893257|NCT02037048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893258|NCT02037048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5893259|NCT02037048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893260|NCT02037048|Antimetabolites|antimetabolites|mesh-ancestor
5893261|NCT02037048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5893262|NCT02037048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5616729|NCT03813121|Ketamine|ketamine|mesh-list
5616730|NCT03813121|Analgesics|analgesics|mesh-ancestor
5616731|NCT03813121|Sensory System Agents|sensory system agents|mesh-ancestor
5616732|NCT03813121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5616733|NCT03813121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736224|NCT03129490|Rivaroxaban|rivaroxaban|mesh-list
5736225|NCT03129490|Apixaban|apixaban|mesh-list
5736226|NCT03129490|Edoxaban|edoxaban|mesh-list
5736227|NCT03129490|Dabigatran|dabigatran|mesh-list
5736228|NCT03129490|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5736229|NCT03129490|Antithrombins|antithrombins|mesh-ancestor
5736230|NCT03129490|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5736231|NCT03129490|Protease Inhibitors|protease inhibitors|mesh-ancestor
5736232|NCT03129490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5736233|NCT03129490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736234|NCT03129490|Anticoagulants|anticoagulants|mesh-ancestor
5736235|NCT03129555|Rivaroxaban|rivaroxaban|mesh-list
5736236|NCT03129555|Apixaban|apixaban|mesh-list
5736237|NCT03129555|Edoxaban|edoxaban|mesh-list
5736238|NCT03129555|Dabigatran|dabigatran|mesh-list
5736239|NCT03129555|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5736240|NCT03129555|Antithrombins|antithrombins|mesh-ancestor
5736241|NCT03129555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5736242|NCT03129555|Protease Inhibitors|protease inhibitors|mesh-ancestor
5736243|NCT03129555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5736244|NCT03129555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736245|NCT03129555|Anticoagulants|anticoagulants|mesh-ancestor
5736246|NCT03129542|Midodrine|midodrine|mesh-list
5736247|NCT03129542|Sympathomimetics|sympathomimetics|mesh-ancestor
5736248|NCT03129542|Autonomic Agents|autonomic agents|mesh-ancestor
5616734|NCT03813121|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5616735|NCT03813121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5616736|NCT03813121|Anesthetics, General|anesthetics, general|mesh-ancestor
5616737|NCT03813121|Anesthetics|anesthetics|mesh-ancestor
5736249|NCT03129542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5736250|NCT03129542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736251|NCT03129542|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5736252|NCT03129542|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5736253|NCT03129542|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5616738|NCT03813121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5616739|NCT03813121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5616740|NCT03813121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5616741|NCT03813121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5616742|NCT03813121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616743|NCT03813121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5616744|NCT03813121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5616745|NCT03813121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5616746|NCT03813121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5616747|NCT03813121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5616748|NCT03813121|GABA Modulators|gaba modulators|mesh-ancestor
5616749|NCT03813121|GABA Agents|gaba agents|mesh-ancestor
5616750|NCT03778229|Osimertinib|osimertinib|mesh-list
5616751|NCT03778229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5616752|NCT03778229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5616753|NCT03778229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5616754|NCT03778229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616755|NCT03695172|Ropivacaine|ropivacaine|mesh-list
5616756|NCT03695172|Anesthetics, Local|anesthetics, local|mesh-ancestor
5616757|NCT03695172|Anesthetics|anesthetics|mesh-ancestor
5616758|NCT03695172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5616759|NCT03695172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616760|NCT03695172|Sensory System Agents|sensory system agents|mesh-ancestor
5616761|NCT03695172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5616762|NCT03554044|Tamoxifen|tamoxifen|mesh-list
5616763|NCT03554044|Gemcitabine|gemcitabine|mesh-list
5616764|NCT03554044|Paclitaxel|paclitaxel|mesh-list
5616765|NCT03554044|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5616766|NCT03554044|Carboplatin|carboplatin|mesh-list
5616767|NCT03554044|Letrozole|letrozole|mesh-list
5616768|NCT03554044|Fulvestrant|fulvestrant|mesh-list
5616769|NCT03554044|Anastrozole|anastrozole|mesh-list
5616770|NCT03554044|Exemestane|exemestane|mesh-list
5616771|NCT03554044|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
5616772|NCT03554044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5736254|NCT03129542|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5736255|NCT03129542|Adrenergic Agents|adrenergic agents|mesh-ancestor
5736256|NCT03129542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5736257|NCT03129542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736258|NCT03129256|Apatinib|apatinib|mesh-list
5736259|NCT03129256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5616773|NCT03554044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5616774|NCT03554044|Tubulin Modulators|tubulin modulators|mesh-ancestor
5736260|NCT03129256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5736261|NCT03129256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5736262|NCT03129256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736263|NCT03129074|Capecitabine|capecitabine|mesh-list
5736264|NCT03129074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5736265|NCT03129074|Antimetabolites|antimetabolites|mesh-ancestor
5736266|NCT03129074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736267|NCT03129074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5736268|NCT03129022|Anesthetics|anesthetics|mesh-list
5736269|NCT03129022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5736270|NCT03129022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736271|NCT03129009|Anesthetics|anesthetics|mesh-list
5736272|NCT03129009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5736273|NCT03129009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736274|NCT03128866|Tranexamic Acid|tranexamic acid|mesh-list
5616775|NCT03554044|Antimitotic Agents|antimitotic agents|mesh-ancestor
5616776|NCT03554044|Mitosis Modulators|mitosis modulators|mesh-ancestor
5616777|NCT03554044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616778|NCT03554044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5616779|NCT03554044|Antimetabolites|antimetabolites|mesh-ancestor
5616780|NCT03554044|Antiviral Agents|antiviral agents|mesh-ancestor
5616781|NCT03554044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5616782|NCT03554044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5616783|NCT03554044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5616784|NCT03554044|Immunologic Factors|immunologic factors|mesh-ancestor
5616785|NCT03554044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616786|NCT03554044|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5616787|NCT03554044|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5616788|NCT03554044|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5616789|NCT03554044|Hormone Antagonists|hormone antagonists|mesh-ancestor
5616790|NCT03554044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5616791|NCT03554044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5616792|NCT03554044|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5736275|NCT03128866|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5736276|NCT03128866|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5736277|NCT03128866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736278|NCT03128866|Hemostatics|hemostatics|mesh-ancestor
5736279|NCT03128866|Coagulants|coagulants|mesh-ancestor
5736280|NCT03128736|Esomeprazole|esomeprazole|mesh-list
5736281|NCT03128736|Dexlansoprazole|dexlansoprazole|mesh-list
5736282|NCT03128736|Lansoprazole|lansoprazole|mesh-list
5736283|NCT03128736|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5736284|NCT03128736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5736285|NCT03128736|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5736286|NCT03128736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5736287|NCT03128736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736288|NCT03128879|Venetoclax|venetoclax|mesh-list
5736289|NCT03128879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5736290|NCT03128515|Hydroxyurea|hydroxyurea|mesh-list
5736291|NCT03128515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5736292|NCT03128515|Antisickling Agents|antisickling agents|mesh-ancestor
5736293|NCT03128515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5736294|NCT03128515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736295|NCT03128515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5736296|NCT03128528|Empagliflozin|empagliflozin|mesh-list
5616793|NCT03554044|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5616794|NCT03554044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5736297|NCT03128528|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5736298|NCT03128528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736299|NCT03128528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5736300|NCT03128528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736301|NCT03128242|Oxytocin|oxytocin|mesh-list
5736302|NCT03128242|Oxytocics|oxytocics|mesh-ancestor
5736303|NCT03128242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5736304|NCT03128242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736305|NCT03128216|Bupivacaine|bupivacaine|mesh-list
5736306|NCT03128216|Ropivacaine|ropivacaine|mesh-list
5736307|NCT03128216|Anesthetics, Local|anesthetics, local|mesh-list
5736308|NCT03128216|Anesthetics|anesthetics|mesh-list
5736309|NCT03128216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5736310|NCT03128216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736311|NCT03128216|Sensory System Agents|sensory system agents|mesh-ancestor
5736312|NCT03128216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5736313|NCT03128034|Cyclosporine|cyclosporine|mesh-list
5736314|NCT03128034|Sirolimus|sirolimus|mesh-list
5736315|NCT03128034|Mycophenolic Acid|mycophenolic acid|mesh-list
5736316|NCT03128034|Fludarabine|fludarabine|mesh-list
5736317|NCT03128034|Fludarabine phosphate|fludarabine phosphate|mesh-list
5736318|NCT03128034|Cyclosporins|cyclosporins|mesh-list
5736319|NCT03128034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5736320|NCT03128034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5736321|NCT03128034|Antimetabolites|antimetabolites|mesh-ancestor
5736322|NCT03128034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736323|NCT03128034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5736324|NCT03128034|Immunologic Factors|immunologic factors|mesh-ancestor
5736325|NCT03128034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736326|NCT03128034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5736327|NCT03128034|Antifungal Agents|antifungal agents|mesh-ancestor
5736328|NCT03128034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5736329|NCT03128034|Dermatologic Agents|dermatologic agents|mesh-ancestor
5736330|NCT03128034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5736331|NCT03128034|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5736332|NCT03128034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5736333|NCT03128034|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5736334|NCT03128034|Antitubercular Agents|antitubercular agents|mesh-ancestor
5736335|NCT03128034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5736336|NCT03128398|Domperidone|domperidone|mesh-list
5736337|NCT03128398|Antiemetics|antiemetics|mesh-ancestor
5736338|NCT03128398|Autonomic Agents|autonomic agents|mesh-ancestor
5736339|NCT03128398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5736340|NCT03128398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736341|NCT03128398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5736342|NCT03128398|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5736343|NCT03128398|Dopamine Agents|dopamine agents|mesh-ancestor
5736344|NCT03128398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5616795|NCT03554044|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5616796|NCT03554044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5616797|NCT03552380|Nivolumab|nivolumab|mesh-list
5616798|NCT03552380|Ipilimumab|ipilimumab|mesh-list
5616799|NCT03552380|Entinostat|entinostat|mesh-list
5616800|NCT03552380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5616801|NCT03552380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5736345|NCT03128398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736346|NCT03128346|Aspirin|aspirin|mesh-list
5736347|NCT03128346|Acetaminophen|acetaminophen|mesh-list
5736348|NCT03128346|Fentanyl|fentanyl|mesh-list
5736349|NCT03128346|Hydromorphone|hydromorphone|mesh-list
5736350|NCT03128346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5736351|NCT03128346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5736352|NCT03128346|Analgesics|analgesics|mesh-ancestor
5736353|NCT03128346|Sensory System Agents|sensory system agents|mesh-ancestor
5736354|NCT03128346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5736355|NCT03128346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736356|NCT03128346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5736357|NCT03128346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5736358|NCT03128346|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5736359|NCT03128346|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5736360|NCT03128346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616802|NCT03552380|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5616803|NCT03552380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616804|NCT03552380|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5616805|NCT03552380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5616806|NCT03534804|Pembrolizumab|pembrolizumab|mesh-list
5616807|NCT03534804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5616808|NCT03534804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5616809|NCT03491267|Tretinoin|tretinoin|mesh-list
5616810|NCT03491267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5616811|NCT03491267|Keratolytic Agents|keratolytic agents|mesh-ancestor
5616812|NCT03491267|Dermatologic Agents|dermatologic agents|mesh-ancestor
5616813|NCT03485287|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
5616814|NCT03485287|Hallucinogens|hallucinogens|mesh-ancestor
5616815|NCT03485287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616816|NCT03485287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5616817|NCT03485287|Serotonin Agents|serotonin agents|mesh-ancestor
5616818|NCT03485287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5736361|NCT03128346|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5736362|NCT03128346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5736363|NCT03128346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5736364|NCT03128346|Antipyretics|antipyretics|mesh-ancestor
5736365|NCT03128346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5736366|NCT03128346|Narcotics|narcotics|mesh-ancestor
5736367|NCT03128346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5616819|NCT03485287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616820|NCT03485287|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5616821|NCT03485287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5616822|NCT03485287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5616823|NCT03485287|Adrenergic Agents|adrenergic agents|mesh-ancestor
5616824|NCT03473756|Atezolizumab|atezolizumab|mesh-list
5616825|NCT03473756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5616826|NCT03470675|Morphine|morphine|mesh-list
5616827|NCT03470675|Ketamine|ketamine|mesh-list
5616828|NCT03470675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5616829|NCT03470675|Narcotics|narcotics|mesh-ancestor
5616830|NCT03470675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5736368|NCT03128346|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5736369|NCT03128346|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5736370|NCT03128346|Anesthetics, General|anesthetics, general|mesh-ancestor
5616831|NCT03470675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616832|NCT03470675|Analgesics|analgesics|mesh-ancestor
5616833|NCT03470675|Sensory System Agents|sensory system agents|mesh-ancestor
5616834|NCT03470675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5736371|NCT03128346|Anesthetics|anesthetics|mesh-ancestor
5736372|NCT03128203|Oxytocin|oxytocin|mesh-list
5736373|NCT03128203|Oxytocics|oxytocics|mesh-ancestor
5736374|NCT03128203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5736375|NCT03128203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736376|NCT03127592|Etodolac|etodolac|mesh-list
5736377|NCT03127592|Cyclobenzaprine|cyclobenzaprine|mesh-list
5736378|NCT03127592|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5736379|NCT03127592|Antidepressive Agents|antidepressive agents|mesh-ancestor
5736380|NCT03127592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5736381|NCT03127592|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5736382|NCT03127592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736383|NCT03127592|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5736384|NCT03127592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5736385|NCT03127592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5736386|NCT03127592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5736387|NCT03127592|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5736388|NCT03127592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5736389|NCT03127592|Analgesics|analgesics|mesh-ancestor
5736390|NCT03127592|Sensory System Agents|sensory system agents|mesh-ancestor
5736391|NCT03127592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5736392|NCT03127592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5736393|NCT03127592|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5736394|NCT03127592|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5736395|NCT03127592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5736396|NCT03127592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736397|NCT03127774|Sodium thiosulfate|sodium thiosulfate|mesh-list
5736398|NCT03127774|Antidotes|antidotes|mesh-ancestor
5736399|NCT03127774|Protective Agents|protective agents|mesh-ancestor
5736400|NCT03127774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736401|NCT03127774|Antioxidants|antioxidants|mesh-ancestor
5736402|NCT03127774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736403|NCT03127774|Antitubercular Agents|antitubercular agents|mesh-ancestor
5736404|NCT03127774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5616835|NCT03470675|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5616836|NCT03470675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5736405|NCT03127774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5736406|NCT03127774|Chelating Agents|chelating agents|mesh-ancestor
5736407|NCT03127774|Sequestering Agents|sequestering agents|mesh-ancestor
5893263|NCT02037048|Immunologic Factors|immunologic factors|mesh-ancestor
5893264|NCT02037048|Antidotes|antidotes|mesh-ancestor
5893265|NCT02037048|Protective Agents|protective agents|mesh-ancestor
5893266|NCT02037048|Vitamin B Complex|vitamin b complex|mesh-ancestor
5893267|NCT02037048|Vitamins|vitamins|mesh-ancestor
5893268|NCT02037048|Micronutrients|micronutrients|mesh-ancestor
5616837|NCT03470675|Anesthetics, General|anesthetics, general|mesh-ancestor
5616838|NCT03470675|Anesthetics|anesthetics|mesh-ancestor
5616839|NCT03470675|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5616840|NCT03470675|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5616841|NCT03470675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5893269|NCT02023905|Everolimus|everolimus|mesh-list
5893270|NCT02023905|Temozolomide|temozolomide|mesh-list
5893271|NCT02023905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5893272|NCT02023905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5893273|NCT02023905|Immunologic Factors|immunologic factors|mesh-ancestor
5893274|NCT02023905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893275|NCT02023905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5893276|NCT02023905|Alkylating Agents|alkylating agents|mesh-ancestor
5616842|NCT03470675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616843|NCT03467360|Etoposide|etoposide|mesh-list
5616844|NCT03467360|Acetazolamide|acetazolamide|mesh-list
5893277|NCT02023905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893278|NCT01909414|Vaccines|vaccines|mesh-list
5893279|NCT01909414|Immunologic Factors|immunologic factors|mesh-ancestor
5893280|NCT01909414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893281|NCT01890252|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5893282|NCT01698307|Adalimumab|adalimumab|mesh-list
5893283|NCT01698307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5893284|NCT01698307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5893285|NCT05118984|Azithromycin|azithromycin|mesh-list
5893286|NCT05118984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5893287|NCT05118984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5907738|NCT05211323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5907739|NCT05211323|Cisplatin|cisplatin|mesh-list
5907740|NCT05211323|Atezolizumab|atezolizumab|mesh-list
5907741|NCT05211323|Endothelial Growth Factors|endothelial growth factors|mesh-list
5907742|NCT05211323|Antibodies|antibodies|mesh-list
5616845|NCT03467360|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5616846|NCT03467360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5616847|NCT03467360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5616848|NCT03467360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5907743|NCT05211323|Immunoglobulins|immunoglobulins|mesh-list
5907744|NCT05211323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5907745|NCT05211323|Immunoglobulin G|immunoglobulin g|mesh-list
5907746|NCT05211323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5907747|NCT05211323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5907748|NCT05211323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5907749|NCT05211323|Growth Substances|growth substances|mesh-ancestor
5907750|NCT05211323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907751|NCT05211323|Growth Inhibitors|growth inhibitors|mesh-ancestor
5907752|NCT05211323|Immunologic Factors|immunologic factors|mesh-ancestor
5907753|NCT05211323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5907754|NCT05211323|Antimetabolites|antimetabolites|mesh-ancestor
5907755|NCT05211323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907756|NCT05211323|Antiviral Agents|antiviral agents|mesh-ancestor
5907757|NCT05211323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5907758|NCT05211323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5907759|NCT05211323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5908756|NCT04133532|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5908757|NCT04133532|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5908758|NCT04133532|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5908759|NCT04133532|Adrenergic Agents|adrenergic agents|mesh-ancestor
5908760|NCT04133532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5908761|NCT04133532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908762|NCT04129554|Tenofovir|tenofovir|mesh-list
5908763|NCT04129554|Entecavir|entecavir|mesh-list
5908764|NCT04129554|Antiviral Agents|antiviral agents|mesh-ancestor
5908765|NCT04129554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5908766|NCT04129554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5908767|NCT04129554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5908768|NCT04129554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5908769|NCT04129554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908770|NCT04129554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5736408|NCT03127800|Morphine|morphine|mesh-list
5736409|NCT03127800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5736410|NCT03127800|Narcotics|narcotics|mesh-ancestor
5736411|NCT03127800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5736412|NCT03127800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736413|NCT03127800|Analgesics|analgesics|mesh-ancestor
5736414|NCT03127800|Sensory System Agents|sensory system agents|mesh-ancestor
5736415|NCT03127800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5736416|NCT03127605|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
5736417|NCT03127605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5736418|NCT03127605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5736419|NCT03127605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5736420|NCT03127371|Nitrous Oxide|nitrous oxide|mesh-list
5736421|NCT03127371|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5736422|NCT03127371|Anesthetics, General|anesthetics, general|mesh-ancestor
5736423|NCT03127371|Anesthetics|anesthetics|mesh-ancestor
5736424|NCT03127371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5736425|NCT03127371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736426|NCT03127371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5736427|NCT03127371|Analgesics|analgesics|mesh-ancestor
5736428|NCT03127371|Sensory System Agents|sensory system agents|mesh-ancestor
5736429|NCT03127371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5736430|NCT03127267|Riluzole|riluzole|mesh-list
5736431|NCT03127267|Anticonvulsants|anticonvulsants|mesh-ancestor
5736432|NCT03127267|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5736433|NCT03127267|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5736434|NCT03127267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5736435|NCT03127267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736436|NCT03127267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736437|NCT03127267|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5736438|NCT03127267|Protective Agents|protective agents|mesh-ancestor
5736439|NCT03127449|Aflutinib|aflutinib|mesh-list
5616849|NCT03467360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5736440|NCT03127449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5736441|NCT03127449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5736442|NCT03127449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736443|NCT03127631|Aspirin|aspirin|mesh-list
5736444|NCT03127631|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
5736445|NCT03127631|Atorvastatin|atorvastatin|mesh-list
5736446|NCT03127631|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5736447|NCT03127631|Simvastatin|simvastatin|mesh-list
5736448|NCT03127631|Pravastatin|pravastatin|mesh-list
5736449|NCT03127631|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
5736450|NCT03127631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5736451|NCT03127631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5736452|NCT03127631|Analgesics|analgesics|mesh-ancestor
5736453|NCT03127631|Sensory System Agents|sensory system agents|mesh-ancestor
5616850|NCT03467360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616851|NCT03467360|Anticonvulsants|anticonvulsants|mesh-ancestor
5616852|NCT03467360|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5616853|NCT03467360|Diuretics|diuretics|mesh-ancestor
5616854|NCT03467360|Natriuretic Agents|natriuretic agents|mesh-ancestor
5616855|NCT03467360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616856|NCT03452072|Timolol|timolol|mesh-list
5616857|NCT03452072|Petrolatum|petrolatum|mesh-list
5616858|NCT03452072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5616859|NCT03452072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5616860|NCT03452072|Adrenergic Agents|adrenergic agents|mesh-ancestor
5616861|NCT03452072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5616862|NCT03452072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616863|NCT03452072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616864|NCT03452072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5616865|NCT03452072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5736454|NCT03127631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5616866|NCT03452072|Emollients|emollients|mesh-ancestor
5893288|NCT05118945|Insulin|insulin|mesh-list
5736455|NCT03127631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736456|NCT03127631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5736457|NCT03127631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5736458|NCT03127631|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5736459|NCT03127631|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5736460|NCT03127631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736461|NCT03127631|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5736462|NCT03127631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5736463|NCT03127631|Antipyretics|antipyretics|mesh-ancestor
5736464|NCT03127631|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5736465|NCT03127631|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5736466|NCT03127631|Antimetabolites|antimetabolites|mesh-ancestor
5736467|NCT03127631|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5736468|NCT03127631|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5736469|NCT03127631|Protease Inhibitors|protease inhibitors|mesh-ancestor
5736470|NCT03127137|Triamcinolone|triamcinolone|mesh-list
5736471|NCT03127137|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5736472|NCT03127137|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5736473|NCT03127137|Lidocaine|lidocaine|mesh-list
5736474|NCT03127137|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5736475|NCT03127137|Anesthetics, Local|anesthetics, local|mesh-ancestor
5736476|NCT03127137|Anesthetics|anesthetics|mesh-ancestor
5736477|NCT03127137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5616867|NCT03452072|Dermatologic Agents|dermatologic agents|mesh-ancestor
5616868|NCT03433040|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
5616869|NCT03433040|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
5616870|NCT03433040|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5616871|NCT03433040|Hormone Antagonists|hormone antagonists|mesh-ancestor
5616872|NCT03433040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5736478|NCT03127137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736479|NCT03127137|Sensory System Agents|sensory system agents|mesh-ancestor
5736480|NCT03127137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5736481|NCT03127137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5736482|NCT03127137|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5736483|NCT03127137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5736484|NCT03127137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5736485|NCT03127137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736486|NCT03127137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5736487|NCT03127137|Glucocorticoids|glucocorticoids|mesh-ancestor
5736488|NCT03127137|Hormones|hormones|mesh-ancestor
5736489|NCT03127137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5736490|NCT03127137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5736491|NCT03127137|Immunologic Factors|immunologic factors|mesh-ancestor
5736492|NCT03127137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5736493|NCT03127319|Docetaxel|docetaxel|mesh-list
5736494|NCT03127319|Apatinib|apatinib|mesh-list
5736495|NCT03127319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5736496|NCT03127319|Tubulin Modulators|tubulin modulators|mesh-ancestor
5736497|NCT03127319|Antimitotic Agents|antimitotic agents|mesh-ancestor
6489235|NCT00590174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6489236|NCT00590174|Antipyretics|antipyretics|mesh-ancestor
6489237|NCT00590174|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6489238|NCT00590174|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6489239|NCT00590174|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6489240|NCT00590174|Purinergic Agents|purinergic agents|mesh-ancestor
6489241|NCT00590174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6672814|NCT01558622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5616873|NCT03433040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616874|NCT03433040|Progestins|progestins|mesh-ancestor
5616875|NCT03433040|Hormones|hormones|mesh-ancestor
5616876|NCT03432065|Buspirone|buspirone|mesh-list
5616877|NCT03432065|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5616878|NCT03432065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5616879|NCT03432065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5616880|NCT03432065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616881|NCT03432065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5616882|NCT03432065|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5616883|NCT03432065|Serotonin Agents|serotonin agents|mesh-ancestor
5616884|NCT03432065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5616885|NCT03432065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616886|NCT03412799|Gemcitabine|gemcitabine|mesh-list
5616887|NCT03412799|Paclitaxel|paclitaxel|mesh-list
5616888|NCT03412799|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5736498|NCT03127319|Mitosis Modulators|mitosis modulators|mesh-ancestor
5736499|NCT03127319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616889|NCT03412799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5616890|NCT03412799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5736500|NCT03127319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5736501|NCT03127319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5736502|NCT03127345|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
5736503|NCT03127345|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
5736504|NCT03127345|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5736505|NCT03127345|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5736506|NCT03127189|Rilpivirine|rilpivirine|mesh-list
5736507|NCT03127189|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5736508|NCT03127189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5736509|NCT03127189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5736510|NCT03127189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736511|NCT03127189|Antiviral Agents|antiviral agents|mesh-ancestor
5736512|NCT03127189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5736513|NCT03127189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5736514|NCT03127189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5736515|NCT03127007|Atezolizumab|atezolizumab|mesh-list
5736516|NCT03127007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5736517|NCT03127124|Leucovorin|leucovorin|mesh-list
5736518|NCT03127124|Fluorouracil|fluorouracil|mesh-list
5736519|NCT03127124|Bevacizumab|bevacizumab|mesh-list
5736520|NCT03127124|Oxaliplatin|oxaliplatin|mesh-list
5736521|NCT03127124|Calcium|calcium|mesh-list
5736522|NCT03127124|Levoleucovorin|levoleucovorin|mesh-list
5616891|NCT03412799|Tubulin Modulators|tubulin modulators|mesh-ancestor
5616892|NCT03412799|Antimitotic Agents|antimitotic agents|mesh-ancestor
5616893|NCT03412799|Mitosis Modulators|mitosis modulators|mesh-ancestor
5616894|NCT03412799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616895|NCT03412799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5616896|NCT03412799|Antimetabolites|antimetabolites|mesh-ancestor
5616897|NCT03412799|Antiviral Agents|antiviral agents|mesh-ancestor
5616898|NCT03412799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5736523|NCT03127124|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5736524|NCT03127124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736525|NCT03127124|Antimetabolites|antimetabolites|mesh-ancestor
5736526|NCT03127124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736527|NCT03127124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5736528|NCT03127124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5736529|NCT03127124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5736530|NCT03127124|Immunologic Factors|immunologic factors|mesh-ancestor
5736531|NCT03127124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5736532|NCT03127124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5736533|NCT03127124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5736534|NCT03127124|Growth Substances|growth substances|mesh-ancestor
5736535|NCT03127124|Growth Inhibitors|growth inhibitors|mesh-ancestor
5736536|NCT03127124|Antidotes|antidotes|mesh-ancestor
5736537|NCT03127124|Protective Agents|protective agents|mesh-ancestor
5736538|NCT03127124|Vitamin B Complex|vitamin b complex|mesh-ancestor
5736539|NCT03127124|Vitamins|vitamins|mesh-ancestor
5736540|NCT03127124|Micronutrients|micronutrients|mesh-ancestor
5736541|NCT03127046|Aceclofenac|aceclofenac|mesh-list
5736542|NCT03127046|Diclofenac|diclofenac|mesh-list
5736543|NCT03127046|Esomeprazole|esomeprazole|mesh-list
5736544|NCT03127046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5736545|NCT03127046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5736546|NCT03127046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6489242|NCT00590187|Sapacitabine|sapacitabine|mesh-list
6489243|NCT00590187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6489244|NCT00590213|Bicalutamide|bicalutamide|mesh-list
6489245|NCT00590213|Androgen Antagonists|androgen antagonists|mesh-ancestor
5736547|NCT03127046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5736548|NCT03127046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736549|NCT03127046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5736550|NCT03127046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5736551|NCT03127046|Analgesics|analgesics|mesh-ancestor
5736552|NCT03127046|Sensory System Agents|sensory system agents|mesh-ancestor
5736553|NCT03127046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5736554|NCT03127046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736555|NCT03127046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5736556|NCT03127046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5736557|NCT03127046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5736558|NCT03126877|Mitomycins|mitomycins|mesh-list
5736559|NCT03126877|Mitomycin|mitomycin|mesh-list
5736560|NCT03126877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5736561|NCT03126877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6672815|NCT01558622|Narcotics|narcotics|mesh-ancestor
5616899|NCT03412799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5736562|NCT03126877|Alkylating Agents|alkylating agents|mesh-ancestor
5736563|NCT03126877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736564|NCT03126877|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5736565|NCT03126877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5736566|NCT03126799|Bevacizumab|bevacizumab|mesh-list
5736567|NCT03126799|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5736568|NCT03126799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5736569|NCT03126799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5736570|NCT03126799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5736571|NCT03126799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5736572|NCT03126799|Growth Substances|growth substances|mesh-ancestor
5736573|NCT03126799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736574|NCT03126799|Growth Inhibitors|growth inhibitors|mesh-ancestor
5736575|NCT03126799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5736576|NCT03126799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5736577|NCT03126799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736578|NCT03126864|Vidarabine|vidarabine|mesh-list
5736579|NCT03126864|Cyclophosphamide|cyclophosphamide|mesh-list
5736580|NCT03126864|Fludarabine|fludarabine|mesh-list
5736581|NCT03126864|Fludarabine phosphate|fludarabine phosphate|mesh-list
5736582|NCT03126864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5736583|NCT03126864|Immunologic Factors|immunologic factors|mesh-ancestor
5736584|NCT03126864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736585|NCT03126864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5736586|NCT03126864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5736587|NCT03126864|Alkylating Agents|alkylating agents|mesh-ancestor
5736588|NCT03126864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736589|NCT03126864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5736590|NCT03126864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5616900|NCT03412799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5616901|NCT03412799|Immunologic Factors|immunologic factors|mesh-ancestor
5616902|NCT03412799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616903|NCT03405870|SMOFlipid|smoflipid|mesh-list
5616904|NCT03405870|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
5616905|NCT03405870|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5616906|NCT03405870|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5616907|NCT03394027|TIC10 compound|tic10 compound|mesh-list
5616908|NCT03394027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5616909|NCT03391882|Apomorphine|apomorphine|mesh-list
5616910|NCT03391882|Emetics|emetics|mesh-ancestor
5616911|NCT03391882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616912|NCT03391882|Autonomic Agents|autonomic agents|mesh-ancestor
5616913|NCT03391882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5616914|NCT03391882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5616915|NCT03391882|Dopamine Agonists|dopamine agonists|mesh-ancestor
5616916|NCT03391882|Dopamine Agents|dopamine agents|mesh-ancestor
5616917|NCT03391882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5616918|NCT03391882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736591|NCT03126864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5736592|NCT03126864|Antimetabolites|antimetabolites|mesh-ancestor
5736593|NCT03126864|Antiviral Agents|antiviral agents|mesh-ancestor
5736594|NCT03126864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5736595|NCT03126578|Midazolam|midazolam|mesh-list
5736596|NCT03126578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5736597|NCT03126578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5736598|NCT03126578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5736599|NCT03126578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736600|NCT03126578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5736601|NCT03126578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5736602|NCT03126578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5736603|NCT03126578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5736604|NCT03126578|Anesthetics, General|anesthetics, general|mesh-ancestor
5736605|NCT03126578|Anesthetics|anesthetics|mesh-ancestor
5736606|NCT03126578|GABA Modulators|gaba modulators|mesh-ancestor
5736607|NCT03126578|GABA Agents|gaba agents|mesh-ancestor
5736608|NCT03126578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5736609|NCT03126578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736610|NCT03126656|Methyltestosterone|methyltestosterone|mesh-list
5736611|NCT03126656|Testosterone|testosterone|mesh-list
5736612|NCT03126656|Testosterone undecanoate|testosterone undecanoate|mesh-list
5736613|NCT03126656|Testosterone enanthate|testosterone enanthate|mesh-list
5736614|NCT03126656|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5616919|NCT03382574|Denosumab|denosumab|mesh-list
5616920|NCT03382574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5736615|NCT03126656|Androgens|androgens|mesh-ancestor
5616921|NCT03382574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616922|NCT03366155|Oxaliplatin|oxaliplatin|mesh-list
5616923|NCT03366155|Irinotecan|irinotecan|mesh-list
5616924|NCT03366155|Cetuximab|cetuximab|mesh-list
5616925|NCT03366155|Panitumumab|panitumumab|mesh-list
5616926|NCT03366155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5736616|NCT03126656|Hormones|hormones|mesh-ancestor
5736617|NCT03126656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5736618|NCT03126656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736619|NCT03126656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5736620|NCT03126656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5736621|NCT03126656|Anabolic Agents|anabolic agents|mesh-ancestor
5736622|NCT03126721|Midazolam|midazolam|mesh-list
5736623|NCT03126721|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5736624|NCT03126721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5736625|NCT03126721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5736626|NCT03126721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736627|NCT03126721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5736628|NCT03126721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5736629|NCT03126721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5736630|NCT03126721|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5736631|NCT03126721|Anesthetics, General|anesthetics, general|mesh-ancestor
5736632|NCT03126721|Anesthetics|anesthetics|mesh-ancestor
5736633|NCT03126721|GABA Modulators|gaba modulators|mesh-ancestor
5736634|NCT03126721|GABA Agents|gaba agents|mesh-ancestor
5736635|NCT03126721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5736636|NCT03126721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736637|NCT03126916|Vitamin A|vitamin a|mesh-list
5736638|NCT03126916|Cyclophosphamide|cyclophosphamide|mesh-list
5736639|NCT03126916|Melphalan|melphalan|mesh-list
5736640|NCT03126916|Busulfan|busulfan|mesh-list
5736641|NCT03126916|Thiotepa|thiotepa|mesh-list
5736642|NCT03126916|Cisplatin|cisplatin|mesh-list
5736643|NCT03126916|Carboplatin|carboplatin|mesh-list
5736644|NCT03126916|Doxorubicin|doxorubicin|mesh-list
5736645|NCT03126916|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5736646|NCT03126916|Etoposide|etoposide|mesh-list
5736647|NCT03126916|Vincristine|vincristine|mesh-list
5736648|NCT03126916|Topotecan|topotecan|mesh-list
5736649|NCT03126916|Tretinoin|tretinoin|mesh-list
5736650|NCT03126916|Crizotinib|crizotinib|mesh-list
5736651|NCT03126916|Etoposide phosphate|etoposide phosphate|mesh-list
5736652|NCT03126916|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
5736653|NCT03126916|Dinutuximab|dinutuximab|mesh-list
5736654|NCT03126916|Dexrazoxane|dexrazoxane|mesh-list
5736655|NCT03126916|Razoxane|razoxane|mesh-list
5736656|NCT03126916|Isotretinoin|isotretinoin|mesh-list
5736657|NCT03126916|Sargramostim|sargramostim|mesh-list
5736658|NCT03126916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5736659|NCT03126916|Immunologic Factors|immunologic factors|mesh-ancestor
5736660|NCT03126916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736661|NCT03126916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5736662|NCT03126916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5736663|NCT03126916|Alkylating Agents|alkylating agents|mesh-ancestor
5736664|NCT03126916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736665|NCT03126916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5736666|NCT03126916|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5736667|NCT03126916|Vitamins|vitamins|mesh-ancestor
5736668|NCT03126916|Micronutrients|micronutrients|mesh-ancestor
5736669|NCT03126916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5736670|NCT03126916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5736671|NCT03126916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5736672|NCT03126916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5736673|NCT03126916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5736674|NCT03126916|Tubulin Modulators|tubulin modulators|mesh-ancestor
5736675|NCT03126916|Antimitotic Agents|antimitotic agents|mesh-ancestor
5736676|NCT03126916|Mitosis Modulators|mitosis modulators|mesh-ancestor
5736677|NCT03126916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5736678|NCT03126916|Protective Agents|protective agents|mesh-ancestor
5736679|NCT03126916|Keratolytic Agents|keratolytic agents|mesh-ancestor
5736680|NCT03126916|Dermatologic Agents|dermatologic agents|mesh-ancestor
5736681|NCT03126916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5736682|NCT03126916|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5736683|NCT03126916|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5616927|NCT03366155|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5736684|NCT03126812|Paclitaxel|paclitaxel|mesh-list
5736685|NCT03126812|Carboplatin|carboplatin|mesh-list
5736686|NCT03126812|Pembrolizumab|pembrolizumab|mesh-list
5616928|NCT03366155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5616929|NCT03366155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5736687|NCT03126812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5616930|NCT03366155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616931|NCT03366155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5616932|NCT03357952|Daratumumab|daratumumab|mesh-list
5616933|NCT03357952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5616934|NCT03323463|Carboplatin|carboplatin|mesh-list
5616935|NCT03323463|Fluorouracil|fluorouracil|mesh-list
5736688|NCT03126812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5736689|NCT03126812|Tubulin Modulators|tubulin modulators|mesh-ancestor
5736690|NCT03126812|Antimitotic Agents|antimitotic agents|mesh-ancestor
5736691|NCT03126812|Mitosis Modulators|mitosis modulators|mesh-ancestor
5736692|NCT03126812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736693|NCT03126812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5736694|NCT03126708|Paclitaxel|paclitaxel|mesh-list
5736695|NCT03126708|Cetuximab|cetuximab|mesh-list
5736696|NCT03126708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5736697|NCT03126708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5736698|NCT03126708|Tubulin Modulators|tubulin modulators|mesh-ancestor
5616936|NCT03323463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5616937|NCT03323463|Antimetabolites|antimetabolites|mesh-ancestor
5616938|NCT03323463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616939|NCT03323463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5616940|NCT03323463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5616941|NCT03323463|Immunologic Factors|immunologic factors|mesh-ancestor
5616942|NCT03323463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616943|NCT03323151|Ixazomib|ixazomib|mesh-list
5616944|NCT03323151|Glycine|glycine|mesh-list
5616945|NCT03323151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5616946|NCT03323151|Protease Inhibitors|protease inhibitors|mesh-ancestor
5616947|NCT03323151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5616948|NCT03323151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616949|NCT03323151|Glycine Agents|glycine agents|mesh-ancestor
5616950|NCT03323151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5616951|NCT03323151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616952|NCT03287947|Nintedanib|nintedanib|mesh-list
5616953|NCT03287947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5616954|NCT03287947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5616955|NCT03287947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5616956|NCT03287947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616957|NCT03286556|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5616958|NCT03286556|Autoantibodies|autoantibodies|mesh-list
5616959|NCT03286556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5616960|NCT03286556|Immunologic Factors|immunologic factors|mesh-ancestor
5616961|NCT03286556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616962|NCT03258281|Evolocumab|evolocumab|mesh-list
5616963|NCT03258281|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5616964|NCT03258281|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5616965|NCT03258281|Antimetabolites|antimetabolites|mesh-ancestor
5616966|NCT03258281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616967|NCT03258281|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5692314|NCT03409835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5692315|NCT03409835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5692316|NCT03409835|Serotonin Agents|serotonin agents|mesh-ancestor
5692317|NCT03409835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5692318|NCT03409835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692319|NCT03409679|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5736699|NCT03126708|Antimitotic Agents|antimitotic agents|mesh-ancestor
5736700|NCT03126708|Mitosis Modulators|mitosis modulators|mesh-ancestor
5736701|NCT03126708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736702|NCT03126708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5736703|NCT03126695|Ticagrelor|ticagrelor|mesh-list
5736704|NCT03126695|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5736705|NCT03126695|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5736706|NCT03126695|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5692320|NCT03409679|Murepavadin|murepavadin|mesh-list
5692321|NCT03409679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5692322|NCT03409588|Riociguat|riociguat|mesh-list
5692323|NCT03409588|Enzyme Activators|enzyme activators|mesh-ancestor
5692324|NCT03409588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692325|NCT03409432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5692326|NCT03409432|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5692327|NCT03409432|Lenalidomide|lenalidomide|mesh-list
5692328|NCT03409432|Antibodies|antibodies|mesh-list
5692329|NCT03409432|Immunoglobulins|immunoglobulins|mesh-list
5692330|NCT03409432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5692331|NCT03409432|Immunoconjugates|immunoconjugates|mesh-list
5736707|NCT03126695|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5736708|NCT03126695|Purinergic Agents|purinergic agents|mesh-ancestor
5736709|NCT03126695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5736710|NCT03126695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736711|NCT03126695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736712|NCT03126591|Pembrolizumab|pembrolizumab|mesh-list
5736713|NCT03126591|Olaratumab|olaratumab|mesh-list
5736714|NCT03126591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5736715|NCT03126591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5736716|NCT03126422|Dexmedetomidine|dexmedetomidine|mesh-list
5736717|NCT03126422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5736718|NCT03126422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5736719|NCT03126422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736720|NCT03126422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5736721|NCT03126422|Analgesics|analgesics|mesh-ancestor
5736722|NCT03126422|Sensory System Agents|sensory system agents|mesh-ancestor
5736723|NCT03126422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5736724|NCT03126422|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5736725|NCT03126422|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5736726|NCT03126422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5736727|NCT03126422|Adrenergic Agents|adrenergic agents|mesh-ancestor
5736728|NCT03126422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5736729|NCT03126422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736730|NCT03126461|Nivolumab|nivolumab|mesh-list
5736731|NCT03126461|Ipilimumab|ipilimumab|mesh-list
5736732|NCT03126461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5736733|NCT03126461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5736734|NCT03126461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5736735|NCT03126461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736736|NCT03126188|Sertraline|sertraline|mesh-list
5736737|NCT03126188|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
5736738|NCT03126188|Antidepressive Agents|antidepressive agents|mesh-ancestor
5736739|NCT03126188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5736740|NCT03126188|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5736741|NCT03126188|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5736742|NCT03126188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5736743|NCT03126188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736744|NCT03126188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5736745|NCT03126188|Serotonin Agents|serotonin agents|mesh-ancestor
5736746|NCT03126188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736747|NCT03126188|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5736748|NCT03126188|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5736749|NCT03126123|Acetic Acid|acetic acid|mesh-list
5736750|NCT03126123|Retinol acetate|retinol acetate|mesh-list
5736751|NCT03126123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5736752|NCT03126123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5736753|NCT03126123|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5736754|NCT03126123|Immunologic Factors|immunologic factors|mesh-ancestor
5736755|NCT03126123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736756|NCT03126123|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5736757|NCT03126123|Protective Agents|protective agents|mesh-ancestor
5736758|NCT03126123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5736759|NCT03126084|Acetaminophen|acetaminophen|mesh-list
5736760|NCT03126084|Tramadol|tramadol|mesh-list
5736761|NCT03126084|Bupivacaine|bupivacaine|mesh-list
5736762|NCT03126084|Anesthetics, Local|anesthetics, local|mesh-ancestor
5736763|NCT03126084|Anesthetics|anesthetics|mesh-ancestor
5736764|NCT03126084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5736765|NCT03126084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736766|NCT03126084|Sensory System Agents|sensory system agents|mesh-ancestor
5616968|NCT03241186|Nivolumab|nivolumab|mesh-list
5616969|NCT03241186|Ipilimumab|ipilimumab|mesh-list
5616970|NCT03241186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5616971|NCT03241186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5616972|NCT03241186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5616973|NCT03241186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616974|NCT03194542|Luspatercept|luspatercept|mesh-list
5616975|NCT03194542|Hematinics|hematinics|mesh-ancestor
5616976|NCT03113422|Venetoclax|venetoclax|mesh-list
5616977|NCT03113422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5616978|NCT03066622|Olanzapine|olanzapine|mesh-list
5616979|NCT03066622|Antiemetics|antiemetics|mesh-ancestor
5616980|NCT03066622|Autonomic Agents|autonomic agents|mesh-ancestor
5616981|NCT03066622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5893289|NCT05118945|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5616982|NCT03066622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616983|NCT03066622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5616984|NCT03066622|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5616985|NCT03066622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5616986|NCT03066622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5616987|NCT03066622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5616988|NCT03066622|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5616989|NCT03066622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5616990|NCT03066622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5616991|NCT03066622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5616992|NCT03066622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5616993|NCT03066622|Serotonin Agents|serotonin agents|mesh-ancestor
5616994|NCT03029598|Carboplatin|carboplatin|mesh-list
5616995|NCT03029598|Pembrolizumab|pembrolizumab|mesh-list
5736767|NCT03126084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5736768|NCT03126084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5736769|NCT03126084|Analgesics|analgesics|mesh-ancestor
5736770|NCT03126084|Antipyretics|antipyretics|mesh-ancestor
5736771|NCT03126084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5736772|NCT03126084|Narcotics|narcotics|mesh-ancestor
5893290|NCT05118945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5893291|NCT05118945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5616996|NCT03029598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5616997|NCT03029598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5616998|NCT03020030|Leucovorin|leucovorin|mesh-list
5616999|NCT03020030|Cytarabine|cytarabine|mesh-list
5617000|NCT03020030|Dexamethasone|dexamethasone|mesh-list
5617001|NCT03020030|Hydrocortisone|hydrocortisone|mesh-list
5617002|NCT03020030|Cyclophosphamide|cyclophosphamide|mesh-list
5617003|NCT03020030|Doxorubicin|doxorubicin|mesh-list
5617004|NCT03020030|Methotrexate|methotrexate|mesh-list
5617005|NCT03020030|Etoposide|etoposide|mesh-list
5617006|NCT03020030|Vincristine|vincristine|mesh-list
5617007|NCT03020030|Asparaginase|asparaginase|mesh-list
5617008|NCT03020030|Dasatinib|dasatinib|mesh-list
5617009|NCT03020030|Mercaptopurine|mercaptopurine|mesh-list
5617010|NCT03020030|Pegaspargase|pegaspargase|mesh-list
5617011|NCT03020030|Dexrazoxane|dexrazoxane|mesh-list
5893292|NCT05118854|Cisplatin|cisplatin|mesh-list
5893293|NCT05118854|Carboplatin|carboplatin|mesh-list
5893294|NCT05118854|Pemetrexed|pemetrexed|mesh-list
5893295|NCT05118854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5893296|NCT05118854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5893297|NCT05118854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893298|NCT05118854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5893299|NCT05118854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5893300|NCT05118672|Acetaminophen|acetaminophen|mesh-list
5893301|NCT05118672|Fexofenadine|fexofenadine|mesh-list
5617012|NCT03020030|Razoxane|razoxane|mesh-list
5617013|NCT03020030|Levoleucovorin|levoleucovorin|mesh-list
5617014|NCT03020030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5617015|NCT03020030|Immunologic Factors|immunologic factors|mesh-ancestor
5617016|NCT03020030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617017|NCT03020030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5617018|NCT03020030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5893302|NCT05118672|Phenylephrine|phenylephrine|mesh-list
5893303|NCT05118672|Oxymetazoline|oxymetazoline|mesh-list
5893304|NCT05118672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5893305|NCT05118672|Analgesics|analgesics|mesh-ancestor
5893306|NCT05118672|Sensory System Agents|sensory system agents|mesh-ancestor
5893307|NCT05118672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5893308|NCT05118672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893309|NCT05118672|Antipyretics|antipyretics|mesh-ancestor
5893310|NCT05118672|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5893311|NCT05118672|Mydriatics|mydriatics|mesh-ancestor
5893312|NCT05118672|Autonomic Agents|autonomic agents|mesh-ancestor
5893313|NCT05118672|Sympathomimetics|sympathomimetics|mesh-ancestor
5893314|NCT05118672|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5893315|NCT05118672|Nasal Decongestants|nasal decongestants|mesh-ancestor
5893316|NCT05118672|Respiratory System Agents|respiratory system agents|mesh-ancestor
5893317|NCT05118672|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5893318|NCT05118672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5893319|NCT05118672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5617019|NCT03020030|Alkylating Agents|alkylating agents|mesh-ancestor
5617020|NCT03020030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5617021|NCT03020030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5617022|NCT03020030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5617023|NCT03020030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5893320|NCT05118672|Adrenergic Agents|adrenergic agents|mesh-ancestor
5893321|NCT05118672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5617024|NCT03020030|Antiemetics|antiemetics|mesh-ancestor
5617025|NCT03020030|Autonomic Agents|autonomic agents|mesh-ancestor
5617026|NCT03020030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5617027|NCT03020030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5617028|NCT03020030|Glucocorticoids|glucocorticoids|mesh-ancestor
5617029|NCT03020030|Hormones|hormones|mesh-ancestor
5617030|NCT03020030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5617031|NCT03020030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5617032|NCT03020030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5617033|NCT03020030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5617034|NCT03020030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5736773|NCT03126214|Warfarin|warfarin|mesh-list
5736774|NCT03126214|Anticoagulants|anticoagulants|mesh-list
5736775|NCT03125980|Capecitabine|capecitabine|mesh-list
5736776|NCT03125980|Oxaliplatin|oxaliplatin|mesh-list
5736777|NCT03125980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5617035|NCT03020030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5617036|NCT03020030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5617037|NCT03020030|Abortifacient Agents|abortifacient agents|mesh-ancestor
5617038|NCT03020030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5617039|NCT03020030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5617040|NCT03020030|Antimetabolites|antimetabolites|mesh-ancestor
5617041|NCT03020030|Dermatologic Agents|dermatologic agents|mesh-ancestor
5617042|NCT03020030|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5617043|NCT03020030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5617044|NCT03020030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5617045|NCT03020030|Antiviral Agents|antiviral agents|mesh-ancestor
5617046|NCT03020030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5617047|NCT03020030|Antidotes|antidotes|mesh-ancestor
5617048|NCT03020030|Protective Agents|protective agents|mesh-ancestor
5617049|NCT03020030|Vitamin B Complex|vitamin b complex|mesh-ancestor
5617050|NCT03020030|Vitamins|vitamins|mesh-ancestor
5617051|NCT03020030|Micronutrients|micronutrients|mesh-ancestor
5617052|NCT03020030|Tubulin Modulators|tubulin modulators|mesh-ancestor
5617053|NCT03020030|Antimitotic Agents|antimitotic agents|mesh-ancestor
5617054|NCT03020030|Mitosis Modulators|mitosis modulators|mesh-ancestor
5617055|NCT03020030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5617056|NCT03020030|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5617057|NCT03016312|Atezolizumab|atezolizumab|mesh-list
5617058|NCT03016312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5617059|NCT02968212|Clofazimine|clofazimine|mesh-list
5617060|NCT02968212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5736778|NCT03125980|Antimetabolites|antimetabolites|mesh-ancestor
5736779|NCT03125980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736780|NCT03125980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5736781|NCT03126097|Drospirenone|drospirenone|mesh-list
5736782|NCT03126097|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5736783|NCT03126097|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
5736784|NCT03126097|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5736785|NCT03126097|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5736786|NCT03126097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5736787|NCT03126097|Contraceptive Agents|contraceptive agents|mesh-ancestor
5736788|NCT03126097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5736789|NCT03126097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736790|NCT03126097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5736791|NCT03126097|Estrogens|estrogens|mesh-ancestor
5736792|NCT03126097|Hormones|hormones|mesh-ancestor
5736793|NCT03126097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5736794|NCT03126097|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5736795|NCT03126097|Hormone Antagonists|hormone antagonists|mesh-ancestor
5736796|NCT03126097|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5736797|NCT03126097|Diuretics|diuretics|mesh-ancestor
5736798|NCT03126097|Natriuretic Agents|natriuretic agents|mesh-ancestor
5736799|NCT03126071|Bevacizumab|bevacizumab|mesh-list
5736800|NCT03126071|Oxaliplatin|oxaliplatin|mesh-list
5736801|NCT03126071|Irinotecan|irinotecan|mesh-list
5736802|NCT03126071|Raltitrexed|raltitrexed|mesh-list
5736803|NCT03126071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5736804|NCT03126071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5736805|NCT03126071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5736806|NCT03126071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5736807|NCT03126071|Growth Substances|growth substances|mesh-ancestor
5617061|NCT02968212|Leprostatic Agents|leprostatic agents|mesh-ancestor
5617062|NCT02968212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5617063|NCT02968212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5617064|NCT02932618|Factor VIII|factor viii|mesh-list
5736808|NCT03126071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736809|NCT03126071|Growth Inhibitors|growth inhibitors|mesh-ancestor
5736810|NCT03126071|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5736811|NCT03126071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5617065|NCT02932618|Coagulants|coagulants|mesh-ancestor
5617066|NCT02799212|Somatostatin|somatostatin|mesh-list
5617067|NCT02799212|Hormones|hormones|mesh-ancestor
5617068|NCT02799212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5617069|NCT02799212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617070|NCT02756897|Venetoclax|venetoclax|mesh-list
5617071|NCT02756897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5617072|NCT02675959|Defibrotide|defibrotide|mesh-list
5617073|NCT02675959|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5617074|NCT02675959|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5617075|NCT02675959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5617076|NCT02675959|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5617077|NCT02553941|Azacitidine|azacitidine|mesh-list
5617078|NCT02553941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5617079|NCT02553941|Antimetabolites|antimetabolites|mesh-ancestor
5617080|NCT02553941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5617081|NCT02553941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5617082|NCT02553941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5736812|NCT03126071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5736813|NCT03126071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736814|NCT03126071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5736815|NCT03126071|Antimetabolites|antimetabolites|mesh-ancestor
5736816|NCT03126071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5736817|NCT03125811|Ethanol|ethanol|mesh-list
5736818|NCT03125811|Ondansetron|ondansetron|mesh-list
5736819|NCT03125811|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5736820|NCT03125811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5736821|NCT03125811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5736822|NCT03125811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736823|NCT03125811|Antiemetics|antiemetics|mesh-ancestor
5736824|NCT03125811|Autonomic Agents|autonomic agents|mesh-ancestor
5736825|NCT03125811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5736826|NCT03125811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5736827|NCT03125811|Antipruritics|antipruritics|mesh-ancestor
5736828|NCT03125811|Dermatologic Agents|dermatologic agents|mesh-ancestor
5736829|NCT03125811|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5736830|NCT03125811|Serotonin Agents|serotonin agents|mesh-ancestor
5736831|NCT03125811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5736832|NCT03125811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736833|NCT03125811|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5736834|NCT03125811|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5736835|NCT03125811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5736836|NCT03125811|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5736837|NCT03125772|Paclitaxel|paclitaxel|mesh-list
5736838|NCT03125772|Everolimus|everolimus|mesh-list
5736839|NCT03125772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5736840|NCT03125772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5736841|NCT03125772|Tubulin Modulators|tubulin modulators|mesh-ancestor
5736842|NCT03125772|Antimitotic Agents|antimitotic agents|mesh-ancestor
5736843|NCT03125772|Mitosis Modulators|mitosis modulators|mesh-ancestor
5736844|NCT03125772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736845|NCT03125772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5736846|NCT03125772|Immunologic Factors|immunologic factors|mesh-ancestor
5736847|NCT03125772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736848|NCT03125694|Pioglitazone|pioglitazone|mesh-list
5736849|NCT03125694|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5736850|NCT03125694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5736851|NCT03125694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736852|NCT03125694|Incretins|incretins|mesh-ancestor
6208572|NCT02132637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736853|NCT03125694|Hormones|hormones|mesh-ancestor
5907760|NCT05203445|Pembrolizumab|pembrolizumab|mesh-list
5736854|NCT03125694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5736855|NCT03125694|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5736856|NCT03125694|Protease Inhibitors|protease inhibitors|mesh-ancestor
5736857|NCT03125694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5736858|NCT03125694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736859|NCT03125746|Exemestane|exemestane|mesh-list
5736860|NCT03125746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5617097|NCT02482753|Exemestane|exemestane|mesh-list
5617098|NCT02482753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5617099|NCT02482753|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5617100|NCT02482753|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5617101|NCT02482753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5617102|NCT02482753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5617103|NCT02482753|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5617104|NCT02482753|Hormone Antagonists|hormone antagonists|mesh-ancestor
5617105|NCT02482753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5617106|NCT02482753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617107|NCT02420574|Albendazole|albendazole|mesh-list
5617108|NCT02420574|Anthelmintics|anthelmintics|mesh-ancestor
5617109|NCT02420574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5617110|NCT02420574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5617111|NCT02420574|Anticestodal Agents|anticestodal agents|mesh-ancestor
5617112|NCT02420574|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5617113|NCT02420574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5617114|NCT02420574|Tubulin Modulators|tubulin modulators|mesh-ancestor
5617115|NCT02420574|Antimitotic Agents|antimitotic agents|mesh-ancestor
5617116|NCT02420574|Mitosis Modulators|mitosis modulators|mesh-ancestor
5617117|NCT02420574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5617118|NCT02420574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5617119|NCT02403193|Spartalizumab|spartalizumab|mesh-list
5617120|NCT02403193|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5617121|NCT02403193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5617122|NCT02403193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5617123|NCT02358681|Ketorolac|ketorolac|mesh-list
5617124|NCT02358681|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
5736861|NCT03125746|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5736862|NCT03125746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5736863|NCT03125746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5736864|NCT03125746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736865|NCT03125746|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5736866|NCT03125746|Hormone Antagonists|hormone antagonists|mesh-ancestor
5736867|NCT03125746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5736868|NCT03125746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736869|NCT03125616|Vaccines|vaccines|mesh-list
5736870|NCT03125616|Immunologic Factors|immunologic factors|mesh-ancestor
5736871|NCT03125616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736872|NCT03125486|Belimumab|belimumab|mesh-list
5736873|NCT03125486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5736874|NCT03125486|Immunologic Factors|immunologic factors|mesh-ancestor
5736875|NCT03125486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736876|NCT03125473|Vaccines|vaccines|mesh-list
5736877|NCT03125473|Immunologic Factors|immunologic factors|mesh-ancestor
5736878|NCT03125473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736879|NCT03125187|Heparin|heparin|mesh-list
5736880|NCT03125187|Calcium heparin|calcium heparin|mesh-list
5736881|NCT03125187|Anticoagulants|anticoagulants|mesh-ancestor
5736882|NCT03125187|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5736883|NCT03125187|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5736884|NCT03125187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736885|NCT03125213|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5736886|NCT03125213|Antiviral Agents|antiviral agents|mesh-ancestor
5736887|NCT03125213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5736888|NCT03124680|Analgesics, Opioid|analgesics, opioid|mesh-list
5736889|NCT03124680|Narcotics|narcotics|mesh-ancestor
5736890|NCT03124680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5736891|NCT03124680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736892|NCT03124680|Analgesics|analgesics|mesh-ancestor
5736893|NCT03124680|Sensory System Agents|sensory system agents|mesh-ancestor
5736894|NCT03124680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5736895|NCT03124524|Dienogest|dienogest|mesh-list
5736896|NCT03124524|Drospirenone|drospirenone|mesh-list
5692332|NCT03409432|Immunologic Factors|immunologic factors|mesh-ancestor
5617125|NCT02358681|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5736897|NCT03124524|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5736898|NCT03124524|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5736899|NCT03124524|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5736900|NCT03124524|Estradiol|estradiol|mesh-list
5736901|NCT03124524|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5736902|NCT03124524|Estrogens|estrogens|mesh-ancestor
5736903|NCT03124524|Hormones|hormones|mesh-ancestor
5736904|NCT03124524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5736905|NCT03124524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736906|NCT03124524|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5736907|NCT03124524|Contraceptive Agents|contraceptive agents|mesh-ancestor
5736908|NCT03124524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5736909|NCT03124524|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5736910|NCT03124524|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5736911|NCT03124524|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5736912|NCT03124524|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5736913|NCT03124524|Hormone Antagonists|hormone antagonists|mesh-ancestor
5736914|NCT03124524|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5736915|NCT03124524|Diuretics|diuretics|mesh-ancestor
5736916|NCT03124524|Natriuretic Agents|natriuretic agents|mesh-ancestor
5736917|NCT03124524|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5736918|NCT03124524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5736919|NCT03124524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5736920|NCT03124420|Amoxicillin|amoxicillin|mesh-list
5736921|NCT03124420|Clarithromycin|clarithromycin|mesh-list
5736922|NCT03124420|Lansoprazole|lansoprazole|mesh-list
5736923|NCT03124420|Dexlansoprazole|dexlansoprazole|mesh-list
5736924|NCT03124420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5736925|NCT03124420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5736926|NCT03124420|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5736927|NCT03124420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5736928|NCT03124420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736929|NCT03124420|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5736930|NCT03124420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5736931|NCT03124420|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5736932|NCT03124420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5736933|NCT03124420|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5893322|NCT05118672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893323|NCT05118672|Protective Agents|protective agents|mesh-ancestor
5893324|NCT05118672|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5893325|NCT05118672|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5893326|NCT05118672|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5893327|NCT05118672|Histamine Antagonists|histamine antagonists|mesh-ancestor
5617126|NCT02358681|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5617127|NCT02358681|Analgesics|analgesics|mesh-ancestor
5617128|NCT02358681|Sensory System Agents|sensory system agents|mesh-ancestor
5617129|NCT02358681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5617130|NCT02358681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617131|NCT02358681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5617132|NCT02358681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5617133|NCT02358681|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5617134|NCT02358681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5617135|NCT02358681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5617136|NCT02339168|Metformin|metformin|mesh-list
5617137|NCT02339168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5617138|NCT02339168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617139|NCT02269267|Tin Fluorides|tin fluorides|mesh-list
5617140|NCT02269267|Cariostatic Agents|cariostatic agents|mesh-ancestor
5617141|NCT02269267|Protective Agents|protective agents|mesh-ancestor
5617142|NCT02269267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617143|NCT02101788|Tamoxifen|tamoxifen|mesh-list
5893328|NCT05118672|Histamine Agents|histamine agents|mesh-ancestor
5893329|NCT05118542|Methimazole|methimazole|mesh-list
5893330|NCT05118542|Propylthiouracil|propylthiouracil|mesh-list
5893331|NCT05118542|Antithyroid Agents|antithyroid agents|mesh-ancestor
5893332|NCT05118542|Hormone Antagonists|hormone antagonists|mesh-ancestor
5893333|NCT05118542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5893334|NCT05118542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893335|NCT05118542|Antimetabolites|antimetabolites|mesh-ancestor
5893336|NCT05118542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893337|NCT05118490|Isoniazid|isoniazid|mesh-list
5893338|NCT05118490|Rifapentine|rifapentine|mesh-list
5893339|NCT05118490|Rifampin|rifampin|mesh-list
5617144|NCT02101788|Paclitaxel|paclitaxel|mesh-list
5736934|NCT03124082|Lidocaine|lidocaine|mesh-list
5736935|NCT03124082|Clonidine|clonidine|mesh-list
5736936|NCT03124082|Ketamine|ketamine|mesh-list
5736937|NCT03124082|Remifentanil|remifentanil|mesh-list
5736938|NCT03124082|Anesthetics, Local|anesthetics, local|mesh-ancestor
5736939|NCT03124082|Anesthetics|anesthetics|mesh-ancestor
5736940|NCT03124082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5736941|NCT03124082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736942|NCT03124082|Sensory System Agents|sensory system agents|mesh-ancestor
5736943|NCT03124082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5736944|NCT03124082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5736945|NCT03124082|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5736946|NCT03124082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5736947|NCT03124082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5736948|NCT03124082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736949|NCT03124082|Analgesics|analgesics|mesh-ancestor
5736950|NCT03124082|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5736951|NCT03124082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5736952|NCT03124082|Anesthetics, General|anesthetics, general|mesh-ancestor
5736953|NCT03124082|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5736954|NCT03124082|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5736955|NCT03124082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5736956|NCT03124082|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5736957|NCT03124082|Narcotics|narcotics|mesh-ancestor
5736958|NCT03124082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5736959|NCT03124082|Sympatholytics|sympatholytics|mesh-ancestor
5736960|NCT03124082|Autonomic Agents|autonomic agents|mesh-ancestor
5736961|NCT03124082|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5736962|NCT03124082|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5736963|NCT03124082|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5736964|NCT03124082|Adrenergic Agents|adrenergic agents|mesh-ancestor
5736965|NCT03123913|Methyltestosterone|methyltestosterone|mesh-list
5736966|NCT03123913|Testosterone|testosterone|mesh-list
5617145|NCT02101788|Doxorubicin|doxorubicin|mesh-list
5617146|NCT02101788|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5617147|NCT02101788|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5617148|NCT02101788|Letrozole|letrozole|mesh-list
5736967|NCT03123913|Testosterone undecanoate|testosterone undecanoate|mesh-list
5736968|NCT03123913|Testosterone enanthate|testosterone enanthate|mesh-list
5736969|NCT03123913|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5736970|NCT03123913|Androgens|androgens|mesh-ancestor
5736971|NCT03123913|Hormones|hormones|mesh-ancestor
5736972|NCT03123913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5736973|NCT03123913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736974|NCT03123913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5736975|NCT03123913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5736976|NCT03123913|Anabolic Agents|anabolic agents|mesh-ancestor
6208573|NCT02132754|Pembrolizumab|pembrolizumab|mesh-list
6208574|NCT02132754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6208575|NCT02132754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6208576|NCT02132767|Digoxin|digoxin|mesh-list
6208577|NCT02132767|Amiodarone|amiodarone|mesh-list
6208578|NCT02132767|Calcium Channel Blockers|calcium channel blockers|mesh-list
6208579|NCT02132767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5736984|NCT03123770|Cyclophosphamide|cyclophosphamide|mesh-list
5736985|NCT03123770|Docetaxel|docetaxel|mesh-list
5736986|NCT03123770|Doxorubicin|doxorubicin|mesh-list
5736987|NCT03123770|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5736988|NCT03123770|Epirubicin|epirubicin|mesh-list
5736989|NCT03123770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5736990|NCT03123770|Immunologic Factors|immunologic factors|mesh-ancestor
5617149|NCT02101788|Topotecan|topotecan|mesh-list
5617150|NCT02101788|Trametinib|trametinib|mesh-list
5617151|NCT02101788|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
5617152|NCT02101788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5617153|NCT02101788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5617154|NCT02101788|Tubulin Modulators|tubulin modulators|mesh-ancestor
5617155|NCT02101788|Antimitotic Agents|antimitotic agents|mesh-ancestor
5617156|NCT02101788|Mitosis Modulators|mitosis modulators|mesh-ancestor
5617157|NCT02101788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5617158|NCT02101788|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5617159|NCT02101788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5617160|NCT02101788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5617161|NCT02101788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5617162|NCT02101788|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5736991|NCT03123770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5736992|NCT03123770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5736993|NCT03123770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5736994|NCT03123770|Alkylating Agents|alkylating agents|mesh-ancestor
5617163|NCT02101788|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5617164|NCT02101788|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5617165|NCT02101788|Hormone Antagonists|hormone antagonists|mesh-ancestor
5617166|NCT02101788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5617167|NCT02101788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617168|NCT02101788|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5617169|NCT02101788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5617170|NCT02101788|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5617171|NCT02101788|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5736995|NCT03123770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5736996|NCT03123770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5736997|NCT03123770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5736998|NCT03123770|Tubulin Modulators|tubulin modulators|mesh-ancestor
5736999|NCT03123770|Antimitotic Agents|antimitotic agents|mesh-ancestor
5737000|NCT03123770|Mitosis Modulators|mitosis modulators|mesh-ancestor
5737001|NCT03123770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5737002|NCT03123770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5737003|NCT03123770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5737004|NCT03123770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5737005|NCT03123692|N,N'-Bis(2-mercaptoethyl)isophthalamide|n,n'-bis(2-mercaptoethyl)isophthalamide|mesh-list
5737006|NCT03123692|Chelating Agents|chelating agents|mesh-ancestor
5737007|NCT03123692|Sequestering Agents|sequestering agents|mesh-ancestor
5737008|NCT03123692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737009|NCT03123679|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
5737010|NCT03123679|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5737011|NCT03123679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737012|NCT03123744|Palbociclib|palbociclib|mesh-list
5737013|NCT03123744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5737014|NCT03123744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5737015|NCT03123744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5737016|NCT03123744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737017|NCT03123718|Methotrexate|methotrexate|mesh-list
5737018|NCT03123718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5737019|NCT03123718|Abortifacient Agents|abortifacient agents|mesh-ancestor
5737020|NCT03123718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5737021|NCT03123718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617172|NCT02101788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5617173|NCT02101788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5617174|NCT02101788|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
5617175|NCT02101788|Protective Agents|protective agents|mesh-ancestor
5617176|NCT02101788|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5617177|NCT02101788|Antioxidants|antioxidants|mesh-ancestor
5617178|NCT02081378|Niacinamide|niacinamide|mesh-list
5617179|NCT02081378|Imatinib Mesylate|imatinib mesylate|mesh-list
5617180|NCT02081378|Dasatinib|dasatinib|mesh-list
5617181|NCT02081378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5737022|NCT03123718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5737023|NCT03123718|Antimetabolites|antimetabolites|mesh-ancestor
5737024|NCT03123718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737025|NCT03123718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5737026|NCT03123718|Dermatologic Agents|dermatologic agents|mesh-ancestor
5737027|NCT03123718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5737028|NCT03123718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5737029|NCT03123718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5737030|NCT03123718|Immunologic Factors|immunologic factors|mesh-ancestor
5737031|NCT03123718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5737032|NCT03123718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5737033|NCT03123406|Cinacalcet|cinacalcet|mesh-list
5737034|NCT03123406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5737035|NCT03123406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737036|NCT03123406|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
5737037|NCT03123406|Hormone Antagonists|hormone antagonists|mesh-ancestor
5737038|NCT03123406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5737039|NCT03123484|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5737040|NCT03123484|Gefitinib|gefitinib|mesh-list
5737041|NCT03123484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5737042|NCT03123484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5737043|NCT03123484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5737044|NCT03123484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737045|NCT03123289|Gallium citrate|gallium citrate|mesh-list
5893340|NCT05118490|Antitubercular Agents|antitubercular agents|mesh-ancestor
5737046|NCT03123289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737047|NCT03123289|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5737048|NCT03123445|Gemcitabine|gemcitabine|mesh-list
5737049|NCT03123445|Endostar protein|endostar protein|mesh-list
5737050|NCT03123445|Endostatins|endostatins|mesh-list
5737051|NCT03123445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5737052|NCT03123445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5737053|NCT03123445|Antimetabolites|antimetabolites|mesh-ancestor
5737054|NCT03123445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737055|NCT03123445|Antiviral Agents|antiviral agents|mesh-ancestor
5737056|NCT03123445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5737057|NCT03123445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5737058|NCT03123445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5737059|NCT03123445|Immunologic Factors|immunologic factors|mesh-ancestor
5737060|NCT03123445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737061|NCT03123445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5737062|NCT03123445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5737063|NCT03123445|Growth Substances|growth substances|mesh-ancestor
5737064|NCT03123445|Growth Inhibitors|growth inhibitors|mesh-ancestor
5737065|NCT03123276|Gemcitabine|gemcitabine|mesh-list
5737066|NCT03123276|Pembrolizumab|pembrolizumab|mesh-list
5737067|NCT03123276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5737068|NCT03123276|Antimetabolites|antimetabolites|mesh-ancestor
5737069|NCT03123276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737070|NCT03123276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5737071|NCT03123276|Antiviral Agents|antiviral agents|mesh-ancestor
5737072|NCT03123276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5737073|NCT03123276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5737074|NCT03123276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5737075|NCT03123276|Immunologic Factors|immunologic factors|mesh-ancestor
5737076|NCT03123276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737077|NCT03123276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5737078|NCT03123211|Veliparib|veliparib|mesh-list
5737079|NCT03123211|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5617182|NCT02081378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5617183|NCT02081378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5617184|NCT02081378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5617185|NCT02081378|Vitamin B Complex|vitamin b complex|mesh-ancestor
5617186|NCT02081378|Vitamins|vitamins|mesh-ancestor
5617187|NCT02081378|Micronutrients|micronutrients|mesh-ancestor
5617188|NCT02081378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617189|NCT01970410|Teriflunomide|teriflunomide|mesh-list
5617190|NCT01970410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5737080|NCT03123211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5737081|NCT03123211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737082|NCT03123211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5737083|NCT03123016|Apremilast|apremilast|mesh-list
5737084|NCT03123016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5737085|NCT03123016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5737086|NCT03123016|Analgesics|analgesics|mesh-ancestor
5737087|NCT03123016|Sensory System Agents|sensory system agents|mesh-ancestor
5737088|NCT03123016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5737089|NCT03123016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737090|NCT03123016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5737091|NCT03123016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5617191|NCT01970410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5617192|NCT01970410|Analgesics|analgesics|mesh-ancestor
5617193|NCT01970410|Sensory System Agents|sensory system agents|mesh-ancestor
5617194|NCT01970410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5617195|NCT01970410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617196|NCT01970410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5617197|NCT01970410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5617198|NCT01970410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5617199|NCT01970410|Immunologic Factors|immunologic factors|mesh-ancestor
5617200|NCT01963728|Insulin|insulin|mesh-list
5617201|NCT01963728|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5617202|NCT01963728|Insulin Glargine|insulin glargine|mesh-list
5617203|NCT01963728|Insulin, Isophane|insulin, isophane|mesh-list
5617204|NCT01963728|Isophane Insulin, Human|isophane insulin, human|mesh-list
5617205|NCT01963728|Isophane insulin, beef|isophane insulin, beef|mesh-list
5617206|NCT01963728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5617207|NCT01963728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737092|NCT03123016|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5737093|NCT03123016|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5737094|NCT03123016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5737095|NCT03123016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5617208|NCT01936480|Moxifloxacin|moxifloxacin|mesh-list
5617209|NCT01936480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5617210|NCT01936480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5617211|NCT01936480|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5737096|NCT03123029|Venetoclax|venetoclax|mesh-list
5737097|NCT03123029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5737098|NCT03123107|Ascorbic Acid|ascorbic acid|mesh-list
5737099|NCT03123107|Vitamins|vitamins|mesh-ancestor
5737100|NCT03123107|Micronutrients|micronutrients|mesh-ancestor
5737101|NCT03123107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737102|NCT03123107|Antioxidants|antioxidants|mesh-ancestor
5737103|NCT03123107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737104|NCT03123107|Protective Agents|protective agents|mesh-ancestor
5737105|NCT03122938|Lactoferrin|lactoferrin|mesh-list
5737106|NCT03122938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5737107|NCT03122782|Tranexamic Acid|tranexamic acid|mesh-list
5737108|NCT03122782|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5737109|NCT03122782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5617212|NCT01936480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5617213|NCT01936480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5617214|NCT01936480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5617215|NCT01936480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5617216|NCT01880567|Rituximab|rituximab|mesh-list
5617217|NCT01880567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5617218|NCT01880567|Antibodies|antibodies|mesh-list
5617219|NCT01880567|Immunoglobulins|immunoglobulins|mesh-list
5617220|NCT01880567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5617221|NCT01880567|Immunologic Factors|immunologic factors|mesh-ancestor
5617222|NCT01880567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617223|NCT01880567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5617224|NCT01880567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5617225|NCT01842282|Amlexanox|amlexanox|mesh-list
5617226|NCT01842282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5617227|NCT01622335|Nitrous Oxide|nitrous oxide|mesh-list
5737110|NCT03122782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737111|NCT03122782|Hemostatics|hemostatics|mesh-ancestor
5737112|NCT03122782|Coagulants|coagulants|mesh-ancestor
5737113|NCT03122561|Acetaminophen|acetaminophen|mesh-list
5737114|NCT03122561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5737115|NCT03122561|Analgesics|analgesics|mesh-ancestor
5737116|NCT03122561|Sensory System Agents|sensory system agents|mesh-ancestor
5737117|NCT03122561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5737118|NCT03122561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737119|NCT03122561|Antipyretics|antipyretics|mesh-ancestor
5737120|NCT03122509|Durvalumab|durvalumab|mesh-list
5737121|NCT03122509|Tremelimumab|tremelimumab|mesh-list
5737122|NCT03122509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5737123|NCT03122509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5737124|NCT03122639|Atorvastatin|atorvastatin|mesh-list
5737125|NCT03122639|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5737126|NCT03122639|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5737127|NCT03122639|Antimetabolites|antimetabolites|mesh-ancestor
6489246|NCT00590213|Hormone Antagonists|hormone antagonists|mesh-ancestor
6489247|NCT00590213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6489248|NCT00590213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489249|NCT00590213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6489250|NCT00590278|Raltitrexed|raltitrexed|mesh-list
6489251|NCT00590278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5617228|NCT01622335|Anesthetics|anesthetics|mesh-ancestor
5617229|NCT01622335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5737128|NCT03122639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489252|NCT00590278|Antimetabolites|antimetabolites|mesh-ancestor
6489253|NCT00590278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489254|NCT00590278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6489255|NCT00590278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5737129|NCT03122639|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5737130|NCT03122639|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5737131|NCT03122639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5737132|NCT03122652|Teriflunomide|teriflunomide|mesh-list
5737133|NCT03122652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5737134|NCT03122652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5737135|NCT03122652|Analgesics|analgesics|mesh-ancestor
6489256|NCT00590278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6489257|NCT00590343|Vatalanib|vatalanib|mesh-list
5737136|NCT03122652|Sensory System Agents|sensory system agents|mesh-ancestor
5737137|NCT03122652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5737138|NCT03122652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737139|NCT03122652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5737140|NCT03122652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5737141|NCT03122652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5737142|NCT03122652|Immunologic Factors|immunologic factors|mesh-ancestor
5737143|NCT03122730|Epoprostenol|epoprostenol|mesh-list
5737144|NCT03122730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5737145|NCT03122730|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5737146|NCT03122613|Curcumin|curcumin|mesh-list
5737147|NCT03122613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5737148|NCT03122613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5737149|NCT03122613|Analgesics|analgesics|mesh-ancestor
6672816|NCT01558622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6672817|NCT01558622|Analgesics|analgesics|mesh-ancestor
6672818|NCT01558622|Sensory System Agents|sensory system agents|mesh-ancestor
6672819|NCT01558622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6672820|NCT01558622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6672821|NCT01558622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6672822|NCT01558622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6672823|NCT01558622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6672824|NCT01558622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6672825|NCT01558622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5737150|NCT03122613|Sensory System Agents|sensory system agents|mesh-ancestor
5737151|NCT03122613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5737152|NCT03122613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737153|NCT03122613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5737154|NCT03122613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5737155|NCT03122613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5737156|NCT03122613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5737157|NCT03122613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737158|NCT03122756|Dexamethasone|dexamethasone|mesh-list
5737159|NCT03122756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5737160|NCT03122756|Antiemetics|antiemetics|mesh-ancestor
5737161|NCT03122756|Autonomic Agents|autonomic agents|mesh-ancestor
5737162|NCT03122756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5737163|NCT03122756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737164|NCT03122756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5737165|NCT03122756|Glucocorticoids|glucocorticoids|mesh-ancestor
5737166|NCT03122756|Hormones|hormones|mesh-ancestor
5737167|NCT03122756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5737168|NCT03122756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5737169|NCT03122756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5737170|NCT03122678|Thiamine|thiamine|mesh-list
5737171|NCT03122678|Vitamins|vitamins|mesh-ancestor
5737172|NCT03122678|Micronutrients|micronutrients|mesh-ancestor
5737173|NCT03122678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737174|NCT03122678|Vitamin B Complex|vitamin b complex|mesh-ancestor
5893341|NCT05118490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5893342|NCT05118490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5893343|NCT05118490|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5893344|NCT05118490|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6489258|NCT00590343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6489259|NCT00590343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6489260|NCT00590343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489261|NCT00590408|Ubiquinone|ubiquinone|mesh-list
6489262|NCT00590408|Coenzyme Q10|coenzyme q10|mesh-list
6489263|NCT00590408|Micronutrients|micronutrients|mesh-ancestor
6489264|NCT00590408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489265|NCT00590408|Vitamins|vitamins|mesh-ancestor
6489266|NCT00590447|Rituximab|rituximab|mesh-list
6489267|NCT00590447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6489268|NCT00590447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6489269|NCT00590447|Immunologic Factors|immunologic factors|mesh-ancestor
6489270|NCT00590447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737175|NCT03122717|Gefitinib|gefitinib|mesh-list
5737176|NCT03122717|Osimertinib|osimertinib|mesh-list
5737177|NCT03122717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5737178|NCT03122717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5737179|NCT03122717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5737180|NCT03122717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737181|NCT03122665|Nefopam|nefopam|mesh-list
5737182|NCT03122665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5737183|NCT03122665|Analgesics|analgesics|mesh-ancestor
5737184|NCT03122665|Sensory System Agents|sensory system agents|mesh-ancestor
5737185|NCT03122665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5737186|NCT03122665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737187|NCT03122444|Imipramine|imipramine|mesh-list
5617230|NCT01622335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617231|NCT01622335|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5617232|NCT01622335|Anesthetics, General|anesthetics, general|mesh-ancestor
5617233|NCT01622335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5617234|NCT01622335|Analgesics|analgesics|mesh-ancestor
5617235|NCT01622335|Sensory System Agents|sensory system agents|mesh-ancestor
5617236|NCT01622335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5617237|NCT01509339|Vancomycin|vancomycin|mesh-list
5617238|NCT01509339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5617239|NCT01509339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5617240|NCT01500551|Tofacitinib|tofacitinib|mesh-list
5617241|NCT01500551|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5617242|NCT01500551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5617243|NCT01500551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5617244|NCT01362374|Leucovorin|leucovorin|mesh-list
5617245|NCT01362374|Paclitaxel|paclitaxel|mesh-list
5617246|NCT01362374|Docetaxel|docetaxel|mesh-list
5617247|NCT01362374|Oxaliplatin|oxaliplatin|mesh-list
5617248|NCT01362374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5617249|NCT01362374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5617250|NCT01362374|Tubulin Modulators|tubulin modulators|mesh-ancestor
5617251|NCT01362374|Antimitotic Agents|antimitotic agents|mesh-ancestor
5617252|NCT01362374|Mitosis Modulators|mitosis modulators|mesh-ancestor
5617253|NCT01362374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5617254|NCT01362374|Antidotes|antidotes|mesh-ancestor
5617255|NCT01362374|Protective Agents|protective agents|mesh-ancestor
5737188|NCT03122444|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5737189|NCT03122444|Antidepressive Agents|antidepressive agents|mesh-ancestor
5737190|NCT03122444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5737191|NCT03122444|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5617256|NCT01362374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617257|NCT01362374|Vitamin B Complex|vitamin b complex|mesh-ancestor
5737192|NCT03122444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5737193|NCT03122444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5737194|NCT03122444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5617258|NCT01362374|Vitamins|vitamins|mesh-ancestor
5617259|NCT01362374|Micronutrients|micronutrients|mesh-ancestor
5617260|NCT01248247|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5617261|NCT01248247|Sorafenib|sorafenib|mesh-list
5617262|NCT01248247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5617263|NCT01248247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5617264|NCT01248247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5617265|NCT01248247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5617266|NCT01164228|Gemcitabine|gemcitabine|mesh-list
5617267|NCT01164228|Sunitinib|sunitinib|mesh-list
5617268|NCT01164228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5617269|NCT01164228|Antimetabolites|antimetabolites|mesh-ancestor
5617270|NCT01164228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5617271|NCT01164228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5737195|NCT03122444|Adrenergic Agents|adrenergic agents|mesh-ancestor
5737196|NCT03122444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5737197|NCT03122444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737198|NCT03122769|Metformin|metformin|mesh-list
5737199|NCT03122769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5737200|NCT03122769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737201|NCT03122353|Calcitriol|calcitriol|mesh-list
5737202|NCT03122353|Betamethasone|betamethasone|mesh-list
5737203|NCT03122353|Betamethasone Valerate|betamethasone valerate|mesh-list
5737204|NCT03122353|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5737205|NCT03122353|Betamethasone benzoate|betamethasone benzoate|mesh-list
5737206|NCT03122353|Calcipotriene|calcipotriene|mesh-list
5617272|NCT01164228|Antiviral Agents|antiviral agents|mesh-ancestor
5617273|NCT01164228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5737207|NCT03122353|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
5737208|NCT03122353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5737209|NCT03122353|Glucocorticoids|glucocorticoids|mesh-ancestor
5737210|NCT03122353|Hormones|hormones|mesh-ancestor
5737211|NCT03122353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5737212|NCT03122353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617274|NCT01164228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5617275|NCT01164228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5737213|NCT03122353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5737214|NCT03122353|Respiratory System Agents|respiratory system agents|mesh-ancestor
5737215|NCT03122353|Dermatologic Agents|dermatologic agents|mesh-ancestor
5737216|NCT03122353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5737217|NCT03122353|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
5737218|NCT03122353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5737219|NCT03122353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737220|NCT03122353|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5737221|NCT03122353|Vitamins|vitamins|mesh-ancestor
5737222|NCT03122353|Micronutrients|micronutrients|mesh-ancestor
5737223|NCT03122353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5737224|NCT03122197|Letrozole|letrozole|mesh-list
5737225|NCT03122197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5737226|NCT03122197|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5737227|NCT03122197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5737228|NCT03122197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5737229|NCT03122197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737230|NCT03122197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5737231|NCT03122197|Hormone Antagonists|hormone antagonists|mesh-ancestor
5617276|NCT01164228|Immunologic Factors|immunologic factors|mesh-ancestor
5617277|NCT01164228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617278|NCT01164228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5617279|NCT01164228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5617280|NCT01164228|Growth Substances|growth substances|mesh-ancestor
5617281|NCT01164228|Growth Inhibitors|growth inhibitors|mesh-ancestor
5617282|NCT01164228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5617283|NCT01012167|Galantamine|galantamine|mesh-list
5617284|NCT01012167|Oxytocin|oxytocin|mesh-list
5617285|NCT01012167|Oxytocics|oxytocics|mesh-ancestor
5617286|NCT01012167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5617287|NCT01012167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617288|NCT01012167|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5737232|NCT03122197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5737233|NCT03122197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737234|NCT03122262|Tenofovir|tenofovir|mesh-list
5737235|NCT03122262|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5737236|NCT03122262|Dolutegravir|dolutegravir|mesh-list
5737237|NCT03122262|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5737238|NCT03122262|Antiviral Agents|antiviral agents|mesh-ancestor
5737239|NCT03122262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5737240|NCT03122262|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5617289|NCT01012167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5617290|NCT01012167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5617291|NCT01012167|Cholinergic Agents|cholinergic agents|mesh-ancestor
5617292|NCT01012167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5617293|NCT01012167|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5617294|NCT01012167|Autonomic Agents|autonomic agents|mesh-ancestor
5617295|NCT01012167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5737241|NCT03122262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5737242|NCT03122262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5737243|NCT03122262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737244|NCT03122262|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5737245|NCT03122262|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5737246|NCT03122262|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5737247|NCT03122262|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5737248|NCT03122158|Citalopram|citalopram|mesh-list
5737249|NCT03122158|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5737250|NCT03122158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5737251|NCT03122158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5737252|NCT03122158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737253|NCT03122158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5737254|NCT03122158|Serotonin Agents|serotonin agents|mesh-ancestor
5737255|NCT03122158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737256|NCT03122158|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5617296|NCT01012167|Nootropic Agents|nootropic agents|mesh-ancestor
5617297|NCT00924326|Vidarabine|vidarabine|mesh-list
5737257|NCT03122158|Antidepressive Agents|antidepressive agents|mesh-ancestor
5737258|NCT03122158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5737259|NCT03121963|Acetaminophen|acetaminophen|mesh-list
5737260|NCT03121963|Celecoxib|celecoxib|mesh-list
5737261|NCT03121963|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
5737262|NCT03121963|Oxycodone|oxycodone|mesh-list
5737263|NCT03121963|Gabapentin|gabapentin|mesh-list
5737264|NCT03121963|Hydrocodone|hydrocodone|mesh-list
5737265|NCT03121963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5737266|NCT03121963|Analgesics|analgesics|mesh-ancestor
5737267|NCT03121963|Sensory System Agents|sensory system agents|mesh-ancestor
5737268|NCT03121963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5737269|NCT03121963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737270|NCT03121963|Antipyretics|antipyretics|mesh-ancestor
5737271|NCT03121963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5737272|NCT03121963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5737273|NCT03121963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5737274|NCT03121963|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5617298|NCT00924326|Aldesleukin|aldesleukin|mesh-list
5617299|NCT00924326|Cyclophosphamide|cyclophosphamide|mesh-list
5617300|NCT00924326|Fludarabine|fludarabine|mesh-list
5617301|NCT00924326|Fludarabine phosphate|fludarabine phosphate|mesh-list
5617302|NCT00924326|Interleukin-2|interleukin-2|mesh-list
5617303|NCT00924326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5617304|NCT00924326|Immunologic Factors|immunologic factors|mesh-ancestor
5617305|NCT00924326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617306|NCT00924326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5617307|NCT00924326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5617308|NCT00924326|Alkylating Agents|alkylating agents|mesh-ancestor
5617309|NCT00924326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5617310|NCT00924326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5737275|NCT03121963|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5737276|NCT03121963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5737277|NCT03121963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737278|NCT03121963|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5737279|NCT03121963|Narcotics|narcotics|mesh-ancestor
5737280|NCT03121963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5617311|NCT00924326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5617312|NCT00924326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5737281|NCT03121963|Anticonvulsants|anticonvulsants|mesh-ancestor
5737282|NCT03121963|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5737283|NCT03121963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5737284|NCT03121963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5737285|NCT03121963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5737286|NCT03121963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5737287|NCT03121963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5737288|NCT03121963|Antimanic Agents|antimanic agents|mesh-ancestor
5737289|NCT03121963|Antitussive Agents|antitussive agents|mesh-ancestor
5737290|NCT03121963|Respiratory System Agents|respiratory system agents|mesh-ancestor
5737291|NCT03122132|Ritonavir|ritonavir|mesh-list
5737292|NCT03122132|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5737293|NCT03122132|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5737294|NCT03122132|Protease Inhibitors|protease inhibitors|mesh-ancestor
5737295|NCT03122132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5737296|NCT03122132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737297|NCT03122132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5737298|NCT03122132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5737299|NCT03122132|Antiviral Agents|antiviral agents|mesh-ancestor
5737300|NCT03122132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5737301|NCT03122132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5737302|NCT03122132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5737303|NCT03122002|Aspirin|aspirin|mesh-list
5737304|NCT03122002|Clopidogrel|clopidogrel|mesh-list
5737305|NCT03122002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5737306|NCT03122002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5737307|NCT03122002|Analgesics|analgesics|mesh-ancestor
5737308|NCT03122002|Sensory System Agents|sensory system agents|mesh-ancestor
5737309|NCT03122002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5737310|NCT03122002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737311|NCT03122002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5737312|NCT03122002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5737313|NCT03122002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5737314|NCT03122002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5893345|NCT05118490|Antimetabolites|antimetabolites|mesh-ancestor
5617313|NCT00924326|Antimetabolites|antimetabolites|mesh-ancestor
5737315|NCT03122002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737316|NCT03122002|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5737317|NCT03122002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5737318|NCT03122002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5737319|NCT03122002|Antipyretics|antipyretics|mesh-ancestor
5737320|NCT03122002|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5737321|NCT03122002|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5737322|NCT03122002|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5737323|NCT03122002|Purinergic Agents|purinergic agents|mesh-ancestor
5737324|NCT03122002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5737325|NCT03122041|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5737326|NCT03122041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5737327|NCT03122041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737328|NCT03122041|Incretins|incretins|mesh-ancestor
5737329|NCT03122041|Hormones|hormones|mesh-ancestor
5737330|NCT03122041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5737331|NCT03122041|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5737332|NCT03122041|Protease Inhibitors|protease inhibitors|mesh-ancestor
5737333|NCT03122041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5737334|NCT03122041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737335|NCT03121846|Apatinib|apatinib|mesh-list
5737336|NCT03121846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5737337|NCT03121846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5737338|NCT03121846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5737339|NCT03121846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737340|NCT03122314|Acetaminophen|acetaminophen|mesh-list
5737341|NCT03122314|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
5737342|NCT03122314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5737343|NCT03122314|Analgesics|analgesics|mesh-ancestor
5737344|NCT03122314|Sensory System Agents|sensory system agents|mesh-ancestor
5737345|NCT03122314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5737346|NCT03122314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737347|NCT03122314|Antipyretics|antipyretics|mesh-ancestor
5737348|NCT03122314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5737349|NCT03122314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5737350|NCT03122314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5737351|NCT03122067|Oxytocin|oxytocin|mesh-list
5737352|NCT03122067|Oxytocics|oxytocics|mesh-ancestor
5737353|NCT03122067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5737354|NCT03122067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737355|NCT03121833|Endostar protein|endostar protein|mesh-list
5737356|NCT03121833|Endostatins|endostatins|mesh-list
5737357|NCT03121833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5737358|NCT03121833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5737359|NCT03121833|Growth Substances|growth substances|mesh-ancestor
5737360|NCT03121833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737361|NCT03121833|Growth Inhibitors|growth inhibitors|mesh-ancestor
5737362|NCT03121833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5737363|NCT03121807|Leucovorin|leucovorin|mesh-list
5737364|NCT03121807|Fluorouracil|fluorouracil|mesh-list
5737365|NCT03121807|Oxaliplatin|oxaliplatin|mesh-list
5737366|NCT03121807|Antimetabolites|antimetabolites|mesh-ancestor
5737367|NCT03121807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737368|NCT03121807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5737369|NCT03121807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5737370|NCT03121807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5737371|NCT03121807|Immunologic Factors|immunologic factors|mesh-ancestor
5737372|NCT03121807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737373|NCT03121807|Antidotes|antidotes|mesh-ancestor
5737374|NCT03121807|Protective Agents|protective agents|mesh-ancestor
5737375|NCT03121807|Vitamin B Complex|vitamin b complex|mesh-ancestor
5737376|NCT03121807|Vitamins|vitamins|mesh-ancestor
5737377|NCT03121807|Micronutrients|micronutrients|mesh-ancestor
5737378|NCT03121521|Melatonin|melatonin|mesh-list
5737379|NCT03121521|Antioxidants|antioxidants|mesh-ancestor
5737380|NCT03121521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737381|NCT03121521|Protective Agents|protective agents|mesh-ancestor
5737382|NCT03121521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737383|NCT03121521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5737384|NCT03121716|Gemcitabine|gemcitabine|mesh-list
5737385|NCT03121716|Cisplatin|cisplatin|mesh-list
5737386|NCT03121716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5737387|NCT03121716|Antimetabolites|antimetabolites|mesh-ancestor
5737388|NCT03121716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737389|NCT03121716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5617314|NCT00924326|Antiviral Agents|antiviral agents|mesh-ancestor
5617315|NCT00924326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5617316|NCT00924326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5617317|NCT00924326|Analgesics|analgesics|mesh-ancestor
5737390|NCT03121716|Antiviral Agents|antiviral agents|mesh-ancestor
5737391|NCT03121716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5737392|NCT03121716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5737393|NCT03121716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5737394|NCT03121716|Immunologic Factors|immunologic factors|mesh-ancestor
5737395|NCT03121716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737396|NCT03121664|Itraconazole|itraconazole|mesh-list
5737397|NCT03121664|Antifungal Agents|antifungal agents|mesh-ancestor
5737398|NCT03121664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5737399|NCT03121664|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5737400|NCT03121664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5737401|NCT03121664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5737402|NCT03121664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737403|NCT03121664|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5737404|NCT03121664|Hormone Antagonists|hormone antagonists|mesh-ancestor
5737405|NCT03121664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5617318|NCT00924326|Sensory System Agents|sensory system agents|mesh-ancestor
5617319|NCT00924326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5617320|NCT00924326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5617321|NCT00924326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5737406|NCT03121664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737407|NCT03121664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5737408|NCT03121573|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5737409|NCT03121573|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5737410|NCT03121573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5737411|NCT03121573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5737412|NCT03121573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737413|NCT03121573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5737414|NCT03121573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737415|NCT03121573|Analgesics|analgesics|mesh-ancestor
5737416|NCT03121573|Sensory System Agents|sensory system agents|mesh-ancestor
5737417|NCT03121573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5737418|NCT03121573|Antidepressive Agents|antidepressive agents|mesh-ancestor
5737419|NCT03121573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5737420|NCT03121573|Dopamine Agents|dopamine agents|mesh-ancestor
5737421|NCT03121417|Nivolumab|nivolumab|mesh-list
5737422|NCT03121417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5737423|NCT03121417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5737424|NCT03121417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5737425|NCT03121417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737426|NCT03121313|Tegafur|tegafur|mesh-list
5737427|NCT03121313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5737428|NCT03121313|Antimetabolites|antimetabolites|mesh-ancestor
5737429|NCT03121313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737430|NCT03121313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5737431|NCT03121352|Paclitaxel|paclitaxel|mesh-list
5737432|NCT03121352|Carboplatin|carboplatin|mesh-list
5737433|NCT03121352|Pembrolizumab|pembrolizumab|mesh-list
5737434|NCT03121352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5737435|NCT03121352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5737436|NCT03121352|Tubulin Modulators|tubulin modulators|mesh-ancestor
5737437|NCT03121352|Antimitotic Agents|antimitotic agents|mesh-ancestor
5737438|NCT03121352|Mitosis Modulators|mitosis modulators|mesh-ancestor
5737439|NCT03121352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737440|NCT03121352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5737441|NCT03121599|Alovudine|alovudine|mesh-list
5737442|NCT03121599|Antiviral Agents|antiviral agents|mesh-ancestor
5737443|NCT03121599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5737444|NCT03121690|Prednisone|prednisone|mesh-list
5737445|NCT03121690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5737446|NCT03121690|Glucocorticoids|glucocorticoids|mesh-ancestor
5737447|NCT03121690|Hormones|hormones|mesh-ancestor
5737448|NCT03121690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5737449|NCT03121690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737450|NCT03121690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5737451|NCT03121690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5737452|NCT03121547|Tramadol|tramadol|mesh-list
5737453|NCT03121547|Tapentadol|tapentadol|mesh-list
5907761|NCT05203445|Olaparib|olaparib|mesh-list
5617322|NCT00591318|Ceftriaxone|ceftriaxone|mesh-list
5617323|NCT00591318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5617324|NCT00591318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5617325|NCT00321100|Bevacizumab|bevacizumab|mesh-list
5617326|NCT00321100|Cetuximab|cetuximab|mesh-list
5617327|NCT00321100|Capecitabine|capecitabine|mesh-list
5617328|NCT00321100|Oxaliplatin|oxaliplatin|mesh-list
5617329|NCT00321100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5617330|NCT00321100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5737454|NCT03121547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737455|NCT03121547|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5737456|NCT03121547|Narcotics|narcotics|mesh-ancestor
5737457|NCT03121547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5737458|NCT03121547|Analgesics|analgesics|mesh-ancestor
5737459|NCT03121547|Sensory System Agents|sensory system agents|mesh-ancestor
5737460|NCT03121547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5737461|NCT03121547|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5737462|NCT03121547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5737463|NCT03121547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5737464|NCT03121547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737465|NCT03121547|Adrenergic Agents|adrenergic agents|mesh-ancestor
5737466|NCT03121547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5737467|NCT03121339|Vaccines|vaccines|mesh-list
5737468|NCT03121339|Immunologic Factors|immunologic factors|mesh-ancestor
5737469|NCT03121339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737470|NCT03121261|Clonidine|clonidine|mesh-list
5737471|NCT03121261|Levobupivacaine|levobupivacaine|mesh-list
5737472|NCT03121261|Anesthetics, Local|anesthetics, local|mesh-ancestor
5737473|NCT03121261|Anesthetics|anesthetics|mesh-ancestor
5737474|NCT03121261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5737475|NCT03121261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737476|NCT03121261|Sensory System Agents|sensory system agents|mesh-ancestor
5737477|NCT03121261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5737478|NCT03121261|Analgesics|analgesics|mesh-ancestor
5617331|NCT00321100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5617332|NCT00321100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5617333|NCT00321100|Growth Substances|growth substances|mesh-ancestor
5617334|NCT00321100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617335|NCT00321100|Growth Inhibitors|growth inhibitors|mesh-ancestor
5617336|NCT00321100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5617337|NCT00321100|Antimetabolites|antimetabolites|mesh-ancestor
5617338|NCT00321100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737479|NCT03121261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5737480|NCT03121261|Sympatholytics|sympatholytics|mesh-ancestor
5737481|NCT03121261|Autonomic Agents|autonomic agents|mesh-ancestor
5737482|NCT03121261|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5737483|NCT03121261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5737484|NCT03121261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5737485|NCT03121261|Adrenergic Agents|adrenergic agents|mesh-ancestor
5737486|NCT03121261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5737487|NCT03121261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737488|NCT03121222|Acetylcysteine|acetylcysteine|mesh-list
5737489|NCT03121222|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5737490|NCT03121222|Antiviral Agents|antiviral agents|mesh-ancestor
5737491|NCT03121222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5737492|NCT03121222|Expectorants|expectorants|mesh-ancestor
5737493|NCT03121222|Respiratory System Agents|respiratory system agents|mesh-ancestor
5737494|NCT03121222|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5737495|NCT03121222|Antioxidants|antioxidants|mesh-ancestor
5737496|NCT03121222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737497|NCT03121222|Protective Agents|protective agents|mesh-ancestor
5737498|NCT03121222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737499|NCT03121222|Antidotes|antidotes|mesh-ancestor
5737500|NCT03121014|Methotrexate|methotrexate|mesh-list
5737501|NCT03121014|Fludarabine|fludarabine|mesh-list
5737502|NCT03121014|Busulfan|busulfan|mesh-list
5737503|NCT03121014|Tacrolimus|tacrolimus|mesh-list
5737504|NCT03121014|Thymoglobulin|thymoglobulin|mesh-list
5737505|NCT03121014|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5737506|NCT03121014|Abortifacient Agents|abortifacient agents|mesh-ancestor
5737507|NCT03121014|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5737508|NCT03121014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737509|NCT03121014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5737510|NCT03121014|Antimetabolites|antimetabolites|mesh-ancestor
5737511|NCT03121014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737512|NCT03121014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5737513|NCT03121014|Dermatologic Agents|dermatologic agents|mesh-ancestor
5737514|NCT03121014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5737515|NCT03121014|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5737516|NCT03121014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5737517|NCT03121014|Immunologic Factors|immunologic factors|mesh-ancestor
5737518|NCT03121014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5737519|NCT03121014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5617339|NCT05191784|Bevacizumab|bevacizumab|mesh-list
5617340|NCT05191784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5617341|NCT05191784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5617342|NCT05191784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5617343|NCT05191784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5617344|NCT05191784|Growth Substances|growth substances|mesh-ancestor
5617345|NCT05191784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617346|NCT05191784|Growth Inhibitors|growth inhibitors|mesh-ancestor
5617347|NCT05191706|Dexamethasone|dexamethasone|mesh-list
5617348|NCT05191706|Prednisolone|prednisolone|mesh-list
5617349|NCT05191706|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5617350|NCT05191706|Methylprednisolone|methylprednisolone|mesh-list
5617351|NCT05191706|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5617352|NCT05191706|Prednisolone acetate|prednisolone acetate|mesh-list
5737520|NCT03121014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5737521|NCT03121014|Alkylating Agents|alkylating agents|mesh-ancestor
5737522|NCT03121014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5737523|NCT03121014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5737524|NCT03120962|Famciclovir|famciclovir|mesh-list
5737525|NCT03120962|Oxycodone|oxycodone|mesh-list
5737526|NCT03120962|Gabapentin|gabapentin|mesh-list
5737527|NCT03120962|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5737528|NCT03120962|Narcotics|narcotics|mesh-ancestor
5737529|NCT03120962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5737530|NCT03120962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737531|NCT03120962|Analgesics|analgesics|mesh-ancestor
5737532|NCT03120962|Sensory System Agents|sensory system agents|mesh-ancestor
5737533|NCT03120962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5737534|NCT03120962|Anticonvulsants|anticonvulsants|mesh-ancestor
5737535|NCT03120962|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5737536|NCT03120962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5737537|NCT03120962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5737538|NCT03120962|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5737539|NCT03120962|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5737540|NCT03120962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5737541|NCT03120962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737542|NCT03120962|Antimanic Agents|antimanic agents|mesh-ancestor
5737543|NCT03120962|Antiviral Agents|antiviral agents|mesh-ancestor
5737544|NCT03120962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5617353|NCT05191706|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5617354|NCT05191706|Prednisolone phosphate|prednisolone phosphate|mesh-list
5617355|NCT05191706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5617356|NCT05191706|Antiemetics|antiemetics|mesh-ancestor
5617357|NCT05191706|Autonomic Agents|autonomic agents|mesh-ancestor
5617358|NCT05191706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5617359|NCT05191706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617360|NCT05191706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5617361|NCT05191706|Glucocorticoids|glucocorticoids|mesh-ancestor
5617362|NCT05191706|Hormones|hormones|mesh-ancestor
5617363|NCT05191706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5617364|NCT05191706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5617365|NCT05191706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5617366|NCT05191706|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5617367|NCT05191706|Protective Agents|protective agents|mesh-ancestor
5617368|NCT05191472|Pembrolizumab|pembrolizumab|mesh-list
5617369|NCT05191472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5737545|NCT03120962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5737546|NCT03120962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5737547|NCT03120936|Tenofovir|tenofovir|mesh-list
5737548|NCT03120936|Emtricitabine|emtricitabine|mesh-list
5737549|NCT03120936|Antiviral Agents|antiviral agents|mesh-ancestor
5737550|NCT03120936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5617370|NCT05191472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5692333|NCT03409432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737551|NCT03120936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5737552|NCT03120936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5737553|NCT03120936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5737554|NCT03120936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737555|NCT03120936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5617371|NCT05191446|Ethanol|ethanol|mesh-list
5617372|NCT05191446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5617373|NCT05191446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5617374|NCT05191446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5617375|NCT05191446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617376|NCT05191394|Antibodies|antibodies|mesh-list
5617377|NCT05191394|Immunologic Factors|immunologic factors|mesh-ancestor
5617378|NCT05191394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617379|NCT05191277|Antidepressive Agents|antidepressive agents|mesh-list
5617380|NCT05191277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5617381|NCT05191225|Rituximab|rituximab|mesh-list
5617382|NCT05191225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5617383|NCT05191225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5617384|NCT05191225|Immunologic Factors|immunologic factors|mesh-ancestor
5617385|NCT05191225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617386|NCT05191225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5617387|NCT05191004|Fulvestrant|fulvestrant|mesh-list
5617388|NCT05191004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5617389|NCT05191004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5617390|NCT05191004|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5617391|NCT05191004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5617392|NCT05191004|Hormone Antagonists|hormone antagonists|mesh-ancestor
5617393|NCT05191004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5617394|NCT05191004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617395|NCT05190952|Dexamethasone|dexamethasone|mesh-list
5617396|NCT05190952|Ketamine|ketamine|mesh-list
5617397|NCT05190952|Bupivacaine|bupivacaine|mesh-list
5617398|NCT05190952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5617399|NCT05190952|Antiemetics|antiemetics|mesh-ancestor
5617400|NCT05190952|Autonomic Agents|autonomic agents|mesh-ancestor
5617401|NCT05190952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5617402|NCT05190952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617403|NCT05190952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5617404|NCT05190952|Glucocorticoids|glucocorticoids|mesh-ancestor
5617405|NCT05190952|Hormones|hormones|mesh-ancestor
5617406|NCT05190952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5617407|NCT05190952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5617408|NCT05190952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5617409|NCT05190952|Anesthetics, Local|anesthetics, local|mesh-ancestor
5617410|NCT05190952|Anesthetics|anesthetics|mesh-ancestor
5617411|NCT05190952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5617412|NCT05190952|Sensory System Agents|sensory system agents|mesh-ancestor
5617413|NCT05190952|Analgesics|analgesics|mesh-ancestor
5617414|NCT05190952|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5617415|NCT05190952|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5617416|NCT05190952|Anesthetics, General|anesthetics, general|mesh-ancestor
5617417|NCT05190952|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5617418|NCT05190952|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5617419|NCT05190952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5617420|NCT05190952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5617421|NCT05190705|Dexamethasone|dexamethasone|mesh-list
5617422|NCT05190705|Dexamethasone acetate|dexamethasone acetate|mesh-list
5617423|NCT05190705|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
5617424|NCT05190705|BB 1101|bb 1101|mesh-list
5737556|NCT03120936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5737557|NCT03121079|Interferons|interferons|mesh-list
5737558|NCT03121079|Interferon-alpha|interferon-alpha|mesh-list
5737559|NCT03121079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5737560|NCT03121079|Antiviral Agents|antiviral agents|mesh-ancestor
5737561|NCT03121079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5737562|NCT03121079|Immunologic Factors|immunologic factors|mesh-ancestor
5737563|NCT03121079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893346|NCT05118490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893347|NCT05118490|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5893348|NCT05118490|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5893349|NCT05118490|Leprostatic Agents|leprostatic agents|mesh-ancestor
5617425|NCT05190705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5617426|NCT05190705|Antiemetics|antiemetics|mesh-ancestor
5617427|NCT05190705|Autonomic Agents|autonomic agents|mesh-ancestor
5893350|NCT05118490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5617428|NCT05190705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5617429|NCT05190705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617430|NCT05190705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5617431|NCT05190705|Glucocorticoids|glucocorticoids|mesh-ancestor
5617432|NCT05190705|Hormones|hormones|mesh-ancestor
5617433|NCT05190705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5617434|NCT05190705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5617435|NCT05190705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5617436|NCT05190705|Protease Inhibitors|protease inhibitors|mesh-ancestor
5617437|NCT05190705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5617438|NCT05190705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5617439|NCT05190705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5617440|NCT05190562|Zinc Sulfate|zinc sulfate|mesh-list
5617441|NCT05190562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617442|NCT05190562|Astringents|astringents|mesh-ancestor
5737564|NCT03120923|Triamcinolone|triamcinolone|mesh-list
5737565|NCT03120923|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5737566|NCT03120923|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5737567|NCT03120923|Lidocaine|lidocaine|mesh-list
5737568|NCT03120923|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5737569|NCT03120923|Anesthetics, Local|anesthetics, local|mesh-ancestor
5737570|NCT03120923|Anesthetics|anesthetics|mesh-ancestor
5737571|NCT03120923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5737572|NCT03120923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737573|NCT03120923|Sensory System Agents|sensory system agents|mesh-ancestor
5737574|NCT03120923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5617443|NCT05190562|Dermatologic Agents|dermatologic agents|mesh-ancestor
5617444|NCT05190471|Decitabine|decitabine|mesh-list
5617445|NCT05190471|Oblimersen|oblimersen|mesh-list
5617446|NCT05190471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5617447|NCT05190471|Antimetabolites|antimetabolites|mesh-ancestor
5617448|NCT05190471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5617449|NCT05190471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5617450|NCT05190471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5737575|NCT03120923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5737576|NCT03120923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5737577|NCT03120923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5737578|NCT03120923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5737579|NCT03120923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737580|NCT03120923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5737581|NCT03120923|Glucocorticoids|glucocorticoids|mesh-ancestor
5737582|NCT03120923|Hormones|hormones|mesh-ancestor
5737583|NCT03120923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5737584|NCT03120923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5737585|NCT03120923|Immunologic Factors|immunologic factors|mesh-ancestor
5737586|NCT03120923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5737587|NCT03120975|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5737588|NCT03120975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5737589|NCT03120780|Fentanyl|fentanyl|mesh-list
5737590|NCT03120780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5737591|NCT03120780|Narcotics|narcotics|mesh-ancestor
5737592|NCT03120780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5737593|NCT03120780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737594|NCT03120780|Analgesics|analgesics|mesh-ancestor
5617451|NCT05190432|Taxifolin|taxifolin|mesh-list
5617452|NCT05190432|Ergothioneine|ergothioneine|mesh-list
5737595|NCT03120780|Sensory System Agents|sensory system agents|mesh-ancestor
5737596|NCT03120780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5737597|NCT03120780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5737598|NCT03120780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5737599|NCT03120780|Anesthetics, General|anesthetics, general|mesh-ancestor
5737600|NCT03120780|Anesthetics|anesthetics|mesh-ancestor
5737601|NCT03120728|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5737602|NCT03120728|Etonogestrel|etonogestrel|mesh-list
5737603|NCT03120728|NuvaRing|nuvaring|mesh-list
5737604|NCT03120728|Contraceptive Agents|contraceptive agents|mesh-list
5737605|NCT03120728|Estradiol|estradiol|mesh-list
5737606|NCT03120728|Estrogens|estrogens|mesh-ancestor
5737607|NCT03120728|Hormones|hormones|mesh-ancestor
5737608|NCT03120728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5737609|NCT03120728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737610|NCT03120728|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5737611|NCT03120728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5737612|NCT03120728|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5737613|NCT03120728|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5737614|NCT03120728|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6489271|NCT00590447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5617453|NCT05190432|Antioxidants|antioxidants|mesh-ancestor
5617454|NCT05190432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737615|NCT03120442|Fentanyl|fentanyl|mesh-list
5737616|NCT03120442|Dexmedetomidine|dexmedetomidine|mesh-list
5737617|NCT03120442|Propofol|propofol|mesh-list
5737618|NCT03120442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5737619|NCT03120442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5737620|NCT03120442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737621|NCT03120442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5737622|NCT03120442|Anesthetics, General|anesthetics, general|mesh-ancestor
5737623|NCT03120442|Anesthetics|anesthetics|mesh-ancestor
5737624|NCT03120442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5737625|NCT03120442|Analgesics|analgesics|mesh-ancestor
5737626|NCT03120442|Sensory System Agents|sensory system agents|mesh-ancestor
5737627|NCT03120442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5737628|NCT03120442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5737629|NCT03120442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5737630|NCT03120442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5737631|NCT03120442|Adrenergic Agents|adrenergic agents|mesh-ancestor
5737632|NCT03120442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5737633|NCT03120442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737634|NCT03120442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5737635|NCT03120442|Narcotics|narcotics|mesh-ancestor
5737636|NCT03120442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5737637|NCT03120468|Topiramate|topiramate|mesh-list
5737638|NCT03120468|Acetylcysteine|acetylcysteine|mesh-list
5737639|NCT03120468|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5737640|NCT03120468|Anticonvulsants|anticonvulsants|mesh-ancestor
5737641|NCT03120468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5737642|NCT03120468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737643|NCT03120468|Antiviral Agents|antiviral agents|mesh-ancestor
5737644|NCT03120468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5737645|NCT03120468|Expectorants|expectorants|mesh-ancestor
5737646|NCT03120468|Respiratory System Agents|respiratory system agents|mesh-ancestor
5737647|NCT03120468|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5737648|NCT03120468|Antioxidants|antioxidants|mesh-ancestor
5737649|NCT03120468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737650|NCT03120468|Protective Agents|protective agents|mesh-ancestor
5737651|NCT03120468|Antidotes|antidotes|mesh-ancestor
5737652|NCT03120715|Heparin|heparin|mesh-list
5737653|NCT03120715|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5737654|NCT03120715|Tinzaparin|tinzaparin|mesh-list
5737655|NCT03120715|Dalteparin|dalteparin|mesh-list
5737656|NCT03120715|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5737657|NCT03120715|Progesterone|progesterone|mesh-list
5737658|NCT03120715|Estrogens|estrogens|mesh-list
5737659|NCT03120715|Anticoagulants|anticoagulants|mesh-ancestor
5737660|NCT03120715|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5737661|NCT03120715|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5737662|NCT03120715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737663|NCT03120715|Progestins|progestins|mesh-ancestor
5737664|NCT03120715|Hormones|hormones|mesh-ancestor
5737665|NCT03120715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5737666|NCT03120715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737667|NCT03120715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5737668|NCT03120533|Treprostinil|treprostinil|mesh-list
5737669|NCT03120533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5737670|NCT03120403|Morphine|morphine|mesh-list
5617455|NCT05190432|Protective Agents|protective agents|mesh-ancestor
5617456|NCT05190432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617457|NCT05190432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5617458|NCT05190432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5617459|NCT05190432|Analgesics|analgesics|mesh-ancestor
5617460|NCT05190432|Sensory System Agents|sensory system agents|mesh-ancestor
5737671|NCT03120403|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5737672|NCT03120403|Narcotics|narcotics|mesh-ancestor
5737673|NCT03120403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5737674|NCT03120403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737675|NCT03120403|Analgesics|analgesics|mesh-ancestor
5737676|NCT03120403|Sensory System Agents|sensory system agents|mesh-ancestor
5737677|NCT03120403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5737678|NCT03120494|Tenofovir|tenofovir|mesh-list
5737679|NCT03120494|Emtricitabine|emtricitabine|mesh-list
5737680|NCT03120494|Antiviral Agents|antiviral agents|mesh-ancestor
5737681|NCT03120494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5737682|NCT03120494|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5737683|NCT03120494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5737684|NCT03120494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5617461|NCT05190432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5617462|NCT05190432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5737685|NCT03120494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737686|NCT03120494|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5617463|NCT05190432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5617464|NCT05190341|Ibuprofen|ibuprofen|mesh-list
5737687|NCT03120494|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5737688|NCT03120637|Methylene Blue|methylene blue|mesh-list
5737689|NCT03120637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5737690|NCT03120637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737691|NCT03120663|Amoxicillin|amoxicillin|mesh-list
5737692|NCT03120663|Clindamycin|clindamycin|mesh-list
5737693|NCT03120663|Meropenem|meropenem|mesh-list
5737694|NCT03120663|Tazobactam|tazobactam|mesh-list
5737695|NCT03120663|Piperacillin|piperacillin|mesh-list
5737696|NCT03120663|Clavulanic Acids|clavulanic acids|mesh-list
5737697|NCT03120663|Clavulanic Acid|clavulanic acid|mesh-list
5737698|NCT03120663|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
5737699|NCT03120663|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5737700|NCT03120663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6489272|NCT00590603|Ascorbic Acid|ascorbic acid|mesh-list
6489273|NCT00590603|Bortezomib|bortezomib|mesh-list
6489274|NCT00590603|Arsenic Trioxide|arsenic trioxide|mesh-list
6489275|NCT00590603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6489276|NCT00590603|Antioxidants|antioxidants|mesh-ancestor
5617465|NCT05190341|Ketorolac|ketorolac|mesh-list
5617466|NCT05190341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5617467|NCT05190341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5617468|NCT05190341|Analgesics|analgesics|mesh-ancestor
5617469|NCT05190341|Sensory System Agents|sensory system agents|mesh-ancestor
5617470|NCT05190341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5737701|NCT03120663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5737702|NCT03120663|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5737703|NCT03120663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5737704|NCT03120663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737705|NCT03120663|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5737706|NCT03120273|Lansoprazole|lansoprazole|mesh-list
5737707|NCT03120273|Dexlansoprazole|dexlansoprazole|mesh-list
5737708|NCT03120273|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5737709|NCT03120273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5737710|NCT03120273|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5737711|NCT03120273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5737712|NCT03120273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737713|NCT03120247|Dexmedetomidine|dexmedetomidine|mesh-list
5737714|NCT03120247|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5737715|NCT03120247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5737716|NCT03120247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737717|NCT03120247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5737718|NCT03120247|Analgesics|analgesics|mesh-ancestor
5737719|NCT03120247|Sensory System Agents|sensory system agents|mesh-ancestor
5737720|NCT03120247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5737721|NCT03120247|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5737722|NCT03120247|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5617471|NCT05190341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617472|NCT05190341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5617473|NCT05190341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5617474|NCT05190341|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5737723|NCT03120247|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5737724|NCT03120247|Adrenergic Agents|adrenergic agents|mesh-ancestor
5737725|NCT03120247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5737726|NCT03120247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737727|NCT03120234|Fentanyl|fentanyl|mesh-list
5617475|NCT05190341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6489277|NCT00590603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737728|NCT03120234|Dexmedetomidine|dexmedetomidine|mesh-list
5617476|NCT05190341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5617477|NCT05190120|Ropivacaine|ropivacaine|mesh-list
5617478|NCT05190120|Anesthetics, Local|anesthetics, local|mesh-ancestor
5617479|NCT05190120|Anesthetics|anesthetics|mesh-ancestor
5617480|NCT05190120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5617481|NCT05190120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617482|NCT05190120|Sensory System Agents|sensory system agents|mesh-ancestor
5617483|NCT05190120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5617484|NCT05190094|Letrozole|letrozole|mesh-list
5617485|NCT05190094|Palbociclib|palbociclib|mesh-list
5617486|NCT05190094|Anastrozole|anastrozole|mesh-list
5617487|NCT05190094|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5617488|NCT05190094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5617489|NCT05190094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5617490|NCT05190094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5617491|NCT05190094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737729|NCT03120234|Ketamine|ketamine|mesh-list
5737730|NCT03120234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5737731|NCT03120234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5737732|NCT03120234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737733|NCT03120234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5737734|NCT03120234|Analgesics|analgesics|mesh-ancestor
5737735|NCT03120234|Sensory System Agents|sensory system agents|mesh-ancestor
5737736|NCT03120234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5737737|NCT03120234|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5737738|NCT03120234|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5737739|NCT03120234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5737740|NCT03120234|Adrenergic Agents|adrenergic agents|mesh-ancestor
5737741|NCT03120234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5737742|NCT03120234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737743|NCT03120234|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5737744|NCT03120234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5737745|NCT03120234|Anesthetics, General|anesthetics, general|mesh-ancestor
5737746|NCT03120234|Anesthetics|anesthetics|mesh-ancestor
5737747|NCT03120234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5737748|NCT03120234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5737749|NCT03120234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5737750|NCT03120234|Narcotics|narcotics|mesh-ancestor
5737751|NCT03120234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5737752|NCT03119857|Docetaxel|docetaxel|mesh-list
5617492|NCT05190094|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5617493|NCT05190094|Hormone Antagonists|hormone antagonists|mesh-ancestor
5617494|NCT05190094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5617495|NCT05190094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617496|NCT05190094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5617497|NCT05190094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5617498|NCT05189977|Propranolol|propranolol|mesh-list
5617499|NCT05189977|Prazosin|prazosin|mesh-list
5617500|NCT05189977|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5617501|NCT05189977|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5617502|NCT05189977|Adrenergic Agents|adrenergic agents|mesh-ancestor
5617503|NCT05189977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5617504|NCT05189977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5617505|NCT05189977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617506|NCT05189977|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5617507|NCT05189977|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5617508|NCT05189977|Vasodilator Agents|vasodilator agents|mesh-ancestor
5617509|NCT05189977|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5617510|NCT05189977|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5617511|NCT05189769|Levonorgestrel|levonorgestrel|mesh-list
5617512|NCT05189769|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5617513|NCT05189769|Contraceptive Agents|contraceptive agents|mesh-ancestor
5617514|NCT05189769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5617515|NCT05189769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617516|NCT05189769|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5617517|NCT05189769|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5617518|NCT05189769|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5617519|NCT05189704|Analgesics, Opioid|analgesics, opioid|mesh-list
5617520|NCT05189704|Narcotics|narcotics|mesh-ancestor
5617521|NCT05189704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5737753|NCT03119857|Androgen Antagonists|androgen antagonists|mesh-list
5737754|NCT03119857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5737755|NCT03119857|Tubulin Modulators|tubulin modulators|mesh-ancestor
5617522|NCT05189704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617523|NCT05189704|Analgesics|analgesics|mesh-ancestor
5617524|NCT05189704|Sensory System Agents|sensory system agents|mesh-ancestor
5617525|NCT05189704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5617526|NCT05186883|Parathyroid Hormone|parathyroid hormone|mesh-list
5617527|NCT05186883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5617528|NCT05186883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617529|NCT05180773|Bromocriptine|bromocriptine|mesh-list
5617530|NCT05180773|Rivaroxaban|rivaroxaban|mesh-list
5617531|NCT05180773|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5617532|NCT05180773|Antithrombins|antithrombins|mesh-ancestor
5737756|NCT03119857|Antimitotic Agents|antimitotic agents|mesh-ancestor
5737757|NCT03119857|Mitosis Modulators|mitosis modulators|mesh-ancestor
5737758|NCT03119857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737759|NCT03119857|Hormone Antagonists|hormone antagonists|mesh-ancestor
5737760|NCT03119857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5737761|NCT03119857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737762|NCT03120182|Aspirin|aspirin|mesh-list
5737763|NCT03120182|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5737764|NCT03120182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5737765|NCT03120182|Analgesics|analgesics|mesh-ancestor
5737766|NCT03120182|Sensory System Agents|sensory system agents|mesh-ancestor
5737767|NCT03120182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5737768|NCT03120182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737769|NCT03120182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5737770|NCT03120182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5737771|NCT03120182|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5737772|NCT03120182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5737773|NCT03120182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737774|NCT03120182|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5737775|NCT03120182|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5737776|NCT03120182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5737777|NCT03120182|Antipyretics|antipyretics|mesh-ancestor
5737778|NCT03119948|Botulinum Toxins|botulinum toxins|mesh-list
5737779|NCT03119948|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5737780|NCT03119948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5737781|NCT03119948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737782|NCT03119948|Cholinergic Agents|cholinergic agents|mesh-ancestor
5737783|NCT03119948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5737784|NCT03119948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737785|NCT03119532|Metronidazole|metronidazole|mesh-list
5737786|NCT03119532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5737787|NCT03119532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5737788|NCT03119532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5737789|NCT03119532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5737790|NCT03119584|Linaclotide|linaclotide|mesh-list
5737791|NCT03119584|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
5737792|NCT03119584|Enzyme Activators|enzyme activators|mesh-ancestor
5737793|NCT03119584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737794|NCT03119584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5737795|NCT03119623|Valsartan|valsartan|mesh-list
5617533|NCT05180773|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5617534|NCT05180773|Protease Inhibitors|protease inhibitors|mesh-ancestor
5617535|NCT05180773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5617536|NCT05180773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5617537|NCT05180773|Anticoagulants|anticoagulants|mesh-ancestor
5617538|NCT05180773|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5617539|NCT05180773|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5617540|NCT05180773|Hormone Antagonists|hormone antagonists|mesh-ancestor
5617541|NCT05180773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5617542|NCT05180773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617543|NCT05180773|Dopamine Agonists|dopamine agonists|mesh-ancestor
5617544|NCT05180773|Dopamine Agents|dopamine agents|mesh-ancestor
5617545|NCT05180773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5692334|NCT03409432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5692335|NCT03409432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5692336|NCT03409432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5692337|NCT03409432|Growth Substances|growth substances|mesh-ancestor
5692338|NCT03409432|Growth Inhibitors|growth inhibitors|mesh-ancestor
5692339|NCT03409367|Emollients|emollients|mesh-list
5692340|NCT03409367|Petrolatum|petrolatum|mesh-list
5692341|NCT03409367|Dermatologic Agents|dermatologic agents|mesh-ancestor
5692342|NCT03409276|Vaccines|vaccines|mesh-list
5692343|NCT03409276|Immunologic Factors|immunologic factors|mesh-ancestor
5737796|NCT03119623|Enalapril|enalapril|mesh-list
5737797|NCT03119623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5737798|NCT03119623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5737799|NCT03119623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5737800|NCT03119623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737801|NCT03119623|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5737802|NCT03119623|Protease Inhibitors|protease inhibitors|mesh-ancestor
5737803|NCT03119623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5737804|NCT03119454|Betamethasone|betamethasone|mesh-list
5737805|NCT03119454|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
5737806|NCT03119454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5737807|NCT03119454|Glucocorticoids|glucocorticoids|mesh-ancestor
5737808|NCT03119454|Hormones|hormones|mesh-ancestor
5737809|NCT03119454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5737810|NCT03119454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737811|NCT03119454|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5737812|NCT03119454|Respiratory System Agents|respiratory system agents|mesh-ancestor
5737813|NCT03119636|Levodopa|levodopa|mesh-list
5737814|NCT03119636|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5737815|NCT03119636|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5737816|NCT03119636|Dopamine Agents|dopamine agents|mesh-ancestor
5737817|NCT03119636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5737818|NCT03119636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737819|NCT03119636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737820|NCT03119714|Pemirolast|pemirolast|mesh-list
5737821|NCT03119714|Histamine Antagonists|histamine antagonists|mesh-ancestor
5737822|NCT03119714|Histamine Agents|histamine agents|mesh-ancestor
5737823|NCT03119714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5737824|NCT03119714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737825|NCT03119714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737826|NCT03119428|Nivolumab|nivolumab|mesh-list
5737827|NCT03119428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5737828|NCT03119428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5737829|NCT03119428|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5737830|NCT03119428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893351|NCT05118490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5893352|NCT05118490|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5893353|NCT05118490|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5893354|NCT05118490|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5893355|NCT05118490|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5893356|NCT05118490|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5893357|NCT05118490|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5893358|NCT05103358|Sirolimus|sirolimus|mesh-list
5893359|NCT05103358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5617546|NCT05167084|Hydrocortisone|hydrocortisone|mesh-list
5617547|NCT05167084|Metyrapone|metyrapone|mesh-list
5617548|NCT05167084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5617549|NCT05167084|Antimetabolites|antimetabolites|mesh-ancestor
5893360|NCT05103358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5893361|NCT05103358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5617550|NCT05167084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5617551|NCT05167084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5617552|NCT05165992|Fentanyl|fentanyl|mesh-list
5617553|NCT05165992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5617554|NCT05165992|Narcotics|narcotics|mesh-ancestor
5617555|NCT05165992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5617556|NCT05165992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617557|NCT05165992|Analgesics|analgesics|mesh-ancestor
5617558|NCT05165992|Sensory System Agents|sensory system agents|mesh-ancestor
5617559|NCT05165992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5617560|NCT05165992|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5617561|NCT05165992|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5617562|NCT05165992|Anesthetics, General|anesthetics, general|mesh-ancestor
5617563|NCT05165992|Anesthetics|anesthetics|mesh-ancestor
5617564|NCT05154968|Mannitol|mannitol|mesh-list
5617565|NCT05154968|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5617566|NCT05154968|Diuretics|diuretics|mesh-ancestor
5617567|NCT05154968|Natriuretic Agents|natriuretic agents|mesh-ancestor
5617568|NCT05154968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617569|NCT05147415|Metoprolol|metoprolol|mesh-list
5617570|NCT05147415|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5617571|NCT05147415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5617572|NCT05147415|Sympatholytics|sympatholytics|mesh-ancestor
5617573|NCT05147415|Autonomic Agents|autonomic agents|mesh-ancestor
5737831|NCT03119012|Aspirin|aspirin|mesh-list
5737832|NCT03119012|Clopidogrel|clopidogrel|mesh-list
5737833|NCT03119012|Ticagrelor|ticagrelor|mesh-list
5737834|NCT03119012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5737835|NCT03119012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5737836|NCT03119012|Analgesics|analgesics|mesh-ancestor
5737837|NCT03119012|Sensory System Agents|sensory system agents|mesh-ancestor
5737838|NCT03119012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5737839|NCT03119012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737840|NCT03119012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5737841|NCT03119012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5737842|NCT03119012|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5737843|NCT03119012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5737844|NCT03119012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737845|NCT03119012|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5737846|NCT03119012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5737847|NCT03119012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5737848|NCT03119012|Antipyretics|antipyretics|mesh-ancestor
5737849|NCT03119012|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5737850|NCT03119012|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5737851|NCT03119012|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5737852|NCT03119012|Purinergic Agents|purinergic agents|mesh-ancestor
5737853|NCT03119012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5617574|NCT05147415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5617575|NCT05147415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617576|NCT05147415|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5617577|NCT05147415|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5617578|NCT05147415|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5617579|NCT05147415|Adrenergic Agents|adrenergic agents|mesh-ancestor
5617580|NCT05147415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5617581|NCT05147415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5617582|NCT05128344|Vigabatrin|vigabatrin|mesh-list
5617583|NCT05128344|Anticonvulsants|anticonvulsants|mesh-ancestor
5617584|NCT05128344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5617585|NCT05128344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5617586|NCT05128344|GABA Agents|gaba agents|mesh-ancestor
5617587|NCT05128344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5737854|NCT03118986|Olanzapine|olanzapine|mesh-list
5737855|NCT03118986|Antiemetics|antiemetics|mesh-ancestor
5737856|NCT03118986|Autonomic Agents|autonomic agents|mesh-ancestor
5737857|NCT03118986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5737858|NCT03118986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737859|NCT03118986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5737860|NCT03118986|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5737861|NCT03118986|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5737862|NCT03118986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5737863|NCT03118986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5737864|NCT03118986|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5737865|NCT03118986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5737866|NCT03118986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5737867|NCT03118986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737868|NCT03118986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5737869|NCT03118986|Serotonin Agents|serotonin agents|mesh-ancestor
5737870|NCT03119116|Rivaroxaban|rivaroxaban|mesh-list
5737871|NCT03119116|Apixaban|apixaban|mesh-list
5737872|NCT03119116|Dabigatran|dabigatran|mesh-list
5737873|NCT03119116|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5737874|NCT03119116|Antithrombins|antithrombins|mesh-ancestor
5737875|NCT03119116|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5737876|NCT03119116|Protease Inhibitors|protease inhibitors|mesh-ancestor
5737877|NCT03119116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5737878|NCT03119116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737879|NCT03119116|Anticoagulants|anticoagulants|mesh-ancestor
5737880|NCT03119077|Itraconazole|itraconazole|mesh-list
5737881|NCT03119077|Antifungal Agents|antifungal agents|mesh-ancestor
5737882|NCT03119077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5737883|NCT03119077|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5737884|NCT03119077|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5617588|NCT05128344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617589|NCT05118256|Pirfenidone|pirfenidone|mesh-list
5617590|NCT05118256|Analgesics|analgesics|mesh-ancestor
5617591|NCT05118256|Sensory System Agents|sensory system agents|mesh-ancestor
5737885|NCT03119077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5737886|NCT03119077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489278|NCT00590603|Protective Agents|protective agents|mesh-ancestor
5737887|NCT03119077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5737888|NCT03119077|Hormone Antagonists|hormone antagonists|mesh-ancestor
5737889|NCT03119077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5737890|NCT03119077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737891|NCT03119077|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5737892|NCT03119194|Opicapone|opicapone|mesh-list
5737893|NCT03119194|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
5737894|NCT03119194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5737895|NCT03119194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737896|NCT03119194|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5617592|NCT05118256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5617593|NCT05118256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617594|NCT05118256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5617595|NCT05118256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5617596|NCT05118256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5617597|NCT05118256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5617598|NCT05118256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5617599|NCT05109429|Analgesics, Opioid|analgesics, opioid|mesh-list
5617600|NCT05109429|Narcotics|narcotics|mesh-ancestor
5617601|NCT05109429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5617602|NCT05109429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617603|NCT05109429|Analgesics|analgesics|mesh-ancestor
5617604|NCT05109429|Sensory System Agents|sensory system agents|mesh-ancestor
5737897|NCT03119194|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5737898|NCT03119038|Ketorolac|ketorolac|mesh-list
5737899|NCT03119038|Clonidine|clonidine|mesh-list
5737900|NCT03119038|Epinephrine|epinephrine|mesh-list
5737901|NCT03119038|Bupivacaine|bupivacaine|mesh-list
5737902|NCT03119038|Ropivacaine|ropivacaine|mesh-list
6489279|NCT00590603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489280|NCT00590603|Vitamins|vitamins|mesh-ancestor
6489281|NCT00590603|Micronutrients|micronutrients|mesh-ancestor
6489282|NCT00590629|Niacin|niacin|mesh-list
6489283|NCT00590629|Nicotinic Acids|nicotinic acids|mesh-list
6489284|NCT00590629|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6489285|NCT00590629|Antimetabolites|antimetabolites|mesh-ancestor
6489286|NCT00590629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489287|NCT00590629|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6489288|NCT00590629|Vasodilator Agents|vasodilator agents|mesh-ancestor
6489289|NCT00590629|Vitamin B Complex|vitamin b complex|mesh-ancestor
6489290|NCT00590629|Vitamins|vitamins|mesh-ancestor
6489291|NCT00590629|Micronutrients|micronutrients|mesh-ancestor
6489292|NCT00590629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489293|NCT00590694|Ranibizumab|ranibizumab|mesh-list
5737903|NCT03119038|Anesthetics, Local|anesthetics, local|mesh-ancestor
5737904|NCT03119038|Anesthetics|anesthetics|mesh-ancestor
5737905|NCT03119038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5737906|NCT03119038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737907|NCT03119038|Sensory System Agents|sensory system agents|mesh-ancestor
5737908|NCT03119038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5617605|NCT05109429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5617606|NCT05106335|Docetaxel|docetaxel|mesh-list
5617607|NCT05106335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5617608|NCT05106335|Tubulin Modulators|tubulin modulators|mesh-ancestor
5617609|NCT05106335|Antimitotic Agents|antimitotic agents|mesh-ancestor
5617610|NCT05106335|Mitosis Modulators|mitosis modulators|mesh-ancestor
5617611|NCT05106335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5617612|NCT05096845|Vaccines|vaccines|mesh-list
5617613|NCT05096845|Immunologic Factors|immunologic factors|mesh-ancestor
5617614|NCT05096845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617615|NCT05096832|Vaccines|vaccines|mesh-list
5617616|NCT05096832|Immunologic Factors|immunologic factors|mesh-ancestor
5617617|NCT05096832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737909|NCT03119038|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5737910|NCT03119038|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5737911|NCT03119038|Adrenergic Agents|adrenergic agents|mesh-ancestor
5737912|NCT03119038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5737913|NCT03119038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737914|NCT03119038|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5737915|NCT03119038|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5737916|NCT03119038|Autonomic Agents|autonomic agents|mesh-ancestor
5737917|NCT03119038|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5617618|NCT05078866|Vaccines|vaccines|mesh-list
5737918|NCT03119038|Respiratory System Agents|respiratory system agents|mesh-ancestor
5737919|NCT03119038|Mydriatics|mydriatics|mesh-ancestor
5617619|NCT05078866|Immunologic Factors|immunologic factors|mesh-ancestor
6489294|NCT00590694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5617620|NCT05078866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617621|NCT05060965|Nicotine|nicotine|mesh-list
5617622|NCT05060965|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5617623|NCT05060965|Autonomic Agents|autonomic agents|mesh-ancestor
5617624|NCT05060965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5617625|NCT05060965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617626|NCT05060965|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5737920|NCT03119038|Sympathomimetics|sympathomimetics|mesh-ancestor
5737921|NCT03119038|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5737922|NCT03119038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5737923|NCT03119038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5737924|NCT03119038|Analgesics|analgesics|mesh-ancestor
5737925|NCT03119038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5737926|NCT03119038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5737927|NCT03119038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5737928|NCT03119038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5737929|NCT03119038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5737930|NCT03119038|Sympatholytics|sympatholytics|mesh-ancestor
5737931|NCT03119038|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5737932|NCT03119324|Nimesulide|nimesulide|mesh-list
5737933|NCT03119324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5737934|NCT03119324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5737935|NCT03119324|Analgesics|analgesics|mesh-ancestor
5737936|NCT03119324|Sensory System Agents|sensory system agents|mesh-ancestor
5737937|NCT03119324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5737938|NCT03119324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737939|NCT03119324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5737940|NCT03119324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5737941|NCT03119324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5737942|NCT03119324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5737943|NCT03119324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737944|NCT03118830|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5737945|NCT03118830|Cetrorelix|cetrorelix|mesh-list
5737946|NCT03118830|Hormones|hormones|mesh-list
5737947|NCT03118830|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5737948|NCT03118830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5737949|NCT03118830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737950|NCT03118830|Luteolytic Agents|luteolytic agents|mesh-ancestor
5737951|NCT03118830|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5737952|NCT03118830|Contraceptive Agents|contraceptive agents|mesh-ancestor
5737953|NCT03118830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5737954|NCT03118830|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5737955|NCT03118830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5737956|NCT03118830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5737957|NCT03118830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5737958|NCT03118830|Fertility Agents|fertility agents|mesh-ancestor
5737959|NCT03118830|Hormone Antagonists|hormone antagonists|mesh-ancestor
5737960|NCT03118492|Mycophenolic Acid|mycophenolic acid|mesh-list
5737961|NCT03118492|Cyclophosphamide|cyclophosphamide|mesh-list
5737962|NCT03118492|Melphalan|melphalan|mesh-list
5737963|NCT03118492|Mechlorethamine|mechlorethamine|mesh-list
5737964|NCT03118492|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
5737965|NCT03118492|Fludarabine|fludarabine|mesh-list
5737966|NCT03118492|Tacrolimus|tacrolimus|mesh-list
5737967|NCT03118492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5737968|NCT03118492|Immunologic Factors|immunologic factors|mesh-ancestor
5737969|NCT03118492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737970|NCT03118492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5737971|NCT03118492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5737972|NCT03118492|Alkylating Agents|alkylating agents|mesh-ancestor
5737973|NCT03118492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737974|NCT03118492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5737975|NCT03118492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5737976|NCT03118492|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5737977|NCT03118492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5737978|NCT03118492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5737979|NCT03118492|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5737980|NCT03118492|Antitubercular Agents|antitubercular agents|mesh-ancestor
5737981|NCT03118492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5737982|NCT03118492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5617627|NCT05060965|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5617628|NCT05060965|Cholinergic Agents|cholinergic agents|mesh-ancestor
5617629|NCT05060965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5617630|NCT05060965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5617631|NCT05043090|Durvalumab|durvalumab|mesh-list
5617632|NCT05043090|Sunitinib|sunitinib|mesh-list
5617633|NCT05043090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5737983|NCT03118674|Sofosbuvir|sofosbuvir|mesh-list
5737984|NCT03118674|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
5737985|NCT03118674|Ledipasvir|ledipasvir|mesh-list
5737986|NCT03118674|Antiviral Agents|antiviral agents|mesh-ancestor
5737987|NCT03118674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5737988|NCT03118713|Metformin|metformin|mesh-list
5737989|NCT03118713|Glimepiride|glimepiride|mesh-list
5737990|NCT03118713|Ipragliflozin|ipragliflozin|mesh-list
5737991|NCT03118713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5737992|NCT03118713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5737993|NCT03118713|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5737994|NCT03118713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5737995|NCT03118713|Immunologic Factors|immunologic factors|mesh-ancestor
5737996|NCT03118713|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5737997|NCT03118713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5737998|NCT03118479|Anastrozole|anastrozole|mesh-list
5737999|NCT03118479|Testosterone|testosterone|mesh-list
5738000|NCT03118479|Androgens|androgens|mesh-ancestor
5738001|NCT03118479|Hormones|hormones|mesh-ancestor
5617634|NCT05043090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5617635|NCT05043090|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5617636|NCT05043090|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5738002|NCT03118479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5738003|NCT03118479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738004|NCT03118479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5738005|NCT03118479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5738006|NCT03118479|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5738007|NCT03118479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5738008|NCT03118479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5738009|NCT03118479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5738010|NCT03118479|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5738011|NCT03118479|Hormone Antagonists|hormone antagonists|mesh-ancestor
5738012|NCT03118362|Plasma-lyte 148|plasma-lyte 148|mesh-list
5617637|NCT05043090|Growth Substances|growth substances|mesh-ancestor
5617638|NCT05043090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617639|NCT05043090|Growth Inhibitors|growth inhibitors|mesh-ancestor
5617640|NCT05043090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5617641|NCT05043090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5617642|NCT05043090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5617643|NCT05042947|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
5617644|NCT05042947|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
5617645|NCT05042947|beta-Endorphin|beta-endorphin|mesh-list
5617646|NCT05042947|Hormones|hormones|mesh-ancestor
5617647|NCT05042947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5617648|NCT05042947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617649|NCT05042947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5617650|NCT05042947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5617651|NCT05033847|Vaccines|vaccines|mesh-list
5617652|NCT05033847|Immunologic Factors|immunologic factors|mesh-ancestor
5617653|NCT05033847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617654|NCT05019560|Sevoflurane|sevoflurane|mesh-list
5617655|NCT05019560|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5617656|NCT05019560|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5617657|NCT05019560|Anesthetics, General|anesthetics, general|mesh-ancestor
5617658|NCT05019560|Anesthetics|anesthetics|mesh-ancestor
5617659|NCT05019560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5738013|NCT03118362|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5738014|NCT03118362|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5738015|NCT03118232|Chlorhexidine|chlorhexidine|mesh-list
5738016|NCT03118232|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5738017|NCT03118232|Povidone-Iodine|povidone-iodine|mesh-list
5738018|NCT03118232|Povidone|povidone|mesh-list
5738019|NCT03118232|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5617660|NCT05019560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208580|NCT02132767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208581|NCT02132767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6208582|NCT02132767|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6208583|NCT02132767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6208584|NCT02132767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208585|NCT02132767|Protective Agents|protective agents|mesh-ancestor
6208586|NCT02132767|Vasodilator Agents|vasodilator agents|mesh-ancestor
5738020|NCT03118232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5738021|NCT03118232|Disinfectants|disinfectants|mesh-ancestor
5738022|NCT03118232|Dermatologic Agents|dermatologic agents|mesh-ancestor
5738023|NCT03118232|Plasma Substitutes|plasma substitutes|mesh-ancestor
5738024|NCT03118232|Blood Substitutes|blood substitutes|mesh-ancestor
5738025|NCT03118336|Empagliflozin|empagliflozin|mesh-list
5738026|NCT03118336|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5738027|NCT03118336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5738028|NCT03118336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5738029|NCT03118336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738030|NCT03118167|Antioxidants|antioxidants|mesh-list
5738031|NCT03118167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5738032|NCT03118167|Protective Agents|protective agents|mesh-ancestor
5738033|NCT03118167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738034|NCT03118037|Zaleplon|zaleplon|mesh-list
6208587|NCT02132767|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6208588|NCT02132767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6208589|NCT02132767|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6208590|NCT02132767|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6208591|NCT02132767|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6208592|NCT02132767|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6208593|NCT02132767|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6208594|NCT02132767|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6208595|NCT02132832|Buspirone|buspirone|mesh-list
6208596|NCT02132832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6208597|NCT02132832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6208598|NCT02132832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6208599|NCT02132832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208600|NCT02132832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5617683|NCT04994509|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5617684|NCT04994509|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
5617685|NCT04994509|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5617686|NCT04994509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5617687|NCT04994509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5617688|NCT04994509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5617689|NCT04994509|Antiviral Agents|antiviral agents|mesh-ancestor
5617690|NCT04994509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5617691|NCT04994509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5617692|NCT04994509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5617693|NCT04990323|Vidarabine|vidarabine|mesh-list
5617694|NCT04990323|Cyclophosphamide|cyclophosphamide|mesh-list
5617695|NCT04990323|Busulfan|busulfan|mesh-list
5617696|NCT04990323|Thiotepa|thiotepa|mesh-list
5617697|NCT04990323|Fludarabine|fludarabine|mesh-list
5617698|NCT04990323|Fludarabine phosphate|fludarabine phosphate|mesh-list
5617699|NCT04990323|Clofarabine|clofarabine|mesh-list
5617700|NCT04990323|Tacrolimus|tacrolimus|mesh-list
5617701|NCT04990323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5617702|NCT04990323|Immunologic Factors|immunologic factors|mesh-ancestor
5617703|NCT04990323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617704|NCT04990323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5617705|NCT04990323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5617706|NCT04990323|Alkylating Agents|alkylating agents|mesh-ancestor
5617707|NCT04990323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5738035|NCT03118037|Anticonvulsants|anticonvulsants|mesh-ancestor
5738036|NCT03118037|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5738037|NCT03118037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5738038|NCT03118037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738039|NCT03118037|GABA Modulators|gaba modulators|mesh-ancestor
5738040|NCT03118037|GABA Agents|gaba agents|mesh-ancestor
5738041|NCT03118037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5738042|NCT03118037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5738043|NCT03118076|Dexmedetomidine|dexmedetomidine|mesh-list
5738044|NCT03118076|Ropivacaine|ropivacaine|mesh-list
5738045|NCT03118076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5738046|NCT03118076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5738047|NCT03118076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738048|NCT03118076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5738049|NCT03118076|Analgesics|analgesics|mesh-ancestor
5738050|NCT03118076|Sensory System Agents|sensory system agents|mesh-ancestor
5738051|NCT03118076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5738052|NCT03118076|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5738053|NCT03118076|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5738054|NCT03118076|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5617708|NCT04990323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5738055|NCT03118076|Adrenergic Agents|adrenergic agents|mesh-ancestor
5738056|NCT03118076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5617709|NCT04990323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5617710|NCT04990323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5617711|NCT04990323|Antimetabolites|antimetabolites|mesh-ancestor
5617712|NCT04990323|Antiviral Agents|antiviral agents|mesh-ancestor
5617713|NCT04990323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5617714|NCT04990323|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5617715|NCT04990323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5617716|NCT04989829|Omeprazole|omeprazole|mesh-list
5617717|NCT04989829|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5617718|NCT04989829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5617719|NCT04989829|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5617720|NCT04989829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5617721|NCT04989829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5617722|NCT04972110|Olaparib|olaparib|mesh-list
5617723|NCT04972110|Niraparib|niraparib|mesh-list
5617724|NCT04972110|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5738057|NCT03118076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5738058|NCT03118076|Anesthetics, Local|anesthetics, local|mesh-ancestor
5738059|NCT03118076|Anesthetics|anesthetics|mesh-ancestor
5738060|NCT03118128|Metformin|metformin|mesh-list
5738061|NCT03118128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5738062|NCT03118128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738063|NCT03117790|Dexmedetomidine|dexmedetomidine|mesh-list
5738064|NCT03117790|Morphine|morphine|mesh-list
5738065|NCT03117790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5738066|NCT03117790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5738067|NCT03117790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738068|NCT03117790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5738069|NCT03117790|Analgesics|analgesics|mesh-ancestor
5738070|NCT03117790|Sensory System Agents|sensory system agents|mesh-ancestor
5738071|NCT03117790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5738072|NCT03117790|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5738073|NCT03117790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5738074|NCT03117790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5738075|NCT03117790|Adrenergic Agents|adrenergic agents|mesh-ancestor
5738076|NCT03117790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5738077|NCT03117790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5738078|NCT03117790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5738079|NCT03117790|Narcotics|narcotics|mesh-ancestor
5738080|NCT03117894|Acetaminophen|acetaminophen|mesh-list
5738081|NCT03117894|Etoricoxib|etoricoxib|mesh-list
5738082|NCT03117894|Morphine|morphine|mesh-list
5738083|NCT03117894|Remifentanil|remifentanil|mesh-list
5738084|NCT03117894|Ondansetron|ondansetron|mesh-list
5738085|NCT03117894|Propofol|propofol|mesh-list
5738086|NCT03117894|Ropivacaine|ropivacaine|mesh-list
5738087|NCT03117894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5738088|NCT03117894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5738089|NCT03117894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738090|NCT03117894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5738091|NCT03117894|Anesthetics, General|anesthetics, general|mesh-ancestor
5738092|NCT03117894|Anesthetics|anesthetics|mesh-ancestor
5738093|NCT03117894|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5738094|NCT03117894|Narcotics|narcotics|mesh-ancestor
5738095|NCT03117894|Analgesics|analgesics|mesh-ancestor
5738096|NCT03117894|Sensory System Agents|sensory system agents|mesh-ancestor
5738097|NCT03117894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5738098|NCT03117894|Anesthetics, Local|anesthetics, local|mesh-ancestor
5738099|NCT03117894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5738100|NCT03117894|Antipyretics|antipyretics|mesh-ancestor
6489295|NCT00590694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6489296|NCT00590694|Growth Substances|growth substances|mesh-ancestor
6489297|NCT00590694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489298|NCT00590694|Growth Inhibitors|growth inhibitors|mesh-ancestor
6489299|NCT00590694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6489300|NCT00590785|Tamoxifen|tamoxifen|mesh-list
6489301|NCT00590785|Ciprofloxacin|ciprofloxacin|mesh-list
6489302|NCT00590785|Cyclophosphamide|cyclophosphamide|mesh-list
6489303|NCT00590785|Doxorubicin|doxorubicin|mesh-list
6489304|NCT00590785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6489305|NCT00590785|Immunologic Factors|immunologic factors|mesh-ancestor
5738101|NCT03117894|Antiemetics|antiemetics|mesh-ancestor
5738102|NCT03117894|Autonomic Agents|autonomic agents|mesh-ancestor
5617725|NCT04972110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5738103|NCT03117894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5738104|NCT03117894|Antipruritics|antipruritics|mesh-ancestor
5738105|NCT03117894|Dermatologic Agents|dermatologic agents|mesh-ancestor
6672826|NCT01558622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5738106|NCT03117894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5617726|NCT04972110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5617727|NCT04972110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5617728|NCT04953962|Nivolumab|nivolumab|mesh-list
5617729|NCT04953962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5617730|NCT04953962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5617731|NCT04953962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5617732|NCT04953962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5617733|NCT04947332|Vaccines|vaccines|mesh-list
5617734|NCT04947332|Immunologic Factors|immunologic factors|mesh-ancestor
5617735|NCT04947332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617736|NCT04945720|Durvalumab|durvalumab|mesh-list
5617737|NCT04945720|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5617738|NCT04945720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5617739|NCT04945720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5617740|NCT04945720|Immunologic Factors|immunologic factors|mesh-ancestor
5617741|NCT04945720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617742|NCT04944290|Brimonidine Tartrate|brimonidine tartrate|mesh-list
5617743|NCT04944290|Brinzolamide|brinzolamide|mesh-list
5617744|NCT04944290|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5617745|NCT04944290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5617746|NCT04944290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5617747|NCT04944290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5617748|NCT04944290|Adrenergic Agents|adrenergic agents|mesh-ancestor
5617749|NCT04944290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5617750|NCT04944290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489306|NCT00590785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489307|NCT00590785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5738107|NCT03117894|Serotonin Agents|serotonin agents|mesh-ancestor
5738108|NCT03117894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5738109|NCT03117894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5738110|NCT03117894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5738111|NCT03117894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5738112|NCT03117894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5738113|NCT03117894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5738114|NCT03117894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5738115|NCT03117894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5738116|NCT03117894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5738117|NCT03117894|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5738118|NCT03117894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5738119|NCT03117894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6489308|NCT00590785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6489309|NCT00590785|Alkylating Agents|alkylating agents|mesh-ancestor
6489310|NCT00590785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489311|NCT00590785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6489312|NCT00590785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6489313|NCT00590785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6489314|NCT00590785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6489315|NCT00590785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6489316|NCT00590785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6489317|NCT00590785|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5738120|NCT03117660|Vitamin A|vitamin a|mesh-list
5738121|NCT03117660|Vitamins|vitamins|mesh-ancestor
5738122|NCT03117660|Micronutrients|micronutrients|mesh-ancestor
6489318|NCT00590785|Hormone Antagonists|hormone antagonists|mesh-ancestor
6489319|NCT00590785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6489320|NCT00590785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6489321|NCT00590785|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6489322|NCT00590785|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6489323|NCT00590785|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6489324|NCT00590785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6489325|NCT00590785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6489326|NCT00590785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6489327|NCT00590785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6489328|NCT00590837|Lomustine|lomustine|mesh-list
6489329|NCT00590837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6489330|NCT00590837|Alkylating Agents|alkylating agents|mesh-ancestor
6496359|NCT00627731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5617751|NCT04944290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617752|NCT04944290|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5738123|NCT03117660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893362|NCT05103358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5738124|NCT03117972|Leucovorin|leucovorin|mesh-list
5738125|NCT03117972|Bevacizumab|bevacizumab|mesh-list
5738126|NCT03117972|Fluorouracil|fluorouracil|mesh-list
5738127|NCT03117972|Capecitabine|capecitabine|mesh-list
5738128|NCT03117972|Oxaliplatin|oxaliplatin|mesh-list
5738129|NCT03117972|Irinotecan|irinotecan|mesh-list
5738130|NCT03117972|Levoleucovorin|levoleucovorin|mesh-list
5617753|NCT04944290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5617754|NCT04939090|Megestrol|megestrol|mesh-list
5617755|NCT04939090|Megestrol Acetate|megestrol acetate|mesh-list
5617756|NCT04939090|Olanzapine|olanzapine|mesh-list
5617757|NCT04939090|Antiemetics|antiemetics|mesh-ancestor
5617758|NCT04939090|Autonomic Agents|autonomic agents|mesh-ancestor
5617759|NCT04939090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5617760|NCT04939090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617761|NCT04939090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5617762|NCT04939090|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5617763|NCT04939090|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5617764|NCT04939090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5617765|NCT04939090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5617766|NCT04939090|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5617767|NCT04939090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5617768|NCT04939090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5617769|NCT04939090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5617770|NCT04939090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5617771|NCT04939090|Serotonin Agents|serotonin agents|mesh-ancestor
5617772|NCT04939090|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5617773|NCT04939090|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5617774|NCT04939090|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5617775|NCT04939090|Contraceptive Agents|contraceptive agents|mesh-ancestor
5617776|NCT04939090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5617777|NCT04939090|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5617778|NCT04939090|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5617779|NCT04939090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5617780|NCT04939090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5617781|NCT04939090|Appetite Stimulants|appetite stimulants|mesh-ancestor
5617782|NCT04939090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5617783|NCT04926181|Androgens|androgens|mesh-list
5617784|NCT04926181|Hormones|hormones|mesh-ancestor
5617785|NCT04926181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5617786|NCT04926181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617787|NCT04925752|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5617788|NCT04925752|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5617789|NCT04925752|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5617790|NCT04925752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5617791|NCT04925752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5617792|NCT04925752|Antiviral Agents|antiviral agents|mesh-ancestor
5617793|NCT04925752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5617794|NCT04925752|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5617795|NCT04925752|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5617796|NCT04924166|Hydrocortisone|hydrocortisone|mesh-list
5617797|NCT04924166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5692344|NCT03409276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692345|NCT03409250|Ranibizumab|ranibizumab|mesh-list
5692346|NCT03409250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5692347|NCT03409250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5692348|NCT03409250|Growth Substances|growth substances|mesh-ancestor
5692349|NCT03409250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692350|NCT03409250|Growth Inhibitors|growth inhibitors|mesh-ancestor
5692351|NCT03409250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5692352|NCT03409237|Mannitol|mannitol|mesh-list
5692353|NCT03409237|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5692354|NCT03409237|Diuretics|diuretics|mesh-ancestor
5692355|NCT03409237|Natriuretic Agents|natriuretic agents|mesh-ancestor
5692356|NCT03409237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692357|NCT03409068|Anesthetics|anesthetics|mesh-list
5692358|NCT03409068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5692359|NCT03409068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692360|NCT03408847|Beclomethasone|beclomethasone|mesh-list
5692361|NCT03408847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5738131|NCT03117972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5738132|NCT03117972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5738133|NCT03117972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5692362|NCT03408847|Glucocorticoids|glucocorticoids|mesh-ancestor
5738134|NCT03117972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5738135|NCT03117972|Growth Substances|growth substances|mesh-ancestor
5617798|NCT04902703|Molgramostim|molgramostim|mesh-list
5617799|NCT04902703|Sargramostim|sargramostim|mesh-list
5617800|NCT04902703|Immunologic Factors|immunologic factors|mesh-ancestor
5617801|NCT04902703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738136|NCT03117972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738137|NCT03117972|Growth Inhibitors|growth inhibitors|mesh-ancestor
5738138|NCT03117972|Antimetabolites|antimetabolites|mesh-ancestor
5738139|NCT03117972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5738140|NCT03117972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5738141|NCT03117972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5738142|NCT03117972|Immunologic Factors|immunologic factors|mesh-ancestor
5738143|NCT03117972|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5738144|NCT03117972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5738145|NCT03117972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5738146|NCT03117972|Antidotes|antidotes|mesh-ancestor
5738147|NCT03117972|Protective Agents|protective agents|mesh-ancestor
5738148|NCT03117972|Vitamin B Complex|vitamin b complex|mesh-ancestor
5738149|NCT03117972|Vitamins|vitamins|mesh-ancestor
5738150|NCT03117972|Micronutrients|micronutrients|mesh-ancestor
5738151|NCT03117920|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
5738152|NCT03117920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5738153|NCT03117920|Alkylating Agents|alkylating agents|mesh-ancestor
5738154|NCT03117920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5738155|NCT03117920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5738156|NCT03117855|Capecitabine|capecitabine|mesh-list
5738157|NCT03117855|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5738158|NCT03117855|Antimetabolites|antimetabolites|mesh-ancestor
5738159|NCT03117855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5738160|NCT03117855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5617802|NCT04902703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5617803|NCT04894435|Vaccines|vaccines|mesh-list
5617804|NCT04894435|Immunologic Factors|immunologic factors|mesh-ancestor
5617805|NCT04894435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617806|NCT04872790|Prednisone|prednisone|mesh-list
5617807|NCT04872790|Cortisone|cortisone|mesh-list
5617808|NCT04872790|Rituximab|rituximab|mesh-list
5617809|NCT04872790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5617810|NCT04872790|Methotrexate|methotrexate|mesh-list
5617811|NCT04872790|Dasatinib|dasatinib|mesh-list
5617812|NCT04872790|Venetoclax|venetoclax|mesh-list
5617813|NCT04872790|Antibodies|antibodies|mesh-list
5617814|NCT04872790|Immunoglobulins|immunoglobulins|mesh-list
5617815|NCT04872790|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5617816|NCT04872790|Immunologic Factors|immunologic factors|mesh-ancestor
5617817|NCT04872790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738161|NCT03117998|Volagidemab|volagidemab|mesh-list
5738162|NCT03117998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5738163|NCT03117998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738164|NCT03117595|Fentanyl|fentanyl|mesh-list
5738165|NCT03117595|Morphine|morphine|mesh-list
5738166|NCT03117595|Bupivacaine|bupivacaine|mesh-list
5738167|NCT03117595|Anesthetics, Local|anesthetics, local|mesh-ancestor
5738168|NCT03117595|Anesthetics|anesthetics|mesh-ancestor
5738169|NCT03117595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5738170|NCT03117595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738171|NCT03117595|Sensory System Agents|sensory system agents|mesh-ancestor
5738172|NCT03117595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5738173|NCT03117595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5738174|NCT03117595|Narcotics|narcotics|mesh-ancestor
5738175|NCT03117595|Analgesics|analgesics|mesh-ancestor
5738176|NCT03117595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5738177|NCT03117595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5738178|NCT03117595|Anesthetics, General|anesthetics, general|mesh-ancestor
5738179|NCT03117335|Endostatins|endostatins|mesh-list
5738180|NCT03117335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5738181|NCT03117335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5738182|NCT03117335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5738183|NCT03117335|Growth Substances|growth substances|mesh-ancestor
5738184|NCT03117335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738185|NCT03117335|Growth Inhibitors|growth inhibitors|mesh-ancestor
5738186|NCT03117439|Antifungal Agents|antifungal agents|mesh-list
5738187|NCT03117439|Clotrimazole|clotrimazole|mesh-list
5738188|NCT03117439|Miconazole|miconazole|mesh-list
5738189|NCT03117439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5738190|NCT03117439|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5738191|NCT03117439|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5617818|NCT04872790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5738192|NCT03117439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5738193|NCT03117439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5738194|NCT03117439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5738195|NCT03117439|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5738196|NCT03117439|Hormone Antagonists|hormone antagonists|mesh-ancestor
5738197|NCT03117439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5738198|NCT03117439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738199|NCT03117439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5617819|NCT04872790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5617820|NCT04872790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5617821|NCT04872790|Glucocorticoids|glucocorticoids|mesh-ancestor
5617822|NCT04872790|Hormones|hormones|mesh-ancestor
5617823|NCT04872790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5617824|NCT04872790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5617825|NCT04872790|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5617826|NCT04872790|Abortifacient Agents|abortifacient agents|mesh-ancestor
5617827|NCT04872790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5617828|NCT04872790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5617829|NCT04872790|Antimetabolites|antimetabolites|mesh-ancestor
5617830|NCT04872790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5617831|NCT04872790|Dermatologic Agents|dermatologic agents|mesh-ancestor
5617832|NCT04872790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5617833|NCT04872790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5617834|NCT04872790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5738200|NCT03117439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5738201|NCT03117530|Minocycline|minocycline|mesh-list
5738202|NCT03117530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5738203|NCT03117530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5617835|NCT04872790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5617836|NCT04872790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5617837|NCT04870125|Carbon Monoxide|carbon monoxide|mesh-list
5617838|NCT04870125|Antimetabolites|antimetabolites|mesh-ancestor
5617839|NCT04870125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5617840|NCT04870125|Gasotransmitters|gasotransmitters|mesh-ancestor
5617841|NCT04870125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5617842|NCT04870125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738204|NCT03117725|Melatonin|melatonin|mesh-list
5738205|NCT03117725|Antioxidants|antioxidants|mesh-ancestor
5738206|NCT03117725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5738207|NCT03117725|Protective Agents|protective agents|mesh-ancestor
5738208|NCT03117725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617843|NCT04865497|Vaccines|vaccines|mesh-list
5617844|NCT04865497|Immunologic Factors|immunologic factors|mesh-ancestor
5617845|NCT04865497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617846|NCT04865042|Gabapentin|gabapentin|mesh-list
5617847|NCT04865042|Analgesics|analgesics|mesh-ancestor
5617848|NCT04865042|Sensory System Agents|sensory system agents|mesh-ancestor
5617849|NCT04865042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5617850|NCT04865042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617851|NCT04865042|Anticonvulsants|anticonvulsants|mesh-ancestor
5617852|NCT04865042|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5617853|NCT04865042|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5617854|NCT04865042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5617855|NCT04865042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5738209|NCT03117725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5738210|NCT03117257|Cisplatin|cisplatin|mesh-list
5738211|NCT03117257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5738212|NCT03117192|Zinc Sulfate|zinc sulfate|mesh-list
5738213|NCT03117192|Astringents|astringents|mesh-ancestor
5738214|NCT03117192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738215|NCT03117192|Dermatologic Agents|dermatologic agents|mesh-ancestor
5738216|NCT03117010|Dexamethasone|dexamethasone|mesh-list
5738217|NCT03117010|Etoposide|etoposide|mesh-list
5738218|NCT03117010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5738219|NCT03117010|Antiemetics|antiemetics|mesh-ancestor
5738220|NCT03117010|Autonomic Agents|autonomic agents|mesh-ancestor
5738221|NCT03117010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5738222|NCT03117010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738223|NCT03117010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5738224|NCT03117010|Glucocorticoids|glucocorticoids|mesh-ancestor
5738225|NCT03117010|Hormones|hormones|mesh-ancestor
5738226|NCT03117010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5738227|NCT03117010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5738228|NCT03117010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5738229|NCT03117010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5738230|NCT03117010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5738231|NCT03117010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5738232|NCT03117010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5738233|NCT03117010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5738234|NCT03116997|Glycopyrrolate|glycopyrrolate|mesh-list
5738235|NCT03116997|Neostigmine|neostigmine|mesh-list
5738236|NCT03116997|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5738237|NCT03116997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5738238|NCT03116997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5738239|NCT03116997|Cholinergic Agents|cholinergic agents|mesh-ancestor
5738240|NCT03116997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5738241|NCT03116997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738242|NCT03116997|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5738243|NCT03116997|Autonomic Agents|autonomic agents|mesh-ancestor
5617856|NCT04865042|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5617857|NCT04865042|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5617858|NCT04865042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5617859|NCT04865042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5617860|NCT04865042|Antimanic Agents|antimanic agents|mesh-ancestor
5617861|NCT04823247|Interleukin-23|interleukin-23|mesh-list
5617862|NCT04823247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5617863|NCT04823247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5617864|NCT04823247|Growth Substances|growth substances|mesh-ancestor
5617865|NCT04823247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617866|NCT04823247|Growth Inhibitors|growth inhibitors|mesh-ancestor
5617867|NCT04823247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5617868|NCT04817787|Metformin|metformin|mesh-list
5617869|NCT04817787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5617870|NCT04817787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617871|NCT04816162|Dexmedetomidine|dexmedetomidine|mesh-list
5617872|NCT04816162|Ketamine|ketamine|mesh-list
5617873|NCT04816162|Propofol|propofol|mesh-list
5738244|NCT03116997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5738245|NCT03116997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5617874|NCT04816162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5617875|NCT04816162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5617876|NCT04816162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617877|NCT04816162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5617878|NCT04816162|Anesthetics, General|anesthetics, general|mesh-ancestor
5617879|NCT04816162|Anesthetics|anesthetics|mesh-ancestor
5617880|NCT04816162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5617881|NCT04816162|Analgesics|analgesics|mesh-ancestor
5617882|NCT04816162|Sensory System Agents|sensory system agents|mesh-ancestor
5617883|NCT04816162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5617884|NCT04816162|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5617885|NCT04816162|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5617886|NCT04816162|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5617887|NCT04816162|Adrenergic Agents|adrenergic agents|mesh-ancestor
5617888|NCT04816162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5617889|NCT04816162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5617890|NCT04816162|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5617891|NCT04816162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5617892|NCT04816162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5617893|NCT04809831|Chlorhexidine|chlorhexidine|mesh-list
5617894|NCT04809831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5617895|NCT04809831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5617896|NCT04809831|Disinfectants|disinfectants|mesh-ancestor
6672827|NCT01558648|Analgesics|analgesics|mesh-list
6672828|NCT01558648|Sensory System Agents|sensory system agents|mesh-ancestor
6672829|NCT01558648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6672830|NCT01558648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672831|NCT01558713|Fentanyl|fentanyl|mesh-list
6672832|NCT01558713|Bupivacaine|bupivacaine|mesh-list
6672833|NCT01558713|Ropivacaine|ropivacaine|mesh-list
5738246|NCT03116997|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5738247|NCT03116997|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5738248|NCT03117166|Lidocaine|lidocaine|mesh-list
5738249|NCT03117166|Anesthetics, Local|anesthetics, local|mesh-ancestor
5738250|NCT03117166|Anesthetics|anesthetics|mesh-ancestor
5738251|NCT03117166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5738252|NCT03117166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738253|NCT03117166|Sensory System Agents|sensory system agents|mesh-ancestor
6672834|NCT01558713|Levobupivacaine|levobupivacaine|mesh-list
5617897|NCT04800510|Carbon Fiber|carbon fiber|mesh-list
5617898|NCT04800510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5617899|NCT04800510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5617900|NCT04787965|Opicapone|opicapone|mesh-list
5617901|NCT04787965|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
5617902|NCT04787965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5617903|NCT04787965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5617904|NCT04787965|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5617905|NCT04787965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5738254|NCT03117166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5738255|NCT03117166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5738256|NCT03117166|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5738257|NCT03117166|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5738258|NCT03117166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5738259|NCT03117166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5738260|NCT03116971|Etoposide|etoposide|mesh-list
5738261|NCT03116971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5738262|NCT03116971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5738263|NCT03116971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5738264|NCT03116971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5738265|NCT03116971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5738266|NCT03116971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5738267|NCT03116945|Gallium citrate|gallium citrate|mesh-list
5617906|NCT04782180|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
5617907|NCT04782180|Antiviral Agents|antiviral agents|mesh-ancestor
5617908|NCT04782180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5617909|NCT04782180|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5617910|NCT04782180|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5617911|NCT04782180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5617912|NCT04782180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5617913|NCT04782180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5617914|NCT04782180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5617915|NCT04770272|Paclitaxel|paclitaxel|mesh-list
5617916|NCT04770272|Cyclophosphamide|cyclophosphamide|mesh-list
5617917|NCT04770272|Carboplatin|carboplatin|mesh-list
5617918|NCT04770272|Atezolizumab|atezolizumab|mesh-list
5617919|NCT04770272|Epirubicin|epirubicin|mesh-list
5617920|NCT04770272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5617921|NCT04770272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5617922|NCT04770272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5738268|NCT03116945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5738269|NCT03116945|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5738270|NCT03117023|Dexmedetomidine|dexmedetomidine|mesh-list
5738271|NCT03117023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5617923|NCT04770272|Tubulin Modulators|tubulin modulators|mesh-ancestor
5617924|NCT04770272|Antimitotic Agents|antimitotic agents|mesh-ancestor
5617925|NCT04770272|Mitosis Modulators|mitosis modulators|mesh-ancestor
5617926|NCT04770272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5617927|NCT04770272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5617928|NCT04770272|Immunologic Factors|immunologic factors|mesh-ancestor
5617929|NCT04770272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617930|NCT04770272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5617931|NCT04770272|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5617932|NCT04770272|Alkylating Agents|alkylating agents|mesh-ancestor
5617933|NCT04770272|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5617934|NCT04770272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5617935|NCT04770272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5617936|NCT04770272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5617937|NCT04770272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5617938|NCT04748172|Antibodies|antibodies|mesh-list
5617939|NCT04748172|Immunologic Factors|immunologic factors|mesh-ancestor
5617940|NCT04748172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208601|NCT02132832|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6208602|NCT02132832|Serotonin Agents|serotonin agents|mesh-ancestor
5617943|NCT04716946|Durvalumab|durvalumab|mesh-list
5617944|NCT04716946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5617945|NCT04716946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5617946|NCT04716075|Acalabrutinib|acalabrutinib|mesh-list
5738272|NCT03117023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5738273|NCT03117023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738274|NCT03117023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5738275|NCT03117023|Analgesics|analgesics|mesh-ancestor
5738276|NCT03117023|Sensory System Agents|sensory system agents|mesh-ancestor
5617947|NCT04716075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5617948|NCT04713358|Nalmefene|nalmefene|mesh-list
5617949|NCT04713358|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5738277|NCT03117023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5738278|NCT03117023|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5738279|NCT03117023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5738280|NCT03117023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5738281|NCT03117023|Adrenergic Agents|adrenergic agents|mesh-ancestor
5738282|NCT03117023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5738283|NCT03117023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5738284|NCT03117062|Salicylic Acid|salicylic acid|mesh-list
5738285|NCT03117062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5738286|NCT03117062|Antifungal Agents|antifungal agents|mesh-ancestor
5738287|NCT03117062|Keratolytic Agents|keratolytic agents|mesh-ancestor
5738288|NCT03117062|Dermatologic Agents|dermatologic agents|mesh-ancestor
5738289|NCT03117049|Paclitaxel|paclitaxel|mesh-list
5738290|NCT03117049|Bevacizumab|bevacizumab|mesh-list
5738291|NCT03117049|Carboplatin|carboplatin|mesh-list
5738292|NCT03117049|Nivolumab|nivolumab|mesh-list
5738293|NCT03117049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5738294|NCT03117049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5738295|NCT03117049|Tubulin Modulators|tubulin modulators|mesh-ancestor
5738296|NCT03117049|Antimitotic Agents|antimitotic agents|mesh-ancestor
5738297|NCT03117049|Mitosis Modulators|mitosis modulators|mesh-ancestor
5738298|NCT03117049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5738299|NCT03117049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5738300|NCT03117049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5738301|NCT03117049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5738302|NCT03117049|Growth Substances|growth substances|mesh-ancestor
6672835|NCT01558713|Anesthetics, Local|anesthetics, local|mesh-ancestor
6672836|NCT01558713|Anesthetics|anesthetics|mesh-ancestor
6672837|NCT01558713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6672838|NCT01558713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672839|NCT01558713|Sensory System Agents|sensory system agents|mesh-ancestor
6672840|NCT01558713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5617950|NCT04713358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617951|NCT04713358|Sensory System Agents|sensory system agents|mesh-ancestor
5617952|NCT04713358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5617953|NCT04696952|Zopiclone|zopiclone|mesh-list
5617954|NCT04696952|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5617955|NCT04696952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5617956|NCT04696952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617957|NCT04695977|Nivolumab|nivolumab|mesh-list
5617958|NCT04695977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5617959|NCT04695977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5617960|NCT04695977|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5617961|NCT04695977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5617962|NCT04676802|Analgesics, Opioid|analgesics, opioid|mesh-list
5617963|NCT04676802|Narcotics|narcotics|mesh-ancestor
5617964|NCT04676802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5617965|NCT04676802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617966|NCT04676802|Analgesics|analgesics|mesh-ancestor
5617967|NCT04676802|Sensory System Agents|sensory system agents|mesh-ancestor
5617968|NCT04676802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5617969|NCT04668950|Fluvoxamine|fluvoxamine|mesh-list
5617970|NCT04668950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5617971|NCT04668950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5617972|NCT04668950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5617973|NCT04668950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617974|NCT04668950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5738303|NCT03117049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672841|NCT01558713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6672842|NCT01558713|Narcotics|narcotics|mesh-ancestor
6672843|NCT01558713|Analgesics|analgesics|mesh-ancestor
6672844|NCT01558713|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6672845|NCT01558713|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6672846|NCT01558713|Anesthetics, General|anesthetics, general|mesh-ancestor
6672847|NCT01558830|Ranolazine|ranolazine|mesh-list
5738304|NCT03117049|Growth Inhibitors|growth inhibitors|mesh-ancestor
5738305|NCT03117049|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5738306|NCT03116893|Itraconazole|itraconazole|mesh-list
5738307|NCT03116893|Rifampin|rifampin|mesh-list
5738308|NCT03116893|Antifungal Agents|antifungal agents|mesh-ancestor
5738309|NCT03116893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5738310|NCT03116893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5738311|NCT03116893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5738312|NCT03116893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6672848|NCT01558830|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5738313|NCT03116893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5738314|NCT03116893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5738315|NCT03116893|Hormone Antagonists|hormone antagonists|mesh-ancestor
5738316|NCT03116893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5738317|NCT03116893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738318|NCT03116893|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5738319|NCT03116893|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5738320|NCT03116893|Antitubercular Agents|antitubercular agents|mesh-ancestor
5738321|NCT03116893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5738322|NCT03116893|Leprostatic Agents|leprostatic agents|mesh-ancestor
5738323|NCT03116893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5738324|NCT03116893|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5738325|NCT03116893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5738326|NCT03116893|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5738327|NCT03116893|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5738328|NCT03116893|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5738329|NCT03116893|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5738330|NCT03116776|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5738331|NCT03116776|Hyaluronic Acid|hyaluronic acid|mesh-list
5738332|NCT03116776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5738333|NCT03116776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5738334|NCT03116776|Immunologic Factors|immunologic factors|mesh-ancestor
5738335|NCT03116776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738336|NCT03116776|Viscosupplements|viscosupplements|mesh-ancestor
5738337|NCT03116776|Protective Agents|protective agents|mesh-ancestor
5738338|NCT03116737|Benzocaine|benzocaine|mesh-list
5738339|NCT03116737|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5738340|NCT03116737|Anesthetics, Local|anesthetics, local|mesh-ancestor
5738341|NCT03116737|Anesthetics|anesthetics|mesh-ancestor
5738342|NCT03116737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5738343|NCT03116737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738344|NCT03116737|Sensory System Agents|sensory system agents|mesh-ancestor
5738345|NCT03116737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5738346|NCT03116659|Doxycycline|doxycycline|mesh-list
5738347|NCT03116659|Imiquimod|imiquimod|mesh-list
5738348|NCT03116659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5738349|NCT03116659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5738350|NCT03116659|Antimalarials|antimalarials|mesh-ancestor
5738351|NCT03116659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5738352|NCT03116659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5738353|NCT03116659|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5738354|NCT03116659|Immunologic Factors|immunologic factors|mesh-ancestor
5738355|NCT03116659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738356|NCT03116659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5738357|NCT03116659|Interferon Inducers|interferon inducers|mesh-ancestor
5738358|NCT03116672|Diclofenac|diclofenac|mesh-list
5738359|NCT03116672|Ketorolac|ketorolac|mesh-list
5738360|NCT03116672|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5738361|NCT03116672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5738362|NCT03116672|Analgesics|analgesics|mesh-ancestor
5738363|NCT03116672|Sensory System Agents|sensory system agents|mesh-ancestor
5738364|NCT03116672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5738365|NCT03116672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738366|NCT03116672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5738367|NCT03116672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5617975|NCT04668950|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5617976|NCT04668950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5617977|NCT04668950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5617978|NCT04668950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5617979|NCT04668950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5617980|NCT04668950|Serotonin Agents|serotonin agents|mesh-ancestor
5617981|NCT04668950|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5738368|NCT03116672|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5738369|NCT03116672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5738370|NCT03116672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5617982|NCT04668950|Antidepressive Agents|antidepressive agents|mesh-ancestor
5617983|NCT04668950|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5617984|NCT04668950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5617985|NCT04668950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5617986|NCT04668950|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5617987|NCT04641871|Irinotecan|irinotecan|mesh-list
5617988|NCT04641871|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5738371|NCT03116490|Anesthetics|anesthetics|mesh-list
5738372|NCT03116490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5738373|NCT03116490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738374|NCT03116542|Alovudine|alovudine|mesh-list
5738375|NCT03116542|Antiviral Agents|antiviral agents|mesh-ancestor
5738376|NCT03116542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5738377|NCT03116347|Immunoglobulins|immunoglobulins|mesh-list
5738378|NCT03116347|Antibodies|antibodies|mesh-list
5738379|NCT03116347|gamma-Globulins|gamma-globulins|mesh-list
5738380|NCT03116347|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5738381|NCT03116347|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5738382|NCT03116347|Immunoglobulin G|immunoglobulin g|mesh-list
5738383|NCT03116347|Immunologic Factors|immunologic factors|mesh-ancestor
5738384|NCT03116347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738385|NCT03116555|Irinotecan|irinotecan|mesh-list
5738386|NCT03116555|Apatinib|apatinib|mesh-list
5738387|NCT03116555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5738388|NCT03116555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5738389|NCT03116555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5738390|NCT03116555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5738391|NCT03116555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5738392|NCT03116555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5738393|NCT03116425|Pantothenic Acid|pantothenic acid|mesh-list
5738394|NCT03116425|Vitamin B Complex|vitamin b complex|mesh-ancestor
5738395|NCT03116425|Vitamins|vitamins|mesh-ancestor
5738396|NCT03116425|Micronutrients|micronutrients|mesh-ancestor
5738397|NCT03116425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738398|NCT03116516|Amlodipine|amlodipine|mesh-list
5738399|NCT03116516|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5738400|NCT03116516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5738401|NCT03116516|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5738402|NCT03116516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5738403|NCT03116516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5738404|NCT03116516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5738405|NCT03116516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738406|NCT03116516|Vasodilator Agents|vasodilator agents|mesh-ancestor
5617989|NCT04641871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5617990|NCT04641871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5617991|NCT04641871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5617992|NCT04641871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5617993|NCT04631471|Ibudilast|ibudilast|mesh-list
5617994|NCT04631471|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5617995|NCT04631471|Autonomic Agents|autonomic agents|mesh-ancestor
5617996|NCT04631471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5617997|NCT04631471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5617998|NCT04631471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5617999|NCT04631471|Respiratory System Agents|respiratory system agents|mesh-ancestor
5618000|NCT04631471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5618001|NCT04631471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5618002|NCT04631471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618003|NCT04631471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5618004|NCT04631471|Vasodilator Agents|vasodilator agents|mesh-ancestor
5618005|NCT04609904|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
5618006|NCT04609904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5738407|NCT03116516|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5738408|NCT03116516|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5738409|NCT03116516|Antimetabolites|antimetabolites|mesh-ancestor
5738410|NCT03116516|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5738411|NCT03116516|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5738412|NCT03116516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5618007|NCT04609904|Respiratory System Agents|respiratory system agents|mesh-ancestor
5618008|NCT04609878|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
5618009|NCT04609878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5618010|NCT04609878|Respiratory System Agents|respiratory system agents|mesh-ancestor
5618011|NCT04602598|Zanubrutinib|zanubrutinib|mesh-list
5618012|NCT04602598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5618013|NCT04602598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5618014|NCT04602598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5618015|NCT04602598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618016|NCT04563520|Coagulants|coagulants|mesh-list
5618017|NCT04563520|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
5618018|NCT04562896|Carbon Fiber|carbon fiber|mesh-list
5618019|NCT04562896|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5738413|NCT03116269|Aspirin|aspirin|mesh-list
5738414|NCT03116269|Cilostazol|cilostazol|mesh-list
5738415|NCT03116269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5618020|NCT04562896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5618021|NCT04558502|Amoxicillin|amoxicillin|mesh-list
5618022|NCT04558502|Clarithromycin|clarithromycin|mesh-list
5618023|NCT04558502|Minocycline|minocycline|mesh-list
5618024|NCT04558502|Esomeprazole|esomeprazole|mesh-list
5618025|NCT04558502|Bismuth|bismuth|mesh-list
5618026|NCT04558502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5618027|NCT04558502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5618028|NCT04558502|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5618029|NCT04558502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5618030|NCT04558502|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5618031|NCT04558502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5618032|NCT04558502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618033|NCT04558502|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5618034|NCT04558502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5618035|NCT04558502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5618036|NCT04558502|Antacids|antacids|mesh-ancestor
5618037|NCT04550455|Cladribine|cladribine|mesh-list
5618038|NCT04550455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5618039|NCT04550455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5618040|NCT04550455|Immunologic Factors|immunologic factors|mesh-ancestor
5618041|NCT04550455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738416|NCT03116269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5738417|NCT03116269|Analgesics|analgesics|mesh-ancestor
5738418|NCT03116269|Sensory System Agents|sensory system agents|mesh-ancestor
5738419|NCT03116269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5738420|NCT03116269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738421|NCT03116269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5738422|NCT03116269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5738423|NCT03116269|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5738424|NCT03116269|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5738425|NCT03116269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5738426|NCT03116269|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5738427|NCT03116269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5738428|NCT03116269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5738429|NCT03116269|Antipyretics|antipyretics|mesh-ancestor
5738430|NCT03116269|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5738431|NCT03116269|Autonomic Agents|autonomic agents|mesh-ancestor
5738432|NCT03116269|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5738433|NCT03116269|Respiratory System Agents|respiratory system agents|mesh-ancestor
5738434|NCT03116269|Vasodilator Agents|vasodilator agents|mesh-ancestor
5738435|NCT03116269|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5738436|NCT03116269|Protective Agents|protective agents|mesh-ancestor
5738437|NCT03116269|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5738438|NCT03116269|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5893363|NCT05103358|Antifungal Agents|antifungal agents|mesh-ancestor
5893364|NCT05103358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5893365|NCT05103358|Immunologic Factors|immunologic factors|mesh-ancestor
5618042|NCT04544267|Vaccines|vaccines|mesh-list
5618043|NCT04544267|Immunologic Factors|immunologic factors|mesh-ancestor
5618044|NCT04544267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208603|NCT02132832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6208604|NCT02132832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208605|NCT02132936|Calcipotriene|calcipotriene|mesh-list
6208606|NCT02132936|Dermatologic Agents|dermatologic agents|mesh-ancestor
6208607|NCT02132949|Paclitaxel|paclitaxel|mesh-list
6208608|NCT02132949|Docetaxel|docetaxel|mesh-list
6208609|NCT02132949|Cyclophosphamide|cyclophosphamide|mesh-list
6208610|NCT02132949|Doxorubicin|doxorubicin|mesh-list
5893366|NCT05103358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893367|NCT05094154|Penicillins|penicillins|mesh-list
5893368|NCT05094154|Cephalosporins|cephalosporins|mesh-list
5893369|NCT05094154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5893370|NCT05094154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6208611|NCT02132949|Fluorouracil|fluorouracil|mesh-list
6208612|NCT02132949|Trastuzumab|trastuzumab|mesh-list
6208613|NCT02132949|Epirubicin|epirubicin|mesh-list
5618056|NCT04525599|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5618057|NCT04525599|Immunologic Factors|immunologic factors|mesh-ancestor
5618058|NCT04525599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618059|NCT04505735|Corticosterone|corticosterone|mesh-list
5618060|NCT04505735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5618061|NCT04485104|Cannabidiol|cannabidiol|mesh-list
5618062|NCT04485104|Anticonvulsants|anticonvulsants|mesh-ancestor
5618063|NCT04479267|Prednisone|prednisone|mesh-list
6208614|NCT02132949|Pertuzumab|pertuzumab|mesh-list
5618064|NCT04479267|Methylprednisolone|methylprednisolone|mesh-list
5738439|NCT03116126|Guanfacine|guanfacine|mesh-list
5738440|NCT03116126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5738441|NCT03116126|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5738442|NCT03116126|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5738443|NCT03116126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5738444|NCT03116126|Adrenergic Agents|adrenergic agents|mesh-ancestor
5738445|NCT03116126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5618065|NCT04479267|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5618066|NCT04479267|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5618067|NCT04479267|Prednisolone|prednisolone|mesh-list
5618068|NCT04479267|Prednisolone acetate|prednisolone acetate|mesh-list
5618069|NCT04479267|Hydrocortisone|hydrocortisone|mesh-list
5618070|NCT04479267|Cortisone|cortisone|mesh-list
5618071|NCT04479267|Cyclophosphamide|cyclophosphamide|mesh-list
5618072|NCT04479267|Rituximab|rituximab|mesh-list
5618073|NCT04479267|Doxorubicin|doxorubicin|mesh-list
5618074|NCT04479267|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5618075|NCT04479267|Antibodies|antibodies|mesh-list
5618076|NCT04479267|Immunoglobulins|immunoglobulins|mesh-list
5738446|NCT03116126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5738447|NCT03116126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738448|NCT03116321|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
5738449|NCT03116321|Anticonvulsants|anticonvulsants|mesh-ancestor
5738450|NCT03116321|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5738451|NCT03116321|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5738452|NCT03116321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5738453|NCT03116321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5738454|NCT03116087|Methyltestosterone|methyltestosterone|mesh-list
5738455|NCT03116087|Testosterone|testosterone|mesh-list
5738456|NCT03116087|Testosterone undecanoate|testosterone undecanoate|mesh-list
5738457|NCT03116087|Testosterone enanthate|testosterone enanthate|mesh-list
5738458|NCT03116087|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5738459|NCT03116087|Androgens|androgens|mesh-ancestor
5738460|NCT03116087|Hormones|hormones|mesh-ancestor
5738461|NCT03116087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5738462|NCT03116087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738463|NCT03116087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5738464|NCT03116087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5738465|NCT03116087|Anabolic Agents|anabolic agents|mesh-ancestor
5738466|NCT03116308|Opicapone|opicapone|mesh-list
5738467|NCT03116308|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
5738468|NCT03116308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5738469|NCT03116308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5738470|NCT03116308|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5738471|NCT03116308|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5738472|NCT03116282|Ethanol|ethanol|mesh-list
5738473|NCT03116282|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5618077|NCT04479267|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5618078|NCT04479267|Immunoconjugates|immunoconjugates|mesh-list
5618079|NCT04479267|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5618080|NCT04479267|Prednisolone phosphate|prednisolone phosphate|mesh-list
5618081|NCT04479267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5618082|NCT04479267|Immunologic Factors|immunologic factors|mesh-ancestor
5618083|NCT04479267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618084|NCT04479267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5618085|NCT04479267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5618086|NCT04479267|Alkylating Agents|alkylating agents|mesh-ancestor
5618087|NCT04479267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618088|NCT04479267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5618089|NCT04479267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5738474|NCT03116282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5738475|NCT03116282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5738476|NCT03116282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738477|NCT03116295|Opicapone|opicapone|mesh-list
5738478|NCT03116295|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
5738479|NCT03116295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5738480|NCT03116295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5738481|NCT03116295|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5738482|NCT03116295|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5738483|NCT03115892|Chlorhexidine|chlorhexidine|mesh-list
5738484|NCT03115892|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5738485|NCT03115892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5738486|NCT03115892|Disinfectants|disinfectants|mesh-ancestor
5738487|NCT03115697|Rifaximin|rifaximin|mesh-list
5738488|NCT03115697|Lactulose|lactulose|mesh-list
5618090|NCT04479267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5738489|NCT03115697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5738490|NCT03115697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5738491|NCT03115697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5738492|NCT03115736|Tenofovir|tenofovir|mesh-list
5738493|NCT03115736|Antiviral Agents|antiviral agents|mesh-ancestor
5738494|NCT03115736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5738495|NCT03115736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5738496|NCT03115736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5738497|NCT03115736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5738498|NCT03115736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5738499|NCT03115736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5738500|NCT03115736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5738501|NCT03115775|Vitamin D|vitamin d|mesh-list
5738502|NCT03115775|Ergocalciferols|ergocalciferols|mesh-list
5738503|NCT03115775|Vitamins|vitamins|mesh-list
5738504|NCT03115775|Micronutrients|micronutrients|mesh-ancestor
5738505|NCT03115775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738506|NCT03115775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5738507|NCT03115775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5738508|NCT03115489|Ketamine|ketamine|mesh-list
5738509|NCT03115489|Propofol|propofol|mesh-list
5738510|NCT03115489|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5738511|NCT03115489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5738512|NCT03115489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738513|NCT03115489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5738514|NCT03115489|Anesthetics, General|anesthetics, general|mesh-ancestor
5738515|NCT03115489|Anesthetics|anesthetics|mesh-ancestor
5738516|NCT03115489|Analgesics|analgesics|mesh-ancestor
5738517|NCT03115489|Sensory System Agents|sensory system agents|mesh-ancestor
5738518|NCT03115489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5738519|NCT03115489|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5738520|NCT03115489|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5738521|NCT03115489|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5618091|NCT04479267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5618092|NCT04479267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5618093|NCT04479267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5618094|NCT04479267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5618095|NCT04479267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5618096|NCT04479267|Glucocorticoids|glucocorticoids|mesh-ancestor
5618097|NCT04479267|Hormones|hormones|mesh-ancestor
5618098|NCT04479267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5618099|NCT04479267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5618100|NCT04479267|Antiemetics|antiemetics|mesh-ancestor
5738522|NCT03115489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5738523|NCT03115489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5738524|NCT03115762|Bevacizumab|bevacizumab|mesh-list
5738525|NCT03115762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5738526|NCT03115762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5738527|NCT03115762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5738528|NCT03115762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5738529|NCT03115762|Growth Substances|growth substances|mesh-ancestor
5738530|NCT03115762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738531|NCT03115762|Growth Inhibitors|growth inhibitors|mesh-ancestor
5738532|NCT03115307|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5738533|NCT03115307|Luteolytic Agents|luteolytic agents|mesh-ancestor
5738534|NCT03115307|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5738535|NCT03115307|Contraceptive Agents|contraceptive agents|mesh-ancestor
5738536|NCT03115307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5738537|NCT03115307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738538|NCT03115307|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5738539|NCT03115307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5738540|NCT03115307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5738541|NCT03115320|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5738542|NCT03115320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5738543|NCT03115320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738544|NCT03115619|Pirfenidone|pirfenidone|mesh-list
5738545|NCT03115619|Analgesics|analgesics|mesh-ancestor
5738546|NCT03115619|Sensory System Agents|sensory system agents|mesh-ancestor
5738547|NCT03115619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5738548|NCT03115619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738549|NCT03115619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5738550|NCT03115619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5738551|NCT03115619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5618101|NCT04479267|Autonomic Agents|autonomic agents|mesh-ancestor
5738552|NCT03115619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5738553|NCT03115619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5738554|NCT03115567|Triamcinolone|triamcinolone|mesh-list
5738555|NCT03115567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5738556|NCT03115567|Glucocorticoids|glucocorticoids|mesh-ancestor
5738557|NCT03115567|Hormones|hormones|mesh-ancestor
5738558|NCT03115567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5738559|NCT03115567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738560|NCT03115255|Ranibizumab|ranibizumab|mesh-list
5738561|NCT03115255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5738562|NCT03115255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5738563|NCT03115255|Growth Substances|growth substances|mesh-ancestor
5738564|NCT03115255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738565|NCT03115255|Growth Inhibitors|growth inhibitors|mesh-ancestor
5738566|NCT03115255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5738567|NCT03114865|Dexamethasone|dexamethasone|mesh-list
5738568|NCT03114865|Blinatumomab|blinatumomab|mesh-list
5738569|NCT03114865|Antibodies, Bispecific|antibodies, bispecific|mesh-list
5738570|NCT03114865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5738571|NCT03114865|Antiemetics|antiemetics|mesh-ancestor
5738572|NCT03114865|Autonomic Agents|autonomic agents|mesh-ancestor
5738573|NCT03114865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5738574|NCT03114865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738575|NCT03114865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5738576|NCT03114865|Glucocorticoids|glucocorticoids|mesh-ancestor
5738577|NCT03114865|Hormones|hormones|mesh-ancestor
5618102|NCT04479267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5618103|NCT04479267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5618104|NCT04479267|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5618105|NCT04479267|Protective Agents|protective agents|mesh-ancestor
5692363|NCT03408847|Hormones|hormones|mesh-ancestor
5692364|NCT03408847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5692365|NCT03408847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692366|NCT03408847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5692367|NCT03408847|Respiratory System Agents|respiratory system agents|mesh-ancestor
5692368|NCT03408756|Methotrexate|methotrexate|mesh-list
5692369|NCT03408756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5692370|NCT03408756|Abortifacient Agents|abortifacient agents|mesh-ancestor
5692371|NCT03408756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5692372|NCT03408756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692373|NCT03408756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5692374|NCT03408756|Antimetabolites|antimetabolites|mesh-ancestor
5692375|NCT03408756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692376|NCT03408756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5692377|NCT03408756|Dermatologic Agents|dermatologic agents|mesh-ancestor
5738578|NCT03114865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5738579|NCT03114865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5738580|NCT03114865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5738581|NCT03114865|Immunologic Factors|immunologic factors|mesh-ancestor
5738582|NCT03115047|Meperidine|meperidine|mesh-list
5738583|NCT03115047|Dexmedetomidine|dexmedetomidine|mesh-list
5738584|NCT03115047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5738585|NCT03115047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5738586|NCT03115047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738587|NCT03115047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5738588|NCT03115047|Analgesics|analgesics|mesh-ancestor
5738589|NCT03115047|Sensory System Agents|sensory system agents|mesh-ancestor
5738590|NCT03115047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5738591|NCT03115047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5738592|NCT03115047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5738593|NCT03115047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5738594|NCT03115047|Adrenergic Agents|adrenergic agents|mesh-ancestor
5738595|NCT03115047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5738596|NCT03115047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5738597|NCT03115047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5738598|NCT03115047|Narcotics|narcotics|mesh-ancestor
5738599|NCT03115047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5738600|NCT03115060|Plasma-lyte 148|plasma-lyte 148|mesh-list
5738601|NCT03115060|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5738602|NCT03115060|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5738603|NCT03115034|Melatonin|melatonin|mesh-list
5738604|NCT03115034|Antioxidants|antioxidants|mesh-ancestor
5738605|NCT03115034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5738606|NCT03115034|Protective Agents|protective agents|mesh-ancestor
5893371|NCT05093205|Midazolam|midazolam|mesh-list
5738607|NCT03115034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738608|NCT03115034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5738609|NCT03114904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
5738610|NCT03114904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5738611|NCT03114904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738612|NCT03115073|Clotrimazole|clotrimazole|mesh-list
5738613|NCT03115073|Miconazole|miconazole|mesh-list
5738614|NCT03115073|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5738615|NCT03115073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5738616|NCT03115073|Antifungal Agents|antifungal agents|mesh-ancestor
5738617|NCT03115073|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5738618|NCT03115073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5738619|NCT03115073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5738620|NCT03115073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618106|NCT04471597|Bupivacaine|bupivacaine|mesh-list
5618107|NCT04471597|Anesthetics, Local|anesthetics, local|mesh-ancestor
5618108|NCT04471597|Anesthetics|anesthetics|mesh-ancestor
5618109|NCT04471597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5618110|NCT04471597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618111|NCT04471597|Sensory System Agents|sensory system agents|mesh-ancestor
5618112|NCT04471597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5618113|NCT04459416|Analgesics, Opioid|analgesics, opioid|mesh-list
5618114|NCT04459416|Narcotics|narcotics|mesh-ancestor
5738621|NCT03115073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5738622|NCT03115073|Hormone Antagonists|hormone antagonists|mesh-ancestor
5738623|NCT03115073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5738624|NCT03115073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738625|NCT03115073|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5738626|NCT03115073|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5738627|NCT03115151|Fentanyl|fentanyl|mesh-list
5738628|NCT03115151|Hydromorphone|hydromorphone|mesh-list
5738629|NCT03115151|Bupivacaine|bupivacaine|mesh-list
5738630|NCT03115151|Anesthetics, Local|anesthetics, local|mesh-ancestor
5738631|NCT03115151|Anesthetics|anesthetics|mesh-ancestor
5738632|NCT03115151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5738633|NCT03115151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738634|NCT03115151|Sensory System Agents|sensory system agents|mesh-ancestor
5738635|NCT03115151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5738636|NCT03115151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5738637|NCT03115151|Narcotics|narcotics|mesh-ancestor
5738638|NCT03115151|Analgesics|analgesics|mesh-ancestor
5738639|NCT03115151|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5738640|NCT03115151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5738641|NCT03115151|Anesthetics, General|anesthetics, general|mesh-ancestor
5738642|NCT03115099|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5738643|NCT03115099|Liraglutide|liraglutide|mesh-list
5738644|NCT03115099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5738645|NCT03115099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738646|NCT03115099|Incretins|incretins|mesh-ancestor
5738647|NCT03115099|Hormones|hormones|mesh-ancestor
5738648|NCT03115099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5738649|NCT03115099|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5738650|NCT03115099|Protease Inhibitors|protease inhibitors|mesh-ancestor
5738651|NCT03115099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5738652|NCT03115099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5738653|NCT03114813|Carvedilol|carvedilol|mesh-list
5738654|NCT03114813|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5738655|NCT03114813|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5738656|NCT03114813|Adrenergic Agents|adrenergic agents|mesh-ancestor
5738657|NCT03114813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5738658|NCT03114813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5738659|NCT03114813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618115|NCT04459416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5618116|NCT04459416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618117|NCT04459416|Analgesics|analgesics|mesh-ancestor
5618118|NCT04459416|Sensory System Agents|sensory system agents|mesh-ancestor
5618119|NCT04459416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5618120|NCT04449549|Paclitaxel|paclitaxel|mesh-list
5618121|NCT04449549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5618122|NCT04449549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5618123|NCT04449549|Tubulin Modulators|tubulin modulators|mesh-ancestor
5618124|NCT04449549|Antimitotic Agents|antimitotic agents|mesh-ancestor
5618125|NCT04449549|Mitosis Modulators|mitosis modulators|mesh-ancestor
5738660|NCT03114813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5738661|NCT03114813|Antioxidants|antioxidants|mesh-ancestor
5738662|NCT03114813|Protective Agents|protective agents|mesh-ancestor
5738663|NCT03114813|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5738664|NCT03114813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5738665|NCT03114813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5738666|NCT03114813|Vasodilator Agents|vasodilator agents|mesh-ancestor
5738667|NCT03114813|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5618126|NCT04449549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618127|NCT04431778|Ethosuximide|ethosuximide|mesh-list
5618128|NCT04431778|Anticonvulsants|anticonvulsants|mesh-ancestor
5618129|NCT04420455|Enoximone|enoximone|mesh-list
5618130|NCT04420455|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5618131|NCT04420455|Vasodilator Agents|vasodilator agents|mesh-ancestor
5618132|NCT04420455|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5618133|NCT04420455|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5618134|NCT04420455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5618135|NCT04420455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618136|NCT04420455|Protective Agents|protective agents|mesh-ancestor
5618137|NCT04420455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618138|NCT04419337|Metformin|metformin|mesh-list
5618139|NCT04419337|Pioglitazone|pioglitazone|mesh-list
5618140|NCT04419337|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
5618141|NCT04419337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5618142|NCT04419337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618143|NCT04419337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618144|NCT04417166|Pembrolizumab|pembrolizumab|mesh-list
5618145|NCT04417166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5618146|NCT04417166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5618147|NCT04410796|Carboplatin|carboplatin|mesh-list
5618148|NCT04410796|Pemetrexed|pemetrexed|mesh-list
5618149|NCT04410796|Osimertinib|osimertinib|mesh-list
5618150|NCT04410796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5618151|NCT04410796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5618152|NCT04410796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618153|NCT04410796|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5618154|NCT04410796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5618155|NCT04410796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5738668|NCT03114813|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5893372|NCT05093205|Atorvastatin|atorvastatin|mesh-list
5893373|NCT05093205|Levonorgestrel|levonorgestrel|mesh-list
5893374|NCT05093205|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5893375|NCT05093205|Estradiol|estradiol|mesh-list
5893376|NCT05093205|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5893377|NCT05093205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5893378|NCT05093205|Antimetabolites|antimetabolites|mesh-ancestor
5893379|NCT05093205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893380|NCT05093205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5893381|NCT05093205|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5893382|NCT05093205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5618156|NCT04318717|Pembrolizumab|pembrolizumab|mesh-list
5618157|NCT04318717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5618158|NCT04318717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5618159|NCT04304755|Zoledronic Acid|zoledronic acid|mesh-list
5618160|NCT04304755|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5618161|NCT04304755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618162|NCT04297592|Doxycycline|doxycycline|mesh-list
5618163|NCT04297592|Cephalexin|cephalexin|mesh-list
5618164|NCT04297592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5618165|NCT04297592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5618166|NCT04297592|Antimalarials|antimalarials|mesh-ancestor
5618167|NCT04297592|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5618168|NCT04297592|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5618169|NCT04294160|Trametinib|trametinib|mesh-list
5618170|NCT04294160|Dabrafenib|dabrafenib|mesh-list
5618171|NCT04294160|Spartalizumab|spartalizumab|mesh-list
5618172|NCT04294160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5618173|NCT04294160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5618174|NCT04294160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5618175|NCT04294160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618176|NCT04294160|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5618177|NCT04251715|Leucovorin|leucovorin|mesh-list
5618178|NCT04251715|Dexamethasone|dexamethasone|mesh-list
5618179|NCT04251715|Dexamethasone acetate|dexamethasone acetate|mesh-list
5893383|NCT05093205|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5618180|NCT04251715|Fluorouracil|fluorouracil|mesh-list
5618181|NCT04251715|Oxaliplatin|oxaliplatin|mesh-list
5618182|NCT04251715|Irinotecan|irinotecan|mesh-list
5738669|NCT03114527|Everolimus|everolimus|mesh-list
5738670|NCT03114527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5738671|NCT03114527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5738672|NCT03114527|Immunologic Factors|immunologic factors|mesh-ancestor
5738673|NCT03114527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738674|NCT03114371|Oxytocin|oxytocin|mesh-list
5738675|NCT03114371|Oxytocics|oxytocics|mesh-ancestor
5738676|NCT03114371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5738677|NCT03114371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738678|NCT03114280|Carboplatin|carboplatin|mesh-list
5738679|NCT03114280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5738680|NCT03114228|Midostaurin|midostaurin|mesh-list
5738681|NCT03114228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5738682|NCT03114228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5738683|NCT03114228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5738684|NCT03114228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5738685|NCT03114111|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5738686|NCT03114111|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5738687|NCT03114111|Dermatologic Agents|dermatologic agents|mesh-ancestor
5738688|NCT03114085|Capecitabine|capecitabine|mesh-list
5738689|NCT03114085|Apatinib|apatinib|mesh-list
5738690|NCT03114085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5738691|NCT03114085|Antimetabolites|antimetabolites|mesh-ancestor
5738692|NCT03114085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5738693|NCT03114085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5738694|NCT03114085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5738695|NCT03114085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5618183|NCT04251715|Floxuridine|floxuridine|mesh-list
5618184|NCT04251715|BB 1101|bb 1101|mesh-list
5618185|NCT04251715|Deoxyuridine|deoxyuridine|mesh-list
5618186|NCT04251715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5618187|NCT04251715|Antiemetics|antiemetics|mesh-ancestor
5618188|NCT04251715|Autonomic Agents|autonomic agents|mesh-ancestor
5618189|NCT04251715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5618190|NCT04251715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618191|NCT04251715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5618192|NCT04251715|Glucocorticoids|glucocorticoids|mesh-ancestor
5618193|NCT04251715|Hormones|hormones|mesh-ancestor
5618194|NCT04251715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5618195|NCT04251715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5618196|NCT04251715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5618197|NCT04251715|Protease Inhibitors|protease inhibitors|mesh-ancestor
5618198|NCT04251715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5618199|NCT04251715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618200|NCT04251715|Antimetabolites|antimetabolites|mesh-ancestor
5738696|NCT03114072|Methamphetamine|methamphetamine|mesh-list
5738697|NCT03114072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5738698|NCT03114072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738699|NCT03114072|Sympathomimetics|sympathomimetics|mesh-ancestor
5738700|NCT03114072|Autonomic Agents|autonomic agents|mesh-ancestor
5738701|NCT03114072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5738702|NCT03114072|Dopamine Agents|dopamine agents|mesh-ancestor
5738703|NCT03114072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5738704|NCT03114072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5738705|NCT03114072|Adrenergic Agents|adrenergic agents|mesh-ancestor
5738706|NCT03114072|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5738707|NCT03114072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5738708|NCT03114072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5738709|NCT03114072|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5738710|NCT03114215|Biotin|biotin|mesh-list
5738711|NCT03114215|Vitamin B Complex|vitamin b complex|mesh-ancestor
5738712|NCT03114215|Vitamins|vitamins|mesh-ancestor
5738713|NCT03114215|Micronutrients|micronutrients|mesh-ancestor
5738714|NCT03114215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738715|NCT03113942|Thalidomide|thalidomide|mesh-list
5738716|NCT03113942|Pomalidomide|pomalidomide|mesh-list
5738717|NCT03113942|Immunologic Factors|immunologic factors|mesh-ancestor
5738718|NCT03113942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738719|NCT03113942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5738720|NCT03113942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5738721|NCT03113942|Growth Substances|growth substances|mesh-ancestor
5738722|NCT03113942|Growth Inhibitors|growth inhibitors|mesh-ancestor
5738723|NCT03113942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5738724|NCT03113942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5738725|NCT03113942|Leprostatic Agents|leprostatic agents|mesh-ancestor
5738726|NCT03113942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5738727|NCT03113942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5738728|NCT03114020|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5738729|NCT03114020|Hyaluronic Acid|hyaluronic acid|mesh-list
5738730|NCT03114020|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5618201|NCT04251715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5618202|NCT04251715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5618203|NCT04251715|Immunologic Factors|immunologic factors|mesh-ancestor
5618204|NCT04251715|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5618205|NCT04251715|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5738731|NCT03114020|Immunologic Factors|immunologic factors|mesh-ancestor
5738732|NCT03114020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738733|NCT03114020|Viscosupplements|viscosupplements|mesh-ancestor
5738734|NCT03114020|Protective Agents|protective agents|mesh-ancestor
5738735|NCT03113968|Ketamine|ketamine|mesh-list
5738736|NCT03113968|Analgesics|analgesics|mesh-ancestor
5738737|NCT03113968|Sensory System Agents|sensory system agents|mesh-ancestor
5738738|NCT03113968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5738739|NCT03113968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738740|NCT03113968|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5738741|NCT03113968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5738742|NCT03113968|Anesthetics, General|anesthetics, general|mesh-ancestor
5738743|NCT03113968|Anesthetics|anesthetics|mesh-ancestor
5738744|NCT03113968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5738745|NCT03113968|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5738746|NCT03113968|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5738747|NCT03113968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5738748|NCT03113968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5738749|NCT03113851|Molgramostim|molgramostim|mesh-list
5738750|NCT03113851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5738751|NCT03113773|Aldesleukin|aldesleukin|mesh-list
5738752|NCT03113773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5618206|NCT04251715|Antidotes|antidotes|mesh-ancestor
5618207|NCT04251715|Protective Agents|protective agents|mesh-ancestor
5618208|NCT04251715|Vitamin B Complex|vitamin b complex|mesh-ancestor
5618209|NCT04251715|Vitamins|vitamins|mesh-ancestor
5738753|NCT03113773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5738754|NCT03113773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5738755|NCT03113773|Antiviral Agents|antiviral agents|mesh-ancestor
5738756|NCT03113773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5738757|NCT03113448|Capsaicin|capsaicin|mesh-list
5738758|NCT03113448|Antipruritics|antipruritics|mesh-ancestor
5738759|NCT03113448|Dermatologic Agents|dermatologic agents|mesh-ancestor
5738760|NCT03113448|Sensory System Agents|sensory system agents|mesh-ancestor
5738761|NCT03113448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5738762|NCT03113448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738763|NCT03113500|Prednisone|prednisone|mesh-list
5738764|NCT03113500|Cortisone|cortisone|mesh-list
5738765|NCT03113500|Cyclophosphamide|cyclophosphamide|mesh-list
5738766|NCT03113500|Doxorubicin|doxorubicin|mesh-list
5738767|NCT03113500|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5738768|NCT03113500|Etoposide|etoposide|mesh-list
5738769|NCT03113500|Etoposide phosphate|etoposide phosphate|mesh-list
5738770|NCT03113500|Daunorubicin|daunorubicin|mesh-list
5738771|NCT03113500|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5738772|NCT03113500|Podophyllotoxin|podophyllotoxin|mesh-list
5738773|NCT03113500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5738774|NCT03113500|Antibodies|antibodies|mesh-list
5738775|NCT03113500|Immunoglobulins|immunoglobulins|mesh-list
5618210|NCT04251715|Micronutrients|micronutrients|mesh-ancestor
5618211|NCT04249739|Pembrolizumab|pembrolizumab|mesh-list
5618212|NCT04249739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5618213|NCT04249739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5618214|NCT04234464|Budesonide|budesonide|mesh-list
5618215|NCT04234464|Albuterol|albuterol|mesh-list
5618216|NCT04234464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5618217|NCT04234464|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5618218|NCT04234464|Autonomic Agents|autonomic agents|mesh-ancestor
5618219|NCT04234464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5618220|NCT04234464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618221|NCT04234464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5618222|NCT04234464|Respiratory System Agents|respiratory system agents|mesh-ancestor
5618223|NCT04234464|Glucocorticoids|glucocorticoids|mesh-ancestor
5618224|NCT04234464|Hormones|hormones|mesh-ancestor
5738776|NCT03113500|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5738777|NCT03113500|Immunoconjugates|immunoconjugates|mesh-list
5738778|NCT03113500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5618225|NCT04234464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5738779|NCT03113500|Immunologic Factors|immunologic factors|mesh-ancestor
5738780|NCT03113500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738781|NCT03113500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5738782|NCT03113500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5738783|NCT03113500|Alkylating Agents|alkylating agents|mesh-ancestor
5738784|NCT03113500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5738785|NCT03113500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5738786|NCT03113500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5738787|NCT03113500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5738788|NCT03113500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5738789|NCT03113500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5738790|NCT03113500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5738791|NCT03113500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5738792|NCT03113500|Glucocorticoids|glucocorticoids|mesh-ancestor
5738793|NCT03113500|Hormones|hormones|mesh-ancestor
5738794|NCT03113500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5738795|NCT03113500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5738796|NCT03113500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5738797|NCT03113500|Keratolytic Agents|keratolytic agents|mesh-ancestor
5738798|NCT03113500|Dermatologic Agents|dermatologic agents|mesh-ancestor
5738799|NCT03113500|Tubulin Modulators|tubulin modulators|mesh-ancestor
5738800|NCT03113500|Antimitotic Agents|antimitotic agents|mesh-ancestor
5738801|NCT03113500|Mitosis Modulators|mitosis modulators|mesh-ancestor
5738802|NCT03113695|Lenalidomide|lenalidomide|mesh-list
5738803|NCT03113695|Obinutuzumab|obinutuzumab|mesh-list
5738804|NCT03113695|Immunologic Factors|immunologic factors|mesh-ancestor
5738805|NCT03113695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738806|NCT03113695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5738807|NCT03113695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5738808|NCT03113695|Growth Substances|growth substances|mesh-ancestor
5738809|NCT03113695|Growth Inhibitors|growth inhibitors|mesh-ancestor
5738810|NCT03113695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5738811|NCT03113695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5738812|NCT03113396|Baclofen|baclofen|mesh-list
5738813|NCT03113396|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5738814|NCT03113396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738815|NCT03113396|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5738816|NCT03113396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5738817|NCT03113396|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
5738818|NCT03113396|GABA Agonists|gaba agonists|mesh-ancestor
5738819|NCT03113396|GABA Agents|gaba agents|mesh-ancestor
5738820|NCT03113396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5738821|NCT03113396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5738822|NCT03113409|Naltrexone|naltrexone|mesh-list
5738823|NCT03113409|Buprenorphine|buprenorphine|mesh-list
5738824|NCT03113409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5738825|NCT03113409|Narcotics|narcotics|mesh-ancestor
5738826|NCT03113409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5738827|NCT03113409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738828|NCT03113409|Analgesics|analgesics|mesh-ancestor
5738829|NCT03113409|Sensory System Agents|sensory system agents|mesh-ancestor
5738830|NCT03113409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5738831|NCT03113409|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5738832|NCT03113409|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5738833|NCT03113708|Heparin|heparin|mesh-list
5738834|NCT03113708|Calcium heparin|calcium heparin|mesh-list
5738835|NCT03113708|Anticoagulants|anticoagulants|mesh-ancestor
5738836|NCT03113708|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5738837|NCT03113708|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5738838|NCT03113708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618226|NCT04234464|Tocolytic Agents|tocolytic agents|mesh-ancestor
5618227|NCT04234464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5618228|NCT04234464|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5618229|NCT04234464|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5618230|NCT04234464|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5618231|NCT04234464|Adrenergic Agents|adrenergic agents|mesh-ancestor
5618232|NCT04234464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5618233|NCT04234464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618234|NCT04228965|Varenicline|varenicline|mesh-list
5618235|NCT04228965|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5618236|NCT04228965|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5618237|NCT04228965|Cholinergic Agents|cholinergic agents|mesh-ancestor
5618238|NCT04228965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5618239|NCT04228965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618240|NCT04228965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618241|NCT04211675|Irinotecan|irinotecan|mesh-list
5618242|NCT04211675|Temozolomide|temozolomide|mesh-list
5618243|NCT04211675|Dinutuximab|dinutuximab|mesh-list
5618244|NCT04211675|Sargramostim|sargramostim|mesh-list
5618245|NCT04211675|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5618246|NCT04211675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5618247|NCT04211675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5618248|NCT04211675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618249|NCT04211675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5618250|NCT04211675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5618251|NCT04211675|Alkylating Agents|alkylating agents|mesh-ancestor
5618252|NCT04211675|Immunologic Factors|immunologic factors|mesh-ancestor
5618253|NCT04211675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618254|NCT04204122|Moxifloxacin|moxifloxacin|mesh-list
5618255|NCT04204122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5618256|NCT04204122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5618257|NCT04204122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5618258|NCT04204122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5738839|NCT03113617|Gastrin-Releasing Peptide|gastrin-releasing peptide|mesh-list
5738840|NCT03113617|Bombesin|bombesin|mesh-list
5738841|NCT03113617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5738842|NCT03113617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5738843|NCT03113617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738844|NCT03113617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5738845|NCT03113344|Amoxicillin|amoxicillin|mesh-list
5738846|NCT03113344|Azithromycin|azithromycin|mesh-list
5738847|NCT03113344|Meropenem|meropenem|mesh-list
5738848|NCT03113344|Ceftriaxone|ceftriaxone|mesh-list
5738849|NCT03113344|Imipenem|imipenem|mesh-list
5738850|NCT03113344|Penicillins|penicillins|mesh-list
5738851|NCT03113344|Erythromycin|erythromycin|mesh-list
5738852|NCT03113344|Ceftazidime|ceftazidime|mesh-list
5738853|NCT03113344|Ampicillin|ampicillin|mesh-list
5738854|NCT03113344|Cephalosporins|cephalosporins|mesh-list
5738855|NCT03113344|Acyclovir|acyclovir|mesh-list
5738856|NCT03113344|Ganciclovir|ganciclovir|mesh-list
5738857|NCT03113344|Antiviral Agents|antiviral agents|mesh-list
5618259|NCT04204122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5618260|NCT04204122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618261|NCT04204122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5618262|NCT04198805|Vitamins|vitamins|mesh-list
5618263|NCT04198805|Vitamin E|vitamin e|mesh-list
5618264|NCT04198805|Tocopherols|tocopherols|mesh-list
5618265|NCT04198805|Tocotrienols|tocotrienols|mesh-list
5618266|NCT04198805|alpha-Tocopherol|alpha-tocopherol|mesh-list
5738858|NCT03113344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5738859|NCT03113344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5738860|NCT03113344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5738861|NCT03113344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5738862|NCT03113344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5738863|NCT03113344|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5738864|NCT03113123|Tenofovir|tenofovir|mesh-list
5738865|NCT03113123|Emtricitabine|emtricitabine|mesh-list
5738866|NCT03113123|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5738867|NCT03113123|Antiviral Agents|antiviral agents|mesh-ancestor
5738868|NCT03113123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5738869|NCT03113123|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5738870|NCT03113123|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5738871|NCT03113123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5738872|NCT03113123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5738873|NCT03113123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5738874|NCT03113123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5738875|NCT03113084|Heparin|heparin|mesh-list
5738876|NCT03113084|Calcium heparin|calcium heparin|mesh-list
5738877|NCT03113084|Anticoagulants|anticoagulants|mesh-ancestor
5738878|NCT03113084|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5738879|NCT03113084|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5738880|NCT03113084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5738881|NCT03113266|Antibodies|antibodies|mesh-list
5738882|NCT03113266|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5738883|NCT03113266|Immunologic Factors|immunologic factors|mesh-ancestor
5738884|NCT03113266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893384|NCT05093205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5893385|NCT05093205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5893386|NCT05093205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893387|NCT05093205|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6208615|NCT02132949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5618267|NCT04198805|Micronutrients|micronutrients|mesh-ancestor
5893388|NCT05093205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5893389|NCT05093205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5893390|NCT05093205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5738885|NCT03113019|Vaccines|vaccines|mesh-list
5738886|NCT03113019|Immunologic Factors|immunologic factors|mesh-ancestor
5738887|NCT03113019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738888|NCT03113110|Empagliflozin|empagliflozin|mesh-list
5738889|NCT03113110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5738890|NCT03113110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5738891|NCT03113110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5738892|NCT03113110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738893|NCT03113162|Cytarabine|cytarabine|mesh-list
5738894|NCT03113162|Etoposide|etoposide|mesh-list
5738895|NCT03113162|Melphalan|melphalan|mesh-list
5738896|NCT03113162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5738897|NCT03113162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5738898|NCT03113162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5738899|NCT03113162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5738900|NCT03113162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5738901|NCT03113162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5738902|NCT03113162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5738903|NCT03113162|Antimetabolites|antimetabolites|mesh-ancestor
5738904|NCT03113162|Antiviral Agents|antiviral agents|mesh-ancestor
5738905|NCT03113162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5738906|NCT03113162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5738907|NCT03113162|Immunologic Factors|immunologic factors|mesh-ancestor
5738908|NCT03113162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738909|NCT03113162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5738910|NCT03113162|Alkylating Agents|alkylating agents|mesh-ancestor
5738911|NCT03113162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5738912|NCT03112889|Valproic Acid|valproic acid|mesh-list
5738913|NCT03112889|Anticonvulsants|anticonvulsants|mesh-ancestor
5738914|NCT03112889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5738915|NCT03112889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5738916|NCT03112889|GABA Agents|gaba agents|mesh-ancestor
5738917|NCT03112889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5738918|NCT03112889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618268|NCT04198805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618269|NCT04198805|Antioxidants|antioxidants|mesh-ancestor
5618270|NCT04198805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618271|NCT04198805|Protective Agents|protective agents|mesh-ancestor
5618272|NCT04183868|Empagliflozin|empagliflozin|mesh-list
5618273|NCT04183868|Glimepiride|glimepiride|mesh-list
5618274|NCT04183868|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5618275|NCT04183868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618276|NCT04183868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5618277|NCT04183868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618278|NCT04183868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5618279|NCT04183868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5738919|NCT03112889|Antimanic Agents|antimanic agents|mesh-ancestor
5738920|NCT03112889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5738921|NCT03112889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5738922|NCT03112889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5738923|NCT03112707|Aspirin|aspirin|mesh-list
5738924|NCT03112707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5738925|NCT03112707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5738926|NCT03112707|Analgesics|analgesics|mesh-ancestor
5738927|NCT03112707|Sensory System Agents|sensory system agents|mesh-ancestor
5738928|NCT03112707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5738929|NCT03112707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738930|NCT03112707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5738931|NCT03112707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5738932|NCT03112707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5738933|NCT03112707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5738934|NCT03112707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618280|NCT04183868|Immunologic Factors|immunologic factors|mesh-ancestor
5618281|NCT04161755|Atezolizumab|atezolizumab|mesh-list
5738935|NCT03112707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5738936|NCT03112707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5738937|NCT03112707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5738938|NCT03112707|Antipyretics|antipyretics|mesh-ancestor
5738939|NCT03112642|Anesthetics|anesthetics|mesh-list
5738940|NCT03112642|Bupivacaine|bupivacaine|mesh-list
5738941|NCT03112642|Anesthetics, Local|anesthetics, local|mesh-list
5738942|NCT03112642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5738943|NCT03112642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738944|NCT03112642|Sensory System Agents|sensory system agents|mesh-ancestor
5893391|NCT05093205|Anesthetics, General|anesthetics, general|mesh-ancestor
5738945|NCT03112642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5738946|NCT03112577|Fluticasone|fluticasone|mesh-list
5738947|NCT03112577|Xhance|xhance|mesh-list
5738948|NCT03112577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5738949|NCT03112577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5738950|NCT03112577|Autonomic Agents|autonomic agents|mesh-ancestor
5738951|NCT03112577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5738952|NCT03112577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738953|NCT03112577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5738954|NCT03112577|Respiratory System Agents|respiratory system agents|mesh-ancestor
5738955|NCT03112577|Dermatologic Agents|dermatologic agents|mesh-ancestor
5738956|NCT03112577|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5738957|NCT03112538|Insulin|insulin|mesh-list
5738958|NCT03112538|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5738959|NCT03112538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5738960|NCT03112538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738961|NCT03112785|Cimetidine|cimetidine|mesh-list
5738962|NCT03112785|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5738963|NCT03112785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5618282|NCT04161755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5618283|NCT04154189|Etoposide|etoposide|mesh-list
5618284|NCT04154189|Ifosfamide|ifosfamide|mesh-list
5618285|NCT04154189|Lenvatinib|lenvatinib|mesh-list
5618286|NCT04154189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5618287|NCT04154189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5618288|NCT04154189|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5618289|NCT04154189|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5618290|NCT04154189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5618291|NCT04154189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618292|NCT04154189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5618293|NCT04154189|Alkylating Agents|alkylating agents|mesh-ancestor
5618294|NCT04154189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5618295|NCT04143061|Vaccines|vaccines|mesh-list
5618296|NCT04143061|Immunologic Factors|immunologic factors|mesh-ancestor
5618297|NCT04143061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618298|NCT04137107|Oxaliplatin|oxaliplatin|mesh-list
5618299|NCT04137107|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5618300|NCT04137107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5618301|NCT04137107|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5618302|NCT04137107|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5738964|NCT03112785|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5738965|NCT03112785|Histamine Antagonists|histamine antagonists|mesh-ancestor
5738966|NCT03112785|Histamine Agents|histamine agents|mesh-ancestor
5738967|NCT03112785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5738968|NCT03112785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5738969|NCT03112785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738970|NCT03112785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5738971|NCT03112785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5738972|NCT03112785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5738973|NCT03112551|Magnesium Sulfate|magnesium sulfate|mesh-list
5738974|NCT03112551|Analgesics|analgesics|mesh-ancestor
5738975|NCT03112551|Sensory System Agents|sensory system agents|mesh-ancestor
5738976|NCT03112551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5738977|NCT03112551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5738978|NCT03112551|Anesthetics|anesthetics|mesh-ancestor
5738979|NCT03112551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5738980|NCT03112551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5738981|NCT03112551|Anticonvulsants|anticonvulsants|mesh-ancestor
5738982|NCT03112551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5738983|NCT03112551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5738984|NCT03112551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5738985|NCT03112551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5738986|NCT03112551|Tocolytic Agents|tocolytic agents|mesh-ancestor
5738987|NCT03112551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5738988|NCT03112564|Fentanyl|fentanyl|mesh-list
5738989|NCT03112564|Sevoflurane|sevoflurane|mesh-list
5738990|NCT03112564|Rocuronium|rocuronium|mesh-list
5738991|NCT03112564|Cisatracurium|cisatracurium|mesh-list
5738992|NCT03112564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5738993|NCT03112564|Narcotics|narcotics|mesh-ancestor
5618303|NCT04137107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5618304|NCT04137107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5738994|NCT03112564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5618305|NCT04137107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5738995|NCT03112564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618306|NCT04137107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618307|NCT04137107|Analgesics|analgesics|mesh-ancestor
5618308|NCT04137107|Sensory System Agents|sensory system agents|mesh-ancestor
5618309|NCT04137107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5618310|NCT04137107|Antidepressive Agents|antidepressive agents|mesh-ancestor
5618311|NCT04137107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5618312|NCT04137107|Dopamine Agents|dopamine agents|mesh-ancestor
5618313|NCT04126733|Nivolumab|nivolumab|mesh-list
5618314|NCT04126733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5618315|NCT04126733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5618316|NCT04126733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5618317|NCT04126733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618318|NCT04118387|Acetazolamide|acetazolamide|mesh-list
5618319|NCT04118387|Zolpidem|zolpidem|mesh-list
5618320|NCT04118387|Buspirone|buspirone|mesh-list
5738996|NCT03112564|Analgesics|analgesics|mesh-ancestor
5738997|NCT03112564|Sensory System Agents|sensory system agents|mesh-ancestor
5618321|NCT04118387|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5618322|NCT04118387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5618323|NCT04118387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5738998|NCT03112564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5738999|NCT03112564|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5739000|NCT03112564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5739001|NCT03112564|Anesthetics, General|anesthetics, general|mesh-ancestor
5739002|NCT03112564|Anesthetics|anesthetics|mesh-ancestor
5739003|NCT03112564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5618324|NCT04118387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618325|NCT04118387|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
5618326|NCT04118387|GABA Agonists|gaba agonists|mesh-ancestor
5618327|NCT04118387|GABA Agents|gaba agents|mesh-ancestor
5618328|NCT04118387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5739004|NCT03112564|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5739005|NCT03112564|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5739006|NCT03112564|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5739007|NCT03112564|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5739008|NCT03112655|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
5739009|NCT03112655|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5739010|NCT03112655|Antidepressive Agents|antidepressive agents|mesh-ancestor
5739011|NCT03112655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5739012|NCT03112148|Tofacitinib|tofacitinib|mesh-list
5739013|NCT03112148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5739014|NCT03112148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5739015|NCT03112148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739016|NCT03112434|Botulinum Toxins|botulinum toxins|mesh-list
5739017|NCT03112434|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5739018|NCT03112434|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5739019|NCT03112434|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5739020|NCT03112434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5739021|NCT03112434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739022|NCT03112434|Cholinergic Agents|cholinergic agents|mesh-ancestor
5739023|NCT03112434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5739024|NCT03112434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618329|NCT04118387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618330|NCT04118387|Anticonvulsants|anticonvulsants|mesh-ancestor
5618331|NCT04118387|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5618332|NCT04118387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5618333|NCT04118387|Diuretics|diuretics|mesh-ancestor
5618334|NCT04118387|Natriuretic Agents|natriuretic agents|mesh-ancestor
5618335|NCT04118387|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5618336|NCT04118387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5618337|NCT04118387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5618338|NCT04118387|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5618339|NCT04118387|Serotonin Agents|serotonin agents|mesh-ancestor
5618340|NCT04093362|Gemcitabine|gemcitabine|mesh-list
5739025|NCT03112434|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5618341|NCT04093362|Futibatinib|futibatinib|mesh-list
5618342|NCT04093362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5618343|NCT04093362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5618344|NCT04093362|Antimetabolites|antimetabolites|mesh-ancestor
5618345|NCT04093362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618346|NCT04093362|Antiviral Agents|antiviral agents|mesh-ancestor
5618347|NCT04093362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5618348|NCT04093362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5618349|NCT04093362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5618350|NCT04093362|Immunologic Factors|immunologic factors|mesh-ancestor
5618351|NCT04093362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618352|NCT04089514|Adalimumab|adalimumab|mesh-list
5618353|NCT04089514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5618354|NCT04089514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5618355|NCT04073433|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
5618356|NCT04073433|Hallucinogens|hallucinogens|mesh-ancestor
5618357|NCT04073433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618358|NCT04073433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5618359|NCT04073433|Serotonin Agents|serotonin agents|mesh-ancestor
5618360|NCT04073433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5618361|NCT04073433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618362|NCT04073433|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5618363|NCT04073433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5618364|NCT04073433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5618365|NCT04073433|Adrenergic Agents|adrenergic agents|mesh-ancestor
5618366|NCT04050436|Cemiplimab|cemiplimab|mesh-list
5618367|NCT04050436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5618368|NCT04050436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5618388|NCT04027348|Dexamethasone|dexamethasone|mesh-list
5618389|NCT04027348|Octreotide|octreotide|mesh-list
5618390|NCT04027348|Metoclopramide|metoclopramide|mesh-list
5618391|NCT04027348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5618392|NCT04027348|Antiemetics|antiemetics|mesh-ancestor
5618393|NCT04027348|Autonomic Agents|autonomic agents|mesh-ancestor
5618394|NCT04027348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5618395|NCT04027348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739026|NCT03112434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5739027|NCT03112187|Iron|iron|mesh-list
5739028|NCT03112187|Trace Elements|trace elements|mesh-ancestor
5739029|NCT03112187|Micronutrients|micronutrients|mesh-ancestor
5739030|NCT03112187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739031|NCT03112135|Epinephrine|epinephrine|mesh-list
5739032|NCT03112135|Tranexamic Acid|tranexamic acid|mesh-list
5739033|NCT03112135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5739034|NCT03112135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5739035|NCT03112135|Adrenergic Agents|adrenergic agents|mesh-ancestor
5739036|NCT03112135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5739037|NCT03112135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739038|NCT03112135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739039|NCT03112135|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5739040|NCT03112135|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5739041|NCT03112135|Autonomic Agents|autonomic agents|mesh-ancestor
5739042|NCT03112135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5618396|NCT04027348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5618397|NCT04027348|Glucocorticoids|glucocorticoids|mesh-ancestor
5618398|NCT04027348|Hormones|hormones|mesh-ancestor
5618399|NCT04027348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5618400|NCT04027348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5618401|NCT04027348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5618402|NCT04027348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5618403|NCT04027348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5618404|NCT04027348|Dopamine Agents|dopamine agents|mesh-ancestor
5618405|NCT04027348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5618406|NCT04027348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739043|NCT03112135|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5739044|NCT03112135|Respiratory System Agents|respiratory system agents|mesh-ancestor
5739045|NCT03112135|Mydriatics|mydriatics|mesh-ancestor
5739046|NCT03112135|Sympathomimetics|sympathomimetics|mesh-ancestor
5739047|NCT03112135|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5739048|NCT03112135|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5739049|NCT03112135|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5739050|NCT03112135|Hemostatics|hemostatics|mesh-ancestor
5618407|NCT03998839|Pyrimethamine|pyrimethamine|mesh-list
5618408|NCT03998839|Sulfadoxine|sulfadoxine|mesh-list
5618409|NCT03998839|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
5618410|NCT03998839|Antimalarials|antimalarials|mesh-ancestor
5618411|NCT03998839|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5618412|NCT03998839|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5618413|NCT03998839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5618414|NCT03998839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5618415|NCT03998839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5618416|NCT03998839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618417|NCT03998839|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5618418|NCT03998839|Renal Agents|renal agents|mesh-ancestor
5618419|NCT03941509|Anti-Infective Agents|anti-infective agents|mesh-list
5618420|NCT03941509|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5618421|NCT03915496|Abrocitinib|abrocitinib|mesh-list
5618422|NCT03915496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5618423|NCT03915496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5618424|NCT03915496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618425|NCT03906539|Atorvastatin|atorvastatin|mesh-list
5618426|NCT03906539|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5618427|NCT03906539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5618428|NCT03906539|Antimetabolites|antimetabolites|mesh-ancestor
5618429|NCT03906539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618430|NCT03906539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5618431|NCT03906539|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5618432|NCT03906539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5618433|NCT03875235|Durvalumab|durvalumab|mesh-list
5618434|NCT03875235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5618435|NCT03875235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5692378|NCT03408756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5692379|NCT03408756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5692380|NCT03408756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5692381|NCT03408756|Immunologic Factors|immunologic factors|mesh-ancestor
5692382|NCT03408756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5692383|NCT03408756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5692384|NCT03408587|Ipilimumab|ipilimumab|mesh-list
5692385|NCT03408587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5692386|NCT03408587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5692387|NCT03408587|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5692388|NCT03408587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692389|NCT03408457|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5692390|NCT03408457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5692391|NCT03408405|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
5692392|NCT03408405|Hormones|hormones|mesh-ancestor
5739051|NCT03112135|Coagulants|coagulants|mesh-ancestor
5739052|NCT03112278|Salicylic Acid|salicylic acid|mesh-list
5739053|NCT03112278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5692393|NCT03408405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5739054|NCT03112278|Antifungal Agents|antifungal agents|mesh-ancestor
5739055|NCT03112278|Keratolytic Agents|keratolytic agents|mesh-ancestor
5739056|NCT03112278|Dermatologic Agents|dermatologic agents|mesh-ancestor
5739057|NCT03112382|Vitamins|vitamins|mesh-list
5739058|NCT03112382|Vitamin A|vitamin a|mesh-list
5739059|NCT03112382|Retinol palmitate|retinol palmitate|mesh-list
5739060|NCT03112382|Micronutrients|micronutrients|mesh-ancestor
5739061|NCT03112382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739062|NCT03112382|Antioxidants|antioxidants|mesh-ancestor
5739063|NCT03112382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739064|NCT03112382|Protective Agents|protective agents|mesh-ancestor
5739065|NCT03112382|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5739066|NCT03112382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5739067|NCT03112226|Estradiol|estradiol|mesh-list
5739068|NCT03112226|LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|lhrh, n-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|mesh-list
5739069|NCT03112226|Estrogens|estrogens|mesh-ancestor
5739070|NCT03112226|Hormones|hormones|mesh-ancestor
5739071|NCT03112226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5739072|NCT03112226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739073|NCT03112226|Hormone Antagonists|hormone antagonists|mesh-ancestor
5739074|NCT03112005|Mydriatics|mydriatics|mesh-list
5618436|NCT03845114|Insulin|insulin|mesh-list
5618437|NCT03845114|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5618438|NCT03845114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5618439|NCT03845114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618440|NCT03798691|Vaccines|vaccines|mesh-list
5618441|NCT03798691|Immunologic Factors|immunologic factors|mesh-ancestor
5618442|NCT03798691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618443|NCT03789318|Acetaminophen|acetaminophen|mesh-list
5618444|NCT03789318|Fentanyl|fentanyl|mesh-list
5618445|NCT03789318|Oxycodone|oxycodone|mesh-list
5618446|NCT03789318|Hydromorphone|hydromorphone|mesh-list
5618447|NCT03789318|Bupivacaine|bupivacaine|mesh-list
5739075|NCT03112005|Autonomic Agents|autonomic agents|mesh-ancestor
5739076|NCT03112005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5739077|NCT03112005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739078|NCT03111966|Grazoprevir|grazoprevir|mesh-list
5739079|NCT03111966|Antiviral Agents|antiviral agents|mesh-ancestor
5739080|NCT03111966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5739081|NCT03112031|Tamoxifen|tamoxifen|mesh-list
5739082|NCT03112031|Fluconazole|fluconazole|mesh-list
5739083|NCT03112031|Amphotericin B|amphotericin b|mesh-list
5618448|NCT03789318|Anesthetics, Local|anesthetics, local|mesh-ancestor
5618449|NCT03789318|Anesthetics|anesthetics|mesh-ancestor
5618450|NCT03789318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5618451|NCT03789318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618452|NCT03789318|Sensory System Agents|sensory system agents|mesh-ancestor
5618453|NCT03789318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5618454|NCT03789318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5618455|NCT03789318|Narcotics|narcotics|mesh-ancestor
5739084|NCT03112031|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
5739085|NCT03112031|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5739086|NCT03112031|Hormone Antagonists|hormone antagonists|mesh-ancestor
5739087|NCT03112031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5739088|NCT03112031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739089|NCT03112031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5739090|NCT03112031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5739091|NCT03112031|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5739092|NCT03112031|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5739093|NCT03112031|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5739094|NCT03112031|Antifungal Agents|antifungal agents|mesh-ancestor
5739095|NCT03112031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5739096|NCT03112031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5618456|NCT03789318|Analgesics|analgesics|mesh-ancestor
5618457|NCT03789318|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5618458|NCT03789318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5618459|NCT03789318|Anesthetics, General|anesthetics, general|mesh-ancestor
5618460|NCT03789318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5618461|NCT03789318|Antipyretics|antipyretics|mesh-ancestor
5618462|NCT03781414|Tacrolimus|tacrolimus|mesh-list
5618463|NCT03781414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5618464|NCT03781414|Immunologic Factors|immunologic factors|mesh-ancestor
5739097|NCT03112031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5739098|NCT03112031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5739099|NCT03112031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739100|NCT03112031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5739101|NCT03112031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5739102|NCT03112031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5739103|NCT03112031|Amebicides|amebicides|mesh-ancestor
5739104|NCT03112031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5739105|NCT03112031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5739106|NCT03112031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5739107|NCT03111901|Pembrolizumab|pembrolizumab|mesh-list
5739108|NCT03111901|Interleukin-2|interleukin-2|mesh-list
5739109|NCT03111901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5618465|NCT03781414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618466|NCT03781414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5618467|NCT03781414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5739110|NCT03111901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5739111|NCT03111901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5739112|NCT03111901|Analgesics|analgesics|mesh-ancestor
5739113|NCT03111901|Sensory System Agents|sensory system agents|mesh-ancestor
5739114|NCT03111901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5739115|NCT03111901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739116|NCT03111797|Morphine|morphine|mesh-list
5739117|NCT03111797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5739118|NCT03111797|Narcotics|narcotics|mesh-ancestor
5739119|NCT03111797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5739120|NCT03111797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739121|NCT03111797|Analgesics|analgesics|mesh-ancestor
5739122|NCT03111797|Sensory System Agents|sensory system agents|mesh-ancestor
5739123|NCT03111797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5739124|NCT03112044|Sofosbuvir|sofosbuvir|mesh-list
5739125|NCT03112044|Velpatasvir|velpatasvir|mesh-list
5739126|NCT03112044|Antiviral Agents|antiviral agents|mesh-ancestor
5739127|NCT03112044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5739128|NCT03111810|Prednisolone|prednisolone|mesh-list
5739129|NCT03111810|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5618468|NCT03781414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618469|NCT03774875|Apremilast|apremilast|mesh-list
5618470|NCT03774875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5618471|NCT03774875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5618472|NCT03774875|Analgesics|analgesics|mesh-ancestor
5618473|NCT03774875|Sensory System Agents|sensory system agents|mesh-ancestor
5618474|NCT03774875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5618475|NCT03774875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618476|NCT03774875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5618477|NCT03774875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5618478|NCT03774875|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5618479|NCT03774875|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5618480|NCT03774875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5618481|NCT03774875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618482|NCT03767348|Nivolumab|nivolumab|mesh-list
5618483|NCT03767348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5618484|NCT03767348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5618485|NCT03767348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5618486|NCT03767348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618487|NCT03724942|Brexpiprazole|brexpiprazole|mesh-list
5618488|NCT03724942|Serotonin Agents|serotonin agents|mesh-ancestor
5618489|NCT03724942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5618490|NCT03724942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618491|NCT03724942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618492|NCT03724942|Dopamine Agonists|dopamine agonists|mesh-ancestor
5618493|NCT03724942|Dopamine Agents|dopamine agents|mesh-ancestor
5618494|NCT03705169|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
5618495|NCT03705169|Antiviral Agents|antiviral agents|mesh-ancestor
5618496|NCT03705169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5739130|NCT03111810|Methylprednisolone|methylprednisolone|mesh-list
5739131|NCT03111810|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5739132|NCT03111810|Prednisolone acetate|prednisolone acetate|mesh-list
5739133|NCT03111810|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5739134|NCT03111810|Prednisolone phosphate|prednisolone phosphate|mesh-list
5739135|NCT03111810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5739136|NCT03111810|Glucocorticoids|glucocorticoids|mesh-ancestor
5739137|NCT03111810|Hormones|hormones|mesh-ancestor
5739138|NCT03111810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5739139|NCT03111810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739140|NCT03111810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5739141|NCT03111810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5739142|NCT03111810|Antiemetics|antiemetics|mesh-ancestor
5739143|NCT03111810|Autonomic Agents|autonomic agents|mesh-ancestor
5739144|NCT03111810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5739145|NCT03111810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5739146|NCT03111810|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5739147|NCT03111810|Protective Agents|protective agents|mesh-ancestor
5739148|NCT03111537|Nicotine|nicotine|mesh-list
5739149|NCT03111537|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5739150|NCT03111537|Autonomic Agents|autonomic agents|mesh-ancestor
5739151|NCT03111537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5739152|NCT03111537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739153|NCT03111537|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5739154|NCT03111537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5739155|NCT03111537|Cholinergic Agents|cholinergic agents|mesh-ancestor
5618497|NCT03663335|Tacrolimus|tacrolimus|mesh-list
5618498|NCT03663335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5618499|NCT03663335|Immunologic Factors|immunologic factors|mesh-ancestor
5618500|NCT03663335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618501|NCT03663335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5618502|NCT03663335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5618503|NCT03663335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208616|NCT02132949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6208617|NCT02132949|Tubulin Modulators|tubulin modulators|mesh-ancestor
6208618|NCT02132949|Antimitotic Agents|antimitotic agents|mesh-ancestor
6208619|NCT02132949|Mitosis Modulators|mitosis modulators|mesh-ancestor
6208620|NCT02132949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208621|NCT02132949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5739156|NCT03111537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5739157|NCT03111537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739158|NCT03111511|Drospirenone|drospirenone|mesh-list
5618510|NCT03646461|Nivolumab|nivolumab|mesh-list
5618511|NCT03646461|Cetuximab|cetuximab|mesh-list
5618512|NCT03646461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5618513|NCT03646461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5618514|NCT03646461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5618515|NCT03646461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618516|NCT03632720|Vaccines|vaccines|mesh-list
5618517|NCT03632720|Immunologic Factors|immunologic factors|mesh-ancestor
5618518|NCT03632720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618519|NCT03631004|Olanzapine|olanzapine|mesh-list
5618520|NCT03631004|Antiemetics|antiemetics|mesh-ancestor
5739159|NCT03111511|Midazolam|midazolam|mesh-list
5739160|NCT03111511|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5739161|NCT03111511|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
5739162|NCT03111511|Betadex|betadex|mesh-list
5739163|NCT03111511|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5739164|NCT03111511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5739165|NCT03111511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5739166|NCT03111511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739167|NCT03111511|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5739168|NCT03111511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5739169|NCT03111511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5739170|NCT03111511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5739171|NCT03111511|Anesthetics, General|anesthetics, general|mesh-ancestor
5739172|NCT03111511|Anesthetics|anesthetics|mesh-ancestor
5739173|NCT03111511|GABA Modulators|gaba modulators|mesh-ancestor
5739174|NCT03111511|GABA Agents|gaba agents|mesh-ancestor
5739175|NCT03111511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5739176|NCT03111511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739177|NCT03111511|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5739178|NCT03111511|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5739179|NCT03111511|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5739180|NCT03111511|Contraceptive Agents|contraceptive agents|mesh-ancestor
5739181|NCT03111511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5739182|NCT03111511|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5618521|NCT03631004|Autonomic Agents|autonomic agents|mesh-ancestor
5618522|NCT03631004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5618523|NCT03631004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618524|NCT03631004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5618525|NCT03631004|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5739183|NCT03111511|Estrogens|estrogens|mesh-ancestor
5739184|NCT03111511|Hormones|hormones|mesh-ancestor
5739185|NCT03111511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5739186|NCT03111511|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5739187|NCT03111511|Hormone Antagonists|hormone antagonists|mesh-ancestor
5739188|NCT03111511|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5739189|NCT03111511|Diuretics|diuretics|mesh-ancestor
5739190|NCT03111511|Natriuretic Agents|natriuretic agents|mesh-ancestor
5739191|NCT03111511|Sequestering Agents|sequestering agents|mesh-ancestor
5893392|NCT05093205|Anesthetics|anesthetics|mesh-ancestor
5893393|NCT05093205|GABA Modulators|gaba modulators|mesh-ancestor
6489331|NCT00590837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489332|NCT00590837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6489333|NCT00590915|Asparaginase|asparaginase|mesh-list
6489334|NCT00590915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6489335|NCT00590928|Esomeprazole|esomeprazole|mesh-list
6489336|NCT00590928|Ranitidine|ranitidine|mesh-list
5618526|NCT03631004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5618527|NCT03631004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5893394|NCT05093205|GABA Agents|gaba agents|mesh-ancestor
6489337|NCT00590928|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
6489338|NCT00590928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6489339|NCT00590928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5739192|NCT03111485|Levodopa|levodopa|mesh-list
5739193|NCT03111485|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
5739194|NCT03111485|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5739195|NCT03111485|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5739196|NCT03111485|Dopamine Agents|dopamine agents|mesh-ancestor
5739197|NCT03111485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5739198|NCT03111485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739199|NCT03111485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739200|NCT03111485|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5739201|NCT03111485|Immunologic Factors|immunologic factors|mesh-ancestor
5739202|NCT03111485|Dopamine Agonists|dopamine agonists|mesh-ancestor
5739203|NCT03111342|Lidocaine|lidocaine|mesh-list
5739204|NCT03111342|Anesthetics, Local|anesthetics, local|mesh-ancestor
5739205|NCT03111342|Anesthetics|anesthetics|mesh-ancestor
5739206|NCT03111342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5739207|NCT03111342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739208|NCT03111342|Sensory System Agents|sensory system agents|mesh-ancestor
5739209|NCT03111342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5739210|NCT03111342|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5739211|NCT03111342|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5739212|NCT03111342|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5739213|NCT03111342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5739214|NCT03111342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739215|NCT03111420|Clopidogrel|clopidogrel|mesh-list
5739216|NCT03111420|Ticagrelor|ticagrelor|mesh-list
5739217|NCT03111420|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
5618528|NCT03631004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5618529|NCT03631004|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5618530|NCT03631004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5618531|NCT03631004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5618532|NCT03631004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618533|NCT03631004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5618534|NCT03631004|Serotonin Agents|serotonin agents|mesh-ancestor
6208622|NCT02132949|Immunologic Factors|immunologic factors|mesh-ancestor
6208623|NCT02132949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208624|NCT02132949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5618538|NCT03615664|Gemcitabine|gemcitabine|mesh-list
5618539|NCT03615664|Dexamethasone|dexamethasone|mesh-list
5618540|NCT03615664|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5618541|NCT03615664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5618542|NCT03615664|Antiemetics|antiemetics|mesh-ancestor
5618543|NCT03615664|Autonomic Agents|autonomic agents|mesh-ancestor
5739218|NCT03111420|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5739219|NCT03111420|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5739220|NCT03111420|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5739221|NCT03111420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5739222|NCT03111420|Purinergic Agents|purinergic agents|mesh-ancestor
5618544|NCT03615664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5618545|NCT03615664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618546|NCT03615664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5618547|NCT03615664|Glucocorticoids|glucocorticoids|mesh-ancestor
5618548|NCT03615664|Hormones|hormones|mesh-ancestor
5618549|NCT03615664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5618550|NCT03615664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5618551|NCT03615664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5618552|NCT03615664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5618553|NCT03615664|Antimetabolites|antimetabolites|mesh-ancestor
5618554|NCT03615664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618555|NCT03615664|Antiviral Agents|antiviral agents|mesh-ancestor
5618556|NCT03615664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5618557|NCT03615664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5618558|NCT03615664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5618559|NCT03615664|Immunologic Factors|immunologic factors|mesh-ancestor
5618560|NCT03615664|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5618561|NCT03615664|Alkylating Agents|alkylating agents|mesh-ancestor
5618562|NCT03556345|Trastuzumab|trastuzumab|mesh-list
5618563|NCT03556345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5618564|NCT03556345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5618565|NCT03522584|Durvalumab|durvalumab|mesh-list
5618566|NCT03522584|Ipilimumab|ipilimumab|mesh-list
5618567|NCT03522584|Tremelimumab|tremelimumab|mesh-list
5618568|NCT03522584|Immunoglobulins|immunoglobulins|mesh-list
5739223|NCT03111420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5739224|NCT03111420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739225|NCT03111420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739226|NCT03111433|Ubiquinone|ubiquinone|mesh-list
5739227|NCT03111433|Coenzyme Q10|coenzyme q10|mesh-list
5739228|NCT03111433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739229|NCT03111433|Micronutrients|micronutrients|mesh-ancestor
5739230|NCT03111433|Vitamins|vitamins|mesh-ancestor
5739231|NCT03111615|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5739232|NCT03111615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5739233|NCT03111615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5739234|NCT03111615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739235|NCT03111615|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5739236|NCT03111615|Hormone Antagonists|hormone antagonists|mesh-ancestor
5739237|NCT03111615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5739238|NCT03111615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739239|NCT03111446|Anesthetics|anesthetics|mesh-list
5739240|NCT03111446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5739241|NCT03111446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618569|NCT03522584|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5618570|NCT03522584|Immunoglobulin G|immunoglobulin g|mesh-list
5618571|NCT03522584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5618572|NCT03522584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5618573|NCT03522584|Immunologic Factors|immunologic factors|mesh-ancestor
5618574|NCT03522584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618575|NCT03522584|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5739242|NCT03111186|Acetaminophen|acetaminophen|mesh-list
5739243|NCT03111186|Ibuprofen|ibuprofen|mesh-list
5739244|NCT03111186|Oxycodone|oxycodone|mesh-list
5739245|NCT03111186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5739246|NCT03111186|Analgesics|analgesics|mesh-ancestor
5739247|NCT03111186|Sensory System Agents|sensory system agents|mesh-ancestor
5739248|NCT03111186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5739249|NCT03111186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618576|NCT03522584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618577|NCT03513250|Scopolamine|scopolamine|mesh-list
5618578|NCT03513250|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
5618579|NCT03513250|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5618580|NCT03513250|Antiemetics|antiemetics|mesh-ancestor
5618581|NCT03513250|Autonomic Agents|autonomic agents|mesh-ancestor
5618582|NCT03513250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5618583|NCT03513250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618584|NCT03513250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5618585|NCT03513250|Mydriatics|mydriatics|mesh-ancestor
5739250|NCT03111186|Antipyretics|antipyretics|mesh-ancestor
5739251|NCT03111186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5739252|NCT03111186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5739253|NCT03111186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5739254|NCT03111186|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5739255|NCT03111186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5739256|NCT03111186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739257|NCT03111186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5739258|NCT03111186|Narcotics|narcotics|mesh-ancestor
5618586|NCT03513250|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5618587|NCT03513250|Cholinergic Agents|cholinergic agents|mesh-ancestor
5618588|NCT03513250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5618589|NCT03513250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618590|NCT03513250|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5618591|NCT03513250|Parasympatholytics|parasympatholytics|mesh-ancestor
5618592|NCT03455270|Palbociclib|palbociclib|mesh-list
5618593|NCT03455270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5618594|NCT03455270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5618595|NCT03455270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5618596|NCT03455270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618597|NCT03436563|Atezolizumab|atezolizumab|mesh-list
5618598|NCT03436563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5618599|NCT03406156|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5618600|NCT03406156|Venetoclax|venetoclax|mesh-list
5618601|NCT03406156|Obinutuzumab|obinutuzumab|mesh-list
5618602|NCT03406156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5618603|NCT03406156|Alkylating Agents|alkylating agents|mesh-ancestor
5618604|NCT03406156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618605|NCT03406156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5739259|NCT03111186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5739260|NCT03111121|Glycopyrrolate|glycopyrrolate|mesh-list
5739261|NCT03111121|Neostigmine|neostigmine|mesh-list
5739262|NCT03111121|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5739263|NCT03111121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5739264|NCT03111121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739265|NCT03111121|Cholinergic Agents|cholinergic agents|mesh-ancestor
5739266|NCT03111121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5739267|NCT03111121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739268|NCT03111121|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5739269|NCT03111121|Autonomic Agents|autonomic agents|mesh-ancestor
5739270|NCT03111121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5739271|NCT03111121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5739272|NCT03111121|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5739273|NCT03111121|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5739274|NCT03110952|Vaccines|vaccines|mesh-list
5739275|NCT03110952|Immunologic Factors|immunologic factors|mesh-ancestor
5739276|NCT03110952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739277|NCT03110822|Methylprednisolone|methylprednisolone|mesh-list
5739278|NCT03110822|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5739279|NCT03110822|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5739280|NCT03110822|Prednisolone|prednisolone|mesh-list
5739281|NCT03110822|Prednisolone acetate|prednisolone acetate|mesh-list
5618606|NCT03406156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5618607|NCT03368963|Trifluridine|trifluridine|mesh-list
5618608|NCT03368963|Irinotecan|irinotecan|mesh-list
5618609|NCT03368963|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5618610|NCT03368963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5618611|NCT03368963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5618612|NCT03368963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618613|NCT03368963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5618614|NCT03368963|Antimetabolites|antimetabolites|mesh-ancestor
5618615|NCT03368963|Antiviral Agents|antiviral agents|mesh-ancestor
5739282|NCT03110822|Lenalidomide|lenalidomide|mesh-list
5739283|NCT03110822|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5739284|NCT03110822|Prednisolone phosphate|prednisolone phosphate|mesh-list
5739285|NCT03110822|Immunologic Factors|immunologic factors|mesh-ancestor
5739286|NCT03110822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739287|NCT03110822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5739288|NCT03110822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5739289|NCT03110822|Growth Substances|growth substances|mesh-ancestor
5739290|NCT03110822|Growth Inhibitors|growth inhibitors|mesh-ancestor
5739291|NCT03110822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5739292|NCT03110822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5739293|NCT03110822|Antiemetics|antiemetics|mesh-ancestor
5739294|NCT03110822|Autonomic Agents|autonomic agents|mesh-ancestor
5739295|NCT03110822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5739296|NCT03110822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5739297|NCT03110822|Glucocorticoids|glucocorticoids|mesh-ancestor
5739298|NCT03110822|Hormones|hormones|mesh-ancestor
5618616|NCT03368963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5618617|NCT03345823|Upadacitinib|upadacitinib|mesh-list
5618618|NCT03345823|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
5618619|NCT03345823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5618620|NCT03345823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5739299|NCT03110822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5739300|NCT03110822|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5739301|NCT03110822|Protective Agents|protective agents|mesh-ancestor
5739302|NCT03110822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5739303|NCT03111069|Doxorubicin|doxorubicin|mesh-list
5739304|NCT03111069|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5739305|NCT03111069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5739306|NCT03111069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5739307|NCT03111069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5739308|NCT03111069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5739309|NCT03111069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5739310|NCT03111069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739311|NCT03110757|Aluminum Hydroxide|aluminum hydroxide|mesh-list
5739312|NCT03110757|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5739313|NCT03110757|Immunologic Factors|immunologic factors|mesh-ancestor
5739314|NCT03110757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739315|NCT03110757|Antacids|antacids|mesh-ancestor
5618621|NCT03345823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618622|NCT03345823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5739316|NCT03110757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208625|NCT02132949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6208626|NCT02132949|Alkylating Agents|alkylating agents|mesh-ancestor
6208627|NCT02132949|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5618627|NCT03229382|Obinutuzumab|obinutuzumab|mesh-list
5739317|NCT03110757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5739318|NCT03110848|Methylprednisolone|methylprednisolone|mesh-list
5739319|NCT03110848|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5739320|NCT03110848|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5739321|NCT03110848|Prednisolone|prednisolone|mesh-list
5739322|NCT03110848|Prednisolone acetate|prednisolone acetate|mesh-list
5739323|NCT03110848|Atorvastatin|atorvastatin|mesh-list
5739324|NCT03110848|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5739325|NCT03110848|Prednisolone phosphate|prednisolone phosphate|mesh-list
5739326|NCT03110848|Glucocorticoids|glucocorticoids|mesh-list
5739327|NCT03110848|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5739328|NCT03110848|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5739329|NCT03110848|Antimetabolites|antimetabolites|mesh-ancestor
5739330|NCT03110848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739331|NCT03110848|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5739332|NCT03110848|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5739333|NCT03110848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5739334|NCT03110848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5739335|NCT03110848|Antiemetics|antiemetics|mesh-ancestor
5739336|NCT03110848|Autonomic Agents|autonomic agents|mesh-ancestor
5739337|NCT03110848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5739338|NCT03110848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739339|NCT03110848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5739340|NCT03110848|Hormones|hormones|mesh-ancestor
5739341|NCT03110848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5739342|NCT03110848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5739343|NCT03110848|Protective Agents|protective agents|mesh-ancestor
5739344|NCT03110848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5739345|NCT03110848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5739346|NCT03110653|Remifentanil|remifentanil|mesh-list
5739347|NCT03110653|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5618628|NCT03229382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5618629|NCT03229382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5618630|NCT03198351|Teriflunomide|teriflunomide|mesh-list
5618631|NCT03198351|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5618632|NCT03198351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5618633|NCT03198351|Analgesics|analgesics|mesh-ancestor
5618634|NCT03198351|Sensory System Agents|sensory system agents|mesh-ancestor
5618635|NCT03198351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5618636|NCT03198351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618637|NCT03198351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5618638|NCT03198351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5618639|NCT03198351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5618640|NCT03198351|Immunologic Factors|immunologic factors|mesh-ancestor
5618641|NCT03158688|Dexamethasone|dexamethasone|mesh-list
5618642|NCT03158688|Daratumumab|daratumumab|mesh-list
5618643|NCT03158688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5739348|NCT03110653|Narcotics|narcotics|mesh-ancestor
5739349|NCT03110653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5739350|NCT03110653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739351|NCT03110653|Analgesics|analgesics|mesh-ancestor
5739352|NCT03110653|Sensory System Agents|sensory system agents|mesh-ancestor
5739353|NCT03110653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5739354|NCT03110640|Cyclophosphamide|cyclophosphamide|mesh-list
5739355|NCT03110640|Fludarabine|fludarabine|mesh-list
5739356|NCT03110640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5739357|NCT03110640|Immunologic Factors|immunologic factors|mesh-ancestor
5739358|NCT03110640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739359|NCT03110640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5739360|NCT03110640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5739361|NCT03110640|Alkylating Agents|alkylating agents|mesh-ancestor
5739362|NCT03110640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739363|NCT03110640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5739364|NCT03110640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5739365|NCT03110341|Epoetin Alfa|epoetin alfa|mesh-list
5739366|NCT03110341|Hematinics|hematinics|mesh-ancestor
5739367|NCT03110679|Hyaluronic Acid|hyaluronic acid|mesh-list
5739368|NCT03110679|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5739369|NCT03110679|Immunologic Factors|immunologic factors|mesh-ancestor
5739370|NCT03110679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618644|NCT03158688|Antiemetics|antiemetics|mesh-ancestor
5618645|NCT03158688|Autonomic Agents|autonomic agents|mesh-ancestor
5739371|NCT03110679|Viscosupplements|viscosupplements|mesh-ancestor
5739372|NCT03110679|Protective Agents|protective agents|mesh-ancestor
5739373|NCT03110315|Suvorexant|suvorexant|mesh-list
5739374|NCT03110315|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5739375|NCT03110315|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5739376|NCT03110315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5739377|NCT03110315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739378|NCT03110315|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
5739379|NCT03110315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5739380|NCT03110315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739381|NCT03110328|Pembrolizumab|pembrolizumab|mesh-list
5739382|NCT03110328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5739383|NCT03110328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5739384|NCT03110432|Nicotinic Acids|nicotinic acids|mesh-list
5739385|NCT03110432|Niacin|niacin|mesh-list
5739386|NCT03110432|Ezetimibe|ezetimibe|mesh-list
5739387|NCT03110432|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
5739388|NCT03110432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5739389|NCT03110432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5739390|NCT03110432|Antimetabolites|antimetabolites|mesh-ancestor
5739391|NCT03110432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739392|NCT03110432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5618646|NCT03158688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5618647|NCT03158688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618648|NCT03158688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5618649|NCT03158688|Glucocorticoids|glucocorticoids|mesh-ancestor
5618650|NCT03158688|Hormones|hormones|mesh-ancestor
5618651|NCT03158688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5618652|NCT03158688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5618653|NCT03158688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5618654|NCT03152786|Propranolol|propranolol|mesh-list
5618655|NCT03152786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5618656|NCT03152786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5618657|NCT03152786|Adrenergic Agents|adrenergic agents|mesh-ancestor
5618658|NCT03152786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5618659|NCT03152786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618660|NCT03152786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618661|NCT03152786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5618662|NCT03152786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5618663|NCT03152786|Vasodilator Agents|vasodilator agents|mesh-ancestor
6208628|NCT02132949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6208629|NCT02132949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6208630|NCT02132949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6208631|NCT02132949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6208632|NCT02132949|Antimetabolites|antimetabolites|mesh-ancestor
5618669|NCT03130036|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5739393|NCT03110432|Vitamin B Complex|vitamin b complex|mesh-ancestor
5739394|NCT03110432|Vitamins|vitamins|mesh-ancestor
5739395|NCT03110432|Micronutrients|micronutrients|mesh-ancestor
5739396|NCT03110432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739397|NCT03110432|Vasodilator Agents|vasodilator agents|mesh-ancestor
5739398|NCT03110510|Leucovorin|leucovorin|mesh-list
5739399|NCT03110510|Fluorouracil|fluorouracil|mesh-list
5739400|NCT03110510|Irinotecan|irinotecan|mesh-list
5739401|NCT03110510|Calcium|calcium|mesh-list
5739402|NCT03110510|Levoleucovorin|levoleucovorin|mesh-list
5739403|NCT03110510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5739404|NCT03110510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739405|NCT03110510|Antimetabolites|antimetabolites|mesh-ancestor
5739406|NCT03110510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739407|NCT03110510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5618670|NCT03130036|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5618671|NCT03130036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618672|NCT03127215|Olaparib|olaparib|mesh-list
5618673|NCT03127215|Trabectedin|trabectedin|mesh-list
5618674|NCT03127215|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5618675|NCT03127215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5618676|NCT03127215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618677|NCT03127215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5739408|NCT03110510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5739409|NCT03110510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6672849|NCT01558830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5739410|NCT03110510|Immunologic Factors|immunologic factors|mesh-ancestor
5739411|NCT03110510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5739412|NCT03110510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5618678|NCT03127215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5618679|NCT03127215|Alkylating Agents|alkylating agents|mesh-ancestor
5618680|NCT02983071|Fulvestrant|fulvestrant|mesh-list
5618681|NCT02983071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5739413|NCT03110510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5739414|NCT03110510|Antidotes|antidotes|mesh-ancestor
5739415|NCT03110510|Protective Agents|protective agents|mesh-ancestor
5739416|NCT03110510|Vitamin B Complex|vitamin b complex|mesh-ancestor
5739417|NCT03110510|Vitamins|vitamins|mesh-ancestor
5739418|NCT03110510|Micronutrients|micronutrients|mesh-ancestor
5739419|NCT03110484|Pemetrexed|pemetrexed|mesh-list
5739420|NCT03110484|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5739421|NCT03110484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5739422|NCT03110484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5739423|NCT03110484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739424|NCT03110484|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5739425|NCT03110484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5739426|NCT03110484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5739427|NCT03110094|Adalimumab|adalimumab|mesh-list
5739428|NCT03110094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5739429|NCT03110094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5739430|NCT03110120|Levobupivacaine|levobupivacaine|mesh-list
5739431|NCT03110120|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5739432|NCT03110120|Anesthetics|anesthetics|mesh-ancestor
5739433|NCT03110120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5739434|NCT03110120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739435|NCT03110120|Anesthetics, Local|anesthetics, local|mesh-ancestor
5739436|NCT03110120|Sensory System Agents|sensory system agents|mesh-ancestor
5739437|NCT03110120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5739438|NCT03110172|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5739439|NCT03110172|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5739440|NCT03110172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5739441|NCT03110172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5739442|NCT03110172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739443|NCT03110172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5739444|NCT03110172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739445|NCT03110172|Analgesics|analgesics|mesh-ancestor
5739446|NCT03110172|Sensory System Agents|sensory system agents|mesh-ancestor
5739447|NCT03110172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5739448|NCT03110172|Antidepressive Agents|antidepressive agents|mesh-ancestor
5739449|NCT03110172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5739450|NCT03110172|Dopamine Agents|dopamine agents|mesh-ancestor
5739451|NCT03109886|Maleic acid|maleic acid|mesh-list
5739452|NCT03109886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5739453|NCT03109886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739454|NCT03110198|Hydrocortisone|hydrocortisone|mesh-list
5739455|NCT03110198|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
5739456|NCT03110198|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
5739457|NCT03110198|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
5739458|NCT03110198|Mesalamine|mesalamine|mesh-list
5618682|NCT02983071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5618683|NCT02983071|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5618684|NCT02983071|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5618685|NCT02983071|Hormone Antagonists|hormone antagonists|mesh-ancestor
5618686|NCT02983071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5739459|NCT03110198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5739460|NCT03110198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5739461|NCT03110198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5739462|NCT03110198|Analgesics|analgesics|mesh-ancestor
5739463|NCT03110198|Sensory System Agents|sensory system agents|mesh-ancestor
5739464|NCT03110198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5739465|NCT03110198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739466|NCT03110198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5739467|NCT03110159|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5739468|NCT03110159|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5618687|NCT02983071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618688|NCT02935595|Ketamine|ketamine|mesh-list
5618689|NCT02935595|Analgesics|analgesics|mesh-ancestor
5618690|NCT02935595|Sensory System Agents|sensory system agents|mesh-ancestor
5618691|NCT02935595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5618692|NCT02935595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618693|NCT02935595|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5618694|NCT02935595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5618695|NCT02935595|Anesthetics, General|anesthetics, general|mesh-ancestor
5618696|NCT02935595|Anesthetics|anesthetics|mesh-ancestor
5618697|NCT02935595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5618698|NCT02935595|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5618699|NCT02935595|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5618700|NCT02935595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5618701|NCT02935595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618702|NCT02887248|Gemcitabine|gemcitabine|mesh-list
5618703|NCT02887248|Paclitaxel|paclitaxel|mesh-list
5618704|NCT02887248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5618705|NCT02887248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5618706|NCT02887248|Tubulin Modulators|tubulin modulators|mesh-ancestor
5618707|NCT02887248|Antimitotic Agents|antimitotic agents|mesh-ancestor
5618708|NCT02887248|Mitosis Modulators|mitosis modulators|mesh-ancestor
5618709|NCT02887248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618710|NCT02887248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5618711|NCT02887248|Antimetabolites|antimetabolites|mesh-ancestor
5618712|NCT02887248|Antiviral Agents|antiviral agents|mesh-ancestor
5618713|NCT02887248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5618714|NCT02887248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5618715|NCT02887248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5618716|NCT02887248|Immunologic Factors|immunologic factors|mesh-ancestor
5618717|NCT02887248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692394|NCT03408405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697634|NCT03374540|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5697635|NCT03374540|Protease Inhibitors|protease inhibitors|mesh-ancestor
5697636|NCT03374540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5697637|NCT03374540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697638|NCT03374540|Anticoagulants|anticoagulants|mesh-ancestor
5697639|NCT03374540|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5697640|NCT03374540|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5697641|NCT03374540|Hemostatics|hemostatics|mesh-ancestor
5697642|NCT03374540|Coagulants|coagulants|mesh-ancestor
5697643|NCT03374514|Dexamethasone|dexamethasone|mesh-list
5697644|NCT03374514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5697645|NCT03374514|Antiemetics|antiemetics|mesh-ancestor
5697646|NCT03374514|Autonomic Agents|autonomic agents|mesh-ancestor
5697647|NCT03374514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5697648|NCT03374514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697649|NCT03374514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5697650|NCT03374514|Glucocorticoids|glucocorticoids|mesh-ancestor
5697651|NCT03374514|Hormones|hormones|mesh-ancestor
5739469|NCT03110159|Dermatologic Agents|dermatologic agents|mesh-ancestor
5739470|NCT03109977|Pertuzumab|pertuzumab|mesh-list
5739471|NCT03109977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5697652|NCT03374514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5697653|NCT03374514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5697654|NCT03374514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5697655|NCT03374501|PAZ320|paz320|mesh-list
5697656|NCT03374501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5697657|NCT03374501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697658|NCT03374345|Juzentaihoto|juzentaihoto|mesh-list
5697659|NCT03374345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5697660|NCT03374345|Mitogens|mitogens|mesh-ancestor
5697661|NCT03374345|Mitosis Modulators|mitosis modulators|mesh-ancestor
5697662|NCT03374345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697663|NCT03374332|Gemtuzumab|gemtuzumab|mesh-list
5697664|NCT03374332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5697665|NCT03374332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5697666|NCT03374306|Atropine|atropine|mesh-list
5697667|NCT03374306|Lubricant Eye Drops|lubricant eye drops|mesh-list
5697668|NCT03374306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5697669|NCT03374306|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5697670|NCT03374306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5697671|NCT03374306|Autonomic Agents|autonomic agents|mesh-ancestor
5697672|NCT03374306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5697673|NCT03374306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697674|NCT03374306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5697675|NCT03374306|Respiratory System Agents|respiratory system agents|mesh-ancestor
5697676|NCT03374306|Mydriatics|mydriatics|mesh-ancestor
5697677|NCT03374306|Parasympatholytics|parasympatholytics|mesh-ancestor
5697678|NCT03374306|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5697679|NCT03374306|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5697680|NCT03374306|Cholinergic Agents|cholinergic agents|mesh-ancestor
5697681|NCT03374306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5698106|NCT03371342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739472|NCT03109977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5739473|NCT03110055|Grazoprevir|grazoprevir|mesh-list
5739474|NCT03110055|Antiviral Agents|antiviral agents|mesh-ancestor
5739475|NCT03110055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5739476|NCT03109990|Dexmedetomidine|dexmedetomidine|mesh-list
5739477|NCT03109990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5739478|NCT03109990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5739479|NCT03109990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739480|NCT03109990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5739481|NCT03109990|Analgesics|analgesics|mesh-ancestor
5739482|NCT03109990|Sensory System Agents|sensory system agents|mesh-ancestor
5739483|NCT03109990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5739484|NCT03109990|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5739485|NCT03109990|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5739486|NCT03109990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5739487|NCT03109990|Adrenergic Agents|adrenergic agents|mesh-ancestor
5739488|NCT03109990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5739489|NCT03109990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893395|NCT05093205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5893396|NCT05093205|Estrogens|estrogens|mesh-ancestor
5893397|NCT05093205|Hormones|hormones|mesh-ancestor
5893398|NCT05093205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5893399|NCT05093205|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5893400|NCT05093205|Contraceptive Agents|contraceptive agents|mesh-ancestor
5893401|NCT05093205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5893402|NCT05093205|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5893403|NCT05093205|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5893404|NCT05093205|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5893405|NCT05093205|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5893406|NCT05084534|Midodrine|midodrine|mesh-list
5893407|NCT05084534|Sympathomimetics|sympathomimetics|mesh-ancestor
5893408|NCT05084534|Autonomic Agents|autonomic agents|mesh-ancestor
5893409|NCT05084534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5893410|NCT05084534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893411|NCT05084534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5893412|NCT05084534|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5893413|NCT05084534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5893414|NCT05084534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5893415|NCT05084534|Adrenergic Agents|adrenergic agents|mesh-ancestor
5893416|NCT05084534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5893417|NCT05084534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893418|NCT05081219|Insulin|insulin|mesh-list
5893419|NCT05081219|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6489340|NCT00590928|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6489341|NCT00590928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6489342|NCT00590928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618718|NCT02849990|Prednisone|prednisone|mesh-list
5618719|NCT02849990|Cortisone|cortisone|mesh-list
5618720|NCT02849990|Indomethacin|indomethacin|mesh-list
5618721|NCT02849990|Abiraterone Acetate|abiraterone acetate|mesh-list
5618722|NCT02849990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5618723|NCT02849990|Glucocorticoids|glucocorticoids|mesh-ancestor
5618724|NCT02849990|Hormones|hormones|mesh-ancestor
5618725|NCT02849990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5618726|NCT02849990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618727|NCT02849990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5618728|NCT02849990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5618729|NCT02849990|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5618730|NCT02849990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5618731|NCT02849990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618732|NCT02849990|Hormone Antagonists|hormone antagonists|mesh-ancestor
5618733|NCT02849990|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5618734|NCT02849990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5618735|NCT02849990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5618736|NCT02849990|Analgesics|analgesics|mesh-ancestor
5893420|NCT05081219|Empagliflozin|empagliflozin|mesh-list
5893421|NCT05081219|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5893422|NCT05081219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893423|NCT05081219|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5893424|NCT05081219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893425|NCT05038475|Antibodies|antibodies|mesh-list
6489343|NCT00590928|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6489344|NCT00590928|Histamine Antagonists|histamine antagonists|mesh-ancestor
5618737|NCT02849990|Sensory System Agents|sensory system agents|mesh-ancestor
5618738|NCT02849990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5618739|NCT02849990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5618740|NCT02849990|Gout Suppressants|gout suppressants|mesh-ancestor
5618741|NCT02849990|Tocolytic Agents|tocolytic agents|mesh-ancestor
5618742|NCT02849990|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5618743|NCT02849990|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5618744|NCT02819752|Pembrolizumab|pembrolizumab|mesh-list
5618745|NCT02819752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5618746|NCT02819752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5618747|NCT02817347|Tazobactam|tazobactam|mesh-list
5618748|NCT02817347|Piperacillin|piperacillin|mesh-list
5618749|NCT02817347|Dexamethasone|dexamethasone|mesh-list
5618750|NCT02817347|Dexamethasone acetate|dexamethasone acetate|mesh-list
5739490|NCT03109847|Metformin|metformin|mesh-list
5739491|NCT03109847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5739492|NCT03109847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739493|NCT03109691|Dexamethasone|dexamethasone|mesh-list
5739494|NCT03109691|Bupivacaine|bupivacaine|mesh-list
5739495|NCT03109691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5739496|NCT03109691|Antiemetics|antiemetics|mesh-ancestor
5739497|NCT03109691|Autonomic Agents|autonomic agents|mesh-ancestor
5739498|NCT03109691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5739499|NCT03109691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739500|NCT03109691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5739501|NCT03109691|Glucocorticoids|glucocorticoids|mesh-ancestor
5739502|NCT03109691|Hormones|hormones|mesh-ancestor
5739503|NCT03109691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5739504|NCT03109691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5739505|NCT03109691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5739506|NCT03109691|Anesthetics, Local|anesthetics, local|mesh-ancestor
5739507|NCT03109691|Anesthetics|anesthetics|mesh-ancestor
5739508|NCT03109691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5739509|NCT03109691|Sensory System Agents|sensory system agents|mesh-ancestor
5739510|NCT03109730|Tenofovir|tenofovir|mesh-list
5739511|NCT03109730|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5739512|NCT03109730|Entecavir|entecavir|mesh-list
5739513|NCT03109730|Antiviral Agents|antiviral agents|mesh-ancestor
5739514|NCT03109730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5739515|NCT03109730|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5739516|NCT03109730|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5739517|NCT03109730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5739518|NCT03109730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739519|NCT03109730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5739520|NCT03109730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5739521|NCT03109756|Gaboxadol|gaboxadol|mesh-list
5739522|NCT03109756|Analgesics|analgesics|mesh-ancestor
5739523|NCT03109756|Sensory System Agents|sensory system agents|mesh-ancestor
5739524|NCT03109756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5739525|NCT03109756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739526|NCT03109756|Anticonvulsants|anticonvulsants|mesh-ancestor
5739527|NCT03109756|GABA Agonists|gaba agonists|mesh-ancestor
5739528|NCT03109756|GABA Agents|gaba agents|mesh-ancestor
5739529|NCT03109756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5739530|NCT03109756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739531|NCT03109795|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5739532|NCT03109795|Clonidine|clonidine|mesh-list
5739533|NCT03109795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5739534|NCT03109795|Diuretics|diuretics|mesh-ancestor
5739535|NCT03109795|Natriuretic Agents|natriuretic agents|mesh-ancestor
5739536|NCT03109795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739537|NCT03109795|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5739538|NCT03109795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5739539|NCT03109795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739540|NCT03109795|Analgesics|analgesics|mesh-ancestor
5739541|NCT03109795|Sensory System Agents|sensory system agents|mesh-ancestor
5739542|NCT03109795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5739543|NCT03109795|Sympatholytics|sympatholytics|mesh-ancestor
5739544|NCT03109795|Autonomic Agents|autonomic agents|mesh-ancestor
5739545|NCT03109795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5618751|NCT02817347|BB 1101|bb 1101|mesh-list
5739546|NCT03109795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5739547|NCT03109795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5618752|NCT02817347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5618753|NCT02817347|Antiemetics|antiemetics|mesh-ancestor
5618754|NCT02817347|Autonomic Agents|autonomic agents|mesh-ancestor
5739548|NCT03109795|Adrenergic Agents|adrenergic agents|mesh-ancestor
5739549|NCT03109795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5739550|NCT03109717|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-list
5739551|NCT03109717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5739552|NCT03109717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618755|NCT02817347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5618756|NCT02817347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618757|NCT02817347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5618758|NCT02817347|Glucocorticoids|glucocorticoids|mesh-ancestor
5618759|NCT02817347|Hormones|hormones|mesh-ancestor
5618760|NCT02817347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5618761|NCT02817347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5618762|NCT02817347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5618763|NCT02817347|Protease Inhibitors|protease inhibitors|mesh-ancestor
5618764|NCT02817347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5618765|NCT02817347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618766|NCT02817347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5618767|NCT02817347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5618768|NCT02817347|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5618769|NCT02800824|Budesonide|budesonide|mesh-list
5618770|NCT02800824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5618771|NCT02800824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5618772|NCT02800824|Autonomic Agents|autonomic agents|mesh-ancestor
5618773|NCT02800824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5739553|NCT03109600|Vaccines|vaccines|mesh-list
5739554|NCT03109600|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5739555|NCT03109600|Immunologic Factors|immunologic factors|mesh-ancestor
5739556|NCT03109600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739557|NCT03109652|Tranexamic Acid|tranexamic acid|mesh-list
5739558|NCT03109652|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5739559|NCT03109652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5739560|NCT03109652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739561|NCT03109652|Hemostatics|hemostatics|mesh-ancestor
5739562|NCT03109652|Coagulants|coagulants|mesh-ancestor
5739563|NCT03109093|Blinatumomab|blinatumomab|mesh-list
5739564|NCT03109093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5739565|NCT03109392|Lidocaine|lidocaine|mesh-list
5618774|NCT02800824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618775|NCT02800824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5618776|NCT02800824|Respiratory System Agents|respiratory system agents|mesh-ancestor
5618777|NCT02800824|Glucocorticoids|glucocorticoids|mesh-ancestor
5739566|NCT03109392|Anesthetics, Local|anesthetics, local|mesh-ancestor
5739567|NCT03109392|Anesthetics|anesthetics|mesh-ancestor
5739568|NCT03109392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5739569|NCT03109392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739570|NCT03109392|Sensory System Agents|sensory system agents|mesh-ancestor
5739571|NCT03109392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5739572|NCT03109392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5739573|NCT03109392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5739574|NCT03109392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5739575|NCT03109392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5739576|NCT03109392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739577|NCT03109379|Trospium chloride|trospium chloride|mesh-list
5618778|NCT02800824|Hormones|hormones|mesh-ancestor
5618779|NCT02800824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5618780|NCT02782949|Curcumin|curcumin|mesh-list
5618781|NCT02782949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5618782|NCT02782949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5618783|NCT02782949|Analgesics|analgesics|mesh-ancestor
5618784|NCT02782949|Sensory System Agents|sensory system agents|mesh-ancestor
5618785|NCT02782949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5618786|NCT02782949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618787|NCT02782949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5618788|NCT02782949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5618789|NCT02782949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5618790|NCT02782949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5618791|NCT02782949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618792|NCT02780401|Vaccines|vaccines|mesh-list
5618793|NCT02780401|Sargramostim|sargramostim|mesh-list
5618794|NCT02780401|Immunologic Factors|immunologic factors|mesh-ancestor
5618795|NCT02780401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618796|NCT02760498|Cemiplimab|cemiplimab|mesh-list
5618797|NCT02760498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5618798|NCT02760498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5618799|NCT02673151|Edetic Acid|edetic acid|mesh-list
5739578|NCT03109379|Parasympatholytics|parasympatholytics|mesh-ancestor
5739579|NCT03109379|Autonomic Agents|autonomic agents|mesh-ancestor
5739580|NCT03109379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5739581|NCT03109379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739582|NCT03109379|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5739583|NCT03109379|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5739584|NCT03109379|Cholinergic Agents|cholinergic agents|mesh-ancestor
5739585|NCT03109379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5739586|NCT03109379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739587|NCT03109379|Urological Agents|urological agents|mesh-ancestor
5739588|NCT03109080|Olaparib|olaparib|mesh-list
5739589|NCT03109080|Adenosine|adenosine|mesh-list
5739590|NCT03109080|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5739591|NCT03109080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5739592|NCT03109080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739593|NCT03109080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5739594|NCT03109080|Analgesics|analgesics|mesh-ancestor
5618800|NCT02673151|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5618801|NCT02673151|Chelating Agents|chelating agents|mesh-ancestor
5618802|NCT02673151|Sequestering Agents|sequestering agents|mesh-ancestor
5618803|NCT02673151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739595|NCT03109080|Sensory System Agents|sensory system agents|mesh-ancestor
5739596|NCT03109080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5739597|NCT03109080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739598|NCT03109080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5739599|NCT03109080|Vasodilator Agents|vasodilator agents|mesh-ancestor
5739600|NCT03109080|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5739601|NCT03109080|Purinergic Agonists|purinergic agonists|mesh-ancestor
5739602|NCT03109080|Purinergic Agents|purinergic agents|mesh-ancestor
5739603|NCT03109080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5739604|NCT03109158|Cetuximab|cetuximab|mesh-list
5739605|NCT03109158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5739606|NCT03109158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5739607|NCT03109119|Propofol|propofol|mesh-list
5739608|NCT03109119|Sevoflurane|sevoflurane|mesh-list
5618804|NCT02673151|Anticoagulants|anticoagulants|mesh-ancestor
5618805|NCT02673151|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5618806|NCT02673151|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5618807|NCT02653092|Heparin|heparin|mesh-list
5618808|NCT02653092|Anticoagulants|anticoagulants|mesh-list
5618809|NCT02653092|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
5618810|NCT02653092|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5618811|NCT02653092|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5618812|NCT02653092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618813|NCT02653092|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
5618814|NCT02653092|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5618815|NCT02653092|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5618816|NCT02593175|Paclitaxel|paclitaxel|mesh-list
5618817|NCT02593175|Carboplatin|carboplatin|mesh-list
5618818|NCT02593175|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5618819|NCT02593175|Panitumumab|panitumumab|mesh-list
5618820|NCT02593175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5618821|NCT02593175|Antibodies|antibodies|mesh-list
5618822|NCT02593175|Immunoglobulins|immunoglobulins|mesh-list
5618823|NCT02593175|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5618824|NCT02593175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5618825|NCT02593175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5618826|NCT02593175|Tubulin Modulators|tubulin modulators|mesh-ancestor
5618827|NCT02593175|Antimitotic Agents|antimitotic agents|mesh-ancestor
5618828|NCT02593175|Mitosis Modulators|mitosis modulators|mesh-ancestor
5618829|NCT02593175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618830|NCT02593175|Immunologic Factors|immunologic factors|mesh-ancestor
5618831|NCT02593175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739609|NCT03109119|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5739610|NCT03109119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5739611|NCT03109119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739612|NCT03109119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5739613|NCT03109119|Anesthetics, General|anesthetics, general|mesh-ancestor
5739614|NCT03109119|Anesthetics|anesthetics|mesh-ancestor
5739615|NCT03109119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5739616|NCT03109119|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5739617|NCT03109314|Donepezil|donepezil|mesh-list
5739618|NCT03109314|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5739619|NCT03109314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5739620|NCT03109314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739621|NCT03109314|Cholinergic Agents|cholinergic agents|mesh-ancestor
5739622|NCT03109314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5739623|NCT03109314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739624|NCT03109314|Nootropic Agents|nootropic agents|mesh-ancestor
5739625|NCT03108846|Citalopram|citalopram|mesh-list
5618832|NCT02590393|Nicotine|nicotine|mesh-list
5618833|NCT02590393|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5618834|NCT02590393|Autonomic Agents|autonomic agents|mesh-ancestor
5618835|NCT02590393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5618836|NCT02590393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618837|NCT02590393|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5618838|NCT02590393|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5618839|NCT02590393|Cholinergic Agents|cholinergic agents|mesh-ancestor
5618840|NCT02590393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5618841|NCT02590393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618842|NCT02589600|Vitamin D|vitamin d|mesh-list
5618843|NCT02589600|Zoledronic Acid|zoledronic acid|mesh-list
5618844|NCT02589600|Calcium|calcium|mesh-list
5618845|NCT02589600|Vitamins|vitamins|mesh-ancestor
5618846|NCT02589600|Micronutrients|micronutrients|mesh-ancestor
5618847|NCT02589600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618848|NCT02589600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5618849|NCT02589600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5618850|NCT02567578|YH12852|yh12852|mesh-list
5618851|NCT02567578|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
5618852|NCT02567578|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5618853|NCT02567578|Serotonin Agents|serotonin agents|mesh-ancestor
5618854|NCT02567578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5618855|NCT02567578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618856|NCT02567578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618857|NCT02523274|Resveratrol|resveratrol|mesh-list
5618858|NCT02523274|Antioxidants|antioxidants|mesh-ancestor
5618859|NCT02523274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618860|NCT02523274|Protective Agents|protective agents|mesh-ancestor
5618861|NCT02523274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618862|NCT02523274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5618863|NCT02523274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5618864|NCT02467270|Ponatinib|ponatinib|mesh-list
5618865|NCT02467270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5618866|NCT02467270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5618867|NCT02467270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5618868|NCT02467270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618869|NCT02452554|Maytansine|maytansine|mesh-list
5618870|NCT02452554|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
5618871|NCT02452554|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
5739626|NCT03108846|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5739627|NCT03108846|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5739628|NCT03108846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5739629|NCT03108846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739630|NCT03108846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5739631|NCT03108846|Serotonin Agents|serotonin agents|mesh-ancestor
5739632|NCT03108846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739633|NCT03108846|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5739634|NCT03108846|Antidepressive Agents|antidepressive agents|mesh-ancestor
5739635|NCT03108846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5739636|NCT03108937|Dexmedetomidine|dexmedetomidine|mesh-list
5739637|NCT03108937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5739638|NCT03108937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5739639|NCT03108937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739640|NCT03108937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5739641|NCT03108937|Analgesics|analgesics|mesh-ancestor
5618872|NCT02452554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5739642|NCT03108937|Sensory System Agents|sensory system agents|mesh-ancestor
5739643|NCT03108937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5739644|NCT03108937|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5739645|NCT03108937|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5739646|NCT03108937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5739647|NCT03108937|Adrenergic Agents|adrenergic agents|mesh-ancestor
5739648|NCT03108937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5739649|NCT03108937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739650|NCT03108833|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5739651|NCT03108833|Saruplase|saruplase|mesh-list
5739652|NCT03108833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5739653|NCT03108833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5739654|NCT03108833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739655|NCT03108963|Metformin|metformin|mesh-list
5739656|NCT03108963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5739657|NCT03108963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739658|NCT03108989|Neostigmine|neostigmine|mesh-list
5739659|NCT03108989|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5618873|NCT02452554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5618874|NCT02452554|Tubulin Modulators|tubulin modulators|mesh-ancestor
5618875|NCT02452554|Antimitotic Agents|antimitotic agents|mesh-ancestor
5618876|NCT02452554|Mitosis Modulators|mitosis modulators|mesh-ancestor
5618877|NCT02452554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618878|NCT02452554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5618879|NCT02432560|Sirolimus|sirolimus|mesh-list
5618880|NCT02432560|Everolimus|everolimus|mesh-list
5618881|NCT02432560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5618882|NCT02432560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5618883|NCT02432560|Immunologic Factors|immunologic factors|mesh-ancestor
5618884|NCT02432560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739660|NCT03108989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5739661|NCT03108989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739662|NCT03108989|Cholinergic Agents|cholinergic agents|mesh-ancestor
5739663|NCT03108989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5739664|NCT03108989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739665|NCT03108989|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5739666|NCT03108989|Autonomic Agents|autonomic agents|mesh-ancestor
5739667|NCT03108989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5739668|NCT03108872|Anticoagulants|anticoagulants|mesh-list
5739669|NCT03108690|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5739670|NCT03108690|Meropenem|meropenem|mesh-list
5739671|NCT03108690|Tazobactam|tazobactam|mesh-list
5739672|NCT03108690|Piperacillin|piperacillin|mesh-list
5739673|NCT03108690|Ampicillin|ampicillin|mesh-list
5739674|NCT03108690|Cefuroxime|cefuroxime|mesh-list
5739675|NCT03108690|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
5739676|NCT03108690|Lactams|lactams|mesh-list
5739677|NCT03108690|beta-Lactams|beta-lactams|mesh-list
5739678|NCT03108690|Penicillin G|penicillin g|mesh-list
5739679|NCT03108690|Dicloxacillin|dicloxacillin|mesh-list
5739680|NCT03108690|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5739681|NCT03108690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5739682|NCT03108690|Antitubercular Agents|antitubercular agents|mesh-ancestor
5739683|NCT03108690|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5739684|NCT03108690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5739685|NCT03108690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739686|NCT03108807|Fibrin fragment D|fibrin fragment d|mesh-list
5739687|NCT03108807|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5739688|NCT03108807|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5739689|NCT03108807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739690|NCT03108807|Hemostatics|hemostatics|mesh-ancestor
5739691|NCT03108807|Coagulants|coagulants|mesh-ancestor
5739692|NCT03108729|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
5739693|NCT03108729|Anticonvulsants|anticonvulsants|mesh-ancestor
5739694|NCT03108729|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5739695|NCT03108729|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5739696|NCT03108729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5739697|NCT03108729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739698|NCT03108664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5739699|NCT03108664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5739700|NCT03108313|Fluorides|fluorides|mesh-list
5618885|NCT02432560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5618886|NCT02432560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5618887|NCT02432560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5739701|NCT03108313|Cariostatic Agents|cariostatic agents|mesh-ancestor
5739702|NCT03108313|Protective Agents|protective agents|mesh-ancestor
5739703|NCT03108313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739704|NCT03108625|Vortioxetine|vortioxetine|mesh-list
5739705|NCT03108625|Antidepressive Agents|antidepressive agents|mesh-ancestor
5739706|NCT03108625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5739707|NCT03108625|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5739708|NCT03108625|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5739709|NCT03108625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5739710|NCT03108625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739711|NCT03108625|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5739712|NCT03108625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5739713|NCT03108625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5739714|NCT03108625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618888|NCT02432560|Antifungal Agents|antifungal agents|mesh-ancestor
5618889|NCT02427568|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
5618890|NCT02427568|Hallucinogens|hallucinogens|mesh-ancestor
5618891|NCT02427568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618892|NCT02427568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5618893|NCT02427568|Serotonin Agents|serotonin agents|mesh-ancestor
5739715|NCT03108625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5739716|NCT03108625|Serotonin Agents|serotonin agents|mesh-ancestor
5739717|NCT03108625|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5739718|NCT03108625|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5739719|NCT03108625|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5739720|NCT03108625|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5739721|NCT03108300|Doxorubicin|doxorubicin|mesh-list
5739722|NCT03108300|Propranolol|propranolol|mesh-list
5739723|NCT03108300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5739724|NCT03108300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5739725|NCT03108300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5739726|NCT03108300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5739727|NCT03108300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5739728|NCT03108300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739729|NCT03108300|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5739730|NCT03108300|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5739731|NCT03108300|Adrenergic Agents|adrenergic agents|mesh-ancestor
5739732|NCT03108300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5739733|NCT03108300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739734|NCT03108300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5739735|NCT03108300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5739736|NCT03108300|Vasodilator Agents|vasodilator agents|mesh-ancestor
5893426|NCT05038475|Immunologic Factors|immunologic factors|mesh-ancestor
5893427|NCT05038475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893428|NCT05025163|Fluorides|fluorides|mesh-list
5893429|NCT05025163|Fluorides, Topical|fluorides, topical|mesh-list
5893430|NCT05025163|Cariostatic Agents|cariostatic agents|mesh-ancestor
5893431|NCT05025163|Protective Agents|protective agents|mesh-ancestor
5893432|NCT05025163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893433|NCT05018013|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5618894|NCT02427568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5618895|NCT02427568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618896|NCT02427568|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5618897|NCT02427568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5618898|NCT02427568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5618899|NCT02427568|Adrenergic Agents|adrenergic agents|mesh-ancestor
5618900|NCT02359175|Acetaminophen|acetaminophen|mesh-list
5618901|NCT02359175|Fentanyl|fentanyl|mesh-list
5618902|NCT02359175|Analgesics, Opioid|analgesics, opioid|mesh-list
5618903|NCT02359175|Bupivacaine|bupivacaine|mesh-list
5618904|NCT02359175|Anesthetics, Local|anesthetics, local|mesh-ancestor
5618905|NCT02359175|Anesthetics|anesthetics|mesh-ancestor
5618906|NCT02359175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5618907|NCT02359175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618908|NCT02359175|Sensory System Agents|sensory system agents|mesh-ancestor
5618909|NCT02359175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5893434|NCT05018013|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5893435|NCT05018013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5893436|NCT05018013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5893437|NCT05018013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893438|NCT05018013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5893439|NCT05018013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893440|NCT05018013|Analgesics|analgesics|mesh-ancestor
5893441|NCT05018013|Sensory System Agents|sensory system agents|mesh-ancestor
5618910|NCT02359175|Narcotics|narcotics|mesh-ancestor
5618911|NCT02359175|Analgesics|analgesics|mesh-ancestor
5618912|NCT02359175|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5618913|NCT02359175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5618914|NCT02359175|Anesthetics, General|anesthetics, general|mesh-ancestor
5618915|NCT02359175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5618916|NCT02359175|Antipyretics|antipyretics|mesh-ancestor
5618917|NCT02335424|Pembrolizumab|pembrolizumab|mesh-list
5618918|NCT02335424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5618919|NCT02335424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5739742|NCT03108326|Infliximab|infliximab|mesh-list
5739743|NCT03108326|Ustekinumab|ustekinumab|mesh-list
5739744|NCT03108326|Vedolizumab|vedolizumab|mesh-list
5739745|NCT03108326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5739746|NCT03108326|Dermatologic Agents|dermatologic agents|mesh-ancestor
5739747|NCT03108326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5739748|NCT03108365|Hemostatics|hemostatics|mesh-list
5739749|NCT03108365|Chitosan|chitosan|mesh-list
5739750|NCT03108365|Coagulants|coagulants|mesh-ancestor
5739751|NCT03108365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5739752|NCT03108365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5739753|NCT03108365|Antimetabolites|antimetabolites|mesh-ancestor
5739754|NCT03108365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739755|NCT03108365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5739756|NCT03108365|Chelating Agents|chelating agents|mesh-ancestor
5739757|NCT03108365|Sequestering Agents|sequestering agents|mesh-ancestor
5739758|NCT03108248|Doxorubicin|doxorubicin|mesh-list
5739759|NCT03108248|Ethiodized Oil|ethiodized oil|mesh-list
5739760|NCT03108248|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
5739761|NCT03108248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5618927|NCT02332577|Amoxicillin|amoxicillin|mesh-list
5618928|NCT02332577|Pristinamycin|pristinamycin|mesh-list
5739762|NCT03108248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5739763|NCT03108248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5739764|NCT03108248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5739765|NCT03108248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5739766|NCT03108248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739767|NCT03108248|Hemostatics|hemostatics|mesh-ancestor
5739768|NCT03108248|Coagulants|coagulants|mesh-ancestor
5739769|NCT03108287|Amoxicillin|amoxicillin|mesh-list
5739770|NCT03108287|Clarithromycin|clarithromycin|mesh-list
5739771|NCT03108287|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
5739772|NCT03108287|Rabeprazole|rabeprazole|mesh-list
5739773|NCT03108287|Bismuth|bismuth|mesh-list
5739774|NCT03108287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5739775|NCT03108287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5739776|NCT03108287|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5739777|NCT03108287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5739778|NCT03108287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739779|NCT03108287|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5739780|NCT03108287|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5739781|NCT03108287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5739782|NCT03108287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5739783|NCT03108287|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5739784|NCT03108287|Antacids|antacids|mesh-ancestor
5739785|NCT03108495|Pembrolizumab|pembrolizumab|mesh-list
5618929|NCT02332577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5618930|NCT02332577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5618931|NCT02323698|Caffeine|caffeine|mesh-list
5618932|NCT02323698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5618933|NCT02323698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618934|NCT02323698|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5739786|NCT03108495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5618935|NCT02323698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5739787|NCT03108495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5692395|NCT03408236|Botulinum Toxins|botulinum toxins|mesh-list
5739788|NCT03108274|Fexofenadine|fexofenadine|mesh-list
5739789|NCT03108274|Mycophenolic Acid|mycophenolic acid|mesh-list
5618936|NCT02323698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618937|NCT02323698|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5739790|NCT03108274|Midazolam|midazolam|mesh-list
5739791|NCT03108274|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5739792|NCT03108274|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5739793|NCT03108274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5739794|NCT03108274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739795|NCT03108274|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5739796|NCT03108274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5739797|NCT03108274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5739798|NCT03108274|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5739799|NCT03108274|Anesthetics, General|anesthetics, general|mesh-ancestor
5739800|NCT03108274|Anesthetics|anesthetics|mesh-ancestor
5739801|NCT03108274|GABA Modulators|gaba modulators|mesh-ancestor
5739802|NCT03108274|GABA Agents|gaba agents|mesh-ancestor
5739803|NCT03108274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5739804|NCT03108274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618938|NCT02323698|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5618939|NCT02323698|Purinergic Agents|purinergic agents|mesh-ancestor
5618940|NCT02323698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5618941|NCT02323659|Interferons|interferons|mesh-list
5618942|NCT02323659|Interferon-alpha|interferon-alpha|mesh-list
5618943|NCT02323659|Interferon alpha-2|interferon alpha-2|mesh-list
5618944|NCT02323659|Methotrexate|methotrexate|mesh-list
5618945|NCT02323659|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5618946|NCT02323659|Abortifacient Agents|abortifacient agents|mesh-ancestor
5618947|NCT02323659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5739805|NCT03108274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5739806|NCT03108274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5739807|NCT03108274|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5739808|NCT03108274|Antitubercular Agents|antitubercular agents|mesh-ancestor
5739809|NCT03108274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5739810|NCT03108274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5739811|NCT03108274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5739812|NCT03108274|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5739813|NCT03108274|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5739814|NCT03108274|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5739815|NCT03108274|Histamine Antagonists|histamine antagonists|mesh-ancestor
5739816|NCT03108274|Histamine Agents|histamine agents|mesh-ancestor
5739817|NCT03107858|Dopamine|dopamine|mesh-list
5739818|NCT03107858|Norepinephrine|norepinephrine|mesh-list
5739819|NCT03107858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5739820|NCT03107858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5739821|NCT03107858|Adrenergic Agents|adrenergic agents|mesh-ancestor
5739822|NCT03107858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5739823|NCT03107858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739824|NCT03107858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739825|NCT03107858|Sympathomimetics|sympathomimetics|mesh-ancestor
5739826|NCT03107858|Autonomic Agents|autonomic agents|mesh-ancestor
5739827|NCT03107858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5739828|NCT03107858|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5739829|NCT03107858|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5739830|NCT03107858|Dopamine Agents|dopamine agents|mesh-ancestor
5739831|NCT03107858|Protective Agents|protective agents|mesh-ancestor
5739832|NCT03107962|Pembrolizumab|pembrolizumab|mesh-list
5739833|NCT03107962|Antibodies|antibodies|mesh-list
6489345|NCT00590928|Histamine Agents|histamine agents|mesh-ancestor
6489346|NCT00590928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6489347|NCT00590928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489348|NCT00591162|Tetracycline|tetracycline|mesh-list
6489349|NCT00591162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6489350|NCT00591162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5739834|NCT03107962|Antibodies, Blocking|antibodies, blocking|mesh-list
5739835|NCT03107962|Immunologic Factors|immunologic factors|mesh-ancestor
5739836|NCT03107962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739837|NCT03107962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5739838|NCT03107962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5739839|NCT03107884|Metformin|metformin|mesh-list
5739840|NCT03107884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5739841|NCT03107884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739842|NCT03107923|Dobutamine|dobutamine|mesh-list
5739843|NCT03107923|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5618948|NCT02323659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739844|NCT03107923|Sympathomimetics|sympathomimetics|mesh-ancestor
5739845|NCT03107923|Autonomic Agents|autonomic agents|mesh-ancestor
5739846|NCT03107923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5618949|NCT02323659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5618950|NCT02323659|Antimetabolites|antimetabolites|mesh-ancestor
5739847|NCT03107923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739848|NCT03107923|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5739849|NCT03107923|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5739850|NCT03107923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5739851|NCT03107923|Adrenergic Agents|adrenergic agents|mesh-ancestor
5618951|NCT02323659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618952|NCT02323659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5618953|NCT02323659|Dermatologic Agents|dermatologic agents|mesh-ancestor
5618954|NCT02323659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5618955|NCT02323659|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5618956|NCT02323659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5618957|NCT02323659|Immunologic Factors|immunologic factors|mesh-ancestor
5618958|NCT02323659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5618959|NCT02323659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5618960|NCT02323659|Antiviral Agents|antiviral agents|mesh-ancestor
5618961|NCT02323659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5618962|NCT02318277|Durvalumab|durvalumab|mesh-list
5618963|NCT02318277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5618964|NCT02318277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5618965|NCT02296801|Letrozole|letrozole|mesh-list
5618966|NCT02296801|Palbociclib|palbociclib|mesh-list
5618967|NCT02296801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5618968|NCT02296801|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5618969|NCT02296801|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5618970|NCT02296801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5739852|NCT03107923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5739853|NCT03107923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739854|NCT03107923|Protective Agents|protective agents|mesh-ancestor
5739855|NCT03107689|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
5739856|NCT03107689|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5739857|NCT03107689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5739858|NCT03107702|Melatonin|melatonin|mesh-list
5739859|NCT03107702|Antioxidants|antioxidants|mesh-ancestor
5739860|NCT03107702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739861|NCT03107702|Protective Agents|protective agents|mesh-ancestor
5739862|NCT03107702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739863|NCT03107702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5739864|NCT03107481|Acetaminophen|acetaminophen|mesh-list
5739865|NCT03107481|Hydromorphone|hydromorphone|mesh-list
5739866|NCT03107481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5739867|NCT03107481|Analgesics|analgesics|mesh-ancestor
5739868|NCT03107481|Sensory System Agents|sensory system agents|mesh-ancestor
5739869|NCT03107481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5739870|NCT03107481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739871|NCT03107481|Antipyretics|antipyretics|mesh-ancestor
5739872|NCT03107481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5739873|NCT03107481|Narcotics|narcotics|mesh-ancestor
5739874|NCT03107481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5739875|NCT03107429|Acetazolamide|acetazolamide|mesh-list
5739876|NCT03107429|Anticonvulsants|anticonvulsants|mesh-ancestor
5739877|NCT03107429|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5739878|NCT03107429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5739879|NCT03107429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739880|NCT03107429|Diuretics|diuretics|mesh-ancestor
5739881|NCT03107429|Natriuretic Agents|natriuretic agents|mesh-ancestor
5739882|NCT03107429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739883|NCT03107325|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5739884|NCT03107325|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5739885|NCT03107325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739886|NCT03107208|Insulin Glargine|insulin glargine|mesh-list
5739887|NCT03107208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5739888|NCT03107208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739889|NCT03107247|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
5739890|NCT03107247|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5739891|NCT03107247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739892|NCT03107338|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
5739893|NCT03107338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5739894|NCT03107338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5739895|NCT03107338|Analgesics|analgesics|mesh-ancestor
5739896|NCT03107338|Sensory System Agents|sensory system agents|mesh-ancestor
5739897|NCT03107338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5739898|NCT03107338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739899|NCT03107338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5739900|NCT03107338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5739901|NCT03107507|Levetiracetam|levetiracetam|mesh-list
5739902|NCT03107507|Phenobarbital|phenobarbital|mesh-list
5739903|NCT03107507|Anticonvulsants|anticonvulsants|mesh-ancestor
5739904|NCT03107507|Nootropic Agents|nootropic agents|mesh-ancestor
5739905|NCT03107507|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5739906|NCT03107507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5618971|NCT02296801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5618972|NCT02296801|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5618973|NCT02296801|Hormone Antagonists|hormone antagonists|mesh-ancestor
5618974|NCT02296801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5618975|NCT02296801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618976|NCT02296801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5618977|NCT02283853|Interferons|interferons|mesh-list
5618978|NCT02283853|Interferon-beta|interferon-beta|mesh-list
5618979|NCT02283853|Interferon beta-1a|interferon beta-1a|mesh-list
5618980|NCT02283853|Dimethyl Fumarate|dimethyl fumarate|mesh-list
5739907|NCT03107507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739908|NCT03107507|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5739909|NCT03107507|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5739910|NCT03107507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5739911|NCT03107507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739912|NCT03107507|GABA Modulators|gaba modulators|mesh-ancestor
5739913|NCT03107507|GABA Agents|gaba agents|mesh-ancestor
5739914|NCT03107507|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5739915|NCT03107507|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5739916|NCT03107507|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5739917|NCT03107078|Methylprednisolone|methylprednisolone|mesh-list
5739918|NCT03107078|Glucocorticoids|glucocorticoids|mesh-list
5739919|NCT03107078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5739920|NCT03107078|Antiemetics|antiemetics|mesh-ancestor
5739921|NCT03107078|Autonomic Agents|autonomic agents|mesh-ancestor
5739922|NCT03107078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5739923|NCT03107078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739924|NCT03107078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5739925|NCT03107078|Hormones|hormones|mesh-ancestor
5739926|NCT03107078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5739927|NCT03107078|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5739928|NCT03107078|Protective Agents|protective agents|mesh-ancestor
5739929|NCT03106948|Ascorbic Acid|ascorbic acid|mesh-list
5739930|NCT03106948|Penicillamine|penicillamine|mesh-list
5739931|NCT03106948|Antioxidants|antioxidants|mesh-ancestor
5739932|NCT03106948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739933|NCT03106948|Protective Agents|protective agents|mesh-ancestor
5739934|NCT03106948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618981|NCT02283853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5618982|NCT02283853|Antiviral Agents|antiviral agents|mesh-ancestor
5618983|NCT02283853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5739935|NCT03106948|Vitamins|vitamins|mesh-ancestor
5739936|NCT03106948|Micronutrients|micronutrients|mesh-ancestor
5739937|NCT03106948|Antidotes|antidotes|mesh-ancestor
5739938|NCT03106948|Chelating Agents|chelating agents|mesh-ancestor
5739939|NCT03106948|Sequestering Agents|sequestering agents|mesh-ancestor
5739940|NCT03106948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5739941|NCT03107169|Vancomycin|vancomycin|mesh-list
5739942|NCT03107169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5739943|NCT03107169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5739944|NCT03106831|Norepinephrine|norepinephrine|mesh-list
5739945|NCT03106831|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5739946|NCT03106831|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5618984|NCT02283853|Dermatologic Agents|dermatologic agents|mesh-ancestor
5618985|NCT02283853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5618986|NCT02283853|Immunologic Factors|immunologic factors|mesh-ancestor
5618987|NCT02283853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618988|NCT02283853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5618989|NCT02176668|Esomeprazole|esomeprazole|mesh-list
5618990|NCT02176668|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5618991|NCT02176668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5618992|NCT02176668|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5618993|NCT02176668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5618994|NCT02176668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739947|NCT03106831|Adrenergic Agents|adrenergic agents|mesh-ancestor
5739948|NCT03106831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5739949|NCT03106831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739950|NCT03106831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5618995|NCT02143063|Cocaine|cocaine|mesh-list
5618996|NCT02143063|Anesthetics, Local|anesthetics, local|mesh-ancestor
5618997|NCT02143063|Anesthetics|anesthetics|mesh-ancestor
5618998|NCT02143063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5618999|NCT02143063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5619000|NCT02143063|Sensory System Agents|sensory system agents|mesh-ancestor
5619001|NCT02143063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5619002|NCT02143063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5619003|NCT02143063|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5739951|NCT03106831|Sympathomimetics|sympathomimetics|mesh-ancestor
5739952|NCT03106831|Autonomic Agents|autonomic agents|mesh-ancestor
5739953|NCT03106831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5739954|NCT03106831|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5893442|NCT05018013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5619004|NCT02143063|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5619005|NCT02143063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5619006|NCT02143063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619007|NCT02143063|Dopamine Agents|dopamine agents|mesh-ancestor
5619008|NCT02143063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5619009|NCT02073097|Acyclovir|acyclovir|mesh-list
5619010|NCT02073097|Prednisone|prednisone|mesh-list
5619011|NCT02073097|Cyclophosphamide|cyclophosphamide|mesh-list
5619012|NCT02073097|Rituximab|rituximab|mesh-list
5619013|NCT02073097|Doxorubicin|doxorubicin|mesh-list
5619014|NCT02073097|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5619015|NCT02073097|Vincristine|vincristine|mesh-list
5619016|NCT02073097|Sargramostim|sargramostim|mesh-list
5619017|NCT02073097|Lenograstim|lenograstim|mesh-list
5619018|NCT02073097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5619019|NCT02073097|Immunologic Factors|immunologic factors|mesh-ancestor
5619020|NCT02073097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5619021|NCT02073097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5619022|NCT02073097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5619023|NCT02073097|Alkylating Agents|alkylating agents|mesh-ancestor
5619024|NCT02073097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619025|NCT02073097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5619026|NCT02073097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5619027|NCT02073097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5619028|NCT02073097|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5619029|NCT02073097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5619030|NCT02073097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5619031|NCT02073097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5619032|NCT02073097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5893443|NCT05018013|Antidepressive Agents|antidepressive agents|mesh-ancestor
5893444|NCT05018013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5893445|NCT05018013|Dopamine Agents|dopamine agents|mesh-ancestor
5893446|NCT04908800|Itraconazole|itraconazole|mesh-list
5893447|NCT04908800|Antifungal Agents|antifungal agents|mesh-ancestor
5893448|NCT04908800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5893449|NCT04908800|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5893450|NCT04908800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5893451|NCT04908800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5893452|NCT04908800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893453|NCT04908800|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5893454|NCT04908800|Hormone Antagonists|hormone antagonists|mesh-ancestor
5619033|NCT02073097|Glucocorticoids|glucocorticoids|mesh-ancestor
5619034|NCT02073097|Hormones|hormones|mesh-ancestor
5619035|NCT02073097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5893455|NCT04908800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5893456|NCT04908800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893457|NCT04908800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5893458|NCT04872582|Bevacizumab|bevacizumab|mesh-list
5893459|NCT04872582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5893460|NCT04872582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5893461|NCT04872582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5893462|NCT04872582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5893463|NCT04872582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5893464|NCT04872582|Growth Substances|growth substances|mesh-ancestor
5893465|NCT04872582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893466|NCT04872582|Growth Inhibitors|growth inhibitors|mesh-ancestor
5893467|NCT04872582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619036|NCT02073097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5619037|NCT02073097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5619038|NCT02073097|Tubulin Modulators|tubulin modulators|mesh-ancestor
5619039|NCT02073097|Antimitotic Agents|antimitotic agents|mesh-ancestor
5619040|NCT02073097|Mitosis Modulators|mitosis modulators|mesh-ancestor
5619041|NCT02073097|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5619042|NCT02073097|Antiviral Agents|antiviral agents|mesh-ancestor
5619043|NCT02073097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5619044|NCT02017964|Cyclophosphamide|cyclophosphamide|mesh-list
5619045|NCT02017964|Carboplatin|carboplatin|mesh-list
5619046|NCT02017964|Methotrexate|methotrexate|mesh-list
5619047|NCT02017964|Etoposide|etoposide|mesh-list
5619048|NCT02017964|Vincristine|vincristine|mesh-list
5619049|NCT02017964|Etoposide phosphate|etoposide phosphate|mesh-list
5619050|NCT02017964|Podophyllotoxin|podophyllotoxin|mesh-list
5619051|NCT02017964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5619052|NCT02017964|Immunologic Factors|immunologic factors|mesh-ancestor
5619053|NCT02017964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5619054|NCT02017964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5619055|NCT02017964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5619056|NCT02017964|Alkylating Agents|alkylating agents|mesh-ancestor
5619057|NCT02017964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619058|NCT02017964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5619059|NCT02017964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5739955|NCT03106740|Minocycline|minocycline|mesh-list
5739956|NCT03106740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5739957|NCT03106740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5739958|NCT03106597|Amlodipine|amlodipine|mesh-list
5739959|NCT03106597|Manidipine|manidipine|mesh-list
5739960|NCT03106597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5739961|NCT03106597|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5739962|NCT03106597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5739963|NCT03106597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739964|NCT03106597|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5739965|NCT03106597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739966|NCT03106597|Vasodilator Agents|vasodilator agents|mesh-ancestor
5739967|NCT03106818|Ketorolac|ketorolac|mesh-list
5739968|NCT03106818|Magnesium Sulfate|magnesium sulfate|mesh-list
5739969|NCT03106818|Bupivacaine|bupivacaine|mesh-list
5739970|NCT03106818|Anesthetics, Local|anesthetics, local|mesh-list
5739971|NCT03106818|Anesthetics|anesthetics|mesh-list
5739972|NCT03106818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5739973|NCT03106818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5739974|NCT03106818|Sensory System Agents|sensory system agents|mesh-ancestor
5739975|NCT03106818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5739976|NCT03106818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5739977|NCT03106818|Analgesics|analgesics|mesh-ancestor
5739978|NCT03106818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5739979|NCT03106818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5739980|NCT03106818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5739981|NCT03106818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5739982|NCT03106818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5739983|NCT03106818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739984|NCT03106818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5739985|NCT03106818|Anticonvulsants|anticonvulsants|mesh-ancestor
5739986|NCT03106818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5739987|NCT03106818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5739988|NCT03106818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5739989|NCT03106818|Tocolytic Agents|tocolytic agents|mesh-ancestor
5739990|NCT03106818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5739991|NCT03106662|Cyclophosphamide|cyclophosphamide|mesh-list
5739992|NCT03106662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5739993|NCT03106662|Immunologic Factors|immunologic factors|mesh-ancestor
5739994|NCT03106662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208633|NCT02132949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5619060|NCT02017964|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5619061|NCT02017964|Abortifacient Agents|abortifacient agents|mesh-ancestor
5619062|NCT02017964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5619063|NCT02017964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5619064|NCT02017964|Antimetabolites|antimetabolites|mesh-ancestor
5619065|NCT02017964|Dermatologic Agents|dermatologic agents|mesh-ancestor
6208634|NCT02132949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5619066|NCT02017964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5619067|NCT02017964|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5619068|NCT02017964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5619069|NCT02017964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5739995|NCT03106662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5739996|NCT03106662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5739997|NCT03106662|Alkylating Agents|alkylating agents|mesh-ancestor
5739998|NCT03106662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5739999|NCT03106662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5740000|NCT03106662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5740001|NCT03106623|Solifenacin Succinate|solifenacin succinate|mesh-list
5740002|NCT03106623|Mirabegron|mirabegron|mesh-list
5740003|NCT03106623|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5740004|NCT03106623|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5740005|NCT03106623|Cholinergic Agents|cholinergic agents|mesh-ancestor
5740006|NCT03106623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5740007|NCT03106623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5740008|NCT03106623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740009|NCT03106623|Urological Agents|urological agents|mesh-ancestor
5619070|NCT02017964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5619071|NCT02017964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5619072|NCT02017964|Tubulin Modulators|tubulin modulators|mesh-ancestor
5619073|NCT02017964|Antimitotic Agents|antimitotic agents|mesh-ancestor
5619074|NCT02017964|Mitosis Modulators|mitosis modulators|mesh-ancestor
5619075|NCT02017964|Keratolytic Agents|keratolytic agents|mesh-ancestor
5619076|NCT01956110|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5619077|NCT01956110|Hormones|hormones|mesh-ancestor
5619078|NCT01956110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5619079|NCT01956110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5619080|NCT01404754|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
5619081|NCT01404754|Hallucinogens|hallucinogens|mesh-ancestor
5619082|NCT01404754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5619083|NCT01404754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5619084|NCT01404754|Serotonin Agents|serotonin agents|mesh-ancestor
5619085|NCT01404754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5619086|NCT01404754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619087|NCT01404754|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5619088|NCT01404754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5619089|NCT01404754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5619090|NCT01404754|Adrenergic Agents|adrenergic agents|mesh-ancestor
5619091|NCT01335581|Tretinoin|tretinoin|mesh-list
5619092|NCT01335581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5619093|NCT01335581|Keratolytic Agents|keratolytic agents|mesh-ancestor
5619094|NCT01335581|Dermatologic Agents|dermatologic agents|mesh-ancestor
5619095|NCT00920387|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
5619096|NCT00920387|Hallucinogens|hallucinogens|mesh-ancestor
5619097|NCT00920387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5619098|NCT00920387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5619099|NCT00920387|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5619100|NCT00920387|Serotonin Agents|serotonin agents|mesh-ancestor
5619101|NCT00920387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5740010|NCT03106623|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
5740011|NCT03106623|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5740012|NCT03106623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5740013|NCT03106623|Adrenergic Agents|adrenergic agents|mesh-ancestor
5740014|NCT03106610|Nivolumab|nivolumab|mesh-list
5740015|NCT03106610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5740016|NCT03106610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5740017|NCT03106610|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5740018|NCT03106610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5740019|NCT03106571|Methamphetamine|methamphetamine|mesh-list
5740020|NCT03106571|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5740021|NCT03106571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740022|NCT03106571|Sympathomimetics|sympathomimetics|mesh-ancestor
5740023|NCT03106571|Autonomic Agents|autonomic agents|mesh-ancestor
5740024|NCT03106571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5740025|NCT03106571|Dopamine Agents|dopamine agents|mesh-ancestor
5740026|NCT03106571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5740027|NCT03106571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5740028|NCT03106571|Adrenergic Agents|adrenergic agents|mesh-ancestor
5740029|NCT03106571|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5740030|NCT03106571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5740031|NCT03106571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5740032|NCT03106571|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5740033|NCT03106532|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5740034|NCT03106532|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5740035|NCT03106545|Bupivacaine|bupivacaine|mesh-list
5740036|NCT03106545|Anesthetics, Local|anesthetics, local|mesh-ancestor
5740037|NCT03106545|Anesthetics|anesthetics|mesh-ancestor
6208635|NCT02133001|Esketamine|esketamine|mesh-list
6208636|NCT02133001|Antidepressive Agents|antidepressive agents|mesh-ancestor
6208637|NCT02133001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6208638|NCT02133131|Sofosbuvir|sofosbuvir|mesh-list
6208639|NCT02133131|Grazoprevir|grazoprevir|mesh-list
6208640|NCT02133131|Antiviral Agents|antiviral agents|mesh-ancestor
6208641|NCT02133131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5619102|NCT00920387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5740038|NCT03106545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5619103|NCT00920387|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5619104|NCT00882895|Mycophenolic Acid|mycophenolic acid|mesh-list
5619105|NCT00882895|Methylprednisolone|methylprednisolone|mesh-list
5619106|NCT00882895|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5619107|NCT00882895|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5619108|NCT00882895|Prednisolone|prednisolone|mesh-list
5619109|NCT00882895|Prednisolone acetate|prednisolone acetate|mesh-list
5619110|NCT00882895|Tacrolimus|tacrolimus|mesh-list
5619111|NCT00882895|Thymoglobulin|thymoglobulin|mesh-list
5619112|NCT00882895|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5619113|NCT00882895|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5619114|NCT00882895|Prednisolone phosphate|prednisolone phosphate|mesh-list
5619115|NCT00882895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5619116|NCT00882895|Immunologic Factors|immunologic factors|mesh-ancestor
5619117|NCT00882895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5619118|NCT00882895|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5619119|NCT00882895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5619120|NCT00882895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619121|NCT00882895|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5619122|NCT00882895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5619123|NCT00882895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5619124|NCT00882895|Antitubercular Agents|antitubercular agents|mesh-ancestor
5619125|NCT00882895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5619126|NCT00882895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5619127|NCT00882895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5619128|NCT00882895|Antiemetics|antiemetics|mesh-ancestor
5619129|NCT00882895|Autonomic Agents|autonomic agents|mesh-ancestor
5619130|NCT00882895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5619131|NCT00882895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5619132|NCT00882895|Glucocorticoids|glucocorticoids|mesh-ancestor
5619133|NCT00882895|Hormones|hormones|mesh-ancestor
5619134|NCT00882895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5740039|NCT03106545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740040|NCT03106545|Sensory System Agents|sensory system agents|mesh-ancestor
5740041|NCT03106545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5740042|NCT03106454|Ferrous fumarate|ferrous fumarate|mesh-list
5740043|NCT03106454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5619135|NCT00882895|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5619136|NCT00882895|Protective Agents|protective agents|mesh-ancestor
5619137|NCT00882895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5619138|NCT00867178|Vitamin A|vitamin a|mesh-list
5619139|NCT00867178|Cyclophosphamide|cyclophosphamide|mesh-list
5619140|NCT00867178|Thiotepa|thiotepa|mesh-list
5619141|NCT00867178|Cisplatin|cisplatin|mesh-list
5740044|NCT03106454|Norethindrone|norethindrone|mesh-list
5740045|NCT03106454|Norethindrone Acetate|norethindrone acetate|mesh-list
5740046|NCT03106454|Estradiol|estradiol|mesh-list
5740047|NCT03106454|Estrogens|estrogens|mesh-ancestor
5740048|NCT03106454|Hormones|hormones|mesh-ancestor
5740049|NCT03106454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5740050|NCT03106454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740051|NCT03106454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5740052|NCT03106454|Contraceptive Agents|contraceptive agents|mesh-ancestor
5740053|NCT03106454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5740054|NCT03106454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5740055|NCT03106454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5740056|NCT03106454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5619142|NCT00867178|Carboplatin|carboplatin|mesh-list
5619143|NCT00867178|Etoposide|etoposide|mesh-list
5619144|NCT00867178|Vincristine|vincristine|mesh-list
5740057|NCT03106454|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5740058|NCT03106454|Trace Elements|trace elements|mesh-ancestor
5740059|NCT03106454|Micronutrients|micronutrients|mesh-ancestor
5619145|NCT00867178|Vorinostat|vorinostat|mesh-list
5619146|NCT00867178|Tretinoin|tretinoin|mesh-list
5740060|NCT03106363|Ethanol|ethanol|mesh-list
5740061|NCT03106363|Dronabinol|dronabinol|mesh-list
5740062|NCT03106363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6208642|NCT02133352|Ranolazine|ranolazine|mesh-list
6208643|NCT02133352|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5740063|NCT03106363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5740064|NCT03106363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5740065|NCT03106363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740066|NCT03106363|Hallucinogens|hallucinogens|mesh-ancestor
5740067|NCT03106363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5740068|NCT03106363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5740069|NCT03106363|Analgesics|analgesics|mesh-ancestor
5740070|NCT03106363|Sensory System Agents|sensory system agents|mesh-ancestor
5740071|NCT03106363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5740072|NCT03106363|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5740073|NCT03106363|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5740074|NCT03106363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5740075|NCT03106363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5740076|NCT03106363|Hormones|hormones|mesh-ancestor
5740077|NCT03106363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5740078|NCT03106519|Bupivacaine|bupivacaine|mesh-list
5740079|NCT03106519|Anesthetics, Local|anesthetics, local|mesh-ancestor
5740080|NCT03106519|Anesthetics|anesthetics|mesh-ancestor
5740081|NCT03106519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5740082|NCT03106519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740083|NCT03106519|Sensory System Agents|sensory system agents|mesh-ancestor
5619147|NCT00867178|Etoposide phosphate|etoposide phosphate|mesh-list
5619148|NCT00867178|Isotretinoin|isotretinoin|mesh-list
5619149|NCT00867178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5619150|NCT00867178|Immunologic Factors|immunologic factors|mesh-ancestor
5619151|NCT00867178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5619152|NCT00867178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5619153|NCT00867178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5619154|NCT00867178|Alkylating Agents|alkylating agents|mesh-ancestor
5619155|NCT00867178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619156|NCT00867178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5619157|NCT00867178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5619158|NCT00867178|Vitamins|vitamins|mesh-ancestor
5619159|NCT00867178|Micronutrients|micronutrients|mesh-ancestor
5619160|NCT00867178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5740084|NCT03106519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5740085|NCT03106389|Misoprostol|misoprostol|mesh-list
5740086|NCT03106389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5740087|NCT03106389|Abortifacient Agents|abortifacient agents|mesh-ancestor
5740088|NCT03106389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5740089|NCT03106389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5619161|NCT00867178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5619162|NCT00867178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5619163|NCT00867178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5619164|NCT00867178|Tubulin Modulators|tubulin modulators|mesh-ancestor
5619165|NCT00867178|Antimitotic Agents|antimitotic agents|mesh-ancestor
5619166|NCT00867178|Mitosis Modulators|mitosis modulators|mesh-ancestor
5619167|NCT00867178|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5740090|NCT03106389|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5740091|NCT03106389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5740092|NCT03106389|Oxytocics|oxytocics|mesh-ancestor
5740093|NCT03106311|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5740094|NCT03106311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5740095|NCT03106311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740096|NCT03106402|Bromfenac|bromfenac|mesh-list
5740097|NCT03106402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5740098|NCT03106402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5740099|NCT03106402|Analgesics|analgesics|mesh-ancestor
5740100|NCT03106402|Sensory System Agents|sensory system agents|mesh-ancestor
5740101|NCT03106402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5740102|NCT03106402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740103|NCT03106402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5740104|NCT03106402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5740105|NCT03106298|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
5740106|NCT03106298|Hematinics|hematinics|mesh-ancestor
5740107|NCT03106324|Lenalidomide|lenalidomide|mesh-list
5740108|NCT03106324|Immunologic Factors|immunologic factors|mesh-ancestor
5740109|NCT03106324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740110|NCT03106324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5740111|NCT03106324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5740112|NCT03106324|Growth Substances|growth substances|mesh-ancestor
5740113|NCT03106324|Growth Inhibitors|growth inhibitors|mesh-ancestor
5740114|NCT03106324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5740115|NCT03105830|Acetaminophen|acetaminophen|mesh-list
5619168|NCT00867178|Keratolytic Agents|keratolytic agents|mesh-ancestor
5619169|NCT00867178|Dermatologic Agents|dermatologic agents|mesh-ancestor
5619170|NCT00787176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5619171|NCT00787176|Oxytocin|oxytocin|mesh-list
5740116|NCT03105830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5740117|NCT03105830|Analgesics|analgesics|mesh-ancestor
5740118|NCT03105830|Sensory System Agents|sensory system agents|mesh-ancestor
5740119|NCT03105830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5740120|NCT03105830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740121|NCT03105830|Antipyretics|antipyretics|mesh-ancestor
5740122|NCT03105986|Probenecid|probenecid|mesh-list
5740123|NCT03105986|Uricosuric Agents|uricosuric agents|mesh-ancestor
5740124|NCT03105986|Gout Suppressants|gout suppressants|mesh-ancestor
5740125|NCT03105986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5740126|NCT03105986|Renal Agents|renal agents|mesh-ancestor
5619172|NCT00787176|Oxytocics|oxytocics|mesh-ancestor
5619173|NCT00787176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5619174|NCT00787176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5619175|NCT00352534|Dactinomycin|dactinomycin|mesh-list
5619176|NCT00352534|Cactinomycin|cactinomycin|mesh-list
5619177|NCT00352534|Doxorubicin|doxorubicin|mesh-list
5619178|NCT00352534|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5619179|NCT00352534|Vincristine|vincristine|mesh-list
5619180|NCT00352534|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5619181|NCT00352534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5619182|NCT00352534|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5619183|NCT00352534|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5619184|NCT00352534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5740140|NCT03105960|Chlorhexidine|chlorhexidine|mesh-list
5740141|NCT03105960|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5740142|NCT03105960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5740143|NCT03105960|Disinfectants|disinfectants|mesh-ancestor
5740144|NCT03105661|Atenolol|atenolol|mesh-list
5740145|NCT03105661|Labetalol|labetalol|mesh-list
5740146|NCT03105661|Nifedipine|nifedipine|mesh-list
5740147|NCT03105661|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5740148|NCT03105661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5619185|NCT00352534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619186|NCT00352534|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5619187|NCT00352534|Tubulin Modulators|tubulin modulators|mesh-ancestor
5619188|NCT00352534|Antimitotic Agents|antimitotic agents|mesh-ancestor
5619189|NCT00352534|Mitosis Modulators|mitosis modulators|mesh-ancestor
5619190|NCT00352534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5619191|NCT00352534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5619192|NCT00352534|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5619193|NCT00352534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5619194|NCT00033293|Prednisone|prednisone|mesh-list
5619195|NCT00033293|Cyclophosphamide|cyclophosphamide|mesh-list
5619196|NCT00033293|Immunoglobulins|immunoglobulins|mesh-list
5619197|NCT00033293|Antibodies|antibodies|mesh-list
5619198|NCT00033293|gamma-Globulins|gamma-globulins|mesh-list
5619199|NCT00033293|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5740149|NCT03105661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5740150|NCT03105661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5740151|NCT03105661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740152|NCT03105661|Vasodilator Agents|vasodilator agents|mesh-ancestor
5740153|NCT03105661|Tocolytic Agents|tocolytic agents|mesh-ancestor
5740154|NCT03105661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5740155|NCT03105661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5740156|NCT03105661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5740157|NCT03105661|Sympatholytics|sympatholytics|mesh-ancestor
5740158|NCT03105661|Autonomic Agents|autonomic agents|mesh-ancestor
5740159|NCT03105661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5619200|NCT00033293|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5619201|NCT00033293|Hormones|hormones|mesh-list
5740160|NCT03105661|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5740161|NCT03105661|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5740162|NCT03105661|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5740163|NCT03105661|Adrenergic Agents|adrenergic agents|mesh-ancestor
5740164|NCT03105661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5740165|NCT03105661|Sympathomimetics|sympathomimetics|mesh-ancestor
5740166|NCT03105661|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5740167|NCT03105661|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5740168|NCT03105791|Analgesics, Opioid|analgesics, opioid|mesh-list
5740169|NCT03105791|Narcotics|narcotics|mesh-ancestor
5740170|NCT03105791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5740171|NCT03105791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740172|NCT03105791|Analgesics|analgesics|mesh-ancestor
5740173|NCT03105791|Sensory System Agents|sensory system agents|mesh-ancestor
5740174|NCT03105791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5740175|NCT03105674|Anesthetics|anesthetics|mesh-list
5740176|NCT03105674|Anesthetics, Local|anesthetics, local|mesh-list
5740177|NCT03105674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5740178|NCT03105674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740179|NCT03105674|Sensory System Agents|sensory system agents|mesh-ancestor
5740180|NCT03105674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5740181|NCT03105765|Ketamine|ketamine|mesh-list
5740182|NCT03105765|Analgesics|analgesics|mesh-ancestor
5740183|NCT03105765|Sensory System Agents|sensory system agents|mesh-ancestor
5740184|NCT03105765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5740185|NCT03105765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740186|NCT03105765|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5740187|NCT03105765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5740188|NCT03105765|Anesthetics, General|anesthetics, general|mesh-ancestor
5740189|NCT03105765|Anesthetics|anesthetics|mesh-ancestor
5740190|NCT03105765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5740191|NCT03105765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5740192|NCT03105765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5740193|NCT03105765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5740194|NCT03105765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5740195|NCT03105505|Fusidic Acid|fusidic acid|mesh-list
5740196|NCT03105505|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5740197|NCT03105505|Permethrin|permethrin|mesh-list
5740198|NCT03105505|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5740199|NCT03105505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5740200|NCT03105505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5740201|NCT03105505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5619202|NCT00033293|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
5619203|NCT00033293|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
5619204|NCT00033293|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
5619205|NCT00033293|beta-Endorphin|beta-endorphin|mesh-list
5619206|NCT00033293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5619207|NCT00033293|Immunologic Factors|immunologic factors|mesh-ancestor
5619208|NCT00033293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5619209|NCT00033293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5619210|NCT00033293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5619211|NCT00033293|Alkylating Agents|alkylating agents|mesh-ancestor
5619212|NCT00033293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619213|NCT00033293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5619214|NCT00033293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5619215|NCT00033293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5619216|NCT00033293|Glucocorticoids|glucocorticoids|mesh-ancestor
5619217|NCT00033293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5740202|NCT03105505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5740203|NCT03105505|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5740204|NCT03105193|Lidocaine|lidocaine|mesh-list
5740205|NCT03105193|Anesthetics, Local|anesthetics, local|mesh-ancestor
5740206|NCT03105193|Anesthetics|anesthetics|mesh-ancestor
5740207|NCT03105193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5740208|NCT03105193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740209|NCT03105193|Sensory System Agents|sensory system agents|mesh-ancestor
5740210|NCT03105193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5740211|NCT03105193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5740212|NCT03105193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5740213|NCT03105193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5740214|NCT03105193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5740215|NCT03105193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619218|NCT00033293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5619219|NCT00033293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5619220|NCT05193370|Vasopressins|vasopressins|mesh-list
5619221|NCT05193370|Arginine Vasopressin|arginine vasopressin|mesh-list
5619222|NCT05193370|Angiotensin II|angiotensin ii|mesh-list
5619223|NCT05193370|Giapreza|giapreza|mesh-list
5619224|NCT05193370|Angiotensinogen|angiotensinogen|mesh-list
5619225|NCT05193370|Hemostatics|hemostatics|mesh-ancestor
5619226|NCT05193370|Coagulants|coagulants|mesh-ancestor
5619227|NCT05193370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5619228|NCT05193370|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5740216|NCT03105310|Interferons|interferons|mesh-list
5740217|NCT03105310|Interferon-alpha|interferon-alpha|mesh-list
5740218|NCT03105310|Ezetimibe|ezetimibe|mesh-list
5740219|NCT03105310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5740220|NCT03105310|Antiviral Agents|antiviral agents|mesh-ancestor
5740221|NCT03105310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5740222|NCT03105310|Immunologic Factors|immunologic factors|mesh-ancestor
5740223|NCT03105310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740224|NCT03105310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5740225|NCT03105310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5740226|NCT03105310|Antimetabolites|antimetabolites|mesh-ancestor
5740227|NCT03105310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5740228|NCT03105310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5740229|NCT03105583|Vitamins|vitamins|mesh-list
5740230|NCT03105583|Micronutrients|micronutrients|mesh-ancestor
5740231|NCT03105583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740232|NCT03105180|Mannitol|mannitol|mesh-list
5740233|NCT03105180|Sorbitol|sorbitol|mesh-list
5740234|NCT03105180|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5740235|NCT03105180|Diuretics|diuretics|mesh-ancestor
5740236|NCT03105180|Natriuretic Agents|natriuretic agents|mesh-ancestor
5740237|NCT03105180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740238|NCT03105180|Cathartics|cathartics|mesh-ancestor
5740239|NCT03105180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5893468|NCT04818372|Dexamethasone|dexamethasone|mesh-list
5893469|NCT04818372|Lenalidomide|lenalidomide|mesh-list
5893470|NCT04818372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5893471|NCT04818372|Antiemetics|antiemetics|mesh-ancestor
5893472|NCT04818372|Autonomic Agents|autonomic agents|mesh-ancestor
5893473|NCT04818372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5893474|NCT04818372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893475|NCT04818372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5893476|NCT04818372|Glucocorticoids|glucocorticoids|mesh-ancestor
5619229|NCT05193370|Natriuretic Agents|natriuretic agents|mesh-ancestor
5619230|NCT05193370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5619231|NCT05193370|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5619232|NCT05193370|Protease Inhibitors|protease inhibitors|mesh-ancestor
5619233|NCT05193370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5619234|NCT05193370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619235|NCT05193318|Ketamine|ketamine|mesh-list
5893477|NCT04818372|Hormones|hormones|mesh-ancestor
5893478|NCT04818372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5893479|NCT04818372|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5893480|NCT04818372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5893481|NCT04818372|Immunologic Factors|immunologic factors|mesh-ancestor
5893482|NCT04818372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5893483|NCT04818372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5893484|NCT04818372|Growth Substances|growth substances|mesh-ancestor
5893485|NCT04818372|Growth Inhibitors|growth inhibitors|mesh-ancestor
5893486|NCT04784299|Lidocaine|lidocaine|mesh-list
5893487|NCT04784299|Anesthetics, Local|anesthetics, local|mesh-ancestor
5893488|NCT04784299|Anesthetics|anesthetics|mesh-ancestor
5893489|NCT04784299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5893490|NCT04784299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893491|NCT04784299|Sensory System Agents|sensory system agents|mesh-ancestor
5893492|NCT04784299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5893493|NCT04784299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5619236|NCT05193318|Analgesics|analgesics|mesh-ancestor
5619237|NCT05193318|Sensory System Agents|sensory system agents|mesh-ancestor
5619238|NCT05193318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5619239|NCT05193318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893494|NCT04784299|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5893495|NCT04784299|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5893496|NCT04784299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5619240|NCT05193318|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5619241|NCT05193318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5907762|NCT05203445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5619242|NCT05193318|Anesthetics, General|anesthetics, general|mesh-ancestor
5619243|NCT05193318|Anesthetics|anesthetics|mesh-ancestor
5619244|NCT05193318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5619245|NCT05193318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5619246|NCT05193318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5619247|NCT05193318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5619248|NCT05193318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619249|NCT05193292|Trastuzumab|trastuzumab|mesh-list
5619250|NCT05193292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5619251|NCT05193292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5619252|NCT05193227|Lidocaine|lidocaine|mesh-list
5619253|NCT05193227|Bupivacaine|bupivacaine|mesh-list
5619254|NCT05193227|Anesthetics, Local|anesthetics, local|mesh-ancestor
5619255|NCT05193227|Anesthetics|anesthetics|mesh-ancestor
5619256|NCT05193227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5619257|NCT05193227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5619258|NCT05193227|Sensory System Agents|sensory system agents|mesh-ancestor
5619259|NCT05193227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5619260|NCT05193227|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5619261|NCT05193227|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5619262|NCT05193227|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5619263|NCT05193227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5740240|NCT03105115|Fentanyl|fentanyl|mesh-list
5740241|NCT03105115|Bupivacaine|bupivacaine|mesh-list
5740242|NCT03105115|Anesthetics, Local|anesthetics, local|mesh-ancestor
5740243|NCT03105115|Anesthetics|anesthetics|mesh-ancestor
5740244|NCT03105115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5740245|NCT03105115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740246|NCT03105115|Sensory System Agents|sensory system agents|mesh-ancestor
5740247|NCT03105115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5740248|NCT03105115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5740249|NCT03105115|Narcotics|narcotics|mesh-ancestor
5740250|NCT03105115|Analgesics|analgesics|mesh-ancestor
5740251|NCT03105115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5740252|NCT03105115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5740253|NCT03105115|Anesthetics, General|anesthetics, general|mesh-ancestor
5740254|NCT03105349|Ribavirin|ribavirin|mesh-list
5619264|NCT05193227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619265|NCT05193214|Antibodies|antibodies|mesh-list
5619266|NCT05193214|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5619267|NCT05193214|Immunologic Factors|immunologic factors|mesh-ancestor
5619268|NCT05193214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740255|NCT03105349|Sofosbuvir|sofosbuvir|mesh-list
5740256|NCT03105349|Grazoprevir|grazoprevir|mesh-list
5740257|NCT03105349|Antimetabolites|antimetabolites|mesh-ancestor
5740258|NCT03105349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5740259|NCT03105349|Antiviral Agents|antiviral agents|mesh-ancestor
5740260|NCT03105349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5619269|NCT05193188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5619270|NCT05193188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619271|NCT05193188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5740261|NCT03105245|Thiopental|thiopental|mesh-list
5740262|NCT03105245|Anesthetics|anesthetics|mesh-list
5740263|NCT03105245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5740264|NCT03105245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740265|NCT03105245|Anticonvulsants|anticonvulsants|mesh-ancestor
5740266|NCT03105245|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5740267|NCT03105245|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5740268|NCT03105245|Anesthetics, General|anesthetics, general|mesh-ancestor
5740269|NCT03105245|GABA Modulators|gaba modulators|mesh-ancestor
5740270|NCT03105245|GABA Agents|gaba agents|mesh-ancestor
5740271|NCT03105245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5740272|NCT03105245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5740273|NCT03105336|Cyclophosphamide|cyclophosphamide|mesh-list
5740274|NCT03105336|Fludarabine|fludarabine|mesh-list
5740275|NCT03105336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5740276|NCT03105336|Immunologic Factors|immunologic factors|mesh-ancestor
5740277|NCT03105336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740278|NCT03105336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5740279|NCT03105336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5740280|NCT03105336|Alkylating Agents|alkylating agents|mesh-ancestor
5740281|NCT03105336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5740282|NCT03105336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5740283|NCT03105336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5740284|NCT03105375|Omeprazole|omeprazole|mesh-list
5740285|NCT03105375|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5740286|NCT03105375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5740287|NCT03105375|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5740288|NCT03105375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5740289|NCT03105375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5740290|NCT03105466|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
5740291|NCT03105466|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5740292|NCT03105466|Tacrolimus|tacrolimus|mesh-list
5740293|NCT03105466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5740294|NCT03105466|Immunologic Factors|immunologic factors|mesh-ancestor
5740295|NCT03105466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5619294|NCT05193019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
5692396|NCT03408236|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5692397|NCT03408236|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5692398|NCT03408236|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5692399|NCT03408236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5692400|NCT03408236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692401|NCT03408236|Cholinergic Agents|cholinergic agents|mesh-ancestor
5692402|NCT03408236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5692403|NCT03408236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692404|NCT03408236|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5692405|NCT03408236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5692406|NCT03408145|Hyaluronic Acid|hyaluronic acid|mesh-list
5692407|NCT03408145|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5692408|NCT03408145|Immunologic Factors|immunologic factors|mesh-ancestor
5692409|NCT03408145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692410|NCT03408145|Viscosupplements|viscosupplements|mesh-ancestor
5692411|NCT03408145|Protective Agents|protective agents|mesh-ancestor
5692412|NCT03408119|Vitamin D|vitamin d|mesh-list
5692413|NCT03408119|Calcium|calcium|mesh-list
5692414|NCT03408119|Vitamins|vitamins|mesh-ancestor
5692415|NCT03408119|Micronutrients|micronutrients|mesh-ancestor
5692416|NCT03408119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692417|NCT03408119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5692418|NCT03408119|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5692419|NCT03408093|Interferons|interferons|mesh-list
5692420|NCT03408093|Interferon-beta|interferon-beta|mesh-list
5692421|NCT03408093|Interferon beta-1b|interferon beta-1b|mesh-list
5692422|NCT03408093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5692423|NCT03408093|Antiviral Agents|antiviral agents|mesh-ancestor
5692424|NCT03408093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5692425|NCT03408093|Immunologic Factors|immunologic factors|mesh-ancestor
5692426|NCT03408093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692427|NCT03408093|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5692428|NCT03408054|Nitroglycerin|nitroglycerin|mesh-list
5692429|NCT03408054|Oxytocin|oxytocin|mesh-list
5692430|NCT03408054|Oxytocics|oxytocics|mesh-ancestor
5692431|NCT03408054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5692432|NCT03408054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692433|NCT03408054|Vasodilator Agents|vasodilator agents|mesh-ancestor
5692434|NCT03408015|Lifitegrast|lifitegrast|mesh-list
5692435|NCT03408015|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5692436|NCT03408015|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5692437|NCT03407976|Pembrolizumab|pembrolizumab|mesh-list
5740296|NCT03105466|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5619295|NCT05192902|Anesthetics|anesthetics|mesh-list
5619296|NCT05192902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5619297|NCT05192902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5619298|NCT05192889|Leucovorin|leucovorin|mesh-list
5619299|NCT05192889|Cytarabine|cytarabine|mesh-list
5619300|NCT05192889|Dexamethasone|dexamethasone|mesh-list
5619301|NCT05192889|Hydrocortisone|hydrocortisone|mesh-list
5619302|NCT05192889|Cyclophosphamide|cyclophosphamide|mesh-list
5619303|NCT05192889|Methotrexate|methotrexate|mesh-list
5619304|NCT05192889|Etoposide|etoposide|mesh-list
5619305|NCT05192889|Vincristine|vincristine|mesh-list
5619306|NCT05192889|Asparaginase|asparaginase|mesh-list
5619307|NCT05192889|Dasatinib|dasatinib|mesh-list
5619308|NCT05192889|Venetoclax|venetoclax|mesh-list
5619309|NCT05192889|Mercaptopurine|mercaptopurine|mesh-list
5619310|NCT05192889|Pegaspargase|pegaspargase|mesh-list
5619311|NCT05192889|Blinatumomab|blinatumomab|mesh-list
5619312|NCT05192889|Navitoclax|navitoclax|mesh-list
5619313|NCT05192889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5740297|NCT03105466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5740298|NCT03105466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5740299|NCT03105466|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5740300|NCT03105466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5740301|NCT03105466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5740302|NCT03105466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5619314|NCT05192889|Immunologic Factors|immunologic factors|mesh-ancestor
5740303|NCT03105466|Glucocorticoids|glucocorticoids|mesh-ancestor
5740304|NCT03105466|Hormones|hormones|mesh-ancestor
5740305|NCT03105466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5740306|NCT03105102|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5740307|NCT03105102|Immunologic Factors|immunologic factors|mesh-ancestor
5740308|NCT03105102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740309|NCT03104959|Acetylcysteine|acetylcysteine|mesh-list
5740310|NCT03104959|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5740311|NCT03104959|Antiviral Agents|antiviral agents|mesh-ancestor
5740312|NCT03104959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5740313|NCT03104959|Expectorants|expectorants|mesh-ancestor
5740314|NCT03104959|Respiratory System Agents|respiratory system agents|mesh-ancestor
5740315|NCT03104959|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5740316|NCT03104959|Antioxidants|antioxidants|mesh-ancestor
5740317|NCT03104959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5740318|NCT03104959|Protective Agents|protective agents|mesh-ancestor
5740319|NCT03104959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740320|NCT03104959|Antidotes|antidotes|mesh-ancestor
5740321|NCT03104998|Ubiquinone|ubiquinone|mesh-list
5740322|NCT03104998|Coenzyme Q10|coenzyme q10|mesh-list
5740323|NCT03104998|Micronutrients|micronutrients|mesh-ancestor
5740324|NCT03104998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740325|NCT03104998|Vitamins|vitamins|mesh-ancestor
5740326|NCT03104790|Vaccines|vaccines|mesh-list
5740327|NCT03104790|Immunologic Factors|immunologic factors|mesh-ancestor
5740328|NCT03104790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740329|NCT03104842|Dexamethasone|dexamethasone|mesh-list
5740330|NCT03104842|Lenalidomide|lenalidomide|mesh-list
5619315|NCT05192889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5619316|NCT05192889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5619317|NCT05192889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5619318|NCT05192889|Alkylating Agents|alkylating agents|mesh-ancestor
5740331|NCT03104842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5740332|NCT03104842|Antiemetics|antiemetics|mesh-ancestor
5740333|NCT03104842|Autonomic Agents|autonomic agents|mesh-ancestor
5740334|NCT03104842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5740335|NCT03104842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740336|NCT03104842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5740337|NCT03104842|Glucocorticoids|glucocorticoids|mesh-ancestor
5740338|NCT03104842|Hormones|hormones|mesh-ancestor
5740339|NCT03104842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5740340|NCT03104842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5740341|NCT03104842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5740342|NCT03104842|Immunologic Factors|immunologic factors|mesh-ancestor
5740343|NCT03104842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5740344|NCT03104842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5740345|NCT03104842|Growth Substances|growth substances|mesh-ancestor
5740346|NCT03104842|Growth Inhibitors|growth inhibitors|mesh-ancestor
5740347|NCT03104855|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
5740348|NCT03104855|Calcifediol|calcifediol|mesh-list
5740349|NCT03104855|Vitamins|vitamins|mesh-ancestor
5740350|NCT03104855|Micronutrients|micronutrients|mesh-ancestor
5740351|NCT03104855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740352|NCT03104855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5740353|NCT03104621|Benzalkonium Compounds|benzalkonium compounds|mesh-list
5740354|NCT03104621|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5740355|NCT03104621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5740356|NCT03104634|Bromides|bromides|mesh-list
5740357|NCT03104634|Formoterol Fumarate|formoterol fumarate|mesh-list
5740358|NCT03104634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5740359|NCT03104634|Autonomic Agents|autonomic agents|mesh-ancestor
5740360|NCT03104634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5740361|NCT03104634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740362|NCT03104634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5740363|NCT03104634|Respiratory System Agents|respiratory system agents|mesh-ancestor
5740364|NCT03104634|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5740365|NCT03104634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5740366|NCT03104634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5740367|NCT03104634|Adrenergic Agents|adrenergic agents|mesh-ancestor
5740368|NCT03104634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5740369|NCT03104634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5740370|NCT03104634|Anticonvulsants|anticonvulsants|mesh-ancestor
5740371|NCT03104491|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
5740372|NCT03104491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5740373|NCT03104491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5740374|NCT03104491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5740375|NCT03104426|Darbepoetin alfa|darbepoetin alfa|mesh-list
5740376|NCT03104426|Hematinics|hematinics|mesh-ancestor
5740377|NCT03104439|Nivolumab|nivolumab|mesh-list
5740378|NCT03104439|Ipilimumab|ipilimumab|mesh-list
5740379|NCT03104439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5740380|NCT03104439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5740381|NCT03104439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5740382|NCT03104439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5740383|NCT03104283|Apatinib|apatinib|mesh-list
5619319|NCT05192889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619320|NCT05192889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5619321|NCT05192889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5619322|NCT05192889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5619323|NCT05192889|Antiemetics|antiemetics|mesh-ancestor
5619324|NCT05192889|Autonomic Agents|autonomic agents|mesh-ancestor
5619325|NCT05192889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5619326|NCT05192889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5740384|NCT03104283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5740385|NCT03104283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5740386|NCT03104283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5740387|NCT03104283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5740388|NCT03104335|Apatinib|apatinib|mesh-list
5740389|NCT03104335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5740390|NCT03104335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5740391|NCT03104335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5740392|NCT03104335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619327|NCT05192889|Glucocorticoids|glucocorticoids|mesh-ancestor
5619328|NCT05192889|Hormones|hormones|mesh-ancestor
5619329|NCT05192889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5619330|NCT05192889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5619331|NCT05192889|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5619332|NCT05192889|Abortifacient Agents|abortifacient agents|mesh-ancestor
5619333|NCT05192889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5619334|NCT05192889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5619335|NCT05192889|Antimetabolites|antimetabolites|mesh-ancestor
5619336|NCT05192889|Dermatologic Agents|dermatologic agents|mesh-ancestor
5619337|NCT05192889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5619338|NCT05192889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5619339|NCT05192889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5619340|NCT05192889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5619341|NCT05192889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5619342|NCT05192889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5619343|NCT05192889|Antiviral Agents|antiviral agents|mesh-ancestor
5619344|NCT05192889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5619345|NCT05192889|Antidotes|antidotes|mesh-ancestor
5619346|NCT05192889|Protective Agents|protective agents|mesh-ancestor
5619347|NCT05192889|Vitamin B Complex|vitamin b complex|mesh-ancestor
5619348|NCT05192889|Vitamins|vitamins|mesh-ancestor
5619349|NCT05192889|Micronutrients|micronutrients|mesh-ancestor
5619350|NCT05192889|Tubulin Modulators|tubulin modulators|mesh-ancestor
5619351|NCT05192889|Antimitotic Agents|antimitotic agents|mesh-ancestor
5740393|NCT03104309|Levonorgestrel|levonorgestrel|mesh-list
5740394|NCT03104309|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5740395|NCT03104309|Contraceptive Agents|contraceptive agents|mesh-ancestor
5740396|NCT03104309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5740397|NCT03104309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740398|NCT03104309|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5740399|NCT03104309|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5740400|NCT03104309|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5619352|NCT05192889|Mitosis Modulators|mitosis modulators|mesh-ancestor
5619353|NCT05192889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5619354|NCT05192850|Metformin|metformin|mesh-list
5619355|NCT05192850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5619356|NCT05192850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5619357|NCT05192798|Paclitaxel|paclitaxel|mesh-list
5619358|NCT05192798|Bevacizumab|bevacizumab|mesh-list
5619359|NCT05192798|Apatinib|apatinib|mesh-list
5740401|NCT03104140|Ketamine|ketamine|mesh-list
5740402|NCT03104140|Thiopental|thiopental|mesh-list
5740403|NCT03104140|Analgesics|analgesics|mesh-ancestor
5740404|NCT03104140|Sensory System Agents|sensory system agents|mesh-ancestor
5740405|NCT03104140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5740406|NCT03104140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740407|NCT03104140|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5740408|NCT03104140|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5740409|NCT03104140|Anesthetics, General|anesthetics, general|mesh-ancestor
5740410|NCT03104140|Anesthetics|anesthetics|mesh-ancestor
5740411|NCT03104140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5740412|NCT03104140|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5740413|NCT03104140|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5740414|NCT03104140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5740415|NCT03104140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5740416|NCT03104140|Anticonvulsants|anticonvulsants|mesh-ancestor
5740417|NCT03104140|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5740418|NCT03104140|GABA Modulators|gaba modulators|mesh-ancestor
5740419|NCT03104140|GABA Agents|gaba agents|mesh-ancestor
5740420|NCT03104270|Dexamethasone|dexamethasone|mesh-list
5740421|NCT03104270|Pomalidomide|pomalidomide|mesh-list
5619360|NCT05192798|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5740422|NCT03104270|Elotuzumab|elotuzumab|mesh-list
5740423|NCT03104270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5740424|NCT03104270|Antiemetics|antiemetics|mesh-ancestor
5740425|NCT03104270|Autonomic Agents|autonomic agents|mesh-ancestor
5740426|NCT03104270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5740427|NCT03104270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740428|NCT03104270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5740429|NCT03104270|Glucocorticoids|glucocorticoids|mesh-ancestor
5740430|NCT03104270|Hormones|hormones|mesh-ancestor
5740431|NCT03104270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5740432|NCT03104270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5740433|NCT03104270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5740434|NCT03104270|Immunologic Factors|immunologic factors|mesh-ancestor
5740435|NCT03104270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5740436|NCT03104270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5740437|NCT03104270|Growth Substances|growth substances|mesh-ancestor
5619361|NCT05192798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5619362|NCT05192798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5619363|NCT05192798|Tubulin Modulators|tubulin modulators|mesh-ancestor
5619364|NCT05192798|Antimitotic Agents|antimitotic agents|mesh-ancestor
5619365|NCT05192798|Mitosis Modulators|mitosis modulators|mesh-ancestor
5619366|NCT05192798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619367|NCT05192798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5619368|NCT05192798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5619369|NCT05192798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5619370|NCT05192798|Growth Substances|growth substances|mesh-ancestor
5619371|NCT05192798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5619372|NCT05192798|Growth Inhibitors|growth inhibitors|mesh-ancestor
5619373|NCT05192798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5619374|NCT05192798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5619375|NCT05192681|Docetaxel|docetaxel|mesh-list
5619376|NCT05192681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5619377|NCT05192681|Tubulin Modulators|tubulin modulators|mesh-ancestor
5619378|NCT05192681|Antimitotic Agents|antimitotic agents|mesh-ancestor
5619379|NCT05192681|Mitosis Modulators|mitosis modulators|mesh-ancestor
5619380|NCT05192681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619381|NCT05192629|Midazolam|midazolam|mesh-list
5619382|NCT05192629|Dexmedetomidine|dexmedetomidine|mesh-list
5619383|NCT05192629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5619384|NCT05192629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5619385|NCT05192629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5619386|NCT05192629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5619387|NCT05192629|Analgesics|analgesics|mesh-ancestor
5619388|NCT05192629|Sensory System Agents|sensory system agents|mesh-ancestor
6672850|NCT01558830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672851|NCT01558869|Capecitabine|capecitabine|mesh-list
6672852|NCT01558869|Oxaliplatin|oxaliplatin|mesh-list
6672853|NCT01558869|Irinotecan|irinotecan|mesh-list
6672854|NCT01558869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6672855|NCT01558869|Antimetabolites|antimetabolites|mesh-ancestor
6672856|NCT01558869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672857|NCT01558869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6672858|NCT01558869|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6672859|NCT01558869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6672860|NCT01558869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6672861|NCT01558934|Lofexidine|lofexidine|mesh-list
6672862|NCT01558934|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6672863|NCT01558934|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6672864|NCT01558934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672865|NCT01558934|Sensory System Agents|sensory system agents|mesh-ancestor
6672866|NCT01558934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6672867|NCT01558934|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6672868|NCT01558934|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5619389|NCT05192629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5619390|NCT05192629|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5619391|NCT05192629|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5619392|NCT05192629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5619393|NCT05192629|Adrenergic Agents|adrenergic agents|mesh-ancestor
5619394|NCT05192629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5619395|NCT05192629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5740438|NCT03104270|Growth Inhibitors|growth inhibitors|mesh-ancestor
5740439|NCT03104010|Hormones|hormones|mesh-list
5740440|NCT03104010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5740441|NCT03104010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740442|NCT03103893|Sirolimus|sirolimus|mesh-list
5740443|NCT03103893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5619396|NCT05192629|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5619397|NCT05192629|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5619398|NCT05192629|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5619399|NCT05192629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5619400|NCT05192629|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5619401|NCT05192629|Anesthetics, General|anesthetics, general|mesh-ancestor
5619402|NCT05192629|Anesthetics|anesthetics|mesh-ancestor
5619403|NCT05192629|GABA Modulators|gaba modulators|mesh-ancestor
5619404|NCT05192629|GABA Agents|gaba agents|mesh-ancestor
5619405|NCT05192369|Moxifloxacin|moxifloxacin|mesh-list
5619406|NCT05192369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5619407|NCT05192369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5619408|NCT05192369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5619409|NCT05192369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5619410|NCT05192369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5619411|NCT05192369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619412|NCT05192369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5740444|NCT03103893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5619413|NCT05192304|Maleic acid|maleic acid|mesh-list
5619414|NCT05192304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5619415|NCT05192304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619416|NCT05192265|Artesunate|artesunate|mesh-list
5619417|NCT05192265|Lumefantrine|lumefantrine|mesh-list
5619418|NCT05192265|Artemether|artemether|mesh-list
5619419|NCT05192265|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
5619420|NCT05192265|Pyronaridine|pyronaridine|mesh-list
5619421|NCT05192265|Antimalarials|antimalarials|mesh-list
5619422|NCT05192265|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5619423|NCT05192265|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5619424|NCT05192265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5619425|NCT05192265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5619426|NCT05192265|Antiviral Agents|antiviral agents|mesh-ancestor
5619427|NCT05192265|Schistosomicides|schistosomicides|mesh-ancestor
5619428|NCT05192265|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5619429|NCT05192265|Anthelmintics|anthelmintics|mesh-ancestor
5619430|NCT05192213|Ascorbic Acid|ascorbic acid|mesh-list
5619431|NCT05192213|Thiamine|thiamine|mesh-list
5619432|NCT05192213|Hydrocortisone|hydrocortisone|mesh-list
5619433|NCT05192213|Vitamins|vitamins|mesh-ancestor
5619434|NCT05192213|Micronutrients|micronutrients|mesh-ancestor
5619435|NCT05192213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5619436|NCT05192213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5619437|NCT05192213|Antioxidants|antioxidants|mesh-ancestor
5619438|NCT05192213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619439|NCT05192213|Protective Agents|protective agents|mesh-ancestor
5619440|NCT05192213|Vitamin B Complex|vitamin b complex|mesh-ancestor
5619441|NCT05191940|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5619442|NCT05191940|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5619443|NCT05191940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619444|NCT05191914|Fulvestrant|fulvestrant|mesh-list
5619445|NCT05191914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5619446|NCT05191914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5619447|NCT05191914|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5740445|NCT03103893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5740446|NCT03103893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5740447|NCT03103893|Antifungal Agents|antifungal agents|mesh-ancestor
5740448|NCT03103893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5740449|NCT03103893|Immunologic Factors|immunologic factors|mesh-ancestor
5740450|NCT03103893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740451|NCT03104036|Mesalamine|mesalamine|mesh-list
5740452|NCT03104036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5619448|NCT05191914|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5619449|NCT05191914|Hormone Antagonists|hormone antagonists|mesh-ancestor
5619450|NCT05191914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5619451|NCT05191914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740453|NCT03104036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5740454|NCT03104036|Analgesics|analgesics|mesh-ancestor
5740455|NCT03104036|Sensory System Agents|sensory system agents|mesh-ancestor
5740456|NCT03104036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5740457|NCT03104036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740458|NCT03104036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5740459|NCT03104036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5619452|NCT05191888|Amoxicillin|amoxicillin|mesh-list
5619453|NCT05191888|Metronidazole|metronidazole|mesh-list
5619454|NCT05191888|Clarithromycin|clarithromycin|mesh-list
5619455|NCT05191888|Rabeprazole|rabeprazole|mesh-list
5619456|NCT05191888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5619457|NCT05191888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5619458|NCT05191888|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5619459|NCT05191888|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5619460|NCT05191888|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5619461|NCT05191888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5619462|NCT05191888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619463|NCT05191888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5619464|NCT05191888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5619465|NCT05191888|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5619466|NCT05191888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5619467|NCT05191888|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5619468|NCT05191875|Doxycycline|doxycycline|mesh-list
5740460|NCT03103867|Insulin|insulin|mesh-list
5740461|NCT03103867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5619469|NCT05191875|Furazolidone|furazolidone|mesh-list
5619470|NCT05191875|Bismuth|bismuth|mesh-list
5619471|NCT05191875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5740462|NCT03103867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740463|NCT03103685|Clopidogrel|clopidogrel|mesh-list
5740464|NCT03103685|Ticagrelor|ticagrelor|mesh-list
5740465|NCT03103685|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
5740466|NCT03103685|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5740467|NCT03103685|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5740468|NCT03103685|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5740469|NCT03103685|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5740470|NCT03103685|Purinergic Agents|purinergic agents|mesh-ancestor
5740471|NCT03103685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5740472|NCT03103685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5740473|NCT03103685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740474|NCT03103555|Cyclophosphamide|cyclophosphamide|mesh-list
5740475|NCT03103555|Bortezomib|bortezomib|mesh-list
5619472|NCT05191875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5619473|NCT05191875|Antimalarials|antimalarials|mesh-ancestor
5619474|NCT05191875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5619475|NCT05191875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5619476|NCT05191875|Antacids|antacids|mesh-ancestor
5619477|NCT05191875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5740476|NCT03103555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5740477|NCT03103555|Immunologic Factors|immunologic factors|mesh-ancestor
5740478|NCT03103555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740479|NCT03103555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5740480|NCT03103555|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5740481|NCT03103555|Alkylating Agents|alkylating agents|mesh-ancestor
5740482|NCT03103555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5740483|NCT03103555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5740484|NCT03103555|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5740485|NCT03103412|Tofacitinib|tofacitinib|mesh-list
5740486|NCT03103412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5740487|NCT03103412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5740488|NCT03103412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5740489|NCT03103568|Tolbutamide|tolbutamide|mesh-list
5740490|NCT03103568|Metoprolol|metoprolol|mesh-list
5740491|NCT03103568|Furosemide|furosemide|mesh-list
5619478|NCT05191875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5619479|NCT05191875|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5619480|NCT05191875|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5619481|NCT05191875|Renal Agents|renal agents|mesh-ancestor
5619482|NCT05191875|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
5619483|NCT05191875|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
5740492|NCT03103568|Chlorzoxazone|chlorzoxazone|mesh-list
5740493|NCT03103568|Nitisinone|nitisinone|mesh-list
5740494|NCT03103568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5740495|NCT03103568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5740496|NCT03103568|Sympatholytics|sympatholytics|mesh-ancestor
5740497|NCT03103568|Autonomic Agents|autonomic agents|mesh-ancestor
5740498|NCT03103568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5740499|NCT03103568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740500|NCT03103568|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5740501|NCT03103568|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5619484|NCT05191875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5619485|NCT05191862|Cilostazol|cilostazol|mesh-list
5619486|NCT05191862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5619487|NCT05191862|Autonomic Agents|autonomic agents|mesh-ancestor
5619488|NCT05191862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5619489|NCT05191862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5619490|NCT05191862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5619491|NCT05191862|Respiratory System Agents|respiratory system agents|mesh-ancestor
5619492|NCT05191862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5619493|NCT05191862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5619494|NCT05191862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619495|NCT05191862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5619496|NCT05191862|Vasodilator Agents|vasodilator agents|mesh-ancestor
5740502|NCT03103568|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5740503|NCT03103568|Adrenergic Agents|adrenergic agents|mesh-ancestor
5740504|NCT03103568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5740505|NCT03103568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5740506|NCT03103568|Diuretics|diuretics|mesh-ancestor
5740507|NCT03103568|Natriuretic Agents|natriuretic agents|mesh-ancestor
5740508|NCT03103568|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5740509|NCT03103568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5740510|NCT03103568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5740511|NCT03103568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5740512|NCT03103568|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5740513|NCT03103568|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5740514|NCT03103451|Antibodies, Bispecific|antibodies, bispecific|mesh-list
5740515|NCT03103451|Immunologic Factors|immunologic factors|mesh-ancestor
5740516|NCT03103451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740517|NCT03103646|Itraconazole|itraconazole|mesh-list
5740518|NCT03103646|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
5740519|NCT03103646|Antifungal Agents|antifungal agents|mesh-ancestor
5740520|NCT03103646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5740521|NCT03103646|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5740522|NCT03103646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5740523|NCT03103646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5740524|NCT03103646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5740525|NCT03103646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5740526|NCT03103646|Hormone Antagonists|hormone antagonists|mesh-ancestor
5619497|NCT05191862|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5619498|NCT05191862|Protective Agents|protective agents|mesh-ancestor
5619499|NCT05191862|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5619500|NCT05191862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5619501|NCT05191862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5619502|NCT05191797|Atezolizumab|atezolizumab|mesh-list
5619503|NCT05191797|Immunoglobulins|immunoglobulins|mesh-list
5619504|NCT05191797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5619505|NCT05191797|Immunoglobulin G|immunoglobulin g|mesh-list
5619506|NCT05191797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5619507|NCT05191797|Immunologic Factors|immunologic factors|mesh-ancestor
5619508|NCT05191797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5619509|NCT05189483|Paclitaxel|paclitaxel|mesh-list
5619510|NCT05189483|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5619511|NCT05189483|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5619512|NCT05189483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5619513|NCT05189483|Tubulin Modulators|tubulin modulators|mesh-ancestor
5619514|NCT05189483|Antimitotic Agents|antimitotic agents|mesh-ancestor
5619515|NCT05189483|Mitosis Modulators|mitosis modulators|mesh-ancestor
5619516|NCT05189483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619517|NCT05173857|Paclitaxel|paclitaxel|mesh-list
5619518|NCT05173857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5619519|NCT05173857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5619520|NCT05173857|Tubulin Modulators|tubulin modulators|mesh-ancestor
5619521|NCT05173857|Antimitotic Agents|antimitotic agents|mesh-ancestor
5619522|NCT05173857|Mitosis Modulators|mitosis modulators|mesh-ancestor
5619523|NCT05173857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619524|NCT05173324|Vaccines|vaccines|mesh-list
5619525|NCT05173324|Immunologic Factors|immunologic factors|mesh-ancestor
5619526|NCT05173324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5619527|NCT05169008|Vaccines|vaccines|mesh-list
5619528|NCT05169008|Immunologic Factors|immunologic factors|mesh-ancestor
5619529|NCT05169008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5619530|NCT05168527|Gemcitabine|gemcitabine|mesh-list
5619531|NCT05168527|Paclitaxel|paclitaxel|mesh-list
5619532|NCT05168527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5619533|NCT05168527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5619534|NCT05168527|Tubulin Modulators|tubulin modulators|mesh-ancestor
5619535|NCT05168527|Antimitotic Agents|antimitotic agents|mesh-ancestor
5619536|NCT05168527|Mitosis Modulators|mitosis modulators|mesh-ancestor
5619537|NCT05168527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619538|NCT05168527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5619539|NCT05168527|Antimetabolites|antimetabolites|mesh-ancestor
5619540|NCT05168527|Antiviral Agents|antiviral agents|mesh-ancestor
5619541|NCT05168527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5619542|NCT05168527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5619543|NCT05168527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5619544|NCT05168527|Immunologic Factors|immunologic factors|mesh-ancestor
5619545|NCT05168527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5619546|NCT05166811|Magnesium Sulfate|magnesium sulfate|mesh-list
5619547|NCT05166811|Analgesics|analgesics|mesh-ancestor
5619548|NCT05166811|Sensory System Agents|sensory system agents|mesh-ancestor
5619549|NCT05166811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5619550|NCT05166811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740527|NCT03103646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5740528|NCT03103646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740529|NCT03103646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5740530|NCT03103204|Chlorhexidine|chlorhexidine|mesh-list
5619551|NCT05166811|Anesthetics|anesthetics|mesh-ancestor
5619552|NCT05166811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5619553|NCT05166811|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5619554|NCT05166811|Anticonvulsants|anticonvulsants|mesh-ancestor
5619555|NCT05166811|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5619556|NCT05166811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5619557|NCT05166811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619558|NCT05166811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5619559|NCT05166811|Tocolytic Agents|tocolytic agents|mesh-ancestor
5619560|NCT05166811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5619561|NCT05159245|Trastuzumab|trastuzumab|mesh-list
5619562|NCT05159245|Pertuzumab|pertuzumab|mesh-list
5619563|NCT05159245|Atezolizumab|atezolizumab|mesh-list
5619564|NCT05159245|Vemurafenib|vemurafenib|mesh-list
5619565|NCT05159245|Entrectinib|entrectinib|mesh-list
5619566|NCT05159245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5619567|NCT05159245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5619568|NCT05159245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5619569|NCT05159245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5619570|NCT05159245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619571|NCT05149365|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5619572|NCT05149365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5619573|NCT05149365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5619574|NCT05149365|Incretins|incretins|mesh-ancestor
5619575|NCT05149365|Hormones|hormones|mesh-ancestor
5619576|NCT05149365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5619577|NCT05149365|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5619578|NCT05149365|Protease Inhibitors|protease inhibitors|mesh-ancestor
5619579|NCT05149365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5619580|NCT05149365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692438|NCT03407976|Apatinib|apatinib|mesh-list
5692439|NCT03407976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5692440|NCT03407976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5692441|NCT03407976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5692442|NCT03407976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5692443|NCT03407976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692444|NCT03407937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
5692445|NCT03407937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5692446|NCT03407937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692447|NCT03407872|Esketamine|esketamine|mesh-list
5692448|NCT03407872|Antidepressive Agents|antidepressive agents|mesh-ancestor
5692449|NCT03407872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5692450|NCT03407703|Grazoprevir|grazoprevir|mesh-list
5692451|NCT03407703|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
5692452|NCT03407703|Antiviral Agents|antiviral agents|mesh-ancestor
5692453|NCT03407703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5692454|NCT03407599|Insulin Aspart|insulin aspart|mesh-list
5692455|NCT03407599|Insulin, Long-Acting|insulin, long-acting|mesh-list
5692456|NCT03407599|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
5692457|NCT03407599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5692458|NCT03407599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692459|NCT03407521|Isosorbide|isosorbide|mesh-list
5692460|NCT03407521|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
5692461|NCT03407521|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
5692462|NCT03407521|Misoprostol|misoprostol|mesh-list
5692463|NCT03407521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5740531|NCT03103204|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5740532|NCT03103204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5740533|NCT03103204|Disinfectants|disinfectants|mesh-ancestor
5740534|NCT03103399|Levodopa|levodopa|mesh-list
5740535|NCT03103399|Carbidopa|carbidopa|mesh-list
5740536|NCT03103399|Entacapone|entacapone|mesh-list
5740537|NCT03103399|Benserazide|benserazide|mesh-list
5740538|NCT03103399|Dopa Decarboxylase|dopa decarboxylase|mesh-list
5740539|NCT03103399|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-list
5740540|NCT03103399|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5740541|NCT03103399|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5740542|NCT03103399|Dopamine Agents|dopamine agents|mesh-ancestor
5740543|NCT03103399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5740544|NCT03103399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5740545|NCT03103399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740546|NCT03103399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5740547|NCT03103399|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
5740548|NCT03103334|Methotrexate|methotrexate|mesh-list
5692464|NCT03407521|Abortifacient Agents|abortifacient agents|mesh-ancestor
5692465|NCT03407521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5740549|NCT03103334|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5619581|NCT05133297|Tofacitinib|tofacitinib|mesh-list
5619582|NCT05133297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5619583|NCT05133297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5619584|NCT05133297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619585|NCT05126238|Lithium Carbonate|lithium carbonate|mesh-list
5619586|NCT05126238|Antidepressive Agents|antidepressive agents|mesh-ancestor
5619587|NCT05126238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5619588|NCT05126238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5619589|NCT05126238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5740550|NCT03103334|Abortifacient Agents|abortifacient agents|mesh-ancestor
5740551|NCT03103334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5740552|NCT03103334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740553|NCT03103334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5740554|NCT03103334|Antimetabolites|antimetabolites|mesh-ancestor
5740555|NCT03103334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5740556|NCT03103334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5740557|NCT03103334|Dermatologic Agents|dermatologic agents|mesh-ancestor
5740558|NCT03103334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5740559|NCT03103334|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5740560|NCT03103334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5740561|NCT03103334|Immunologic Factors|immunologic factors|mesh-ancestor
5740562|NCT03103334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5740563|NCT03103334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5740564|NCT03103152|Aspirin|aspirin|mesh-list
5740565|NCT03103152|Vitamin D|vitamin d|mesh-list
5740566|NCT03103152|Ergocalciferols|ergocalciferols|mesh-list
5740567|NCT03103152|Vitamins|vitamins|mesh-list
5740568|NCT03103152|Micronutrients|micronutrients|mesh-ancestor
5740569|NCT03103152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740570|NCT03103152|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5740571|NCT03103152|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5740572|NCT03103152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5740573|NCT03103152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5740574|NCT03103152|Analgesics|analgesics|mesh-ancestor
5740575|NCT03103152|Sensory System Agents|sensory system agents|mesh-ancestor
5740576|NCT03103152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5740577|NCT03103152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5740578|NCT03103152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5740579|NCT03103152|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5740580|NCT03103152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5740581|NCT03103152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5740582|NCT03103152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5740583|NCT03103152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5740584|NCT03103152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5740585|NCT03103152|Antipyretics|antipyretics|mesh-ancestor
5619590|NCT05126238|Antimanic Agents|antimanic agents|mesh-ancestor
5619591|NCT05126238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5619592|NCT05126238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5619593|NCT05126238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5619594|NCT05123820|Midazolam|midazolam|mesh-list
5619595|NCT05123820|Omeprazole|omeprazole|mesh-list
5619596|NCT05123820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5619597|NCT05123820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5619598|NCT05123820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5619599|NCT05123820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5619600|NCT05123820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5619601|NCT05123820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5619602|NCT05123820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5619603|NCT05123820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5619604|NCT05123820|Anesthetics, General|anesthetics, general|mesh-ancestor
5619605|NCT05123820|Anesthetics|anesthetics|mesh-ancestor
5619606|NCT05123820|GABA Modulators|gaba modulators|mesh-ancestor
5619607|NCT05123820|GABA Agents|gaba agents|mesh-ancestor
5740586|NCT03103074|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
5740587|NCT03103074|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5740588|NCT03103074|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5740589|NCT03103074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5740590|NCT03103074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5740591|NCT03103074|Cholinergic Agents|cholinergic agents|mesh-ancestor
5740592|NCT03103074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5740593|NCT03103074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5619608|NCT05123820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5619609|NCT05123820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619610|NCT05123820|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5740594|NCT03102892|Anti-Infective Agents|anti-infective agents|mesh-list
5740595|NCT03102892|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5740596|NCT03103009|Pasireotide|pasireotide|mesh-list
5740597|NCT03103009|Hormones|hormones|mesh-ancestor
5740598|NCT03103009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5740599|NCT03103009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740600|NCT03103022|Acetaminophen|acetaminophen|mesh-list
5740601|NCT03103022|Ibuprofen|ibuprofen|mesh-list
5740602|NCT03103022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5740603|NCT03103022|Analgesics|analgesics|mesh-ancestor
5740604|NCT03103022|Sensory System Agents|sensory system agents|mesh-ancestor
5740605|NCT03103022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5740606|NCT03103022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740607|NCT03103022|Antipyretics|antipyretics|mesh-ancestor
5740608|NCT03103022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5740609|NCT03103022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5740610|NCT03103022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5740611|NCT03103022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5740612|NCT03103022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5740613|NCT03103022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5740614|NCT03102658|Micafungin|micafungin|mesh-list
5740615|NCT03102658|Antifungal Agents|antifungal agents|mesh-ancestor
5740616|NCT03102658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5740617|NCT03102723|Cangrelor|cangrelor|mesh-list
5740618|NCT03102723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5740619|NCT03102723|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5740620|NCT03102723|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5740621|NCT03102723|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5740622|NCT03102723|Purinergic Agents|purinergic agents|mesh-ancestor
5740623|NCT03102723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5740624|NCT03102723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5740625|NCT03102723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740626|NCT03102801|Insulin|insulin|mesh-list
5740627|NCT03102801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5619611|NCT05123820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5619612|NCT05123820|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5619613|NCT05123820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5619614|NCT05121246|Palivizumab|palivizumab|mesh-list
5619615|NCT05121246|Antiviral Agents|antiviral agents|mesh-ancestor
5740628|NCT03102801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5740629|NCT03102801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740630|NCT03102476|Insulin Lispro|insulin lispro|mesh-list
5740631|NCT03102476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5740632|NCT03102476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740633|NCT03102359|Dexmedetomidine|dexmedetomidine|mesh-list
5740634|NCT03102359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5740635|NCT03102359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5740636|NCT03102359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740637|NCT03102359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5740638|NCT03102359|Analgesics|analgesics|mesh-ancestor
5740639|NCT03102359|Sensory System Agents|sensory system agents|mesh-ancestor
5740640|NCT03102359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5740641|NCT03102359|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5740642|NCT03102359|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5740643|NCT03102359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5740644|NCT03102359|Adrenergic Agents|adrenergic agents|mesh-ancestor
5619616|NCT05121246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5619617|NCT05113745|Reboxetine|reboxetine|mesh-list
5619618|NCT05113745|Antidepressive Agents|antidepressive agents|mesh-ancestor
5619619|NCT05113745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5619620|NCT05113745|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5619621|NCT05113745|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5619622|NCT05113745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5619623|NCT05113745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619624|NCT05113745|Adrenergic Agents|adrenergic agents|mesh-ancestor
5619625|NCT05113745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5619626|NCT05113745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5619627|NCT05112965|Atezolizumab|atezolizumab|mesh-list
5619628|NCT05112965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5619629|NCT05103631|Cyclophosphamide|cyclophosphamide|mesh-list
5619630|NCT05103631|Fludarabine|fludarabine|mesh-list
5619631|NCT05103631|Fludarabine phosphate|fludarabine phosphate|mesh-list
5740645|NCT03102359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5740646|NCT03102359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619632|NCT05103631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5619633|NCT05103631|Immunologic Factors|immunologic factors|mesh-ancestor
5740647|NCT03102398|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
5740648|NCT03102398|Vasodilator Agents|vasodilator agents|mesh-ancestor
5740649|NCT03102398|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5740650|NCT03102398|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5740651|NCT03102398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5619634|NCT05103631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5619635|NCT05103631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5619636|NCT05103631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5619637|NCT05103631|Alkylating Agents|alkylating agents|mesh-ancestor
5619638|NCT05103631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619639|NCT05103631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5619640|NCT05103631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5619641|NCT05103631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5619642|NCT05103631|Antimetabolites|antimetabolites|mesh-ancestor
5619643|NCT05085574|Celecoxib|celecoxib|mesh-list
5619644|NCT05085574|Famotidine|famotidine|mesh-list
5619645|NCT05085574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5619646|NCT05085574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5619647|NCT05085574|Analgesics|analgesics|mesh-ancestor
5619648|NCT05085574|Sensory System Agents|sensory system agents|mesh-ancestor
5619649|NCT05085574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5619650|NCT05085574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5619651|NCT05085574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5619652|NCT05085574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5619653|NCT05085574|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5740652|NCT03102398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5740653|NCT03102398|Urological Agents|urological agents|mesh-ancestor
5740654|NCT03101995|Gemcitabine|gemcitabine|mesh-list
5740655|NCT03101995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5740656|NCT03101995|Antimetabolites|antimetabolites|mesh-ancestor
5619654|NCT05085574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5619655|NCT05085574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5619656|NCT05085574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619657|NCT05085574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5619658|NCT05085574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5619659|NCT05085574|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5619660|NCT05085574|Histamine Antagonists|histamine antagonists|mesh-ancestor
5619661|NCT05085574|Histamine Agents|histamine agents|mesh-ancestor
5619662|NCT05085574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5619663|NCT05085340|Pyrimethamine|pyrimethamine|mesh-list
5619664|NCT05085340|Sulfadoxine|sulfadoxine|mesh-list
5619665|NCT05085340|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
5619666|NCT05085340|Antimalarials|antimalarials|mesh-ancestor
5740657|NCT03101995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5740658|NCT03101995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5740659|NCT03101995|Antiviral Agents|antiviral agents|mesh-ancestor
5740660|NCT03101995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5740661|NCT03101995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5740662|NCT03101995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5740663|NCT03101995|Immunologic Factors|immunologic factors|mesh-ancestor
5740664|NCT03101995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740665|NCT03102242|Atezolizumab|atezolizumab|mesh-list
5740666|NCT03102242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5740667|NCT03102450|Benzalkonium Compounds|benzalkonium compounds|mesh-list
5740668|NCT03102450|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5740669|NCT03102450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5740670|NCT03102047|Durvalumab|durvalumab|mesh-list
5740671|NCT03102047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5740672|NCT03102047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5740673|NCT03102320|Gemcitabine|gemcitabine|mesh-list
5740674|NCT03102320|Maytansine|maytansine|mesh-list
5740675|NCT03102320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5740676|NCT03102320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5740677|NCT03102320|Antimetabolites|antimetabolites|mesh-ancestor
5740678|NCT03102320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5740679|NCT03102320|Antiviral Agents|antiviral agents|mesh-ancestor
5740680|NCT03102320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5740681|NCT03102320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5740682|NCT03102320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5740683|NCT03102320|Immunologic Factors|immunologic factors|mesh-ancestor
5619667|NCT05085340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5619668|NCT05085340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5619669|NCT05085340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5619670|NCT05085340|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5619671|NCT05085340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5619672|NCT05085340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619673|NCT05085340|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5619674|NCT05085340|Renal Agents|renal agents|mesh-ancestor
5619675|NCT05084430|Pembrolizumab|pembrolizumab|mesh-list
5740684|NCT03102320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740685|NCT03102320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5740686|NCT03102320|Tubulin Modulators|tubulin modulators|mesh-ancestor
5740687|NCT03102320|Antimitotic Agents|antimitotic agents|mesh-ancestor
5740688|NCT03102320|Mitosis Modulators|mitosis modulators|mesh-ancestor
5619676|NCT05084430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5619677|NCT05084430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5619678|NCT05078671|Cobicistat|cobicistat|mesh-list
5619679|NCT05078671|Olaparib|olaparib|mesh-list
5619680|NCT05078671|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5619681|NCT05078671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5619682|NCT05078671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619683|NCT05078671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5619684|NCT05078671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5619685|NCT05078671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5619686|NCT05078671|Antiviral Agents|antiviral agents|mesh-ancestor
5619687|NCT05078671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5619688|NCT05078671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5619689|NCT05078671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5619690|NCT05077800|Losartan|losartan|mesh-list
5619691|NCT05077800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5619692|NCT05077800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5619693|NCT05077800|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5619694|NCT05077800|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5619695|NCT05077800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619696|NCT05070585|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
5619697|NCT05070585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5619698|NCT05070585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619699|NCT05070585|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5619700|NCT05070585|Protective Agents|protective agents|mesh-ancestor
5619701|NCT05070585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5619702|NCT05070585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5619703|NCT05070364|Interferons|interferons|mesh-list
5619704|NCT05070364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5619705|NCT05070364|Antiviral Agents|antiviral agents|mesh-ancestor
5619706|NCT05070364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5619707|NCT05059223|Reboxetine|reboxetine|mesh-list
5619708|NCT05059223|Antidepressive Agents|antidepressive agents|mesh-ancestor
5619709|NCT05059223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5619710|NCT05059223|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5619711|NCT05059223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5619712|NCT05059223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5619713|NCT05059223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619714|NCT05059223|Adrenergic Agents|adrenergic agents|mesh-ancestor
5619715|NCT05059223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5619716|NCT05059223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5619717|NCT05057819|Empagliflozin|empagliflozin|mesh-list
5619718|NCT05057819|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5619719|NCT05057819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619720|NCT05057819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5740689|NCT03102021|Epoetin Alfa|epoetin alfa|mesh-list
5740690|NCT03102021|Hematinics|hematinics|mesh-ancestor
5893497|NCT04784299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893498|NCT04706507|Ganciclovir|ganciclovir|mesh-list
5893499|NCT04706507|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
5893500|NCT04706507|Antiviral Agents|antiviral agents|mesh-ancestor
5893501|NCT04706507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5893502|NCT04706507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5893503|NCT04706507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5893504|NCT04706507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893505|NCT04682158|Paclitaxel|paclitaxel|mesh-list
5893506|NCT04682158|Carboplatin|carboplatin|mesh-list
5619721|NCT05057819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5619722|NCT05027308|Teduglutide|teduglutide|mesh-list
5619723|NCT05027308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5619724|NCT05027308|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5619725|NCT05027308|Protective Agents|protective agents|mesh-ancestor
5893507|NCT04682158|Propranolol|propranolol|mesh-list
5619726|NCT05027308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5619727|NCT05026736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5619728|NCT05026736|Antibodies|antibodies|mesh-list
5619729|NCT05026736|Immunoglobulins|immunoglobulins|mesh-list
5619730|NCT05026736|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5619731|NCT05026736|Immunologic Factors|immunologic factors|mesh-ancestor
5619732|NCT05026736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5619733|NCT05026736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5740691|NCT03101930|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5740692|NCT03101930|Liraglutide|liraglutide|mesh-list
5740693|NCT03101930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5740694|NCT03101930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740695|NCT03101930|Incretins|incretins|mesh-ancestor
5740696|NCT03101930|Hormones|hormones|mesh-ancestor
5740697|NCT03101930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5740698|NCT03101930|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5740699|NCT03101930|Protease Inhibitors|protease inhibitors|mesh-ancestor
5740700|NCT03101930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5740701|NCT03101930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5740702|NCT03101800|Azathioprine|azathioprine|mesh-list
5740703|NCT03101800|Allopurinol|allopurinol|mesh-list
5740704|NCT03101800|Antimetabolites|antimetabolites|mesh-ancestor
5740705|NCT03101800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5740706|NCT03101800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5740707|NCT03101800|Gout Suppressants|gout suppressants|mesh-ancestor
5619734|NCT05011812|Ritonavir|ritonavir|mesh-list
5619735|NCT05011812|Midazolam|midazolam|mesh-list
5619736|NCT05011812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5619737|NCT05011812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5619738|NCT05011812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5619739|NCT05011812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5619740|NCT05011812|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5740708|NCT03101800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5740709|NCT03101800|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5740710|NCT03101800|Antioxidants|antioxidants|mesh-ancestor
5740711|NCT03101800|Protective Agents|protective agents|mesh-ancestor
5740712|NCT03101800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740713|NCT03101800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5740714|NCT03101800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5740715|NCT03101800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5740716|NCT03101800|Immunologic Factors|immunologic factors|mesh-ancestor
5740717|NCT03101735|Dimethyl Fumarate|dimethyl fumarate|mesh-list
5740718|NCT03101735|Dermatologic Agents|dermatologic agents|mesh-ancestor
5740719|NCT03101735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5740720|NCT03101735|Immunologic Factors|immunologic factors|mesh-ancestor
5740721|NCT03101735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740722|NCT03101423|Interleukin-2|interleukin-2|mesh-list
5740723|NCT03101423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5740724|NCT03101423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5740725|NCT03101423|Analgesics|analgesics|mesh-ancestor
5740726|NCT03101423|Sensory System Agents|sensory system agents|mesh-ancestor
5740727|NCT03101423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5740728|NCT03101423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740729|NCT03101722|Huperzine A|huperzine a|mesh-list
5740730|NCT03101722|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
5740731|NCT03101722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5740732|NCT03101722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5740733|NCT03101722|Cholinergic Agents|cholinergic agents|mesh-ancestor
5740734|NCT03101722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5740735|NCT03101722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740736|NCT03101722|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5740737|NCT03101722|Protective Agents|protective agents|mesh-ancestor
5740738|NCT03101579|Folic Acid|folic acid|mesh-list
5740739|NCT03101579|Vitamin B 12|vitamin b 12|mesh-list
5740740|NCT03101579|Hydroxocobalamin|hydroxocobalamin|mesh-list
5740741|NCT03101579|Dexamethasone|dexamethasone|mesh-list
5740742|NCT03101579|Pemetrexed|pemetrexed|mesh-list
6208644|NCT02133352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6672869|NCT01558934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5619741|NCT05011812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5619742|NCT05011812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5619743|NCT05011812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5619744|NCT05011812|Anesthetics, General|anesthetics, general|mesh-ancestor
5619745|NCT05011812|Anesthetics|anesthetics|mesh-ancestor
5619746|NCT05011812|GABA Modulators|gaba modulators|mesh-ancestor
5740743|NCT03101579|Vitamins|vitamins|mesh-ancestor
5740744|NCT03101579|Micronutrients|micronutrients|mesh-ancestor
5740745|NCT03101579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5619747|NCT05011812|GABA Agents|gaba agents|mesh-ancestor
5619748|NCT05011812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5619749|NCT05011812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619750|NCT05011812|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5619751|NCT05011812|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5740746|NCT03101579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5740747|NCT03101579|Antiemetics|antiemetics|mesh-ancestor
5740748|NCT03101579|Autonomic Agents|autonomic agents|mesh-ancestor
5740749|NCT03101579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5740750|NCT03101579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5740751|NCT03101579|Glucocorticoids|glucocorticoids|mesh-ancestor
5740752|NCT03101579|Hormones|hormones|mesh-ancestor
5740753|NCT03101579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5740754|NCT03101579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5740755|NCT03101579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5740756|NCT03101579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5740757|NCT03101579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5740758|NCT03101579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5740759|NCT03101579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5740760|NCT03101579|Hematinics|hematinics|mesh-ancestor
5740761|NCT03101579|Vitamin B Complex|vitamin b complex|mesh-ancestor
5740762|NCT03101709|Cyclophosphamide|cyclophosphamide|mesh-list
5740763|NCT03101709|Fludarabine|fludarabine|mesh-list
5740764|NCT03101709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5740765|NCT03101709|Immunologic Factors|immunologic factors|mesh-ancestor
5740766|NCT03101709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740767|NCT03101709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5740768|NCT03101709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5740769|NCT03101709|Alkylating Agents|alkylating agents|mesh-ancestor
5740770|NCT03101709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5740771|NCT03101709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5740772|NCT03101709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5740773|NCT03101475|Durvalumab|durvalumab|mesh-list
5740774|NCT03101475|Tremelimumab|tremelimumab|mesh-list
5740775|NCT03101475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5740776|NCT03101475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5740777|NCT03101501|Mitomycins|mitomycins|mesh-list
5740778|NCT03101501|Mitomycin|mitomycin|mesh-list
5740779|NCT03101501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5740780|NCT03101501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5740781|NCT03101501|Alkylating Agents|alkylating agents|mesh-ancestor
5740782|NCT03101501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5740783|NCT03101501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5740784|NCT03101501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5740785|NCT03101319|Vitamin D|vitamin d|mesh-list
5740786|NCT03101319|Cholecalciferol|cholecalciferol|mesh-list
5619752|NCT05011812|Protease Inhibitors|protease inhibitors|mesh-ancestor
5619753|NCT05011812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5619754|NCT05011812|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5619755|NCT05011812|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5619756|NCT05011812|Antiviral Agents|antiviral agents|mesh-ancestor
5740787|NCT03101319|Vitamins|vitamins|mesh-ancestor
5740788|NCT03101319|Micronutrients|micronutrients|mesh-ancestor
5740789|NCT03101319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740790|NCT03101319|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5740791|NCT03101319|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5740792|NCT03101280|Atezolizumab|atezolizumab|mesh-list
5740793|NCT03101280|Rucaparib|rucaparib|mesh-list
5740794|NCT03101280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5740795|NCT03101280|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5740796|NCT03101280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5740797|NCT03101280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5740798|NCT03101748|Paclitaxel|paclitaxel|mesh-list
5740799|NCT03101748|Cyclophosphamide|cyclophosphamide|mesh-list
5740800|NCT03101748|Doxorubicin|doxorubicin|mesh-list
5740801|NCT03101748|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5740802|NCT03101748|Trastuzumab|trastuzumab|mesh-list
5740803|NCT03101748|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5740804|NCT03101748|Daunorubicin|daunorubicin|mesh-list
5740805|NCT03101748|Pertuzumab|pertuzumab|mesh-list
6208645|NCT02133352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208646|NCT02133664|Thioctic Acid|thioctic acid|mesh-list
6208647|NCT02133664|Antioxidants|antioxidants|mesh-ancestor
6208648|NCT02133664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208649|NCT02133664|Protective Agents|protective agents|mesh-ancestor
5740806|NCT03101748|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
5740807|NCT03101748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5740808|NCT03101748|Antibodies|antibodies|mesh-list
5740809|NCT03101748|Immunoglobulins|immunoglobulins|mesh-list
5740810|NCT03101748|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5740811|NCT03101748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5740812|NCT03101748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5740813|NCT03101748|Tubulin Modulators|tubulin modulators|mesh-ancestor
5740814|NCT03101748|Antimitotic Agents|antimitotic agents|mesh-ancestor
5740815|NCT03101748|Mitosis Modulators|mitosis modulators|mesh-ancestor
5740816|NCT03101748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5740817|NCT03101748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5740818|NCT03101748|Immunologic Factors|immunologic factors|mesh-ancestor
5740819|NCT03101748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740820|NCT03101748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5740821|NCT03101748|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5619757|NCT05011812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5619758|NCT05011812|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5619759|NCT05011812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5619760|NCT05007873|Decitabine|decitabine|mesh-list
5740822|NCT03101748|Alkylating Agents|alkylating agents|mesh-ancestor
5740823|NCT03101748|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5740824|NCT03101748|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5740825|NCT03101748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5740826|NCT03101748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5740827|NCT03101748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5740828|NCT03101644|Darunavir|darunavir|mesh-list
5740829|NCT03101644|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5740830|NCT03101644|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5740831|NCT03101644|Protease Inhibitors|protease inhibitors|mesh-ancestor
5740832|NCT03101644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5740833|NCT03101644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619761|NCT05007873|Dasatinib|dasatinib|mesh-list
5619762|NCT05007873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5619763|NCT05007873|Antimetabolites|antimetabolites|mesh-ancestor
5619764|NCT05007873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619765|NCT05007873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5619766|NCT05007873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5619767|NCT05007873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5619768|NCT04980222|Prednisone|prednisone|mesh-list
5619769|NCT04980222|Cyclophosphamide|cyclophosphamide|mesh-list
5619770|NCT04980222|Rituximab|rituximab|mesh-list
5619771|NCT04980222|Doxorubicin|doxorubicin|mesh-list
5619772|NCT04980222|Vincristine|vincristine|mesh-list
5619773|NCT04980222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5619774|NCT04980222|Immunologic Factors|immunologic factors|mesh-ancestor
5619775|NCT04980222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5619776|NCT04980222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5619777|NCT04980222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5619778|NCT04980222|Alkylating Agents|alkylating agents|mesh-ancestor
5619779|NCT04980222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619780|NCT04980222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5619781|NCT04980222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5619782|NCT04980222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5619783|NCT04980222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5619784|NCT04980222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5619785|NCT04980222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5619786|NCT04980222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5619787|NCT04980222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5740834|NCT03101644|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5740835|NCT03101644|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5740836|NCT03101644|Antiviral Agents|antiviral agents|mesh-ancestor
5740837|NCT03101644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5740838|NCT03101072|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5740839|NCT03101072|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5740840|NCT03101072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5740841|NCT03101072|Antitubercular Agents|antitubercular agents|mesh-ancestor
5740842|NCT03100955|Cisplatin|cisplatin|mesh-list
5740843|NCT03100955|Etoposide|etoposide|mesh-list
5740844|NCT03100955|Etoposide phosphate|etoposide phosphate|mesh-list
5740845|NCT03100955|Apatinib|apatinib|mesh-list
5740846|NCT03100955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5740847|NCT03100955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5740848|NCT03100955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5740849|NCT03100955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5740850|NCT03100955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6672870|NCT01558934|Adrenergic Agents|adrenergic agents|mesh-ancestor
5619788|NCT04980222|Glucocorticoids|glucocorticoids|mesh-ancestor
5619789|NCT04980222|Hormones|hormones|mesh-ancestor
5619790|NCT04980222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5619791|NCT04980222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5619792|NCT04980222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5740851|NCT03100955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5740852|NCT03100955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5740853|NCT03101137|Dexamethasone|dexamethasone|mesh-list
5740854|NCT03101137|Bupivacaine|bupivacaine|mesh-list
5740855|NCT03101137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5740856|NCT03101137|Antiemetics|antiemetics|mesh-ancestor
5740857|NCT03101137|Autonomic Agents|autonomic agents|mesh-ancestor
5740858|NCT03101137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5740859|NCT03101137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740860|NCT03101137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5740861|NCT03101137|Glucocorticoids|glucocorticoids|mesh-ancestor
5740862|NCT03101137|Hormones|hormones|mesh-ancestor
5619793|NCT04980222|Tubulin Modulators|tubulin modulators|mesh-ancestor
5619794|NCT04980222|Antimitotic Agents|antimitotic agents|mesh-ancestor
5619795|NCT04980222|Mitosis Modulators|mitosis modulators|mesh-ancestor
5619796|NCT04950868|Quetiapine Fumarate|quetiapine fumarate|mesh-list
5619797|NCT04950868|Antidepressive Agents|antidepressive agents|mesh-ancestor
5619798|NCT04950868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5619799|NCT04950868|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5619800|NCT04950868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5740863|NCT03101137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5740864|NCT03101137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5740865|NCT03101137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5740866|NCT03101137|Anesthetics, Local|anesthetics, local|mesh-ancestor
5740867|NCT03101137|Anesthetics|anesthetics|mesh-ancestor
5740868|NCT03101137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5740869|NCT03101137|Sensory System Agents|sensory system agents|mesh-ancestor
5740870|NCT03101085|Equol|equol|mesh-list
5740871|NCT03101085|Phytoestrogens|phytoestrogens|mesh-ancestor
5740872|NCT03101085|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
5740873|NCT03101085|Estrogens|estrogens|mesh-ancestor
5740874|NCT03101085|Hormones|hormones|mesh-ancestor
5740875|NCT03101085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5740876|NCT03101085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740877|NCT03101124|Tranexamic Acid|tranexamic acid|mesh-list
5740878|NCT03101124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5740879|NCT03101124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5740880|NCT03101124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5740881|NCT03101124|Hemostatics|hemostatics|mesh-ancestor
5740882|NCT03101124|Coagulants|coagulants|mesh-ancestor
5740883|NCT03101254|Vemurafenib|vemurafenib|mesh-list
5740884|NCT03101254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5740885|NCT03101254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5740886|NCT03101254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5740887|NCT03101254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5740888|NCT03100994|Bupivacaine|bupivacaine|mesh-list
5740889|NCT03100994|Anesthetics, Local|anesthetics, local|mesh-ancestor
5740890|NCT03100994|Anesthetics|anesthetics|mesh-ancestor
5740891|NCT03100994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5740892|NCT03100994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740893|NCT03100994|Sensory System Agents|sensory system agents|mesh-ancestor
5740894|NCT03100994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5740895|NCT03101163|Hyaluronic Acid|hyaluronic acid|mesh-list
5740896|NCT03101163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5740897|NCT03101163|Immunologic Factors|immunologic factors|mesh-ancestor
5740898|NCT03101163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740899|NCT03101163|Viscosupplements|viscosupplements|mesh-ancestor
5740900|NCT03101163|Protective Agents|protective agents|mesh-ancestor
5740901|NCT03100877|Cyclophosphamide|cyclophosphamide|mesh-list
5740902|NCT03100877|Melphalan|melphalan|mesh-list
5740903|NCT03100877|Mechlorethamine|mechlorethamine|mesh-list
5619801|NCT04950868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5619802|NCT04950868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5619803|NCT04933149|Ketamine|ketamine|mesh-list
5619804|NCT04933149|Analgesics|analgesics|mesh-ancestor
5619805|NCT04933149|Sensory System Agents|sensory system agents|mesh-ancestor
5619806|NCT04933149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5619807|NCT04933149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5619808|NCT04933149|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5740904|NCT03100877|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
5740905|NCT03100877|Lenalidomide|lenalidomide|mesh-list
5740906|NCT03100877|Lenograstim|lenograstim|mesh-list
5619809|NCT04933149|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5619810|NCT04933149|Anesthetics, General|anesthetics, general|mesh-ancestor
5619811|NCT04933149|Anesthetics|anesthetics|mesh-ancestor
5619812|NCT04933149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5619813|NCT04933149|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5619814|NCT04933149|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5619815|NCT04933149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5619816|NCT04933149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619817|NCT04927312|Metronidazole|metronidazole|mesh-list
5619818|NCT04927312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5740907|NCT03100877|Mitogens|mitogens|mesh-list
5740908|NCT03100877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5740909|NCT03100877|Immunologic Factors|immunologic factors|mesh-ancestor
5740910|NCT03100877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740911|NCT03100877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5740912|NCT03100877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5740913|NCT03100877|Alkylating Agents|alkylating agents|mesh-ancestor
5740914|NCT03100877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5740915|NCT03100877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5740916|NCT03100877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5740917|NCT03100877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5740918|NCT03100877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5740919|NCT03100877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5740920|NCT03100877|Growth Substances|growth substances|mesh-ancestor
5740921|NCT03100877|Growth Inhibitors|growth inhibitors|mesh-ancestor
5740922|NCT03100877|Mitosis Modulators|mitosis modulators|mesh-ancestor
5740923|NCT03100604|Sevoflurane|sevoflurane|mesh-list
5740924|NCT03100604|Desflurane|desflurane|mesh-list
5740925|NCT03100604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5740926|NCT03100604|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5740927|NCT03100604|Anesthetics, General|anesthetics, general|mesh-ancestor
5740928|NCT03100604|Anesthetics|anesthetics|mesh-ancestor
5740929|NCT03100604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5740930|NCT03100604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740931|NCT03100513|Lactulose|lactulose|mesh-list
5740932|NCT03100513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5740933|NCT03100734|Etanercept|etanercept|mesh-list
5740934|NCT03100734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5740935|NCT03100734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5740936|NCT03100734|Analgesics|analgesics|mesh-ancestor
5740937|NCT03100734|Sensory System Agents|sensory system agents|mesh-ancestor
5740938|NCT03100734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5740939|NCT03100734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740940|NCT03100734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5740941|NCT03100734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5740942|NCT03100734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5740943|NCT03100734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5740944|NCT03100734|Immunologic Factors|immunologic factors|mesh-ancestor
5740945|NCT03100786|Dexamethasone|dexamethasone|mesh-list
5740946|NCT03100786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5740947|NCT03100786|Antiemetics|antiemetics|mesh-ancestor
5740948|NCT03100786|Autonomic Agents|autonomic agents|mesh-ancestor
5740949|NCT03100786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5740950|NCT03100786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740951|NCT03100786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5740952|NCT03100786|Glucocorticoids|glucocorticoids|mesh-ancestor
5740953|NCT03100786|Hormones|hormones|mesh-ancestor
5740954|NCT03100786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5740955|NCT03100786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5740956|NCT03100786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5740957|NCT03100565|Lidocaine|lidocaine|mesh-list
5740958|NCT03100565|Anesthetics, Local|anesthetics, local|mesh-ancestor
5740959|NCT03100565|Anesthetics|anesthetics|mesh-ancestor
5740960|NCT03100565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5740961|NCT03100565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740962|NCT03100565|Sensory System Agents|sensory system agents|mesh-ancestor
5740963|NCT03100565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5740964|NCT03100565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5740965|NCT03100565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5740966|NCT03100565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5740967|NCT03100565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5740968|NCT03100565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5740969|NCT03100435|Carbon Fiber|carbon fiber|mesh-list
5740970|NCT03100435|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5740971|NCT03100435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5893508|NCT04682158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5893509|NCT04682158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5893510|NCT04682158|Tubulin Modulators|tubulin modulators|mesh-ancestor
5893511|NCT04682158|Antimitotic Agents|antimitotic agents|mesh-ancestor
5893512|NCT04682158|Mitosis Modulators|mitosis modulators|mesh-ancestor
5893513|NCT04682158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893514|NCT04682158|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5893515|NCT04682158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5893516|NCT04682158|Adrenergic Agents|adrenergic agents|mesh-ancestor
5893517|NCT04682158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5893518|NCT04682158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893519|NCT04682158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5893520|NCT04682158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5893521|NCT04682158|Vasodilator Agents|vasodilator agents|mesh-ancestor
5893522|NCT04645316|Propofol|propofol|mesh-list
5893523|NCT04645316|Sevoflurane|sevoflurane|mesh-list
5893524|NCT04645316|Desflurane|desflurane|mesh-list
5893525|NCT04645316|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5893526|NCT04645316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5893527|NCT04645316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893528|NCT04645316|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5893529|NCT04645316|Anesthetics, General|anesthetics, general|mesh-ancestor
5893530|NCT04645316|Anesthetics|anesthetics|mesh-ancestor
5893531|NCT04645316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5893532|NCT04645316|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5893533|NCT04620382|Midodrine|midodrine|mesh-list
5893534|NCT04620382|Sympathomimetics|sympathomimetics|mesh-ancestor
5893535|NCT04620382|Autonomic Agents|autonomic agents|mesh-ancestor
5893536|NCT04620382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5893537|NCT04620382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893538|NCT04620382|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5893539|NCT04620382|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5893540|NCT04620382|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5893541|NCT04620382|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5619819|NCT04927312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5619820|NCT04927312|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5619821|NCT04927312|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5619826|NCT04893161|Belimumab|belimumab|mesh-list
5619827|NCT04893161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5619828|NCT04893161|Immunologic Factors|immunologic factors|mesh-ancestor
5619829|NCT04893161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5619830|NCT04887285|Anesthetics|anesthetics|mesh-list
5619831|NCT04887285|Anesthetics, Local|anesthetics, local|mesh-list
5619832|NCT04887285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5619833|NCT04887285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5619834|NCT04887285|Sensory System Agents|sensory system agents|mesh-ancestor
5619835|NCT04887285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5619836|NCT04880434|Cyclophosphamide|cyclophosphamide|mesh-list
5619837|NCT04880434|Fludarabine|fludarabine|mesh-list
5619838|NCT04880434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5619839|NCT04880434|Immunologic Factors|immunologic factors|mesh-ancestor
5619840|NCT04880434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5619841|NCT04880434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5619842|NCT04880434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5619843|NCT04880434|Alkylating Agents|alkylating agents|mesh-ancestor
5619844|NCT04880434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893542|NCT04620382|Adrenergic Agents|adrenergic agents|mesh-ancestor
5893543|NCT04620382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5893544|NCT04620382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893545|NCT04602533|Durvalumab|durvalumab|mesh-list
5893546|NCT04602533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5893547|NCT04602533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5893548|NCT04594382|Analgesics, Opioid|analgesics, opioid|mesh-list
5893549|NCT04594382|Narcotics|narcotics|mesh-ancestor
5893550|NCT04594382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5893551|NCT04594382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893552|NCT04594382|Analgesics|analgesics|mesh-ancestor
5893553|NCT04594382|Sensory System Agents|sensory system agents|mesh-ancestor
5619845|NCT04880434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5619846|NCT04880434|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5740972|NCT03100253|Adalimumab|adalimumab|mesh-list
5740973|NCT03100253|Etanercept|etanercept|mesh-list
5740974|NCT03100253|Golimumab|golimumab|mesh-list
5740975|NCT03100253|Infliximab|infliximab|mesh-list
5740976|NCT03100253|Certolizumab Pegol|certolizumab pegol|mesh-list
5740977|NCT03100253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5740978|NCT03100253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5740979|NCT03100253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5740980|NCT03100253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5740981|NCT03100253|Analgesics|analgesics|mesh-ancestor
5740982|NCT03100253|Sensory System Agents|sensory system agents|mesh-ancestor
5619847|NCT04871165|Immunoglobulins|immunoglobulins|mesh-list
5619848|NCT04871165|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5619849|NCT04871165|Antibodies|antibodies|mesh-list
5619850|NCT04871165|Immunologic Factors|immunologic factors|mesh-ancestor
5740983|NCT03100253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5740984|NCT03100253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5740985|NCT03100253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5740986|NCT03100253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5740987|NCT03100253|Immunologic Factors|immunologic factors|mesh-ancestor
5740988|NCT03100253|Dermatologic Agents|dermatologic agents|mesh-ancestor
5740989|NCT03100253|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
5740990|NCT03100318|Dotinurad|dotinurad|mesh-list
5740991|NCT03100318|Benzbromarone|benzbromarone|mesh-list
5740992|NCT03100318|Uricosuric Agents|uricosuric agents|mesh-ancestor
5740993|NCT03100318|Gout Suppressants|gout suppressants|mesh-ancestor
5740994|NCT03100318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5740995|NCT03100318|Renal Agents|renal agents|mesh-ancestor
5740996|NCT03100422|Armin|armin|mesh-list
5740997|NCT03100422|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5740998|NCT03100422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5740999|NCT03100422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741000|NCT03100422|Cholinergic Agents|cholinergic agents|mesh-ancestor
5741001|NCT03100422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5741002|NCT03100422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741003|NCT03100019|Resveratrol|resveratrol|mesh-list
5741004|NCT03100019|Antioxidants|antioxidants|mesh-ancestor
5741005|NCT03100019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741006|NCT03100019|Protective Agents|protective agents|mesh-ancestor
5741007|NCT03100019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741008|NCT03100019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5741009|NCT03100019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5741010|NCT03100071|Apixaban|apixaban|mesh-list
5741011|NCT03100071|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5619851|NCT04871165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5619852|NCT04867928|Azacitidine|azacitidine|mesh-list
5619853|NCT04867928|Venetoclax|venetoclax|mesh-list
5741012|NCT03100071|Antithrombins|antithrombins|mesh-ancestor
5741013|NCT03100071|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5741014|NCT03100071|Protease Inhibitors|protease inhibitors|mesh-ancestor
5741015|NCT03100071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5741016|NCT03100071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741017|NCT03100071|Anticoagulants|anticoagulants|mesh-ancestor
5741018|NCT03100006|Nivolumab|nivolumab|mesh-list
5741019|NCT03100006|Oregovomab|oregovomab|mesh-list
5741020|NCT03100006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5741021|NCT03100006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5741022|NCT03100006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5741023|NCT03100006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741024|NCT03099720|Ropivacaine|ropivacaine|mesh-list
5741025|NCT03099720|Anesthetics, Local|anesthetics, local|mesh-ancestor
5741026|NCT03099720|Anesthetics|anesthetics|mesh-ancestor
5741027|NCT03099720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5741028|NCT03099720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741029|NCT03099720|Sensory System Agents|sensory system agents|mesh-ancestor
5741030|NCT03099720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5741031|NCT03099759|Vitamin D|vitamin d|mesh-list
5741032|NCT03099759|Cholecalciferol|cholecalciferol|mesh-list
5741033|NCT03099759|Ergocalciferols|ergocalciferols|mesh-list
5741034|NCT03099759|Vitamins|vitamins|mesh-ancestor
5741035|NCT03099759|Micronutrients|micronutrients|mesh-ancestor
5741036|NCT03099759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5619854|NCT04867928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5619855|NCT04867928|Antimetabolites|antimetabolites|mesh-ancestor
5741037|NCT03099759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5741038|NCT03099759|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5741039|NCT03099824|Avasopasem manganese|avasopasem manganese|mesh-list
5741040|NCT03099824|Antioxidants|antioxidants|mesh-ancestor
5741041|NCT03099824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741042|NCT03099824|Protective Agents|protective agents|mesh-ancestor
5741043|NCT03099824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741044|NCT03099785|Rifamycins|rifamycins|mesh-list
5741045|NCT03099785|Rifamycin SV|rifamycin sv|mesh-list
5741046|NCT03099785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5619856|NCT04867928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619857|NCT04867928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5619858|NCT04867928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5692466|NCT03407521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692467|NCT03407521|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5741047|NCT03099785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5741048|NCT03099785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5741049|NCT03099590|Puerarin|puerarin|mesh-list
5741050|NCT03099590|Vasodilator Agents|vasodilator agents|mesh-ancestor
5741051|NCT03099499|TIC10 compound|tic10 compound|mesh-list
5741052|NCT03099499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5741053|NCT03099616|Propofol|propofol|mesh-list
5741054|NCT03099616|Desflurane|desflurane|mesh-list
5741055|NCT03099616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5741056|NCT03099616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5741057|NCT03099616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741058|NCT03099616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5741059|NCT03099616|Anesthetics, General|anesthetics, general|mesh-ancestor
5741060|NCT03099616|Anesthetics|anesthetics|mesh-ancestor
5741061|NCT03099616|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5692468|NCT03407521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5692469|NCT03407521|Oxytocics|oxytocics|mesh-ancestor
5692470|NCT03407521|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5692471|NCT03407521|Diuretics|diuretics|mesh-ancestor
5692472|NCT03407521|Natriuretic Agents|natriuretic agents|mesh-ancestor
5741062|NCT03099382|Docetaxel|docetaxel|mesh-list
5741063|NCT03099382|Irinotecan|irinotecan|mesh-list
5741064|NCT03099382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5741065|NCT03099382|Tubulin Modulators|tubulin modulators|mesh-ancestor
5741066|NCT03099382|Antimitotic Agents|antimitotic agents|mesh-ancestor
5741067|NCT03099382|Mitosis Modulators|mitosis modulators|mesh-ancestor
5741068|NCT03099382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741069|NCT03099382|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5741070|NCT03099382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5741071|NCT03099382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5741072|NCT03099278|Ezetimibe|ezetimibe|mesh-list
5741073|NCT03099278|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5741074|NCT03099278|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5741075|NCT03099278|Antimetabolites|antimetabolites|mesh-ancestor
5741076|NCT03099278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741077|NCT03099278|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5741078|NCT03099122|Mycophenolic Acid|mycophenolic acid|mesh-list
5741079|NCT03099122|Prednisone|prednisone|mesh-list
5741080|NCT03099122|Methylprednisolone|methylprednisolone|mesh-list
5741081|NCT03099122|Tacrolimus|tacrolimus|mesh-list
5741082|NCT03099122|Thymoglobulin|thymoglobulin|mesh-list
5741083|NCT03099122|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5692473|NCT03407521|Vasodilator Agents|vasodilator agents|mesh-ancestor
5692474|NCT03407521|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5692475|NCT03407521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692476|NCT03407404|Midazolam|midazolam|mesh-list
5692477|NCT03407404|Morphine|morphine|mesh-list
5692478|NCT03407404|Ketamine|ketamine|mesh-list
5692479|NCT03407404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5692480|NCT03407404|Narcotics|narcotics|mesh-ancestor
5692481|NCT03407404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5692482|NCT03407404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692483|NCT03407404|Analgesics|analgesics|mesh-ancestor
5741084|NCT03099122|Immunoglobulins|immunoglobulins|mesh-list
5741085|NCT03099122|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5741086|NCT03099122|Antibodies|antibodies|mesh-list
5741087|NCT03099122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5741088|NCT03099122|Glucocorticoids|glucocorticoids|mesh-ancestor
5741089|NCT03099122|Hormones|hormones|mesh-ancestor
6672871|NCT01558934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6672872|NCT01558934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672873|NCT01558960|Melphalan|melphalan|mesh-list
5692484|NCT03407404|Sensory System Agents|sensory system agents|mesh-ancestor
5741090|NCT03099122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5741091|NCT03099122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741092|NCT03099122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5741093|NCT03099122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5741094|NCT03099122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5741095|NCT03099122|Immunologic Factors|immunologic factors|mesh-ancestor
5741096|NCT03099122|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5741097|NCT03099122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5741098|NCT03099122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741099|NCT03099122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5741100|NCT03099122|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5741101|NCT03099122|Antitubercular Agents|antitubercular agents|mesh-ancestor
5741102|NCT03099122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5741103|NCT03099122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5741104|NCT03099122|Antiemetics|antiemetics|mesh-ancestor
5741105|NCT03099122|Autonomic Agents|autonomic agents|mesh-ancestor
5741106|NCT03099122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5741107|NCT03099122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5741108|NCT03099122|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5741109|NCT03099122|Protective Agents|protective agents|mesh-ancestor
5741110|NCT03099408|Metronidazole|metronidazole|mesh-list
5741111|NCT03099408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5741112|NCT03099408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5741113|NCT03099408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5741114|NCT03099408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5619859|NCT04857385|Hemostatics|hemostatics|mesh-list
5619860|NCT04857385|Coagulants|coagulants|mesh-ancestor
5619861|NCT04857138|Atezolizumab|atezolizumab|mesh-list
5619862|NCT04857138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5619863|NCT04781855|Nivolumab|nivolumab|mesh-list
5619864|NCT04781855|Ipilimumab|ipilimumab|mesh-list
5619865|NCT04781855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5619866|NCT04781855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5619867|NCT04781855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5619868|NCT04781855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619869|NCT04768101|Corticosterone|corticosterone|mesh-list
5619870|NCT04768101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5619871|NCT04735185|Anesthetics|anesthetics|mesh-list
5619872|NCT04735185|Anesthetics, Local|anesthetics, local|mesh-list
5619873|NCT04735185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5619874|NCT04735185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5619875|NCT04735185|Sensory System Agents|sensory system agents|mesh-ancestor
5619876|NCT04735185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5619877|NCT04666389|Atorvastatin|atorvastatin|mesh-list
5619878|NCT04666389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5619879|NCT04666389|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5619880|NCT04666389|Antimetabolites|antimetabolites|mesh-ancestor
5619881|NCT04666389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619882|NCT04666389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5619883|NCT04666389|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5619884|NCT04666389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5619885|NCT04640545|Axitinib|axitinib|mesh-list
5619886|NCT04640545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5619887|NCT04640545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5619888|NCT04640545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5619889|NCT04640545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619890|NCT04635631|Talazoparib|talazoparib|mesh-list
5619891|NCT04635631|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5619892|NCT04635631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5619893|NCT04635631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619894|NCT04635631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5619895|NCT04614168|Hypoglycemic Agents|hypoglycemic agents|mesh-list
5619896|NCT04614168|Glycerol|glycerol|mesh-list
5619897|NCT04614168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5619898|NCT04614168|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
5619899|NCT04614168|Protective Agents|protective agents|mesh-ancestor
6208650|NCT02133664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208651|NCT02133664|Vitamin B Complex|vitamin b complex|mesh-ancestor
6208652|NCT02133664|Vitamins|vitamins|mesh-ancestor
6208653|NCT02133664|Micronutrients|micronutrients|mesh-ancestor
5619904|NCT04559139|Gemcitabine|gemcitabine|mesh-list
5619905|NCT04559139|Cisplatin|cisplatin|mesh-list
5619906|NCT04559139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5619907|NCT04559139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5619908|NCT04559139|Antimetabolites|antimetabolites|mesh-ancestor
5619909|NCT04559139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619910|NCT04559139|Antiviral Agents|antiviral agents|mesh-ancestor
5741115|NCT03099265|Leucovorin|leucovorin|mesh-list
5741116|NCT03099265|Fluorouracil|fluorouracil|mesh-list
5741117|NCT03099265|Oxaliplatin|oxaliplatin|mesh-list
5741118|NCT03099265|Irinotecan|irinotecan|mesh-list
5741119|NCT03099265|Antimetabolites|antimetabolites|mesh-ancestor
5741120|NCT03099265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741121|NCT03099265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5741122|NCT03099265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5741123|NCT03099265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5741124|NCT03099265|Immunologic Factors|immunologic factors|mesh-ancestor
5741125|NCT03099265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741126|NCT03099265|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5741127|NCT03099265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5741128|NCT03099265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5741129|NCT03099265|Antidotes|antidotes|mesh-ancestor
5741130|NCT03099265|Protective Agents|protective agents|mesh-ancestor
5741131|NCT03099265|Vitamin B Complex|vitamin b complex|mesh-ancestor
5741132|NCT03099265|Vitamins|vitamins|mesh-ancestor
5741133|NCT03099265|Micronutrients|micronutrients|mesh-ancestor
5741134|NCT03099213|Ramipril|ramipril|mesh-list
5741135|NCT03099213|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5741136|NCT03099213|Protease Inhibitors|protease inhibitors|mesh-ancestor
5741137|NCT03099213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5619911|NCT04559139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5619912|NCT04559139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5619913|NCT04559139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5619914|NCT04559139|Immunologic Factors|immunologic factors|mesh-ancestor
5619915|NCT04559139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5619916|NCT04553419|Cephalexin|cephalexin|mesh-list
5619917|NCT04553419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5619918|NCT04553419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6208654|NCT02133742|Pembrolizumab|pembrolizumab|mesh-list
6208655|NCT02133742|Axitinib|axitinib|mesh-list
5741138|NCT03099213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741139|NCT03099213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5741140|NCT03098875|Remifentanil|remifentanil|mesh-list
5741141|NCT03098875|Propofol|propofol|mesh-list
5741142|NCT03098875|Sevoflurane|sevoflurane|mesh-list
5741143|NCT03098875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5741144|NCT03098875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5741145|NCT03098875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741146|NCT03098875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5741147|NCT03098875|Anesthetics, General|anesthetics, general|mesh-ancestor
5741148|NCT03098875|Anesthetics|anesthetics|mesh-ancestor
5741149|NCT03098875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5741150|NCT03098875|Narcotics|narcotics|mesh-ancestor
5741151|NCT03098875|Analgesics|analgesics|mesh-ancestor
5741152|NCT03098875|Sensory System Agents|sensory system agents|mesh-ancestor
5741153|NCT03098875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5741154|NCT03098875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5741155|NCT03098875|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5741156|NCT03099031|Tinzaparin|tinzaparin|mesh-list
5741157|NCT03099031|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5741158|NCT03099031|Dalteparin|dalteparin|mesh-list
5741159|NCT03099031|Anticoagulants|anticoagulants|mesh-ancestor
5741160|NCT03099031|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5741161|NCT03099031|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5741162|NCT03099031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741163|NCT03098953|Loteprednol Etabonate|loteprednol etabonate|mesh-list
5741164|NCT03098953|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5741165|NCT03098823|Prednisone|prednisone|mesh-list
5741166|NCT03098823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5741167|NCT03098823|Glucocorticoids|glucocorticoids|mesh-ancestor
5741168|NCT03098823|Hormones|hormones|mesh-ancestor
5741169|NCT03098823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5741170|NCT03098823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741171|NCT03098823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6208656|NCT02133742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6208657|NCT02133742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6208658|NCT02133742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5619924|NCT04528108|Hemostatics|hemostatics|mesh-list
5619925|NCT04528108|Coagulants|coagulants|mesh-ancestor
5619926|NCT04527549|Hydroxychloroquine|hydroxychloroquine|mesh-list
5619927|NCT04527549|Trametinib|trametinib|mesh-list
5619928|NCT04527549|Dabrafenib|dabrafenib|mesh-list
5619929|NCT04527549|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
5619930|NCT04527549|Antimalarials|antimalarials|mesh-ancestor
5619931|NCT04527549|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5619932|NCT04527549|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5619933|NCT04527549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5619934|NCT04527549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5619935|NCT04527549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208659|NCT02133742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5741172|NCT03098823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5741173|NCT03098810|Zinc Sulfate|zinc sulfate|mesh-list
5741174|NCT03098810|Astringents|astringents|mesh-ancestor
5741175|NCT03098810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741176|NCT03098810|Dermatologic Agents|dermatologic agents|mesh-ancestor
5893554|NCT04594382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5893555|NCT04530604|Defibrotide|defibrotide|mesh-list
5893556|NCT04530604|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5893557|NCT04530604|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5893558|NCT04530604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893559|NCT04530604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5893560|NCT04451863|Caryophyllene|caryophyllene|mesh-list
5893561|NCT04451863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893562|NCT04451863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5893563|NCT04451863|Analgesics|analgesics|mesh-ancestor
5893564|NCT04451863|Sensory System Agents|sensory system agents|mesh-ancestor
5893565|NCT04451863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5893566|NCT04451863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5619936|NCT04527549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5619937|NCT04527549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5619938|NCT04527549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5619939|NCT04527549|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
5619940|NCT04527549|Protective Agents|protective agents|mesh-ancestor
5619941|NCT04527549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5619942|NCT04527549|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5619943|NCT04527549|Antioxidants|antioxidants|mesh-ancestor
5619944|NCT04521114|Leronlimab|leronlimab|mesh-list
5619945|NCT04521114|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5619946|NCT04521114|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5619947|NCT04521114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619948|NCT04521114|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5619949|NCT04521114|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5619950|NCT04521114|Antiviral Agents|antiviral agents|mesh-ancestor
5619951|NCT04521114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5619952|NCT04504942|Leronlimab|leronlimab|mesh-list
5619953|NCT04504942|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5619954|NCT04504942|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5619955|NCT04504942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619956|NCT04504942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5619957|NCT04504942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5619958|NCT04504942|Antiviral Agents|antiviral agents|mesh-ancestor
5893567|NCT04451863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5893568|NCT04451863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5893569|NCT04450394|Insulin|insulin|mesh-list
5893570|NCT04450394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5893571|NCT04450394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893572|NCT04413201|Afatinib|afatinib|mesh-list
5893573|NCT04413201|Osimertinib|osimertinib|mesh-list
5893574|NCT04413201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5893575|NCT04413201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5619959|NCT04504942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5619960|NCT04485039|Sevelamer|sevelamer|mesh-list
5619961|NCT04485039|Calcium acetate|calcium acetate|mesh-list
5619962|NCT04485039|Chelating Agents|chelating agents|mesh-ancestor
5619963|NCT04485039|Sequestering Agents|sequestering agents|mesh-ancestor
5619964|NCT04485039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619965|NCT04478084|Vaccines|vaccines|mesh-list
5619966|NCT04478084|Immunoglobulins|immunoglobulins|mesh-list
5619967|NCT04478084|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5619968|NCT04478084|Antibodies|antibodies|mesh-list
5619969|NCT04478084|Immunologic Factors|immunologic factors|mesh-ancestor
5619970|NCT04478084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5619971|NCT04477837|Rivaroxaban|rivaroxaban|mesh-list
5619972|NCT04477837|Apixaban|apixaban|mesh-list
5619973|NCT04477837|Edoxaban|edoxaban|mesh-list
5619974|NCT04477837|Dabigatran|dabigatran|mesh-list
5619975|NCT04477837|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5619976|NCT04477837|Antithrombins|antithrombins|mesh-ancestor
5619977|NCT04477837|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5619978|NCT04477837|Protease Inhibitors|protease inhibitors|mesh-ancestor
5619979|NCT04477837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5619980|NCT04477837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893576|NCT04413201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5893577|NCT04413201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619981|NCT04477837|Anticoagulants|anticoagulants|mesh-ancestor
5619982|NCT04473807|Sotalol|sotalol|mesh-list
5619983|NCT04473807|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5741177|NCT03098680|Verapamil|verapamil|mesh-list
5741178|NCT03098680|Nicardipine|nicardipine|mesh-list
5741179|NCT03098680|Phentolamine|phentolamine|mesh-list
5741180|NCT03098680|Phenylephrine|phenylephrine|mesh-list
5741181|NCT03098680|Dobutamine|dobutamine|mesh-list
5741182|NCT03098680|Oxymetazoline|oxymetazoline|mesh-list
5619984|NCT04473807|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5619985|NCT04473807|Adrenergic Agents|adrenergic agents|mesh-ancestor
5619986|NCT04473807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5619987|NCT04473807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5619988|NCT04473807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5619989|NCT04473807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5619990|NCT04473807|Sympatholytics|sympatholytics|mesh-ancestor
5619991|NCT04473807|Autonomic Agents|autonomic agents|mesh-ancestor
5619992|NCT04473807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5619993|NCT04452344|Analgesics|analgesics|mesh-list
5619994|NCT04452344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5619995|NCT04452344|Sensory System Agents|sensory system agents|mesh-ancestor
5619996|NCT04452344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5619997|NCT04436744|Palbociclib|palbociclib|mesh-list
5619998|NCT04436744|Anastrozole|anastrozole|mesh-list
5619999|NCT04436744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5620000|NCT04436744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5620001|NCT04436744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5620002|NCT04436744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620003|NCT04436744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5620004|NCT04436744|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5620005|NCT04436744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5620006|NCT04436744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5620007|NCT04436744|Hormone Antagonists|hormone antagonists|mesh-ancestor
5620008|NCT04436744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5620009|NCT04436744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741183|NCT03098680|Albuterol|albuterol|mesh-list
5741184|NCT03098680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5741185|NCT03098680|Autonomic Agents|autonomic agents|mesh-ancestor
5741186|NCT03098680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5741187|NCT03098680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741188|NCT03098680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5741189|NCT03098680|Respiratory System Agents|respiratory system agents|mesh-ancestor
5741190|NCT03098680|Tocolytic Agents|tocolytic agents|mesh-ancestor
5741191|NCT03098680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5741192|NCT03098680|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5741193|NCT03098680|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5741194|NCT03098680|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5741195|NCT03098680|Adrenergic Agents|adrenergic agents|mesh-ancestor
5741196|NCT03098680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5741197|NCT03098680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741198|NCT03098680|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5741199|NCT03098680|Mydriatics|mydriatics|mesh-ancestor
5741200|NCT03098680|Sympathomimetics|sympathomimetics|mesh-ancestor
5741201|NCT03098680|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5741202|NCT03098680|Nasal Decongestants|nasal decongestants|mesh-ancestor
5741203|NCT03098680|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5741204|NCT03098680|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5741205|NCT03098680|Protective Agents|protective agents|mesh-ancestor
5741206|NCT03098680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5741207|NCT03098680|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5741208|NCT03098680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5741209|NCT03098680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5741210|NCT03098680|Vasodilator Agents|vasodilator agents|mesh-ancestor
5741211|NCT03098680|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5741212|NCT03098680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5741213|NCT03098680|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5741214|NCT03098680|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5741215|NCT03098537|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
5741216|NCT03098537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5741217|NCT03098537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741218|NCT03098407|Buprenorphine|buprenorphine|mesh-list
5741219|NCT03098407|Methadone|methadone|mesh-list
5741220|NCT03098407|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5741221|NCT03098407|Narcotics|narcotics|mesh-ancestor
5741222|NCT03098407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5741223|NCT03098407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741224|NCT03098407|Analgesics|analgesics|mesh-ancestor
5741225|NCT03098407|Sensory System Agents|sensory system agents|mesh-ancestor
5620010|NCT04423068|Contraceptive Agents|contraceptive agents|mesh-list
5620011|NCT04423068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5620012|NCT04423068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620013|NCT04418661|Pembrolizumab|pembrolizumab|mesh-list
5620014|NCT04418661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5620015|NCT04418661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5620016|NCT04406649|Dihydroergotamine|dihydroergotamine|mesh-list
5741226|NCT03098407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5741227|NCT03098407|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5741228|NCT03098407|Antitussive Agents|antitussive agents|mesh-ancestor
5620017|NCT04406649|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5620018|NCT04406649|Dopamine Agonists|dopamine agonists|mesh-ancestor
5620019|NCT04406649|Dopamine Agents|dopamine agents|mesh-ancestor
5620020|NCT04406649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5620021|NCT04406649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620022|NCT04406649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620023|NCT04406649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5620024|NCT04406649|Analgesics|analgesics|mesh-ancestor
5620025|NCT04406649|Sensory System Agents|sensory system agents|mesh-ancestor
5620026|NCT04406649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5620027|NCT04398368|Gemcitabine|gemcitabine|mesh-list
5620028|NCT04398368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5620029|NCT04398368|Antimetabolites|antimetabolites|mesh-ancestor
5620030|NCT04398368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620031|NCT04398368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5620032|NCT04398368|Antiviral Agents|antiviral agents|mesh-ancestor
5741229|NCT03098407|Respiratory System Agents|respiratory system agents|mesh-ancestor
5741230|NCT03098589|Lenalidomide|lenalidomide|mesh-list
5741231|NCT03098589|Immunologic Factors|immunologic factors|mesh-ancestor
5741232|NCT03098589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741233|NCT03098589|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5741234|NCT03098589|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5741235|NCT03098589|Growth Substances|growth substances|mesh-ancestor
5741236|NCT03098589|Growth Inhibitors|growth inhibitors|mesh-ancestor
5741237|NCT03098589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5741238|NCT03098368|Rotigotine|rotigotine|mesh-list
5741239|NCT03098368|Dopamine Agonists|dopamine agonists|mesh-ancestor
5741240|NCT03098368|Dopamine Agents|dopamine agents|mesh-ancestor
5741241|NCT03098368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5741242|NCT03098368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741243|NCT03098368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741244|NCT03098355|Interleukin-2|interleukin-2|mesh-list
5741245|NCT03098355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5741246|NCT03098355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5741247|NCT03098355|Analgesics|analgesics|mesh-ancestor
5741248|NCT03098355|Sensory System Agents|sensory system agents|mesh-ancestor
5741249|NCT03098355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5741250|NCT03098355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741251|NCT03098342|Amorolfine|amorolfine|mesh-list
5741252|NCT03098342|Methylene Blue|methylene blue|mesh-list
5741253|NCT03098342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5741254|NCT03098342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620033|NCT04398368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5620034|NCT04398368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5620035|NCT04398368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5620036|NCT04398368|Immunologic Factors|immunologic factors|mesh-ancestor
5620037|NCT04398368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620038|NCT04388475|Temozolomide|temozolomide|mesh-list
5620039|NCT04388475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5741255|NCT03098342|Antifungal Agents|antifungal agents|mesh-ancestor
5741256|NCT03098342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5741257|NCT03098225|Methylprednisolone|methylprednisolone|mesh-list
5620040|NCT04388475|Alkylating Agents|alkylating agents|mesh-ancestor
5620041|NCT04388475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620042|NCT04388475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5620043|NCT04357951|Cycloserine|cycloserine|mesh-list
5620044|NCT04357951|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5620045|NCT04357951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5620046|NCT04357951|Renal Agents|renal agents|mesh-ancestor
5620047|NCT04357951|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5620048|NCT04357951|Antitubercular Agents|antitubercular agents|mesh-ancestor
5620049|NCT04357951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5620050|NCT04357951|Antimetabolites|antimetabolites|mesh-ancestor
5741258|NCT03098225|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6208660|NCT02133742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741259|NCT03098225|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5741260|NCT03098225|Prednisolone|prednisolone|mesh-list
5741261|NCT03098225|Prednisolone acetate|prednisolone acetate|mesh-list
5741262|NCT03098225|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5741263|NCT03098225|Prednisolone phosphate|prednisolone phosphate|mesh-list
5741264|NCT03098225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5741265|NCT03098225|Antiemetics|antiemetics|mesh-ancestor
5741266|NCT03098225|Autonomic Agents|autonomic agents|mesh-ancestor
5741267|NCT03098225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5741268|NCT03098225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741269|NCT03098225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5741270|NCT03098225|Glucocorticoids|glucocorticoids|mesh-ancestor
5741271|NCT03098225|Hormones|hormones|mesh-ancestor
5741272|NCT03098225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5620051|NCT04357951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620052|NCT04347239|Leronlimab|leronlimab|mesh-list
5620053|NCT04347239|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5620054|NCT04347239|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5620055|NCT04347239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620056|NCT04347239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5620057|NCT04347239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5741273|NCT03098225|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5741274|NCT03098225|Protective Agents|protective agents|mesh-ancestor
5741275|NCT03098225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5741276|NCT03098225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5741277|NCT03098160|Ipilimumab|ipilimumab|mesh-list
5741278|NCT03098160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5741279|NCT03098160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5741280|NCT03098160|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5741281|NCT03098160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741282|NCT03098199|Menotropins|menotropins|mesh-list
5741283|NCT03098199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741284|NCT03098199|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5741285|NCT03098199|Fertility Agents|fertility agents|mesh-ancestor
5741286|NCT03098199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5741287|NCT03098121|Grazoprevir|grazoprevir|mesh-list
5620058|NCT04347239|Antiviral Agents|antiviral agents|mesh-ancestor
5620059|NCT04347239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5692485|NCT03407404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5692486|NCT03407404|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5692487|NCT03407404|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5692488|NCT03407404|Anesthetics, General|anesthetics, general|mesh-ancestor
5692489|NCT03407404|Anesthetics|anesthetics|mesh-ancestor
5692490|NCT03407404|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5692491|NCT03407404|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5692492|NCT03407404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5741288|NCT03098121|Antiviral Agents|antiviral agents|mesh-ancestor
5741289|NCT03098121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5741290|NCT03097939|Nivolumab|nivolumab|mesh-list
5741291|NCT03097939|Ipilimumab|ipilimumab|mesh-list
5741292|NCT03097939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5741293|NCT03097939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5741294|NCT03097939|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5741295|NCT03097939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741296|NCT03097796|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
5741297|NCT03097796|Respiratory System Agents|respiratory system agents|mesh-ancestor
5741298|NCT03097848|Sorafenib|sorafenib|mesh-list
5741299|NCT03097848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5741300|NCT03097848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5741301|NCT03097848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5692493|NCT03407404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692494|NCT03407404|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5692495|NCT03407404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5692496|NCT03407404|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5692497|NCT03407404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5692498|NCT03407404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5692499|NCT03407404|GABA Modulators|gaba modulators|mesh-ancestor
5692500|NCT03407404|GABA Agents|gaba agents|mesh-ancestor
5692501|NCT03407300|Docetaxel|docetaxel|mesh-list
5741302|NCT03097848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741303|NCT03097900|Caffeine|caffeine|mesh-list
5741304|NCT03097900|Caffeine citrate|caffeine citrate|mesh-list
5741305|NCT03097900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741306|NCT03097900|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5741307|NCT03097900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208661|NCT02133781|Vaccines|vaccines|mesh-list
5620060|NCT04315181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
5620061|NCT04315181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5620062|NCT04315181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620063|NCT04285086|Anagrelide|anagrelide|mesh-list
5620064|NCT04285086|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5620065|NCT04285086|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5620066|NCT04285086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620067|NCT04285086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5620068|NCT04249167|Paclitaxel|paclitaxel|mesh-list
5620069|NCT04249167|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5620070|NCT04249167|Atezolizumab|atezolizumab|mesh-list
5620071|NCT04249167|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5620072|NCT04249167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5620073|NCT04249167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5620074|NCT04249167|Tubulin Modulators|tubulin modulators|mesh-ancestor
5620075|NCT04249167|Antimitotic Agents|antimitotic agents|mesh-ancestor
5620076|NCT04249167|Mitosis Modulators|mitosis modulators|mesh-ancestor
5620077|NCT04249167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620078|NCT04249167|Immunologic Factors|immunologic factors|mesh-ancestor
6208662|NCT02133781|Immunologic Factors|immunologic factors|mesh-ancestor
6208663|NCT02133781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620079|NCT04249167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208664|NCT02134015|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6208665|NCT02134015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6208666|NCT02134015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5620083|NCT04245423|Analgesics, Opioid|analgesics, opioid|mesh-list
5620084|NCT04245423|Narcotics|narcotics|mesh-ancestor
5620085|NCT04245423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5620086|NCT04245423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620087|NCT04245423|Analgesics|analgesics|mesh-ancestor
5620088|NCT04245423|Sensory System Agents|sensory system agents|mesh-ancestor
5620089|NCT04245423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5620090|NCT04230265|Cyclophosphamide|cyclophosphamide|mesh-list
5620091|NCT04230265|Fludarabine|fludarabine|mesh-list
5620092|NCT04230265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5620093|NCT04230265|Immunologic Factors|immunologic factors|mesh-ancestor
5620094|NCT04230265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620095|NCT04230265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5620096|NCT04230265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5620097|NCT04230265|Alkylating Agents|alkylating agents|mesh-ancestor
5620098|NCT04230265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620099|NCT04230265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5620100|NCT04230265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5620101|NCT04218656|Rivaroxaban|rivaroxaban|mesh-list
5620102|NCT04218656|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5620103|NCT04218656|Antithrombins|antithrombins|mesh-ancestor
5620104|NCT04218656|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5620105|NCT04218656|Protease Inhibitors|protease inhibitors|mesh-ancestor
5620106|NCT04218656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5620107|NCT04218656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208667|NCT02134015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6208668|NCT02134015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208669|NCT02134184|Vaccines|vaccines|mesh-list
6208670|NCT02134184|Immunologic Factors|immunologic factors|mesh-ancestor
6208671|NCT02134184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741308|NCT03097900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5741309|NCT03097900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5741310|NCT03097900|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5741311|NCT03097900|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5741312|NCT03097900|Purinergic Agents|purinergic agents|mesh-ancestor
6672874|NCT01558960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5620108|NCT04218656|Anticoagulants|anticoagulants|mesh-ancestor
5620109|NCT04198363|Amoxicillin|amoxicillin|mesh-list
5620110|NCT04198363|Clarithromycin|clarithromycin|mesh-list
5620111|NCT04198363|Potassium Citrate|potassium citrate|mesh-list
5620112|NCT04198363|Esomeprazole|esomeprazole|mesh-list
5620113|NCT04198363|Bismuth|bismuth|mesh-list
5620114|NCT04198363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620115|NCT04198363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5620116|NCT04198363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5620117|NCT04198363|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5620118|NCT04198363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5620119|NCT04198363|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5620120|NCT04198363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5620121|NCT04198363|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5620122|NCT04198363|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5620123|NCT04198363|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5620124|NCT04198363|Antacids|antacids|mesh-ancestor
5620125|NCT04198363|Diuretics|diuretics|mesh-ancestor
5620126|NCT04198363|Natriuretic Agents|natriuretic agents|mesh-ancestor
5620127|NCT04198363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620128|NCT04198363|Expectorants|expectorants|mesh-ancestor
5620129|NCT04198363|Respiratory System Agents|respiratory system agents|mesh-ancestor
5620130|NCT04161885|Azacitidine|azacitidine|mesh-list
5620131|NCT04161885|Venetoclax|venetoclax|mesh-list
5620132|NCT04161885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5620133|NCT04161885|Antimetabolites|antimetabolites|mesh-ancestor
5620134|NCT04161885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620135|NCT04161885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5620136|NCT04161885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5741313|NCT03097900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5741314|NCT03097835|Anesthetics|anesthetics|mesh-list
5741315|NCT03097835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5741316|NCT03097835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741317|NCT03097601|Sunitinib|sunitinib|mesh-list
5741318|NCT03097601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5620137|NCT04126824|Triamcinolone|triamcinolone|mesh-list
5620138|NCT04126824|Bupivacaine|bupivacaine|mesh-list
5620139|NCT04126824|Anesthetics, Local|anesthetics, local|mesh-ancestor
5620140|NCT04126824|Anesthetics|anesthetics|mesh-ancestor
5620141|NCT04126824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5620142|NCT04126824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620143|NCT04126824|Sensory System Agents|sensory system agents|mesh-ancestor
5620144|NCT04126824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5620145|NCT04126824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5620146|NCT04126824|Glucocorticoids|glucocorticoids|mesh-ancestor
5620147|NCT04126824|Hormones|hormones|mesh-ancestor
5620148|NCT04126824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5620149|NCT04095689|Docetaxel|docetaxel|mesh-list
5620150|NCT04095689|Pembrolizumab|pembrolizumab|mesh-list
5620151|NCT04095689|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
5620152|NCT04095689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5741319|NCT03097601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5741320|NCT03097601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5741321|NCT03097601|Growth Substances|growth substances|mesh-ancestor
5741322|NCT03097601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741323|NCT03097601|Growth Inhibitors|growth inhibitors|mesh-ancestor
5741324|NCT03097601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5741325|NCT03097601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5741326|NCT03097601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741327|NCT03097380|Tiotropium Bromide|tiotropium bromide|mesh-list
5741328|NCT03097380|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5741329|NCT03097380|Autonomic Agents|autonomic agents|mesh-ancestor
5741330|NCT03097380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5741331|NCT03097380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741332|NCT03097380|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5741333|NCT03097380|Respiratory System Agents|respiratory system agents|mesh-ancestor
5741334|NCT03097380|Parasympatholytics|parasympatholytics|mesh-ancestor
5741335|NCT03097380|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5741336|NCT03097380|Cholinergic Agents|cholinergic agents|mesh-ancestor
5741337|NCT03097380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5741338|NCT03097380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741339|NCT03097445|Nicotine|nicotine|mesh-list
5741340|NCT03097445|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5741341|NCT03097445|Autonomic Agents|autonomic agents|mesh-ancestor
5741342|NCT03097445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5741343|NCT03097445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741344|NCT03097445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5620153|NCT04095689|Tubulin Modulators|tubulin modulators|mesh-ancestor
5741345|NCT03097445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5741346|NCT03097445|Cholinergic Agents|cholinergic agents|mesh-ancestor
5741347|NCT03097445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5741348|NCT03097445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741349|NCT03097406|Imidacloprid|imidacloprid|mesh-list
5741350|NCT03097406|Cholinergic Agents|cholinergic agents|mesh-ancestor
5741351|NCT03097406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5741352|NCT03097406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741353|NCT03097406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741354|NCT03097120|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
5741355|NCT03097120|Medroxyprogesterone|medroxyprogesterone|mesh-list
5620154|NCT04095689|Antimitotic Agents|antimitotic agents|mesh-ancestor
5620155|NCT04095689|Mitosis Modulators|mitosis modulators|mesh-ancestor
5620156|NCT04095689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620157|NCT04095689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5620158|NCT04095689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5620159|NCT04057469|Tulobuterol|tulobuterol|mesh-list
5620160|NCT04057469|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5620161|NCT04057469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5620162|NCT04057469|Adrenergic Agents|adrenergic agents|mesh-ancestor
5620163|NCT04057469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5620164|NCT04057469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620165|NCT04057469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620166|NCT04057469|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5620167|NCT04057469|Autonomic Agents|autonomic agents|mesh-ancestor
5620168|NCT04057469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5620169|NCT04057469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5620170|NCT04057469|Respiratory System Agents|respiratory system agents|mesh-ancestor
5741356|NCT03097120|Estrogens|estrogens|mesh-list
5741357|NCT03097120|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
5741358|NCT03097120|Hormones|hormones|mesh-ancestor
5741359|NCT03097120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5741360|NCT03097120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741361|NCT03097120|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5741362|NCT03097120|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5741363|NCT03097120|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5741364|NCT03097120|Contraceptive Agents|contraceptive agents|mesh-ancestor
5741365|NCT03097120|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5741366|NCT03097120|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5741367|NCT03097120|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5741368|NCT03097120|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5741369|NCT03097120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5741370|NCT03097120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5741371|NCT03097068|Ranibizumab|ranibizumab|mesh-list
5741372|NCT03097068|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5741373|NCT03097068|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5741374|NCT03097068|Growth Substances|growth substances|mesh-ancestor
5741375|NCT03097068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741376|NCT03097068|Growth Inhibitors|growth inhibitors|mesh-ancestor
5741377|NCT03097068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5741378|NCT03097211|Levodopa|levodopa|mesh-list
5741379|NCT03097211|Benserazide|benserazide|mesh-list
5741380|NCT03097211|Resveratrol|resveratrol|mesh-list
5741381|NCT03097211|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
5741382|NCT03097211|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5741383|NCT03097211|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5741384|NCT03097211|Dopamine Agents|dopamine agents|mesh-ancestor
5741385|NCT03097211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5741386|NCT03097211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741387|NCT03097211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741388|NCT03097211|Antioxidants|antioxidants|mesh-ancestor
5741389|NCT03097211|Protective Agents|protective agents|mesh-ancestor
5741390|NCT03097211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5741391|NCT03097211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5741392|NCT03097198|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5741393|NCT03097198|Tropicamide|tropicamide|mesh-list
6672875|NCT01558960|Alkylating Agents|alkylating agents|mesh-ancestor
5741394|NCT03097198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5741395|NCT03097198|Mydriatics|mydriatics|mesh-ancestor
5741396|NCT03097198|Autonomic Agents|autonomic agents|mesh-ancestor
5741397|NCT03097198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5741398|NCT03097198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741399|NCT03097198|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5741400|NCT03097198|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5741401|NCT03097198|Cholinergic Agents|cholinergic agents|mesh-ancestor
5620171|NCT04020809|Atezolizumab|atezolizumab|mesh-list
5620172|NCT04020809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5620173|NCT04005209|Ketamine|ketamine|mesh-list
5620174|NCT04005209|Analgesics|analgesics|mesh-ancestor
5620175|NCT04005209|Sensory System Agents|sensory system agents|mesh-ancestor
5620176|NCT04005209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5620177|NCT04005209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620178|NCT04005209|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5620179|NCT04005209|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5620180|NCT04005209|Anesthetics, General|anesthetics, general|mesh-ancestor
5620181|NCT04005209|Anesthetics|anesthetics|mesh-ancestor
5620182|NCT04005209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5620183|NCT04005209|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5620184|NCT04005209|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5620185|NCT04005209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5620186|NCT04005209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620187|NCT04002180|Vedolizumab|vedolizumab|mesh-list
5620188|NCT04002180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5620189|NCT03997123|Paclitaxel|paclitaxel|mesh-list
5620190|NCT03997123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5620191|NCT03997123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5620192|NCT03997123|Tubulin Modulators|tubulin modulators|mesh-ancestor
5620193|NCT03997123|Antimitotic Agents|antimitotic agents|mesh-ancestor
5620194|NCT03997123|Mitosis Modulators|mitosis modulators|mesh-ancestor
5620195|NCT03997123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620196|NCT03961789|Analgesics, Opioid|analgesics, opioid|mesh-list
5620197|NCT03961789|Narcotics|narcotics|mesh-ancestor
5741402|NCT03097198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5741403|NCT03097198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893578|NCT04303325|Esketamine|esketamine|mesh-list
5893579|NCT04303325|Antidepressive Agents|antidepressive agents|mesh-ancestor
5893580|NCT04303325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5893581|NCT04293393|Paclitaxel|paclitaxel|mesh-list
5893582|NCT04293393|Docetaxel|docetaxel|mesh-list
5893583|NCT04293393|Cyclophosphamide|cyclophosphamide|mesh-list
5893584|NCT04293393|Doxorubicin|doxorubicin|mesh-list
5893585|NCT04293393|Letrozole|letrozole|mesh-list
5893586|NCT04293393|Leuprolide|leuprolide|mesh-list
5893587|NCT04293393|Goserelin|goserelin|mesh-list
5893588|NCT04293393|Taxane|taxane|mesh-list
5893589|NCT04293393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5893590|NCT04293393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5893591|NCT04293393|Tubulin Modulators|tubulin modulators|mesh-ancestor
5620198|NCT03961789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5620199|NCT03961789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620200|NCT03961789|Analgesics|analgesics|mesh-ancestor
5620201|NCT03961789|Sensory System Agents|sensory system agents|mesh-ancestor
5620202|NCT03961789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5620203|NCT03951870|Vaccines|vaccines|mesh-list
5620204|NCT03951870|Immunologic Factors|immunologic factors|mesh-ancestor
5620205|NCT03951870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620206|NCT03950570|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5620207|NCT03950570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5620208|NCT03912064|Ipilimumab|ipilimumab|mesh-list
5620209|NCT03912064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5620210|NCT03912064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5620211|NCT03912064|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5620212|NCT03912064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620213|NCT03894540|Paclitaxel|paclitaxel|mesh-list
5620214|NCT03894540|Pembrolizumab|pembrolizumab|mesh-list
5620215|NCT03894540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5620216|NCT03894540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5620217|NCT03894540|Tubulin Modulators|tubulin modulators|mesh-ancestor
5893592|NCT04293393|Antimitotic Agents|antimitotic agents|mesh-ancestor
5893593|NCT04293393|Mitosis Modulators|mitosis modulators|mesh-ancestor
5893594|NCT04293393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620218|NCT03894540|Antimitotic Agents|antimitotic agents|mesh-ancestor
5620219|NCT03894540|Mitosis Modulators|mitosis modulators|mesh-ancestor
5620220|NCT03894540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620221|NCT03894540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5620222|NCT03878095|Olaparib|olaparib|mesh-list
5893595|NCT04293393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5893596|NCT04293393|Immunologic Factors|immunologic factors|mesh-ancestor
5893597|NCT04293393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893598|NCT04293393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5620223|NCT03878095|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
5741404|NCT03097003|Apremilast|apremilast|mesh-list
5741405|NCT03097003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5741406|NCT03097003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5741407|NCT03097003|Analgesics|analgesics|mesh-ancestor
5741408|NCT03097003|Sensory System Agents|sensory system agents|mesh-ancestor
5741409|NCT03097003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5741410|NCT03097003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741411|NCT03097003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5741412|NCT03097003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5741413|NCT03097003|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5741414|NCT03097003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5741415|NCT03097003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5741416|NCT03097003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741417|NCT03096990|Apremilast|apremilast|mesh-list
5741418|NCT03096990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5741419|NCT03096990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5741420|NCT03096990|Analgesics|analgesics|mesh-ancestor
5741421|NCT03096990|Sensory System Agents|sensory system agents|mesh-ancestor
5741422|NCT03096990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5741423|NCT03096990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741424|NCT03096990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5741425|NCT03096990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5741426|NCT03096990|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5741427|NCT03096990|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5741428|NCT03096990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5741429|NCT03096990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741430|NCT03096782|Mycophenolic Acid|mycophenolic acid|mesh-list
5741431|NCT03096782|Cyclophosphamide|cyclophosphamide|mesh-list
5741432|NCT03096782|Melphalan|melphalan|mesh-list
5741433|NCT03096782|Busulfan|busulfan|mesh-list
5741434|NCT03096782|Mechlorethamine|mechlorethamine|mesh-list
5741435|NCT03096782|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
5741436|NCT03096782|Rituximab|rituximab|mesh-list
5741437|NCT03096782|Fludarabine|fludarabine|mesh-list
5741438|NCT03096782|Clofarabine|clofarabine|mesh-list
5741439|NCT03096782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5741440|NCT03096782|Tacrolimus|tacrolimus|mesh-list
5741441|NCT03096782|Thymoglobulin|thymoglobulin|mesh-list
5620224|NCT03878095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5620225|NCT03878095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741442|NCT03096782|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5741443|NCT03096782|Antibodies|antibodies|mesh-list
5741444|NCT03096782|Immunoglobulins|immunoglobulins|mesh-list
5741445|NCT03096782|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5741446|NCT03096782|Lenograstim|lenograstim|mesh-list
5741447|NCT03096782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5741448|NCT03096782|Immunologic Factors|immunologic factors|mesh-ancestor
5741449|NCT03096782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741450|NCT03096782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5741451|NCT03096782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5741452|NCT03096782|Alkylating Agents|alkylating agents|mesh-ancestor
5741453|NCT03096782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741454|NCT03096782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5741455|NCT03096782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5741456|NCT03096782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5741457|NCT03096782|Antimetabolites|antimetabolites|mesh-ancestor
5620226|NCT03878095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5620227|NCT03873675|Hormones|hormones|mesh-list
5620228|NCT03873675|Parathyroid Hormone|parathyroid hormone|mesh-list
5620229|NCT03873675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5620230|NCT03873675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620231|NCT03873675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5620232|NCT03871348|Cemiplimab|cemiplimab|mesh-list
5620233|NCT03871348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5620234|NCT03871348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5620235|NCT03838367|Leronlimab|leronlimab|mesh-list
5620236|NCT03838367|Carboplatin|carboplatin|mesh-list
5620237|NCT03838367|HIV Antibodies|hiv antibodies|mesh-list
5741458|NCT03096782|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5741459|NCT03096782|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5741460|NCT03096782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5741461|NCT03096782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5741462|NCT03096782|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5741463|NCT03096782|Antitubercular Agents|antitubercular agents|mesh-ancestor
5741464|NCT03096782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5741465|NCT03096782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5741466|NCT03096756|Avasopasem manganese|avasopasem manganese|mesh-list
5741467|NCT03096756|Antioxidants|antioxidants|mesh-ancestor
5741468|NCT03096756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741469|NCT03096756|Protective Agents|protective agents|mesh-ancestor
5741470|NCT03096756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741471|NCT03096704|Vitamin D|vitamin d|mesh-list
5741472|NCT03096704|Vitamins|vitamins|mesh-ancestor
5741473|NCT03096704|Micronutrients|micronutrients|mesh-ancestor
5741474|NCT03096704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741475|NCT03096704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5741476|NCT03096470|Anesthetics|anesthetics|mesh-list
5741477|NCT03096470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5741478|NCT03096470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741479|NCT03096301|Salicylic Acid|salicylic acid|mesh-list
5741480|NCT03096301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5741481|NCT03096301|Antifungal Agents|antifungal agents|mesh-ancestor
5741482|NCT03096301|Keratolytic Agents|keratolytic agents|mesh-ancestor
5741483|NCT03096301|Dermatologic Agents|dermatologic agents|mesh-ancestor
5741484|NCT03096275|Glucocorticoids|glucocorticoids|mesh-list
5741485|NCT03096275|Hormones|hormones|mesh-ancestor
5741486|NCT03096275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5741487|NCT03096275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741488|NCT03096327|Montelukast|montelukast|mesh-list
5741489|NCT03096327|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5741490|NCT03096327|Respiratory System Agents|respiratory system agents|mesh-ancestor
5741491|NCT03096327|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5741492|NCT03096327|Hormone Antagonists|hormone antagonists|mesh-ancestor
5741493|NCT03096327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5741494|NCT03096327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741495|NCT03096327|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5741496|NCT03096327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5741497|NCT03096327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741498|NCT03096340|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
5741499|NCT03096340|Irinotecan|irinotecan|mesh-list
5741500|NCT03096340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5741501|NCT03096340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5741502|NCT03096340|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5620238|NCT03838367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5620239|NCT03838367|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5620240|NCT03838367|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5620241|NCT03838367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620242|NCT03838367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5620243|NCT03838367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5620244|NCT03838367|Antiviral Agents|antiviral agents|mesh-ancestor
5620245|NCT03838367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5620246|NCT03838367|Immunologic Factors|immunologic factors|mesh-ancestor
5620247|NCT03838367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620248|NCT03826992|Cytarabine|cytarabine|mesh-list
5620249|NCT03826992|Daunorubicin|daunorubicin|mesh-list
5620250|NCT03826992|Venetoclax|venetoclax|mesh-list
5620251|NCT03826992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5620252|NCT03826992|Antimetabolites|antimetabolites|mesh-ancestor
5741503|NCT03096340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5741504|NCT03096340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5741505|NCT03096340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741506|NCT03096392|Insulin|insulin|mesh-list
5741507|NCT03096392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5741508|NCT03096392|Insulin Lispro|insulin lispro|mesh-list
5741509|NCT03096392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5741510|NCT03096392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741511|NCT03096522|Phenytoin|phenytoin|mesh-list
5741512|NCT03096522|Anticonvulsants|anticonvulsants|mesh-ancestor
5741513|NCT03096522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5741514|NCT03096522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5741515|NCT03096522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5741516|NCT03096522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741517|NCT03096522|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5741518|NCT03096522|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5741519|NCT03096457|Paromomycin|paromomycin|mesh-list
5741520|NCT03096457|Pentamidine|pentamidine|mesh-list
5741521|NCT03096457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5741522|NCT03096457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5741523|NCT03096457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5620253|NCT03826992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620254|NCT03826992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5620255|NCT03826992|Antiviral Agents|antiviral agents|mesh-ancestor
5741524|NCT03096457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5741525|NCT03096457|Antifungal Agents|antifungal agents|mesh-ancestor
5741526|NCT03096457|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5741527|NCT03096405|Methicillin|methicillin|mesh-list
5741528|NCT03096405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5741529|NCT03096405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5741530|NCT03096249|Oxytocin|oxytocin|mesh-list
5741531|NCT03096249|Oxytocics|oxytocics|mesh-ancestor
5741532|NCT03096249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5741533|NCT03096249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741534|NCT03096223|KHK4083|khk4083|mesh-list
5741535|NCT03096223|Dermatologic Agents|dermatologic agents|mesh-ancestor
5741536|NCT03095872|Petrolatum|petrolatum|mesh-list
5741537|NCT03095872|Emollients|emollients|mesh-ancestor
5741538|NCT03095872|Dermatologic Agents|dermatologic agents|mesh-ancestor
5741539|NCT03096080|XL647|xl647|mesh-list
5741540|NCT03096080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5741541|NCT03096080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5741542|NCT03096080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5741543|NCT03096080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741544|NCT03096184|Apatinib|apatinib|mesh-list
5741545|NCT03096184|Tegafur|tegafur|mesh-list
5741546|NCT03096184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5741547|NCT03096184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5741548|NCT03096184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5741549|NCT03096184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741550|NCT03096184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5741551|NCT03096184|Antimetabolites|antimetabolites|mesh-ancestor
5741552|NCT03096028|Vitamin B 12|vitamin b 12|mesh-list
5741553|NCT03096028|Hydroxocobalamin|hydroxocobalamin|mesh-list
5741554|NCT03096028|Vitamins|vitamins|mesh-ancestor
5741555|NCT03096028|Micronutrients|micronutrients|mesh-ancestor
5741556|NCT03096028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741557|NCT03096028|Vitamin B Complex|vitamin b complex|mesh-ancestor
5741558|NCT03096028|Hematinics|hematinics|mesh-ancestor
5741559|NCT03095547|Cyclosporine|cyclosporine|mesh-list
5741560|NCT03095547|Posaconazole|posaconazole|mesh-list
5741561|NCT03095547|Olorofim|olorofim|mesh-list
5741562|NCT03095547|Pantoprazole|pantoprazole|mesh-list
5741563|NCT03095547|Tacrolimus|tacrolimus|mesh-list
5620256|NCT03826992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5620257|NCT03826992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5620258|NCT03826992|Immunologic Factors|immunologic factors|mesh-ancestor
5620259|NCT03826992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620260|NCT03826992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5620261|NCT03826992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5620262|NCT03826992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5620263|NCT03826992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5620264|NCT03809767|Antibodies|antibodies|mesh-list
5620265|NCT03809767|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5620266|NCT03809767|Immunologic Factors|immunologic factors|mesh-ancestor
5620267|NCT03809767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741564|NCT03095547|Cyclosporins|cyclosporins|mesh-list
5741565|NCT03095547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5741566|NCT03095547|Immunologic Factors|immunologic factors|mesh-ancestor
5741567|NCT03095547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741568|NCT03095547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5741569|NCT03095547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5741570|NCT03095547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741571|NCT03095547|Antifungal Agents|antifungal agents|mesh-ancestor
5741572|NCT03095547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5741573|NCT03095547|Dermatologic Agents|dermatologic agents|mesh-ancestor
5741574|NCT03095547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5741575|NCT03095547|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5741576|NCT03095547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5741577|NCT03095547|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5741578|NCT03095547|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5741579|NCT03095547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5741580|NCT03095547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5741581|NCT03095547|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5741582|NCT03095547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5741583|NCT03095547|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5741584|NCT03095547|Hormone Antagonists|hormone antagonists|mesh-ancestor
5620268|NCT03740529|Rituximab|rituximab|mesh-list
5741585|NCT03095547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5741586|NCT03095703|Sirolimus|sirolimus|mesh-list
5620269|NCT03740529|Venetoclax|venetoclax|mesh-list
5741587|NCT03095703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5741588|NCT03095703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5741589|NCT03095703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5741590|NCT03095703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5741591|NCT03095703|Antifungal Agents|antifungal agents|mesh-ancestor
5741592|NCT03095703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5741593|NCT03095703|Immunologic Factors|immunologic factors|mesh-ancestor
5741594|NCT03095703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741595|NCT03095469|Dexmedetomidine|dexmedetomidine|mesh-list
5741596|NCT03095469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5741597|NCT03095469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5741598|NCT03095469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741599|NCT03095469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5741600|NCT03095469|Analgesics|analgesics|mesh-ancestor
5741601|NCT03095469|Sensory System Agents|sensory system agents|mesh-ancestor
5741602|NCT03095469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5741603|NCT03095469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5620270|NCT03740529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5620271|NCT03740529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5620272|NCT03740529|Immunologic Factors|immunologic factors|mesh-ancestor
5620273|NCT03740529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620274|NCT03740529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5692502|NCT03407300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5692503|NCT03407300|Tubulin Modulators|tubulin modulators|mesh-ancestor
5692504|NCT03407300|Antimitotic Agents|antimitotic agents|mesh-ancestor
5692505|NCT03407300|Mitosis Modulators|mitosis modulators|mesh-ancestor
5692506|NCT03407300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692507|NCT03407209|Anesthetics|anesthetics|mesh-list
5692508|NCT03407209|Anesthetics, Local|anesthetics, local|mesh-list
5692509|NCT03407209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5741604|NCT03095469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5741605|NCT03095469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5741606|NCT03095469|Adrenergic Agents|adrenergic agents|mesh-ancestor
5741607|NCT03095469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5741608|NCT03095469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893599|NCT04293393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5893600|NCT04293393|Alkylating Agents|alkylating agents|mesh-ancestor
5893601|NCT04293393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5893602|NCT04293393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5893603|NCT04293393|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5893604|NCT04293393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5893605|NCT04293393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5893606|NCT04293393|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5893607|NCT04293393|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5893608|NCT04293393|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5893609|NCT04293393|Hormone Antagonists|hormone antagonists|mesh-ancestor
5893610|NCT04293393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5893611|NCT04293393|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5893612|NCT04293393|Fertility Agents|fertility agents|mesh-ancestor
5893613|NCT04293393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5893614|NCT04293393|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5893615|NCT04247750|Sirolimus|sirolimus|mesh-list
5692510|NCT03407209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692511|NCT03407209|Sensory System Agents|sensory system agents|mesh-ancestor
5692512|NCT03407209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5893616|NCT04247750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5893617|NCT04247750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5893618|NCT04247750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5893619|NCT04247750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5893620|NCT04247750|Antifungal Agents|antifungal agents|mesh-ancestor
5893621|NCT04247750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5893622|NCT04247750|Immunologic Factors|immunologic factors|mesh-ancestor
5893623|NCT04247750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692513|NCT03407196|Dapagliflozin|dapagliflozin|mesh-list
5692514|NCT03407196|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5692515|NCT03407196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692516|NCT03407196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5692517|NCT03407196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692518|NCT03407105|Ipilimumab|ipilimumab|mesh-list
5692519|NCT03407105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5692520|NCT03407105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5692521|NCT03407105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5692522|NCT03407105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741609|NCT03095404|Lidocaine|lidocaine|mesh-list
5741610|NCT03095404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5620275|NCT03732820|Olaparib|olaparib|mesh-list
5620276|NCT03732820|Abiraterone Acetate|abiraterone acetate|mesh-list
5620277|NCT03732820|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5620278|NCT03732820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5620279|NCT03732820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620280|NCT03732820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5620281|NCT03732820|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5620282|NCT03732820|Hormone Antagonists|hormone antagonists|mesh-ancestor
5620283|NCT03732820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5620284|NCT03732820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620285|NCT03732820|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5620286|NCT03728179|Aspirin|aspirin|mesh-list
5620287|NCT03728179|Celecoxib|celecoxib|mesh-list
5620288|NCT03728179|Cyclophosphamide|cyclophosphamide|mesh-list
5620289|NCT03728179|Nivolumab|nivolumab|mesh-list
5620290|NCT03728179|Ipilimumab|ipilimumab|mesh-list
5620291|NCT03728179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5620292|NCT03728179|Immunologic Factors|immunologic factors|mesh-ancestor
5620293|NCT03728179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620294|NCT03728179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5741611|NCT03095404|Anesthetics, Local|anesthetics, local|mesh-ancestor
5741612|NCT03095404|Anesthetics|anesthetics|mesh-ancestor
5741613|NCT03095404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5741614|NCT03095404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741615|NCT03095404|Sensory System Agents|sensory system agents|mesh-ancestor
5741616|NCT03095404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5741617|NCT03095404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5741618|NCT03095404|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5741619|NCT03095404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5741620|NCT03095404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5741621|NCT03095404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741622|NCT03095274|Durvalumab|durvalumab|mesh-list
5741623|NCT03095274|Tremelimumab|tremelimumab|mesh-list
5741624|NCT03095274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5741625|NCT03095274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5620295|NCT03728179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5620296|NCT03728179|Alkylating Agents|alkylating agents|mesh-ancestor
5620297|NCT03728179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741626|NCT03095144|Anesthetics|anesthetics|mesh-list
5741627|NCT03095144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5741628|NCT03095144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741629|NCT03095352|Carboplatin|carboplatin|mesh-list
5741630|NCT03095352|Pembrolizumab|pembrolizumab|mesh-list
5741631|NCT03095352|Trastuzumab|trastuzumab|mesh-list
5741632|NCT03095352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5741633|NCT03095352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5741634|NCT03095209|Paclitaxel|paclitaxel|mesh-list
5741635|NCT03095209|Carboplatin|carboplatin|mesh-list
5741636|NCT03095209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5741637|NCT03095209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5620298|NCT03728179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5620299|NCT03728179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5620300|NCT03728179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5620301|NCT03728179|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5620302|NCT03728179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5620303|NCT03728179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5620304|NCT03728179|Analgesics|analgesics|mesh-ancestor
5620305|NCT03728179|Sensory System Agents|sensory system agents|mesh-ancestor
5620306|NCT03728179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5620307|NCT03728179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5620308|NCT03728179|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5620309|NCT03728179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5620310|NCT03728179|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5620311|NCT03728179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5620312|NCT03728179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5620313|NCT03728179|Antipyretics|antipyretics|mesh-ancestor
5620314|NCT03728179|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5620315|NCT03626376|Valacyclovir|valacyclovir|mesh-list
5620316|NCT03626376|Acyclovir|acyclovir|mesh-list
5620317|NCT03626376|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5620318|NCT03626376|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5620319|NCT03626376|Antiviral Agents|antiviral agents|mesh-ancestor
5620320|NCT03626376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5741638|NCT03095209|Tubulin Modulators|tubulin modulators|mesh-ancestor
5741639|NCT03095209|Antimitotic Agents|antimitotic agents|mesh-ancestor
5741640|NCT03095209|Mitosis Modulators|mitosis modulators|mesh-ancestor
5741641|NCT03095209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741642|NCT03095222|Ketamine|ketamine|mesh-list
5741643|NCT03095222|Analgesics|analgesics|mesh-ancestor
5741644|NCT03095222|Sensory System Agents|sensory system agents|mesh-ancestor
5741645|NCT03095222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5741646|NCT03095222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741647|NCT03095222|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5741648|NCT03095222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5741649|NCT03095222|Anesthetics, General|anesthetics, general|mesh-ancestor
5741650|NCT03095222|Anesthetics|anesthetics|mesh-ancestor
5741651|NCT03095222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5741652|NCT03095222|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5741653|NCT03095222|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5741654|NCT03095222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5741655|NCT03095222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741656|NCT03095378|Anti-Infective Agents|anti-infective agents|mesh-list
5741657|NCT03095378|Tetracycline|tetracycline|mesh-list
5741658|NCT03095378|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5741659|NCT03095378|Citric Acid|citric acid|mesh-list
5741660|NCT03095378|Sodium Citrate|sodium citrate|mesh-list
5741661|NCT03095378|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5741662|NCT03095378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5741663|NCT03095378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741664|NCT03095378|Anticoagulants|anticoagulants|mesh-ancestor
5741665|NCT03095378|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5741666|NCT03095378|Chelating Agents|chelating agents|mesh-ancestor
5741667|NCT03095378|Sequestering Agents|sequestering agents|mesh-ancestor
5741668|NCT03095326|Zinc|zinc|mesh-list
5741669|NCT03095326|Zinc Sulfate|zinc sulfate|mesh-list
5741670|NCT03095326|Vaccines|vaccines|mesh-list
5741671|NCT03095326|Immunologic Factors|immunologic factors|mesh-ancestor
5741672|NCT03095326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741673|NCT03095326|Trace Elements|trace elements|mesh-ancestor
5741674|NCT03095326|Micronutrients|micronutrients|mesh-ancestor
5741675|NCT03095326|Astringents|astringents|mesh-ancestor
5741676|NCT03095326|Dermatologic Agents|dermatologic agents|mesh-ancestor
5741677|NCT03095235|Riboflavin|riboflavin|mesh-list
5741678|NCT03095235|Vitamins|vitamins|mesh-ancestor
5741679|NCT03095235|Micronutrients|micronutrients|mesh-ancestor
5741680|NCT03095235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741681|NCT03095235|Vitamin B Complex|vitamin b complex|mesh-ancestor
5741682|NCT03095235|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5741683|NCT03095235|Dermatologic Agents|dermatologic agents|mesh-ancestor
5741684|NCT03095105|Resveratrol|resveratrol|mesh-list
5741685|NCT03095105|Antioxidants|antioxidants|mesh-ancestor
5741686|NCT03095105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741687|NCT03095105|Protective Agents|protective agents|mesh-ancestor
5620321|NCT03624036|Cyclophosphamide|cyclophosphamide|mesh-list
5620322|NCT03624036|Fludarabine|fludarabine|mesh-list
5620323|NCT03624036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5620324|NCT03624036|Immunologic Factors|immunologic factors|mesh-ancestor
5620325|NCT03624036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620326|NCT03624036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5620327|NCT03624036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5620328|NCT03624036|Alkylating Agents|alkylating agents|mesh-ancestor
5620329|NCT03624036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620330|NCT03624036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5620331|NCT03624036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5620332|NCT03600805|Prednisone|prednisone|mesh-list
5620333|NCT03600805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5620334|NCT03600805|Glucocorticoids|glucocorticoids|mesh-ancestor
5620335|NCT03600805|Hormones|hormones|mesh-ancestor
5620336|NCT03600805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5620337|NCT03600805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620338|NCT03600805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5620339|NCT03600805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5620340|NCT03556358|Paclitaxel|paclitaxel|mesh-list
5620341|NCT03556358|Cyclophosphamide|cyclophosphamide|mesh-list
5620342|NCT03556358|Trastuzumab|trastuzumab|mesh-list
5741688|NCT03095105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620343|NCT03556358|Epirubicin|epirubicin|mesh-list
5741689|NCT03095105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5741690|NCT03095105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5741691|NCT03095079|Endostatins|endostatins|mesh-list
5741692|NCT03095079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5620344|NCT03556358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5620345|NCT03556358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5620346|NCT03556358|Tubulin Modulators|tubulin modulators|mesh-ancestor
5620347|NCT03556358|Antimitotic Agents|antimitotic agents|mesh-ancestor
5620348|NCT03556358|Mitosis Modulators|mitosis modulators|mesh-ancestor
5620349|NCT03556358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620350|NCT03556358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5620351|NCT03556358|Immunologic Factors|immunologic factors|mesh-ancestor
5620352|NCT03556358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620353|NCT03556358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5620354|NCT03556358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5620355|NCT03556358|Alkylating Agents|alkylating agents|mesh-ancestor
5620356|NCT03556358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5620357|NCT03556358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5620358|NCT03556358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5620359|NCT03556358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5620360|NCT03556358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5620361|NCT03556358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5620362|NCT03555578|Leuprolide|leuprolide|mesh-list
5620363|NCT03555578|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5620364|NCT03555578|Fertility Agents|fertility agents|mesh-ancestor
5620365|NCT03555578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5620366|NCT03555578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620367|NCT03555578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5620368|NCT03555578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5620369|NCT03539302|Flecainide|flecainide|mesh-list
5741693|NCT03095079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5741694|NCT03095079|Growth Substances|growth substances|mesh-ancestor
5741695|NCT03095079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741696|NCT03095079|Growth Inhibitors|growth inhibitors|mesh-ancestor
5741697|NCT03095079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5741698|NCT03095040|Everolimus|everolimus|mesh-list
5741699|NCT03095040|Vorolanib|vorolanib|mesh-list
5741700|NCT03095040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5741701|NCT03095040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5741702|NCT03095040|Immunologic Factors|immunologic factors|mesh-ancestor
5741703|NCT03095040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741704|NCT03095040|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5741705|NCT03095040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5620370|NCT03539302|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5620371|NCT03539302|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5620372|NCT03539302|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5741706|NCT03095040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741707|NCT03095001|Paclitaxel|paclitaxel|mesh-list
5741708|NCT03095001|Bevacizumab|bevacizumab|mesh-list
5741709|NCT03095001|Carboplatin|carboplatin|mesh-list
5741710|NCT03095001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5741711|NCT03095001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5741712|NCT03095001|Tubulin Modulators|tubulin modulators|mesh-ancestor
5741713|NCT03095001|Antimitotic Agents|antimitotic agents|mesh-ancestor
5741714|NCT03095001|Mitosis Modulators|mitosis modulators|mesh-ancestor
5741715|NCT03095001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741716|NCT03095001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5741717|NCT03095001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5741718|NCT03095001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5741719|NCT03095001|Growth Substances|growth substances|mesh-ancestor
5741720|NCT03095001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741721|NCT03095001|Growth Inhibitors|growth inhibitors|mesh-ancestor
5741722|NCT03094663|Cefazolin|cefazolin|mesh-list
5741723|NCT03094663|Dexamethasone|dexamethasone|mesh-list
5741724|NCT03094663|Dexamethasone acetate|dexamethasone acetate|mesh-list
5741725|NCT03094663|Methylprednisolone|methylprednisolone|mesh-list
5741726|NCT03094663|Epinephrine|epinephrine|mesh-list
5620373|NCT03539302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5620374|NCT03539302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620375|NCT03520790|Gemcitabine|gemcitabine|mesh-list
5620376|NCT03520790|Paclitaxel|paclitaxel|mesh-list
5620377|NCT03520790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5620378|NCT03520790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5620379|NCT03520790|Tubulin Modulators|tubulin modulators|mesh-ancestor
5620380|NCT03520790|Antimitotic Agents|antimitotic agents|mesh-ancestor
5620381|NCT03520790|Mitosis Modulators|mitosis modulators|mesh-ancestor
5620382|NCT03520790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741727|NCT03094663|Bupivacaine|bupivacaine|mesh-list
5741728|NCT03094663|BB 1101|bb 1101|mesh-list
5741729|NCT03094663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5741730|NCT03094663|Antiemetics|antiemetics|mesh-ancestor
5741731|NCT03094663|Autonomic Agents|autonomic agents|mesh-ancestor
5741732|NCT03094663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5741733|NCT03094663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741734|NCT03094663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5741735|NCT03094663|Glucocorticoids|glucocorticoids|mesh-ancestor
5741736|NCT03094663|Hormones|hormones|mesh-ancestor
5741737|NCT03094663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5741738|NCT03094663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5741739|NCT03094663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5741740|NCT03094663|Protease Inhibitors|protease inhibitors|mesh-ancestor
5741741|NCT03094663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5741742|NCT03094663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741743|NCT03094663|Anesthetics, Local|anesthetics, local|mesh-ancestor
5741744|NCT03094663|Anesthetics|anesthetics|mesh-ancestor
5741745|NCT03094663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5741746|NCT03094663|Sensory System Agents|sensory system agents|mesh-ancestor
5741747|NCT03094663|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5741748|NCT03094663|Protective Agents|protective agents|mesh-ancestor
5741749|NCT03094663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5741750|NCT03094663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5741751|NCT03094663|Adrenergic Agents|adrenergic agents|mesh-ancestor
5741752|NCT03094663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5741753|NCT03094663|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5741754|NCT03094663|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5741755|NCT03094663|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5741756|NCT03094663|Respiratory System Agents|respiratory system agents|mesh-ancestor
5741757|NCT03094663|Mydriatics|mydriatics|mesh-ancestor
5741758|NCT03094663|Sympathomimetics|sympathomimetics|mesh-ancestor
5741759|NCT03094663|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5741760|NCT03094663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5741761|NCT03094663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5741762|NCT03094286|Durvalumab|durvalumab|mesh-list
5741763|NCT03094286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5741764|NCT03094286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5741765|NCT03094481|Epinephrine|epinephrine|mesh-list
5741766|NCT03094481|Bupivacaine|bupivacaine|mesh-list
5741767|NCT03094481|Anesthetics, Local|anesthetics, local|mesh-ancestor
5741768|NCT03094481|Anesthetics|anesthetics|mesh-ancestor
5741769|NCT03094481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5741770|NCT03094481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741771|NCT03094481|Sensory System Agents|sensory system agents|mesh-ancestor
5741772|NCT03094481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5741773|NCT03094481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5741774|NCT03094481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5741775|NCT03094481|Adrenergic Agents|adrenergic agents|mesh-ancestor
5741776|NCT03094481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5741777|NCT03094481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620383|NCT03520790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5620384|NCT03520790|Antimetabolites|antimetabolites|mesh-ancestor
5620385|NCT03520790|Antiviral Agents|antiviral agents|mesh-ancestor
5620386|NCT03520790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5620387|NCT03520790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5620388|NCT03520790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5620389|NCT03520790|Immunologic Factors|immunologic factors|mesh-ancestor
5620390|NCT03520790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620391|NCT03490760|Durvalumab|durvalumab|mesh-list
5620392|NCT03490760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5620393|NCT03490760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5620394|NCT03455504|Venetoclax|venetoclax|mesh-list
5620395|NCT03455504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5620396|NCT03436108|Bisphenol A|bisphenol a|mesh-list
5741778|NCT03094481|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5741779|NCT03094481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5741780|NCT03094481|Autonomic Agents|autonomic agents|mesh-ancestor
5741781|NCT03094481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5741782|NCT03094481|Respiratory System Agents|respiratory system agents|mesh-ancestor
5741783|NCT03094481|Mydriatics|mydriatics|mesh-ancestor
5741784|NCT03094481|Sympathomimetics|sympathomimetics|mesh-ancestor
5741785|NCT03094481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5741786|NCT03094533|Propofol|propofol|mesh-list
5741787|NCT03094533|Sevoflurane|sevoflurane|mesh-list
5741788|NCT03094533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5741789|NCT03094533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5893624|NCT04230408|Paclitaxel|paclitaxel|mesh-list
5620397|NCT03436108|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
5741790|NCT03094533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741791|NCT03094533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5741792|NCT03094533|Anesthetics, General|anesthetics, general|mesh-ancestor
5741793|NCT03094533|Anesthetics|anesthetics|mesh-ancestor
5741794|NCT03094533|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5741795|NCT03094533|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5741796|NCT03094403|Azelaic acid|azelaic acid|mesh-list
5741797|NCT03094403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5741798|NCT03094403|Dermatologic Agents|dermatologic agents|mesh-ancestor
5741799|NCT03094468|Terbinafine|terbinafine|mesh-list
5741800|NCT03094468|Antifungal Agents|antifungal agents|mesh-ancestor
5741801|NCT03094468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5741802|NCT03094468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5741803|NCT03094468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741804|NCT03094507|Darunavir|darunavir|mesh-list
5741805|NCT03094507|Dolutegravir|dolutegravir|mesh-list
5741806|NCT03094507|Cobicistat|cobicistat|mesh-list
5741807|NCT03094507|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5741808|NCT03094507|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5741809|NCT03094507|Protease Inhibitors|protease inhibitors|mesh-ancestor
5741810|NCT03094507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5741811|NCT03094507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741812|NCT03094507|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5741813|NCT03094507|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5741814|NCT03094507|Antiviral Agents|antiviral agents|mesh-ancestor
5741815|NCT03094507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5741816|NCT03094507|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5741817|NCT03094507|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5741818|NCT03094507|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5741819|NCT03094507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5741820|NCT03094182|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
5741821|NCT03094182|Hematinics|hematinics|mesh-ancestor
5741822|NCT03094442|Dexamethasone|dexamethasone|mesh-list
5741823|NCT03094442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5741824|NCT03094442|Antiemetics|antiemetics|mesh-ancestor
5741825|NCT03094442|Autonomic Agents|autonomic agents|mesh-ancestor
5741826|NCT03094442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5741827|NCT03094442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741828|NCT03094442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5620398|NCT03436108|Estrogens|estrogens|mesh-ancestor
5620399|NCT03436108|Hormones|hormones|mesh-ancestor
5620400|NCT03436108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5620401|NCT03436108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620402|NCT03436108|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5620403|NCT03436108|Antioxidants|antioxidants|mesh-ancestor
5620404|NCT03436108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620405|NCT03436108|Protective Agents|protective agents|mesh-ancestor
5620406|NCT03433248|Empagliflozin|empagliflozin|mesh-list
5620407|NCT03433248|Gliclazide|gliclazide|mesh-list
5620408|NCT03433248|Linagliptin|linagliptin|mesh-list
5620409|NCT03433248|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5741829|NCT03094442|Glucocorticoids|glucocorticoids|mesh-ancestor
5741830|NCT03094442|Hormones|hormones|mesh-ancestor
5741831|NCT03094442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5741832|NCT03094442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5741833|NCT03094442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5741834|NCT03094247|Amoxicillin|amoxicillin|mesh-list
5741835|NCT03094247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5741836|NCT03094247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5741837|NCT03094156|Resveratrol|resveratrol|mesh-list
5741838|NCT03094156|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
5620410|NCT03433248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620411|NCT03433248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5620412|NCT03433248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620413|NCT03433248|Incretins|incretins|mesh-ancestor
5620414|NCT03433248|Hormones|hormones|mesh-ancestor
5620415|NCT03433248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5620416|NCT03433248|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5620417|NCT03433248|Protease Inhibitors|protease inhibitors|mesh-ancestor
5620418|NCT03433248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5620419|NCT03417999|Dexmedetomidine|dexmedetomidine|mesh-list
5620420|NCT03417999|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5620421|NCT03417999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5741839|NCT03094156|Antioxidants|antioxidants|mesh-ancestor
5741840|NCT03094156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741841|NCT03094156|Protective Agents|protective agents|mesh-ancestor
5741842|NCT03094156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741843|NCT03094156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5741844|NCT03094156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5741845|NCT03094156|Dopamine Agents|dopamine agents|mesh-ancestor
5620422|NCT03417999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620423|NCT03417999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5620424|NCT03417999|Analgesics|analgesics|mesh-ancestor
5620425|NCT03417999|Sensory System Agents|sensory system agents|mesh-ancestor
5620426|NCT03417999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5620427|NCT03417999|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5620428|NCT03417999|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5620429|NCT03417999|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5620430|NCT03417999|Adrenergic Agents|adrenergic agents|mesh-ancestor
5620431|NCT03417999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5620432|NCT03417999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620433|NCT03348670|BCG Vaccine|bcg vaccine|mesh-list
6489351|NCT00591162|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6489352|NCT00591162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6489353|NCT00591162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489354|NCT00591188|Interferons|interferons|mesh-list
6489355|NCT00591188|Interferon-alpha|interferon-alpha|mesh-list
6489356|NCT00591188|Capecitabine|capecitabine|mesh-list
5741846|NCT03094156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5741847|NCT03093805|Calcipotriene|calcipotriene|mesh-list
5741848|NCT03093805|Dermatologic Agents|dermatologic agents|mesh-ancestor
5741849|NCT03093883|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
5741850|NCT03093883|Hematinics|hematinics|mesh-ancestor
5741851|NCT03093909|Gemcitabine|gemcitabine|mesh-list
5741852|NCT03093909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5741853|NCT03093909|Antimetabolites|antimetabolites|mesh-ancestor
5741854|NCT03093909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741855|NCT03093909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5741856|NCT03093909|Antiviral Agents|antiviral agents|mesh-ancestor
5741857|NCT03093909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5741858|NCT03093909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5741859|NCT03093909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5741860|NCT03093909|Immunologic Factors|immunologic factors|mesh-ancestor
5741861|NCT03093909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893625|NCT04230408|Carboplatin|carboplatin|mesh-list
5893626|NCT04230408|Durvalumab|durvalumab|mesh-list
5893627|NCT04230408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5893628|NCT04230408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5893629|NCT04230408|Tubulin Modulators|tubulin modulators|mesh-ancestor
5893630|NCT04230408|Antimitotic Agents|antimitotic agents|mesh-ancestor
5893631|NCT04230408|Mitosis Modulators|mitosis modulators|mesh-ancestor
5893632|NCT04230408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893633|NCT04230408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5893634|NCT04169698|Denosumab|denosumab|mesh-list
5893635|NCT04169698|Alendronate|alendronate|mesh-list
5893636|NCT04169698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5893637|NCT04169698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893638|NCT04155203|Calcium, Dietary|calcium, dietary|mesh-list
5893639|NCT04155203|Mupirocin|mupirocin|mesh-list
5893640|NCT04155203|Calcium|calcium|mesh-list
5893641|NCT04155203|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5893642|NCT04155203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893643|NCT04155203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5893644|NCT04155203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5893645|NCT04155203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5893646|NCT04155203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5893647|NCT04155203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6489357|NCT00591188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6489358|NCT00591188|Antimetabolites|antimetabolites|mesh-ancestor
6489359|NCT00591188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620434|NCT03348670|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5893648|NCT04155203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893649|NCT04128956|Aspirin|aspirin|mesh-list
5893650|NCT04128956|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5893651|NCT04128956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5893652|NCT04128956|Analgesics|analgesics|mesh-ancestor
5893653|NCT04128956|Sensory System Agents|sensory system agents|mesh-ancestor
5893654|NCT04128956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5893655|NCT04128956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620435|NCT03348670|Immunologic Factors|immunologic factors|mesh-ancestor
5620436|NCT03348670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620437|NCT03345771|Anti-Infective Agents|anti-infective agents|mesh-list
5620438|NCT03345771|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5620439|NCT03282981|Timolol|timolol|mesh-list
5620440|NCT03282981|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5620441|NCT03282981|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5741862|NCT03093467|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
5741863|NCT03093467|Antipsychotic Agents|antipsychotic agents|mesh-list
5741864|NCT03093467|Antidepressive Agents|antidepressive agents|mesh-list
5620442|NCT03282981|Adrenergic Agents|adrenergic agents|mesh-ancestor
5620443|NCT03282981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5620444|NCT03282981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620445|NCT03282981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620446|NCT03282981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5620447|NCT03282981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5620448|NCT03282916|Valacyclovir|valacyclovir|mesh-list
5620449|NCT03282916|Antiviral Agents|antiviral agents|mesh-ancestor
5620450|NCT03282916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5620451|NCT03274661|Pembrolizumab|pembrolizumab|mesh-list
5620452|NCT03274661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5620453|NCT03274661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5620454|NCT03263559|Cyclophosphamide|cyclophosphamide|mesh-list
5620455|NCT03263559|Thiotepa|thiotepa|mesh-list
5620456|NCT03263559|Fludarabine|fludarabine|mesh-list
5620457|NCT03263559|Hydroxyurea|hydroxyurea|mesh-list
5620458|NCT03263559|Thymoglobulin|thymoglobulin|mesh-list
5741865|NCT03093467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5741866|NCT03093467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5741867|NCT03093467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5741868|NCT03093467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741869|NCT03093740|Sofosbuvir|sofosbuvir|mesh-list
5741870|NCT03093740|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
5741871|NCT03093740|Antiviral Agents|antiviral agents|mesh-ancestor
5741872|NCT03093740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5741873|NCT03093428|Pembrolizumab|pembrolizumab|mesh-list
5741874|NCT03093428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5741875|NCT03093428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5741876|NCT03093545|Immunoglobulins|immunoglobulins|mesh-list
5741877|NCT03093545|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5741878|NCT03093545|Antibodies|antibodies|mesh-list
5741879|NCT03093545|Immunologic Factors|immunologic factors|mesh-ancestor
5741880|NCT03093545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741881|NCT03093597|Petrolatum|petrolatum|mesh-list
5741882|NCT03093597|Emollients|emollients|mesh-ancestor
5741883|NCT03093597|Dermatologic Agents|dermatologic agents|mesh-ancestor
5741884|NCT03093402|Lenabasum|lenabasum|mesh-list
5741885|NCT03093402|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5741886|NCT03093402|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5741887|NCT03093402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5741888|NCT03093402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208672|NCT02134210|Etanercept|etanercept|mesh-list
6208673|NCT02134210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6208674|NCT02134210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6208675|NCT02134210|Analgesics|analgesics|mesh-ancestor
5741889|NCT03093402|Hormones|hormones|mesh-ancestor
5741890|NCT03093402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5741891|NCT03093402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741892|NCT03093155|Bevacizumab|bevacizumab|mesh-list
5741893|NCT03093155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5741894|NCT03093155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5741895|NCT03093155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5741896|NCT03093155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5741897|NCT03093155|Growth Substances|growth substances|mesh-ancestor
5741898|NCT03093155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741899|NCT03093155|Growth Inhibitors|growth inhibitors|mesh-ancestor
5620459|NCT03263559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5620460|NCT03263559|Immunologic Factors|immunologic factors|mesh-ancestor
5620461|NCT03263559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620462|NCT03263559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5620463|NCT03263559|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5741900|NCT03093129|Artesunate|artesunate|mesh-list
5741901|NCT03093129|Antimalarials|antimalarials|mesh-ancestor
6208676|NCT02134210|Sensory System Agents|sensory system agents|mesh-ancestor
6208677|NCT02134210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5620464|NCT03263559|Alkylating Agents|alkylating agents|mesh-ancestor
5741902|NCT03093129|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5620465|NCT03263559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620466|NCT03263559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5620467|NCT03263559|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5620468|NCT03263559|Antisickling Agents|antisickling agents|mesh-ancestor
5620469|NCT03263559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5620470|NCT03263559|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5620471|NCT03228680|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5620472|NCT03228680|Hormones|hormones|mesh-ancestor
5620473|NCT03228680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5620474|NCT03228680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620475|NCT03209479|Glatiramer Acetate|glatiramer acetate|mesh-list
5741903|NCT03093129|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5741904|NCT03093129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5741905|NCT03093129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5741906|NCT03093129|Antiviral Agents|antiviral agents|mesh-ancestor
5741907|NCT03093129|Schistosomicides|schistosomicides|mesh-ancestor
5741908|NCT03093129|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5741909|NCT03093129|Anthelmintics|anthelmintics|mesh-ancestor
5741910|NCT03093389|Resveratrol|resveratrol|mesh-list
5741911|NCT03093389|Antioxidants|antioxidants|mesh-ancestor
5741912|NCT03093389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741913|NCT03093389|Protective Agents|protective agents|mesh-ancestor
5741914|NCT03093389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741915|NCT03093389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5741916|NCT03093389|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5741917|NCT03093090|Furosemide|furosemide|mesh-list
5741918|NCT03093090|Diuretics|diuretics|mesh-ancestor
5741919|NCT03093090|Natriuretic Agents|natriuretic agents|mesh-ancestor
5741920|NCT03093090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741921|NCT03093090|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5741922|NCT03093090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5741923|NCT03093090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741924|NCT03093168|Cyclophosphamide|cyclophosphamide|mesh-list
5741925|NCT03093168|Fludarabine|fludarabine|mesh-list
5620476|NCT03209479|(T,G)-A-L|(t,g)-a-l|mesh-list
5620477|NCT03209479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5620478|NCT03209479|Immunologic Factors|immunologic factors|mesh-ancestor
5620479|NCT03209479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620480|NCT03209479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5620481|NCT03209479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5620482|NCT03170882|Dexamethasone|dexamethasone|mesh-list
5620483|NCT03170882|Pomalidomide|pomalidomide|mesh-list
5620484|NCT03170882|Ixazomib|ixazomib|mesh-list
5741926|NCT03093168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5741927|NCT03093168|Immunologic Factors|immunologic factors|mesh-ancestor
5741928|NCT03093168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741929|NCT03093168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5741930|NCT03093168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5741931|NCT03093168|Alkylating Agents|alkylating agents|mesh-ancestor
5741932|NCT03093168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741933|NCT03093168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5741934|NCT03093168|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5741935|NCT03093103|Empagliflozin|empagliflozin|mesh-list
5741936|NCT03093103|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5741937|NCT03093103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741938|NCT03093103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5741939|NCT03093103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741940|NCT03092986|Paclitaxel|paclitaxel|mesh-list
5741941|NCT03092986|Vinblastine|vinblastine|mesh-list
5741942|NCT03092986|Carboplatin|carboplatin|mesh-list
5741943|NCT03092986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5741944|NCT03092986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5741945|NCT03092986|Tubulin Modulators|tubulin modulators|mesh-ancestor
5741946|NCT03092986|Antimitotic Agents|antimitotic agents|mesh-ancestor
5741947|NCT03092986|Mitosis Modulators|mitosis modulators|mesh-ancestor
5741948|NCT03092986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741949|NCT03092908|Acetic Acid|acetic acid|mesh-list
5741950|NCT03092908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5741951|NCT03092908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5741952|NCT03092895|Apatinib|apatinib|mesh-list
5741953|NCT03092895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5741954|NCT03092895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5741955|NCT03092895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5893656|NCT04128956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5620485|NCT03170882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5741956|NCT03092895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741957|NCT03093064|Natalizumab|natalizumab|mesh-list
5741958|NCT03093064|Immunologic Factors|immunologic factors|mesh-ancestor
5741959|NCT03093064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741960|NCT03092817|Dexamethasone|dexamethasone|mesh-list
5741961|NCT03092817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5741962|NCT03092817|Antiemetics|antiemetics|mesh-ancestor
5741963|NCT03092817|Autonomic Agents|autonomic agents|mesh-ancestor
5741964|NCT03092817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5741965|NCT03092817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741966|NCT03092817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5741967|NCT03092817|Glucocorticoids|glucocorticoids|mesh-ancestor
5741968|NCT03092817|Hormones|hormones|mesh-ancestor
5741969|NCT03092817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5741970|NCT03092817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5620486|NCT03170882|Antiemetics|antiemetics|mesh-ancestor
5620487|NCT03170882|Autonomic Agents|autonomic agents|mesh-ancestor
5620488|NCT03170882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5620489|NCT03170882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620490|NCT03170882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5620491|NCT03170882|Glucocorticoids|glucocorticoids|mesh-ancestor
5620492|NCT03170882|Hormones|hormones|mesh-ancestor
5620493|NCT03170882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5620494|NCT03170882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5620495|NCT03170882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5620496|NCT03170882|Immunologic Factors|immunologic factors|mesh-ancestor
5620497|NCT03170882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5620498|NCT03170882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5620499|NCT03170882|Growth Substances|growth substances|mesh-ancestor
5620500|NCT03170882|Growth Inhibitors|growth inhibitors|mesh-ancestor
5620501|NCT03170882|Protease Inhibitors|protease inhibitors|mesh-ancestor
5620502|NCT03170882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5620503|NCT03170882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620504|NCT03112174|Venetoclax|venetoclax|mesh-list
5620505|NCT03112174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5620506|NCT03082729|Apremilast|apremilast|mesh-list
5620507|NCT03082729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5620508|NCT03082729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5620509|NCT03082729|Analgesics|analgesics|mesh-ancestor
5620510|NCT03082729|Sensory System Agents|sensory system agents|mesh-ancestor
5620511|NCT03082729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5620512|NCT03082729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741971|NCT03092817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5741972|NCT03092856|Axitinib|axitinib|mesh-list
5741973|NCT03092856|Antibodies|antibodies|mesh-list
5741974|NCT03092856|Immunologic Factors|immunologic factors|mesh-ancestor
5741975|NCT03092856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741976|NCT03092856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5741977|NCT03092856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5741978|NCT03092856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5741979|NCT03092856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741980|NCT03092765|Quetmolimab|quetmolimab|mesh-list
5741981|NCT03092765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5741982|NCT03092544|Dimethyl Fumarate|dimethyl fumarate|mesh-list
5741983|NCT03092544|Dermatologic Agents|dermatologic agents|mesh-ancestor
5741984|NCT03092544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5741985|NCT03092544|Immunologic Factors|immunologic factors|mesh-ancestor
5620513|NCT03082729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5620514|NCT03082729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5620515|NCT03082729|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5620516|NCT03082729|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5620517|NCT03082729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5620518|NCT03082729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620519|NCT03064126|Paclitaxel|paclitaxel|mesh-list
5620520|NCT03064126|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5620521|NCT03064126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5741986|NCT03092544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741987|NCT03092310|Pancrelipase|pancrelipase|mesh-list
5741988|NCT03092310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5741989|NCT03092193|Naproxen|naproxen|mesh-list
5741990|NCT03092193|Esomeprazole|esomeprazole|mesh-list
5741991|NCT03092193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5741992|NCT03092193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5620522|NCT03064126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5620523|NCT03064126|Tubulin Modulators|tubulin modulators|mesh-ancestor
5741993|NCT03092193|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5620524|NCT03064126|Antimitotic Agents|antimitotic agents|mesh-ancestor
5620525|NCT03064126|Mitosis Modulators|mitosis modulators|mesh-ancestor
5620526|NCT03064126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620527|NCT03062826|Aspirin|aspirin|mesh-list
5620528|NCT03062826|Clopidogrel|clopidogrel|mesh-list
5620529|NCT03062826|Ticagrelor|ticagrelor|mesh-list
5620530|NCT03062826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5620531|NCT03062826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5620532|NCT03062826|Analgesics|analgesics|mesh-ancestor
5620533|NCT03062826|Sensory System Agents|sensory system agents|mesh-ancestor
5620534|NCT03062826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5620535|NCT03062826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5741994|NCT03092193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5741995|NCT03092193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5741996|NCT03092193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5741997|NCT03092193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5741998|NCT03092193|Analgesics|analgesics|mesh-ancestor
5741999|NCT03092193|Sensory System Agents|sensory system agents|mesh-ancestor
5742000|NCT03092193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5742001|NCT03092193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742002|NCT03092193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5742003|NCT03092193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5742004|NCT03092193|Gout Suppressants|gout suppressants|mesh-ancestor
5742005|NCT03092193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5742006|NCT03092323|Pembrolizumab|pembrolizumab|mesh-list
5742007|NCT03092323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5742008|NCT03092323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5742009|NCT03092206|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5742010|NCT03092206|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
5742011|NCT03092206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5742012|NCT03092206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5742013|NCT03092206|Antiviral Agents|antiviral agents|mesh-ancestor
5742014|NCT03092206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5742015|NCT03092206|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5742016|NCT03092206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5620536|NCT03062826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5620537|NCT03062826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5620538|NCT03062826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5620539|NCT03062826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5620540|NCT03062826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620541|NCT03062826|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5620542|NCT03062826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5620543|NCT03062826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5620544|NCT03062826|Antipyretics|antipyretics|mesh-ancestor
5620545|NCT03062826|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5620546|NCT03062826|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5620547|NCT03062826|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5620548|NCT03062826|Purinergic Agents|purinergic agents|mesh-ancestor
5620549|NCT03062826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5620550|NCT03047070|Lidocaine|lidocaine|mesh-list
5620551|NCT03047070|Anesthetics, Local|anesthetics, local|mesh-ancestor
5620552|NCT03047070|Anesthetics|anesthetics|mesh-ancestor
5620553|NCT03047070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5620554|NCT03047070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620555|NCT03047070|Sensory System Agents|sensory system agents|mesh-ancestor
5620556|NCT03047070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5620557|NCT03047070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5620558|NCT03047070|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5742017|NCT03092206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5742018|NCT03092206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742019|NCT03092466|Ropivacaine|ropivacaine|mesh-list
5742020|NCT03092466|Anesthetics, Local|anesthetics, local|mesh-ancestor
5742021|NCT03092466|Anesthetics|anesthetics|mesh-ancestor
5742022|NCT03092466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5742023|NCT03092466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742024|NCT03092466|Sensory System Agents|sensory system agents|mesh-ancestor
5742025|NCT03092466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5742026|NCT03092154|Hypolipidemic Agents|hypolipidemic agents|mesh-list
5742027|NCT03092154|Antimetabolites|antimetabolites|mesh-ancestor
5620559|NCT03047070|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5620560|NCT03047070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5692523|NCT03407027|Triamcinolone|triamcinolone|mesh-list
5742028|NCT03092154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742029|NCT03092154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5893657|NCT04128956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5893658|NCT04128956|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5893659|NCT04128956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5893660|NCT04128956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893661|NCT04128956|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5893662|NCT04128956|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5893663|NCT04128956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5893664|NCT04128956|Antipyretics|antipyretics|mesh-ancestor
5893665|NCT04042701|Pembrolizumab|pembrolizumab|mesh-list
5893666|NCT04042701|Trastuzumab|trastuzumab|mesh-list
5893667|NCT04042701|Camptothecin|camptothecin|mesh-list
5893668|NCT04042701|Immunoconjugates|immunoconjugates|mesh-list
5893669|NCT04042701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5893670|NCT04042701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5893671|NCT04042701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5893672|NCT04042701|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5893673|NCT04042701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5893674|NCT04042701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5893675|NCT04042701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893676|NCT04042701|Immunologic Factors|immunologic factors|mesh-ancestor
5893677|NCT04042701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893678|NCT03906617|Dexamethasone|dexamethasone|mesh-list
5893679|NCT03906617|Epinephrine|epinephrine|mesh-list
5893680|NCT03906617|Bupivacaine|bupivacaine|mesh-list
5893681|NCT03906617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5620561|NCT03047070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620562|NCT03029611|Paclitaxel|paclitaxel|mesh-list
5620563|NCT03029611|Carboplatin|carboplatin|mesh-list
5620564|NCT03029611|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5620565|NCT03029611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5620566|NCT03029611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5620567|NCT03029611|Tubulin Modulators|tubulin modulators|mesh-ancestor
5620568|NCT03029611|Antimitotic Agents|antimitotic agents|mesh-ancestor
5620569|NCT03029611|Mitosis Modulators|mitosis modulators|mesh-ancestor
5620570|NCT03029611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620571|NCT03024996|Atezolizumab|atezolizumab|mesh-list
5893682|NCT03906617|Antiemetics|antiemetics|mesh-ancestor
5893683|NCT03906617|Autonomic Agents|autonomic agents|mesh-ancestor
5893684|NCT03906617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5893685|NCT03906617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893686|NCT03906617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5893687|NCT03906617|Glucocorticoids|glucocorticoids|mesh-ancestor
5893688|NCT03906617|Hormones|hormones|mesh-ancestor
5893689|NCT03906617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5893690|NCT03906617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5620572|NCT03024996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5620573|NCT02914977|Daunorubicin|daunorubicin|mesh-list
5620574|NCT02914977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5620575|NCT02914977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5620576|NCT02914977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5620577|NCT02914977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5620578|NCT02914977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5620579|NCT02914977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620580|NCT02891798|Dexamethasone|dexamethasone|mesh-list
5620581|NCT02891798|Dexamethasone acetate|dexamethasone acetate|mesh-list
5620582|NCT02891798|Clonidine|clonidine|mesh-list
5620583|NCT02891798|Buprenorphine|buprenorphine|mesh-list
5620584|NCT02891798|Bupivacaine|bupivacaine|mesh-list
5620585|NCT02891798|BB 1101|bb 1101|mesh-list
5620586|NCT02891798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5620587|NCT02891798|Antiemetics|antiemetics|mesh-ancestor
5620588|NCT02891798|Autonomic Agents|autonomic agents|mesh-ancestor
5620589|NCT02891798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5620590|NCT02891798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893691|NCT03906617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5893692|NCT03906617|Anesthetics, Local|anesthetics, local|mesh-ancestor
5893693|NCT03906617|Anesthetics|anesthetics|mesh-ancestor
5893694|NCT03906617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5893695|NCT03906617|Sensory System Agents|sensory system agents|mesh-ancestor
5893696|NCT03906617|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5893697|NCT03906617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5620591|NCT02891798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5620592|NCT02891798|Glucocorticoids|glucocorticoids|mesh-ancestor
5620593|NCT02891798|Hormones|hormones|mesh-ancestor
5742030|NCT03092011|Clonidine|clonidine|mesh-list
5742031|NCT03092011|Morphine|morphine|mesh-list
5742032|NCT03092011|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5742033|NCT03092011|Narcotics|narcotics|mesh-ancestor
5742034|NCT03092011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5620594|NCT02891798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5620595|NCT02891798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5620596|NCT02891798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5620597|NCT02891798|Protease Inhibitors|protease inhibitors|mesh-ancestor
5620598|NCT02891798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5620599|NCT02891798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620600|NCT02891798|Anesthetics, Local|anesthetics, local|mesh-ancestor
5620601|NCT02891798|Anesthetics|anesthetics|mesh-ancestor
5620602|NCT02891798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5620603|NCT02891798|Sensory System Agents|sensory system agents|mesh-ancestor
5620604|NCT02891798|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5620605|NCT02891798|Narcotics|narcotics|mesh-ancestor
5620606|NCT02891798|Analgesics|analgesics|mesh-ancestor
5620607|NCT02891798|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5620608|NCT02891798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5620609|NCT02891798|Sympatholytics|sympatholytics|mesh-ancestor
5620610|NCT02891798|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5620611|NCT02891798|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5620612|NCT02891798|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5620613|NCT02891798|Adrenergic Agents|adrenergic agents|mesh-ancestor
5620614|NCT02891798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5620615|NCT02870218|Nicotine|nicotine|mesh-list
5620616|NCT02870218|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5620617|NCT02870218|Autonomic Agents|autonomic agents|mesh-ancestor
5620618|NCT02870218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5620619|NCT02870218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742035|NCT03092011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742036|NCT03092011|Analgesics|analgesics|mesh-ancestor
5742037|NCT03092011|Sensory System Agents|sensory system agents|mesh-ancestor
5742038|NCT03092011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5742039|NCT03092011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5742040|NCT03092011|Sympatholytics|sympatholytics|mesh-ancestor
5742041|NCT03092011|Autonomic Agents|autonomic agents|mesh-ancestor
5742042|NCT03092011|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5742043|NCT03092011|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5742044|NCT03092011|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5742045|NCT03092011|Adrenergic Agents|adrenergic agents|mesh-ancestor
5742046|NCT03092011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5742047|NCT03092011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742048|NCT03092076|Ticagrelor|ticagrelor|mesh-list
5742049|NCT03092076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6672876|NCT01558960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672877|NCT01558960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6672878|NCT01558960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5742050|NCT03092076|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5742051|NCT03092076|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5742052|NCT03092076|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5742053|NCT03092076|Purinergic Agents|purinergic agents|mesh-ancestor
5742054|NCT03092076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5742055|NCT03092076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742056|NCT03092076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742057|NCT03091894|Dexmedetomidine|dexmedetomidine|mesh-list
5742058|NCT03091894|Propofol|propofol|mesh-list
5742059|NCT03091894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5742060|NCT03091894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5742061|NCT03091894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742062|NCT03091894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5742063|NCT03091894|Anesthetics, General|anesthetics, general|mesh-ancestor
5742064|NCT03091894|Anesthetics|anesthetics|mesh-ancestor
5742065|NCT03091894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5742066|NCT03091894|Analgesics|analgesics|mesh-ancestor
5742067|NCT03091894|Sensory System Agents|sensory system agents|mesh-ancestor
5742068|NCT03091894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5742069|NCT03091894|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5742070|NCT03091894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5742071|NCT03091894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5742072|NCT03091894|Adrenergic Agents|adrenergic agents|mesh-ancestor
5742073|NCT03091894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5742074|NCT03091894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620620|NCT02870218|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5620621|NCT02870218|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5620622|NCT02870218|Cholinergic Agents|cholinergic agents|mesh-ancestor
5620623|NCT02870218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5620624|NCT02870218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620625|NCT02864992|Tepotinib|tepotinib|mesh-list
5620626|NCT02864992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5620627|NCT02859961|Leronlimab|leronlimab|mesh-list
5620628|NCT02859961|HIV Antibodies|hiv antibodies|mesh-list
5620629|NCT02859961|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5620630|NCT02859961|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5620631|NCT02859961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620632|NCT02859961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5620633|NCT02859961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5620634|NCT02859961|Antiviral Agents|antiviral agents|mesh-ancestor
5620635|NCT02859961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5742075|NCT03091881|Granisetron|granisetron|mesh-list
5742076|NCT03091881|Antiemetics|antiemetics|mesh-ancestor
5742077|NCT03091881|Autonomic Agents|autonomic agents|mesh-ancestor
5742078|NCT03091881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5742079|NCT03091881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742080|NCT03091881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5742081|NCT03091881|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5742082|NCT03091881|Serotonin Agents|serotonin agents|mesh-ancestor
5742083|NCT03091881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5742084|NCT03091881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742085|NCT03091868|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
5742086|NCT03091868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5742087|NCT03091868|Immunologic Factors|immunologic factors|mesh-ancestor
5742088|NCT03091868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742089|NCT03091868|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5742090|NCT03091868|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5742091|NCT03091868|Dopamine Agonists|dopamine agonists|mesh-ancestor
5742092|NCT03091868|Dopamine Agents|dopamine agents|mesh-ancestor
5742093|NCT03091868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5742094|NCT03091868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620636|NCT02859961|Immunologic Factors|immunologic factors|mesh-ancestor
5620637|NCT02859961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620638|NCT02769520|Pembrolizumab|pembrolizumab|mesh-list
5620639|NCT02769520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5742095|NCT03091803|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
5742096|NCT03091803|Chelating Agents|chelating agents|mesh-ancestor
5742097|NCT03091803|Sequestering Agents|sequestering agents|mesh-ancestor
5620640|NCT02769520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5620641|NCT02679781|Midazolam|midazolam|mesh-list
5620642|NCT02679781|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5620643|NCT02679781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5620644|NCT02679781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5620645|NCT02679781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620646|NCT02679781|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5620647|NCT02679781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5620648|NCT02679781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5620649|NCT02679781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5620650|NCT02679781|Anesthetics, General|anesthetics, general|mesh-ancestor
5620651|NCT02679781|Anesthetics|anesthetics|mesh-ancestor
5620652|NCT02679781|GABA Modulators|gaba modulators|mesh-ancestor
5620653|NCT02679781|GABA Agents|gaba agents|mesh-ancestor
5620654|NCT02679781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5620655|NCT02679781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620656|NCT02679508|Lansoprazole|lansoprazole|mesh-list
5620657|NCT02679508|Dexlansoprazole|dexlansoprazole|mesh-list
5742098|NCT03091803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742099|NCT03091712|Insulin|insulin|mesh-list
5742100|NCT03091712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5742101|NCT03091712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742102|NCT03091699|Nicotine|nicotine|mesh-list
5620658|NCT02679508|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5620659|NCT02679508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5620660|NCT02679508|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5620661|NCT02679508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5620662|NCT02679508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620663|NCT02624869|Evolocumab|evolocumab|mesh-list
5620664|NCT02624869|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5620665|NCT02624869|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5620666|NCT02624869|Antimetabolites|antimetabolites|mesh-ancestor
5742103|NCT03091699|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5742104|NCT03091699|Autonomic Agents|autonomic agents|mesh-ancestor
5620667|NCT02624869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620668|NCT02624869|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5620669|NCT02614690|Calpastatin|calpastatin|mesh-list
5620670|NCT02614690|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
5620671|NCT02614690|Protease Inhibitors|protease inhibitors|mesh-ancestor
5620672|NCT02614690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5620673|NCT02614690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620674|NCT02595424|Carboplatin|carboplatin|mesh-list
5620675|NCT02595424|Capecitabine|capecitabine|mesh-list
5620676|NCT02595424|Etoposide|etoposide|mesh-list
5620677|NCT02595424|Temozolomide|temozolomide|mesh-list
5620678|NCT02595424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5620679|NCT02595424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5620680|NCT02595424|Antimetabolites|antimetabolites|mesh-ancestor
5620681|NCT02595424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620682|NCT02595424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5620683|NCT02595424|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5620684|NCT02595424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5620685|NCT02595424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5620686|NCT02595424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5620687|NCT02595424|Alkylating Agents|alkylating agents|mesh-ancestor
5620688|NCT02569242|Paclitaxel|paclitaxel|mesh-list
5620689|NCT02569242|Docetaxel|docetaxel|mesh-list
5620690|NCT02569242|Nivolumab|nivolumab|mesh-list
5620691|NCT02569242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5620692|NCT02569242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5620693|NCT02569242|Tubulin Modulators|tubulin modulators|mesh-ancestor
5620694|NCT02569242|Antimitotic Agents|antimitotic agents|mesh-ancestor
5620695|NCT02569242|Mitosis Modulators|mitosis modulators|mesh-ancestor
5620696|NCT02569242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620697|NCT02569242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5620698|NCT02569242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5692524|NCT03407027|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5692525|NCT03407027|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5692526|NCT03407027|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5692527|NCT03407027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5692528|NCT03407027|Glucocorticoids|glucocorticoids|mesh-ancestor
5742105|NCT03091699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5742106|NCT03091699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742107|NCT03091699|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5742108|NCT03091699|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5742109|NCT03091699|Cholinergic Agents|cholinergic agents|mesh-ancestor
5742110|NCT03091699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5742111|NCT03091699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742112|NCT03091543|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
5692529|NCT03407027|Hormones|hormones|mesh-ancestor
5692530|NCT03407027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5742113|NCT03091543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5742114|NCT03091543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742115|NCT03091543|Dopamine Agents|dopamine agents|mesh-ancestor
5742116|NCT03091543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5742117|NCT03091543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742118|NCT03091491|Nivolumab|nivolumab|mesh-list
5742119|NCT03091491|Ipilimumab|ipilimumab|mesh-list
5742120|NCT03091491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5692531|NCT03407027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692532|NCT03407027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5692533|NCT03407027|Immunologic Factors|immunologic factors|mesh-ancestor
5692534|NCT03407027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5692535|NCT03407027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692536|NCT03406988|Nifedipine|nifedipine|mesh-list
5692537|NCT03406988|Iloprost|iloprost|mesh-list
5692538|NCT03406988|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5692539|NCT03406988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5692540|NCT03406988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692541|NCT03406988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5692542|NCT03406988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692543|NCT03406988|Vasodilator Agents|vasodilator agents|mesh-ancestor
5692544|NCT03406988|Tocolytic Agents|tocolytic agents|mesh-ancestor
5692545|NCT03406988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5742121|NCT03091491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5620699|NCT02435433|Ramucirumab|ramucirumab|mesh-list
5620700|NCT02435433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5620701|NCT02426125|Docetaxel|docetaxel|mesh-list
5620702|NCT02426125|Ramucirumab|ramucirumab|mesh-list
5620703|NCT02426125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5620704|NCT02426125|Tubulin Modulators|tubulin modulators|mesh-ancestor
5620705|NCT02426125|Antimitotic Agents|antimitotic agents|mesh-ancestor
5620706|NCT02426125|Mitosis Modulators|mitosis modulators|mesh-ancestor
5620707|NCT02426125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620708|NCT02417142|Exenatide|exenatide|mesh-list
5620709|NCT02417142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5620710|NCT02417142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620711|NCT02417142|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5620712|NCT02417142|Incretins|incretins|mesh-ancestor
5620713|NCT02417142|Hormones|hormones|mesh-ancestor
5620714|NCT02417142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5620715|NCT02368886|Clobetasol|clobetasol|mesh-list
5620716|NCT02368886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5620717|NCT02368886|Glucocorticoids|glucocorticoids|mesh-ancestor
5620718|NCT02368886|Hormones|hormones|mesh-ancestor
5620719|NCT02368886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5620720|NCT02368886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620721|NCT02354703|Ondansetron|ondansetron|mesh-list
5620722|NCT02354703|Antiemetics|antiemetics|mesh-ancestor
5620723|NCT02354703|Autonomic Agents|autonomic agents|mesh-ancestor
5620724|NCT02354703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5742122|NCT03091491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5742123|NCT03091491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742124|NCT03091660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5742125|NCT03091660|Vaccines|vaccines|mesh-list
5742126|NCT03091660|BCG Vaccine|bcg vaccine|mesh-list
5742127|NCT03091660|Immunologic Factors|immunologic factors|mesh-ancestor
5742128|NCT03091660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742129|NCT03091660|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5742130|NCT03091569|Vitamin K|vitamin k|mesh-list
5742131|NCT03091569|Vitamins|vitamins|mesh-ancestor
5742132|NCT03091569|Micronutrients|micronutrients|mesh-ancestor
5742133|NCT03091569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742134|NCT03091569|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5742135|NCT03091569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5742136|NCT03091569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742137|NCT03091569|Hemostatics|hemostatics|mesh-ancestor
5742138|NCT03091569|Coagulants|coagulants|mesh-ancestor
5742139|NCT03091595|Drospirenone|drospirenone|mesh-list
5742140|NCT03091595|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5742141|NCT03091595|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5742142|NCT03091595|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5742143|NCT03091595|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5742144|NCT03091595|Contraceptive Agents|contraceptive agents|mesh-ancestor
5742145|NCT03091595|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5742146|NCT03091595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742147|NCT03091595|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5742148|NCT03091595|Estrogens|estrogens|mesh-ancestor
5742149|NCT03091595|Hormones|hormones|mesh-ancestor
5742150|NCT03091595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5742151|NCT03091595|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5742152|NCT03091595|Hormone Antagonists|hormone antagonists|mesh-ancestor
5742153|NCT03091595|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5742154|NCT03091595|Diuretics|diuretics|mesh-ancestor
5742155|NCT03091595|Natriuretic Agents|natriuretic agents|mesh-ancestor
5742156|NCT03091426|Antimicrobial Cationic Peptides|antimicrobial cationic peptides|mesh-list
5742157|NCT03091426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5742158|NCT03091504|Albuterol|albuterol|mesh-list
5742159|NCT03091504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5742160|NCT03091504|Autonomic Agents|autonomic agents|mesh-ancestor
5742161|NCT03091504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5742162|NCT03091504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742163|NCT03091504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5742164|NCT03091504|Respiratory System Agents|respiratory system agents|mesh-ancestor
5742165|NCT03091504|Tocolytic Agents|tocolytic agents|mesh-ancestor
5742166|NCT03091504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5742167|NCT03091504|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5742168|NCT03091504|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6489360|NCT00591188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5620725|NCT02354703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620726|NCT02354703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5742169|NCT03091504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5742170|NCT03091504|Adrenergic Agents|adrenergic agents|mesh-ancestor
5742171|NCT03091504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5742172|NCT03091504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742173|NCT03091166|Dexmedetomidine|dexmedetomidine|mesh-list
5742174|NCT03091166|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5742175|NCT03091166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5742176|NCT03091166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742177|NCT03091166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5742178|NCT03091166|Analgesics|analgesics|mesh-ancestor
5742179|NCT03091166|Sensory System Agents|sensory system agents|mesh-ancestor
5620727|NCT02354703|Antipruritics|antipruritics|mesh-ancestor
5620728|NCT02354703|Dermatologic Agents|dermatologic agents|mesh-ancestor
5620729|NCT02354703|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5620730|NCT02354703|Serotonin Agents|serotonin agents|mesh-ancestor
5620731|NCT02354703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5620732|NCT02354703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620733|NCT02354703|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5620734|NCT02354703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5620735|NCT02354703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5620736|NCT02354703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5620737|NCT02354703|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5620738|NCT02312258|Ixazomib|ixazomib|mesh-list
5620739|NCT02312258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5620740|NCT02312258|Protease Inhibitors|protease inhibitors|mesh-ancestor
5620741|NCT02312258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5620742|NCT02312258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620743|NCT02258451|Everolimus|everolimus|mesh-list
5620744|NCT02258451|Exemestane|exemestane|mesh-list
5620745|NCT02258451|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
5620746|NCT02258451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5620747|NCT02258451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5742180|NCT03091166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5742181|NCT03091166|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5742182|NCT03091166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5742183|NCT03091166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5742184|NCT03091166|Adrenergic Agents|adrenergic agents|mesh-ancestor
5742185|NCT03091166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5742186|NCT03091166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742187|NCT03091075|Oxandrolone|oxandrolone|mesh-list
5742188|NCT03091075|Androgens|androgens|mesh-ancestor
5742189|NCT03091075|Hormones|hormones|mesh-ancestor
5742190|NCT03091075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5742191|NCT03091075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742192|NCT03091075|Anabolic Agents|anabolic agents|mesh-ancestor
5742193|NCT03091257|Trametinib|trametinib|mesh-list
5742194|NCT03091257|Dabrafenib|dabrafenib|mesh-list
5742195|NCT03091257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5742196|NCT03091257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5742197|NCT03091257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5742198|NCT03091257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742199|NCT03090971|Diclofenac|diclofenac|mesh-list
5742200|NCT03090971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5742201|NCT03090971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5742202|NCT03090971|Analgesics|analgesics|mesh-ancestor
5742203|NCT03090971|Sensory System Agents|sensory system agents|mesh-ancestor
5742204|NCT03090971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5742205|NCT03090971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742206|NCT03090971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5742207|NCT03090971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5742208|NCT03090971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5742209|NCT03090971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5742210|NCT03090971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742211|NCT03090698|Triamcinolone|triamcinolone|mesh-list
5742212|NCT03090698|Hylan|hylan|mesh-list
5742213|NCT03090698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5742214|NCT03090698|Glucocorticoids|glucocorticoids|mesh-ancestor
5742215|NCT03090698|Hormones|hormones|mesh-ancestor
5742216|NCT03090698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5742217|NCT03090698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742218|NCT03090698|Viscosupplements|viscosupplements|mesh-ancestor
5742219|NCT03090698|Protective Agents|protective agents|mesh-ancestor
5742220|NCT03090737|Nivolumab|nivolumab|mesh-list
5742221|NCT03090737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6489361|NCT00591188|Antiviral Agents|antiviral agents|mesh-ancestor
5742222|NCT03090737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5742223|NCT03090737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5742224|NCT03090737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742225|NCT03090776|Ketamine|ketamine|mesh-list
5742226|NCT03090776|Analgesics|analgesics|mesh-ancestor
5742227|NCT03090776|Sensory System Agents|sensory system agents|mesh-ancestor
5742228|NCT03090776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5742229|NCT03090776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742230|NCT03090776|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5742231|NCT03090776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5742232|NCT03090776|Anesthetics, General|anesthetics, general|mesh-ancestor
5742233|NCT03090776|Anesthetics|anesthetics|mesh-ancestor
5742234|NCT03090776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5742235|NCT03090776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5742236|NCT03090776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5742237|NCT03090776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5742238|NCT03090776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893698|NCT03906617|Adrenergic Agents|adrenergic agents|mesh-ancestor
5893699|NCT03906617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5893700|NCT03906617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893701|NCT03906617|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5893702|NCT03906617|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5893703|NCT03906617|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5893704|NCT03906617|Respiratory System Agents|respiratory system agents|mesh-ancestor
5893705|NCT03906617|Mydriatics|mydriatics|mesh-ancestor
5893706|NCT03906617|Sympathomimetics|sympathomimetics|mesh-ancestor
5893707|NCT03906617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5893708|NCT03897673|Iron|iron|mesh-list
5893709|NCT03897673|Trace Elements|trace elements|mesh-ancestor
5620748|NCT02258451|Immunologic Factors|immunologic factors|mesh-ancestor
5620749|NCT02258451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620750|NCT02258451|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5620751|NCT02258451|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5620752|NCT02258451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5620753|NCT02258451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620754|NCT02258451|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5620755|NCT02258451|Hormone Antagonists|hormone antagonists|mesh-ancestor
5620756|NCT02258451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5620757|NCT02029443|Acalabrutinib|acalabrutinib|mesh-list
5620758|NCT02029443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5620759|NCT01772472|Trastuzumab|trastuzumab|mesh-list
5620760|NCT01772472|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
5620761|NCT01772472|Maytansine|maytansine|mesh-list
5620762|NCT01772472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5620763|NCT01772472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5620764|NCT01772472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5893710|NCT03897673|Micronutrients|micronutrients|mesh-ancestor
5893711|NCT03897673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893712|NCT03886649|Venetoclax|venetoclax|mesh-list
5893713|NCT03886649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5893714|NCT03874494|Aripiprazole|aripiprazole|mesh-list
5893715|NCT03874494|Brexpiprazole|brexpiprazole|mesh-list
5893716|NCT03874494|Antidepressive Agents|antidepressive agents|mesh-ancestor
5893717|NCT03874494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5893718|NCT03874494|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5893719|NCT03874494|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5893720|NCT03874494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5893721|NCT03874494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893722|NCT03874494|Dopamine Agonists|dopamine agonists|mesh-ancestor
5893723|NCT03874494|Dopamine Agents|dopamine agents|mesh-ancestor
5893724|NCT03874494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5893725|NCT03874494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893726|NCT03874494|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5893727|NCT03874494|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5893728|NCT03874494|Serotonin Agents|serotonin agents|mesh-ancestor
5893729|NCT03874494|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5893730|NCT03874494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5893731|NCT03874494|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5893732|NCT03874494|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5893733|NCT03862859|Warfarin|warfarin|mesh-list
5893734|NCT03862859|Anticoagulants|anticoagulants|mesh-ancestor
5893735|NCT03807817|Ethanol|ethanol|mesh-list
5893736|NCT03807817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5893737|NCT03807817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5742239|NCT03090880|Tinzaparin|tinzaparin|mesh-list
5742240|NCT03090880|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5742241|NCT03090880|Dalteparin|dalteparin|mesh-list
5742242|NCT03090880|Anticoagulants|anticoagulants|mesh-ancestor
5742243|NCT03090880|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5742244|NCT03090880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5742245|NCT03090880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620765|NCT01772472|Tubulin Modulators|tubulin modulators|mesh-ancestor
5620766|NCT01772472|Antimitotic Agents|antimitotic agents|mesh-ancestor
5620767|NCT01772472|Mitosis Modulators|mitosis modulators|mesh-ancestor
5620768|NCT01772472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620769|NCT01442194|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
5620770|NCT01442194|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5620771|NCT01442194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620772|NCT01442194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5620773|NCT01442194|Immunologic Factors|immunologic factors|mesh-ancestor
5620774|NCT01442194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620775|NCT01365195|Ketamine|ketamine|mesh-list
5620776|NCT01365195|Analgesics|analgesics|mesh-ancestor
5620777|NCT01365195|Sensory System Agents|sensory system agents|mesh-ancestor
5620778|NCT01365195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5620779|NCT01365195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620780|NCT01365195|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5620781|NCT01365195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5742246|NCT03090503|Risperidone|risperidone|mesh-list
5742247|NCT03090503|Aripiprazole|aripiprazole|mesh-list
5742248|NCT03090503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5742249|NCT03090503|Serotonin Agents|serotonin agents|mesh-ancestor
5742250|NCT03090503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5742251|NCT03090503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742252|NCT03090503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742253|NCT03090503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5742254|NCT03090503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5742255|NCT03090503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5742256|NCT03090503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5742257|NCT03090503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5742258|NCT03090503|Dopamine Agents|dopamine agents|mesh-ancestor
5742259|NCT03090503|Antidepressive Agents|antidepressive agents|mesh-ancestor
5742260|NCT03090503|Dopamine Agonists|dopamine agonists|mesh-ancestor
5742261|NCT03090503|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5742262|NCT03090503|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5742263|NCT03090503|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5742264|NCT03090503|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5742265|NCT03090490|Antipsychotic Agents|antipsychotic agents|mesh-list
5742266|NCT03090490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5742267|NCT03090490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5742268|NCT03090490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742269|NCT03090490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5742270|NCT03090516|Donepezil|donepezil|mesh-list
5742271|NCT03090516|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5742272|NCT03090516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5742273|NCT03090516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742274|NCT03090516|Cholinergic Agents|cholinergic agents|mesh-ancestor
5742275|NCT03090516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5742276|NCT03090516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742277|NCT03090516|Nootropic Agents|nootropic agents|mesh-ancestor
5742278|NCT03090269|Methylphenidate|methylphenidate|mesh-list
5742279|NCT03090269|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5742280|NCT03090269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742281|NCT03090269|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5742282|NCT03090269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5742283|NCT03090269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5742284|NCT03090269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742285|NCT03090269|Dopamine Agents|dopamine agents|mesh-ancestor
5742286|NCT03090269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5742287|NCT03090087|Regadenoson|regadenoson|mesh-list
5742288|NCT03090087|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
5742289|NCT03090087|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5742290|NCT03090087|Purinergic Agonists|purinergic agonists|mesh-ancestor
5742291|NCT03090087|Purinergic Agents|purinergic agents|mesh-ancestor
5742292|NCT03090087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5620782|NCT01365195|Anesthetics, General|anesthetics, general|mesh-ancestor
5620783|NCT01365195|Anesthetics|anesthetics|mesh-ancestor
5620784|NCT01365195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5620785|NCT01365195|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5620786|NCT01365195|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5620787|NCT01365195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5742293|NCT03090087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742294|NCT03090087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742295|NCT03090152|Bupivacaine|bupivacaine|mesh-list
5742296|NCT03090152|Anesthetics, Local|anesthetics, local|mesh-ancestor
5742297|NCT03090152|Anesthetics|anesthetics|mesh-ancestor
5742298|NCT03090152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5742299|NCT03090152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742300|NCT03090152|Sensory System Agents|sensory system agents|mesh-ancestor
5742301|NCT03090152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5742302|NCT03089866|Midazolam|midazolam|mesh-list
5742303|NCT03089866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5742304|NCT03089866|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5742305|NCT03089866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5742306|NCT03089866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620788|NCT01365195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620789|NCT00796068|Cyclosporine|cyclosporine|mesh-list
5620790|NCT00796068|Mycophenolic Acid|mycophenolic acid|mesh-list
5620791|NCT00796068|Fludarabine|fludarabine|mesh-list
5620792|NCT00796068|Fludarabine phosphate|fludarabine phosphate|mesh-list
5742307|NCT03089866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5742308|NCT03089866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5742309|NCT03089866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5742310|NCT03089866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5742311|NCT03089866|Anesthetics, General|anesthetics, general|mesh-ancestor
5742312|NCT03089866|Anesthetics|anesthetics|mesh-ancestor
5742313|NCT03089866|GABA Modulators|gaba modulators|mesh-ancestor
5742314|NCT03089866|GABA Agents|gaba agents|mesh-ancestor
5742315|NCT03089866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5742316|NCT03089866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742317|NCT03089957|Urinastatin|urinastatin|mesh-list
5742318|NCT03089957|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5742319|NCT03089957|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5742320|NCT03089957|Protease Inhibitors|protease inhibitors|mesh-ancestor
5620793|NCT00796068|Treosulfan|treosulfan|mesh-list
5620794|NCT00796068|Busulfan|busulfan|mesh-list
5620795|NCT00796068|Cyclosporins|cyclosporins|mesh-list
5620796|NCT00796068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5620797|NCT00796068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5742321|NCT03089957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5742322|NCT03089957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742323|NCT03090048|Vitamin A|vitamin a|mesh-list
5742324|NCT03090048|Azithromycin|azithromycin|mesh-list
5742325|NCT03090048|Retinol palmitate|retinol palmitate|mesh-list
5742326|NCT03090048|Vitamins|vitamins|mesh-ancestor
5742327|NCT03090048|Micronutrients|micronutrients|mesh-ancestor
5742328|NCT03090048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742329|NCT03090048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5742330|NCT03090048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5742331|NCT03090048|Antioxidants|antioxidants|mesh-ancestor
5742332|NCT03090048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742333|NCT03090048|Protective Agents|protective agents|mesh-ancestor
5742334|NCT03090048|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5742335|NCT03090048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5742336|NCT03090035|Interferons|interferons|mesh-list
5742337|NCT03090035|Ribavirin|ribavirin|mesh-list
5742338|NCT03090035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5742339|NCT03090035|Antiviral Agents|antiviral agents|mesh-ancestor
5742340|NCT03090035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5742341|NCT03090035|Antimetabolites|antimetabolites|mesh-ancestor
5742342|NCT03090035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742343|NCT03089983|Isoniazid|isoniazid|mesh-list
5742344|NCT03089983|Rifapentine|rifapentine|mesh-list
5742345|NCT03089983|Buprenorphine|buprenorphine|mesh-list
5742346|NCT03089983|Methadone|methadone|mesh-list
5742347|NCT03089983|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
5742348|NCT03089983|Naloxone|naloxone|mesh-list
5742349|NCT03089983|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5742350|NCT03089983|Narcotics|narcotics|mesh-ancestor
5742351|NCT03089983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5742352|NCT03089983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620798|NCT00796068|Antimetabolites|antimetabolites|mesh-ancestor
5742353|NCT03089983|Analgesics|analgesics|mesh-ancestor
5742354|NCT03089983|Sensory System Agents|sensory system agents|mesh-ancestor
5742355|NCT03089983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5620799|NCT00796068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620800|NCT00796068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5620801|NCT00796068|Immunologic Factors|immunologic factors|mesh-ancestor
5620802|NCT00796068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620803|NCT00796068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5620804|NCT00796068|Antifungal Agents|antifungal agents|mesh-ancestor
5620805|NCT00796068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5620806|NCT00796068|Dermatologic Agents|dermatologic agents|mesh-ancestor
5620807|NCT00796068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5620808|NCT00796068|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5620809|NCT00796068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5620810|NCT00796068|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5620811|NCT00796068|Antitubercular Agents|antitubercular agents|mesh-ancestor
5620812|NCT00796068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5620813|NCT00796068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5620814|NCT00796068|Alkylating Agents|alkylating agents|mesh-ancestor
5620815|NCT00796068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5620816|NCT00468130|Aripiprazole|aripiprazole|mesh-list
5620817|NCT00468130|Antidepressive Agents|antidepressive agents|mesh-ancestor
5620818|NCT00468130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5620819|NCT00468130|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5620820|NCT00468130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5620821|NCT00468130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5620822|NCT00468130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620823|NCT00468130|Dopamine Agonists|dopamine agonists|mesh-ancestor
5620824|NCT00468130|Dopamine Agents|dopamine agents|mesh-ancestor
5620825|NCT00468130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5620826|NCT00468130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620827|NCT00468130|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5620828|NCT00468130|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5620829|NCT00468130|Serotonin Agents|serotonin agents|mesh-ancestor
5620830|NCT00468130|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5620831|NCT00468130|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5620832|NCT00468130|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5620833|NCT00468130|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5620834|NCT05197751|Aluminum Hydroxide|aluminum hydroxide|mesh-list
5620835|NCT05197751|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5620836|NCT05197751|Immunologic Factors|immunologic factors|mesh-ancestor
5620837|NCT05197751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620838|NCT05197751|Antacids|antacids|mesh-ancestor
5620839|NCT05197751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620840|NCT05197751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5620841|NCT05197621|Vaccines|vaccines|mesh-list
5620842|NCT05197621|Immunologic Factors|immunologic factors|mesh-ancestor
5620843|NCT05197621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620844|NCT05197504|Bevacizumab|bevacizumab|mesh-list
5620845|NCT05197504|Atezolizumab|atezolizumab|mesh-list
5620846|NCT05197504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5620847|NCT05197504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5742356|NCT03089983|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5742357|NCT03089983|Antitussive Agents|antitussive agents|mesh-ancestor
5742358|NCT03089983|Respiratory System Agents|respiratory system agents|mesh-ancestor
5742359|NCT03089983|Antitubercular Agents|antitubercular agents|mesh-ancestor
5742360|NCT03089983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5742361|NCT03089983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5742362|NCT03089983|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5742363|NCT03089983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5742364|NCT03089983|Antimetabolites|antimetabolites|mesh-ancestor
5742365|NCT03089983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742366|NCT03089983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5742367|NCT03089983|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5742368|NCT03089983|Leprostatic Agents|leprostatic agents|mesh-ancestor
5742369|NCT03089905|Dexmedetomidine|dexmedetomidine|mesh-list
5742370|NCT03089905|Remifentanil|remifentanil|mesh-list
5742371|NCT03089905|Sevoflurane|sevoflurane|mesh-list
5742372|NCT03089905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5742373|NCT03089905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5620848|NCT05197504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5620849|NCT05197504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5620850|NCT05197504|Growth Substances|growth substances|mesh-ancestor
5620851|NCT05197504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620852|NCT05197504|Growth Inhibitors|growth inhibitors|mesh-ancestor
5742374|NCT03089905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620853|NCT05197439|Dexmedetomidine|dexmedetomidine|mesh-list
5742375|NCT03089905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5742376|NCT03089905|Analgesics|analgesics|mesh-ancestor
5742377|NCT03089905|Sensory System Agents|sensory system agents|mesh-ancestor
5742378|NCT03089905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5742379|NCT03089905|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5742380|NCT03089905|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5742381|NCT03089905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5742382|NCT03089905|Adrenergic Agents|adrenergic agents|mesh-ancestor
5742383|NCT03089905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5742384|NCT03089905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742385|NCT03089905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5742386|NCT03089905|Narcotics|narcotics|mesh-ancestor
5742387|NCT03089905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5742388|NCT03089905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5742389|NCT03089905|Anesthetics, General|anesthetics, general|mesh-ancestor
5742390|NCT03089905|Anesthetics|anesthetics|mesh-ancestor
5742391|NCT03090009|Flurbiprofen|flurbiprofen|mesh-list
5742392|NCT03090009|Analgesics|analgesics|mesh-ancestor
5742393|NCT03090009|Sensory System Agents|sensory system agents|mesh-ancestor
5742394|NCT03090009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5742395|NCT03090009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742396|NCT03090009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5742397|NCT03090009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5742398|NCT03090009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5742399|NCT03090009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5742400|NCT03090009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5742401|NCT03090009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5742402|NCT03090009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742403|NCT03089723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5742404|NCT03089671|Vitamins|vitamins|mesh-list
5742405|NCT03089671|Riboflavin|riboflavin|mesh-list
5742406|NCT03089671|Vitamin B Complex|vitamin b complex|mesh-list
5742407|NCT03089671|Micronutrients|micronutrients|mesh-ancestor
5742408|NCT03089671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742409|NCT03089671|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5742410|NCT03089671|Dermatologic Agents|dermatologic agents|mesh-ancestor
5742411|NCT03089645|Docetaxel|docetaxel|mesh-list
5742412|NCT03089645|Durvalumab|durvalumab|mesh-list
5742413|NCT03089645|Tremelimumab|tremelimumab|mesh-list
5742414|NCT03089645|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5742415|NCT03089645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5742416|NCT03089645|Tubulin Modulators|tubulin modulators|mesh-ancestor
5620854|NCT05197439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5620855|NCT05197439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5620856|NCT05197439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620857|NCT05197439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5620858|NCT05197439|Analgesics|analgesics|mesh-ancestor
5620859|NCT05197439|Sensory System Agents|sensory system agents|mesh-ancestor
5620860|NCT05197439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5620861|NCT05197439|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5620862|NCT05197439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5620863|NCT05197439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5742417|NCT03089645|Antimitotic Agents|antimitotic agents|mesh-ancestor
5742418|NCT03089645|Mitosis Modulators|mitosis modulators|mesh-ancestor
5742419|NCT03089645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742420|NCT03089645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5742421|NCT03089645|Immunologic Factors|immunologic factors|mesh-ancestor
5742422|NCT03089645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742423|NCT03089567|Listerine|listerine|mesh-list
5742424|NCT03089567|Fluorides|fluorides|mesh-list
5742425|NCT03089567|Sodium Fluoride|sodium fluoride|mesh-list
5742426|NCT03089567|Cariostatic Agents|cariostatic agents|mesh-ancestor
5742427|NCT03089567|Protective Agents|protective agents|mesh-ancestor
5742428|NCT03089567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742429|NCT03089567|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5742430|NCT03089567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5620864|NCT05197439|Adrenergic Agents|adrenergic agents|mesh-ancestor
5620865|NCT05197439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5620866|NCT05197439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742431|NCT03089658|Avelumab|avelumab|mesh-list
5742432|NCT03089658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5742433|NCT03089658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5742434|NCT03089333|Dapagliflozin|dapagliflozin|mesh-list
5742435|NCT03089333|Glyburide|glyburide|mesh-list
5742436|NCT03089333|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5893738|NCT03807817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5620867|NCT05197426|Azacitidine|azacitidine|mesh-list
5620868|NCT05197426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5620869|NCT05197426|Antimetabolites|antimetabolites|mesh-ancestor
5620870|NCT05197426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620871|NCT05197426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5620872|NCT05197426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5620873|NCT05197270|Aflibercept|aflibercept|mesh-list
5620874|NCT05197270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5620875|NCT05197270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5620876|NCT05197270|Growth Substances|growth substances|mesh-ancestor
5620877|NCT05197270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742437|NCT03089333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742438|NCT03089333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5742439|NCT03089333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893739|NCT03807817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893740|NCT03797326|Pembrolizumab|pembrolizumab|mesh-list
5893741|NCT03797326|Lenvatinib|lenvatinib|mesh-list
5893742|NCT03797326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5893743|NCT03797326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5893744|NCT03797326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5893745|NCT03797326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5893746|NCT03797326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893747|NCT03775850|Pembrolizumab|pembrolizumab|mesh-list
5893748|NCT03775850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5893749|NCT03775850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5893750|NCT03739710|Docetaxel|docetaxel|mesh-list
5893751|NCT03739710|Ipilimumab|ipilimumab|mesh-list
5893752|NCT03739710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5893753|NCT03739710|Tubulin Modulators|tubulin modulators|mesh-ancestor
5893754|NCT03739710|Antimitotic Agents|antimitotic agents|mesh-ancestor
5893755|NCT03739710|Mitosis Modulators|mitosis modulators|mesh-ancestor
5893756|NCT03739710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893757|NCT03739710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5893758|NCT03739710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5893759|NCT03709446|Leflunomide|leflunomide|mesh-list
5893760|NCT03709446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5893761|NCT03709446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893762|NCT03709446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5893763|NCT03709446|Immunologic Factors|immunologic factors|mesh-ancestor
5893764|NCT03709446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893765|NCT03683069|Amlodipine|amlodipine|mesh-list
5893766|NCT03683069|Eplerenone|eplerenone|mesh-list
5893767|NCT03683069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5893768|NCT03683069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5893769|NCT03683069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5893770|NCT03683069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893771|NCT03683069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5893772|NCT03683069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620878|NCT05197270|Growth Inhibitors|growth inhibitors|mesh-ancestor
5620879|NCT05197270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5620880|NCT05197192|Venetoclax|venetoclax|mesh-list
5620881|NCT05197192|Obinutuzumab|obinutuzumab|mesh-list
5620882|NCT05197192|Acalabrutinib|acalabrutinib|mesh-list
5620883|NCT05197192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5620884|NCT05197192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5893773|NCT03683069|Vasodilator Agents|vasodilator agents|mesh-ancestor
5893774|NCT03683069|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5893775|NCT03683069|Hormone Antagonists|hormone antagonists|mesh-ancestor
5893776|NCT03683069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5893777|NCT03683069|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5893778|NCT03683069|Diuretics|diuretics|mesh-ancestor
5893779|NCT03683069|Natriuretic Agents|natriuretic agents|mesh-ancestor
5893780|NCT03677115|Dexmedetomidine|dexmedetomidine|mesh-list
5893781|NCT03677115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5893782|NCT03677115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5893783|NCT03677115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893784|NCT03677115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5893785|NCT03677115|Analgesics|analgesics|mesh-ancestor
5893786|NCT03677115|Sensory System Agents|sensory system agents|mesh-ancestor
5893787|NCT03677115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5893788|NCT03677115|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5893789|NCT03677115|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5620885|NCT05197101|Oxytocin|oxytocin|mesh-list
5620886|NCT05197101|Oxytocics|oxytocics|mesh-ancestor
5620887|NCT05197101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5620888|NCT05197101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620889|NCT05197088|Tamsulosin|tamsulosin|mesh-list
5742440|NCT03089073|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
5742441|NCT03089073|Hemostatics|hemostatics|mesh-ancestor
5742442|NCT03089073|Coagulants|coagulants|mesh-ancestor
5742443|NCT03089073|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5742444|NCT03089073|Natriuretic Agents|natriuretic agents|mesh-ancestor
5742445|NCT03089073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742446|NCT03088891|Antioxidants|antioxidants|mesh-list
5742447|NCT03088891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742448|NCT03088891|Protective Agents|protective agents|mesh-ancestor
5742449|NCT03088891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742450|NCT03088826|Acetaminophen|acetaminophen|mesh-list
5742451|NCT03088826|Morphine|morphine|mesh-list
5742452|NCT03088826|Oxycodone|oxycodone|mesh-list
5742453|NCT03088826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5742454|NCT03088826|Narcotics|narcotics|mesh-ancestor
5742455|NCT03088826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5742456|NCT03088826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742457|NCT03088826|Analgesics|analgesics|mesh-ancestor
5742458|NCT03088826|Sensory System Agents|sensory system agents|mesh-ancestor
5742459|NCT03088826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5742460|NCT03088826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5742461|NCT03088826|Antipyretics|antipyretics|mesh-ancestor
5742462|NCT03088852|Magnesium citrate|magnesium citrate|mesh-list
5742463|NCT03088852|Cathartics|cathartics|mesh-ancestor
5742464|NCT03088852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5742465|NCT03088722|Contraceptive Agents|contraceptive agents|mesh-list
5742466|NCT03088722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5742467|NCT03088722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742468|NCT03088631|Metformin|metformin|mesh-list
5742469|NCT03088631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5742470|NCT03088631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742471|NCT03088670|Metformin|metformin|mesh-list
5742472|NCT03088670|Vildagliptin|vildagliptin|mesh-list
5742473|NCT03088670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5742474|NCT03088670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742475|NCT03088670|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5620890|NCT05197088|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5620891|NCT05197088|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5620892|NCT05197088|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5620893|NCT05197088|Adrenergic Agents|adrenergic agents|mesh-ancestor
5620894|NCT05197088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5620895|NCT05197088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620896|NCT05197088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620897|NCT05197088|Urological Agents|urological agents|mesh-ancestor
5620898|NCT05197075|Darunavir|darunavir|mesh-list
5620899|NCT05197075|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5620900|NCT05197075|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5620901|NCT05197075|Protease Inhibitors|protease inhibitors|mesh-ancestor
5620902|NCT05197075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5620903|NCT05197075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620904|NCT05197075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5620905|NCT05197075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5620906|NCT05197075|Antiviral Agents|antiviral agents|mesh-ancestor
5620907|NCT05197075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5620908|NCT05197062|Aticaprant|aticaprant|mesh-list
5620909|NCT05197062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5620910|NCT05197062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620911|NCT05197062|Sensory System Agents|sensory system agents|mesh-ancestor
5620912|NCT05197062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5620913|NCT05196815|Dobutamine|dobutamine|mesh-list
5620914|NCT05196815|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5620915|NCT05196815|Sympathomimetics|sympathomimetics|mesh-ancestor
5620916|NCT05196815|Autonomic Agents|autonomic agents|mesh-ancestor
5620917|NCT05196815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5620918|NCT05196815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620919|NCT05196815|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5620920|NCT05196815|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5620921|NCT05196815|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5620922|NCT05196815|Adrenergic Agents|adrenergic agents|mesh-ancestor
5620923|NCT05196815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5620924|NCT05196815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742476|NCT03088670|Protease Inhibitors|protease inhibitors|mesh-ancestor
5742477|NCT03088670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5620925|NCT05196815|Protective Agents|protective agents|mesh-ancestor
5692546|NCT03406988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5692547|NCT03406936|Midazolam|midazolam|mesh-list
5692548|NCT03406936|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5692549|NCT03406936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5692550|NCT03406936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5692551|NCT03406936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692552|NCT03406936|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5692553|NCT03406936|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5692554|NCT03406936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5692555|NCT03406936|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5742478|NCT03088670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742479|NCT03088709|Mycophenolic Acid|mycophenolic acid|mesh-list
5742480|NCT03088709|Cyclophosphamide|cyclophosphamide|mesh-list
5742481|NCT03088709|Tacrolimus|tacrolimus|mesh-list
5742482|NCT03088709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5742483|NCT03088709|Immunologic Factors|immunologic factors|mesh-ancestor
5742484|NCT03088709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742485|NCT03088709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5742486|NCT03088709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5742487|NCT03088709|Alkylating Agents|alkylating agents|mesh-ancestor
5742488|NCT03088709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742489|NCT03088709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5742490|NCT03088709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5742491|NCT03088709|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5742492|NCT03088709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5742493|NCT03088709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5742494|NCT03088709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5742495|NCT03088709|Antitubercular Agents|antitubercular agents|mesh-ancestor
5742496|NCT03088709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5742497|NCT03088709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5742498|NCT03088644|(18)F-JNJ-64413739|(18)f-jnj-64413739|mesh-list
5742499|NCT03088644|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5742500|NCT03088644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742501|NCT03088358|Enoxaparin|enoxaparin|mesh-list
5742502|NCT03088358|Anticoagulants|anticoagulants|mesh-ancestor
5742503|NCT03088358|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5742504|NCT03088358|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5742505|NCT03088358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742506|NCT03088254|Amlodipine|amlodipine|mesh-list
5742507|NCT03088254|Telmisartan|telmisartan|mesh-list
5742508|NCT03088254|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5742509|NCT03088254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5742510|NCT03088254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5742511|NCT03088254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5742512|NCT03088254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742513|NCT03088254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5742514|NCT03088254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742515|NCT03088254|Vasodilator Agents|vasodilator agents|mesh-ancestor
5742516|NCT03088254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5742517|NCT03088254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5742518|NCT03088254|Antimetabolites|antimetabolites|mesh-ancestor
5742519|NCT03088254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5742520|NCT03088254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5742521|NCT03088254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5742522|NCT03088254|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5742523|NCT03088254|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5742524|NCT03088371|Lidocaine|lidocaine|mesh-list
5742525|NCT03088371|Bupivacaine|bupivacaine|mesh-list
5742526|NCT03088371|Anesthetics, Local|anesthetics, local|mesh-ancestor
5742527|NCT03088371|Anesthetics|anesthetics|mesh-ancestor
5742528|NCT03088371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5742529|NCT03088371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742530|NCT03088371|Sensory System Agents|sensory system agents|mesh-ancestor
5742531|NCT03088371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5742532|NCT03088371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5742533|NCT03088371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5742534|NCT03088371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5742535|NCT03088371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5742536|NCT03088371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742537|NCT03088410|Zidovudine|zidovudine|mesh-list
5742538|NCT03088410|Nevirapine|nevirapine|mesh-list
5742539|NCT03088410|Antimetabolites|antimetabolites|mesh-ancestor
5893790|NCT03677115|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5742540|NCT03088410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742541|NCT03088410|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5742542|NCT03088410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5620926|NCT05196347|Dapagliflozin|dapagliflozin|mesh-list
5620927|NCT05196347|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5620928|NCT05196347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620929|NCT05196347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5620930|NCT05196347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620931|NCT05196308|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
5620932|NCT05196308|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5620933|NCT05196308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5620934|NCT05196308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620935|NCT05196308|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5620936|NCT05196308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5620937|NCT05196308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620938|NCT05196308|Cholinergic Agents|cholinergic agents|mesh-ancestor
5620939|NCT05196308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5620940|NCT05196256|Sufentanil|sufentanil|mesh-list
5620941|NCT05196256|Levobupivacaine|levobupivacaine|mesh-list
5620942|NCT05196256|Anesthetics, Local|anesthetics, local|mesh-ancestor
5620943|NCT05196256|Anesthetics|anesthetics|mesh-ancestor
5620944|NCT05196256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5620945|NCT05196256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620946|NCT05196256|Sensory System Agents|sensory system agents|mesh-ancestor
5620947|NCT05196256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5620948|NCT05196256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5620949|NCT05196256|Narcotics|narcotics|mesh-ancestor
5620950|NCT05196256|Analgesics|analgesics|mesh-ancestor
5620951|NCT05196256|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5620952|NCT05196256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5620953|NCT05196256|Anesthetics, General|anesthetics, general|mesh-ancestor
5620954|NCT05196191|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5620955|NCT05196191|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5620956|NCT05196191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5620957|NCT05196191|Dermatologic Agents|dermatologic agents|mesh-ancestor
5620958|NCT05195996|Propranolol|propranolol|mesh-list
5620959|NCT05195996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5620960|NCT05195996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5620961|NCT05195996|Adrenergic Agents|adrenergic agents|mesh-ancestor
5620962|NCT05195996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5742543|NCT03088410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5742544|NCT03088410|Antiviral Agents|antiviral agents|mesh-ancestor
5742545|NCT03088410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5742546|NCT03088410|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5742547|NCT03088410|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5742548|NCT03088410|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5742549|NCT03088410|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5742550|NCT03088540|Gemcitabine|gemcitabine|mesh-list
5742551|NCT03088540|Paclitaxel|paclitaxel|mesh-list
5742552|NCT03088540|Carboplatin|carboplatin|mesh-list
5742553|NCT03088540|Pemetrexed|pemetrexed|mesh-list
5742554|NCT03088540|Cemiplimab|cemiplimab|mesh-list
5742555|NCT03088540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5742556|NCT03088540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5742557|NCT03088540|Tubulin Modulators|tubulin modulators|mesh-ancestor
5742558|NCT03088540|Antimitotic Agents|antimitotic agents|mesh-ancestor
5742559|NCT03088540|Mitosis Modulators|mitosis modulators|mesh-ancestor
5742560|NCT03088540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742561|NCT03088540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5742562|NCT03088540|Antimetabolites|antimetabolites|mesh-ancestor
5742563|NCT03088540|Antiviral Agents|antiviral agents|mesh-ancestor
5742564|NCT03088540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5742565|NCT03088540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5742566|NCT03088540|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5742567|NCT03088540|Immunologic Factors|immunologic factors|mesh-ancestor
5742568|NCT03088540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742569|NCT03088540|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5742570|NCT03088540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5742571|NCT03088540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5742572|NCT03088280|Thymoglobulin|thymoglobulin|mesh-list
5742573|NCT03088280|Immunologic Factors|immunologic factors|mesh-ancestor
5742574|NCT03088280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620963|NCT05195996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620964|NCT05195996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742575|NCT03088280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5742576|NCT03088306|Acetaminophen|acetaminophen|mesh-list
5742577|NCT03088306|Fentanyl|fentanyl|mesh-list
5742578|NCT03088306|Ketamine|ketamine|mesh-list
5742579|NCT03088306|Gabapentin|gabapentin|mesh-list
5742580|NCT03088306|Hydromorphone|hydromorphone|mesh-list
5742581|NCT03088306|Anesthetics|anesthetics|mesh-ancestor
5742582|NCT03088306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5620965|NCT05195996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5620966|NCT05195996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5620967|NCT05195996|Vasodilator Agents|vasodilator agents|mesh-ancestor
5620968|NCT05195944|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5620969|NCT05195944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5620970|NCT05195944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620971|NCT05195944|Incretins|incretins|mesh-ancestor
5620972|NCT05195944|Hormones|hormones|mesh-ancestor
5620973|NCT05195944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5620974|NCT05195944|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5620975|NCT05195944|Protease Inhibitors|protease inhibitors|mesh-ancestor
5620976|NCT05195944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5620977|NCT05195944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620978|NCT05195918|Pirfenidone|pirfenidone|mesh-list
5620979|NCT05195918|Nintedanib|nintedanib|mesh-list
5620980|NCT05195918|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
5620981|NCT05195918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5742583|NCT03088306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742584|NCT03088306|Analgesics|analgesics|mesh-ancestor
5742585|NCT03088306|Sensory System Agents|sensory system agents|mesh-ancestor
5742586|NCT03088306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5742587|NCT03088306|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5742588|NCT03088306|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5742589|NCT03088306|Anesthetics, General|anesthetics, general|mesh-ancestor
5742590|NCT03088306|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5620982|NCT05195918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5620983|NCT05195918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5620984|NCT05195918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5620985|NCT05195918|Analgesics|analgesics|mesh-ancestor
5620986|NCT05195918|Sensory System Agents|sensory system agents|mesh-ancestor
5620987|NCT05195918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5620988|NCT05195918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5620989|NCT05195918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5620990|NCT05195918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5620991|NCT05195918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5620992|NCT05195918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5620993|NCT05195918|Antioxidants|antioxidants|mesh-ancestor
5620994|NCT05195918|Protective Agents|protective agents|mesh-ancestor
5620995|NCT05195918|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
5620996|NCT05195918|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5620997|NCT05195918|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5620998|NCT05195775|Tadalafil|tadalafil|mesh-list
5620999|NCT05195775|Vasodilator Agents|vasodilator agents|mesh-ancestor
5621000|NCT05195775|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5621001|NCT05195775|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5621002|NCT05195775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5692556|NCT03406936|Anesthetics, General|anesthetics, general|mesh-ancestor
5692557|NCT03406936|Anesthetics|anesthetics|mesh-ancestor
5692558|NCT03406936|GABA Modulators|gaba modulators|mesh-ancestor
5692559|NCT03406936|GABA Agents|gaba agents|mesh-ancestor
5692560|NCT03406936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5692561|NCT03406936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692562|NCT03406871|Nivolumab|nivolumab|mesh-list
5692563|NCT03406871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5692564|NCT03406871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5692565|NCT03406871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5692566|NCT03406871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692567|NCT03406858|Pembrolizumab|pembrolizumab|mesh-list
5692568|NCT03406858|Antibodies, Bispecific|antibodies, bispecific|mesh-list
5692569|NCT03406858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5692570|NCT03406858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5692571|NCT03406858|Immunologic Factors|immunologic factors|mesh-ancestor
5692572|NCT03406858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692573|NCT03406832|Nitroprusside|nitroprusside|mesh-list
5692574|NCT03406832|Tirofiban|tirofiban|mesh-list
5692575|NCT03406832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5692576|NCT03406832|Vasodilator Agents|vasodilator agents|mesh-ancestor
5692577|NCT03406832|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5621003|NCT05195775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5621004|NCT05195775|Urological Agents|urological agents|mesh-ancestor
5621005|NCT05195645|Abatacept|abatacept|mesh-list
5621006|NCT05195645|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5621007|NCT05195645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742591|NCT03088306|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5742592|NCT03088306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5742593|NCT03088306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742594|NCT03088306|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5742595|NCT03088306|Narcotics|narcotics|mesh-ancestor
5742596|NCT03088306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5742597|NCT03088306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5742598|NCT03088306|Antipyretics|antipyretics|mesh-ancestor
5742599|NCT03088306|Anticonvulsants|anticonvulsants|mesh-ancestor
5742600|NCT03088306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5742601|NCT03088306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5742602|NCT03088306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5742603|NCT03088306|Antimanic Agents|antimanic agents|mesh-ancestor
5742604|NCT03088293|Cyclophosphamide|cyclophosphamide|mesh-list
5742605|NCT03088293|Infliximab|infliximab|mesh-list
5742606|NCT03088293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5742607|NCT03088293|Immunologic Factors|immunologic factors|mesh-ancestor
5742608|NCT03088293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742609|NCT03088293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5742610|NCT03088293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5621008|NCT05195645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5621009|NCT05195645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5621010|NCT05195645|Immunologic Factors|immunologic factors|mesh-ancestor
5621011|NCT05195645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742611|NCT03088293|Alkylating Agents|alkylating agents|mesh-ancestor
5742612|NCT03088293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742613|NCT03088293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5742614|NCT03088293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5742615|NCT03088293|Dermatologic Agents|dermatologic agents|mesh-ancestor
5742616|NCT03088293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5742617|NCT03087968|Prednisolone|prednisolone|mesh-list
5742618|NCT03087968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5742619|NCT03087968|Glucocorticoids|glucocorticoids|mesh-ancestor
5742620|NCT03087968|Hormones|hormones|mesh-ancestor
5742621|NCT03087968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5742622|NCT03087968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742623|NCT03087968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5742624|NCT03087968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5742625|NCT03087942|Indoleacetic Acids|indoleacetic acids|mesh-list
5742626|NCT03087942|Plant Growth Regulators|plant growth regulators|mesh-ancestor
5742627|NCT03087942|Growth Substances|growth substances|mesh-ancestor
5742628|NCT03087942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742629|NCT03088046|Progesterone|progesterone|mesh-list
5742630|NCT03088046|Progestins|progestins|mesh-ancestor
5742631|NCT03088046|Hormones|hormones|mesh-ancestor
5742632|NCT03088046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5742633|NCT03088046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742634|NCT03088384|Ketamine|ketamine|mesh-list
5742635|NCT03088384|Analgesics|analgesics|mesh-ancestor
5742636|NCT03088384|Sensory System Agents|sensory system agents|mesh-ancestor
5742637|NCT03088384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5742638|NCT03088384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742639|NCT03088384|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5742640|NCT03088384|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5742641|NCT03088384|Anesthetics, General|anesthetics, general|mesh-ancestor
5742642|NCT03088384|Anesthetics|anesthetics|mesh-ancestor
5742643|NCT03088384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5742644|NCT03088384|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5742645|NCT03088384|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5742646|NCT03088384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5742647|NCT03088384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742648|NCT03088176|Trametinib|trametinib|mesh-list
5742649|NCT03088176|Dabrafenib|dabrafenib|mesh-list
5742650|NCT03088176|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
5742651|NCT03088176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5742652|NCT03088176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5742653|NCT03088176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5742654|NCT03088176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742655|NCT03088176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5742656|NCT03088072|Aspirin|aspirin|mesh-list
5742657|NCT03088072|Warfarin|warfarin|mesh-list
5742658|NCT03088072|Edoxaban|edoxaban|mesh-list
5742659|NCT03088072|Clopidogrel|clopidogrel|mesh-list
5742660|NCT03088072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5742661|NCT03088072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5742662|NCT03088072|Analgesics|analgesics|mesh-ancestor
5621012|NCT05195645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5621013|NCT05195619|Cyclophosphamide|cyclophosphamide|mesh-list
5621014|NCT05195619|Vaccines|vaccines|mesh-list
5742663|NCT03088072|Sensory System Agents|sensory system agents|mesh-ancestor
5621015|NCT05195619|Immunologic Factors|immunologic factors|mesh-ancestor
5621016|NCT05195619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621017|NCT05195619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5621018|NCT05195619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5621019|NCT05195619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5621020|NCT05195619|Alkylating Agents|alkylating agents|mesh-ancestor
5621021|NCT05195619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5621022|NCT05195619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5621023|NCT05195619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5621033|NCT05195294|Lenvatinib|lenvatinib|mesh-list
5621034|NCT05195294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5621035|NCT05195294|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5621036|NCT05195294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5621037|NCT05195294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5621038|NCT05195177|Anesthetics|anesthetics|mesh-list
5621039|NCT05195177|Anesthetics, Local|anesthetics, local|mesh-list
5621040|NCT05195177|Histamine|histamine|mesh-list
5621041|NCT05195177|Histamine Antagonists|histamine antagonists|mesh-list
5621042|NCT05195177|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
5621043|NCT05195177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5621044|NCT05195177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621045|NCT05195177|Sensory System Agents|sensory system agents|mesh-ancestor
5621046|NCT05195177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5621047|NCT05195177|Histamine Agonists|histamine agonists|mesh-ancestor
5621048|NCT05195177|Histamine Agents|histamine agents|mesh-ancestor
5621049|NCT05195177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5621050|NCT05195177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5621051|NCT05195086|Mycophenolic Acid|mycophenolic acid|mesh-list
5621052|NCT05195086|Cyclophosphamide|cyclophosphamide|mesh-list
5621053|NCT05195086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5621054|NCT05195086|Immunologic Factors|immunologic factors|mesh-ancestor
5621055|NCT05195086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621056|NCT05195086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5621057|NCT05195086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5621058|NCT05195086|Alkylating Agents|alkylating agents|mesh-ancestor
5621059|NCT05195086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5621060|NCT05195086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5621061|NCT05195086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5621062|NCT05195086|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5621063|NCT05195086|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5621064|NCT05195086|Antitubercular Agents|antitubercular agents|mesh-ancestor
5621065|NCT05195086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5621066|NCT05195086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5621067|NCT05195086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5621068|NCT05195034|Dexmedetomidine|dexmedetomidine|mesh-list
5621069|NCT05195034|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5621070|NCT05195034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5621071|NCT05195034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621072|NCT05195034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5621073|NCT05195034|Analgesics|analgesics|mesh-ancestor
5621074|NCT05195034|Sensory System Agents|sensory system agents|mesh-ancestor
5621075|NCT05195034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5621076|NCT05195034|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5621077|NCT05195034|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5742664|NCT03088072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5742665|NCT03088072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742666|NCT03088072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5742667|NCT03088072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5742668|NCT03088072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5742669|NCT03088072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5742670|NCT03088072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742671|NCT03088072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5742672|NCT03088072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5742673|NCT03088072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5742674|NCT03088072|Antipyretics|antipyretics|mesh-ancestor
5742675|NCT03088072|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5742676|NCT03088072|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5742677|NCT03088072|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5742678|NCT03088072|Purinergic Agents|purinergic agents|mesh-ancestor
5742679|NCT03088072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5742680|NCT03088072|Anticoagulants|anticoagulants|mesh-ancestor
5742681|NCT03088072|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5742682|NCT03088072|Antithrombins|antithrombins|mesh-ancestor
5621078|NCT05195034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5621079|NCT05195034|Adrenergic Agents|adrenergic agents|mesh-ancestor
5621080|NCT05195034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5621081|NCT05195034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742683|NCT03088072|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5742684|NCT03088072|Protease Inhibitors|protease inhibitors|mesh-ancestor
5742685|NCT03087890|Trimethoprim|trimethoprim|mesh-list
5742686|NCT03087890|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
5742687|NCT03087890|Sulfamethoxazole|sulfamethoxazole|mesh-list
5742688|NCT03087890|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5742689|NCT03087890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5742690|NCT03087890|Renal Agents|renal agents|mesh-ancestor
5742691|NCT03087890|Antimalarials|antimalarials|mesh-ancestor
5742692|NCT03087890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5742693|NCT03087890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5742694|NCT03087890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5742695|NCT03087890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5742696|NCT03087890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5621082|NCT05194995|Cetuximab|cetuximab|mesh-list
5621083|NCT05194995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5621084|NCT05194995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5692578|NCT03406832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742697|NCT03087890|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5742698|NCT03087890|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
5742699|NCT03087890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5742700|NCT03087890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5742701|NCT03087903|Grape Seed Extract|grape seed extract|mesh-list
5742702|NCT03087903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5742703|NCT03087903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5742704|NCT03087903|Antioxidants|antioxidants|mesh-ancestor
5742705|NCT03087903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742706|NCT03087903|Protective Agents|protective agents|mesh-ancestor
5742707|NCT03087903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742708|NCT03087877|Acetaminophen|acetaminophen|mesh-list
5742709|NCT03087877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5742710|NCT03087877|Analgesics|analgesics|mesh-ancestor
5742711|NCT03087877|Sensory System Agents|sensory system agents|mesh-ancestor
5742712|NCT03087877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5742713|NCT03087877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742714|NCT03087877|Antipyretics|antipyretics|mesh-ancestor
5742715|NCT03087864|Paclitaxel|paclitaxel|mesh-list
5742716|NCT03087864|Carboplatin|carboplatin|mesh-list
5742717|NCT03087864|Atezolizumab|atezolizumab|mesh-list
5742718|NCT03087864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5742719|NCT03087864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5742720|NCT03087864|Tubulin Modulators|tubulin modulators|mesh-ancestor
5742721|NCT03087864|Antimitotic Agents|antimitotic agents|mesh-ancestor
5742722|NCT03087864|Mitosis Modulators|mitosis modulators|mesh-ancestor
5742723|NCT03087864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742724|NCT03087669|Norepinephrine|norepinephrine|mesh-list
5742725|NCT03087669|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5742726|NCT03087669|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5742727|NCT03087669|Adrenergic Agents|adrenergic agents|mesh-ancestor
5742728|NCT03087669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5742729|NCT03087669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742730|NCT03087669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742731|NCT03087669|Sympathomimetics|sympathomimetics|mesh-ancestor
5742732|NCT03087669|Autonomic Agents|autonomic agents|mesh-ancestor
5621085|NCT05194969|Petrolatum|petrolatum|mesh-list
5621086|NCT05194969|Emollients|emollients|mesh-ancestor
5621087|NCT05194969|Dermatologic Agents|dermatologic agents|mesh-ancestor
5621088|NCT05194904|Ketorolac|ketorolac|mesh-list
5621089|NCT05194904|Dexmedetomidine|dexmedetomidine|mesh-list
5742733|NCT03087669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5742734|NCT03087669|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5742735|NCT03087578|Mirabegron|mirabegron|mesh-list
5742736|NCT03087578|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
5742737|NCT03087578|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5742738|NCT03087578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5742739|NCT03087578|Adrenergic Agents|adrenergic agents|mesh-ancestor
5742740|NCT03087578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5742741|NCT03087578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742742|NCT03087578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742743|NCT03087578|Urological Agents|urological agents|mesh-ancestor
5742744|NCT03087539|Abciximab|abciximab|mesh-list
5742745|NCT03087539|Anticoagulants|anticoagulants|mesh-ancestor
5742746|NCT03087539|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5742747|NCT03087708|Naloxegol|naloxegol|mesh-list
5742748|NCT03087708|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5742749|NCT03087708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742750|NCT03087708|Sensory System Agents|sensory system agents|mesh-ancestor
5742751|NCT03087708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5893791|NCT03677115|Adrenergic Agents|adrenergic agents|mesh-ancestor
5893792|NCT03677115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5893793|NCT03677115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893794|NCT03673228|Nicotine|nicotine|mesh-list
5893795|NCT03673228|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5893796|NCT03673228|Autonomic Agents|autonomic agents|mesh-ancestor
5893797|NCT03673228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5893798|NCT03673228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893799|NCT03673228|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5893800|NCT03673228|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5893801|NCT03673228|Cholinergic Agents|cholinergic agents|mesh-ancestor
5893802|NCT03673228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5893803|NCT03673228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893804|NCT03589326|Cytarabine|cytarabine|mesh-list
5893805|NCT03589326|Dexamethasone|dexamethasone|mesh-list
5893806|NCT03589326|Prednisone|prednisone|mesh-list
5893807|NCT03589326|Methotrexate|methotrexate|mesh-list
5893808|NCT03589326|Vincristine|vincristine|mesh-list
5893809|NCT03589326|Imatinib Mesylate|imatinib mesylate|mesh-list
5621090|NCT05194904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5621091|NCT05194904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5621092|NCT05194904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621093|NCT05194904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5893810|NCT03589326|Ponatinib|ponatinib|mesh-list
5893811|NCT03589326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5893812|NCT03589326|Antiemetics|antiemetics|mesh-ancestor
5893813|NCT03589326|Autonomic Agents|autonomic agents|mesh-ancestor
5893814|NCT03589326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5893815|NCT03589326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893816|NCT03589326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5893817|NCT03589326|Glucocorticoids|glucocorticoids|mesh-ancestor
5893818|NCT03589326|Hormones|hormones|mesh-ancestor
5893819|NCT03589326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5893820|NCT03589326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5893821|NCT03589326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5621094|NCT05194904|Analgesics|analgesics|mesh-ancestor
5893822|NCT03589326|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5742752|NCT03087201|Nabiximols|nabiximols|mesh-list
5742753|NCT03087201|Analgesics|analgesics|mesh-ancestor
5742754|NCT03087201|Sensory System Agents|sensory system agents|mesh-ancestor
5742755|NCT03087201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5742756|NCT03087201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742757|NCT03087032|Insulin Glargine|insulin glargine|mesh-list
5742758|NCT03087032|Liraglutide|liraglutide|mesh-list
5742759|NCT03087032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5742760|NCT03087032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742761|NCT03087032|Incretins|incretins|mesh-ancestor
5621095|NCT05194904|Sensory System Agents|sensory system agents|mesh-ancestor
5621096|NCT05194904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5621097|NCT05194904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5621098|NCT05194904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5621099|NCT05194904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5742762|NCT03087032|Hormones|hormones|mesh-ancestor
5742763|NCT03087032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5742764|NCT03087162|Dexlansoprazole|dexlansoprazole|mesh-list
5742765|NCT03087162|Lansoprazole|lansoprazole|mesh-list
5742766|NCT03087162|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5742767|NCT03087162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5742768|NCT03087162|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5742769|NCT03087162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5742770|NCT03087162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742771|NCT03087149|Vitamin D|vitamin d|mesh-list
5742772|NCT03087149|Vitamins|vitamins|mesh-ancestor
5742773|NCT03087149|Micronutrients|micronutrients|mesh-ancestor
5742774|NCT03087149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742775|NCT03087149|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5742776|NCT03087136|polysaccharide-K|polysaccharide-k|mesh-list
5742777|NCT03087136|Antibodies|antibodies|mesh-list
5742778|NCT03087136|Immunologic Factors|immunologic factors|mesh-ancestor
5742779|NCT03087136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742780|NCT03087136|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5742781|NCT03087136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5742782|NCT03087136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5621100|NCT05194904|Adrenergic Agents|adrenergic agents|mesh-ancestor
5621101|NCT05194904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5621102|NCT05194904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5621103|NCT05194904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5621104|NCT05194904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5742783|NCT03087136|Antiviral Agents|antiviral agents|mesh-ancestor
5742784|NCT03087136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5742785|NCT03087136|Interferon Inducers|interferon inducers|mesh-ancestor
5621105|NCT05194904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5621106|NCT05194904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5621107|NCT05194904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5621108|NCT05194852|Anesthetics|anesthetics|mesh-list
5621109|NCT05194852|Anesthetics, Local|anesthetics, local|mesh-list
5621110|NCT05194852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5621111|NCT05194852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621112|NCT05194852|Sensory System Agents|sensory system agents|mesh-ancestor
5621113|NCT05194852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5621114|NCT05194592|Dapagliflozin|dapagliflozin|mesh-list
5621115|NCT05194592|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5621116|NCT05194592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5621117|NCT05194592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5621118|NCT05194592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742786|NCT03087136|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5742787|NCT03087136|Protective Agents|protective agents|mesh-ancestor
5742788|NCT03086993|Gemcitabine|gemcitabine|mesh-list
5742789|NCT03086993|Melphalan|melphalan|mesh-list
5742790|NCT03086993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5742791|NCT03086993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5742792|NCT03086993|Antimetabolites|antimetabolites|mesh-ancestor
5742793|NCT03086993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742794|NCT03086993|Antiviral Agents|antiviral agents|mesh-ancestor
5742795|NCT03086993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5742796|NCT03086993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5742797|NCT03086993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5742798|NCT03086993|Immunologic Factors|immunologic factors|mesh-ancestor
5742799|NCT03086993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742800|NCT03086993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5742801|NCT03086993|Alkylating Agents|alkylating agents|mesh-ancestor
5742802|NCT03086993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5621119|NCT05194449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
5621120|NCT05194449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5742803|NCT03087071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5742804|NCT03087071|Panitumumab|panitumumab|mesh-list
5742805|NCT03087071|Trametinib|trametinib|mesh-list
5742806|NCT03087071|Antibodies|antibodies|mesh-list
5742807|NCT03087071|Immunoglobulins|immunoglobulins|mesh-list
5742808|NCT03087071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5742809|NCT03087071|Immunologic Factors|immunologic factors|mesh-ancestor
5742810|NCT03087071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742811|NCT03087071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5742812|NCT03087071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5742813|NCT03087071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5742814|NCT03087071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742815|NCT03086642|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
5742816|NCT03086642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5742817|NCT03086642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5742818|NCT03086720|Sodium Hypochlorite|sodium hypochlorite|mesh-list
5742819|NCT03086720|Eusol|eusol|mesh-list
5742820|NCT03086720|Disinfectants|disinfectants|mesh-ancestor
5742821|NCT03086720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5742822|NCT03086681|Cisplatin|cisplatin|mesh-list
5742823|NCT03086681|Endostar protein|endostar protein|mesh-list
5742824|NCT03086681|Endostatins|endostatins|mesh-list
5742825|NCT03086681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5742826|NCT03086681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5742827|NCT03086681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5742828|NCT03086681|Growth Substances|growth substances|mesh-ancestor
5742829|NCT03086681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742830|NCT03086681|Growth Inhibitors|growth inhibitors|mesh-ancestor
5742831|NCT03086759|Triamcinolone|triamcinolone|mesh-list
5742832|NCT03086759|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5742833|NCT03086759|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5742834|NCT03086759|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5742835|NCT03086759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5742836|NCT03086759|Glucocorticoids|glucocorticoids|mesh-ancestor
5742837|NCT03086759|Hormones|hormones|mesh-ancestor
5742838|NCT03086759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5742839|NCT03086759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742840|NCT03086759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5742841|NCT03086759|Immunologic Factors|immunologic factors|mesh-ancestor
5742842|NCT03086759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5742843|NCT03086759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742844|NCT03086733|Metformin|metformin|mesh-list
5742845|NCT03086733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5742846|NCT03086733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742847|NCT03086785|Apatinib|apatinib|mesh-list
5621121|NCT05194449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621122|NCT05194397|Niacinamide|niacinamide|mesh-list
5621123|NCT05194397|Niacin|niacin|mesh-list
5621124|NCT05194397|Nicotinic Acids|nicotinic acids|mesh-list
5621125|NCT05194397|Vitamin B Complex|vitamin b complex|mesh-ancestor
5621126|NCT05194397|Vitamins|vitamins|mesh-ancestor
5621127|NCT05194397|Micronutrients|micronutrients|mesh-ancestor
5621128|NCT05194397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621129|NCT05194397|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5621130|NCT05194397|Antimetabolites|antimetabolites|mesh-ancestor
5621131|NCT05194397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5621132|NCT05194397|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5621133|NCT05194397|Vasodilator Agents|vasodilator agents|mesh-ancestor
5621134|NCT05194046|Amoxicillin|amoxicillin|mesh-list
5621135|NCT05194046|Clarithromycin|clarithromycin|mesh-list
5621136|NCT05194046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5621137|NCT05194046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5621138|NCT05194046|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5621139|NCT05194046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5621140|NCT05194046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5621141|NCT05194046|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5621142|NCT05194046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5621143|NCT05193994|Lamivudine|lamivudine|mesh-list
5742848|NCT03086785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5742849|NCT03086785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5742850|NCT03086785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5621144|NCT05193994|Abacavir|abacavir|mesh-list
5893823|NCT03589326|Abortifacient Agents|abortifacient agents|mesh-ancestor
5621145|NCT05193994|Dolutegravir|dolutegravir|mesh-list
5621146|NCT05193994|Triumeq|triumeq|mesh-list
5621147|NCT05193994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5742851|NCT03086785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742852|NCT03086382|Lacosamide|lacosamide|mesh-list
5742853|NCT03086382|Anticonvulsants|anticonvulsants|mesh-ancestor
5742854|NCT03086382|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5621148|NCT05193994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5621149|NCT05193994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5621150|NCT05193994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742855|NCT03086382|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5742856|NCT03086382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5742857|NCT03086382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742858|NCT03086538|Pemetrexed|pemetrexed|mesh-list
5742859|NCT03086538|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5742860|NCT03086538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5742861|NCT03086538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5742862|NCT03086538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742863|NCT03086538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5742864|NCT03086538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5742865|NCT03086538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5742866|NCT03086226|Itraconazole|itraconazole|mesh-list
5742867|NCT03086226|Antifungal Agents|antifungal agents|mesh-ancestor
5742868|NCT03086226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5742869|NCT03086226|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5742870|NCT03086226|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5742871|NCT03086226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5742872|NCT03086226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742873|NCT03086226|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5742874|NCT03086226|Hormone Antagonists|hormone antagonists|mesh-ancestor
5742875|NCT03086226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5621151|NCT05193994|Antiviral Agents|antiviral agents|mesh-ancestor
5621152|NCT05193994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5621153|NCT05193994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5621154|NCT05193994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5621155|NCT05193994|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5621156|NCT05193994|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5621157|NCT05193851|Ricolinostat|ricolinostat|mesh-list
5621158|NCT05193851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5621159|NCT05193851|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5621160|NCT05193851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5621161|NCT05193851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5621162|NCT05193838|Allopurinol|allopurinol|mesh-list
5621163|NCT05193838|Antimetabolites|antimetabolites|mesh-ancestor
5621164|NCT05193838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5621165|NCT05193838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5621166|NCT05193838|Gout Suppressants|gout suppressants|mesh-ancestor
5621167|NCT05193838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5742876|NCT03086226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742877|NCT03086226|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5742878|NCT03086291|Simvastatin|simvastatin|mesh-list
5742879|NCT03086291|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5742880|NCT03086291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5742881|NCT03086291|Antimetabolites|antimetabolites|mesh-ancestor
5742882|NCT03086291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5621168|NCT05193838|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5621169|NCT05193838|Antioxidants|antioxidants|mesh-ancestor
5621170|NCT05193838|Protective Agents|protective agents|mesh-ancestor
5621171|NCT05193838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621172|NCT05193747|Anesthetics|anesthetics|mesh-list
5621173|NCT05193747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5621174|NCT05193747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621175|NCT05193734|Hemagglutinins|hemagglutinins|mesh-list
5621176|NCT05193734|Agglutinins|agglutinins|mesh-ancestor
5621177|NCT05193734|Immunologic Factors|immunologic factors|mesh-ancestor
5621178|NCT05193734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621179|NCT05193604|Gemcitabine|gemcitabine|mesh-list
5621180|NCT05193604|Paclitaxel|paclitaxel|mesh-list
5621181|NCT05193604|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5621182|NCT05193604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5621183|NCT05193604|Tubulin Modulators|tubulin modulators|mesh-ancestor
5621184|NCT05193604|Antimitotic Agents|antimitotic agents|mesh-ancestor
5621185|NCT05193604|Mitosis Modulators|mitosis modulators|mesh-ancestor
5621186|NCT05193604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692579|NCT03406832|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5742883|NCT03086291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5742884|NCT03086291|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5742885|NCT03086291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5742886|NCT03086564|Chlorotrianisene|chlorotrianisene|mesh-list
5742887|NCT03086564|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
5742888|NCT03086564|Estrogens|estrogens|mesh-ancestor
5742889|NCT03086564|Hormones|hormones|mesh-ancestor
5742890|NCT03086564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5621187|NCT05193604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5621188|NCT05193604|Antimetabolites|antimetabolites|mesh-ancestor
5621189|NCT05193604|Antiviral Agents|antiviral agents|mesh-ancestor
5621190|NCT05193604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5621191|NCT05193604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5621192|NCT05193604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5742891|NCT03086564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742892|NCT03086564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5742893|NCT03086564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5742894|NCT03086395|Obinutuzumab|obinutuzumab|mesh-list
5742895|NCT03086395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5742896|NCT03086395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5742897|NCT03086473|Caffeine|caffeine|mesh-list
5742898|NCT03086473|Caffeine citrate|caffeine citrate|mesh-list
5742899|NCT03086473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742900|NCT03086473|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5742901|NCT03086473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742902|NCT03086473|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5742903|NCT03086473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5742904|NCT03086473|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5742905|NCT03086473|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5742906|NCT03086473|Purinergic Agents|purinergic agents|mesh-ancestor
5742907|NCT03086473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5742908|NCT03086915|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
5742909|NCT03086915|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5742910|NCT03086915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5742911|NCT03086915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742912|NCT03086174|Antibodies|antibodies|mesh-list
5742913|NCT03086174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5742914|NCT03086174|Immunologic Factors|immunologic factors|mesh-ancestor
5742915|NCT03086174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742916|NCT03085992|Bevacizumab|bevacizumab|mesh-list
5742917|NCT03085992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5742918|NCT03085992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5742919|NCT03085992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5742920|NCT03085992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5742921|NCT03085992|Growth Substances|growth substances|mesh-ancestor
5742922|NCT03085992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742923|NCT03085992|Growth Inhibitors|growth inhibitors|mesh-ancestor
5742924|NCT03086044|Sofosbuvir|sofosbuvir|mesh-list
5742925|NCT03086044|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
5621193|NCT05193604|Immunologic Factors|immunologic factors|mesh-ancestor
5621194|NCT05193604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621195|NCT05193552|gamma-Globulins|gamma-globulins|mesh-list
5621196|NCT05193552|Immunologic Factors|immunologic factors|mesh-ancestor
5621197|NCT05193552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621198|NCT05193253|Liver Extracts|liver extracts|mesh-list
5621199|NCT05193253|Hematinics|hematinics|mesh-ancestor
5621200|NCT05190445|Paclitaxel|paclitaxel|mesh-list
5621201|NCT05190445|Ramucirumab|ramucirumab|mesh-list
5621202|NCT05190445|Tucatinib|tucatinib|mesh-list
5621203|NCT05190445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5621204|NCT05190445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5621205|NCT05190445|Tubulin Modulators|tubulin modulators|mesh-ancestor
5621206|NCT05190445|Antimitotic Agents|antimitotic agents|mesh-ancestor
5621207|NCT05190445|Mitosis Modulators|mitosis modulators|mesh-ancestor
5621208|NCT05190445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5621209|NCT05190445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5621210|NCT05190445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5621211|NCT05188508|Pembrolizumab|pembrolizumab|mesh-list
5621212|NCT05188508|Temozolomide|temozolomide|mesh-list
5621213|NCT05188508|Olaparib|olaparib|mesh-list
5621214|NCT05188508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5621215|NCT05188508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5621216|NCT05188508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5621217|NCT05188508|Alkylating Agents|alkylating agents|mesh-ancestor
5692580|NCT03406832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5742926|NCT03086044|Velpatasvir|velpatasvir|mesh-list
5742927|NCT03086044|Antiviral Agents|antiviral agents|mesh-ancestor
5742928|NCT03086044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5742929|NCT03086005|Metformin|metformin|mesh-list
5742930|NCT03086005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5742931|NCT03086005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742932|NCT03086070|Omeprazole|omeprazole|mesh-list
5742933|NCT03086070|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5742934|NCT03086070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5742935|NCT03086070|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5742936|NCT03086070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5742937|NCT03086070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742938|NCT03085940|Hydroxychloroquine|hydroxychloroquine|mesh-list
5742939|NCT03085940|Antimalarials|antimalarials|mesh-ancestor
5742940|NCT03085940|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5742941|NCT03085940|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5742942|NCT03085940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5742943|NCT03085940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5742944|NCT03085940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742945|NCT03085940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5742946|NCT03086148|Ketamine|ketamine|mesh-list
5742947|NCT03086148|Analgesics|analgesics|mesh-ancestor
5742948|NCT03086148|Sensory System Agents|sensory system agents|mesh-ancestor
5742949|NCT03086148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5742950|NCT03086148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742951|NCT03086148|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5742952|NCT03086148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5742953|NCT03086148|Anesthetics, General|anesthetics, general|mesh-ancestor
5742954|NCT03086148|Anesthetics|anesthetics|mesh-ancestor
5742955|NCT03086148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5742956|NCT03086148|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5742957|NCT03086148|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5742958|NCT03086148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5742959|NCT03086148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742960|NCT03085654|Oxytocin|oxytocin|mesh-list
5742961|NCT03085654|Oxytocics|oxytocics|mesh-ancestor
5742962|NCT03085654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5742963|NCT03085654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621218|NCT05188508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5621219|NCT05188508|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5621220|NCT05188508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5692581|NCT03406832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5692582|NCT03406819|Nitroprusside|nitroprusside|mesh-list
5692583|NCT03406819|Tirofiban|tirofiban|mesh-list
5692584|NCT03406819|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5692585|NCT03406819|Vasodilator Agents|vasodilator agents|mesh-ancestor
5692586|NCT03406819|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5692587|NCT03406819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692588|NCT03406819|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5692589|NCT03406819|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5893824|NCT03589326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5893825|NCT03589326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5893826|NCT03589326|Antimetabolites|antimetabolites|mesh-ancestor
5893827|NCT03589326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893828|NCT03589326|Dermatologic Agents|dermatologic agents|mesh-ancestor
5893829|NCT03589326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5893830|NCT03589326|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5893831|NCT03589326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5893832|NCT03589326|Immunologic Factors|immunologic factors|mesh-ancestor
5893833|NCT03589326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5893834|NCT03589326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5893835|NCT03589326|Antiviral Agents|antiviral agents|mesh-ancestor
5893836|NCT03589326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5893837|NCT03589326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5893838|NCT03589326|Tubulin Modulators|tubulin modulators|mesh-ancestor
5893839|NCT03589326|Antimitotic Agents|antimitotic agents|mesh-ancestor
5893840|NCT03589326|Mitosis Modulators|mitosis modulators|mesh-ancestor
5893841|NCT03589326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5893842|NCT03575403|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5893843|NCT03575403|Methylphenidate|methylphenidate|mesh-list
5893844|NCT03575403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5893845|NCT03575403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893846|NCT03575403|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5893847|NCT03575403|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5621221|NCT05176158|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
5621222|NCT05176158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5621223|NCT05176158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5621224|NCT05176158|Analgesics|analgesics|mesh-ancestor
5621225|NCT05176158|Sensory System Agents|sensory system agents|mesh-ancestor
5621226|NCT05176158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5621227|NCT05176158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621228|NCT05176158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5621229|NCT05176158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5621230|NCT05173597|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5621231|NCT05173597|Hormones|hormones|mesh-ancestor
5621232|NCT05173597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5742964|NCT03085628|Oxytocin|oxytocin|mesh-list
5742965|NCT03085628|Oxytocics|oxytocics|mesh-ancestor
5742966|NCT03085628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5742967|NCT03085628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742968|NCT03085771|Deferoxamine|deferoxamine|mesh-list
5742969|NCT03085771|Siderophores|siderophores|mesh-ancestor
5742970|NCT03085771|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5742971|NCT03085771|Chelating Agents|chelating agents|mesh-ancestor
5742972|NCT03085771|Sequestering Agents|sequestering agents|mesh-ancestor
5742973|NCT03085771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5742974|NCT03085784|Aflibercept|aflibercept|mesh-list
5742975|NCT03085784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5742976|NCT03085784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5742977|NCT03085784|Growth Substances|growth substances|mesh-ancestor
5742978|NCT03085784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742979|NCT03085784|Growth Inhibitors|growth inhibitors|mesh-ancestor
5742980|NCT03085784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5742981|NCT03085849|Durvalumab|durvalumab|mesh-list
5742982|NCT03085849|Tremelimumab|tremelimumab|mesh-list
5742983|NCT03085849|Guadecitabine|guadecitabine|mesh-list
5621233|NCT05173597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621234|NCT05172999|Levonorgestrel|levonorgestrel|mesh-list
5621235|NCT05172999|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5621236|NCT05172999|Contraceptive Agents|contraceptive agents|mesh-ancestor
5621237|NCT05172999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5621238|NCT05172999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621239|NCT05172999|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5621240|NCT05172999|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5621241|NCT05172999|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5621242|NCT05171777|Atezolizumab|atezolizumab|mesh-list
5621243|NCT05171777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5621244|NCT05170763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5621245|NCT05170464|Caffeine|caffeine|mesh-list
5621246|NCT05170464|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5621247|NCT05170464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742984|NCT03085849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5742985|NCT03085849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5742986|NCT03085823|Sirolimus|sirolimus|mesh-list
5742987|NCT03085823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5742988|NCT03085823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5742989|NCT03085823|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5742990|NCT03085823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5742991|NCT03085823|Antifungal Agents|antifungal agents|mesh-ancestor
5742992|NCT03085823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5742993|NCT03085823|Immunologic Factors|immunologic factors|mesh-ancestor
5742994|NCT03085823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5742995|NCT03085563|Midazolam|midazolam|mesh-list
5742996|NCT03085563|Nitrous Oxide|nitrous oxide|mesh-list
5742997|NCT03085563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5742998|NCT03085563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5742999|NCT03085563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5743000|NCT03085563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743001|NCT03085563|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5743002|NCT03085563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5743003|NCT03085563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5743004|NCT03085563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5743005|NCT03085563|Anesthetics, General|anesthetics, general|mesh-ancestor
5743006|NCT03085563|Anesthetics|anesthetics|mesh-ancestor
5743007|NCT03085563|GABA Modulators|gaba modulators|mesh-ancestor
5743008|NCT03085563|GABA Agents|gaba agents|mesh-ancestor
5743009|NCT03085563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5743010|NCT03085563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743011|NCT03085563|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5743012|NCT03085563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5621248|NCT05170464|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5621249|NCT05170464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5621250|NCT05170464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5621251|NCT05170464|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5621252|NCT05170464|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5621253|NCT05170464|Purinergic Agents|purinergic agents|mesh-ancestor
5621254|NCT05170464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5621255|NCT05170438|Paclitaxel|paclitaxel|mesh-list
5621256|NCT05170438|Lenvatinib|lenvatinib|mesh-list
5621257|NCT05170438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5621258|NCT05170438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5621259|NCT05170438|Tubulin Modulators|tubulin modulators|mesh-ancestor
5621260|NCT05170438|Antimitotic Agents|antimitotic agents|mesh-ancestor
5621261|NCT05170438|Mitosis Modulators|mitosis modulators|mesh-ancestor
5621262|NCT05170438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5621263|NCT05170438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5621264|NCT05170438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5621265|NCT05168865|Letrozole|letrozole|mesh-list
5621266|NCT05168865|Estradiol|estradiol|mesh-list
5621267|NCT05168865|Progesterone|progesterone|mesh-list
5621268|NCT05168865|Estrogens|estrogens|mesh-ancestor
5743013|NCT03085563|Analgesics|analgesics|mesh-ancestor
5743014|NCT03085563|Sensory System Agents|sensory system agents|mesh-ancestor
5743015|NCT03085563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5743016|NCT03085225|Durvalumab|durvalumab|mesh-list
5743017|NCT03085225|Trabectedin|trabectedin|mesh-list
5743018|NCT03085225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5743019|NCT03085225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5743020|NCT03085225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5743021|NCT03085225|Alkylating Agents|alkylating agents|mesh-ancestor
5743022|NCT03085225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743023|NCT03085485|Ivacaftor|ivacaftor|mesh-list
5743024|NCT03085485|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
5743025|NCT03085485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5743026|NCT03085485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743027|NCT03085368|Trastuzumab|trastuzumab|mesh-list
5743028|NCT03085368|Lapatinib|lapatinib|mesh-list
5743029|NCT03085368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5743030|NCT03085368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5743031|NCT03085368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5743032|NCT03085368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5743033|NCT03085368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743034|NCT03085290|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5743035|NCT03085290|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5743036|NCT03085394|Tranexamic Acid|tranexamic acid|mesh-list
5743037|NCT03085394|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5743038|NCT03085394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5743039|NCT03085394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743040|NCT03085394|Hemostatics|hemostatics|mesh-ancestor
5743041|NCT03085394|Coagulants|coagulants|mesh-ancestor
5743042|NCT03085186|Crizotinib|crizotinib|mesh-list
5743043|NCT03085186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5743044|NCT03085186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5743045|NCT03085186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5743046|NCT03085186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743047|NCT03085056|Paclitaxel|paclitaxel|mesh-list
5743048|NCT03085056|Trametinib|trametinib|mesh-list
5743049|NCT03085056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5743050|NCT03085056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5621269|NCT05168865|Hormones|hormones|mesh-ancestor
5621270|NCT05168865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5621271|NCT05168865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621272|NCT05168865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5621273|NCT05168865|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5621274|NCT05168865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5621275|NCT05168865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5621276|NCT05168865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5621277|NCT05168865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5621278|NCT05168865|Hormone Antagonists|hormone antagonists|mesh-ancestor
5621279|NCT05168865|Progestins|progestins|mesh-ancestor
5621280|NCT05165251|Amlodipine|amlodipine|mesh-list
5743051|NCT03085056|Tubulin Modulators|tubulin modulators|mesh-ancestor
5743052|NCT03085056|Antimitotic Agents|antimitotic agents|mesh-ancestor
5621281|NCT05165251|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
5621282|NCT05165251|Atorvastatin|atorvastatin|mesh-list
5743053|NCT03085056|Mitosis Modulators|mitosis modulators|mesh-ancestor
5743054|NCT03085056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743055|NCT03085056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5743056|NCT03085056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5621283|NCT05165251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5621284|NCT05165251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5621285|NCT05165251|Antimetabolites|antimetabolites|mesh-ancestor
5621286|NCT05165251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5621287|NCT05165251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5743057|NCT03084952|Meglumine Antimoniate|meglumine antimoniate|mesh-list
5743058|NCT03084952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5743059|NCT03084952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5743060|NCT03084952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5743061|NCT03084861|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5743062|NCT03084861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5743063|NCT03084978|Anesthetics|anesthetics|mesh-list
5743064|NCT03084978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5743065|NCT03084978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743066|NCT03085030|Antioxidants|antioxidants|mesh-list
5743067|NCT03085030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743068|NCT03085030|Protective Agents|protective agents|mesh-ancestor
5743069|NCT03085030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743070|NCT03084809|Leucovorin|leucovorin|mesh-list
5743071|NCT03084809|Oxaliplatin|oxaliplatin|mesh-list
5743072|NCT03084809|Fluorouracil|fluorouracil|mesh-list
5743073|NCT03084809|Levoleucovorin|levoleucovorin|mesh-list
5743074|NCT03084809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5743075|NCT03084809|Antidotes|antidotes|mesh-ancestor
5743076|NCT03084809|Protective Agents|protective agents|mesh-ancestor
5743077|NCT03084809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621288|NCT05165251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5621289|NCT05165251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5621290|NCT05165251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5621291|NCT05165251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5621292|NCT05165251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5621293|NCT05165251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5621294|NCT05165251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621295|NCT05165251|Vasodilator Agents|vasodilator agents|mesh-ancestor
5621296|NCT05154669|Nicotine|nicotine|mesh-list
5621297|NCT05154669|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5621298|NCT05154669|Autonomic Agents|autonomic agents|mesh-ancestor
5621299|NCT05154669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5621300|NCT05154669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621301|NCT05154669|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5621302|NCT05154669|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5743078|NCT03084809|Vitamin B Complex|vitamin b complex|mesh-ancestor
5743079|NCT03084809|Vitamins|vitamins|mesh-ancestor
5743080|NCT03084809|Micronutrients|micronutrients|mesh-ancestor
5743081|NCT03084809|Antimetabolites|antimetabolites|mesh-ancestor
5743082|NCT03084809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743083|NCT03084809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5743084|NCT03084809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5743085|NCT03084809|Immunologic Factors|immunologic factors|mesh-ancestor
5743086|NCT03084588|Methadone|methadone|mesh-list
5743087|NCT03084588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5743088|NCT03084588|Narcotics|narcotics|mesh-ancestor
5743089|NCT03084588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5743090|NCT03084588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743091|NCT03084588|Analgesics|analgesics|mesh-ancestor
5743092|NCT03084588|Sensory System Agents|sensory system agents|mesh-ancestor
5743093|NCT03084588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5743094|NCT03084588|Antitussive Agents|antitussive agents|mesh-ancestor
5743095|NCT03084588|Respiratory System Agents|respiratory system agents|mesh-ancestor
5743096|NCT03084575|Glycerol|glycerol|mesh-list
5743097|NCT03084575|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
5743098|NCT03084575|Protective Agents|protective agents|mesh-ancestor
5743099|NCT03084575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743100|NCT03084783|Dexamethasone|dexamethasone|mesh-list
5743101|NCT03084783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5743102|NCT03084783|Antiemetics|antiemetics|mesh-ancestor
5743103|NCT03084783|Autonomic Agents|autonomic agents|mesh-ancestor
5743104|NCT03084783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5743105|NCT03084783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743106|NCT03084783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5743107|NCT03084783|Glucocorticoids|glucocorticoids|mesh-ancestor
5743108|NCT03084783|Hormones|hormones|mesh-ancestor
5743109|NCT03084783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5743110|NCT03084783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5743111|NCT03084783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5621303|NCT05154669|Cholinergic Agents|cholinergic agents|mesh-ancestor
5621304|NCT05154669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5621305|NCT05154669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5621306|NCT05153564|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
5621307|NCT05153564|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
5621308|NCT05153564|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5621309|NCT05153564|Contraceptive Agents|contraceptive agents|mesh-ancestor
5621310|NCT05153564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5621311|NCT05153564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743112|NCT03084536|Acetaminophen|acetaminophen|mesh-list
5743113|NCT03084536|Celecoxib|celecoxib|mesh-list
5743114|NCT03084536|Fentanyl|fentanyl|mesh-list
5743115|NCT03084536|Midazolam|midazolam|mesh-list
5743116|NCT03084536|Gabapentin|gabapentin|mesh-list
5743117|NCT03084536|Bupivacaine|bupivacaine|mesh-list
5743118|NCT03084536|Anesthetics, Local|anesthetics, local|mesh-ancestor
5743119|NCT03084536|Anesthetics|anesthetics|mesh-ancestor
5743120|NCT03084536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5743121|NCT03084536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743122|NCT03084536|Sensory System Agents|sensory system agents|mesh-ancestor
5743123|NCT03084536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5743124|NCT03084536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5743125|NCT03084536|Narcotics|narcotics|mesh-ancestor
5743126|NCT03084536|Analgesics|analgesics|mesh-ancestor
5743127|NCT03084536|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5743128|NCT03084536|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5743129|NCT03084536|Anesthetics, General|anesthetics, general|mesh-ancestor
5743130|NCT03084536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5743131|NCT03084536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5743132|NCT03084536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5743133|NCT03084536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5743134|NCT03084536|GABA Modulators|gaba modulators|mesh-ancestor
5743135|NCT03084536|GABA Agents|gaba agents|mesh-ancestor
5743136|NCT03084536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5743137|NCT03084536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743138|NCT03084536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5743139|NCT03084536|Antipyretics|antipyretics|mesh-ancestor
5743140|NCT03084536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5743141|NCT03084536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5743142|NCT03084536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5743143|NCT03084536|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5743144|NCT03084536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5743145|NCT03084536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5743146|NCT03084536|Anticonvulsants|anticonvulsants|mesh-ancestor
5743147|NCT03084536|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5743148|NCT03084536|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5621312|NCT05153564|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5621313|NCT05153564|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5743149|NCT03084536|Antimanic Agents|antimanic agents|mesh-ancestor
5743150|NCT03084250|Tenofovir|tenofovir|mesh-list
5743151|NCT03084250|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5743152|NCT03084250|Entecavir|entecavir|mesh-list
5743153|NCT03084250|Adefovir|adefovir|mesh-list
5743154|NCT03084250|Antiviral Agents|antiviral agents|mesh-ancestor
5743155|NCT03084250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5743156|NCT03084250|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5743157|NCT03084250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5743158|NCT03084250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5743159|NCT03084250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743160|NCT03084250|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5743161|NCT03084250|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5743162|NCT03084419|Abatacept|abatacept|mesh-list
5743163|NCT03084419|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5743164|NCT03084419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743165|NCT03084419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5621314|NCT05153564|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5621315|NCT05153564|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5621316|NCT05153564|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5743166|NCT03084419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5743167|NCT03084419|Immunologic Factors|immunologic factors|mesh-ancestor
5743168|NCT03084419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743169|NCT03084419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5743170|NCT03084328|Vitamin D|vitamin d|mesh-list
5743171|NCT03084328|Vitamins|vitamins|mesh-ancestor
5743172|NCT03084328|Micronutrients|micronutrients|mesh-ancestor
5743173|NCT03084328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743174|NCT03084328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5743175|NCT03084380|Cyclophosphamide|cyclophosphamide|mesh-list
5743176|NCT03084380|Fludarabine|fludarabine|mesh-list
5743177|NCT03084380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5743178|NCT03084380|Immunologic Factors|immunologic factors|mesh-ancestor
5743179|NCT03084380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743180|NCT03084380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5743181|NCT03084380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5743182|NCT03084380|Alkylating Agents|alkylating agents|mesh-ancestor
5743183|NCT03084380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743184|NCT03084380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5743185|NCT03084380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5893848|NCT03575403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5893849|NCT03575403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893850|NCT03575403|Dopamine Agents|dopamine agents|mesh-ancestor
5893851|NCT03575403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5893852|NCT03575403|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5893853|NCT03575403|Analgesics|analgesics|mesh-ancestor
5893854|NCT03575403|Sensory System Agents|sensory system agents|mesh-ancestor
5893855|NCT03575403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5893856|NCT03575403|Antidepressive Agents|antidepressive agents|mesh-ancestor
5621317|NCT05153564|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
5621318|NCT05153564|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5621319|NCT05153564|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5621320|NCT05151146|Metformin|metformin|mesh-list
5621321|NCT05151146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5621322|NCT05151146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621323|NCT05150652|Tamoxifen|tamoxifen|mesh-list
5621324|NCT05150652|Letrozole|letrozole|mesh-list
5621325|NCT05150652|Anastrozole|anastrozole|mesh-list
5621326|NCT05150652|Exemestane|exemestane|mesh-list
5621327|NCT05150652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5621328|NCT05150652|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5621329|NCT05150652|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5621330|NCT05150652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5621331|NCT05150652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893857|NCT03575403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5893858|NCT03564691|Paclitaxel|paclitaxel|mesh-list
5893859|NCT03564691|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5893860|NCT03564691|Cisplatin|cisplatin|mesh-list
5893861|NCT03564691|Carboplatin|carboplatin|mesh-list
5893862|NCT03564691|Pembrolizumab|pembrolizumab|mesh-list
5893863|NCT03564691|Pemetrexed|pemetrexed|mesh-list
5893864|NCT03564691|Lenvatinib|lenvatinib|mesh-list
5893865|NCT03564691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5893866|NCT03564691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5893867|NCT03564691|Tubulin Modulators|tubulin modulators|mesh-ancestor
5893868|NCT03564691|Antimitotic Agents|antimitotic agents|mesh-ancestor
5893869|NCT03564691|Mitosis Modulators|mitosis modulators|mesh-ancestor
5893870|NCT03564691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893871|NCT03564691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5893872|NCT03564691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5893873|NCT03564691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5893874|NCT03564691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5893875|NCT03564691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5893876|NCT03554174|Psilocybin|psilocybin|mesh-list
5893877|NCT03554174|Hallucinogens|hallucinogens|mesh-ancestor
5893878|NCT03554174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893879|NCT03554174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5893880|NCT03482297|Midodrine|midodrine|mesh-list
5893881|NCT03482297|Sympathomimetics|sympathomimetics|mesh-ancestor
5893882|NCT03482297|Autonomic Agents|autonomic agents|mesh-ancestor
5893883|NCT03482297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5893884|NCT03482297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893885|NCT03482297|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5893886|NCT03482297|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5893887|NCT03482297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5893888|NCT03482297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5893889|NCT03482297|Adrenergic Agents|adrenergic agents|mesh-ancestor
5893890|NCT03482297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5621332|NCT05150652|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5893891|NCT03482297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5621333|NCT05150652|Hormone Antagonists|hormone antagonists|mesh-ancestor
5621334|NCT05150652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5621335|NCT05150652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621336|NCT05150652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5621337|NCT05150652|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5621338|NCT05150652|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5621339|NCT05150652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5621340|NCT05143489|Lidocaine|lidocaine|mesh-list
5621341|NCT05143489|Anesthetics, Local|anesthetics, local|mesh-ancestor
5621342|NCT05143489|Anesthetics|anesthetics|mesh-ancestor
5621343|NCT05143489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5621344|NCT05143489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621345|NCT05143489|Sensory System Agents|sensory system agents|mesh-ancestor
5621346|NCT05143489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5621347|NCT05143489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5621348|NCT05143489|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5621349|NCT05143489|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5621350|NCT05143489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5621351|NCT05143489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5621352|NCT05143073|Ethanol|ethanol|mesh-list
5621353|NCT05143073|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5621354|NCT05143073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5621355|NCT05143073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5621356|NCT05143073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621357|NCT05139875|Triamcinolone|triamcinolone|mesh-list
5621358|NCT05139875|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5621359|NCT05139875|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5621360|NCT05139875|Betamethasone|betamethasone|mesh-list
5621361|NCT05139875|Betamethasone Valerate|betamethasone valerate|mesh-list
5621362|NCT05139875|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5621363|NCT05139875|Betamethasone benzoate|betamethasone benzoate|mesh-list
5621364|NCT05139875|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
5621365|NCT05139875|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5621366|NCT05139875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5621367|NCT05139875|Glucocorticoids|glucocorticoids|mesh-ancestor
5621368|NCT05139875|Hormones|hormones|mesh-ancestor
5621369|NCT05139875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5621370|NCT05139875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621371|NCT05139875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5621372|NCT05139875|Immunologic Factors|immunologic factors|mesh-ancestor
5621373|NCT05139875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5621374|NCT05139875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5621375|NCT05139875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5621376|NCT05139875|Respiratory System Agents|respiratory system agents|mesh-ancestor
5621377|NCT05137860|Bortezomib|bortezomib|mesh-list
5621378|NCT05137860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5621379|NCT05136898|Mitomycins|mitomycins|mesh-list
5621380|NCT05136898|Mitomycin|mitomycin|mesh-list
5621381|NCT05136898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5621382|NCT05136898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5621383|NCT05136898|Alkylating Agents|alkylating agents|mesh-ancestor
5621384|NCT05136898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5621385|NCT05136898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5621386|NCT05136898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5621387|NCT05131997|Atorvastatin|atorvastatin|mesh-list
5621388|NCT05131997|Ezetimibe|ezetimibe|mesh-list
5621389|NCT05131997|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5621390|NCT05131997|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5621391|NCT05131997|Antimetabolites|antimetabolites|mesh-ancestor
5743186|NCT03084237|Docetaxel|docetaxel|mesh-list
5743187|NCT03084237|Trastuzumab|trastuzumab|mesh-list
5743188|NCT03084237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5743189|NCT03084237|Tubulin Modulators|tubulin modulators|mesh-ancestor
5743190|NCT03084237|Antimitotic Agents|antimitotic agents|mesh-ancestor
5743191|NCT03084237|Mitosis Modulators|mitosis modulators|mesh-ancestor
5743192|NCT03084237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743193|NCT03084237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5743194|NCT03084601|Calcium|calcium|mesh-list
5743195|NCT03084601|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5743196|NCT03084601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743197|NCT03084029|Oxytocin|oxytocin|mesh-list
5743198|NCT03084029|Oxytocics|oxytocics|mesh-ancestor
5743199|NCT03084029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5893892|NCT03314935|Leucovorin|leucovorin|mesh-list
6208678|NCT02134210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208679|NCT02134210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6208680|NCT02134210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6208681|NCT02134210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6208682|NCT02134210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6208683|NCT02134210|Immunologic Factors|immunologic factors|mesh-ancestor
6208684|NCT02134314|Complement C1s|complement c1s|mesh-list
6208685|NCT02134314|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
5743200|NCT03084029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743201|NCT03083821|Entecavir|entecavir|mesh-list
5743202|NCT03083821|Antiviral Agents|antiviral agents|mesh-ancestor
5743203|NCT03083821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5743204|NCT03083782|Cyclosporine|cyclosporine|mesh-list
5743205|NCT03083782|Apixaban|apixaban|mesh-list
5743206|NCT03083782|Tacrolimus|tacrolimus|mesh-list
5743207|NCT03083782|Cyclosporins|cyclosporins|mesh-list
5743208|NCT03083782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5743209|NCT03083782|Immunologic Factors|immunologic factors|mesh-ancestor
5743210|NCT03083782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743211|NCT03083782|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5743212|NCT03083782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5743213|NCT03083782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743214|NCT03083782|Antifungal Agents|antifungal agents|mesh-ancestor
5743215|NCT03083782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5743216|NCT03083782|Dermatologic Agents|dermatologic agents|mesh-ancestor
5743217|NCT03083782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5621392|NCT05131997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5621393|NCT05131997|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5621394|NCT05131997|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5621395|NCT05131997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5621396|NCT05129644|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5621397|NCT05129644|Antiviral Agents|antiviral agents|mesh-ancestor
5621398|NCT05129644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5621399|NCT05128487|Pembrolizumab|pembrolizumab|mesh-list
5621400|NCT05128487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5621401|NCT05128487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5621402|NCT05123170|Lidocaine|lidocaine|mesh-list
5621403|NCT05123170|Dexmedetomidine|dexmedetomidine|mesh-list
5743218|NCT03083782|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5743219|NCT03083782|Antithrombins|antithrombins|mesh-ancestor
5743220|NCT03083782|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5743221|NCT03083782|Protease Inhibitors|protease inhibitors|mesh-ancestor
5743222|NCT03083782|Anticoagulants|anticoagulants|mesh-ancestor
5743223|NCT03083834|Cosyntropin|cosyntropin|mesh-list
5743224|NCT03083834|Hormones|hormones|mesh-ancestor
5743225|NCT03083834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5743226|NCT03083834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743227|NCT03083678|Afatinib|afatinib|mesh-list
5743228|NCT03083678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5743229|NCT03083678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5743230|NCT03083678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5743231|NCT03083678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743232|NCT03083613|Paclitaxel|paclitaxel|mesh-list
5743233|NCT03083613|Raltitrexed|raltitrexed|mesh-list
5743234|NCT03083613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5743235|NCT03083613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5743236|NCT03083613|Tubulin Modulators|tubulin modulators|mesh-ancestor
5743237|NCT03083613|Antimitotic Agents|antimitotic agents|mesh-ancestor
5743238|NCT03083613|Mitosis Modulators|mitosis modulators|mesh-ancestor
5743239|NCT03083613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743240|NCT03083613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5743241|NCT03083613|Antimetabolites|antimetabolites|mesh-ancestor
5743242|NCT03083613|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5743243|NCT03083613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5743244|NCT03083691|Nivolumab|nivolumab|mesh-list
5743245|NCT03083691|Ipilimumab|ipilimumab|mesh-list
5743246|NCT03083691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5743247|NCT03083691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5743248|NCT03083691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5621404|NCT05123170|Anesthetics, Local|anesthetics, local|mesh-ancestor
5621405|NCT05123170|Anesthetics|anesthetics|mesh-ancestor
5621406|NCT05123170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5621407|NCT05123170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621408|NCT05123170|Sensory System Agents|sensory system agents|mesh-ancestor
5743249|NCT03083691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743250|NCT03083704|Enoxaparin|enoxaparin|mesh-list
5743251|NCT03083704|Rivaroxaban|rivaroxaban|mesh-list
5743252|NCT03083704|Apixaban|apixaban|mesh-list
5743253|NCT03083704|Edoxaban|edoxaban|mesh-list
5743254|NCT03083704|Enoxaparin sodium|enoxaparin sodium|mesh-list
5743255|NCT03083704|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5743256|NCT03083704|Antithrombins|antithrombins|mesh-ancestor
5743257|NCT03083704|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5743258|NCT03083704|Protease Inhibitors|protease inhibitors|mesh-ancestor
5743259|NCT03083704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5743260|NCT03083704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743261|NCT03083704|Anticoagulants|anticoagulants|mesh-ancestor
5743262|NCT03083704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5743263|NCT03083704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5743264|NCT03083457|Anesthetics|anesthetics|mesh-list
5743265|NCT03083457|Anesthetics, General|anesthetics, general|mesh-list
5743266|NCT03083457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5743267|NCT03083457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743268|NCT03083405|Opipramol|opipramol|mesh-list
5743269|NCT03083405|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5743270|NCT03083405|Antidepressive Agents|antidepressive agents|mesh-ancestor
5743271|NCT03083405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5743272|NCT03083405|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5743273|NCT03083405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5743274|NCT03083405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5743275|NCT03083405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743276|NCT03083405|Adrenergic Agents|adrenergic agents|mesh-ancestor
5743277|NCT03083405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5743278|NCT03083405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743279|NCT03083431|Propranolol|propranolol|mesh-list
5743280|NCT03083431|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5743281|NCT03083431|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5743282|NCT03083431|Adrenergic Agents|adrenergic agents|mesh-ancestor
5743283|NCT03083431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5743284|NCT03083431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743285|NCT03083431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743286|NCT03083431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5743287|NCT03083431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5743288|NCT03083431|Vasodilator Agents|vasodilator agents|mesh-ancestor
5743289|NCT03083353|Isradipine|isradipine|mesh-list
5743290|NCT03083353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5743291|NCT03083353|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5743292|NCT03083353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5743293|NCT03083353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743294|NCT03083353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5743295|NCT03083353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743296|NCT03083353|Vasodilator Agents|vasodilator agents|mesh-ancestor
5743297|NCT03083210|Lanreotide|lanreotide|mesh-list
5743298|NCT03083210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5743299|NCT03083197|Azithromycin|azithromycin|mesh-list
5743300|NCT03083197|Doxycycline|doxycycline|mesh-list
5743301|NCT03083197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5621409|NCT05123170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5743302|NCT03083197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5743303|NCT03083197|Antimalarials|antimalarials|mesh-ancestor
5743304|NCT03083197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5743305|NCT03083197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5743306|NCT03083184|Ethanol|ethanol|mesh-list
5743307|NCT03083184|Enoxaparin|enoxaparin|mesh-list
5743308|NCT03083184|Anticoagulants|anticoagulants|mesh-ancestor
5743309|NCT03083184|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5743310|NCT03083184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5743311|NCT03083184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743312|NCT03083184|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5743313|NCT03083184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5743314|NCT03083184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5621410|NCT05123170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5621411|NCT05123170|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5621412|NCT05123170|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5621413|NCT05123170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5621414|NCT05123170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5621415|NCT05123170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5621416|NCT05123170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5621417|NCT05123170|Analgesics|analgesics|mesh-ancestor
5743315|NCT03083184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621418|NCT05123170|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5621419|NCT05123170|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5621420|NCT05123170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5621421|NCT05123170|Adrenergic Agents|adrenergic agents|mesh-ancestor
5621422|NCT05123170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5621423|NCT05123131|Dexamethasone|dexamethasone|mesh-list
5621424|NCT05123131|Lenalidomide|lenalidomide|mesh-list
5621425|NCT05123131|Bortezomib|bortezomib|mesh-list
5621426|NCT05123131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5621427|NCT05123131|Antiemetics|antiemetics|mesh-ancestor
5743316|NCT03083041|Apatinib|apatinib|mesh-list
5743317|NCT03083041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5743318|NCT03083041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5743319|NCT03083041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5743320|NCT03083041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743321|NCT03083067|Budesonide|budesonide|mesh-list
5743322|NCT03083067|Bromides|bromides|mesh-list
5621428|NCT05123131|Autonomic Agents|autonomic agents|mesh-ancestor
5621429|NCT05123131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5621430|NCT05123131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621431|NCT05123131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5621432|NCT05123131|Glucocorticoids|glucocorticoids|mesh-ancestor
5621433|NCT05123131|Hormones|hormones|mesh-ancestor
5621434|NCT05123131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5621435|NCT05123131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5621436|NCT05123131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5621437|NCT05123131|Immunologic Factors|immunologic factors|mesh-ancestor
5621438|NCT05123131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5621439|NCT05123131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5621440|NCT05123131|Growth Substances|growth substances|mesh-ancestor
5621441|NCT05123131|Growth Inhibitors|growth inhibitors|mesh-ancestor
5621442|NCT05116241|Vaccines|vaccines|mesh-list
5621443|NCT05116241|Immunologic Factors|immunologic factors|mesh-ancestor
5621444|NCT05116241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621445|NCT05112536|Paclitaxel|paclitaxel|mesh-list
5621446|NCT05112536|Carboplatin|carboplatin|mesh-list
5621447|NCT05112536|Doxorubicin|doxorubicin|mesh-list
5621448|NCT05112536|Pembrolizumab|pembrolizumab|mesh-list
5621449|NCT05112536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5621450|NCT05112536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5621451|NCT05112536|Tubulin Modulators|tubulin modulators|mesh-ancestor
5621452|NCT05112536|Antimitotic Agents|antimitotic agents|mesh-ancestor
5621453|NCT05112536|Mitosis Modulators|mitosis modulators|mesh-ancestor
5621454|NCT05112536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5621455|NCT05112536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5621456|NCT05112536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5621457|NCT05112536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5621458|NCT05112536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5621459|NCT05112536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5621460|NCT05109442|Atezolizumab|atezolizumab|mesh-list
5621461|NCT05109442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5621462|NCT05108935|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5743323|NCT03083067|Formoterol Fumarate|formoterol fumarate|mesh-list
5743324|NCT03083067|Tiotropium Bromide|tiotropium bromide|mesh-list
5743325|NCT03083067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5743326|NCT03083067|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5743327|NCT03083067|Autonomic Agents|autonomic agents|mesh-ancestor
5743328|NCT03083067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5743329|NCT03083067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743330|NCT03083067|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5743331|NCT03083067|Respiratory System Agents|respiratory system agents|mesh-ancestor
5743332|NCT03083067|Glucocorticoids|glucocorticoids|mesh-ancestor
5743333|NCT03083067|Hormones|hormones|mesh-ancestor
5743334|NCT03083067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5743335|NCT03083067|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5621463|NCT05108935|Buprenorphine|buprenorphine|mesh-list
5621464|NCT05108935|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
5621465|NCT05108935|Naloxone|naloxone|mesh-list
5621466|NCT05108935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5621467|NCT05108935|Narcotics|narcotics|mesh-ancestor
5621468|NCT05108935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5621469|NCT05108935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743336|NCT03083067|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5621470|NCT05108935|Analgesics|analgesics|mesh-ancestor
5621471|NCT05108935|Sensory System Agents|sensory system agents|mesh-ancestor
5621472|NCT05108935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5743337|NCT03083067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5743338|NCT03083067|Adrenergic Agents|adrenergic agents|mesh-ancestor
5743339|NCT03083067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5743340|NCT03083067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743341|NCT03083067|Parasympatholytics|parasympatholytics|mesh-ancestor
5743342|NCT03083067|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5743343|NCT03083067|Cholinergic Agents|cholinergic agents|mesh-ancestor
5743344|NCT03083067|Anticonvulsants|anticonvulsants|mesh-ancestor
5743345|NCT03083080|Epinephrine|epinephrine|mesh-list
5743346|NCT03083080|Ropivacaine|ropivacaine|mesh-list
5743347|NCT03083080|Anesthetics, Local|anesthetics, local|mesh-ancestor
5743348|NCT03083080|Anesthetics|anesthetics|mesh-ancestor
5621473|NCT05108935|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5621474|NCT05108935|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5621475|NCT05108935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5621476|NCT05108935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5621477|NCT05108935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5621478|NCT05108935|Antiviral Agents|antiviral agents|mesh-ancestor
5621479|NCT05108935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5621480|NCT05108935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5621481|NCT05108935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5621482|NCT05105750|Aspirin|aspirin|mesh-list
5621483|NCT05105750|Indobufen|indobufen|mesh-list
5621484|NCT05105750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5621485|NCT05105750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5621486|NCT05105750|Analgesics|analgesics|mesh-ancestor
5743349|NCT03083080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5743350|NCT03083080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743351|NCT03083080|Sensory System Agents|sensory system agents|mesh-ancestor
5743352|NCT03083080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5743353|NCT03083080|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5743354|NCT03083080|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5743355|NCT03083080|Adrenergic Agents|adrenergic agents|mesh-ancestor
5743356|NCT03083080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5743357|NCT03083080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743358|NCT03083080|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5743359|NCT03083080|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5743360|NCT03083080|Autonomic Agents|autonomic agents|mesh-ancestor
5743361|NCT03083080|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5743362|NCT03083080|Respiratory System Agents|respiratory system agents|mesh-ancestor
5743363|NCT03083080|Mydriatics|mydriatics|mesh-ancestor
5743364|NCT03083080|Sympathomimetics|sympathomimetics|mesh-ancestor
5621487|NCT05105750|Sensory System Agents|sensory system agents|mesh-ancestor
5621488|NCT05105750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5621489|NCT05105750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621490|NCT05105750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5621491|NCT05105750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5621492|NCT05105750|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5621493|NCT05105750|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5621494|NCT05105750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5621495|NCT05105750|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5621496|NCT05105750|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5621497|NCT05105750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5621498|NCT05105750|Antipyretics|antipyretics|mesh-ancestor
5692590|NCT03406819|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5692591|NCT03406793|Iron|iron|mesh-list
5692592|NCT03406793|Zinc|zinc|mesh-list
5692593|NCT03406793|Trace Elements|trace elements|mesh-ancestor
5692594|NCT03406793|Micronutrients|micronutrients|mesh-ancestor
5692595|NCT03406793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697682|NCT03374306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697683|NCT03374306|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5697684|NCT03374306|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5697685|NCT03374293|Antibodies|antibodies|mesh-list
5697686|NCT03374293|Immunologic Factors|immunologic factors|mesh-ancestor
5697687|NCT03374293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697688|NCT03374280|Cisplatin|cisplatin|mesh-list
5697689|NCT03374280|Pemetrexed|pemetrexed|mesh-list
5697690|NCT03374280|Gefitinib|gefitinib|mesh-list
5697691|NCT03374280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5697692|NCT03374280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5697693|NCT03374280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697694|NCT03374280|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5697695|NCT03374280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5697696|NCT03374280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5697697|NCT03374254|Leucovorin|leucovorin|mesh-list
5743365|NCT03083080|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5743366|NCT03082846|Temozolomide|temozolomide|mesh-list
5743367|NCT03082846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5743368|NCT03082846|Alkylating Agents|alkylating agents|mesh-ancestor
5743369|NCT03082846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743370|NCT03082846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5743371|NCT03082885|Thymalfasin|thymalfasin|mesh-list
5743372|NCT03082885|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5743373|NCT03082885|Immunologic Factors|immunologic factors|mesh-ancestor
5743374|NCT03082885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743375|NCT03082677|Ixazomib|ixazomib|mesh-list
5743376|NCT03082677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5743377|NCT03082677|Protease Inhibitors|protease inhibitors|mesh-ancestor
5743378|NCT03082677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5743379|NCT03082677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743380|NCT03082742|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5743381|NCT03082742|Furosemide|furosemide|mesh-list
5743382|NCT03082742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5743383|NCT03082742|Diuretics|diuretics|mesh-ancestor
5743384|NCT03082742|Natriuretic Agents|natriuretic agents|mesh-ancestor
5743385|NCT03082742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743386|NCT03082742|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5743387|NCT03082742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5743388|NCT03082742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743389|NCT03082742|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5893893|NCT03314935|Gemcitabine|gemcitabine|mesh-list
5893894|NCT03314935|Paclitaxel|paclitaxel|mesh-list
5893895|NCT03314935|Fluorouracil|fluorouracil|mesh-list
5893896|NCT03314935|Oxaliplatin|oxaliplatin|mesh-list
5893897|NCT03314935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5893898|NCT03314935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5621499|NCT05081089|Lumefantrine|lumefantrine|mesh-list
5621500|NCT05081089|Artemether|artemether|mesh-list
5621501|NCT05081089|Pyrimethamine|pyrimethamine|mesh-list
5621502|NCT05081089|Primaquine|primaquine|mesh-list
5621503|NCT05081089|Sulfadoxine|sulfadoxine|mesh-list
5621504|NCT05081089|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
5621505|NCT05081089|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
5621506|NCT05081089|Amodiaquine|amodiaquine|mesh-list
5621507|NCT05081089|Tafenoquine|tafenoquine|mesh-list
5621508|NCT05081089|Antimalarials|antimalarials|mesh-ancestor
6489362|NCT00591188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6489363|NCT00591188|Immunologic Factors|immunologic factors|mesh-ancestor
6489364|NCT00591188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489365|NCT00591201|Infliximab|infliximab|mesh-list
6489366|NCT00591201|Dermatologic Agents|dermatologic agents|mesh-ancestor
6489367|NCT00591201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6489368|NCT00591201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6489369|NCT00591357|Loperamide|loperamide|mesh-list
6489370|NCT00591357|Antidiarrheals|antidiarrheals|mesh-list
6489371|NCT00591357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6489372|NCT00591383|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5893899|NCT03314935|Tubulin Modulators|tubulin modulators|mesh-ancestor
5893900|NCT03314935|Antimitotic Agents|antimitotic agents|mesh-ancestor
5893901|NCT03314935|Mitosis Modulators|mitosis modulators|mesh-ancestor
5893902|NCT03314935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893903|NCT03314935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5893904|NCT03314935|Antimetabolites|antimetabolites|mesh-ancestor
5893905|NCT03314935|Antiviral Agents|antiviral agents|mesh-ancestor
5893906|NCT03314935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5893907|NCT03314935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5893908|NCT03314935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5893909|NCT03314935|Immunologic Factors|immunologic factors|mesh-ancestor
5893910|NCT03314935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893911|NCT03314935|Antidotes|antidotes|mesh-ancestor
5893912|NCT03314935|Protective Agents|protective agents|mesh-ancestor
5893913|NCT03314935|Vitamin B Complex|vitamin b complex|mesh-ancestor
5893914|NCT03314935|Vitamins|vitamins|mesh-ancestor
5893915|NCT03314935|Micronutrients|micronutrients|mesh-ancestor
5893916|NCT03278717|Olaparib|olaparib|mesh-list
5893917|NCT03278717|Cediranib|cediranib|mesh-list
5893918|NCT03278717|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5893919|NCT03278717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5893920|NCT03278717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893921|NCT03278717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5621509|NCT05081089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6489373|NCT00591383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6489374|NCT00591383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5743390|NCT03082755|Gabapentin|gabapentin|mesh-list
5743391|NCT03082755|Analgesics|analgesics|mesh-ancestor
5743392|NCT03082755|Sensory System Agents|sensory system agents|mesh-ancestor
5743393|NCT03082755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5743394|NCT03082755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743395|NCT03082755|Anticonvulsants|anticonvulsants|mesh-ancestor
5743396|NCT03082755|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5743397|NCT03082755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5743398|NCT03082755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5743399|NCT03082755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5743400|NCT03082755|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5743401|NCT03082755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5743402|NCT03082755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5743403|NCT03082755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743404|NCT03082755|Antimanic Agents|antimanic agents|mesh-ancestor
5743405|NCT03082339|Cortisone|cortisone|mesh-list
5743406|NCT03082339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5743407|NCT03082300|Naquotinib|naquotinib|mesh-list
5743408|NCT03082300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5743409|NCT03082300|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5743410|NCT03082300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5743411|NCT03082300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489375|NCT00591383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6489376|NCT00591383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489377|NCT00591487|Lidocaine|lidocaine|mesh-list
6489378|NCT00591487|Anesthetics, Local|anesthetics, local|mesh-ancestor
6489379|NCT00591487|Anesthetics|anesthetics|mesh-ancestor
6489380|NCT00591487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6489381|NCT00591487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489382|NCT00591487|Sensory System Agents|sensory system agents|mesh-ancestor
6489383|NCT00591487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6489384|NCT00591487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5621510|NCT05081089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5621511|NCT05081089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5621512|NCT05081089|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5743412|NCT03082521|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5743413|NCT03082521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5743414|NCT03082534|Pembrolizumab|pembrolizumab|mesh-list
5621513|NCT05081089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5621514|NCT05081089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5621515|NCT05081089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5621516|NCT05081089|Renal Agents|renal agents|mesh-ancestor
5621517|NCT05068661|Fentanyl|fentanyl|mesh-list
5621518|NCT05068661|Bupivacaine|bupivacaine|mesh-list
5621519|NCT05068661|Ropivacaine|ropivacaine|mesh-list
5621520|NCT05068661|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5621521|NCT05068661|Anesthetics, Local|anesthetics, local|mesh-ancestor
5621522|NCT05068661|Anesthetics|anesthetics|mesh-ancestor
5621523|NCT05068661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5621524|NCT05068661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621525|NCT05068661|Sensory System Agents|sensory system agents|mesh-ancestor
5621526|NCT05068661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5621527|NCT05068661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5621528|NCT05068661|Narcotics|narcotics|mesh-ancestor
5621529|NCT05068661|Analgesics|analgesics|mesh-ancestor
5621530|NCT05068661|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5621531|NCT05068661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5621532|NCT05068661|Anesthetics, General|anesthetics, general|mesh-ancestor
5621533|NCT05065216|Kallikreins|kallikreins|mesh-list
5621534|NCT05065216|Coagulants|coagulants|mesh-ancestor
5621535|NCT05065216|Fertility Agents, Male|fertility agents, male|mesh-ancestor
5621536|NCT05065216|Fertility Agents|fertility agents|mesh-ancestor
5621537|NCT05065216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5621538|NCT05065216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621539|NCT05064800|Ritonavir|ritonavir|mesh-list
5621540|NCT05064800|Dabigatran|dabigatran|mesh-list
5621541|NCT05064800|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5743415|NCT03082534|Cetuximab|cetuximab|mesh-list
5743416|NCT03082534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5743417|NCT03082534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5743418|NCT03082573|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
5743419|NCT03082573|Hormones|hormones|mesh-ancestor
5743420|NCT03082573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5621542|NCT05064800|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5743421|NCT03082573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621543|NCT05064800|Protease Inhibitors|protease inhibitors|mesh-ancestor
5621544|NCT05064800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5621545|NCT05064800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5621546|NCT05064800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5621547|NCT05064800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5743422|NCT03082352|Metoprolol|metoprolol|mesh-list
5743423|NCT03082352|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5743424|NCT03082352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5743425|NCT03082352|Sympatholytics|sympatholytics|mesh-ancestor
5743426|NCT03082352|Autonomic Agents|autonomic agents|mesh-ancestor
5743427|NCT03082352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5743428|NCT03082352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743429|NCT03082352|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5743430|NCT03082352|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5743431|NCT03082352|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5743432|NCT03082352|Adrenergic Agents|adrenergic agents|mesh-ancestor
5743433|NCT03082352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5743434|NCT03082352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743435|NCT03082092|Methylprednisolone|methylprednisolone|mesh-list
5743436|NCT03082092|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5743437|NCT03082092|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5743438|NCT03082092|Prednisolone|prednisolone|mesh-list
5743439|NCT03082092|Prednisolone acetate|prednisolone acetate|mesh-list
5743440|NCT03082092|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5743441|NCT03082092|Prednisolone phosphate|prednisolone phosphate|mesh-list
5743442|NCT03082092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5743443|NCT03082092|Antiemetics|antiemetics|mesh-ancestor
5743444|NCT03082092|Autonomic Agents|autonomic agents|mesh-ancestor
5743445|NCT03082092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5743446|NCT03082092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743447|NCT03082092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5743448|NCT03082092|Glucocorticoids|glucocorticoids|mesh-ancestor
5743449|NCT03082092|Hormones|hormones|mesh-ancestor
5743450|NCT03082092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5743451|NCT03082092|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5743452|NCT03082092|Protective Agents|protective agents|mesh-ancestor
5743453|NCT03082092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5743454|NCT03082092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5743455|NCT03082183|Rifampin|rifampin|mesh-list
5743456|NCT03082183|BI 425809|bi 425809|mesh-list
5743457|NCT03082183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5743458|NCT03082183|Antitubercular Agents|antitubercular agents|mesh-ancestor
5743459|NCT03082183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5743460|NCT03082183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5743461|NCT03082183|Leprostatic Agents|leprostatic agents|mesh-ancestor
5743462|NCT03082183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5743463|NCT03082183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5743464|NCT03082183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743465|NCT03082183|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5743466|NCT03082183|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5743467|NCT03082183|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5743468|NCT03082183|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5743469|NCT03082183|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5743470|NCT03082183|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5743471|NCT03082183|Nootropic Agents|nootropic agents|mesh-ancestor
5743472|NCT03082053|Capecitabine|capecitabine|mesh-list
5743473|NCT03082053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5743474|NCT03082053|Antimetabolites|antimetabolites|mesh-ancestor
5743475|NCT03082053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743476|NCT03082053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5743477|NCT03081923|Durvalumab|durvalumab|mesh-list
5743478|NCT03081923|Tremelimumab|tremelimumab|mesh-list
5743479|NCT03081923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5743480|NCT03081923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5743481|NCT03082001|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5743482|NCT03081949|Selenium|selenium|mesh-list
5621548|NCT05064800|Antiviral Agents|antiviral agents|mesh-ancestor
5621549|NCT05064800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5621550|NCT05064800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5621551|NCT05064800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5621552|NCT05064800|Antithrombins|antithrombins|mesh-ancestor
5621553|NCT05064800|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5621554|NCT05064800|Anticoagulants|anticoagulants|mesh-ancestor
5743483|NCT03081949|Selenious Acid|selenious acid|mesh-list
5743484|NCT03081949|Sodium Selenite|sodium selenite|mesh-list
5743485|NCT03081949|Antioxidants|antioxidants|mesh-ancestor
5743486|NCT03081949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743487|NCT03081949|Protective Agents|protective agents|mesh-ancestor
5743488|NCT03081949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743489|NCT03081949|Trace Elements|trace elements|mesh-ancestor
5743490|NCT03081949|Micronutrients|micronutrients|mesh-ancestor
5743491|NCT03081832|Oxytocin|oxytocin|mesh-list
5743492|NCT03081832|Oxytocics|oxytocics|mesh-ancestor
5743493|NCT03081832|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5743494|NCT03081832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743495|NCT03082482|Nicotine|nicotine|mesh-list
5743496|NCT03082482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5743497|NCT03082482|Autonomic Agents|autonomic agents|mesh-ancestor
5621559|NCT05062889|Leucovorin|leucovorin|mesh-list
5621560|NCT05062889|Trifluridine|trifluridine|mesh-list
5621561|NCT05062889|Fluorouracil|fluorouracil|mesh-list
5621562|NCT05062889|Capecitabine|capecitabine|mesh-list
5621563|NCT05062889|Oxaliplatin|oxaliplatin|mesh-list
5621564|NCT05062889|Irinotecan|irinotecan|mesh-list
5621565|NCT05062889|Levoleucovorin|levoleucovorin|mesh-list
5621566|NCT05062889|Antimetabolites|antimetabolites|mesh-ancestor
5621567|NCT05062889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5621568|NCT05062889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5621569|NCT05062889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5621570|NCT05062889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5621571|NCT05062889|Immunologic Factors|immunologic factors|mesh-ancestor
5743498|NCT03082482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5743499|NCT03082482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743500|NCT03082482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5743501|NCT03082482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5743502|NCT03082482|Cholinergic Agents|cholinergic agents|mesh-ancestor
5743503|NCT03082482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5743504|NCT03082482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743505|NCT03082014|Losartan|losartan|mesh-list
5743506|NCT03082014|Atenolol|atenolol|mesh-list
5743507|NCT03082014|Amlodipine|amlodipine|mesh-list
5743508|NCT03082014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5743509|NCT03082014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5743510|NCT03082014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5743511|NCT03082014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5621572|NCT05062889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621573|NCT05062889|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5621574|NCT05062889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5621575|NCT05062889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5621576|NCT05062889|Antidotes|antidotes|mesh-ancestor
5621577|NCT05062889|Protective Agents|protective agents|mesh-ancestor
5621578|NCT05062889|Vitamin B Complex|vitamin b complex|mesh-ancestor
5621579|NCT05062889|Vitamins|vitamins|mesh-ancestor
5621580|NCT05062889|Micronutrients|micronutrients|mesh-ancestor
5621581|NCT05062889|Antiviral Agents|antiviral agents|mesh-ancestor
5621582|NCT05062889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5621583|NCT05057806|Empagliflozin|empagliflozin|mesh-list
5621584|NCT05057806|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5621585|NCT05057806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5621586|NCT05057806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5621587|NCT05057806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621588|NCT05050942|Octreotide|octreotide|mesh-list
5621589|NCT05050942|Lanreotide|lanreotide|mesh-list
5621590|NCT05050942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5621591|NCT05050942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5621592|NCT05050942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5621593|NCT05048719|Dulaglutide|dulaglutide|mesh-list
5743512|NCT03082014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5743513|NCT03082014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743514|NCT03082014|Vasodilator Agents|vasodilator agents|mesh-ancestor
5743515|NCT03082014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5743516|NCT03082014|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5743517|NCT03082014|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5743518|NCT03082014|Sympatholytics|sympatholytics|mesh-ancestor
5621594|NCT05048719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5621595|NCT05048719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621596|NCT05046795|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5621597|NCT05042505|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5743519|NCT03082014|Autonomic Agents|autonomic agents|mesh-ancestor
5743520|NCT03082014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5743521|NCT03082014|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5743522|NCT03082014|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5743523|NCT03082014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5743524|NCT03082014|Adrenergic Agents|adrenergic agents|mesh-ancestor
5743525|NCT03082014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5743526|NCT03081494|Spartalizumab|spartalizumab|mesh-list
5743527|NCT03081494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5743528|NCT03081494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743529|NCT03081494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5743530|NCT03081702|Hydroxychloroquine|hydroxychloroquine|mesh-list
5743531|NCT03081702|Itraconazole|itraconazole|mesh-list
5743532|NCT03081702|Antimalarials|antimalarials|mesh-ancestor
5743533|NCT03081702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5743534|NCT03081702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5621598|NCT05042505|Dapagliflozin|dapagliflozin|mesh-list
5621599|NCT05042505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5621600|NCT05042505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621601|NCT05042505|Incretins|incretins|mesh-ancestor
5621602|NCT05042505|Hormones|hormones|mesh-ancestor
5621603|NCT05042505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5621604|NCT05042505|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5621605|NCT05042505|Protease Inhibitors|protease inhibitors|mesh-ancestor
5621606|NCT05042505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5621607|NCT05042505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5621608|NCT05042505|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5621609|NCT05041673|Metformin|metformin|mesh-list
5621610|NCT05041673|Liraglutide|liraglutide|mesh-list
5621611|NCT05041673|Empagliflozin|empagliflozin|mesh-list
5621612|NCT05041673|Vildagliptin|vildagliptin|mesh-list
5621613|NCT05041673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5621614|NCT05041673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621615|NCT05041673|Incretins|incretins|mesh-ancestor
5621616|NCT05041673|Hormones|hormones|mesh-ancestor
5621617|NCT05041673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5621618|NCT05041673|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5621619|NCT05041673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5621620|NCT05041673|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5621621|NCT05041673|Protease Inhibitors|protease inhibitors|mesh-ancestor
5621622|NCT05041673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5621623|NCT05032950|Ritonavir|ritonavir|mesh-list
5621624|NCT05032950|Midazolam|midazolam|mesh-list
5621625|NCT05032950|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5621626|NCT05032950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5621627|NCT05032950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5621628|NCT05032950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621629|NCT05032950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5621630|NCT05032950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5621631|NCT05032950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5621632|NCT05032950|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5621633|NCT05032950|Anesthetics, General|anesthetics, general|mesh-ancestor
5621634|NCT05032950|Anesthetics|anesthetics|mesh-ancestor
5621635|NCT05032950|GABA Modulators|gaba modulators|mesh-ancestor
5621636|NCT05032950|GABA Agents|gaba agents|mesh-ancestor
5621637|NCT05032950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5743535|NCT03081702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5743536|NCT03081702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5743537|NCT03081702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743538|NCT03081702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5743539|NCT03081702|Antifungal Agents|antifungal agents|mesh-ancestor
5743540|NCT03081702|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5743541|NCT03081702|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5743542|NCT03081702|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5743543|NCT03081702|Hormone Antagonists|hormone antagonists|mesh-ancestor
5743544|NCT03081702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5743545|NCT03081702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743546|NCT03081702|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5743547|NCT03081728|Acetaminophen|acetaminophen|mesh-list
5743548|NCT03081728|Diclofenac|diclofenac|mesh-list
5743549|NCT03081728|Ropivacaine|ropivacaine|mesh-list
5743550|NCT03081728|Anesthetics, Local|anesthetics, local|mesh-ancestor
5743551|NCT03081728|Anesthetics|anesthetics|mesh-ancestor
5743552|NCT03081728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6672879|NCT01558960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5692596|NCT03406689|Nepafenac|nepafenac|mesh-list
5743553|NCT03081728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743554|NCT03081728|Sensory System Agents|sensory system agents|mesh-ancestor
5743555|NCT03081728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5743556|NCT03081728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5621638|NCT05032950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5621639|NCT05032950|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5621640|NCT05032950|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5621641|NCT05032950|Protease Inhibitors|protease inhibitors|mesh-ancestor
5621642|NCT05032950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5621643|NCT05032950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5621644|NCT05032950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5621645|NCT05032950|Antiviral Agents|antiviral agents|mesh-ancestor
5621646|NCT05032950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5621647|NCT05032950|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5621648|NCT05032950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5621649|NCT05030766|Nicotine|nicotine|mesh-list
5621650|NCT05030766|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5621651|NCT05030766|Autonomic Agents|autonomic agents|mesh-ancestor
5621652|NCT05030766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5621653|NCT05030766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621654|NCT05030766|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5743557|NCT03081728|Analgesics|analgesics|mesh-ancestor
5743558|NCT03081728|Antipyretics|antipyretics|mesh-ancestor
5743559|NCT03081728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5743560|NCT03081728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5743561|NCT03081728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5621655|NCT05030766|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5621656|NCT05030766|Cholinergic Agents|cholinergic agents|mesh-ancestor
5621657|NCT05030766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5621658|NCT05030766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5621659|NCT05030441|Ivosidenib|ivosidenib|mesh-list
5621660|NCT05030441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5621661|NCT05030441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5621662|NCT05030441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5621663|NCT05026320|Diclofenac|diclofenac|mesh-list
5621664|NCT05026320|Naproxen|naproxen|mesh-list
5743562|NCT03081728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5743563|NCT03081728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5743564|NCT03081728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743565|NCT03081689|Paclitaxel|paclitaxel|mesh-list
5743566|NCT03081689|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5743567|NCT03081689|Carboplatin|carboplatin|mesh-list
5743568|NCT03081689|Nivolumab|nivolumab|mesh-list
5743569|NCT03081689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5743570|NCT03081689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5743571|NCT03081689|Tubulin Modulators|tubulin modulators|mesh-ancestor
5743572|NCT03081689|Antimitotic Agents|antimitotic agents|mesh-ancestor
5743573|NCT03081689|Mitosis Modulators|mitosis modulators|mesh-ancestor
5743574|NCT03081689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5621665|NCT05026320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5621666|NCT05026320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5621667|NCT05026320|Analgesics|analgesics|mesh-ancestor
5621668|NCT05026320|Sensory System Agents|sensory system agents|mesh-ancestor
5621669|NCT05026320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5621670|NCT05026320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621671|NCT05026320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5621672|NCT05026320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5743575|NCT03081689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5743576|NCT03081689|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5743577|NCT03081676|Glimepiride|glimepiride|mesh-list
5743578|NCT03081676|Glucagon|glucagon|mesh-list
5743579|NCT03081676|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
5743580|NCT03081676|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5743581|NCT03081676|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5743582|NCT03081676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5743583|NCT03081676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743584|NCT03081676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5743585|NCT03081676|Immunologic Factors|immunologic factors|mesh-ancestor
5743586|NCT03081676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5743587|NCT03081676|Hormones|hormones|mesh-ancestor
5743588|NCT03081676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5743589|NCT03081676|Incretins|incretins|mesh-ancestor
5743590|NCT03081416|Diphenhydramine|diphenhydramine|mesh-list
6672880|NCT01558960|Immunologic Factors|immunologic factors|mesh-ancestor
5743591|NCT03081416|Dexamethasone|dexamethasone|mesh-list
5621673|NCT05026320|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5621674|NCT05026320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5621675|NCT05026320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5621676|NCT05026320|Gout Suppressants|gout suppressants|mesh-ancestor
5621677|NCT05022927|Bevacizumab|bevacizumab|mesh-list
5621678|NCT05022927|Atezolizumab|atezolizumab|mesh-list
5621679|NCT05022927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5621680|NCT05022927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5621681|NCT05022927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5621682|NCT05022927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5621683|NCT05022927|Growth Substances|growth substances|mesh-ancestor
5621684|NCT05022927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621685|NCT05022927|Growth Inhibitors|growth inhibitors|mesh-ancestor
5621686|NCT05013437|Acetaminophen|acetaminophen|mesh-list
5621687|NCT05013437|Diphenhydramine|diphenhydramine|mesh-list
5621688|NCT05013437|Promethazine|promethazine|mesh-list
5743592|NCT03081416|Ketorolac|ketorolac|mesh-list
5743593|NCT03081416|Ketamine|ketamine|mesh-list
5743594|NCT03081416|Metoclopramide|metoclopramide|mesh-list
5743595|NCT03081416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5743596|NCT03081416|Antiemetics|antiemetics|mesh-ancestor
5743597|NCT03081416|Autonomic Agents|autonomic agents|mesh-ancestor
5743598|NCT03081416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5743599|NCT03081416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743600|NCT03081416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5743601|NCT03081416|Glucocorticoids|glucocorticoids|mesh-ancestor
5743602|NCT03081416|Hormones|hormones|mesh-ancestor
5743603|NCT03081416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5743604|NCT03081416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5743605|NCT03081416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5743606|NCT03081416|Analgesics|analgesics|mesh-ancestor
5743607|NCT03081416|Sensory System Agents|sensory system agents|mesh-ancestor
5743608|NCT03081416|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5743609|NCT03081416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5743610|NCT03081416|Anesthetics, General|anesthetics, general|mesh-ancestor
5743611|NCT03081416|Anesthetics|anesthetics|mesh-ancestor
5743612|NCT03081416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5743613|NCT03081416|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5743614|NCT03081416|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5743615|NCT03081416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5743616|NCT03081416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743617|NCT03081416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5743618|NCT03081416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5743619|NCT03081416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5743620|NCT03081416|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5743621|NCT03081416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5743622|NCT03081416|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5743623|NCT03081416|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5743624|NCT03081416|Dopamine Agents|dopamine agents|mesh-ancestor
5743625|NCT03081416|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5743626|NCT03081416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5743627|NCT03081416|Anesthetics, Local|anesthetics, local|mesh-ancestor
5743628|NCT03081416|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5743629|NCT03081416|Histamine Antagonists|histamine antagonists|mesh-ancestor
5743630|NCT03081416|Histamine Agents|histamine agents|mesh-ancestor
5743631|NCT03081416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5743632|NCT03081039|Gemcitabine|gemcitabine|mesh-list
5743633|NCT03081039|Carboplatin|carboplatin|mesh-list
5743634|NCT03081039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5743635|NCT03081039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5743636|NCT03081039|Antimetabolites|antimetabolites|mesh-ancestor
5743637|NCT03081039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743638|NCT03081039|Antiviral Agents|antiviral agents|mesh-ancestor
5743639|NCT03081039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5743640|NCT03081039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5743641|NCT03081039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5743642|NCT03081039|Immunologic Factors|immunologic factors|mesh-ancestor
5743643|NCT03081039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743644|NCT03081169|Heparin|heparin|mesh-list
5743645|NCT03081169|Enoxaparin|enoxaparin|mesh-list
5743646|NCT03081169|Enoxaparin sodium|enoxaparin sodium|mesh-list
5743647|NCT03081169|Anticoagulants|anticoagulants|mesh-ancestor
5621689|NCT05013437|Melphalan|melphalan|mesh-list
5621690|NCT05013437|Prochlorperazine|prochlorperazine|mesh-list
5621691|NCT05013437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5743648|NCT03081169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5743649|NCT03081169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5743650|NCT03081169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893922|NCT03278717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5893923|NCT03235505|Nicotine|nicotine|mesh-list
5893924|NCT03235505|Varenicline|varenicline|mesh-list
5893925|NCT03235505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5893926|NCT03235505|Autonomic Agents|autonomic agents|mesh-ancestor
5893927|NCT03235505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5893928|NCT03235505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893929|NCT03235505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5893930|NCT03235505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5893931|NCT03235505|Cholinergic Agents|cholinergic agents|mesh-ancestor
5893932|NCT03235505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5893933|NCT03235505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893934|NCT03159897|Doxorubicin|doxorubicin|mesh-list
5893935|NCT03159897|Bleomycin|bleomycin|mesh-list
5893936|NCT03159897|Dacarbazine|dacarbazine|mesh-list
5893937|NCT03159897|Vinblastine|vinblastine|mesh-list
5893938|NCT03159897|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5893939|NCT03159897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5893940|NCT03159897|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5893941|NCT03159897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5893942|NCT03159897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5893943|NCT03159897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893944|NCT03159897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5893945|NCT03159897|Alkylating Agents|alkylating agents|mesh-ancestor
5893946|NCT03159897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5893947|NCT03159897|Tubulin Modulators|tubulin modulators|mesh-ancestor
5893948|NCT03159897|Antimitotic Agents|antimitotic agents|mesh-ancestor
5893949|NCT03159897|Mitosis Modulators|mitosis modulators|mesh-ancestor
5893950|NCT03025035|Pembrolizumab|pembrolizumab|mesh-list
5893951|NCT03025035|Olaparib|olaparib|mesh-list
5893952|NCT03025035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5893953|NCT03025035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5893954|NCT03025035|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5893955|NCT03025035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5893956|NCT03025035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893957|NCT03018288|Pembrolizumab|pembrolizumab|mesh-list
6672881|NCT01558960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672882|NCT01558986|Cefazolin|cefazolin|mesh-list
6672883|NCT01558986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6672884|NCT01558986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6672885|NCT01559025|Vildagliptin|vildagliptin|mesh-list
6672886|NCT01559025|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
6672887|NCT01559025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6672888|NCT01559025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672889|NCT01559025|Protease Inhibitors|protease inhibitors|mesh-ancestor
6672890|NCT01559025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6672891|NCT01559025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5621692|NCT05013437|Analgesics|analgesics|mesh-ancestor
5621693|NCT05013437|Sensory System Agents|sensory system agents|mesh-ancestor
5621694|NCT05013437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5621695|NCT05013437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621696|NCT05013437|Antipyretics|antipyretics|mesh-ancestor
5621697|NCT05013437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5621698|NCT05013437|Alkylating Agents|alkylating agents|mesh-ancestor
5621699|NCT05013437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5621700|NCT05013437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5621701|NCT05013437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5621702|NCT05013437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5621703|NCT05013437|Immunologic Factors|immunologic factors|mesh-ancestor
5621704|NCT05013437|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5621705|NCT05013437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5621706|NCT05013437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5621707|NCT05013437|Anesthetics, Local|anesthetics, local|mesh-ancestor
5621708|NCT05013437|Anesthetics|anesthetics|mesh-ancestor
5621709|NCT05013437|Antiemetics|antiemetics|mesh-ancestor
5621710|NCT05013437|Autonomic Agents|autonomic agents|mesh-ancestor
5621711|NCT05013437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5621712|NCT05013437|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5621713|NCT05013437|Histamine Antagonists|histamine antagonists|mesh-ancestor
5621714|NCT05013437|Histamine Agents|histamine agents|mesh-ancestor
6672892|NCT01559051|Anesthetics|anesthetics|mesh-list
6672893|NCT01559051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5621715|NCT05013437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5893958|NCT03018288|Temozolomide|temozolomide|mesh-list
5743651|NCT03081052|Nitric Oxide|nitric oxide|mesh-list
5743652|NCT03081052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5743653|NCT03081052|Autonomic Agents|autonomic agents|mesh-ancestor
5743654|NCT03081052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5743655|NCT03081052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743656|NCT03081052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5743657|NCT03081052|Respiratory System Agents|respiratory system agents|mesh-ancestor
5743658|NCT03081052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5743659|NCT03081052|Antioxidants|antioxidants|mesh-ancestor
5743660|NCT03081052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743661|NCT03081052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5743662|NCT03081052|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5743663|NCT03081052|Vasodilator Agents|vasodilator agents|mesh-ancestor
5743664|NCT03081052|Gasotransmitters|gasotransmitters|mesh-ancestor
5743665|NCT03081052|Protective Agents|protective agents|mesh-ancestor
5743666|NCT03081442|Misoprostol|misoprostol|mesh-list
5743667|NCT03081442|Contraceptive Agents|contraceptive agents|mesh-list
5743668|NCT03081442|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5743669|NCT03081442|Abortifacient Agents|abortifacient agents|mesh-ancestor
5743670|NCT03081442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5743671|NCT03081442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743672|NCT03081442|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5743673|NCT03081442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5743674|NCT03081442|Oxytocics|oxytocics|mesh-ancestor
5743675|NCT03081143|Paclitaxel|paclitaxel|mesh-list
5743676|NCT03081143|Ramucirumab|ramucirumab|mesh-list
5743677|NCT03081143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5743678|NCT03081143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5743679|NCT03081143|Tubulin Modulators|tubulin modulators|mesh-ancestor
5743680|NCT03081143|Antimitotic Agents|antimitotic agents|mesh-ancestor
5743681|NCT03081143|Mitosis Modulators|mitosis modulators|mesh-ancestor
5743682|NCT03081143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743683|NCT03080974|Nivolumab|nivolumab|mesh-list
5743684|NCT03080974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5743685|NCT03080974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5743686|NCT03080974|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5743687|NCT03080974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743688|NCT03080675|Vitamins|vitamins|mesh-list
5743689|NCT03080675|Micronutrients|micronutrients|mesh-ancestor
5743690|NCT03080675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743691|NCT03080740|Metronidazole|metronidazole|mesh-list
5743692|NCT03080740|Clindamycin|clindamycin|mesh-list
5743693|NCT03080740|Clindamycin palmitate|clindamycin palmitate|mesh-list
5743694|NCT03080740|Clindamycin phosphate|clindamycin phosphate|mesh-list
5743695|NCT03080740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5743696|NCT03080740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5743697|NCT03080740|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5621716|NCT05013437|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5621717|NCT05013437|Antipruritics|antipruritics|mesh-ancestor
5621718|NCT05013437|Dermatologic Agents|dermatologic agents|mesh-ancestor
5621719|NCT05013437|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5621720|NCT05013437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5621721|NCT05013437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5621722|NCT05013437|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5621723|NCT05013437|Dopamine Agents|dopamine agents|mesh-ancestor
5621727|NCT05008276|Dextrans|dextrans|mesh-list
5621728|NCT05008276|Anticoagulants|anticoagulants|mesh-ancestor
5621729|NCT05008276|Plasma Substitutes|plasma substitutes|mesh-ancestor
5621730|NCT05008276|Blood Substitutes|blood substitutes|mesh-ancestor
5621731|NCT05005312|Ritonavir|ritonavir|mesh-list
5621732|NCT05005312|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5621733|NCT05005312|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5743698|NCT03080740|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5743699|NCT03080740|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5743700|NCT03080740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5743701|NCT03080740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743702|NCT03080766|Decitabine|decitabine|mesh-list
5743703|NCT03080766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5743704|NCT03080766|Antimetabolites|antimetabolites|mesh-ancestor
5743705|NCT03080766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743706|NCT03080766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5743707|NCT03080766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5621734|NCT05005312|Protease Inhibitors|protease inhibitors|mesh-ancestor
5621735|NCT05005312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5621736|NCT05005312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5621737|NCT05005312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5621738|NCT05005312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5621739|NCT05005312|Antiviral Agents|antiviral agents|mesh-ancestor
5621740|NCT05005312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5621741|NCT05005312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5621742|NCT05005312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5621743|NCT04995120|Paclitaxel|paclitaxel|mesh-list
5621744|NCT04995120|Cisplatin|cisplatin|mesh-list
5621745|NCT04995120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5743708|NCT03080441|Midodrine|midodrine|mesh-list
5743709|NCT03080441|Sympathomimetics|sympathomimetics|mesh-ancestor
5743710|NCT03080441|Autonomic Agents|autonomic agents|mesh-ancestor
5743711|NCT03080441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5743712|NCT03080441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743713|NCT03080441|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5743714|NCT03080441|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5743715|NCT03080441|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5743716|NCT03080441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5743717|NCT03080441|Adrenergic Agents|adrenergic agents|mesh-ancestor
5743718|NCT03080441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5743719|NCT03080441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743720|NCT03080805|Capecitabine|capecitabine|mesh-list
5743721|NCT03080805|Lapatinib|lapatinib|mesh-list
5621746|NCT04995120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5621747|NCT04995120|Tubulin Modulators|tubulin modulators|mesh-ancestor
5621748|NCT04995120|Antimitotic Agents|antimitotic agents|mesh-ancestor
5621749|NCT04995120|Mitosis Modulators|mitosis modulators|mesh-ancestor
5621750|NCT04995120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5621751|NCT04989946|Nivolumab|nivolumab|mesh-list
5621752|NCT04989946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5621753|NCT04989946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5621754|NCT04989946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5621755|NCT04989946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5621756|NCT04973150|Anesthetics|anesthetics|mesh-list
5621757|NCT04973150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5621758|NCT04973150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621759|NCT04971837|Cannabidiol|cannabidiol|mesh-list
5621760|NCT04971837|Sorbitol|sorbitol|mesh-list
5621761|NCT04971837|Anticonvulsants|anticonvulsants|mesh-ancestor
5621762|NCT04971837|Cathartics|cathartics|mesh-ancestor
5621763|NCT04971837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5621764|NCT04971499|Dapansutrile|dapansutrile|mesh-list
5621765|NCT04971499|Pembrolizumab|pembrolizumab|mesh-list
5621766|NCT04971499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5621767|NCT04971499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5621768|NCT04971499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5621769|NCT04964960|Paclitaxel|paclitaxel|mesh-list
5621770|NCT04964960|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5743722|NCT03080805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5743723|NCT03080805|Antimetabolites|antimetabolites|mesh-ancestor
5743724|NCT03080805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743725|NCT03080805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5743726|NCT03080805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5743727|NCT03080805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5743728|NCT03080415|Sofosbuvir|sofosbuvir|mesh-list
5743729|NCT03080415|Antiviral Agents|antiviral agents|mesh-ancestor
5743730|NCT03080415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5743731|NCT03080363|Lidocaine|lidocaine|mesh-list
5743732|NCT03080363|Bupivacaine|bupivacaine|mesh-list
5743733|NCT03080363|Anesthetics, Local|anesthetics, local|mesh-ancestor
5743734|NCT03080363|Anesthetics|anesthetics|mesh-ancestor
5743735|NCT03080363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5743736|NCT03080363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621771|NCT04964960|Carboplatin|carboplatin|mesh-list
5621772|NCT04964960|Pembrolizumab|pembrolizumab|mesh-list
5621773|NCT04964960|Pemetrexed|pemetrexed|mesh-list
5621774|NCT04964960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5621775|NCT04964960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5621776|NCT04964960|Tubulin Modulators|tubulin modulators|mesh-ancestor
5621777|NCT04964960|Antimitotic Agents|antimitotic agents|mesh-ancestor
5621778|NCT04964960|Mitosis Modulators|mitosis modulators|mesh-ancestor
5621779|NCT04964960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743737|NCT03080363|Sensory System Agents|sensory system agents|mesh-ancestor
5621780|NCT04964960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5743738|NCT03080363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5621781|NCT04964960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5621782|NCT04964960|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5621783|NCT04964960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5621784|NCT04959175|Mycophenolic Acid|mycophenolic acid|mesh-list
5621785|NCT04959175|Sirolimus|sirolimus|mesh-list
5621786|NCT04959175|Cyclophosphamide|cyclophosphamide|mesh-list
5621787|NCT04959175|Fludarabine|fludarabine|mesh-list
5743739|NCT03080363|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5743740|NCT03080363|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5743741|NCT03080363|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5743742|NCT03080363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5743743|NCT03080363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743744|NCT03080324|Fentanyl|fentanyl|mesh-list
5743745|NCT03080324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5743746|NCT03080324|Narcotics|narcotics|mesh-ancestor
5743747|NCT03080324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5743748|NCT03080324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743749|NCT03080324|Analgesics|analgesics|mesh-ancestor
5743750|NCT03080324|Sensory System Agents|sensory system agents|mesh-ancestor
5743751|NCT03080324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5743752|NCT03080324|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5743753|NCT03080324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5743754|NCT03080324|Anesthetics, General|anesthetics, general|mesh-ancestor
5743755|NCT03080324|Anesthetics|anesthetics|mesh-ancestor
5743756|NCT03080545|Calcitriol|calcitriol|mesh-list
5743757|NCT03080545|Betamethasone|betamethasone|mesh-list
5743758|NCT03080545|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5743759|NCT03080545|Calcipotriene|calcipotriene|mesh-list
5743760|NCT03080545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5743761|NCT03080545|Glucocorticoids|glucocorticoids|mesh-ancestor
5743762|NCT03080545|Hormones|hormones|mesh-ancestor
5743763|NCT03080545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5743764|NCT03080545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743765|NCT03080545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5743766|NCT03080545|Respiratory System Agents|respiratory system agents|mesh-ancestor
5743767|NCT03080545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5743768|NCT03080545|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
5743769|NCT03080545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5743770|NCT03080545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743771|NCT03080545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5743772|NCT03080545|Vitamins|vitamins|mesh-ancestor
5743773|NCT03080545|Micronutrients|micronutrients|mesh-ancestor
5743774|NCT03080545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5743775|NCT03080545|Dermatologic Agents|dermatologic agents|mesh-ancestor
5743776|NCT03080480|Pioglitazone|pioglitazone|mesh-list
5743777|NCT03080480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5743778|NCT03080480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743779|NCT03080350|Fentanyl|fentanyl|mesh-list
5743780|NCT03080350|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5743781|NCT03080350|Narcotics|narcotics|mesh-ancestor
5621788|NCT04959175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5621789|NCT04959175|Immunologic Factors|immunologic factors|mesh-ancestor
5621790|NCT04959175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621791|NCT04959175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5621792|NCT04959175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5743782|NCT03080350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5743783|NCT03080350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743784|NCT03080350|Analgesics|analgesics|mesh-ancestor
5743785|NCT03080350|Sensory System Agents|sensory system agents|mesh-ancestor
5743786|NCT03080350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5743787|NCT03080350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5743788|NCT03080350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5743789|NCT03080350|Anesthetics, General|anesthetics, general|mesh-ancestor
5743790|NCT03080350|Anesthetics|anesthetics|mesh-ancestor
5743791|NCT03080181|Pasireotide|pasireotide|mesh-list
5743792|NCT03080181|Hormones|hormones|mesh-ancestor
5743793|NCT03080181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5621793|NCT04959175|Alkylating Agents|alkylating agents|mesh-ancestor
5621794|NCT04959175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5621795|NCT04959175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5621796|NCT04959175|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5621797|NCT04959175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5621798|NCT04959175|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5621799|NCT04959175|Antitubercular Agents|antitubercular agents|mesh-ancestor
5743794|NCT03080181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621800|NCT04959175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5621801|NCT04959175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5621802|NCT04959175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5621803|NCT04959175|Antifungal Agents|antifungal agents|mesh-ancestor
5621804|NCT04958044|Calcium|calcium|mesh-list
5621805|NCT04958044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5621806|NCT04958044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621807|NCT04954196|Amlodipine|amlodipine|mesh-list
5621808|NCT04954196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5621809|NCT04954196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5621810|NCT04954196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5621811|NCT04954196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5621812|NCT04954196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5743795|NCT03080194|Paliperidone Palmitate|paliperidone palmitate|mesh-list
5743796|NCT03080194|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5743797|NCT03080194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5743798|NCT03080194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5743799|NCT03080194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743800|NCT03080194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5743801|NCT03080194|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5743802|NCT03080194|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5743803|NCT03080194|Serotonin Agents|serotonin agents|mesh-ancestor
5743804|NCT03080194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5743805|NCT03080194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743806|NCT03080194|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5743807|NCT03080194|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5743808|NCT03080194|Dopamine Agents|dopamine agents|mesh-ancestor
5743809|NCT03079921|Propranolol|propranolol|mesh-list
5743810|NCT03079921|Phentolamine|phentolamine|mesh-list
5743811|NCT03079921|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5743812|NCT03079921|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5743813|NCT03079921|Adrenergic Agents|adrenergic agents|mesh-ancestor
5743814|NCT03079921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5743815|NCT03079921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743816|NCT03079921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743817|NCT03079921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5743818|NCT03079921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5743819|NCT03079921|Vasodilator Agents|vasodilator agents|mesh-ancestor
5743820|NCT03079921|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5743821|NCT03079973|Calcipotriene|calcipotriene|mesh-list
5743822|NCT03079973|Dermatologic Agents|dermatologic agents|mesh-ancestor
5743823|NCT03079830|Pirinitramide|pirinitramide|mesh-list
5743824|NCT03079830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5743825|NCT03079830|Narcotics|narcotics|mesh-ancestor
5743826|NCT03079830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5743827|NCT03079830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743828|NCT03079830|Analgesics|analgesics|mesh-ancestor
5743829|NCT03079830|Sensory System Agents|sensory system agents|mesh-ancestor
5743830|NCT03079830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5743831|NCT03080103|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5743832|NCT03080103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5621813|NCT04954196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621814|NCT04954196|Vasodilator Agents|vasodilator agents|mesh-ancestor
5692597|NCT03406689|Lubricant Eye Drops|lubricant eye drops|mesh-list
5692598|NCT03406689|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5692599|NCT03406689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5692600|NCT03406689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5692601|NCT03406689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5692602|NCT03406689|Analgesics|analgesics|mesh-ancestor
5692603|NCT03406689|Sensory System Agents|sensory system agents|mesh-ancestor
5692604|NCT03406689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5692605|NCT03406689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692606|NCT03406689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5692607|NCT03406689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5692608|NCT03406676|Methylene Blue|methylene blue|mesh-list
5692609|NCT03406676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5692610|NCT03406676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692611|NCT03406650|Durvalumab|durvalumab|mesh-list
5692612|NCT03406650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5692613|NCT03406650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5692614|NCT03406546|Dexmedetomidine|dexmedetomidine|mesh-list
5692615|NCT03406546|Remifentanil|remifentanil|mesh-list
5692616|NCT03406546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5743833|NCT03079895|Nicotine|nicotine|mesh-list
5692617|NCT03406546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5743834|NCT03079895|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5743835|NCT03079895|Autonomic Agents|autonomic agents|mesh-ancestor
5743836|NCT03079895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5743837|NCT03079895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743838|NCT03079895|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5743839|NCT03079895|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5743840|NCT03079895|Cholinergic Agents|cholinergic agents|mesh-ancestor
5743841|NCT03079895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5743842|NCT03079895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893959|NCT03018288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5893960|NCT03018288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5893961|NCT03018288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5893962|NCT03018288|Alkylating Agents|alkylating agents|mesh-ancestor
5893963|NCT03018288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893964|NCT03003325|Aspirin|aspirin|mesh-list
5893965|NCT03003325|Interferons|interferons|mesh-list
5893966|NCT03003325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5893967|NCT03003325|Antiviral Agents|antiviral agents|mesh-ancestor
5893968|NCT03003325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5893969|NCT03003325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5893970|NCT03003325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5893971|NCT03003325|Analgesics|analgesics|mesh-ancestor
5893972|NCT03003325|Sensory System Agents|sensory system agents|mesh-ancestor
5893973|NCT03003325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5893974|NCT03003325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5893975|NCT03003325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5893976|NCT03003325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5893977|NCT03003325|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5893978|NCT03003325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5893979|NCT03003325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5893980|NCT03003325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5893981|NCT03003325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5893982|NCT03003325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5893983|NCT03003325|Antipyretics|antipyretics|mesh-ancestor
5893984|NCT02955823|Dexamethasone|dexamethasone|mesh-list
5893985|NCT02955823|Rituximab|rituximab|mesh-list
5893986|NCT02955823|Lenalidomide|lenalidomide|mesh-list
5893987|NCT02955823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5893988|NCT02955823|Antiemetics|antiemetics|mesh-ancestor
5893989|NCT02955823|Autonomic Agents|autonomic agents|mesh-ancestor
5893990|NCT02955823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5621815|NCT04942067|Dexamethasone|dexamethasone|mesh-list
5621816|NCT04942067|Dexamethasone acetate|dexamethasone acetate|mesh-list
5621817|NCT04942067|Lenalidomide|lenalidomide|mesh-list
5621818|NCT04942067|Daratumumab|daratumumab|mesh-list
5621819|NCT04942067|Pomalidomide|pomalidomide|mesh-list
5621820|NCT04942067|BB 1101|bb 1101|mesh-list
5621821|NCT04942067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5621822|NCT04942067|Antiemetics|antiemetics|mesh-ancestor
5621823|NCT04942067|Autonomic Agents|autonomic agents|mesh-ancestor
5621824|NCT04942067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5621825|NCT04942067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621826|NCT04942067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5621827|NCT04942067|Glucocorticoids|glucocorticoids|mesh-ancestor
5621828|NCT04942067|Hormones|hormones|mesh-ancestor
5621829|NCT04942067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5621830|NCT04942067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5621831|NCT04942067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5621832|NCT04942067|Protease Inhibitors|protease inhibitors|mesh-ancestor
5621833|NCT04942067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5621834|NCT04942067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5621835|NCT04942067|Immunologic Factors|immunologic factors|mesh-ancestor
5621836|NCT04942067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5621837|NCT04942067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5621838|NCT04942067|Growth Substances|growth substances|mesh-ancestor
5621839|NCT04942067|Growth Inhibitors|growth inhibitors|mesh-ancestor
5621840|NCT04931342|Paclitaxel|paclitaxel|mesh-list
5621841|NCT04931342|Maytansine|maytansine|mesh-list
5621842|NCT04931342|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
5621843|NCT04931342|Bevacizumab|bevacizumab|mesh-list
5621844|NCT04931342|Trastuzumab|trastuzumab|mesh-list
5621845|NCT04931342|Atezolizumab|atezolizumab|mesh-list
5621846|NCT04931342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5621847|NCT04931342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5621848|NCT04931342|Tubulin Modulators|tubulin modulators|mesh-ancestor
5893991|NCT02955823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743843|NCT03079687|Olaparib|olaparib|mesh-list
5743844|NCT03079687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5743845|NCT03079687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5743846|NCT03079687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743847|NCT03079687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5743848|NCT03079440|Capecitabine|capecitabine|mesh-list
5743849|NCT03079440|Temozolomide|temozolomide|mesh-list
5743850|NCT03079440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5743851|NCT03079440|Antimetabolites|antimetabolites|mesh-ancestor
5743852|NCT03079440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743853|NCT03079440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5743854|NCT03079440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5743855|NCT03079440|Alkylating Agents|alkylating agents|mesh-ancestor
5743856|NCT03079557|Botulinum Toxins|botulinum toxins|mesh-list
5743857|NCT03079557|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5743858|NCT03079557|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5743859|NCT03079557|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5743860|NCT03079557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5743861|NCT03079557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743862|NCT03079557|Cholinergic Agents|cholinergic agents|mesh-ancestor
5743863|NCT03079557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5743864|NCT03079557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743865|NCT03079557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5743866|NCT03079557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5743867|NCT03079453|Dexamethasone|dexamethasone|mesh-list
5621849|NCT04931342|Antimitotic Agents|antimitotic agents|mesh-ancestor
5621850|NCT04931342|Mitosis Modulators|mitosis modulators|mesh-ancestor
5621851|NCT04931342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5621852|NCT04931342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5621853|NCT04931342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5621854|NCT04931342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5621855|NCT04931342|Growth Substances|growth substances|mesh-ancestor
5621856|NCT04931342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743868|NCT03079453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5743869|NCT03079453|Antiemetics|antiemetics|mesh-ancestor
5743870|NCT03079453|Autonomic Agents|autonomic agents|mesh-ancestor
5743871|NCT03079453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5743872|NCT03079453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743873|NCT03079453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5743874|NCT03079453|Glucocorticoids|glucocorticoids|mesh-ancestor
5621857|NCT04931342|Growth Inhibitors|growth inhibitors|mesh-ancestor
5621858|NCT04907214|Empagliflozin|empagliflozin|mesh-list
5621859|NCT04907214|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5621860|NCT04907214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5621861|NCT04907214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5743875|NCT03079453|Hormones|hormones|mesh-ancestor
5743876|NCT03079453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5743877|NCT03079453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5743878|NCT03079453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5743879|NCT03079388|Azithromycin|azithromycin|mesh-list
5743880|NCT03079388|Pyrimethamine|pyrimethamine|mesh-list
5743881|NCT03079388|Sulfadoxine|sulfadoxine|mesh-list
5743882|NCT03079388|Albendazole|albendazole|mesh-list
5743883|NCT03079388|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
5621862|NCT04907214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621863|NCT04891809|Dexamethasone|dexamethasone|mesh-list
5621864|NCT04891809|Lenalidomide|lenalidomide|mesh-list
5621865|NCT04891809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5621866|NCT04891809|Antiemetics|antiemetics|mesh-ancestor
5621867|NCT04891809|Autonomic Agents|autonomic agents|mesh-ancestor
5621868|NCT04891809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5621869|NCT04891809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621870|NCT04891809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5621871|NCT04891809|Glucocorticoids|glucocorticoids|mesh-ancestor
5621872|NCT04891809|Hormones|hormones|mesh-ancestor
5621873|NCT04891809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5621874|NCT04891809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5621875|NCT04891809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5621876|NCT04891809|Immunologic Factors|immunologic factors|mesh-ancestor
5621877|NCT04891809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5621878|NCT04891809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5621879|NCT04891809|Growth Substances|growth substances|mesh-ancestor
5621880|NCT04891809|Growth Inhibitors|growth inhibitors|mesh-ancestor
5621881|NCT04891419|Lidocaine|lidocaine|mesh-list
5743884|NCT03079388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5743885|NCT03079388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5621882|NCT04891419|Anesthetics, Local|anesthetics, local|mesh-ancestor
5621883|NCT04891419|Anesthetics|anesthetics|mesh-ancestor
5621884|NCT04891419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5621885|NCT04891419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621886|NCT04891419|Sensory System Agents|sensory system agents|mesh-ancestor
5621887|NCT04891419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5621888|NCT04891419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5621889|NCT04891419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5621890|NCT04891419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5621891|NCT04891419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5621892|NCT04891419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743886|NCT03079388|Antimalarials|antimalarials|mesh-ancestor
5743887|NCT03079388|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5743888|NCT03079388|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5743889|NCT03079388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5743890|NCT03079388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5743891|NCT03079388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743892|NCT03079388|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5743893|NCT03079388|Renal Agents|renal agents|mesh-ancestor
5743894|NCT03079388|Anthelmintics|anthelmintics|mesh-ancestor
5743895|NCT03079388|Anticestodal Agents|anticestodal agents|mesh-ancestor
5743896|NCT03079388|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5743897|NCT03079388|Tubulin Modulators|tubulin modulators|mesh-ancestor
5743898|NCT03079388|Antimitotic Agents|antimitotic agents|mesh-ancestor
5743899|NCT03079388|Mitosis Modulators|mitosis modulators|mesh-ancestor
5743900|NCT03079388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5743901|NCT03079544|Asparaginase|asparaginase|mesh-list
5743902|NCT03079544|Pegaspargase|pegaspargase|mesh-list
5743903|NCT03079544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5743904|NCT03079505|Dasatinib|dasatinib|mesh-list
5743905|NCT03079505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5743906|NCT03079505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5743907|NCT03079505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5743908|NCT03079505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743909|NCT03079427|Gemcitabine|gemcitabine|mesh-list
5743910|NCT03079427|Cisplatin|cisplatin|mesh-list
5743911|NCT03079427|Capecitabine|capecitabine|mesh-list
5743912|NCT03079427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5743913|NCT03079427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5743914|NCT03079427|Antimetabolites|antimetabolites|mesh-ancestor
5743915|NCT03079427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743916|NCT03079427|Antiviral Agents|antiviral agents|mesh-ancestor
5743917|NCT03079427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5743918|NCT03079427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5743919|NCT03079427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5743920|NCT03079427|Immunologic Factors|immunologic factors|mesh-ancestor
5743921|NCT03079427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743922|NCT03079219|Dexamethasone|dexamethasone|mesh-list
5743923|NCT03079219|Dexamethasone acetate|dexamethasone acetate|mesh-list
5743924|NCT03079219|Ondansetron|ondansetron|mesh-list
5743925|NCT03079219|Olanzapine|olanzapine|mesh-list
5743926|NCT03079219|Aprepitant|aprepitant|mesh-list
5743927|NCT03079219|Fosaprepitant|fosaprepitant|mesh-list
5743928|NCT03079219|BB 1101|bb 1101|mesh-list
5743929|NCT03079219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5743930|NCT03079219|Antiemetics|antiemetics|mesh-ancestor
5743931|NCT03079219|Autonomic Agents|autonomic agents|mesh-ancestor
5743932|NCT03079219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5743933|NCT03079219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743934|NCT03079219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5743935|NCT03079219|Glucocorticoids|glucocorticoids|mesh-ancestor
5743936|NCT03079219|Hormones|hormones|mesh-ancestor
5743937|NCT03079219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6672894|NCT01559051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672895|NCT01559142|Azathioprine|azathioprine|mesh-list
6672896|NCT01559142|Infliximab|infliximab|mesh-list
6672897|NCT01559142|Dermatologic Agents|dermatologic agents|mesh-ancestor
5621893|NCT04890106|Bimatoprost|bimatoprost|mesh-list
5621894|NCT04890106|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5621895|NCT04890106|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5621896|NCT04890106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5621897|NCT04885881|Lidocaine|lidocaine|mesh-list
5743938|NCT03079219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5743939|NCT03079219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5743940|NCT03079219|Protease Inhibitors|protease inhibitors|mesh-ancestor
5743941|NCT03079219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5621898|NCT04885881|Anesthetics, Local|anesthetics, local|mesh-ancestor
5621899|NCT04885881|Anesthetics|anesthetics|mesh-ancestor
5743942|NCT03079219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743943|NCT03079219|Antipruritics|antipruritics|mesh-ancestor
5743944|NCT03079219|Dermatologic Agents|dermatologic agents|mesh-ancestor
5743945|NCT03079219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5743946|NCT03079219|Serotonin Agents|serotonin agents|mesh-ancestor
5743947|NCT03079219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5743948|NCT03079219|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5743949|NCT03079219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5743950|NCT03079219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5743951|NCT03079219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5743952|NCT03079219|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5743953|NCT03079219|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5743954|NCT03079219|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5743955|NCT03079219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5743956|NCT03079219|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5743957|NCT03079271|Benzocaine|benzocaine|mesh-list
5743958|NCT03079271|Anesthetics, Local|anesthetics, local|mesh-ancestor
5743959|NCT03079271|Anesthetics|anesthetics|mesh-ancestor
5743960|NCT03079271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5743961|NCT03079271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743962|NCT03079271|Sensory System Agents|sensory system agents|mesh-ancestor
5743963|NCT03079271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5743964|NCT03078933|Nitric Oxide|nitric oxide|mesh-list
5743965|NCT03078933|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5743966|NCT03078933|Autonomic Agents|autonomic agents|mesh-ancestor
5743967|NCT03078933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5743968|NCT03078933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743969|NCT03078933|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5743970|NCT03078933|Respiratory System Agents|respiratory system agents|mesh-ancestor
5621900|NCT04885881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5621901|NCT04885881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621902|NCT04885881|Sensory System Agents|sensory system agents|mesh-ancestor
5621903|NCT04885881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5621904|NCT04885881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5743971|NCT03078933|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5743972|NCT03078933|Antioxidants|antioxidants|mesh-ancestor
5743973|NCT03078933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5743974|NCT03078933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5743975|NCT03078933|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5743976|NCT03078933|Vasodilator Agents|vasodilator agents|mesh-ancestor
5743977|NCT03078933|Gasotransmitters|gasotransmitters|mesh-ancestor
5743978|NCT03078933|Protective Agents|protective agents|mesh-ancestor
5743979|NCT03079167|Epoetin Alfa|epoetin alfa|mesh-list
5743980|NCT03079167|Hematinics|hematinics|mesh-ancestor
5743981|NCT03078855|Vitamin D|vitamin d|mesh-list
5743982|NCT03078855|Cholecalciferol|cholecalciferol|mesh-list
5743983|NCT03078855|Rituximab|rituximab|mesh-list
5743984|NCT03078855|Vitamins|vitamins|mesh-ancestor
5743985|NCT03078855|Micronutrients|micronutrients|mesh-ancestor
5743986|NCT03078855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743987|NCT03078855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5743988|NCT03078855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5743989|NCT03078855|Immunologic Factors|immunologic factors|mesh-ancestor
5743990|NCT03078855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5621905|NCT04885881|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5621906|NCT04885881|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5743991|NCT03078855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5743992|NCT03078855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5743993|NCT03078829|Leuprolide|leuprolide|mesh-list
5743994|NCT03078829|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5743995|NCT03078829|Fertility Agents|fertility agents|mesh-ancestor
5743996|NCT03078829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5743997|NCT03078829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5743998|NCT03078829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5743999|NCT03078829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5744000|NCT03079011|Letrozole|letrozole|mesh-list
5744001|NCT03079011|Fulvestrant|fulvestrant|mesh-list
5744002|NCT03079011|Palbociclib|palbociclib|mesh-list
5621907|NCT04885881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5621908|NCT04885881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5621909|NCT04885257|Methylphenidate|methylphenidate|mesh-list
5744003|NCT03079011|Anastrozole|anastrozole|mesh-list
5744004|NCT03079011|Exemestane|exemestane|mesh-list
5744005|NCT03079011|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5744006|NCT03079011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5744007|NCT03079011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5744008|NCT03079011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5744009|NCT03079011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744010|NCT03079011|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5744011|NCT03079011|Hormone Antagonists|hormone antagonists|mesh-ancestor
5744012|NCT03079011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5744013|NCT03079011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744014|NCT03079011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5744015|NCT03079011|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5744016|NCT03079011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5744017|NCT03079050|Dexlansoprazole|dexlansoprazole|mesh-list
5744018|NCT03079050|Lansoprazole|lansoprazole|mesh-list
5744019|NCT03079050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5744020|NCT03079050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5744021|NCT03079050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5744022|NCT03079050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5744023|NCT03079050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744024|NCT03079076|Bupivacaine|bupivacaine|mesh-list
5744025|NCT03079076|Anesthetics, Local|anesthetics, local|mesh-ancestor
5744026|NCT03079076|Anesthetics|anesthetics|mesh-ancestor
5744027|NCT03079076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5744028|NCT03079076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489385|NCT00591487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6489386|NCT00591487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6489387|NCT00591487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6489388|NCT00591487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489389|NCT00591526|Cytarabine|cytarabine|mesh-list
5744029|NCT03079076|Sensory System Agents|sensory system agents|mesh-ancestor
5744030|NCT03079076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5744031|NCT03079141|Eplerenone|eplerenone|mesh-list
5744032|NCT03079141|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5744033|NCT03079141|Hormone Antagonists|hormone antagonists|mesh-ancestor
5744034|NCT03079141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5744035|NCT03079141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744036|NCT03079141|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5744037|NCT03079141|Diuretics|diuretics|mesh-ancestor
5744038|NCT03079141|Natriuretic Agents|natriuretic agents|mesh-ancestor
5621910|NCT04885257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5621911|NCT04885257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621912|NCT04885257|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5621913|NCT04885257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5621914|NCT04885257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5621915|NCT04885257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5621916|NCT04885257|Dopamine Agents|dopamine agents|mesh-ancestor
5621917|NCT04885257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5621918|NCT04875533|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5621919|NCT04875533|Immunologic Factors|immunologic factors|mesh-ancestor
5621920|NCT04875533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621921|NCT04872595|Cyclophosphamide|cyclophosphamide|mesh-list
5621922|NCT04872595|Melphalan|melphalan|mesh-list
5621923|NCT04872595|Busulfan|busulfan|mesh-list
5621924|NCT04872595|Thiotepa|thiotepa|mesh-list
5621925|NCT04872595|Fludarabine|fludarabine|mesh-list
5621926|NCT04872595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5621927|NCT04872595|Immunologic Factors|immunologic factors|mesh-ancestor
5621928|NCT04872595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621929|NCT04872595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5621930|NCT04872595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5621931|NCT04872595|Alkylating Agents|alkylating agents|mesh-ancestor
5621932|NCT04872595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744039|NCT03079141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5744040|NCT03079115|Atorvastatin|atorvastatin|mesh-list
5744041|NCT03079115|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5744042|NCT03079115|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5744043|NCT03079115|Antimetabolites|antimetabolites|mesh-ancestor
5744044|NCT03079115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744045|NCT03079115|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5744046|NCT03079115|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5744047|NCT03079115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5744048|NCT03078842|Zinc|zinc|mesh-list
5744049|NCT03078842|Trace Elements|trace elements|mesh-ancestor
5744050|NCT03078842|Micronutrients|micronutrients|mesh-ancestor
5744051|NCT03078842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744052|NCT03078725|Metformin|metformin|mesh-list
5744053|NCT03078725|Glyburide|glyburide|mesh-list
5744054|NCT03078725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5744055|NCT03078725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744056|NCT03078465|Clopidogrel|clopidogrel|mesh-list
5744057|NCT03078465|Ticagrelor|ticagrelor|mesh-list
5744058|NCT03078465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5744059|NCT03078465|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5744060|NCT03078465|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5744061|NCT03078465|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5744062|NCT03078465|Purinergic Agents|purinergic agents|mesh-ancestor
5744063|NCT03078465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5621933|NCT04872595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5621934|NCT04872595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5621935|NCT04871360|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
5621936|NCT04871360|Laxatives|laxatives|mesh-ancestor
5621937|NCT04871360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5621938|NCT04860804|Aspirin|aspirin|mesh-list
5621939|NCT04860804|Ketamine|ketamine|mesh-list
5744064|NCT03078465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744065|NCT03078465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744066|NCT03078777|Fexofenadine|fexofenadine|mesh-list
5744067|NCT03078777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5744068|NCT03078777|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5744069|NCT03078777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5744070|NCT03078777|Histamine Antagonists|histamine antagonists|mesh-ancestor
5744071|NCT03078777|Histamine Agents|histamine agents|mesh-ancestor
5744072|NCT03078777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5744073|NCT03078777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744074|NCT03078777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744075|NCT03078374|Warfarin|warfarin|mesh-list
5744076|NCT03078374|Anticoagulants|anticoagulants|mesh-ancestor
5744077|NCT03078309|Cannabidiol|cannabidiol|mesh-list
5744078|NCT03078309|Anticonvulsants|anticonvulsants|mesh-ancestor
5744079|NCT03078569|Testosterone|testosterone|mesh-list
5744080|NCT03078569|Androgens|androgens|mesh-ancestor
5744081|NCT03078569|Hormones|hormones|mesh-ancestor
5744082|NCT03078569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5744083|NCT03078569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744084|NCT03078257|Aspirin|aspirin|mesh-list
5744085|NCT03078257|Tirofiban|tirofiban|mesh-list
5744086|NCT03078257|Fibrinolysin|fibrinolysin|mesh-list
5744087|NCT03078257|Clopidogrel|clopidogrel|mesh-list
5744088|NCT03078257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5744089|NCT03078257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5744090|NCT03078257|Analgesics|analgesics|mesh-ancestor
5744091|NCT03078257|Sensory System Agents|sensory system agents|mesh-ancestor
5744092|NCT03078257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5744093|NCT03078257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744094|NCT03078257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5744095|NCT03078257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5744096|NCT03078257|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5744097|NCT03078257|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5744098|NCT03078257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744099|NCT03078257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5744100|NCT03078257|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5744101|NCT03078257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5744102|NCT03078257|Antipyretics|antipyretics|mesh-ancestor
5744103|NCT03078257|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5744104|NCT03078257|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5744105|NCT03078257|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5744106|NCT03078257|Purinergic Agents|purinergic agents|mesh-ancestor
5744107|NCT03078257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5744108|NCT03078231|Mydriatics|mydriatics|mesh-list
5744109|NCT03078231|Autonomic Agents|autonomic agents|mesh-ancestor
5744110|NCT03078231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5744111|NCT03078231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744112|NCT03078062|Dexamethasone|dexamethasone|mesh-list
5621940|NCT04860804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5621941|NCT04860804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5744113|NCT03078062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5744114|NCT03078062|Antiemetics|antiemetics|mesh-ancestor
5744115|NCT03078062|Autonomic Agents|autonomic agents|mesh-ancestor
5621942|NCT04860804|Analgesics|analgesics|mesh-ancestor
5744116|NCT03078062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5744117|NCT03078062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744118|NCT03078062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5744119|NCT03078062|Glucocorticoids|glucocorticoids|mesh-ancestor
5744120|NCT03078062|Hormones|hormones|mesh-ancestor
5744121|NCT03078062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5744122|NCT03078062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5744123|NCT03078062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5893992|NCT02955823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5893993|NCT02955823|Glucocorticoids|glucocorticoids|mesh-ancestor
5893994|NCT02955823|Hormones|hormones|mesh-ancestor
5893995|NCT02955823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5893996|NCT02955823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5893997|NCT02955823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5893998|NCT02955823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5893999|NCT02955823|Immunologic Factors|immunologic factors|mesh-ancestor
5894000|NCT02955823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5894001|NCT02955823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5894002|NCT02955823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5894003|NCT02955823|Growth Substances|growth substances|mesh-ancestor
5894004|NCT02955823|Growth Inhibitors|growth inhibitors|mesh-ancestor
5894005|NCT02917993|Osimertinib|osimertinib|mesh-list
5894006|NCT02917993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5894007|NCT02917993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5621943|NCT04860804|Sensory System Agents|sensory system agents|mesh-ancestor
5621944|NCT04860804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5621945|NCT04860804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621946|NCT04860804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5621947|NCT04860804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5621948|NCT04860804|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5621949|NCT04860804|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5621950|NCT04860804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5621951|NCT04860804|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5621952|NCT04860804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5621953|NCT04860804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5621954|NCT04860804|Antipyretics|antipyretics|mesh-ancestor
5894008|NCT02917993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5894009|NCT02917993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894010|NCT02862132|Vedolizumab|vedolizumab|mesh-list
5894011|NCT02862132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5894012|NCT02772081|Poractant alfa|poractant alfa|mesh-list
5894013|NCT02772081|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
5894014|NCT02772081|Respiratory System Agents|respiratory system agents|mesh-ancestor
5894015|NCT02578394|Methylprednisolone|methylprednisolone|mesh-list
5894016|NCT02578394|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5894017|NCT02578394|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5894018|NCT02578394|Prednisolone|prednisolone|mesh-list
5894019|NCT02578394|Prednisolone acetate|prednisolone acetate|mesh-list
5894020|NCT02578394|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5894021|NCT02578394|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5894022|NCT02578394|Prednisolone phosphate|prednisolone phosphate|mesh-list
5894023|NCT02578394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5894024|NCT02578394|Antiemetics|antiemetics|mesh-ancestor
5621955|NCT04860804|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5621956|NCT04860804|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5621957|NCT04860804|Anesthetics, General|anesthetics, general|mesh-ancestor
5621958|NCT04860804|Anesthetics|anesthetics|mesh-ancestor
5621959|NCT04860804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5621960|NCT04860804|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5697698|NCT03374254|Fluorouracil|fluorouracil|mesh-list
5894025|NCT02578394|Autonomic Agents|autonomic agents|mesh-ancestor
5621961|NCT04860804|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5621962|NCT04860804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5621963|NCT04856904|Trifarotene|trifarotene|mesh-list
5621964|NCT04856904|Dermatologic Agents|dermatologic agents|mesh-ancestor
5621965|NCT04856488|Lugol's solution|lugol's solution|mesh-list
5621966|NCT04856488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5621967|NCT04856488|Hemostatics|hemostatics|mesh-ancestor
5621968|NCT04856488|Coagulants|coagulants|mesh-ancestor
6208686|NCT02134314|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
6208687|NCT02134314|Immunologic Factors|immunologic factors|mesh-ancestor
6208688|NCT02134314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208689|NCT02134314|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6208690|NCT02134314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6208691|NCT02134353|Mannitol|mannitol|mesh-list
5621975|NCT04843761|Remdesivir|remdesivir|mesh-list
5621976|NCT04843761|Phentolamine|phentolamine|mesh-list
5621977|NCT04843761|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
5621978|NCT04843761|Antimetabolites|antimetabolites|mesh-ancestor
5621979|NCT04843761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5621980|NCT04843761|Antiviral Agents|antiviral agents|mesh-ancestor
5621981|NCT04843761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5621982|NCT04843761|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5621983|NCT04843761|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5621984|NCT04843761|Adrenergic Agents|adrenergic agents|mesh-ancestor
5621985|NCT04843761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5744124|NCT03078101|Empagliflozin|empagliflozin|mesh-list
5744125|NCT03078101|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5744126|NCT03078101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744127|NCT03078101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5744128|NCT03078101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744129|NCT03077633|Progesterone|progesterone|mesh-list
5744130|NCT03077633|Progestins|progestins|mesh-ancestor
5744131|NCT03077633|Hormones|hormones|mesh-ancestor
5744132|NCT03077633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5744133|NCT03077633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744134|NCT03077698|Megestrol|megestrol|mesh-list
5744135|NCT03077698|Megestrol Acetate|megestrol acetate|mesh-list
5744136|NCT03077698|Progestins|progestins|mesh-list
5744137|NCT03077698|10-carboxymethyl-9-acridanone|10-carboxymethyl-9-acridanone|mesh-list
5744138|NCT03077698|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5744139|NCT03077698|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5744140|NCT03077698|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5744141|NCT03077698|Contraceptive Agents|contraceptive agents|mesh-ancestor
5744142|NCT03077698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5744143|NCT03077698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744144|NCT03077698|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5744145|NCT03077698|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5744146|NCT03077698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5744147|NCT03077698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5744148|NCT03077698|Appetite Stimulants|appetite stimulants|mesh-ancestor
5744149|NCT03077698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5744150|NCT03077698|Hormones|hormones|mesh-ancestor
5744151|NCT03077698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5744152|NCT03077698|Interferon Inducers|interferon inducers|mesh-ancestor
5744153|NCT03077698|Immunologic Factors|immunologic factors|mesh-ancestor
5744154|NCT03077581|Anesthetics|anesthetics|mesh-list
5744155|NCT03077581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5744156|NCT03077581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744157|NCT03077828|Carboplatin|carboplatin|mesh-list
5744158|NCT03077828|Pembrolizumab|pembrolizumab|mesh-list
5744159|NCT03077828|Etoposide|etoposide|mesh-list
5744160|NCT03077828|Etoposide phosphate|etoposide phosphate|mesh-list
5744161|NCT03077828|Ifosfamide|ifosfamide|mesh-list
5744162|NCT03077828|Isophosphamide mustard|isophosphamide mustard|mesh-list
5744163|NCT03077828|Podophyllotoxin|podophyllotoxin|mesh-list
5744164|NCT03077828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5744165|NCT03077828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5744166|NCT03077828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5744167|NCT03077828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5744168|NCT03077828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5744169|NCT03077828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5744170|NCT03077828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744171|NCT03077828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5621986|NCT04843761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621987|NCT04843761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5621988|NCT04843761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5621989|NCT04843761|Vasodilator Agents|vasodilator agents|mesh-ancestor
5621990|NCT04843761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5621991|NCT04843761|Protective Agents|protective agents|mesh-ancestor
5621992|NCT04823052|Sulindac|sulindac|mesh-list
5621993|NCT04823052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5621994|NCT04823052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5621995|NCT04823052|Analgesics|analgesics|mesh-ancestor
5621996|NCT04823052|Sensory System Agents|sensory system agents|mesh-ancestor
5621997|NCT04823052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5621998|NCT04823052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5621999|NCT04823052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5622000|NCT04823052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5622001|NCT04823052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5622002|NCT04823052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5622003|NCT04823052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5622004|NCT04823052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744172|NCT03077828|Alkylating Agents|alkylating agents|mesh-ancestor
5744173|NCT03077828|Keratolytic Agents|keratolytic agents|mesh-ancestor
5744174|NCT03077828|Dermatologic Agents|dermatologic agents|mesh-ancestor
5744175|NCT03077828|Tubulin Modulators|tubulin modulators|mesh-ancestor
5744176|NCT03077828|Antimitotic Agents|antimitotic agents|mesh-ancestor
5744177|NCT03077828|Mitosis Modulators|mitosis modulators|mesh-ancestor
5744178|NCT03077503|Fentanyl|fentanyl|mesh-list
5744179|NCT03077503|Dexmedetomidine|dexmedetomidine|mesh-list
5744180|NCT03077503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5744181|NCT03077503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5744182|NCT03077503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744183|NCT03077503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5744184|NCT03077503|Analgesics|analgesics|mesh-ancestor
5744185|NCT03077503|Sensory System Agents|sensory system agents|mesh-ancestor
5744186|NCT03077503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5744187|NCT03077503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5744188|NCT03077503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5744189|NCT03077503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5744190|NCT03077503|Adrenergic Agents|adrenergic agents|mesh-ancestor
5744191|NCT03077503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5744192|NCT03077503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744193|NCT03077503|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5744194|NCT03077503|Narcotics|narcotics|mesh-ancestor
5744195|NCT03077503|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5744196|NCT03077503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5744197|NCT03077503|Anesthetics, General|anesthetics, general|mesh-ancestor
5744198|NCT03077503|Anesthetics|anesthetics|mesh-ancestor
5744199|NCT03077516|Meloxicam|meloxicam|mesh-list
5744200|NCT03077516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5744201|NCT03077516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5744202|NCT03077516|Analgesics|analgesics|mesh-ancestor
5744203|NCT03077516|Sensory System Agents|sensory system agents|mesh-ancestor
5744204|NCT03077516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5622005|NCT04810494|Lidocaine|lidocaine|mesh-list
5622006|NCT04810494|Anesthetics, Local|anesthetics, local|mesh-ancestor
5622007|NCT04810494|Anesthetics|anesthetics|mesh-ancestor
5622008|NCT04810494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5622009|NCT04810494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622010|NCT04810494|Sensory System Agents|sensory system agents|mesh-ancestor
5622011|NCT04810494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5622012|NCT04810494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5622013|NCT04810494|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5622014|NCT04810494|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5622015|NCT04810494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5744205|NCT03077516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744206|NCT03077516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5744207|NCT03077516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5744208|NCT03077516|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5744209|NCT03077516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5744210|NCT03077516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5744211|NCT03077516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744212|NCT03077555|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6672898|NCT01559142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6672899|NCT01559142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6672900|NCT01559142|Antimetabolites|antimetabolites|mesh-ancestor
5697699|NCT03374254|Pembrolizumab|pembrolizumab|mesh-list
5744213|NCT03077555|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5744214|NCT03077555|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5744215|NCT03077555|Estradiol|estradiol|mesh-list
5744216|NCT03077555|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5744217|NCT03077555|Estrogens|estrogens|mesh-ancestor
5744218|NCT03077555|Hormones|hormones|mesh-ancestor
5744219|NCT03077555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5744220|NCT03077555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744221|NCT03077555|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5744222|NCT03077555|Contraceptive Agents|contraceptive agents|mesh-ancestor
5744223|NCT03077555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5744224|NCT03077555|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5744225|NCT03077555|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5744226|NCT03077555|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5744227|NCT03077451|Nelfinavir|nelfinavir|mesh-list
5744228|NCT03077451|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5744229|NCT03077451|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5744230|NCT03077451|Protease Inhibitors|protease inhibitors|mesh-ancestor
5744231|NCT03077451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5744232|NCT03077451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622016|NCT04810494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622017|NCT04796948|Leucovorin|leucovorin|mesh-list
5622018|NCT04796948|Fluorouracil|fluorouracil|mesh-list
5622019|NCT04796948|Oxaliplatin|oxaliplatin|mesh-list
5622020|NCT04796948|Irinotecan|irinotecan|mesh-list
5622021|NCT04796948|Calcium|calcium|mesh-list
5622022|NCT04796948|Levoleucovorin|levoleucovorin|mesh-list
5622023|NCT04796948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5622024|NCT04796948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622025|NCT04796948|Antimetabolites|antimetabolites|mesh-ancestor
5622026|NCT04796948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622027|NCT04796948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5622028|NCT04796948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5622029|NCT04796948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5622030|NCT04796948|Immunologic Factors|immunologic factors|mesh-ancestor
5622031|NCT04796948|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5622032|NCT04796948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5622033|NCT04796948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5622034|NCT04796948|Antidotes|antidotes|mesh-ancestor
5622035|NCT04796948|Protective Agents|protective agents|mesh-ancestor
5622036|NCT04796948|Vitamin B Complex|vitamin b complex|mesh-ancestor
5622037|NCT04796948|Vitamins|vitamins|mesh-ancestor
5622038|NCT04796948|Micronutrients|micronutrients|mesh-ancestor
5622039|NCT04792567|Siponimod|siponimod|mesh-list
5622040|NCT04792567|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5622041|NCT04792567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622042|NCT04792567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5622043|NCT04792567|Immunologic Factors|immunologic factors|mesh-ancestor
5744233|NCT03077451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5744234|NCT03077451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5744235|NCT03077451|Antiviral Agents|antiviral agents|mesh-ancestor
5744236|NCT03077451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5744237|NCT03077217|Rifaximin|rifaximin|mesh-list
5744238|NCT03077217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5744239|NCT03077217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5744240|NCT03077217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5744241|NCT03077009|Hyaluronic Acid|hyaluronic acid|mesh-list
5744242|NCT03077009|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5744243|NCT03077009|Immunologic Factors|immunologic factors|mesh-ancestor
5622044|NCT04792567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622045|NCT04788563|Antihypertensive Agents|antihypertensive agents|mesh-list
5692618|NCT03406546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692619|NCT03406546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5692620|NCT03406546|Analgesics|analgesics|mesh-ancestor
5692621|NCT03406546|Sensory System Agents|sensory system agents|mesh-ancestor
5692622|NCT03406546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5692623|NCT03406546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5692624|NCT03406546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5692625|NCT03406546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5692626|NCT03406546|Adrenergic Agents|adrenergic agents|mesh-ancestor
5692627|NCT03406546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5744244|NCT03077009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744245|NCT03077009|Viscosupplements|viscosupplements|mesh-ancestor
5744246|NCT03077009|Protective Agents|protective agents|mesh-ancestor
5744247|NCT03076905|Olorofim|olorofim|mesh-list
5692628|NCT03406546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744248|NCT03076905|Antifungal Agents|antifungal agents|mesh-ancestor
5744249|NCT03076905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5744250|NCT03076710|Bupivacaine|bupivacaine|mesh-list
5744251|NCT03076710|Anesthetics, Local|anesthetics, local|mesh-ancestor
5744252|NCT03076710|Anesthetics|anesthetics|mesh-ancestor
5744253|NCT03076710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5744254|NCT03076710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744255|NCT03076710|Sensory System Agents|sensory system agents|mesh-ancestor
5744256|NCT03076710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5744257|NCT03076762|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5744258|NCT03076762|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5744259|NCT03076762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5744260|NCT03076762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5744261|NCT03076762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744262|NCT03076762|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5744263|NCT03076762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5744264|NCT03076762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744265|NCT03076762|Cholinergic Agents|cholinergic agents|mesh-ancestor
5744266|NCT03076762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5622046|NCT04774315|Omalizumab|omalizumab|mesh-list
5622047|NCT04774315|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5622048|NCT04774315|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5622049|NCT04774315|Respiratory System Agents|respiratory system agents|mesh-ancestor
5622050|NCT04774107|Ribavirin|ribavirin|mesh-list
5622051|NCT04774107|Antimetabolites|antimetabolites|mesh-ancestor
5622052|NCT04774107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622053|NCT04774107|Antiviral Agents|antiviral agents|mesh-ancestor
5622054|NCT04774107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5622055|NCT04763577|Bradykinin|bradykinin|mesh-list
5622056|NCT04763577|Kininogens|kininogens|mesh-list
5622057|NCT04763577|Vasodilator Agents|vasodilator agents|mesh-ancestor
5622058|NCT04763577|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
5622059|NCT04763577|Protease Inhibitors|protease inhibitors|mesh-ancestor
5622060|NCT04763577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5622061|NCT04763577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622062|NCT04750824|Afatinib|afatinib|mesh-list
5622063|NCT04750824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5622064|NCT04750824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5622065|NCT04750824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5622066|NCT04750824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622067|NCT04731233|Triamcinolone|triamcinolone|mesh-list
5622068|NCT04731233|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5622069|NCT04731233|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5622070|NCT04731233|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5622071|NCT04731233|Mitogens|mitogens|mesh-list
5622072|NCT04731233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5744267|NCT03076684|Allopurinol|allopurinol|mesh-list
5744268|NCT03076684|Antimetabolites|antimetabolites|mesh-ancestor
5744269|NCT03076684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744270|NCT03076684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5744271|NCT03076684|Gout Suppressants|gout suppressants|mesh-ancestor
5744272|NCT03076684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5744273|NCT03076684|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5744274|NCT03076684|Antioxidants|antioxidants|mesh-ancestor
5744275|NCT03076684|Protective Agents|protective agents|mesh-ancestor
5744276|NCT03076684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744277|NCT03076151|Tacrolimus|tacrolimus|mesh-list
5744278|NCT03076151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5744279|NCT03076151|Immunologic Factors|immunologic factors|mesh-ancestor
5622073|NCT04731233|Glucocorticoids|glucocorticoids|mesh-ancestor
5622074|NCT04731233|Hormones|hormones|mesh-ancestor
5622075|NCT04731233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5622076|NCT04731233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622077|NCT04731233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5622078|NCT04731233|Immunologic Factors|immunologic factors|mesh-ancestor
5622079|NCT04731233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5622080|NCT04731233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622081|NCT04731233|Mitosis Modulators|mitosis modulators|mesh-ancestor
5622082|NCT04726618|Xenon|xenon|mesh-list
5622083|NCT04726618|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5622084|NCT04726618|Anesthetics, General|anesthetics, general|mesh-ancestor
5622085|NCT04726618|Anesthetics|anesthetics|mesh-ancestor
5622086|NCT04726618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5622087|NCT04726618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622088|NCT04726475|Cannabidiol|cannabidiol|mesh-list
6208692|NCT02134353|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5622089|NCT04726475|Anticonvulsants|anticonvulsants|mesh-ancestor
5622090|NCT04721613|Melatonin|melatonin|mesh-list
5744280|NCT03076151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622091|NCT04721613|Antioxidants|antioxidants|mesh-ancestor
5622092|NCT04721613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622093|NCT04721613|Protective Agents|protective agents|mesh-ancestor
5622094|NCT04721613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622095|NCT04721613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5622096|NCT04720976|Pembrolizumab|pembrolizumab|mesh-list
5622097|NCT04720976|Osimertinib|osimertinib|mesh-list
5744281|NCT03076151|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5744282|NCT03076151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5744283|NCT03076151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894026|NCT02578394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5894027|NCT02578394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894028|NCT02578394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5894029|NCT02578394|Glucocorticoids|glucocorticoids|mesh-ancestor
5894030|NCT02578394|Hormones|hormones|mesh-ancestor
5894031|NCT02578394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5894032|NCT02578394|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5894033|NCT02578394|Protective Agents|protective agents|mesh-ancestor
5894034|NCT02578394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5894035|NCT02578394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5894036|NCT02578394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5894037|NCT02341989|Carboplatin|carboplatin|mesh-list
5894038|NCT02341989|Etoposide|etoposide|mesh-list
5894039|NCT02341989|Bleomycin|bleomycin|mesh-list
5894040|NCT02341989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5894041|NCT02341989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5894042|NCT02341989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5894043|NCT02341989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5894044|NCT02341989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5894045|NCT02341989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894046|NCT02341989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5894047|NCT02184767|Loxapine|loxapine|mesh-list
5894048|NCT02184767|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5894049|NCT02184767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5894050|NCT02184767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5894051|NCT02184767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894052|NCT02184767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5894053|NCT02184767|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5894054|NCT02184767|Dopamine Agents|dopamine agents|mesh-ancestor
5894055|NCT02184767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5894056|NCT02184767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894057|NCT02122718|Allopurinol|allopurinol|mesh-list
5894058|NCT02122718|Antimetabolites|antimetabolites|mesh-ancestor
5894059|NCT02122718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894060|NCT02122718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5622098|NCT04720976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5622099|NCT04720976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5622100|NCT04720976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5622101|NCT04720976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5622102|NCT04720976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622103|NCT04717362|Methyltestosterone|methyltestosterone|mesh-list
5622104|NCT04717362|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5622105|NCT04717362|Testosterone|testosterone|mesh-list
5622106|NCT04717362|Testosterone undecanoate|testosterone undecanoate|mesh-list
5622107|NCT04717362|Testosterone enanthate|testosterone enanthate|mesh-list
5622108|NCT04717362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5622109|NCT04717362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5622110|NCT04717362|Anabolic Agents|anabolic agents|mesh-ancestor
5622111|NCT04717362|Hormones|hormones|mesh-ancestor
5622112|NCT04717362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5622113|NCT04717362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622114|NCT04717362|Androgens|androgens|mesh-ancestor
5622115|NCT04711837|Propofol|propofol|mesh-list
5622116|NCT04711837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5622117|NCT04711837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5622118|NCT04711837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622119|NCT04711837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5622120|NCT04711837|Anesthetics, General|anesthetics, general|mesh-ancestor
5622121|NCT04711837|Anesthetics|anesthetics|mesh-ancestor
5622122|NCT04707326|Lamivudine|lamivudine|mesh-list
5622123|NCT04707326|Dolutegravir|dolutegravir|mesh-list
5622124|NCT04707326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5622125|NCT04707326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6672901|NCT01559142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672902|NCT01559142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6672903|NCT01559142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6672904|NCT01559142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6672905|NCT01559142|Immunologic Factors|immunologic factors|mesh-ancestor
5744284|NCT03076112|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5744285|NCT03076112|Ipragliflozin|ipragliflozin|mesh-list
5744286|NCT03076112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5744287|NCT03076112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744288|NCT03076112|Incretins|incretins|mesh-ancestor
5744289|NCT03076112|Hormones|hormones|mesh-ancestor
5744290|NCT03076112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5744291|NCT03076112|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5744292|NCT03076112|Protease Inhibitors|protease inhibitors|mesh-ancestor
5744293|NCT03076112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5744294|NCT03076112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744295|NCT03076112|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5744296|NCT03076203|Niraparib|niraparib|mesh-list
5744297|NCT03076203|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
5744298|NCT03076203|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5744299|NCT03076203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5744300|NCT03076203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744301|NCT03076203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5744302|NCT03076320|Adapalene|adapalene|mesh-list
5744303|NCT03076320|Benzoyl Peroxide|benzoyl peroxide|mesh-list
5744304|NCT03076320|Dermatologic Agents|dermatologic agents|mesh-ancestor
5744305|NCT03076320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5744306|NCT03076320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5744307|NCT03076320|Analgesics|analgesics|mesh-ancestor
5744308|NCT03076320|Sensory System Agents|sensory system agents|mesh-ancestor
5744309|NCT03076320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5744310|NCT03076320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744311|NCT03076320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5744312|NCT03076320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5744313|NCT03076281|Metformin|metformin|mesh-list
5744314|NCT03076281|Doxycycline|doxycycline|mesh-list
5744315|NCT03076281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5744316|NCT03076281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744317|NCT03076281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5744318|NCT03076281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5744319|NCT03076281|Antimalarials|antimalarials|mesh-ancestor
5744320|NCT03076281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5622126|NCT04707326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5622127|NCT04707326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622128|NCT04707326|Antiviral Agents|antiviral agents|mesh-ancestor
5622129|NCT04707326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5622130|NCT04707326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5622131|NCT04707326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5622132|NCT04707326|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5622133|NCT04707326|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5622134|NCT04707196|Fulvestrant|fulvestrant|mesh-list
5622135|NCT04707196|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5622136|NCT04707196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5622137|NCT04707196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5622138|NCT04707196|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5622139|NCT04707196|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5622140|NCT04707196|Hormone Antagonists|hormone antagonists|mesh-ancestor
5622141|NCT04707196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5622142|NCT04707196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622143|NCT04707196|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5622144|NCT04707196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5692629|NCT03406546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5744321|NCT03076281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5744322|NCT03076021|Dextromethorphan|dextromethorphan|mesh-list
5744323|NCT03076021|Isotretinoin|isotretinoin|mesh-list
5744324|NCT03076021|Antitussive Agents|antitussive agents|mesh-ancestor
5744325|NCT03076021|Respiratory System Agents|respiratory system agents|mesh-ancestor
5744326|NCT03076021|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5744327|NCT03076021|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5744328|NCT03076021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5744329|NCT03076021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744330|NCT03076021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744331|NCT03076021|Dermatologic Agents|dermatologic agents|mesh-ancestor
5744332|NCT03076099|Dexmedetomidine|dexmedetomidine|mesh-list
5744333|NCT03076099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5744334|NCT03076099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5744335|NCT03076099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744336|NCT03076099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5622145|NCT04707196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622146|NCT04704934|Paclitaxel|paclitaxel|mesh-list
5622147|NCT04704934|Trastuzumab|trastuzumab|mesh-list
5622148|NCT04704934|Ramucirumab|ramucirumab|mesh-list
5622149|NCT04704934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5622150|NCT04704934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5622151|NCT04704934|Tubulin Modulators|tubulin modulators|mesh-ancestor
5622152|NCT04704934|Antimitotic Agents|antimitotic agents|mesh-ancestor
5622153|NCT04704934|Mitosis Modulators|mitosis modulators|mesh-ancestor
5622154|NCT04704934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622155|NCT04704934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5622156|NCT04703101|Leucovorin|leucovorin|mesh-list
5622157|NCT04703101|Fluorouracil|fluorouracil|mesh-list
5622158|NCT04703101|Capecitabine|capecitabine|mesh-list
5622159|NCT04703101|Oxaliplatin|oxaliplatin|mesh-list
5622160|NCT04703101|Antimetabolites|antimetabolites|mesh-ancestor
5744337|NCT03076099|Analgesics|analgesics|mesh-ancestor
5744338|NCT03076099|Sensory System Agents|sensory system agents|mesh-ancestor
5744339|NCT03076099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5744340|NCT03076099|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5744341|NCT03076099|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5744342|NCT03076099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5744343|NCT03076099|Adrenergic Agents|adrenergic agents|mesh-ancestor
5744344|NCT03076099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5744345|NCT03076099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744346|NCT03075657|Haloperidol|haloperidol|mesh-list
5744347|NCT03075657|Risperidone|risperidone|mesh-list
5744348|NCT03075657|Haloperidol decanoate|haloperidol decanoate|mesh-list
5744349|NCT03075657|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5744350|NCT03075657|Serotonin Agents|serotonin agents|mesh-ancestor
6672906|NCT01559142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675572|NCT01576315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5622161|NCT04703101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622162|NCT04703101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5622163|NCT04703101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5622164|NCT04703101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5622165|NCT04703101|Immunologic Factors|immunologic factors|mesh-ancestor
5622166|NCT04703101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622167|NCT04703101|Antidotes|antidotes|mesh-ancestor
5622168|NCT04703101|Protective Agents|protective agents|mesh-ancestor
5622169|NCT04703101|Vitamin B Complex|vitamin b complex|mesh-ancestor
5622170|NCT04703101|Vitamins|vitamins|mesh-ancestor
5622171|NCT04703101|Micronutrients|micronutrients|mesh-ancestor
5622172|NCT04690023|Ropivacaine|ropivacaine|mesh-list
5622173|NCT04690023|Anesthetics, Local|anesthetics, local|mesh-ancestor
5622174|NCT04690023|Anesthetics|anesthetics|mesh-ancestor
5622175|NCT04690023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5622176|NCT04690023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622177|NCT04690023|Sensory System Agents|sensory system agents|mesh-ancestor
5622178|NCT04690023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5622181|NCT04678895|Naltrexone|naltrexone|mesh-list
5622182|NCT04678895|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5622183|NCT04678895|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5622184|NCT04678895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622185|NCT04678895|Sensory System Agents|sensory system agents|mesh-ancestor
5622186|NCT04678895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5622187|NCT04677504|Gemcitabine|gemcitabine|mesh-list
5622188|NCT04677504|Bevacizumab|bevacizumab|mesh-list
5622189|NCT04677504|Atezolizumab|atezolizumab|mesh-list
6675573|NCT01576315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675574|NCT01576315|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6675575|NCT01576354|4-Aminopyridine|4-aminopyridine|mesh-list
6675576|NCT01576354|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6675577|NCT01576354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5744351|NCT03075657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6208693|NCT02134353|Diuretics|diuretics|mesh-ancestor
5622190|NCT04677504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5622191|NCT04677504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5622192|NCT04677504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5744352|NCT03075657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744353|NCT03075657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622193|NCT04677504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5622194|NCT04677504|Growth Substances|growth substances|mesh-ancestor
5622195|NCT04677504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744354|NCT03075657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5744355|NCT03075657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5744356|NCT03075657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5744357|NCT03075657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5744358|NCT03075657|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5744359|NCT03075657|Dopamine Agents|dopamine agents|mesh-ancestor
5744360|NCT03075657|Antiemetics|antiemetics|mesh-ancestor
5744361|NCT03075657|Autonomic Agents|autonomic agents|mesh-ancestor
5744362|NCT03075657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5744363|NCT03075657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5744364|NCT03075657|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5744365|NCT03075579|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
5744366|NCT03075579|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5744367|NCT03075579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5744368|NCT03075579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5744369|NCT03075579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744370|NCT03075579|Adrenergic Agents|adrenergic agents|mesh-ancestor
5744371|NCT03075579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5744372|NCT03075579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744373|NCT03075826|Guadecitabine|guadecitabine|mesh-list
5744374|NCT03075826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5744375|NCT03075462|Apatinib|apatinib|mesh-list
5744376|NCT03075462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5744377|NCT03075462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5744378|NCT03075462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5744379|NCT03075462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744380|NCT03075358|Lidocaine|lidocaine|mesh-list
5744381|NCT03075358|Anesthetics, Local|anesthetics, local|mesh-ancestor
5744382|NCT03075358|Anesthetics|anesthetics|mesh-ancestor
5744383|NCT03075358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5744384|NCT03075358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744385|NCT03075358|Sensory System Agents|sensory system agents|mesh-ancestor
5744386|NCT03075358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5744387|NCT03075358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5744388|NCT03075358|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5744389|NCT03075358|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5744390|NCT03075358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5744391|NCT03075358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744392|NCT03074942|Reslizumab|reslizumab|mesh-list
5744393|NCT03074942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5744394|NCT03074942|Respiratory System Agents|respiratory system agents|mesh-ancestor
5744395|NCT03074968|Benzydamine|benzydamine|mesh-list
5744396|NCT03074968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5744397|NCT03075020|Carbon Monoxide|carbon monoxide|mesh-list
5744398|NCT03075020|Antimetabolites|antimetabolites|mesh-ancestor
5744399|NCT03075020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744400|NCT03075020|Gasotransmitters|gasotransmitters|mesh-ancestor
5744401|NCT03075020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5744402|NCT03075020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744403|NCT03074994|Anesthetics|anesthetics|mesh-list
5744404|NCT03074994|Anesthetics, Local|anesthetics, local|mesh-list
5744405|NCT03074994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5744406|NCT03074994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744407|NCT03074994|Sensory System Agents|sensory system agents|mesh-ancestor
5744408|NCT03074994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5744409|NCT03074864|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5744410|NCT03074864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5744411|NCT03074864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5744412|NCT03074864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5744413|NCT03074864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744414|NCT03075241|Zolpidem|zolpidem|mesh-list
5744415|NCT03075241|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5622196|NCT04677504|Growth Inhibitors|growth inhibitors|mesh-ancestor
5622197|NCT04677504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5622198|NCT04677504|Antimetabolites|antimetabolites|mesh-ancestor
5622199|NCT04677504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622200|NCT04677504|Antiviral Agents|antiviral agents|mesh-ancestor
5622201|NCT04677504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5622202|NCT04677504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5622203|NCT04677504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5622204|NCT04677504|Immunologic Factors|immunologic factors|mesh-ancestor
6208694|NCT02134353|Natriuretic Agents|natriuretic agents|mesh-ancestor
6208695|NCT02134353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208696|NCT02134951|Ketamine|ketamine|mesh-list
6208697|NCT02134951|Analgesics|analgesics|mesh-ancestor
6208698|NCT02134951|Sensory System Agents|sensory system agents|mesh-ancestor
6208699|NCT02134951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6208700|NCT02134951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622212|NCT04653818|Sofosbuvir|sofosbuvir|mesh-list
5622213|NCT04653818|Velpatasvir|velpatasvir|mesh-list
5744416|NCT03075241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5744417|NCT03075241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5744418|NCT03075241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744419|NCT03075241|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
5744420|NCT03075241|GABA Agonists|gaba agonists|mesh-ancestor
5744421|NCT03075241|GABA Agents|gaba agents|mesh-ancestor
5744422|NCT03075241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5744423|NCT03075241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744424|NCT03074825|Chiauranib|chiauranib|mesh-list
5744425|NCT03074825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5744426|NCT03074825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5744427|NCT03074825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5744428|NCT03074825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744429|NCT03074773|Dexamethasone|dexamethasone|mesh-list
5744430|NCT03074773|Bupivacaine|bupivacaine|mesh-list
5744431|NCT03074773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5744432|NCT03074773|Antiemetics|antiemetics|mesh-ancestor
5622214|NCT04653818|Antiviral Agents|antiviral agents|mesh-ancestor
5622215|NCT04653818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5622216|NCT04646590|Vaccines|vaccines|mesh-list
5622217|NCT04646590|Immunologic Factors|immunologic factors|mesh-ancestor
5622218|NCT04646590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622219|NCT04646005|Cemiplimab|cemiplimab|mesh-list
5622220|NCT04646005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5622221|NCT04646005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5622222|NCT04645667|Tacrolimus|tacrolimus|mesh-list
5622223|NCT04645667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5622224|NCT04645667|Immunologic Factors|immunologic factors|mesh-ancestor
5622225|NCT04645667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622226|NCT04645667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5622227|NCT04645667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5622228|NCT04645667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692630|NCT03406546|Narcotics|narcotics|mesh-ancestor
5692631|NCT03406533|Fentanyl|fentanyl|mesh-list
5692632|NCT03406533|Midazolam|midazolam|mesh-list
5692633|NCT03406533|Dexmedetomidine|dexmedetomidine|mesh-list
5692634|NCT03406533|Remifentanil|remifentanil|mesh-list
5692635|NCT03406533|Propofol|propofol|mesh-list
5692636|NCT03406533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5692637|NCT03406533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5692638|NCT03406533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692639|NCT03406533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5692640|NCT03406533|Anesthetics, General|anesthetics, general|mesh-ancestor
5692641|NCT03406533|Anesthetics|anesthetics|mesh-ancestor
5744433|NCT03074773|Autonomic Agents|autonomic agents|mesh-ancestor
5744434|NCT03074773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5744435|NCT03074773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744436|NCT03074773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5744437|NCT03074773|Glucocorticoids|glucocorticoids|mesh-ancestor
5744438|NCT03074773|Hormones|hormones|mesh-ancestor
5744439|NCT03074773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5744440|NCT03074773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5744441|NCT03074773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5744442|NCT03074773|Anesthetics, Local|anesthetics, local|mesh-ancestor
5744443|NCT03074773|Anesthetics|anesthetics|mesh-ancestor
5744444|NCT03074773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5744445|NCT03074773|Sensory System Agents|sensory system agents|mesh-ancestor
5894061|NCT02122718|Gout Suppressants|gout suppressants|mesh-ancestor
5894062|NCT02122718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5894063|NCT02122718|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5894064|NCT02122718|Antioxidants|antioxidants|mesh-ancestor
5894065|NCT02122718|Protective Agents|protective agents|mesh-ancestor
5692642|NCT03406533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5692643|NCT03406533|Analgesics|analgesics|mesh-ancestor
5692644|NCT03406533|Sensory System Agents|sensory system agents|mesh-ancestor
5692645|NCT03406533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5622229|NCT04638309|Azacitidine|azacitidine|mesh-list
5622230|NCT04638309|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5622231|NCT04638309|Antimetabolites|antimetabolites|mesh-ancestor
5622232|NCT04638309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622233|NCT04638309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5622234|NCT04638309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5622235|NCT04635254|Histamine|histamine|mesh-list
5622236|NCT04635254|Histamine Agonists|histamine agonists|mesh-ancestor
5622237|NCT04635254|Histamine Agents|histamine agents|mesh-ancestor
5622238|NCT04635254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5622239|NCT04635254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622240|NCT04635254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622241|NCT04625946|Metformin|metformin|mesh-list
5622242|NCT04625946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5622243|NCT04625946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622244|NCT04622007|Pembrolizumab|pembrolizumab|mesh-list
5622245|NCT04622007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5622246|NCT04622007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5622247|NCT04616196|Cetuximab|cetuximab|mesh-list
5622248|NCT04616196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5622249|NCT04616196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5744446|NCT03074539|Riociguat|riociguat|mesh-list
5744447|NCT03074539|Enzyme Activators|enzyme activators|mesh-ancestor
5744448|NCT03074539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744449|NCT03074786|Tenofovir|tenofovir|mesh-list
5744450|NCT03074786|Emtricitabine|emtricitabine|mesh-list
5744451|NCT03074786|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5744452|NCT03074786|Dapivirine|dapivirine|mesh-list
5744453|NCT03074786|Antiviral Agents|antiviral agents|mesh-ancestor
5622250|NCT04608344|Atorvastatin|atorvastatin|mesh-list
5622251|NCT04608344|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5622252|NCT04608344|Pravastatin|pravastatin|mesh-list
5622253|NCT04608344|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5622254|NCT04608344|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5622255|NCT04608344|Antimetabolites|antimetabolites|mesh-ancestor
5622256|NCT04608344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622257|NCT04608344|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5622258|NCT04608344|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5622259|NCT04608344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5622260|NCT04591002|Osimertinib|osimertinib|mesh-list
5622261|NCT04591002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5622262|NCT04591002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5622263|NCT04591002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5622264|NCT04591002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622265|NCT04590963|Cetuximab|cetuximab|mesh-list
5622266|NCT04590963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5622267|NCT04590963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5622268|NCT04589351|Ezetimibe|ezetimibe|mesh-list
5622269|NCT04589351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5622270|NCT04589351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5622271|NCT04589351|Antimetabolites|antimetabolites|mesh-ancestor
5622272|NCT04589351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744454|NCT03074786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5744455|NCT03074786|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5744456|NCT03074786|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5744457|NCT03074786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5744458|NCT03074786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744459|NCT03074786|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5622273|NCT04589351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5622274|NCT04588246|Memantine|memantine|mesh-list
5622275|NCT04588246|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5744460|NCT03074786|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5744461|NCT03074591|Ferric Compounds|ferric compounds|mesh-list
5744462|NCT03074591|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5744463|NCT03074591|Hematinics|hematinics|mesh-ancestor
5622276|NCT04588246|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5622277|NCT04588246|Dopamine Agents|dopamine agents|mesh-ancestor
5622278|NCT04588246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5622279|NCT04588246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622280|NCT04588246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622281|NCT04588246|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5622282|NCT04588246|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5622283|NCT04583592|Gabexate|gabexate|mesh-list
5622284|NCT04583592|Camostat|camostat|mesh-list
5622285|NCT04583592|Protease Inhibitors|protease inhibitors|mesh-ancestor
5744464|NCT03074578|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
5744465|NCT03074578|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
5744466|NCT03074578|beta-Endorphin|beta-endorphin|mesh-list
5744467|NCT03074578|Hormones|hormones|mesh-ancestor
5744468|NCT03074578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5744469|NCT03074578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744470|NCT03074578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5744471|NCT03074578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744472|NCT03074318|Avelumab|avelumab|mesh-list
5744473|NCT03074318|Trabectedin|trabectedin|mesh-list
5744474|NCT03074318|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5744475|NCT03074318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5744476|NCT03074318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5744477|NCT03074318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5744478|NCT03074318|Alkylating Agents|alkylating agents|mesh-ancestor
5744479|NCT03074318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744480|NCT03074318|Immunologic Factors|immunologic factors|mesh-ancestor
5744481|NCT03074318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744482|NCT03074448|Picosulfate sodium|picosulfate sodium|mesh-list
5744483|NCT03074448|Cathartics|cathartics|mesh-ancestor
5744484|NCT03074448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5744485|NCT03074435|Ivermectin|ivermectin|mesh-list
5744486|NCT03074435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5744487|NCT03074435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5744488|NCT03074344|Hyaluronic Acid|hyaluronic acid|mesh-list
5744489|NCT03074344|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5744490|NCT03074344|Immunologic Factors|immunologic factors|mesh-ancestor
5744491|NCT03074344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744492|NCT03074344|Viscosupplements|viscosupplements|mesh-ancestor
5744493|NCT03074344|Protective Agents|protective agents|mesh-ancestor
5744494|NCT03073980|Acetaminophen|acetaminophen|mesh-list
5744495|NCT03073980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5744496|NCT03073980|Analgesics|analgesics|mesh-ancestor
5744497|NCT03073980|Sensory System Agents|sensory system agents|mesh-ancestor
5744498|NCT03073980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5744499|NCT03073980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744500|NCT03073980|Antipyretics|antipyretics|mesh-ancestor
5744501|NCT03074097|Bupivacaine|bupivacaine|mesh-list
5744502|NCT03074097|Anesthetics, Local|anesthetics, local|mesh-ancestor
5744503|NCT03074097|Anesthetics|anesthetics|mesh-ancestor
5744504|NCT03074097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5744505|NCT03074097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622286|NCT04583592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5622287|NCT04583592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622288|NCT04583592|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5622289|NCT04583592|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5622290|NCT04583592|Anticoagulants|anticoagulants|mesh-ancestor
5622291|NCT04570904|Vaccines|vaccines|mesh-list
5622292|NCT04570904|Immunologic Factors|immunologic factors|mesh-ancestor
5622293|NCT04570904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622294|NCT04546841|Vaccines|vaccines|mesh-list
5622295|NCT04546841|Immunologic Factors|immunologic factors|mesh-ancestor
5622296|NCT04546841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744506|NCT03074097|Sensory System Agents|sensory system agents|mesh-ancestor
5744507|NCT03074097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5744508|NCT03074123|Cosyntropin|cosyntropin|mesh-list
5744509|NCT03074123|Hormones|hormones|mesh-ancestor
5744510|NCT03074123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5744511|NCT03074123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744512|NCT03073928|Ropivacaine|ropivacaine|mesh-list
5744513|NCT03073928|Anesthetics, Local|anesthetics, local|mesh-ancestor
5744514|NCT03073928|Anesthetics|anesthetics|mesh-ancestor
5744515|NCT03073928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5744516|NCT03073928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744517|NCT03073928|Sensory System Agents|sensory system agents|mesh-ancestor
5744518|NCT03073928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5744519|NCT03074136|Sodium Hypochlorite|sodium hypochlorite|mesh-list
5744520|NCT03074136|Eusol|eusol|mesh-list
5744521|NCT03074136|Disinfectants|disinfectants|mesh-ancestor
5744522|NCT03074136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5744523|NCT03073850|Aspirin|aspirin|mesh-list
5744524|NCT03073850|Edoxaban|edoxaban|mesh-list
5744525|NCT03073850|Anticoagulants|anticoagulants|mesh-list
5622297|NCT04540705|Nivolumab|nivolumab|mesh-list
5744526|NCT03073850|Clopidogrel|clopidogrel|mesh-list
5744527|NCT03073850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5744528|NCT03073850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5744529|NCT03073850|Analgesics|analgesics|mesh-ancestor
5744530|NCT03073850|Sensory System Agents|sensory system agents|mesh-ancestor
5744531|NCT03073850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5744532|NCT03073850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744533|NCT03073850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5744534|NCT03073850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5744535|NCT03073850|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5744536|NCT03073850|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5744537|NCT03073850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744538|NCT03073850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5744539|NCT03073850|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5744540|NCT03073850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5744541|NCT03073850|Antipyretics|antipyretics|mesh-ancestor
5622298|NCT04540705|Axitinib|axitinib|mesh-list
5622299|NCT04540705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5622300|NCT04540705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5622301|NCT04540705|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5622302|NCT04540705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622303|NCT04540705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5622304|NCT04540705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5622305|NCT04529850|Avasopasem manganese|avasopasem manganese|mesh-list
5622306|NCT04529850|Antioxidants|antioxidants|mesh-ancestor
5622307|NCT04529850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744542|NCT03073850|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5744543|NCT03073850|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5744544|NCT03073850|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5744545|NCT03073850|Purinergic Agents|purinergic agents|mesh-ancestor
5744546|NCT03073850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5744547|NCT03073850|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5744548|NCT03073850|Antithrombins|antithrombins|mesh-ancestor
5744549|NCT03073850|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5744550|NCT03073850|Protease Inhibitors|protease inhibitors|mesh-ancestor
5744551|NCT03073863|Atorvastatin|atorvastatin|mesh-list
5744552|NCT03073863|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5622308|NCT04529850|Protective Agents|protective agents|mesh-ancestor
5622309|NCT04529850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622310|NCT04524910|Aflibercept|aflibercept|mesh-list
5622311|NCT04524910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5622312|NCT04524910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5622313|NCT04524910|Growth Substances|growth substances|mesh-ancestor
5622314|NCT04524910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622315|NCT04524910|Growth Inhibitors|growth inhibitors|mesh-ancestor
5622316|NCT04524910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5622317|NCT04523961|Lidocaine|lidocaine|mesh-list
5622318|NCT04523961|Tetracaine|tetracaine|mesh-list
5622319|NCT04523961|Prilocaine|prilocaine|mesh-list
5622320|NCT04523961|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
5622321|NCT04523961|Anesthetics, Local|anesthetics, local|mesh-ancestor
5622322|NCT04523961|Anesthetics|anesthetics|mesh-ancestor
5744553|NCT03073863|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5744554|NCT03073863|Antimetabolites|antimetabolites|mesh-ancestor
5744555|NCT03073863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744556|NCT03073863|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5744557|NCT03073863|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5744558|NCT03073863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5744559|NCT03073889|Ropivacaine|ropivacaine|mesh-list
5744560|NCT03073889|Anesthetics, Local|anesthetics, local|mesh-ancestor
5744561|NCT03073889|Anesthetics|anesthetics|mesh-ancestor
5744562|NCT03073889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5744563|NCT03073889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744564|NCT03073889|Sensory System Agents|sensory system agents|mesh-ancestor
5744565|NCT03073889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5744566|NCT03073694|Melphalan|melphalan|mesh-list
5744567|NCT03073694|Mitomycins|mitomycins|mesh-list
5744568|NCT03073694|Mitomycin|mitomycin|mesh-list
5622323|NCT04523961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5622324|NCT04523961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622325|NCT04523961|Sensory System Agents|sensory system agents|mesh-ancestor
5622326|NCT04523961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5622327|NCT04523961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5622328|NCT04523961|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5622329|NCT04523961|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5622330|NCT04523961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5622331|NCT04523961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744569|NCT03073694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5744570|NCT03073694|Alkylating Agents|alkylating agents|mesh-ancestor
5744571|NCT03073694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744572|NCT03073694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5744573|NCT03073694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5744574|NCT03073694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5744575|NCT03073694|Immunologic Factors|immunologic factors|mesh-ancestor
5744576|NCT03073694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744577|NCT03073694|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5744578|NCT03073694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5744579|NCT03073694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5744580|NCT03073408|Propofol|propofol|mesh-list
5744581|NCT03073408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5744582|NCT03073408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5744583|NCT03073408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744584|NCT03073408|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5744585|NCT03073408|Anesthetics, General|anesthetics, general|mesh-ancestor
5622332|NCT04523961|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
5622333|NCT04505059|Anesthetics|anesthetics|mesh-list
6489390|NCT00591526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6489391|NCT00591526|Antimetabolites|antimetabolites|mesh-ancestor
5744586|NCT03073408|Anesthetics|anesthetics|mesh-ancestor
5744587|NCT03073317|Mitogens|mitogens|mesh-list
5744588|NCT03073317|Mitosis Modulators|mitosis modulators|mesh-ancestor
5744589|NCT03073317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744590|NCT03073343|Betaine|betaine|mesh-list
5744591|NCT03073343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5744592|NCT03073343|Lipotropic Agents|lipotropic agents|mesh-ancestor
5744593|NCT03073343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5744594|NCT03073343|Antimetabolites|antimetabolites|mesh-ancestor
5744595|NCT03073343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744596|NCT03073343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5744597|NCT03072992|Curcumin|curcumin|mesh-list
5744598|NCT03072992|Paclitaxel|paclitaxel|mesh-list
5744599|NCT03072992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5744600|NCT03072992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5744601|NCT03072992|Tubulin Modulators|tubulin modulators|mesh-ancestor
5744602|NCT03072992|Antimitotic Agents|antimitotic agents|mesh-ancestor
5744603|NCT03072992|Mitosis Modulators|mitosis modulators|mesh-ancestor
5744604|NCT03072992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744605|NCT03072992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5744606|NCT03072992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5744607|NCT03072992|Analgesics|analgesics|mesh-ancestor
5744608|NCT03072992|Sensory System Agents|sensory system agents|mesh-ancestor
5744609|NCT03072992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5744610|NCT03072992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744611|NCT03072992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5744612|NCT03072992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6489392|NCT00591526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489393|NCT00591526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6489394|NCT00591526|Antiviral Agents|antiviral agents|mesh-ancestor
6489395|NCT00591526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5744613|NCT03072992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5744614|NCT03073265|Apixaban|apixaban|mesh-list
5744615|NCT03073265|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5744616|NCT03073265|Antithrombins|antithrombins|mesh-ancestor
5744617|NCT03073265|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5744618|NCT03073265|Protease Inhibitors|protease inhibitors|mesh-ancestor
5744619|NCT03073265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5744620|NCT03073265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744621|NCT03073265|Anticoagulants|anticoagulants|mesh-ancestor
5622334|NCT04505059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5622335|NCT04505059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622336|NCT04502394|Acalabrutinib|acalabrutinib|mesh-list
5622337|NCT04502394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5622338|NCT04500509|Diclofenac|diclofenac|mesh-list
5622339|NCT04500509|Dinoprostone|dinoprostone|mesh-list
5622340|NCT04500509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5622341|NCT04500509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5622342|NCT04500509|Analgesics|analgesics|mesh-ancestor
5622343|NCT04500509|Sensory System Agents|sensory system agents|mesh-ancestor
5622344|NCT04500509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6489396|NCT00591526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5622345|NCT04500509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622346|NCT04500509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5622347|NCT04500509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5622348|NCT04500509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5622349|NCT04500509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5622350|NCT04500509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622351|NCT04500509|Oxytocics|oxytocics|mesh-ancestor
5622352|NCT04500509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5622353|NCT04500470|Ketoprofen|ketoprofen|mesh-list
5622354|NCT04500470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5622355|NCT04500470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5622356|NCT04500470|Analgesics|analgesics|mesh-ancestor
5744622|NCT03073304|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5744623|NCT03073057|Budesonide|budesonide|mesh-list
5744624|NCT03073057|Formoterol Fumarate|formoterol fumarate|mesh-list
5744625|NCT03073057|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
5744626|NCT03073057|Charcoal|charcoal|mesh-list
5744627|NCT03073057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5744628|NCT03073057|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5744629|NCT03073057|Autonomic Agents|autonomic agents|mesh-ancestor
5744630|NCT03073057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5744631|NCT03073057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744632|NCT03073057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5744633|NCT03073057|Respiratory System Agents|respiratory system agents|mesh-ancestor
5622357|NCT04500470|Sensory System Agents|sensory system agents|mesh-ancestor
5622358|NCT04500470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5622359|NCT04500470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622360|NCT04500470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5622361|NCT04500470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5622362|NCT04500470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5622363|NCT04500470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5622364|NCT04500470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622365|NCT04472598|Navitoclax|navitoclax|mesh-list
5622366|NCT04472598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5622367|NCT04461015|Insulin|insulin|mesh-list
5622368|NCT04461015|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5622369|NCT04461015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5622370|NCT04461015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622371|NCT04457297|Trifluridine|trifluridine|mesh-list
5622372|NCT04457297|Antimetabolites|antimetabolites|mesh-ancestor
5622373|NCT04457297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622374|NCT04457297|Antiviral Agents|antiviral agents|mesh-ancestor
5622375|NCT04457297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5622376|NCT04441073|Lidocaine|lidocaine|mesh-list
5622377|NCT04441073|Anesthetics, Local|anesthetics, local|mesh-ancestor
5622378|NCT04441073|Anesthetics|anesthetics|mesh-ancestor
5622379|NCT04441073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5622380|NCT04441073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622381|NCT04441073|Sensory System Agents|sensory system agents|mesh-ancestor
5622382|NCT04441073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5622383|NCT04441073|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5622384|NCT04441073|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5622385|NCT04441073|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5622386|NCT04441073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5622387|NCT04441073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692646|NCT03406533|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5692647|NCT03406533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5692648|NCT03406533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5692649|NCT03406533|Adrenergic Agents|adrenergic agents|mesh-ancestor
5692650|NCT03406533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5692651|NCT03406533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692652|NCT03406533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5692653|NCT03406533|Narcotics|narcotics|mesh-ancestor
5692654|NCT03406533|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5692655|NCT03406533|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5692656|NCT03406533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5692657|NCT03406533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5692658|NCT03406533|GABA Modulators|gaba modulators|mesh-ancestor
5744634|NCT03073057|Glucocorticoids|glucocorticoids|mesh-ancestor
5744635|NCT03073057|Hormones|hormones|mesh-ancestor
5744636|NCT03073057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5744637|NCT03073057|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5744638|NCT03073057|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5744639|NCT03073057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5744640|NCT03073057|Adrenergic Agents|adrenergic agents|mesh-ancestor
5744641|NCT03073057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5622388|NCT04409665|Ketamine|ketamine|mesh-list
5622389|NCT04409665|Analgesics|analgesics|mesh-ancestor
5622390|NCT04409665|Sensory System Agents|sensory system agents|mesh-ancestor
5622391|NCT04409665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5622392|NCT04409665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622393|NCT04409665|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5622394|NCT04409665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5622395|NCT04409665|Anesthetics, General|anesthetics, general|mesh-ancestor
5622396|NCT04409665|Anesthetics|anesthetics|mesh-ancestor
5622397|NCT04409665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5622398|NCT04409665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5622399|NCT04409665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5622400|NCT04409665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5622401|NCT04409665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622424|NCT04386057|Hydroxychloroquine|hydroxychloroquine|mesh-list
5622425|NCT04386057|Antimalarials|antimalarials|mesh-ancestor
5622426|NCT04386057|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5744642|NCT03073057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744643|NCT03073057|Antidotes|antidotes|mesh-ancestor
5744644|NCT03073057|Protective Agents|protective agents|mesh-ancestor
5744645|NCT03073018|Fosinopril|fosinopril|mesh-list
5744646|NCT03073018|Pravastatin|pravastatin|mesh-list
5744647|NCT03073018|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5744648|NCT03073018|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5744649|NCT03073018|Antimetabolites|antimetabolites|mesh-ancestor
5744650|NCT03073018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744651|NCT03073018|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5622427|NCT04386057|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5622428|NCT04386057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5622429|NCT04386057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5622430|NCT04386057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622431|NCT04386057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5622432|NCT04382937|Ribavirin|ribavirin|mesh-list
5622433|NCT04382937|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
5622434|NCT04382937|Antimetabolites|antimetabolites|mesh-ancestor
5622435|NCT04382937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622436|NCT04382937|Antiviral Agents|antiviral agents|mesh-ancestor
5622437|NCT04382937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5622438|NCT04380090|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
5622439|NCT04380090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5622440|NCT04380090|Antidiarrheals|antidiarrheals|mesh-ancestor
5622441|NCT04377620|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
5622442|NCT04377620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5622443|NCT04377620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5622444|NCT04377620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622445|NCT04351698|Montelukast|montelukast|mesh-list
5622446|NCT04351698|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5622447|NCT04351698|Respiratory System Agents|respiratory system agents|mesh-ancestor
5622448|NCT04351698|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5622449|NCT04351698|Hormone Antagonists|hormone antagonists|mesh-ancestor
5622450|NCT04351698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5622451|NCT04351698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622452|NCT04351698|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5622453|NCT04351698|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5622454|NCT04351698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622455|NCT04339036|Capecitabine|capecitabine|mesh-list
5622456|NCT04339036|Temozolomide|temozolomide|mesh-list
5622457|NCT04339036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5622458|NCT04339036|Antimetabolites|antimetabolites|mesh-ancestor
5622459|NCT04339036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744652|NCT03073018|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5744653|NCT03073018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5744654|NCT03073018|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5744655|NCT03073018|Protease Inhibitors|protease inhibitors|mesh-ancestor
5744656|NCT03073018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5744657|NCT03073369|Ergocalciferols|ergocalciferols|mesh-list
5744658|NCT03073369|Vitamin D|vitamin d|mesh-list
5744659|NCT03073369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5622460|NCT04339036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5622461|NCT04339036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5622462|NCT04339036|Alkylating Agents|alkylating agents|mesh-ancestor
5622463|NCT04321330|Atezolizumab|atezolizumab|mesh-list
5622464|NCT04321330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5622465|NCT04319627|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5622466|NCT04319627|Calcium|calcium|mesh-list
5622467|NCT04319627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5622468|NCT04319627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622469|NCT04319627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5744660|NCT03073369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744661|NCT03073369|Vitamins|vitamins|mesh-ancestor
5744662|NCT03073369|Micronutrients|micronutrients|mesh-ancestor
5744663|NCT03073369|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5744664|NCT03072849|Fluticasone|fluticasone|mesh-list
5744665|NCT03072849|Azithromycin|azithromycin|mesh-list
5744666|NCT03072849|Montelukast|montelukast|mesh-list
5744667|NCT03072849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5744668|NCT03072849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5744669|NCT03072849|Autonomic Agents|autonomic agents|mesh-ancestor
5744670|NCT03072849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5744671|NCT03072849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744672|NCT03072849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5744673|NCT03072849|Respiratory System Agents|respiratory system agents|mesh-ancestor
5744674|NCT03072849|Dermatologic Agents|dermatologic agents|mesh-ancestor
5744675|NCT03072849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5744676|NCT03072849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5744677|NCT03072849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5622470|NCT04319627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5622471|NCT04319627|Antimetabolites|antimetabolites|mesh-ancestor
5622472|NCT04319627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622473|NCT04319627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5622474|NCT04319627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5622475|NCT04319627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6208701|NCT02134951|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6208702|NCT02134951|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6208703|NCT02134951|Anesthetics, General|anesthetics, general|mesh-ancestor
6208704|NCT02134951|Anesthetics|anesthetics|mesh-ancestor
6208705|NCT02134951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6208706|NCT02134951|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6208707|NCT02134951|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5622483|NCT04305496|Fulvestrant|fulvestrant|mesh-list
5622484|NCT04305496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5622485|NCT04305496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5622486|NCT04305496|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5622487|NCT04305496|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5622488|NCT04305496|Hormone Antagonists|hormone antagonists|mesh-ancestor
5622489|NCT04305496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5622490|NCT04305496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622491|NCT04272606|Tranexamic Acid|tranexamic acid|mesh-list
5622492|NCT04272606|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5622493|NCT04272606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5692659|NCT03406533|GABA Agents|gaba agents|mesh-ancestor
5744678|NCT03072849|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5744679|NCT03072849|Hormone Antagonists|hormone antagonists|mesh-ancestor
5744680|NCT03072849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5744681|NCT03072849|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5744682|NCT03072849|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5622494|NCT04272606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622495|NCT04272606|Hemostatics|hemostatics|mesh-ancestor
5622496|NCT04272606|Coagulants|coagulants|mesh-ancestor
5622497|NCT04233879|Tenofovir|tenofovir|mesh-list
5622498|NCT04233879|Emtricitabine|emtricitabine|mesh-list
5622499|NCT04233879|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
5622500|NCT04233879|Islatravir|islatravir|mesh-list
5622501|NCT04233879|Antiviral Agents|antiviral agents|mesh-ancestor
5622502|NCT04233879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5744683|NCT03072849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744684|NCT03072771|Cytarabine|cytarabine|mesh-list
5744685|NCT03072771|Etoposide|etoposide|mesh-list
5744686|NCT03072771|Melphalan|melphalan|mesh-list
5744687|NCT03072771|Carmustine|carmustine|mesh-list
5744688|NCT03072771|Blinatumomab|blinatumomab|mesh-list
5744689|NCT03072771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5622503|NCT04233879|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5622504|NCT04233879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5622505|NCT04233879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5622506|NCT04233879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622507|NCT04233879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5622508|NCT04233879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5622509|NCT04226833|Entrectinib|entrectinib|mesh-list
5622510|NCT04226833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5744690|NCT03072771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5744691|NCT03072771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5744692|NCT03072771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5744693|NCT03072771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5744694|NCT03072771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744695|NCT03072771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5744696|NCT03072771|Antimetabolites|antimetabolites|mesh-ancestor
5744697|NCT03072771|Antiviral Agents|antiviral agents|mesh-ancestor
5744698|NCT03072771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5744699|NCT03072771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5744700|NCT03072771|Immunologic Factors|immunologic factors|mesh-ancestor
5744701|NCT03072771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622511|NCT04226833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5622512|NCT04226833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622513|NCT04214860|Azacitidine|azacitidine|mesh-list
5622514|NCT04214860|Venetoclax|venetoclax|mesh-list
5622515|NCT04214860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5622516|NCT04214860|Antimetabolites|antimetabolites|mesh-ancestor
5622517|NCT04214860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622518|NCT04214860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5622519|NCT04214860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5622520|NCT04206020|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5622521|NCT04206020|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5622522|NCT04205994|Tolcapone|tolcapone|mesh-list
5622523|NCT04205994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5622524|NCT04205994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5622525|NCT04205994|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
5744702|NCT03072771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5744703|NCT03072771|Alkylating Agents|alkylating agents|mesh-ancestor
5744704|NCT03072771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5744705|NCT03072485|Metformin|metformin|mesh-list
5744706|NCT03072485|Sirolimus|sirolimus|mesh-list
5744707|NCT03072485|Diclofenac|diclofenac|mesh-list
5744708|NCT03072485|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6489397|NCT00591526|Immunologic Factors|immunologic factors|mesh-ancestor
6489398|NCT00591526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489399|NCT00591604|Vitamin D|vitamin d|mesh-list
5744709|NCT03072485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489400|NCT00591604|Vitamins|vitamins|mesh-ancestor
6489401|NCT00591604|Micronutrients|micronutrients|mesh-ancestor
6489402|NCT00591604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489403|NCT00591604|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5744710|NCT03072485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5744711|NCT03072485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5744712|NCT03072485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5744713|NCT03072485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5744714|NCT03072485|Antifungal Agents|antifungal agents|mesh-ancestor
5744715|NCT03072485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5744716|NCT03072485|Immunologic Factors|immunologic factors|mesh-ancestor
5744717|NCT03072485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5744718|NCT03072485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5744719|NCT03072485|Analgesics|analgesics|mesh-ancestor
5744720|NCT03072485|Sensory System Agents|sensory system agents|mesh-ancestor
5744721|NCT03072485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5744722|NCT03072485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5744723|NCT03072485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5744724|NCT03072485|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5744725|NCT03072485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5744726|NCT03072485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622526|NCT04205994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5622527|NCT04205994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622528|NCT04200313|Pancrelipase|pancrelipase|mesh-list
5622529|NCT04200313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5622530|NCT04197310|Nivolumab|nivolumab|mesh-list
5622531|NCT04197310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5744727|NCT03072589|Regadenoson|regadenoson|mesh-list
5744728|NCT03072589|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
5744729|NCT03072589|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5622532|NCT04197310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5622533|NCT04197310|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5622534|NCT04197310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744730|NCT03072589|Purinergic Agonists|purinergic agonists|mesh-ancestor
5744731|NCT03072589|Purinergic Agents|purinergic agents|mesh-ancestor
5744732|NCT03072589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5622535|NCT04194944|Carboplatin|carboplatin|mesh-list
5622536|NCT04194944|Pembrolizumab|pembrolizumab|mesh-list
5622537|NCT04194944|Pemetrexed|pemetrexed|mesh-list
5622538|NCT04194944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5622539|NCT04194944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5622540|NCT04194944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5622541|NCT04194944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622542|NCT04194944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5622543|NCT04194944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5622544|NCT04180215|Pembrolizumab|pembrolizumab|mesh-list
5622545|NCT04180215|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5622546|NCT04180215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5622547|NCT04180215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5622548|NCT04180215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622549|NCT04178798|Acalabrutinib|acalabrutinib|mesh-list
5622550|NCT04178798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5622551|NCT04176848|Durvalumab|durvalumab|mesh-list
5622552|NCT04176848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5622553|NCT04176848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5622554|NCT04168112|Dexamethasone|dexamethasone|mesh-list
5622555|NCT04168112|Prednisolone|prednisolone|mesh-list
5622556|NCT04168112|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5622557|NCT04168112|Methylprednisolone|methylprednisolone|mesh-list
5622558|NCT04168112|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5622559|NCT04168112|Prednisolone acetate|prednisolone acetate|mesh-list
5744733|NCT03072589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744734|NCT03072589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744735|NCT03072511|Nicotine|nicotine|mesh-list
5744736|NCT03072511|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5744737|NCT03072511|Autonomic Agents|autonomic agents|mesh-ancestor
5744738|NCT03072511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5744739|NCT03072511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744740|NCT03072511|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5744741|NCT03072511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5744742|NCT03072511|Cholinergic Agents|cholinergic agents|mesh-ancestor
5744743|NCT03072511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6489404|NCT00591617|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
5622560|NCT04168112|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5622561|NCT04168112|Prednisolone phosphate|prednisolone phosphate|mesh-list
5622562|NCT04168112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5622563|NCT04168112|Antiemetics|antiemetics|mesh-ancestor
5622564|NCT04168112|Autonomic Agents|autonomic agents|mesh-ancestor
5744744|NCT03072511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744745|NCT03072264|Fluoxetine|fluoxetine|mesh-list
5744746|NCT03072264|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5744747|NCT03072264|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5744748|NCT03072264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5744749|NCT03072264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744750|NCT03072264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5622565|NCT04168112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5622566|NCT04168112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622567|NCT04168112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5622568|NCT04168112|Glucocorticoids|glucocorticoids|mesh-ancestor
5622569|NCT04168112|Hormones|hormones|mesh-ancestor
5622570|NCT04168112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5622571|NCT04168112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5622572|NCT04168112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5622573|NCT04168112|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5622574|NCT04168112|Protective Agents|protective agents|mesh-ancestor
5692660|NCT03406520|Chlorhexidine|chlorhexidine|mesh-list
5692661|NCT03406520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5692662|NCT03406520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5692663|NCT03406520|Disinfectants|disinfectants|mesh-ancestor
5692664|NCT03406507|Ravulizumab|ravulizumab|mesh-list
5692665|NCT03406507|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5692666|NCT03406507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5692667|NCT03406507|Immunologic Factors|immunologic factors|mesh-ancestor
5692668|NCT03406507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692669|NCT03406403|Anesthetics|anesthetics|mesh-list
5692670|NCT03406403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5692671|NCT03406403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744751|NCT03072264|Serotonin Agents|serotonin agents|mesh-ancestor
5744752|NCT03072264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744753|NCT03072264|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5744754|NCT03072264|Antidepressive Agents|antidepressive agents|mesh-ancestor
5744755|NCT03072264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5744756|NCT03072264|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5744757|NCT03072264|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5744758|NCT03072264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5744759|NCT03072394|Lidocaine|lidocaine|mesh-list
5692672|NCT03406299|Leucovorin|leucovorin|mesh-list
5692673|NCT03406299|Gemcitabine|gemcitabine|mesh-list
5692674|NCT03406299|Oxaliplatin|oxaliplatin|mesh-list
5692675|NCT03406299|Tegafur|tegafur|mesh-list
5692676|NCT03406299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5692677|NCT03406299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5744760|NCT03072394|Anesthetics, Local|anesthetics, local|mesh-list
5744761|NCT03072394|Anesthetics|anesthetics|mesh-list
5744762|NCT03072394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5744763|NCT03072394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744764|NCT03072394|Sensory System Agents|sensory system agents|mesh-ancestor
5744765|NCT03072394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5744766|NCT03072394|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5744767|NCT03072394|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5744768|NCT03072394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5744769|NCT03072394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5744770|NCT03072394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744771|NCT03072329|Bupivacaine|bupivacaine|mesh-list
5744772|NCT03072329|Anesthetics, Local|anesthetics, local|mesh-ancestor
5744773|NCT03072329|Anesthetics|anesthetics|mesh-ancestor
5744774|NCT03072329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5744775|NCT03072329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744776|NCT03072329|Sensory System Agents|sensory system agents|mesh-ancestor
5744777|NCT03072329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5744778|NCT03072082|Aspirin|aspirin|mesh-list
5744779|NCT03072082|Metoprolol|metoprolol|mesh-list
5744780|NCT03072082|Isosorbide|isosorbide|mesh-list
5692678|NCT03406299|Antimetabolites|antimetabolites|mesh-ancestor
5692679|NCT03406299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692680|NCT03406299|Antiviral Agents|antiviral agents|mesh-ancestor
5692681|NCT03406299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5744781|NCT03072082|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
5744782|NCT03072082|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
5744783|NCT03072082|Trimetazidine|trimetazidine|mesh-list
5744784|NCT03072082|Clopidogrel|clopidogrel|mesh-list
5744785|NCT03072082|Atorvastatin|atorvastatin|mesh-list
5744786|NCT03072082|Calcium|calcium|mesh-list
5744787|NCT03072082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5744788|NCT03072082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744789|NCT03072082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5744790|NCT03072082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5744791|NCT03072082|Analgesics|analgesics|mesh-ancestor
5744792|NCT03072082|Sensory System Agents|sensory system agents|mesh-ancestor
5744793|NCT03072082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5744794|NCT03072082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5744795|NCT03072082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5744796|NCT03072082|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5744797|NCT03072082|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5744798|NCT03072082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744799|NCT03072082|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5622575|NCT04165317|BCG Vaccine|bcg vaccine|mesh-list
5622576|NCT04165317|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5622577|NCT04165317|Immunologic Factors|immunologic factors|mesh-ancestor
5622578|NCT04165317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622579|NCT04165122|Valacyclovir|valacyclovir|mesh-list
5622580|NCT04165122|Antiviral Agents|antiviral agents|mesh-ancestor
5744800|NCT03072082|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5744801|NCT03072082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5744802|NCT03072082|Antipyretics|antipyretics|mesh-ancestor
5744803|NCT03072082|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5744804|NCT03072082|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5744805|NCT03072082|Antimetabolites|antimetabolites|mesh-ancestor
5744806|NCT03072082|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5622581|NCT04165122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5622582|NCT04162210|Dexamethasone|dexamethasone|mesh-list
5622583|NCT04162210|Pomalidomide|pomalidomide|mesh-list
5622584|NCT04162210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5622585|NCT04162210|Antiemetics|antiemetics|mesh-ancestor
5622586|NCT04162210|Autonomic Agents|autonomic agents|mesh-ancestor
5622587|NCT04162210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5622588|NCT04162210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622589|NCT04162210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5622590|NCT04162210|Glucocorticoids|glucocorticoids|mesh-ancestor
5622591|NCT04162210|Hormones|hormones|mesh-ancestor
5622592|NCT04162210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5622593|NCT04162210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5744807|NCT03072082|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5744808|NCT03072082|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5744809|NCT03072082|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5744810|NCT03072082|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5744811|NCT03072082|Purinergic Agents|purinergic agents|mesh-ancestor
5744812|NCT03072082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5744813|NCT03072082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5622594|NCT04162210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5622595|NCT04162210|Immunologic Factors|immunologic factors|mesh-ancestor
5622596|NCT04162210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5622597|NCT04162210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5622598|NCT04162210|Growth Substances|growth substances|mesh-ancestor
5622599|NCT04162210|Growth Inhibitors|growth inhibitors|mesh-ancestor
5622600|NCT04154787|Rituximab|rituximab|mesh-list
5622601|NCT04154787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5622602|NCT04154787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5622603|NCT04154787|Immunologic Factors|immunologic factors|mesh-ancestor
5622604|NCT04154787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622605|NCT04154787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5622606|NCT04103554|Valsartan|valsartan|mesh-list
5622607|NCT04103554|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5622608|NCT04103554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5622609|NCT04103554|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5622610|NCT04103554|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5622611|NCT04103554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744814|NCT03072082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5744815|NCT03072082|Sympatholytics|sympatholytics|mesh-ancestor
5744816|NCT03072082|Autonomic Agents|autonomic agents|mesh-ancestor
5744817|NCT03072082|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5622612|NCT04088890|Cyclophosphamide|cyclophosphamide|mesh-list
5622613|NCT04088890|Fludarabine|fludarabine|mesh-list
5622614|NCT04088890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5622615|NCT04088890|Immunologic Factors|immunologic factors|mesh-ancestor
5744818|NCT03072082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5744819|NCT03072082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5744820|NCT03072082|Adrenergic Agents|adrenergic agents|mesh-ancestor
5744821|NCT03072082|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5744822|NCT03072082|Diuretics|diuretics|mesh-ancestor
5744823|NCT03072082|Natriuretic Agents|natriuretic agents|mesh-ancestor
5744824|NCT03072082|Vasodilator Agents|vasodilator agents|mesh-ancestor
5744825|NCT03072082|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5744826|NCT03072290|Triamcinolone|triamcinolone|mesh-list
5744827|NCT03072290|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5744828|NCT03072290|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5744829|NCT03072290|Lidocaine|lidocaine|mesh-list
5744830|NCT03072290|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5744831|NCT03072290|Anesthetics, Local|anesthetics, local|mesh-ancestor
5744832|NCT03072290|Anesthetics|anesthetics|mesh-ancestor
5744833|NCT03072290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5744834|NCT03072290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744835|NCT03072290|Sensory System Agents|sensory system agents|mesh-ancestor
5744836|NCT03072290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5744837|NCT03072290|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5744838|NCT03072290|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5744839|NCT03072290|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5622616|NCT04088890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622617|NCT04088890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5622618|NCT04088890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5622619|NCT04088890|Alkylating Agents|alkylating agents|mesh-ancestor
5622620|NCT04088890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622621|NCT04088890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5622622|NCT04088890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5622623|NCT04088409|Adalimumab|adalimumab|mesh-list
5622624|NCT04088409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5622625|NCT04088409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5622626|NCT04080843|Capecitabine|capecitabine|mesh-list
5622627|NCT04080843|Oxaliplatin|oxaliplatin|mesh-list
5622628|NCT04080843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5622629|NCT04080843|Antimetabolites|antimetabolites|mesh-ancestor
5622630|NCT04080843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622631|NCT04080843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5622632|NCT04073147|Venetoclax|venetoclax|mesh-list
5622633|NCT04073147|Obinutuzumab|obinutuzumab|mesh-list
5622634|NCT04073147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5622635|NCT04073147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5744840|NCT03072290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5744841|NCT03072290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744842|NCT03072290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5744843|NCT03072290|Glucocorticoids|glucocorticoids|mesh-ancestor
5744844|NCT03072290|Hormones|hormones|mesh-ancestor
5744845|NCT03072290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5744846|NCT03072290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5622636|NCT04054375|Prednisone|prednisone|mesh-list
5622637|NCT04054375|Prednisolone|prednisolone|mesh-list
5622638|NCT04054375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5622639|NCT04054375|Glucocorticoids|glucocorticoids|mesh-ancestor
5622640|NCT04054375|Hormones|hormones|mesh-ancestor
5622641|NCT04054375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5622642|NCT04054375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622643|NCT04054375|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5622644|NCT04054375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5622645|NCT04052139|Naltrexone|naltrexone|mesh-list
5622646|NCT04052139|Gabapentin|gabapentin|mesh-list
5622647|NCT04052139|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5622648|NCT04052139|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5622649|NCT04052139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622650|NCT04052139|Sensory System Agents|sensory system agents|mesh-ancestor
5622651|NCT04052139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5622652|NCT04052139|Analgesics|analgesics|mesh-ancestor
5622653|NCT04052139|Anticonvulsants|anticonvulsants|mesh-ancestor
5622654|NCT04052139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5622655|NCT04052139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5622656|NCT04052139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5622657|NCT04052139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5622658|NCT04052139|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5622659|NCT04052139|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5622660|NCT04052139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5622661|NCT04052139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622662|NCT04052139|Antimanic Agents|antimanic agents|mesh-ancestor
5622663|NCT04032301|Ketamine|ketamine|mesh-list
5622664|NCT04032301|Analgesics|analgesics|mesh-ancestor
5622665|NCT04032301|Sensory System Agents|sensory system agents|mesh-ancestor
5622666|NCT04032301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5622667|NCT04032301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622668|NCT04032301|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5622669|NCT04032301|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5622670|NCT04032301|Anesthetics, General|anesthetics, general|mesh-ancestor
5622671|NCT04032301|Anesthetics|anesthetics|mesh-ancestor
5622672|NCT04032301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5622673|NCT04032301|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5622674|NCT04032301|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5622675|NCT04032301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5622676|NCT04032301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208708|NCT02134951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6208709|NCT02134951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208710|NCT02134977|Leuprolide|leuprolide|mesh-list
6208711|NCT02134977|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6208712|NCT02134977|Fertility Agents|fertility agents|mesh-ancestor
6208713|NCT02134977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6208714|NCT02134977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208715|NCT02134977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6489405|NCT00591617|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5622686|NCT03998319|Tenecteplase|tenecteplase|mesh-list
5622687|NCT03998319|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5622688|NCT03998319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5622689|NCT03998319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622690|NCT03984214|Dronabinol|dronabinol|mesh-list
5622691|NCT03984214|Hallucinogens|hallucinogens|mesh-ancestor
5622692|NCT03984214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622693|NCT03984214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5622694|NCT03984214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5622695|NCT03984214|Analgesics|analgesics|mesh-ancestor
5622696|NCT03984214|Sensory System Agents|sensory system agents|mesh-ancestor
5622697|NCT03984214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5622698|NCT03984214|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5622699|NCT03984214|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5622700|NCT03984214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5622701|NCT03984214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622702|NCT03984214|Hormones|hormones|mesh-ancestor
5622703|NCT03984214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5622704|NCT03983850|Mycophenolic Acid|mycophenolic acid|mesh-list
5744847|NCT03072290|Immunologic Factors|immunologic factors|mesh-ancestor
5744848|NCT03072290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5744849|NCT03072121|Aspirin|aspirin|mesh-list
5744850|NCT03072121|Metoprolol|metoprolol|mesh-list
5744851|NCT03072121|Isosorbide|isosorbide|mesh-list
5744852|NCT03072121|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
5744853|NCT03072121|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
5744854|NCT03072121|Trimetazidine|trimetazidine|mesh-list
5744855|NCT03072121|Clopidogrel|clopidogrel|mesh-list
5744856|NCT03072121|Atorvastatin|atorvastatin|mesh-list
5744857|NCT03072121|Calcium|calcium|mesh-list
5744858|NCT03072121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5744859|NCT03072121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744860|NCT03072121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5744861|NCT03072121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5744862|NCT03072121|Analgesics|analgesics|mesh-ancestor
5744863|NCT03072121|Sensory System Agents|sensory system agents|mesh-ancestor
5744864|NCT03072121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5744865|NCT03072121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5744866|NCT03072121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5744867|NCT03072121|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5744868|NCT03072121|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5744869|NCT03072121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744870|NCT03072121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5744871|NCT03072121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5744872|NCT03072121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5744873|NCT03072121|Antipyretics|antipyretics|mesh-ancestor
5744874|NCT03072121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5744875|NCT03072121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5622705|NCT03983850|Sirolimus|sirolimus|mesh-list
5622706|NCT03983850|Cyclophosphamide|cyclophosphamide|mesh-list
5622707|NCT03983850|Busulfan|busulfan|mesh-list
5622708|NCT03983850|Fludarabine|fludarabine|mesh-list
5622709|NCT03983850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5622710|NCT03983850|Immunologic Factors|immunologic factors|mesh-ancestor
5622711|NCT03983850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622712|NCT03983850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5622713|NCT03983850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5622714|NCT03983850|Alkylating Agents|alkylating agents|mesh-ancestor
5622715|NCT03983850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622716|NCT03983850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5622717|NCT03983850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5622718|NCT03983850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5622719|NCT03983850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5622720|NCT03983850|Antitubercular Agents|antitubercular agents|mesh-ancestor
5622721|NCT03983850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5622722|NCT03983850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5622723|NCT03983850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5622724|NCT03983850|Antifungal Agents|antifungal agents|mesh-ancestor
5622725|NCT03976323|Cisplatin|cisplatin|mesh-list
5622726|NCT03976323|Carboplatin|carboplatin|mesh-list
5622727|NCT03976323|Pembrolizumab|pembrolizumab|mesh-list
5622728|NCT03976323|Pemetrexed|pemetrexed|mesh-list
5622729|NCT03976323|Olaparib|olaparib|mesh-list
5622730|NCT03976323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5622731|NCT03976323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5622732|NCT03976323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5622733|NCT03976323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622734|NCT03976323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5622735|NCT03976323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5622736|NCT03976323|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5622737|NCT03965130|Glucagon|glucagon|mesh-list
5744876|NCT03072121|Antimetabolites|antimetabolites|mesh-ancestor
5744877|NCT03072121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5744878|NCT03072121|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5744879|NCT03072121|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5744880|NCT03072121|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5744881|NCT03072121|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5744882|NCT03072121|Purinergic Agents|purinergic agents|mesh-ancestor
5744883|NCT03072121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5744884|NCT03072121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5744885|NCT03072121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5744886|NCT03072121|Sympatholytics|sympatholytics|mesh-ancestor
5744887|NCT03072121|Autonomic Agents|autonomic agents|mesh-ancestor
5744888|NCT03072121|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5744889|NCT03072121|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5744890|NCT03072121|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5744891|NCT03072121|Adrenergic Agents|adrenergic agents|mesh-ancestor
5744892|NCT03072121|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5744893|NCT03072121|Diuretics|diuretics|mesh-ancestor
5744894|NCT03072121|Natriuretic Agents|natriuretic agents|mesh-ancestor
5744895|NCT03072121|Vasodilator Agents|vasodilator agents|mesh-ancestor
5622738|NCT03965130|Hormones|hormones|mesh-ancestor
5622739|NCT03965130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5622740|NCT03965130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622741|NCT03965130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5622742|NCT03958383|Nivolumab|nivolumab|mesh-list
5622743|NCT03958383|Ipilimumab|ipilimumab|mesh-list
5622744|NCT03958383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5622745|NCT03958383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5622746|NCT03958383|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5622747|NCT03958383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744896|NCT03072121|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5744897|NCT03072173|Xylometazoline|xylometazoline|mesh-list
5744898|NCT03072173|Nasal Decongestants|nasal decongestants|mesh-ancestor
5744899|NCT03072173|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5744900|NCT03072173|Respiratory System Agents|respiratory system agents|mesh-ancestor
5744901|NCT03072199|Rituximab|rituximab|mesh-list
5744902|NCT03072199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5744903|NCT03072199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5744904|NCT03072199|Immunologic Factors|immunologic factors|mesh-ancestor
5744905|NCT03072199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744906|NCT03072199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5622748|NCT03953079|Sunitinib|sunitinib|mesh-list
5622749|NCT03953079|Aflibercept|aflibercept|mesh-list
5622750|NCT03953079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5622751|NCT03953079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5622752|NCT03953079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5622753|NCT03953079|Growth Substances|growth substances|mesh-ancestor
5622754|NCT03953079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622755|NCT03953079|Growth Inhibitors|growth inhibitors|mesh-ancestor
5622756|NCT03953079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5622757|NCT03953079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5622758|NCT03953079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622759|NCT03944876|Botulinum Toxins|botulinum toxins|mesh-list
5744907|NCT03071926|Doxorubicin|doxorubicin|mesh-list
5744908|NCT03071926|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5744909|NCT03071926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5744910|NCT03071926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5744911|NCT03071926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5744912|NCT03071926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5744913|NCT03071926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5744914|NCT03071926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744915|NCT03071861|Darbepoetin alfa|darbepoetin alfa|mesh-list
5744916|NCT03071861|Hematinics|hematinics|mesh-ancestor
5744917|NCT03071679|Antimicrobial Cationic Peptides|antimicrobial cationic peptides|mesh-list
5744918|NCT03071679|Imiquimod|imiquimod|mesh-list
5744919|NCT03071679|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5744920|NCT03071679|Immunologic Factors|immunologic factors|mesh-ancestor
5744921|NCT03071679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744922|NCT03071679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5744923|NCT03071679|Interferon Inducers|interferon inducers|mesh-ancestor
5744924|NCT03071679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5744925|NCT03071666|Vitamin B 12|vitamin b 12|mesh-list
5744926|NCT03071666|Vitamins|vitamins|mesh-ancestor
5744927|NCT03071666|Micronutrients|micronutrients|mesh-ancestor
5744928|NCT03071666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744929|NCT03071666|Vitamin B Complex|vitamin b complex|mesh-ancestor
5744930|NCT03071822|Gemcitabine|gemcitabine|mesh-list
5744931|NCT03071822|Dexamethasone|dexamethasone|mesh-list
5622760|NCT03944876|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5622761|NCT03944876|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5744932|NCT03071822|Etoposide|etoposide|mesh-list
5744933|NCT03071822|Asparaginase|asparaginase|mesh-list
5744934|NCT03071822|Ifosfamide|ifosfamide|mesh-list
5744935|NCT03071822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5622762|NCT03944876|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5622763|NCT03944876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5622764|NCT03944876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622765|NCT03944876|Cholinergic Agents|cholinergic agents|mesh-ancestor
5622766|NCT03944876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5622767|NCT03944876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622768|NCT03944876|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5622769|NCT03944876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5622770|NCT03944577|Evolocumab|evolocumab|mesh-list
5622771|NCT03944577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5622772|NCT03944577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5622773|NCT03944577|Antimetabolites|antimetabolites|mesh-ancestor
5622774|NCT03944577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622775|NCT03944577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5622776|NCT03940703|Osimertinib|osimertinib|mesh-list
5622777|NCT03940703|Tepotinib|tepotinib|mesh-list
5744936|NCT03071822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5744937|NCT03071822|Antiemetics|antiemetics|mesh-ancestor
5744938|NCT03071822|Autonomic Agents|autonomic agents|mesh-ancestor
5744939|NCT03071822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5744940|NCT03071822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744941|NCT03071822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5744942|NCT03071822|Glucocorticoids|glucocorticoids|mesh-ancestor
5744943|NCT03071822|Hormones|hormones|mesh-ancestor
5744944|NCT03071822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5744945|NCT03071822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5744946|NCT03071822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5744947|NCT03071822|Antimetabolites|antimetabolites|mesh-ancestor
5744948|NCT03071822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744949|NCT03071822|Antiviral Agents|antiviral agents|mesh-ancestor
5744950|NCT03071822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5622778|NCT03940703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5692682|NCT03406299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5744951|NCT03071822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5744952|NCT03071822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5744953|NCT03071822|Immunologic Factors|immunologic factors|mesh-ancestor
5744954|NCT03071822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5744955|NCT03071822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5744956|NCT03071822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5744957|NCT03071822|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5744958|NCT03071822|Alkylating Agents|alkylating agents|mesh-ancestor
5744959|NCT03071731|Bromides|bromides|mesh-list
5744960|NCT03071731|Ipratropium|ipratropium|mesh-list
5744961|NCT03071731|Bronchodilator Agents|bronchodilator agents|mesh-list
5744962|NCT03071731|Anticonvulsants|anticonvulsants|mesh-ancestor
5744963|NCT03071731|Autonomic Agents|autonomic agents|mesh-ancestor
5744964|NCT03071731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5744965|NCT03071731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744966|NCT03071731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5744967|NCT03071731|Respiratory System Agents|respiratory system agents|mesh-ancestor
5744968|NCT03071731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5622779|NCT03940703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5622780|NCT03940703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5622781|NCT03940703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622782|NCT03931291|Azacitidine|azacitidine|mesh-list
5622783|NCT03931291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5622784|NCT03931291|Antimetabolites|antimetabolites|mesh-ancestor
5622785|NCT03931291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622786|NCT03931291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5744969|NCT03071731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744970|NCT03071731|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5744971|NCT03071731|Cholinergic Agents|cholinergic agents|mesh-ancestor
5744972|NCT03071536|Furosemide|furosemide|mesh-list
5744973|NCT03071536|Diuretics|diuretics|mesh-ancestor
5744974|NCT03071536|Natriuretic Agents|natriuretic agents|mesh-ancestor
5744975|NCT03071536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744976|NCT03071536|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5744977|NCT03071536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5622787|NCT03931291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5622788|NCT03922750|Insulin|insulin|mesh-list
5622789|NCT03922750|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5622790|NCT03922750|Insulin Glargine|insulin glargine|mesh-list
5622791|NCT03922750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5622792|NCT03922750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622793|NCT03914300|Nivolumab|nivolumab|mesh-list
5622794|NCT03914300|Ipilimumab|ipilimumab|mesh-list
5622795|NCT03914300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5744978|NCT03071536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744979|NCT03071575|Vaccines|vaccines|mesh-list
5744980|NCT03071575|Immunologic Factors|immunologic factors|mesh-ancestor
5744981|NCT03071575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744982|NCT03071549|Salicylic Acid|salicylic acid|mesh-list
5744983|NCT03071549|Salicylates|salicylates|mesh-list
5744984|NCT03071549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5744985|NCT03071549|Antifungal Agents|antifungal agents|mesh-ancestor
5622796|NCT03914300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5622797|NCT03914300|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5622798|NCT03914300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622799|NCT03910673|Fosfomycin|fosfomycin|mesh-list
5622800|NCT03910673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5622801|NCT03910673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5692683|NCT03406299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5692684|NCT03406299|Immunologic Factors|immunologic factors|mesh-ancestor
5692685|NCT03406299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692686|NCT03406299|Antidotes|antidotes|mesh-ancestor
5692687|NCT03406299|Protective Agents|protective agents|mesh-ancestor
5692688|NCT03406299|Vitamin B Complex|vitamin b complex|mesh-ancestor
5744986|NCT03071549|Keratolytic Agents|keratolytic agents|mesh-ancestor
5744987|NCT03071549|Dermatologic Agents|dermatologic agents|mesh-ancestor
5744988|NCT03071549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5744989|NCT03071549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5744990|NCT03071549|Analgesics|analgesics|mesh-ancestor
5744991|NCT03071549|Sensory System Agents|sensory system agents|mesh-ancestor
5744992|NCT03071549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5744993|NCT03071549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5744994|NCT03071549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5744995|NCT03071549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5744996|NCT03071549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5744997|NCT03071549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5692689|NCT03406299|Vitamins|vitamins|mesh-ancestor
6489406|NCT00591617|Narcotics|narcotics|mesh-ancestor
5744998|NCT03071549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5744999|NCT03071601|Lidocaine|lidocaine|mesh-list
5745000|NCT03071601|Epinephrine|epinephrine|mesh-list
5745001|NCT03071601|Prilocaine|prilocaine|mesh-list
5745002|NCT03071601|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
5622802|NCT03882970|Tirzepatide|tirzepatide|mesh-list
5622803|NCT03882970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5622804|NCT03882970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622805|NCT03882970|Incretins|incretins|mesh-ancestor
5622806|NCT03882970|Hormones|hormones|mesh-ancestor
5622807|NCT03882970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5622808|NCT03867734|Aztreonam|aztreonam|mesh-list
5622809|NCT03867734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5622810|NCT03867734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5622811|NCT03854903|Fulvestrant|fulvestrant|mesh-list
5622812|NCT03854903|Palbociclib|palbociclib|mesh-list
5622813|NCT03854903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5622814|NCT03854903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5622815|NCT03854903|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5622816|NCT03854903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5622817|NCT03854903|Hormone Antagonists|hormone antagonists|mesh-ancestor
5622818|NCT03854903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5622819|NCT03854903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622820|NCT03854903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5745003|NCT03071601|Anesthetics, Local|anesthetics, local|mesh-ancestor
5745004|NCT03071601|Anesthetics|anesthetics|mesh-ancestor
5745005|NCT03071601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5745006|NCT03071601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745007|NCT03071601|Sensory System Agents|sensory system agents|mesh-ancestor
5622821|NCT03854903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5622822|NCT03854903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622823|NCT03829891|Insulin Glargine|insulin glargine|mesh-list
5622824|NCT03829891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5622825|NCT03829891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622826|NCT03829683|Ascorbic Acid|ascorbic acid|mesh-list
5622827|NCT03829683|Vitamins|vitamins|mesh-ancestor
5622828|NCT03829683|Micronutrients|micronutrients|mesh-ancestor
5622829|NCT03829683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622830|NCT03829683|Antioxidants|antioxidants|mesh-ancestor
5745008|NCT03071601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5745009|NCT03071601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5745010|NCT03071601|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5745011|NCT03071601|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5745012|NCT03071601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5745013|NCT03071601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745014|NCT03071601|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5745015|NCT03071601|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5745016|NCT03071601|Adrenergic Agents|adrenergic agents|mesh-ancestor
5745017|NCT03071601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5745018|NCT03071601|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5745019|NCT03071601|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5745020|NCT03071601|Autonomic Agents|autonomic agents|mesh-ancestor
5745021|NCT03071601|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5745022|NCT03071601|Respiratory System Agents|respiratory system agents|mesh-ancestor
5745023|NCT03071601|Mydriatics|mydriatics|mesh-ancestor
5745024|NCT03071601|Sympathomimetics|sympathomimetics|mesh-ancestor
5745025|NCT03071601|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5745026|NCT03071601|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
5622831|NCT03829683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622832|NCT03829683|Protective Agents|protective agents|mesh-ancestor
5622833|NCT03829410|Bevacizumab|bevacizumab|mesh-list
5622834|NCT03829410|Onvansertib|onvansertib|mesh-list
5622835|NCT03829410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5622836|NCT03829410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5622837|NCT03829410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5622838|NCT03829410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5622839|NCT03829410|Growth Substances|growth substances|mesh-ancestor
5622840|NCT03829410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622841|NCT03829410|Growth Inhibitors|growth inhibitors|mesh-ancestor
5622842|NCT03829410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5622843|NCT03829410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5622844|NCT03829410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622845|NCT03818802|Niacinamide|niacinamide|mesh-list
5622846|NCT03818802|Niacin|niacin|mesh-list
5622847|NCT03818802|Nicotinic Acids|nicotinic acids|mesh-list
5745027|NCT03071770|Ivosidenib|ivosidenib|mesh-list
5745028|NCT03071770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5745029|NCT03071770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5745030|NCT03071770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622848|NCT03818802|Vitamin B Complex|vitamin b complex|mesh-ancestor
5622849|NCT03818802|Vitamins|vitamins|mesh-ancestor
5622850|NCT03818802|Micronutrients|micronutrients|mesh-ancestor
5622851|NCT03818802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622852|NCT03818802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5622853|NCT03818802|Antimetabolites|antimetabolites|mesh-ancestor
5622854|NCT03818802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622855|NCT03818802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5622856|NCT03818802|Vasodilator Agents|vasodilator agents|mesh-ancestor
5622857|NCT03816345|Nivolumab|nivolumab|mesh-list
5622858|NCT03816345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5622859|NCT03816345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5622860|NCT03816345|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5622861|NCT03816345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622862|NCT03810313|Aflibercept|aflibercept|mesh-list
5622863|NCT03810313|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5622864|NCT03810313|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5622865|NCT03810313|Growth Substances|growth substances|mesh-ancestor
5622866|NCT03810313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622867|NCT03810313|Growth Inhibitors|growth inhibitors|mesh-ancestor
5622868|NCT03810313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5622869|NCT03806335|Anesthetics|anesthetics|mesh-list
5622870|NCT03806335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5622871|NCT03806335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622872|NCT03805932|Rituximab|rituximab|mesh-list
5622873|NCT03805932|Immunotoxin HA22|immunotoxin ha22|mesh-list
5622874|NCT03805932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5622875|NCT03805932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5622876|NCT03805932|Immunologic Factors|immunologic factors|mesh-ancestor
5622877|NCT03805932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622878|NCT03805932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5622879|NCT03802630|Aflibercept|aflibercept|mesh-list
5622880|NCT03802630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5622881|NCT03802630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5622882|NCT03802630|Growth Substances|growth substances|mesh-ancestor
5622883|NCT03802630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622884|NCT03802630|Growth Inhibitors|growth inhibitors|mesh-ancestor
5622885|NCT03802630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5622886|NCT03799003|Pembrolizumab|pembrolizumab|mesh-list
5622887|NCT03799003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5622888|NCT03799003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5622889|NCT03796156|Aspirin|aspirin|mesh-list
5622890|NCT03796156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5622891|NCT03796156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5622892|NCT03796156|Analgesics|analgesics|mesh-ancestor
5622893|NCT03796156|Sensory System Agents|sensory system agents|mesh-ancestor
5622894|NCT03796156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5622895|NCT03796156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622896|NCT03796156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5622897|NCT03796156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5622898|NCT03796156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5622899|NCT03796156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5622900|NCT03796156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622901|NCT03796156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5622902|NCT03796156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5622903|NCT03796156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5622904|NCT03796156|Antipyretics|antipyretics|mesh-ancestor
5622905|NCT03794427|Anesthetics|anesthetics|mesh-list
5622906|NCT03794427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5622907|NCT03794427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622908|NCT03787095|Cemiplimab|cemiplimab|mesh-list
5622909|NCT03787095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5622910|NCT03787095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5622911|NCT03775421|Macitentan|macitentan|mesh-list
5622912|NCT03775421|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
5622913|NCT03775421|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5622914|NCT03775421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622915|NCT03775421|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
5622916|NCT03770676|Selenium|selenium|mesh-list
5622917|NCT03770676|Antioxidants|antioxidants|mesh-ancestor
5745031|NCT03071497|Protoporphyrin IX|protoporphyrin ix|mesh-list
5745032|NCT03071497|Zinc protoporphyrin|zinc protoporphyrin|mesh-list
5745033|NCT03071497|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5745034|NCT03071497|Dermatologic Agents|dermatologic agents|mesh-ancestor
5745035|NCT03071497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5745036|NCT03071497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745037|NCT03071705|Metformin|metformin|mesh-list
5745038|NCT03071705|Gefitinib|gefitinib|mesh-list
5745039|NCT03071705|Afatinib|afatinib|mesh-list
5745040|NCT03071705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5745041|NCT03071705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745042|NCT03071705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5745043|NCT03071705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6489407|NCT00591617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6489408|NCT00591617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489409|NCT00591617|Analgesics|analgesics|mesh-ancestor
6489410|NCT00591617|Sensory System Agents|sensory system agents|mesh-ancestor
6489411|NCT00591617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5622918|NCT03770676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622919|NCT03770676|Protective Agents|protective agents|mesh-ancestor
5622920|NCT03770676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622921|NCT03770676|Trace Elements|trace elements|mesh-ancestor
5622922|NCT03770676|Micronutrients|micronutrients|mesh-ancestor
5622923|NCT03770455|Avelumab|avelumab|mesh-list
5622924|NCT03770455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5622925|NCT03770455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5622926|NCT03764735|Benzalkonium Compounds|benzalkonium compounds|mesh-list
5622927|NCT03764735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5692690|NCT03406299|Micronutrients|micronutrients|mesh-ancestor
5692691|NCT03406247|Nivolumab|nivolumab|mesh-list
5692692|NCT03406247|Ipilimumab|ipilimumab|mesh-list
5692693|NCT03406247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5692694|NCT03406247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5692695|NCT03406247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5692696|NCT03406247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692697|NCT03406169|Sildenafil Citrate|sildenafil citrate|mesh-list
5692698|NCT03406169|Pentoxifylline|pentoxifylline|mesh-list
5692699|NCT03406169|Vasodilator Agents|vasodilator agents|mesh-ancestor
5692700|NCT03406169|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5692701|NCT03406169|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5692702|NCT03406169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5692703|NCT03406169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692704|NCT03406169|Urological Agents|urological agents|mesh-ancestor
5692705|NCT03406169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5692706|NCT03406169|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5692707|NCT03406169|Protective Agents|protective agents|mesh-ancestor
5692708|NCT03406169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692709|NCT03406169|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5692710|NCT03406169|Antioxidants|antioxidants|mesh-ancestor
5692711|NCT03406091|Plerixafor|plerixafor|mesh-list
5692712|NCT03406091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5692713|NCT03406091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5692714|NCT03406091|Antiviral Agents|antiviral agents|mesh-ancestor
5692715|NCT03406091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5692716|NCT03406000|Insulin Glargine|insulin glargine|mesh-list
5692717|NCT03406000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5692718|NCT03406000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692719|NCT03405974|Aspirin|aspirin|mesh-list
5692720|NCT03405974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5692721|NCT03405974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5692722|NCT03405974|Analgesics|analgesics|mesh-ancestor
5692723|NCT03405974|Sensory System Agents|sensory system agents|mesh-ancestor
5692724|NCT03405974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5692725|NCT03405974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692726|NCT03405974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5692727|NCT03405974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5692728|NCT03405974|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5692729|NCT03405974|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5692730|NCT03405974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692731|NCT03405974|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5692732|NCT03405974|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5692733|NCT03405974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5692734|NCT03405974|Antipyretics|antipyretics|mesh-ancestor
5692735|NCT03405948|Botulinum Toxins|botulinum toxins|mesh-list
5745044|NCT03071705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5745045|NCT03071705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894066|NCT02122718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907763|NCT05203445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5907764|NCT05203445|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5907765|NCT05203445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5907766|NCT05203445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907767|NCT05201612|Pembrolizumab|pembrolizumab|mesh-list
5907768|NCT05201612|Olaparib|olaparib|mesh-list
5622928|NCT03764735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5622929|NCT03760458|Lamivudine|lamivudine|mesh-list
5622930|NCT03760458|Abacavir|abacavir|mesh-list
5622931|NCT03760458|Dideoxynucleosides|dideoxynucleosides|mesh-list
5622932|NCT03760458|Dolutegravir|dolutegravir|mesh-list
5622933|NCT03760458|Triumeq|triumeq|mesh-list
5622934|NCT03760458|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5622935|NCT03760458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5622936|NCT03760458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5622937|NCT03760458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622938|NCT03760458|Antiviral Agents|antiviral agents|mesh-ancestor
5622939|NCT03760458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5622940|NCT03760458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5622941|NCT03760458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5622942|NCT03760458|Antimetabolites|antimetabolites|mesh-ancestor
5622943|NCT03760458|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5622944|NCT03760458|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5622945|NCT03739996|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
5622946|NCT03739996|Cabotegravir|cabotegravir|mesh-list
5622947|NCT03739996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5622948|NCT03739996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5622949|NCT03739996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622950|NCT03739996|Antiviral Agents|antiviral agents|mesh-ancestor
5622951|NCT03739996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5622952|NCT03739996|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5622953|NCT03739996|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5622954|NCT03739996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5622955|NCT03739996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5622956|NCT03689712|Avasopasem manganese|avasopasem manganese|mesh-list
5622957|NCT03689712|Antioxidants|antioxidants|mesh-ancestor
5622958|NCT03689712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622959|NCT03689712|Protective Agents|protective agents|mesh-ancestor
5622960|NCT03689712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5622961|NCT03631446|Picosulfate sodium|picosulfate sodium|mesh-list
5622962|NCT03631446|Magnesium Oxide|magnesium oxide|mesh-list
5622963|NCT03631446|Citric Acid|citric acid|mesh-list
5622964|NCT03631446|Sodium Citrate|sodium citrate|mesh-list
5622965|NCT03631446|Cathartics|cathartics|mesh-ancestor
5622966|NCT03631446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5622967|NCT03631446|Anticoagulants|anticoagulants|mesh-ancestor
5622968|NCT03631446|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5622969|NCT03631446|Chelating Agents|chelating agents|mesh-ancestor
5622970|NCT03631446|Sequestering Agents|sequestering agents|mesh-ancestor
5622971|NCT03631446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622972|NCT03631446|Antacids|antacids|mesh-ancestor
5622973|NCT03630640|Nivolumab|nivolumab|mesh-list
5622974|NCT03630640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5622975|NCT03630640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5622976|NCT03630640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5622977|NCT03630640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622978|NCT03625388|Dasatinib|dasatinib|mesh-list
5622979|NCT03625388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5622980|NCT03625388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5622981|NCT03625388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5622982|NCT03625388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622983|NCT03577704|Gemcitabine|gemcitabine|mesh-list
5622984|NCT03577704|Paclitaxel|paclitaxel|mesh-list
5622985|NCT03577704|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5622986|NCT03577704|Cisplatin|cisplatin|mesh-list
5622987|NCT03577704|Carboplatin|carboplatin|mesh-list
5622988|NCT03577704|Oxaliplatin|oxaliplatin|mesh-list
5622989|NCT03577704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5622990|NCT03577704|Antibodies|antibodies|mesh-list
5622991|NCT03577704|Immunoglobulins|immunoglobulins|mesh-list
5622992|NCT03577704|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5622993|NCT03577704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5622994|NCT03577704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5622995|NCT03577704|Tubulin Modulators|tubulin modulators|mesh-ancestor
5745046|NCT03071289|Cisplatin|cisplatin|mesh-list
5745047|NCT03071289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5745048|NCT03071302|Tissue Inhibitor of Metalloproteinase-3|tissue inhibitor of metalloproteinase-3|mesh-list
5745049|NCT03071302|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
5745050|NCT03071302|Protease Inhibitors|protease inhibitors|mesh-ancestor
5745051|NCT03071302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5745052|NCT03071302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745053|NCT03071380|Rivaroxaban|rivaroxaban|mesh-list
5745054|NCT03071380|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5745055|NCT03071380|Antithrombins|antithrombins|mesh-ancestor
5745056|NCT03071380|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5745057|NCT03071380|Protease Inhibitors|protease inhibitors|mesh-ancestor
5745058|NCT03071380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5745059|NCT03071380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745060|NCT03071380|Anticoagulants|anticoagulants|mesh-ancestor
5745061|NCT03071055|Ranibizumab|ranibizumab|mesh-list
5745062|NCT03071055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5745063|NCT03071055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5745064|NCT03071055|Growth Substances|growth substances|mesh-ancestor
5745065|NCT03071055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745066|NCT03071055|Growth Inhibitors|growth inhibitors|mesh-ancestor
5745067|NCT03071055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5745068|NCT03071172|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5745069|NCT03071172|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5745070|NCT03071172|Progesterone|progesterone|mesh-list
5745071|NCT03071172|Hormones|hormones|mesh-ancestor
5745072|NCT03071172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5745073|NCT03071172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745074|NCT03071172|Progestins|progestins|mesh-ancestor
5745075|NCT03071172|Luteolytic Agents|luteolytic agents|mesh-ancestor
5745076|NCT03071172|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5745077|NCT03071172|Contraceptive Agents|contraceptive agents|mesh-ancestor
5745078|NCT03071172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5745079|NCT03071172|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5745080|NCT03071172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5745081|NCT03071172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5745082|NCT03070938|Anti-Infective Agents|anti-infective agents|mesh-list
5745083|NCT03070938|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5745084|NCT03071042|Docetaxel|docetaxel|mesh-list
5745085|NCT03071042|Apatinib|apatinib|mesh-list
5745086|NCT03071042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5745087|NCT03071042|Tubulin Modulators|tubulin modulators|mesh-ancestor
5745088|NCT03071042|Antimitotic Agents|antimitotic agents|mesh-ancestor
5622996|NCT03577704|Antimitotic Agents|antimitotic agents|mesh-ancestor
5622997|NCT03577704|Mitosis Modulators|mitosis modulators|mesh-ancestor
5622998|NCT03577704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5622999|NCT03577704|Immunologic Factors|immunologic factors|mesh-ancestor
5623000|NCT03577704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623001|NCT03577704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5623002|NCT03577704|Antimetabolites|antimetabolites|mesh-ancestor
5623003|NCT03577704|Antiviral Agents|antiviral agents|mesh-ancestor
5623004|NCT03577704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5623005|NCT03577704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5623006|NCT03577704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5623007|NCT03567057|Amantadine|amantadine|mesh-list
5623008|NCT03567057|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5623009|NCT03567057|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5623010|NCT03567057|Antiviral Agents|antiviral agents|mesh-ancestor
5745089|NCT03071042|Mitosis Modulators|mitosis modulators|mesh-ancestor
5745090|NCT03071042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745091|NCT03071042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5745092|NCT03071042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5745093|NCT03071068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5745094|NCT03071068|Antibodies|antibodies|mesh-list
5745095|NCT03071068|Immunoglobulins|immunoglobulins|mesh-list
5745096|NCT03071068|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5745097|NCT03071068|Immunologic Factors|immunologic factors|mesh-ancestor
5745098|NCT03071068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745099|NCT03071068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5745100|NCT03070925|Anti-Infective Agents|anti-infective agents|mesh-list
5745101|NCT03070925|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5745102|NCT03070860|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5745103|NCT03070860|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5623011|NCT03567057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5623012|NCT03567057|Dopamine Agents|dopamine agents|mesh-ancestor
5745104|NCT03070860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623013|NCT03567057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5623014|NCT03567057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623015|NCT03567057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623016|NCT03567057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5623017|NCT03567057|Analgesics|analgesics|mesh-ancestor
5623018|NCT03567057|Sensory System Agents|sensory system agents|mesh-ancestor
5745105|NCT03070847|Tranexamic Acid|tranexamic acid|mesh-list
5745106|NCT03070847|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5745107|NCT03070847|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5745108|NCT03070847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745109|NCT03070847|Hemostatics|hemostatics|mesh-ancestor
5745110|NCT03070847|Coagulants|coagulants|mesh-ancestor
5745111|NCT03070665|Norepinephrine|norepinephrine|mesh-list
5745112|NCT03070665|Ephedrine|ephedrine|mesh-list
5745113|NCT03070665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5745114|NCT03070665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5745115|NCT03070665|Adrenergic Agents|adrenergic agents|mesh-ancestor
5745116|NCT03070665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5745117|NCT03070665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745118|NCT03070665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745119|NCT03070665|Sympathomimetics|sympathomimetics|mesh-ancestor
5623019|NCT03567057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5623020|NCT03566511|Diazoxide|diazoxide|mesh-list
5623021|NCT03566511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5623022|NCT03566511|Vasodilator Agents|vasodilator agents|mesh-ancestor
5623023|NCT03553563|Esomeprazole|esomeprazole|mesh-list
5745120|NCT03070665|Autonomic Agents|autonomic agents|mesh-ancestor
5745121|NCT03070665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5745122|NCT03070665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5745123|NCT03070665|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5745124|NCT03070574|Aminosalicylic Acid|aminosalicylic acid|mesh-list
5745125|NCT03070574|Mesalamine|mesalamine|mesh-list
5745126|NCT03070574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5745127|NCT03070574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5745128|NCT03070574|Analgesics|analgesics|mesh-ancestor
5745129|NCT03070574|Sensory System Agents|sensory system agents|mesh-ancestor
5745130|NCT03070574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5745131|NCT03070574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745132|NCT03070574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5745133|NCT03070574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5745134|NCT03070574|Antitubercular Agents|antitubercular agents|mesh-ancestor
5745135|NCT03070574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5745136|NCT03070574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5745137|NCT03070704|Liraglutide|liraglutide|mesh-list
5745138|NCT03070704|Xultophy|xultophy|mesh-list
5745139|NCT03070704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5745140|NCT03070704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745141|NCT03070704|Incretins|incretins|mesh-ancestor
5745142|NCT03070704|Hormones|hormones|mesh-ancestor
5745143|NCT03070704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5745144|NCT03070678|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
5745145|NCT03070678|Mefenamic Acid|mefenamic acid|mesh-list
5745146|NCT03070678|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5745147|NCT03070678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745148|NCT03070678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5745149|NCT03070678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745150|NCT03070678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5745151|NCT03070678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5745152|NCT03070678|Analgesics|analgesics|mesh-ancestor
5745153|NCT03070678|Sensory System Agents|sensory system agents|mesh-ancestor
5745154|NCT03070678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5745155|NCT03070678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5745156|NCT03070678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5745157|NCT03070678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5745158|NCT03070678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5745159|NCT03070522|Prednisone|prednisone|mesh-list
5745160|NCT03070522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5745161|NCT03070522|Glucocorticoids|glucocorticoids|mesh-ancestor
5745162|NCT03070522|Hormones|hormones|mesh-ancestor
5745163|NCT03070522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5745164|NCT03070522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894067|NCT01882816|Doxorubicin|doxorubicin|mesh-list
6672907|NCT01559272|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6672908|NCT01559272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5745165|NCT03070522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5745166|NCT03070522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5745167|NCT03070613|Lectins|lectins|mesh-list
5745168|NCT03070613|Agglutinins|agglutinins|mesh-ancestor
5745169|NCT03070613|Immunologic Factors|immunologic factors|mesh-ancestor
5745170|NCT03070613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745171|NCT03070613|Coagulants|coagulants|mesh-ancestor
5745172|NCT03070509|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
5745173|NCT03070509|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5623024|NCT03553563|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5623025|NCT03553563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5623026|NCT03553563|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5623027|NCT03553563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5623028|NCT03553563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623029|NCT03552068|Clonidine|clonidine|mesh-list
5623030|NCT03552068|Analgesics|analgesics|mesh-ancestor
5623031|NCT03552068|Sensory System Agents|sensory system agents|mesh-ancestor
5623032|NCT03552068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5623033|NCT03552068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623034|NCT03552068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5623035|NCT03552068|Sympatholytics|sympatholytics|mesh-ancestor
5623036|NCT03552068|Autonomic Agents|autonomic agents|mesh-ancestor
5745174|NCT03070509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745175|NCT03070509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5745176|NCT03070509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5745177|NCT03070509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5745178|NCT03070509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745179|NCT03070509|Dopamine Agents|dopamine agents|mesh-ancestor
5745180|NCT03070509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5745181|NCT03070379|Lidocaine|lidocaine|mesh-list
5623037|NCT03552068|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5623038|NCT03552068|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5623039|NCT03552068|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5623040|NCT03552068|Adrenergic Agents|adrenergic agents|mesh-ancestor
5623041|NCT03552068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5623042|NCT03552068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692736|NCT03405948|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5692737|NCT03405948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5692738|NCT03405948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692739|NCT03405948|Cholinergic Agents|cholinergic agents|mesh-ancestor
5692740|NCT03405948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5692741|NCT03405948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692742|NCT03405805|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5692743|NCT03405805|Immunologic Factors|immunologic factors|mesh-ancestor
5692744|NCT03405805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692745|NCT03405584|Amoxicillin|amoxicillin|mesh-list
5692746|NCT03405584|Potassium Citrate|potassium citrate|mesh-list
5692747|NCT03405584|Esomeprazole|esomeprazole|mesh-list
5745182|NCT03070379|Anesthetics, Local|anesthetics, local|mesh-ancestor
5745183|NCT03070379|Anesthetics|anesthetics|mesh-ancestor
5745184|NCT03070379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5745185|NCT03070379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745186|NCT03070379|Sensory System Agents|sensory system agents|mesh-ancestor
5745187|NCT03070379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5745188|NCT03070379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5745189|NCT03070379|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5692748|NCT03405584|Bismuth|bismuth|mesh-list
5692749|NCT03405584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692750|NCT03405584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5692751|NCT03405584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5692752|NCT03405584|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5692753|NCT03405584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5692754|NCT03405584|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5692755|NCT03405584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5692756|NCT03405584|Antacids|antacids|mesh-ancestor
5692757|NCT03405584|Diuretics|diuretics|mesh-ancestor
5692758|NCT03405584|Natriuretic Agents|natriuretic agents|mesh-ancestor
5692759|NCT03405584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692760|NCT03405584|Expectorants|expectorants|mesh-ancestor
5692761|NCT03405584|Respiratory System Agents|respiratory system agents|mesh-ancestor
5692762|NCT03405454|Durvalumab|durvalumab|mesh-list
5692763|NCT03405454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5692764|NCT03405454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5692765|NCT03405376|Aflibercept|aflibercept|mesh-list
5623043|NCT03548064|Vaccines|vaccines|mesh-list
5623044|NCT03548064|Immunologic Factors|immunologic factors|mesh-ancestor
5623045|NCT03548064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623046|NCT03534635|Pembrolizumab|pembrolizumab|mesh-list
5623047|NCT03534635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5623048|NCT03534635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5623049|NCT03527316|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
5623050|NCT03527316|Hallucinogens|hallucinogens|mesh-ancestor
5623051|NCT03527316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623052|NCT03527316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5623053|NCT03527316|Serotonin Agents|serotonin agents|mesh-ancestor
5623054|NCT03527316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5623055|NCT03527316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623056|NCT03527316|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5623057|NCT03527316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5623058|NCT03527316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5623059|NCT03527316|Adrenergic Agents|adrenergic agents|mesh-ancestor
5623060|NCT03526679|Lenvatinib|lenvatinib|mesh-list
5623061|NCT03526679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5623062|NCT03526679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5623063|NCT03526679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5623064|NCT03526679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745190|NCT03070379|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5745191|NCT03070379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5745192|NCT03070379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745193|NCT03070405|Tenofovir|tenofovir|mesh-list
5745194|NCT03070405|Aminosalicylic Acid|aminosalicylic acid|mesh-list
5745195|NCT03070405|Antiviral Agents|antiviral agents|mesh-ancestor
5745196|NCT03070405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5745197|NCT03070405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5745198|NCT03070405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5745199|NCT03070405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5745200|NCT03070405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745201|NCT03070405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5745202|NCT03070405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6672909|NCT01559272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5745203|NCT03070405|Antitubercular Agents|antitubercular agents|mesh-ancestor
5745204|NCT03070405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5745205|NCT03070353|Dextrans|dextrans|mesh-list
5745206|NCT03070353|Anticoagulants|anticoagulants|mesh-ancestor
5745207|NCT03070353|Plasma Substitutes|plasma substitutes|mesh-ancestor
5745208|NCT03070353|Blood Substitutes|blood substitutes|mesh-ancestor
5745209|NCT03070275|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
5745210|NCT03070275|Hemostatics|hemostatics|mesh-ancestor
5745211|NCT03070275|Coagulants|coagulants|mesh-ancestor
5745212|NCT03070223|Pitavastatin|pitavastatin|mesh-list
5745213|NCT03070223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5745214|NCT03070223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5745215|NCT03070223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5745216|NCT03070223|Antimetabolites|antimetabolites|mesh-ancestor
5745217|NCT03070223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745218|NCT03070223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5745219|NCT03070223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5745220|NCT03070028|Phenol|phenol|mesh-list
5745221|NCT03070028|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5745222|NCT03070028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5745223|NCT03070028|Disinfectants|disinfectants|mesh-ancestor
5745224|NCT03070028|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
5745225|NCT03070028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5745226|NCT03070054|Epinephrine|epinephrine|mesh-list
5745227|NCT03070054|Bupivacaine|bupivacaine|mesh-list
5745228|NCT03070054|Anesthetics, Local|anesthetics, local|mesh-ancestor
5745229|NCT03070054|Anesthetics|anesthetics|mesh-ancestor
5745230|NCT03070054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5745231|NCT03070054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745232|NCT03070054|Sensory System Agents|sensory system agents|mesh-ancestor
5745233|NCT03070054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5745234|NCT03070054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5745235|NCT03070054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5745236|NCT03070054|Adrenergic Agents|adrenergic agents|mesh-ancestor
5745237|NCT03070054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5745238|NCT03070054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745239|NCT03070054|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5623065|NCT03521232|Niclosamide|niclosamide|mesh-list
5745240|NCT03070054|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5745241|NCT03070054|Autonomic Agents|autonomic agents|mesh-ancestor
5745242|NCT03070054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5745243|NCT03070054|Respiratory System Agents|respiratory system agents|mesh-ancestor
5745244|NCT03070054|Mydriatics|mydriatics|mesh-ancestor
5745245|NCT03070054|Sympathomimetics|sympathomimetics|mesh-ancestor
5745246|NCT03070054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5745247|NCT03069963|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
5745248|NCT03069963|Antacids|antacids|mesh-ancestor
5623066|NCT03521232|Anticestodal Agents|anticestodal agents|mesh-ancestor
5623067|NCT03521232|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5623068|NCT03521232|Anthelmintics|anthelmintics|mesh-ancestor
5623069|NCT03521232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5623070|NCT03521232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5623071|NCT03521232|Antinematodal Agents|antinematodal agents|mesh-ancestor
5623072|NCT03511963|Bevacizumab|bevacizumab|mesh-list
5623073|NCT03511963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5623074|NCT03511963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5623075|NCT03511963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5623076|NCT03511963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5623077|NCT03511963|Growth Substances|growth substances|mesh-ancestor
5623078|NCT03511963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623079|NCT03511963|Growth Inhibitors|growth inhibitors|mesh-ancestor
5623080|NCT03502785|Atezolizumab|atezolizumab|mesh-list
5623081|NCT03502785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5623082|NCT03502668|Decitabine|decitabine|mesh-list
5623083|NCT03502668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5623084|NCT03502668|Antimetabolites|antimetabolites|mesh-ancestor
5745249|NCT03069963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745250|NCT03069963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5745251|NCT03069976|Metronidazole|metronidazole|mesh-list
5745252|NCT03069976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5745253|NCT03069976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5745254|NCT03069976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5745255|NCT03069976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5745256|NCT03069937|Docetaxel|docetaxel|mesh-list
5745257|NCT03069937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5745258|NCT03069937|Tubulin Modulators|tubulin modulators|mesh-ancestor
5745259|NCT03069937|Antimitotic Agents|antimitotic agents|mesh-ancestor
5745260|NCT03069937|Mitosis Modulators|mitosis modulators|mesh-ancestor
5745261|NCT03069937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745262|NCT03069950|Leucovorin|leucovorin|mesh-list
5745263|NCT03069950|Dexamethasone|dexamethasone|mesh-list
5745264|NCT03069950|Fluorouracil|fluorouracil|mesh-list
5745265|NCT03069950|Irinotecan|irinotecan|mesh-list
5745266|NCT03069950|Panitumumab|panitumumab|mesh-list
5745267|NCT03069950|Floxuridine|floxuridine|mesh-list
5745268|NCT03069950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5745269|NCT03069950|Antiemetics|antiemetics|mesh-ancestor
5745270|NCT03069950|Autonomic Agents|autonomic agents|mesh-ancestor
5745271|NCT03069950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5745272|NCT03069950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745273|NCT03069950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5745274|NCT03069950|Glucocorticoids|glucocorticoids|mesh-ancestor
5745275|NCT03069950|Hormones|hormones|mesh-ancestor
5745276|NCT03069950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5745277|NCT03069950|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5745278|NCT03069950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5745279|NCT03069950|Antimetabolites|antimetabolites|mesh-ancestor
5745280|NCT03069950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745281|NCT03069950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5745282|NCT03069950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5745283|NCT03069950|Immunologic Factors|immunologic factors|mesh-ancestor
5745284|NCT03069950|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5745285|NCT03069950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5745286|NCT03069950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5745287|NCT03069950|Antidotes|antidotes|mesh-ancestor
5745288|NCT03069950|Protective Agents|protective agents|mesh-ancestor
5745289|NCT03069950|Vitamin B Complex|vitamin b complex|mesh-ancestor
5745290|NCT03069950|Vitamins|vitamins|mesh-ancestor
5745291|NCT03069950|Micronutrients|micronutrients|mesh-ancestor
5745292|NCT03069950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5894068|NCT01882816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5894069|NCT01882816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5623085|NCT03502668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623086|NCT03502668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5894070|NCT01882816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5745293|NCT03069781|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5745294|NCT03069781|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5745295|NCT03069781|Estradiol|estradiol|mesh-list
5745296|NCT03069781|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5745297|NCT03069781|Estrogens|estrogens|mesh-ancestor
5745298|NCT03069781|Hormones|hormones|mesh-ancestor
5623087|NCT03502668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5623088|NCT03496610|Bupivacaine|bupivacaine|mesh-list
5623089|NCT03496610|Anesthetics, Local|anesthetics, local|mesh-ancestor
5623090|NCT03496610|Anesthetics|anesthetics|mesh-ancestor
5623091|NCT03496610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5623092|NCT03496610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623093|NCT03496610|Sensory System Agents|sensory system agents|mesh-ancestor
5623094|NCT03496610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5623095|NCT03462342|Olaparib|olaparib|mesh-list
5623096|NCT03462342|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5623097|NCT03462342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5623098|NCT03462342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623099|NCT03462342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5623100|NCT03461406|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
5623101|NCT03461406|Hemostatics|hemostatics|mesh-ancestor
5623102|NCT03461406|Coagulants|coagulants|mesh-ancestor
5623103|NCT03458117|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
5623104|NCT03458117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5623105|NCT03458117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5623106|NCT03446456|Vasopressins|vasopressins|mesh-list
5623107|NCT03446456|Arginine Vasopressin|arginine vasopressin|mesh-list
5745299|NCT03069781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5745300|NCT03069781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745301|NCT03069781|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5745302|NCT03069781|Contraceptive Agents|contraceptive agents|mesh-ancestor
5745303|NCT03069781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5745304|NCT03069781|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5745305|NCT03069820|Docetaxel|docetaxel|mesh-list
5745306|NCT03069820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5745307|NCT03069820|Tubulin Modulators|tubulin modulators|mesh-ancestor
5745308|NCT03069820|Antimitotic Agents|antimitotic agents|mesh-ancestor
5745309|NCT03069820|Mitosis Modulators|mitosis modulators|mesh-ancestor
5745310|NCT03069820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745311|NCT03069768|Varenicline|varenicline|mesh-list
5745312|NCT03069768|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5745313|NCT03069768|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5745314|NCT03069768|Cholinergic Agents|cholinergic agents|mesh-ancestor
5745315|NCT03069768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5745316|NCT03069768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745317|NCT03069768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745318|NCT03069924|Nicotine|nicotine|mesh-list
5745319|NCT03069924|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5745320|NCT03069924|Autonomic Agents|autonomic agents|mesh-ancestor
5745321|NCT03069924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5745322|NCT03069924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745323|NCT03069924|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5745324|NCT03069924|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5745325|NCT03069924|Cholinergic Agents|cholinergic agents|mesh-ancestor
5745326|NCT03069924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5745327|NCT03069924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745328|NCT03069703|Rituximab|rituximab|mesh-list
5745329|NCT03069703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5745330|NCT03069703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5623108|NCT03446456|Hemostatics|hemostatics|mesh-ancestor
5623109|NCT03446456|Coagulants|coagulants|mesh-ancestor
5623110|NCT03446456|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5623111|NCT03446456|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5623112|NCT03446456|Natriuretic Agents|natriuretic agents|mesh-ancestor
5745331|NCT03069703|Immunologic Factors|immunologic factors|mesh-ancestor
5745332|NCT03069703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745333|NCT03069703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5623113|NCT03446456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623114|NCT03424005|Gemcitabine|gemcitabine|mesh-list
5745334|NCT03069911|Botulinum Toxins|botulinum toxins|mesh-list
5745335|NCT03069911|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5745336|NCT03069911|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5745337|NCT03069911|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5745338|NCT03069911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5745339|NCT03069911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745340|NCT03069911|Cholinergic Agents|cholinergic agents|mesh-ancestor
5745341|NCT03069911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5745342|NCT03069911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745343|NCT03069911|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5745344|NCT03069911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5745345|NCT03069638|Dexmedetomidine|dexmedetomidine|mesh-list
5745346|NCT03069638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
5745347|NCT03069638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5745348|NCT03069638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623115|NCT03424005|Paclitaxel|paclitaxel|mesh-list
5623116|NCT03424005|Bevacizumab|bevacizumab|mesh-list
5623117|NCT03424005|Carboplatin|carboplatin|mesh-list
5623118|NCT03424005|Capecitabine|capecitabine|mesh-list
5623119|NCT03424005|Atezolizumab|atezolizumab|mesh-list
5623120|NCT03424005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5623121|NCT03424005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5623122|NCT03424005|Tubulin Modulators|tubulin modulators|mesh-ancestor
5623123|NCT03424005|Antimitotic Agents|antimitotic agents|mesh-ancestor
5623124|NCT03424005|Mitosis Modulators|mitosis modulators|mesh-ancestor
5745349|NCT03069638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5745350|NCT03069638|Analgesics|analgesics|mesh-ancestor
5745351|NCT03069638|Sensory System Agents|sensory system agents|mesh-ancestor
5745352|NCT03069638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5745353|NCT03069638|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5745354|NCT03069638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5745355|NCT03069638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5745356|NCT03069638|Adrenergic Agents|adrenergic agents|mesh-ancestor
5745357|NCT03069638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5745358|NCT03069638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745359|NCT03069326|Thalidomide|thalidomide|mesh-list
5745360|NCT03069326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5745361|NCT03069326|Immunologic Factors|immunologic factors|mesh-ancestor
5745362|NCT03069326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745363|NCT03069326|Leprostatic Agents|leprostatic agents|mesh-ancestor
5745364|NCT03069326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5745365|NCT03069326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5745366|NCT03069326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5745367|NCT03069326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5745368|NCT03069326|Growth Substances|growth substances|mesh-ancestor
5745369|NCT03069326|Growth Inhibitors|growth inhibitors|mesh-ancestor
5745370|NCT03069326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5745371|NCT03069339|Carvedilol|carvedilol|mesh-list
5745372|NCT03069339|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5745373|NCT03069339|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5745374|NCT03069339|Adrenergic Agents|adrenergic agents|mesh-ancestor
5745375|NCT03069339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5745376|NCT03069339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745377|NCT03069339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745378|NCT03069339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5745379|NCT03069339|Antioxidants|antioxidants|mesh-ancestor
5745380|NCT03069339|Protective Agents|protective agents|mesh-ancestor
5745381|NCT03069339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5745382|NCT03069339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5623125|NCT03424005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623126|NCT03424005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5623127|NCT03424005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5623128|NCT03424005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5623129|NCT03424005|Growth Substances|growth substances|mesh-ancestor
5745383|NCT03069339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5623130|NCT03424005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745384|NCT03069339|Vasodilator Agents|vasodilator agents|mesh-ancestor
5745385|NCT03069339|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5745386|NCT03069339|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5623131|NCT03424005|Growth Inhibitors|growth inhibitors|mesh-ancestor
5623132|NCT03424005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5623133|NCT03424005|Antimetabolites|antimetabolites|mesh-ancestor
5623134|NCT03424005|Antiviral Agents|antiviral agents|mesh-ancestor
5623135|NCT03424005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5623136|NCT03424005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5623137|NCT03424005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5623138|NCT03424005|Immunologic Factors|immunologic factors|mesh-ancestor
5623139|NCT03408574|Mecamylamine|mecamylamine|mesh-list
5623140|NCT03408574|Nicotine|nicotine|mesh-list
5623141|NCT03408574|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5623142|NCT03408574|Autonomic Agents|autonomic agents|mesh-ancestor
5623143|NCT03408574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5623144|NCT03408574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623145|NCT03408574|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5623146|NCT03408574|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5745387|NCT03069001|Ribavirin|ribavirin|mesh-list
5745388|NCT03069001|Sofosbuvir|sofosbuvir|mesh-list
5745389|NCT03069001|Simeprevir|simeprevir|mesh-list
5745390|NCT03069001|Antimetabolites|antimetabolites|mesh-ancestor
5745391|NCT03069001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745392|NCT03069001|Antiviral Agents|antiviral agents|mesh-ancestor
5745393|NCT03069001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5745394|NCT03069001|Protease Inhibitors|protease inhibitors|mesh-ancestor
5745395|NCT03069001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5745396|NCT03069131|Rifaximin|rifaximin|mesh-list
5745397|NCT03069131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5745398|NCT03069131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5623147|NCT03408574|Cholinergic Agents|cholinergic agents|mesh-ancestor
5623148|NCT03408574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5623149|NCT03408574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623150|NCT03408574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5623151|NCT03408574|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
5623152|NCT03408574|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
5623153|NCT03408574|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5623154|NCT03396692|Morphine|morphine|mesh-list
5623155|NCT03396692|Ropivacaine|ropivacaine|mesh-list
5745399|NCT03069131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5745400|NCT03069027|Lidocaine|lidocaine|mesh-list
5745401|NCT03069027|Epinephrine|epinephrine|mesh-list
5745402|NCT03069027|Racepinephrine|racepinephrine|mesh-list
5745403|NCT03069027|Epinephryl borate|epinephryl borate|mesh-list
5623156|NCT03396692|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5623157|NCT03396692|Narcotics|narcotics|mesh-ancestor
5623158|NCT03396692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5623159|NCT03396692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623160|NCT03396692|Analgesics|analgesics|mesh-ancestor
5623161|NCT03396692|Sensory System Agents|sensory system agents|mesh-ancestor
5623162|NCT03396692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5623163|NCT03396692|Anesthetics, Local|anesthetics, local|mesh-ancestor
5745404|NCT03069027|Anesthetics, Local|anesthetics, local|mesh-ancestor
5745405|NCT03069027|Anesthetics|anesthetics|mesh-ancestor
5745406|NCT03069027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5745407|NCT03069027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745408|NCT03069027|Sensory System Agents|sensory system agents|mesh-ancestor
5745409|NCT03069027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5745410|NCT03069027|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5623164|NCT03396692|Anesthetics|anesthetics|mesh-ancestor
5623165|NCT03395639|Heparin|heparin|mesh-list
5623166|NCT03395639|Enoxaparin|enoxaparin|mesh-list
5623167|NCT03395639|Warfarin|warfarin|mesh-list
5623168|NCT03395639|Edoxaban|edoxaban|mesh-list
5745411|NCT03069027|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5745412|NCT03069027|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5745413|NCT03069027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5745414|NCT03069027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745415|NCT03069027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5745416|NCT03069027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5745417|NCT03069027|Adrenergic Agents|adrenergic agents|mesh-ancestor
5745418|NCT03069027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5745419|NCT03069027|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5745420|NCT03069027|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5745421|NCT03069027|Autonomic Agents|autonomic agents|mesh-ancestor
5623169|NCT03395639|Anticoagulants|anticoagulants|mesh-ancestor
5745422|NCT03069027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5745423|NCT03069027|Respiratory System Agents|respiratory system agents|mesh-ancestor
5623170|NCT03395639|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5623171|NCT03395639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5697700|NCT03374254|Oxaliplatin|oxaliplatin|mesh-list
5745424|NCT03069027|Mydriatics|mydriatics|mesh-ancestor
5623172|NCT03395639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623173|NCT03395639|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5623174|NCT03395639|Antithrombins|antithrombins|mesh-ancestor
5623175|NCT03395639|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5623176|NCT03395639|Protease Inhibitors|protease inhibitors|mesh-ancestor
5623177|NCT03395639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5745425|NCT03069027|Sympathomimetics|sympathomimetics|mesh-ancestor
5745426|NCT03069027|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5745427|NCT03069183|Ropivacaine|ropivacaine|mesh-list
5745428|NCT03069183|Anesthetics, Local|anesthetics, local|mesh-ancestor
5745429|NCT03069183|Anesthetics|anesthetics|mesh-ancestor
5745430|NCT03069183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5745431|NCT03069183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745432|NCT03069183|Sensory System Agents|sensory system agents|mesh-ancestor
5745433|NCT03069183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5745434|NCT03069248|Interferons|interferons|mesh-list
5745435|NCT03069248|Interferon-alpha|interferon-alpha|mesh-list
5745436|NCT03069248|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
5745437|NCT03069248|Rituximab|rituximab|mesh-list
5745438|NCT03069248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5745439|NCT03069248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5745440|NCT03069248|Immunologic Factors|immunologic factors|mesh-ancestor
5745441|NCT03069248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745442|NCT03069248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5745443|NCT03069248|Antiviral Agents|antiviral agents|mesh-ancestor
5745444|NCT03069248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5745445|NCT03068975|Alvimopan|alvimopan|mesh-list
5745446|NCT03068975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5745447|NCT03068962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
5745448|NCT03068962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5745449|NCT03068936|Cisplatin|cisplatin|mesh-list
5745450|NCT03068936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5745451|NCT03068832|Poly I-C|poly i-c|mesh-list
5745452|NCT03068832|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
5745453|NCT03068832|Poly ICLC|poly iclc|mesh-list
5745454|NCT03068832|Interferon Inducers|interferon inducers|mesh-ancestor
5745455|NCT03068832|Immunologic Factors|immunologic factors|mesh-ancestor
5745456|NCT03068832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623178|NCT03388190|Leucovorin|leucovorin|mesh-list
5623179|NCT03388190|Fluorouracil|fluorouracil|mesh-list
5623180|NCT03388190|Oxaliplatin|oxaliplatin|mesh-list
5623181|NCT03388190|Nivolumab|nivolumab|mesh-list
5623182|NCT03388190|Levoleucovorin|levoleucovorin|mesh-list
5623183|NCT03388190|Antimetabolites|antimetabolites|mesh-ancestor
5623184|NCT03388190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623185|NCT03388190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5745457|NCT03068832|Laxatives|laxatives|mesh-ancestor
5745458|NCT03068832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5745459|NCT03068832|Antiviral Agents|antiviral agents|mesh-ancestor
5745460|NCT03068832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5745461|NCT03068741|Ceftriaxone|ceftriaxone|mesh-list
5745462|NCT03068741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5745463|NCT03068741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5745464|NCT03068910|Spironolactone|spironolactone|mesh-list
5745465|NCT03068910|Progesterone|progesterone|mesh-list
5745466|NCT03068910|Progestins|progestins|mesh-ancestor
5745467|NCT03068910|Hormones|hormones|mesh-ancestor
5745468|NCT03068910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5745469|NCT03068910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745470|NCT03068910|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5745471|NCT03068910|Hormone Antagonists|hormone antagonists|mesh-ancestor
5623186|NCT03388190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5623187|NCT03388190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5623188|NCT03388190|Immunologic Factors|immunologic factors|mesh-ancestor
5623189|NCT03388190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623190|NCT03388190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5623191|NCT03388190|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5623192|NCT03388190|Antidotes|antidotes|mesh-ancestor
5623193|NCT03388190|Protective Agents|protective agents|mesh-ancestor
5623194|NCT03388190|Vitamin B Complex|vitamin b complex|mesh-ancestor
5623195|NCT03388190|Vitamins|vitamins|mesh-ancestor
5623196|NCT03388190|Micronutrients|micronutrients|mesh-ancestor
5623197|NCT03382834|Tamoxifen|tamoxifen|mesh-list
5623198|NCT03382834|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
5623199|NCT03382834|Vorinostat|vorinostat|mesh-list
5623200|NCT03382834|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5623201|NCT03382834|Hormone Antagonists|hormone antagonists|mesh-ancestor
5692766|NCT03405376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5745472|NCT03068910|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5745473|NCT03068910|Diuretics|diuretics|mesh-ancestor
5623202|NCT03382834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5623203|NCT03382834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623204|NCT03382834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5623205|NCT03382834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5623206|NCT03382834|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5623207|NCT03382834|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5623208|NCT03382834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5623209|NCT03382834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5623210|NCT03382834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5623211|NCT03382834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623212|NCT03382834|Antiviral Agents|antiviral agents|mesh-ancestor
5623213|NCT03382834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5623214|NCT03353350|Efpeglenatide|efpeglenatide|mesh-list
5623215|NCT03353350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5623216|NCT03353350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623217|NCT03329313|Dialysis Solutions|dialysis solutions|mesh-list
5623218|NCT03329313|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5623219|NCT03326193|Bevacizumab|bevacizumab|mesh-list
5623220|NCT03326193|Niraparib|niraparib|mesh-list
5745474|NCT03068910|Natriuretic Agents|natriuretic agents|mesh-ancestor
5745475|NCT03069144|Calcitriol|calcitriol|mesh-list
5623221|NCT03326193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5623222|NCT03326193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5623223|NCT03326193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5623224|NCT03326193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5623225|NCT03326193|Growth Substances|growth substances|mesh-ancestor
5745476|NCT03069144|Calcipotriene|calcipotriene|mesh-list
5745477|NCT03069144|Dermatologic Agents|dermatologic agents|mesh-ancestor
5745478|NCT03069144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5745479|NCT03069144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745480|NCT03069144|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
5745481|NCT03069144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5745482|NCT03069144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745483|NCT03069144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5745484|NCT03069144|Vitamins|vitamins|mesh-ancestor
5745485|NCT03069144|Micronutrients|micronutrients|mesh-ancestor
5745486|NCT03069144|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5745487|NCT03068650|Rindopepimut|rindopepimut|mesh-list
5745488|NCT03068650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5745489|NCT03068650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5745490|NCT03068624|Aldesleukin|aldesleukin|mesh-list
5745491|NCT03068624|Cyclophosphamide|cyclophosphamide|mesh-list
5745492|NCT03068624|Ipilimumab|ipilimumab|mesh-list
5745493|NCT03068624|Interleukin-2|interleukin-2|mesh-list
5745494|NCT03068624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5745495|NCT03068624|Immunologic Factors|immunologic factors|mesh-ancestor
5745496|NCT03068624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745497|NCT03068624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5623226|NCT03326193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623227|NCT03326193|Growth Inhibitors|growth inhibitors|mesh-ancestor
5623228|NCT03326193|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5623229|NCT03326193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5623230|NCT03326193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623231|NCT03310905|Immunosuppressive Agents|immunosuppressive agents|mesh-list
5623232|NCT03310905|Immunologic Factors|immunologic factors|mesh-ancestor
5623233|NCT03310905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623234|NCT03302286|Mannitol|mannitol|mesh-list
5623235|NCT03302286|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5623236|NCT03302286|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5623237|NCT03302286|Diuretics|diuretics|mesh-ancestor
5623238|NCT03302286|Natriuretic Agents|natriuretic agents|mesh-ancestor
5623239|NCT03302286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623240|NCT03285763|Atezolizumab|atezolizumab|mesh-list
5623241|NCT03285763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5623242|NCT03271021|Minocycline|minocycline|mesh-list
5623243|NCT03271021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5623244|NCT03271021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5623245|NCT03264352|Amlodipine|amlodipine|mesh-list
5623246|NCT03264352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5623247|NCT03264352|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5623248|NCT03264352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5745498|NCT03068624|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5745499|NCT03068624|Alkylating Agents|alkylating agents|mesh-ancestor
5745500|NCT03068624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745501|NCT03068624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5745502|NCT03068624|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5745503|NCT03068624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5745504|NCT03068624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5745505|NCT03068624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5745506|NCT03068624|Analgesics|analgesics|mesh-ancestor
5745507|NCT03068624|Sensory System Agents|sensory system agents|mesh-ancestor
5745508|NCT03068624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5745509|NCT03068624|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5745510|NCT03068624|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5745511|NCT03068624|Antiviral Agents|antiviral agents|mesh-ancestor
5745512|NCT03068624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5745513|NCT03068533|Calcium Carbonate|calcium carbonate|mesh-list
5745514|NCT03068533|Calcium|calcium|mesh-list
5745515|NCT03068533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5745516|NCT03068533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745517|NCT03068533|Antacids|antacids|mesh-ancestor
5745518|NCT03068533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745519|NCT03068533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5745520|NCT03068442|Flutemetamol|flutemetamol|mesh-list
5745521|NCT03068442|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5745522|NCT03068442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745523|NCT03068429|Sertraline|sertraline|mesh-list
5745524|NCT03068429|Antidepressive Agents|antidepressive agents|mesh-ancestor
5745525|NCT03068429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5745526|NCT03068429|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5745527|NCT03068429|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5745528|NCT03068429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5745529|NCT03068429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745530|NCT03068429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5745531|NCT03068429|Serotonin Agents|serotonin agents|mesh-ancestor
5745532|NCT03068429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745533|NCT03068351|Daratumumab|daratumumab|mesh-list
5745534|NCT03068351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5745535|NCT03068247|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5745536|NCT03068247|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5745537|NCT03068247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5745538|NCT03068247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5745539|NCT03068247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745540|NCT03068247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5745541|NCT03068247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745542|NCT03068247|Analgesics|analgesics|mesh-ancestor
5745543|NCT03068247|Sensory System Agents|sensory system agents|mesh-ancestor
5745544|NCT03068247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5745545|NCT03068247|Antidepressive Agents|antidepressive agents|mesh-ancestor
5623249|NCT03264352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745546|NCT03068247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5745547|NCT03068247|Dopamine Agents|dopamine agents|mesh-ancestor
5745548|NCT03068065|Metformin|metformin|mesh-list
5745549|NCT03068065|Liraglutide|liraglutide|mesh-list
5745550|NCT03068065|Gliclazide|gliclazide|mesh-list
5745551|NCT03068065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5745552|NCT03068065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745553|NCT03068065|Incretins|incretins|mesh-ancestor
5745554|NCT03068065|Hormones|hormones|mesh-ancestor
5745555|NCT03068065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5745556|NCT03068234|Pirfenidone|pirfenidone|mesh-list
5745557|NCT03068234|Analgesics|analgesics|mesh-ancestor
5745558|NCT03068234|Sensory System Agents|sensory system agents|mesh-ancestor
5745559|NCT03068234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5745560|NCT03068234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745561|NCT03068234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5745562|NCT03068234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5745563|NCT03068234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5745564|NCT03068234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5745565|NCT03068234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5894071|NCT01882816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5894072|NCT01882816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5894073|NCT01882816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894074|NCT01758614|Aspirin|aspirin|mesh-list
5894075|NCT01758614|Clopidogrel|clopidogrel|mesh-list
5894076|NCT01758614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5894077|NCT01758614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5894078|NCT01758614|Analgesics|analgesics|mesh-ancestor
5894079|NCT01758614|Sensory System Agents|sensory system agents|mesh-ancestor
5894080|NCT01758614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5894081|NCT01758614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894082|NCT01758614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5894083|NCT01758614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5894084|NCT01758614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5894085|NCT01758614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5894086|NCT01758614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894087|NCT01758614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5894088|NCT01758614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5894089|NCT01758614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5894090|NCT01758614|Antipyretics|antipyretics|mesh-ancestor
5623250|NCT03264352|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5623251|NCT03264352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623252|NCT03264352|Vasodilator Agents|vasodilator agents|mesh-ancestor
5623253|NCT03255083|Osimertinib|osimertinib|mesh-list
5623254|NCT03255083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5623255|NCT03255083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5623256|NCT03255083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5894091|NCT01758614|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5894092|NCT01758614|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5894093|NCT01758614|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5894094|NCT01758614|Purinergic Agents|purinergic agents|mesh-ancestor
5894095|NCT01758614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5894096|NCT01593241|Carboplatin|carboplatin|mesh-list
5894097|NCT01593241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5894098|NCT01515527|Cytarabine|cytarabine|mesh-list
5894099|NCT01515527|Decitabine|decitabine|mesh-list
5894100|NCT01515527|Cladribine|cladribine|mesh-list
5894101|NCT01515527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5623257|NCT03255083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623258|NCT03253172|Potassium Citrate|potassium citrate|mesh-list
5623259|NCT03253172|Diuretics|diuretics|mesh-ancestor
5745566|NCT03068260|Acetaminophen|acetaminophen|mesh-list
5745567|NCT03068260|Ibuprofen|ibuprofen|mesh-list
5745568|NCT03068260|Morphine|morphine|mesh-list
5745569|NCT03068260|Ropivacaine|ropivacaine|mesh-list
5745570|NCT03068260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5745571|NCT03068260|Narcotics|narcotics|mesh-ancestor
5745572|NCT03068260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5745573|NCT03068260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745574|NCT03068260|Analgesics|analgesics|mesh-ancestor
5745575|NCT03068260|Sensory System Agents|sensory system agents|mesh-ancestor
5745576|NCT03068260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5623260|NCT03253172|Natriuretic Agents|natriuretic agents|mesh-ancestor
5623261|NCT03253172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623262|NCT03253172|Expectorants|expectorants|mesh-ancestor
5745577|NCT03068260|Anesthetics, Local|anesthetics, local|mesh-ancestor
5745578|NCT03068260|Anesthetics|anesthetics|mesh-ancestor
5745579|NCT03068260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5745580|NCT03068260|Antipyretics|antipyretics|mesh-ancestor
5745581|NCT03068260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5745582|NCT03068260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5745583|NCT03068260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5745584|NCT03068260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5745585|NCT03068260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5745586|NCT03068260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745587|NCT03068208|Methylene Blue|methylene blue|mesh-list
5745588|NCT03068208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5745589|NCT03068208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745590|NCT03067974|Ketamine|ketamine|mesh-list
5745591|NCT03067974|Analgesics|analgesics|mesh-ancestor
5745592|NCT03067974|Sensory System Agents|sensory system agents|mesh-ancestor
5745593|NCT03067974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5745594|NCT03067974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745595|NCT03067974|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5745596|NCT03067974|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5745597|NCT03067974|Anesthetics, General|anesthetics, general|mesh-ancestor
5745598|NCT03067974|Anesthetics|anesthetics|mesh-ancestor
5745599|NCT03067974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5623263|NCT03253172|Respiratory System Agents|respiratory system agents|mesh-ancestor
5623264|NCT03227471|Ivacaftor|ivacaftor|mesh-list
5623265|NCT03227471|Elexacaftor|elexacaftor|mesh-list
5623266|NCT03227471|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
5623267|NCT03227471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5623268|NCT03227471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623269|NCT03221842|Complement C1s|complement c1s|mesh-list
5623270|NCT03221842|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
5623271|NCT03221842|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
5623272|NCT03221842|Immunologic Factors|immunologic factors|mesh-ancestor
5623273|NCT03221842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623274|NCT03221842|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5745600|NCT03067974|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5745601|NCT03067974|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5745602|NCT03067974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5745603|NCT03067974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745604|NCT03067935|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
5623275|NCT03221842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5623276|NCT03195478|Nivolumab|nivolumab|mesh-list
5623277|NCT03195478|Ipilimumab|ipilimumab|mesh-list
5623278|NCT03195478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5623279|NCT03195478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5623280|NCT03195478|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5623281|NCT03195478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623282|NCT03194321|Tacrolimus|tacrolimus|mesh-list
5623283|NCT03194321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5623284|NCT03194321|Immunologic Factors|immunologic factors|mesh-ancestor
5623285|NCT03194321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623286|NCT03194321|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5623287|NCT03194321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5623288|NCT03194321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623289|NCT03189693|Anesthetics|anesthetics|mesh-list
5623290|NCT03189693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5623291|NCT03189693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623292|NCT03170206|Palbociclib|palbociclib|mesh-list
5623293|NCT03170206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5623294|NCT03170206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5623295|NCT03170206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5623296|NCT03170206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623297|NCT03165721|Guadecitabine|guadecitabine|mesh-list
5745605|NCT03067935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5745606|NCT03067935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5745607|NCT03067883|Ritonavir|ritonavir|mesh-list
5745608|NCT03067883|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5745609|NCT03067883|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5745610|NCT03067883|Protease Inhibitors|protease inhibitors|mesh-ancestor
5745611|NCT03067883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5745612|NCT03067883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745613|NCT03067883|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5745614|NCT03067883|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5745615|NCT03067883|Antiviral Agents|antiviral agents|mesh-ancestor
5745616|NCT03067883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5745617|NCT03067883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5745618|NCT03067883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5745619|NCT03067896|Magnesium Sulfate|magnesium sulfate|mesh-list
5745620|NCT03067896|Dexmedetomidine|dexmedetomidine|mesh-list
5745621|NCT03067896|Bupivacaine|bupivacaine|mesh-list
5745622|NCT03067896|Anesthetics, Local|anesthetics, local|mesh-ancestor
5745623|NCT03067896|Anesthetics|anesthetics|mesh-ancestor
5745624|NCT03067896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5745625|NCT03067896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745626|NCT03067896|Sensory System Agents|sensory system agents|mesh-ancestor
5745627|NCT03067896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5745628|NCT03067896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5745629|NCT03067896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5745630|NCT03067896|Analgesics|analgesics|mesh-ancestor
5745631|NCT03067896|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5745632|NCT03067896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5745633|NCT03067896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5745634|NCT03067896|Adrenergic Agents|adrenergic agents|mesh-ancestor
5745635|NCT03067896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5745636|NCT03067896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745637|NCT03067896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5745638|NCT03067896|Anticonvulsants|anticonvulsants|mesh-ancestor
5745639|NCT03067896|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5745640|NCT03067896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5745641|NCT03067896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5745642|NCT03067896|Tocolytic Agents|tocolytic agents|mesh-ancestor
5745643|NCT03067896|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5745644|NCT03067740|Dexmedetomidine|dexmedetomidine|mesh-list
5745645|NCT03067740|Bupivacaine|bupivacaine|mesh-list
5745646|NCT03067740|Anesthetics, Local|anesthetics, local|mesh-ancestor
5745647|NCT03067740|Anesthetics|anesthetics|mesh-ancestor
5745648|NCT03067740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5745649|NCT03067740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745650|NCT03067740|Sensory System Agents|sensory system agents|mesh-ancestor
5745651|NCT03067740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5745652|NCT03067740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5745653|NCT03067740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5745654|NCT03067740|Analgesics|analgesics|mesh-ancestor
5745655|NCT03067740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5745656|NCT03067740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5745657|NCT03067740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5745658|NCT03067740|Adrenergic Agents|adrenergic agents|mesh-ancestor
5745659|NCT03067740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5745660|NCT03067740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745661|NCT03067571|Daratumumab|daratumumab|mesh-list
5623298|NCT03165721|Azacitidine|azacitidine|mesh-list
5623299|NCT03165721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5745662|NCT03067571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5745663|NCT03067610|Paclitaxel|paclitaxel|mesh-list
5745664|NCT03067610|Cisplatin|cisplatin|mesh-list
5745665|NCT03067610|Carboplatin|carboplatin|mesh-list
5745666|NCT03067610|Cetuximab|cetuximab|mesh-list
5745667|NCT03067610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5745668|NCT03067610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5745669|NCT03067610|Tubulin Modulators|tubulin modulators|mesh-ancestor
6489412|NCT00591617|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5745670|NCT03067610|Antimitotic Agents|antimitotic agents|mesh-ancestor
5745671|NCT03067610|Mitosis Modulators|mitosis modulators|mesh-ancestor
5623300|NCT03165721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5623301|NCT03165721|Antimetabolites|antimetabolites|mesh-ancestor
5623302|NCT03165721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623303|NCT03165721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5623304|NCT03158064|Durvalumab|durvalumab|mesh-list
5623305|NCT03158064|Tremelimumab|tremelimumab|mesh-list
5623306|NCT03158064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5623307|NCT03158064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5745672|NCT03067610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745673|NCT03067610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5745674|NCT03067701|Carbon Monoxide|carbon monoxide|mesh-list
5745675|NCT03067701|Antimetabolites|antimetabolites|mesh-ancestor
5745676|NCT03067701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745677|NCT03067701|Gasotransmitters|gasotransmitters|mesh-ancestor
5745678|NCT03067701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5745679|NCT03067701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745680|NCT03067753|Methylprednisolone|methylprednisolone|mesh-list
5745681|NCT03067753|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5745682|NCT03067753|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5745683|NCT03067753|Prednisolone|prednisolone|mesh-list
5745684|NCT03067753|Prednisolone acetate|prednisolone acetate|mesh-list
5745685|NCT03067753|Hormones|hormones|mesh-list
5745686|NCT03067753|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5623308|NCT03150173|Buprenorphine|buprenorphine|mesh-list
5623309|NCT03150173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5623310|NCT03150173|Narcotics|narcotics|mesh-ancestor
5623311|NCT03150173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5623312|NCT03150173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623313|NCT03150173|Analgesics|analgesics|mesh-ancestor
5623314|NCT03150173|Sensory System Agents|sensory system agents|mesh-ancestor
5623315|NCT03150173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5623316|NCT03150173|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5623317|NCT03093922|Gemcitabine|gemcitabine|mesh-list
5623318|NCT03093922|Atezolizumab|atezolizumab|mesh-list
5623319|NCT03093922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5623320|NCT03093922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5623321|NCT03093922|Antimetabolites|antimetabolites|mesh-ancestor
5623322|NCT03093922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623323|NCT03093922|Antiviral Agents|antiviral agents|mesh-ancestor
5623324|NCT03093922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5623325|NCT03093922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5623326|NCT03093922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5623327|NCT03093922|Immunologic Factors|immunologic factors|mesh-ancestor
5623328|NCT03093922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692767|NCT03405376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5692768|NCT03405376|Growth Substances|growth substances|mesh-ancestor
5692769|NCT03405376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692770|NCT03405376|Growth Inhibitors|growth inhibitors|mesh-ancestor
5692771|NCT03405376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5692772|NCT03405337|Factor VIII|factor viii|mesh-list
5692773|NCT03405337|Coagulants|coagulants|mesh-ancestor
5745687|NCT03067753|Prednisolone phosphate|prednisolone phosphate|mesh-list
5745688|NCT03067753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5745689|NCT03067753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745690|NCT03067753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5745691|NCT03067753|Antiemetics|antiemetics|mesh-ancestor
5745692|NCT03067753|Autonomic Agents|autonomic agents|mesh-ancestor
5745693|NCT03067753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5745694|NCT03067753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5745695|NCT03067753|Glucocorticoids|glucocorticoids|mesh-ancestor
5745696|NCT03067753|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5745697|NCT03067753|Protective Agents|protective agents|mesh-ancestor
5745698|NCT03067753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5745699|NCT03067753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5745700|NCT03067792|Leucovorin|leucovorin|mesh-list
5745701|NCT03067792|Docetaxel|docetaxel|mesh-list
5745702|NCT03067792|Fluorouracil|fluorouracil|mesh-list
5745703|NCT03067792|Irinotecan|irinotecan|mesh-list
5745704|NCT03067792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5745705|NCT03067792|Tubulin Modulators|tubulin modulators|mesh-ancestor
5745706|NCT03067792|Antimitotic Agents|antimitotic agents|mesh-ancestor
5745707|NCT03067792|Mitosis Modulators|mitosis modulators|mesh-ancestor
5745708|NCT03067792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745709|NCT03067792|Antimetabolites|antimetabolites|mesh-ancestor
5692774|NCT03405272|Cetuximab|cetuximab|mesh-list
5692775|NCT03405272|Antibodies|antibodies|mesh-list
5745710|NCT03067792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5745711|NCT03067792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5745712|NCT03067792|Immunologic Factors|immunologic factors|mesh-ancestor
5745713|NCT03067792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745714|NCT03067792|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5745715|NCT03067792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5745716|NCT03067792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5745717|NCT03067792|Antidotes|antidotes|mesh-ancestor
5745718|NCT03067792|Protective Agents|protective agents|mesh-ancestor
5745719|NCT03067792|Vitamin B Complex|vitamin b complex|mesh-ancestor
5745720|NCT03067792|Vitamins|vitamins|mesh-ancestor
5745721|NCT03067792|Micronutrients|micronutrients|mesh-ancestor
5745722|NCT03067597|Dinoprostone|dinoprostone|mesh-list
5745723|NCT03067597|Oxytocics|oxytocics|mesh-ancestor
5745724|NCT03067597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5745725|NCT03067597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745726|NCT03067688|Amlodipine|amlodipine|mesh-list
5745727|NCT03067688|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
5745728|NCT03067688|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5745729|NCT03067688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5745730|NCT03067688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5745731|NCT03067688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5745732|NCT03067688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745733|NCT03067688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5745734|NCT03067688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745735|NCT03067688|Vasodilator Agents|vasodilator agents|mesh-ancestor
5745736|NCT03067688|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5745737|NCT03067688|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5745738|NCT03067688|Antimetabolites|antimetabolites|mesh-ancestor
5745739|NCT03067688|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5745740|NCT03067688|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5745741|NCT03067688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5745742|NCT03067688|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5745743|NCT03067688|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5745744|NCT03067727|Dinoprostone|dinoprostone|mesh-list
5745745|NCT03067727|Oxytocics|oxytocics|mesh-ancestor
5745746|NCT03067727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5745747|NCT03067727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745748|NCT03067155|Antiviral Agents|antiviral agents|mesh-list
5745749|NCT03067155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5745750|NCT03067103|Ketamine|ketamine|mesh-list
5745751|NCT03067103|Tramadol|tramadol|mesh-list
5745752|NCT03067103|Analgesics|analgesics|mesh-ancestor
5745753|NCT03067103|Sensory System Agents|sensory system agents|mesh-ancestor
5745754|NCT03067103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5745755|NCT03067103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745756|NCT03067103|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5745757|NCT03067103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5745758|NCT03067103|Anesthetics, General|anesthetics, general|mesh-ancestor
5745759|NCT03067103|Anesthetics|anesthetics|mesh-ancestor
5745760|NCT03067103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5745761|NCT03067103|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5745762|NCT03067103|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5745763|NCT03067103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5745764|NCT03067103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745765|NCT03067103|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5745766|NCT03067103|Narcotics|narcotics|mesh-ancestor
5745767|NCT03067168|Bupivacaine|bupivacaine|mesh-list
5745768|NCT03067168|Anesthetics, Local|anesthetics, local|mesh-ancestor
5745769|NCT03067168|Anesthetics|anesthetics|mesh-ancestor
5745770|NCT03067168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5745771|NCT03067168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745772|NCT03067168|Sensory System Agents|sensory system agents|mesh-ancestor
5745773|NCT03067168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5745774|NCT03067194|Celecoxib|celecoxib|mesh-list
5745775|NCT03067194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5745776|NCT03067194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5745777|NCT03067194|Analgesics|analgesics|mesh-ancestor
5745778|NCT03067194|Sensory System Agents|sensory system agents|mesh-ancestor
5745779|NCT03067194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5745780|NCT03067194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745781|NCT03067194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5745782|NCT03067194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5745783|NCT03067194|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5745784|NCT03067194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5745785|NCT03067194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5745786|NCT03067194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745787|NCT03067051|Verteporfin|verteporfin|mesh-list
5745788|NCT03067051|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5745789|NCT03067051|Dermatologic Agents|dermatologic agents|mesh-ancestor
5745790|NCT03067415|Latanoprost|latanoprost|mesh-list
5745791|NCT03067415|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5745792|NCT03067415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5745793|NCT03066635|Botulinum Toxins|botulinum toxins|mesh-list
5745794|NCT03066635|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5745795|NCT03066635|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5745796|NCT03066635|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5745797|NCT03066635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5745798|NCT03066635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745799|NCT03066635|Cholinergic Agents|cholinergic agents|mesh-ancestor
5745800|NCT03066635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5745801|NCT03066635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745802|NCT03066635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5745803|NCT03066635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5745804|NCT03066791|Curcumin|curcumin|mesh-list
5745805|NCT03066791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5745806|NCT03066791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5745807|NCT03066791|Analgesics|analgesics|mesh-ancestor
5623329|NCT03085095|Leuprolide|leuprolide|mesh-list
5623330|NCT03085095|Relugolix|relugolix|mesh-list
5623331|NCT03085095|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5623332|NCT03085095|Fertility Agents|fertility agents|mesh-ancestor
5623333|NCT03085095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5623334|NCT03085095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623335|NCT03085095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5623336|NCT03085095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5623337|NCT03085095|Androgen Antagonists|androgen antagonists|mesh-ancestor
5745808|NCT03066791|Sensory System Agents|sensory system agents|mesh-ancestor
5745809|NCT03066791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5745810|NCT03066791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745811|NCT03066791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5745812|NCT03066791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5745813|NCT03066791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5745814|NCT03066791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5745815|NCT03066791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745816|NCT03066817|Ergocalciferols|ergocalciferols|mesh-list
5745817|NCT03066817|Vitamin D|vitamin d|mesh-list
5745818|NCT03066817|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5745819|NCT03066817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745820|NCT03066817|Vitamins|vitamins|mesh-ancestor
5745821|NCT03066817|Micronutrients|micronutrients|mesh-ancestor
5745822|NCT03066817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5745823|NCT03066661|Entrectinib|entrectinib|mesh-list
5745824|NCT03066661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5745825|NCT03066661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5745826|NCT03066661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745827|NCT03066700|Hemostatics|hemostatics|mesh-list
5745828|NCT03066700|Coagulants|coagulants|mesh-ancestor
5894102|NCT01515527|Antimetabolites|antimetabolites|mesh-ancestor
5894103|NCT01515527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894104|NCT01515527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5894105|NCT01515527|Antiviral Agents|antiviral agents|mesh-ancestor
5894106|NCT01515527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5894107|NCT01515527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5894108|NCT01515527|Immunologic Factors|immunologic factors|mesh-ancestor
5894109|NCT01515527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894110|NCT01515527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5623338|NCT03085095|Hormone Antagonists|hormone antagonists|mesh-ancestor
5623339|NCT03085095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5623340|NCT03074045|Drospirenone|drospirenone|mesh-list
5623341|NCT03074045|Levonorgestrel|levonorgestrel|mesh-list
5623342|NCT03074045|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5623343|NCT03074045|Estradiol|estradiol|mesh-list
5894111|NCT01352520|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5894112|NCT01352520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5894113|NCT01352520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5894114|NCT01097746|Paclitaxel|paclitaxel|mesh-list
5894115|NCT01097746|Bevacizumab|bevacizumab|mesh-list
5894116|NCT01097746|Carboplatin|carboplatin|mesh-list
5894117|NCT01097746|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6489413|NCT00591643|Epinephrine|epinephrine|mesh-list
5623344|NCT03074045|Estrogens|estrogens|mesh-ancestor
5623345|NCT03074045|Hormones|hormones|mesh-ancestor
5745829|NCT03066557|Apatinib|apatinib|mesh-list
5745830|NCT03066557|Chlorotrianisene|chlorotrianisene|mesh-list
5745831|NCT03066557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5745832|NCT03066557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5745833|NCT03066557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5745834|NCT03066557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745835|NCT03066557|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
5745836|NCT03066557|Estrogens|estrogens|mesh-ancestor
5745837|NCT03066557|Hormones|hormones|mesh-ancestor
5745838|NCT03066557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5745839|NCT03066557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745840|NCT03066557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5745841|NCT03066544|Dexamethasone|dexamethasone|mesh-list
5745842|NCT03066544|Ketorolac|ketorolac|mesh-list
5745843|NCT03066544|Naratriptan|naratriptan|mesh-list
5745844|NCT03066544|Bupivacaine|bupivacaine|mesh-list
5745845|NCT03066544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5745846|NCT03066544|Antiemetics|antiemetics|mesh-ancestor
5745847|NCT03066544|Autonomic Agents|autonomic agents|mesh-ancestor
5745848|NCT03066544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5745849|NCT03066544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745850|NCT03066544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5745851|NCT03066544|Glucocorticoids|glucocorticoids|mesh-ancestor
5745852|NCT03066544|Hormones|hormones|mesh-ancestor
5745853|NCT03066544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5745854|NCT03066544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5745855|NCT03066544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5745856|NCT03066544|Anesthetics, Local|anesthetics, local|mesh-ancestor
5745857|NCT03066544|Anesthetics|anesthetics|mesh-ancestor
5745858|NCT03066544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5745859|NCT03066544|Sensory System Agents|sensory system agents|mesh-ancestor
5623346|NCT03074045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5623347|NCT03074045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623348|NCT03074045|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5623349|NCT03074045|Contraceptive Agents|contraceptive agents|mesh-ancestor
5623350|NCT03074045|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5623351|NCT03074045|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5623352|NCT03074045|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5623353|NCT03074045|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5623354|NCT03074045|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5623355|NCT03074045|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5623356|NCT03074045|Hormone Antagonists|hormone antagonists|mesh-ancestor
5623357|NCT03074045|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5623358|NCT03074045|Diuretics|diuretics|mesh-ancestor
5623359|NCT03074045|Natriuretic Agents|natriuretic agents|mesh-ancestor
5623360|NCT03065062|Palbociclib|palbociclib|mesh-list
5623361|NCT03065062|Gedatolisib|gedatolisib|mesh-list
5623362|NCT03065062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5623363|NCT03065062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5623364|NCT03065062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5623365|NCT03065062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623366|NCT03057431|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5623367|NCT03057431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5623368|NCT03057431|Diuretics|diuretics|mesh-ancestor
5623369|NCT03057431|Natriuretic Agents|natriuretic agents|mesh-ancestor
5623370|NCT03057431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623371|NCT03057431|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5623372|NCT03057431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5745860|NCT03066544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5745861|NCT03066544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5745862|NCT03066544|Analgesics|analgesics|mesh-ancestor
5745863|NCT03066544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5745864|NCT03066544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5745865|NCT03066544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5745866|NCT03066544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745867|NCT03066544|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5745868|NCT03066544|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5745869|NCT03066544|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5745870|NCT03066544|Serotonin Agents|serotonin agents|mesh-ancestor
5745871|NCT03066544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5745872|NCT03066466|Methotrexate|methotrexate|mesh-list
5745873|NCT03066466|Atorvastatin|atorvastatin|mesh-list
5745874|NCT03066466|Tacrolimus|tacrolimus|mesh-list
5745875|NCT03066466|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5745876|NCT03066466|Abortifacient Agents|abortifacient agents|mesh-ancestor
5745877|NCT03066466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5745878|NCT03066466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745879|NCT03066466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5745880|NCT03066466|Antimetabolites|antimetabolites|mesh-ancestor
5745881|NCT03066466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623373|NCT03057431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623374|NCT03048422|Tenofovir|tenofovir|mesh-list
5623375|NCT03048422|Emtricitabine|emtricitabine|mesh-list
5623376|NCT03048422|Efavirenz|efavirenz|mesh-list
5623377|NCT03048422|Dolutegravir|dolutegravir|mesh-list
5623378|NCT03048422|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5623379|NCT03048422|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
5623380|NCT03048422|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5623381|NCT03048422|Antiviral Agents|antiviral agents|mesh-ancestor
5745882|NCT03066466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5745883|NCT03066466|Dermatologic Agents|dermatologic agents|mesh-ancestor
5745884|NCT03066466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5745885|NCT03066466|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5745886|NCT03066466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5745887|NCT03066466|Immunologic Factors|immunologic factors|mesh-ancestor
5745888|NCT03066466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5745889|NCT03066466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5745890|NCT03066466|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5745891|NCT03066466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5745892|NCT03066466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5745893|NCT03066466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5745894|NCT03066466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5745895|NCT03066518|Melatonin|melatonin|mesh-list
5745896|NCT03066518|Antioxidants|antioxidants|mesh-ancestor
5745897|NCT03066518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745898|NCT03066518|Protective Agents|protective agents|mesh-ancestor
5745899|NCT03066518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745900|NCT03066518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5745901|NCT03066427|Sunitinib|sunitinib|mesh-list
5745902|NCT03066427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5745903|NCT03066427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5745904|NCT03066427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5745905|NCT03066427|Growth Substances|growth substances|mesh-ancestor
5745906|NCT03066427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745907|NCT03066427|Growth Inhibitors|growth inhibitors|mesh-ancestor
5745908|NCT03066427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5745909|NCT03066427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5745910|NCT03066427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745911|NCT03066076|Propylthiouracil|propylthiouracil|mesh-list
5745912|NCT03066076|Antithyroid Agents|antithyroid agents|mesh-list
5745913|NCT03066076|Antimetabolites|antimetabolites|mesh-ancestor
5745914|NCT03066076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745915|NCT03066076|Hormone Antagonists|hormone antagonists|mesh-ancestor
5745916|NCT03066076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5623382|NCT03048422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5623383|NCT03048422|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5623384|NCT03048422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5623385|NCT03048422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5623386|NCT03048422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623387|NCT03048422|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5623388|NCT03048422|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5623389|NCT03048422|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5623390|NCT03048422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5623391|NCT03048422|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5623392|NCT03048422|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5623393|NCT03048422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5623394|NCT03048422|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5623395|NCT03048422|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5745917|NCT03066076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745918|NCT03066115|Ascorbic Acid|ascorbic acid|mesh-list
5745919|NCT03066115|Ketorolac|ketorolac|mesh-list
5745920|NCT03066115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5745921|NCT03066115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5745922|NCT03066115|Analgesics|analgesics|mesh-ancestor
5745923|NCT03066115|Sensory System Agents|sensory system agents|mesh-ancestor
5745924|NCT03066115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5745925|NCT03066115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745926|NCT03066115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5745927|NCT03066115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5745928|NCT03066115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5623396|NCT03048422|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5623397|NCT03022279|Ropivacaine|ropivacaine|mesh-list
5623398|NCT03022279|Anesthetics, Local|anesthetics, local|mesh-ancestor
5623399|NCT03022279|Anesthetics|anesthetics|mesh-ancestor
5745929|NCT03066115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5745930|NCT03066115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745931|NCT03066115|Antioxidants|antioxidants|mesh-ancestor
5745932|NCT03066115|Protective Agents|protective agents|mesh-ancestor
5745933|NCT03066115|Vitamins|vitamins|mesh-ancestor
5745934|NCT03066115|Micronutrients|micronutrients|mesh-ancestor
5745935|NCT03066154|Ritonavir|ritonavir|mesh-list
5745936|NCT03066154|Docetaxel|docetaxel|mesh-list
5745937|NCT03066154|Androgens|androgens|mesh-list
5745938|NCT03066154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5745939|NCT03066154|Tubulin Modulators|tubulin modulators|mesh-ancestor
5745940|NCT03066154|Antimitotic Agents|antimitotic agents|mesh-ancestor
5745941|NCT03066154|Mitosis Modulators|mitosis modulators|mesh-ancestor
5745942|NCT03066154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745943|NCT03066154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5745944|NCT03066154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5623400|NCT03022279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5623401|NCT03022279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623402|NCT03022279|Sensory System Agents|sensory system agents|mesh-ancestor
5623403|NCT03022279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5623404|NCT02984800|Anesthetics|anesthetics|mesh-list
5623405|NCT02984800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5623406|NCT02984800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745945|NCT03066154|Protease Inhibitors|protease inhibitors|mesh-ancestor
5745946|NCT03066154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5745947|NCT03066154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5745948|NCT03066154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5745949|NCT03066154|Antiviral Agents|antiviral agents|mesh-ancestor
5745950|NCT03066154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5745951|NCT03066154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5745952|NCT03066154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5745953|NCT03066154|Hormones|hormones|mesh-ancestor
5745954|NCT03066154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5745955|NCT03066154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745956|NCT03065842|Contraceptive Agents|contraceptive agents|mesh-list
5745957|NCT03065842|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5745958|NCT03065842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745959|NCT03065868|Clarithromycin|clarithromycin|mesh-list
5745960|NCT03065868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5745961|NCT03065868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5745962|NCT03065868|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5745963|NCT03065868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5745964|NCT03065868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745965|NCT03065868|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5745966|NCT03065868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5745967|NCT03066011|Voriconazole|voriconazole|mesh-list
5745968|NCT03066011|Posaconazole|posaconazole|mesh-list
5745969|NCT03066011|Isavuconazole|isavuconazole|mesh-list
5745970|NCT03066011|Antifungal Agents|antifungal agents|mesh-ancestor
5745971|NCT03066011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5745972|NCT03066011|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5745973|NCT03066011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5745974|NCT03066011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5745975|NCT03066011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745976|NCT03066011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5745977|NCT03066011|Hormone Antagonists|hormone antagonists|mesh-ancestor
5745978|NCT03066011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5745979|NCT03066011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745980|NCT03066011|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5745981|NCT03066011|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5745982|NCT03066011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5745983|NCT03066011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5745984|NCT03065998|Baclofen|baclofen|mesh-list
5623407|NCT02977780|Temozolomide|temozolomide|mesh-list
5745985|NCT03065998|Opipramol|opipramol|mesh-list
5745986|NCT03065998|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5745987|NCT03065998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5745988|NCT03065998|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5745989|NCT03065998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5745990|NCT03065998|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
5745991|NCT03065998|GABA Agonists|gaba agonists|mesh-ancestor
5745992|NCT03065998|GABA Agents|gaba agents|mesh-ancestor
5745993|NCT03065998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5745994|NCT03065998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5745995|NCT03065998|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5745996|NCT03065998|Antidepressive Agents|antidepressive agents|mesh-ancestor
5745997|NCT03065998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5745998|NCT03065998|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5745999|NCT03065998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5746000|NCT03065998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5746001|NCT03065998|Adrenergic Agents|adrenergic agents|mesh-ancestor
5746002|NCT03065816|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
5746003|NCT03065816|Antacids|antacids|mesh-ancestor
5746004|NCT03065816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5746005|NCT03065816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5746006|NCT03065764|Pembrolizumab|pembrolizumab|mesh-list
5746007|NCT03065764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5623408|NCT02977780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5623409|NCT02977780|Alkylating Agents|alkylating agents|mesh-ancestor
5623410|NCT02977780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623411|NCT02977780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5623412|NCT02964884|Lovastatin|lovastatin|mesh-list
5623413|NCT02964884|L 647318|l 647318|mesh-list
5623414|NCT02964884|Dihydromevinolin|dihydromevinolin|mesh-list
5623415|NCT02964884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5623416|NCT02964884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5623417|NCT02964884|Antimetabolites|antimetabolites|mesh-ancestor
5623418|NCT02964884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623419|NCT02964884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5623420|NCT02964884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5746008|NCT03065764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5746009|NCT03065504|Turmeric extract|turmeric extract|mesh-list
5746010|NCT03065504|Antioxidants|antioxidants|mesh-ancestor
5746011|NCT03065504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5746012|NCT03065504|Protective Agents|protective agents|mesh-ancestor
5746013|NCT03065504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746014|NCT03065387|Everolimus|everolimus|mesh-list
5746015|NCT03065387|Palbociclib|palbociclib|mesh-list
5746016|NCT03065387|Trametinib|trametinib|mesh-list
5746017|NCT03065387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5746018|NCT03065387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5746019|NCT03065387|Immunologic Factors|immunologic factors|mesh-ancestor
5746020|NCT03065387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746021|NCT03065387|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5623421|NCT02964884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5623422|NCT02925650|Phenserine|phenserine|mesh-list
5623423|NCT02925650|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5623424|NCT02925650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5623425|NCT02925650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623426|NCT02925650|Cholinergic Agents|cholinergic agents|mesh-ancestor
5623427|NCT02925650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5623428|NCT02925650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623429|NCT02910843|Capecitabine|capecitabine|mesh-list
5623430|NCT02910843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5623431|NCT02910843|Antimetabolites|antimetabolites|mesh-ancestor
5623432|NCT02910843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623433|NCT02910843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5746022|NCT03065387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5746023|NCT03065387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5746024|NCT03065569|Bupivacaine|bupivacaine|mesh-list
5746025|NCT03065569|Anesthetics, Local|anesthetics, local|mesh-ancestor
5746026|NCT03065569|Anesthetics|anesthetics|mesh-ancestor
5746027|NCT03065569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5746028|NCT03065569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746029|NCT03065569|Sensory System Agents|sensory system agents|mesh-ancestor
5746030|NCT03065569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5746031|NCT03065660|Mifepristone|mifepristone|mesh-list
5746032|NCT03065660|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5746033|NCT03065660|Abortifacient Agents|abortifacient agents|mesh-ancestor
5746034|NCT03065660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5746035|NCT03065660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746036|NCT03065660|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5746037|NCT03065660|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5746038|NCT03065660|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5746039|NCT03065660|Contraceptive Agents|contraceptive agents|mesh-ancestor
5623434|NCT02908672|Atezolizumab|atezolizumab|mesh-list
5623435|NCT02908672|Vemurafenib|vemurafenib|mesh-list
5746040|NCT03065660|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5746041|NCT03065660|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5746042|NCT03065660|Hormone Antagonists|hormone antagonists|mesh-ancestor
5746043|NCT03065660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5746044|NCT03065660|Luteolytic Agents|luteolytic agents|mesh-ancestor
5746045|NCT03065660|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5746046|NCT03065660|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5746047|NCT03065621|Palbociclib|palbociclib|mesh-list
5746048|NCT03065621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5746049|NCT03065621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5746050|NCT03065621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5746051|NCT03065621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5746052|NCT03065218|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
5746053|NCT03065218|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5746054|NCT03065218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5746055|NCT03065309|Remifentanil|remifentanil|mesh-list
5746056|NCT03065309|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5746057|NCT03065309|Narcotics|narcotics|mesh-ancestor
5746058|NCT03065309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5746059|NCT03065309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746060|NCT03065309|Analgesics|analgesics|mesh-ancestor
5746061|NCT03065309|Sensory System Agents|sensory system agents|mesh-ancestor
5746062|NCT03065309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5894118|NCT01097746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5623436|NCT02908672|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5623437|NCT02908672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5623438|NCT02908672|Immunologic Factors|immunologic factors|mesh-ancestor
5623439|NCT02908672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623440|NCT02908672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5623441|NCT02908672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5623442|NCT02908672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623443|NCT02891811|Thalidomide|thalidomide|mesh-list
5623444|NCT02891811|Dexamethasone|dexamethasone|mesh-list
5623445|NCT02891811|Lenalidomide|lenalidomide|mesh-list
5623446|NCT02891811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5623447|NCT02891811|Antiemetics|antiemetics|mesh-ancestor
5623448|NCT02891811|Autonomic Agents|autonomic agents|mesh-ancestor
5623449|NCT02891811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5623450|NCT02891811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894119|NCT01097746|Endothelial Growth Factors|endothelial growth factors|mesh-list
5894120|NCT01097746|Antibodies|antibodies|mesh-list
5894121|NCT01097746|Immunoglobulins|immunoglobulins|mesh-list
5894122|NCT01097746|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5894123|NCT01097746|Immunoglobulin G|immunoglobulin g|mesh-list
5894124|NCT01097746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5894125|NCT01097746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5894126|NCT01097746|Tubulin Modulators|tubulin modulators|mesh-ancestor
5894127|NCT01097746|Antimitotic Agents|antimitotic agents|mesh-ancestor
5894128|NCT01097746|Mitosis Modulators|mitosis modulators|mesh-ancestor
5894129|NCT01097746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894130|NCT01097746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5894131|NCT01097746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5894132|NCT01097746|Growth Substances|growth substances|mesh-ancestor
5623451|NCT02891811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5623452|NCT02891811|Glucocorticoids|glucocorticoids|mesh-ancestor
5623453|NCT02891811|Hormones|hormones|mesh-ancestor
5623454|NCT02891811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5623455|NCT02891811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5623456|NCT02891811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5623457|NCT02891811|Immunologic Factors|immunologic factors|mesh-ancestor
5623458|NCT02891811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5623459|NCT02891811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5623460|NCT02891811|Growth Substances|growth substances|mesh-ancestor
5623461|NCT02891811|Growth Inhibitors|growth inhibitors|mesh-ancestor
5623462|NCT02891811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5623463|NCT02891811|Leprostatic Agents|leprostatic agents|mesh-ancestor
5623464|NCT02891811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5623465|NCT02891811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5623466|NCT02876510|Vidarabine|vidarabine|mesh-list
5623467|NCT02876510|Aldesleukin|aldesleukin|mesh-list
5623468|NCT02876510|Cyclophosphamide|cyclophosphamide|mesh-list
5623469|NCT02876510|Fludarabine|fludarabine|mesh-list
5623470|NCT02876510|Fludarabine phosphate|fludarabine phosphate|mesh-list
5623471|NCT02876510|Atezolizumab|atezolizumab|mesh-list
5623472|NCT02876510|Interleukin-2|interleukin-2|mesh-list
5623473|NCT02876510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5623474|NCT02876510|Immunologic Factors|immunologic factors|mesh-ancestor
5623475|NCT02876510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623476|NCT02876510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5623477|NCT02876510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5623478|NCT02876510|Alkylating Agents|alkylating agents|mesh-ancestor
5623479|NCT02876510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623480|NCT02876510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5623481|NCT02876510|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5623482|NCT02876510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5623483|NCT02876510|Antimetabolites|antimetabolites|mesh-ancestor
5623484|NCT02876510|Antiviral Agents|antiviral agents|mesh-ancestor
5623485|NCT02876510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5623486|NCT02876510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5623487|NCT02876510|Analgesics|analgesics|mesh-ancestor
5623488|NCT02876510|Sensory System Agents|sensory system agents|mesh-ancestor
5623489|NCT02876510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5623490|NCT02876510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5623491|NCT02876510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5623492|NCT02867384|Obinutuzumab|obinutuzumab|mesh-list
5623493|NCT02867384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5623494|NCT02867384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5623495|NCT02864407|Tiotropium Bromide|tiotropium bromide|mesh-list
5623496|NCT02864407|Olodaterol|olodaterol|mesh-list
5623497|NCT02864407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5623498|NCT02864407|Autonomic Agents|autonomic agents|mesh-ancestor
5623499|NCT02864407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5746063|NCT03064984|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5746064|NCT03064984|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5746065|NCT03064906|Pancrelipase|pancrelipase|mesh-list
5746066|NCT03064906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5746067|NCT03064854|Gemcitabine|gemcitabine|mesh-list
5746068|NCT03064854|Paclitaxel|paclitaxel|mesh-list
5746069|NCT03064854|Carboplatin|carboplatin|mesh-list
5746070|NCT03064854|Pemetrexed|pemetrexed|mesh-list
5746071|NCT03064854|Spartalizumab|spartalizumab|mesh-list
5746072|NCT03064854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5746073|NCT03064854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5746074|NCT03064854|Tubulin Modulators|tubulin modulators|mesh-ancestor
5746075|NCT03064854|Antimitotic Agents|antimitotic agents|mesh-ancestor
5746076|NCT03064854|Mitosis Modulators|mitosis modulators|mesh-ancestor
5746077|NCT03064854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5746078|NCT03064854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5746079|NCT03064854|Antimetabolites|antimetabolites|mesh-ancestor
5746080|NCT03064854|Antiviral Agents|antiviral agents|mesh-ancestor
5746081|NCT03064854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5746082|NCT03064854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5746083|NCT03064854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5746084|NCT03064854|Immunologic Factors|immunologic factors|mesh-ancestor
5746085|NCT03064854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623500|NCT02864407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623501|NCT02864407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5623502|NCT02864407|Respiratory System Agents|respiratory system agents|mesh-ancestor
5623503|NCT02864407|Parasympatholytics|parasympatholytics|mesh-ancestor
5623504|NCT02864407|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5746086|NCT03064854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5746087|NCT03064854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5746088|NCT03064854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5746089|NCT03064633|Dexamethasone|dexamethasone|mesh-list
5746090|NCT03064633|Dexamethasone acetate|dexamethasone acetate|mesh-list
5746091|NCT03064633|Dexmedetomidine|dexmedetomidine|mesh-list
5746092|NCT03064633|Bupivacaine|bupivacaine|mesh-list
5746093|NCT03064633|BB 1101|bb 1101|mesh-list
5746094|NCT03064633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5746095|NCT03064633|Antiemetics|antiemetics|mesh-ancestor
5746096|NCT03064633|Autonomic Agents|autonomic agents|mesh-ancestor
5746097|NCT03064633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5746098|NCT03064633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746099|NCT03064633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5746100|NCT03064633|Glucocorticoids|glucocorticoids|mesh-ancestor
5746101|NCT03064633|Hormones|hormones|mesh-ancestor
5746102|NCT03064633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5746103|NCT03064633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5746104|NCT03064633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5746105|NCT03064633|Protease Inhibitors|protease inhibitors|mesh-ancestor
5746106|NCT03064633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5746107|NCT03064633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5746108|NCT03064633|Anesthetics, Local|anesthetics, local|mesh-ancestor
5746109|NCT03064633|Anesthetics|anesthetics|mesh-ancestor
5746110|NCT03064633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5746111|NCT03064633|Sensory System Agents|sensory system agents|mesh-ancestor
5746112|NCT03064633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5746113|NCT03064633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5746114|NCT03064633|Analgesics|analgesics|mesh-ancestor
5746115|NCT03064633|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5746116|NCT03064633|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5746117|NCT03064633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5746118|NCT03064633|Adrenergic Agents|adrenergic agents|mesh-ancestor
5746119|NCT03064633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5746120|NCT03064542|Carbimazole|carbimazole|mesh-list
5746121|NCT03064542|Antithyroid Agents|antithyroid agents|mesh-ancestor
5623505|NCT02864407|Cholinergic Agents|cholinergic agents|mesh-ancestor
5623506|NCT02864407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5623507|NCT02864407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623508|NCT02839915|Leucovorin|leucovorin|mesh-list
5623509|NCT02839915|Folic Acid|folic acid|mesh-list
5746122|NCT03064542|Hormone Antagonists|hormone antagonists|mesh-ancestor
5746123|NCT03064542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5746124|NCT03064542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746125|NCT03064568|Misoprostol|misoprostol|mesh-list
5746126|NCT03064568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5746127|NCT03064568|Abortifacient Agents|abortifacient agents|mesh-ancestor
5746128|NCT03064568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5746129|NCT03064568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746130|NCT03064568|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5746131|NCT03064568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5746132|NCT03064568|Oxytocics|oxytocics|mesh-ancestor
5746133|NCT03064282|Papaverine|papaverine|mesh-list
5746134|NCT03064282|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5746135|NCT03064282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5746136|NCT03064282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5746137|NCT03064282|Vasodilator Agents|vasodilator agents|mesh-ancestor
5746138|NCT03064282|Urological Agents|urological agents|mesh-ancestor
5746139|NCT03064191|Calcium, Dietary|calcium, dietary|mesh-list
5746140|NCT03064191|Chlorhexidine|chlorhexidine|mesh-list
5746141|NCT03064191|Calcium|calcium|mesh-list
5746142|NCT03064191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5746143|NCT03064191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746144|NCT03064191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5746145|NCT03064191|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5746146|NCT03064191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5746147|NCT03064191|Disinfectants|disinfectants|mesh-ancestor
5746148|NCT03064165|Epinephrine|epinephrine|mesh-list
5746149|NCT03064165|Bupivacaine|bupivacaine|mesh-list
5746150|NCT03064165|Anesthetics, Local|anesthetics, local|mesh-ancestor
5746151|NCT03064165|Anesthetics|anesthetics|mesh-ancestor
5746152|NCT03064165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5746153|NCT03064165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489414|NCT00591643|Racepinephrine|racepinephrine|mesh-list
5623510|NCT02839915|Levoleucovorin|levoleucovorin|mesh-list
6489415|NCT00591643|Epinephryl borate|epinephryl borate|mesh-list
6489416|NCT00591643|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5623511|NCT02839915|Antidotes|antidotes|mesh-ancestor
5623512|NCT02839915|Protective Agents|protective agents|mesh-ancestor
6489417|NCT00591643|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6489418|NCT00591643|Adrenergic Agents|adrenergic agents|mesh-ancestor
6489419|NCT00591643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6489420|NCT00591643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489421|NCT00591643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489422|NCT00591643|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6489423|NCT00591643|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6672910|NCT01559272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6672911|NCT01559272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746154|NCT03064165|Sensory System Agents|sensory system agents|mesh-ancestor
5746155|NCT03064165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5746156|NCT03064165|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5746157|NCT03064165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6489424|NCT00591643|Autonomic Agents|autonomic agents|mesh-ancestor
5623513|NCT02839915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623514|NCT02839915|Vitamin B Complex|vitamin b complex|mesh-ancestor
5623515|NCT02839915|Vitamins|vitamins|mesh-ancestor
5623516|NCT02839915|Micronutrients|micronutrients|mesh-ancestor
5623517|NCT02839915|Hematinics|hematinics|mesh-ancestor
5623518|NCT02835690|Pembrolizumab|pembrolizumab|mesh-list
5623519|NCT02835690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5623520|NCT02835690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5623521|NCT02829723|Spartalizumab|spartalizumab|mesh-list
5623522|NCT02829723|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5623523|NCT02829723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623524|NCT02829723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5623525|NCT02828761|Calcium, Dietary|calcium, dietary|mesh-list
5623526|NCT02828761|Calcium|calcium|mesh-list
5623527|NCT02828761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5623528|NCT02828761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692776|NCT03405272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5692777|NCT03405272|Immunologic Factors|immunologic factors|mesh-ancestor
5692778|NCT03405272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692779|NCT03405272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5692780|NCT03405272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5697701|NCT03374254|Irinotecan|irinotecan|mesh-list
5697702|NCT03374254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697703|NCT03374254|Antimetabolites|antimetabolites|mesh-ancestor
5697704|NCT03374254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697705|NCT03374254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5697706|NCT03374254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5697707|NCT03374254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5697708|NCT03374254|Immunologic Factors|immunologic factors|mesh-ancestor
5697709|NCT03374254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5697710|NCT03374254|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5697711|NCT03374254|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5697712|NCT03374254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5697713|NCT03374254|Antidotes|antidotes|mesh-ancestor
5697714|NCT03374254|Protective Agents|protective agents|mesh-ancestor
5697715|NCT03374254|Vitamin B Complex|vitamin b complex|mesh-ancestor
5697716|NCT03374254|Vitamins|vitamins|mesh-ancestor
5697717|NCT03374254|Micronutrients|micronutrients|mesh-ancestor
5697718|NCT03374228|Linrodostat|linrodostat|mesh-list
5697719|NCT03374228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5697720|NCT03374228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697721|NCT03374163|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
5697722|NCT03374163|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
5697723|NCT03374163|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5697724|NCT03374163|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5697725|NCT03374085|Dexamethasone|dexamethasone|mesh-list
5697726|NCT03374085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5697727|NCT03374085|Antiemetics|antiemetics|mesh-ancestor
5697728|NCT03374085|Autonomic Agents|autonomic agents|mesh-ancestor
5697729|NCT03374085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5697730|NCT03374085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697731|NCT03374085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5697732|NCT03374085|Glucocorticoids|glucocorticoids|mesh-ancestor
5697733|NCT03374085|Hormones|hormones|mesh-ancestor
5697734|NCT03374085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5697735|NCT03374085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5697736|NCT03374085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5697737|NCT03374007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5697738|NCT03374007|Antibodies|antibodies|mesh-list
5746158|NCT03064165|Adrenergic Agents|adrenergic agents|mesh-ancestor
5746159|NCT03064165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5746160|NCT03064165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5746161|NCT03064165|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5746162|NCT03064165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5746163|NCT03064165|Autonomic Agents|autonomic agents|mesh-ancestor
5746164|NCT03064165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5746165|NCT03064165|Respiratory System Agents|respiratory system agents|mesh-ancestor
5746166|NCT03064165|Mydriatics|mydriatics|mesh-ancestor
5746167|NCT03064165|Sympathomimetics|sympathomimetics|mesh-ancestor
5746168|NCT03064165|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5746169|NCT03064295|Adenosine|adenosine|mesh-list
5746170|NCT03064295|Regadenoson|regadenoson|mesh-list
5746171|NCT03064295|Analgesics|analgesics|mesh-ancestor
5746172|NCT03064295|Sensory System Agents|sensory system agents|mesh-ancestor
5746173|NCT03064295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5746174|NCT03064295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623529|NCT02828761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5623530|NCT02821754|Durvalumab|durvalumab|mesh-list
5746175|NCT03064295|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5746176|NCT03064295|Vasodilator Agents|vasodilator agents|mesh-ancestor
5746177|NCT03064295|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5746178|NCT03064295|Purinergic Agonists|purinergic agonists|mesh-ancestor
5746179|NCT03064295|Purinergic Agents|purinergic agents|mesh-ancestor
5746180|NCT03064295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5746181|NCT03064295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5746182|NCT03064295|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
5746183|NCT03064243|Apatinib|apatinib|mesh-list
5746184|NCT03064243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5746185|NCT03064243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5746186|NCT03064243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5746187|NCT03064243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5746188|NCT03063983|Cyclophosphamide|cyclophosphamide|mesh-list
5746189|NCT03063983|Methotrexate|methotrexate|mesh-list
5746190|NCT03063983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5746191|NCT03063983|Immunologic Factors|immunologic factors|mesh-ancestor
5746192|NCT03063983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746193|NCT03063983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5746194|NCT03063983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5746195|NCT03063983|Alkylating Agents|alkylating agents|mesh-ancestor
5746196|NCT03063983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5746197|NCT03063983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5746198|NCT03063983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5746199|NCT03063983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5746200|NCT03063983|Abortifacient Agents|abortifacient agents|mesh-ancestor
5746201|NCT03063983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5746202|NCT03063983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5746203|NCT03063983|Antimetabolites|antimetabolites|mesh-ancestor
5746204|NCT03063983|Dermatologic Agents|dermatologic agents|mesh-ancestor
5746205|NCT03063983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5746206|NCT03063983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5746207|NCT03063983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5746208|NCT03064035|Thrombin|thrombin|mesh-list
5746209|NCT03064035|Hemostatics|hemostatics|mesh-ancestor
5746210|NCT03064035|Coagulants|coagulants|mesh-ancestor
5746211|NCT03063762|Bevacizumab|bevacizumab|mesh-list
5623531|NCT02821754|Tremelimumab|tremelimumab|mesh-list
5623532|NCT02821754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5623533|NCT02821754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5623534|NCT02815280|Minocycline|minocycline|mesh-list
5623535|NCT02815280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5623536|NCT02815280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5623537|NCT02815267|Minocycline|minocycline|mesh-list
5623538|NCT02815267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5623539|NCT02815267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5623540|NCT02813785|Docetaxel|docetaxel|mesh-list
6672912|NCT01559272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6672913|NCT01559272|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6672914|NCT01559272|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5623541|NCT02813785|Atezolizumab|atezolizumab|mesh-list
5623542|NCT02813785|Antibodies|antibodies|mesh-list
5623543|NCT02813785|Immunologic Factors|immunologic factors|mesh-ancestor
5623544|NCT02813785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672915|NCT01559272|Serotonin Agents|serotonin agents|mesh-ancestor
5623545|NCT02813785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6672916|NCT01559272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5623546|NCT02813785|Tubulin Modulators|tubulin modulators|mesh-ancestor
5746212|NCT03063762|Atezolizumab|atezolizumab|mesh-list
5746213|NCT03063762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5746214|NCT03063762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5746215|NCT03063762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5746216|NCT03063762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5746217|NCT03063762|Growth Substances|growth substances|mesh-ancestor
5746218|NCT03063762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746219|NCT03063762|Growth Inhibitors|growth inhibitors|mesh-ancestor
5746220|NCT03063892|Tranexamic Acid|tranexamic acid|mesh-list
5746221|NCT03063892|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5746222|NCT03063892|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5746223|NCT03063892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5746224|NCT03063892|Hemostatics|hemostatics|mesh-ancestor
5746225|NCT03063892|Coagulants|coagulants|mesh-ancestor
5746226|NCT03063905|Buprenorphine|buprenorphine|mesh-list
5746227|NCT03063905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5746228|NCT03063905|Narcotics|narcotics|mesh-ancestor
5746229|NCT03063905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5746230|NCT03063905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746231|NCT03063905|Analgesics|analgesics|mesh-ancestor
5746232|NCT03063905|Sensory System Agents|sensory system agents|mesh-ancestor
5746233|NCT03063905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5746234|NCT03063905|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5746235|NCT03063710|Olaparib|olaparib|mesh-list
5623547|NCT02813785|Antimitotic Agents|antimitotic agents|mesh-ancestor
5623548|NCT02813785|Mitosis Modulators|mitosis modulators|mesh-ancestor
5623549|NCT02813785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623550|NCT02811783|Naloxone|naloxone|mesh-list
5623551|NCT02811783|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5623552|NCT02811783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623553|NCT02811783|Sensory System Agents|sensory system agents|mesh-ancestor
5623554|NCT02811783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5623555|NCT02807636|Gemcitabine|gemcitabine|mesh-list
5623556|NCT02807636|Carboplatin|carboplatin|mesh-list
5623557|NCT02807636|Atezolizumab|atezolizumab|mesh-list
5623558|NCT02807636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5623559|NCT02807636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5623560|NCT02807636|Antimetabolites|antimetabolites|mesh-ancestor
5623561|NCT02807636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623562|NCT02807636|Antiviral Agents|antiviral agents|mesh-ancestor
5623563|NCT02807636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5623564|NCT02807636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5746236|NCT03063710|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5746237|NCT03063710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5746238|NCT03063710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5746239|NCT03063710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5746240|NCT03063775|Fibrin Foam|fibrin foam|mesh-list
5746241|NCT03063775|Hemostatics|hemostatics|mesh-ancestor
5746242|NCT03063775|Coagulants|coagulants|mesh-ancestor
5746243|NCT03063879|Sofosbuvir|sofosbuvir|mesh-list
5746244|NCT03063879|Antiviral Agents|antiviral agents|mesh-ancestor
5746245|NCT03063879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5746246|NCT03063580|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
5746247|NCT03063580|Rifampin|rifampin|mesh-list
5746248|NCT03063580|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5746249|NCT03063580|Antitubercular Agents|antitubercular agents|mesh-ancestor
5746250|NCT03063580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5746251|NCT03063580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5746252|NCT03063580|Leprostatic Agents|leprostatic agents|mesh-ancestor
5746253|NCT03063580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5746254|NCT03063580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5746255|NCT03063580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5746256|NCT03063580|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5623565|NCT02807636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5623566|NCT02807636|Immunologic Factors|immunologic factors|mesh-ancestor
5623567|NCT02807636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623568|NCT02802228|Ifetroban|ifetroban|mesh-list
5623569|NCT02802228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5623570|NCT02801448|Sulforaphane|sulforaphane|mesh-list
5623571|NCT02801448|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5623572|NCT02801448|Protective Agents|protective agents|mesh-ancestor
5746257|NCT03063580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5623573|NCT02801448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623574|NCT02801448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5746258|NCT03063580|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5746259|NCT03063580|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5746260|NCT03063580|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5746261|NCT03063580|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5746262|NCT03063580|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5746263|NCT03063580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5746264|NCT03063580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746265|NCT03063749|Sirolimus|sirolimus|mesh-list
5746266|NCT03063749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5746267|NCT03063749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5746268|NCT03063749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5746269|NCT03063749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5746270|NCT03063749|Antifungal Agents|antifungal agents|mesh-ancestor
5746271|NCT03063749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5746272|NCT03063749|Immunologic Factors|immunologic factors|mesh-ancestor
5746273|NCT03063749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746274|NCT03063541|Aspirin|aspirin|mesh-list
5746275|NCT03063541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5746276|NCT03063541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5746277|NCT03063541|Analgesics|analgesics|mesh-ancestor
5746278|NCT03063541|Sensory System Agents|sensory system agents|mesh-ancestor
5746279|NCT03063541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5746280|NCT03063541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746281|NCT03063541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5746282|NCT03063541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5746283|NCT03063541|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5746284|NCT03063541|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5746285|NCT03063541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5746286|NCT03063541|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5746287|NCT03063541|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5746288|NCT03063541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5746289|NCT03063541|Antipyretics|antipyretics|mesh-ancestor
5746290|NCT03063723|Sofosbuvir|sofosbuvir|mesh-list
5746291|NCT03063723|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
5746292|NCT03063723|Ledipasvir|ledipasvir|mesh-list
6672917|NCT01559272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672918|NCT01559272|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6672919|NCT01559272|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6672920|NCT01559272|Dopamine Agents|dopamine agents|mesh-ancestor
6672921|NCT01559285|Ropivacaine|ropivacaine|mesh-list
5746293|NCT03063723|Antiviral Agents|antiviral agents|mesh-ancestor
5746294|NCT03063723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5623575|NCT02787005|Pembrolizumab|pembrolizumab|mesh-list
5623576|NCT02787005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5623577|NCT02787005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5623578|NCT02675790|Hydroxyurea|hydroxyurea|mesh-list
5623579|NCT02675790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5623580|NCT02675790|Antisickling Agents|antisickling agents|mesh-ancestor
5623581|NCT02675790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5623582|NCT02675790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623583|NCT02675790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5623584|NCT02661022|Dexamethasone|dexamethasone|mesh-list
5623585|NCT02661022|Pomalidomide|pomalidomide|mesh-list
5623586|NCT02661022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5623587|NCT02661022|Antiemetics|antiemetics|mesh-ancestor
5623588|NCT02661022|Autonomic Agents|autonomic agents|mesh-ancestor
5746295|NCT03063671|Dexmedetomidine|dexmedetomidine|mesh-list
5746296|NCT03063671|Ketamine|ketamine|mesh-list
5746297|NCT03063671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5746298|NCT03063671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5746299|NCT03063671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746300|NCT03063671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5746301|NCT03063671|Analgesics|analgesics|mesh-ancestor
5746302|NCT03063671|Sensory System Agents|sensory system agents|mesh-ancestor
5746303|NCT03063671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5746304|NCT03063671|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5746305|NCT03063671|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5746306|NCT03063671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5746307|NCT03063671|Adrenergic Agents|adrenergic agents|mesh-ancestor
5746308|NCT03063671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5746309|NCT03063671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5746310|NCT03063671|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5746311|NCT03063671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5746312|NCT03063671|Anesthetics, General|anesthetics, general|mesh-ancestor
5746313|NCT03063671|Anesthetics|anesthetics|mesh-ancestor
5746314|NCT03063671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5746315|NCT03063671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5746316|NCT03063632|Interferons|interferons|mesh-list
5746317|NCT03063632|Interferon-gamma|interferon-gamma|mesh-list
5746318|NCT03063632|Pembrolizumab|pembrolizumab|mesh-list
5746319|NCT03063632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5746320|NCT03063632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5746321|NCT03063632|Antiviral Agents|antiviral agents|mesh-ancestor
5746322|NCT03063632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5746323|NCT03063788|Copper|copper|mesh-list
5746324|NCT03063788|Trace Elements|trace elements|mesh-ancestor
5746325|NCT03063788|Micronutrients|micronutrients|mesh-ancestor
5746326|NCT03063788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746327|NCT03063658|Acetaminophen|acetaminophen|mesh-list
5746328|NCT03063658|Ibuprofen|ibuprofen|mesh-list
5746329|NCT03063658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5746330|NCT03063658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5746331|NCT03063658|Analgesics|analgesics|mesh-ancestor
5746332|NCT03063658|Sensory System Agents|sensory system agents|mesh-ancestor
5746333|NCT03063658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5746334|NCT03063658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746335|NCT03063658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5746336|NCT03063658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5746337|NCT03063658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5746338|NCT03063658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5746339|NCT03063658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5746340|NCT03063658|Antipyretics|antipyretics|mesh-ancestor
5746341|NCT03063619|Tamoxifen|tamoxifen|mesh-list
5746342|NCT03063619|Afimoxifene|afimoxifene|mesh-list
5746343|NCT03063619|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5746344|NCT03063619|Hormone Antagonists|hormone antagonists|mesh-ancestor
5746345|NCT03063619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5746346|NCT03063619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746347|NCT03063619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5746348|NCT03063619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5746349|NCT03063619|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5623589|NCT02661022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5623590|NCT02661022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623591|NCT02661022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5623592|NCT02661022|Glucocorticoids|glucocorticoids|mesh-ancestor
5623593|NCT02661022|Hormones|hormones|mesh-ancestor
5746350|NCT03063619|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5746351|NCT03063619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5746352|NCT03063827|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5746353|NCT03063827|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5746354|NCT03063827|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5746355|NCT03063827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5746356|NCT03063827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746357|NCT03063827|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5746358|NCT03063827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5746359|NCT03063827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489425|NCT00591643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6489426|NCT00591643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6489427|NCT00591643|Respiratory System Agents|respiratory system agents|mesh-ancestor
6489428|NCT00591643|Mydriatics|mydriatics|mesh-ancestor
6489429|NCT00591643|Sympathomimetics|sympathomimetics|mesh-ancestor
5623594|NCT02661022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5623595|NCT02661022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5623596|NCT02661022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5623597|NCT02661022|Immunologic Factors|immunologic factors|mesh-ancestor
5623598|NCT02661022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5623599|NCT02661022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5623600|NCT02661022|Growth Substances|growth substances|mesh-ancestor
5623601|NCT02661022|Growth Inhibitors|growth inhibitors|mesh-ancestor
5623602|NCT02655016|Niraparib|niraparib|mesh-list
5623603|NCT02655016|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5746360|NCT03063827|Cholinergic Agents|cholinergic agents|mesh-ancestor
5746361|NCT03063827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5746362|NCT03063866|Fentanyl|fentanyl|mesh-list
5746363|NCT03063866|Midazolam|midazolam|mesh-list
5623604|NCT02655016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5623605|NCT02655016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623606|NCT02655016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5623607|NCT02652195|Oxytocin|oxytocin|mesh-list
5623608|NCT02652195|Oxytocics|oxytocics|mesh-ancestor
5623609|NCT02652195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5623610|NCT02652195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623611|NCT02650271|Tenofovir|tenofovir|mesh-list
5623612|NCT02650271|Entecavir|entecavir|mesh-list
5746364|NCT03063866|Propofol|propofol|mesh-list
5746365|NCT03063866|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5746366|NCT03063866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5746367|NCT03063866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746368|NCT03063866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5746369|NCT03063866|Anesthetics, General|anesthetics, general|mesh-ancestor
5746370|NCT03063866|Anesthetics|anesthetics|mesh-ancestor
5746371|NCT03063866|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5746372|NCT03063866|Narcotics|narcotics|mesh-ancestor
5746373|NCT03063866|Analgesics|analgesics|mesh-ancestor
5746374|NCT03063866|Sensory System Agents|sensory system agents|mesh-ancestor
5746375|NCT03063866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5746376|NCT03063866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5746377|NCT03063866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5746378|NCT03063866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5746379|NCT03063866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5746380|NCT03063866|GABA Modulators|gaba modulators|mesh-ancestor
5746381|NCT03063866|GABA Agents|gaba agents|mesh-ancestor
5746382|NCT03063866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5746383|NCT03063866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5746384|NCT03063515|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
5746385|NCT03063515|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5746386|NCT03063515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5746387|NCT03063515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5746388|NCT03063515|Cholinergic Agents|cholinergic agents|mesh-ancestor
5623613|NCT02650271|Antiviral Agents|antiviral agents|mesh-ancestor
5623614|NCT02650271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5623615|NCT02650271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5623616|NCT02650271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5623617|NCT02650271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5623618|NCT02650271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623619|NCT02650271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5746389|NCT03063515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5746390|NCT03063515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894133|NCT01097746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894134|NCT01097746|Growth Inhibitors|growth inhibitors|mesh-ancestor
5894135|NCT01097746|Immunologic Factors|immunologic factors|mesh-ancestor
5894136|NCT00307242|Adefovir|adefovir|mesh-list
5894137|NCT00307242|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
5894138|NCT00307242|Antiviral Agents|antiviral agents|mesh-ancestor
5894139|NCT00307242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5894140|NCT00307242|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5894141|NCT00307242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5894142|NCT00307242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5894143|NCT00307242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894144|NCT05120687|Cyclosporine|cyclosporine|mesh-list
5894145|NCT05120687|Mycophenolic Acid|mycophenolic acid|mesh-list
5894146|NCT05120687|Adalimumab|adalimumab|mesh-list
5894147|NCT05120687|Cyclophosphamide|cyclophosphamide|mesh-list
5623620|NCT02650271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5623621|NCT02649855|Docetaxel|docetaxel|mesh-list
5623622|NCT02649855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5623623|NCT02649855|Tubulin Modulators|tubulin modulators|mesh-ancestor
5623624|NCT02649855|Antimitotic Agents|antimitotic agents|mesh-ancestor
5623625|NCT02649855|Mitosis Modulators|mitosis modulators|mesh-ancestor
5623626|NCT02649855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623627|NCT02570984|Omalizumab|omalizumab|mesh-list
5746391|NCT03063489|Loteprednol Etabonate|loteprednol etabonate|mesh-list
5746392|NCT03063489|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5746393|NCT03063307|Fluorides|fluorides|mesh-list
5746394|NCT03063307|Cariostatic Agents|cariostatic agents|mesh-ancestor
5746395|NCT03063307|Protective Agents|protective agents|mesh-ancestor
5746396|NCT03063307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746397|NCT03063359|Fentanyl|fentanyl|mesh-list
5746398|NCT03063359|Morphine|morphine|mesh-list
5746399|NCT03063359|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5746400|NCT03063359|Narcotics|narcotics|mesh-ancestor
5746401|NCT03063359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5746402|NCT03063359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746403|NCT03063359|Analgesics|analgesics|mesh-ancestor
5746404|NCT03063359|Sensory System Agents|sensory system agents|mesh-ancestor
5746405|NCT03063359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5746406|NCT03063359|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5746407|NCT03063359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5746408|NCT03063359|Anesthetics, General|anesthetics, general|mesh-ancestor
5746409|NCT03063359|Anesthetics|anesthetics|mesh-ancestor
5746410|NCT03063190|Vitamin D|vitamin d|mesh-list
5746411|NCT03063190|Vitamins|vitamins|mesh-ancestor
5746412|NCT03063190|Micronutrients|micronutrients|mesh-ancestor
5746413|NCT03063190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746414|NCT03063190|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5746415|NCT03063242|Sargramostim|sargramostim|mesh-list
5746416|NCT03063242|Immunologic Factors|immunologic factors|mesh-ancestor
5746417|NCT03063242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746418|NCT03063203|Decitabine|decitabine|mesh-list
5746419|NCT03063203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5746420|NCT03063203|Antimetabolites|antimetabolites|mesh-ancestor
5746421|NCT03063203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5746422|NCT03063203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5746423|NCT03063203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5746424|NCT03062943|Nintedanib|nintedanib|mesh-list
5746425|NCT03062943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5746426|NCT03062943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5746427|NCT03062943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5746428|NCT03062943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5746429|NCT03062839|Melatonin|melatonin|mesh-list
5746430|NCT03062839|Antioxidants|antioxidants|mesh-ancestor
5746431|NCT03062839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5746432|NCT03062839|Protective Agents|protective agents|mesh-ancestor
5746433|NCT03062839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746434|NCT03062839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5746435|NCT03062800|Thalidomide|thalidomide|mesh-list
5746436|NCT03062800|Carboplatin|carboplatin|mesh-list
5746437|NCT03062800|Pemetrexed|pemetrexed|mesh-list
5746438|NCT03062800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5746439|NCT03062800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5746440|NCT03062800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5746441|NCT03062800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5746442|NCT03062800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5746443|NCT03062800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5746444|NCT03062800|Immunologic Factors|immunologic factors|mesh-ancestor
5746445|NCT03062800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746446|NCT03062800|Leprostatic Agents|leprostatic agents|mesh-ancestor
5746447|NCT03062800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5746448|NCT03062800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5746449|NCT03062800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5746450|NCT03062800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5746451|NCT03062800|Growth Substances|growth substances|mesh-ancestor
5746452|NCT03062800|Growth Inhibitors|growth inhibitors|mesh-ancestor
5746453|NCT03062813|Entecavir|entecavir|mesh-list
5746454|NCT03062813|Tacrolimus|tacrolimus|mesh-list
5746455|NCT03062813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5746456|NCT03062813|Immunologic Factors|immunologic factors|mesh-ancestor
5746457|NCT03062813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746458|NCT03062813|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5746459|NCT03062813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5623628|NCT02570984|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5623629|NCT02570984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5623630|NCT02570984|Respiratory System Agents|respiratory system agents|mesh-ancestor
5623631|NCT02539693|Lidocaine|lidocaine|mesh-list
5623632|NCT02539693|Clonidine|clonidine|mesh-list
5623633|NCT02539693|Anesthetics, Local|anesthetics, local|mesh-ancestor
5623634|NCT02539693|Anesthetics|anesthetics|mesh-ancestor
5623635|NCT02539693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5623636|NCT02539693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623637|NCT02539693|Sensory System Agents|sensory system agents|mesh-ancestor
5623638|NCT02539693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5623639|NCT02539693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5623640|NCT02539693|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5746460|NCT03062813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5746461|NCT03062813|Antiviral Agents|antiviral agents|mesh-ancestor
5746462|NCT03062813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5746463|NCT03062904|Methacholine Chloride|methacholine chloride|mesh-list
5746464|NCT03062904|Bronchodilator Agents|bronchodilator agents|mesh-list
5746465|NCT03062904|Miotics|miotics|mesh-ancestor
5746466|NCT03062904|Autonomic Agents|autonomic agents|mesh-ancestor
5746467|NCT03062904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5746468|NCT03062904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746469|NCT03062904|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5746470|NCT03062904|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
5746471|NCT03062904|Respiratory System Agents|respiratory system agents|mesh-ancestor
5746472|NCT03062904|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
5746473|NCT03062904|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5746474|NCT03062904|Cholinergic Agents|cholinergic agents|mesh-ancestor
5746475|NCT03062904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5746476|NCT03062904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5746477|NCT03062904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5746478|NCT03062787|Triamcinolone|triamcinolone|mesh-list
5746479|NCT03062787|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5746480|NCT03062787|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5746481|NCT03062787|Hyaluronic Acid|hyaluronic acid|mesh-list
5746482|NCT03062787|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5746483|NCT03062787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5746484|NCT03062787|Glucocorticoids|glucocorticoids|mesh-ancestor
5746485|NCT03062787|Hormones|hormones|mesh-ancestor
5746486|NCT03062787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5746487|NCT03062787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746488|NCT03062787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5746489|NCT03062787|Immunologic Factors|immunologic factors|mesh-ancestor
5746490|NCT03062787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5746491|NCT03062787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5746492|NCT03062787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5746493|NCT03062787|Viscosupplements|viscosupplements|mesh-ancestor
5746494|NCT03062787|Protective Agents|protective agents|mesh-ancestor
5746495|NCT03063073|Dexmedetomidine|dexmedetomidine|mesh-list
5746496|NCT03063073|Bupivacaine|bupivacaine|mesh-list
5746497|NCT03063073|Anesthetics, Local|anesthetics, local|mesh-ancestor
5746498|NCT03063073|Anesthetics|anesthetics|mesh-ancestor
5746499|NCT03063073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5746500|NCT03063073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746501|NCT03063073|Sensory System Agents|sensory system agents|mesh-ancestor
5746502|NCT03063073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5746503|NCT03063073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5746504|NCT03063073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5623641|NCT02539693|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5623642|NCT02539693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5623643|NCT02539693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623644|NCT02539693|Analgesics|analgesics|mesh-ancestor
5623645|NCT02539693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5623646|NCT02539693|Sympatholytics|sympatholytics|mesh-ancestor
5623647|NCT02539693|Autonomic Agents|autonomic agents|mesh-ancestor
5623648|NCT02539693|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5623649|NCT02539693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5623650|NCT02539693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5623651|NCT02539693|Adrenergic Agents|adrenergic agents|mesh-ancestor
5623652|NCT02539693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5623653|NCT02535312|Cisplatin|cisplatin|mesh-list
5623654|NCT02535312|Pemetrexed|pemetrexed|mesh-list
5623655|NCT02535312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5623656|NCT02535312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5623657|NCT02535312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623658|NCT02535312|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5623659|NCT02535312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5623660|NCT02534012|Anesthetics|anesthetics|mesh-list
5746505|NCT03063073|Analgesics|analgesics|mesh-ancestor
5894148|NCT05120687|Methotrexate|methotrexate|mesh-list
5746506|NCT03063073|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5746507|NCT03063073|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5746508|NCT03063073|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5746509|NCT03063073|Adrenergic Agents|adrenergic agents|mesh-ancestor
5746510|NCT03063073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5746511|NCT03063073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5746512|NCT03063112|Ethanol|ethanol|mesh-list
5746513|NCT03063112|Lidocaine|lidocaine|mesh-list
5746514|NCT03063112|Anesthetics, Local|anesthetics, local|mesh-ancestor
5746515|NCT03063112|Anesthetics|anesthetics|mesh-ancestor
5746516|NCT03063112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5746517|NCT03063112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746518|NCT03063112|Sensory System Agents|sensory system agents|mesh-ancestor
5746519|NCT03063112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5746520|NCT03063112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5746521|NCT03063112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5746522|NCT03063112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5746523|NCT03063112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5746524|NCT03063112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5746525|NCT03063112|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5746526|NCT03063112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5746527|NCT03063060|Vitamin D|vitamin d|mesh-list
5746528|NCT03063060|Calcium|calcium|mesh-list
5746529|NCT03063060|Vitamins|vitamins|mesh-ancestor
5746530|NCT03063060|Micronutrients|micronutrients|mesh-ancestor
5746531|NCT03063060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746532|NCT03063060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5746533|NCT03063060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5746534|NCT03062644|Celecoxib|celecoxib|mesh-list
5746535|NCT03062644|Tramadol|tramadol|mesh-list
5746536|NCT03062644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5746537|NCT03062644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5746538|NCT03062644|Analgesics|analgesics|mesh-ancestor
5746539|NCT03062644|Sensory System Agents|sensory system agents|mesh-ancestor
5746540|NCT03062644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5746541|NCT03062644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746542|NCT03062644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5746543|NCT03062644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5746544|NCT03062644|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5746545|NCT03062644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5746546|NCT03062644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5746547|NCT03062644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5746548|NCT03062644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5746549|NCT03062644|Narcotics|narcotics|mesh-ancestor
5746550|NCT03062644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5746551|NCT03062436|Tin Fluorides|tin fluorides|mesh-list
5746552|NCT03062436|Cariostatic Agents|cariostatic agents|mesh-ancestor
5746553|NCT03062436|Protective Agents|protective agents|mesh-ancestor
5746554|NCT03062436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746555|NCT03062423|Sofosbuvir|sofosbuvir|mesh-list
5746556|NCT03062423|Antiviral Agents|antiviral agents|mesh-ancestor
5746557|NCT03062423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5746558|NCT03062631|Amifampridine|amifampridine|mesh-list
5746559|NCT03062631|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5746560|NCT03062631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5746561|NCT03062631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746562|NCT03062631|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5746563|NCT03062631|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5746564|NCT03062631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5746565|NCT03062501|Hydroxyurea|hydroxyurea|mesh-list
5746566|NCT03062501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5746567|NCT03062501|Antisickling Agents|antisickling agents|mesh-ancestor
5746568|NCT03062501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5746569|NCT03062501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5746570|NCT03062501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5746571|NCT03062462|Clopidogrel|clopidogrel|mesh-list
5746572|NCT03062462|Ticagrelor|ticagrelor|mesh-list
5746573|NCT03062462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5746574|NCT03062462|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5746575|NCT03062462|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5746576|NCT03062462|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5746577|NCT03062462|Purinergic Agents|purinergic agents|mesh-ancestor
5746578|NCT03062462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5894149|NCT05120687|Cyclosporins|cyclosporins|mesh-list
5623661|NCT02534012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5746579|NCT03062462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5746580|NCT03062462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746581|NCT03062358|Pembrolizumab|pembrolizumab|mesh-list
5746582|NCT03062358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5746583|NCT03062358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5746584|NCT03062319|Anticoagulants|anticoagulants|mesh-list
5746585|NCT03062319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
5746586|NCT03062280|Hydrocortisone|hydrocortisone|mesh-list
5746587|NCT03062280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5746588|NCT03062176|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5746589|NCT03062176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5746590|NCT03061955|Vaccines|vaccines|mesh-list
5746591|NCT03061955|Immunologic Factors|immunologic factors|mesh-ancestor
5746592|NCT03061955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746593|NCT03062072|Antineoplastic Agents|antineoplastic agents|mesh-list
5894150|NCT05120687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5894151|NCT05120687|Immunologic Factors|immunologic factors|mesh-ancestor
5894152|NCT05120687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894153|NCT05120687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5894154|NCT05120687|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5894155|NCT05120687|Alkylating Agents|alkylating agents|mesh-ancestor
5623662|NCT02534012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623663|NCT02505204|Clonidine|clonidine|mesh-list
5623664|NCT02505204|Analgesics|analgesics|mesh-ancestor
5623665|NCT02505204|Sensory System Agents|sensory system agents|mesh-ancestor
5623666|NCT02505204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5623667|NCT02505204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623668|NCT02505204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5623669|NCT02505204|Sympatholytics|sympatholytics|mesh-ancestor
5623670|NCT02505204|Autonomic Agents|autonomic agents|mesh-ancestor
5623671|NCT02505204|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5623672|NCT02505204|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5623673|NCT02505204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5623674|NCT02505204|Adrenergic Agents|adrenergic agents|mesh-ancestor
5623675|NCT02505204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5623676|NCT02505204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623677|NCT02503774|Durvalumab|durvalumab|mesh-list
5623678|NCT02503774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5623679|NCT02503774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5623680|NCT02487979|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
5894156|NCT05120687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894157|NCT05120687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5894158|NCT05120687|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5894159|NCT05120687|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5894160|NCT05120687|Abortifacient Agents|abortifacient agents|mesh-ancestor
5894161|NCT05120687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5894162|NCT05120687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5894163|NCT05120687|Antimetabolites|antimetabolites|mesh-ancestor
5894164|NCT05120687|Dermatologic Agents|dermatologic agents|mesh-ancestor
5894165|NCT05120687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5894166|NCT05120687|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5894167|NCT05120687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5894168|NCT05120687|Antifungal Agents|antifungal agents|mesh-ancestor
5894169|NCT05120687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5894170|NCT05120687|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5894171|NCT05120687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5894172|NCT05120687|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5894173|NCT05120687|Antitubercular Agents|antitubercular agents|mesh-ancestor
5894174|NCT05120687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5894175|NCT05120687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5894176|NCT05120622|Tremelimumab|tremelimumab|mesh-list
5894177|NCT05120622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5894178|NCT05120596|Pembrolizumab|pembrolizumab|mesh-list
5894179|NCT05120596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5894180|NCT05120596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5894181|NCT05120206|Chlorhexidine|chlorhexidine|mesh-list
5894182|NCT05120206|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5894183|NCT05120206|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5894184|NCT05120206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5894185|NCT05120206|Disinfectants|disinfectants|mesh-ancestor
5894186|NCT05120206|Dermatologic Agents|dermatologic agents|mesh-ancestor
5894187|NCT05120076|Dexamethasone|dexamethasone|mesh-list
5894188|NCT05120076|Dexamethasone acetate|dexamethasone acetate|mesh-list
6672922|NCT01559285|Anesthetics, Local|anesthetics, local|mesh-ancestor
5623681|NCT02487979|Immunoconjugates|immunoconjugates|mesh-list
5623682|NCT02487979|Immunotoxins|immunotoxins|mesh-list
5623683|NCT02487979|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5623684|NCT02487979|Immunologic Factors|immunologic factors|mesh-ancestor
5623685|NCT02487979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623686|NCT02487979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5623687|NCT02487979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5692781|NCT03405207|Vitamin D|vitamin d|mesh-list
5692782|NCT03405207|Cholecalciferol|cholecalciferol|mesh-list
5746594|NCT03061838|Rituximab|rituximab|mesh-list
5746595|NCT03061838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5746596|NCT03061838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5746597|NCT03061838|Immunologic Factors|immunologic factors|mesh-ancestor
5746598|NCT03061838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746599|NCT03061838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5746600|NCT03061981|Metformin|metformin|mesh-list
5746601|NCT03061981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5746602|NCT03061981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746603|NCT03061903|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
5746604|NCT03061903|Laxatives|laxatives|mesh-ancestor
5746605|NCT03061903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5746606|NCT03062254|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
5746607|NCT03062254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5746608|NCT03062163|Thioctic Acid|thioctic acid|mesh-list
5746609|NCT03062163|Resveratrol|resveratrol|mesh-list
5692783|NCT03405207|Vitamins|vitamins|mesh-ancestor
5692784|NCT03405207|Micronutrients|micronutrients|mesh-ancestor
5692785|NCT03405207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692786|NCT03405207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5692787|NCT03405207|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5692788|NCT03405194|Efavirenz|efavirenz|mesh-list
5692789|NCT03405194|Cobicistat|cobicistat|mesh-list
5692790|NCT03405194|Elvitegravir|elvitegravir|mesh-list
5692791|NCT03405194|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5692792|NCT03405194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5692793|NCT03405194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5746610|NCT03062163|Antioxidants|antioxidants|mesh-ancestor
5746611|NCT03062163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5746612|NCT03062163|Protective Agents|protective agents|mesh-ancestor
5746613|NCT03062163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746614|NCT03062163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5692794|NCT03405194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692795|NCT03405194|Antiviral Agents|antiviral agents|mesh-ancestor
5692796|NCT03405194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5692797|NCT03405194|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5692798|NCT03405194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5692799|NCT03405194|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5692800|NCT03405194|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5692801|NCT03405194|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5692802|NCT03405194|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5746615|NCT03062163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5746616|NCT03062163|Vitamin B Complex|vitamin b complex|mesh-ancestor
5746617|NCT03062163|Vitamins|vitamins|mesh-ancestor
5746618|NCT03062163|Micronutrients|micronutrients|mesh-ancestor
5746619|NCT03061734|Acetaminophen|acetaminophen|mesh-list
5746620|NCT03061734|Naltrexone|naltrexone|mesh-list
5746621|NCT03061734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5746622|NCT03061734|Analgesics|analgesics|mesh-ancestor
5746623|NCT03061734|Sensory System Agents|sensory system agents|mesh-ancestor
5746624|NCT03061734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5746625|NCT03061734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746626|NCT03061734|Antipyretics|antipyretics|mesh-ancestor
5746627|NCT03061734|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5746628|NCT03061734|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5692803|NCT03405194|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5692804|NCT03405194|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5692805|NCT03405194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5692806|NCT03405194|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5692807|NCT03405168|Moxifloxacin|moxifloxacin|mesh-list
5692808|NCT03405168|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
5692809|NCT03405168|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5692810|NCT03405168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5692811|NCT03405168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5746629|NCT03062150|Cycloserine|cycloserine|mesh-list
5692812|NCT03405168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5746630|NCT03062150|Fludrocortisone|fludrocortisone|mesh-list
6672923|NCT01559285|Anesthetics|anesthetics|mesh-ancestor
5623688|NCT02310867|Abatacept|abatacept|mesh-list
5623689|NCT02310867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5623690|NCT02310867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623691|NCT02310867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5623692|NCT02310867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5623693|NCT02310867|Immunologic Factors|immunologic factors|mesh-ancestor
6489430|NCT00591643|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6489431|NCT00591708|Calcium, Dietary|calcium, dietary|mesh-list
6489432|NCT00591708|Citric Acid|citric acid|mesh-list
6489433|NCT00591708|Sodium Citrate|sodium citrate|mesh-list
6489434|NCT00591708|Calcium|calcium|mesh-list
6489435|NCT00591708|Calcium citrate malate|calcium citrate malate|mesh-list
5623694|NCT02310867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623695|NCT02310867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6489436|NCT00591708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6489437|NCT00591708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489438|NCT00591708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6489439|NCT00591708|Anticoagulants|anticoagulants|mesh-ancestor
6489440|NCT00591708|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6489441|NCT00591708|Chelating Agents|chelating agents|mesh-ancestor
6489442|NCT00591708|Sequestering Agents|sequestering agents|mesh-ancestor
6496360|NCT00627731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5623696|NCT02303431|Edoxaban|edoxaban|mesh-list
5623697|NCT02303431|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5623698|NCT02303431|Antithrombins|antithrombins|mesh-ancestor
5623699|NCT02303431|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5623700|NCT02303431|Protease Inhibitors|protease inhibitors|mesh-ancestor
5623701|NCT02303431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5623702|NCT02303431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623703|NCT02303431|Anticoagulants|anticoagulants|mesh-ancestor
5623704|NCT02288897|Temozolomide|temozolomide|mesh-list
5623705|NCT02288897|Dacarbazine|dacarbazine|mesh-list
5623706|NCT02288897|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
5623707|NCT02288897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5623708|NCT02288897|Alkylating Agents|alkylating agents|mesh-ancestor
5692813|NCT03405168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5692814|NCT03405168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692815|NCT03405168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5692816|NCT03405168|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5692817|NCT03405168|Contraceptive Agents|contraceptive agents|mesh-ancestor
5692818|NCT03405168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5692819|NCT03405168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692820|NCT03405168|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5692821|NCT03405168|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5692822|NCT03405168|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5692823|NCT03405155|Nivolumab|nivolumab|mesh-list
5692824|NCT03405155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5692825|NCT03405155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5692826|NCT03405155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5692827|NCT03405155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692828|NCT03405142|Panitumumab|panitumumab|mesh-list
5692829|NCT03405142|Diethylenetriamine|diethylenetriamine|mesh-list
5692830|NCT03405142|Dextrans|dextrans|mesh-list
5692831|NCT03405142|Edetic Acid|edetic acid|mesh-list
5692832|NCT03405142|Pentetic Acid|pentetic acid|mesh-list
5692833|NCT03405142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5692834|NCT03405142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5692835|NCT03405142|Anticoagulants|anticoagulants|mesh-ancestor
5692836|NCT03405142|Plasma Substitutes|plasma substitutes|mesh-ancestor
5692837|NCT03405142|Blood Substitutes|blood substitutes|mesh-ancestor
5692838|NCT03405142|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5692839|NCT03405142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692840|NCT03405142|Antidotes|antidotes|mesh-ancestor
5692841|NCT03405142|Protective Agents|protective agents|mesh-ancestor
5692842|NCT03405142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692843|NCT03405142|Chelating Agents|chelating agents|mesh-ancestor
5692844|NCT03405142|Sequestering Agents|sequestering agents|mesh-ancestor
5692845|NCT03405142|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5692846|NCT03405142|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5692847|NCT03405090|Fentanyl|fentanyl|mesh-list
5692848|NCT03405090|Bronchodilator Agents|bronchodilator agents|mesh-list
5692849|NCT03405090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5692850|NCT03405090|Narcotics|narcotics|mesh-ancestor
5692851|NCT03405090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5692852|NCT03405090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623709|NCT02288897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623710|NCT02288897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5746631|NCT03062150|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5746632|NCT03062150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5746633|NCT03062150|Renal Agents|renal agents|mesh-ancestor
5623711|NCT02288897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6208716|NCT02134977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6208717|NCT02135016|Lidocaine|lidocaine|mesh-list
6208718|NCT02135016|Anesthetics, Local|anesthetics, local|mesh-ancestor
6208719|NCT02135016|Anesthetics|anesthetics|mesh-ancestor
5746634|NCT03062150|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5746635|NCT03062150|Antitubercular Agents|antitubercular agents|mesh-ancestor
5746636|NCT03062150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5746637|NCT03062150|Antimetabolites|antimetabolites|mesh-ancestor
5746638|NCT03062150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5746639|NCT03062150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5746640|NCT03061656|Cyclophosphamide|cyclophosphamide|mesh-list
5746641|NCT03061656|Melphalan|melphalan|mesh-list
5746642|NCT03061656|Thiotepa|thiotepa|mesh-list
5746643|NCT03061656|Carboplatin|carboplatin|mesh-list
5746644|NCT03061656|Etoposide|etoposide|mesh-list
5746645|NCT03061656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5746646|NCT03061656|Immunologic Factors|immunologic factors|mesh-ancestor
6208720|NCT02135016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6208721|NCT02135016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208722|NCT02135016|Sensory System Agents|sensory system agents|mesh-ancestor
6208723|NCT02135016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6208724|NCT02135016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6208725|NCT02135016|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6208726|NCT02135016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6208727|NCT02135016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6208728|NCT02135016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208729|NCT02135094|Oxymetazoline|oxymetazoline|mesh-list
5623726|NCT02213926|Acalabrutinib|acalabrutinib|mesh-list
5623727|NCT02213926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5623728|NCT02179086|Temozolomide|temozolomide|mesh-list
5623729|NCT02179086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5746647|NCT03061656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746648|NCT03061656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5746649|NCT03061656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5746650|NCT03061656|Alkylating Agents|alkylating agents|mesh-ancestor
5746651|NCT03061656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5746652|NCT03061656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5746653|NCT03061656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5746654|NCT03061656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5746655|NCT03061656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5746656|NCT03061656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5746657|NCT03061656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5746658|NCT03061916|Chlorhexidine|chlorhexidine|mesh-list
5746659|NCT03061916|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5746660|NCT03061916|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5746661|NCT03061916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5746662|NCT03061916|Disinfectants|disinfectants|mesh-ancestor
5746663|NCT03061916|Dermatologic Agents|dermatologic agents|mesh-ancestor
5746664|NCT03062059|Gemcitabine|gemcitabine|mesh-list
5746665|NCT03062059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5746666|NCT03062059|Antimetabolites|antimetabolites|mesh-ancestor
5746667|NCT03062059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5746668|NCT03062059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5746669|NCT03062059|Antiviral Agents|antiviral agents|mesh-ancestor
5746670|NCT03062059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5746671|NCT03062059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5746672|NCT03062059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5746673|NCT03062059|Immunologic Factors|immunologic factors|mesh-ancestor
5746674|NCT03062059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746675|NCT03061604|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5746676|NCT03061604|Ceftriaxone|ceftriaxone|mesh-list
5746677|NCT03061604|Octreotide|octreotide|mesh-list
5746678|NCT03061604|Hemostatics|hemostatics|mesh-list
5746679|NCT03061604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5746680|NCT03061604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5746681|NCT03061604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5746682|NCT03061604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5746683|NCT03061604|Coagulants|coagulants|mesh-ancestor
5746684|NCT03061643|Docetaxel|docetaxel|mesh-list
5746685|NCT03061643|Androgens|androgens|mesh-list
5746686|NCT03061643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5746687|NCT03061643|Tubulin Modulators|tubulin modulators|mesh-ancestor
5746688|NCT03061643|Antimitotic Agents|antimitotic agents|mesh-ancestor
5746689|NCT03061643|Mitosis Modulators|mitosis modulators|mesh-ancestor
5746690|NCT03061643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5746691|NCT03061643|Hormones|hormones|mesh-ancestor
5746692|NCT03061643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5746693|NCT03061643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746694|NCT03061630|Gemcitabine|gemcitabine|mesh-list
5746695|NCT03061630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5746696|NCT03061630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5746697|NCT03061630|Antimetabolites|antimetabolites|mesh-ancestor
5746698|NCT03061630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5746699|NCT03061630|Antiviral Agents|antiviral agents|mesh-ancestor
5746700|NCT03061630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5746701|NCT03061630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5746702|NCT03061630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5746703|NCT03061630|Immunologic Factors|immunologic factors|mesh-ancestor
5746704|NCT03061630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623730|NCT02179086|Alkylating Agents|alkylating agents|mesh-ancestor
5623731|NCT02179086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623732|NCT02179086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5623733|NCT02166463|Prednisone|prednisone|mesh-list
5746705|NCT03061565|Epoetin Alfa|epoetin alfa|mesh-list
5746706|NCT03061565|Hematinics|hematinics|mesh-ancestor
5746707|NCT03061253|Nicotine|nicotine|mesh-list
5746708|NCT03061253|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5746709|NCT03061253|Autonomic Agents|autonomic agents|mesh-ancestor
5746710|NCT03061253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5746711|NCT03061253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746712|NCT03061253|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5746713|NCT03061253|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5746714|NCT03061253|Cholinergic Agents|cholinergic agents|mesh-ancestor
5746715|NCT03061253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5746716|NCT03061253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623734|NCT02166463|Methylprednisolone|methylprednisolone|mesh-list
5623735|NCT02166463|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5623736|NCT02166463|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5623737|NCT02166463|Prednisolone|prednisolone|mesh-list
5623738|NCT02166463|Prednisolone acetate|prednisolone acetate|mesh-list
5623739|NCT02166463|Cortisone|cortisone|mesh-list
5623740|NCT02166463|Cyclophosphamide|cyclophosphamide|mesh-list
5623741|NCT02166463|Doxorubicin|doxorubicin|mesh-list
5623742|NCT02166463|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5623743|NCT02166463|Etoposide|etoposide|mesh-list
5623744|NCT02166463|Vincristine|vincristine|mesh-list
5623745|NCT02166463|Etoposide phosphate|etoposide phosphate|mesh-list
5746717|NCT03061058|Docetaxel|docetaxel|mesh-list
5746718|NCT03061058|Oxaliplatin|oxaliplatin|mesh-list
5746719|NCT03061058|Irinotecan|irinotecan|mesh-list
5746720|NCT03061058|Pemetrexed|pemetrexed|mesh-list
5746721|NCT03061058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5746722|NCT03061058|Tubulin Modulators|tubulin modulators|mesh-ancestor
5746723|NCT03061058|Antimitotic Agents|antimitotic agents|mesh-ancestor
5746724|NCT03061058|Mitosis Modulators|mitosis modulators|mesh-ancestor
5746725|NCT03061058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5746726|NCT03061058|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5746727|NCT03061058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5746728|NCT03061058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5746729|NCT03061058|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5746730|NCT03061058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5746731|NCT03061006|Warfarin|warfarin|mesh-list
5746732|NCT03061006|Dabigatran|dabigatran|mesh-list
5746733|NCT03061006|Anticoagulants|anticoagulants|mesh-ancestor
5746734|NCT03061006|Antithrombins|antithrombins|mesh-ancestor
5746735|NCT03061006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5746736|NCT03061006|Protease Inhibitors|protease inhibitors|mesh-ancestor
5623746|NCT02166463|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5623747|NCT02166463|Bleomycin|bleomycin|mesh-list
5746737|NCT03061006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5746738|NCT03061006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5746739|NCT03061227|Glucagon|glucagon|mesh-list
5746740|NCT03061227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5746741|NCT03061227|Hormones|hormones|mesh-ancestor
5746742|NCT03061227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5746743|NCT03061227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746744|NCT03061136|Clonazepam|clonazepam|mesh-list
5746745|NCT03061136|Anticonvulsants|anticonvulsants|mesh-ancestor
5746746|NCT03061136|GABA Modulators|gaba modulators|mesh-ancestor
5746747|NCT03061136|GABA Agents|gaba agents|mesh-ancestor
5746748|NCT03061136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5746749|NCT03061136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5746750|NCT03061136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746751|NCT03061032|Ribavirin|ribavirin|mesh-list
5746752|NCT03061032|Sofosbuvir|sofosbuvir|mesh-list
5746753|NCT03061032|Ledipasvir|ledipasvir|mesh-list
5746754|NCT03061032|Antimetabolites|antimetabolites|mesh-ancestor
5746755|NCT03061032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5746756|NCT03061032|Antiviral Agents|antiviral agents|mesh-ancestor
5746757|NCT03061032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5746758|NCT03060889|Tranexamic Acid|tranexamic acid|mesh-list
5746759|NCT03060889|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5746760|NCT03060889|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5746761|NCT03060889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5746762|NCT03060889|Hemostatics|hemostatics|mesh-ancestor
5746763|NCT03060889|Coagulants|coagulants|mesh-ancestor
5746764|NCT03060603|Epoetin Alfa|epoetin alfa|mesh-list
5746765|NCT03060603|Hematinics|hematinics|mesh-ancestor
5746766|NCT03060707|Bromides|bromides|mesh-list
5746767|NCT03060707|Rocuronium|rocuronium|mesh-list
5746768|NCT03060707|Anticonvulsants|anticonvulsants|mesh-ancestor
5746769|NCT03060707|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5746770|NCT03060707|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5746771|NCT03060707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5746772|NCT03060707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5746773|NCT03060707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746774|NCT03060681|Bupivacaine|bupivacaine|mesh-list
5746775|NCT03060681|Anesthetics, Local|anesthetics, local|mesh-ancestor
5746776|NCT03060681|Anesthetics|anesthetics|mesh-ancestor
5746777|NCT03060681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5746778|NCT03060681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746779|NCT03060681|Sensory System Agents|sensory system agents|mesh-ancestor
5746780|NCT03060681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5746781|NCT03060850|Abivertinib|abivertinib|mesh-list
5746782|NCT03060850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5746783|NCT03060850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5746784|NCT03060850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5746785|NCT03060798|Desflurane|desflurane|mesh-list
5746786|NCT03060798|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5746787|NCT03060798|Anesthetics, General|anesthetics, general|mesh-ancestor
5623748|NCT02166463|Podophyllotoxin|podophyllotoxin|mesh-list
5623749|NCT02166463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5623750|NCT02166463|Antibodies|antibodies|mesh-list
5623751|NCT02166463|Immunoglobulins|immunoglobulins|mesh-list
5623752|NCT02166463|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5623753|NCT02166463|Immunoconjugates|immunoconjugates|mesh-list
5623754|NCT02166463|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5623755|NCT02166463|Prednisolone phosphate|prednisolone phosphate|mesh-list
5746788|NCT03060798|Anesthetics|anesthetics|mesh-ancestor
5746789|NCT03060798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5746790|NCT03060798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746791|NCT03060785|Tenofovir|tenofovir|mesh-list
5746792|NCT03060785|Emtricitabine|emtricitabine|mesh-list
5746793|NCT03060785|Antiviral Agents|antiviral agents|mesh-ancestor
5746794|NCT03060785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5746795|NCT03060785|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5746796|NCT03060785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5746797|NCT03060785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5746798|NCT03060785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5746799|NCT03060785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5746800|NCT03060785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5894189|NCT05120076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5894190|NCT05120076|Antiemetics|antiemetics|mesh-ancestor
5623756|NCT02166463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5623757|NCT02166463|Immunologic Factors|immunologic factors|mesh-ancestor
5623758|NCT02166463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894191|NCT05120076|Autonomic Agents|autonomic agents|mesh-ancestor
5623759|NCT02166463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5692853|NCT03405090|Analgesics|analgesics|mesh-ancestor
5894192|NCT05120076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6496361|NCT00627744|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5623760|NCT02166463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5623761|NCT02166463|Alkylating Agents|alkylating agents|mesh-ancestor
5623762|NCT02166463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623763|NCT02166463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5623764|NCT02166463|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5623765|NCT02166463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5623766|NCT02166463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5623767|NCT02166463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5623768|NCT02166463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5623769|NCT02166463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5623770|NCT02166463|Glucocorticoids|glucocorticoids|mesh-ancestor
5746801|NCT03060278|Nicotine|nicotine|mesh-list
5746802|NCT03060278|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5746803|NCT03060278|Autonomic Agents|autonomic agents|mesh-ancestor
5746804|NCT03060278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5746805|NCT03060278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746806|NCT03060278|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5746807|NCT03060278|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5746808|NCT03060278|Cholinergic Agents|cholinergic agents|mesh-ancestor
5746809|NCT03060278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5746810|NCT03060278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5746811|NCT03060434|Acetaminophen|acetaminophen|mesh-list
5746812|NCT03060434|Ibuprofen|ibuprofen|mesh-list
5746813|NCT03060434|Pregabalin|pregabalin|mesh-list
5746814|NCT03060434|Pentoxifylline|pentoxifylline|mesh-list
5623771|NCT02166463|Hormones|hormones|mesh-ancestor
5623772|NCT02166463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5623773|NCT02166463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5623774|NCT02166463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5623775|NCT02166463|Tubulin Modulators|tubulin modulators|mesh-ancestor
5623776|NCT02166463|Antimitotic Agents|antimitotic agents|mesh-ancestor
5623777|NCT02166463|Mitosis Modulators|mitosis modulators|mesh-ancestor
5623778|NCT02166463|Antiemetics|antiemetics|mesh-ancestor
5623779|NCT02166463|Autonomic Agents|autonomic agents|mesh-ancestor
5623780|NCT02166463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5623781|NCT02166463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5623782|NCT02166463|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5623783|NCT02166463|Protective Agents|protective agents|mesh-ancestor
5623784|NCT02166463|Keratolytic Agents|keratolytic agents|mesh-ancestor
5623785|NCT02166463|Dermatologic Agents|dermatologic agents|mesh-ancestor
5623786|NCT02022982|Palbociclib|palbociclib|mesh-list
5623787|NCT02022982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5623788|NCT02022982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5623789|NCT02022982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5623790|NCT02022982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623791|NCT02008396|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
5623792|NCT02008396|Hallucinogens|hallucinogens|mesh-ancestor
5623793|NCT02008396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623794|NCT02008396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5623795|NCT02008396|Serotonin Agents|serotonin agents|mesh-ancestor
5623796|NCT02008396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5623797|NCT02008396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623798|NCT02008396|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5623799|NCT02008396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5623800|NCT02008396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5623801|NCT02008396|Adrenergic Agents|adrenergic agents|mesh-ancestor
5623802|NCT01898312|Mifepristone|mifepristone|mesh-list
5623803|NCT01898312|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5623804|NCT01898312|Abortifacient Agents|abortifacient agents|mesh-ancestor
5623805|NCT01898312|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5623806|NCT01898312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623807|NCT01898312|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5623808|NCT01898312|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5623809|NCT01898312|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5623810|NCT01898312|Contraceptive Agents|contraceptive agents|mesh-ancestor
5746815|NCT03060434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5746816|NCT03060434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5746817|NCT03060434|Analgesics|analgesics|mesh-ancestor
5746818|NCT03060434|Sensory System Agents|sensory system agents|mesh-ancestor
5746819|NCT03060434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6496362|NCT00627744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5746820|NCT03060434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746821|NCT03060434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5746822|NCT03060434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5746823|NCT03060434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5746824|NCT03060434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5746825|NCT03060434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5746826|NCT03060434|Anticonvulsants|anticonvulsants|mesh-ancestor
5746827|NCT03060434|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5746828|NCT03060434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5746829|NCT03060434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5746830|NCT03060434|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5746831|NCT03060434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5746832|NCT03060434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5746833|NCT03060434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5746834|NCT03060434|Antipyretics|antipyretics|mesh-ancestor
5746835|NCT03060434|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5746836|NCT03060434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5746837|NCT03060434|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5746838|NCT03060434|Protective Agents|protective agents|mesh-ancestor
5746839|NCT03060434|Vasodilator Agents|vasodilator agents|mesh-ancestor
5746840|NCT03060434|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5746841|NCT03060434|Antioxidants|antioxidants|mesh-ancestor
5746842|NCT03060304|Tamoxifen|tamoxifen|mesh-list
5746843|NCT03060304|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5746844|NCT03060304|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5746845|NCT03060304|Estradiol|estradiol|mesh-list
5746846|NCT03060304|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5746847|NCT03060304|Estrogens|estrogens|mesh-ancestor
5746848|NCT03060304|Hormones|hormones|mesh-ancestor
5746849|NCT03060304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5746850|NCT03060304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746851|NCT03060304|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5746852|NCT03060304|Contraceptive Agents|contraceptive agents|mesh-ancestor
5623811|NCT01898312|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5623812|NCT01898312|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5623813|NCT01898312|Hormone Antagonists|hormone antagonists|mesh-ancestor
5623814|NCT01898312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5623815|NCT01898312|Luteolytic Agents|luteolytic agents|mesh-ancestor
5746853|NCT03060304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5746854|NCT03060304|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5746855|NCT03060304|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5746856|NCT03060304|Hormone Antagonists|hormone antagonists|mesh-ancestor
5623816|NCT01898312|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5623817|NCT01898312|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5623818|NCT01883804|Methyldopa|methyldopa|mesh-list
5623819|NCT01883804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5623820|NCT01883804|Sympatholytics|sympatholytics|mesh-ancestor
5623821|NCT01883804|Autonomic Agents|autonomic agents|mesh-ancestor
5623822|NCT01883804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5623823|NCT01883804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623824|NCT01883804|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5623825|NCT01883804|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5623826|NCT01883804|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5623827|NCT01883804|Adrenergic Agents|adrenergic agents|mesh-ancestor
5623828|NCT01883804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5623829|NCT01883804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623830|NCT01881048|Celecoxib|celecoxib|mesh-list
5623831|NCT01881048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5623832|NCT01881048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5623833|NCT01881048|Analgesics|analgesics|mesh-ancestor
5623834|NCT01881048|Sensory System Agents|sensory system agents|mesh-ancestor
5746857|NCT03060304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5746858|NCT03060304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5746859|NCT03060304|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5746860|NCT03060304|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5746861|NCT03060304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5746862|NCT03060265|Acetaminophen|acetaminophen|mesh-list
5746863|NCT03060265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5746864|NCT03060265|Analgesics|analgesics|mesh-ancestor
5746865|NCT03060265|Sensory System Agents|sensory system agents|mesh-ancestor
5746866|NCT03060265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5746867|NCT03060265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746868|NCT03060265|Antipyretics|antipyretics|mesh-ancestor
5746869|NCT03060083|Nicotine|nicotine|mesh-list
5746870|NCT03060083|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5746871|NCT03060083|Autonomic Agents|autonomic agents|mesh-ancestor
5746872|NCT03060083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5746873|NCT03060083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746874|NCT03060083|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5746875|NCT03060083|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5746876|NCT03060083|Cholinergic Agents|cholinergic agents|mesh-ancestor
5746877|NCT03060083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5746878|NCT03060083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5746879|NCT03060070|Dexmedetomidine|dexmedetomidine|mesh-list
5746880|NCT03060070|Ketamine|ketamine|mesh-list
5746881|NCT03060070|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5746882|NCT03060070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5746883|NCT03060070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746884|NCT03060070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5623835|NCT01881048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5623836|NCT01881048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623837|NCT01881048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5623838|NCT01881048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5623839|NCT01881048|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5623840|NCT01881048|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5623841|NCT01881048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5623842|NCT01881048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623843|NCT01838187|Vorinostat|vorinostat|mesh-list
5623844|NCT01838187|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
5623845|NCT01838187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5623846|NCT01838187|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5623847|NCT01838187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5623848|NCT01838187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623849|NCT01838187|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5623850|NCT01771107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5623851|NCT01771107|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5623852|NCT01771107|Doxorubicin|doxorubicin|mesh-list
5623853|NCT01771107|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5623854|NCT01771107|Dacarbazine|dacarbazine|mesh-list
5623855|NCT01771107|Vinblastine|vinblastine|mesh-list
5623856|NCT01771107|Antibodies|antibodies|mesh-list
5623857|NCT01771107|Immunoglobulins|immunoglobulins|mesh-list
5623858|NCT01771107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5623859|NCT01771107|Immunoconjugates|immunoconjugates|mesh-list
5623860|NCT01771107|Imidazole|imidazole|mesh-list
5623861|NCT01771107|Immunologic Factors|immunologic factors|mesh-ancestor
5623862|NCT01771107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623863|NCT01771107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5746885|NCT03060070|Analgesics|analgesics|mesh-ancestor
5746886|NCT03060070|Sensory System Agents|sensory system agents|mesh-ancestor
5746887|NCT03060070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5746888|NCT03060070|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5746889|NCT03060070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5746890|NCT03060070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5746891|NCT03060070|Adrenergic Agents|adrenergic agents|mesh-ancestor
5746892|NCT03060070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5746893|NCT03060070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5746894|NCT03060070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5746895|NCT03060070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5746896|NCT03060070|Anesthetics, General|anesthetics, general|mesh-ancestor
5746897|NCT03060070|Anesthetics|anesthetics|mesh-ancestor
5746898|NCT03060070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5746899|NCT03060070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5746900|NCT03059888|Abatacept|abatacept|mesh-list
5746901|NCT03059888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5746902|NCT03059888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5746903|NCT03059888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5746904|NCT03059888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5746905|NCT03059888|Immunologic Factors|immunologic factors|mesh-ancestor
5746906|NCT03059888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746907|NCT03059888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5746908|NCT03059992|Ibrexafungerp|ibrexafungerp|mesh-list
5623864|NCT01771107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5623865|NCT01771107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5623866|NCT01771107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5623867|NCT01771107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5623868|NCT01771107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623869|NCT01771107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5746909|NCT03059992|Antifungal Agents|antifungal agents|mesh-ancestor
5746910|NCT03059992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5746911|NCT03059849|Adalimumab|adalimumab|mesh-list
5746912|NCT03059849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5746913|NCT03059849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5746914|NCT03060018|Oxitropium|oxitropium|mesh-list
5746915|NCT03060018|Parasympatholytics|parasympatholytics|mesh-ancestor
5746916|NCT03060018|Autonomic Agents|autonomic agents|mesh-ancestor
5746917|NCT03060018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5746918|NCT03060018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746919|NCT03059979|Methylprednisolone|methylprednisolone|mesh-list
5746920|NCT03059979|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5746921|NCT03059979|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5746922|NCT03059979|Prednisolone|prednisolone|mesh-list
5746923|NCT03059979|Prednisolone acetate|prednisolone acetate|mesh-list
5746924|NCT03059979|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5746925|NCT03059979|Prednisolone phosphate|prednisolone phosphate|mesh-list
5746926|NCT03059979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5746927|NCT03059979|Antiemetics|antiemetics|mesh-ancestor
5746928|NCT03059979|Autonomic Agents|autonomic agents|mesh-ancestor
5746929|NCT03059979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5746930|NCT03059979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746931|NCT03059979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5746932|NCT03059979|Glucocorticoids|glucocorticoids|mesh-ancestor
5746933|NCT03059979|Hormones|hormones|mesh-ancestor
5746934|NCT03059979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5623870|NCT01771107|Alkylating Agents|alkylating agents|mesh-ancestor
5623871|NCT01771107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5623872|NCT01771107|Tubulin Modulators|tubulin modulators|mesh-ancestor
5623873|NCT01771107|Antimitotic Agents|antimitotic agents|mesh-ancestor
5623874|NCT01771107|Mitosis Modulators|mitosis modulators|mesh-ancestor
5623875|NCT01720147|Quercetin|quercetin|mesh-list
5623876|NCT01720147|Antioxidants|antioxidants|mesh-ancestor
5746935|NCT03059979|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5746936|NCT03059979|Protective Agents|protective agents|mesh-ancestor
5746937|NCT03059979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5623877|NCT01720147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623878|NCT01720147|Protective Agents|protective agents|mesh-ancestor
5623879|NCT01720147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623880|NCT01718743|Lenalidomide|lenalidomide|mesh-list
5623881|NCT01718743|Ixazomib|ixazomib|mesh-list
5623882|NCT01718743|Glycine|glycine|mesh-list
5623883|NCT01718743|Immunologic Factors|immunologic factors|mesh-ancestor
5623884|NCT01718743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623885|NCT01718743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5623886|NCT01718743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5623887|NCT01718743|Growth Substances|growth substances|mesh-ancestor
5746938|NCT03059979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5746939|NCT03060044|Fluticasone|fluticasone|mesh-list
5746940|NCT03060044|Xhance|xhance|mesh-list
5746941|NCT03060044|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5746942|NCT03060044|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
5746943|NCT03060044|Charcoal|charcoal|mesh-list
5746944|NCT03060044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5623888|NCT01718743|Growth Inhibitors|growth inhibitors|mesh-ancestor
5623889|NCT01718743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5623890|NCT01718743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623891|NCT01718743|Protease Inhibitors|protease inhibitors|mesh-ancestor
5623892|NCT01718743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5623893|NCT01718743|Glycine Agents|glycine agents|mesh-ancestor
5623894|NCT01718743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5623895|NCT01694004|Benzocaine|benzocaine|mesh-list
5623896|NCT01694004|Anesthetics, Local|anesthetics, local|mesh-ancestor
5623897|NCT01694004|Anesthetics|anesthetics|mesh-ancestor
5746945|NCT03060044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5746946|NCT03060044|Autonomic Agents|autonomic agents|mesh-ancestor
5746947|NCT03060044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5746948|NCT03060044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746949|NCT03060044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5746950|NCT03060044|Respiratory System Agents|respiratory system agents|mesh-ancestor
5623898|NCT01694004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5623899|NCT01694004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623900|NCT01694004|Sensory System Agents|sensory system agents|mesh-ancestor
5623901|NCT01694004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5623902|NCT01566695|Azacitidine|azacitidine|mesh-list
5623903|NCT01566695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5623904|NCT01566695|Antimetabolites|antimetabolites|mesh-ancestor
5623905|NCT01566695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623906|NCT01566695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5623907|NCT01566695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5746951|NCT03060044|Dermatologic Agents|dermatologic agents|mesh-ancestor
5746952|NCT03060044|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5746953|NCT03060044|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5746954|NCT03060044|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5746955|NCT03060044|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5746956|NCT03060044|Adrenergic Agents|adrenergic agents|mesh-ancestor
5746957|NCT03060044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5746958|NCT03060044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5746959|NCT03060044|Glucocorticoids|glucocorticoids|mesh-ancestor
5746960|NCT03060044|Hormones|hormones|mesh-ancestor
5746961|NCT03060044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5746962|NCT03060044|Sympathomimetics|sympathomimetics|mesh-ancestor
5746963|NCT03060044|Antidotes|antidotes|mesh-ancestor
5746964|NCT03060044|Protective Agents|protective agents|mesh-ancestor
5746965|NCT03059719|Exenatide|exenatide|mesh-list
5746966|NCT03059719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5746967|NCT03059719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746968|NCT03059719|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5746969|NCT03059719|Incretins|incretins|mesh-ancestor
5746970|NCT03059719|Hormones|hormones|mesh-ancestor
5623908|NCT01491763|Imatinib Mesylate|imatinib mesylate|mesh-list
5623909|NCT01491763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5623910|NCT01491763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5623911|NCT01491763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5623912|NCT01491763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623913|NCT01412333|Interferons|interferons|mesh-list
5623914|NCT01412333|Interferon-beta|interferon-beta|mesh-list
5623915|NCT01412333|Interferon beta-1a|interferon beta-1a|mesh-list
5623916|NCT01412333|Ocrelizumab|ocrelizumab|mesh-list
5623917|NCT01412333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5623918|NCT01412333|Antiviral Agents|antiviral agents|mesh-ancestor
5623919|NCT01412333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5623920|NCT01412333|Immunologic Factors|immunologic factors|mesh-ancestor
5746971|NCT03059719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5746972|NCT03059862|Tryptophan|tryptophan|mesh-list
5746973|NCT03059862|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5746974|NCT03059862|Antidepressive Agents|antidepressive agents|mesh-ancestor
5746975|NCT03059862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5746976|NCT03060031|Oxytocin|oxytocin|mesh-list
5746977|NCT03060031|Oxytocics|oxytocics|mesh-ancestor
5746978|NCT03060031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5746979|NCT03060031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746980|NCT03060005|Dextrans|dextrans|mesh-list
5746981|NCT03060005|Anticoagulants|anticoagulants|mesh-ancestor
5746982|NCT03060005|Plasma Substitutes|plasma substitutes|mesh-ancestor
5623921|NCT01412333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623922|NCT01412333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5623923|NCT01376427|Dexamethasone|dexamethasone|mesh-list
5623924|NCT01376427|Methotrexate|methotrexate|mesh-list
5623925|NCT01376427|Vincristine|vincristine|mesh-list
5623926|NCT01376427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5623927|NCT01376427|Antiemetics|antiemetics|mesh-ancestor
5623928|NCT01376427|Autonomic Agents|autonomic agents|mesh-ancestor
5623929|NCT01376427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5623930|NCT01376427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623931|NCT01376427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5623932|NCT01376427|Glucocorticoids|glucocorticoids|mesh-ancestor
5623933|NCT01376427|Hormones|hormones|mesh-ancestor
5623934|NCT01376427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5623935|NCT01376427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5623936|NCT01376427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5623937|NCT01376427|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5623938|NCT01376427|Abortifacient Agents|abortifacient agents|mesh-ancestor
5623939|NCT01376427|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5623940|NCT01376427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5623941|NCT01376427|Antimetabolites|antimetabolites|mesh-ancestor
5623942|NCT01376427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623943|NCT01376427|Dermatologic Agents|dermatologic agents|mesh-ancestor
5623944|NCT01376427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5623945|NCT01376427|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5623946|NCT01376427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5746983|NCT03060005|Blood Substitutes|blood substitutes|mesh-ancestor
5746984|NCT03059940|Nicotine|nicotine|mesh-list
5746985|NCT03059940|Carbon Monoxide|carbon monoxide|mesh-list
5746986|NCT03059940|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5746987|NCT03059940|Autonomic Agents|autonomic agents|mesh-ancestor
5746988|NCT03059940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5746989|NCT03059940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5746990|NCT03059940|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5746991|NCT03059940|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5746992|NCT03059940|Cholinergic Agents|cholinergic agents|mesh-ancestor
5746993|NCT03059940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5746994|NCT03059940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5746995|NCT03059940|Antimetabolites|antimetabolites|mesh-ancestor
5746996|NCT03059940|Gasotransmitters|gasotransmitters|mesh-ancestor
5746997|NCT03059667|Carboplatin|carboplatin|mesh-list
5746998|NCT03059667|Etoposide|etoposide|mesh-list
5746999|NCT03059667|Atezolizumab|atezolizumab|mesh-list
5747000|NCT03059667|Topotecan|topotecan|mesh-list
5747001|NCT03059667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5747002|NCT03059667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5747003|NCT03059667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5623947|NCT01376427|Immunologic Factors|immunologic factors|mesh-ancestor
5623948|NCT01376427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5623949|NCT01376427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5623950|NCT01376427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5623951|NCT01376427|Tubulin Modulators|tubulin modulators|mesh-ancestor
5623952|NCT01376427|Antimitotic Agents|antimitotic agents|mesh-ancestor
5623953|NCT01376427|Mitosis Modulators|mitosis modulators|mesh-ancestor
5623954|NCT01366898|Methotrexate|methotrexate|mesh-list
5623955|NCT01366898|Idarubicin|idarubicin|mesh-list
5623956|NCT01366898|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5623957|NCT01366898|Abortifacient Agents|abortifacient agents|mesh-ancestor
5623958|NCT01366898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5623959|NCT01366898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623960|NCT01366898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5623961|NCT01366898|Antimetabolites|antimetabolites|mesh-ancestor
5623962|NCT01366898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623963|NCT01366898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5623964|NCT01366898|Dermatologic Agents|dermatologic agents|mesh-ancestor
5623965|NCT01366898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5623966|NCT01366898|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5623967|NCT01366898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5623968|NCT01366898|Immunologic Factors|immunologic factors|mesh-ancestor
5623969|NCT01366898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5623970|NCT01366898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5623971|NCT01366898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5623972|NCT01366898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5623973|NCT01366898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5623974|NCT01358201|Cytarabine|cytarabine|mesh-list
5623975|NCT01358201|Dexamethasone|dexamethasone|mesh-list
5623976|NCT01358201|Methotrexate|methotrexate|mesh-list
5623977|NCT01358201|Vincristine|vincristine|mesh-list
5623978|NCT01358201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5623979|NCT01358201|Antiemetics|antiemetics|mesh-ancestor
5623980|NCT01358201|Autonomic Agents|autonomic agents|mesh-ancestor
5623981|NCT01358201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5623982|NCT01358201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5623983|NCT01358201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5623984|NCT01358201|Glucocorticoids|glucocorticoids|mesh-ancestor
5623985|NCT01358201|Hormones|hormones|mesh-ancestor
5623986|NCT01358201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5623987|NCT01358201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5623988|NCT01358201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5623989|NCT01358201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5623990|NCT01358201|Abortifacient Agents|abortifacient agents|mesh-ancestor
5623991|NCT01358201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5623992|NCT01358201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5623993|NCT01358201|Antimetabolites|antimetabolites|mesh-ancestor
5623994|NCT01358201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5623995|NCT01358201|Dermatologic Agents|dermatologic agents|mesh-ancestor
5623996|NCT01358201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5747004|NCT03059667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5747005|NCT03059667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5747006|NCT03059667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5747007|NCT03059667|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5747008|NCT03059563|Varenicline|varenicline|mesh-list
5747009|NCT03059563|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5747010|NCT03059563|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5747011|NCT03059563|Cholinergic Agents|cholinergic agents|mesh-ancestor
5747012|NCT03059563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5747013|NCT03059563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5747014|NCT03059563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747015|NCT03059615|Doxorubicin|doxorubicin|mesh-list
5747016|NCT03059615|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5747017|NCT03059615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5747018|NCT03059615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5747019|NCT03059615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5747020|NCT03059615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5747021|NCT03059615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5747022|NCT03059277|Aflibercept|aflibercept|mesh-list
5747023|NCT03059277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5747024|NCT03059277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5747025|NCT03059277|Growth Substances|growth substances|mesh-ancestor
5747026|NCT03059277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747027|NCT03059277|Growth Inhibitors|growth inhibitors|mesh-ancestor
5747028|NCT03059277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5747029|NCT03059316|Labetalol|labetalol|mesh-list
5747030|NCT03059316|Nitroglycerin|nitroglycerin|mesh-list
5747031|NCT03059316|Vasodilator Agents|vasodilator agents|mesh-ancestor
5747032|NCT03059316|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5747033|NCT03059316|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5747034|NCT03059316|Adrenergic Agents|adrenergic agents|mesh-ancestor
5747035|NCT03059316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5747036|NCT03059316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5747037|NCT03059316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747038|NCT03059316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5747039|NCT03059316|Sympathomimetics|sympathomimetics|mesh-ancestor
5747040|NCT03059316|Autonomic Agents|autonomic agents|mesh-ancestor
5747041|NCT03059316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5747042|NCT03059316|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5747043|NCT03059316|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5623997|NCT01358201|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5623998|NCT01358201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5623999|NCT01358201|Immunologic Factors|immunologic factors|mesh-ancestor
5624000|NCT01358201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5624001|NCT01358201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5624002|NCT01358201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5624003|NCT01358201|Tubulin Modulators|tubulin modulators|mesh-ancestor
5624004|NCT01358201|Antimitotic Agents|antimitotic agents|mesh-ancestor
5624005|NCT01358201|Mitosis Modulators|mitosis modulators|mesh-ancestor
5624006|NCT01358201|Antiviral Agents|antiviral agents|mesh-ancestor
5624007|NCT01358201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5624008|NCT01338636|Ambrisentan|ambrisentan|mesh-list
5624009|NCT01338636|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5624010|NCT01308034|Sunitinib|sunitinib|mesh-list
5624011|NCT01308034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5624012|NCT01308034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5624013|NCT01308034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5624014|NCT01308034|Growth Substances|growth substances|mesh-ancestor
5747044|NCT03059303|Simeprevir|simeprevir|mesh-list
5747045|NCT03059303|Odalasvir|odalasvir|mesh-list
5747046|NCT03059303|Omeprazole|omeprazole|mesh-list
5747047|NCT03059303|Lansoprazole|lansoprazole|mesh-list
5747048|NCT03059303|Dexlansoprazole|dexlansoprazole|mesh-list
6489443|NCT00591708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489444|NCT00591916|Thrombin|thrombin|mesh-list
6489445|NCT00591916|Hyaluronic Acid|hyaluronic acid|mesh-list
5624015|NCT01308034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5624016|NCT01308034|Growth Inhibitors|growth inhibitors|mesh-ancestor
5624017|NCT01308034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5624018|NCT01308034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5624019|NCT01308034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5624020|NCT01253161|Pasireotide|pasireotide|mesh-list
6489446|NCT00591916|Hemostatics|hemostatics|mesh-ancestor
6489447|NCT00591916|Coagulants|coagulants|mesh-ancestor
5624021|NCT01253161|Hormones|hormones|mesh-ancestor
5624022|NCT01253161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5624023|NCT01253161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5624024|NCT01247324|Interferons|interferons|mesh-list
5624025|NCT01247324|Interferon-beta|interferon-beta|mesh-list
5624026|NCT01247324|Interferon beta-1a|interferon beta-1a|mesh-list
5624027|NCT01247324|Ocrelizumab|ocrelizumab|mesh-list
5624028|NCT01247324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6489448|NCT00591916|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5624029|NCT01247324|Antiviral Agents|antiviral agents|mesh-ancestor
6489449|NCT00591916|Immunologic Factors|immunologic factors|mesh-ancestor
5624030|NCT01247324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5624031|NCT01247324|Immunologic Factors|immunologic factors|mesh-ancestor
5624032|NCT01247324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5624033|NCT01247324|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5624034|NCT01149083|Carboplatin|carboplatin|mesh-list
5624035|NCT01149083|Veliparib|veliparib|mesh-list
5624036|NCT01149083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5624037|NCT01149083|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5624038|NCT01149083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5624039|NCT01149083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5624040|NCT01063517|Paclitaxel|paclitaxel|mesh-list
5624041|NCT01063517|Olaparib|olaparib|mesh-list
5624042|NCT01063517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5624043|NCT01063517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5624044|NCT01063517|Tubulin Modulators|tubulin modulators|mesh-ancestor
5624045|NCT01063517|Antimitotic Agents|antimitotic agents|mesh-ancestor
5624046|NCT01063517|Mitosis Modulators|mitosis modulators|mesh-ancestor
6489450|NCT00591916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747049|NCT03059303|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5747050|NCT03059303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5747051|NCT03059303|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5747052|NCT03059303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5747053|NCT03059303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5747054|NCT03059303|Antiviral Agents|antiviral agents|mesh-ancestor
5747055|NCT03059303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5747056|NCT03059303|Protease Inhibitors|protease inhibitors|mesh-ancestor
5747057|NCT03059537|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
5747058|NCT03059537|Cathartics|cathartics|mesh-ancestor
5747059|NCT03059537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5747060|NCT03059238|Celecoxib|celecoxib|mesh-list
5747061|NCT03059238|Parecoxib|parecoxib|mesh-list
5747062|NCT03059238|Oxycodone|oxycodone|mesh-list
5747063|NCT03059238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5747064|NCT03059238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5747065|NCT03059238|Analgesics|analgesics|mesh-ancestor
5747066|NCT03059238|Sensory System Agents|sensory system agents|mesh-ancestor
5747067|NCT03059238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5747068|NCT03059238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747069|NCT03059238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5624047|NCT01063517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5624048|NCT01063517|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5624049|NCT01063517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5624050|NCT00938912|Lacosamide|lacosamide|mesh-list
5747070|NCT03059238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5747071|NCT03059238|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5747072|NCT03059238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5747073|NCT03059238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5747074|NCT03059238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5747075|NCT03059238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5747076|NCT03059238|Narcotics|narcotics|mesh-ancestor
5747077|NCT03059238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5747078|NCT03059134|Mirabegron|mirabegron|mesh-list
5747079|NCT03059134|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
5624051|NCT00938912|Anticonvulsants|anticonvulsants|mesh-ancestor
5624052|NCT00938912|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5624053|NCT00938912|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5624054|NCT00938912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5624055|NCT00938912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5624056|NCT00925652|Cyclophosphamide|cyclophosphamide|mesh-list
5624057|NCT00925652|Bevacizumab|bevacizumab|mesh-list
5624058|NCT00925652|Methotrexate|methotrexate|mesh-list
5624059|NCT00925652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5747080|NCT03059134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5747081|NCT03059134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5747082|NCT03059134|Adrenergic Agents|adrenergic agents|mesh-ancestor
5747083|NCT03059134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5747084|NCT03059134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5747085|NCT03059134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747086|NCT03059134|Urological Agents|urological agents|mesh-ancestor
5747087|NCT03059147|Nivolumab|nivolumab|mesh-list
5747088|NCT03059147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5747089|NCT03059147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5747090|NCT03059147|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5624060|NCT00925652|Immunologic Factors|immunologic factors|mesh-ancestor
5624061|NCT00925652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747091|NCT03059147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5747092|NCT03058757|Mitomycins|mitomycins|mesh-list
5747093|NCT03058757|Mitomycin|mitomycin|mesh-list
5747094|NCT03058757|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5747095|NCT03058757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5747096|NCT03058757|Alkylating Agents|alkylating agents|mesh-ancestor
5747097|NCT03058757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5747098|NCT03058757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5747099|NCT03058757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5747100|NCT03058939|Tamoxifen|tamoxifen|mesh-list
5747101|NCT03058939|Paclitaxel|paclitaxel|mesh-list
5747102|NCT03058939|Carboplatin|carboplatin|mesh-list
5747103|NCT03058939|Trastuzumab|trastuzumab|mesh-list
5747104|NCT03058939|Letrozole|letrozole|mesh-list
5747105|NCT03058939|Pertuzumab|pertuzumab|mesh-list
5747106|NCT03058939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5747107|NCT03058939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5747108|NCT03058939|Tubulin Modulators|tubulin modulators|mesh-ancestor
5747109|NCT03058939|Antimitotic Agents|antimitotic agents|mesh-ancestor
5747110|NCT03058939|Mitosis Modulators|mitosis modulators|mesh-ancestor
5747111|NCT03058939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5747112|NCT03058939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5747113|NCT03058939|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5747114|NCT03058939|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5747115|NCT03058939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5747116|NCT03058939|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5747117|NCT03058939|Hormone Antagonists|hormone antagonists|mesh-ancestor
5747118|NCT03058939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5747119|NCT03058939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747120|NCT03058939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5747121|NCT03058939|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5747122|NCT03058939|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5747123|NCT03058939|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5747124|NCT03058978|Etonogestrel|etonogestrel|mesh-list
5747125|NCT03058978|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5747126|NCT03058978|Contraceptive Agents|contraceptive agents|mesh-ancestor
5747127|NCT03058978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5747128|NCT03058978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747129|NCT03058978|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5747130|NCT03059004|TEMPO|tempo|mesh-list
5624062|NCT00925652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5624063|NCT00925652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5624064|NCT00925652|Alkylating Agents|alkylating agents|mesh-ancestor
5624065|NCT00925652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5624066|NCT00925652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5624067|NCT00925652|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5624068|NCT00925652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5624069|NCT00925652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5624070|NCT00925652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5624071|NCT00925652|Growth Substances|growth substances|mesh-ancestor
5624072|NCT00925652|Growth Inhibitors|growth inhibitors|mesh-ancestor
5624073|NCT00925652|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5624074|NCT00925652|Abortifacient Agents|abortifacient agents|mesh-ancestor
5624075|NCT00925652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5747131|NCT03059004|Antioxidants|antioxidants|mesh-ancestor
5747132|NCT03059004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5747133|NCT03059004|Protective Agents|protective agents|mesh-ancestor
5747134|NCT03059004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747135|NCT03058900|Methotrexate|methotrexate|mesh-list
5747136|NCT03058900|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5747137|NCT03058900|Abortifacient Agents|abortifacient agents|mesh-ancestor
5747138|NCT03058900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5747139|NCT03058900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747140|NCT03058900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5747141|NCT03058900|Antimetabolites|antimetabolites|mesh-ancestor
5747142|NCT03058900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5747143|NCT03058900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5747144|NCT03058900|Dermatologic Agents|dermatologic agents|mesh-ancestor
5747145|NCT03058900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5747146|NCT03058900|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5747147|NCT03058900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5747148|NCT03058900|Immunologic Factors|immunologic factors|mesh-ancestor
5747149|NCT03058900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5747150|NCT03058900|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5747151|NCT03058835|Tenofovir|tenofovir|mesh-list
5747152|NCT03058835|Emtricitabine|emtricitabine|mesh-list
5747153|NCT03058835|Antiviral Agents|antiviral agents|mesh-ancestor
5747154|NCT03058835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5747155|NCT03058835|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5747156|NCT03058835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5747157|NCT03058835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5747158|NCT03058835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5747159|NCT03058835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5747160|NCT03058835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5747161|NCT03059017|Albuterol|albuterol|mesh-list
5747162|NCT03059017|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5747163|NCT03059017|Autonomic Agents|autonomic agents|mesh-ancestor
5747164|NCT03059017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5747165|NCT03059017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747166|NCT03059017|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5747167|NCT03059017|Respiratory System Agents|respiratory system agents|mesh-ancestor
5747168|NCT03059017|Tocolytic Agents|tocolytic agents|mesh-ancestor
5747169|NCT03059017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5624076|NCT00925652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5747170|NCT03059017|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5747171|NCT03059017|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5747172|NCT03059017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5747173|NCT03059017|Adrenergic Agents|adrenergic agents|mesh-ancestor
5624077|NCT00925652|Antimetabolites|antimetabolites|mesh-ancestor
5624078|NCT00925652|Dermatologic Agents|dermatologic agents|mesh-ancestor
5624079|NCT00925652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5624080|NCT00925652|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5624081|NCT00925652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5624082|NCT00792948|Calcium, Dietary|calcium, dietary|mesh-list
5624083|NCT00792948|Leucovorin|leucovorin|mesh-list
5624084|NCT00792948|Folic Acid|folic acid|mesh-list
5624085|NCT00792948|Cytarabine|cytarabine|mesh-list
5624086|NCT00792948|Sirolimus|sirolimus|mesh-list
5624087|NCT00792948|Dexamethasone|dexamethasone|mesh-list
5624088|NCT00792948|Dexamethasone acetate|dexamethasone acetate|mesh-list
5747174|NCT03059017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5747175|NCT03059017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894193|NCT05120076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894194|NCT05120076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5894195|NCT05120076|Glucocorticoids|glucocorticoids|mesh-ancestor
5894196|NCT05120076|Hormones|hormones|mesh-ancestor
5894197|NCT05120076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5894198|NCT05120076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5894199|NCT05120076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5894200|NCT05119712|Terbinafine|terbinafine|mesh-list
5894201|NCT05119712|Antifungal Agents|antifungal agents|mesh-ancestor
5894202|NCT05119712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5894203|NCT05119712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5894204|NCT05119712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894205|NCT05119452|Adalimumab|adalimumab|mesh-list
5894206|NCT05119452|Etanercept|etanercept|mesh-list
5894207|NCT05119452|Golimumab|golimumab|mesh-list
5894208|NCT05119452|Infliximab|infliximab|mesh-list
5894209|NCT05119452|Certolizumab Pegol|certolizumab pegol|mesh-list
5894210|NCT05119452|Antirheumatic Agents|antirheumatic agents|mesh-list
5894211|NCT05119452|Tofacitinib|tofacitinib|mesh-list
5894212|NCT05119452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5894213|NCT05119452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5894214|NCT05119452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5894215|NCT05119452|Analgesics|analgesics|mesh-ancestor
5894216|NCT05119452|Sensory System Agents|sensory system agents|mesh-ancestor
5894217|NCT05119452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5894218|NCT05119452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5624089|NCT00792948|Prednisone|prednisone|mesh-list
5624090|NCT00792948|Methylprednisolone|methylprednisolone|mesh-list
5894219|NCT05119452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5894220|NCT05119452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6489451|NCT00591916|Viscosupplements|viscosupplements|mesh-ancestor
5747176|NCT03058744|Clobetasol|clobetasol|mesh-list
5747177|NCT03058744|Halobetasol|halobetasol|mesh-list
5747178|NCT03058744|Tazarotene|tazarotene|mesh-list
5747179|NCT03058744|Dermatologic Agents|dermatologic agents|mesh-ancestor
5747180|NCT03058744|Keratolytic Agents|keratolytic agents|mesh-ancestor
5747181|NCT03058744|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5747182|NCT03058744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5624091|NCT00792948|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5624092|NCT00792948|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5624093|NCT00792948|Prednisolone|prednisolone|mesh-list
5624094|NCT00792948|Prednisolone acetate|prednisolone acetate|mesh-list
5624095|NCT00792948|Cortisone|cortisone|mesh-list
5624096|NCT00792948|Cyclophosphamide|cyclophosphamide|mesh-list
5624097|NCT00792948|Doxorubicin|doxorubicin|mesh-list
5624098|NCT00792948|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5624099|NCT00792948|Methotrexate|methotrexate|mesh-list
5747183|NCT03058744|Glucocorticoids|glucocorticoids|mesh-ancestor
5747184|NCT03058744|Hormones|hormones|mesh-ancestor
5747185|NCT03058744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5747186|NCT03058744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747187|NCT03059251|Obinutuzumab|obinutuzumab|mesh-list
5747188|NCT03059251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5747189|NCT03059251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5747190|NCT03059056|Empagliflozin|empagliflozin|mesh-list
5747191|NCT03059056|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5747192|NCT03059056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5747193|NCT03059056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5747194|NCT03059056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747195|NCT03058666|Calfactant|calfactant|mesh-list
5747196|NCT03058666|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
5747197|NCT03058666|Respiratory System Agents|respiratory system agents|mesh-ancestor
5747198|NCT03058354|Propofol|propofol|mesh-list
5747199|NCT03058354|Anesthetics|anesthetics|mesh-ancestor
5747200|NCT03058354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5747201|NCT03058354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747202|NCT03058354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5624100|NCT00792948|Etoposide|etoposide|mesh-list
5624101|NCT00792948|Vincristine|vincristine|mesh-list
5624102|NCT00792948|Etoposide phosphate|etoposide phosphate|mesh-list
5624103|NCT00792948|Dasatinib|dasatinib|mesh-list
5624104|NCT00792948|Podophyllotoxin|podophyllotoxin|mesh-list
5624105|NCT00792948|Tacrolimus|tacrolimus|mesh-list
5624106|NCT00792948|Lenograstim|lenograstim|mesh-list
5624107|NCT00792948|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5624108|NCT00792948|Prednisolone phosphate|prednisolone phosphate|mesh-list
5624109|NCT00792948|BB 1101|bb 1101|mesh-list
5624110|NCT00792948|Calcium|calcium|mesh-list
5624111|NCT00792948|Levoleucovorin|levoleucovorin|mesh-list
5624112|NCT00792948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5624113|NCT00792948|Immunologic Factors|immunologic factors|mesh-ancestor
5624114|NCT00792948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5624115|NCT00792948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5747203|NCT03058354|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5747204|NCT03058354|Anesthetics, General|anesthetics, general|mesh-ancestor
5747205|NCT03058419|Midazolam|midazolam|mesh-list
5747206|NCT03058419|Dextromethorphan|dextromethorphan|mesh-list
5747207|NCT03058419|Caffeine|caffeine|mesh-list
5747208|NCT03058419|Bupropion|bupropion|mesh-list
5747209|NCT03058419|Omeprazole|omeprazole|mesh-list
5747210|NCT03058419|Warfarin|warfarin|mesh-list
5747211|NCT03058419|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5747212|NCT03058419|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5747213|NCT03058419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5747214|NCT03058419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747215|NCT03058419|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5747216|NCT03058419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5624116|NCT00792948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5624117|NCT00792948|Alkylating Agents|alkylating agents|mesh-ancestor
5624118|NCT00792948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5624119|NCT00792948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5624120|NCT00792948|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5624121|NCT00792948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5624122|NCT00792948|Antiemetics|antiemetics|mesh-ancestor
5624123|NCT00792948|Autonomic Agents|autonomic agents|mesh-ancestor
5747217|NCT03058419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5624124|NCT00792948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5624125|NCT00792948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5624126|NCT00792948|Glucocorticoids|glucocorticoids|mesh-ancestor
5624127|NCT00792948|Hormones|hormones|mesh-ancestor
5697739|NCT03374007|Immunoglobulins|immunoglobulins|mesh-list
5747218|NCT03058419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5747219|NCT03058419|Anesthetics, General|anesthetics, general|mesh-ancestor
5747220|NCT03058419|Anesthetics|anesthetics|mesh-ancestor
5747221|NCT03058419|GABA Modulators|gaba modulators|mesh-ancestor
5747222|NCT03058419|GABA Agents|gaba agents|mesh-ancestor
5747223|NCT03058419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5747224|NCT03058419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5747225|NCT03058419|Anticoagulants|anticoagulants|mesh-ancestor
5747226|NCT03058419|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5747227|NCT03058419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5747228|NCT03058419|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5747229|NCT03058419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5747230|NCT03058419|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5747231|NCT03058419|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5747232|NCT03058419|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5747233|NCT03058419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5747234|NCT03058419|Purinergic Agents|purinergic agents|mesh-ancestor
5747235|NCT03058419|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5747236|NCT03058419|Antidepressive Agents|antidepressive agents|mesh-ancestor
5747237|NCT03058419|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5747238|NCT03058419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5747239|NCT03058419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5747240|NCT03058419|Dopamine Agents|dopamine agents|mesh-ancestor
5747241|NCT03058419|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5747242|NCT03058419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5747243|NCT03058419|Antitussive Agents|antitussive agents|mesh-ancestor
5747244|NCT03058419|Respiratory System Agents|respiratory system agents|mesh-ancestor
5747245|NCT03058419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5747246|NCT03058419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5747247|NCT03058536|Progesterone|progesterone|mesh-list
5747248|NCT03058536|Progestins|progestins|mesh-ancestor
5747249|NCT03058536|Hormones|hormones|mesh-ancestor
5747250|NCT03058536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5747251|NCT03058536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747252|NCT03058341|Propofol|propofol|mesh-list
5747253|NCT03058341|Sevoflurane|sevoflurane|mesh-list
5747254|NCT03058341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5747255|NCT03058341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5747256|NCT03058341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747257|NCT03058341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5747258|NCT03058341|Anesthetics, General|anesthetics, general|mesh-ancestor
5747259|NCT03058341|Anesthetics|anesthetics|mesh-ancestor
5747260|NCT03058341|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5747261|NCT03058341|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5624128|NCT00792948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5624129|NCT00792948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5624130|NCT00792948|Protease Inhibitors|protease inhibitors|mesh-ancestor
5624131|NCT00792948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5624132|NCT00792948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5624133|NCT00792948|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5624134|NCT00792948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5624135|NCT00792948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5624136|NCT00792948|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5624137|NCT00792948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5624138|NCT00792948|Abortifacient Agents|abortifacient agents|mesh-ancestor
5624139|NCT00792948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5624140|NCT00792948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5624141|NCT00792948|Antimetabolites|antimetabolites|mesh-ancestor
5624142|NCT00792948|Dermatologic Agents|dermatologic agents|mesh-ancestor
5624143|NCT00792948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5624144|NCT00792948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5624145|NCT00792948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5747262|NCT03058289|Pembrolizumab|pembrolizumab|mesh-list
5747263|NCT03058289|Ipilimumab|ipilimumab|mesh-list
5747264|NCT03058289|Antibodies|antibodies|mesh-list
5747265|NCT03058289|Immunoglobulins|immunoglobulins|mesh-list
5747266|NCT03058289|Immunologic Factors|immunologic factors|mesh-ancestor
5747267|NCT03058289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747268|NCT03058289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5747269|NCT03058289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5747270|NCT03058289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5747271|NCT03058289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5747272|NCT03058471|Methotrexate|methotrexate|mesh-list
5894221|NCT05119452|Immunologic Factors|immunologic factors|mesh-ancestor
5747273|NCT03058471|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5747274|NCT03058471|Abortifacient Agents|abortifacient agents|mesh-ancestor
5747275|NCT03058471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5747276|NCT03058471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747277|NCT03058471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5747278|NCT03058471|Antimetabolites|antimetabolites|mesh-ancestor
5747279|NCT03058471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5747280|NCT03058471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5747281|NCT03058471|Dermatologic Agents|dermatologic agents|mesh-ancestor
5747282|NCT03058471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5747283|NCT03058471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5747284|NCT03058471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5747285|NCT03058471|Immunologic Factors|immunologic factors|mesh-ancestor
5747286|NCT03058471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5747287|NCT03058471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5747288|NCT03058263|Neostigmine|neostigmine|mesh-list
5624146|NCT00792948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5624147|NCT00792948|Antiviral Agents|antiviral agents|mesh-ancestor
5624148|NCT00792948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5624149|NCT00792948|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5624150|NCT00792948|Antidotes|antidotes|mesh-ancestor
5624151|NCT00792948|Protective Agents|protective agents|mesh-ancestor
5624152|NCT00792948|Vitamin B Complex|vitamin b complex|mesh-ancestor
5624153|NCT00792948|Vitamins|vitamins|mesh-ancestor
5624154|NCT00792948|Micronutrients|micronutrients|mesh-ancestor
5624155|NCT00792948|Tubulin Modulators|tubulin modulators|mesh-ancestor
5624156|NCT00792948|Antimitotic Agents|antimitotic agents|mesh-ancestor
5624157|NCT00792948|Mitosis Modulators|mitosis modulators|mesh-ancestor
5624158|NCT00792948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5747289|NCT03058263|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5747290|NCT03058263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5747291|NCT03058263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5747292|NCT03058263|Cholinergic Agents|cholinergic agents|mesh-ancestor
5747293|NCT03058263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5747294|NCT03058263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5624159|NCT00792948|Antifungal Agents|antifungal agents|mesh-ancestor
5624160|NCT00792948|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5624161|NCT00792948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5624162|NCT00792948|Hematinics|hematinics|mesh-ancestor
5624163|NCT00792948|Keratolytic Agents|keratolytic agents|mesh-ancestor
5624164|NCT00700258|Sirolimus|sirolimus|mesh-list
5624165|NCT00700258|Sunitinib|sunitinib|mesh-list
5624166|NCT00700258|Axitinib|axitinib|mesh-list
5747295|NCT03058263|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6672924|NCT01559285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6672925|NCT01559285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672926|NCT01559285|Sensory System Agents|sensory system agents|mesh-ancestor
6672927|NCT01559285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6672928|NCT01559298|Aspirin|aspirin|mesh-list
6672929|NCT01559298|Clopidogrel|clopidogrel|mesh-list
6672930|NCT01559298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5624167|NCT00700258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5747296|NCT03058263|Autonomic Agents|autonomic agents|mesh-ancestor
5747297|NCT03058263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5747298|NCT03058224|Acetaminophen|acetaminophen|mesh-list
5747299|NCT03058224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5747300|NCT03058224|Analgesics|analgesics|mesh-ancestor
5747301|NCT03058224|Sensory System Agents|sensory system agents|mesh-ancestor
5747302|NCT03058224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5747303|NCT03058224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747304|NCT03058224|Antipyretics|antipyretics|mesh-ancestor
5747305|NCT03058237|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
5747306|NCT03058237|Baclofen|baclofen|mesh-list
5747307|NCT03058237|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5747308|NCT03058237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747309|NCT03058237|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5747310|NCT03058237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5747311|NCT03058237|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
5747312|NCT03058237|GABA Agonists|gaba agonists|mesh-ancestor
5747313|NCT03058237|GABA Agents|gaba agents|mesh-ancestor
5747314|NCT03058237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5747315|NCT03058237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5747316|NCT03058094|Pemetrexed|pemetrexed|mesh-list
5747317|NCT03058094|Abivertinib|abivertinib|mesh-list
5624168|NCT00700258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5624169|NCT00700258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5747318|NCT03058094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5747319|NCT03058094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5747320|NCT03058094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5747321|NCT03058094|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5747322|NCT03058094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5747323|NCT03058094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5747324|NCT03057990|Pyrimethamine|pyrimethamine|mesh-list
5747325|NCT03057990|Antimalarials|antimalarials|mesh-ancestor
5747326|NCT03057990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5747327|NCT03057990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5747328|NCT03057990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5747329|NCT03057990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5747330|NCT03057990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5747331|NCT03057990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5747332|NCT03057951|Empagliflozin|empagliflozin|mesh-list
5747333|NCT03057951|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5747334|NCT03057951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5624170|NCT00700258|Growth Substances|growth substances|mesh-ancestor
5624171|NCT00700258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5624172|NCT00700258|Growth Inhibitors|growth inhibitors|mesh-ancestor
5747335|NCT03057951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5747336|NCT03057951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747337|NCT03057847|Sofosbuvir|sofosbuvir|mesh-list
5747338|NCT03057847|Velpatasvir|velpatasvir|mesh-list
5747339|NCT03057847|Antiviral Agents|antiviral agents|mesh-ancestor
5747340|NCT03057847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5747341|NCT03057769|Indomethacin|indomethacin|mesh-list
5747342|NCT03057769|Epinephrine|epinephrine|mesh-list
5747343|NCT03057769|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6489452|NCT00591916|Protective Agents|protective agents|mesh-ancestor
6489453|NCT00591994|Piribedil|piribedil|mesh-list
6489454|NCT00591994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5624173|NCT00700258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5624174|NCT00700258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5624175|NCT00700258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489455|NCT00591994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6489456|NCT00591994|Dopamine Agonists|dopamine agonists|mesh-ancestor
6489457|NCT00591994|Dopamine Agents|dopamine agents|mesh-ancestor
6489458|NCT00591994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6489459|NCT00591994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489460|NCT00591994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5624176|NCT00700258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5624177|NCT00700258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5624178|NCT00700258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5624179|NCT00700258|Antifungal Agents|antifungal agents|mesh-ancestor
5624180|NCT00700258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5624181|NCT00700258|Immunologic Factors|immunologic factors|mesh-ancestor
5624182|NCT00676715|Interferons|interferons|mesh-list
5624183|NCT00676715|Interferon-beta|interferon-beta|mesh-list
6489461|NCT00592111|Prednisone|prednisone|mesh-list
6489462|NCT00592111|Cyclophosphamide|cyclophosphamide|mesh-list
6489463|NCT00592111|Etoposide|etoposide|mesh-list
6489464|NCT00592111|Vincristine|vincristine|mesh-list
6489465|NCT00592111|Doxorubicin|doxorubicin|mesh-list
5624184|NCT00676715|Ocrelizumab|ocrelizumab|mesh-list
5747344|NCT03057769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5747345|NCT03057769|Adrenergic Agents|adrenergic agents|mesh-ancestor
5747346|NCT03057769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5747347|NCT03057769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5747348|NCT03057769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747349|NCT03057769|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5747350|NCT03057769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5747351|NCT03057769|Autonomic Agents|autonomic agents|mesh-ancestor
5747352|NCT03057769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5747353|NCT03057769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5747354|NCT03057769|Respiratory System Agents|respiratory system agents|mesh-ancestor
5747355|NCT03057769|Mydriatics|mydriatics|mesh-ancestor
5747356|NCT03057769|Sympathomimetics|sympathomimetics|mesh-ancestor
5747357|NCT03057769|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5747358|NCT03057769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5747359|NCT03057769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5747360|NCT03057769|Analgesics|analgesics|mesh-ancestor
5747361|NCT03057769|Sensory System Agents|sensory system agents|mesh-ancestor
5747362|NCT03057769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5747363|NCT03057769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6489466|NCT00592111|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6489467|NCT00592111|Bleomycin|bleomycin|mesh-list
6489468|NCT00592111|Vinblastine|vinblastine|mesh-list
5747364|NCT03057769|Gout Suppressants|gout suppressants|mesh-ancestor
5747365|NCT03057769|Tocolytic Agents|tocolytic agents|mesh-ancestor
5747366|NCT03057769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5747367|NCT03057769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5747368|NCT03057769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5747369|NCT03057821|Hydrogen Peroxide|hydrogen peroxide|mesh-list
5747370|NCT03057821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5747371|NCT03057821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5747372|NCT03057691|Antidepressive Agents|antidepressive agents|mesh-list
5747373|NCT03057691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5747374|NCT03057509|Octreotide|octreotide|mesh-list
5747375|NCT03057509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5747376|NCT03057509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5747377|NCT03057509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5747378|NCT03057483|Vaccines|vaccines|mesh-list
5747379|NCT03057483|Immunologic Factors|immunologic factors|mesh-ancestor
5747380|NCT03057483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894222|NCT05119452|Dermatologic Agents|dermatologic agents|mesh-ancestor
5894223|NCT05119452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5894224|NCT05119452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5894225|NCT05119452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894226|NCT05119452|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
5624185|NCT00676715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5624186|NCT00676715|Antiviral Agents|antiviral agents|mesh-ancestor
5624187|NCT00676715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5624188|NCT00676715|Immunologic Factors|immunologic factors|mesh-ancestor
5624189|NCT00676715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5624190|NCT00604617|Interferons|interferons|mesh-list
5894227|NCT05119439|Misoprostol|misoprostol|mesh-list
5894228|NCT05119439|Mifepristone|mifepristone|mesh-list
5894229|NCT05119439|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5894230|NCT05119439|Abortifacient Agents|abortifacient agents|mesh-ancestor
5894231|NCT05119439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5894232|NCT05119439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894233|NCT05119439|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5894234|NCT05119439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5894235|NCT05119439|Oxytocics|oxytocics|mesh-ancestor
5894236|NCT05119439|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5894237|NCT05119439|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5894238|NCT05119439|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5894239|NCT05119439|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5894240|NCT05119439|Contraceptive Agents|contraceptive agents|mesh-ancestor
5894241|NCT05119439|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5894242|NCT05119439|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5894243|NCT05119439|Hormone Antagonists|hormone antagonists|mesh-ancestor
5894244|NCT05119439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5894245|NCT05119439|Luteolytic Agents|luteolytic agents|mesh-ancestor
5894246|NCT05119439|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5894247|NCT05119439|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5894248|NCT05119257|Antibodies|antibodies|mesh-list
5894249|NCT05119257|Antibodies, Bispecific|antibodies, bispecific|mesh-list
5894250|NCT05119257|Immunologic Factors|immunologic factors|mesh-ancestor
5894251|NCT05119257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894252|NCT05112263|Cyclosporine|cyclosporine|mesh-list
5894253|NCT05112263|Cyclosporins|cyclosporins|mesh-list
5894254|NCT05112263|Tofacitinib|tofacitinib|mesh-list
5894255|NCT05112263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5894256|NCT05112263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894257|NCT05112263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5894258|NCT05112263|Immunologic Factors|immunologic factors|mesh-ancestor
5894259|NCT05112263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894260|NCT05112263|Antifungal Agents|antifungal agents|mesh-ancestor
5894261|NCT05112263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5894262|NCT05112263|Dermatologic Agents|dermatologic agents|mesh-ancestor
5894263|NCT05112263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5894264|NCT05112263|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5624191|NCT00604617|Interferon-gamma|interferon-gamma|mesh-list
5624192|NCT00604617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5624193|NCT00604617|Antiviral Agents|antiviral agents|mesh-ancestor
5624194|NCT00604617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5624195|NCT00579826|Letrozole|letrozole|mesh-list
5624196|NCT00579826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5624197|NCT00579826|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5624198|NCT00579826|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5624199|NCT00579826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5624200|NCT00579826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5624201|NCT00579826|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5624202|NCT00579826|Hormone Antagonists|hormone antagonists|mesh-ancestor
5624203|NCT00579826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5624204|NCT00579826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5624205|NCT00365157|Halichondrin B|halichondrin b|mesh-list
5624206|NCT00365157|Tubulin Modulators|tubulin modulators|mesh-ancestor
5624207|NCT00365157|Antimitotic Agents|antimitotic agents|mesh-ancestor
5624208|NCT00365157|Mitosis Modulators|mitosis modulators|mesh-ancestor
5624209|NCT00365157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5624210|NCT00365157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5624211|NCT00186888|Cyclophosphamide|cyclophosphamide|mesh-list
5624212|NCT00186888|Carboplatin|carboplatin|mesh-list
5624213|NCT00186888|Doxorubicin|doxorubicin|mesh-list
5624214|NCT00186888|Etoposide|etoposide|mesh-list
5747381|NCT03057470|Insulin|insulin|mesh-list
5747382|NCT03057470|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5747383|NCT03057470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5747384|NCT03057470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747385|NCT03057314|Calcium Carbonate|calcium carbonate|mesh-list
5747386|NCT03057314|Calcium|calcium|mesh-list
5747387|NCT03057314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5747388|NCT03057314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747389|NCT03057314|Antacids|antacids|mesh-ancestor
5747390|NCT03057314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5747391|NCT03057314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5747392|NCT03057574|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5747393|NCT03057574|Hormones|hormones|mesh-ancestor
5747394|NCT03057574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5747395|NCT03057574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747396|NCT03057561|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
5747397|NCT03057561|Chelating Agents|chelating agents|mesh-ancestor
5624215|NCT00186888|Etoposide phosphate|etoposide phosphate|mesh-list
5624216|NCT00186888|Vincristine|vincristine|mesh-list
5624217|NCT00186888|Topotecan|topotecan|mesh-list
5624218|NCT00186888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5624219|NCT00186888|Immunologic Factors|immunologic factors|mesh-ancestor
5624220|NCT00186888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5624221|NCT00186888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5624222|NCT00186888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5624223|NCT00186888|Alkylating Agents|alkylating agents|mesh-ancestor
5624224|NCT00186888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5624225|NCT00186888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5624226|NCT00186888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5624227|NCT00186888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5697740|NCT03374007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5697741|NCT03374007|Immunologic Factors|immunologic factors|mesh-ancestor
5697742|NCT03374007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697743|NCT03374007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5697744|NCT03373994|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5697745|NCT03373994|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5697746|NCT03373994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697747|NCT03373955|Pembrolizumab|pembrolizumab|mesh-list
5697748|NCT03373955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5697749|NCT03373955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5697750|NCT03373903|Everolimus|everolimus|mesh-list
5697751|NCT03373903|Dactolisib|dactolisib|mesh-list
5697752|NCT03373903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5697753|NCT03373903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5697754|NCT03373903|Immunologic Factors|immunologic factors|mesh-ancestor
5697755|NCT03373903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697756|NCT03373877|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
5697757|NCT03373877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5697758|NCT03373864|Anesthetics|anesthetics|mesh-list
5697759|NCT03373864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5697760|NCT03373864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697761|NCT03373851|Sufentanil|sufentanil|mesh-list
5697762|NCT03373851|Dsuvia|dsuvia|mesh-list
5697763|NCT03373851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5697764|NCT03373851|Narcotics|narcotics|mesh-ancestor
5697765|NCT03373851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5697766|NCT03373851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697767|NCT03373851|Analgesics|analgesics|mesh-ancestor
5697768|NCT03373851|Sensory System Agents|sensory system agents|mesh-ancestor
5747398|NCT03057561|Sequestering Agents|sequestering agents|mesh-ancestor
5747399|NCT03057561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5747400|NCT03057145|Olaparib|olaparib|mesh-list
5624228|NCT00186888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5624229|NCT00186888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5624230|NCT00186888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5624231|NCT00186888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5624232|NCT00186888|Tubulin Modulators|tubulin modulators|mesh-ancestor
5624233|NCT00186888|Antimitotic Agents|antimitotic agents|mesh-ancestor
5624234|NCT00186888|Mitosis Modulators|mitosis modulators|mesh-ancestor
5624235|NCT00186888|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5624236|NCT00001563|Rituximab|rituximab|mesh-list
5624237|NCT00001563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5624238|NCT00001563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5624239|NCT00001563|Immunologic Factors|immunologic factors|mesh-ancestor
5624240|NCT00001563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5624241|NCT00001563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5624242|NCT05200559|Pembrolizumab|pembrolizumab|mesh-list
5624243|NCT05200559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5624244|NCT05200559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5624245|NCT05200481|Carboplatin|carboplatin|mesh-list
5624246|NCT05200481|Pemetrexed|pemetrexed|mesh-list
5624247|NCT05200481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5747401|NCT03057145|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5747402|NCT03057145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5747403|NCT03057145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5747404|NCT03057145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5747405|NCT03057041|Fentanyl|fentanyl|mesh-list
5747406|NCT03057041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5747407|NCT03057041|Narcotics|narcotics|mesh-ancestor
5747408|NCT03057041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5747409|NCT03057041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747410|NCT03057041|Analgesics|analgesics|mesh-ancestor
5747411|NCT03057041|Sensory System Agents|sensory system agents|mesh-ancestor
5747412|NCT03057041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5747413|NCT03057041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5747414|NCT03057041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5747415|NCT03057041|Anesthetics, General|anesthetics, general|mesh-ancestor
5747416|NCT03057041|Anesthetics|anesthetics|mesh-ancestor
5747417|NCT03056846|Sulfalene|sulfalene|mesh-list
5747418|NCT03056846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5747419|NCT03056846|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5747420|NCT03056846|Renal Agents|renal agents|mesh-ancestor
5747421|NCT03056846|Antimalarials|antimalarials|mesh-ancestor
5747422|NCT03056846|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5747423|NCT03056846|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5747424|NCT03057015|Dexamethasone|dexamethasone|mesh-list
5747425|NCT03057015|Clonidine|clonidine|mesh-list
5747426|NCT03057015|Epinephrine|epinephrine|mesh-list
5747427|NCT03057015|Ropivacaine|ropivacaine|mesh-list
5624248|NCT05200481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5624249|NCT05200481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5624250|NCT05200481|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5624251|NCT05200481|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5624252|NCT05200442|Cetuximab|cetuximab|mesh-list
5624253|NCT05200442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5624254|NCT05200442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5624255|NCT05200429|Ivacaftor|ivacaftor|mesh-list
5624256|NCT05200429|Elexacaftor|elexacaftor|mesh-list
5624257|NCT05200429|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
5624258|NCT05200429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5624259|NCT05200429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5747428|NCT03057015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5747429|NCT03057015|Antiemetics|antiemetics|mesh-ancestor
5747430|NCT03057015|Autonomic Agents|autonomic agents|mesh-ancestor
5747431|NCT03057015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5747432|NCT03057015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747433|NCT03057015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5747434|NCT03057015|Glucocorticoids|glucocorticoids|mesh-ancestor
5747435|NCT03057015|Hormones|hormones|mesh-ancestor
5747436|NCT03057015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5747437|NCT03057015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5747438|NCT03057015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5747439|NCT03057015|Anesthetics, Local|anesthetics, local|mesh-ancestor
5747440|NCT03057015|Anesthetics|anesthetics|mesh-ancestor
5747441|NCT03057015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5747442|NCT03057015|Sensory System Agents|sensory system agents|mesh-ancestor
5747443|NCT03057015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5747444|NCT03057015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5747445|NCT03057015|Adrenergic Agents|adrenergic agents|mesh-ancestor
5747446|NCT03057015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5747447|NCT03057015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5747448|NCT03057015|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5747449|NCT03057015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5747450|NCT03057015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5747451|NCT03057015|Respiratory System Agents|respiratory system agents|mesh-ancestor
5747452|NCT03057015|Mydriatics|mydriatics|mesh-ancestor
5747453|NCT03057015|Sympathomimetics|sympathomimetics|mesh-ancestor
5747454|NCT03057015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5747455|NCT03057015|Analgesics|analgesics|mesh-ancestor
5624260|NCT05200364|Bevacizumab|bevacizumab|mesh-list
5624261|NCT05200364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5624262|NCT05200364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5624263|NCT05200364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5624264|NCT05200364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5624265|NCT05200364|Growth Substances|growth substances|mesh-ancestor
5624266|NCT05200364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5624267|NCT05200364|Growth Inhibitors|growth inhibitors|mesh-ancestor
5624268|NCT05200299|Leucovorin|leucovorin|mesh-list
5624269|NCT05200299|Fluorouracil|fluorouracil|mesh-list
5624270|NCT05200299|Capecitabine|capecitabine|mesh-list
5624271|NCT05200299|Oxaliplatin|oxaliplatin|mesh-list
5624272|NCT05200299|Irinotecan|irinotecan|mesh-list
5624273|NCT05200299|Levoleucovorin|levoleucovorin|mesh-list
5747456|NCT03057015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5747457|NCT03057015|Sympatholytics|sympatholytics|mesh-ancestor
5747458|NCT03057015|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5747459|NCT03056924|Vaccines|vaccines|mesh-list
5747460|NCT03056924|Immunologic Factors|immunologic factors|mesh-ancestor
5747461|NCT03056924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747462|NCT03056833|Paclitaxel|paclitaxel|mesh-list
5747463|NCT03056833|Carboplatin|carboplatin|mesh-list
5747464|NCT03056833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5747465|NCT03056833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5747466|NCT03056833|Tubulin Modulators|tubulin modulators|mesh-ancestor
5747467|NCT03056833|Antimitotic Agents|antimitotic agents|mesh-ancestor
5747468|NCT03056833|Mitosis Modulators|mitosis modulators|mesh-ancestor
5747469|NCT03056833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5747470|NCT03057028|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5747471|NCT03057028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5747472|NCT03056495|Vorinostat|vorinostat|mesh-list
5747473|NCT03056495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5747474|NCT03056495|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5747475|NCT03056495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5624274|NCT05200299|Antimetabolites|antimetabolites|mesh-ancestor
5624275|NCT05200299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5624276|NCT05200299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5624277|NCT05200299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5624278|NCT05200299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5624279|NCT05200299|Immunologic Factors|immunologic factors|mesh-ancestor
5624280|NCT05200299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747476|NCT03056495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5747477|NCT03056625|Vitamin A|vitamin a|mesh-list
5747478|NCT03056625|Vitamins|vitamins|mesh-ancestor
5747479|NCT03056625|Micronutrients|micronutrients|mesh-ancestor
5747480|NCT03056625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747481|NCT03056703|Aspirin|aspirin|mesh-list
5747482|NCT03056703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5747483|NCT03056703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5747484|NCT03056703|Analgesics|analgesics|mesh-ancestor
5747485|NCT03056703|Sensory System Agents|sensory system agents|mesh-ancestor
5747486|NCT03056703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5747487|NCT03056703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747488|NCT03056703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5624281|NCT05200299|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5624282|NCT05200299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5624283|NCT05200299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5624284|NCT05200299|Antidotes|antidotes|mesh-ancestor
5624285|NCT05200299|Protective Agents|protective agents|mesh-ancestor
5747489|NCT03056703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5747490|NCT03056703|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5747491|NCT03056703|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5624286|NCT05200299|Vitamin B Complex|vitamin b complex|mesh-ancestor
5624287|NCT05200299|Vitamins|vitamins|mesh-ancestor
5624288|NCT05200299|Micronutrients|micronutrients|mesh-ancestor
5624289|NCT05200286|Olorofim|olorofim|mesh-list
5624290|NCT05200286|Antifungal Agents|antifungal agents|mesh-ancestor
5747492|NCT03056703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5747493|NCT03056703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5747494|NCT03056703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5747495|NCT03056703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5747496|NCT03056703|Antipyretics|antipyretics|mesh-ancestor
5747497|NCT03056482|Haloperidol|haloperidol|mesh-list
5747498|NCT03056482|Ondansetron|ondansetron|mesh-list
5747499|NCT03056482|Haloperidol decanoate|haloperidol decanoate|mesh-list
5747500|NCT03056482|Antiemetics|antiemetics|mesh-ancestor
5747501|NCT03056482|Autonomic Agents|autonomic agents|mesh-ancestor
5747502|NCT03056482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5747503|NCT03056482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747504|NCT03056482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5747505|NCT03056482|Antipruritics|antipruritics|mesh-ancestor
5747506|NCT03056482|Dermatologic Agents|dermatologic agents|mesh-ancestor
5747507|NCT03056482|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5747508|NCT03056482|Serotonin Agents|serotonin agents|mesh-ancestor
5747509|NCT03056482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5747510|NCT03056482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5747511|NCT03056482|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5747512|NCT03056482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5747513|NCT03056482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5747514|NCT03056482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5747515|NCT03056482|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5747516|NCT03056482|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5624291|NCT05200286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5624292|NCT05200260|Niraparib|niraparib|mesh-list
5624293|NCT05200260|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
5624294|NCT05200260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5624295|NCT05200260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5624296|NCT05200260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5624297|NCT05200156|Choline|choline|mesh-list
5624298|NCT05200156|Lipotropic Agents|lipotropic agents|mesh-ancestor
5624299|NCT05200156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5624300|NCT05200156|Antimetabolites|antimetabolites|mesh-ancestor
5624301|NCT05200156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5624302|NCT05200156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5624303|NCT05200156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5624304|NCT05200156|Nootropic Agents|nootropic agents|mesh-ancestor
5624305|NCT05199909|Zanubrutinib|zanubrutinib|mesh-list
5624306|NCT05199909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5624307|NCT05199909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5747517|NCT03056482|Dopamine Agents|dopamine agents|mesh-ancestor
5747518|NCT03056482|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5747519|NCT03056599|Gemcitabine|gemcitabine|mesh-list
5624308|NCT05199909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5624309|NCT05199909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5624310|NCT05199818|Palonosetron|palonosetron|mesh-list
5624311|NCT05199818|Antiemetics|antiemetics|mesh-ancestor
5624312|NCT05199818|Autonomic Agents|autonomic agents|mesh-ancestor
5624313|NCT05199818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5624314|NCT05199818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5624315|NCT05199818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5624316|NCT05199818|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5624317|NCT05199818|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5747520|NCT03056599|Interferons|interferons|mesh-list
5747521|NCT03056599|Interferon-alpha|interferon-alpha|mesh-list
5624318|NCT05199818|Serotonin Agents|serotonin agents|mesh-ancestor
5624319|NCT05199818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5624320|NCT05199818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5624321|NCT05199727|Tadalafil|tadalafil|mesh-list
5624322|NCT05199727|Vasodilator Agents|vasodilator agents|mesh-ancestor
5624323|NCT05199727|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5624324|NCT05199727|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5624325|NCT05199727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5624326|NCT05199727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5624327|NCT05199727|Urological Agents|urological agents|mesh-ancestor
5747522|NCT03056599|Interferon alpha-2|interferon alpha-2|mesh-list
5747523|NCT03056599|Aldesleukin|aldesleukin|mesh-list
5747524|NCT03056599|Interferon-gamma|interferon-gamma|mesh-list
5747525|NCT03056599|Docetaxel|docetaxel|mesh-list
5747526|NCT03056599|Doxorubicin|doxorubicin|mesh-list
5747527|NCT03056599|Pembrolizumab|pembrolizumab|mesh-list
5747528|NCT03056599|Nivolumab|nivolumab|mesh-list
5747529|NCT03056599|Bortezomib|bortezomib|mesh-list
5747530|NCT03056599|Ipilimumab|ipilimumab|mesh-list
5747531|NCT03056599|Durvalumab|durvalumab|mesh-list
5747532|NCT03056599|Atezolizumab|atezolizumab|mesh-list
5747533|NCT03056599|Avelumab|avelumab|mesh-list
5747534|NCT03056599|Trabectedin|trabectedin|mesh-list
5747535|NCT03056599|Olaratumab|olaratumab|mesh-list
5747536|NCT03056599|Entrectinib|entrectinib|mesh-list
5747537|NCT03056599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5747538|NCT03056599|Antimetabolites|antimetabolites|mesh-ancestor
6489469|NCT00592111|Procarbazine|procarbazine|mesh-list
6489470|NCT00592111|Mitogens|mitogens|mesh-list
6489471|NCT00592111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5747539|NCT03056599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5747540|NCT03056599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5747541|NCT03056599|Antiviral Agents|antiviral agents|mesh-ancestor
5747542|NCT03056599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5747543|NCT03056599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5624328|NCT05199714|Pramlintide|pramlintide|mesh-list
5624329|NCT05199714|Pancrelipase|pancrelipase|mesh-list
5624330|NCT05199714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5624331|NCT05199714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5624332|NCT05199714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5624333|NCT05199597|Atropine|atropine|mesh-list
5624334|NCT05199597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5624335|NCT05199597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5624336|NCT05199597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5624337|NCT05199597|Autonomic Agents|autonomic agents|mesh-ancestor
5624338|NCT05199597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5624339|NCT05199597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5624340|NCT05199597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5624341|NCT05199597|Respiratory System Agents|respiratory system agents|mesh-ancestor
5624342|NCT05199597|Mydriatics|mydriatics|mesh-ancestor
5624343|NCT05199597|Parasympatholytics|parasympatholytics|mesh-ancestor
5624344|NCT05199597|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5624345|NCT05199597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5624346|NCT05199597|Cholinergic Agents|cholinergic agents|mesh-ancestor
5624347|NCT05199597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5624348|NCT05199597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5624349|NCT05199571|Ofatumumab|ofatumumab|mesh-list
5624350|NCT05199571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5624351|NCT05199324|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5747544|NCT03056599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5747545|NCT03056599|Immunologic Factors|immunologic factors|mesh-ancestor
5747546|NCT03056599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747547|NCT03056599|Tubulin Modulators|tubulin modulators|mesh-ancestor
5747548|NCT03056599|Antimitotic Agents|antimitotic agents|mesh-ancestor
5747549|NCT03056599|Mitosis Modulators|mitosis modulators|mesh-ancestor
5747550|NCT03056599|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5747551|NCT03056599|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5747552|NCT03056599|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5747553|NCT03056599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5747554|NCT03056599|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5747555|NCT03056599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5747556|NCT03056599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5747557|NCT03056599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5624352|NCT05199324|Ciprofloxacin|ciprofloxacin|mesh-list
5624353|NCT05199324|Cefazolin|cefazolin|mesh-list
5624354|NCT05199324|Ceftriaxone|ceftriaxone|mesh-list
5747558|NCT03056599|Alkylating Agents|alkylating agents|mesh-ancestor
5747559|NCT03056599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5747560|NCT03056391|Acetaminophen|acetaminophen|mesh-list
5747561|NCT03056391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5747562|NCT03056391|Analgesics|analgesics|mesh-ancestor
5624355|NCT05199324|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
5624356|NCT05199324|Fluoroquinolones|fluoroquinolones|mesh-list
5624357|NCT05199324|Trimethoprim|trimethoprim|mesh-list
5624358|NCT05199324|Sulfamethoxazole|sulfamethoxazole|mesh-list
5624359|NCT05199324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5624360|NCT05199324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5624361|NCT05199324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5624362|NCT05199324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5624363|NCT05199324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5624364|NCT05199324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5624365|NCT05199324|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5624366|NCT05199324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5747563|NCT03056391|Sensory System Agents|sensory system agents|mesh-ancestor
5747564|NCT03056391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5747565|NCT03056391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747566|NCT03056391|Antipyretics|antipyretics|mesh-ancestor
5747567|NCT03056014|Acetylcysteine|acetylcysteine|mesh-list
5747568|NCT03056014|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5747569|NCT03056014|Antiviral Agents|antiviral agents|mesh-ancestor
5747570|NCT03056014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5747571|NCT03056014|Expectorants|expectorants|mesh-ancestor
5747572|NCT03056014|Respiratory System Agents|respiratory system agents|mesh-ancestor
5747573|NCT03056014|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5747574|NCT03056014|Antioxidants|antioxidants|mesh-ancestor
5747575|NCT03056014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5747576|NCT03056014|Protective Agents|protective agents|mesh-ancestor
5747577|NCT03056014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747578|NCT03056014|Antidotes|antidotes|mesh-ancestor
5747579|NCT03056274|Metformin|metformin|mesh-list
5747580|NCT03056274|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
5747581|NCT03056274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5747582|NCT03056274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747583|NCT03056274|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5747584|NCT03056274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5747585|NCT03056118|Aspirin|aspirin|mesh-list
5747586|NCT03056118|Clopidogrel|clopidogrel|mesh-list
5747587|NCT03056118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5747588|NCT03056118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5747589|NCT03056118|Analgesics|analgesics|mesh-ancestor
5747590|NCT03056118|Sensory System Agents|sensory system agents|mesh-ancestor
5747591|NCT03056118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5747592|NCT03056118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747593|NCT03056118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5747594|NCT03056118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5747595|NCT03056118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5747596|NCT03056118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5747597|NCT03056118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5747598|NCT03056118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5747599|NCT03056118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5747600|NCT03056118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5747601|NCT03056118|Antipyretics|antipyretics|mesh-ancestor
5747602|NCT03056118|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5747603|NCT03056118|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5747604|NCT03056118|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5747605|NCT03056118|Purinergic Agents|purinergic agents|mesh-ancestor
5747606|NCT03056118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5747607|NCT03056079|Aflibercept|aflibercept|mesh-list
5747608|NCT03056079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5747609|NCT03056079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5747610|NCT03056079|Growth Substances|growth substances|mesh-ancestor
5747611|NCT03056079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747612|NCT03056079|Growth Inhibitors|growth inhibitors|mesh-ancestor
5747613|NCT03056079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5747614|NCT03056053|Zolpidem|zolpidem|mesh-list
5747615|NCT03056053|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5747616|NCT03056053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5747617|NCT03056053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5747618|NCT03056053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747619|NCT03056053|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
5747620|NCT03056053|GABA Agonists|gaba agonists|mesh-ancestor
5747621|NCT03056053|GABA Agents|gaba agents|mesh-ancestor
5747622|NCT03056053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5747623|NCT03056053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5747624|NCT03056261|Anesthetics|anesthetics|mesh-list
5624367|NCT05199324|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5624368|NCT05199324|Renal Agents|renal agents|mesh-ancestor
5624369|NCT05199324|Antimalarials|antimalarials|mesh-ancestor
5624370|NCT05199324|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5624371|NCT05199324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5624372|NCT05199324|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5624373|NCT05199324|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5624374|NCT05199324|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
5624375|NCT05199324|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5624376|NCT05199311|Dexamethasone|dexamethasone|mesh-list
5624377|NCT05199311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5624378|NCT05199311|Antiemetics|antiemetics|mesh-ancestor
5624379|NCT05199311|Autonomic Agents|autonomic agents|mesh-ancestor
5624380|NCT05199311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5624381|NCT05199311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5624382|NCT05199311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5747625|NCT03056261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5747626|NCT03056261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747627|NCT03056092|Ranibizumab|ranibizumab|mesh-list
5747628|NCT03056092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5747629|NCT03056092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5747630|NCT03056092|Growth Substances|growth substances|mesh-ancestor
5747631|NCT03056092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747632|NCT03056092|Growth Inhibitors|growth inhibitors|mesh-ancestor
5747633|NCT03056092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5747634|NCT03056248|Lithium Carbonate|lithium carbonate|mesh-list
5747635|NCT03056248|Antidepressive Agents|antidepressive agents|mesh-ancestor
5747636|NCT03056248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5747637|NCT03056248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5747638|NCT03056248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5747639|NCT03056248|Antimanic Agents|antimanic agents|mesh-ancestor
5747640|NCT03056248|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5747641|NCT03056248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5747642|NCT03056248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747643|NCT03055663|Midazolam|midazolam|mesh-list
5624383|NCT05199311|Glucocorticoids|glucocorticoids|mesh-ancestor
5624384|NCT05199311|Hormones|hormones|mesh-ancestor
5624385|NCT05199311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5624386|NCT05199311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5624387|NCT05199311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5747644|NCT03055663|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
5747645|NCT03055663|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5747646|NCT03055663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5747647|NCT03055663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747648|NCT03055663|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5747649|NCT03055663|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5747650|NCT03055663|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5747651|NCT03055663|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5747652|NCT03055663|Anesthetics, General|anesthetics, general|mesh-ancestor
5747653|NCT03055663|Anesthetics|anesthetics|mesh-ancestor
5747654|NCT03055663|GABA Modulators|gaba modulators|mesh-ancestor
5747655|NCT03055663|GABA Agents|gaba agents|mesh-ancestor
5747656|NCT03055663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5747657|NCT03055663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5747658|NCT03055741|Donepezil|donepezil|mesh-list
5747659|NCT03055741|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5747660|NCT03055741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5747661|NCT03055741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5747662|NCT03055741|Cholinergic Agents|cholinergic agents|mesh-ancestor
5747663|NCT03055741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5747664|NCT03055741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747665|NCT03055741|Nootropic Agents|nootropic agents|mesh-ancestor
5894265|NCT05112263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5894266|NCT05108155|Tacrine|tacrine|mesh-list
5894267|NCT05108155|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5894268|NCT05108155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5894269|NCT05108155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894270|NCT05108155|Cholinergic Agents|cholinergic agents|mesh-ancestor
5624388|NCT05199103|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5624389|NCT05199103|Thymoglobulin|thymoglobulin|mesh-list
5624390|NCT05199103|Immunologic Factors|immunologic factors|mesh-ancestor
5624391|NCT05199103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5624392|NCT05199103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5624393|NCT05199051|Cytarabine|cytarabine|mesh-list
5624394|NCT05199051|Gemtuzumab|gemtuzumab|mesh-list
6489472|NCT00592111|Immunologic Factors|immunologic factors|mesh-ancestor
6489473|NCT00592111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489474|NCT00592111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6489475|NCT00592111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5624395|NCT05199051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5624396|NCT05199051|Antimetabolites|antimetabolites|mesh-ancestor
5624397|NCT05199051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5624398|NCT05199051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5624399|NCT05199051|Antiviral Agents|antiviral agents|mesh-ancestor
5624400|NCT05199051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5624401|NCT05199051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5624402|NCT05199051|Immunologic Factors|immunologic factors|mesh-ancestor
5624403|NCT05199051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5624404|NCT05199051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5624405|NCT05199038|Octreotide|octreotide|mesh-list
5624406|NCT05199038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5624407|NCT05199038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5624408|NCT05199038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5624409|NCT05198960|Aspirin|aspirin|mesh-list
5624410|NCT05198960|Anticoagulants|anticoagulants|mesh-list
5624411|NCT05198960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5624412|NCT05198960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5624413|NCT05198960|Analgesics|analgesics|mesh-ancestor
5624414|NCT05198960|Sensory System Agents|sensory system agents|mesh-ancestor
5624415|NCT05198960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5624416|NCT05198960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5624417|NCT05198960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5624418|NCT05198960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5624419|NCT05198960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5624420|NCT05198960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5624421|NCT05198960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5624422|NCT05198960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5624423|NCT05198960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5624424|NCT05198960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5624425|NCT05198960|Antipyretics|antipyretics|mesh-ancestor
5624426|NCT05198947|Ivermectin|ivermectin|mesh-list
5624427|NCT05198947|Permethrin|permethrin|mesh-list
5624428|NCT05198947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5624429|NCT05198947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5624430|NCT05198947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5624431|NCT05198947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5624432|NCT05198856|Thalidomide|thalidomide|mesh-list
5624433|NCT05198856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6489476|NCT00592111|Alkylating Agents|alkylating agents|mesh-ancestor
5747666|NCT03055767|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5747667|NCT03055767|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5747668|NCT03055767|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5747669|NCT03055767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5747670|NCT03055767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747671|NCT03055767|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5747672|NCT03055767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5747673|NCT03055767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5747674|NCT03055767|Cholinergic Agents|cholinergic agents|mesh-ancestor
5747675|NCT03055767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5747676|NCT03055793|Budesonide|budesonide|mesh-list
5747677|NCT03055793|Formoterol Fumarate|formoterol fumarate|mesh-list
5747678|NCT03055793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5747679|NCT03055793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5747680|NCT03055793|Autonomic Agents|autonomic agents|mesh-ancestor
5747681|NCT03055793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5747682|NCT03055793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747683|NCT03055793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5747684|NCT03055793|Respiratory System Agents|respiratory system agents|mesh-ancestor
5747685|NCT03055793|Glucocorticoids|glucocorticoids|mesh-ancestor
5747686|NCT03055793|Hormones|hormones|mesh-ancestor
5747687|NCT03055793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5747688|NCT03055793|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5747689|NCT03055793|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5747690|NCT03055793|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5747691|NCT03055793|Adrenergic Agents|adrenergic agents|mesh-ancestor
5747692|NCT03055793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5747693|NCT03055793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5624434|NCT05198856|Immunologic Factors|immunologic factors|mesh-ancestor
5747694|NCT03055546|Oxytocin|oxytocin|mesh-list
5747695|NCT03055546|Oxytocics|oxytocics|mesh-ancestor
5747696|NCT03055546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5747697|NCT03055546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747698|NCT03055507|Acetaminophen|acetaminophen|mesh-list
5747699|NCT03055507|Ibuprofen|ibuprofen|mesh-list
5747700|NCT03055507|Oxycodone|oxycodone|mesh-list
5747701|NCT03055507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5747702|NCT03055507|Analgesics|analgesics|mesh-ancestor
5747703|NCT03055507|Sensory System Agents|sensory system agents|mesh-ancestor
5747704|NCT03055507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5747705|NCT03055507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747706|NCT03055507|Antipyretics|antipyretics|mesh-ancestor
5747707|NCT03055507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5747708|NCT03055507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5747709|NCT03055507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5747710|NCT03055507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5747711|NCT03055507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5747712|NCT03055507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5747713|NCT03055507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5747714|NCT03055507|Narcotics|narcotics|mesh-ancestor
5747715|NCT03055507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5747716|NCT03055234|Treprostinil|treprostinil|mesh-list
5747717|NCT03055234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5747718|NCT03055312|Bicalutamide|bicalutamide|mesh-list
5747719|NCT03055312|Androgen Antagonists|androgen antagonists|mesh-ancestor
5747720|NCT03055312|Hormone Antagonists|hormone antagonists|mesh-ancestor
5747721|NCT03055312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5747722|NCT03055312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747723|NCT03055312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5747724|NCT03055390|Scopolamine|scopolamine|mesh-list
5747725|NCT03055390|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
5747726|NCT03055390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5747727|NCT03055390|Antiemetics|antiemetics|mesh-ancestor
5747728|NCT03055390|Autonomic Agents|autonomic agents|mesh-ancestor
5747729|NCT03055390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5747730|NCT03055390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747731|NCT03055390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5747732|NCT03055390|Mydriatics|mydriatics|mesh-ancestor
5747733|NCT03055390|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5747734|NCT03055390|Cholinergic Agents|cholinergic agents|mesh-ancestor
5747735|NCT03055390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5747736|NCT03055390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5747737|NCT03055390|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5747738|NCT03055390|Parasympatholytics|parasympatholytics|mesh-ancestor
5747739|NCT03055247|Ibuprofen|ibuprofen|mesh-list
5747740|NCT03055247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5747741|NCT03055247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5747742|NCT03055247|Analgesics|analgesics|mesh-ancestor
5747743|NCT03055247|Sensory System Agents|sensory system agents|mesh-ancestor
5747744|NCT03055247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5747745|NCT03055247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747746|NCT03055247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5747747|NCT03055247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5747748|NCT03055247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5747749|NCT03055247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5747750|NCT03055247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5747751|NCT03055442|Inositol|inositol|mesh-list
5747752|NCT03055442|Vitamin B Complex|vitamin b complex|mesh-ancestor
5747753|NCT03055442|Vitamins|vitamins|mesh-ancestor
5624435|NCT05198856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5624436|NCT05198856|Leprostatic Agents|leprostatic agents|mesh-ancestor
5624437|NCT05198856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5624438|NCT05198856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5624439|NCT05198856|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5624440|NCT05198856|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5624441|NCT05198856|Growth Substances|growth substances|mesh-ancestor
5624442|NCT05198856|Growth Inhibitors|growth inhibitors|mesh-ancestor
5624443|NCT05198856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5747754|NCT03055442|Micronutrients|micronutrients|mesh-ancestor
5747755|NCT03055442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747756|NCT03055377|Acetylcysteine|acetylcysteine|mesh-list
5747757|NCT03055377|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5747758|NCT03055377|Antiviral Agents|antiviral agents|mesh-ancestor
5624444|NCT05198843|Dasatinib|dasatinib|mesh-list
5747759|NCT03055377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5747760|NCT03055377|Expectorants|expectorants|mesh-ancestor
5747761|NCT03055377|Respiratory System Agents|respiratory system agents|mesh-ancestor
5747762|NCT03055377|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5747763|NCT03055377|Antioxidants|antioxidants|mesh-ancestor
5747764|NCT03055377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5747765|NCT03055377|Protective Agents|protective agents|mesh-ancestor
5747766|NCT03055377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747767|NCT03055377|Antidotes|antidotes|mesh-ancestor
5747768|NCT03055091|Sorbitol|sorbitol|mesh-list
5624445|NCT05198843|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
5624446|NCT05198843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5624447|NCT05198843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5624448|NCT05198843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5624449|NCT05198843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5624450|NCT05198843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5624451|NCT05198843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5624452|NCT05198830|Cisplatin|cisplatin|mesh-list
5624453|NCT05198830|Pemetrexed|pemetrexed|mesh-list
5624454|NCT05198830|Durvalumab|durvalumab|mesh-list
5624455|NCT05198830|Immunoglobulins|immunoglobulins|mesh-list
5624456|NCT05198830|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5624457|NCT05198830|Immunoglobulin G|immunoglobulin g|mesh-list
5624458|NCT05198830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5624459|NCT05198830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5624460|NCT05198830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5624461|NCT05198830|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5624462|NCT05198830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5624463|NCT05198830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5624464|NCT05198830|Immunologic Factors|immunologic factors|mesh-ancestor
5624465|NCT05198830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5624466|NCT05198609|Apatinib|apatinib|mesh-list
5624467|NCT05198609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5624468|NCT05198609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5624469|NCT05198609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5624470|NCT05198609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692854|NCT03405090|Sensory System Agents|sensory system agents|mesh-ancestor
5692855|NCT03405090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5692856|NCT03405090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5692857|NCT03405090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5692858|NCT03405090|Anesthetics, General|anesthetics, general|mesh-ancestor
5692859|NCT03405090|Anesthetics|anesthetics|mesh-ancestor
5692860|NCT03405090|Autonomic Agents|autonomic agents|mesh-ancestor
5692861|NCT03405090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5692862|NCT03405090|Respiratory System Agents|respiratory system agents|mesh-ancestor
5692863|NCT03405064|Linezolid|linezolid|mesh-list
5692864|NCT03405064|Levonadifloxacin|levonadifloxacin|mesh-list
5692865|NCT03405064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5692866|NCT03405064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5692867|NCT03405064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5692868|NCT03405064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5692869|NCT03405064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692870|NCT03404947|Ethanol|ethanol|mesh-list
5692871|NCT03404947|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5692872|NCT03404947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5692873|NCT03404947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5747769|NCT03055091|Cathartics|cathartics|mesh-ancestor
5747770|NCT03055091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5747771|NCT03055026|Rivaroxaban|rivaroxaban|mesh-list
5747772|NCT03055026|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5747773|NCT03055026|Antithrombins|antithrombins|mesh-ancestor
5747774|NCT03055026|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5747775|NCT03055026|Protease Inhibitors|protease inhibitors|mesh-ancestor
5747776|NCT03055026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5747777|NCT03055026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5747778|NCT03055026|Anticoagulants|anticoagulants|mesh-ancestor
5747779|NCT03054896|Venetoclax|venetoclax|mesh-list
5747780|NCT03054896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5747781|NCT03054948|SMOFlipid|smoflipid|mesh-list
5747782|NCT03054948|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
5747783|NCT03054948|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5747784|NCT03054948|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5747785|NCT03054831|Oxycodone|oxycodone|mesh-list
5747786|NCT03054831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5747787|NCT03054831|Narcotics|narcotics|mesh-ancestor
5747788|NCT03054831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5747789|NCT03054831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747790|NCT03054831|Analgesics|analgesics|mesh-ancestor
5624471|NCT05198180|Hydrogen Peroxide|hydrogen peroxide|mesh-list
5624472|NCT05198180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5624473|NCT05198180|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5624474|NCT05198180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5624475|NCT05198141|Letrozole|letrozole|mesh-list
5624476|NCT05198141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5624477|NCT05198141|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5624478|NCT05198141|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5624479|NCT05198141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5624480|NCT05198141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5624481|NCT05198141|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5624482|NCT05198141|Hormone Antagonists|hormone antagonists|mesh-ancestor
5624483|NCT05198141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5624484|NCT05198141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5624485|NCT05198050|Letrozole|letrozole|mesh-list
5624486|NCT05198050|Alprostadil|alprostadil|mesh-list
5624487|NCT05198050|Misoprostol|misoprostol|mesh-list
5624488|NCT05198050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5624489|NCT05198050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5624490|NCT05198050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5624491|NCT05198050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5624492|NCT05198050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5624493|NCT05198050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5624494|NCT05198050|Hormone Antagonists|hormone antagonists|mesh-ancestor
5624495|NCT05198050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5624496|NCT05198050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5624497|NCT05198050|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5624498|NCT05198050|Abortifacient Agents|abortifacient agents|mesh-ancestor
5624499|NCT05198050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5624500|NCT05198050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5624501|NCT05198050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5624502|NCT05198050|Oxytocics|oxytocics|mesh-ancestor
5624503|NCT05198050|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5624504|NCT05198050|Vasodilator Agents|vasodilator agents|mesh-ancestor
5624505|NCT05198050|Urological Agents|urological agents|mesh-ancestor
6208730|NCT02135094|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6208731|NCT02135094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6208732|NCT02135094|Adrenergic Agents|adrenergic agents|mesh-ancestor
6208733|NCT02135094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6208734|NCT02135094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208735|NCT02135094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208736|NCT02135094|Sympathomimetics|sympathomimetics|mesh-ancestor
6208737|NCT02135094|Autonomic Agents|autonomic agents|mesh-ancestor
6208738|NCT02135094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6208739|NCT02135094|Nasal Decongestants|nasal decongestants|mesh-ancestor
6208740|NCT02135094|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6208741|NCT02135094|Respiratory System Agents|respiratory system agents|mesh-ancestor
6208742|NCT02135107|Rabeprazole|rabeprazole|mesh-list
6208743|NCT02135107|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6208744|NCT02135107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6208745|NCT02135107|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5624522|NCT05197517|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5624523|NCT05197517|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5624524|NCT05197517|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5624525|NCT05197517|Antimetabolites|antimetabolites|mesh-ancestor
5624526|NCT05197517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5624527|NCT05197517|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5624528|NCT05197517|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5624529|NCT05197517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5624530|NCT05188898|Hyaluronic Acid|hyaluronic acid|mesh-list
5624531|NCT05188898|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5624532|NCT05188898|Immunologic Factors|immunologic factors|mesh-ancestor
5624533|NCT05188898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5624534|NCT05188898|Viscosupplements|viscosupplements|mesh-ancestor
5624535|NCT05188898|Protective Agents|protective agents|mesh-ancestor
5624536|NCT05184920|Nicotine|nicotine|mesh-list
5624537|NCT05184920|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5624538|NCT05184920|Autonomic Agents|autonomic agents|mesh-ancestor
5624539|NCT05184920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5624540|NCT05184920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5624541|NCT05184920|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5624542|NCT05184920|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5624543|NCT05184920|Cholinergic Agents|cholinergic agents|mesh-ancestor
6208746|NCT02135107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5747791|NCT03054831|Sensory System Agents|sensory system agents|mesh-ancestor
5747792|NCT03054831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5624544|NCT05184920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5624545|NCT05184920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208747|NCT02135107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208748|NCT02135146|Plasma-lyte 148|plasma-lyte 148|mesh-list
6208749|NCT02135146|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6208750|NCT02135146|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6208751|NCT02135432|Ivacaftor|ivacaftor|mesh-list
5624552|NCT05178225|Ubiquinone|ubiquinone|mesh-list
5624553|NCT05178225|Coenzyme Q10|coenzyme q10|mesh-list
5624554|NCT05178225|Anticoagulants|anticoagulants|mesh-list
5624555|NCT05178225|Micronutrients|micronutrients|mesh-ancestor
5747793|NCT03054766|Ranibizumab|ranibizumab|mesh-list
5747794|NCT03054766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5747795|NCT03054766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5747796|NCT03054766|Growth Substances|growth substances|mesh-ancestor
5747797|NCT03054766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747798|NCT03054766|Growth Inhibitors|growth inhibitors|mesh-ancestor
5747799|NCT03054766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5747800|NCT03054662|Hemostatics|hemostatics|mesh-list
5747801|NCT03054662|Coagulants|coagulants|mesh-ancestor
5747802|NCT03054610|Betamethasone|betamethasone|mesh-list
5747803|NCT03054610|Betamethasone Valerate|betamethasone valerate|mesh-list
5747804|NCT03054610|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5747805|NCT03054610|Betamethasone benzoate|betamethasone benzoate|mesh-list
5747806|NCT03054610|Ropivacaine|ropivacaine|mesh-list
5747807|NCT03054610|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
5747808|NCT03054610|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5747809|NCT03054610|Botulinum Toxins|botulinum toxins|mesh-list
5747810|NCT03054610|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5747811|NCT03054610|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
5747812|NCT03054610|Anesthetics, Local|anesthetics, local|mesh-ancestor
5747813|NCT03054610|Anesthetics|anesthetics|mesh-ancestor
5747814|NCT03054610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5747815|NCT03054610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747816|NCT03054610|Sensory System Agents|sensory system agents|mesh-ancestor
5747817|NCT03054610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5747818|NCT03054610|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5747819|NCT03054610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5747820|NCT03054610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5747821|NCT03054610|Cholinergic Agents|cholinergic agents|mesh-ancestor
5747822|NCT03054610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5747823|NCT03054610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5747824|NCT03054610|Glucocorticoids|glucocorticoids|mesh-ancestor
5747825|NCT03054610|Hormones|hormones|mesh-ancestor
5747826|NCT03054610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5747827|NCT03054610|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5747828|NCT03054610|Respiratory System Agents|respiratory system agents|mesh-ancestor
5747829|NCT03054610|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5747830|NCT03054610|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5624556|NCT05178225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5624557|NCT05178225|Vitamins|vitamins|mesh-ancestor
5624558|NCT05178173|Ethanol|ethanol|mesh-list
5624559|NCT05178173|Cetylpyridinium|cetylpyridinium|mesh-list
5624560|NCT05178173|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5624561|NCT05178173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5624562|NCT05178173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5624563|NCT05178173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5624564|NCT05177484|Ferric maltol|ferric maltol|mesh-list
5624565|NCT05177484|Hematinics|hematinics|mesh-ancestor
5624566|NCT05162443|Adagrasib|adagrasib|mesh-list
5624567|NCT05162443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5624568|NCT05139849|Methylprednisolone|methylprednisolone|mesh-list
5624569|NCT05139849|Hydrocortisone|hydrocortisone|mesh-list
5624570|NCT05139849|Vasopressins|vasopressins|mesh-list
5624571|NCT05139849|Arginine Vasopressin|arginine vasopressin|mesh-list
5624572|NCT05139849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5624573|NCT05139849|Antiemetics|antiemetics|mesh-ancestor
5624574|NCT05139849|Autonomic Agents|autonomic agents|mesh-ancestor
5747831|NCT03054610|Autonomic Agents|autonomic agents|mesh-ancestor
5747832|NCT03054532|Durvalumab|durvalumab|mesh-list
5747833|NCT03054532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5624575|NCT05139849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5747834|NCT03054532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5624576|NCT05139849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747835|NCT03054480|Botulinum Toxins|botulinum toxins|mesh-list
5747836|NCT03054480|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5747837|NCT03054480|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5747838|NCT03054480|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5747839|NCT03054480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5747840|NCT03054480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5747841|NCT03054480|Cholinergic Agents|cholinergic agents|mesh-ancestor
5747842|NCT03054480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5747843|NCT03054480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747844|NCT03054480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5747845|NCT03054480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5747846|NCT03054207|Clopidogrel|clopidogrel|mesh-list
5624577|NCT05139849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5624578|NCT05139849|Glucocorticoids|glucocorticoids|mesh-ancestor
5624579|NCT05139849|Hormones|hormones|mesh-ancestor
5624580|NCT05139849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5624581|NCT05139849|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5624582|NCT05139849|Protective Agents|protective agents|mesh-ancestor
5624583|NCT05139849|Hemostatics|hemostatics|mesh-ancestor
5624584|NCT05139849|Coagulants|coagulants|mesh-ancestor
5747847|NCT03054207|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
5747848|NCT03054207|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5747849|NCT03054207|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5747850|NCT03054207|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5747851|NCT03054207|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5747852|NCT03054207|Purinergic Agents|purinergic agents|mesh-ancestor
5747853|NCT03054207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5747854|NCT03054207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5747855|NCT03054207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747856|NCT03054285|Levetiracetam|levetiracetam|mesh-list
5747857|NCT03054285|Anticonvulsants|anticonvulsants|mesh-ancestor
5747858|NCT03054285|Nootropic Agents|nootropic agents|mesh-ancestor
5747859|NCT03054467|Amlodipine|amlodipine|mesh-list
5747860|NCT03054467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5747861|NCT03054467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5747862|NCT03054467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5747863|NCT03054467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5747864|NCT03054467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5747865|NCT03054467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747866|NCT03054467|Vasodilator Agents|vasodilator agents|mesh-ancestor
5747867|NCT03054168|Goserelin|goserelin|mesh-list
5747868|NCT03054168|Testosterone|testosterone|mesh-list
5747869|NCT03054168|Hormones|hormones|mesh-ancestor
5747870|NCT03054168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5624585|NCT05139849|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5624586|NCT05139849|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5624587|NCT05139849|Natriuretic Agents|natriuretic agents|mesh-ancestor
5624588|NCT05131698|Lenvatinib|lenvatinib|mesh-list
5624589|NCT05131698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5624590|NCT05131698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5624591|NCT05131698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5624592|NCT05131698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5624593|NCT05127304|Bromides|bromides|mesh-list
5624594|NCT05127304|Tiotropium Bromide|tiotropium bromide|mesh-list
5747871|NCT03054168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747872|NCT03054168|Androgens|androgens|mesh-ancestor
5747873|NCT03054168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5747874|NCT03054168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5747875|NCT03054363|Letrozole|letrozole|mesh-list
5747876|NCT03054363|Palbociclib|palbociclib|mesh-list
5747877|NCT03054363|Tucatinib|tucatinib|mesh-list
5747878|NCT03054363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5747879|NCT03054363|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5747880|NCT03054363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5747881|NCT03054363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5747882|NCT03054363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5624595|NCT05127304|Olodaterol|olodaterol|mesh-list
5624596|NCT05127304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5624597|NCT05127304|Autonomic Agents|autonomic agents|mesh-ancestor
5624598|NCT05127304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5624599|NCT05127304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747883|NCT03054363|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5747884|NCT03054363|Hormone Antagonists|hormone antagonists|mesh-ancestor
5747885|NCT03054363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5624600|NCT05127304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5624601|NCT05127304|Respiratory System Agents|respiratory system agents|mesh-ancestor
5624602|NCT05127304|Parasympatholytics|parasympatholytics|mesh-ancestor
5747886|NCT03054363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747887|NCT03054363|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5747888|NCT03054181|Immunoglobulins|immunoglobulins|mesh-list
5747889|NCT03054181|Immunologic Factors|immunologic factors|mesh-ancestor
5747890|NCT03054181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489477|NCT00592111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489478|NCT00592111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6489479|NCT00592111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6489480|NCT00592111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6489481|NCT00592111|Glucocorticoids|glucocorticoids|mesh-ancestor
5624603|NCT05127304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5624604|NCT05127304|Cholinergic Agents|cholinergic agents|mesh-ancestor
5624605|NCT05127304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5624606|NCT05127304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5624607|NCT05127304|Anticonvulsants|anticonvulsants|mesh-ancestor
5624608|NCT05115513|Dronabinol|dronabinol|mesh-list
5624609|NCT05115513|Hallucinogens|hallucinogens|mesh-ancestor
5624610|NCT05115513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5624611|NCT05115513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5624612|NCT05115513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5624613|NCT05115513|Analgesics|analgesics|mesh-ancestor
6489482|NCT00592111|Hormones|hormones|mesh-ancestor
6489483|NCT00592111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6672931|NCT01559298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6672932|NCT01559298|Analgesics|analgesics|mesh-ancestor
6489484|NCT00592111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5747891|NCT03054220|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5747892|NCT03054220|Tramadol|tramadol|mesh-list
5747893|NCT03054220|Dextromethorphan|dextromethorphan|mesh-list
5747894|NCT03054220|Paroxetine|paroxetine|mesh-list
5747895|NCT03054220|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5747896|NCT03054220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5747897|NCT03054220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5747898|NCT03054220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5747899|NCT03054220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5747900|NCT03054220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747901|NCT03054220|Analgesics|analgesics|mesh-ancestor
5747902|NCT03054220|Sensory System Agents|sensory system agents|mesh-ancestor
5747903|NCT03054220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5624614|NCT05115513|Sensory System Agents|sensory system agents|mesh-ancestor
5624615|NCT05115513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5624616|NCT05115513|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5624617|NCT05115513|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5624618|NCT05115513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5624619|NCT05115513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5624620|NCT05115513|Hormones|hormones|mesh-ancestor
5624621|NCT05115513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5624622|NCT05110781|Atezolizumab|atezolizumab|mesh-list
5624623|NCT05110781|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5624624|NCT05110781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5624625|NCT05110781|Immunologic Factors|immunologic factors|mesh-ancestor
5624626|NCT05110781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692874|NCT03404947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692875|NCT03404908|Acetaminophen|acetaminophen|mesh-list
5692876|NCT03404908|Dipyrone|dipyrone|mesh-list
5692877|NCT03404908|Ketoprofen|ketoprofen|mesh-list
5692878|NCT03404908|Morphine|morphine|mesh-list
5692879|NCT03404908|Ropivacaine|ropivacaine|mesh-list
5692880|NCT03404908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5747904|NCT03054220|Antidepressive Agents|antidepressive agents|mesh-ancestor
5747905|NCT03054220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5747906|NCT03054220|Dopamine Agents|dopamine agents|mesh-ancestor
5747907|NCT03054220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5747908|NCT03054220|Narcotics|narcotics|mesh-ancestor
5747909|NCT03054220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5692881|NCT03404908|Narcotics|narcotics|mesh-ancestor
5692882|NCT03404908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5692883|NCT03404908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692884|NCT03404908|Analgesics|analgesics|mesh-ancestor
5692885|NCT03404908|Sensory System Agents|sensory system agents|mesh-ancestor
5624630|NCT05099276|Tranexamic Acid|tranexamic acid|mesh-list
5624631|NCT05099276|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5624632|NCT05099276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5624633|NCT05099276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5624634|NCT05099276|Hemostatics|hemostatics|mesh-ancestor
5624635|NCT05099276|Coagulants|coagulants|mesh-ancestor
5624636|NCT05090371|Ofatumumab|ofatumumab|mesh-list
5624637|NCT05090371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5624638|NCT05087212|Plerixafor|plerixafor|mesh-list
5624639|NCT05087212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5624640|NCT05087212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5624641|NCT05087212|Antiviral Agents|antiviral agents|mesh-ancestor
5624642|NCT05087212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5624643|NCT05081479|Acetylcysteine|acetylcysteine|mesh-list
5624644|NCT05081479|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5624645|NCT05081479|Antiviral Agents|antiviral agents|mesh-ancestor
5624646|NCT05081479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5624647|NCT05081479|Expectorants|expectorants|mesh-ancestor
5624648|NCT05081479|Respiratory System Agents|respiratory system agents|mesh-ancestor
5624649|NCT05081479|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5624650|NCT05081479|Antioxidants|antioxidants|mesh-ancestor
5624651|NCT05081479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5624652|NCT05081479|Protective Agents|protective agents|mesh-ancestor
5624653|NCT05081479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5624654|NCT05081479|Antidotes|antidotes|mesh-ancestor
5624655|NCT05077449|Fulvestrant|fulvestrant|mesh-list
5624656|NCT05077449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5624657|NCT05077449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5624658|NCT05077449|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5624659|NCT05077449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5624660|NCT05077449|Hormone Antagonists|hormone antagonists|mesh-ancestor
5624661|NCT05077449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5624662|NCT05077449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5624663|NCT05074485|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5624664|NCT05074485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5624665|NCT05073575|Hyaluronic Acid|hyaluronic acid|mesh-list
5624666|NCT05073575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5747910|NCT03054220|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5747911|NCT03054220|Serotonin Agents|serotonin agents|mesh-ancestor
5747912|NCT03054220|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5747913|NCT03054220|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5747914|NCT03054220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5747915|NCT03054220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5747916|NCT03054220|Antitussive Agents|antitussive agents|mesh-ancestor
5747917|NCT03054220|Respiratory System Agents|respiratory system agents|mesh-ancestor
5747918|NCT03054220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5747919|NCT03054220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5747920|NCT03054259|Methylprednisolone|methylprednisolone|mesh-list
5624667|NCT05073575|Immunologic Factors|immunologic factors|mesh-ancestor
5624668|NCT05073575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5624669|NCT05073575|Viscosupplements|viscosupplements|mesh-ancestor
5624670|NCT05073575|Protective Agents|protective agents|mesh-ancestor
5624671|NCT05072093|Tenofovir|tenofovir|mesh-list
5624672|NCT05072093|Emtricitabine|emtricitabine|mesh-list
5624673|NCT05072093|Doxycycline|doxycycline|mesh-list
5624674|NCT05072093|Antiviral Agents|antiviral agents|mesh-ancestor
5624675|NCT05072093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5624676|NCT05072093|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5624677|NCT05072093|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5624678|NCT05072093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5624679|NCT05072093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5624680|NCT05072093|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5624681|NCT05072093|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5624682|NCT05072093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5624683|NCT05072093|Antimalarials|antimalarials|mesh-ancestor
5624684|NCT05072093|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5624685|NCT05072093|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5624686|NCT05063994|Hydrocortisone|hydrocortisone|mesh-list
5624687|NCT05063994|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
5624688|NCT05063994|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
5624689|NCT05063994|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
5624690|NCT05063994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5624691|NCT05062135|Progesterone|progesterone|mesh-list
5624692|NCT05062135|Progestins|progestins|mesh-ancestor
5624693|NCT05062135|Hormones|hormones|mesh-ancestor
5692886|NCT03404908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5624694|NCT05062135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5624695|NCT05062135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5624696|NCT05046184|Midazolam|midazolam|mesh-list
5624697|NCT05046184|Ketamine|ketamine|mesh-list
5624698|NCT05046184|Analgesics|analgesics|mesh-ancestor
5624699|NCT05046184|Sensory System Agents|sensory system agents|mesh-ancestor
5624700|NCT05046184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5624701|NCT05046184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5624702|NCT05046184|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5747921|NCT03054259|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5747922|NCT03054259|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5747923|NCT03054259|Prednisolone|prednisolone|mesh-list
5747924|NCT03054259|Prednisolone acetate|prednisolone acetate|mesh-list
5747925|NCT03054259|Rituximab|rituximab|mesh-list
5747926|NCT03054259|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5747927|NCT03054259|Prednisolone phosphate|prednisolone phosphate|mesh-list
5747928|NCT03054259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5747929|NCT03054259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5747930|NCT03054259|Immunologic Factors|immunologic factors|mesh-ancestor
5747931|NCT03054259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747932|NCT03054259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5747933|NCT03054259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5747934|NCT03054259|Antiemetics|antiemetics|mesh-ancestor
5747935|NCT03054259|Autonomic Agents|autonomic agents|mesh-ancestor
5624703|NCT05046184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5624704|NCT05046184|Anesthetics, General|anesthetics, general|mesh-ancestor
5624705|NCT05046184|Anesthetics|anesthetics|mesh-ancestor
5624706|NCT05046184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5747936|NCT03054259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5747937|NCT03054259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5747938|NCT03054259|Glucocorticoids|glucocorticoids|mesh-ancestor
5747939|NCT03054259|Hormones|hormones|mesh-ancestor
5747940|NCT03054259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5747941|NCT03054259|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5747942|NCT03054259|Protective Agents|protective agents|mesh-ancestor
5747943|NCT03054259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5747944|NCT03053739|Bosentan|bosentan|mesh-list
5747945|NCT03053739|Sildenafil Citrate|sildenafil citrate|mesh-list
5747946|NCT03053739|Vasodilator Agents|vasodilator agents|mesh-ancestor
5747947|NCT03053739|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5747948|NCT03053739|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5747949|NCT03053739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5747950|NCT03053739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5747951|NCT03053739|Urological Agents|urological agents|mesh-ancestor
5747952|NCT03053739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5747953|NCT03053739|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5894271|NCT05108155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5894272|NCT05108155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894273|NCT05108155|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5894274|NCT05108155|Autonomic Agents|autonomic agents|mesh-ancestor
5894275|NCT05108155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5894276|NCT05108155|Nootropic Agents|nootropic agents|mesh-ancestor
5894277|NCT05105542|Cholinergic Agents|cholinergic agents|mesh-list
5894278|NCT05105542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5894279|NCT05105542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894280|NCT05105542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907769|NCT05201612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5907770|NCT05201612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5907771|NCT05201612|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5907772|NCT05201612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5907773|NCT05201612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907774|NCT05200208|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
5907775|NCT05200208|Nootropic Agents|nootropic agents|mesh-ancestor
5907776|NCT05200052|Colchicine|colchicine|mesh-list
5907777|NCT05200052|Gout Suppressants|gout suppressants|mesh-ancestor
5907778|NCT05200052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5907779|NCT05200052|Tubulin Modulators|tubulin modulators|mesh-ancestor
5907780|NCT05200052|Antimitotic Agents|antimitotic agents|mesh-ancestor
5907781|NCT05200052|Mitosis Modulators|mitosis modulators|mesh-ancestor
5907782|NCT05200052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907783|NCT05200052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5692887|NCT03404908|Anesthetics, Local|anesthetics, local|mesh-ancestor
5907784|NCT05198804|Niraparib|niraparib|mesh-list
5907785|NCT05198804|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5624707|NCT05046184|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5624708|NCT05046184|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5624709|NCT05046184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5624710|NCT05046184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5624711|NCT05046184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5624712|NCT05046184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5624713|NCT05046184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5624714|NCT05046184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5747954|NCT03053856|Paclitaxel|paclitaxel|mesh-list
5747955|NCT03053856|Pembrolizumab|pembrolizumab|mesh-list
5747956|NCT03053856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5747957|NCT03053856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5747958|NCT03053856|Tubulin Modulators|tubulin modulators|mesh-ancestor
5747959|NCT03053856|Antimitotic Agents|antimitotic agents|mesh-ancestor
5747960|NCT03053856|Mitosis Modulators|mitosis modulators|mesh-ancestor
5747961|NCT03053856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5747962|NCT03053856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5747963|NCT03053869|Diazepam|diazepam|mesh-list
5747964|NCT03053869|Lorazepam|lorazepam|mesh-list
5747965|NCT03053869|Alprazolam|alprazolam|mesh-list
5624715|NCT05046184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5624716|NCT05046184|GABA Modulators|gaba modulators|mesh-ancestor
5624717|NCT05046184|GABA Agents|gaba agents|mesh-ancestor
5624718|NCT05033964|Sirolimus|sirolimus|mesh-list
5624719|NCT05033964|Rivaroxaban|rivaroxaban|mesh-list
5624720|NCT05033964|Argatroban|argatroban|mesh-list
5624721|NCT05033964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5624722|NCT05033964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5624723|NCT05033964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5624724|NCT05033964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5624725|NCT05033964|Antifungal Agents|antifungal agents|mesh-ancestor
5624726|NCT05033964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5624727|NCT05033964|Immunologic Factors|immunologic factors|mesh-ancestor
5624728|NCT05033964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5624729|NCT05033964|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5624730|NCT05033964|Antithrombins|antithrombins|mesh-ancestor
5624731|NCT05033964|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5624732|NCT05033964|Protease Inhibitors|protease inhibitors|mesh-ancestor
5747966|NCT03053869|Anticonvulsants|anticonvulsants|mesh-ancestor
5747967|NCT03053869|Antiemetics|antiemetics|mesh-ancestor
5747968|NCT03053869|Autonomic Agents|autonomic agents|mesh-ancestor
5747969|NCT03053869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5747970|NCT03053869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747971|NCT03053869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5747972|NCT03053869|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5747973|NCT03053869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5747974|NCT03053869|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5747975|NCT03053869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5747976|NCT03053869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5747977|NCT03053869|GABA Modulators|gaba modulators|mesh-ancestor
5747978|NCT03053869|GABA Agents|gaba agents|mesh-ancestor
5747979|NCT03053869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5747980|NCT03053869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5747981|NCT03053869|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5747982|NCT03053869|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5747983|NCT03053869|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5747984|NCT03053869|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5747985|NCT03053869|Anesthetics, General|anesthetics, general|mesh-ancestor
5747986|NCT03053869|Anesthetics|anesthetics|mesh-ancestor
5747987|NCT03053947|Ketamine|ketamine|mesh-list
5747988|NCT03053947|Analgesics|analgesics|mesh-ancestor
5747989|NCT03053947|Sensory System Agents|sensory system agents|mesh-ancestor
5747990|NCT03053947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5747991|NCT03053947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5747992|NCT03053947|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5747993|NCT03053947|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5747994|NCT03053947|Anesthetics, General|anesthetics, general|mesh-ancestor
5747995|NCT03053947|Anesthetics|anesthetics|mesh-ancestor
5747996|NCT03053947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5747997|NCT03053947|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5747998|NCT03053947|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5747999|NCT03053947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5748000|NCT03053947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748001|NCT03053830|Ketamine|ketamine|mesh-list
5748002|NCT03053830|Analgesics|analgesics|mesh-ancestor
5624733|NCT05033964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5748003|NCT03053830|Sensory System Agents|sensory system agents|mesh-ancestor
5748004|NCT03053830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5624734|NCT05033964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5624735|NCT05033964|Anticoagulants|anticoagulants|mesh-ancestor
5624736|NCT05033964|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5748005|NCT03053830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748006|NCT03053830|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5748007|NCT03053830|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5748008|NCT03053830|Anesthetics, General|anesthetics, general|mesh-ancestor
5748009|NCT03053830|Anesthetics|anesthetics|mesh-ancestor
5748010|NCT03053830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5748011|NCT03053830|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5748012|NCT03053830|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6672933|NCT01559298|Sensory System Agents|sensory system agents|mesh-ancestor
6672934|NCT01559298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5748013|NCT03053830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5748014|NCT03053830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748015|NCT03054038|Afatinib|afatinib|mesh-list
5748016|NCT03054038|Necitumumab|necitumumab|mesh-list
5748017|NCT03054038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5748018|NCT03054038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5748019|NCT03054038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5748020|NCT03054038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748021|NCT03054038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5748022|NCT03053388|Nitric Oxide|nitric oxide|mesh-list
5748023|NCT03053388|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5748024|NCT03053388|Autonomic Agents|autonomic agents|mesh-ancestor
5748025|NCT03053388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5748026|NCT03053388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748027|NCT03053388|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5748028|NCT03053388|Respiratory System Agents|respiratory system agents|mesh-ancestor
5748029|NCT03053388|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5748030|NCT03053388|Antioxidants|antioxidants|mesh-ancestor
5748031|NCT03053388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748032|NCT03053388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5748033|NCT03053388|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5748034|NCT03053388|Vasodilator Agents|vasodilator agents|mesh-ancestor
5748035|NCT03053388|Gasotransmitters|gasotransmitters|mesh-ancestor
5748036|NCT03053388|Protective Agents|protective agents|mesh-ancestor
5748037|NCT03053544|Metformin|metformin|mesh-list
5748038|NCT03053544|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5748039|NCT03053544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748040|NCT03053622|Mirikizumab|mirikizumab|mesh-list
5748041|NCT03053622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5748042|NCT03053622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5748043|NCT03053622|Analgesics|analgesics|mesh-ancestor
5748044|NCT03053622|Sensory System Agents|sensory system agents|mesh-ancestor
5748045|NCT03053622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5748046|NCT03053622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748047|NCT03053622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5748048|NCT03053622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5624737|NCT05005182|Hydroxyurea|hydroxyurea|mesh-list
5624738|NCT05005182|Luspatercept|luspatercept|mesh-list
5624739|NCT05005182|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
5624740|NCT05005182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5624741|NCT05005182|Antisickling Agents|antisickling agents|mesh-ancestor
5748049|NCT03053622|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5748050|NCT03053622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5748051|NCT03053583|Pyrithione zinc|pyrithione zinc|mesh-list
5748052|NCT03053583|Keratolytic Agents|keratolytic agents|mesh-ancestor
5748053|NCT03053583|Dermatologic Agents|dermatologic agents|mesh-ancestor
5748054|NCT03053414|Vitamin D|vitamin d|mesh-list
5748055|NCT03053414|Cholecalciferol|cholecalciferol|mesh-list
5748056|NCT03053414|Ergocalciferols|ergocalciferols|mesh-list
5748057|NCT03053414|Vitamins|vitamins|mesh-ancestor
5748058|NCT03053414|Micronutrients|micronutrients|mesh-ancestor
5748059|NCT03053414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748060|NCT03053414|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5748061|NCT03053414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5748062|NCT03053505|Vancomycin|vancomycin|mesh-list
5624742|NCT05005182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5624743|NCT05005182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748063|NCT03053505|Fidaxomicin|fidaxomicin|mesh-list
5748064|NCT03053505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5624744|NCT05005182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5624745|NCT05005182|Hematinics|hematinics|mesh-ancestor
5624746|NCT05005182|Immunologic Factors|immunologic factors|mesh-ancestor
5624747|NCT05005182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5624748|NCT04997902|Tipifarnib|tipifarnib|mesh-list
5624749|NCT04997902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5624750|NCT04996823|Ipilimumab|ipilimumab|mesh-list
5624751|NCT04996823|Axitinib|axitinib|mesh-list
5624752|NCT04996823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5624753|NCT04996823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5624754|NCT04996823|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5624755|NCT04996823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5624756|NCT04996823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5624757|NCT04996823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5624758|NCT04945148|Metformin|metformin|mesh-list
5624759|NCT04945148|Temozolomide|temozolomide|mesh-list
5624760|NCT04945148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5624761|NCT04945148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5624762|NCT04945148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5624763|NCT04945148|Alkylating Agents|alkylating agents|mesh-ancestor
5624764|NCT04945148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5624765|NCT04945148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5624766|NCT04937816|Empagliflozin|empagliflozin|mesh-list
5624767|NCT04937816|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5624768|NCT04937816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5624769|NCT04937816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5624770|NCT04937816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5624771|NCT04934449|Salicylic Acid|salicylic acid|mesh-list
5624772|NCT04934449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5624773|NCT04934449|Antifungal Agents|antifungal agents|mesh-ancestor
5624774|NCT04934449|Keratolytic Agents|keratolytic agents|mesh-ancestor
5624775|NCT04934449|Dermatologic Agents|dermatologic agents|mesh-ancestor
5624776|NCT04925960|Epalrestat|epalrestat|mesh-list
5624777|NCT04925960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5624778|NCT04925960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5624779|NCT04923594|Mazindol|mazindol|mesh-list
5624780|NCT04923594|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5624781|NCT04923594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5624782|NCT04923594|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5624783|NCT04923594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5624784|NCT04923594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5624785|NCT04923594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5624786|NCT04923594|Adrenergic Agents|adrenergic agents|mesh-ancestor
5624787|NCT04923594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5624788|NCT04923594|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5624789|NCT04923594|Dopamine Agents|dopamine agents|mesh-ancestor
5624790|NCT04906902|Acalabrutinib|acalabrutinib|mesh-list
5624791|NCT04906902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5624792|NCT04878211|Interferons|interferons|mesh-list
5624793|NCT04878211|Ofatumumab|ofatumumab|mesh-list
5624794|NCT04878211|Glatiramer Acetate|glatiramer acetate|mesh-list
5624795|NCT04878211|(T,G)-A-L|(t,g)-a-l|mesh-list
5624796|NCT04878211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5624797|NCT04878211|Antiviral Agents|antiviral agents|mesh-ancestor
5624798|NCT04878211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5624799|NCT04878211|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5624800|NCT04878211|Immunologic Factors|immunologic factors|mesh-ancestor
5624801|NCT04878211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5624802|NCT04878211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5624803|NCT04878211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5624804|NCT04872686|Povidone-Iodine|povidone-iodine|mesh-list
5624805|NCT04872686|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5624806|NCT04872686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5624807|NCT04865731|Esomeprazole|esomeprazole|mesh-list
5624808|NCT04865731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5624809|NCT04865731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5624810|NCT04865731|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5624811|NCT04865731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5624812|NCT04865731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748065|NCT03053505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5748066|NCT03053284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5748067|NCT03053284|Pasireotide|pasireotide|mesh-list
5748068|NCT03053284|Hormones|hormones|mesh-ancestor
5624813|NCT04865289|Paclitaxel|paclitaxel|mesh-list
5748069|NCT03053284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5894281|NCT05065918|Ethanol|ethanol|mesh-list
5624814|NCT04865289|Carboplatin|carboplatin|mesh-list
5624815|NCT04865289|Pembrolizumab|pembrolizumab|mesh-list
5624816|NCT04865289|Lenvatinib|lenvatinib|mesh-list
5624817|NCT04865289|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5624818|NCT04865289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5624819|NCT04865289|Tubulin Modulators|tubulin modulators|mesh-ancestor
5624820|NCT04865289|Antimitotic Agents|antimitotic agents|mesh-ancestor
5624821|NCT04865289|Mitosis Modulators|mitosis modulators|mesh-ancestor
5624822|NCT04865289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5624823|NCT04865289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5748070|NCT03053284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748071|NCT03053219|Abivertinib|abivertinib|mesh-list
5748072|NCT03053219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5748073|NCT03053219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5748074|NCT03053219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5624824|NCT04865289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5624825|NCT04865289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5624826|NCT04856293|Crizotinib|crizotinib|mesh-list
5624827|NCT04856293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5624828|NCT04856293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5624829|NCT04856293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5624830|NCT04856293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5624831|NCT04844619|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5624832|NCT04844619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5748075|NCT03052998|Ivermectin|ivermectin|mesh-list
5748076|NCT03052998|Anticonvulsants|anticonvulsants|mesh-list
5748077|NCT03052998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5748078|NCT03052998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5748079|NCT03053167|Irinotecan|irinotecan|mesh-list
5748080|NCT03053167|Raltitrexed|raltitrexed|mesh-list
5748081|NCT03053167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5748082|NCT03053167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5748083|NCT03053167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5748084|NCT03053167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748085|NCT03053167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5748086|NCT03053167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5748087|NCT03053167|Antimetabolites|antimetabolites|mesh-ancestor
5748088|NCT03053167|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5748089|NCT03052933|Gemcitabine|gemcitabine|mesh-list
5748090|NCT03052933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5748091|NCT03052933|Antimetabolites|antimetabolites|mesh-ancestor
5748092|NCT03052933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748093|NCT03052933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5748094|NCT03052933|Antiviral Agents|antiviral agents|mesh-ancestor
5748095|NCT03052933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5748096|NCT03052933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5748097|NCT03052933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5748098|NCT03052933|Immunologic Factors|immunologic factors|mesh-ancestor
5748099|NCT03052933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748100|NCT03052673|Fentanyl|fentanyl|mesh-list
5748101|NCT03052673|Ketamine|ketamine|mesh-list
5748102|NCT03052673|Analgesics|analgesics|mesh-ancestor
5748103|NCT03052673|Sensory System Agents|sensory system agents|mesh-ancestor
5748104|NCT03052673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5748105|NCT03052673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748106|NCT03052673|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5748107|NCT03052673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5624833|NCT04783233|Chitosan|chitosan|mesh-list
5624834|NCT04783233|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
5624835|NCT04783233|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5624836|NCT04783233|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5624837|NCT04783233|Antimetabolites|antimetabolites|mesh-ancestor
5624838|NCT04783233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5624839|NCT04783233|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5624840|NCT04783233|Chelating Agents|chelating agents|mesh-ancestor
5624841|NCT04783233|Sequestering Agents|sequestering agents|mesh-ancestor
5624842|NCT04783233|Hemostatics|hemostatics|mesh-ancestor
5624843|NCT04783233|Coagulants|coagulants|mesh-ancestor
5748108|NCT03052673|Anesthetics, General|anesthetics, general|mesh-ancestor
5748109|NCT03052673|Anesthetics|anesthetics|mesh-ancestor
5624844|NCT04743505|Osimertinib|osimertinib|mesh-list
5624845|NCT04743505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5624846|NCT04743505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5748110|NCT03052673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5748111|NCT03052673|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5748112|NCT03052673|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5748113|NCT03052673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5748114|NCT03052673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748115|NCT03052673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5748116|NCT03052673|Narcotics|narcotics|mesh-ancestor
5748117|NCT03052673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5748118|NCT03052569|Agerafenib|agerafenib|mesh-list
5748119|NCT03052569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5748120|NCT03052569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5748121|NCT03052569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748122|NCT03052660|Midazolam|midazolam|mesh-list
5748123|NCT03052660|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5748124|NCT03052660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5748125|NCT03052660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5748126|NCT03052660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748127|NCT03052660|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5748128|NCT03052660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5748129|NCT03052660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5748130|NCT03052660|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5748131|NCT03052660|Anesthetics, General|anesthetics, general|mesh-ancestor
5624847|NCT04743505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5624848|NCT04743505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5624849|NCT04742036|Paclitaxel|paclitaxel|mesh-list
5624850|NCT04742036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5624851|NCT04742036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5624852|NCT04742036|Tubulin Modulators|tubulin modulators|mesh-ancestor
5624853|NCT04742036|Antimitotic Agents|antimitotic agents|mesh-ancestor
5624854|NCT04742036|Mitosis Modulators|mitosis modulators|mesh-ancestor
5624855|NCT04742036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692888|NCT03404908|Anesthetics|anesthetics|mesh-ancestor
5692889|NCT03404908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5692890|NCT03404908|Antipyretics|antipyretics|mesh-ancestor
5692891|NCT03404908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5692892|NCT03404908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5692893|NCT03404908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5692894|NCT03404908|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5692895|NCT03404908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5692896|NCT03404908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692897|NCT03404804|Amoxicillin|amoxicillin|mesh-list
5692898|NCT03404804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5692899|NCT03404804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5692900|NCT03404752|Lenograstim|lenograstim|mesh-list
5692901|NCT03404752|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5692902|NCT03404752|Immunologic Factors|immunologic factors|mesh-ancestor
5692903|NCT03404752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748132|NCT03052660|Anesthetics|anesthetics|mesh-ancestor
5748133|NCT03052660|GABA Modulators|gaba modulators|mesh-ancestor
5748134|NCT03052660|GABA Agents|gaba agents|mesh-ancestor
5748135|NCT03052660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5748136|NCT03052660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748137|NCT03052348|Fusidic Acid|fusidic acid|mesh-list
5748138|NCT03052348|Betamethasone|betamethasone|mesh-list
5748139|NCT03052348|Betamethasone Valerate|betamethasone valerate|mesh-list
5748140|NCT03052348|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5748141|NCT03052348|Betamethasone benzoate|betamethasone benzoate|mesh-list
5748142|NCT03052348|Ether|ether|mesh-list
5748143|NCT03052348|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
5748144|NCT03052348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5748145|NCT03052348|Glucocorticoids|glucocorticoids|mesh-ancestor
5748146|NCT03052348|Hormones|hormones|mesh-ancestor
5748147|NCT03052348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5748148|NCT03052348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748149|NCT03052348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5748150|NCT03052348|Respiratory System Agents|respiratory system agents|mesh-ancestor
5748151|NCT03052348|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5748152|NCT03052348|Anesthetics, General|anesthetics, general|mesh-ancestor
5748153|NCT03052348|Anesthetics|anesthetics|mesh-ancestor
5748154|NCT03052348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5692904|NCT03404739|Ceftazidime|ceftazidime|mesh-list
5692905|NCT03404739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5692906|NCT03404739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5692907|NCT03404661|Secretin|secretin|mesh-list
5692908|NCT03404661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5692909|NCT03404661|Hormones|hormones|mesh-ancestor
5692910|NCT03404661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5748155|NCT03052348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5748156|NCT03052348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5748157|NCT03052348|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5748158|NCT03052348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5748159|NCT03052348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748160|NCT03052400|Mifepristone|mifepristone|mesh-list
5748161|NCT03052400|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5748162|NCT03052400|Abortifacient Agents|abortifacient agents|mesh-ancestor
5748163|NCT03052400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5748164|NCT03052400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5624856|NCT04707391|Vaccines|vaccines|mesh-list
5624857|NCT04707391|Immunologic Factors|immunologic factors|mesh-ancestor
5624858|NCT04707391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5624859|NCT04707183|Lidocaine|lidocaine|mesh-list
5624860|NCT04707183|Anesthetics, Local|anesthetics, local|mesh-ancestor
5748165|NCT03052400|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5748166|NCT03052400|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5748167|NCT03052400|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5748168|NCT03052400|Contraceptive Agents|contraceptive agents|mesh-ancestor
5748169|NCT03052400|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5748170|NCT03052400|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5748171|NCT03052400|Hormone Antagonists|hormone antagonists|mesh-ancestor
5748172|NCT03052400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5748173|NCT03052400|Luteolytic Agents|luteolytic agents|mesh-ancestor
5748174|NCT03052400|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5748175|NCT03052400|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5748176|NCT03052361|Ondansetron|ondansetron|mesh-list
5748177|NCT03052361|Antiemetics|antiemetics|mesh-ancestor
5748178|NCT03052361|Autonomic Agents|autonomic agents|mesh-ancestor
5748179|NCT03052361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5748180|NCT03052361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748181|NCT03052361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5748182|NCT03052361|Antipruritics|antipruritics|mesh-ancestor
5748183|NCT03052361|Dermatologic Agents|dermatologic agents|mesh-ancestor
5748184|NCT03052361|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5748185|NCT03052361|Serotonin Agents|serotonin agents|mesh-ancestor
5748186|NCT03052361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5748187|NCT03052361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748188|NCT03052361|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5748189|NCT03052361|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5748190|NCT03052361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5748191|NCT03052361|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5748192|NCT03052361|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5894282|NCT05065918|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5894283|NCT05065918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5894284|NCT05065918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5894285|NCT05065918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894286|NCT05061992|Lactulose|lactulose|mesh-list
5894287|NCT05061992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5894288|NCT05021861|Cyproterone Acetate|cyproterone acetate|mesh-list
5894289|NCT05021861|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5894290|NCT05021861|Estradiol|estradiol|mesh-list
5894291|NCT05021861|Cyproterone|cyproterone|mesh-list
5624861|NCT04707183|Anesthetics|anesthetics|mesh-ancestor
5624862|NCT04707183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5624863|NCT04707183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5624864|NCT04707183|Sensory System Agents|sensory system agents|mesh-ancestor
5624865|NCT04707183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5624866|NCT04707183|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5624867|NCT04707183|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5624868|NCT04707183|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5624869|NCT04707183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5624870|NCT04707183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5624871|NCT04703205|Ivermectin|ivermectin|mesh-list
5624872|NCT04703205|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5624873|NCT04703205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5624874|NCT04686799|Doxycycline|doxycycline|mesh-list
5624875|NCT04686799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5894292|NCT05021861|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
5894293|NCT05021861|Estrogens|estrogens|mesh-ancestor
5894294|NCT05021861|Hormones|hormones|mesh-ancestor
5894295|NCT05021861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5894296|NCT05021861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894297|NCT05021861|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5624876|NCT04686799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5748193|NCT03052140|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5748194|NCT03052140|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5748195|NCT03051932|Acetaminophen|acetaminophen|mesh-list
5748196|NCT03051932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5748197|NCT03051932|Analgesics|analgesics|mesh-ancestor
5748198|NCT03051932|Sensory System Agents|sensory system agents|mesh-ancestor
5748199|NCT03051932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5748200|NCT03051932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748201|NCT03051932|Antipyretics|antipyretics|mesh-ancestor
5748202|NCT03051945|Ketamine|ketamine|mesh-list
5748203|NCT03051945|Analgesics|analgesics|mesh-ancestor
5748204|NCT03051945|Sensory System Agents|sensory system agents|mesh-ancestor
5748205|NCT03051945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5748206|NCT03051945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748207|NCT03051945|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5748208|NCT03051945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5748209|NCT03051945|Anesthetics, General|anesthetics, general|mesh-ancestor
5748210|NCT03051945|Anesthetics|anesthetics|mesh-ancestor
5748211|NCT03051945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5748212|NCT03051945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5748213|NCT03051945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5748214|NCT03051945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5748215|NCT03051945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748216|NCT03051906|Cetuximab|cetuximab|mesh-list
5748217|NCT03051906|Durvalumab|durvalumab|mesh-list
5748218|NCT03051906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5748219|NCT03051906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5748220|NCT03051841|Dexamethasone|dexamethasone|mesh-list
5748221|NCT03051841|Bortezomib|bortezomib|mesh-list
5748222|NCT03051841|CKD-581|ckd-581|mesh-list
5748223|NCT03051841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5748224|NCT03051841|Antiemetics|antiemetics|mesh-ancestor
5748225|NCT03051841|Autonomic Agents|autonomic agents|mesh-ancestor
5748226|NCT03051841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5748227|NCT03051841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748228|NCT03051841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5748229|NCT03051841|Glucocorticoids|glucocorticoids|mesh-ancestor
5748230|NCT03051841|Hormones|hormones|mesh-ancestor
5748231|NCT03051841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5748232|NCT03051841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5748233|NCT03051841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5748234|NCT03051841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5748235|NCT03051841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748236|NCT03051841|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5748237|NCT03051542|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5748238|NCT03051542|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5748239|NCT03051542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748240|NCT03051555|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5748241|NCT03051555|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5748242|NCT03051555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748243|NCT03051711|Pyrazole|pyrazole|mesh-list
5748244|NCT03051711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5624877|NCT04686799|Antimalarials|antimalarials|mesh-ancestor
5624878|NCT04686799|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5624879|NCT04686799|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5624880|NCT04680598|Antiviral Agents|antiviral agents|mesh-list
5624881|NCT04680598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5624882|NCT04676334|Rucaparib|rucaparib|mesh-list
5624883|NCT04676334|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5624884|NCT04676334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5624885|NCT04676334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5624886|NCT04676334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5624887|NCT04646395|Acalabrutinib|acalabrutinib|mesh-list
5624888|NCT04646395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5748245|NCT03051711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748246|NCT03051568|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5748247|NCT03051568|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5748248|NCT03051568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748249|NCT03051581|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5748250|NCT03051581|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5748251|NCT03051581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748252|NCT03051529|Anesthetics|anesthetics|mesh-list
5894298|NCT05021861|Contraceptive Agents|contraceptive agents|mesh-ancestor
5624889|NCT04639414|Empagliflozin|empagliflozin|mesh-list
5624890|NCT04639414|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5624891|NCT04639414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5624892|NCT04639414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5624893|NCT04639414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5624894|NCT04615949|Cannabidiol|cannabidiol|mesh-list
5624895|NCT04615949|Anticonvulsants|anticonvulsants|mesh-ancestor
5624896|NCT04608903|Sulforaphane|sulforaphane|mesh-list
5624897|NCT04608903|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5624898|NCT04608903|Protective Agents|protective agents|mesh-ancestor
5624899|NCT04608903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748253|NCT03051529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5748254|NCT03051529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748255|NCT03051698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5748256|NCT03051698|Metronidazole|metronidazole|mesh-list
5748257|NCT03051698|Vancomycin|vancomycin|mesh-list
5748258|NCT03051698|Ciprofloxacin|ciprofloxacin|mesh-list
5748259|NCT03051698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5748260|NCT03051698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5624900|NCT04608903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5624901|NCT04572815|Interleukin-12|interleukin-12|mesh-list
5624902|NCT04572815|Ustekinumab|ustekinumab|mesh-list
5624903|NCT04572815|Immunoglobulins|immunoglobulins|mesh-list
5624904|NCT04572815|Immunoglobulin G|immunoglobulin g|mesh-list
5624905|NCT04572815|Immunologic Factors|immunologic factors|mesh-ancestor
5624906|NCT04572815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5624907|NCT04572815|Dermatologic Agents|dermatologic agents|mesh-ancestor
5624908|NCT04572815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5624909|NCT04572815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5624910|NCT04572815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5624911|NCT04572815|Growth Substances|growth substances|mesh-ancestor
5748261|NCT03051698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5748262|NCT03051698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5748263|NCT03051698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5748264|NCT03051698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5748265|NCT03051698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748266|NCT03051698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5748267|NCT03051698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5748268|NCT03051698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5748269|NCT03051503|Fentanyl|fentanyl|mesh-list
5748270|NCT03051503|Morphine|morphine|mesh-list
5748271|NCT03051503|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5748272|NCT03051503|Narcotics|narcotics|mesh-ancestor
5748273|NCT03051503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5748274|NCT03051503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748275|NCT03051503|Analgesics|analgesics|mesh-ancestor
5748276|NCT03051503|Sensory System Agents|sensory system agents|mesh-ancestor
5748277|NCT03051503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5748278|NCT03051503|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5748279|NCT03051503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5748280|NCT03051503|Anesthetics, General|anesthetics, general|mesh-ancestor
5748281|NCT03051503|Anesthetics|anesthetics|mesh-ancestor
5748282|NCT03051451|Metformin|metformin|mesh-list
5748283|NCT03051451|Fluoxetine|fluoxetine|mesh-list
5748284|NCT03051451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5748285|NCT03051451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748286|NCT03051451|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5748287|NCT03051451|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5748288|NCT03051451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5748289|NCT03051451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748290|NCT03051451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5748291|NCT03051451|Serotonin Agents|serotonin agents|mesh-ancestor
5748292|NCT03051451|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5748293|NCT03051451|Antidepressive Agents|antidepressive agents|mesh-ancestor
5748294|NCT03051451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5624912|NCT04572815|Growth Inhibitors|growth inhibitors|mesh-ancestor
5624913|NCT04572815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5624914|NCT04572295|Fulvestrant|fulvestrant|mesh-list
5624915|NCT04572295|Exemestane|exemestane|mesh-list
5624916|NCT04572295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5624917|NCT04572295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5624918|NCT04572295|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5624919|NCT04572295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5624920|NCT04572295|Hormone Antagonists|hormone antagonists|mesh-ancestor
5624921|NCT04572295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5748295|NCT03051451|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5748296|NCT03051451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5748297|NCT03051451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5748298|NCT03051373|Gemcitabine|gemcitabine|mesh-list
5748299|NCT03051373|Paclitaxel|paclitaxel|mesh-list
5748300|NCT03051373|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5748301|NCT03051373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5748302|NCT03051373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5748303|NCT03051373|Tubulin Modulators|tubulin modulators|mesh-ancestor
5748304|NCT03051373|Antimitotic Agents|antimitotic agents|mesh-ancestor
5748305|NCT03051373|Mitosis Modulators|mitosis modulators|mesh-ancestor
5748306|NCT03051373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748307|NCT03051373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5748308|NCT03051373|Antimetabolites|antimetabolites|mesh-ancestor
5624922|NCT04572295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5624923|NCT04572295|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5624924|NCT04572295|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5624925|NCT04572295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5624926|NCT04572295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5624927|NCT04560127|Apatinib|apatinib|mesh-list
5624928|NCT04560127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5624929|NCT04560127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5748309|NCT03051373|Antiviral Agents|antiviral agents|mesh-ancestor
5748310|NCT03051373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5748311|NCT03051373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5748312|NCT03051373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5748313|NCT03051373|Immunologic Factors|immunologic factors|mesh-ancestor
5748314|NCT03051373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748315|NCT03051087|Ganirelix|ganirelix|mesh-list
5748316|NCT03051087|Hormone Antagonists|hormone antagonists|mesh-ancestor
5748317|NCT03051087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5748318|NCT03051087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748319|NCT03051269|Calcium, Dietary|calcium, dietary|mesh-list
5748320|NCT03051269|Calcium|calcium|mesh-list
5748321|NCT03051269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5748322|NCT03051269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748323|NCT03051269|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5748324|NCT03051243|Insulin|insulin|mesh-list
5748325|NCT03051243|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5748326|NCT03051243|Linagliptin|linagliptin|mesh-list
5748327|NCT03051243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5748328|NCT03051243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748329|NCT03051243|Incretins|incretins|mesh-ancestor
5748330|NCT03051243|Hormones|hormones|mesh-ancestor
5748331|NCT03051243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5748332|NCT03051243|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5748333|NCT03051243|Protease Inhibitors|protease inhibitors|mesh-ancestor
5748334|NCT03051243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5748335|NCT03051243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748336|NCT03050866|Antiemetics|antiemetics|mesh-list
5748337|NCT03050866|Histamine|histamine|mesh-list
5748338|NCT03050866|Histamine Antagonists|histamine antagonists|mesh-list
5748339|NCT03050866|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
5748340|NCT03050866|Histamine Agonists|histamine agonists|mesh-ancestor
5748341|NCT03050866|Histamine Agents|histamine agents|mesh-ancestor
5748342|NCT03050866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5748343|NCT03050866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748344|NCT03050866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748345|NCT03050866|Autonomic Agents|autonomic agents|mesh-ancestor
5748346|NCT03050866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5748347|NCT03050866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5748348|NCT03050905|Ritonavir|ritonavir|mesh-list
5748349|NCT03050905|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5748350|NCT03050905|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5748351|NCT03050905|Protease Inhibitors|protease inhibitors|mesh-ancestor
5748352|NCT03050905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5748353|NCT03050905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748354|NCT03050905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5748355|NCT03050905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5748356|NCT03050905|Antiviral Agents|antiviral agents|mesh-ancestor
5748357|NCT03050905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5748358|NCT03050905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5748359|NCT03050905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5748360|NCT03050827|Oxybutynin|oxybutynin|mesh-list
5748361|NCT03050827|Parasympatholytics|parasympatholytics|mesh-ancestor
5748362|NCT03050827|Autonomic Agents|autonomic agents|mesh-ancestor
5748363|NCT03050827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5748364|NCT03050827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748365|NCT03050827|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5748366|NCT03050827|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5748367|NCT03050827|Cholinergic Agents|cholinergic agents|mesh-ancestor
5748368|NCT03050827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5748369|NCT03050827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748370|NCT03050827|Urological Agents|urological agents|mesh-ancestor
5748371|NCT03050957|Menthol|menthol|mesh-list
5748372|NCT03050957|Antipruritics|antipruritics|mesh-ancestor
5748373|NCT03050957|Dermatologic Agents|dermatologic agents|mesh-ancestor
5748374|NCT03051009|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
5748375|NCT03051009|Hemostatics|hemostatics|mesh-ancestor
5748376|NCT03051009|Coagulants|coagulants|mesh-ancestor
5748377|NCT03051009|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5748378|NCT03051009|Natriuretic Agents|natriuretic agents|mesh-ancestor
5748379|NCT03051009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748380|NCT03051022|Dexamethasone|dexamethasone|mesh-list
5748381|NCT03051022|Morphine|morphine|mesh-list
5624930|NCT04560127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5624931|NCT04560127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5624932|NCT04544098|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
5624933|NCT04544098|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5624934|NCT04544098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5624935|NCT04526132|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
5624936|NCT04526132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5624937|NCT04526132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5624938|NCT04526132|Analgesics|analgesics|mesh-ancestor
5624939|NCT04526132|Sensory System Agents|sensory system agents|mesh-ancestor
5624940|NCT04526132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5624941|NCT04526132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5624942|NCT04526132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5624943|NCT04526132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5624944|NCT04522973|Ethanol|ethanol|mesh-list
5624945|NCT04522973|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5624946|NCT04522973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5624947|NCT04522973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5624948|NCT04522973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5624949|NCT04518345|Azacitidine|azacitidine|mesh-list
5624950|NCT04518345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5624951|NCT04518345|Antimetabolites|antimetabolites|mesh-ancestor
5624952|NCT04518345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5624953|NCT04518345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5624954|NCT04518345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5624955|NCT04515472|Hormones|hormones|mesh-list
5624956|NCT04515472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5624957|NCT04515472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5624958|NCT04512079|Enoxaparin|enoxaparin|mesh-list
5624959|NCT04512079|Apixaban|apixaban|mesh-list
5624960|NCT04512079|Anticoagulants|anticoagulants|mesh-ancestor
5624961|NCT04512079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5624962|NCT04512079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5624963|NCT04512079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5624964|NCT04512079|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5624965|NCT04512079|Antithrombins|antithrombins|mesh-ancestor
5624966|NCT04512079|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5624967|NCT04512079|Protease Inhibitors|protease inhibitors|mesh-ancestor
5624968|NCT04512079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5624969|NCT04511247|Sirolimus|sirolimus|mesh-list
5748382|NCT03051022|Bupivacaine|bupivacaine|mesh-list
5748383|NCT03051022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5748384|NCT03051022|Antiemetics|antiemetics|mesh-ancestor
5748385|NCT03051022|Autonomic Agents|autonomic agents|mesh-ancestor
5748386|NCT03051022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5748387|NCT03051022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748388|NCT03051022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5748389|NCT03051022|Glucocorticoids|glucocorticoids|mesh-ancestor
5748390|NCT03051022|Hormones|hormones|mesh-ancestor
5748391|NCT03051022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5748392|NCT03051022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5748393|NCT03051022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5748394|NCT03051022|Anesthetics, Local|anesthetics, local|mesh-ancestor
5748395|NCT03051022|Anesthetics|anesthetics|mesh-ancestor
5748396|NCT03051022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5748397|NCT03051022|Sensory System Agents|sensory system agents|mesh-ancestor
5748398|NCT03051022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5748399|NCT03051022|Narcotics|narcotics|mesh-ancestor
5748400|NCT03051022|Analgesics|analgesics|mesh-ancestor
5748401|NCT03050736|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
5748402|NCT03050736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5748403|NCT03050736|Alkylating Agents|alkylating agents|mesh-ancestor
5748404|NCT03050736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748405|NCT03050736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5748406|NCT03050710|Lidocaine|lidocaine|mesh-list
5748407|NCT03050710|Anesthetics, Local|anesthetics, local|mesh-ancestor
5748408|NCT03050710|Anesthetics|anesthetics|mesh-ancestor
5624970|NCT04511247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5624971|NCT04511247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5624972|NCT04511247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5624973|NCT04511247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5624974|NCT04511247|Antifungal Agents|antifungal agents|mesh-ancestor
5624975|NCT04511247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5624976|NCT04511247|Immunologic Factors|immunologic factors|mesh-ancestor
5624977|NCT04511247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5624978|NCT04511234|Sirolimus|sirolimus|mesh-list
5624979|NCT04511234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5624980|NCT04511234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5624981|NCT04511234|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5624982|NCT04511234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5624983|NCT04511234|Antifungal Agents|antifungal agents|mesh-ancestor
5624984|NCT04511234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5748409|NCT03050710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5748410|NCT03050710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748411|NCT03050710|Sensory System Agents|sensory system agents|mesh-ancestor
5748412|NCT03050710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5748413|NCT03050710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5748414|NCT03050710|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5748415|NCT03050710|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5748416|NCT03050710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5748417|NCT03050710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748418|NCT03050437|Pemetrexed|pemetrexed|mesh-list
5748419|NCT03050437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5748420|NCT03050437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5748421|NCT03050437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748422|NCT03050437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5748423|NCT03050437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5894299|NCT05021861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5894300|NCT05021861|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5894301|NCT05021861|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5894302|NCT05021861|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5894303|NCT05021861|Androgen Antagonists|androgen antagonists|mesh-ancestor
5894304|NCT05021861|Hormone Antagonists|hormone antagonists|mesh-ancestor
5894305|NCT05021861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5894306|NCT05021861|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5894307|NCT04995874|Micronutrients|micronutrients|mesh-list
5894308|NCT04995874|Trace Elements|trace elements|mesh-list
5894309|NCT04995874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894310|NCT04990921|Pembrolizumab|pembrolizumab|mesh-list
5894311|NCT04990921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5894312|NCT04990921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5894313|NCT04961281|Triamcinolone|triamcinolone|mesh-list
5894314|NCT04961281|Dexmedetomidine|dexmedetomidine|mesh-list
5894315|NCT04961281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5894316|NCT04961281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5894317|NCT04961281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894318|NCT04961281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5894319|NCT04961281|Analgesics|analgesics|mesh-ancestor
5894320|NCT04961281|Sensory System Agents|sensory system agents|mesh-ancestor
5894321|NCT04961281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5894322|NCT04961281|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5894323|NCT04961281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5894324|NCT04961281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5894325|NCT04961281|Adrenergic Agents|adrenergic agents|mesh-ancestor
5894326|NCT04961281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5907786|NCT05198804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5624985|NCT04511234|Immunologic Factors|immunologic factors|mesh-ancestor
5624986|NCT04511234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5624987|NCT04491617|Analgesics, Opioid|analgesics, opioid|mesh-list
5624988|NCT04491617|Narcotics|narcotics|mesh-ancestor
5624989|NCT04491617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5624990|NCT04491617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748424|NCT03050411|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5748425|NCT03050411|Apatinib|apatinib|mesh-list
5748426|NCT03050411|Gefitinib|gefitinib|mesh-list
5624991|NCT04491617|Analgesics|analgesics|mesh-ancestor
5624992|NCT04491617|Sensory System Agents|sensory system agents|mesh-ancestor
5624993|NCT04491617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5624994|NCT04450654|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5624995|NCT04450654|Immunologic Factors|immunologic factors|mesh-ancestor
5624996|NCT04450654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5624997|NCT04437485|Norepinephrine|norepinephrine|mesh-list
5624998|NCT04437485|Bupropion|bupropion|mesh-list
5624999|NCT04437485|Antidepressive Agents|antidepressive agents|mesh-list
5625000|NCT04437485|Serotonin|serotonin|mesh-list
5625001|NCT04437485|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
5748427|NCT03050411|Osimertinib|osimertinib|mesh-list
5748428|NCT03050411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5748429|NCT03050411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5748430|NCT03050411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5748431|NCT03050411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748432|NCT03050554|Avelumab|avelumab|mesh-list
5748433|NCT03050554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5748434|NCT03050554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5748435|NCT03050086|Minocycline|minocycline|mesh-list
5748436|NCT03050086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5625002|NCT04437485|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5625003|NCT04437485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5625004|NCT04437485|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5625005|NCT04437485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5625006|NCT04437485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5625007|NCT04437485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625008|NCT04437485|Dopamine Agents|dopamine agents|mesh-ancestor
5625009|NCT04437485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5625010|NCT04437485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625011|NCT04437485|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5625012|NCT04437485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5625013|NCT04437485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5625014|NCT04437485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5625015|NCT04437485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5625016|NCT04437485|Adrenergic Agents|adrenergic agents|mesh-ancestor
5625017|NCT04437485|Sympathomimetics|sympathomimetics|mesh-ancestor
5625018|NCT04437485|Autonomic Agents|autonomic agents|mesh-ancestor
5625019|NCT04437485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5625020|NCT04437485|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5625021|NCT04437485|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5625022|NCT04437485|Serotonin Agents|serotonin agents|mesh-ancestor
5625023|NCT04436224|Fentanyl|fentanyl|mesh-list
5625024|NCT04436224|Hydromorphone|hydromorphone|mesh-list
5625025|NCT04436224|Butorphanol|butorphanol|mesh-list
5625026|NCT04436224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5625027|NCT04436224|Narcotics|narcotics|mesh-ancestor
5625028|NCT04436224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5625029|NCT04436224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625030|NCT04436224|Analgesics|analgesics|mesh-ancestor
5748437|NCT03050086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5748438|NCT03050242|Glycopyrrolate|glycopyrrolate|mesh-list
5748439|NCT03050242|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5748440|NCT03050242|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5748441|NCT03050242|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5748442|NCT03050242|Cholinergic Agents|cholinergic agents|mesh-ancestor
5748443|NCT03050242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5625031|NCT04436224|Sensory System Agents|sensory system agents|mesh-ancestor
5625032|NCT04436224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5625033|NCT04436224|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5625034|NCT04436224|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5625035|NCT04436224|Anesthetics, General|anesthetics, general|mesh-ancestor
5625036|NCT04436224|Anesthetics|anesthetics|mesh-ancestor
5625037|NCT04436224|Antitussive Agents|antitussive agents|mesh-ancestor
5625038|NCT04436224|Respiratory System Agents|respiratory system agents|mesh-ancestor
5625039|NCT04436224|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5625040|NCT04433988|Pentoxifylline|pentoxifylline|mesh-list
5748444|NCT03050242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748445|NCT03050242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748446|NCT03050177|Gefitinib|gefitinib|mesh-list
5625041|NCT04433988|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5625042|NCT04433988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5625043|NCT04433988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748447|NCT03050177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5748448|NCT03050177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5748449|NCT03050177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5748450|NCT03050177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748451|NCT03050229|Empagliflozin|empagliflozin|mesh-list
5748452|NCT03050229|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5748453|NCT03050229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625044|NCT04433988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5625045|NCT04433988|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5625046|NCT04433988|Protective Agents|protective agents|mesh-ancestor
5625047|NCT04433988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625048|NCT04433988|Vasodilator Agents|vasodilator agents|mesh-ancestor
5625049|NCT04433988|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5625050|NCT04433988|Antioxidants|antioxidants|mesh-ancestor
5625051|NCT04414722|Amoxicillin|amoxicillin|mesh-list
5625052|NCT04414722|Clavulanic Acid|clavulanic acid|mesh-list
5625053|NCT04414722|Clavulanic Acids|clavulanic acids|mesh-list
5625054|NCT04414722|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5625055|NCT04414722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5625056|NCT04414722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5625057|NCT04414722|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5625058|NCT04414722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5625059|NCT04414722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625060|NCT04410341|Vildagliptin|vildagliptin|mesh-list
5625061|NCT04410341|Citalopram|citalopram|mesh-list
5625062|NCT04410341|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5625063|NCT04410341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5625064|NCT04410341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5625065|NCT04410341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625066|NCT04410341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5625067|NCT04410341|Serotonin Agents|serotonin agents|mesh-ancestor
5625068|NCT04410341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625069|NCT04410341|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5625070|NCT04410341|Antidepressive Agents|antidepressive agents|mesh-ancestor
5625071|NCT04410341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5625072|NCT04410341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5748454|NCT03050229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5748455|NCT03050229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748456|NCT03050164|Gefitinib|gefitinib|mesh-list
5748457|NCT03050164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5748458|NCT03050164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5748459|NCT03050164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5748460|NCT03050164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748461|NCT03049930|Ketamine|ketamine|mesh-list
5748462|NCT03049930|Analgesics|analgesics|mesh-ancestor
5748463|NCT03049930|Sensory System Agents|sensory system agents|mesh-ancestor
5748464|NCT03049930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5748465|NCT03049930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625073|NCT04410341|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5625074|NCT04410341|Protease Inhibitors|protease inhibitors|mesh-ancestor
5625075|NCT04410341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5625076|NCT04383938|Pembrolizumab|pembrolizumab|mesh-list
5625077|NCT04383938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5748466|NCT03049930|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5748467|NCT03049930|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5748468|NCT03049930|Anesthetics, General|anesthetics, general|mesh-ancestor
5748469|NCT03049930|Anesthetics|anesthetics|mesh-ancestor
5748470|NCT03049930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5748471|NCT03049930|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5748472|NCT03049930|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5625078|NCT04383938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5625079|NCT04381936|Aspirin|aspirin|mesh-list
5625080|NCT04381936|Empagliflozin|empagliflozin|mesh-list
5625081|NCT04381936|Ritonavir|ritonavir|mesh-list
5625082|NCT04381936|Lopinavir|lopinavir|mesh-list
5625083|NCT04381936|Azithromycin|azithromycin|mesh-list
5625084|NCT04381936|Hydroxychloroquine|hydroxychloroquine|mesh-list
5625085|NCT04381936|Colchicine|colchicine|mesh-list
5625086|NCT04381936|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5625087|NCT04381936|Dimethyl Fumarate|dimethyl fumarate|mesh-list
5625088|NCT04381936|Antibodies|antibodies|mesh-list
5625089|NCT04381936|Immunoglobulins|immunoglobulins|mesh-list
5625090|NCT04381936|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5625091|NCT04381936|Immunologic Factors|immunologic factors|mesh-ancestor
5625092|NCT04381936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748473|NCT03049930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5748474|NCT03049930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748475|NCT03049878|Acetaminophen|acetaminophen|mesh-list
5748476|NCT03049878|Codeine|codeine|mesh-list
5748477|NCT03049878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5748478|NCT03049878|Analgesics|analgesics|mesh-ancestor
5748479|NCT03049878|Sensory System Agents|sensory system agents|mesh-ancestor
5748480|NCT03049878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5748481|NCT03049878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748482|NCT03049878|Antipyretics|antipyretics|mesh-ancestor
5748483|NCT03049878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5748484|NCT03049878|Narcotics|narcotics|mesh-ancestor
5625093|NCT04381936|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5625094|NCT04381936|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5625095|NCT04381936|Analgesics|analgesics|mesh-ancestor
5625096|NCT04381936|Sensory System Agents|sensory system agents|mesh-ancestor
5748485|NCT03049878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5748486|NCT03049878|Antitussive Agents|antitussive agents|mesh-ancestor
5748487|NCT03049878|Respiratory System Agents|respiratory system agents|mesh-ancestor
5748488|NCT03049163|Proxymetacaine|proxymetacaine|mesh-list
5748489|NCT03049163|Propoxycaine|propoxycaine|mesh-list
5748490|NCT03049163|Anesthetics|anesthetics|mesh-ancestor
5748491|NCT03049163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5748492|NCT03049163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748493|NCT03049163|Anesthetics, Local|anesthetics, local|mesh-ancestor
5748494|NCT03049163|Sensory System Agents|sensory system agents|mesh-ancestor
5748495|NCT03049163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5748496|NCT03049306|Propranolol|propranolol|mesh-list
5748497|NCT03049306|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5748498|NCT03049306|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5748499|NCT03049306|Adrenergic Agents|adrenergic agents|mesh-ancestor
5748500|NCT03049306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5748501|NCT03049306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748502|NCT03049306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748503|NCT03049306|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5748504|NCT03049306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5748505|NCT03049306|Vasodilator Agents|vasodilator agents|mesh-ancestor
5748506|NCT03049176|Tenofovir|tenofovir|mesh-list
5748507|NCT03049176|Emtricitabine|emtricitabine|mesh-list
5748508|NCT03049176|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5748509|NCT03049176|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
5748510|NCT03049176|Antiviral Agents|antiviral agents|mesh-ancestor
5748511|NCT03049176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5748512|NCT03049176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5748513|NCT03049176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5748514|NCT03049176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5748515|NCT03049176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748516|NCT03049176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5748517|NCT03049059|Hydroquinone|hydroquinone|mesh-list
5748518|NCT03049059|Antioxidants|antioxidants|mesh-ancestor
5748519|NCT03049059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748520|NCT03049059|Protective Agents|protective agents|mesh-ancestor
5748521|NCT03049059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748522|NCT03049059|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5748523|NCT03049293|Midazolam|midazolam|mesh-list
5748524|NCT03049293|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5748525|NCT03049293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5748526|NCT03049293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5748527|NCT03049293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748528|NCT03049293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5748529|NCT03049293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5748530|NCT03049293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5748531|NCT03049293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5748532|NCT03049293|Anesthetics, General|anesthetics, general|mesh-ancestor
5748533|NCT03049293|Anesthetics|anesthetics|mesh-ancestor
5748534|NCT03049293|GABA Modulators|gaba modulators|mesh-ancestor
5748535|NCT03049293|GABA Agents|gaba agents|mesh-ancestor
5748536|NCT03049293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5908771|NCT04129554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5625097|NCT04381936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5625098|NCT04381936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5625099|NCT04381936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5625100|NCT04381936|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5625101|NCT04381936|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5625102|NCT04381936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748537|NCT03049293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748538|NCT03049267|Apremilast|apremilast|mesh-list
5748539|NCT03049267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5748540|NCT03049267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5748541|NCT03049267|Analgesics|analgesics|mesh-ancestor
5748542|NCT03049267|Sensory System Agents|sensory system agents|mesh-ancestor
5748543|NCT03049267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5748544|NCT03049267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625103|NCT04381936|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5625104|NCT04381936|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5625105|NCT04381936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5625106|NCT04381936|Antipyretics|antipyretics|mesh-ancestor
5625107|NCT04381936|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5625108|NCT04381936|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5625109|NCT04381936|Protease Inhibitors|protease inhibitors|mesh-ancestor
5625110|NCT04381936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5748545|NCT03049267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5748546|NCT03049267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5748547|NCT03049267|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5748548|NCT03049267|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5748549|NCT03049267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5748550|NCT03049267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748551|NCT03049046|Caffeic acid|caffeic acid|mesh-list
5748552|NCT03049046|Antioxidants|antioxidants|mesh-ancestor
5748553|NCT03049046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748554|NCT03049046|Protective Agents|protective agents|mesh-ancestor
5748555|NCT03049046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748556|NCT03049085|Aspirin|aspirin|mesh-list
5748557|NCT03049085|Ascorbic Acid|ascorbic acid|mesh-list
5748558|NCT03049085|Vitamins|vitamins|mesh-ancestor
5748559|NCT03049085|Micronutrients|micronutrients|mesh-ancestor
5748560|NCT03049085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625111|NCT04381936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5625112|NCT04381936|Antiviral Agents|antiviral agents|mesh-ancestor
5625113|NCT04381936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5625114|NCT04381936|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5625115|NCT04381936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5625116|NCT04381936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5625117|NCT04381936|Antimalarials|antimalarials|mesh-ancestor
5625118|NCT04381936|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5625119|NCT04381936|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5625120|NCT04381936|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5625121|NCT04381936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5625122|NCT04381936|Gout Suppressants|gout suppressants|mesh-ancestor
5625123|NCT04381936|Tubulin Modulators|tubulin modulators|mesh-ancestor
5625124|NCT04381936|Antimitotic Agents|antimitotic agents|mesh-ancestor
5625125|NCT04381936|Mitosis Modulators|mitosis modulators|mesh-ancestor
5748561|NCT03049085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5748562|NCT03049085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5748563|NCT03049085|Analgesics|analgesics|mesh-ancestor
5748564|NCT03049085|Sensory System Agents|sensory system agents|mesh-ancestor
5748565|NCT03049085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5748566|NCT03049085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5748567|NCT03049085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5748568|NCT03049085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5748569|NCT03049085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5625126|NCT04381936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5625127|NCT04381936|Dermatologic Agents|dermatologic agents|mesh-ancestor
5625128|NCT04381936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5692911|NCT03404661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692912|NCT03404635|Rivaroxaban|rivaroxaban|mesh-list
5692913|NCT03404635|Apixaban|apixaban|mesh-list
5692914|NCT03404635|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5692915|NCT03404635|Antithrombins|antithrombins|mesh-ancestor
5692916|NCT03404635|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5692917|NCT03404635|Protease Inhibitors|protease inhibitors|mesh-ancestor
5692918|NCT03404635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5692919|NCT03404635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692920|NCT03404635|Anticoagulants|anticoagulants|mesh-ancestor
5692921|NCT03404544|Carbetocin|carbetocin|mesh-list
5692922|NCT03404544|Oxytocin|oxytocin|mesh-list
5692923|NCT03404544|Oxytocics|oxytocics|mesh-ancestor
5748570|NCT03049085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748571|NCT03049085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5748572|NCT03049085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5692924|NCT03404544|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5625129|NCT04374019|Artesunate|artesunate|mesh-list
5625130|NCT04374019|Ivermectin|ivermectin|mesh-list
5625131|NCT04374019|Camostat|camostat|mesh-list
5625132|NCT04374019|Antimalarials|antimalarials|mesh-ancestor
5625133|NCT04374019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5625134|NCT04374019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5625135|NCT04374019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5625136|NCT04374019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5625137|NCT04374019|Antiviral Agents|antiviral agents|mesh-ancestor
5625138|NCT04374019|Schistosomicides|schistosomicides|mesh-ancestor
5625139|NCT04374019|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5625140|NCT04374019|Anthelmintics|anthelmintics|mesh-ancestor
5625141|NCT04374019|Protease Inhibitors|protease inhibitors|mesh-ancestor
5625142|NCT04374019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5625143|NCT04374019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625144|NCT04374019|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5625145|NCT04374019|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5625146|NCT04372927|Cisplatin|cisplatin|mesh-list
5625147|NCT04372927|Etoposide|etoposide|mesh-list
5625148|NCT04372927|Pemetrexed|pemetrexed|mesh-list
5625149|NCT04372927|Etoposide phosphate|etoposide phosphate|mesh-list
5625150|NCT04372927|Durvalumab|durvalumab|mesh-list
5625151|NCT04372927|Podophyllotoxin|podophyllotoxin|mesh-list
5625152|NCT04372927|Immunoglobulins|immunoglobulins|mesh-list
5625153|NCT04372927|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5748573|NCT03049085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5748574|NCT03049085|Antipyretics|antipyretics|mesh-ancestor
5748575|NCT03049085|Antioxidants|antioxidants|mesh-ancestor
5748576|NCT03049085|Protective Agents|protective agents|mesh-ancestor
5748577|NCT03049345|Methylene Blue|methylene blue|mesh-list
5748578|NCT03049345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5748579|NCT03049345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894327|NCT04961281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894328|NCT04961281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5894329|NCT04961281|Glucocorticoids|glucocorticoids|mesh-ancestor
5894330|NCT04961281|Hormones|hormones|mesh-ancestor
5894331|NCT04961281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5894332|NCT04949191|Pembrolizumab|pembrolizumab|mesh-list
5894333|NCT04949191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5894334|NCT04949191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5894335|NCT04941664|Levobupivacaine|levobupivacaine|mesh-list
5894336|NCT04941664|Anesthetics, Local|anesthetics, local|mesh-ancestor
5894337|NCT04941664|Anesthetics|anesthetics|mesh-ancestor
5894338|NCT04941664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5894339|NCT04941664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894340|NCT04941664|Sensory System Agents|sensory system agents|mesh-ancestor
5894341|NCT04941664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5894342|NCT04918186|Durvalumab|durvalumab|mesh-list
5894343|NCT04918186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5894344|NCT04918186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5894345|NCT04908371|Lidocaine|lidocaine|mesh-list
5894346|NCT04908371|Epinephrine|epinephrine|mesh-list
5894347|NCT04908371|Racepinephrine|racepinephrine|mesh-list
5894348|NCT04908371|Levobupivacaine|levobupivacaine|mesh-list
5894349|NCT04908371|Epinephryl borate|epinephryl borate|mesh-list
5894350|NCT04908371|Anesthetics, Local|anesthetics, local|mesh-ancestor
5894351|NCT04908371|Anesthetics|anesthetics|mesh-ancestor
5894352|NCT04908371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5894353|NCT04908371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894354|NCT04908371|Sensory System Agents|sensory system agents|mesh-ancestor
5894355|NCT04908371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5894356|NCT04908371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5894357|NCT04908371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5625154|NCT04372927|Immunoglobulin G|immunoglobulin g|mesh-list
5625155|NCT04372927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5625156|NCT04372927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5625157|NCT04372927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5625158|NCT04372927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5625159|NCT04372927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5625160|NCT04372927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894358|NCT04908371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5894359|NCT04908371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5625161|NCT04372927|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5625162|NCT04372927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5625163|NCT04372927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5625164|NCT04372927|Immunologic Factors|immunologic factors|mesh-ancestor
5894360|NCT04908371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748580|NCT03048877|Apatinib|apatinib|mesh-list
5748581|NCT03048877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5748582|NCT03048877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5748583|NCT03048877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5748584|NCT03048877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748585|NCT03048825|Colchicine|colchicine|mesh-list
5625165|NCT04372927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625166|NCT04372927|Keratolytic Agents|keratolytic agents|mesh-ancestor
5625167|NCT04372927|Dermatologic Agents|dermatologic agents|mesh-ancestor
5625168|NCT04372927|Tubulin Modulators|tubulin modulators|mesh-ancestor
5625169|NCT04372927|Antimitotic Agents|antimitotic agents|mesh-ancestor
5625170|NCT04372927|Mitosis Modulators|mitosis modulators|mesh-ancestor
5625171|NCT04357730|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5625172|NCT04357730|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5625173|NCT04357730|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5625174|NCT04357730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625175|NCT04344678|Sildenafil Citrate|sildenafil citrate|mesh-list
5748586|NCT03048825|Spironolactone|spironolactone|mesh-list
5748587|NCT03048825|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5748588|NCT03048825|Hormone Antagonists|hormone antagonists|mesh-ancestor
5748589|NCT03048825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5748590|NCT03048825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748591|NCT03048825|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5748592|NCT03048825|Diuretics|diuretics|mesh-ancestor
5748593|NCT03048825|Natriuretic Agents|natriuretic agents|mesh-ancestor
5748594|NCT03048825|Gout Suppressants|gout suppressants|mesh-ancestor
5748595|NCT03048825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5748596|NCT03048825|Tubulin Modulators|tubulin modulators|mesh-ancestor
5748597|NCT03048825|Antimitotic Agents|antimitotic agents|mesh-ancestor
5748598|NCT03048825|Mitosis Modulators|mitosis modulators|mesh-ancestor
5748599|NCT03048825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748600|NCT03048825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5748601|NCT03048942|Paclitaxel|paclitaxel|mesh-list
5748602|NCT03048942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5748603|NCT03048942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5748604|NCT03048942|Tubulin Modulators|tubulin modulators|mesh-ancestor
5748605|NCT03048942|Antimitotic Agents|antimitotic agents|mesh-ancestor
5748606|NCT03048942|Mitosis Modulators|mitosis modulators|mesh-ancestor
5748607|NCT03048942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748608|NCT03048643|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5748609|NCT03048643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5748610|NCT03048474|Nivolumab|nivolumab|mesh-list
5625176|NCT04344678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625177|NCT04344678|Vasodilator Agents|vasodilator agents|mesh-ancestor
5625178|NCT04344678|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5625179|NCT04344678|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5625180|NCT04344678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5625181|NCT04344678|Urological Agents|urological agents|mesh-ancestor
5625182|NCT04338399|Paclitaxel|paclitaxel|mesh-list
5625183|NCT04338399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5625184|NCT04338399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5625185|NCT04338399|Tubulin Modulators|tubulin modulators|mesh-ancestor
5748611|NCT03048474|Ipilimumab|ipilimumab|mesh-list
5748612|NCT03048474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5748613|NCT03048474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5748614|NCT03048474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5748615|NCT03048474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748616|NCT03048578|Liraglutide|liraglutide|mesh-list
5748617|NCT03048578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5748618|NCT03048578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748619|NCT03048578|Incretins|incretins|mesh-ancestor
5748620|NCT03048578|Hormones|hormones|mesh-ancestor
5748621|NCT03048578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5748622|NCT03048214|Anesthetics|anesthetics|mesh-list
5748623|NCT03048214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5748624|NCT03048214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748625|NCT03047928|Nivolumab|nivolumab|mesh-list
5748626|NCT03047928|Vaccines|vaccines|mesh-list
5748627|NCT03047928|Immunologic Factors|immunologic factors|mesh-ancestor
5748628|NCT03047928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748629|NCT03047928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5748630|NCT03047928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5748631|NCT03047928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5625186|NCT04338399|Antimitotic Agents|antimitotic agents|mesh-ancestor
5625187|NCT04338399|Mitosis Modulators|mitosis modulators|mesh-ancestor
5748632|NCT03047928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748633|NCT03048110|Itraconazole|itraconazole|mesh-list
5748634|NCT03048110|Rifampin|rifampin|mesh-list
5748635|NCT03048110|Antifungal Agents|antifungal agents|mesh-ancestor
5748636|NCT03048110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5748637|NCT03048110|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5748638|NCT03048110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5748639|NCT03048110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5748640|NCT03048110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748641|NCT03048110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5748642|NCT03048110|Hormone Antagonists|hormone antagonists|mesh-ancestor
5748643|NCT03048110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5748644|NCT03048110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748645|NCT03048110|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5748646|NCT03048110|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5748647|NCT03048110|Antitubercular Agents|antitubercular agents|mesh-ancestor
5748648|NCT03048110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5748649|NCT03048110|Leprostatic Agents|leprostatic agents|mesh-ancestor
5748650|NCT03048110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5748651|NCT03048110|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5748652|NCT03048110|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5748653|NCT03048110|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5748654|NCT03048110|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5748655|NCT03048110|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5748656|NCT03048110|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5748657|NCT03048097|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5748658|NCT03048097|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5748659|NCT03048097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748660|NCT03047837|Aspirin|aspirin|mesh-list
5748661|NCT03047837|Metformin|metformin|mesh-list
5748662|NCT03047837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5748663|NCT03047837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748664|NCT03047837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5748665|NCT03047837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5748666|NCT03047837|Analgesics|analgesics|mesh-ancestor
5748667|NCT03047837|Sensory System Agents|sensory system agents|mesh-ancestor
5748668|NCT03047837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5748669|NCT03047837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5748670|NCT03047837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5748671|NCT03047837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5748672|NCT03047837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5748673|NCT03047837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748674|NCT03047837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5748675|NCT03047837|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5748676|NCT03047837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5748677|NCT03047837|Antipyretics|antipyretics|mesh-ancestor
5748678|NCT03048084|Levetiracetam|levetiracetam|mesh-list
5748679|NCT03048084|Valproic Acid|valproic acid|mesh-list
5748680|NCT03048084|Anticonvulsants|anticonvulsants|mesh-ancestor
5748681|NCT03048084|Nootropic Agents|nootropic agents|mesh-ancestor
5748682|NCT03048084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5748683|NCT03048084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748684|NCT03048084|GABA Agents|gaba agents|mesh-ancestor
5748685|NCT03048084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5748686|NCT03048084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748687|NCT03048084|Antimanic Agents|antimanic agents|mesh-ancestor
5748688|NCT03048084|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5748689|NCT03048084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5748690|NCT03048084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5625188|NCT04338399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625189|NCT04311463|Paroxetine|paroxetine|mesh-list
5625190|NCT04311463|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5625191|NCT04311463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5625192|NCT04311463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5625193|NCT04311463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625194|NCT04311463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5625195|NCT04311463|Serotonin Agents|serotonin agents|mesh-ancestor
5625196|NCT04311463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625197|NCT04311463|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5625198|NCT04311463|Antidepressive Agents|antidepressive agents|mesh-ancestor
5625199|NCT04311463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5625200|NCT04311463|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5625201|NCT04311463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5625202|NCT04311463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5625203|NCT04295005|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5625204|NCT04295005|Empagliflozin|empagliflozin|mesh-list
5625205|NCT04295005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5625206|NCT04295005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625207|NCT04295005|Incretins|incretins|mesh-ancestor
5748697|NCT03048136|Nivolumab|nivolumab|mesh-list
5748698|NCT03048136|Ipilimumab|ipilimumab|mesh-list
5748699|NCT03048136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5748700|NCT03048136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5748701|NCT03048136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5748702|NCT03048136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748703|NCT03047954|Broncho-Vaxom|broncho-vaxom|mesh-list
5625208|NCT04295005|Hormones|hormones|mesh-ancestor
5625209|NCT04295005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5625210|NCT04295005|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5625211|NCT04295005|Protease Inhibitors|protease inhibitors|mesh-ancestor
5625212|NCT04295005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5748704|NCT03047954|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5748705|NCT03047954|Immunologic Factors|immunologic factors|mesh-ancestor
5748706|NCT03047954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748707|NCT03048019|Tirofiban|tirofiban|mesh-list
5748708|NCT03048019|Cangrelor|cangrelor|mesh-list
5748709|NCT03048019|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5625213|NCT04295005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625214|NCT04295005|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5625215|NCT04291105|Cemiplimab|cemiplimab|mesh-list
5625216|NCT04291105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5625217|NCT04291105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5625218|NCT04265651|Infigratinib|infigratinib|mesh-list
5625219|NCT04265651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5748710|NCT03048019|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5748711|NCT03048019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748712|NCT03048019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5748713|NCT03048019|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5908772|NCT04128696|Pembrolizumab|pembrolizumab|mesh-list
5625220|NCT04225988|Tacrolimus|tacrolimus|mesh-list
5625221|NCT04225988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5625222|NCT04225988|Immunologic Factors|immunologic factors|mesh-ancestor
5625223|NCT04225988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625224|NCT04225988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5625225|NCT04225988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5625226|NCT04225988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625227|NCT04212364|Naloxone|naloxone|mesh-list
5625228|NCT04212364|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5625229|NCT04212364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625230|NCT04212364|Sensory System Agents|sensory system agents|mesh-ancestor
5625231|NCT04212364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5625232|NCT04195750|Everolimus|everolimus|mesh-list
5625233|NCT04195750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5625234|NCT04195750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5625235|NCT04195750|Immunologic Factors|immunologic factors|mesh-ancestor
5625236|NCT04195750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625237|NCT04180436|Rivaroxaban|rivaroxaban|mesh-list
5625238|NCT04180436|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5625239|NCT04180436|Antithrombins|antithrombins|mesh-ancestor
5625240|NCT04180436|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5625241|NCT04180436|Protease Inhibitors|protease inhibitors|mesh-ancestor
5625242|NCT04180436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5625243|NCT04180436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625244|NCT04180436|Anticoagulants|anticoagulants|mesh-ancestor
5625245|NCT04179890|Afatinib|afatinib|mesh-list
5625246|NCT04179890|Mitogens|mitogens|mesh-list
5625247|NCT04179890|Mitosis Modulators|mitosis modulators|mesh-ancestor
5625248|NCT04179890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625249|NCT04179890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5625250|NCT04179890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5625251|NCT04179890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5625252|NCT04175509|Acetaminophen|acetaminophen|mesh-list
5625253|NCT04175509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5625254|NCT04175509|Analgesics|analgesics|mesh-ancestor
5625255|NCT04175509|Sensory System Agents|sensory system agents|mesh-ancestor
5625256|NCT04175509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5625257|NCT04175509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625258|NCT04175509|Antipyretics|antipyretics|mesh-ancestor
5625259|NCT04148105|Cilostazol|cilostazol|mesh-list
5625260|NCT04148105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5625261|NCT04148105|Autonomic Agents|autonomic agents|mesh-ancestor
5748714|NCT03048019|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5748715|NCT03048019|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5748716|NCT03048019|Purinergic Agents|purinergic agents|mesh-ancestor
5748717|NCT03048019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5748718|NCT03048019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748719|NCT03047772|Atorvastatin|atorvastatin|mesh-list
5748720|NCT03047772|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5748721|NCT03047772|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5748722|NCT03047772|Antimetabolites|antimetabolites|mesh-ancestor
5748723|NCT03047772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748724|NCT03047772|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5748725|NCT03047772|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5748726|NCT03047772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5748727|NCT03047538|Amlodipine|amlodipine|mesh-list
5748728|NCT03047538|Perindopril|perindopril|mesh-list
5748729|NCT03047538|Atorvastatin|atorvastatin|mesh-list
5748730|NCT03047538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5748731|NCT03047538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5748732|NCT03047538|Antimetabolites|antimetabolites|mesh-ancestor
5748733|NCT03047538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748734|NCT03047538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5748735|NCT03047538|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5748736|NCT03047538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5748737|NCT03047538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5748738|NCT03047538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5625262|NCT04148105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5625263|NCT04148105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625264|NCT04148105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5625265|NCT04148105|Respiratory System Agents|respiratory system agents|mesh-ancestor
5625266|NCT04148105|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5625267|NCT04148105|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5625268|NCT04148105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625269|NCT04148105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5625270|NCT04148105|Vasodilator Agents|vasodilator agents|mesh-ancestor
5625271|NCT04148105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5625272|NCT04148105|Protective Agents|protective agents|mesh-ancestor
5625273|NCT04148105|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5625274|NCT04148105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5625275|NCT04148105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5625276|NCT04147351|Bevacizumab|bevacizumab|mesh-list
5748739|NCT03047538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5748740|NCT03047538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5748741|NCT03047538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748742|NCT03047538|Vasodilator Agents|vasodilator agents|mesh-ancestor
5748743|NCT03047538|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5748744|NCT03047538|Protease Inhibitors|protease inhibitors|mesh-ancestor
5748745|NCT03047473|Avelumab|avelumab|mesh-list
5748746|NCT03047473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5748747|NCT03047473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5748748|NCT03047499|Botulinum Toxins|botulinum toxins|mesh-list
5748749|NCT03047499|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5748750|NCT03047499|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5748751|NCT03047499|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5748752|NCT03047499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5748753|NCT03047499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748754|NCT03047499|Cholinergic Agents|cholinergic agents|mesh-ancestor
5748755|NCT03047499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5748756|NCT03047499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748757|NCT03047499|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5748758|NCT03047499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5748759|NCT03047733|Tacrolimus|tacrolimus|mesh-list
5625277|NCT04147351|Atezolizumab|atezolizumab|mesh-list
5625278|NCT04147351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5625279|NCT04147351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5625280|NCT04147351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5625281|NCT04147351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5625282|NCT04147351|Growth Substances|growth substances|mesh-ancestor
5625283|NCT04147351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748760|NCT03047733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5748761|NCT03047733|Immunologic Factors|immunologic factors|mesh-ancestor
5748762|NCT03047733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748763|NCT03047733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5748764|NCT03047733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5748765|NCT03047733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894361|NCT04908371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5894362|NCT04908371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5894363|NCT04908371|Adrenergic Agents|adrenergic agents|mesh-ancestor
5894364|NCT04908371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5894365|NCT04908371|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5894366|NCT04908371|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5894367|NCT04908371|Autonomic Agents|autonomic agents|mesh-ancestor
5894368|NCT04908371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5894369|NCT04908371|Respiratory System Agents|respiratory system agents|mesh-ancestor
5894370|NCT04908371|Mydriatics|mydriatics|mesh-ancestor
5894371|NCT04908371|Sympathomimetics|sympathomimetics|mesh-ancestor
5894372|NCT04908371|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5894373|NCT04824144|Dexmedetomidine|dexmedetomidine|mesh-list
5894374|NCT04824144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5894375|NCT04824144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5894376|NCT04824144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894377|NCT04824144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5894378|NCT04824144|Analgesics|analgesics|mesh-ancestor
5894379|NCT04824144|Sensory System Agents|sensory system agents|mesh-ancestor
5894380|NCT04824144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5894381|NCT04824144|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5894382|NCT04824144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5894383|NCT04824144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5894384|NCT04824144|Adrenergic Agents|adrenergic agents|mesh-ancestor
5894385|NCT04824144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5894386|NCT04824144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625284|NCT04147351|Growth Inhibitors|growth inhibitors|mesh-ancestor
5625285|NCT04140396|Lidocaine|lidocaine|mesh-list
5625286|NCT04140396|Anesthetics, Local|anesthetics, local|mesh-ancestor
5625287|NCT04140396|Anesthetics|anesthetics|mesh-ancestor
5625288|NCT04140396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5625289|NCT04140396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625290|NCT04140396|Sensory System Agents|sensory system agents|mesh-ancestor
5894387|NCT04814745|Morphine|morphine|mesh-list
5894388|NCT04814745|Tramadol|tramadol|mesh-list
5894389|NCT04814745|Ropivacaine|ropivacaine|mesh-list
5894390|NCT04814745|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5894391|NCT04814745|Narcotics|narcotics|mesh-ancestor
5894392|NCT04814745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5894393|NCT04814745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894394|NCT04814745|Analgesics|analgesics|mesh-ancestor
5894395|NCT04814745|Sensory System Agents|sensory system agents|mesh-ancestor
5894396|NCT04814745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5894397|NCT04814745|Anesthetics, Local|anesthetics, local|mesh-ancestor
5894398|NCT04814745|Anesthetics|anesthetics|mesh-ancestor
5894399|NCT04752527|Sorafenib|sorafenib|mesh-list
5894400|NCT04752527|Decitabine|decitabine|mesh-list
5625291|NCT04140396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5625292|NCT04140396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5625293|NCT04140396|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5625294|NCT04140396|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5625295|NCT04140396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5625296|NCT04140396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208752|NCT02135432|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6208753|NCT02135432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5625300|NCT04075110|Montelukast|montelukast|mesh-list
5625301|NCT04075110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5625302|NCT04075110|Respiratory System Agents|respiratory system agents|mesh-ancestor
5625303|NCT04075110|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5625304|NCT04075110|Hormone Antagonists|hormone antagonists|mesh-ancestor
5625305|NCT04075110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5894401|NCT04752527|Venetoclax|venetoclax|mesh-list
5748766|NCT03047278|Cetirizine|cetirizine|mesh-list
5748767|NCT03047278|Gabapentin|gabapentin|mesh-list
5748768|NCT03047278|Analgesics|analgesics|mesh-ancestor
5748769|NCT03047278|Sensory System Agents|sensory system agents|mesh-ancestor
5748770|NCT03047278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5748771|NCT03047278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748772|NCT03047278|Anticonvulsants|anticonvulsants|mesh-ancestor
5748773|NCT03047278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5625306|NCT04075110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625307|NCT04075110|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5625308|NCT04075110|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5625309|NCT04075110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625310|NCT04059003|Taxane|taxane|mesh-list
5748774|NCT03047278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5748775|NCT03047278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5748776|NCT03047278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5748777|NCT03047278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5748778|NCT03047278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5748779|NCT03047278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5748780|NCT03047278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748781|NCT03047278|Antimanic Agents|antimanic agents|mesh-ancestor
5748782|NCT03047278|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5748783|NCT03047278|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5748784|NCT03047278|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5748785|NCT03047278|Histamine Antagonists|histamine antagonists|mesh-ancestor
5748786|NCT03047278|Histamine Agents|histamine agents|mesh-ancestor
5748787|NCT03047096|Hyaluronic Acid|hyaluronic acid|mesh-list
5748788|NCT03047096|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5748789|NCT03047096|Immunologic Factors|immunologic factors|mesh-ancestor
5625311|NCT04059003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5625312|NCT04050410|Moxonidine|moxonidine|mesh-list
5625313|NCT04050410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5625314|NCT04046575|Paclitaxel|paclitaxel|mesh-list
5625315|NCT04046575|Carboplatin|carboplatin|mesh-list
5625316|NCT04046575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5625317|NCT04046575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5625318|NCT04046575|Tubulin Modulators|tubulin modulators|mesh-ancestor
5625319|NCT04046575|Antimitotic Agents|antimitotic agents|mesh-ancestor
5625320|NCT04046575|Mitosis Modulators|mitosis modulators|mesh-ancestor
5625321|NCT04046575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625322|NCT04044209|Nivolumab|nivolumab|mesh-list
5625323|NCT04044209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5625324|NCT04044209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5625325|NCT04044209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5625326|NCT04044209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625327|NCT03998813|Ropivacaine|ropivacaine|mesh-list
5625328|NCT03998813|Anesthetics, Local|anesthetics, local|mesh-ancestor
5625329|NCT03998813|Anesthetics|anesthetics|mesh-ancestor
5625330|NCT03998813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5625331|NCT03998813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625332|NCT03998813|Sensory System Agents|sensory system agents|mesh-ancestor
5748790|NCT03047096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748791|NCT03047096|Viscosupplements|viscosupplements|mesh-ancestor
5748792|NCT03047096|Protective Agents|protective agents|mesh-ancestor
5748793|NCT03046953|Avelumab|avelumab|mesh-list
5748794|NCT03046953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5748795|NCT03046953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5748796|NCT03046979|Apatinib|apatinib|mesh-list
5748797|NCT03046979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5748798|NCT03046979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5748799|NCT03046979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5748800|NCT03046979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748801|NCT03047057|Lidocaine|lidocaine|mesh-list
5748802|NCT03047057|Anesthetics, Local|anesthetics, local|mesh-ancestor
5748803|NCT03047057|Anesthetics|anesthetics|mesh-ancestor
5748804|NCT03047057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5748805|NCT03047057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748806|NCT03047057|Sensory System Agents|sensory system agents|mesh-ancestor
5625333|NCT03998813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5625334|NCT03990363|Allopurinol|allopurinol|mesh-list
5625335|NCT03990363|Verinurad|verinurad|mesh-list
5625336|NCT03990363|Antimetabolites|antimetabolites|mesh-ancestor
5625337|NCT03990363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625338|NCT03990363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5625339|NCT03990363|Gout Suppressants|gout suppressants|mesh-ancestor
5748807|NCT03047057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5625340|NCT03990363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5625341|NCT03990363|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5625342|NCT03990363|Antioxidants|antioxidants|mesh-ancestor
5625343|NCT03990363|Protective Agents|protective agents|mesh-ancestor
5625344|NCT03990363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625345|NCT03930186|Apremilast|apremilast|mesh-list
5625346|NCT03930186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5625347|NCT03930186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5625348|NCT03930186|Analgesics|analgesics|mesh-ancestor
5625349|NCT03930186|Sensory System Agents|sensory system agents|mesh-ancestor
5625350|NCT03930186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5625351|NCT03930186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625352|NCT03930186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5625353|NCT03930186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5748808|NCT03047057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5748809|NCT03047057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5748810|NCT03047057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5748811|NCT03047057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5748812|NCT03047057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748813|NCT03047109|Phenylephrine|phenylephrine|mesh-list
5748814|NCT03047109|Oxymetazoline|oxymetazoline|mesh-list
5748815|NCT03047109|Ephedrine|ephedrine|mesh-list
5748816|NCT03047109|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5748817|NCT03047109|Mydriatics|mydriatics|mesh-ancestor
5748818|NCT03047109|Autonomic Agents|autonomic agents|mesh-ancestor
5748819|NCT03047109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5748820|NCT03047109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748821|NCT03047109|Sympathomimetics|sympathomimetics|mesh-ancestor
5748822|NCT03047109|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5748823|NCT03047109|Nasal Decongestants|nasal decongestants|mesh-ancestor
5748824|NCT03047109|Respiratory System Agents|respiratory system agents|mesh-ancestor
5748825|NCT03047109|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5748826|NCT03047109|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5748827|NCT03047109|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5748828|NCT03047109|Adrenergic Agents|adrenergic agents|mesh-ancestor
5748829|NCT03047109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5748830|NCT03047109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748831|NCT03047109|Protective Agents|protective agents|mesh-ancestor
5748832|NCT03047109|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5748833|NCT03047265|Paclitaxel|paclitaxel|mesh-list
5748834|NCT03047265|Cisplatin|cisplatin|mesh-list
5748835|NCT03047265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5748836|NCT03047265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5748837|NCT03047265|Tubulin Modulators|tubulin modulators|mesh-ancestor
5748838|NCT03047265|Antimitotic Agents|antimitotic agents|mesh-ancestor
5748839|NCT03047265|Mitosis Modulators|mitosis modulators|mesh-ancestor
5748840|NCT03047265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748841|NCT03047330|Leuprolide|leuprolide|mesh-list
5748842|NCT03047330|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5748843|NCT03047330|Fertility Agents|fertility agents|mesh-ancestor
5748844|NCT03047330|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5748845|NCT03047330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748846|NCT03047330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5748847|NCT03047330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5748848|NCT03046901|Vancomycin|vancomycin|mesh-list
5748849|NCT03046901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5625354|NCT03930186|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5625355|NCT03930186|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5625356|NCT03930186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5625357|NCT03930186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625358|NCT03911973|Talazoparib|talazoparib|mesh-list
5625359|NCT03911973|Gedatolisib|gedatolisib|mesh-list
5625360|NCT03911973|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5625361|NCT03911973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5625362|NCT03911973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625363|NCT03911973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5625364|NCT03911973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5625365|NCT03910972|Aluminum Hydroxide|aluminum hydroxide|mesh-list
5625366|NCT03910972|Vaccines|vaccines|mesh-list
5625367|NCT03910972|Immunologic Factors|immunologic factors|mesh-ancestor
5748850|NCT03046901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5748851|NCT03046836|Oxytocin|oxytocin|mesh-list
5748852|NCT03046836|Oxytocics|oxytocics|mesh-ancestor
5625368|NCT03910972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748853|NCT03046836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5748854|NCT03046836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748855|NCT03046693|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
5748856|NCT03046693|Nootropic Agents|nootropic agents|mesh-ancestor
5748857|NCT03046758|Metronidazole|metronidazole|mesh-list
5748858|NCT03046758|Fosfomycin|fosfomycin|mesh-list
5748859|NCT03046758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5748860|NCT03046758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5748861|NCT03046758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5748862|NCT03046758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5748863|NCT03046511|Cefazolin|cefazolin|mesh-list
5625369|NCT03910972|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5625370|NCT03910972|Antacids|antacids|mesh-ancestor
5625371|NCT03910972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625372|NCT03910972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5625373|NCT03883828|Chlorhexidine|chlorhexidine|mesh-list
5625374|NCT03883828|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5625375|NCT03883828|Mupirocin|mupirocin|mesh-list
5625376|NCT03883828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5625377|NCT03883828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5625378|NCT03883828|Disinfectants|disinfectants|mesh-ancestor
5625379|NCT03883828|Dermatologic Agents|dermatologic agents|mesh-ancestor
5625380|NCT03883828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5625381|NCT03883828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5748864|NCT03046511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5748865|NCT03046511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5748866|NCT03046719|Bupivacaine|bupivacaine|mesh-list
5748867|NCT03046719|Anesthetics, Local|anesthetics, local|mesh-ancestor
5748868|NCT03046719|Anesthetics|anesthetics|mesh-ancestor
5748869|NCT03046719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5748870|NCT03046719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748871|NCT03046719|Sensory System Agents|sensory system agents|mesh-ancestor
5748872|NCT03046719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5748873|NCT03046082|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5748874|NCT03046082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5748875|NCT03046173|Mitogens|mitogens|mesh-list
5748876|NCT03046173|Mitosis Modulators|mitosis modulators|mesh-ancestor
5748877|NCT03046173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748878|NCT03046017|Lidocaine|lidocaine|mesh-list
5748879|NCT03046017|Anesthetics, Local|anesthetics, local|mesh-ancestor
5748880|NCT03046017|Anesthetics|anesthetics|mesh-ancestor
5748881|NCT03046017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5748882|NCT03046017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748883|NCT03046017|Sensory System Agents|sensory system agents|mesh-ancestor
5748884|NCT03046017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5748885|NCT03046017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5748886|NCT03046017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5748887|NCT03046017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5748888|NCT03046017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5625382|NCT03883828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5625383|NCT03883828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625384|NCT03854474|Pembrolizumab|pembrolizumab|mesh-list
5625385|NCT03854474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5625386|NCT03854474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5625387|NCT03854227|Docetaxel|docetaxel|mesh-list
5625388|NCT03854227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5625389|NCT03854227|Tubulin Modulators|tubulin modulators|mesh-ancestor
5625390|NCT03854227|Antimitotic Agents|antimitotic agents|mesh-ancestor
5625391|NCT03854227|Mitosis Modulators|mitosis modulators|mesh-ancestor
5625392|NCT03854227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625393|NCT03835819|Pembrolizumab|pembrolizumab|mesh-list
5625394|NCT03835819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5625395|NCT03835819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5625396|NCT03817463|Empagliflozin|empagliflozin|mesh-list
5625397|NCT03817463|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
5625398|NCT03817463|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5625399|NCT03817463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625400|NCT03817463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5748889|NCT03046017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748890|NCT03046251|Natalizumab|natalizumab|mesh-list
5748891|NCT03046251|Immunologic Factors|immunologic factors|mesh-ancestor
5748892|NCT03046251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748893|NCT03046108|Triamcinolone|triamcinolone|mesh-list
5625401|NCT03817463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748894|NCT03046108|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5748895|NCT03046108|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5748896|NCT03046108|Mepivacaine|mepivacaine|mesh-list
5748897|NCT03046108|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5748898|NCT03046108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5748899|NCT03046108|Glucocorticoids|glucocorticoids|mesh-ancestor
5748900|NCT03046108|Hormones|hormones|mesh-ancestor
5748901|NCT03046108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5748902|NCT03046108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748903|NCT03046108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5748904|NCT03046108|Immunologic Factors|immunologic factors|mesh-ancestor
5748905|NCT03046108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5748906|NCT03046108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748907|NCT03046108|Anesthetics, Local|anesthetics, local|mesh-ancestor
5748908|NCT03046108|Anesthetics|anesthetics|mesh-ancestor
5748909|NCT03046108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5748910|NCT03046108|Sensory System Agents|sensory system agents|mesh-ancestor
5748911|NCT03046108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5748912|NCT03046290|Lidocaine|lidocaine|mesh-list
5748913|NCT03046290|Ropivacaine|ropivacaine|mesh-list
5748914|NCT03046290|Anesthetics, Local|anesthetics, local|mesh-ancestor
5748915|NCT03046290|Anesthetics|anesthetics|mesh-ancestor
5748916|NCT03046290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5625402|NCT03817463|Protease Inhibitors|protease inhibitors|mesh-ancestor
5625403|NCT03817463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5625404|NCT03787849|Anesthetics|anesthetics|mesh-list
5625405|NCT03787849|Propofol|propofol|mesh-list
5625406|NCT03787849|Sevoflurane|sevoflurane|mesh-list
5625407|NCT03787849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5625408|NCT03787849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625409|NCT03787849|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5625410|NCT03787849|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5625411|NCT03787849|Anesthetics, General|anesthetics, general|mesh-ancestor
5625412|NCT03787849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5748917|NCT03046290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748918|NCT03046290|Sensory System Agents|sensory system agents|mesh-ancestor
5748919|NCT03046290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5748920|NCT03046290|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5748921|NCT03046290|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5748922|NCT03046290|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5748923|NCT03046290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5748924|NCT03046290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748925|NCT03046238|Dexmedetomidine|dexmedetomidine|mesh-list
5748926|NCT03046238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5748927|NCT03046238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5748928|NCT03046238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748929|NCT03046238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5748930|NCT03046238|Analgesics|analgesics|mesh-ancestor
5748931|NCT03046238|Sensory System Agents|sensory system agents|mesh-ancestor
5748932|NCT03046238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5748933|NCT03046238|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5748934|NCT03046238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5748935|NCT03046238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5748936|NCT03046238|Adrenergic Agents|adrenergic agents|mesh-ancestor
5748937|NCT03046238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5748938|NCT03046238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894402|NCT04752527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5625413|NCT03787849|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5625414|NCT03781440|Lidocaine|lidocaine|mesh-list
5625415|NCT03781440|Anesthetics, Local|anesthetics, local|mesh-ancestor
5894403|NCT04752527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5894404|NCT04752527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5894405|NCT04752527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894406|NCT04752527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5894407|NCT04752527|Antimetabolites|antimetabolites|mesh-ancestor
5894408|NCT04738422|Glycine|glycine|mesh-list
5894409|NCT04738422|Glycine Agents|glycine agents|mesh-ancestor
5894410|NCT04738422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5894411|NCT04738422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894412|NCT04738422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894413|NCT04716335|Harmine|harmine|mesh-list
5894414|NCT04716335|Hallucinogens|hallucinogens|mesh-ancestor
5894415|NCT04716335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625416|NCT03781440|Anesthetics|anesthetics|mesh-ancestor
5625417|NCT03781440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5748939|NCT03045783|Cefotiam|cefotiam|mesh-list
5748940|NCT03045783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5748941|NCT03045783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5748942|NCT03045770|Leucovorin|leucovorin|mesh-list
5748943|NCT03045770|Paclitaxel|paclitaxel|mesh-list
5748944|NCT03045770|Fluorouracil|fluorouracil|mesh-list
5748945|NCT03045770|Oxaliplatin|oxaliplatin|mesh-list
5748946|NCT03045770|Irinotecan|irinotecan|mesh-list
5748947|NCT03045770|Calcium|calcium|mesh-list
5748948|NCT03045770|Levoleucovorin|levoleucovorin|mesh-list
5748949|NCT03045770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5748950|NCT03045770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5748951|NCT03045770|Tubulin Modulators|tubulin modulators|mesh-ancestor
5748952|NCT03045770|Antimitotic Agents|antimitotic agents|mesh-ancestor
5748953|NCT03045770|Mitosis Modulators|mitosis modulators|mesh-ancestor
5748954|NCT03045770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748955|NCT03045770|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5748956|NCT03045770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748957|NCT03045770|Antimetabolites|antimetabolites|mesh-ancestor
5748958|NCT03045770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5748959|NCT03045770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5625418|NCT03781440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625419|NCT03781440|Sensory System Agents|sensory system agents|mesh-ancestor
5625420|NCT03781440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5625421|NCT03781440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5625422|NCT03781440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5625423|NCT03781440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5625424|NCT03781440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5625425|NCT03781440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625426|NCT03777319|Prednisolone|prednisolone|mesh-list
5625427|NCT03777319|Spironolactone|spironolactone|mesh-list
5625428|NCT03777319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5625429|NCT03777319|Glucocorticoids|glucocorticoids|mesh-ancestor
5625430|NCT03777319|Hormones|hormones|mesh-ancestor
5625431|NCT03777319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5625432|NCT03777319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625433|NCT03777319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5625434|NCT03777319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5625435|NCT03777319|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5625436|NCT03777319|Hormone Antagonists|hormone antagonists|mesh-ancestor
5625437|NCT03777319|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5625438|NCT03777319|Diuretics|diuretics|mesh-ancestor
5625439|NCT03777319|Natriuretic Agents|natriuretic agents|mesh-ancestor
5625440|NCT03740100|Sirolimus|sirolimus|mesh-list
5625441|NCT03740100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5625442|NCT03740100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5625443|NCT03740100|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5625444|NCT03740100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5625445|NCT03740100|Antifungal Agents|antifungal agents|mesh-ancestor
5625446|NCT03740100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5625447|NCT03740100|Immunologic Factors|immunologic factors|mesh-ancestor
5625448|NCT03740100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692925|NCT03404544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692926|NCT03404518|Acetaminophen|acetaminophen|mesh-list
5692927|NCT03404518|Ibuprofen|ibuprofen|mesh-list
5692928|NCT03404518|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
5692929|NCT03404518|Hydrocodone|hydrocodone|mesh-list
5692930|NCT03404518|Narcotics|narcotics|mesh-list
5692931|NCT03404518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5692932|NCT03404518|Analgesics|analgesics|mesh-ancestor
5692933|NCT03404518|Sensory System Agents|sensory system agents|mesh-ancestor
5692934|NCT03404518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5692935|NCT03404518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692936|NCT03404518|Antipyretics|antipyretics|mesh-ancestor
5692937|NCT03404518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5692938|NCT03404518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5692939|NCT03404518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5692940|NCT03404518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5692941|NCT03404518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5692942|NCT03404518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692943|NCT03404518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5692944|NCT03404518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5692945|NCT03404518|Antitussive Agents|antitussive agents|mesh-ancestor
5692946|NCT03404518|Respiratory System Agents|respiratory system agents|mesh-ancestor
5748960|NCT03045770|Immunologic Factors|immunologic factors|mesh-ancestor
5625449|NCT03687814|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
5625450|NCT03687814|Laxatives|laxatives|mesh-ancestor
5625451|NCT03687814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5748961|NCT03045770|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5748962|NCT03045770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5748963|NCT03045770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5748964|NCT03045770|Antidotes|antidotes|mesh-ancestor
5748965|NCT03045770|Protective Agents|protective agents|mesh-ancestor
5748966|NCT03045770|Vitamin B Complex|vitamin b complex|mesh-ancestor
5748967|NCT03045770|Vitamins|vitamins|mesh-ancestor
5748968|NCT03045770|Micronutrients|micronutrients|mesh-ancestor
5748969|NCT03045627|Cytarabine|cytarabine|mesh-list
5625452|NCT03635983|Nivolumab|nivolumab|mesh-list
5625453|NCT03635983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5625454|NCT03635983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5625455|NCT03635983|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5625456|NCT03635983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625457|NCT03626337|Thiamine|thiamine|mesh-list
5625458|NCT03626337|Vitamin B Complex|vitamin b complex|mesh-ancestor
5625459|NCT03626337|Vitamins|vitamins|mesh-ancestor
5625460|NCT03626337|Micronutrients|micronutrients|mesh-ancestor
5625461|NCT03626337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625462|NCT03600649|Cyclophosphamide|cyclophosphamide|mesh-list
5625463|NCT03600649|Topotecan|topotecan|mesh-list
5625464|NCT03600649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5625465|NCT03600649|Immunologic Factors|immunologic factors|mesh-ancestor
5625466|NCT03600649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625467|NCT03600649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5625468|NCT03600649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5625469|NCT03600649|Alkylating Agents|alkylating agents|mesh-ancestor
5625470|NCT03600649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625471|NCT03600649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5625472|NCT03600649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5625473|NCT03600649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5625474|NCT03600649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5625475|NCT03600649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5625476|NCT03547115|Voruciclib|voruciclib|mesh-list
5625477|NCT03547115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5625478|NCT03547115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5625479|NCT03547115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5625480|NCT03547115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625481|NCT03515304|Evolocumab|evolocumab|mesh-list
5625482|NCT03515304|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5625483|NCT03515304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5625484|NCT03515304|Antimetabolites|antimetabolites|mesh-ancestor
5625485|NCT03515304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625486|NCT03515304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5625487|NCT03501368|Trametinib|trametinib|mesh-list
5625488|NCT03501368|Ceritinib|ceritinib|mesh-list
5625489|NCT03501368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5625490|NCT03501368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5625491|NCT03501368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5625492|NCT03501368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625493|NCT03490513|Anastrozole|anastrozole|mesh-list
5625494|NCT03490513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5625495|NCT03490513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5625496|NCT03490513|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5625497|NCT03490513|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5625498|NCT03490513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5625499|NCT03490513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625500|NCT03490513|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5625501|NCT03490513|Hormone Antagonists|hormone antagonists|mesh-ancestor
5625502|NCT03490513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5625503|NCT03490513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625504|NCT03481660|Aflibercept|aflibercept|mesh-list
5625505|NCT03481660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5625506|NCT03481660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5748970|NCT03045627|Aclarubicin|aclarubicin|mesh-list
5748971|NCT03045627|Lenograstim|lenograstim|mesh-list
5748972|NCT03045627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5748973|NCT03045627|Antimetabolites|antimetabolites|mesh-ancestor
5748974|NCT03045627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5748975|NCT03045627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5748976|NCT03045627|Antiviral Agents|antiviral agents|mesh-ancestor
5625507|NCT03481660|Growth Substances|growth substances|mesh-ancestor
5748977|NCT03045627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5625508|NCT03481660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625509|NCT03481660|Growth Inhibitors|growth inhibitors|mesh-ancestor
5625510|NCT03481660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5625511|NCT03478878|Vitamin A|vitamin a|mesh-list
5625512|NCT03478878|Retinol palmitate|retinol palmitate|mesh-list
5625513|NCT03478878|Vitamins|vitamins|mesh-ancestor
5625514|NCT03478878|Micronutrients|micronutrients|mesh-ancestor
5625515|NCT03478878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625516|NCT03478878|Antioxidants|antioxidants|mesh-ancestor
5748978|NCT03045627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5748979|NCT03045627|Immunologic Factors|immunologic factors|mesh-ancestor
5748980|NCT03045627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748981|NCT03045627|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5748982|NCT03045627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5748983|NCT03045627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5748984|NCT03045627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5748985|NCT03045627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5748986|NCT03045484|Oxycodone|oxycodone|mesh-list
5748987|NCT03045484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5748988|NCT03045484|Narcotics|narcotics|mesh-ancestor
5748989|NCT03045484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5748990|NCT03045484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5748991|NCT03045484|Analgesics|analgesics|mesh-ancestor
5748992|NCT03045484|Sensory System Agents|sensory system agents|mesh-ancestor
5748993|NCT03045484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5748994|NCT03045471|Prednisolone|prednisolone|mesh-list
5748995|NCT03045471|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5748996|NCT03045471|Methylprednisolone|methylprednisolone|mesh-list
5748997|NCT03045471|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5748998|NCT03045471|Prednisolone acetate|prednisolone acetate|mesh-list
5748999|NCT03045471|Cyclophosphamide|cyclophosphamide|mesh-list
5749000|NCT03045471|Rituximab|rituximab|mesh-list
5625517|NCT03478878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625518|NCT03478878|Protective Agents|protective agents|mesh-ancestor
5625519|NCT03478878|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5625520|NCT03478878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5625521|NCT03471728|Linaclotide|linaclotide|mesh-list
5625522|NCT03471728|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
5625523|NCT03471728|Enzyme Activators|enzyme activators|mesh-ancestor
5625524|NCT03471728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625525|NCT03471728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5625526|NCT03463057|Atezolizumab|atezolizumab|mesh-list
5625527|NCT03463057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5625528|NCT03456635|Anti-Infective Agents|anti-infective agents|mesh-list
5625529|NCT03456635|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5625530|NCT03404596|Nicotine|nicotine|mesh-list
5625531|NCT03404596|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5749001|NCT03045471|Etoposide|etoposide|mesh-list
5749002|NCT03045471|Vincristine|vincristine|mesh-list
5749003|NCT03045471|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5749004|NCT03045471|Prednisolone phosphate|prednisolone phosphate|mesh-list
5749005|NCT03045471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5749006|NCT03045471|Immunologic Factors|immunologic factors|mesh-ancestor
5749007|NCT03045471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749008|NCT03045471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5749009|NCT03045471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5749010|NCT03045471|Alkylating Agents|alkylating agents|mesh-ancestor
5749011|NCT03045471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5749012|NCT03045471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5749013|NCT03045471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5749014|NCT03045471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5749015|NCT03045471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5749016|NCT03045471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5749017|NCT03045471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5749018|NCT03045471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5625532|NCT03404596|Autonomic Agents|autonomic agents|mesh-ancestor
5625533|NCT03404596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5625534|NCT03404596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625535|NCT03404596|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5625536|NCT03404596|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5625537|NCT03404596|Cholinergic Agents|cholinergic agents|mesh-ancestor
5625538|NCT03404596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5625539|NCT03404596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625540|NCT03342027|Bupropion|bupropion|mesh-list
5749019|NCT03045471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5749020|NCT03045471|Glucocorticoids|glucocorticoids|mesh-ancestor
5749021|NCT03045471|Hormones|hormones|mesh-ancestor
5625541|NCT03342027|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5625542|NCT03342027|Antidepressive Agents|antidepressive agents|mesh-ancestor
5625543|NCT03342027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5625544|NCT03342027|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5625545|NCT03342027|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5625546|NCT03342027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5625547|NCT03342027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625548|NCT03342027|Dopamine Agents|dopamine agents|mesh-ancestor
5625549|NCT03342027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5625550|NCT03342027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625551|NCT03342027|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5625552|NCT03342027|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5625553|NCT03342027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5625554|NCT03321513|Bevacizumab|bevacizumab|mesh-list
5625555|NCT03321513|Aflibercept|aflibercept|mesh-list
5749022|NCT03045471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5749023|NCT03045471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5749024|NCT03045471|Antiemetics|antiemetics|mesh-ancestor
5749025|NCT03045471|Autonomic Agents|autonomic agents|mesh-ancestor
5749026|NCT03045471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5749027|NCT03045471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5749028|NCT03045471|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5749029|NCT03045471|Protective Agents|protective agents|mesh-ancestor
5749030|NCT03045471|Tubulin Modulators|tubulin modulators|mesh-ancestor
5749031|NCT03045471|Antimitotic Agents|antimitotic agents|mesh-ancestor
5749032|NCT03045471|Mitosis Modulators|mitosis modulators|mesh-ancestor
5749033|NCT03045510|Decitabine|decitabine|mesh-list
5749034|NCT03045510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5749035|NCT03045510|Antimetabolites|antimetabolites|mesh-ancestor
5749036|NCT03045510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5749037|NCT03045510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5749038|NCT03045510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5749039|NCT03045406|Dalteparin|dalteparin|mesh-list
5749040|NCT03045406|Tinzaparin|tinzaparin|mesh-list
5749041|NCT03045406|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5749042|NCT03045406|Apixaban|apixaban|mesh-list
5749043|NCT03045406|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5749044|NCT03045406|Antithrombins|antithrombins|mesh-ancestor
5749045|NCT03045406|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5749046|NCT03045406|Protease Inhibitors|protease inhibitors|mesh-ancestor
5749047|NCT03045406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5749048|NCT03045406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5749049|NCT03045406|Anticoagulants|anticoagulants|mesh-ancestor
5749050|NCT03045406|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5749051|NCT03045406|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5749052|NCT03045185|Metronidazole|metronidazole|mesh-list
5749053|NCT03045185|Ciprofloxacin|ciprofloxacin|mesh-list
5749054|NCT03045185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5749055|NCT03045185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5749056|NCT03045185|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5749057|NCT03045185|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5749058|NCT03045185|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5749059|NCT03045185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5749060|NCT03045185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5749061|NCT03045185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5749062|NCT03045185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5749063|NCT03045185|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5749064|NCT03045185|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5749065|NCT03045198|Azithromycin|azithromycin|mesh-list
5749066|NCT03045198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5749067|NCT03045198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5749068|NCT03045341|Naltrexone|naltrexone|mesh-list
5749069|NCT03045341|Bupropion|bupropion|mesh-list
5749070|NCT03045341|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5749071|NCT03045341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5749072|NCT03045341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749073|NCT03045341|Sensory System Agents|sensory system agents|mesh-ancestor
5749074|NCT03045341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5749075|NCT03045341|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5749076|NCT03045341|Antidepressive Agents|antidepressive agents|mesh-ancestor
5749077|NCT03045341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5749078|NCT03045341|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5749079|NCT03045341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5749080|NCT03045341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5749081|NCT03045341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5749082|NCT03045341|Dopamine Agents|dopamine agents|mesh-ancestor
5749083|NCT03045341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5749084|NCT03045341|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5749085|NCT03045341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5749086|NCT03045341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5749087|NCT03045393|Maytansine|maytansine|mesh-list
5749088|NCT03045393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5749089|NCT03045393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5749090|NCT03045393|Tubulin Modulators|tubulin modulators|mesh-ancestor
5749091|NCT03045393|Antimitotic Agents|antimitotic agents|mesh-ancestor
5749092|NCT03045393|Mitosis Modulators|mitosis modulators|mesh-ancestor
5749093|NCT03045393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672935|NCT01559298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672936|NCT01559298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6672937|NCT01559298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6672938|NCT01559298|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6672939|NCT01559298|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6672940|NCT01559298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672941|NCT01559298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6672942|NCT01559298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6672943|NCT01559298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6672944|NCT01559298|Antipyretics|antipyretics|mesh-ancestor
5625556|NCT03321513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5625557|NCT03321513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5625558|NCT03321513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5625559|NCT03321513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5625560|NCT03321513|Growth Substances|growth substances|mesh-ancestor
5625561|NCT03321513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625562|NCT03321513|Growth Inhibitors|growth inhibitors|mesh-ancestor
5625563|NCT03315910|Nicotine|nicotine|mesh-list
5625564|NCT03315910|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5625565|NCT03315910|Autonomic Agents|autonomic agents|mesh-ancestor
5625566|NCT03315910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6672945|NCT01559298|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6672946|NCT01559298|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6672947|NCT01559298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5625567|NCT03315910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625568|NCT03315910|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5625569|NCT03315910|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5625570|NCT03315910|Cholinergic Agents|cholinergic agents|mesh-ancestor
5625571|NCT03315910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5625572|NCT03315910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625573|NCT03273023|Chromium|chromium|mesh-list
5625574|NCT03273023|Everolimus|everolimus|mesh-list
5625575|NCT03273023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5625576|NCT03273023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5625577|NCT03273023|Immunologic Factors|immunologic factors|mesh-ancestor
5625578|NCT03273023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625579|NCT03273023|Trace Elements|trace elements|mesh-ancestor
5625580|NCT03273023|Micronutrients|micronutrients|mesh-ancestor
5625581|NCT03206060|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5625582|NCT03206060|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5692947|NCT03404479|Celecoxib|celecoxib|mesh-list
5692948|NCT03404479|Diacetylrhein|diacetylrhein|mesh-list
5692949|NCT03404479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5692950|NCT03404479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5692951|NCT03404479|Analgesics|analgesics|mesh-ancestor
5692952|NCT03404479|Sensory System Agents|sensory system agents|mesh-ancestor
5692953|NCT03404479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5692954|NCT03404479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692955|NCT03404479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5692956|NCT03404479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5692957|NCT03404479|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5692958|NCT03404479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5692959|NCT03404479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5692960|NCT03404479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692961|NCT03404414|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5692962|NCT03404414|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5692963|NCT03404414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692964|NCT03404310|Zinc Sulfate|zinc sulfate|mesh-list
5692965|NCT03404310|Astringents|astringents|mesh-ancestor
5692966|NCT03404310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749094|NCT03045133|Morphine|morphine|mesh-list
5749095|NCT03045133|Methadone|methadone|mesh-list
5749096|NCT03045133|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5749097|NCT03045133|Narcotics|narcotics|mesh-ancestor
5749098|NCT03045133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5749099|NCT03045133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749100|NCT03045133|Analgesics|analgesics|mesh-ancestor
5749101|NCT03045133|Sensory System Agents|sensory system agents|mesh-ancestor
5625583|NCT03206060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625584|NCT03164616|Gemcitabine|gemcitabine|mesh-list
5625585|NCT03164616|Cisplatin|cisplatin|mesh-list
5625586|NCT03164616|Carboplatin|carboplatin|mesh-list
5625587|NCT03164616|Pemetrexed|pemetrexed|mesh-list
5749102|NCT03045133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5749103|NCT03045133|Antitussive Agents|antitussive agents|mesh-ancestor
5749104|NCT03045133|Respiratory System Agents|respiratory system agents|mesh-ancestor
5749105|NCT03045016|Prazosin|prazosin|mesh-list
6672948|NCT01559298|Purinergic Agents|purinergic agents|mesh-ancestor
6672949|NCT01559298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6672950|NCT01559480|Desogestrel|desogestrel|mesh-list
6672951|NCT01559480|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6672952|NCT01559480|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6672953|NCT01559480|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6672954|NCT01559480|Contraceptive Agents|contraceptive agents|mesh-ancestor
6672955|NCT01559480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5625588|NCT03164616|Durvalumab|durvalumab|mesh-list
5749106|NCT03045016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5749107|NCT03045016|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5625589|NCT03164616|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5625590|NCT03164616|Tremelimumab|tremelimumab|mesh-list
5625591|NCT03164616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5625592|NCT03164616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5625593|NCT03164616|Antimetabolites|antimetabolites|mesh-ancestor
5625594|NCT03164616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5749108|NCT03045016|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5749109|NCT03045016|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5749110|NCT03045016|Adrenergic Agents|adrenergic agents|mesh-ancestor
5749111|NCT03045016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5749112|NCT03045016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5749113|NCT03045016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749114|NCT03045029|Treprostinil|treprostinil|mesh-list
5749115|NCT03045029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5749116|NCT03044912|Mirabegron|mirabegron|mesh-list
5749117|NCT03044912|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
5749118|NCT03044912|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5749119|NCT03044912|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5749120|NCT03044912|Adrenergic Agents|adrenergic agents|mesh-ancestor
5749121|NCT03044912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5749122|NCT03044912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5749123|NCT03044912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749124|NCT03044912|Urological Agents|urological agents|mesh-ancestor
5749125|NCT03044964|Ranolazine|ranolazine|mesh-list
5749126|NCT03044964|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5749127|NCT03044964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5749128|NCT03044964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5749129|NCT03044873|BMS-986165|bms-986165|mesh-list
5749130|NCT03044873|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5749131|NCT03044873|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5749132|NCT03044873|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5749133|NCT03044873|Antimetabolites|antimetabolites|mesh-ancestor
5749134|NCT03044873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5749135|NCT03044873|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5749136|NCT03044873|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5749137|NCT03044873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5749138|NCT03044873|Dermatologic Agents|dermatologic agents|mesh-ancestor
5749139|NCT03044873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5749140|NCT03044626|Nivolumab|nivolumab|mesh-list
5749141|NCT03044626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5749142|NCT03044626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5749143|NCT03044626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5749144|NCT03044626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5749145|NCT03044743|Cyclophosphamide|cyclophosphamide|mesh-list
5749146|NCT03044743|Fludarabine|fludarabine|mesh-list
5749147|NCT03044743|Interleukin-2|interleukin-2|mesh-list
5625595|NCT03164616|Antiviral Agents|antiviral agents|mesh-ancestor
5749148|NCT03044743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5749149|NCT03044743|Immunologic Factors|immunologic factors|mesh-ancestor
5749150|NCT03044743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749151|NCT03044743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5749152|NCT03044743|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5749153|NCT03044743|Alkylating Agents|alkylating agents|mesh-ancestor
5749154|NCT03044743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5749155|NCT03044743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5749156|NCT03044743|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5749157|NCT03044743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5749158|NCT03044743|Analgesics|analgesics|mesh-ancestor
5749159|NCT03044743|Sensory System Agents|sensory system agents|mesh-ancestor
5749160|NCT03044743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5749161|NCT03044795|Veliparib|veliparib|mesh-list
5749162|NCT03044795|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5625596|NCT03164616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5625597|NCT03164616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5625598|NCT03164616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5625599|NCT03164616|Immunologic Factors|immunologic factors|mesh-ancestor
5625600|NCT03164616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625601|NCT03164616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5625602|NCT03164616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5625603|NCT03164616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5625604|NCT03125928|Paclitaxel|paclitaxel|mesh-list
5625605|NCT03125928|Trastuzumab|trastuzumab|mesh-list
5625606|NCT03125928|Atezolizumab|atezolizumab|mesh-list
5625607|NCT03125928|Pertuzumab|pertuzumab|mesh-list
5625608|NCT03125928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5625609|NCT03125928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5625610|NCT03125928|Tubulin Modulators|tubulin modulators|mesh-ancestor
5625611|NCT03125928|Antimitotic Agents|antimitotic agents|mesh-ancestor
5625612|NCT03125928|Mitosis Modulators|mitosis modulators|mesh-ancestor
5749163|NCT03044795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5749164|NCT03044795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5749165|NCT03044795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5749166|NCT03044665|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5749167|NCT03044665|Ezetimibe|ezetimibe|mesh-list
5749168|NCT03044665|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5749169|NCT03044665|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5749170|NCT03044665|Antimetabolites|antimetabolites|mesh-ancestor
5749171|NCT03044665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5749172|NCT03044665|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5749173|NCT03044665|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5749174|NCT03044665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5749175|NCT03044587|Leucovorin|leucovorin|mesh-list
6489485|NCT00592111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6489486|NCT00592111|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6489487|NCT00592111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6489488|NCT00592111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6489489|NCT00592111|Tubulin Modulators|tubulin modulators|mesh-ancestor
5749176|NCT03044587|Gemcitabine|gemcitabine|mesh-list
5749177|NCT03044587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5749178|NCT03044587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5625613|NCT03125928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625614|NCT03125928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5625615|NCT03086369|Gemcitabine|gemcitabine|mesh-list
5625616|NCT03086369|Paclitaxel|paclitaxel|mesh-list
5625617|NCT03086369|Olaratumab|olaratumab|mesh-list
5625618|NCT03086369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5625619|NCT03086369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5625620|NCT03086369|Tubulin Modulators|tubulin modulators|mesh-ancestor
5625621|NCT03086369|Antimitotic Agents|antimitotic agents|mesh-ancestor
5625622|NCT03086369|Mitosis Modulators|mitosis modulators|mesh-ancestor
5625623|NCT03086369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625624|NCT03086369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5749179|NCT03044587|Antimetabolites|antimetabolites|mesh-ancestor
5749180|NCT03044587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5749181|NCT03044587|Antiviral Agents|antiviral agents|mesh-ancestor
5749182|NCT03044587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5749183|NCT03044587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5749184|NCT03044587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5749185|NCT03044587|Immunologic Factors|immunologic factors|mesh-ancestor
5625625|NCT03086369|Antimetabolites|antimetabolites|mesh-ancestor
5625626|NCT03086369|Antiviral Agents|antiviral agents|mesh-ancestor
5625627|NCT03086369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5749186|NCT03044587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749187|NCT03044587|Antidotes|antidotes|mesh-ancestor
5749188|NCT03044587|Protective Agents|protective agents|mesh-ancestor
5625628|NCT03086369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5625629|NCT03086369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5625630|NCT03086369|Immunologic Factors|immunologic factors|mesh-ancestor
5625631|NCT03086369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625632|NCT03081910|Cyclophosphamide|cyclophosphamide|mesh-list
5625633|NCT03081910|Fludarabine|fludarabine|mesh-list
5625634|NCT03081910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5625635|NCT03081910|Immunologic Factors|immunologic factors|mesh-ancestor
5625636|NCT03081910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625637|NCT03081910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5625638|NCT03081910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5625639|NCT03081910|Alkylating Agents|alkylating agents|mesh-ancestor
5625640|NCT03081910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625641|NCT03081910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5625642|NCT03081910|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5749189|NCT03044587|Vitamin B Complex|vitamin b complex|mesh-ancestor
5749190|NCT03044587|Vitamins|vitamins|mesh-ancestor
5749191|NCT03044587|Micronutrients|micronutrients|mesh-ancestor
5749192|NCT03044613|Paclitaxel|paclitaxel|mesh-list
5749193|NCT03044613|Carboplatin|carboplatin|mesh-list
5749194|NCT03044613|Nivolumab|nivolumab|mesh-list
5749195|NCT03044613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5749196|NCT03044613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5749197|NCT03044613|Tubulin Modulators|tubulin modulators|mesh-ancestor
5749198|NCT03044613|Antimitotic Agents|antimitotic agents|mesh-ancestor
5749199|NCT03044613|Mitosis Modulators|mitosis modulators|mesh-ancestor
5749200|NCT03044613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625643|NCT03081858|Paclitaxel|paclitaxel|mesh-list
5625644|NCT03081858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5625645|NCT03081858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5625646|NCT03081858|Tubulin Modulators|tubulin modulators|mesh-ancestor
5749201|NCT03044613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5749202|NCT03044613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5749203|NCT03044808|Lidocaine|lidocaine|mesh-list
6208754|NCT02135432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208755|NCT02135445|Relugolix|relugolix|mesh-list
6208756|NCT02135445|Androgen Antagonists|androgen antagonists|mesh-ancestor
6208757|NCT02135445|Hormone Antagonists|hormone antagonists|mesh-ancestor
6208758|NCT02135445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5625647|NCT03081858|Antimitotic Agents|antimitotic agents|mesh-ancestor
5625648|NCT03081858|Mitosis Modulators|mitosis modulators|mesh-ancestor
6208759|NCT02135445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208760|NCT02136420|Promethazine|promethazine|mesh-list
6208761|NCT02136420|Diphenhydramine|diphenhydramine|mesh-list
6208762|NCT02136420|Antipruritics|antipruritics|mesh-ancestor
6208763|NCT02136420|Dermatologic Agents|dermatologic agents|mesh-ancestor
6208764|NCT02136420|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6489490|NCT00592111|Antimitotic Agents|antimitotic agents|mesh-ancestor
5749204|NCT03044808|Anesthetics, Local|anesthetics, local|mesh-ancestor
5749205|NCT03044808|Anesthetics|anesthetics|mesh-ancestor
5625649|NCT03081858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625650|NCT03053362|Vortioxetine|vortioxetine|mesh-list
5625651|NCT03053362|Antidepressive Agents|antidepressive agents|mesh-ancestor
5625652|NCT03053362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5625653|NCT03053362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5625654|NCT03053362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5625655|NCT03053362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5625656|NCT03053362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625657|NCT03053362|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5625658|NCT03053362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5625659|NCT03053362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5625660|NCT03053362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625661|NCT03053362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5625662|NCT03053362|Serotonin Agents|serotonin agents|mesh-ancestor
5625663|NCT03053362|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5625664|NCT03053362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5625665|NCT03053362|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5625666|NCT03053362|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5625667|NCT02906332|Dexamethasone|dexamethasone|mesh-list
5625668|NCT02906332|Pembrolizumab|pembrolizumab|mesh-list
5625669|NCT02906332|Lenalidomide|lenalidomide|mesh-list
5749206|NCT03044808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5749207|NCT03044808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749208|NCT03044808|Sensory System Agents|sensory system agents|mesh-ancestor
5749209|NCT03044808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5749210|NCT03044808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5749211|NCT03044808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5749212|NCT03044808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5749213|NCT03044808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5749214|NCT03044808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5749215|NCT03044561|Sildenafil Citrate|sildenafil citrate|mesh-list
5749216|NCT03044561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5749217|NCT03044561|Vasodilator Agents|vasodilator agents|mesh-ancestor
5749218|NCT03044561|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5749219|NCT03044561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5749220|NCT03044561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5749221|NCT03044561|Urological Agents|urological agents|mesh-ancestor
5749222|NCT03044522|Analgesics, Opioid|analgesics, opioid|mesh-list
5749223|NCT03044522|Narcotics|narcotics|mesh-ancestor
5749224|NCT03044522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5749225|NCT03044522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749226|NCT03044522|Analgesics|analgesics|mesh-ancestor
5749227|NCT03044522|Sensory System Agents|sensory system agents|mesh-ancestor
5749228|NCT03044522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5749229|NCT03044938|Albuterol|albuterol|mesh-list
5749230|NCT03044938|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5749231|NCT03044938|Autonomic Agents|autonomic agents|mesh-ancestor
5749232|NCT03044938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5749233|NCT03044938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749234|NCT03044938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5625670|NCT02906332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5625671|NCT02906332|Antiemetics|antiemetics|mesh-ancestor
5625672|NCT02906332|Autonomic Agents|autonomic agents|mesh-ancestor
5625673|NCT02906332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5625674|NCT02906332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625675|NCT02906332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5625676|NCT02906332|Glucocorticoids|glucocorticoids|mesh-ancestor
5625677|NCT02906332|Hormones|hormones|mesh-ancestor
5625678|NCT02906332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5625679|NCT02906332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5625680|NCT02906332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5749235|NCT03044938|Respiratory System Agents|respiratory system agents|mesh-ancestor
5749236|NCT03044938|Tocolytic Agents|tocolytic agents|mesh-ancestor
5749237|NCT03044938|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5749238|NCT03044938|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5749239|NCT03044938|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5749240|NCT03044938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5749241|NCT03044938|Adrenergic Agents|adrenergic agents|mesh-ancestor
5749242|NCT03044938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5749243|NCT03044938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5749244|NCT03044639|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
5749245|NCT03044639|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5749246|NCT03044639|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5625681|NCT02906332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5625682|NCT02906332|Immunologic Factors|immunologic factors|mesh-ancestor
5625683|NCT02906332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5625684|NCT02906332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5625685|NCT02906332|Growth Substances|growth substances|mesh-ancestor
5625686|NCT02906332|Growth Inhibitors|growth inhibitors|mesh-ancestor
5625687|NCT02890069|Everolimus|everolimus|mesh-list
5625688|NCT02890069|Panobinostat|panobinostat|mesh-list
5625689|NCT02890069|Spartalizumab|spartalizumab|mesh-list
5625690|NCT02890069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5625691|NCT02890069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5749247|NCT03044366|Anesthetics|anesthetics|mesh-list
5749248|NCT03044366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5749249|NCT03044366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749250|NCT03044379|Dapivirine|dapivirine|mesh-list
5749251|NCT03044379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5749252|NCT03044379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5749253|NCT03044379|Antiviral Agents|antiviral agents|mesh-ancestor
5749254|NCT03044379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5894416|NCT04716335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5894417|NCT04716335|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
5625692|NCT02890069|Immunologic Factors|immunologic factors|mesh-ancestor
5625693|NCT02890069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749255|NCT03044171|Listerine|listerine|mesh-list
5749256|NCT03044171|Hydrogen Peroxide|hydrogen peroxide|mesh-list
5749257|NCT03044171|Fluorides|fluorides|mesh-list
5749258|NCT03044171|Sodium Fluoride|sodium fluoride|mesh-list
5749259|NCT03044171|Cariostatic Agents|cariostatic agents|mesh-ancestor
5625694|NCT02890069|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5625695|NCT02890069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5625696|NCT02890069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625697|NCT02890069|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5625698|NCT02810418|Paclitaxel|paclitaxel|mesh-list
5625699|NCT02810418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5625700|NCT02810418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5749260|NCT03044171|Protective Agents|protective agents|mesh-ancestor
5749261|NCT03044171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749262|NCT03044171|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5749263|NCT03044171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5749264|NCT03044184|Tranylcypromine|tranylcypromine|mesh-list
5749265|NCT03044184|Tranexamic Acid|tranexamic acid|mesh-list
5749266|NCT03044184|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5749267|NCT03044184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5749268|NCT03044184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5749269|NCT03044184|Hemostatics|hemostatics|mesh-ancestor
5749270|NCT03044184|Coagulants|coagulants|mesh-ancestor
5749271|NCT03044184|Antidepressive Agents|antidepressive agents|mesh-ancestor
5625701|NCT02810418|Tubulin Modulators|tubulin modulators|mesh-ancestor
5625702|NCT02810418|Antimitotic Agents|antimitotic agents|mesh-ancestor
5625703|NCT02810418|Mitosis Modulators|mitosis modulators|mesh-ancestor
5692967|NCT03404310|Dermatologic Agents|dermatologic agents|mesh-ancestor
5749272|NCT03044184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5749273|NCT03044184|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
5749274|NCT03044184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5749275|NCT03044184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5749276|NCT03044184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5749277|NCT03044184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5749278|NCT03044184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749279|NCT03044041|Tranexamic Acid|tranexamic acid|mesh-list
5749280|NCT03044041|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5749281|NCT03044041|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5749282|NCT03044041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5749283|NCT03044041|Hemostatics|hemostatics|mesh-ancestor
5749284|NCT03044041|Coagulants|coagulants|mesh-ancestor
5749285|NCT03044093|Misoprostol|misoprostol|mesh-list
5749286|NCT03044093|Mifepristone|mifepristone|mesh-list
5749287|NCT03044093|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5749288|NCT03044093|Abortifacient Agents|abortifacient agents|mesh-ancestor
5749289|NCT03044093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5749290|NCT03044093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749291|NCT03044093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5749292|NCT03044093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5749293|NCT03044093|Oxytocics|oxytocics|mesh-ancestor
5749294|NCT03044093|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5749295|NCT03044093|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5749296|NCT03044093|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5749297|NCT03044093|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5749298|NCT03044093|Contraceptive Agents|contraceptive agents|mesh-ancestor
5749299|NCT03044093|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5749300|NCT03044093|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5749301|NCT03044093|Hormone Antagonists|hormone antagonists|mesh-ancestor
5749302|NCT03044093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5749303|NCT03044093|Luteolytic Agents|luteolytic agents|mesh-ancestor
5749304|NCT03044093|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5749305|NCT03044093|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5749306|NCT03044080|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5749307|NCT03044080|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
5749308|NCT03044080|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5749309|NCT03044080|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5749310|NCT03044080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5749311|NCT03044080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749312|NCT03044080|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5749313|NCT03044080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5749314|NCT03044080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5749315|NCT03044080|Cholinergic Agents|cholinergic agents|mesh-ancestor
5749316|NCT03044080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5749317|NCT03043807|Docetaxel|docetaxel|mesh-list
5749318|NCT03043807|Leuprolide|leuprolide|mesh-list
6672956|NCT01559480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672957|NCT01559480|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6672958|NCT01559480|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6672959|NCT01559480|Progestins|progestins|mesh-ancestor
6672960|NCT01559480|Hormones|hormones|mesh-ancestor
6672961|NCT01559480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5749319|NCT03043807|Abiraterone Acetate|abiraterone acetate|mesh-list
5749320|NCT03043807|Bicalutamide|bicalutamide|mesh-list
5749321|NCT03043807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5749322|NCT03043807|Tubulin Modulators|tubulin modulators|mesh-ancestor
5749323|NCT03043807|Antimitotic Agents|antimitotic agents|mesh-ancestor
5749324|NCT03043807|Mitosis Modulators|mitosis modulators|mesh-ancestor
5749325|NCT03043807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5749326|NCT03043807|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5749327|NCT03043807|Fertility Agents|fertility agents|mesh-ancestor
5749328|NCT03043807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5749329|NCT03043807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749330|NCT03043807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5749331|NCT03043807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5749332|NCT03043807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5749333|NCT03043807|Hormone Antagonists|hormone antagonists|mesh-ancestor
5749334|NCT03043807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5749335|NCT03043807|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5749336|NCT03043807|Androgen Antagonists|androgen antagonists|mesh-ancestor
5749337|NCT03043677|Adalimumab|adalimumab|mesh-list
5749338|NCT03043677|Golimumab|golimumab|mesh-list
5749339|NCT03043677|Infliximab|infliximab|mesh-list
5749340|NCT03043677|Ustekinumab|ustekinumab|mesh-list
5749341|NCT03043677|Vedolizumab|vedolizumab|mesh-list
5749342|NCT03043677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5749343|NCT03043677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5749344|NCT03043677|Dermatologic Agents|dermatologic agents|mesh-ancestor
5749345|NCT03043677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5749346|NCT03043677|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
5749347|NCT03043677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5749348|NCT03043677|Immunologic Factors|immunologic factors|mesh-ancestor
5749349|NCT03043677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625704|NCT02810418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625705|NCT02795988|Fluorouracil|fluorouracil|mesh-list
5625706|NCT02795988|Capecitabine|capecitabine|mesh-list
5749350|NCT03043820|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
5749351|NCT03043820|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5749352|NCT03043820|Hormone Antagonists|hormone antagonists|mesh-ancestor
5749353|NCT03043820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5749354|NCT03043820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749355|NCT03043820|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5749356|NCT03043820|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5749357|NCT03043820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5749358|NCT03043989|Clarithromycin|clarithromycin|mesh-list
5749359|NCT03043989|Docetaxel|docetaxel|mesh-list
5749360|NCT03043989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5749361|NCT03043989|Tubulin Modulators|tubulin modulators|mesh-ancestor
5749362|NCT03043989|Antimitotic Agents|antimitotic agents|mesh-ancestor
5749363|NCT03043989|Mitosis Modulators|mitosis modulators|mesh-ancestor
5749364|NCT03043989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5749365|NCT03043989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5749366|NCT03043989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5749367|NCT03043989|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5749368|NCT03043989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5749369|NCT03043989|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5749370|NCT03043989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5749371|NCT03043664|Pembrolizumab|pembrolizumab|mesh-list
5749372|NCT03043664|Lanreotide|lanreotide|mesh-list
5749373|NCT03043664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5625707|NCT02795988|Oxaliplatin|oxaliplatin|mesh-list
5625708|NCT02795988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5625709|NCT02795988|Antimetabolites|antimetabolites|mesh-ancestor
5625710|NCT02795988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625711|NCT02795988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5625712|NCT02795988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5625713|NCT02795988|Immunologic Factors|immunologic factors|mesh-ancestor
5625714|NCT02795988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625715|NCT02786329|Lidocaine|lidocaine|mesh-list
5749374|NCT03043664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5749375|NCT03043924|Cyproterone Acetate|cyproterone acetate|mesh-list
5749376|NCT03043924|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5749377|NCT03043924|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5749378|NCT03043924|Levonorgestrel|levonorgestrel|mesh-list
5749379|NCT03043924|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5749380|NCT03043924|Estradiol|estradiol|mesh-list
5749381|NCT03043924|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5749382|NCT03043924|Cyproterone|cyproterone|mesh-list
5625716|NCT02786329|Sevoflurane|sevoflurane|mesh-list
5625717|NCT02786329|Anesthetics, Local|anesthetics, local|mesh-ancestor
5625718|NCT02786329|Anesthetics|anesthetics|mesh-ancestor
5625719|NCT02786329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5625720|NCT02786329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625721|NCT02786329|Sensory System Agents|sensory system agents|mesh-ancestor
5625722|NCT02786329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5625723|NCT02786329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5625724|NCT02786329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5625725|NCT02786329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5625726|NCT02786329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5625727|NCT02786329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692968|NCT03404284|Vaccines|vaccines|mesh-list
5692969|NCT03404284|Immunologic Factors|immunologic factors|mesh-ancestor
5692970|NCT03404284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692971|NCT03404193|Decitabine|decitabine|mesh-list
5692972|NCT03404193|Venetoclax|venetoclax|mesh-list
5692973|NCT03404193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5692974|NCT03404193|Antimetabolites|antimetabolites|mesh-ancestor
5692975|NCT03404193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692976|NCT03404193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5692977|NCT03404193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5692978|NCT03404037|Endostatins|endostatins|mesh-list
5692979|NCT03404037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5692980|NCT03404037|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5692981|NCT03404037|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5692982|NCT03404037|Growth Substances|growth substances|mesh-ancestor
5692983|NCT03404037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692984|NCT03404037|Growth Inhibitors|growth inhibitors|mesh-ancestor
5692985|NCT03404024|Mitogens|mitogens|mesh-list
5692986|NCT03404024|Mitosis Modulators|mitosis modulators|mesh-ancestor
5692987|NCT03404024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5692988|NCT03404011|Glycerol|glycerol|mesh-list
5692989|NCT03404011|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
5692990|NCT03404011|Protective Agents|protective agents|mesh-ancestor
5692991|NCT03404011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692992|NCT03403985|Calcium|calcium|mesh-list
5692993|NCT03403985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5692994|NCT03403985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5692995|NCT03403972|Vancomycin|vancomycin|mesh-list
5692996|NCT03403972|Simvastatin|simvastatin|mesh-list
5692997|NCT03403972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5692998|NCT03403972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5692999|NCT03403972|Antimetabolites|antimetabolites|mesh-ancestor
5693000|NCT03403972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693001|NCT03403972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5693002|NCT03403972|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5693003|NCT03403972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5693004|NCT03403972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5693005|NCT03403972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5693006|NCT03403946|Pyrithione zinc|pyrithione zinc|mesh-list
5693007|NCT03403946|Keratolytic Agents|keratolytic agents|mesh-ancestor
5693008|NCT03403946|Dermatologic Agents|dermatologic agents|mesh-ancestor
5693009|NCT03403842|Sufentanil|sufentanil|mesh-list
5693010|NCT03403842|Morphine|morphine|mesh-list
5693011|NCT03403842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5693012|NCT03403842|Narcotics|narcotics|mesh-ancestor
5693013|NCT03403842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5693014|NCT03403842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693015|NCT03403842|Analgesics|analgesics|mesh-ancestor
5693016|NCT03403842|Sensory System Agents|sensory system agents|mesh-ancestor
5693017|NCT03403842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5693018|NCT03403842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5693019|NCT03403842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5693020|NCT03403842|Anesthetics, General|anesthetics, general|mesh-ancestor
5693021|NCT03403842|Anesthetics|anesthetics|mesh-ancestor
5693022|NCT03403829|Gemcitabine|gemcitabine|mesh-list
5749383|NCT03043924|Estrogens|estrogens|mesh-ancestor
5749384|NCT03043924|Hormones|hormones|mesh-ancestor
5749385|NCT03043924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5749386|NCT03043924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749387|NCT03043924|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5749388|NCT03043924|Contraceptive Agents|contraceptive agents|mesh-ancestor
5749389|NCT03043924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5749390|NCT03043924|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5749391|NCT03043924|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5749392|NCT03043924|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5749393|NCT03043924|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5749394|NCT03043924|Androgen Antagonists|androgen antagonists|mesh-ancestor
5749395|NCT03043924|Hormone Antagonists|hormone antagonists|mesh-ancestor
5749396|NCT03043924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5749397|NCT03043924|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5749398|NCT03043950|Panitumumab|panitumumab|mesh-list
5749399|NCT03043950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5749400|NCT03043950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5749401|NCT03043612|Doxazosin|doxazosin|mesh-list
5749402|NCT03043612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5749403|NCT03043612|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5749404|NCT03043612|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5749405|NCT03043612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5749406|NCT03043612|Adrenergic Agents|adrenergic agents|mesh-ancestor
5749407|NCT03043612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5749408|NCT03043612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5749409|NCT03043612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625728|NCT02786329|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5625729|NCT02786329|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5625730|NCT02786329|Anesthetics, General|anesthetics, general|mesh-ancestor
5625731|NCT02779855|Paclitaxel|paclitaxel|mesh-list
5625732|NCT02779855|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
5625733|NCT02779855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5625734|NCT02779855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5625735|NCT02779855|Tubulin Modulators|tubulin modulators|mesh-ancestor
5625736|NCT02779855|Antimitotic Agents|antimitotic agents|mesh-ancestor
5749410|NCT03043521|Dexlansoprazole|dexlansoprazole|mesh-list
5749411|NCT03043521|Lansoprazole|lansoprazole|mesh-list
5749412|NCT03043521|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5749413|NCT03043521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5749414|NCT03043521|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5749415|NCT03043521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5749416|NCT03043521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5749417|NCT03043547|Leucovorin|leucovorin|mesh-list
5749418|NCT03043547|Antidotes|antidotes|mesh-ancestor
5749419|NCT03043547|Protective Agents|protective agents|mesh-ancestor
5749420|NCT03043547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749421|NCT03043547|Vitamin B Complex|vitamin b complex|mesh-ancestor
5749422|NCT03043547|Vitamins|vitamins|mesh-ancestor
5749423|NCT03043547|Micronutrients|micronutrients|mesh-ancestor
5749424|NCT03043430|Midazolam|midazolam|mesh-list
5749425|NCT03043430|Ketamine|ketamine|mesh-list
5749426|NCT03043430|Analgesics|analgesics|mesh-ancestor
5749427|NCT03043430|Sensory System Agents|sensory system agents|mesh-ancestor
5749428|NCT03043430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5749429|NCT03043430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749430|NCT03043430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5749431|NCT03043430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5749432|NCT03043430|Anesthetics, General|anesthetics, general|mesh-ancestor
5749433|NCT03043430|Anesthetics|anesthetics|mesh-ancestor
5749434|NCT03043430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5749435|NCT03043430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5749436|NCT03043430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5749437|NCT03043430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5749438|NCT03043430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5749439|NCT03043430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5749440|NCT03043430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5749441|NCT03043430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5749442|NCT03043430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5749443|NCT03043430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5749444|NCT03043430|GABA Modulators|gaba modulators|mesh-ancestor
5749445|NCT03043430|GABA Agents|gaba agents|mesh-ancestor
5749446|NCT03043248|Digoxin|digoxin|mesh-list
5749447|NCT03043248|Midazolam|midazolam|mesh-list
5749448|NCT03043248|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5625737|NCT02779855|Mitosis Modulators|mitosis modulators|mesh-ancestor
5749449|NCT03043248|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5749450|NCT03043248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5749451|NCT03043248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749452|NCT03043248|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5749453|NCT03043248|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5749454|NCT03043248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5749455|NCT03043248|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5749456|NCT03043248|Anesthetics, General|anesthetics, general|mesh-ancestor
5625738|NCT02779855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625739|NCT02779855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5625740|NCT02731352|Apatinib|apatinib|mesh-list
5625741|NCT02731352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5625742|NCT02731352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5625743|NCT02731352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5625744|NCT02731352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625745|NCT02726659|Celecoxib|celecoxib|mesh-list
5625746|NCT02726659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5625747|NCT02726659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5625748|NCT02726659|Analgesics|analgesics|mesh-ancestor
5625749|NCT02726659|Sensory System Agents|sensory system agents|mesh-ancestor
5749457|NCT03043248|Anesthetics|anesthetics|mesh-ancestor
5749458|NCT03043248|GABA Modulators|gaba modulators|mesh-ancestor
5749459|NCT03043248|GABA Agents|gaba agents|mesh-ancestor
5749460|NCT03043248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5749461|NCT03043248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5749462|NCT03043248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5749463|NCT03043248|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5749464|NCT03043248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5749465|NCT03043248|Protective Agents|protective agents|mesh-ancestor
5749466|NCT03043326|Tenofovir|tenofovir|mesh-list
5749467|NCT03043326|Emtricitabine|emtricitabine|mesh-list
5749468|NCT03043326|Antiviral Agents|antiviral agents|mesh-ancestor
5625750|NCT02726659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5625751|NCT02726659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625752|NCT02726659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5625753|NCT02726659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5625754|NCT02726659|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5625755|NCT02726659|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5625756|NCT02726659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5625757|NCT02726659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625758|NCT02654132|Dexamethasone|dexamethasone|mesh-list
5625759|NCT02654132|Dexamethasone acetate|dexamethasone acetate|mesh-list
5625760|NCT02654132|Pomalidomide|pomalidomide|mesh-list
5625761|NCT02654132|Elotuzumab|elotuzumab|mesh-list
5625762|NCT02654132|BB 1101|bb 1101|mesh-list
5625763|NCT02654132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5625764|NCT02654132|Antiemetics|antiemetics|mesh-ancestor
5625765|NCT02654132|Autonomic Agents|autonomic agents|mesh-ancestor
5625766|NCT02654132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5625767|NCT02654132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625768|NCT02654132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5625769|NCT02654132|Glucocorticoids|glucocorticoids|mesh-ancestor
5625770|NCT02654132|Hormones|hormones|mesh-ancestor
5625771|NCT02654132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5625772|NCT02654132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5625773|NCT02654132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5625774|NCT02654132|Protease Inhibitors|protease inhibitors|mesh-ancestor
5625775|NCT02654132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5625776|NCT02654132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625777|NCT02654132|Immunologic Factors|immunologic factors|mesh-ancestor
5625778|NCT02654132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5749469|NCT03043326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5749470|NCT03043326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5749471|NCT03043326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5749472|NCT03043326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5749473|NCT03043326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5749474|NCT03043326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5749475|NCT03043326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5625779|NCT02654132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5625780|NCT02654132|Growth Substances|growth substances|mesh-ancestor
5625781|NCT02654132|Growth Inhibitors|growth inhibitors|mesh-ancestor
5625782|NCT02646475|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
5749476|NCT03043482|Calcitriol|calcitriol|mesh-list
5625783|NCT02646475|Angiotensin II|angiotensin ii|mesh-list
5625784|NCT02646475|Angiotensinogen|angiotensinogen|mesh-list
5894418|NCT04716335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5749477|NCT03043482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5749478|NCT03043482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749479|NCT03043482|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
5749480|NCT03043482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5749481|NCT03043482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5749482|NCT03043482|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5749483|NCT03043482|Vitamins|vitamins|mesh-ancestor
5625785|NCT02646475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5625786|NCT02646475|Vasodilator Agents|vasodilator agents|mesh-ancestor
5625787|NCT02646475|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5625788|NCT02646475|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5625789|NCT02646475|Protease Inhibitors|protease inhibitors|mesh-ancestor
5625790|NCT02646475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5625791|NCT02646475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5749484|NCT03043482|Micronutrients|micronutrients|mesh-ancestor
5749485|NCT03043482|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5749486|NCT03043287|Botulinum Toxins|botulinum toxins|mesh-list
5749487|NCT03043287|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5749488|NCT03043287|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5749489|NCT03043287|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5749490|NCT03043287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5749491|NCT03043287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5749492|NCT03043287|Cholinergic Agents|cholinergic agents|mesh-ancestor
5749493|NCT03043287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5749494|NCT03043287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749495|NCT03043287|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5749496|NCT03043287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5749497|NCT03043443|Melatonin|melatonin|mesh-list
6489491|NCT00592111|Mitosis Modulators|mitosis modulators|mesh-ancestor
6489492|NCT00592111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6489493|NCT00592137|Calcium, Dietary|calcium, dietary|mesh-list
6489494|NCT00592137|Calcium|calcium|mesh-list
6489495|NCT00592137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6489496|NCT00592137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749498|NCT03043443|Antioxidants|antioxidants|mesh-ancestor
5749499|NCT03043443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5749500|NCT03043443|Protective Agents|protective agents|mesh-ancestor
5749501|NCT03043443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749502|NCT03043443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5749503|NCT03043495|Dexamethasone|dexamethasone|mesh-list
5749504|NCT03043495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5749505|NCT03043495|Antiemetics|antiemetics|mesh-ancestor
5749506|NCT03043495|Autonomic Agents|autonomic agents|mesh-ancestor
5749507|NCT03043495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5749508|NCT03043495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749509|NCT03043495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5749510|NCT03043495|Glucocorticoids|glucocorticoids|mesh-ancestor
5749511|NCT03043495|Hormones|hormones|mesh-ancestor
5749512|NCT03043495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5749513|NCT03043495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5749514|NCT03043495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5749515|NCT03043157|Rocuronium|rocuronium|mesh-list
5749516|NCT03043157|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5749517|NCT03043157|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5749518|NCT03043157|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5749519|NCT03043157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5749520|NCT03043157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625792|NCT02603432|Avelumab|avelumab|mesh-list
5625793|NCT02603432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5749521|NCT03043196|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5749522|NCT03043196|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5749523|NCT03043196|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5749524|NCT03043196|Antimetabolites|antimetabolites|mesh-ancestor
5625794|NCT02603432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5625795|NCT02603432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5625796|NCT02603432|Immunologic Factors|immunologic factors|mesh-ancestor
5625797|NCT02603432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625798|NCT02602314|Imatinib Mesylate|imatinib mesylate|mesh-list
5625799|NCT02602314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5625800|NCT02602314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5749525|NCT03043196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5749526|NCT03043196|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6489497|NCT00592137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5625801|NCT02602314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5625802|NCT02602314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625803|NCT02600923|Letrozole|letrozole|mesh-list
5625804|NCT02600923|Palbociclib|palbociclib|mesh-list
5625805|NCT02600923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6672962|NCT01559545|Metronidazole|metronidazole|mesh-list
6672963|NCT01559545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6672964|NCT01559545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5749527|NCT03043196|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5749528|NCT03043196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5749529|NCT03043131|Plasma-lyte 148|plasma-lyte 148|mesh-list
5749530|NCT03043131|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5749531|NCT03043131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5749532|NCT03042936|Insulin|insulin|mesh-list
5749533|NCT03042936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5749534|NCT03042936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749535|NCT03042923|Mannitol|mannitol|mesh-list
5749536|NCT03042923|Lactulose|lactulose|mesh-list
5749537|NCT03042923|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5749538|NCT03042923|Diuretics|diuretics|mesh-ancestor
5749539|NCT03042923|Natriuretic Agents|natriuretic agents|mesh-ancestor
5749540|NCT03042923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749541|NCT03042923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5749542|NCT03043053|Oxytocin|oxytocin|mesh-list
5749543|NCT03043053|Oxytocics|oxytocics|mesh-ancestor
5749544|NCT03043053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5749545|NCT03043053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749546|NCT03043001|Memantine|memantine|mesh-list
5749547|NCT03043001|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5749548|NCT03043001|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5749549|NCT03043001|Dopamine Agents|dopamine agents|mesh-ancestor
5749550|NCT03043001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5749551|NCT03043001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5749552|NCT03043001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749553|NCT03043001|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5749554|NCT03043001|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5749555|NCT03043027|Bupivacaine|bupivacaine|mesh-list
5749556|NCT03043027|Anesthetics, Local|anesthetics, local|mesh-ancestor
5749557|NCT03043027|Anesthetics|anesthetics|mesh-ancestor
5749558|NCT03043027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5749559|NCT03043027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749560|NCT03043027|Sensory System Agents|sensory system agents|mesh-ancestor
5749561|NCT03043027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5749562|NCT03043066|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5625806|NCT02600923|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5625807|NCT02600923|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5749563|NCT03043066|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5749564|NCT03043066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5749565|NCT03043066|Antitubercular Agents|antitubercular agents|mesh-ancestor
5749566|NCT03043014|Misoprostol|misoprostol|mesh-list
5749567|NCT03043014|Mifepristone|mifepristone|mesh-list
5749568|NCT03043014|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5749569|NCT03043014|Abortifacient Agents|abortifacient agents|mesh-ancestor
5749570|NCT03043014|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6489498|NCT00592150|Fenoldopam|fenoldopam|mesh-list
5625808|NCT02600923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5749571|NCT03043014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489499|NCT00592150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6489500|NCT00592150|Vasodilator Agents|vasodilator agents|mesh-ancestor
6489501|NCT00592150|Dopamine Agonists|dopamine agonists|mesh-ancestor
6489502|NCT00592150|Dopamine Agents|dopamine agents|mesh-ancestor
5749572|NCT03043014|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5749573|NCT03043014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5749574|NCT03043014|Oxytocics|oxytocics|mesh-ancestor
5749575|NCT03043014|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5749576|NCT03043014|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5749577|NCT03043014|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5749578|NCT03043014|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5749579|NCT03043014|Contraceptive Agents|contraceptive agents|mesh-ancestor
5749580|NCT03043014|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5749581|NCT03043014|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5749582|NCT03043014|Hormone Antagonists|hormone antagonists|mesh-ancestor
5749583|NCT03043014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5749584|NCT03043014|Luteolytic Agents|luteolytic agents|mesh-ancestor
5749585|NCT03043014|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5749586|NCT03043014|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5625809|NCT02600923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625810|NCT02600923|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5625811|NCT02600923|Hormone Antagonists|hormone antagonists|mesh-ancestor
5625812|NCT02600923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5625813|NCT02600923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625814|NCT02600923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6208765|NCT02136420|Histamine Antagonists|histamine antagonists|mesh-ancestor
6208766|NCT02136420|Histamine Agents|histamine agents|mesh-ancestor
6208767|NCT02136420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6208768|NCT02136420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208769|NCT02136420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208770|NCT02136420|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6208771|NCT02136420|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5625822|NCT02484664|Celecoxib|celecoxib|mesh-list
5749587|NCT03042871|Ranibizumab|ranibizumab|mesh-list
5749588|NCT03042871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5749589|NCT03042871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5749590|NCT03042871|Growth Substances|growth substances|mesh-ancestor
5749591|NCT03042871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749592|NCT03042871|Growth Inhibitors|growth inhibitors|mesh-ancestor
5749593|NCT03042871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5894419|NCT04716335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894420|NCT04675151|Phentolamine|phentolamine|mesh-list
5894421|NCT04675151|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5894422|NCT04675151|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5894423|NCT04675151|Pilocarpine|pilocarpine|mesh-list
5894424|NCT04675151|Miotics|miotics|mesh-ancestor
5894425|NCT04675151|Autonomic Agents|autonomic agents|mesh-ancestor
5894426|NCT04675151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5894427|NCT04675151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894428|NCT04675151|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
5894429|NCT04675151|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5894430|NCT04675151|Cholinergic Agents|cholinergic agents|mesh-ancestor
6489503|NCT00592150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5625823|NCT02484664|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5625824|NCT02484664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5625825|NCT02484664|Analgesics|analgesics|mesh-ancestor
5625826|NCT02484664|Sensory System Agents|sensory system agents|mesh-ancestor
5625827|NCT02484664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5625828|NCT02484664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625829|NCT02484664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5625830|NCT02484664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5625831|NCT02484664|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5625832|NCT02484664|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5625833|NCT02484664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5625834|NCT02484664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625835|NCT02460900|Varenicline|varenicline|mesh-list
5625836|NCT02460900|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5625837|NCT02460900|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5625838|NCT02460900|Cholinergic Agents|cholinergic agents|mesh-ancestor
5625839|NCT02460900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5625840|NCT02460900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625841|NCT02460900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693023|NCT03403829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5693024|NCT03403829|Antimetabolites|antimetabolites|mesh-ancestor
5697769|NCT03373851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6489504|NCT00592150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625842|NCT02428647|Zinc|zinc|mesh-list
5749594|NCT03042546|Calcium|calcium|mesh-list
5749595|NCT03042546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5749596|NCT03042546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749597|NCT03042637|Tacrolimus|tacrolimus|mesh-list
5749598|NCT03042637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5749599|NCT03042637|Immunologic Factors|immunologic factors|mesh-ancestor
5749600|NCT03042637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749601|NCT03042637|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5749602|NCT03042637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5749603|NCT03042637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5749604|NCT03042429|Cyclophosphamide|cyclophosphamide|mesh-list
5749605|NCT03042429|Ifosfamide|ifosfamide|mesh-list
5749606|NCT03042429|Cisplatin|cisplatin|mesh-list
5749607|NCT03042429|Doxorubicin|doxorubicin|mesh-list
5749608|NCT03042429|Etoposide|etoposide|mesh-list
5749609|NCT03042429|Topotecan|topotecan|mesh-list
5749610|NCT03042429|Vindesine|vindesine|mesh-list
5749611|NCT03042429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5749612|NCT03042429|Immunologic Factors|immunologic factors|mesh-ancestor
5749613|NCT03042429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749614|NCT03042429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5749615|NCT03042429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5749616|NCT03042429|Alkylating Agents|alkylating agents|mesh-ancestor
5749617|NCT03042429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5749618|NCT03042429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5749619|NCT03042429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5749620|NCT03042429|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5749621|NCT03042429|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5749622|NCT03042429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5749623|NCT03042429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5749624|NCT03042429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5749625|NCT03042429|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5749626|NCT03042429|Tubulin Modulators|tubulin modulators|mesh-ancestor
5749627|NCT03042429|Antimitotic Agents|antimitotic agents|mesh-ancestor
5749628|NCT03042429|Mitosis Modulators|mitosis modulators|mesh-ancestor
5749629|NCT03042377|Calcium, Dietary|calcium, dietary|mesh-list
5625843|NCT02428647|Trace Elements|trace elements|mesh-ancestor
5625844|NCT02428647|Micronutrients|micronutrients|mesh-ancestor
5625845|NCT02428647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625846|NCT02371889|Topiramate|topiramate|mesh-list
5625847|NCT02371889|Anticonvulsants|anticonvulsants|mesh-ancestor
5625848|NCT02371889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5625849|NCT02371889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749630|NCT03042377|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5749631|NCT03042377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5749632|NCT03042377|Calcium|calcium|mesh-list
5749633|NCT03042377|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5749634|NCT03042377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749635|NCT03042377|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5749636|NCT03042377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5749637|NCT03042377|Antitubercular Agents|antitubercular agents|mesh-ancestor
5625850|NCT02362451|Vaccines|vaccines|mesh-list
5625851|NCT02362451|Immunologic Factors|immunologic factors|mesh-ancestor
5625852|NCT02362451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625853|NCT02337829|Acalabrutinib|acalabrutinib|mesh-list
5625854|NCT02337829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5625855|NCT02272803|Dexamethasone|dexamethasone|mesh-list
5625856|NCT02272803|Lenalidomide|lenalidomide|mesh-list
5625857|NCT02272803|Elotuzumab|elotuzumab|mesh-list
5625858|NCT02272803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5625859|NCT02272803|Antiemetics|antiemetics|mesh-ancestor
5625860|NCT02272803|Autonomic Agents|autonomic agents|mesh-ancestor
5625861|NCT02272803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5625862|NCT02272803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625863|NCT02272803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5625864|NCT02272803|Glucocorticoids|glucocorticoids|mesh-ancestor
5625865|NCT02272803|Hormones|hormones|mesh-ancestor
5625866|NCT02272803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5625867|NCT02272803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5625868|NCT02272803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5625869|NCT02272803|Immunologic Factors|immunologic factors|mesh-ancestor
5625870|NCT02272803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5625871|NCT02272803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5749638|NCT03042611|Apatinib|apatinib|mesh-list
5625872|NCT02272803|Growth Substances|growth substances|mesh-ancestor
5625873|NCT02272803|Growth Inhibitors|growth inhibitors|mesh-ancestor
5625874|NCT02257424|Hydroxychloroquine|hydroxychloroquine|mesh-list
5749639|NCT03042611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5749640|NCT03042611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5749641|NCT03042611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5749642|NCT03042611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5749643|NCT03042325|Alogliptin|alogliptin|mesh-list
5749644|NCT03042325|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5749645|NCT03042325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749646|NCT03042325|Incretins|incretins|mesh-ancestor
5749647|NCT03042325|Hormones|hormones|mesh-ancestor
6489505|NCT00592150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749648|NCT03042325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5749649|NCT03042325|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5749650|NCT03042325|Protease Inhibitors|protease inhibitors|mesh-ancestor
5749651|NCT03042325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5749652|NCT03042325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625875|NCT02257424|Trametinib|trametinib|mesh-list
5625876|NCT02257424|Dabrafenib|dabrafenib|mesh-list
5625877|NCT02257424|Antimalarials|antimalarials|mesh-ancestor
5625878|NCT02257424|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5625879|NCT02257424|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5625880|NCT02257424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5625881|NCT02257424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5625882|NCT02257424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625883|NCT02257424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5625884|NCT02257424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5625885|NCT02257424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5625886|NCT02186834|Dexamethasone|dexamethasone|mesh-list
5625887|NCT02186834|Doxorubicin|doxorubicin|mesh-list
5749653|NCT03042260|Trimethoprim|trimethoprim|mesh-list
6489506|NCT00592215|Misoprostol|misoprostol|mesh-list
6489507|NCT00592215|Mifepristone|mifepristone|mesh-list
6489508|NCT00592215|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6489509|NCT00592215|Abortifacient Agents|abortifacient agents|mesh-ancestor
6489510|NCT00592215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6489511|NCT00592215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489512|NCT00592215|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6489513|NCT00592215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6489514|NCT00592215|Oxytocics|oxytocics|mesh-ancestor
5625888|NCT02186834|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5625889|NCT02186834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5625890|NCT02186834|Antiemetics|antiemetics|mesh-ancestor
6489515|NCT00592215|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6489516|NCT00592215|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6489517|NCT00592215|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6489518|NCT00592215|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6489519|NCT00592215|Contraceptive Agents|contraceptive agents|mesh-ancestor
6489520|NCT00592215|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6489521|NCT00592215|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6489522|NCT00592215|Hormone Antagonists|hormone antagonists|mesh-ancestor
6489523|NCT00592215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6489524|NCT00592215|Luteolytic Agents|luteolytic agents|mesh-ancestor
6489525|NCT00592215|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6489526|NCT00592215|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6496363|NCT00627744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496364|NCT00627744|Incretins|incretins|mesh-ancestor
6496365|NCT00627744|Hormones|hormones|mesh-ancestor
5625891|NCT02186834|Autonomic Agents|autonomic agents|mesh-ancestor
5749654|NCT03042260|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
5749655|NCT03042260|Sulfamethoxazole|sulfamethoxazole|mesh-list
5749656|NCT03042260|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5749657|NCT03042260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5749658|NCT03042260|Renal Agents|renal agents|mesh-ancestor
5749659|NCT03042260|Antimalarials|antimalarials|mesh-ancestor
5749660|NCT03042260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5749661|NCT03042260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5749662|NCT03042260|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5749663|NCT03042260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5749664|NCT03042260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5749665|NCT03042260|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5749666|NCT03042260|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
5749667|NCT03042260|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5749668|NCT03042260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5749669|NCT03042234|Insulin|insulin|mesh-list
5625892|NCT02186834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5749670|NCT03042234|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5749671|NCT03042234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5749672|NCT03042234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749673|NCT03041883|Riboflavin|riboflavin|mesh-list
5749674|NCT03041883|Vitamin B Complex|vitamin b complex|mesh-ancestor
5749675|NCT03041883|Vitamins|vitamins|mesh-ancestor
5749676|NCT03041883|Micronutrients|micronutrients|mesh-ancestor
5749677|NCT03041883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749678|NCT03041883|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5749679|NCT03041883|Dermatologic Agents|dermatologic agents|mesh-ancestor
5749680|NCT03041935|Acetaminophen|acetaminophen|mesh-list
5749681|NCT03041935|Dexamethasone|dexamethasone|mesh-list
5749682|NCT03041935|Ketorolac|ketorolac|mesh-list
5749683|NCT03041935|Morphine|morphine|mesh-list
5749684|NCT03041935|Remifentanil|remifentanil|mesh-list
5749685|NCT03041935|Ondansetron|ondansetron|mesh-list
5625893|NCT02186834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625894|NCT02186834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5625895|NCT02186834|Glucocorticoids|glucocorticoids|mesh-ancestor
5625896|NCT02186834|Hormones|hormones|mesh-ancestor
5625897|NCT02186834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5625898|NCT02186834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5625899|NCT02186834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5625900|NCT02186834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5625901|NCT02186834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5749686|NCT03041935|Propofol|propofol|mesh-list
5749687|NCT03041935|Ropivacaine|ropivacaine|mesh-list
5749688|NCT03041935|Sevoflurane|sevoflurane|mesh-list
5749689|NCT03041935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5749690|NCT03041935|Antiemetics|antiemetics|mesh-ancestor
5749691|NCT03041935|Autonomic Agents|autonomic agents|mesh-ancestor
5749692|NCT03041935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5625902|NCT02186834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5625903|NCT02186834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5625904|NCT02186834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625905|NCT02059265|Dasatinib|dasatinib|mesh-list
5625906|NCT02059265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5625907|NCT02059265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5625908|NCT02059265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5625909|NCT02059265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625910|NCT02034422|Antioxidants|antioxidants|mesh-list
5749693|NCT03041935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749694|NCT03041935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5749695|NCT03041935|Glucocorticoids|glucocorticoids|mesh-ancestor
5749696|NCT03041935|Hormones|hormones|mesh-ancestor
5749697|NCT03041935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5749698|NCT03041935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5749699|NCT03041935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5749700|NCT03041935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5749701|NCT03041935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5749702|NCT03041935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5749703|NCT03041935|Anesthetics, General|anesthetics, general|mesh-ancestor
5749704|NCT03041935|Anesthetics|anesthetics|mesh-ancestor
5749705|NCT03041935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5749706|NCT03041935|Narcotics|narcotics|mesh-ancestor
5749707|NCT03041935|Analgesics|analgesics|mesh-ancestor
5749708|NCT03041935|Sensory System Agents|sensory system agents|mesh-ancestor
5749709|NCT03041935|Anesthetics, Local|anesthetics, local|mesh-ancestor
5749710|NCT03041935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5749711|NCT03041935|Antipyretics|antipyretics|mesh-ancestor
5749712|NCT03041935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5749713|NCT03041935|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5749714|NCT03041935|Antipruritics|antipruritics|mesh-ancestor
5749715|NCT03041935|Dermatologic Agents|dermatologic agents|mesh-ancestor
5749716|NCT03041935|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5749717|NCT03041935|Serotonin Agents|serotonin agents|mesh-ancestor
5749718|NCT03041935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5749719|NCT03041935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5749720|NCT03041935|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6489527|NCT00592241|Insulin|insulin|mesh-list
6489528|NCT00592241|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6489529|NCT00592241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6489530|NCT00592241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489531|NCT00592280|Pancrelipase|pancrelipase|mesh-list
6489532|NCT00592280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6489533|NCT00592306|Thymoglobulin|thymoglobulin|mesh-list
6489534|NCT00592306|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6489535|NCT00592306|Immunologic Factors|immunologic factors|mesh-ancestor
6489536|NCT00592306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749721|NCT03041935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5749722|NCT03041935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5749723|NCT03041935|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5749724|NCT03041935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5749725|NCT03041935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5749726|NCT03041935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5749727|NCT03041935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5749728|NCT03042013|Naquotinib|naquotinib|mesh-list
5749729|NCT03042013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5625911|NCT02034422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625912|NCT02034422|Protective Agents|protective agents|mesh-ancestor
5625913|NCT02034422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625914|NCT02003222|Cytarabine|cytarabine|mesh-list
5625915|NCT02003222|Dexamethasone|dexamethasone|mesh-list
5625916|NCT02003222|Dexamethasone acetate|dexamethasone acetate|mesh-list
5625917|NCT02003222|Prednisone|prednisone|mesh-list
5625918|NCT02003222|Cortisone|cortisone|mesh-list
5625919|NCT02003222|Cyclophosphamide|cyclophosphamide|mesh-list
5625920|NCT02003222|Rituximab|rituximab|mesh-list
5625921|NCT02003222|Methotrexate|methotrexate|mesh-list
5625922|NCT02003222|Etoposide|etoposide|mesh-list
5625923|NCT02003222|Vincristine|vincristine|mesh-list
5625924|NCT02003222|Etoposide phosphate|etoposide phosphate|mesh-list
5625925|NCT02003222|Daunorubicin|daunorubicin|mesh-list
5625926|NCT02003222|Asparaginase|asparaginase|mesh-list
5625927|NCT02003222|Mercaptopurine|mercaptopurine|mesh-list
5625928|NCT02003222|Podophyllotoxin|podophyllotoxin|mesh-list
5625929|NCT02003222|Pegaspargase|pegaspargase|mesh-list
5625930|NCT02003222|Blinatumomab|blinatumomab|mesh-list
5625931|NCT02003222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5625932|NCT02003222|Muromonab-CD3|muromonab-cd3|mesh-list
5625933|NCT02003222|Antibodies|antibodies|mesh-list
5625934|NCT02003222|Immunoglobulins|immunoglobulins|mesh-list
5625935|NCT02003222|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5625936|NCT02003222|Antibodies, Bispecific|antibodies, bispecific|mesh-list
5625937|NCT02003222|BB 1101|bb 1101|mesh-list
5625938|NCT02003222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5625939|NCT02003222|Immunologic Factors|immunologic factors|mesh-ancestor
5625940|NCT02003222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625941|NCT02003222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5625942|NCT02003222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5625943|NCT02003222|Alkylating Agents|alkylating agents|mesh-ancestor
5625944|NCT02003222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625945|NCT02003222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5625946|NCT02003222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5625947|NCT02003222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5625948|NCT02003222|Antiemetics|antiemetics|mesh-ancestor
5625949|NCT02003222|Autonomic Agents|autonomic agents|mesh-ancestor
5625950|NCT02003222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5625951|NCT02003222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5625952|NCT02003222|Glucocorticoids|glucocorticoids|mesh-ancestor
5625953|NCT02003222|Hormones|hormones|mesh-ancestor
5625954|NCT02003222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5625955|NCT02003222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5625956|NCT02003222|Protease Inhibitors|protease inhibitors|mesh-ancestor
5749730|NCT03042013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5749731|NCT03042013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5749732|NCT03042013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5749733|NCT03042000|Capecitabine|capecitabine|mesh-list
5749734|NCT03042000|Oxaliplatin|oxaliplatin|mesh-list
5749735|NCT03042000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5749736|NCT03042000|Antimetabolites|antimetabolites|mesh-ancestor
5749737|NCT03042000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5749738|NCT03042000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5749739|NCT03041948|Acetaminophen|acetaminophen|mesh-list
5749740|NCT03041948|Dexamethasone|dexamethasone|mesh-list
5749741|NCT03041948|Ketorolac|ketorolac|mesh-list
5749742|NCT03041948|Morphine|morphine|mesh-list
5749743|NCT03041948|Remifentanil|remifentanil|mesh-list
5749744|NCT03041948|Ondansetron|ondansetron|mesh-list
5749745|NCT03041948|Propofol|propofol|mesh-list
5749746|NCT03041948|Sevoflurane|sevoflurane|mesh-list
5749747|NCT03041948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5625957|NCT02003222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5625958|NCT02003222|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5625959|NCT02003222|Abortifacient Agents|abortifacient agents|mesh-ancestor
5625960|NCT02003222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5625961|NCT02003222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5749748|NCT03041948|Antiemetics|antiemetics|mesh-ancestor
5749749|NCT03041948|Autonomic Agents|autonomic agents|mesh-ancestor
6672965|NCT01559545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5625962|NCT02003222|Antimetabolites|antimetabolites|mesh-ancestor
5625963|NCT02003222|Dermatologic Agents|dermatologic agents|mesh-ancestor
5625964|NCT02003222|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5625965|NCT02003222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5625966|NCT02003222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5625967|NCT02003222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5625968|NCT02003222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5625969|NCT02003222|Antiviral Agents|antiviral agents|mesh-ancestor
5625970|NCT02003222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5749750|NCT03041948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5749751|NCT03041948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749752|NCT03041948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5749753|NCT03041948|Glucocorticoids|glucocorticoids|mesh-ancestor
5749754|NCT03041948|Hormones|hormones|mesh-ancestor
5749755|NCT03041948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5749756|NCT03041948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5749757|NCT03041948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5749758|NCT03041948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5749759|NCT03041948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5749760|NCT03041948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5749761|NCT03041948|Anesthetics, General|anesthetics, general|mesh-ancestor
5749762|NCT03041948|Anesthetics|anesthetics|mesh-ancestor
5749763|NCT03041948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5749764|NCT03041948|Narcotics|narcotics|mesh-ancestor
5749765|NCT03041948|Analgesics|analgesics|mesh-ancestor
5749766|NCT03041948|Sensory System Agents|sensory system agents|mesh-ancestor
5749767|NCT03041948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5749768|NCT03041948|Antipyretics|antipyretics|mesh-ancestor
5749769|NCT03041948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5749770|NCT03041948|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5749771|NCT03041948|Antipruritics|antipruritics|mesh-ancestor
5749772|NCT03041948|Dermatologic Agents|dermatologic agents|mesh-ancestor
5749773|NCT03041948|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5749774|NCT03041948|Serotonin Agents|serotonin agents|mesh-ancestor
5749775|NCT03041948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5749776|NCT03041948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5749777|NCT03041948|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5749778|NCT03041948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5749779|NCT03041948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5749780|NCT03041948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5749781|NCT03041948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5749782|NCT03041948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5749783|NCT03041948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5749784|NCT03041948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5749785|NCT03042182|Vaccines|vaccines|mesh-list
5749786|NCT03042182|Immunologic Factors|immunologic factors|mesh-ancestor
5749787|NCT03042182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749788|NCT03042091|Metronidazole|metronidazole|mesh-list
5749789|NCT03042091|Ethanol|ethanol|mesh-list
5749790|NCT03042091|Neomycin|neomycin|mesh-list
5749791|NCT03042091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5749792|NCT03042091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5749793|NCT03042091|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5749794|NCT03042091|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5749795|NCT03042091|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5749796|NCT03042091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5749797|NCT03042091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749798|NCT03042091|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5749799|NCT03042091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5749800|NCT03042091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208772|NCT02136420|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6208773|NCT02136420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6208774|NCT02136420|Anesthetics, Local|anesthetics, local|mesh-ancestor
6208775|NCT02136420|Anesthetics|anesthetics|mesh-ancestor
6208776|NCT02136420|Sensory System Agents|sensory system agents|mesh-ancestor
6208777|NCT02136420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5749801|NCT03042052|Botulinum Toxins|botulinum toxins|mesh-list
5749802|NCT03042052|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5749803|NCT03042052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5625971|NCT02003222|Tubulin Modulators|tubulin modulators|mesh-ancestor
5625972|NCT02003222|Antimitotic Agents|antimitotic agents|mesh-ancestor
5625973|NCT02003222|Mitosis Modulators|mitosis modulators|mesh-ancestor
5625974|NCT02003222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5749804|NCT03042052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208778|NCT02136420|Antiemetics|antiemetics|mesh-ancestor
5625975|NCT02003222|Keratolytic Agents|keratolytic agents|mesh-ancestor
5625976|NCT01988883|Propranolol|propranolol|mesh-list
5625977|NCT01988883|Modafinil|modafinil|mesh-list
5625978|NCT01988883|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5625979|NCT01988883|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5625980|NCT01988883|Adrenergic Agents|adrenergic agents|mesh-ancestor
5625981|NCT01988883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5625982|NCT01988883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5625983|NCT01988883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5625984|NCT01988883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5625985|NCT01988883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5625986|NCT01988883|Vasodilator Agents|vasodilator agents|mesh-ancestor
5625987|NCT01988883|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5749805|NCT03042052|Cholinergic Agents|cholinergic agents|mesh-ancestor
5749806|NCT03042052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5749807|NCT03042052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749808|NCT03042143|Plasma-lyte 148|plasma-lyte 148|mesh-list
5749809|NCT03042143|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5749810|NCT03042143|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5749811|NCT03041779|Acetaminophen|acetaminophen|mesh-list
5749812|NCT03041779|Diclofenac|diclofenac|mesh-list
5749813|NCT03041779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5749814|NCT03041779|Analgesics|analgesics|mesh-ancestor
5749815|NCT03041779|Sensory System Agents|sensory system agents|mesh-ancestor
5749816|NCT03041779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5749817|NCT03041779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749818|NCT03041779|Antipyretics|antipyretics|mesh-ancestor
5749819|NCT03041779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5749820|NCT03041779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5749821|NCT03041779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5749822|NCT03041779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5749823|NCT03041779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5749824|NCT03041779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5749825|NCT03041740|Perflubron|perflubron|mesh-list
5749826|NCT03041740|Bromides|bromides|mesh-list
5749827|NCT03041740|Anticonvulsants|anticonvulsants|mesh-ancestor
5749828|NCT03041740|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5749829|NCT03041506|Lidocaine|lidocaine|mesh-list
5749830|NCT03041506|Midazolam|midazolam|mesh-list
5749831|NCT03041506|Ketamine|ketamine|mesh-list
5749832|NCT03041506|Anesthetics, Local|anesthetics, local|mesh-ancestor
5749833|NCT03041506|Anesthetics|anesthetics|mesh-ancestor
5749834|NCT03041506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5749835|NCT03041506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749836|NCT03041506|Sensory System Agents|sensory system agents|mesh-ancestor
5749837|NCT03041506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5749838|NCT03041506|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5749839|NCT03041506|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5749840|NCT03041506|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5625988|NCT01988883|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
5625989|NCT01988883|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5625990|NCT01988883|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5625991|NCT01945775|Talazoparib|talazoparib|mesh-list
5625992|NCT01945775|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5625993|NCT01945775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5625994|NCT01945775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5749841|NCT03041506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5749842|NCT03041506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5749843|NCT03041506|Analgesics|analgesics|mesh-ancestor
5625995|NCT01945775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5625996|NCT01886859|Lenalidomide|lenalidomide|mesh-list
5625997|NCT01886859|Immunologic Factors|immunologic factors|mesh-ancestor
5749844|NCT03041506|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5749845|NCT03041506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5749846|NCT03041506|Anesthetics, General|anesthetics, general|mesh-ancestor
5749847|NCT03041506|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5749848|NCT03041506|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5749849|NCT03041506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5749850|NCT03041506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5749851|NCT03041506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5749852|NCT03041506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5749853|NCT03041506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5749854|NCT03041506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5625998|NCT01886859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749855|NCT03041506|GABA Modulators|gaba modulators|mesh-ancestor
5749856|NCT03041506|GABA Agents|gaba agents|mesh-ancestor
5625999|NCT01886859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5749857|NCT03041207|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5749858|NCT03041207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5749859|NCT03040999|Cisplatin|cisplatin|mesh-list
5749860|NCT03040999|Pembrolizumab|pembrolizumab|mesh-list
5749861|NCT03040999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5749862|NCT03040999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5749863|NCT03041012|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
5749864|NCT03041012|Romidepsin|romidepsin|mesh-list
5749865|NCT03041012|Antibodies, Blocking|antibodies, blocking|mesh-list
5749866|NCT03041012|Antiviral Agents|antiviral agents|mesh-ancestor
5749867|NCT03041012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5749868|NCT03041012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5749869|NCT03041012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5749870|NCT03041012|Immunologic Factors|immunologic factors|mesh-ancestor
5749871|NCT03041012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749872|NCT03040973|Gefitinib|gefitinib|mesh-list
5749873|NCT03040973|Nazartinib|nazartinib|mesh-list
5626000|NCT01886859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5626001|NCT01886859|Growth Substances|growth substances|mesh-ancestor
5626002|NCT01886859|Growth Inhibitors|growth inhibitors|mesh-ancestor
5626003|NCT01886859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5626004|NCT01858922|Cytarabine|cytarabine|mesh-list
5626005|NCT01858922|Dexamethasone|dexamethasone|mesh-list
5626006|NCT01858922|Prednisone|prednisone|mesh-list
5626007|NCT01858922|Cyclophosphamide|cyclophosphamide|mesh-list
5626008|NCT01858922|Cisplatin|cisplatin|mesh-list
5626009|NCT01858922|Doxorubicin|doxorubicin|mesh-list
5626010|NCT01858922|Etoposide|etoposide|mesh-list
5749874|NCT03040973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5749875|NCT03040973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5749876|NCT03040973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5749877|NCT03040973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894431|NCT04675151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5894432|NCT04675151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894433|NCT04675151|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5894434|NCT04675151|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5894435|NCT04675151|Adrenergic Agents|adrenergic agents|mesh-ancestor
5894436|NCT04675151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5894437|NCT04666961|Tamoxifen|tamoxifen|mesh-list
5894438|NCT04666961|Anastrozole|anastrozole|mesh-list
5626011|NCT01858922|Etoposide phosphate|etoposide phosphate|mesh-list
5626012|NCT01858922|Vincristine|vincristine|mesh-list
5626013|NCT01858922|Bleomycin|bleomycin|mesh-list
5626014|NCT01858922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5626015|NCT01858922|Immunologic Factors|immunologic factors|mesh-ancestor
5626016|NCT01858922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626017|NCT01858922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5626018|NCT01858922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5626019|NCT01858922|Alkylating Agents|alkylating agents|mesh-ancestor
5626020|NCT01858922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5626021|NCT01858922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5626022|NCT01858922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5626023|NCT01858922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5626024|NCT01858922|Antiemetics|antiemetics|mesh-ancestor
5626025|NCT01858922|Autonomic Agents|autonomic agents|mesh-ancestor
5626026|NCT01858922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5626027|NCT01858922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5894439|NCT04666961|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5894440|NCT04666961|Hormone Antagonists|hormone antagonists|mesh-ancestor
5894441|NCT04666961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5894442|NCT04666961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894443|NCT04666961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5894444|NCT04666961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5894445|NCT04666961|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5894446|NCT04666961|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5894447|NCT04666961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5894448|NCT04666961|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5894449|NCT04666961|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5894450|NCT04666961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5894451|NCT04666961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894452|NCT04663308|Volixibat|volixibat|mesh-list
5626028|NCT01858922|Glucocorticoids|glucocorticoids|mesh-ancestor
5894453|NCT04663308|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5894454|NCT04640571|Metformin|metformin|mesh-list
5626029|NCT01858922|Hormones|hormones|mesh-ancestor
5626030|NCT01858922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5626031|NCT01858922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5626032|NCT01858922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5626033|NCT01858922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5626034|NCT01858922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5626035|NCT01858922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5626036|NCT01858922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5626037|NCT01858922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5626038|NCT01858922|Antimetabolites|antimetabolites|mesh-ancestor
5626039|NCT01858922|Antiviral Agents|antiviral agents|mesh-ancestor
5626040|NCT01858922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5626041|NCT01858922|Tubulin Modulators|tubulin modulators|mesh-ancestor
5626042|NCT01858922|Antimitotic Agents|antimitotic agents|mesh-ancestor
5749878|NCT03040778|Vitamin E|vitamin e|mesh-list
5749879|NCT03040778|Tocopherols|tocopherols|mesh-list
5749880|NCT03040778|Tocotrienols|tocotrienols|mesh-list
5749881|NCT03040778|alpha-Tocopherol|alpha-tocopherol|mesh-list
5749882|NCT03040778|Pentoxifylline|pentoxifylline|mesh-list
5749883|NCT03040778|Vitamins|vitamins|mesh-ancestor
5749884|NCT03040778|Micronutrients|micronutrients|mesh-ancestor
5749885|NCT03040778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749886|NCT03040778|Antioxidants|antioxidants|mesh-ancestor
5749887|NCT03040778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5749888|NCT03040778|Protective Agents|protective agents|mesh-ancestor
5749889|NCT03040778|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5749890|NCT03040778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5749891|NCT03040778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5749892|NCT03040778|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5749893|NCT03040778|Vasodilator Agents|vasodilator agents|mesh-ancestor
5749894|NCT03040778|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5749895|NCT03040934|Sirolimus|sirolimus|mesh-list
5749896|NCT03040934|Everolimus|everolimus|mesh-list
5749897|NCT03040934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5749898|NCT03040934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5749899|NCT03040934|Immunologic Factors|immunologic factors|mesh-ancestor
5749900|NCT03040934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749901|NCT03040934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5749902|NCT03040934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5626043|NCT01858922|Mitosis Modulators|mitosis modulators|mesh-ancestor
5626044|NCT01781637|Omalizumab|omalizumab|mesh-list
5626045|NCT01781637|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5626046|NCT01781637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5626047|NCT01781637|Respiratory System Agents|respiratory system agents|mesh-ancestor
5626048|NCT01773278|Antioxidants|antioxidants|mesh-list
5626049|NCT01773278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5626050|NCT01773278|Protective Agents|protective agents|mesh-ancestor
5626051|NCT01773278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626052|NCT01723839|Cyclophosphamide|cyclophosphamide|mesh-list
5626053|NCT01723839|Rituximab|rituximab|mesh-list
5626054|NCT01723839|Fludarabine|fludarabine|mesh-list
5626055|NCT01723839|Lenalidomide|lenalidomide|mesh-list
5626056|NCT01723839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5626057|NCT01723839|Immunologic Factors|immunologic factors|mesh-ancestor
5626058|NCT01723839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626059|NCT01723839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5626060|NCT01723839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5626061|NCT01723839|Alkylating Agents|alkylating agents|mesh-ancestor
5626062|NCT01723839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5749903|NCT03040934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5749904|NCT03040934|Antifungal Agents|antifungal agents|mesh-ancestor
6489537|NCT00592306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6489538|NCT00592332|Alprazolam|alprazolam|mesh-list
6489539|NCT00592332|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6489540|NCT00592332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6489541|NCT00592332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489542|NCT00592332|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6489543|NCT00592332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6489544|NCT00592332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5626063|NCT01723839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5626064|NCT01723839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5626065|NCT01723839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5626066|NCT01723839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5626067|NCT01723839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5626068|NCT01723839|Growth Substances|growth substances|mesh-ancestor
6489545|NCT00592332|GABA Modulators|gaba modulators|mesh-ancestor
6489546|NCT00592332|GABA Agents|gaba agents|mesh-ancestor
6489547|NCT00592332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5749905|NCT03040791|Nivolumab|nivolumab|mesh-list
5894455|NCT04640571|Valacyclovir|valacyclovir|mesh-list
5626069|NCT01723839|Growth Inhibitors|growth inhibitors|mesh-ancestor
5626070|NCT01711541|Paclitaxel|paclitaxel|mesh-list
5626071|NCT01711541|Cisplatin|cisplatin|mesh-list
5626072|NCT01711541|Carboplatin|carboplatin|mesh-list
5749906|NCT03040791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5749907|NCT03040791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5749908|NCT03040791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5749909|NCT03040791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5749910|NCT03040830|Progesterone|progesterone|mesh-list
5749911|NCT03040830|Progestins|progestins|mesh-ancestor
5749912|NCT03040830|Hormones|hormones|mesh-ancestor
5749913|NCT03040830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5749914|NCT03040830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749915|NCT03040752|Nifedipine|nifedipine|mesh-list
5749916|NCT03040752|Ritodrine|ritodrine|mesh-list
5749917|NCT03040752|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5749918|NCT03040752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5749919|NCT03040752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5749920|NCT03040752|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5749921|NCT03040752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749922|NCT03040752|Vasodilator Agents|vasodilator agents|mesh-ancestor
5749923|NCT03040752|Tocolytic Agents|tocolytic agents|mesh-ancestor
5749924|NCT03040752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5749925|NCT03040752|Sympathomimetics|sympathomimetics|mesh-ancestor
5749926|NCT03040752|Autonomic Agents|autonomic agents|mesh-ancestor
5749927|NCT03040752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5749928|NCT03040752|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5749929|NCT03040752|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5749930|NCT03040752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5749931|NCT03040752|Adrenergic Agents|adrenergic agents|mesh-ancestor
5626073|NCT01711541|Fluorouracil|fluorouracil|mesh-list
5626074|NCT01711541|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5749932|NCT03040752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5749933|NCT03040817|Esomeprazole|esomeprazole|mesh-list
5749934|NCT03040817|Mosapride|mosapride|mesh-list
5749935|NCT03040817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5749936|NCT03040817|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5749937|NCT03040817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5749938|NCT03040817|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5749939|NCT03040817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5749940|NCT03040817|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5749941|NCT03040817|Serotonin Agents|serotonin agents|mesh-ancestor
5749942|NCT03040817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5749943|NCT03040817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749944|NCT03040765|Zoledronic Acid|zoledronic acid|mesh-list
5749945|NCT03040765|Denosumab|denosumab|mesh-list
5749946|NCT03040765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5626075|NCT01711541|Hydroxyurea|hydroxyurea|mesh-list
5626076|NCT01711541|Veliparib|veliparib|mesh-list
5626077|NCT01711541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5749947|NCT03040765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749948|NCT03040635|Risdiplam|risdiplam|mesh-list
5626078|NCT01711541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5626079|NCT01711541|Tubulin Modulators|tubulin modulators|mesh-ancestor
5626080|NCT01711541|Antimitotic Agents|antimitotic agents|mesh-ancestor
5626081|NCT01711541|Mitosis Modulators|mitosis modulators|mesh-ancestor
5626082|NCT01711541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5626083|NCT01711541|Antimetabolites|antimetabolites|mesh-ancestor
5626084|NCT01711541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5626085|NCT01711541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5626086|NCT01711541|Immunologic Factors|immunologic factors|mesh-ancestor
5626087|NCT01711541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626088|NCT01711541|Antisickling Agents|antisickling agents|mesh-ancestor
5626089|NCT01711541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5626090|NCT01711541|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5626091|NCT01711541|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5626092|NCT01670539|Triamcinolone|triamcinolone|mesh-list
5626093|NCT01670539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5626094|NCT01670539|Glucocorticoids|glucocorticoids|mesh-ancestor
5626095|NCT01670539|Hormones|hormones|mesh-ancestor
5626096|NCT01670539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5626097|NCT01670539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749949|NCT03040635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5626098|NCT01552434|Sirolimus|sirolimus|mesh-list
5626099|NCT01552434|Bevacizumab|bevacizumab|mesh-list
5626100|NCT01552434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5749950|NCT03040635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5749951|NCT03040635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749952|NCT03040596|Fluticasone|fluticasone|mesh-list
5749953|NCT03040596|Xhance|xhance|mesh-list
5749954|NCT03040596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5749955|NCT03040596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5749956|NCT03040596|Autonomic Agents|autonomic agents|mesh-ancestor
5626101|NCT01552434|Cetuximab|cetuximab|mesh-list
5626102|NCT01552434|Valproic Acid|valproic acid|mesh-list
5626103|NCT01552434|Endothelial Growth Factors|endothelial growth factors|mesh-list
5626104|NCT01552434|Antibodies|antibodies|mesh-list
5626105|NCT01552434|Immunoglobulins|immunoglobulins|mesh-list
5626106|NCT01552434|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5626107|NCT01552434|Immunoglobulin G|immunoglobulin g|mesh-list
5626108|NCT01552434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5626109|NCT01552434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5749957|NCT03040596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5749958|NCT03040596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749959|NCT03040596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5749960|NCT03040596|Respiratory System Agents|respiratory system agents|mesh-ancestor
5749961|NCT03040596|Dermatologic Agents|dermatologic agents|mesh-ancestor
5749962|NCT03040596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5749963|NCT03040531|Vitamin D|vitamin d|mesh-list
5749964|NCT03040531|Cholecalciferol|cholecalciferol|mesh-list
5749965|NCT03040531|Alendronate|alendronate|mesh-list
5749966|NCT03040531|Genistein|genistein|mesh-list
5749967|NCT03040531|Calcium|calcium|mesh-list
5749968|NCT03040531|Vitamins|vitamins|mesh-ancestor
5749969|NCT03040531|Micronutrients|micronutrients|mesh-ancestor
5749970|NCT03040531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749971|NCT03040531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5749972|NCT03040531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5749973|NCT03040531|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5749974|NCT03040531|Protective Agents|protective agents|mesh-ancestor
5749975|NCT03040531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5749976|NCT03040531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5749977|NCT03040531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5626110|NCT01552434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5626111|NCT01552434|Growth Substances|growth substances|mesh-ancestor
5626112|NCT01552434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626113|NCT01552434|Growth Inhibitors|growth inhibitors|mesh-ancestor
5626114|NCT01552434|Immunologic Factors|immunologic factors|mesh-ancestor
5626115|NCT01552434|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5626116|NCT01552434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5626117|NCT01552434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5626118|NCT01552434|Antifungal Agents|antifungal agents|mesh-ancestor
5626119|NCT01552434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5626120|NCT01552434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5626121|NCT01552434|Anticonvulsants|anticonvulsants|mesh-ancestor
5626122|NCT01552434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5626123|NCT01552434|GABA Agents|gaba agents|mesh-ancestor
5626124|NCT01552434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5626125|NCT01552434|Antimanic Agents|antimanic agents|mesh-ancestor
5626126|NCT01552434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5626127|NCT01552434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5626128|NCT01552434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5626129|NCT01480154|Hydroxychloroquine|hydroxychloroquine|mesh-list
5626130|NCT01480154|Antimalarials|antimalarials|mesh-ancestor
5626131|NCT01480154|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5626132|NCT01480154|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5626133|NCT01480154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5749978|NCT03040531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5749979|NCT03040531|Phytoestrogens|phytoestrogens|mesh-ancestor
5749980|NCT03040531|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
5749981|NCT03040531|Estrogens|estrogens|mesh-ancestor
5749982|NCT03040531|Hormones|hormones|mesh-ancestor
5749983|NCT03040531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5749984|NCT03040219|Folic Acid|folic acid|mesh-list
5749985|NCT03040219|Hematinics|hematinics|mesh-ancestor
5749986|NCT03040219|Vitamin B Complex|vitamin b complex|mesh-ancestor
5749987|NCT03040219|Vitamins|vitamins|mesh-ancestor
5749988|NCT03040219|Micronutrients|micronutrients|mesh-ancestor
5749989|NCT03040219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5749990|NCT03040141|Oseltamivir|oseltamivir|mesh-list
5626134|NCT01480154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5749991|NCT03040141|Antiviral Agents|antiviral agents|mesh-ancestor
5626135|NCT01480154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5749992|NCT03040141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5749993|NCT03040141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5749994|NCT03040141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5749995|NCT03040401|Aldesleukin|aldesleukin|mesh-list
5749996|NCT03040401|Interleukin-2|interleukin-2|mesh-list
5749997|NCT03040401|Histamine|histamine|mesh-list
5749998|NCT03040401|Histamine phosphate|histamine phosphate|mesh-list
5749999|NCT03040401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5750000|NCT03040401|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5750001|NCT03040401|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5750002|NCT03040401|Antiviral Agents|antiviral agents|mesh-ancestor
5750003|NCT03040401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5750004|NCT03040401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5750005|NCT03040401|Analgesics|analgesics|mesh-ancestor
5750006|NCT03040401|Sensory System Agents|sensory system agents|mesh-ancestor
5750007|NCT03040401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5750008|NCT03040401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750009|NCT03040401|Histamine Agonists|histamine agonists|mesh-ancestor
5750010|NCT03040401|Histamine Agents|histamine agents|mesh-ancestor
5750011|NCT03040401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5750012|NCT03040401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5750013|NCT03040180|Bleomycin|bleomycin|mesh-list
5750014|NCT03040180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5750015|NCT03040180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5750016|NCT03040167|Epinephrine|epinephrine|mesh-list
5750017|NCT03040167|Bupivacaine|bupivacaine|mesh-list
5750018|NCT03040167|Anesthetics, Local|anesthetics, local|mesh-ancestor
5750019|NCT03040167|Anesthetics|anesthetics|mesh-ancestor
5750020|NCT03040167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5750021|NCT03040167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750022|NCT03040167|Sensory System Agents|sensory system agents|mesh-ancestor
5750023|NCT03040167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5750024|NCT03040167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5750025|NCT03040167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5750026|NCT03040167|Adrenergic Agents|adrenergic agents|mesh-ancestor
5750027|NCT03040167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5750028|NCT03040167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5750029|NCT03040167|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5750030|NCT03040167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5750031|NCT03040167|Autonomic Agents|autonomic agents|mesh-ancestor
5750032|NCT03040167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5626136|NCT01480154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5626137|NCT01416935|Amiodarone|amiodarone|mesh-list
5750033|NCT03040167|Respiratory System Agents|respiratory system agents|mesh-ancestor
5750034|NCT03040167|Mydriatics|mydriatics|mesh-ancestor
5750035|NCT03040167|Sympathomimetics|sympathomimetics|mesh-ancestor
5750036|NCT03040167|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5750037|NCT03040193|Lidocaine|lidocaine|mesh-list
5750038|NCT03040193|Anesthetics, Local|anesthetics, local|mesh-ancestor
5750039|NCT03040193|Anesthetics|anesthetics|mesh-ancestor
5750040|NCT03040193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5750041|NCT03040193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750042|NCT03040193|Sensory System Agents|sensory system agents|mesh-ancestor
5750043|NCT03040193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5750044|NCT03040193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5750045|NCT03040193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5750046|NCT03040193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5750047|NCT03040193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5750048|NCT03040193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5750049|NCT03040128|Minocycline|minocycline|mesh-list
5750050|NCT03040128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5750051|NCT03040128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5750052|NCT03039985|Lithium Carbonate|lithium carbonate|mesh-list
5750053|NCT03039985|Antidepressive Agents|antidepressive agents|mesh-ancestor
5750054|NCT03039985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5750055|NCT03039985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5626138|NCT01416935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5626139|NCT01416935|Vasodilator Agents|vasodilator agents|mesh-ancestor
5626140|NCT01416935|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5626141|NCT01416935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5750056|NCT03039985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5750057|NCT03039985|Antimanic Agents|antimanic agents|mesh-ancestor
5750058|NCT03039985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5750059|NCT03039985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5626142|NCT01416935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5626143|NCT01416935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5626144|NCT01416935|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5626145|NCT01416935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5626146|NCT01416935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5626147|NCT01416935|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5626148|NCT01416935|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5626149|NCT01416935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5626150|NCT01371981|Cytarabine|cytarabine|mesh-list
5626151|NCT01371981|Etoposide|etoposide|mesh-list
5626152|NCT01371981|Podophyllotoxin|podophyllotoxin|mesh-list
5626153|NCT01371981|Daunorubicin|daunorubicin|mesh-list
5626154|NCT01371981|Mitoxantrone|mitoxantrone|mesh-list
5626155|NCT01371981|Bortezomib|bortezomib|mesh-list
5626156|NCT01371981|Etoposide phosphate|etoposide phosphate|mesh-list
5626157|NCT01371981|Sorafenib|sorafenib|mesh-list
5626158|NCT01371981|Asparaginase|asparaginase|mesh-list
5626159|NCT01371981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5626160|NCT01371981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5626161|NCT01371981|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5626162|NCT01371981|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5626163|NCT01371981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5626164|NCT01371981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5626165|NCT01371981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5626166|NCT01371981|Antimetabolites|antimetabolites|mesh-ancestor
5626167|NCT01371981|Antiviral Agents|antiviral agents|mesh-ancestor
5626168|NCT01371981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5626169|NCT01371981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5750060|NCT03039985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750061|NCT03039842|Valproic Acid|valproic acid|mesh-list
5750062|NCT03039842|Memantine|memantine|mesh-list
5750063|NCT03039842|Dextromethorphan|dextromethorphan|mesh-list
5750064|NCT03039842|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5750065|NCT03039842|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5750066|NCT03039842|Dopamine Agents|dopamine agents|mesh-ancestor
5750067|NCT03039842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5750068|NCT03039842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5750069|NCT03039842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750070|NCT03039842|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5750071|NCT03039842|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5750072|NCT03039842|Antitussive Agents|antitussive agents|mesh-ancestor
5750073|NCT03039842|Respiratory System Agents|respiratory system agents|mesh-ancestor
5750074|NCT03039842|Anticonvulsants|anticonvulsants|mesh-ancestor
5750075|NCT03039842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5750076|NCT03039842|GABA Agents|gaba agents|mesh-ancestor
6672966|NCT01559545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6672967|NCT01559584|Triamcinolone|triamcinolone|mesh-list
6672968|NCT01559584|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6672969|NCT01559584|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6672970|NCT01559584|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6672971|NCT01559584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6672972|NCT01559584|Glucocorticoids|glucocorticoids|mesh-ancestor
6672973|NCT01559584|Hormones|hormones|mesh-ancestor
6672974|NCT01559584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6672975|NCT01559584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672976|NCT01559584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6672977|NCT01559584|Immunologic Factors|immunologic factors|mesh-ancestor
6672978|NCT01559584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6672979|NCT01559584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672980|NCT01559727|Prednisone|prednisone|mesh-list
5626170|NCT01371981|Immunologic Factors|immunologic factors|mesh-ancestor
5626171|NCT01371981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626172|NCT01371981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5626173|NCT01371981|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5626174|NCT01371981|Analgesics|analgesics|mesh-ancestor
5626175|NCT01371981|Sensory System Agents|sensory system agents|mesh-ancestor
5626176|NCT01371981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5626177|NCT01371981|Keratolytic Agents|keratolytic agents|mesh-ancestor
5626178|NCT01371981|Dermatologic Agents|dermatologic agents|mesh-ancestor
5626179|NCT01371981|Tubulin Modulators|tubulin modulators|mesh-ancestor
5626180|NCT01371981|Antimitotic Agents|antimitotic agents|mesh-ancestor
5626181|NCT01371981|Mitosis Modulators|mitosis modulators|mesh-ancestor
5626182|NCT01351909|Cyclophosphamide|cyclophosphamide|mesh-list
5626183|NCT01351909|Veliparib|veliparib|mesh-list
5626184|NCT01351909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5626185|NCT01351909|Immunologic Factors|immunologic factors|mesh-ancestor
6672981|NCT01559727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5626186|NCT01351909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626187|NCT01351909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6672982|NCT01559727|Glucocorticoids|glucocorticoids|mesh-ancestor
6672983|NCT01559727|Hormones|hormones|mesh-ancestor
6672984|NCT01559727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6672985|NCT01559727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626188|NCT01351909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5626189|NCT01351909|Alkylating Agents|alkylating agents|mesh-ancestor
5626190|NCT01351909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5626191|NCT01351909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5626192|NCT01351909|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5626193|NCT01351909|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5626194|NCT01351909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5626195|NCT01351896|Lenalidomide|lenalidomide|mesh-list
5626196|NCT01351896|Vaccines|vaccines|mesh-list
5626197|NCT01351896|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5626198|NCT01351896|Immunologic Factors|immunologic factors|mesh-ancestor
5626199|NCT01351896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626200|NCT01351896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5626201|NCT01351896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5626202|NCT01351896|Growth Substances|growth substances|mesh-ancestor
5626203|NCT01351896|Growth Inhibitors|growth inhibitors|mesh-ancestor
5626204|NCT01351896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5626205|NCT01196390|Paclitaxel|paclitaxel|mesh-list
5626206|NCT01196390|Carboplatin|carboplatin|mesh-list
5626207|NCT01196390|Trastuzumab|trastuzumab|mesh-list
5626208|NCT01196390|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5750077|NCT03039842|Antimanic Agents|antimanic agents|mesh-ancestor
5750078|NCT03039842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5750079|NCT03039842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5750080|NCT03039842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5750081|NCT03039608|Prednisone|prednisone|mesh-list
5750082|NCT03039608|Triamcinolone|triamcinolone|mesh-list
5626209|NCT01196390|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
5626210|NCT01196390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5750083|NCT03039608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5750084|NCT03039608|Glucocorticoids|glucocorticoids|mesh-ancestor
5750085|NCT03039608|Hormones|hormones|mesh-ancestor
5626211|NCT01196390|Antibodies|antibodies|mesh-list
5626212|NCT01196390|Immunoglobulins|immunoglobulins|mesh-list
5626213|NCT01196390|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5626214|NCT01196390|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5626215|NCT01196390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5750086|NCT03039608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5750087|NCT03039608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750088|NCT03039608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5750089|NCT03039608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5750090|NCT03039413|Copper|copper|mesh-list
5750091|NCT03039413|Trace Elements|trace elements|mesh-ancestor
5750092|NCT03039413|Micronutrients|micronutrients|mesh-ancestor
5750093|NCT03039413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750094|NCT03039491|Vaccines|vaccines|mesh-list
5750095|NCT03039491|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5750096|NCT03039491|Immunologic Factors|immunologic factors|mesh-ancestor
6489548|NCT00592332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489549|NCT00592410|Insulin|insulin|mesh-list
6489550|NCT00592410|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6489551|NCT00592410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5626216|NCT01196390|Tubulin Modulators|tubulin modulators|mesh-ancestor
5626217|NCT01196390|Antimitotic Agents|antimitotic agents|mesh-ancestor
5626218|NCT01196390|Mitosis Modulators|mitosis modulators|mesh-ancestor
5626219|NCT01196390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5626220|NCT01196390|Immunologic Factors|immunologic factors|mesh-ancestor
5626221|NCT01196390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626222|NCT01046825|Leucovorin|leucovorin|mesh-list
5626223|NCT01046825|Folic Acid|folic acid|mesh-list
5626224|NCT01046825|Cytarabine|cytarabine|mesh-list
5626225|NCT01046825|Prednisone|prednisone|mesh-list
5626226|NCT01046825|Cyclophosphamide|cyclophosphamide|mesh-list
5626227|NCT01046825|Doxorubicin|doxorubicin|mesh-list
5626228|NCT01046825|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5626229|NCT01046825|Rituximab|rituximab|mesh-list
6489552|NCT00592410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489553|NCT00592527|Insulin Detemir|insulin detemir|mesh-list
6489554|NCT00592527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5626230|NCT01046825|Rasburicase|rasburicase|mesh-list
5626231|NCT01046825|Lenograstim|lenograstim|mesh-list
5626232|NCT01046825|Levoleucovorin|levoleucovorin|mesh-list
5626233|NCT01046825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5626234|NCT01046825|Glucocorticoids|glucocorticoids|mesh-ancestor
5750097|NCT03039491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750098|NCT03039426|Diclofenac|diclofenac|mesh-list
5750099|NCT03039426|Bupivacaine|bupivacaine|mesh-list
5750100|NCT03039426|Anesthetics, Local|anesthetics, local|mesh-ancestor
5750101|NCT03039426|Anesthetics|anesthetics|mesh-ancestor
5750102|NCT03039426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5750103|NCT03039426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750104|NCT03039426|Sensory System Agents|sensory system agents|mesh-ancestor
5750105|NCT03039426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5750106|NCT03039426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5750107|NCT03039426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5750108|NCT03039426|Analgesics|analgesics|mesh-ancestor
5750109|NCT03039426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5750110|NCT03039426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5750111|NCT03039426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5750112|NCT03039426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5750113|NCT03039426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5750114|NCT03039478|Erythritol|erythritol|mesh-list
5750115|NCT03039478|Vasodilator Agents|vasodilator agents|mesh-ancestor
5750116|NCT03039205|Clopidogrel|clopidogrel|mesh-list
5750117|NCT03039205|Ticagrelor|ticagrelor|mesh-list
5750118|NCT03039205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5750119|NCT03039205|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5750120|NCT03039205|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5750121|NCT03039205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5750122|NCT03039205|Purinergic Agents|purinergic agents|mesh-ancestor
5750123|NCT03039205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5626235|NCT01046825|Hormones|hormones|mesh-ancestor
5626236|NCT01046825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5626237|NCT01046825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626238|NCT01046825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5626239|NCT01046825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5626240|NCT01046825|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5626241|NCT01046825|Immunologic Factors|immunologic factors|mesh-ancestor
5626242|NCT01046825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5626243|NCT01046825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5626244|NCT01046825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5626245|NCT01046825|Alkylating Agents|alkylating agents|mesh-ancestor
5626246|NCT01046825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5626247|NCT01046825|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5626248|NCT01046825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5626249|NCT01046825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5626250|NCT01046825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5626251|NCT01046825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5626252|NCT01046825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5626253|NCT01046825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5750124|NCT03039205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5750125|NCT03039205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750126|NCT03039257|Vitamin A|vitamin a|mesh-list
5750127|NCT03039257|Vitamins|vitamins|mesh-ancestor
5750128|NCT03039257|Micronutrients|micronutrients|mesh-ancestor
5750129|NCT03039257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750130|NCT03038919|Methyltestosterone|methyltestosterone|mesh-list
5750131|NCT03038919|Testosterone|testosterone|mesh-list
5750132|NCT03038919|Testosterone undecanoate|testosterone undecanoate|mesh-list
5750133|NCT03038919|Testosterone enanthate|testosterone enanthate|mesh-list
5750134|NCT03038919|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5750135|NCT03038919|Androgens|androgens|mesh-ancestor
5750136|NCT03038919|Hormones|hormones|mesh-ancestor
5750137|NCT03038919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5750138|NCT03038919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750139|NCT03038919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5750140|NCT03038919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5750141|NCT03038919|Anabolic Agents|anabolic agents|mesh-ancestor
5750142|NCT03039101|Montelukast|montelukast|mesh-list
5750143|NCT03039101|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5750144|NCT03039101|Respiratory System Agents|respiratory system agents|mesh-ancestor
5750145|NCT03039101|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5750146|NCT03039101|Hormone Antagonists|hormone antagonists|mesh-ancestor
5750147|NCT03039101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5750148|NCT03039101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750149|NCT03039101|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5750150|NCT03039101|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5750151|NCT03039101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5750152|NCT03038958|Prilocaine|prilocaine|mesh-list
5626254|NCT01046825|Antimetabolites|antimetabolites|mesh-ancestor
5626255|NCT01046825|Antiviral Agents|antiviral agents|mesh-ancestor
5626256|NCT01046825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5626257|NCT01046825|Antidotes|antidotes|mesh-ancestor
5626258|NCT01046825|Protective Agents|protective agents|mesh-ancestor
5626259|NCT01046825|Vitamin B Complex|vitamin b complex|mesh-ancestor
5626260|NCT01046825|Vitamins|vitamins|mesh-ancestor
5626261|NCT01046825|Micronutrients|micronutrients|mesh-ancestor
5626262|NCT01046825|Hematinics|hematinics|mesh-ancestor
5626263|NCT01046825|Gout Suppressants|gout suppressants|mesh-ancestor
5626264|NCT01019356|Rosiglitazone|rosiglitazone|mesh-list
5626265|NCT01019356|Acarbose|acarbose|mesh-list
5626266|NCT01019356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5626267|NCT01019356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626268|NCT01019356|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
5626269|NCT01019356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5626270|NCT01019356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5626271|NCT00980460|Sirolimus|sirolimus|mesh-list
5626272|NCT00980460|Cisplatin|cisplatin|mesh-list
5626273|NCT00980460|Doxorubicin|doxorubicin|mesh-list
5750153|NCT03038958|Chloroprocaine|chloroprocaine|mesh-list
5750154|NCT03038958|Anesthetics, Local|anesthetics, local|mesh-ancestor
5750155|NCT03038958|Anesthetics|anesthetics|mesh-ancestor
5750156|NCT03038958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5750157|NCT03038958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750158|NCT03038958|Sensory System Agents|sensory system agents|mesh-ancestor
5750159|NCT03038958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5750160|NCT03039075|Metformin|metformin|mesh-list
5750161|NCT03039075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5750162|NCT03039075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750163|NCT03039049|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5750164|NCT03039049|Luteolytic Agents|luteolytic agents|mesh-ancestor
5750165|NCT03039049|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5750166|NCT03039049|Contraceptive Agents|contraceptive agents|mesh-ancestor
5750167|NCT03039049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5750168|NCT03039049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750169|NCT03039049|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5750170|NCT03039049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5750171|NCT03039049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5750172|NCT03038776|Hemagglutinins|hemagglutinins|mesh-list
5750173|NCT03038776|Agglutinins|agglutinins|mesh-ancestor
5750174|NCT03038776|Immunologic Factors|immunologic factors|mesh-ancestor
5750175|NCT03038776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750176|NCT03038802|Vaccines|vaccines|mesh-list
5750177|NCT03038802|Immunologic Factors|immunologic factors|mesh-ancestor
5750178|NCT03038802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750179|NCT03038607|Aspirin|aspirin|mesh-list
5750180|NCT03038607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5750181|NCT03038607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5750182|NCT03038607|Analgesics|analgesics|mesh-ancestor
5750183|NCT03038607|Sensory System Agents|sensory system agents|mesh-ancestor
5750184|NCT03038607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5750185|NCT03038607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750186|NCT03038607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5750187|NCT03038607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5750188|NCT03038607|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5750189|NCT03038607|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5750190|NCT03038607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5750191|NCT03038607|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5750192|NCT03038607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5750193|NCT03038607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5750194|NCT03038607|Antipyretics|antipyretics|mesh-ancestor
5750195|NCT03038516|Cholecalciferol|cholecalciferol|mesh-list
5750196|NCT03038516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5750197|NCT03038516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750198|NCT03038516|Vitamins|vitamins|mesh-ancestor
5750199|NCT03038516|Micronutrients|micronutrients|mesh-ancestor
5750200|NCT03038516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5750201|NCT03038477|Durvalumab|durvalumab|mesh-list
5750202|NCT03038477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5750203|NCT03038477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5750204|NCT03038503|Terlipressin|terlipressin|mesh-list
5750205|NCT03038503|Methylene Blue|methylene blue|mesh-list
5626274|NCT00980460|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5626275|NCT00980460|Fluorouracil|fluorouracil|mesh-list
5626276|NCT00980460|Irinotecan|irinotecan|mesh-list
5750206|NCT03038503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5894456|NCT04640571|Enalaprilat|enalaprilat|mesh-list
5626277|NCT00980460|Vincristine|vincristine|mesh-list
5626278|NCT00980460|Camptothecin|camptothecin|mesh-list
5626279|NCT00980460|Dexrazoxane|dexrazoxane|mesh-list
5750207|NCT03038503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5750208|NCT03038503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5750209|NCT03038503|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5750210|NCT03038451|Amlodipine|amlodipine|mesh-list
5750211|NCT03038451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5750212|NCT03038451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5750213|NCT03038451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5750214|NCT03038451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5750215|NCT03038451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5626280|NCT00980460|Razoxane|razoxane|mesh-list
5626281|NCT00980460|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|mesh-list
5626282|NCT00980460|Liver Extracts|liver extracts|mesh-list
5626283|NCT00980460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5626284|NCT00980460|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5626285|NCT00980460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5626286|NCT00980460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5626287|NCT00980460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5626288|NCT00980460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5626289|NCT00980460|Antimetabolites|antimetabolites|mesh-ancestor
5626290|NCT00980460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5626291|NCT00980460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5626292|NCT00980460|Immunologic Factors|immunologic factors|mesh-ancestor
5626293|NCT00980460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626294|NCT00980460|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5626295|NCT00980460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5626296|NCT00980460|Tubulin Modulators|tubulin modulators|mesh-ancestor
5626297|NCT00980460|Antimitotic Agents|antimitotic agents|mesh-ancestor
5626298|NCT00980460|Mitosis Modulators|mitosis modulators|mesh-ancestor
5626299|NCT00980460|Hematinics|hematinics|mesh-ancestor
5626300|NCT00980460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5626301|NCT00980460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5626302|NCT00980460|Antifungal Agents|antifungal agents|mesh-ancestor
5626303|NCT00980460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5626304|NCT00980460|Protective Agents|protective agents|mesh-ancestor
5626305|NCT00576654|Irinotecan|irinotecan|mesh-list
5626306|NCT00576654|Camptothecin|camptothecin|mesh-list
5626307|NCT00576654|Veliparib|veliparib|mesh-list
5626308|NCT00576654|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5750216|NCT03038451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750217|NCT03038451|Vasodilator Agents|vasodilator agents|mesh-ancestor
5750218|NCT03038243|Vaccines|vaccines|mesh-list
5750219|NCT03038243|Immunologic Factors|immunologic factors|mesh-ancestor
5750220|NCT03038243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750221|NCT03038295|Propranolol|propranolol|mesh-list
5750222|NCT03038295|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5750223|NCT03038295|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5626309|NCT00576654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5626310|NCT00576654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5626311|NCT00576654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5626312|NCT00576654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5626313|NCT00576654|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5626314|NCT00576654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5626315|NCT00345345|Alemtuzumab|alemtuzumab|mesh-list
5626316|NCT00345345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5626317|NCT00345345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5626318|NCT05202730|Anesthetics|anesthetics|mesh-list
5626319|NCT05202730|Anesthetics, Local|anesthetics, local|mesh-list
5626320|NCT05202730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5626321|NCT05202730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626322|NCT05202730|Sensory System Agents|sensory system agents|mesh-ancestor
5626323|NCT05202730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5626324|NCT05202665|Fluorides|fluorides|mesh-list
5626325|NCT05202665|Fluorides, Topical|fluorides, topical|mesh-list
5626326|NCT05202665|Cariostatic Agents|cariostatic agents|mesh-ancestor
5626327|NCT05202665|Protective Agents|protective agents|mesh-ancestor
5626328|NCT05202665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626329|NCT05202561|Vaccines|vaccines|mesh-list
5626330|NCT05202561|Immunologic Factors|immunologic factors|mesh-ancestor
5626331|NCT05202561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626332|NCT05202496|Calcitriol|calcitriol|mesh-list
5626333|NCT05202496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5626334|NCT05202496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626335|NCT05202496|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
5626336|NCT05202496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5626337|NCT05202496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5626338|NCT05202496|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5626339|NCT05202496|Vitamins|vitamins|mesh-ancestor
5626340|NCT05202496|Micronutrients|micronutrients|mesh-ancestor
5626341|NCT05202496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5626342|NCT05202288|Vaccines|vaccines|mesh-list
5626343|NCT05202288|Immunologic Factors|immunologic factors|mesh-ancestor
5626344|NCT05202288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626345|NCT05202275|Olanzapine|olanzapine|mesh-list
5626346|NCT05202275|Aprepitant|aprepitant|mesh-list
5626347|NCT05202275|Palonosetron|palonosetron|mesh-list
5626348|NCT05202275|Antiemetics|antiemetics|mesh-ancestor
5750224|NCT03038295|Adrenergic Agents|adrenergic agents|mesh-ancestor
5750225|NCT03038295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5750226|NCT03038295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5750227|NCT03038295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750228|NCT03038295|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5750229|NCT03038295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5750230|NCT03038295|Vasodilator Agents|vasodilator agents|mesh-ancestor
5626349|NCT05202275|Autonomic Agents|autonomic agents|mesh-ancestor
5626350|NCT05202275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5626351|NCT05202275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626352|NCT05202275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5626353|NCT05202275|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5626354|NCT05202275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5626355|NCT05202275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5626356|NCT05202275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5626357|NCT05202275|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5626358|NCT05202275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5626359|NCT05202275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5626360|NCT05202275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5626361|NCT05202275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5626362|NCT05202275|Serotonin Agents|serotonin agents|mesh-ancestor
5750231|NCT03038321|Levofloxacin|levofloxacin|mesh-list
5750232|NCT03038321|Lornoxicam|lornoxicam|mesh-list
5750233|NCT03038321|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5750234|NCT03038321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5750235|NCT03038321|Renal Agents|renal agents|mesh-ancestor
5750236|NCT03038321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5750237|NCT03038321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5750238|NCT03038321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5750239|NCT03038321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5750240|NCT03038321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5750241|NCT03038321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5750242|NCT03038321|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5750243|NCT03038321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6672986|NCT01559727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6672987|NCT01559727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6672988|NCT01559740|Bupivacaine|bupivacaine|mesh-list
6672989|NCT01559740|Anesthetics, Local|anesthetics, local|mesh-ancestor
5750244|NCT03038321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5750245|NCT03038321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5750246|NCT03038321|Analgesics|analgesics|mesh-ancestor
5750247|NCT03038321|Sensory System Agents|sensory system agents|mesh-ancestor
5750248|NCT03038321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5750249|NCT03038321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750250|NCT03038321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5750251|NCT03038321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5750252|NCT03038282|Chromium|chromium|mesh-list
5626363|NCT05202275|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5626364|NCT05202275|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5626365|NCT05202275|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6208779|NCT02136420|Autonomic Agents|autonomic agents|mesh-ancestor
5750253|NCT03038282|Chromous chloride|chromous chloride|mesh-list
5750254|NCT03038282|Trace Elements|trace elements|mesh-ancestor
5750255|NCT03038282|Micronutrients|micronutrients|mesh-ancestor
5750256|NCT03038282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750257|NCT03038282|Antioxidants|antioxidants|mesh-ancestor
5750258|NCT03038282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5750259|NCT03038282|Protective Agents|protective agents|mesh-ancestor
5750260|NCT03038217|Capecitabine|capecitabine|mesh-list
6208780|NCT02136420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6672990|NCT01559740|Anesthetics|anesthetics|mesh-ancestor
5750261|NCT03038217|Oxaliplatin|oxaliplatin|mesh-list
5750262|NCT03038217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5750263|NCT03038217|Antimetabolites|antimetabolites|mesh-ancestor
5750264|NCT03038217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5750265|NCT03038217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5750266|NCT03038425|Ropivacaine|ropivacaine|mesh-list
5750267|NCT03038425|Anesthetics, Local|anesthetics, local|mesh-ancestor
5750268|NCT03038425|Anesthetics|anesthetics|mesh-ancestor
5750269|NCT03038425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5750270|NCT03038425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750271|NCT03038425|Sensory System Agents|sensory system agents|mesh-ancestor
5750272|NCT03038425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5750273|NCT03038256|Capecitabine|capecitabine|mesh-list
5750274|NCT03038256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5750275|NCT03038256|Antimetabolites|antimetabolites|mesh-ancestor
5750276|NCT03038256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5750277|NCT03038256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5750278|NCT03038230|Antibodies|antibodies|mesh-list
5750279|NCT03038230|Antibodies, Bispecific|antibodies, bispecific|mesh-list
5750280|NCT03038230|Immunologic Factors|immunologic factors|mesh-ancestor
5750281|NCT03038230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750282|NCT03038334|Magnesium Sulfate|magnesium sulfate|mesh-list
5750283|NCT03038334|Analgesics|analgesics|mesh-ancestor
5750284|NCT03038334|Sensory System Agents|sensory system agents|mesh-ancestor
5750285|NCT03038334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5750286|NCT03038334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750287|NCT03038334|Anesthetics|anesthetics|mesh-ancestor
5750288|NCT03038334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5750289|NCT03038334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5750290|NCT03038334|Anticonvulsants|anticonvulsants|mesh-ancestor
5750291|NCT03038334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5750292|NCT03038334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5750293|NCT03038334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5750294|NCT03038334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5750295|NCT03038334|Tocolytic Agents|tocolytic agents|mesh-ancestor
5750296|NCT03038334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5750297|NCT03037970|Becaplermin|becaplermin|mesh-list
5750298|NCT03037970|Anticoagulants|anticoagulants|mesh-ancestor
5750299|NCT03037970|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
5750300|NCT03037970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5750301|NCT03037970|Growth Substances|growth substances|mesh-ancestor
5750302|NCT03037970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750303|NCT03037944|Drospirenone|drospirenone|mesh-list
5750304|NCT03037944|Levonorgestrel|levonorgestrel|mesh-list
5750305|NCT03037944|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5750306|NCT03037944|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
5750307|NCT03037944|Estradiol|estradiol|mesh-list
5750308|NCT03037944|Estrogens|estrogens|mesh-ancestor
5750309|NCT03037944|Hormones|hormones|mesh-ancestor
5750310|NCT03037944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5750311|NCT03037944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750312|NCT03037944|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5750313|NCT03037944|Contraceptive Agents|contraceptive agents|mesh-ancestor
5750314|NCT03037944|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5750315|NCT03037944|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5750316|NCT03037944|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5750317|NCT03037944|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5750318|NCT03037944|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5894457|NCT04640571|Enalapril|enalapril|mesh-list
6208781|NCT02136498|Varenicline|varenicline|mesh-list
5626369|NCT05202145|Cyclosporine|cyclosporine|mesh-list
5626370|NCT05202145|Tacrolimus|tacrolimus|mesh-list
5626371|NCT05202145|Cyclosporins|cyclosporins|mesh-list
5626372|NCT05202145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5626373|NCT05202145|Immunologic Factors|immunologic factors|mesh-ancestor
5626374|NCT05202145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626375|NCT05202145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5626376|NCT05202145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5626377|NCT05202145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5626378|NCT05202145|Antifungal Agents|antifungal agents|mesh-ancestor
5626379|NCT05202145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5626380|NCT05202145|Dermatologic Agents|dermatologic agents|mesh-ancestor
5626381|NCT05202145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5693025|NCT03403829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5750319|NCT03037944|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5750320|NCT03037944|Hormone Antagonists|hormone antagonists|mesh-ancestor
5750321|NCT03037944|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5750322|NCT03037944|Diuretics|diuretics|mesh-ancestor
5750323|NCT03037944|Natriuretic Agents|natriuretic agents|mesh-ancestor
5750324|NCT03038048|Ranibizumab|ranibizumab|mesh-list
5750325|NCT03038048|Aflibercept|aflibercept|mesh-list
5750326|NCT03038048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5750327|NCT03038048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5750328|NCT03038048|Growth Substances|growth substances|mesh-ancestor
5750329|NCT03038048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750330|NCT03038048|Growth Inhibitors|growth inhibitors|mesh-ancestor
5750331|NCT03038048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5750332|NCT03037775|Nicotine|nicotine|mesh-list
5750333|NCT03037775|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5750334|NCT03037775|Autonomic Agents|autonomic agents|mesh-ancestor
5750335|NCT03037775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5750336|NCT03037775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750337|NCT03037775|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5750338|NCT03037775|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5750339|NCT03037775|Cholinergic Agents|cholinergic agents|mesh-ancestor
5750340|NCT03037775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5750341|NCT03037775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5750342|NCT03037736|Bevacizumab|bevacizumab|mesh-list
5750343|NCT03037736|Fluorouracil|fluorouracil|mesh-list
5750344|NCT03037736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5750345|NCT03037736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5750346|NCT03037736|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5750347|NCT03037736|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5750348|NCT03037736|Growth Substances|growth substances|mesh-ancestor
5750349|NCT03037736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750350|NCT03037736|Growth Inhibitors|growth inhibitors|mesh-ancestor
5750351|NCT03037736|Antimetabolites|antimetabolites|mesh-ancestor
5626382|NCT05201859|Capecitabine|capecitabine|mesh-list
5626383|NCT05201859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5626384|NCT05201859|Antimetabolites|antimetabolites|mesh-ancestor
5626385|NCT05201859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5626386|NCT05201859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5626387|NCT05201846|Insulin|insulin|mesh-list
5626388|NCT05201846|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5626389|NCT05201846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5626390|NCT05201846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626391|NCT05201638|Calcium, Dietary|calcium, dietary|mesh-list
5626392|NCT05201638|Calcium|calcium|mesh-list
5626393|NCT05201638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5626394|NCT05201638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626395|NCT05201638|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5626396|NCT05201560|Fentanyl|fentanyl|mesh-list
5626397|NCT05201560|Butorphanol|butorphanol|mesh-list
5626398|NCT05201560|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5626399|NCT05201560|Narcotics|narcotics|mesh-ancestor
5626400|NCT05201560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5750352|NCT03037736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5750353|NCT03037736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5750354|NCT03037736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5750355|NCT03037736|Immunologic Factors|immunologic factors|mesh-ancestor
5750356|NCT03037892|Fentanyl|fentanyl|mesh-list
5750357|NCT03037892|Midazolam|midazolam|mesh-list
5750358|NCT03037892|Remifentanil|remifentanil|mesh-list
5750359|NCT03037892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5750360|NCT03037892|Narcotics|narcotics|mesh-ancestor
5750361|NCT03037892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5750362|NCT03037892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750363|NCT03037892|Analgesics|analgesics|mesh-ancestor
5750364|NCT03037892|Sensory System Agents|sensory system agents|mesh-ancestor
5750365|NCT03037892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5750366|NCT03037892|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5750367|NCT03037892|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6489555|NCT00592527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489556|NCT00592566|Dexamethasone|dexamethasone|mesh-list
6489557|NCT00592566|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
6489558|NCT00592566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5626401|NCT05201560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626402|NCT05201560|Analgesics|analgesics|mesh-ancestor
5626403|NCT05201560|Sensory System Agents|sensory system agents|mesh-ancestor
5750368|NCT03037892|Anesthetics, General|anesthetics, general|mesh-ancestor
5750369|NCT03037892|Anesthetics|anesthetics|mesh-ancestor
5626404|NCT05201560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5626405|NCT05201560|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5626406|NCT05201560|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5626407|NCT05201560|Anesthetics, General|anesthetics, general|mesh-ancestor
5626408|NCT05201560|Anesthetics|anesthetics|mesh-ancestor
5626409|NCT05201560|Antitussive Agents|antitussive agents|mesh-ancestor
5626410|NCT05201560|Respiratory System Agents|respiratory system agents|mesh-ancestor
5626411|NCT05201560|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5626412|NCT05201430|Capecitabine|capecitabine|mesh-list
5626413|NCT05201430|Oxaliplatin|oxaliplatin|mesh-list
5626414|NCT05201430|Irinotecan|irinotecan|mesh-list
5626415|NCT05201430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5626416|NCT05201430|Antimetabolites|antimetabolites|mesh-ancestor
5626417|NCT05201430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5626418|NCT05201430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5626419|NCT05201430|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5626420|NCT05201430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5626421|NCT05201430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5626422|NCT05201352|Trifluridine|trifluridine|mesh-list
5750370|NCT03037892|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5750371|NCT03037892|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5750372|NCT03037892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5750373|NCT03037892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5750374|NCT03037892|GABA Modulators|gaba modulators|mesh-ancestor
5750375|NCT03037892|GABA Agents|gaba agents|mesh-ancestor
5750376|NCT03037892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5750377|NCT03037892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5750378|NCT03038009|Pantoprazole|pantoprazole|mesh-list
5750379|NCT03038009|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5750380|NCT03038009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5750381|NCT03038009|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5750382|NCT03038009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5750383|NCT03038009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894458|NCT04640571|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
5894459|NCT04640571|Pravastatin|pravastatin|mesh-list
5894460|NCT04640571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5894461|NCT04640571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894462|NCT04640571|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5894463|NCT04640571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5894464|NCT04640571|Antimetabolites|antimetabolites|mesh-ancestor
5894465|NCT04640571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894466|NCT04640571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5894467|NCT04640571|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5894468|NCT04640571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5894469|NCT04640571|Antiviral Agents|antiviral agents|mesh-ancestor
5894470|NCT04640571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5626423|NCT05201352|Antimetabolites|antimetabolites|mesh-ancestor
5626424|NCT05201352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894471|NCT04640571|Cathartics|cathartics|mesh-ancestor
5894472|NCT04640571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5894473|NCT04640571|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5894474|NCT04640571|Protease Inhibitors|protease inhibitors|mesh-ancestor
5894475|NCT04640571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5894476|NCT04572100|Paclitaxel|paclitaxel|mesh-list
5894477|NCT04572100|Carboplatin|carboplatin|mesh-list
5894478|NCT04572100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5894479|NCT04572100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5894480|NCT04572100|Tubulin Modulators|tubulin modulators|mesh-ancestor
5894481|NCT04572100|Antimitotic Agents|antimitotic agents|mesh-ancestor
5894482|NCT04572100|Mitosis Modulators|mitosis modulators|mesh-ancestor
5894483|NCT04572100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894484|NCT04564885|Meloxicam|meloxicam|mesh-list
5894485|NCT04564885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5894486|NCT04564885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5894487|NCT04564885|Analgesics|analgesics|mesh-ancestor
5894488|NCT04564885|Sensory System Agents|sensory system agents|mesh-ancestor
5894489|NCT04564885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5894490|NCT04564885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894491|NCT04564885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5894492|NCT04564885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5894493|NCT04564885|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5894494|NCT04564885|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5894495|NCT04564885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5626425|NCT05201352|Antiviral Agents|antiviral agents|mesh-ancestor
5626426|NCT05201352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5626427|NCT05201326|Bevacizumab|bevacizumab|mesh-list
5750384|NCT03037606|Rabeprazole|rabeprazole|mesh-list
5750385|NCT03037606|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5750386|NCT03037606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5750387|NCT03037606|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5750388|NCT03037606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5626428|NCT05201326|Irinotecan|irinotecan|mesh-list
5626429|NCT05201326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5626430|NCT05201326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5626431|NCT05201326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5626432|NCT05201326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5626433|NCT05201326|Growth Substances|growth substances|mesh-ancestor
5626434|NCT05201326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750389|NCT03037606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5750390|NCT03037593|Vitamin D|vitamin d|mesh-list
5750391|NCT03037593|Cholecalciferol|cholecalciferol|mesh-list
5750392|NCT03037593|Vitamins|vitamins|mesh-ancestor
5750393|NCT03037593|Micronutrients|micronutrients|mesh-ancestor
5750394|NCT03037593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750395|NCT03037593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5750396|NCT03037593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5750397|NCT03037515|Tranexamic Acid|tranexamic acid|mesh-list
5750398|NCT03037515|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5750399|NCT03037515|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5750400|NCT03037515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489559|NCT00592566|Antiemetics|antiemetics|mesh-ancestor
6489560|NCT00592566|Autonomic Agents|autonomic agents|mesh-ancestor
6489561|NCT00592566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6489562|NCT00592566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489563|NCT00592566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6489564|NCT00592566|Glucocorticoids|glucocorticoids|mesh-ancestor
6489565|NCT00592566|Hormones|hormones|mesh-ancestor
6489566|NCT00592566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6672991|NCT01559740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5750401|NCT03037515|Hemostatics|hemostatics|mesh-ancestor
5750402|NCT03037515|Coagulants|coagulants|mesh-ancestor
5750403|NCT03037359|Immunoglobulin G|immunoglobulin g|mesh-list
5750404|NCT03037359|Immunologic Factors|immunologic factors|mesh-ancestor
5750405|NCT03037359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750406|NCT03037372|Atorvastatin|atorvastatin|mesh-list
5750407|NCT03037372|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5750408|NCT03037372|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
5750409|NCT03037372|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5750410|NCT03037372|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5750411|NCT03037372|Antimetabolites|antimetabolites|mesh-ancestor
5750412|NCT03037372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6672992|NCT01559740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6672993|NCT01559740|Sensory System Agents|sensory system agents|mesh-ancestor
6672994|NCT01559740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6672995|NCT01559753|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6672996|NCT01559753|Amoxicillin|amoxicillin|mesh-list
6672997|NCT01559753|Ceftriaxone|ceftriaxone|mesh-list
6672998|NCT01559753|Tobramycin|tobramycin|mesh-list
6672999|NCT01559753|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6673000|NCT01559753|Clavulanic Acids|clavulanic acids|mesh-list
6673001|NCT01559753|Clavulanic Acid|clavulanic acid|mesh-list
5626435|NCT05201326|Growth Inhibitors|growth inhibitors|mesh-ancestor
5626436|NCT05201326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5626437|NCT05201326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5626438|NCT05201326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5626439|NCT05201326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5626440|NCT05201313|Lidocaine|lidocaine|mesh-list
5626441|NCT05201313|Mepivacaine|mepivacaine|mesh-list
5626442|NCT05201313|Anesthetics, Local|anesthetics, local|mesh-ancestor
5626443|NCT05201313|Anesthetics|anesthetics|mesh-ancestor
5626444|NCT05201313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5626445|NCT05201313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626446|NCT05201313|Sensory System Agents|sensory system agents|mesh-ancestor
5626447|NCT05201313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5626448|NCT05201313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5626449|NCT05201313|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5626450|NCT05201313|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5626451|NCT05201313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5693026|NCT03403829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5750413|NCT03037372|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6489567|NCT00592566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5750414|NCT03037372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5750415|NCT03037437|Hydroxychloroquine|hydroxychloroquine|mesh-list
5750416|NCT03037437|Sorafenib|sorafenib|mesh-list
5750417|NCT03037437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5750418|NCT03037437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5750419|NCT03037437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5750420|NCT03037437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5750421|NCT03037437|Antimalarials|antimalarials|mesh-ancestor
5750422|NCT03037437|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5750423|NCT03037437|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5750424|NCT03037437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5750425|NCT03037437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5750426|NCT03036995|Apremilast|apremilast|mesh-list
5750427|NCT03036995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5750428|NCT03036995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5750429|NCT03036995|Analgesics|analgesics|mesh-ancestor
5750430|NCT03036995|Sensory System Agents|sensory system agents|mesh-ancestor
5750431|NCT03036995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5750432|NCT03036995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750433|NCT03036995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5750434|NCT03036995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5626452|NCT05201313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5626453|NCT05201248|Prednisone|prednisone|mesh-list
5626454|NCT05201248|Cyclophosphamide|cyclophosphamide|mesh-list
5626455|NCT05201248|Rituximab|rituximab|mesh-list
5750435|NCT03036995|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5750436|NCT03036995|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6208782|NCT02136498|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6208783|NCT02136498|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6208784|NCT02136498|Cholinergic Agents|cholinergic agents|mesh-ancestor
6208785|NCT02136498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6208786|NCT02136498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208787|NCT02136498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208788|NCT02136576|Listerine|listerine|mesh-list
6208789|NCT02136576|Sodium Fluoride|sodium fluoride|mesh-list
6208790|NCT02136576|Cariostatic Agents|cariostatic agents|mesh-ancestor
6208791|NCT02136576|Protective Agents|protective agents|mesh-ancestor
6208792|NCT02136576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208793|NCT02136576|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6208794|NCT02136576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6208795|NCT02136914|Amantadine|amantadine|mesh-list
6208796|NCT02136914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6208797|NCT02136914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6673002|NCT01559753|Cefotaxime|cefotaxime|mesh-list
5626456|NCT05201248|Doxorubicin|doxorubicin|mesh-list
5626457|NCT05201248|Vincristine|vincristine|mesh-list
5626458|NCT05201248|Lenalidomide|lenalidomide|mesh-list
5626459|NCT05201248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5626460|NCT05201248|Immunologic Factors|immunologic factors|mesh-ancestor
5626461|NCT05201248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626462|NCT05201248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5626463|NCT05201248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5626464|NCT05201248|Alkylating Agents|alkylating agents|mesh-ancestor
5626465|NCT05201248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5626466|NCT05201248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5626467|NCT05201248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5626468|NCT05201248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5626469|NCT05201248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5626470|NCT05201248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5626471|NCT05201248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5626472|NCT05201248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5626473|NCT05201248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5626474|NCT05201248|Glucocorticoids|glucocorticoids|mesh-ancestor
5626475|NCT05201248|Hormones|hormones|mesh-ancestor
5693027|NCT03403829|Antiviral Agents|antiviral agents|mesh-ancestor
5750437|NCT03036995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6208798|NCT02136914|Antiviral Agents|antiviral agents|mesh-ancestor
6208799|NCT02136914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6208800|NCT02136914|Dopamine Agents|dopamine agents|mesh-ancestor
6208801|NCT02136914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6673003|NCT01559753|Cefoxitin|cefoxitin|mesh-list
5750438|NCT03036995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5750439|NCT03036826|Meropenem|meropenem|mesh-list
5750440|NCT03036826|Tazobactam|tazobactam|mesh-list
5750441|NCT03036826|Piperacillin|piperacillin|mesh-list
5750442|NCT03036826|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
5750443|NCT03036826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5750444|NCT03036826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5750445|NCT03036826|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5750446|NCT03036826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5750447|NCT03036826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5750448|NCT03037073|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6673004|NCT01559753|Netilmicin|netilmicin|mesh-list
6673005|NCT01559753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6673006|NCT01559753|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6673007|NCT01559753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5626476|NCT05201248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5626477|NCT05201248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5626478|NCT05201248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5626479|NCT05201248|Tubulin Modulators|tubulin modulators|mesh-ancestor
5626480|NCT05201248|Antimitotic Agents|antimitotic agents|mesh-ancestor
5626481|NCT05201248|Mitosis Modulators|mitosis modulators|mesh-ancestor
5626482|NCT05201248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5626483|NCT05201248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5626484|NCT05201248|Growth Substances|growth substances|mesh-ancestor
5626485|NCT05201248|Growth Inhibitors|growth inhibitors|mesh-ancestor
5626486|NCT05201183|Fludarabine|fludarabine|mesh-list
5626487|NCT05201183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5626488|NCT05201079|Fidaxomicin|fidaxomicin|mesh-list
5626489|NCT05201079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5626490|NCT05201079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5626491|NCT05201066|Azacitidine|azacitidine|mesh-list
5626492|NCT05201066|Decitabine|decitabine|mesh-list
5626493|NCT05201066|Venetoclax|venetoclax|mesh-list
5626494|NCT05201066|Spartalizumab|spartalizumab|mesh-list
5626495|NCT05201066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5626496|NCT05201066|Antimetabolites|antimetabolites|mesh-ancestor
5626497|NCT05201066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5626498|NCT05201066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5626499|NCT05201066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5626500|NCT05201066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5626501|NCT05201001|Carboplatin|carboplatin|mesh-list
5626502|NCT05201001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5626503|NCT05200988|Nivolumab|nivolumab|mesh-list
5626504|NCT05200988|Ipilimumab|ipilimumab|mesh-list
5750449|NCT03037073|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5750450|NCT03037073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5750451|NCT03037073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5750452|NCT03037073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5750453|NCT03037073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5750454|NCT03037073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750455|NCT03037073|Analgesics|analgesics|mesh-ancestor
5750456|NCT03037073|Sensory System Agents|sensory system agents|mesh-ancestor
6673008|NCT01559753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5750457|NCT03037073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5750458|NCT03037073|Antidepressive Agents|antidepressive agents|mesh-ancestor
5750459|NCT03037073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5750460|NCT03037073|Dopamine Agents|dopamine agents|mesh-ancestor
5750461|NCT03036891|Naloxegol|naloxegol|mesh-list
5750462|NCT03036891|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5750463|NCT03036891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750464|NCT03036891|Sensory System Agents|sensory system agents|mesh-ancestor
5750465|NCT03036891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5750466|NCT03036800|Liraglutide|liraglutide|mesh-list
5750467|NCT03036800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6673009|NCT01559753|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5626505|NCT05200988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5626506|NCT05200988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5626507|NCT05200988|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5626508|NCT05200988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5626509|NCT05200884|Lidocaine|lidocaine|mesh-list
5626510|NCT05200884|Carticaine|carticaine|mesh-list
5626511|NCT05200884|Anesthetics, Local|anesthetics, local|mesh-ancestor
5750468|NCT03036800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750469|NCT03036800|Incretins|incretins|mesh-ancestor
5750470|NCT03036800|Hormones|hormones|mesh-ancestor
5750471|NCT03036800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5750472|NCT03036904|Prednisone|prednisone|mesh-list
5750473|NCT03036904|Cyclophosphamide|cyclophosphamide|mesh-list
5750474|NCT03036904|Rituximab|rituximab|mesh-list
5750475|NCT03036904|Doxorubicin|doxorubicin|mesh-list
5750476|NCT03036904|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5750477|NCT03036904|Etoposide|etoposide|mesh-list
5750478|NCT03036904|Vincristine|vincristine|mesh-list
5750479|NCT03036904|Venetoclax|venetoclax|mesh-list
5750480|NCT03036904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5750481|NCT03036904|Immunologic Factors|immunologic factors|mesh-ancestor
5750482|NCT03036904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750483|NCT03036904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5750484|NCT03036904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5750485|NCT03036904|Alkylating Agents|alkylating agents|mesh-ancestor
5750486|NCT03036904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5750487|NCT03036904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5626512|NCT05200884|Anesthetics|anesthetics|mesh-ancestor
5626513|NCT05200884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5626514|NCT05200884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626515|NCT05200884|Sensory System Agents|sensory system agents|mesh-ancestor
5626516|NCT05200884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5626517|NCT05200884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5750488|NCT03036904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5750489|NCT03036904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5750490|NCT03036904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5750491|NCT03036904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5750492|NCT03036904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5750493|NCT03036904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5750494|NCT03036904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5750495|NCT03036904|Glucocorticoids|glucocorticoids|mesh-ancestor
5750496|NCT03036904|Hormones|hormones|mesh-ancestor
5750497|NCT03036904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5626518|NCT05200884|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5626519|NCT05200884|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5626520|NCT05200884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5626521|NCT05200884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5626522|NCT05200845|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5626523|NCT05200793|Metformin|metformin|mesh-list
5750498|NCT03036904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5750499|NCT03036904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5750500|NCT03036904|Tubulin Modulators|tubulin modulators|mesh-ancestor
5750501|NCT03036904|Antimitotic Agents|antimitotic agents|mesh-ancestor
5750502|NCT03036904|Mitosis Modulators|mitosis modulators|mesh-ancestor
5750503|NCT03036748|Amiloride|amiloride|mesh-list
5750504|NCT03036748|Diuretics|diuretics|mesh-ancestor
5750505|NCT03036748|Natriuretic Agents|natriuretic agents|mesh-ancestor
5750506|NCT03036748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750507|NCT03036748|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
5750508|NCT03036748|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5750509|NCT03036748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5750510|NCT03036748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5750511|NCT03036748|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
5750512|NCT03036748|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5750513|NCT03036488|Paclitaxel|paclitaxel|mesh-list
5750514|NCT03036488|Cyclophosphamide|cyclophosphamide|mesh-list
5750515|NCT03036488|Carboplatin|carboplatin|mesh-list
5750516|NCT03036488|Doxorubicin|doxorubicin|mesh-list
5750517|NCT03036488|Pembrolizumab|pembrolizumab|mesh-list
5750518|NCT03036488|Epirubicin|epirubicin|mesh-list
5750519|NCT03036488|Lenograstim|lenograstim|mesh-list
5750520|NCT03036488|Sargramostim|sargramostim|mesh-list
5750521|NCT03036488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5750522|NCT03036488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5750523|NCT03036488|Tubulin Modulators|tubulin modulators|mesh-ancestor
5750524|NCT03036488|Antimitotic Agents|antimitotic agents|mesh-ancestor
5750525|NCT03036488|Mitosis Modulators|mitosis modulators|mesh-ancestor
5750526|NCT03036488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5750527|NCT03036488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5750528|NCT03036488|Immunologic Factors|immunologic factors|mesh-ancestor
5750529|NCT03036488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750530|NCT03036488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6673010|NCT01559974|Cholecalciferol|cholecalciferol|mesh-list
5750531|NCT03036488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5750532|NCT03036488|Alkylating Agents|alkylating agents|mesh-ancestor
5626524|NCT05200793|Empagliflozin|empagliflozin|mesh-list
5626525|NCT05200793|Linagliptin|linagliptin|mesh-list
5626526|NCT05200793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5626527|NCT05200793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626528|NCT05200793|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5626529|NCT05200793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5750533|NCT03036488|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5750534|NCT03036488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5750535|NCT03036488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5750536|NCT03036488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5750537|NCT03036488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5750538|NCT03036488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5750539|NCT03036488|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5750540|NCT03036605|Dexamethasone|dexamethasone|mesh-list
5750541|NCT03036605|Dexamethasone acetate|dexamethasone acetate|mesh-list
5750542|NCT03036605|Bupivacaine|bupivacaine|mesh-list
5750543|NCT03036605|BB 1101|bb 1101|mesh-list
5750544|NCT03036605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5750545|NCT03036605|Antiemetics|antiemetics|mesh-ancestor
5750546|NCT03036605|Autonomic Agents|autonomic agents|mesh-ancestor
5750547|NCT03036605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5626530|NCT05200793|Incretins|incretins|mesh-ancestor
5626531|NCT05200793|Hormones|hormones|mesh-ancestor
5626532|NCT05200793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5626533|NCT05200793|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5626534|NCT05200793|Protease Inhibitors|protease inhibitors|mesh-ancestor
5626535|NCT05200793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5626536|NCT05200663|Tamoxifen|tamoxifen|mesh-list
5626537|NCT05200663|Vitamin E|vitamin e|mesh-list
5626538|NCT05200663|Vitamins|vitamins|mesh-ancestor
5626539|NCT05200663|Micronutrients|micronutrients|mesh-ancestor
5626540|NCT05200663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626541|NCT05200663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5626542|NCT05200663|Hormone Antagonists|hormone antagonists|mesh-ancestor
5626543|NCT05200663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5626544|NCT05200663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5626545|NCT05200663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5626546|NCT05200663|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5626547|NCT05200663|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5626548|NCT05200663|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5626549|NCT05200663|Antioxidants|antioxidants|mesh-ancestor
5626550|NCT05200663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5626551|NCT05200663|Protective Agents|protective agents|mesh-ancestor
5626552|NCT05198531|Gemcitabine|gemcitabine|mesh-list
5626553|NCT05198531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5626554|NCT05198531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5626555|NCT05198531|Antimetabolites|antimetabolites|mesh-ancestor
5626556|NCT05198531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5750548|NCT03036605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750549|NCT03036605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5750550|NCT03036605|Glucocorticoids|glucocorticoids|mesh-ancestor
5750551|NCT03036605|Hormones|hormones|mesh-ancestor
5750552|NCT03036605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5750553|NCT03036605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5750554|NCT03036605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5750555|NCT03036605|Protease Inhibitors|protease inhibitors|mesh-ancestor
5750556|NCT03036605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5750557|NCT03036605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5750558|NCT03036605|Anesthetics, Local|anesthetics, local|mesh-ancestor
5750559|NCT03036605|Anesthetics|anesthetics|mesh-ancestor
5750560|NCT03036605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5750561|NCT03036605|Sensory System Agents|sensory system agents|mesh-ancestor
5750562|NCT03036501|Risdiplam|risdiplam|mesh-list
5750563|NCT03036501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5750564|NCT03036501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5750565|NCT03036501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750566|NCT03036514|Sufentanil|sufentanil|mesh-list
5750567|NCT03036514|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5750568|NCT03036514|Narcotics|narcotics|mesh-ancestor
5750569|NCT03036514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5750570|NCT03036514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750571|NCT03036514|Analgesics|analgesics|mesh-ancestor
5750572|NCT03036514|Sensory System Agents|sensory system agents|mesh-ancestor
5750573|NCT03036514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5750574|NCT03036514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5750575|NCT03036514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5750576|NCT03036514|Anesthetics, General|anesthetics, general|mesh-ancestor
5750577|NCT03036514|Anesthetics|anesthetics|mesh-ancestor
5750578|NCT03036566|Lithium Carbonate|lithium carbonate|mesh-list
5750579|NCT03036566|Antidepressive Agents|antidepressive agents|mesh-ancestor
5750580|NCT03036566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5750581|NCT03036566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5750582|NCT03036566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5750583|NCT03036566|Antimanic Agents|antimanic agents|mesh-ancestor
5750584|NCT03036566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5750585|NCT03036566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5750586|NCT03036566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750587|NCT03036644|Nicotine|nicotine|mesh-list
5626557|NCT05198531|Antiviral Agents|antiviral agents|mesh-ancestor
5626558|NCT05198531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5626559|NCT05198531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5626560|NCT05198531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5626561|NCT05198531|Immunologic Factors|immunologic factors|mesh-ancestor
5626562|NCT05198531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626563|NCT05184192|Gabapentin|gabapentin|mesh-list
5626564|NCT05184192|Analgesics|analgesics|mesh-ancestor
5626565|NCT05184192|Sensory System Agents|sensory system agents|mesh-ancestor
5626566|NCT05184192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5626567|NCT05184192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626568|NCT05184192|Anticonvulsants|anticonvulsants|mesh-ancestor
5626569|NCT05184192|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5626570|NCT05184192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5626571|NCT05184192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5626572|NCT05184192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5626573|NCT05184192|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5626574|NCT05184192|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5626575|NCT05184192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5750588|NCT03036644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5750589|NCT03036644|Autonomic Agents|autonomic agents|mesh-ancestor
5750590|NCT03036644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5750591|NCT03036644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750592|NCT03036644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5750593|NCT03036644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5750594|NCT03036644|Cholinergic Agents|cholinergic agents|mesh-ancestor
5750595|NCT03036644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5750596|NCT03036644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5750597|NCT03036046|Fluconazole|fluconazole|mesh-list
5750598|NCT03036046|Posaconazole|posaconazole|mesh-list
5750599|NCT03036046|Olorofim|olorofim|mesh-list
5750600|NCT03036046|Antifungal Agents|antifungal agents|mesh-ancestor
5750601|NCT03036046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5750602|NCT03036046|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5750603|NCT03036046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5750604|NCT03036046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5750605|NCT03036046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5750606|NCT03036046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5750607|NCT03036046|Hormone Antagonists|hormone antagonists|mesh-ancestor
5750608|NCT03036046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5750609|NCT03036046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750610|NCT03036046|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5750611|NCT03036046|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5750612|NCT03036046|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5750613|NCT03036046|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5750614|NCT03036046|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5750615|NCT03036202|Epinephrine|epinephrine|mesh-list
5750616|NCT03036202|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5750617|NCT03036202|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5750618|NCT03036202|Adrenergic Agents|adrenergic agents|mesh-ancestor
5750619|NCT03036202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5750620|NCT03036202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5750621|NCT03036202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750622|NCT03036202|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5750623|NCT03036202|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5750624|NCT03036202|Autonomic Agents|autonomic agents|mesh-ancestor
5626576|NCT05184192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5626577|NCT05184192|Antimanic Agents|antimanic agents|mesh-ancestor
5626578|NCT05180214|Ketorolac|ketorolac|mesh-list
5626579|NCT05180214|Bupivacaine|bupivacaine|mesh-list
5626580|NCT05180214|Anesthetics, Local|anesthetics, local|mesh-ancestor
5626581|NCT05180214|Anesthetics|anesthetics|mesh-ancestor
5626582|NCT05180214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5626583|NCT05180214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626584|NCT05180214|Sensory System Agents|sensory system agents|mesh-ancestor
5626585|NCT05180214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5626586|NCT05180214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5626587|NCT05180214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5626588|NCT05180214|Analgesics|analgesics|mesh-ancestor
5750625|NCT03036202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5750626|NCT03036202|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5750627|NCT03036202|Respiratory System Agents|respiratory system agents|mesh-ancestor
5750628|NCT03036202|Mydriatics|mydriatics|mesh-ancestor
5750629|NCT03036202|Sympathomimetics|sympathomimetics|mesh-ancestor
5750630|NCT03036202|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5750631|NCT03036059|Ivermectin|ivermectin|mesh-list
5750632|NCT03036059|Albendazole|albendazole|mesh-list
5750633|NCT03036059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5750634|NCT03036059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5750635|NCT03036059|Anthelmintics|anthelmintics|mesh-ancestor
5750636|NCT03036059|Anticestodal Agents|anticestodal agents|mesh-ancestor
5750637|NCT03036059|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5750638|NCT03036059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5750639|NCT03036059|Tubulin Modulators|tubulin modulators|mesh-ancestor
5750640|NCT03036059|Antimitotic Agents|antimitotic agents|mesh-ancestor
5750641|NCT03036059|Mitosis Modulators|mitosis modulators|mesh-ancestor
5750642|NCT03036059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5750643|NCT03036059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5750644|NCT03036111|Trimebutine|trimebutine|mesh-list
5750645|NCT03036111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5750646|NCT03036111|Parasympatholytics|parasympatholytics|mesh-ancestor
5750647|NCT03036111|Autonomic Agents|autonomic agents|mesh-ancestor
5750648|NCT03036111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5750649|NCT03036111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750650|NCT03036085|Epinephrine|epinephrine|mesh-list
5750651|NCT03036085|Bupivacaine|bupivacaine|mesh-list
5750652|NCT03036085|Anesthetics, Local|anesthetics, local|mesh-ancestor
5750653|NCT03036085|Anesthetics|anesthetics|mesh-ancestor
5750654|NCT03036085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5750655|NCT03036085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750656|NCT03036085|Sensory System Agents|sensory system agents|mesh-ancestor
5750657|NCT03036085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5750658|NCT03036085|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5750659|NCT03036085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5750660|NCT03036085|Adrenergic Agents|adrenergic agents|mesh-ancestor
5750661|NCT03036085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5750662|NCT03036085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5750663|NCT03036085|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5750664|NCT03036085|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5750665|NCT03036085|Autonomic Agents|autonomic agents|mesh-ancestor
5750666|NCT03036085|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5750667|NCT03036085|Respiratory System Agents|respiratory system agents|mesh-ancestor
5750668|NCT03036085|Mydriatics|mydriatics|mesh-ancestor
5750669|NCT03036085|Sympathomimetics|sympathomimetics|mesh-ancestor
5750670|NCT03036085|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5894496|NCT04564885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894497|NCT04551885|Aldesleukin|aldesleukin|mesh-list
5894498|NCT04551885|Cyclophosphamide|cyclophosphamide|mesh-list
5894499|NCT04551885|Fludarabine|fludarabine|mesh-list
5894500|NCT04551885|Avelumab|avelumab|mesh-list
5894501|NCT04551885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5894502|NCT04551885|Immunologic Factors|immunologic factors|mesh-ancestor
5894503|NCT04551885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894504|NCT04551885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5894505|NCT04551885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5894506|NCT04551885|Alkylating Agents|alkylating agents|mesh-ancestor
5894507|NCT04551885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894508|NCT04551885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5626589|NCT05180214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5894509|NCT04551885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5894510|NCT04551885|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5894511|NCT04551885|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5894512|NCT04551885|Antiviral Agents|antiviral agents|mesh-ancestor
5894513|NCT04551885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5626590|NCT05180214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5626591|NCT05180214|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5626592|NCT05180214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5626593|NCT05180214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5626594|NCT05179668|Empagliflozin|empagliflozin|mesh-list
5626595|NCT05179668|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5626596|NCT05179668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5750671|NCT03035838|Fosaprepitant|fosaprepitant|mesh-list
5750672|NCT03035838|Aprepitant|aprepitant|mesh-list
5750673|NCT03035838|Antiemetics|antiemetics|mesh-ancestor
5750674|NCT03035838|Autonomic Agents|autonomic agents|mesh-ancestor
5750675|NCT03035838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5750676|NCT03035838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750677|NCT03035838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5750678|NCT03035838|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5750679|NCT03035838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5750680|NCT03035838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5750681|NCT03035656|Ropivacaine|ropivacaine|mesh-list
6673011|NCT01559974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6673012|NCT01559974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673013|NCT01559974|Vitamins|vitamins|mesh-ancestor
6673014|NCT01559974|Micronutrients|micronutrients|mesh-ancestor
6673015|NCT01559974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6673016|NCT01560013|Naltrexone|naltrexone|mesh-list
6673017|NCT01560013|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5750682|NCT03035656|Anesthetics, Local|anesthetics, local|mesh-ancestor
5750683|NCT03035656|Anesthetics|anesthetics|mesh-ancestor
5750684|NCT03035656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5750685|NCT03035656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750686|NCT03035656|Sensory System Agents|sensory system agents|mesh-ancestor
5750687|NCT03035656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5750688|NCT03035695|Hemostatics|hemostatics|mesh-list
5750689|NCT03035695|Coagulants|coagulants|mesh-ancestor
5750690|NCT03035578|Morphine|morphine|mesh-list
5750691|NCT03035578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5750692|NCT03035578|Narcotics|narcotics|mesh-ancestor
5750693|NCT03035578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5750694|NCT03035578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626597|NCT05179668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5626598|NCT05179668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626599|NCT05170893|Ubiquinone|ubiquinone|mesh-list
5626600|NCT05170893|Coenzyme Q10|coenzyme q10|mesh-list
5626601|NCT05170893|Micronutrients|micronutrients|mesh-ancestor
5626602|NCT05170893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626603|NCT05170893|Vitamins|vitamins|mesh-ancestor
5626604|NCT05158374|Aspirin|aspirin|mesh-list
5626605|NCT05158374|Metformin|metformin|mesh-list
5750695|NCT03035578|Analgesics|analgesics|mesh-ancestor
5750696|NCT03035578|Sensory System Agents|sensory system agents|mesh-ancestor
5750697|NCT03035578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5750698|NCT03035617|Bupivacaine|bupivacaine|mesh-list
5750699|NCT03035617|Anesthetics, Local|anesthetics, local|mesh-ancestor
5750700|NCT03035617|Anesthetics|anesthetics|mesh-ancestor
5750701|NCT03035617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5750702|NCT03035617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750703|NCT03035617|Sensory System Agents|sensory system agents|mesh-ancestor
5750704|NCT03035617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5750705|NCT03035227|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
5750706|NCT03035357|Daratumumab|daratumumab|mesh-list
6489568|NCT00592566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6489569|NCT00592566|Hemostatics|hemostatics|mesh-ancestor
6489570|NCT00592566|Coagulants|coagulants|mesh-ancestor
6489571|NCT00592566|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6489572|NCT00592566|Natriuretic Agents|natriuretic agents|mesh-ancestor
6489573|NCT00592579|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
6489574|NCT00592579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6489575|NCT00592579|Tubulin Modulators|tubulin modulators|mesh-ancestor
6489576|NCT00592579|Antimitotic Agents|antimitotic agents|mesh-ancestor
6489577|NCT00592579|Mitosis Modulators|mitosis modulators|mesh-ancestor
5626606|NCT05158374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5626607|NCT05158374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626608|NCT05158374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6673018|NCT01560013|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5750707|NCT03035357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5750708|NCT03035305|Pyrimethamine|pyrimethamine|mesh-list
6489578|NCT00592579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489579|NCT00592618|Acetylcysteine|acetylcysteine|mesh-list
6673019|NCT01560013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673020|NCT01560013|Sensory System Agents|sensory system agents|mesh-ancestor
6673021|NCT01560013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6673022|NCT01560052|Methylprednisolone|methylprednisolone|mesh-list
6673023|NCT01560052|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6673024|NCT01560052|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6208802|NCT02136914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208803|NCT02136914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208804|NCT02136914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6208805|NCT02136914|Analgesics|analgesics|mesh-ancestor
6208806|NCT02136914|Sensory System Agents|sensory system agents|mesh-ancestor
6208807|NCT02136914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6208808|NCT02137226|Adalimumab|adalimumab|mesh-list
6208809|NCT02137226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6208810|NCT02137226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6208811|NCT02137369|Dexetimide|dexetimide|mesh-list
6208812|NCT02137369|Citalopram|citalopram|mesh-list
6208813|NCT02137369|Sertraline|sertraline|mesh-list
6208814|NCT02137369|Antidepressive Agents|antidepressive agents|mesh-list
6208815|NCT02137369|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
6208816|NCT02137369|Serotonin|serotonin|mesh-list
6208817|NCT02137369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6208818|NCT02137369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6208819|NCT02137369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208820|NCT02137369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6208821|NCT02137369|Serotonin Agents|serotonin agents|mesh-ancestor
5626609|NCT05158374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5626610|NCT05158374|Analgesics|analgesics|mesh-ancestor
5626611|NCT05158374|Sensory System Agents|sensory system agents|mesh-ancestor
6208822|NCT02137369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208823|NCT02137369|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6208824|NCT02137369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5626612|NCT05158374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5626613|NCT05158374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6673025|NCT01560052|Prednisolone|prednisolone|mesh-list
6673026|NCT01560052|Prednisolone acetate|prednisolone acetate|mesh-list
6673027|NCT01560052|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6673028|NCT01560052|Prednisolone phosphate|prednisolone phosphate|mesh-list
6673029|NCT01560052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5750709|NCT03035305|Sulfadoxine|sulfadoxine|mesh-list
5750710|NCT03035305|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
5750711|NCT03035305|Amodiaquine|amodiaquine|mesh-list
5626614|NCT05158374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5626615|NCT05158374|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5626616|NCT05158374|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5626617|NCT05158374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5626618|NCT05158374|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5626619|NCT05158374|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5626620|NCT05158374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5626621|NCT05158374|Antipyretics|antipyretics|mesh-ancestor
5750712|NCT03035305|Antimalarials|antimalarials|mesh-ancestor
5750713|NCT03035305|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5693028|NCT03403829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5693029|NCT03403829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5693030|NCT03403829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5693031|NCT03403829|Immunologic Factors|immunologic factors|mesh-ancestor
5693032|NCT03403829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693033|NCT03403790|Quetiapine Fumarate|quetiapine fumarate|mesh-list
5693034|NCT03403790|Antidepressive Agents|antidepressive agents|mesh-ancestor
5693035|NCT03403790|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5693036|NCT03403790|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5693037|NCT03403790|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5693038|NCT03403790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5693039|NCT03403790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693040|NCT03403777|Avelumab|avelumab|mesh-list
5693041|NCT03403777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5693042|NCT03403777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5693043|NCT03403647|Vitamin D|vitamin d|mesh-list
5750714|NCT03035305|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5750715|NCT03035305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5750716|NCT03035305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5750717|NCT03035305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5750718|NCT03035305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208825|NCT02137369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6208826|NCT02137369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6673030|NCT01560052|Antiemetics|antiemetics|mesh-ancestor
5626622|NCT05147272|Gemcitabine|gemcitabine|mesh-list
5626623|NCT05147272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5626624|NCT05147272|Antimetabolites|antimetabolites|mesh-ancestor
5626625|NCT05147272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5626626|NCT05147272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5626627|NCT05147272|Antiviral Agents|antiviral agents|mesh-ancestor
5626628|NCT05147272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5626629|NCT05147272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5750719|NCT03035305|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5750720|NCT03035305|Renal Agents|renal agents|mesh-ancestor
5750721|NCT03035214|Dexamethasone|dexamethasone|mesh-list
5750722|NCT03035214|Dexamethasone acetate|dexamethasone acetate|mesh-list
5750723|NCT03035214|BB 1101|bb 1101|mesh-list
5750724|NCT03035214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5750725|NCT03035214|Antiemetics|antiemetics|mesh-ancestor
5750726|NCT03035214|Autonomic Agents|autonomic agents|mesh-ancestor
5750727|NCT03035214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5750728|NCT03035214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750729|NCT03035214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5750730|NCT03035214|Glucocorticoids|glucocorticoids|mesh-ancestor
5750731|NCT03035214|Hormones|hormones|mesh-ancestor
5750732|NCT03035214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5750733|NCT03035214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5750734|NCT03035214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5750735|NCT03035214|Protease Inhibitors|protease inhibitors|mesh-ancestor
5750736|NCT03035214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5750737|NCT03035214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5750738|NCT03035331|Pembrolizumab|pembrolizumab|mesh-list
5626630|NCT05147272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5626631|NCT05147272|Immunologic Factors|immunologic factors|mesh-ancestor
5626632|NCT05147272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626633|NCT05139017|Gemcitabine|gemcitabine|mesh-list
5626634|NCT05139017|Rituximab|rituximab|mesh-list
5626635|NCT05139017|Oxaliplatin|oxaliplatin|mesh-list
5626636|NCT05139017|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5626637|NCT05139017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5626638|NCT05139017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5626639|NCT05139017|Immunologic Factors|immunologic factors|mesh-ancestor
5626640|NCT05139017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626641|NCT05139017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5750739|NCT03035331|Vaccines|vaccines|mesh-list
5750740|NCT03035331|Immunologic Factors|immunologic factors|mesh-ancestor
5750741|NCT03035331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750742|NCT03035331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5750743|NCT03035331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5750744|NCT03035253|Antibodies, Bispecific|antibodies, bispecific|mesh-list
5750745|NCT03035253|Immunologic Factors|immunologic factors|mesh-ancestor
5750746|NCT03035253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750747|NCT03035084|Vitamin D|vitamin d|mesh-list
5750748|NCT03035084|Ergocalciferols|ergocalciferols|mesh-list
5750749|NCT03035084|Cholecalciferol|cholecalciferol|mesh-list
5750750|NCT03035084|Vitamins|vitamins|mesh-list
5750751|NCT03035084|Micronutrients|micronutrients|mesh-ancestor
5750752|NCT03035084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750753|NCT03035084|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5750754|NCT03035084|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5750755|NCT03034941|Metformin|metformin|mesh-list
5750756|NCT03034941|Liraglutide|liraglutide|mesh-list
5750757|NCT03034941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5750758|NCT03034941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750759|NCT03034941|Incretins|incretins|mesh-ancestor
5750760|NCT03034941|Hormones|hormones|mesh-ancestor
5750761|NCT03034941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5626642|NCT05139017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5750762|NCT03034850|Doxorubicin|doxorubicin|mesh-list
5750763|NCT03034850|Fluorouracil|fluorouracil|mesh-list
5750764|NCT03034850|Ifosfamide|ifosfamide|mesh-list
5750765|NCT03034850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5750766|NCT03034850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5750767|NCT03034850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5750768|NCT03034850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5750769|NCT03034850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5750770|NCT03034850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5750771|NCT03034850|Antimetabolites|antimetabolites|mesh-ancestor
5750772|NCT03034850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5626643|NCT05139017|Antimetabolites|antimetabolites|mesh-ancestor
5626644|NCT05139017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5626645|NCT05139017|Antiviral Agents|antiviral agents|mesh-ancestor
5626646|NCT05139017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5626647|NCT05139017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5626648|NCT05139017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5626649|NCT05139017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5626650|NCT05139017|Alkylating Agents|alkylating agents|mesh-ancestor
5626651|NCT05108454|Micronutrients|micronutrients|mesh-list
5626652|NCT05108454|Trace Elements|trace elements|mesh-list
5626653|NCT05108454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626654|NCT05102162|Meropenem|meropenem|mesh-list
5626655|NCT05102162|Tazobactam|tazobactam|mesh-list
5626656|NCT05102162|Piperacillin|piperacillin|mesh-list
5626657|NCT05102162|Cefepime|cefepime|mesh-list
5626658|NCT05102162|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
5626659|NCT05102162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5750773|NCT03034850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5750774|NCT03034850|Immunologic Factors|immunologic factors|mesh-ancestor
5750775|NCT03034850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750776|NCT03034850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5750777|NCT03034850|Alkylating Agents|alkylating agents|mesh-ancestor
5750778|NCT03034759|Insulin|insulin|mesh-list
5750779|NCT03034759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5626660|NCT05102162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5626661|NCT05102162|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5626662|NCT05102162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5626663|NCT05102162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5626664|NCT05095961|Prednisone|prednisone|mesh-list
5626665|NCT05095961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5626666|NCT05095961|Glucocorticoids|glucocorticoids|mesh-ancestor
5626667|NCT05095961|Hormones|hormones|mesh-ancestor
5750780|NCT03034759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750781|NCT03035058|Vedolizumab|vedolizumab|mesh-list
5750782|NCT03035058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5750783|NCT03035045|Acetaminophen|acetaminophen|mesh-list
5750784|NCT03035045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5750785|NCT03035045|Analgesics|analgesics|mesh-ancestor
5750786|NCT03035045|Sensory System Agents|sensory system agents|mesh-ancestor
5750787|NCT03035045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5750788|NCT03035045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750789|NCT03035045|Antipyretics|antipyretics|mesh-ancestor
5750790|NCT03034733|Dexamethasone|dexamethasone|mesh-list
5750791|NCT03034733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5750792|NCT03034733|Antiemetics|antiemetics|mesh-ancestor
5750793|NCT03034733|Autonomic Agents|autonomic agents|mesh-ancestor
5626668|NCT05095961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5626669|NCT05095961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626670|NCT05095961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5626671|NCT05095961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5626672|NCT05074121|Acetylcysteine|acetylcysteine|mesh-list
5626673|NCT05074121|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5626674|NCT05074121|Antiviral Agents|antiviral agents|mesh-ancestor
5626675|NCT05074121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5626676|NCT05074121|Expectorants|expectorants|mesh-ancestor
5626677|NCT05074121|Respiratory System Agents|respiratory system agents|mesh-ancestor
5626678|NCT05074121|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5626679|NCT05074121|Antioxidants|antioxidants|mesh-ancestor
6489580|NCT00592618|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6489581|NCT00592618|Antiviral Agents|antiviral agents|mesh-ancestor
6489582|NCT00592618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6489583|NCT00592618|Expectorants|expectorants|mesh-ancestor
5750794|NCT03034733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5750795|NCT03034733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750796|NCT03034733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5750797|NCT03034733|Glucocorticoids|glucocorticoids|mesh-ancestor
6489584|NCT00592618|Respiratory System Agents|respiratory system agents|mesh-ancestor
6489585|NCT00592618|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5750798|NCT03034733|Hormones|hormones|mesh-ancestor
5750799|NCT03034733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5750800|NCT03034733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5750801|NCT03034733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5750802|NCT03034707|Biotin|biotin|mesh-list
5626680|NCT05074121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5750803|NCT03034707|Vitamin B Complex|vitamin b complex|mesh-ancestor
5750804|NCT03034707|Vitamins|vitamins|mesh-ancestor
5750805|NCT03034707|Micronutrients|micronutrients|mesh-ancestor
5750806|NCT03034707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750807|NCT03034408|Mannitol|mannitol|mesh-list
5750808|NCT03034408|Baclofen|baclofen|mesh-list
5750809|NCT03034408|Nalmefene|nalmefene|mesh-list
5750810|NCT03034408|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5750811|NCT03034408|Diuretics|diuretics|mesh-ancestor
5750812|NCT03034408|Natriuretic Agents|natriuretic agents|mesh-ancestor
5626681|NCT05074121|Protective Agents|protective agents|mesh-ancestor
5626682|NCT05074121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626683|NCT05074121|Antidotes|antidotes|mesh-ancestor
5626684|NCT05069012|Morphine|morphine|mesh-list
5626685|NCT05069012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5626686|NCT05069012|Narcotics|narcotics|mesh-ancestor
5750813|NCT03034408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750814|NCT03034408|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5750815|NCT03034408|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5750816|NCT03034408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5750817|NCT03034408|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
5750818|NCT03034408|GABA Agonists|gaba agonists|mesh-ancestor
5750819|NCT03034408|GABA Agents|gaba agents|mesh-ancestor
5750820|NCT03034408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5750821|NCT03034408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5750822|NCT03034408|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5626687|NCT05069012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5626688|NCT05069012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626689|NCT05069012|Analgesics|analgesics|mesh-ancestor
5626690|NCT05069012|Sensory System Agents|sensory system agents|mesh-ancestor
5626691|NCT05069012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5626692|NCT05052229|Nitric Oxide|nitric oxide|mesh-list
5626693|NCT05052229|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5626694|NCT05052229|Autonomic Agents|autonomic agents|mesh-ancestor
5626695|NCT05052229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5626696|NCT05052229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626697|NCT05052229|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5626698|NCT05052229|Respiratory System Agents|respiratory system agents|mesh-ancestor
6489586|NCT00592618|Antioxidants|antioxidants|mesh-ancestor
5750823|NCT03034408|Sensory System Agents|sensory system agents|mesh-ancestor
5750824|NCT03034382|Lidocaine|lidocaine|mesh-list
5750825|NCT03034382|Epinephrine|epinephrine|mesh-list
5750826|NCT03034382|Morphine|morphine|mesh-list
5750827|NCT03034382|Nalbuphine|nalbuphine|mesh-list
5750828|NCT03034382|Bupivacaine|bupivacaine|mesh-list
5750829|NCT03034382|Anesthetics, Local|anesthetics, local|mesh-ancestor
5750830|NCT03034382|Anesthetics|anesthetics|mesh-ancestor
5750831|NCT03034382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5750832|NCT03034382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750833|NCT03034382|Sensory System Agents|sensory system agents|mesh-ancestor
5750834|NCT03034382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5750835|NCT03034382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5750836|NCT03034382|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5750837|NCT03034382|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5750838|NCT03034382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5750839|NCT03034382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5750840|NCT03034382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5750841|NCT03034382|Narcotics|narcotics|mesh-ancestor
5750842|NCT03034382|Analgesics|analgesics|mesh-ancestor
5750843|NCT03034382|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5750844|NCT03034382|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5750845|NCT03034382|Adrenergic Agents|adrenergic agents|mesh-ancestor
5626699|NCT05052229|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5626700|NCT05052229|Antioxidants|antioxidants|mesh-ancestor
5750846|NCT03034382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5750847|NCT03034382|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5750848|NCT03034382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5750849|NCT03034382|Autonomic Agents|autonomic agents|mesh-ancestor
5750850|NCT03034382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5750851|NCT03034382|Respiratory System Agents|respiratory system agents|mesh-ancestor
5750852|NCT03034382|Mydriatics|mydriatics|mesh-ancestor
5750853|NCT03034382|Sympathomimetics|sympathomimetics|mesh-ancestor
5750854|NCT03034382|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5894514|NCT04551885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5894515|NCT04533451|Carboplatin|carboplatin|mesh-list
5894516|NCT04533451|Pembrolizumab|pembrolizumab|mesh-list
5894517|NCT04533451|Pemetrexed|pemetrexed|mesh-list
5894518|NCT04533451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5894519|NCT04533451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5894520|NCT04533451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5894521|NCT04533451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894522|NCT04533451|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5894523|NCT04533451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5894524|NCT04520776|Meloxicam|meloxicam|mesh-list
5894525|NCT04520776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5894526|NCT04520776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5894527|NCT04520776|Analgesics|analgesics|mesh-ancestor
5894528|NCT04520776|Sensory System Agents|sensory system agents|mesh-ancestor
5894529|NCT04520776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5894530|NCT04520776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894531|NCT04520776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5894532|NCT04520776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5894533|NCT04520776|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5894534|NCT04520776|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5894535|NCT04520776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5894536|NCT04520776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907787|NCT05198804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907788|NCT05198804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5907789|NCT05196945|Amoxicillin|amoxicillin|mesh-list
5907790|NCT05196945|Clarithromycin|clarithromycin|mesh-list
5907791|NCT05196945|Potassium Citrate|potassium citrate|mesh-list
5907792|NCT05196945|Esomeprazole|esomeprazole|mesh-list
5907793|NCT05196945|Bismuth|bismuth|mesh-list
5907794|NCT05196945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907795|NCT05196945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6489587|NCT00592618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907796|NCT05196945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5626701|NCT05052229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5626702|NCT05052229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5626703|NCT05052229|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5626704|NCT05052229|Vasodilator Agents|vasodilator agents|mesh-ancestor
5626705|NCT05052229|Gasotransmitters|gasotransmitters|mesh-ancestor
5626706|NCT05052229|Protective Agents|protective agents|mesh-ancestor
5626707|NCT05050162|Cisplatin|cisplatin|mesh-list
5626708|NCT05050162|1,2-diaminocyclohexaneplatinum II citrate|1,2-diaminocyclohexaneplatinum ii citrate|mesh-list
5626709|NCT05050162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5626710|NCT05049343|Ketamine|ketamine|mesh-list
5626711|NCT05049343|Analgesics|analgesics|mesh-ancestor
5626712|NCT05049343|Sensory System Agents|sensory system agents|mesh-ancestor
5626713|NCT05049343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5626714|NCT05049343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626715|NCT05049343|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5626716|NCT05049343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5626717|NCT05049343|Anesthetics, General|anesthetics, general|mesh-ancestor
5626718|NCT05049343|Anesthetics|anesthetics|mesh-ancestor
5626719|NCT05049343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5626720|NCT05049343|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5626721|NCT05049343|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5626722|NCT05049343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5626723|NCT05049343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5626724|NCT05042609|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5626725|NCT05042609|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5626726|NCT05041322|Buspirone|buspirone|mesh-list
5626727|NCT05041322|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5907797|NCT05196945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5907798|NCT05196945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5907799|NCT05196945|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5626728|NCT05041322|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5907800|NCT05196945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5750855|NCT03034304|Ifosfamide|ifosfamide|mesh-list
5750856|NCT03034304|Antibodies|antibodies|mesh-list
5750857|NCT03034304|Immunologic Factors|immunologic factors|mesh-ancestor
5750858|NCT03034304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750859|NCT03034304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5750860|NCT03034304|Alkylating Agents|alkylating agents|mesh-ancestor
5750861|NCT03034304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5750862|NCT03034304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5750863|NCT03034005|Budesonide|budesonide|mesh-list
5750864|NCT03034005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5750865|NCT03034005|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5750866|NCT03034005|Autonomic Agents|autonomic agents|mesh-ancestor
5750867|NCT03034005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5750868|NCT03034005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750869|NCT03034005|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5750870|NCT03034005|Respiratory System Agents|respiratory system agents|mesh-ancestor
5750871|NCT03034005|Glucocorticoids|glucocorticoids|mesh-ancestor
5750872|NCT03034005|Hormones|hormones|mesh-ancestor
5750873|NCT03034005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5750874|NCT03033589|Bupivacaine|bupivacaine|mesh-list
5750875|NCT03033589|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5750876|NCT03033589|Anesthetics, Local|anesthetics, local|mesh-ancestor
5750877|NCT03033589|Anesthetics|anesthetics|mesh-ancestor
5750878|NCT03033589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5750879|NCT03033589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750880|NCT03033589|Sensory System Agents|sensory system agents|mesh-ancestor
5750881|NCT03033589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5750882|NCT03033537|Verapamil|verapamil|mesh-list
5750883|NCT03033537|Calcium Channel Blockers|calcium channel blockers|mesh-list
5750884|NCT03033537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5750885|NCT03033537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750886|NCT03033537|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5750887|NCT03033537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5750888|NCT03033537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5750889|NCT03033537|Vasodilator Agents|vasodilator agents|mesh-ancestor
5750890|NCT03033758|Budesonide|budesonide|mesh-list
5750891|NCT03033758|Formoterol Fumarate|formoterol fumarate|mesh-list
5750892|NCT03033758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5750893|NCT03033758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5626729|NCT05041322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5626730|NCT05041322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626731|NCT05041322|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5626732|NCT05041322|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5626733|NCT05041322|Serotonin Agents|serotonin agents|mesh-ancestor
5626734|NCT05041322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5626735|NCT05041322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5626736|NCT05040568|Vidarabine|vidarabine|mesh-list
5626737|NCT05040568|Cyclophosphamide|cyclophosphamide|mesh-list
5626738|NCT05040568|Fludarabine|fludarabine|mesh-list
5626739|NCT05040568|Fludarabine phosphate|fludarabine phosphate|mesh-list
5626740|NCT05040568|Cetuximab|cetuximab|mesh-list
5626741|NCT05040568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5626742|NCT05040568|Immunologic Factors|immunologic factors|mesh-ancestor
5626743|NCT05040568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626744|NCT05040568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5626745|NCT05040568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5626746|NCT05040568|Alkylating Agents|alkylating agents|mesh-ancestor
5626747|NCT05040568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5626748|NCT05040568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5626749|NCT05040568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5626750|NCT05040568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5626751|NCT05040568|Antimetabolites|antimetabolites|mesh-ancestor
5626752|NCT05040568|Antiviral Agents|antiviral agents|mesh-ancestor
5626753|NCT05040568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5626754|NCT05040568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6489588|NCT00592618|Protective Agents|protective agents|mesh-ancestor
5750894|NCT03033758|Autonomic Agents|autonomic agents|mesh-ancestor
5750895|NCT03033758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5750896|NCT03033758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750897|NCT03033758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5750898|NCT03033758|Respiratory System Agents|respiratory system agents|mesh-ancestor
5750899|NCT03033758|Glucocorticoids|glucocorticoids|mesh-ancestor
5750900|NCT03033758|Hormones|hormones|mesh-ancestor
5626755|NCT05036278|Factor VIII|factor viii|mesh-list
5894537|NCT04497870|Peppermint oil|peppermint oil|mesh-list
5626756|NCT05036278|Coagulants|coagulants|mesh-ancestor
5626757|NCT05028673|Aluminum Hydroxide|aluminum hydroxide|mesh-list
5626758|NCT05028673|Antacids|antacids|mesh-list
5626759|NCT05028673|Magnesium Hydroxide|magnesium hydroxide|mesh-list
5626760|NCT05028673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5626761|NCT05028673|Immunologic Factors|immunologic factors|mesh-ancestor
5626762|NCT05028673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626763|NCT05028673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5626764|NCT05028673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5626765|NCT05023512|Vaccines|vaccines|mesh-list
5626766|NCT05023512|Immunologic Factors|immunologic factors|mesh-ancestor
5626767|NCT05023512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626768|NCT05010122|Decitabine|decitabine|mesh-list
5626769|NCT05010122|Venetoclax|venetoclax|mesh-list
5626770|NCT05010122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5626771|NCT05010122|Antimetabolites|antimetabolites|mesh-ancestor
5626772|NCT05010122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5626773|NCT05010122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5626774|NCT05010122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5626775|NCT05006417|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5626776|NCT05006417|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5626777|NCT05006417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5626778|NCT05006417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626779|NCT05006417|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5626780|NCT05006417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5626781|NCT05006417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5626782|NCT05006417|Cholinergic Agents|cholinergic agents|mesh-ancestor
5626783|NCT05006417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5626784|NCT04996368|Tranexamic Acid|tranexamic acid|mesh-list
5750901|NCT03033758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5750902|NCT03033758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5750903|NCT03033758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5750904|NCT03033758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5750905|NCT03033758|Adrenergic Agents|adrenergic agents|mesh-ancestor
5750906|NCT03033758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5750907|NCT03033758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5750908|NCT03033654|Sunscreening Agents|sunscreening agents|mesh-list
5750909|NCT03033654|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5750910|NCT03033654|Protective Agents|protective agents|mesh-ancestor
5750911|NCT03033654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750912|NCT03033654|Dermatologic Agents|dermatologic agents|mesh-ancestor
5750913|NCT03033732|Buprenorphine|buprenorphine|mesh-list
5750914|NCT03033732|Methadone|methadone|mesh-list
5750915|NCT03033732|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
5750916|NCT03033732|Naloxone|naloxone|mesh-list
5750917|NCT03033732|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5750918|NCT03033732|Narcotics|narcotics|mesh-ancestor
5750919|NCT03033732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5750920|NCT03033732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750921|NCT03033732|Analgesics|analgesics|mesh-ancestor
5750922|NCT03033732|Sensory System Agents|sensory system agents|mesh-ancestor
5750923|NCT03033732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5750924|NCT03033732|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5626785|NCT04996368|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5626786|NCT04996368|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5626787|NCT04996368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5626788|NCT04996368|Hemostatics|hemostatics|mesh-ancestor
5626789|NCT04996368|Coagulants|coagulants|mesh-ancestor
5626790|NCT04941755|Famotidine|famotidine|mesh-list
5626791|NCT04941755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5626792|NCT04941755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5626793|NCT04941755|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5626794|NCT04941755|Histamine Antagonists|histamine antagonists|mesh-ancestor
5626795|NCT04941755|Histamine Agents|histamine agents|mesh-ancestor
5626796|NCT04941755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5626797|NCT04941755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5626798|NCT04941755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626799|NCT04939701|Pembrolizumab|pembrolizumab|mesh-list
5626800|NCT04939701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5626801|NCT04939701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5626802|NCT04933227|Capecitabine|capecitabine|mesh-list
5626803|NCT04933227|Oxaliplatin|oxaliplatin|mesh-list
5626804|NCT04933227|Atezolizumab|atezolizumab|mesh-list
5626805|NCT04933227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5750925|NCT03033732|Antitussive Agents|antitussive agents|mesh-ancestor
5750926|NCT03033732|Respiratory System Agents|respiratory system agents|mesh-ancestor
5750927|NCT03033472|Clindamycin|clindamycin|mesh-list
5750928|NCT03033472|Clindamycin palmitate|clindamycin palmitate|mesh-list
5750929|NCT03033472|Clindamycin phosphate|clindamycin phosphate|mesh-list
5750930|NCT03033472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5750931|NCT03033472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5750932|NCT03033472|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5750933|NCT03033472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5750934|NCT03033472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5750935|NCT03033836|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5750936|NCT03033836|Dolutegravir|dolutegravir|mesh-list
5750937|NCT03033836|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5750938|NCT03033836|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5750939|NCT03033836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5750940|NCT03033836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5750941|NCT03033836|Antiviral Agents|antiviral agents|mesh-ancestor
5750942|NCT03033836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5750943|NCT03033836|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5750944|NCT03033836|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5750945|NCT03033836|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5750946|NCT03033836|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5750947|NCT03033446|Nivolumab|nivolumab|mesh-list
5626806|NCT04933227|Antimetabolites|antimetabolites|mesh-ancestor
5626807|NCT04933227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5626808|NCT04933227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5626809|NCT04931641|Ferrous fumarate|ferrous fumarate|mesh-list
5626810|NCT04931641|Trace Elements|trace elements|mesh-ancestor
5626811|NCT04931641|Micronutrients|micronutrients|mesh-ancestor
5626812|NCT04931641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693044|NCT03403647|Vitamins|vitamins|mesh-ancestor
5693045|NCT03403647|Micronutrients|micronutrients|mesh-ancestor
5693046|NCT03403647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693047|NCT03403647|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5750948|NCT03033446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5750949|NCT03033446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5750950|NCT03033446|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5750951|NCT03033446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5750952|NCT03033355|Botulinum Toxins|botulinum toxins|mesh-list
5750953|NCT03033355|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5750954|NCT03033355|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5750955|NCT03033355|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5750956|NCT03033355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5750957|NCT03033355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5750958|NCT03033355|Cholinergic Agents|cholinergic agents|mesh-ancestor
5750959|NCT03033355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5750960|NCT03033355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750961|NCT03033355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5750962|NCT03033355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5750963|NCT03033121|Hormones|hormones|mesh-list
5750964|NCT03033121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5750965|NCT03033121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750966|NCT03033264|Dinoprostone|dinoprostone|mesh-list
5750967|NCT03033264|Oxytocics|oxytocics|mesh-ancestor
5750968|NCT03033264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5750969|NCT03033264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750970|NCT03033199|Dexamethasone|dexamethasone|mesh-list
5750971|NCT03033199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5750972|NCT03033199|Antiemetics|antiemetics|mesh-ancestor
5750973|NCT03033199|Autonomic Agents|autonomic agents|mesh-ancestor
5750974|NCT03033199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5750975|NCT03033199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5750976|NCT03033199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5750977|NCT03033199|Glucocorticoids|glucocorticoids|mesh-ancestor
5750978|NCT03033199|Hormones|hormones|mesh-ancestor
5750979|NCT03033199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5750980|NCT03033199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5750981|NCT03033199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5750982|NCT03033368|Rilpivirine|rilpivirine|mesh-list
5750983|NCT03033368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5750984|NCT03033368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5750985|NCT03033368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5693048|NCT03403595|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
5693049|NCT03403595|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5626813|NCT04887948|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5626814|NCT04887948|Immunologic Factors|immunologic factors|mesh-ancestor
5626815|NCT04887948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626816|NCT04878627|Cannabidiol|cannabidiol|mesh-list
5626817|NCT04878627|Anticonvulsants|anticonvulsants|mesh-ancestor
5626818|NCT04872426|Insulin|insulin|mesh-list
5626819|NCT04872426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5626820|NCT04872426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626821|NCT04856176|Paclitaxel|paclitaxel|mesh-list
5750986|NCT03033368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5750987|NCT03033368|Antiviral Agents|antiviral agents|mesh-ancestor
5750988|NCT03033368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5750989|NCT03033368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5750990|NCT03033368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5750991|NCT03033147|Amoxicillin|amoxicillin|mesh-list
5750992|NCT03033147|Clavulanic Acid|clavulanic acid|mesh-list
5750993|NCT03033147|Clavulanic Acids|clavulanic acids|mesh-list
5750994|NCT03033147|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5750995|NCT03033147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5750996|NCT03033147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5750997|NCT03033147|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5626822|NCT04856176|Carboplatin|carboplatin|mesh-list
5626823|NCT04856176|Pembrolizumab|pembrolizumab|mesh-list
5626824|NCT04856176|Pemetrexed|pemetrexed|mesh-list
5626825|NCT04856176|Molgramostim|molgramostim|mesh-list
5626826|NCT04856176|Sargramostim|sargramostim|mesh-list
5626827|NCT04856176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5626828|NCT04856176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5626829|NCT04856176|Tubulin Modulators|tubulin modulators|mesh-ancestor
5626830|NCT04856176|Antimitotic Agents|antimitotic agents|mesh-ancestor
5626831|NCT04856176|Mitosis Modulators|mitosis modulators|mesh-ancestor
5626832|NCT04856176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5626833|NCT04856176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5626834|NCT04856176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5750998|NCT03033147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5750999|NCT03033147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751000|NCT03033342|Omeprazole|omeprazole|mesh-list
5751001|NCT03033342|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5751002|NCT03033342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5751003|NCT03033342|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5751004|NCT03033342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5751005|NCT03033342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751006|NCT03033095|Etanercept|etanercept|mesh-list
5751007|NCT03033095|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5751008|NCT03033095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5626835|NCT04856176|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5626836|NCT04856176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5626837|NCT04856176|Immunologic Factors|immunologic factors|mesh-ancestor
5626838|NCT04856176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626839|NCT04853043|Cetuximab|cetuximab|mesh-list
5626840|NCT04853043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5626841|NCT04853043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5626842|NCT04848337|Pembrolizumab|pembrolizumab|mesh-list
5626843|NCT04848337|Lenvatinib|lenvatinib|mesh-list
5626844|NCT04848337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5626845|NCT04848337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5626846|NCT04848337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5626847|NCT04848337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5626848|NCT04848337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5626849|NCT04837196|Pembrolizumab|pembrolizumab|mesh-list
5751009|NCT03033095|Analgesics|analgesics|mesh-ancestor
5751010|NCT03033095|Sensory System Agents|sensory system agents|mesh-ancestor
5751011|NCT03033095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5751012|NCT03033095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751013|NCT03033095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5751014|NCT03033095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5751015|NCT03033095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5751016|NCT03033095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5751017|NCT03033095|Immunologic Factors|immunologic factors|mesh-ancestor
5751018|NCT03032978|Calcium, Dietary|calcium, dietary|mesh-list
5751019|NCT03032978|Calcium|calcium|mesh-list
5751020|NCT03032978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5626850|NCT04837196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5626851|NCT04837196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5626852|NCT04832854|Gemcitabine|gemcitabine|mesh-list
5751021|NCT03032978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751022|NCT03032978|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5751023|NCT03033160|Estradiol|estradiol|mesh-list
5751024|NCT03033160|Estrogens|estrogens|mesh-ancestor
5751025|NCT03033160|Hormones|hormones|mesh-ancestor
5751026|NCT03033160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5751027|NCT03033160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751028|NCT03033316|Dexamethasone|dexamethasone|mesh-list
5751029|NCT03033316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5751030|NCT03033316|Antiemetics|antiemetics|mesh-ancestor
5751031|NCT03033316|Autonomic Agents|autonomic agents|mesh-ancestor
5751032|NCT03033316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5751033|NCT03033316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751034|NCT03033316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5751035|NCT03033316|Glucocorticoids|glucocorticoids|mesh-ancestor
5751036|NCT03033316|Hormones|hormones|mesh-ancestor
5751037|NCT03033316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5751038|NCT03033316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5751039|NCT03033316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5751040|NCT03032848|Estrogens|estrogens|mesh-list
5751041|NCT03032848|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
5751042|NCT03032848|Hormones|hormones|mesh-ancestor
5751043|NCT03032848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5751044|NCT03032848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751045|NCT03032783|Mycophenolic Acid|mycophenolic acid|mesh-list
5751046|NCT03032783|Cyclophosphamide|cyclophosphamide|mesh-list
5751047|NCT03032783|Tacrolimus|tacrolimus|mesh-list
5751048|NCT03032783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5751049|NCT03032783|Immunologic Factors|immunologic factors|mesh-ancestor
5751050|NCT03032783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751051|NCT03032783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5751052|NCT03032783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5751053|NCT03032783|Alkylating Agents|alkylating agents|mesh-ancestor
5751054|NCT03032783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751055|NCT03032783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5751056|NCT03032783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5751057|NCT03032783|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5751058|NCT03032783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5751059|NCT03032783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5751060|NCT03032783|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5751061|NCT03032783|Antitubercular Agents|antitubercular agents|mesh-ancestor
5751062|NCT03032783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5751063|NCT03032783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5894538|NCT04497870|Menthol|menthol|mesh-list
5894539|NCT04497870|Antipruritics|antipruritics|mesh-ancestor
5894540|NCT04497870|Dermatologic Agents|dermatologic agents|mesh-ancestor
5894541|NCT04497870|Antiemetics|antiemetics|mesh-ancestor
5894542|NCT04497870|Autonomic Agents|autonomic agents|mesh-ancestor
5894543|NCT04497870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5894544|NCT04497870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894545|NCT04497870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5894546|NCT04497870|Parasympatholytics|parasympatholytics|mesh-ancestor
5894547|NCT04487041|Vaccines|vaccines|mesh-list
5894548|NCT04487041|Immunologic Factors|immunologic factors|mesh-ancestor
5894549|NCT04487041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894550|NCT04431141|Empagliflozin|empagliflozin|mesh-list
5894551|NCT04431141|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5894552|NCT04431141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894553|NCT04431141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5894554|NCT04431141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894555|NCT04412395|Lactoferrin|lactoferrin|mesh-list
5894556|NCT04412395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5894557|NCT04310748|Anesthetics|anesthetics|mesh-list
5894558|NCT04310748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5894559|NCT04310748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894560|NCT04304768|Vaccines|vaccines|mesh-list
5894561|NCT04304768|Immunologic Factors|immunologic factors|mesh-ancestor
5894562|NCT04304768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626853|NCT04832854|Paclitaxel|paclitaxel|mesh-list
5626854|NCT04832854|Carboplatin|carboplatin|mesh-list
5626855|NCT04832854|Pemetrexed|pemetrexed|mesh-list
5626856|NCT04832854|Atezolizumab|atezolizumab|mesh-list
5626857|NCT04832854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5626858|NCT04832854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5626859|NCT04832854|Tubulin Modulators|tubulin modulators|mesh-ancestor
5626860|NCT04832854|Antimitotic Agents|antimitotic agents|mesh-ancestor
5626861|NCT04832854|Mitosis Modulators|mitosis modulators|mesh-ancestor
5894563|NCT04294498|Entecavir|entecavir|mesh-list
5626862|NCT04832854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5626863|NCT04832854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5626864|NCT04832854|Antimetabolites|antimetabolites|mesh-ancestor
5626865|NCT04832854|Antiviral Agents|antiviral agents|mesh-ancestor
5626866|NCT04832854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5626867|NCT04832854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5626868|NCT04832854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5626869|NCT04832854|Immunologic Factors|immunologic factors|mesh-ancestor
5626870|NCT04832854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626871|NCT04832854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5626872|NCT04832854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5626873|NCT04815902|Losartan|losartan|mesh-list
5626874|NCT04815902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5626875|NCT04815902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5626876|NCT04815902|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5626877|NCT04815902|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5626878|NCT04815902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5626879|NCT04804644|Memantine|memantine|mesh-list
5626880|NCT04804644|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5626881|NCT04804644|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5626882|NCT04804644|Dopamine Agents|dopamine agents|mesh-ancestor
5626883|NCT04804644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5626884|NCT04804644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5626885|NCT04804644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626886|NCT04804644|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5626887|NCT04804644|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5626888|NCT04800627|Pembrolizumab|pembrolizumab|mesh-list
5626889|NCT04800627|Enzyme Inhibitors|enzyme inhibitors|mesh-list
5626890|NCT04800627|Pevonedistat|pevonedistat|mesh-list
5751064|NCT03032666|Sofosbuvir|sofosbuvir|mesh-list
5751065|NCT03032666|Velpatasvir|velpatasvir|mesh-list
5751066|NCT03032666|Antiviral Agents|antiviral agents|mesh-ancestor
5751067|NCT03032666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5751068|NCT03032536|Tenofovir|tenofovir|mesh-list
5751069|NCT03032536|Entecavir|entecavir|mesh-list
5751070|NCT03032536|Antiviral Agents|antiviral agents|mesh-ancestor
5751071|NCT03032536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5751072|NCT03032536|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5751073|NCT03032536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5751074|NCT03032536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5626891|NCT04800627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5626892|NCT04800627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5626893|NCT04800627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5626894|NCT04792073|Avelumab|avelumab|mesh-list
5626895|NCT04792073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5626896|NCT04792073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5626897|NCT04782687|Dexamethasone|dexamethasone|mesh-list
5626898|NCT04782687|Lenalidomide|lenalidomide|mesh-list
5626899|NCT04782687|Daratumumab|daratumumab|mesh-list
5626900|NCT04782687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5751075|NCT03032536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751076|NCT03032536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5751077|NCT03032536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6489589|NCT00592618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489590|NCT00592618|Antidotes|antidotes|mesh-ancestor
6489591|NCT00592670|Fluoxetine|fluoxetine|mesh-list
5626901|NCT04782687|Antiemetics|antiemetics|mesh-ancestor
5626902|NCT04782687|Autonomic Agents|autonomic agents|mesh-ancestor
5751078|NCT03032484|Bevacizumab|bevacizumab|mesh-list
5751079|NCT03032484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5751080|NCT03032484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5751081|NCT03032484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5751082|NCT03032484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5751083|NCT03032484|Growth Substances|growth substances|mesh-ancestor
5626903|NCT04782687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5626904|NCT04782687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626905|NCT04782687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5626906|NCT04782687|Glucocorticoids|glucocorticoids|mesh-ancestor
6489592|NCT00592670|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6489593|NCT00592670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6489594|NCT00592670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6489595|NCT00592670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489596|NCT00592670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6489597|NCT00592670|Serotonin Agents|serotonin agents|mesh-ancestor
5751084|NCT03032484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489598|NCT00592670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489599|NCT00592670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6208827|NCT02137369|Parasympatholytics|parasympatholytics|mesh-ancestor
6208828|NCT02137369|Autonomic Agents|autonomic agents|mesh-ancestor
6208829|NCT02137369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6208830|NCT02137369|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6208831|NCT02137369|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6208832|NCT02137369|Cholinergic Agents|cholinergic agents|mesh-ancestor
6208833|NCT02137369|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6208834|NCT02137382|Pancrelipase|pancrelipase|mesh-list
6208835|NCT02137382|Pancreatin|pancreatin|mesh-list
5626907|NCT04782687|Hormones|hormones|mesh-ancestor
5626908|NCT04782687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5626909|NCT04782687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5626910|NCT04782687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5626911|NCT04782687|Immunologic Factors|immunologic factors|mesh-ancestor
5626912|NCT04782687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5626913|NCT04782687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5626914|NCT04782687|Growth Substances|growth substances|mesh-ancestor
5626915|NCT04782687|Growth Inhibitors|growth inhibitors|mesh-ancestor
5626916|NCT04742673|Guanfacine|guanfacine|mesh-list
5626917|NCT04742673|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5626918|NCT04742673|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5626919|NCT04742673|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5626920|NCT04742673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6208836|NCT02137382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6208837|NCT02137538|Letrozole|letrozole|mesh-list
6208838|NCT02137538|Anastrozole|anastrozole|mesh-list
6208839|NCT02137538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6208840|NCT02137538|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6208841|NCT02137538|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6208842|NCT02137538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6208843|NCT02137538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751085|NCT03032484|Growth Inhibitors|growth inhibitors|mesh-ancestor
5751086|NCT03032614|Carboplatin|carboplatin|mesh-list
5751087|NCT03032614|Veliparib|veliparib|mesh-list
5751088|NCT03032614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5751089|NCT03032614|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5751090|NCT03032614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5751091|NCT03032614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751092|NCT03032458|Ketorolac|ketorolac|mesh-list
5751093|NCT03032458|Lidocaine|lidocaine|mesh-list
5751094|NCT03032458|Meperidine|meperidine|mesh-list
5751095|NCT03032458|Anesthetics, Local|anesthetics, local|mesh-ancestor
5751096|NCT03032458|Anesthetics|anesthetics|mesh-ancestor
5751097|NCT03032458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5626921|NCT04742673|Adrenergic Agents|adrenergic agents|mesh-ancestor
5626922|NCT04742673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5626923|NCT04742673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5626924|NCT04742673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626925|NCT04734990|Azacitidine|azacitidine|mesh-list
5626926|NCT04734990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5626927|NCT04734990|Antimetabolites|antimetabolites|mesh-ancestor
5626928|NCT04734990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5626929|NCT04734990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5626930|NCT04734990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5626931|NCT04718181|Omeprazole|omeprazole|mesh-list
5626932|NCT04718181|Risdiplam|risdiplam|mesh-list
5626933|NCT04718181|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5626934|NCT04718181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5751098|NCT03032458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751099|NCT03032458|Sensory System Agents|sensory system agents|mesh-ancestor
5751100|NCT03032458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5751101|NCT03032458|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5751102|NCT03032458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5751103|NCT03032458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5751104|NCT03032458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5751105|NCT03032458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751106|NCT03032458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5751107|NCT03032458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5751108|NCT03032458|Analgesics|analgesics|mesh-ancestor
5751109|NCT03032458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5751110|NCT03032458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6208844|NCT02137538|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6208845|NCT02137538|Hormone Antagonists|hormone antagonists|mesh-ancestor
5751111|NCT03032458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5751112|NCT03032458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5751113|NCT03032458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5751114|NCT03032458|Narcotics|narcotics|mesh-ancestor
5751115|NCT03032458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5751116|NCT03032406|Hydroxychloroquine|hydroxychloroquine|mesh-list
5751117|NCT03032406|Everolimus|everolimus|mesh-list
5751118|NCT03032406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5751119|NCT03032406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5751120|NCT03032406|Immunologic Factors|immunologic factors|mesh-ancestor
5751121|NCT03032406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751122|NCT03032406|Antimalarials|antimalarials|mesh-ancestor
5626935|NCT04718181|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5626936|NCT04718181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5626937|NCT04718181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5626938|NCT04718181|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5626939|NCT04718181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5626940|NCT04718181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626941|NCT04712851|Pembrolizumab|pembrolizumab|mesh-list
5626942|NCT04712851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5626943|NCT04712851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5626944|NCT04704271|Dronabinol|dronabinol|mesh-list
5626945|NCT04704271|Hallucinogens|hallucinogens|mesh-ancestor
5626946|NCT04704271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751123|NCT03032406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5751124|NCT03032406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5751125|NCT03032406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5751126|NCT03032406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5751127|NCT03032406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751128|NCT03032406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5751129|NCT03032367|Bedaquiline|bedaquiline|mesh-list
5751130|NCT03032367|Antitubercular Agents|antitubercular agents|mesh-ancestor
5751131|NCT03032367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5626947|NCT04704271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5626948|NCT04704271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5626949|NCT04704271|Analgesics|analgesics|mesh-ancestor
5626950|NCT04704271|Sensory System Agents|sensory system agents|mesh-ancestor
5626951|NCT04704271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5626952|NCT04704271|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5626953|NCT04704271|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5626954|NCT04704271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5626955|NCT04704271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5626956|NCT04704271|Hormones|hormones|mesh-ancestor
5626957|NCT04704271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5626958|NCT04665843|Atezolizumab|atezolizumab|mesh-list
5626959|NCT04665843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5626960|NCT04641975|Mirabegron|mirabegron|mesh-list
5626961|NCT04641975|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
5626962|NCT04641975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5626963|NCT04641975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5626964|NCT04641975|Adrenergic Agents|adrenergic agents|mesh-ancestor
5626965|NCT04641975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5626966|NCT04641975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5626967|NCT04641975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626968|NCT04641975|Urological Agents|urological agents|mesh-ancestor
5626969|NCT04630730|Gemcitabine|gemcitabine|mesh-list
5751132|NCT03032367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5751133|NCT03032419|Vaccines|vaccines|mesh-list
5751134|NCT03032419|Immunologic Factors|immunologic factors|mesh-ancestor
5751135|NCT03032419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751136|NCT03032042|Azithromycin|azithromycin|mesh-list
5751137|NCT03032042|Albendazole|albendazole|mesh-list
5751138|NCT03032042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5751139|NCT03032042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5751140|NCT03032042|Anthelmintics|anthelmintics|mesh-ancestor
5751141|NCT03032042|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5751142|NCT03032042|Anticestodal Agents|anticestodal agents|mesh-ancestor
5751143|NCT03032042|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5751144|NCT03032042|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5751145|NCT03032042|Tubulin Modulators|tubulin modulators|mesh-ancestor
5751146|NCT03032042|Antimitotic Agents|antimitotic agents|mesh-ancestor
5626970|NCT04630730|Atezolizumab|atezolizumab|mesh-list
5626971|NCT04630730|BCG Vaccine|bcg vaccine|mesh-list
5626972|NCT04630730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5751147|NCT03032042|Mitosis Modulators|mitosis modulators|mesh-ancestor
5751148|NCT03032042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751149|NCT03032042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5751150|NCT03032315|Amlodipine|amlodipine|mesh-list
5751151|NCT03032315|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5751152|NCT03032315|Telmisartan|telmisartan|mesh-list
5751153|NCT03032315|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
5751154|NCT03032315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5751155|NCT03032315|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5751156|NCT03032315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5751157|NCT03032315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208846|NCT02137538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6208847|NCT02137538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208848|NCT02137538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6208849|NCT02137772|Letermovir|letermovir|mesh-list
6208850|NCT02137772|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6208851|NCT02137772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5751158|NCT03032315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5751159|NCT03032315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751160|NCT03032315|Vasodilator Agents|vasodilator agents|mesh-ancestor
5751161|NCT03032315|Diuretics|diuretics|mesh-ancestor
5751162|NCT03032315|Natriuretic Agents|natriuretic agents|mesh-ancestor
5751163|NCT03032315|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5751164|NCT03032315|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5751165|NCT03032315|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5751166|NCT03032107|Pembrolizumab|pembrolizumab|mesh-list
5751167|NCT03032107|Trastuzumab|trastuzumab|mesh-list
5751168|NCT03032107|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
5751169|NCT03032107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5751170|NCT03032107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5751171|NCT03032107|Tubulin Modulators|tubulin modulators|mesh-ancestor
5751172|NCT03032107|Antimitotic Agents|antimitotic agents|mesh-ancestor
5751173|NCT03032107|Mitosis Modulators|mitosis modulators|mesh-ancestor
5751174|NCT03032107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751175|NCT03031834|Quinapril|quinapril|mesh-list
5751176|NCT03031834|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5751177|NCT03031834|Protease Inhibitors|protease inhibitors|mesh-ancestor
5751178|NCT03031834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5751179|NCT03031834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751180|NCT03031834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5751181|NCT03031691|Trifluridine|trifluridine|mesh-list
5751182|NCT03031691|Antimetabolites|antimetabolites|mesh-ancestor
5751183|NCT03031691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751184|NCT03031691|Antiviral Agents|antiviral agents|mesh-ancestor
5751185|NCT03031691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5751186|NCT03031808|Lidocaine|lidocaine|mesh-list
5751187|NCT03031808|Rocuronium|rocuronium|mesh-list
5751188|NCT03031808|Anesthetics, Local|anesthetics, local|mesh-ancestor
5751189|NCT03031808|Anesthetics|anesthetics|mesh-ancestor
5751190|NCT03031808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5751191|NCT03031808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751192|NCT03031808|Sensory System Agents|sensory system agents|mesh-ancestor
5751193|NCT03031808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5751194|NCT03031808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5626973|NCT04630730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5626974|NCT04630730|Antimetabolites|antimetabolites|mesh-ancestor
5626975|NCT04630730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5626976|NCT04630730|Antiviral Agents|antiviral agents|mesh-ancestor
5626977|NCT04630730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5626978|NCT04630730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5626979|NCT04630730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5626980|NCT04630730|Immunologic Factors|immunologic factors|mesh-ancestor
5626981|NCT04630730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626982|NCT04630730|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5626983|NCT04623944|Cyclophosphamide|cyclophosphamide|mesh-list
5626984|NCT04623944|Fludarabine|fludarabine|mesh-list
5626985|NCT04623944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5626986|NCT04623944|Immunologic Factors|immunologic factors|mesh-ancestor
5626987|NCT04623944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5626988|NCT04623944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5626989|NCT04623944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5751195|NCT03031808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5751196|NCT03031808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5751197|NCT03031808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5894564|NCT04294498|Durvalumab|durvalumab|mesh-list
5751198|NCT03031808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751199|NCT03031808|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5751200|NCT03031808|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5751201|NCT03031808|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5751202|NCT03031756|Glycine|glycine|mesh-list
5751203|NCT03031756|Glycine Agents|glycine agents|mesh-ancestor
5751204|NCT03031756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5751205|NCT03031756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751206|NCT03031756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751207|NCT03031535|Octreotide|octreotide|mesh-list
5751208|NCT03031535|Hormones|hormones|mesh-list
5751209|NCT03031535|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
5751210|NCT03031535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5751211|NCT03031535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751212|NCT03031535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5751213|NCT03031535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5751214|NCT03031535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5751215|NCT03031210|Amoxicillin|amoxicillin|mesh-list
5751216|NCT03031210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5751217|NCT03031210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5751218|NCT03031405|Oxytocin|oxytocin|mesh-list
5751219|NCT03031405|Oxytocics|oxytocics|mesh-ancestor
5751220|NCT03031405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5751221|NCT03031405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751222|NCT03031444|Leucovorin|leucovorin|mesh-list
5751223|NCT03031444|Cetuximab|cetuximab|mesh-list
5751224|NCT03031444|Fluorouracil|fluorouracil|mesh-list
5751225|NCT03031444|Oxaliplatin|oxaliplatin|mesh-list
5751226|NCT03031444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5626990|NCT04623944|Alkylating Agents|alkylating agents|mesh-ancestor
5626991|NCT04623944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5626992|NCT04623944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5626993|NCT04623944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5626994|NCT04604782|Regadenoson|regadenoson|mesh-list
5626995|NCT04604782|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
5626996|NCT04604782|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5626997|NCT04604782|Purinergic Agonists|purinergic agonists|mesh-ancestor
5626998|NCT04604782|Purinergic Agents|purinergic agents|mesh-ancestor
5626999|NCT04604782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5627000|NCT04604782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627001|NCT04604782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5627002|NCT04596033|Cyclophosphamide|cyclophosphamide|mesh-list
5627003|NCT04596033|Fludarabine|fludarabine|mesh-list
5627004|NCT04596033|Interleukin-2|interleukin-2|mesh-list
5627005|NCT04596033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5627006|NCT04596033|Immunologic Factors|immunologic factors|mesh-ancestor
5627007|NCT04596033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5627008|NCT04596033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5627009|NCT04596033|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5627010|NCT04596033|Alkylating Agents|alkylating agents|mesh-ancestor
5627011|NCT04596033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627012|NCT04596033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5627013|NCT04596033|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5627014|NCT04596033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5627015|NCT04596033|Analgesics|analgesics|mesh-ancestor
5627016|NCT04596033|Sensory System Agents|sensory system agents|mesh-ancestor
5627017|NCT04596033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5627018|NCT04586023|Teriflunomide|teriflunomide|mesh-list
5751227|NCT03031444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5751228|NCT03031444|Antimetabolites|antimetabolites|mesh-ancestor
5751229|NCT03031444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751230|NCT03031444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5627019|NCT04586023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5627020|NCT04586023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5627021|NCT04586023|Analgesics|analgesics|mesh-ancestor
5627022|NCT04586023|Sensory System Agents|sensory system agents|mesh-ancestor
5751231|NCT03031444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5751232|NCT03031444|Immunologic Factors|immunologic factors|mesh-ancestor
5751233|NCT03031444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751234|NCT03031444|Antidotes|antidotes|mesh-ancestor
5751235|NCT03031444|Protective Agents|protective agents|mesh-ancestor
5751236|NCT03031444|Vitamin B Complex|vitamin b complex|mesh-ancestor
5627023|NCT04586023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5751237|NCT03031444|Vitamins|vitamins|mesh-ancestor
5751238|NCT03031444|Micronutrients|micronutrients|mesh-ancestor
5627024|NCT04586023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751239|NCT03031249|Cytarabine|cytarabine|mesh-list
5751240|NCT03031249|Tretinoin|tretinoin|mesh-list
5751241|NCT03031249|Arsenic Trioxide|arsenic trioxide|mesh-list
5751242|NCT03031249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5751243|NCT03031249|Antimetabolites|antimetabolites|mesh-ancestor
5751244|NCT03031249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751245|NCT03031249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5751246|NCT03031249|Antiviral Agents|antiviral agents|mesh-ancestor
5751247|NCT03031249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5751248|NCT03031249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5751249|NCT03031249|Immunologic Factors|immunologic factors|mesh-ancestor
5751250|NCT03031249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751251|NCT03031249|Keratolytic Agents|keratolytic agents|mesh-ancestor
5627025|NCT04586023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5627026|NCT04586023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5627027|NCT04586023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5627028|NCT04586023|Immunologic Factors|immunologic factors|mesh-ancestor
5627029|NCT04586010|Teriflunomide|teriflunomide|mesh-list
5627030|NCT04586010|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5627031|NCT04586010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5627032|NCT04586010|Analgesics|analgesics|mesh-ancestor
5627033|NCT04586010|Sensory System Agents|sensory system agents|mesh-ancestor
5627034|NCT04586010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5627035|NCT04586010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5627036|NCT04586010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5627037|NCT04586010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5627038|NCT04586010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5627039|NCT04586010|Immunologic Factors|immunologic factors|mesh-ancestor
5627040|NCT04578652|Metformin|metformin|mesh-list
5627041|NCT04578652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5627042|NCT04578652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5627043|NCT04544449|Ocrelizumab|ocrelizumab|mesh-list
5751252|NCT03031249|Dermatologic Agents|dermatologic agents|mesh-ancestor
5751253|NCT03031184|Mirtazapine|mirtazapine|mesh-list
5751254|NCT03031184|Antidepressive Agents|antidepressive agents|mesh-ancestor
5751255|NCT03031184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5751256|NCT03031184|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5751257|NCT03031184|Histamine Antagonists|histamine antagonists|mesh-ancestor
5751258|NCT03031184|Histamine Agents|histamine agents|mesh-ancestor
5751259|NCT03031184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5751260|NCT03031184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751261|NCT03031184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751262|NCT03031184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5751263|NCT03031184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5751264|NCT03031184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5751265|NCT03031184|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5751266|NCT03031184|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5751267|NCT03031184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5751268|NCT03031184|Adrenergic Agents|adrenergic agents|mesh-ancestor
5751269|NCT03031184|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5751270|NCT03031184|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5751271|NCT03031184|Serotonin Agents|serotonin agents|mesh-ancestor
5751272|NCT03031184|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5751273|NCT03031327|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5751274|NCT03031327|Hyaluronic Acid|hyaluronic acid|mesh-list
5751275|NCT03031327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5751276|NCT03031327|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5751277|NCT03031327|Immunologic Factors|immunologic factors|mesh-ancestor
5751278|NCT03031327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751279|NCT03031327|Viscosupplements|viscosupplements|mesh-ancestor
5751280|NCT03031327|Protective Agents|protective agents|mesh-ancestor
5751281|NCT03031353|Misoprostol|misoprostol|mesh-list
5751282|NCT03031353|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5751283|NCT03031353|Abortifacient Agents|abortifacient agents|mesh-ancestor
5751284|NCT03031353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5751285|NCT03031353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751286|NCT03031353|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5751287|NCT03031353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5751288|NCT03031353|Oxytocics|oxytocics|mesh-ancestor
5751289|NCT03031483|Clarithromycin|clarithromycin|mesh-list
5751290|NCT03031483|Lenalidomide|lenalidomide|mesh-list
5751291|NCT03031483|Immunologic Factors|immunologic factors|mesh-ancestor
5627044|NCT04544449|Immunologic Factors|immunologic factors|mesh-ancestor
5751292|NCT03031483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751293|NCT03031483|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5627045|NCT04544449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5627046|NCT04537806|Pregnanolone|pregnanolone|mesh-list
5627047|NCT04537806|Brexanolone|brexanolone|mesh-list
5627048|NCT04537806|Anesthetics|anesthetics|mesh-ancestor
5627049|NCT04537806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5627050|NCT04537806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5627051|NCT04537806|Neurosteroids|neurosteroids|mesh-ancestor
5627052|NCT04537806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5627053|NCT04537806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627054|NCT04537806|GABA Modulators|gaba modulators|mesh-ancestor
5627055|NCT04537806|GABA Agents|gaba agents|mesh-ancestor
5627056|NCT04501978|Remdesivir|remdesivir|mesh-list
5627057|NCT04501978|Antimetabolites|antimetabolites|mesh-ancestor
5627058|NCT04501978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627059|NCT04501978|Antiviral Agents|antiviral agents|mesh-ancestor
5627060|NCT04501978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5693050|NCT03403595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697770|NCT03373851|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5697771|NCT03373851|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5697772|NCT03373851|Anesthetics, General|anesthetics, general|mesh-ancestor
5697773|NCT03373851|Anesthetics|anesthetics|mesh-ancestor
5697774|NCT03373825|Fentanyl|fentanyl|mesh-list
5697775|NCT03373825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5697776|NCT03373825|Narcotics|narcotics|mesh-ancestor
5697777|NCT03373825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5697778|NCT03373825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697779|NCT03373825|Analgesics|analgesics|mesh-ancestor
5697780|NCT03373825|Sensory System Agents|sensory system agents|mesh-ancestor
5697781|NCT03373825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5697782|NCT03373825|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5697783|NCT03373825|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5697784|NCT03373825|Anesthetics, General|anesthetics, general|mesh-ancestor
5751294|NCT03031483|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5751295|NCT03031483|Growth Substances|growth substances|mesh-ancestor
5751296|NCT03031483|Growth Inhibitors|growth inhibitors|mesh-ancestor
5751297|NCT03031483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5751298|NCT03031483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5751299|NCT03031483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5751300|NCT03031483|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5751301|NCT03031483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5751302|NCT03031483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751303|NCT03031483|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5751304|NCT03031483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5751305|NCT03031054|Hyaluronic Acid|hyaluronic acid|mesh-list
5751306|NCT03031054|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5751307|NCT03031054|Immunologic Factors|immunologic factors|mesh-ancestor
5751308|NCT03031054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751309|NCT03031054|Viscosupplements|viscosupplements|mesh-ancestor
5751310|NCT03031054|Protective Agents|protective agents|mesh-ancestor
5751311|NCT03030911|Fentanyl|fentanyl|mesh-list
5751312|NCT03030911|Midazolam|midazolam|mesh-list
5751313|NCT03030911|Dexmedetomidine|dexmedetomidine|mesh-list
5751314|NCT03030911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5751315|NCT03030911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5751316|NCT03030911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751317|NCT03030911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5751318|NCT03030911|Analgesics|analgesics|mesh-ancestor
5751319|NCT03030911|Sensory System Agents|sensory system agents|mesh-ancestor
5751320|NCT03030911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6673031|NCT01560052|Autonomic Agents|autonomic agents|mesh-ancestor
6673032|NCT01560052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6673033|NCT01560052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673034|NCT01560052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5697785|NCT03373825|Anesthetics|anesthetics|mesh-ancestor
5697786|NCT03373708|Tamoxifen|tamoxifen|mesh-list
5697787|NCT03373708|Cyclophosphamide|cyclophosphamide|mesh-list
5627061|NCT04501614|Ponatinib|ponatinib|mesh-list
5627062|NCT04501614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5627063|NCT04501614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5627064|NCT04501614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5627065|NCT04501614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627066|NCT04491942|Gemcitabine|gemcitabine|mesh-list
5627067|NCT04491942|Cisplatin|cisplatin|mesh-list
5627068|NCT04491942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5627069|NCT04491942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5627070|NCT04491942|Antimetabolites|antimetabolites|mesh-ancestor
5627071|NCT04491942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627072|NCT04491942|Antiviral Agents|antiviral agents|mesh-ancestor
5627073|NCT04491942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5627074|NCT04491942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5627075|NCT04491942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5627076|NCT04491942|Immunologic Factors|immunologic factors|mesh-ancestor
5627077|NCT04491942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5627078|NCT04476030|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5627079|NCT04476030|Citalopram|citalopram|mesh-list
5627080|NCT04476030|Sertraline|sertraline|mesh-list
5627081|NCT04476030|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
5627082|NCT04476030|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5751321|NCT03030911|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5751322|NCT03030911|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5751323|NCT03030911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5751324|NCT03030911|Adrenergic Agents|adrenergic agents|mesh-ancestor
5751325|NCT03030911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5751326|NCT03030911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751327|NCT03030911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5751328|NCT03030911|Narcotics|narcotics|mesh-ancestor
5751329|NCT03030911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5751330|NCT03030911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5751331|NCT03030911|Anesthetics, General|anesthetics, general|mesh-ancestor
5751332|NCT03030911|Anesthetics|anesthetics|mesh-ancestor
5751333|NCT03030911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5751334|NCT03030911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5751335|NCT03030911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5751336|NCT03030911|GABA Modulators|gaba modulators|mesh-ancestor
5751337|NCT03030911|GABA Agents|gaba agents|mesh-ancestor
5894565|NCT04294498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5894566|NCT04294498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5894567|NCT04294498|Antiviral Agents|antiviral agents|mesh-ancestor
5894568|NCT04294498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5894569|NCT04276493|Docetaxel|docetaxel|mesh-list
5894570|NCT04276493|Capecitabine|capecitabine|mesh-list
5894571|NCT04276493|Oxaliplatin|oxaliplatin|mesh-list
5894572|NCT04276493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5894573|NCT04276493|Tubulin Modulators|tubulin modulators|mesh-ancestor
5894574|NCT04276493|Antimitotic Agents|antimitotic agents|mesh-ancestor
5894575|NCT04276493|Mitosis Modulators|mitosis modulators|mesh-ancestor
5894576|NCT04276493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894577|NCT04276493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5894578|NCT04276493|Antimetabolites|antimetabolites|mesh-ancestor
5894579|NCT04235634|Alprostadil|alprostadil|mesh-list
5894580|NCT04235634|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5894581|NCT04235634|Vasodilator Agents|vasodilator agents|mesh-ancestor
5894582|NCT04235634|Urological Agents|urological agents|mesh-ancestor
5894583|NCT04206488|Digoxin|digoxin|mesh-list
5894584|NCT04206488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5894585|NCT04206488|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5894586|NCT04206488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5894587|NCT04206488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894588|NCT04206488|Protective Agents|protective agents|mesh-ancestor
5894589|NCT04206488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894590|NCT04188418|Fentanyl|fentanyl|mesh-list
5894591|NCT04188418|Morphine|morphine|mesh-list
5894592|NCT04188418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5894593|NCT04188418|Narcotics|narcotics|mesh-ancestor
5894594|NCT04188418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5894595|NCT04188418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894596|NCT04188418|Analgesics|analgesics|mesh-ancestor
5894597|NCT04188418|Sensory System Agents|sensory system agents|mesh-ancestor
5894598|NCT04188418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5894599|NCT04188418|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5894600|NCT04188418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5894601|NCT04188418|Anesthetics, General|anesthetics, general|mesh-ancestor
5894602|NCT04188418|Anesthetics|anesthetics|mesh-ancestor
5693051|NCT03403569|Triptolide|triptolide|mesh-list
5627083|NCT04476030|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5627084|NCT04476030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5627085|NCT04476030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627086|NCT04476030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5627087|NCT04476030|Serotonin Agents|serotonin agents|mesh-ancestor
5627088|NCT04476030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5627089|NCT04476030|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5627090|NCT04476030|Antidepressive Agents|antidepressive agents|mesh-ancestor
5751338|NCT03030950|Dexmedetomidine|dexmedetomidine|mesh-list
5751339|NCT03030950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5751340|NCT03030950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5751341|NCT03030950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751342|NCT03030950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5751343|NCT03030950|Analgesics|analgesics|mesh-ancestor
5751344|NCT03030950|Sensory System Agents|sensory system agents|mesh-ancestor
5751345|NCT03030950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5751346|NCT03030950|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5627091|NCT04476030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5627092|NCT04476030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5627093|NCT04476030|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5627094|NCT04476030|Analgesics|analgesics|mesh-ancestor
5627095|NCT04476030|Sensory System Agents|sensory system agents|mesh-ancestor
5627096|NCT04476030|Dopamine Agents|dopamine agents|mesh-ancestor
5627097|NCT04467723|Pirfenidone|pirfenidone|mesh-list
5627098|NCT04467723|Atezolizumab|atezolizumab|mesh-list
5751347|NCT03030950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5751348|NCT03030950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5751349|NCT03030950|Adrenergic Agents|adrenergic agents|mesh-ancestor
5751350|NCT03030950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5751351|NCT03030950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751352|NCT03030768|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5751353|NCT03030768|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5751354|NCT03030768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5751355|NCT03030768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5751356|NCT03030768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751357|NCT03030768|Antiviral Agents|antiviral agents|mesh-ancestor
5751358|NCT03030768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5751359|NCT03030768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5751360|NCT03030768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5751361|NCT03030937|Irinotecan|irinotecan|mesh-list
5751362|NCT03030937|Apatinib|apatinib|mesh-list
5751363|NCT03030937|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5751364|NCT03030937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5751365|NCT03030937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5751366|NCT03030937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751367|NCT03030937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5751368|NCT03030937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5751369|NCT03030976|Cyclophosphamide|cyclophosphamide|mesh-list
5751370|NCT03030976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5751371|NCT03030976|Immunologic Factors|immunologic factors|mesh-ancestor
5751372|NCT03030976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751373|NCT03030976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5751374|NCT03030976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5751375|NCT03030976|Alkylating Agents|alkylating agents|mesh-ancestor
5751376|NCT03030976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751377|NCT03030976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5751378|NCT03030976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5751379|NCT03030690|Methamphetamine|methamphetamine|mesh-list
5751380|NCT03030690|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5751381|NCT03030690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751382|NCT03030690|Sympathomimetics|sympathomimetics|mesh-ancestor
5751383|NCT03030690|Autonomic Agents|autonomic agents|mesh-ancestor
5751384|NCT03030690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5751385|NCT03030690|Dopamine Agents|dopamine agents|mesh-ancestor
5751386|NCT03030690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5751387|NCT03030690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751388|NCT03030690|Adrenergic Agents|adrenergic agents|mesh-ancestor
5751389|NCT03030690|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5751390|NCT03030690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5751391|NCT03030690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5751392|NCT03030690|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5751393|NCT03030716|Proanthocyanidin|proanthocyanidin|mesh-list
5751394|NCT03030716|Grape Seed Extract|grape seed extract|mesh-list
5751395|NCT03030716|Procyanidin|procyanidin|mesh-list
5751396|NCT03030716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5751397|NCT03030716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5751398|NCT03030716|Antioxidants|antioxidants|mesh-ancestor
5751399|NCT03030716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751400|NCT03030716|Protective Agents|protective agents|mesh-ancestor
5751401|NCT03030716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751402|NCT03030716|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5751403|NCT03030716|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5751404|NCT03030716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5751405|NCT03031119|Atorvastatin|atorvastatin|mesh-list
5751406|NCT03031119|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5751407|NCT03031119|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5751408|NCT03031119|Antimetabolites|antimetabolites|mesh-ancestor
5751409|NCT03031119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751410|NCT03031119|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5751411|NCT03031119|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5751412|NCT03031119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5751413|NCT03030430|Bevacizumab|bevacizumab|mesh-list
5751414|NCT03030430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5751415|NCT03030430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5751416|NCT03030430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5751417|NCT03030430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5751418|NCT03030430|Growth Substances|growth substances|mesh-ancestor
5751419|NCT03030430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751420|NCT03030430|Growth Inhibitors|growth inhibitors|mesh-ancestor
5751421|NCT03030703|Inositol|inositol|mesh-list
5751422|NCT03030703|Vitamin B Complex|vitamin b complex|mesh-ancestor
5751423|NCT03030703|Vitamins|vitamins|mesh-ancestor
5751424|NCT03030703|Micronutrients|micronutrients|mesh-ancestor
5751425|NCT03030703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751426|NCT03030469|Analgesics, Opioid|analgesics, opioid|mesh-list
5751427|NCT03030469|Analgesics|analgesics|mesh-list
5751428|NCT03030469|Narcotics|narcotics|mesh-ancestor
5751429|NCT03030469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5751430|NCT03030469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751431|NCT03030469|Sensory System Agents|sensory system agents|mesh-ancestor
5751432|NCT03030469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5751433|NCT03030560|Lidocaine|lidocaine|mesh-list
5627099|NCT04467723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5627100|NCT04467723|Analgesics|analgesics|mesh-ancestor
5627101|NCT04467723|Sensory System Agents|sensory system agents|mesh-ancestor
5627102|NCT04467723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5627103|NCT04467723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5627104|NCT04467723|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5627105|NCT04467723|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5627106|NCT04467723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5627107|NCT04467723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5627108|NCT04416451|Rituximab|rituximab|mesh-list
5627109|NCT04416451|Venetoclax|venetoclax|mesh-list
5627110|NCT04416451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5627111|NCT04416451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5751434|NCT03030560|Anesthetics, Local|anesthetics, local|mesh-ancestor
5751435|NCT03030560|Anesthetics|anesthetics|mesh-ancestor
5751436|NCT03030560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5751437|NCT03030560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751438|NCT03030560|Sensory System Agents|sensory system agents|mesh-ancestor
5751439|NCT03030560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5751440|NCT03030560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5751441|NCT03030560|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5751442|NCT03030560|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5751443|NCT03030560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5627112|NCT04416451|Immunologic Factors|immunologic factors|mesh-ancestor
5627113|NCT04416451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5627114|NCT04416451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5627115|NCT04400838|Vaccines|vaccines|mesh-list
5627116|NCT04400838|Immunologic Factors|immunologic factors|mesh-ancestor
5627117|NCT04400838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5627118|NCT04396574|Lasmiditan|lasmiditan|mesh-list
5627119|NCT04396574|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5627120|NCT04396574|Serotonin Agents|serotonin agents|mesh-ancestor
5751444|NCT03030560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627121|NCT04396574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5697788|NCT03373708|Docetaxel|docetaxel|mesh-list
5627122|NCT04396574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627123|NCT04396574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5627124|NCT04396236|Lasmiditan|lasmiditan|mesh-list
5627125|NCT04396236|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5627126|NCT04396236|Serotonin Agents|serotonin agents|mesh-ancestor
5627127|NCT04396236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5627128|NCT04396236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627129|NCT04396236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5627130|NCT04391049|Paclitaxel|paclitaxel|mesh-list
5627131|NCT04391049|Carboplatin|carboplatin|mesh-list
5627132|NCT04391049|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5627133|NCT04391049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5751445|NCT03030677|Lidocaine|lidocaine|mesh-list
5751446|NCT03030677|Anesthetics, Local|anesthetics, local|mesh-ancestor
5751447|NCT03030677|Anesthetics|anesthetics|mesh-ancestor
5751448|NCT03030677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5751449|NCT03030677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751450|NCT03030677|Sensory System Agents|sensory system agents|mesh-ancestor
5751451|NCT03030677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5751452|NCT03030677|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5751453|NCT03030677|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5751454|NCT03030677|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5751455|NCT03030677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5751456|NCT03030677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751457|NCT03031262|Cytarabine|cytarabine|mesh-list
5751458|NCT03031262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5751459|NCT03031262|Antimetabolites|antimetabolites|mesh-ancestor
5751460|NCT03031262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751461|NCT03031262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5751462|NCT03031262|Antiviral Agents|antiviral agents|mesh-ancestor
5751463|NCT03031262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6489600|NCT00592670|Antidepressive Agents|antidepressive agents|mesh-ancestor
6489601|NCT00592670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6489602|NCT00592670|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6489603|NCT00592670|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6489604|NCT00592670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6489605|NCT00592917|Cholecalciferol|cholecalciferol|mesh-list
6489606|NCT00592917|Calcium Carbonate|calcium carbonate|mesh-list
6489607|NCT00592917|Calcium|calcium|mesh-list
5751464|NCT03031262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5751465|NCT03031262|Immunologic Factors|immunologic factors|mesh-ancestor
5751466|NCT03031262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751467|NCT03030131|Durvalumab|durvalumab|mesh-list
5751468|NCT03030131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5751469|NCT03030131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5751470|NCT03030287|Paclitaxel|paclitaxel|mesh-list
5751471|NCT03030287|Antibodies, Bispecific|antibodies, bispecific|mesh-list
5751472|NCT03030287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5751473|NCT03030287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5751474|NCT03030287|Tubulin Modulators|tubulin modulators|mesh-ancestor
5751475|NCT03030287|Antimitotic Agents|antimitotic agents|mesh-ancestor
5751476|NCT03030287|Mitosis Modulators|mitosis modulators|mesh-ancestor
5751477|NCT03030287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751478|NCT03030287|Immunologic Factors|immunologic factors|mesh-ancestor
5751479|NCT03030287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751480|NCT03030300|Metformin|metformin|mesh-list
5751481|NCT03030300|Pioglitazone|pioglitazone|mesh-list
5751482|NCT03030300|Insulin|insulin|mesh-list
5751483|NCT03030300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5751484|NCT03030300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751485|NCT03030001|Antibodies|antibodies|mesh-list
5751486|NCT03030001|Immunologic Factors|immunologic factors|mesh-ancestor
5751487|NCT03030001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751488|NCT03030196|Denosumab|denosumab|mesh-list
5751489|NCT03030196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5751490|NCT03030196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751491|NCT03030105|Scopolamine|scopolamine|mesh-list
5627134|NCT04391049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5627135|NCT04391049|Tubulin Modulators|tubulin modulators|mesh-ancestor
5627136|NCT04391049|Antimitotic Agents|antimitotic agents|mesh-ancestor
5627137|NCT04391049|Mitosis Modulators|mitosis modulators|mesh-ancestor
5627138|NCT04391049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751492|NCT03030105|Donepezil|donepezil|mesh-list
5751493|NCT03030105|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
5894603|NCT04177355|Aluminum Hydroxide|aluminum hydroxide|mesh-list
5751494|NCT03030105|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5751495|NCT03030105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5751496|NCT03030105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751497|NCT03030105|Cholinergic Agents|cholinergic agents|mesh-ancestor
5751498|NCT03030105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5751499|NCT03030105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751500|NCT03030105|Nootropic Agents|nootropic agents|mesh-ancestor
5751501|NCT03030105|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5751502|NCT03030105|Antiemetics|antiemetics|mesh-ancestor
5751503|NCT03030105|Autonomic Agents|autonomic agents|mesh-ancestor
5751504|NCT03030105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5751505|NCT03030105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5751506|NCT03030105|Mydriatics|mydriatics|mesh-ancestor
5751507|NCT03030105|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5751508|NCT03030105|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5751509|NCT03030105|Parasympatholytics|parasympatholytics|mesh-ancestor
5751510|NCT03030248|Vancomycin|vancomycin|mesh-list
5751511|NCT03030248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5751512|NCT03030248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5751513|NCT03030157|Pirarubicin|pirarubicin|mesh-list
5751514|NCT03030157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5751515|NCT03029533|Leuprolide|leuprolide|mesh-list
5751516|NCT03029533|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5751517|NCT03029533|Fertility Agents|fertility agents|mesh-ancestor
5751518|NCT03029533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5751519|NCT03029533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751520|NCT03029533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5751521|NCT03029533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5751522|NCT03029676|Fentanyl|fentanyl|mesh-list
5751523|NCT03029676|Midazolam|midazolam|mesh-list
5751524|NCT03029676|Anesthetics|anesthetics|mesh-ancestor
5751525|NCT03029676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5751526|NCT03029676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751527|NCT03029676|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5751528|NCT03029676|Narcotics|narcotics|mesh-ancestor
5751529|NCT03029676|Analgesics|analgesics|mesh-ancestor
5751530|NCT03029676|Sensory System Agents|sensory system agents|mesh-ancestor
5627139|NCT04378933|Methamphetamine|methamphetamine|mesh-list
5751531|NCT03029676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5751532|NCT03029676|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5751533|NCT03029676|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5751534|NCT03029676|Anesthetics, General|anesthetics, general|mesh-ancestor
5751535|NCT03029676|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5751536|NCT03029676|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5751537|NCT03029676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5751538|NCT03029676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5751539|NCT03029676|GABA Modulators|gaba modulators|mesh-ancestor
5751540|NCT03029676|GABA Agents|gaba agents|mesh-ancestor
5751541|NCT03029676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5751542|NCT03029676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751543|NCT03029689|Raltegravir Potassium|raltegravir potassium|mesh-list
5751544|NCT03029689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5751545|NCT03029689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5627140|NCT04378933|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5627141|NCT04378933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5627142|NCT04378933|Sympathomimetics|sympathomimetics|mesh-ancestor
5627143|NCT04378933|Autonomic Agents|autonomic agents|mesh-ancestor
5627144|NCT04378933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5627145|NCT04378933|Dopamine Agents|dopamine agents|mesh-ancestor
5627146|NCT04378933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5627147|NCT04378933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627148|NCT04378933|Adrenergic Agents|adrenergic agents|mesh-ancestor
5627149|NCT04378933|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5627150|NCT04378933|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5627151|NCT04378933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5751546|NCT03029689|Antiviral Agents|antiviral agents|mesh-ancestor
5751547|NCT03029689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5627152|NCT04378933|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5627153|NCT04368559|Fluconazole|fluconazole|mesh-list
5627154|NCT04368559|Posaconazole|posaconazole|mesh-list
5627155|NCT04368559|Rezafungin|rezafungin|mesh-list
5627156|NCT04368559|Trimethoprim|trimethoprim|mesh-list
5627157|NCT04368559|Sulfamethoxazole|sulfamethoxazole|mesh-list
5751548|NCT03029689|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5627158|NCT04368559|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
5751549|NCT03029689|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5751550|NCT03029689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5751551|NCT03029689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751552|NCT03029455|Ivacaftor|ivacaftor|mesh-list
5751553|NCT03029455|VX-659|vx-659|mesh-list
5751554|NCT03029455|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
5751555|NCT03029455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5751556|NCT03029455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751557|NCT03029494|Ascorbic Acid|ascorbic acid|mesh-list
5751558|NCT03029494|Vitamins|vitamins|mesh-ancestor
5751559|NCT03029494|Micronutrients|micronutrients|mesh-ancestor
5751560|NCT03029494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751561|NCT03029494|Antioxidants|antioxidants|mesh-ancestor
5751562|NCT03029494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627159|NCT04368559|Antifungal Agents|antifungal agents|mesh-ancestor
5627160|NCT04368559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5627161|NCT04368559|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5627162|NCT04368559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5627163|NCT04368559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5627164|NCT04368559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627165|NCT04368559|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5751563|NCT03029494|Protective Agents|protective agents|mesh-ancestor
5751564|NCT03029702|Metformin|metformin|mesh-list
5751565|NCT03029702|Glyburide|glyburide|mesh-list
5627166|NCT04368559|Hormone Antagonists|hormone antagonists|mesh-ancestor
5627167|NCT04368559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5627168|NCT04368559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5627169|NCT04368559|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5627170|NCT04368559|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5627171|NCT04368559|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5627172|NCT04368559|Renal Agents|renal agents|mesh-ancestor
5627173|NCT04368559|Antimalarials|antimalarials|mesh-ancestor
5627174|NCT04368559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5627175|NCT04368559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5627176|NCT04368559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5627177|NCT04368559|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5627178|NCT04368559|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
5627179|NCT04368559|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5751566|NCT03029702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5751567|NCT03029702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751568|NCT03029845|Propranolol|propranolol|mesh-list
5751569|NCT03029845|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5751570|NCT03029845|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5751571|NCT03029845|Adrenergic Agents|adrenergic agents|mesh-ancestor
5751572|NCT03029845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5751573|NCT03029845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751574|NCT03029845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751575|NCT03029845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5751576|NCT03029845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5751577|NCT03029845|Vasodilator Agents|vasodilator agents|mesh-ancestor
5751578|NCT03029442|Denosumab|denosumab|mesh-list
5751579|NCT03029442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5751580|NCT03029442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751581|NCT03029390|Metformin|metformin|mesh-list
5751582|NCT03029390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5751583|NCT03029390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894604|NCT04177355|1018 oligonucleotide|1018 oligonucleotide|mesh-list
5894605|NCT04177355|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5894606|NCT04177355|Immunologic Factors|immunologic factors|mesh-ancestor
5894607|NCT04177355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894608|NCT04177355|Antacids|antacids|mesh-ancestor
5894609|NCT04177355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894610|NCT04177355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5894611|NCT04161066|Psilocybin|psilocybin|mesh-list
5894612|NCT04161066|Hallucinogens|hallucinogens|mesh-ancestor
5894613|NCT04161066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894614|NCT04161066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5894615|NCT04007705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
5894616|NCT03946969|Paclitaxel|paclitaxel|mesh-list
5894617|NCT03946969|Cisplatin|cisplatin|mesh-list
5894618|NCT03946969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5894619|NCT03946969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5894620|NCT03946969|Tubulin Modulators|tubulin modulators|mesh-ancestor
5894621|NCT03946969|Antimitotic Agents|antimitotic agents|mesh-ancestor
5894622|NCT03946969|Mitosis Modulators|mitosis modulators|mesh-ancestor
5627180|NCT04368559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6673035|NCT01560052|Glucocorticoids|glucocorticoids|mesh-ancestor
5751584|NCT03029429|Theophylline|theophylline|mesh-list
5751585|NCT03029429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5751586|NCT03029429|Autonomic Agents|autonomic agents|mesh-ancestor
5751587|NCT03029429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5751588|NCT03029429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751589|NCT03029429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5751590|NCT03029429|Respiratory System Agents|respiratory system agents|mesh-ancestor
5751591|NCT03029429|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5751592|NCT03029429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5751593|NCT03029429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751594|NCT03029429|Vasodilator Agents|vasodilator agents|mesh-ancestor
5751595|NCT03029429|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5751596|NCT03029429|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5751597|NCT03029429|Purinergic Agents|purinergic agents|mesh-ancestor
5751598|NCT03029429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5751599|NCT03029351|Exenatide|exenatide|mesh-list
5751600|NCT03029351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5751601|NCT03029351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751602|NCT03029351|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5751603|NCT03029351|Incretins|incretins|mesh-ancestor
5751604|NCT03029351|Hormones|hormones|mesh-ancestor
5751605|NCT03029351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5627181|NCT04364048|Cisplatin|cisplatin|mesh-list
5627182|NCT04364048|Carboplatin|carboplatin|mesh-list
5627183|NCT04364048|Etoposide|etoposide|mesh-list
5627184|NCT04364048|Pemetrexed|pemetrexed|mesh-list
5627185|NCT04364048|Durvalumab|durvalumab|mesh-list
5627186|NCT04364048|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5627187|NCT04364048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5627188|NCT04364048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5627189|NCT04364048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5627190|NCT04364048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5627191|NCT04364048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5627192|NCT04364048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627193|NCT04364048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5627194|NCT04364048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5627195|NCT04364048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5627196|NCT04364048|Immunologic Factors|immunologic factors|mesh-ancestor
5627197|NCT04364048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5627198|NCT04344444|Azithromycin|azithromycin|mesh-list
5751606|NCT03029273|Cyclophosphamide|cyclophosphamide|mesh-list
5751607|NCT03029273|Fludarabine|fludarabine|mesh-list
5751608|NCT03029273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5751609|NCT03029273|Immunologic Factors|immunologic factors|mesh-ancestor
5751610|NCT03029273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751611|NCT03029273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5751612|NCT03029273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6489608|NCT00592917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6489609|NCT00592917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489610|NCT00592917|Vitamins|vitamins|mesh-ancestor
6489611|NCT00592917|Micronutrients|micronutrients|mesh-ancestor
6489612|NCT00592917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6489613|NCT00592917|Antacids|antacids|mesh-ancestor
6489614|NCT00592917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627199|NCT04344444|Hydroxychloroquine|hydroxychloroquine|mesh-list
5627200|NCT04344444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5751613|NCT03029273|Alkylating Agents|alkylating agents|mesh-ancestor
5751614|NCT03029273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751615|NCT03029273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5751616|NCT03029273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5751617|NCT03029013|Apatinib|apatinib|mesh-list
5751618|NCT03029013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5751619|NCT03029013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5751620|NCT03029013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5751621|NCT03029013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751622|NCT03028883|Buprenorphine|buprenorphine|mesh-list
5751623|NCT03028883|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5751624|NCT03028883|Narcotics|narcotics|mesh-ancestor
5751625|NCT03028883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5751626|NCT03028883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751627|NCT03028883|Analgesics|analgesics|mesh-ancestor
5751628|NCT03028883|Sensory System Agents|sensory system agents|mesh-ancestor
5751629|NCT03028883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5751630|NCT03028883|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5751631|NCT03029169|Amiodarone|amiodarone|mesh-list
5751632|NCT03029169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
5751633|NCT03029169|Propafenone|propafenone|mesh-list
5751634|NCT03029169|Vasodilator Agents|vasodilator agents|mesh-ancestor
5627201|NCT04344444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5627202|NCT04344444|Antimalarials|antimalarials|mesh-ancestor
5627203|NCT04344444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5627204|NCT04344444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5627205|NCT04344444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5627206|NCT04344444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627207|NCT04344444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5627208|NCT04342715|Paromomycin|paromomycin|mesh-list
5627209|NCT04342715|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
5627210|NCT04342715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5627211|NCT04342715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5627212|NCT04342715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5627213|NCT04342715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5627214|NCT04342715|Schistosomicides|schistosomicides|mesh-ancestor
5627215|NCT04342715|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5627216|NCT04342715|Anthelmintics|anthelmintics|mesh-ancestor
5627217|NCT04324606|Acetaminophen|acetaminophen|mesh-list
5627218|NCT04324606|Vaccines|vaccines|mesh-list
5627219|NCT04324606|Immunologic Factors|immunologic factors|mesh-ancestor
5627220|NCT04324606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5627221|NCT04324606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5627222|NCT04324606|Analgesics|analgesics|mesh-ancestor
5627223|NCT04324606|Sensory System Agents|sensory system agents|mesh-ancestor
5627224|NCT04324606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5627225|NCT04324606|Antipyretics|antipyretics|mesh-ancestor
5627226|NCT04324463|Aspirin|aspirin|mesh-list
5627227|NCT04324463|Interferons|interferons|mesh-list
5627228|NCT04324463|Interferon-beta|interferon-beta|mesh-list
5627229|NCT04324463|Colchicine|colchicine|mesh-list
5627230|NCT04324463|Rivaroxaban|rivaroxaban|mesh-list
5627231|NCT04324463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5627232|NCT04324463|Antiviral Agents|antiviral agents|mesh-ancestor
5627233|NCT04324463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5627234|NCT04324463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5751635|NCT03029169|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5751636|NCT03029169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5751637|NCT03029169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751638|NCT03029169|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5751639|NCT03029169|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5751640|NCT03029169|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5751641|NCT03029169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5751642|NCT03029169|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5751643|NCT03029169|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5751644|NCT03029169|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5751645|NCT03029169|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5751646|NCT03028701|Budesonide|budesonide|mesh-list
5751647|NCT03028701|Formoterol Fumarate|formoterol fumarate|mesh-list
5751648|NCT03028701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5751649|NCT03028701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5751650|NCT03028701|Autonomic Agents|autonomic agents|mesh-ancestor
5627235|NCT04324463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5627236|NCT04324463|Analgesics|analgesics|mesh-ancestor
5627237|NCT04324463|Sensory System Agents|sensory system agents|mesh-ancestor
5627238|NCT04324463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5751651|NCT03028701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5751652|NCT03028701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751653|NCT03028701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5751654|NCT03028701|Respiratory System Agents|respiratory system agents|mesh-ancestor
5751655|NCT03028701|Glucocorticoids|glucocorticoids|mesh-ancestor
5751656|NCT03028701|Hormones|hormones|mesh-ancestor
5751657|NCT03028701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5751658|NCT03028701|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5751659|NCT03028701|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5751660|NCT03028701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5751661|NCT03028701|Adrenergic Agents|adrenergic agents|mesh-ancestor
5751662|NCT03028701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5751663|NCT03028701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751664|NCT03028740|Cenicriviroc|cenicriviroc|mesh-list
5751665|NCT03028740|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
5751666|NCT03028740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751667|NCT03028740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5627239|NCT04324463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5627240|NCT04324463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5627241|NCT04324463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5627242|NCT04324463|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5627243|NCT04324463|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5627244|NCT04324463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627245|NCT04324463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5627246|NCT04324463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5627247|NCT04324463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5627248|NCT04324463|Antipyretics|antipyretics|mesh-ancestor
5627249|NCT04324463|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5627250|NCT04324463|Antithrombins|antithrombins|mesh-ancestor
5627251|NCT04324463|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5751668|NCT03028740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5751669|NCT03028740|Antiviral Agents|antiviral agents|mesh-ancestor
5751670|NCT03028740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5751671|NCT03028766|Adavosertib|adavosertib|mesh-list
5751672|NCT03028766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5751673|NCT03028766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751674|NCT03028909|Oseltamivir|oseltamivir|mesh-list
5751675|NCT03028909|MEDI8852|medi8852|mesh-list
5751676|NCT03028909|Antiviral Agents|antiviral agents|mesh-ancestor
5751677|NCT03028909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5751678|NCT03028909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5751679|NCT03028909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751680|NCT03028311|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
5751681|NCT03028311|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5751682|NCT03028311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751683|NCT03028298|Sildenafil Citrate|sildenafil citrate|mesh-list
5751684|NCT03028298|Citric Acid|citric acid|mesh-list
5751685|NCT03028298|Sodium Citrate|sodium citrate|mesh-list
5751686|NCT03028298|Anticoagulants|anticoagulants|mesh-ancestor
5751687|NCT03028298|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5751688|NCT03028298|Chelating Agents|chelating agents|mesh-ancestor
6489615|NCT00592917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6489616|NCT00592930|Olanzapine|olanzapine|mesh-list
6489617|NCT00592930|Antiemetics|antiemetics|mesh-ancestor
6489618|NCT00592930|Autonomic Agents|autonomic agents|mesh-ancestor
6489619|NCT00592930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6489620|NCT00592930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751689|NCT03028298|Sequestering Agents|sequestering agents|mesh-ancestor
5751690|NCT03028298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751691|NCT03028298|Vasodilator Agents|vasodilator agents|mesh-ancestor
5751692|NCT03028298|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5751693|NCT03028298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5751694|NCT03028298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5751695|NCT03028298|Urological Agents|urological agents|mesh-ancestor
5751696|NCT03028428|Hyaluronic Acid|hyaluronic acid|mesh-list
5751697|NCT03028428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5751698|NCT03028428|Immunologic Factors|immunologic factors|mesh-ancestor
5751699|NCT03028428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751700|NCT03028428|Viscosupplements|viscosupplements|mesh-ancestor
5751701|NCT03028428|Protective Agents|protective agents|mesh-ancestor
5751702|NCT03028519|Vitamin D|vitamin d|mesh-list
5751703|NCT03028519|Cholecalciferol|cholecalciferol|mesh-list
5751704|NCT03028519|Vitamins|vitamins|mesh-ancestor
5751705|NCT03028519|Micronutrients|micronutrients|mesh-ancestor
5751706|NCT03028519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751707|NCT03028519|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5751708|NCT03028519|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5751709|NCT03028571|Trimethaphan|trimethaphan|mesh-list
5751710|NCT03028571|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
5751711|NCT03028571|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5751712|NCT03028571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5751713|NCT03028571|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
5751714|NCT03028571|Autonomic Agents|autonomic agents|mesh-ancestor
5751715|NCT03028571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5751716|NCT03028571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751717|NCT03028571|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
5751718|NCT03028571|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5751719|NCT03028571|Cholinergic Agents|cholinergic agents|mesh-ancestor
5751720|NCT03028571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5751721|NCT03028571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751722|NCT03028571|Vasodilator Agents|vasodilator agents|mesh-ancestor
5751723|NCT03028532|Clomiphene|clomiphene|mesh-list
5751724|NCT03028532|Enclomiphene|enclomiphene|mesh-list
5751725|NCT03028532|Zuclomiphene|zuclomiphene|mesh-list
5751726|NCT03028532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5751727|NCT03028532|Hormone Antagonists|hormone antagonists|mesh-ancestor
5751728|NCT03028532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5751729|NCT03028532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5627252|NCT04324463|Protease Inhibitors|protease inhibitors|mesh-ancestor
5627253|NCT04324463|Anticoagulants|anticoagulants|mesh-ancestor
5627254|NCT04324463|Immunologic Factors|immunologic factors|mesh-ancestor
5627255|NCT04324463|Gout Suppressants|gout suppressants|mesh-ancestor
5627256|NCT04324463|Tubulin Modulators|tubulin modulators|mesh-ancestor
5627257|NCT04324463|Antimitotic Agents|antimitotic agents|mesh-ancestor
5627258|NCT04324463|Mitosis Modulators|mitosis modulators|mesh-ancestor
5751730|NCT03028532|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5751731|NCT03028532|Fertility Agents|fertility agents|mesh-ancestor
5627259|NCT04320940|Phenobarbital|phenobarbital|mesh-list
5627260|NCT04320940|Anticonvulsants|anticonvulsants|mesh-ancestor
5627261|NCT04320940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5627262|NCT04320940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5627263|NCT04320940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5627264|NCT04320940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5627265|NCT04320940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5627266|NCT04320940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5697789|NCT03373708|Letrozole|letrozole|mesh-list
5697790|NCT03373708|Epirubicin|epirubicin|mesh-list
5697791|NCT03373708|Goserelin|goserelin|mesh-list
5697792|NCT03373708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5697793|NCT03373708|Immunologic Factors|immunologic factors|mesh-ancestor
5697794|NCT03373708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697795|NCT03373708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5697796|NCT03373708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5697797|NCT03373708|Alkylating Agents|alkylating agents|mesh-ancestor
5697798|NCT03373708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697799|NCT03373708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5697800|NCT03373708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5697801|NCT03373708|Tubulin Modulators|tubulin modulators|mesh-ancestor
5697802|NCT03373708|Antimitotic Agents|antimitotic agents|mesh-ancestor
5697803|NCT03373708|Mitosis Modulators|mitosis modulators|mesh-ancestor
5697804|NCT03373708|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5697805|NCT03373708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5697806|NCT03373708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5697807|NCT03373708|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5697808|NCT03373708|Hormone Antagonists|hormone antagonists|mesh-ancestor
5697809|NCT03373708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5697810|NCT03373708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5697811|NCT03373708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5697812|NCT03373708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5697813|NCT03373708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5697814|NCT03373708|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5697815|NCT03373708|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5697816|NCT03373708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5697817|NCT03373669|Vaccines|vaccines|mesh-list
5697818|NCT03373669|Immunologic Factors|immunologic factors|mesh-ancestor
5697819|NCT03373669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697820|NCT03373656|Vaccines|vaccines|mesh-list
5697821|NCT03373656|Immunologic Factors|immunologic factors|mesh-ancestor
5697822|NCT03373656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5627267|NCT04320940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627268|NCT04320940|GABA Modulators|gaba modulators|mesh-ancestor
5627269|NCT04320940|GABA Agents|gaba agents|mesh-ancestor
5627270|NCT04320940|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5627271|NCT04320940|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5627272|NCT04320940|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5627273|NCT04295577|Niraparib|niraparib|mesh-list
5627274|NCT04295577|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5751732|NCT03028532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5751733|NCT03028532|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5751734|NCT03028532|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5751735|NCT03028350|Ifetroban|ifetroban|mesh-list
5751736|NCT03028350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5751737|NCT03028155|Oxaliplatin|oxaliplatin|mesh-list
5751738|NCT03028155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5751739|NCT03027960|Empagliflozin|empagliflozin|mesh-list
5751740|NCT03027960|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5751741|NCT03027960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751742|NCT03027960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5627275|NCT04295577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5627276|NCT04295577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627277|NCT04295577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5627278|NCT04261218|Paclitaxel|paclitaxel|mesh-list
5627279|NCT04261218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5627280|NCT04261218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5627281|NCT04261218|Tubulin Modulators|tubulin modulators|mesh-ancestor
5627282|NCT04261218|Antimitotic Agents|antimitotic agents|mesh-ancestor
5627283|NCT04261218|Mitosis Modulators|mitosis modulators|mesh-ancestor
5627284|NCT04261218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627285|NCT04251689|Mannitol|mannitol|mesh-list
5627286|NCT04251689|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5627287|NCT04251689|Diuretics|diuretics|mesh-ancestor
5627288|NCT04251689|Natriuretic Agents|natriuretic agents|mesh-ancestor
5627289|NCT04251689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5627290|NCT04232423|Olanzapine|olanzapine|mesh-list
5627291|NCT04232423|Antiemetics|antiemetics|mesh-ancestor
5627292|NCT04232423|Autonomic Agents|autonomic agents|mesh-ancestor
5627293|NCT04232423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5751743|NCT03027960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751744|NCT03027934|Ticagrelor|ticagrelor|mesh-list
5751745|NCT03027934|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
5751746|NCT03027934|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5751747|NCT03027934|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5751748|NCT03027934|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5751749|NCT03027934|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5751750|NCT03027934|Purinergic Agents|purinergic agents|mesh-ancestor
5751751|NCT03027934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5751752|NCT03027934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751753|NCT03027934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751754|NCT03027973|Tranexamic Acid|tranexamic acid|mesh-list
5627294|NCT04232423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5627295|NCT04232423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5627296|NCT04232423|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5627297|NCT04232423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5627298|NCT04232423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5627299|NCT04232423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5627300|NCT04232423|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5627301|NCT04232423|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5751755|NCT03027973|Ulipristal acetate|ulipristal acetate|mesh-list
5751756|NCT03027973|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5751757|NCT03027973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5627302|NCT04232423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5627303|NCT04232423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627304|NCT04232423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5627305|NCT04232423|Serotonin Agents|serotonin agents|mesh-ancestor
5627306|NCT04231877|Prednisone|prednisone|mesh-list
5751758|NCT03027973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751759|NCT03027973|Hemostatics|hemostatics|mesh-ancestor
5751760|NCT03027973|Coagulants|coagulants|mesh-ancestor
5751761|NCT03027973|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5751762|NCT03027973|Contraceptive Agents|contraceptive agents|mesh-ancestor
5751763|NCT03027973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5751764|NCT03027973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751765|NCT03027973|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5751766|NCT03027908|Fluorides|fluorides|mesh-list
5751767|NCT03027908|Cariostatic Agents|cariostatic agents|mesh-ancestor
5751768|NCT03027908|Protective Agents|protective agents|mesh-ancestor
5751769|NCT03027908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751770|NCT03027843|Hormones|hormones|mesh-list
5751771|NCT03027843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5751772|NCT03027843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894623|NCT03946969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894624|NCT03912363|Insulin|insulin|mesh-list
5894625|NCT03912363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5894626|NCT03912363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894627|NCT03901131|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5894628|NCT03901131|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5894629|NCT03901131|Norethindrone|norethindrone|mesh-list
5894630|NCT03901131|Norethindrone Acetate|norethindrone acetate|mesh-list
5894631|NCT03901131|Norethindrone enanthate|norethindrone enanthate|mesh-list
5894632|NCT03901131|Estradiol|estradiol|mesh-list
5894633|NCT03901131|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5894634|NCT03901131|Estrogens|estrogens|mesh-ancestor
5894635|NCT03901131|Hormones|hormones|mesh-ancestor
5894636|NCT03901131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5894637|NCT03901131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894638|NCT03901131|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5894639|NCT03901131|Contraceptive Agents|contraceptive agents|mesh-ancestor
5894640|NCT03901131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5894641|NCT03901131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5894642|NCT03901131|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5894643|NCT03901131|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5894644|NCT03901131|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5627307|NCT04231877|Cortisone|cortisone|mesh-list
5627308|NCT04231877|Cyclophosphamide|cyclophosphamide|mesh-list
5627309|NCT04231877|Rituximab|rituximab|mesh-list
5627310|NCT04231877|Doxorubicin|doxorubicin|mesh-list
5627311|NCT04231877|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5627312|NCT04231877|Etoposide|etoposide|mesh-list
5627313|NCT04231877|Daunorubicin|daunorubicin|mesh-list
5627314|NCT04231877|Podophyllotoxin|podophyllotoxin|mesh-list
5627315|NCT04231877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5627316|NCT04231877|Antibodies|antibodies|mesh-list
5894645|NCT03814317|Treprostinil|treprostinil|mesh-list
5894646|NCT03814317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5894647|NCT03744026|Carboplatin|carboplatin|mesh-list
5894648|NCT03744026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5894649|NCT03737955|Gemtuzumab|gemtuzumab|mesh-list
5894650|NCT03737955|Calicheamicins|calicheamicins|mesh-list
5894651|NCT03737955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5894652|NCT03737955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5627317|NCT04231877|Immunoglobulins|immunoglobulins|mesh-list
5627318|NCT04231877|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5627319|NCT04231877|Lenograstim|lenograstim|mesh-list
5627320|NCT04231877|Immunoconjugates|immunoconjugates|mesh-list
5627321|NCT04231877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5627322|NCT04231877|Immunologic Factors|immunologic factors|mesh-ancestor
5627323|NCT04231877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751773|NCT03027635|Ciprofloxacin|ciprofloxacin|mesh-list
5751774|NCT03027635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5751775|NCT03027635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5751776|NCT03027635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5751777|NCT03027635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5627324|NCT04231877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5627325|NCT04231877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5627326|NCT04231877|Alkylating Agents|alkylating agents|mesh-ancestor
5627327|NCT04231877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627328|NCT04231877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5627329|NCT04231877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5627330|NCT04231877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5627331|NCT04231877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5627332|NCT04231877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5627333|NCT04231877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5627334|NCT04231877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5751778|NCT03027635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5751779|NCT03027635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751780|NCT03027635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5751781|NCT03027635|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5751782|NCT03027635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5751783|NCT03027674|Nifedipine|nifedipine|mesh-list
5751784|NCT03027674|Sildenafil Citrate|sildenafil citrate|mesh-list
5751785|NCT03027674|Vasodilator Agents|vasodilator agents|mesh-ancestor
5751786|NCT03027674|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5751787|NCT03027674|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5751788|NCT03027674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5751789|NCT03027674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751790|NCT03027674|Urological Agents|urological agents|mesh-ancestor
5751791|NCT03027674|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5751792|NCT03027674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5751793|NCT03027674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5751794|NCT03027674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751795|NCT03027674|Tocolytic Agents|tocolytic agents|mesh-ancestor
5751796|NCT03027674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5751797|NCT03027648|Levonorgestrel|levonorgestrel|mesh-list
5751798|NCT03027648|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5751799|NCT03027648|Contraceptive Agents|contraceptive agents|mesh-ancestor
5751800|NCT03027648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5751801|NCT03027648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751802|NCT03027648|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5751803|NCT03027648|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5751804|NCT03027648|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5751805|NCT03027284|Gemcitabine|gemcitabine|mesh-list
5751806|NCT03027284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5751807|NCT03027284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5751808|NCT03027284|Antimetabolites|antimetabolites|mesh-ancestor
5751809|NCT03027284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751810|NCT03027284|Antiviral Agents|antiviral agents|mesh-ancestor
5751811|NCT03027284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5627335|NCT04231877|Glucocorticoids|glucocorticoids|mesh-ancestor
5627336|NCT04231877|Hormones|hormones|mesh-ancestor
5627337|NCT04231877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5627338|NCT04231877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5627339|NCT04231877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5627340|NCT04231877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5627341|NCT04231877|Keratolytic Agents|keratolytic agents|mesh-ancestor
5627342|NCT04231877|Dermatologic Agents|dermatologic agents|mesh-ancestor
5627343|NCT04231877|Tubulin Modulators|tubulin modulators|mesh-ancestor
5627344|NCT04231877|Antimitotic Agents|antimitotic agents|mesh-ancestor
5627345|NCT04231877|Mitosis Modulators|mitosis modulators|mesh-ancestor
5627346|NCT04205409|Nivolumab|nivolumab|mesh-list
5627347|NCT04205409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5627348|NCT04205409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5627349|NCT04205409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5627350|NCT04205409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627351|NCT04196010|Cytarabine|cytarabine|mesh-list
5627352|NCT04196010|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
5627353|NCT04196010|Mitoxantrone|mitoxantrone|mesh-list
5627354|NCT04196010|Cladribine|cladribine|mesh-list
5627355|NCT04196010|Sargramostim|sargramostim|mesh-list
5627356|NCT04196010|Lenograstim|lenograstim|mesh-list
5627357|NCT04196010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5627358|NCT04196010|Antimetabolites|antimetabolites|mesh-ancestor
5751812|NCT03027284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5751813|NCT03027284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5751814|NCT03027284|Immunologic Factors|immunologic factors|mesh-ancestor
5751815|NCT03027284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751816|NCT03027167|Aspirin|aspirin|mesh-list
5751817|NCT03027167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5751818|NCT03027167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5751819|NCT03027167|Analgesics|analgesics|mesh-ancestor
5751820|NCT03027167|Sensory System Agents|sensory system agents|mesh-ancestor
5751821|NCT03027167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5751822|NCT03027167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751823|NCT03027167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5751824|NCT03027167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5751825|NCT03027167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5751826|NCT03027167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5751827|NCT03027167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751828|NCT03027167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5751829|NCT03027167|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5751830|NCT03027167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5751831|NCT03027167|Antipyretics|antipyretics|mesh-ancestor
5751832|NCT03027219|Alprostadil|alprostadil|mesh-list
5751833|NCT03027219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5751834|NCT03027219|Vasodilator Agents|vasodilator agents|mesh-ancestor
5751835|NCT03027219|Urological Agents|urological agents|mesh-ancestor
5751836|NCT03026933|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5751837|NCT03026933|Calcium|calcium|mesh-list
5751838|NCT03026933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5751839|NCT03026933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751840|NCT03026933|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5751841|NCT03026933|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5751842|NCT03026933|Antimetabolites|antimetabolites|mesh-ancestor
5751843|NCT03026933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751844|NCT03026933|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5751845|NCT03026933|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5751846|NCT03026933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5751847|NCT03026842|Cytarabine|cytarabine|mesh-list
5751848|NCT03026842|Decitabine|decitabine|mesh-list
5751849|NCT03026842|Daunorubicin|daunorubicin|mesh-list
5751850|NCT03026842|Mitoxantrone|mitoxantrone|mesh-list
5751851|NCT03026842|Aclacinomycins|aclacinomycins|mesh-list
5751852|NCT03026842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5751853|NCT03026842|Antimetabolites|antimetabolites|mesh-ancestor
5751854|NCT03026842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751855|NCT03026842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5751856|NCT03026842|Antiviral Agents|antiviral agents|mesh-ancestor
5751857|NCT03026842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5751858|NCT03026842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6489621|NCT00592930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6489622|NCT00592930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6489623|NCT00592930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6489624|NCT00592930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6489625|NCT00592930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6489626|NCT00592930|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6489627|NCT00592930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6489628|NCT00592930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6489629|NCT00592930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489630|NCT00592930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6489631|NCT00592930|Serotonin Agents|serotonin agents|mesh-ancestor
6489632|NCT00592969|Metformin|metformin|mesh-list
6489633|NCT00592969|Insulin Aspart|insulin aspart|mesh-list
6489634|NCT00592969|Biphasic Insulins|biphasic insulins|mesh-list
6489635|NCT00592969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6489636|NCT00592969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489637|NCT00593008|Gemcitabine|gemcitabine|mesh-list
6489638|NCT00593008|Sirolimus|sirolimus|mesh-list
6489639|NCT00593008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6489640|NCT00593008|Antimetabolites|antimetabolites|mesh-ancestor
6489641|NCT00593008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489642|NCT00593008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6489643|NCT00593008|Antiviral Agents|antiviral agents|mesh-ancestor
6489644|NCT00593008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6489645|NCT00593008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6489646|NCT00593008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6489647|NCT00593008|Immunologic Factors|immunologic factors|mesh-ancestor
6489648|NCT00593008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5627359|NCT04196010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627360|NCT04196010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5627361|NCT04196010|Antiviral Agents|antiviral agents|mesh-ancestor
5627362|NCT04196010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5627363|NCT04196010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5627364|NCT04196010|Immunologic Factors|immunologic factors|mesh-ancestor
5627365|NCT04196010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5627366|NCT04196010|Analgesics|analgesics|mesh-ancestor
5627367|NCT04196010|Sensory System Agents|sensory system agents|mesh-ancestor
5627368|NCT04196010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5627369|NCT04196010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5627370|NCT04196010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5627371|NCT04196010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5627372|NCT04196010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5627373|NCT04190433|Carvedilol|carvedilol|mesh-list
5627374|NCT04190433|Lisinopril|lisinopril|mesh-list
5627375|NCT04190433|Spironolactone|spironolactone|mesh-list
5627376|NCT04190433|Pravastatin|pravastatin|mesh-list
5627377|NCT04190433|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5627378|NCT04190433|Hormone Antagonists|hormone antagonists|mesh-ancestor
5627379|NCT04190433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5627380|NCT04190433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5627381|NCT04190433|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5627382|NCT04190433|Diuretics|diuretics|mesh-ancestor
5627383|NCT04190433|Natriuretic Agents|natriuretic agents|mesh-ancestor
5751859|NCT03026842|Immunologic Factors|immunologic factors|mesh-ancestor
5751860|NCT03026842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751861|NCT03026842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5751862|NCT03026842|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5751863|NCT03026842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5751864|NCT03026842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5751865|NCT03026842|Analgesics|analgesics|mesh-ancestor
5751866|NCT03026842|Sensory System Agents|sensory system agents|mesh-ancestor
5751867|NCT03026842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5751868|NCT03026842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6489649|NCT00593008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6489650|NCT00593008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6489651|NCT00593008|Antifungal Agents|antifungal agents|mesh-ancestor
6489652|NCT00593060|Sirolimus|sirolimus|mesh-list
6489653|NCT00593060|Cetuximab|cetuximab|mesh-list
6489654|NCT00593060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6489655|NCT00593060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6489656|NCT00593060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6489657|NCT00593060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6489658|NCT00593060|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6489659|NCT00593060|Antifungal Agents|antifungal agents|mesh-ancestor
6489660|NCT00593060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6489661|NCT00593060|Immunologic Factors|immunologic factors|mesh-ancestor
6489662|NCT00593060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489663|NCT00593099|Bupropion|bupropion|mesh-list
6489664|NCT00593099|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5751869|NCT03026894|Salicylic Acid|salicylic acid|mesh-list
5751870|NCT03026894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5751871|NCT03026894|Antifungal Agents|antifungal agents|mesh-ancestor
5751872|NCT03026894|Keratolytic Agents|keratolytic agents|mesh-ancestor
5751873|NCT03026894|Dermatologic Agents|dermatologic agents|mesh-ancestor
5751874|NCT03026972|Vaccines|vaccines|mesh-list
5751875|NCT03026972|Immunologic Factors|immunologic factors|mesh-ancestor
5751876|NCT03026972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751877|NCT03027115|Tamsulosin|tamsulosin|mesh-list
5751878|NCT03027115|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5751879|NCT03027115|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5627384|NCT04190433|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5627385|NCT04190433|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5627386|NCT04190433|Adrenergic Agents|adrenergic agents|mesh-ancestor
5627387|NCT04190433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5627388|NCT04190433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627389|NCT04190433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5627390|NCT04190433|Antioxidants|antioxidants|mesh-ancestor
5627391|NCT04190433|Protective Agents|protective agents|mesh-ancestor
5627392|NCT04190433|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5627393|NCT04190433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5627394|NCT04190433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5751880|NCT03027115|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6489665|NCT00593099|Antidepressive Agents|antidepressive agents|mesh-ancestor
5627395|NCT04190433|Vasodilator Agents|vasodilator agents|mesh-ancestor
5627396|NCT04190433|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5627397|NCT04190433|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5751881|NCT03027115|Adrenergic Agents|adrenergic agents|mesh-ancestor
5751882|NCT03027115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5751883|NCT03027115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751884|NCT03027115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751885|NCT03027115|Urological Agents|urological agents|mesh-ancestor
5627398|NCT04190433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5627399|NCT04190433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5627400|NCT04190433|Antimetabolites|antimetabolites|mesh-ancestor
5627401|NCT04190433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5627402|NCT04190433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5751886|NCT03026881|Paclitaxel|paclitaxel|mesh-list
5751887|NCT03026881|Apatinib|apatinib|mesh-list
5751888|NCT03026881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5751889|NCT03026881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5751890|NCT03026881|Tubulin Modulators|tubulin modulators|mesh-ancestor
5751891|NCT03026881|Antimitotic Agents|antimitotic agents|mesh-ancestor
5751892|NCT03026881|Mitosis Modulators|mitosis modulators|mesh-ancestor
5751893|NCT03026881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489666|NCT00593099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5751894|NCT03026881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5751895|NCT03026881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5751896|NCT03026946|Cyclosporine|cyclosporine|mesh-list
5751897|NCT03026946|Alitretinoin|alitretinoin|mesh-list
5751898|NCT03026946|Cyclosporins|cyclosporins|mesh-list
5751899|NCT03026946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5751900|NCT03026946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627403|NCT04190433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5627404|NCT04190433|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5627405|NCT04190433|Protease Inhibitors|protease inhibitors|mesh-ancestor
5627406|NCT04190433|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5627407|NCT04178993|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5627408|NCT04178993|Methylphenidate|methylphenidate|mesh-list
5627409|NCT04178993|Methamphetamine|methamphetamine|mesh-list
5627410|NCT04178993|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5627411|NCT04178993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5627412|NCT04178993|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5627413|NCT04178993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5627414|NCT04178993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5627415|NCT04178993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627416|NCT04178993|Dopamine Agents|dopamine agents|mesh-ancestor
5627417|NCT04178993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5627418|NCT04178993|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5627419|NCT04178993|Analgesics|analgesics|mesh-ancestor
5627420|NCT04178993|Sensory System Agents|sensory system agents|mesh-ancestor
5627421|NCT04178993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5627422|NCT04178993|Antidepressive Agents|antidepressive agents|mesh-ancestor
5627423|NCT04178993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5627424|NCT04178993|Sympathomimetics|sympathomimetics|mesh-ancestor
5627425|NCT04178993|Autonomic Agents|autonomic agents|mesh-ancestor
5627426|NCT04178993|Adrenergic Agents|adrenergic agents|mesh-ancestor
5627427|NCT04178993|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5627428|NCT04158258|Bevacizumab|bevacizumab|mesh-list
5627429|NCT04158258|Trastuzumab|trastuzumab|mesh-list
5627430|NCT04158258|Pertuzumab|pertuzumab|mesh-list
5627431|NCT04158258|Capecitabine|capecitabine|mesh-list
5627432|NCT04158258|Atezolizumab|atezolizumab|mesh-list
5627433|NCT04158258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5627434|NCT04158258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5627435|NCT04158258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5627436|NCT04158258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5627437|NCT04158258|Growth Substances|growth substances|mesh-ancestor
5627438|NCT04158258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5627439|NCT04158258|Growth Inhibitors|growth inhibitors|mesh-ancestor
5627440|NCT04158258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5627441|NCT04158258|Antimetabolites|antimetabolites|mesh-ancestor
5751901|NCT03026946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5751902|NCT03026946|Immunologic Factors|immunologic factors|mesh-ancestor
5751903|NCT03026946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751904|NCT03026946|Antifungal Agents|antifungal agents|mesh-ancestor
5751905|NCT03026946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5751906|NCT03026946|Dermatologic Agents|dermatologic agents|mesh-ancestor
5751907|NCT03026946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5627442|NCT04158258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627443|NCT04156828|Gemcitabine|gemcitabine|mesh-list
5627444|NCT04156828|Dexamethasone|dexamethasone|mesh-list
5627445|NCT04156828|Dexamethasone acetate|dexamethasone acetate|mesh-list
5627446|NCT04156828|Rituximab|rituximab|mesh-list
5627447|NCT04156828|Carboplatin|carboplatin|mesh-list
5627448|NCT04156828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5627449|NCT04156828|Antibodies|antibodies|mesh-list
5627450|NCT04156828|Immunoglobulins|immunoglobulins|mesh-list
5627451|NCT04156828|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5627452|NCT04156828|Lenograstim|lenograstim|mesh-list
5627453|NCT04156828|BB 1101|bb 1101|mesh-list
5627454|NCT04156828|Immunologic Factors|immunologic factors|mesh-ancestor
5627455|NCT04156828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5627456|NCT04156828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5627457|NCT04156828|Antiemetics|antiemetics|mesh-ancestor
5627458|NCT04156828|Autonomic Agents|autonomic agents|mesh-ancestor
5627459|NCT04156828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5627460|NCT04156828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5627461|NCT04156828|Glucocorticoids|glucocorticoids|mesh-ancestor
5627462|NCT04156828|Hormones|hormones|mesh-ancestor
5627463|NCT04156828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5627464|NCT04156828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5627465|NCT04156828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5627466|NCT04156828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5627467|NCT04156828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5627468|NCT04156828|Antimetabolites|antimetabolites|mesh-ancestor
5627469|NCT04156828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627470|NCT04156828|Antiviral Agents|antiviral agents|mesh-ancestor
5627471|NCT04156828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5627472|NCT04156828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5627473|NCT04156828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5751908|NCT03026946|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5751909|NCT03026946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5627474|NCT04156828|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5627475|NCT04156828|Protease Inhibitors|protease inhibitors|mesh-ancestor
5627476|NCT04107727|Cytarabine|cytarabine|mesh-list
5627477|NCT04107727|Idarubicin|idarubicin|mesh-list
5627478|NCT04107727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5627479|NCT04107727|Antimetabolites|antimetabolites|mesh-ancestor
5627480|NCT04107727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627481|NCT04107727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5627482|NCT04107727|Antiviral Agents|antiviral agents|mesh-ancestor
5627483|NCT04107727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5627484|NCT04107727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5627485|NCT04107727|Immunologic Factors|immunologic factors|mesh-ancestor
5627486|NCT04107727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5627487|NCT04107727|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5627488|NCT04107727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5627489|NCT04107727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5751910|NCT03026907|Azathioprine|azathioprine|mesh-list
5751911|NCT03026907|Alitretinoin|alitretinoin|mesh-list
5751912|NCT03026907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5751913|NCT03026907|Dermatologic Agents|dermatologic agents|mesh-ancestor
5751914|NCT03026907|Antimetabolites|antimetabolites|mesh-ancestor
5751915|NCT03026907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751916|NCT03026907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5751917|NCT03026907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5751918|NCT03026907|Immunologic Factors|immunologic factors|mesh-ancestor
5751919|NCT03026907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751920|NCT03026907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5751921|NCT03026790|Buprenorphine|buprenorphine|mesh-list
5751922|NCT03026790|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
5751923|NCT03026790|Naloxone|naloxone|mesh-list
5751924|NCT03026790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5751925|NCT03026790|Narcotics|narcotics|mesh-ancestor
5751926|NCT03026790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5751927|NCT03026790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751928|NCT03026790|Analgesics|analgesics|mesh-ancestor
5751929|NCT03026790|Sensory System Agents|sensory system agents|mesh-ancestor
5751930|NCT03026790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5627490|NCT04107727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5627491|NCT04107077|Mitomycins|mitomycins|mesh-list
5627492|NCT04107077|Mitomycin|mitomycin|mesh-list
5627493|NCT04107077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5627494|NCT04107077|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5627495|NCT04107077|Alkylating Agents|alkylating agents|mesh-ancestor
5627496|NCT04107077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627497|NCT04107077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5627498|NCT04107077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5751931|NCT03026790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5751932|NCT03026725|Calcium|calcium|mesh-list
5751933|NCT03026725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5751934|NCT03026725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751935|NCT03026517|Phenformin|phenformin|mesh-list
5751936|NCT03026517|Trametinib|trametinib|mesh-list
5751937|NCT03026517|Dabrafenib|dabrafenib|mesh-list
5751938|NCT03026517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5751939|NCT03026517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5751940|NCT03026517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5751941|NCT03026517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751942|NCT03026517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5751943|NCT03026517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751944|NCT03026478|Betamethasone|betamethasone|mesh-list
5751945|NCT03026478|Betamethasone Valerate|betamethasone valerate|mesh-list
5751946|NCT03026478|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5751947|NCT03026478|Betamethasone benzoate|betamethasone benzoate|mesh-list
5751948|NCT03026478|Clobetasol|clobetasol|mesh-list
5751949|NCT03026478|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
5751950|NCT03026478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5751951|NCT03026478|Glucocorticoids|glucocorticoids|mesh-ancestor
5751952|NCT03026478|Hormones|hormones|mesh-ancestor
5751953|NCT03026478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5751954|NCT03026478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5627502|NCT04065074|FX006|fx006|mesh-list
5751955|NCT03026478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5751956|NCT03026478|Respiratory System Agents|respiratory system agents|mesh-ancestor
5751957|NCT03026205|Cetylpyridinium|cetylpyridinium|mesh-list
5751958|NCT03026205|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5751959|NCT03026205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5627503|NCT04065074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5627504|NCT04065074|Glucocorticoids|glucocorticoids|mesh-ancestor
5627505|NCT04065074|Hormones|hormones|mesh-ancestor
5627506|NCT04065074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5627507|NCT04065074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5627508|NCT04065074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5627509|NCT04065074|Immunologic Factors|immunologic factors|mesh-ancestor
5751960|NCT03026244|Vitamin D|vitamin d|mesh-list
5751961|NCT03026244|Caseins|caseins|mesh-list
5751962|NCT03026244|Vitamins|vitamins|mesh-ancestor
5751963|NCT03026244|Micronutrients|micronutrients|mesh-ancestor
5751964|NCT03026244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673036|NCT01560052|Hormones|hormones|mesh-ancestor
6673037|NCT01560052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5751965|NCT03026244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5751966|NCT03026244|Chelating Agents|chelating agents|mesh-ancestor
5751967|NCT03026244|Sequestering Agents|sequestering agents|mesh-ancestor
6489667|NCT00593099|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6489668|NCT00593099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6489669|NCT00593099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6489670|NCT00593099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489671|NCT00593099|Dopamine Agents|dopamine agents|mesh-ancestor
6489672|NCT00593099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5751968|NCT03026244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751969|NCT03026140|Celecoxib|celecoxib|mesh-list
5627510|NCT04042116|Nivolumab|nivolumab|mesh-list
5627511|NCT04042116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5627512|NCT04042116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5627513|NCT04042116|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5627514|NCT04042116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627515|NCT04037254|Niraparib|niraparib|mesh-list
5627516|NCT04037254|Hormones|hormones|mesh-list
5627517|NCT04037254|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
5627518|NCT04037254|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5627519|NCT04037254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5751970|NCT03026140|Nivolumab|nivolumab|mesh-list
5751971|NCT03026140|Ipilimumab|ipilimumab|mesh-list
5751972|NCT03026140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5751973|NCT03026140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5751974|NCT03026140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5751975|NCT03026140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751976|NCT03026140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5751977|NCT03026140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5751978|NCT03026140|Analgesics|analgesics|mesh-ancestor
5751979|NCT03026140|Sensory System Agents|sensory system agents|mesh-ancestor
5751980|NCT03026140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5751981|NCT03026140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751982|NCT03026140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5751983|NCT03026140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5751984|NCT03026140|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5751985|NCT03026140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5751986|NCT03026140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5894653|NCT03737955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5894654|NCT03688633|Candesartan|candesartan|mesh-list
5627520|NCT04037254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5627521|NCT04037254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5627522|NCT04037254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5627523|NCT04037254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627524|NCT04037254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5627525|NCT04017390|Allantoin|allantoin|mesh-list
5627526|NCT04017390|Dermatologic Agents|dermatologic agents|mesh-ancestor
5627527|NCT03997097|Sildenafil Citrate|sildenafil citrate|mesh-list
5627528|NCT03997097|Vasodilator Agents|vasodilator agents|mesh-ancestor
5627529|NCT03997097|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5627530|NCT03997097|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5627531|NCT03997097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5627532|NCT03997097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627533|NCT03997097|Urological Agents|urological agents|mesh-ancestor
5627534|NCT03979885|Nicotine|nicotine|mesh-list
5627535|NCT03979885|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5627536|NCT03979885|Autonomic Agents|autonomic agents|mesh-ancestor
5627537|NCT03979885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5627538|NCT03979885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5627539|NCT03979885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5627540|NCT03979885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5627541|NCT03979885|Cholinergic Agents|cholinergic agents|mesh-ancestor
5627542|NCT03979885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5627543|NCT03979885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693052|NCT03403569|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
5693053|NCT03403569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693054|NCT03403569|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5693055|NCT03403569|Contraceptive Agents|contraceptive agents|mesh-ancestor
5693056|NCT03403569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5693057|NCT03403569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5894655|NCT03688633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5894656|NCT03688633|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5894657|NCT03688633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5894658|NCT03688633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673038|NCT01560052|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6673039|NCT01560052|Protective Agents|protective agents|mesh-ancestor
6673040|NCT01560052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6673041|NCT01560052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6673042|NCT01560065|Folic Acid|folic acid|mesh-list
6673043|NCT01560065|Vitamin B Complex|vitamin b complex|mesh-list
6673044|NCT01560065|Inositol|inositol|mesh-list
6673045|NCT01560065|Hematinics|hematinics|mesh-ancestor
6673046|NCT01560065|Vitamins|vitamins|mesh-ancestor
6673047|NCT01560065|Micronutrients|micronutrients|mesh-ancestor
5894659|NCT03613116|Vitamin D|vitamin d|mesh-list
5894660|NCT03613116|Cholecalciferol|cholecalciferol|mesh-list
5894661|NCT03613116|Vitamins|vitamins|mesh-ancestor
5894662|NCT03613116|Micronutrients|micronutrients|mesh-ancestor
5894663|NCT03613116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894664|NCT03613116|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5894665|NCT03613116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5894666|NCT03565900|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5894667|NCT03565900|Immunologic Factors|immunologic factors|mesh-ancestor
5894668|NCT03565900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894669|NCT03555851|Cyclophosphamide|cyclophosphamide|mesh-list
5894670|NCT03555851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6673048|NCT01560065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673049|NCT01560091|Tamsulosin|tamsulosin|mesh-list
5751987|NCT03026101|Nitroglycerin|nitroglycerin|mesh-list
5751988|NCT03026101|Vasodilator Agents|vasodilator agents|mesh-ancestor
5751989|NCT03026036|Raclopride|raclopride|mesh-list
5751990|NCT03026036|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5627544|NCT03970252|Calcium, Dietary|calcium, dietary|mesh-list
5627545|NCT03970252|Leucovorin|leucovorin|mesh-list
5627546|NCT03970252|Folic Acid|folic acid|mesh-list
5627547|NCT03970252|Fluorouracil|fluorouracil|mesh-list
5627548|NCT03970252|Oxaliplatin|oxaliplatin|mesh-list
5627549|NCT03970252|Nivolumab|nivolumab|mesh-list
5627550|NCT03970252|Irinotecan|irinotecan|mesh-list
5627551|NCT03970252|Camptothecin|camptothecin|mesh-list
5627552|NCT03970252|Calcium|calcium|mesh-list
5627553|NCT03970252|Levoleucovorin|levoleucovorin|mesh-list
5627554|NCT03970252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5627555|NCT03970252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5627556|NCT03970252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5627557|NCT03970252|Antimetabolites|antimetabolites|mesh-ancestor
5627558|NCT03970252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627559|NCT03970252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5627560|NCT03970252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5627561|NCT03970252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5627562|NCT03970252|Immunologic Factors|immunologic factors|mesh-ancestor
5627563|NCT03970252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5751991|NCT03026036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5751992|NCT03026036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5751993|NCT03026036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5751994|NCT03026036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5751995|NCT03026036|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5751996|NCT03026036|Dopamine Agents|dopamine agents|mesh-ancestor
5751997|NCT03026036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5751998|NCT03026036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5751999|NCT03026023|Ribavirin|ribavirin|mesh-list
5752000|NCT03026023|Grazoprevir|grazoprevir|mesh-list
5627564|NCT03970252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5627565|NCT03970252|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5627566|NCT03970252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5627567|NCT03970252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5627568|NCT03970252|Antidotes|antidotes|mesh-ancestor
5627569|NCT03970252|Protective Agents|protective agents|mesh-ancestor
5627570|NCT03970252|Vitamin B Complex|vitamin b complex|mesh-ancestor
5627571|NCT03970252|Vitamins|vitamins|mesh-ancestor
5627572|NCT03970252|Micronutrients|micronutrients|mesh-ancestor
5627573|NCT03970252|Hematinics|hematinics|mesh-ancestor
5627574|NCT03970252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5627575|NCT03970200|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5627576|NCT03970200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5627577|NCT03951961|Midostaurin|midostaurin|mesh-list
5627578|NCT03951961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5627579|NCT03951961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5627580|NCT03951961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5752001|NCT03026023|Antimetabolites|antimetabolites|mesh-ancestor
5752002|NCT03026023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752003|NCT03026023|Antiviral Agents|antiviral agents|mesh-ancestor
5752004|NCT03026023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5752005|NCT03025841|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
5752006|NCT03025841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5752007|NCT03025841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5752008|NCT03025750|Vaccines|vaccines|mesh-list
5752009|NCT03025750|Immunologic Factors|immunologic factors|mesh-ancestor
5752010|NCT03025750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752011|NCT03025867|Niraparib|niraparib|mesh-list
5752012|NCT03025867|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5752013|NCT03025867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5752014|NCT03025867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752015|NCT03025867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5627581|NCT03951961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627582|NCT03949153|Nivolumab|nivolumab|mesh-list
5627583|NCT03949153|Ipilimumab|ipilimumab|mesh-list
5627584|NCT03949153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5752016|NCT03025724|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5752017|NCT03025724|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5752018|NCT03025724|Dermatologic Agents|dermatologic agents|mesh-ancestor
5752019|NCT03025880|Gemcitabine|gemcitabine|mesh-list
5627585|NCT03949153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5627586|NCT03949153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5627587|NCT03949153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627588|NCT03947216|Pimavanserin|pimavanserin|mesh-list
5752020|NCT03025880|Pembrolizumab|pembrolizumab|mesh-list
5752021|NCT03025880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5752022|NCT03025880|Antimetabolites|antimetabolites|mesh-ancestor
5752023|NCT03025880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752024|NCT03025880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5752025|NCT03025880|Antiviral Agents|antiviral agents|mesh-ancestor
5752026|NCT03025880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5627589|NCT03947216|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5627590|NCT03947216|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5627591|NCT03947216|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5627592|NCT03947216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5627593|NCT03947216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5627594|NCT03947216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5627595|NCT03947216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5627596|NCT03947216|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5627597|NCT03947216|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5627598|NCT03947216|Serotonin Agents|serotonin agents|mesh-ancestor
5627599|NCT03947216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5627600|NCT03947216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627601|NCT03939520|Pirfenidone|pirfenidone|mesh-list
5627602|NCT03939520|Nintedanib|nintedanib|mesh-list
5627603|NCT03939520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5627604|NCT03939520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5627605|NCT03939520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5627606|NCT03939520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627607|NCT03939520|Analgesics|analgesics|mesh-ancestor
5627608|NCT03939520|Sensory System Agents|sensory system agents|mesh-ancestor
5627609|NCT03939520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5627610|NCT03939520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5627611|NCT03939520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5627612|NCT03939520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5627613|NCT03939520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5627614|NCT03939520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5752027|NCT03025880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5752028|NCT03025880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5752029|NCT03025880|Immunologic Factors|immunologic factors|mesh-ancestor
5752030|NCT03025880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752031|NCT03025880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5752032|NCT03025828|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
5752033|NCT03025828|Hormones|hormones|mesh-ancestor
5752034|NCT03025828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5752035|NCT03025828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752036|NCT03025958|Nimotuzumab|nimotuzumab|mesh-list
5627615|NCT03920306|Silver Nitrate|silver nitrate|mesh-list
5627616|NCT03920306|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5627617|NCT03920306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5627618|NCT03906708|Carbon Monoxide|carbon monoxide|mesh-list
5627619|NCT03906708|Antimetabolites|antimetabolites|mesh-ancestor
5627620|NCT03906708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627621|NCT03906708|Gasotransmitters|gasotransmitters|mesh-ancestor
5627622|NCT03906708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5627623|NCT03906708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752037|NCT03025958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5752038|NCT03025958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5752039|NCT03025893|Sunitinib|sunitinib|mesh-list
5752040|NCT03025893|Lomustine|lomustine|mesh-list
5752041|NCT03025893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5752042|NCT03025893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5752043|NCT03025893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5752044|NCT03025893|Growth Substances|growth substances|mesh-ancestor
5752045|NCT03025893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752046|NCT03025893|Growth Inhibitors|growth inhibitors|mesh-ancestor
5752047|NCT03025893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5752048|NCT03025893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5752049|NCT03025893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752050|NCT03025893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5752051|NCT03025893|Alkylating Agents|alkylating agents|mesh-ancestor
5752052|NCT03025906|Valproic Acid|valproic acid|mesh-list
5752053|NCT03025906|Phenobarbital|phenobarbital|mesh-list
5752054|NCT03025906|Anticonvulsants|anticonvulsants|mesh-ancestor
5752055|NCT03025906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5752056|NCT03025906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752057|NCT03025906|GABA Agents|gaba agents|mesh-ancestor
5752058|NCT03025906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5752059|NCT03025906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752060|NCT03025906|Antimanic Agents|antimanic agents|mesh-ancestor
5752061|NCT03025906|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5752062|NCT03025906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5752063|NCT03025906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5752064|NCT03025906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5752065|NCT03025906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5752066|NCT03025906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5752067|NCT03025906|GABA Modulators|gaba modulators|mesh-ancestor
5752068|NCT03025906|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5752069|NCT03025906|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5752070|NCT03025906|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5752071|NCT03025477|Paclitaxel|paclitaxel|mesh-list
5752072|NCT03025477|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5627624|NCT03906292|Niacinamide|niacinamide|mesh-list
5627625|NCT03906292|Imatinib Mesylate|imatinib mesylate|mesh-list
5627626|NCT03906292|Dasatinib|dasatinib|mesh-list
5627627|NCT03906292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5627628|NCT03906292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5627629|NCT03906292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5627630|NCT03906292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627631|NCT03906292|Vitamin B Complex|vitamin b complex|mesh-ancestor
5627632|NCT03906292|Vitamins|vitamins|mesh-ancestor
5627633|NCT03906292|Micronutrients|micronutrients|mesh-ancestor
5627634|NCT03906292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5627635|NCT03891901|Isoniazid|isoniazid|mesh-list
5627636|NCT03891901|Rifabutin|rifabutin|mesh-list
5627637|NCT03891901|Imatinib Mesylate|imatinib mesylate|mesh-list
5627638|NCT03891901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5627639|NCT03891901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5627640|NCT03891901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5627641|NCT03891901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627642|NCT03891901|Antitubercular Agents|antitubercular agents|mesh-ancestor
5627643|NCT03891901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5627644|NCT03891901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5627645|NCT03891901|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5627646|NCT03891901|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5627647|NCT03891901|Antimetabolites|antimetabolites|mesh-ancestor
5627648|NCT03891901|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5627649|NCT03891901|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5627650|NCT03847519|Pembrolizumab|pembrolizumab|mesh-list
5627651|NCT03847519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5627652|NCT03847519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5627653|NCT03836105|Cemiplimab|cemiplimab|mesh-list
5693058|NCT03403569|Immunologic Factors|immunologic factors|mesh-ancestor
5693059|NCT03403569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5693060|NCT03403569|Alkylating Agents|alkylating agents|mesh-ancestor
5693061|NCT03403569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693062|NCT03403569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5693063|NCT03403452|Apatinib|apatinib|mesh-list
5693064|NCT03403452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5693065|NCT03403452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5693066|NCT03403452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5693067|NCT03403452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693068|NCT03403439|Itraconazole|itraconazole|mesh-list
5693069|NCT03403439|Antifungal Agents|antifungal agents|mesh-ancestor
5693070|NCT03403439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5693071|NCT03403439|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5693072|NCT03403439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5693073|NCT03403439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5693074|NCT03403439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693075|NCT03403439|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5693076|NCT03403439|Hormone Antagonists|hormone antagonists|mesh-ancestor
5693077|NCT03403439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5693078|NCT03403439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693079|NCT03403439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5693080|NCT03403140|Etanercept|etanercept|mesh-list
5693081|NCT03403140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5693082|NCT03403140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5693083|NCT03403140|Analgesics|analgesics|mesh-ancestor
5693084|NCT03403140|Sensory System Agents|sensory system agents|mesh-ancestor
5693085|NCT03403140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5693086|NCT03403140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5627654|NCT03836105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5752073|NCT03025477|Cisplatin|cisplatin|mesh-list
5752074|NCT03025477|Carboplatin|carboplatin|mesh-list
5752075|NCT03025477|Epirubicin|epirubicin|mesh-list
5752076|NCT03025477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5752077|NCT03025477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5752078|NCT03025477|Tubulin Modulators|tubulin modulators|mesh-ancestor
5752079|NCT03025477|Antimitotic Agents|antimitotic agents|mesh-ancestor
5752080|NCT03025477|Mitosis Modulators|mitosis modulators|mesh-ancestor
5752081|NCT03025477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752082|NCT03025477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5752083|NCT03025477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5752084|NCT03025477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5752085|NCT03025477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5752086|NCT03025594|Ketorolac|ketorolac|mesh-list
5752087|NCT03025594|Epinephrine|epinephrine|mesh-list
5752088|NCT03025594|Levobupivacaine|levobupivacaine|mesh-list
5752089|NCT03025594|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5752090|NCT03025594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5752091|NCT03025594|Adrenergic Agents|adrenergic agents|mesh-ancestor
5752092|NCT03025594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5752093|NCT03025594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752094|NCT03025594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752095|NCT03025594|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5752096|NCT03025594|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5752097|NCT03025594|Autonomic Agents|autonomic agents|mesh-ancestor
5752098|NCT03025594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5627655|NCT03836105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5627656|NCT03801876|Paclitaxel|paclitaxel|mesh-list
5627657|NCT03801876|Docetaxel|docetaxel|mesh-list
5627658|NCT03801876|Carboplatin|carboplatin|mesh-list
5627659|NCT03801876|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5627660|NCT03801876|Fluorouracil|fluorouracil|mesh-list
5627661|NCT03801876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5627662|NCT03801876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5627663|NCT03801876|Tubulin Modulators|tubulin modulators|mesh-ancestor
5752099|NCT03025594|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5752100|NCT03025594|Respiratory System Agents|respiratory system agents|mesh-ancestor
5752101|NCT03025594|Mydriatics|mydriatics|mesh-ancestor
5752102|NCT03025594|Sympathomimetics|sympathomimetics|mesh-ancestor
5752103|NCT03025594|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5752104|NCT03025594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5752105|NCT03025594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5752106|NCT03025594|Analgesics|analgesics|mesh-ancestor
5752107|NCT03025594|Sensory System Agents|sensory system agents|mesh-ancestor
5752108|NCT03025594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5752109|NCT03025594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5752110|NCT03025594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5752111|NCT03025594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5752112|NCT03025594|Anesthetics, Local|anesthetics, local|mesh-ancestor
5752113|NCT03025594|Anesthetics|anesthetics|mesh-ancestor
5752114|NCT03025594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5627664|NCT03801876|Antimitotic Agents|antimitotic agents|mesh-ancestor
5627665|NCT03801876|Mitosis Modulators|mitosis modulators|mesh-ancestor
5627666|NCT03801876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627667|NCT03801876|Antimetabolites|antimetabolites|mesh-ancestor
5627668|NCT03801876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5627669|NCT03801876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5627670|NCT03801876|Immunologic Factors|immunologic factors|mesh-ancestor
5627671|NCT03801876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5627672|NCT03793010|FX006|fx006|mesh-list
5627673|NCT03793010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5627674|NCT03793010|Glucocorticoids|glucocorticoids|mesh-ancestor
5627675|NCT03793010|Hormones|hormones|mesh-ancestor
5627676|NCT03793010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5627677|NCT03793010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752115|NCT03025269|Ocrelizumab|ocrelizumab|mesh-list
5752116|NCT03025269|Immunologic Factors|immunologic factors|mesh-ancestor
5752117|NCT03025269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752118|NCT03025282|Betamethasone|betamethasone|mesh-list
5752119|NCT03025282|Betamethasone Valerate|betamethasone valerate|mesh-list
5752120|NCT03025282|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5752121|NCT03025282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5752122|NCT03025282|Glucocorticoids|glucocorticoids|mesh-ancestor
5627678|NCT03793010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5752123|NCT03025282|Hormones|hormones|mesh-ancestor
5752124|NCT03025282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5627679|NCT03793010|Immunologic Factors|immunologic factors|mesh-ancestor
5627680|NCT03781219|Vemurafenib|vemurafenib|mesh-list
5627681|NCT03781219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5627682|NCT03781219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5627683|NCT03781219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5627684|NCT03781219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627685|NCT03749460|Nivolumab|nivolumab|mesh-list
5627686|NCT03749460|Ipilimumab|ipilimumab|mesh-list
5627687|NCT03749460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5627688|NCT03749460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5627689|NCT03749460|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5627690|NCT03749460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627691|NCT03728556|Antibodies|antibodies|mesh-list
5627692|NCT03728556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5627693|NCT03728556|Immunologic Factors|immunologic factors|mesh-ancestor
5752125|NCT03025282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752126|NCT03025282|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5752127|NCT03025282|Respiratory System Agents|respiratory system agents|mesh-ancestor
5752128|NCT03025256|Nivolumab|nivolumab|mesh-list
5752129|NCT03025256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5752130|NCT03025256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5752131|NCT03025256|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5752132|NCT03025256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752133|NCT03025295|Dexmedetomidine|dexmedetomidine|mesh-list
5752134|NCT03025295|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5752135|NCT03025295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5752136|NCT03025295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752137|NCT03025295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5752138|NCT03025295|Analgesics|analgesics|mesh-ancestor
5752139|NCT03025295|Sensory System Agents|sensory system agents|mesh-ancestor
5752140|NCT03025295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5752141|NCT03025295|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5752142|NCT03025295|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5752143|NCT03025295|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5752144|NCT03025295|Adrenergic Agents|adrenergic agents|mesh-ancestor
5752145|NCT03025295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5752146|NCT03025295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752147|NCT03025009|Insulin|insulin|mesh-list
5752148|NCT03025009|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5752149|NCT03025009|Insulin Glargine|insulin glargine|mesh-list
5752150|NCT03025009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5752151|NCT03025009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752152|NCT03024879|Erythromycin|erythromycin|mesh-list
5752153|NCT03024879|Erythromycin Estolate|erythromycin estolate|mesh-list
5752154|NCT03024879|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
5752155|NCT03024879|Erythromycin stearate|erythromycin stearate|mesh-list
5752156|NCT03024879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5752157|NCT03024879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5752158|NCT03024879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5752159|NCT03024879|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5752160|NCT03024879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5752161|NCT03024879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752162|NCT03024905|Misoprostol|misoprostol|mesh-list
5752163|NCT03024905|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5752164|NCT03024905|Abortifacient Agents|abortifacient agents|mesh-ancestor
5752165|NCT03024905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5752166|NCT03024905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752167|NCT03024905|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5627694|NCT03728556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5627695|NCT03684980|Leucovorin|leucovorin|mesh-list
5627696|NCT03684980|Rituximab|rituximab|mesh-list
5627697|NCT03684980|Methotrexate|methotrexate|mesh-list
5627698|NCT03684980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5627699|NCT03684980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5627700|NCT03684980|Immunologic Factors|immunologic factors|mesh-ancestor
5627701|NCT03684980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5627702|NCT03684980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5627703|NCT03684980|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5627704|NCT03684980|Abortifacient Agents|abortifacient agents|mesh-ancestor
5752168|NCT03024905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5752169|NCT03024905|Oxytocics|oxytocics|mesh-ancestor
5752170|NCT03024957|Dexmedetomidine|dexmedetomidine|mesh-list
5752171|NCT03024957|Morphine|morphine|mesh-list
5752172|NCT03024957|Bupivacaine|bupivacaine|mesh-list
5627705|NCT03684980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5627706|NCT03684980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5627707|NCT03684980|Antimetabolites|antimetabolites|mesh-ancestor
5627708|NCT03684980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752173|NCT03024957|Anesthetics, Local|anesthetics, local|mesh-ancestor
5752174|NCT03024957|Anesthetics|anesthetics|mesh-ancestor
5752175|NCT03024957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5752176|NCT03024957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752177|NCT03024957|Sensory System Agents|sensory system agents|mesh-ancestor
5752178|NCT03024957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5752179|NCT03024957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5752180|NCT03024957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5752181|NCT03024957|Analgesics|analgesics|mesh-ancestor
5752182|NCT03024957|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5752183|NCT03024957|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5752184|NCT03024957|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5752185|NCT03024957|Adrenergic Agents|adrenergic agents|mesh-ancestor
5752186|NCT03024957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5752187|NCT03024957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752188|NCT03024957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5752189|NCT03024957|Narcotics|narcotics|mesh-ancestor
5752190|NCT03025113|Ketoprofen|ketoprofen|mesh-list
5752191|NCT03025113|Amitriptyline|amitriptyline|mesh-list
5752192|NCT03025113|Cyclobenzaprine|cyclobenzaprine|mesh-list
5752193|NCT03025113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5627709|NCT03684980|Dermatologic Agents|dermatologic agents|mesh-ancestor
5627710|NCT03684980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5627711|NCT03684980|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5627712|NCT03684980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5627713|NCT03684980|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5627714|NCT03684980|Antidotes|antidotes|mesh-ancestor
5627715|NCT03684980|Protective Agents|protective agents|mesh-ancestor
5627716|NCT03684980|Vitamin B Complex|vitamin b complex|mesh-ancestor
5752194|NCT03025113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5752195|NCT03025113|Analgesics|analgesics|mesh-ancestor
5752196|NCT03025113|Sensory System Agents|sensory system agents|mesh-ancestor
5752197|NCT03025113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5752198|NCT03025113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752199|NCT03025113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5752200|NCT03025113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5752201|NCT03025113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5752202|NCT03025113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5752203|NCT03025113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752204|NCT03025113|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5752205|NCT03025113|Antidepressive Agents|antidepressive agents|mesh-ancestor
5752206|NCT03025113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5752207|NCT03025113|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5752208|NCT03025113|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5627717|NCT03684980|Vitamins|vitamins|mesh-ancestor
5627718|NCT03684980|Micronutrients|micronutrients|mesh-ancestor
5752209|NCT03025113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5752210|NCT03025113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5752211|NCT03025113|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5752212|NCT03025113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5752213|NCT03025113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5752214|NCT03025113|Adrenergic Agents|adrenergic agents|mesh-ancestor
5752215|NCT03025113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5752216|NCT03024840|Propofol|propofol|mesh-list
5752217|NCT03024840|Sevoflurane|sevoflurane|mesh-list
5752218|NCT03024840|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5752219|NCT03024840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5752220|NCT03024840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752221|NCT03024840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5752222|NCT03024840|Anesthetics, General|anesthetics, general|mesh-ancestor
5752223|NCT03024840|Anesthetics|anesthetics|mesh-ancestor
5752224|NCT03024840|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5752225|NCT03024840|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5752226|NCT03024814|Acetaminophen|acetaminophen|mesh-list
5752227|NCT03024814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5752228|NCT03024814|Analgesics|analgesics|mesh-ancestor
5752229|NCT03024814|Sensory System Agents|sensory system agents|mesh-ancestor
5752230|NCT03024814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5752231|NCT03024814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752232|NCT03024814|Antipyretics|antipyretics|mesh-ancestor
5752233|NCT03024502|Clotrimazole|clotrimazole|mesh-list
5752234|NCT03024502|Miconazole|miconazole|mesh-list
5752235|NCT03024502|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5752236|NCT03024502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5752237|NCT03024502|Antifungal Agents|antifungal agents|mesh-ancestor
5752238|NCT03024502|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5752239|NCT03024502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5627734|NCT03642067|Nivolumab|nivolumab|mesh-list
5627735|NCT03642067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5627736|NCT03642067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5627737|NCT03642067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5627738|NCT03642067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627739|NCT03634241|Pembrolizumab|pembrolizumab|mesh-list
5627740|NCT03634241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5627741|NCT03634241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5752240|NCT03024502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5752241|NCT03024502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752242|NCT03024502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5752243|NCT03024502|Hormone Antagonists|hormone antagonists|mesh-ancestor
5752244|NCT03024502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5752245|NCT03024502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752246|NCT03024502|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5752247|NCT03024502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5752248|NCT03024580|Tamoxifen|tamoxifen|mesh-list
5752249|NCT03024580|Letrozole|letrozole|mesh-list
5752250|NCT03024580|Fulvestrant|fulvestrant|mesh-list
5752251|NCT03024580|Anastrozole|anastrozole|mesh-list
5752252|NCT03024580|Exemestane|exemestane|mesh-list
5752253|NCT03024580|Megestrol|megestrol|mesh-list
5752254|NCT03024580|Megestrol Acetate|megestrol acetate|mesh-list
5752255|NCT03024580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5752256|NCT03024580|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5752257|NCT03024580|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5752258|NCT03024580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5752259|NCT03024580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752260|NCT03024580|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5752261|NCT03024580|Hormone Antagonists|hormone antagonists|mesh-ancestor
5752262|NCT03024580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5752263|NCT03024580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752264|NCT03024580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5752265|NCT03024580|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5752266|NCT03024580|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5752267|NCT03024580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5752268|NCT03024580|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5752269|NCT03024580|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5752270|NCT03024580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5752271|NCT03024580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5752272|NCT03024580|Contraceptive Agents|contraceptive agents|mesh-ancestor
5752273|NCT03024580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5752274|NCT03024580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5752275|NCT03024580|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5752276|NCT03024580|Appetite Stimulants|appetite stimulants|mesh-ancestor
5752277|NCT03024580|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5894671|NCT03555851|Immunologic Factors|immunologic factors|mesh-ancestor
5894672|NCT03555851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894673|NCT03555851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5894674|NCT03555851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5894675|NCT03555851|Alkylating Agents|alkylating agents|mesh-ancestor
5894676|NCT03555851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752278|NCT03024489|Cetuximab|cetuximab|mesh-list
5752279|NCT03024489|Palbociclib|palbociclib|mesh-list
5752280|NCT03024489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5752281|NCT03024489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5752282|NCT03024489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5752283|NCT03024489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5752284|NCT03024489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673050|NCT01560091|Silodosin|silodosin|mesh-list
6673051|NCT01560091|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6673052|NCT01560091|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5627742|NCT03606967|Gemcitabine|gemcitabine|mesh-list
5627743|NCT03606967|Poly I-C|poly i-c|mesh-list
6673053|NCT01560091|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6673054|NCT01560091|Adrenergic Agents|adrenergic agents|mesh-ancestor
6673055|NCT01560091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6673056|NCT01560091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627744|NCT03606967|Paclitaxel|paclitaxel|mesh-list
5627745|NCT03606967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5627746|NCT03606967|Carboplatin|carboplatin|mesh-list
5627747|NCT03606967|Durvalumab|durvalumab|mesh-list
5627748|NCT03606967|Tremelimumab|tremelimumab|mesh-list
6673057|NCT01560091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673058|NCT01560091|Urological Agents|urological agents|mesh-ancestor
6673059|NCT01560117|Rituximab|rituximab|mesh-list
6673060|NCT01560117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6673061|NCT01560117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6673062|NCT01560117|Immunologic Factors|immunologic factors|mesh-ancestor
6673063|NCT01560117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673064|NCT01560117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6673065|NCT01560221|Buprenorphine|buprenorphine|mesh-list
5627749|NCT03606967|Ipilimumab|ipilimumab|mesh-list
5627750|NCT03606967|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
5627751|NCT03606967|Vaccines|vaccines|mesh-list
5627752|NCT03606967|Immunoglobulins|immunoglobulins|mesh-list
5627753|NCT03606967|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5627754|NCT03606967|Immunoglobulin G|immunoglobulin g|mesh-list
5627755|NCT03606967|Poly ICLC|poly iclc|mesh-list
5627756|NCT03606967|Immunologic Factors|immunologic factors|mesh-ancestor
5627757|NCT03606967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5627758|NCT03606967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5627759|NCT03606967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5627760|NCT03606967|Tubulin Modulators|tubulin modulators|mesh-ancestor
5627761|NCT03606967|Antimitotic Agents|antimitotic agents|mesh-ancestor
5627762|NCT03606967|Mitosis Modulators|mitosis modulators|mesh-ancestor
5627763|NCT03606967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627764|NCT03606967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5627765|NCT03606967|Antimetabolites|antimetabolites|mesh-ancestor
5627766|NCT03606967|Antiviral Agents|antiviral agents|mesh-ancestor
5627767|NCT03606967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5627768|NCT03606967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5627769|NCT03606967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5627770|NCT03606967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5627771|NCT03606967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5627772|NCT03606967|Interferon Inducers|interferon inducers|mesh-ancestor
5627773|NCT03606967|Laxatives|laxatives|mesh-ancestor
5627774|NCT03606967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5627775|NCT03596905|Plecanatide|plecanatide|mesh-list
5627776|NCT03596905|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
5627777|NCT03596905|Enzyme Activators|enzyme activators|mesh-ancestor
5627778|NCT03596905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627779|NCT03596905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6673066|NCT01560221|Methadone|methadone|mesh-list
6673067|NCT01560221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6673068|NCT01560221|Narcotics|narcotics|mesh-ancestor
6673069|NCT01560221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5627780|NCT03584516|Prednisone|prednisone|mesh-list
5627781|NCT03584516|Methylprednisolone|methylprednisolone|mesh-list
5627782|NCT03584516|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5627783|NCT03584516|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5627784|NCT03584516|Prednisolone|prednisolone|mesh-list
5627785|NCT03584516|Prednisolone acetate|prednisolone acetate|mesh-list
5627786|NCT03584516|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5627787|NCT03584516|Prednisolone phosphate|prednisolone phosphate|mesh-list
5627788|NCT03584516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5627789|NCT03584516|Glucocorticoids|glucocorticoids|mesh-ancestor
5627790|NCT03584516|Hormones|hormones|mesh-ancestor
5627791|NCT03584516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5752285|NCT03024515|Analgesics, Opioid|analgesics, opioid|mesh-list
6673070|NCT01560221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673071|NCT01560221|Analgesics|analgesics|mesh-ancestor
6673072|NCT01560221|Sensory System Agents|sensory system agents|mesh-ancestor
6673073|NCT01560221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6673074|NCT01560221|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6673075|NCT01560221|Antitussive Agents|antitussive agents|mesh-ancestor
6673076|NCT01560221|Respiratory System Agents|respiratory system agents|mesh-ancestor
6673077|NCT01560299|Methimazole|methimazole|mesh-list
6673078|NCT01560299|Antithyroid Agents|antithyroid agents|mesh-ancestor
6673079|NCT01560299|Hormone Antagonists|hormone antagonists|mesh-ancestor
5627792|NCT03584516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752286|NCT03024515|Narcotics|narcotics|mesh-ancestor
5752287|NCT03024515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5752288|NCT03024515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752289|NCT03024515|Analgesics|analgesics|mesh-ancestor
5752290|NCT03024515|Sensory System Agents|sensory system agents|mesh-ancestor
5752291|NCT03024515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5752292|NCT03024450|Trastuzumab|trastuzumab|mesh-list
5752293|NCT03024450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5752294|NCT03024450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5752295|NCT03024697|Anesthetics|anesthetics|mesh-list
5752296|NCT03024697|Anesthetics, Local|anesthetics, local|mesh-list
5752297|NCT03024697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5752298|NCT03024697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752299|NCT03024697|Sensory System Agents|sensory system agents|mesh-ancestor
5752300|NCT03024697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5752301|NCT03024684|Atorvastatin|atorvastatin|mesh-list
5752302|NCT03024684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5752303|NCT03024684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5752304|NCT03024684|Antimetabolites|antimetabolites|mesh-ancestor
5752305|NCT03024684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752306|NCT03024684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5627793|NCT03584516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5627794|NCT03584516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5627795|NCT03584516|Antiemetics|antiemetics|mesh-ancestor
5627796|NCT03584516|Autonomic Agents|autonomic agents|mesh-ancestor
5627797|NCT03584516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5627798|NCT03584516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5627799|NCT03584516|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5627800|NCT03584516|Protective Agents|protective agents|mesh-ancestor
5752307|NCT03024684|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5752308|NCT03024684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5752309|NCT03024476|Olmesartan|olmesartan|mesh-list
5752310|NCT03024476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5752311|NCT03024476|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5752312|NCT03024476|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5752313|NCT03024476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752314|NCT03024437|Bevacizumab|bevacizumab|mesh-list
5752315|NCT03024437|Atezolizumab|atezolizumab|mesh-list
5752316|NCT03024437|Entinostat|entinostat|mesh-list
5752317|NCT03024437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5752318|NCT03024437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5752319|NCT03024437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5752320|NCT03024437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5752321|NCT03024437|Growth Substances|growth substances|mesh-ancestor
5752322|NCT03024437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752323|NCT03024437|Growth Inhibitors|growth inhibitors|mesh-ancestor
5752324|NCT03024437|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5752325|NCT03024437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5752326|NCT03024437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752327|NCT03024060|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5752328|NCT03024060|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5752329|NCT03024060|Dermatologic Agents|dermatologic agents|mesh-ancestor
5752330|NCT03024216|Atezolizumab|atezolizumab|mesh-list
5752331|NCT03024216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5752332|NCT03023982|Morphine|morphine|mesh-list
5627801|NCT03579316|Olaparib|olaparib|mesh-list
5627802|NCT03579316|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
5627803|NCT03579316|Adavosertib|adavosertib|mesh-list
5627804|NCT03579316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5627805|NCT03579316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627806|NCT03579316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5627807|NCT03560531|Palbociclib|palbociclib|mesh-list
5752333|NCT03023982|Bupivacaine|bupivacaine|mesh-list
6673080|NCT01560299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5627808|NCT03560531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5752334|NCT03023982|Anesthetics, Local|anesthetics, local|mesh-ancestor
5752335|NCT03023982|Anesthetics|anesthetics|mesh-ancestor
5752336|NCT03023982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5752337|NCT03023982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752338|NCT03023982|Sensory System Agents|sensory system agents|mesh-ancestor
5752339|NCT03023982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5752340|NCT03023982|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5627809|NCT03560531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5627810|NCT03560531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5752341|NCT03023982|Narcotics|narcotics|mesh-ancestor
5752342|NCT03023982|Analgesics|analgesics|mesh-ancestor
5752343|NCT03023852|Oseltamivir|oseltamivir|mesh-list
5752344|NCT03023852|Antiviral Agents|antiviral agents|mesh-ancestor
5752345|NCT03023852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5752346|NCT03023852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5752347|NCT03023852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627811|NCT03560531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627812|NCT03529942|FX006|fx006|mesh-list
5627813|NCT03529942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5627814|NCT03529942|Glucocorticoids|glucocorticoids|mesh-ancestor
5627815|NCT03529942|Hormones|hormones|mesh-ancestor
5627816|NCT03529942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5627817|NCT03529942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5627818|NCT03529942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5627819|NCT03529942|Immunologic Factors|immunologic factors|mesh-ancestor
5627820|NCT03503370|Chlorhexidine|chlorhexidine|mesh-list
5627821|NCT03503370|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5627822|NCT03503370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5627823|NCT03503370|Disinfectants|disinfectants|mesh-ancestor
5627824|NCT03501940|Fluorides|fluorides|mesh-list
5627825|NCT03501940|Cariostatic Agents|cariostatic agents|mesh-ancestor
5627826|NCT03501940|Protective Agents|protective agents|mesh-ancestor
5627827|NCT03501940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5627828|NCT03473340|Pirfenidone|pirfenidone|mesh-list
5627829|NCT03473340|Analgesics|analgesics|mesh-ancestor
5627830|NCT03473340|Sensory System Agents|sensory system agents|mesh-ancestor
5627831|NCT03473340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5627832|NCT03473340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5627833|NCT03473340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5627834|NCT03473340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5627835|NCT03473340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5627836|NCT03473340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5627837|NCT03473340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5627838|NCT03471663|Palbociclib|palbociclib|mesh-list
5627839|NCT03471663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5627840|NCT03471663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5627841|NCT03471663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5627842|NCT03471663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627843|NCT03373760|Durvalumab|durvalumab|mesh-list
5627844|NCT03373760|Ipilimumab|ipilimumab|mesh-list
5627845|NCT03373760|Tremelimumab|tremelimumab|mesh-list
5627846|NCT03373760|Immunoglobulins|immunoglobulins|mesh-list
5627847|NCT03373760|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5627848|NCT03373760|Immunoglobulin G|immunoglobulin g|mesh-list
5627849|NCT03373760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5627850|NCT03373760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5627851|NCT03373760|Immunologic Factors|immunologic factors|mesh-ancestor
5627852|NCT03373760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5627853|NCT03373760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5627854|NCT03373760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627855|NCT03366844|Pembrolizumab|pembrolizumab|mesh-list
5627856|NCT03366844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5627857|NCT03366844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5627858|NCT03349775|Metformin|metformin|mesh-list
5627859|NCT03349775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5627860|NCT03349775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5627861|NCT03337724|Paclitaxel|paclitaxel|mesh-list
5627862|NCT03337724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5627863|NCT03337724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5627864|NCT03337724|Tubulin Modulators|tubulin modulators|mesh-ancestor
5627865|NCT03337724|Antimitotic Agents|antimitotic agents|mesh-ancestor
5627866|NCT03337724|Mitosis Modulators|mitosis modulators|mesh-ancestor
5627867|NCT03337724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693087|NCT03403140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5752348|NCT03023774|Sargramostim|sargramostim|mesh-list
5752349|NCT03023774|Lenograstim|lenograstim|mesh-list
5752350|NCT03023774|Immunologic Factors|immunologic factors|mesh-ancestor
5752351|NCT03023774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752352|NCT03023774|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5752353|NCT03023566|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
5752354|NCT03023566|Chelating Agents|chelating agents|mesh-ancestor
5752355|NCT03023566|Sequestering Agents|sequestering agents|mesh-ancestor
5752356|NCT03023566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752357|NCT03023904|Nivolumab|nivolumab|mesh-list
5752358|NCT03023904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5752359|NCT03023904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5752360|NCT03023904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5752361|NCT03023904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752362|NCT03023527|Dexamethasone|dexamethasone|mesh-list
5752363|NCT03023527|Nivolumab|nivolumab|mesh-list
5752364|NCT03023527|Pomalidomide|pomalidomide|mesh-list
5752365|NCT03023527|Elotuzumab|elotuzumab|mesh-list
5752366|NCT03023527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5752367|NCT03023527|Antiemetics|antiemetics|mesh-ancestor
5752368|NCT03023527|Autonomic Agents|autonomic agents|mesh-ancestor
5752369|NCT03023527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5752370|NCT03023527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752371|NCT03023527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5752372|NCT03023527|Glucocorticoids|glucocorticoids|mesh-ancestor
5752373|NCT03023527|Hormones|hormones|mesh-ancestor
5752374|NCT03023527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5752375|NCT03023527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5752376|NCT03023527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5752377|NCT03023527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5752378|NCT03023527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5752379|NCT03023527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752380|NCT03023527|Immunologic Factors|immunologic factors|mesh-ancestor
5752381|NCT03023527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5752382|NCT03023527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5752383|NCT03023527|Growth Substances|growth substances|mesh-ancestor
5752384|NCT03023527|Growth Inhibitors|growth inhibitors|mesh-ancestor
5752385|NCT03023514|Thioctic Acid|thioctic acid|mesh-list
5627868|NCT03263078|Propofol|propofol|mesh-list
5627869|NCT03263078|Sevoflurane|sevoflurane|mesh-list
5627870|NCT03263078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5627871|NCT03263078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5627872|NCT03263078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5627873|NCT03263078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5627874|NCT03263078|Anesthetics, General|anesthetics, general|mesh-ancestor
5627875|NCT03263078|Anesthetics|anesthetics|mesh-ancestor
5627876|NCT03263078|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5627877|NCT03263078|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5627878|NCT03256344|Atezolizumab|atezolizumab|mesh-list
5627879|NCT03256344|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
5752386|NCT03023514|Progesterone|progesterone|mesh-list
5752387|NCT03023514|Progestins|progestins|mesh-ancestor
5752388|NCT03023514|Hormones|hormones|mesh-ancestor
5752389|NCT03023514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5752390|NCT03023514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752391|NCT03023514|Antioxidants|antioxidants|mesh-ancestor
5752392|NCT03023514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627880|NCT03256344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5627881|NCT03256344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5627882|NCT03216187|Pregabalin|pregabalin|mesh-list
5627883|NCT03216187|Analgesics|analgesics|mesh-ancestor
5627884|NCT03216187|Sensory System Agents|sensory system agents|mesh-ancestor
5627885|NCT03216187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5627886|NCT03216187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5627887|NCT03216187|Anticonvulsants|anticonvulsants|mesh-ancestor
5627888|NCT03216187|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5627889|NCT03216187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5627890|NCT03216187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627891|NCT03216187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5627892|NCT03216187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5627893|NCT03216187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5627894|NCT03216187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5627895|NCT03216187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5752393|NCT03023514|Protective Agents|protective agents|mesh-ancestor
5752394|NCT03023514|Vitamin B Complex|vitamin b complex|mesh-ancestor
5752395|NCT03023514|Vitamins|vitamins|mesh-ancestor
5752396|NCT03023514|Micronutrients|micronutrients|mesh-ancestor
5752397|NCT03023501|Gabapentin|gabapentin|mesh-list
5752398|NCT03023501|Analgesics|analgesics|mesh-ancestor
5752399|NCT03023501|Sensory System Agents|sensory system agents|mesh-ancestor
6489673|NCT00593099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489674|NCT00593099|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6489675|NCT00593099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6489676|NCT00593099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5752400|NCT03023501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5752401|NCT03023501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752402|NCT03023501|Anticonvulsants|anticonvulsants|mesh-ancestor
5752403|NCT03023501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5752404|NCT03023501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5752405|NCT03023501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5752406|NCT03023501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5627896|NCT03207815|Prednisone|prednisone|mesh-list
5627897|NCT03207815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5627898|NCT03207815|Glucocorticoids|glucocorticoids|mesh-ancestor
5627899|NCT03207815|Hormones|hormones|mesh-ancestor
5627900|NCT03207815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5627901|NCT03207815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5627902|NCT03207815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5627903|NCT03207815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5627904|NCT03159936|Tofacitinib|tofacitinib|mesh-list
5627905|NCT03159936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752407|NCT03023501|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5752408|NCT03023501|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5752409|NCT03023501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5752410|NCT03023501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752411|NCT03023501|Antimanic Agents|antimanic agents|mesh-ancestor
5752412|NCT03023436|Fluorouracil|fluorouracil|mesh-list
5752413|NCT03023436|Capecitabine|capecitabine|mesh-list
5752414|NCT03023436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5752415|NCT03023436|Antimetabolites|antimetabolites|mesh-ancestor
5752416|NCT03023436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752417|NCT03023436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5752418|NCT03023436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5752419|NCT03023436|Immunologic Factors|immunologic factors|mesh-ancestor
5752420|NCT03023436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752421|NCT03023046|Prednisone|prednisone|mesh-list
5752422|NCT03023046|Cortisone|cortisone|mesh-list
5752423|NCT03023046|Cyclophosphamide|cyclophosphamide|mesh-list
5752424|NCT03023046|Rituximab|rituximab|mesh-list
5752425|NCT03023046|Doxorubicin|doxorubicin|mesh-list
5752426|NCT03023046|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5752427|NCT03023046|Etoposide|etoposide|mesh-list
5752428|NCT03023046|Vincristine|vincristine|mesh-list
5752429|NCT03023046|Etoposide phosphate|etoposide phosphate|mesh-list
5752430|NCT03023046|Imatinib Mesylate|imatinib mesylate|mesh-list
5752431|NCT03023046|Daunorubicin|daunorubicin|mesh-list
5752432|NCT03023046|Dasatinib|dasatinib|mesh-list
5752433|NCT03023046|Podophyllotoxin|podophyllotoxin|mesh-list
5752434|NCT03023046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5752435|NCT03023046|Antibodies|antibodies|mesh-list
5752436|NCT03023046|Immunoglobulins|immunoglobulins|mesh-list
5752437|NCT03023046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5752438|NCT03023046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5752439|NCT03023046|Immunologic Factors|immunologic factors|mesh-ancestor
5627906|NCT03159936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5627907|NCT03159936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5627908|NCT03156816|Colchicine|colchicine|mesh-list
5627909|NCT03156816|Gout Suppressants|gout suppressants|mesh-ancestor
5627910|NCT03156816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5627911|NCT03156816|Tubulin Modulators|tubulin modulators|mesh-ancestor
5627912|NCT03156816|Antimitotic Agents|antimitotic agents|mesh-ancestor
5627913|NCT03156816|Mitosis Modulators|mitosis modulators|mesh-ancestor
5627914|NCT03156816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627915|NCT03156816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5627916|NCT03141983|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5627917|NCT03141983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5627918|NCT03074513|Bevacizumab|bevacizumab|mesh-list
5627919|NCT03074513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5752440|NCT03023046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752441|NCT03023046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5752442|NCT03023046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5752443|NCT03023046|Alkylating Agents|alkylating agents|mesh-ancestor
6489677|NCT00593125|Levetiracetam|levetiracetam|mesh-list
5627920|NCT03074513|Atezolizumab|atezolizumab|mesh-list
5627921|NCT03074513|Endothelial Growth Factors|endothelial growth factors|mesh-list
5627922|NCT03074513|Antibodies|antibodies|mesh-list
5627923|NCT03074513|Immunoglobulins|immunoglobulins|mesh-list
5627924|NCT03074513|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5627925|NCT03074513|Immunoglobulin G|immunoglobulin g|mesh-list
5627926|NCT03074513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5627927|NCT03074513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5627928|NCT03074513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5627929|NCT03074513|Growth Substances|growth substances|mesh-ancestor
5627930|NCT03074513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5627931|NCT03074513|Growth Inhibitors|growth inhibitors|mesh-ancestor
5627932|NCT03074513|Immunologic Factors|immunologic factors|mesh-ancestor
5627933|NCT03070886|Docetaxel|docetaxel|mesh-list
5627934|NCT03070886|Leuprolide|leuprolide|mesh-list
5627935|NCT03070886|Goserelin|goserelin|mesh-list
5627936|NCT03070886|Bicalutamide|bicalutamide|mesh-list
5627937|NCT03070886|Flutamide|flutamide|mesh-list
5752444|NCT03023046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752445|NCT03023046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5752446|NCT03023046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5752447|NCT03023046|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5752448|NCT03023046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5752449|NCT03023046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5752450|NCT03023046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5752451|NCT03023046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5752452|NCT03023046|Glucocorticoids|glucocorticoids|mesh-ancestor
5752453|NCT03023046|Hormones|hormones|mesh-ancestor
5752454|NCT03023046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5752455|NCT03023046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5752456|NCT03023046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5752457|NCT03023046|Tubulin Modulators|tubulin modulators|mesh-ancestor
5752458|NCT03023046|Antimitotic Agents|antimitotic agents|mesh-ancestor
5752459|NCT03023046|Mitosis Modulators|mitosis modulators|mesh-ancestor
5752460|NCT03023046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5752461|NCT03023046|Keratolytic Agents|keratolytic agents|mesh-ancestor
5752462|NCT03023046|Dermatologic Agents|dermatologic agents|mesh-ancestor
5752463|NCT03023306|Antiemetics|antiemetics|mesh-list
5752464|NCT03023306|Autonomic Agents|autonomic agents|mesh-ancestor
5752465|NCT03023306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5752466|NCT03023306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752467|NCT03023306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5752468|NCT03023189|Tranexamic Acid|tranexamic acid|mesh-list
5752469|NCT03023189|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5752470|NCT03023189|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5752471|NCT03023189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752472|NCT03023189|Hemostatics|hemostatics|mesh-ancestor
5752473|NCT03023189|Coagulants|coagulants|mesh-ancestor
5752474|NCT03023111|Miltefosine|miltefosine|mesh-list
5752475|NCT03023111|Meglumine Antimoniate|meglumine antimoniate|mesh-list
5752476|NCT03023111|Molgramostim|molgramostim|mesh-list
5752477|NCT03023111|Sargramostim|sargramostim|mesh-list
5752478|NCT03023111|Immunologic Factors|immunologic factors|mesh-ancestor
5752479|NCT03023111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752480|NCT03023111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5752481|NCT03023111|Antifungal Agents|antifungal agents|mesh-ancestor
5752482|NCT03023111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5752483|NCT03023111|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5752484|NCT03023111|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5752485|NCT03023358|Prednisone|prednisone|mesh-list
5752486|NCT03023358|Cyclophosphamide|cyclophosphamide|mesh-list
5752487|NCT03023358|Doxorubicin|doxorubicin|mesh-list
5752488|NCT03023358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5627938|NCT03070886|Nilutamide|nilutamide|mesh-list
5627939|NCT03070886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5627940|NCT03070886|Tubulin Modulators|tubulin modulators|mesh-ancestor
5627941|NCT03070886|Antimitotic Agents|antimitotic agents|mesh-ancestor
5627942|NCT03070886|Mitosis Modulators|mitosis modulators|mesh-ancestor
5627943|NCT03070886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627944|NCT03070886|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5627945|NCT03070886|Fertility Agents|fertility agents|mesh-ancestor
5627946|NCT03070886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5627947|NCT03070886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752489|NCT03023358|Vincristine|vincristine|mesh-list
5752490|NCT03023358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5752491|NCT03023358|Immunologic Factors|immunologic factors|mesh-ancestor
5627948|NCT03070886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5627949|NCT03070886|Androgen Antagonists|androgen antagonists|mesh-ancestor
5752492|NCT03023358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5627950|NCT03070886|Hormone Antagonists|hormone antagonists|mesh-ancestor
5627951|NCT03070886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5627952|NCT03026062|Durvalumab|durvalumab|mesh-list
5752493|NCT03023358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5752494|NCT03023358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5752495|NCT03023358|Alkylating Agents|alkylating agents|mesh-ancestor
5752496|NCT03023358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752497|NCT03023358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5752498|NCT03023358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5752499|NCT03023358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5752500|NCT03023358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5752501|NCT03023358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5752502|NCT03023358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5752503|NCT03023358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5752504|NCT03023358|Glucocorticoids|glucocorticoids|mesh-ancestor
5627953|NCT03026062|Ipilimumab|ipilimumab|mesh-list
5627954|NCT03026062|Tremelimumab|tremelimumab|mesh-list
5627955|NCT03026062|Immunoglobulins|immunoglobulins|mesh-list
5627956|NCT03026062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5627957|NCT03026062|Immunoglobulin G|immunoglobulin g|mesh-list
5627958|NCT03026062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5627959|NCT03026062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5627960|NCT03026062|Immunologic Factors|immunologic factors|mesh-ancestor
5627961|NCT03026062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5627962|NCT03026062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5627963|NCT03026062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627964|NCT03019640|Cytarabine|cytarabine|mesh-list
5627965|NCT03019640|Rituximab|rituximab|mesh-list
5752505|NCT03023358|Hormones|hormones|mesh-ancestor
5752506|NCT03023358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5752507|NCT03023358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5752508|NCT03023358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5752509|NCT03023358|Tubulin Modulators|tubulin modulators|mesh-ancestor
5752510|NCT03023358|Antimitotic Agents|antimitotic agents|mesh-ancestor
5752511|NCT03023358|Mitosis Modulators|mitosis modulators|mesh-ancestor
5752512|NCT03023059|Levodopa|levodopa|mesh-list
5752513|NCT03023059|Carbidopa|carbidopa|mesh-list
5627966|NCT03019640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5627967|NCT03019640|Etoposide|etoposide|mesh-list
5627968|NCT03019640|Lenalidomide|lenalidomide|mesh-list
5627969|NCT03019640|Etoposide phosphate|etoposide phosphate|mesh-list
5627970|NCT03019640|Melphalan|melphalan|mesh-list
5627971|NCT03019640|Mechlorethamine|mechlorethamine|mesh-list
5627972|NCT03019640|Carmustine|carmustine|mesh-list
5627973|NCT03019640|Podophyllotoxin|podophyllotoxin|mesh-list
5627974|NCT03019640|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
5627975|NCT03019640|Antibodies|antibodies|mesh-list
5627976|NCT03019640|Immunoglobulins|immunoglobulins|mesh-list
5627977|NCT03019640|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5627978|NCT03019640|Lenograstim|lenograstim|mesh-list
5627979|NCT03019640|Immunologic Factors|immunologic factors|mesh-ancestor
5627980|NCT03019640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752514|NCT03023059|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
5752515|NCT03023059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5752516|NCT03023059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5752517|NCT03023059|Dopamine Agents|dopamine agents|mesh-ancestor
5752518|NCT03023059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5752519|NCT03023059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752520|NCT03023059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752521|NCT03023059|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5752522|NCT03023059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5752523|NCT03023059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5752524|NCT03023059|Immunologic Factors|immunologic factors|mesh-ancestor
5752525|NCT03023059|Dopamine Agonists|dopamine agonists|mesh-ancestor
5894677|NCT03555851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5894678|NCT03555851|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5894679|NCT03441750|Metformin|metformin|mesh-list
5894680|NCT03441750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5894681|NCT03441750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894682|NCT03423264|Gabapentin|gabapentin|mesh-list
5894683|NCT03423264|Analgesics|analgesics|mesh-ancestor
5894684|NCT03423264|Sensory System Agents|sensory system agents|mesh-ancestor
5627981|NCT03019640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5627982|NCT03019640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5627983|NCT03019640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5627984|NCT03019640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5627985|NCT03019640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5627986|NCT03019640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5627987|NCT03019640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5627988|NCT03019640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5627989|NCT03019640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5627990|NCT03019640|Antimetabolites|antimetabolites|mesh-ancestor
5627991|NCT03019640|Antiviral Agents|antiviral agents|mesh-ancestor
5627992|NCT03019640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5627993|NCT03019640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5627994|NCT03019640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5627995|NCT03019640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5627996|NCT03019640|Growth Substances|growth substances|mesh-ancestor
5627997|NCT03019640|Growth Inhibitors|growth inhibitors|mesh-ancestor
5627998|NCT03019640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5627999|NCT03019640|Alkylating Agents|alkylating agents|mesh-ancestor
5628000|NCT03019640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5628001|NCT03019640|Keratolytic Agents|keratolytic agents|mesh-ancestor
5628002|NCT03019640|Dermatologic Agents|dermatologic agents|mesh-ancestor
5628003|NCT03019640|Tubulin Modulators|tubulin modulators|mesh-ancestor
5628004|NCT03019640|Antimitotic Agents|antimitotic agents|mesh-ancestor
5628005|NCT03019640|Mitosis Modulators|mitosis modulators|mesh-ancestor
5628006|NCT02991937|Tazobactam|tazobactam|mesh-list
5628007|NCT02991937|Piperacillin|piperacillin|mesh-list
5628008|NCT02991937|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
5628009|NCT02991937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5628010|NCT02991937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5628011|NCT02991937|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5628012|NCT02991937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5628013|NCT02991937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5628014|NCT02968563|Obinutuzumab|obinutuzumab|mesh-list
5628015|NCT02968563|Idelalisib|idelalisib|mesh-list
5752526|NCT03023319|Pemetrexed|pemetrexed|mesh-list
5752527|NCT03023319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5752528|NCT03023319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5752529|NCT03023319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752530|NCT03023319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5752531|NCT03023319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5752532|NCT03023020|Aspirin|aspirin|mesh-list
5752533|NCT03023020|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
5752534|NCT03023020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5752535|NCT03023020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5752536|NCT03023020|Analgesics|analgesics|mesh-ancestor
5752537|NCT03023020|Sensory System Agents|sensory system agents|mesh-ancestor
5752538|NCT03023020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5752539|NCT03023020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752540|NCT03023020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5752541|NCT03023020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5752542|NCT03023020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5752543|NCT03023020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5752544|NCT03023020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752545|NCT03023020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5752546|NCT03023020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5752547|NCT03023020|Antipyretics|antipyretics|mesh-ancestor
5752548|NCT03023007|Anesthetics|anesthetics|mesh-list
5752549|NCT03023007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5752550|NCT03023007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752551|NCT03022838|Caffeine|caffeine|mesh-list
5752552|NCT03022838|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5752553|NCT03022838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752554|NCT03022838|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5752555|NCT03022838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5752556|NCT03022838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752557|NCT03022838|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5752558|NCT03022838|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5752559|NCT03022838|Purinergic Agents|purinergic agents|mesh-ancestor
5752560|NCT03022838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5752561|NCT03022877|Simendan|simendan|mesh-list
5752562|NCT03022877|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5752563|NCT03022877|Vasodilator Agents|vasodilator agents|mesh-ancestor
5752564|NCT03022877|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5752565|NCT03022877|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5752566|NCT03022877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5752567|NCT03022877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752568|NCT03022877|Protective Agents|protective agents|mesh-ancestor
5628016|NCT02968563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5752569|NCT03022877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752570|NCT03022773|Carotenoids|carotenoids|mesh-list
5752571|NCT03022773|Antioxidants|antioxidants|mesh-ancestor
5752572|NCT03022773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752573|NCT03022773|Protective Agents|protective agents|mesh-ancestor
5752574|NCT03022773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628017|NCT02968563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5628018|NCT02968563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5628019|NCT02968563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5628020|NCT02931890|Paclitaxel|paclitaxel|mesh-list
5628021|NCT02931890|Docetaxel|docetaxel|mesh-list
5628022|NCT02931890|Carboplatin|carboplatin|mesh-list
5628023|NCT02931890|Capecitabine|capecitabine|mesh-list
5628024|NCT02931890|Oxaliplatin|oxaliplatin|mesh-list
5628025|NCT02931890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5628026|NCT02931890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5628027|NCT02931890|Tubulin Modulators|tubulin modulators|mesh-ancestor
5628028|NCT02931890|Antimitotic Agents|antimitotic agents|mesh-ancestor
5628029|NCT02931890|Mitosis Modulators|mitosis modulators|mesh-ancestor
5628030|NCT02931890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5628031|NCT02931890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5628032|NCT02931890|Antimetabolites|antimetabolites|mesh-ancestor
5628033|NCT02915783|Everolimus|everolimus|mesh-list
5628034|NCT02915783|Lenvatinib|lenvatinib|mesh-list
5628035|NCT02915783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5628036|NCT02915783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5628037|NCT02915783|Immunologic Factors|immunologic factors|mesh-ancestor
5752575|NCT03022929|Anti-Infective Agents|anti-infective agents|mesh-list
5752576|NCT03022929|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5752577|NCT03022747|Allopurinol|allopurinol|mesh-list
5752578|NCT03022747|Antimetabolites|antimetabolites|mesh-ancestor
5752579|NCT03022747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752580|NCT03022747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5752581|NCT03022747|Gout Suppressants|gout suppressants|mesh-ancestor
5752582|NCT03022747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5752583|NCT03022747|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5752584|NCT03022747|Antioxidants|antioxidants|mesh-ancestor
5752585|NCT03022747|Protective Agents|protective agents|mesh-ancestor
5752586|NCT03022747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752587|NCT03022565|Vorinostat|vorinostat|mesh-list
5752588|NCT03022565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5752589|NCT03022565|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5752590|NCT03022565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5752591|NCT03022565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752592|NCT03022318|Levodopa|levodopa|mesh-list
5752593|NCT03022318|Carbidopa|carbidopa|mesh-list
5752594|NCT03022318|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
5752595|NCT03022318|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5752596|NCT03022318|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5752597|NCT03022318|Dopamine Agents|dopamine agents|mesh-ancestor
5752598|NCT03022318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5752599|NCT03022318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752600|NCT03022318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752601|NCT03022318|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5752602|NCT03022318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5752603|NCT03022318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5752604|NCT03022318|Immunologic Factors|immunologic factors|mesh-ancestor
5752605|NCT03022318|Dopamine Agonists|dopamine agonists|mesh-ancestor
5752606|NCT03022409|Olaparib|olaparib|mesh-list
5752607|NCT03022409|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5752608|NCT03022409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5752609|NCT03022409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752610|NCT03022409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5752611|NCT03022240|Ondansetron|ondansetron|mesh-list
5752612|NCT03022240|Propofol|propofol|mesh-list
5752613|NCT03022240|Sevoflurane|sevoflurane|mesh-list
5752614|NCT03022240|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5752615|NCT03022240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5752616|NCT03022240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752617|NCT03022240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5752618|NCT03022240|Anesthetics, General|anesthetics, general|mesh-ancestor
5752619|NCT03022240|Anesthetics|anesthetics|mesh-ancestor
5752620|NCT03022240|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5752621|NCT03022240|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5628038|NCT02915783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752622|NCT03022240|Antiemetics|antiemetics|mesh-ancestor
5752623|NCT03022240|Autonomic Agents|autonomic agents|mesh-ancestor
5752624|NCT03022240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5752625|NCT03022240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5752626|NCT03022240|Antipruritics|antipruritics|mesh-ancestor
5752627|NCT03022240|Dermatologic Agents|dermatologic agents|mesh-ancestor
5752628|NCT03022240|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5752629|NCT03022240|Serotonin Agents|serotonin agents|mesh-ancestor
5752630|NCT03022240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5752631|NCT03022240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752632|NCT03022240|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5752633|NCT03022240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5752634|NCT03022240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5752635|NCT03022240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5752636|NCT03022201|Domperidone|domperidone|mesh-list
5752637|NCT03022201|Antiemetics|antiemetics|mesh-ancestor
6489678|NCT00593125|Anticonvulsants|anticonvulsants|mesh-ancestor
6489679|NCT00593125|Nootropic Agents|nootropic agents|mesh-ancestor
6489680|NCT00593138|Methylphenidate|methylphenidate|mesh-list
6489681|NCT00593138|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
5752638|NCT03022201|Autonomic Agents|autonomic agents|mesh-ancestor
5752639|NCT03022201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5752640|NCT03022201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752641|NCT03022201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5752642|NCT03022201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5752643|NCT03022201|Dopamine Agents|dopamine agents|mesh-ancestor
5752644|NCT03022201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5752645|NCT03022201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752646|NCT03022253|Acetaminophen|acetaminophen|mesh-list
5752647|NCT03022253|Ibuprofen|ibuprofen|mesh-list
5752648|NCT03022253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5752649|NCT03022253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5752650|NCT03022253|Analgesics|analgesics|mesh-ancestor
5752651|NCT03022253|Sensory System Agents|sensory system agents|mesh-ancestor
5752652|NCT03022253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5752653|NCT03022253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752654|NCT03022253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5752655|NCT03022253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5752656|NCT03022253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5752657|NCT03022253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5752658|NCT03022253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752659|NCT03022253|Antipyretics|antipyretics|mesh-ancestor
5752660|NCT03022500|Durvalumab|durvalumab|mesh-list
5752661|NCT03022500|Tremelimumab|tremelimumab|mesh-list
5752662|NCT03022500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5752663|NCT03022500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5752664|NCT03021772|Dexamethasone|dexamethasone|mesh-list
5752665|NCT03021772|Neostigmine|neostigmine|mesh-list
5752666|NCT03021772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5752667|NCT03021772|Antiemetics|antiemetics|mesh-ancestor
5752668|NCT03021772|Autonomic Agents|autonomic agents|mesh-ancestor
5752669|NCT03021772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5752670|NCT03021772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752671|NCT03021772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5752672|NCT03021772|Glucocorticoids|glucocorticoids|mesh-ancestor
5752673|NCT03021772|Hormones|hormones|mesh-ancestor
5752674|NCT03021772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5752675|NCT03021772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5752676|NCT03021772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5628039|NCT02915783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5628040|NCT02915783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5628041|NCT02915783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5628042|NCT02913482|Risdiplam|risdiplam|mesh-list
5628043|NCT02913482|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5628044|NCT02913482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5628045|NCT02913482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628046|NCT02897648|Lactams|lactams|mesh-list
5628047|NCT02897648|beta-Lactams|beta-lactams|mesh-list
5628048|NCT02897648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5628049|NCT02897648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5752677|NCT03021772|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5752678|NCT03021772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5752679|NCT03021772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752680|NCT03021772|Cholinergic Agents|cholinergic agents|mesh-ancestor
5752681|NCT03021772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5752682|NCT03021772|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5752683|NCT03022123|Prednisone|prednisone|mesh-list
5752684|NCT03022123|Cyclophosphamide|cyclophosphamide|mesh-list
5752685|NCT03022123|Doxorubicin|doxorubicin|mesh-list
5752686|NCT03022123|Vincristine|vincristine|mesh-list
5752687|NCT03022123|Epirubicin|epirubicin|mesh-list
5752688|NCT03022123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5752689|NCT03022123|Immunologic Factors|immunologic factors|mesh-ancestor
5752690|NCT03022123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752691|NCT03022123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5752692|NCT03022123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5752693|NCT03022123|Alkylating Agents|alkylating agents|mesh-ancestor
5752694|NCT03022123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752695|NCT03022123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5752696|NCT03022123|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5628050|NCT02817659|Glucagon|glucagon|mesh-list
5628051|NCT02817659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5628052|NCT02817659|Hormones|hormones|mesh-ancestor
5628053|NCT02817659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5628054|NCT02817659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628055|NCT02811510|Dronabinol|dronabinol|mesh-list
5628056|NCT02811510|Hallucinogens|hallucinogens|mesh-ancestor
5628057|NCT02811510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752697|NCT03022123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5752698|NCT03022123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5752699|NCT03022123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5752700|NCT03022123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5752701|NCT03022123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5752702|NCT03022123|Glucocorticoids|glucocorticoids|mesh-ancestor
5752703|NCT03022123|Hormones|hormones|mesh-ancestor
5752704|NCT03022123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5752705|NCT03022123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5752706|NCT03022123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5752707|NCT03022123|Tubulin Modulators|tubulin modulators|mesh-ancestor
5752708|NCT03022123|Antimitotic Agents|antimitotic agents|mesh-ancestor
5752709|NCT03022123|Mitosis Modulators|mitosis modulators|mesh-ancestor
5752710|NCT03021785|Bevacizumab|bevacizumab|mesh-list
5752711|NCT03021785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5752712|NCT03021785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5752713|NCT03021785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5752714|NCT03021785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5752715|NCT03021785|Growth Substances|growth substances|mesh-ancestor
5752716|NCT03021785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752717|NCT03021785|Growth Inhibitors|growth inhibitors|mesh-ancestor
5752718|NCT03022006|Grazoprevir|grazoprevir|mesh-list
5752719|NCT03022006|Antiviral Agents|antiviral agents|mesh-ancestor
5752720|NCT03022006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5752721|NCT03021616|Moxifloxacin|moxifloxacin|mesh-list
5752722|NCT03021616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5752723|NCT03021616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5752724|NCT03021616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5752725|NCT03021616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5752726|NCT03021616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5752727|NCT03021616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752728|NCT03021616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5752729|NCT03021486|Haloperidol|haloperidol|mesh-list
5752730|NCT03021486|Chlorpromazine|chlorpromazine|mesh-list
5752731|NCT03021486|Haloperidol decanoate|haloperidol decanoate|mesh-list
5752732|NCT03021486|Antiemetics|antiemetics|mesh-ancestor
5752733|NCT03021486|Autonomic Agents|autonomic agents|mesh-ancestor
5752734|NCT03021486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5752735|NCT03021486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752736|NCT03021486|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5752737|NCT03021486|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5752738|NCT03021486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5752739|NCT03021486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5752740|NCT03021486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5752741|NCT03021486|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5752742|NCT03021486|Dopamine Agents|dopamine agents|mesh-ancestor
5752743|NCT03021486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5752744|NCT03021486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752745|NCT03021486|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5752746|NCT03021629|Vitamin D|vitamin d|mesh-list
5752747|NCT03021629|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
5752748|NCT03021629|Vitamins|vitamins|mesh-ancestor
5752749|NCT03021629|Micronutrients|micronutrients|mesh-ancestor
5752750|NCT03021629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673081|NCT01560299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752751|NCT03021629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5752752|NCT03021590|Amoxicillin|amoxicillin|mesh-list
5752753|NCT03021590|Clarithromycin|clarithromycin|mesh-list
5752754|NCT03021590|Levofloxacin|levofloxacin|mesh-list
5752755|NCT03021590|Ofloxacin|ofloxacin|mesh-list
5752756|NCT03021590|Tinidazole|tinidazole|mesh-list
5752757|NCT03021590|Esomeprazole|esomeprazole|mesh-list
5752758|NCT03021590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5752759|NCT03021590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5752760|NCT03021590|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5752761|NCT03021590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5752762|NCT03021590|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5752763|NCT03021590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5752764|NCT03021590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752765|NCT03021590|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5752766|NCT03021590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5752767|NCT03021590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5752768|NCT03021590|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5752769|NCT03021590|Renal Agents|renal agents|mesh-ancestor
5752770|NCT03021590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5752771|NCT03021590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5752772|NCT03021590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5752773|NCT03021590|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5752774|NCT03021590|Alkylating Agents|alkylating agents|mesh-ancestor
5752775|NCT03021590|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
5752776|NCT03021590|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5752777|NCT03021590|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5752778|NCT03021694|Caseins|caseins|mesh-list
5628058|NCT02811510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5628059|NCT02811510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5628060|NCT02811510|Analgesics|analgesics|mesh-ancestor
5628061|NCT02811510|Sensory System Agents|sensory system agents|mesh-ancestor
5628062|NCT02811510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5628063|NCT02811510|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5628064|NCT02811510|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5628065|NCT02811510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5628066|NCT02811510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752779|NCT03021694|Chelating Agents|chelating agents|mesh-ancestor
5752780|NCT03021694|Sequestering Agents|sequestering agents|mesh-ancestor
5752781|NCT03021694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752782|NCT03021460|Pembrolizumab|pembrolizumab|mesh-list
5752783|NCT03021460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5752784|NCT03021460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5752785|NCT03021395|Decitabine|decitabine|mesh-list
5752786|NCT03021395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5752787|NCT03021395|Antimetabolites|antimetabolites|mesh-ancestor
5752788|NCT03021395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5628067|NCT02811510|Hormones|hormones|mesh-ancestor
5628068|NCT02811510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5628069|NCT02798523|Methylprednisolone|methylprednisolone|mesh-list
5628070|NCT02798523|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5628071|NCT02798523|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5628072|NCT02798523|Prednisolone|prednisolone|mesh-list
5628073|NCT02798523|Prednisolone acetate|prednisolone acetate|mesh-list
5628074|NCT02798523|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
5628075|NCT02798523|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5628076|NCT02798523|Prednisolone phosphate|prednisolone phosphate|mesh-list
5628077|NCT02798523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5628078|NCT02798523|Antiemetics|antiemetics|mesh-ancestor
5752789|NCT03021395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6489682|NCT00593138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5628079|NCT02798523|Autonomic Agents|autonomic agents|mesh-ancestor
5628080|NCT02798523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5628081|NCT02798523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628082|NCT02798523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6489683|NCT00593138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628083|NCT02798523|Glucocorticoids|glucocorticoids|mesh-ancestor
6489684|NCT00593138|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6489685|NCT00593138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6489686|NCT00593138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6489687|NCT00593138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489688|NCT00593138|Dopamine Agents|dopamine agents|mesh-ancestor
6489689|NCT00593138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6673082|NCT01560390|Ketamine|ketamine|mesh-list
5628084|NCT02798523|Hormones|hormones|mesh-ancestor
5752790|NCT03021395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5752791|NCT03021317|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
5752792|NCT03021317|Hormones|hormones|mesh-ancestor
5628085|NCT02798523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5628086|NCT02798523|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5628087|NCT02798523|Protective Agents|protective agents|mesh-ancestor
5628088|NCT02798523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5628089|NCT02798523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5628090|NCT02796261|Eflornithine|eflornithine|mesh-list
5628091|NCT02796261|Lomustine|lomustine|mesh-list
5628092|NCT02796261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5628093|NCT02796261|Alkylating Agents|alkylating agents|mesh-ancestor
5628094|NCT02796261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5628095|NCT02796261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5628096|NCT02796261|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5628097|NCT02796261|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5628098|NCT02796261|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5628099|NCT02796261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5628100|NCT02796261|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
5628101|NCT02796261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5628102|NCT02787044|Vaccines|vaccines|mesh-list
5628103|NCT02787044|Immunologic Factors|immunologic factors|mesh-ancestor
5628104|NCT02787044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628105|NCT02782468|Azacitidine|azacitidine|mesh-list
5628106|NCT02782468|Pevonedistat|pevonedistat|mesh-list
5628107|NCT02782468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5628108|NCT02782468|Antimetabolites|antimetabolites|mesh-ancestor
5628109|NCT02782468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5628110|NCT02782468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5628111|NCT02782468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5628112|NCT02781519|Dronabinol|dronabinol|mesh-list
5628113|NCT02781519|Hallucinogens|hallucinogens|mesh-ancestor
5628114|NCT02781519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628115|NCT02781519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5628116|NCT02781519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5628117|NCT02781519|Analgesics|analgesics|mesh-ancestor
5628118|NCT02781519|Sensory System Agents|sensory system agents|mesh-ancestor
5628119|NCT02781519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5628120|NCT02781519|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5628121|NCT02781519|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5628122|NCT02781519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5628123|NCT02781519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752793|NCT03021317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5752794|NCT03021317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752795|NCT03021330|Cytarabine|cytarabine|mesh-list
5752796|NCT03021330|Daunorubicin|daunorubicin|mesh-list
5752797|NCT03021330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5752798|NCT03021330|Antimetabolites|antimetabolites|mesh-ancestor
5752799|NCT03021330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752800|NCT03021330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5752801|NCT03021330|Antiviral Agents|antiviral agents|mesh-ancestor
5752802|NCT03021330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5752803|NCT03021330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5628124|NCT02781519|Hormones|hormones|mesh-ancestor
5628125|NCT02781519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5628126|NCT02773732|Ciprofloxacin|ciprofloxacin|mesh-list
5628127|NCT02773732|Etoposide|etoposide|mesh-list
5628128|NCT02773732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5752804|NCT03021330|Immunologic Factors|immunologic factors|mesh-ancestor
6489690|NCT00593151|Interferons|interferons|mesh-list
6489691|NCT00593151|Interferon-alpha|interferon-alpha|mesh-list
6489692|NCT00593151|Interferon alpha-2|interferon alpha-2|mesh-list
6489693|NCT00593151|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6489694|NCT00593151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6489695|NCT00593151|Antiviral Agents|antiviral agents|mesh-ancestor
6489696|NCT00593151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6489697|NCT00593151|Immunologic Factors|immunologic factors|mesh-ancestor
6489698|NCT00593151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489699|NCT00593164|Magnesium Sulfate|magnesium sulfate|mesh-list
6489700|NCT00593164|Analgesics|analgesics|mesh-ancestor
6489701|NCT00593164|Sensory System Agents|sensory system agents|mesh-ancestor
6489702|NCT00593164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6489703|NCT00593164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693088|NCT03403140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6489704|NCT00593164|Anesthetics|anesthetics|mesh-ancestor
5628129|NCT02773732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5628130|NCT02773732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5752805|NCT03021330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752806|NCT03021330|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5752807|NCT03021330|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5752808|NCT03021330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5628131|NCT02773732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5628132|NCT02773732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5628133|NCT02773732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5628134|NCT02773732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5628135|NCT02773732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5628136|NCT02773732|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5628137|NCT02773732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5628138|NCT02764489|Thrombin|thrombin|mesh-list
5752809|NCT03021330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5894685|NCT03423264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5894686|NCT03423264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894687|NCT03423264|Anticonvulsants|anticonvulsants|mesh-ancestor
5894688|NCT03423264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5894689|NCT03423264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5894690|NCT03423264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5894691|NCT03423264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5894692|NCT03423264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5894693|NCT03423264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5894694|NCT03423264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5894695|NCT03423264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894696|NCT03423264|Antimanic Agents|antimanic agents|mesh-ancestor
5907801|NCT05196945|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5907802|NCT05196945|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5907803|NCT05196945|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5907804|NCT05196945|Antacids|antacids|mesh-ancestor
5907805|NCT05196945|Diuretics|diuretics|mesh-ancestor
5907806|NCT05196945|Natriuretic Agents|natriuretic agents|mesh-ancestor
5907807|NCT05196945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907808|NCT05196945|Expectorants|expectorants|mesh-ancestor
5907809|NCT05196945|Respiratory System Agents|respiratory system agents|mesh-ancestor
5907810|NCT05186974|Carboplatin|carboplatin|mesh-list
5907811|NCT05186974|Pembrolizumab|pembrolizumab|mesh-list
5907812|NCT05186974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5907813|NCT05186974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5907814|NCT05183126|Paclitaxel|paclitaxel|mesh-list
5907815|NCT05183126|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5907816|NCT05183126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5907817|NCT05183126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5907818|NCT05183126|Tubulin Modulators|tubulin modulators|mesh-ancestor
5907819|NCT05183126|Antimitotic Agents|antimitotic agents|mesh-ancestor
5907820|NCT05183126|Mitosis Modulators|mitosis modulators|mesh-ancestor
5907821|NCT05183126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907822|NCT05168657|Pancrelipase|pancrelipase|mesh-list
5907823|NCT05168657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5907824|NCT05167331|Nitrous Oxide|nitrous oxide|mesh-list
5907825|NCT05167331|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5907826|NCT05167331|Anesthetics, General|anesthetics, general|mesh-ancestor
6489705|NCT00593164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6489706|NCT00593164|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6489707|NCT00593164|Anticonvulsants|anticonvulsants|mesh-ancestor
6489708|NCT00593164|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6489709|NCT00593164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6489710|NCT00593164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489711|NCT00593164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6489712|NCT00593164|Tocolytic Agents|tocolytic agents|mesh-ancestor
6489713|NCT00593164|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6489714|NCT00593177|Parathyroid Hormone|parathyroid hormone|mesh-list
5628139|NCT02764489|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
5628140|NCT02764489|Coagulants|coagulants|mesh-list
5628141|NCT02764489|Hemostatics|hemostatics|mesh-ancestor
5628142|NCT02756845|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
5628143|NCT02756845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5628144|NCT02756845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5628145|NCT02659241|Adavosertib|adavosertib|mesh-list
6489715|NCT00593177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6489716|NCT00593177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489717|NCT00593255|Insulin|insulin|mesh-list
5628146|NCT02659241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5628147|NCT02659241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5628148|NCT02607813|Spartalizumab|spartalizumab|mesh-list
5628149|NCT02607813|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5628150|NCT02607813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5628151|NCT02607813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5628152|NCT02586857|Acalabrutinib|acalabrutinib|mesh-list
5628153|NCT02586857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5628154|NCT02586675|Tamoxifen|tamoxifen|mesh-list
5628155|NCT02586675|Goserelin|goserelin|mesh-list
5628156|NCT02586675|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5628157|NCT02586675|Hormone Antagonists|hormone antagonists|mesh-ancestor
5628158|NCT02586675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5628159|NCT02586675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628160|NCT02586675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5628161|NCT02586675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5628162|NCT02586675|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5628163|NCT02586675|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5628164|NCT02586675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5628165|NCT02582905|Choline|choline|mesh-list
5628166|NCT02582905|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
5628167|NCT02582905|Lipotropic Agents|lipotropic agents|mesh-ancestor
5628168|NCT02582905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5628169|NCT02582905|Antimetabolites|antimetabolites|mesh-ancestor
5628170|NCT02582905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5628171|NCT02582905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5628172|NCT02582905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5628173|NCT02582905|Nootropic Agents|nootropic agents|mesh-ancestor
5628174|NCT02572843|Durvalumab|durvalumab|mesh-list
5628175|NCT02572843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5628176|NCT02572843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5628177|NCT02560805|Losartan|losartan|mesh-list
5628178|NCT02560805|Atenolol|atenolol|mesh-list
5628179|NCT02560805|Nitroprusside|nitroprusside|mesh-list
5628180|NCT02560805|Phenylephrine|phenylephrine|mesh-list
5628181|NCT02560805|Oxymetazoline|oxymetazoline|mesh-list
5628182|NCT02560805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5628183|NCT02560805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5628184|NCT02560805|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5752810|NCT03021421|Bupivacaine|bupivacaine|mesh-list
5752811|NCT03021421|Anesthetics, Local|anesthetics, local|mesh-ancestor
5752812|NCT03021421|Anesthetics|anesthetics|mesh-ancestor
5752813|NCT03021421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5752814|NCT03021421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752815|NCT03021421|Sensory System Agents|sensory system agents|mesh-ancestor
5752816|NCT03021421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5752817|NCT03021083|Fentanyl|fentanyl|mesh-list
5752818|NCT03021083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5752819|NCT03021083|Narcotics|narcotics|mesh-ancestor
5752820|NCT03021083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5752821|NCT03021083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752822|NCT03021083|Analgesics|analgesics|mesh-ancestor
5752823|NCT03021083|Sensory System Agents|sensory system agents|mesh-ancestor
5752824|NCT03021083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5752825|NCT03021083|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5752826|NCT03021083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5752827|NCT03021083|Anesthetics, General|anesthetics, general|mesh-ancestor
5752828|NCT03021083|Anesthetics|anesthetics|mesh-ancestor
5752829|NCT03021057|Pembrolizumab|pembrolizumab|mesh-list
5752830|NCT03021057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5752831|NCT03021057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5752832|NCT03020979|Apatinib|apatinib|mesh-list
5752833|NCT03020979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5752834|NCT03020979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5752835|NCT03020979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5752836|NCT03020979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752837|NCT03020953|Estrogens|estrogens|mesh-list
5752838|NCT03020953|Hormones|hormones|mesh-ancestor
5752839|NCT03020953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5752840|NCT03020953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752841|NCT03020914|Methamphetamine|methamphetamine|mesh-list
5752842|NCT03020914|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5752843|NCT03020914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628185|NCT02560805|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5628186|NCT02560805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5628187|NCT02560805|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5628188|NCT02560805|Mydriatics|mydriatics|mesh-ancestor
5628189|NCT02560805|Autonomic Agents|autonomic agents|mesh-ancestor
5628190|NCT02560805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5628191|NCT02560805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628192|NCT02560805|Sympathomimetics|sympathomimetics|mesh-ancestor
5628193|NCT02560805|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5628194|NCT02560805|Nasal Decongestants|nasal decongestants|mesh-ancestor
5752844|NCT03020914|Sympathomimetics|sympathomimetics|mesh-ancestor
5752845|NCT03020914|Autonomic Agents|autonomic agents|mesh-ancestor
5752846|NCT03020914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5752847|NCT03020914|Dopamine Agents|dopamine agents|mesh-ancestor
5752848|NCT03020914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5752849|NCT03020914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752850|NCT03020914|Adrenergic Agents|adrenergic agents|mesh-ancestor
5752851|NCT03020914|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5752852|NCT03020914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5752853|NCT03020914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5752854|NCT03020914|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5752855|NCT03020940|Cefuroxime|cefuroxime|mesh-list
5752856|NCT03020940|Cefuroxime axetil|cefuroxime axetil|mesh-list
5752857|NCT03020940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5752858|NCT03020940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5752859|NCT03020901|Teicoplanin|teicoplanin|mesh-list
5752860|NCT03020901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5752861|NCT03020901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5752862|NCT03020875|Acetaminophen|acetaminophen|mesh-list
5752863|NCT03020875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5752864|NCT03020875|Analgesics|analgesics|mesh-ancestor
5752865|NCT03020875|Sensory System Agents|sensory system agents|mesh-ancestor
5752866|NCT03020875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5752867|NCT03020875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752868|NCT03020875|Antipyretics|antipyretics|mesh-ancestor
5752869|NCT03020680|Ubiquinone|ubiquinone|mesh-list
5752870|NCT03020680|Coenzyme Q10|coenzyme q10|mesh-list
5752871|NCT03020680|Micronutrients|micronutrients|mesh-ancestor
5752872|NCT03020680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752873|NCT03020680|Vitamins|vitamins|mesh-ancestor
5752874|NCT03020563|Bupivacaine|bupivacaine|mesh-list
5752875|NCT03020563|Anesthetics, Local|anesthetics, local|mesh-ancestor
5752876|NCT03020563|Anesthetics|anesthetics|mesh-ancestor
5752877|NCT03020563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5752878|NCT03020563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752879|NCT03020563|Sensory System Agents|sensory system agents|mesh-ancestor
5752880|NCT03020563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5752881|NCT03020706|Magnesium Sulfate|magnesium sulfate|mesh-list
5752882|NCT03020706|Analgesics|analgesics|mesh-ancestor
5752883|NCT03020706|Sensory System Agents|sensory system agents|mesh-ancestor
5752884|NCT03020706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5752885|NCT03020706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628195|NCT02560805|Respiratory System Agents|respiratory system agents|mesh-ancestor
5628196|NCT02560805|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5628197|NCT02560805|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5628198|NCT02560805|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5628199|NCT02560805|Adrenergic Agents|adrenergic agents|mesh-ancestor
5628200|NCT02560805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5628201|NCT02560805|Protective Agents|protective agents|mesh-ancestor
5752886|NCT03020706|Anesthetics|anesthetics|mesh-ancestor
5752887|NCT03020706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5752888|NCT03020706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5752889|NCT03020706|Anticonvulsants|anticonvulsants|mesh-ancestor
5752890|NCT03020706|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5752891|NCT03020706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5752892|NCT03020706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752893|NCT03020706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5752894|NCT03020706|Tocolytic Agents|tocolytic agents|mesh-ancestor
5752895|NCT03020706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5752896|NCT03020602|Ubiquinone|ubiquinone|mesh-list
5752897|NCT03020602|Coenzyme Q10|coenzyme q10|mesh-list
5752898|NCT03020602|Micronutrients|micronutrients|mesh-ancestor
5752899|NCT03020602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752900|NCT03020602|Vitamins|vitamins|mesh-ancestor
5752901|NCT03020589|Tacrolimus|tacrolimus|mesh-list
5628202|NCT02560805|Sympatholytics|sympatholytics|mesh-ancestor
5628203|NCT02560805|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5628204|NCT02560805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5628205|NCT02560805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5752902|NCT03020589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5752903|NCT03020589|Immunologic Factors|immunologic factors|mesh-ancestor
5752904|NCT03020589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628206|NCT02560805|Vasodilator Agents|vasodilator agents|mesh-ancestor
5628207|NCT02560805|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5628208|NCT02557672|Thrombin|thrombin|mesh-list
5628209|NCT02557672|Hemostatics|hemostatics|mesh-ancestor
5628210|NCT02557672|Coagulants|coagulants|mesh-ancestor
5628211|NCT02529930|Vaccines|vaccines|mesh-list
5628212|NCT02529930|Immunologic Factors|immunologic factors|mesh-ancestor
5752905|NCT03020589|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5752906|NCT03020589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5752907|NCT03020589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752908|NCT03020368|Diclofenac|diclofenac|mesh-list
5752909|NCT03020368|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5752910|NCT03020368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5752911|NCT03020368|Analgesics|analgesics|mesh-ancestor
5752912|NCT03020368|Sensory System Agents|sensory system agents|mesh-ancestor
5752913|NCT03020368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5752914|NCT03020368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752915|NCT03020368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5752916|NCT03020368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5752917|NCT03020368|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5752918|NCT03020368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5752919|NCT03020368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752920|NCT03020329|Paclitaxel|paclitaxel|mesh-list
5752921|NCT03020329|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5752922|NCT03020329|Cisplatin|cisplatin|mesh-list
5752923|NCT03020329|Fluorouracil|fluorouracil|mesh-list
5628213|NCT02529930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628214|NCT02504151|Cannabidiol|cannabidiol|mesh-list
5628215|NCT02504151|Anticonvulsants|anticonvulsants|mesh-ancestor
5628216|NCT02485418|Propofol|propofol|mesh-list
5628217|NCT02485418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5628218|NCT02485418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5628219|NCT02485418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628220|NCT02485418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5628221|NCT02485418|Anesthetics, General|anesthetics, general|mesh-ancestor
5628222|NCT02485418|Anesthetics|anesthetics|mesh-ancestor
5628223|NCT02367105|Testosterone|testosterone|mesh-list
5752924|NCT03020329|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5752925|NCT03020329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5752926|NCT03020329|Tubulin Modulators|tubulin modulators|mesh-ancestor
5752927|NCT03020329|Antimitotic Agents|antimitotic agents|mesh-ancestor
5752928|NCT03020329|Mitosis Modulators|mitosis modulators|mesh-ancestor
5752929|NCT03020329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752930|NCT03020329|Antimetabolites|antimetabolites|mesh-ancestor
5752931|NCT03020329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5752932|NCT03020329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5752933|NCT03020329|Immunologic Factors|immunologic factors|mesh-ancestor
5752934|NCT03020329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628224|NCT02367105|Androgens|androgens|mesh-ancestor
5628225|NCT02367105|Hormones|hormones|mesh-ancestor
5628226|NCT02367105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5628227|NCT02367105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752935|NCT03020303|Spironolactone|spironolactone|mesh-list
5752936|NCT03020303|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5752937|NCT03020303|Hormone Antagonists|hormone antagonists|mesh-ancestor
5752938|NCT03020303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5752939|NCT03020303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752940|NCT03020303|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5752941|NCT03020303|Diuretics|diuretics|mesh-ancestor
5752942|NCT03020303|Natriuretic Agents|natriuretic agents|mesh-ancestor
5752943|NCT03020134|Ritonavir|ritonavir|mesh-list
5752944|NCT03020134|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5752945|NCT03020134|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5752946|NCT03020134|Protease Inhibitors|protease inhibitors|mesh-ancestor
5752947|NCT03020134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5752948|NCT03020134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752949|NCT03020134|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5752950|NCT03020134|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5752951|NCT03020134|Antiviral Agents|antiviral agents|mesh-ancestor
5752952|NCT03020134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5894697|NCT03367715|Nivolumab|nivolumab|mesh-list
5628228|NCT02352948|Gemcitabine|gemcitabine|mesh-list
5628229|NCT02352948|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5628230|NCT02352948|Durvalumab|durvalumab|mesh-list
5628231|NCT02352948|Vinorelbine|vinorelbine|mesh-list
5752953|NCT03020134|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5752954|NCT03020134|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5752955|NCT03020056|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5752956|NCT03020056|Antioxidants|antioxidants|mesh-list
5752957|NCT03020056|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5752958|NCT03020056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752959|NCT03020056|Protective Agents|protective agents|mesh-ancestor
5752960|NCT03020056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752961|NCT03019822|Amphetamine|amphetamine|mesh-list
5752962|NCT03019822|Dextroamphetamine|dextroamphetamine|mesh-list
5752963|NCT03019822|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
5752964|NCT03019822|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
5752965|NCT03019822|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5752966|NCT03019822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5752967|NCT03019822|Sympathomimetics|sympathomimetics|mesh-ancestor
5752968|NCT03019822|Autonomic Agents|autonomic agents|mesh-ancestor
5752969|NCT03019822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5752970|NCT03019822|Dopamine Agents|dopamine agents|mesh-ancestor
5752971|NCT03019822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5752972|NCT03019822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752973|NCT03019822|Adrenergic Agents|adrenergic agents|mesh-ancestor
5752974|NCT03019822|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5752975|NCT03019822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5752976|NCT03019822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5752977|NCT03019822|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5752978|NCT03019822|Hallucinogens|hallucinogens|mesh-ancestor
5752979|NCT03019822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5752980|NCT03019822|Serotonin Agents|serotonin agents|mesh-ancestor
5752981|NCT03019822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5752982|NCT03019822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5752983|NCT03019991|Ritonavir|ritonavir|mesh-list
5752984|NCT03019991|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5752985|NCT03019991|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5752986|NCT03019991|Protease Inhibitors|protease inhibitors|mesh-ancestor
5752987|NCT03019991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5752988|NCT03019991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5752989|NCT03019991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5752990|NCT03019991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5752991|NCT03019991|Antiviral Agents|antiviral agents|mesh-ancestor
5752992|NCT03019991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5752993|NCT03019991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5752994|NCT03019991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5752995|NCT03019926|Hydroxychloroquine|hydroxychloroquine|mesh-list
5752996|NCT03019926|Antimalarials|antimalarials|mesh-ancestor
5752997|NCT03019926|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5752998|NCT03019926|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5752999|NCT03019926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5753000|NCT03019926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5753001|NCT03019926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5753002|NCT03019926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5753003|NCT03019835|Neostigmine|neostigmine|mesh-list
5753004|NCT03019835|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5753005|NCT03019835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5753006|NCT03019835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5753007|NCT03019835|Cholinergic Agents|cholinergic agents|mesh-ancestor
5753008|NCT03019835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5753009|NCT03019835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753010|NCT03019835|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5753011|NCT03019835|Autonomic Agents|autonomic agents|mesh-ancestor
5753012|NCT03019835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5753013|NCT03019848|Curcumin|curcumin|mesh-list
5753014|NCT03019848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5753015|NCT03019848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5753016|NCT03019848|Analgesics|analgesics|mesh-ancestor
5753017|NCT03019848|Sensory System Agents|sensory system agents|mesh-ancestor
5753018|NCT03019848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5753019|NCT03019848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753020|NCT03019848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5753021|NCT03019848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5753022|NCT03019848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5753023|NCT03019848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5753024|NCT03019848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5753025|NCT03019809|Plerixafor|plerixafor|mesh-list
5753026|NCT03019809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5753027|NCT03019809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5753028|NCT03019809|Antiviral Agents|antiviral agents|mesh-ancestor
5753029|NCT03019809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5753030|NCT03019614|Hydrocortisone|hydrocortisone|mesh-list
5753031|NCT03019614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5894698|NCT03367715|Ipilimumab|ipilimumab|mesh-list
5894699|NCT03367715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5894700|NCT03367715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5894701|NCT03367715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5894702|NCT03367715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894703|NCT03360890|Docetaxel|docetaxel|mesh-list
5894704|NCT03360890|Pembrolizumab|pembrolizumab|mesh-list
5894705|NCT03360890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5894706|NCT03360890|Tubulin Modulators|tubulin modulators|mesh-ancestor
5894707|NCT03360890|Antimitotic Agents|antimitotic agents|mesh-ancestor
5894708|NCT03360890|Mitosis Modulators|mitosis modulators|mesh-ancestor
5628232|NCT02352948|Tremelimumab|tremelimumab|mesh-list
5628233|NCT02352948|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5628234|NCT02352948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5628235|NCT02352948|Antimetabolites|antimetabolites|mesh-ancestor
5628236|NCT02352948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5628237|NCT02352948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5628238|NCT02352948|Antiviral Agents|antiviral agents|mesh-ancestor
5628239|NCT02352948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5628240|NCT02352948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5628241|NCT02352948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5628242|NCT02352948|Immunologic Factors|immunologic factors|mesh-ancestor
5628243|NCT02352948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628244|NCT02352948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5628245|NCT02352948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5628246|NCT02352948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5628247|NCT02352948|Tubulin Modulators|tubulin modulators|mesh-ancestor
5628248|NCT02352948|Antimitotic Agents|antimitotic agents|mesh-ancestor
5628249|NCT02352948|Mitosis Modulators|mitosis modulators|mesh-ancestor
5628250|NCT02332590|Adalimumab|adalimumab|mesh-list
5628251|NCT02332590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5628252|NCT02332590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5628253|NCT02274571|Estrogens|estrogens|mesh-list
5628254|NCT02274571|Hormones|hormones|mesh-ancestor
5628255|NCT02274571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5628256|NCT02274571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628257|NCT02269670|Tamoxifen|tamoxifen|mesh-list
5628258|NCT02269670|Everolimus|everolimus|mesh-list
5628259|NCT02269670|Letrozole|letrozole|mesh-list
5628260|NCT02269670|Fulvestrant|fulvestrant|mesh-list
5628261|NCT02269670|Anastrozole|anastrozole|mesh-list
5628262|NCT02269670|Megestrol|megestrol|mesh-list
5628263|NCT02269670|Megestrol Acetate|megestrol acetate|mesh-list
5628264|NCT02269670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5628265|NCT02269670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5628266|NCT02269670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5628267|NCT02269670|Immunologic Factors|immunologic factors|mesh-ancestor
5628268|NCT02269670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894709|NCT03360890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894710|NCT03360890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5894711|NCT03225547|Pembrolizumab|pembrolizumab|mesh-list
5894712|NCT03225547|Mifepristone|mifepristone|mesh-list
5894713|NCT03225547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5894714|NCT03225547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5894715|NCT03225547|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5894716|NCT03225547|Abortifacient Agents|abortifacient agents|mesh-ancestor
5894717|NCT03225547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5894718|NCT03225547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894719|NCT03225547|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5894720|NCT03225547|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5894721|NCT03225547|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5894722|NCT03225547|Contraceptive Agents|contraceptive agents|mesh-ancestor
5894723|NCT03225547|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5894724|NCT03225547|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5894725|NCT03225547|Hormone Antagonists|hormone antagonists|mesh-ancestor
5894726|NCT03225547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5894727|NCT03225547|Luteolytic Agents|luteolytic agents|mesh-ancestor
5894728|NCT03225547|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5894729|NCT03225547|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5894730|NCT03132454|Dexamethasone|dexamethasone|mesh-list
5753032|NCT03019666|Niacinamide|niacinamide|mesh-list
5753033|NCT03019666|Niacin|niacin|mesh-list
5753034|NCT03019666|Nicotinic Acids|nicotinic acids|mesh-list
5753035|NCT03019666|Vitamin B Complex|vitamin b complex|mesh-ancestor
5753036|NCT03019666|Vitamins|vitamins|mesh-ancestor
5753037|NCT03019666|Micronutrients|micronutrients|mesh-ancestor
5753038|NCT03019666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753039|NCT03019666|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5753040|NCT03019666|Antimetabolites|antimetabolites|mesh-ancestor
5753041|NCT03019666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5753042|NCT03019666|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5753043|NCT03019666|Vasodilator Agents|vasodilator agents|mesh-ancestor
5753044|NCT03019588|Paclitaxel|paclitaxel|mesh-list
5753045|NCT03019588|Pembrolizumab|pembrolizumab|mesh-list
5753046|NCT03019588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5753047|NCT03019588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5753048|NCT03019588|Tubulin Modulators|tubulin modulators|mesh-ancestor
5753049|NCT03019588|Antimitotic Agents|antimitotic agents|mesh-ancestor
5753050|NCT03019588|Mitosis Modulators|mitosis modulators|mesh-ancestor
5753051|NCT03019588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5753052|NCT03019588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5753053|NCT03019536|Flutemetamol|flutemetamol|mesh-list
5753054|NCT03019536|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5753055|NCT03019536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5753056|NCT03019523|Caffeine|caffeine|mesh-list
5628269|NCT02269670|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5628270|NCT02269670|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5628271|NCT02269670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5628272|NCT02269670|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5628273|NCT02269670|Hormone Antagonists|hormone antagonists|mesh-ancestor
5628274|NCT02269670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5628275|NCT02269670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5628276|NCT02269670|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5628277|NCT02269670|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5628278|NCT02269670|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5628279|NCT02269670|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5628280|NCT02269670|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5628281|NCT02269670|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5628282|NCT02269670|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5628283|NCT02269670|Contraceptive Agents|contraceptive agents|mesh-ancestor
5628284|NCT02269670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5628285|NCT02269670|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5753057|NCT03019523|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5753058|NCT03019523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753059|NCT03019523|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5628286|NCT02269670|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5628287|NCT02269670|Appetite Stimulants|appetite stimulants|mesh-ancestor
5628288|NCT02269670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5628289|NCT02162420|Cyclophosphamide|cyclophosphamide|mesh-list
5628290|NCT02162420|Fludarabine|fludarabine|mesh-list
5628291|NCT02162420|Alemtuzumab|alemtuzumab|mesh-list
5628292|NCT02162420|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5628293|NCT02162420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5628294|NCT02162420|Immunologic Factors|immunologic factors|mesh-ancestor
5628295|NCT02162420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628296|NCT02162420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5628297|NCT02162420|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5628298|NCT02162420|Alkylating Agents|alkylating agents|mesh-ancestor
5628299|NCT02162420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5628300|NCT02162420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5628301|NCT02162420|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5628302|NCT02162420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5628303|NCT02157324|Acalabrutinib|acalabrutinib|mesh-list
5628304|NCT02157324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5753060|NCT03019523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5753061|NCT03019523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5753062|NCT03019523|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5753063|NCT03019523|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5753064|NCT03019523|Purinergic Agents|purinergic agents|mesh-ancestor
5753065|NCT03019523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5753066|NCT03019562|Fentanyl|fentanyl|mesh-list
5753067|NCT03019562|Oxycodone|oxycodone|mesh-list
5753068|NCT03019562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5753069|NCT03019562|Narcotics|narcotics|mesh-ancestor
5753070|NCT03019562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5628305|NCT02135042|Gemcitabine|gemcitabine|mesh-list
5628306|NCT02135042|Paclitaxel|paclitaxel|mesh-list
5628307|NCT02135042|Cisplatin|cisplatin|mesh-list
5628308|NCT02135042|Fluorouracil|fluorouracil|mesh-list
5628309|NCT02135042|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5628310|NCT02135042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5628311|NCT02135042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5628312|NCT02135042|Tubulin Modulators|tubulin modulators|mesh-ancestor
5628313|NCT02135042|Antimitotic Agents|antimitotic agents|mesh-ancestor
5628314|NCT02135042|Mitosis Modulators|mitosis modulators|mesh-ancestor
5628315|NCT02135042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5628316|NCT02135042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5628317|NCT02135042|Antimetabolites|antimetabolites|mesh-ancestor
5753071|NCT03019562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753072|NCT03019562|Analgesics|analgesics|mesh-ancestor
5753073|NCT03019562|Sensory System Agents|sensory system agents|mesh-ancestor
5753074|NCT03019562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5753075|NCT03019562|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5753076|NCT03019562|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5753077|NCT03019562|Anesthetics, General|anesthetics, general|mesh-ancestor
5753078|NCT03019562|Anesthetics|anesthetics|mesh-ancestor
5753079|NCT03019237|Omalizumab|omalizumab|mesh-list
5753080|NCT03019237|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5628318|NCT02135042|Antiviral Agents|antiviral agents|mesh-ancestor
5628319|NCT02135042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5628320|NCT02135042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5628321|NCT02135042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5628322|NCT02135042|Immunologic Factors|immunologic factors|mesh-ancestor
5753081|NCT03019237|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5753082|NCT03019237|Respiratory System Agents|respiratory system agents|mesh-ancestor
5753083|NCT03019224|Hydrogen Peroxide|hydrogen peroxide|mesh-list
5753084|NCT03019224|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5753085|NCT03019224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5753086|NCT03019081|Isoproterenol|isoproterenol|mesh-list
5753087|NCT03019081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5753088|NCT03019081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5753089|NCT03019081|Adrenergic Agents|adrenergic agents|mesh-ancestor
5753090|NCT03019081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5753091|NCT03019081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5753092|NCT03019081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753093|NCT03019081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5753094|NCT03019081|Autonomic Agents|autonomic agents|mesh-ancestor
5753095|NCT03019081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5753096|NCT03019081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5753097|NCT03019081|Respiratory System Agents|respiratory system agents|mesh-ancestor
5753098|NCT03019081|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5753099|NCT03019081|Sympathomimetics|sympathomimetics|mesh-ancestor
5753100|NCT03019081|Protective Agents|protective agents|mesh-ancestor
5753101|NCT03019120|Vitamin D|vitamin d|mesh-list
5753102|NCT03019120|Vitamins|vitamins|mesh-ancestor
5628323|NCT02135042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628324|NCT02051218|Denosumab|denosumab|mesh-list
5628325|NCT02051218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5628326|NCT02051218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628327|NCT01972217|Prednisone|prednisone|mesh-list
5628328|NCT01972217|Prednisolone|prednisolone|mesh-list
5628329|NCT01972217|Olaparib|olaparib|mesh-list
5753103|NCT03019120|Micronutrients|micronutrients|mesh-ancestor
5753104|NCT03019120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753105|NCT03019120|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5753106|NCT03018899|Anesthetics|anesthetics|mesh-list
5753107|NCT03018899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5753108|NCT03018899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753109|NCT03018990|Ethanol|ethanol|mesh-list
5753110|NCT03018990|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5753111|NCT03018990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5753112|NCT03018990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5753113|NCT03018990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753114|NCT03018977|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
5753115|NCT03018977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5628330|NCT01972217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5628331|NCT01972217|Glucocorticoids|glucocorticoids|mesh-ancestor
5894731|NCT03132454|Dexamethasone acetate|dexamethasone acetate|mesh-list
5628332|NCT01972217|Hormones|hormones|mesh-ancestor
5628333|NCT01972217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5628334|NCT01972217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628335|NCT01972217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5628336|NCT01972217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5628337|NCT01972217|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5628338|NCT01972217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5628339|NCT01972217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5628340|NCT01822652|Cyclophosphamide|cyclophosphamide|mesh-list
5628341|NCT01822652|Pembrolizumab|pembrolizumab|mesh-list
5628342|NCT01822652|Fludarabine|fludarabine|mesh-list
5628343|NCT01822652|Fludarabine phosphate|fludarabine phosphate|mesh-list
5753116|NCT03018977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753117|NCT03019198|Tranexamic Acid|tranexamic acid|mesh-list
5753118|NCT03019198|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5753119|NCT03019198|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5753120|NCT03019198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5753121|NCT03019198|Hemostatics|hemostatics|mesh-ancestor
5753122|NCT03019198|Coagulants|coagulants|mesh-ancestor
5753123|NCT03018821|Tenofovir|tenofovir|mesh-list
5753124|NCT03018821|Entecavir|entecavir|mesh-list
5753125|NCT03018821|Antiviral Agents|antiviral agents|mesh-ancestor
5753126|NCT03018821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5753127|NCT03018821|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5753128|NCT03018821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5753129|NCT03018821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5753130|NCT03018821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5753131|NCT03018821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5753132|NCT03018821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5753133|NCT03018834|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5753134|NCT03018834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5753135|NCT03018665|Metformin|metformin|mesh-list
5753136|NCT03018665|Exenatide|exenatide|mesh-list
5753137|NCT03018665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5753138|NCT03018665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753139|NCT03018665|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5753140|NCT03018665|Incretins|incretins|mesh-ancestor
5753141|NCT03018665|Hormones|hormones|mesh-ancestor
5753142|NCT03018665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5753143|NCT03018626|Prednisone|prednisone|mesh-list
5753144|NCT03018626|Cyclophosphamide|cyclophosphamide|mesh-list
5753145|NCT03018626|Rituximab|rituximab|mesh-list
5753146|NCT03018626|Doxorubicin|doxorubicin|mesh-list
5753147|NCT03018626|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5753148|NCT03018626|Etoposide|etoposide|mesh-list
5753149|NCT03018626|Vincristine|vincristine|mesh-list
5753150|NCT03018626|Bleomycin|bleomycin|mesh-list
5753151|NCT03018626|Vindesine|vindesine|mesh-list
5753152|NCT03018626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5753153|NCT03018626|Immunologic Factors|immunologic factors|mesh-ancestor
5753154|NCT03018626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753155|NCT03018626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5753156|NCT03018626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5753157|NCT03018626|Alkylating Agents|alkylating agents|mesh-ancestor
5753158|NCT03018626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5753159|NCT03018626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5753160|NCT03018626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5753161|NCT03018626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5753162|NCT03018626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5753163|NCT03018626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5753164|NCT03018626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5753165|NCT03018626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5753166|NCT03018626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5753167|NCT03018626|Glucocorticoids|glucocorticoids|mesh-ancestor
5753168|NCT03018626|Hormones|hormones|mesh-ancestor
5753169|NCT03018626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5628344|NCT01822652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5628345|NCT01822652|Immunologic Factors|immunologic factors|mesh-ancestor
5628346|NCT01822652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628347|NCT01822652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5628348|NCT01822652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5628349|NCT01822652|Alkylating Agents|alkylating agents|mesh-ancestor
5628350|NCT01822652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5628351|NCT01822652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5628352|NCT01822652|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5628353|NCT01822652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5628354|NCT01822652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5628355|NCT01822652|Antimetabolites|antimetabolites|mesh-ancestor
5753170|NCT03018626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5753171|NCT03018626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5753172|NCT03018626|Tubulin Modulators|tubulin modulators|mesh-ancestor
5628356|NCT01821690|Buspirone|buspirone|mesh-list
5628357|NCT01821690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5628358|NCT01821690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5628359|NCT01821690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5628360|NCT01821690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628361|NCT01821690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5628362|NCT01821690|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5628363|NCT01821690|Serotonin Agents|serotonin agents|mesh-ancestor
5628364|NCT01821690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5628365|NCT01821690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5753173|NCT03018626|Antimitotic Agents|antimitotic agents|mesh-ancestor
5753174|NCT03018626|Mitosis Modulators|mitosis modulators|mesh-ancestor
5753175|NCT03018535|Methylprednisolone|methylprednisolone|mesh-list
5753176|NCT03018535|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5753177|NCT03018535|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5753178|NCT03018535|Prednisolone|prednisolone|mesh-list
5753179|NCT03018535|Prednisolone acetate|prednisolone acetate|mesh-list
5753180|NCT03018535|Cyclophosphamide|cyclophosphamide|mesh-list
5753181|NCT03018535|Rituximab|rituximab|mesh-list
5753182|NCT03018535|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5753183|NCT03018535|Prednisolone phosphate|prednisolone phosphate|mesh-list
5753184|NCT03018535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5753185|NCT03018535|Immunologic Factors|immunologic factors|mesh-ancestor
5753186|NCT03018535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753187|NCT03018535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5753188|NCT03018535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5753189|NCT03018535|Alkylating Agents|alkylating agents|mesh-ancestor
5753190|NCT03018535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489718|NCT00593255|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6489719|NCT00593255|Insulin Aspart|insulin aspart|mesh-list
6489720|NCT00593255|Isophane Insulin, Human|isophane insulin, human|mesh-list
6489721|NCT00593255|Insulin, Isophane|insulin, isophane|mesh-list
6489722|NCT00593255|Isophane insulin, beef|isophane insulin, beef|mesh-list
6489723|NCT00593255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6489724|NCT00593255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489725|NCT00593294|Drospirenone|drospirenone|mesh-list
6489726|NCT00593294|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5628366|NCT01816165|Acipimox|acipimox|mesh-list
5753191|NCT03018535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5753192|NCT03018535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5753193|NCT03018535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5753194|NCT03018535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5753195|NCT03018535|Antiemetics|antiemetics|mesh-ancestor
5753196|NCT03018535|Autonomic Agents|autonomic agents|mesh-ancestor
5753197|NCT03018535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5753198|NCT03018535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5628367|NCT01816165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5628368|NCT01816165|Antimetabolites|antimetabolites|mesh-ancestor
5628369|NCT01816165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5628370|NCT01816165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5628371|NCT01813929|Metformin|metformin|mesh-list
5628372|NCT01813929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5628373|NCT01813929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693089|NCT03403140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5693090|NCT03403140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5693091|NCT03403140|Immunologic Factors|immunologic factors|mesh-ancestor
5693092|NCT03403101|Oxaliplatin|oxaliplatin|mesh-list
5693093|NCT03403101|Irinotecan|irinotecan|mesh-list
5693094|NCT03403101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5693095|NCT03403101|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5693096|NCT03403101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5693097|NCT03403101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5693098|NCT03403101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693099|NCT03403049|Gemcitabine|gemcitabine|mesh-list
5693100|NCT03403049|Capecitabine|capecitabine|mesh-list
5693101|NCT03403049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5693102|NCT03403049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5693103|NCT03403049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5693104|NCT03403049|Antimetabolites|antimetabolites|mesh-ancestor
5693105|NCT03403049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693106|NCT03403049|Antiviral Agents|antiviral agents|mesh-ancestor
5693107|NCT03403049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5753199|NCT03018535|Glucocorticoids|glucocorticoids|mesh-ancestor
6489727|NCT00593294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673083|NCT01560390|Analgesics|analgesics|mesh-ancestor
5753200|NCT03018535|Hormones|hormones|mesh-ancestor
5753201|NCT03018535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5753202|NCT03018535|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5753203|NCT03018535|Protective Agents|protective agents|mesh-ancestor
5753204|NCT03018535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5753205|NCT03018652|Immunoglobulins|immunoglobulins|mesh-list
5753206|NCT03018652|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5753207|NCT03018652|Antibodies|antibodies|mesh-list
5753208|NCT03018652|gamma-Globulins|gamma-globulins|mesh-list
5753209|NCT03018652|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5753210|NCT03018652|Immunologic Factors|immunologic factors|mesh-ancestor
5753211|NCT03018652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753212|NCT03018704|Topiramate|topiramate|mesh-list
5753213|NCT03018704|Anticonvulsants|anticonvulsants|mesh-ancestor
5753214|NCT03018704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5753215|NCT03018704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753216|NCT03018756|Fentanyl|fentanyl|mesh-list
5753217|NCT03018756|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5753218|NCT03018756|Narcotics|narcotics|mesh-ancestor
5753219|NCT03018756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5753220|NCT03018756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753221|NCT03018756|Analgesics|analgesics|mesh-ancestor
5753222|NCT03018756|Sensory System Agents|sensory system agents|mesh-ancestor
5753223|NCT03018756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5753224|NCT03018756|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5753225|NCT03018756|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5753226|NCT03018756|Anesthetics, General|anesthetics, general|mesh-ancestor
5753227|NCT03018756|Anesthetics|anesthetics|mesh-ancestor
5753228|NCT03018444|Atorvastatin|atorvastatin|mesh-list
5753229|NCT03018444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5753230|NCT03018444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5753231|NCT03018444|Antimetabolites|antimetabolites|mesh-ancestor
5753232|NCT03018444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5753233|NCT03018444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5753234|NCT03018444|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5753235|NCT03018444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5753236|NCT03018418|Mitomycins|mitomycins|mesh-list
5753237|NCT03018418|Mitomycin|mitomycin|mesh-list
5753238|NCT03018418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5753239|NCT03018418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5753240|NCT03018418|Alkylating Agents|alkylating agents|mesh-ancestor
5753241|NCT03018418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5753242|NCT03018418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5753243|NCT03018418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5753244|NCT03018171|Clonidine|clonidine|mesh-list
5753245|NCT03018171|Sufentanil|sufentanil|mesh-list
5753246|NCT03018171|Analgesics|analgesics|mesh-ancestor
5753247|NCT03018171|Sensory System Agents|sensory system agents|mesh-ancestor
5753248|NCT03018171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5753249|NCT03018171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753250|NCT03018171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5753251|NCT03018171|Sympatholytics|sympatholytics|mesh-ancestor
5753252|NCT03018171|Autonomic Agents|autonomic agents|mesh-ancestor
5753253|NCT03018171|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5753254|NCT03018171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5753255|NCT03018171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5628374|NCT01693783|Ipilimumab|ipilimumab|mesh-list
5628375|NCT01693783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5628376|NCT01693783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5628377|NCT01693783|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5628378|NCT01693783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5628379|NCT01555281|Nelfinavir|nelfinavir|mesh-list
5628380|NCT01555281|Dexamethasone|dexamethasone|mesh-list
5628381|NCT01555281|Lenalidomide|lenalidomide|mesh-list
5628382|NCT01555281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5628383|NCT01555281|Antiemetics|antiemetics|mesh-ancestor
5628384|NCT01555281|Autonomic Agents|autonomic agents|mesh-ancestor
5628385|NCT01555281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5628386|NCT01555281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628387|NCT01555281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5628388|NCT01555281|Glucocorticoids|glucocorticoids|mesh-ancestor
5628389|NCT01555281|Hormones|hormones|mesh-ancestor
5628390|NCT01555281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5753256|NCT03018171|Adrenergic Agents|adrenergic agents|mesh-ancestor
5753257|NCT03018171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5753258|NCT03018171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5628391|NCT01555281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5628392|NCT01555281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5628393|NCT01555281|Immunologic Factors|immunologic factors|mesh-ancestor
5628394|NCT01555281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5628395|NCT01555281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5753259|NCT03018171|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5753260|NCT03018171|Narcotics|narcotics|mesh-ancestor
5753261|NCT03018171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5753262|NCT03018171|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5753263|NCT03018171|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5753264|NCT03018171|Anesthetics, General|anesthetics, general|mesh-ancestor
5753265|NCT03018171|Anesthetics|anesthetics|mesh-ancestor
5753266|NCT03018301|Ketamine|ketamine|mesh-list
5753267|NCT03018301|Analgesics|analgesics|mesh-ancestor
5753268|NCT03018301|Sensory System Agents|sensory system agents|mesh-ancestor
5753269|NCT03018301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5753270|NCT03018301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753271|NCT03018301|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5753272|NCT03018301|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5628396|NCT01555281|Growth Substances|growth substances|mesh-ancestor
5628397|NCT01555281|Growth Inhibitors|growth inhibitors|mesh-ancestor
5628398|NCT01555281|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5628399|NCT01555281|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5628400|NCT01555281|Protease Inhibitors|protease inhibitors|mesh-ancestor
5628401|NCT01555281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5628402|NCT01555281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5628403|NCT01555281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5628404|NCT01555281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5628405|NCT01555281|Antiviral Agents|antiviral agents|mesh-ancestor
5628406|NCT01555281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5628407|NCT01502085|Dexamethasone|dexamethasone|mesh-list
5628408|NCT01502085|Vorinostat|vorinostat|mesh-list
5628409|NCT01502085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5628410|NCT01502085|Antiemetics|antiemetics|mesh-ancestor
5628411|NCT01502085|Autonomic Agents|autonomic agents|mesh-ancestor
5628412|NCT01502085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5753273|NCT03018301|Anesthetics, General|anesthetics, general|mesh-ancestor
5753274|NCT03018301|Anesthetics|anesthetics|mesh-ancestor
5753275|NCT03018301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5753276|NCT03018301|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5753277|NCT03018301|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5753278|NCT03018301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5753279|NCT03018301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5753280|NCT03018236|Ethanol|ethanol|mesh-list
5753281|NCT03018236|Acetylcysteine|acetylcysteine|mesh-list
5753282|NCT03018236|Cocaine|cocaine|mesh-list
5753283|NCT03018236|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5753284|NCT03018236|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5753285|NCT03018236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5753286|NCT03018236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5753287|NCT03018236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753288|NCT03018236|Antiviral Agents|antiviral agents|mesh-ancestor
5753289|NCT03018236|Expectorants|expectorants|mesh-ancestor
5753290|NCT03018236|Respiratory System Agents|respiratory system agents|mesh-ancestor
5753291|NCT03018236|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5753292|NCT03018236|Antioxidants|antioxidants|mesh-ancestor
5753293|NCT03018236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5753294|NCT03018236|Protective Agents|protective agents|mesh-ancestor
5753295|NCT03018236|Antidotes|antidotes|mesh-ancestor
5753296|NCT03018236|Anesthetics, Local|anesthetics, local|mesh-ancestor
5753297|NCT03018236|Anesthetics|anesthetics|mesh-ancestor
5753298|NCT03018236|Sensory System Agents|sensory system agents|mesh-ancestor
5753299|NCT03018236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5753300|NCT03018236|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5753301|NCT03018236|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5753302|NCT03018236|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5753303|NCT03018236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5753304|NCT03018236|Dopamine Agents|dopamine agents|mesh-ancestor
5753305|NCT03018236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5753306|NCT03018015|Ibuprofen|ibuprofen|mesh-list
5753307|NCT03018015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5753308|NCT03018015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5753309|NCT03018015|Analgesics|analgesics|mesh-ancestor
5753310|NCT03018015|Sensory System Agents|sensory system agents|mesh-ancestor
5753311|NCT03018015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5628413|NCT01502085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753312|NCT03018015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753313|NCT03018015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5753314|NCT03018015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5753315|NCT03018015|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5753316|NCT03018015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5753317|NCT03018015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5753318|NCT03017963|Sodium thiosulfate|sodium thiosulfate|mesh-list
5753319|NCT03017963|Antidotes|antidotes|mesh-ancestor
5753320|NCT03017963|Protective Agents|protective agents|mesh-ancestor
5628414|NCT01502085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5628415|NCT01502085|Glucocorticoids|glucocorticoids|mesh-ancestor
5628416|NCT01502085|Hormones|hormones|mesh-ancestor
5628417|NCT01502085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5628418|NCT01502085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5628419|NCT01502085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5628420|NCT01502085|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5628421|NCT01502085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5628422|NCT01502085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5628423|NCT01413100|Mycophenolic Acid|mycophenolic acid|mesh-list
5628424|NCT01413100|Plerixafor|plerixafor|mesh-list
5628425|NCT01413100|Cyclophosphamide|cyclophosphamide|mesh-list
5628426|NCT01413100|Thymoglobulin|thymoglobulin|mesh-list
5628427|NCT01413100|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5753321|NCT03017963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753322|NCT03017963|Antioxidants|antioxidants|mesh-ancestor
5753323|NCT03017963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5753324|NCT03017963|Antitubercular Agents|antitubercular agents|mesh-ancestor
5753325|NCT03017963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5753326|NCT03017963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5628428|NCT01413100|Lenograstim|lenograstim|mesh-list
5628429|NCT01413100|Sargramostim|sargramostim|mesh-list
5628430|NCT01413100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5628431|NCT01413100|Immunologic Factors|immunologic factors|mesh-ancestor
5628432|NCT01413100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628433|NCT01413100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5628434|NCT01413100|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5628435|NCT01413100|Alkylating Agents|alkylating agents|mesh-ancestor
5628436|NCT01413100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5628437|NCT01413100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5628438|NCT01413100|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5628439|NCT01413100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5628440|NCT01413100|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5628441|NCT01413100|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5628442|NCT01413100|Antitubercular Agents|antitubercular agents|mesh-ancestor
5628443|NCT01413100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5628444|NCT01413100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5628445|NCT01413100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5628446|NCT01413100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5628447|NCT01413100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5628448|NCT01413100|Antiviral Agents|antiviral agents|mesh-ancestor
5628449|NCT01294020|Tacrolimus|tacrolimus|mesh-list
5628450|NCT01294020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5628451|NCT01294020|Immunologic Factors|immunologic factors|mesh-ancestor
5628452|NCT01294020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628453|NCT01294020|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5628454|NCT01294020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5628455|NCT01294020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5628456|NCT01178814|Lenalidomide|lenalidomide|mesh-list
5628457|NCT01178814|Immunologic Factors|immunologic factors|mesh-ancestor
5628458|NCT01178814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753327|NCT03017963|Chelating Agents|chelating agents|mesh-ancestor
5628459|NCT01178814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5628460|NCT01178814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5628461|NCT01178814|Growth Substances|growth substances|mesh-ancestor
5753328|NCT03017963|Sequestering Agents|sequestering agents|mesh-ancestor
5753329|NCT03018366|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5753330|NCT03018366|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5753331|NCT03018366|Estradiol|estradiol|mesh-list
5753332|NCT03018366|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5753333|NCT03018366|Progesterone|progesterone|mesh-list
5753334|NCT03018366|Estrogens|estrogens|mesh-ancestor
5753335|NCT03018366|Hormones|hormones|mesh-ancestor
5753336|NCT03018366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5753337|NCT03018366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673084|NCT01560390|Sensory System Agents|sensory system agents|mesh-ancestor
6673085|NCT01560390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6673086|NCT01560390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673087|NCT01560390|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6673088|NCT01560390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6673089|NCT01560390|Anesthetics, General|anesthetics, general|mesh-ancestor
6673090|NCT01560390|Anesthetics|anesthetics|mesh-ancestor
6673091|NCT01560390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6673092|NCT01560390|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6673093|NCT01560390|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5628462|NCT01178814|Growth Inhibitors|growth inhibitors|mesh-ancestor
5628463|NCT01178814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5628464|NCT01125176|Thalidomide|thalidomide|mesh-list
5628465|NCT01125176|Rituximab|rituximab|mesh-list
5628466|NCT01125176|Lenalidomide|lenalidomide|mesh-list
5628467|NCT01125176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5628468|NCT01125176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5628469|NCT01125176|Immunologic Factors|immunologic factors|mesh-ancestor
5628470|NCT01125176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628471|NCT01125176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5628472|NCT01125176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5628473|NCT01125176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5753338|NCT03018366|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5753339|NCT03018366|Contraceptive Agents|contraceptive agents|mesh-ancestor
5753340|NCT03018366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5753341|NCT03018366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5753342|NCT03018366|Progestins|progestins|mesh-ancestor
5753343|NCT03018353|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
5753344|NCT03018353|Antiviral Agents|antiviral agents|mesh-ancestor
5753345|NCT03018353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5753346|NCT03017872|Ritonavir|ritonavir|mesh-list
5753347|NCT03017872|Darunavir|darunavir|mesh-list
5753348|NCT03017872|Dolutegravir|dolutegravir|mesh-list
5753349|NCT03017872|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5753350|NCT03017872|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5753351|NCT03017872|Protease Inhibitors|protease inhibitors|mesh-ancestor
5753352|NCT03017872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5753353|NCT03017872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5753354|NCT03017872|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5753355|NCT03017872|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5753356|NCT03017872|Antiviral Agents|antiviral agents|mesh-ancestor
5753357|NCT03017872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5753358|NCT03017872|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5753359|NCT03017872|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5753360|NCT03017872|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5628474|NCT01125176|Growth Substances|growth substances|mesh-ancestor
5628475|NCT01125176|Growth Inhibitors|growth inhibitors|mesh-ancestor
5628476|NCT01125176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5628477|NCT01125176|Leprostatic Agents|leprostatic agents|mesh-ancestor
5628478|NCT01125176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5628479|NCT01125176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5753361|NCT03017872|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5894732|NCT03132454|Sorafenib|sorafenib|mesh-list
5894733|NCT03132454|Decitabine|decitabine|mesh-list
5894734|NCT03132454|Palbociclib|palbociclib|mesh-list
5894735|NCT03132454|Ichthammol|ichthammol|mesh-list
5894736|NCT03132454|BB 1101|bb 1101|mesh-list
5894737|NCT03132454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5894738|NCT03132454|Antiemetics|antiemetics|mesh-ancestor
5628480|NCT00882050|Exenatide|exenatide|mesh-list
5628481|NCT00882050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5693108|NCT03403049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5894739|NCT03132454|Autonomic Agents|autonomic agents|mesh-ancestor
5894740|NCT03132454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5894741|NCT03132454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753362|NCT03017703|Eplerenone|eplerenone|mesh-list
5753363|NCT03017703|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5753364|NCT03017703|Hormone Antagonists|hormone antagonists|mesh-ancestor
5753365|NCT03017703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5753366|NCT03017703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753367|NCT03017703|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5753368|NCT03017703|Diuretics|diuretics|mesh-ancestor
5753369|NCT03017703|Natriuretic Agents|natriuretic agents|mesh-ancestor
5753370|NCT03017703|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5753371|NCT03017768|Tryptophan|tryptophan|mesh-list
5753372|NCT03017768|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5753373|NCT03017768|Antidepressive Agents|antidepressive agents|mesh-ancestor
5753374|NCT03017768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5753375|NCT03017807|Antibodies|antibodies|mesh-list
5753376|NCT03017807|Immunologic Factors|immunologic factors|mesh-ancestor
5753377|NCT03017807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753378|NCT03017729|Botulinum Toxins|botulinum toxins|mesh-list
5753379|NCT03017729|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5753380|NCT03017729|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5753381|NCT03017729|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5628482|NCT00882050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628483|NCT00882050|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5628484|NCT00882050|Incretins|incretins|mesh-ancestor
5628485|NCT00882050|Hormones|hormones|mesh-ancestor
5628486|NCT00882050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5628487|NCT00790829|Nicotine|nicotine|mesh-list
5628488|NCT00790829|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5628489|NCT00790829|Autonomic Agents|autonomic agents|mesh-ancestor
5628490|NCT00790829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5628491|NCT00790829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628492|NCT00790829|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5628493|NCT00790829|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5628494|NCT00790829|Cholinergic Agents|cholinergic agents|mesh-ancestor
5628495|NCT00790829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5628496|NCT00790829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5628497|NCT00070564|Paclitaxel|paclitaxel|mesh-list
5628498|NCT00070564|Cyclophosphamide|cyclophosphamide|mesh-list
5628499|NCT00070564|Doxorubicin|doxorubicin|mesh-list
5628500|NCT00070564|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5628501|NCT00070564|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5628502|NCT00070564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5628503|NCT00070564|Tubulin Modulators|tubulin modulators|mesh-ancestor
5628504|NCT00070564|Antimitotic Agents|antimitotic agents|mesh-ancestor
5628505|NCT00070564|Mitosis Modulators|mitosis modulators|mesh-ancestor
5628506|NCT00070564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5753382|NCT03017729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5753383|NCT03017729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5753384|NCT03017729|Cholinergic Agents|cholinergic agents|mesh-ancestor
5753385|NCT03017729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5753386|NCT03017729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753387|NCT03017729|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5753388|NCT03017729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5753389|NCT03017833|Metformin|metformin|mesh-list
5753390|NCT03017833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5753391|NCT03017833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753392|NCT03017495|Midazolam|midazolam|mesh-list
5753393|NCT03017495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5753394|NCT03017495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5753395|NCT03017495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5753396|NCT03017495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753397|NCT03017495|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5753398|NCT03017495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5753399|NCT03017495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5753400|NCT03017495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5753401|NCT03017495|Anesthetics, General|anesthetics, general|mesh-ancestor
5753402|NCT03017495|Anesthetics|anesthetics|mesh-ancestor
5753403|NCT03017495|GABA Modulators|gaba modulators|mesh-ancestor
5753404|NCT03017495|GABA Agents|gaba agents|mesh-ancestor
5753405|NCT03017495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5628507|NCT00070564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5628508|NCT00070564|Immunologic Factors|immunologic factors|mesh-ancestor
5628509|NCT00070564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628510|NCT00070564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5697823|NCT03373409|Albuterol|albuterol|mesh-list
5753406|NCT03017495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5753407|NCT03017222|Ondansetron|ondansetron|mesh-list
5628511|NCT00070564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5628512|NCT00070564|Alkylating Agents|alkylating agents|mesh-ancestor
5628513|NCT00070564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5628514|NCT00070564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5628515|NCT00070564|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5628516|NCT00070564|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5628517|NCT00070564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5628518|NCT05206955|Tadalafil|tadalafil|mesh-list
5628519|NCT05206955|Vasodilator Agents|vasodilator agents|mesh-ancestor
5753408|NCT03017222|Ramosetron|ramosetron|mesh-list
5753409|NCT03017222|Antiemetics|antiemetics|mesh-ancestor
5753410|NCT03017222|Autonomic Agents|autonomic agents|mesh-ancestor
5753411|NCT03017222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5753412|NCT03017222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753413|NCT03017222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5753414|NCT03017222|Antipruritics|antipruritics|mesh-ancestor
5753415|NCT03017222|Dermatologic Agents|dermatologic agents|mesh-ancestor
5753416|NCT03017222|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5753417|NCT03017222|Serotonin Agents|serotonin agents|mesh-ancestor
5753418|NCT03017222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5753419|NCT03017222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5753420|NCT03017222|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5753421|NCT03017222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5753422|NCT03017222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5753423|NCT03017222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5753424|NCT03017222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5753425|NCT03017248|Morphine|morphine|mesh-list
5753426|NCT03017248|Ketamine|ketamine|mesh-list
5753427|NCT03017248|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5753428|NCT03017248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5753429|NCT03017248|Narcotics|narcotics|mesh-ancestor
5753430|NCT03017248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5753431|NCT03017248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753432|NCT03017248|Analgesics|analgesics|mesh-ancestor
5753433|NCT03017248|Sensory System Agents|sensory system agents|mesh-ancestor
5753434|NCT03017248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5753435|NCT03017248|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5753436|NCT03017248|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5753437|NCT03017248|Anesthetics, General|anesthetics, general|mesh-ancestor
5753438|NCT03017248|Anesthetics|anesthetics|mesh-ancestor
5753439|NCT03017248|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5753440|NCT03017248|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5753441|NCT03017248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5753442|NCT03017248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5753443|NCT03017391|Dexamethasone|dexamethasone|mesh-list
5753444|NCT03017391|Metoclopramide|metoclopramide|mesh-list
5753445|NCT03017391|Granisetron|granisetron|mesh-list
5753446|NCT03017391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5753447|NCT03017391|Antiemetics|antiemetics|mesh-ancestor
5753448|NCT03017391|Autonomic Agents|autonomic agents|mesh-ancestor
5753449|NCT03017391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5753450|NCT03017391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753451|NCT03017391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5628520|NCT05206955|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5628521|NCT05206955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5628522|NCT05206955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5628523|NCT05206955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5753452|NCT03017391|Glucocorticoids|glucocorticoids|mesh-ancestor
5753453|NCT03017391|Hormones|hormones|mesh-ancestor
5753454|NCT03017391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5753455|NCT03017391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5753456|NCT03017391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5753457|NCT03017391|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5753458|NCT03017391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5753459|NCT03017391|Dopamine Agents|dopamine agents|mesh-ancestor
5753460|NCT03017391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5753461|NCT03017391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5753462|NCT03017391|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5753463|NCT03017391|Serotonin Agents|serotonin agents|mesh-ancestor
5753464|NCT03017326|Gemcitabine|gemcitabine|mesh-list
5753465|NCT03017326|Carboplatin|carboplatin|mesh-list
5753466|NCT03017326|Doxorubicin|doxorubicin|mesh-list
5753467|NCT03017326|Fluorouracil|fluorouracil|mesh-list
5753468|NCT03017326|Oxaliplatin|oxaliplatin|mesh-list
5753469|NCT03017326|Irinotecan|irinotecan|mesh-list
5753470|NCT03017326|Etoposide|etoposide|mesh-list
5753471|NCT03017326|Vincristine|vincristine|mesh-list
5753472|NCT03017326|Sorafenib|sorafenib|mesh-list
5753473|NCT03017326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5753474|NCT03017326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5753475|NCT03017326|Antimetabolites|antimetabolites|mesh-ancestor
5753476|NCT03017326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5753477|NCT03017326|Antiviral Agents|antiviral agents|mesh-ancestor
5628524|NCT05206955|Urological Agents|urological agents|mesh-ancestor
5628525|NCT05206747|Methamphetamine|methamphetamine|mesh-list
5628526|NCT05206747|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5628527|NCT05206747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628528|NCT05206747|Sympathomimetics|sympathomimetics|mesh-ancestor
5628529|NCT05206747|Autonomic Agents|autonomic agents|mesh-ancestor
5628530|NCT05206747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5628531|NCT05206747|Dopamine Agents|dopamine agents|mesh-ancestor
5628532|NCT05206747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5628533|NCT05206747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5628534|NCT05206747|Adrenergic Agents|adrenergic agents|mesh-ancestor
5628535|NCT05206747|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5628536|NCT05206747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5628537|NCT05206747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5628538|NCT05206747|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5628539|NCT05206721|Chlorhexidine|chlorhexidine|mesh-list
5628540|NCT05206721|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5753478|NCT03017326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5753479|NCT03017326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5753480|NCT03017326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5753481|NCT03017326|Immunologic Factors|immunologic factors|mesh-ancestor
5753482|NCT03017326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753483|NCT03017326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5753484|NCT03017326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5753485|NCT03017326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5753486|NCT03017326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5753487|NCT03017326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5753488|NCT03017326|Tubulin Modulators|tubulin modulators|mesh-ancestor
5753489|NCT03017326|Antimitotic Agents|antimitotic agents|mesh-ancestor
5753490|NCT03017326|Mitosis Modulators|mitosis modulators|mesh-ancestor
5753491|NCT03017326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5753492|NCT03017131|Aldesleukin|aldesleukin|mesh-list
5753493|NCT03017131|Cyclophosphamide|cyclophosphamide|mesh-list
5753494|NCT03017131|Decitabine|decitabine|mesh-list
5753495|NCT03017131|Interleukin-2|interleukin-2|mesh-list
5753496|NCT03017131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5753497|NCT03017131|Immunologic Factors|immunologic factors|mesh-ancestor
5753498|NCT03017131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628541|NCT05206721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5628542|NCT05206721|Disinfectants|disinfectants|mesh-ancestor
5628543|NCT05206682|Goserelin|goserelin|mesh-list
5628544|NCT05206682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5628545|NCT05206682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5628546|NCT05206500|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5628547|NCT05206500|Amoxicillin|amoxicillin|mesh-list
5628548|NCT05206500|Metronidazole|metronidazole|mesh-list
5628549|NCT05206500|Clindamycin|clindamycin|mesh-list
5628550|NCT05206500|Linezolid|linezolid|mesh-list
5628551|NCT05206500|Tetracycline|tetracycline|mesh-list
5628552|NCT05206500|Penicillins|penicillins|mesh-list
5628553|NCT05206500|Ampicillin|ampicillin|mesh-list
5628554|NCT05206500|Fosfomycin|fosfomycin|mesh-list
5628555|NCT05206500|Nitrofurantoin|nitrofurantoin|mesh-list
5753499|NCT03017131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5628556|NCT05206500|Cephalosporins|cephalosporins|mesh-list
5628557|NCT05206500|Fluoroquinolones|fluoroquinolones|mesh-list
5628558|NCT05206500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5628559|NCT05206500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5628560|NCT05206500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5628561|NCT05206500|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5628562|NCT05206500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5628563|NCT05206500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5628564|NCT05206500|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5628565|NCT05206500|Renal Agents|renal agents|mesh-ancestor
5628566|NCT05206500|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5628567|NCT05206448|Letrozole|letrozole|mesh-list
5628568|NCT05206448|Clomiphene|clomiphene|mesh-list
5628569|NCT05206448|Enclomiphene|enclomiphene|mesh-list
5628570|NCT05206448|Zuclomiphene|zuclomiphene|mesh-list
5628571|NCT05206448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5753500|NCT03017131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5628572|NCT05206448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5628573|NCT05206448|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5628574|NCT05206448|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5628575|NCT05206448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5753501|NCT03017131|Alkylating Agents|alkylating agents|mesh-ancestor
5753502|NCT03017131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5753503|NCT03017131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5753504|NCT03017131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5753505|NCT03017131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5753506|NCT03017131|Antimetabolites|antimetabolites|mesh-ancestor
5753507|NCT03017131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5753508|NCT03017131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5753509|NCT03017131|Analgesics|analgesics|mesh-ancestor
5628576|NCT05206448|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5628577|NCT05206448|Hormone Antagonists|hormone antagonists|mesh-ancestor
5628578|NCT05206448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5628579|NCT05206448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628580|NCT05206448|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5628581|NCT05206448|Fertility Agents|fertility agents|mesh-ancestor
5628582|NCT05206448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5628583|NCT05206448|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5628584|NCT05206448|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5628585|NCT05206435|Nicotine|nicotine|mesh-list
5628586|NCT05206435|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5628587|NCT05206435|Autonomic Agents|autonomic agents|mesh-ancestor
5628588|NCT05206435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5628589|NCT05206435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628590|NCT05206435|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5628591|NCT05206435|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5628592|NCT05206435|Cholinergic Agents|cholinergic agents|mesh-ancestor
5628593|NCT05206435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5628594|NCT05206435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5628595|NCT05206318|Cysteamine|cysteamine|mesh-list
5628596|NCT05206318|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
5628597|NCT05206318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5753510|NCT03017131|Sensory System Agents|sensory system agents|mesh-ancestor
5753511|NCT03017131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5753512|NCT03017131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5753513|NCT03017131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5753514|NCT03017131|Antiviral Agents|antiviral agents|mesh-ancestor
5753515|NCT03017131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5753516|NCT03017430|Ketorolac|ketorolac|mesh-list
5628598|NCT05206175|Methamphetamine|methamphetamine|mesh-list
5628599|NCT05206175|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5628600|NCT05206175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628601|NCT05206175|Sympathomimetics|sympathomimetics|mesh-ancestor
5628602|NCT05206175|Autonomic Agents|autonomic agents|mesh-ancestor
5628603|NCT05206175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5628604|NCT05206175|Dopamine Agents|dopamine agents|mesh-ancestor
5628605|NCT05206175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5628606|NCT05206175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5628607|NCT05206175|Adrenergic Agents|adrenergic agents|mesh-ancestor
5628608|NCT05206175|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5628609|NCT05206175|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5628610|NCT05206175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5628611|NCT05206175|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5628612|NCT05206110|Ketorolac|ketorolac|mesh-list
5628613|NCT05206110|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
5628614|NCT05206110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5628615|NCT05206110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5628616|NCT05206110|Analgesics|analgesics|mesh-ancestor
5628617|NCT05206110|Sensory System Agents|sensory system agents|mesh-ancestor
5628618|NCT05206110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5753517|NCT03017430|Phenazepam|phenazepam|mesh-list
5753518|NCT03017430|Clonidine|clonidine|mesh-list
5753519|NCT03017430|Pregabalin|pregabalin|mesh-list
5753520|NCT03017430|Metoclopramide|metoclopramide|mesh-list
5753521|NCT03017430|Loperamide|loperamide|mesh-list
5753522|NCT03017430|Antidiarrheals|antidiarrheals|mesh-list
5753523|NCT03017430|Analgesics|analgesics|mesh-ancestor
5753524|NCT03017430|Sensory System Agents|sensory system agents|mesh-ancestor
5753525|NCT03017430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5753526|NCT03017430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753527|NCT03017430|Anticonvulsants|anticonvulsants|mesh-ancestor
5753528|NCT03017430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6208852|NCT02137772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5753529|NCT03017430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5753530|NCT03017430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5753531|NCT03017430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5753532|NCT03017430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5753533|NCT03017430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5753534|NCT03017430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5753535|NCT03017430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5753536|NCT03017430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5753537|NCT03017430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5753538|NCT03017430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5753539|NCT03017430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5753540|NCT03017430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5753541|NCT03017430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5753542|NCT03017430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5753543|NCT03017430|Sympatholytics|sympatholytics|mesh-ancestor
5753544|NCT03017430|Autonomic Agents|autonomic agents|mesh-ancestor
5753545|NCT03017430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5753546|NCT03017430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5753547|NCT03017430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5753548|NCT03017430|Adrenergic Agents|adrenergic agents|mesh-ancestor
5753549|NCT03017430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5753550|NCT03017430|Antiemetics|antiemetics|mesh-ancestor
5753551|NCT03017430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5628619|NCT05206110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628620|NCT05206110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5628621|NCT05206110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5753552|NCT03017430|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5753553|NCT03017430|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5753554|NCT03017430|Dopamine Agents|dopamine agents|mesh-ancestor
5753555|NCT03017430|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5753556|NCT03017430|Immunologic Factors|immunologic factors|mesh-ancestor
5753557|NCT03017430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5753558|NCT03017430|GABA Agents|gaba agents|mesh-ancestor
5753559|NCT03017352|Exenatide|exenatide|mesh-list
5753560|NCT03017352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5753561|NCT03017352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753562|NCT03017352|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5753563|NCT03017352|Incretins|incretins|mesh-ancestor
5753564|NCT03017352|Hormones|hormones|mesh-ancestor
5753565|NCT03017352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5753566|NCT03017404|Cyclophosphamide|cyclophosphamide|mesh-list
5753567|NCT03017404|Docetaxel|docetaxel|mesh-list
5753568|NCT03017404|Doxorubicin|doxorubicin|mesh-list
5753569|NCT03017404|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6489728|NCT00593294|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6489729|NCT00593294|Hormone Antagonists|hormone antagonists|mesh-ancestor
6489730|NCT00593294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6489731|NCT00593294|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6489732|NCT00593294|Diuretics|diuretics|mesh-ancestor
6489733|NCT00593294|Natriuretic Agents|natriuretic agents|mesh-ancestor
6489734|NCT00593294|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6489735|NCT00593294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5753570|NCT03017404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5753571|NCT03017404|Immunologic Factors|immunologic factors|mesh-ancestor
5753572|NCT03017404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753573|NCT03017404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5753574|NCT03017404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5753575|NCT03017404|Alkylating Agents|alkylating agents|mesh-ancestor
5753576|NCT03017404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5753577|NCT03017404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5753578|NCT03017404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5753579|NCT03017404|Tubulin Modulators|tubulin modulators|mesh-ancestor
5753580|NCT03017404|Antimitotic Agents|antimitotic agents|mesh-ancestor
5753581|NCT03017404|Mitosis Modulators|mitosis modulators|mesh-ancestor
5753582|NCT03017404|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5753583|NCT03017404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5753584|NCT03017404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5628622|NCT05206110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5628623|NCT05206110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5628624|NCT05206110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5628625|NCT05206084|Sirolimus|sirolimus|mesh-list
5628626|NCT05206084|Everolimus|everolimus|mesh-list
5628627|NCT05206084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5628628|NCT05206084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5753585|NCT03017404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5753586|NCT03016884|Vaccines|vaccines|mesh-list
5753587|NCT03016884|Immunologic Factors|immunologic factors|mesh-ancestor
5753588|NCT03016884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753589|NCT03016988|Cytarabine|cytarabine|mesh-list
5753590|NCT03016988|Fludarabine|fludarabine|mesh-list
5753591|NCT03016988|Bortezomib|bortezomib|mesh-list
5753592|NCT03016988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5753593|NCT03016988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5753594|NCT03016988|Antimetabolites|antimetabolites|mesh-ancestor
5753595|NCT03016988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5753596|NCT03016988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5753597|NCT03016988|Immunologic Factors|immunologic factors|mesh-ancestor
5753598|NCT03016988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753599|NCT03016988|Antiviral Agents|antiviral agents|mesh-ancestor
5753600|NCT03016988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5753601|NCT03017066|Anesthetics|anesthetics|mesh-list
5753602|NCT03017066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5753603|NCT03017066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753604|NCT03016832|Irbesartan|irbesartan|mesh-list
5753605|NCT03016832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5753606|NCT03016832|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5753607|NCT03016832|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5753608|NCT03016832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5753609|NCT03016871|Carboplatin|carboplatin|mesh-list
5753610|NCT03016871|Nivolumab|nivolumab|mesh-list
5753611|NCT03016871|Etoposide|etoposide|mesh-list
5753612|NCT03016871|Etoposide phosphate|etoposide phosphate|mesh-list
5753613|NCT03016871|Ifosfamide|ifosfamide|mesh-list
5753614|NCT03016871|Isophosphamide mustard|isophosphamide mustard|mesh-list
5753615|NCT03016871|Podophyllotoxin|podophyllotoxin|mesh-list
6489736|NCT00593294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5628629|NCT05206084|Immunologic Factors|immunologic factors|mesh-ancestor
5628630|NCT05206084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628631|NCT05206084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5628632|NCT05206084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5628633|NCT05206084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6489737|NCT00593294|Contraceptive Agents|contraceptive agents|mesh-ancestor
5753616|NCT03016871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5753617|NCT03016871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5753618|NCT03016871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5753619|NCT03016871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5753620|NCT03016871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5753621|NCT03016871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5753622|NCT03016871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5753623|NCT03016871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5753624|NCT03016871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5753625|NCT03016871|Alkylating Agents|alkylating agents|mesh-ancestor
5753626|NCT03016871|Keratolytic Agents|keratolytic agents|mesh-ancestor
5753627|NCT03016871|Dermatologic Agents|dermatologic agents|mesh-ancestor
5753628|NCT03016871|Tubulin Modulators|tubulin modulators|mesh-ancestor
5753629|NCT03016871|Antimitotic Agents|antimitotic agents|mesh-ancestor
5753630|NCT03016871|Mitosis Modulators|mitosis modulators|mesh-ancestor
5753631|NCT03016806|Cyclophosphamide|cyclophosphamide|mesh-list
5753632|NCT03016806|Melphalan|melphalan|mesh-list
5753633|NCT03016806|Busulfan|busulfan|mesh-list
5753634|NCT03016806|Fludarabine|fludarabine|mesh-list
5753635|NCT03016806|Mesna|mesna|mesh-list
5753636|NCT03016806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5753637|NCT03016806|Immunologic Factors|immunologic factors|mesh-ancestor
5753638|NCT03016806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753639|NCT03016806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5753640|NCT03016806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5753641|NCT03016806|Alkylating Agents|alkylating agents|mesh-ancestor
5753642|NCT03016806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5753643|NCT03016806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5753644|NCT03016806|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5753645|NCT03016806|Protective Agents|protective agents|mesh-ancestor
5753646|NCT03016715|Sirolimus|sirolimus|mesh-list
5753647|NCT03016715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5753648|NCT03016715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6489738|NCT00593294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5628634|NCT05206084|Antifungal Agents|antifungal agents|mesh-ancestor
5628635|NCT05205837|Letrozole|letrozole|mesh-list
5628636|NCT05205837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5628637|NCT05205837|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5628638|NCT05205837|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5628639|NCT05205837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5753649|NCT03016715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5753650|NCT03016715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5753651|NCT03016715|Antifungal Agents|antifungal agents|mesh-ancestor
5753652|NCT03016715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5753653|NCT03016715|Immunologic Factors|immunologic factors|mesh-ancestor
5753654|NCT03016715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753655|NCT03016793|Puerarin|puerarin|mesh-list
5753656|NCT03016793|Vasodilator Agents|vasodilator agents|mesh-ancestor
5753657|NCT03016741|Prednisone|prednisone|mesh-list
5753658|NCT03016741|Abiraterone Acetate|abiraterone acetate|mesh-list
5753659|NCT03016741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5753660|NCT03016741|Glucocorticoids|glucocorticoids|mesh-ancestor
5753661|NCT03016741|Hormones|hormones|mesh-ancestor
5753662|NCT03016741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5753663|NCT03016741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753664|NCT03016741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5753665|NCT03016741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5753666|NCT03016741|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6489739|NCT00593294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6489740|NCT00593294|Estrogens|estrogens|mesh-ancestor
6489741|NCT00593294|Hormones|hormones|mesh-ancestor
6489742|NCT00593463|Cycloserine|cycloserine|mesh-list
6489743|NCT00593463|Verapamil|verapamil|mesh-list
6489744|NCT00593463|Diltiazem|diltiazem|mesh-list
5753667|NCT03016741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5753668|NCT03016741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5753669|NCT03016741|Hormone Antagonists|hormone antagonists|mesh-ancestor
5753670|NCT03016741|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5753671|NCT03016650|Acetaminophen|acetaminophen|mesh-list
5753672|NCT03016650|Ibuprofen|ibuprofen|mesh-list
5753673|NCT03016650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5753674|NCT03016650|Analgesics|analgesics|mesh-ancestor
5753675|NCT03016650|Sensory System Agents|sensory system agents|mesh-ancestor
5753676|NCT03016650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5753677|NCT03016650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753678|NCT03016650|Antipyretics|antipyretics|mesh-ancestor
5753679|NCT03016650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5753680|NCT03016650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5753681|NCT03016650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5753682|NCT03016650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5753683|NCT03016650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5753684|NCT03016650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5753685|NCT03016611|Ticagrelor|ticagrelor|mesh-list
5753686|NCT03016611|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
5753687|NCT03016611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5753688|NCT03016611|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5753689|NCT03016611|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5628640|NCT05205837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5628641|NCT05205837|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5628642|NCT05205837|Hormone Antagonists|hormone antagonists|mesh-ancestor
5628643|NCT05205837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5628644|NCT05205837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628645|NCT05205811|Zonisamide|zonisamide|mesh-list
5628646|NCT05205811|Bupropion|bupropion|mesh-list
5628647|NCT05205811|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5628648|NCT05205811|Antidepressive Agents|antidepressive agents|mesh-ancestor
5628649|NCT05205811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5628650|NCT05205811|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5628651|NCT05205811|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5628652|NCT05205811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5628653|NCT05205811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5753690|NCT03016611|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5753691|NCT03016611|Purinergic Agents|purinergic agents|mesh-ancestor
5753692|NCT03016611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5753693|NCT03016611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5753694|NCT03016611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753695|NCT03016442|Dinoprostone|dinoprostone|mesh-list
5753696|NCT03016442|Oxytocics|oxytocics|mesh-ancestor
5753697|NCT03016442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5628654|NCT05205811|Dopamine Agents|dopamine agents|mesh-ancestor
5628655|NCT05205811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5628656|NCT05205811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489745|NCT00593463|Isradipine|isradipine|mesh-list
6489746|NCT00593463|Nifedipine|nifedipine|mesh-list
6489747|NCT00593463|Gabapentin|gabapentin|mesh-list
5753698|NCT03016442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753699|NCT03016260|Adalimumab|adalimumab|mesh-list
5753700|NCT03016260|Etanercept|etanercept|mesh-list
5753701|NCT03016260|Golimumab|golimumab|mesh-list
5753702|NCT03016260|Infliximab|infliximab|mesh-list
5753703|NCT03016260|Certolizumab Pegol|certolizumab pegol|mesh-list
5753704|NCT03016260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5753705|NCT03016260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5753706|NCT03016260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5753707|NCT03016260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5753708|NCT03016260|Analgesics|analgesics|mesh-ancestor
5753709|NCT03016260|Sensory System Agents|sensory system agents|mesh-ancestor
5753710|NCT03016260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5753711|NCT03016260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753712|NCT03016260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5753713|NCT03016260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5753714|NCT03016260|Immunologic Factors|immunologic factors|mesh-ancestor
5753715|NCT03016260|Dermatologic Agents|dermatologic agents|mesh-ancestor
5753716|NCT03016260|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
5894742|NCT03132454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5894743|NCT03132454|Glucocorticoids|glucocorticoids|mesh-ancestor
5894744|NCT03132454|Hormones|hormones|mesh-ancestor
5894745|NCT03132454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5894746|NCT03132454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5894747|NCT03132454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5894748|NCT03132454|Protease Inhibitors|protease inhibitors|mesh-ancestor
5894749|NCT03132454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5894750|NCT03132454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894751|NCT03132454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5894752|NCT03132454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5894753|NCT03132454|Antimetabolites|antimetabolites|mesh-ancestor
5894754|NCT03132454|Dermatologic Agents|dermatologic agents|mesh-ancestor
5894755|NCT03121677|Poly I-C|poly i-c|mesh-list
5894756|NCT03121677|Rituximab|rituximab|mesh-list
5894757|NCT03121677|Nivolumab|nivolumab|mesh-list
5894758|NCT03121677|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
5894759|NCT03121677|Poly ICLC|poly iclc|mesh-list
5894760|NCT03121677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5894761|NCT03121677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5894762|NCT03121677|Immunologic Factors|immunologic factors|mesh-ancestor
5894763|NCT03121677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894764|NCT03121677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5894765|NCT03121677|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5894766|NCT03121677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894767|NCT03121677|Interferon Inducers|interferon inducers|mesh-ancestor
5894768|NCT03121677|Laxatives|laxatives|mesh-ancestor
5894769|NCT03121677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5894770|NCT03121677|Antiviral Agents|antiviral agents|mesh-ancestor
5894771|NCT03121677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5894772|NCT03107182|Diphenhydramine|diphenhydramine|mesh-list
5894773|NCT03107182|Promethazine|promethazine|mesh-list
5894774|NCT03107182|Dexamethasone|dexamethasone|mesh-list
5894775|NCT03107182|Paclitaxel|paclitaxel|mesh-list
5894776|NCT03107182|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5894777|NCT03107182|Carboplatin|carboplatin|mesh-list
5894778|NCT03107182|Nivolumab|nivolumab|mesh-list
5894779|NCT03107182|Hydroxyurea|hydroxyurea|mesh-list
5894780|NCT03107182|Famotidine|famotidine|mesh-list
5894781|NCT03107182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5894782|NCT03107182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5894783|NCT03107182|Tubulin Modulators|tubulin modulators|mesh-ancestor
5894784|NCT03107182|Antimitotic Agents|antimitotic agents|mesh-ancestor
5894785|NCT03107182|Mitosis Modulators|mitosis modulators|mesh-ancestor
5894786|NCT03107182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894787|NCT03107182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5894788|NCT03107182|Antiemetics|antiemetics|mesh-ancestor
5894789|NCT03107182|Autonomic Agents|autonomic agents|mesh-ancestor
5894790|NCT03107182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5894791|NCT03107182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894792|NCT03107182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5894793|NCT03107182|Glucocorticoids|glucocorticoids|mesh-ancestor
5894794|NCT03107182|Hormones|hormones|mesh-ancestor
5894795|NCT03107182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5894796|NCT03107182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5894797|NCT03107182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5894798|NCT03107182|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5894799|NCT03107182|Antisickling Agents|antisickling agents|mesh-ancestor
5628657|NCT05205811|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5628658|NCT05205811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5628659|NCT05205811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5628660|NCT05205811|Anticonvulsants|anticonvulsants|mesh-ancestor
5628661|NCT05205811|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5628662|NCT05205811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5628663|NCT05205720|Ropivacaine|ropivacaine|mesh-list
5628664|NCT05205720|Anesthetics, Local|anesthetics, local|mesh-ancestor
5753717|NCT03016234|Propofol|propofol|mesh-list
5753718|NCT03016234|Desflurane|desflurane|mesh-list
5753719|NCT03016234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5753720|NCT03016234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5753721|NCT03016234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753722|NCT03016234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5753723|NCT03016234|Anesthetics, General|anesthetics, general|mesh-ancestor
5753724|NCT03016234|Anesthetics|anesthetics|mesh-ancestor
5753725|NCT03016234|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5753726|NCT03016468|Treprostinil|treprostinil|mesh-list
5628665|NCT05205720|Anesthetics|anesthetics|mesh-ancestor
5628666|NCT05205720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5628667|NCT05205720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628668|NCT05205720|Sensory System Agents|sensory system agents|mesh-ancestor
5628669|NCT05205720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5693109|NCT03403049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5753727|NCT03016468|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5753728|NCT03016208|Misoprostol|misoprostol|mesh-list
5753729|NCT03016208|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5753730|NCT03016208|Abortifacient Agents|abortifacient agents|mesh-ancestor
5753731|NCT03016208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5753732|NCT03016208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753733|NCT03016208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5753734|NCT03016208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5753735|NCT03016208|Oxytocics|oxytocics|mesh-ancestor
5753736|NCT03016000|Thalidomide|thalidomide|mesh-list
5753737|NCT03016000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5753738|NCT03016000|Immunologic Factors|immunologic factors|mesh-ancestor
5753739|NCT03016000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753740|NCT03016000|Leprostatic Agents|leprostatic agents|mesh-ancestor
5753741|NCT03016000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5753742|NCT03016000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5753743|NCT03016000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5693110|NCT03403049|Immunologic Factors|immunologic factors|mesh-ancestor
5693111|NCT03403049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693112|NCT03403049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5693113|NCT03403023|Cyclosporine|cyclosporine|mesh-list
5693114|NCT03403023|Cyclosporins|cyclosporins|mesh-list
5693115|NCT03403023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5693116|NCT03403023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693117|NCT03403023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5693118|NCT03403023|Immunologic Factors|immunologic factors|mesh-ancestor
5693119|NCT03403023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693120|NCT03403023|Antifungal Agents|antifungal agents|mesh-ancestor
5693121|NCT03403023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5693122|NCT03403023|Dermatologic Agents|dermatologic agents|mesh-ancestor
5693123|NCT03403023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5753744|NCT03016000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5753745|NCT03016000|Growth Substances|growth substances|mesh-ancestor
5753746|NCT03016000|Growth Inhibitors|growth inhibitors|mesh-ancestor
5753747|NCT03016000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5753748|NCT03015844|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
5753749|NCT03015844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5753750|NCT03015844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5753751|NCT03015844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5753752|NCT03015844|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5753753|NCT03016039|Curcumin|curcumin|mesh-list
5693124|NCT03403023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5894800|NCT03107182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6673094|NCT01560390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6673095|NCT01560390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673096|NCT01560442|Buprenorphine|buprenorphine|mesh-list
6673097|NCT01560442|Methadone|methadone|mesh-list
6673098|NCT01560442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6673099|NCT01560442|Narcotics|narcotics|mesh-ancestor
5753754|NCT03016039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5753755|NCT03016039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5753756|NCT03016039|Analgesics|analgesics|mesh-ancestor
5753757|NCT03016039|Sensory System Agents|sensory system agents|mesh-ancestor
5753758|NCT03016039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5753759|NCT03016039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753760|NCT03016039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5753761|NCT03016039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5753762|NCT03016039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5753763|NCT03016039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5753764|NCT03016039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5753765|NCT03015818|Calcium|calcium|mesh-list
5753766|NCT03015818|Fluorides|fluorides|mesh-list
5753767|NCT03015818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5628670|NCT05205603|Mesalamine|mesalamine|mesh-list
5628671|NCT05205603|Infliximab|infliximab|mesh-list
5628672|NCT05205603|Vedolizumab|vedolizumab|mesh-list
5628673|NCT05205603|Dermatologic Agents|dermatologic agents|mesh-ancestor
5628674|NCT05205603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5628675|NCT05205603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5628676|NCT05205603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5628677|NCT05205603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5628678|NCT05205603|Analgesics|analgesics|mesh-ancestor
5753768|NCT03015818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753769|NCT03015818|Cariostatic Agents|cariostatic agents|mesh-ancestor
5753770|NCT03015818|Protective Agents|protective agents|mesh-ancestor
5628679|NCT05205603|Sensory System Agents|sensory system agents|mesh-ancestor
5628680|NCT05205603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5628681|NCT05205603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753771|NCT03015792|Dexamethasone|dexamethasone|mesh-list
5753772|NCT03015792|Dexamethasone acetate|dexamethasone acetate|mesh-list
5753773|NCT03015792|Lenalidomide|lenalidomide|mesh-list
5753774|NCT03015792|Ichthammol|ichthammol|mesh-list
5753775|NCT03015792|BB 1101|bb 1101|mesh-list
5753776|NCT03015792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5753777|NCT03015792|Antiemetics|antiemetics|mesh-ancestor
5753778|NCT03015792|Autonomic Agents|autonomic agents|mesh-ancestor
5753779|NCT03015792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5753780|NCT03015792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753781|NCT03015792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5753782|NCT03015792|Glucocorticoids|glucocorticoids|mesh-ancestor
5753783|NCT03015792|Hormones|hormones|mesh-ancestor
5753784|NCT03015792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5753785|NCT03015792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5753786|NCT03015792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5753787|NCT03015792|Immunologic Factors|immunologic factors|mesh-ancestor
5753788|NCT03015792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5753789|NCT03015792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5753790|NCT03015792|Growth Substances|growth substances|mesh-ancestor
5753791|NCT03015792|Growth Inhibitors|growth inhibitors|mesh-ancestor
5628682|NCT05205603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5628683|NCT05205577|Iodine|iodine|mesh-list
5628684|NCT05205577|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5628685|NCT05205577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5628686|NCT05205577|Trace Elements|trace elements|mesh-ancestor
5628687|NCT05205577|Micronutrients|micronutrients|mesh-ancestor
5628688|NCT05205577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628689|NCT05205525|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5628690|NCT05205525|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5628691|NCT05205525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5628692|NCT05205525|Antitubercular Agents|antitubercular agents|mesh-ancestor
5628693|NCT05205499|Sirolimus|sirolimus|mesh-list
5628694|NCT05205499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5628695|NCT05205499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5628696|NCT05205499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5628697|NCT05205499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5628698|NCT05205499|Antifungal Agents|antifungal agents|mesh-ancestor
5628699|NCT05205499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5628700|NCT05205499|Immunologic Factors|immunologic factors|mesh-ancestor
6673100|NCT01560442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5693125|NCT03402984|Z 338|z 338|mesh-list
5753792|NCT03015792|Protease Inhibitors|protease inhibitors|mesh-ancestor
5753793|NCT03015792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5753794|NCT03015792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5753795|NCT03015792|Dermatologic Agents|dermatologic agents|mesh-ancestor
5753796|NCT03015857|Phenylephrine|phenylephrine|mesh-list
5753797|NCT03015857|Oxymetazoline|oxymetazoline|mesh-list
5753798|NCT03015857|Norepinephrine|norepinephrine|mesh-list
5753799|NCT03015857|Fentanyl|fentanyl|mesh-list
5753800|NCT03015857|Bupivacaine|bupivacaine|mesh-list
5753801|NCT03015857|Anesthetics, Local|anesthetics, local|mesh-ancestor
5753802|NCT03015857|Anesthetics|anesthetics|mesh-ancestor
5628701|NCT05205499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628702|NCT05205486|Cefazolin|cefazolin|mesh-list
5628703|NCT05205486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5628704|NCT05205486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5628705|NCT05205447|Itraconazole|itraconazole|mesh-list
5628706|NCT05205447|Carbamazepine|carbamazepine|mesh-list
5628707|NCT05205447|Antifungal Agents|antifungal agents|mesh-ancestor
5628708|NCT05205447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5628709|NCT05205447|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5628710|NCT05205447|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5628711|NCT05205447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5628712|NCT05205447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5628713|NCT05205447|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5628714|NCT05205447|Hormone Antagonists|hormone antagonists|mesh-ancestor
5628715|NCT05205447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5628716|NCT05205447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628717|NCT05205447|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5628718|NCT05205447|Anticonvulsants|anticonvulsants|mesh-ancestor
5628719|NCT05205447|Antimanic Agents|antimanic agents|mesh-ancestor
5628720|NCT05205447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5628721|NCT05205447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5628722|NCT05205447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5628723|NCT05205447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5628724|NCT05205447|Analgesics|analgesics|mesh-ancestor
5628725|NCT05205447|Sensory System Agents|sensory system agents|mesh-ancestor
5628726|NCT05205447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5628727|NCT05205447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5628728|NCT05205447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5628729|NCT05205447|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5628730|NCT05205447|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5628731|NCT05205382|Nicotine|nicotine|mesh-list
5628732|NCT05205382|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5753803|NCT03015857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5753804|NCT03015857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753805|NCT03015857|Sensory System Agents|sensory system agents|mesh-ancestor
5753806|NCT03015857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5753807|NCT03015857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5753808|NCT03015857|Narcotics|narcotics|mesh-ancestor
5753809|NCT03015857|Analgesics|analgesics|mesh-ancestor
5753810|NCT03015857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5753811|NCT03015857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5753812|NCT03015857|Anesthetics, General|anesthetics, general|mesh-ancestor
5753813|NCT03015857|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5753814|NCT03015857|Mydriatics|mydriatics|mesh-ancestor
5753815|NCT03015857|Autonomic Agents|autonomic agents|mesh-ancestor
5628733|NCT05205382|Autonomic Agents|autonomic agents|mesh-ancestor
5628734|NCT05205382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5628735|NCT05205382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628736|NCT05205382|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5628737|NCT05205382|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5628738|NCT05205382|Cholinergic Agents|cholinergic agents|mesh-ancestor
5628739|NCT05205382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5628740|NCT05205382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5628741|NCT05205317|Metformin|metformin|mesh-list
5628742|NCT05205317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5628743|NCT05205317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208853|NCT02137772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6208854|NCT02137772|Antiviral Agents|antiviral agents|mesh-ancestor
6208855|NCT02137772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6208856|NCT02137785|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6208857|NCT02137785|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6208858|NCT02137785|Dermatologic Agents|dermatologic agents|mesh-ancestor
6208859|NCT02137837|Everolimus|everolimus|mesh-list
6208860|NCT02137837|Fulvestrant|fulvestrant|mesh-list
6208861|NCT02137837|Anastrozole|anastrozole|mesh-list
6208862|NCT02137837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5753816|NCT03015857|Sympathomimetics|sympathomimetics|mesh-ancestor
5753817|NCT03015857|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5753818|NCT03015857|Nasal Decongestants|nasal decongestants|mesh-ancestor
5753819|NCT03015857|Respiratory System Agents|respiratory system agents|mesh-ancestor
5753820|NCT03015857|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5753821|NCT03015857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5753822|NCT03015857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6208863|NCT02137837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6208864|NCT02137837|Immunologic Factors|immunologic factors|mesh-ancestor
6208865|NCT02137837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208866|NCT02137837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6208867|NCT02137837|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6208868|NCT02137837|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6208869|NCT02137837|Hormone Antagonists|hormone antagonists|mesh-ancestor
6208870|NCT02137837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6208871|NCT02137837|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6208872|NCT02137837|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6208873|NCT02137837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6208874|NCT02137837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208875|NCT02138006|Insulin|insulin|mesh-list
6208876|NCT02138006|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6208877|NCT02138006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5753823|NCT03015857|Adrenergic Agents|adrenergic agents|mesh-ancestor
5753824|NCT03015857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5753825|NCT03015857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5753826|NCT03015857|Protective Agents|protective agents|mesh-ancestor
5753827|NCT03016091|Pembrolizumab|pembrolizumab|mesh-list
5753828|NCT03016091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5753829|NCT03016091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5753830|NCT03015922|Lenalidomide|lenalidomide|mesh-list
5753831|NCT03015922|Pomalidomide|pomalidomide|mesh-list
5753832|NCT03015922|Immunologic Factors|immunologic factors|mesh-ancestor
5753833|NCT03015922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753834|NCT03015922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5753835|NCT03015922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5753836|NCT03015922|Growth Substances|growth substances|mesh-ancestor
5753837|NCT03015922|Growth Inhibitors|growth inhibitors|mesh-ancestor
5753838|NCT03015922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5753839|NCT03015727|Docetaxel|docetaxel|mesh-list
5753840|NCT03015727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5753841|NCT03015727|Tubulin Modulators|tubulin modulators|mesh-ancestor
6208878|NCT02138006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628771|NCT05205200|Paclitaxel|paclitaxel|mesh-list
5628772|NCT05205200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5753842|NCT03015727|Antimitotic Agents|antimitotic agents|mesh-ancestor
5753843|NCT03015727|Mitosis Modulators|mitosis modulators|mesh-ancestor
5753844|NCT03015727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5753845|NCT03015974|Mycophenolic Acid|mycophenolic acid|mesh-list
5753846|NCT03015974|Prednisone|prednisone|mesh-list
5753847|NCT03015974|Prednisolone|prednisolone|mesh-list
5753848|NCT03015974|Deflazacort|deflazacort|mesh-list
5753849|NCT03015974|Cyclophosphamide|cyclophosphamide|mesh-list
5753850|NCT03015974|Dipyridamole|dipyridamole|mesh-list
5753851|NCT03015974|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
5753852|NCT03015974|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
5753853|NCT03015974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5753854|NCT03015974|Immunologic Factors|immunologic factors|mesh-ancestor
5753855|NCT03015974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753856|NCT03015974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5753857|NCT03015974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5753858|NCT03015974|Alkylating Agents|alkylating agents|mesh-ancestor
5753859|NCT03015974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5628773|NCT05205200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5628774|NCT05205200|Tubulin Modulators|tubulin modulators|mesh-ancestor
5628775|NCT05205200|Antimitotic Agents|antimitotic agents|mesh-ancestor
5628776|NCT05205200|Mitosis Modulators|mitosis modulators|mesh-ancestor
5628777|NCT05205200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5753860|NCT03015974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5753861|NCT03015974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5753862|NCT03015974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5753863|NCT03015974|Glucocorticoids|glucocorticoids|mesh-ancestor
5753864|NCT03015974|Hormones|hormones|mesh-ancestor
5753865|NCT03015974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5753866|NCT03015974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5753867|NCT03015974|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5753868|NCT03015974|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5753869|NCT03015974|Antitubercular Agents|antitubercular agents|mesh-ancestor
5753870|NCT03015974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5753871|NCT03015974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5753872|NCT03015974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5753873|NCT03015974|Protease Inhibitors|protease inhibitors|mesh-ancestor
5753874|NCT03015974|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5753875|NCT03015974|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6673101|NCT01560442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673102|NCT01560442|Analgesics|analgesics|mesh-ancestor
5628778|NCT05205122|Mitomycins|mitomycins|mesh-list
5628779|NCT05205122|Mitomycin|mitomycin|mesh-list
5628780|NCT05205122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5628781|NCT05205122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5628782|NCT05205122|Alkylating Agents|alkylating agents|mesh-ancestor
5628783|NCT05205122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5628784|NCT05205122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5628785|NCT05205122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5628786|NCT05204979|Misoprostol|misoprostol|mesh-list
5628787|NCT05204979|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5628788|NCT05204979|Abortifacient Agents|abortifacient agents|mesh-ancestor
5628789|NCT05204979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5628790|NCT05204979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628791|NCT05204979|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5628792|NCT05204979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5628793|NCT05204979|Oxytocics|oxytocics|mesh-ancestor
5628794|NCT05204862|Antibodies|antibodies|mesh-list
5628795|NCT05204862|Immunologic Factors|immunologic factors|mesh-ancestor
5628796|NCT05204862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628797|NCT05204836|Zoledronic Acid|zoledronic acid|mesh-list
5628798|NCT05204836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5628799|NCT05204836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628800|NCT05204667|Acetaminophen|acetaminophen|mesh-list
5628801|NCT05204667|Aspirin|aspirin|mesh-list
5628802|NCT05204667|Methocarbamol|methocarbamol|mesh-list
5628803|NCT05204667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5628804|NCT05204667|Analgesics|analgesics|mesh-ancestor
5628805|NCT05204667|Sensory System Agents|sensory system agents|mesh-ancestor
5628806|NCT05204667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5628807|NCT05204667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628808|NCT05204667|Antipyretics|antipyretics|mesh-ancestor
5628809|NCT05204667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5628810|NCT05204667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5628811|NCT05204667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5628812|NCT05204667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5628813|NCT05204667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5628814|NCT05204667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5628815|NCT05204667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5628816|NCT05204667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5628817|NCT05204667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6673103|NCT01560442|Sensory System Agents|sensory system agents|mesh-ancestor
6673104|NCT01560442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6673105|NCT01560442|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6673106|NCT01560442|Antitussive Agents|antitussive agents|mesh-ancestor
6673107|NCT01560442|Respiratory System Agents|respiratory system agents|mesh-ancestor
6673108|NCT01560481|Metformin|metformin|mesh-list
6673109|NCT01560481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6673110|NCT01560481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673111|NCT01560546|Testosterone|testosterone|mesh-list
6673112|NCT01560546|Androgens|androgens|mesh-ancestor
6673113|NCT01560546|Hormones|hormones|mesh-ancestor
6673114|NCT01560546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6673115|NCT01560546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673116|NCT01560585|Isotretinoin|isotretinoin|mesh-list
6673117|NCT01560585|Dermatologic Agents|dermatologic agents|mesh-ancestor
6673118|NCT01560637|Treprostinil|treprostinil|mesh-list
5753876|NCT03015974|Vasodilator Agents|vasodilator agents|mesh-ancestor
5753877|NCT03015896|Nivolumab|nivolumab|mesh-list
5753878|NCT03015896|Lenalidomide|lenalidomide|mesh-list
5753879|NCT03015896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5753880|NCT03015896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5753881|NCT03015896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5753882|NCT03015896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5753883|NCT03015896|Immunologic Factors|immunologic factors|mesh-ancestor
5753884|NCT03015896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673119|NCT01560637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5753885|NCT03015896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5753886|NCT03015896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5753887|NCT03015896|Growth Substances|growth substances|mesh-ancestor
5753888|NCT03015896|Growth Inhibitors|growth inhibitors|mesh-ancestor
5753889|NCT03015831|Colchicine|colchicine|mesh-list
5753890|NCT03015831|Gout Suppressants|gout suppressants|mesh-ancestor
5753891|NCT03015831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5753892|NCT03015831|Tubulin Modulators|tubulin modulators|mesh-ancestor
5753893|NCT03015831|Antimitotic Agents|antimitotic agents|mesh-ancestor
5753894|NCT03015831|Mitosis Modulators|mitosis modulators|mesh-ancestor
5753895|NCT03015831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5753896|NCT03015831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5628818|NCT05204667|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5628819|NCT05204667|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5628820|NCT05204641|Rifaximin|rifaximin|mesh-list
5628821|NCT05204641|Levodopa|levodopa|mesh-list
5628822|NCT05204641|Benserazide|benserazide|mesh-list
5628823|NCT05204641|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5628824|NCT05204641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5628825|NCT05204641|Dopamine Agents|dopamine agents|mesh-ancestor
5628826|NCT05204641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5628827|NCT05204641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5628828|NCT05204641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628829|NCT05204641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5628830|NCT05204641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5628831|NCT05204641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5628832|NCT05204641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5628833|NCT05204628|Crizotinib|crizotinib|mesh-list
5628834|NCT05204628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5628835|NCT05204628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5628836|NCT05204628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5628837|NCT05204628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5628838|NCT05204550|Heparin|heparin|mesh-list
5628839|NCT05204550|Calcium heparin|calcium heparin|mesh-list
5628840|NCT05204550|Anticoagulants|anticoagulants|mesh-ancestor
5628841|NCT05204550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5628842|NCT05204550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5753897|NCT03015701|Mifepristone|mifepristone|mesh-list
5753898|NCT03015701|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5753899|NCT03015701|Abortifacient Agents|abortifacient agents|mesh-ancestor
5753900|NCT03015701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5753901|NCT03015701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753902|NCT03015701|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5753903|NCT03015701|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5753904|NCT03015701|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5753905|NCT03015701|Contraceptive Agents|contraceptive agents|mesh-ancestor
5753906|NCT03015701|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5753907|NCT03015701|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5753908|NCT03015701|Hormone Antagonists|hormone antagonists|mesh-ancestor
5753909|NCT03015701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5753910|NCT03015701|Luteolytic Agents|luteolytic agents|mesh-ancestor
5753911|NCT03015701|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5753912|NCT03015701|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5753913|NCT03015675|Ascorbic Acid|ascorbic acid|mesh-list
6208879|NCT02138136|Lubiprostone|lubiprostone|mesh-list
5628843|NCT05204550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5628844|NCT05204524|Temozolomide|temozolomide|mesh-list
5628845|NCT05204524|Epirubicin|epirubicin|mesh-list
5628846|NCT05204524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5628847|NCT05204524|Alkylating Agents|alkylating agents|mesh-ancestor
5628848|NCT05204524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5628849|NCT05204524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5628850|NCT05204524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5628851|NCT05204524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5628852|NCT05204524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5628853|NCT05204524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5628854|NCT05204329|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5628855|NCT05204329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5628856|NCT05204173|Paclitaxel|paclitaxel|mesh-list
5628857|NCT05204173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5628858|NCT05204173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5628859|NCT05204173|Tubulin Modulators|tubulin modulators|mesh-ancestor
5628860|NCT05204173|Antimitotic Agents|antimitotic agents|mesh-ancestor
5628861|NCT05204173|Mitosis Modulators|mitosis modulators|mesh-ancestor
5693126|NCT03402984|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5628862|NCT05204173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5628863|NCT05204160|Pembrolizumab|pembrolizumab|mesh-list
5628864|NCT05204160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5753914|NCT03015675|Vitamins|vitamins|mesh-ancestor
5753915|NCT03015675|Micronutrients|micronutrients|mesh-ancestor
5753916|NCT03015675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753917|NCT03015675|Antioxidants|antioxidants|mesh-ancestor
5753918|NCT03015675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5753919|NCT03015675|Protective Agents|protective agents|mesh-ancestor
5753920|NCT03015519|rGLP-1 protein|rglp-1 protein|mesh-list
5753921|NCT03015519|Incretins|incretins|mesh-ancestor
5753922|NCT03015519|Hormones|hormones|mesh-ancestor
5753923|NCT03015519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5753924|NCT03015519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753925|NCT03015610|Lansoprazole|lansoprazole|mesh-list
5753926|NCT03015610|Dexlansoprazole|dexlansoprazole|mesh-list
5753927|NCT03015610|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5753928|NCT03015610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5753929|NCT03015610|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5753930|NCT03015610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5628865|NCT05204160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5628866|NCT05204147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5628867|NCT05204147|Antibodies|antibodies|mesh-list
5628868|NCT05204147|Immunoglobulins|immunoglobulins|mesh-list
5628869|NCT05204147|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5628870|NCT05204147|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
5628871|NCT05204147|Immunologic Factors|immunologic factors|mesh-ancestor
5628872|NCT05204147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628873|NCT05204147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5628874|NCT05204147|Chelating Agents|chelating agents|mesh-ancestor
5628875|NCT05204147|Sequestering Agents|sequestering agents|mesh-ancestor
5628876|NCT05204147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5628877|NCT05204134|Insulin|insulin|mesh-list
5628878|NCT05204134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5628879|NCT05204134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628880|NCT05204121|Elsulfavirine|elsulfavirine|mesh-list
5628881|NCT05204121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5628882|NCT05204121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5628883|NCT05204121|Antiviral Agents|antiviral agents|mesh-ancestor
5628884|NCT05204121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5628885|NCT05204069|Cyclopentolate|cyclopentolate|mesh-list
5628886|NCT05204069|Mydriatics|mydriatics|mesh-ancestor
5628887|NCT05204069|Autonomic Agents|autonomic agents|mesh-ancestor
5628888|NCT05204069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5628889|NCT05204069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628890|NCT05204069|Parasympatholytics|parasympatholytics|mesh-ancestor
5628891|NCT05204069|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5628892|NCT05204069|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5628893|NCT05204069|Cholinergic Agents|cholinergic agents|mesh-ancestor
5628894|NCT05204069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5628895|NCT05204069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5628896|NCT05204056|Epinephrine|epinephrine|mesh-list
5628897|NCT05204056|Morphine|morphine|mesh-list
5628898|NCT05204056|Ropivacaine|ropivacaine|mesh-list
5628899|NCT05204056|Tranexamic Acid|tranexamic acid|mesh-list
5628900|NCT05204056|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5628901|NCT05204056|Narcotics|narcotics|mesh-ancestor
5628902|NCT05204056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5628903|NCT05204056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628904|NCT05204056|Analgesics|analgesics|mesh-ancestor
5628905|NCT05204056|Sensory System Agents|sensory system agents|mesh-ancestor
5628906|NCT05204056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5628907|NCT05204056|Anesthetics, Local|anesthetics, local|mesh-ancestor
5628908|NCT05204056|Anesthetics|anesthetics|mesh-ancestor
5628909|NCT05204056|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5628910|NCT05204056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5628911|NCT05204056|Adrenergic Agents|adrenergic agents|mesh-ancestor
5753931|NCT03015610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5753932|NCT03015350|Sevoflurane|sevoflurane|mesh-list
5753933|NCT03015350|Desflurane|desflurane|mesh-list
5753934|NCT03015350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5753935|NCT03015350|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5753936|NCT03015350|Anesthetics, General|anesthetics, general|mesh-ancestor
5753937|NCT03015350|Anesthetics|anesthetics|mesh-ancestor
5628912|NCT05204056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5693127|NCT03402984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5753938|NCT03015350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5753939|NCT03015350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753940|NCT03015246|Morphine|morphine|mesh-list
5753941|NCT03015246|Buprenorphine|buprenorphine|mesh-list
5753942|NCT03015246|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
5753943|NCT03015246|Naloxone|naloxone|mesh-list
5753944|NCT03015246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5753945|NCT03015246|Narcotics|narcotics|mesh-ancestor
5753946|NCT03015246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5753947|NCT03015246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753948|NCT03015246|Analgesics|analgesics|mesh-ancestor
5753949|NCT03015246|Sensory System Agents|sensory system agents|mesh-ancestor
5753950|NCT03015246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5753951|NCT03015246|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5753952|NCT03014947|Adalimumab|adalimumab|mesh-list
5753953|NCT03014947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5753954|NCT03014947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5753955|NCT03015090|Theophylline|theophylline|mesh-list
5753956|NCT03015090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5753957|NCT03015090|Autonomic Agents|autonomic agents|mesh-ancestor
5753958|NCT03015090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5753959|NCT03015090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753960|NCT03015090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5753961|NCT03015090|Respiratory System Agents|respiratory system agents|mesh-ancestor
5753962|NCT03015090|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5753963|NCT03015090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5753964|NCT03015090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5753965|NCT03015090|Vasodilator Agents|vasodilator agents|mesh-ancestor
5753966|NCT03015090|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5753967|NCT03015090|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5753968|NCT03015090|Purinergic Agents|purinergic agents|mesh-ancestor
5753969|NCT03015090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5753970|NCT03015168|Capecitabine|capecitabine|mesh-list
5753971|NCT03015168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5753972|NCT03015168|Antimetabolites|antimetabolites|mesh-ancestor
5753973|NCT03015168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5753974|NCT03015168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5753975|NCT03015025|Acenocoumarol|acenocoumarol|mesh-list
5753976|NCT03015025|Anticoagulants|anticoagulants|mesh-ancestor
5753977|NCT03014843|Bromides|bromides|mesh-list
5753978|NCT03014843|Naloxone|naloxone|mesh-list
5753979|NCT03014843|Methylnaltrexone|methylnaltrexone|mesh-list
5753980|NCT03014843|Anticonvulsants|anticonvulsants|mesh-ancestor
5753981|NCT03014843|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5753982|NCT03014843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753983|NCT03014843|Sensory System Agents|sensory system agents|mesh-ancestor
5753984|NCT03014843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5753985|NCT03014882|Acetylcysteine|acetylcysteine|mesh-list
5753986|NCT03014882|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5628913|NCT05204056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5628914|NCT05204056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5628915|NCT05204056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5628916|NCT05204056|Autonomic Agents|autonomic agents|mesh-ancestor
5628917|NCT05204056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5628918|NCT05204056|Respiratory System Agents|respiratory system agents|mesh-ancestor
5628919|NCT05204056|Mydriatics|mydriatics|mesh-ancestor
5628920|NCT05204056|Sympathomimetics|sympathomimetics|mesh-ancestor
5628921|NCT05204056|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5628922|NCT05204056|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5628923|NCT05204056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5628924|NCT05204056|Hemostatics|hemostatics|mesh-ancestor
5753987|NCT03014882|Antiviral Agents|antiviral agents|mesh-ancestor
5753988|NCT03014882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5753989|NCT03014882|Expectorants|expectorants|mesh-ancestor
5753990|NCT03014882|Respiratory System Agents|respiratory system agents|mesh-ancestor
5753991|NCT03014882|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5753992|NCT03014882|Antioxidants|antioxidants|mesh-ancestor
5753993|NCT03014882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5753994|NCT03014882|Protective Agents|protective agents|mesh-ancestor
5753995|NCT03014882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5753996|NCT03014882|Antidotes|antidotes|mesh-ancestor
5894801|NCT03107182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5894802|NCT03107182|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5894803|NCT03107182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5894804|NCT03107182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5628925|NCT05204056|Coagulants|coagulants|mesh-ancestor
5628926|NCT05203913|Paclitaxel|paclitaxel|mesh-list
5894805|NCT03107182|Anesthetics, Local|anesthetics, local|mesh-ancestor
5894806|NCT03107182|Anesthetics|anesthetics|mesh-ancestor
5894807|NCT03107182|Sensory System Agents|sensory system agents|mesh-ancestor
5894808|NCT03107182|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5894809|NCT03107182|Histamine Antagonists|histamine antagonists|mesh-ancestor
5894810|NCT03107182|Histamine Agents|histamine agents|mesh-ancestor
5894811|NCT03107182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5894812|NCT03107182|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5894813|NCT03107182|Antipruritics|antipruritics|mesh-ancestor
5894814|NCT03107182|Dermatologic Agents|dermatologic agents|mesh-ancestor
5894815|NCT03107182|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5894816|NCT03107182|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5894817|NCT02969837|Dexamethasone|dexamethasone|mesh-list
5894818|NCT02969837|Lenalidomide|lenalidomide|mesh-list
5894819|NCT02969837|Elotuzumab|elotuzumab|mesh-list
5894820|NCT02969837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5894821|NCT02969837|Antiemetics|antiemetics|mesh-ancestor
5894822|NCT02969837|Autonomic Agents|autonomic agents|mesh-ancestor
5894823|NCT02969837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5894824|NCT02969837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628927|NCT05203913|Nivolumab|nivolumab|mesh-list
5628928|NCT05203913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5628929|NCT05203913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5628930|NCT05203913|Tubulin Modulators|tubulin modulators|mesh-ancestor
5628931|NCT05203913|Antimitotic Agents|antimitotic agents|mesh-ancestor
5628932|NCT05203913|Mitosis Modulators|mitosis modulators|mesh-ancestor
5628933|NCT05203913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5628934|NCT05203913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5628935|NCT05203913|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5693128|NCT03402984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693129|NCT03402984|Cholinergic Agents|cholinergic agents|mesh-ancestor
5907827|NCT05167331|Anesthetics|anesthetics|mesh-ancestor
5753997|NCT03014713|Flurbiprofen|flurbiprofen|mesh-list
5753998|NCT03014713|Dexmedetomidine|dexmedetomidine|mesh-list
5753999|NCT03014713|Dezocine|dezocine|mesh-list
5754000|NCT03014713|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5754001|NCT03014713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5754002|NCT03014713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754003|NCT03014713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5754004|NCT03014713|Analgesics|analgesics|mesh-ancestor
5754005|NCT03014713|Sensory System Agents|sensory system agents|mesh-ancestor
5754006|NCT03014713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5628936|NCT05203822|Itraconazole|itraconazole|mesh-list
5628937|NCT05203822|Tepotinib|tepotinib|mesh-list
5628938|NCT05203822|Antifungal Agents|antifungal agents|mesh-ancestor
5628939|NCT05203822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5628940|NCT05203822|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5628941|NCT05203822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5628942|NCT05203822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5754007|NCT03014713|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5754008|NCT03014713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5754009|NCT03014713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5754010|NCT03014713|Adrenergic Agents|adrenergic agents|mesh-ancestor
5754011|NCT03014713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5754012|NCT03014713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5754013|NCT03014713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5754014|NCT03014713|Narcotics|narcotics|mesh-ancestor
5754015|NCT03014713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5754016|NCT03014713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5754017|NCT03014713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5754018|NCT03014713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5754019|NCT03014713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5754020|NCT03014687|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5754021|NCT03014687|Cefdinir|cefdinir|mesh-list
5754022|NCT03014687|Cephalosporins|cephalosporins|mesh-list
5754023|NCT03014687|Trimethoprim|trimethoprim|mesh-list
5754024|NCT03014687|Sulfamethoxazole|sulfamethoxazole|mesh-list
5754025|NCT03014687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5754026|NCT03014687|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5754027|NCT03014687|Renal Agents|renal agents|mesh-ancestor
5754028|NCT03014687|Antimalarials|antimalarials|mesh-ancestor
5754029|NCT03014687|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5754030|NCT03014687|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5754031|NCT03014687|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5754032|NCT03014687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5754033|NCT03014687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5754034|NCT03014687|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5754035|NCT03014687|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
5754036|NCT03014687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5754037|NCT03014804|Nivolumab|nivolumab|mesh-list
5754038|NCT03014804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5754039|NCT03014804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5754040|NCT03014804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5754041|NCT03014804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5754042|NCT03014778|Chlorhexidine|chlorhexidine|mesh-list
5754043|NCT03014778|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5754044|NCT03014778|Povidone-Iodine|povidone-iodine|mesh-list
5754045|NCT03014778|Povidone|povidone|mesh-list
5754046|NCT03014778|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5754047|NCT03014778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5754048|NCT03014778|Disinfectants|disinfectants|mesh-ancestor
5754049|NCT03014778|Dermatologic Agents|dermatologic agents|mesh-ancestor
5754050|NCT03014778|Plasma Substitutes|plasma substitutes|mesh-ancestor
5754051|NCT03014778|Blood Substitutes|blood substitutes|mesh-ancestor
5754052|NCT03014440|Cannabidiol|cannabidiol|mesh-list
5754053|NCT03014440|Anticonvulsants|anticonvulsants|mesh-ancestor
5754054|NCT03014323|Galantamine|galantamine|mesh-list
5754055|NCT03014323|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5754056|NCT03014323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5754057|NCT03014323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5754058|NCT03014323|Cholinergic Agents|cholinergic agents|mesh-ancestor
5754059|NCT03014323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5754060|NCT03014323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754061|NCT03014323|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5754062|NCT03014323|Autonomic Agents|autonomic agents|mesh-ancestor
5628943|NCT05203822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5628944|NCT05203822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5628945|NCT05203822|Hormone Antagonists|hormone antagonists|mesh-ancestor
5754063|NCT03014323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5754064|NCT03014323|Nootropic Agents|nootropic agents|mesh-ancestor
5754065|NCT03014297|Everolimus|everolimus|mesh-list
5754066|NCT03014297|Fosbretabulin|fosbretabulin|mesh-list
5754067|NCT03014297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5754068|NCT03014297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5754069|NCT03014297|Immunologic Factors|immunologic factors|mesh-ancestor
5754070|NCT03014297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754071|NCT03014297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5754072|NCT03014167|Albendazole|albendazole|mesh-list
5754073|NCT03014167|Anthelmintics|anthelmintics|mesh-ancestor
5754074|NCT03014167|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5754075|NCT03014167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5754076|NCT03014167|Anticestodal Agents|anticestodal agents|mesh-ancestor
5754077|NCT03014167|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5754078|NCT03014167|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5754079|NCT03014167|Tubulin Modulators|tubulin modulators|mesh-ancestor
5754080|NCT03014167|Antimitotic Agents|antimitotic agents|mesh-ancestor
5754081|NCT03014167|Mitosis Modulators|mitosis modulators|mesh-ancestor
5754082|NCT03014167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5754083|NCT03014167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5754084|NCT03014076|Trastuzumab|trastuzumab|mesh-list
5754085|NCT03014076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5754086|NCT03014076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5754087|NCT03013998|Cytarabine|cytarabine|mesh-list
5754088|NCT03013998|Azacitidine|azacitidine|mesh-list
5754089|NCT03013998|Decitabine|decitabine|mesh-list
5754090|NCT03013998|Daunorubicin|daunorubicin|mesh-list
5754091|NCT03013998|Venetoclax|venetoclax|mesh-list
5754092|NCT03013998|AZD5991|azd5991|mesh-list
5754093|NCT03013998|Pevonedistat|pevonedistat|mesh-list
5754094|NCT03013998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5754095|NCT03013998|Antimetabolites|antimetabolites|mesh-ancestor
5754096|NCT03013998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5754097|NCT03013998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5754098|NCT03013998|Antiviral Agents|antiviral agents|mesh-ancestor
5754099|NCT03013998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5754100|NCT03013998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5754101|NCT03013998|Immunologic Factors|immunologic factors|mesh-ancestor
5754102|NCT03013998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754103|NCT03013998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5754104|NCT03013998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5754105|NCT03013998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5754106|NCT03013998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5754107|NCT03013959|Pyranoprofen|pyranoprofen|mesh-list
6673120|NCT01560663|Carboplatin|carboplatin|mesh-list
6673121|NCT01560663|Docetaxel|docetaxel|mesh-list
6673122|NCT01560663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5628946|NCT05203822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5628947|NCT05203822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628948|NCT05203822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5628949|NCT05203822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5628950|NCT05203744|Tafenoquine|tafenoquine|mesh-list
5628951|NCT05203744|Antimalarials|antimalarials|mesh-ancestor
5628952|NCT05203744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5628953|NCT05203744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5628954|NCT05203744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5628955|NCT05203705|Enoxaparin|enoxaparin|mesh-list
5628956|NCT05203705|Anticoagulants|anticoagulants|mesh-ancestor
5628957|NCT05203705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5628958|NCT05203705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5628959|NCT05203705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5754108|NCT03013959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5754109|NCT03013959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5754110|NCT03013959|Analgesics|analgesics|mesh-ancestor
5754111|NCT03013959|Sensory System Agents|sensory system agents|mesh-ancestor
5754112|NCT03013959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5754113|NCT03013959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754114|NCT03013959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5754115|NCT03013959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5754116|NCT03013959|Gout Suppressants|gout suppressants|mesh-ancestor
5754117|NCT03013881|Trastuzumab|trastuzumab|mesh-list
5754118|NCT03013881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5754119|NCT03013881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5754120|NCT03013751|Udenafil|udenafil|mesh-list
5754121|NCT03013751|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5754122|NCT03013751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5628960|NCT05203588|Vitamin D|vitamin d|mesh-list
5628961|NCT05203588|Denosumab|denosumab|mesh-list
5628962|NCT05203588|Calcium|calcium|mesh-list
5628963|NCT05203588|Vitamins|vitamins|mesh-ancestor
5628964|NCT05203588|Micronutrients|micronutrients|mesh-ancestor
5628965|NCT05203588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628966|NCT05203588|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5628967|NCT05203588|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5628968|NCT05203562|Letrozole|letrozole|mesh-list
5628969|NCT05203562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5628970|NCT05203562|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5628971|NCT05203562|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5628972|NCT05203562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5628973|NCT05203562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5628974|NCT05203562|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5628975|NCT05203562|Hormone Antagonists|hormone antagonists|mesh-ancestor
5628976|NCT05203562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5628977|NCT05203562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628978|NCT05203510|Treprostinil|treprostinil|mesh-list
5628979|NCT05203510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5628980|NCT05203432|Atropine|atropine|mesh-list
5628981|NCT05203432|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5754123|NCT03013751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5754124|NCT03013751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5754125|NCT03013933|Cyclosporine|cyclosporine|mesh-list
5628982|NCT05203432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5628983|NCT05203432|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5628984|NCT05203432|Autonomic Agents|autonomic agents|mesh-ancestor
5628985|NCT05203432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5628986|NCT05203432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5628987|NCT05203432|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5628988|NCT05203432|Respiratory System Agents|respiratory system agents|mesh-ancestor
5628989|NCT05203432|Mydriatics|mydriatics|mesh-ancestor
5628990|NCT05203432|Parasympatholytics|parasympatholytics|mesh-ancestor
5628991|NCT05203432|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5628992|NCT05203432|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5628993|NCT05203432|Cholinergic Agents|cholinergic agents|mesh-ancestor
5628994|NCT05203432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5628995|NCT05203432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5628996|NCT05203354|Acitretin|acitretin|mesh-list
5628997|NCT05203354|Keratolytic Agents|keratolytic agents|mesh-ancestor
5628998|NCT05203354|Dermatologic Agents|dermatologic agents|mesh-ancestor
5628999|NCT05203172|Cetuximab|cetuximab|mesh-list
5629000|NCT05203172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5629001|NCT05203172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5629002|NCT05203055|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
5629003|NCT05203055|Interferon-alpha|interferon-alpha|mesh-list
5629004|NCT05203055|Antiviral Agents|antiviral agents|mesh-ancestor
5629005|NCT05203055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5629006|NCT05203055|Immunologic Factors|immunologic factors|mesh-ancestor
5629007|NCT05203055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629008|NCT05202860|Vaccines|vaccines|mesh-list
5629009|NCT05202860|Immunologic Factors|immunologic factors|mesh-ancestor
5629010|NCT05202860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629011|NCT05202821|Fluorides|fluorides|mesh-list
5629012|NCT05202821|Fluorides, Topical|fluorides, topical|mesh-list
5754126|NCT03013933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5754127|NCT03013933|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5754128|NCT03013933|Verapamil|verapamil|mesh-list
5754129|NCT03013933|Antibodies|antibodies|mesh-list
5754130|NCT03013933|Immunoglobulins|immunoglobulins|mesh-list
5754131|NCT03013933|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5754132|NCT03013933|Cyclosporins|cyclosporins|mesh-list
5754133|NCT03013933|Immunoconjugates|immunoconjugates|mesh-list
5754134|NCT03013933|Immunologic Factors|immunologic factors|mesh-ancestor
5754135|NCT03013933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754136|NCT03013933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5754137|NCT03013933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5754138|NCT03013933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5754139|NCT03013933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5754140|NCT03013933|Antifungal Agents|antifungal agents|mesh-ancestor
5754141|NCT03013933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5754142|NCT03013933|Dermatologic Agents|dermatologic agents|mesh-ancestor
5754143|NCT03013933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5754144|NCT03013933|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5629013|NCT05202821|Cariostatic Agents|cariostatic agents|mesh-ancestor
5629014|NCT05202821|Protective Agents|protective agents|mesh-ancestor
5754145|NCT03013933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5629015|NCT05202821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629016|NCT05202782|Zanubrutinib|zanubrutinib|mesh-list
5629017|NCT05202782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5629018|NCT05202782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5754146|NCT03013933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5754147|NCT03013933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5754148|NCT03013933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5754149|NCT03013933|Vasodilator Agents|vasodilator agents|mesh-ancestor
5754150|NCT03013647|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5754151|NCT03013647|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
5754152|NCT03013647|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5754153|NCT03013647|Dermatologic Agents|dermatologic agents|mesh-ancestor
5754154|NCT03013790|Melatonin|melatonin|mesh-list
5754155|NCT03013790|Antioxidants|antioxidants|mesh-ancestor
5754156|NCT03013790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5754157|NCT03013790|Protective Agents|protective agents|mesh-ancestor
5754158|NCT03013790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754159|NCT03013790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5754160|NCT03013335|Nivolumab|nivolumab|mesh-list
5754161|NCT03013335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5754162|NCT03013335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5754163|NCT03013335|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5754164|NCT03013335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5754165|NCT03013439|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
5754166|NCT03013439|Hematinics|hematinics|mesh-ancestor
5629019|NCT05202782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5629020|NCT05202782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629021|NCT05199662|Tenecteplase|tenecteplase|mesh-list
5629022|NCT05199662|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5629023|NCT05199662|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5629024|NCT05199662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629025|NCT05199194|Tenecteplase|tenecteplase|mesh-list
5629026|NCT05199194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5629027|NCT05199194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5629028|NCT05199194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629029|NCT05198388|Endorphins|endorphins|mesh-list
5629030|NCT05198388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5629031|NCT05198388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629032|NCT05198388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629033|NCT05185089|Maleic acid|maleic acid|mesh-list
5629034|NCT05185089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5629035|NCT05185089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629036|NCT05180032|Denosumab|denosumab|mesh-list
5629037|NCT05180032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5629038|NCT05180032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629039|NCT05178485|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5629040|NCT05178485|Bupivacaine|bupivacaine|mesh-list
5629041|NCT05178485|Anesthetics, Local|anesthetics, local|mesh-ancestor
5629042|NCT05178485|Anesthetics|anesthetics|mesh-ancestor
5629043|NCT05178485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5629044|NCT05178485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629045|NCT05178485|Sensory System Agents|sensory system agents|mesh-ancestor
5629046|NCT05178485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5629047|NCT05178485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5629048|NCT05178485|Glucocorticoids|glucocorticoids|mesh-ancestor
5629049|NCT05178485|Hormones|hormones|mesh-ancestor
5629050|NCT05178485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5629051|NCT05178485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5629052|NCT05178485|Immunologic Factors|immunologic factors|mesh-ancestor
5693130|NCT03402984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5693131|NCT03402984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693132|NCT03402984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5693133|NCT03402945|Vancomycin|vancomycin|mesh-list
5693134|NCT03402945|Cefazolin|cefazolin|mesh-list
5693135|NCT03402945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5693136|NCT03402945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5693137|NCT03402880|Pembrolizumab|pembrolizumab|mesh-list
5693138|NCT03402880|Immunoglobulins|immunoglobulins|mesh-list
5693139|NCT03402880|Immunoglobulin G|immunoglobulin g|mesh-list
5693140|NCT03402880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5693141|NCT03402880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5693142|NCT03402880|Immunologic Factors|immunologic factors|mesh-ancestor
5693143|NCT03402880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693144|NCT03402815|Maraviroc|maraviroc|mesh-list
5754167|NCT03013218|Paclitaxel|paclitaxel|mesh-list
5754168|NCT03013218|Rituximab|rituximab|mesh-list
5754169|NCT03013218|Pembrolizumab|pembrolizumab|mesh-list
5754170|NCT03013218|Trastuzumab|trastuzumab|mesh-list
5754171|NCT03013218|Ramucirumab|ramucirumab|mesh-list
5754172|NCT03013218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5754173|NCT03013218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5629053|NCT05172050|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
5629054|NCT05172050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5629055|NCT05172050|Hormone Antagonists|hormone antagonists|mesh-ancestor
5629056|NCT05172050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5629057|NCT05172050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629058|NCT05172050|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5629059|NCT05172050|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5629060|NCT05172050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5629061|NCT05171686|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5629062|NCT05171686|Chlorthalidone|chlorthalidone|mesh-list
5629063|NCT05171686|Torsemide|torsemide|mesh-list
5754174|NCT03013218|Tubulin Modulators|tubulin modulators|mesh-ancestor
5754175|NCT03013218|Antimitotic Agents|antimitotic agents|mesh-ancestor
5754176|NCT03013218|Mitosis Modulators|mitosis modulators|mesh-ancestor
5754177|NCT03013218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5754178|NCT03013218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5629064|NCT05171686|Furosemide|furosemide|mesh-list
5629065|NCT05171686|Bumetanide|bumetanide|mesh-list
5629066|NCT05171686|Diuretics|diuretics|mesh-list
5629067|NCT05171686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5629068|NCT05171686|Natriuretic Agents|natriuretic agents|mesh-ancestor
5629069|NCT05171686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629070|NCT05171686|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5629071|NCT05171686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5629072|NCT05171686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629073|NCT05171686|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5629074|NCT05167370|Amifostine|amifostine|mesh-list
5629075|NCT05167370|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5629076|NCT05167370|Protective Agents|protective agents|mesh-ancestor
5629077|NCT05167370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629078|NCT05156879|Aspirin|aspirin|mesh-list
5629079|NCT05156879|Drospirenone|drospirenone|mesh-list
5629080|NCT05156879|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5629081|NCT05156879|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
5629082|NCT05156879|Estradiol|estradiol|mesh-list
5629083|NCT05156879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5629084|NCT05156879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5629085|NCT05156879|Analgesics|analgesics|mesh-ancestor
5629086|NCT05156879|Sensory System Agents|sensory system agents|mesh-ancestor
5629087|NCT05156879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5754179|NCT03013218|Immunologic Factors|immunologic factors|mesh-ancestor
5754180|NCT03013218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754181|NCT03013218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5754182|NCT03013504|Cyclophosphamide|cyclophosphamide|mesh-list
5754183|NCT03013504|Docetaxel|docetaxel|mesh-list
5754184|NCT03013504|Trastuzumab|trastuzumab|mesh-list
5754185|NCT03013504|Epirubicin|epirubicin|mesh-list
5754186|NCT03013504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5754187|NCT03013504|Immunologic Factors|immunologic factors|mesh-ancestor
5754188|NCT03013504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754189|NCT03013504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5754190|NCT03013504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5754191|NCT03013504|Alkylating Agents|alkylating agents|mesh-ancestor
5754192|NCT03013504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5754193|NCT03013504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5754194|NCT03013504|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5754195|NCT03013504|Tubulin Modulators|tubulin modulators|mesh-ancestor
5754196|NCT03013504|Antimitotic Agents|antimitotic agents|mesh-ancestor
5754197|NCT03013504|Mitosis Modulators|mitosis modulators|mesh-ancestor
5754198|NCT03013504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5754199|NCT03013504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5754200|NCT03013504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6489748|NCT00593463|Naloxone|naloxone|mesh-list
6489749|NCT00593463|Analgesics|analgesics|mesh-ancestor
5629088|NCT05156879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629089|NCT05156879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5754201|NCT03013504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5754202|NCT03013504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6489750|NCT00593463|Sensory System Agents|sensory system agents|mesh-ancestor
5629090|NCT05156879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5629091|NCT05156879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5629092|NCT05156879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5629093|NCT05156879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629094|NCT05156879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5629095|NCT05156879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5754203|NCT03013387|Octreotide|octreotide|mesh-list
5754204|NCT03013387|Edotreotide|edotreotide|mesh-list
5754205|NCT03013387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5754206|NCT03013387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5754207|NCT03013387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5754208|NCT03013387|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5754209|NCT03013387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5754210|NCT03013556|Tenofovir|tenofovir|mesh-list
5754211|NCT03013556|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5754212|NCT03013556|Interferon-alpha|interferon-alpha|mesh-list
5754213|NCT03013556|Antiviral Agents|antiviral agents|mesh-ancestor
5754214|NCT03013556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5754215|NCT03013556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5754216|NCT03013556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5754217|NCT03013556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5754218|NCT03013556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5754219|NCT03013556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5629096|NCT05156879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5629097|NCT05156879|Antipyretics|antipyretics|mesh-ancestor
5629098|NCT05156879|Estrogens|estrogens|mesh-ancestor
5629099|NCT05156879|Hormones|hormones|mesh-ancestor
5629100|NCT05156879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5629101|NCT05156879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5629102|NCT05156879|Contraceptive Agents|contraceptive agents|mesh-ancestor
5629103|NCT05156879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5629104|NCT05156879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5629105|NCT05156879|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5629106|NCT05156879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5629107|NCT05156879|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5629108|NCT05156879|Hormone Antagonists|hormone antagonists|mesh-ancestor
5629109|NCT05156879|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5629110|NCT05156879|Diuretics|diuretics|mesh-ancestor
5629111|NCT05156879|Natriuretic Agents|natriuretic agents|mesh-ancestor
5629112|NCT05147662|Factor VIII|factor viii|mesh-list
5629113|NCT05147662|Coagulants|coagulants|mesh-ancestor
5629114|NCT05145309|Magnesium citrate|magnesium citrate|mesh-list
5754220|NCT03013556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5754221|NCT03013556|Immunologic Factors|immunologic factors|mesh-ancestor
5754222|NCT03013556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754223|NCT03013205|Triamcinolone|triamcinolone|mesh-list
5754224|NCT03013205|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5754225|NCT03013205|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5754226|NCT03013205|Lidocaine|lidocaine|mesh-list
5754227|NCT03013205|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5754228|NCT03013205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5754229|NCT03013205|Glucocorticoids|glucocorticoids|mesh-ancestor
5754230|NCT03013205|Hormones|hormones|mesh-ancestor
5754231|NCT03013205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5754232|NCT03013205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754233|NCT03013205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5754234|NCT03013205|Immunologic Factors|immunologic factors|mesh-ancestor
5754235|NCT03013205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5754236|NCT03013205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5754237|NCT03013205|Anesthetics, Local|anesthetics, local|mesh-ancestor
5629115|NCT05145309|Cathartics|cathartics|mesh-ancestor
5629116|NCT05145309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5629117|NCT05138575|Empagliflozin|empagliflozin|mesh-list
5629118|NCT05138575|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5629119|NCT05138575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5754238|NCT03013205|Anesthetics|anesthetics|mesh-ancestor
5754239|NCT03013205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5754240|NCT03013205|Sensory System Agents|sensory system agents|mesh-ancestor
5754241|NCT03013205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5754242|NCT03013205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5754243|NCT03013205|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5754244|NCT03013205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5629120|NCT05138575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5629121|NCT05138575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629122|NCT05136560|Dexamethasone|dexamethasone|mesh-list
5629123|NCT05136560|Dexamethasone acetate|dexamethasone acetate|mesh-list
5629124|NCT05136560|BB 1101|bb 1101|mesh-list
5629125|NCT05136560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5629126|NCT05136560|Antiemetics|antiemetics|mesh-ancestor
5629127|NCT05136560|Autonomic Agents|autonomic agents|mesh-ancestor
5629128|NCT05136560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5629129|NCT05136560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629130|NCT05136560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5629131|NCT05136560|Glucocorticoids|glucocorticoids|mesh-ancestor
5629132|NCT05136560|Hormones|hormones|mesh-ancestor
5629133|NCT05136560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5629134|NCT05136560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5629135|NCT05136560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5629136|NCT05136560|Protease Inhibitors|protease inhibitors|mesh-ancestor
5629137|NCT05136560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5629138|NCT05136560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629139|NCT05125523|Sirolimus|sirolimus|mesh-list
5754245|NCT03013205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5754246|NCT03013400|Ebselen|ebselen|mesh-list
5754247|NCT03013400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5754248|NCT03013400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5754249|NCT03013400|Analgesics|analgesics|mesh-ancestor
6489751|NCT00593463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6489752|NCT00593463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489753|NCT00593463|Anticonvulsants|anticonvulsants|mesh-ancestor
6489754|NCT00593463|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5754250|NCT03013400|Sensory System Agents|sensory system agents|mesh-ancestor
5754251|NCT03013400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5754252|NCT03013400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754253|NCT03013400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5754254|NCT03013400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5754255|NCT03013400|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5754256|NCT03013400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5754257|NCT03013400|Antioxidants|antioxidants|mesh-ancestor
5754258|NCT03013400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5754259|NCT03013400|Protective Agents|protective agents|mesh-ancestor
5754260|NCT03013400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5754261|NCT03013400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5754262|NCT03013400|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5894825|NCT02969837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5894826|NCT02969837|Glucocorticoids|glucocorticoids|mesh-ancestor
5894827|NCT02969837|Hormones|hormones|mesh-ancestor
5894828|NCT02969837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5894829|NCT02969837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5894830|NCT02969837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5894831|NCT02969837|Immunologic Factors|immunologic factors|mesh-ancestor
5894832|NCT02969837|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5894833|NCT02969837|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5894834|NCT02969837|Growth Substances|growth substances|mesh-ancestor
5894835|NCT02969837|Growth Inhibitors|growth inhibitors|mesh-ancestor
5894836|NCT02870738|Triamcinolone|triamcinolone|mesh-list
5894837|NCT02870738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5894838|NCT02870738|Glucocorticoids|glucocorticoids|mesh-ancestor
5894839|NCT02870738|Hormones|hormones|mesh-ancestor
5894840|NCT02870738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5894841|NCT02870738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894842|NCT02802852|Lenograstim|lenograstim|mesh-list
5894843|NCT02802852|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5894844|NCT02802852|Immunologic Factors|immunologic factors|mesh-ancestor
5894845|NCT02802852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894846|NCT02789020|Rasagiline|rasagiline|mesh-list
5894847|NCT02789020|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
5894848|NCT02789020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5894849|NCT02789020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894850|NCT02789020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5894851|NCT02789020|Protective Agents|protective agents|mesh-ancestor
5894852|NCT02789020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894853|NCT02524275|Docetaxel|docetaxel|mesh-list
5894854|NCT02524275|Capecitabine|capecitabine|mesh-list
5894855|NCT02524275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5894856|NCT02524275|Tubulin Modulators|tubulin modulators|mesh-ancestor
5894857|NCT02524275|Antimitotic Agents|antimitotic agents|mesh-ancestor
5894858|NCT02524275|Mitosis Modulators|mitosis modulators|mesh-ancestor
5894859|NCT02524275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629140|NCT05125523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5629141|NCT05125523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5754263|NCT03013634|Dexmedetomidine|dexmedetomidine|mesh-list
5754264|NCT03013634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5754265|NCT03013634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5754266|NCT03013634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754267|NCT03013634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5754268|NCT03013634|Analgesics|analgesics|mesh-ancestor
5754269|NCT03013634|Sensory System Agents|sensory system agents|mesh-ancestor
5754270|NCT03013634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5754271|NCT03013634|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5754272|NCT03013634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5629142|NCT05125523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5629143|NCT05125523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5629144|NCT05125523|Antifungal Agents|antifungal agents|mesh-ancestor
5629145|NCT05125523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5629146|NCT05125523|Immunologic Factors|immunologic factors|mesh-ancestor
5754273|NCT03013634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5754274|NCT03013634|Adrenergic Agents|adrenergic agents|mesh-ancestor
5754275|NCT03013634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5754276|NCT03013634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5754277|NCT03013322|Physostigmine|physostigmine|mesh-list
5754278|NCT03013322|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5754279|NCT03013322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5754280|NCT03013322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5754281|NCT03013322|Cholinergic Agents|cholinergic agents|mesh-ancestor
5754282|NCT03013322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5754283|NCT03013322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754284|NCT03013322|Miotics|miotics|mesh-ancestor
5754285|NCT03013322|Autonomic Agents|autonomic agents|mesh-ancestor
5754286|NCT03013322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5754287|NCT03013361|Bupivacaine|bupivacaine|mesh-list
5754288|NCT03013361|Ropivacaine|ropivacaine|mesh-list
5754289|NCT03013361|Anesthetics, Local|anesthetics, local|mesh-ancestor
5754290|NCT03013361|Anesthetics|anesthetics|mesh-ancestor
5754291|NCT03013361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5754292|NCT03013361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754293|NCT03013361|Sensory System Agents|sensory system agents|mesh-ancestor
5754294|NCT03013361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5754295|NCT03013036|Fentanyl|fentanyl|mesh-list
5754296|NCT03013036|Midazolam|midazolam|mesh-list
5754297|NCT03013036|Propofol|propofol|mesh-list
5754298|NCT03013036|Sevoflurane|sevoflurane|mesh-list
5754299|NCT03013036|Rocuronium|rocuronium|mesh-list
5754300|NCT03013036|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5754301|NCT03013036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5754302|NCT03013036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629147|NCT05125523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629148|NCT05124678|Isoniazid|isoniazid|mesh-list
5629149|NCT05124678|Antitubercular Agents|antitubercular agents|mesh-ancestor
5754303|NCT03013036|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5754304|NCT03013036|Anesthetics, General|anesthetics, general|mesh-ancestor
5754305|NCT03013036|Anesthetics|anesthetics|mesh-ancestor
5629150|NCT05124678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5629151|NCT05124678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5629152|NCT05124678|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5629153|NCT05124678|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5629154|NCT05124678|Antimetabolites|antimetabolites|mesh-ancestor
5629155|NCT05124678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629156|NCT05124678|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5629157|NCT05123365|Acetylcysteine|acetylcysteine|mesh-list
5629158|NCT05123365|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5629159|NCT05123365|Antiviral Agents|antiviral agents|mesh-ancestor
5629160|NCT05123365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5754306|NCT03013036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5754307|NCT03013036|Narcotics|narcotics|mesh-ancestor
5754308|NCT03013036|Analgesics|analgesics|mesh-ancestor
5754309|NCT03013036|Sensory System Agents|sensory system agents|mesh-ancestor
5754310|NCT03013036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5754311|NCT03013036|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5754312|NCT03013036|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5754313|NCT03013036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5754314|NCT03013036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5629161|NCT05123365|Expectorants|expectorants|mesh-ancestor
5629162|NCT05123365|Respiratory System Agents|respiratory system agents|mesh-ancestor
5754315|NCT03013036|GABA Modulators|gaba modulators|mesh-ancestor
5754316|NCT03013036|GABA Agents|gaba agents|mesh-ancestor
5754317|NCT03013036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5754318|NCT03013036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5754319|NCT03013036|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5754320|NCT03013036|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5754321|NCT03013036|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5754322|NCT03013036|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5754323|NCT03013036|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5754324|NCT03013010|Oxaliplatin|oxaliplatin|mesh-list
5754325|NCT03013010|Tegafur|tegafur|mesh-list
5629163|NCT05123365|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5629164|NCT05123365|Antioxidants|antioxidants|mesh-ancestor
5629165|NCT05123365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629166|NCT05123365|Protective Agents|protective agents|mesh-ancestor
5629167|NCT05123365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629168|NCT05123365|Antidotes|antidotes|mesh-ancestor
5629169|NCT05106192|Triamcinolone|triamcinolone|mesh-list
5629170|NCT05106192|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5629171|NCT05106192|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5629172|NCT05106192|Mechlorethamine|mechlorethamine|mesh-list
5629173|NCT05106192|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
5629174|NCT05106192|Bexarotene|bexarotene|mesh-list
5629175|NCT05106192|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5629176|NCT05106192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5629177|NCT05106192|Glucocorticoids|glucocorticoids|mesh-ancestor
5629178|NCT05106192|Hormones|hormones|mesh-ancestor
6489755|NCT00593463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5629179|NCT05106192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5629180|NCT05106192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629181|NCT05106192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5629182|NCT05106192|Immunologic Factors|immunologic factors|mesh-ancestor
5754326|NCT03013010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5754327|NCT03013010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5754328|NCT03013010|Antimetabolites|antimetabolites|mesh-ancestor
5754329|NCT03013010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5754330|NCT03012945|Anesthetics|anesthetics|mesh-list
5754331|NCT03012945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5754332|NCT03012945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754333|NCT03012971|Dexmedetomidine|dexmedetomidine|mesh-list
5754334|NCT03012971|Morphine|morphine|mesh-list
5754335|NCT03012971|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5754336|NCT03012971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5754337|NCT03012971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754338|NCT03012971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5754339|NCT03012971|Analgesics|analgesics|mesh-ancestor
5754340|NCT03012971|Sensory System Agents|sensory system agents|mesh-ancestor
5754341|NCT03012971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5754342|NCT03012971|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5754343|NCT03012971|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5754344|NCT03012971|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5754345|NCT03012971|Adrenergic Agents|adrenergic agents|mesh-ancestor
5629183|NCT05106192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5629184|NCT05106192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629185|NCT05106192|Alkylating Agents|alkylating agents|mesh-ancestor
5754346|NCT03012971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5754347|NCT03012971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5754348|NCT03012971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5754349|NCT03012971|Narcotics|narcotics|mesh-ancestor
5754350|NCT03013140|Anesthetics|anesthetics|mesh-list
5754351|NCT03013140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5629186|NCT05106192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5629187|NCT05106192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5629188|NCT05104554|Folic Acid|folic acid|mesh-list
5629189|NCT05104554|Micronutrients|micronutrients|mesh-list
5629190|NCT05104554|Trace Elements|trace elements|mesh-list
5629191|NCT05104554|Hematinics|hematinics|mesh-ancestor
5629192|NCT05104554|Vitamin B Complex|vitamin b complex|mesh-ancestor
5629193|NCT05104554|Vitamins|vitamins|mesh-ancestor
5629194|NCT05104554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754352|NCT03013140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629195|NCT05101564|Tamoxifen|tamoxifen|mesh-list
5629196|NCT05101564|Letrozole|letrozole|mesh-list
5629197|NCT05101564|Infigratinib|infigratinib|mesh-list
5629198|NCT05101564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5629199|NCT05101564|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5629200|NCT05101564|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5629201|NCT05101564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5629202|NCT05101564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629203|NCT05101564|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5629204|NCT05101564|Hormone Antagonists|hormone antagonists|mesh-ancestor
5629205|NCT05101564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5629206|NCT05101564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629207|NCT05101564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5629208|NCT05101564|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5629209|NCT05101564|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5629210|NCT05101564|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5629211|NCT05098938|Acyclovir|acyclovir|mesh-list
5629212|NCT05098938|Antiviral Agents|antiviral agents|mesh-ancestor
5629213|NCT05098938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5629214|NCT05092360|Gemcitabine|gemcitabine|mesh-list
5629215|NCT05092360|Paclitaxel|paclitaxel|mesh-list
5629216|NCT05092360|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5629217|NCT05092360|Doxorubicin|doxorubicin|mesh-list
5629218|NCT05092360|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5629219|NCT05092360|Pembrolizumab|pembrolizumab|mesh-list
5629220|NCT05092360|Topotecan|topotecan|mesh-list
5629221|NCT05092360|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5629222|NCT05092360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5629223|NCT05092360|Tubulin Modulators|tubulin modulators|mesh-ancestor
5629224|NCT05092360|Antimitotic Agents|antimitotic agents|mesh-ancestor
5629225|NCT05092360|Mitosis Modulators|mitosis modulators|mesh-ancestor
5629226|NCT05092360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629227|NCT05092360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5754353|NCT03013075|Morphine|morphine|mesh-list
5754354|NCT03013075|Bupivacaine|bupivacaine|mesh-list
5754355|NCT03013075|Anesthetics|anesthetics|mesh-list
5754356|NCT03013075|Anesthetics, General|anesthetics, general|mesh-list
5754357|NCT03013075|Anesthetics, Local|anesthetics, local|mesh-ancestor
5754358|NCT03013075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5754359|NCT03013075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754360|NCT03013075|Sensory System Agents|sensory system agents|mesh-ancestor
5754361|NCT03013075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5754362|NCT03013075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5754363|NCT03013075|Narcotics|narcotics|mesh-ancestor
5754364|NCT03013075|Analgesics|analgesics|mesh-ancestor
5754365|NCT03013127|Pembrolizumab|pembrolizumab|mesh-list
5754366|NCT03013127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5754367|NCT03013127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5754368|NCT03013101|Antibodies|antibodies|mesh-list
5629228|NCT05092360|Antimetabolites|antimetabolites|mesh-ancestor
5629229|NCT05092360|Antiviral Agents|antiviral agents|mesh-ancestor
5629230|NCT05092360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5629231|NCT05092360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5629232|NCT05092360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5629233|NCT05092360|Immunologic Factors|immunologic factors|mesh-ancestor
5754369|NCT03013101|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5754370|NCT03013101|Immunologic Factors|immunologic factors|mesh-ancestor
5754371|NCT03013101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629234|NCT05092360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629235|NCT05092360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5629236|NCT05092360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5754372|NCT03013114|Bortezomib|bortezomib|mesh-list
5754373|NCT03013114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5754374|NCT03012984|Dexmedetomidine|dexmedetomidine|mesh-list
5754375|NCT03012984|Morphine|morphine|mesh-list
5754376|NCT03012984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5754377|NCT03012984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5754378|NCT03012984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754379|NCT03012984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5754380|NCT03012984|Analgesics|analgesics|mesh-ancestor
5754381|NCT03012984|Sensory System Agents|sensory system agents|mesh-ancestor
5754382|NCT03012984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5754383|NCT03012984|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5754384|NCT03012984|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5754385|NCT03012984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5754386|NCT03012984|Adrenergic Agents|adrenergic agents|mesh-ancestor
5754387|NCT03012984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5754388|NCT03012984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5754389|NCT03012984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5629237|NCT05092360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5754390|NCT03012984|Narcotics|narcotics|mesh-ancestor
5754391|NCT03012581|Nivolumab|nivolumab|mesh-list
6489756|NCT00593463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5629238|NCT05092360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5629239|NCT05092360|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5629240|NCT05083910|Misoprostol|misoprostol|mesh-list
5629241|NCT05083910|Oxytocin|oxytocin|mesh-list
5629242|NCT05083910|Carbetocin|carbetocin|mesh-list
5629243|NCT05083910|Oxytocics|oxytocics|mesh-ancestor
5629244|NCT05083910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5629245|NCT05083910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629246|NCT05083910|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5629247|NCT05083910|Abortifacient Agents|abortifacient agents|mesh-ancestor
5629248|NCT05083910|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5754392|NCT03012581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5754393|NCT03012581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5754394|NCT03012581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5754395|NCT03012581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5754396|NCT03012880|Dexamethasone|dexamethasone|mesh-list
5754397|NCT03012880|Dexamethasone acetate|dexamethasone acetate|mesh-list
5754398|NCT03012880|Lenalidomide|lenalidomide|mesh-list
5754399|NCT03012880|Daratumumab|daratumumab|mesh-list
5754400|NCT03012880|Ixazomib|ixazomib|mesh-list
5754401|NCT03012880|Ichthammol|ichthammol|mesh-list
5754402|NCT03012880|BB 1101|bb 1101|mesh-list
5754403|NCT03012880|Glycine|glycine|mesh-list
5754404|NCT03012880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5754405|NCT03012880|Antiemetics|antiemetics|mesh-ancestor
5754406|NCT03012880|Autonomic Agents|autonomic agents|mesh-ancestor
5754407|NCT03012880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5754408|NCT03012880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754409|NCT03012880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5754410|NCT03012880|Glucocorticoids|glucocorticoids|mesh-ancestor
5754411|NCT03012880|Hormones|hormones|mesh-ancestor
5754412|NCT03012880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5754413|NCT03012880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5754414|NCT03012880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5754415|NCT03012880|Immunologic Factors|immunologic factors|mesh-ancestor
5754416|NCT03012880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5754417|NCT03012880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5754418|NCT03012880|Growth Substances|growth substances|mesh-ancestor
5754419|NCT03012880|Growth Inhibitors|growth inhibitors|mesh-ancestor
5754420|NCT03012880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5754421|NCT03012880|Protease Inhibitors|protease inhibitors|mesh-ancestor
5754422|NCT03012880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5754423|NCT03012880|Dermatologic Agents|dermatologic agents|mesh-ancestor
5754424|NCT03012880|Glycine Agents|glycine agents|mesh-ancestor
5754425|NCT03012880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5754426|NCT03012646|Treprostinil|treprostinil|mesh-list
5754427|NCT03012646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5629249|NCT05083910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5629250|NCT05083780|Hydroxychloroquine|hydroxychloroquine|mesh-list
5629251|NCT05083780|Chlorphenesin|chlorphenesin|mesh-list
5629252|NCT05083780|Antimalarials|antimalarials|mesh-ancestor
5629253|NCT05083780|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5629254|NCT05083780|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5629255|NCT05083780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5629256|NCT05083780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5629257|NCT05083780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629258|NCT05083780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5629259|NCT05083780|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5629260|NCT05083780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629261|NCT05083780|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5629262|NCT05083780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5629263|NCT05082610|Pembrolizumab|pembrolizumab|mesh-list
5629264|NCT05082610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5754428|NCT03012763|Acetaminophen|acetaminophen|mesh-list
5754429|NCT03012763|Fexofenadine|fexofenadine|mesh-list
5754430|NCT03012763|Sulfasalazine|sulfasalazine|mesh-list
5754431|NCT03012763|Valsartan|valsartan|mesh-list
5754432|NCT03012763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5754433|NCT03012763|Analgesics|analgesics|mesh-ancestor
5754434|NCT03012763|Sensory System Agents|sensory system agents|mesh-ancestor
5754435|NCT03012763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5754436|NCT03012763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629265|NCT05082610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5629266|NCT05081609|Pembrolizumab|pembrolizumab|mesh-list
5754437|NCT03012763|Antipyretics|antipyretics|mesh-ancestor
5754438|NCT03012763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5754439|NCT03012763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5754440|NCT03012763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5754441|NCT03012763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5754442|NCT03012763|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5754443|NCT03012763|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5754444|NCT03012763|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5754445|NCT03012763|Histamine Antagonists|histamine antagonists|mesh-ancestor
5754446|NCT03012763|Histamine Agents|histamine agents|mesh-ancestor
5754447|NCT03012763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5754448|NCT03012763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5754449|NCT03012763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5754450|NCT03012763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5754451|NCT03012763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5754452|NCT03012763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5754453|NCT03012607|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5754454|NCT03012607|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5754455|NCT03012607|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5754456|NCT03012607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5629267|NCT05081609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5629268|NCT05081609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5629269|NCT05080959|Ropivacaine|ropivacaine|mesh-list
5629270|NCT05080959|Anesthetics, Local|anesthetics, local|mesh-ancestor
5629271|NCT05080959|Anesthetics|anesthetics|mesh-ancestor
5629272|NCT05080959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5629273|NCT05080959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629274|NCT05080959|Sensory System Agents|sensory system agents|mesh-ancestor
5629275|NCT05080959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5629276|NCT05079841|Oxytocin|oxytocin|mesh-list
5629277|NCT05079841|Oxytocics|oxytocics|mesh-ancestor
5629278|NCT05079841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5629279|NCT05079841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629280|NCT05068791|Dextromethorphan|dextromethorphan|mesh-list
5629281|NCT05068791|Psilocybin|psilocybin|mesh-list
5629282|NCT05068791|Antitussive Agents|antitussive agents|mesh-ancestor
5629283|NCT05068791|Respiratory System Agents|respiratory system agents|mesh-ancestor
5629284|NCT05068791|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5629285|NCT05068791|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5629286|NCT05068791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5629287|NCT05068791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5754457|NCT03012607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5754458|NCT03012607|Antiviral Agents|antiviral agents|mesh-ancestor
5754459|NCT03012607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5754460|NCT03012607|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5754461|NCT03012607|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5754462|NCT03012815|Chlordiazepoxide|chlordiazepoxide|mesh-list
5754463|NCT03012815|Gabapentin|gabapentin|mesh-list
5754464|NCT03012815|Lorazepam|lorazepam|mesh-list
5754465|NCT03012815|Valproic Acid|valproic acid|mesh-list
5754466|NCT03012815|Analgesics|analgesics|mesh-ancestor
5754467|NCT03012815|Sensory System Agents|sensory system agents|mesh-ancestor
5754468|NCT03012815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5754469|NCT03012815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754470|NCT03012815|Anticonvulsants|anticonvulsants|mesh-ancestor
5754471|NCT03012815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5754472|NCT03012815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5754473|NCT03012815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5754474|NCT03012815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5754475|NCT03012815|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5754476|NCT03012815|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5754477|NCT03012815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5754478|NCT03012815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5754479|NCT03012815|Antimanic Agents|antimanic agents|mesh-ancestor
5754480|NCT03012815|Antiemetics|antiemetics|mesh-ancestor
5754481|NCT03012815|Autonomic Agents|autonomic agents|mesh-ancestor
5754482|NCT03012815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5754483|NCT03012815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5754484|NCT03012815|GABA Modulators|gaba modulators|mesh-ancestor
5754485|NCT03012815|GABA Agents|gaba agents|mesh-ancestor
5754486|NCT03012815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5754487|NCT03012815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5754488|NCT03012659|Contraceptive Agents|contraceptive agents|mesh-list
5754489|NCT03012659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5754490|NCT03012659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754491|NCT03012620|Pembrolizumab|pembrolizumab|mesh-list
5754492|NCT03012620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5754493|NCT03012620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5629288|NCT05068791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629289|NCT05068791|Hallucinogens|hallucinogens|mesh-ancestor
5629290|NCT05068791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5629291|NCT05063500|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
5629292|NCT05063500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5629293|NCT05063500|Antimetabolites|antimetabolites|mesh-ancestor
5629294|NCT05063500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629295|NCT05063500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5629296|NCT05062044|Folic Acid|folic acid|mesh-list
5754494|NCT03012230|Pembrolizumab|pembrolizumab|mesh-list
5754495|NCT03012230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5629297|NCT05062044|Hematinics|hematinics|mesh-ancestor
5629298|NCT05062044|Vitamin B Complex|vitamin b complex|mesh-ancestor
5629299|NCT05062044|Vitamins|vitamins|mesh-ancestor
5629300|NCT05062044|Micronutrients|micronutrients|mesh-ancestor
5629301|NCT05062044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693145|NCT03402815|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5693146|NCT03402815|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5693147|NCT03402815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693148|NCT03402815|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5693149|NCT03402815|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5693150|NCT03402815|Antiviral Agents|antiviral agents|mesh-ancestor
5693151|NCT03402815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5693152|NCT03402815|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
5693153|NCT03402698|Cholecalciferol|cholecalciferol|mesh-list
5693154|NCT03402698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5693155|NCT03402698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693156|NCT03402698|Vitamins|vitamins|mesh-ancestor
5693157|NCT03402698|Micronutrients|micronutrients|mesh-ancestor
5693158|NCT03402698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5754496|NCT03012230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5754497|NCT03012386|Sildenafil Citrate|sildenafil citrate|mesh-list
5754498|NCT03012386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5754499|NCT03012386|Vasodilator Agents|vasodilator agents|mesh-ancestor
5754500|NCT03012386|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5754501|NCT03012386|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5754502|NCT03012386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5754503|NCT03012386|Urological Agents|urological agents|mesh-ancestor
5754504|NCT03012321|Prednisone|prednisone|mesh-list
5754505|NCT03012321|Olaparib|olaparib|mesh-list
5754506|NCT03012321|Abiraterone Acetate|abiraterone acetate|mesh-list
5754507|NCT03012321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5754508|NCT03012321|Glucocorticoids|glucocorticoids|mesh-ancestor
5754509|NCT03012321|Hormones|hormones|mesh-ancestor
5754510|NCT03012321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5754511|NCT03012321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754512|NCT03012321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5754513|NCT03012321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5754514|NCT03012321|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5754515|NCT03012321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5754516|NCT03012321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5754517|NCT03012321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5754518|NCT03012321|Hormone Antagonists|hormone antagonists|mesh-ancestor
5754519|NCT03012321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5754520|NCT03012347|Sunscreening Agents|sunscreening agents|mesh-list
5754521|NCT03012347|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5754522|NCT03012347|Protective Agents|protective agents|mesh-ancestor
5754523|NCT03012347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754524|NCT03012347|Dermatologic Agents|dermatologic agents|mesh-ancestor
5754525|NCT03012360|Ciprofloxacin|ciprofloxacin|mesh-list
5754526|NCT03012360|Ceftriaxone|ceftriaxone|mesh-list
5754527|NCT03012360|Linezolid|linezolid|mesh-list
5754528|NCT03012360|Imipenem|imipenem|mesh-list
5754529|NCT03012360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5754530|NCT03012360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5754531|NCT03012360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5754532|NCT03012360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5754533|NCT03012360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5754534|NCT03012360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5754535|NCT03012360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5754536|NCT03012360|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5754537|NCT03012360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5754538|NCT03012360|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5754539|NCT03011970|Oxytocin|oxytocin|mesh-list
5693159|NCT03402503|Montelukast|montelukast|mesh-list
5629302|NCT05060003|Atezolizumab|atezolizumab|mesh-list
5629303|NCT05060003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5754540|NCT03011970|Oxytocics|oxytocics|mesh-ancestor
5754541|NCT03011970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5754542|NCT03011970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754543|NCT03011905|Acetaminophen|acetaminophen|mesh-list
5754544|NCT03011905|Dexamethasone|dexamethasone|mesh-list
5754545|NCT03011905|Etoricoxib|etoricoxib|mesh-list
5754546|NCT03011905|Oxycodone|oxycodone|mesh-list
5629304|NCT05055999|Atezolizumab|atezolizumab|mesh-list
5629305|NCT05055999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5629306|NCT05055947|Atezolizumab|atezolizumab|mesh-list
5629307|NCT05055947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5629308|NCT05055908|Atezolizumab|atezolizumab|mesh-list
5629309|NCT05055908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5629310|NCT05052957|Temozolomide|temozolomide|mesh-list
5754547|NCT03011905|Ropivacaine|ropivacaine|mesh-list
5754548|NCT03011905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5754549|NCT03011905|Antiemetics|antiemetics|mesh-ancestor
5754550|NCT03011905|Autonomic Agents|autonomic agents|mesh-ancestor
5754551|NCT03011905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5754552|NCT03011905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754553|NCT03011905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5754554|NCT03011905|Glucocorticoids|glucocorticoids|mesh-ancestor
5754555|NCT03011905|Hormones|hormones|mesh-ancestor
5754556|NCT03011905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5754557|NCT03011905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5754558|NCT03011905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5754559|NCT03011905|Anesthetics, Local|anesthetics, local|mesh-ancestor
5754560|NCT03011905|Anesthetics|anesthetics|mesh-ancestor
5754561|NCT03011905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5754562|NCT03011905|Sensory System Agents|sensory system agents|mesh-ancestor
5754563|NCT03011905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5754564|NCT03011905|Analgesics|analgesics|mesh-ancestor
5754565|NCT03011905|Antipyretics|antipyretics|mesh-ancestor
5754566|NCT03011905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5754567|NCT03011905|Narcotics|narcotics|mesh-ancestor
5754568|NCT03011905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5754569|NCT03011905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5754570|NCT03011905|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5754571|NCT03011905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5754572|NCT03011905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5754573|NCT03011905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5754574|NCT03011918|Vitamin D|vitamin d|mesh-list
5754575|NCT03011918|Vitamins|vitamins|mesh-ancestor
5754576|NCT03011918|Micronutrients|micronutrients|mesh-ancestor
5754577|NCT03011918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754578|NCT03011918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5754579|NCT03011775|Aspirin|aspirin|mesh-list
5754580|NCT03011775|Pioglitazone|pioglitazone|mesh-list
5754581|NCT03011775|Ramipril|ramipril|mesh-list
5754582|NCT03011775|Bisoprolol|bisoprolol|mesh-list
5754583|NCT03011775|Isosorbide|isosorbide|mesh-list
5754584|NCT03011775|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
5754585|NCT03011775|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
5754586|NCT03011775|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5754587|NCT03011775|Calcium|calcium|mesh-list
5754588|NCT03011775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5754589|NCT03011775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754590|NCT03011775|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5754591|NCT03011775|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5754592|NCT03011775|Antimetabolites|antimetabolites|mesh-ancestor
5754593|NCT03011775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5754594|NCT03011775|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5754595|NCT03011775|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5754596|NCT03011775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5754597|NCT03011775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5754598|NCT03011775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5754599|NCT03011775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5754600|NCT03011775|Analgesics|analgesics|mesh-ancestor
5754601|NCT03011775|Sensory System Agents|sensory system agents|mesh-ancestor
5754602|NCT03011775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5754603|NCT03011775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5629311|NCT05052957|Carmustine|carmustine|mesh-list
5629312|NCT05052957|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
5754604|NCT03011775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5754605|NCT03011775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5754606|NCT03011775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5754607|NCT03011775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5754608|NCT03011775|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5754609|NCT03011775|Antipyretics|antipyretics|mesh-ancestor
5754610|NCT03011775|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5754611|NCT03011775|Protease Inhibitors|protease inhibitors|mesh-ancestor
5754612|NCT03011775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5754613|NCT03011775|Sympatholytics|sympatholytics|mesh-ancestor
5754614|NCT03011775|Autonomic Agents|autonomic agents|mesh-ancestor
5754615|NCT03011775|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5754616|NCT03011775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5754617|NCT03011775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5754618|NCT03011775|Adrenergic Agents|adrenergic agents|mesh-ancestor
5754619|NCT03011775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5754620|NCT03011775|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5754621|NCT03011775|Diuretics|diuretics|mesh-ancestor
5754622|NCT03011775|Natriuretic Agents|natriuretic agents|mesh-ancestor
5754623|NCT03011775|Vasodilator Agents|vasodilator agents|mesh-ancestor
5754624|NCT03011775|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5754625|NCT03012009|Lidocaine|lidocaine|mesh-list
5754626|NCT03012009|Epinephrine|epinephrine|mesh-list
5754627|NCT03012009|Racepinephrine|racepinephrine|mesh-list
5754628|NCT03012009|Anesthetics, Local|anesthetics, local|mesh-list
5754629|NCT03012009|Anesthetics|anesthetics|mesh-list
5629313|NCT05052957|Lenograstim|lenograstim|mesh-list
5629314|NCT05052957|Sargramostim|sargramostim|mesh-list
5629315|NCT05052957|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5629316|NCT05052957|Immunologic Factors|immunologic factors|mesh-ancestor
5629317|NCT05052957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629318|NCT05052957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5629319|NCT05052957|Alkylating Agents|alkylating agents|mesh-ancestor
5629320|NCT05052957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629321|NCT05052957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5629322|NCT05052957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5629323|NCT05051735|Acetaminophen|acetaminophen|mesh-list
5629324|NCT05051735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5629325|NCT05051735|Analgesics|analgesics|mesh-ancestor
5629326|NCT05051735|Sensory System Agents|sensory system agents|mesh-ancestor
5629327|NCT05051735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5629328|NCT05051735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629329|NCT05051735|Antipyretics|antipyretics|mesh-ancestor
5629330|NCT05050981|Hormones|hormones|mesh-list
5629331|NCT05050981|Serotonin|serotonin|mesh-list
5629332|NCT05050981|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
5629333|NCT05050981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5629334|NCT05050981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629335|NCT05050981|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5629336|NCT05050981|Serotonin Agents|serotonin agents|mesh-ancestor
5629337|NCT05050981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5629338|NCT05050981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629339|NCT05050981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5629340|NCT05050981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5629341|NCT05049226|Vaccines|vaccines|mesh-list
5629342|NCT05049226|Immunologic Factors|immunologic factors|mesh-ancestor
5629343|NCT05049226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629344|NCT05048238|Tofacitinib|tofacitinib|mesh-list
5629345|NCT05048238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5629346|NCT05048238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5629347|NCT05048238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629348|NCT05042128|Gemcitabine|gemcitabine|mesh-list
5629349|NCT05042128|Paclitaxel|paclitaxel|mesh-list
5629350|NCT05042128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5629351|NCT05042128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5629352|NCT05042128|Tubulin Modulators|tubulin modulators|mesh-ancestor
5629353|NCT05042128|Antimitotic Agents|antimitotic agents|mesh-ancestor
5629354|NCT05042128|Mitosis Modulators|mitosis modulators|mesh-ancestor
5629355|NCT05042128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629356|NCT05042128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5629357|NCT05042128|Antimetabolites|antimetabolites|mesh-ancestor
5629358|NCT05042128|Antiviral Agents|antiviral agents|mesh-ancestor
5754630|NCT03012009|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
5754631|NCT03012009|Epinephryl borate|epinephryl borate|mesh-list
5754632|NCT03012009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5754633|NCT03012009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754634|NCT03012009|Sensory System Agents|sensory system agents|mesh-ancestor
5754635|NCT03012009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5754636|NCT03012009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6489757|NCT00593463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5629359|NCT05042128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5629360|NCT05042128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5629361|NCT05042128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5629362|NCT05042128|Immunologic Factors|immunologic factors|mesh-ancestor
5629363|NCT05042128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629364|NCT05033054|Dapagliflozin|dapagliflozin|mesh-list
5629365|NCT05033054|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5629366|NCT05033054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629367|NCT05033054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5629368|NCT05033054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629369|NCT05029999|Doxorubicin|doxorubicin|mesh-list
5629370|NCT05029999|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5629371|NCT05029999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5629372|NCT05029999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5629373|NCT05029999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5629374|NCT05029999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5629375|NCT05029999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5629376|NCT05029999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629377|NCT05029466|Psilocybin|psilocybin|mesh-list
5629378|NCT05029466|Hallucinogens|hallucinogens|mesh-ancestor
5629379|NCT05029466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629380|NCT05029466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6208880|NCT02138136|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6208881|NCT02138136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6208882|NCT02138136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208883|NCT02138747|Mirabegron|mirabegron|mesh-list
6208884|NCT02138747|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6208885|NCT02138747|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6208886|NCT02138747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5754637|NCT03012009|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5754638|NCT03012009|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5754639|NCT03012009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5754640|NCT03012009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5754641|NCT03012009|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5754642|NCT03012009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5754643|NCT03012009|Adrenergic Agents|adrenergic agents|mesh-ancestor
5754644|NCT03012009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5754645|NCT03012009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5754646|NCT03012009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5754647|NCT03012009|Autonomic Agents|autonomic agents|mesh-ancestor
5754648|NCT03012009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5754649|NCT03012009|Respiratory System Agents|respiratory system agents|mesh-ancestor
5754650|NCT03012009|Mydriatics|mydriatics|mesh-ancestor
5754651|NCT03012009|Sympathomimetics|sympathomimetics|mesh-ancestor
5754652|NCT03012009|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6489758|NCT00593463|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6489759|NCT00593463|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5754653|NCT03012009|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5754654|NCT03012009|Dermatologic Agents|dermatologic agents|mesh-ancestor
5754655|NCT03012113|Mirabegron|mirabegron|mesh-list
5754656|NCT03012113|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
5754657|NCT03012113|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5629381|NCT05028634|Vaccines|vaccines|mesh-list
5754658|NCT03012113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5754659|NCT03012113|Adrenergic Agents|adrenergic agents|mesh-ancestor
5754660|NCT03012113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5754661|NCT03012113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5754662|NCT03012113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754663|NCT03012113|Urological Agents|urological agents|mesh-ancestor
5754664|NCT03011931|Simvastatin|simvastatin|mesh-list
5754665|NCT03011931|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5754666|NCT03011931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5754667|NCT03011931|Antimetabolites|antimetabolites|mesh-ancestor
5754668|NCT03011931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629382|NCT05028634|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5629383|NCT05028634|Immunologic Factors|immunologic factors|mesh-ancestor
5629384|NCT05028634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754669|NCT03011931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5754670|NCT03011931|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5754671|NCT03011931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5754672|NCT03011996|Amoxicillin|amoxicillin|mesh-list
5754673|NCT03011996|Clarithromycin|clarithromycin|mesh-list
6489760|NCT00593463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6489761|NCT00593463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5754674|NCT03011996|Pantoprazole|pantoprazole|mesh-list
5754675|NCT03011996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5754676|NCT03011996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5754677|NCT03011996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5754678|NCT03011996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5754679|NCT03011996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5754680|NCT03011996|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5754681|NCT03011996|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5754682|NCT03011996|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5754683|NCT03011996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5754684|NCT03011996|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5754685|NCT03011684|Tamoxifen|tamoxifen|mesh-list
5754686|NCT03011684|Letrozole|letrozole|mesh-list
5754687|NCT03011684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5754688|NCT03011684|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5754689|NCT03011684|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5754690|NCT03011684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5754691|NCT03011684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5754692|NCT03011684|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5754693|NCT03011684|Hormone Antagonists|hormone antagonists|mesh-ancestor
5754694|NCT03011684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5754695|NCT03011684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754696|NCT03011684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5754697|NCT03011684|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5754698|NCT03011684|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5629385|NCT05023837|Pembrolizumab|pembrolizumab|mesh-list
5629386|NCT05023837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5629387|NCT05023837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5629388|NCT05017246|Lidocaine|lidocaine|mesh-list
5629389|NCT05017246|Morphine|morphine|mesh-list
5629390|NCT05017246|Bupivacaine|bupivacaine|mesh-list
5629391|NCT05017246|Anesthetics, Local|anesthetics, local|mesh-ancestor
5629392|NCT05017246|Anesthetics|anesthetics|mesh-ancestor
5754699|NCT03011684|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5894860|NCT02524275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5894861|NCT02524275|Antimetabolites|antimetabolites|mesh-ancestor
5894862|NCT02473042|Promethazine|promethazine|mesh-list
5894863|NCT02473042|Dexamethasone|dexamethasone|mesh-list
5894864|NCT02473042|Ondansetron|ondansetron|mesh-list
5894865|NCT02473042|Famotidine|famotidine|mesh-list
5894866|NCT02473042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5894867|NCT02473042|Antiemetics|antiemetics|mesh-ancestor
5894868|NCT02473042|Autonomic Agents|autonomic agents|mesh-ancestor
5894869|NCT02473042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5894870|NCT02473042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894871|NCT02473042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5894872|NCT02473042|Glucocorticoids|glucocorticoids|mesh-ancestor
5894873|NCT02473042|Hormones|hormones|mesh-ancestor
5894874|NCT02473042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5894875|NCT02473042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5894876|NCT02473042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5894877|NCT02473042|Antipruritics|antipruritics|mesh-ancestor
5629393|NCT05017246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5894878|NCT02473042|Dermatologic Agents|dermatologic agents|mesh-ancestor
5754700|NCT03011671|Temozolomide|temozolomide|mesh-list
5754701|NCT03011671|Acetazolamide|acetazolamide|mesh-list
5754702|NCT03011671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5754703|NCT03011671|Alkylating Agents|alkylating agents|mesh-ancestor
5754704|NCT03011671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5754705|NCT03011671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5754706|NCT03011671|Anticonvulsants|anticonvulsants|mesh-ancestor
5754707|NCT03011671|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5754708|NCT03011671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5754709|NCT03011671|Diuretics|diuretics|mesh-ancestor
5754710|NCT03011671|Natriuretic Agents|natriuretic agents|mesh-ancestor
5754711|NCT03011671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754712|NCT03011476|Donepezil|donepezil|mesh-list
5754713|NCT03011476|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5754714|NCT03011476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5754715|NCT03011476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5754716|NCT03011476|Cholinergic Agents|cholinergic agents|mesh-ancestor
5754717|NCT03011476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5754718|NCT03011476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754719|NCT03011476|Nootropic Agents|nootropic agents|mesh-ancestor
5754720|NCT03011463|Clarithromycin|clarithromycin|mesh-list
5754721|NCT03011463|Ranitidine|ranitidine|mesh-list
5754722|NCT03011463|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
5754723|NCT03011463|Trospium chloride|trospium chloride|mesh-list
5754724|NCT03011463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5754725|NCT03011463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5754726|NCT03011463|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5754727|NCT03011463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5754728|NCT03011463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5754729|NCT03011463|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5754730|NCT03011463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5754731|NCT03011463|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5754732|NCT03011463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5754733|NCT03011463|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5754734|NCT03011463|Histamine Antagonists|histamine antagonists|mesh-ancestor
5754735|NCT03011463|Histamine Agents|histamine agents|mesh-ancestor
5754736|NCT03011463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5754737|NCT03011463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754738|NCT03011463|Parasympatholytics|parasympatholytics|mesh-ancestor
5754739|NCT03011463|Autonomic Agents|autonomic agents|mesh-ancestor
5754740|NCT03011463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6489762|NCT00593463|Antimanic Agents|antimanic agents|mesh-ancestor
6489763|NCT00593463|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6489764|NCT00593463|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6489765|NCT00593463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6489766|NCT00593463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6489767|NCT00593463|Vasodilator Agents|vasodilator agents|mesh-ancestor
6489768|NCT00593463|Tocolytic Agents|tocolytic agents|mesh-ancestor
6489769|NCT00593463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6489770|NCT00593463|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5629394|NCT05017246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754741|NCT03011463|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5754742|NCT03011463|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5754743|NCT03011463|Cholinergic Agents|cholinergic agents|mesh-ancestor
5754744|NCT03011463|Urological Agents|urological agents|mesh-ancestor
5754745|NCT03011645|Ziprasidone|ziprasidone|mesh-list
5629395|NCT05017246|Sensory System Agents|sensory system agents|mesh-ancestor
5629396|NCT05017246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5629397|NCT05017246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5629398|NCT05017246|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5629399|NCT05017246|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5754746|NCT03011645|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5754747|NCT03011645|Serotonin Agents|serotonin agents|mesh-ancestor
5754748|NCT03011645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5754749|NCT03011645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629400|NCT05017246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5629401|NCT05017246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5754750|NCT03011645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754751|NCT03011645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5754752|NCT03011645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5754753|NCT03011645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5754754|NCT03011645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5754755|NCT03011645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5754756|NCT03011645|Dopamine Agents|dopamine agents|mesh-ancestor
5754757|NCT03011632|Mometasone Furoate|mometasone furoate|mesh-list
5754758|NCT03011632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5754759|NCT03011632|Dermatologic Agents|dermatologic agents|mesh-ancestor
5754760|NCT03011632|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5754761|NCT03011567|Acetaminophen|acetaminophen|mesh-list
5754762|NCT03011567|Ibuprofen|ibuprofen|mesh-list
5754763|NCT03011567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5629402|NCT05017246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5629403|NCT05017246|Narcotics|narcotics|mesh-ancestor
5629404|NCT05017246|Analgesics|analgesics|mesh-ancestor
5629405|NCT05014542|Analgesics|analgesics|mesh-list
5629406|NCT05014542|Sensory System Agents|sensory system agents|mesh-ancestor
5629407|NCT05014542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5629408|NCT05014542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629409|NCT05014438|Branebrutinib|branebrutinib|mesh-list
5629410|NCT05014438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5754764|NCT03011567|Analgesics|analgesics|mesh-ancestor
5754765|NCT03011567|Sensory System Agents|sensory system agents|mesh-ancestor
5754766|NCT03011567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5754767|NCT03011567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754768|NCT03011567|Antipyretics|antipyretics|mesh-ancestor
5754769|NCT03011567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5754770|NCT03011567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5754771|NCT03011567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5754772|NCT03011567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5754773|NCT03011567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5754774|NCT03011567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5754775|NCT03011281|Tofacitinib|tofacitinib|mesh-list
6489771|NCT00593463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6489772|NCT00593463|Renal Agents|renal agents|mesh-ancestor
6489773|NCT00593463|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6489774|NCT00593463|Antitubercular Agents|antitubercular agents|mesh-ancestor
5629411|NCT05014438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5754776|NCT03011281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5754777|NCT03011281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5754778|NCT03011281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5754779|NCT03011177|Linagliptin|linagliptin|mesh-list
5754780|NCT03011177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5754781|NCT03011177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754782|NCT03011177|Incretins|incretins|mesh-ancestor
5629412|NCT05014438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629413|NCT05013255|Pioglitazone|pioglitazone|mesh-list
5629414|NCT05013255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5629415|NCT05013255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629427|NCT05003076|Methamphetamine|methamphetamine|mesh-list
5629428|NCT05003076|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5629429|NCT05003076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754783|NCT03011177|Hormones|hormones|mesh-ancestor
5754784|NCT03011177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5754785|NCT03011177|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5754786|NCT03011177|Protease Inhibitors|protease inhibitors|mesh-ancestor
5754787|NCT03011177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5754788|NCT03011177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5754789|NCT03011268|Adalimumab|adalimumab|mesh-list
5754790|NCT03011268|Golimumab|golimumab|mesh-list
5754791|NCT03011268|Infliximab|infliximab|mesh-list
6489775|NCT00593463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5629430|NCT05003076|Sympathomimetics|sympathomimetics|mesh-ancestor
5629431|NCT05003076|Autonomic Agents|autonomic agents|mesh-ancestor
5629432|NCT05003076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5754792|NCT03011268|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5754793|NCT03011268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5754794|NCT03011268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5754795|NCT03011268|Dermatologic Agents|dermatologic agents|mesh-ancestor
5754796|NCT03011268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5754797|NCT03011268|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
5754798|NCT03011268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5754799|NCT03011268|Immunologic Factors|immunologic factors|mesh-ancestor
5754800|NCT03011268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754801|NCT03010917|Ethanol|ethanol|mesh-list
5754802|NCT03010917|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5754803|NCT03010917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5754804|NCT03010917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5754805|NCT03010917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754806|NCT03010865|Butyric Acid|butyric acid|mesh-list
5754807|NCT03010865|Histamine Antagonists|histamine antagonists|mesh-ancestor
5754808|NCT03010865|Histamine Agents|histamine agents|mesh-ancestor
5754809|NCT03010865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5754810|NCT03010865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5754811|NCT03010865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754812|NCT03011008|Liraglutide|liraglutide|mesh-list
5754813|NCT03011008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5754814|NCT03011008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754815|NCT03011008|Incretins|incretins|mesh-ancestor
5754816|NCT03011008|Hormones|hormones|mesh-ancestor
5754817|NCT03011008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5754818|NCT03010995|Prazosin|prazosin|mesh-list
5754819|NCT03010995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5754820|NCT03010995|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5754821|NCT03010995|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5754822|NCT03010995|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5754823|NCT03010995|Adrenergic Agents|adrenergic agents|mesh-ancestor
5754824|NCT03010995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5754825|NCT03010995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5754826|NCT03010995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754827|NCT03011125|Dexlansoprazole|dexlansoprazole|mesh-list
5754828|NCT03011125|Lansoprazole|lansoprazole|mesh-list
5754829|NCT03011125|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5754830|NCT03011125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5754831|NCT03011125|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5754832|NCT03011125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5629433|NCT05003076|Dopamine Agents|dopamine agents|mesh-ancestor
5629434|NCT05003076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5629435|NCT05003076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629436|NCT05003076|Adrenergic Agents|adrenergic agents|mesh-ancestor
5629437|NCT05003076|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5629438|NCT05003076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5629439|NCT05003076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5629440|NCT05003076|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5629441|NCT04991025|Gemcitabine|gemcitabine|mesh-list
5629442|NCT04991025|Carboplatin|carboplatin|mesh-list
5629443|NCT04991025|Pemetrexed|pemetrexed|mesh-list
5629444|NCT04991025|Certolizumab Pegol|certolizumab pegol|mesh-list
5629445|NCT04991025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5629446|NCT04991025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5629447|NCT04991025|Antimetabolites|antimetabolites|mesh-ancestor
5629448|NCT04991025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629449|NCT04991025|Antiviral Agents|antiviral agents|mesh-ancestor
5629450|NCT04991025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5629451|NCT04991025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5629452|NCT04991025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5629453|NCT04991025|Immunologic Factors|immunologic factors|mesh-ancestor
5629454|NCT04991025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629455|NCT04991025|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5629456|NCT04991025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5629457|NCT04991025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5629458|NCT04989816|Trastuzumab|trastuzumab|mesh-list
5629459|NCT04989816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5629460|NCT04989816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5754833|NCT03011125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629461|NCT04984330|Dexamethasone|dexamethasone|mesh-list
5754834|NCT03011060|Capecitabine|capecitabine|mesh-list
5629462|NCT04984330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5629463|NCT04984330|Antiemetics|antiemetics|mesh-ancestor
5629464|NCT04984330|Autonomic Agents|autonomic agents|mesh-ancestor
5629465|NCT04984330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5629466|NCT04984330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629467|NCT04984330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5629468|NCT04984330|Glucocorticoids|glucocorticoids|mesh-ancestor
5629469|NCT04984330|Hormones|hormones|mesh-ancestor
5754835|NCT03011060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5754836|NCT03011060|Antimetabolites|antimetabolites|mesh-ancestor
5754837|NCT03011060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629470|NCT04984330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5629471|NCT04984330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5629472|NCT04984330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5754838|NCT03011060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5754839|NCT03010670|Oxytocin|oxytocin|mesh-list
6208887|NCT02138747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6208888|NCT02138747|Adrenergic Agents|adrenergic agents|mesh-ancestor
6208889|NCT02138747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5754840|NCT03010670|Oxytocics|oxytocics|mesh-ancestor
5754841|NCT03010670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5754842|NCT03010670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754843|NCT03010579|Epoetin Alfa|epoetin alfa|mesh-list
5754844|NCT03010579|Ferrous succinate|ferrous succinate|mesh-list
5754845|NCT03010579|Hematinics|hematinics|mesh-list
6208890|NCT02138747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208891|NCT02138747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208892|NCT02138747|Urological Agents|urological agents|mesh-ancestor
6208893|NCT02138747|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6208894|NCT02138747|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6208895|NCT02138747|Cholinergic Agents|cholinergic agents|mesh-ancestor
6208896|NCT02138825|Riociguat|riociguat|mesh-list
5629483|NCT04971720|Valsartan|valsartan|mesh-list
5629484|NCT04971720|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5629485|NCT04971720|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5629486|NCT04971720|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5629487|NCT04971720|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5629488|NCT04971720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5754846|NCT03010761|Citalopram|citalopram|mesh-list
5754847|NCT03010761|Moclobemide|moclobemide|mesh-list
5754848|NCT03010761|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5754849|NCT03010761|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5754850|NCT03010761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5754851|NCT03010761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5754852|NCT03010761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5754853|NCT03010761|Serotonin Agents|serotonin agents|mesh-ancestor
5754854|NCT03010761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754855|NCT03010761|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5754856|NCT03010761|Antidepressive Agents|antidepressive agents|mesh-ancestor
5754857|NCT03010761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5754858|NCT03010761|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
5754859|NCT03010761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5754860|NCT03011021|Liraglutide|liraglutide|mesh-list
5754861|NCT03011021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5754862|NCT03011021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754863|NCT03011021|Incretins|incretins|mesh-ancestor
5754864|NCT03011021|Hormones|hormones|mesh-ancestor
5754865|NCT03011021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5754866|NCT03010540|Fentanyl|fentanyl|mesh-list
5754867|NCT03010540|Morphine|morphine|mesh-list
5754868|NCT03010540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5754869|NCT03010540|Narcotics|narcotics|mesh-ancestor
5754870|NCT03010540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5629489|NCT04970901|Gemcitabine|gemcitabine|mesh-list
5629490|NCT04970901|Lenalidomide|lenalidomide|mesh-list
5629491|NCT04970901|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
5629492|NCT04970901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5629493|NCT04970901|Antimetabolites|antimetabolites|mesh-ancestor
5629494|NCT04970901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629495|NCT04970901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5629496|NCT04970901|Antiviral Agents|antiviral agents|mesh-ancestor
5754871|NCT03010540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754872|NCT03010540|Analgesics|analgesics|mesh-ancestor
6208897|NCT02138825|Enzyme Activators|enzyme activators|mesh-ancestor
5629497|NCT04970901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5629498|NCT04970901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5629499|NCT04970901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5629500|NCT04970901|Immunologic Factors|immunologic factors|mesh-ancestor
5629501|NCT04970901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629502|NCT04970901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5629503|NCT04970901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5629504|NCT04970901|Growth Substances|growth substances|mesh-ancestor
5629505|NCT04970901|Growth Inhibitors|growth inhibitors|mesh-ancestor
5629506|NCT04970901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5629507|NCT04966481|Cetuximab|cetuximab|mesh-list
5754873|NCT03010540|Sensory System Agents|sensory system agents|mesh-ancestor
5754874|NCT03010540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5754875|NCT03010540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5754876|NCT03010540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5754877|NCT03010540|Anesthetics, General|anesthetics, general|mesh-ancestor
5754878|NCT03010540|Anesthetics|anesthetics|mesh-ancestor
5754879|NCT03010475|Furosemide|furosemide|mesh-list
5754880|NCT03010475|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5754881|NCT03010475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5754882|NCT03010475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5754883|NCT03010475|Antimetabolites|antimetabolites|mesh-ancestor
5754884|NCT03010475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5754885|NCT03010475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5754886|NCT03010475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5754887|NCT03010475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5754888|NCT03010475|Diuretics|diuretics|mesh-ancestor
5754889|NCT03010475|Natriuretic Agents|natriuretic agents|mesh-ancestor
5754890|NCT03010475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754891|NCT03010475|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5754892|NCT03010475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5754893|NCT03010436|Benralizumab|benralizumab|mesh-list
5754894|NCT03010436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5754895|NCT03010436|Respiratory System Agents|respiratory system agents|mesh-ancestor
5754896|NCT03010358|Obinutuzumab|obinutuzumab|mesh-list
5754897|NCT03010358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5754898|NCT03010358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5754899|NCT03010228|Aluminum sulfate|aluminum sulfate|mesh-list
5754900|NCT03010228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5754901|NCT03010228|Immunologic Factors|immunologic factors|mesh-ancestor
5754902|NCT03010228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754903|NCT03010267|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
5754904|NCT03010267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5754905|NCT03010267|Hormone Antagonists|hormone antagonists|mesh-ancestor
5754906|NCT03010267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5754907|NCT03010267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754908|NCT03010267|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5754909|NCT03010267|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5754910|NCT03010267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5894879|NCT02473042|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5894880|NCT02473042|Serotonin Agents|serotonin agents|mesh-ancestor
5894881|NCT02473042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5894882|NCT02473042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894883|NCT02473042|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5894884|NCT02473042|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5894885|NCT02473042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5894886|NCT02473042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5894887|NCT02473042|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5894888|NCT02473042|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5894889|NCT02473042|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5894890|NCT02473042|Histamine Antagonists|histamine antagonists|mesh-ancestor
5894891|NCT02473042|Histamine Agents|histamine agents|mesh-ancestor
5894892|NCT02473042|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5894893|NCT02473042|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5894894|NCT02333149|Melatonin|melatonin|mesh-list
5894895|NCT02333149|Antioxidants|antioxidants|mesh-ancestor
5894896|NCT02333149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894897|NCT02333149|Protective Agents|protective agents|mesh-ancestor
5894898|NCT02333149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894899|NCT02333149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5894900|NCT02221310|Gemtuzumab|gemtuzumab|mesh-list
5894901|NCT02221310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5894902|NCT02221310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5629508|NCT04966481|Palbociclib|palbociclib|mesh-list
5629509|NCT04966481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5629510|NCT04966481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5629511|NCT04966481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5629512|NCT04966481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5629513|NCT04966481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629514|NCT04953910|Decitabine|decitabine|mesh-list
5754911|NCT03010202|Dexamethasone|dexamethasone|mesh-list
5754912|NCT03010202|Rituximab|rituximab|mesh-list
5754913|NCT03010202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5754914|NCT03010202|Antiemetics|antiemetics|mesh-ancestor
5754915|NCT03010202|Autonomic Agents|autonomic agents|mesh-ancestor
5754916|NCT03010202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5754917|NCT03010202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754918|NCT03010202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5754919|NCT03010202|Glucocorticoids|glucocorticoids|mesh-ancestor
5754920|NCT03010202|Hormones|hormones|mesh-ancestor
5754921|NCT03010202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5754922|NCT03010202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5754923|NCT03010202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5754924|NCT03010202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5754925|NCT03010202|Immunologic Factors|immunologic factors|mesh-ancestor
5754926|NCT03010202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5754927|NCT03010098|Remifentanil|remifentanil|mesh-list
5754928|NCT03010098|Propofol|propofol|mesh-list
5754929|NCT03010098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5754930|NCT03010098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5754931|NCT03010098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754932|NCT03010098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5754933|NCT03010098|Anesthetics, General|anesthetics, general|mesh-ancestor
5754934|NCT03010098|Anesthetics|anesthetics|mesh-ancestor
5754935|NCT03010098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5754936|NCT03010098|Narcotics|narcotics|mesh-ancestor
5754937|NCT03010098|Analgesics|analgesics|mesh-ancestor
5754938|NCT03010098|Sensory System Agents|sensory system agents|mesh-ancestor
5754939|NCT03010098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5754940|NCT03009981|Prednisone|prednisone|mesh-list
5754941|NCT03009981|Leuprolide|leuprolide|mesh-list
5754942|NCT03009981|Abiraterone Acetate|abiraterone acetate|mesh-list
5754943|NCT03009981|Bicalutamide|bicalutamide|mesh-list
5754944|NCT03009981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5754945|NCT03009981|Glucocorticoids|glucocorticoids|mesh-ancestor
5754946|NCT03009981|Hormones|hormones|mesh-ancestor
5754947|NCT03009981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5754948|NCT03009981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208898|NCT02138825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208899|NCT02138838|Cinacalcet|cinacalcet|mesh-list
6208900|NCT02138838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6208901|NCT02138838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208902|NCT02138838|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6208903|NCT02138838|Hormone Antagonists|hormone antagonists|mesh-ancestor
6208904|NCT02138838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6208905|NCT02138916|Benralizumab|benralizumab|mesh-list
6208906|NCT02138916|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6208907|NCT02138916|Respiratory System Agents|respiratory system agents|mesh-ancestor
6208908|NCT02139007|Alendronate|alendronate|mesh-list
6208909|NCT02139007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5629515|NCT04953910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5629516|NCT04953910|Antimetabolites|antimetabolites|mesh-ancestor
5629517|NCT04953910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629518|NCT04953910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5754949|NCT03009981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6208910|NCT02139007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208911|NCT02139046|Naproxen|naproxen|mesh-list
6208912|NCT02139046|Colchicine|colchicine|mesh-list
6208913|NCT02139046|Febuxostat|febuxostat|mesh-list
5754950|NCT03009981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5754951|NCT03009981|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5754952|NCT03009981|Fertility Agents|fertility agents|mesh-ancestor
5754953|NCT03009981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5754954|NCT03009981|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5754955|NCT03009981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5754956|NCT03009981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5754957|NCT03009981|Hormone Antagonists|hormone antagonists|mesh-ancestor
6208914|NCT02139046|Lansoprazole|lansoprazole|mesh-list
5754958|NCT03009981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6208915|NCT02139046|Dexlansoprazole|dexlansoprazole|mesh-list
5754959|NCT03009981|Androgen Antagonists|androgen antagonists|mesh-ancestor
5754960|NCT03010072|Ferric Compounds|ferric compounds|mesh-list
5754961|NCT03010072|Hematinics|hematinics|mesh-ancestor
5754962|NCT03009877|Fentanyl|fentanyl|mesh-list
5754963|NCT03009877|Midazolam|midazolam|mesh-list
5754964|NCT03009877|Propofol|propofol|mesh-list
5754965|NCT03009877|Rocuronium|rocuronium|mesh-list
5754966|NCT03009877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5754967|NCT03009877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5754968|NCT03009877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754969|NCT03009877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5754970|NCT03009877|Anesthetics, General|anesthetics, general|mesh-ancestor
5754971|NCT03009877|Anesthetics|anesthetics|mesh-ancestor
5754972|NCT03009877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5754973|NCT03009877|Narcotics|narcotics|mesh-ancestor
5754974|NCT03009877|Analgesics|analgesics|mesh-ancestor
5754975|NCT03009877|Sensory System Agents|sensory system agents|mesh-ancestor
5754976|NCT03009877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5754977|NCT03009877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5754978|NCT03009877|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5754979|NCT03009877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5754980|NCT03009877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5754981|NCT03009877|GABA Modulators|gaba modulators|mesh-ancestor
5754982|NCT03009877|GABA Agents|gaba agents|mesh-ancestor
5754983|NCT03009877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5754984|NCT03009877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5754985|NCT03009877|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5754986|NCT03009877|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5754987|NCT03009877|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5754988|NCT03009916|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
5754989|NCT03009916|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5754990|NCT03009916|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5754991|NCT03009916|Antimetabolites|antimetabolites|mesh-ancestor
5754992|NCT03009916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5754993|NCT03009916|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5754994|NCT03009643|Nitric Oxide|nitric oxide|mesh-list
5754995|NCT03009643|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5754996|NCT03009643|Autonomic Agents|autonomic agents|mesh-ancestor
5754997|NCT03009643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5754998|NCT03009643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5754999|NCT03009643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5755000|NCT03009643|Respiratory System Agents|respiratory system agents|mesh-ancestor
5755001|NCT03009643|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5755002|NCT03009643|Antioxidants|antioxidants|mesh-ancestor
5755003|NCT03009643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5755004|NCT03009643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5755005|NCT03009643|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5755006|NCT03009643|Vasodilator Agents|vasodilator agents|mesh-ancestor
5755007|NCT03009643|Gasotransmitters|gasotransmitters|mesh-ancestor
5755008|NCT03009643|Protective Agents|protective agents|mesh-ancestor
5755009|NCT03009604|Simethicone|simethicone|mesh-list
5755010|NCT03009604|Antifoaming Agents|antifoaming agents|mesh-ancestor
5755011|NCT03009604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5755012|NCT03009604|Emollients|emollients|mesh-ancestor
5755013|NCT03009604|Dermatologic Agents|dermatologic agents|mesh-ancestor
5755014|NCT03009682|Olaparib|olaparib|mesh-list
5755015|NCT03009682|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5755016|NCT03009682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5755017|NCT03009682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5755018|NCT03009682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5755019|NCT03009799|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
5755020|NCT03009799|Laxatives|laxatives|mesh-ancestor
5755021|NCT03009799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5755022|NCT03009461|Sorafenib|sorafenib|mesh-list
5629519|NCT04953910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5629520|NCT04953897|Decitabine|decitabine|mesh-list
5629521|NCT04953897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5629522|NCT04953897|Antimetabolites|antimetabolites|mesh-ancestor
5629523|NCT04953897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629524|NCT04953897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5629525|NCT04953897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5629526|NCT04952610|Etripamil|etripamil|mesh-list
5629527|NCT04952610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5629528|NCT04952610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5755023|NCT03009461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5755024|NCT03009461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5755025|NCT03009461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5755026|NCT03009461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5755027|NCT03009838|Letrozole|letrozole|mesh-list
5755028|NCT03009838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5755029|NCT03009838|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5755030|NCT03009838|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5755031|NCT03009838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5755032|NCT03009838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5755033|NCT03009838|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5755034|NCT03009838|Hormone Antagonists|hormone antagonists|mesh-ancestor
5755035|NCT03009838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5755036|NCT03009838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5755037|NCT03009500|Methylprednisolone|methylprednisolone|mesh-list
5755038|NCT03009500|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5755039|NCT03009500|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5755040|NCT03009500|Prednisolone|prednisolone|mesh-list
5629529|NCT04952610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629530|NCT04952610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5629531|NCT04952610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629532|NCT04949022|Insulin|insulin|mesh-list
5629533|NCT04949022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5755041|NCT03009500|Prednisolone acetate|prednisolone acetate|mesh-list
5755042|NCT03009500|Lidocaine|lidocaine|mesh-list
5755043|NCT03009500|Bupivacaine|bupivacaine|mesh-list
5755044|NCT03009500|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5755045|NCT03009500|Prednisolone phosphate|prednisolone phosphate|mesh-list
5755046|NCT03009500|Anesthetics, Local|anesthetics, local|mesh-ancestor
5755047|NCT03009500|Anesthetics|anesthetics|mesh-ancestor
5755048|NCT03009500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5755049|NCT03009500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5755050|NCT03009500|Sensory System Agents|sensory system agents|mesh-ancestor
5755051|NCT03009500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5755052|NCT03009500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5755053|NCT03009500|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5755054|NCT03009500|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5629534|NCT04949022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629535|NCT04948892|Anesthetics|anesthetics|mesh-list
5629536|NCT04948892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5629537|NCT04948892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629538|NCT04929379|Fenofibrate|fenofibrate|mesh-list
5755055|NCT03009500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5755056|NCT03009500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5755057|NCT03009500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5755058|NCT03009500|Antiemetics|antiemetics|mesh-ancestor
5755059|NCT03009500|Autonomic Agents|autonomic agents|mesh-ancestor
5755060|NCT03009500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5755061|NCT03009500|Glucocorticoids|glucocorticoids|mesh-ancestor
5755062|NCT03009500|Hormones|hormones|mesh-ancestor
5629539|NCT04929379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5629540|NCT04929379|Antimetabolites|antimetabolites|mesh-ancestor
5629541|NCT04929379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629542|NCT04929379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5693160|NCT03402503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5693161|NCT03402503|Respiratory System Agents|respiratory system agents|mesh-ancestor
5693162|NCT03402503|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5693163|NCT03402503|Hormone Antagonists|hormone antagonists|mesh-ancestor
5693164|NCT03402503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5693165|NCT03402503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693166|NCT03402503|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5755063|NCT03009500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5755064|NCT03009500|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5755065|NCT03009500|Protective Agents|protective agents|mesh-ancestor
5693167|NCT03402503|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5693168|NCT03402503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693169|NCT03402438|Fulacimstat|fulacimstat|mesh-list
5693170|NCT03402438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5693171|NCT03402438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5755066|NCT03009500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5755067|NCT03009500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5755068|NCT03009513|Glimepiride|glimepiride|mesh-list
5755069|NCT03009513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5755070|NCT03009513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5894903|NCT02213575|Minocycline|minocycline|mesh-list
5629543|NCT04920292|Oxfendazole|oxfendazole|mesh-list
5629544|NCT04920292|Anthelmintics|anthelmintics|mesh-ancestor
5629545|NCT04920292|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5629546|NCT04920292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5629547|NCT04920292|Antinematodal Agents|antinematodal agents|mesh-ancestor
5629548|NCT04917029|Dexmedetomidine|dexmedetomidine|mesh-list
5629549|NCT04917029|Bupivacaine|bupivacaine|mesh-list
5629550|NCT04917029|Anesthetics, Local|anesthetics, local|mesh-ancestor
5629551|NCT04917029|Anesthetics|anesthetics|mesh-ancestor
5629552|NCT04917029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5629553|NCT04917029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629554|NCT04917029|Sensory System Agents|sensory system agents|mesh-ancestor
5629555|NCT04917029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5629556|NCT04917029|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5629557|NCT04917029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5629558|NCT04917029|Analgesics|analgesics|mesh-ancestor
5629559|NCT04917029|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5629560|NCT04917029|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5629561|NCT04917029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5629562|NCT04917029|Adrenergic Agents|adrenergic agents|mesh-ancestor
5629563|NCT04917029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5629564|NCT04917029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629565|NCT04914195|Leuprolide|leuprolide|mesh-list
5629566|NCT04914195|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5629567|NCT04914195|Fertility Agents|fertility agents|mesh-ancestor
5629568|NCT04914195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5629569|NCT04914195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629570|NCT04914195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5629571|NCT04914195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5629572|NCT04913805|Niacinamide|niacinamide|mesh-list
5629573|NCT04913805|Niacin|niacin|mesh-list
5629574|NCT04913805|Nicotinic Acids|nicotinic acids|mesh-list
5629575|NCT04913805|Vitamin B Complex|vitamin b complex|mesh-ancestor
5629576|NCT04913805|Vitamins|vitamins|mesh-ancestor
5629577|NCT04913805|Micronutrients|micronutrients|mesh-ancestor
5629578|NCT04913805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629579|NCT04913805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5629580|NCT04913805|Antimetabolites|antimetabolites|mesh-ancestor
5629581|NCT04913805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629582|NCT04913805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5629583|NCT04913805|Vasodilator Agents|vasodilator agents|mesh-ancestor
5629584|NCT04909450|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5629585|NCT04909450|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5629586|NCT04903119|Trametinib|trametinib|mesh-list
5629587|NCT04903119|Dabrafenib|dabrafenib|mesh-list
5629588|NCT04903119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5629589|NCT04903119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5629590|NCT04903119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5629591|NCT04903119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629592|NCT04892875|Cisplatin|cisplatin|mesh-list
5629593|NCT04892875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5629594|NCT04892420|Dexamethasone|dexamethasone|mesh-list
5629595|NCT04892420|Magnesium Sulfate|magnesium sulfate|mesh-list
5629596|NCT04892420|Dexmedetomidine|dexmedetomidine|mesh-list
5629597|NCT04892420|Bupivacaine|bupivacaine|mesh-list
5629598|NCT04892420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5629599|NCT04892420|Antiemetics|antiemetics|mesh-ancestor
5629600|NCT04892420|Autonomic Agents|autonomic agents|mesh-ancestor
5629601|NCT04892420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5629602|NCT04892420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629603|NCT04892420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5629604|NCT04892420|Glucocorticoids|glucocorticoids|mesh-ancestor
5629605|NCT04892420|Hormones|hormones|mesh-ancestor
5755071|NCT03009513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5755072|NCT03009513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5755073|NCT03009513|Immunologic Factors|immunologic factors|mesh-ancestor
5755074|NCT03009474|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
5755075|NCT03009474|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5755076|NCT03009474|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5629606|NCT04892420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5629607|NCT04892420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5629608|NCT04892420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5629609|NCT04892420|Anesthetics, Local|anesthetics, local|mesh-ancestor
5629610|NCT04892420|Anesthetics|anesthetics|mesh-ancestor
5629611|NCT04892420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5629612|NCT04892420|Sensory System Agents|sensory system agents|mesh-ancestor
5629613|NCT04892420|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5755077|NCT03009474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5755078|NCT03009474|Antimetabolites|antimetabolites|mesh-ancestor
5755079|NCT03009474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5755080|NCT03009474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5755081|NCT03009474|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5755082|NCT03009474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5755083|NCT03009474|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5755084|NCT03009526|Pyrimethamine|pyrimethamine|mesh-list
5755085|NCT03009526|Piperaquine|piperaquine|mesh-list
5755086|NCT03009526|Sulfadoxine|sulfadoxine|mesh-list
5755087|NCT03009526|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
5755088|NCT03009526|Artenimol|artenimol|mesh-list
5755089|NCT03009526|Antimalarials|antimalarials|mesh-ancestor
5755090|NCT03009526|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5755091|NCT03009526|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5755092|NCT03009526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5755093|NCT03009526|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5629614|NCT04892420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5629615|NCT04892420|Analgesics|analgesics|mesh-ancestor
5629616|NCT04892420|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5629617|NCT04892420|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5629618|NCT04892420|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5629619|NCT04892420|Adrenergic Agents|adrenergic agents|mesh-ancestor
5629620|NCT04892420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5629621|NCT04892420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629622|NCT04892420|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5629623|NCT04892420|Anticonvulsants|anticonvulsants|mesh-ancestor
5755094|NCT03009526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5755095|NCT03009526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5755096|NCT03009526|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5755097|NCT03009526|Renal Agents|renal agents|mesh-ancestor
5755098|NCT03009422|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
5755099|NCT03009422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5755100|NCT03009422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5755101|NCT03009422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5755102|NCT03009422|Schistosomicides|schistosomicides|mesh-ancestor
5755103|NCT03009422|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5755104|NCT03009422|Anthelmintics|anthelmintics|mesh-ancestor
5755105|NCT03009292|Lenvatinib|lenvatinib|mesh-list
5755106|NCT03009292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5755107|NCT03009292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5755108|NCT03009292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5755109|NCT03009292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5755110|NCT03009578|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
5755111|NCT03009578|Hematinics|hematinics|mesh-ancestor
5755112|NCT03009097|Atorvastatin|atorvastatin|mesh-list
5755113|NCT03009097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5755114|NCT03009097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5755115|NCT03009097|Antimetabolites|antimetabolites|mesh-ancestor
5755116|NCT03009097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5755117|NCT03009097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5755118|NCT03009097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5755119|NCT03009097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5755120|NCT03009045|Tedizolid|tedizolid|mesh-list
5755121|NCT03009045|Tedizolid phosphate|tedizolid phosphate|mesh-list
5755122|NCT03009045|Oxazolidinones|oxazolidinones|mesh-list
5755123|NCT03009045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5755124|NCT03009045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5755125|NCT03009045|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5755126|NCT03009045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5629624|NCT04892420|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5629625|NCT04892420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5629626|NCT04892420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5629627|NCT04892420|Tocolytic Agents|tocolytic agents|mesh-ancestor
5755127|NCT03009045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5755128|NCT03009058|Leucovorin|leucovorin|mesh-list
5629628|NCT04892420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5629629|NCT04891068|Azacitidine|azacitidine|mesh-list
5629630|NCT04891068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5629631|NCT04891068|Antimetabolites|antimetabolites|mesh-ancestor
5629632|NCT04891068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629633|NCT04891068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5629634|NCT04891068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5755129|NCT03009058|Folic Acid|folic acid|mesh-list
5755130|NCT03009058|Gemcitabine|gemcitabine|mesh-list
5755131|NCT03009058|Cyclophosphamide|cyclophosphamide|mesh-list
5755132|NCT03009058|Fluorouracil|fluorouracil|mesh-list
5755133|NCT03009058|Pembrolizumab|pembrolizumab|mesh-list
5755134|NCT03009058|Capecitabine|capecitabine|mesh-list
5755135|NCT03009058|Oxaliplatin|oxaliplatin|mesh-list
5755136|NCT03009058|Nivolumab|nivolumab|mesh-list
5755137|NCT03009058|Irinotecan|irinotecan|mesh-list
5755138|NCT03009058|Cetuximab|cetuximab|mesh-list
5755139|NCT03009058|Ipilimumab|ipilimumab|mesh-list
5755140|NCT03009058|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5755141|NCT03009058|Levoleucovorin|levoleucovorin|mesh-list
5755142|NCT03009058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5755143|NCT03009058|Immunologic Factors|immunologic factors|mesh-ancestor
5755144|NCT03009058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5755145|NCT03009058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5755146|NCT03009058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5755147|NCT03009058|Alkylating Agents|alkylating agents|mesh-ancestor
5755148|NCT03009058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5755149|NCT03009058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5755150|NCT03009058|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5755151|NCT03009058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5629635|NCT04876677|Beclomethasone|beclomethasone|mesh-list
5629636|NCT04876677|Glycopyrrolate|glycopyrrolate|mesh-list
5629637|NCT04876677|Formoterol Fumarate|formoterol fumarate|mesh-list
5629638|NCT04876677|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5629639|NCT04876677|Autonomic Agents|autonomic agents|mesh-ancestor
5629640|NCT04876677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5629641|NCT04876677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629642|NCT04876677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5629643|NCT04876677|Respiratory System Agents|respiratory system agents|mesh-ancestor
5629644|NCT04876677|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5629645|NCT04876677|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5629646|NCT04876677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5629647|NCT04876677|Adrenergic Agents|adrenergic agents|mesh-ancestor
5629648|NCT04876677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5629649|NCT04876677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629650|NCT04876677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5629651|NCT04876677|Glucocorticoids|glucocorticoids|mesh-ancestor
5629652|NCT04876677|Hormones|hormones|mesh-ancestor
5629653|NCT04876677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5629654|NCT04876677|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5629655|NCT04876677|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5629656|NCT04876677|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5755152|NCT03009058|Antimetabolites|antimetabolites|mesh-ancestor
5755153|NCT03009058|Antiviral Agents|antiviral agents|mesh-ancestor
5755154|NCT03009058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5755155|NCT03009058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5755156|NCT03009058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5755157|NCT03009058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5755158|NCT03009058|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5755159|NCT03009058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5755160|NCT03009058|Antidotes|antidotes|mesh-ancestor
5755161|NCT03009058|Protective Agents|protective agents|mesh-ancestor
5755162|NCT03009058|Vitamin B Complex|vitamin b complex|mesh-ancestor
5755163|NCT03009058|Vitamins|vitamins|mesh-ancestor
5755164|NCT03009058|Micronutrients|micronutrients|mesh-ancestor
5755165|NCT03009058|Hematinics|hematinics|mesh-ancestor
5755166|NCT03009409|Ketamine|ketamine|mesh-list
5755167|NCT03009409|Analgesics|analgesics|mesh-ancestor
5755168|NCT03009409|Sensory System Agents|sensory system agents|mesh-ancestor
5755169|NCT03009409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5755170|NCT03009409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5755171|NCT03009409|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5755172|NCT03009409|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5755173|NCT03009409|Anesthetics, General|anesthetics, general|mesh-ancestor
5755174|NCT03009409|Anesthetics|anesthetics|mesh-ancestor
5755175|NCT03009409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5629657|NCT04876677|Cholinergic Agents|cholinergic agents|mesh-ancestor
5629658|NCT04874194|Venetoclax|venetoclax|mesh-list
5629659|NCT04874194|Homoharringtonine|homoharringtonine|mesh-list
5629660|NCT04874194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5629661|NCT04874194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5629662|NCT04874194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5629663|NCT04874194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5629664|NCT04874194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629665|NCT04866602|Atovaquone|atovaquone|mesh-list
5629666|NCT04866602|Proguanil|proguanil|mesh-list
5629667|NCT04866602|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
5629668|NCT04866602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5629669|NCT04866602|Antimalarials|antimalarials|mesh-ancestor
5629670|NCT04866602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5629671|NCT04866602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5629672|NCT04866602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5629673|NCT04866602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629674|NCT04866602|Antimetabolites|antimetabolites|mesh-ancestor
5755176|NCT03009409|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5755177|NCT03009409|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5755178|NCT03009409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5755179|NCT03009409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5755180|NCT03009006|Calcium, Dietary|calcium, dietary|mesh-list
5755181|NCT03009006|Chlorhexidine|chlorhexidine|mesh-list
5755182|NCT03009006|Calcium|calcium|mesh-list
5755183|NCT03009006|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5755184|NCT03009006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5755185|NCT03009006|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5755186|NCT03009006|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5755187|NCT03009006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5755188|NCT03009006|Disinfectants|disinfectants|mesh-ancestor
5755189|NCT03008876|Acetaminophen|acetaminophen|mesh-list
5629675|NCT04857398|Insulin|insulin|mesh-list
5629676|NCT04857398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5629677|NCT04857398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629678|NCT04854512|Metformin|metformin|mesh-list
5629679|NCT04854512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5629680|NCT04854512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629681|NCT04847466|Pembrolizumab|pembrolizumab|mesh-list
5629682|NCT04847466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5629683|NCT04847466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5629684|NCT04845919|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5629685|NCT04845919|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5629686|NCT04845919|Dermatologic Agents|dermatologic agents|mesh-ancestor
5629687|NCT04843579|Clarithromycin|clarithromycin|mesh-list
5629688|NCT04843579|Dexamethasone|dexamethasone|mesh-list
5629689|NCT04843579|Pomalidomide|pomalidomide|mesh-list
5629690|NCT04843579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5629691|NCT04843579|Antiemetics|antiemetics|mesh-ancestor
5629692|NCT04843579|Autonomic Agents|autonomic agents|mesh-ancestor
5629693|NCT04843579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5629694|NCT04843579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629695|NCT04843579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5629696|NCT04843579|Glucocorticoids|glucocorticoids|mesh-ancestor
5629697|NCT04843579|Hormones|hormones|mesh-ancestor
5629698|NCT04843579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5629699|NCT04843579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5629700|NCT04843579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5755190|NCT03008876|Ibuprofen|ibuprofen|mesh-list
5755191|NCT03008876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5755192|NCT03008876|Analgesics|analgesics|mesh-ancestor
5755193|NCT03008876|Sensory System Agents|sensory system agents|mesh-ancestor
5755194|NCT03008876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5755195|NCT03008876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5755196|NCT03008876|Antipyretics|antipyretics|mesh-ancestor
5755197|NCT03008876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5755198|NCT03008876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5755199|NCT03008876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5755200|NCT03008876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5755201|NCT03008876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5755202|NCT03008876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894904|NCT02213575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5894905|NCT02213575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5894906|NCT02192021|Doxorubicin|doxorubicin|mesh-list
5894907|NCT02192021|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5629701|NCT04843579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5629702|NCT04843579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5629703|NCT04843579|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5629704|NCT04843579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5629705|NCT04843579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629706|NCT04843579|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5629707|NCT04843579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5629708|NCT04843579|Immunologic Factors|immunologic factors|mesh-ancestor
5629709|NCT04843579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5629710|NCT04843579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5629711|NCT04843579|Growth Substances|growth substances|mesh-ancestor
5629712|NCT04843579|Growth Inhibitors|growth inhibitors|mesh-ancestor
5629713|NCT04840823|Enoxacin|enoxacin|mesh-list
5629714|NCT04840823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5629715|NCT04840823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5629716|NCT04840823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5629717|NCT04840823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5629718|NCT04840823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5629719|NCT04840823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629720|NCT04840823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5629721|NCT04840823|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5629722|NCT04840823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5629723|NCT04838769|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
5629724|NCT04838769|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
5755203|NCT03008655|Tranexamic Acid|tranexamic acid|mesh-list
5755204|NCT03008655|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5755205|NCT03008655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5755206|NCT03008655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5755207|NCT03008655|Hemostatics|hemostatics|mesh-ancestor
5755208|NCT03008655|Coagulants|coagulants|mesh-ancestor
5755209|NCT03008512|Paclitaxel|paclitaxel|mesh-list
5755210|NCT03008512|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5755211|NCT03008512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5755212|NCT03008512|Tubulin Modulators|tubulin modulators|mesh-ancestor
5755213|NCT03008512|Antimitotic Agents|antimitotic agents|mesh-ancestor
5755214|NCT03008512|Mitosis Modulators|mitosis modulators|mesh-ancestor
5755215|NCT03008512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5755216|NCT03008551|Metformin|metformin|mesh-list
5755217|NCT03008551|Empagliflozin|empagliflozin|mesh-list
5755218|NCT03008551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5755219|NCT03008551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5755220|NCT03008551|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5755221|NCT03008551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5755222|NCT03008616|Digoxin|digoxin|mesh-list
5755223|NCT03008616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5629725|NCT04838769|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5629726|NCT04838769|Adrenergic Agents|adrenergic agents|mesh-ancestor
5629727|NCT04838769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5629728|NCT04838769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629729|NCT04838769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629730|NCT04838769|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5629731|NCT04838769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5629732|NCT04838769|Hormone Antagonists|hormone antagonists|mesh-ancestor
5629733|NCT04838769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5629734|NCT04831450|Cemiplimab|cemiplimab|mesh-list
5629735|NCT04831450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5629736|NCT04831450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5629737|NCT04821375|Bazedoxifene|bazedoxifene|mesh-list
5629738|NCT04821375|Estrogens|estrogens|mesh-list
5755224|NCT03008616|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5755225|NCT03008616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5755226|NCT03008616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5755227|NCT03008616|Protective Agents|protective agents|mesh-ancestor
5755228|NCT03008616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5755229|NCT03008408|Everolimus|everolimus|mesh-list
5755230|NCT03008408|Letrozole|letrozole|mesh-list
5755231|NCT03008408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5755232|NCT03008408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5755233|NCT03008408|Immunologic Factors|immunologic factors|mesh-ancestor
5755234|NCT03008408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5755235|NCT03008408|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5755236|NCT03008408|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5629739|NCT04821375|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
5629740|NCT04821375|Hormones|hormones|mesh-ancestor
5755237|NCT03008408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5755238|NCT03008408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5755239|NCT03008408|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5755240|NCT03008408|Hormone Antagonists|hormone antagonists|mesh-ancestor
5755241|NCT03008408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5755242|NCT03008317|Chromium|chromium|mesh-list
5755243|NCT03008317|Trace Elements|trace elements|mesh-ancestor
5755244|NCT03008317|Micronutrients|micronutrients|mesh-ancestor
5755245|NCT03008317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5755246|NCT03008252|Caseins|caseins|mesh-list
5755247|NCT03008252|Chelating Agents|chelating agents|mesh-ancestor
5755248|NCT03008252|Sequestering Agents|sequestering agents|mesh-ancestor
5755249|NCT03008252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5755250|NCT03008148|Temozolomide|temozolomide|mesh-list
5755251|NCT03008148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5755252|NCT03008148|Alkylating Agents|alkylating agents|mesh-ancestor
5755253|NCT03008148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5755254|NCT03008148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5755255|NCT03007927|Dexamethasone|dexamethasone|mesh-list
5755256|NCT03007927|Bupivacaine|bupivacaine|mesh-list
5755257|NCT03007927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5755258|NCT03007927|Antiemetics|antiemetics|mesh-ancestor
5755259|NCT03007927|Autonomic Agents|autonomic agents|mesh-ancestor
5755260|NCT03007927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5755261|NCT03007927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5755262|NCT03007927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5755263|NCT03007927|Glucocorticoids|glucocorticoids|mesh-ancestor
5755264|NCT03007927|Hormones|hormones|mesh-ancestor
5755265|NCT03007927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5755266|NCT03007927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5755267|NCT03007927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5629741|NCT04821375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5629742|NCT04821375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629743|NCT04821375|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5629744|NCT04821375|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5629745|NCT04821375|Hormone Antagonists|hormone antagonists|mesh-ancestor
5629746|NCT04821375|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5629747|NCT04820309|Xanomeline|xanomeline|mesh-list
5629748|NCT04820309|Trospium chloride|trospium chloride|mesh-list
5629749|NCT04820309|Parasympatholytics|parasympatholytics|mesh-ancestor
5629750|NCT04820309|Autonomic Agents|autonomic agents|mesh-ancestor
5629751|NCT04820309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5629752|NCT04820309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629753|NCT04820309|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5629754|NCT04820309|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5755268|NCT03007927|Anesthetics, Local|anesthetics, local|mesh-ancestor
5755269|NCT03007927|Anesthetics|anesthetics|mesh-ancestor
5755270|NCT03007927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5755271|NCT03007927|Sensory System Agents|sensory system agents|mesh-ancestor
5755272|NCT03008005|Dronabinol|dronabinol|mesh-list
5755273|NCT03008005|Hallucinogens|hallucinogens|mesh-ancestor
5755274|NCT03008005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629755|NCT04820309|Cholinergic Agents|cholinergic agents|mesh-ancestor
5629756|NCT04820309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5629757|NCT04820309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629758|NCT04820309|Urological Agents|urological agents|mesh-ancestor
5629759|NCT04820309|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5629760|NCT04820309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5629761|NCT04820309|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
5629762|NCT04820309|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5629763|NCT04808505|Miglustat|miglustat|mesh-list
5629764|NCT04808505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5629765|NCT04808505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629766|NCT04808505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5629767|NCT04808505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5629768|NCT04808505|Antiviral Agents|antiviral agents|mesh-ancestor
5629769|NCT04808505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5629770|NCT04808505|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
5629771|NCT04808505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5629772|NCT04808505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629773|NCT04807972|Folfirinox|folfirinox|mesh-list
5629774|NCT04807972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5629775|NCT04806919|Progesterone|progesterone|mesh-list
5629776|NCT04806919|Progestins|progestins|mesh-ancestor
5755275|NCT03008005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5755276|NCT03008005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5755277|NCT03008005|Analgesics|analgesics|mesh-ancestor
5755278|NCT03008005|Sensory System Agents|sensory system agents|mesh-ancestor
5755279|NCT03008005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5755280|NCT03008005|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5755281|NCT03008005|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5755282|NCT03008005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5755283|NCT03008005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5755284|NCT03008005|Hormones|hormones|mesh-ancestor
5755285|NCT03008005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5755286|NCT03008109|Endostatins|endostatins|mesh-list
5755287|NCT03008109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5755288|NCT03008109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5755289|NCT03008109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5755290|NCT03008109|Growth Substances|growth substances|mesh-ancestor
5755291|NCT03008109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5755292|NCT03008109|Growth Inhibitors|growth inhibitors|mesh-ancestor
5755293|NCT03007992|Vinorelbine|vinorelbine|mesh-list
5755294|NCT03007992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5755295|NCT03007992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5755296|NCT03007992|Tubulin Modulators|tubulin modulators|mesh-ancestor
5755297|NCT03007992|Antimitotic Agents|antimitotic agents|mesh-ancestor
5755298|NCT03007992|Mitosis Modulators|mitosis modulators|mesh-ancestor
5755299|NCT03007992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5755300|NCT03008057|Vitamin D|vitamin d|mesh-list
5755301|NCT03008057|Ergocalciferols|ergocalciferols|mesh-list
5755302|NCT03008057|Vitamins|vitamins|mesh-list
5755303|NCT03008057|Micronutrients|micronutrients|mesh-ancestor
5755304|NCT03008057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5755305|NCT03008057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5755306|NCT03008057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5755307|NCT03008083|Clopidogrel|clopidogrel|mesh-list
5629777|NCT04806919|Hormones|hormones|mesh-ancestor
5629778|NCT04806919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5629779|NCT04806919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629780|NCT04801797|Cytarabine|cytarabine|mesh-list
5629781|NCT04801797|Azacitidine|azacitidine|mesh-list
5629782|NCT04801797|Daunorubicin|daunorubicin|mesh-list
5629783|NCT04801797|Venetoclax|venetoclax|mesh-list
5629784|NCT04801797|Idarubicin|idarubicin|mesh-list
5629785|NCT04801797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5755308|NCT03008083|Ticagrelor|ticagrelor|mesh-list
5755309|NCT03008083|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5755310|NCT03008083|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5755311|NCT03008083|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5755312|NCT03008083|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5755313|NCT03008083|Purinergic Agents|purinergic agents|mesh-ancestor
5755314|NCT03008083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5755315|NCT03008083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5755316|NCT03008083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5755317|NCT03007810|Hemay005|hemay005|mesh-list
5755318|NCT03007810|Dermatologic Agents|dermatologic agents|mesh-ancestor
5755319|NCT03007810|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5755320|NCT03007810|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5755321|NCT03007810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5755322|NCT03007810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5755323|NCT03007797|Vaccines|vaccines|mesh-list
5755324|NCT03007797|Immunologic Factors|immunologic factors|mesh-ancestor
5755325|NCT03007797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5755326|NCT03007446|Oxaliplatin|oxaliplatin|mesh-list
5755327|NCT03007446|Apatinib|apatinib|mesh-list
5755328|NCT03007446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5755329|NCT03007446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5755330|NCT03007446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5755331|NCT03007446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5755332|NCT03007420|Lidocaine|lidocaine|mesh-list
5755333|NCT03007420|Anesthetics, Local|anesthetics, local|mesh-ancestor
5755334|NCT03007420|Anesthetics|anesthetics|mesh-ancestor
5755335|NCT03007420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5755336|NCT03007420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5755337|NCT03007420|Sensory System Agents|sensory system agents|mesh-ancestor
5755338|NCT03007420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5755339|NCT03007420|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6489776|NCT00593463|Antimetabolites|antimetabolites|mesh-ancestor
5629786|NCT04801797|Antimetabolites|antimetabolites|mesh-ancestor
5755340|NCT03007420|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5755341|NCT03007420|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5755342|NCT03007420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5755343|NCT03007420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5755344|NCT03007381|Ketorolac|ketorolac|mesh-list
5755345|NCT03007381|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
5755346|NCT03007381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5755347|NCT03007381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5755348|NCT03007381|Analgesics|analgesics|mesh-ancestor
5755349|NCT03007381|Sensory System Agents|sensory system agents|mesh-ancestor
5755350|NCT03007381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5755351|NCT03007381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5755352|NCT03007381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5755353|NCT03007381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5755354|NCT03007381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5755355|NCT03007381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5755356|NCT03007381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5755357|NCT03007303|Olanzapine|olanzapine|mesh-list
5755358|NCT03007303|Risperidone|risperidone|mesh-list
5755359|NCT03007303|Quetiapine Fumarate|quetiapine fumarate|mesh-list
5755360|NCT03007303|Ziprasidone|ziprasidone|mesh-list
5755361|NCT03007303|Antipsychotic Agents|antipsychotic agents|mesh-list
5755362|NCT03007303|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5755363|NCT03007303|Serotonin Agents|serotonin agents|mesh-ancestor
5755364|NCT03007303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5755365|NCT03007303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5755366|NCT03007303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5755367|NCT03007303|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5755368|NCT03007303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5755369|NCT03007303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5755370|NCT03007303|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5755371|NCT03007303|Dopamine Agents|dopamine agents|mesh-ancestor
5755372|NCT03007303|Antiemetics|antiemetics|mesh-ancestor
5629787|NCT04801797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629788|NCT04801797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5629789|NCT04801797|Antiviral Agents|antiviral agents|mesh-ancestor
5629790|NCT04801797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5629791|NCT04801797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5629792|NCT04801797|Immunologic Factors|immunologic factors|mesh-ancestor
5629793|NCT04801797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629794|NCT04801797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5629795|NCT04801797|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5629796|NCT04801797|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5629797|NCT04801797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5629798|NCT04796194|Pembrolizumab|pembrolizumab|mesh-list
5629799|NCT04796194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5629800|NCT04796194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5629801|NCT04785950|Levonorgestrel|levonorgestrel|mesh-list
5629802|NCT04785950|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5629803|NCT04785950|Contraceptive Agents|contraceptive agents|mesh-ancestor
5629804|NCT04785950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5629805|NCT04785950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629806|NCT04785950|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5755373|NCT03007303|Autonomic Agents|autonomic agents|mesh-ancestor
5755374|NCT03007303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5755375|NCT03007303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5755376|NCT03007303|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5629807|NCT04785950|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5629808|NCT04785950|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5629809|NCT04785638|Bupivacaine|bupivacaine|mesh-list
5629810|NCT04785638|Anesthetics, Local|anesthetics, local|mesh-ancestor
5629811|NCT04785638|Anesthetics|anesthetics|mesh-ancestor
5629812|NCT04785638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5629813|NCT04785638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629814|NCT04785638|Sensory System Agents|sensory system agents|mesh-ancestor
5629815|NCT04785638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5629816|NCT04785625|Bupivacaine|bupivacaine|mesh-list
5755377|NCT03007303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5755378|NCT03007303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5755379|NCT03007303|Antidepressive Agents|antidepressive agents|mesh-ancestor
5755380|NCT03007589|Sunscreening Agents|sunscreening agents|mesh-list
5755381|NCT03007589|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5755382|NCT03007589|Protective Agents|protective agents|mesh-ancestor
5755383|NCT03007589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5755384|NCT03007589|Dermatologic Agents|dermatologic agents|mesh-ancestor
5755385|NCT03007342|Amoxicillin|amoxicillin|mesh-list
5755386|NCT03007342|Clavulanic Acid|clavulanic acid|mesh-list
5755387|NCT03007342|Clavulanic Acids|clavulanic acids|mesh-list
5755388|NCT03007342|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5755389|NCT03007342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5755390|NCT03007342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5755391|NCT03007342|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5755392|NCT03007342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5755393|NCT03007342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5755394|NCT03007537|Epoetin Alfa|epoetin alfa|mesh-list
5755395|NCT03007537|Hematinics|hematinics|mesh-ancestor
5755396|NCT03007563|Bilirubin|bilirubin|mesh-list
5755397|NCT03007563|Antioxidants|antioxidants|mesh-ancestor
5755398|NCT03007563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5755399|NCT03007563|Protective Agents|protective agents|mesh-ancestor
5629817|NCT04785625|Anesthetics, Local|anesthetics, local|mesh-ancestor
6489777|NCT00593463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6489778|NCT00593463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6489779|NCT00593502|Oseltamivir|oseltamivir|mesh-list
6489780|NCT00593502|Antiviral Agents|antiviral agents|mesh-ancestor
6489781|NCT00593502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6489782|NCT00593502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6489783|NCT00593502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629818|NCT04785625|Anesthetics|anesthetics|mesh-ancestor
5629819|NCT04785625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5629820|NCT04785625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489784|NCT00593567|Levofloxacin|levofloxacin|mesh-list
6489785|NCT00593567|Ofloxacin|ofloxacin|mesh-list
6489786|NCT00593567|Gentamicins|gentamicins|mesh-list
6489787|NCT00593567|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6489788|NCT00593567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6489789|NCT00593567|Renal Agents|renal agents|mesh-ancestor
6489790|NCT00593567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5629821|NCT04785625|Sensory System Agents|sensory system agents|mesh-ancestor
5629822|NCT04785625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5693172|NCT03402321|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
5693173|NCT03402321|Hemostatics|hemostatics|mesh-ancestor
5693174|NCT03402321|Coagulants|coagulants|mesh-ancestor
5693175|NCT03402295|Thalidomide|thalidomide|mesh-list
5693176|NCT03402295|Dexamethasone|dexamethasone|mesh-list
5693177|NCT03402295|Cyclophosphamide|cyclophosphamide|mesh-list
5693178|NCT03402295|Bortezomib|bortezomib|mesh-list
5693179|NCT03402295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5693180|NCT03402295|Immunologic Factors|immunologic factors|mesh-ancestor
5693181|NCT03402295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693182|NCT03402295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5693183|NCT03402295|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5693184|NCT03402295|Alkylating Agents|alkylating agents|mesh-ancestor
5693185|NCT03402295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693186|NCT03402295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5693187|NCT03402295|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5693188|NCT03402295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5693189|NCT03402295|Antiemetics|antiemetics|mesh-ancestor
6489791|NCT00593567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6489792|NCT00593567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6489793|NCT00593567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6489794|NCT00593567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489795|NCT00593567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6489796|NCT00593567|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6489797|NCT00593567|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6489798|NCT00593567|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6489799|NCT00593580|Cholecalciferol|cholecalciferol|mesh-list
6489800|NCT00593580|Alendronate|alendronate|mesh-list
6489801|NCT00593580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6489802|NCT00593580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489803|NCT00593580|Vitamins|vitamins|mesh-ancestor
6489804|NCT00593580|Micronutrients|micronutrients|mesh-ancestor
6489805|NCT00593580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6489806|NCT00593619|Iron|iron|mesh-list
6489807|NCT00593619|Dextrans|dextrans|mesh-list
6489808|NCT00593619|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6489809|NCT00593619|Iron-Dextran Complex|iron-dextran complex|mesh-list
6489810|NCT00593619|Trace Elements|trace elements|mesh-ancestor
5693190|NCT03402295|Autonomic Agents|autonomic agents|mesh-ancestor
5755400|NCT03007563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489811|NCT00593619|Micronutrients|micronutrients|mesh-ancestor
5755401|NCT03007407|Durvalumab|durvalumab|mesh-list
5755402|NCT03007407|Tremelimumab|tremelimumab|mesh-list
5755403|NCT03007407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5755404|NCT03007407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5755405|NCT03007524|Calcium, Dietary|calcium, dietary|mesh-list
5755406|NCT03007524|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5755407|NCT03007524|Calcium|calcium|mesh-list
5755408|NCT03007524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5755409|NCT03007524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5755410|NCT03007524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5755411|NCT03007524|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5755412|NCT03007524|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5755413|NCT03007524|Antimetabolites|antimetabolites|mesh-ancestor
5755414|NCT03007524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5755415|NCT03007524|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5755416|NCT03007524|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5755417|NCT03007524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5755418|NCT03007654|Chitosan|chitosan|mesh-list
5755419|NCT03007654|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5755420|NCT03007654|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5755421|NCT03007654|Antimetabolites|antimetabolites|mesh-ancestor
5755422|NCT03007654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5755423|NCT03007654|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5755424|NCT03007654|Chelating Agents|chelating agents|mesh-ancestor
5755425|NCT03007654|Sequestering Agents|sequestering agents|mesh-ancestor
5755426|NCT03007654|Hemostatics|hemostatics|mesh-ancestor
5755427|NCT03007654|Coagulants|coagulants|mesh-ancestor
5755428|NCT03007329|Dapagliflozin|dapagliflozin|mesh-list
5755429|NCT03007329|Exenatide|exenatide|mesh-list
5755430|NCT03007329|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5629823|NCT04779307|Vedolizumab|vedolizumab|mesh-list
5629824|NCT04779307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5629825|NCT04776980|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
5629826|NCT04776980|Hematinics|hematinics|mesh-ancestor
5629827|NCT04776980|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5629828|NCT04776980|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5629829|NCT04772079|BMS-986165|bms-986165|mesh-list
5629830|NCT04772079|Dermatologic Agents|dermatologic agents|mesh-ancestor
5629831|NCT04772079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5755431|NCT03007329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5755432|NCT03007329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5755433|NCT03007329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629832|NCT04772079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5629833|NCT04772079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629834|NCT04765059|Cisplatin|cisplatin|mesh-list
5755434|NCT03007329|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5755435|NCT03007329|Incretins|incretins|mesh-ancestor
5755436|NCT03007329|Hormones|hormones|mesh-ancestor
5755437|NCT03007329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5755438|NCT03007238|Aldesleukin|aldesleukin|mesh-list
5755439|NCT03007238|Interleukin-2|interleukin-2|mesh-list
5755440|NCT03007238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5755441|NCT03007238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5755442|NCT03007238|Analgesics|analgesics|mesh-ancestor
5755443|NCT03007238|Sensory System Agents|sensory system agents|mesh-ancestor
5755444|NCT03007238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5755445|NCT03007238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5755446|NCT03007238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5755447|NCT03007238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5755448|NCT03007238|Antiviral Agents|antiviral agents|mesh-ancestor
5755449|NCT03007238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5755450|NCT03007160|Potassium Citrate|potassium citrate|mesh-list
5755451|NCT03007160|Diuretics|diuretics|mesh-ancestor
5755452|NCT03007160|Natriuretic Agents|natriuretic agents|mesh-ancestor
5755453|NCT03007160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5755454|NCT03007160|Expectorants|expectorants|mesh-ancestor
5755455|NCT03007160|Respiratory System Agents|respiratory system agents|mesh-ancestor
5755456|NCT03007147|Calcium, Dietary|calcium, dietary|mesh-list
5755457|NCT03007147|Leucovorin|leucovorin|mesh-list
5755458|NCT03007147|Folic Acid|folic acid|mesh-list
5755459|NCT03007147|Cytarabine|cytarabine|mesh-list
5755460|NCT03007147|Dexamethasone|dexamethasone|mesh-list
5755461|NCT03007147|Dexamethasone acetate|dexamethasone acetate|mesh-list
5755462|NCT03007147|Methylprednisolone|methylprednisolone|mesh-list
5755463|NCT03007147|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5629835|NCT04765059|Carboplatin|carboplatin|mesh-list
5755464|NCT03007147|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5755465|NCT03007147|Prednisolone|prednisolone|mesh-list
5755466|NCT03007147|Prednisolone acetate|prednisolone acetate|mesh-list
5755467|NCT03007147|Hydrocortisone|hydrocortisone|mesh-list
5755468|NCT03007147|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
5755469|NCT03007147|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
5755470|NCT03007147|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
5755471|NCT03007147|Cyclophosphamide|cyclophosphamide|mesh-list
5755472|NCT03007147|Ifosfamide|ifosfamide|mesh-list
5755473|NCT03007147|Isophosphamide mustard|isophosphamide mustard|mesh-list
5755474|NCT03007147|Doxorubicin|doxorubicin|mesh-list
5755475|NCT03007147|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5755476|NCT03007147|Methotrexate|methotrexate|mesh-list
5755477|NCT03007147|Etoposide|etoposide|mesh-list
5755478|NCT03007147|Vincristine|vincristine|mesh-list
5755479|NCT03007147|Etoposide phosphate|etoposide phosphate|mesh-list
5755480|NCT03007147|Imatinib Mesylate|imatinib mesylate|mesh-list
5755481|NCT03007147|Daunorubicin|daunorubicin|mesh-list
5755482|NCT03007147|Asparaginase|asparaginase|mesh-list
5755483|NCT03007147|Mercaptopurine|mercaptopurine|mesh-list
5755484|NCT03007147|Podophyllotoxin|podophyllotoxin|mesh-list
5755485|NCT03007147|Pegaspargase|pegaspargase|mesh-list
5755486|NCT03007147|Thioguanine|thioguanine|mesh-list
5755487|NCT03007147|Dexrazoxane|dexrazoxane|mesh-list
5755488|NCT03007147|Razoxane|razoxane|mesh-list
5755489|NCT03007147|Azathioprine|azathioprine|mesh-list
5755490|NCT03007147|Lenograstim|lenograstim|mesh-list
5755491|NCT03007147|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5755492|NCT03007147|Prednisolone phosphate|prednisolone phosphate|mesh-list
5755493|NCT03007147|BB 1101|bb 1101|mesh-list
5755494|NCT03007147|Calcium|calcium|mesh-list
5755495|NCT03007147|2-Aminopurine|2-aminopurine|mesh-list
5755496|NCT03007147|Levoleucovorin|levoleucovorin|mesh-list
5755497|NCT03007147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5755498|NCT03007147|Immunologic Factors|immunologic factors|mesh-ancestor
5755499|NCT03007147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5755500|NCT03007147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5755501|NCT03007147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5755502|NCT03007147|Alkylating Agents|alkylating agents|mesh-ancestor
5755503|NCT03007147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5755504|NCT03007147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5755505|NCT03007147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5755506|NCT03007147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5755507|NCT03007147|Antiemetics|antiemetics|mesh-ancestor
5755508|NCT03007147|Autonomic Agents|autonomic agents|mesh-ancestor
5755509|NCT03007147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5755510|NCT03007147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5755511|NCT03007147|Glucocorticoids|glucocorticoids|mesh-ancestor
5755512|NCT03007147|Hormones|hormones|mesh-ancestor
5629836|NCT04765059|Pemetrexed|pemetrexed|mesh-list
5629837|NCT04765059|Osimertinib|osimertinib|mesh-list
5629838|NCT04765059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5629839|NCT04765059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5629840|NCT04765059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5755513|NCT03007147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5755514|NCT03007147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5755515|NCT03007147|Protease Inhibitors|protease inhibitors|mesh-ancestor
5755516|NCT03007147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5755517|NCT03007147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5755518|NCT03007147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6489812|NCT00593619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489813|NCT00593619|Hematinics|hematinics|mesh-ancestor
6489814|NCT00593619|Anticoagulants|anticoagulants|mesh-ancestor
6489815|NCT00593619|Plasma Substitutes|plasma substitutes|mesh-ancestor
6489816|NCT00593619|Blood Substitutes|blood substitutes|mesh-ancestor
6489817|NCT00593658|Pentoxifylline|pentoxifylline|mesh-list
5755519|NCT03007147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5755520|NCT03007147|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5755521|NCT03007147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5755522|NCT03007147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5755523|NCT03007147|Abortifacient Agents|abortifacient agents|mesh-ancestor
5755524|NCT03007147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5755525|NCT03007147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5629841|NCT04765059|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5629842|NCT04765059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5629843|NCT04765059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5629844|NCT04756063|Ascorbic Acid|ascorbic acid|mesh-list
5629845|NCT04756063|Vitamins|vitamins|mesh-ancestor
5629846|NCT04756063|Micronutrients|micronutrients|mesh-ancestor
5755526|NCT03007147|Antimetabolites|antimetabolites|mesh-ancestor
5755527|NCT03007147|Dermatologic Agents|dermatologic agents|mesh-ancestor
5755528|NCT03007147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6489818|NCT00593658|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5755529|NCT03007147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5755530|NCT03007147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5755531|NCT03007147|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5755532|NCT03007147|Antiviral Agents|antiviral agents|mesh-ancestor
5755533|NCT03007147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5755534|NCT03007147|Antidotes|antidotes|mesh-ancestor
5755535|NCT03007147|Protective Agents|protective agents|mesh-ancestor
5755536|NCT03007147|Vitamin B Complex|vitamin b complex|mesh-ancestor
5755537|NCT03007147|Vitamins|vitamins|mesh-ancestor
5755538|NCT03007147|Micronutrients|micronutrients|mesh-ancestor
5755539|NCT03007147|Tubulin Modulators|tubulin modulators|mesh-ancestor
5755540|NCT03007147|Antimitotic Agents|antimitotic agents|mesh-ancestor
5755541|NCT03007147|Mitosis Modulators|mitosis modulators|mesh-ancestor
5755542|NCT03007147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5755543|NCT03007147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5755544|NCT03007147|Hematinics|hematinics|mesh-ancestor
5755545|NCT03007147|Keratolytic Agents|keratolytic agents|mesh-ancestor
5755546|NCT03007147|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5894908|NCT02192021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5894909|NCT02192021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5894910|NCT02192021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5894911|NCT02192021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5894912|NCT02192021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5894913|NCT02192021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894914|NCT02144857|Cyclosporine|cyclosporine|mesh-list
5894915|NCT02144857|Etanercept|etanercept|mesh-list
5894916|NCT02144857|Apremilast|apremilast|mesh-list
5894917|NCT02144857|Ustekinumab|ustekinumab|mesh-list
5894918|NCT02144857|Cyclosporins|cyclosporins|mesh-list
5894919|NCT02144857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5629847|NCT04756063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629848|NCT04756063|Antioxidants|antioxidants|mesh-ancestor
5629849|NCT04756063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629850|NCT04756063|Protective Agents|protective agents|mesh-ancestor
5629851|NCT04742634|Decitabine|decitabine|mesh-list
5629852|NCT04742634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5629853|NCT04742634|Antimetabolites|antimetabolites|mesh-ancestor
5629854|NCT04742634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629855|NCT04742634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5629856|NCT04742634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5629857|NCT04742075|Durvalumab|durvalumab|mesh-list
5629858|NCT04742075|Olaparib|olaparib|mesh-list
5629859|NCT04742075|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5629860|NCT04742075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5629861|NCT04742075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5629862|NCT04742075|Immunologic Factors|immunologic factors|mesh-ancestor
5894920|NCT02144857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894921|NCT02144857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5894922|NCT02144857|Immunologic Factors|immunologic factors|mesh-ancestor
5894923|NCT02144857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894924|NCT02144857|Antifungal Agents|antifungal agents|mesh-ancestor
5894925|NCT02144857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5894926|NCT02144857|Dermatologic Agents|dermatologic agents|mesh-ancestor
5894927|NCT02144857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5894928|NCT02144857|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5894929|NCT02144857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5894930|NCT02144857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5894931|NCT02144857|Analgesics|analgesics|mesh-ancestor
5894932|NCT02144857|Sensory System Agents|sensory system agents|mesh-ancestor
5894933|NCT02144857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5894934|NCT02144857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5894935|NCT02144857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5894936|NCT02144857|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5894937|NCT02144857|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5629863|NCT04742075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629864|NCT04742075|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5629865|NCT04742075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5629866|NCT04742075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629867|NCT04739371|Insulin|insulin|mesh-list
5629868|NCT04739371|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5629869|NCT04739371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5629870|NCT04739371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629871|NCT04729595|Tempol|tempol|mesh-list
5629872|NCT04729595|Antioxidants|antioxidants|mesh-ancestor
5629873|NCT04729595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894938|NCT02133872|Minocycline|minocycline|mesh-list
5755547|NCT03006874|Esomeprazole|esomeprazole|mesh-list
5755548|NCT03006874|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5755549|NCT03006874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5755550|NCT03006874|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5755551|NCT03006874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5755552|NCT03006874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5755553|NCT03006965|Factor VIII|factor viii|mesh-list
5755554|NCT03006965|BAX 855|bax 855|mesh-list
5755555|NCT03006965|Coagulants|coagulants|mesh-ancestor
5755556|NCT03007004|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
5755557|NCT03007004|Botulinum Toxins|botulinum toxins|mesh-list
5755558|NCT03007004|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5755559|NCT03007004|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5755560|NCT03007004|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5755561|NCT03007004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5755562|NCT03007004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5755563|NCT03007004|Cholinergic Agents|cholinergic agents|mesh-ancestor
5755564|NCT03007004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5755565|NCT03007004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5755566|NCT03007004|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5755567|NCT03007004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5755568|NCT03007004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5755569|NCT03007121|Sufentanil|sufentanil|mesh-list
5755570|NCT03007121|Morphine|morphine|mesh-list
5755571|NCT03007121|Dsuvia|dsuvia|mesh-list
5755572|NCT03007121|Bupivacaine|bupivacaine|mesh-list
5755573|NCT03007121|Anesthetics, Local|anesthetics, local|mesh-ancestor
5755574|NCT03007121|Anesthetics|anesthetics|mesh-ancestor
5629874|NCT04729595|Protective Agents|protective agents|mesh-ancestor
5629875|NCT04729595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629876|NCT04729595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5629877|NCT04729595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5629878|NCT04729595|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5629879|NCT04729595|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5755575|NCT03007121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5755576|NCT03007121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5755577|NCT03007121|Sensory System Agents|sensory system agents|mesh-ancestor
5755578|NCT03007121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5755579|NCT03007121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5755580|NCT03007121|Narcotics|narcotics|mesh-ancestor
5755581|NCT03007121|Analgesics|analgesics|mesh-ancestor
5755582|NCT03007121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5755583|NCT03007121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5755584|NCT03007121|Anesthetics, General|anesthetics, general|mesh-ancestor
5755585|NCT03006835|Clopidogrel|clopidogrel|mesh-list
5755586|NCT03006835|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5755587|NCT03006835|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5755588|NCT03006835|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5755589|NCT03006835|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5755590|NCT03006835|Purinergic Agents|purinergic agents|mesh-ancestor
5755591|NCT03006835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5755592|NCT03006835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5755593|NCT03006835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5755594|NCT03006809|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5755595|NCT03006809|Metronidazole|metronidazole|mesh-list
5755596|NCT03006809|Vancomycin|vancomycin|mesh-list
5755597|NCT03006809|Neomycin|neomycin|mesh-list
5755598|NCT03006809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5755599|NCT03006809|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5755600|NCT03006809|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5629880|NCT04725994|Irinotecan|irinotecan|mesh-list
5629881|NCT04725994|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5629882|NCT04725994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5629883|NCT04725994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5629884|NCT04725994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629885|NCT04725994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5629886|NCT04716699|Lidocaine|lidocaine|mesh-list
5629887|NCT04716699|Anesthetics, Local|anesthetics, local|mesh-ancestor
5629888|NCT04716699|Anesthetics|anesthetics|mesh-ancestor
5629889|NCT04716699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5629890|NCT04716699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629891|NCT04716699|Sensory System Agents|sensory system agents|mesh-ancestor
5629892|NCT04716699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5629893|NCT04716699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5755601|NCT03006809|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5755602|NCT03006809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5894939|NCT02133872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5755603|NCT03006809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629894|NCT04716699|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5629895|NCT04716699|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5629896|NCT04716699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5629897|NCT04716699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629898|NCT04712942|Azacitidine|azacitidine|mesh-list
5629899|NCT04712942|Pevonedistat|pevonedistat|mesh-list
5755604|NCT03006952|Losartan|losartan|mesh-list
5755605|NCT03006952|Pentoxifylline|pentoxifylline|mesh-list
6673123|NCT01560663|Tubulin Modulators|tubulin modulators|mesh-ancestor
6673124|NCT01560663|Antimitotic Agents|antimitotic agents|mesh-ancestor
6673125|NCT01560663|Mitosis Modulators|mitosis modulators|mesh-ancestor
6673126|NCT01560663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673127|NCT01560689|Budesonide|budesonide|mesh-list
6673128|NCT01560689|Formoterol Fumarate|formoterol fumarate|mesh-list
6673129|NCT01560689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6673130|NCT01560689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6673131|NCT01560689|Autonomic Agents|autonomic agents|mesh-ancestor
6208916|NCT02139046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6208917|NCT02139046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5629900|NCT04712942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5629901|NCT04712942|Antimetabolites|antimetabolites|mesh-ancestor
5629902|NCT04712942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629903|NCT04712942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6208918|NCT02139046|Analgesics|analgesics|mesh-ancestor
6208919|NCT02139046|Sensory System Agents|sensory system agents|mesh-ancestor
6673132|NCT01560689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6673133|NCT01560689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673134|NCT01560689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6673135|NCT01560689|Respiratory System Agents|respiratory system agents|mesh-ancestor
6673136|NCT01560689|Glucocorticoids|glucocorticoids|mesh-ancestor
6673137|NCT01560689|Hormones|hormones|mesh-ancestor
6673138|NCT01560689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6673139|NCT01560689|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6673140|NCT01560689|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6673141|NCT01560689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6673142|NCT01560689|Adrenergic Agents|adrenergic agents|mesh-ancestor
6673143|NCT01560689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6673144|NCT01560689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629904|NCT04712942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5629905|NCT04708145|Aflibercept|aflibercept|mesh-list
5629906|NCT04708145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5629907|NCT04708145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5629908|NCT04708145|Growth Substances|growth substances|mesh-ancestor
5629909|NCT04708145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629910|NCT04708145|Growth Inhibitors|growth inhibitors|mesh-ancestor
5629911|NCT04708145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5629912|NCT04688177|Nicotine|nicotine|mesh-list
5629913|NCT04688177|Carbon Monoxide|carbon monoxide|mesh-list
5629914|NCT04688177|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5629915|NCT04688177|Autonomic Agents|autonomic agents|mesh-ancestor
5629916|NCT04688177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5629917|NCT04688177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629918|NCT04688177|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5629919|NCT04688177|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5629920|NCT04688177|Cholinergic Agents|cholinergic agents|mesh-ancestor
5629921|NCT04688177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5629922|NCT04688177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629923|NCT04688177|Antimetabolites|antimetabolites|mesh-ancestor
5629924|NCT04688177|Gasotransmitters|gasotransmitters|mesh-ancestor
5629925|NCT04685590|Dasatinib|dasatinib|mesh-list
5629926|NCT04685590|Quercetin|quercetin|mesh-list
5629927|NCT04685590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5629928|NCT04685590|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5629929|NCT04685590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5629930|NCT04685590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629931|NCT04685590|Antioxidants|antioxidants|mesh-ancestor
5629932|NCT04685590|Protective Agents|protective agents|mesh-ancestor
5629933|NCT04685590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629934|NCT04680910|Propofol|propofol|mesh-list
5629935|NCT04680910|Anesthetics|anesthetics|mesh-list
5629936|NCT04680910|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5629937|NCT04680910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5629938|NCT04680910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629939|NCT04680910|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5629940|NCT04680910|Anesthetics, General|anesthetics, general|mesh-ancestor
5629941|NCT04671810|Eculizumab|eculizumab|mesh-list
5629942|NCT04671810|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5629943|NCT04671810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5629944|NCT04671810|Immunologic Factors|immunologic factors|mesh-ancestor
5629945|NCT04671810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629946|NCT04671615|Palbociclib|palbociclib|mesh-list
5629947|NCT04671615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5629948|NCT04671615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5629949|NCT04671615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6489819|NCT00593658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6489820|NCT00593658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489821|NCT00593658|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6489822|NCT00593658|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6489823|NCT00593658|Protective Agents|protective agents|mesh-ancestor
6489824|NCT00593658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489825|NCT00593658|Vasodilator Agents|vasodilator agents|mesh-ancestor
6489826|NCT00593658|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6489827|NCT00593658|Antioxidants|antioxidants|mesh-ancestor
6489828|NCT00593697|Docetaxel|docetaxel|mesh-list
6489829|NCT00593697|Trastuzumab|trastuzumab|mesh-list
6489830|NCT00593697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6489831|NCT00593697|Tubulin Modulators|tubulin modulators|mesh-ancestor
6489832|NCT00593697|Antimitotic Agents|antimitotic agents|mesh-ancestor
6489833|NCT00593697|Mitosis Modulators|mitosis modulators|mesh-ancestor
6489834|NCT00593697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489835|NCT00593697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6673145|NCT01560702|Epinephrine|epinephrine|mesh-list
6673146|NCT01560702|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6673147|NCT01560702|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5629950|NCT04671615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629951|NCT04668365|Prednisone|prednisone|mesh-list
5629952|NCT04668365|Cyclophosphamide|cyclophosphamide|mesh-list
5629953|NCT04668365|Rituximab|rituximab|mesh-list
5629954|NCT04668365|Vincristine|vincristine|mesh-list
5629955|NCT04668365|Epirubicin|epirubicin|mesh-list
5629956|NCT04668365|Zanubrutinib|zanubrutinib|mesh-list
5629957|NCT04668365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5629958|NCT04668365|Immunologic Factors|immunologic factors|mesh-ancestor
5629959|NCT04668365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629960|NCT04668365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5629961|NCT04668365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5629962|NCT04668365|Alkylating Agents|alkylating agents|mesh-ancestor
5629963|NCT04668365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629964|NCT04668365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5629965|NCT04668365|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5629966|NCT04668365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5629967|NCT04668365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5629968|NCT04668365|Glucocorticoids|glucocorticoids|mesh-ancestor
5629969|NCT04668365|Hormones|hormones|mesh-ancestor
5629970|NCT04668365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5629971|NCT04668365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5629972|NCT04668365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5629973|NCT04668365|Tubulin Modulators|tubulin modulators|mesh-ancestor
5629974|NCT04668365|Antimitotic Agents|antimitotic agents|mesh-ancestor
6673148|NCT01560702|Adrenergic Agents|adrenergic agents|mesh-ancestor
6673149|NCT01560702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6673150|NCT01560702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673151|NCT01560702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673152|NCT01560702|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6673153|NCT01560702|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6673154|NCT01560702|Autonomic Agents|autonomic agents|mesh-ancestor
6673155|NCT01560702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6673156|NCT01560702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6673157|NCT01560702|Respiratory System Agents|respiratory system agents|mesh-ancestor
6673158|NCT01560702|Mydriatics|mydriatics|mesh-ancestor
5755606|NCT03006952|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5755607|NCT03006952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5755608|NCT03006952|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5755609|NCT03006952|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5629975|NCT04668365|Mitosis Modulators|mitosis modulators|mesh-ancestor
5755610|NCT03006952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629976|NCT04668365|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5629977|NCT04668365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5629978|NCT04668365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5629979|NCT04668365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5629980|NCT04668365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5629981|NCT04667039|Ranibizumab|ranibizumab|mesh-list
5629982|NCT04667039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5629983|NCT04667039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5629984|NCT04667039|Growth Substances|growth substances|mesh-ancestor
5629985|NCT04667039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629986|NCT04667039|Growth Inhibitors|growth inhibitors|mesh-ancestor
5629987|NCT04667039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5629988|NCT04642820|Methamphetamine|methamphetamine|mesh-list
5755611|NCT03006952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5755612|NCT03006952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5755613|NCT03006952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5755614|NCT03006952|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5755615|NCT03006952|Protective Agents|protective agents|mesh-ancestor
5755616|NCT03006952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5755617|NCT03006952|Vasodilator Agents|vasodilator agents|mesh-ancestor
5755618|NCT03006952|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5755619|NCT03006952|Antioxidants|antioxidants|mesh-ancestor
5755620|NCT03006757|Titanium dioxide|titanium dioxide|mesh-list
5755621|NCT03006757|Sunscreening Agents|sunscreening agents|mesh-ancestor
5755622|NCT03006757|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5755623|NCT03006757|Protective Agents|protective agents|mesh-ancestor
5755624|NCT03006757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5755625|NCT03006757|Dermatologic Agents|dermatologic agents|mesh-ancestor
5755626|NCT03006757|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5755627|NCT03006679|Meropenem|meropenem|mesh-list
5755628|NCT03006679|Tazobactam|tazobactam|mesh-list
5755629|NCT03006679|Piperacillin|piperacillin|mesh-list
5755630|NCT03006679|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
5755631|NCT03006679|Vaborbactam|vaborbactam|mesh-list
5755632|NCT03006679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5755633|NCT03006679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5755634|NCT03006679|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5755635|NCT03006679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5755636|NCT03006679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5755637|NCT03006614|Gemcitabine|gemcitabine|mesh-list
5755638|NCT03006614|Cisplatin|cisplatin|mesh-list
5755639|NCT03006614|Docetaxel|docetaxel|mesh-list
5755640|NCT03006614|Capecitabine|capecitabine|mesh-list
5755641|NCT03006614|Trastuzumab|trastuzumab|mesh-list
5629989|NCT04642820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5629990|NCT04642820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5629991|NCT04642820|Sympathomimetics|sympathomimetics|mesh-ancestor
5629992|NCT04642820|Autonomic Agents|autonomic agents|mesh-ancestor
5629993|NCT04642820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5629994|NCT04642820|Dopamine Agents|dopamine agents|mesh-ancestor
5629995|NCT04642820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5629996|NCT04642820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5629997|NCT04642820|Adrenergic Agents|adrenergic agents|mesh-ancestor
5629998|NCT04642820|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5629999|NCT04642820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5630000|NCT04642820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5630001|NCT04642820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5630002|NCT04641702|Atropine|atropine|mesh-list
5630003|NCT04641702|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5630004|NCT04641702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5630005|NCT04641702|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5630006|NCT04641702|Autonomic Agents|autonomic agents|mesh-ancestor
5630007|NCT04641702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5630008|NCT04641702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630009|NCT04641702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5630010|NCT04641702|Respiratory System Agents|respiratory system agents|mesh-ancestor
5630011|NCT04641702|Mydriatics|mydriatics|mesh-ancestor
5630012|NCT04641702|Parasympatholytics|parasympatholytics|mesh-ancestor
5630013|NCT04641702|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5630014|NCT04641702|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5755642|NCT03006614|Vinorelbine|vinorelbine|mesh-list
5755643|NCT03006614|Epirubicin|epirubicin|mesh-list
5755644|NCT03006614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5755645|NCT03006614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5755646|NCT03006614|Antimetabolites|antimetabolites|mesh-ancestor
5755647|NCT03006614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5755648|NCT03006614|Antiviral Agents|antiviral agents|mesh-ancestor
5755649|NCT03006614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5755650|NCT03006614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5755651|NCT03006614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5755652|NCT03006614|Immunologic Factors|immunologic factors|mesh-ancestor
5755653|NCT03006614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630015|NCT04641702|Cholinergic Agents|cholinergic agents|mesh-ancestor
5630016|NCT04641702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5630017|NCT04641702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630018|NCT04635735|Ipilimumab|ipilimumab|mesh-list
5630019|NCT04635735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5755654|NCT03006614|Tubulin Modulators|tubulin modulators|mesh-ancestor
5755655|NCT03006614|Antimitotic Agents|antimitotic agents|mesh-ancestor
5755656|NCT03006614|Mitosis Modulators|mitosis modulators|mesh-ancestor
5755657|NCT03006614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5755658|NCT03006614|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5755659|NCT03006614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5755660|NCT03006614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5755661|NCT03006614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5755662|NCT03006380|Oxytocin|oxytocin|mesh-list
5755663|NCT03006380|Oxytocics|oxytocics|mesh-ancestor
5755664|NCT03006380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5755665|NCT03006380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5755666|NCT03006445|Dotinurad|dotinurad|mesh-list
5755667|NCT03006445|Uricosuric Agents|uricosuric agents|mesh-ancestor
5630020|NCT04635735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5630021|NCT04635735|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5630022|NCT04635735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630023|NCT04632069|Acetylcysteine|acetylcysteine|mesh-list
5630024|NCT04632069|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5630025|NCT04632069|Antiviral Agents|antiviral agents|mesh-ancestor
5630026|NCT04632069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5630027|NCT04632069|Expectorants|expectorants|mesh-ancestor
5630028|NCT04632069|Respiratory System Agents|respiratory system agents|mesh-ancestor
5630029|NCT04632069|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5630030|NCT04632069|Antioxidants|antioxidants|mesh-ancestor
5630031|NCT04632069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630032|NCT04632069|Protective Agents|protective agents|mesh-ancestor
5630033|NCT04632069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630034|NCT04632069|Antidotes|antidotes|mesh-ancestor
5630035|NCT04629378|Amoxicillin|amoxicillin|mesh-list
5630036|NCT04629378|Meropenem|meropenem|mesh-list
5630037|NCT04629378|Clavulanic Acid|clavulanic acid|mesh-list
5630038|NCT04629378|Clavulanic Acids|clavulanic acids|mesh-list
5630039|NCT04629378|Pyrazinamide|pyrazinamide|mesh-list
5630040|NCT04629378|Bedaquiline|bedaquiline|mesh-list
5630041|NCT04629378|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5630042|NCT04629378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5630043|NCT04629378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5630044|NCT04629378|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5630045|NCT04629378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5630046|NCT04629378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630047|NCT04629378|Antitubercular Agents|antitubercular agents|mesh-ancestor
5630048|NCT04628572|Ceftazidime|ceftazidime|mesh-list
5630049|NCT04628572|Avibactam|avibactam|mesh-list
5630050|NCT04628572|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
5630051|NCT04628572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5755668|NCT03006445|Gout Suppressants|gout suppressants|mesh-ancestor
5755669|NCT03006445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5630052|NCT04628572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5755670|NCT03006445|Renal Agents|renal agents|mesh-ancestor
5755671|NCT03006627|Morphine|morphine|mesh-list
5755672|NCT03006627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5755673|NCT03006627|Narcotics|narcotics|mesh-ancestor
5755674|NCT03006627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5755675|NCT03006627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5755676|NCT03006627|Analgesics|analgesics|mesh-ancestor
5755677|NCT03006627|Sensory System Agents|sensory system agents|mesh-ancestor
5755678|NCT03006627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5755679|NCT03006250|Sevoflurane|sevoflurane|mesh-list
5755680|NCT03006250|Desflurane|desflurane|mesh-list
5755681|NCT03006250|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5755682|NCT03006250|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5755683|NCT03006250|Anesthetics, General|anesthetics, general|mesh-ancestor
5755684|NCT03006250|Anesthetics|anesthetics|mesh-ancestor
5755685|NCT03006250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5755686|NCT03006250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5755687|NCT03006419|Thymoglobulin|thymoglobulin|mesh-list
5755688|NCT03006419|Basiliximab|basiliximab|mesh-list
5755689|NCT03006419|Immunologic Factors|immunologic factors|mesh-ancestor
5755690|NCT03006419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5755691|NCT03006419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5755692|NCT03006705|Capecitabine|capecitabine|mesh-list
5755693|NCT03006705|Tegafur|tegafur|mesh-list
5755694|NCT03006705|Oxaliplatin|oxaliplatin|mesh-list
5755695|NCT03006705|Nivolumab|nivolumab|mesh-list
5755696|NCT03006705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5755697|NCT03006705|Antimetabolites|antimetabolites|mesh-ancestor
5755698|NCT03006705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5755699|NCT03006705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5755700|NCT03006705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5755701|NCT03006705|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5755702|NCT03006432|Leucovorin|leucovorin|mesh-list
5755703|NCT03006432|Folic Acid|folic acid|mesh-list
5755704|NCT03006432|Docetaxel|docetaxel|mesh-list
5755705|NCT03006432|Fluorouracil|fluorouracil|mesh-list
5755706|NCT03006432|Oxaliplatin|oxaliplatin|mesh-list
5755707|NCT03006432|Levoleucovorin|levoleucovorin|mesh-list
5755708|NCT03006432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5755709|NCT03006432|Tubulin Modulators|tubulin modulators|mesh-ancestor
5755710|NCT03006432|Antimitotic Agents|antimitotic agents|mesh-ancestor
5755711|NCT03006432|Mitosis Modulators|mitosis modulators|mesh-ancestor
5630053|NCT04628572|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5630054|NCT04628572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5630055|NCT04628572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630056|NCT04619797|Carboplatin|carboplatin|mesh-list
5630057|NCT04619797|Pembrolizumab|pembrolizumab|mesh-list
5630058|NCT04619797|Pemetrexed|pemetrexed|mesh-list
5630059|NCT04619797|Atezolizumab|atezolizumab|mesh-list
5630060|NCT04619797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5630061|NCT04619797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5630062|NCT04619797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5630063|NCT04619797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630064|NCT04619797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5630065|NCT04619797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5630066|NCT04616183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5630067|NCT04616183|Cetuximab|cetuximab|mesh-list
5755712|NCT03006432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5755713|NCT03006432|Antimetabolites|antimetabolites|mesh-ancestor
5755714|NCT03006432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5755715|NCT03006432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5755716|NCT03006432|Immunologic Factors|immunologic factors|mesh-ancestor
5755717|NCT03006432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5755718|NCT03006432|Antidotes|antidotes|mesh-ancestor
5755719|NCT03006432|Protective Agents|protective agents|mesh-ancestor
5755720|NCT03006432|Vitamin B Complex|vitamin b complex|mesh-ancestor
5630068|NCT04616183|Antibodies|antibodies|mesh-list
5630069|NCT04616183|Immunoglobulins|immunoglobulins|mesh-list
5630070|NCT04616183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5630071|NCT04616183|Immunologic Factors|immunologic factors|mesh-ancestor
5630072|NCT04616183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630073|NCT04616183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5693191|NCT03402295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5693192|NCT03402295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5693193|NCT03402295|Glucocorticoids|glucocorticoids|mesh-ancestor
5693194|NCT03402295|Hormones|hormones|mesh-ancestor
5755721|NCT03006432|Vitamins|vitamins|mesh-ancestor
5755722|NCT03006432|Micronutrients|micronutrients|mesh-ancestor
5755723|NCT03006432|Hematinics|hematinics|mesh-ancestor
5755724|NCT03006211|Nitric Oxide|nitric oxide|mesh-list
5755725|NCT03006211|Nitrous Oxide|nitrous oxide|mesh-list
5755726|NCT03006211|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5755727|NCT03006211|Anesthetics, General|anesthetics, general|mesh-ancestor
5755728|NCT03006211|Anesthetics|anesthetics|mesh-ancestor
5755729|NCT03006211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5755730|NCT03006211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5755731|NCT03006211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5755732|NCT03006211|Analgesics|analgesics|mesh-ancestor
5755733|NCT03006211|Sensory System Agents|sensory system agents|mesh-ancestor
5755734|NCT03006211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5755735|NCT03006211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5693195|NCT03402295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5755736|NCT03006211|Autonomic Agents|autonomic agents|mesh-ancestor
5755737|NCT03006211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5755738|NCT03006211|Respiratory System Agents|respiratory system agents|mesh-ancestor
5755739|NCT03006211|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5755740|NCT03006211|Antioxidants|antioxidants|mesh-ancestor
5755741|NCT03006211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5755742|NCT03006211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5755743|NCT03006211|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5755744|NCT03006211|Vasodilator Agents|vasodilator agents|mesh-ancestor
5755745|NCT03006211|Gasotransmitters|gasotransmitters|mesh-ancestor
5755746|NCT03006211|Protective Agents|protective agents|mesh-ancestor
5755747|NCT03006302|Cyclophosphamide|cyclophosphamide|mesh-list
5755748|NCT03006302|Pembrolizumab|pembrolizumab|mesh-list
5755749|NCT03006302|Immunologic Factors|immunologic factors|mesh-ancestor
5755750|NCT03006302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5755751|NCT03006302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5755752|NCT03006302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5755753|NCT03006302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5755754|NCT03006302|Alkylating Agents|alkylating agents|mesh-ancestor
5755755|NCT03006302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5755756|NCT03006302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5755757|NCT03006302|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5755758|NCT03006302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5755759|NCT03006146|Molgramostim|molgramostim|mesh-list
5755760|NCT03006146|Sargramostim|sargramostim|mesh-list
5755761|NCT03006146|Immunologic Factors|immunologic factors|mesh-ancestor
5755762|NCT03006146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5755763|NCT03006146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5755764|NCT03006003|Alendronate|alendronate|mesh-list
5755765|NCT03006003|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
5755766|NCT03006003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5755767|NCT03006003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5755768|NCT03006003|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5755769|NCT03006003|Hormone Antagonists|hormone antagonists|mesh-ancestor
5755770|NCT03006003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5755771|NCT03006003|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5630074|NCT04608318|Venetoclax|venetoclax|mesh-list
5630075|NCT04608318|Obinutuzumab|obinutuzumab|mesh-list
5630076|NCT04608318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5630077|NCT04608318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5630078|NCT04606446|Letrozole|letrozole|mesh-list
5630079|NCT04606446|Fulvestrant|fulvestrant|mesh-list
5630080|NCT04606446|Palbociclib|palbociclib|mesh-list
5630081|NCT04606446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5630082|NCT04606446|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5630083|NCT04606446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5630084|NCT04606446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5630085|NCT04606446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630086|NCT04606446|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5630087|NCT04606446|Hormone Antagonists|hormone antagonists|mesh-ancestor
5630088|NCT04606446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5630089|NCT04606446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630090|NCT04606446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5630091|NCT04606446|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5630092|NCT04606446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5630093|NCT04606069|Regadenoson|regadenoson|mesh-list
5755772|NCT03006003|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5755773|NCT03006107|Piroxicam|piroxicam|mesh-list
5755774|NCT03006107|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5755775|NCT03006107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5755776|NCT03006107|Analgesics|analgesics|mesh-ancestor
5755777|NCT03006107|Sensory System Agents|sensory system agents|mesh-ancestor
5630094|NCT04606069|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
5630095|NCT04606069|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5630096|NCT04606069|Purinergic Agonists|purinergic agonists|mesh-ancestor
5630097|NCT04606069|Purinergic Agents|purinergic agents|mesh-ancestor
5630098|NCT04606069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5630099|NCT04606069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630100|NCT04606069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630101|NCT04603846|Paclitaxel|paclitaxel|mesh-list
5755778|NCT03006107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5755779|NCT03006107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5755780|NCT03006107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5755781|NCT03006107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5755782|NCT03006107|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5755783|NCT03006107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5755784|NCT03006107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5755785|NCT03006081|Aflibercept|aflibercept|mesh-list
5755786|NCT03006081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5755787|NCT03006081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5755788|NCT03006081|Growth Substances|growth substances|mesh-ancestor
5755789|NCT03006081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5755790|NCT03006081|Growth Inhibitors|growth inhibitors|mesh-ancestor
5755791|NCT03006081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5755792|NCT03005860|Fentanyl|fentanyl|mesh-list
5755793|NCT03005860|Propofol|propofol|mesh-list
5755794|NCT03005860|Sevoflurane|sevoflurane|mesh-list
5755795|NCT03005860|Atracurium|atracurium|mesh-list
5755796|NCT03005860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5755797|NCT03005860|Narcotics|narcotics|mesh-ancestor
5755798|NCT03005860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5755799|NCT03005860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5755800|NCT03005860|Analgesics|analgesics|mesh-ancestor
5755801|NCT03005860|Sensory System Agents|sensory system agents|mesh-ancestor
5755802|NCT03005860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5630102|NCT04603846|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5630103|NCT04603846|Antibodies|antibodies|mesh-list
5630104|NCT04603846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5630105|NCT04603846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5630106|NCT04603846|Tubulin Modulators|tubulin modulators|mesh-ancestor
5630107|NCT04603846|Antimitotic Agents|antimitotic agents|mesh-ancestor
5630108|NCT04603846|Mitosis Modulators|mitosis modulators|mesh-ancestor
5630109|NCT04603846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630110|NCT04603846|Immunologic Factors|immunologic factors|mesh-ancestor
5630111|NCT04603846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630112|NCT04603742|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5630113|NCT04603742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5630114|NCT04591353|Lidocaine|lidocaine|mesh-list
5630115|NCT04591353|Anesthetics, Local|anesthetics, local|mesh-ancestor
5630116|NCT04591353|Anesthetics|anesthetics|mesh-ancestor
5755803|NCT03005860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5755804|NCT03005860|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5755805|NCT03005860|Anesthetics, General|anesthetics, general|mesh-ancestor
5755806|NCT03005860|Anesthetics|anesthetics|mesh-ancestor
5630117|NCT04591353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5630118|NCT04591353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630119|NCT04591353|Sensory System Agents|sensory system agents|mesh-ancestor
5755807|NCT03005860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5755808|NCT03005860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5755809|NCT03005860|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5755810|NCT03005860|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5755811|NCT03005860|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5755812|NCT03005860|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5755813|NCT03005860|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
5755814|NCT03005860|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5755815|NCT03005860|Cholinergic Agents|cholinergic agents|mesh-ancestor
5755816|NCT03005860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5755817|NCT03005860|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5755818|NCT03006042|Bupivacaine|bupivacaine|mesh-list
5755819|NCT03006042|Anesthetics, Local|anesthetics, local|mesh-ancestor
5755820|NCT03006042|Anesthetics|anesthetics|mesh-ancestor
5755821|NCT03006042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5755822|NCT03006042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5755823|NCT03006042|Sensory System Agents|sensory system agents|mesh-ancestor
5755824|NCT03006042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5755825|NCT03005639|Vemurafenib|vemurafenib|mesh-list
5755826|NCT03005639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5755827|NCT03005639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5630120|NCT04591353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5630121|NCT04591353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5630122|NCT04591353|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5630123|NCT04591353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5630124|NCT04591353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5630125|NCT04591353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630126|NCT04589663|Mometasone Furoate|mometasone furoate|mesh-list
5630127|NCT04589663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5630128|NCT04589663|Dermatologic Agents|dermatologic agents|mesh-ancestor
5630129|NCT04589663|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5630130|NCT04581395|Rocuronium|rocuronium|mesh-list
5630131|NCT04581395|Succinylcholine|succinylcholine|mesh-list
5630132|NCT04581395|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5630133|NCT04581395|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5630134|NCT04581395|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5630135|NCT04581395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5630136|NCT04581395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630137|NCT04581395|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
5630138|NCT04578756|Cariprazine|cariprazine|mesh-list
5630139|NCT04578756|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5630140|NCT04578756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5630141|NCT04578756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5630142|NCT04578756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630143|NCT04578756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5630144|NCT04578106|Trastuzumab|trastuzumab|mesh-list
5630145|NCT04578106|Pertuzumab|pertuzumab|mesh-list
5630146|NCT04578106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5630147|NCT04578106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5630148|NCT04568902|Histamine Antagonists|histamine antagonists|mesh-list
5630149|NCT04568902|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
5630150|NCT04568902|Histamine Agents|histamine agents|mesh-ancestor
5630151|NCT04568902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5630152|NCT04568902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630153|NCT04568902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630154|NCT04566692|Immunoglobulins|immunoglobulins|mesh-list
5630155|NCT04566692|gamma-Globulins|gamma-globulins|mesh-list
5630156|NCT04566692|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5630157|NCT04566692|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5630158|NCT04566692|Immunologic Factors|immunologic factors|mesh-ancestor
5630159|NCT04566692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630160|NCT04565236|Factor VIII|factor viii|mesh-list
5630161|NCT04565236|Coagulants|coagulants|mesh-ancestor
5630162|NCT04553367|Meropenem|meropenem|mesh-list
5630163|NCT04553367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5630164|NCT04553367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5630165|NCT04549376|Iodine|iodine|mesh-list
5630166|NCT04549376|Cadexomer iodine|cadexomer iodine|mesh-list
5630167|NCT04549376|Povidone-Iodine|povidone-iodine|mesh-list
5630168|NCT04549376|Povidone|povidone|mesh-list
5630169|NCT04549376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5630170|NCT04549376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5630171|NCT04549376|Trace Elements|trace elements|mesh-ancestor
5630172|NCT04549376|Micronutrients|micronutrients|mesh-ancestor
5630173|NCT04549376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5755828|NCT03005639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5755829|NCT03005639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5755830|NCT03005496|Vitamin D|vitamin d|mesh-list
5755831|NCT03005496|Cholecalciferol|cholecalciferol|mesh-list
5755832|NCT03005496|Beta Carotene|beta carotene|mesh-list
5630174|NCT04549376|Plasma Substitutes|plasma substitutes|mesh-ancestor
5630175|NCT04549376|Blood Substitutes|blood substitutes|mesh-ancestor
5630176|NCT04546399|Calcium, Dietary|calcium, dietary|mesh-list
5630177|NCT04546399|Leucovorin|leucovorin|mesh-list
5630178|NCT04546399|Folic Acid|folic acid|mesh-list
5630179|NCT04546399|Cytarabine|cytarabine|mesh-list
5630180|NCT04546399|Dexamethasone|dexamethasone|mesh-list
5630181|NCT04546399|Dexamethasone acetate|dexamethasone acetate|mesh-list
5630182|NCT04546399|Hydrocortisone|hydrocortisone|mesh-list
5630183|NCT04546399|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
5755833|NCT03005496|Zinc|zinc|mesh-list
5755834|NCT03005496|Dexamethasone|dexamethasone|mesh-list
5755835|NCT03005496|Dexamethasone acetate|dexamethasone acetate|mesh-list
5755836|NCT03005496|Nifedipine|nifedipine|mesh-list
5755837|NCT03005496|BB 1101|bb 1101|mesh-list
5755838|NCT03005496|Carotenoids|carotenoids|mesh-list
5755839|NCT03005496|Picolinic acid|picolinic acid|mesh-list
5755840|NCT03005496|Vitamins|vitamins|mesh-ancestor
5755841|NCT03005496|Micronutrients|micronutrients|mesh-ancestor
5630184|NCT04546399|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
5630185|NCT04546399|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
5630186|NCT04546399|Cyclophosphamide|cyclophosphamide|mesh-list
5630187|NCT04546399|Methotrexate|methotrexate|mesh-list
5630188|NCT04546399|Nivolumab|nivolumab|mesh-list
5630189|NCT04546399|Etoposide|etoposide|mesh-list
5630190|NCT04546399|Vincristine|vincristine|mesh-list
5630191|NCT04546399|Etoposide phosphate|etoposide phosphate|mesh-list
5630192|NCT04546399|Asparaginase|asparaginase|mesh-list
5630193|NCT04546399|Mercaptopurine|mercaptopurine|mesh-list
5630194|NCT04546399|Podophyllotoxin|podophyllotoxin|mesh-list
5630195|NCT04546399|Pegaspargase|pegaspargase|mesh-list
5630196|NCT04546399|Thioguanine|thioguanine|mesh-list
5630197|NCT04546399|Blinatumomab|blinatumomab|mesh-list
5630198|NCT04546399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5630199|NCT04546399|Muromonab-CD3|muromonab-cd3|mesh-list
5630200|NCT04546399|Antibodies|antibodies|mesh-list
5630201|NCT04546399|Immunoglobulins|immunoglobulins|mesh-list
5630202|NCT04546399|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5630203|NCT04546399|Antibodies, Bispecific|antibodies, bispecific|mesh-list
5630204|NCT04546399|BB 1101|bb 1101|mesh-list
5630205|NCT04546399|Calcium|calcium|mesh-list
5630206|NCT04546399|2-Aminopurine|2-aminopurine|mesh-list
5755842|NCT03005496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630207|NCT04546399|Levoleucovorin|levoleucovorin|mesh-list
5630208|NCT04546399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5630209|NCT04546399|Immunologic Factors|immunologic factors|mesh-ancestor
5630210|NCT04546399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630211|NCT04546399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5630212|NCT04546399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5755843|NCT03005496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5755844|NCT03005496|Antiemetics|antiemetics|mesh-ancestor
5755845|NCT03005496|Autonomic Agents|autonomic agents|mesh-ancestor
5630213|NCT04546399|Alkylating Agents|alkylating agents|mesh-ancestor
5630214|NCT04546399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630215|NCT04546399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5630216|NCT04546399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5630217|NCT04546399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5630218|NCT04546399|Antiemetics|antiemetics|mesh-ancestor
5630219|NCT04546399|Autonomic Agents|autonomic agents|mesh-ancestor
5630220|NCT04546399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5630221|NCT04546399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5630222|NCT04546399|Glucocorticoids|glucocorticoids|mesh-ancestor
5630223|NCT04546399|Hormones|hormones|mesh-ancestor
5630224|NCT04546399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5630225|NCT04546399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5630226|NCT04546399|Protease Inhibitors|protease inhibitors|mesh-ancestor
5630227|NCT04546399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5630228|NCT04546399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5630229|NCT04546399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5630230|NCT04546399|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5630231|NCT04546399|Abortifacient Agents|abortifacient agents|mesh-ancestor
5630232|NCT04546399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5630233|NCT04546399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5630234|NCT04546399|Antimetabolites|antimetabolites|mesh-ancestor
5630235|NCT04546399|Dermatologic Agents|dermatologic agents|mesh-ancestor
5630236|NCT04546399|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5630237|NCT04546399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5630238|NCT04546399|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5630239|NCT04546399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5630240|NCT04546399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5630241|NCT04546399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5630242|NCT04546399|Antiviral Agents|antiviral agents|mesh-ancestor
5630243|NCT04546399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5755846|NCT03005496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5755847|NCT03005496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5755848|NCT03005496|Glucocorticoids|glucocorticoids|mesh-ancestor
5755849|NCT03005496|Hormones|hormones|mesh-ancestor
5755850|NCT03005496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5755851|NCT03005496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5755852|NCT03005496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5755853|NCT03005496|Protease Inhibitors|protease inhibitors|mesh-ancestor
5755854|NCT03005496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5755855|NCT03005496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5755856|NCT03005496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5755857|NCT03005496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5755858|NCT03005496|Trace Elements|trace elements|mesh-ancestor
5755859|NCT03005496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5755860|NCT03005496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5755861|NCT03005496|Vasodilator Agents|vasodilator agents|mesh-ancestor
5755862|NCT03005496|Tocolytic Agents|tocolytic agents|mesh-ancestor
5755863|NCT03005496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5755864|NCT03005496|Antioxidants|antioxidants|mesh-ancestor
5755865|NCT03005496|Protective Agents|protective agents|mesh-ancestor
5755866|NCT03005496|Provitamins|provitamins|mesh-ancestor
5755867|NCT03005496|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5755868|NCT03005496|Chelating Agents|chelating agents|mesh-ancestor
5755869|NCT03005496|Sequestering Agents|sequestering agents|mesh-ancestor
5755870|NCT03005808|Ropivacaine|ropivacaine|mesh-list
5755871|NCT03005808|Anesthetics, Local|anesthetics, local|mesh-ancestor
5755872|NCT03005808|Anesthetics|anesthetics|mesh-ancestor
5755873|NCT03005808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5630244|NCT04546399|Antidotes|antidotes|mesh-ancestor
5755874|NCT03005808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5755875|NCT03005808|Sensory System Agents|sensory system agents|mesh-ancestor
5755876|NCT03005808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5755877|NCT03005665|Acetazolamide|acetazolamide|mesh-list
5755878|NCT03005665|Anticonvulsants|anticonvulsants|mesh-ancestor
5755879|NCT03005665|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5755880|NCT03005665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5755881|NCT03005665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5755882|NCT03005665|Diuretics|diuretics|mesh-ancestor
5755883|NCT03005665|Natriuretic Agents|natriuretic agents|mesh-ancestor
5630245|NCT04546399|Protective Agents|protective agents|mesh-ancestor
5630246|NCT04546399|Vitamin B Complex|vitamin b complex|mesh-ancestor
5630247|NCT04546399|Vitamins|vitamins|mesh-ancestor
5630248|NCT04546399|Micronutrients|micronutrients|mesh-ancestor
5630249|NCT04546399|Tubulin Modulators|tubulin modulators|mesh-ancestor
5630250|NCT04546399|Antimitotic Agents|antimitotic agents|mesh-ancestor
5630251|NCT04546399|Mitosis Modulators|mitosis modulators|mesh-ancestor
5630252|NCT04546399|Hematinics|hematinics|mesh-ancestor
5630253|NCT04546399|Keratolytic Agents|keratolytic agents|mesh-ancestor
5630254|NCT04545151|Verapamil|verapamil|mesh-list
5630255|NCT04545151|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5630256|NCT04545151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5630257|NCT04545151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5630258|NCT04545151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630259|NCT04545151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5630260|NCT04545151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630261|NCT04545151|Vasodilator Agents|vasodilator agents|mesh-ancestor
5630262|NCT04537598|Morphine|morphine|mesh-list
5630263|NCT04537598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5630264|NCT04537598|Narcotics|narcotics|mesh-ancestor
5630265|NCT04537598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5630266|NCT04537598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630267|NCT04537598|Analgesics|analgesics|mesh-ancestor
5630268|NCT04537598|Sensory System Agents|sensory system agents|mesh-ancestor
5630269|NCT04537598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5630270|NCT04534205|Pembrolizumab|pembrolizumab|mesh-list
5630271|NCT04534205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5755884|NCT03005665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5755885|NCT03005405|Methamphetamine|methamphetamine|mesh-list
5755886|NCT03005405|Fluorides|fluorides|mesh-list
5630272|NCT04534205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5630273|NCT04528134|Listerine|listerine|mesh-list
5630274|NCT04528134|Fluorides|fluorides|mesh-list
5755887|NCT03005405|Cariostatic Agents|cariostatic agents|mesh-ancestor
5755888|NCT03005405|Protective Agents|protective agents|mesh-ancestor
5755889|NCT03005405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5755890|NCT03005405|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5755891|NCT03005405|Sympathomimetics|sympathomimetics|mesh-ancestor
5755892|NCT03005405|Autonomic Agents|autonomic agents|mesh-ancestor
5755893|NCT03005405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5755894|NCT03005405|Dopamine Agents|dopamine agents|mesh-ancestor
5755895|NCT03005405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5755896|NCT03005405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630275|NCT04528134|Sodium Fluoride|sodium fluoride|mesh-list
5630276|NCT04528134|Fluorides, Topical|fluorides, topical|mesh-list
5630277|NCT04528134|Cariostatic Agents|cariostatic agents|mesh-ancestor
5755897|NCT03005405|Adrenergic Agents|adrenergic agents|mesh-ancestor
5755898|NCT03005405|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5755899|NCT03005405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5755900|NCT03005405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5755901|NCT03005405|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5755902|NCT03005444|Enoxaparin|enoxaparin|mesh-list
5755903|NCT03005444|Nadroparin|nadroparin|mesh-list
5755904|NCT03005444|Rivaroxaban|rivaroxaban|mesh-list
5755905|NCT03005444|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5755906|NCT03005444|Antithrombins|antithrombins|mesh-ancestor
5755907|NCT03005444|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5755908|NCT03005444|Protease Inhibitors|protease inhibitors|mesh-ancestor
5755909|NCT03005444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5755910|NCT03005444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5755911|NCT03005444|Anticoagulants|anticoagulants|mesh-ancestor
5755912|NCT03005444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5755913|NCT03005444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5755914|NCT03005704|Aspirin|aspirin|mesh-list
5755915|NCT03005704|Ticagrelor|ticagrelor|mesh-list
5755916|NCT03005704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5755917|NCT03005704|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5755918|NCT03005704|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5755919|NCT03005704|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5755920|NCT03005704|Purinergic Agents|purinergic agents|mesh-ancestor
5755921|NCT03005704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5755922|NCT03005704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5755923|NCT03005704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630278|NCT04528134|Protective Agents|protective agents|mesh-ancestor
5630279|NCT04528134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630280|NCT04528134|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5630281|NCT04528134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5630282|NCT04518501|Arsenic Trioxide|arsenic trioxide|mesh-list
5630283|NCT04518501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5630284|NCT04518046|Nivolumab|nivolumab|mesh-list
5630285|NCT04518046|Ipilimumab|ipilimumab|mesh-list
5630286|NCT04518046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5630287|NCT04518046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5630288|NCT04518046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5630289|NCT04518046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630290|NCT04502381|Amphotericin B|amphotericin b|mesh-list
5630291|NCT04502381|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
5630292|NCT04502381|Deoxycholic Acid|deoxycholic acid|mesh-list
5755924|NCT03005704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5755925|NCT03005704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5755926|NCT03005704|Analgesics|analgesics|mesh-ancestor
5755927|NCT03005704|Sensory System Agents|sensory system agents|mesh-ancestor
5755928|NCT03005704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5755929|NCT03005704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5755930|NCT03005704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5755931|NCT03005704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5755932|NCT03005704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5755933|NCT03005704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5755934|NCT03005704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5755935|NCT03005704|Antipyretics|antipyretics|mesh-ancestor
5894940|NCT02133872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5630293|NCT04502381|Amebicides|amebicides|mesh-ancestor
5630294|NCT04502381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5630295|NCT04502381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5630296|NCT04502381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5630297|NCT04502381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5630298|NCT04502381|Antifungal Agents|antifungal agents|mesh-ancestor
5630299|NCT04502381|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5630300|NCT04502381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5894941|NCT02117297|Gemtuzumab|gemtuzumab|mesh-list
5894942|NCT02117297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5894943|NCT02117297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5894944|NCT01462578|Azacitidine|azacitidine|mesh-list
5894945|NCT01462578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5894946|NCT01462578|Antimetabolites|antimetabolites|mesh-ancestor
5894947|NCT01462578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894948|NCT01462578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5894949|NCT01462578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5894950|NCT01219075|Phytoestrogens|phytoestrogens|mesh-list
5894951|NCT01219075|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
5894952|NCT01219075|Estrogens|estrogens|mesh-ancestor
5894953|NCT01219075|Hormones|hormones|mesh-ancestor
5894954|NCT01219075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5894955|NCT01219075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894956|NCT00876031|Etoposide|etoposide|mesh-list
5894957|NCT00876031|Idarubicin|idarubicin|mesh-list
5894958|NCT00876031|Trofosfamide|trofosfamide|mesh-list
5894959|NCT00876031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5894960|NCT00876031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5894961|NCT00876031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5894962|NCT00876031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5894963|NCT00876031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5894964|NCT00876031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894965|NCT00876031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5894966|NCT00876031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5894967|NCT00876031|Immunologic Factors|immunologic factors|mesh-ancestor
5894968|NCT00876031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894969|NCT00876031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5894970|NCT00876031|Alkylating Agents|alkylating agents|mesh-ancestor
5894971|NCT05122494|Capecitabine|capecitabine|mesh-list
5894972|NCT05122494|Lapatinib|lapatinib|mesh-list
5894973|NCT05122494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5894974|NCT05122494|Antimetabolites|antimetabolites|mesh-ancestor
5894975|NCT05122494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894976|NCT05122494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5894977|NCT05122494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5894978|NCT05122494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5894979|NCT05122481|Ascorbic Acid|ascorbic acid|mesh-list
5894980|NCT05122481|Vitamins|vitamins|mesh-ancestor
5894981|NCT05122481|Micronutrients|micronutrients|mesh-ancestor
5894982|NCT05122481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5894983|NCT05122481|Antioxidants|antioxidants|mesh-ancestor
5894984|NCT05122481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894985|NCT05122481|Protective Agents|protective agents|mesh-ancestor
5894986|NCT05122455|Edoxaban|edoxaban|mesh-list
5894987|NCT05122455|Clopidogrel|clopidogrel|mesh-list
5894988|NCT05122455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5894989|NCT05122455|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5894990|NCT05122455|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5894991|NCT05122455|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5894992|NCT05122455|Purinergic Agents|purinergic agents|mesh-ancestor
5894993|NCT05122455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5894994|NCT05122455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894995|NCT05122455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630301|NCT04485559|Everolimus|everolimus|mesh-list
5755936|NCT03005717|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5755937|NCT03005717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5755938|NCT03005717|Autonomic Agents|autonomic agents|mesh-ancestor
5755939|NCT03005717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5630302|NCT04485559|Trametinib|trametinib|mesh-list
5630303|NCT04485559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5630304|NCT04485559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5630305|NCT04485559|Immunologic Factors|immunologic factors|mesh-ancestor
5630306|NCT04485559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630307|NCT04485559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5630308|NCT04485559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5630309|NCT04485559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630310|NCT04472182|Calcium|calcium|mesh-list
5755940|NCT03005717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5755941|NCT03005717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5755942|NCT03005717|Respiratory System Agents|respiratory system agents|mesh-ancestor
5755943|NCT03005717|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5755944|NCT03005717|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5755945|NCT03005717|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5755946|NCT03005717|Adrenergic Agents|adrenergic agents|mesh-ancestor
5755947|NCT03005717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5755948|NCT03005717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5755949|NCT03005678|Denosumab|denosumab|mesh-list
5755950|NCT03005678|Alendronate|alendronate|mesh-list
5755951|NCT03005678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5755952|NCT03005678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5755953|NCT03005548|Morphine|morphine|mesh-list
5755954|NCT03005548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5755955|NCT03005548|Narcotics|narcotics|mesh-ancestor
5755956|NCT03005548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5755957|NCT03005548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5755958|NCT03005548|Analgesics|analgesics|mesh-ancestor
5755959|NCT03005548|Sensory System Agents|sensory system agents|mesh-ancestor
5755960|NCT03005548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5755961|NCT03005483|Gabapentin|gabapentin|mesh-list
5755962|NCT03005483|Analgesics|analgesics|mesh-ancestor
5755963|NCT03005483|Sensory System Agents|sensory system agents|mesh-ancestor
5755964|NCT03005483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5755965|NCT03005483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5755966|NCT03005483|Anticonvulsants|anticonvulsants|mesh-ancestor
6489836|NCT00593710|Losartan|losartan|mesh-list
5755967|NCT03005483|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5755968|NCT03005483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5755969|NCT03005483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5755970|NCT03005483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5755971|NCT03005483|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5755972|NCT03005483|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5755973|NCT03005483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5755974|NCT03005483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5755975|NCT03005483|Antimanic Agents|antimanic agents|mesh-ancestor
5755976|NCT03005782|Cemiplimab|cemiplimab|mesh-list
5755977|NCT03005782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5755978|NCT03005782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5755979|NCT03005522|Dexamethasone|dexamethasone|mesh-list
5755980|NCT03005522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5755981|NCT03005522|Antiemetics|antiemetics|mesh-ancestor
5755982|NCT03005522|Autonomic Agents|autonomic agents|mesh-ancestor
5755983|NCT03005522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5755984|NCT03005522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630311|NCT04472182|Fluorides|fluorides|mesh-list
5630312|NCT04472182|Fluorides, Topical|fluorides, topical|mesh-list
5630313|NCT04472182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5630314|NCT04472182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630315|NCT04472182|Cariostatic Agents|cariostatic agents|mesh-ancestor
5755985|NCT03005522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5755986|NCT03005522|Glucocorticoids|glucocorticoids|mesh-ancestor
5755987|NCT03005522|Hormones|hormones|mesh-ancestor
5755988|NCT03005522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5755989|NCT03005522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5755990|NCT03005522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5755991|NCT03005210|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
5755992|NCT03005210|Antiviral Agents|antiviral agents|mesh-ancestor
5755993|NCT03005210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5755994|NCT03005353|Clotrimazole|clotrimazole|mesh-list
5755995|NCT03005353|Miconazole|miconazole|mesh-list
5755996|NCT03005353|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5755997|NCT03005353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5755998|NCT03005353|Antifungal Agents|antifungal agents|mesh-ancestor
5755999|NCT03005353|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5630316|NCT04472182|Protective Agents|protective agents|mesh-ancestor
5630317|NCT04467905|Etripamil|etripamil|mesh-list
5630318|NCT04467905|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5630319|NCT04467905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5630320|NCT04467905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630321|NCT04467905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5630322|NCT04467905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630323|NCT04462965|Temozolomide|temozolomide|mesh-list
6489837|NCT00593710|Atenolol|atenolol|mesh-list
6489838|NCT00593710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6489839|NCT00593710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6489840|NCT00593710|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6489841|NCT00593710|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6489842|NCT00593710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489843|NCT00593710|Sympatholytics|sympatholytics|mesh-ancestor
6489844|NCT00593710|Autonomic Agents|autonomic agents|mesh-ancestor
6489845|NCT00593710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6489846|NCT00593710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489847|NCT00593710|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6489848|NCT00593710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6489849|NCT00593710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6489850|NCT00593710|Adrenergic Agents|adrenergic agents|mesh-ancestor
6489851|NCT00593710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6489852|NCT00593801|Epoetin Alfa|epoetin alfa|mesh-list
6489853|NCT00593801|Hematinics|hematinics|mesh-ancestor
5756000|NCT03005353|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5756001|NCT03005353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5756002|NCT03005353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5756003|NCT03005353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5756004|NCT03005353|Hormone Antagonists|hormone antagonists|mesh-ancestor
5756005|NCT03005353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5756006|NCT03005353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756007|NCT03005353|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5756008|NCT03005353|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5756009|NCT03005015|Doxorubicin|doxorubicin|mesh-list
5756010|NCT03005015|Lenvatinib|lenvatinib|mesh-list
5756011|NCT03005015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5756012|NCT03005015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5756013|NCT03005015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5756014|NCT03005015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5756015|NCT03005015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5756016|NCT03005015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5756017|NCT03005015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5756018|NCT03005340|Cholecalciferol|cholecalciferol|mesh-list
5630324|NCT04462965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5630325|NCT04462965|Alkylating Agents|alkylating agents|mesh-ancestor
5630326|NCT04462965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630327|NCT04462965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5630328|NCT04430738|Leucovorin|leucovorin|mesh-list
5630329|NCT04430738|Fluorouracil|fluorouracil|mesh-list
5630330|NCT04430738|Capecitabine|capecitabine|mesh-list
5630331|NCT04430738|Pembrolizumab|pembrolizumab|mesh-list
5630332|NCT04430738|Oxaliplatin|oxaliplatin|mesh-list
5630333|NCT04430738|Trastuzumab|trastuzumab|mesh-list
5630334|NCT04430738|Tucatinib|tucatinib|mesh-list
5630335|NCT04430738|Antimetabolites|antimetabolites|mesh-ancestor
5630336|NCT04430738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630337|NCT04430738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5630338|NCT04430738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5630339|NCT04430738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5630340|NCT04430738|Immunologic Factors|immunologic factors|mesh-ancestor
5630341|NCT04430738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630342|NCT04430738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5630343|NCT04430738|Antidotes|antidotes|mesh-ancestor
5630344|NCT04430738|Protective Agents|protective agents|mesh-ancestor
5630345|NCT04430738|Vitamin B Complex|vitamin b complex|mesh-ancestor
5630346|NCT04430738|Vitamins|vitamins|mesh-ancestor
5630347|NCT04430738|Micronutrients|micronutrients|mesh-ancestor
5630348|NCT04430738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5630349|NCT04430738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5630350|NCT04423744|Moxifloxacin|moxifloxacin|mesh-list
5630351|NCT04423744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5630352|NCT04423744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5630353|NCT04423744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5756019|NCT03005340|Bazedoxifene|bazedoxifene|mesh-list
5756020|NCT03005340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6489854|NCT00593853|Methylphenidate|methylphenidate|mesh-list
6489855|NCT00593853|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6489856|NCT00593853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489857|NCT00593853|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6489858|NCT00593853|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5630354|NCT04423744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5630355|NCT04423744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5756021|NCT03005340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756022|NCT03005340|Vitamins|vitamins|mesh-ancestor
5756023|NCT03005340|Micronutrients|micronutrients|mesh-ancestor
5756024|NCT03005340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5756025|NCT03005340|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5756026|NCT03005340|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5756027|NCT03005340|Hormone Antagonists|hormone antagonists|mesh-ancestor
5756028|NCT03005340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5756029|NCT03005171|Lidocaine|lidocaine|mesh-list
5756030|NCT03005171|Bupivacaine|bupivacaine|mesh-list
5756031|NCT03005171|Anesthetics, Local|anesthetics, local|mesh-ancestor
5756032|NCT03005171|Anesthetics|anesthetics|mesh-ancestor
5756033|NCT03005171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5756034|NCT03005171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756035|NCT03005171|Sensory System Agents|sensory system agents|mesh-ancestor
5756036|NCT03005171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5756037|NCT03005171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6208920|NCT02139046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6489859|NCT00593853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6489860|NCT00593853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489861|NCT00593853|Dopamine Agents|dopamine agents|mesh-ancestor
6489862|NCT00593853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6489863|NCT00593879|Mecamylamine|mecamylamine|mesh-list
6489864|NCT00593879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6489865|NCT00593879|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
6489866|NCT00593879|Autonomic Agents|autonomic agents|mesh-ancestor
6208921|NCT02139046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208922|NCT02139046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6208923|NCT02139046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6208924|NCT02139046|Gout Suppressants|gout suppressants|mesh-ancestor
5630356|NCT04423744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630357|NCT04423744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5630358|NCT04423029|Nivolumab|nivolumab|mesh-list
5630359|NCT04423029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6208925|NCT02139046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6208926|NCT02139046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6208927|NCT02139046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208928|NCT02139046|Tubulin Modulators|tubulin modulators|mesh-ancestor
6489867|NCT00593879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5630360|NCT04423029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5630361|NCT04423029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5630362|NCT04423029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630363|NCT04413617|Tofacitinib|tofacitinib|mesh-list
5630364|NCT04413617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5630365|NCT04413617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5630366|NCT04413617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630367|NCT04413123|Nivolumab|nivolumab|mesh-list
5630368|NCT04413123|Ipilimumab|ipilimumab|mesh-list
5630369|NCT04413123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5630370|NCT04413123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5630371|NCT04413123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5756038|NCT03005171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5756039|NCT03005171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5756040|NCT03005171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5756041|NCT03005171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5756042|NCT03005366|Flecainide|flecainide|mesh-list
5756043|NCT03005366|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5756044|NCT03005366|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5756045|NCT03005366|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5756046|NCT03005366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5756047|NCT03005366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5756048|NCT03005184|Icatibant|icatibant|mesh-list
5756049|NCT03005184|Valsartan|valsartan|mesh-list
5756050|NCT03005184|Enalapril|enalapril|mesh-list
5756051|NCT03005184|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5756052|NCT03005184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5630372|NCT04413123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630373|NCT04409509|Antibodies|antibodies|mesh-list
5630374|NCT04409509|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5630375|NCT04409509|Immunologic Factors|immunologic factors|mesh-ancestor
5630376|NCT04409509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693196|NCT03402295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5693197|NCT03402295|Leprostatic Agents|leprostatic agents|mesh-ancestor
5693198|NCT03402295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5756053|NCT03005184|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5756054|NCT03005184|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5756055|NCT03005184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5894996|NCT05122455|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6208929|NCT02139046|Antimitotic Agents|antimitotic agents|mesh-ancestor
6208930|NCT02139046|Mitosis Modulators|mitosis modulators|mesh-ancestor
5693199|NCT03402295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5693200|NCT03402295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5693201|NCT03402295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5693202|NCT03402295|Growth Substances|growth substances|mesh-ancestor
5693203|NCT03402295|Growth Inhibitors|growth inhibitors|mesh-ancestor
5693204|NCT03402204|Ubenimex|ubenimex|mesh-list
5693205|NCT03402204|Simvastatin|simvastatin|mesh-list
5693206|NCT03402204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5693207|NCT03402204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5693208|NCT03402204|Antimetabolites|antimetabolites|mesh-ancestor
5630377|NCT04401865|Riboflavin|riboflavin|mesh-list
5630378|NCT04401865|Vitamin B Complex|vitamin b complex|mesh-ancestor
5630379|NCT04401865|Vitamins|vitamins|mesh-ancestor
5630380|NCT04401865|Micronutrients|micronutrients|mesh-ancestor
5630381|NCT04401865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630382|NCT04401865|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5630383|NCT04401865|Dermatologic Agents|dermatologic agents|mesh-ancestor
5630384|NCT04401150|Ascorbic Acid|ascorbic acid|mesh-list
5630385|NCT04401150|Vitamins|vitamins|mesh-ancestor
5630386|NCT04401150|Micronutrients|micronutrients|mesh-ancestor
5630387|NCT04401150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630388|NCT04401150|Antioxidants|antioxidants|mesh-ancestor
5630389|NCT04401150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630390|NCT04401150|Protective Agents|protective agents|mesh-ancestor
5630391|NCT04388852|Ipilimumab|ipilimumab|mesh-list
5630392|NCT04388852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5630393|NCT04388852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5630394|NCT04388852|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5630395|NCT04388852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630396|NCT04386811|Calcitriol|calcitriol|mesh-list
6208931|NCT02139046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6208932|NCT02139046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6208933|NCT02139046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5630397|NCT04386811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5630398|NCT04386811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630399|NCT04386811|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6208934|NCT02139046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5756056|NCT03005184|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5756057|NCT03005184|Protease Inhibitors|protease inhibitors|mesh-ancestor
5756058|NCT03005184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5756059|NCT03005184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5756060|NCT03005184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5756061|NCT03005184|Analgesics|analgesics|mesh-ancestor
5756062|NCT03005184|Sensory System Agents|sensory system agents|mesh-ancestor
5756063|NCT03005184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5756064|NCT03005184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756065|NCT03005184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5756066|NCT03005184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5756067|NCT03005184|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
5756068|NCT03005184|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
5756069|NCT03005184|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5756070|NCT03005184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5756071|NCT03005184|Immunologic Factors|immunologic factors|mesh-ancestor
5756072|NCT03005002|Durvalumab|durvalumab|mesh-list
5756073|NCT03005002|Ipilimumab|ipilimumab|mesh-list
5756074|NCT03005002|Tremelimumab|tremelimumab|mesh-list
5756075|NCT03005002|Immunoglobulins|immunoglobulins|mesh-list
5756076|NCT03005002|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5630400|NCT04386811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5630401|NCT04386811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630402|NCT04386811|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5630403|NCT04386811|Vitamins|vitamins|mesh-ancestor
5630404|NCT04386811|Micronutrients|micronutrients|mesh-ancestor
5630405|NCT04386811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5630406|NCT04381143|Aspirin|aspirin|mesh-list
5630407|NCT04381143|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5630408|NCT04381143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5756077|NCT03005002|Immunoglobulin G|immunoglobulin g|mesh-list
6208935|NCT02139280|Cyclophosphamide|cyclophosphamide|mesh-list
6208936|NCT02139280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6208937|NCT02139280|Immunologic Factors|immunologic factors|mesh-ancestor
6208938|NCT02139280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208939|NCT02139280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6208940|NCT02139280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6208941|NCT02139280|Alkylating Agents|alkylating agents|mesh-ancestor
6212579|NCT02189889|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5756078|NCT03005002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5756079|NCT03005002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5756080|NCT03005002|Immunologic Factors|immunologic factors|mesh-ancestor
5756081|NCT03005002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756082|NCT03005002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5756083|NCT03005002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5756084|NCT03004833|Nivolumab|nivolumab|mesh-list
5756085|NCT03004833|Doxorubicin|doxorubicin|mesh-list
5630409|NCT04381143|Analgesics|analgesics|mesh-ancestor
5630410|NCT04381143|Sensory System Agents|sensory system agents|mesh-ancestor
5630411|NCT04381143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5630412|NCT04381143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630413|NCT04381143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5630414|NCT04381143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5630415|NCT04381143|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5630416|NCT04381143|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5630417|NCT04381143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630418|NCT04381143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5630419|NCT04381143|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5630420|NCT04381143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5630421|NCT04381143|Antipyretics|antipyretics|mesh-ancestor
5630422|NCT04369014|Anesthetics|anesthetics|mesh-list
5630423|NCT04369014|Propofol|propofol|mesh-list
5630424|NCT04369014|Etomidate|etomidate|mesh-list
5630425|NCT04369014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5630426|NCT04369014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630427|NCT04369014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5630428|NCT04369014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5630429|NCT04369014|Anesthetics, General|anesthetics, general|mesh-ancestor
5630430|NCT04358133|Morphine|morphine|mesh-list
5630431|NCT04358133|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5630432|NCT04358133|Narcotics|narcotics|mesh-ancestor
5630433|NCT04358133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5630434|NCT04358133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630435|NCT04358133|Analgesics|analgesics|mesh-ancestor
5630436|NCT04358133|Sensory System Agents|sensory system agents|mesh-ancestor
5630437|NCT04358133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5630438|NCT04349371|Chloroquine|chloroquine|mesh-list
5630439|NCT04349371|Amebicides|amebicides|mesh-ancestor
5630440|NCT04349371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5756086|NCT03004833|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5756087|NCT03004833|Dacarbazine|dacarbazine|mesh-list
5756088|NCT03004833|Vinblastine|vinblastine|mesh-list
5756089|NCT03004833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5756090|NCT03004833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5630441|NCT04349371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5630442|NCT04349371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5630443|NCT04349371|Antimalarials|antimalarials|mesh-ancestor
5630444|NCT04349371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5630445|NCT04332211|Pseudoephedrine|pseudoephedrine|mesh-list
5630446|NCT04332211|Ephedrine|ephedrine|mesh-list
5630447|NCT04332211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5630448|NCT04332211|Autonomic Agents|autonomic agents|mesh-ancestor
5756091|NCT03004833|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5756092|NCT03004833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5756093|NCT03004833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5756094|NCT03004833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5756095|NCT03004833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5756096|NCT03004833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5756097|NCT03004833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5756098|NCT03004833|Alkylating Agents|alkylating agents|mesh-ancestor
5756099|NCT03004833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5756100|NCT03004833|Tubulin Modulators|tubulin modulators|mesh-ancestor
5756101|NCT03004833|Antimitotic Agents|antimitotic agents|mesh-ancestor
5756102|NCT03004833|Mitosis Modulators|mitosis modulators|mesh-ancestor
5630449|NCT04332211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5630450|NCT04332211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630451|NCT04332211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5630452|NCT04332211|Respiratory System Agents|respiratory system agents|mesh-ancestor
5630453|NCT04332211|Nasal Decongestants|nasal decongestants|mesh-ancestor
5630454|NCT04332211|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5630455|NCT04332211|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5630456|NCT04332211|Sympathomimetics|sympathomimetics|mesh-ancestor
5630457|NCT04332211|Adrenergic Agents|adrenergic agents|mesh-ancestor
5630458|NCT04332211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5630459|NCT04332211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630460|NCT04309773|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
5630461|NCT04309773|Bezafibrate|bezafibrate|mesh-list
5756103|NCT03004768|BMS-986165|bms-986165|mesh-list
5756104|NCT03004768|Dermatologic Agents|dermatologic agents|mesh-ancestor
5756105|NCT03004768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5756106|NCT03004768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5756107|NCT03004768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5756108|NCT03005236|Tacrolimus|tacrolimus|mesh-list
5756109|NCT03005236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5756110|NCT03005236|Immunologic Factors|immunologic factors|mesh-ancestor
5630462|NCT04309773|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5630463|NCT04309773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5630464|NCT04309773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5630465|NCT04309773|Antimetabolites|antimetabolites|mesh-ancestor
5630466|NCT04309773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630467|NCT04309773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5630468|NCT04299867|Metronidazole|metronidazole|mesh-list
5630469|NCT04299867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5630470|NCT04299867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5630471|NCT04299867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5756111|NCT03005236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756112|NCT03005236|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5756113|NCT03005236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5756114|NCT03005236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5756115|NCT03005145|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5756116|NCT03005145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5756117|NCT03005145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5630472|NCT04299867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5630473|NCT04294628|Trastuzumab|trastuzumab|mesh-list
5630474|NCT04294628|Camptothecin|camptothecin|mesh-list
5630475|NCT04294628|Immunoconjugates|immunoconjugates|mesh-list
5630476|NCT04294628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5630477|NCT04294628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5630478|NCT04294628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5630479|NCT04294628|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5630480|NCT04294628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5630481|NCT04294628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5630482|NCT04294628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630483|NCT04294628|Immunologic Factors|immunologic factors|mesh-ancestor
5630484|NCT04294628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630485|NCT04294459|Acetaminophen|acetaminophen|mesh-list
5630486|NCT04294459|Diphenhydramine|diphenhydramine|mesh-list
5630487|NCT04294459|Promethazine|promethazine|mesh-list
5630488|NCT04294459|Methylprednisolone|methylprednisolone|mesh-list
5630489|NCT04294459|Ranitidine|ranitidine|mesh-list
5630490|NCT04294459|Montelukast|montelukast|mesh-list
5630491|NCT04294459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5630492|NCT04294459|Analgesics|analgesics|mesh-ancestor
5630493|NCT04294459|Sensory System Agents|sensory system agents|mesh-ancestor
5630494|NCT04294459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5630495|NCT04294459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630496|NCT04294459|Antipyretics|antipyretics|mesh-ancestor
5630497|NCT04294459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5630498|NCT04294459|Antiemetics|antiemetics|mesh-ancestor
5630499|NCT04294459|Autonomic Agents|autonomic agents|mesh-ancestor
5630500|NCT04294459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5630501|NCT04294459|Glucocorticoids|glucocorticoids|mesh-ancestor
5630502|NCT04294459|Hormones|hormones|mesh-ancestor
5630503|NCT04294459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5630504|NCT04294459|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5630505|NCT04294459|Protective Agents|protective agents|mesh-ancestor
5630506|NCT04294459|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5630507|NCT04294459|Respiratory System Agents|respiratory system agents|mesh-ancestor
5630508|NCT04294459|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5630509|NCT04294459|Hormone Antagonists|hormone antagonists|mesh-ancestor
5630510|NCT04294459|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5630511|NCT04294459|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5630512|NCT04294459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5756118|NCT03005145|Antitubercular Agents|antitubercular agents|mesh-ancestor
5756119|NCT03004625|Ribavirin|ribavirin|mesh-list
5756120|NCT03004625|Asunaprevir|asunaprevir|mesh-list
5756121|NCT03004625|Antimetabolites|antimetabolites|mesh-ancestor
5756122|NCT03004625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5756123|NCT03004625|Antiviral Agents|antiviral agents|mesh-ancestor
5756124|NCT03004625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5756125|NCT03004625|Protease Inhibitors|protease inhibitors|mesh-ancestor
5756126|NCT03004625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5756127|NCT03004612|Metformin|metformin|mesh-list
5756128|NCT03004612|Linagliptin|linagliptin|mesh-list
5756129|NCT03004612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5756130|NCT03004612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756131|NCT03004612|Incretins|incretins|mesh-ancestor
5756132|NCT03004612|Hormones|hormones|mesh-ancestor
5756133|NCT03004612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5756134|NCT03004612|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5756135|NCT03004612|Protease Inhibitors|protease inhibitors|mesh-ancestor
5630513|NCT04294459|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5630514|NCT04294459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5630515|NCT04294459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5630516|NCT04294459|Anesthetics, Local|anesthetics, local|mesh-ancestor
5630517|NCT04294459|Anesthetics|anesthetics|mesh-ancestor
5630518|NCT04294459|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5630519|NCT04294459|Histamine Antagonists|histamine antagonists|mesh-ancestor
5630520|NCT04294459|Histamine Agents|histamine agents|mesh-ancestor
5756136|NCT03004612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5756137|NCT03004612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5756138|NCT03004521|Quetiapine Fumarate|quetiapine fumarate|mesh-list
5756139|NCT03004521|Antidepressive Agents|antidepressive agents|mesh-ancestor
5756140|NCT03004521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5756141|NCT03004521|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5756142|NCT03004521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5756143|NCT03004521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5756144|NCT03004521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756145|NCT03004183|Valacyclovir|valacyclovir|mesh-list
5630521|NCT04294459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5630522|NCT04294459|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5630523|NCT04294459|Antipruritics|antipruritics|mesh-ancestor
5630524|NCT04294459|Dermatologic Agents|dermatologic agents|mesh-ancestor
5630525|NCT04294459|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5630526|NCT04294459|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5630527|NCT04291885|Avelumab|avelumab|mesh-list
5630528|NCT04291885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5630529|NCT04291885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5630530|NCT04289779|Atezolizumab|atezolizumab|mesh-list
5630531|NCT04289779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5630532|NCT04286867|Ethanol|ethanol|mesh-list
5630533|NCT04286867|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5630534|NCT04286867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5630535|NCT04286867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5630536|NCT04286867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630537|NCT04284657|Citric Acid|citric acid|mesh-list
5630538|NCT04284657|Sodium Citrate|sodium citrate|mesh-list
5630539|NCT04284657|Pravastatin|pravastatin|mesh-list
5630540|NCT04284657|Anticoagulants|anticoagulants|mesh-ancestor
5630541|NCT04284657|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5630542|NCT04284657|Chelating Agents|chelating agents|mesh-ancestor
5630543|NCT04284657|Sequestering Agents|sequestering agents|mesh-ancestor
5630544|NCT04284657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630545|NCT04284657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5630546|NCT04284657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5630547|NCT04284657|Antimetabolites|antimetabolites|mesh-ancestor
5630548|NCT04284657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5630549|NCT04284657|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5630550|NCT04284657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5630551|NCT04263831|Aldesleukin|aldesleukin|mesh-list
5630552|NCT04263831|Interleukin-2|interleukin-2|mesh-list
5630553|NCT04263831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5630554|NCT04263831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5630555|NCT04263831|Analgesics|analgesics|mesh-ancestor
5630556|NCT04263831|Sensory System Agents|sensory system agents|mesh-ancestor
5630557|NCT04263831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5630558|NCT04263831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630559|NCT04263831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5630560|NCT04263831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5630561|NCT04263831|Antiviral Agents|antiviral agents|mesh-ancestor
5630562|NCT04263831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5630563|NCT04226352|Dextromethorphan|dextromethorphan|mesh-list
5756146|NCT03004183|Pembrolizumab|pembrolizumab|mesh-list
5756147|NCT03004183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5756148|NCT03004183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5756149|NCT03004183|Antiviral Agents|antiviral agents|mesh-ancestor
5756150|NCT03004183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5756151|NCT03004287|Thalidomide|thalidomide|mesh-list
5756152|NCT03004287|Dexamethasone|dexamethasone|mesh-list
5756153|NCT03004287|Cyclophosphamide|cyclophosphamide|mesh-list
5756154|NCT03004287|Melphalan|melphalan|mesh-list
5756155|NCT03004287|Doxorubicin|doxorubicin|mesh-list
5756156|NCT03004287|Etoposide|etoposide|mesh-list
5756157|NCT03004287|Lenalidomide|lenalidomide|mesh-list
5756158|NCT03004287|Bortezomib|bortezomib|mesh-list
5756159|NCT03004287|Daratumumab|daratumumab|mesh-list
5756160|NCT03004287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5756161|NCT03004287|Immunologic Factors|immunologic factors|mesh-ancestor
5756162|NCT03004287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756163|NCT03004287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5756164|NCT03004287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5756165|NCT03004287|Alkylating Agents|alkylating agents|mesh-ancestor
5630564|NCT04226352|Antitussive Agents|antitussive agents|mesh-ancestor
5630565|NCT04226352|Respiratory System Agents|respiratory system agents|mesh-ancestor
5756166|NCT03004287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5756167|NCT03004287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5756168|NCT03004287|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5756169|NCT03004287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5756170|NCT03004287|Antiemetics|antiemetics|mesh-ancestor
5756171|NCT03004287|Autonomic Agents|autonomic agents|mesh-ancestor
5756172|NCT03004287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5756173|NCT03004287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5756174|NCT03004287|Glucocorticoids|glucocorticoids|mesh-ancestor
5756175|NCT03004287|Hormones|hormones|mesh-ancestor
5756176|NCT03004287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5756177|NCT03004287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5756178|NCT03004287|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5756179|NCT03004287|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5756180|NCT03004287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5756181|NCT03004287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5756182|NCT03004287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5756183|NCT03004287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5756184|NCT03004287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5756185|NCT03004287|Growth Substances|growth substances|mesh-ancestor
5756186|NCT03004287|Growth Inhibitors|growth inhibitors|mesh-ancestor
5756187|NCT03004287|Leprostatic Agents|leprostatic agents|mesh-ancestor
5756188|NCT03004287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5756189|NCT03004287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5756190|NCT03004105|Durvalumab|durvalumab|mesh-list
5756191|NCT03004105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5756192|NCT03004105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5756193|NCT03004339|Betamethasone|betamethasone|mesh-list
5756194|NCT03004339|Betamethasone Valerate|betamethasone valerate|mesh-list
5630566|NCT04226352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5630567|NCT04226352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5630568|NCT04226352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5630569|NCT04226352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630570|NCT04226352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630571|NCT04222816|Lithium Carbonate|lithium carbonate|mesh-list
5756195|NCT03004339|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5756196|NCT03004339|Betamethasone benzoate|betamethasone benzoate|mesh-list
5630572|NCT04222816|Antidepressive Agents|antidepressive agents|mesh-ancestor
5630573|NCT04222816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5630574|NCT04222816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5630575|NCT04222816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630576|NCT04222816|Antimanic Agents|antimanic agents|mesh-ancestor
5630577|NCT04222816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5630578|NCT04222816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5630579|NCT04222816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630580|NCT04216316|Gemcitabine|gemcitabine|mesh-list
5630581|NCT04216316|Carboplatin|carboplatin|mesh-list
6208942|NCT02139280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630582|NCT04216316|Pembrolizumab|pembrolizumab|mesh-list
5630583|NCT04216316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5630584|NCT04216316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5630585|NCT04216316|Antimetabolites|antimetabolites|mesh-ancestor
5630586|NCT04216316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630587|NCT04216316|Antiviral Agents|antiviral agents|mesh-ancestor
5630588|NCT04216316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5630589|NCT04216316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5630590|NCT04216316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5630591|NCT04216316|Immunologic Factors|immunologic factors|mesh-ancestor
5630592|NCT04216316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630593|NCT04216316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5756197|NCT03004339|Calcipotriene|calcipotriene|mesh-list
5756198|NCT03004339|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
5756199|NCT03004339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5756200|NCT03004339|Glucocorticoids|glucocorticoids|mesh-ancestor
5756201|NCT03004339|Hormones|hormones|mesh-ancestor
5756202|NCT03004339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5894997|NCT05122455|Antithrombins|antithrombins|mesh-ancestor
6208943|NCT02139280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6208944|NCT02139280|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6208945|NCT02139358|Gemcitabine|gemcitabine|mesh-list
6208946|NCT02139358|Trastuzumab|trastuzumab|mesh-list
6208947|NCT02139358|Pertuzumab|pertuzumab|mesh-list
6212580|NCT02189941|Deferiprone|deferiprone|mesh-list
5630594|NCT04185311|Nivolumab|nivolumab|mesh-list
5630595|NCT04185311|Ipilimumab|ipilimumab|mesh-list
5630596|NCT04185311|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
6208948|NCT02139358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6208949|NCT02139358|Antimetabolites|antimetabolites|mesh-ancestor
6208950|NCT02139358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208951|NCT02139358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6208952|NCT02139358|Antiviral Agents|antiviral agents|mesh-ancestor
6208953|NCT02139358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6208954|NCT02139358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6208955|NCT02139358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6208956|NCT02139358|Immunologic Factors|immunologic factors|mesh-ancestor
5756203|NCT03004339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756204|NCT03004339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6208957|NCT02139358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756205|NCT03004339|Respiratory System Agents|respiratory system agents|mesh-ancestor
6208958|NCT02139358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6208959|NCT02139540|Nitrous Oxide|nitrous oxide|mesh-list
6208960|NCT02139540|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6208961|NCT02139540|Anesthetics, General|anesthetics, general|mesh-ancestor
6208962|NCT02139540|Anesthetics|anesthetics|mesh-ancestor
6208963|NCT02139540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6208964|NCT02139540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630597|NCT04185311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5630598|NCT04185311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5630599|NCT04185311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5630600|NCT04185311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630601|NCT04182334|TEMPO|tempo|mesh-list
5630602|NCT04182334|Antioxidants|antioxidants|mesh-ancestor
5630603|NCT04182334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630604|NCT04182334|Protective Agents|protective agents|mesh-ancestor
5630605|NCT04182334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630606|NCT04179968|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5630607|NCT04179968|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5756206|NCT03004339|Dermatologic Agents|dermatologic agents|mesh-ancestor
5756207|NCT03004066|Daptomycin|daptomycin|mesh-list
5756208|NCT03004066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5756209|NCT03004066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5756210|NCT03004118|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
5756211|NCT03004118|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5756212|NCT03004118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5630608|NCT04179968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630609|NCT04161248|Gemcitabine|gemcitabine|mesh-list
5630610|NCT04161248|Dexamethasone|dexamethasone|mesh-list
5756213|NCT03004222|Bupivacaine|bupivacaine|mesh-list
5756214|NCT03004222|Anesthetics, Local|anesthetics, local|mesh-ancestor
5630611|NCT04161248|Rituximab|rituximab|mesh-list
5630612|NCT04161248|Venetoclax|venetoclax|mesh-list
5630613|NCT04161248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5630614|NCT04161248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5630615|NCT04161248|Antiemetics|antiemetics|mesh-ancestor
5630616|NCT04161248|Autonomic Agents|autonomic agents|mesh-ancestor
5630617|NCT04161248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5630618|NCT04161248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756215|NCT03004222|Anesthetics|anesthetics|mesh-ancestor
5756216|NCT03004222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5756217|NCT03004222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756218|NCT03004222|Sensory System Agents|sensory system agents|mesh-ancestor
5756219|NCT03004222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5756220|NCT03004196|Chlorhexidine|chlorhexidine|mesh-list
5756221|NCT03004196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5756222|NCT03004196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5756223|NCT03004196|Disinfectants|disinfectants|mesh-ancestor
5756224|NCT03004209|Epoetin Alfa|epoetin alfa|mesh-list
5756225|NCT03004209|Hematinics|hematinics|mesh-ancestor
6208965|NCT02139540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5756226|NCT03004261|Ganciclovir|ganciclovir|mesh-list
5756227|NCT03004261|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
5630619|NCT04161248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5630620|NCT04161248|Glucocorticoids|glucocorticoids|mesh-ancestor
5630621|NCT04161248|Hormones|hormones|mesh-ancestor
5630622|NCT04161248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5630623|NCT04161248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5630624|NCT04161248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5630625|NCT04161248|Immunologic Factors|immunologic factors|mesh-ancestor
5630626|NCT04161248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5630627|NCT04161248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5630628|NCT04161248|Antimetabolites|antimetabolites|mesh-ancestor
5630629|NCT04161248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630630|NCT04161248|Antiviral Agents|antiviral agents|mesh-ancestor
5630631|NCT04161248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5630632|NCT04161248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5630633|NCT04161248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5630634|NCT04160910|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
5630635|NCT04160910|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5630636|NCT04160910|Antidepressive Agents|antidepressive agents|mesh-ancestor
5630637|NCT04160910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5630638|NCT04155580|Decitabine|decitabine|mesh-list
5630639|NCT04155580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5630640|NCT04155580|Antimetabolites|antimetabolites|mesh-ancestor
5630641|NCT04155580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630642|NCT04155580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5630643|NCT04155580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5630644|NCT04149145|Niraparib|niraparib|mesh-list
5630645|NCT04149145|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5630646|NCT04149145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5630647|NCT04149145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630648|NCT04149145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5630649|NCT04136548|Fentanyl|fentanyl|mesh-list
5630650|NCT04136548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5630651|NCT04136548|Narcotics|narcotics|mesh-ancestor
5630652|NCT04136548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5630653|NCT04136548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630654|NCT04136548|Analgesics|analgesics|mesh-ancestor
5756228|NCT03004261|Foscarnet|foscarnet|mesh-list
5756229|NCT03004261|Antiviral Agents|antiviral agents|mesh-ancestor
5756230|NCT03004261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5756231|NCT03004261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5756232|NCT03004261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5756233|NCT03004261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5756234|NCT03004261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5894998|NCT05122455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5894999|NCT05122455|Protease Inhibitors|protease inhibitors|mesh-ancestor
5895000|NCT05122455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5895001|NCT05122455|Anticoagulants|anticoagulants|mesh-ancestor
5895002|NCT05122377|Goserelin|goserelin|mesh-list
5895003|NCT05122377|Leuprolide|leuprolide|mesh-list
5895004|NCT05122377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5895005|NCT05122377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5895006|NCT05122377|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5895007|NCT05122377|Fertility Agents|fertility agents|mesh-ancestor
5895008|NCT05122377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5895009|NCT05122377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895010|NCT05122351|Acetaminophen|acetaminophen|mesh-list
5895011|NCT05122351|Bupivacaine|bupivacaine|mesh-list
5895012|NCT05122351|Anesthetics, Local|anesthetics, local|mesh-ancestor
5895013|NCT05122351|Anesthetics|anesthetics|mesh-ancestor
5895014|NCT05122351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5895015|NCT05122351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895016|NCT05122351|Sensory System Agents|sensory system agents|mesh-ancestor
5895017|NCT05122351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5895018|NCT05122351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5895019|NCT05122351|Analgesics|analgesics|mesh-ancestor
5895020|NCT05122351|Antipyretics|antipyretics|mesh-ancestor
5895021|NCT05122338|Lidocaine|lidocaine|mesh-list
5895022|NCT05122338|Ropivacaine|ropivacaine|mesh-list
5895023|NCT05122338|Esketamine|esketamine|mesh-list
5630655|NCT04136548|Sensory System Agents|sensory system agents|mesh-ancestor
5630656|NCT04136548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5630657|NCT04136548|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5630658|NCT04136548|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5630659|NCT04136548|Anesthetics, General|anesthetics, general|mesh-ancestor
5630660|NCT04136548|Anesthetics|anesthetics|mesh-ancestor
5630661|NCT04111627|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5630662|NCT04111627|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5630663|NCT04111627|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5630664|NCT04111627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5630665|NCT04111627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895024|NCT05122338|Anesthetics, Local|anesthetics, local|mesh-ancestor
5895025|NCT05122338|Anesthetics|anesthetics|mesh-ancestor
5895026|NCT05122338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5895027|NCT05122338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630666|NCT04111627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5630667|NCT04111627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630668|NCT04111627|Analgesics|analgesics|mesh-ancestor
5630669|NCT04111627|Sensory System Agents|sensory system agents|mesh-ancestor
5630670|NCT04111627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5630671|NCT04111627|Antidepressive Agents|antidepressive agents|mesh-ancestor
5630672|NCT04111627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5630673|NCT04111627|Dopamine Agents|dopamine agents|mesh-ancestor
5630674|NCT04102020|Azacitidine|azacitidine|mesh-list
5630675|NCT04102020|Venetoclax|venetoclax|mesh-list
5630676|NCT04102020|Cc-486|cc-486|mesh-list
5630677|NCT04102020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5630678|NCT04102020|Antimetabolites|antimetabolites|mesh-ancestor
5630679|NCT04102020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630680|NCT04102020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5630681|NCT04102020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5630682|NCT04098393|Fludarabine|fludarabine|mesh-list
5895028|NCT05122338|Sensory System Agents|sensory system agents|mesh-ancestor
5630683|NCT04098393|Melphalan|melphalan|mesh-list
5630684|NCT04098393|Busulfan|busulfan|mesh-list
5630685|NCT04098393|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5630686|NCT04098393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5630687|NCT04098393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5756235|NCT03004014|Propofol|propofol|mesh-list
5756236|NCT03004014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5756237|NCT03004014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5756238|NCT03004014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756239|NCT03004014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5756240|NCT03004014|Anesthetics, General|anesthetics, general|mesh-ancestor
5756241|NCT03004014|Anesthetics|anesthetics|mesh-ancestor
5756242|NCT03004001|Atorvastatin|atorvastatin|mesh-list
5756243|NCT03004001|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5756244|NCT03004001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5756245|NCT03004001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5756246|NCT03004001|Antimetabolites|antimetabolites|mesh-ancestor
5756247|NCT03004001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5756248|NCT03004001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5756249|NCT03004001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5756250|NCT03004001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5756251|NCT03004001|Immunologic Factors|immunologic factors|mesh-ancestor
5756252|NCT03004001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756253|NCT03003884|Propofol|propofol|mesh-list
5756254|NCT03003884|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5756255|NCT03003884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5756256|NCT03003884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756257|NCT03003884|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5756258|NCT03003884|Anesthetics, General|anesthetics, general|mesh-ancestor
5756259|NCT03003884|Anesthetics|anesthetics|mesh-ancestor
5756260|NCT03003832|Analgesics, Opioid|analgesics, opioid|mesh-list
5756261|NCT03003832|Analgesics|analgesics|mesh-list
5756262|NCT03003832|Narcotics|narcotics|mesh-ancestor
5630688|NCT04098393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5630689|NCT04098393|Immunologic Factors|immunologic factors|mesh-ancestor
5630690|NCT04098393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630691|NCT04098393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5630692|NCT04098393|Alkylating Agents|alkylating agents|mesh-ancestor
5630693|NCT04098393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5630694|NCT04087395|Lidocaine|lidocaine|mesh-list
5630695|NCT04087395|Anesthetics|anesthetics|mesh-list
5630696|NCT04087395|Anesthetics, Local|anesthetics, local|mesh-ancestor
5630697|NCT04087395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5630698|NCT04087395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630699|NCT04087395|Sensory System Agents|sensory system agents|mesh-ancestor
5630700|NCT04087395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5630701|NCT04087395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5630702|NCT04087395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5756263|NCT03003832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5756264|NCT03003832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756265|NCT03003832|Sensory System Agents|sensory system agents|mesh-ancestor
5756266|NCT03003832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5756267|NCT03003871|Chlorhexidine|chlorhexidine|mesh-list
5756268|NCT03003871|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5756269|NCT03003871|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5756270|NCT03003871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5756271|NCT03003871|Disinfectants|disinfectants|mesh-ancestor
5756272|NCT03003871|Dermatologic Agents|dermatologic agents|mesh-ancestor
5756273|NCT03003728|Melphalan|melphalan|mesh-list
5756274|NCT03003728|Elotuzumab|elotuzumab|mesh-list
5756275|NCT03003728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5756276|NCT03003728|Alkylating Agents|alkylating agents|mesh-ancestor
5756277|NCT03003728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5756278|NCT03003728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5756279|NCT03003728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5630703|NCT04087395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5630704|NCT04087395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5630705|NCT04087395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630706|NCT04085887|Panitumumab|panitumumab|mesh-list
5630707|NCT04085887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5756280|NCT03003728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5756281|NCT03003728|Immunologic Factors|immunologic factors|mesh-ancestor
5756282|NCT03003728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756283|NCT03003637|Nivolumab|nivolumab|mesh-list
5756284|NCT03003637|Ipilimumab|ipilimumab|mesh-list
5756285|NCT03003637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5756286|NCT03003637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5756287|NCT03003637|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6673159|NCT01560702|Sympathomimetics|sympathomimetics|mesh-ancestor
6673160|NCT01560702|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6673161|NCT01560754|Nicotine|nicotine|mesh-list
5756288|NCT03003637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5756289|NCT03003611|Anesthetics|anesthetics|mesh-list
5756290|NCT03003611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5756291|NCT03003611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756292|NCT03003273|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5756293|NCT03003273|Amoxicillin|amoxicillin|mesh-list
5756294|NCT03003273|Levofloxacin|levofloxacin|mesh-list
5756295|NCT03003273|Ofloxacin|ofloxacin|mesh-list
5756296|NCT03003273|Clavulanic Acids|clavulanic acids|mesh-list
5756297|NCT03003273|Clavulanic Acid|clavulanic acid|mesh-list
5756298|NCT03003273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5756299|NCT03003273|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5756300|NCT03003273|Renal Agents|renal agents|mesh-ancestor
5756301|NCT03003273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5756302|NCT03003273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5756303|NCT03003273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5756304|NCT03003273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5756305|NCT03003273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5756306|NCT03003273|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5756307|NCT03003273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5630708|NCT04085887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5630709|NCT04079712|Nivolumab|nivolumab|mesh-list
5630710|NCT04079712|Ipilimumab|ipilimumab|mesh-list
5630711|NCT04079712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5630712|NCT04079712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5630713|NCT04079712|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5630714|NCT04079712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630715|NCT04074785|Bevacizumab|bevacizumab|mesh-list
5630716|NCT04074785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5630717|NCT04074785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5630718|NCT04074785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5630719|NCT04074785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5630720|NCT04074785|Growth Substances|growth substances|mesh-ancestor
5630721|NCT04074785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630722|NCT04074785|Growth Inhibitors|growth inhibitors|mesh-ancestor
5630723|NCT04069585|Lidocaine|lidocaine|mesh-list
5630724|NCT04069585|Anesthetics|anesthetics|mesh-list
5630725|NCT04069585|Anesthetics, Local|anesthetics, local|mesh-ancestor
5630726|NCT04069585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5630727|NCT04069585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630728|NCT04069585|Sensory System Agents|sensory system agents|mesh-ancestor
5630729|NCT04069585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5630730|NCT04069585|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5630731|NCT04069585|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5630732|NCT04069585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5630733|NCT04069585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5630734|NCT04069585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630735|NCT04060108|Methamphetamine|methamphetamine|mesh-list
5630736|NCT04060108|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5630737|NCT04060108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630738|NCT04060108|Sympathomimetics|sympathomimetics|mesh-ancestor
5630739|NCT04060108|Autonomic Agents|autonomic agents|mesh-ancestor
5630740|NCT04060108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5630741|NCT04060108|Dopamine Agents|dopamine agents|mesh-ancestor
5630742|NCT04060108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5630743|NCT04060108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630744|NCT04060108|Adrenergic Agents|adrenergic agents|mesh-ancestor
5630745|NCT04060108|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5630746|NCT04060108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5756308|NCT03003273|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5756309|NCT03003416|Dexamethasone|dexamethasone|mesh-list
5756310|NCT03003416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5756311|NCT03003416|Antiemetics|antiemetics|mesh-ancestor
5756312|NCT03003416|Autonomic Agents|autonomic agents|mesh-ancestor
5756313|NCT03003416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5756314|NCT03003416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756315|NCT03003416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5756316|NCT03003416|Glucocorticoids|glucocorticoids|mesh-ancestor
5756317|NCT03003416|Hormones|hormones|mesh-ancestor
5756318|NCT03003416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5756319|NCT03003416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5756320|NCT03003416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5756321|NCT03003468|Pembrolizumab|pembrolizumab|mesh-list
5756322|NCT03003468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5756323|NCT03003468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5756324|NCT03003065|Temoporfin|temoporfin|mesh-list
5756325|NCT03003065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5756326|NCT03003065|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5756327|NCT03003065|Dermatologic Agents|dermatologic agents|mesh-ancestor
5756328|NCT03003143|Vigabatrin|vigabatrin|mesh-list
5630747|NCT04060108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5630748|NCT04060108|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5630749|NCT04055753|Doxorubicin|doxorubicin|mesh-list
5630750|NCT04055753|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5630751|NCT04055753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5630752|NCT04055753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5630753|NCT04055753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5630754|NCT04055753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5630755|NCT04055753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630756|NCT04053634|Benralizumab|benralizumab|mesh-list
5630757|NCT04053634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5630758|NCT04053634|Respiratory System Agents|respiratory system agents|mesh-ancestor
6208966|NCT02139540|Analgesics|analgesics|mesh-ancestor
6208967|NCT02139540|Sensory System Agents|sensory system agents|mesh-ancestor
6208968|NCT02139540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6208969|NCT02139592|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6208970|NCT02139592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6208971|NCT02139592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6208972|NCT02139644|Fluticasone|fluticasone|mesh-list
6208973|NCT02139644|Xhance|xhance|mesh-list
5756329|NCT03003143|Anticonvulsants|anticonvulsants|mesh-ancestor
5756330|NCT03003143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5756331|NCT03003143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208974|NCT02139644|Beclomethasone|beclomethasone|mesh-list
6208975|NCT02139644|Albuterol|albuterol|mesh-list
6208976|NCT02139644|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6208977|NCT02139644|Adrenergic Agonists|adrenergic agonists|mesh-list
6208978|NCT02139644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6208979|NCT02139644|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6208980|NCT02139644|Autonomic Agents|autonomic agents|mesh-ancestor
5630774|NCT04029012|Methoxyflurane|methoxyflurane|mesh-list
5630775|NCT04029012|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5630776|NCT04029012|Anesthetics, General|anesthetics, general|mesh-ancestor
5630777|NCT04029012|Anesthetics|anesthetics|mesh-ancestor
5630778|NCT04029012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5630779|NCT04029012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630780|NCT03968653|Carboplatin|carboplatin|mesh-list
5630781|NCT03968653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6208981|NCT02139644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6208982|NCT02139644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6208983|NCT02139644|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5630785|NCT03919773|Immunoglobulins|immunoglobulins|mesh-list
5630786|NCT03919773|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5630787|NCT03919773|gamma-Globulins|gamma-globulins|mesh-list
5630788|NCT03919773|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5630789|NCT03919773|Immunologic Factors|immunologic factors|mesh-ancestor
5630790|NCT03919773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693209|NCT03402204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693210|NCT03402204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5693211|NCT03402204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5693212|NCT03402204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5756332|NCT03003143|GABA Agents|gaba agents|mesh-ancestor
5756333|NCT03003143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5756334|NCT03003143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756335|NCT03003039|Rituximab|rituximab|mesh-list
5756336|NCT03003039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5756337|NCT03003039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5756338|NCT03003039|Immunologic Factors|immunologic factors|mesh-ancestor
5756339|NCT03003039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756340|NCT03003039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5756341|NCT03002844|Gemcitabine|gemcitabine|mesh-list
5756342|NCT03002844|Carboplatin|carboplatin|mesh-list
6208984|NCT02139644|Respiratory System Agents|respiratory system agents|mesh-ancestor
5630791|NCT03911713|Ivacaftor|ivacaftor|mesh-list
5630792|NCT03911713|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
5630793|NCT03911713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5630794|NCT03911713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630795|NCT03852459|Ibuprofen|ibuprofen|mesh-list
5630796|NCT03852459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5630797|NCT03852459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5630798|NCT03852459|Analgesics|analgesics|mesh-ancestor
5630799|NCT03852459|Sensory System Agents|sensory system agents|mesh-ancestor
5630800|NCT03852459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5630801|NCT03852459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630802|NCT03852459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5630803|NCT03852459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5630804|NCT03852459|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5630805|NCT03852459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5630806|NCT03852459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630807|NCT03849768|Gefitinib|gefitinib|mesh-list
5756343|NCT03002844|Pemetrexed|pemetrexed|mesh-list
5756344|NCT03002844|Gefitinib|gefitinib|mesh-list
5756345|NCT03002844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5756346|NCT03002844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5756347|NCT03002844|Antimetabolites|antimetabolites|mesh-ancestor
5756348|NCT03002844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5756349|NCT03002844|Antiviral Agents|antiviral agents|mesh-ancestor
5756350|NCT03002844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5630808|NCT03849768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5630809|NCT03849768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5630810|NCT03849768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5630811|NCT03849768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630812|NCT03828799|Folfirinox|folfirinox|mesh-list
5630813|NCT03828799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5630814|NCT03824808|Lidocaine|lidocaine|mesh-list
5630815|NCT03824808|Anesthetics, Local|anesthetics, local|mesh-ancestor
5630816|NCT03824808|Anesthetics|anesthetics|mesh-ancestor
5630817|NCT03824808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5630818|NCT03824808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630819|NCT03824808|Sensory System Agents|sensory system agents|mesh-ancestor
5630820|NCT03824808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5630821|NCT03824808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5630822|NCT03824808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5630823|NCT03824808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5630824|NCT03824808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5630825|NCT03824808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630826|NCT03824106|Vitamin D|vitamin d|mesh-list
5630827|NCT03824106|Vitamins|vitamins|mesh-ancestor
5630828|NCT03824106|Micronutrients|micronutrients|mesh-ancestor
5630829|NCT03824106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630830|NCT03824106|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5630831|NCT03816332|Prednisone|prednisone|mesh-list
5630832|NCT03816332|Cortisone|cortisone|mesh-list
5630833|NCT03816332|Nivolumab|nivolumab|mesh-list
5630834|NCT03816332|Ipilimumab|ipilimumab|mesh-list
5756351|NCT03002844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5756352|NCT03002844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5756353|NCT03002844|Immunologic Factors|immunologic factors|mesh-ancestor
5756354|NCT03002844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756355|NCT03002844|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5756356|NCT03002844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5756357|NCT03002844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5756358|NCT03002831|Tegafur|tegafur|mesh-list
5756359|NCT03002831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5756360|NCT03002831|Antimetabolites|antimetabolites|mesh-ancestor
5756361|NCT03002831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5756362|NCT03002831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5756363|NCT03002961|Buprenorphine|buprenorphine|mesh-list
5756364|NCT03002961|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
5756365|NCT03002961|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5756366|NCT03002961|Narcotics|narcotics|mesh-ancestor
5756367|NCT03002961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5630835|NCT03816332|Tacrolimus|tacrolimus|mesh-list
5630836|NCT03816332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5630837|NCT03816332|Glucocorticoids|glucocorticoids|mesh-ancestor
5630838|NCT03816332|Hormones|hormones|mesh-ancestor
5630839|NCT03816332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5630840|NCT03816332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630841|NCT03816332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5630842|NCT03816332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5630843|NCT03816332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5630844|NCT03816332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5756368|NCT03002961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756369|NCT03002961|Analgesics|analgesics|mesh-ancestor
5756370|NCT03002961|Sensory System Agents|sensory system agents|mesh-ancestor
5756371|NCT03002961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5756372|NCT03002961|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5630845|NCT03816332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630846|NCT03816332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5630847|NCT03816332|Immunologic Factors|immunologic factors|mesh-ancestor
5630848|NCT03816332|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5630849|NCT03816332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5630850|NCT03808610|Cytarabine|cytarabine|mesh-list
5630851|NCT03808610|6-methoxypurine arabinoside|6-methoxypurine arabinoside|mesh-list
5630852|NCT03808610|Dexamethasone|dexamethasone|mesh-list
5756373|NCT03002805|Doxorubicin|doxorubicin|mesh-list
5756374|NCT03002805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5756375|NCT03002805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5756376|NCT03002805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5756377|NCT03002805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5756378|NCT03002805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5756379|NCT03002805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5756380|NCT03002935|Coenzyme Q10|coenzyme q10|mesh-list
5756381|NCT03002935|Micronutrients|micronutrients|mesh-ancestor
5756382|NCT03002935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756383|NCT03002935|Vitamins|vitamins|mesh-ancestor
5756384|NCT03002792|Anesthetics|anesthetics|mesh-list
5756385|NCT03002792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5756386|NCT03002792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756387|NCT03002675|Exenatide|exenatide|mesh-list
5756388|NCT03002675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5756389|NCT03002675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756390|NCT03002675|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5756391|NCT03002675|Incretins|incretins|mesh-ancestor
5756392|NCT03002675|Hormones|hormones|mesh-ancestor
5756393|NCT03002675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5756394|NCT03002493|Rifampin|rifampin|mesh-list
5756395|NCT03002493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5756396|NCT03002493|Antitubercular Agents|antitubercular agents|mesh-ancestor
5756397|NCT03002493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5756398|NCT03002493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5630853|NCT03808610|Dexamethasone acetate|dexamethasone acetate|mesh-list
5630854|NCT03808610|Prednisone|prednisone|mesh-list
5630855|NCT03808610|Cortisone|cortisone|mesh-list
5630856|NCT03808610|Cyclophosphamide|cyclophosphamide|mesh-list
5630857|NCT03808610|Rituximab|rituximab|mesh-list
5630858|NCT03808610|Methotrexate|methotrexate|mesh-list
5630859|NCT03808610|Vincristine|vincristine|mesh-list
5630860|NCT03808610|Asparaginase|asparaginase|mesh-list
5630861|NCT03808610|Venetoclax|venetoclax|mesh-list
5630862|NCT03808610|Pegaspargase|pegaspargase|mesh-list
5630863|NCT03808610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5756399|NCT03002493|Leprostatic Agents|leprostatic agents|mesh-ancestor
5756400|NCT03002493|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5756401|NCT03002493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5756402|NCT03002493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5756403|NCT03002493|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5756404|NCT03002493|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5756405|NCT03002493|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5756406|NCT03002493|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5756407|NCT03002493|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5756408|NCT03002493|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5756409|NCT03002428|Teriparatide|teriparatide|mesh-list
5756410|NCT03002428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5756411|NCT03002428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756412|NCT03002428|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5756413|NCT03002545|Magnesium citrate|magnesium citrate|mesh-list
5756414|NCT03002545|Cathartics|cathartics|mesh-ancestor
5756415|NCT03002545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5756416|NCT03002649|Tofacitinib|tofacitinib|mesh-list
5895029|NCT05122338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5630864|NCT03808610|Antibodies|antibodies|mesh-list
5630865|NCT03808610|Immunoglobulins|immunoglobulins|mesh-list
5630866|NCT03808610|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5630867|NCT03808610|BB 1101|bb 1101|mesh-list
5756417|NCT03002649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5756418|NCT03002649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5756419|NCT03002649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5756420|NCT03002636|Anesthetics|anesthetics|mesh-list
5756421|NCT03002636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5756422|NCT03002636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895030|NCT05122338|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5895031|NCT05122338|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5895032|NCT05122338|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5895033|NCT05122338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5895034|NCT05122338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895035|NCT05122338|Antidepressive Agents|antidepressive agents|mesh-ancestor
5895036|NCT05122338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5895037|NCT05122221|Cyclophosphamide|cyclophosphamide|mesh-list
5895038|NCT05122221|Fludarabine|fludarabine|mesh-list
5895039|NCT05122221|Interleukin-2|interleukin-2|mesh-list
5895040|NCT05122221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5895041|NCT05122221|Immunologic Factors|immunologic factors|mesh-ancestor
5895042|NCT05122221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895043|NCT05122221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5895044|NCT05122221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5895045|NCT05122221|Alkylating Agents|alkylating agents|mesh-ancestor
5895046|NCT05122221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895047|NCT05122221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5895048|NCT05122221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5895049|NCT05122221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5630868|NCT03808610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5630869|NCT03808610|Immunologic Factors|immunologic factors|mesh-ancestor
5630870|NCT03808610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630871|NCT03808610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5630872|NCT03808610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5630873|NCT03808610|Alkylating Agents|alkylating agents|mesh-ancestor
5630874|NCT03808610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630875|NCT03808610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5630876|NCT03808610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5630877|NCT03808610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5630878|NCT03808610|Antiemetics|antiemetics|mesh-ancestor
5630879|NCT03808610|Autonomic Agents|autonomic agents|mesh-ancestor
5630880|NCT03808610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5630881|NCT03808610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5630882|NCT03808610|Glucocorticoids|glucocorticoids|mesh-ancestor
5630883|NCT03808610|Hormones|hormones|mesh-ancestor
5630884|NCT03808610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5630885|NCT03808610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5630886|NCT03808610|Protease Inhibitors|protease inhibitors|mesh-ancestor
5895050|NCT05122221|Analgesics|analgesics|mesh-ancestor
5895051|NCT05122221|Sensory System Agents|sensory system agents|mesh-ancestor
5895052|NCT05122221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5895053|NCT05122208|Famotidine|famotidine|mesh-list
5895054|NCT05122208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5895055|NCT05122208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5630887|NCT03808610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5630888|NCT03808610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5630889|NCT03808610|Abortifacient Agents|abortifacient agents|mesh-ancestor
5630890|NCT03808610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5630891|NCT03808610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5630892|NCT03808610|Antimetabolites|antimetabolites|mesh-ancestor
5630893|NCT03808610|Dermatologic Agents|dermatologic agents|mesh-ancestor
5630894|NCT03808610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5630895|NCT03808610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5630896|NCT03808610|Antiviral Agents|antiviral agents|mesh-ancestor
5630897|NCT03808610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5630898|NCT03808610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5630899|NCT03808610|Tubulin Modulators|tubulin modulators|mesh-ancestor
5630900|NCT03808610|Antimitotic Agents|antimitotic agents|mesh-ancestor
5630901|NCT03808610|Mitosis Modulators|mitosis modulators|mesh-ancestor
5630902|NCT03800134|Gemcitabine|gemcitabine|mesh-list
5630903|NCT03800134|Paclitaxel|paclitaxel|mesh-list
5630904|NCT03800134|Cisplatin|cisplatin|mesh-list
5895056|NCT05122208|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5895057|NCT05122208|Histamine Antagonists|histamine antagonists|mesh-ancestor
5895058|NCT05122208|Histamine Agents|histamine agents|mesh-ancestor
5895059|NCT05122208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5895060|NCT05122208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5756423|NCT03002389|Fluticasone|fluticasone|mesh-list
5756424|NCT03002389|Xhance|xhance|mesh-list
5756425|NCT03002389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5630905|NCT03800134|Carboplatin|carboplatin|mesh-list
5630906|NCT03800134|Pemetrexed|pemetrexed|mesh-list
5630907|NCT03800134|Durvalumab|durvalumab|mesh-list
5630908|NCT03800134|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5630909|NCT03800134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5630910|NCT03800134|Tubulin Modulators|tubulin modulators|mesh-ancestor
5630911|NCT03800134|Antimitotic Agents|antimitotic agents|mesh-ancestor
5630912|NCT03800134|Mitosis Modulators|mitosis modulators|mesh-ancestor
5630913|NCT03800134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630914|NCT03800134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5630915|NCT03800134|Antimetabolites|antimetabolites|mesh-ancestor
5756426|NCT03002389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5756427|NCT03002389|Autonomic Agents|autonomic agents|mesh-ancestor
5756428|NCT03002389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5756429|NCT03002389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756430|NCT03002389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5756431|NCT03002389|Respiratory System Agents|respiratory system agents|mesh-ancestor
5756432|NCT03002389|Dermatologic Agents|dermatologic agents|mesh-ancestor
5756433|NCT03002389|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5630916|NCT03800134|Antiviral Agents|antiviral agents|mesh-ancestor
5630917|NCT03800134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5630918|NCT03800134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5630919|NCT03800134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5630920|NCT03800134|Immunologic Factors|immunologic factors|mesh-ancestor
5630921|NCT03800134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630922|NCT03800134|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5630923|NCT03800134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5630924|NCT03800134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5630925|NCT03797560|Pregabalin|pregabalin|mesh-list
5630926|NCT03797560|Analgesics|analgesics|mesh-ancestor
5630927|NCT03797560|Sensory System Agents|sensory system agents|mesh-ancestor
5630928|NCT03797560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5630929|NCT03797560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630930|NCT03797560|Anticonvulsants|anticonvulsants|mesh-ancestor
5630931|NCT03797560|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5630932|NCT03797560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5756434|NCT03002259|Dexamethasone|dexamethasone|mesh-list
5756435|NCT03002259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5756436|NCT03002259|Antiemetics|antiemetics|mesh-ancestor
5756437|NCT03002259|Autonomic Agents|autonomic agents|mesh-ancestor
5756438|NCT03002259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5756439|NCT03002259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756440|NCT03002259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6208985|NCT02139644|Dermatologic Agents|dermatologic agents|mesh-ancestor
5630933|NCT03797560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630934|NCT03797560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5630935|NCT03797560|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5630936|NCT03797560|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5630937|NCT03797560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5630938|NCT03797560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5630939|NCT03740919|Insulin|insulin|mesh-list
5630940|NCT03740919|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5630941|NCT03740919|Insulin Glargine|insulin glargine|mesh-list
5630942|NCT03740919|Insulin Lispro|insulin lispro|mesh-list
5630943|NCT03740919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5630944|NCT03740919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630945|NCT03737565|Tryptophan|tryptophan|mesh-list
5630946|NCT03737565|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5630947|NCT03737565|Antidepressive Agents|antidepressive agents|mesh-ancestor
5630948|NCT03737565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5630949|NCT03708315|Dexmedetomidine|dexmedetomidine|mesh-list
5630950|NCT03708315|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5630951|NCT03708315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5630952|NCT03708315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630953|NCT03708315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5630954|NCT03708315|Analgesics|analgesics|mesh-ancestor
5630955|NCT03708315|Sensory System Agents|sensory system agents|mesh-ancestor
5630956|NCT03708315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5630957|NCT03708315|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5630958|NCT03708315|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5630959|NCT03708315|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5630960|NCT03708315|Adrenergic Agents|adrenergic agents|mesh-ancestor
5630961|NCT03708315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5630962|NCT03708315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630963|NCT03702270|Penicillins|penicillins|mesh-list
5630964|NCT03702270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5630965|NCT03702270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5630966|NCT03700970|Bupivacaine|bupivacaine|mesh-list
5630967|NCT03700970|Anesthetics, Local|anesthetics, local|mesh-ancestor
5630968|NCT03700970|Anesthetics|anesthetics|mesh-ancestor
5630969|NCT03700970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5630970|NCT03700970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630971|NCT03700970|Sensory System Agents|sensory system agents|mesh-ancestor
5630972|NCT03700970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5630973|NCT03686345|Midostaurin|midostaurin|mesh-list
5630974|NCT03686345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5630975|NCT03686345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5630976|NCT03686345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5630977|NCT03686345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630978|NCT03684590|Analgesics, Opioid|analgesics, opioid|mesh-list
5630979|NCT03684590|Narcotics|narcotics|mesh-ancestor
5630980|NCT03684590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5630981|NCT03684590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5630982|NCT03684590|Analgesics|analgesics|mesh-ancestor
5630983|NCT03684590|Sensory System Agents|sensory system agents|mesh-ancestor
5630984|NCT03684590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5630985|NCT03674567|Pembrolizumab|pembrolizumab|mesh-list
5630986|NCT03674567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5630987|NCT03674567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5630988|NCT03672643|Crizotinib|crizotinib|mesh-list
5630989|NCT03672643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5630990|NCT03672643|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5630991|NCT03672643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5630992|NCT03672643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5630993|NCT03647488|Docetaxel|docetaxel|mesh-list
5630994|NCT03647488|Spartalizumab|spartalizumab|mesh-list
5630995|NCT03647488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5630996|NCT03647488|Tubulin Modulators|tubulin modulators|mesh-ancestor
5630997|NCT03647488|Antimitotic Agents|antimitotic agents|mesh-ancestor
5630998|NCT03647488|Mitosis Modulators|mitosis modulators|mesh-ancestor
5630999|NCT03647488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631000|NCT03647488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5631001|NCT03642132|Bevacizumab|bevacizumab|mesh-list
5631002|NCT03642132|Avelumab|avelumab|mesh-list
5756441|NCT03002259|Glucocorticoids|glucocorticoids|mesh-ancestor
5756442|NCT03002259|Hormones|hormones|mesh-ancestor
5756443|NCT03002259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5756444|NCT03002259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5756445|NCT03002259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5631003|NCT03642132|Talazoparib|talazoparib|mesh-list
5631004|NCT03642132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5631005|NCT03642132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5631006|NCT03642132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5631007|NCT03642132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5631008|NCT03642132|Growth Substances|growth substances|mesh-ancestor
5631009|NCT03642132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5631010|NCT03642132|Growth Inhibitors|growth inhibitors|mesh-ancestor
5631011|NCT03642132|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5631012|NCT03642132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5631013|NCT03642132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631014|NCT03635164|Durvalumab|durvalumab|mesh-list
5631015|NCT03635164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5631016|NCT03635164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5631017|NCT03632759|Liraglutide|liraglutide|mesh-list
5631018|NCT03632759|Golimumab|golimumab|mesh-list
5631019|NCT03632759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5631020|NCT03632759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5631021|NCT03632759|Incretins|incretins|mesh-ancestor
5631022|NCT03632759|Hormones|hormones|mesh-ancestor
5631023|NCT03632759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5631024|NCT03632759|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
5631025|NCT03632759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5631026|NCT03632759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5631027|NCT03632759|Immunologic Factors|immunologic factors|mesh-ancestor
5631028|NCT03618537|Dexamethasone|dexamethasone|mesh-list
5631029|NCT03618537|Ixazomib|ixazomib|mesh-list
5631030|NCT03618537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5631031|NCT03618537|Antiemetics|antiemetics|mesh-ancestor
5756446|NCT03002376|Cemiplimab|cemiplimab|mesh-list
5631032|NCT03618537|Autonomic Agents|autonomic agents|mesh-ancestor
5631033|NCT03618537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5631034|NCT03618537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5631035|NCT03618537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5631036|NCT03618537|Glucocorticoids|glucocorticoids|mesh-ancestor
5631037|NCT03618537|Hormones|hormones|mesh-ancestor
5631038|NCT03618537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5631039|NCT03618537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5631040|NCT03618537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5631041|NCT03618537|Protease Inhibitors|protease inhibitors|mesh-ancestor
5631042|NCT03618537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5631043|NCT03618537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631044|NCT03615105|Cyclophosphamide|cyclophosphamide|mesh-list
5631045|NCT03615105|Melphalan|melphalan|mesh-list
5631046|NCT03615105|Busulfan|busulfan|mesh-list
5631047|NCT03615105|Thiotepa|thiotepa|mesh-list
5631048|NCT03615105|Rituximab|rituximab|mesh-list
5631049|NCT03615105|Fludarabine|fludarabine|mesh-list
5631050|NCT03615105|Clofarabine|clofarabine|mesh-list
5631051|NCT03615105|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5631052|NCT03615105|Thymoglobulin|thymoglobulin|mesh-list
5631053|NCT03615105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5631054|NCT03615105|Immunologic Factors|immunologic factors|mesh-ancestor
5631055|NCT03615105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5631056|NCT03615105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5631057|NCT03615105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5631058|NCT03615105|Alkylating Agents|alkylating agents|mesh-ancestor
5631059|NCT03615105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631060|NCT03615105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5631061|NCT03615105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5631062|NCT03615105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5756447|NCT03002376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5756448|NCT03002376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5756449|NCT03002064|Docetaxel|docetaxel|mesh-list
5631063|NCT03615105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5631064|NCT03615105|Antimetabolites|antimetabolites|mesh-ancestor
5631065|NCT03614923|Mometasone Furoate|mometasone furoate|mesh-list
5631066|NCT03614923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5631067|NCT03614923|Dermatologic Agents|dermatologic agents|mesh-ancestor
5631068|NCT03614923|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5631076|NCT03613532|Fludarabine|fludarabine|mesh-list
5631077|NCT03613532|Azacitidine|azacitidine|mesh-list
5631078|NCT03613532|Busulfan|busulfan|mesh-list
5631079|NCT03613532|Decitabine|decitabine|mesh-list
5631080|NCT03613532|Venetoclax|venetoclax|mesh-list
5631081|NCT03613532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5631082|NCT03613532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5631083|NCT03613532|Antimetabolites|antimetabolites|mesh-ancestor
5756450|NCT03002064|Fluorouracil|fluorouracil|mesh-list
5756451|NCT03002064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5756452|NCT03002064|Tubulin Modulators|tubulin modulators|mesh-ancestor
5756453|NCT03002064|Antimitotic Agents|antimitotic agents|mesh-ancestor
5756454|NCT03002064|Mitosis Modulators|mitosis modulators|mesh-ancestor
5756455|NCT03002064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5756456|NCT03002064|Antimetabolites|antimetabolites|mesh-ancestor
5756457|NCT03002064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5756458|NCT03002064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5756459|NCT03002064|Immunologic Factors|immunologic factors|mesh-ancestor
5631084|NCT03613532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631085|NCT03613532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5631086|NCT03613532|Immunologic Factors|immunologic factors|mesh-ancestor
5631087|NCT03613532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5631088|NCT03613532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5631089|NCT03613532|Alkylating Agents|alkylating agents|mesh-ancestor
5631090|NCT03613532|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5631091|NCT03613532|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5631092|NCT03598608|Pembrolizumab|pembrolizumab|mesh-list
5631093|NCT03598608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5631094|NCT03598608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5631095|NCT03595059|Paclitaxel|paclitaxel|mesh-list
5631096|NCT03595059|Docetaxel|docetaxel|mesh-list
5631097|NCT03595059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5631098|NCT03595059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5631099|NCT03595059|Tubulin Modulators|tubulin modulators|mesh-ancestor
5631100|NCT03595059|Antimitotic Agents|antimitotic agents|mesh-ancestor
5631101|NCT03595059|Mitosis Modulators|mitosis modulators|mesh-ancestor
5756460|NCT03002064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756461|NCT03002090|Iron|iron|mesh-list
5756462|NCT03002090|Trace Elements|trace elements|mesh-ancestor
5756463|NCT03002090|Micronutrients|micronutrients|mesh-ancestor
5756464|NCT03002090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756465|NCT03001869|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5756466|NCT03001869|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5756467|NCT03001869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5756468|NCT03001882|Nivolumab|nivolumab|mesh-list
5756469|NCT03001882|Ipilimumab|ipilimumab|mesh-list
5756470|NCT03001882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5756471|NCT03001882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5756472|NCT03001882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5756473|NCT03001882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5756474|NCT03001960|Clopidogrel|clopidogrel|mesh-list
5756475|NCT03001960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5756476|NCT03001960|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5756477|NCT03001960|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5756478|NCT03001960|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5631102|NCT03595059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631103|NCT03579160|Timolol|timolol|mesh-list
5631104|NCT03579160|Petrolatum|petrolatum|mesh-list
5756479|NCT03001960|Purinergic Agents|purinergic agents|mesh-ancestor
5756480|NCT03001960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5756481|NCT03001960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5756482|NCT03001960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756483|NCT03001687|Vitamin D|vitamin d|mesh-list
5756484|NCT03001687|Vitamins|vitamins|mesh-ancestor
5756485|NCT03001687|Micronutrients|micronutrients|mesh-ancestor
5756486|NCT03001687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756487|NCT03001687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5756488|NCT03001739|Urapidil|urapidil|mesh-list
5756489|NCT03001739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5756490|NCT03001739|Vasodilator Agents|vasodilator agents|mesh-ancestor
5756491|NCT03001739|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5756492|NCT03001739|Serotonin Agents|serotonin agents|mesh-ancestor
5756493|NCT03001739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5756494|NCT03001739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5756495|NCT03001739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756496|NCT03001739|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5756497|NCT03001739|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5756498|NCT03001739|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5756499|NCT03001739|Adrenergic Agents|adrenergic agents|mesh-ancestor
5756500|NCT03001609|Abivertinib|abivertinib|mesh-list
5756501|NCT03001609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5631105|NCT03579160|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5631106|NCT03579160|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5631107|NCT03579160|Adrenergic Agents|adrenergic agents|mesh-ancestor
5631108|NCT03579160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5631109|NCT03579160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631110|NCT03579160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756502|NCT03001609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5756503|NCT03001609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5756504|NCT03001726|Docetaxel|docetaxel|mesh-list
5756505|NCT03001726|Oxaliplatin|oxaliplatin|mesh-list
5756506|NCT03001726|Tegafur|tegafur|mesh-list
5756507|NCT03001726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5631111|NCT03579160|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5631112|NCT03579160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5631113|NCT03579160|Emollients|emollients|mesh-ancestor
5631114|NCT03579160|Dermatologic Agents|dermatologic agents|mesh-ancestor
5693213|NCT03402204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5693214|NCT03402204|Immunologic Factors|immunologic factors|mesh-ancestor
5693215|NCT03402204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693216|NCT03402204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5693217|NCT03402204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5693218|NCT03402204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5756508|NCT03001726|Tubulin Modulators|tubulin modulators|mesh-ancestor
5693219|NCT03402204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5631115|NCT03556696|Remifentanil|remifentanil|mesh-list
5631116|NCT03556696|Propofol|propofol|mesh-list
5631117|NCT03556696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5631118|NCT03556696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5631119|NCT03556696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5631120|NCT03556696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5631121|NCT03556696|Anesthetics, General|anesthetics, general|mesh-ancestor
5631122|NCT03556696|Anesthetics|anesthetics|mesh-ancestor
5631123|NCT03556696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5756509|NCT03001726|Antimitotic Agents|antimitotic agents|mesh-ancestor
5756510|NCT03001726|Mitosis Modulators|mitosis modulators|mesh-ancestor
5756511|NCT03001726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5756512|NCT03001726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5756513|NCT03001726|Antimetabolites|antimetabolites|mesh-ancestor
5756514|NCT03001661|Dinoprostone|dinoprostone|mesh-list
5756515|NCT03001661|Oxytocics|oxytocics|mesh-ancestor
5756516|NCT03001661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5756517|NCT03001661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756518|NCT03001635|Oxytocin|oxytocin|mesh-list
5756519|NCT03001635|Oxytocics|oxytocics|mesh-ancestor
5756520|NCT03001635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5756521|NCT03001635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756522|NCT03001570|Cetuximab|cetuximab|mesh-list
5756523|NCT03001570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5756524|NCT03001570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5756525|NCT03001466|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5756526|NCT03001466|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5756527|NCT03001271|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
5756528|NCT03001271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5756529|NCT03001271|Vasodilator Agents|vasodilator agents|mesh-ancestor
5756530|NCT03001349|Octreotide|octreotide|mesh-list
5756531|NCT03001349|Edotreotide|edotreotide|mesh-list
5756532|NCT03001349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5756533|NCT03001349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5756534|NCT03001349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5756535|NCT03001349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5756536|NCT03001349|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5756537|NCT03001089|Fludrocortisone|fludrocortisone|mesh-list
5756538|NCT03001089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5756539|NCT03001193|Oxytocin|oxytocin|mesh-list
5756540|NCT03001193|Oxytocics|oxytocics|mesh-ancestor
5756541|NCT03001193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5756542|NCT03001193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756543|NCT03001102|Chlorhexidine|chlorhexidine|mesh-list
5756544|NCT03001102|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5756545|NCT03001102|Povidone-Iodine|povidone-iodine|mesh-list
5756546|NCT03001102|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
5756547|NCT03001102|Povidone|povidone|mesh-list
5756548|NCT03001102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5756549|NCT03001102|Disinfectants|disinfectants|mesh-ancestor
5756550|NCT03001102|Dermatologic Agents|dermatologic agents|mesh-ancestor
5756551|NCT03001102|Plasma Substitutes|plasma substitutes|mesh-ancestor
5756552|NCT03001102|Blood Substitutes|blood substitutes|mesh-ancestor
5756553|NCT03000946|Octreotide|octreotide|mesh-list
5631124|NCT03556696|Narcotics|narcotics|mesh-ancestor
5631125|NCT03556696|Analgesics|analgesics|mesh-ancestor
5631126|NCT03556696|Sensory System Agents|sensory system agents|mesh-ancestor
5631127|NCT03556696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5631128|NCT03556332|Dexamethasone|dexamethasone|mesh-list
5631129|NCT03556332|Lenalidomide|lenalidomide|mesh-list
5631130|NCT03556332|Daratumumab|daratumumab|mesh-list
5631131|NCT03556332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5756554|NCT03000946|Somatostatin|somatostatin|mesh-list
5756555|NCT03000946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5756556|NCT03000946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5756557|NCT03000946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5756558|NCT03000946|Hormones|hormones|mesh-ancestor
5756559|NCT03000946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5756560|NCT03000946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756561|NCT03001128|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
5756562|NCT03001128|Antiviral Agents|antiviral agents|mesh-ancestor
5756563|NCT03001128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5631132|NCT03556332|Antiemetics|antiemetics|mesh-ancestor
5631133|NCT03556332|Autonomic Agents|autonomic agents|mesh-ancestor
5631134|NCT03556332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5756564|NCT03000660|Dexamethasone|dexamethasone|mesh-list
5756565|NCT03000660|Venetoclax|venetoclax|mesh-list
5756566|NCT03000660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5756567|NCT03000660|Antiemetics|antiemetics|mesh-ancestor
5756568|NCT03000660|Autonomic Agents|autonomic agents|mesh-ancestor
5631135|NCT03556332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5631136|NCT03556332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5631137|NCT03556332|Glucocorticoids|glucocorticoids|mesh-ancestor
5631138|NCT03556332|Hormones|hormones|mesh-ancestor
5631139|NCT03556332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5631140|NCT03556332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5631141|NCT03556332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5631142|NCT03556332|Immunologic Factors|immunologic factors|mesh-ancestor
5631143|NCT03556332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5631144|NCT03556332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5631145|NCT03556332|Growth Substances|growth substances|mesh-ancestor
5631146|NCT03556332|Growth Inhibitors|growth inhibitors|mesh-ancestor
5631147|NCT03531736|Cyclophosphamide|cyclophosphamide|mesh-list
5631148|NCT03531736|Fludarabine|fludarabine|mesh-list
5631149|NCT03531736|Rituximab|rituximab|mesh-list
5631150|NCT03531736|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5631151|NCT03531736|Thymoglobulin|thymoglobulin|mesh-list
5631152|NCT03531736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5631153|NCT03531736|Immunologic Factors|immunologic factors|mesh-ancestor
5631154|NCT03531736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5631155|NCT03531736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5631156|NCT03531736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5631157|NCT03531736|Alkylating Agents|alkylating agents|mesh-ancestor
5631158|NCT03531736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631159|NCT03531736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5631160|NCT03531736|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5631161|NCT03531736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5631162|NCT03527537|Insulin|insulin|mesh-list
5631163|NCT03527537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5631164|NCT03527537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5631181|NCT03517540|Cenicriviroc|cenicriviroc|mesh-list
5631182|NCT03517540|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
5631183|NCT03517540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631184|NCT03517540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5631185|NCT03517540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5631186|NCT03517540|Antiviral Agents|antiviral agents|mesh-ancestor
5631187|NCT03517540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5631188|NCT03514069|Temozolomide|temozolomide|mesh-list
5756569|NCT03000660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5756570|NCT03000660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489868|NCT00593879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489869|NCT00593879|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
6489870|NCT00593879|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6489871|NCT00593879|Cholinergic Agents|cholinergic agents|mesh-ancestor
6489872|NCT00593879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6489873|NCT00593879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489874|NCT00593996|Vitamin D|vitamin d|mesh-list
5631189|NCT03514069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5631190|NCT03514069|Alkylating Agents|alkylating agents|mesh-ancestor
5631191|NCT03514069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631192|NCT03514069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5631193|NCT03513445|Epinephrine|epinephrine|mesh-list
5631194|NCT03513445|Morphine|morphine|mesh-list
5631195|NCT03513445|Ropivacaine|ropivacaine|mesh-list
5631196|NCT03513445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6489875|NCT00593996|Ergocalciferols|ergocalciferols|mesh-list
6489876|NCT00593996|Vitamins|vitamins|mesh-ancestor
6489877|NCT00593996|Micronutrients|micronutrients|mesh-ancestor
5631197|NCT03513445|Narcotics|narcotics|mesh-ancestor
6489878|NCT00593996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489879|NCT00593996|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6489880|NCT00593996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6489881|NCT00594087|Eszopiclone|eszopiclone|mesh-list
6489882|NCT00594087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6489883|NCT00594087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6208986|NCT02139644|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6208987|NCT02139644|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6208988|NCT02139644|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5631198|NCT03513445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5631199|NCT03513445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5631200|NCT03513445|Analgesics|analgesics|mesh-ancestor
5631201|NCT03513445|Sensory System Agents|sensory system agents|mesh-ancestor
5631202|NCT03513445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5631203|NCT03513445|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5631204|NCT03513445|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5631205|NCT03513445|Adrenergic Agents|adrenergic agents|mesh-ancestor
5631206|NCT03513445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5631207|NCT03513445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631208|NCT03513445|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5631209|NCT03513445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5631210|NCT03513445|Autonomic Agents|autonomic agents|mesh-ancestor
5631211|NCT03513445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5631212|NCT03513445|Respiratory System Agents|respiratory system agents|mesh-ancestor
5631213|NCT03513445|Mydriatics|mydriatics|mesh-ancestor
5631214|NCT03513445|Sympathomimetics|sympathomimetics|mesh-ancestor
5631215|NCT03513445|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5631216|NCT03513445|Anesthetics, Local|anesthetics, local|mesh-ancestor
5631217|NCT03513445|Anesthetics|anesthetics|mesh-ancestor
5631218|NCT03511118|Metformin|metformin|mesh-list
5631219|NCT03511118|Topiramate|topiramate|mesh-list
5631220|NCT03511118|Azithromycin|azithromycin|mesh-list
5631221|NCT03511118|Doxycycline|doxycycline|mesh-list
5631222|NCT03511118|Ciprofloxacin|ciprofloxacin|mesh-list
6208989|NCT02139644|Adrenergic Agents|adrenergic agents|mesh-ancestor
6208990|NCT02139644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5756571|NCT03000660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5756572|NCT03000660|Glucocorticoids|glucocorticoids|mesh-ancestor
5756573|NCT03000660|Hormones|hormones|mesh-ancestor
5756574|NCT03000660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6208991|NCT02139644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6208992|NCT02139644|Tocolytic Agents|tocolytic agents|mesh-ancestor
6208993|NCT02139644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6208994|NCT02139644|Glucocorticoids|glucocorticoids|mesh-ancestor
6208995|NCT02139644|Hormones|hormones|mesh-ancestor
6208996|NCT02139644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6208997|NCT02139943|Canagliflozin|canagliflozin|mesh-list
5631223|NCT03511118|Levofloxacin|levofloxacin|mesh-list
5631224|NCT03511118|Clindamycin|clindamycin|mesh-list
5631225|NCT03511118|Valganciclovir|valganciclovir|mesh-list
5631226|NCT03511118|Remdesivir|remdesivir|mesh-list
5631227|NCT03511118|Hydroxyurea|hydroxyurea|mesh-list
5631228|NCT03511118|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5631229|NCT03511118|Verapamil|verapamil|mesh-list
5631230|NCT03511118|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6208998|NCT02139943|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6208999|NCT02139943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209000|NCT02139943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6209001|NCT02139943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209002|NCT02139982|Ropivacaine|ropivacaine|mesh-list
6209003|NCT02139982|Anesthetics, Local|anesthetics, local|mesh-ancestor
5631231|NCT03511118|Labetalol|labetalol|mesh-list
5631232|NCT03511118|Nifedipine|nifedipine|mesh-list
5631233|NCT03511118|Furosemide|furosemide|mesh-list
5631234|NCT03511118|Sumatriptan|sumatriptan|mesh-list
5631235|NCT03511118|Oxycodone|oxycodone|mesh-list
5631236|NCT03511118|Gabapentin|gabapentin|mesh-list
5631237|NCT03511118|Ondansetron|ondansetron|mesh-list
5631238|NCT03511118|Trazodone|trazodone|mesh-list
5631239|NCT03511118|Fluvoxamine|fluvoxamine|mesh-list
5631240|NCT03511118|Cyclobenzaprine|cyclobenzaprine|mesh-list
5631241|NCT03511118|Methylphenidate|methylphenidate|mesh-list
5631242|NCT03511118|Citalopram|citalopram|mesh-list
5631243|NCT03511118|Sertraline|sertraline|mesh-list
5631244|NCT03511118|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
5756575|NCT03000660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5756576|NCT03000660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5895061|NCT05122208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895062|NCT05122117|Methylene Blue|methylene blue|mesh-list
6209004|NCT02139982|Anesthetics|anesthetics|mesh-ancestor
6209005|NCT02139982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6209006|NCT02139982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209007|NCT02139982|Sensory System Agents|sensory system agents|mesh-ancestor
6209008|NCT02139982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6209009|NCT02140060|Travoprost|travoprost|mesh-list
6209010|NCT02140060|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6209011|NCT02140060|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6209012|NCT02140060|Brinzolamide|brinzolamide|mesh-list
5756577|NCT03000413|Fentanyl|fentanyl|mesh-list
5756578|NCT03000413|Ketamine|ketamine|mesh-list
5756579|NCT03000413|Analgesics|analgesics|mesh-ancestor
5756580|NCT03000413|Sensory System Agents|sensory system agents|mesh-ancestor
5756581|NCT03000413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5756582|NCT03000413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756583|NCT03000413|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5756584|NCT03000413|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5756585|NCT03000413|Anesthetics, General|anesthetics, general|mesh-ancestor
5756586|NCT03000413|Anesthetics|anesthetics|mesh-ancestor
5756587|NCT03000413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5756588|NCT03000413|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5756589|NCT03000413|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5756590|NCT03000413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5631245|NCT03511118|Tranexamic Acid|tranexamic acid|mesh-list
5631246|NCT03511118|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5631247|NCT03511118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5631248|NCT03511118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756591|NCT03000413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5756592|NCT03000413|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5756593|NCT03000413|Narcotics|narcotics|mesh-ancestor
5756594|NCT03000413|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5756595|NCT03000777|Melatonin|melatonin|mesh-list
5756596|NCT03000777|Antioxidants|antioxidants|mesh-ancestor
5756597|NCT03000777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5756598|NCT03000777|Protective Agents|protective agents|mesh-ancestor
5756599|NCT03000777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756600|NCT03000777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5756601|NCT03000634|Dexamethasone|dexamethasone|mesh-list
5756602|NCT03000634|Lenalidomide|lenalidomide|mesh-list
5756603|NCT03000634|Bortezomib|bortezomib|mesh-list
5756604|NCT03000634|Elotuzumab|elotuzumab|mesh-list
5756605|NCT03000634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5756606|NCT03000634|Antiemetics|antiemetics|mesh-ancestor
5756607|NCT03000634|Autonomic Agents|autonomic agents|mesh-ancestor
5756608|NCT03000634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5756609|NCT03000634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756610|NCT03000634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5756611|NCT03000634|Glucocorticoids|glucocorticoids|mesh-ancestor
5756612|NCT03000634|Hormones|hormones|mesh-ancestor
5756613|NCT03000634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5756614|NCT03000634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5756615|NCT03000634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5756616|NCT03000634|Immunologic Factors|immunologic factors|mesh-ancestor
5631249|NCT03511118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5631250|NCT03511118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5631251|NCT03511118|Antimetabolites|antimetabolites|mesh-ancestor
5631252|NCT03511118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631253|NCT03511118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5631254|NCT03511118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5631255|NCT03511118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5631256|NCT03511118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5631257|NCT03511118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5631258|NCT03511118|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5631259|NCT03511118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5631260|NCT03511118|Hemostatics|hemostatics|mesh-ancestor
5631261|NCT03511118|Coagulants|coagulants|mesh-ancestor
5631262|NCT03511118|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5756617|NCT03000634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5756618|NCT03000634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5756619|NCT03000634|Growth Substances|growth substances|mesh-ancestor
5756620|NCT03000634|Growth Inhibitors|growth inhibitors|mesh-ancestor
5756621|NCT03000556|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5756622|NCT03000556|Hyaluronic Acid|hyaluronic acid|mesh-list
5756623|NCT03000556|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5631263|NCT03511118|Narcotics|narcotics|mesh-ancestor
5756624|NCT03000556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6209013|NCT02140060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5756625|NCT03000556|Immunologic Factors|immunologic factors|mesh-ancestor
5756626|NCT03000556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756627|NCT03000556|Viscosupplements|viscosupplements|mesh-ancestor
5756628|NCT03000556|Protective Agents|protective agents|mesh-ancestor
5756629|NCT03000387|Nicotine|nicotine|mesh-list
5756630|NCT03000387|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5756631|NCT03000387|Autonomic Agents|autonomic agents|mesh-ancestor
5756632|NCT03000387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5756633|NCT03000387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756634|NCT03000387|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5756635|NCT03000387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5756636|NCT03000387|Cholinergic Agents|cholinergic agents|mesh-ancestor
5756637|NCT03000387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5756638|NCT03000387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5756639|NCT03000374|Leucovorin|leucovorin|mesh-list
5631264|NCT03511118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5631265|NCT03511118|Analgesics|analgesics|mesh-ancestor
5756640|NCT03000374|Fluorouracil|fluorouracil|mesh-list
5756641|NCT03000374|Oxaliplatin|oxaliplatin|mesh-list
5756642|NCT03000374|Panitumumab|panitumumab|mesh-list
5756643|NCT03000374|Antimetabolites|antimetabolites|mesh-ancestor
5756644|NCT03000374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5756645|NCT03000374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5756646|NCT03000374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5756647|NCT03000374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5756648|NCT03000374|Immunologic Factors|immunologic factors|mesh-ancestor
5756649|NCT03000374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756650|NCT03000374|Antidotes|antidotes|mesh-ancestor
5756651|NCT03000374|Protective Agents|protective agents|mesh-ancestor
5756652|NCT03000374|Vitamin B Complex|vitamin b complex|mesh-ancestor
5756653|NCT03000374|Vitamins|vitamins|mesh-ancestor
5631266|NCT03511118|Sensory System Agents|sensory system agents|mesh-ancestor
5631267|NCT03511118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5631268|NCT03511118|Anticonvulsants|anticonvulsants|mesh-ancestor
5631269|NCT03511118|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5631270|NCT03511118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5631271|NCT03511118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5631272|NCT03511118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5631273|NCT03511118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5631274|NCT03511118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5631275|NCT03511118|Antimanic Agents|antimanic agents|mesh-ancestor
5631276|NCT03511118|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5631277|NCT03511118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5631278|NCT03511118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5631279|NCT03511118|Serotonin Agents|serotonin agents|mesh-ancestor
5631280|NCT03511118|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5631281|NCT03511118|Antidepressive Agents|antidepressive agents|mesh-ancestor
5631282|NCT03511118|Autonomic Agents|autonomic agents|mesh-ancestor
5631283|NCT03511118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5631284|NCT03511118|Diuretics|diuretics|mesh-ancestor
5631285|NCT03511118|Natriuretic Agents|natriuretic agents|mesh-ancestor
5631286|NCT03511118|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5631287|NCT03511118|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5631288|NCT03511118|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5631289|NCT03511118|Dopamine Agents|dopamine agents|mesh-ancestor
5631290|NCT03511118|Antiemetics|antiemetics|mesh-ancestor
5631291|NCT03511118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5631292|NCT03511118|Antipruritics|antipruritics|mesh-ancestor
5631293|NCT03511118|Dermatologic Agents|dermatologic agents|mesh-ancestor
5631294|NCT03511118|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5631295|NCT03511118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5631296|NCT03511118|Antimalarials|antimalarials|mesh-ancestor
5631297|NCT03511118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5631298|NCT03511118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5631299|NCT03511118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5756654|NCT03000374|Micronutrients|micronutrients|mesh-ancestor
5756655|NCT03000374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5756656|NCT03000257|Venetoclax|venetoclax|mesh-list
5756657|NCT03000257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5756658|NCT03000127|Testosterone|testosterone|mesh-list
5756659|NCT03000127|Androgens|androgens|mesh-ancestor
5756660|NCT03000127|Hormones|hormones|mesh-ancestor
5756661|NCT03000127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5756662|NCT03000127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5631300|NCT03511118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5756663|NCT03000218|Metformin|metformin|mesh-list
5756664|NCT03000218|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
5631301|NCT03511118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5631302|NCT03511118|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5631303|NCT03511118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5631304|NCT03511118|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5631305|NCT03511118|Renal Agents|renal agents|mesh-ancestor
5631306|NCT03511118|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5631307|NCT03511118|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5631308|NCT03511118|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5631309|NCT03511118|Antisickling Agents|antisickling agents|mesh-ancestor
5631310|NCT03511118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5631311|NCT03511118|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5631312|NCT03511118|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5631313|NCT03511118|Vasodilator Agents|vasodilator agents|mesh-ancestor
5631314|NCT03511118|Tocolytic Agents|tocolytic agents|mesh-ancestor
5631315|NCT03511118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5631316|NCT03511118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5631317|NCT03511118|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5631318|NCT03511118|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5631319|NCT03511118|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5631320|NCT03511118|Antiviral Agents|antiviral agents|mesh-ancestor
5631321|NCT03511118|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5631322|NCT03511118|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5631323|NCT03511118|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5631324|NCT03511118|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5631325|NCT03511118|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5631326|NCT03511118|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5631327|NCT03511118|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5631328|NCT03511118|Adrenergic Agents|adrenergic agents|mesh-ancestor
5631329|NCT03511118|Sympathomimetics|sympathomimetics|mesh-ancestor
5631330|NCT03511118|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5756665|NCT03000218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6209014|NCT02140060|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6209015|NCT02140060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6209016|NCT02140060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631331|NCT03511118|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5631332|NCT03498014|Analgesics, Opioid|analgesics, opioid|mesh-list
5631333|NCT03498014|Narcotics|narcotics|mesh-ancestor
5631334|NCT03498014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5631335|NCT03498014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5631336|NCT03498014|Analgesics|analgesics|mesh-ancestor
5631337|NCT03498014|Sensory System Agents|sensory system agents|mesh-ancestor
5631338|NCT03498014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6209017|NCT02140164|Minocycline|minocycline|mesh-list
6209018|NCT02140164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6209019|NCT02140164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6209020|NCT02140372|Colchicine|colchicine|mesh-list
6209021|NCT02140372|Gout Suppressants|gout suppressants|mesh-ancestor
5756666|NCT03000218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756667|NCT03000218|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5756668|NCT03000218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5631339|NCT03475277|Ketamine|ketamine|mesh-list
5631340|NCT03475277|Analgesics|analgesics|mesh-ancestor
5631341|NCT03475277|Sensory System Agents|sensory system agents|mesh-ancestor
5631342|NCT03475277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5631343|NCT03475277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5631344|NCT03475277|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5631345|NCT03475277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5631346|NCT03475277|Anesthetics, General|anesthetics, general|mesh-ancestor
5631347|NCT03475277|Anesthetics|anesthetics|mesh-ancestor
5756669|NCT03000205|Lidocaine|lidocaine|mesh-list
5756670|NCT03000205|Anesthetics, Local|anesthetics, local|mesh-ancestor
5756671|NCT03000205|Anesthetics|anesthetics|mesh-ancestor
5756672|NCT03000205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5756673|NCT03000205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756674|NCT03000205|Sensory System Agents|sensory system agents|mesh-ancestor
5756675|NCT03000205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6673162|NCT01560754|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6673163|NCT01560754|Autonomic Agents|autonomic agents|mesh-ancestor
6673164|NCT01560754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6673165|NCT01560754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756676|NCT03000205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5756677|NCT03000205|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6209022|NCT02140372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5756678|NCT03000205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5756679|NCT03000205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5756680|NCT03000205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5756681|NCT03000036|Doxorubicin|doxorubicin|mesh-list
5756682|NCT03000036|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
5756683|NCT03000036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5756684|NCT03000036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5756685|NCT03000036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5756686|NCT03000036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5756687|NCT03000036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5756688|NCT03000036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5756689|NCT03000036|Chelating Agents|chelating agents|mesh-ancestor
5631348|NCT03475277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5631349|NCT03475277|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5631350|NCT03475277|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5631351|NCT03475277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5631352|NCT03475277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631353|NCT03475004|Bevacizumab|bevacizumab|mesh-list
5631354|NCT03475004|Pembrolizumab|pembrolizumab|mesh-list
5631355|NCT03475004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5631356|NCT03475004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5631357|NCT03475004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5631358|NCT03475004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5631359|NCT03475004|Growth Substances|growth substances|mesh-ancestor
5631360|NCT03475004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5631361|NCT03475004|Growth Inhibitors|growth inhibitors|mesh-ancestor
5631362|NCT03458247|Abiraterone Acetate|abiraterone acetate|mesh-list
5631363|NCT03458247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5756690|NCT03000036|Sequestering Agents|sequestering agents|mesh-ancestor
5756691|NCT02999958|Thioctic Acid|thioctic acid|mesh-list
5756692|NCT02999958|Acetylcarnitine|acetylcarnitine|mesh-list
5756693|NCT02999958|Acetylcysteine|acetylcysteine|mesh-list
5756694|NCT02999958|Antioxidants|antioxidants|mesh-list
5756695|NCT02999958|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5756696|NCT02999958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5756697|NCT02999958|Protective Agents|protective agents|mesh-ancestor
5756698|NCT02999958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756699|NCT02999958|Vitamin B Complex|vitamin b complex|mesh-ancestor
5756700|NCT02999958|Vitamins|vitamins|mesh-ancestor
5756701|NCT02999958|Micronutrients|micronutrients|mesh-ancestor
5756702|NCT02999958|Nootropic Agents|nootropic agents|mesh-ancestor
5756703|NCT02999958|Antiviral Agents|antiviral agents|mesh-ancestor
5756704|NCT02999958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5756705|NCT02999958|Expectorants|expectorants|mesh-ancestor
5631364|NCT03458247|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5631365|NCT03458247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5631366|NCT03458247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5756706|NCT02999958|Respiratory System Agents|respiratory system agents|mesh-ancestor
5756707|NCT02999958|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5756708|NCT02999958|Antidotes|antidotes|mesh-ancestor
5756709|NCT02999776|Etanercept|etanercept|mesh-list
5756710|NCT02999776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5756711|NCT02999776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5631367|NCT03458247|Hormone Antagonists|hormone antagonists|mesh-ancestor
5631368|NCT03458247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5631369|NCT03458247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693220|NCT03402204|Protease Inhibitors|protease inhibitors|mesh-ancestor
5756712|NCT02999776|Analgesics|analgesics|mesh-ancestor
5756713|NCT02999776|Sensory System Agents|sensory system agents|mesh-ancestor
5756714|NCT02999776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5756715|NCT02999776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756716|NCT02999776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5756717|NCT02999776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5756718|NCT02999776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5756719|NCT02999776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5756720|NCT02999776|Immunologic Factors|immunologic factors|mesh-ancestor
5756721|NCT02999815|Immunoglobulins|immunoglobulins|mesh-list
5756722|NCT02999815|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5756723|NCT02999815|Antibodies|antibodies|mesh-list
5756724|NCT02999815|Antitoxins|antitoxins|mesh-list
5756725|NCT02999815|Immunologic Factors|immunologic factors|mesh-ancestor
5756726|NCT02999815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756727|NCT02999854|Cyclophosphamide|cyclophosphamide|mesh-list
5756728|NCT02999854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5756729|NCT02999854|Immunologic Factors|immunologic factors|mesh-ancestor
5756730|NCT02999854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756731|NCT02999854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5756732|NCT02999854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5756733|NCT02999854|Alkylating Agents|alkylating agents|mesh-ancestor
5756734|NCT02999854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5756735|NCT02999854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5756736|NCT02999854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5756737|NCT02999841|Vildagliptin|vildagliptin|mesh-list
5756738|NCT02999841|Acarbose|acarbose|mesh-list
5756739|NCT02999841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5756740|NCT02999841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756741|NCT02999841|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5756742|NCT02999841|Protease Inhibitors|protease inhibitors|mesh-ancestor
5756743|NCT02999841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5756744|NCT02999841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5756745|NCT02999841|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
5756746|NCT02999906|Treprostinil|treprostinil|mesh-list
5756747|NCT02999906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5756748|NCT02999724|Gabapentin|gabapentin|mesh-list
5756749|NCT02999724|Analgesics|analgesics|mesh-ancestor
5756750|NCT02999724|Sensory System Agents|sensory system agents|mesh-ancestor
5756751|NCT02999724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5756752|NCT02999724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756753|NCT02999724|Anticonvulsants|anticonvulsants|mesh-ancestor
5756754|NCT02999724|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5756755|NCT02999724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5756756|NCT02999724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5756757|NCT02999724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5631370|NCT03458247|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5631371|NCT03447262|Ivacaftor|ivacaftor|mesh-list
5631372|NCT03447262|VX-659|vx-659|mesh-list
5631373|NCT03447262|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
5631374|NCT03447262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5631375|NCT03447262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631376|NCT03441061|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
5631377|NCT03441061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5631378|NCT03441061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5631379|NCT03441061|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5631380|NCT03434730|Cyclosporine|cyclosporine|mesh-list
5631381|NCT03434730|Mycophenolic Acid|mycophenolic acid|mesh-list
5756758|NCT02999724|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5756759|NCT02999724|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5756760|NCT02999724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5631382|NCT03434730|Lenograstim|lenograstim|mesh-list
5631383|NCT03434730|Cyclosporins|cyclosporins|mesh-list
5631384|NCT03434730|Sargramostim|sargramostim|mesh-list
5631385|NCT03434730|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5631386|NCT03434730|Immunologic Factors|immunologic factors|mesh-ancestor
5631387|NCT03434730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756761|NCT02999724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5756762|NCT02999724|Antimanic Agents|antimanic agents|mesh-ancestor
5756763|NCT02999919|Bupivacaine|bupivacaine|mesh-list
5756764|NCT02999919|Anesthetics, Local|anesthetics, local|mesh-ancestor
5756765|NCT02999919|Anesthetics|anesthetics|mesh-ancestor
5756766|NCT02999919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5756767|NCT02999919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756768|NCT02999919|Sensory System Agents|sensory system agents|mesh-ancestor
5756769|NCT02999919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5756770|NCT02999594|Tramadol|tramadol|mesh-list
5756771|NCT02999594|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5756772|NCT02999594|Narcotics|narcotics|mesh-ancestor
5756773|NCT02999594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5756774|NCT02999594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756775|NCT02999594|Analgesics|analgesics|mesh-ancestor
5756776|NCT02999594|Sensory System Agents|sensory system agents|mesh-ancestor
5756777|NCT02999594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5756778|NCT02999490|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5756779|NCT02999490|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5756780|NCT02999490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209023|NCT02140372|Tubulin Modulators|tubulin modulators|mesh-ancestor
6209024|NCT02140372|Antimitotic Agents|antimitotic agents|mesh-ancestor
6209025|NCT02140372|Mitosis Modulators|mitosis modulators|mesh-ancestor
5756781|NCT02999295|Nivolumab|nivolumab|mesh-list
5631388|NCT03434730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5631389|NCT03434730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631390|NCT03434730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5631391|NCT03434730|Antifungal Agents|antifungal agents|mesh-ancestor
5631392|NCT03434730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5756782|NCT02999295|Ramucirumab|ramucirumab|mesh-list
5756783|NCT02999295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5756784|NCT02999295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5756785|NCT02999295|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5756786|NCT02999295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631393|NCT03434730|Dermatologic Agents|dermatologic agents|mesh-ancestor
5631394|NCT03434730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5631395|NCT03434730|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5631396|NCT03434730|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5631397|NCT03434730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5631398|NCT03434730|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5631399|NCT03434730|Antitubercular Agents|antitubercular agents|mesh-ancestor
5631400|NCT03434730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5631401|NCT03417180|Remifentanil|remifentanil|mesh-list
5631402|NCT03417180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5631403|NCT03417180|Narcotics|narcotics|mesh-ancestor
5631404|NCT03417180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5631405|NCT03417180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5631406|NCT03417180|Analgesics|analgesics|mesh-ancestor
5631407|NCT03417180|Sensory System Agents|sensory system agents|mesh-ancestor
5631408|NCT03417180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5631409|NCT03392246|Osimertinib|osimertinib|mesh-list
5631410|NCT03392246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5631411|NCT03392246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5631412|NCT03392246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5631413|NCT03392246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631414|NCT03365791|Spartalizumab|spartalizumab|mesh-list
5631415|NCT03365791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5631416|NCT03365791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631417|NCT03365791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5631418|NCT03361345|Tranexamic Acid|tranexamic acid|mesh-list
5631419|NCT03361345|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5631420|NCT03361345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5756787|NCT02999230|Listerine|listerine|mesh-list
5756788|NCT02999230|Fluorides|fluorides|mesh-list
5756789|NCT02999230|Sodium Fluoride|sodium fluoride|mesh-list
5756790|NCT02999230|Cariostatic Agents|cariostatic agents|mesh-ancestor
5756791|NCT02999230|Protective Agents|protective agents|mesh-ancestor
5756792|NCT02999230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756793|NCT02999230|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5756794|NCT02999230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5756795|NCT02999204|Vitamin D|vitamin d|mesh-list
5756796|NCT02999204|Cholecalciferol|cholecalciferol|mesh-list
5756797|NCT02999204|Vitamins|vitamins|mesh-ancestor
5756798|NCT02999204|Micronutrients|micronutrients|mesh-ancestor
5756799|NCT02999204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756800|NCT02999204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5756801|NCT02999204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5756802|NCT02999217|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
5756803|NCT02999217|Hematinics|hematinics|mesh-ancestor
5756804|NCT02999087|Cetuximab|cetuximab|mesh-list
5756805|NCT02999087|Avelumab|avelumab|mesh-list
5631421|NCT03361345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631422|NCT03361345|Hemostatics|hemostatics|mesh-ancestor
5631423|NCT03361345|Coagulants|coagulants|mesh-ancestor
5631424|NCT03361306|Elotuzumab|elotuzumab|mesh-list
5756806|NCT02999087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5756807|NCT02999087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5756808|NCT02999126|Remifentanil|remifentanil|mesh-list
5756809|NCT02999126|Propofol|propofol|mesh-list
5631425|NCT03361306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5631426|NCT03358706|Vitamin K|vitamin k|mesh-list
5631427|NCT03358706|Midazolam|midazolam|mesh-list
5631428|NCT03358706|Dextromethorphan|dextromethorphan|mesh-list
5631429|NCT03358706|Caffeine|caffeine|mesh-list
5631430|NCT03358706|Ustekinumab|ustekinumab|mesh-list
5631431|NCT03358706|Omeprazole|omeprazole|mesh-list
5631432|NCT03358706|Warfarin|warfarin|mesh-list
5631433|NCT03358706|Vitamins|vitamins|mesh-ancestor
5631434|NCT03358706|Micronutrients|micronutrients|mesh-ancestor
5631435|NCT03358706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5631436|NCT03358706|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5631437|NCT03358706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5756810|NCT02999126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5895063|NCT05122117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5631438|NCT03358706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5631439|NCT03358706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5631440|NCT03358706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5631441|NCT03358706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5631442|NCT03358706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5631443|NCT03358706|Anesthetics, General|anesthetics, general|mesh-ancestor
5631444|NCT03358706|Anesthetics|anesthetics|mesh-ancestor
5631445|NCT03358706|GABA Modulators|gaba modulators|mesh-ancestor
5631446|NCT03358706|GABA Agents|gaba agents|mesh-ancestor
5631447|NCT03358706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5631448|NCT03358706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631449|NCT03358706|Anticoagulants|anticoagulants|mesh-ancestor
5631450|NCT03358706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5631451|NCT03358706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5631452|NCT03358706|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5631453|NCT03358706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5631454|NCT03358706|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5631455|NCT03358706|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5756811|NCT02999126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5756812|NCT02999126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756813|NCT02999126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5756814|NCT02999126|Anesthetics, General|anesthetics, general|mesh-ancestor
5756815|NCT02999126|Anesthetics|anesthetics|mesh-ancestor
5756816|NCT02999126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5756817|NCT02999126|Narcotics|narcotics|mesh-ancestor
5756818|NCT02999126|Analgesics|analgesics|mesh-ancestor
5756819|NCT02999126|Sensory System Agents|sensory system agents|mesh-ancestor
5756820|NCT02999126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5895064|NCT05122117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895065|NCT05122026|Isoniazid|isoniazid|mesh-list
5895066|NCT05122026|Rifapentine|rifapentine|mesh-list
5895067|NCT05122026|Rifampin|rifampin|mesh-list
5895068|NCT05122026|Antitubercular Agents|antitubercular agents|mesh-ancestor
5895069|NCT05122026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5895070|NCT05122026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5895071|NCT05122026|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5895072|NCT05122026|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5895073|NCT05122026|Antimetabolites|antimetabolites|mesh-ancestor
5895074|NCT05122026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895075|NCT05122026|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5895076|NCT05122026|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5895077|NCT05122026|Leprostatic Agents|leprostatic agents|mesh-ancestor
5631456|NCT03358706|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5631457|NCT03358706|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5631458|NCT03358706|Purinergic Agents|purinergic agents|mesh-ancestor
5631459|NCT03358706|Dermatologic Agents|dermatologic agents|mesh-ancestor
5631460|NCT03358706|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5631461|NCT03358706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5631462|NCT03358706|Hemostatics|hemostatics|mesh-ancestor
5631463|NCT03358706|Coagulants|coagulants|mesh-ancestor
5631464|NCT03358706|Antitussive Agents|antitussive agents|mesh-ancestor
5631465|NCT03358706|Respiratory System Agents|respiratory system agents|mesh-ancestor
5631466|NCT03358706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5895078|NCT05122026|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5895079|NCT05122026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5895080|NCT05122026|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5895081|NCT05122026|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5895082|NCT05122026|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5895083|NCT05122026|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5895084|NCT05122026|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5895085|NCT05122026|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5895086|NCT05121883|Edaravone|edaravone|mesh-list
5895087|NCT05121883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5895088|NCT05121883|Antioxidants|antioxidants|mesh-ancestor
5895089|NCT05121883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895090|NCT05121883|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5895091|NCT05121883|Protective Agents|protective agents|mesh-ancestor
5895092|NCT05121883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895093|NCT05121779|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5895094|NCT05121779|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5895095|NCT05121779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907828|NCT05167331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5907829|NCT05167331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907830|NCT05167331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5631467|NCT03358706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5631468|NCT03342196|Fludarabine|fludarabine|mesh-list
5631469|NCT03342196|Melphalan|melphalan|mesh-list
5756821|NCT02998970|Empagliflozin|empagliflozin|mesh-list
5756822|NCT02998970|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5756823|NCT02998970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5756824|NCT02998970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5756825|NCT02998970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756826|NCT02998918|Curcumin|curcumin|mesh-list
5756827|NCT02998918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5756828|NCT02998918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5756829|NCT02998918|Analgesics|analgesics|mesh-ancestor
5756830|NCT02998918|Sensory System Agents|sensory system agents|mesh-ancestor
5756831|NCT02998918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5756832|NCT02998918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756833|NCT02998918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5756834|NCT02998918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5756835|NCT02998918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5756836|NCT02998918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5756837|NCT02998918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5756838|NCT02998827|Thalidomide|thalidomide|mesh-list
5756839|NCT02998827|Azathioprine|azathioprine|mesh-list
5756840|NCT02998827|Infliximab|infliximab|mesh-list
5756841|NCT02998827|Dermatologic Agents|dermatologic agents|mesh-ancestor
5895096|NCT05121324|Midazolam|midazolam|mesh-list
6209026|NCT02140372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209027|NCT02140372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6209028|NCT02140411|Ranibizumab|ranibizumab|mesh-list
6209029|NCT02140411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6209030|NCT02140411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5631470|NCT03342196|Thiotepa|thiotepa|mesh-list
5631471|NCT03342196|Mitogens|mitogens|mesh-list
5631472|NCT03342196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5631473|NCT03342196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631474|NCT03342196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5631475|NCT03342196|Immunologic Factors|immunologic factors|mesh-ancestor
5631476|NCT03342196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5631477|NCT03342196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6209031|NCT02140411|Growth Substances|growth substances|mesh-ancestor
6209032|NCT02140411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5631478|NCT03342196|Alkylating Agents|alkylating agents|mesh-ancestor
5631479|NCT03342196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5631480|NCT03342196|Mitosis Modulators|mitosis modulators|mesh-ancestor
5631481|NCT03334617|Trastuzumab|trastuzumab|mesh-list
5631482|NCT03334617|Durvalumab|durvalumab|mesh-list
5631483|NCT03334617|Olaparib|olaparib|mesh-list
5631484|NCT03334617|Cediranib|cediranib|mesh-list
5631485|NCT03334617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6209033|NCT02140411|Growth Inhibitors|growth inhibitors|mesh-ancestor
6209034|NCT02140411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6209035|NCT02140593|Rocuronium|rocuronium|mesh-list
6209036|NCT02140593|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6209037|NCT02140593|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6209038|NCT02140593|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5631486|NCT03334617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5631487|NCT03334617|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5631488|NCT03334617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5631489|NCT03334617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631490|NCT03334617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6209039|NCT02140593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6209040|NCT02140593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209041|NCT02140645|Linagliptin|linagliptin|mesh-list
6209042|NCT02140645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6209043|NCT02140645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209044|NCT02140645|Incretins|incretins|mesh-ancestor
6209045|NCT02140645|Hormones|hormones|mesh-ancestor
6209046|NCT02140645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6209047|NCT02140645|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6209048|NCT02140645|Protease Inhibitors|protease inhibitors|mesh-ancestor
6209049|NCT02140645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6489884|NCT00594087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489885|NCT00594126|Imetelstat|imetelstat|mesh-list
6489886|NCT00594126|Motesanib diphosphate|motesanib diphosphate|mesh-list
6489887|NCT00594126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6489888|NCT00594126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489889|NCT00594126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6496366|NCT00627744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6496367|NCT00627744|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6496368|NCT00627744|Protease Inhibitors|protease inhibitors|mesh-ancestor
6496369|NCT00627744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6496370|NCT00627744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496371|NCT00627796|Lanreotide|lanreotide|mesh-list
6496372|NCT00627796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6496373|NCT00627809|Streptokinase|streptokinase|mesh-list
6496374|NCT00627809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6496375|NCT00627809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5631491|NCT03331289|Dapagliflozin|dapagliflozin|mesh-list
5631492|NCT03331289|Exenatide|exenatide|mesh-list
5631493|NCT03331289|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5631494|NCT03331289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631495|NCT03331289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5631496|NCT03331289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5631497|NCT03331289|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5631498|NCT03331289|Incretins|incretins|mesh-ancestor
5631499|NCT03331289|Hormones|hormones|mesh-ancestor
6496491|NCT00628225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5631500|NCT03331289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5631501|NCT03322566|Pembrolizumab|pembrolizumab|mesh-list
5756842|NCT02998827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5756843|NCT02998827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5631502|NCT03322566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5631503|NCT03322566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5631504|NCT03322540|Pembrolizumab|pembrolizumab|mesh-list
5756844|NCT02998827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5756845|NCT02998827|Immunologic Factors|immunologic factors|mesh-ancestor
5756846|NCT02998827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756847|NCT02998827|Leprostatic Agents|leprostatic agents|mesh-ancestor
5631505|NCT03322540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5631506|NCT03322540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5631507|NCT03321188|Paclitaxel|paclitaxel|mesh-list
5631508|NCT03321188|Carboplatin|carboplatin|mesh-list
5631509|NCT03321188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5631510|NCT03321188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5631511|NCT03321188|Tubulin Modulators|tubulin modulators|mesh-ancestor
5631512|NCT03321188|Antimitotic Agents|antimitotic agents|mesh-ancestor
5631513|NCT03321188|Mitosis Modulators|mitosis modulators|mesh-ancestor
5631514|NCT03321188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5756848|NCT02998827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5756849|NCT02998827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5756850|NCT02998827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5756851|NCT02998827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5756852|NCT02998827|Growth Substances|growth substances|mesh-ancestor
5756853|NCT02998827|Growth Inhibitors|growth inhibitors|mesh-ancestor
5756854|NCT02998827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5756855|NCT02998827|Antimetabolites|antimetabolites|mesh-ancestor
5631515|NCT03315260|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
5631516|NCT03315260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5631517|NCT03315026|Siltuximab|siltuximab|mesh-list
5631518|NCT03315026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5631519|NCT03311308|Metformin|metformin|mesh-list
5631520|NCT03311308|Pembrolizumab|pembrolizumab|mesh-list
5631521|NCT03311308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5631522|NCT03311308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5631523|NCT03311308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5631524|NCT03311308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6209050|NCT02140645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209051|NCT02140970|Ibuprofen|ibuprofen|mesh-list
6209052|NCT02140970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6209053|NCT02140970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6209054|NCT02140970|Analgesics|analgesics|mesh-ancestor
6209055|NCT02140970|Sensory System Agents|sensory system agents|mesh-ancestor
6209056|NCT02140970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6209057|NCT02140970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209058|NCT02140970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6209059|NCT02140970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5756856|NCT02998827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5756857|NCT02998827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5756858|NCT02998905|Aspirin|aspirin|mesh-list
5756859|NCT02998905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5756860|NCT02998905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5756861|NCT02998905|Analgesics|analgesics|mesh-ancestor
5756862|NCT02998905|Sensory System Agents|sensory system agents|mesh-ancestor
5756863|NCT02998905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5756864|NCT02998905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756865|NCT02998905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5756866|NCT02998905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5756867|NCT02998905|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5756868|NCT02998905|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5756869|NCT02998905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5756870|NCT02998905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5756871|NCT02998905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5756872|NCT02998905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5756873|NCT02998905|Antipyretics|antipyretics|mesh-ancestor
5756874|NCT02998736|Tadalafil|tadalafil|mesh-list
5756875|NCT02998736|Vasodilator Agents|vasodilator agents|mesh-ancestor
5756876|NCT02998736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5756877|NCT02998736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5756878|NCT02998736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5756879|NCT02998736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5756880|NCT02998736|Urological Agents|urological agents|mesh-ancestor
5756881|NCT02998606|Naloxegol|naloxegol|mesh-list
5756882|NCT02998606|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5756883|NCT02998606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756884|NCT02998606|Sensory System Agents|sensory system agents|mesh-ancestor
5756885|NCT02998606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5756886|NCT02998437|Amoxicillin|amoxicillin|mesh-list
5756887|NCT02998437|Clarithromycin|clarithromycin|mesh-list
5756888|NCT02998437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5756889|NCT02998437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5756890|NCT02998437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5756891|NCT02998437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5756892|NCT02998437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5756893|NCT02998437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5756894|NCT02998437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5756895|NCT02998567|Pembrolizumab|pembrolizumab|mesh-list
5756896|NCT02998567|Guadecitabine|guadecitabine|mesh-list
5756897|NCT02998567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5756898|NCT02998567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5756899|NCT02998424|Propofol|propofol|mesh-list
5756900|NCT02998424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5756901|NCT02998424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5756902|NCT02998424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756903|NCT02998424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5631536|NCT03292133|Gefitinib|gefitinib|mesh-list
5756904|NCT02998424|Anesthetics, General|anesthetics, general|mesh-ancestor
5756905|NCT02998424|Anesthetics|anesthetics|mesh-ancestor
5756906|NCT02998528|Gemcitabine|gemcitabine|mesh-list
5756907|NCT02998528|Paclitaxel|paclitaxel|mesh-list
5756908|NCT02998528|Vinorelbine|vinorelbine|mesh-list
5756909|NCT02998528|Docetaxel|docetaxel|mesh-list
5631537|NCT03292133|Nazartinib|nazartinib|mesh-list
5631538|NCT03292133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5631539|NCT03292133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5631540|NCT03292133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5631541|NCT03292133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631542|NCT03267589|Durvalumab|durvalumab|mesh-list
5631543|NCT03267589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5631544|NCT03267589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5631545|NCT03255096|Rituximab|rituximab|mesh-list
5756910|NCT02998528|Carboplatin|carboplatin|mesh-list
5756911|NCT02998528|Nivolumab|nivolumab|mesh-list
5756912|NCT02998528|Pemetrexed|pemetrexed|mesh-list
5756913|NCT02998528|Ipilimumab|ipilimumab|mesh-list
5756914|NCT02998528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5756915|NCT02998528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5631546|NCT03255096|Venetoclax|venetoclax|mesh-list
5631547|NCT03255096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5756916|NCT02998528|Tubulin Modulators|tubulin modulators|mesh-ancestor
5756917|NCT02998528|Antimitotic Agents|antimitotic agents|mesh-ancestor
5756918|NCT02998528|Mitosis Modulators|mitosis modulators|mesh-ancestor
5756919|NCT02998528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5756920|NCT02998528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5756921|NCT02998528|Antimetabolites|antimetabolites|mesh-ancestor
5756922|NCT02998528|Antiviral Agents|antiviral agents|mesh-ancestor
5756923|NCT02998528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5756924|NCT02998528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5756925|NCT02998528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5756926|NCT02998528|Immunologic Factors|immunologic factors|mesh-ancestor
5756927|NCT02998528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756928|NCT02998528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5756929|NCT02998528|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5756930|NCT02998528|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5756931|NCT02998528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5756932|NCT02998242|Apatinib|apatinib|mesh-list
5756933|NCT02998242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6673166|NCT01560754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6673167|NCT01560754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6673168|NCT01560754|Cholinergic Agents|cholinergic agents|mesh-ancestor
6673169|NCT01560754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6673170|NCT01560754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631548|NCT03255096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5631549|NCT03255096|Immunologic Factors|immunologic factors|mesh-ancestor
5631550|NCT03255096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5631551|NCT03255096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5631552|NCT03237702|Carotenoids|carotenoids|mesh-list
5631553|NCT03237702|Antioxidants|antioxidants|mesh-ancestor
5631554|NCT03237702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631555|NCT03237702|Protective Agents|protective agents|mesh-ancestor
5756934|NCT02998242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5756935|NCT02998242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5756936|NCT02998242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5756937|NCT02998385|Cisplatin|cisplatin|mesh-list
5756938|NCT02998385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5756939|NCT02998398|Infliximab|infliximab|mesh-list
5756940|NCT02998398|Dermatologic Agents|dermatologic agents|mesh-ancestor
5756941|NCT02998398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5756942|NCT02998398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5756943|NCT02998268|Paclitaxel|paclitaxel|mesh-list
5756944|NCT02998268|Carboplatin|carboplatin|mesh-list
5756945|NCT02998268|Pembrolizumab|pembrolizumab|mesh-list
5756946|NCT02998268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5756947|NCT02998268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5756948|NCT02998268|Tubulin Modulators|tubulin modulators|mesh-ancestor
5756949|NCT02998268|Antimitotic Agents|antimitotic agents|mesh-ancestor
5756950|NCT02998268|Mitosis Modulators|mitosis modulators|mesh-ancestor
5631556|NCT03237702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5631557|NCT03233139|Ipilimumab|ipilimumab|mesh-list
5631558|NCT03233139|Cemiplimab|cemiplimab|mesh-list
5631559|NCT03233139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5631560|NCT03233139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5631561|NCT03233139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5631562|NCT03233139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631563|NCT03221751|Prazosin|prazosin|mesh-list
5631564|NCT03221751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5756951|NCT02998268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5756952|NCT02998268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5895097|NCT05121324|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5631565|NCT03221751|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5631566|NCT03221751|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5756953|NCT02998320|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5756954|NCT02998320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5756955|NCT02998320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5756956|NCT02998320|Antiviral Agents|antiviral agents|mesh-ancestor
5756957|NCT02998320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5756958|NCT02998047|Lintuzumab|lintuzumab|mesh-list
5756959|NCT02998047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5756960|NCT02998047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5756961|NCT02997969|Vaccines|vaccines|mesh-list
5756962|NCT02997969|MF59 oil emulsion|mf59 oil emulsion|mesh-list
5756963|NCT02997969|Immunologic Factors|immunologic factors|mesh-ancestor
5756964|NCT02997969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756965|NCT02997969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5756966|NCT02997995|Durvalumab|durvalumab|mesh-list
5756967|NCT02997995|Tremelimumab|tremelimumab|mesh-list
5756968|NCT02997995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5756969|NCT02997995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5756970|NCT02997800|Labetalol|labetalol|mesh-list
5756971|NCT02997800|Fentanyl|fentanyl|mesh-list
5756972|NCT02997800|Esmolol|esmolol|mesh-list
5756973|NCT02997800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5756974|NCT02997800|Narcotics|narcotics|mesh-ancestor
5756975|NCT02997800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5756976|NCT02997800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756977|NCT02997800|Analgesics|analgesics|mesh-ancestor
5756978|NCT02997800|Sensory System Agents|sensory system agents|mesh-ancestor
5756979|NCT02997800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5756980|NCT02997800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5756981|NCT02997800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5756982|NCT02997800|Anesthetics, General|anesthetics, general|mesh-ancestor
5756983|NCT02997800|Anesthetics|anesthetics|mesh-ancestor
5756984|NCT02997800|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5756985|NCT02997800|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5756986|NCT02997800|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5756987|NCT02997800|Adrenergic Agents|adrenergic agents|mesh-ancestor
5756988|NCT02997800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5756989|NCT02997800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5756990|NCT02997800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5756991|NCT02997800|Sympathomimetics|sympathomimetics|mesh-ancestor
5756992|NCT02997800|Autonomic Agents|autonomic agents|mesh-ancestor
5756993|NCT02997800|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5756994|NCT02997800|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5756995|NCT02997657|Nicotine|nicotine|mesh-list
5756996|NCT02997657|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5756997|NCT02997657|Autonomic Agents|autonomic agents|mesh-ancestor
6489890|NCT00594191|Simvastatin|simvastatin|mesh-list
6489891|NCT00594191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6489892|NCT00594191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6489893|NCT00594191|Antimetabolites|antimetabolites|mesh-ancestor
6489894|NCT00594191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489895|NCT00594191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6489896|NCT00594191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6489897|NCT00594191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6489898|NCT00594217|Progesterone|progesterone|mesh-list
6489899|NCT00594217|Progestins|progestins|mesh-ancestor
6489900|NCT00594217|Hormones|hormones|mesh-ancestor
6489901|NCT00594217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6489902|NCT00594217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489903|NCT00594269|Risperidone|risperidone|mesh-list
6489904|NCT00594269|Citalopram|citalopram|mesh-list
6489905|NCT00594269|Sertraline|sertraline|mesh-list
6489906|NCT00594269|Paroxetine|paroxetine|mesh-list
6489907|NCT00594269|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6489908|NCT00594269|Serotonin Agents|serotonin agents|mesh-ancestor
6489909|NCT00594269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6489910|NCT00594269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489911|NCT00594269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5756998|NCT02997657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5756999|NCT02997657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757000|NCT02997657|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5757001|NCT02997657|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5757002|NCT02997657|Cholinergic Agents|cholinergic agents|mesh-ancestor
5757003|NCT02997657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5757004|NCT02997657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489912|NCT00594269|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5757005|NCT02997982|Valacyclovir|valacyclovir|mesh-list
5757006|NCT02997982|Antiviral Agents|antiviral agents|mesh-ancestor
5757007|NCT02997982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5757008|NCT02997514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5757009|NCT02997605|Prednisone|prednisone|mesh-list
5757010|NCT02997605|Hydrocortisone|hydrocortisone|mesh-list
5757011|NCT02997605|Glucocorticoids|glucocorticoids|mesh-list
5757012|NCT02997605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5757013|NCT02997605|Hormones|hormones|mesh-ancestor
5757014|NCT02997605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5757015|NCT02997605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757016|NCT02997605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5757017|NCT02997605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5895098|NCT05121324|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5895099|NCT05121324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5895100|NCT05121324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895101|NCT05121324|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5895102|NCT05121324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5895103|NCT05121324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5895104|NCT05121324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5631567|NCT03221751|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5631568|NCT03221751|Adrenergic Agents|adrenergic agents|mesh-ancestor
5631569|NCT03221751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5631570|NCT03221751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631571|NCT03221751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5631572|NCT03191084|Dronabinol|dronabinol|mesh-list
5631573|NCT03191084|Hallucinogens|hallucinogens|mesh-ancestor
5631574|NCT03191084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5631575|NCT03191084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5631576|NCT03191084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5631577|NCT03191084|Analgesics|analgesics|mesh-ancestor
5631578|NCT03191084|Sensory System Agents|sensory system agents|mesh-ancestor
5631579|NCT03191084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5631580|NCT03191084|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5631581|NCT03191084|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5631582|NCT03191084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5631583|NCT03191084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631584|NCT03191084|Hormones|hormones|mesh-ancestor
5631585|NCT03191084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5631586|NCT03189719|Pembrolizumab|pembrolizumab|mesh-list
5631587|NCT03189719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5631588|NCT03189719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5631589|NCT03184155|Nicardipine|nicardipine|mesh-list
5631590|NCT03184155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5631591|NCT03184155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5631592|NCT03184155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5631593|NCT03184155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631594|NCT03184155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5631595|NCT03184155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5631596|NCT03184155|Vasodilator Agents|vasodilator agents|mesh-ancestor
5631597|NCT03181867|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5895105|NCT05121324|Anesthetics, General|anesthetics, general|mesh-ancestor
5895106|NCT05121324|Anesthetics|anesthetics|mesh-ancestor
5895107|NCT05121324|GABA Modulators|gaba modulators|mesh-ancestor
5895108|NCT05121324|GABA Agents|gaba agents|mesh-ancestor
5895109|NCT05121324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5895110|NCT05121324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631598|NCT03181867|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5631599|NCT03181867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631600|NCT03173924|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5631601|NCT03173924|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5631602|NCT03173924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631603|NCT03161912|Aflibercept|aflibercept|mesh-list
5631604|NCT03161912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5631605|NCT03161912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5631606|NCT03161912|Growth Substances|growth substances|mesh-ancestor
5631607|NCT03161912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5631608|NCT03161912|Growth Inhibitors|growth inhibitors|mesh-ancestor
5631609|NCT03161912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5631610|NCT03149809|Solifenacin Succinate|solifenacin succinate|mesh-list
5631611|NCT03149809|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5631612|NCT03149809|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5631613|NCT03149809|Cholinergic Agents|cholinergic agents|mesh-ancestor
5895111|NCT05121233|Diclofenac|diclofenac|mesh-list
5631614|NCT03149809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5631615|NCT03149809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631616|NCT03149809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5631617|NCT03149809|Urological Agents|urological agents|mesh-ancestor
5693221|NCT03402204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5757018|NCT02997371|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5757019|NCT02997371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5757020|NCT02997410|Salicylic Acid|salicylic acid|mesh-list
5757021|NCT02997410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5757022|NCT02997410|Antifungal Agents|antifungal agents|mesh-ancestor
5757023|NCT02997410|Keratolytic Agents|keratolytic agents|mesh-ancestor
5757024|NCT02997410|Dermatologic Agents|dermatologic agents|mesh-ancestor
5757025|NCT02997332|Docetaxel|docetaxel|mesh-list
5757026|NCT02997332|Fluorouracil|fluorouracil|mesh-list
5757027|NCT02997332|Durvalumab|durvalumab|mesh-list
5757028|NCT02997332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5757029|NCT02997332|Tubulin Modulators|tubulin modulators|mesh-ancestor
5757030|NCT02997332|Antimitotic Agents|antimitotic agents|mesh-ancestor
5757031|NCT02997332|Mitosis Modulators|mitosis modulators|mesh-ancestor
5757032|NCT02997332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757033|NCT02997332|Antimetabolites|antimetabolites|mesh-ancestor
5757034|NCT02997332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5757035|NCT02997332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5693222|NCT03402204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5693223|NCT03402204|Antiviral Agents|antiviral agents|mesh-ancestor
5693224|NCT03402191|Sildenafil Citrate|sildenafil citrate|mesh-list
5693225|NCT03402191|Vasodilator Agents|vasodilator agents|mesh-ancestor
5693226|NCT03402191|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5693227|NCT03402191|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5693228|NCT03402191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5693229|NCT03402191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693230|NCT03402191|Urological Agents|urological agents|mesh-ancestor
5693231|NCT03402165|Sofosbuvir|sofosbuvir|mesh-list
5693232|NCT03402165|Ledipasvir|ledipasvir|mesh-list
5693233|NCT03402165|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
5693234|NCT03402165|Antiviral Agents|antiviral agents|mesh-ancestor
5693235|NCT03402165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5693236|NCT03402152|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
5693237|NCT03402152|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5693238|NCT03402152|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5693239|NCT03402152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5693240|NCT03402152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693241|NCT03402152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5693242|NCT03402152|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5693243|NCT03402152|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5693244|NCT03402152|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5693245|NCT03402152|Adrenergic Agents|adrenergic agents|mesh-ancestor
5757036|NCT02997332|Immunologic Factors|immunologic factors|mesh-ancestor
5757037|NCT02997332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757038|NCT02997332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5757039|NCT02997215|Lidocaine|lidocaine|mesh-list
5757040|NCT02997215|Anesthetics, Local|anesthetics, local|mesh-ancestor
5757041|NCT02997215|Anesthetics|anesthetics|mesh-ancestor
5757042|NCT02997215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5757043|NCT02997215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757044|NCT02997215|Sensory System Agents|sensory system agents|mesh-ancestor
5757045|NCT02997215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5757046|NCT02997215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5757047|NCT02997215|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5757048|NCT02997215|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5757049|NCT02997215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5757050|NCT02997215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757051|NCT02996916|Amlodipine|amlodipine|mesh-list
5757052|NCT02996916|Olmesartan|olmesartan|mesh-list
5757053|NCT02996916|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5757054|NCT02996916|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6673171|NCT01560962|Azithromycin|azithromycin|mesh-list
6673172|NCT01560962|Tobramycin|tobramycin|mesh-list
6673173|NCT01560962|Povidone-Iodine|povidone-iodine|mesh-list
6673174|NCT01560962|Povidone|povidone|mesh-list
6673175|NCT01560962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5757055|NCT02996916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6673176|NCT01560962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5693246|NCT03402152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5757056|NCT02996916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757057|NCT02996916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5757058|NCT02996916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757059|NCT02996916|Vasodilator Agents|vasodilator agents|mesh-ancestor
5757060|NCT02996916|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5631618|NCT03126435|Gemcitabine|gemcitabine|mesh-list
5631619|NCT03126435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5631620|NCT03126435|Antimetabolites|antimetabolites|mesh-ancestor
5631621|NCT03126435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631622|NCT03126435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5631623|NCT03126435|Antiviral Agents|antiviral agents|mesh-ancestor
5631624|NCT03126435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5631625|NCT03126435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5631626|NCT03126435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5631627|NCT03126435|Immunologic Factors|immunologic factors|mesh-ancestor
5631628|NCT03126435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5631629|NCT03104400|Adalimumab|adalimumab|mesh-list
5631630|NCT03104400|Upadacitinib|upadacitinib|mesh-list
5631631|NCT03104400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5631632|NCT03104400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5631633|NCT03104400|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
5757061|NCT02996916|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5757062|NCT02996942|Factor VIII|factor viii|mesh-list
5757063|NCT02996942|Coagulants|coagulants|mesh-ancestor
5757064|NCT02997059|Fluconazole|fluconazole|mesh-list
5757065|NCT02997059|Antifungal Agents|antifungal agents|mesh-ancestor
5757066|NCT02997059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5757067|NCT02997059|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5757068|NCT02997059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5757069|NCT02997059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5757070|NCT02997059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757071|NCT02997059|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5757072|NCT02997059|Hormone Antagonists|hormone antagonists|mesh-ancestor
5757073|NCT02997059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5757074|NCT02997059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757075|NCT02997059|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5757076|NCT02997059|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5631634|NCT03104400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5631635|NCT03104400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5631636|NCT03104400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631637|NCT03104374|Upadacitinib|upadacitinib|mesh-list
5631638|NCT03104374|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
5631639|NCT03104374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5631640|NCT03104374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5631641|NCT03104374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631642|NCT03104374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5631643|NCT03098654|Metformin|metformin|mesh-list
5631644|NCT03098654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5631645|NCT03098654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5631646|NCT03078010|Tazobactam|tazobactam|mesh-list
5631647|NCT03078010|Piperacillin|piperacillin|mesh-list
5631648|NCT03078010|Cefepime|cefepime|mesh-list
5631649|NCT03078010|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
5631650|NCT03078010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5631651|NCT03078010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5631652|NCT03078010|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5631653|NCT03078010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5631654|NCT03078010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631655|NCT03072043|Azacitidine|azacitidine|mesh-list
5631656|NCT03072043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5631657|NCT03072043|Antimetabolites|antimetabolites|mesh-ancestor
5631658|NCT03072043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757077|NCT02996734|Denosumab|denosumab|mesh-list
5757078|NCT02996734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5757079|NCT02996734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757080|NCT02996760|Mitogens|mitogens|mesh-list
5757081|NCT02996760|Mitosis Modulators|mitosis modulators|mesh-ancestor
5757082|NCT02996760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757083|NCT02996656|Cefazolin|cefazolin|mesh-list
5757084|NCT02996656|Ceftriaxone|ceftriaxone|mesh-list
5757085|NCT02996656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5757086|NCT02996656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5757087|NCT02996721|Vitamin D|vitamin d|mesh-list
5757088|NCT02996721|Cholecalciferol|cholecalciferol|mesh-list
5631659|NCT03072043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5631660|NCT03072043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5631661|NCT03049462|Ascorbic Acid|ascorbic acid|mesh-list
5631662|NCT03049462|Mirabegron|mirabegron|mesh-list
5631663|NCT03049462|Vitamins|vitamins|mesh-ancestor
5631664|NCT03049462|Micronutrients|micronutrients|mesh-ancestor
5631665|NCT03049462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5631666|NCT03049462|Antioxidants|antioxidants|mesh-ancestor
5631667|NCT03049462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631668|NCT03049462|Protective Agents|protective agents|mesh-ancestor
5631669|NCT03049462|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
5631670|NCT03049462|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5631671|NCT03049462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5631672|NCT03049462|Adrenergic Agents|adrenergic agents|mesh-ancestor
5631673|NCT03049462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5631674|NCT03049462|Urological Agents|urological agents|mesh-ancestor
5631675|NCT03016013|Methotrexate|methotrexate|mesh-list
5631676|NCT03016013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5631677|NCT03016013|Abortifacient Agents|abortifacient agents|mesh-ancestor
5631678|NCT03016013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5631679|NCT03016013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5631680|NCT03016013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5757089|NCT02996721|Vitamins|vitamins|mesh-ancestor
5757090|NCT02996721|Micronutrients|micronutrients|mesh-ancestor
5757091|NCT02996721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757092|NCT02996721|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5757093|NCT02996721|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5757094|NCT02996773|Cyclophosphamide|cyclophosphamide|mesh-list
5757095|NCT02996773|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5757096|NCT02996773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5757097|NCT02996773|Immunologic Factors|immunologic factors|mesh-ancestor
5757098|NCT02996773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757099|NCT02996773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5757100|NCT02996773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5757101|NCT02996773|Alkylating Agents|alkylating agents|mesh-ancestor
5757102|NCT02996773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757103|NCT02996773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5757104|NCT02996773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5757105|NCT02996695|Artesunate|artesunate|mesh-list
5757106|NCT02996695|Chloroquine|chloroquine|mesh-list
5757107|NCT02996695|Antimalarials|antimalarials|mesh-ancestor
5757108|NCT02996695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5757109|NCT02996695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5757110|NCT02996695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5757111|NCT02996695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5757112|NCT02996695|Antiviral Agents|antiviral agents|mesh-ancestor
5757113|NCT02996695|Schistosomicides|schistosomicides|mesh-ancestor
5631681|NCT03016013|Antimetabolites|antimetabolites|mesh-ancestor
5631682|NCT03016013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631683|NCT03016013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5631684|NCT03016013|Dermatologic Agents|dermatologic agents|mesh-ancestor
5631685|NCT03016013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5631686|NCT03016013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5631687|NCT03016013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5631688|NCT03016013|Immunologic Factors|immunologic factors|mesh-ancestor
5631689|NCT03016013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5757114|NCT02996695|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5757115|NCT02996695|Anthelmintics|anthelmintics|mesh-ancestor
5757116|NCT02996695|Amebicides|amebicides|mesh-ancestor
5757117|NCT02996695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5757118|NCT02996513|Vitamin A|vitamin a|mesh-list
5757119|NCT02996513|Vitamins|vitamins|mesh-ancestor
5757120|NCT02996513|Micronutrients|micronutrients|mesh-ancestor
5757121|NCT02996513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757122|NCT02996487|Vancomycin|vancomycin|mesh-list
5757123|NCT02996487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5757124|NCT02996487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5757125|NCT02996409|Lidocaine|lidocaine|mesh-list
5757126|NCT02996409|Anesthetics, Local|anesthetics, local|mesh-ancestor
5757127|NCT02996409|Anesthetics|anesthetics|mesh-ancestor
5757128|NCT02996409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5757129|NCT02996409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757130|NCT02996409|Sensory System Agents|sensory system agents|mesh-ancestor
5757131|NCT02996409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5757132|NCT02996409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5757133|NCT02996409|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5757134|NCT02996409|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5757135|NCT02996409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5631690|NCT03016013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5757136|NCT02996409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757137|NCT02996318|Sirolimus|sirolimus|mesh-list
5757138|NCT02996318|Paclitaxel|paclitaxel|mesh-list
5757139|NCT02996318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5757140|NCT02996318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5757141|NCT02996318|Tubulin Modulators|tubulin modulators|mesh-ancestor
5757142|NCT02996318|Antimitotic Agents|antimitotic agents|mesh-ancestor
5757143|NCT02996318|Mitosis Modulators|mitosis modulators|mesh-ancestor
5631691|NCT03015324|Hydroxychloroquine|hydroxychloroquine|mesh-list
5631692|NCT03015324|Antimalarials|antimalarials|mesh-ancestor
5631693|NCT03015324|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5631694|NCT03015324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5631695|NCT03015324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5631696|NCT03015324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5757144|NCT02996318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757145|NCT02996318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5757146|NCT02996318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5757147|NCT02996318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5757148|NCT02996318|Antifungal Agents|antifungal agents|mesh-ancestor
5757149|NCT02996318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5757150|NCT02996318|Immunologic Factors|immunologic factors|mesh-ancestor
5757151|NCT02996318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757152|NCT02996305|Gaboxadol|gaboxadol|mesh-list
5757153|NCT02996305|Analgesics|analgesics|mesh-ancestor
5757154|NCT02996305|Sensory System Agents|sensory system agents|mesh-ancestor
5757155|NCT02996305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5757156|NCT02996305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757157|NCT02996305|Anticonvulsants|anticonvulsants|mesh-ancestor
5757158|NCT02996305|GABA Agonists|gaba agonists|mesh-ancestor
5757159|NCT02996305|GABA Agents|gaba agents|mesh-ancestor
5757160|NCT02996305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5757161|NCT02996305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757162|NCT02996227|Bupivacaine|bupivacaine|mesh-list
5757163|NCT02996227|Anesthetics, Local|anesthetics, local|mesh-ancestor
5757164|NCT02996227|Anesthetics|anesthetics|mesh-ancestor
5757165|NCT02996227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5757166|NCT02996227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757167|NCT02996227|Sensory System Agents|sensory system agents|mesh-ancestor
5757168|NCT02996227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5757169|NCT02996214|Gemcitabine|gemcitabine|mesh-list
5757170|NCT02996214|Paclitaxel|paclitaxel|mesh-list
5757171|NCT02996214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5757172|NCT02996214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5757173|NCT02996214|Tubulin Modulators|tubulin modulators|mesh-ancestor
5757174|NCT02996214|Antimitotic Agents|antimitotic agents|mesh-ancestor
5757175|NCT02996214|Mitosis Modulators|mitosis modulators|mesh-ancestor
5757176|NCT02996214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757177|NCT02996214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5757178|NCT02996214|Antimetabolites|antimetabolites|mesh-ancestor
5757179|NCT02996214|Antiviral Agents|antiviral agents|mesh-ancestor
5757180|NCT02996214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5757181|NCT02996214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6489913|NCT00594269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6489914|NCT00594269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6489915|NCT00594269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6489916|NCT00594269|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6489917|NCT00594269|Dopamine Agents|dopamine agents|mesh-ancestor
5631697|NCT03015324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631698|NCT03015324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5631699|NCT03011307|Oxytocin|oxytocin|mesh-list
5757182|NCT02996214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5757183|NCT02996214|Immunologic Factors|immunologic factors|mesh-ancestor
5757184|NCT02996214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757185|NCT02995954|Amlodipine|amlodipine|mesh-list
5757186|NCT02995954|Perindopril|perindopril|mesh-list
5757187|NCT02995954|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5757188|NCT02995954|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5757189|NCT02995954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5757190|NCT02995954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757191|NCT02995954|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5757192|NCT02995954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757193|NCT02995954|Vasodilator Agents|vasodilator agents|mesh-ancestor
5757194|NCT02995954|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5757195|NCT02995954|Protease Inhibitors|protease inhibitors|mesh-ancestor
5631700|NCT03011307|Oxytocics|oxytocics|mesh-ancestor
5631701|NCT03011307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5631702|NCT03011307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5631703|NCT02981069|Dapagliflozin|dapagliflozin|mesh-list
5631704|NCT02981069|Exenatide|exenatide|mesh-list
5631705|NCT02981069|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5631706|NCT02981069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631707|NCT02981069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5631708|NCT02981069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757196|NCT02995954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5757197|NCT02996058|Dexmedetomidine|dexmedetomidine|mesh-list
5757198|NCT02996058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5757199|NCT02996058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5757200|NCT02996058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757201|NCT02996058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5757202|NCT02996058|Analgesics|analgesics|mesh-ancestor
5757203|NCT02996058|Sensory System Agents|sensory system agents|mesh-ancestor
5757204|NCT02996058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5757205|NCT02996058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5757206|NCT02996058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5757207|NCT02996058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5757208|NCT02996058|Adrenergic Agents|adrenergic agents|mesh-ancestor
5757209|NCT02996058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5757210|NCT02996058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757211|NCT02996110|Nivolumab|nivolumab|mesh-list
6489918|NCT00594269|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6489919|NCT00594269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6489920|NCT00594269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6489921|NCT00594269|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6489922|NCT00594269|Antidepressive Agents|antidepressive agents|mesh-ancestor
6489923|NCT00594269|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6489924|NCT00594269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6489925|NCT00594269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6489926|NCT00594334|Risedronic Acid|risedronic acid|mesh-list
6489927|NCT00594334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6489928|NCT00594334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6496492|NCT00628225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5631709|NCT02981069|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5631710|NCT02981069|Incretins|incretins|mesh-ancestor
5631711|NCT02981069|Hormones|hormones|mesh-ancestor
5631712|NCT02981069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5631713|NCT02970981|Nivolumab|nivolumab|mesh-list
5631714|NCT02970981|Ipilimumab|ipilimumab|mesh-list
5631715|NCT02970981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5631716|NCT02970981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5631717|NCT02970981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5631718|NCT02970981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757212|NCT02996110|Ipilimumab|ipilimumab|mesh-list
5757213|NCT02996110|Linrodostat|linrodostat|mesh-list
5757214|NCT02996110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5757215|NCT02996110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5757216|NCT02996110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5757217|NCT02996110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757218|NCT02996110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5757219|NCT02996019|Etrolizumab|etrolizumab|mesh-list
5757220|NCT02996019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5757221|NCT02996019|Immunologic Factors|immunologic factors|mesh-ancestor
5757222|NCT02996019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895112|NCT05121233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5895113|NCT05121233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6489929|NCT00594334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496493|NCT00628238|Rituximab|rituximab|mesh-list
5757223|NCT02995772|Tamoxifen|tamoxifen|mesh-list
5757224|NCT02995772|Fluorouracil|fluorouracil|mesh-list
5757225|NCT02995772|Letrozole|letrozole|mesh-list
5757226|NCT02995772|Anastrozole|anastrozole|mesh-list
5757227|NCT02995772|Exemestane|exemestane|mesh-list
5757228|NCT02995772|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5757229|NCT02995772|Antimetabolites|antimetabolites|mesh-ancestor
5757230|NCT02995772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757231|NCT02995772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5757232|NCT02995772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5757233|NCT02995772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5757234|NCT02995772|Immunologic Factors|immunologic factors|mesh-ancestor
5757235|NCT02995772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757236|NCT02995772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5757237|NCT02995772|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5757238|NCT02995772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5757239|NCT02995772|Hormone Antagonists|hormone antagonists|mesh-ancestor
5757240|NCT02995772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5757241|NCT02995772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5757242|NCT02995772|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5757243|NCT02995772|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5757244|NCT02995772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5757245|NCT02995824|Raltegravir Potassium|raltegravir potassium|mesh-list
5757246|NCT02995824|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
5757247|NCT02995824|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5757248|NCT02995824|Antiviral Agents|antiviral agents|mesh-ancestor
5757249|NCT02995824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5757250|NCT02995824|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5757251|NCT02995824|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5757252|NCT02995824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5757253|NCT02995824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757254|NCT02995720|Amlodipine|amlodipine|mesh-list
5757255|NCT02995720|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5757256|NCT02995720|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5757257|NCT02995720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5757258|NCT02995720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5757259|NCT02995720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757260|NCT02995720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5757261|NCT02995720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757262|NCT02995720|Vasodilator Agents|vasodilator agents|mesh-ancestor
5757263|NCT02995720|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5757264|NCT02995720|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5757265|NCT02995720|Antimetabolites|antimetabolites|mesh-ancestor
5757266|NCT02995720|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5757267|NCT02995720|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5757268|NCT02995720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5757269|NCT02995707|Thalidomide|thalidomide|mesh-list
5757270|NCT02995707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5757271|NCT02995707|Immunologic Factors|immunologic factors|mesh-ancestor
5757272|NCT02995707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757273|NCT02995707|Leprostatic Agents|leprostatic agents|mesh-ancestor
5757274|NCT02995707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5757275|NCT02995707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5757276|NCT02995707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5757277|NCT02995707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5757278|NCT02995707|Growth Substances|growth substances|mesh-ancestor
5757279|NCT02995707|Growth Inhibitors|growth inhibitors|mesh-ancestor
5757280|NCT02995707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5757281|NCT02995746|Dexamethasone|dexamethasone|mesh-list
5757282|NCT02995746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5757283|NCT02995746|Antiemetics|antiemetics|mesh-ancestor
5757284|NCT02995746|Autonomic Agents|autonomic agents|mesh-ancestor
5631719|NCT02932956|Cyclophosphamide|cyclophosphamide|mesh-list
5631720|NCT02932956|Fludarabine|fludarabine|mesh-list
5631721|NCT02932956|Fludarabine phosphate|fludarabine phosphate|mesh-list
5895114|NCT05121233|Analgesics|analgesics|mesh-ancestor
5631722|NCT02932956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5631723|NCT02932956|Immunologic Factors|immunologic factors|mesh-ancestor
5631724|NCT02932956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5631725|NCT02932956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5631726|NCT02932956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5631727|NCT02932956|Alkylating Agents|alkylating agents|mesh-ancestor
5631728|NCT02932956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631729|NCT02932956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5631730|NCT02932956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5631731|NCT02932956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5631732|NCT02932956|Antimetabolites|antimetabolites|mesh-ancestor
5631733|NCT02911935|Azithromycin|azithromycin|mesh-list
5631734|NCT02911935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5631735|NCT02911935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5631736|NCT02909452|Pembrolizumab|pembrolizumab|mesh-list
5757285|NCT02995746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5757286|NCT02995746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757287|NCT02995746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5757288|NCT02995746|Glucocorticoids|glucocorticoids|mesh-ancestor
5757289|NCT02995746|Hormones|hormones|mesh-ancestor
5757290|NCT02995746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5757291|NCT02995746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5757292|NCT02995746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5757293|NCT02995512|Colchicine|colchicine|mesh-list
5757294|NCT02995512|Gout Suppressants|gout suppressants|mesh-ancestor
5757295|NCT02995512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5757296|NCT02995512|Tubulin Modulators|tubulin modulators|mesh-ancestor
5757297|NCT02995512|Antimitotic Agents|antimitotic agents|mesh-ancestor
5757298|NCT02995512|Mitosis Modulators|mitosis modulators|mesh-ancestor
5757299|NCT02995512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757300|NCT02995512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5757301|NCT02995642|Arginyl-glycyl-aspartic acid|arginyl-glycyl-aspartic acid|mesh-list
5757302|NCT02995642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5757303|NCT02995655|Azacitidine|azacitidine|mesh-list
5757304|NCT02995655|Heparin|heparin|mesh-list
5757305|NCT02995655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5757306|NCT02995655|Antimetabolites|antimetabolites|mesh-ancestor
5757307|NCT02995655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631737|NCT02909452|Entinostat|entinostat|mesh-list
5631738|NCT02909452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5631739|NCT02909452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5631740|NCT02909452|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5631741|NCT02909452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5631742|NCT02909452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631743|NCT02909036|Melphalan|melphalan|mesh-list
5631744|NCT02909036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5631745|NCT02909036|Alkylating Agents|alkylating agents|mesh-ancestor
5631746|NCT02909036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631747|NCT02909036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5757308|NCT02995655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5757309|NCT02995655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5757310|NCT02995655|Anticoagulants|anticoagulants|mesh-ancestor
5757311|NCT02995655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5757312|NCT02995655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5757313|NCT02995291|Phentolamine|phentolamine|mesh-list
5757314|NCT02995291|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5757315|NCT02995291|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5757316|NCT02995291|Adrenergic Agents|adrenergic agents|mesh-ancestor
5757317|NCT02995291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5757318|NCT02995291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757319|NCT02995291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757320|NCT02995291|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5631748|NCT02909036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5631749|NCT02909036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5757321|NCT02995330|Cyclophosphamide|cyclophosphamide|mesh-list
5757322|NCT02995330|Methyltestosterone|methyltestosterone|mesh-list
5757323|NCT02995330|Testosterone|testosterone|mesh-list
5757324|NCT02995330|Testosterone undecanoate|testosterone undecanoate|mesh-list
5757325|NCT02995330|Testosterone enanthate|testosterone enanthate|mesh-list
5757326|NCT02995330|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5757327|NCT02995330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5757328|NCT02995330|Immunologic Factors|immunologic factors|mesh-ancestor
5757329|NCT02995330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5631750|NCT02909036|Immunologic Factors|immunologic factors|mesh-ancestor
5631751|NCT02909036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5631752|NCT02898506|Liraglutide|liraglutide|mesh-list
5631753|NCT02898506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5631754|NCT02898506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5631755|NCT02898506|Incretins|incretins|mesh-ancestor
5631756|NCT02898506|Hormones|hormones|mesh-ancestor
5631757|NCT02898506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5631758|NCT02880982|Vitamin D|vitamin d|mesh-list
5631759|NCT02880982|Cholecalciferol|cholecalciferol|mesh-list
5631760|NCT02880982|Vitamins|vitamins|mesh-ancestor
5631761|NCT02880982|Micronutrients|micronutrients|mesh-ancestor
5631762|NCT02880982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5631763|NCT02880982|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5631764|NCT02880982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5631765|NCT02880293|Mycophenolic Acid|mycophenolic acid|mesh-list
5631766|NCT02880293|Cyclophosphamide|cyclophosphamide|mesh-list
5631767|NCT02880293|Melphalan|melphalan|mesh-list
5631768|NCT02880293|Thiotepa|thiotepa|mesh-list
5631769|NCT02880293|Fludarabine|fludarabine|mesh-list
5631770|NCT02880293|Tacrolimus|tacrolimus|mesh-list
5631771|NCT02880293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5631772|NCT02880293|Immunologic Factors|immunologic factors|mesh-ancestor
5631773|NCT02880293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5631774|NCT02880293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5631775|NCT02880293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5631776|NCT02880293|Alkylating Agents|alkylating agents|mesh-ancestor
5631777|NCT02880293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631778|NCT02880293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5631779|NCT02880293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5631780|NCT02880293|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5631781|NCT02880293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5631782|NCT02880293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5631783|NCT02880293|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5631784|NCT02880293|Antitubercular Agents|antitubercular agents|mesh-ancestor
5631785|NCT02880293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5631786|NCT02880293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5631787|NCT02853500|Doxorubicin|doxorubicin|mesh-list
5631788|NCT02853500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5631789|NCT02853500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5631790|NCT02853500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5631791|NCT02853500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5631792|NCT02853500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5631793|NCT02853500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631794|NCT02842827|Tretinoin|tretinoin|mesh-list
5631795|NCT02842827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5631796|NCT02842827|Keratolytic Agents|keratolytic agents|mesh-ancestor
5631797|NCT02842827|Dermatologic Agents|dermatologic agents|mesh-ancestor
5631798|NCT02837029|Nivolumab|nivolumab|mesh-list
5631799|NCT02837029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5631800|NCT02837029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5631801|NCT02837029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5631802|NCT02837029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631803|NCT02819635|Upadacitinib|upadacitinib|mesh-list
5631804|NCT02819635|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
5631805|NCT02819635|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5631806|NCT02819635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5631807|NCT02819635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631808|NCT02819635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5631809|NCT02773238|Deoxyglucose|deoxyglucose|mesh-list
5757330|NCT02995330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5757331|NCT02995330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5757332|NCT02995330|Alkylating Agents|alkylating agents|mesh-ancestor
5757333|NCT02995330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757334|NCT02995330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5757335|NCT02995330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5631810|NCT02773238|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5631811|NCT02773238|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
5757336|NCT02995330|Androgens|androgens|mesh-ancestor
5757337|NCT02995330|Hormones|hormones|mesh-ancestor
5757338|NCT02995330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5757339|NCT02995330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5757340|NCT02995330|Anabolic Agents|anabolic agents|mesh-ancestor
5757341|NCT02995187|Apatinib|apatinib|mesh-list
5757342|NCT02995187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5757343|NCT02995187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5757344|NCT02995187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5757345|NCT02995187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757346|NCT02995057|Nickel|nickel|mesh-list
5631812|NCT02773238|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
5631813|NCT02773238|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5631814|NCT02773238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631815|NCT02773238|Antimetabolites|antimetabolites|mesh-ancestor
5631816|NCT02773238|Antiviral Agents|antiviral agents|mesh-ancestor
5631817|NCT02773238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5631818|NCT02740127|Dexamethasone|dexamethasone|mesh-list
5631819|NCT02740127|Clonidine|clonidine|mesh-list
5631820|NCT02740127|Epinephrine|epinephrine|mesh-list
5631821|NCT02740127|Propofol|propofol|mesh-list
5631822|NCT02740127|Ropivacaine|ropivacaine|mesh-list
5631823|NCT02740127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5631824|NCT02740127|Antiemetics|antiemetics|mesh-ancestor
5631825|NCT02740127|Autonomic Agents|autonomic agents|mesh-ancestor
5631826|NCT02740127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5631827|NCT02740127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5631828|NCT02740127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5631829|NCT02740127|Glucocorticoids|glucocorticoids|mesh-ancestor
5631830|NCT02740127|Hormones|hormones|mesh-ancestor
5631831|NCT02740127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5631832|NCT02740127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5631833|NCT02740127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5631834|NCT02740127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631835|NCT02740127|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5631836|NCT02740127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5631837|NCT02740127|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5631838|NCT02740127|Anesthetics, General|anesthetics, general|mesh-ancestor
5631839|NCT02740127|Anesthetics|anesthetics|mesh-ancestor
5631840|NCT02740127|Anesthetics, Local|anesthetics, local|mesh-ancestor
5631841|NCT02740127|Sensory System Agents|sensory system agents|mesh-ancestor
5631842|NCT02740127|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5631843|NCT02740127|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5631844|NCT02740127|Adrenergic Agents|adrenergic agents|mesh-ancestor
5631845|NCT02740127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5631846|NCT02740127|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5631847|NCT02740127|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5631848|NCT02740127|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5631849|NCT02740127|Respiratory System Agents|respiratory system agents|mesh-ancestor
5757347|NCT02995057|Trace Elements|trace elements|mesh-ancestor
5757348|NCT02995057|Micronutrients|micronutrients|mesh-ancestor
5757349|NCT02995057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757350|NCT02995304|Midazolam|midazolam|mesh-list
5757351|NCT02995304|Morphine|morphine|mesh-list
5757352|NCT02995304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5757353|NCT02995304|Narcotics|narcotics|mesh-ancestor
5757354|NCT02995304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5757355|NCT02995304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757356|NCT02995304|Analgesics|analgesics|mesh-ancestor
5757357|NCT02995304|Sensory System Agents|sensory system agents|mesh-ancestor
5757358|NCT02995304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5757359|NCT02995304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5757360|NCT02995304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5757361|NCT02995304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5757362|NCT02995304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5757363|NCT02995304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5757364|NCT02995304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5757365|NCT02995304|Anesthetics, General|anesthetics, general|mesh-ancestor
5757366|NCT02995304|Anesthetics|anesthetics|mesh-ancestor
5757367|NCT02995304|GABA Modulators|gaba modulators|mesh-ancestor
5757368|NCT02995304|GABA Agents|gaba agents|mesh-ancestor
5757369|NCT02995304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5757370|NCT02995304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757371|NCT02994927|Prednisone|prednisone|mesh-list
5757372|NCT02994927|Cyclophosphamide|cyclophosphamide|mesh-list
5631850|NCT02740127|Mydriatics|mydriatics|mesh-ancestor
5631851|NCT02740127|Sympathomimetics|sympathomimetics|mesh-ancestor
5757373|NCT02994927|Rituximab|rituximab|mesh-list
5757374|NCT02994927|Azathioprine|azathioprine|mesh-list
5631852|NCT02740127|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5757375|NCT02994927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5757376|NCT02994927|Immunologic Factors|immunologic factors|mesh-ancestor
5757377|NCT02994927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757378|NCT02994927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5757379|NCT02994927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5757380|NCT02994927|Alkylating Agents|alkylating agents|mesh-ancestor
5757381|NCT02994927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757382|NCT02994927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5757383|NCT02994927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5757384|NCT02994927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5757385|NCT02994927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5757386|NCT02994927|Glucocorticoids|glucocorticoids|mesh-ancestor
5757387|NCT02994927|Hormones|hormones|mesh-ancestor
5757388|NCT02994927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5757389|NCT02994927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5757390|NCT02994927|Antimetabolites|antimetabolites|mesh-ancestor
5757391|NCT02994927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5757392|NCT02994953|Avelumab|avelumab|mesh-list
5757393|NCT02994953|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5757394|NCT02994953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5757395|NCT02994953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5757396|NCT02994953|Immunologic Factors|immunologic factors|mesh-ancestor
5757397|NCT02994953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757398|NCT02995083|Methylprednisolone|methylprednisolone|mesh-list
5757399|NCT02995083|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5757400|NCT02995083|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5757401|NCT02995083|Prednisolone|prednisolone|mesh-list
5757402|NCT02995083|Prednisolone acetate|prednisolone acetate|mesh-list
5757403|NCT02995083|Lidocaine|lidocaine|mesh-list
5757404|NCT02995083|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5757405|NCT02995083|Prednisolone phosphate|prednisolone phosphate|mesh-list
5757406|NCT02995083|Anesthetics, Local|anesthetics, local|mesh-ancestor
5757407|NCT02995083|Anesthetics|anesthetics|mesh-ancestor
5757408|NCT02995083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5757409|NCT02995083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757410|NCT02995083|Sensory System Agents|sensory system agents|mesh-ancestor
5757411|NCT02995083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5757412|NCT02995083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5757413|NCT02995083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5757414|NCT02995083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5757415|NCT02995083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5631853|NCT02740127|Analgesics|analgesics|mesh-ancestor
5631854|NCT02740127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5631855|NCT02740127|Sympatholytics|sympatholytics|mesh-ancestor
5631856|NCT02740127|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5631857|NCT02737475|Cyclophosphamide|cyclophosphamide|mesh-list
5631858|NCT02737475|Nivolumab|nivolumab|mesh-list
5631859|NCT02737475|Ipilimumab|ipilimumab|mesh-list
5631860|NCT02737475|Vaccines|vaccines|mesh-list
5631861|NCT02737475|Immunologic Factors|immunologic factors|mesh-ancestor
5631862|NCT02737475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5631863|NCT02737475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5631864|NCT02737475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5631865|NCT02737475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5631866|NCT02737475|Alkylating Agents|alkylating agents|mesh-ancestor
5631867|NCT02737475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631868|NCT02737475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5757416|NCT02995083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757417|NCT02995083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5757418|NCT02995083|Antiemetics|antiemetics|mesh-ancestor
5757419|NCT02995083|Autonomic Agents|autonomic agents|mesh-ancestor
5757420|NCT02995083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5757421|NCT02995083|Glucocorticoids|glucocorticoids|mesh-ancestor
5757422|NCT02995083|Hormones|hormones|mesh-ancestor
5757423|NCT02995083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5757424|NCT02995083|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5757425|NCT02995083|Protective Agents|protective agents|mesh-ancestor
5631869|NCT02737475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5631870|NCT02737475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5631871|NCT02737475|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5631872|NCT02717624|Acalabrutinib|acalabrutinib|mesh-list
5631873|NCT02717624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5631874|NCT02709512|Cisplatin|cisplatin|mesh-list
5631875|NCT02709512|Pemetrexed|pemetrexed|mesh-list
5757426|NCT02995083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5757427|NCT02995083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5757428|NCT02994745|Atorvastatin|atorvastatin|mesh-list
5757429|NCT02994745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5757430|NCT02994745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5631876|NCT02709512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5631877|NCT02709512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5631878|NCT02709512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757431|NCT02994745|Antimetabolites|antimetabolites|mesh-ancestor
5757432|NCT02994745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757433|NCT02994745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5631879|NCT02709512|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5631880|NCT02709512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5631881|NCT02703714|Pembrolizumab|pembrolizumab|mesh-list
5631882|NCT02703714|Sargramostim|sargramostim|mesh-list
5757434|NCT02994745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5757435|NCT02994745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5757436|NCT02994888|Cetuximab|cetuximab|mesh-list
5757437|NCT02994888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5757438|NCT02994888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5757439|NCT02994875|Acetylcysteine|acetylcysteine|mesh-list
6673177|NCT01560962|Plasma Substitutes|plasma substitutes|mesh-ancestor
6673178|NCT01560962|Blood Substitutes|blood substitutes|mesh-ancestor
6673179|NCT01560962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6673180|NCT01561014|Fluorouracil|fluorouracil|mesh-list
6673181|NCT01561014|Oxaliplatin|oxaliplatin|mesh-list
6673182|NCT01561014|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6673183|NCT01561014|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6673184|NCT01561014|Antimetabolites|antimetabolites|mesh-ancestor
6673185|NCT01561014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673186|NCT01561014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6673187|NCT01561014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6673188|NCT01561014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6673189|NCT01561014|Immunologic Factors|immunologic factors|mesh-ancestor
6673190|NCT01561014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757440|NCT02994875|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5757441|NCT02994875|Antiviral Agents|antiviral agents|mesh-ancestor
5757442|NCT02994875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5757443|NCT02994875|Expectorants|expectorants|mesh-ancestor
5757444|NCT02994875|Respiratory System Agents|respiratory system agents|mesh-ancestor
5757445|NCT02994875|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5757446|NCT02994875|Antioxidants|antioxidants|mesh-ancestor
5757447|NCT02994875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757448|NCT02994875|Protective Agents|protective agents|mesh-ancestor
5757449|NCT02994875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757450|NCT02994875|Antidotes|antidotes|mesh-ancestor
5757451|NCT02994719|Amantadine|amantadine|mesh-list
5757452|NCT02994719|Levodopa|levodopa|mesh-list
5757453|NCT02994719|Carbidopa|carbidopa|mesh-list
5757454|NCT02994719|Pramipexole|pramipexole|mesh-list
5757455|NCT02994719|Ropinirole|ropinirole|mesh-list
5757456|NCT02994719|Entacapone|entacapone|mesh-list
5757457|NCT02994719|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
5757458|NCT02994719|Tolcapone|tolcapone|mesh-list
5757459|NCT02994719|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5757460|NCT02994719|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5757461|NCT02994719|Dopamine Agents|dopamine agents|mesh-ancestor
5757462|NCT02994719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5757463|NCT02994719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757464|NCT02994719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757465|NCT02994719|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5757466|NCT02994719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5757467|NCT02994719|Antioxidants|antioxidants|mesh-ancestor
5757468|NCT02994719|Protective Agents|protective agents|mesh-ancestor
5631883|NCT02703714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5631884|NCT02703714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5631885|NCT02703714|Immunologic Factors|immunologic factors|mesh-ancestor
5631886|NCT02703714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5631887|NCT02689440|Dasatinib|dasatinib|mesh-list
5631888|NCT02689440|Venetoclax|venetoclax|mesh-list
5631889|NCT02689440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5631890|NCT02689440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5631891|NCT02689440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5757469|NCT02994719|Dopamine Agonists|dopamine agonists|mesh-ancestor
5757470|NCT02994719|Antiviral Agents|antiviral agents|mesh-ancestor
6673191|NCT01561014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5757471|NCT02994719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5757472|NCT02994719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5631892|NCT02689440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631893|NCT02684006|Sunitinib|sunitinib|mesh-list
5631894|NCT02684006|Avelumab|avelumab|mesh-list
5631895|NCT02684006|Axitinib|axitinib|mesh-list
5631896|NCT02684006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5631897|NCT02684006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5631898|NCT02684006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5631899|NCT02684006|Growth Substances|growth substances|mesh-ancestor
5631900|NCT02684006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5631901|NCT02684006|Growth Inhibitors|growth inhibitors|mesh-ancestor
5631902|NCT02684006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5631903|NCT02684006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5631904|NCT02684006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631905|NCT02684006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5631906|NCT02652052|Dasatinib|dasatinib|mesh-list
5631907|NCT02652052|Quercetin|quercetin|mesh-list
5631908|NCT02652052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5631909|NCT02652052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5631910|NCT02652052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5631911|NCT02652052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631912|NCT02652052|Antioxidants|antioxidants|mesh-ancestor
5631913|NCT02652052|Protective Agents|protective agents|mesh-ancestor
5631914|NCT02652052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5631915|NCT02642965|Cytarabine|cytarabine|mesh-list
5631916|NCT02642965|Fludarabine|fludarabine|mesh-list
5631917|NCT02642965|Fludarabine phosphate|fludarabine phosphate|mesh-list
5631918|NCT02642965|Daunorubicin|daunorubicin|mesh-list
5631919|NCT02642965|Lenograstim|lenograstim|mesh-list
5631920|NCT02642965|Sargramostim|sargramostim|mesh-list
5631921|NCT02642965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5631922|NCT02642965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5631923|NCT02642965|Antimetabolites|antimetabolites|mesh-ancestor
5631924|NCT02642965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631925|NCT02642965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5631926|NCT02642965|Immunologic Factors|immunologic factors|mesh-ancestor
5631927|NCT02642965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757473|NCT02994719|Analgesics|analgesics|mesh-ancestor
5757474|NCT02994719|Sensory System Agents|sensory system agents|mesh-ancestor
5757475|NCT02994719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5757476|NCT02994719|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
5757477|NCT02994719|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5757478|NCT02994719|Immunologic Factors|immunologic factors|mesh-ancestor
5757479|NCT02995005|Tenofovir|tenofovir|mesh-list
5757480|NCT02995005|Antiviral Agents|antiviral agents|mesh-ancestor
5757481|NCT02995005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5757482|NCT02995005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5757483|NCT02995005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5757484|NCT02995005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5757485|NCT02995005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757486|NCT02995005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5757487|NCT02995005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5757488|NCT02994836|Adalimumab|adalimumab|mesh-list
5757489|NCT02994836|Infliximab|infliximab|mesh-list
5757490|NCT02994836|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5757491|NCT02994836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5757492|NCT02994836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5757493|NCT02994836|Dermatologic Agents|dermatologic agents|mesh-ancestor
5757494|NCT02994836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5757495|NCT02994576|Atezolizumab|atezolizumab|mesh-list
5757496|NCT02994576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5757497|NCT02994381|Ozanimod|ozanimod|mesh-list
5757498|NCT02994381|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5757499|NCT02994381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757500|NCT02994381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5631928|NCT02642965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5631929|NCT02642965|Antiviral Agents|antiviral agents|mesh-ancestor
5631930|NCT02642965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5631931|NCT02642965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5631932|NCT02642965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5631933|NCT02642965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5631934|NCT02642965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5631935|NCT02638090|Pembrolizumab|pembrolizumab|mesh-list
5631936|NCT02638090|Vorinostat|vorinostat|mesh-list
5631937|NCT02638090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5631938|NCT02638090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5631939|NCT02638090|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5631940|NCT02638090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5631941|NCT02638090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631942|NCT02632175|Adalimumab|adalimumab|mesh-list
5631943|NCT02632175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5631944|NCT02632175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5631945|NCT02629809|Cyclophosphamide|cyclophosphamide|mesh-list
5631946|NCT02629809|Fludarabine|fludarabine|mesh-list
5631947|NCT02629809|Fludarabine phosphate|fludarabine phosphate|mesh-list
5757501|NCT02994381|Immunologic Factors|immunologic factors|mesh-ancestor
5757502|NCT02994381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757503|NCT02994602|ST 1435|st 1435|mesh-list
5757504|NCT02994602|Testosterone|testosterone|mesh-list
5757505|NCT02994602|Androgens|androgens|mesh-ancestor
5757506|NCT02994602|Hormones|hormones|mesh-ancestor
5757507|NCT02994602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5631948|NCT02629809|Obinutuzumab|obinutuzumab|mesh-list
5631949|NCT02629809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5631950|NCT02629809|Immunologic Factors|immunologic factors|mesh-ancestor
5631951|NCT02629809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5631952|NCT02629809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5631953|NCT02629809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5631954|NCT02629809|Alkylating Agents|alkylating agents|mesh-ancestor
5631955|NCT02629809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631956|NCT02629809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5631957|NCT02629809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5631958|NCT02629809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5631959|NCT02629809|Antimetabolites|antimetabolites|mesh-ancestor
5631960|NCT02629809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5631961|NCT02629159|Adalimumab|adalimumab|mesh-list
5631962|NCT02629159|Upadacitinib|upadacitinib|mesh-list
5631963|NCT02629159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5631964|NCT02629159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5631965|NCT02629159|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
5631966|NCT02629159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5631967|NCT02629159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5631968|NCT02629159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631969|NCT02628067|Pembrolizumab|pembrolizumab|mesh-list
5631970|NCT02628067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5631971|NCT02628067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5631972|NCT02611232|Liraglutide|liraglutide|mesh-list
5631973|NCT02611232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5631974|NCT02611232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757508|NCT02994602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757509|NCT02994602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5757510|NCT02994602|Contraceptive Agents|contraceptive agents|mesh-ancestor
5757511|NCT02994602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5757512|NCT02994602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5757513|NCT02994290|Vaccines|vaccines|mesh-list
5757514|NCT02994290|Immunologic Factors|immunologic factors|mesh-ancestor
5757515|NCT02994290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757516|NCT02994433|Nitrous Oxide|nitrous oxide|mesh-list
5757517|NCT02994433|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5757518|NCT02994433|Anesthetics, General|anesthetics, general|mesh-ancestor
5757519|NCT02994433|Anesthetics|anesthetics|mesh-ancestor
5757520|NCT02994433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5757521|NCT02994433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757522|NCT02994433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5631975|NCT02611232|Incretins|incretins|mesh-ancestor
5631976|NCT02611232|Hormones|hormones|mesh-ancestor
5631977|NCT02611232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5631978|NCT02604433|Luspatercept|luspatercept|mesh-list
5631979|NCT02604433|Hematinics|hematinics|mesh-ancestor
5631980|NCT02598895|Carboplatin|carboplatin|mesh-list
5631981|NCT02598895|Docetaxel|docetaxel|mesh-list
5757523|NCT02994433|Analgesics|analgesics|mesh-ancestor
5631982|NCT02598895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5757524|NCT02994433|Sensory System Agents|sensory system agents|mesh-ancestor
5757525|NCT02994433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5757526|NCT02994485|Simvastatin|simvastatin|mesh-list
5757527|NCT02994485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5757528|NCT02994485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5757529|NCT02994485|Antimetabolites|antimetabolites|mesh-ancestor
5757530|NCT02994485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757531|NCT02994485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5757532|NCT02994485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5757533|NCT02994485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5895115|NCT05121233|Sensory System Agents|sensory system agents|mesh-ancestor
5895116|NCT05121233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5895117|NCT05121233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895118|NCT05121233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5895119|NCT05121233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5895120|NCT05121233|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5895121|NCT05121233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5895122|NCT05121233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895123|NCT05121168|Bupivacaine|bupivacaine|mesh-list
5895124|NCT05121168|Anesthetics, Local|anesthetics, local|mesh-ancestor
5895125|NCT05121168|Anesthetics|anesthetics|mesh-ancestor
5895126|NCT05121168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5895127|NCT05121168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895128|NCT05121168|Sensory System Agents|sensory system agents|mesh-ancestor
5631983|NCT02598895|Tubulin Modulators|tubulin modulators|mesh-ancestor
5631984|NCT02598895|Antimitotic Agents|antimitotic agents|mesh-ancestor
5631985|NCT02598895|Mitosis Modulators|mitosis modulators|mesh-ancestor
5631986|NCT02598895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5631987|NCT02582775|Vidarabine|vidarabine|mesh-list
5631988|NCT02582775|Mycophenolic Acid|mycophenolic acid|mesh-list
5895129|NCT05121168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5895130|NCT05120960|Osimertinib|osimertinib|mesh-list
5895131|NCT05120960|Tepotinib|tepotinib|mesh-list
5895132|NCT05120960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5895133|NCT05120960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5895134|NCT05120960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5895135|NCT05120960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895136|NCT05120934|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5895137|NCT05120934|Amitriptyline|amitriptyline|mesh-list
5895138|NCT05120934|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
5895139|NCT05120934|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5895140|NCT05120934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5895141|NCT05120934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5895142|NCT05120934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895143|NCT05120934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5895144|NCT05120934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895145|NCT05120934|Analgesics|analgesics|mesh-ancestor
5895146|NCT05120934|Sensory System Agents|sensory system agents|mesh-ancestor
5895147|NCT05120934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5895148|NCT05120934|Antidepressive Agents|antidepressive agents|mesh-ancestor
5895149|NCT05120934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5895150|NCT05120934|Dopamine Agents|dopamine agents|mesh-ancestor
5895151|NCT05120934|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5895152|NCT05120934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5895153|NCT05120934|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5631989|NCT02582775|Cyclophosphamide|cyclophosphamide|mesh-list
5631990|NCT02582775|Busulfan|busulfan|mesh-list
5631991|NCT02582775|Fludarabine|fludarabine|mesh-list
5631992|NCT02582775|Fludarabine phosphate|fludarabine phosphate|mesh-list
5631993|NCT02582775|Tacrolimus|tacrolimus|mesh-list
5631994|NCT02582775|Thymoglobulin|thymoglobulin|mesh-list
5631995|NCT02582775|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5631996|NCT02582775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5631997|NCT02582775|Immunologic Factors|immunologic factors|mesh-ancestor
5631998|NCT02582775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5631999|NCT02582775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5632000|NCT02582775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5632001|NCT02582775|Alkylating Agents|alkylating agents|mesh-ancestor
5632002|NCT02582775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632003|NCT02582775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5632004|NCT02582775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5632005|NCT02582775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5632006|NCT02582775|Antimetabolites|antimetabolites|mesh-ancestor
5757534|NCT02994173|Ketamine|ketamine|mesh-list
5757535|NCT02994173|Oxycodone|oxycodone|mesh-list
5757536|NCT02994173|Esketamine|esketamine|mesh-list
5757537|NCT02994173|Analgesics|analgesics|mesh-ancestor
5757538|NCT02994173|Sensory System Agents|sensory system agents|mesh-ancestor
5757539|NCT02994173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5757540|NCT02994173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757541|NCT02994173|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5757542|NCT02994173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5757543|NCT02994173|Anesthetics, General|anesthetics, general|mesh-ancestor
5757544|NCT02994173|Anesthetics|anesthetics|mesh-ancestor
5757545|NCT02994173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5757546|NCT02994173|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5632007|NCT02582775|Antiviral Agents|antiviral agents|mesh-ancestor
5632008|NCT02582775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5632009|NCT02582775|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5632010|NCT02582775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5632011|NCT02582775|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5632012|NCT02582775|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5632013|NCT02582775|Antitubercular Agents|antitubercular agents|mesh-ancestor
5757547|NCT02994173|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5757548|NCT02994173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5757549|NCT02994173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757550|NCT02994173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5757551|NCT02994173|Narcotics|narcotics|mesh-ancestor
5757552|NCT02994173|Antidepressive Agents|antidepressive agents|mesh-ancestor
5757553|NCT02994173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5757554|NCT02994082|Bupropion|bupropion|mesh-list
5757555|NCT02994082|Nicotine|nicotine|mesh-list
5757556|NCT02994082|Varenicline|varenicline|mesh-list
5757557|NCT02994082|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5757558|NCT02994082|Autonomic Agents|autonomic agents|mesh-ancestor
5757559|NCT02994082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5757560|NCT02994082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757561|NCT02994082|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5757562|NCT02994082|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5757563|NCT02994082|Cholinergic Agents|cholinergic agents|mesh-ancestor
5757564|NCT02994082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5757565|NCT02994082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757566|NCT02994082|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5757567|NCT02994082|Antidepressive Agents|antidepressive agents|mesh-ancestor
5757568|NCT02994082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5757569|NCT02994082|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5757570|NCT02994082|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5757571|NCT02994082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5757572|NCT02994082|Dopamine Agents|dopamine agents|mesh-ancestor
5632014|NCT02582775|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5632015|NCT02570542|Cytarabine|cytarabine|mesh-list
5632016|NCT02570542|Plerixafor|plerixafor|mesh-list
5632017|NCT02570542|Etoposide|etoposide|mesh-list
5632018|NCT02570542|Melphalan|melphalan|mesh-list
5632019|NCT02570542|Carmustine|carmustine|mesh-list
5632020|NCT02570542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5632021|NCT02570542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5632022|NCT02570542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5632023|NCT02570542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5632024|NCT02570542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5632025|NCT02570542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632026|NCT02570542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5632027|NCT02570542|Antimetabolites|antimetabolites|mesh-ancestor
5632028|NCT02570542|Antiviral Agents|antiviral agents|mesh-ancestor
5632029|NCT02570542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5632030|NCT02570542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5632031|NCT02570542|Immunologic Factors|immunologic factors|mesh-ancestor
5632032|NCT02570542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632033|NCT02570542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5632034|NCT02570542|Alkylating Agents|alkylating agents|mesh-ancestor
5632035|NCT02570542|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5632036|NCT02570542|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5632037|NCT02570542|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5632038|NCT02550652|Mycophenolic Acid|mycophenolic acid|mesh-list
5632039|NCT02550652|Prednisone|prednisone|mesh-list
5632040|NCT02550652|Methylprednisolone|methylprednisolone|mesh-list
5632041|NCT02550652|Obinutuzumab|obinutuzumab|mesh-list
5632042|NCT02550652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5757573|NCT02994082|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5757574|NCT02994082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5757575|NCT02994082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5757576|NCT02995096|Sirolimus|sirolimus|mesh-list
5757577|NCT02995096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5757578|NCT02995096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5757579|NCT02995096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5757580|NCT02995096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5757581|NCT02995096|Antifungal Agents|antifungal agents|mesh-ancestor
5757582|NCT02995096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5757583|NCT02995096|Immunologic Factors|immunologic factors|mesh-ancestor
5757584|NCT02995096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757585|NCT02993991|Durvalumab|durvalumab|mesh-list
5757586|NCT02993991|Mocetinostat|mocetinostat|mesh-list
5632043|NCT02550652|Glucocorticoids|glucocorticoids|mesh-ancestor
5632044|NCT02550652|Hormones|hormones|mesh-ancestor
5632045|NCT02550652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5632046|NCT02550652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632047|NCT02550652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5632048|NCT02550652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5632049|NCT02550652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5632050|NCT02550652|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5632051|NCT02550652|Antitubercular Agents|antitubercular agents|mesh-ancestor
5632052|NCT02550652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5632053|NCT02550652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5632054|NCT02550652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5757587|NCT02993991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5757588|NCT02993991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5757589|NCT02993991|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5757590|NCT02993991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5757591|NCT02993991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757592|NCT02993835|Iron|iron|mesh-list
5757593|NCT02993835|Trace Elements|trace elements|mesh-ancestor
5757594|NCT02993835|Micronutrients|micronutrients|mesh-ancestor
5757595|NCT02993835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757596|NCT02993861|Anticonvulsants|anticonvulsants|mesh-list
5757597|NCT02993718|Dexmedetomidine|dexmedetomidine|mesh-list
5757598|NCT02993718|Propofol|propofol|mesh-list
5757599|NCT02993718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5757600|NCT02993718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5757601|NCT02993718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757602|NCT02993718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5757603|NCT02993718|Anesthetics, General|anesthetics, general|mesh-ancestor
5757604|NCT02993718|Anesthetics|anesthetics|mesh-ancestor
5757605|NCT02993718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5757606|NCT02993718|Analgesics|analgesics|mesh-ancestor
5757607|NCT02993718|Sensory System Agents|sensory system agents|mesh-ancestor
5757608|NCT02993718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5757609|NCT02993718|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5757610|NCT02993718|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5757611|NCT02993718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5757612|NCT02993718|Adrenergic Agents|adrenergic agents|mesh-ancestor
5757613|NCT02993718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5757614|NCT02993718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757615|NCT02993575|Floxacillin|floxacillin|mesh-list
5757616|NCT02993575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5757617|NCT02993575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5757618|NCT02993640|Vasopressins|vasopressins|mesh-list
5757619|NCT02993640|Arginine Vasopressin|arginine vasopressin|mesh-list
5757620|NCT02993640|Hemostatics|hemostatics|mesh-ancestor
5757621|NCT02993640|Coagulants|coagulants|mesh-ancestor
5757622|NCT02993640|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5757623|NCT02993640|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5757624|NCT02993640|Natriuretic Agents|natriuretic agents|mesh-ancestor
5757625|NCT02993640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757626|NCT02993406|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
5757627|NCT02993406|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5757628|NCT02993406|Antimetabolites|antimetabolites|mesh-ancestor
5757629|NCT02993406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757630|NCT02993406|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5757631|NCT02993406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5757632|NCT02993406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5757633|NCT02993406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757634|NCT02993367|3-n-butylphthalide|3-n-butylphthalide|mesh-list
5757635|NCT02993367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5757636|NCT02993367|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5757637|NCT02993367|Protective Agents|protective agents|mesh-ancestor
5895154|NCT05120934|Adrenergic Agents|adrenergic agents|mesh-ancestor
5757638|NCT02993367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757639|NCT02993523|Azacitidine|azacitidine|mesh-list
5757640|NCT02993523|Venetoclax|venetoclax|mesh-list
5757641|NCT02993523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5757642|NCT02993523|Antimetabolites|antimetabolites|mesh-ancestor
5757643|NCT02993523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757644|NCT02993523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5757645|NCT02993523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5757646|NCT02993588|Melatonin|melatonin|mesh-list
5757647|NCT02993588|Antioxidants|antioxidants|mesh-ancestor
5757648|NCT02993588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757649|NCT02993588|Protective Agents|protective agents|mesh-ancestor
5757650|NCT02993588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757651|NCT02993588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5757652|NCT02993705|Trabectedin|trabectedin|mesh-list
5757653|NCT02993705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5757654|NCT02993705|Alkylating Agents|alkylating agents|mesh-ancestor
5757655|NCT02993705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757656|NCT02993705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5757657|NCT02993341|Tranexamic Acid|tranexamic acid|mesh-list
5757658|NCT02993341|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5757659|NCT02993341|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5757660|NCT02993341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757661|NCT02993341|Hemostatics|hemostatics|mesh-ancestor
5757662|NCT02993341|Coagulants|coagulants|mesh-ancestor
5632055|NCT02550652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632056|NCT02550652|Antiemetics|antiemetics|mesh-ancestor
5632057|NCT02550652|Autonomic Agents|autonomic agents|mesh-ancestor
5757663|NCT02993315|Vaccines|vaccines|mesh-list
5757664|NCT02993315|Immunologic Factors|immunologic factors|mesh-ancestor
5757665|NCT02993315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757666|NCT02993094|Carboplatin|carboplatin|mesh-list
5757667|NCT02993094|Ixazomib|ixazomib|mesh-list
5757668|NCT02993094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5757669|NCT02993094|Protease Inhibitors|protease inhibitors|mesh-ancestor
5757670|NCT02993094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5757671|NCT02993094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757672|NCT02993198|Carvedilol|carvedilol|mesh-list
5757673|NCT02993198|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5757674|NCT02993198|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5757675|NCT02993198|Adrenergic Agents|adrenergic agents|mesh-ancestor
5757676|NCT02993198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5757677|NCT02993198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757678|NCT02993198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757679|NCT02993198|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5757680|NCT02993198|Antioxidants|antioxidants|mesh-ancestor
5757681|NCT02993198|Protective Agents|protective agents|mesh-ancestor
5757682|NCT02993198|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5757683|NCT02993198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5757684|NCT02993198|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5757685|NCT02993198|Vasodilator Agents|vasodilator agents|mesh-ancestor
5757686|NCT02993198|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5757687|NCT02993198|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5757688|NCT02993159|Tamoxifen|tamoxifen|mesh-list
5757689|NCT02993159|Afimoxifene|afimoxifene|mesh-list
5757690|NCT02993159|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5757691|NCT02993159|Hormone Antagonists|hormone antagonists|mesh-ancestor
5757692|NCT02993159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5757693|NCT02993159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757694|NCT02993159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5757695|NCT02993159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5757696|NCT02993159|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5632058|NCT02550652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5632059|NCT02550652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5632060|NCT02550652|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5632061|NCT02550652|Protective Agents|protective agents|mesh-ancestor
5632062|NCT02550652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5632063|NCT02537418|Durvalumab|durvalumab|mesh-list
5632064|NCT02537418|Tremelimumab|tremelimumab|mesh-list
5632065|NCT02537418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5632066|NCT02537418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5632067|NCT02520154|Paclitaxel|paclitaxel|mesh-list
5632068|NCT02520154|Carboplatin|carboplatin|mesh-list
5632069|NCT02520154|Pembrolizumab|pembrolizumab|mesh-list
5632070|NCT02520154|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5632071|NCT02520154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5632072|NCT02520154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5632073|NCT02520154|Tubulin Modulators|tubulin modulators|mesh-ancestor
5632074|NCT02520154|Antimitotic Agents|antimitotic agents|mesh-ancestor
5632075|NCT02520154|Mitosis Modulators|mitosis modulators|mesh-ancestor
5632076|NCT02520154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632077|NCT02520154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5632078|NCT02519738|Silver Nitrate|silver nitrate|mesh-list
5632079|NCT02519738|Triamcinolone|triamcinolone|mesh-list
5632080|NCT02519738|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5632081|NCT02519738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5632082|NCT02519738|Glucocorticoids|glucocorticoids|mesh-ancestor
5757697|NCT02993159|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5757698|NCT02993159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5757699|NCT02993029|Celecoxib|celecoxib|mesh-list
5757700|NCT02993029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5757701|NCT02993029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5757702|NCT02993029|Analgesics|analgesics|mesh-ancestor
5757703|NCT02993029|Sensory System Agents|sensory system agents|mesh-ancestor
5757704|NCT02993029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5757705|NCT02993029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757706|NCT02993029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5757707|NCT02993029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5757708|NCT02993029|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5757709|NCT02993029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5757710|NCT02993029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5757711|NCT02993029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757712|NCT02993133|Mycophenolic Acid|mycophenolic acid|mesh-list
5757713|NCT02993133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5757714|NCT02993133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5757715|NCT02993133|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5757716|NCT02993133|Antitubercular Agents|antitubercular agents|mesh-ancestor
5757717|NCT02993133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5757718|NCT02993133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5757719|NCT02993133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5757720|NCT02993133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757721|NCT02992964|Nivolumab|nivolumab|mesh-list
5757722|NCT02992964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5757723|NCT02992964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5632083|NCT02519738|Hormones|hormones|mesh-ancestor
5632084|NCT02519738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5632085|NCT02519738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632086|NCT02519738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5632087|NCT02519738|Immunologic Factors|immunologic factors|mesh-ancestor
5632088|NCT02519738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5632089|NCT02519738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5693247|NCT03402152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693248|NCT03402152|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5693249|NCT03402152|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5693250|NCT03402152|Serotonin Agents|serotonin agents|mesh-ancestor
5693251|NCT03402152|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5693252|NCT03402152|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5693253|NCT03402152|Dopamine Agents|dopamine agents|mesh-ancestor
5693254|NCT03402113|Midazolam|midazolam|mesh-list
5693255|NCT03402113|Dexmedetomidine|dexmedetomidine|mesh-list
5693256|NCT03402113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5693257|NCT03402113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5693258|NCT03402113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693259|NCT03402113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5757724|NCT02992964|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5757725|NCT02992964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757726|NCT02992808|Menotropins|menotropins|mesh-list
5757727|NCT02992808|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5757728|NCT02992808|Fertility Agents|fertility agents|mesh-ancestor
5757729|NCT02992808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5757730|NCT02992808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757731|NCT02992756|Mitogens|mitogens|mesh-list
5757732|NCT02992756|Mitosis Modulators|mitosis modulators|mesh-ancestor
5757733|NCT02992756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757734|NCT02992938|Acetazolamide|acetazolamide|mesh-list
5757735|NCT02992938|Anticonvulsants|anticonvulsants|mesh-ancestor
5693260|NCT03402113|Analgesics|analgesics|mesh-ancestor
5632090|NCT02430077|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
5632091|NCT02430077|Cathartics|cathartics|mesh-ancestor
5632092|NCT02430077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6209060|NCT02140970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6209061|NCT02140970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6209062|NCT02140970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209063|NCT02141217|Amoxicillin|amoxicillin|mesh-list
6209064|NCT02141217|Clindamycin|clindamycin|mesh-list
5757736|NCT02992938|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5757737|NCT02992938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5757738|NCT02992938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757739|NCT02992938|Diuretics|diuretics|mesh-ancestor
5757740|NCT02992938|Natriuretic Agents|natriuretic agents|mesh-ancestor
5757741|NCT02992938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673192|NCT01561014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6673193|NCT01561014|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6673194|NCT01561040|Vitamin D|vitamin d|mesh-list
6673195|NCT01561040|Vitamin A|vitamin a|mesh-list
6673196|NCT01561040|Vitamins|vitamins|mesh-ancestor
6673197|NCT01561040|Micronutrients|micronutrients|mesh-ancestor
6673198|NCT01561040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673199|NCT01561040|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6673200|NCT01561066|Octreotide|octreotide|mesh-list
6673201|NCT01561066|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
5757742|NCT02992886|Raltitrexed|raltitrexed|mesh-list
5757743|NCT02992886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5757744|NCT02992886|Antimetabolites|antimetabolites|mesh-ancestor
5757745|NCT02992886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757746|NCT02992886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5757747|NCT02992886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5632093|NCT02420821|Bevacizumab|bevacizumab|mesh-list
5632094|NCT02420821|Sunitinib|sunitinib|mesh-list
5632095|NCT02420821|Atezolizumab|atezolizumab|mesh-list
5632096|NCT02420821|Antibodies|antibodies|mesh-list
5632097|NCT02420821|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5632098|NCT02420821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5632099|NCT02420821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5632100|NCT02420821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5632101|NCT02420821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5632102|NCT02420821|Growth Substances|growth substances|mesh-ancestor
5632103|NCT02420821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632104|NCT02420821|Growth Inhibitors|growth inhibitors|mesh-ancestor
5632105|NCT02420821|Immunologic Factors|immunologic factors|mesh-ancestor
5632106|NCT02420821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5632107|NCT02420821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5632108|NCT02420821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632109|NCT02412670|Gemcitabine|gemcitabine|mesh-list
5632110|NCT02412670|Cisplatin|cisplatin|mesh-list
5632111|NCT02412670|Carboplatin|carboplatin|mesh-list
5632112|NCT02412670|Doxorubicin|doxorubicin|mesh-list
5632113|NCT02412670|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5632114|NCT02412670|Methotrexate|methotrexate|mesh-list
5632115|NCT02412670|Vinblastine|vinblastine|mesh-list
5632116|NCT02412670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5632117|NCT02412670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5632118|NCT02412670|Antimetabolites|antimetabolites|mesh-ancestor
5632119|NCT02412670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632120|NCT02412670|Antiviral Agents|antiviral agents|mesh-ancestor
5632121|NCT02412670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5757748|NCT02992886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5757749|NCT02992925|Vaccines|vaccines|mesh-list
5757750|NCT02992925|Immunologic Factors|immunologic factors|mesh-ancestor
5757751|NCT02992925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757752|NCT02992678|Pentoxifylline|pentoxifylline|mesh-list
5757753|NCT02992678|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5632122|NCT02412670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5632123|NCT02412670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5632124|NCT02412670|Immunologic Factors|immunologic factors|mesh-ancestor
5632125|NCT02412670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632126|NCT02412670|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5632127|NCT02412670|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5632128|NCT02412670|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5632129|NCT02412670|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5632130|NCT02412670|Abortifacient Agents|abortifacient agents|mesh-ancestor
5757754|NCT02992678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6673202|NCT01561066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6673203|NCT01561066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5632131|NCT02412670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5757755|NCT02992678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757756|NCT02992678|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5757757|NCT02992678|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5757758|NCT02992678|Protective Agents|protective agents|mesh-ancestor
5757759|NCT02992678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757760|NCT02992678|Vasodilator Agents|vasodilator agents|mesh-ancestor
5757761|NCT02992678|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5757762|NCT02992678|Antioxidants|antioxidants|mesh-ancestor
5757763|NCT02992912|Atezolizumab|atezolizumab|mesh-list
5632132|NCT02412670|Dermatologic Agents|dermatologic agents|mesh-ancestor
5632133|NCT02412670|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5632134|NCT02412670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5632135|NCT02412670|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5632136|NCT02412670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5632137|NCT02412670|Tubulin Modulators|tubulin modulators|mesh-ancestor
5757764|NCT02992912|Antibodies|antibodies|mesh-list
5757765|NCT02992912|Immunologic Factors|immunologic factors|mesh-ancestor
5757766|NCT02992912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757767|NCT02992912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5757768|NCT02992704|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5757769|NCT02992704|Antiviral Agents|antiviral agents|mesh-ancestor
5757770|NCT02992704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5895155|NCT05120934|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5895156|NCT05120934|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5895157|NCT05120934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5895158|NCT05114720|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5895159|NCT05114720|Moxifloxacin|moxifloxacin|mesh-list
5895160|NCT05114720|Cyclophosphamide|cyclophosphamide|mesh-list
5895161|NCT05114720|Docetaxel|docetaxel|mesh-list
5895162|NCT05114720|Doxorubicin|doxorubicin|mesh-list
5895163|NCT05114720|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5895164|NCT05114720|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
5895165|NCT05114720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5895166|NCT05114720|Immunologic Factors|immunologic factors|mesh-ancestor
5895167|NCT05114720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895168|NCT05114720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5895169|NCT05114720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5895170|NCT05114720|Alkylating Agents|alkylating agents|mesh-ancestor
5895171|NCT05114720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895172|NCT05114720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5895173|NCT05114720|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5895174|NCT05114720|Tubulin Modulators|tubulin modulators|mesh-ancestor
5895175|NCT05114720|Antimitotic Agents|antimitotic agents|mesh-ancestor
5895176|NCT05114720|Mitosis Modulators|mitosis modulators|mesh-ancestor
5895177|NCT05114720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5895178|NCT05114720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5895179|NCT05114720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5895180|NCT05114720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5895181|NCT05114720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5895182|NCT05114720|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5895183|NCT05114720|Contraceptive Agents|contraceptive agents|mesh-ancestor
5895184|NCT05114720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5895185|NCT05114720|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5895186|NCT05114720|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5895187|NCT05114720|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5632138|NCT02412670|Antimitotic Agents|antimitotic agents|mesh-ancestor
5632139|NCT02412670|Mitosis Modulators|mitosis modulators|mesh-ancestor
5632140|NCT02410343|Hormones|hormones|mesh-list
5632141|NCT02410343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5632142|NCT02410343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632143|NCT02370329|Interferons|interferons|mesh-list
5632144|NCT02370329|Interferon-alpha|interferon-alpha|mesh-list
5632145|NCT02370329|Interferon alpha-2|interferon alpha-2|mesh-list
5632146|NCT02370329|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
5632147|NCT02370329|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
5632148|NCT02370329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5632149|NCT02370329|Antiviral Agents|antiviral agents|mesh-ancestor
5632150|NCT02370329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5895188|NCT05113394|Immunologic Factors|immunologic factors|mesh-list
5895189|NCT05113394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895190|NCT05112211|Doxycycline|doxycycline|mesh-list
5895191|NCT05112211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5895192|NCT05112211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5895193|NCT05112211|Antimalarials|antimalarials|mesh-ancestor
5895194|NCT05112211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5632151|NCT02370329|Immunologic Factors|immunologic factors|mesh-ancestor
5757771|NCT02992496|Midazolam|midazolam|mesh-list
5757772|NCT02992496|Ketamine|ketamine|mesh-list
5632152|NCT02370329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632153|NCT02352753|Denosumab|denosumab|mesh-list
5632154|NCT02352753|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5632155|NCT02352753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632156|NCT02343224|Interferons|interferons|mesh-list
5632157|NCT02343224|Interferon-alpha|interferon-alpha|mesh-list
5632158|NCT02343224|Interferon alpha-2|interferon alpha-2|mesh-list
5632159|NCT02343224|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
5632160|NCT02343224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5632161|NCT02343224|Antiviral Agents|antiviral agents|mesh-ancestor
5757773|NCT02992496|Analgesics|analgesics|mesh-ancestor
5757774|NCT02992496|Sensory System Agents|sensory system agents|mesh-ancestor
5757775|NCT02992496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5632162|NCT02343224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5632163|NCT02343224|Immunologic Factors|immunologic factors|mesh-ancestor
5632164|NCT02343224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632165|NCT02339740|Vitamins|vitamins|mesh-list
5632166|NCT02339740|Vitamin A|vitamin a|mesh-list
5632167|NCT02339740|Cytarabine|cytarabine|mesh-list
5632168|NCT02339740|Dexamethasone|dexamethasone|mesh-list
5632169|NCT02339740|Dexamethasone acetate|dexamethasone acetate|mesh-list
5632170|NCT02339740|Mitoxantrone|mitoxantrone|mesh-list
5632171|NCT02339740|Idarubicin|idarubicin|mesh-list
5632172|NCT02339740|Retinol palmitate|retinol palmitate|mesh-list
5632173|NCT02339740|Tretinoin|tretinoin|mesh-list
5632174|NCT02339740|Arsenic Trioxide|arsenic trioxide|mesh-list
5632175|NCT02339740|BB 1101|bb 1101|mesh-list
5632176|NCT02339740|Micronutrients|micronutrients|mesh-ancestor
5632177|NCT02339740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632178|NCT02339740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5757776|NCT02992496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757777|NCT02992496|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5757778|NCT02992496|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5757779|NCT02992496|Anesthetics, General|anesthetics, general|mesh-ancestor
5757780|NCT02992496|Anesthetics|anesthetics|mesh-ancestor
5757781|NCT02992496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5757782|NCT02992496|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5757783|NCT02992496|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5757784|NCT02992496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5757785|NCT02992496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757786|NCT02992496|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5757787|NCT02992496|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5757788|NCT02992496|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5757789|NCT02992496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5757790|NCT02992496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5757791|NCT02992496|GABA Modulators|gaba modulators|mesh-ancestor
5757792|NCT02992496|GABA Agents|gaba agents|mesh-ancestor
5757793|NCT02992665|Ionophores|ionophores|mesh-list
5757794|NCT02992665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5757795|NCT02992665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757796|NCT02992548|Pravastatin|pravastatin|mesh-list
6489930|NCT00594334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6489931|NCT00594334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489932|NCT00594334|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6489933|NCT00594347|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6489934|NCT00594347|Immunologic Factors|immunologic factors|mesh-ancestor
6489935|NCT00594347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489936|NCT00594373|Tenofovir|tenofovir|mesh-list
6489937|NCT00594373|Antiviral Agents|antiviral agents|mesh-ancestor
6489938|NCT00594373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6489939|NCT00594373|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6489940|NCT00594373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6489941|NCT00594373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6489942|NCT00594373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489943|NCT00594373|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6489944|NCT00594373|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5757797|NCT02992548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5757798|NCT02992548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5757799|NCT02992548|Antimetabolites|antimetabolites|mesh-ancestor
6489945|NCT00594542|Lidocaine|lidocaine|mesh-list
5632179|NCT02339740|Antiemetics|antiemetics|mesh-ancestor
5632180|NCT02339740|Autonomic Agents|autonomic agents|mesh-ancestor
5632181|NCT02339740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5632182|NCT02339740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5632183|NCT02339740|Glucocorticoids|glucocorticoids|mesh-ancestor
5895195|NCT05112211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5632184|NCT02339740|Hormones|hormones|mesh-ancestor
5632185|NCT02339740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5632186|NCT02339740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5632187|NCT02339740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5632188|NCT02339740|Protease Inhibitors|protease inhibitors|mesh-ancestor
5632189|NCT02339740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5632190|NCT02339740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757800|NCT02992548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757801|NCT02992548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5757802|NCT02992548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5632191|NCT02339740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5632192|NCT02339740|Antimetabolites|antimetabolites|mesh-ancestor
5632193|NCT02339740|Antiviral Agents|antiviral agents|mesh-ancestor
5632194|NCT02339740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5632195|NCT02339740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5632196|NCT02339740|Immunologic Factors|immunologic factors|mesh-ancestor
5632197|NCT02339740|Analgesics|analgesics|mesh-ancestor
5632198|NCT02339740|Sensory System Agents|sensory system agents|mesh-ancestor
5632199|NCT02339740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5632200|NCT02339740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5632201|NCT02339740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5632202|NCT02339740|Antioxidants|antioxidants|mesh-ancestor
5632203|NCT02339740|Protective Agents|protective agents|mesh-ancestor
5632204|NCT02339740|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5632205|NCT02339740|Keratolytic Agents|keratolytic agents|mesh-ancestor
5632206|NCT02339740|Dermatologic Agents|dermatologic agents|mesh-ancestor
5632207|NCT02291445|Peppermint oil|peppermint oil|mesh-list
5632208|NCT02291445|Antiemetics|antiemetics|mesh-ancestor
5632209|NCT02291445|Autonomic Agents|autonomic agents|mesh-ancestor
5632210|NCT02291445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5632211|NCT02291445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632212|NCT02291445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5632213|NCT02291445|Parasympatholytics|parasympatholytics|mesh-ancestor
5632214|NCT02262026|Saracatinib|saracatinib|mesh-list
5632215|NCT02262026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5632216|NCT02262026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5632217|NCT02262026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632218|NCT02159989|Aflibercept|aflibercept|mesh-list
5632219|NCT02159989|Endothelial Growth Factors|endothelial growth factors|mesh-list
5632220|NCT02159989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5632221|NCT02159989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5632222|NCT02159989|Growth Substances|growth substances|mesh-ancestor
5632223|NCT02159989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632224|NCT02159989|Growth Inhibitors|growth inhibitors|mesh-ancestor
5757803|NCT02992548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5757804|NCT02992652|Allopurinol|allopurinol|mesh-list
5757805|NCT02992652|Antimetabolites|antimetabolites|mesh-ancestor
5757806|NCT02992652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757807|NCT02992652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5757808|NCT02992652|Gout Suppressants|gout suppressants|mesh-ancestor
5757809|NCT02992652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5757810|NCT02992652|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5757811|NCT02992652|Antioxidants|antioxidants|mesh-ancestor
5757812|NCT02992652|Protective Agents|protective agents|mesh-ancestor
5757813|NCT02992652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757814|NCT02992522|Lenalidomide|lenalidomide|mesh-list
5757815|NCT02992522|Venetoclax|venetoclax|mesh-list
5757816|NCT02992522|Obinutuzumab|obinutuzumab|mesh-list
6489946|NCT00594542|Anesthetics, Local|anesthetics, local|mesh-ancestor
6489947|NCT00594542|Anesthetics|anesthetics|mesh-ancestor
6489948|NCT00594542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6496494|NCT00628238|Lenalidomide|lenalidomide|mesh-list
5757817|NCT02992522|Immunologic Factors|immunologic factors|mesh-ancestor
5757818|NCT02992522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632225|NCT02159989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5632226|NCT02125461|Durvalumab|durvalumab|mesh-list
5632227|NCT02125461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5632228|NCT02125461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5632229|NCT02124902|Carboplatin|carboplatin|mesh-list
5632230|NCT02124902|Docetaxel|docetaxel|mesh-list
5757819|NCT02992522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5757820|NCT02992522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5757821|NCT02992522|Growth Substances|growth substances|mesh-ancestor
5757822|NCT02992522|Growth Inhibitors|growth inhibitors|mesh-ancestor
5757823|NCT02992522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5895196|NCT05111717|Desflurane|desflurane|mesh-list
5757824|NCT02992522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5757825|NCT02992457|Interferons|interferons|mesh-list
5757826|NCT02992457|Ribavirin|ribavirin|mesh-list
5757827|NCT02992457|Interferon-alpha|interferon-alpha|mesh-list
5757828|NCT02992457|Interferon alpha-2|interferon alpha-2|mesh-list
5757829|NCT02992457|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5757830|NCT02992457|Sofosbuvir|sofosbuvir|mesh-list
5757831|NCT02992457|Ledipasvir|ledipasvir|mesh-list
5757832|NCT02992457|Simeprevir|simeprevir|mesh-list
5757833|NCT02992457|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
5757834|NCT02992457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5757835|NCT02992457|Antiviral Agents|antiviral agents|mesh-ancestor
5757836|NCT02992457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5757837|NCT02992457|Antimetabolites|antimetabolites|mesh-ancestor
5757838|NCT02992457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757839|NCT02992457|Immunologic Factors|immunologic factors|mesh-ancestor
5757840|NCT02992457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757841|NCT02992457|Protease Inhibitors|protease inhibitors|mesh-ancestor
5757842|NCT02992457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5757843|NCT02992392|Dextrans|dextrans|mesh-list
5757844|NCT02992392|Anticoagulants|anticoagulants|mesh-ancestor
5757845|NCT02992392|Plasma Substitutes|plasma substitutes|mesh-ancestor
5757846|NCT02992392|Blood Substitutes|blood substitutes|mesh-ancestor
5757847|NCT02992340|Gemcitabine|gemcitabine|mesh-list
5757848|NCT02992340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5757849|NCT02992340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5757850|NCT02992340|Antimetabolites|antimetabolites|mesh-ancestor
5757851|NCT02992340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757852|NCT02992340|Antiviral Agents|antiviral agents|mesh-ancestor
5757853|NCT02992340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5757854|NCT02992340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5757855|NCT02992340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5757856|NCT02992340|Immunologic Factors|immunologic factors|mesh-ancestor
5757857|NCT02992340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632231|NCT02124902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5632232|NCT02124902|Tubulin Modulators|tubulin modulators|mesh-ancestor
5632233|NCT02124902|Antimitotic Agents|antimitotic agents|mesh-ancestor
5632234|NCT02124902|Mitosis Modulators|mitosis modulators|mesh-ancestor
5632235|NCT02124902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632236|NCT02113878|Cisplatin|cisplatin|mesh-list
5632237|NCT02113878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5632238|NCT02097680|Letrozole|letrozole|mesh-list
5632239|NCT02097680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5632240|NCT02097680|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5632241|NCT02097680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5632242|NCT02097680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5632243|NCT02097680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632244|NCT02097680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5632245|NCT02097680|Hormone Antagonists|hormone antagonists|mesh-ancestor
5632246|NCT02097680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5632247|NCT02097680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632248|NCT02025556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5632249|NCT02025556|Immunologic Factors|immunologic factors|mesh-ancestor
5757858|NCT02992028|Vitamins|vitamins|mesh-list
5757859|NCT02992028|Micronutrients|micronutrients|mesh-ancestor
5757860|NCT02992028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757861|NCT02991950|Parnaparin|parnaparin|mesh-list
5757862|NCT02991950|Anticoagulants|anticoagulants|mesh-ancestor
5757863|NCT02991950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5632250|NCT02025556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632251|NCT01995578|Azacitidine|azacitidine|mesh-list
5632252|NCT01995578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5632253|NCT01995578|Antimetabolites|antimetabolites|mesh-ancestor
5632254|NCT01995578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757864|NCT02991950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5757865|NCT02991950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757866|NCT02991781|Varenicline|varenicline|mesh-list
5757867|NCT02991781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5757868|NCT02991781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5757869|NCT02991781|Cholinergic Agents|cholinergic agents|mesh-ancestor
5757870|NCT02991781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5757871|NCT02991781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757872|NCT02991781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757873|NCT02991651|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5757874|NCT02991651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6489949|NCT00594542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757875|NCT02991651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5757876|NCT02991651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5757877|NCT02991651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757878|NCT02991768|Budesonide|budesonide|mesh-list
5757879|NCT02991768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5757880|NCT02991768|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5757881|NCT02991768|Autonomic Agents|autonomic agents|mesh-ancestor
5757882|NCT02991768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5757883|NCT02991768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757884|NCT02991768|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5632255|NCT01995578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5632256|NCT01995578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5632257|NCT01986075|Amphetamine|amphetamine|mesh-list
5632258|NCT01986075|Adderall|adderall|mesh-list
5632259|NCT01986075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6489950|NCT00594542|Sensory System Agents|sensory system agents|mesh-ancestor
6489951|NCT00594542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6489952|NCT00594542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5632260|NCT01986075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632261|NCT01986075|Sympathomimetics|sympathomimetics|mesh-ancestor
5632262|NCT01986075|Autonomic Agents|autonomic agents|mesh-ancestor
5632263|NCT01986075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5632264|NCT01986075|Dopamine Agents|dopamine agents|mesh-ancestor
5632265|NCT01986075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5632266|NCT01986075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632267|NCT01986075|Adrenergic Agents|adrenergic agents|mesh-ancestor
5632268|NCT01986075|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5632269|NCT01986075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5632270|NCT01986075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5632271|NCT01986075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5632272|NCT01935466|Pioglitazone|pioglitazone|mesh-list
5632273|NCT01935466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5632274|NCT01935466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632275|NCT01850888|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
5632276|NCT01850888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5632277|NCT01850888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5632278|NCT01850888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5632279|NCT01850888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632280|NCT01850888|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5632281|NCT01835145|Temozolomide|temozolomide|mesh-list
5632282|NCT01835145|Dacarbazine|dacarbazine|mesh-list
5632283|NCT01835145|Imidazole|imidazole|mesh-list
5632284|NCT01835145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5632285|NCT01835145|Alkylating Agents|alkylating agents|mesh-ancestor
5632286|NCT01835145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632287|NCT01835145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5632288|NCT01835145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5632289|NCT01799538|Albuterol|albuterol|mesh-list
5632290|NCT01799538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5632291|NCT01799538|Autonomic Agents|autonomic agents|mesh-ancestor
5632292|NCT01799538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5632293|NCT01799538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632294|NCT01799538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5632295|NCT01799538|Respiratory System Agents|respiratory system agents|mesh-ancestor
5632296|NCT01799538|Tocolytic Agents|tocolytic agents|mesh-ancestor
5632297|NCT01799538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5632298|NCT01799538|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5632299|NCT01799538|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5757885|NCT02991768|Respiratory System Agents|respiratory system agents|mesh-ancestor
5757886|NCT02991768|Glucocorticoids|glucocorticoids|mesh-ancestor
5757887|NCT02991768|Hormones|hormones|mesh-ancestor
5757888|NCT02991768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5757889|NCT02991612|Rifaximin|rifaximin|mesh-list
5757890|NCT02991612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5757891|NCT02991612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5757892|NCT02991612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5757893|NCT02991339|Dexamethasone|dexamethasone|mesh-list
5757894|NCT02991339|Dexamethasone acetate|dexamethasone acetate|mesh-list
5757895|NCT02991339|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
5757896|NCT02991339|BB 1101|bb 1101|mesh-list
5757897|NCT02991339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5757898|NCT02991339|Antiemetics|antiemetics|mesh-ancestor
5632300|NCT01799538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5632301|NCT01799538|Adrenergic Agents|adrenergic agents|mesh-ancestor
5632302|NCT01799538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5757899|NCT02991339|Autonomic Agents|autonomic agents|mesh-ancestor
5757900|NCT02991339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5757901|NCT02991339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757902|NCT02991339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5757903|NCT02991339|Glucocorticoids|glucocorticoids|mesh-ancestor
5757904|NCT02991339|Hormones|hormones|mesh-ancestor
5757905|NCT02991339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5757906|NCT02991339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5632303|NCT01799538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632304|NCT01759836|Atorvastatin|atorvastatin|mesh-list
5632305|NCT01759836|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5632306|NCT01759836|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5632307|NCT01759836|Antimetabolites|antimetabolites|mesh-ancestor
5632308|NCT01759836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632309|NCT01759836|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5632310|NCT01759836|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5757907|NCT02991339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5757908|NCT02991339|Protease Inhibitors|protease inhibitors|mesh-ancestor
5757909|NCT02991339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5757910|NCT02991339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757911|NCT02991456|Ondansetron|ondansetron|mesh-list
5757912|NCT02991456|Rolapitant|rolapitant|mesh-list
5757913|NCT02991456|Antiemetics|antiemetics|mesh-ancestor
5757914|NCT02991456|Autonomic Agents|autonomic agents|mesh-ancestor
5757915|NCT02991456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5757916|NCT02991456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757917|NCT02991456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5757918|NCT02991456|Antipruritics|antipruritics|mesh-ancestor
5757919|NCT02991456|Dermatologic Agents|dermatologic agents|mesh-ancestor
5757920|NCT02991456|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5757921|NCT02991456|Serotonin Agents|serotonin agents|mesh-ancestor
5757922|NCT02991456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5632311|NCT01759836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5632312|NCT01758328|Fludarabine|fludarabine|mesh-list
5632313|NCT01758328|Melphalan|melphalan|mesh-list
5632314|NCT01758328|Busulfan|busulfan|mesh-list
5632315|NCT01758328|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5632316|NCT01758328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5757923|NCT02991456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757924|NCT02991456|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5757925|NCT02991456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5757926|NCT02991456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5757927|NCT02991456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5757928|NCT02991456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5757929|NCT02991456|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5757930|NCT02991365|Insulin|insulin|mesh-list
5632317|NCT01758328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632318|NCT01758328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5632319|NCT01758328|Immunologic Factors|immunologic factors|mesh-ancestor
5632320|NCT01758328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632321|NCT01758328|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5632322|NCT01758328|Alkylating Agents|alkylating agents|mesh-ancestor
5632323|NCT01758328|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5632324|NCT01746849|Cyclophosphamide|cyclophosphamide|mesh-list
5632325|NCT01746849|Thiotepa|thiotepa|mesh-list
5632326|NCT01746849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5757931|NCT02991365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5757932|NCT02991365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757933|NCT02991209|Testosterone|testosterone|mesh-list
5757934|NCT02991209|Androgens|androgens|mesh-ancestor
5757935|NCT02991209|Hormones|hormones|mesh-ancestor
5757936|NCT02991209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5757937|NCT02991209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757938|NCT02991196|Nivolumab|nivolumab|mesh-list
5757939|NCT02991196|DS-8273a|ds-8273a|mesh-list
5757940|NCT02991196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5757941|NCT02991196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5757942|NCT02991196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5757943|NCT02991196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757944|NCT02991131|Linezolid|linezolid|mesh-list
5757945|NCT02991131|Tedizolid|tedizolid|mesh-list
5757946|NCT02991131|Tedizolid phosphate|tedizolid phosphate|mesh-list
5632327|NCT01746849|Immunologic Factors|immunologic factors|mesh-ancestor
5757947|NCT02991131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5757948|NCT02991131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5757949|NCT02991131|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5632328|NCT01746849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632329|NCT01746849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5632330|NCT01746849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5632331|NCT01746849|Alkylating Agents|alkylating agents|mesh-ancestor
5632332|NCT01746849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632333|NCT01746849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5632334|NCT01746849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5632335|NCT01745588|Clarithromycin|clarithromycin|mesh-list
5632336|NCT01745588|Dexamethasone|dexamethasone|mesh-list
5632337|NCT01745588|Pomalidomide|pomalidomide|mesh-list
5632338|NCT01745588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5632339|NCT01745588|Antiemetics|antiemetics|mesh-ancestor
5632340|NCT01745588|Autonomic Agents|autonomic agents|mesh-ancestor
6209065|NCT02141217|Clindamycin palmitate|clindamycin palmitate|mesh-list
6209066|NCT02141217|Clindamycin phosphate|clindamycin phosphate|mesh-list
5632341|NCT01745588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5632342|NCT01745588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632343|NCT01745588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5632344|NCT01745588|Glucocorticoids|glucocorticoids|mesh-ancestor
5632345|NCT01745588|Hormones|hormones|mesh-ancestor
5757950|NCT02991131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5757951|NCT02991131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757952|NCT02991157|Nimodipine|nimodipine|mesh-list
5757953|NCT02991157|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5757954|NCT02991157|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5757955|NCT02991157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5757956|NCT02991157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757957|NCT02991157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5757958|NCT02991157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757959|NCT02991157|Vasodilator Agents|vasodilator agents|mesh-ancestor
5895197|NCT05111717|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5895198|NCT05111717|Anesthetics, General|anesthetics, general|mesh-ancestor
5895199|NCT05111717|Anesthetics|anesthetics|mesh-ancestor
5632346|NCT01745588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5632347|NCT01745588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5632348|NCT01745588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5632349|NCT01745588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5632350|NCT01745588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5632351|NCT01745588|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5632352|NCT01745588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5632353|NCT01745588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632354|NCT01745588|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5632355|NCT01745588|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5632356|NCT01745588|Immunologic Factors|immunologic factors|mesh-ancestor
5632357|NCT01745588|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5632358|NCT01745588|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5632359|NCT01745588|Growth Substances|growth substances|mesh-ancestor
5632360|NCT01745588|Growth Inhibitors|growth inhibitors|mesh-ancestor
5632361|NCT01701674|Aldesleukin|aldesleukin|mesh-list
5632362|NCT01701674|Cyclophosphamide|cyclophosphamide|mesh-list
5632363|NCT01701674|Fludarabine|fludarabine|mesh-list
5632364|NCT01701674|Ipilimumab|ipilimumab|mesh-list
5632365|NCT01701674|Interleukin-2|interleukin-2|mesh-list
5632366|NCT01701674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5632367|NCT01701674|Immunologic Factors|immunologic factors|mesh-ancestor
5895200|NCT05111717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5895201|NCT05111717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895202|NCT05110040|Immunosuppressive Agents|immunosuppressive agents|mesh-list
5895203|NCT05110040|Immunologic Factors|immunologic factors|mesh-ancestor
5895204|NCT05110040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632368|NCT01701674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632369|NCT01701674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5632370|NCT01701674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5632371|NCT01701674|Alkylating Agents|alkylating agents|mesh-ancestor
5632372|NCT01701674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632373|NCT01701674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5632374|NCT01701674|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5632375|NCT01701674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5895205|NCT05087589|Tofacitinib|tofacitinib|mesh-list
5895206|NCT05087589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5895207|NCT05087589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5895208|NCT05087589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895209|NCT05077488|Lidocaine|lidocaine|mesh-list
5757960|NCT02990975|Ketamine|ketamine|mesh-list
5757961|NCT02990975|Analgesics|analgesics|mesh-ancestor
5757962|NCT02990975|Sensory System Agents|sensory system agents|mesh-ancestor
5632376|NCT01701674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5632377|NCT01701674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5632378|NCT01701674|Analgesics|analgesics|mesh-ancestor
5632379|NCT01701674|Sensory System Agents|sensory system agents|mesh-ancestor
5632380|NCT01701674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5632381|NCT01701674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5632382|NCT01701674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5632383|NCT01701674|Antiviral Agents|antiviral agents|mesh-ancestor
5632384|NCT01701674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5632385|NCT01643460|Ethanol|ethanol|mesh-list
5632386|NCT01643460|Paclitaxel|paclitaxel|mesh-list
5757963|NCT02990975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5757964|NCT02990975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757965|NCT02990975|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5757966|NCT02990975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5757967|NCT02990975|Anesthetics, General|anesthetics, general|mesh-ancestor
5757968|NCT02990975|Anesthetics|anesthetics|mesh-ancestor
5757969|NCT02990975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5757970|NCT02990975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5757971|NCT02990975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5757972|NCT02990975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5757973|NCT02990975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757974|NCT02991053|Ketamine|ketamine|mesh-list
5757975|NCT02991053|Analgesics|analgesics|mesh-ancestor
5757976|NCT02991053|Sensory System Agents|sensory system agents|mesh-ancestor
5757977|NCT02991053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5757978|NCT02991053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757979|NCT02991053|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5757980|NCT02991053|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5757981|NCT02991053|Anesthetics, General|anesthetics, general|mesh-ancestor
5757982|NCT02991053|Anesthetics|anesthetics|mesh-ancestor
5757983|NCT02991053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5757984|NCT02991053|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5757985|NCT02991053|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5757986|NCT02991053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5757987|NCT02991053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757988|NCT02990728|Metformin|metformin|mesh-list
5757989|NCT02990728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5757990|NCT02990728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757991|NCT02990962|Triamcinolone|triamcinolone|mesh-list
5757992|NCT02990962|Lidocaine|lidocaine|mesh-list
5757993|NCT02990962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5757994|NCT02990962|Glucocorticoids|glucocorticoids|mesh-ancestor
5757995|NCT02990962|Hormones|hormones|mesh-ancestor
5757996|NCT02990962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5757997|NCT02990962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5757998|NCT02990962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5757999|NCT02990962|Anesthetics, Local|anesthetics, local|mesh-ancestor
5758000|NCT02990962|Anesthetics|anesthetics|mesh-ancestor
5758001|NCT02990962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5758002|NCT02990962|Sensory System Agents|sensory system agents|mesh-ancestor
5758003|NCT02990962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5758004|NCT02990962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5758005|NCT02990962|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5758006|NCT02990962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5758007|NCT02990962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5758008|NCT02990702|Bupivacaine|bupivacaine|mesh-list
5758009|NCT02990702|Anesthetics, Local|anesthetics, local|mesh-ancestor
5758010|NCT02990702|Anesthetics|anesthetics|mesh-ancestor
5758011|NCT02990702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5758012|NCT02990702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758013|NCT02990702|Sensory System Agents|sensory system agents|mesh-ancestor
5632387|NCT01643460|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5632388|NCT01643460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5632389|NCT01643460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5632390|NCT01643460|Tubulin Modulators|tubulin modulators|mesh-ancestor
5632391|NCT01643460|Antimitotic Agents|antimitotic agents|mesh-ancestor
5632392|NCT01643460|Mitosis Modulators|mitosis modulators|mesh-ancestor
5632393|NCT01643460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632394|NCT01643460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5632395|NCT01643460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5758014|NCT02990702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5758015|NCT02990845|Pembrolizumab|pembrolizumab|mesh-list
5758016|NCT02990845|Leuprolide|leuprolide|mesh-list
5758017|NCT02990845|Exemestane|exemestane|mesh-list
5758018|NCT02990845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5758019|NCT02990845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5758020|NCT02990845|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5758021|NCT02990845|Fertility Agents|fertility agents|mesh-ancestor
5632396|NCT01643460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5632397|NCT01643460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632398|NCT01597388|Fulvestrant|fulvestrant|mesh-list
5632399|NCT01597388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5632400|NCT01597388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5632401|NCT01597388|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5632402|NCT01597388|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5632403|NCT01597388|Hormone Antagonists|hormone antagonists|mesh-ancestor
5632404|NCT01597388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5632405|NCT01597388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632406|NCT01553214|Dexamethasone|dexamethasone|mesh-list
5632407|NCT01553214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5632408|NCT01553214|Antiemetics|antiemetics|mesh-ancestor
5632409|NCT01553214|Autonomic Agents|autonomic agents|mesh-ancestor
5632410|NCT01553214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5632411|NCT01553214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632412|NCT01553214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5632413|NCT01553214|Glucocorticoids|glucocorticoids|mesh-ancestor
5758022|NCT02990845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5758023|NCT02990845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758024|NCT02990845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5758025|NCT02990845|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5758026|NCT02990845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5758027|NCT02990845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5758028|NCT02990845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5758029|NCT02990845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5758030|NCT02990845|Hormone Antagonists|hormone antagonists|mesh-ancestor
5758031|NCT02990845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5758032|NCT02990884|Ketamine|ketamine|mesh-list
5758033|NCT02990884|Analgesics|analgesics|mesh-ancestor
5758034|NCT02990884|Sensory System Agents|sensory system agents|mesh-ancestor
5758035|NCT02990884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5758036|NCT02990884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758037|NCT02990884|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5758038|NCT02990884|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5758039|NCT02990884|Anesthetics, General|anesthetics, general|mesh-ancestor
5758040|NCT02990884|Anesthetics|anesthetics|mesh-ancestor
5758041|NCT02990884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5758042|NCT02990884|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5758043|NCT02990884|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5758044|NCT02990884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5758045|NCT02990884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5758046|NCT02990858|Leronlimab|leronlimab|mesh-list
5758047|NCT02990858|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5758048|NCT02990858|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5632414|NCT01553214|Hormones|hormones|mesh-ancestor
5632415|NCT01553214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5632416|NCT01553214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5632417|NCT01553214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5632418|NCT01528046|Metformin|metformin|mesh-list
5758049|NCT02990858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5758050|NCT02990858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5758051|NCT02990858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5758052|NCT02990858|Antiviral Agents|antiviral agents|mesh-ancestor
5758053|NCT02990858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5758054|NCT02990403|Aspirin|aspirin|mesh-list
5632419|NCT01528046|Irinotecan|irinotecan|mesh-list
5632420|NCT01528046|Camptothecin|camptothecin|mesh-list
5632421|NCT01528046|Vincristine|vincristine|mesh-list
5632422|NCT01528046|Temozolomide|temozolomide|mesh-list
5632423|NCT01528046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5758055|NCT02990403|Prednisone|prednisone|mesh-list
5758056|NCT02990403|Heparin|heparin|mesh-list
5758057|NCT02990403|Dydrogesterone|dydrogesterone|mesh-list
5758058|NCT02990403|Immunoglobulins|immunoglobulins|mesh-list
5758059|NCT02990403|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5758060|NCT02990403|Antibodies|antibodies|mesh-list
5632424|NCT01528046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758061|NCT02990403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5758062|NCT02990403|Glucocorticoids|glucocorticoids|mesh-ancestor
5758063|NCT02990403|Hormones|hormones|mesh-ancestor
5758064|NCT02990403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5758065|NCT02990403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758066|NCT02990403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5758067|NCT02990403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5758068|NCT02990403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5758069|NCT02990403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5632425|NCT01528046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5632426|NCT01528046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5632427|NCT01528046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5632428|NCT01528046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632429|NCT01528046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5632430|NCT01528046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5632431|NCT01528046|Tubulin Modulators|tubulin modulators|mesh-ancestor
5758070|NCT02990403|Analgesics|analgesics|mesh-ancestor
5758071|NCT02990403|Sensory System Agents|sensory system agents|mesh-ancestor
5758072|NCT02990403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5758073|NCT02990403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5758074|NCT02990403|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5758075|NCT02990403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5758076|NCT02990403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5758077|NCT02990403|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5632432|NCT01528046|Antimitotic Agents|antimitotic agents|mesh-ancestor
5632433|NCT01528046|Mitosis Modulators|mitosis modulators|mesh-ancestor
5632434|NCT01528046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5632435|NCT01528046|Alkylating Agents|alkylating agents|mesh-ancestor
5632436|NCT01318486|Heparin|heparin|mesh-list
5632437|NCT01318486|Anticoagulants|anticoagulants|mesh-ancestor
5632438|NCT01318486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5632439|NCT01318486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5632440|NCT01318486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632441|NCT01194570|Ocrelizumab|ocrelizumab|mesh-list
5632442|NCT01194570|Immunologic Factors|immunologic factors|mesh-ancestor
5632443|NCT01194570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632444|NCT01116648|Olaparib|olaparib|mesh-list
5632445|NCT01116648|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
5632446|NCT01116648|Cediranib|cediranib|mesh-list
5632447|NCT01116648|Maleic acid|maleic acid|mesh-list
5758078|NCT02990403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5758079|NCT02990403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5758080|NCT02990403|Antipyretics|antipyretics|mesh-ancestor
5632448|NCT01116648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5632449|NCT01116648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632450|NCT01116648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5632451|NCT01116648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5632452|NCT01064648|Cisplatin|cisplatin|mesh-list
5632453|NCT01064648|Pemetrexed|pemetrexed|mesh-list
5632454|NCT01064648|Cediranib|cediranib|mesh-list
5632455|NCT01064648|Maleic acid|maleic acid|mesh-list
5632456|NCT01064648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5632457|NCT01064648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5632458|NCT01064648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632459|NCT01064648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5632460|NCT01064648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5632461|NCT01064648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5632462|NCT01064479|Cisplatin|cisplatin|mesh-list
5632463|NCT01064479|Carboplatin|carboplatin|mesh-list
5632464|NCT01064479|Docetaxel|docetaxel|mesh-list
5632465|NCT01064479|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5758081|NCT02990403|Anticoagulants|anticoagulants|mesh-ancestor
5758082|NCT02990403|Immunologic Factors|immunologic factors|mesh-ancestor
5758083|NCT02990403|Progestins|progestins|mesh-ancestor
5758084|NCT02990533|Methyltestosterone|methyltestosterone|mesh-list
5758085|NCT02990533|Testosterone|testosterone|mesh-list
5758086|NCT02990533|Testosterone undecanoate|testosterone undecanoate|mesh-list
5758087|NCT02990533|Testosterone enanthate|testosterone enanthate|mesh-list
5758088|NCT02990533|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5758089|NCT02990533|Androgens|androgens|mesh-ancestor
5758090|NCT02990533|Hormones|hormones|mesh-ancestor
5758091|NCT02990533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5758092|NCT02990533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758093|NCT02990533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5758094|NCT02990533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5758095|NCT02990533|Anabolic Agents|anabolic agents|mesh-ancestor
5758096|NCT02990455|Nicotine|nicotine|mesh-list
5758097|NCT02990455|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5758098|NCT02990455|Autonomic Agents|autonomic agents|mesh-ancestor
5758099|NCT02990455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5758100|NCT02990455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758101|NCT02990455|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5758102|NCT02990455|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5758103|NCT02990455|Cholinergic Agents|cholinergic agents|mesh-ancestor
5758104|NCT02990455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5758105|NCT02990455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5758106|NCT02990364|Lidocaine|lidocaine|mesh-list
5758107|NCT02990364|Anesthetics, Local|anesthetics, local|mesh-list
5758108|NCT02990364|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
5758109|NCT02990364|Anesthetics|anesthetics|mesh-list
5758110|NCT02990364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5758111|NCT02990364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758112|NCT02990364|Sensory System Agents|sensory system agents|mesh-ancestor
5632466|NCT01064479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5632467|NCT01064479|Tubulin Modulators|tubulin modulators|mesh-ancestor
5632468|NCT01064479|Antimitotic Agents|antimitotic agents|mesh-ancestor
5632469|NCT01064479|Mitosis Modulators|mitosis modulators|mesh-ancestor
5632470|NCT01064479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632471|NCT01064479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5632472|NCT01064479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5632473|NCT01042522|Paclitaxel|paclitaxel|mesh-list
5632474|NCT01042522|Etoposide|etoposide|mesh-list
5632475|NCT01042522|Cisplatin|cisplatin|mesh-list
5632476|NCT01042522|Carboplatin|carboplatin|mesh-list
5758113|NCT02990364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5758114|NCT02990364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5758115|NCT02990364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5758116|NCT02990364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5758117|NCT02990364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5758118|NCT02990364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5758119|NCT02990364|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
5758120|NCT02990416|Pembrolizumab|pembrolizumab|mesh-list
5758121|NCT02990416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5758122|NCT02990416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5758123|NCT02990507|Methyltestosterone|methyltestosterone|mesh-list
5758124|NCT02990507|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5758125|NCT02990507|Testosterone|testosterone|mesh-list
5758126|NCT02990507|Testosterone undecanoate|testosterone undecanoate|mesh-list
5758127|NCT02990507|Testosterone enanthate|testosterone enanthate|mesh-list
5632477|NCT01042522|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5632478|NCT01042522|Bleomycin|bleomycin|mesh-list
5632479|NCT01042522|Etoposide phosphate|etoposide phosphate|mesh-list
5632480|NCT01042522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5632481|NCT01042522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5632482|NCT01042522|Tubulin Modulators|tubulin modulators|mesh-ancestor
5632483|NCT01042522|Antimitotic Agents|antimitotic agents|mesh-ancestor
5632484|NCT01042522|Mitosis Modulators|mitosis modulators|mesh-ancestor
5632485|NCT01042522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632486|NCT01042522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5632487|NCT01042522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5632488|NCT01042522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5758128|NCT02990507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5758129|NCT02990507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5632489|NCT01042522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5632490|NCT00958737|Leucovorin|leucovorin|mesh-list
5632491|NCT00958737|Fluorouracil|fluorouracil|mesh-list
5758130|NCT02990507|Anabolic Agents|anabolic agents|mesh-ancestor
5758131|NCT02990507|Hormones|hormones|mesh-ancestor
5758132|NCT02990507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5758133|NCT02990507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758134|NCT02990507|Androgens|androgens|mesh-ancestor
5758135|NCT02990468|Cisplatin|cisplatin|mesh-list
5758136|NCT02990468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5758137|NCT02990546|Midodrine|midodrine|mesh-list
5758138|NCT02990546|Sympathomimetics|sympathomimetics|mesh-ancestor
5758139|NCT02990546|Autonomic Agents|autonomic agents|mesh-ancestor
5758140|NCT02990546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5758141|NCT02990546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758142|NCT02990546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5758143|NCT02990546|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5758144|NCT02990546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5758145|NCT02990546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5758146|NCT02990546|Adrenergic Agents|adrenergic agents|mesh-ancestor
5758147|NCT02990546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5758148|NCT02990546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632492|NCT00958737|Capecitabine|capecitabine|mesh-list
5632493|NCT00958737|Oxaliplatin|oxaliplatin|mesh-list
5632494|NCT00958737|Calcium|calcium|mesh-list
5632495|NCT00958737|Levoleucovorin|levoleucovorin|mesh-list
5632496|NCT00958737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5632497|NCT00958737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632498|NCT00958737|Antimetabolites|antimetabolites|mesh-ancestor
5632499|NCT00958737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632500|NCT00958737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5632501|NCT00958737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5632502|NCT00958737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5632503|NCT00958737|Immunologic Factors|immunologic factors|mesh-ancestor
5758149|NCT02990286|Mycophenolic Acid|mycophenolic acid|mesh-list
5758150|NCT02990286|Rituximab|rituximab|mesh-list
5758151|NCT02990286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5758152|NCT02990286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5758153|NCT02990286|Immunologic Factors|immunologic factors|mesh-ancestor
5758154|NCT02990286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758155|NCT02990286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5758156|NCT02990286|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5758157|NCT02990286|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5758158|NCT02990286|Antitubercular Agents|antitubercular agents|mesh-ancestor
5758159|NCT02990286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5758160|NCT02990286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5758161|NCT02990286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5758162|NCT02990286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5758163|NCT02990312|Sirolimus|sirolimus|mesh-list
5758164|NCT02990312|Maraviroc|maraviroc|mesh-list
5758165|NCT02990312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5758166|NCT02990312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5758167|NCT02990312|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5758168|NCT02990312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5758169|NCT02990312|Antifungal Agents|antifungal agents|mesh-ancestor
5758170|NCT02990312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5758171|NCT02990312|Immunologic Factors|immunologic factors|mesh-ancestor
6489953|NCT00594542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6489954|NCT00594542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6489955|NCT00594542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6489956|NCT00594542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489957|NCT00594555|Cytarabine|cytarabine|mesh-list
6489958|NCT00594555|Imatinib Mesylate|imatinib mesylate|mesh-list
6489959|NCT00594555|Cladribine|cladribine|mesh-list
6489960|NCT00594555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6489961|NCT00594555|Antimetabolites|antimetabolites|mesh-ancestor
6673204|NCT01561066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6673205|NCT01561066|Hemostatics|hemostatics|mesh-ancestor
5758172|NCT02990312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632504|NCT00958737|Antidotes|antidotes|mesh-ancestor
5632505|NCT00958737|Protective Agents|protective agents|mesh-ancestor
5632506|NCT00958737|Vitamin B Complex|vitamin b complex|mesh-ancestor
5632507|NCT00958737|Vitamins|vitamins|mesh-ancestor
5632508|NCT00958737|Micronutrients|micronutrients|mesh-ancestor
5632509|NCT00826462|Triamcinolone|triamcinolone|mesh-list
5632510|NCT00826462|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5758173|NCT02990312|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5758174|NCT02990312|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5895210|NCT05077488|Anesthetics, Local|anesthetics, local|mesh-ancestor
5632511|NCT00826462|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5632512|NCT00826462|Naproxen|naproxen|mesh-list
5632513|NCT00826462|Lidocaine|lidocaine|mesh-list
5758175|NCT02990312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5758176|NCT02990312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5758177|NCT02990312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5758178|NCT02990312|Antiviral Agents|antiviral agents|mesh-ancestor
5758179|NCT02990312|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
5758180|NCT02990078|Sildenafil Citrate|sildenafil citrate|mesh-list
5632514|NCT00826462|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5632515|NCT00826462|Anesthetics, Local|anesthetics, local|mesh-ancestor
5632516|NCT00826462|Anesthetics|anesthetics|mesh-ancestor
5632517|NCT00826462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5632518|NCT00826462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632519|NCT00826462|Sensory System Agents|sensory system agents|mesh-ancestor
5632520|NCT00826462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5632521|NCT00826462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5632522|NCT00826462|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5632523|NCT00826462|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5632524|NCT00826462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5632525|NCT00826462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632526|NCT00826462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5632527|NCT00826462|Glucocorticoids|glucocorticoids|mesh-ancestor
5632528|NCT00826462|Hormones|hormones|mesh-ancestor
5632529|NCT00826462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5632530|NCT00826462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5632531|NCT00826462|Immunologic Factors|immunologic factors|mesh-ancestor
5632532|NCT00826462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5632533|NCT00826462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5632534|NCT00826462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5632535|NCT00826462|Analgesics|analgesics|mesh-ancestor
5632536|NCT00826462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5632537|NCT00826462|Gout Suppressants|gout suppressants|mesh-ancestor
5632538|NCT00826462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5632539|NCT00710970|Tamoxifen|tamoxifen|mesh-list
5632540|NCT00710970|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
5632541|NCT00710970|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5632542|NCT00710970|Hormone Antagonists|hormone antagonists|mesh-ancestor
5632543|NCT00710970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5632544|NCT00710970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632545|NCT00710970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5632546|NCT00710970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5632547|NCT00710970|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5758181|NCT02990078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5758182|NCT02990078|Vasodilator Agents|vasodilator agents|mesh-ancestor
5758183|NCT02990078|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5758184|NCT02990078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5758185|NCT02990078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5758186|NCT02990078|Urological Agents|urological agents|mesh-ancestor
5758187|NCT02989870|Sorafenib|sorafenib|mesh-list
5758188|NCT02989870|Bavituximab|bavituximab|mesh-list
5758189|NCT02989870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5758190|NCT02989870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5758191|NCT02989870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5758192|NCT02989870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5758193|NCT02989870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5758194|NCT02989662|Mifepristone|mifepristone|mesh-list
5758195|NCT02989662|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5758196|NCT02989662|Abortifacient Agents|abortifacient agents|mesh-ancestor
5632548|NCT00710970|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5632549|NCT00710970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5632550|NCT00685919|Carbidopa|carbidopa|mesh-list
5758197|NCT02989662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5758198|NCT02989662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758199|NCT02989662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5758200|NCT02989662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5758201|NCT02989662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5758202|NCT02989662|Contraceptive Agents|contraceptive agents|mesh-ancestor
5758203|NCT02989662|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5632551|NCT00685919|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5632552|NCT00685919|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5632553|NCT00685919|Dopamine Agents|dopamine agents|mesh-ancestor
5632554|NCT00685919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5632555|NCT00685919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632556|NCT00685919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632557|NCT00685919|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5758204|NCT02989662|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5758205|NCT02989662|Hormone Antagonists|hormone antagonists|mesh-ancestor
5758206|NCT02989662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5758207|NCT02989662|Luteolytic Agents|luteolytic agents|mesh-ancestor
5758208|NCT02989662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5758209|NCT02989662|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5758210|NCT02990013|Chlorhexidine|chlorhexidine|mesh-list
5758211|NCT02990013|Povidone-Iodine|povidone-iodine|mesh-list
5758212|NCT02990013|Povidone|povidone|mesh-list
5758213|NCT02990013|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5758214|NCT02990013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5758215|NCT02990013|Disinfectants|disinfectants|mesh-ancestor
5758216|NCT02990013|Plasma Substitutes|plasma substitutes|mesh-ancestor
5758217|NCT02990013|Blood Substitutes|blood substitutes|mesh-ancestor
5758218|NCT02989701|Plerixafor|plerixafor|mesh-list
5758219|NCT02989701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5758220|NCT02989701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5758221|NCT02989701|Antiviral Agents|antiviral agents|mesh-ancestor
5758222|NCT02989701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5758223|NCT02989584|Gemcitabine|gemcitabine|mesh-list
5758224|NCT02989584|Atezolizumab|atezolizumab|mesh-list
5758225|NCT02989584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5758226|NCT02989584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5758227|NCT02989584|Antimetabolites|antimetabolites|mesh-ancestor
5758228|NCT02989584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5758229|NCT02989584|Antiviral Agents|antiviral agents|mesh-ancestor
5758230|NCT02989584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5758231|NCT02989584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5758232|NCT02989584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5758233|NCT02989584|Immunologic Factors|immunologic factors|mesh-ancestor
5758234|NCT02989584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758235|NCT02989519|Progesterone|progesterone|mesh-list
5758236|NCT02989519|Dydrogesterone|dydrogesterone|mesh-list
5758237|NCT02989519|Progestins|progestins|mesh-ancestor
5758238|NCT02989519|Hormones|hormones|mesh-ancestor
5758239|NCT02989519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5758240|NCT02989519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758241|NCT02989623|Copper|copper|mesh-list
5632558|NCT00685919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5693261|NCT03402113|Sensory System Agents|sensory system agents|mesh-ancestor
5693262|NCT03402113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5693263|NCT03402113|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5693264|NCT03402113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5693265|NCT03402113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5693266|NCT03402113|Adrenergic Agents|adrenergic agents|mesh-ancestor
5693267|NCT03402113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5693268|NCT03402113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693269|NCT03402113|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5693270|NCT03402113|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5693271|NCT03402113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5693272|NCT03402113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5693273|NCT03402113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5693274|NCT03402113|Anesthetics, General|anesthetics, general|mesh-ancestor
5693275|NCT03402113|Anesthetics|anesthetics|mesh-ancestor
5693276|NCT03402113|GABA Modulators|gaba modulators|mesh-ancestor
5693277|NCT03402113|GABA Agents|gaba agents|mesh-ancestor
5693278|NCT03402100|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5693279|NCT03402100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5693280|NCT03402087|Leucovorin|leucovorin|mesh-list
5693281|NCT03402087|Methotrexate|methotrexate|mesh-list
5693282|NCT03402087|BMS-986165|bms-986165|mesh-list
5758242|NCT02989623|Trace Elements|trace elements|mesh-ancestor
5758243|NCT02989623|Micronutrients|micronutrients|mesh-ancestor
5758244|NCT02989623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758245|NCT02989558|Aspirin|aspirin|mesh-list
5758246|NCT02989558|Clopidogrel|clopidogrel|mesh-list
5758247|NCT02989558|Ticagrelor|ticagrelor|mesh-list
5758248|NCT02989558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5758249|NCT02989558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5758250|NCT02989558|Analgesics|analgesics|mesh-ancestor
5693283|NCT03402087|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5693284|NCT03402087|Abortifacient Agents|abortifacient agents|mesh-ancestor
5693285|NCT03402087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5758251|NCT02989558|Sensory System Agents|sensory system agents|mesh-ancestor
5693286|NCT03402087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758252|NCT02989558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5758253|NCT02989558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758254|NCT02989558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5758255|NCT02989558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5758256|NCT02989558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5758257|NCT02989558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5758258|NCT02989558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632559|NCT00574496|Gemcitabine|gemcitabine|mesh-list
5632560|NCT00574496|Cyclosporine|cyclosporine|mesh-list
5632561|NCT00574496|Mycophenolic Acid|mycophenolic acid|mesh-list
5632562|NCT00574496|Prednisone|prednisone|mesh-list
5632563|NCT00574496|Cyclophosphamide|cyclophosphamide|mesh-list
5632564|NCT00574496|Melphalan|melphalan|mesh-list
5632565|NCT00574496|Ifosfamide|ifosfamide|mesh-list
5632566|NCT00574496|Mechlorethamine|mechlorethamine|mesh-list
5632567|NCT00574496|Methotrexate|methotrexate|mesh-list
5632568|NCT00574496|Fludarabine|fludarabine|mesh-list
5632569|NCT00574496|Fludarabine phosphate|fludarabine phosphate|mesh-list
5632570|NCT00574496|Vincristine|vincristine|mesh-list
5632571|NCT00574496|Vinorelbine|vinorelbine|mesh-list
5632572|NCT00574496|Procarbazine|procarbazine|mesh-list
5632573|NCT00574496|Cyclosporins|cyclosporins|mesh-list
5632574|NCT00574496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5632575|NCT00574496|Immunologic Factors|immunologic factors|mesh-ancestor
5632576|NCT00574496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632577|NCT00574496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5632578|NCT00574496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5632579|NCT00574496|Alkylating Agents|alkylating agents|mesh-ancestor
5632580|NCT00574496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632581|NCT00574496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5632582|NCT00574496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5632583|NCT00574496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5632584|NCT00574496|Antimetabolites|antimetabolites|mesh-ancestor
5632585|NCT00574496|Antiviral Agents|antiviral agents|mesh-ancestor
5632586|NCT00574496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5632587|NCT00574496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5632588|NCT00574496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5632589|NCT00574496|Glucocorticoids|glucocorticoids|mesh-ancestor
5632590|NCT00574496|Hormones|hormones|mesh-ancestor
5632591|NCT00574496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5632592|NCT00574496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5632593|NCT00574496|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5632594|NCT00574496|Abortifacient Agents|abortifacient agents|mesh-ancestor
5632595|NCT00574496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5632596|NCT00574496|Dermatologic Agents|dermatologic agents|mesh-ancestor
5632597|NCT00574496|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5632598|NCT00574496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5632599|NCT00574496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5632600|NCT00574496|Tubulin Modulators|tubulin modulators|mesh-ancestor
5632601|NCT00574496|Antimitotic Agents|antimitotic agents|mesh-ancestor
5632602|NCT00574496|Mitosis Modulators|mitosis modulators|mesh-ancestor
5632603|NCT00574496|Antifungal Agents|antifungal agents|mesh-ancestor
5632604|NCT00574496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5632605|NCT00574496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5632606|NCT00574496|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5758259|NCT02989558|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5758260|NCT02989558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5758261|NCT02989558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6489962|NCT00594555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489963|NCT00594555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6489964|NCT00594555|Antiviral Agents|antiviral agents|mesh-ancestor
6489965|NCT00594555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6489966|NCT00594555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6489967|NCT00594555|Immunologic Factors|immunologic factors|mesh-ancestor
6489968|NCT00594555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489969|NCT00594555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6489970|NCT00594555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6489971|NCT00594633|Donepezil|donepezil|mesh-list
6489972|NCT00594633|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6489973|NCT00594633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6489974|NCT00594633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489975|NCT00594633|Cholinergic Agents|cholinergic agents|mesh-ancestor
6489976|NCT00594633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6489977|NCT00594633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758262|NCT02989558|Antipyretics|antipyretics|mesh-ancestor
5758263|NCT02989558|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5632607|NCT00574496|Antitubercular Agents|antitubercular agents|mesh-ancestor
5632608|NCT00574496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5758264|NCT02989558|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5758265|NCT02989558|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5758266|NCT02989558|Purinergic Agents|purinergic agents|mesh-ancestor
5758267|NCT02989558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5758268|NCT02989467|Aprepitant|aprepitant|mesh-list
5758269|NCT02989467|Antiemetics|antiemetics|mesh-ancestor
5758270|NCT02989467|Autonomic Agents|autonomic agents|mesh-ancestor
5758271|NCT02989467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5758272|NCT02989467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758273|NCT02989467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5758274|NCT02989467|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5758275|NCT02989467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5758276|NCT02989467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895211|NCT05077488|Anesthetics|anesthetics|mesh-ancestor
5895212|NCT05077488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5895213|NCT05077488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895214|NCT05077488|Sensory System Agents|sensory system agents|mesh-ancestor
5895215|NCT05077488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5895216|NCT05077488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5895217|NCT05077488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5895218|NCT05077488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5895219|NCT05077488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5895220|NCT05077488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895221|NCT05075200|Tranexamic Acid|tranexamic acid|mesh-list
5895222|NCT05075200|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5895223|NCT05075200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5895224|NCT05075200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895225|NCT05075200|Hemostatics|hemostatics|mesh-ancestor
5895226|NCT05075200|Coagulants|coagulants|mesh-ancestor
5895227|NCT05073484|Antibodies|antibodies|mesh-list
5895228|NCT05073484|Immunoglobulins|immunoglobulins|mesh-list
5895229|NCT05073484|Immunologic Factors|immunologic factors|mesh-ancestor
5895230|NCT05073484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895231|NCT05230368|Decitabine|decitabine|mesh-list
5895232|NCT05230368|Romidepsin|romidepsin|mesh-list
5895233|NCT05230368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5895234|NCT05230368|Antimetabolites|antimetabolites|mesh-ancestor
5895235|NCT05230368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895236|NCT05230368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5895237|NCT05230368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5895238|NCT05230368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5895239|NCT05230303|Caffeine|caffeine|mesh-list
5895240|NCT05230303|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5895241|NCT05230303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895242|NCT05230303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5895243|NCT05230303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5895244|NCT05230303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895245|NCT05230303|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5895246|NCT05230303|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5895247|NCT05230303|Purinergic Agents|purinergic agents|mesh-ancestor
5895248|NCT05230303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5895249|NCT05229991|Ritonavir|ritonavir|mesh-list
5895250|NCT05229991|Lonafarnib|lonafarnib|mesh-list
5895251|NCT05229991|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5895252|NCT05229991|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5895253|NCT05229991|Protease Inhibitors|protease inhibitors|mesh-ancestor
5895254|NCT05229991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5895255|NCT05229991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895256|NCT05229991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5907831|NCT05167331|Analgesics|analgesics|mesh-ancestor
5632609|NCT00344487|Ritonavir|ritonavir|mesh-list
5632610|NCT00344487|Lopinavir|lopinavir|mesh-list
5632611|NCT00344487|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5632612|NCT00344487|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5632613|NCT00344487|Protease Inhibitors|protease inhibitors|mesh-ancestor
5632614|NCT00344487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5632615|NCT00344487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632616|NCT00344487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5632617|NCT00344487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5632618|NCT00344487|Antiviral Agents|antiviral agents|mesh-ancestor
5632619|NCT00344487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5632620|NCT00344487|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5632621|NCT00344487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5632622|NCT00281658|Paclitaxel|paclitaxel|mesh-list
5632623|NCT00281658|Lapatinib|lapatinib|mesh-list
5758277|NCT02989324|Misoprostol|misoprostol|mesh-list
5758278|NCT02989324|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5758279|NCT02989324|Abortifacient Agents|abortifacient agents|mesh-ancestor
5758280|NCT02989324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5758281|NCT02989324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758282|NCT02989324|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5758283|NCT02989324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5758284|NCT02989324|Oxytocics|oxytocics|mesh-ancestor
5758285|NCT02989259|Apatinib|apatinib|mesh-list
5758286|NCT02989259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5758287|NCT02989259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5758288|NCT02989259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5758289|NCT02989259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5758290|NCT02989272|Magnesium Sulfate|magnesium sulfate|mesh-list
5758291|NCT02989272|Analgesics|analgesics|mesh-ancestor
5758292|NCT02989272|Sensory System Agents|sensory system agents|mesh-ancestor
5758293|NCT02989272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5758294|NCT02989272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758295|NCT02989272|Anesthetics|anesthetics|mesh-ancestor
5758296|NCT02989272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5758297|NCT02989272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5758298|NCT02989272|Anticonvulsants|anticonvulsants|mesh-ancestor
5758299|NCT02989272|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5758300|NCT02989272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5758301|NCT02989272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632624|NCT00281658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5632625|NCT00281658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5632626|NCT00281658|Tubulin Modulators|tubulin modulators|mesh-ancestor
5632627|NCT00281658|Antimitotic Agents|antimitotic agents|mesh-ancestor
5758302|NCT02989272|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5758303|NCT02989272|Tocolytic Agents|tocolytic agents|mesh-ancestor
5758304|NCT02989272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5758305|NCT02989038|Nicotine|nicotine|mesh-list
5758306|NCT02989038|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5758307|NCT02989038|Autonomic Agents|autonomic agents|mesh-ancestor
5758308|NCT02989038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5758309|NCT02989038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758310|NCT02989038|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5758311|NCT02989038|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5758312|NCT02989038|Cholinergic Agents|cholinergic agents|mesh-ancestor
5758313|NCT02989038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5758314|NCT02989038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5758315|NCT02989207|Mitomycins|mitomycins|mesh-list
5758316|NCT02989207|Mitomycin|mitomycin|mesh-list
5758317|NCT02989207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5758318|NCT02989207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5758319|NCT02989207|Alkylating Agents|alkylating agents|mesh-ancestor
5758320|NCT02989207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5758321|NCT02989207|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5758322|NCT02989207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5632628|NCT00281658|Mitosis Modulators|mitosis modulators|mesh-ancestor
5632629|NCT00281658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632630|NCT00281658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5632631|NCT00281658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5632632|NCT05209529|Durvalumab|durvalumab|mesh-list
5632633|NCT05209529|Olaparib|olaparib|mesh-list
5632634|NCT05209529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5632635|NCT05209529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5632636|NCT05209529|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5632637|NCT05209529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5632638|NCT05209529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632639|NCT05209425|Vitamin D|vitamin d|mesh-list
5758323|NCT02989311|Iron|iron|mesh-list
5758324|NCT02989311|Trace Elements|trace elements|mesh-ancestor
5758325|NCT02989311|Micronutrients|micronutrients|mesh-ancestor
5758326|NCT02989311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758327|NCT02989129|Quercetin|quercetin|mesh-list
5758328|NCT02989129|Antioxidants|antioxidants|mesh-ancestor
5758329|NCT02989129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5758330|NCT02989129|Protective Agents|protective agents|mesh-ancestor
5758331|NCT02989129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758332|NCT02988999|Erythritol|erythritol|mesh-list
5758333|NCT02988999|Vasodilator Agents|vasodilator agents|mesh-ancestor
5758334|NCT02989012|Oseltamivir|oseltamivir|mesh-list
5632640|NCT05209425|Cholecalciferol|cholecalciferol|mesh-list
5758335|NCT02989012|Antiviral Agents|antiviral agents|mesh-ancestor
5758336|NCT02989012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5758337|NCT02989012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5758338|NCT02989012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5758339|NCT02988869|Formoterol Fumarate|formoterol fumarate|mesh-list
5758340|NCT02988869|Tiotropium Bromide|tiotropium bromide|mesh-list
5758341|NCT02988869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5758342|NCT02988869|Autonomic Agents|autonomic agents|mesh-ancestor
5758343|NCT02988869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5758344|NCT02988869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758345|NCT02988869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5632641|NCT05209425|Vitamins|vitamins|mesh-ancestor
5632642|NCT05209425|Micronutrients|micronutrients|mesh-ancestor
5632643|NCT05209425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758346|NCT02988869|Respiratory System Agents|respiratory system agents|mesh-ancestor
5758347|NCT02988869|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5758348|NCT02988869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5632644|NCT05209425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5632645|NCT05209425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5632646|NCT05209412|Aspirin|aspirin|mesh-list
5632647|NCT05209412|Paclitaxel|paclitaxel|mesh-list
5632648|NCT05209412|Clopidogrel|clopidogrel|mesh-list
5632649|NCT05209412|Ticagrelor|ticagrelor|mesh-list
5632650|NCT05209412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5632651|NCT05209412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5632652|NCT05209412|Tubulin Modulators|tubulin modulators|mesh-ancestor
5632653|NCT05209412|Antimitotic Agents|antimitotic agents|mesh-ancestor
5632654|NCT05209412|Mitosis Modulators|mitosis modulators|mesh-ancestor
5632655|NCT05209412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632656|NCT05209412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5632657|NCT05209412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5632658|NCT05209412|Analgesics|analgesics|mesh-ancestor
5632659|NCT05209412|Sensory System Agents|sensory system agents|mesh-ancestor
5632660|NCT05209412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5632661|NCT05209412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632662|NCT05209412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5632663|NCT05209412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5632664|NCT05209412|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5632665|NCT05209412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5632666|NCT05209412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5632667|NCT05209412|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5632668|NCT05209412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5632669|NCT05209412|Antipyretics|antipyretics|mesh-ancestor
5632670|NCT05209412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5632671|NCT05209412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5632672|NCT05209412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5632673|NCT05209412|Purinergic Agents|purinergic agents|mesh-ancestor
5632674|NCT05209412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5632675|NCT05209347|Carbon Fiber|carbon fiber|mesh-list
5632676|NCT05209347|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5758349|NCT02988869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5758350|NCT02988869|Adrenergic Agents|adrenergic agents|mesh-ancestor
5758351|NCT02988869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5758352|NCT02988869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5758353|NCT02988869|Parasympatholytics|parasympatholytics|mesh-ancestor
5758354|NCT02988869|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5758355|NCT02988869|Cholinergic Agents|cholinergic agents|mesh-ancestor
5758356|NCT02988921|Paclitaxel|paclitaxel|mesh-list
5758357|NCT02988921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5758358|NCT02988921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5758359|NCT02988921|Tubulin Modulators|tubulin modulators|mesh-ancestor
5758360|NCT02988921|Antimitotic Agents|antimitotic agents|mesh-ancestor
5758361|NCT02988921|Mitosis Modulators|mitosis modulators|mesh-ancestor
5758362|NCT02988921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5758363|NCT02988908|Donepezil|donepezil|mesh-list
5758364|NCT02988908|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5758365|NCT02988908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5758366|NCT02988908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5758367|NCT02988908|Cholinergic Agents|cholinergic agents|mesh-ancestor
5758368|NCT02988908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5758369|NCT02988908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758370|NCT02988908|Nootropic Agents|nootropic agents|mesh-ancestor
5758371|NCT02988700|Bupivacaine|bupivacaine|mesh-list
5758372|NCT02988700|Anesthetics, Local|anesthetics, local|mesh-ancestor
5632677|NCT05209347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5758373|NCT02988700|Anesthetics|anesthetics|mesh-ancestor
5758374|NCT02988700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5758375|NCT02988700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758376|NCT02988700|Sensory System Agents|sensory system agents|mesh-ancestor
5758377|NCT02988700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5758378|NCT02988362|Amlodipine|amlodipine|mesh-list
5758379|NCT02988362|Candesartan|candesartan|mesh-list
5758380|NCT02988362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5758381|NCT02988362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5632678|NCT05209295|Azacitidine|azacitidine|mesh-list
5632679|NCT05209295|Cc-486|cc-486|mesh-list
5632680|NCT05209295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5632681|NCT05209295|Antimetabolites|antimetabolites|mesh-ancestor
5758382|NCT02988362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5758383|NCT02988362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5758384|NCT02988362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5758385|NCT02988362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758386|NCT02988362|Vasodilator Agents|vasodilator agents|mesh-ancestor
5632682|NCT05209295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632683|NCT05209295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5632684|NCT05209295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5632685|NCT05209256|Pemetrexed|pemetrexed|mesh-list
5632686|NCT05209256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5632687|NCT05209256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5632688|NCT05209256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632689|NCT05209256|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5632690|NCT05209256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5632691|NCT05209152|Azacitidine|azacitidine|mesh-list
5632692|NCT05209152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5632693|NCT05209152|Antimetabolites|antimetabolites|mesh-ancestor
5632694|NCT05209152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632695|NCT05209152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5632696|NCT05209152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5632697|NCT05209035|Trazodone|trazodone|mesh-list
5632698|NCT05209035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5632699|NCT05209035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5632700|NCT05209035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5758387|NCT02988362|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5758388|NCT02988362|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5758389|NCT02988024|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
5758390|NCT02988024|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5758391|NCT02988024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5758392|NCT02988024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5758393|NCT02988024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5758394|NCT02988024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5758395|NCT02988024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758396|NCT02988024|Antidepressive Agents|antidepressive agents|mesh-ancestor
5758397|NCT02988024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5758398|NCT02988297|RNS60|rns60|mesh-list
5758399|NCT02988297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5758400|NCT02988297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5758401|NCT02988297|Analgesics|analgesics|mesh-ancestor
5758402|NCT02988297|Sensory System Agents|sensory system agents|mesh-ancestor
5758403|NCT02988297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5758404|NCT02988297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758405|NCT02988297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5758406|NCT02988297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5758407|NCT02988297|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5758408|NCT02987998|Pembrolizumab|pembrolizumab|mesh-list
5758409|NCT02987998|Etoposide|etoposide|mesh-list
5758410|NCT02987998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5758411|NCT02987998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5758412|NCT02987998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5758413|NCT02987998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5758414|NCT02987998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5758415|NCT02987998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5758416|NCT02987998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5758417|NCT02988440|Sorafenib|sorafenib|mesh-list
5632701|NCT05209035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632702|NCT05209035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5632703|NCT05209035|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5632704|NCT05209035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5632705|NCT05209035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5632706|NCT05209035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632707|NCT05209035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5632708|NCT05209035|Serotonin Agents|serotonin agents|mesh-ancestor
5632709|NCT05209035|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5632710|NCT05209035|Antidepressive Agents|antidepressive agents|mesh-ancestor
5632711|NCT05208983|Vaccines|vaccines|mesh-list
5632712|NCT05208983|Immunologic Factors|immunologic factors|mesh-ancestor
5632713|NCT05208983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632714|NCT05208944|Cemiplimab|cemiplimab|mesh-list
5632715|NCT05208944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5632716|NCT05208944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5632717|NCT05208931|Mitogens|mitogens|mesh-list
5632718|NCT05208931|Endothelial Growth Factors|endothelial growth factors|mesh-list
5632719|NCT05208931|Mitosis Modulators|mitosis modulators|mesh-ancestor
5632720|NCT05208931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632721|NCT05208931|Growth Substances|growth substances|mesh-ancestor
5632722|NCT05208931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632723|NCT05208892|Dexmedetomidine|dexmedetomidine|mesh-list
5632724|NCT05208892|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5632725|NCT05208892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5632726|NCT05208892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632727|NCT05208892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5632728|NCT05208892|Analgesics|analgesics|mesh-ancestor
5632729|NCT05208892|Sensory System Agents|sensory system agents|mesh-ancestor
5632730|NCT05208892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5632731|NCT05208892|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5632732|NCT05208892|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5632733|NCT05208892|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5632734|NCT05208892|Adrenergic Agents|adrenergic agents|mesh-ancestor
5632735|NCT05208892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5632736|NCT05208892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632737|NCT05208879|Carotenoids|carotenoids|mesh-list
5632738|NCT05208879|Antioxidants|antioxidants|mesh-ancestor
5632739|NCT05208879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632740|NCT05208879|Protective Agents|protective agents|mesh-ancestor
5632741|NCT05208879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632742|NCT05208827|Vitamin D|vitamin d|mesh-list
5632743|NCT05208827|Ergocalciferols|ergocalciferols|mesh-list
5632744|NCT05208827|Cholecalciferol|cholecalciferol|mesh-list
5632745|NCT05208827|Vitamins|vitamins|mesh-list
5632746|NCT05208827|Micronutrients|micronutrients|mesh-ancestor
5632747|NCT05208827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632748|NCT05208827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5632749|NCT05208827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5632750|NCT05208801|Morphine|morphine|mesh-list
5632751|NCT05208801|Bupivacaine|bupivacaine|mesh-list
5632752|NCT05208801|Anesthetics, Local|anesthetics, local|mesh-ancestor
5632753|NCT05208801|Anesthetics|anesthetics|mesh-ancestor
5632754|NCT05208801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5632755|NCT05208801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632756|NCT05208801|Sensory System Agents|sensory system agents|mesh-ancestor
5632757|NCT05208801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5632758|NCT05208801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5632759|NCT05208801|Narcotics|narcotics|mesh-ancestor
5632760|NCT05208801|Analgesics|analgesics|mesh-ancestor
5632761|NCT05208398|Warfarin|warfarin|mesh-list
5632762|NCT05208398|Apixaban|apixaban|mesh-list
5632763|NCT05208398|Anticoagulants|anticoagulants|mesh-ancestor
5632764|NCT05208398|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5632765|NCT05208398|Antithrombins|antithrombins|mesh-ancestor
5632766|NCT05208398|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5632767|NCT05208398|Protease Inhibitors|protease inhibitors|mesh-ancestor
5632768|NCT05208398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5632769|NCT05208398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632770|NCT05208333|Albendazole|albendazole|mesh-list
5632771|NCT05208333|Anthelmintics|anthelmintics|mesh-ancestor
5632772|NCT05208333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5632773|NCT05208333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5632774|NCT05208333|Anticestodal Agents|anticestodal agents|mesh-ancestor
5632775|NCT05208333|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5758418|NCT02988440|Spartalizumab|spartalizumab|mesh-list
5758419|NCT02988440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5758420|NCT02988440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5632776|NCT05208333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5632777|NCT05208333|Tubulin Modulators|tubulin modulators|mesh-ancestor
5632778|NCT05208333|Antimitotic Agents|antimitotic agents|mesh-ancestor
5632779|NCT05208333|Mitosis Modulators|mitosis modulators|mesh-ancestor
5632780|NCT05208333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632781|NCT05208333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5632782|NCT05208307|Dexamethasone|dexamethasone|mesh-list
5632783|NCT05208307|Dexamethasone acetate|dexamethasone acetate|mesh-list
5632784|NCT05208307|Pomalidomide|pomalidomide|mesh-list
5632785|NCT05208307|Ichthammol|ichthammol|mesh-list
5632786|NCT05208307|BB 1101|bb 1101|mesh-list
5632787|NCT05208307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5632788|NCT05208307|Antiemetics|antiemetics|mesh-ancestor
5632789|NCT05208307|Autonomic Agents|autonomic agents|mesh-ancestor
5632790|NCT05208307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5632791|NCT05208307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632792|NCT05208307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5632793|NCT05208307|Glucocorticoids|glucocorticoids|mesh-ancestor
5632794|NCT05208307|Hormones|hormones|mesh-ancestor
5758421|NCT02988440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5758422|NCT02988440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5758423|NCT02988440|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5758424|NCT02988089|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5758425|NCT02988089|Amoxicillin|amoxicillin|mesh-list
5758426|NCT02988089|Metronidazole|metronidazole|mesh-list
5758427|NCT02988089|Clarithromycin|clarithromycin|mesh-list
5758428|NCT02988089|Levofloxacin|levofloxacin|mesh-list
5632795|NCT05208307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5632796|NCT05208307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5632797|NCT05208307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5632798|NCT05208307|Protease Inhibitors|protease inhibitors|mesh-ancestor
5632799|NCT05208307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5632800|NCT05208307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632801|NCT05208307|Immunologic Factors|immunologic factors|mesh-ancestor
5632802|NCT05208307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5632803|NCT05208307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5632804|NCT05208307|Growth Substances|growth substances|mesh-ancestor
5632805|NCT05208307|Growth Inhibitors|growth inhibitors|mesh-ancestor
5632806|NCT05208307|Dermatologic Agents|dermatologic agents|mesh-ancestor
5632807|NCT05208294|Sulpiride|sulpiride|mesh-list
5758429|NCT02988089|Ofloxacin|ofloxacin|mesh-list
5758430|NCT02988089|Tetracycline|tetracycline|mesh-list
5758431|NCT02988089|Tinidazole|tinidazole|mesh-list
5758432|NCT02988089|Furazolidone|furazolidone|mesh-list
5758433|NCT02988089|Bismuth|bismuth|mesh-list
6673206|NCT01561066|Coagulants|coagulants|mesh-ancestor
6673207|NCT01561092|Citalopram|citalopram|mesh-list
6673208|NCT01561092|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6673209|NCT01561092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6673210|NCT01561092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6673211|NCT01561092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673212|NCT01561092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6673213|NCT01561092|Serotonin Agents|serotonin agents|mesh-ancestor
6673214|NCT01561092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673215|NCT01561092|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5632808|NCT05208294|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5758434|NCT02988089|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
5758435|NCT02988089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5758436|NCT02988089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5758437|NCT02988089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5758438|NCT02988089|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5758439|NCT02988089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5758440|NCT02988089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5758441|NCT02988089|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5758442|NCT02988089|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5758443|NCT02988089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5758444|NCT02988089|Renal Agents|renal agents|mesh-ancestor
5758445|NCT02988089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5758446|NCT02988089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5758447|NCT02988089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5758448|NCT02988089|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5758449|NCT02988089|Antacids|antacids|mesh-ancestor
5758450|NCT02988089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5758451|NCT02988089|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5758452|NCT02988089|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
5758453|NCT02988089|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
5758454|NCT02988089|Alkylating Agents|alkylating agents|mesh-ancestor
5758455|NCT02988063|Polidocanol|polidocanol|mesh-list
5758456|NCT02988063|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
5758457|NCT02988063|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5758458|NCT02987985|Acetaminophen|acetaminophen|mesh-list
5758459|NCT02987985|Dexamethasone|dexamethasone|mesh-list
5758460|NCT02987985|Lidocaine|lidocaine|mesh-list
5758461|NCT02987985|Fentanyl|fentanyl|mesh-list
5758462|NCT02987985|Dexmedetomidine|dexmedetomidine|mesh-list
5758463|NCT02987985|Ketamine|ketamine|mesh-list
5758464|NCT02987985|Gabapentin|gabapentin|mesh-list
5758465|NCT02987985|Analgesics, Opioid|analgesics, opioid|mesh-list
5758466|NCT02987985|Ondansetron|ondansetron|mesh-list
5758467|NCT02987985|Sevoflurane|sevoflurane|mesh-list
5758468|NCT02987985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5758469|NCT02987985|Antiemetics|antiemetics|mesh-ancestor
5758470|NCT02987985|Autonomic Agents|autonomic agents|mesh-ancestor
5632809|NCT05208294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5632810|NCT05208294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5632811|NCT05208294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632812|NCT05208294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5632813|NCT05208294|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5632814|NCT05208294|Dopamine Agents|dopamine agents|mesh-ancestor
5632815|NCT05208294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5632816|NCT05208294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632817|NCT05208294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5632818|NCT05208294|Antidepressive Agents|antidepressive agents|mesh-ancestor
5632819|NCT05208268|Rabeprazole|rabeprazole|mesh-list
5632820|NCT05208268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5632821|NCT05208268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5632822|NCT05208268|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5632823|NCT05208268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5632824|NCT05208268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632825|NCT05208242|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5632826|NCT05208190|Clozapine|clozapine|mesh-list
5632827|NCT05208190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5632828|NCT05208190|Serotonin Agents|serotonin agents|mesh-ancestor
5632829|NCT05208190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5632830|NCT05208190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632831|NCT05208190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632832|NCT05208190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5632833|NCT05208190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5632834|NCT05208190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5632835|NCT05208190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5632836|NCT05208190|GABA Antagonists|gaba antagonists|mesh-ancestor
5632837|NCT05208190|GABA Agents|gaba agents|mesh-ancestor
5693287|NCT03402087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5693288|NCT03402087|Antimetabolites|antimetabolites|mesh-ancestor
5693289|NCT03402087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693290|NCT03402087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5693291|NCT03402087|Dermatologic Agents|dermatologic agents|mesh-ancestor
5693292|NCT03402087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5693293|NCT03402087|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6489978|NCT00594633|Nootropic Agents|nootropic agents|mesh-ancestor
6489979|NCT00594737|Memantine|memantine|mesh-list
6489980|NCT00594737|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6489981|NCT00594737|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6489982|NCT00594737|Dopamine Agents|dopamine agents|mesh-ancestor
6489983|NCT00594737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6489984|NCT00594737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6489985|NCT00594737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693294|NCT03402087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5693295|NCT03402087|Immunologic Factors|immunologic factors|mesh-ancestor
5693296|NCT03402087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5758471|NCT02987985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5758472|NCT02987985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758473|NCT02987985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5758474|NCT02987985|Glucocorticoids|glucocorticoids|mesh-ancestor
5758475|NCT02987985|Hormones|hormones|mesh-ancestor
5632838|NCT05207904|Paclitaxel|paclitaxel|mesh-list
5632839|NCT05207904|Carboplatin|carboplatin|mesh-list
5632840|NCT05207904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5632841|NCT05207904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5758476|NCT02987985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5758477|NCT02987985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5758478|NCT02987985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5758479|NCT02987985|Anesthetics, Local|anesthetics, local|mesh-ancestor
5758480|NCT02987985|Anesthetics|anesthetics|mesh-ancestor
5758481|NCT02987985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5758482|NCT02987985|Sensory System Agents|sensory system agents|mesh-ancestor
5632842|NCT05207904|Tubulin Modulators|tubulin modulators|mesh-ancestor
5632843|NCT05207904|Antimitotic Agents|antimitotic agents|mesh-ancestor
5632844|NCT05207904|Mitosis Modulators|mitosis modulators|mesh-ancestor
5632845|NCT05207904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632846|NCT05207774|Oxytocin|oxytocin|mesh-list
5632847|NCT05207774|Oxytocics|oxytocics|mesh-ancestor
5632848|NCT05207774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5632849|NCT05207774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632850|NCT05207735|Capecitabine|capecitabine|mesh-list
6673216|NCT01561092|Antidepressive Agents|antidepressive agents|mesh-ancestor
6673217|NCT01561092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6673218|NCT01561131|Calcium|calcium|mesh-list
6673219|NCT01561131|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5632851|NCT05207735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5758483|NCT02987985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5758484|NCT02987985|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5758485|NCT02987985|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5758486|NCT02987985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5758487|NCT02987985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5758488|NCT02987985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5758489|NCT02987985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5758490|NCT02987985|Analgesics|analgesics|mesh-ancestor
5758491|NCT02987985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5758492|NCT02987985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5758493|NCT02987985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5758494|NCT02987985|Adrenergic Agents|adrenergic agents|mesh-ancestor
5758495|NCT02987985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5758496|NCT02987985|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5758497|NCT02987985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5758498|NCT02987985|Anesthetics, General|anesthetics, general|mesh-ancestor
5758499|NCT02987985|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5758500|NCT02987985|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5758501|NCT02987985|Narcotics|narcotics|mesh-ancestor
5758502|NCT02987985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5758503|NCT02987985|Antipyretics|antipyretics|mesh-ancestor
5758504|NCT02987985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5758505|NCT02987985|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5758506|NCT02987985|Anticonvulsants|anticonvulsants|mesh-ancestor
5758507|NCT02987985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5758508|NCT02987985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5758509|NCT02987985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5758510|NCT02987985|Antimanic Agents|antimanic agents|mesh-ancestor
5758511|NCT02987985|Antipruritics|antipruritics|mesh-ancestor
5758512|NCT02987985|Dermatologic Agents|dermatologic agents|mesh-ancestor
5758513|NCT02987985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5758514|NCT02987985|Serotonin Agents|serotonin agents|mesh-ancestor
5758515|NCT02987985|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5758516|NCT02987946|Nadroparin|nadroparin|mesh-list
5758517|NCT02987946|Anticoagulants|anticoagulants|mesh-ancestor
5758518|NCT02987946|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5632852|NCT05207735|Antimetabolites|antimetabolites|mesh-ancestor
5632853|NCT05207735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632854|NCT05207735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5632855|NCT05207709|Paclitaxel|paclitaxel|mesh-list
5632856|NCT05207709|Letrozole|letrozole|mesh-list
5632857|NCT05207709|Palbociclib|palbociclib|mesh-list
5632858|NCT05207709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5632859|NCT05207709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5632860|NCT05207709|Tubulin Modulators|tubulin modulators|mesh-ancestor
5758519|NCT02987946|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5758520|NCT02987946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5758521|NCT02987920|Acetaminophen|acetaminophen|mesh-list
5758522|NCT02987920|Celecoxib|celecoxib|mesh-list
5758523|NCT02987920|Ketorolac|ketorolac|mesh-list
5632861|NCT05207709|Antimitotic Agents|antimitotic agents|mesh-ancestor
5758524|NCT02987920|Oxycodone|oxycodone|mesh-list
5758525|NCT02987920|Gabapentin|gabapentin|mesh-list
5758526|NCT02987920|Hydromorphone|hydromorphone|mesh-list
5758527|NCT02987920|Dextromethorphan|dextromethorphan|mesh-list
5758528|NCT02987920|Pantoprazole|pantoprazole|mesh-list
5758529|NCT02987920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5758530|NCT02987920|Analgesics|analgesics|mesh-ancestor
5758531|NCT02987920|Sensory System Agents|sensory system agents|mesh-ancestor
5758532|NCT02987920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5758533|NCT02987920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758534|NCT02987920|Antipyretics|antipyretics|mesh-ancestor
5758535|NCT02987920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5758536|NCT02987920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5758537|NCT02987920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5758538|NCT02987920|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5758539|NCT02987920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5758540|NCT02987920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5632862|NCT05207709|Mitosis Modulators|mitosis modulators|mesh-ancestor
5632863|NCT05207709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632864|NCT05207709|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5632865|NCT05207709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5632866|NCT05207709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5632867|NCT05207709|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5632868|NCT05207709|Hormone Antagonists|hormone antagonists|mesh-ancestor
5632869|NCT05207709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5632870|NCT05207709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632871|NCT05207709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5632872|NCT05207683|Antibodies|antibodies|mesh-list
5632873|NCT05207683|Antibodies, Antinuclear|antibodies, antinuclear|mesh-list
5632874|NCT05207683|Immunologic Factors|immunologic factors|mesh-ancestor
5632875|NCT05207683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632876|NCT05207514|Ethanol|ethanol|mesh-list
5632877|NCT05207514|Cyclophosphamide|cyclophosphamide|mesh-list
5632878|NCT05207514|Docetaxel|docetaxel|mesh-list
5632879|NCT05207514|Doxorubicin|doxorubicin|mesh-list
5632880|NCT05207514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5632881|NCT05207514|Immunologic Factors|immunologic factors|mesh-ancestor
5632882|NCT05207514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632883|NCT05207514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5632884|NCT05207514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5632885|NCT05207514|Alkylating Agents|alkylating agents|mesh-ancestor
5632886|NCT05207514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632887|NCT05207514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5632888|NCT05207514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5632889|NCT05207514|Tubulin Modulators|tubulin modulators|mesh-ancestor
5632890|NCT05207514|Antimitotic Agents|antimitotic agents|mesh-ancestor
5632891|NCT05207514|Mitosis Modulators|mitosis modulators|mesh-ancestor
5632892|NCT05207514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5632893|NCT05207514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5632894|NCT05207514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5632895|NCT05207514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5632896|NCT05207514|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5632897|NCT05207514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5632898|NCT05207514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5632899|NCT05207436|Oxytocin|oxytocin|mesh-list
5632900|NCT05207436|Oxytocics|oxytocics|mesh-ancestor
5632901|NCT05207436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5632902|NCT05207436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632903|NCT05207358|Mycophenolic Acid|mycophenolic acid|mesh-list
5758541|NCT02987920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5758542|NCT02987920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5758543|NCT02987920|Narcotics|narcotics|mesh-ancestor
5758544|NCT02987920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5758545|NCT02987920|Anticonvulsants|anticonvulsants|mesh-ancestor
5758546|NCT02987920|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5758547|NCT02987920|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5758548|NCT02987920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5758549|NCT02987920|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5758550|NCT02987920|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5758551|NCT02987920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5758552|NCT02987920|Antimanic Agents|antimanic agents|mesh-ancestor
5758553|NCT02987920|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5758554|NCT02987920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5758555|NCT02987920|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5632904|NCT05207358|Cyclophosphamide|cyclophosphamide|mesh-list
5632905|NCT05207358|Rituximab|rituximab|mesh-list
5758556|NCT02987920|Antitussive Agents|antitussive agents|mesh-ancestor
5632906|NCT05207358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5632907|NCT05207358|Immunologic Factors|immunologic factors|mesh-ancestor
5758557|NCT02987920|Respiratory System Agents|respiratory system agents|mesh-ancestor
5758558|NCT02987907|Dexamethasone|dexamethasone|mesh-list
5758559|NCT02987907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5758560|NCT02987907|Antiemetics|antiemetics|mesh-ancestor
5758561|NCT02987907|Autonomic Agents|autonomic agents|mesh-ancestor
5758562|NCT02987907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5758563|NCT02987907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758564|NCT02987907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5758565|NCT02987907|Glucocorticoids|glucocorticoids|mesh-ancestor
5758566|NCT02987907|Hormones|hormones|mesh-ancestor
5758567|NCT02987907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5758568|NCT02987907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5758569|NCT02987907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5758570|NCT02987751|Insulin|insulin|mesh-list
5758571|NCT02987751|Insulin Glargine|insulin glargine|mesh-list
5758572|NCT02987751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5758573|NCT02987751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895257|NCT05229991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5895258|NCT05229991|Antiviral Agents|antiviral agents|mesh-ancestor
5895259|NCT05229991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5632908|NCT05207358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632909|NCT05207358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5632910|NCT05207358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5895260|NCT05229991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5895261|NCT05229991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5895262|NCT05229965|Acetaminophen|acetaminophen|mesh-list
5895263|NCT05229965|Codeine|codeine|mesh-list
5895264|NCT05229965|Caffeine|caffeine|mesh-list
5895265|NCT05229965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5895266|NCT05229965|Analgesics|analgesics|mesh-ancestor
5895267|NCT05229965|Sensory System Agents|sensory system agents|mesh-ancestor
5895268|NCT05229965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5895269|NCT05229965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895270|NCT05229965|Antipyretics|antipyretics|mesh-ancestor
5895271|NCT05229965|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5895272|NCT05229965|Narcotics|narcotics|mesh-ancestor
5895273|NCT05229965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5895274|NCT05229965|Antitussive Agents|antitussive agents|mesh-ancestor
5895275|NCT05229965|Respiratory System Agents|respiratory system agents|mesh-ancestor
5895276|NCT05229965|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5895277|NCT05229965|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5895278|NCT05229965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5895279|NCT05229965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895280|NCT05229965|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5895281|NCT05229965|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5895282|NCT05229965|Purinergic Agents|purinergic agents|mesh-ancestor
5895283|NCT05229965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5895284|NCT05229913|Esketamine|esketamine|mesh-list
5895285|NCT05229913|Antidepressive Agents|antidepressive agents|mesh-ancestor
5895286|NCT05229913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5907832|NCT05167331|Sensory System Agents|sensory system agents|mesh-ancestor
5907833|NCT05167331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5907834|NCT05160597|Edetic Acid|edetic acid|mesh-list
5907835|NCT05160597|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5907836|NCT05160597|Chelating Agents|chelating agents|mesh-ancestor
5907837|NCT05160597|Sequestering Agents|sequestering agents|mesh-ancestor
5907838|NCT05160597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907839|NCT05160597|Anticoagulants|anticoagulants|mesh-ancestor
5907840|NCT05160597|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5907841|NCT05160597|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5907842|NCT05159999|Antihypertensive Agents|antihypertensive agents|mesh-list
5907843|NCT05156710|Rituximab|rituximab|mesh-list
5907844|NCT05156710|Tacrolimus|tacrolimus|mesh-list
5907845|NCT05156710|Immunoglobulins|immunoglobulins|mesh-list
5907846|NCT05156710|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5907847|NCT05156710|Antibodies|antibodies|mesh-list
5907848|NCT05156710|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5907849|NCT05156710|gamma-Globulins|gamma-globulins|mesh-list
5907850|NCT05156710|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5632911|NCT05207358|Alkylating Agents|alkylating agents|mesh-ancestor
5632912|NCT05207358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907851|NCT05156710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5907852|NCT05156710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5907853|NCT05156710|Immunologic Factors|immunologic factors|mesh-ancestor
6209067|NCT02141217|Clavulanic Acid|clavulanic acid|mesh-list
5758574|NCT02987699|Leucovorin|leucovorin|mesh-list
5758575|NCT02987699|Oxaliplatin|oxaliplatin|mesh-list
5758576|NCT02987699|Fluorouracil|fluorouracil|mesh-list
5758577|NCT02987699|Levoleucovorin|levoleucovorin|mesh-list
5758578|NCT02987699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5758579|NCT02987699|Antidotes|antidotes|mesh-ancestor
5758580|NCT02987699|Protective Agents|protective agents|mesh-ancestor
5758581|NCT02987699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758582|NCT02987699|Vitamin B Complex|vitamin b complex|mesh-ancestor
5758583|NCT02987699|Vitamins|vitamins|mesh-ancestor
5758584|NCT02987699|Micronutrients|micronutrients|mesh-ancestor
5758585|NCT02987699|Antimetabolites|antimetabolites|mesh-ancestor
5758586|NCT02987699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5758587|NCT02987699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5758588|NCT02987699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5758589|NCT02987699|Immunologic Factors|immunologic factors|mesh-ancestor
5758590|NCT02987738|Dapagliflozin|dapagliflozin|mesh-list
5758591|NCT02987738|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5758592|NCT02987738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5758593|NCT02987738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5758594|NCT02987738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758595|NCT02987556|Insulin|insulin|mesh-list
5632913|NCT05207358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5632914|NCT05207358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5632915|NCT05207358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5632916|NCT05207358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5632917|NCT05207358|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5632918|NCT05207358|Antitubercular Agents|antitubercular agents|mesh-ancestor
5632919|NCT05207358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5632920|NCT05207358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5632921|NCT05207358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5632922|NCT05207280|Terlipressin|terlipressin|mesh-list
5632923|NCT05207280|Norepinephrine|norepinephrine|mesh-list
5632924|NCT05207280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5632925|NCT05207280|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5632926|NCT05207280|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5632927|NCT05207280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5632928|NCT05207280|Adrenergic Agents|adrenergic agents|mesh-ancestor
5632929|NCT05207280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5632930|NCT05207280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632931|NCT05207280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632932|NCT05207280|Sympathomimetics|sympathomimetics|mesh-ancestor
5632933|NCT05207280|Autonomic Agents|autonomic agents|mesh-ancestor
5632934|NCT05207280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5632935|NCT05199753|Antibodies|antibodies|mesh-list
5758596|NCT02987556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5758597|NCT02987556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758598|NCT02987465|Norepinephrine|norepinephrine|mesh-list
5758599|NCT02987465|Acetylcholine|acetylcholine|mesh-list
5758600|NCT02987465|Darbepoetin alfa|darbepoetin alfa|mesh-list
5758601|NCT02987465|Hematinics|hematinics|mesh-ancestor
5758602|NCT02987465|Vasodilator Agents|vasodilator agents|mesh-ancestor
5632936|NCT05199753|Immunologic Factors|immunologic factors|mesh-ancestor
5632937|NCT05199753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632938|NCT05187338|Pembrolizumab|pembrolizumab|mesh-list
5632939|NCT05187338|Ipilimumab|ipilimumab|mesh-list
5632940|NCT05187338|Durvalumab|durvalumab|mesh-list
5632941|NCT05187338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5632942|NCT05187338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5632943|NCT05187338|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5632944|NCT05187338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5758603|NCT02987465|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5758604|NCT02987465|Cholinergic Agents|cholinergic agents|mesh-ancestor
5758605|NCT02987465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5758606|NCT02987465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5758607|NCT02987465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758608|NCT02987465|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5758609|NCT02987465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5758610|NCT02987465|Adrenergic Agents|adrenergic agents|mesh-ancestor
5758611|NCT02987465|Sympathomimetics|sympathomimetics|mesh-ancestor
5632945|NCT05187208|Niraparib|niraparib|mesh-list
5632946|NCT05187208|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5758612|NCT02987465|Autonomic Agents|autonomic agents|mesh-ancestor
5758613|NCT02987465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5632947|NCT05187208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5758614|NCT02987465|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5758615|NCT02987400|Venetoclax|venetoclax|mesh-list
5758616|NCT02987400|Obinutuzumab|obinutuzumab|mesh-list
5758617|NCT02987400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5758618|NCT02987400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5758619|NCT02987218|Propofol|propofol|mesh-list
5758620|NCT02987218|Desflurane|desflurane|mesh-list
5758621|NCT02987218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5758622|NCT02987218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5758623|NCT02987218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758624|NCT02987218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5758625|NCT02987218|Anesthetics, General|anesthetics, general|mesh-ancestor
5758626|NCT02987218|Anesthetics|anesthetics|mesh-ancestor
5758627|NCT02987218|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5758628|NCT02987270|Piperaquine|piperaquine|mesh-list
5758629|NCT02987270|Artenimol|artenimol|mesh-list
5758630|NCT02987270|Antimalarials|antimalarials|mesh-ancestor
5758631|NCT02987270|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5758632|NCT02987270|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5758633|NCT02987270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5758634|NCT02987244|Prednisone|prednisone|mesh-list
5758635|NCT02987244|Cyclophosphamide|cyclophosphamide|mesh-list
5758636|NCT02987244|Etoposide|etoposide|mesh-list
5758637|NCT02987244|Epirubicin|epirubicin|mesh-list
5758638|NCT02987244|Vindesine|vindesine|mesh-list
5758639|NCT02987244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5632948|NCT05187208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632949|NCT05187208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5632950|NCT05186467|Magnesium Sulfate|magnesium sulfate|mesh-list
5632951|NCT05186467|Analgesics|analgesics|mesh-ancestor
5632952|NCT05186467|Sensory System Agents|sensory system agents|mesh-ancestor
5632953|NCT05186467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5632954|NCT05186467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632955|NCT05186467|Anesthetics|anesthetics|mesh-ancestor
5632956|NCT05186467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5632957|NCT05186467|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5632958|NCT05186467|Anticonvulsants|anticonvulsants|mesh-ancestor
5632959|NCT05186467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5632960|NCT05186467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5632961|NCT05186467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632962|NCT05186467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5632963|NCT05186467|Tocolytic Agents|tocolytic agents|mesh-ancestor
5758640|NCT02987244|Immunologic Factors|immunologic factors|mesh-ancestor
5758641|NCT02987244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758642|NCT02987244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5758643|NCT02987244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5758644|NCT02987244|Alkylating Agents|alkylating agents|mesh-ancestor
5758645|NCT02987244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5758646|NCT02987244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5758647|NCT02987244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5758648|NCT02987244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5758649|NCT02987244|Glucocorticoids|glucocorticoids|mesh-ancestor
5758650|NCT02987244|Hormones|hormones|mesh-ancestor
5758651|NCT02987244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5758652|NCT02987244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5758653|NCT02987244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5758654|NCT02987244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5758655|NCT02987244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5758656|NCT02987244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5758657|NCT02987244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5632964|NCT05186467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5632965|NCT05185739|Pembrolizumab|pembrolizumab|mesh-list
5632966|NCT05185739|Lenvatinib|lenvatinib|mesh-list
5632967|NCT05185739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5632968|NCT05185739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5632969|NCT05185739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5632970|NCT05185739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5632971|NCT05185739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632972|NCT05185024|Iron|iron|mesh-list
5632973|NCT05185024|Trace Elements|trace elements|mesh-ancestor
5632974|NCT05185024|Micronutrients|micronutrients|mesh-ancestor
5632975|NCT05185024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632976|NCT05184335|RP5063|rp5063|mesh-list
5758658|NCT02987244|Tubulin Modulators|tubulin modulators|mesh-ancestor
5758659|NCT02987244|Antimitotic Agents|antimitotic agents|mesh-ancestor
5758660|NCT02987244|Mitosis Modulators|mitosis modulators|mesh-ancestor
5758661|NCT02987166|Pembrolizumab|pembrolizumab|mesh-list
5758662|NCT02987166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5895287|NCT05229796|Empagliflozin|empagliflozin|mesh-list
5632977|NCT05184335|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5632978|NCT05184335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5632979|NCT05184335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5632980|NCT05184335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632981|NCT05184335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5632982|NCT05184335|Serotonin Agents|serotonin agents|mesh-ancestor
5632983|NCT05184335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5632984|NCT05184335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632985|NCT05182892|Dopamine|dopamine|mesh-list
5632986|NCT05182892|Dopamine Agonists|dopamine agonists|mesh-list
5632987|NCT05182892|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5632988|NCT05182892|Sympathomimetics|sympathomimetics|mesh-ancestor
5632989|NCT05182892|Autonomic Agents|autonomic agents|mesh-ancestor
5632990|NCT05182892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5632991|NCT05182892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5632992|NCT05182892|Dopamine Agents|dopamine agents|mesh-ancestor
5632993|NCT05182892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5632994|NCT05182892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5632995|NCT05182892|Protective Agents|protective agents|mesh-ancestor
5758663|NCT02987166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5758664|NCT02987348|Insulin|insulin|mesh-list
5758665|NCT02987348|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5758666|NCT02987348|Exenatide|exenatide|mesh-list
5758667|NCT02987348|Insulin, Long-Acting|insulin, long-acting|mesh-list
5758668|NCT02987348|Glucagon|glucagon|mesh-list
5758669|NCT02987348|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5758670|NCT02987348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5758671|NCT02987348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758672|NCT02987348|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5758673|NCT02987348|Incretins|incretins|mesh-ancestor
5758674|NCT02987348|Hormones|hormones|mesh-ancestor
5632996|NCT05180097|Gemcitabine|gemcitabine|mesh-list
5632997|NCT05180097|Dexamethasone|dexamethasone|mesh-list
5632998|NCT05180097|Pembrolizumab|pembrolizumab|mesh-list
5632999|NCT05180097|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5633000|NCT05180097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5633001|NCT05180097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5633002|NCT05180097|Antiemetics|antiemetics|mesh-ancestor
5633003|NCT05180097|Autonomic Agents|autonomic agents|mesh-ancestor
5633004|NCT05180097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5633005|NCT05180097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5633006|NCT05180097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5633007|NCT05180097|Glucocorticoids|glucocorticoids|mesh-ancestor
5633008|NCT05180097|Hormones|hormones|mesh-ancestor
5633009|NCT05180097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5633010|NCT05180097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5633011|NCT05180097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5633012|NCT05180097|Antimetabolites|antimetabolites|mesh-ancestor
5633013|NCT05180097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5633014|NCT05180097|Antiviral Agents|antiviral agents|mesh-ancestor
5633015|NCT05180097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5633016|NCT05180097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5633017|NCT05180097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5633018|NCT05180097|Immunologic Factors|immunologic factors|mesh-ancestor
5633019|NCT05180097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5633020|NCT05171673|Diclofenac|diclofenac|mesh-list
5633021|NCT05171673|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
5633022|NCT05171673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5633023|NCT05171673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5633024|NCT05171673|Analgesics|analgesics|mesh-ancestor
5633025|NCT05171673|Sensory System Agents|sensory system agents|mesh-ancestor
5633026|NCT05171673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5633027|NCT05171673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5633028|NCT05171673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5633029|NCT05171673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5633030|NCT05171673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5633031|NCT05171673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5633032|NCT05171673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693297|NCT03402087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5693298|NCT03402087|Antidotes|antidotes|mesh-ancestor
5693299|NCT03402087|Protective Agents|protective agents|mesh-ancestor
5693300|NCT03402087|Vitamin B Complex|vitamin b complex|mesh-ancestor
5758675|NCT02987348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5693301|NCT03402087|Vitamins|vitamins|mesh-ancestor
5693302|NCT03402087|Micronutrients|micronutrients|mesh-ancestor
5758676|NCT02987348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5758677|NCT02986685|Rabeprazole|rabeprazole|mesh-list
5758678|NCT02986685|Trimebutine|trimebutine|mesh-list
5758679|NCT02986685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5758680|NCT02986685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5758681|NCT02986685|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5758682|NCT02986685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5758683|NCT02986685|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5758684|NCT02986685|Parasympatholytics|parasympatholytics|mesh-ancestor
5758685|NCT02986685|Autonomic Agents|autonomic agents|mesh-ancestor
5758686|NCT02986685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5758687|NCT02986685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758688|NCT02986750|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5758689|NCT02986750|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5758690|NCT02986880|Botulinum Toxins|botulinum toxins|mesh-list
5758691|NCT02986880|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5758692|NCT02986880|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5758693|NCT02986880|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5758694|NCT02986880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5758695|NCT02986880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5758696|NCT02986880|Cholinergic Agents|cholinergic agents|mesh-ancestor
5758697|NCT02986880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5758698|NCT02986880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5633033|NCT05167487|Cisplatin|cisplatin|mesh-list
5633034|NCT05167487|Carboplatin|carboplatin|mesh-list
5633035|NCT05167487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5633036|NCT05166239|Lenvatinib|lenvatinib|mesh-list
5633037|NCT05166239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5633038|NCT05166239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5633039|NCT05166239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5633040|NCT05166239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5633041|NCT05155254|Pembrolizumab|pembrolizumab|mesh-list
5758699|NCT02986880|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5758700|NCT02986880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5758701|NCT02986906|Triamcinolone|triamcinolone|mesh-list
5758702|NCT02986906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6673220|NCT01561131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673221|NCT01561209|Amitriptyline|amitriptyline|mesh-list
6673222|NCT01561209|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6673223|NCT01561209|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6673224|NCT01561209|Antidepressive Agents|antidepressive agents|mesh-ancestor
5633042|NCT05155254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5633043|NCT05155254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5633044|NCT05149287|Ceftriaxone|ceftriaxone|mesh-list
5633045|NCT05149287|Lidocaine|lidocaine|mesh-list
5633046|NCT05149287|Anesthetics, Local|anesthetics, local|mesh-ancestor
5633047|NCT05149287|Anesthetics|anesthetics|mesh-ancestor
5633048|NCT05149287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5633049|NCT05149287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5633050|NCT05149287|Sensory System Agents|sensory system agents|mesh-ancestor
5633051|NCT05149287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5633052|NCT05149287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5633053|NCT05149287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6673225|NCT01561209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6673226|NCT01561209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5758703|NCT02986906|Glucocorticoids|glucocorticoids|mesh-ancestor
5758704|NCT02986906|Hormones|hormones|mesh-ancestor
5758705|NCT02986906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5758706|NCT02986906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758707|NCT02986347|Epinephrine|epinephrine|mesh-list
5758708|NCT02986347|Racepinephrine|racepinephrine|mesh-list
5758709|NCT02986347|Anesthetics|anesthetics|mesh-list
5758710|NCT02986347|Epinephryl borate|epinephryl borate|mesh-list
5758711|NCT02986347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5633054|NCT05149287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5633055|NCT05149287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5633056|NCT05149287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5633057|NCT05149287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5633058|NCT05149287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5633059|NCT05122130|Melatonin|melatonin|mesh-list
5633060|NCT05122130|Antioxidants|antioxidants|mesh-ancestor
5633061|NCT05122130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5633062|NCT05122130|Protective Agents|protective agents|mesh-ancestor
5633063|NCT05122130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5633064|NCT05122130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5758712|NCT02986347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758713|NCT02986347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5758714|NCT02986347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5758715|NCT02986347|Adrenergic Agents|adrenergic agents|mesh-ancestor
5758716|NCT02986347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5758717|NCT02986347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5758718|NCT02986347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5758719|NCT02986347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5633065|NCT05119166|Niacinamide|niacinamide|mesh-list
5633066|NCT05119166|Azithromycin|azithromycin|mesh-list
5633067|NCT05119166|Vitamins|vitamins|mesh-ancestor
5633068|NCT05119166|Micronutrients|micronutrients|mesh-ancestor
5633069|NCT05119166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5633070|NCT05119166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5633071|NCT05119166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5633072|NCT05119166|Vitamin B Complex|vitamin b complex|mesh-ancestor
5633073|NCT05112848|Vaccines|vaccines|mesh-list
5633074|NCT05112848|Immunologic Factors|immunologic factors|mesh-ancestor
5633075|NCT05112848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5633076|NCT05096325|Insulin|insulin|mesh-list
5633077|NCT05096325|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5633078|NCT05096325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5633079|NCT05087381|Cyproheptadine|cyproheptadine|mesh-list
5758720|NCT02986347|Autonomic Agents|autonomic agents|mesh-ancestor
5758721|NCT02986347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5758722|NCT02986347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5758723|NCT02986347|Respiratory System Agents|respiratory system agents|mesh-ancestor
5758724|NCT02986347|Mydriatics|mydriatics|mesh-ancestor
5758725|NCT02986347|Sympathomimetics|sympathomimetics|mesh-ancestor
5758726|NCT02986347|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5758727|NCT02986503|Cisplatin|cisplatin|mesh-list
5758728|NCT02986503|Doxorubicin|doxorubicin|mesh-list
5758729|NCT02986503|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5758730|NCT02986503|Methotrexate|methotrexate|mesh-list
5758731|NCT02986503|Ifosfamide|ifosfamide|mesh-list
5758732|NCT02986503|Isophosphamide mustard|isophosphamide mustard|mesh-list
5758733|NCT02986503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5633080|NCT05087381|Niclosamide|niclosamide|mesh-list
5633081|NCT05087381|Fluvoxamine|fluvoxamine|mesh-list
5633082|NCT05087381|Bromhexine|bromhexine|mesh-list
5633083|NCT05087381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5633084|NCT05087381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5633085|NCT05087381|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5633086|NCT05087381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5758734|NCT02986503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5758735|NCT02986503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5758736|NCT02986503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5758737|NCT02986503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5633087|NCT05087381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5633088|NCT05087381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5633089|NCT05087381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5633090|NCT05087381|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5633091|NCT05087381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5633092|NCT05087381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5633093|NCT05087381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5633094|NCT05087381|Serotonin Agents|serotonin agents|mesh-ancestor
5633095|NCT05087381|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5633096|NCT05087381|Antidepressive Agents|antidepressive agents|mesh-ancestor
5633097|NCT05087381|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5633098|NCT05087381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5633099|NCT05087381|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5633100|NCT05087381|Anticestodal Agents|anticestodal agents|mesh-ancestor
5633101|NCT05087381|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5633102|NCT05087381|Anthelmintics|anthelmintics|mesh-ancestor
5633103|NCT05087381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5633104|NCT05087381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5758738|NCT02986503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5758739|NCT02986503|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5758740|NCT02986503|Abortifacient Agents|abortifacient agents|mesh-ancestor
5758741|NCT02986503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5758742|NCT02986503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758743|NCT02986503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5758744|NCT02986503|Antimetabolites|antimetabolites|mesh-ancestor
5758745|NCT02986503|Dermatologic Agents|dermatologic agents|mesh-ancestor
5758746|NCT02986503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5758747|NCT02986503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5758748|NCT02986503|Immunologic Factors|immunologic factors|mesh-ancestor
5758749|NCT02986503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5758750|NCT02986503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5758751|NCT02986503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5758752|NCT02986503|Alkylating Agents|alkylating agents|mesh-ancestor
5758753|NCT02986451|Clarithromycin|clarithromycin|mesh-list
5758754|NCT02986451|Dexamethasone|dexamethasone|mesh-list
5758755|NCT02986451|Lenalidomide|lenalidomide|mesh-list
5758756|NCT02986451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5758757|NCT02986451|Antiemetics|antiemetics|mesh-ancestor
5758758|NCT02986451|Autonomic Agents|autonomic agents|mesh-ancestor
5758759|NCT02986451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5633105|NCT05087381|Antinematodal Agents|antinematodal agents|mesh-ancestor
5633106|NCT05087381|Antipruritics|antipruritics|mesh-ancestor
5633107|NCT05087381|Dermatologic Agents|dermatologic agents|mesh-ancestor
5633108|NCT05087381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5633109|NCT05087381|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5633110|NCT05087381|Histamine Antagonists|histamine antagonists|mesh-ancestor
5633111|NCT05087381|Histamine Agents|histamine agents|mesh-ancestor
5633112|NCT05087381|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5633113|NCT05087381|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5633114|NCT05087381|Expectorants|expectorants|mesh-ancestor
5633115|NCT05087381|Respiratory System Agents|respiratory system agents|mesh-ancestor
5633116|NCT05086250|Ketamine|ketamine|mesh-list
5633117|NCT05086250|Analgesics|analgesics|mesh-ancestor
5758760|NCT02986451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758761|NCT02986451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5758762|NCT02986451|Glucocorticoids|glucocorticoids|mesh-ancestor
5758763|NCT02986451|Hormones|hormones|mesh-ancestor
5758764|NCT02986451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5633118|NCT05086250|Sensory System Agents|sensory system agents|mesh-ancestor
5633119|NCT05086250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5633120|NCT05086250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5633121|NCT05086250|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5633122|NCT05086250|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5633123|NCT05086250|Anesthetics, General|anesthetics, general|mesh-ancestor
6673227|NCT01561209|Analgesics|analgesics|mesh-ancestor
6673228|NCT01561209|Sensory System Agents|sensory system agents|mesh-ancestor
6673229|NCT01561209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6673230|NCT01561209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673231|NCT01561209|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6673232|NCT01561209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6673233|NCT01561209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6673234|NCT01561209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673235|NCT01561209|Adrenergic Agents|adrenergic agents|mesh-ancestor
6673236|NCT01561209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6673237|NCT01561209|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6673238|NCT01561209|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6673239|NCT01561209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5758765|NCT02986451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5758766|NCT02986451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5758767|NCT02986451|Immunologic Factors|immunologic factors|mesh-ancestor
5633124|NCT05086250|Anesthetics|anesthetics|mesh-ancestor
5633125|NCT05086250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5633126|NCT05086250|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5633127|NCT05086250|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5633128|NCT05086250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5633129|NCT05086250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5633130|NCT05082688|Vaccines|vaccines|mesh-list
5633131|NCT05082688|Immunologic Factors|immunologic factors|mesh-ancestor
5633132|NCT05082688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5633133|NCT05081206|Propofol|propofol|mesh-list
5633134|NCT05081206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5633135|NCT05081206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5758768|NCT02986451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5758769|NCT02986451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5758770|NCT02986451|Growth Substances|growth substances|mesh-ancestor
5758771|NCT02986451|Growth Inhibitors|growth inhibitors|mesh-ancestor
5758772|NCT02986451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5758773|NCT02986451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5758774|NCT02986451|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5633136|NCT05081206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758775|NCT02986451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5758776|NCT02986451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5758777|NCT02986451|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5758778|NCT02986451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5758779|NCT02986607|Parathyroid Hormone|parathyroid hormone|mesh-list
5758780|NCT02986607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5758781|NCT02986607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758785|NCT02986334|Naproxen|naproxen|mesh-list
5758786|NCT02986334|Omeprazole|omeprazole|mesh-list
5758787|NCT02986334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5758788|NCT02986334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5633137|NCT05081206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5633138|NCT05081206|Anesthetics, General|anesthetics, general|mesh-ancestor
5633139|NCT05081206|Anesthetics|anesthetics|mesh-ancestor
5633140|NCT05079360|Everolimus|everolimus|mesh-list
5633141|NCT05079360|Exemestane|exemestane|mesh-list
5633142|NCT05079360|Estrogens|estrogens|mesh-list
5758789|NCT02986334|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5758790|NCT02986334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5758791|NCT02986334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5758792|NCT02986334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5758793|NCT02986334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5758794|NCT02986334|Analgesics|analgesics|mesh-ancestor
5758795|NCT02986334|Sensory System Agents|sensory system agents|mesh-ancestor
5758796|NCT02986334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5758797|NCT02986334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758798|NCT02986334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5758799|NCT02986334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5758800|NCT02986334|Gout Suppressants|gout suppressants|mesh-ancestor
5758801|NCT02986334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5758802|NCT02986321|Budesonide|budesonide|mesh-list
5758803|NCT02986321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5758804|NCT02986321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5758805|NCT02986321|Autonomic Agents|autonomic agents|mesh-ancestor
5758806|NCT02986321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5758807|NCT02986321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758808|NCT02986321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5758809|NCT02986321|Respiratory System Agents|respiratory system agents|mesh-ancestor
5758810|NCT02986321|Glucocorticoids|glucocorticoids|mesh-ancestor
5758811|NCT02986321|Hormones|hormones|mesh-ancestor
5633143|NCT05079360|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-list
5633144|NCT05079360|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-list
5633145|NCT05079360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5633146|NCT05079360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5633147|NCT05079360|Immunologic Factors|immunologic factors|mesh-ancestor
5633148|NCT05079360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5633149|NCT05079360|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5633150|NCT05079360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5633151|NCT05079360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5633152|NCT05079360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5633153|NCT05079360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5633154|NCT05079360|Hormone Antagonists|hormone antagonists|mesh-ancestor
5633155|NCT05079360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5633156|NCT05079360|Hormones|hormones|mesh-ancestor
5633157|NCT05077969|Celecoxib|celecoxib|mesh-list
5633158|NCT05077969|Famotidine|famotidine|mesh-list
5633159|NCT05077969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5633160|NCT05077969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5633161|NCT05077969|Analgesics|analgesics|mesh-ancestor
5633162|NCT05077969|Sensory System Agents|sensory system agents|mesh-ancestor
5633163|NCT05077969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5633164|NCT05077969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5633165|NCT05077969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5633166|NCT05077969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5633167|NCT05077969|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5633168|NCT05077969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5633169|NCT05077969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5633170|NCT05077969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5633171|NCT05077969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5633172|NCT05077969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5633173|NCT05077969|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5633174|NCT05077969|Histamine Antagonists|histamine antagonists|mesh-ancestor
5633175|NCT05077969|Histamine Agents|histamine agents|mesh-ancestor
5758812|NCT02986321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5758813|NCT02986594|Aspirin|aspirin|mesh-list
5758814|NCT02986594|Heparin|heparin|mesh-list
5758815|NCT02986594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5758816|NCT02986594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5758817|NCT02986594|Analgesics|analgesics|mesh-ancestor
5758818|NCT02986594|Sensory System Agents|sensory system agents|mesh-ancestor
5758819|NCT02986594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5758820|NCT02986594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758821|NCT02986594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5758822|NCT02986594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5758823|NCT02986594|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5758824|NCT02986594|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5758825|NCT02986594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5758826|NCT02986594|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5633176|NCT05077969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5633177|NCT05056727|Valsartan|valsartan|mesh-list
5633178|NCT05056727|Lisinopril|lisinopril|mesh-list
5633179|NCT05056727|Irbesartan|irbesartan|mesh-list
5633180|NCT05056727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5633181|NCT05056727|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5633182|NCT05056727|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5633183|NCT05056727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5633184|NCT05056727|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5633185|NCT05056727|Protease Inhibitors|protease inhibitors|mesh-ancestor
5633186|NCT05056727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5758827|NCT02986594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5758828|NCT02986594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5758829|NCT02986594|Antipyretics|antipyretics|mesh-ancestor
5758830|NCT02986594|Anticoagulants|anticoagulants|mesh-ancestor
5895288|NCT05229796|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5895289|NCT05229796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895290|NCT05229796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5895291|NCT05229796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895292|NCT05229653|Ketamine|ketamine|mesh-list
5895293|NCT05229653|Analgesics|analgesics|mesh-ancestor
5895294|NCT05229653|Sensory System Agents|sensory system agents|mesh-ancestor
5895295|NCT05229653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5895296|NCT05229653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895297|NCT05229653|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5895298|NCT05229653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5895299|NCT05229653|Anesthetics, General|anesthetics, general|mesh-ancestor
5895300|NCT05229653|Anesthetics|anesthetics|mesh-ancestor
5895301|NCT05229653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5895302|NCT05229653|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5895303|NCT05229653|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5895304|NCT05229653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5895305|NCT05229653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895306|NCT05229627|Methylphenidate|methylphenidate|mesh-list
5633187|NCT05056727|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5633188|NCT05056727|Protective Agents|protective agents|mesh-ancestor
5633189|NCT05056727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5633190|NCT05056155|Lubricant Eye Drops|lubricant eye drops|mesh-list
5633191|NCT05056155|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5633192|NCT05056155|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5633193|NCT05047939|Propofol|propofol|mesh-list
5633194|NCT05047939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5633195|NCT05047939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5633196|NCT05047939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5633197|NCT05047939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5633198|NCT05047939|Anesthetics, General|anesthetics, general|mesh-ancestor
5633199|NCT05047939|Anesthetics|anesthetics|mesh-ancestor
5633200|NCT05047731|Antihypertensive Agents|antihypertensive agents|mesh-list
5633201|NCT05042687|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
5633202|NCT05042687|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5895307|NCT05229627|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
5895308|NCT05229627|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5895309|NCT05229627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895310|NCT05229627|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5895311|NCT05229627|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5895312|NCT05229627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5633203|NCT05042687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5633204|NCT05022329|Vaccines|vaccines|mesh-list
5633205|NCT05022329|Immunologic Factors|immunologic factors|mesh-ancestor
5633206|NCT05022329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5633207|NCT05012254|Paclitaxel|paclitaxel|mesh-list
5633208|NCT05012254|Cisplatin|cisplatin|mesh-list
5633209|NCT05012254|Carboplatin|carboplatin|mesh-list
5758831|NCT02986100|Rucaparib|rucaparib|mesh-list
5758832|NCT02986100|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5758833|NCT02986100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5758834|NCT02986100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5758835|NCT02986100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5758836|NCT02985736|Desoximetasone|desoximetasone|mesh-list
5758837|NCT02985736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5758838|NCT02985736|Glucocorticoids|glucocorticoids|mesh-ancestor
5758839|NCT02985736|Hormones|hormones|mesh-ancestor
5758840|NCT02985736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5758841|NCT02985736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758842|NCT02985697|Midazolam|midazolam|mesh-list
5633210|NCT05012254|Nivolumab|nivolumab|mesh-list
5633211|NCT05012254|Pemetrexed|pemetrexed|mesh-list
5633212|NCT05012254|Ipilimumab|ipilimumab|mesh-list
5633213|NCT05012254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5633214|NCT05012254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5633215|NCT05012254|Tubulin Modulators|tubulin modulators|mesh-ancestor
5633216|NCT05012254|Antimitotic Agents|antimitotic agents|mesh-ancestor
5633217|NCT05012254|Mitosis Modulators|mitosis modulators|mesh-ancestor
5633218|NCT05012254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5633219|NCT05012254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5633220|NCT05012254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5633221|NCT05012254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5633222|NCT05012254|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5633223|NCT05012254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5633224|NCT05009069|Fluorouracil|fluorouracil|mesh-list
5633225|NCT05009069|Capecitabine|capecitabine|mesh-list
5633226|NCT05009069|Atezolizumab|atezolizumab|mesh-list
5633227|NCT05009069|Antimetabolites|antimetabolites|mesh-ancestor
5633228|NCT05009069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5633229|NCT05009069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5633230|NCT05009069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5633231|NCT05009069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5633232|NCT05009069|Immunologic Factors|immunologic factors|mesh-ancestor
5633233|NCT05009069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5633234|NCT05005273|Nivolumab|nivolumab|mesh-list
5633235|NCT05005273|Ipilimumab|ipilimumab|mesh-list
5633236|NCT05005273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5633237|NCT05005273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5633238|NCT05005273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5633239|NCT05005273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5633240|NCT05003245|Ranibizumab|ranibizumab|mesh-list
5633241|NCT05003245|Antibodies|antibodies|mesh-list
5633242|NCT05003245|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5633243|NCT05003245|Mitogens|mitogens|mesh-list
5633244|NCT05003245|Endothelial Growth Factors|endothelial growth factors|mesh-list
5633245|NCT05003245|Immunologic Factors|immunologic factors|mesh-ancestor
5633246|NCT05003245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5633247|NCT05003245|Mitosis Modulators|mitosis modulators|mesh-ancestor
5633248|NCT05003245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5633249|NCT05003245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5633250|NCT05003245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5633251|NCT05003245|Growth Substances|growth substances|mesh-ancestor
5633252|NCT05003245|Growth Inhibitors|growth inhibitors|mesh-ancestor
5633253|NCT05003245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5633254|NCT04997811|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
5633255|NCT04997811|Valproic Acid|valproic acid|mesh-list
5633256|NCT04997811|Bezafibrate|bezafibrate|mesh-list
5633257|NCT04997811|Medroxyprogesterone|medroxyprogesterone|mesh-list
5633258|NCT04997811|Danazol|danazol|mesh-list
5633259|NCT04997811|Anticonvulsants|anticonvulsants|mesh-ancestor
5633260|NCT04997811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5633261|NCT04997811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5633262|NCT04997811|GABA Agents|gaba agents|mesh-ancestor
5758843|NCT02985697|Dexmedetomidine|dexmedetomidine|mesh-list
5633263|NCT04997811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5633264|NCT04997811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5633265|NCT04997811|Antimanic Agents|antimanic agents|mesh-ancestor
5633266|NCT04997811|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5633267|NCT04997811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5758844|NCT02985697|Nitrous Oxide|nitrous oxide|mesh-list
5633268|NCT04997811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5633269|NCT04997811|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5633270|NCT04997811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5633271|NCT04997811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5633272|NCT04997811|Contraceptive Agents|contraceptive agents|mesh-ancestor
5633273|NCT04997811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5633274|NCT04997811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5633275|NCT04997811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5633276|NCT04997811|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5633277|NCT04997811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5633278|NCT04997811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5633279|NCT04997811|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5633280|NCT04997811|Hormone Antagonists|hormone antagonists|mesh-ancestor
5633281|NCT04997811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5633282|NCT04997811|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5633283|NCT04997811|Antimetabolites|antimetabolites|mesh-ancestor
5633284|NCT04997811|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5633285|NCT04973800|Simvastatin|simvastatin|mesh-list
5633286|NCT04973800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5633287|NCT04973800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5633288|NCT04973800|Antimetabolites|antimetabolites|mesh-ancestor
5758845|NCT02985697|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5758846|NCT02985697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5758847|NCT02985697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758848|NCT02985697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5758849|NCT02985697|Analgesics|analgesics|mesh-ancestor
5758850|NCT02985697|Sensory System Agents|sensory system agents|mesh-ancestor
5758851|NCT02985697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5758852|NCT02985697|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5758853|NCT02985697|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5758854|NCT02985697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5758855|NCT02985697|Adrenergic Agents|adrenergic agents|mesh-ancestor
5758856|NCT02985697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5758857|NCT02985697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5758858|NCT02985697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5758859|NCT02985697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5758860|NCT02985697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5758861|NCT02985697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5758862|NCT02985697|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5758863|NCT02985697|Anesthetics, General|anesthetics, general|mesh-ancestor
5758864|NCT02985697|Anesthetics|anesthetics|mesh-ancestor
5758865|NCT02985697|GABA Modulators|gaba modulators|mesh-ancestor
5758866|NCT02985697|GABA Agents|gaba agents|mesh-ancestor
5758867|NCT02985697|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5758868|NCT02985866|Pancrelipase|pancrelipase|mesh-list
5758869|NCT02985866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5633289|NCT04973800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5633290|NCT04973800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5758870|NCT02985983|Brodalumab|brodalumab|mesh-list
5758871|NCT02985983|Dermatologic Agents|dermatologic agents|mesh-ancestor
5758872|NCT02985749|Oxytocin|oxytocin|mesh-list
5758873|NCT02985749|Oxytocics|oxytocics|mesh-ancestor
5758874|NCT02985749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5758875|NCT02985749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758876|NCT02985905|Zinc Sulfate|zinc sulfate|mesh-list
5758877|NCT02985905|Astringents|astringents|mesh-ancestor
5758878|NCT02985905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758879|NCT02985905|Dermatologic Agents|dermatologic agents|mesh-ancestor
5758880|NCT02985658|Cisplatin|cisplatin|mesh-list
5758881|NCT02985658|Vinorelbine|vinorelbine|mesh-list
5758882|NCT02985658|Veliparib|veliparib|mesh-list
5758883|NCT02985658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5758884|NCT02985658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5758885|NCT02985658|Tubulin Modulators|tubulin modulators|mesh-ancestor
5758886|NCT02985658|Antimitotic Agents|antimitotic agents|mesh-ancestor
5758887|NCT02985658|Mitosis Modulators|mitosis modulators|mesh-ancestor
5758888|NCT02985658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5758889|NCT02985658|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5758890|NCT02985658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5758891|NCT02985671|Acetaminophen|acetaminophen|mesh-list
5758892|NCT02985671|Diclofenac|diclofenac|mesh-list
5758893|NCT02985671|Orphenadrine|orphenadrine|mesh-list
5758894|NCT02985671|Caffeine|caffeine|mesh-list
5758895|NCT02985671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5758896|NCT02985671|Analgesics|analgesics|mesh-ancestor
5758897|NCT02985671|Sensory System Agents|sensory system agents|mesh-ancestor
5633291|NCT04973800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5633292|NCT04973800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5758898|NCT02985671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5758899|NCT02985671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758900|NCT02985671|Antipyretics|antipyretics|mesh-ancestor
5758901|NCT02985671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5633293|NCT04973254|Rilpivirine|rilpivirine|mesh-list
5633294|NCT04973254|Cabotegravir|cabotegravir|mesh-list
5633295|NCT04973254|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5633296|NCT04973254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5633297|NCT04973254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5633298|NCT04973254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5633299|NCT04973254|Antiviral Agents|antiviral agents|mesh-ancestor
5633300|NCT04973254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5633301|NCT04973254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5633302|NCT04973254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5633303|NCT04973254|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5633304|NCT04973254|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5633305|NCT04972253|Infigratinib|infigratinib|mesh-list
5633306|NCT04972253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5758902|NCT02985671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5758903|NCT02985671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5758904|NCT02985671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5758905|NCT02985671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5758906|NCT02985671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5758907|NCT02985671|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5758908|NCT02985671|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5758909|NCT02985671|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5758910|NCT02985671|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5758911|NCT02985671|Purinergic Agents|purinergic agents|mesh-ancestor
5758912|NCT02985671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5758913|NCT02985671|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5758914|NCT02985671|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5758915|NCT02985671|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5758916|NCT02985671|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5758917|NCT02985671|Parasympatholytics|parasympatholytics|mesh-ancestor
5758918|NCT02985671|Autonomic Agents|autonomic agents|mesh-ancestor
5758919|NCT02985671|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5758920|NCT02985671|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5758921|NCT02985671|Cholinergic Agents|cholinergic agents|mesh-ancestor
5633307|NCT04947059|Gemcitabine|gemcitabine|mesh-list
5633308|NCT04947059|Epirubicin|epirubicin|mesh-list
5633309|NCT04947059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5633310|NCT04947059|Antimetabolites|antimetabolites|mesh-ancestor
5633311|NCT04947059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5633312|NCT04947059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5633313|NCT04947059|Antiviral Agents|antiviral agents|mesh-ancestor
5633314|NCT04947059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5633315|NCT04947059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5633316|NCT04947059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5633317|NCT04947059|Immunologic Factors|immunologic factors|mesh-ancestor
5633318|NCT04947059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5633319|NCT04947059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5633320|NCT04947059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5633321|NCT04947059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5693303|NCT03402087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5693304|NCT03402048|Gemcitabine|gemcitabine|mesh-list
5693305|NCT03402048|Carboplatin|carboplatin|mesh-list
5693306|NCT03402048|Docetaxel|docetaxel|mesh-list
5693307|NCT03402048|Pemetrexed|pemetrexed|mesh-list
5693308|NCT03402048|Vinorelbine|vinorelbine|mesh-list
5693309|NCT03402048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5693310|NCT03402048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5693311|NCT03402048|Antimetabolites|antimetabolites|mesh-ancestor
5693312|NCT03402048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693313|NCT03402048|Antiviral Agents|antiviral agents|mesh-ancestor
5693314|NCT03402048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5693315|NCT03402048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5693316|NCT03402048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5693317|NCT03402048|Immunologic Factors|immunologic factors|mesh-ancestor
5693318|NCT03402048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693319|NCT03402048|Tubulin Modulators|tubulin modulators|mesh-ancestor
5693320|NCT03402048|Antimitotic Agents|antimitotic agents|mesh-ancestor
5693321|NCT03402048|Mitosis Modulators|mitosis modulators|mesh-ancestor
5693322|NCT03402048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5758922|NCT02985671|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
5758923|NCT02985671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5758924|NCT02985541|Levonorgestrel|levonorgestrel|mesh-list
5758925|NCT02985541|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5758926|NCT02985541|Contraceptive Agents|contraceptive agents|mesh-ancestor
5758927|NCT02985541|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5758928|NCT02985541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758929|NCT02985541|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5758930|NCT02985541|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5758931|NCT02985541|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5758932|NCT02985593|KHK4083|khk4083|mesh-list
5758933|NCT02985593|Dermatologic Agents|dermatologic agents|mesh-ancestor
5633322|NCT04941716|Venetoclax|venetoclax|mesh-list
5633323|NCT04941716|Acalabrutinib|acalabrutinib|mesh-list
5633324|NCT04941716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5633325|NCT04938609|Pembrolizumab|pembrolizumab|mesh-list
5633326|NCT04938609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5633327|NCT04938609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5633328|NCT04921735|Cisatracurium|cisatracurium|mesh-list
5633329|NCT04921735|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5633330|NCT04921735|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5633331|NCT04921735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5633332|NCT04921735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209068|NCT02141217|Clavulanic Acids|clavulanic acids|mesh-list
6209069|NCT02141217|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6209070|NCT02141217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5633336|NCT04912427|Dexamethasone|dexamethasone|mesh-list
5633337|NCT04912427|Bortezomib|bortezomib|mesh-list
5633338|NCT04912427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5633339|NCT04912427|Antiemetics|antiemetics|mesh-ancestor
5633340|NCT04912427|Autonomic Agents|autonomic agents|mesh-ancestor
5633341|NCT04912427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5633342|NCT04912427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5633343|NCT04912427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5633344|NCT04912427|Glucocorticoids|glucocorticoids|mesh-ancestor
5758934|NCT02985606|Caffeine|caffeine|mesh-list
5758935|NCT02985606|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5758936|NCT02985606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758937|NCT02985606|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5758938|NCT02985606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5758939|NCT02985606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5758940|NCT02985606|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5758941|NCT02985606|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5758942|NCT02985606|Purinergic Agents|purinergic agents|mesh-ancestor
5758943|NCT02985606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5758944|NCT02985229|Misoprostol|misoprostol|mesh-list
5758945|NCT02985229|Mifepristone|mifepristone|mesh-list
5758946|NCT02985229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5758947|NCT02985229|Abortifacient Agents|abortifacient agents|mesh-ancestor
5633345|NCT04912427|Hormones|hormones|mesh-ancestor
5633346|NCT04912427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5633347|NCT04912427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5633348|NCT04912427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5633349|NCT04908475|Apremilast|apremilast|mesh-list
5633350|NCT04908475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5633351|NCT04908475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5633352|NCT04908475|Analgesics|analgesics|mesh-ancestor
5633353|NCT04908475|Sensory System Agents|sensory system agents|mesh-ancestor
5758948|NCT02985229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5758949|NCT02985229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758950|NCT02985229|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5758951|NCT02985229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5758952|NCT02985229|Oxytocics|oxytocics|mesh-ancestor
5758953|NCT02985229|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5758954|NCT02985229|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5758955|NCT02985229|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5758956|NCT02985229|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5758957|NCT02985229|Contraceptive Agents|contraceptive agents|mesh-ancestor
5758958|NCT02985229|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5758959|NCT02985229|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5758960|NCT02985229|Hormone Antagonists|hormone antagonists|mesh-ancestor
5758961|NCT02985229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5758962|NCT02985229|Luteolytic Agents|luteolytic agents|mesh-ancestor
5633354|NCT04908475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5758963|NCT02985229|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5758964|NCT02985229|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5758965|NCT02985372|Cytarabine|cytarabine|mesh-list
5758966|NCT02985372|Decitabine|decitabine|mesh-list
5758967|NCT02985372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5758968|NCT02985372|Antimetabolites|antimetabolites|mesh-ancestor
5758969|NCT02985372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5758970|NCT02985372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5633355|NCT04908475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5633356|NCT04908475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5633357|NCT04908475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5633358|NCT04908475|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5633359|NCT04908475|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5633360|NCT04908475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5633361|NCT04908475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5633362|NCT04892446|Dexamethasone|dexamethasone|mesh-list
5633363|NCT04892446|Bortezomib|bortezomib|mesh-list
5633364|NCT04892446|Daratumumab|daratumumab|mesh-list
5633365|NCT04892446|Pomalidomide|pomalidomide|mesh-list
5758971|NCT02985372|Antiviral Agents|antiviral agents|mesh-ancestor
5758972|NCT02985372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5758973|NCT02985372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5758974|NCT02985372|Immunologic Factors|immunologic factors|mesh-ancestor
5758975|NCT02985372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758976|NCT02985372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5758977|NCT02985216|Pregabalin|pregabalin|mesh-list
5758978|NCT02985216|Analgesics|analgesics|mesh-ancestor
5758979|NCT02985216|Sensory System Agents|sensory system agents|mesh-ancestor
5758980|NCT02985216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5758981|NCT02985216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5758982|NCT02985216|Anticonvulsants|anticonvulsants|mesh-ancestor
5758983|NCT02985216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5758984|NCT02985216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5758985|NCT02985216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5758986|NCT02985216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5758987|NCT02985216|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5758988|NCT02985216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5758989|NCT02985216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5758990|NCT02985216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5758991|NCT02985333|Dexamethasone|dexamethasone|mesh-list
5758992|NCT02985333|Paclitaxel|paclitaxel|mesh-list
5758993|NCT02985333|Cyclophosphamide|cyclophosphamide|mesh-list
5758994|NCT02985333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5758995|NCT02985333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5758996|NCT02985333|Tubulin Modulators|tubulin modulators|mesh-ancestor
5758997|NCT02985333|Antimitotic Agents|antimitotic agents|mesh-ancestor
5758998|NCT02985333|Mitosis Modulators|mitosis modulators|mesh-ancestor
5758999|NCT02985333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759000|NCT02985333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5759001|NCT02985333|Immunologic Factors|immunologic factors|mesh-ancestor
5633366|NCT04892446|Magrolimab|magrolimab|mesh-list
5633367|NCT04892446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6489986|NCT00594737|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6489987|NCT00594737|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6489988|NCT00594867|Aspirin|aspirin|mesh-list
5633368|NCT04892446|Antiemetics|antiemetics|mesh-ancestor
5633369|NCT04892446|Autonomic Agents|autonomic agents|mesh-ancestor
5633370|NCT04892446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5633371|NCT04892446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5633372|NCT04892446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5633373|NCT04892446|Glucocorticoids|glucocorticoids|mesh-ancestor
5633374|NCT04892446|Hormones|hormones|mesh-ancestor
5633375|NCT04892446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5633376|NCT04892446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5633377|NCT04892446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5633378|NCT04892446|Immunologic Factors|immunologic factors|mesh-ancestor
5633379|NCT04892446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5633380|NCT04892446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5633381|NCT04892446|Growth Substances|growth substances|mesh-ancestor
5633382|NCT04892446|Growth Inhibitors|growth inhibitors|mesh-ancestor
5633383|NCT04892446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5633384|NCT04883281|Paclitaxel|paclitaxel|mesh-list
5759002|NCT02985333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759003|NCT02985333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5633385|NCT04883281|Carboplatin|carboplatin|mesh-list
6489989|NCT00594867|Acetaminophen|acetaminophen|mesh-list
5759004|NCT02985333|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5759005|NCT02985333|Alkylating Agents|alkylating agents|mesh-ancestor
5759006|NCT02985333|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5759007|NCT02985333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5759008|NCT02985333|Antiemetics|antiemetics|mesh-ancestor
5759009|NCT02985333|Autonomic Agents|autonomic agents|mesh-ancestor
5759010|NCT02985333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5759011|NCT02985333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5759012|NCT02985333|Glucocorticoids|glucocorticoids|mesh-ancestor
5759013|NCT02985333|Hormones|hormones|mesh-ancestor
5759014|NCT02985333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5759015|NCT02985333|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5759016|NCT02985437|Pulmonary Surfactants|pulmonary surfactants|mesh-list
5759017|NCT02985437|Respiratory System Agents|respiratory system agents|mesh-ancestor
5759018|NCT02985190|Azacitidine|azacitidine|mesh-list
5759019|NCT02985190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5759020|NCT02985190|Antimetabolites|antimetabolites|mesh-ancestor
5759021|NCT02985190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759022|NCT02985190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5759023|NCT02985190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5759024|NCT02985177|Ibuprofen|ibuprofen|mesh-list
5759025|NCT02985177|Fentanyl|fentanyl|mesh-list
5759026|NCT02985177|Hydromorphone|hydromorphone|mesh-list
5759027|NCT02985177|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5759028|NCT02985177|Narcotics|narcotics|mesh-ancestor
5759029|NCT02985177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5759030|NCT02985177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759031|NCT02985177|Analgesics|analgesics|mesh-ancestor
5759032|NCT02985177|Sensory System Agents|sensory system agents|mesh-ancestor
5759033|NCT02985177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5759034|NCT02985177|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5759035|NCT02985177|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5759036|NCT02985177|Anesthetics, General|anesthetics, general|mesh-ancestor
5759037|NCT02985177|Anesthetics|anesthetics|mesh-ancestor
5759038|NCT02985177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5759039|NCT02985177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5759040|NCT02985177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5759041|NCT02985177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5759042|NCT02985177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5759043|NCT02985177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5759044|NCT02985177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759045|NCT02985424|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5759046|NCT02985424|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5633386|NCT04883281|Cetuximab|cetuximab|mesh-list
5633387|NCT04883281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5633388|NCT04883281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5633389|NCT04883281|Tubulin Modulators|tubulin modulators|mesh-ancestor
5633390|NCT04883281|Antimitotic Agents|antimitotic agents|mesh-ancestor
5633391|NCT04883281|Mitosis Modulators|mitosis modulators|mesh-ancestor
5633392|NCT04883281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5633393|NCT04883281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5633394|NCT04879368|Trifluridine|trifluridine|mesh-list
5633395|NCT04879368|Paclitaxel|paclitaxel|mesh-list
5633396|NCT04879368|Docetaxel|docetaxel|mesh-list
5633397|NCT04879368|Nivolumab|nivolumab|mesh-list
5633398|NCT04879368|Irinotecan|irinotecan|mesh-list
5633399|NCT04879368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5633400|NCT04879368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5633401|NCT04879368|Tubulin Modulators|tubulin modulators|mesh-ancestor
5633402|NCT04879368|Antimitotic Agents|antimitotic agents|mesh-ancestor
5633403|NCT04879368|Mitosis Modulators|mitosis modulators|mesh-ancestor
5633404|NCT04879368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5633405|NCT04879368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5633406|NCT04879368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5633407|NCT04879368|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5633408|NCT04879368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5633409|NCT04879368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5633410|NCT04879368|Antimetabolites|antimetabolites|mesh-ancestor
5633411|NCT04879368|Antiviral Agents|antiviral agents|mesh-ancestor
5633412|NCT04879368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5633413|NCT04870112|Carboplatin|carboplatin|mesh-list
5633414|NCT04870112|Etoposide|etoposide|mesh-list
5633415|NCT04870112|Durvalumab|durvalumab|mesh-list
5633416|NCT04870112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5759047|NCT02985424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759048|NCT02985255|Docetaxel|docetaxel|mesh-list
5759049|NCT02985255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5759050|NCT02985255|Tubulin Modulators|tubulin modulators|mesh-ancestor
5759051|NCT02985255|Antimitotic Agents|antimitotic agents|mesh-ancestor
5759052|NCT02985255|Mitosis Modulators|mitosis modulators|mesh-ancestor
5759053|NCT02985255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759054|NCT02985203|Vinorelbine|vinorelbine|mesh-list
5759055|NCT02985203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5759056|NCT02985203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5759057|NCT02985203|Tubulin Modulators|tubulin modulators|mesh-ancestor
5759058|NCT02985203|Antimitotic Agents|antimitotic agents|mesh-ancestor
5759059|NCT02985203|Mitosis Modulators|mitosis modulators|mesh-ancestor
5759060|NCT02985203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759061|NCT02985554|Nivolumab|nivolumab|mesh-list
5759062|NCT02985554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5759063|NCT02985554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5759064|NCT02985554|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5759065|NCT02985554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759066|NCT02985242|Empagliflozin|empagliflozin|mesh-list
5759067|NCT02985242|Glimepiride|glimepiride|mesh-list
5759068|NCT02985242|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5759069|NCT02985242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759070|NCT02985242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5759071|NCT02985242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759072|NCT02985242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5759073|NCT02985242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5759074|NCT02985242|Immunologic Factors|immunologic factors|mesh-ancestor
5759075|NCT02985281|Ribavirin|ribavirin|mesh-list
5759076|NCT02985281|Sofosbuvir|sofosbuvir|mesh-list
5759077|NCT02985281|Antimetabolites|antimetabolites|mesh-ancestor
5759078|NCT02985281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5633417|NCT04870112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5633418|NCT04870112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5633419|NCT04870112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5633420|NCT04870112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5633421|NCT04870112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5633422|NCT04870112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5633423|NCT04860830|BI 425809|bi 425809|mesh-list
5633424|NCT04860830|Nootropic Agents|nootropic agents|mesh-ancestor
5633425|NCT04854499|Carboplatin|carboplatin|mesh-list
5633426|NCT04854499|Docetaxel|docetaxel|mesh-list
5633427|NCT04854499|Pembrolizumab|pembrolizumab|mesh-list
5633428|NCT04854499|Magrolimab|magrolimab|mesh-list
5633429|NCT04854499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5633430|NCT04854499|Tubulin Modulators|tubulin modulators|mesh-ancestor
5633431|NCT04854499|Antimitotic Agents|antimitotic agents|mesh-ancestor
5633432|NCT04854499|Mitosis Modulators|mitosis modulators|mesh-ancestor
5633433|NCT04854499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5633434|NCT04854499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5633435|NCT04808245|Atezolizumab|atezolizumab|mesh-list
5633436|NCT04808245|Imiquimod|imiquimod|mesh-list
5633437|NCT04808245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5633438|NCT04808245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5759079|NCT02985281|Antiviral Agents|antiviral agents|mesh-ancestor
5759080|NCT02985281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5759081|NCT02985125|Everolimus|everolimus|mesh-list
5759082|NCT02985125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5759083|NCT02985125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6673240|NCT01561222|Calcitriol|calcitriol|mesh-list
6673241|NCT01561222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6673242|NCT01561222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673243|NCT01561222|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6673244|NCT01561222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6673245|NCT01561222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673246|NCT01561222|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6673247|NCT01561222|Vitamins|vitamins|mesh-ancestor
6673248|NCT01561222|Micronutrients|micronutrients|mesh-ancestor
6673249|NCT01561222|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6673250|NCT01561235|Hormones|hormones|mesh-list
6673251|NCT01561235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6673252|NCT01561235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673253|NCT01561274|Bupivacaine|bupivacaine|mesh-list
6673254|NCT01561274|Anesthetics, Local|anesthetics, local|mesh-ancestor
5633439|NCT04808245|Immunologic Factors|immunologic factors|mesh-ancestor
5633440|NCT04808245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5633441|NCT04808245|Interferon Inducers|interferon inducers|mesh-ancestor
5633442|NCT04786964|Folic Acid|folic acid|mesh-list
6673255|NCT01561274|Anesthetics|anesthetics|mesh-ancestor
5633443|NCT04786964|Vitamin B 12|vitamin b 12|mesh-list
5633444|NCT04786964|Hydroxocobalamin|hydroxocobalamin|mesh-list
5633445|NCT04786964|Dexamethasone|dexamethasone|mesh-list
5633446|NCT04786964|Carboplatin|carboplatin|mesh-list
5633447|NCT04786964|Pemetrexed|pemetrexed|mesh-list
5633448|NCT04786964|Vitamins|vitamins|mesh-ancestor
5633449|NCT04786964|Micronutrients|micronutrients|mesh-ancestor
5633450|NCT04786964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5633451|NCT04786964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5633452|NCT04786964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5633453|NCT04786964|Antiemetics|antiemetics|mesh-ancestor
6673256|NCT01561274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6673257|NCT01561274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673258|NCT01561274|Sensory System Agents|sensory system agents|mesh-ancestor
6673259|NCT01561274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6673260|NCT01561391|Factor VIII|factor viii|mesh-list
6673261|NCT01561391|Coagulants|coagulants|mesh-ancestor
6673262|NCT01561404|Everolimus|everolimus|mesh-list
5633454|NCT04786964|Autonomic Agents|autonomic agents|mesh-ancestor
5759084|NCT02985125|Immunologic Factors|immunologic factors|mesh-ancestor
5759085|NCT02985125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759086|NCT02985099|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5759087|NCT02985099|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5759088|NCT02985099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5759089|NCT02985099|Antimetabolites|antimetabolites|mesh-ancestor
5759090|NCT02985099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759091|NCT02985099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5759092|NCT02985099|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5759093|NCT02985099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5759094|NCT02984930|Esomeprazole|esomeprazole|mesh-list
5759095|NCT02984930|Mosapride|mosapride|mesh-list
5759096|NCT02984930|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5759097|NCT02984930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5759098|NCT02984930|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5633455|NCT04786964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5633456|NCT04786964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5633457|NCT04786964|Glucocorticoids|glucocorticoids|mesh-ancestor
5633458|NCT04786964|Hormones|hormones|mesh-ancestor
5633459|NCT04786964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5633460|NCT04786964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5633461|NCT04786964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5633462|NCT04786964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5633463|NCT04786964|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5633464|NCT04786964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5633465|NCT04786964|Hematinics|hematinics|mesh-ancestor
5633466|NCT04786964|Vitamin B Complex|vitamin b complex|mesh-ancestor
5633467|NCT04776447|Carboplatin|carboplatin|mesh-list
5633468|NCT04776447|Atezolizumab|atezolizumab|mesh-list
5633469|NCT04776447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5633470|NCT04739865|Psilocybin|psilocybin|mesh-list
5633471|NCT04739865|Hallucinogens|hallucinogens|mesh-ancestor
5633472|NCT04739865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5633473|NCT04739865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5633474|NCT04732195|Pilocarpine|pilocarpine|mesh-list
5633475|NCT04732195|Miotics|miotics|mesh-ancestor
5633476|NCT04732195|Autonomic Agents|autonomic agents|mesh-ancestor
5633477|NCT04732195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5633478|NCT04732195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5633479|NCT04732195|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
5633480|NCT04732195|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5633481|NCT04732195|Cholinergic Agents|cholinergic agents|mesh-ancestor
5633482|NCT04732195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5633483|NCT04732195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5633484|NCT04722887|Protease Inhibitors|protease inhibitors|mesh-list
5633485|NCT04722887|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
5633486|NCT04722887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5633487|NCT04722887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5633488|NCT04722887|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5633489|NCT04722887|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5759099|NCT02984930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6673263|NCT01561404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5633499|NCT04720963|Dexmedetomidine|dexmedetomidine|mesh-list
5633500|NCT04720963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5633501|NCT04720963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5633502|NCT04720963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759100|NCT02984930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759101|NCT02984930|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5759102|NCT02984930|Serotonin Agents|serotonin agents|mesh-ancestor
5759103|NCT02984930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5759104|NCT02984930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759105|NCT02985086|Cefoxitin|cefoxitin|mesh-list
5759106|NCT02985086|Misoprostol|misoprostol|mesh-list
5759107|NCT02985086|Oxytocin|oxytocin|mesh-list
5759108|NCT02985086|Oxytocics|oxytocics|mesh-ancestor
5759109|NCT02985086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5759110|NCT02985086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759111|NCT02985086|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5633503|NCT04720963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5633504|NCT04720963|Analgesics|analgesics|mesh-ancestor
5633505|NCT04720963|Sensory System Agents|sensory system agents|mesh-ancestor
5633506|NCT04720963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5633507|NCT04720963|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5633508|NCT04720963|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5633509|NCT04720963|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5633510|NCT04720963|Adrenergic Agents|adrenergic agents|mesh-ancestor
5633511|NCT04720963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5633512|NCT04720963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5633513|NCT04699357|Atropine|atropine|mesh-list
5633514|NCT04699357|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5759112|NCT02985086|Abortifacient Agents|abortifacient agents|mesh-ancestor
5759113|NCT02985086|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5759114|NCT02985086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5759115|NCT02985086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5759116|NCT02985086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5759117|NCT02984865|Flurbiprofen|flurbiprofen|mesh-list
5759118|NCT02984865|Sufentanil|sufentanil|mesh-list
5759119|NCT02984865|Nalbuphine|nalbuphine|mesh-list
5759120|NCT02984865|Dsuvia|dsuvia|mesh-list
5759121|NCT02984865|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5759122|NCT02984865|Narcotics|narcotics|mesh-ancestor
5759123|NCT02984865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5759124|NCT02984865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759125|NCT02984865|Analgesics|analgesics|mesh-ancestor
5759126|NCT02984865|Sensory System Agents|sensory system agents|mesh-ancestor
5759127|NCT02984865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5759128|NCT02984865|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5759129|NCT02984865|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5759130|NCT02984865|Anesthetics, General|anesthetics, general|mesh-ancestor
5759131|NCT02984865|Anesthetics|anesthetics|mesh-ancestor
5633515|NCT04699357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5633516|NCT04699357|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5633517|NCT04699357|Autonomic Agents|autonomic agents|mesh-ancestor
5633518|NCT04699357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5633519|NCT04699357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5633520|NCT04699357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5633521|NCT04699357|Respiratory System Agents|respiratory system agents|mesh-ancestor
5759132|NCT02984865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5759133|NCT02984865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5759134|NCT02984865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5759135|NCT02984865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5759136|NCT02984865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5759137|NCT02984865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5759138|NCT02984865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759139|NCT02984852|Tenofovir|tenofovir|mesh-list
5759140|NCT02984852|Emtricitabine|emtricitabine|mesh-list
5759141|NCT02984852|Darunavir|darunavir|mesh-list
5759142|NCT02984852|Cobicistat|cobicistat|mesh-list
5759143|NCT02984852|Antiviral Agents|antiviral agents|mesh-ancestor
5759144|NCT02984852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5759145|NCT02984852|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6209071|NCT02141217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5633522|NCT04699357|Mydriatics|mydriatics|mesh-ancestor
5759146|NCT02984852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5759147|NCT02984852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5759148|NCT02984852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759149|NCT02984852|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5759150|NCT02984852|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5759151|NCT02984852|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5759152|NCT02984852|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5759153|NCT02984852|Protease Inhibitors|protease inhibitors|mesh-ancestor
5759154|NCT02984852|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5759155|NCT02984852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5759156|NCT02984722|Metformin|metformin|mesh-list
5759157|NCT02984722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5759158|NCT02984722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759159|NCT02984696|Estradiol|estradiol|mesh-list
5759160|NCT02984696|Estrogens|estrogens|mesh-ancestor
5759161|NCT02984696|Hormones|hormones|mesh-ancestor
5759162|NCT02984696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5759163|NCT02984696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759164|NCT02984657|Anesthetics|anesthetics|mesh-list
5759165|NCT02984657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5759166|NCT02984657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5633523|NCT04699357|Parasympatholytics|parasympatholytics|mesh-ancestor
5633524|NCT04699357|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5633525|NCT04699357|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5633526|NCT04699357|Cholinergic Agents|cholinergic agents|mesh-ancestor
5633527|NCT04699357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5633528|NCT04699357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5633529|NCT04690192|Gemcitabine|gemcitabine|mesh-list
5633530|NCT04690192|Melphalan|melphalan|mesh-list
5633531|NCT04690192|Busulfan|busulfan|mesh-list
5633532|NCT04690192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5633533|NCT04690192|Antimetabolites|antimetabolites|mesh-ancestor
5633534|NCT04690192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5633535|NCT04690192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5633536|NCT04690192|Antiviral Agents|antiviral agents|mesh-ancestor
5633537|NCT04690192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5633538|NCT04690192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5633539|NCT04690192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5633540|NCT04690192|Immunologic Factors|immunologic factors|mesh-ancestor
5895313|NCT05229627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5633541|NCT04690192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5633542|NCT04690192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5633543|NCT04690192|Alkylating Agents|alkylating agents|mesh-ancestor
5633544|NCT04690192|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5633545|NCT04673175|Tazobactam|tazobactam|mesh-list
5633546|NCT04673175|Ceftolozane|ceftolozane|mesh-list
5633547|NCT04673175|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
5633548|NCT04673175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5633549|NCT04673175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5633550|NCT04673175|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5633551|NCT04673175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5633552|NCT04673175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5633553|NCT04673175|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5633554|NCT04673175|Renal Agents|renal agents|mesh-ancestor
5633555|NCT04661007|Lenalidomide|lenalidomide|mesh-list
5633556|NCT04661007|Immunologic Factors|immunologic factors|mesh-ancestor
5633557|NCT04661007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5633558|NCT04661007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5633559|NCT04661007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5633560|NCT04661007|Growth Substances|growth substances|mesh-ancestor
5633561|NCT04661007|Growth Inhibitors|growth inhibitors|mesh-ancestor
5633562|NCT04661007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6209072|NCT02141217|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6209073|NCT02141217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6209074|NCT02141217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209075|NCT02141217|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6209076|NCT02141295|Leucovorin|leucovorin|mesh-list
6209077|NCT02141295|Folic Acid|folic acid|mesh-list
6209078|NCT02141295|Bevacizumab|bevacizumab|mesh-list
6209079|NCT02141295|Oxaliplatin|oxaliplatin|mesh-list
6209080|NCT02141295|Levoleucovorin|levoleucovorin|mesh-list
6209081|NCT02141295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6209082|NCT02141295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6209083|NCT02141295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6209084|NCT02141295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5895314|NCT05229627|Dopamine Agents|dopamine agents|mesh-ancestor
5895315|NCT05229627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5759167|NCT02984345|Caseins|caseins|mesh-list
5759168|NCT02984345|Chelating Agents|chelating agents|mesh-ancestor
5759169|NCT02984345|Sequestering Agents|sequestering agents|mesh-ancestor
5759170|NCT02984345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759171|NCT02984475|Metformin|metformin|mesh-list
5759172|NCT02984475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5759173|NCT02984475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759174|NCT02984514|Deoxyglucose|deoxyglucose|mesh-list
5759175|NCT02984514|Antimetabolites|antimetabolites|mesh-ancestor
5759176|NCT02984514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209085|NCT02141295|Growth Substances|growth substances|mesh-ancestor
6209086|NCT02141295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209087|NCT02141295|Growth Inhibitors|growth inhibitors|mesh-ancestor
6209088|NCT02141295|Antidotes|antidotes|mesh-ancestor
6209089|NCT02141295|Protective Agents|protective agents|mesh-ancestor
6209090|NCT02141295|Vitamin B Complex|vitamin b complex|mesh-ancestor
6209091|NCT02141295|Vitamins|vitamins|mesh-ancestor
6209092|NCT02141295|Micronutrients|micronutrients|mesh-ancestor
5633584|NCT04644068|Paclitaxel|paclitaxel|mesh-list
5633585|NCT04644068|Carboplatin|carboplatin|mesh-list
5633586|NCT04644068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5633587|NCT04644068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5633588|NCT04644068|Tubulin Modulators|tubulin modulators|mesh-ancestor
5633589|NCT04644068|Antimitotic Agents|antimitotic agents|mesh-ancestor
5633590|NCT04644068|Mitosis Modulators|mitosis modulators|mesh-ancestor
5633591|NCT04644068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209093|NCT02141295|Hematinics|hematinics|mesh-ancestor
6209094|NCT02141451|Rituximab|rituximab|mesh-list
6209095|NCT02141451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6209096|NCT02141451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6209097|NCT02141451|Immunologic Factors|immunologic factors|mesh-ancestor
6209098|NCT02141451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209099|NCT02141451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6209100|NCT02141490|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
6209101|NCT02141490|Hematinics|hematinics|mesh-ancestor
6209102|NCT02141490|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6209103|NCT02141490|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6209104|NCT02141555|Misoprostol|misoprostol|mesh-list
6209105|NCT02141555|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6209106|NCT02141555|Abortifacient Agents|abortifacient agents|mesh-ancestor
6209107|NCT02141555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6209108|NCT02141555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209109|NCT02141555|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6209110|NCT02141555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5633610|NCT04632992|Paclitaxel|paclitaxel|mesh-list
5633611|NCT04632992|Maytansine|maytansine|mesh-list
5633612|NCT04632992|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
5633613|NCT04632992|Trastuzumab|trastuzumab|mesh-list
5633614|NCT04632992|Atezolizumab|atezolizumab|mesh-list
5633615|NCT04632992|Pertuzumab|pertuzumab|mesh-list
5633616|NCT04632992|Tucatinib|tucatinib|mesh-list
5633617|NCT04632992|Pralsetinib|pralsetinib|mesh-list
5633618|NCT04632992|Entrectinib|entrectinib|mesh-list
5633619|NCT04632992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5633620|NCT04632992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5633621|NCT04632992|Tubulin Modulators|tubulin modulators|mesh-ancestor
5633622|NCT04632992|Antimitotic Agents|antimitotic agents|mesh-ancestor
5633623|NCT04632992|Mitosis Modulators|mitosis modulators|mesh-ancestor
5633624|NCT04632992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5633625|NCT04632992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5633626|NCT04632992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5633627|NCT04632992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5633628|NCT04630756|Acalabrutinib|acalabrutinib|mesh-list
5633629|NCT04630756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5633630|NCT04629651|Captopril|captopril|mesh-list
5759177|NCT02984514|Antiviral Agents|antiviral agents|mesh-ancestor
5759178|NCT02984514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5759179|NCT02984397|Ketotifen|ketotifen|mesh-list
5759180|NCT02984397|Antipruritics|antipruritics|mesh-ancestor
5633631|NCT04629651|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5633632|NCT04629651|Protease Inhibitors|protease inhibitors|mesh-ancestor
5633633|NCT04629651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5633634|NCT04629651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5633635|NCT04629651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5633636|NCT04626024|Imatinib Mesylate|imatinib mesylate|mesh-list
5633637|NCT04626024|Dasatinib|dasatinib|mesh-list
5759181|NCT02984397|Dermatologic Agents|dermatologic agents|mesh-ancestor
6209111|NCT02141555|Oxytocics|oxytocics|mesh-ancestor
6209112|NCT02141581|Vaccines|vaccines|mesh-list
5633638|NCT04626024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6489990|NCT00594867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6489991|NCT00594867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5759182|NCT02984397|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5759183|NCT02984397|Histamine Antagonists|histamine antagonists|mesh-ancestor
5759184|NCT02984397|Histamine Agents|histamine agents|mesh-ancestor
5759185|NCT02984397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5759186|NCT02984397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759187|NCT02984397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759188|NCT02984397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5759189|NCT02984293|Atorvastatin|atorvastatin|mesh-list
5759190|NCT02984293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5759191|NCT02984293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5759192|NCT02984293|Antimetabolites|antimetabolites|mesh-ancestor
5759193|NCT02984293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759194|NCT02984293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5759195|NCT02984293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5759196|NCT02984293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5759197|NCT02984176|Simethicone|simethicone|mesh-list
5759198|NCT02984176|Antifoaming Agents|antifoaming agents|mesh-ancestor
5759199|NCT02984176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759200|NCT02984176|Emollients|emollients|mesh-ancestor
6489992|NCT00594867|Analgesics|analgesics|mesh-ancestor
6489993|NCT00594867|Sensory System Agents|sensory system agents|mesh-ancestor
5633639|NCT04626024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5633640|NCT04626024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5633641|NCT04626024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5633642|NCT04616963|Tenofovir|tenofovir|mesh-list
5633643|NCT04616963|Emtricitabine|emtricitabine|mesh-list
5633644|NCT04616963|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
5633645|NCT04616963|Antiviral Agents|antiviral agents|mesh-ancestor
5633646|NCT04616963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5633647|NCT04616963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5633648|NCT04616963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5633649|NCT04616963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5633650|NCT04616963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5633651|NCT04616963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5633652|NCT04616963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5633653|NCT04607954|Durvalumab|durvalumab|mesh-list
5633654|NCT04607954|Topotecan|topotecan|mesh-list
5633655|NCT04607954|Immunoglobulins|immunoglobulins|mesh-list
5633656|NCT04607954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5633657|NCT04607954|Immunoglobulin G|immunoglobulin g|mesh-list
5633658|NCT04607954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5633659|NCT04607954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5633660|NCT04607954|Immunologic Factors|immunologic factors|mesh-ancestor
5633661|NCT04607954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5633662|NCT04607954|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5633663|NCT04607954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5633664|NCT04607954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5633665|NCT04607954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5633666|NCT04594811|Nivolumab|nivolumab|mesh-list
5633667|NCT04594811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5633668|NCT04594811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5633669|NCT04594811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5633670|NCT04594811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5633671|NCT04590781|Pembrolizumab|pembrolizumab|mesh-list
5633672|NCT04590781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5633673|NCT04590781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5633674|NCT04589208|Ketamine|ketamine|mesh-list
5633675|NCT04589208|Analgesics|analgesics|mesh-ancestor
5633676|NCT04589208|Sensory System Agents|sensory system agents|mesh-ancestor
5633677|NCT04589208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5633678|NCT04589208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5633679|NCT04589208|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5633680|NCT04589208|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5633681|NCT04589208|Anesthetics, General|anesthetics, general|mesh-ancestor
5633682|NCT04589208|Anesthetics|anesthetics|mesh-ancestor
5633683|NCT04589208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5633684|NCT04589208|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5633685|NCT04589208|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5633686|NCT04589208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5693323|NCT03402048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5633687|NCT04589208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5633688|NCT04584112|Paclitaxel|paclitaxel|mesh-list
5633689|NCT04584112|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5633690|NCT04584112|Cyclophosphamide|cyclophosphamide|mesh-list
5633691|NCT04584112|Carboplatin|carboplatin|mesh-list
5633692|NCT04584112|Doxorubicin|doxorubicin|mesh-list
5633693|NCT04584112|Atezolizumab|atezolizumab|mesh-list
5633694|NCT04584112|Molgramostim|molgramostim|mesh-list
5633695|NCT04584112|Lenograstim|lenograstim|mesh-list
5633696|NCT04584112|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5633697|NCT04584112|Sargramostim|sargramostim|mesh-list
5633698|NCT04584112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5633699|NCT04584112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5633700|NCT04584112|Tubulin Modulators|tubulin modulators|mesh-ancestor
5633701|NCT04584112|Antimitotic Agents|antimitotic agents|mesh-ancestor
5633702|NCT04584112|Mitosis Modulators|mitosis modulators|mesh-ancestor
5633703|NCT04584112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5633704|NCT04584112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5633705|NCT04584112|Immunologic Factors|immunologic factors|mesh-ancestor
5633706|NCT04584112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5633707|NCT04584112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5633708|NCT04584112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5633709|NCT04584112|Alkylating Agents|alkylating agents|mesh-ancestor
5633710|NCT04584112|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5633711|NCT04584112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5759201|NCT02984176|Dermatologic Agents|dermatologic agents|mesh-ancestor
5759202|NCT02984111|Epoetin Alfa|epoetin alfa|mesh-list
5759203|NCT02984111|Hematinics|hematinics|mesh-ancestor
5633712|NCT04584112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5633713|NCT04584112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5633714|NCT04584112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5633715|NCT04584112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5633716|NCT04577638|Nivolumab|nivolumab|mesh-list
5633717|NCT04577638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5633718|NCT04577638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5633719|NCT04577638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5633720|NCT04577638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5633721|NCT04561557|Cyclophosphamide|cyclophosphamide|mesh-list
5633722|NCT04561557|Fludarabine|fludarabine|mesh-list
5633723|NCT04561557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5633724|NCT04561557|Immunologic Factors|immunologic factors|mesh-ancestor
5633725|NCT04561557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5633726|NCT04561557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5759204|NCT02984384|Aspirin|aspirin|mesh-list
5759205|NCT02984384|Heparin|heparin|mesh-list
5759206|NCT02984384|Enoxaparin|enoxaparin|mesh-list
5759207|NCT02984384|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5759208|NCT02984384|Tinzaparin|tinzaparin|mesh-list
5759209|NCT02984384|Dalteparin|dalteparin|mesh-list
5633727|NCT04561557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6489994|NCT00594867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6489995|NCT00594867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6489996|NCT00594867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6489997|NCT00594867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6489998|NCT00594867|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5759210|NCT02984384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5759211|NCT02984384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5759212|NCT02984384|Analgesics|analgesics|mesh-ancestor
5759213|NCT02984384|Sensory System Agents|sensory system agents|mesh-ancestor
5759214|NCT02984384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5759215|NCT02984384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759216|NCT02984384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5759217|NCT02984384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5759218|NCT02984384|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5759219|NCT02984384|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5759220|NCT02984384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759221|NCT02984384|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5759222|NCT02984384|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5759223|NCT02984384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6489999|NCT00594867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5633728|NCT04561557|Alkylating Agents|alkylating agents|mesh-ancestor
5759224|NCT02984384|Antipyretics|antipyretics|mesh-ancestor
5633729|NCT04561557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5633730|NCT04561557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5633731|NCT04561557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5759225|NCT02984384|Anticoagulants|anticoagulants|mesh-ancestor
5759226|NCT02984228|Hyaluronic Acid|hyaluronic acid|mesh-list
5759227|NCT02984228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5759228|NCT02984228|Immunologic Factors|immunologic factors|mesh-ancestor
5759229|NCT02984228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759230|NCT02984228|Viscosupplements|viscosupplements|mesh-ancestor
5759231|NCT02984228|Protective Agents|protective agents|mesh-ancestor
5759232|NCT02984072|Menthol|menthol|mesh-list
5759233|NCT02984072|Antipruritics|antipruritics|mesh-ancestor
5759234|NCT02984072|Dermatologic Agents|dermatologic agents|mesh-ancestor
5759235|NCT02983799|Olaparib|olaparib|mesh-list
5759236|NCT02983799|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5759237|NCT02983799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5759238|NCT02983799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759239|NCT02983799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5759240|NCT02983747|Loxoprofen|loxoprofen|mesh-list
5759241|NCT02983747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5759242|NCT02983747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5759243|NCT02983747|Analgesics|analgesics|mesh-ancestor
5759244|NCT02983747|Sensory System Agents|sensory system agents|mesh-ancestor
5633732|NCT04540120|Dapansutrile|dapansutrile|mesh-list
5633733|NCT04540120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5633734|NCT04524611|Ustekinumab|ustekinumab|mesh-list
5633735|NCT04524611|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5633736|NCT04524611|Dermatologic Agents|dermatologic agents|mesh-ancestor
5633737|NCT04524611|Immunologic Factors|immunologic factors|mesh-ancestor
5633738|NCT04524611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5633739|NCT04513925|Durvalumab|durvalumab|mesh-list
5759245|NCT02983747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5759246|NCT02983747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759247|NCT02983747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5759248|NCT02983747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5759249|NCT02983591|Misoprostol|misoprostol|mesh-list
5759250|NCT02983591|Oxytocin|oxytocin|mesh-list
5759251|NCT02983591|Oxytocics|oxytocics|mesh-ancestor
5759252|NCT02983591|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5759253|NCT02983591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759254|NCT02983591|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5759255|NCT02983591|Abortifacient Agents|abortifacient agents|mesh-ancestor
5759256|NCT02983591|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5759257|NCT02983591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5633740|NCT04513925|Atezolizumab|atezolizumab|mesh-list
5633741|NCT04513925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5633742|NCT04513925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5633743|NCT04513860|Cenobamate|cenobamate|mesh-list
5633744|NCT04513860|Anticonvulsants|anticonvulsants|mesh-ancestor
5633745|NCT04510194|Metformin|metformin|mesh-list
5633746|NCT04510194|Ivermectin|ivermectin|mesh-list
5633747|NCT04510194|Fluvoxamine|fluvoxamine|mesh-list
5633748|NCT04510194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5633749|NCT04510194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5633750|NCT04510194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5633751|NCT04510194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5633752|NCT04510194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5759258|NCT02983890|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5759259|NCT02983890|Dicloxacillin|dicloxacillin|mesh-list
5759260|NCT02983890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5759261|NCT02983682|Lidocaine|lidocaine|mesh-list
5759262|NCT02983682|Anesthetics, Local|anesthetics, local|mesh-ancestor
5759263|NCT02983682|Anesthetics|anesthetics|mesh-ancestor
5759264|NCT02983682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5759265|NCT02983682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759266|NCT02983682|Sensory System Agents|sensory system agents|mesh-ancestor
5759267|NCT02983682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5759268|NCT02983682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5759269|NCT02983682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5759270|NCT02983682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5759271|NCT02983682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5759272|NCT02983682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5633753|NCT04510194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5633754|NCT04510194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5633755|NCT04510194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5633756|NCT04510194|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5633757|NCT04510194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5633758|NCT04510194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5759273|NCT02983773|Dronabinol|dronabinol|mesh-list
5633759|NCT04510194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759274|NCT02983773|Hallucinogens|hallucinogens|mesh-ancestor
5759275|NCT02983773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759276|NCT02983773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5759277|NCT02983773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5759278|NCT02983773|Analgesics|analgesics|mesh-ancestor
5759279|NCT02983773|Sensory System Agents|sensory system agents|mesh-ancestor
5759280|NCT02983773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5633760|NCT04510194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5633761|NCT04510194|Serotonin Agents|serotonin agents|mesh-ancestor
5633762|NCT04510194|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5633763|NCT04510194|Antidepressive Agents|antidepressive agents|mesh-ancestor
5633764|NCT04510194|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5633765|NCT04510194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5633766|NCT04510194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5633767|NCT04510194|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5633768|NCT04503148|Propofol|propofol|mesh-list
5633769|NCT04503148|Anesthetics|anesthetics|mesh-list
5633770|NCT04503148|Anesthetics, General|anesthetics, general|mesh-list
5633771|NCT04503148|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
5633772|NCT04503148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5633773|NCT04503148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5633774|NCT04503148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5633775|NCT04503148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5633776|NCT04502706|Rituximab|rituximab|mesh-list
5633777|NCT04502706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6490000|NCT00594867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490001|NCT00594867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6490002|NCT00594867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5633778|NCT04502706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5633779|NCT04502706|Immunologic Factors|immunologic factors|mesh-ancestor
5633780|NCT04502706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5633781|NCT04502706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5633782|NCT04498468|Dexamethasone|dexamethasone|mesh-list
5633783|NCT04498468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5759281|NCT02983773|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5759282|NCT02983773|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5759283|NCT02983773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5759284|NCT02983773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759285|NCT02983773|Hormones|hormones|mesh-ancestor
5759286|NCT02983773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5633784|NCT04498468|Antiemetics|antiemetics|mesh-ancestor
5633785|NCT04498468|Autonomic Agents|autonomic agents|mesh-ancestor
5633786|NCT04498468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5633787|NCT04498468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5633788|NCT04498468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5633789|NCT04498468|Glucocorticoids|glucocorticoids|mesh-ancestor
5633790|NCT04498468|Hormones|hormones|mesh-ancestor
5633791|NCT04498468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5633792|NCT04498468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5633793|NCT04498468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5633794|NCT04477200|Mycophenolic Acid|mycophenolic acid|mesh-list
5633795|NCT04477200|Temozolomide|temozolomide|mesh-list
5633796|NCT04477200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5633797|NCT04477200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5633798|NCT04477200|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5633799|NCT04477200|Antitubercular Agents|antitubercular agents|mesh-ancestor
5633800|NCT04477200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5633801|NCT04477200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5633802|NCT04477200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5633803|NCT04477200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5633804|NCT04477200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5633805|NCT04477200|Alkylating Agents|alkylating agents|mesh-ancestor
5633806|NCT04474223|Dexamethasone|dexamethasone|mesh-list
5633807|NCT04474223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5633808|NCT04474223|Antiemetics|antiemetics|mesh-ancestor
5633809|NCT04474223|Autonomic Agents|autonomic agents|mesh-ancestor
5633810|NCT04474223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5633811|NCT04474223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759287|NCT02983734|Cycloserine|cycloserine|mesh-list
5759288|NCT02983734|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5759289|NCT02983734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5759290|NCT02983734|Renal Agents|renal agents|mesh-ancestor
5633812|NCT04474223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5759291|NCT02983734|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5633813|NCT04474223|Glucocorticoids|glucocorticoids|mesh-ancestor
5633814|NCT04474223|Hormones|hormones|mesh-ancestor
5633815|NCT04474223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5633816|NCT04474223|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5633817|NCT04474223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5633818|NCT04459468|Ethiodized Oil|ethiodized oil|mesh-list
5759292|NCT02983734|Antitubercular Agents|antitubercular agents|mesh-ancestor
5759293|NCT02983734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5759294|NCT02983734|Antimetabolites|antimetabolites|mesh-ancestor
5759295|NCT02983734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759296|NCT02983630|Penicillins|penicillins|mesh-list
5759297|NCT02983630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5759298|NCT02983630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5759299|NCT02983461|Sildenafil Citrate|sildenafil citrate|mesh-list
5759300|NCT02983461|Vasodilator Agents|vasodilator agents|mesh-ancestor
5759301|NCT02983461|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5759302|NCT02983461|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5633819|NCT04459468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6209113|NCT02141581|Immunologic Factors|immunologic factors|mesh-ancestor
6209114|NCT02141581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212581|NCT02189941|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5633823|NCT04405102|Ozanimod|ozanimod|mesh-list
5633824|NCT04405102|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5633825|NCT04405102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5633826|NCT04405102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5633827|NCT04405102|Immunologic Factors|immunologic factors|mesh-ancestor
5633828|NCT04405102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5633829|NCT04401384|Pyridoxine|pyridoxine|mesh-list
5633830|NCT04401384|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
5633831|NCT04401384|Doxylamine|doxylamine|mesh-list
5633832|NCT04401384|Dicyclomine|dicyclomine|mesh-list
5633833|NCT04401384|Antiemetics|antiemetics|mesh-ancestor
5633834|NCT04401384|Autonomic Agents|autonomic agents|mesh-ancestor
5633835|NCT04401384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5633836|NCT04401384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5633837|NCT04401384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5633838|NCT04401384|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5633839|NCT04401384|Histamine Antagonists|histamine antagonists|mesh-ancestor
5633840|NCT04401384|Histamine Agents|histamine agents|mesh-ancestor
5633841|NCT04401384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5633842|NCT04401384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5633843|NCT04401384|Parasympatholytics|parasympatholytics|mesh-ancestor
5759303|NCT02983461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5759304|NCT02983461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759305|NCT02983461|Urological Agents|urological agents|mesh-ancestor
5633844|NCT04401384|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5633845|NCT04401384|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5633846|NCT04401384|Cholinergic Agents|cholinergic agents|mesh-ancestor
5633847|NCT04401384|Vitamin B Complex|vitamin b complex|mesh-ancestor
5633848|NCT04401384|Vitamins|vitamins|mesh-ancestor
5633849|NCT04401384|Micronutrients|micronutrients|mesh-ancestor
5633850|NCT04400799|Enoxaparin|enoxaparin|mesh-list
5759306|NCT02983214|Cilostazol|cilostazol|mesh-list
5759307|NCT02983214|Clopidogrel|clopidogrel|mesh-list
5759308|NCT02983214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5759309|NCT02983214|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5759310|NCT02983214|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5759311|NCT02983214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5759312|NCT02983214|Purinergic Agents|purinergic agents|mesh-ancestor
5759313|NCT02983214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5759314|NCT02983214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759315|NCT02983214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759316|NCT02983214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5759317|NCT02983214|Autonomic Agents|autonomic agents|mesh-ancestor
5759318|NCT02983214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5759319|NCT02983214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5759320|NCT02983214|Respiratory System Agents|respiratory system agents|mesh-ancestor
5759321|NCT02983214|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5759322|NCT02983214|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5759323|NCT02983214|Vasodilator Agents|vasodilator agents|mesh-ancestor
5759324|NCT02983214|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5759325|NCT02983214|Protective Agents|protective agents|mesh-ancestor
5633851|NCT04400799|Anticoagulants|anticoagulants|mesh-ancestor
5633852|NCT04400799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5633853|NCT04400799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5759326|NCT02983214|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5759327|NCT02983214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5759328|NCT02983214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5759329|NCT02983188|Antipsychotic Agents|antipsychotic agents|mesh-list
5759330|NCT02983188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5759331|NCT02983188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5759332|NCT02983188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759333|NCT02983188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5759334|NCT02983344|Fentanyl|fentanyl|mesh-list
5759335|NCT02983344|Ropivacaine|ropivacaine|mesh-list
5759336|NCT02983344|Anesthetics, Local|anesthetics, local|mesh-ancestor
5759337|NCT02983344|Anesthetics|anesthetics|mesh-ancestor
5759338|NCT02983344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5759339|NCT02983344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759340|NCT02983344|Sensory System Agents|sensory system agents|mesh-ancestor
5759341|NCT02983344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5759342|NCT02983344|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5759343|NCT02983344|Narcotics|narcotics|mesh-ancestor
5759344|NCT02983344|Analgesics|analgesics|mesh-ancestor
5759345|NCT02983344|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5759346|NCT02983344|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5759347|NCT02983344|Anesthetics, General|anesthetics, general|mesh-ancestor
5759348|NCT02983084|Copper|copper|mesh-list
5759349|NCT02983084|Nickel|nickel|mesh-list
5759350|NCT02983084|Trace Elements|trace elements|mesh-ancestor
5633854|NCT04400799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5633855|NCT04368910|Artesunate|artesunate|mesh-list
5633856|NCT04368910|Chloroquine|chloroquine|mesh-list
5633857|NCT04368910|Pyronaridine|pyronaridine|mesh-list
5633858|NCT04368910|Antimalarials|antimalarials|mesh-ancestor
5633859|NCT04368910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5633860|NCT04368910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5633861|NCT04368910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5633862|NCT04368910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5633863|NCT04368910|Antiviral Agents|antiviral agents|mesh-ancestor
5633864|NCT04368910|Schistosomicides|schistosomicides|mesh-ancestor
5633865|NCT04368910|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5633866|NCT04368910|Anthelmintics|anthelmintics|mesh-ancestor
5633867|NCT04368910|Amebicides|amebicides|mesh-ancestor
5633868|NCT04368910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5633869|NCT04365985|Naltrexone|naltrexone|mesh-list
5759351|NCT02983084|Micronutrients|micronutrients|mesh-ancestor
5759352|NCT02983084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759353|NCT02983422|Aminophylline|aminophylline|mesh-list
5759354|NCT02983422|Furosemide|furosemide|mesh-list
5759355|NCT02983422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5759356|NCT02983422|Autonomic Agents|autonomic agents|mesh-ancestor
5759357|NCT02983422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5759358|NCT02983422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759359|NCT02983422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5759360|NCT02983422|Respiratory System Agents|respiratory system agents|mesh-ancestor
5759361|NCT02983422|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5759362|NCT02983422|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5759363|NCT02983422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5759364|NCT02983422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759365|NCT02983422|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5759366|NCT02983422|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5759367|NCT02983422|Purinergic Agents|purinergic agents|mesh-ancestor
5759368|NCT02983422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5759369|NCT02983422|Protective Agents|protective agents|mesh-ancestor
5759370|NCT02983422|Diuretics|diuretics|mesh-ancestor
5759371|NCT02983422|Natriuretic Agents|natriuretic agents|mesh-ancestor
5633870|NCT04365985|Ketamine|ketamine|mesh-list
5633871|NCT04365985|Analgesics|analgesics|mesh-ancestor
5633872|NCT04365985|Sensory System Agents|sensory system agents|mesh-ancestor
5633873|NCT04365985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5633874|NCT04365985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5633875|NCT04365985|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5633876|NCT04365985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5633877|NCT04365985|Anesthetics, General|anesthetics, general|mesh-ancestor
5633878|NCT04365985|Anesthetics|anesthetics|mesh-ancestor
5633879|NCT04365985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5633880|NCT04365985|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5759372|NCT02983422|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5759373|NCT02983422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5633881|NCT04365985|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5759374|NCT02983097|Cytarabine|cytarabine|mesh-list
5759375|NCT02983097|Dexamethasone|dexamethasone|mesh-list
5633882|NCT04365985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5633883|NCT04365985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5633884|NCT04365985|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5633885|NCT04365985|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5633886|NCT04345913|Halichondrin B|halichondrin b|mesh-list
5633887|NCT04345913|Tubulin Modulators|tubulin modulators|mesh-ancestor
5633888|NCT04345913|Antimitotic Agents|antimitotic agents|mesh-ancestor
5633889|NCT04345913|Mitosis Modulators|mitosis modulators|mesh-ancestor
5633890|NCT04345913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5633891|NCT04345913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5633892|NCT04338061|Teriflunomide|teriflunomide|mesh-list
5633893|NCT04338061|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5633894|NCT04338061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5633895|NCT04338061|Analgesics|analgesics|mesh-ancestor
5633896|NCT04338061|Sensory System Agents|sensory system agents|mesh-ancestor
5633897|NCT04338061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5633898|NCT04338061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5633899|NCT04338061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5633900|NCT04338061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5759376|NCT02983097|Rituximab|rituximab|mesh-list
5759377|NCT02983097|Carboplatin|carboplatin|mesh-list
5759378|NCT02983097|Lenalidomide|lenalidomide|mesh-list
5759379|NCT02983097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5633901|NCT04338061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5633902|NCT04338061|Immunologic Factors|immunologic factors|mesh-ancestor
5633903|NCT04327206|Vaccines|vaccines|mesh-list
5633904|NCT04327206|BCG Vaccine|bcg vaccine|mesh-list
5633905|NCT04327206|Immunologic Factors|immunologic factors|mesh-ancestor
5633906|NCT04327206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5633907|NCT04327206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5633908|NCT04269200|Paclitaxel|paclitaxel|mesh-list
5633909|NCT04269200|Carboplatin|carboplatin|mesh-list
5759380|NCT02983097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5759381|NCT02983097|Antiemetics|antiemetics|mesh-ancestor
5759382|NCT02983097|Autonomic Agents|autonomic agents|mesh-ancestor
5759383|NCT02983097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5759384|NCT02983097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759385|NCT02983097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5633910|NCT04269200|Durvalumab|durvalumab|mesh-list
5633911|NCT04269200|Olaparib|olaparib|mesh-list
5633912|NCT04269200|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5633913|NCT04269200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5633914|NCT04269200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5633915|NCT04269200|Tubulin Modulators|tubulin modulators|mesh-ancestor
5633916|NCT04269200|Antimitotic Agents|antimitotic agents|mesh-ancestor
5633917|NCT04269200|Mitosis Modulators|mitosis modulators|mesh-ancestor
5633918|NCT04269200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5633919|NCT04269200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5633920|NCT04269200|Immunologic Factors|immunologic factors|mesh-ancestor
5633921|NCT04269200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5633922|NCT04269200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5759386|NCT02983097|Glucocorticoids|glucocorticoids|mesh-ancestor
5759387|NCT02983097|Hormones|hormones|mesh-ancestor
5759388|NCT02983097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5759389|NCT02983097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5759390|NCT02983097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5759391|NCT02983097|Immunologic Factors|immunologic factors|mesh-ancestor
5759392|NCT02983097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5759393|NCT02983097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5759394|NCT02983097|Antimetabolites|antimetabolites|mesh-ancestor
5759395|NCT02983097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759396|NCT02983097|Antiviral Agents|antiviral agents|mesh-ancestor
5759397|NCT02983097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5759398|NCT02983097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5759399|NCT02983097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5633923|NCT04269200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5633924|NCT04251351|Acetaminophen|acetaminophen|mesh-list
5633925|NCT04251351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5633926|NCT04251351|Analgesics|analgesics|mesh-ancestor
5633927|NCT04251351|Sensory System Agents|sensory system agents|mesh-ancestor
5633928|NCT04251351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5633929|NCT04251351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759400|NCT02983097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5633930|NCT04251351|Antipyretics|antipyretics|mesh-ancestor
5633931|NCT04249258|Dobutamine|dobutamine|mesh-list
5633932|NCT04249258|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5759401|NCT02983097|Growth Substances|growth substances|mesh-ancestor
5759402|NCT02983097|Growth Inhibitors|growth inhibitors|mesh-ancestor
5759403|NCT02983383|Anesthetics|anesthetics|mesh-list
5759404|NCT02983383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5759405|NCT02983383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759406|NCT02982798|Metformin|metformin|mesh-list
5759407|NCT02982798|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5759408|NCT02982798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5759409|NCT02982798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5633933|NCT04249258|Sympathomimetics|sympathomimetics|mesh-ancestor
5633934|NCT04249258|Autonomic Agents|autonomic agents|mesh-ancestor
5633935|NCT04249258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5633936|NCT04249258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5633937|NCT04249258|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5633938|NCT04249258|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5633939|NCT04249258|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5633940|NCT04249258|Adrenergic Agents|adrenergic agents|mesh-ancestor
5633941|NCT04249258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5633942|NCT04249258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5633943|NCT04249258|Protective Agents|protective agents|mesh-ancestor
5633944|NCT04238546|Sirolimus|sirolimus|mesh-list
5633945|NCT04238546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5759410|NCT02982798|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5759411|NCT02982798|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5759412|NCT02982798|Antimetabolites|antimetabolites|mesh-ancestor
5759413|NCT02982798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759414|NCT02982798|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5759415|NCT02982798|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5759416|NCT02982798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5895316|NCT05229627|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5895317|NCT05229627|Adrenergic Agents|adrenergic agents|mesh-ancestor
5895318|NCT05229614|Pembrolizumab|pembrolizumab|mesh-list
5895319|NCT05229614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5895320|NCT05229614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5895321|NCT05229536|Vaccines|vaccines|mesh-list
5895322|NCT05229536|Immunologic Factors|immunologic factors|mesh-ancestor
5895323|NCT05229536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895324|NCT05229510|Ribavirin|ribavirin|mesh-list
5895325|NCT05229510|Antimetabolites|antimetabolites|mesh-ancestor
5895326|NCT05229510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895327|NCT05229510|Antiviral Agents|antiviral agents|mesh-ancestor
5895328|NCT05229510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5895329|NCT05229497|Carboplatin|carboplatin|mesh-list
5895330|NCT05229497|Fluorouracil|fluorouracil|mesh-list
5895331|NCT05229497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5895332|NCT05229497|Antimetabolites|antimetabolites|mesh-ancestor
5895333|NCT05229497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895334|NCT05229497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5895335|NCT05229497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5895336|NCT05229497|Immunologic Factors|immunologic factors|mesh-ancestor
5895337|NCT05229497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895338|NCT05229445|Insulin|insulin|mesh-list
5895339|NCT05229445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5895340|NCT05229445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895341|NCT05229276|Bone wax|bone wax|mesh-list
5895342|NCT05229276|Hemostatics|hemostatics|mesh-ancestor
5895343|NCT05229276|Coagulants|coagulants|mesh-ancestor
5895344|NCT05229055|Ketamine|ketamine|mesh-list
5633946|NCT04238546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5633947|NCT04238546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5633948|NCT04238546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5895345|NCT05229055|Analgesics|analgesics|mesh-ancestor
5895346|NCT05229055|Sensory System Agents|sensory system agents|mesh-ancestor
5895347|NCT05229055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5895348|NCT05229055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895349|NCT05229055|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5895350|NCT05229055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5895351|NCT05229055|Anesthetics, General|anesthetics, general|mesh-ancestor
5895352|NCT05229055|Anesthetics|anesthetics|mesh-ancestor
5633949|NCT04238546|Antifungal Agents|antifungal agents|mesh-ancestor
5633950|NCT04238546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5633951|NCT04238546|Immunologic Factors|immunologic factors|mesh-ancestor
5633952|NCT04238546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5633953|NCT04235608|Propofol|propofol|mesh-list
5895353|NCT05229055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5895354|NCT05229055|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6209115|NCT02141620|Acetylcysteine|acetylcysteine|mesh-list
6209116|NCT02141620|Cocaine|cocaine|mesh-list
6209117|NCT02141620|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6209118|NCT02141620|Antiviral Agents|antiviral agents|mesh-ancestor
6209119|NCT02141620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6209120|NCT02141620|Expectorants|expectorants|mesh-ancestor
5759417|NCT02982889|Bupivacaine|bupivacaine|mesh-list
5759418|NCT02982889|Hyaluronic Acid|hyaluronic acid|mesh-list
5759419|NCT02982889|Anesthetics, Local|anesthetics, local|mesh-ancestor
5759420|NCT02982889|Anesthetics|anesthetics|mesh-ancestor
5759421|NCT02982889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5759422|NCT02982889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759423|NCT02982889|Sensory System Agents|sensory system agents|mesh-ancestor
5759424|NCT02982889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5759425|NCT02982889|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5759426|NCT02982889|Immunologic Factors|immunologic factors|mesh-ancestor
5759427|NCT02982889|Viscosupplements|viscosupplements|mesh-ancestor
5759428|NCT02982889|Protective Agents|protective agents|mesh-ancestor
5759429|NCT02982694|Bevacizumab|bevacizumab|mesh-list
5759430|NCT02982694|Atezolizumab|atezolizumab|mesh-list
5759431|NCT02982694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5759432|NCT02982694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5759433|NCT02982694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5759434|NCT02982694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5759435|NCT02982694|Growth Substances|growth substances|mesh-ancestor
5759436|NCT02982694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759437|NCT02982694|Growth Inhibitors|growth inhibitors|mesh-ancestor
5759438|NCT02982850|Aspirin|aspirin|mesh-list
5633954|NCT04235608|Sevoflurane|sevoflurane|mesh-list
5633955|NCT04235608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5633956|NCT04235608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5759439|NCT02982850|Warfarin|warfarin|mesh-list
5759440|NCT02982850|Dabigatran|dabigatran|mesh-list
5759441|NCT02982850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5759442|NCT02982850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5759443|NCT02982850|Analgesics|analgesics|mesh-ancestor
5759444|NCT02982850|Sensory System Agents|sensory system agents|mesh-ancestor
5759445|NCT02982850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5759446|NCT02982850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759447|NCT02982850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5759448|NCT02982850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5759449|NCT02982850|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5759450|NCT02982850|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5759451|NCT02982850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759452|NCT02982850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5759453|NCT02982850|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5759454|NCT02982850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5759455|NCT02982850|Antipyretics|antipyretics|mesh-ancestor
5759456|NCT02982850|Anticoagulants|anticoagulants|mesh-ancestor
5759457|NCT02982850|Antithrombins|antithrombins|mesh-ancestor
5759458|NCT02982850|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5759459|NCT02982850|Protease Inhibitors|protease inhibitors|mesh-ancestor
5759460|NCT02982551|Insulin|insulin|mesh-list
5759461|NCT02982551|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5759462|NCT02982551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5759463|NCT02982551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759464|NCT02982486|Nivolumab|nivolumab|mesh-list
5759465|NCT02982486|Ipilimumab|ipilimumab|mesh-list
5633957|NCT04235608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5633958|NCT04235608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5633959|NCT04235608|Anesthetics, General|anesthetics, general|mesh-ancestor
5633960|NCT04235608|Anesthetics|anesthetics|mesh-ancestor
5633961|NCT04235608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5633962|NCT04235608|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5633963|NCT04231838|Nicotine|nicotine|mesh-list
5633964|NCT04231838|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5633965|NCT04231838|Autonomic Agents|autonomic agents|mesh-ancestor
5633966|NCT04231838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5633967|NCT04231838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5633968|NCT04231838|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5633969|NCT04231838|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5633970|NCT04231838|Cholinergic Agents|cholinergic agents|mesh-ancestor
5759466|NCT02982486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5633971|NCT04231838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5759467|NCT02982486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6209121|NCT02141620|Respiratory System Agents|respiratory system agents|mesh-ancestor
5693324|NCT03402048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6209122|NCT02141620|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5759468|NCT02982486|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5759469|NCT02982486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5633972|NCT04231838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5633973|NCT04176419|Acetaminophen|acetaminophen|mesh-list
5633974|NCT04176419|Celecoxib|celecoxib|mesh-list
5633975|NCT04176419|Lidocaine|lidocaine|mesh-list
5633976|NCT04176419|Ketamine|ketamine|mesh-list
5633977|NCT04176419|Gabapentin|gabapentin|mesh-list
5633978|NCT04176419|Anesthetics, Local|anesthetics, local|mesh-ancestor
5633979|NCT04176419|Anesthetics|anesthetics|mesh-ancestor
5633980|NCT04176419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5633981|NCT04176419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5633982|NCT04176419|Sensory System Agents|sensory system agents|mesh-ancestor
5633983|NCT04176419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5633984|NCT04176419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5633985|NCT04176419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5633986|NCT04176419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5633987|NCT04176419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5759470|NCT02982577|Pilocarpine|pilocarpine|mesh-list
5759471|NCT02982577|Miotics|miotics|mesh-ancestor
5759472|NCT02982577|Autonomic Agents|autonomic agents|mesh-ancestor
5633988|NCT04176419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5633989|NCT04176419|Analgesics|analgesics|mesh-ancestor
5633990|NCT04176419|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5633991|NCT04176419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5633992|NCT04176419|Anesthetics, General|anesthetics, general|mesh-ancestor
5633993|NCT04176419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5633994|NCT04176419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5633995|NCT04176419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5633996|NCT04176419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5633997|NCT04176419|Antipyretics|antipyretics|mesh-ancestor
5633998|NCT04176419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5633999|NCT04176419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5759473|NCT02982577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5759474|NCT02982577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759475|NCT02982577|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
5759476|NCT02982577|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5759477|NCT02982577|Cholinergic Agents|cholinergic agents|mesh-ancestor
5634000|NCT04176419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5634001|NCT04176419|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5634002|NCT04176419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5634003|NCT04176419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5634004|NCT04176419|Anticonvulsants|anticonvulsants|mesh-ancestor
5634005|NCT04176419|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5634006|NCT04176419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5634007|NCT04176419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5634008|NCT04176419|Antimanic Agents|antimanic agents|mesh-ancestor
5634009|NCT04170283|Zanubrutinib|zanubrutinib|mesh-list
5634010|NCT04170283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634011|NCT04170283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5634012|NCT04170283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5634013|NCT04170283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634014|NCT04166383|Nivolumab|nivolumab|mesh-list
5759478|NCT02982577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5759479|NCT02982577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759480|NCT02982512|Dexmedetomidine|dexmedetomidine|mesh-list
5759481|NCT02982512|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5759482|NCT02982512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5759483|NCT02982512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759484|NCT02982512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5759485|NCT02982512|Analgesics|analgesics|mesh-ancestor
5759486|NCT02982512|Sensory System Agents|sensory system agents|mesh-ancestor
5759487|NCT02982512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5759488|NCT02982512|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5759489|NCT02982512|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5759490|NCT02982512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5759491|NCT02982512|Adrenergic Agents|adrenergic agents|mesh-ancestor
5759492|NCT02982512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5759493|NCT02982512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759494|NCT02982434|Botulinum Toxins|botulinum toxins|mesh-list
5759495|NCT02982434|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5759496|NCT02982434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5895355|NCT05229055|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5634015|NCT04166383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5759497|NCT02982434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759498|NCT02982434|Cholinergic Agents|cholinergic agents|mesh-ancestor
5759499|NCT02982434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5759500|NCT02982434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759501|NCT02982161|Celecoxib|celecoxib|mesh-list
5759502|NCT02982161|Tramadol|tramadol|mesh-list
5759503|NCT02982161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5759504|NCT02982161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5759505|NCT02982161|Analgesics|analgesics|mesh-ancestor
5759506|NCT02982161|Sensory System Agents|sensory system agents|mesh-ancestor
5759507|NCT02982161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5759508|NCT02982161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759509|NCT02982161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5759510|NCT02982161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6490003|NCT00594867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6490004|NCT00594867|Antipyretics|antipyretics|mesh-ancestor
6490005|NCT00595049|Bosentan|bosentan|mesh-list
6490006|NCT00595049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6490007|NCT00595049|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5634016|NCT04166383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634017|NCT04166383|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5634018|NCT04166383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634019|NCT04146324|Nivolumab|nivolumab|mesh-list
5634020|NCT04146324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5634021|NCT04146324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634022|NCT04146324|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5634023|NCT04146324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634024|NCT04141579|Evolocumab|evolocumab|mesh-list
5634025|NCT04141579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5634026|NCT04141579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5634027|NCT04141579|Antimetabolites|antimetabolites|mesh-ancestor
5634028|NCT04141579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634029|NCT04141579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5634030|NCT04094519|Digoxin|digoxin|mesh-list
5634031|NCT04094519|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5634032|NCT04094519|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5634033|NCT04094519|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5634034|NCT04094519|Antimetabolites|antimetabolites|mesh-ancestor
5634035|NCT04094519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634036|NCT04094519|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5634037|NCT04094519|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5634038|NCT04094519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6490008|NCT00595049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490009|NCT00595140|Octreotide|octreotide|mesh-list
6490010|NCT00595140|Dopamine|dopamine|mesh-list
6490011|NCT00595140|Cabergoline|cabergoline|mesh-list
6490012|NCT00595140|Somatostatin|somatostatin|mesh-list
6490013|NCT00595140|Dopamine Agonists|dopamine agonists|mesh-list
6490014|NCT00595140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6490015|NCT00595140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6490016|NCT00595140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6490017|NCT00595140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5634039|NCT04094519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5634040|NCT04094519|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5634041|NCT04094519|Protective Agents|protective agents|mesh-ancestor
5634042|NCT04094519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5634043|NCT04083170|Vidarabine|vidarabine|mesh-list
5634044|NCT04083170|Cyclophosphamide|cyclophosphamide|mesh-list
5634045|NCT04083170|Thiotepa|thiotepa|mesh-list
5634046|NCT04083170|Fludarabine|fludarabine|mesh-list
5634047|NCT04083170|Fludarabine phosphate|fludarabine phosphate|mesh-list
5634048|NCT04083170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5634049|NCT04083170|Immunologic Factors|immunologic factors|mesh-ancestor
5634050|NCT04083170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5634051|NCT04083170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5634052|NCT04083170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5634053|NCT04083170|Alkylating Agents|alkylating agents|mesh-ancestor
5634054|NCT04083170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634055|NCT04083170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634056|NCT04083170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5634057|NCT04083170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5634058|NCT04083170|Antimetabolites|antimetabolites|mesh-ancestor
5634059|NCT04083170|Antiviral Agents|antiviral agents|mesh-ancestor
6209123|NCT02141620|Antioxidants|antioxidants|mesh-ancestor
6490018|NCT00595140|Sympathomimetics|sympathomimetics|mesh-ancestor
6490019|NCT00595140|Autonomic Agents|autonomic agents|mesh-ancestor
5634060|NCT04083170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6490020|NCT00595140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6490021|NCT00595140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490022|NCT00595140|Dopamine Agents|dopamine agents|mesh-ancestor
6490023|NCT00595140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6490024|NCT00595140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490025|NCT00595140|Protective Agents|protective agents|mesh-ancestor
5759511|NCT02982161|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6209124|NCT02141620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209125|NCT02141620|Protective Agents|protective agents|mesh-ancestor
5759512|NCT02982161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5759513|NCT02982161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5759514|NCT02982161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759515|NCT02982161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5759516|NCT02982161|Narcotics|narcotics|mesh-ancestor
5759517|NCT02982161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5759518|NCT02982395|Ethanol|ethanol|mesh-list
5759519|NCT02982395|Docetaxel|docetaxel|mesh-list
5759520|NCT02982395|Mitomycins|mitomycins|mesh-list
5759521|NCT02982395|Mitomycin|mitomycin|mesh-list
5759522|NCT02982395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5759523|NCT02982395|Tubulin Modulators|tubulin modulators|mesh-ancestor
5634061|NCT04080531|Vaccines|vaccines|mesh-list
5634062|NCT04080531|Immunologic Factors|immunologic factors|mesh-ancestor
5634063|NCT04080531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5634064|NCT04064359|Antibodies|antibodies|mesh-list
5634065|NCT04064359|Immunoconjugates|immunoconjugates|mesh-list
5634066|NCT04064359|Immunologic Factors|immunologic factors|mesh-ancestor
5634067|NCT04064359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5634068|NCT04045028|Rituximab|rituximab|mesh-list
5634069|NCT04045028|Atezolizumab|atezolizumab|mesh-list
5634070|NCT04045028|Daratumumab|daratumumab|mesh-list
5634071|NCT04045028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5634072|NCT04045028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634073|NCT04045028|Immunologic Factors|immunologic factors|mesh-ancestor
5634074|NCT04045028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5634075|NCT04045028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5634076|NCT03970837|Tofacitinib|tofacitinib|mesh-list
5634077|NCT03970837|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5634078|NCT03970837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5634079|NCT03970837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634080|NCT03938584|Ascorbic Acid|ascorbic acid|mesh-list
5634081|NCT03938584|Vitamins|vitamins|mesh-ancestor
5634082|NCT03938584|Micronutrients|micronutrients|mesh-ancestor
5634083|NCT03938584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5634084|NCT03938584|Antioxidants|antioxidants|mesh-ancestor
5634085|NCT03938584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634086|NCT03938584|Protective Agents|protective agents|mesh-ancestor
5634087|NCT03917381|Docetaxel|docetaxel|mesh-list
5634088|NCT03917381|Pembrolizumab|pembrolizumab|mesh-list
5634089|NCT03917381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634090|NCT03917381|Tubulin Modulators|tubulin modulators|mesh-ancestor
5634091|NCT03917381|Antimitotic Agents|antimitotic agents|mesh-ancestor
5634092|NCT03917381|Mitosis Modulators|mitosis modulators|mesh-ancestor
5634093|NCT03917381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634094|NCT03917381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5693325|NCT03401957|Cetuximab|cetuximab|mesh-list
5693326|NCT03401957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5693327|NCT03401957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5697824|NCT03373409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5697825|NCT03373409|Autonomic Agents|autonomic agents|mesh-ancestor
5697826|NCT03373409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5697827|NCT03373409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697828|NCT03373409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5697829|NCT03373409|Respiratory System Agents|respiratory system agents|mesh-ancestor
5697830|NCT03373409|Tocolytic Agents|tocolytic agents|mesh-ancestor
5697831|NCT03373409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5697832|NCT03373409|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5697833|NCT03373409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5697834|NCT03373409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5697835|NCT03373409|Adrenergic Agents|adrenergic agents|mesh-ancestor
5697836|NCT03373409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5697837|NCT03373409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697838|NCT03373318|Plasma-lyte 148|plasma-lyte 148|mesh-list
5759524|NCT02982395|Antimitotic Agents|antimitotic agents|mesh-ancestor
5759525|NCT02982395|Mitosis Modulators|mitosis modulators|mesh-ancestor
5759526|NCT02982395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759527|NCT02982395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5759528|NCT02982395|Alkylating Agents|alkylating agents|mesh-ancestor
5759529|NCT02982395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5759530|NCT02982395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5759531|NCT02982395|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5759532|NCT02982395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5759533|NCT02982395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5759534|NCT02982395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759535|NCT02982005|Brodalumab|brodalumab|mesh-list
5759536|NCT02982005|Dermatologic Agents|dermatologic agents|mesh-ancestor
5759537|NCT02982148|Methylene Blue|methylene blue|mesh-list
5759538|NCT02982148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5759539|NCT02982148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759540|NCT02982122|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
5759541|NCT02981966|Dapagliflozin|dapagliflozin|mesh-list
5759542|NCT02981966|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5759543|NCT02981966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759544|NCT02981966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5759545|NCT02981966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759546|NCT02981979|Prednisone|prednisone|mesh-list
5759547|NCT02981979|Leflunomide|leflunomide|mesh-list
5759548|NCT02981979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5759549|NCT02981979|Glucocorticoids|glucocorticoids|mesh-ancestor
5759550|NCT02981979|Hormones|hormones|mesh-ancestor
5759551|NCT02981979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5759552|NCT02981979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759553|NCT02981979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5759554|NCT02981979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5759555|NCT02981979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5759556|NCT02981979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759557|NCT02981979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5759558|NCT02981979|Immunologic Factors|immunologic factors|mesh-ancestor
5759559|NCT02981836|Vaccines|vaccines|mesh-list
5759560|NCT02981836|Immunologic Factors|immunologic factors|mesh-ancestor
5759561|NCT02981836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759562|NCT02981784|Ponatinib|ponatinib|mesh-list
5759563|NCT02981784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5759564|NCT02981784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5759565|NCT02981784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5634095|NCT03837873|Cytarabine|cytarabine|mesh-list
5634096|NCT03837873|Dexamethasone|dexamethasone|mesh-list
5634097|NCT03837873|Cyclophosphamide|cyclophosphamide|mesh-list
5634098|NCT03837873|Rituximab|rituximab|mesh-list
5634099|NCT03837873|Doxorubicin|doxorubicin|mesh-list
5634100|NCT03837873|Etoposide|etoposide|mesh-list
5634101|NCT03837873|Vincristine|vincristine|mesh-list
5634102|NCT03837873|Lenalidomide|lenalidomide|mesh-list
5634103|NCT03837873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5634104|NCT03837873|Immunologic Factors|immunologic factors|mesh-ancestor
5634105|NCT03837873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5634106|NCT03837873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5634107|NCT03837873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5634108|NCT03837873|Alkylating Agents|alkylating agents|mesh-ancestor
5634109|NCT03837873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634110|NCT03837873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634111|NCT03837873|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5634112|NCT03837873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5634113|NCT03837873|Antiemetics|antiemetics|mesh-ancestor
5634114|NCT03837873|Autonomic Agents|autonomic agents|mesh-ancestor
5634115|NCT03837873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5634116|NCT03837873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5634117|NCT03837873|Glucocorticoids|glucocorticoids|mesh-ancestor
5634118|NCT03837873|Hormones|hormones|mesh-ancestor
5634119|NCT03837873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5634120|NCT03837873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5634121|NCT03837873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5634122|NCT03837873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5634123|NCT03837873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5634124|NCT03837873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5634125|NCT03837873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5634126|NCT03837873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5634127|NCT03837873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5634128|NCT03837873|Antimetabolites|antimetabolites|mesh-ancestor
6209126|NCT02141620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759566|NCT02981784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759567|NCT02981914|Pembrolizumab|pembrolizumab|mesh-list
5759568|NCT02981914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5759569|NCT02981914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5759570|NCT02981719|Gemcitabine|gemcitabine|mesh-list
5759571|NCT02981719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5759572|NCT02981719|Antimetabolites|antimetabolites|mesh-ancestor
5759573|NCT02981719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759574|NCT02981719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5759575|NCT02981719|Antiviral Agents|antiviral agents|mesh-ancestor
5759576|NCT02981719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5759577|NCT02981719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5759578|NCT02981719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5759579|NCT02981719|Immunologic Factors|immunologic factors|mesh-ancestor
5759580|NCT02981719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759581|NCT02981615|Levofloxacin|levofloxacin|mesh-list
5759582|NCT02981615|Ofloxacin|ofloxacin|mesh-list
5759583|NCT02981615|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5759584|NCT02981615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5759585|NCT02981615|Renal Agents|renal agents|mesh-ancestor
5759586|NCT02981615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5759587|NCT02981615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5759588|NCT02981615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5759589|NCT02981615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5759590|NCT02981615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759591|NCT02981615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5759592|NCT02981615|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5759593|NCT02981615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5759594|NCT02981446|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5759595|NCT02981446|Latanoprost|latanoprost|mesh-list
5759596|NCT02981446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5759597|NCT02981329|Metformin|metformin|mesh-list
5759598|NCT02981329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5759599|NCT02981329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5634129|NCT03837873|Antiviral Agents|antiviral agents|mesh-ancestor
5634130|NCT03837873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5634131|NCT03837873|Tubulin Modulators|tubulin modulators|mesh-ancestor
5634132|NCT03837873|Antimitotic Agents|antimitotic agents|mesh-ancestor
5634133|NCT03837873|Mitosis Modulators|mitosis modulators|mesh-ancestor
5634134|NCT03837873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5634135|NCT03837873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5634136|NCT03837873|Growth Substances|growth substances|mesh-ancestor
5634137|NCT03837873|Growth Inhibitors|growth inhibitors|mesh-ancestor
5634138|NCT03836209|Cytarabine|cytarabine|mesh-list
5634139|NCT03836209|Daunorubicin|daunorubicin|mesh-list
5634140|NCT03836209|Midostaurin|midostaurin|mesh-list
5895356|NCT05229055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5895357|NCT05229055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895358|NCT05229042|Ricolinostat|ricolinostat|mesh-list
5895359|NCT05229042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5895360|NCT05229042|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5895361|NCT05229042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5895362|NCT05229042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895363|NCT05228951|Trastuzumab|trastuzumab|mesh-list
5895364|NCT05228951|Letrozole|letrozole|mesh-list
5895365|NCT05228951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5895366|NCT05228951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5895367|NCT05228951|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5895368|NCT05228951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5895369|NCT05228951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5895370|NCT05228951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634141|NCT03836209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5634142|NCT03836209|Antimetabolites|antimetabolites|mesh-ancestor
5634143|NCT03836209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634144|NCT03836209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634145|NCT03836209|Antiviral Agents|antiviral agents|mesh-ancestor
5634146|NCT03836209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5895371|NCT05228951|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5895372|NCT05228951|Hormone Antagonists|hormone antagonists|mesh-ancestor
5895373|NCT05228951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5895374|NCT05228951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895375|NCT05228925|Vitamin D|vitamin d|mesh-list
5895376|NCT05228925|Vitamins|vitamins|mesh-ancestor
5634147|NCT03836209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5634148|NCT03836209|Immunologic Factors|immunologic factors|mesh-ancestor
5634149|NCT03836209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5634150|NCT03836209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5634151|NCT03836209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5634152|NCT03836209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5634153|NCT03836209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5634154|NCT03836209|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5634155|NCT03810495|Naltrexone|naltrexone|mesh-list
5634156|NCT03810495|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5634157|NCT03810495|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5759600|NCT02981290|Mycophenolic Acid|mycophenolic acid|mesh-list
5759601|NCT02981290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5759602|NCT02981290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5759603|NCT02981290|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5759604|NCT02981290|Antitubercular Agents|antitubercular agents|mesh-ancestor
5759605|NCT02981290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5759606|NCT02981290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5759607|NCT02981290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5759608|NCT02981290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759609|NCT02981212|Mycophenolic Acid|mycophenolic acid|mesh-list
5759610|NCT02981212|Prednisolone|prednisolone|mesh-list
5634158|NCT03810495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5634159|NCT03810495|Sensory System Agents|sensory system agents|mesh-ancestor
5634160|NCT03810495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5634161|NCT03775200|Psilocybin|psilocybin|mesh-list
5634162|NCT03775200|Hallucinogens|hallucinogens|mesh-ancestor
5634163|NCT03775200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5634164|NCT03775200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5634165|NCT03769766|Curcumin|curcumin|mesh-list
5634166|NCT03769766|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5634167|NCT03769766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5634168|NCT03769766|Analgesics|analgesics|mesh-ancestor
5634169|NCT03769766|Sensory System Agents|sensory system agents|mesh-ancestor
5634170|NCT03769766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5634171|NCT03769766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5634172|NCT03769766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5634173|NCT03769766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5634174|NCT03769766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634175|NCT03769766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5634176|NCT03769766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759611|NCT02981212|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
5759612|NCT02981212|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5759613|NCT02981212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5759614|NCT02981212|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5634177|NCT03753555|Calcium, Dietary|calcium, dietary|mesh-list
5634178|NCT03753555|Atorvastatin|atorvastatin|mesh-list
5634179|NCT03753555|Probucol|probucol|mesh-list
5634180|NCT03753555|Calcium|calcium|mesh-list
5634181|NCT03753555|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5634182|NCT03753555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5634183|NCT03753555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5634184|NCT03753555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5634185|NCT03753555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5634186|NCT03753555|Antimetabolites|antimetabolites|mesh-ancestor
5634187|NCT03753555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634188|NCT03753555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5634189|NCT03753555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5634190|NCT03753555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5634191|NCT03753555|Antioxidants|antioxidants|mesh-ancestor
5634192|NCT03753555|Protective Agents|protective agents|mesh-ancestor
5634193|NCT03734029|Gemcitabine|gemcitabine|mesh-list
5634194|NCT03734029|Paclitaxel|paclitaxel|mesh-list
5634195|NCT03734029|Camptothecin|camptothecin|mesh-list
5634196|NCT03734029|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5634197|NCT03734029|Capecitabine|capecitabine|mesh-list
5759615|NCT02981212|Antitubercular Agents|antitubercular agents|mesh-ancestor
5634198|NCT03734029|Trastuzumab|trastuzumab|mesh-list
5634199|NCT03734029|Immunoconjugates|immunoconjugates|mesh-list
5634200|NCT03734029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5634201|NCT03734029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634202|NCT03734029|Tubulin Modulators|tubulin modulators|mesh-ancestor
5634203|NCT03734029|Antimitotic Agents|antimitotic agents|mesh-ancestor
5634204|NCT03734029|Mitosis Modulators|mitosis modulators|mesh-ancestor
5634205|NCT03734029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634206|NCT03734029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5759616|NCT02981212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5634207|NCT03734029|Antimetabolites|antimetabolites|mesh-ancestor
5634208|NCT03734029|Antiviral Agents|antiviral agents|mesh-ancestor
5634209|NCT03734029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5759617|NCT02981212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5759618|NCT02981212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5759619|NCT02981212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759620|NCT02981212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5634210|NCT03734029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5634211|NCT03734029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5634212|NCT03734029|Immunologic Factors|immunologic factors|mesh-ancestor
5634213|NCT03734029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5634214|NCT03734029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5634215|NCT03734029|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5634216|NCT03734029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5634217|NCT03732677|Gemcitabine|gemcitabine|mesh-list
5634218|NCT03732677|Durvalumab|durvalumab|mesh-list
5634219|NCT03732677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634220|NCT03732677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5634221|NCT03732677|Antimetabolites|antimetabolites|mesh-ancestor
5634222|NCT03732677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634223|NCT03732677|Antiviral Agents|antiviral agents|mesh-ancestor
5634224|NCT03732677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5634225|NCT03732677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5634226|NCT03732677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5634227|NCT03732677|Immunologic Factors|immunologic factors|mesh-ancestor
5634228|NCT03732677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5634229|NCT03732677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5634230|NCT03716609|Magnesium citrate|magnesium citrate|mesh-list
5634231|NCT03716609|Citric Acid|citric acid|mesh-list
5634232|NCT03716609|Sodium Citrate|sodium citrate|mesh-list
5634233|NCT03716609|Anticoagulants|anticoagulants|mesh-ancestor
5634234|NCT03716609|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5634235|NCT03716609|Chelating Agents|chelating agents|mesh-ancestor
5634236|NCT03716609|Sequestering Agents|sequestering agents|mesh-ancestor
5634237|NCT03716609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634238|NCT03716609|Cathartics|cathartics|mesh-ancestor
5634239|NCT03716609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5634240|NCT03709355|Clarithromycin|clarithromycin|mesh-list
5634241|NCT03709355|Rifampin|rifampin|mesh-list
5759621|NCT02981212|Glucocorticoids|glucocorticoids|mesh-ancestor
5759622|NCT02981212|Hormones|hormones|mesh-ancestor
5759623|NCT02981212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5759624|NCT02981212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759625|NCT02981212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5759626|NCT02981212|Protease Inhibitors|protease inhibitors|mesh-ancestor
5759627|NCT02981303|Pembrolizumab|pembrolizumab|mesh-list
5759628|NCT02981303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5759629|NCT02981303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5759630|NCT02981264|Lidocaine|lidocaine|mesh-list
5634242|NCT03709355|Rifabutin|rifabutin|mesh-list
5634243|NCT03709355|Elsulfavirine|elsulfavirine|mesh-list
5634244|NCT03709355|Omeprazole|omeprazole|mesh-list
5634245|NCT03709355|Atorvastatin|atorvastatin|mesh-list
5634246|NCT03709355|Levonorgestrel|levonorgestrel|mesh-list
5634247|NCT03709355|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5634248|NCT03709355|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
5634249|NCT03709355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5634250|NCT03709355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5634251|NCT03709355|Antimetabolites|antimetabolites|mesh-ancestor
5634252|NCT03709355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759631|NCT02981264|Anesthetics, Local|anesthetics, local|mesh-ancestor
5759632|NCT02981264|Anesthetics|anesthetics|mesh-ancestor
5759633|NCT02981264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5759634|NCT02981264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759635|NCT02981264|Sensory System Agents|sensory system agents|mesh-ancestor
5759636|NCT02981264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5759637|NCT02981264|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5759638|NCT02981264|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5759639|NCT02981264|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6209127|NCT02141620|Antidotes|antidotes|mesh-ancestor
5634253|NCT03709355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5634254|NCT03709355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5634255|NCT03709355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5634256|NCT03709355|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5634257|NCT03709355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5895377|NCT05228925|Micronutrients|micronutrients|mesh-ancestor
5759640|NCT02981264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5634258|NCT03709355|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5634259|NCT03709355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5634260|NCT03709355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5634261|NCT03709355|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5634262|NCT03709355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5634263|NCT03709355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5634264|NCT03709355|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5634265|NCT03709355|Contraceptive Agents|contraceptive agents|mesh-ancestor
5634266|NCT03709355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5634267|NCT03709355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5634268|NCT03709355|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5634269|NCT03709355|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5634270|NCT03709355|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5634271|NCT03709355|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5634272|NCT03709355|Antitubercular Agents|antitubercular agents|mesh-ancestor
5634273|NCT03709355|Leprostatic Agents|leprostatic agents|mesh-ancestor
5634274|NCT03709355|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5634275|NCT03709355|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5634276|NCT03709355|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5634277|NCT03709355|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5634278|NCT03709355|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5634279|NCT03709355|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5634280|NCT03709355|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5634281|NCT03709355|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5634282|NCT03709355|Estrogens|estrogens|mesh-ancestor
5634283|NCT03709355|Hormones|hormones|mesh-ancestor
5634284|NCT03709355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5634285|NCT03709355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5634286|NCT03709355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5634287|NCT03709355|Antiviral Agents|antiviral agents|mesh-ancestor
5634288|NCT03709355|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5634289|NCT03700658|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
5634290|NCT03700658|Medroxyprogesterone|medroxyprogesterone|mesh-list
5634291|NCT03700658|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5634292|NCT03700658|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5634293|NCT03700658|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5759641|NCT02981264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759642|NCT02981459|Mirabegron|mirabegron|mesh-list
5759643|NCT02981459|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
5759644|NCT02981459|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5759645|NCT02981459|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5759646|NCT02981459|Adrenergic Agents|adrenergic agents|mesh-ancestor
5759647|NCT02981459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5759648|NCT02981459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759649|NCT02981459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759650|NCT02981459|Urological Agents|urological agents|mesh-ancestor
5759651|NCT02981173|Psilocybin|psilocybin|mesh-list
5759652|NCT02981173|Hallucinogens|hallucinogens|mesh-ancestor
5759653|NCT02981173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759654|NCT02981173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5759655|NCT02981121|Metformin|metformin|mesh-list
5634294|NCT03700658|Contraceptive Agents|contraceptive agents|mesh-ancestor
5634295|NCT03700658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5634296|NCT03700658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5634297|NCT03700658|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5634298|NCT03700658|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5634299|NCT03700658|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5634300|NCT03700658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5634301|NCT03700658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634302|NCT03698552|Epratuzumab|epratuzumab|mesh-list
5634303|NCT03698552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5634304|NCT03698552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634305|NCT03669133|Vitamin E|vitamin e|mesh-list
5634306|NCT03669133|Vitamins|vitamins|mesh-ancestor
5634307|NCT03669133|Micronutrients|micronutrients|mesh-ancestor
5634308|NCT03669133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5634309|NCT03669133|Antioxidants|antioxidants|mesh-ancestor
5634310|NCT03669133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634311|NCT03669133|Protective Agents|protective agents|mesh-ancestor
5634312|NCT03637491|Avelumab|avelumab|mesh-list
5759656|NCT02981121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6209128|NCT02141620|Anesthetics, Local|anesthetics, local|mesh-ancestor
5634313|NCT03637491|Talazoparib|talazoparib|mesh-list
5634314|NCT03637491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5634315|NCT03637491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5759657|NCT02981121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759658|NCT02981095|Bupivacaine|bupivacaine|mesh-list
5759659|NCT02981095|Anesthetics, Local|anesthetics, local|mesh-ancestor
6209129|NCT02141620|Anesthetics|anesthetics|mesh-ancestor
6209130|NCT02141620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6209131|NCT02141620|Sensory System Agents|sensory system agents|mesh-ancestor
6490026|NCT00595140|Hormones|hormones|mesh-ancestor
6490027|NCT00595140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6490028|NCT00595140|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6490029|NCT00595140|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6490030|NCT00595322|Bevacizumab|bevacizumab|mesh-list
6490031|NCT00595322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6490032|NCT00595322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634316|NCT03637491|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5759660|NCT02981095|Anesthetics|anesthetics|mesh-ancestor
5759661|NCT02981095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5759662|NCT02981095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759663|NCT02981095|Sensory System Agents|sensory system agents|mesh-ancestor
5759664|NCT02981095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5759665|NCT02980991|Pemetrexed|pemetrexed|mesh-list
5759666|NCT02980991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5759667|NCT02980991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5759668|NCT02980991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759669|NCT02980991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5759670|NCT02980991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5759671|NCT02981082|Dimethyl Fumarate|dimethyl fumarate|mesh-list
5634317|NCT03637491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5634318|NCT03637491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634319|NCT03582618|Sorafenib|sorafenib|mesh-list
5634320|NCT03582618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634321|NCT03582618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5634322|NCT03582618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5634323|NCT03582618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634324|NCT03514017|Pembrolizumab|pembrolizumab|mesh-list
5634325|NCT03514017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5634326|NCT03514017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634327|NCT03511625|Methylprednisolone|methylprednisolone|mesh-list
5634328|NCT03511625|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5634329|NCT03511625|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5634330|NCT03511625|Prednisolone|prednisolone|mesh-list
5634331|NCT03511625|Prednisolone acetate|prednisolone acetate|mesh-list
5634332|NCT03511625|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5634333|NCT03511625|Prednisolone phosphate|prednisolone phosphate|mesh-list
5634334|NCT03511625|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
5759672|NCT02981082|Dermatologic Agents|dermatologic agents|mesh-ancestor
5759673|NCT02981082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5759674|NCT02981082|Immunologic Factors|immunologic factors|mesh-ancestor
5759675|NCT02981082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759676|NCT02981030|Misoprostol|misoprostol|mesh-list
5759677|NCT02981030|Mifepristone|mifepristone|mesh-list
5759678|NCT02981030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5759679|NCT02981030|Abortifacient Agents|abortifacient agents|mesh-ancestor
5759680|NCT02981030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5759681|NCT02981030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759682|NCT02981030|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5759683|NCT02981030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5759684|NCT02981030|Oxytocics|oxytocics|mesh-ancestor
5759685|NCT02981030|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5759686|NCT02981030|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5759687|NCT02981030|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5759688|NCT02981030|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6212582|NCT02189941|Chelating Agents|chelating agents|mesh-ancestor
5634335|NCT03511625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5634336|NCT03511625|Antiemetics|antiemetics|mesh-ancestor
5634337|NCT03511625|Autonomic Agents|autonomic agents|mesh-ancestor
5634338|NCT03511625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5634339|NCT03511625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5634340|NCT03511625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5634341|NCT03511625|Glucocorticoids|glucocorticoids|mesh-ancestor
5634342|NCT03511625|Hormones|hormones|mesh-ancestor
5693328|NCT03401827|Gemcitabine|gemcitabine|mesh-list
5693329|NCT03401827|Paclitaxel|paclitaxel|mesh-list
5759689|NCT02981030|Contraceptive Agents|contraceptive agents|mesh-ancestor
5759690|NCT02981030|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5759691|NCT02981030|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5634343|NCT03511625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5634344|NCT03511625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5634345|NCT03511625|Protective Agents|protective agents|mesh-ancestor
5634346|NCT03511625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5634347|NCT03511625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634348|NCT03498391|Ketamine|ketamine|mesh-list
5634349|NCT03498391|Propofol|propofol|mesh-list
5634350|NCT03498391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5634351|NCT03498391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5634352|NCT03498391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5634353|NCT03498391|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5634354|NCT03498391|Anesthetics, General|anesthetics, general|mesh-ancestor
5759692|NCT02981030|Hormone Antagonists|hormone antagonists|mesh-ancestor
5759693|NCT02981030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5759694|NCT02981030|Luteolytic Agents|luteolytic agents|mesh-ancestor
5759695|NCT02981030|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6490033|NCT00595322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6490034|NCT00595322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6490035|NCT00595322|Growth Substances|growth substances|mesh-ancestor
6490036|NCT00595322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490037|NCT00595322|Growth Inhibitors|growth inhibitors|mesh-ancestor
6490038|NCT00595374|Insulin|insulin|mesh-list
6490039|NCT00595374|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5634355|NCT03498391|Anesthetics|anesthetics|mesh-ancestor
5634356|NCT03498391|Analgesics|analgesics|mesh-ancestor
5634357|NCT03498391|Sensory System Agents|sensory system agents|mesh-ancestor
5634358|NCT03498391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5634359|NCT03498391|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5634360|NCT03498391|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5634361|NCT03498391|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5634362|NCT03498391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5634363|NCT03498391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634364|NCT03477162|Metformin|metformin|mesh-list
5634365|NCT03477162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5634366|NCT03477162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5634367|NCT03461952|Nivolumab|nivolumab|mesh-list
5634368|NCT03461952|Ipilimumab|ipilimumab|mesh-list
5634369|NCT03461952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5634370|NCT03461952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634371|NCT03461952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5634372|NCT03461952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634373|NCT03420508|Ensartinib|ensartinib|mesh-list
6490040|NCT00595374|Insulin Aspart|insulin aspart|mesh-list
6490041|NCT00595374|Insulin Detemir|insulin detemir|mesh-list
6490042|NCT00595374|Isophane Insulin, Human|isophane insulin, human|mesh-list
6490043|NCT00595374|Insulin, Isophane|insulin, isophane|mesh-list
6490044|NCT00595374|Isophane insulin, beef|isophane insulin, beef|mesh-list
6490045|NCT00595374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6490046|NCT00595374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673264|NCT01561404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5759696|NCT02981030|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5759697|NCT02980809|Apatinib|apatinib|mesh-list
5759698|NCT02980809|Topotecan|topotecan|mesh-list
5759699|NCT02980809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5759700|NCT02980809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5759701|NCT02980809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5759702|NCT02980809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759703|NCT02980809|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5759704|NCT02980809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5759705|NCT02980926|Bupivacaine|bupivacaine|mesh-list
5759706|NCT02980926|Mepivacaine|mepivacaine|mesh-list
5759707|NCT02980926|Anesthetics, Local|anesthetics, local|mesh-ancestor
5759708|NCT02980926|Anesthetics|anesthetics|mesh-ancestor
5759709|NCT02980926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5759710|NCT02980926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759711|NCT02980926|Sensory System Agents|sensory system agents|mesh-ancestor
5759712|NCT02980926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5759713|NCT02980913|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5759714|NCT02980913|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5759715|NCT02980835|Dexamethasone|dexamethasone|mesh-list
6490047|NCT00595543|Diclofenac|diclofenac|mesh-list
6490048|NCT00595543|Ketorolac|ketorolac|mesh-list
6490049|NCT00595543|Bromfenac|bromfenac|mesh-list
5634374|NCT03420508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634375|NCT03420508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5634376|NCT03420508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5634377|NCT03420508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634378|NCT03390296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5634379|NCT03390296|Avelumab|avelumab|mesh-list
5634380|NCT03390296|Gemtuzumab|gemtuzumab|mesh-list
5634381|NCT03390296|Azacitidine|azacitidine|mesh-list
5634382|NCT03390296|Venetoclax|venetoclax|mesh-list
5634383|NCT03390296|Calicheamicins|calicheamicins|mesh-list
5634384|NCT03390296|Antibodies|antibodies|mesh-list
5634385|NCT03390296|Immunoglobulins|immunoglobulins|mesh-list
5634386|NCT03390296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5634387|NCT03390296|Maleic acid|maleic acid|mesh-list
5634388|NCT03390296|Immunologic Factors|immunologic factors|mesh-ancestor
5634389|NCT03390296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5634390|NCT03390296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634391|NCT03390296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5634392|NCT03390296|Antimetabolites|antimetabolites|mesh-ancestor
5634393|NCT03390296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634394|NCT03390296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5634395|NCT03390296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5634396|NCT03340727|Caffeine|caffeine|mesh-list
5634397|NCT03340727|Caffeine citrate|caffeine citrate|mesh-list
5634398|NCT03340727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634399|NCT03340727|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5634400|NCT03340727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5634401|NCT03340727|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5634402|NCT03340727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5634403|NCT03340727|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5634404|NCT03340727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5634405|NCT03340727|Purinergic Agents|purinergic agents|mesh-ancestor
5634406|NCT03340727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5634407|NCT03334539|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5634408|NCT03334539|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5634409|NCT03333486|Cyclophosphamide|cyclophosphamide|mesh-list
5634410|NCT03333486|Fludarabine|fludarabine|mesh-list
5634411|NCT03333486|Fludarabine phosphate|fludarabine phosphate|mesh-list
5634412|NCT03333486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5634413|NCT03333486|Immunologic Factors|immunologic factors|mesh-ancestor
5634414|NCT03333486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5634415|NCT03333486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5634416|NCT03333486|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5759716|NCT02980835|Epinephrine|epinephrine|mesh-list
5759717|NCT02980835|Ropivacaine|ropivacaine|mesh-list
5759718|NCT02980835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5759719|NCT02980835|Antiemetics|antiemetics|mesh-ancestor
5759720|NCT02980835|Autonomic Agents|autonomic agents|mesh-ancestor
5759721|NCT02980835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5759722|NCT02980835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759723|NCT02980835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5759724|NCT02980835|Glucocorticoids|glucocorticoids|mesh-ancestor
5759725|NCT02980835|Hormones|hormones|mesh-ancestor
5759726|NCT02980835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5759727|NCT02980835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5634417|NCT03333486|Alkylating Agents|alkylating agents|mesh-ancestor
5634418|NCT03333486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634419|NCT03333486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634420|NCT03333486|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5634421|NCT03333486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5634422|NCT03333486|Antimetabolites|antimetabolites|mesh-ancestor
5634423|NCT03309878|Pembrolizumab|pembrolizumab|mesh-list
5634424|NCT03309878|Mogamulizumab|mogamulizumab|mesh-list
5634425|NCT03309878|Immunoglobulins|immunoglobulins|mesh-list
5634426|NCT03309878|Immunoglobulin G|immunoglobulin g|mesh-list
5634427|NCT03309878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5634428|NCT03309878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634429|NCT03309878|Immunologic Factors|immunologic factors|mesh-ancestor
5634430|NCT03309878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5634431|NCT03296813|Torsemide|torsemide|mesh-list
5634432|NCT03296813|Furosemide|furosemide|mesh-list
5634433|NCT03296813|Diuretics|diuretics|mesh-ancestor
5634434|NCT03296813|Natriuretic Agents|natriuretic agents|mesh-ancestor
5634435|NCT03296813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759728|NCT02980835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634436|NCT03296813|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5634437|NCT03296813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5634438|NCT03296813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634439|NCT03296813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5634440|NCT03277638|Pembrolizumab|pembrolizumab|mesh-list
5634441|NCT03277638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5634442|NCT03277638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634443|NCT03269344|Gabapentin|gabapentin|mesh-list
5634444|NCT03269344|Analgesics|analgesics|mesh-ancestor
5634445|NCT03269344|Sensory System Agents|sensory system agents|mesh-ancestor
5634446|NCT03269344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5634447|NCT03269344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5634448|NCT03269344|Anticonvulsants|anticonvulsants|mesh-ancestor
5634449|NCT03269344|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5634450|NCT03269344|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5634451|NCT03269344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5634452|NCT03269344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5634453|NCT03269344|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5634454|NCT03269344|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5634455|NCT03269344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5634456|NCT03269344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634457|NCT03269344|Antimanic Agents|antimanic agents|mesh-ancestor
5634458|NCT03218683|Venetoclax|venetoclax|mesh-list
5634459|NCT03218683|AZD5991|azd5991|mesh-list
5634460|NCT03218683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634461|NCT03215095|Durvalumab|durvalumab|mesh-list
5634462|NCT03215095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5759729|NCT02980835|Anesthetics, Local|anesthetics, local|mesh-ancestor
5759730|NCT02980835|Anesthetics|anesthetics|mesh-ancestor
5759731|NCT02980835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5759732|NCT02980835|Sensory System Agents|sensory system agents|mesh-ancestor
5759733|NCT02980835|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5759734|NCT02980835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5759735|NCT02980835|Adrenergic Agents|adrenergic agents|mesh-ancestor
5759736|NCT02980835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5759737|NCT02980835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759738|NCT02980835|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5759739|NCT02980835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5759740|NCT02980835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5759741|NCT02980835|Respiratory System Agents|respiratory system agents|mesh-ancestor
5759742|NCT02980835|Mydriatics|mydriatics|mesh-ancestor
5759743|NCT02980835|Sympathomimetics|sympathomimetics|mesh-ancestor
5759744|NCT02980835|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5759745|NCT02980965|Cyclophosphamide|cyclophosphamide|mesh-list
5759746|NCT02980965|Docetaxel|docetaxel|mesh-list
5759747|NCT02980965|Fluorouracil|fluorouracil|mesh-list
5759748|NCT02980965|Letrozole|letrozole|mesh-list
5759749|NCT02980965|Epirubicin|epirubicin|mesh-list
5759750|NCT02980965|Leuprolide|leuprolide|mesh-list
5759751|NCT02980965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5759752|NCT02980965|Immunologic Factors|immunologic factors|mesh-ancestor
5634463|NCT03215095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634464|NCT03201458|Atezolizumab|atezolizumab|mesh-list
5634465|NCT03201458|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5634466|NCT03201458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634467|NCT03201458|Immunologic Factors|immunologic factors|mesh-ancestor
5634468|NCT03201458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5634469|NCT03169101|Nicotine|nicotine|mesh-list
5634470|NCT03169101|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5634471|NCT03169101|Autonomic Agents|autonomic agents|mesh-ancestor
5634472|NCT03169101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5634473|NCT03169101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5634474|NCT03169101|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5634475|NCT03169101|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5634476|NCT03169101|Cholinergic Agents|cholinergic agents|mesh-ancestor
5759753|NCT02980965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759754|NCT02980965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5759755|NCT02980965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5759756|NCT02980965|Alkylating Agents|alkylating agents|mesh-ancestor
5759757|NCT02980965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759758|NCT02980965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5759759|NCT02980965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5759760|NCT02980965|Tubulin Modulators|tubulin modulators|mesh-ancestor
5634477|NCT03169101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5693330|NCT03401827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5759761|NCT02980965|Antimitotic Agents|antimitotic agents|mesh-ancestor
5759762|NCT02980965|Mitosis Modulators|mitosis modulators|mesh-ancestor
5759763|NCT02980965|Antimetabolites|antimetabolites|mesh-ancestor
5759764|NCT02980965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5759765|NCT02980965|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5759766|NCT02980965|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5759767|NCT02980965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5759768|NCT02980965|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5759769|NCT02980965|Hormone Antagonists|hormone antagonists|mesh-ancestor
5759770|NCT02980965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5759771|NCT02980965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5759772|NCT02980965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5759773|NCT02980965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5759774|NCT02980965|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5759775|NCT02980965|Fertility Agents|fertility agents|mesh-ancestor
5759776|NCT02980965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5634478|NCT03169101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634479|NCT03151746|Gabapentin|gabapentin|mesh-list
5634480|NCT03151746|Analgesics|analgesics|mesh-ancestor
5634481|NCT03151746|Sensory System Agents|sensory system agents|mesh-ancestor
5634482|NCT03151746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5634483|NCT03151746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5634484|NCT03151746|Anticonvulsants|anticonvulsants|mesh-ancestor
5634485|NCT03151746|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5634486|NCT03151746|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5634487|NCT03151746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5634488|NCT03151746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5634489|NCT03151746|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5634490|NCT03151746|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5634491|NCT03151746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5759777|NCT02980965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5759778|NCT02980757|Gliclazide|gliclazide|mesh-list
5759779|NCT02980757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5759780|NCT02980757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209132|NCT02141620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6209133|NCT02141620|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6490050|NCT00595543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6490051|NCT00595543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6490052|NCT00595543|Analgesics|analgesics|mesh-ancestor
6490053|NCT00595543|Sensory System Agents|sensory system agents|mesh-ancestor
6490054|NCT00595543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6490055|NCT00595543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5634492|NCT03151746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634493|NCT03151746|Antimanic Agents|antimanic agents|mesh-ancestor
5634494|NCT03071406|Nivolumab|nivolumab|mesh-list
6490056|NCT00595543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6490057|NCT00595543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6490058|NCT00595543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6490059|NCT00595543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6490060|NCT00595543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490061|NCT00595569|Insulin|insulin|mesh-list
6490062|NCT00595569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5634495|NCT03071406|Ipilimumab|ipilimumab|mesh-list
5634496|NCT03071406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5634497|NCT03071406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634498|NCT03071406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5634499|NCT03071406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634500|NCT03065335|Ketamine|ketamine|mesh-list
6209134|NCT02141620|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6490063|NCT00595569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490064|NCT00595933|Muramidase|muramidase|mesh-list
6490065|NCT00595933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6490066|NCT00595972|Endostar protein|endostar protein|mesh-list
6490067|NCT00595972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6490068|NCT00595972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6490069|NCT00595972|Growth Substances|growth substances|mesh-ancestor
6490070|NCT00595972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490071|NCT00595972|Growth Inhibitors|growth inhibitors|mesh-ancestor
6490072|NCT00595972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6490073|NCT00595985|Sorafenib|sorafenib|mesh-list
6490074|NCT00595985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6490075|NCT00595985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6209135|NCT02141620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6209136|NCT02141620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6209137|NCT02141620|Dopamine Agents|dopamine agents|mesh-ancestor
6490076|NCT00595985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5634501|NCT03065335|Analgesics|analgesics|mesh-ancestor
5634502|NCT03065335|Sensory System Agents|sensory system agents|mesh-ancestor
5634503|NCT03065335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5634504|NCT03065335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5634505|NCT03065335|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5634506|NCT03065335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5634507|NCT03065335|Anesthetics, General|anesthetics, general|mesh-ancestor
5634508|NCT03065335|Anesthetics|anesthetics|mesh-ancestor
5634509|NCT03065335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5634510|NCT03065335|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5634511|NCT03065335|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5634512|NCT03065335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5634513|NCT03065335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634514|NCT03028857|Choline|choline|mesh-list
5634515|NCT03028857|Lipotropic Agents|lipotropic agents|mesh-ancestor
5634516|NCT03028857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5634517|NCT03028857|Antimetabolites|antimetabolites|mesh-ancestor
5634518|NCT03028857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634519|NCT03028857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5634520|NCT03028857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5634521|NCT03028857|Nootropic Agents|nootropic agents|mesh-ancestor
5693331|NCT03401827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5693332|NCT03401827|Tubulin Modulators|tubulin modulators|mesh-ancestor
5693333|NCT03401827|Antimitotic Agents|antimitotic agents|mesh-ancestor
5693334|NCT03401827|Mitosis Modulators|mitosis modulators|mesh-ancestor
5693335|NCT03401827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693336|NCT03401827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5693337|NCT03401827|Antimetabolites|antimetabolites|mesh-ancestor
5693338|NCT03401827|Antiviral Agents|antiviral agents|mesh-ancestor
5693339|NCT03401827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5693340|NCT03401827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5693341|NCT03401827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5759781|NCT02980653|Megestrol|megestrol|mesh-list
5759782|NCT02980653|Megestrol Acetate|megestrol acetate|mesh-list
5759783|NCT02980653|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5759784|NCT02980653|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5759785|NCT02980653|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6490077|NCT00595985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490078|NCT00596037|Hormones|hormones|mesh-list
6490079|NCT00596037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6490080|NCT00596037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490081|NCT00596050|Lidocaine|lidocaine|mesh-list
6490082|NCT00596050|Fentanyl|fentanyl|mesh-list
6490083|NCT00596050|Midazolam|midazolam|mesh-list
6490084|NCT00596050|Ketamine|ketamine|mesh-list
6490085|NCT00596050|Etomidate|etomidate|mesh-list
6490086|NCT00596050|Anesthetics, Local|anesthetics, local|mesh-ancestor
6490087|NCT00596050|Anesthetics|anesthetics|mesh-ancestor
5693342|NCT03401827|Immunologic Factors|immunologic factors|mesh-ancestor
5693343|NCT03401827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693344|NCT03401749|Chlorhexidine|chlorhexidine|mesh-list
5693345|NCT03401749|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5693346|NCT03401749|Allantoin|allantoin|mesh-list
5693347|NCT03401749|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5693348|NCT03401749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5693349|NCT03401749|Disinfectants|disinfectants|mesh-ancestor
5693350|NCT03401749|Dermatologic Agents|dermatologic agents|mesh-ancestor
5693351|NCT03401736|Midazolam|midazolam|mesh-list
5693352|NCT03401736|Dexmedetomidine|dexmedetomidine|mesh-list
5693353|NCT03401736|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5693354|NCT03401736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5693355|NCT03401736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693356|NCT03401736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5693357|NCT03401736|Analgesics|analgesics|mesh-ancestor
5693358|NCT03401736|Sensory System Agents|sensory system agents|mesh-ancestor
5693359|NCT03401736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5693360|NCT03401736|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5693361|NCT03401736|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5693362|NCT03401736|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5693363|NCT03401736|Adrenergic Agents|adrenergic agents|mesh-ancestor
5693364|NCT03401736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5693365|NCT03401736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693366|NCT03401736|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5693367|NCT03401736|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5759786|NCT02980653|Contraceptive Agents|contraceptive agents|mesh-ancestor
5759787|NCT02980653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5759788|NCT02980653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759789|NCT02980653|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5759790|NCT02980653|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5759791|NCT02980653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5759792|NCT02980653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5759793|NCT02980653|Appetite Stimulants|appetite stimulants|mesh-ancestor
5759794|NCT02980653|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5759795|NCT02980562|Bisacodyl|bisacodyl|mesh-list
5759796|NCT02980562|Cathartics|cathartics|mesh-ancestor
5759797|NCT02980562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5759798|NCT02980562|Laxatives|laxatives|mesh-ancestor
5634522|NCT02974725|Trametinib|trametinib|mesh-list
5634523|NCT02974725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634524|NCT02974725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5634525|NCT02974725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5634526|NCT02974725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634527|NCT02971501|Bevacizumab|bevacizumab|mesh-list
5634528|NCT02971501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5634529|NCT02971501|Osimertinib|osimertinib|mesh-list
5634530|NCT02971501|Endothelial Growth Factors|endothelial growth factors|mesh-list
5634531|NCT02971501|Antibodies|antibodies|mesh-list
5634532|NCT02971501|Immunoglobulins|immunoglobulins|mesh-list
5634533|NCT02971501|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5634534|NCT02971501|Immunoglobulin G|immunoglobulin g|mesh-list
5634535|NCT02971501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634536|NCT02971501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5634537|NCT02971501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5634538|NCT02971501|Growth Substances|growth substances|mesh-ancestor
5634539|NCT02971501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5634540|NCT02971501|Growth Inhibitors|growth inhibitors|mesh-ancestor
5634541|NCT02971501|Immunologic Factors|immunologic factors|mesh-ancestor
5634542|NCT02971501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634543|NCT02971501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5634544|NCT02971501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5634545|NCT02970448|Temozolomide|temozolomide|mesh-list
5634546|NCT02970448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5634547|NCT02970448|Alkylating Agents|alkylating agents|mesh-ancestor
5634548|NCT02970448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634549|NCT02970448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634550|NCT02966093|Lenvatinib|lenvatinib|mesh-list
5634551|NCT02966093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634552|NCT02966093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5634553|NCT02966093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5634554|NCT02966093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634555|NCT02953093|Acarbose|acarbose|mesh-list
5634556|NCT02953093|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
5634557|NCT02953093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5634558|NCT02953093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634559|NCT02953093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5634560|NCT02953093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5634561|NCT02936752|Pembrolizumab|pembrolizumab|mesh-list
5634562|NCT02936752|Entinostat|entinostat|mesh-list
5634563|NCT02936752|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
5634564|NCT02936752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5634565|NCT02936752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634566|NCT02936752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5634567|NCT02936752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634568|NCT02933944|Pembrolizumab|pembrolizumab|mesh-list
5634569|NCT02933944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5634570|NCT02933944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634571|NCT02921997|Vaccines|vaccines|mesh-list
5634572|NCT02921997|Immunologic Factors|immunologic factors|mesh-ancestor
5634573|NCT02921997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5634574|NCT02890329|Ipilimumab|ipilimumab|mesh-list
5634575|NCT02890329|Decitabine|decitabine|mesh-list
5634576|NCT02890329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5634577|NCT02890329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634578|NCT02890329|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5634579|NCT02890329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634580|NCT02890329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5634581|NCT02890329|Antimetabolites|antimetabolites|mesh-ancestor
5634582|NCT02890329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5634583|NCT02879162|Durvalumab|durvalumab|mesh-list
5759799|NCT02980497|Ethanol|ethanol|mesh-list
5634584|NCT02879162|Tremelimumab|tremelimumab|mesh-list
5759800|NCT02980497|Listerine|listerine|mesh-list
5759801|NCT02980497|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
5759802|NCT02980497|Sodium Fluoride|sodium fluoride|mesh-list
5759803|NCT02980497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5759804|NCT02980497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5759805|NCT02980497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5634585|NCT02879162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5634586|NCT02879162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634587|NCT02822092|Risperidone|risperidone|mesh-list
5634588|NCT02822092|Aripiprazole|aripiprazole|mesh-list
5634589|NCT02822092|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6490088|NCT00596050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6490089|NCT00596050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490090|NCT00596050|Sensory System Agents|sensory system agents|mesh-ancestor
6490091|NCT00596050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6490092|NCT00596050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6490093|NCT00596050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6490094|NCT00596050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6490095|NCT00596050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6490096|NCT00596050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490097|NCT00596050|Analgesics|analgesics|mesh-ancestor
6490098|NCT00596050|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6490099|NCT00596050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5634590|NCT02822092|Serotonin Agents|serotonin agents|mesh-ancestor
5634591|NCT02822092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5634592|NCT02822092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634593|NCT02822092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5634594|NCT02822092|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5634595|NCT02822092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5634596|NCT02822092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5634597|NCT02822092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5634598|NCT02822092|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5634599|NCT02822092|Dopamine Agents|dopamine agents|mesh-ancestor
5634600|NCT02822092|Antidepressive Agents|antidepressive agents|mesh-ancestor
5634601|NCT02822092|Dopamine Agonists|dopamine agonists|mesh-ancestor
5634602|NCT02822092|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5634603|NCT02822092|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5634604|NCT02822092|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5634605|NCT02822092|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5634606|NCT02804074|Antihypertensive Agents|antihypertensive agents|mesh-list
5634607|NCT02717416|Hemostatics|hemostatics|mesh-list
5634608|NCT02717416|Coagulants|coagulants|mesh-ancestor
5634609|NCT02712905|Nivolumab|nivolumab|mesh-list
5634610|NCT02712905|Azacitidine|azacitidine|mesh-list
5634611|NCT02712905|Tretinoin|tretinoin|mesh-list
5634612|NCT02712905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5634613|NCT02712905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634614|NCT02712905|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5634615|NCT02712905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634616|NCT02712905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5634617|NCT02712905|Antimetabolites|antimetabolites|mesh-ancestor
5634618|NCT02712905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5634619|NCT02712905|Keratolytic Agents|keratolytic agents|mesh-ancestor
5634620|NCT02712905|Dermatologic Agents|dermatologic agents|mesh-ancestor
5634621|NCT02675946|Pembrolizumab|pembrolizumab|mesh-list
6490100|NCT00596050|Anesthetics, General|anesthetics, general|mesh-ancestor
6490101|NCT00596050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6490102|NCT00596050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6490103|NCT00596050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6490104|NCT00596050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6490105|NCT00596050|Narcotics|narcotics|mesh-ancestor
6490106|NCT00596050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6490107|NCT00596050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6490108|NCT00596050|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6490109|NCT00596050|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6490110|NCT00596050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6490111|NCT00596050|GABA Modulators|gaba modulators|mesh-ancestor
6490112|NCT00596050|GABA Agents|gaba agents|mesh-ancestor
5634622|NCT02675946|Cetuximab|cetuximab|mesh-list
5634623|NCT02675946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5634624|NCT02675946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634625|NCT02660827|Insulin|insulin|mesh-list
5634626|NCT02660827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5634627|NCT02660827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5634628|NCT02627963|Sorafenib|sorafenib|mesh-list
5634629|NCT02627963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634630|NCT02627963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5634631|NCT02627963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5634632|NCT02627963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634637|NCT02520063|Everolimus|everolimus|mesh-list
5634638|NCT02520063|Letrozole|letrozole|mesh-list
5634639|NCT02520063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634640|NCT02520063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5634641|NCT02520063|Immunologic Factors|immunologic factors|mesh-ancestor
5634642|NCT02520063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5634643|NCT02520063|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5634644|NCT02520063|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5634645|NCT02520063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5634646|NCT02520063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634647|NCT02520063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5634648|NCT02520063|Hormone Antagonists|hormone antagonists|mesh-ancestor
5634649|NCT02520063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5634650|NCT02496676|Magnesium Sulfate|magnesium sulfate|mesh-list
5634651|NCT02496676|Analgesics|analgesics|mesh-ancestor
5634652|NCT02496676|Sensory System Agents|sensory system agents|mesh-ancestor
5634653|NCT02496676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5634654|NCT02496676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5634655|NCT02496676|Anesthetics|anesthetics|mesh-ancestor
5634656|NCT02496676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5634657|NCT02496676|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5634658|NCT02496676|Anticonvulsants|anticonvulsants|mesh-ancestor
5759806|NCT02980497|Cariostatic Agents|cariostatic agents|mesh-ancestor
5759807|NCT02980497|Protective Agents|protective agents|mesh-ancestor
5759808|NCT02980510|Leucovorin|leucovorin|mesh-list
5759809|NCT02980510|Folic Acid|folic acid|mesh-list
5759810|NCT02980510|Oxaliplatin|oxaliplatin|mesh-list
5759811|NCT02980510|Irinotecan|irinotecan|mesh-list
5759812|NCT02980510|Panitumumab|panitumumab|mesh-list
5759813|NCT02980510|Fluorouracil|fluorouracil|mesh-list
5759814|NCT02980510|Levoleucovorin|levoleucovorin|mesh-list
5759815|NCT02980510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5759816|NCT02980510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5759817|NCT02980510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5759818|NCT02980510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5759819|NCT02980510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759820|NCT02980510|Antidotes|antidotes|mesh-ancestor
5759821|NCT02980510|Protective Agents|protective agents|mesh-ancestor
5759822|NCT02980510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759823|NCT02980510|Vitamin B Complex|vitamin b complex|mesh-ancestor
5759824|NCT02980510|Vitamins|vitamins|mesh-ancestor
5759825|NCT02980510|Micronutrients|micronutrients|mesh-ancestor
5634659|NCT02496676|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5634660|NCT02496676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5634661|NCT02496676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634662|NCT02496676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5634663|NCT02496676|Tocolytic Agents|tocolytic agents|mesh-ancestor
5634664|NCT02496676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5634665|NCT02496663|Osimertinib|osimertinib|mesh-list
5634666|NCT02496663|Necitumumab|necitumumab|mesh-list
5634667|NCT02496663|Cetuximab|cetuximab|mesh-list
5634668|NCT02496663|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5634669|NCT02496663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634670|NCT02496663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634671|NCT02496663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5759826|NCT02980510|Hematinics|hematinics|mesh-ancestor
6490113|NCT00596063|Insulin|insulin|mesh-list
6490114|NCT00596063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6490115|NCT00596063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490116|NCT00596115|Pramipexole|pramipexole|mesh-list
6490117|NCT00596115|Antioxidants|antioxidants|mesh-ancestor
6490118|NCT00596115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209138|NCT02141620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6209139|NCT02141633|Fluticasone|fluticasone|mesh-list
6209140|NCT02141633|Xhance|xhance|mesh-list
6209141|NCT02141633|Albuterol|albuterol|mesh-list
6209142|NCT02141633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6209143|NCT02141633|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5759827|NCT02980510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6209144|NCT02141633|Autonomic Agents|autonomic agents|mesh-ancestor
6673265|NCT01561404|Immunologic Factors|immunologic factors|mesh-ancestor
5634672|NCT02496663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5634673|NCT02496663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5634674|NCT02496663|Immunologic Factors|immunologic factors|mesh-ancestor
5634675|NCT02496663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5634676|NCT02437370|Gemcitabine|gemcitabine|mesh-list
5634677|NCT02437370|Docetaxel|docetaxel|mesh-list
5634678|NCT02437370|Pembrolizumab|pembrolizumab|mesh-list
5634679|NCT02437370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5634680|NCT02437370|Antimetabolites|antimetabolites|mesh-ancestor
5634681|NCT02437370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634682|NCT02437370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5759828|NCT02980510|Antimetabolites|antimetabolites|mesh-ancestor
5759829|NCT02980510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5759830|NCT02980510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5634683|NCT02437370|Antiviral Agents|antiviral agents|mesh-ancestor
5634684|NCT02437370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5634685|NCT02437370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5634686|NCT02437370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5634687|NCT02437370|Immunologic Factors|immunologic factors|mesh-ancestor
5634688|NCT02437370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5634689|NCT02437370|Tubulin Modulators|tubulin modulators|mesh-ancestor
5634690|NCT02437370|Antimitotic Agents|antimitotic agents|mesh-ancestor
5634691|NCT02437370|Mitosis Modulators|mitosis modulators|mesh-ancestor
5634692|NCT02437370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5634693|NCT02437110|Ritonavir|ritonavir|mesh-list
5634694|NCT02437110|Darunavir|darunavir|mesh-list
5634695|NCT02437110|Tenofovir|tenofovir|mesh-list
5634696|NCT02437110|Dolutegravir|dolutegravir|mesh-list
5634697|NCT02437110|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5634698|NCT02437110|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5634699|NCT02437110|Protease Inhibitors|protease inhibitors|mesh-ancestor
5634700|NCT02437110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5634701|NCT02437110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634702|NCT02437110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5634703|NCT02437110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5759831|NCT02980510|Immunologic Factors|immunologic factors|mesh-ancestor
5759832|NCT02980458|Deferiprone|deferiprone|mesh-list
5759833|NCT02980458|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5759834|NCT02980458|Chelating Agents|chelating agents|mesh-ancestor
5759835|NCT02980458|Sequestering Agents|sequestering agents|mesh-ancestor
5759836|NCT02980458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759837|NCT02980250|Domperidone|domperidone|mesh-list
5759838|NCT02980250|Antiemetics|antiemetics|mesh-ancestor
5759839|NCT02980250|Autonomic Agents|autonomic agents|mesh-ancestor
5759840|NCT02980250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5759841|NCT02980250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759842|NCT02980250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5759843|NCT02980250|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5759844|NCT02980250|Dopamine Agents|dopamine agents|mesh-ancestor
5759845|NCT02980250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5759846|NCT02980250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759847|NCT02980094|Vitamins|vitamins|mesh-list
5759848|NCT02980094|Vitamin E|vitamin e|mesh-list
5759849|NCT02980094|Tocopherols|tocopherols|mesh-list
5759850|NCT02980094|Tocotrienols|tocotrienols|mesh-list
5759851|NCT02980094|alpha-Tocopherol|alpha-tocopherol|mesh-list
6209145|NCT02141633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6490119|NCT00596115|Protective Agents|protective agents|mesh-ancestor
6490120|NCT00596115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490121|NCT00596115|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5634704|NCT02437110|Antiviral Agents|antiviral agents|mesh-ancestor
5634705|NCT02437110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5634706|NCT02437110|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5634707|NCT02437110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5634708|NCT02437110|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5634709|NCT02437110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5634710|NCT02437110|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6490122|NCT00596115|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6490123|NCT00596115|Dopamine Agonists|dopamine agonists|mesh-ancestor
6490124|NCT00596115|Dopamine Agents|dopamine agents|mesh-ancestor
6490125|NCT00596115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6490126|NCT00596128|Insulin|insulin|mesh-list
5759852|NCT02980094|Selenium|selenium|mesh-list
5759853|NCT02980094|Antioxidants|antioxidants|mesh-list
5759854|NCT02980094|Micronutrients|micronutrients|mesh-ancestor
5759855|NCT02980094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490127|NCT00596128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5634711|NCT02437110|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5634712|NCT02425644|Teriflunomide|teriflunomide|mesh-list
5634713|NCT02425644|Ponesimod|ponesimod|mesh-list
5634714|NCT02425644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5634715|NCT02425644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5634716|NCT02425644|Analgesics|analgesics|mesh-ancestor
5634717|NCT02425644|Sensory System Agents|sensory system agents|mesh-ancestor
5634718|NCT02425644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5634719|NCT02425644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5634720|NCT02425644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5634721|NCT02425644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5634722|NCT02425644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5634723|NCT02425644|Immunologic Factors|immunologic factors|mesh-ancestor
5634724|NCT02425644|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5634725|NCT02425644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634726|NCT02415153|Pomalidomide|pomalidomide|mesh-list
5634727|NCT02415153|Immunologic Factors|immunologic factors|mesh-ancestor
5634728|NCT02415153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5634729|NCT02415153|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5759856|NCT02980094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759857|NCT02980094|Protective Agents|protective agents|mesh-ancestor
5759858|NCT02980094|Trace Elements|trace elements|mesh-ancestor
5759859|NCT02980276|Metformin|metformin|mesh-list
5759860|NCT02980276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5759861|NCT02980276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759862|NCT02979886|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5759863|NCT02979886|Menotropins|menotropins|mesh-list
5759864|NCT02979886|Luteolytic Agents|luteolytic agents|mesh-ancestor
5759865|NCT02979886|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5759866|NCT02979886|Contraceptive Agents|contraceptive agents|mesh-ancestor
5759867|NCT02979886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5759868|NCT02979886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759869|NCT02979886|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5759870|NCT02979886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5759871|NCT02979886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5759872|NCT02979886|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5759873|NCT02979886|Fertility Agents|fertility agents|mesh-ancestor
5759874|NCT02980016|Isoniazid|isoniazid|mesh-list
5759875|NCT02980016|Rifapentine|rifapentine|mesh-list
5759876|NCT02980016|Rifampin|rifampin|mesh-list
5759877|NCT02980016|Antitubercular Agents|antitubercular agents|mesh-ancestor
5759878|NCT02980016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5759879|NCT02980016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5759880|NCT02980016|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5759881|NCT02980016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5759882|NCT02980016|Antimetabolites|antimetabolites|mesh-ancestor
5759883|NCT02980016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759884|NCT02980016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5759885|NCT02980016|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5759886|NCT02980016|Leprostatic Agents|leprostatic agents|mesh-ancestor
5759887|NCT02980016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5634730|NCT02415153|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5634731|NCT02415153|Growth Substances|growth substances|mesh-ancestor
5634732|NCT02415153|Growth Inhibitors|growth inhibitors|mesh-ancestor
5759888|NCT02980016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5759889|NCT02980016|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5759890|NCT02980016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5759891|NCT02980016|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5759892|NCT02980016|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5759893|NCT02980016|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5759894|NCT02980016|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5759895|NCT02979665|Ranibizumab|ranibizumab|mesh-list
5759896|NCT02979665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5759897|NCT02979665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5759898|NCT02979665|Growth Substances|growth substances|mesh-ancestor
5759899|NCT02979665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759900|NCT02979665|Growth Inhibitors|growth inhibitors|mesh-ancestor
5759901|NCT02979665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5895378|NCT05228925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895379|NCT05228925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5895380|NCT05228743|Paclitaxel|paclitaxel|mesh-list
5895381|NCT05228743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5895382|NCT05228743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5895383|NCT05228743|Tubulin Modulators|tubulin modulators|mesh-ancestor
5895384|NCT05228743|Antimitotic Agents|antimitotic agents|mesh-ancestor
5634733|NCT02415153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634734|NCT02395614|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5634735|NCT02395614|Gentamicins|gentamicins|mesh-list
5759902|NCT02979704|Atorvastatin|atorvastatin|mesh-list
5759903|NCT02979704|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5759904|NCT02979704|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5759905|NCT02979704|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5759906|NCT02979704|Antimetabolites|antimetabolites|mesh-ancestor
5759907|NCT02979704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759908|NCT02979704|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5759909|NCT02979704|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5759910|NCT02979704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5759911|NCT02979548|Ondansetron|ondansetron|mesh-list
5759912|NCT02979548|Aprepitant|aprepitant|mesh-list
5759913|NCT02979548|Metoclopramide|metoclopramide|mesh-list
5759914|NCT02979548|Antiemetics|antiemetics|mesh-ancestor
5759915|NCT02979548|Autonomic Agents|autonomic agents|mesh-ancestor
5759916|NCT02979548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5759917|NCT02979548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759918|NCT02979548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5759919|NCT02979548|Antipruritics|antipruritics|mesh-ancestor
5759920|NCT02979548|Dermatologic Agents|dermatologic agents|mesh-ancestor
5759921|NCT02979548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5759922|NCT02979548|Serotonin Agents|serotonin agents|mesh-ancestor
5759923|NCT02979548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5759924|NCT02979548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759925|NCT02979548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5759926|NCT02979548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5759927|NCT02979548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5759928|NCT02979548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5759929|NCT02979548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5759930|NCT02979548|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5759931|NCT02979548|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5759932|NCT02979548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5759933|NCT02979548|Dopamine Agents|dopamine agents|mesh-ancestor
5759934|NCT02979561|Warfarin|warfarin|mesh-list
5759935|NCT02979561|Dabigatran|dabigatran|mesh-list
5759936|NCT02979561|Anticoagulants|anticoagulants|mesh-ancestor
5634736|NCT02395614|Cefazolin|cefazolin|mesh-list
5634737|NCT02395614|Bacitracin|bacitracin|mesh-list
5634738|NCT02395614|Chlorhexidine|chlorhexidine|mesh-list
5634739|NCT02395614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5634740|NCT02395614|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5634741|NCT02395614|Disinfectants|disinfectants|mesh-ancestor
5634742|NCT02395614|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5634743|NCT02395614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5634744|NCT02395614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634745|NCT02381561|Ropidoxuridine|ropidoxuridine|mesh-list
5634746|NCT02381561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634747|NCT02379416|Paclitaxel|paclitaxel|mesh-list
5634748|NCT02379416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5634749|NCT02379416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634750|NCT02379416|Tubulin Modulators|tubulin modulators|mesh-ancestor
5759937|NCT02979561|Antithrombins|antithrombins|mesh-ancestor
5759938|NCT02979561|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5759939|NCT02979561|Protease Inhibitors|protease inhibitors|mesh-ancestor
5759940|NCT02979561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5759941|NCT02979561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759942|NCT02979405|Phenylephrine|phenylephrine|mesh-list
5759943|NCT02979405|Oxymetazoline|oxymetazoline|mesh-list
5759944|NCT02979405|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5759945|NCT02979405|Mydriatics|mydriatics|mesh-ancestor
5634751|NCT02379416|Antimitotic Agents|antimitotic agents|mesh-ancestor
5634752|NCT02379416|Mitosis Modulators|mitosis modulators|mesh-ancestor
5634753|NCT02379416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634754|NCT02345265|Olaparib|olaparib|mesh-list
5634755|NCT02345265|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
5634756|NCT02345265|Cediranib|cediranib|mesh-list
5634757|NCT02345265|Maleic acid|maleic acid|mesh-list
5634758|NCT02345265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5634759|NCT02345265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634760|NCT02345265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634761|NCT02345265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5634762|NCT02340221|Fulvestrant|fulvestrant|mesh-list
5634763|NCT02340221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5634764|NCT02340221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5759946|NCT02979405|Autonomic Agents|autonomic agents|mesh-ancestor
5759947|NCT02979405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5634765|NCT02340221|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5634766|NCT02340221|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5634767|NCT02340221|Hormone Antagonists|hormone antagonists|mesh-ancestor
5634768|NCT02340221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5759948|NCT02979405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759949|NCT02979405|Sympathomimetics|sympathomimetics|mesh-ancestor
5759950|NCT02979405|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5759951|NCT02979405|Nasal Decongestants|nasal decongestants|mesh-ancestor
5759952|NCT02979405|Respiratory System Agents|respiratory system agents|mesh-ancestor
5759953|NCT02979405|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5759954|NCT02979405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5759955|NCT02979405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5759956|NCT02979405|Adrenergic Agents|adrenergic agents|mesh-ancestor
5759957|NCT02979405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5759958|NCT02979405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759959|NCT02979405|Protective Agents|protective agents|mesh-ancestor
5759960|NCT02979392|Paclitaxel|paclitaxel|mesh-list
5759961|NCT02979392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5759962|NCT02979392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5759963|NCT02979392|Tubulin Modulators|tubulin modulators|mesh-ancestor
5759964|NCT02979392|Antimitotic Agents|antimitotic agents|mesh-ancestor
5759965|NCT02979392|Mitosis Modulators|mitosis modulators|mesh-ancestor
5759966|NCT02979392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759967|NCT02979327|Adderall|adderall|mesh-list
5759968|NCT02979327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5759969|NCT02979327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759970|NCT02979223|Ascorbic Acid|ascorbic acid|mesh-list
5759971|NCT02979223|Picosulfate sodium|picosulfate sodium|mesh-list
5759972|NCT02979223|Magnesium citrate|magnesium citrate|mesh-list
5759973|NCT02979223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759974|NCT02979223|Antioxidants|antioxidants|mesh-ancestor
5759975|NCT02979223|Protective Agents|protective agents|mesh-ancestor
5759976|NCT02979223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5634769|NCT02340221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5634770|NCT02317874|Paclitaxel|paclitaxel|mesh-list
5634771|NCT02317874|Carboplatin|carboplatin|mesh-list
5634772|NCT02317874|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5634773|NCT02317874|Talazoparib|talazoparib|mesh-list
5634774|NCT02317874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5634775|NCT02317874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634776|NCT02317874|Tubulin Modulators|tubulin modulators|mesh-ancestor
5634777|NCT02317874|Antimitotic Agents|antimitotic agents|mesh-ancestor
5634778|NCT02317874|Mitosis Modulators|mitosis modulators|mesh-ancestor
5634779|NCT02317874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634780|NCT02317874|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5634781|NCT02317874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5634782|NCT02311920|Nivolumab|nivolumab|mesh-list
5634783|NCT02311920|Ipilimumab|ipilimumab|mesh-list
5634784|NCT02311920|Temozolomide|temozolomide|mesh-list
5634785|NCT02311920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5634786|NCT02311920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634787|NCT02311920|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5634788|NCT02311920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634789|NCT02311920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5634790|NCT02311920|Alkylating Agents|alkylating agents|mesh-ancestor
5634791|NCT02270957|Abatacept|abatacept|mesh-list
5634792|NCT02270957|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5634793|NCT02270957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634794|NCT02270957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634795|NCT02270957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5634796|NCT02270957|Immunologic Factors|immunologic factors|mesh-ancestor
5634797|NCT02270957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5634798|NCT02270957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5634799|NCT02237183|Iloprost|iloprost|mesh-list
5634800|NCT02237183|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5634801|NCT02237183|Vasodilator Agents|vasodilator agents|mesh-ancestor
5634802|NCT02204085|Decitabine|decitabine|mesh-list
5634803|NCT02204085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5634804|NCT02204085|Antimetabolites|antimetabolites|mesh-ancestor
5634805|NCT02204085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5759977|NCT02979223|Vitamins|vitamins|mesh-ancestor
5759978|NCT02979223|Micronutrients|micronutrients|mesh-ancestor
5759979|NCT02979223|Cathartics|cathartics|mesh-ancestor
5759980|NCT02979223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5759981|NCT02979093|Oxytocin|oxytocin|mesh-list
5634806|NCT02204085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634807|NCT02204085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5634808|NCT02134925|Poly ICLC|poly iclc|mesh-list
5634809|NCT02134925|Interferon Inducers|interferon inducers|mesh-ancestor
6209146|NCT02141633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209147|NCT02141633|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6209148|NCT02141633|Respiratory System Agents|respiratory system agents|mesh-ancestor
6209149|NCT02141633|Dermatologic Agents|dermatologic agents|mesh-ancestor
5759982|NCT02979093|Oxytocics|oxytocics|mesh-ancestor
5759983|NCT02979093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5759984|NCT02979093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209150|NCT02141633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6209151|NCT02141633|Tocolytic Agents|tocolytic agents|mesh-ancestor
6209152|NCT02141633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6209153|NCT02141633|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6209154|NCT02141633|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6209155|NCT02141633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6209156|NCT02141633|Adrenergic Agents|adrenergic agents|mesh-ancestor
5634810|NCT02134925|Immunologic Factors|immunologic factors|mesh-ancestor
5634811|NCT02134925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5634812|NCT02133573|Progesterone|progesterone|mesh-list
5634813|NCT02133573|Progestins|progestins|mesh-ancestor
5634814|NCT02133573|Hormones|hormones|mesh-ancestor
5693368|NCT03401736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5693369|NCT03401736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5693370|NCT03401736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5693371|NCT03401736|Anesthetics, General|anesthetics, general|mesh-ancestor
5693372|NCT03401736|Anesthetics|anesthetics|mesh-ancestor
5693373|NCT03401736|GABA Modulators|gaba modulators|mesh-ancestor
5693374|NCT03401736|GABA Agents|gaba agents|mesh-ancestor
5693375|NCT03401619|Vitamin D|vitamin d|mesh-list
5693376|NCT03401619|Calcitonin|calcitonin|mesh-list
5693377|NCT03401619|Salmon calcitonin|salmon calcitonin|mesh-list
5693378|NCT03401619|Diphosphonates|diphosphonates|mesh-list
5693379|NCT03401619|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
5693380|NCT03401619|Katacalcin|katacalcin|mesh-list
5693381|NCT03401619|Vitamins|vitamins|mesh-ancestor
5693382|NCT03401619|Micronutrients|micronutrients|mesh-ancestor
5693383|NCT03401619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693384|NCT03401619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5693385|NCT03401619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5693386|NCT03401619|Vasodilator Agents|vasodilator agents|mesh-ancestor
5693387|NCT03401606|Dexmedetomidine|dexmedetomidine|mesh-list
5693388|NCT03401606|Remifentanil|remifentanil|mesh-list
5693389|NCT03401606|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5693390|NCT03401606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5693391|NCT03401606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693392|NCT03401606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5693393|NCT03401606|Analgesics|analgesics|mesh-ancestor
5693394|NCT03401606|Sensory System Agents|sensory system agents|mesh-ancestor
5693395|NCT03401606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5693396|NCT03401606|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5693397|NCT03401606|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5693398|NCT03401606|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5693399|NCT03401606|Adrenergic Agents|adrenergic agents|mesh-ancestor
5693400|NCT03401606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5693401|NCT03401606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693402|NCT03401606|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5693403|NCT03401606|Narcotics|narcotics|mesh-ancestor
5693404|NCT03401593|Fentanyl|fentanyl|mesh-list
5693405|NCT03401593|Midazolam|midazolam|mesh-list
5693406|NCT03401593|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5693407|NCT03401593|Narcotics|narcotics|mesh-ancestor
5693408|NCT03401593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5693409|NCT03401593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693410|NCT03401593|Analgesics|analgesics|mesh-ancestor
5693411|NCT03401593|Sensory System Agents|sensory system agents|mesh-ancestor
5693412|NCT03401593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5693413|NCT03401593|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5693414|NCT03401593|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5693415|NCT03401593|Anesthetics, General|anesthetics, general|mesh-ancestor
5693416|NCT03401593|Anesthetics|anesthetics|mesh-ancestor
5693417|NCT03401593|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5693418|NCT03401593|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5693419|NCT03401593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5693420|NCT03401593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5693421|NCT03401593|GABA Modulators|gaba modulators|mesh-ancestor
6209157|NCT02141633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6209158|NCT02141633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634815|NCT02133573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5634816|NCT02133573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759985|NCT02978976|Betamethasone|betamethasone|mesh-list
5759986|NCT02978976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5759987|NCT02978976|Glucocorticoids|glucocorticoids|mesh-ancestor
5759988|NCT02978976|Hormones|hormones|mesh-ancestor
5759989|NCT02978976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5759990|NCT02978976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759991|NCT02978976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5759992|NCT02978976|Respiratory System Agents|respiratory system agents|mesh-ancestor
5634817|NCT02101853|Calcium, Dietary|calcium, dietary|mesh-list
5634818|NCT02101853|Leucovorin|leucovorin|mesh-list
5634819|NCT02101853|Folic Acid|folic acid|mesh-list
5634820|NCT02101853|Cytarabine|cytarabine|mesh-list
5634821|NCT02101853|Dexamethasone|dexamethasone|mesh-list
5634822|NCT02101853|Dexamethasone acetate|dexamethasone acetate|mesh-list
5634823|NCT02101853|Hydrocortisone|hydrocortisone|mesh-list
5634824|NCT02101853|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
5634825|NCT02101853|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
5634826|NCT02101853|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
5634827|NCT02101853|Cyclophosphamide|cyclophosphamide|mesh-list
5634828|NCT02101853|Methotrexate|methotrexate|mesh-list
5634829|NCT02101853|Etoposide|etoposide|mesh-list
5634830|NCT02101853|Vincristine|vincristine|mesh-list
5634831|NCT02101853|Etoposide phosphate|etoposide phosphate|mesh-list
5634832|NCT02101853|Asparaginase|asparaginase|mesh-list
5634833|NCT02101853|Mercaptopurine|mercaptopurine|mesh-list
5634834|NCT02101853|Mitoxantrone|mitoxantrone|mesh-list
5634835|NCT02101853|Podophyllotoxin|podophyllotoxin|mesh-list
5634836|NCT02101853|Pegaspargase|pegaspargase|mesh-list
5634837|NCT02101853|Thioguanine|thioguanine|mesh-list
5634838|NCT02101853|Blinatumomab|blinatumomab|mesh-list
5634839|NCT02101853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5634840|NCT02101853|Muromonab-CD3|muromonab-cd3|mesh-list
5634841|NCT02101853|Antibodies|antibodies|mesh-list
5634842|NCT02101853|Immunoglobulins|immunoglobulins|mesh-list
5634843|NCT02101853|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5634844|NCT02101853|Antibodies, Bispecific|antibodies, bispecific|mesh-list
5634845|NCT02101853|BB 1101|bb 1101|mesh-list
5634846|NCT02101853|Calcium|calcium|mesh-list
5634847|NCT02101853|2-Aminopurine|2-aminopurine|mesh-list
5634848|NCT02101853|Levoleucovorin|levoleucovorin|mesh-list
5634849|NCT02101853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5634850|NCT02101853|Immunologic Factors|immunologic factors|mesh-ancestor
5634851|NCT02101853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5634852|NCT02101853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5634853|NCT02101853|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5634854|NCT02101853|Alkylating Agents|alkylating agents|mesh-ancestor
5634855|NCT02101853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634856|NCT02101853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634857|NCT02101853|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5759993|NCT02979132|Iron|iron|mesh-list
5759994|NCT02979132|Trace Elements|trace elements|mesh-ancestor
5759995|NCT02979132|Micronutrients|micronutrients|mesh-ancestor
5759996|NCT02979132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5759997|NCT02978755|Paclitaxel|paclitaxel|mesh-list
5759998|NCT02978755|Carboplatin|carboplatin|mesh-list
5759999|NCT02978755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5760000|NCT02978755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634858|NCT02101853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5634859|NCT02101853|Antiemetics|antiemetics|mesh-ancestor
5634860|NCT02101853|Autonomic Agents|autonomic agents|mesh-ancestor
5634861|NCT02101853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5634862|NCT02101853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5634863|NCT02101853|Glucocorticoids|glucocorticoids|mesh-ancestor
5634864|NCT02101853|Hormones|hormones|mesh-ancestor
5634865|NCT02101853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5634866|NCT02101853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5634867|NCT02101853|Protease Inhibitors|protease inhibitors|mesh-ancestor
5634868|NCT02101853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5760001|NCT02978755|Tubulin Modulators|tubulin modulators|mesh-ancestor
5760002|NCT02978755|Antimitotic Agents|antimitotic agents|mesh-ancestor
5634869|NCT02101853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5634870|NCT02101853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5634871|NCT02101853|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5634872|NCT02101853|Abortifacient Agents|abortifacient agents|mesh-ancestor
5760003|NCT02978755|Mitosis Modulators|mitosis modulators|mesh-ancestor
5634873|NCT02101853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5634874|NCT02101853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5634875|NCT02101853|Antimetabolites|antimetabolites|mesh-ancestor
5634876|NCT02101853|Dermatologic Agents|dermatologic agents|mesh-ancestor
5634877|NCT02101853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5634878|NCT02101853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5634879|NCT02101853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5760004|NCT02978755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760005|NCT02978612|Capecitabine|capecitabine|mesh-list
5760006|NCT02978612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5760007|NCT02978612|Antimetabolites|antimetabolites|mesh-ancestor
5760008|NCT02978612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760009|NCT02978612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5760010|NCT02978456|Sirolimus|sirolimus|mesh-list
5760011|NCT02978456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5760012|NCT02978456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5760013|NCT02978456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5760014|NCT02978456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5760015|NCT02978456|Antifungal Agents|antifungal agents|mesh-ancestor
5760016|NCT02978456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5760017|NCT02978456|Immunologic Factors|immunologic factors|mesh-ancestor
5634880|NCT02101853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5634881|NCT02101853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5634882|NCT02101853|Antiviral Agents|antiviral agents|mesh-ancestor
5634883|NCT02101853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5634884|NCT02101853|Antidotes|antidotes|mesh-ancestor
5634885|NCT02101853|Protective Agents|protective agents|mesh-ancestor
5634886|NCT02101853|Vitamin B Complex|vitamin b complex|mesh-ancestor
5634887|NCT02101853|Vitamins|vitamins|mesh-ancestor
5634888|NCT02101853|Micronutrients|micronutrients|mesh-ancestor
5634889|NCT02101853|Tubulin Modulators|tubulin modulators|mesh-ancestor
5634890|NCT02101853|Antimitotic Agents|antimitotic agents|mesh-ancestor
5634891|NCT02101853|Mitosis Modulators|mitosis modulators|mesh-ancestor
5634892|NCT02101853|Hematinics|hematinics|mesh-ancestor
5634893|NCT02101853|Analgesics|analgesics|mesh-ancestor
5634894|NCT02101853|Sensory System Agents|sensory system agents|mesh-ancestor
5634895|NCT02101853|Keratolytic Agents|keratolytic agents|mesh-ancestor
5634896|NCT02054104|Celecoxib|celecoxib|mesh-list
5634897|NCT02054104|Cyclophosphamide|cyclophosphamide|mesh-list
5634898|NCT02054104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5634899|NCT02054104|Immunologic Factors|immunologic factors|mesh-ancestor
5634900|NCT02054104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5634901|NCT02054104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5634902|NCT02054104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5634903|NCT02054104|Alkylating Agents|alkylating agents|mesh-ancestor
5634904|NCT02054104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634905|NCT02054104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634906|NCT02054104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5634907|NCT02054104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5634908|NCT02054104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5634909|NCT02054104|Analgesics|analgesics|mesh-ancestor
5634910|NCT02054104|Sensory System Agents|sensory system agents|mesh-ancestor
5634911|NCT02054104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5634912|NCT02054104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5634913|NCT02054104|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5634914|NCT02054104|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5634915|NCT02054104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5634916|NCT01954979|Abatacept|abatacept|mesh-list
5634917|NCT01954979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5634918|NCT01954979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634919|NCT01954979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634920|NCT01954979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5634921|NCT01954979|Immunologic Factors|immunologic factors|mesh-ancestor
5634922|NCT01954979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5634923|NCT01954979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5634924|NCT01899144|Albuterol|albuterol|mesh-list
5634925|NCT01899144|Procaterol|procaterol|mesh-list
5634926|NCT01899144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5634927|NCT01899144|Autonomic Agents|autonomic agents|mesh-ancestor
5634928|NCT01899144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5634929|NCT01899144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5634930|NCT01899144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5634931|NCT01899144|Respiratory System Agents|respiratory system agents|mesh-ancestor
5634932|NCT01899144|Tocolytic Agents|tocolytic agents|mesh-ancestor
5634933|NCT01899144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5634934|NCT01899144|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5760018|NCT02978456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760019|NCT02978482|Durvalumab|durvalumab|mesh-list
5760020|NCT02978482|Tremelimumab|tremelimumab|mesh-list
5760021|NCT02978482|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5634935|NCT01899144|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5634936|NCT01899144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5634937|NCT01899144|Adrenergic Agents|adrenergic agents|mesh-ancestor
5634938|NCT01899144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5634939|NCT01899144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634940|NCT01899144|Sympathomimetics|sympathomimetics|mesh-ancestor
5634941|NCT01853631|Cyclophosphamide|cyclophosphamide|mesh-list
5634942|NCT01853631|Fludarabine|fludarabine|mesh-list
5634943|NCT01853631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5634944|NCT01853631|Immunologic Factors|immunologic factors|mesh-ancestor
5634945|NCT01853631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5634946|NCT01853631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5634947|NCT01853631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5634948|NCT01853631|Alkylating Agents|alkylating agents|mesh-ancestor
5634949|NCT01853631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634950|NCT01853631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634951|NCT01853631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5634952|NCT01793610|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
5634953|NCT01793610|Hallucinogens|hallucinogens|mesh-ancestor
5634954|NCT01793610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5634955|NCT01793610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5634956|NCT01793610|Serotonin Agents|serotonin agents|mesh-ancestor
5634957|NCT01793610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5693422|NCT03401593|GABA Agents|gaba agents|mesh-ancestor
5693423|NCT03401593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5693424|NCT03401593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693425|NCT03401541|Vitamin D|vitamin d|mesh-list
5693426|NCT03401541|Calcifediol|calcifediol|mesh-list
5693427|NCT03401541|Ergocalciferols|ergocalciferols|mesh-list
5693428|NCT03401541|Vitamins|vitamins|mesh-ancestor
5693429|NCT03401541|Micronutrients|micronutrients|mesh-ancestor
5693430|NCT03401541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693431|NCT03401541|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5693432|NCT03401541|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5693433|NCT03401515|Propranolol|propranolol|mesh-list
5693434|NCT03401515|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5693435|NCT03401515|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5693436|NCT03401515|Adrenergic Agents|adrenergic agents|mesh-ancestor
5693437|NCT03401515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5693438|NCT03401515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693439|NCT03401515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693440|NCT03401515|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5693441|NCT03401515|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5693442|NCT03401515|Vasodilator Agents|vasodilator agents|mesh-ancestor
5693443|NCT03401502|Ranolazine|ranolazine|mesh-list
5693444|NCT03401502|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5693445|NCT03401502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5693446|NCT03401502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693447|NCT03401476|Morphine|morphine|mesh-list
5693448|NCT03401476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5693449|NCT03401476|Narcotics|narcotics|mesh-ancestor
5693450|NCT03401476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5693451|NCT03401476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693452|NCT03401476|Analgesics|analgesics|mesh-ancestor
5693453|NCT03401476|Sensory System Agents|sensory system agents|mesh-ancestor
5693454|NCT03401476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5693455|NCT03401372|Doxycycline|doxycycline|mesh-list
5693456|NCT03401372|Dexamethasone|dexamethasone|mesh-list
5693457|NCT03401372|Cyclophosphamide|cyclophosphamide|mesh-list
5693458|NCT03401372|Bortezomib|bortezomib|mesh-list
5693459|NCT03401372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5693460|NCT03401372|Immunologic Factors|immunologic factors|mesh-ancestor
5693461|NCT03401372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693462|NCT03401372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5693463|NCT03401372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5693464|NCT03401372|Alkylating Agents|alkylating agents|mesh-ancestor
5693465|NCT03401372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693466|NCT03401372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5693467|NCT03401372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5693468|NCT03401372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5634958|NCT01793610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634959|NCT01793610|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5634960|NCT01793610|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5634961|NCT01793610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5634962|NCT01793610|Adrenergic Agents|adrenergic agents|mesh-ancestor
5634963|NCT01724879|Dasatinib|dasatinib|mesh-list
5634964|NCT01724879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634965|NCT01724879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5634966|NCT01724879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5634967|NCT01724879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760022|NCT02978482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5760023|NCT02978482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5760024|NCT02978482|Immunologic Factors|immunologic factors|mesh-ancestor
5760025|NCT02978482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760026|NCT02978313|Cetuximab|cetuximab|mesh-list
5760027|NCT02978313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5760028|NCT02978313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5760029|NCT02978391|Epinephrine|epinephrine|mesh-list
5760030|NCT02978391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5760031|NCT02978391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5760032|NCT02978391|Adrenergic Agents|adrenergic agents|mesh-ancestor
5760033|NCT02978391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5760034|NCT02978391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760035|NCT02978391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760036|NCT02978391|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5760037|NCT02978391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5760038|NCT02978391|Autonomic Agents|autonomic agents|mesh-ancestor
5760039|NCT02978391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5760040|NCT02978391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5760041|NCT02978391|Respiratory System Agents|respiratory system agents|mesh-ancestor
5760042|NCT02978391|Mydriatics|mydriatics|mesh-ancestor
5760043|NCT02978391|Sympathomimetics|sympathomimetics|mesh-ancestor
5760044|NCT02978391|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5760045|NCT02978404|Nivolumab|nivolumab|mesh-list
5760046|NCT02978404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5760047|NCT02978404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5760048|NCT02978404|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5760049|NCT02978404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760050|NCT02978495|Paclitaxel|paclitaxel|mesh-list
5760051|NCT02978495|Cyclophosphamide|cyclophosphamide|mesh-list
5760052|NCT02978495|Carboplatin|carboplatin|mesh-list
5760053|NCT02978495|Doxorubicin|doxorubicin|mesh-list
5760054|NCT02978495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5760055|NCT02978495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5760056|NCT02978495|Tubulin Modulators|tubulin modulators|mesh-ancestor
5760057|NCT02978495|Antimitotic Agents|antimitotic agents|mesh-ancestor
5760058|NCT02978495|Mitosis Modulators|mitosis modulators|mesh-ancestor
5760059|NCT02978495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760060|NCT02978495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5760061|NCT02978495|Immunologic Factors|immunologic factors|mesh-ancestor
5760062|NCT02978495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760063|NCT02978495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5760064|NCT02978495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5760065|NCT02978495|Alkylating Agents|alkylating agents|mesh-ancestor
5760066|NCT02978495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5760067|NCT02978495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5634968|NCT01631617|Doxycycline|doxycycline|mesh-list
5634969|NCT01631617|Cephalexin|cephalexin|mesh-list
5634970|NCT01631617|Trimethoprim|trimethoprim|mesh-list
5634971|NCT01631617|Sulfamethoxazole|sulfamethoxazole|mesh-list
5634972|NCT01631617|Sodium Hypochlorite|sodium hypochlorite|mesh-list
5634973|NCT01631617|Eusol|eusol|mesh-list
5634974|NCT01631617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5634975|NCT01631617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5634976|NCT01631617|Antimalarials|antimalarials|mesh-ancestor
5634977|NCT01631617|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5634978|NCT01631617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5634979|NCT01631617|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5634980|NCT01631617|Renal Agents|renal agents|mesh-ancestor
5760068|NCT02978495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5760069|NCT02978495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5760070|NCT02978495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5760071|NCT02978547|Metformin|metformin|mesh-list
5760072|NCT02978547|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5760073|NCT02978547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760074|NCT02978222|Molgramostim|molgramostim|mesh-list
5760075|NCT02978222|Sargramostim|sargramostim|mesh-list
5760076|NCT02978222|Immunologic Factors|immunologic factors|mesh-ancestor
5760077|NCT02978222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760078|NCT02978222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5760079|NCT02978534|Quetiapine Fumarate|quetiapine fumarate|mesh-list
5760080|NCT02978534|Antidepressive Agents|antidepressive agents|mesh-ancestor
5760081|NCT02978534|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5760082|NCT02978534|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5760083|NCT02978534|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5760084|NCT02978534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5760085|NCT02978534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760086|NCT02978443|Nivolumab|nivolumab|mesh-list
5760087|NCT02978443|Ipilimumab|ipilimumab|mesh-list
5760088|NCT02978443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5760089|NCT02978443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5760090|NCT02978443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5760091|NCT02978443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760092|NCT02977897|Octreotide|octreotide|mesh-list
5760093|NCT02977897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5760094|NCT02977897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5760095|NCT02977897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5895385|NCT05228743|Mitosis Modulators|mitosis modulators|mesh-ancestor
5895386|NCT05228743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895387|NCT05228613|Vaccines|vaccines|mesh-list
5895388|NCT05228613|Immunologic Factors|immunologic factors|mesh-ancestor
5895389|NCT05228613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895390|NCT05228574|Amiloride|amiloride|mesh-list
5895391|NCT05228574|Diuretics|diuretics|mesh-ancestor
5895392|NCT05228574|Natriuretic Agents|natriuretic agents|mesh-ancestor
5895393|NCT05228574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895394|NCT05228574|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
5895395|NCT05228574|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5895396|NCT05228574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5895397|NCT05228574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895398|NCT05228574|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
5895399|NCT05228574|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5895400|NCT05228483|Mometasone Furoate|mometasone furoate|mesh-list
5895401|NCT05228483|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5895402|NCT05228483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5895403|NCT05228483|Dermatologic Agents|dermatologic agents|mesh-ancestor
5634981|NCT01631617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5634982|NCT01631617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5634983|NCT01631617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5634984|NCT01631617|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5634985|NCT01631617|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
5634986|NCT01631617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5634987|NCT01631617|Disinfectants|disinfectants|mesh-ancestor
5634988|NCT01485861|Prednisone|prednisone|mesh-list
5634989|NCT01485861|Prednisolone|prednisolone|mesh-list
5634990|NCT01485861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5634991|NCT01485861|Glucocorticoids|glucocorticoids|mesh-ancestor
5634992|NCT01485861|Hormones|hormones|mesh-ancestor
5634993|NCT01485861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5634994|NCT01485861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5634995|NCT01485861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5634996|NCT01485861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5634997|NCT01468831|Minocycline|minocycline|mesh-list
5634998|NCT01468831|Bevacizumab|bevacizumab|mesh-list
5634999|NCT01468831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5635000|NCT01468831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5635001|NCT01468831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5635002|NCT01468831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5635003|NCT01468831|Growth Substances|growth substances|mesh-ancestor
5635004|NCT01468831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635005|NCT01468831|Growth Inhibitors|growth inhibitors|mesh-ancestor
5635006|NCT01468831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5635007|NCT01468831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5635008|NCT01383109|Pyronaridine|pyronaridine|mesh-list
5635009|NCT01383109|Antimalarials|antimalarials|mesh-ancestor
5635010|NCT01383109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5635011|NCT01383109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5635012|NCT01383109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5635013|NCT01059786|Rituximab|rituximab|mesh-list
5635014|NCT01059786|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5635015|NCT01059786|Pentostatin|pentostatin|mesh-list
5635016|NCT01059786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5635017|NCT01059786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5635018|NCT01059786|Immunologic Factors|immunologic factors|mesh-ancestor
5635019|NCT01059786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760096|NCT02977949|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
5760097|NCT02977949|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5760098|NCT02977949|Hormone Antagonists|hormone antagonists|mesh-ancestor
5760099|NCT02977949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5760100|NCT02977949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760101|NCT02977949|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5760102|NCT02977949|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5760103|NCT02977949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5760104|NCT02978040|Tirofiban|tirofiban|mesh-list
5760105|NCT02978040|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
5760106|NCT02978040|Cangrelor|cangrelor|mesh-list
5760107|NCT02978040|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5760108|NCT02978040|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5760109|NCT02978040|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5760110|NCT02978040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760111|NCT02978040|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5760112|NCT02978040|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5760113|NCT02978040|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5760114|NCT02978040|Purinergic Agents|purinergic agents|mesh-ancestor
5760115|NCT02978040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5760116|NCT02978040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760117|NCT02977832|Alfuzosin|alfuzosin|mesh-list
5760118|NCT02977832|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5760119|NCT02977832|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5760120|NCT02977832|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5760121|NCT02977832|Adrenergic Agents|adrenergic agents|mesh-ancestor
5760122|NCT02977832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5760123|NCT02977832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760124|NCT02977832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760125|NCT02977832|Urological Agents|urological agents|mesh-ancestor
5760126|NCT02978066|Anesthetics|anesthetics|mesh-list
5760127|NCT02978066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5760128|NCT02978066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760129|NCT02978001|Glycerol|glycerol|mesh-list
5760130|NCT02978001|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
5760131|NCT02978001|Protective Agents|protective agents|mesh-ancestor
5760132|NCT02978001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760133|NCT02977468|Pembrolizumab|pembrolizumab|mesh-list
5760134|NCT02977468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5760135|NCT02977468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5760136|NCT02977637|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
5760137|NCT02977637|Hematinics|hematinics|mesh-ancestor
5760138|NCT02977637|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5760139|NCT02977637|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5635020|NCT01059786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5635021|NCT01059786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5635022|NCT01059786|Alkylating Agents|alkylating agents|mesh-ancestor
5635023|NCT01059786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635024|NCT01059786|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
5635025|NCT01059786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5635026|NCT00822120|Prednisone|prednisone|mesh-list
5635027|NCT00822120|Cyclophosphamide|cyclophosphamide|mesh-list
5635028|NCT00822120|Dacarbazine|dacarbazine|mesh-list
5635029|NCT00822120|Doxorubicin|doxorubicin|mesh-list
5635030|NCT00822120|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5635031|NCT00822120|Etoposide|etoposide|mesh-list
5635032|NCT00822120|Vincristine|vincristine|mesh-list
5635033|NCT00822120|Bleomycin|bleomycin|mesh-list
5635034|NCT00822120|Vinblastine|vinblastine|mesh-list
5635035|NCT00822120|Procarbazine|procarbazine|mesh-list
5635036|NCT00822120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5760140|NCT02977741|Olanzapine|olanzapine|mesh-list
5760141|NCT02977741|Antiemetics|antiemetics|mesh-ancestor
5760142|NCT02977741|Autonomic Agents|autonomic agents|mesh-ancestor
5760143|NCT02977741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5760144|NCT02977741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760145|NCT02977741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5760146|NCT02977741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5760147|NCT02977741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5635037|NCT00822120|Immunologic Factors|immunologic factors|mesh-ancestor
5635038|NCT00822120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760148|NCT02977741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5760149|NCT02977741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5760150|NCT02977741|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5760151|NCT02977741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5760152|NCT02977741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5760153|NCT02977741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760154|NCT02977741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5635039|NCT00822120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5635040|NCT00822120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5635041|NCT00822120|Alkylating Agents|alkylating agents|mesh-ancestor
5635042|NCT00822120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635043|NCT00822120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5635044|NCT00822120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5635045|NCT00822120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5635046|NCT00822120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5635047|NCT00822120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5635048|NCT00822120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5635049|NCT00822120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5635050|NCT00822120|Glucocorticoids|glucocorticoids|mesh-ancestor
5635051|NCT00822120|Hormones|hormones|mesh-ancestor
5635052|NCT00822120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5635053|NCT00822120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5635054|NCT00822120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5760155|NCT02977741|Serotonin Agents|serotonin agents|mesh-ancestor
5760156|NCT02977533|Acyclovir|acyclovir|mesh-list
5760157|NCT02977533|Antiviral Agents|antiviral agents|mesh-ancestor
5760158|NCT02977533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5760159|NCT02977611|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
5635055|NCT00822120|Tubulin Modulators|tubulin modulators|mesh-ancestor
5635056|NCT00822120|Antimitotic Agents|antimitotic agents|mesh-ancestor
5635057|NCT00822120|Mitosis Modulators|mitosis modulators|mesh-ancestor
5635058|NCT00799110|Imiquimod|imiquimod|mesh-list
5635059|NCT00799110|Vaccines|vaccines|mesh-list
5635060|NCT00799110|Immunologic Factors|immunologic factors|mesh-ancestor
5635061|NCT00799110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635062|NCT00799110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5635063|NCT00799110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5635064|NCT00799110|Interferon Inducers|interferon inducers|mesh-ancestor
5635065|NCT00697684|Clofarabine|clofarabine|mesh-list
5635066|NCT00697684|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5635067|NCT00697684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5635068|NCT00697684|Antimetabolites|antimetabolites|mesh-ancestor
5635069|NCT00697684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635070|NCT00697684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5635071|NCT00697684|Immunologic Factors|immunologic factors|mesh-ancestor
5635072|NCT00697684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635073|NCT00697684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5693469|NCT03401372|Antiemetics|antiemetics|mesh-ancestor
5693470|NCT03401372|Autonomic Agents|autonomic agents|mesh-ancestor
5693471|NCT03401372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5693472|NCT03401372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5693473|NCT03401372|Glucocorticoids|glucocorticoids|mesh-ancestor
5693474|NCT03401372|Hormones|hormones|mesh-ancestor
5693475|NCT03401372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5760160|NCT02977611|Hematinics|hematinics|mesh-ancestor
5760161|NCT02977494|Dexamethasone|dexamethasone|mesh-list
5760162|NCT02977494|Dexamethasone acetate|dexamethasone acetate|mesh-list
5760163|NCT02977494|Bortezomib|bortezomib|mesh-list
5760164|NCT02977494|Daratumumab|daratumumab|mesh-list
5760165|NCT02977494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5760166|NCT02977494|Antiemetics|antiemetics|mesh-ancestor
5760167|NCT02977494|Autonomic Agents|autonomic agents|mesh-ancestor
5760168|NCT02977494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5760169|NCT02977494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760170|NCT02977494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5760171|NCT02977494|Glucocorticoids|glucocorticoids|mesh-ancestor
5760172|NCT02977494|Hormones|hormones|mesh-ancestor
5760173|NCT02977494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5760174|NCT02977494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5760175|NCT02977494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5760176|NCT02977208|Gabapentin|gabapentin|mesh-list
5760177|NCT02977208|Analgesics|analgesics|mesh-ancestor
5760178|NCT02977208|Sensory System Agents|sensory system agents|mesh-ancestor
5760179|NCT02977208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5697839|NCT03373318|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5760180|NCT02977208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760181|NCT02977208|Anticonvulsants|anticonvulsants|mesh-ancestor
5635074|NCT00603954|Vidarabine|vidarabine|mesh-list
5635075|NCT00603954|Fludarabine|fludarabine|mesh-list
5635076|NCT00603954|Fludarabine phosphate|fludarabine phosphate|mesh-list
5635077|NCT00603954|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5635078|NCT00603954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5635079|NCT00603954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5635080|NCT00603954|Antimetabolites|antimetabolites|mesh-ancestor
5635081|NCT00603954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760182|NCT02977208|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5760183|NCT02977208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5760184|NCT02977208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5760185|NCT02977208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5760186|NCT02977208|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5760187|NCT02977208|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5760188|NCT02977208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5760189|NCT02977208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760190|NCT02977208|Antimanic Agents|antimanic agents|mesh-ancestor
5760191|NCT02977169|Cisplatin|cisplatin|mesh-list
5760192|NCT02977169|Carboplatin|carboplatin|mesh-list
5760193|NCT02977169|Pemetrexed|pemetrexed|mesh-list
5760194|NCT02977169|Vinorelbine|vinorelbine|mesh-list
5760195|NCT02977169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5760196|NCT02977169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5760197|NCT02977169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760198|NCT02977169|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5760199|NCT02977169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5760200|NCT02977169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5760201|NCT02977169|Tubulin Modulators|tubulin modulators|mesh-ancestor
5760202|NCT02977169|Antimitotic Agents|antimitotic agents|mesh-ancestor
5760203|NCT02977169|Mitosis Modulators|mitosis modulators|mesh-ancestor
5635082|NCT00603954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5635083|NCT00603954|Immunologic Factors|immunologic factors|mesh-ancestor
5635084|NCT00603954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635085|NCT00603954|Antiviral Agents|antiviral agents|mesh-ancestor
5635086|NCT00603954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5635087|NCT00392353|Azacitidine|azacitidine|mesh-list
5635088|NCT00392353|Vorinostat|vorinostat|mesh-list
5635089|NCT00392353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5635090|NCT00392353|Antimetabolites|antimetabolites|mesh-ancestor
5635091|NCT00392353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635092|NCT00392353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5635093|NCT00392353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5635094|NCT00392353|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5635095|NCT00003777|Fluorouracil|fluorouracil|mesh-list
5635096|NCT00003777|Amifostine|amifostine|mesh-list
5635097|NCT00003777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5635098|NCT00003777|Antimetabolites|antimetabolites|mesh-ancestor
5635099|NCT00003777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635100|NCT00003777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5635101|NCT00003777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5760204|NCT02977117|Dialysis Solutions|dialysis solutions|mesh-list
5760205|NCT02977117|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5760206|NCT02977312|Imatinib Mesylate|imatinib mesylate|mesh-list
5760207|NCT02977312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5760208|NCT02977312|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5760209|NCT02977312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5760210|NCT02977312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760211|NCT02977299|Aripiprazole|aripiprazole|mesh-list
5760212|NCT02977299|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
5760213|NCT02977299|Antidepressive Agents|antidepressive agents|mesh-ancestor
5760214|NCT02977299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5760215|NCT02977299|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5760216|NCT02977299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5760217|NCT02977299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5760218|NCT02977299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760219|NCT02977299|Dopamine Agonists|dopamine agonists|mesh-ancestor
5760220|NCT02977299|Dopamine Agents|dopamine agents|mesh-ancestor
5760221|NCT02977299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5760222|NCT02977299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760223|NCT02977299|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5635102|NCT00003777|Immunologic Factors|immunologic factors|mesh-ancestor
5635103|NCT00003777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760224|NCT02977299|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5635104|NCT00003777|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5635105|NCT00003777|Protective Agents|protective agents|mesh-ancestor
5760225|NCT02977299|Serotonin Agents|serotonin agents|mesh-ancestor
5760226|NCT02977299|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5760227|NCT02977299|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5760228|NCT02977299|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5760229|NCT02977299|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5760230|NCT02977299|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5760231|NCT02977299|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5760232|NCT02977299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5760233|NCT02977299|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5760234|NCT02977286|Methylnaltrexone|methylnaltrexone|mesh-list
5760235|NCT02977286|Naloxegol|naloxegol|mesh-list
5760236|NCT02977286|Bisacodyl|bisacodyl|mesh-list
5635106|NCT05214599|Budesonide|budesonide|mesh-list
5635107|NCT05214599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5635108|NCT05214599|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5635109|NCT05214599|Autonomic Agents|autonomic agents|mesh-ancestor
5635110|NCT05214599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5635111|NCT05214599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635112|NCT05214599|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5635113|NCT05214599|Respiratory System Agents|respiratory system agents|mesh-ancestor
5635114|NCT05214599|Glucocorticoids|glucocorticoids|mesh-ancestor
5635115|NCT05214599|Hormones|hormones|mesh-ancestor
5635116|NCT05214599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5635117|NCT05214573|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
5760237|NCT02977286|Magnesium citrate|magnesium citrate|mesh-list
5760238|NCT02977286|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
5760239|NCT02977286|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5635118|NCT05214573|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
5635119|NCT05214573|Glucagon|glucagon|mesh-list
5635120|NCT05214573|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5635121|NCT05214573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5635122|NCT05214573|Hormones|hormones|mesh-ancestor
5635123|NCT05214573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5635124|NCT05214573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635125|NCT05214573|Incretins|incretins|mesh-ancestor
5635126|NCT05214573|Protease Inhibitors|protease inhibitors|mesh-ancestor
5635127|NCT05214573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5635128|NCT05214573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635129|NCT05214573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6209159|NCT02141659|Relugolix|relugolix|mesh-list
6209160|NCT02141659|Androgen Antagonists|androgen antagonists|mesh-ancestor
6209161|NCT02141659|Hormone Antagonists|hormone antagonists|mesh-ancestor
6209162|NCT02141659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6209163|NCT02141659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209164|NCT02141672|Cyclosporine|cyclosporine|mesh-list
6209165|NCT02141672|Antifungal Agents|antifungal agents|mesh-ancestor
6209166|NCT02141672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6209167|NCT02141672|Dermatologic Agents|dermatologic agents|mesh-ancestor
6209168|NCT02141672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6209169|NCT02141672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209170|NCT02141672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6209171|NCT02141672|Immunologic Factors|immunologic factors|mesh-ancestor
6209172|NCT02141672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635144|NCT05214391|Zanubrutinib|zanubrutinib|mesh-list
5635145|NCT05214391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5635146|NCT05214391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5760240|NCT02977286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760241|NCT02977286|Sensory System Agents|sensory system agents|mesh-ancestor
5760242|NCT02977286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5760243|NCT02977286|Cathartics|cathartics|mesh-ancestor
5760244|NCT02977286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5760245|NCT02977286|Laxatives|laxatives|mesh-ancestor
5760246|NCT02977286|Antidiarrheals|antidiarrheals|mesh-ancestor
5760247|NCT02977052|Nivolumab|nivolumab|mesh-list
5760248|NCT02977052|Ipilimumab|ipilimumab|mesh-list
5760249|NCT02977052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5760250|NCT02977052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5760251|NCT02977052|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5760252|NCT02977052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760253|NCT02977065|Atorvastatin|atorvastatin|mesh-list
5760254|NCT02977065|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5635147|NCT05214391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6209173|NCT02141672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5760255|NCT02977065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5760256|NCT02977065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5760257|NCT02977065|Antimetabolites|antimetabolites|mesh-ancestor
5760258|NCT02977065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760259|NCT02977065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5760260|NCT02977065|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5760261|NCT02977065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5760262|NCT02977013|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5760263|NCT02977013|Dalteparin|dalteparin|mesh-list
5760264|NCT02977013|Anticoagulants|anticoagulants|mesh-ancestor
5760265|NCT02977013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5760266|NCT02977013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5760267|NCT02977013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760268|NCT02977000|Propranolol|propranolol|mesh-list
5760269|NCT02977000|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5760270|NCT02977000|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5760271|NCT02977000|Adrenergic Agents|adrenergic agents|mesh-ancestor
5760272|NCT02977000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5760273|NCT02977000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760274|NCT02977000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760275|NCT02977000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5760276|NCT02977000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5760277|NCT02977000|Vasodilator Agents|vasodilator agents|mesh-ancestor
5760278|NCT02976987|Cidofovir|cidofovir|mesh-list
5760279|NCT02976987|Antiviral Agents|antiviral agents|mesh-ancestor
5760280|NCT02976987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5760281|NCT02976987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5760282|NCT02976987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760283|NCT02976805|Bisacodyl|bisacodyl|mesh-list
5760284|NCT02976805|Cathartics|cathartics|mesh-ancestor
5760285|NCT02976805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5635148|NCT05214391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635149|NCT05214339|Bevacizumab|bevacizumab|mesh-list
5635150|NCT05214339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5635151|NCT05214339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5635152|NCT05214339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5635153|NCT05214339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5635154|NCT05214339|Growth Substances|growth substances|mesh-ancestor
5635155|NCT05214339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635156|NCT05214339|Growth Inhibitors|growth inhibitors|mesh-ancestor
5635157|NCT05214235|Hypoglycemic Agents|hypoglycemic agents|mesh-list
5635158|NCT05214235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760286|NCT02976805|Laxatives|laxatives|mesh-ancestor
5760287|NCT02976909|Paclitaxel|paclitaxel|mesh-list
5760288|NCT02976909|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5760289|NCT02976909|Cisplatin|cisplatin|mesh-list
5760290|NCT02976909|Fluorouracil|fluorouracil|mesh-list
5760291|NCT02976909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5760292|NCT02976909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5760293|NCT02976909|Tubulin Modulators|tubulin modulators|mesh-ancestor
5760294|NCT02976909|Antimitotic Agents|antimitotic agents|mesh-ancestor
5760295|NCT02976909|Mitosis Modulators|mitosis modulators|mesh-ancestor
5760296|NCT02976909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760297|NCT02976909|Antimetabolites|antimetabolites|mesh-ancestor
5760298|NCT02976909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5760299|NCT02976909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5760300|NCT02976909|Immunologic Factors|immunologic factors|mesh-ancestor
5760301|NCT02976909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760302|NCT02976727|Vitamin D|vitamin d|mesh-list
5760303|NCT02976727|Lidocaine|lidocaine|mesh-list
5760304|NCT02976727|Prilocaine|prilocaine|mesh-list
5760305|NCT02976727|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
5760306|NCT02976727|Calcipotriene|calcipotriene|mesh-list
5760307|NCT02976727|Vitamins|vitamins|mesh-ancestor
5760308|NCT02976727|Micronutrients|micronutrients|mesh-ancestor
5760309|NCT02976727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760310|NCT02976727|Anesthetics, Local|anesthetics, local|mesh-ancestor
5635159|NCT05214222|Paclitaxel|paclitaxel|mesh-list
5635160|NCT05214222|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5635161|NCT05214222|Cisplatin|cisplatin|mesh-list
5635162|NCT05214222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5635163|NCT05214222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5635164|NCT05214222|Tubulin Modulators|tubulin modulators|mesh-ancestor
5635165|NCT05214222|Antimitotic Agents|antimitotic agents|mesh-ancestor
5635166|NCT05214222|Mitosis Modulators|mitosis modulators|mesh-ancestor
5635167|NCT05214222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635168|NCT05214157|Bupivacaine|bupivacaine|mesh-list
5635169|NCT05214157|Anesthetics, Local|anesthetics, local|mesh-ancestor
5635170|NCT05214157|Anesthetics|anesthetics|mesh-ancestor
5635171|NCT05214157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5635172|NCT05214157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635173|NCT05214157|Sensory System Agents|sensory system agents|mesh-ancestor
5635174|NCT05214157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5760311|NCT02976727|Anesthetics|anesthetics|mesh-ancestor
5760312|NCT02976727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5760313|NCT02976727|Sensory System Agents|sensory system agents|mesh-ancestor
5635175|NCT05214001|Almotriptan|almotriptan|mesh-list
5635176|NCT05214001|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5635177|NCT05214001|Serotonin Agents|serotonin agents|mesh-ancestor
5635178|NCT05214001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5635179|NCT05214001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635180|NCT05214001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635181|NCT05213988|Clofibric Acid|clofibric acid|mesh-list
5635182|NCT05213988|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5635183|NCT05213988|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5635184|NCT05213988|Antimetabolites|antimetabolites|mesh-ancestor
5635185|NCT05213988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635186|NCT05213988|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5635187|NCT05213884|Cisplatin|cisplatin|mesh-list
5635188|NCT05213884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5635189|NCT05213832|Isoflurane|isoflurane|mesh-list
5635190|NCT05213832|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5760314|NCT02976727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5760315|NCT02976727|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5760316|NCT02976727|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5760317|NCT02976727|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5760318|NCT02976727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5760319|NCT02976727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760320|NCT02976727|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5635191|NCT05213832|Anesthetics, General|anesthetics, general|mesh-ancestor
5635192|NCT05213832|Anesthetics|anesthetics|mesh-ancestor
5635193|NCT05213832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5635194|NCT05213832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635195|NCT05213728|Vaccines|vaccines|mesh-list
5635196|NCT05213728|Immunologic Factors|immunologic factors|mesh-ancestor
5635197|NCT05213728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635198|NCT05213676|Nitric Oxide|nitric oxide|mesh-list
5635199|NCT05213676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5635200|NCT05213676|Autonomic Agents|autonomic agents|mesh-ancestor
5635201|NCT05213676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5635202|NCT05213676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635203|NCT05213676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5635204|NCT05213676|Respiratory System Agents|respiratory system agents|mesh-ancestor
5635205|NCT05213676|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5635206|NCT05213676|Antioxidants|antioxidants|mesh-ancestor
5760321|NCT02976727|Dermatologic Agents|dermatologic agents|mesh-ancestor
5760322|NCT02976727|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
5760323|NCT02976740|Immunologic Factors|immunologic factors|mesh-list
5760324|NCT02976740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760325|NCT02976571|Bupivacaine|bupivacaine|mesh-list
5760326|NCT02976571|Anesthetics, Local|anesthetics, local|mesh-ancestor
5760327|NCT02976571|Anesthetics|anesthetics|mesh-ancestor
5760328|NCT02976571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5760329|NCT02976571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760330|NCT02976571|Sensory System Agents|sensory system agents|mesh-ancestor
5635207|NCT05213676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635208|NCT05213676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5635209|NCT05213676|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5635210|NCT05213676|Vasodilator Agents|vasodilator agents|mesh-ancestor
5635211|NCT05213676|Gasotransmitters|gasotransmitters|mesh-ancestor
5635212|NCT05213676|Protective Agents|protective agents|mesh-ancestor
5760331|NCT02976571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5760332|NCT02976935|Xenon|xenon|mesh-list
5760333|NCT02976935|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5760334|NCT02976935|Anesthetics, General|anesthetics, general|mesh-ancestor
5760335|NCT02976935|Anesthetics|anesthetics|mesh-ancestor
5760336|NCT02976935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5760337|NCT02976935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760338|NCT02976623|Metronidazole|metronidazole|mesh-list
5760339|NCT02976623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5760340|NCT02976623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5760341|NCT02976623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5760342|NCT02976623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5635213|NCT05213585|Ivermectin|ivermectin|mesh-list
5635214|NCT05213585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5635215|NCT05213585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5635216|NCT05213312|Paclitaxel|paclitaxel|mesh-list
5635217|NCT05213312|Fluorouracil|fluorouracil|mesh-list
5635218|NCT05213312|Nivolumab|nivolumab|mesh-list
5635219|NCT05213312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5635220|NCT05213312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5635221|NCT05213312|Tubulin Modulators|tubulin modulators|mesh-ancestor
5635222|NCT05213312|Antimitotic Agents|antimitotic agents|mesh-ancestor
5635223|NCT05213312|Mitosis Modulators|mitosis modulators|mesh-ancestor
5635224|NCT05213312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635225|NCT05213312|Antimetabolites|antimetabolites|mesh-ancestor
5635226|NCT05213312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5635227|NCT05213312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5635228|NCT05213312|Immunologic Factors|immunologic factors|mesh-ancestor
5635229|NCT05213312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635230|NCT05213312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5635231|NCT05213312|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5635232|NCT05213169|Apomorphine|apomorphine|mesh-list
5635233|NCT05213169|Emetics|emetics|mesh-ancestor
5635234|NCT05213169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635235|NCT05213169|Autonomic Agents|autonomic agents|mesh-ancestor
5635236|NCT05213169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5635237|NCT05213169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5635238|NCT05213169|Dopamine Agonists|dopamine agonists|mesh-ancestor
5635239|NCT05213169|Dopamine Agents|dopamine agents|mesh-ancestor
5635240|NCT05213169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5635241|NCT05213169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635242|NCT05213143|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
5635243|NCT05213143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5635244|NCT05213143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5635245|NCT05213143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5635246|NCT05213143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635247|NCT05213143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5635248|NCT05213143|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5635249|NCT05213143|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5635250|NCT05213143|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5635251|NCT05213143|Adrenergic Agents|adrenergic agents|mesh-ancestor
5760343|NCT02976896|Apatinib|apatinib|mesh-list
5760344|NCT02976896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5760345|NCT02976896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5760346|NCT02976896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5760347|NCT02976896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895404|NCT05228483|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5635252|NCT05213143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5635253|NCT05213143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635254|NCT05213143|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5635255|NCT05213143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5635256|NCT05213143|Serotonin Agents|serotonin agents|mesh-ancestor
5635257|NCT05213143|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5635258|NCT05213143|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5635259|NCT05213143|Dopamine Agents|dopamine agents|mesh-ancestor
5635260|NCT05213104|Flecainide|flecainide|mesh-list
5635261|NCT05213104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5635262|NCT05213104|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5635263|NCT05213104|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5895405|NCT05228483|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5907854|NCT05156710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907855|NCT05156710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5907856|NCT05156710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5635264|NCT05213104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5907857|NCT05156710|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5635265|NCT05213104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635266|NCT05213065|Bupivacaine|bupivacaine|mesh-list
5635267|NCT05213065|Anesthetics, Local|anesthetics, local|mesh-ancestor
5635268|NCT05213065|Anesthetics|anesthetics|mesh-ancestor
5635269|NCT05213065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5635270|NCT05213065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635271|NCT05213065|Sensory System Agents|sensory system agents|mesh-ancestor
5635272|NCT05213065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5693476|NCT03401372|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5693477|NCT03401372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5693478|NCT03401372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5693479|NCT03401372|Antimalarials|antimalarials|mesh-ancestor
5693480|NCT03401372|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5693481|NCT03401372|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5693482|NCT03401346|Dihydroergotamine|dihydroergotamine|mesh-list
5693483|NCT03401346|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5693484|NCT03401346|Dopamine Agonists|dopamine agonists|mesh-ancestor
5693485|NCT03401346|Dopamine Agents|dopamine agents|mesh-ancestor
5693486|NCT03401346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5760348|NCT02976272|Bortezomib|bortezomib|mesh-list
5760349|NCT02976272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5760350|NCT02976259|Dolutegravir|dolutegravir|mesh-list
5760351|NCT02976259|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5760352|NCT02976259|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5760353|NCT02976259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5760354|NCT02976259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760355|NCT02976259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5760356|NCT02976259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5760357|NCT02976259|Antiviral Agents|antiviral agents|mesh-ancestor
5760358|NCT02976259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5760359|NCT02976597|Morphine|morphine|mesh-list
5760360|NCT02976597|Bupivacaine|bupivacaine|mesh-list
5760361|NCT02976597|Anesthetics, Local|anesthetics, local|mesh-ancestor
5760362|NCT02976597|Anesthetics|anesthetics|mesh-ancestor
5760363|NCT02976597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5760364|NCT02976597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760365|NCT02976597|Sensory System Agents|sensory system agents|mesh-ancestor
5760366|NCT02976597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5760367|NCT02976597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5760368|NCT02976597|Narcotics|narcotics|mesh-ancestor
5760369|NCT02976597|Analgesics|analgesics|mesh-ancestor
5693487|NCT03401346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693488|NCT03401346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693489|NCT03401346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5760370|NCT02976194|Ranibizumab|ranibizumab|mesh-list
5760371|NCT02976194|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5760372|NCT02976194|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5760373|NCT02976194|Growth Substances|growth substances|mesh-ancestor
5760374|NCT02976194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760375|NCT02976194|Growth Inhibitors|growth inhibitors|mesh-ancestor
5760376|NCT02976194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5760377|NCT02976467|Fulacimstat|fulacimstat|mesh-list
5760378|NCT02976467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5760379|NCT02976467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760380|NCT02976441|Temozolomide|temozolomide|mesh-list
5760381|NCT02976441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5693490|NCT03401346|Analgesics|analgesics|mesh-ancestor
5693491|NCT03401346|Sensory System Agents|sensory system agents|mesh-ancestor
5693492|NCT03401346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5693493|NCT03401294|Leucovorin|leucovorin|mesh-list
5693494|NCT03401294|Bevacizumab|bevacizumab|mesh-list
5693495|NCT03401294|Oxaliplatin|oxaliplatin|mesh-list
5693496|NCT03401294|Irinotecan|irinotecan|mesh-list
5693497|NCT03401294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5693498|NCT03401294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5693499|NCT03401294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5693500|NCT03401294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5693501|NCT03401294|Growth Substances|growth substances|mesh-ancestor
5693502|NCT03401294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760382|NCT02976441|Alkylating Agents|alkylating agents|mesh-ancestor
5760383|NCT02976441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693503|NCT03401294|Growth Inhibitors|growth inhibitors|mesh-ancestor
5760384|NCT02976441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6490128|NCT00596128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760385|NCT02976246|Vitamin K|vitamin k|mesh-list
5760386|NCT02976246|Vitamin K 2|vitamin k 2|mesh-list
5760387|NCT02976246|Vitamins|vitamins|mesh-ancestor
6490129|NCT00596154|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6490130|NCT00596154|Cyclophosphamide|cyclophosphamide|mesh-list
5635273|NCT05212857|Leuprolide|leuprolide|mesh-list
5635274|NCT05212857|Goserelin|goserelin|mesh-list
5635275|NCT05212857|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5635276|NCT05212857|Abiraterone Acetate|abiraterone acetate|mesh-list
5635277|NCT05212857|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5635278|NCT05212857|Fertility Agents|fertility agents|mesh-ancestor
5635279|NCT05212857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5635280|NCT05212857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635281|NCT05212857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5635282|NCT05212857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5635283|NCT05212857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5635284|NCT05212857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5760388|NCT02976246|Micronutrients|micronutrients|mesh-ancestor
5760389|NCT02976246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760390|NCT02976246|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5760391|NCT02976246|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5760392|NCT02976246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635285|NCT05212857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760393|NCT02976246|Hemostatics|hemostatics|mesh-ancestor
5760394|NCT02976246|Coagulants|coagulants|mesh-ancestor
5760395|NCT02976116|Gefitinib|gefitinib|mesh-list
5760396|NCT02976116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5760397|NCT02976116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5760398|NCT02976116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5760399|NCT02976116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760400|NCT02975921|Povidone-Iodine|povidone-iodine|mesh-list
5760401|NCT02975921|Povidone|povidone|mesh-list
5760402|NCT02975921|Plasma Substitutes|plasma substitutes|mesh-ancestor
5760403|NCT02975921|Blood Substitutes|blood substitutes|mesh-ancestor
5760404|NCT02975921|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5760405|NCT02975921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5760406|NCT02975843|Beclomethasone|beclomethasone|mesh-list
5760407|NCT02975843|Glycopyrrolate|glycopyrrolate|mesh-list
5760408|NCT02975843|Formoterol Fumarate|formoterol fumarate|mesh-list
5760409|NCT02975843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5760410|NCT02975843|Autonomic Agents|autonomic agents|mesh-ancestor
5760411|NCT02975843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5760412|NCT02975843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760413|NCT02975843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5760414|NCT02975843|Respiratory System Agents|respiratory system agents|mesh-ancestor
5760415|NCT02975843|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5760416|NCT02975843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5760417|NCT02975843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5760418|NCT02975843|Adrenergic Agents|adrenergic agents|mesh-ancestor
5760419|NCT02975843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5760420|NCT02975843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760421|NCT02975843|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5760422|NCT02975843|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5760423|NCT02975843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5760424|NCT02975843|Cholinergic Agents|cholinergic agents|mesh-ancestor
5760425|NCT02975843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5760426|NCT02975843|Glucocorticoids|glucocorticoids|mesh-ancestor
5760427|NCT02975843|Hormones|hormones|mesh-ancestor
5760428|NCT02975843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5760429|NCT02975986|Technetium Tc 99m Mertiatide|technetium tc 99m mertiatide|mesh-list
6490131|NCT00596154|Busulfan|busulfan|mesh-list
5760430|NCT02975986|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6209174|NCT02141672|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6209175|NCT02141854|Fluticasone|fluticasone|mesh-list
6209176|NCT02141854|Xhance|xhance|mesh-list
6209177|NCT02141854|Albuterol|albuterol|mesh-list
6209178|NCT02141854|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6209179|NCT02141854|Adrenergic Agonists|adrenergic agonists|mesh-list
6209180|NCT02141854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6209181|NCT02141854|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6209182|NCT02141854|Autonomic Agents|autonomic agents|mesh-ancestor
6209183|NCT02141854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6209184|NCT02141854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209185|NCT02141854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6209186|NCT02141854|Respiratory System Agents|respiratory system agents|mesh-ancestor
6209187|NCT02141854|Dermatologic Agents|dermatologic agents|mesh-ancestor
6209188|NCT02141854|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6490132|NCT00596154|Thiotepa|thiotepa|mesh-list
6490133|NCT00596154|Rituximab|rituximab|mesh-list
6490134|NCT00596154|Methotrexate|methotrexate|mesh-list
6490135|NCT00596154|Vincristine|vincristine|mesh-list
6490136|NCT00596154|Procarbazine|procarbazine|mesh-list
6490137|NCT00596154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6490138|NCT00596154|Immunologic Factors|immunologic factors|mesh-ancestor
6490139|NCT00596154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490140|NCT00596154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5635286|NCT05212857|Hormone Antagonists|hormone antagonists|mesh-ancestor
5635287|NCT05212857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5635288|NCT05212857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5635289|NCT05212857|Luteolytic Agents|luteolytic agents|mesh-ancestor
5635290|NCT05212857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5635291|NCT05212857|Contraceptive Agents|contraceptive agents|mesh-ancestor
5635292|NCT05212857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5635293|NCT05212766|Vaccines|vaccines|mesh-list
5635294|NCT05212766|Immunologic Factors|immunologic factors|mesh-ancestor
5635295|NCT05212766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635296|NCT05212662|Cysteamine|cysteamine|mesh-list
5635297|NCT05212662|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
5635298|NCT05212662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490141|NCT00596154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6490142|NCT00596154|Alkylating Agents|alkylating agents|mesh-ancestor
6490143|NCT00596154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490144|NCT00596154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6490145|NCT00596154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6490146|NCT00596154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6490147|NCT00596154|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6490148|NCT00596154|Abortifacient Agents|abortifacient agents|mesh-ancestor
6490149|NCT00596154|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6490150|NCT00596154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6490151|NCT00596154|Antimetabolites|antimetabolites|mesh-ancestor
6490152|NCT00596154|Dermatologic Agents|dermatologic agents|mesh-ancestor
6490153|NCT00596154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5760431|NCT02975986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760432|NCT02975999|Vasopressins|vasopressins|mesh-list
5760433|NCT02975999|Arginine Vasopressin|arginine vasopressin|mesh-list
5760434|NCT02975999|Hemostatics|hemostatics|mesh-ancestor
5760435|NCT02975999|Coagulants|coagulants|mesh-ancestor
5760436|NCT02975999|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5760437|NCT02975999|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5760438|NCT02975999|Natriuretic Agents|natriuretic agents|mesh-ancestor
5760439|NCT02975999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635299|NCT05212636|Antidepressive Agents|antidepressive agents|mesh-list
5635300|NCT05212636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5635301|NCT05212623|Vaccines|vaccines|mesh-list
5635302|NCT05212623|Immunologic Factors|immunologic factors|mesh-ancestor
5635303|NCT05212623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635304|NCT05212597|Losartan|losartan|mesh-list
5635305|NCT05212597|Amlodipine|amlodipine|mesh-list
5635306|NCT05212597|Valsartan|valsartan|mesh-list
5760440|NCT02976012|Aflibercept|aflibercept|mesh-list
5760441|NCT02976012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5760442|NCT02976012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5760443|NCT02976012|Growth Substances|growth substances|mesh-ancestor
5760444|NCT02976012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760445|NCT02976012|Growth Inhibitors|growth inhibitors|mesh-ancestor
5760446|NCT02976012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5760447|NCT02975882|Sirolimus|sirolimus|mesh-list
5760448|NCT02975882|Irinotecan|irinotecan|mesh-list
5760449|NCT02975882|Camptothecin|camptothecin|mesh-list
5760450|NCT02975882|Temozolomide|temozolomide|mesh-list
5760451|NCT02975882|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5760452|NCT02975882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5760453|NCT02975882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5760454|NCT02975882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760455|NCT02975882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5760456|NCT02975882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5760457|NCT02975882|Alkylating Agents|alkylating agents|mesh-ancestor
5760458|NCT02975882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5760459|NCT02975882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5760460|NCT02975882|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5760461|NCT02975882|Antifungal Agents|antifungal agents|mesh-ancestor
5760462|NCT02975882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5760463|NCT02975882|Immunologic Factors|immunologic factors|mesh-ancestor
5760464|NCT02975882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760465|NCT02975882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5760466|NCT02975934|Docetaxel|docetaxel|mesh-list
5635307|NCT05212597|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5635308|NCT05212597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5635309|NCT05212597|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5635310|NCT05212597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5635311|NCT05212597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635312|NCT05212597|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5635313|NCT05212597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635314|NCT05212597|Vasodilator Agents|vasodilator agents|mesh-ancestor
5635315|NCT05212597|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5760467|NCT02975934|Abiraterone Acetate|abiraterone acetate|mesh-list
5760468|NCT02975934|Rucaparib|rucaparib|mesh-list
5760469|NCT02975934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5760470|NCT02975934|Tubulin Modulators|tubulin modulators|mesh-ancestor
5760471|NCT02975934|Antimitotic Agents|antimitotic agents|mesh-ancestor
5760472|NCT02975934|Mitosis Modulators|mitosis modulators|mesh-ancestor
5760473|NCT02975934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760474|NCT02975934|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5760475|NCT02975934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5760476|NCT02975934|Hormone Antagonists|hormone antagonists|mesh-ancestor
5635316|NCT05212597|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5635317|NCT05212597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5635318|NCT05212571|Ketamine|ketamine|mesh-list
5635319|NCT05212571|Esketamine|esketamine|mesh-list
5635320|NCT05212571|Analgesics|analgesics|mesh-ancestor
5635321|NCT05212571|Sensory System Agents|sensory system agents|mesh-ancestor
5635322|NCT05212571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5635323|NCT05212571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635324|NCT05212571|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5635325|NCT05212571|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5635326|NCT05212571|Anesthetics, General|anesthetics, general|mesh-ancestor
5635327|NCT05212571|Anesthetics|anesthetics|mesh-ancestor
5635328|NCT05212571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5635329|NCT05212571|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5635330|NCT05212571|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5635331|NCT05212571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5635332|NCT05212571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635333|NCT05212571|Antidepressive Agents|antidepressive agents|mesh-ancestor
5760477|NCT02975934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5760478|NCT02975934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760479|NCT02975934|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5760480|NCT02975934|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5760481|NCT02975453|Rivaroxaban|rivaroxaban|mesh-list
5760482|NCT02975453|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5760483|NCT02975453|Antithrombins|antithrombins|mesh-ancestor
5635334|NCT05212571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5635335|NCT05212454|Capecitabine|capecitabine|mesh-list
5635336|NCT05212454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5635337|NCT05212454|Antimetabolites|antimetabolites|mesh-ancestor
5635338|NCT05212454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635339|NCT05212454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5760484|NCT02975453|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5760485|NCT02975453|Protease Inhibitors|protease inhibitors|mesh-ancestor
5760486|NCT02975453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5760487|NCT02975453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760488|NCT02975453|Anticoagulants|anticoagulants|mesh-ancestor
5760489|NCT02975440|Rifampin|rifampin|mesh-list
5760490|NCT02975440|Midazolam|midazolam|mesh-list
5760491|NCT02975440|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5760492|NCT02975440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5760493|NCT02975440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5760494|NCT02975440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760495|NCT02975440|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5760496|NCT02975440|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5760497|NCT02975440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5760498|NCT02975440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5760499|NCT02975440|Anesthetics, General|anesthetics, general|mesh-ancestor
5760500|NCT02975440|Anesthetics|anesthetics|mesh-ancestor
5760501|NCT02975440|GABA Modulators|gaba modulators|mesh-ancestor
5760502|NCT02975440|GABA Agents|gaba agents|mesh-ancestor
5760503|NCT02975440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5760504|NCT02975440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635346|NCT05212337|Denosumab|denosumab|mesh-list
5635347|NCT05212337|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5635348|NCT05212337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635349|NCT05212311|Chitosan|chitosan|mesh-list
5635350|NCT05212311|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5635351|NCT05212311|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5635352|NCT05212311|Antimetabolites|antimetabolites|mesh-ancestor
5635353|NCT05212311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635354|NCT05212311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5760505|NCT02975440|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5760506|NCT02975440|Antitubercular Agents|antitubercular agents|mesh-ancestor
5760507|NCT02975440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5635355|NCT05212311|Chelating Agents|chelating agents|mesh-ancestor
5635356|NCT05212311|Sequestering Agents|sequestering agents|mesh-ancestor
5635357|NCT05212311|Hemostatics|hemostatics|mesh-ancestor
5635358|NCT05212311|Coagulants|coagulants|mesh-ancestor
5635359|NCT05212246|Imiquimod|imiquimod|mesh-list
5635360|NCT05212246|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5635361|NCT05212246|Immunologic Factors|immunologic factors|mesh-ancestor
5635362|NCT05212246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635363|NCT05212246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5635364|NCT05212246|Interferon Inducers|interferon inducers|mesh-ancestor
5635365|NCT05212025|Gemcitabine|gemcitabine|mesh-list
5760508|NCT02975440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5760509|NCT02975440|Leprostatic Agents|leprostatic agents|mesh-ancestor
5760510|NCT02975440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5760511|NCT02975440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5760512|NCT02975440|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5760513|NCT02975440|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5760514|NCT02975440|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5760515|NCT02975440|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5760516|NCT02975440|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5635366|NCT05212025|Adavosertib|adavosertib|mesh-list
5635367|NCT05212025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5635368|NCT05212025|Antimetabolites|antimetabolites|mesh-ancestor
5635369|NCT05212025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635370|NCT05212025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5635371|NCT05212025|Antiviral Agents|antiviral agents|mesh-ancestor
5635372|NCT05212025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5635373|NCT05212025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5635374|NCT05212025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5635375|NCT05212025|Immunologic Factors|immunologic factors|mesh-ancestor
5635376|NCT05212025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635377|NCT05212012|Methadone|methadone|mesh-list
5760517|NCT02975440|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5760518|NCT02975583|Vorapaxar|vorapaxar|mesh-list
5760519|NCT02975583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5760520|NCT02975570|Levofloxacin|levofloxacin|mesh-list
5760521|NCT02975570|Ofloxacin|ofloxacin|mesh-list
5760522|NCT02975570|Linezolid|linezolid|mesh-list
5760523|NCT02975570|Pyrazinamide|pyrazinamide|mesh-list
5760524|NCT02975570|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5760525|NCT02975570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5635378|NCT05212012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5635379|NCT05212012|Narcotics|narcotics|mesh-ancestor
5635380|NCT05212012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5635381|NCT05212012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635382|NCT05212012|Analgesics|analgesics|mesh-ancestor
5635383|NCT05212012|Sensory System Agents|sensory system agents|mesh-ancestor
5635384|NCT05212012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5635385|NCT05212012|Antitussive Agents|antitussive agents|mesh-ancestor
5635386|NCT05212012|Respiratory System Agents|respiratory system agents|mesh-ancestor
5760526|NCT02975570|Renal Agents|renal agents|mesh-ancestor
5760527|NCT02975570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5760528|NCT02975570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5760529|NCT02975570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5760530|NCT02975570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5760531|NCT02975570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760532|NCT02975570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5635387|NCT05211804|Ranibizumab|ranibizumab|mesh-list
5635388|NCT05211804|Aflibercept|aflibercept|mesh-list
5635389|NCT05211804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5635390|NCT05211804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5635391|NCT05211804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5635392|NCT05211804|Growth Substances|growth substances|mesh-ancestor
5635393|NCT05211804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635394|NCT05211804|Growth Inhibitors|growth inhibitors|mesh-ancestor
5635395|NCT05211791|Anesthetics|anesthetics|mesh-list
5635396|NCT05211791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5635397|NCT05211791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635398|NCT05211622|Thioctic Acid|thioctic acid|mesh-list
5635399|NCT05211622|Chlorhexidine|chlorhexidine|mesh-list
5635400|NCT05211622|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5635401|NCT05211622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5635402|NCT05211622|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5635403|NCT05211622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5635404|NCT05211622|Disinfectants|disinfectants|mesh-ancestor
5635405|NCT05211622|Dermatologic Agents|dermatologic agents|mesh-ancestor
5635406|NCT05211622|Antioxidants|antioxidants|mesh-ancestor
5635407|NCT05211622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635408|NCT05211622|Protective Agents|protective agents|mesh-ancestor
5635409|NCT05211622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635410|NCT05211622|Vitamin B Complex|vitamin b complex|mesh-ancestor
5635411|NCT05211622|Vitamins|vitamins|mesh-ancestor
5635412|NCT05211622|Micronutrients|micronutrients|mesh-ancestor
5895406|NCT05228431|Capecitabine|capecitabine|mesh-list
6490154|NCT00596154|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5635425|NCT05211583|Progesterone|progesterone|mesh-list
5635426|NCT05211583|Progestins|progestins|mesh-ancestor
5635427|NCT05211583|Hormones|hormones|mesh-ancestor
5635428|NCT05211583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5635429|NCT05211583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693504|NCT03401294|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5693505|NCT03401294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5693506|NCT03401294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5693507|NCT03401294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693508|NCT03401294|Antidotes|antidotes|mesh-ancestor
5693509|NCT03401294|Protective Agents|protective agents|mesh-ancestor
5693510|NCT03401294|Vitamin B Complex|vitamin b complex|mesh-ancestor
5693511|NCT03401294|Vitamins|vitamins|mesh-ancestor
5693512|NCT03401294|Micronutrients|micronutrients|mesh-ancestor
5693513|NCT03401268|Immunoglobulins|immunoglobulins|mesh-list
5693514|NCT03401268|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5693515|NCT03401268|Antibodies|antibodies|mesh-list
5693516|NCT03401268|Immunologic Factors|immunologic factors|mesh-ancestor
5693517|NCT03401268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693518|NCT03401177|Naproxen|naproxen|mesh-list
5693519|NCT03401177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5693520|NCT03401177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5693521|NCT03401177|Analgesics|analgesics|mesh-ancestor
5693522|NCT03401177|Sensory System Agents|sensory system agents|mesh-ancestor
5693523|NCT03401177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5693524|NCT03401177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693525|NCT03401177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5693526|NCT03401177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5693527|NCT03401177|Gout Suppressants|gout suppressants|mesh-ancestor
5693528|NCT03401177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5693529|NCT03401177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5693530|NCT03401177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693531|NCT03401073|Immunoglobulins|immunoglobulins|mesh-list
5693532|NCT03401073|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5693533|NCT03401073|Antibodies|antibodies|mesh-list
5693534|NCT03401073|gamma-Globulins|gamma-globulins|mesh-list
5693535|NCT03401073|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5693536|NCT03401073|Immunologic Factors|immunologic factors|mesh-ancestor
5635430|NCT05211050|Cromakalim|cromakalim|mesh-list
5635431|NCT05211050|Sumatriptan|sumatriptan|mesh-list
5635432|NCT05211050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5760533|NCT02975570|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5760534|NCT02975570|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5760535|NCT02975570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5760536|NCT02975570|Antitubercular Agents|antitubercular agents|mesh-ancestor
5760537|NCT02975258|Nitric Oxide|nitric oxide|mesh-list
5760538|NCT02975258|Methacholine Chloride|methacholine chloride|mesh-list
5760539|NCT02975258|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5760540|NCT02975258|Autonomic Agents|autonomic agents|mesh-ancestor
5760541|NCT02975258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5760542|NCT02975258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760543|NCT02975258|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5760544|NCT02975258|Respiratory System Agents|respiratory system agents|mesh-ancestor
5760545|NCT02975258|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5760546|NCT02975258|Antioxidants|antioxidants|mesh-ancestor
5760547|NCT02975258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760548|NCT02975258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5760549|NCT02975258|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5760550|NCT02975258|Vasodilator Agents|vasodilator agents|mesh-ancestor
5760551|NCT02975258|Gasotransmitters|gasotransmitters|mesh-ancestor
5760552|NCT02975258|Protective Agents|protective agents|mesh-ancestor
5760553|NCT02975258|Miotics|miotics|mesh-ancestor
5760554|NCT02975258|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5760555|NCT02975258|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
5760556|NCT02975258|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
5760557|NCT02975258|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5760558|NCT02975258|Cholinergic Agents|cholinergic agents|mesh-ancestor
5760559|NCT02975310|Anesthetics|anesthetics|mesh-list
5760560|NCT02975310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5760561|NCT02975310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760562|NCT02975102|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5760563|NCT02975102|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5760564|NCT02975076|Aspirin|aspirin|mesh-list
5760565|NCT02975076|Clopidogrel|clopidogrel|mesh-list
5760566|NCT02975076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5760567|NCT02975076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5760568|NCT02975076|Analgesics|analgesics|mesh-ancestor
5760569|NCT02975076|Sensory System Agents|sensory system agents|mesh-ancestor
5760570|NCT02975076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5760571|NCT02975076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760572|NCT02975076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5760573|NCT02975076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5760574|NCT02975076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5760575|NCT02975076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5760576|NCT02975076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760577|NCT02975076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5760578|NCT02975076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5760579|NCT02975076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5760580|NCT02975076|Antipyretics|antipyretics|mesh-ancestor
5760581|NCT02975076|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5760582|NCT02975076|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5760583|NCT02975076|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5760584|NCT02975076|Purinergic Agents|purinergic agents|mesh-ancestor
5760585|NCT02975076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5760586|NCT02975037|Itraconazole|itraconazole|mesh-list
5760587|NCT02975037|Erythromycin|erythromycin|mesh-list
5635433|NCT05211050|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5635434|NCT05211050|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5635435|NCT05211050|Serotonin Agents|serotonin agents|mesh-ancestor
5635436|NCT05211050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5635437|NCT05211050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635438|NCT05211050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635439|NCT05211050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5635440|NCT05211050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5635441|NCT05211050|Autonomic Agents|autonomic agents|mesh-ancestor
5635442|NCT05211050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5635443|NCT05211050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5635444|NCT05211050|Respiratory System Agents|respiratory system agents|mesh-ancestor
5635445|NCT05211050|Parasympatholytics|parasympatholytics|mesh-ancestor
5635446|NCT05211050|Vasodilator Agents|vasodilator agents|mesh-ancestor
5635447|NCT05211011|Fosfomycin|fosfomycin|mesh-list
5635448|NCT05211011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5760588|NCT02975037|Erythromycin Estolate|erythromycin estolate|mesh-list
5635449|NCT05211011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5635450|NCT05210764|Ketamine|ketamine|mesh-list
5635451|NCT05210764|Anesthetics|anesthetics|mesh-list
5635452|NCT05210764|Propofol|propofol|mesh-list
5635453|NCT05210764|Sevoflurane|sevoflurane|mesh-list
5635454|NCT05210764|Esketamine|esketamine|mesh-list
5635455|NCT05210764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5635456|NCT05210764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635457|NCT05210764|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5635458|NCT05210764|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5635459|NCT05210764|Anesthetics, General|anesthetics, general|mesh-ancestor
5635460|NCT05210764|Analgesics|analgesics|mesh-ancestor
5635461|NCT05210764|Sensory System Agents|sensory system agents|mesh-ancestor
5635462|NCT05210764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5635463|NCT05210764|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5635464|NCT05210764|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5635465|NCT05210764|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5635466|NCT05210764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5635467|NCT05210764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635468|NCT05210764|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5635469|NCT05210764|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5635470|NCT05210764|Antidepressive Agents|antidepressive agents|mesh-ancestor
5635471|NCT05210764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5635472|NCT05210725|Rivaroxaban|rivaroxaban|mesh-list
5760589|NCT02975037|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
5760590|NCT02975037|Erythromycin stearate|erythromycin stearate|mesh-list
5760591|NCT02975037|Sildenafil Citrate|sildenafil citrate|mesh-list
5760592|NCT02975037|Vasodilator Agents|vasodilator agents|mesh-ancestor
5760593|NCT02975037|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5760594|NCT02975037|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5760595|NCT02975037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5760596|NCT02975037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760597|NCT02975037|Urological Agents|urological agents|mesh-ancestor
5760598|NCT02975037|Antifungal Agents|antifungal agents|mesh-ancestor
5760599|NCT02975037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5760600|NCT02975037|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5760601|NCT02975037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5760602|NCT02975037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5760603|NCT02975037|Hormone Antagonists|hormone antagonists|mesh-ancestor
5760604|NCT02975037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5760605|NCT02975037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760606|NCT02975037|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5760607|NCT02975037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5760608|NCT02975037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5760609|NCT02975037|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5760610|NCT02975219|Bevacizumab|bevacizumab|mesh-list
5760611|NCT02975219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5760612|NCT02975219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5760613|NCT02975219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5760614|NCT02975219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5760615|NCT02975219|Growth Substances|growth substances|mesh-ancestor
5760616|NCT02975219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760617|NCT02975219|Growth Inhibitors|growth inhibitors|mesh-ancestor
5895407|NCT05228431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5895408|NCT05228431|Antimetabolites|antimetabolites|mesh-ancestor
5895409|NCT05228431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895410|NCT05228431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5895411|NCT05228418|Naltrexone|naltrexone|mesh-list
5895412|NCT05228418|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5895413|NCT05228418|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5895414|NCT05228418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895415|NCT05228418|Sensory System Agents|sensory system agents|mesh-ancestor
5895416|NCT05228418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5895417|NCT05228314|Aluminum Hydroxide|aluminum hydroxide|mesh-list
5895418|NCT05228314|Vaccines|vaccines|mesh-list
5895419|NCT05228314|Aluminum sulfate|aluminum sulfate|mesh-list
5895420|NCT05228314|Immunologic Factors|immunologic factors|mesh-ancestor
5895421|NCT05228314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895422|NCT05228314|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5895423|NCT05228314|Antacids|antacids|mesh-ancestor
5895424|NCT05228314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895425|NCT05228314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5895426|NCT05228288|Pyrithione zinc|pyrithione zinc|mesh-list
5895427|NCT05228288|Keratolytic Agents|keratolytic agents|mesh-ancestor
5760618|NCT02975323|Carvedilol|carvedilol|mesh-list
5760619|NCT02975323|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5760620|NCT02975323|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5760621|NCT02975323|Adrenergic Agents|adrenergic agents|mesh-ancestor
5760622|NCT02975323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5760623|NCT02975323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760624|NCT02975323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760625|NCT02975323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5760626|NCT02975323|Antioxidants|antioxidants|mesh-ancestor
5760627|NCT02975323|Protective Agents|protective agents|mesh-ancestor
5760628|NCT02975323|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5760629|NCT02975323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5760630|NCT02975323|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5760631|NCT02975323|Vasodilator Agents|vasodilator agents|mesh-ancestor
5760632|NCT02975323|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5760633|NCT02975323|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5760634|NCT02975141|Gemcitabine|gemcitabine|mesh-list
5760635|NCT02975141|Paclitaxel|paclitaxel|mesh-list
5760636|NCT02975141|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6673266|NCT01561404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673267|NCT01561456|Docetaxel|docetaxel|mesh-list
6673268|NCT01561456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6673269|NCT01561456|Tubulin Modulators|tubulin modulators|mesh-ancestor
6673270|NCT01561456|Antimitotic Agents|antimitotic agents|mesh-ancestor
6673271|NCT01561456|Mitosis Modulators|mitosis modulators|mesh-ancestor
6673272|NCT01561456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673273|NCT01561482|Metformin|metformin|mesh-list
6673274|NCT01561482|Simvastatin|simvastatin|mesh-list
5635473|NCT05210725|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5635474|NCT05210725|Antithrombins|antithrombins|mesh-ancestor
5635475|NCT05210725|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5635476|NCT05210725|Protease Inhibitors|protease inhibitors|mesh-ancestor
5635477|NCT05210725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5635478|NCT05210725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673275|NCT01561482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6673276|NCT01561482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673277|NCT01561482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5635479|NCT05210725|Anticoagulants|anticoagulants|mesh-ancestor
5760637|NCT02975141|Afatinib|afatinib|mesh-list
5760638|NCT02975141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5760639|NCT02975141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5760640|NCT02975141|Tubulin Modulators|tubulin modulators|mesh-ancestor
5760641|NCT02975141|Antimitotic Agents|antimitotic agents|mesh-ancestor
5760642|NCT02975141|Mitosis Modulators|mitosis modulators|mesh-ancestor
5760643|NCT02975141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760644|NCT02975141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5760645|NCT02975141|Antimetabolites|antimetabolites|mesh-ancestor
5760646|NCT02975141|Antiviral Agents|antiviral agents|mesh-ancestor
5760647|NCT02975141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5760648|NCT02975141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5760649|NCT02975141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5760650|NCT02975141|Immunologic Factors|immunologic factors|mesh-ancestor
5760651|NCT02975141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760652|NCT02975141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5760653|NCT02974985|Hyaluronic Acid|hyaluronic acid|mesh-list
5760654|NCT02974985|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5760655|NCT02974985|Immunologic Factors|immunologic factors|mesh-ancestor
5635480|NCT05210595|Clopidogrel|clopidogrel|mesh-list
5635481|NCT05210595|Ticagrelor|ticagrelor|mesh-list
5635482|NCT05210595|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5635483|NCT05210595|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5760656|NCT02974985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760657|NCT02974985|Viscosupplements|viscosupplements|mesh-ancestor
5760658|NCT02974985|Protective Agents|protective agents|mesh-ancestor
5760659|NCT02974920|Aspirin|aspirin|mesh-list
5760660|NCT02974920|Rivaroxaban|rivaroxaban|mesh-list
5760661|NCT02974920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5760662|NCT02974920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5760663|NCT02974920|Analgesics|analgesics|mesh-ancestor
5760664|NCT02974920|Sensory System Agents|sensory system agents|mesh-ancestor
5760665|NCT02974920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5760666|NCT02974920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760667|NCT02974920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5760668|NCT02974920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5760669|NCT02974920|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6673278|NCT01561482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5760670|NCT02974920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5635484|NCT05210595|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5635485|NCT05210595|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5635486|NCT05210595|Purinergic Agents|purinergic agents|mesh-ancestor
5635487|NCT05210595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5635488|NCT05210595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635489|NCT05210595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635490|NCT05210582|Afamelanotide|afamelanotide|mesh-list
5635491|NCT05210582|Dermatologic Agents|dermatologic agents|mesh-ancestor
5635492|NCT05210517|Empagliflozin|empagliflozin|mesh-list
5635493|NCT05210517|Benzbromarone|benzbromarone|mesh-list
5635494|NCT05210517|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5635495|NCT05210517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635496|NCT05210517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5635497|NCT05210517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635498|NCT05210517|Uricosuric Agents|uricosuric agents|mesh-ancestor
5635499|NCT05210517|Gout Suppressants|gout suppressants|mesh-ancestor
5635500|NCT05210517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5635501|NCT05210517|Renal Agents|renal agents|mesh-ancestor
5635502|NCT05210465|Dobutamine|dobutamine|mesh-list
5635503|NCT05210465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5635504|NCT05210465|Sympathomimetics|sympathomimetics|mesh-ancestor
5635505|NCT05210465|Autonomic Agents|autonomic agents|mesh-ancestor
5635506|NCT05210465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5635507|NCT05210465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635508|NCT05210465|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5635509|NCT05210465|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5635510|NCT05210465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5635511|NCT05210465|Adrenergic Agents|adrenergic agents|mesh-ancestor
5635512|NCT05210465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5635513|NCT05210465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635514|NCT05210465|Protective Agents|protective agents|mesh-ancestor
5635515|NCT05210439|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5635516|NCT05210439|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5635517|NCT05210439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5635518|NCT05210439|Antitubercular Agents|antitubercular agents|mesh-ancestor
5635519|NCT05210413|Spartalizumab|spartalizumab|mesh-list
5635520|NCT05210413|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5635521|NCT05210413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673279|NCT01561482|Antimetabolites|antimetabolites|mesh-ancestor
6673280|NCT01561482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673281|NCT01561482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5760671|NCT02974920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760672|NCT02974920|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5760673|NCT02974920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5760674|NCT02974920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5760675|NCT02974920|Antipyretics|antipyretics|mesh-ancestor
5760676|NCT02974920|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5760677|NCT02974920|Antithrombins|antithrombins|mesh-ancestor
5760678|NCT02974920|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5760679|NCT02974920|Protease Inhibitors|protease inhibitors|mesh-ancestor
5760680|NCT02974920|Anticoagulants|anticoagulants|mesh-ancestor
6673282|NCT01561482|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6673283|NCT01561482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6673284|NCT01561508|Butyric Acid|butyric acid|mesh-list
5635522|NCT05210413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5635523|NCT05210374|Copper|copper|mesh-list
5635524|NCT05210374|Doxorubicin|doxorubicin|mesh-list
5635525|NCT05210374|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5635526|NCT05210374|Disulfiram|disulfiram|mesh-list
5635527|NCT05210374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5635528|NCT05210374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5635529|NCT05210374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5635530|NCT05210374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5635531|NCT05210374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5760681|NCT02974933|Pemetrexed|pemetrexed|mesh-list
5760682|NCT02974933|Apatinib|apatinib|mesh-list
5760683|NCT02974933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5760684|NCT02974933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5760685|NCT02974933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760686|NCT02974933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5760687|NCT02974933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5760688|NCT02974933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5760689|NCT02974712|Fentanyl|fentanyl|mesh-list
5760690|NCT02974712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5760691|NCT02974712|Narcotics|narcotics|mesh-ancestor
5760692|NCT02974712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5760693|NCT02974712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760694|NCT02974712|Analgesics|analgesics|mesh-ancestor
5760695|NCT02974712|Sensory System Agents|sensory system agents|mesh-ancestor
5760696|NCT02974712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5760697|NCT02974712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5760698|NCT02974712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5760699|NCT02974712|Anesthetics, General|anesthetics, general|mesh-ancestor
5760700|NCT02974712|Anesthetics|anesthetics|mesh-ancestor
5760701|NCT02974556|Capecitabine|capecitabine|mesh-list
5760702|NCT02974556|Oxaliplatin|oxaliplatin|mesh-list
5760703|NCT02974556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5760704|NCT02974556|Antimetabolites|antimetabolites|mesh-ancestor
5760705|NCT02974556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760706|NCT02974556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5760707|NCT02974660|Protamines|protamines|mesh-list
5760708|NCT02974660|Heparin Antagonists|heparin antagonists|mesh-ancestor
5760709|NCT02974660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760710|NCT02974660|Coagulants|coagulants|mesh-ancestor
5760711|NCT02974439|Amlodipine|amlodipine|mesh-list
5760712|NCT02974439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5760713|NCT02974439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5760714|NCT02974439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5635532|NCT05210374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635533|NCT05210374|Trace Elements|trace elements|mesh-ancestor
5635534|NCT05210374|Micronutrients|micronutrients|mesh-ancestor
5635535|NCT05210374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635536|NCT05210374|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5635537|NCT05210374|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
5635538|NCT05210192|Lidocaine|lidocaine|mesh-list
5635539|NCT05210192|Anesthetics, Local|anesthetics, local|mesh-ancestor
5635540|NCT05210192|Anesthetics|anesthetics|mesh-ancestor
5635541|NCT05210192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5635542|NCT05210192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635543|NCT05210192|Sensory System Agents|sensory system agents|mesh-ancestor
5635544|NCT05210192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5635545|NCT05210192|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5635546|NCT05210192|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5760715|NCT02974439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760716|NCT02974439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5760717|NCT02974439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760718|NCT02974439|Vasodilator Agents|vasodilator agents|mesh-ancestor
5760719|NCT02974621|Bevacizumab|bevacizumab|mesh-list
5760720|NCT02974621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5760721|NCT02974621|Olaparib|olaparib|mesh-list
5760722|NCT02974621|Cediranib|cediranib|mesh-list
5760723|NCT02974621|Endothelial Growth Factors|endothelial growth factors|mesh-list
5760724|NCT02974621|Antibodies|antibodies|mesh-list
5760725|NCT02974621|Immunoglobulins|immunoglobulins|mesh-list
5760726|NCT02974621|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5760727|NCT02974621|Immunoglobulin G|immunoglobulin g|mesh-list
5760728|NCT02974621|Maleic acid|maleic acid|mesh-list
5760729|NCT02974621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5760730|NCT02974621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5760731|NCT02974621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5760732|NCT02974621|Growth Substances|growth substances|mesh-ancestor
5760733|NCT02974621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760734|NCT02974621|Growth Inhibitors|growth inhibitors|mesh-ancestor
5760735|NCT02974621|Immunologic Factors|immunologic factors|mesh-ancestor
5635547|NCT05210192|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5635548|NCT05210192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5635549|NCT05210192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635550|NCT05210166|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
5635551|NCT05210166|Antioxidants|antioxidants|mesh-ancestor
5635552|NCT05210166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635553|NCT05210166|Protective Agents|protective agents|mesh-ancestor
5635554|NCT05210166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635555|NCT05210166|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5635556|NCT05210166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5635557|NCT05210153|Sertraline|sertraline|mesh-list
5635558|NCT05210153|Antidepressive Agents|antidepressive agents|mesh-ancestor
5635559|NCT05210153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5635560|NCT05210153|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5895428|NCT05228288|Dermatologic Agents|dermatologic agents|mesh-ancestor
5760736|NCT02974621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760737|NCT02974621|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5760738|NCT02974621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5760739|NCT02974621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5760740|NCT02974387|Loteprednol Etabonate|loteprednol etabonate|mesh-list
5760741|NCT02974387|Fluorometholone|fluorometholone|mesh-list
5760742|NCT02974387|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5760743|NCT02974387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5635561|NCT05210153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5635562|NCT05210153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5635563|NCT05210153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635564|NCT05210153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5635565|NCT05210153|Serotonin Agents|serotonin agents|mesh-ancestor
5635566|NCT05210153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760744|NCT02974387|Glucocorticoids|glucocorticoids|mesh-ancestor
5760745|NCT02974387|Hormones|hormones|mesh-ancestor
5760746|NCT02974387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5760747|NCT02974387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760748|NCT02974504|Linagliptin|linagliptin|mesh-list
5760749|NCT02974504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5635567|NCT05210140|Citalopram|citalopram|mesh-list
5635568|NCT05210140|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5635569|NCT05210140|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5635570|NCT05210140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5635571|NCT05210140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635572|NCT05210140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5635573|NCT05210140|Serotonin Agents|serotonin agents|mesh-ancestor
5635574|NCT05210140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635575|NCT05210140|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5635576|NCT05210140|Antidepressive Agents|antidepressive agents|mesh-ancestor
5635577|NCT05210140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5635578|NCT05210062|Succinylcholine|succinylcholine|mesh-list
5635579|NCT05210062|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
5635580|NCT05210062|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5635581|NCT05210062|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5635582|NCT05210062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5635583|NCT05210062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635584|NCT05209984|Topiramate|topiramate|mesh-list
5635585|NCT05209984|Sibutramine|sibutramine|mesh-list
5635586|NCT05209984|Anticonvulsants|anticonvulsants|mesh-ancestor
5635587|NCT05209984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5635588|NCT05209984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635589|NCT05209984|Antidepressive Agents|antidepressive agents|mesh-ancestor
5635590|NCT05209984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5635591|NCT05209984|Appetite Depressants|appetite depressants|mesh-ancestor
5635592|NCT05209984|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5635593|NCT05209906|Fentanyl|fentanyl|mesh-list
5635594|NCT05209906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5635595|NCT05209906|Narcotics|narcotics|mesh-ancestor
5635596|NCT05209906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5635597|NCT05209906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635598|NCT05209906|Analgesics|analgesics|mesh-ancestor
5760750|NCT02974504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760751|NCT02974504|Incretins|incretins|mesh-ancestor
5760752|NCT02974504|Hormones|hormones|mesh-ancestor
5760753|NCT02974504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5760754|NCT02974504|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5760755|NCT02974504|Protease Inhibitors|protease inhibitors|mesh-ancestor
5760756|NCT02974504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5760757|NCT02974504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760758|NCT02974426|Cisplatin|cisplatin|mesh-list
5760759|NCT02974426|Carboplatin|carboplatin|mesh-list
5760760|NCT02974426|Pemetrexed|pemetrexed|mesh-list
5760761|NCT02974426|Vinorelbine|vinorelbine|mesh-list
5760762|NCT02974426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5760763|NCT02974426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5635599|NCT05209906|Sensory System Agents|sensory system agents|mesh-ancestor
5635600|NCT05209906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5635601|NCT05209906|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5760764|NCT02974426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760765|NCT02974426|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5760766|NCT02974426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5635602|NCT05209906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5635603|NCT05209906|Anesthetics, General|anesthetics, general|mesh-ancestor
5635604|NCT05209906|Anesthetics|anesthetics|mesh-ancestor
5635605|NCT05209841|Heparin|heparin|mesh-list
5760767|NCT02974426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5760768|NCT02974426|Tubulin Modulators|tubulin modulators|mesh-ancestor
5760769|NCT02974426|Antimitotic Agents|antimitotic agents|mesh-ancestor
5760770|NCT02974426|Mitosis Modulators|mitosis modulators|mesh-ancestor
5760771|NCT02974244|Exenatide|exenatide|mesh-list
5760772|NCT02974244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5760773|NCT02974244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760774|NCT02974244|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5760775|NCT02974244|Incretins|incretins|mesh-ancestor
5635606|NCT05209841|Anticoagulants|anticoagulants|mesh-ancestor
5635607|NCT05209841|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5635608|NCT05209841|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5635609|NCT05209841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693537|NCT03401073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693538|NCT03401060|Denosumab|denosumab|mesh-list
5693539|NCT03401060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5693540|NCT03401060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693541|NCT03401047|Estradiol|estradiol|mesh-list
5693542|NCT03401047|Estrogens|estrogens|mesh-ancestor
5693543|NCT03401047|Hormones|hormones|mesh-ancestor
5693544|NCT03401047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5693545|NCT03401047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693546|NCT03400995|Ziresovir|ziresovir|mesh-list
5693547|NCT03400995|Antiviral Agents|antiviral agents|mesh-ancestor
5693548|NCT03400995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5693549|NCT03400969|Glycerol|glycerol|mesh-list
5693550|NCT03400969|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
5693551|NCT03400969|Protective Agents|protective agents|mesh-ancestor
5693552|NCT03400969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693553|NCT03400826|Simvastatin|simvastatin|mesh-list
5693554|NCT03400826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5693555|NCT03400826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5693556|NCT03400826|Antimetabolites|antimetabolites|mesh-ancestor
5693557|NCT03400826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693558|NCT03400826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5693559|NCT03400826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5693560|NCT03400826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5693561|NCT03400735|Cefdinir|cefdinir|mesh-list
5693562|NCT03400735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5693563|NCT03400735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5693564|NCT03400722|Clomiphene|clomiphene|mesh-list
5693565|NCT03400722|Hormones|hormones|mesh-list
5693566|NCT03400722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5693567|NCT03400722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693568|NCT03400722|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5693569|NCT03400722|Hormone Antagonists|hormone antagonists|mesh-ancestor
5693570|NCT03400722|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5693571|NCT03400722|Fertility Agents|fertility agents|mesh-ancestor
5693572|NCT03400722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5693573|NCT03400722|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5693574|NCT03400722|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5693575|NCT03400709|Acetylcysteine|acetylcysteine|mesh-list
5693576|NCT03400709|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5693577|NCT03400709|Antiviral Agents|antiviral agents|mesh-ancestor
5693578|NCT03400709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5693579|NCT03400709|Expectorants|expectorants|mesh-ancestor
5693580|NCT03400709|Respiratory System Agents|respiratory system agents|mesh-ancestor
5693581|NCT03400709|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5693582|NCT03400709|Antioxidants|antioxidants|mesh-ancestor
5693583|NCT03400709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693584|NCT03400709|Protective Agents|protective agents|mesh-ancestor
5693585|NCT03400709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693586|NCT03400709|Antidotes|antidotes|mesh-ancestor
5693587|NCT03400683|Letrozole|letrozole|mesh-list
5693588|NCT03400683|Misoprostol|misoprostol|mesh-list
5693589|NCT03400683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5693590|NCT03400683|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5693591|NCT03400683|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5693592|NCT03400683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5693593|NCT03400683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693594|NCT03400683|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5693595|NCT03400683|Hormone Antagonists|hormone antagonists|mesh-ancestor
5760776|NCT02974244|Hormones|hormones|mesh-ancestor
5760777|NCT02974244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5760778|NCT02974361|Ibuprofen|ibuprofen|mesh-list
5760779|NCT02974361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5760780|NCT02974361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5760781|NCT02974361|Analgesics|analgesics|mesh-ancestor
5760782|NCT02974361|Sensory System Agents|sensory system agents|mesh-ancestor
5760783|NCT02974361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5760784|NCT02974361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760785|NCT02974361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5635610|NCT05209217|Ketamine|ketamine|mesh-list
5635611|NCT05209217|Analgesics|analgesics|mesh-ancestor
5635612|NCT05209217|Sensory System Agents|sensory system agents|mesh-ancestor
5635613|NCT05209217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5635614|NCT05209217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635615|NCT05209217|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5635616|NCT05209217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5635617|NCT05209217|Anesthetics, General|anesthetics, general|mesh-ancestor
5635618|NCT05209217|Anesthetics|anesthetics|mesh-ancestor
5635619|NCT05209217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5635620|NCT05209217|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5635621|NCT05209217|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5635622|NCT05209217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5635623|NCT05209217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635624|NCT05197049|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5635625|NCT05197049|Immunologic Factors|immunologic factors|mesh-ancestor
5635626|NCT05197049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635627|NCT05191264|Analgesics|analgesics|mesh-list
5635628|NCT05191264|Sensory System Agents|sensory system agents|mesh-ancestor
5635629|NCT05191264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5635630|NCT05191264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635631|NCT05190627|Loratadine|loratadine|mesh-list
5635632|NCT05190627|Sirolimus|sirolimus|mesh-list
5760786|NCT02974361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5760787|NCT02974361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5760788|NCT02974361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5635633|NCT05190627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5635634|NCT05190627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5635635|NCT05190627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5635636|NCT05190627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5635637|NCT05190627|Antifungal Agents|antifungal agents|mesh-ancestor
5635638|NCT05190627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5635639|NCT05190627|Immunologic Factors|immunologic factors|mesh-ancestor
5635640|NCT05190627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635641|NCT05190627|Antipruritics|antipruritics|mesh-ancestor
5635642|NCT05190627|Dermatologic Agents|dermatologic agents|mesh-ancestor
5635643|NCT05190627|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5760789|NCT02974361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760790|NCT02974348|Acetaminophen|acetaminophen|mesh-list
5760791|NCT02974348|Amoxicillin|amoxicillin|mesh-list
5760792|NCT02974348|Artesunate|artesunate|mesh-list
5760793|NCT02974348|Lumefantrine|lumefantrine|mesh-list
5635644|NCT05190627|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5635645|NCT05190627|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5635646|NCT05190627|Histamine Antagonists|histamine antagonists|mesh-ancestor
5635647|NCT05190627|Histamine Agents|histamine agents|mesh-ancestor
5635648|NCT05190627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5760794|NCT02974348|Piperaquine|piperaquine|mesh-list
5760795|NCT02974348|Artenimol|artenimol|mesh-list
5760796|NCT02974348|Mefloquine|mefloquine|mesh-list
5760797|NCT02974348|Quinine|quinine|mesh-list
5760798|NCT02974348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5760799|NCT02974348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5760800|NCT02974348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5760801|NCT02974348|Analgesics|analgesics|mesh-ancestor
5760802|NCT02974348|Sensory System Agents|sensory system agents|mesh-ancestor
5760803|NCT02974348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5760804|NCT02974348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760805|NCT02974348|Antipyretics|antipyretics|mesh-ancestor
5635649|NCT05190627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760806|NCT02974348|Antimalarials|antimalarials|mesh-ancestor
5760807|NCT02974348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5760808|NCT02974348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5760809|NCT02974348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5760810|NCT02974348|Antiviral Agents|antiviral agents|mesh-ancestor
5635655|NCT05188820|Cortisone|cortisone|mesh-list
5635656|NCT05188820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5635657|NCT05188417|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5635658|NCT05188417|Tirofiban|tirofiban|mesh-list
5635659|NCT05188417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5635660|NCT05188417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5635661|NCT05188417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635662|NCT05188417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5635663|NCT05188326|Azacitidine|azacitidine|mesh-list
5760811|NCT02974348|Schistosomicides|schistosomicides|mesh-ancestor
5760812|NCT02974348|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5760813|NCT02974348|Anthelmintics|anthelmintics|mesh-ancestor
5760814|NCT02974348|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5760815|NCT02974348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5760816|NCT02974166|Ibuprofen|ibuprofen|mesh-list
5760817|NCT02974166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
5760818|NCT02974166|Cyclobenzaprine|cyclobenzaprine|mesh-list
5760819|NCT02974166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5760820|NCT02974166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5760821|NCT02974166|Analgesics|analgesics|mesh-ancestor
5635664|NCT05188326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5635665|NCT05188326|Antimetabolites|antimetabolites|mesh-ancestor
5635666|NCT05188326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635667|NCT05188326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5635668|NCT05188326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5635669|NCT05187039|Anesthetics|anesthetics|mesh-list
5635670|NCT05187039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5635671|NCT05187039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760822|NCT02974166|Sensory System Agents|sensory system agents|mesh-ancestor
5760823|NCT02974166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5760824|NCT02974166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760825|NCT02974166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5760826|NCT02974166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5760827|NCT02974166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6673285|NCT01561508|Histamine Antagonists|histamine antagonists|mesh-ancestor
6673286|NCT01561508|Histamine Agents|histamine agents|mesh-ancestor
6673287|NCT01561508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5635672|NCT05186454|Dexamethasone|dexamethasone|mesh-list
5635673|NCT05186454|Midazolam|midazolam|mesh-list
5635674|NCT05186454|Morphine|morphine|mesh-list
5635675|NCT05186454|Bupivacaine|bupivacaine|mesh-list
5635676|NCT05186454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5635677|NCT05186454|Antiemetics|antiemetics|mesh-ancestor
5635678|NCT05186454|Autonomic Agents|autonomic agents|mesh-ancestor
6673288|NCT01561508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673289|NCT01561508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673290|NCT01561586|Cisplatin|cisplatin|mesh-list
6673291|NCT01561586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6673292|NCT01561742|Minocycline|minocycline|mesh-list
6673293|NCT01561742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6673294|NCT01561742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6673295|NCT01561781|Digoxin|digoxin|mesh-list
6673296|NCT01561781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6673297|NCT01561781|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6673298|NCT01561781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6673299|NCT01561781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673300|NCT01561781|Protective Agents|protective agents|mesh-ancestor
6673301|NCT01561781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673302|NCT01561794|Ciprofloxacin|ciprofloxacin|mesh-list
6673303|NCT01561794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6673304|NCT01561794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6673305|NCT01561794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6673306|NCT01561794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6673307|NCT01561794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6673308|NCT01561794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212583|NCT02189941|Sequestering Agents|sequestering agents|mesh-ancestor
5635679|NCT05186454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5635680|NCT05186454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635681|NCT05186454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5635682|NCT05186454|Glucocorticoids|glucocorticoids|mesh-ancestor
6673309|NCT01561794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5635683|NCT05186454|Hormones|hormones|mesh-ancestor
5697840|NCT03373318|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5895429|NCT05228249|Cytarabine|cytarabine|mesh-list
6673310|NCT01561794|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6673311|NCT01561794|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6673312|NCT01561911|Antibodies|antibodies|mesh-list
6673313|NCT01561911|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6673314|NCT01561911|Immunologic Factors|immunologic factors|mesh-ancestor
6673315|NCT01561911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673316|NCT01561937|Warfarin|warfarin|mesh-list
6673317|NCT01561937|Anticoagulants|anticoagulants|mesh-ancestor
5760828|NCT02974166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760829|NCT02974166|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5760830|NCT02974166|Antidepressive Agents|antidepressive agents|mesh-ancestor
5760831|NCT02974166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5760832|NCT02974166|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5760833|NCT02974166|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5760834|NCT02974166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5760835|NCT02974166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5760836|NCT02974270|Leuprolide|leuprolide|mesh-list
5760837|NCT02974270|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5760838|NCT02974270|Fertility Agents|fertility agents|mesh-ancestor
5760839|NCT02974270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5760840|NCT02974270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760841|NCT02974270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5760842|NCT02974270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5635684|NCT05186454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5635685|NCT05186454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5635686|NCT05186454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5635687|NCT05186454|Anesthetics, Local|anesthetics, local|mesh-ancestor
5635688|NCT05186454|Anesthetics|anesthetics|mesh-ancestor
5635689|NCT05186454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5635690|NCT05186454|Sensory System Agents|sensory system agents|mesh-ancestor
5635691|NCT05186454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5635692|NCT05186454|Narcotics|narcotics|mesh-ancestor
5635693|NCT05186454|Analgesics|analgesics|mesh-ancestor
5635694|NCT05186454|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5760843|NCT02974257|Thiamine|thiamine|mesh-list
5760844|NCT02974257|Vitamins|vitamins|mesh-ancestor
5760845|NCT02974257|Micronutrients|micronutrients|mesh-ancestor
5760846|NCT02974257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760847|NCT02974257|Vitamin B Complex|vitamin b complex|mesh-ancestor
5760848|NCT02974049|Ivermectin|ivermectin|mesh-list
5760849|NCT02974049|Albendazole|albendazole|mesh-list
5760850|NCT02974049|Diethylcarbamazine|diethylcarbamazine|mesh-list
5760851|NCT02974049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5760852|NCT02974049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5760853|NCT02974049|Anthelmintics|anthelmintics|mesh-ancestor
5760854|NCT02974049|Anticestodal Agents|anticestodal agents|mesh-ancestor
5760855|NCT02974049|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5760856|NCT02974049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5760857|NCT02974049|Tubulin Modulators|tubulin modulators|mesh-ancestor
5760858|NCT02974049|Antimitotic Agents|antimitotic agents|mesh-ancestor
5760859|NCT02974049|Mitosis Modulators|mitosis modulators|mesh-ancestor
5760860|NCT02974049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760861|NCT02974049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5760862|NCT02974049|Filaricides|filaricides|mesh-ancestor
5760863|NCT02974049|Antinematodal Agents|antinematodal agents|mesh-ancestor
5635695|NCT05186454|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5635696|NCT05186454|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5635697|NCT05186454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5635698|NCT05186454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5635699|NCT05186454|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5635700|NCT05186454|Anesthetics, General|anesthetics, general|mesh-ancestor
5635701|NCT05186454|GABA Modulators|gaba modulators|mesh-ancestor
5635702|NCT05186454|GABA Agents|gaba agents|mesh-ancestor
5635703|NCT05186454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5760864|NCT02974049|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
5760865|NCT02974049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5760866|NCT02973880|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5760867|NCT02973880|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5760868|NCT02973958|Acetaminophen|acetaminophen|mesh-list
5760869|NCT02973958|Ibuprofen|ibuprofen|mesh-list
5760870|NCT02973958|Ketorolac|ketorolac|mesh-list
5760871|NCT02973958|Bupivacaine|bupivacaine|mesh-list
5760872|NCT02973958|Sevoflurane|sevoflurane|mesh-list
5760873|NCT02973958|Anesthetics, Local|anesthetics, local|mesh-ancestor
5635704|NCT05186454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673318|NCT01561950|Clopidogrel|clopidogrel|mesh-list
5760874|NCT02973958|Anesthetics|anesthetics|mesh-ancestor
5760875|NCT02973958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5760876|NCT02973958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760877|NCT02973958|Sensory System Agents|sensory system agents|mesh-ancestor
5760878|NCT02973958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5760879|NCT02973958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5760880|NCT02973958|Analgesics|analgesics|mesh-ancestor
5760881|NCT02973958|Antipyretics|antipyretics|mesh-ancestor
5760882|NCT02973958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5760883|NCT02973958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5760884|NCT02973958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5760885|NCT02973958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5760886|NCT02973958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5760887|NCT02973958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760888|NCT02973958|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5760889|NCT02973958|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5635705|NCT05179772|Olanzapine|olanzapine|mesh-list
5635706|NCT05179772|Antiemetics|antiemetics|mesh-ancestor
5635707|NCT05179772|Autonomic Agents|autonomic agents|mesh-ancestor
5635708|NCT05179772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5635709|NCT05179772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635710|NCT05179772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5635711|NCT05179772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5635712|NCT05179772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5635713|NCT05179772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5635714|NCT05179772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5635715|NCT05179772|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5635716|NCT05179772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5760890|NCT02973958|Anesthetics, General|anesthetics, general|mesh-ancestor
5760891|NCT02973737|Capecitabine|capecitabine|mesh-list
5760892|NCT02973737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5635717|NCT05179772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5635718|NCT05179772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635719|NCT05179772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5635720|NCT05179772|Serotonin Agents|serotonin agents|mesh-ancestor
5635721|NCT05176483|Nivolumab|nivolumab|mesh-list
5635722|NCT05176483|Ipilimumab|ipilimumab|mesh-list
5635723|NCT05176483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5635724|NCT05176483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5635725|NCT05176483|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5635726|NCT05176483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635727|NCT05176080|Fulvestrant|fulvestrant|mesh-list
5635728|NCT05176080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5635729|NCT05176080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5635730|NCT05176080|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5635731|NCT05176080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5635732|NCT05176080|Hormone Antagonists|hormone antagonists|mesh-ancestor
5635733|NCT05176080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5635734|NCT05176080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635735|NCT05162898|Lenvatinib|lenvatinib|mesh-list
5635736|NCT05162898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5635737|NCT05162898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5635738|NCT05162898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5635739|NCT05162898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635740|NCT05157126|Gentamicins|gentamicins|mesh-list
5635741|NCT05157126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5760893|NCT02973737|Antimetabolites|antimetabolites|mesh-ancestor
5760894|NCT02973737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760895|NCT02973737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5760896|NCT02973763|Aflutinib|aflutinib|mesh-list
5760897|NCT02973763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5760898|NCT02973763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5760899|NCT02973763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760900|NCT02973724|Remifentanil|remifentanil|mesh-list
5760901|NCT02973724|Propofol|propofol|mesh-list
5760902|NCT02973724|Anesthetics|anesthetics|mesh-ancestor
5760903|NCT02973724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5760904|NCT02973724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760905|NCT02973724|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5635742|NCT05157126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5635743|NCT05157126|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5635744|NCT05157126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5635745|NCT05157126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760906|NCT02973724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5760907|NCT02973724|Anesthetics, General|anesthetics, general|mesh-ancestor
5760908|NCT02973724|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5760909|NCT02973724|Narcotics|narcotics|mesh-ancestor
5760910|NCT02973724|Analgesics|analgesics|mesh-ancestor
5760911|NCT02973724|Sensory System Agents|sensory system agents|mesh-ancestor
5760912|NCT02973724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5760913|NCT02973776|Clobetasol|clobetasol|mesh-list
5760914|NCT02973776|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5760915|NCT02973776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5760916|NCT02973776|Glucocorticoids|glucocorticoids|mesh-ancestor
5760917|NCT02973776|Hormones|hormones|mesh-ancestor
5760918|NCT02973776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5760919|NCT02973776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760920|NCT02973646|Tenofovir|tenofovir|mesh-list
5760921|NCT02973646|Entecavir|entecavir|mesh-list
5760922|NCT02973646|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
5760923|NCT02973646|Antiviral Agents|antiviral agents|mesh-ancestor
5760924|NCT02973646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5760925|NCT02973646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5760926|NCT02973646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5760927|NCT02973646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5760928|NCT02973646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760929|NCT02973646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5760930|NCT02973646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5760931|NCT02973659|Oxybutynin|oxybutynin|mesh-list
5760932|NCT02973659|Parasympatholytics|parasympatholytics|mesh-ancestor
5760933|NCT02973659|Autonomic Agents|autonomic agents|mesh-ancestor
5760934|NCT02973659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5760935|NCT02973659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760936|NCT02973659|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5760937|NCT02973659|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5760938|NCT02973659|Cholinergic Agents|cholinergic agents|mesh-ancestor
5760939|NCT02973659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5760940|NCT02973659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760941|NCT02973659|Urological Agents|urological agents|mesh-ancestor
5760942|NCT02973633|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
5760943|NCT02973633|Chelating Agents|chelating agents|mesh-ancestor
5760944|NCT02973633|Sequestering Agents|sequestering agents|mesh-ancestor
5760945|NCT02973633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760946|NCT02973620|Simendan|simendan|mesh-list
5760947|NCT02973620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5760948|NCT02973620|Vasodilator Agents|vasodilator agents|mesh-ancestor
5760949|NCT02973620|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5760950|NCT02973620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5760951|NCT02973620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5760952|NCT02973620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760953|NCT02973620|Protective Agents|protective agents|mesh-ancestor
5760954|NCT02973620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760955|NCT02973386|Cisplatin|cisplatin|mesh-list
5760956|NCT02973386|Capecitabine|capecitabine|mesh-list
5760957|NCT02973386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5760958|NCT02973386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5760959|NCT02973386|Antimetabolites|antimetabolites|mesh-ancestor
5760960|NCT02973386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895430|NCT05228249|Etoposide|etoposide|mesh-list
5895431|NCT05228249|Podophyllotoxin|podophyllotoxin|mesh-list
5895432|NCT05228249|Etoposide phosphate|etoposide phosphate|mesh-list
5895433|NCT05228249|Melphalan|melphalan|mesh-list
5895434|NCT05228249|Mechlorethamine|mechlorethamine|mesh-list
5895435|NCT05228249|Carmustine|carmustine|mesh-list
5895436|NCT05228249|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
5895437|NCT05228249|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
5895438|NCT05228249|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5895439|NCT05228249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5895440|NCT05228249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5895441|NCT05228249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5895442|NCT05228249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5895443|NCT05228249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895444|NCT05228249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5895445|NCT05228249|Antimetabolites|antimetabolites|mesh-ancestor
5895446|NCT05228249|Antiviral Agents|antiviral agents|mesh-ancestor
5895447|NCT05228249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5895448|NCT05228249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5895449|NCT05228249|Immunologic Factors|immunologic factors|mesh-ancestor
5895450|NCT05228249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895451|NCT05228249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5760961|NCT02973451|Bupivacaine|bupivacaine|mesh-list
5760962|NCT02973451|Anesthetics, Local|anesthetics, local|mesh-ancestor
5760963|NCT02973451|Anesthetics|anesthetics|mesh-ancestor
5760964|NCT02973451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5760965|NCT02973451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760966|NCT02973451|Sensory System Agents|sensory system agents|mesh-ancestor
5760967|NCT02973451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5760968|NCT02973464|Valganciclovir|valganciclovir|mesh-list
5760969|NCT02973464|Ganciclovir|ganciclovir|mesh-list
5760970|NCT02973464|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
5760971|NCT02973464|Antiviral Agents|antiviral agents|mesh-ancestor
5760972|NCT02973464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5760973|NCT02973464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5760974|NCT02973464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5760975|NCT02973464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760976|NCT02973542|Ethosuximide|ethosuximide|mesh-list
5760977|NCT02973542|Anticonvulsants|anticonvulsants|mesh-ancestor
5760978|NCT02973295|Silymarin|silymarin|mesh-list
5760979|NCT02973295|Antioxidants|antioxidants|mesh-ancestor
5760980|NCT02973295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760981|NCT02973295|Protective Agents|protective agents|mesh-ancestor
5760982|NCT02973295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760983|NCT02973581|Acetaminophen|acetaminophen|mesh-list
5760984|NCT02973581|Dipyrone|dipyrone|mesh-list
5760985|NCT02973581|Lidocaine|lidocaine|mesh-list
5760986|NCT02973581|Bupivacaine|bupivacaine|mesh-list
5760987|NCT02973581|Proxymetacaine|proxymetacaine|mesh-list
5760988|NCT02973581|Anesthetics, Local|anesthetics, local|mesh-ancestor
5760989|NCT02973581|Anesthetics|anesthetics|mesh-ancestor
5760990|NCT02973581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5760991|NCT02973581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5760992|NCT02973581|Sensory System Agents|sensory system agents|mesh-ancestor
5760993|NCT02973581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5760994|NCT02973581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5760995|NCT02973581|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5760996|NCT02973581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5760997|NCT02973581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5760998|NCT02973581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5760999|NCT02973581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5761000|NCT02973581|Analgesics|analgesics|mesh-ancestor
5761001|NCT02973581|Antipyretics|antipyretics|mesh-ancestor
5761002|NCT02973581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5761003|NCT02973581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5761004|NCT02973581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5761005|NCT02973113|Nivolumab|nivolumab|mesh-list
5761006|NCT02973113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5761007|NCT02973113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5761008|NCT02973113|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5761009|NCT02973113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761010|NCT02973204|Everolimus|everolimus|mesh-list
5761011|NCT02973204|Sorafenib|sorafenib|mesh-list
5761012|NCT02973204|Octreotide|octreotide|mesh-list
5761013|NCT02973204|Lanreotide|lanreotide|mesh-list
5761014|NCT02973204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5761015|NCT02973204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5761016|NCT02973204|Immunologic Factors|immunologic factors|mesh-ancestor
5761017|NCT02973204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761018|NCT02973204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5761019|NCT02973204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5761020|NCT02973204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761021|NCT02973204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5761022|NCT02973204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5761023|NCT02973035|Amlodipine|amlodipine|mesh-list
5761024|NCT02973035|Valsartan|valsartan|mesh-list
5761025|NCT02973035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5761026|NCT02973035|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5761027|NCT02973035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5761028|NCT02973035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761029|NCT02973035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5761030|NCT02973035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761031|NCT02973035|Vasodilator Agents|vasodilator agents|mesh-ancestor
5761032|NCT02973035|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5761033|NCT02973035|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5761034|NCT02972918|Simendan|simendan|mesh-list
5761035|NCT02972918|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5761036|NCT02972918|Vasodilator Agents|vasodilator agents|mesh-ancestor
5635746|NCT05156268|Pembrolizumab|pembrolizumab|mesh-list
5635747|NCT05156268|Olaparib|olaparib|mesh-list
5635748|NCT05156268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5635749|NCT05156268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5635750|NCT05156268|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5635751|NCT05156268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5635752|NCT05156268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635753|NCT05156060|Ketamine|ketamine|mesh-list
5635754|NCT05156060|Gabapentin|gabapentin|mesh-list
5635755|NCT05156060|Analgesics|analgesics|mesh-ancestor
5635756|NCT05156060|Sensory System Agents|sensory system agents|mesh-ancestor
5635757|NCT05156060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5635758|NCT05156060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635759|NCT05156060|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5635760|NCT05156060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5635761|NCT05156060|Anesthetics, General|anesthetics, general|mesh-ancestor
5635762|NCT05156060|Anesthetics|anesthetics|mesh-ancestor
5635763|NCT05156060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5635764|NCT05156060|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5635765|NCT05156060|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5635766|NCT05156060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5635767|NCT05156060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635768|NCT05156060|Anticonvulsants|anticonvulsants|mesh-ancestor
5635769|NCT05156060|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5635770|NCT05156060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5635771|NCT05156060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5635772|NCT05156060|Antimanic Agents|antimanic agents|mesh-ancestor
5635773|NCT05155137|Amlodipine|amlodipine|mesh-list
5635774|NCT05155137|Valsartan|valsartan|mesh-list
5635775|NCT05155137|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5635776|NCT05155137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5635777|NCT05155137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5635778|NCT05155137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5635779|NCT05155137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635780|NCT05155137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5635781|NCT05155137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635782|NCT05155137|Vasodilator Agents|vasodilator agents|mesh-ancestor
5635783|NCT05155137|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5635784|NCT05155137|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5635785|NCT05155137|Antimetabolites|antimetabolites|mesh-ancestor
5635786|NCT05155137|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5635787|NCT05155137|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5635788|NCT05155137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5635789|NCT05155137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5635790|NCT05155137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5635791|NCT05153525|Cisatracurium|cisatracurium|mesh-list
5635792|NCT05153525|Atracurium|atracurium|mesh-list
5635793|NCT05153525|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5635794|NCT05153525|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5635795|NCT05153525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5635796|NCT05153525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635797|NCT05153525|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5635798|NCT05153525|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
5635799|NCT05153525|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5635800|NCT05153525|Cholinergic Agents|cholinergic agents|mesh-ancestor
5635801|NCT05153525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5635802|NCT05153525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635803|NCT05153239|Irinotecan|irinotecan|mesh-list
5635804|NCT05153239|Topotecan|topotecan|mesh-list
5635805|NCT05153239|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5635806|NCT05153239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5635807|NCT05153239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5635808|NCT05153239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635809|NCT05153239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5635810|NCT05150938|Vitamin K|vitamin k|mesh-list
5635811|NCT05150938|Heparin|heparin|mesh-list
5635812|NCT05150938|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5635813|NCT05150938|Tinzaparin|tinzaparin|mesh-list
5635814|NCT05150938|Dalteparin|dalteparin|mesh-list
5635815|NCT05150938|Rivaroxaban|rivaroxaban|mesh-list
5635816|NCT05150938|Vitamins|vitamins|mesh-ancestor
5635817|NCT05150938|Micronutrients|micronutrients|mesh-ancestor
5635818|NCT05150938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635819|NCT05150938|Anticoagulants|anticoagulants|mesh-ancestor
5635820|NCT05150938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5635821|NCT05150938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5761037|NCT02972918|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5761038|NCT02972918|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5761039|NCT02972918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6490155|NCT00596154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6490156|NCT00596154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6490157|NCT00596154|Tubulin Modulators|tubulin modulators|mesh-ancestor
6490158|NCT00596154|Antimitotic Agents|antimitotic agents|mesh-ancestor
6490159|NCT00596154|Mitosis Modulators|mitosis modulators|mesh-ancestor
5761040|NCT02972918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761041|NCT02972918|Protective Agents|protective agents|mesh-ancestor
5761042|NCT02972918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761043|NCT02972957|Azithromycin|azithromycin|mesh-list
5761044|NCT02972957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5761045|NCT02972957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5761046|NCT02972983|Daptomycin|daptomycin|mesh-list
5761047|NCT02972983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5635822|NCT05150938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635823|NCT05150938|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5635824|NCT05150938|Antithrombins|antithrombins|mesh-ancestor
5635825|NCT05150938|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5635826|NCT05150938|Protease Inhibitors|protease inhibitors|mesh-ancestor
5635827|NCT05150938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5635828|NCT05150938|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5635829|NCT05150938|Hemostatics|hemostatics|mesh-ancestor
5635830|NCT05150938|Coagulants|coagulants|mesh-ancestor
5635831|NCT05148078|Anesthetics|anesthetics|mesh-list
5635832|NCT05148078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5635833|NCT05148078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635834|NCT05145764|Suvorexant|suvorexant|mesh-list
5761048|NCT02972983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5761049|NCT02972905|Nemiralisib|nemiralisib|mesh-list
5761050|NCT02972905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5635835|NCT05145764|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5635836|NCT05145764|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5635837|NCT05145764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5635838|NCT05145764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635839|NCT05145764|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
5635840|NCT05145764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5635841|NCT05145764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635842|NCT05144295|Lactulose|lactulose|mesh-list
5635843|NCT05144295|Bisacodyl|bisacodyl|mesh-list
5635844|NCT05144295|Picosulfate sodium|picosulfate sodium|mesh-list
5635845|NCT05144295|Lubiprostone|lubiprostone|mesh-list
5635846|NCT05144295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5635847|NCT05144295|Cathartics|cathartics|mesh-ancestor
6490160|NCT00596154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6490161|NCT00596206|Leflunomide|leflunomide|mesh-list
6490162|NCT00596206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6490163|NCT00596206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490164|NCT00596206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6490165|NCT00596206|Immunologic Factors|immunologic factors|mesh-ancestor
6490166|NCT00596206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490167|NCT00596219|Celecoxib|celecoxib|mesh-list
6490168|NCT00596219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6490169|NCT00596219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6490170|NCT00596219|Analgesics|analgesics|mesh-ancestor
6490171|NCT00596219|Sensory System Agents|sensory system agents|mesh-ancestor
6490172|NCT00596219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5635848|NCT05144295|Laxatives|laxatives|mesh-ancestor
5635849|NCT05144295|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
5635850|NCT05144295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5635851|NCT05144295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693596|NCT03400683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5693597|NCT03400683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693598|NCT03400683|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5693599|NCT03400683|Abortifacient Agents|abortifacient agents|mesh-ancestor
5693600|NCT03400683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5693601|NCT03400683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6490173|NCT00596219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490174|NCT00596219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5761051|NCT02972905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5761052|NCT02972905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761053|NCT02972866|Budesonide|budesonide|mesh-list
5761054|NCT02972866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5761055|NCT02972866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5761056|NCT02972866|Autonomic Agents|autonomic agents|mesh-ancestor
5761057|NCT02972866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5761058|NCT02972866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761059|NCT02972866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5761060|NCT02972866|Respiratory System Agents|respiratory system agents|mesh-ancestor
5761061|NCT02972866|Glucocorticoids|glucocorticoids|mesh-ancestor
5761062|NCT02972866|Hormones|hormones|mesh-ancestor
5761063|NCT02972866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5761064|NCT02972723|Metformin|metformin|mesh-list
5761065|NCT02972723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5761066|NCT02972723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761067|NCT02972762|Propofol|propofol|mesh-list
5761068|NCT02972762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5761069|NCT02972762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5761070|NCT02972762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761071|NCT02972762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5761072|NCT02972762|Anesthetics, General|anesthetics, general|mesh-ancestor
5761073|NCT02972762|Anesthetics|anesthetics|mesh-ancestor
5761074|NCT02972463|Immunoglobulins|immunoglobulins|mesh-list
5761075|NCT02972463|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5761076|NCT02972463|Antibodies|antibodies|mesh-list
5761077|NCT02972463|Immunologic Factors|immunologic factors|mesh-ancestor
5761078|NCT02972463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761079|NCT02972450|Vedolizumab|vedolizumab|mesh-list
5761080|NCT02972450|Vaccines|vaccines|mesh-list
5761081|NCT02972450|Immunologic Factors|immunologic factors|mesh-ancestor
5761082|NCT02972450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761083|NCT02972450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5761084|NCT02972476|Fluticasone|fluticasone|mesh-list
5761085|NCT02972476|Xhance|xhance|mesh-list
5761086|NCT02972476|Budesonide|budesonide|mesh-list
5761087|NCT02972476|Bromides|bromides|mesh-list
5761088|NCT02972476|Formoterol Fumarate|formoterol fumarate|mesh-list
5761089|NCT02972476|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5635852|NCT05144243|Azacitidine|azacitidine|mesh-list
5635853|NCT05144243|Venetoclax|venetoclax|mesh-list
5635854|NCT05144243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5635855|NCT05144243|Antimetabolites|antimetabolites|mesh-ancestor
5635856|NCT05144243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635857|NCT05144243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5635858|NCT05144243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5635859|NCT05142241|Temozolomide|temozolomide|mesh-list
5635860|NCT05142241|Talazoparib|talazoparib|mesh-list
5635861|NCT05142241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5635862|NCT05142241|Alkylating Agents|alkylating agents|mesh-ancestor
5635863|NCT05142241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635864|NCT05142241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5635865|NCT05142241|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5635866|NCT05142241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5635867|NCT05139316|Prednisolone|prednisolone|mesh-list
5635868|NCT05139316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5635869|NCT05139316|Glucocorticoids|glucocorticoids|mesh-ancestor
5635870|NCT05139316|Hormones|hormones|mesh-ancestor
5635871|NCT05139316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5635872|NCT05139316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635873|NCT05139316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5635874|NCT05139316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5635875|NCT05137067|Cisplatin|cisplatin|mesh-list
5635876|NCT05137067|Docetaxel|docetaxel|mesh-list
5635877|NCT05137067|Antineoplastic Agents|antineoplastic agents|mesh-list
5635878|NCT05137067|Tubulin Modulators|tubulin modulators|mesh-ancestor
5635879|NCT05137067|Antimitotic Agents|antimitotic agents|mesh-ancestor
5635880|NCT05137067|Mitosis Modulators|mitosis modulators|mesh-ancestor
5635881|NCT05137067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635882|NCT05136846|Paclitaxel|paclitaxel|mesh-list
5635883|NCT05136846|Carboplatin|carboplatin|mesh-list
5635884|NCT05136846|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5635885|NCT05136846|Durvalumab|durvalumab|mesh-list
5761090|NCT02972476|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
5761091|NCT02972476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5761092|NCT02972476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5761093|NCT02972476|Autonomic Agents|autonomic agents|mesh-ancestor
5635886|NCT05136846|Papaverine|papaverine|mesh-list
5635887|NCT05136846|Immunoglobulins|immunoglobulins|mesh-list
5635888|NCT05136846|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5761094|NCT02972476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5761095|NCT02972476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761096|NCT02972476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5761097|NCT02972476|Respiratory System Agents|respiratory system agents|mesh-ancestor
5761098|NCT02972476|Dermatologic Agents|dermatologic agents|mesh-ancestor
5761099|NCT02972476|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5761100|NCT02972476|Glucocorticoids|glucocorticoids|mesh-ancestor
5761101|NCT02972476|Hormones|hormones|mesh-ancestor
5761102|NCT02972476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5761103|NCT02972476|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5761104|NCT02972476|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5761105|NCT02972476|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5761106|NCT02972476|Adrenergic Agents|adrenergic agents|mesh-ancestor
5761107|NCT02972476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5761108|NCT02972476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761109|NCT02972476|Anticonvulsants|anticonvulsants|mesh-ancestor
5761110|NCT02972476|Sympathomimetics|sympathomimetics|mesh-ancestor
5761111|NCT02972320|Temozolomide|temozolomide|mesh-list
5761112|NCT02972320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5761113|NCT02972320|Alkylating Agents|alkylating agents|mesh-ancestor
5761114|NCT02972320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761115|NCT02972320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5761116|NCT02972333|Osimertinib|osimertinib|mesh-list
5761117|NCT02972333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5761118|NCT02972333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5761119|NCT02972333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5761120|NCT02972333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761121|NCT02972294|Iron|iron|mesh-list
5761122|NCT02972294|Tranexamic Acid|tranexamic acid|mesh-list
5761123|NCT02972294|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
5761124|NCT02972294|Ferric Compounds|ferric compounds|mesh-list
5761125|NCT02972294|Trace Elements|trace elements|mesh-ancestor
5761126|NCT02972294|Micronutrients|micronutrients|mesh-ancestor
5761127|NCT02972294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761128|NCT02972294|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5761129|NCT02972294|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5761130|NCT02972294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761131|NCT02972294|Hemostatics|hemostatics|mesh-ancestor
5761132|NCT02972294|Coagulants|coagulants|mesh-ancestor
5761133|NCT02972294|Hematinics|hematinics|mesh-ancestor
5761134|NCT02972346|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
5761135|NCT02972346|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
5761136|NCT02972346|beta-Endorphin|beta-endorphin|mesh-list
5761137|NCT02972346|Hormones|hormones|mesh-ancestor
5761138|NCT02972346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5761139|NCT02972346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635889|NCT05136846|Immunoglobulin G|immunoglobulin g|mesh-list
5635890|NCT05136846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5635891|NCT05136846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5761140|NCT02972346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5761141|NCT02972346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761142|NCT02972411|Acetazolamide|acetazolamide|mesh-list
5761143|NCT02972411|Anticonvulsants|anticonvulsants|mesh-ancestor
5761144|NCT02972411|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5761145|NCT02972411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5761146|NCT02972411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635892|NCT05136846|Tubulin Modulators|tubulin modulators|mesh-ancestor
5635893|NCT05136846|Antimitotic Agents|antimitotic agents|mesh-ancestor
5635894|NCT05136846|Mitosis Modulators|mitosis modulators|mesh-ancestor
5635895|NCT05136846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635896|NCT05136846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5635897|NCT05136846|Immunologic Factors|immunologic factors|mesh-ancestor
5635898|NCT05136846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635899|NCT05136846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5635900|NCT05136846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5635901|NCT05136846|Vasodilator Agents|vasodilator agents|mesh-ancestor
5635902|NCT05136846|Urological Agents|urological agents|mesh-ancestor
5635903|NCT05134857|Zonisamide|zonisamide|mesh-list
5635904|NCT05134857|Anticonvulsants|anticonvulsants|mesh-ancestor
5635905|NCT05134857|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5635906|NCT05134857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5635907|NCT05134857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635908|NCT05134857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5635909|NCT05134857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635910|NCT05129358|Furosemide|furosemide|mesh-list
5635911|NCT05129358|Diuretics|diuretics|mesh-ancestor
5635912|NCT05129358|Natriuretic Agents|natriuretic agents|mesh-ancestor
5635913|NCT05129358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635914|NCT05129358|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5635915|NCT05129358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5635916|NCT05129358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635917|NCT05128591|Rivaroxaban|rivaroxaban|mesh-list
5635918|NCT05128591|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5635919|NCT05128591|Antithrombins|antithrombins|mesh-ancestor
5635920|NCT05128591|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5635921|NCT05128591|Protease Inhibitors|protease inhibitors|mesh-ancestor
5635922|NCT05128591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5761147|NCT02972411|Diuretics|diuretics|mesh-ancestor
5635923|NCT05128591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635924|NCT05128591|Anticoagulants|anticoagulants|mesh-ancestor
5635925|NCT05117242|Pembrolizumab|pembrolizumab|mesh-list
5635926|NCT05117242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5635927|NCT05117242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5635928|NCT05113290|Sorafenib|sorafenib|mesh-list
5635929|NCT05113290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5635930|NCT05113290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6490175|NCT00596219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6490176|NCT00596219|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6490177|NCT00596219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5635931|NCT05113290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5635932|NCT05113290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209189|NCT02141854|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6209190|NCT02141854|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6209191|NCT02141854|Adrenergic Agents|adrenergic agents|mesh-ancestor
6209192|NCT02141854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5635937|NCT05107778|Entecavir|entecavir|mesh-list
5635938|NCT05107778|Antiviral Agents|antiviral agents|mesh-ancestor
5635939|NCT05107778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5635940|NCT05102409|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5761148|NCT02972411|Natriuretic Agents|natriuretic agents|mesh-ancestor
5761149|NCT02972411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761150|NCT02972424|Teriparatide|teriparatide|mesh-list
5761151|NCT02972424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5761152|NCT02972424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761153|NCT02972424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5761154|NCT02972268|Tamsulosin|tamsulosin|mesh-list
5761155|NCT02972268|Solifenacin Succinate|solifenacin succinate|mesh-list
6490178|NCT00596219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6490179|NCT00596219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496376|NCT00627809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496377|NCT00627835|Cisplatin|cisplatin|mesh-list
5635941|NCT05102409|Lifitegrast|lifitegrast|mesh-list
5635942|NCT05102409|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5635943|NCT05097716|Tolbutamide|tolbutamide|mesh-list
5635944|NCT05097716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6496378|NCT00627835|Sorafenib|sorafenib|mesh-list
6496379|NCT00627835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6496380|NCT00627835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6496381|NCT00627835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6496382|NCT00627835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496383|NCT00627848|Rivastigmine|rivastigmine|mesh-list
6496384|NCT00627848|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5635945|NCT05097716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635946|NCT05096884|Metoprolol|metoprolol|mesh-list
5635947|NCT05096884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5635948|NCT05096884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5635949|NCT05096884|Sympatholytics|sympatholytics|mesh-ancestor
5635950|NCT05096884|Autonomic Agents|autonomic agents|mesh-ancestor
5635951|NCT05096884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5635952|NCT05096884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635953|NCT05096884|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5635954|NCT05096884|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5635955|NCT05096884|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5635956|NCT05096884|Adrenergic Agents|adrenergic agents|mesh-ancestor
5635957|NCT05096884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6496385|NCT00627848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6496386|NCT00627848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496387|NCT00627848|Cholinergic Agents|cholinergic agents|mesh-ancestor
6496388|NCT00627848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6496389|NCT00627848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635958|NCT05096884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635959|NCT05095857|Ketamine|ketamine|mesh-list
5635960|NCT05095857|Esketamine|esketamine|mesh-list
5635961|NCT05095857|Analgesics|analgesics|mesh-ancestor
5761156|NCT02972268|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5761157|NCT02972268|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5761158|NCT02972268|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5761159|NCT02972268|Adrenergic Agents|adrenergic agents|mesh-ancestor
5761160|NCT02972268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5761161|NCT02972268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761162|NCT02972268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761163|NCT02972268|Urological Agents|urological agents|mesh-ancestor
5761164|NCT02972268|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5761165|NCT02972268|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5761166|NCT02972268|Cholinergic Agents|cholinergic agents|mesh-ancestor
5761167|NCT02972216|Docetaxel|docetaxel|mesh-list
5761168|NCT02972216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5761169|NCT02972216|Tubulin Modulators|tubulin modulators|mesh-ancestor
5761170|NCT02972216|Antimitotic Agents|antimitotic agents|mesh-ancestor
5761171|NCT02972216|Mitosis Modulators|mitosis modulators|mesh-ancestor
5761172|NCT02972216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761173|NCT02972255|Meropenem|meropenem|mesh-list
5761174|NCT02972255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5761175|NCT02972255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5761176|NCT02971930|Factor VIII|factor viii|mesh-list
5761177|NCT02971930|Coagulants|coagulants|mesh-ancestor
5761178|NCT02971982|Dexamethasone|dexamethasone|mesh-list
5761179|NCT02971982|Dexamethasone acetate|dexamethasone acetate|mesh-list
5761180|NCT02971982|Cyclophosphamide|cyclophosphamide|mesh-list
5761181|NCT02971982|Rituximab|rituximab|mesh-list
5761182|NCT02971982|Bortezomib|bortezomib|mesh-list
5761183|NCT02971982|BB 1101|bb 1101|mesh-list
5761184|NCT02971982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5761185|NCT02971982|Immunologic Factors|immunologic factors|mesh-ancestor
5761186|NCT02971982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761187|NCT02971982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5761188|NCT02971982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5761189|NCT02971982|Alkylating Agents|alkylating agents|mesh-ancestor
5761190|NCT02971982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635962|NCT05095857|Sensory System Agents|sensory system agents|mesh-ancestor
5635963|NCT05095857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5635964|NCT05095857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5635965|NCT05095857|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5635966|NCT05095857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5635967|NCT05095857|Anesthetics, General|anesthetics, general|mesh-ancestor
5635968|NCT05095857|Anesthetics|anesthetics|mesh-ancestor
5635969|NCT05095857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5635970|NCT05095857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5761191|NCT02971982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5761192|NCT02971982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5761193|NCT02971982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5761194|NCT02971982|Antiemetics|antiemetics|mesh-ancestor
5761195|NCT02971982|Autonomic Agents|autonomic agents|mesh-ancestor
5761196|NCT02971982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5761197|NCT02971982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5761198|NCT02971982|Glucocorticoids|glucocorticoids|mesh-ancestor
5761199|NCT02971982|Hormones|hormones|mesh-ancestor
5761200|NCT02971982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5761201|NCT02971982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5761202|NCT02971982|Protease Inhibitors|protease inhibitors|mesh-ancestor
5761203|NCT02971982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5761204|NCT02971982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5761205|NCT02972034|Pembrolizumab|pembrolizumab|mesh-list
5761206|NCT02972034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5761207|NCT02972034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5761208|NCT02972125|Lacosamide|lacosamide|mesh-list
5761209|NCT02972125|Anticonvulsants|anticonvulsants|mesh-ancestor
5761210|NCT02972125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5761211|NCT02972125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5761212|NCT02972125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5761213|NCT02972125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761214|NCT02971761|Pembrolizumab|pembrolizumab|mesh-list
5761215|NCT02971761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5761216|NCT02971761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5895452|NCT05228249|Alkylating Agents|alkylating agents|mesh-ancestor
5635971|NCT05095857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5635972|NCT05095857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5635973|NCT05095857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5635974|NCT05095857|Antidepressive Agents|antidepressive agents|mesh-ancestor
5635975|NCT05095857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5635976|NCT05084638|Ofatumumab|ofatumumab|mesh-list
5635977|NCT05084638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6209193|NCT02141854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209194|NCT02141854|Tocolytic Agents|tocolytic agents|mesh-ancestor
6209195|NCT02141854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6209196|NCT02141997|Adalimumab|adalimumab|mesh-list
6209197|NCT02141997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6209198|NCT02141997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6209199|NCT02142049|Lenalidomide|lenalidomide|mesh-list
6209200|NCT02142049|Immunologic Factors|immunologic factors|mesh-ancestor
5761217|NCT02971878|Thioctic Acid|thioctic acid|mesh-list
5761218|NCT02971878|Acetylcarnitine|acetylcarnitine|mesh-list
5761219|NCT02971878|Acetylcysteine|acetylcysteine|mesh-list
5761220|NCT02971878|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5761221|NCT02971878|Antioxidants|antioxidants|mesh-ancestor
5761222|NCT02971878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761223|NCT02971878|Protective Agents|protective agents|mesh-ancestor
5761224|NCT02971878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761225|NCT02971878|Vitamin B Complex|vitamin b complex|mesh-ancestor
5761226|NCT02971878|Vitamins|vitamins|mesh-ancestor
5761227|NCT02971878|Micronutrients|micronutrients|mesh-ancestor
5761228|NCT02971878|Nootropic Agents|nootropic agents|mesh-ancestor
5761229|NCT02971878|Antiviral Agents|antiviral agents|mesh-ancestor
5761230|NCT02971878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5761231|NCT02971878|Expectorants|expectorants|mesh-ancestor
5761232|NCT02971878|Respiratory System Agents|respiratory system agents|mesh-ancestor
5761233|NCT02971878|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5761234|NCT02971878|Antidotes|antidotes|mesh-ancestor
5761235|NCT02971644|Cobalt|cobalt|mesh-list
5761236|NCT02971644|Trace Elements|trace elements|mesh-ancestor
5761237|NCT02971644|Micronutrients|micronutrients|mesh-ancestor
6209201|NCT02142049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209202|NCT02142049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6209203|NCT02142049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6209204|NCT02142049|Growth Substances|growth substances|mesh-ancestor
6209205|NCT02142049|Growth Inhibitors|growth inhibitors|mesh-ancestor
6209206|NCT02142049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6209207|NCT02142153|Olorofim|olorofim|mesh-list
6209208|NCT02142153|Antifungal Agents|antifungal agents|mesh-ancestor
6209209|NCT02142153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6209210|NCT02142712|Diphenhydramine|diphenhydramine|mesh-list
6209211|NCT02142712|Promethazine|promethazine|mesh-list
6209212|NCT02142712|Dextromethorphan|dextromethorphan|mesh-list
5761238|NCT02971644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761239|NCT02971475|Analgesics|analgesics|mesh-list
5761240|NCT02971475|Sensory System Agents|sensory system agents|mesh-ancestor
5761241|NCT02971475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5761242|NCT02971475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761243|NCT02971696|Sorafenib|sorafenib|mesh-list
5761244|NCT02971696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5761245|NCT02971696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5761246|NCT02971696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5761247|NCT02971696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761248|NCT02971423|Imipenem|imipenem|mesh-list
5761249|NCT02971423|Sulbactam|sulbactam|mesh-list
5761250|NCT02971423|Cilastatin|cilastatin|mesh-list
5761251|NCT02971423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5761252|NCT02971423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5761253|NCT02971423|Protease Inhibitors|protease inhibitors|mesh-ancestor
5761254|NCT02971423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5761255|NCT02971423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761256|NCT02971423|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5635998|NCT05076877|Metformin|metformin|mesh-list
5761257|NCT02971410|Simvastatin|simvastatin|mesh-list
5761258|NCT02971410|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5761259|NCT02971410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5761260|NCT02971410|Antimetabolites|antimetabolites|mesh-ancestor
5761261|NCT02971410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761262|NCT02971410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5635999|NCT05076877|Midazolam|midazolam|mesh-list
5636000|NCT05076877|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5636001|NCT05076877|Lazertinib|lazertinib|mesh-list
5636002|NCT05076877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5761263|NCT02971410|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5636003|NCT05076877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636004|NCT05076877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5636005|NCT05076877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5636006|NCT05076877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5636007|NCT05076877|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5636008|NCT05076877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5636009|NCT05076877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5636010|NCT05076877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5636011|NCT05076877|Anesthetics, General|anesthetics, general|mesh-ancestor
5636012|NCT05076877|Anesthetics|anesthetics|mesh-ancestor
5636013|NCT05076877|GABA Modulators|gaba modulators|mesh-ancestor
5636014|NCT05076877|GABA Agents|gaba agents|mesh-ancestor
5636015|NCT05076877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5636016|NCT05076877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5636017|NCT05076877|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5636018|NCT05076877|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5636019|NCT05076877|Antimetabolites|antimetabolites|mesh-ancestor
5761264|NCT02971410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5761265|NCT02971540|Dipyrone|dipyrone|mesh-list
5761266|NCT02971540|Tramadol|tramadol|mesh-list
5761267|NCT02971540|Bupivacaine|bupivacaine|mesh-list
5761268|NCT02971540|Ropivacaine|ropivacaine|mesh-list
5761269|NCT02971540|Anesthetics, Local|anesthetics, local|mesh-ancestor
5761270|NCT02971540|Anesthetics|anesthetics|mesh-ancestor
5761271|NCT02971540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5761272|NCT02971540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761273|NCT02971540|Sensory System Agents|sensory system agents|mesh-ancestor
5761274|NCT02971540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5761275|NCT02971540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5761276|NCT02971540|Narcotics|narcotics|mesh-ancestor
5761277|NCT02971540|Analgesics|analgesics|mesh-ancestor
5761278|NCT02971540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5761279|NCT02971540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5761280|NCT02971540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5761281|NCT02971540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5761282|NCT02971540|Antipyretics|antipyretics|mesh-ancestor
5761283|NCT02971397|Cytarabine|cytarabine|mesh-list
5761284|NCT02971397|Daunorubicin|daunorubicin|mesh-list
5761285|NCT02971397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5761286|NCT02971397|Antimetabolites|antimetabolites|mesh-ancestor
5761287|NCT02971397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761288|NCT02971397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5761289|NCT02971397|Antiviral Agents|antiviral agents|mesh-ancestor
5761290|NCT02971397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5761291|NCT02971397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5761292|NCT02971397|Immunologic Factors|immunologic factors|mesh-ancestor
5761293|NCT02971397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761294|NCT02971397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5761295|NCT02971397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5761296|NCT02971397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5636020|NCT05076877|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5636021|NCT05076877|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5636022|NCT05076877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5636023|NCT05076877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5636024|NCT05076838|Diazepam|diazepam|mesh-list
5761297|NCT02971397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5761298|NCT02971306|Acetylcysteine|acetylcysteine|mesh-list
5761299|NCT02971306|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5761300|NCT02971306|Antiviral Agents|antiviral agents|mesh-ancestor
5761301|NCT02971306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5761302|NCT02971306|Expectorants|expectorants|mesh-ancestor
5761303|NCT02971306|Respiratory System Agents|respiratory system agents|mesh-ancestor
5761304|NCT02971306|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5761305|NCT02971306|Antioxidants|antioxidants|mesh-ancestor
5761306|NCT02971306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761307|NCT02971306|Protective Agents|protective agents|mesh-ancestor
5761308|NCT02971306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761309|NCT02971306|Antidotes|antidotes|mesh-ancestor
5761310|NCT02971254|Sevoflurane|sevoflurane|mesh-list
5761311|NCT02971254|Desflurane|desflurane|mesh-list
5761312|NCT02971254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5761313|NCT02971254|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5761314|NCT02971254|Anesthetics, General|anesthetics, general|mesh-ancestor
5761315|NCT02971254|Anesthetics|anesthetics|mesh-ancestor
5636025|NCT05076838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5761316|NCT02971254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5761317|NCT02971254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761318|NCT02971345|Iodine|iodine|mesh-list
5761319|NCT02971345|Cadexomer iodine|cadexomer iodine|mesh-list
5761320|NCT02971345|Epirubicin|epirubicin|mesh-list
5761321|NCT02971345|Ethiodized Oil|ethiodized oil|mesh-list
5761322|NCT02971345|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5761323|NCT02971345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5761324|NCT02971345|Trace Elements|trace elements|mesh-ancestor
5761325|NCT02971345|Micronutrients|micronutrients|mesh-ancestor
5761326|NCT02971345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761327|NCT02971345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5761328|NCT02971345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5761329|NCT02971345|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5761330|NCT02971345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5761331|NCT02971345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5761332|NCT02971345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761333|NCT02971319|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
5761334|NCT02971319|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5761335|NCT02971319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761336|NCT02971033|Ezetimibe|ezetimibe|mesh-list
5761337|NCT02971033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5761338|NCT02971033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5761339|NCT02971033|Antimetabolites|antimetabolites|mesh-ancestor
5761340|NCT02971033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761341|NCT02971033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5761342|NCT02970773|Rivaroxaban|rivaroxaban|mesh-list
5761343|NCT02970773|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5761344|NCT02970773|Antithrombins|antithrombins|mesh-ancestor
5761345|NCT02970773|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5761346|NCT02970773|Protease Inhibitors|protease inhibitors|mesh-ancestor
5761347|NCT02970773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5761348|NCT02970773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761349|NCT02970773|Anticoagulants|anticoagulants|mesh-ancestor
5761350|NCT02970721|Antipsychotic Agents|antipsychotic agents|mesh-list
5761351|NCT02970721|Antidepressive Agents|antidepressive agents|mesh-list
5761352|NCT02970721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5761353|NCT02970721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5761354|NCT02970721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5761355|NCT02970721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761356|NCT02970916|Aflibercept|aflibercept|mesh-list
5761357|NCT02970916|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5761358|NCT02970916|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5636026|NCT05076838|Anticonvulsants|anticonvulsants|mesh-ancestor
5636027|NCT05076838|Antiemetics|antiemetics|mesh-ancestor
5636028|NCT05076838|Autonomic Agents|autonomic agents|mesh-ancestor
5636029|NCT05076838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5636030|NCT05076838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636031|NCT05076838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5636032|NCT05076838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5636033|NCT05076838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5636034|NCT05076838|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5636035|NCT05076838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5636036|NCT05076838|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5636037|NCT05076838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5636038|NCT05076838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5636039|NCT05076838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5636040|NCT05076838|Anesthetics, General|anesthetics, general|mesh-ancestor
5761359|NCT02970916|Growth Substances|growth substances|mesh-ancestor
5761360|NCT02970916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761361|NCT02970916|Growth Inhibitors|growth inhibitors|mesh-ancestor
5761362|NCT02970916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5761363|NCT02970630|Everolimus|everolimus|mesh-list
5761364|NCT02970630|Tacrolimus|tacrolimus|mesh-list
5761365|NCT02970630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5761366|NCT02970630|Immunologic Factors|immunologic factors|mesh-ancestor
5761367|NCT02970630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761368|NCT02970630|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5761369|NCT02970630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5761370|NCT02970630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761371|NCT02970630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5761372|NCT02970643|Olanzapine|olanzapine|mesh-list
5761373|NCT02970643|Palonosetron|palonosetron|mesh-list
5761374|NCT02970643|Antiemetics|antiemetics|mesh-ancestor
5761375|NCT02970643|Autonomic Agents|autonomic agents|mesh-ancestor
5761376|NCT02970643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5761377|NCT02970643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761378|NCT02970643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5636041|NCT05076838|Anesthetics|anesthetics|mesh-ancestor
5761379|NCT02970643|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5761380|NCT02970643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5761381|NCT02970643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5761382|NCT02970643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5761383|NCT02970643|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5761384|NCT02970643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5761385|NCT02970643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5761386|NCT02970643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761387|NCT02970643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5636042|NCT05076838|GABA Modulators|gaba modulators|mesh-ancestor
5636043|NCT05076838|GABA Agents|gaba agents|mesh-ancestor
5636044|NCT05076838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5636045|NCT05076838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209213|NCT02142712|Pantoprazole|pantoprazole|mesh-list
6209214|NCT02142712|Famotidine|famotidine|mesh-list
6209215|NCT02142712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6209216|NCT02142712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6209217|NCT02142712|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6209218|NCT02142712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5636052|NCT05070039|Antibodies|antibodies|mesh-list
5636053|NCT05070039|Immunologic Factors|immunologic factors|mesh-ancestor
5636054|NCT05070039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761388|NCT02970643|Serotonin Agents|serotonin agents|mesh-ancestor
5761389|NCT02970643|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5761390|NCT02970643|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5761391|NCT02970539|Paclitaxel|paclitaxel|mesh-list
5761392|NCT02970539|Ramucirumab|ramucirumab|mesh-list
5636055|NCT05060549|Cariprazine|cariprazine|mesh-list
5636056|NCT05060549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5636057|NCT05060549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5636058|NCT05060549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5636059|NCT05060549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636060|NCT05060549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5636061|NCT05058872|Levonorgestrel|levonorgestrel|mesh-list
5636062|NCT05058872|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5636063|NCT05058872|Estradiol|estradiol|mesh-list
5636064|NCT05058872|Estrogens|estrogens|mesh-ancestor
5636065|NCT05058872|Hormones|hormones|mesh-ancestor
5636066|NCT05058872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5636067|NCT05058872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636068|NCT05058872|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5761393|NCT02970539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5761394|NCT02970539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5761395|NCT02970539|Tubulin Modulators|tubulin modulators|mesh-ancestor
5761396|NCT02970539|Antimitotic Agents|antimitotic agents|mesh-ancestor
5761397|NCT02970539|Mitosis Modulators|mitosis modulators|mesh-ancestor
5761398|NCT02970539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761399|NCT02970604|Aspirin|aspirin|mesh-list
5636069|NCT05058872|Contraceptive Agents|contraceptive agents|mesh-ancestor
5636070|NCT05058872|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5636071|NCT05058872|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5636072|NCT05058872|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5636073|NCT05058872|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5636074|NCT05058872|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5636075|NCT05054881|Iodine|iodine|mesh-list
5636076|NCT05054881|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5636077|NCT05054881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5761400|NCT02970604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5761401|NCT02970604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5761402|NCT02970604|Analgesics|analgesics|mesh-ancestor
5761403|NCT02970604|Sensory System Agents|sensory system agents|mesh-ancestor
6209219|NCT02142712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5636078|NCT05054881|Trace Elements|trace elements|mesh-ancestor
5636079|NCT05054881|Micronutrients|micronutrients|mesh-ancestor
5636080|NCT05054881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209220|NCT02142712|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6209221|NCT02142712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6209222|NCT02142712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6209223|NCT02142712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209224|NCT02142712|Anesthetics, Local|anesthetics, local|mesh-ancestor
6209225|NCT02142712|Anesthetics|anesthetics|mesh-ancestor
6209226|NCT02142712|Sensory System Agents|sensory system agents|mesh-ancestor
6209227|NCT02142712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6209228|NCT02142712|Antiemetics|antiemetics|mesh-ancestor
5636091|NCT05048797|Carboplatin|carboplatin|mesh-list
5636092|NCT05048797|Pembrolizumab|pembrolizumab|mesh-list
5636093|NCT05048797|Trastuzumab|trastuzumab|mesh-list
5761404|NCT02970604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5761405|NCT02970604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761406|NCT02970604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5761407|NCT02970604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5761408|NCT02970604|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5761409|NCT02970604|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5761410|NCT02970604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761411|NCT02970604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5761412|NCT02970604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5761413|NCT02970604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5761414|NCT02970604|Antipyretics|antipyretics|mesh-ancestor
5761415|NCT02970682|Tamoxifen|tamoxifen|mesh-list
5761416|NCT02970682|Fulvestrant|fulvestrant|mesh-list
5761417|NCT02970682|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5761418|NCT02970682|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5636094|NCT05048797|Pemetrexed|pemetrexed|mesh-list
5636095|NCT05048797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5636096|NCT05048797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5636097|NCT05048797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5636098|NCT05048797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5636099|NCT05048797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5636100|NCT05048797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5693602|NCT03400683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5693603|NCT03400683|Oxytocics|oxytocics|mesh-ancestor
5761419|NCT02970682|Hormone Antagonists|hormone antagonists|mesh-ancestor
5761420|NCT02970682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5761421|NCT02970682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761422|NCT02970682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5761423|NCT02970682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5761424|NCT02970682|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5761425|NCT02970682|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5761426|NCT02970682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5761427|NCT02970682|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5761428|NCT02970682|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5761429|NCT02970682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5761430|NCT02970682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761431|NCT02970526|Oxaliplatin|oxaliplatin|mesh-list
5761432|NCT02970526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5761433|NCT02970409|Heparin|heparin|mesh-list
5761434|NCT02970409|Anticoagulants|anticoagulants|mesh-ancestor
5693604|NCT03400592|Irinotecan|irinotecan|mesh-list
5693605|NCT03400592|Nimotuzumab|nimotuzumab|mesh-list
5693606|NCT03400592|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5693607|NCT03400592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5693608|NCT03400592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5693609|NCT03400592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761435|NCT02970409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5761436|NCT02970409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5761437|NCT02970409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761438|NCT02970383|Narcotics|narcotics|mesh-list
5761439|NCT02970383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5761440|NCT02970383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761441|NCT02970383|Analgesics|analgesics|mesh-ancestor
5761442|NCT02970383|Sensory System Agents|sensory system agents|mesh-ancestor
5761443|NCT02970383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5895453|NCT05228249|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5895454|NCT05228249|Keratolytic Agents|keratolytic agents|mesh-ancestor
5895455|NCT05228249|Dermatologic Agents|dermatologic agents|mesh-ancestor
5895456|NCT05228249|Tubulin Modulators|tubulin modulators|mesh-ancestor
5693610|NCT03400592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5693611|NCT03400592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5693612|NCT03400423|Caffeine|caffeine|mesh-list
5693613|NCT03400423|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5693614|NCT03400423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693615|NCT03400423|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5693616|NCT03400423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5693617|NCT03400423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693618|NCT03400423|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5693619|NCT03400423|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5693620|NCT03400423|Purinergic Agents|purinergic agents|mesh-ancestor
5693621|NCT03400423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5693622|NCT03400332|Nivolumab|nivolumab|mesh-list
5895457|NCT05228249|Antimitotic Agents|antimitotic agents|mesh-ancestor
5636101|NCT05041049|Anesthetics|anesthetics|mesh-list
5636102|NCT05041049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5636103|NCT05041049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636104|NCT05024552|Cytarabine|cytarabine|mesh-list
5636105|NCT05024552|Daunorubicin|daunorubicin|mesh-list
5636106|NCT05024552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5636107|NCT05024552|Antimetabolites|antimetabolites|mesh-ancestor
5636108|NCT05024552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5636109|NCT05024552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5636110|NCT05024552|Antiviral Agents|antiviral agents|mesh-ancestor
5636111|NCT05024552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5636112|NCT05024552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5636113|NCT05024552|Immunologic Factors|immunologic factors|mesh-ancestor
6209229|NCT02142712|Autonomic Agents|autonomic agents|mesh-ancestor
6209230|NCT02142712|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6209231|NCT02142712|Histamine Antagonists|histamine antagonists|mesh-ancestor
6209232|NCT02142712|Histamine Agents|histamine agents|mesh-ancestor
6209233|NCT02142712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6209234|NCT02142712|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6209235|NCT02142712|Antipruritics|antipruritics|mesh-ancestor
5636114|NCT05024552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636115|NCT05024552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5636116|NCT05024552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5636117|NCT05024552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5636118|NCT05024552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5761444|NCT02970175|Terlipressin|terlipressin|mesh-list
5761445|NCT02970175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5761446|NCT02970175|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5761447|NCT02970097|Fentanyl|fentanyl|mesh-list
5761448|NCT02970097|Midazolam|midazolam|mesh-list
5761449|NCT02970097|Ropivacaine|ropivacaine|mesh-list
5761450|NCT02970097|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5761451|NCT02970097|Narcotics|narcotics|mesh-ancestor
5761452|NCT02970097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5761453|NCT02970097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761454|NCT02970097|Analgesics|analgesics|mesh-ancestor
5761455|NCT02970097|Sensory System Agents|sensory system agents|mesh-ancestor
5761456|NCT02970097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5761457|NCT02970097|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5761458|NCT02970097|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5761459|NCT02970097|Anesthetics, General|anesthetics, general|mesh-ancestor
5761460|NCT02970097|Anesthetics|anesthetics|mesh-ancestor
5761461|NCT02970097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5761462|NCT02970097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5761463|NCT02970097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5761464|NCT02970097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5761465|NCT02970097|GABA Modulators|gaba modulators|mesh-ancestor
5761466|NCT02970097|GABA Agents|gaba agents|mesh-ancestor
5761467|NCT02970097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5761468|NCT02970097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761469|NCT02970097|Anesthetics, Local|anesthetics, local|mesh-ancestor
5761470|NCT02970084|Vitamin K|vitamin k|mesh-list
5761471|NCT02970084|Vitamin K 2|vitamin k 2|mesh-list
5761472|NCT02970084|Vitamins|vitamins|mesh-ancestor
5761473|NCT02970084|Micronutrients|micronutrients|mesh-ancestor
5761474|NCT02970084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761475|NCT02970084|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5761476|NCT02970084|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6209236|NCT02142712|Dermatologic Agents|dermatologic agents|mesh-ancestor
6209237|NCT02142712|Antitussive Agents|antitussive agents|mesh-ancestor
6209238|NCT02142712|Respiratory System Agents|respiratory system agents|mesh-ancestor
6209239|NCT02142712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6209240|NCT02142712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6209241|NCT02142712|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6209242|NCT02142738|Gemcitabine|gemcitabine|mesh-list
6209243|NCT02142738|Paclitaxel|paclitaxel|mesh-list
6209244|NCT02142738|Carboplatin|carboplatin|mesh-list
6209245|NCT02142738|Pembrolizumab|pembrolizumab|mesh-list
6209246|NCT02142738|Pemetrexed|pemetrexed|mesh-list
6209247|NCT02142738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6209248|NCT02142738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6209249|NCT02142738|Tubulin Modulators|tubulin modulators|mesh-ancestor
6209250|NCT02142738|Antimitotic Agents|antimitotic agents|mesh-ancestor
6209251|NCT02142738|Mitosis Modulators|mitosis modulators|mesh-ancestor
5761477|NCT02970084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761478|NCT02970084|Hemostatics|hemostatics|mesh-ancestor
5761479|NCT02970084|Coagulants|coagulants|mesh-ancestor
6209252|NCT02142738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761480|NCT02969980|Cyclophosphamide|cyclophosphamide|mesh-list
5761481|NCT02969980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5761482|NCT02969980|Immunologic Factors|immunologic factors|mesh-ancestor
5761483|NCT02969980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761484|NCT02969980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5761485|NCT02969980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5761486|NCT02969980|Alkylating Agents|alkylating agents|mesh-ancestor
5761487|NCT02969980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761488|NCT02969980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5761489|NCT02969980|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5761490|NCT02969720|Titanium dioxide|titanium dioxide|mesh-list
5761491|NCT02969720|Sunscreening Agents|sunscreening agents|mesh-ancestor
5761492|NCT02969720|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5761493|NCT02969720|Protective Agents|protective agents|mesh-ancestor
5761494|NCT02969720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761495|NCT02969720|Dermatologic Agents|dermatologic agents|mesh-ancestor
5761496|NCT02969720|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5761497|NCT02969746|Charcoal|charcoal|mesh-list
5761498|NCT02969746|Antidotes|antidotes|mesh-ancestor
5761499|NCT02969746|Protective Agents|protective agents|mesh-ancestor
5761500|NCT02969746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761501|NCT02969733|Lidocaine|lidocaine|mesh-list
5761502|NCT02969733|Ketamine|ketamine|mesh-list
5761503|NCT02969733|Analgesics|analgesics|mesh-ancestor
5761504|NCT02969733|Sensory System Agents|sensory system agents|mesh-ancestor
5761505|NCT02969733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5761506|NCT02969733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761507|NCT02969733|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5761508|NCT02969733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5761509|NCT02969733|Anesthetics, General|anesthetics, general|mesh-ancestor
5761510|NCT02969733|Anesthetics|anesthetics|mesh-ancestor
5761511|NCT02969733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5761512|NCT02969733|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5761513|NCT02969733|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5761514|NCT02969733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5761515|NCT02969733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761516|NCT02969733|Anesthetics, Local|anesthetics, local|mesh-ancestor
5761517|NCT02969733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5761518|NCT02969733|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5761519|NCT02969733|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5761520|NCT02969733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5761521|NCT02969798|Metformin|metformin|mesh-list
5761522|NCT02969798|Pioglitazone|pioglitazone|mesh-list
5761523|NCT02969798|Dapagliflozin|dapagliflozin|mesh-list
5761524|NCT02969798|Saxagliptin|saxagliptin|mesh-list
5761525|NCT02969798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5761526|NCT02969798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761527|NCT02969798|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5761528|NCT02969798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761529|NCT02969798|Incretins|incretins|mesh-ancestor
5761530|NCT02969798|Hormones|hormones|mesh-ancestor
5761531|NCT02969798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5761532|NCT02969798|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5761533|NCT02969798|Protease Inhibitors|protease inhibitors|mesh-ancestor
5761534|NCT02969798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5761535|NCT02969629|Apomorphine|apomorphine|mesh-list
5761536|NCT02969629|Emetics|emetics|mesh-ancestor
5761537|NCT02969629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761538|NCT02969629|Autonomic Agents|autonomic agents|mesh-ancestor
5761539|NCT02969629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5761540|NCT02969629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5761541|NCT02969629|Dopamine Agonists|dopamine agonists|mesh-ancestor
5761542|NCT02969629|Dopamine Agents|dopamine agents|mesh-ancestor
6209253|NCT02142738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6209254|NCT02142738|Antimetabolites|antimetabolites|mesh-ancestor
6209255|NCT02142738|Antiviral Agents|antiviral agents|mesh-ancestor
6209256|NCT02142738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6209257|NCT02142738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6209258|NCT02142738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6209259|NCT02142738|Immunologic Factors|immunologic factors|mesh-ancestor
5636129|NCT05020145|Vaccines|vaccines|mesh-list
5636130|NCT05020145|Immunologic Factors|immunologic factors|mesh-ancestor
5636131|NCT05020145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761543|NCT02969629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6209260|NCT02142738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636137|NCT05004662|Nicotine|nicotine|mesh-list
5636138|NCT05004662|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5636139|NCT05004662|Autonomic Agents|autonomic agents|mesh-ancestor
5636140|NCT05004662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5636141|NCT05004662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636142|NCT05004662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5636143|NCT05004662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5636144|NCT05004662|Cholinergic Agents|cholinergic agents|mesh-ancestor
5636145|NCT05004662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5636146|NCT05004662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209261|NCT02142738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6209262|NCT02142738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6209263|NCT02142738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6209264|NCT02143141|Morphine|morphine|mesh-list
6209265|NCT02143141|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6209266|NCT02143141|Narcotics|narcotics|mesh-ancestor
6209267|NCT02143141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6209268|NCT02143141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209269|NCT02143141|Analgesics|analgesics|mesh-ancestor
6209270|NCT02143141|Sensory System Agents|sensory system agents|mesh-ancestor
6209271|NCT02143141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5636158|NCT04976049|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5636159|NCT04976049|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5636160|NCT04976049|Dermatologic Agents|dermatologic agents|mesh-ancestor
5636161|NCT04975308|Fulvestrant|fulvestrant|mesh-list
5636162|NCT04975308|Exemestane|exemestane|mesh-list
5636163|NCT04975308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5636164|NCT04975308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5636165|NCT04975308|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5636166|NCT04975308|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5636167|NCT04975308|Hormone Antagonists|hormone antagonists|mesh-ancestor
5636168|NCT04975308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5636169|NCT04975308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636170|NCT04975308|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5636171|NCT04975308|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5636172|NCT04975308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5636173|NCT04975308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5636174|NCT04975256|Adagrasib|adagrasib|mesh-list
5636175|NCT04975256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5636176|NCT04971785|Firsocostat|firsocostat|mesh-list
5636177|NCT04971785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5636178|NCT04971785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490180|NCT00596297|Bevacizumab|bevacizumab|mesh-list
6490181|NCT00596297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5636179|NCT04968366|Temozolomide|temozolomide|mesh-list
5636180|NCT04968366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5636181|NCT04968366|Alkylating Agents|alkylating agents|mesh-ancestor
5636182|NCT04968366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5636183|NCT04968366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6490182|NCT00596297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5636184|NCT04965454|Choline|choline|mesh-list
5636185|NCT04965454|Lipotropic Agents|lipotropic agents|mesh-ancestor
5636186|NCT04965454|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5761544|NCT02969629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761545|NCT02969681|Ascorbic Acid|ascorbic acid|mesh-list
6209272|NCT02143648|Nalbuphine|nalbuphine|mesh-list
6209273|NCT02143648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6209274|NCT02143648|Narcotics|narcotics|mesh-ancestor
6209275|NCT02143648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6209276|NCT02143648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209277|NCT02143648|Analgesics|analgesics|mesh-ancestor
5761546|NCT02969681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761547|NCT02969681|Vitamins|vitamins|mesh-ancestor
5761548|NCT02969681|Micronutrients|micronutrients|mesh-ancestor
5761549|NCT02969681|Antioxidants|antioxidants|mesh-ancestor
6209278|NCT02143648|Sensory System Agents|sensory system agents|mesh-ancestor
6209279|NCT02143648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6209280|NCT02143843|Bimatoprost|bimatoprost|mesh-list
6209281|NCT02143843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6209282|NCT02143973|Nalbuphine|nalbuphine|mesh-list
6209283|NCT02143973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5761550|NCT02969681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761551|NCT02969681|Protective Agents|protective agents|mesh-ancestor
5761552|NCT02969564|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
5761553|NCT02969564|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5761554|NCT02969564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761555|NCT02969447|Oxytocin|oxytocin|mesh-list
5761556|NCT02969447|Oxytocics|oxytocics|mesh-ancestor
5761557|NCT02969447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5761558|NCT02969447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761559|NCT02969473|Cisplatin|cisplatin|mesh-list
5761560|NCT02969473|Docetaxel|docetaxel|mesh-list
5761561|NCT02969473|Fluorouracil|fluorouracil|mesh-list
5761562|NCT02969473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5761563|NCT02969473|Tubulin Modulators|tubulin modulators|mesh-ancestor
5761564|NCT02969473|Antimitotic Agents|antimitotic agents|mesh-ancestor
5761565|NCT02969473|Mitosis Modulators|mitosis modulators|mesh-ancestor
5761566|NCT02969473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761567|NCT02969473|Antimetabolites|antimetabolites|mesh-ancestor
5761568|NCT02969473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5761569|NCT02969473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5761570|NCT02969473|Immunologic Factors|immunologic factors|mesh-ancestor
5761571|NCT02969473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761572|NCT02969304|Dimethyl Fumarate|dimethyl fumarate|mesh-list
5761573|NCT02969304|Dermatologic Agents|dermatologic agents|mesh-ancestor
5761574|NCT02969304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5761575|NCT02969304|Immunologic Factors|immunologic factors|mesh-ancestor
5761576|NCT02969304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636187|NCT04965454|Antimetabolites|antimetabolites|mesh-ancestor
5636188|NCT04965454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5636189|NCT04965454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5636190|NCT04965454|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5636191|NCT04965454|Nootropic Agents|nootropic agents|mesh-ancestor
5636192|NCT04964700|Natalizumab|natalizumab|mesh-list
5636193|NCT04964700|Immunologic Factors|immunologic factors|mesh-ancestor
5636194|NCT04964700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636195|NCT04964128|Insulin|insulin|mesh-list
5636196|NCT04964128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5636197|NCT04964128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636198|NCT04950764|Seladelpar|seladelpar|mesh-list
5636199|NCT04950764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5636200|NCT04950764|Antimetabolites|antimetabolites|mesh-ancestor
5636201|NCT04950764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5636202|NCT04950764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5761577|NCT02969278|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5761578|NCT02969278|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5761579|NCT02969278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761580|NCT02969083|Gemcitabine|gemcitabine|mesh-list
5761581|NCT02969083|Cisplatin|cisplatin|mesh-list
5761582|NCT02969083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5761583|NCT02969083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5761584|NCT02969083|Antimetabolites|antimetabolites|mesh-ancestor
5761585|NCT02969083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761586|NCT02969083|Antiviral Agents|antiviral agents|mesh-ancestor
5761587|NCT02969083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5761588|NCT02969083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5761589|NCT02969083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5761590|NCT02969083|Immunologic Factors|immunologic factors|mesh-ancestor
5761591|NCT02969083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761592|NCT02969265|Amlodipine|amlodipine|mesh-list
5761593|NCT02969265|Candesartan cilexetil|candesartan cilexetil|mesh-list
5761594|NCT02969265|Candesartan|candesartan|mesh-list
6209284|NCT02143973|Narcotics|narcotics|mesh-ancestor
6209285|NCT02143973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6209286|NCT02143973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636206|NCT04942184|Complement Factor H|complement factor h|mesh-list
5636207|NCT04942184|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5636208|NCT04942184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5636209|NCT04942184|Immunologic Factors|immunologic factors|mesh-ancestor
5636210|NCT04942184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636211|NCT04939987|Acetaminophen|acetaminophen|mesh-list
5636212|NCT04939987|Ketorolac|ketorolac|mesh-list
5636213|NCT04939987|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
5636214|NCT04939987|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
5636215|NCT04939987|Ketamine|ketamine|mesh-list
5761595|NCT02969265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5636216|NCT04939987|Oxycodone|oxycodone|mesh-list
5761596|NCT02969265|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5636217|NCT04939987|Gabapentin|gabapentin|mesh-list
5636218|NCT04939987|Tramadol|tramadol|mesh-list
5636219|NCT04939987|Hydrocodone|hydrocodone|mesh-list
5636220|NCT04939987|Analgesics, Opioid|analgesics, opioid|mesh-list
5761597|NCT02969265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5761598|NCT02969265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761599|NCT02969265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5761600|NCT02969265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761601|NCT02969265|Vasodilator Agents|vasodilator agents|mesh-ancestor
5761602|NCT02969265|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5761603|NCT02969265|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5761604|NCT02969252|Rifamycins|rifamycins|mesh-list
5636221|NCT04939987|Analgesics|analgesics|mesh-ancestor
5636222|NCT04939987|Sensory System Agents|sensory system agents|mesh-ancestor
5636223|NCT04939987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5636224|NCT04939987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636225|NCT04939987|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5636226|NCT04939987|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5636227|NCT04939987|Anesthetics, General|anesthetics, general|mesh-ancestor
5761605|NCT02969252|Rifamycin SV|rifamycin sv|mesh-list
5761606|NCT02969252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5761607|NCT02969252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5761608|NCT02969252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5761609|NCT02969239|Phenylephrine|phenylephrine|mesh-list
5761610|NCT02969239|Oxymetazoline|oxymetazoline|mesh-list
5761611|NCT02969239|Norepinephrine|norepinephrine|mesh-list
5761612|NCT02969239|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
5761613|NCT02969239|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5761614|NCT02969239|Mydriatics|mydriatics|mesh-ancestor
5761615|NCT02969239|Autonomic Agents|autonomic agents|mesh-ancestor
5761616|NCT02969239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5761617|NCT02969239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761618|NCT02969239|Sympathomimetics|sympathomimetics|mesh-ancestor
5761619|NCT02969239|Nasal Decongestants|nasal decongestants|mesh-ancestor
5761620|NCT02969239|Respiratory System Agents|respiratory system agents|mesh-ancestor
5761621|NCT02969239|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5761622|NCT02969239|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5636228|NCT04939987|Anesthetics|anesthetics|mesh-ancestor
5636229|NCT04939987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5636230|NCT04939987|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5636231|NCT04939987|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5636232|NCT04939987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5636233|NCT04939987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5636234|NCT04939987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5636235|NCT04939987|Antipyretics|antipyretics|mesh-ancestor
5761623|NCT02969239|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5761624|NCT02969239|Adrenergic Agents|adrenergic agents|mesh-ancestor
5761625|NCT02969239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5761626|NCT02969239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761627|NCT02969239|Protective Agents|protective agents|mesh-ancestor
5761628|NCT02968901|Tadalafil|tadalafil|mesh-list
5761629|NCT02968901|Macitentan|macitentan|mesh-list
5761630|NCT02968901|Vasodilator Agents|vasodilator agents|mesh-ancestor
5761631|NCT02968901|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5761632|NCT02968901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5636236|NCT04939987|Narcotics|narcotics|mesh-ancestor
5636237|NCT04939987|Anticonvulsants|anticonvulsants|mesh-ancestor
5636238|NCT04939987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5636239|NCT04939987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5761633|NCT02968901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5895458|NCT05228249|Mitosis Modulators|mitosis modulators|mesh-ancestor
5636240|NCT04939987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5636241|NCT04939987|Antimanic Agents|antimanic agents|mesh-ancestor
5636242|NCT04939987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5636243|NCT04939987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5636244|NCT04939987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5636245|NCT04939987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5636246|NCT04939987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5636247|NCT04939987|Antitussive Agents|antitussive agents|mesh-ancestor
5636248|NCT04939987|Respiratory System Agents|respiratory system agents|mesh-ancestor
5636249|NCT04936230|Atezolizumab|atezolizumab|mesh-list
5636250|NCT04936230|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5636251|NCT04936230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5636252|NCT04936230|Immunologic Factors|immunologic factors|mesh-ancestor
5636253|NCT04936230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636254|NCT04935177|Antibodies|antibodies|mesh-list
5636255|NCT04935177|Immunoglobulins|immunoglobulins|mesh-list
5761634|NCT02968901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761635|NCT02968901|Urological Agents|urological agents|mesh-ancestor
5761636|NCT02968901|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
5761637|NCT02968901|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5761638|NCT02968901|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
5761639|NCT02968927|Vitamin D|vitamin d|mesh-list
5761640|NCT02968927|Cholecalciferol|cholecalciferol|mesh-list
5761641|NCT02968927|Rifabutin|rifabutin|mesh-list
5761642|NCT02968927|Everolimus|everolimus|mesh-list
5761643|NCT02968927|Auranofin|auranofin|mesh-list
5761644|NCT02968927|Vitamins|vitamins|mesh-ancestor
5761645|NCT02968927|Micronutrients|micronutrients|mesh-ancestor
5761646|NCT02968927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761647|NCT02968927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5761648|NCT02968927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5761649|NCT02968927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5761650|NCT02968927|Immunologic Factors|immunologic factors|mesh-ancestor
5761651|NCT02968927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5761652|NCT02968927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5761653|NCT02968927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5761654|NCT02968927|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5761655|NCT02968927|Antitubercular Agents|antitubercular agents|mesh-ancestor
5761656|NCT02968927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5761657|NCT02968693|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5761658|NCT02968693|Vancomycin|vancomycin|mesh-list
5761659|NCT02968693|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5761660|NCT02968693|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
5761661|NCT02968693|Calcium|calcium|mesh-list
6673319|NCT01561950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6673320|NCT01561950|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5636256|NCT04935177|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5636257|NCT04935177|gamma-Globulins|gamma-globulins|mesh-list
5636258|NCT04935177|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5636259|NCT04935177|Eculizumab|eculizumab|mesh-list
5636260|NCT04935177|Immunologic Factors|immunologic factors|mesh-ancestor
5636261|NCT04935177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636262|NCT04935177|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5636263|NCT04935177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5693623|NCT03400332|Ipilimumab|ipilimumab|mesh-list
5693624|NCT03400332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5693625|NCT03400332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5693626|NCT03400332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5693627|NCT03400332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693628|NCT03400267|Acetaminophen|acetaminophen|mesh-list
5693629|NCT03400267|Fentanyl|fentanyl|mesh-list
5693630|NCT03400267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5693631|NCT03400267|Narcotics|narcotics|mesh-ancestor
5693632|NCT03400267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5693633|NCT03400267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693634|NCT03400267|Analgesics|analgesics|mesh-ancestor
5693635|NCT03400267|Sensory System Agents|sensory system agents|mesh-ancestor
5693636|NCT03400267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5693637|NCT03400267|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5693638|NCT03400267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5693639|NCT03400267|Anesthetics, General|anesthetics, general|mesh-ancestor
5693640|NCT03400267|Anesthetics|anesthetics|mesh-ancestor
5693641|NCT03400267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5693642|NCT03400267|Antipyretics|antipyretics|mesh-ancestor
5693643|NCT03400254|Hydroxychloroquine|hydroxychloroquine|mesh-list
5761662|NCT02968693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5907858|NCT05156710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5761663|NCT02968693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761664|NCT02968693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5761665|NCT02968693|Antitubercular Agents|antitubercular agents|mesh-ancestor
5761666|NCT02968693|Vasodilator Agents|vasodilator agents|mesh-ancestor
5761667|NCT02968693|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
5761668|NCT02968693|Protective Agents|protective agents|mesh-ancestor
5761669|NCT02968719|Donepezil|donepezil|mesh-list
5761670|NCT02968719|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5761671|NCT02968719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5761672|NCT02968719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761673|NCT02968719|Cholinergic Agents|cholinergic agents|mesh-ancestor
5761674|NCT02968719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5761675|NCT02968719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761676|NCT02968719|Nootropic Agents|nootropic agents|mesh-ancestor
5761677|NCT02968641|Ritonavir|ritonavir|mesh-list
5761678|NCT02968641|Lonafarnib|lonafarnib|mesh-list
5761679|NCT02968641|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5761680|NCT02968641|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5761681|NCT02968641|Protease Inhibitors|protease inhibitors|mesh-ancestor
5761682|NCT02968641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5761683|NCT02968641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761684|NCT02968641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6490183|NCT00596297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6490184|NCT00596297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6209287|NCT02143973|Analgesics|analgesics|mesh-ancestor
6209288|NCT02143973|Sensory System Agents|sensory system agents|mesh-ancestor
6209289|NCT02143973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6209290|NCT02144012|Docetaxel|docetaxel|mesh-list
6209291|NCT02144012|Trastuzumab|trastuzumab|mesh-list
6209292|NCT02144012|Maytansine|maytansine|mesh-list
6209293|NCT02144012|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
6209294|NCT02144012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5636264|NCT04923893|Dexamethasone|dexamethasone|mesh-list
5636265|NCT04923893|Cyclophosphamide|cyclophosphamide|mesh-list
5636266|NCT04923893|Fludarabine|fludarabine|mesh-list
5636267|NCT04923893|Lenalidomide|lenalidomide|mesh-list
5636268|NCT04923893|Bortezomib|bortezomib|mesh-list
5636269|NCT04923893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5636270|NCT04923893|Immunologic Factors|immunologic factors|mesh-ancestor
6209295|NCT02144012|Tubulin Modulators|tubulin modulators|mesh-ancestor
6209296|NCT02144012|Antimitotic Agents|antimitotic agents|mesh-ancestor
6209297|NCT02144012|Mitosis Modulators|mitosis modulators|mesh-ancestor
6209298|NCT02144012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209299|NCT02144012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6209300|NCT02144012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6209301|NCT02144077|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6209302|NCT02144077|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
6209303|NCT02144077|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5636271|NCT04923893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636272|NCT04923893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5636273|NCT04923893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5636274|NCT04923893|Alkylating Agents|alkylating agents|mesh-ancestor
5636275|NCT04923893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5636276|NCT04923893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5636277|NCT04923893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5636278|NCT04923893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5636279|NCT04923893|Antiemetics|antiemetics|mesh-ancestor
5636280|NCT04923893|Autonomic Agents|autonomic agents|mesh-ancestor
5636281|NCT04923893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5636282|NCT04923893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5636283|NCT04923893|Glucocorticoids|glucocorticoids|mesh-ancestor
5636284|NCT04923893|Hormones|hormones|mesh-ancestor
5636285|NCT04923893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5636286|NCT04923893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5636287|NCT04923893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5636288|NCT04923893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5636289|NCT04923893|Growth Substances|growth substances|mesh-ancestor
5636290|NCT04923893|Growth Inhibitors|growth inhibitors|mesh-ancestor
6209304|NCT02144077|Dermatologic Agents|dermatologic agents|mesh-ancestor
6490185|NCT00596297|Growth Substances|growth substances|mesh-ancestor
5693644|NCT03400254|Gedatolisib|gedatolisib|mesh-list
5761685|NCT02968641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5761686|NCT02968641|Antiviral Agents|antiviral agents|mesh-ancestor
5761687|NCT02968641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5761688|NCT02968641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5761689|NCT02968641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5761690|NCT02968498|Methamphetamine|methamphetamine|mesh-list
5761691|NCT02968498|Lactulose|lactulose|mesh-list
5761692|NCT02968498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5761693|NCT02968498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5761694|NCT02968498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761695|NCT02968498|Sympathomimetics|sympathomimetics|mesh-ancestor
5761696|NCT02968498|Autonomic Agents|autonomic agents|mesh-ancestor
5761697|NCT02968498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5761698|NCT02968498|Dopamine Agents|dopamine agents|mesh-ancestor
5761699|NCT02968498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5761700|NCT02968498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761701|NCT02968498|Adrenergic Agents|adrenergic agents|mesh-ancestor
5636299|NCT04920617|Cyclophosphamide|cyclophosphamide|mesh-list
5636300|NCT04920617|Pembrolizumab|pembrolizumab|mesh-list
5636301|NCT04920617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5636302|NCT04920617|Immunologic Factors|immunologic factors|mesh-ancestor
5636303|NCT04920617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636304|NCT04920617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5636305|NCT04920617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5636306|NCT04920617|Alkylating Agents|alkylating agents|mesh-ancestor
5636307|NCT04920617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5636308|NCT04920617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5636309|NCT04920617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5636310|NCT04920617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5636311|NCT04918147|Acetaminophen|acetaminophen|mesh-list
5761702|NCT02968498|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5761703|NCT02968498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5761704|NCT02968498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5761705|NCT02968498|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5761706|NCT02968394|Omalizumab|omalizumab|mesh-list
5761707|NCT02968394|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5761708|NCT02968394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5636312|NCT04918147|Diphenhydramine|diphenhydramine|mesh-list
5636313|NCT04918147|Promethazine|promethazine|mesh-list
5636314|NCT04918147|Prednisone|prednisone|mesh-list
5636315|NCT04918147|Methylprednisolone|methylprednisolone|mesh-list
5761709|NCT02968394|Respiratory System Agents|respiratory system agents|mesh-ancestor
5895459|NCT05228249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5895460|NCT05228041|Benralizumab|benralizumab|mesh-list
5895461|NCT05228041|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5895462|NCT05228041|Respiratory System Agents|respiratory system agents|mesh-ancestor
5895463|NCT05227313|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5895464|NCT05222256|Simendan|simendan|mesh-list
5895465|NCT05222256|Epinephrine|epinephrine|mesh-list
5895466|NCT05222256|Racepinephrine|racepinephrine|mesh-list
5895467|NCT05222256|Epinephryl borate|epinephryl borate|mesh-list
5895468|NCT05222256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5895469|NCT05222256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5895470|NCT05222256|Adrenergic Agents|adrenergic agents|mesh-ancestor
5895471|NCT05222256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5895472|NCT05222256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895473|NCT05222256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895474|NCT05222256|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5895475|NCT05222256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5895476|NCT05222256|Autonomic Agents|autonomic agents|mesh-ancestor
5895477|NCT05222256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5895478|NCT05222256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5895479|NCT05222256|Respiratory System Agents|respiratory system agents|mesh-ancestor
5895480|NCT05222256|Mydriatics|mydriatics|mesh-ancestor
5636316|NCT04918147|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5636317|NCT04918147|Elotuzumab|elotuzumab|mesh-list
5636318|NCT04918147|Famotidine|famotidine|mesh-list
5636319|NCT04918147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5636320|NCT04918147|Glucocorticoids|glucocorticoids|mesh-ancestor
5636321|NCT04918147|Hormones|hormones|mesh-ancestor
5895481|NCT05222256|Sympathomimetics|sympathomimetics|mesh-ancestor
5895482|NCT05222256|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5895483|NCT05222256|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5895484|NCT05222256|Vasodilator Agents|vasodilator agents|mesh-ancestor
6209305|NCT02144233|Salicylic Acid|salicylic acid|mesh-list
5761710|NCT02968342|Progesterone|progesterone|mesh-list
5761711|NCT02968342|Progestins|progestins|mesh-ancestor
5761712|NCT02968342|Hormones|hormones|mesh-ancestor
5761713|NCT02968342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5761714|NCT02968342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761715|NCT02968303|Vemurafenib|vemurafenib|mesh-list
5761716|NCT02968303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5761717|NCT02968303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5761718|NCT02968303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5761719|NCT02968303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761720|NCT02968121|Brexpiprazole|brexpiprazole|mesh-list
5636322|NCT04918147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5636323|NCT04918147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636324|NCT04918147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5636325|NCT04918147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5636326|NCT04918147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5636327|NCT04918147|Analgesics|analgesics|mesh-ancestor
5636328|NCT04918147|Sensory System Agents|sensory system agents|mesh-ancestor
5636329|NCT04918147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5636330|NCT04918147|Antipyretics|antipyretics|mesh-ancestor
5636331|NCT04918147|Antiemetics|antiemetics|mesh-ancestor
5761721|NCT02968121|Serotonin Agents|serotonin agents|mesh-ancestor
5761722|NCT02968121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5761723|NCT02968121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761724|NCT02968121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761725|NCT02968121|Dopamine Agonists|dopamine agonists|mesh-ancestor
5761726|NCT02968121|Dopamine Agents|dopamine agents|mesh-ancestor
5761727|NCT02968160|Telmisartan|telmisartan|mesh-list
5761728|NCT02968160|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5761729|NCT02968160|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5761730|NCT02968160|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5761731|NCT02968160|Antimetabolites|antimetabolites|mesh-ancestor
5761732|NCT02968160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761733|NCT02968160|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5761734|NCT02968160|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5761735|NCT02968160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5761736|NCT02968160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5761737|NCT02968160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5761738|NCT02968160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5761739|NCT02968082|Scopolamine|scopolamine|mesh-list
5761740|NCT02968082|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
5761741|NCT02968082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5761742|NCT02968082|Antiemetics|antiemetics|mesh-ancestor
5761743|NCT02968082|Autonomic Agents|autonomic agents|mesh-ancestor
5761744|NCT02968082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5761745|NCT02968082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761746|NCT02968082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5761747|NCT02968082|Mydriatics|mydriatics|mesh-ancestor
5761748|NCT02968082|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5761749|NCT02968082|Cholinergic Agents|cholinergic agents|mesh-ancestor
5761750|NCT02968082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5761751|NCT02968082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761752|NCT02968082|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5761753|NCT02968082|Parasympatholytics|parasympatholytics|mesh-ancestor
5761754|NCT02967939|Tenofovir|tenofovir|mesh-list
5761755|NCT02967939|Antiviral Agents|antiviral agents|mesh-ancestor
5761756|NCT02967939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5761757|NCT02967939|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5761758|NCT02967939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5761759|NCT02967939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5761760|NCT02967939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761761|NCT02967939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5761762|NCT02967939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5761763|NCT02967874|Hyaluronic Acid|hyaluronic acid|mesh-list
5761764|NCT02967874|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5761765|NCT02967874|Immunologic Factors|immunologic factors|mesh-ancestor
5761766|NCT02967874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761767|NCT02967874|Viscosupplements|viscosupplements|mesh-ancestor
5761768|NCT02967874|Protective Agents|protective agents|mesh-ancestor
5761769|NCT02967848|Technetium Tc 99m mebrofenin|technetium tc 99m mebrofenin|mesh-list
5761770|NCT02967848|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5761771|NCT02967848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761772|NCT02967757|Liraglutide|liraglutide|mesh-list
5636332|NCT04918147|Autonomic Agents|autonomic agents|mesh-ancestor
5761773|NCT02967757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5761774|NCT02967757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761775|NCT02967757|Incretins|incretins|mesh-ancestor
5636333|NCT04918147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5636334|NCT04918147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5636335|NCT04918147|Protective Agents|protective agents|mesh-ancestor
5636336|NCT04918147|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5636337|NCT04918147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5636338|NCT04918147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5636339|NCT04918147|Anesthetics, Local|anesthetics, local|mesh-ancestor
5636340|NCT04918147|Anesthetics|anesthetics|mesh-ancestor
5761776|NCT02967757|Hormones|hormones|mesh-ancestor
5761777|NCT02967757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5761778|NCT02967887|Fluorouracil|fluorouracil|mesh-list
5761779|NCT02967887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5761780|NCT02967887|Antimetabolites|antimetabolites|mesh-ancestor
5761781|NCT02967887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5636341|NCT04918147|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5636342|NCT04918147|Histamine Antagonists|histamine antagonists|mesh-ancestor
5636343|NCT04918147|Histamine Agents|histamine agents|mesh-ancestor
5636344|NCT04918147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5636345|NCT04918147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5636346|NCT04918147|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5761782|NCT02967887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5761783|NCT02967887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5761784|NCT02967887|Immunologic Factors|immunologic factors|mesh-ancestor
5761785|NCT02967887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761786|NCT02967731|Mometasone Furoate|mometasone furoate|mesh-list
5761787|NCT02967731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5761788|NCT02967731|Dermatologic Agents|dermatologic agents|mesh-ancestor
5761789|NCT02967731|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5761790|NCT02967302|Triamcinolone|triamcinolone|mesh-list
5761791|NCT02967302|Morphine|morphine|mesh-list
5761792|NCT02967302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5761793|NCT02967302|Narcotics|narcotics|mesh-ancestor
5761794|NCT02967302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5761795|NCT02967302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761796|NCT02967302|Analgesics|analgesics|mesh-ancestor
5761797|NCT02967302|Sensory System Agents|sensory system agents|mesh-ancestor
5761798|NCT02967302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5761799|NCT02967302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5761800|NCT02967302|Glucocorticoids|glucocorticoids|mesh-ancestor
5761801|NCT02967302|Hormones|hormones|mesh-ancestor
5761802|NCT02967302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5761803|NCT02967653|Atorvastatin|atorvastatin|mesh-list
5761804|NCT02967653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5761805|NCT02967653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5761806|NCT02967653|Antimetabolites|antimetabolites|mesh-ancestor
5761807|NCT02967653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761808|NCT02967653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5761809|NCT02967653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5761810|NCT02967653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5761811|NCT02967341|Ciprofloxacin|ciprofloxacin|mesh-list
5761812|NCT02967341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5761813|NCT02967341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5761814|NCT02967341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5761815|NCT02967341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5761816|NCT02967341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5761817|NCT02967341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5636347|NCT04918147|Antipruritics|antipruritics|mesh-ancestor
5636348|NCT04918147|Dermatologic Agents|dermatologic agents|mesh-ancestor
5636349|NCT04918147|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5636350|NCT04918147|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6209306|NCT02144233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6209307|NCT02144233|Antifungal Agents|antifungal agents|mesh-ancestor
6209308|NCT02144233|Keratolytic Agents|keratolytic agents|mesh-ancestor
6209309|NCT02144233|Dermatologic Agents|dermatologic agents|mesh-ancestor
6209310|NCT02144259|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6209311|NCT02144259|Medroxyprogesterone|medroxyprogesterone|mesh-list
6209312|NCT02144259|Etonogestrel|etonogestrel|mesh-list
6209313|NCT02144259|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5761818|NCT02967341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5761819|NCT02967341|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5761820|NCT02967341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5761821|NCT02967614|Timolol|timolol|mesh-list
5761822|NCT02967614|Brimonidine Tartrate|brimonidine tartrate|mesh-list
5761823|NCT02967614|Dorzolamide|dorzolamide|mesh-list
5761824|NCT02967614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5761825|NCT02967614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5761826|NCT02967614|Adrenergic Agents|adrenergic agents|mesh-ancestor
5761827|NCT02967614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5761828|NCT02967614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761829|NCT02967614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761830|NCT02967614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5761831|NCT02967614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6209314|NCT02144259|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6209315|NCT02144259|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6209316|NCT02144259|Contraceptive Agents|contraceptive agents|mesh-ancestor
6209317|NCT02144259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6209318|NCT02144259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636365|NCT04901715|Albuterol|albuterol|mesh-list
5636366|NCT04901715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5636367|NCT04901715|Autonomic Agents|autonomic agents|mesh-ancestor
5636368|NCT04901715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5636369|NCT04901715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636370|NCT04901715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5761832|NCT02967614|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5761833|NCT02967614|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5761834|NCT02967614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5761835|NCT02967614|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5761836|NCT02967614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5761837|NCT02967640|Ketamine|ketamine|mesh-list
5761838|NCT02967640|Analgesics|analgesics|mesh-ancestor
5761839|NCT02967640|Sensory System Agents|sensory system agents|mesh-ancestor
5761840|NCT02967640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5761841|NCT02967640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761842|NCT02967640|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5761843|NCT02967640|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5761844|NCT02967640|Anesthetics, General|anesthetics, general|mesh-ancestor
5761845|NCT02967640|Anesthetics|anesthetics|mesh-ancestor
5761846|NCT02967640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5761847|NCT02967640|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5761848|NCT02967640|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5761849|NCT02967640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5761850|NCT02967640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761851|NCT02967289|Irinotecan|irinotecan|mesh-list
5761852|NCT02967289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5761853|NCT02967289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5761854|NCT02967289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5761855|NCT02967289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761856|NCT02967289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5761857|NCT02967380|Pentetic Acid|pentetic acid|mesh-list
5761858|NCT02967380|Antidotes|antidotes|mesh-ancestor
5761859|NCT02967380|Protective Agents|protective agents|mesh-ancestor
5761860|NCT02967380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761861|NCT02967380|Chelating Agents|chelating agents|mesh-ancestor
5761862|NCT02967380|Sequestering Agents|sequestering agents|mesh-ancestor
5761863|NCT02967380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761864|NCT02967380|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5761865|NCT02967276|Metformin|metformin|mesh-list
5761866|NCT02967276|Dexamethasone|dexamethasone|mesh-list
5761867|NCT02967276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5761868|NCT02967276|Antiemetics|antiemetics|mesh-ancestor
5761869|NCT02967276|Autonomic Agents|autonomic agents|mesh-ancestor
5761870|NCT02967276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5761871|NCT02967276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761872|NCT02967276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5761873|NCT02967276|Glucocorticoids|glucocorticoids|mesh-ancestor
5761874|NCT02967276|Hormones|hormones|mesh-ancestor
5761875|NCT02967276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5761876|NCT02967276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5761877|NCT02967276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5761878|NCT02967276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5761879|NCT02967432|Mupirocin|mupirocin|mesh-list
5761880|NCT02967432|Petrolatum|petrolatum|mesh-list
5761881|NCT02967432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5761882|NCT02967432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5761883|NCT02967432|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5761884|NCT02967432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6209319|NCT02144259|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5636371|NCT04901715|Respiratory System Agents|respiratory system agents|mesh-ancestor
5636372|NCT04901715|Tocolytic Agents|tocolytic agents|mesh-ancestor
5636373|NCT04901715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5636374|NCT04901715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5636375|NCT04901715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5636376|NCT04901715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5636377|NCT04901715|Adrenergic Agents|adrenergic agents|mesh-ancestor
5636378|NCT04901715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5636379|NCT04901715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5636380|NCT04893915|Cyclophosphamide|cyclophosphamide|mesh-list
5636381|NCT04893915|Fludarabine|fludarabine|mesh-list
5636382|NCT04893915|Interleukin-2|interleukin-2|mesh-list
5636383|NCT04893915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5636384|NCT04893915|Immunologic Factors|immunologic factors|mesh-ancestor
5636385|NCT04893915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636386|NCT04893915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5636387|NCT04893915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6673321|NCT01561950|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6673322|NCT01561950|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6673323|NCT01561950|Purinergic Agents|purinergic agents|mesh-ancestor
6673324|NCT01561950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5636388|NCT04893915|Alkylating Agents|alkylating agents|mesh-ancestor
5761885|NCT02967432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761886|NCT02967432|Emollients|emollients|mesh-ancestor
5761887|NCT02967432|Dermatologic Agents|dermatologic agents|mesh-ancestor
5761888|NCT02967172|Epinephrine|epinephrine|mesh-list
5761889|NCT02967172|Morphine|morphine|mesh-list
5761890|NCT02967172|Ropivacaine|ropivacaine|mesh-list
5761891|NCT02967172|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5761892|NCT02967172|Narcotics|narcotics|mesh-ancestor
5761893|NCT02967172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5761894|NCT02967172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636389|NCT04893915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5636390|NCT04893915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5636391|NCT04893915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5636392|NCT04893915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5636393|NCT04893915|Analgesics|analgesics|mesh-ancestor
5636394|NCT04893915|Sensory System Agents|sensory system agents|mesh-ancestor
5636395|NCT04893915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5636396|NCT04884308|BCG Vaccine|bcg vaccine|mesh-list
5636397|NCT04884308|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5636398|NCT04884308|Immunologic Factors|immunologic factors|mesh-ancestor
5636399|NCT04884308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636400|NCT04880707|Anesthetics|anesthetics|mesh-list
5636401|NCT04880707|Anesthetics, Local|anesthetics, local|mesh-list
5761895|NCT02967172|Analgesics|analgesics|mesh-ancestor
5761896|NCT02967172|Sensory System Agents|sensory system agents|mesh-ancestor
5761897|NCT02967172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5761898|NCT02967172|Anesthetics, Local|anesthetics, local|mesh-ancestor
5761899|NCT02967172|Anesthetics|anesthetics|mesh-ancestor
5761900|NCT02967172|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5761901|NCT02967172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5761902|NCT02967172|Adrenergic Agents|adrenergic agents|mesh-ancestor
5761903|NCT02967172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5761904|NCT02967172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761905|NCT02967172|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5761906|NCT02967172|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5761907|NCT02967172|Autonomic Agents|autonomic agents|mesh-ancestor
5761908|NCT02967172|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5761909|NCT02967172|Respiratory System Agents|respiratory system agents|mesh-ancestor
5761910|NCT02967172|Mydriatics|mydriatics|mesh-ancestor
5761911|NCT02967172|Sympathomimetics|sympathomimetics|mesh-ancestor
5761912|NCT02967172|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5761913|NCT02967237|Insulin Glargine|insulin glargine|mesh-list
5761914|NCT02967237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5761915|NCT02967237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636402|NCT04880707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5761916|NCT02967250|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
5761917|NCT02967250|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5761918|NCT02967250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5636403|NCT04880707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636404|NCT04880707|Sensory System Agents|sensory system agents|mesh-ancestor
5636405|NCT04880707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5636406|NCT04874545|Propofol|propofol|mesh-list
5636407|NCT04874545|Sevoflurane|sevoflurane|mesh-list
5636408|NCT04874545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5636409|NCT04874545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5761919|NCT02967211|Insulin|insulin|mesh-list
5761920|NCT02967211|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5761921|NCT02967211|Insulin Glargine|insulin glargine|mesh-list
5761922|NCT02967211|Insulin Detemir|insulin detemir|mesh-list
5761923|NCT02967211|Insulin, Isophane|insulin, isophane|mesh-list
5761924|NCT02967211|Isophane Insulin, Human|isophane insulin, human|mesh-list
5761925|NCT02967211|Isophane insulin, beef|isophane insulin, beef|mesh-list
5761926|NCT02967211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5761927|NCT02967211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761928|NCT02966912|Magnesium Oxide|magnesium oxide|mesh-list
5761929|NCT02966912|Antacids|antacids|mesh-ancestor
5761930|NCT02966912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761931|NCT02966912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5761932|NCT02967029|Remifentanil|remifentanil|mesh-list
5761933|NCT02967029|Esmolol|esmolol|mesh-list
5761934|NCT02967029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5761935|NCT02967029|Narcotics|narcotics|mesh-ancestor
5761936|NCT02967029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5761937|NCT02967029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761938|NCT02967029|Analgesics|analgesics|mesh-ancestor
5761939|NCT02967029|Sensory System Agents|sensory system agents|mesh-ancestor
5761940|NCT02967029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5761941|NCT02967029|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5761942|NCT02967029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5761943|NCT02967029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5761944|NCT02967029|Adrenergic Agents|adrenergic agents|mesh-ancestor
5761945|NCT02967029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5761946|NCT02967029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761947|NCT02967094|Expectorants|expectorants|mesh-list
5761948|NCT02967094|Respiratory System Agents|respiratory system agents|mesh-ancestor
5761949|NCT02967133|Paclitaxel|paclitaxel|mesh-list
5761950|NCT02967133|Nivolumab|nivolumab|mesh-list
5761951|NCT02967133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5761952|NCT02967133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5761953|NCT02967133|Tubulin Modulators|tubulin modulators|mesh-ancestor
5761954|NCT02967133|Antimitotic Agents|antimitotic agents|mesh-ancestor
5761955|NCT02967133|Mitosis Modulators|mitosis modulators|mesh-ancestor
5761956|NCT02967133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5761957|NCT02967133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5761958|NCT02967133|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5761959|NCT02967224|Insulin|insulin|mesh-list
5761960|NCT02967224|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5761961|NCT02967224|Insulin Glargine|insulin glargine|mesh-list
5761962|NCT02967224|Insulin Detemir|insulin detemir|mesh-list
5761963|NCT02967224|Insulin, Isophane|insulin, isophane|mesh-list
5761964|NCT02967224|Isophane Insulin, Human|isophane insulin, human|mesh-list
5761965|NCT02967224|Isophane insulin, beef|isophane insulin, beef|mesh-list
5761966|NCT02967224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5761967|NCT02967224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761968|NCT02966847|Anesthetics|anesthetics|mesh-list
5761969|NCT02966847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5761970|NCT02966847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761971|NCT02966717|Rituximab|rituximab|mesh-list
5761972|NCT02966717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5761973|NCT02966717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5761974|NCT02966717|Immunologic Factors|immunologic factors|mesh-ancestor
5761975|NCT02966717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761976|NCT02966717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5761977|NCT02966522|Thalidomide|thalidomide|mesh-list
5761978|NCT02966522|Dexamethasone|dexamethasone|mesh-list
5761979|NCT02966522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5761980|NCT02966522|Antiemetics|antiemetics|mesh-ancestor
5761981|NCT02966522|Autonomic Agents|autonomic agents|mesh-ancestor
5761982|NCT02966522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5761983|NCT02966522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761984|NCT02966522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5636410|NCT04874545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5761985|NCT02966522|Glucocorticoids|glucocorticoids|mesh-ancestor
5761986|NCT02966522|Hormones|hormones|mesh-ancestor
5761987|NCT02966522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5636411|NCT04874545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5636412|NCT04874545|Anesthetics, General|anesthetics, general|mesh-ancestor
5636413|NCT04874545|Anesthetics|anesthetics|mesh-ancestor
5636414|NCT04874545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5636415|NCT04874545|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5761988|NCT02966522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5761989|NCT02966522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5761990|NCT02966522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5761991|NCT02966522|Immunologic Factors|immunologic factors|mesh-ancestor
5636416|NCT04864678|Vaccines|vaccines|mesh-list
5636417|NCT04864678|Immunologic Factors|immunologic factors|mesh-ancestor
5636418|NCT04864678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636419|NCT04858490|Diazepam|diazepam|mesh-list
5636420|NCT04858490|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5636421|NCT04858490|Anticonvulsants|anticonvulsants|mesh-ancestor
5636422|NCT04858490|Antiemetics|antiemetics|mesh-ancestor
5636423|NCT04858490|Autonomic Agents|autonomic agents|mesh-ancestor
5636424|NCT04858490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5636425|NCT04858490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636426|NCT04858490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5636427|NCT04858490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5636428|NCT04858490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5636429|NCT04858490|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5636430|NCT04858490|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5636431|NCT04858490|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5636432|NCT04858490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5636433|NCT04858490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5636434|NCT04858490|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5636435|NCT04858490|Anesthetics, General|anesthetics, general|mesh-ancestor
5636436|NCT04858490|Anesthetics|anesthetics|mesh-ancestor
5636437|NCT04858490|GABA Modulators|gaba modulators|mesh-ancestor
5636438|NCT04858490|GABA Agents|gaba agents|mesh-ancestor
5636439|NCT04858490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5636440|NCT04858490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5636441|NCT04853251|Ranibizumab|ranibizumab|mesh-list
5636442|NCT04853251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5636443|NCT04853251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5636444|NCT04853251|Growth Substances|growth substances|mesh-ancestor
5636445|NCT04853251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636446|NCT04853251|Growth Inhibitors|growth inhibitors|mesh-ancestor
5636447|NCT04853251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5636448|NCT04851834|Cisplatin|cisplatin|mesh-list
5636449|NCT04851834|Carboplatin|carboplatin|mesh-list
5761992|NCT02966522|Leprostatic Agents|leprostatic agents|mesh-ancestor
5761993|NCT02966522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5761994|NCT02966522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5761995|NCT02966522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5761996|NCT02966522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5761997|NCT02966522|Growth Substances|growth substances|mesh-ancestor
5761998|NCT02966522|Growth Inhibitors|growth inhibitors|mesh-ancestor
5895485|NCT05222256|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5895486|NCT05222256|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5895487|NCT05222256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5895488|NCT05222256|Protective Agents|protective agents|mesh-ancestor
5895489|NCT05220410|Psilocybin|psilocybin|mesh-list
5895490|NCT05220410|Hallucinogens|hallucinogens|mesh-ancestor
5895491|NCT05220410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895492|NCT05220410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5895493|NCT05211947|BI 425809|bi 425809|mesh-list
5895494|NCT05211947|Nootropic Agents|nootropic agents|mesh-ancestor
5895495|NCT05207722|Aldesleukin|aldesleukin|mesh-list
5895496|NCT05207722|Cyclophosphamide|cyclophosphamide|mesh-list
5895497|NCT05207722|Pembrolizumab|pembrolizumab|mesh-list
5895498|NCT05207722|Fludarabine|fludarabine|mesh-list
5895499|NCT05207722|Trastuzumab|trastuzumab|mesh-list
5895500|NCT05207722|Interleukin-2|interleukin-2|mesh-list
5895501|NCT05207722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5895502|NCT05207722|Immunologic Factors|immunologic factors|mesh-ancestor
5895503|NCT05207722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895504|NCT05207722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5895505|NCT05207722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5895506|NCT05207722|Alkylating Agents|alkylating agents|mesh-ancestor
5895507|NCT05207722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5636450|NCT04851834|Temozolomide|temozolomide|mesh-list
5636451|NCT04851834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5636452|NCT04851834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5895508|NCT05207722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5895509|NCT05207722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5761999|NCT02966587|Durvalumab|durvalumab|mesh-list
5762000|NCT02966587|Immunoglobulins|immunoglobulins|mesh-list
5762001|NCT02966587|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5762002|NCT02966587|Immunoglobulin G|immunoglobulin g|mesh-list
5762003|NCT02966587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5762004|NCT02966587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5762005|NCT02966587|Immunologic Factors|immunologic factors|mesh-ancestor
5762006|NCT02966587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762007|NCT02966457|Colistin|colistin|mesh-list
5762008|NCT02966457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5762009|NCT02966457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5762010|NCT02966665|Vitamins|vitamins|mesh-list
5762011|NCT02966665|Vitamin E|vitamin e|mesh-list
5762012|NCT02966665|Thioctic Acid|thioctic acid|mesh-list
5762013|NCT02966665|Fexofenadine|fexofenadine|mesh-list
5762014|NCT02966665|Valsartan|valsartan|mesh-list
5762015|NCT02966665|Nitroprusside|nitroprusside|mesh-list
5762016|NCT02966665|Phentolamine|phentolamine|mesh-list
5762017|NCT02966665|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
5762018|NCT02966665|Norepinephrine|norepinephrine|mesh-list
5762019|NCT02966665|Angiotensin II|angiotensin ii|mesh-list
5762020|NCT02966665|Giapreza|giapreza|mesh-list
5762021|NCT02966665|Acetylcholine|acetylcholine|mesh-list
5762022|NCT02966665|Ranitidine|ranitidine|mesh-list
5762023|NCT02966665|Angiotensinogen|angiotensinogen|mesh-list
5762024|NCT02966665|Micronutrients|micronutrients|mesh-ancestor
5762025|NCT02966665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762026|NCT02966665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5762027|NCT02966665|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5762028|NCT02966665|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5762029|NCT02966665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762030|NCT02966665|Antioxidants|antioxidants|mesh-ancestor
5762031|NCT02966665|Protective Agents|protective agents|mesh-ancestor
5762032|NCT02966665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5762033|NCT02966665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5762034|NCT02966665|Adrenergic Agents|adrenergic agents|mesh-ancestor
5762035|NCT02966665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5762036|NCT02966665|Sympathomimetics|sympathomimetics|mesh-ancestor
5762037|NCT02966665|Autonomic Agents|autonomic agents|mesh-ancestor
5762038|NCT02966665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5762039|NCT02966665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5762040|NCT02966665|Vitamin B Complex|vitamin b complex|mesh-ancestor
5762041|NCT02966665|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5762042|NCT02966665|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5762043|NCT02966665|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5762044|NCT02966665|Histamine Antagonists|histamine antagonists|mesh-ancestor
5762045|NCT02966665|Histamine Agents|histamine agents|mesh-ancestor
5762046|NCT02966665|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5762047|NCT02966665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5636453|NCT04851834|Alkylating Agents|alkylating agents|mesh-ancestor
5636454|NCT04851834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5636455|NCT04849910|Gemtuzumab|gemtuzumab|mesh-list
5636456|NCT04849910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5636457|NCT04849910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5636458|NCT04827979|Daratumumab|daratumumab|mesh-list
5636459|NCT04827979|Abatacept|abatacept|mesh-list
5636460|NCT04827979|Immunoglobulins|immunoglobulins|mesh-list
5636461|NCT04827979|Immunoglobulin G|immunoglobulin g|mesh-list
5762048|NCT02966665|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5762049|NCT02966665|Vasodilator Agents|vasodilator agents|mesh-ancestor
5762050|NCT02966665|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5762051|NCT02966665|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5762052|NCT02966665|Protease Inhibitors|protease inhibitors|mesh-ancestor
5762053|NCT02966665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5762054|NCT02966665|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5762055|NCT02966665|Cholinergic Agents|cholinergic agents|mesh-ancestor
5762056|NCT02966665|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6490186|NCT00596297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490187|NCT00596297|Growth Inhibitors|growth inhibitors|mesh-ancestor
6490188|NCT00596336|Imiquimod|imiquimod|mesh-list
5636462|NCT04827979|Immunologic Factors|immunologic factors|mesh-ancestor
5636463|NCT04827979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636464|NCT04827979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5636465|NCT04827979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5762057|NCT02966665|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5762058|NCT02966665|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5762059|NCT02966743|Midazolam|midazolam|mesh-list
5762060|NCT02966743|Dexmedetomidine|dexmedetomidine|mesh-list
5762061|NCT02966743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6490189|NCT00596336|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5636466|NCT04827979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5636467|NCT04827979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5636468|NCT04827979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5636469|NCT04824092|Prednisone|prednisone|mesh-list
5636470|NCT04824092|Cyclophosphamide|cyclophosphamide|mesh-list
5636471|NCT04824092|Rituximab|rituximab|mesh-list
5636472|NCT04824092|Doxorubicin|doxorubicin|mesh-list
5636473|NCT04824092|Vincristine|vincristine|mesh-list
5636474|NCT04824092|Lenalidomide|lenalidomide|mesh-list
5636475|NCT04824092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5636476|NCT04824092|Immunologic Factors|immunologic factors|mesh-ancestor
5636477|NCT04824092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636478|NCT04824092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5636479|NCT04824092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5636480|NCT04824092|Alkylating Agents|alkylating agents|mesh-ancestor
5636481|NCT04824092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5636482|NCT04824092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5636483|NCT04824092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5636484|NCT04824092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5636485|NCT04824092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5636486|NCT04824092|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5636487|NCT04824092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5636488|NCT04824092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5636489|NCT04824092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5636490|NCT04824092|Glucocorticoids|glucocorticoids|mesh-ancestor
5636491|NCT04824092|Hormones|hormones|mesh-ancestor
5636492|NCT04824092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5636493|NCT04824092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5636494|NCT04824092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5636495|NCT04824092|Tubulin Modulators|tubulin modulators|mesh-ancestor
5636496|NCT04824092|Antimitotic Agents|antimitotic agents|mesh-ancestor
5636497|NCT04824092|Mitosis Modulators|mitosis modulators|mesh-ancestor
5636498|NCT04824092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5636499|NCT04824092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5636500|NCT04824092|Growth Substances|growth substances|mesh-ancestor
5636501|NCT04824092|Growth Inhibitors|growth inhibitors|mesh-ancestor
5636502|NCT04822597|Lidocaine|lidocaine|mesh-list
5636503|NCT04822597|Anesthetics, Local|anesthetics, local|mesh-ancestor
5636504|NCT04822597|Anesthetics|anesthetics|mesh-ancestor
5636505|NCT04822597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5636506|NCT04822597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636507|NCT04822597|Sensory System Agents|sensory system agents|mesh-ancestor
5762062|NCT02966743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5762063|NCT02966743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762064|NCT02966743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5762065|NCT02966743|Analgesics|analgesics|mesh-ancestor
5762066|NCT02966743|Sensory System Agents|sensory system agents|mesh-ancestor
5762067|NCT02966743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5762068|NCT02966743|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5762069|NCT02966743|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5762070|NCT02966743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5762071|NCT02966743|Adrenergic Agents|adrenergic agents|mesh-ancestor
5762072|NCT02966743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5762073|NCT02966743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762074|NCT02966743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5762075|NCT02966743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5762076|NCT02966743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5762077|NCT02966743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5762078|NCT02966743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5762079|NCT02966743|Anesthetics, General|anesthetics, general|mesh-ancestor
5762080|NCT02966743|Anesthetics|anesthetics|mesh-ancestor
5762081|NCT02966743|GABA Modulators|gaba modulators|mesh-ancestor
5762082|NCT02966743|GABA Agents|gaba agents|mesh-ancestor
5762083|NCT02966652|Methyltestosterone|methyltestosterone|mesh-list
5762084|NCT02966652|Testosterone|testosterone|mesh-list
5762085|NCT02966652|Testosterone undecanoate|testosterone undecanoate|mesh-list
5762086|NCT02966652|Testosterone enanthate|testosterone enanthate|mesh-list
5762087|NCT02966652|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5762088|NCT02966652|Androgens|androgens|mesh-ancestor
5762089|NCT02966652|Hormones|hormones|mesh-ancestor
5762090|NCT02966652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5762091|NCT02966652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762092|NCT02966652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5636508|NCT04822597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5762093|NCT02966652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5762094|NCT02966652|Anabolic Agents|anabolic agents|mesh-ancestor
5762095|NCT02966288|Ibuprofen|ibuprofen|mesh-list
5762096|NCT02966288|Ketorolac|ketorolac|mesh-list
5762097|NCT02966288|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
5762098|NCT02966288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5762099|NCT02966288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5762100|NCT02966288|Analgesics|analgesics|mesh-ancestor
5762101|NCT02966288|Sensory System Agents|sensory system agents|mesh-ancestor
5762102|NCT02966288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5762103|NCT02966288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762104|NCT02966288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5762105|NCT02966288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5762106|NCT02966288|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5762107|NCT02966288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5762108|NCT02966288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762109|NCT02966301|Arsenic Trioxide|arsenic trioxide|mesh-list
5762110|NCT02966301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5762111|NCT02966704|Caseins|caseins|mesh-list
5762112|NCT02966704|Chelating Agents|chelating agents|mesh-ancestor
5762113|NCT02966704|Sequestering Agents|sequestering agents|mesh-ancestor
5762114|NCT02966704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762115|NCT02966236|Tranexamic Acid|tranexamic acid|mesh-list
5762116|NCT02966236|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5762117|NCT02966236|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5762118|NCT02966236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762119|NCT02966236|Hemostatics|hemostatics|mesh-ancestor
5762120|NCT02966236|Coagulants|coagulants|mesh-ancestor
5762121|NCT02966119|Aspirin|aspirin|mesh-list
5762122|NCT02966119|Clopidogrel|clopidogrel|mesh-list
5762123|NCT02966119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5762124|NCT02966119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5762125|NCT02966119|Analgesics|analgesics|mesh-ancestor
5762126|NCT02966119|Sensory System Agents|sensory system agents|mesh-ancestor
5762127|NCT02966119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5762128|NCT02966119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762129|NCT02966119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5762130|NCT02966119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5762131|NCT02966119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5762132|NCT02966119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5762133|NCT02966119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762134|NCT02966119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5636509|NCT04822597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5636510|NCT04822597|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5636511|NCT04822597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5636512|NCT04822597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5636513|NCT04822597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5636514|NCT04822350|Avelumab|avelumab|mesh-list
5636515|NCT04822350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5636516|NCT04822350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5636517|NCT04814355|Celecoxib|celecoxib|mesh-list
5636518|NCT04814355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5636519|NCT04814355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5636520|NCT04814355|Analgesics|analgesics|mesh-ancestor
5636521|NCT04814355|Sensory System Agents|sensory system agents|mesh-ancestor
5636522|NCT04814355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5636523|NCT04814355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636524|NCT04814355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5636525|NCT04814355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5636526|NCT04814355|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5636527|NCT04814355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5636528|NCT04814355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5636529|NCT04814355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5636530|NCT04804553|Apremilast|apremilast|mesh-list
5636531|NCT04804553|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5762135|NCT02966119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5762136|NCT02966119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5762137|NCT02966119|Antipyretics|antipyretics|mesh-ancestor
5762138|NCT02966119|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5762139|NCT02966119|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5762140|NCT02966119|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5762141|NCT02966119|Purinergic Agents|purinergic agents|mesh-ancestor
5762142|NCT02966119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5762143|NCT02965950|Cyclophosphamide|cyclophosphamide|mesh-list
5762144|NCT02965950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5762145|NCT02965950|Immunologic Factors|immunologic factors|mesh-ancestor
5762146|NCT02965950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762147|NCT02965950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5762148|NCT02965950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5762149|NCT02965950|Alkylating Agents|alkylating agents|mesh-ancestor
5762150|NCT02965950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762151|NCT02965950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5762152|NCT02965950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5762153|NCT02966067|Anesthetics|anesthetics|mesh-list
5762154|NCT02966067|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5762155|NCT02966067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5762156|NCT02966067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762157|NCT02966041|Ondansetron|ondansetron|mesh-list
5762158|NCT02966041|Antiemetics|antiemetics|mesh-ancestor
5762159|NCT02966041|Autonomic Agents|autonomic agents|mesh-ancestor
5762160|NCT02966041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5762161|NCT02966041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762162|NCT02966041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5762163|NCT02966041|Antipruritics|antipruritics|mesh-ancestor
5762164|NCT02966041|Dermatologic Agents|dermatologic agents|mesh-ancestor
5762165|NCT02966041|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5762166|NCT02966041|Serotonin Agents|serotonin agents|mesh-ancestor
5762167|NCT02966041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5762168|NCT02966041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762169|NCT02966041|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5762170|NCT02966041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5762171|NCT02966041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5762172|NCT02966041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5762173|NCT02966041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5762174|NCT02965911|Fenofibrate|fenofibrate|mesh-list
5762175|NCT02965911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5762176|NCT02965911|Antimetabolites|antimetabolites|mesh-ancestor
5762177|NCT02965911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762178|NCT02965911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5762179|NCT02965963|Dopamine|dopamine|mesh-list
5762180|NCT02965963|Metoclopramide|metoclopramide|mesh-list
5762181|NCT02965963|Antiemetics|antiemetics|mesh-ancestor
5762182|NCT02965963|Autonomic Agents|autonomic agents|mesh-ancestor
5762183|NCT02965963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5762184|NCT02965963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762185|NCT02965963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5636532|NCT04804553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5636533|NCT04804553|Analgesics|analgesics|mesh-ancestor
5636534|NCT04804553|Sensory System Agents|sensory system agents|mesh-ancestor
5762186|NCT02965963|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5762187|NCT02965963|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5762188|NCT02965963|Dopamine Agents|dopamine agents|mesh-ancestor
5762189|NCT02965963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5762190|NCT02965963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762191|NCT02965963|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5762192|NCT02965963|Sympathomimetics|sympathomimetics|mesh-ancestor
5762193|NCT02965963|Protective Agents|protective agents|mesh-ancestor
5762194|NCT02966249|Levobupivacaine|levobupivacaine|mesh-list
5762195|NCT02966249|Anesthetics, Local|anesthetics, local|mesh-ancestor
5762196|NCT02966249|Anesthetics|anesthetics|mesh-ancestor
5762197|NCT02966249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5636535|NCT04804553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5636536|NCT04804553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636537|NCT04804553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5636538|NCT04804553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5636539|NCT04804553|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5636540|NCT04804553|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5636541|NCT04804553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5636542|NCT04804553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5636543|NCT04799431|Poly I-C|poly i-c|mesh-list
5636544|NCT04799431|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
5636545|NCT04799431|Poly ICLC|poly iclc|mesh-list
5636546|NCT04799431|Interferon Inducers|interferon inducers|mesh-ancestor
5636547|NCT04799431|Immunologic Factors|immunologic factors|mesh-ancestor
5636548|NCT04799431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636549|NCT04799431|Laxatives|laxatives|mesh-ancestor
5636550|NCT04799431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5636551|NCT04799431|Antiviral Agents|antiviral agents|mesh-ancestor
5636552|NCT04799431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5762198|NCT02966249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636553|NCT04799054|Pembrolizumab|pembrolizumab|mesh-list
5636554|NCT04799054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5636555|NCT04799054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5636556|NCT04798339|Darbepoetin alfa|darbepoetin alfa|mesh-list
5636557|NCT04798339|Hematinics|hematinics|mesh-ancestor
5636558|NCT04789304|Midazolam|midazolam|mesh-list
5636559|NCT04789304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5636560|NCT04789304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5636561|NCT04789304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5636562|NCT04789304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636563|NCT04789304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5636564|NCT04789304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5636565|NCT04789304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5636566|NCT04789304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5636567|NCT04789304|Anesthetics, General|anesthetics, general|mesh-ancestor
5636568|NCT04789304|Anesthetics|anesthetics|mesh-ancestor
5636569|NCT04789304|GABA Modulators|gaba modulators|mesh-ancestor
5636570|NCT04789304|GABA Agents|gaba agents|mesh-ancestor
5636571|NCT04789304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5636572|NCT04789304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5636573|NCT04788615|Interferons|interferons|mesh-list
5636574|NCT04788615|Teriflunomide|teriflunomide|mesh-list
5636575|NCT04788615|Ofatumumab|ofatumumab|mesh-list
5636576|NCT04788615|Glatiramer Acetate|glatiramer acetate|mesh-list
5636577|NCT04788615|Dimethyl Fumarate|dimethyl fumarate|mesh-list
5636578|NCT04788615|(T,G)-A-L|(t,g)-a-l|mesh-list
5636579|NCT04788615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5636580|NCT04788615|Antiviral Agents|antiviral agents|mesh-ancestor
5636581|NCT04788615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5636582|NCT04788615|Dermatologic Agents|dermatologic agents|mesh-ancestor
5636583|NCT04788615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5636584|NCT04788615|Immunologic Factors|immunologic factors|mesh-ancestor
5636585|NCT04788615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636586|NCT04788615|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5636587|NCT04788615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5636588|NCT04788615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5636589|NCT04788615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5636590|NCT04788615|Analgesics|analgesics|mesh-ancestor
5762199|NCT02966249|Sensory System Agents|sensory system agents|mesh-ancestor
5762200|NCT02966249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5762201|NCT02966080|Heparin|heparin|mesh-list
5762202|NCT02966080|Anticoagulants|anticoagulants|mesh-ancestor
5762203|NCT02966080|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5762204|NCT02966080|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5762205|NCT02966080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762206|NCT02965976|Botulinum Toxins|botulinum toxins|mesh-list
5762207|NCT02965976|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5762208|NCT02965976|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5762209|NCT02965976|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
5762210|NCT02965976|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5762211|NCT02965976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5762212|NCT02965976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762213|NCT02965976|Cholinergic Agents|cholinergic agents|mesh-ancestor
5762214|NCT02965976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5762215|NCT02965976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762216|NCT02965976|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5762217|NCT02965976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5762218|NCT02965859|Adefovir|adefovir|mesh-list
5762219|NCT02965859|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
5762220|NCT02965859|Antiviral Agents|antiviral agents|mesh-ancestor
5636591|NCT04788615|Sensory System Agents|sensory system agents|mesh-ancestor
5636592|NCT04788615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5636593|NCT04788615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5636594|NCT04784637|Insulin|insulin|mesh-list
5636595|NCT04784637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5636596|NCT04784637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636597|NCT04780724|Nitrox|nitrox|mesh-list
5636598|NCT04780724|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5636599|NCT04780724|Protective Agents|protective agents|mesh-ancestor
5636600|NCT04780724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762221|NCT02965859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5762222|NCT02965859|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5762223|NCT02965859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5762224|NCT02965859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5693645|NCT03400254|Antimalarials|antimalarials|mesh-ancestor
5693646|NCT03400254|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5693647|NCT03400254|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6490190|NCT00596336|Immunologic Factors|immunologic factors|mesh-ancestor
5762225|NCT02965859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762226|NCT02965404|Vaccines|vaccines|mesh-list
5762227|NCT02965404|Immunologic Factors|immunologic factors|mesh-ancestor
5762228|NCT02965404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762229|NCT02965677|Paclitaxel|paclitaxel|mesh-list
5762230|NCT02965677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5762231|NCT02965677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5762232|NCT02965677|Tubulin Modulators|tubulin modulators|mesh-ancestor
5762233|NCT02965677|Antimitotic Agents|antimitotic agents|mesh-ancestor
5762234|NCT02965677|Mitosis Modulators|mitosis modulators|mesh-ancestor
5762235|NCT02965677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762236|NCT02965443|Dapagliflozin|dapagliflozin|mesh-list
5762237|NCT02965443|Saxagliptin|saxagliptin|mesh-list
5762238|NCT02965443|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5762239|NCT02965443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762240|NCT02965443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5762241|NCT02965443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762242|NCT02965443|Incretins|incretins|mesh-ancestor
5762243|NCT02965443|Hormones|hormones|mesh-ancestor
5762244|NCT02965443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5762245|NCT02965443|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5636601|NCT04774965|Diphenhydramine|diphenhydramine|mesh-list
5636602|NCT04774965|Promethazine|promethazine|mesh-list
5636603|NCT04774965|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5636604|NCT04774965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5636605|NCT04774965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5636606|NCT04774965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636607|NCT04774965|Anesthetics, Local|anesthetics, local|mesh-ancestor
5636608|NCT04774965|Anesthetics|anesthetics|mesh-ancestor
5762246|NCT02965443|Protease Inhibitors|protease inhibitors|mesh-ancestor
5762247|NCT02965443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5762248|NCT02965768|Naltrexone|naltrexone|mesh-list
5762249|NCT02965768|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5762250|NCT02965768|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5762251|NCT02965768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762252|NCT02965768|Sensory System Agents|sensory system agents|mesh-ancestor
5762253|NCT02965768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5762254|NCT02965053|Sevelamer|sevelamer|mesh-list
5762255|NCT02965053|Chelating Agents|chelating agents|mesh-ancestor
5762256|NCT02965053|Sequestering Agents|sequestering agents|mesh-ancestor
5762257|NCT02965053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5636609|NCT04774965|Sensory System Agents|sensory system agents|mesh-ancestor
5636610|NCT04774965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5636611|NCT04774965|Antiemetics|antiemetics|mesh-ancestor
5636612|NCT04774965|Autonomic Agents|autonomic agents|mesh-ancestor
5636613|NCT04774965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5636614|NCT04774965|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5636615|NCT04774965|Histamine Antagonists|histamine antagonists|mesh-ancestor
5636616|NCT04774965|Histamine Agents|histamine agents|mesh-ancestor
5636617|NCT04774965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5636618|NCT04774965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5636619|NCT04774965|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5636620|NCT04774965|Antipruritics|antipruritics|mesh-ancestor
5636621|NCT04774965|Dermatologic Agents|dermatologic agents|mesh-ancestor
6209320|NCT02144259|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6209321|NCT02144259|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6209322|NCT02144259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5636625|NCT04762875|Plerixafor|plerixafor|mesh-list
5636626|NCT04762875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5636627|NCT04762875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5636628|NCT04762875|Antiviral Agents|antiviral agents|mesh-ancestor
5762258|NCT02965196|Dexamethasone|dexamethasone|mesh-list
5762259|NCT02965196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5762260|NCT02965196|Antiemetics|antiemetics|mesh-ancestor
5762261|NCT02965196|Autonomic Agents|autonomic agents|mesh-ancestor
5762262|NCT02965196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5762263|NCT02965196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762264|NCT02965196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5762265|NCT02965196|Glucocorticoids|glucocorticoids|mesh-ancestor
5762266|NCT02965196|Hormones|hormones|mesh-ancestor
5762267|NCT02965196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5636629|NCT04762875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5636630|NCT04747496|Edoxaban|edoxaban|mesh-list
5636631|NCT04747496|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5636632|NCT04747496|Antithrombins|antithrombins|mesh-ancestor
5636633|NCT04747496|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5762268|NCT02965196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5762269|NCT02965196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5762270|NCT02965248|Calcium, Dietary|calcium, dietary|mesh-list
5762271|NCT02965248|Leucovorin|leucovorin|mesh-list
5762272|NCT02965248|Capecitabine|capecitabine|mesh-list
5762273|NCT02965248|Raltitrexed|raltitrexed|mesh-list
5762274|NCT02965248|Oxaliplatin|oxaliplatin|mesh-list
5762275|NCT02965248|Calcium|calcium|mesh-list
5762276|NCT02965248|Levoleucovorin|levoleucovorin|mesh-list
5762277|NCT02965248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5762278|NCT02965248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762279|NCT02965248|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5762280|NCT02965248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5762281|NCT02965248|Antimetabolites|antimetabolites|mesh-ancestor
5762282|NCT02965248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762283|NCT02965248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5762284|NCT02965248|Antidotes|antidotes|mesh-ancestor
5636634|NCT04747496|Protease Inhibitors|protease inhibitors|mesh-ancestor
5636635|NCT04747496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5636636|NCT04747496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5636637|NCT04747496|Anticoagulants|anticoagulants|mesh-ancestor
5636638|NCT04742959|Paclitaxel|paclitaxel|mesh-list
5636639|NCT04742959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5636640|NCT04742959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5636641|NCT04742959|Tubulin Modulators|tubulin modulators|mesh-ancestor
5636642|NCT04742959|Antimitotic Agents|antimitotic agents|mesh-ancestor
5762285|NCT02965248|Protective Agents|protective agents|mesh-ancestor
5762286|NCT02965248|Vitamin B Complex|vitamin b complex|mesh-ancestor
5762287|NCT02965248|Vitamins|vitamins|mesh-ancestor
5762288|NCT02965248|Micronutrients|micronutrients|mesh-ancestor
5762289|NCT02965248|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5762290|NCT02965248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5762291|NCT02965274|Fluoxetine|fluoxetine|mesh-list
5762292|NCT02965274|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5762293|NCT02965274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5762294|NCT02965274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5762295|NCT02965274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762296|NCT02965274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5762297|NCT02965274|Serotonin Agents|serotonin agents|mesh-ancestor
5762298|NCT02965274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762299|NCT02965274|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5762300|NCT02965274|Antidepressive Agents|antidepressive agents|mesh-ancestor
5762301|NCT02965274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5762302|NCT02965274|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5762303|NCT02965274|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5762304|NCT02965274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5762305|NCT02965261|Fluoxetine|fluoxetine|mesh-list
5762306|NCT02965261|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5762307|NCT02965261|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6490191|NCT00596336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490192|NCT00596336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6490193|NCT00596336|Interferon Inducers|interferon inducers|mesh-ancestor
6490194|NCT00596375|Lidocaine|lidocaine|mesh-list
6490195|NCT00596375|Anesthetics, Local|anesthetics, local|mesh-ancestor
6490196|NCT00596375|Anesthetics|anesthetics|mesh-ancestor
6490197|NCT00596375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6490198|NCT00596375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490199|NCT00596375|Sensory System Agents|sensory system agents|mesh-ancestor
6490200|NCT00596375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5636643|NCT04742959|Mitosis Modulators|mitosis modulators|mesh-ancestor
5636644|NCT04742959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762308|NCT02965261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5762309|NCT02965261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5636645|NCT04737187|Trifluridine|trifluridine|mesh-list
5636646|NCT04737187|Bevacizumab|bevacizumab|mesh-list
5636647|NCT04737187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5636648|NCT04737187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5762310|NCT02965261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5762311|NCT02965261|Serotonin Agents|serotonin agents|mesh-ancestor
5762312|NCT02965261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762313|NCT02965261|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6490201|NCT00596375|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5636649|NCT04737187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5636650|NCT04737187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5762314|NCT02965261|Antidepressive Agents|antidepressive agents|mesh-ancestor
5762315|NCT02965261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5762316|NCT02965261|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5762317|NCT02965261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5762318|NCT02965261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5636651|NCT04737187|Growth Substances|growth substances|mesh-ancestor
5636652|NCT04737187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636653|NCT04737187|Growth Inhibitors|growth inhibitors|mesh-ancestor
5636654|NCT04737187|Antimetabolites|antimetabolites|mesh-ancestor
5636655|NCT04737187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5636656|NCT04737187|Antiviral Agents|antiviral agents|mesh-ancestor
5636657|NCT04737187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5762319|NCT02965027|Prazosin|prazosin|mesh-list
5762320|NCT02965027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5762321|NCT02965027|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5762322|NCT02965027|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5762323|NCT02965027|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5762324|NCT02965027|Adrenergic Agents|adrenergic agents|mesh-ancestor
5762325|NCT02965027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5762326|NCT02965027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762327|NCT02965027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895510|NCT05207722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5895511|NCT05207722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5895512|NCT05207722|Analgesics|analgesics|mesh-ancestor
5895513|NCT05207722|Sensory System Agents|sensory system agents|mesh-ancestor
5895514|NCT05207722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5895515|NCT05207722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5895516|NCT05207722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5895517|NCT05207722|Antiviral Agents|antiviral agents|mesh-ancestor
5895518|NCT05207722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5895519|NCT05207644|Letrozole|letrozole|mesh-list
5895520|NCT05207644|Misoprostol|misoprostol|mesh-list
5895521|NCT05207644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5895522|NCT05207644|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5895523|NCT05207644|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5895524|NCT05207644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5895525|NCT05207644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895526|NCT05207644|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5895527|NCT05207644|Hormone Antagonists|hormone antagonists|mesh-ancestor
5895528|NCT05207644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5895529|NCT05207644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895530|NCT05207644|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5895531|NCT05207644|Abortifacient Agents|abortifacient agents|mesh-ancestor
5895532|NCT05207644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5895533|NCT05207644|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5895534|NCT05207644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5895535|NCT05207644|Oxytocics|oxytocics|mesh-ancestor
5895536|NCT05206877|Insulin|insulin|mesh-list
5895537|NCT05206877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5895538|NCT05206877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5895539|NCT05206877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895540|NCT05200312|Prednisone|prednisone|mesh-list
5895541|NCT05200312|Cyclophosphamide|cyclophosphamide|mesh-list
5895542|NCT05200312|Rituximab|rituximab|mesh-list
5895543|NCT05200312|Doxorubicin|doxorubicin|mesh-list
5895544|NCT05200312|Vincristine|vincristine|mesh-list
5895545|NCT05200312|Lenalidomide|lenalidomide|mesh-list
5895546|NCT05200312|Zanubrutinib|zanubrutinib|mesh-list
5895547|NCT05200312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5895548|NCT05200312|Immunologic Factors|immunologic factors|mesh-ancestor
5895549|NCT05200312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895550|NCT05200312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5895551|NCT05200312|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5895552|NCT05200312|Alkylating Agents|alkylating agents|mesh-ancestor
5895553|NCT05200312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895554|NCT05200312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5895555|NCT05200312|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5895556|NCT05200312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5895557|NCT05200312|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5895558|NCT05200312|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5895559|NCT05200312|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5895560|NCT05200312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5636658|NCT04733937|Caseins|caseins|mesh-list
5636659|NCT04733937|Chelating Agents|chelating agents|mesh-ancestor
5636660|NCT04733937|Sequestering Agents|sequestering agents|mesh-ancestor
5636661|NCT04733937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5636662|NCT04722146|Lenalidomide|lenalidomide|mesh-list
5636663|NCT04722146|Pomalidomide|pomalidomide|mesh-list
5636664|NCT04722146|Bortezomib|bortezomib|mesh-list
5636665|NCT04722146|Daratumumab|daratumumab|mesh-list
5636666|NCT04722146|Immunologic Factors|immunologic factors|mesh-ancestor
5636667|NCT04722146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762328|NCT02964715|Empagliflozin|empagliflozin|mesh-list
5762329|NCT02964715|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5636668|NCT04722146|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5636669|NCT04722146|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5636670|NCT04722146|Growth Substances|growth substances|mesh-ancestor
5636671|NCT04722146|Growth Inhibitors|growth inhibitors|mesh-ancestor
5636672|NCT04722146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5636673|NCT04706741|Prednisone|prednisone|mesh-list
5636674|NCT04706741|Prednisolone|prednisolone|mesh-list
5636675|NCT04706741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5636676|NCT04706741|Glucocorticoids|glucocorticoids|mesh-ancestor
5636677|NCT04706741|Hormones|hormones|mesh-ancestor
5636678|NCT04706741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5762330|NCT02964715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762331|NCT02964715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5762332|NCT02964715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762333|NCT02964949|Edoxaban|edoxaban|mesh-list
5636679|NCT04706741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636680|NCT04706741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5636681|NCT04706741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5636682|NCT04700007|Diphenhydramine|diphenhydramine|mesh-list
5636683|NCT04700007|Promethazine|promethazine|mesh-list
5636684|NCT04700007|Morphine|morphine|mesh-list
5636685|NCT04700007|Capsaicin|capsaicin|mesh-list
5636686|NCT04700007|Histamine|histamine|mesh-list
5636687|NCT04700007|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5636688|NCT04700007|Narcotics|narcotics|mesh-ancestor
5636689|NCT04700007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5636690|NCT04700007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636691|NCT04700007|Analgesics|analgesics|mesh-ancestor
5636692|NCT04700007|Sensory System Agents|sensory system agents|mesh-ancestor
5636693|NCT04700007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5636694|NCT04700007|Antipruritics|antipruritics|mesh-ancestor
5636695|NCT04700007|Dermatologic Agents|dermatologic agents|mesh-ancestor
5636696|NCT04700007|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5636697|NCT04700007|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5636698|NCT04700007|Anesthetics, Local|anesthetics, local|mesh-ancestor
5636699|NCT04700007|Anesthetics|anesthetics|mesh-ancestor
5636700|NCT04700007|Antiemetics|antiemetics|mesh-ancestor
5762334|NCT02964949|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5762335|NCT02964949|Antithrombins|antithrombins|mesh-ancestor
5762336|NCT02964949|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5762337|NCT02964949|Protease Inhibitors|protease inhibitors|mesh-ancestor
5762338|NCT02964949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5762339|NCT02964949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762340|NCT02964949|Anticoagulants|anticoagulants|mesh-ancestor
5762341|NCT02964728|Botulinum Toxins|botulinum toxins|mesh-list
5762342|NCT02964728|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5762343|NCT02964728|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5636701|NCT04700007|Autonomic Agents|autonomic agents|mesh-ancestor
5636702|NCT04700007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5636703|NCT04700007|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5636704|NCT04700007|Histamine Antagonists|histamine antagonists|mesh-ancestor
5636705|NCT04700007|Histamine Agents|histamine agents|mesh-ancestor
5636706|NCT04700007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5636707|NCT04700007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5636708|NCT04700007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5636709|NCT04700007|Histamine Agonists|histamine agonists|mesh-ancestor
6209323|NCT02144259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5762344|NCT02964728|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5762345|NCT02964728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5762346|NCT02964728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762347|NCT02964728|Cholinergic Agents|cholinergic agents|mesh-ancestor
5762348|NCT02964728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5762349|NCT02964728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762350|NCT02964728|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5762351|NCT02964728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6209324|NCT02144675|Cytarabine|cytarabine|mesh-list
6209325|NCT02144675|Choline magnesium trisalicylate|choline magnesium trisalicylate|mesh-list
5636713|NCT04681079|Albuterol|albuterol|mesh-list
5636714|NCT04681079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5636715|NCT04681079|Autonomic Agents|autonomic agents|mesh-ancestor
5636716|NCT04681079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5636717|NCT04681079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762352|NCT02964689|Pemetrexed|pemetrexed|mesh-list
5762353|NCT02964689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5762354|NCT02964689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5762355|NCT02964689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762356|NCT02964689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5762357|NCT02964689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5762358|NCT02964455|Docetaxel|docetaxel|mesh-list
5762359|NCT02964455|Nedaplatin|nedaplatin|mesh-list
5762360|NCT02964455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5762361|NCT02964455|Tubulin Modulators|tubulin modulators|mesh-ancestor
5762362|NCT02964455|Antimitotic Agents|antimitotic agents|mesh-ancestor
5762363|NCT02964455|Mitosis Modulators|mitosis modulators|mesh-ancestor
5762364|NCT02964455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762365|NCT02964585|Canagliflozin|canagliflozin|mesh-list
5762366|NCT02964585|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5762367|NCT02964585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762368|NCT02964585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5762369|NCT02964585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762370|NCT02964572|Empagliflozin|empagliflozin|mesh-list
5762371|NCT02964572|Glimepiride|glimepiride|mesh-list
5762372|NCT02964572|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5762373|NCT02964572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762374|NCT02964572|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5762375|NCT02964572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762376|NCT02964572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5636718|NCT04681079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5636719|NCT04681079|Respiratory System Agents|respiratory system agents|mesh-ancestor
5636720|NCT04681079|Tocolytic Agents|tocolytic agents|mesh-ancestor
5636721|NCT04681079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5636722|NCT04681079|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5636723|NCT04681079|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5636724|NCT04681079|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5762377|NCT02964572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5762378|NCT02964572|Immunologic Factors|immunologic factors|mesh-ancestor
5762379|NCT02964195|Rifaximin|rifaximin|mesh-list
5762380|NCT02964195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5762381|NCT02964195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5762382|NCT02964195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5762383|NCT02964104|Insulin|insulin|mesh-list
6673325|NCT01561950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762384|NCT02964104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5762385|NCT02964104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5762386|NCT02964104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762387|NCT02964403|Indomethacin|indomethacin|mesh-list
5762388|NCT02964403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5762389|NCT02964403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5762390|NCT02964403|Analgesics|analgesics|mesh-ancestor
5762391|NCT02964403|Sensory System Agents|sensory system agents|mesh-ancestor
5762392|NCT02964403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5762393|NCT02964403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762394|NCT02964403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5762395|NCT02964403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5762396|NCT02964403|Gout Suppressants|gout suppressants|mesh-ancestor
5762397|NCT02964403|Tocolytic Agents|tocolytic agents|mesh-ancestor
5762398|NCT02964403|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5762399|NCT02964403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5762400|NCT02964403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5762401|NCT02964403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762402|NCT02964091|Sofosbuvir|sofosbuvir|mesh-list
5762403|NCT02964091|Ledipasvir|ledipasvir|mesh-list
5762404|NCT02964091|Antiviral Agents|antiviral agents|mesh-ancestor
5762405|NCT02964091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5762406|NCT02963779|Apremilast|apremilast|mesh-list
5762407|NCT02963779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5762408|NCT02963779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5762409|NCT02963779|Analgesics|analgesics|mesh-ancestor
5762410|NCT02963779|Sensory System Agents|sensory system agents|mesh-ancestor
5762411|NCT02963779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5762412|NCT02963779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762413|NCT02963779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5762414|NCT02963779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5762415|NCT02963779|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5762416|NCT02963779|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5762417|NCT02963779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6209326|NCT02144675|Salicylates|salicylates|mesh-list
5636725|NCT04681079|Adrenergic Agents|adrenergic agents|mesh-ancestor
5636726|NCT04681079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5636727|NCT04681079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5636728|NCT04680052|Rituximab|rituximab|mesh-list
5636729|NCT04680052|Lenalidomide|lenalidomide|mesh-list
5636730|NCT04680052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5636731|NCT04680052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5636732|NCT04680052|Immunologic Factors|immunologic factors|mesh-ancestor
5636733|NCT04680052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636734|NCT04680052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5636735|NCT04680052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5636736|NCT04680052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5636737|NCT04680052|Growth Substances|growth substances|mesh-ancestor
5636738|NCT04680052|Growth Inhibitors|growth inhibitors|mesh-ancestor
5636739|NCT04676646|Spironolactone|spironolactone|mesh-list
6490202|NCT00596375|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6490203|NCT00596375|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6490204|NCT00596375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6490205|NCT00596375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5636740|NCT04676646|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5636741|NCT04676646|Hormone Antagonists|hormone antagonists|mesh-ancestor
5636742|NCT04676646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5636743|NCT04676646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636744|NCT04676646|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5636745|NCT04676646|Diuretics|diuretics|mesh-ancestor
5636746|NCT04676646|Natriuretic Agents|natriuretic agents|mesh-ancestor
5636747|NCT04672382|Morphine|morphine|mesh-list
5636748|NCT04672382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5636749|NCT04672382|Narcotics|narcotics|mesh-ancestor
5636750|NCT04672382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5636751|NCT04672382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636752|NCT04672382|Analgesics|analgesics|mesh-ancestor
5636753|NCT04672382|Sensory System Agents|sensory system agents|mesh-ancestor
5636754|NCT04672382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5636755|NCT04666610|Brivaracetam|brivaracetam|mesh-list
5636756|NCT04666610|Anticonvulsants|anticonvulsants|mesh-ancestor
5636757|NCT04663282|Insulin|insulin|mesh-list
5636758|NCT04663282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5636759|NCT04663282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636760|NCT04661358|Fenofibrate|fenofibrate|mesh-list
5636761|NCT04661358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5636762|NCT04661358|Antimetabolites|antimetabolites|mesh-ancestor
5636763|NCT04661358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5636764|NCT04661358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6209327|NCT02144675|Idarubicin|idarubicin|mesh-list
6209328|NCT02144675|Choline|choline|mesh-list
6209329|NCT02144675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6209330|NCT02144675|Antimetabolites|antimetabolites|mesh-ancestor
6209331|NCT02144675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209332|NCT02144675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6209333|NCT02144675|Antiviral Agents|antiviral agents|mesh-ancestor
6209334|NCT02144675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6209335|NCT02144675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6209336|NCT02144675|Immunologic Factors|immunologic factors|mesh-ancestor
6209337|NCT02144675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636776|NCT04654689|Curcumin|curcumin|mesh-list
5636777|NCT04654689|Resveratrol|resveratrol|mesh-list
5636778|NCT04654689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5636779|NCT04654689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5636780|NCT04654689|Analgesics|analgesics|mesh-ancestor
5636781|NCT04654689|Sensory System Agents|sensory system agents|mesh-ancestor
5636782|NCT04654689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5636783|NCT04654689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636784|NCT04654689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5636785|NCT04654689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5636786|NCT04654689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5636787|NCT04654689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5636788|NCT04654689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490206|NCT00596414|Midazolam|midazolam|mesh-list
6490207|NCT00596414|Meperidine|meperidine|mesh-list
6490208|NCT00596414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6490209|NCT00596414|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6490210|NCT00596414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6490211|NCT00596414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490212|NCT00596414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6490213|NCT00596414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6490214|NCT00596414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6490215|NCT00596414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6490216|NCT00596414|Anesthetics, General|anesthetics, general|mesh-ancestor
6490217|NCT00596414|Anesthetics|anesthetics|mesh-ancestor
6490218|NCT00596414|GABA Modulators|gaba modulators|mesh-ancestor
6490219|NCT00596414|GABA Agents|gaba agents|mesh-ancestor
6490220|NCT00596414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6490221|NCT00596414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490222|NCT00596414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6490223|NCT00596414|Narcotics|narcotics|mesh-ancestor
6490224|NCT00596414|Analgesics|analgesics|mesh-ancestor
6490225|NCT00596414|Sensory System Agents|sensory system agents|mesh-ancestor
6490226|NCT00596414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6490227|NCT00596479|Lenograstim|lenograstim|mesh-list
6490228|NCT00596479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6490229|NCT00596479|Immunologic Factors|immunologic factors|mesh-ancestor
6490230|NCT00596479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490231|NCT00596531|Acamprosate|acamprosate|mesh-list
6490232|NCT00596531|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5762418|NCT02963779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762419|NCT02963896|Gentamicins|gentamicins|mesh-list
5762420|NCT02963896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5762421|NCT02963896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5762422|NCT02963896|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5762423|NCT02963896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5762424|NCT02963896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762425|NCT02963766|Dulaglutide|dulaglutide|mesh-list
5762426|NCT02963766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5762427|NCT02963766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762428|NCT02963402|Adalimumab|adalimumab|mesh-list
5762429|NCT02963402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5762430|NCT02963402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5762431|NCT02963454|Simendan|simendan|mesh-list
5762432|NCT02963454|Dobutamine|dobutamine|mesh-list
5762433|NCT02963454|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5762434|NCT02963454|Vasodilator Agents|vasodilator agents|mesh-ancestor
5762435|NCT02963454|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5762436|NCT02963454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6490233|NCT00596557|Everolimus|everolimus|mesh-list
5636789|NCT04654689|Antioxidants|antioxidants|mesh-ancestor
5636790|NCT04654689|Protective Agents|protective agents|mesh-ancestor
5636791|NCT04654689|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5636792|NCT04643405|Gemcitabine|gemcitabine|mesh-list
5636793|NCT04643405|Paclitaxel|paclitaxel|mesh-list
5636794|NCT04643405|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5636795|NCT04643405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5636796|NCT04643405|Tubulin Modulators|tubulin modulators|mesh-ancestor
5636797|NCT04643405|Antimitotic Agents|antimitotic agents|mesh-ancestor
5636798|NCT04643405|Mitosis Modulators|mitosis modulators|mesh-ancestor
5636799|NCT04643405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5636800|NCT04643405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5636801|NCT04643405|Antimetabolites|antimetabolites|mesh-ancestor
5636802|NCT04643405|Antiviral Agents|antiviral agents|mesh-ancestor
5636803|NCT04643405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5636804|NCT04643405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5636805|NCT04643405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5636806|NCT04643405|Immunologic Factors|immunologic factors|mesh-ancestor
5636807|NCT04643405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209338|NCT02144675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6209339|NCT02144675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6209340|NCT02144675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6209341|NCT02144675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6209342|NCT02144675|Lipotropic Agents|lipotropic agents|mesh-ancestor
6209343|NCT02144675|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6209344|NCT02144675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6209345|NCT02144675|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6209346|NCT02144675|Nootropic Agents|nootropic agents|mesh-ancestor
6209347|NCT02144675|Analgesics|analgesics|mesh-ancestor
6209348|NCT02144675|Sensory System Agents|sensory system agents|mesh-ancestor
5762437|NCT02963454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6490234|NCT00596557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6490235|NCT00596557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5636819|NCT04639011|Norepinephrine|norepinephrine|mesh-list
5636820|NCT04639011|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5636821|NCT04639011|Serotonin|serotonin|mesh-list
5636822|NCT04639011|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5636823|NCT04639011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5636824|NCT04639011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5636825|NCT04639011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762438|NCT02963454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762439|NCT02963454|Protective Agents|protective agents|mesh-ancestor
5762440|NCT02963454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762441|NCT02963454|Sympathomimetics|sympathomimetics|mesh-ancestor
5762442|NCT02963454|Autonomic Agents|autonomic agents|mesh-ancestor
5762443|NCT02963454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5762444|NCT02963454|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5762445|NCT02963454|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5762446|NCT02963454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5636826|NCT04639011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5636827|NCT04639011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636828|NCT04639011|Analgesics|analgesics|mesh-ancestor
5636829|NCT04639011|Sensory System Agents|sensory system agents|mesh-ancestor
5636830|NCT04639011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5762447|NCT02963454|Adrenergic Agents|adrenergic agents|mesh-ancestor
5762448|NCT02963454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5762449|NCT02963051|Copper|copper|mesh-list
5762450|NCT02963051|Disulfiram|disulfiram|mesh-list
5762451|NCT02963051|Trace Elements|trace elements|mesh-ancestor
5762452|NCT02963051|Micronutrients|micronutrients|mesh-ancestor
5762453|NCT02963051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762454|NCT02963051|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5762455|NCT02963051|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
5762456|NCT02963051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5762457|NCT02963051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762458|NCT02963194|Oxytocin|oxytocin|mesh-list
5762459|NCT02963194|Oxytocics|oxytocics|mesh-ancestor
5762460|NCT02963194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5762461|NCT02963194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762462|NCT02963129|Mupirocin|mupirocin|mesh-list
5762463|NCT02963129|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5762464|NCT02963129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5762465|NCT02963129|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5762466|NCT02963129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5762467|NCT02963129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762468|NCT02963077|Cholestyramine Resin|cholestyramine resin|mesh-list
5762469|NCT02963077|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5762470|NCT02963077|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5762471|NCT02963077|Antimetabolites|antimetabolites|mesh-ancestor
5762472|NCT02963077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762473|NCT02963077|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5762474|NCT02963168|Docetaxel|docetaxel|mesh-list
5762475|NCT02963168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5762476|NCT02963168|Tubulin Modulators|tubulin modulators|mesh-ancestor
5762477|NCT02963168|Antimitotic Agents|antimitotic agents|mesh-ancestor
5762478|NCT02963168|Mitosis Modulators|mitosis modulators|mesh-ancestor
5762479|NCT02963168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762480|NCT02963181|Melatonin|melatonin|mesh-list
5762481|NCT02963181|Yohimbine|yohimbine|mesh-list
5762482|NCT02963181|Antioxidants|antioxidants|mesh-ancestor
5762483|NCT02963181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762484|NCT02963181|Protective Agents|protective agents|mesh-ancestor
5762485|NCT02963181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762486|NCT02963181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5762487|NCT02963181|Mydriatics|mydriatics|mesh-ancestor
5762488|NCT02963181|Autonomic Agents|autonomic agents|mesh-ancestor
5762489|NCT02963181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5762490|NCT02963181|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5762491|NCT02963181|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5762492|NCT02963181|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5762493|NCT02963181|Adrenergic Agents|adrenergic agents|mesh-ancestor
5762494|NCT02963181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5762495|NCT02963181|Urological Agents|urological agents|mesh-ancestor
5895561|NCT05200312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5895562|NCT05200312|Glucocorticoids|glucocorticoids|mesh-ancestor
5895563|NCT05200312|Hormones|hormones|mesh-ancestor
5895564|NCT05200312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5895565|NCT05200312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5895566|NCT05200312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5895567|NCT05200312|Tubulin Modulators|tubulin modulators|mesh-ancestor
5895568|NCT05200312|Antimitotic Agents|antimitotic agents|mesh-ancestor
5895569|NCT05200312|Mitosis Modulators|mitosis modulators|mesh-ancestor
5895570|NCT05200312|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5895571|NCT05200312|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5895572|NCT05200312|Growth Substances|growth substances|mesh-ancestor
5895573|NCT05200312|Growth Inhibitors|growth inhibitors|mesh-ancestor
5895574|NCT05200312|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5895575|NCT05188053|Ketorolac|ketorolac|mesh-list
5895576|NCT05188053|Epinephrine|epinephrine|mesh-list
5895577|NCT05188053|Ropivacaine|ropivacaine|mesh-list
5636831|NCT04639011|Antidepressive Agents|antidepressive agents|mesh-ancestor
5636832|NCT04639011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5636833|NCT04639011|Dopamine Agents|dopamine agents|mesh-ancestor
5636834|NCT04639011|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5636835|NCT04639011|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5636836|NCT04639011|Adrenergic Agents|adrenergic agents|mesh-ancestor
5636837|NCT04639011|Sympathomimetics|sympathomimetics|mesh-ancestor
5636838|NCT04639011|Autonomic Agents|autonomic agents|mesh-ancestor
5636839|NCT04639011|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5636840|NCT04639011|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5636841|NCT04639011|Serotonin Agents|serotonin agents|mesh-ancestor
5636842|NCT04625803|Apatinib|apatinib|mesh-list
5636843|NCT04625803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5636844|NCT04625803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5636845|NCT04625803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5636846|NCT04625803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5636847|NCT04623567|Metformin|metformin|mesh-list
5636848|NCT04623567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5636849|NCT04623567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895578|NCT05188053|Anesthetics, Local|anesthetics, local|mesh-ancestor
5895579|NCT05188053|Anesthetics|anesthetics|mesh-ancestor
5895580|NCT05188053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5895581|NCT05188053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895582|NCT05188053|Sensory System Agents|sensory system agents|mesh-ancestor
5895583|NCT05188053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5895584|NCT05188053|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5895585|NCT05188053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5895586|NCT05188053|Adrenergic Agents|adrenergic agents|mesh-ancestor
5895587|NCT05188053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5895588|NCT05188053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895589|NCT05188053|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5895590|NCT05188053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5895591|NCT05188053|Autonomic Agents|autonomic agents|mesh-ancestor
5895592|NCT05188053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5895593|NCT05188053|Respiratory System Agents|respiratory system agents|mesh-ancestor
5895594|NCT05188053|Mydriatics|mydriatics|mesh-ancestor
5895595|NCT05188053|Sympathomimetics|sympathomimetics|mesh-ancestor
5895596|NCT05188053|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5895597|NCT05188053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5895598|NCT05188053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5895599|NCT05188053|Analgesics|analgesics|mesh-ancestor
5895600|NCT05188053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5895601|NCT05188053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5895602|NCT05188053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5895603|NCT05188053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5895604|NCT05183412|Methamphetamine|methamphetamine|mesh-list
5895605|NCT05183412|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5895606|NCT05183412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895607|NCT05183412|Sympathomimetics|sympathomimetics|mesh-ancestor
5895608|NCT05183412|Autonomic Agents|autonomic agents|mesh-ancestor
5895609|NCT05183412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5636850|NCT04622267|Anti-Infective Agents|anti-infective agents|mesh-list
5636851|NCT04622267|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5762496|NCT02963337|Remifentanil|remifentanil|mesh-list
5762497|NCT02963337|Bupivacaine|bupivacaine|mesh-list
5762498|NCT02963337|Anesthetics, Local|anesthetics, local|mesh-ancestor
5762499|NCT02963337|Anesthetics|anesthetics|mesh-ancestor
5762500|NCT02963337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5762501|NCT02963337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762502|NCT02963337|Sensory System Agents|sensory system agents|mesh-ancestor
5762503|NCT02963337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5762504|NCT02963337|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5762505|NCT02963337|Narcotics|narcotics|mesh-ancestor
5762506|NCT02963337|Analgesics|analgesics|mesh-ancestor
5762507|NCT02963090|Pembrolizumab|pembrolizumab|mesh-list
5762508|NCT02963090|Topotecan|topotecan|mesh-list
5762509|NCT02963090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5762510|NCT02963090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5762511|NCT02963090|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5762512|NCT02963090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5762513|NCT02963090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5762514|NCT02963090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762515|NCT02963116|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5762516|NCT02963116|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5762517|NCT02963116|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5762518|NCT02963116|Antimetabolites|antimetabolites|mesh-ancestor
5762519|NCT02963116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762520|NCT02963116|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5762521|NCT02963116|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5762522|NCT02963116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5762523|NCT02963103|Tacrolimus|tacrolimus|mesh-list
5762524|NCT02963103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5762525|NCT02963103|Immunologic Factors|immunologic factors|mesh-ancestor
5762526|NCT02963103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762527|NCT02963103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5762528|NCT02963103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5762529|NCT02963103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762530|NCT02962999|Ketamine|ketamine|mesh-list
5636852|NCT04617821|Gemcitabine|gemcitabine|mesh-list
5636853|NCT04617821|Paclitaxel|paclitaxel|mesh-list
5636854|NCT04617821|Folfirinox|folfirinox|mesh-list
5636855|NCT04617821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5636856|NCT04617821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5636857|NCT04617821|Tubulin Modulators|tubulin modulators|mesh-ancestor
5636858|NCT04617821|Antimitotic Agents|antimitotic agents|mesh-ancestor
5636859|NCT04617821|Mitosis Modulators|mitosis modulators|mesh-ancestor
5636860|NCT04617821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5636861|NCT04617821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5636862|NCT04617821|Antimetabolites|antimetabolites|mesh-ancestor
5636863|NCT04617821|Antiviral Agents|antiviral agents|mesh-ancestor
5636864|NCT04617821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5762531|NCT02962999|Analgesics|analgesics|mesh-ancestor
5762532|NCT02962999|Sensory System Agents|sensory system agents|mesh-ancestor
5762533|NCT02962999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5762534|NCT02962999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762535|NCT02962999|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5762536|NCT02962999|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5762537|NCT02962999|Anesthetics, General|anesthetics, general|mesh-ancestor
5762538|NCT02962999|Anesthetics|anesthetics|mesh-ancestor
5762539|NCT02962999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5762540|NCT02962999|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5762541|NCT02962999|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5762542|NCT02962999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5636865|NCT04617821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5636866|NCT04617821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5636867|NCT04617821|Immunologic Factors|immunologic factors|mesh-ancestor
5636868|NCT04617821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636869|NCT04610658|Nivolumab|nivolumab|mesh-list
5636870|NCT04610658|Ipilimumab|ipilimumab|mesh-list
5636871|NCT04610658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5636872|NCT04610658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5636873|NCT04610658|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5636874|NCT04610658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5636875|NCT04607980|Ustekinumab|ustekinumab|mesh-list
5636876|NCT04607980|Dermatologic Agents|dermatologic agents|mesh-ancestor
5636877|NCT04601350|Anesthetics|anesthetics|mesh-list
5895610|NCT05183412|Dopamine Agents|dopamine agents|mesh-ancestor
5636878|NCT04601350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5636879|NCT04601350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762543|NCT02962999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762544|NCT02962986|Phenylephrine|phenylephrine|mesh-list
5762545|NCT02962986|Oxymetazoline|oxymetazoline|mesh-list
5762546|NCT02962986|Norepinephrine|norepinephrine|mesh-list
5762547|NCT02962986|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5762548|NCT02962986|Mydriatics|mydriatics|mesh-ancestor
5762549|NCT02962986|Autonomic Agents|autonomic agents|mesh-ancestor
5762550|NCT02962986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5762551|NCT02962986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762552|NCT02962986|Sympathomimetics|sympathomimetics|mesh-ancestor
5762553|NCT02962986|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5762554|NCT02962986|Nasal Decongestants|nasal decongestants|mesh-ancestor
5762555|NCT02962986|Respiratory System Agents|respiratory system agents|mesh-ancestor
5762556|NCT02962986|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5762557|NCT02962986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5762558|NCT02962986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5762559|NCT02962986|Adrenergic Agents|adrenergic agents|mesh-ancestor
5762560|NCT02962986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5762561|NCT02962986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762562|NCT02962986|Protective Agents|protective agents|mesh-ancestor
5762563|NCT02963324|Ivermectin|ivermectin|mesh-list
5762564|NCT02963324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5762565|NCT02963324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5762566|NCT02962947|Propranolol|propranolol|mesh-list
5762567|NCT02962947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5762568|NCT02962947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5762569|NCT02962947|Adrenergic Agents|adrenergic agents|mesh-ancestor
5762570|NCT02962947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5762571|NCT02962947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762572|NCT02962947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762573|NCT02962947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5762574|NCT02962947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5762575|NCT02962947|Vasodilator Agents|vasodilator agents|mesh-ancestor
5762576|NCT02962804|Nivolumab|nivolumab|mesh-list
5762577|NCT02962804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5762578|NCT02962804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5762579|NCT02962804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6209349|NCT02144675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6209350|NCT02144675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6209351|NCT02144675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6209352|NCT02144675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6209353|NCT02144675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6209354|NCT02144675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6209355|NCT02144714|Adalimumab|adalimumab|mesh-list
6209356|NCT02144714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6209357|NCT02144714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6209358|NCT02145026|Epoetin Alfa|epoetin alfa|mesh-list
6209359|NCT02145026|Hematinics|hematinics|mesh-ancestor
6209360|NCT02145039|Cyclophosphamide|cyclophosphamide|mesh-list
6209361|NCT02145039|Fludarabine|fludarabine|mesh-list
6209362|NCT02145039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6209363|NCT02145039|Immunologic Factors|immunologic factors|mesh-ancestor
6209364|NCT02145039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209365|NCT02145039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5636880|NCT04594694|Bezafibrate|bezafibrate|mesh-list
5636881|NCT04594694|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5636882|NCT04594694|Antimetabolites|antimetabolites|mesh-ancestor
5636883|NCT04594694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5636884|NCT04594694|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6209366|NCT02145039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5636887|NCT04585815|Axitinib|axitinib|mesh-list
5636888|NCT04585815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5636889|NCT04585815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5636890|NCT04585815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5636891|NCT04585815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5636892|NCT04581148|Antibodies|antibodies|mesh-list
5636893|NCT04581148|Immunoglobulins|immunoglobulins|mesh-list
5636894|NCT04581148|Immunologic Factors|immunologic factors|mesh-ancestor
5636895|NCT04581148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636896|NCT04579367|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
5636897|NCT04579367|Ezetimibe|ezetimibe|mesh-list
5636898|NCT04579367|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5636899|NCT04579367|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5636900|NCT04579367|Antimetabolites|antimetabolites|mesh-ancestor
5636901|NCT04579367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5636902|NCT04579367|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5636903|NCT04579367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5636904|NCT04579367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6209367|NCT02145039|Alkylating Agents|alkylating agents|mesh-ancestor
6209368|NCT02145039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209369|NCT02145039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5762580|NCT02962804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762581|NCT02962830|Sufentanil|sufentanil|mesh-list
5636905|NCT04579367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209370|NCT02145039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6209371|NCT02145078|Gemcitabine|gemcitabine|mesh-list
6209372|NCT02145078|Docetaxel|docetaxel|mesh-list
6209373|NCT02145078|Pemetrexed|pemetrexed|mesh-list
6209374|NCT02145078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6209375|NCT02145078|Antimetabolites|antimetabolites|mesh-ancestor
6209376|NCT02145078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762582|NCT02962830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5762583|NCT02962830|Narcotics|narcotics|mesh-ancestor
5762584|NCT02962830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5762585|NCT02962830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762586|NCT02962830|Analgesics|analgesics|mesh-ancestor
5762587|NCT02962830|Sensory System Agents|sensory system agents|mesh-ancestor
5762588|NCT02962830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5762589|NCT02962830|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5762590|NCT02962830|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5762591|NCT02962830|Anesthetics, General|anesthetics, general|mesh-ancestor
5762592|NCT02962830|Anesthetics|anesthetics|mesh-ancestor
5762593|NCT02962921|Insulin|insulin|mesh-list
5762594|NCT02962921|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5762595|NCT02962921|Insulin Lispro|insulin lispro|mesh-list
5762596|NCT02962921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5762597|NCT02962921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762598|NCT02962232|Paclitaxel|paclitaxel|mesh-list
5762599|NCT02962232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5762600|NCT02962232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5762601|NCT02962232|Tubulin Modulators|tubulin modulators|mesh-ancestor
5762602|NCT02962232|Antimitotic Agents|antimitotic agents|mesh-ancestor
5762603|NCT02962232|Mitosis Modulators|mitosis modulators|mesh-ancestor
5762604|NCT02962232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762605|NCT02962388|Anagrelide|anagrelide|mesh-list
5762606|NCT02962388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5762607|NCT02962388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5762608|NCT02962388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762609|NCT02962388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5762610|NCT02962401|Obinutuzumab|obinutuzumab|mesh-list
5762611|NCT02962401|Idelalisib|idelalisib|mesh-list
5762612|NCT02962401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5762613|NCT02962401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5762614|NCT02962401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5762615|NCT02962401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762616|NCT02962258|Amlodipine|amlodipine|mesh-list
5762617|NCT02962258|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5762618|NCT02962258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5762619|NCT02962258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5762620|NCT02962258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5762621|NCT02962258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762622|NCT02962258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5762623|NCT02962258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762624|NCT02962258|Vasodilator Agents|vasodilator agents|mesh-ancestor
5762625|NCT02962258|Diuretics|diuretics|mesh-ancestor
5762626|NCT02962258|Natriuretic Agents|natriuretic agents|mesh-ancestor
5762627|NCT02962258|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5762628|NCT02962492|Dapagliflozin|dapagliflozin|mesh-list
5762629|NCT02962492|Exenatide|exenatide|mesh-list
5762630|NCT02962492|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5762631|NCT02962492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762632|NCT02962492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5762633|NCT02962492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762634|NCT02962492|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5762635|NCT02962492|Incretins|incretins|mesh-ancestor
5762636|NCT02962492|Hormones|hormones|mesh-ancestor
5762637|NCT02962492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5762638|NCT02962518|Triamcinolone|triamcinolone|mesh-list
5762639|NCT02962518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5762640|NCT02962518|Glucocorticoids|glucocorticoids|mesh-ancestor
5762641|NCT02962518|Hormones|hormones|mesh-ancestor
5762642|NCT02962518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5762643|NCT02962518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762644|NCT02962336|Amlodipine|amlodipine|mesh-list
5762645|NCT02962336|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5762646|NCT02962336|Olmesartan|olmesartan|mesh-list
5762647|NCT02962336|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
5762648|NCT02962336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5762649|NCT02962336|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5762650|NCT02962336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5762651|NCT02962336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762652|NCT02962336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5762653|NCT02962336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762654|NCT02962336|Vasodilator Agents|vasodilator agents|mesh-ancestor
5762655|NCT02962336|Diuretics|diuretics|mesh-ancestor
5762656|NCT02962336|Natriuretic Agents|natriuretic agents|mesh-ancestor
5762657|NCT02962336|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5762658|NCT02962336|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5762659|NCT02962336|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6209377|NCT02145078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6209378|NCT02145078|Antiviral Agents|antiviral agents|mesh-ancestor
6209379|NCT02145078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6209380|NCT02145078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6209381|NCT02145078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6209382|NCT02145078|Immunologic Factors|immunologic factors|mesh-ancestor
6209383|NCT02145078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209384|NCT02145078|Tubulin Modulators|tubulin modulators|mesh-ancestor
6209385|NCT02145078|Antimitotic Agents|antimitotic agents|mesh-ancestor
5636922|NCT04574232|Triamcinolone|triamcinolone|mesh-list
5636923|NCT04574232|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5636924|NCT04574232|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5636925|NCT04574232|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5762660|NCT02962310|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5762661|NCT02962310|Calcium|calcium|mesh-list
5762662|NCT02962310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5762663|NCT02962310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490236|NCT00596557|Immunologic Factors|immunologic factors|mesh-ancestor
6490237|NCT00596557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490238|NCT00596596|Prucalopride|prucalopride|mesh-list
6490239|NCT00596596|Laxatives|laxatives|mesh-ancestor
6490240|NCT00596596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6490241|NCT00596596|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
6490242|NCT00596596|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6490243|NCT00596596|Serotonin Agents|serotonin agents|mesh-ancestor
6490244|NCT00596596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6490245|NCT00596596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490246|NCT00596596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490247|NCT00596609|Morphine|morphine|mesh-list
6490248|NCT00596609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6490249|NCT00596609|Narcotics|narcotics|mesh-ancestor
6490250|NCT00596609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5636926|NCT04574232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5636927|NCT04574232|Glucocorticoids|glucocorticoids|mesh-ancestor
5636928|NCT04574232|Hormones|hormones|mesh-ancestor
5636929|NCT04574232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5636930|NCT04574232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636931|NCT04574232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5636932|NCT04574232|Immunologic Factors|immunologic factors|mesh-ancestor
5636933|NCT04574232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5636934|NCT04574232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5636935|NCT04561115|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5636936|NCT04561115|Immunologic Factors|immunologic factors|mesh-ancestor
5636937|NCT04561115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636938|NCT04554888|Doxepin|doxepin|mesh-list
5636939|NCT04554888|Histamine|histamine|mesh-list
5636940|NCT04554888|Histamine Agonists|histamine agonists|mesh-ancestor
5636941|NCT04554888|Histamine Agents|histamine agents|mesh-ancestor
5636942|NCT04554888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5636943|NCT04554888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5636944|NCT04554888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762664|NCT02962310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5762665|NCT02962310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6209386|NCT02145078|Mitosis Modulators|mitosis modulators|mesh-ancestor
6490251|NCT00596609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762666|NCT02962310|Antimetabolites|antimetabolites|mesh-ancestor
5762667|NCT02962310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762668|NCT02962310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5762669|NCT02962310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5762670|NCT02962310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5762671|NCT02962323|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5762672|NCT02962323|Calcium|calcium|mesh-list
5762673|NCT02962323|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5762674|NCT02962323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762675|NCT02962323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5762676|NCT02962323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5762677|NCT02962323|Antimetabolites|antimetabolites|mesh-ancestor
5762678|NCT02962323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762679|NCT02962323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5762680|NCT02962323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5762681|NCT02962323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5762682|NCT02962050|Capsaicin|capsaicin|mesh-list
5762683|NCT02962050|Antipruritics|antipruritics|mesh-ancestor
5762684|NCT02962050|Dermatologic Agents|dermatologic agents|mesh-ancestor
5762685|NCT02962050|Sensory System Agents|sensory system agents|mesh-ancestor
5762686|NCT02962050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5762687|NCT02962050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636945|NCT04554888|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5636946|NCT04554888|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5636947|NCT04554888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5636948|NCT04554888|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5636949|NCT04554888|Antidepressive Agents|antidepressive agents|mesh-ancestor
5636950|NCT04554888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5636951|NCT04554888|Histamine Antagonists|histamine antagonists|mesh-ancestor
6209387|NCT02145078|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6209388|NCT02145078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6209389|NCT02145182|Eculizumab|eculizumab|mesh-list
6209390|NCT02145182|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6209391|NCT02145182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6209392|NCT02145182|Immunologic Factors|immunologic factors|mesh-ancestor
6209393|NCT02145182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209394|NCT02145247|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6209395|NCT02145247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6209396|NCT02145247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762688|NCT02962141|Paclitaxel|paclitaxel|mesh-list
5762689|NCT02962141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5762690|NCT02962141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5762691|NCT02962141|Tubulin Modulators|tubulin modulators|mesh-ancestor
5762692|NCT02962141|Antimitotic Agents|antimitotic agents|mesh-ancestor
5762693|NCT02962141|Mitosis Modulators|mitosis modulators|mesh-ancestor
5762694|NCT02962141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762695|NCT02961855|Diclofenac|diclofenac|mesh-list
5762696|NCT02961855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
5762697|NCT02961855|Lidocaine|lidocaine|mesh-list
5762698|NCT02961855|Anesthetics, Local|anesthetics, local|mesh-ancestor
5762699|NCT02961855|Anesthetics|anesthetics|mesh-ancestor
5762700|NCT02961855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5762701|NCT02961855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762702|NCT02961855|Sensory System Agents|sensory system agents|mesh-ancestor
5762703|NCT02961855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5762704|NCT02961855|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5762705|NCT02961855|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5762706|NCT02961855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5762707|NCT02961855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5762708|NCT02961855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762709|NCT02961855|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5762710|NCT02961855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5762711|NCT02961855|Analgesics|analgesics|mesh-ancestor
5762712|NCT02961855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5762713|NCT02961855|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6209397|NCT02145676|Botulinum Toxins|botulinum toxins|mesh-list
6209398|NCT02145676|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6209399|NCT02145676|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5762714|NCT02961855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5762715|NCT02961998|Celecoxib|celecoxib|mesh-list
5762716|NCT02961998|Sorafenib|sorafenib|mesh-list
5762717|NCT02961998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5762718|NCT02961998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6209400|NCT02145676|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6209401|NCT02145676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6209402|NCT02145676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209403|NCT02145676|Cholinergic Agents|cholinergic agents|mesh-ancestor
6209404|NCT02145676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5636971|NCT04548973|Esketamine|esketamine|mesh-list
5636972|NCT04548973|Antidepressive Agents|antidepressive agents|mesh-ancestor
5636973|NCT04548973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5636974|NCT04547985|Naltrexone|naltrexone|mesh-list
5636975|NCT04547985|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5636976|NCT04547985|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5636977|NCT04547985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636978|NCT04547985|Sensory System Agents|sensory system agents|mesh-ancestor
5636979|NCT04547985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5636980|NCT04544189|Fulvestrant|fulvestrant|mesh-list
5636981|NCT04544189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5636982|NCT04544189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5636983|NCT04544189|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5636984|NCT04544189|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6209405|NCT02145676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209406|NCT02145676|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6209407|NCT02145676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6209408|NCT02146248|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6209409|NCT02146248|Contraceptive Agents|contraceptive agents|mesh-list
6209410|NCT02146248|Medroxyprogesterone|medroxyprogesterone|mesh-list
6209411|NCT02146248|Contraceptives, Oral|contraceptives, oral|mesh-list
6209412|NCT02146248|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
6209413|NCT02146248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6209414|NCT02146248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209415|NCT02146248|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6209416|NCT02146248|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6209417|NCT02146248|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6209418|NCT02146248|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6209419|NCT02146248|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6209420|NCT02146248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6209421|NCT02146248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5636985|NCT04544189|Hormone Antagonists|hormone antagonists|mesh-ancestor
5636986|NCT04544189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5636987|NCT04544189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636988|NCT04543617|Atezolizumab|atezolizumab|mesh-list
5636989|NCT04543617|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5636990|NCT04543617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5636991|NCT04543617|Immunologic Factors|immunologic factors|mesh-ancestor
5636992|NCT04543617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636993|NCT04542291|Dapagliflozin|dapagliflozin|mesh-list
5636994|NCT04542291|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5636995|NCT04542291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5636996|NCT04542291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5636997|NCT04542291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5636998|NCT04541017|Mogamulizumab|mogamulizumab|mesh-list
5636999|NCT04541017|Magrolimab|magrolimab|mesh-list
5637000|NCT04541017|Immunoglobulins|immunoglobulins|mesh-list
5637001|NCT04541017|Immunoglobulin G|immunoglobulin g|mesh-list
5637002|NCT04541017|Immunologic Factors|immunologic factors|mesh-ancestor
5637003|NCT04541017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5637004|NCT04541017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5637005|NCT04541017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5637006|NCT04539548|Prednisolone|prednisolone|mesh-list
5637007|NCT04539548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5637008|NCT04539548|Glucocorticoids|glucocorticoids|mesh-ancestor
5637009|NCT04539548|Hormones|hormones|mesh-ancestor
5637010|NCT04539548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5637011|NCT04539548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5637012|NCT04539548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6209422|NCT02146430|Pregabalin|pregabalin|mesh-list
5762719|NCT02961998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5762720|NCT02961998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762721|NCT02961998|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5762722|NCT02961998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5762723|NCT02961998|Analgesics|analgesics|mesh-ancestor
5762724|NCT02961998|Sensory System Agents|sensory system agents|mesh-ancestor
5762725|NCT02961998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5637013|NCT04539548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5762726|NCT02961998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762727|NCT02961998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5762728|NCT02961998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5762729|NCT02961998|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5762730|NCT02961998|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5762731|NCT02961829|Niacinamide|niacinamide|mesh-list
5762732|NCT02961829|Maraviroc|maraviroc|mesh-list
5762733|NCT02961829|Dolutegravir|dolutegravir|mesh-list
5762734|NCT02961829|Auranofin|auranofin|mesh-list
5762735|NCT02961829|Vaccines|vaccines|mesh-list
5762736|NCT02961829|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
5762737|NCT02961829|Immunologic Factors|immunologic factors|mesh-ancestor
5762738|NCT02961829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762739|NCT02961829|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5762740|NCT02961829|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5762741|NCT02961829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762742|NCT02961829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5762743|NCT02961829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5762744|NCT02961829|Antiviral Agents|antiviral agents|mesh-ancestor
5762745|NCT02961829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5762746|NCT02961829|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
5637014|NCT04538040|Tenofovir|tenofovir|mesh-list
5637015|NCT04538040|Emtricitabine|emtricitabine|mesh-list
5637016|NCT04538040|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
5637017|NCT04538040|Antiviral Agents|antiviral agents|mesh-ancestor
5637018|NCT04538040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5637019|NCT04538040|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5637020|NCT04538040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5637021|NCT04538040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5637022|NCT04538040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5637023|NCT04538040|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5637024|NCT04538040|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5637025|NCT04530305|Upadacitinib|upadacitinib|mesh-list
5637026|NCT04530305|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
5637027|NCT04530305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5637028|NCT04530305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5637029|NCT04530305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5637030|NCT04530305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5637031|NCT04527991|Paclitaxel|paclitaxel|mesh-list
5637032|NCT04527991|Docetaxel|docetaxel|mesh-list
5637033|NCT04527991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5637034|NCT04527991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5637035|NCT04527991|Tubulin Modulators|tubulin modulators|mesh-ancestor
5637036|NCT04527991|Antimitotic Agents|antimitotic agents|mesh-ancestor
5637037|NCT04527991|Mitosis Modulators|mitosis modulators|mesh-ancestor
5637038|NCT04527991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209423|NCT02146430|Analgesics|analgesics|mesh-ancestor
6209424|NCT02146430|Sensory System Agents|sensory system agents|mesh-ancestor
5762747|NCT02961829|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5762748|NCT02961829|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5762749|NCT02961829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5762750|NCT02961829|Vitamin B Complex|vitamin b complex|mesh-ancestor
5762751|NCT02961829|Vitamins|vitamins|mesh-ancestor
5762752|NCT02961829|Micronutrients|micronutrients|mesh-ancestor
5762753|NCT02961829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5762754|NCT02961842|Ephedrine|ephedrine|mesh-list
5762755|NCT02961842|Fentanyl|fentanyl|mesh-list
6209425|NCT02146430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6209426|NCT02146430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209427|NCT02146430|Anticonvulsants|anticonvulsants|mesh-ancestor
5637057|NCT04522804|Psilocybin|psilocybin|mesh-list
5637058|NCT04522804|Hallucinogens|hallucinogens|mesh-ancestor
5762756|NCT02961842|Bupivacaine|bupivacaine|mesh-list
5762757|NCT02961842|Anesthetics, Local|anesthetics, local|mesh-ancestor
5762758|NCT02961842|Anesthetics|anesthetics|mesh-ancestor
5762759|NCT02961842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5762760|NCT02961842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762761|NCT02961842|Sensory System Agents|sensory system agents|mesh-ancestor
5762762|NCT02961842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5762763|NCT02961842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5762764|NCT02961842|Narcotics|narcotics|mesh-ancestor
5762765|NCT02961842|Analgesics|analgesics|mesh-ancestor
5762766|NCT02961842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5762767|NCT02961842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5762768|NCT02961842|Anesthetics, General|anesthetics, general|mesh-ancestor
5762769|NCT02961842|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5762770|NCT02961842|Sympathomimetics|sympathomimetics|mesh-ancestor
5762771|NCT02961842|Autonomic Agents|autonomic agents|mesh-ancestor
5762772|NCT02961842|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5762773|NCT02961842|Adrenergic Agents|adrenergic agents|mesh-ancestor
5762774|NCT02961842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5762775|NCT02961842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762776|NCT02962024|Morphine|morphine|mesh-list
5762777|NCT02962024|Bupivacaine|bupivacaine|mesh-list
5762778|NCT02962024|Anesthetics, Local|anesthetics, local|mesh-ancestor
5762779|NCT02962024|Anesthetics|anesthetics|mesh-ancestor
5762780|NCT02962024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5637059|NCT04522804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5637060|NCT04522804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5637061|NCT04519645|Lacosamide|lacosamide|mesh-list
5637062|NCT04519645|Anticonvulsants|anticonvulsants|mesh-ancestor
5762781|NCT02962024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762782|NCT02962024|Sensory System Agents|sensory system agents|mesh-ancestor
5762783|NCT02962024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5762784|NCT02962024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5762785|NCT02962024|Narcotics|narcotics|mesh-ancestor
5762786|NCT02962024|Analgesics|analgesics|mesh-ancestor
5762787|NCT02962037|Melatonin|melatonin|mesh-list
5762788|NCT02962037|Antioxidants|antioxidants|mesh-ancestor
5762789|NCT02962037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762790|NCT02962037|Protective Agents|protective agents|mesh-ancestor
5762791|NCT02962037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762792|NCT02962037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5762793|NCT02962063|Paclitaxel|paclitaxel|mesh-list
5762794|NCT02962063|Carboplatin|carboplatin|mesh-list
5762795|NCT02962063|Durvalumab|durvalumab|mesh-list
5762796|NCT02962063|Tremelimumab|tremelimumab|mesh-list
5762797|NCT02962063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5762798|NCT02962063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5762799|NCT02962063|Tubulin Modulators|tubulin modulators|mesh-ancestor
5762800|NCT02962063|Antimitotic Agents|antimitotic agents|mesh-ancestor
5762801|NCT02962063|Mitosis Modulators|mitosis modulators|mesh-ancestor
5637063|NCT04519645|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5637064|NCT04519645|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5637065|NCT04519645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5637066|NCT04519645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5637067|NCT04512261|Pembrolizumab|pembrolizumab|mesh-list
5762802|NCT02962063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762803|NCT02962063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5762804|NCT02961816|Pyridoxine|pyridoxine|mesh-list
5637068|NCT04512261|Trastuzumab|trastuzumab|mesh-list
6490252|NCT00596609|Analgesics|analgesics|mesh-ancestor
6490253|NCT00596609|Sensory System Agents|sensory system agents|mesh-ancestor
6490254|NCT00596609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6490255|NCT00596648|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6490256|NCT00596648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6490257|NCT00596648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6490258|NCT00596648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6490259|NCT00596648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490260|NCT00596804|Veltuzumab|veltuzumab|mesh-list
6490261|NCT00596804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6490262|NCT00596986|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6490263|NCT00596986|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6490264|NCT00596986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5637069|NCT04512261|Tucatinib|tucatinib|mesh-list
5637070|NCT04512261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5637071|NCT04512261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5637072|NCT04512261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5637073|NCT04512261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5762805|NCT02961816|Gemcitabine|gemcitabine|mesh-list
5762806|NCT02961816|Dexamethasone|dexamethasone|mesh-list
5637074|NCT04512261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209428|NCT02146430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6209429|NCT02146430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6209430|NCT02146430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209431|NCT02146430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6209432|NCT02146430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6209433|NCT02146430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6209434|NCT02146430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6209435|NCT02146430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6209436|NCT02147067|Ranolazine|ranolazine|mesh-list
6209437|NCT02147067|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6209438|NCT02147067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6209439|NCT02147067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209440|NCT02147132|Nicotine|nicotine|mesh-list
6209441|NCT02147132|Varenicline|varenicline|mesh-list
6209442|NCT02147132|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6209443|NCT02147132|Autonomic Agents|autonomic agents|mesh-ancestor
6209444|NCT02147132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6209445|NCT02147132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209446|NCT02147132|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6209447|NCT02147132|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6209448|NCT02147132|Cholinergic Agents|cholinergic agents|mesh-ancestor
6209449|NCT02147132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6209450|NCT02147132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5637099|NCT04477265|Solifenacin Succinate|solifenacin succinate|mesh-list
5637100|NCT04477265|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5637101|NCT04477265|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5637102|NCT04477265|Cholinergic Agents|cholinergic agents|mesh-ancestor
5637103|NCT04477265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5762807|NCT02961816|Rituximab|rituximab|mesh-list
5762808|NCT02961816|Melphalan|melphalan|mesh-list
5762809|NCT02961816|Busulfan|busulfan|mesh-list
5762810|NCT02961816|Panobinostat|panobinostat|mesh-list
5762811|NCT02961816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5762812|NCT02961816|Antiemetics|antiemetics|mesh-ancestor
5762813|NCT02961816|Autonomic Agents|autonomic agents|mesh-ancestor
5762814|NCT02961816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5762815|NCT02961816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762816|NCT02961816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5762817|NCT02961816|Glucocorticoids|glucocorticoids|mesh-ancestor
5762818|NCT02961816|Hormones|hormones|mesh-ancestor
5762819|NCT02961816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5762820|NCT02961816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5762821|NCT02961816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5762822|NCT02961816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5762823|NCT02961816|Immunologic Factors|immunologic factors|mesh-ancestor
5762824|NCT02961816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5762825|NCT02961816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5762826|NCT02961816|Antimetabolites|antimetabolites|mesh-ancestor
5762827|NCT02961816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762828|NCT02961816|Antiviral Agents|antiviral agents|mesh-ancestor
5762829|NCT02961816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5762830|NCT02961816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5762831|NCT02961816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5762832|NCT02961816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5762833|NCT02961816|Alkylating Agents|alkylating agents|mesh-ancestor
5762834|NCT02961816|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5762835|NCT02961816|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5762836|NCT02961816|Vitamin B Complex|vitamin b complex|mesh-ancestor
5637104|NCT04477265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5637105|NCT04477265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5637106|NCT04477265|Urological Agents|urological agents|mesh-ancestor
5637107|NCT04474847|Abatacept|abatacept|mesh-list
5637108|NCT04474847|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5637109|NCT04474847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5637110|NCT04474847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5637111|NCT04474847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5637112|NCT04474847|Immunologic Factors|immunologic factors|mesh-ancestor
5637113|NCT04474847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5637114|NCT04474847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5762837|NCT02961816|Vitamins|vitamins|mesh-ancestor
5762838|NCT02961816|Micronutrients|micronutrients|mesh-ancestor
5762839|NCT02961803|Biotin|biotin|mesh-list
5762840|NCT02961803|Vitamin B Complex|vitamin b complex|mesh-ancestor
5762841|NCT02961803|Vitamins|vitamins|mesh-ancestor
5762842|NCT02961803|Micronutrients|micronutrients|mesh-ancestor
5762843|NCT02961803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762844|NCT02961660|Odalasvir|odalasvir|mesh-list
5762845|NCT02961660|Antiviral Agents|antiviral agents|mesh-ancestor
5762846|NCT02961660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5762847|NCT02961608|Tacrolimus|tacrolimus|mesh-list
5637115|NCT04472429|Paclitaxel|paclitaxel|mesh-list
5637116|NCT04472429|Carboplatin|carboplatin|mesh-list
5637117|NCT04472429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5637118|NCT04472429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5637119|NCT04472429|Tubulin Modulators|tubulin modulators|mesh-ancestor
5637120|NCT04472429|Antimitotic Agents|antimitotic agents|mesh-ancestor
5637121|NCT04472429|Mitosis Modulators|mitosis modulators|mesh-ancestor
5637122|NCT04472429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209451|NCT02147158|Ulipristal acetate|ulipristal acetate|mesh-list
6209452|NCT02147158|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6209453|NCT02147158|Contraceptive Agents|contraceptive agents|mesh-ancestor
6209454|NCT02147158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6209455|NCT02147158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209456|NCT02147158|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6209457|NCT02147197|Ulipristal acetate|ulipristal acetate|mesh-list
6209458|NCT02147197|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6209459|NCT02147197|Contraceptive Agents|contraceptive agents|mesh-ancestor
6209460|NCT02147197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5637133|NCT04464070|Aspirin|aspirin|mesh-list
5637134|NCT04464070|Niacin|niacin|mesh-list
5637135|NCT04464070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5637136|NCT04464070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5637137|NCT04464070|Analgesics|analgesics|mesh-ancestor
5637138|NCT04464070|Sensory System Agents|sensory system agents|mesh-ancestor
5637139|NCT04464070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5637140|NCT04464070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762848|NCT02961608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5762849|NCT02961608|Immunologic Factors|immunologic factors|mesh-ancestor
5762850|NCT02961608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762851|NCT02961608|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5762852|NCT02961608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5762853|NCT02961608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762854|NCT02961634|Ciclopirox|ciclopirox|mesh-list
5762855|NCT02961634|Antifungal Agents|antifungal agents|mesh-ancestor
5762856|NCT02961634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5762857|NCT02961491|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
5762858|NCT02961491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5762859|NCT02961491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5762860|NCT02961491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762861|NCT02961491|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5895611|NCT05183412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5895612|NCT05183412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895613|NCT05183412|Adrenergic Agents|adrenergic agents|mesh-ancestor
5895614|NCT05183412|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5637141|NCT04464070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5637142|NCT04464070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5637143|NCT04464070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5637144|NCT04464070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5637145|NCT04464070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5637146|NCT04464070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5637147|NCT04464070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5637148|NCT04464070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5637149|NCT04464070|Antipyretics|antipyretics|mesh-ancestor
5637150|NCT04464070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5637151|NCT04464070|Antimetabolites|antimetabolites|mesh-ancestor
5895615|NCT05183412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5895616|NCT05183412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5895617|NCT05183412|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5895618|NCT05174858|Hemostatics|hemostatics|mesh-list
5895619|NCT05174858|Coagulants|coagulants|mesh-ancestor
5895620|NCT05174039|Miglustat|miglustat|mesh-list
5895621|NCT05174039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5895622|NCT05174039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895623|NCT05174039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5895624|NCT05174039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5895625|NCT05174039|Antiviral Agents|antiviral agents|mesh-ancestor
5895626|NCT05174039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5895627|NCT05174039|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
5637152|NCT04464070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5637153|NCT04464070|Vasodilator Agents|vasodilator agents|mesh-ancestor
5637154|NCT04464070|Vitamin B Complex|vitamin b complex|mesh-ancestor
5637155|NCT04464070|Vitamins|vitamins|mesh-ancestor
5637156|NCT04464070|Micronutrients|micronutrients|mesh-ancestor
5693648|NCT03400254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5693649|NCT03400254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5693650|NCT03400254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762862|NCT02961166|Immunoglobulins|immunoglobulins|mesh-list
5762863|NCT02961166|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5762864|NCT02961166|Antibodies|antibodies|mesh-list
5762865|NCT02961166|Immunologic Factors|immunologic factors|mesh-ancestor
5762866|NCT02961166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762867|NCT02961426|Sofosbuvir|sofosbuvir|mesh-list
5762868|NCT02961426|Antiviral Agents|antiviral agents|mesh-ancestor
5762869|NCT02961426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5762870|NCT02961361|Dexmedetomidine|dexmedetomidine|mesh-list
5762871|NCT02961361|Ropivacaine|ropivacaine|mesh-list
5693651|NCT03400254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5693652|NCT03400254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5697841|NCT03373305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5697842|NCT03373305|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5697843|NCT03373305|Lenalidomide|lenalidomide|mesh-list
5697844|NCT03373305|Piperidine|piperidine|mesh-list
5697845|NCT03373305|Antibodies|antibodies|mesh-list
5697846|NCT03373305|Immunoglobulins|immunoglobulins|mesh-list
5697847|NCT03373305|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5697848|NCT03373305|Immunoconjugates|immunoconjugates|mesh-list
5697849|NCT03373305|Immunologic Factors|immunologic factors|mesh-ancestor
5697850|NCT03373305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697851|NCT03373305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5697852|NCT03373305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5762872|NCT02961361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5762873|NCT02961361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5762874|NCT02961361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762875|NCT02961361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5762876|NCT02961361|Analgesics|analgesics|mesh-ancestor
5762877|NCT02961361|Sensory System Agents|sensory system agents|mesh-ancestor
5762878|NCT02961361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5762879|NCT02961361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5762880|NCT02961361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5762881|NCT02961361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5762882|NCT02961361|Adrenergic Agents|adrenergic agents|mesh-ancestor
5762883|NCT02961361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5697853|NCT03373305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5697854|NCT03373305|Growth Substances|growth substances|mesh-ancestor
5697855|NCT03373305|Growth Inhibitors|growth inhibitors|mesh-ancestor
5697856|NCT03373305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5697857|NCT03373305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5697858|NCT03373305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697859|NCT03373305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5697860|NCT03373266|Sevoflurane|sevoflurane|mesh-list
5697861|NCT03373266|Isoflurane|isoflurane|mesh-list
5697862|NCT03373266|Anesthetics|anesthetics|mesh-list
5697863|NCT03373266|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5697864|NCT03373266|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5697865|NCT03373266|Anesthetics, General|anesthetics, general|mesh-ancestor
5697866|NCT03373266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5697867|NCT03373266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697868|NCT03373227|Tacrolimus|tacrolimus|mesh-list
5697869|NCT03373227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5697870|NCT03373227|Immunologic Factors|immunologic factors|mesh-ancestor
5697871|NCT03373227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697872|NCT03373227|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5697873|NCT03373227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5697874|NCT03373227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697875|NCT03373149|Hormones|hormones|mesh-list
5697876|NCT03373149|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
5697877|NCT03373149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5697878|NCT03373149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762884|NCT02961361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762885|NCT02961361|Anesthetics, Local|anesthetics, local|mesh-ancestor
5762886|NCT02961361|Anesthetics|anesthetics|mesh-ancestor
5762887|NCT02961257|Prednisone|prednisone|mesh-list
5697879|NCT03372967|Vaccines|vaccines|mesh-list
5697880|NCT03372967|Immunologic Factors|immunologic factors|mesh-ancestor
5762888|NCT02961257|Sargramostim|sargramostim|mesh-list
5762889|NCT02961257|Lenograstim|lenograstim|mesh-list
5762890|NCT02961257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5762891|NCT02961257|Glucocorticoids|glucocorticoids|mesh-ancestor
5762892|NCT02961257|Hormones|hormones|mesh-ancestor
5762893|NCT02961257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5762894|NCT02961257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762895|NCT02961257|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5762896|NCT02961257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5762897|NCT02961257|Immunologic Factors|immunologic factors|mesh-ancestor
5762898|NCT02961257|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5762899|NCT02961101|Decitabine|decitabine|mesh-list
5637157|NCT04458909|Gemcitabine|gemcitabine|mesh-list
5637158|NCT04458909|Cisplatin|cisplatin|mesh-list
5637159|NCT04458909|Carboplatin|carboplatin|mesh-list
5637160|NCT04458909|Nivolumab|nivolumab|mesh-list
5637161|NCT04458909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5637162|NCT04458909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5637163|NCT04458909|Antimetabolites|antimetabolites|mesh-ancestor
5637164|NCT04458909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5637165|NCT04458909|Antiviral Agents|antiviral agents|mesh-ancestor
5637166|NCT04458909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5637167|NCT04458909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5637168|NCT04458909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5637169|NCT04458909|Immunologic Factors|immunologic factors|mesh-ancestor
5637170|NCT04458909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5637171|NCT04458909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5637172|NCT04458909|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5637173|NCT04456517|Ranolazine|ranolazine|mesh-list
5637174|NCT04456517|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5637175|NCT04456517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5637176|NCT04456517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5637177|NCT04447768|Venetoclax|venetoclax|mesh-list
5762900|NCT02961101|Antibodies|antibodies|mesh-list
5762901|NCT02961101|Immunologic Factors|immunologic factors|mesh-ancestor
5762902|NCT02961101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762903|NCT02961101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5762904|NCT02961101|Antimetabolites|antimetabolites|mesh-ancestor
5762905|NCT02961101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762906|NCT02961101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5762907|NCT02961101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5762908|NCT02961075|Anesthetics|anesthetics|mesh-list
5762909|NCT02961075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5762910|NCT02961075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762911|NCT02960763|Aripiprazole|aripiprazole|mesh-list
5762912|NCT02960763|Lithium Carbonate|lithium carbonate|mesh-list
5762913|NCT02960763|Bupropion|bupropion|mesh-list
5762914|NCT02960763|Nortriptyline|nortriptyline|mesh-list
5762915|NCT02960763|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5762916|NCT02960763|Antidepressive Agents|antidepressive agents|mesh-ancestor
5762917|NCT02960763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5637178|NCT04447768|Obinutuzumab|obinutuzumab|mesh-list
5637179|NCT04447768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5637180|NCT04447768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5637181|NCT04442022|Gemcitabine|gemcitabine|mesh-list
5637182|NCT04442022|Dexamethasone|dexamethasone|mesh-list
5762918|NCT02960763|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5762919|NCT02960763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5762920|NCT02960763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5762921|NCT02960763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762922|NCT02960763|Dopamine Agents|dopamine agents|mesh-ancestor
5762923|NCT02960763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5762924|NCT02960763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762925|NCT02960763|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5762926|NCT02960763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5762927|NCT02960763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5762928|NCT02960763|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5762929|NCT02960763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5762930|NCT02960763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5762931|NCT02960763|Dopamine Agonists|dopamine agonists|mesh-ancestor
5762932|NCT02960763|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5762933|NCT02960763|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5762934|NCT02960763|Serotonin Agents|serotonin agents|mesh-ancestor
5762935|NCT02960763|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5762936|NCT02960763|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5762937|NCT02960763|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5762938|NCT02960763|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5762939|NCT02960763|Antimanic Agents|antimanic agents|mesh-ancestor
5762940|NCT02960763|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5762941|NCT02960763|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5762942|NCT02960763|Adrenergic Agents|adrenergic agents|mesh-ancestor
5762943|NCT02960828|Bevacizumab|bevacizumab|mesh-list
5762944|NCT02960828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5762945|NCT02960828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5762946|NCT02960828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5762947|NCT02960828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5762948|NCT02960828|Growth Substances|growth substances|mesh-ancestor
5762949|NCT02960828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762950|NCT02960828|Growth Inhibitors|growth inhibitors|mesh-ancestor
5762951|NCT02960880|Rivaroxaban|rivaroxaban|mesh-list
5762952|NCT02960880|Phenprocoumon|phenprocoumon|mesh-list
5762953|NCT02960880|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5762954|NCT02960880|Antithrombins|antithrombins|mesh-ancestor
5762955|NCT02960880|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5762956|NCT02960880|Protease Inhibitors|protease inhibitors|mesh-ancestor
5762957|NCT02960880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5762958|NCT02960880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762959|NCT02960880|Anticoagulants|anticoagulants|mesh-ancestor
5762960|NCT02960906|Nivolumab|nivolumab|mesh-list
5762961|NCT02960906|Ipilimumab|ipilimumab|mesh-list
5762962|NCT02960906|Sunitinib|sunitinib|mesh-list
5762963|NCT02960906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5762964|NCT02960906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5762965|NCT02960906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5762966|NCT02960906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762967|NCT02960906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5762968|NCT02960906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5762969|NCT02960906|Growth Substances|growth substances|mesh-ancestor
5762970|NCT02960906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762971|NCT02960906|Growth Inhibitors|growth inhibitors|mesh-ancestor
5762972|NCT02960906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5637183|NCT04442022|Rituximab|rituximab|mesh-list
5637184|NCT04442022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5637185|NCT04442022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5637186|NCT04442022|Antiemetics|antiemetics|mesh-ancestor
5637187|NCT04442022|Autonomic Agents|autonomic agents|mesh-ancestor
5637188|NCT04442022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5637189|NCT04442022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5637190|NCT04442022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5637191|NCT04442022|Glucocorticoids|glucocorticoids|mesh-ancestor
5637192|NCT04442022|Hormones|hormones|mesh-ancestor
5637193|NCT04442022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5637194|NCT04442022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5637195|NCT04442022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5637196|NCT04442022|Immunologic Factors|immunologic factors|mesh-ancestor
5637197|NCT04442022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5637198|NCT04442022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5637199|NCT04442022|Antimetabolites|antimetabolites|mesh-ancestor
5637200|NCT04442022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762973|NCT02960906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5762974|NCT02960919|Amoxicillin|amoxicillin|mesh-list
5762975|NCT02960919|Gentamicins|gentamicins|mesh-list
5762976|NCT02960919|Penicillins|penicillins|mesh-list
5762977|NCT02960919|Ampicillin|ampicillin|mesh-list
5762978|NCT02960919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5762979|NCT02960919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5762980|NCT02960919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5762981|NCT02960919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5762982|NCT02960919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5762983|NCT02960815|Imiquimod|imiquimod|mesh-list
5762984|NCT02960815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5762985|NCT02960815|Immunologic Factors|immunologic factors|mesh-ancestor
5762986|NCT02960815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5762987|NCT02960815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5762988|NCT02960815|Interferon Inducers|interferon inducers|mesh-ancestor
5762989|NCT02960503|Azithromycin|azithromycin|mesh-list
5762990|NCT02960503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5762991|NCT02960503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5762992|NCT02960646|Cyclophosphamide|cyclophosphamide|mesh-list
5762993|NCT02960646|Melphalan|melphalan|mesh-list
5762994|NCT02960646|Mechlorethamine|mechlorethamine|mesh-list
5637201|NCT04442022|Antiviral Agents|antiviral agents|mesh-ancestor
5762995|NCT02960646|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
5762996|NCT02960646|Rituximab|rituximab|mesh-list
5762997|NCT02960646|Fludarabine|fludarabine|mesh-list
5762998|NCT02960646|Fludarabine phosphate|fludarabine phosphate|mesh-list
5762999|NCT02960646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5763000|NCT02960646|Tacrolimus|tacrolimus|mesh-list
5763001|NCT02960646|Antibodies|antibodies|mesh-list
5763002|NCT02960646|Immunoglobulins|immunoglobulins|mesh-list
5763003|NCT02960646|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5763004|NCT02960646|Lenograstim|lenograstim|mesh-list
5763005|NCT02960646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5763006|NCT02960646|Immunologic Factors|immunologic factors|mesh-ancestor
5763007|NCT02960646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763008|NCT02960646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5763009|NCT02960646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5763010|NCT02960646|Alkylating Agents|alkylating agents|mesh-ancestor
5763011|NCT02960646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5763012|NCT02960646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5763013|NCT02960646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5763014|NCT02960646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5763015|NCT02960646|Antimetabolites|antimetabolites|mesh-ancestor
5763016|NCT02960646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5763017|NCT02960646|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5763018|NCT02960646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5763019|NCT02960412|Furosemide|furosemide|mesh-list
5763020|NCT02960412|Diuretics|diuretics|mesh-ancestor
5763021|NCT02960412|Natriuretic Agents|natriuretic agents|mesh-ancestor
5763022|NCT02960412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763023|NCT02960412|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5763024|NCT02960412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5763025|NCT02960412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5763026|NCT02960711|Metformin|metformin|mesh-list
5763027|NCT02960711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5763028|NCT02960711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763029|NCT02960048|Salicylic Acid|salicylic acid|mesh-list
5763030|NCT02960048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5763031|NCT02960048|Antifungal Agents|antifungal agents|mesh-ancestor
5763032|NCT02960048|Keratolytic Agents|keratolytic agents|mesh-ancestor
5763033|NCT02960048|Dermatologic Agents|dermatologic agents|mesh-ancestor
5763034|NCT02960126|Aspirin|aspirin|mesh-list
5763035|NCT02960126|Clopidogrel|clopidogrel|mesh-list
5763036|NCT02960126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5763037|NCT02960126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5763038|NCT02960126|Analgesics|analgesics|mesh-ancestor
6673326|NCT01561950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673327|NCT01562197|Axitinib|axitinib|mesh-list
6673328|NCT01562197|Lomustine|lomustine|mesh-list
6673329|NCT01562197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6673330|NCT01562197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5763039|NCT02960126|Sensory System Agents|sensory system agents|mesh-ancestor
5763040|NCT02960126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5763041|NCT02960126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763042|NCT02960126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5763043|NCT02960126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5763044|NCT02960126|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6490265|NCT00596986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6490266|NCT00596986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490267|NCT00596986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6490268|NCT00596986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490269|NCT00596986|Analgesics|analgesics|mesh-ancestor
6490270|NCT00596986|Sensory System Agents|sensory system agents|mesh-ancestor
5763045|NCT02960126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5763046|NCT02960126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5763047|NCT02960126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5763048|NCT02960126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5763049|NCT02960126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5763050|NCT02960126|Antipyretics|antipyretics|mesh-ancestor
5763051|NCT02960126|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5763052|NCT02960126|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5763053|NCT02960126|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5763054|NCT02960126|Purinergic Agents|purinergic agents|mesh-ancestor
5763055|NCT02960126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5763056|NCT02960113|Scopolamine|scopolamine|mesh-list
6490271|NCT00596986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5763057|NCT02960113|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
5763058|NCT02960113|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5763059|NCT02960113|Antiemetics|antiemetics|mesh-ancestor
5763060|NCT02960113|Autonomic Agents|autonomic agents|mesh-ancestor
5763061|NCT02960113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5763062|NCT02960113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763063|NCT02960113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5763064|NCT02960113|Mydriatics|mydriatics|mesh-ancestor
5763065|NCT02960113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5763066|NCT02960113|Cholinergic Agents|cholinergic agents|mesh-ancestor
5763067|NCT02960113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5763068|NCT02960113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5763069|NCT02960113|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5637202|NCT04442022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5637203|NCT04442022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5637204|NCT04442022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5637205|NCT04430452|Durvalumab|durvalumab|mesh-list
5637206|NCT04430452|Ipilimumab|ipilimumab|mesh-list
5637207|NCT04430452|Tremelimumab|tremelimumab|mesh-list
5637208|NCT04430452|Immunoglobulins|immunoglobulins|mesh-list
5763070|NCT02960113|Parasympatholytics|parasympatholytics|mesh-ancestor
5763071|NCT02959957|Cefotaxime|cefotaxime|mesh-list
5763072|NCT02959957|Cefoxitin|cefoxitin|mesh-list
5763073|NCT02959957|Temocillin|temocillin|mesh-list
5763074|NCT02959957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5763075|NCT02959957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5763076|NCT02960035|Etanercept|etanercept|mesh-list
5763077|NCT02960035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5763078|NCT02960035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5763079|NCT02960035|Analgesics|analgesics|mesh-ancestor
5763080|NCT02960035|Sensory System Agents|sensory system agents|mesh-ancestor
5763081|NCT02960035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5763082|NCT02960035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763083|NCT02960035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5763084|NCT02960035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5763085|NCT02960035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5763086|NCT02960035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5763087|NCT02960035|Immunologic Factors|immunologic factors|mesh-ancestor
5763088|NCT02959879|Folfirinox|folfirinox|mesh-list
5763089|NCT02959879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5763090|NCT02959905|Vidarabine|vidarabine|mesh-list
5763091|NCT02959905|Cyclophosphamide|cyclophosphamide|mesh-list
5763092|NCT02959905|Fludarabine|fludarabine|mesh-list
5763093|NCT02959905|Fludarabine phosphate|fludarabine phosphate|mesh-list
5763094|NCT02959905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5763095|NCT02959905|Immunologic Factors|immunologic factors|mesh-ancestor
5763096|NCT02959905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763097|NCT02959905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5763098|NCT02959905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5763099|NCT02959905|Alkylating Agents|alkylating agents|mesh-ancestor
5763100|NCT02959905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5763101|NCT02959905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5763102|NCT02959905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5763103|NCT02959905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5763104|NCT02959905|Antimetabolites|antimetabolites|mesh-ancestor
5763105|NCT02959905|Antiviral Agents|antiviral agents|mesh-ancestor
5763106|NCT02959905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5763107|NCT02959580|Hydrocortisone|hydrocortisone|mesh-list
5763108|NCT02959580|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
5763109|NCT02959580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5763110|NCT02959580|Dermatologic Agents|dermatologic agents|mesh-ancestor
5763111|NCT02959762|Vitamins|vitamins|mesh-list
5763112|NCT02959762|Vitamin K|vitamin k|mesh-list
5763113|NCT02959762|Vitamin K 2|vitamin k 2|mesh-list
5763114|NCT02959762|Vitamin MK 7|vitamin mk 7|mesh-list
5763115|NCT02959762|Micronutrients|micronutrients|mesh-ancestor
5637209|NCT04430452|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5637210|NCT04430452|Immunoglobulin G|immunoglobulin g|mesh-list
5637211|NCT04430452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5637212|NCT04430452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5637213|NCT04430452|Immunologic Factors|immunologic factors|mesh-ancestor
5637214|NCT04430452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5637215|NCT04430452|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5637216|NCT04430452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209461|NCT02147197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209462|NCT02147197|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6209463|NCT02147561|Botulinum Toxins|botulinum toxins|mesh-list
5637220|NCT04370054|Factor VIII|factor viii|mesh-list
5637221|NCT04370054|Coagulants|coagulants|mesh-ancestor
5637222|NCT04360980|Colchicine|colchicine|mesh-list
5637223|NCT04360980|Gout Suppressants|gout suppressants|mesh-ancestor
5763116|NCT02959762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763117|NCT02959762|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5763118|NCT02959762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5763119|NCT02959762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5763120|NCT02959762|Hemostatics|hemostatics|mesh-ancestor
5763121|NCT02959762|Coagulants|coagulants|mesh-ancestor
5763122|NCT02959749|Bevacizumab|bevacizumab|mesh-list
5763123|NCT02959749|Docetaxel|docetaxel|mesh-list
5763124|NCT02959749|Osimertinib|osimertinib|mesh-list
5763125|NCT02959749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5637224|NCT04360980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5637225|NCT04360980|Tubulin Modulators|tubulin modulators|mesh-ancestor
5637226|NCT04360980|Antimitotic Agents|antimitotic agents|mesh-ancestor
5637227|NCT04360980|Mitosis Modulators|mitosis modulators|mesh-ancestor
5637228|NCT04360980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5763126|NCT02959749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5763127|NCT02959749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5763128|NCT02959749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5763129|NCT02959749|Growth Substances|growth substances|mesh-ancestor
5763130|NCT02959749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763131|NCT02959749|Growth Inhibitors|growth inhibitors|mesh-ancestor
5763132|NCT02959749|Tubulin Modulators|tubulin modulators|mesh-ancestor
5763133|NCT02959749|Antimitotic Agents|antimitotic agents|mesh-ancestor
5763134|NCT02959749|Mitosis Modulators|mitosis modulators|mesh-ancestor
5763135|NCT02959749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5763136|NCT02959749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5763137|NCT02959749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5895628|NCT05174039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5895629|NCT05174039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907859|NCT05156710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907860|NCT05155007|Cyclosporine|cyclosporine|mesh-list
5907861|NCT05155007|Cyclosporins|cyclosporins|mesh-list
5907862|NCT05155007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5907863|NCT05155007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907864|NCT05155007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5907865|NCT05155007|Immunologic Factors|immunologic factors|mesh-ancestor
5907866|NCT05155007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907867|NCT05155007|Antifungal Agents|antifungal agents|mesh-ancestor
5637229|NCT04360980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5637230|NCT04339777|Mycophenolic Acid|mycophenolic acid|mesh-list
5637231|NCT04339777|Cyclophosphamide|cyclophosphamide|mesh-list
5637232|NCT04339777|Busulfan|busulfan|mesh-list
5637233|NCT04339777|Fludarabine|fludarabine|mesh-list
5637234|NCT04339777|Alemtuzumab|alemtuzumab|mesh-list
5637235|NCT04339777|Tacrolimus|tacrolimus|mesh-list
5637236|NCT04339777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5637237|NCT04339777|Immunologic Factors|immunologic factors|mesh-ancestor
5637238|NCT04339777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5637239|NCT04339777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5637240|NCT04339777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5637241|NCT04339777|Alkylating Agents|alkylating agents|mesh-ancestor
5637242|NCT04339777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5637243|NCT04339777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5637244|NCT04339777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5637245|NCT04339777|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5637246|NCT04339777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5637247|NCT04339777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5637248|NCT04339777|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5637249|NCT04339777|Antitubercular Agents|antitubercular agents|mesh-ancestor
5637250|NCT04339777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5637251|NCT04339777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5637252|NCT04339777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5637253|NCT04331704|Tenofovir|tenofovir|mesh-list
5637254|NCT04331704|Emtricitabine|emtricitabine|mesh-list
5637255|NCT04331704|Antiviral Agents|antiviral agents|mesh-ancestor
5637256|NCT04331704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5637257|NCT04331704|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5637258|NCT04331704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5637259|NCT04331704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5637260|NCT04331704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5637261|NCT04331704|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5637262|NCT04331704|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5637263|NCT04317105|Nivolumab|nivolumab|mesh-list
5907868|NCT05155007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5637264|NCT04317105|Ipilimumab|ipilimumab|mesh-list
5637265|NCT04317105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5693653|NCT03400241|Bromides|bromides|mesh-list
5763138|NCT02959658|Dimethyl Fumarate|dimethyl fumarate|mesh-list
5763139|NCT02959658|Dermatologic Agents|dermatologic agents|mesh-ancestor
5763140|NCT02959658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5763141|NCT02959658|Immunologic Factors|immunologic factors|mesh-ancestor
5763142|NCT02959658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763143|NCT02959697|Lidocaine|lidocaine|mesh-list
5763144|NCT02959697|Anesthetics, Local|anesthetics, local|mesh-ancestor
5763145|NCT02959697|Anesthetics|anesthetics|mesh-ancestor
5763146|NCT02959697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5763147|NCT02959697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763148|NCT02959697|Sensory System Agents|sensory system agents|mesh-ancestor
5763149|NCT02959697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5763150|NCT02959697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5763151|NCT02959697|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5763152|NCT02959697|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5763153|NCT02959697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5763154|NCT02959697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5763155|NCT02959554|Nivolumab|nivolumab|mesh-list
5763156|NCT02959554|Sunitinib|sunitinib|mesh-list
5763157|NCT02959554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5763158|NCT02959554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5763159|NCT02959554|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5763160|NCT02959554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5763161|NCT02959554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5763162|NCT02959554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5763163|NCT02959554|Growth Substances|growth substances|mesh-ancestor
5763164|NCT02959554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5637266|NCT04317105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5637267|NCT04317105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5637268|NCT04317105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5637269|NCT04313075|Leronlimab|leronlimab|mesh-list
5637270|NCT04313075|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5637271|NCT04313075|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5637272|NCT04313075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5763165|NCT02959554|Growth Inhibitors|growth inhibitors|mesh-ancestor
5763166|NCT02959554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5763167|NCT02959554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5763168|NCT02959606|Sarpogrelate|sarpogrelate|mesh-list
5763169|NCT02959606|Clopidogrel|clopidogrel|mesh-list
5763170|NCT02959606|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5763171|NCT02959606|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5763172|NCT02959606|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5763173|NCT02959606|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5763174|NCT02959606|Purinergic Agents|purinergic agents|mesh-ancestor
5763175|NCT02959606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5763176|NCT02959606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5763177|NCT02959606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763178|NCT02959606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5763179|NCT02959606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5763180|NCT02959606|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5763181|NCT02959606|Serotonin Agents|serotonin agents|mesh-ancestor
5763182|NCT02959541|Leucovorin|leucovorin|mesh-list
5763183|NCT02959541|Levoleucovorin|levoleucovorin|mesh-list
5763184|NCT02959541|Antidotes|antidotes|mesh-ancestor
5763185|NCT02959541|Protective Agents|protective agents|mesh-ancestor
5763186|NCT02959541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763187|NCT02959541|Vitamin B Complex|vitamin b complex|mesh-ancestor
5763188|NCT02959541|Vitamins|vitamins|mesh-ancestor
5763189|NCT02959541|Micronutrients|micronutrients|mesh-ancestor
5763190|NCT02959476|Ropivacaine|ropivacaine|mesh-list
5763191|NCT02959476|Anesthetics, Local|anesthetics, local|mesh-ancestor
5763192|NCT02959476|Anesthetics|anesthetics|mesh-ancestor
5763193|NCT02959476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5637273|NCT04313075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5637274|NCT04313075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5637275|NCT04313075|Antiviral Agents|antiviral agents|mesh-ancestor
5637276|NCT04313075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5637277|NCT04305795|Pembrolizumab|pembrolizumab|mesh-list
5637278|NCT04305795|Cemiplimab|cemiplimab|mesh-list
5637279|NCT04305795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5637280|NCT04305795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5637281|NCT04305756|Enoxaparin|enoxaparin|mesh-list
5763194|NCT02959476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763195|NCT02959476|Sensory System Agents|sensory system agents|mesh-ancestor
5763196|NCT02959476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5637282|NCT04305756|Anticoagulants|anticoagulants|mesh-ancestor
5637283|NCT04305756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5763197|NCT02959255|Esomeprazole|esomeprazole|mesh-list
5763198|NCT02959255|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5763199|NCT02959255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5763200|NCT02959255|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5763201|NCT02959255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5763202|NCT02959255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5763203|NCT02959229|Lactoferrin|lactoferrin|mesh-list
5763204|NCT02959229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5763205|NCT02959359|Ribavirin|ribavirin|mesh-list
5763206|NCT02959359|Sofosbuvir|sofosbuvir|mesh-list
5763207|NCT02959359|Ledipasvir|ledipasvir|mesh-list
5637284|NCT04305756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5637285|NCT04305756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5637286|NCT04304820|Cyclosporine|cyclosporine|mesh-list
5637287|NCT04304820|Cyclosporins|cyclosporins|mesh-list
5637288|NCT04304820|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5637289|NCT04304820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5637290|NCT04304820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5637291|NCT04304820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5637292|NCT04304820|Immunologic Factors|immunologic factors|mesh-ancestor
5637293|NCT04304820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5637294|NCT04304820|Antifungal Agents|antifungal agents|mesh-ancestor
5637295|NCT04304820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5637296|NCT04304820|Dermatologic Agents|dermatologic agents|mesh-ancestor
5637297|NCT04304820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5637298|NCT04304820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5637299|NCT04301934|Estradiol|estradiol|mesh-list
5637300|NCT04301934|Estrogens|estrogens|mesh-list
5637301|NCT04301934|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
5637302|NCT04301934|Hormones|hormones|mesh-ancestor
5637303|NCT04301934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5637304|NCT04301934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5637305|NCT04301765|Testosterone|testosterone|mesh-list
5637306|NCT04301765|Androgens|androgens|mesh-ancestor
5637307|NCT04301765|Hormones|hormones|mesh-ancestor
5637308|NCT04301765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5763208|NCT02959359|Antimetabolites|antimetabolites|mesh-ancestor
5763209|NCT02959359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5763210|NCT02959359|Antiviral Agents|antiviral agents|mesh-ancestor
5763211|NCT02959359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5763212|NCT02959411|Tolvaptan|tolvaptan|mesh-list
5763213|NCT02959411|Diuretics|diuretics|mesh-list
6490272|NCT00596986|Antidepressive Agents|antidepressive agents|mesh-ancestor
6490273|NCT00596986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6490274|NCT00596986|Dopamine Agents|dopamine agents|mesh-ancestor
6490275|NCT00597064|Prednisone|prednisone|mesh-list
6490276|NCT00597064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6490277|NCT00597064|Glucocorticoids|glucocorticoids|mesh-ancestor
6490278|NCT00597064|Hormones|hormones|mesh-ancestor
5763214|NCT02959411|Natriuretic Agents|natriuretic agents|mesh-ancestor
5763215|NCT02959411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763216|NCT02959411|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
5763217|NCT02959411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5637309|NCT04301765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5637310|NCT04301076|Prednisone|prednisone|mesh-list
5637311|NCT04301076|Cortisone|cortisone|mesh-list
5637312|NCT04301076|Cyclophosphamide|cyclophosphamide|mesh-list
5637313|NCT04301076|Doxorubicin|doxorubicin|mesh-list
5637314|NCT04301076|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5637315|NCT04301076|Etoposide|etoposide|mesh-list
5637316|NCT04301076|Vincristine|vincristine|mesh-list
5637317|NCT04301076|Lenalidomide|lenalidomide|mesh-list
5637318|NCT04301076|Etoposide phosphate|etoposide phosphate|mesh-list
5637319|NCT04301076|Podophyllotoxin|podophyllotoxin|mesh-list
5637320|NCT04301076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5637321|NCT04301076|Immunologic Factors|immunologic factors|mesh-ancestor
5637322|NCT04301076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5637323|NCT04301076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5637324|NCT04301076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5637325|NCT04301076|Alkylating Agents|alkylating agents|mesh-ancestor
5637326|NCT04301076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5763218|NCT02959125|Micronutrients|micronutrients|mesh-list
5637327|NCT04301076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5763219|NCT02959125|Trace Elements|trace elements|mesh-list
5763220|NCT02959125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490279|NCT00597064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5763221|NCT02959112|Indomethacin|indomethacin|mesh-list
5763222|NCT02959112|Epinephrine|epinephrine|mesh-list
5763223|NCT02959112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5763224|NCT02959112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5763225|NCT02959112|Adrenergic Agents|adrenergic agents|mesh-ancestor
5763226|NCT02959112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5763227|NCT02959112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5763228|NCT02959112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763229|NCT02959112|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5763230|NCT02959112|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5763231|NCT02959112|Autonomic Agents|autonomic agents|mesh-ancestor
6490280|NCT00597064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490281|NCT00597064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6490282|NCT00597064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6490283|NCT00597181|Mitomycins|mitomycins|mesh-list
6490284|NCT00597181|Mitomycin|mitomycin|mesh-list
6490285|NCT00597181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6490286|NCT00597181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6490287|NCT00597181|Alkylating Agents|alkylating agents|mesh-ancestor
6490288|NCT00597181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490289|NCT00597181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6490290|NCT00597181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6490291|NCT00597233|Insulin|insulin|mesh-list
6490292|NCT00597233|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6490293|NCT00597233|Insulin Aspart|insulin aspart|mesh-list
6490294|NCT00597233|Isophane Insulin, Human|isophane insulin, human|mesh-list
6490295|NCT00597233|Insulin, Isophane|insulin, isophane|mesh-list
6490296|NCT00597233|Isophane insulin, beef|isophane insulin, beef|mesh-list
6209464|NCT02147561|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6209465|NCT02147561|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6209466|NCT02147561|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6209467|NCT02147561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6490297|NCT00597233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6490298|NCT00597233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490299|NCT00597259|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6490300|NCT00597259|Entecavir|entecavir|mesh-list
6490301|NCT00597259|Antiviral Agents|antiviral agents|mesh-ancestor
6490302|NCT00597259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6490303|NCT00597389|Propranolol|propranolol|mesh-list
6490304|NCT00597389|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6490305|NCT00597389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5637328|NCT04301076|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5637329|NCT04301076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5637330|NCT04301076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5637331|NCT04301076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5637332|NCT04301076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5637333|NCT04301076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5637334|NCT04301076|Glucocorticoids|glucocorticoids|mesh-ancestor
5763232|NCT02959112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5763233|NCT02959112|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5763234|NCT02959112|Respiratory System Agents|respiratory system agents|mesh-ancestor
5763235|NCT02959112|Mydriatics|mydriatics|mesh-ancestor
5763236|NCT02959112|Sympathomimetics|sympathomimetics|mesh-ancestor
5763237|NCT02959112|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5763238|NCT02959112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5763239|NCT02959112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5763240|NCT02959112|Analgesics|analgesics|mesh-ancestor
5763241|NCT02959112|Sensory System Agents|sensory system agents|mesh-ancestor
5763242|NCT02959112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5763243|NCT02959112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5763244|NCT02959112|Gout Suppressants|gout suppressants|mesh-ancestor
5763245|NCT02959112|Tocolytic Agents|tocolytic agents|mesh-ancestor
5763246|NCT02959112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6490306|NCT00597389|Adrenergic Agents|adrenergic agents|mesh-ancestor
5637335|NCT04301076|Hormones|hormones|mesh-ancestor
5637336|NCT04301076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5637337|NCT04301076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5637338|NCT04301076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5637339|NCT04301076|Tubulin Modulators|tubulin modulators|mesh-ancestor
5637340|NCT04301076|Antimitotic Agents|antimitotic agents|mesh-ancestor
5637341|NCT04301076|Mitosis Modulators|mitosis modulators|mesh-ancestor
5637342|NCT04301076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5637343|NCT04301076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5637344|NCT04301076|Growth Substances|growth substances|mesh-ancestor
5637345|NCT04301076|Growth Inhibitors|growth inhibitors|mesh-ancestor
5637346|NCT04301076|Keratolytic Agents|keratolytic agents|mesh-ancestor
5763247|NCT02959112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5763248|NCT02959112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5763249|NCT02959060|Rifampin|rifampin|mesh-list
5763250|NCT02959060|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5763251|NCT02959060|Antitubercular Agents|antitubercular agents|mesh-ancestor
5763252|NCT02959060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6490307|NCT00597389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6490308|NCT00597389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490309|NCT00597389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490310|NCT00597389|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6490311|NCT00597389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6490312|NCT00597389|Vasodilator Agents|vasodilator agents|mesh-ancestor
6490313|NCT00597415|Celecoxib|celecoxib|mesh-list
6490314|NCT00597415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6490315|NCT00597415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5763253|NCT02959060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5637347|NCT04301076|Dermatologic Agents|dermatologic agents|mesh-ancestor
5637348|NCT04296305|Hydromorphone|hydromorphone|mesh-list
5637349|NCT04296305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5637350|NCT04296305|Narcotics|narcotics|mesh-ancestor
5637351|NCT04296305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5637352|NCT04296305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5637353|NCT04296305|Analgesics|analgesics|mesh-ancestor
5637354|NCT04296305|Sensory System Agents|sensory system agents|mesh-ancestor
5637355|NCT04296305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5637356|NCT04278144|Nivolumab|nivolumab|mesh-list
5763254|NCT02959060|Leprostatic Agents|leprostatic agents|mesh-ancestor
5763255|NCT02959060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5763256|NCT02959060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5763257|NCT02959060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5763258|NCT02959060|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5763259|NCT02959060|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5637357|NCT04278144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5637358|NCT04278144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5637359|NCT04278144|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5637360|NCT04278144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209468|NCT02147561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209469|NCT02147561|Cholinergic Agents|cholinergic agents|mesh-ancestor
6209470|NCT02147561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6209471|NCT02147561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209472|NCT02147561|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6209473|NCT02147561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6209474|NCT02147587|Tofacitinib|tofacitinib|mesh-list
5637368|NCT04251533|Paclitaxel|paclitaxel|mesh-list
5637369|NCT04251533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5637370|NCT04251533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5763260|NCT02959060|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5763261|NCT02959060|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5763262|NCT02959060|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6490316|NCT00597415|Analgesics|analgesics|mesh-ancestor
6490317|NCT00597415|Sensory System Agents|sensory system agents|mesh-ancestor
6490318|NCT00597415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6490319|NCT00597415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490320|NCT00597415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6209475|NCT02147587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6209476|NCT02147587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6209477|NCT02147587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5637371|NCT04251533|Tubulin Modulators|tubulin modulators|mesh-ancestor
5637372|NCT04251533|Antimitotic Agents|antimitotic agents|mesh-ancestor
5637373|NCT04251533|Mitosis Modulators|mitosis modulators|mesh-ancestor
5637374|NCT04251533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5637375|NCT04233840|Nivolumab|nivolumab|mesh-list
5637376|NCT04233840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5637377|NCT04233840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5637378|NCT04233840|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5637379|NCT04233840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5637380|NCT04229290|Dolutegravir|dolutegravir|mesh-list
5637381|NCT04229290|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5637382|NCT04229290|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5637383|NCT04229290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6209478|NCT02147691|Azelaic acid|azelaic acid|mesh-list
5637384|NCT04229290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5637385|NCT04229290|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5637386|NCT04229290|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5637387|NCT04229290|Antiviral Agents|antiviral agents|mesh-ancestor
5637388|NCT04229290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5693654|NCT03400241|Tiotropium Bromide|tiotropium bromide|mesh-list
5693655|NCT03400241|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5693656|NCT03400241|Autonomic Agents|autonomic agents|mesh-ancestor
5693657|NCT03400241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5693658|NCT03400241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693659|NCT03400241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5693660|NCT03400241|Respiratory System Agents|respiratory system agents|mesh-ancestor
5693661|NCT03400241|Parasympatholytics|parasympatholytics|mesh-ancestor
5693662|NCT03400241|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5693663|NCT03400241|Cholinergic Agents|cholinergic agents|mesh-ancestor
5693664|NCT03400241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5693665|NCT03400241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693666|NCT03400241|Anticonvulsants|anticonvulsants|mesh-ancestor
5693667|NCT03400189|Sulthiame|sulthiame|mesh-list
5763263|NCT02959060|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5763264|NCT02958917|Pirfenidone|pirfenidone|mesh-list
5763265|NCT02958917|Analgesics|analgesics|mesh-ancestor
5763266|NCT02958917|Sensory System Agents|sensory system agents|mesh-ancestor
5763267|NCT02958917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5763268|NCT02958917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763269|NCT02958917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5763270|NCT02958917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5763271|NCT02958917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5763272|NCT02958917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5763273|NCT02958917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5763274|NCT02958852|Letrozole|letrozole|mesh-list
5763275|NCT02958852|Fulvestrant|fulvestrant|mesh-list
5763276|NCT02958852|Atorvastatin|atorvastatin|mesh-list
5763277|NCT02958852|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5763278|NCT02958852|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5763279|NCT02958852|Antimetabolites|antimetabolites|mesh-ancestor
5763280|NCT02958852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5763281|NCT02958852|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5763282|NCT02958852|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5693668|NCT03400189|Anticonvulsants|anticonvulsants|mesh-ancestor
5693669|NCT03400111|Acetaminophen|acetaminophen|mesh-list
5693670|NCT03400111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5693671|NCT03400111|Analgesics|analgesics|mesh-ancestor
5763283|NCT02958852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5763284|NCT02958852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5693672|NCT03400111|Sensory System Agents|sensory system agents|mesh-ancestor
5693673|NCT03400111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5693674|NCT03400111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693675|NCT03400111|Antipyretics|antipyretics|mesh-ancestor
5693676|NCT03400020|Ascorbic Acid|ascorbic acid|mesh-list
5693677|NCT03400020|Vitamins|vitamins|mesh-ancestor
5693678|NCT03400020|Micronutrients|micronutrients|mesh-ancestor
5693679|NCT03400020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693680|NCT03400020|Antioxidants|antioxidants|mesh-ancestor
5693681|NCT03400020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693682|NCT03400020|Protective Agents|protective agents|mesh-ancestor
5693683|NCT03399981|Natalizumab|natalizumab|mesh-list
5693684|NCT03399981|Immunologic Factors|immunologic factors|mesh-ancestor
5693685|NCT03399981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693686|NCT03399955|Amphotericin B|amphotericin b|mesh-list
5693687|NCT03399955|Paromomycin|paromomycin|mesh-list
5693688|NCT03399955|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
5693689|NCT03399955|Miltefosine|miltefosine|mesh-list
5693690|NCT03399955|Amebicides|amebicides|mesh-ancestor
5693691|NCT03399955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5693692|NCT03399955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5693693|NCT03399955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5693694|NCT03399955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5693695|NCT03399955|Antifungal Agents|antifungal agents|mesh-ancestor
5693696|NCT03399955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5693697|NCT03399903|Mesalamine|mesalamine|mesh-list
5693698|NCT03399903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5693699|NCT03399903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5693700|NCT03399903|Analgesics|analgesics|mesh-ancestor
5693701|NCT03399903|Sensory System Agents|sensory system agents|mesh-ancestor
5693702|NCT03399903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5693703|NCT03399903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693704|NCT03399903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5763285|NCT02958852|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5637389|NCT04223661|Dexamethasone|dexamethasone|mesh-list
5637390|NCT04223661|Lenalidomide|lenalidomide|mesh-list
5637391|NCT04223661|Daratumumab|daratumumab|mesh-list
5637392|NCT04223661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5637393|NCT04223661|Antiemetics|antiemetics|mesh-ancestor
5637394|NCT04223661|Autonomic Agents|autonomic agents|mesh-ancestor
5637395|NCT04223661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5637396|NCT04223661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5637397|NCT04223661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5637398|NCT04223661|Glucocorticoids|glucocorticoids|mesh-ancestor
5637399|NCT04223661|Hormones|hormones|mesh-ancestor
5637400|NCT04223661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5637401|NCT04223661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5637402|NCT04223661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5637403|NCT04223661|Immunologic Factors|immunologic factors|mesh-ancestor
5763286|NCT02958852|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5763287|NCT02958852|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5763288|NCT02958852|Hormone Antagonists|hormone antagonists|mesh-ancestor
5763289|NCT02958852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5763290|NCT02958852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763291|NCT02958852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5763292|NCT02958852|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5763293|NCT02958878|Tamsulosin|tamsulosin|mesh-list
5763294|NCT02958878|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5763295|NCT02958878|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5763296|NCT02958878|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5763297|NCT02958878|Adrenergic Agents|adrenergic agents|mesh-ancestor
5763298|NCT02958878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5763299|NCT02958878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5763300|NCT02958878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763301|NCT02958878|Urological Agents|urological agents|mesh-ancestor
5763302|NCT02958800|Olanzapine|olanzapine|mesh-list
5763303|NCT02958800|Risperidone|risperidone|mesh-list
5763304|NCT02958800|Quetiapine Fumarate|quetiapine fumarate|mesh-list
5763305|NCT02958800|Antipsychotic Agents|antipsychotic agents|mesh-list
5763306|NCT02958800|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5763307|NCT02958800|Serotonin Agents|serotonin agents|mesh-ancestor
5763308|NCT02958800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5763309|NCT02958800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5763310|NCT02958800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763311|NCT02958800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5763312|NCT02958800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5763313|NCT02958800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5763314|NCT02958800|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5637404|NCT04223661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5637405|NCT04223661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5637406|NCT04223661|Growth Substances|growth substances|mesh-ancestor
5637407|NCT04223661|Growth Inhibitors|growth inhibitors|mesh-ancestor
5637408|NCT04218240|Lofexidine|lofexidine|mesh-list
5637409|NCT04218240|Pregabalin|pregabalin|mesh-list
5637410|NCT04218240|Analgesics|analgesics|mesh-ancestor
5637411|NCT04218240|Sensory System Agents|sensory system agents|mesh-ancestor
5637412|NCT04218240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5637413|NCT04218240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5637414|NCT04218240|Anticonvulsants|anticonvulsants|mesh-ancestor
5637415|NCT04218240|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5637416|NCT04218240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5637417|NCT04218240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5637418|NCT04218240|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5637419|NCT04218240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5637420|NCT04218240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5637421|NCT04218240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5637422|NCT04218240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5763315|NCT02958800|Dopamine Agents|dopamine agents|mesh-ancestor
5763316|NCT02958800|Antiemetics|antiemetics|mesh-ancestor
5763317|NCT02958800|Autonomic Agents|autonomic agents|mesh-ancestor
5763318|NCT02958800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5763319|NCT02958800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5763320|NCT02958800|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5637423|NCT04218240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5637424|NCT04218240|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5637425|NCT04218240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5637426|NCT04218240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5637427|NCT04218240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5637428|NCT04218240|Adrenergic Agents|adrenergic agents|mesh-ancestor
5637429|NCT04218240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5637430|NCT04209660|Pembrolizumab|pembrolizumab|mesh-list
5637431|NCT04209660|Lenvatinib|lenvatinib|mesh-list
5637432|NCT04209660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5637433|NCT04209660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5763321|NCT02958800|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5763322|NCT02958800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5763323|NCT02958800|Antidepressive Agents|antidepressive agents|mesh-ancestor
5763324|NCT02958761|Hyaluronic Acid|hyaluronic acid|mesh-list
5763325|NCT02958761|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5637434|NCT04209660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5637435|NCT04209660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5637436|NCT04209660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5637437|NCT04207931|Fluocinonide|fluocinonide|mesh-list
5637438|NCT04207931|Triamcinolone|triamcinolone|mesh-list
5637439|NCT04207931|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5637440|NCT04207931|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5637441|NCT04207931|Betamethasone|betamethasone|mesh-list
5637442|NCT04207931|Betamethasone Valerate|betamethasone valerate|mesh-list
5637443|NCT04207931|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5637444|NCT04207931|Betamethasone benzoate|betamethasone benzoate|mesh-list
5637445|NCT04207931|Clobetasol|clobetasol|mesh-list
5637446|NCT04207931|Minoxidil|minoxidil|mesh-list
5637447|NCT04207931|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
5637448|NCT04207931|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5637449|NCT04207931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5637450|NCT04207931|Glucocorticoids|glucocorticoids|mesh-ancestor
5637451|NCT04207931|Hormones|hormones|mesh-ancestor
5637452|NCT04207931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5637453|NCT04207931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5637454|NCT04207931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5637455|NCT04207931|Immunologic Factors|immunologic factors|mesh-ancestor
5637456|NCT04207931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5637457|NCT04207931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5637458|NCT04207931|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5637459|NCT04207931|Respiratory System Agents|respiratory system agents|mesh-ancestor
5637460|NCT04207931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5637461|NCT04207931|Vasodilator Agents|vasodilator agents|mesh-ancestor
5637462|NCT04207931|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5637463|NCT04199468|Ketamine|ketamine|mesh-list
5637464|NCT04199468|Dronabinol|dronabinol|mesh-list
5763326|NCT02958761|Immunologic Factors|immunologic factors|mesh-ancestor
5763327|NCT02958761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763328|NCT02958761|Viscosupplements|viscosupplements|mesh-ancestor
5763329|NCT02958761|Protective Agents|protective agents|mesh-ancestor
5763330|NCT02958566|Acetaminophen|acetaminophen|mesh-list
5763331|NCT02958566|Ketorolac|ketorolac|mesh-list
5763332|NCT02958566|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
5763333|NCT02958566|Lidocaine|lidocaine|mesh-list
5763334|NCT02958566|Fentanyl|fentanyl|mesh-list
5763335|NCT02958566|Morphine|morphine|mesh-list
5763336|NCT02958566|Tramadol|tramadol|mesh-list
5763337|NCT02958566|Methadone|methadone|mesh-list
5763338|NCT02958566|Hydrocodone|hydrocodone|mesh-list
5763339|NCT02958566|Hydromorphone|hydromorphone|mesh-list
5763340|NCT02958566|Ketamine|ketamine|mesh-list
5763341|NCT02958566|Gabapentin|gabapentin|mesh-list
5763342|NCT02958566|Orphenadrine|orphenadrine|mesh-list
5763343|NCT02958566|Bupivacaine|bupivacaine|mesh-list
5763344|NCT02958566|Anesthetics, Local|anesthetics, local|mesh-ancestor
5763345|NCT02958566|Anesthetics|anesthetics|mesh-ancestor
5763346|NCT02958566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5763347|NCT02958566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209479|NCT02147691|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6209480|NCT02147691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6209481|NCT02147691|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6490321|NCT00597415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5637465|NCT04199468|Analgesics|analgesics|mesh-ancestor
5637466|NCT04199468|Sensory System Agents|sensory system agents|mesh-ancestor
5637467|NCT04199468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5637468|NCT04199468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5637469|NCT04199468|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5637470|NCT04199468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6490322|NCT00597415|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5637471|NCT04199468|Anesthetics, General|anesthetics, general|mesh-ancestor
5763348|NCT02958566|Sensory System Agents|sensory system agents|mesh-ancestor
5763349|NCT02958566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5763350|NCT02958566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5763351|NCT02958566|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5763352|NCT02958566|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5763353|NCT02958566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5763354|NCT02958566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5763355|NCT02958566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6490323|NCT00597415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6490324|NCT00597415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6490325|NCT00597415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490326|NCT00597597|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5763356|NCT02958566|Narcotics|narcotics|mesh-ancestor
5763357|NCT02958566|Analgesics|analgesics|mesh-ancestor
5763358|NCT02958566|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5763359|NCT02958566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5763360|NCT02958566|Anesthetics, General|anesthetics, general|mesh-ancestor
5763361|NCT02958566|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5763362|NCT02958566|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5763363|NCT02958566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5763364|NCT02958566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5763365|NCT02958566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5763366|NCT02958566|Antipyretics|antipyretics|mesh-ancestor
5763367|NCT02958566|Anticonvulsants|anticonvulsants|mesh-ancestor
5763368|NCT02958566|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5763369|NCT02958566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5763370|NCT02958566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5763371|NCT02958566|Antimanic Agents|antimanic agents|mesh-ancestor
5763372|NCT02958566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5763373|NCT02958566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5763374|NCT02958566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5763375|NCT02958566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5763376|NCT02958566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5763377|NCT02958566|Antitussive Agents|antitussive agents|mesh-ancestor
5763378|NCT02958566|Respiratory System Agents|respiratory system agents|mesh-ancestor
5763379|NCT02958566|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5763380|NCT02958566|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5763381|NCT02958566|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5763382|NCT02958566|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5763383|NCT02958566|Parasympatholytics|parasympatholytics|mesh-ancestor
5763384|NCT02958566|Autonomic Agents|autonomic agents|mesh-ancestor
5763385|NCT02958566|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5763386|NCT02958566|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5637472|NCT04199468|Anesthetics|anesthetics|mesh-ancestor
5637473|NCT04199468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5637474|NCT04199468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5637475|NCT04199468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5637476|NCT04199468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5637477|NCT04199468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5637478|NCT04199468|Hallucinogens|hallucinogens|mesh-ancestor
5637479|NCT04199468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5637480|NCT04199468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5637481|NCT04199468|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5637482|NCT04199468|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5637483|NCT04199468|Hormones|hormones|mesh-ancestor
5637484|NCT04199468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5637485|NCT04191187|Fludarabine|fludarabine|mesh-list
5637486|NCT04191187|Melphalan|melphalan|mesh-list
5637487|NCT04191187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5763387|NCT02958566|Cholinergic Agents|cholinergic agents|mesh-ancestor
5763388|NCT02958566|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
6490327|NCT00597597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6490328|NCT00597597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6490329|NCT00597597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6490330|NCT00597597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490331|NCT00597623|Adalimumab|adalimumab|mesh-list
5763389|NCT02958566|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5763390|NCT02958514|Tobramycin|tobramycin|mesh-list
5763391|NCT02958514|Dexamethasone|dexamethasone|mesh-list
5763392|NCT02958514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5763393|NCT02958514|Antiemetics|antiemetics|mesh-ancestor
5763394|NCT02958514|Autonomic Agents|autonomic agents|mesh-ancestor
5763395|NCT02958514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5763396|NCT02958514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763397|NCT02958514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5763398|NCT02958514|Glucocorticoids|glucocorticoids|mesh-ancestor
5763399|NCT02958514|Hormones|hormones|mesh-ancestor
5895630|NCT05168683|Rasburicase|rasburicase|mesh-list
5763400|NCT02958514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5763401|NCT02958514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5763402|NCT02958514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5763403|NCT02958514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5763404|NCT02958514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5763405|NCT02958501|Cholecalciferol|cholecalciferol|mesh-list
5763406|NCT02958501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5763407|NCT02958501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5637488|NCT04191187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5637489|NCT04191187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5763408|NCT02958501|Vitamins|vitamins|mesh-ancestor
5763409|NCT02958501|Micronutrients|micronutrients|mesh-ancestor
5763410|NCT02958501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5763411|NCT02958631|Losartan|losartan|mesh-list
5763412|NCT02958631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5763413|NCT02958631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5763414|NCT02958631|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5763415|NCT02958631|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5637490|NCT04191187|Immunologic Factors|immunologic factors|mesh-ancestor
5637491|NCT04191187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5637492|NCT04191187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5637493|NCT04191187|Alkylating Agents|alkylating agents|mesh-ancestor
5637494|NCT04191187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5763416|NCT02958631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5763417|NCT02958423|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
5763418|NCT02958423|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5763419|NCT02958423|Serotonin Agents|serotonin agents|mesh-ancestor
5763420|NCT02958423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5763421|NCT02958423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5763422|NCT02958423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763423|NCT02958059|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5763424|NCT02958059|Cefoxitin|cefoxitin|mesh-list
5763425|NCT02958059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5763426|NCT02958046|Domperidone|domperidone|mesh-list
5763427|NCT02958046|Lansoprazole|lansoprazole|mesh-list
5763428|NCT02958046|Dexlansoprazole|dexlansoprazole|mesh-list
5763429|NCT02958046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5763430|NCT02958046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5763431|NCT02958046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5763432|NCT02958046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5763433|NCT02958046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5763434|NCT02958046|Antiemetics|antiemetics|mesh-ancestor
5763435|NCT02958046|Autonomic Agents|autonomic agents|mesh-ancestor
5763436|NCT02958046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5763437|NCT02958046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763438|NCT02958046|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5763439|NCT02958046|Dopamine Agents|dopamine agents|mesh-ancestor
5763440|NCT02958046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5763441|NCT02957994|Tenofovir|tenofovir|mesh-list
5763442|NCT02957994|Antiviral Agents|antiviral agents|mesh-ancestor
5763443|NCT02957994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5763444|NCT02957994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5763445|NCT02957994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5763446|NCT02957994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5763447|NCT02957994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5763448|NCT02957994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5763449|NCT02957994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5763450|NCT02958111|Capecitabine|capecitabine|mesh-list
5763451|NCT02958111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5763452|NCT02958111|Antimetabolites|antimetabolites|mesh-ancestor
5763453|NCT02958111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5763454|NCT02958111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5763455|NCT02958163|Doxorubicin|doxorubicin|mesh-list
5763456|NCT02958163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5763457|NCT02958163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5763458|NCT02958163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5763459|NCT02958163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5763460|NCT02958163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5763461|NCT02958163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5763462|NCT02958215|Phenylephrine|phenylephrine|mesh-list
5763463|NCT02958215|Oxymetazoline|oxymetazoline|mesh-list
5763464|NCT02958215|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5763465|NCT02958215|Mydriatics|mydriatics|mesh-ancestor
5763466|NCT02958215|Autonomic Agents|autonomic agents|mesh-ancestor
5763467|NCT02958215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5763468|NCT02958215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763469|NCT02958215|Sympathomimetics|sympathomimetics|mesh-ancestor
5763470|NCT02958215|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5763471|NCT02958215|Nasal Decongestants|nasal decongestants|mesh-ancestor
5763472|NCT02958215|Respiratory System Agents|respiratory system agents|mesh-ancestor
5763473|NCT02958215|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5763474|NCT02958215|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5763475|NCT02958215|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5763476|NCT02958215|Adrenergic Agents|adrenergic agents|mesh-ancestor
5763477|NCT02958215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5763478|NCT02958215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5763479|NCT02958215|Protective Agents|protective agents|mesh-ancestor
5763480|NCT02958150|Dexmedetomidine|dexmedetomidine|mesh-list
5763481|NCT02958150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5763482|NCT02958150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5763483|NCT02958150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763484|NCT02958150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5763485|NCT02958150|Analgesics|analgesics|mesh-ancestor
5763486|NCT02958150|Sensory System Agents|sensory system agents|mesh-ancestor
5763487|NCT02958150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5763488|NCT02958150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5763489|NCT02958150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5763490|NCT02958150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5763491|NCT02958150|Adrenergic Agents|adrenergic agents|mesh-ancestor
5763492|NCT02958150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5763493|NCT02958150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895631|NCT05168683|Uric Acid|uric acid|mesh-list
5895632|NCT05168683|Antioxidants|antioxidants|mesh-ancestor
5895633|NCT05168683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895634|NCT05168683|Protective Agents|protective agents|mesh-ancestor
5895635|NCT05168683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895636|NCT05168683|Gout Suppressants|gout suppressants|mesh-ancestor
5895637|NCT05168683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5895638|NCT05159934|Nicotine|nicotine|mesh-list
5895639|NCT05159934|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5895640|NCT05159934|Autonomic Agents|autonomic agents|mesh-ancestor
5895641|NCT05159934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5895642|NCT05159934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895643|NCT05159934|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5895644|NCT05159934|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5895645|NCT05159934|Cholinergic Agents|cholinergic agents|mesh-ancestor
5895646|NCT05159934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5895647|NCT05159934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895648|NCT05150340|Immunoglobulins|immunoglobulins|mesh-list
5895649|NCT05150340|Immunologic Factors|immunologic factors|mesh-ancestor
5895650|NCT05150340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895651|NCT05136326|Capecitabine|capecitabine|mesh-list
5895652|NCT05136326|Temozolomide|temozolomide|mesh-list
5895653|NCT05136326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5895654|NCT05136326|Antimetabolites|antimetabolites|mesh-ancestor
5895655|NCT05136326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895656|NCT05136326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5895657|NCT05136326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5895658|NCT05136326|Alkylating Agents|alkylating agents|mesh-ancestor
5895659|NCT05121974|Azithromycin|azithromycin|mesh-list
5895660|NCT05121974|Ceftriaxone|ceftriaxone|mesh-list
5895661|NCT05121974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5895662|NCT05121974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5895663|NCT05120349|Osimertinib|osimertinib|mesh-list
5895664|NCT05120349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5895665|NCT05120349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5637495|NCT04185883|Bevacizumab|bevacizumab|mesh-list
5637496|NCT04185883|Pembrolizumab|pembrolizumab|mesh-list
5637497|NCT04185883|Panitumumab|panitumumab|mesh-list
5637498|NCT04185883|Carboplatin|carboplatin|mesh-list
5637499|NCT04185883|Docetaxel|docetaxel|mesh-list
5637500|NCT04185883|Pemetrexed|pemetrexed|mesh-list
5637501|NCT04185883|Everolimus|everolimus|mesh-list
5637502|NCT04185883|Atezolizumab|atezolizumab|mesh-list
5637503|NCT04185883|Palbociclib|palbociclib|mesh-list
5637504|NCT04185883|Trametinib|trametinib|mesh-list
5637505|NCT04185883|Afatinib|afatinib|mesh-list
5637506|NCT04185883|Loperamide|loperamide|mesh-list
5637507|NCT04185883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5637508|NCT04185883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5763494|NCT02957903|Ropivacaine|ropivacaine|mesh-list
5763495|NCT02957903|Anesthetics, Local|anesthetics, local|mesh-ancestor
5763496|NCT02957903|Anesthetics|anesthetics|mesh-ancestor
5763497|NCT02957903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5763498|NCT02957903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763499|NCT02957903|Sensory System Agents|sensory system agents|mesh-ancestor
5763500|NCT02957903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5763501|NCT02957864|Tenofovir|tenofovir|mesh-list
5763502|NCT02957864|Abacavir|abacavir|mesh-list
5763503|NCT02957864|Antiviral Agents|antiviral agents|mesh-ancestor
5763504|NCT02957864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5763505|NCT02957864|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5763506|NCT02957864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5763507|NCT02957864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5763508|NCT02957864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5637509|NCT04185883|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5637510|NCT04185883|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5637511|NCT04185883|Growth Substances|growth substances|mesh-ancestor
5637512|NCT04185883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763509|NCT02957864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5763510|NCT02957864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6673331|NCT01562197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6673332|NCT01562197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673333|NCT01562197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6673334|NCT01562197|Alkylating Agents|alkylating agents|mesh-ancestor
6673335|NCT01562210|Olaparib|olaparib|mesh-list
6673336|NCT01562210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6673337|NCT01562210|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5637513|NCT04185883|Growth Inhibitors|growth inhibitors|mesh-ancestor
5637514|NCT04185883|Tubulin Modulators|tubulin modulators|mesh-ancestor
5637515|NCT04185883|Antimitotic Agents|antimitotic agents|mesh-ancestor
5637516|NCT04185883|Mitosis Modulators|mitosis modulators|mesh-ancestor
5637517|NCT04185883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5637518|NCT04185883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5637519|NCT04185883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5637520|NCT04185883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5637521|NCT04185883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5637522|NCT04185883|Immunologic Factors|immunologic factors|mesh-ancestor
5637523|NCT04185883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5637524|NCT04185883|Antidiarrheals|antidiarrheals|mesh-ancestor
5637525|NCT04185883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6209482|NCT02147691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6209483|NCT02147691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6209484|NCT02147691|Adrenergic Agents|adrenergic agents|mesh-ancestor
6209485|NCT02147691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6209486|NCT02147691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209487|NCT02147691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209488|NCT02147691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6209489|NCT02147691|Dermatologic Agents|dermatologic agents|mesh-ancestor
6209490|NCT02147899|Secnidazole|secnidazole|mesh-list
6209491|NCT02147899|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6209492|NCT02147899|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6209493|NCT02147899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6209494|NCT02148250|Insulin|insulin|mesh-list
6209495|NCT02148250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6209496|NCT02148250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6209497|NCT02148250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673338|NCT01562210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5693705|NCT03399903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6209498|NCT02148445|Nicotine|nicotine|mesh-list
5763511|NCT02957760|Hydroxyurea|hydroxyurea|mesh-list
5763512|NCT02957760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5763513|NCT02957760|Antisickling Agents|antisickling agents|mesh-ancestor
5763514|NCT02957760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6209499|NCT02148445|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6209500|NCT02148445|Autonomic Agents|autonomic agents|mesh-ancestor
5637546|NCT04181476|Sunscreening Agents|sunscreening agents|mesh-list
5637547|NCT04181476|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5637548|NCT04181476|Protective Agents|protective agents|mesh-ancestor
5637549|NCT04181476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5637550|NCT04181476|Dermatologic Agents|dermatologic agents|mesh-ancestor
6209501|NCT02148445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6209502|NCT02148445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209503|NCT02148445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6209504|NCT02148445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6209505|NCT02148445|Cholinergic Agents|cholinergic agents|mesh-ancestor
6209506|NCT02148445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6209507|NCT02148445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209508|NCT02148588|Lidocaine|lidocaine|mesh-list
6209509|NCT02148588|Anesthetics, Local|anesthetics, local|mesh-ancestor
6209510|NCT02148588|Anesthetics|anesthetics|mesh-ancestor
6209511|NCT02148588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6209512|NCT02148588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209513|NCT02148588|Sensory System Agents|sensory system agents|mesh-ancestor
6209514|NCT02148588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6209515|NCT02148588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6209516|NCT02148588|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5763515|NCT02957760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5763516|NCT02957760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5763517|NCT02957786|Varenicline|varenicline|mesh-list
5763518|NCT02957786|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5763519|NCT02957786|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5763520|NCT02957786|Cholinergic Agents|cholinergic agents|mesh-ancestor
5763521|NCT02957786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5763522|NCT02957786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5763523|NCT02957786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763524|NCT02957877|Heparin|heparin|mesh-list
5763525|NCT02957877|Calcium heparin|calcium heparin|mesh-list
5637567|NCT04162015|Carboplatin|carboplatin|mesh-list
5637568|NCT04162015|Nivolumab|nivolumab|mesh-list
5637569|NCT04162015|Pemetrexed|pemetrexed|mesh-list
5637570|NCT04162015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5637571|NCT04162015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5637572|NCT04162015|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5637573|NCT04162015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5637574|NCT04162015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5637575|NCT04162015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5637576|NCT04162015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6209517|NCT02148588|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6209518|NCT02148588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6209519|NCT02148588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209520|NCT02148718|Adalimumab|adalimumab|mesh-list
6209521|NCT02148718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6209522|NCT02148718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6209523|NCT02148874|Vaccines|vaccines|mesh-list
5637584|NCT04133636|Dexamethasone|dexamethasone|mesh-list
5637585|NCT04133636|Lenalidomide|lenalidomide|mesh-list
5637586|NCT04133636|Bortezomib|bortezomib|mesh-list
5637587|NCT04133636|Daratumumab|daratumumab|mesh-list
5637588|NCT04133636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5637589|NCT04133636|Antiemetics|antiemetics|mesh-ancestor
5637590|NCT04133636|Autonomic Agents|autonomic agents|mesh-ancestor
5637591|NCT04133636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5637592|NCT04133636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5637593|NCT04133636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5637594|NCT04133636|Glucocorticoids|glucocorticoids|mesh-ancestor
5637595|NCT04133636|Hormones|hormones|mesh-ancestor
5637596|NCT04133636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5637597|NCT04133636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5637598|NCT04133636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5637599|NCT04133636|Immunologic Factors|immunologic factors|mesh-ancestor
5637600|NCT04133636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5637601|NCT04133636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5763526|NCT02957877|Nadroparin|nadroparin|mesh-list
5637602|NCT04133636|Growth Substances|growth substances|mesh-ancestor
5637603|NCT04133636|Growth Inhibitors|growth inhibitors|mesh-ancestor
5637604|NCT04129723|Tin Fluorides|tin fluorides|mesh-list
5637605|NCT04129723|Cariostatic Agents|cariostatic agents|mesh-ancestor
5637606|NCT04129723|Protective Agents|protective agents|mesh-ancestor
5637607|NCT04129723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5637608|NCT04121455|Bevacizumab|bevacizumab|mesh-list
5637609|NCT04121455|Pembrolizumab|pembrolizumab|mesh-list
5637610|NCT04121455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5763527|NCT02957877|Anticoagulants|anticoagulants|mesh-ancestor
5763528|NCT02957877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5763529|NCT02957877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5763530|NCT02957877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5763531|NCT02957890|Vaccines|vaccines|mesh-list
5763532|NCT02957890|Immunologic Factors|immunologic factors|mesh-ancestor
5763533|NCT02957890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763534|NCT02957851|Nitrous Oxide|nitrous oxide|mesh-list
5763535|NCT02957851|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5763536|NCT02957851|Anesthetics, General|anesthetics, general|mesh-ancestor
5763537|NCT02957851|Anesthetics|anesthetics|mesh-ancestor
5637611|NCT04121455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5637612|NCT04121455|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5637613|NCT04121455|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5637614|NCT04121455|Growth Substances|growth substances|mesh-ancestor
5637615|NCT04121455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5637616|NCT04121455|Growth Inhibitors|growth inhibitors|mesh-ancestor
6209524|NCT02148874|Immunologic Factors|immunologic factors|mesh-ancestor
6209525|NCT02148874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5637619|NCT04111978|Letrozole|letrozole|mesh-list
5637620|NCT04111978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5637621|NCT04111978|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5637622|NCT04111978|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5637623|NCT04111978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5637624|NCT04111978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5637625|NCT04111978|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5637626|NCT04111978|Hormone Antagonists|hormone antagonists|mesh-ancestor
5637627|NCT04111978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5637628|NCT04111978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209526|NCT02149108|Nintedanib|nintedanib|mesh-list
6209527|NCT02149108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6209528|NCT02149108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6209529|NCT02149108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6209530|NCT02149108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209531|NCT02149173|Deoxyglucose|deoxyglucose|mesh-list
6209532|NCT02149173|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6209533|NCT02149173|Fluorides|fluorides|mesh-list
6209534|NCT02149173|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6209535|NCT02149173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209536|NCT02149173|Cariostatic Agents|cariostatic agents|mesh-ancestor
6209537|NCT02149173|Protective Agents|protective agents|mesh-ancestor
6209538|NCT02149173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5637642|NCT04100096|Brexpiprazole|brexpiprazole|mesh-list
5637643|NCT04100096|Serotonin Agents|serotonin agents|mesh-ancestor
5637644|NCT04100096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5637645|NCT04100096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5637646|NCT04100096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5637647|NCT04100096|Dopamine Agonists|dopamine agonists|mesh-ancestor
5637648|NCT04100096|Dopamine Agents|dopamine agents|mesh-ancestor
5637649|NCT04082364|Trastuzumab|trastuzumab|mesh-list
5637650|NCT04082364|Margetuximab|margetuximab|mesh-list
5637651|NCT04082364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5637652|NCT04082364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5763538|NCT02957851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5763539|NCT02957851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763540|NCT02957851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5763541|NCT02957851|Analgesics|analgesics|mesh-ancestor
5763542|NCT02957851|Sensory System Agents|sensory system agents|mesh-ancestor
5763543|NCT02957851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5763544|NCT02957643|Iron|iron|mesh-list
5763545|NCT02957643|Trace Elements|trace elements|mesh-ancestor
6209539|NCT02149173|Antimetabolites|antimetabolites|mesh-ancestor
5763546|NCT02957643|Micronutrients|micronutrients|mesh-ancestor
5895666|NCT05120349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6209540|NCT02149173|Antiviral Agents|antiviral agents|mesh-ancestor
6209541|NCT02149173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6209542|NCT02149199|Budesonide|budesonide|mesh-list
6209543|NCT02149199|Terbutaline|terbutaline|mesh-list
6209544|NCT02149199|Formoterol Fumarate|formoterol fumarate|mesh-list
6209545|NCT02149199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6209546|NCT02149199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6209547|NCT02149199|Autonomic Agents|autonomic agents|mesh-ancestor
6209548|NCT02149199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6209549|NCT02149199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5637664|NCT04066751|Ivacaftor|ivacaftor|mesh-list
5637665|NCT04066751|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
5637666|NCT04066751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5637667|NCT04066751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5637668|NCT04065789|Dexamethasone|dexamethasone|mesh-list
5763547|NCT02957643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763548|NCT02957604|Evolocumab|evolocumab|mesh-list
5763549|NCT02957604|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5763550|NCT02957604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5763551|NCT02957604|Antimetabolites|antimetabolites|mesh-ancestor
5763552|NCT02957604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5763553|NCT02957604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5763554|NCT02957435|Eplerenone|eplerenone|mesh-list
5763555|NCT02957435|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5763556|NCT02957435|Hormone Antagonists|hormone antagonists|mesh-ancestor
5763557|NCT02957435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5763558|NCT02957435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763559|NCT02957435|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5763560|NCT02957435|Diuretics|diuretics|mesh-ancestor
5763561|NCT02957435|Natriuretic Agents|natriuretic agents|mesh-ancestor
5763562|NCT02957435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5763563|NCT02957448|Rifampin|rifampin|mesh-list
5763564|NCT02957448|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5763565|NCT02957448|Antitubercular Agents|antitubercular agents|mesh-ancestor
5763566|NCT02957448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5763567|NCT02957448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5763568|NCT02957448|Leprostatic Agents|leprostatic agents|mesh-ancestor
5763569|NCT02957448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5763570|NCT02957448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5763571|NCT02957448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5763572|NCT02957448|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5763573|NCT02957448|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5763574|NCT02957448|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5763575|NCT02957448|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5763576|NCT02957448|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5763577|NCT02957448|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5763578|NCT02957656|Vaccines|vaccines|mesh-list
5763579|NCT02957656|Immunologic Factors|immunologic factors|mesh-ancestor
5763580|NCT02957656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763581|NCT02957630|Drospirenone|drospirenone|mesh-list
5763582|NCT02957630|Levonorgestrel|levonorgestrel|mesh-list
5763583|NCT02957630|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5763584|NCT02957630|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5763585|NCT02957630|Contraceptive Agents|contraceptive agents|mesh-ancestor
6209550|NCT02149199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6490332|NCT00597623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6490333|NCT00597623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6490334|NCT00597662|Icodextrin|icodextrin|mesh-list
6490335|NCT00597662|Dialysis Solutions|dialysis solutions|mesh-ancestor
6490336|NCT00597662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6490337|NCT00597688|Chlorhexidine|chlorhexidine|mesh-list
6490338|NCT00597688|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6673339|NCT01562210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673340|NCT01562223|Motexafin gadolinium|motexafin gadolinium|mesh-list
6673341|NCT01562223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6673342|NCT01562223|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6673343|NCT01562223|Dermatologic Agents|dermatologic agents|mesh-ancestor
6673344|NCT01562301|Carboplatin|carboplatin|mesh-list
5763586|NCT02957630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5763587|NCT02957630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763588|NCT02957630|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5763589|NCT02957630|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5763590|NCT02957630|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5763591|NCT02957630|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5763592|NCT02957630|Estrogens|estrogens|mesh-ancestor
5763593|NCT02957630|Hormones|hormones|mesh-ancestor
5763594|NCT02957630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5763595|NCT02957630|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5763596|NCT02957630|Hormone Antagonists|hormone antagonists|mesh-ancestor
5763597|NCT02957630|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5763598|NCT02957630|Diuretics|diuretics|mesh-ancestor
5763599|NCT02957630|Natriuretic Agents|natriuretic agents|mesh-ancestor
5763600|NCT02957474|Omeprazole|omeprazole|mesh-list
5763601|NCT02957474|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5763602|NCT02957474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5763603|NCT02957474|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5763604|NCT02957474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5763605|NCT02957474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5763606|NCT02957266|Gemcitabine|gemcitabine|mesh-list
5763607|NCT02957266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5763608|NCT02957266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5763609|NCT02957266|Antimetabolites|antimetabolites|mesh-ancestor
5763610|NCT02957266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5637669|NCT04065789|Lenalidomide|lenalidomide|mesh-list
5637670|NCT04065789|Daratumumab|daratumumab|mesh-list
5637671|NCT04065789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5637672|NCT04065789|Antiemetics|antiemetics|mesh-ancestor
5637673|NCT04065789|Autonomic Agents|autonomic agents|mesh-ancestor
5637674|NCT04065789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5637675|NCT04065789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5637676|NCT04065789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5637677|NCT04065789|Glucocorticoids|glucocorticoids|mesh-ancestor
5637678|NCT04065789|Hormones|hormones|mesh-ancestor
5637679|NCT04065789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5637680|NCT04065789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5637681|NCT04065789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5637682|NCT04065789|Immunologic Factors|immunologic factors|mesh-ancestor
5637683|NCT04065789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5637684|NCT04065789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5637685|NCT04065789|Growth Substances|growth substances|mesh-ancestor
5637686|NCT04065789|Growth Inhibitors|growth inhibitors|mesh-ancestor
6209551|NCT02149199|Respiratory System Agents|respiratory system agents|mesh-ancestor
6209552|NCT02149199|Glucocorticoids|glucocorticoids|mesh-ancestor
6209553|NCT02149199|Hormones|hormones|mesh-ancestor
6209554|NCT02149199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6209555|NCT02149199|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6209556|NCT02149199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5637693|NCT04047953|Paclitaxel|paclitaxel|mesh-list
5637694|NCT04047953|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5637695|NCT04047953|Oxaliplatin|oxaliplatin|mesh-list
5637696|NCT04047953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5637697|NCT04047953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5763611|NCT02957266|Antiviral Agents|antiviral agents|mesh-ancestor
5763612|NCT02957266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5763613|NCT02957266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5763614|NCT02957266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5763615|NCT02957266|Immunologic Factors|immunologic factors|mesh-ancestor
5763616|NCT02957266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763617|NCT02957162|Atorvastatin|atorvastatin|mesh-list
5763618|NCT02957162|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5637698|NCT04047953|Tubulin Modulators|tubulin modulators|mesh-ancestor
5637699|NCT04047953|Antimitotic Agents|antimitotic agents|mesh-ancestor
5637700|NCT04047953|Mitosis Modulators|mitosis modulators|mesh-ancestor
5637701|NCT04047953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209557|NCT02149199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6209558|NCT02149199|Adrenergic Agents|adrenergic agents|mesh-ancestor
6209559|NCT02149199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6209560|NCT02149199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209561|NCT02149199|Sympathomimetics|sympathomimetics|mesh-ancestor
6209562|NCT02149199|Tocolytic Agents|tocolytic agents|mesh-ancestor
5763619|NCT02957162|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6209563|NCT02149199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6209564|NCT02149264|Testosterone|testosterone|mesh-list
6209565|NCT02149264|Androgens|androgens|mesh-ancestor
6209566|NCT02149264|Hormones|hormones|mesh-ancestor
6209567|NCT02149264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6209568|NCT02149264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209569|NCT02149303|Dabigatran|dabigatran|mesh-list
6209570|NCT02149303|Antithrombins|antithrombins|mesh-ancestor
6209571|NCT02149303|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6209572|NCT02149303|Protease Inhibitors|protease inhibitors|mesh-ancestor
5637719|NCT04031599|Hormones|hormones|mesh-list
5637720|NCT04031599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5637721|NCT04031599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5637722|NCT04030559|Niraparib|niraparib|mesh-list
5637723|NCT04030559|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5637724|NCT04030559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5637725|NCT04030559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5637726|NCT04030559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5637727|NCT04025658|Oxytocin|oxytocin|mesh-list
5637728|NCT04025658|Oxytocics|oxytocics|mesh-ancestor
5637729|NCT04025658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5637730|NCT04025658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209573|NCT02149303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6209574|NCT02149303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5763620|NCT02957162|Antimetabolites|antimetabolites|mesh-ancestor
5763621|NCT02957162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5763622|NCT02957162|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5763623|NCT02957162|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5763624|NCT02957162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5763625|NCT02957279|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5763626|NCT02957279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5763627|NCT02957097|Gabapentin|gabapentin|mesh-list
5763628|NCT02957097|Analgesics|analgesics|mesh-ancestor
5763629|NCT02957097|Sensory System Agents|sensory system agents|mesh-ancestor
5763630|NCT02957097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5763631|NCT02957097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763632|NCT02957097|Anticonvulsants|anticonvulsants|mesh-ancestor
5763633|NCT02957097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5763634|NCT02957097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5763635|NCT02957097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5763636|NCT02957097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5763637|NCT02957097|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5763638|NCT02957097|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5763639|NCT02957097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5763640|NCT02957097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673345|NCT01562301|Docetaxel|docetaxel|mesh-list
6673346|NCT01562301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6673347|NCT01562301|Tubulin Modulators|tubulin modulators|mesh-ancestor
6673348|NCT01562301|Antimitotic Agents|antimitotic agents|mesh-ancestor
6673349|NCT01562301|Mitosis Modulators|mitosis modulators|mesh-ancestor
6673350|NCT01562301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673351|NCT01562405|Dexamethasone|dexamethasone|mesh-list
6673352|NCT01562405|Lenalidomide|lenalidomide|mesh-list
6673353|NCT01562405|Pomalidomide|pomalidomide|mesh-list
6673354|NCT01562405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6673355|NCT01562405|Antiemetics|antiemetics|mesh-ancestor
6209575|NCT02149303|Anticoagulants|anticoagulants|mesh-ancestor
6212584|NCT02189941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212585|NCT02190903|Anesthetics|anesthetics|mesh-list
6212586|NCT02190903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5637737|NCT04019821|Insulin|insulin|mesh-list
5637738|NCT04019821|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5637739|NCT04019821|Insulin Aspart|insulin aspart|mesh-list
5637740|NCT04019821|Insulin Lispro|insulin lispro|mesh-list
5637741|NCT04019821|Insulin glulisine|insulin glulisine|mesh-list
6490339|NCT00597688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6490340|NCT00597688|Disinfectants|disinfectants|mesh-ancestor
6490341|NCT00597857|Hydrocortisone|hydrocortisone|mesh-list
6490342|NCT00597857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6490343|NCT00598013|Pioglitazone|pioglitazone|mesh-list
6490344|NCT00598013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6490345|NCT00598013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490346|NCT00598052|Citalopram|citalopram|mesh-list
5763641|NCT02957097|Antimanic Agents|antimanic agents|mesh-ancestor
5763642|NCT02957032|Cytarabine|cytarabine|mesh-list
5763643|NCT02957032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5763644|NCT02957032|Antimetabolites|antimetabolites|mesh-ancestor
5763645|NCT02957032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5763646|NCT02957032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5763647|NCT02957032|Antiviral Agents|antiviral agents|mesh-ancestor
5763648|NCT02957032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5763649|NCT02957032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5763650|NCT02957032|Immunologic Factors|immunologic factors|mesh-ancestor
5763651|NCT02957032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763652|NCT02957019|Rituximab|rituximab|mesh-list
5763653|NCT02957019|Interleukin-2|interleukin-2|mesh-list
5763654|NCT02957019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5637742|NCT04019821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5637743|NCT04019821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5637744|NCT04006288|Aspirin|aspirin|mesh-list
5637745|NCT04006288|Rivaroxaban|rivaroxaban|mesh-list
5637746|NCT04006288|Clopidogrel|clopidogrel|mesh-list
5637747|NCT04006288|Ticagrelor|ticagrelor|mesh-list
5637748|NCT04006288|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
5637749|NCT04006288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5637750|NCT04006288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5637751|NCT04006288|Analgesics|analgesics|mesh-ancestor
5763655|NCT02957019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5763656|NCT02957019|Immunologic Factors|immunologic factors|mesh-ancestor
5763657|NCT02957019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763658|NCT02957019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5763659|NCT02957019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5763660|NCT02957019|Analgesics|analgesics|mesh-ancestor
5763661|NCT02957019|Sensory System Agents|sensory system agents|mesh-ancestor
5763662|NCT02957019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5763663|NCT02956772|Arsenic Trioxide|arsenic trioxide|mesh-list
5763664|NCT02956772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5763665|NCT02956811|Dapagliflozin|dapagliflozin|mesh-list
5763666|NCT02956811|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5637752|NCT04006288|Sensory System Agents|sensory system agents|mesh-ancestor
5637753|NCT04006288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5637754|NCT04006288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5637755|NCT04006288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5637756|NCT04006288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5637757|NCT04006288|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5637758|NCT04006288|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5637759|NCT04006288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5637760|NCT04006288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5637761|NCT04006288|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5637762|NCT04006288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5763667|NCT02956811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5763668|NCT02956811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5763669|NCT02956811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763670|NCT02956655|Insulin|insulin|mesh-list
5763671|NCT02956655|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5763672|NCT02956655|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5763673|NCT02956655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763674|NCT02956538|Thalidomide|thalidomide|mesh-list
5763675|NCT02956538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5763676|NCT02956538|Immunologic Factors|immunologic factors|mesh-ancestor
5763677|NCT02956538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763678|NCT02956538|Leprostatic Agents|leprostatic agents|mesh-ancestor
6490347|NCT00598052|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5763679|NCT02956538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5763680|NCT02956538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5763681|NCT02956538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5763682|NCT02956538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5763683|NCT02956538|Growth Substances|growth substances|mesh-ancestor
5637763|NCT04006288|Antipyretics|antipyretics|mesh-ancestor
5637764|NCT04006288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5637765|NCT04006288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5637766|NCT04006288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5637767|NCT04006288|Purinergic Agents|purinergic agents|mesh-ancestor
5637768|NCT04006288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5637769|NCT04006288|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5637770|NCT04006288|Antithrombins|antithrombins|mesh-ancestor
5637771|NCT04006288|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5637772|NCT04006288|Protease Inhibitors|protease inhibitors|mesh-ancestor
5637773|NCT04006288|Anticoagulants|anticoagulants|mesh-ancestor
5637774|NCT04005690|Olaparib|olaparib|mesh-list
5637775|NCT04005690|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
5637776|NCT04005690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5637777|NCT04005690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5637778|NCT04005690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5637779|NCT04005352|Aflibercept|aflibercept|mesh-list
5637780|NCT04005352|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5637781|NCT04005352|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5637782|NCT04005352|Growth Substances|growth substances|mesh-ancestor
5637783|NCT04005352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5637784|NCT04005352|Growth Inhibitors|growth inhibitors|mesh-ancestor
5637785|NCT04005352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5637786|NCT04003805|Nicotine|nicotine|mesh-list
5637787|NCT04003805|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5637788|NCT04003805|Autonomic Agents|autonomic agents|mesh-ancestor
5637789|NCT04003805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5637790|NCT04003805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5637791|NCT04003805|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5637792|NCT04003805|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5637793|NCT04003805|Cholinergic Agents|cholinergic agents|mesh-ancestor
5637794|NCT04003805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5763684|NCT02956538|Growth Inhibitors|growth inhibitors|mesh-ancestor
5763685|NCT02956538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5763686|NCT02956785|Dinoprostone|dinoprostone|mesh-list
5763687|NCT02956785|Oxytocics|oxytocics|mesh-ancestor
5763688|NCT02956785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5763689|NCT02956785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763690|NCT02957409|Valsartan|valsartan|mesh-list
5763691|NCT02957409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5763692|NCT02957409|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5763693|NCT02957409|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5763694|NCT02957409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5763695|NCT02956590|Pitavastatin|pitavastatin|mesh-list
6673356|NCT01562405|Autonomic Agents|autonomic agents|mesh-ancestor
5637795|NCT04003805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5637796|NCT03971734|Regadenoson|regadenoson|mesh-list
5637797|NCT03971734|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
5637798|NCT03971734|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5637799|NCT03971734|Purinergic Agonists|purinergic agonists|mesh-ancestor
5637800|NCT03971734|Purinergic Agents|purinergic agents|mesh-ancestor
5637801|NCT03971734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5637802|NCT03971734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5637803|NCT03971734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209576|NCT02149342|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
6209577|NCT02149342|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6209578|NCT02149342|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5693706|NCT03399838|Midazolam|midazolam|mesh-list
5693707|NCT03399838|Dexmedetomidine|dexmedetomidine|mesh-list
5693708|NCT03399838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5693709|NCT03399838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5693710|NCT03399838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693711|NCT03399838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5693712|NCT03399838|Analgesics|analgesics|mesh-ancestor
5693713|NCT03399838|Sensory System Agents|sensory system agents|mesh-ancestor
5693714|NCT03399838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5693715|NCT03399838|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5763696|NCT02956590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6673357|NCT01562405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5763697|NCT02956590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5763698|NCT02956590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5637807|NCT03964090|Cytarabine|cytarabine|mesh-list
5637808|NCT03964090|Isavuconazole|isavuconazole|mesh-list
5637809|NCT03964090|Methotrexate|methotrexate|mesh-list
5637810|NCT03964090|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5637811|NCT03964090|Abortifacient Agents|abortifacient agents|mesh-ancestor
5763699|NCT02956590|Antimetabolites|antimetabolites|mesh-ancestor
5763700|NCT02956590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5763701|NCT02956590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5763702|NCT02956590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5763703|NCT02956447|Hormones|hormones|mesh-list
5763704|NCT02956447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5763705|NCT02956447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763706|NCT02956252|Anesthetics|anesthetics|mesh-list
5763707|NCT02956252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5763708|NCT02956252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895667|NCT05120349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895668|NCT05102149|Vildagliptin|vildagliptin|mesh-list
5895669|NCT05102149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5895670|NCT05102149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895671|NCT05102149|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5895672|NCT05102149|Protease Inhibitors|protease inhibitors|mesh-ancestor
5895673|NCT05102149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5895674|NCT05102149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895675|NCT05084859|Prednisone|prednisone|mesh-list
5895676|NCT05084859|Docetaxel|docetaxel|mesh-list
5895677|NCT05084859|Panitumumab|panitumumab|mesh-list
5895678|NCT05084859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5895679|NCT05084859|Tubulin Modulators|tubulin modulators|mesh-ancestor
5895680|NCT05084859|Antimitotic Agents|antimitotic agents|mesh-ancestor
5895681|NCT05084859|Mitosis Modulators|mitosis modulators|mesh-ancestor
5895682|NCT05084859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895683|NCT05084859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5895684|NCT05084859|Glucocorticoids|glucocorticoids|mesh-ancestor
5895685|NCT05084859|Hormones|hormones|mesh-ancestor
5637812|NCT03964090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5637813|NCT03964090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5637814|NCT03964090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5637815|NCT03964090|Antimetabolites|antimetabolites|mesh-ancestor
5637816|NCT03964090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5637817|NCT03964090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5637818|NCT03964090|Dermatologic Agents|dermatologic agents|mesh-ancestor
5637819|NCT03964090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5637820|NCT03964090|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5895686|NCT05084859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5895687|NCT05084859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895688|NCT05084859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5895689|NCT05084859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5895690|NCT05081180|Lenvatinib|lenvatinib|mesh-list
5895691|NCT05081180|Avelumab|avelumab|mesh-list
5895692|NCT05081180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5895693|NCT05081180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5895694|NCT05081180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5895695|NCT05081180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895696|NCT05081180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5895697|NCT05061134|Durvalumab|durvalumab|mesh-list
5895698|NCT05061134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5895699|NCT05061134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5895700|NCT05060991|Antimetabolites|antimetabolites|mesh-list
5895701|NCT05060991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895702|NCT05057247|Docetaxel|docetaxel|mesh-list
6490348|NCT00598052|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6490349|NCT00598052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6490350|NCT00598052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490351|NCT00598052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5895703|NCT05057247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5895704|NCT05057247|Tubulin Modulators|tubulin modulators|mesh-ancestor
5895705|NCT05057247|Antimitotic Agents|antimitotic agents|mesh-ancestor
5895706|NCT05057247|Mitosis Modulators|mitosis modulators|mesh-ancestor
5895707|NCT05057247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5637821|NCT03964090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5637822|NCT03964090|Immunologic Factors|immunologic factors|mesh-ancestor
5637823|NCT03964090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5637824|NCT03964090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5637825|NCT03964090|Antiviral Agents|antiviral agents|mesh-ancestor
5637826|NCT03964090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5637827|NCT03964090|Antifungal Agents|antifungal agents|mesh-ancestor
5763709|NCT02956408|Vitamin D|vitamin d|mesh-list
5763710|NCT02956408|Cholecalciferol|cholecalciferol|mesh-list
5763711|NCT02956408|Vitamins|vitamins|mesh-ancestor
5763712|NCT02956408|Micronutrients|micronutrients|mesh-ancestor
5763713|NCT02956408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763714|NCT02956408|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5763715|NCT02956408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5763716|NCT02956421|Vaccines|vaccines|mesh-list
5763717|NCT02956421|Immunologic Factors|immunologic factors|mesh-ancestor
5763718|NCT02956421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763719|NCT02956200|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
5763720|NCT02956200|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5763721|NCT02956200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5763722|NCT02956200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5763723|NCT02956200|Immunologic Factors|immunologic factors|mesh-ancestor
5763724|NCT02956200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763725|NCT02955810|Dexamethasone|dexamethasone|mesh-list
5763726|NCT02955810|Cyclophosphamide|cyclophosphamide|mesh-list
5763727|NCT02955810|Bortezomib|bortezomib|mesh-list
5763728|NCT02955810|Daratumumab|daratumumab|mesh-list
5763729|NCT02955810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5763730|NCT02955810|Immunologic Factors|immunologic factors|mesh-ancestor
5763731|NCT02955810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763732|NCT02955810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5763733|NCT02955810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5763734|NCT02955810|Alkylating Agents|alkylating agents|mesh-ancestor
5763735|NCT02955810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5763736|NCT02955810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5637828|NCT03943667|Gemcitabine|gemcitabine|mesh-list
5637829|NCT03943667|Paclitaxel|paclitaxel|mesh-list
5637830|NCT03943667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5637831|NCT03943667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5637832|NCT03943667|Tubulin Modulators|tubulin modulators|mesh-ancestor
5637833|NCT03943667|Antimitotic Agents|antimitotic agents|mesh-ancestor
5637834|NCT03943667|Mitosis Modulators|mitosis modulators|mesh-ancestor
5637835|NCT03943667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5637836|NCT03943667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5637837|NCT03943667|Antimetabolites|antimetabolites|mesh-ancestor
5637838|NCT03943667|Antiviral Agents|antiviral agents|mesh-ancestor
5637839|NCT03943667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5637840|NCT03943667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5637841|NCT03943667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5637842|NCT03943667|Immunologic Factors|immunologic factors|mesh-ancestor
5637843|NCT03943667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5637844|NCT03941262|Pembrolizumab|pembrolizumab|mesh-list
5637845|NCT03941262|Avelumab|avelumab|mesh-list
5637846|NCT03941262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5637847|NCT03941262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5637848|NCT03936933|Goserelin|goserelin|mesh-list
5637849|NCT03936933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5637850|NCT03936933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5637851|NCT03936218|Goserelin|goserelin|mesh-list
5637852|NCT03936218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5637853|NCT03936218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5637854|NCT03932331|Acalabrutinib|acalabrutinib|mesh-list
5763737|NCT02955810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5763738|NCT02955810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5763739|NCT02955810|Antiemetics|antiemetics|mesh-ancestor
5763740|NCT02955810|Autonomic Agents|autonomic agents|mesh-ancestor
5763741|NCT02955810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5763742|NCT02955810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5763743|NCT02955810|Glucocorticoids|glucocorticoids|mesh-ancestor
5763744|NCT02955810|Hormones|hormones|mesh-ancestor
5763745|NCT02955810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5763746|NCT02955810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5763747|NCT02955940|Capecitabine|capecitabine|mesh-list
5763748|NCT02955940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5763749|NCT02955940|Antimetabolites|antimetabolites|mesh-ancestor
5763750|NCT02955940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5637855|NCT03932331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5763751|NCT02955940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5763752|NCT02956083|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5763753|NCT02956083|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5763754|NCT02955732|Dexmedetomidine|dexmedetomidine|mesh-list
5763755|NCT02955732|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5763756|NCT02955732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5763757|NCT02955732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5637856|NCT03927521|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5637857|NCT03927521|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5637858|NCT03927521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5637859|NCT03926143|Maytansine|maytansine|mesh-list
5637860|NCT03926143|Tubulin Modulators|tubulin modulators|mesh-list
5763758|NCT02955732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5763759|NCT02955732|Analgesics|analgesics|mesh-ancestor
5763760|NCT02955732|Sensory System Agents|sensory system agents|mesh-ancestor
5763761|NCT02955732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5763762|NCT02955732|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5763763|NCT02955732|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5763764|NCT02955732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5763765|NCT02955732|Adrenergic Agents|adrenergic agents|mesh-ancestor
5763766|NCT02955732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5763767|NCT02955732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5763768|NCT02955719|Sertraline|sertraline|mesh-list
5763769|NCT02955719|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
5763770|NCT02955719|Antidepressive Agents|antidepressive agents|mesh-ancestor
5763771|NCT02955719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5637861|NCT03926143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5637862|NCT03926143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5637863|NCT03926143|Antimitotic Agents|antimitotic agents|mesh-ancestor
5637864|NCT03926143|Mitosis Modulators|mitosis modulators|mesh-ancestor
5637865|NCT03926143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5637866|NCT03923699|Anesthetics|anesthetics|mesh-list
5637867|NCT03923699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5637868|NCT03923699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5637869|NCT03911661|Warfarin|warfarin|mesh-list
5637870|NCT03911661|Anticoagulants|anticoagulants|mesh-ancestor
5637871|NCT03908255|Vitamins|vitamins|mesh-list
5637872|NCT03908255|Micronutrients|micronutrients|mesh-ancestor
5637873|NCT03908255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5637874|NCT03902951|Leuprolide|leuprolide|mesh-list
5637875|NCT03902951|Abiraterone Acetate|abiraterone acetate|mesh-list
5637876|NCT03902951|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5637877|NCT03902951|Fertility Agents|fertility agents|mesh-ancestor
5637878|NCT03902951|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5637879|NCT03902951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5637880|NCT03902951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5637881|NCT03902951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5637882|NCT03902951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5637883|NCT03902951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5763772|NCT02955719|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5763773|NCT02955719|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5763774|NCT02955719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5637884|NCT03902951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5637885|NCT03902951|Hormone Antagonists|hormone antagonists|mesh-ancestor
5637886|NCT03902951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5637887|NCT03902951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6209579|NCT02149342|Dermatologic Agents|dermatologic agents|mesh-ancestor
6209580|NCT02149524|Trastuzumab|trastuzumab|mesh-list
6209581|NCT02149524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6209582|NCT02149524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6209583|NCT02149836|Ezogabine|ezogabine|mesh-list
6209584|NCT02149836|Anticonvulsants|anticonvulsants|mesh-ancestor
6209585|NCT02149836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6209586|NCT02149836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209587|NCT02149875|Cerebrolysin|cerebrolysin|mesh-list
5637897|NCT03900754|Oxytocin|oxytocin|mesh-list
5637898|NCT03900754|Oxytocics|oxytocics|mesh-ancestor
5637899|NCT03900754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5637900|NCT03900754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5637901|NCT03897244|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5637902|NCT03897244|Amoxicillin|amoxicillin|mesh-list
5637903|NCT03897244|Metronidazole|metronidazole|mesh-list
5637904|NCT03897244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5637905|NCT03897244|Rabeprazole|rabeprazole|mesh-list
5637906|NCT03897244|Bismuth|bismuth|mesh-list
5763775|NCT02955719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5763776|NCT02955719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5763777|NCT02955719|Serotonin Agents|serotonin agents|mesh-ancestor
5763778|NCT02955719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763779|NCT02955719|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5763780|NCT02955719|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5763781|NCT02955524|Lidocaine|lidocaine|mesh-list
5637907|NCT03897244|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
5637908|NCT03897244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5637909|NCT03897244|Antitubercular Agents|antitubercular agents|mesh-ancestor
5637910|NCT03897244|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5637911|NCT03897244|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5637912|NCT03897244|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5637913|NCT03897244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5637914|NCT03897244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5637915|NCT03897244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5637916|NCT03897244|Antacids|antacids|mesh-ancestor
5637917|NCT03896230|Ketamine|ketamine|mesh-list
5637918|NCT03896230|Analgesics|analgesics|mesh-ancestor
5637919|NCT03896230|Sensory System Agents|sensory system agents|mesh-ancestor
5637920|NCT03896230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5763782|NCT02955524|Tetracaine|tetracaine|mesh-list
5763783|NCT02955524|Anesthetics, Local|anesthetics, local|mesh-ancestor
5763784|NCT02955524|Anesthetics|anesthetics|mesh-ancestor
5763785|NCT02955524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5763786|NCT02955524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763787|NCT02955524|Sensory System Agents|sensory system agents|mesh-ancestor
5637921|NCT03896230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5637922|NCT03896230|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5637923|NCT03896230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5637924|NCT03896230|Anesthetics, General|anesthetics, general|mesh-ancestor
5637925|NCT03896230|Anesthetics|anesthetics|mesh-ancestor
5637926|NCT03896230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5637927|NCT03896230|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5637928|NCT03896230|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5637929|NCT03896230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5637930|NCT03896230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5637931|NCT03878316|Oxytocin|oxytocin|mesh-list
5637932|NCT03878316|Oxytocics|oxytocics|mesh-ancestor
5637933|NCT03878316|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5637934|NCT03878316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209588|NCT02149875|3-n-butylphthalide|3-n-butylphthalide|mesh-list
5763788|NCT02955524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5763789|NCT02955524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5763790|NCT02955524|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5763791|NCT02955524|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5763792|NCT02955524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5763793|NCT02955524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5763794|NCT02955693|Dimethyl Fumarate|dimethyl fumarate|mesh-list
5763795|NCT02955693|Dermatologic Agents|dermatologic agents|mesh-ancestor
5763796|NCT02955693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5763797|NCT02955693|Immunologic Factors|immunologic factors|mesh-ancestor
5763798|NCT02955693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763799|NCT02955602|Seladelpar|seladelpar|mesh-list
5763800|NCT02955602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5763801|NCT02955602|Antimetabolites|antimetabolites|mesh-ancestor
5763802|NCT02955602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5763803|NCT02955602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5763804|NCT02955706|Acetylcarnitine|acetylcarnitine|mesh-list
6673358|NCT01562405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673359|NCT01562405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5763805|NCT02955706|Vitamin B Complex|vitamin b complex|mesh-ancestor
5763806|NCT02955706|Vitamins|vitamins|mesh-ancestor
5763807|NCT02955706|Micronutrients|micronutrients|mesh-ancestor
5763808|NCT02955706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763809|NCT02955706|Nootropic Agents|nootropic agents|mesh-ancestor
5763810|NCT02955641|Dexamethasone|dexamethasone|mesh-list
5763811|NCT02955641|Nepafenac|nepafenac|mesh-list
5763812|NCT02955641|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5763813|NCT02955641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5763814|NCT02955641|Antiemetics|antiemetics|mesh-ancestor
5763815|NCT02955641|Autonomic Agents|autonomic agents|mesh-ancestor
5763816|NCT02955641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5763817|NCT02955641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763818|NCT02955641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6209589|NCT02149875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6209590|NCT02149875|Protective Agents|protective agents|mesh-ancestor
6209591|NCT02149875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209592|NCT02149875|Nootropic Agents|nootropic agents|mesh-ancestor
6209593|NCT02149875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6209594|NCT02150213|Dexamethasone|dexamethasone|mesh-list
6209595|NCT02150213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6209596|NCT02150213|Antiemetics|antiemetics|mesh-ancestor
6209597|NCT02150213|Autonomic Agents|autonomic agents|mesh-ancestor
6209598|NCT02150213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6209599|NCT02150213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209600|NCT02150213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6209601|NCT02150213|Glucocorticoids|glucocorticoids|mesh-ancestor
6209602|NCT02150213|Hormones|hormones|mesh-ancestor
6209603|NCT02150213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6209604|NCT02150213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5637952|NCT03869034|Leucovorin|leucovorin|mesh-list
5637953|NCT03869034|Fluorouracil|fluorouracil|mesh-list
5637954|NCT03869034|Oxaliplatin|oxaliplatin|mesh-list
5637955|NCT03869034|Antimetabolites|antimetabolites|mesh-ancestor
5637956|NCT03869034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5637957|NCT03869034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5637958|NCT03869034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5637959|NCT03869034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5637960|NCT03869034|Immunologic Factors|immunologic factors|mesh-ancestor
5763819|NCT02955641|Glucocorticoids|glucocorticoids|mesh-ancestor
5763820|NCT02955641|Hormones|hormones|mesh-ancestor
5763821|NCT02955641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5763822|NCT02955641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5763823|NCT02955641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5763824|NCT02955641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5763825|NCT02955641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5763826|NCT02955641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5763827|NCT02955641|Analgesics|analgesics|mesh-ancestor
5763828|NCT02955641|Sensory System Agents|sensory system agents|mesh-ancestor
5763829|NCT02955641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5763830|NCT02955927|Atropine|atropine|mesh-list
5763831|NCT02955927|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5763832|NCT02955927|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5763833|NCT02955927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5763834|NCT02955927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5763835|NCT02955927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5763836|NCT02955927|Autonomic Agents|autonomic agents|mesh-ancestor
5763837|NCT02955927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5763838|NCT02955927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5637961|NCT03869034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5637962|NCT03869034|Antidotes|antidotes|mesh-ancestor
5637963|NCT03869034|Protective Agents|protective agents|mesh-ancestor
5637964|NCT03869034|Vitamin B Complex|vitamin b complex|mesh-ancestor
5637965|NCT03869034|Vitamins|vitamins|mesh-ancestor
5637966|NCT03869034|Micronutrients|micronutrients|mesh-ancestor
5637967|NCT03867357|Goserelin|goserelin|mesh-list
5637968|NCT03867357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5637969|NCT03867357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5637970|NCT03855046|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
5637971|NCT03855046|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5637972|NCT03855046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5637973|NCT03855046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5637974|NCT03855046|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5637975|NCT03855046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5637976|NCT03855046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5637977|NCT03855046|Cholinergic Agents|cholinergic agents|mesh-ancestor
5637978|NCT03855046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5637979|NCT03854110|Gemcitabine|gemcitabine|mesh-list
5637980|NCT03854110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5637981|NCT03854110|Antimetabolites|antimetabolites|mesh-ancestor
5637982|NCT03854110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5637983|NCT03854110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5637984|NCT03854110|Antiviral Agents|antiviral agents|mesh-ancestor
5637985|NCT03854110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5637986|NCT03854110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5637987|NCT03854110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5637988|NCT03854110|Immunologic Factors|immunologic factors|mesh-ancestor
5637989|NCT03854110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5637990|NCT03851081|Vincristine|vincristine|mesh-list
5637991|NCT03851081|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
5637992|NCT03851081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5637993|NCT03851081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5637994|NCT03851081|Tubulin Modulators|tubulin modulators|mesh-ancestor
5637995|NCT03851081|Antimitotic Agents|antimitotic agents|mesh-ancestor
5637996|NCT03851081|Mitosis Modulators|mitosis modulators|mesh-ancestor
5637997|NCT03851081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5637998|NCT03851081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5637999|NCT03851081|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5638000|NCT03847428|Bevacizumab|bevacizumab|mesh-list
5638001|NCT03847428|Durvalumab|durvalumab|mesh-list
5638002|NCT03847428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5638003|NCT03847428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5638004|NCT03847428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5763839|NCT02955927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5763840|NCT02955927|Respiratory System Agents|respiratory system agents|mesh-ancestor
5763841|NCT02955927|Mydriatics|mydriatics|mesh-ancestor
5763842|NCT02955927|Parasympatholytics|parasympatholytics|mesh-ancestor
5763843|NCT02955927|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5763844|NCT02955927|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5763845|NCT02955927|Cholinergic Agents|cholinergic agents|mesh-ancestor
5763846|NCT02955927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5763847|NCT02955927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5763848|NCT02955355|Immunoglobulins|immunoglobulins|mesh-list
5763849|NCT02955355|Immunologic Factors|immunologic factors|mesh-ancestor
5763850|NCT02955355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763851|NCT02955654|Aripiprazole|aripiprazole|mesh-list
5638005|NCT03847428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5638006|NCT03847428|Growth Substances|growth substances|mesh-ancestor
5638007|NCT03847428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5638008|NCT03847428|Growth Inhibitors|growth inhibitors|mesh-ancestor
5638009|NCT03833427|Pembrolizumab|pembrolizumab|mesh-list
5638010|NCT03833427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5638011|NCT03833427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5638012|NCT03822468|Letrozole|letrozole|mesh-list
5638013|NCT03822468|Anastrozole|anastrozole|mesh-list
5763852|NCT02955654|Antidepressive Agents|antidepressive agents|mesh-ancestor
5763853|NCT02955654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5763854|NCT02955654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5638014|NCT03822468|Goserelin|goserelin|mesh-list
5638015|NCT03822468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5638016|NCT03822468|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5638017|NCT03822468|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5638018|NCT03822468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5638019|NCT03822468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5638020|NCT03822468|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5638021|NCT03822468|Hormone Antagonists|hormone antagonists|mesh-ancestor
5638022|NCT03822468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5638023|NCT03822468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5638024|NCT03822468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5638025|NCT03819465|Gemcitabine|gemcitabine|mesh-list
5638026|NCT03819465|Paclitaxel|paclitaxel|mesh-list
5763855|NCT02955654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5763856|NCT02955654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5638027|NCT03819465|Carboplatin|carboplatin|mesh-list
5638028|NCT03819465|Pemetrexed|pemetrexed|mesh-list
5638029|NCT03819465|Durvalumab|durvalumab|mesh-list
6490352|NCT00598052|Serotonin Agents|serotonin agents|mesh-ancestor
6490353|NCT00598052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763857|NCT02955654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763858|NCT02955654|Dopamine Agonists|dopamine agonists|mesh-ancestor
5763859|NCT02955654|Dopamine Agents|dopamine agents|mesh-ancestor
5763860|NCT02955654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5763861|NCT02955654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5763862|NCT02955654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5763863|NCT02955654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5763864|NCT02955654|Serotonin Agents|serotonin agents|mesh-ancestor
5763865|NCT02955654|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5763866|NCT02955654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5763867|NCT02955654|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6490354|NCT00598052|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5638030|NCT03819465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5638031|NCT03819465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5638032|NCT03819465|Tubulin Modulators|tubulin modulators|mesh-ancestor
5638033|NCT03819465|Antimitotic Agents|antimitotic agents|mesh-ancestor
5638034|NCT03819465|Mitosis Modulators|mitosis modulators|mesh-ancestor
5638035|NCT03819465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5638036|NCT03819465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5638037|NCT03819465|Antimetabolites|antimetabolites|mesh-ancestor
5763868|NCT02955654|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5763869|NCT02955134|Hydrotalcite|hydrotalcite|mesh-list
5763870|NCT02955134|Antacids|antacids|mesh-ancestor
5763871|NCT02955134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5763872|NCT02955134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5763873|NCT02955056|Teriparatide|teriparatide|mesh-list
5763874|NCT02955056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763875|NCT02955056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5763876|NCT02955056|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5763877|NCT02954939|Prednisone|prednisone|mesh-list
5763878|NCT02954939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5763879|NCT02954939|Glucocorticoids|glucocorticoids|mesh-ancestor
5763880|NCT02954939|Hormones|hormones|mesh-ancestor
5763881|NCT02954939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5763882|NCT02954939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763883|NCT02954939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5763884|NCT02954939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5763885|NCT02955082|Carboplatin|carboplatin|mesh-list
5763886|NCT02955082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5763887|NCT02954991|Nivolumab|nivolumab|mesh-list
5763888|NCT02954991|Mocetinostat|mocetinostat|mesh-list
5763889|NCT02954991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5763890|NCT02954991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5763891|NCT02954991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5763892|NCT02954991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5763893|NCT02954991|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5763894|NCT02954991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5763895|NCT02955251|Nivolumab|nivolumab|mesh-list
5763896|NCT02955251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5763897|NCT02955251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5763898|NCT02955251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5763899|NCT02955251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5763900|NCT02954913|Liver Extracts|liver extracts|mesh-list
5763901|NCT02954913|Hematinics|hematinics|mesh-ancestor
5763902|NCT02954692|Metformin|metformin|mesh-list
5763903|NCT02954692|Insulin Glargine|insulin glargine|mesh-list
5763904|NCT02954692|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
5763905|NCT02954692|Meglitinide|meglitinide|mesh-list
5763906|NCT02954692|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
5763907|NCT02954692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5763908|NCT02954692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763909|NCT02954692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5763910|NCT02954692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895708|NCT05036421|Empagliflozin|empagliflozin|mesh-list
5895709|NCT05036421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5895710|NCT05036421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895711|NCT05036421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5895712|NCT05036421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895713|NCT05035186|Amoxicillin|amoxicillin|mesh-list
5895714|NCT05035186|Clarithromycin|clarithromycin|mesh-list
6490355|NCT00598052|Antidepressive Agents|antidepressive agents|mesh-ancestor
5638038|NCT03819465|Antiviral Agents|antiviral agents|mesh-ancestor
5638039|NCT03819465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5638040|NCT03819465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5638041|NCT03819465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5763911|NCT02954822|Glimepiride|glimepiride|mesh-list
5763912|NCT02954822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5763913|NCT02954822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5763914|NCT02954822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763915|NCT02954822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5763916|NCT02954822|Immunologic Factors|immunologic factors|mesh-ancestor
5763917|NCT02954588|Pyridoxamine|pyridoxamine|mesh-list
5638042|NCT03819465|Immunologic Factors|immunologic factors|mesh-ancestor
5638043|NCT03819465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5638044|NCT03819465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5638045|NCT03819465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5638046|NCT03819465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5638047|NCT03816176|Isavuconazole|isavuconazole|mesh-list
5638048|NCT03816176|Antifungal Agents|antifungal agents|mesh-ancestor
5638049|NCT03816176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5638050|NCT03809000|Leuprolide|leuprolide|mesh-list
5638051|NCT03809000|Goserelin|goserelin|mesh-list
5638052|NCT03809000|Bicalutamide|bicalutamide|mesh-list
5638053|NCT03809000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5638054|NCT03809000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5638055|NCT03809000|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5638056|NCT03809000|Fertility Agents|fertility agents|mesh-ancestor
5638057|NCT03809000|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5638058|NCT03809000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5638059|NCT03809000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5638060|NCT03809000|Androgen Antagonists|androgen antagonists|mesh-ancestor
5638061|NCT03809000|Hormone Antagonists|hormone antagonists|mesh-ancestor
5638062|NCT03802799|Cannabidiol|cannabidiol|mesh-list
5638063|NCT03802799|Anticonvulsants|anticonvulsants|mesh-ancestor
5638064|NCT03799874|Carbon Monoxide|carbon monoxide|mesh-list
5638065|NCT03799874|Antimetabolites|antimetabolites|mesh-ancestor
5763918|NCT02954588|Vitamin B Complex|vitamin b complex|mesh-ancestor
6490356|NCT00598052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6490357|NCT00598091|Gemcitabine|gemcitabine|mesh-list
6490358|NCT00598091|Dasatinib|dasatinib|mesh-list
6490359|NCT00598091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5763919|NCT02954588|Vitamins|vitamins|mesh-ancestor
5763920|NCT02954588|Micronutrients|micronutrients|mesh-ancestor
5763921|NCT02954588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763922|NCT02954549|Vitamin D|vitamin d|mesh-list
5763923|NCT02954549|Cholecalciferol|cholecalciferol|mesh-list
5763924|NCT02954549|Vitamins|vitamins|mesh-ancestor
5763925|NCT02954549|Micronutrients|micronutrients|mesh-ancestor
6490360|NCT00598091|Antimetabolites|antimetabolites|mesh-ancestor
6490361|NCT00598091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5638066|NCT03799874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5638067|NCT03799874|Gasotransmitters|gasotransmitters|mesh-ancestor
5763926|NCT02954549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763927|NCT02954549|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5763928|NCT02954549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5763929|NCT02954536|Fluorouracil|fluorouracil|mesh-list
5763930|NCT02954536|Pembrolizumab|pembrolizumab|mesh-list
5763931|NCT02954536|Capecitabine|capecitabine|mesh-list
5763932|NCT02954536|Oxaliplatin|oxaliplatin|mesh-list
5763933|NCT02954536|Trastuzumab|trastuzumab|mesh-list
5763934|NCT02954536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5763935|NCT02954536|Antimetabolites|antimetabolites|mesh-ancestor
5763936|NCT02954536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5763937|NCT02954536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5763938|NCT02954536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5763939|NCT02954536|Immunologic Factors|immunologic factors|mesh-ancestor
5763940|NCT02954536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763941|NCT02954536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5763942|NCT02954393|Amoxicillin|amoxicillin|mesh-list
5763943|NCT02954393|Metronidazole|metronidazole|mesh-list
5763944|NCT02954393|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5763945|NCT02954393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5763946|NCT02954393|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5763947|NCT02954393|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5763948|NCT02954276|Sumatriptan|sumatriptan|mesh-list
6490362|NCT00598091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6490363|NCT00598091|Antiviral Agents|antiviral agents|mesh-ancestor
6490364|NCT00598091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6490365|NCT00598091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5763949|NCT02954276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5763950|NCT02954276|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5763951|NCT02954276|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5763952|NCT02954276|Serotonin Agents|serotonin agents|mesh-ancestor
5763953|NCT02954276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5763954|NCT02954276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5763955|NCT02954276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763956|NCT02954484|Acetaminophen|acetaminophen|mesh-list
6673360|NCT01562405|Glucocorticoids|glucocorticoids|mesh-ancestor
6673361|NCT01562405|Hormones|hormones|mesh-ancestor
5763957|NCT02954484|Etoricoxib|etoricoxib|mesh-list
5763958|NCT02954484|Pregabalin|pregabalin|mesh-list
5763959|NCT02954484|Morphine|morphine|mesh-list
5763960|NCT02954484|Ropivacaine|ropivacaine|mesh-list
5763961|NCT02954484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5763962|NCT02954484|Narcotics|narcotics|mesh-ancestor
5763963|NCT02954484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5763964|NCT02954484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763965|NCT02954484|Analgesics|analgesics|mesh-ancestor
5763966|NCT02954484|Sensory System Agents|sensory system agents|mesh-ancestor
5763967|NCT02954484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5763968|NCT02954484|Anesthetics, Local|anesthetics, local|mesh-ancestor
5763969|NCT02954484|Anesthetics|anesthetics|mesh-ancestor
5763970|NCT02954484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5763971|NCT02954484|Antipyretics|antipyretics|mesh-ancestor
5763972|NCT02954484|Anticonvulsants|anticonvulsants|mesh-ancestor
5763973|NCT02954484|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5763974|NCT02954484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5763975|NCT02954484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5763976|NCT02954484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5763977|NCT02954484|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5763978|NCT02954484|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5763979|NCT02954484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5763980|NCT02954484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5763981|NCT02954484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5763982|NCT02954484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5763983|NCT02954484|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5763984|NCT02954484|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5763985|NCT02954484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5763986|NCT02954068|Oxytocin|oxytocin|mesh-list
5763987|NCT02954068|Oxytocics|oxytocics|mesh-ancestor
5763988|NCT02954068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5763989|NCT02954068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5763990|NCT02954029|Hemostatics|hemostatics|mesh-list
5763991|NCT02954029|Coagulants|coagulants|mesh-ancestor
5763992|NCT02954055|Paclitaxel|paclitaxel|mesh-list
5763993|NCT02954055|Vinorelbine|vinorelbine|mesh-list
5763994|NCT02954055|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6673362|NCT01562405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6673363|NCT01562405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6673364|NCT01562405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6673365|NCT01562405|Immunologic Factors|immunologic factors|mesh-ancestor
5638068|NCT03799874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5638069|NCT03799874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5638070|NCT03797014|Tenofovir|tenofovir|mesh-list
5638071|NCT03797014|Emtricitabine|emtricitabine|mesh-list
5638072|NCT03797014|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
5638073|NCT03797014|Antiviral Agents|antiviral agents|mesh-ancestor
5638074|NCT03797014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5638075|NCT03797014|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5638076|NCT03797014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5638077|NCT03797014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5638078|NCT03797014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5638079|NCT03797014|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5763995|NCT02954055|Cyclophosphamide|cyclophosphamide|mesh-list
5763996|NCT02954055|Capecitabine|capecitabine|mesh-list
5763997|NCT02954055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5638080|NCT03797014|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5638081|NCT03787628|Cannabidiol|cannabidiol|mesh-list
5638082|NCT03787628|Anticonvulsants|anticonvulsants|mesh-ancestor
5638083|NCT03787602|Avelumab|avelumab|mesh-list
5638084|NCT03787602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5638085|NCT03787602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5638086|NCT03779334|Risdiplam|risdiplam|mesh-list
5638087|NCT03779334|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5638088|NCT03779334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5638089|NCT03779334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5638090|NCT03768960|Daratumumab|daratumumab|mesh-list
5638091|NCT03768960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6209605|NCT02150213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6209606|NCT02150499|Albuterol|albuterol|mesh-list
5763998|NCT02954055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5763999|NCT02954055|Tubulin Modulators|tubulin modulators|mesh-ancestor
5764000|NCT02954055|Antimitotic Agents|antimitotic agents|mesh-ancestor
5764001|NCT02954055|Mitosis Modulators|mitosis modulators|mesh-ancestor
5764002|NCT02954055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764003|NCT02954055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5764004|NCT02954055|Immunologic Factors|immunologic factors|mesh-ancestor
5764005|NCT02954055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5764006|NCT02954055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5764007|NCT02954055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5764008|NCT02954055|Alkylating Agents|alkylating agents|mesh-ancestor
5764009|NCT02954055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5764010|NCT02954055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5764011|NCT02954055|Antimetabolites|antimetabolites|mesh-ancestor
5764012|NCT02953834|Insulin|insulin|mesh-list
5764013|NCT02953834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5764014|NCT02953834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5764015|NCT02953847|Rifampin|rifampin|mesh-list
5764016|NCT02953847|Isoniazid|isoniazid|mesh-list
5764017|NCT02953847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5764018|NCT02953847|Antitubercular Agents|antitubercular agents|mesh-ancestor
5764019|NCT02953847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5764020|NCT02953847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6209607|NCT02150499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6209608|NCT02150499|Autonomic Agents|autonomic agents|mesh-ancestor
5638096|NCT03766126|Cyclophosphamide|cyclophosphamide|mesh-list
5638097|NCT03766126|Fludarabine|fludarabine|mesh-list
5638098|NCT03766126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5638099|NCT03766126|Immunologic Factors|immunologic factors|mesh-ancestor
5638100|NCT03766126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5638101|NCT03766126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5764021|NCT02953847|Leprostatic Agents|leprostatic agents|mesh-ancestor
5764022|NCT02953847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5764023|NCT02953847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5764024|NCT02953847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764025|NCT02953847|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5764026|NCT02953847|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5764027|NCT02953847|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5764028|NCT02953847|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5764029|NCT02953847|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5764030|NCT02953847|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5764031|NCT02953847|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5764032|NCT02953847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5638102|NCT03766126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5638103|NCT03766126|Alkylating Agents|alkylating agents|mesh-ancestor
5638104|NCT03766126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5638105|NCT03766126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5638106|NCT03766126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6490366|NCT00598091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6490367|NCT00598091|Immunologic Factors|immunologic factors|mesh-ancestor
6490368|NCT00598091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490369|NCT00598091|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5764033|NCT02953847|Antimetabolites|antimetabolites|mesh-ancestor
5764034|NCT02953847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5764035|NCT02953743|Lenvatinib|lenvatinib|mesh-list
5764036|NCT02953743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5764037|NCT02953743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5764038|NCT02953743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6490370|NCT00598156|Bevacizumab|bevacizumab|mesh-list
6490371|NCT00598156|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5638107|NCT03761095|Dacarbazine|dacarbazine|mesh-list
5764039|NCT02953743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764040|NCT02953522|Folic Acid|folic acid|mesh-list
5764041|NCT02953522|Vitamin B Complex|vitamin b complex|mesh-list
5764042|NCT02953522|Hematinics|hematinics|mesh-ancestor
5764043|NCT02953522|Vitamins|vitamins|mesh-ancestor
5764044|NCT02953522|Micronutrients|micronutrients|mesh-ancestor
5764045|NCT02953522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5764046|NCT02953535|Sofosbuvir|sofosbuvir|mesh-list
5764047|NCT02953535|Antiviral Agents|antiviral agents|mesh-ancestor
5764048|NCT02953535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5764049|NCT02953457|Durvalumab|durvalumab|mesh-list
5764050|NCT02953457|Ipilimumab|ipilimumab|mesh-list
5764051|NCT02953457|Olaparib|olaparib|mesh-list
5764052|NCT02953457|Tremelimumab|tremelimumab|mesh-list
5764053|NCT02953457|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
5764054|NCT02953457|Immunoglobulins|immunoglobulins|mesh-list
5764055|NCT02953457|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5764056|NCT02953457|Immunoglobulin G|immunoglobulin g|mesh-list
5764057|NCT02953457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5764058|NCT02953457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5764059|NCT02953457|Immunologic Factors|immunologic factors|mesh-ancestor
6490372|NCT00598156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6490373|NCT00598156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6490374|NCT00598156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6490375|NCT00598156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6490376|NCT00598156|Growth Substances|growth substances|mesh-ancestor
5638108|NCT03761095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5638109|NCT03761095|Alkylating Agents|alkylating agents|mesh-ancestor
5638110|NCT03761095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490377|NCT00598156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490378|NCT00598156|Growth Inhibitors|growth inhibitors|mesh-ancestor
6490379|NCT00598156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5764060|NCT02953457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5764061|NCT02953457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5764062|NCT02953457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764063|NCT02953457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5764064|NCT02953405|Clopidogrel|clopidogrel|mesh-list
5764065|NCT02953405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5764066|NCT02953405|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5764067|NCT02953405|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6490380|NCT00598156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6490381|NCT00598156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5638111|NCT03761095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5638112|NCT03758781|Nivolumab|nivolumab|mesh-list
5638113|NCT03758781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5638114|NCT03758781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5764068|NCT02953405|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5764069|NCT02953405|Purinergic Agents|purinergic agents|mesh-ancestor
5764070|NCT02953405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5764071|NCT02953405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764072|NCT02953405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5764073|NCT02953379|Mometasone Furoate|mometasone furoate|mesh-list
5764074|NCT02953379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5764075|NCT02953379|Dermatologic Agents|dermatologic agents|mesh-ancestor
5764076|NCT02953379|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5764077|NCT02953366|Mometasone Furoate|mometasone furoate|mesh-list
5764078|NCT02953366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5764079|NCT02953366|Dermatologic Agents|dermatologic agents|mesh-ancestor
5764080|NCT02953366|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5764081|NCT02953275|Pentoxifylline|pentoxifylline|mesh-list
5764082|NCT02953275|Vedolizumab|vedolizumab|mesh-list
5764083|NCT02953275|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5764084|NCT02953275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5764085|NCT02953275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764086|NCT02953275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5764087|NCT02953275|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5764088|NCT02953275|Protective Agents|protective agents|mesh-ancestor
5764089|NCT02953275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5764090|NCT02953275|Vasodilator Agents|vasodilator agents|mesh-ancestor
5764091|NCT02953275|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5764092|NCT02953275|Antioxidants|antioxidants|mesh-ancestor
5764093|NCT02953275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5764094|NCT02953210|Dexamethasone|dexamethasone|mesh-list
5764095|NCT02953210|Ketorolac|ketorolac|mesh-list
5764096|NCT02953210|Lidocaine|lidocaine|mesh-list
5764097|NCT02953210|Clonidine|clonidine|mesh-list
5764098|NCT02953210|Fentanyl|fentanyl|mesh-list
5764099|NCT02953210|Midazolam|midazolam|mesh-list
5764100|NCT02953210|Ketamine|ketamine|mesh-list
5764101|NCT02953210|Ondansetron|ondansetron|mesh-list
5764102|NCT02953210|Bupivacaine|bupivacaine|mesh-list
5764103|NCT02953210|Propofol|propofol|mesh-list
5764104|NCT02953210|Isoflurane|isoflurane|mesh-list
5764105|NCT02953210|Ranitidine|ranitidine|mesh-list
5764106|NCT02953210|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
5764107|NCT02953210|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5764108|NCT02953210|Rocuronium|rocuronium|mesh-list
5764109|NCT02953210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5764110|NCT02953210|Antiemetics|antiemetics|mesh-ancestor
5764111|NCT02953210|Autonomic Agents|autonomic agents|mesh-ancestor
5764112|NCT02953210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5764113|NCT02953210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5764114|NCT02953210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5764115|NCT02953210|Glucocorticoids|glucocorticoids|mesh-ancestor
5764116|NCT02953210|Hormones|hormones|mesh-ancestor
5764117|NCT02953210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5764118|NCT02953210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5638115|NCT03758781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5638116|NCT03758781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693716|NCT03399838|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5693717|NCT03399838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5693718|NCT03399838|Adrenergic Agents|adrenergic agents|mesh-ancestor
5693719|NCT03399838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5693720|NCT03399838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693721|NCT03399838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5764119|NCT02953210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5764120|NCT02953210|Anesthetics, Local|anesthetics, local|mesh-ancestor
5764121|NCT02953210|Anesthetics|anesthetics|mesh-ancestor
5764122|NCT02953210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5693722|NCT03399838|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5693723|NCT03399838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5693724|NCT03399838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5693725|NCT03399838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5764123|NCT02953210|Sensory System Agents|sensory system agents|mesh-ancestor
5764124|NCT02953210|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5764125|NCT02953210|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5764126|NCT02953210|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5764127|NCT02953210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5764128|NCT02953210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764129|NCT02953210|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5764130|NCT02953210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5764131|NCT02953210|Anesthetics, General|anesthetics, general|mesh-ancestor
5764132|NCT02953210|Analgesics|analgesics|mesh-ancestor
5764133|NCT02953210|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5693726|NCT03399838|Anesthetics, General|anesthetics, general|mesh-ancestor
5693727|NCT03399838|Anesthetics|anesthetics|mesh-ancestor
5693728|NCT03399838|GABA Modulators|gaba modulators|mesh-ancestor
5693729|NCT03399838|GABA Agents|gaba agents|mesh-ancestor
5693730|NCT03399708|Apremilast|apremilast|mesh-list
5693731|NCT03399708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5693732|NCT03399708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5693733|NCT03399708|Analgesics|analgesics|mesh-ancestor
5693734|NCT03399708|Sensory System Agents|sensory system agents|mesh-ancestor
5693735|NCT03399708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5764134|NCT02953210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5764135|NCT02953210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5764136|NCT02953210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5764137|NCT02953210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5764138|NCT02953210|Narcotics|narcotics|mesh-ancestor
5638117|NCT03749070|Silymarin|silymarin|mesh-list
5638118|NCT03749070|Antioxidants|antioxidants|mesh-ancestor
5638119|NCT03749070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5638120|NCT03749070|Protective Agents|protective agents|mesh-ancestor
5638121|NCT03749070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209609|NCT02150499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6209610|NCT02150499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209611|NCT02150499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6209612|NCT02150499|Respiratory System Agents|respiratory system agents|mesh-ancestor
6209613|NCT02150499|Tocolytic Agents|tocolytic agents|mesh-ancestor
6209614|NCT02150499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5764139|NCT02953210|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5764140|NCT02953210|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5764141|NCT02953210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5764142|NCT02953210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5764143|NCT02953210|GABA Modulators|gaba modulators|mesh-ancestor
5764144|NCT02953210|GABA Agents|gaba agents|mesh-ancestor
5764145|NCT02953210|Antipruritics|antipruritics|mesh-ancestor
5764146|NCT02953210|Dermatologic Agents|dermatologic agents|mesh-ancestor
5764147|NCT02953210|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5764148|NCT02953210|Serotonin Agents|serotonin agents|mesh-ancestor
5764149|NCT02953210|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6209615|NCT02150499|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6209616|NCT02150499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6209617|NCT02150499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6209618|NCT02150499|Adrenergic Agents|adrenergic agents|mesh-ancestor
6209619|NCT02150499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6209620|NCT02150499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209621|NCT02150759|Fentanyl|fentanyl|mesh-list
6209622|NCT02150759|Dexmedetomidine|dexmedetomidine|mesh-list
6209623|NCT02150759|Ketamine|ketamine|mesh-list
6209624|NCT02150759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5638138|NCT03742349|Spartalizumab|spartalizumab|mesh-list
5638139|NCT03742349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5638140|NCT03742349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5638141|NCT03742349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5764150|NCT02953210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5764151|NCT02953210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5764152|NCT02953210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5764153|NCT02953210|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5764154|NCT02953210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5764155|NCT02953210|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5764156|NCT02953210|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5764157|NCT02953210|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5764158|NCT02953210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5764159|NCT02953210|Sympatholytics|sympatholytics|mesh-ancestor
5764160|NCT02953210|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5764161|NCT02953210|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5764162|NCT02953210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5764163|NCT02953210|Adrenergic Agents|adrenergic agents|mesh-ancestor
5764164|NCT02953210|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5764165|NCT02953210|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5764166|NCT02953210|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6490382|NCT00598169|Dexamethasone|dexamethasone|mesh-list
6490383|NCT00598169|Rituximab|rituximab|mesh-list
6490384|NCT00598169|Carboplatin|carboplatin|mesh-list
5764167|NCT02953210|Histamine Antagonists|histamine antagonists|mesh-ancestor
5764168|NCT02953210|Histamine Agents|histamine agents|mesh-ancestor
5764169|NCT02953106|Fluticasone|fluticasone|mesh-list
5764170|NCT02953106|Azelastine|azelastine|mesh-list
5764171|NCT02953106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5764172|NCT02953106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5764173|NCT02953106|Autonomic Agents|autonomic agents|mesh-ancestor
5764174|NCT02953106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5764175|NCT02953106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5764176|NCT02953106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5764177|NCT02953106|Respiratory System Agents|respiratory system agents|mesh-ancestor
5764178|NCT02953106|Dermatologic Agents|dermatologic agents|mesh-ancestor
5764179|NCT02953106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5764180|NCT02953106|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
5764181|NCT02953106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5764182|NCT02953106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764183|NCT02953106|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5764184|NCT02953106|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6209625|NCT02150759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6490385|NCT00598169|Etoposide|etoposide|mesh-list
5638142|NCT03742102|Paclitaxel|paclitaxel|mesh-list
5638143|NCT03742102|Trastuzumab|trastuzumab|mesh-list
5764185|NCT02953106|Histamine Antagonists|histamine antagonists|mesh-ancestor
5764186|NCT02953106|Histamine Agents|histamine agents|mesh-ancestor
5764187|NCT02953106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5764188|NCT02952989|Pembrolizumab|pembrolizumab|mesh-list
5764189|NCT02952989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5638144|NCT03742102|Durvalumab|durvalumab|mesh-list
5638145|NCT03742102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5638146|NCT03742102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5638147|NCT03742102|Tubulin Modulators|tubulin modulators|mesh-ancestor
5638148|NCT03742102|Antimitotic Agents|antimitotic agents|mesh-ancestor
5638149|NCT03742102|Mitosis Modulators|mitosis modulators|mesh-ancestor
5638150|NCT03742102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5638151|NCT03742102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5638152|NCT03737136|Bortezomib|bortezomib|mesh-list
5764190|NCT02952989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5764191|NCT02953041|Glycopyrrolate|glycopyrrolate|mesh-list
5764192|NCT02953041|Bromides|bromides|mesh-list
5764193|NCT02953041|Anticonvulsants|anticonvulsants|mesh-ancestor
5764194|NCT02953041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5764195|NCT02953041|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5764196|NCT02953041|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5764197|NCT02953041|Cholinergic Agents|cholinergic agents|mesh-ancestor
5764198|NCT02953041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5764199|NCT02953041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764200|NCT02953041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5764201|NCT02953015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5764202|NCT02953015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5764203|NCT02953015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5764204|NCT02953015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5764205|NCT02953015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5764206|NCT02953015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5764207|NCT02953015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5764208|NCT02953015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764209|NCT02953015|Cholinergic Agents|cholinergic agents|mesh-ancestor
5764210|NCT02953015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5764211|NCT02953145|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
5764212|NCT02953145|Hemostatics|hemostatics|mesh-ancestor
5764213|NCT02953145|Coagulants|coagulants|mesh-ancestor
5764214|NCT02953184|Vitamins|vitamins|mesh-list
5764215|NCT02953184|Vitamin B Complex|vitamin b complex|mesh-list
5764216|NCT02953184|Cyclophosphamide|cyclophosphamide|mesh-list
5764217|NCT02953184|Docetaxel|docetaxel|mesh-list
5764218|NCT02953184|Doxorubicin|doxorubicin|mesh-list
5764219|NCT02953184|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5764220|NCT02953184|Dexrazoxane|dexrazoxane|mesh-list
5764221|NCT02953184|Razoxane|razoxane|mesh-list
5764222|NCT02953184|Pirarubicin|pirarubicin|mesh-list
5764223|NCT02953184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5764224|NCT02953184|Immunologic Factors|immunologic factors|mesh-ancestor
5764225|NCT02953184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5764226|NCT02953184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5764227|NCT02953184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5764228|NCT02953184|Alkylating Agents|alkylating agents|mesh-ancestor
5764229|NCT02953184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764230|NCT02953184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5764231|NCT02953184|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5764232|NCT02953184|Micronutrients|micronutrients|mesh-ancestor
5764233|NCT02953184|Tubulin Modulators|tubulin modulators|mesh-ancestor
5764234|NCT02953184|Antimitotic Agents|antimitotic agents|mesh-ancestor
5638153|NCT03737136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5764235|NCT02953184|Mitosis Modulators|mitosis modulators|mesh-ancestor
5764236|NCT02953184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5764237|NCT02953184|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5764238|NCT02953184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5764239|NCT02953184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5764240|NCT02953184|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5764241|NCT02953184|Protective Agents|protective agents|mesh-ancestor
5895715|NCT05035186|Levofloxacin|levofloxacin|mesh-list
5895716|NCT05035186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5895717|NCT05035186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5895718|NCT05035186|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5895719|NCT05035186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5638154|NCT03736265|Carvedilol|carvedilol|mesh-list
5638155|NCT03736265|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5895720|NCT05035186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5638156|NCT03736265|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5638157|NCT03736265|Adrenergic Agents|adrenergic agents|mesh-ancestor
5638158|NCT03736265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5638159|NCT03736265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5638160|NCT03736265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5638161|NCT03736265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5638162|NCT03736265|Antioxidants|antioxidants|mesh-ancestor
5638163|NCT03736265|Protective Agents|protective agents|mesh-ancestor
5638164|NCT03736265|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5638165|NCT03736265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5638166|NCT03736265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5638167|NCT03736265|Vasodilator Agents|vasodilator agents|mesh-ancestor
5638168|NCT03736265|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5764242|NCT02952963|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
5764243|NCT02952963|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
5764244|NCT02952963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5764245|NCT02952963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5764246|NCT02952963|Antimetabolites|antimetabolites|mesh-ancestor
5764247|NCT02952963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764248|NCT02952963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5764249|NCT02952963|Cathartics|cathartics|mesh-ancestor
5764250|NCT02952963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5764251|NCT02952573|Dexamethasone|dexamethasone|mesh-list
5764252|NCT02952573|Dexamethasone acetate|dexamethasone acetate|mesh-list
5764253|NCT02952573|BB 1101|bb 1101|mesh-list
5764254|NCT02952573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5764255|NCT02952573|Antiemetics|antiemetics|mesh-ancestor
5764256|NCT02952573|Autonomic Agents|autonomic agents|mesh-ancestor
5638169|NCT03736265|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5764257|NCT02952573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5764258|NCT02952573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209626|NCT02150759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209627|NCT02150759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6209628|NCT02150759|Analgesics|analgesics|mesh-ancestor
6209629|NCT02150759|Sensory System Agents|sensory system agents|mesh-ancestor
6209630|NCT02150759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5764259|NCT02952573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5764260|NCT02952573|Glucocorticoids|glucocorticoids|mesh-ancestor
5764261|NCT02952573|Hormones|hormones|mesh-ancestor
5764262|NCT02952573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5764263|NCT02952573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5764264|NCT02952573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5764265|NCT02952573|Protease Inhibitors|protease inhibitors|mesh-ancestor
5764266|NCT02952573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5764267|NCT02952573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764268|NCT02952599|Edoxaban|edoxaban|mesh-list
5764269|NCT02952599|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5764270|NCT02952599|Antithrombins|antithrombins|mesh-ancestor
5764271|NCT02952599|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5764272|NCT02952599|Protease Inhibitors|protease inhibitors|mesh-ancestor
5764273|NCT02952599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5764274|NCT02952599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764275|NCT02952599|Anticoagulants|anticoagulants|mesh-ancestor
5764276|NCT02952807|Misoprostol|misoprostol|mesh-list
5764277|NCT02952807|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5764278|NCT02952807|Abortifacient Agents|abortifacient agents|mesh-ancestor
5764279|NCT02952807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5764280|NCT02952807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5764281|NCT02952807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5764282|NCT02952807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5764283|NCT02952807|Oxytocics|oxytocics|mesh-ancestor
5764284|NCT02952235|Sunscreening Agents|sunscreening agents|mesh-list
6490386|NCT00598169|Bortezomib|bortezomib|mesh-list
5638181|NCT03728881|Vaccines|vaccines|mesh-list
5638182|NCT03728881|Immunologic Factors|immunologic factors|mesh-ancestor
5638183|NCT03728881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5638184|NCT03705507|Dexamethasone|dexamethasone|mesh-list
5764285|NCT02952235|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5764286|NCT02952235|Protective Agents|protective agents|mesh-ancestor
5764287|NCT02952235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5638185|NCT03705507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5638186|NCT03705507|Antiemetics|antiemetics|mesh-ancestor
5638187|NCT03705507|Autonomic Agents|autonomic agents|mesh-ancestor
5638188|NCT03705507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5638189|NCT03705507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5638190|NCT03705507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5638191|NCT03705507|Glucocorticoids|glucocorticoids|mesh-ancestor
5638192|NCT03705507|Hormones|hormones|mesh-ancestor
5638193|NCT03705507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5638194|NCT03705507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5638195|NCT03705507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5638196|NCT03677596|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
5638197|NCT03677596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5638198|NCT03677596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5638199|NCT03677596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5638200|NCT03667716|Nivolumab|nivolumab|mesh-list
5638201|NCT03667716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5638202|NCT03667716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5638203|NCT03667716|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6490387|NCT00598169|Ifosfamide|ifosfamide|mesh-list
6490388|NCT00598169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6490389|NCT00598169|Antiemetics|antiemetics|mesh-ancestor
6490390|NCT00598169|Autonomic Agents|autonomic agents|mesh-ancestor
6490391|NCT00598169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6490392|NCT00598169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490393|NCT00598169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6490394|NCT00598169|Glucocorticoids|glucocorticoids|mesh-ancestor
6490395|NCT00598169|Hormones|hormones|mesh-ancestor
6490396|NCT00598169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6490397|NCT00598169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6490398|NCT00598169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6490399|NCT00598169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6490400|NCT00598169|Immunologic Factors|immunologic factors|mesh-ancestor
6490401|NCT00598169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6490402|NCT00598169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6490403|NCT00598169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6490404|NCT00598169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6490405|NCT00598169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6490406|NCT00598169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490407|NCT00598169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6490408|NCT00598169|Alkylating Agents|alkylating agents|mesh-ancestor
6490409|NCT00598195|Ketamine|ketamine|mesh-list
6490410|NCT00598195|Analgesics|analgesics|mesh-ancestor
5638204|NCT03667716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5638205|NCT03665129|Avdoralimab|avdoralimab|mesh-list
5638206|NCT03665129|Durvalumab|durvalumab|mesh-list
5638207|NCT03665129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5638208|NCT03665129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5638209|NCT03665129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5638210|NCT03665129|Antiviral Agents|antiviral agents|mesh-ancestor
5638211|NCT03665129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6209631|NCT02150759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6209632|NCT02150759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6209633|NCT02150759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6209634|NCT02150759|Adrenergic Agents|adrenergic agents|mesh-ancestor
6209635|NCT02150759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6209636|NCT02150759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209637|NCT02150759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6209638|NCT02150759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6209639|NCT02150759|Anesthetics, General|anesthetics, general|mesh-ancestor
6209640|NCT02150759|Anesthetics|anesthetics|mesh-ancestor
6209641|NCT02150759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6209642|NCT02150759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6209643|NCT02150759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6209644|NCT02150759|Narcotics|narcotics|mesh-ancestor
6209645|NCT02150759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6209646|NCT02150954|Oxytocin|oxytocin|mesh-list
6209647|NCT02150954|Oxytocics|oxytocics|mesh-ancestor
6209648|NCT02150954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6209649|NCT02150954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5638232|NCT03648021|Acetaminophen|acetaminophen|mesh-list
5638233|NCT03648021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5638234|NCT03648021|Analgesics|analgesics|mesh-ancestor
5638235|NCT03648021|Sensory System Agents|sensory system agents|mesh-ancestor
5764288|NCT02952235|Dermatologic Agents|dermatologic agents|mesh-ancestor
5638236|NCT03648021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5638237|NCT03648021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5638238|NCT03648021|Antipyretics|antipyretics|mesh-ancestor
5638239|NCT03646604|Upadacitinib|upadacitinib|mesh-list
5638240|NCT03646604|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
5638241|NCT03646604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5638242|NCT03646604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6673366|NCT01562405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6673367|NCT01562405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6673368|NCT01562405|Growth Substances|growth substances|mesh-ancestor
6673369|NCT01562405|Growth Inhibitors|growth inhibitors|mesh-ancestor
6673370|NCT01562483|Dronabinol|dronabinol|mesh-list
6673371|NCT01562483|Hallucinogens|hallucinogens|mesh-ancestor
6673372|NCT01562483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673373|NCT01562483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6673374|NCT01562483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6673375|NCT01562483|Analgesics|analgesics|mesh-ancestor
6673376|NCT01562483|Sensory System Agents|sensory system agents|mesh-ancestor
6673377|NCT01562483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6673378|NCT01562483|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6673379|NCT01562483|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6673380|NCT01562483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6673381|NCT01562483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673382|NCT01562483|Hormones|hormones|mesh-ancestor
6673383|NCT01562483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5638243|NCT03646604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5638244|NCT03646604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5638245|NCT03641755|Olaparib|olaparib|mesh-list
5638246|NCT03641755|Sapacitabine|sapacitabine|mesh-list
5638247|NCT03641755|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5638248|NCT03641755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5638249|NCT03641755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5638250|NCT03641755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5638251|NCT03617731|Dexamethasone|dexamethasone|mesh-list
5638252|NCT03617731|Lenalidomide|lenalidomide|mesh-list
5638253|NCT03617731|Bortezomib|bortezomib|mesh-list
5638254|NCT03617731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5638255|NCT03617731|Antiemetics|antiemetics|mesh-ancestor
5638256|NCT03617731|Autonomic Agents|autonomic agents|mesh-ancestor
5638257|NCT03617731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5638258|NCT03617731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673384|NCT01562561|Repaglinide|repaglinide|mesh-list
5764289|NCT02952469|Edetic Acid|edetic acid|mesh-list
5764290|NCT02952469|Chelating Agents|chelating agents|mesh-ancestor
5764291|NCT02952469|Sequestering Agents|sequestering agents|mesh-ancestor
5764292|NCT02952469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764293|NCT02952469|Anticoagulants|anticoagulants|mesh-ancestor
5638259|NCT03617731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5638260|NCT03617731|Glucocorticoids|glucocorticoids|mesh-ancestor
5638261|NCT03617731|Hormones|hormones|mesh-ancestor
5638262|NCT03617731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5638263|NCT03617731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5638264|NCT03617731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5638265|NCT03617731|Immunologic Factors|immunologic factors|mesh-ancestor
5764294|NCT02952469|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5764295|NCT02952092|Darbepoetin alfa|darbepoetin alfa|mesh-list
5764296|NCT02952092|Hematinics|hematinics|mesh-ancestor
5764297|NCT02952157|Lidocaine|lidocaine|mesh-list
5764298|NCT02952157|Anesthetics, Local|anesthetics, local|mesh-ancestor
5764299|NCT02952157|Anesthetics|anesthetics|mesh-ancestor
5764300|NCT02952157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5764301|NCT02952157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5764302|NCT02952157|Sensory System Agents|sensory system agents|mesh-ancestor
5764303|NCT02952157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5764304|NCT02952157|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5764305|NCT02952157|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5764306|NCT02952157|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5764307|NCT02952157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5764308|NCT02952157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209650|NCT02151058|Listerine|listerine|mesh-list
5638266|NCT03617731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5638267|NCT03617731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5638268|NCT03617731|Growth Substances|growth substances|mesh-ancestor
5764309|NCT02951754|Methylphenidate|methylphenidate|mesh-list
5764310|NCT02951754|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5764311|NCT02951754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5764312|NCT02951754|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5764313|NCT02951754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5764314|NCT02951754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5764315|NCT02951754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764316|NCT02951754|Dopamine Agents|dopamine agents|mesh-ancestor
5764317|NCT02951754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5764318|NCT02951728|Prednisone|prednisone|mesh-list
5764319|NCT02951728|Cyclophosphamide|cyclophosphamide|mesh-list
5764320|NCT02951728|Rituximab|rituximab|mesh-list
5764321|NCT02951728|Doxorubicin|doxorubicin|mesh-list
5764322|NCT02951728|Vincristine|vincristine|mesh-list
5764323|NCT02951728|Decitabine|decitabine|mesh-list
5764324|NCT02951728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5764325|NCT02951728|Immunologic Factors|immunologic factors|mesh-ancestor
5764326|NCT02951728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5764327|NCT02951728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5764328|NCT02951728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5764329|NCT02951728|Alkylating Agents|alkylating agents|mesh-ancestor
5764330|NCT02951728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764331|NCT02951728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5764332|NCT02951728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5764333|NCT02951728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5764334|NCT02951728|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5638269|NCT03617731|Growth Inhibitors|growth inhibitors|mesh-ancestor
5638270|NCT03614949|Atezolizumab|atezolizumab|mesh-list
5638271|NCT03614949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5638272|NCT03600883|Midazolam|midazolam|mesh-list
5638273|NCT03600883|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5638274|NCT03600883|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5638275|NCT03600883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5638276|NCT03600883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5638277|NCT03600883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5638278|NCT03600883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5638279|NCT03600883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5638280|NCT03600883|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5638281|NCT03600883|Anesthetics, General|anesthetics, general|mesh-ancestor
5638282|NCT03600883|Anesthetics|anesthetics|mesh-ancestor
5638283|NCT03600883|GABA Modulators|gaba modulators|mesh-ancestor
5638284|NCT03600883|GABA Agents|gaba agents|mesh-ancestor
5764335|NCT02951728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5764336|NCT02951728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5764337|NCT02951728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5764338|NCT02951728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5764339|NCT02951728|Glucocorticoids|glucocorticoids|mesh-ancestor
5764340|NCT02951728|Hormones|hormones|mesh-ancestor
5764341|NCT02951728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5764342|NCT02951728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5764343|NCT02951728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5764344|NCT02951728|Tubulin Modulators|tubulin modulators|mesh-ancestor
5764345|NCT02951728|Antimitotic Agents|antimitotic agents|mesh-ancestor
5764346|NCT02951728|Mitosis Modulators|mitosis modulators|mesh-ancestor
5764347|NCT02951728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5764348|NCT02951728|Antimetabolites|antimetabolites|mesh-ancestor
5764349|NCT02951975|Dexamethasone|dexamethasone|mesh-list
5764350|NCT02951975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5764351|NCT02951975|Antiemetics|antiemetics|mesh-ancestor
5764352|NCT02951975|Autonomic Agents|autonomic agents|mesh-ancestor
5764353|NCT02951975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5764354|NCT02951975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5764355|NCT02951975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5764356|NCT02951975|Glucocorticoids|glucocorticoids|mesh-ancestor
5638285|NCT03600883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5638286|NCT03600883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5638287|NCT03596164|Teduglutide|teduglutide|mesh-list
5638288|NCT03596164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5638289|NCT03596164|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5638290|NCT03596164|Protective Agents|protective agents|mesh-ancestor
5638291|NCT03596164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5638292|NCT03590821|Aspirin|aspirin|mesh-list
5638293|NCT03590821|Celecoxib|celecoxib|mesh-list
5638294|NCT03590821|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5638295|NCT03590821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5638296|NCT03590821|Analgesics|analgesics|mesh-ancestor
5638297|NCT03590821|Sensory System Agents|sensory system agents|mesh-ancestor
5764357|NCT02951975|Hormones|hormones|mesh-ancestor
5907869|NCT05155007|Dermatologic Agents|dermatologic agents|mesh-ancestor
5638298|NCT03590821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5638299|NCT03590821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5638300|NCT03590821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5638301|NCT03590821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5638302|NCT03590821|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5638303|NCT03590821|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5638304|NCT03590821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5638305|NCT03590821|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5638306|NCT03590821|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5638307|NCT03590821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5638308|NCT03590821|Antipyretics|antipyretics|mesh-ancestor
5638309|NCT03590821|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5638310|NCT03580044|Aztreonam|aztreonam|mesh-list
5638311|NCT03580044|Avibactam|avibactam|mesh-list
5638312|NCT03580044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5638313|NCT03580044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5638314|NCT03580044|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5638315|NCT03580044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5638316|NCT03580044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5638317|NCT03576612|Valacyclovir|valacyclovir|mesh-list
5638318|NCT03576612|Acyclovir|acyclovir|mesh-list
5764358|NCT02951975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5764359|NCT02951975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5764360|NCT02951975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5764361|NCT02951806|Fentanyl|fentanyl|mesh-list
5764362|NCT02951806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5764363|NCT02951806|Narcotics|narcotics|mesh-ancestor
5764364|NCT02951806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5764365|NCT02951806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5764366|NCT02951806|Analgesics|analgesics|mesh-ancestor
5764367|NCT02951806|Sensory System Agents|sensory system agents|mesh-ancestor
5764368|NCT02951806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5764369|NCT02951806|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5764370|NCT02951806|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5764371|NCT02951806|Anesthetics, General|anesthetics, general|mesh-ancestor
5638319|NCT03576612|Nivolumab|nivolumab|mesh-list
5638320|NCT03576612|Temozolomide|temozolomide|mesh-list
5638321|NCT03576612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5638322|NCT03576612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5764372|NCT02951806|Anesthetics|anesthetics|mesh-ancestor
5764373|NCT02951962|Amlodipine|amlodipine|mesh-list
5764374|NCT02951962|Telmisartan|telmisartan|mesh-list
5764375|NCT02951962|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
5764376|NCT02951962|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5764377|NCT02951962|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5764378|NCT02951962|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5764379|NCT02951962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5764380|NCT02951962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764381|NCT02951962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5764382|NCT02951962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5764383|NCT02951962|Vasodilator Agents|vasodilator agents|mesh-ancestor
5764384|NCT02951962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5764385|NCT02951962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5764386|NCT02951962|Antimetabolites|antimetabolites|mesh-ancestor
5764387|NCT02951962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5764388|NCT02951962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5764389|NCT02951962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5764390|NCT02951962|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5764391|NCT02951962|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5764392|NCT02951793|Psychotropic Drugs|psychotropic drugs|mesh-list
5764393|NCT02951897|Pemetrexed|pemetrexed|mesh-list
5764394|NCT02951897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5764395|NCT02951897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5764396|NCT02951897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764397|NCT02951897|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5764398|NCT02951897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5764399|NCT02951637|Carboplatin|carboplatin|mesh-list
5764400|NCT02951637|Pemetrexed|pemetrexed|mesh-list
5764401|NCT02951637|Gefitinib|gefitinib|mesh-list
5764402|NCT02951637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5764403|NCT02951637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5764404|NCT02951637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764405|NCT02951637|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6490411|NCT00598195|Sensory System Agents|sensory system agents|mesh-ancestor
6490412|NCT00598195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6490413|NCT00598195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490414|NCT00598195|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6490415|NCT00598195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6490416|NCT00598195|Anesthetics, General|anesthetics, general|mesh-ancestor
5764406|NCT02951637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5764407|NCT02951637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5764408|NCT02951234|Aspirin|aspirin|mesh-list
5764409|NCT02951234|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5764410|NCT02951234|gamma-Globulins|gamma-globulins|mesh-list
5764411|NCT02951234|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5764412|NCT02951234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5764413|NCT02951234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5764414|NCT02951234|Analgesics|analgesics|mesh-ancestor
5764415|NCT02951234|Sensory System Agents|sensory system agents|mesh-ancestor
5764416|NCT02951234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5764417|NCT02951234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5764418|NCT02951234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5764419|NCT02951234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5764420|NCT02951234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6209651|NCT02151058|Sodium Fluoride|sodium fluoride|mesh-list
6490417|NCT00598195|Anesthetics|anesthetics|mesh-ancestor
5638323|NCT03576612|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5638324|NCT03576612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5638325|NCT03576612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5638326|NCT03576612|Alkylating Agents|alkylating agents|mesh-ancestor
5638327|NCT03576612|Antiviral Agents|antiviral agents|mesh-ancestor
5638328|NCT03576612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6209652|NCT02151058|Cariostatic Agents|cariostatic agents|mesh-ancestor
6209653|NCT02151058|Protective Agents|protective agents|mesh-ancestor
5638332|NCT03557307|Benralizumab|benralizumab|mesh-list
5638333|NCT03557307|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5638334|NCT03557307|Respiratory System Agents|respiratory system agents|mesh-ancestor
5638335|NCT03543189|Nivolumab|nivolumab|mesh-list
5638336|NCT03543189|Androgens|androgens|mesh-list
5638337|NCT03543189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5638338|NCT03543189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5638339|NCT03543189|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5638340|NCT03543189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5638341|NCT03543189|Hormones|hormones|mesh-ancestor
5638342|NCT03543189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5638343|NCT03543189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5638344|NCT03505710|Trastuzumab|trastuzumab|mesh-list
5638345|NCT03505710|Camptothecin|camptothecin|mesh-list
5638346|NCT03505710|Immunoconjugates|immunoconjugates|mesh-list
5638347|NCT03505710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5638348|NCT03505710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5638349|NCT03505710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5764421|NCT02951234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5764422|NCT02951234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764423|NCT02951234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5764424|NCT02951234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5764425|NCT02951234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5764426|NCT02951234|Antipyretics|antipyretics|mesh-ancestor
5764427|NCT02951234|Immunologic Factors|immunologic factors|mesh-ancestor
5895721|NCT05035186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5895722|NCT05035186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5895723|NCT05035186|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5895724|NCT05035186|Renal Agents|renal agents|mesh-ancestor
5895725|NCT05035186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5895726|NCT05035186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5895727|NCT05035186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5895728|NCT05035186|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5895729|NCT04998617|Curcumin|curcumin|mesh-list
5895730|NCT04998617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5895731|NCT04998617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5895732|NCT04998617|Analgesics|analgesics|mesh-ancestor
5895733|NCT04998617|Sensory System Agents|sensory system agents|mesh-ancestor
5895734|NCT04998617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5895735|NCT04998617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895736|NCT04998617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5895737|NCT04998617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5895738|NCT04998617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5895739|NCT04998617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5895740|NCT04998617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895741|NCT04994808|Fludarabine|fludarabine|mesh-list
5895742|NCT04994808|Clofarabine|clofarabine|mesh-list
5895743|NCT04994808|Treosulfan|treosulfan|mesh-list
5895744|NCT04994808|Busulfan|busulfan|mesh-list
5895745|NCT04994808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5895746|NCT04994808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5895747|NCT04994808|Antimetabolites|antimetabolites|mesh-ancestor
5895748|NCT04994808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895749|NCT04994808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5895750|NCT04994808|Immunologic Factors|immunologic factors|mesh-ancestor
5895751|NCT04994808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895752|NCT04994808|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5895753|NCT04994808|Alkylating Agents|alkylating agents|mesh-ancestor
5895754|NCT04994808|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5895755|NCT04987099|Choline|choline|mesh-list
5895756|NCT04987099|Lipotropic Agents|lipotropic agents|mesh-ancestor
5895757|NCT04987099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6209654|NCT02151058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5638350|NCT03505710|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5638351|NCT03505710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5638352|NCT03505710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5638353|NCT03505710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5638354|NCT03505710|Immunologic Factors|immunologic factors|mesh-ancestor
5638355|NCT03505710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5638356|NCT03493932|Nivolumab|nivolumab|mesh-list
5638357|NCT03493932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5638358|NCT03493932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5638359|NCT03493932|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5638360|NCT03493932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5638361|NCT03482479|Naltrexone|naltrexone|mesh-list
5764428|NCT02951260|Metformin|metformin|mesh-list
5764429|NCT02951260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5764430|NCT02951260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5764431|NCT02951299|Pentoxifylline|pentoxifylline|mesh-list
5764432|NCT02951299|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5764433|NCT02951299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5764434|NCT02951299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764435|NCT02951299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5764436|NCT02951299|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5764437|NCT02951299|Protective Agents|protective agents|mesh-ancestor
5764438|NCT02951299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5764439|NCT02951299|Vasodilator Agents|vasodilator agents|mesh-ancestor
5764440|NCT02951299|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5764441|NCT02951299|Antioxidants|antioxidants|mesh-ancestor
5764442|NCT02951377|Dexamethasone|dexamethasone|mesh-list
5764443|NCT02951377|Lidocaine|lidocaine|mesh-list
5764444|NCT02951377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5764445|NCT02951377|Antiemetics|antiemetics|mesh-ancestor
5764446|NCT02951377|Autonomic Agents|autonomic agents|mesh-ancestor
5764447|NCT02951377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5764448|NCT02951377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5764449|NCT02951377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5764450|NCT02951377|Glucocorticoids|glucocorticoids|mesh-ancestor
5764451|NCT02951377|Hormones|hormones|mesh-ancestor
5764452|NCT02951377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5764453|NCT02951377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5764454|NCT02951377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5764455|NCT02951377|Anesthetics, Local|anesthetics, local|mesh-ancestor
5764456|NCT02951377|Anesthetics|anesthetics|mesh-ancestor
5638362|NCT03482479|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5638363|NCT03482479|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5638364|NCT03482479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5638365|NCT03482479|Sensory System Agents|sensory system agents|mesh-ancestor
5638366|NCT03482479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6209655|NCT02151058|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6209656|NCT02151058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5638369|NCT03468985|Nivolumab|nivolumab|mesh-list
5638370|NCT03468985|Ipilimumab|ipilimumab|mesh-list
5764457|NCT02951377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6490418|NCT00598195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6490419|NCT00598195|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6490420|NCT00598195|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6490421|NCT00598195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6490422|NCT00598195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5638371|NCT03468985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5638372|NCT03468985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5638373|NCT03468985|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5638374|NCT03468985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209657|NCT02151149|Paclitaxel|paclitaxel|mesh-list
6209658|NCT02151149|Carboplatin|carboplatin|mesh-list
6209659|NCT02151149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6209660|NCT02151149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6209661|NCT02151149|Tubulin Modulators|tubulin modulators|mesh-ancestor
6209662|NCT02151149|Antimitotic Agents|antimitotic agents|mesh-ancestor
6209663|NCT02151149|Mitosis Modulators|mitosis modulators|mesh-ancestor
6209664|NCT02151149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5638383|NCT03455829|Osimertinib|osimertinib|mesh-list
5638384|NCT03455829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5638385|NCT03455829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5638386|NCT03455829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5638387|NCT03455829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209665|NCT02151253|Modafinil|modafinil|mesh-list
6209666|NCT02151253|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6209667|NCT02151253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490423|NCT00598234|Celecoxib|celecoxib|mesh-list
5764458|NCT02951377|Sensory System Agents|sensory system agents|mesh-ancestor
5764459|NCT02951377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5764460|NCT02951377|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5764461|NCT02951377|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5764462|NCT02951377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5895758|NCT04987099|Antimetabolites|antimetabolites|mesh-ancestor
5764463|NCT02951377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764464|NCT02950948|Progesterone|progesterone|mesh-list
5764465|NCT02950948|Progestins|progestins|mesh-ancestor
5764466|NCT02950948|Hormones|hormones|mesh-ancestor
5764467|NCT02950948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5764468|NCT02950948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5764469|NCT02951039|Edoxaban|edoxaban|mesh-list
5764470|NCT02951039|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5764471|NCT02951039|Antithrombins|antithrombins|mesh-ancestor
5764472|NCT02951039|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5764473|NCT02951039|Protease Inhibitors|protease inhibitors|mesh-ancestor
5764474|NCT02951039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5764475|NCT02951039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764476|NCT02951039|Anticoagulants|anticoagulants|mesh-ancestor
5764477|NCT02951117|Dexamethasone|dexamethasone|mesh-list
5764478|NCT02951117|Venetoclax|venetoclax|mesh-list
5764479|NCT02951117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5764480|NCT02951117|Antiemetics|antiemetics|mesh-ancestor
5764481|NCT02951117|Autonomic Agents|autonomic agents|mesh-ancestor
5764482|NCT02951117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5764483|NCT02951117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5764484|NCT02951117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5764485|NCT02951117|Glucocorticoids|glucocorticoids|mesh-ancestor
5764486|NCT02951117|Hormones|hormones|mesh-ancestor
5764487|NCT02951117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5764488|NCT02951117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5764489|NCT02951117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5764490|NCT02950935|Progesterone|progesterone|mesh-list
5764491|NCT02950935|Progestins|progestins|mesh-ancestor
5764492|NCT02950935|Hormones|hormones|mesh-ancestor
5764493|NCT02950935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5764494|NCT02950935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5764495|NCT02950870|Ritonavir|ritonavir|mesh-list
5764496|NCT02950870|Ribavirin|ribavirin|mesh-list
5764497|NCT02950870|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5764498|NCT02950870|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5764499|NCT02950870|Protease Inhibitors|protease inhibitors|mesh-ancestor
5764500|NCT02950870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5764501|NCT02950870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764502|NCT02950870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5764503|NCT02950870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5764504|NCT02950870|Antiviral Agents|antiviral agents|mesh-ancestor
5764505|NCT02950870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5764506|NCT02950870|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5764507|NCT02950870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5764508|NCT02950870|Antimetabolites|antimetabolites|mesh-ancestor
5764509|NCT02950766|Ipilimumab|ipilimumab|mesh-list
5764510|NCT02950766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5764511|NCT02950766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5764512|NCT02950766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5764513|NCT02950766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764514|NCT02950623|Titanium dioxide|titanium dioxide|mesh-list
5764515|NCT02950623|Sunscreening Agents|sunscreening agents|mesh-ancestor
5764516|NCT02950623|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5764517|NCT02950623|Protective Agents|protective agents|mesh-ancestor
5764518|NCT02950623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5764519|NCT02950623|Dermatologic Agents|dermatologic agents|mesh-ancestor
5764520|NCT02950623|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5764521|NCT02950584|Titanium dioxide|titanium dioxide|mesh-list
5764522|NCT02950584|Sunscreening Agents|sunscreening agents|mesh-ancestor
6209668|NCT02151253|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6209669|NCT02151253|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6209670|NCT02151253|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6209671|NCT02151253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209672|NCT02151448|Interferons|interferons|mesh-list
6209673|NCT02151448|Interferon-alpha|interferon-alpha|mesh-list
6209674|NCT02151448|Interferon alpha-2|interferon alpha-2|mesh-list
6209675|NCT02151448|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
6209676|NCT02151448|Celecoxib|celecoxib|mesh-list
6209677|NCT02151448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5764523|NCT02950584|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5764524|NCT02950584|Protective Agents|protective agents|mesh-ancestor
5764525|NCT02950584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5764526|NCT02950584|Dermatologic Agents|dermatologic agents|mesh-ancestor
5764527|NCT02950584|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5764528|NCT02950441|Niacinamide|niacinamide|mesh-list
5764529|NCT02950441|Niacin|niacin|mesh-list
5764530|NCT02950441|Nicotinic Acids|nicotinic acids|mesh-list
5764531|NCT02950441|Vitamin B Complex|vitamin b complex|mesh-ancestor
5764532|NCT02950441|Vitamins|vitamins|mesh-ancestor
5764533|NCT02950441|Micronutrients|micronutrients|mesh-ancestor
5764534|NCT02950441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5764535|NCT02950441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5764536|NCT02950441|Antimetabolites|antimetabolites|mesh-ancestor
5764537|NCT02950441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764538|NCT02950441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5764539|NCT02950441|Vasodilator Agents|vasodilator agents|mesh-ancestor
5764540|NCT02950246|Chlorhexidine|chlorhexidine|mesh-list
5764541|NCT02950246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5764542|NCT02950246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5764543|NCT02950246|Disinfectants|disinfectants|mesh-ancestor
5764544|NCT02950220|Pembrolizumab|pembrolizumab|mesh-list
5764545|NCT02950220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5764546|NCT02950220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5764547|NCT02950168|Edoxaban|edoxaban|mesh-list
5764548|NCT02950168|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5764549|NCT02950168|Antithrombins|antithrombins|mesh-ancestor
5764550|NCT02950168|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5764551|NCT02950168|Protease Inhibitors|protease inhibitors|mesh-ancestor
5764552|NCT02950168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5764553|NCT02950168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764554|NCT02950168|Anticoagulants|anticoagulants|mesh-ancestor
5764555|NCT02950233|N-Methylaspartate|n-methylaspartate|mesh-list
5764556|NCT02950233|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
5764557|NCT02950233|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5764558|NCT02950233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5764559|NCT02950233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764560|NCT02950233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5764561|NCT02950155|Rituximab|rituximab|mesh-list
5764562|NCT02950155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5764563|NCT02950155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5764564|NCT02950155|Immunologic Factors|immunologic factors|mesh-ancestor
5764565|NCT02950155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5638401|NCT03446157|Cetuximab|cetuximab|mesh-list
5638402|NCT03446157|Palbociclib|palbociclib|mesh-list
5638403|NCT03446157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5638404|NCT03446157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5638405|NCT03446157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5638406|NCT03446157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5638407|NCT03446157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5638408|NCT03436745|Zolpidem|zolpidem|mesh-list
5764566|NCT02950155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5764567|NCT02950038|Nivolumab|nivolumab|mesh-list
5764568|NCT02950038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5764569|NCT02950038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5764570|NCT02950038|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5764571|NCT02950038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764572|NCT02950051|Cyclophosphamide|cyclophosphamide|mesh-list
5764573|NCT02950051|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5764574|NCT02950051|Rituximab|rituximab|mesh-list
5764575|NCT02950051|Fludarabine|fludarabine|mesh-list
5764576|NCT02950051|Venetoclax|venetoclax|mesh-list
6673385|NCT01562561|Isophane Insulin, Human|isophane insulin, human|mesh-list
6673386|NCT01562561|Insulin, Isophane|insulin, isophane|mesh-list
6673387|NCT01562561|Isophane insulin, beef|isophane insulin, beef|mesh-list
5764577|NCT02950051|Obinutuzumab|obinutuzumab|mesh-list
5764578|NCT02950051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5638409|NCT03436745|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5764579|NCT02950051|Immunologic Factors|immunologic factors|mesh-ancestor
5764580|NCT02950051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5764581|NCT02950051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5764582|NCT02950051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5638410|NCT03436745|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5638411|NCT03436745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5638412|NCT03436745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5638413|NCT03436745|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
5638414|NCT03436745|GABA Agonists|gaba agonists|mesh-ancestor
5638415|NCT03436745|GABA Agents|gaba agents|mesh-ancestor
5638416|NCT03436745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5764583|NCT02950051|Alkylating Agents|alkylating agents|mesh-ancestor
5764584|NCT02950051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764585|NCT02950051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5764586|NCT02950051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5764587|NCT02950051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5764588|NCT02949752|Aripiprazole|aripiprazole|mesh-list
5764589|NCT02949752|Antidepressive Agents|antidepressive agents|mesh-ancestor
5638417|NCT03436745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209678|NCT02151448|Antiviral Agents|antiviral agents|mesh-ancestor
6209679|NCT02151448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6209680|NCT02151448|Immunologic Factors|immunologic factors|mesh-ancestor
6209681|NCT02151448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209682|NCT02151448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6209683|NCT02151448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6209684|NCT02151448|Analgesics|analgesics|mesh-ancestor
6209685|NCT02151448|Sensory System Agents|sensory system agents|mesh-ancestor
6209686|NCT02151448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6209687|NCT02151448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5764590|NCT02949752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5764591|NCT02949752|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5764592|NCT02949752|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5764593|NCT02949752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5764594|NCT02949752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5764595|NCT02949752|Dopamine Agonists|dopamine agonists|mesh-ancestor
5764596|NCT02949752|Dopamine Agents|dopamine agents|mesh-ancestor
6209688|NCT02151448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6209689|NCT02151448|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6209690|NCT02151448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6209691|NCT02151448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6209692|NCT02151448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209693|NCT02151461|Metformin|metformin|mesh-list
5638434|NCT03428958|Leucovorin|leucovorin|mesh-list
5638435|NCT03428958|Bevacizumab|bevacizumab|mesh-list
5638436|NCT03428958|Cetuximab|cetuximab|mesh-list
5638437|NCT03428958|Panitumumab|panitumumab|mesh-list
5638438|NCT03428958|Oxaliplatin|oxaliplatin|mesh-list
5638439|NCT03428958|Irinotecan|irinotecan|mesh-list
5638440|NCT03428958|Levoleucovorin|levoleucovorin|mesh-list
5638441|NCT03428958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5638442|NCT03428958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5638443|NCT03428958|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5638444|NCT03428958|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5638445|NCT03428958|Growth Substances|growth substances|mesh-ancestor
5638446|NCT03428958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5638447|NCT03428958|Growth Inhibitors|growth inhibitors|mesh-ancestor
5638448|NCT03428958|Antidotes|antidotes|mesh-ancestor
5764597|NCT02949752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5764598|NCT02949752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764599|NCT02949752|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5764600|NCT02949752|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5764601|NCT02949752|Serotonin Agents|serotonin agents|mesh-ancestor
5764602|NCT02949752|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5764603|NCT02949752|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6209694|NCT02151461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5638449|NCT03428958|Protective Agents|protective agents|mesh-ancestor
5638450|NCT03428958|Vitamin B Complex|vitamin b complex|mesh-ancestor
5638451|NCT03428958|Vitamins|vitamins|mesh-ancestor
5638452|NCT03428958|Micronutrients|micronutrients|mesh-ancestor
5764604|NCT02949752|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5764605|NCT02949752|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5764606|NCT02949895|Etoposide|etoposide|mesh-list
5764607|NCT02949895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5764608|NCT02949895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5764609|NCT02949895|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5638453|NCT03428958|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5638454|NCT03428958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5638455|NCT03428958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5638456|NCT03428958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693736|NCT03399708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693737|NCT03399708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5693738|NCT03399708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5693739|NCT03399708|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5693740|NCT03399708|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5693741|NCT03399708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5693742|NCT03399708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693743|NCT03399669|Gefitinib|gefitinib|mesh-list
5693744|NCT03399669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5693745|NCT03399669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5764610|NCT02949895|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5764611|NCT02949895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5764612|NCT02949895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764613|NCT02949648|Nicotine|nicotine|mesh-list
5764614|NCT02949648|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5764615|NCT02949648|Autonomic Agents|autonomic agents|mesh-ancestor
5764616|NCT02949648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5764617|NCT02949648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5764618|NCT02949648|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5764619|NCT02949648|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5764620|NCT02949648|Cholinergic Agents|cholinergic agents|mesh-ancestor
5764621|NCT02949648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5764622|NCT02949648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764623|NCT02949583|Chlorhexidine|chlorhexidine|mesh-list
6673388|NCT01562561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5693746|NCT03399669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5693747|NCT03399669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693748|NCT03399643|Atezolizumab|atezolizumab|mesh-list
5693749|NCT03399643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5693750|NCT03399617|Micronutrients|micronutrients|mesh-list
5693751|NCT03399617|Trace Elements|trace elements|mesh-list
5693752|NCT03399617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693753|NCT03399604|Treprostinil|treprostinil|mesh-list
5693754|NCT03399604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6673389|NCT01562561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673390|NCT01562626|Flucytosine|flucytosine|mesh-list
6673391|NCT01562626|Antifungal Agents|antifungal agents|mesh-ancestor
5693755|NCT03399552|Avelumab|avelumab|mesh-list
5693756|NCT03399552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6673392|NCT01562626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6673393|NCT01562626|Antimetabolites|antimetabolites|mesh-ancestor
6673394|NCT01562626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675578|NCT01576354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675579|NCT01576419|Celecoxib|celecoxib|mesh-list
5764624|NCT02949583|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5764625|NCT02949583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5764626|NCT02949583|Disinfectants|disinfectants|mesh-ancestor
5764627|NCT02949934|Tolcapone|tolcapone|mesh-list
5764628|NCT02949934|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5764629|NCT02949934|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5764630|NCT02949934|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
5764631|NCT02949934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5764632|NCT02949934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764633|NCT02949765|Iron|iron|mesh-list
5764634|NCT02949765|Trace Elements|trace elements|mesh-ancestor
5693757|NCT03399552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5764635|NCT02949765|Micronutrients|micronutrients|mesh-ancestor
5764636|NCT02949765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895759|NCT04987099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907870|NCT05155007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5764637|NCT02949843|Pembrolizumab|pembrolizumab|mesh-list
5764638|NCT02949843|Nivolumab|nivolumab|mesh-list
5764639|NCT02949843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5764640|NCT02949843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5764641|NCT02949843|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5638457|NCT03412565|Dexamethasone|dexamethasone|mesh-list
5638458|NCT03412565|Prednisone|prednisone|mesh-list
5638459|NCT03412565|Lenalidomide|lenalidomide|mesh-list
5638460|NCT03412565|Bortezomib|bortezomib|mesh-list
5638461|NCT03412565|Melphalan|melphalan|mesh-list
5638462|NCT03412565|Daratumumab|daratumumab|mesh-list
5638463|NCT03412565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5638464|NCT03412565|Antiemetics|antiemetics|mesh-ancestor
5638465|NCT03412565|Autonomic Agents|autonomic agents|mesh-ancestor
5638466|NCT03412565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5638467|NCT03412565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5638468|NCT03412565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5638469|NCT03412565|Glucocorticoids|glucocorticoids|mesh-ancestor
5638470|NCT03412565|Hormones|hormones|mesh-ancestor
5638471|NCT03412565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5638472|NCT03412565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5638473|NCT03412565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5638474|NCT03412565|Immunologic Factors|immunologic factors|mesh-ancestor
5638475|NCT03412565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5638476|NCT03412565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5764642|NCT02949843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764643|NCT02949778|Ropivacaine|ropivacaine|mesh-list
5764644|NCT02949778|Anesthetics, Local|anesthetics, local|mesh-ancestor
5764645|NCT02949778|Anesthetics|anesthetics|mesh-ancestor
5764646|NCT02949778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5764647|NCT02949778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5764648|NCT02949778|Sensory System Agents|sensory system agents|mesh-ancestor
5764649|NCT02949778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5764650|NCT02949492|Interleukin-2|interleukin-2|mesh-list
5764651|NCT02949492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5764652|NCT02949492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5764653|NCT02949492|Analgesics|analgesics|mesh-ancestor
5764654|NCT02949492|Sensory System Agents|sensory system agents|mesh-ancestor
5764655|NCT02949492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5764656|NCT02949492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5764657|NCT02949232|Prednisolone|prednisolone|mesh-list
5764658|NCT02949232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6673395|NCT01562691|Petrolatum|petrolatum|mesh-list
6673396|NCT01562691|Emollients|emollients|mesh-ancestor
5638477|NCT03412565|Growth Substances|growth substances|mesh-ancestor
5764659|NCT02949232|Glucocorticoids|glucocorticoids|mesh-ancestor
5764660|NCT02949232|Hormones|hormones|mesh-ancestor
5764661|NCT02949232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5764662|NCT02949232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5764663|NCT02949232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5764664|NCT02949232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5764665|NCT02949466|Triamcinolone|triamcinolone|mesh-list
5764666|NCT02949466|Hyaluronic Acid|hyaluronic acid|mesh-list
5638478|NCT03412565|Growth Inhibitors|growth inhibitors|mesh-ancestor
5638479|NCT03412565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5638480|NCT03412565|Alkylating Agents|alkylating agents|mesh-ancestor
5638481|NCT03412565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5638482|NCT03412565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5638483|NCT03412565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6209695|NCT02151461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209696|NCT02151487|Dexamethasone|dexamethasone|mesh-list
6209697|NCT02151487|Dexamethasone acetate|dexamethasone acetate|mesh-list
6209698|NCT02151487|Clonidine|clonidine|mesh-list
5764667|NCT02949466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5764668|NCT02949466|Glucocorticoids|glucocorticoids|mesh-ancestor
5764669|NCT02949466|Hormones|hormones|mesh-ancestor
5764670|NCT02949466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5764671|NCT02949466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5764672|NCT02949466|Immunologic Factors|immunologic factors|mesh-ancestor
5764673|NCT02949466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5764674|NCT02949466|Viscosupplements|viscosupplements|mesh-ancestor
5764675|NCT02949466|Protective Agents|protective agents|mesh-ancestor
5764676|NCT02949310|Nefopam|nefopam|mesh-list
5764677|NCT02949310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6209699|NCT02151487|Ropivacaine|ropivacaine|mesh-list
5764678|NCT02949310|Analgesics|analgesics|mesh-ancestor
6209700|NCT02151487|BB 1101|bb 1101|mesh-list
6673397|NCT01562691|Dermatologic Agents|dermatologic agents|mesh-ancestor
5764679|NCT02949310|Sensory System Agents|sensory system agents|mesh-ancestor
5764680|NCT02949310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5764681|NCT02949310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5764682|NCT02949349|Mycophenolic Acid|mycophenolic acid|mesh-list
5764683|NCT02949349|Prednisolone|prednisolone|mesh-list
5764684|NCT02949349|Azathioprine|azathioprine|mesh-list
5764685|NCT02949349|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5764686|NCT02949349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5764687|NCT02949349|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5764688|NCT02949349|Antitubercular Agents|antitubercular agents|mesh-ancestor
5764689|NCT02949349|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5764690|NCT02949349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5764691|NCT02949349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5764692|NCT02949349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764693|NCT02949349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5764694|NCT02949349|Glucocorticoids|glucocorticoids|mesh-ancestor
5764695|NCT02949349|Hormones|hormones|mesh-ancestor
5764696|NCT02949349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5764697|NCT02949349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5764698|NCT02949349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5764699|NCT02949349|Antimetabolites|antimetabolites|mesh-ancestor
5764700|NCT02949349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5764701|NCT02949349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5764702|NCT02949349|Immunologic Factors|immunologic factors|mesh-ancestor
5764703|NCT02949349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6209701|NCT02151487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6209702|NCT02151487|Antiemetics|antiemetics|mesh-ancestor
6209703|NCT02151487|Autonomic Agents|autonomic agents|mesh-ancestor
6209704|NCT02151487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6209705|NCT02151487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209706|NCT02151487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5638495|NCT03393611|Cytarabine|cytarabine|mesh-list
5638496|NCT03393611|Fludarabine|fludarabine|mesh-list
5638497|NCT03393611|Melphalan|melphalan|mesh-list
5638498|NCT03393611|Daunorubicin|daunorubicin|mesh-list
5638499|NCT03393611|Thymoglobulin|thymoglobulin|mesh-list
5638500|NCT03393611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5638501|NCT03393611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5638502|NCT03393611|Antimetabolites|antimetabolites|mesh-ancestor
5638503|NCT03393611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5638504|NCT03393611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5638505|NCT03393611|Immunologic Factors|immunologic factors|mesh-ancestor
5638506|NCT03393611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5638507|NCT03393611|Antiviral Agents|antiviral agents|mesh-ancestor
5638508|NCT03393611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5638509|NCT03393611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5638510|NCT03393611|Alkylating Agents|alkylating agents|mesh-ancestor
5638511|NCT03393611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5638512|NCT03393611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5638513|NCT03393611|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5638514|NCT03393611|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5638515|NCT03393611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6209707|NCT02151487|Glucocorticoids|glucocorticoids|mesh-ancestor
6209708|NCT02151487|Hormones|hormones|mesh-ancestor
6209709|NCT02151487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6209710|NCT02151487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6209711|NCT02151487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6209712|NCT02151487|Protease Inhibitors|protease inhibitors|mesh-ancestor
6209713|NCT02151487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6209714|NCT02151487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209715|NCT02151487|Anesthetics, Local|anesthetics, local|mesh-ancestor
5638525|NCT03384914|Vaccines|vaccines|mesh-list
5638526|NCT03384914|Immunologic Factors|immunologic factors|mesh-list
5638527|NCT03384914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209716|NCT02151487|Anesthetics|anesthetics|mesh-ancestor
6209717|NCT02151487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6209718|NCT02151487|Sensory System Agents|sensory system agents|mesh-ancestor
5764704|NCT02949206|Thrombin|thrombin|mesh-list
5764705|NCT02949206|Hemostatics|hemostatics|mesh-ancestor
5764706|NCT02949206|Coagulants|coagulants|mesh-ancestor
5764707|NCT02949258|Oxaliplatin|oxaliplatin|mesh-list
5764708|NCT02949258|Etoposide|etoposide|mesh-list
5764709|NCT02949258|Epirubicin|epirubicin|mesh-list
5764710|NCT02949258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5764711|NCT02949258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5764712|NCT02949258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5764713|NCT02949258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5764714|NCT02949258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5764715|NCT02949258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764716|NCT02949258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5764717|NCT02949193|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5764718|NCT02949193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5764719|NCT02949193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5764720|NCT02949193|Incretins|incretins|mesh-ancestor
5764721|NCT02949193|Hormones|hormones|mesh-ancestor
5764722|NCT02949193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5764723|NCT02949193|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5764724|NCT02949193|Protease Inhibitors|protease inhibitors|mesh-ancestor
5764725|NCT02949193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5764726|NCT02949193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764727|NCT02948985|Cetuximab|cetuximab|mesh-list
5764728|NCT02948985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5764729|NCT02948985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5764730|NCT02948998|Spironolactone|spironolactone|mesh-list
5764731|NCT02948998|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5764732|NCT02948998|Hormone Antagonists|hormone antagonists|mesh-ancestor
5764733|NCT02948998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5764734|NCT02948998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5764735|NCT02948998|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5764736|NCT02948998|Diuretics|diuretics|mesh-ancestor
5764737|NCT02948998|Natriuretic Agents|natriuretic agents|mesh-ancestor
5764738|NCT02949284|Prednisone|prednisone|mesh-list
5764739|NCT02949284|Cortisone|cortisone|mesh-list
5764740|NCT02949284|Abiraterone Acetate|abiraterone acetate|mesh-list
5764741|NCT02949284|Hormones|hormones|mesh-list
5764742|NCT02949284|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
5764743|NCT02949284|Androgens|androgens|mesh-list
5764744|NCT02949284|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
5764745|NCT02949284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5764746|NCT02949284|Glucocorticoids|glucocorticoids|mesh-ancestor
6673398|NCT01562704|Acetaminophen|acetaminophen|mesh-list
6209719|NCT02151487|Analgesics|analgesics|mesh-ancestor
6209720|NCT02151487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5764747|NCT02949284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5764748|NCT02949284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5764749|NCT02949284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5764750|NCT02949284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5764751|NCT02949284|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5764752|NCT02949284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5764753|NCT02949284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764754|NCT02949284|Hormone Antagonists|hormone antagonists|mesh-ancestor
5764755|NCT02949284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5764756|NCT02949284|Androgen Antagonists|androgen antagonists|mesh-ancestor
5764757|NCT02948920|Ephedrine|ephedrine|mesh-list
5764758|NCT02948920|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5764759|NCT02948920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5764760|NCT02948920|Sympathomimetics|sympathomimetics|mesh-ancestor
5764761|NCT02948920|Autonomic Agents|autonomic agents|mesh-ancestor
5764762|NCT02948920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5764763|NCT02948920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5764764|NCT02948920|Adrenergic Agents|adrenergic agents|mesh-ancestor
5764765|NCT02948920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5764766|NCT02948920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764767|NCT02948881|Ibandronic Acid|ibandronic acid|mesh-list
5764768|NCT02948881|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5764769|NCT02948881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5764770|NCT02948660|Melatonin|melatonin|mesh-list
5764771|NCT02948660|Zolpidem|zolpidem|mesh-list
5764772|NCT02948660|Antioxidants|antioxidants|mesh-ancestor
6209721|NCT02151487|Sympatholytics|sympatholytics|mesh-ancestor
6209722|NCT02151487|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6209723|NCT02151487|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6209724|NCT02151487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6209725|NCT02151487|Adrenergic Agents|adrenergic agents|mesh-ancestor
6209726|NCT02151487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6209727|NCT02151591|Varenicline|varenicline|mesh-list
6209728|NCT02151591|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6209729|NCT02151591|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6209730|NCT02151591|Cholinergic Agents|cholinergic agents|mesh-ancestor
6209731|NCT02151591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6209732|NCT02151591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764773|NCT02948660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764774|NCT02948660|Protective Agents|protective agents|mesh-ancestor
5764775|NCT02948660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5764776|NCT02948660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5764777|NCT02948660|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5764778|NCT02948660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5764779|NCT02948660|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
5764780|NCT02948660|GABA Agonists|gaba agonists|mesh-ancestor
5764781|NCT02948660|GABA Agents|gaba agents|mesh-ancestor
5764782|NCT02948660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5764783|NCT02948543|Mitomycins|mitomycins|mesh-list
5764784|NCT02948543|Mitomycin|mitomycin|mesh-list
5764785|NCT02948543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5764786|NCT02948543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5764787|NCT02948543|Alkylating Agents|alkylating agents|mesh-ancestor
5764788|NCT02948543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764789|NCT02948543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5764790|NCT02948543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5764791|NCT02948348|Capecitabine|capecitabine|mesh-list
5764792|NCT02948348|Nivolumab|nivolumab|mesh-list
5764793|NCT02948348|Ipilimumab|ipilimumab|mesh-list
5764794|NCT02948348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5764795|NCT02948348|Antimetabolites|antimetabolites|mesh-ancestor
5764796|NCT02948348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764797|NCT02948348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5764798|NCT02948348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5764799|NCT02948348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5764800|NCT02948309|Viscum album peptide|viscum album peptide|mesh-list
5764801|NCT02948309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5764802|NCT02948309|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5764803|NCT02948309|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5764804|NCT02948309|Antiviral Agents|antiviral agents|mesh-ancestor
5764805|NCT02948309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5764806|NCT02948283|Metformin|metformin|mesh-list
5764807|NCT02948283|Ritonavir|ritonavir|mesh-list
5764808|NCT02948283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5764809|NCT02948283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209733|NCT02151591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5764810|NCT02948283|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5764811|NCT02948283|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5764812|NCT02948283|Protease Inhibitors|protease inhibitors|mesh-ancestor
5764813|NCT02948283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5764814|NCT02948283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764815|NCT02948283|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5764816|NCT02948283|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5764817|NCT02948283|Antiviral Agents|antiviral agents|mesh-ancestor
5764818|NCT02948283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5764819|NCT02948283|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5764820|NCT02948283|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5764821|NCT02947945|Reslizumab|reslizumab|mesh-list
5764822|NCT02947945|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5764823|NCT02947945|Respiratory System Agents|respiratory system agents|mesh-ancestor
5764824|NCT02948101|Cyclophosphamide|cyclophosphamide|mesh-list
5764825|NCT02948101|Antibodies|antibodies|mesh-list
5764826|NCT02948101|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5764827|NCT02948101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5764828|NCT02948101|Immunologic Factors|immunologic factors|mesh-ancestor
5764829|NCT02948101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5764830|NCT02948101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5764831|NCT02948101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5764832|NCT02948101|Alkylating Agents|alkylating agents|mesh-ancestor
5764833|NCT02948101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764834|NCT02948101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5764835|NCT02948101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5764836|NCT02948075|Paclitaxel|paclitaxel|mesh-list
5764837|NCT02948075|Carboplatin|carboplatin|mesh-list
5764838|NCT02948075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5764839|NCT02948075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5764840|NCT02948075|Tubulin Modulators|tubulin modulators|mesh-ancestor
5764841|NCT02948075|Antimitotic Agents|antimitotic agents|mesh-ancestor
5764842|NCT02948075|Mitosis Modulators|mitosis modulators|mesh-ancestor
5764843|NCT02948075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209734|NCT02151643|Iron|iron|mesh-list
6209735|NCT02151643|Trace Elements|trace elements|mesh-ancestor
6209736|NCT02151643|Micronutrients|micronutrients|mesh-ancestor
6209737|NCT02151643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209738|NCT02151682|Morphine|morphine|mesh-list
6209739|NCT02151682|Tapentadol|tapentadol|mesh-list
6209740|NCT02151682|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6209741|NCT02151682|Narcotics|narcotics|mesh-ancestor
6209742|NCT02151682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6209743|NCT02151682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209744|NCT02151682|Analgesics|analgesics|mesh-ancestor
6209745|NCT02151682|Sensory System Agents|sensory system agents|mesh-ancestor
6209746|NCT02151682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6209747|NCT02151682|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6209748|NCT02151682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6209749|NCT02151682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6209750|NCT02151682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209751|NCT02151682|Adrenergic Agents|adrenergic agents|mesh-ancestor
6209752|NCT02151682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6209753|NCT02151773|Vaccines|vaccines|mesh-list
6209754|NCT02151773|Immunologic Factors|immunologic factors|mesh-ancestor
6209755|NCT02151773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5638570|NCT03382561|Cisplatin|cisplatin|mesh-list
5638571|NCT03382561|Carboplatin|carboplatin|mesh-list
5638572|NCT03382561|Nivolumab|nivolumab|mesh-list
5638573|NCT03382561|Etoposide|etoposide|mesh-list
5638574|NCT03382561|Etoposide phosphate|etoposide phosphate|mesh-list
5895760|NCT04987099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5895761|NCT04987099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5895762|NCT04987099|Nootropic Agents|nootropic agents|mesh-ancestor
5895763|NCT04985604|Niacinamide|niacinamide|mesh-list
5895764|NCT04985604|Vitamin B Complex|vitamin b complex|mesh-ancestor
5895765|NCT04985604|Vitamins|vitamins|mesh-ancestor
5895766|NCT04985604|Micronutrients|micronutrients|mesh-ancestor
5895767|NCT04985604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895768|NCT04983589|Pilocarpine|pilocarpine|mesh-list
5895769|NCT04983589|Miotics|miotics|mesh-ancestor
5895770|NCT04983589|Autonomic Agents|autonomic agents|mesh-ancestor
5895771|NCT04983589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5638575|NCT03382561|Podophyllotoxin|podophyllotoxin|mesh-list
5895772|NCT04983589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895773|NCT04983589|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
5638576|NCT03382561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6209756|NCT02151786|Lansoprazole|lansoprazole|mesh-list
5764844|NCT02947932|Indomethacin|indomethacin|mesh-list
5764845|NCT02947932|Resveratrol|resveratrol|mesh-list
5764846|NCT02947932|Antioxidants|antioxidants|mesh-ancestor
5764847|NCT02947932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764848|NCT02947932|Protective Agents|protective agents|mesh-ancestor
5764849|NCT02947932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5764850|NCT02947932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5764851|NCT02947932|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5764852|NCT02947932|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5638577|NCT03382561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5638578|NCT03382561|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5638579|NCT03382561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5638580|NCT03382561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5638581|NCT03382561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5764853|NCT02947932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5764854|NCT02947932|Analgesics|analgesics|mesh-ancestor
5764855|NCT02947932|Sensory System Agents|sensory system agents|mesh-ancestor
5764856|NCT02947932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5764857|NCT02947932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5764858|NCT02947932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5764859|NCT02947932|Gout Suppressants|gout suppressants|mesh-ancestor
5764860|NCT02947932|Tocolytic Agents|tocolytic agents|mesh-ancestor
5764861|NCT02947932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5764862|NCT02947932|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5764863|NCT02947880|Bumetanide|bumetanide|mesh-list
5764864|NCT02947880|Diuretics|diuretics|mesh-ancestor
5764865|NCT02947880|Natriuretic Agents|natriuretic agents|mesh-ancestor
5764866|NCT02947880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5764867|NCT02947880|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5764868|NCT02947880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5764869|NCT02947880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764870|NCT02947711|Diltiazem|diltiazem|mesh-list
5764871|NCT02947711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5764872|NCT02947711|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5764873|NCT02947711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5764874|NCT02947711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764875|NCT02947711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5764876|NCT02947711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5764877|NCT02947711|Vasodilator Agents|vasodilator agents|mesh-ancestor
5764878|NCT02947516|Liver Extracts|liver extracts|mesh-list
5764879|NCT02947516|Hematinics|hematinics|mesh-ancestor
5764880|NCT02947620|Metformin|metformin|mesh-list
5764881|NCT02947620|Atorvastatin|atorvastatin|mesh-list
5764882|NCT02947620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5764883|NCT02947620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5764884|NCT02947620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5764885|NCT02947620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5764886|NCT02947620|Antimetabolites|antimetabolites|mesh-ancestor
5764887|NCT02947620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764888|NCT02947620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5764889|NCT02947620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5764890|NCT02947620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5764891|NCT02947854|Photosensitizing Agents|photosensitizing agents|mesh-list
5764892|NCT02947854|Poly ICLC|poly iclc|mesh-list
5764893|NCT02947854|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
5764894|NCT02947854|Interferon Inducers|interferon inducers|mesh-ancestor
5764895|NCT02947854|Immunologic Factors|immunologic factors|mesh-ancestor
5764896|NCT02947854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496390|NCT00627848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5638582|NCT03382561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5638583|NCT03382561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5638584|NCT03382561|Keratolytic Agents|keratolytic agents|mesh-ancestor
5638585|NCT03382561|Dermatologic Agents|dermatologic agents|mesh-ancestor
5638586|NCT03382561|Tubulin Modulators|tubulin modulators|mesh-ancestor
5638587|NCT03382561|Antimitotic Agents|antimitotic agents|mesh-ancestor
5638588|NCT03382561|Mitosis Modulators|mitosis modulators|mesh-ancestor
5638589|NCT03382301|Cyclosporine|cyclosporine|mesh-list
5638590|NCT03382301|Cyclosporins|cyclosporins|mesh-list
5638591|NCT03382301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5638592|NCT03382301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5638593|NCT03382301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5638594|NCT03382301|Immunologic Factors|immunologic factors|mesh-ancestor
5638595|NCT03382301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5638596|NCT03382301|Antifungal Agents|antifungal agents|mesh-ancestor
5638597|NCT03382301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5638598|NCT03382301|Dermatologic Agents|dermatologic agents|mesh-ancestor
5638599|NCT03382301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5638600|NCT03382301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5638601|NCT03340506|Trametinib|trametinib|mesh-list
5638602|NCT03340506|Dabrafenib|dabrafenib|mesh-list
5638603|NCT03340506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5764897|NCT02947854|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5764898|NCT02947854|Dermatologic Agents|dermatologic agents|mesh-ancestor
5764899|NCT02947763|Metronidazole|metronidazole|mesh-list
5764900|NCT02947763|Ciprofloxacin|ciprofloxacin|mesh-list
5764901|NCT02947763|Minocycline|minocycline|mesh-list
5764902|NCT02947763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5764903|NCT02947763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5764904|NCT02947763|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5764905|NCT02947763|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5764906|NCT02947763|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5764907|NCT02947763|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5638604|NCT03340506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5638605|NCT03340506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5638606|NCT03340506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5638607|NCT03331198|Venetoclax|venetoclax|mesh-list
5638608|NCT03331198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5638609|NCT03318952|Lidocaine|lidocaine|mesh-list
5638610|NCT03318952|Carticaine|carticaine|mesh-list
5638611|NCT03318952|Anesthetics, Local|anesthetics, local|mesh-ancestor
5638612|NCT03318952|Anesthetics|anesthetics|mesh-ancestor
5638613|NCT03318952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5638614|NCT03318952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5638615|NCT03318952|Sensory System Agents|sensory system agents|mesh-ancestor
5638616|NCT03318952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5638617|NCT03318952|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5638618|NCT03318952|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5638619|NCT03318952|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5638620|NCT03318952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5638621|NCT03318952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5638622|NCT03308448|Epoetin Alfa|epoetin alfa|mesh-list
5638623|NCT03308448|Hematinics|hematinics|mesh-ancestor
5638624|NCT03304639|Pembrolizumab|pembrolizumab|mesh-list
5638625|NCT03304639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5638626|NCT03304639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6209757|NCT02151786|Dexlansoprazole|dexlansoprazole|mesh-list
6209758|NCT02151786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5638629|NCT03296553|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
5638630|NCT03296553|Valganciclovir|valganciclovir|mesh-list
5638631|NCT03296553|Antiviral Agents|antiviral agents|mesh-ancestor
5638632|NCT03296553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5638633|NCT03291028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5638634|NCT03291028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5638635|NCT03291028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5638636|NCT03289962|Atezolizumab|atezolizumab|mesh-list
5638637|NCT03289962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5638638|NCT03253796|Golimumab|golimumab|mesh-list
5638639|NCT03253796|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
5638640|NCT03253796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5638641|NCT03253796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5638642|NCT03253796|Immunologic Factors|immunologic factors|mesh-ancestor
5638643|NCT03253796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5638644|NCT03244384|Pembrolizumab|pembrolizumab|mesh-list
5764908|NCT02947763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5764909|NCT02947763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764910|NCT02947763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5764911|NCT02947763|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5764912|NCT02947763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5764913|NCT02947815|Botulinum Toxins|botulinum toxins|mesh-list
5764914|NCT02947815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5764915|NCT02947815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5764916|NCT02947815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5764917|NCT02947815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5764918|NCT02947815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764919|NCT02947815|Cholinergic Agents|cholinergic agents|mesh-ancestor
5764920|NCT02947815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5764921|NCT02947815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5764922|NCT02947815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5638645|NCT03244384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5764923|NCT02947815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5764924|NCT02947737|Gentamicins|gentamicins|mesh-list
5764925|NCT02947737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5764926|NCT02947737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5764927|NCT02947737|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5764928|NCT02947737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5764929|NCT02947737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764930|NCT02947529|Tranexamic Acid|tranexamic acid|mesh-list
5764931|NCT02947529|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5764932|NCT02947529|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5764933|NCT02947529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764934|NCT02947529|Hemostatics|hemostatics|mesh-ancestor
5764935|NCT02947529|Coagulants|coagulants|mesh-ancestor
5764936|NCT02947685|Trastuzumab|trastuzumab|mesh-list
5764937|NCT02947685|Pertuzumab|pertuzumab|mesh-list
5764938|NCT02947685|Letrozole|letrozole|mesh-list
5764939|NCT02947685|Fulvestrant|fulvestrant|mesh-list
5764940|NCT02947685|Palbociclib|palbociclib|mesh-list
5764941|NCT02947685|Anastrozole|anastrozole|mesh-list
5764942|NCT02947685|Exemestane|exemestane|mesh-list
5764943|NCT02947685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5764944|NCT02947685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5764945|NCT02947685|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5764946|NCT02947685|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5764947|NCT02947685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5764948|NCT02947685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764949|NCT02947685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5764950|NCT02947685|Hormone Antagonists|hormone antagonists|mesh-ancestor
5764951|NCT02947685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5764952|NCT02947685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5764953|NCT02947685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5764954|NCT02947685|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5764955|NCT02947685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5764956|NCT02947672|Dexamethasone|dexamethasone|mesh-list
5764957|NCT02947672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5764958|NCT02947672|Antiemetics|antiemetics|mesh-ancestor
5764959|NCT02947672|Autonomic Agents|autonomic agents|mesh-ancestor
6496391|NCT00627848|Protective Agents|protective agents|mesh-ancestor
5638646|NCT03244384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6209759|NCT02151786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6209760|NCT02151786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6209761|NCT02151786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6209762|NCT02151786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209763|NCT02151851|Methotrexate|methotrexate|mesh-list
6209764|NCT02151851|Certolizumab Pegol|certolizumab pegol|mesh-list
6209765|NCT02151851|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6209766|NCT02151851|Abortifacient Agents|abortifacient agents|mesh-ancestor
6209767|NCT02151851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6209768|NCT02151851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209769|NCT02151851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6209770|NCT02151851|Antimetabolites|antimetabolites|mesh-ancestor
5764960|NCT02947672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5764961|NCT02947672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5764962|NCT02947672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5764963|NCT02947672|Glucocorticoids|glucocorticoids|mesh-ancestor
5764964|NCT02947672|Hormones|hormones|mesh-ancestor
6209771|NCT02151851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5638661|NCT03233711|Nivolumab|nivolumab|mesh-list
5638662|NCT03233711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5638663|NCT03233711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5638664|NCT03233711|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5638665|NCT03233711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5638666|NCT03228537|Cisplatin|cisplatin|mesh-list
5638667|NCT03228537|Pemetrexed|pemetrexed|mesh-list
5638668|NCT03228537|Atezolizumab|atezolizumab|mesh-list
5638669|NCT03228537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5638670|NCT03228537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5638671|NCT03228537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5638672|NCT03228537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5638673|NCT03228537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5638674|NCT03228537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5638675|NCT03228537|Immunologic Factors|immunologic factors|mesh-ancestor
5638676|NCT03228537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209772|NCT02151851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6209773|NCT02151851|Dermatologic Agents|dermatologic agents|mesh-ancestor
6209774|NCT02151851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6209775|NCT02151851|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6209776|NCT02151851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6209777|NCT02151851|Immunologic Factors|immunologic factors|mesh-ancestor
6209778|NCT02151851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6209779|NCT02151851|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6209780|NCT02151877|Nitric Oxide|nitric oxide|mesh-list
6209781|NCT02151877|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6209782|NCT02151877|Autonomic Agents|autonomic agents|mesh-ancestor
6209783|NCT02151877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6209784|NCT02151877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209785|NCT02151877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6209786|NCT02151877|Respiratory System Agents|respiratory system agents|mesh-ancestor
6209787|NCT02151877|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5638694|NCT03217097|Oxaliplatin|oxaliplatin|mesh-list
5764965|NCT02947672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5764966|NCT02947672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5764967|NCT02947672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5764968|NCT02947178|Bupivacaine|bupivacaine|mesh-list
5764969|NCT02947178|Anesthetics, Local|anesthetics, local|mesh-ancestor
5764970|NCT02947178|Anesthetics|anesthetics|mesh-ancestor
5764971|NCT02947178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5764972|NCT02947178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5764973|NCT02947178|Sensory System Agents|sensory system agents|mesh-ancestor
5764974|NCT02947178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5764975|NCT02947438|Epoetin Alfa|epoetin alfa|mesh-list
5764976|NCT02947438|Hematinics|hematinics|mesh-ancestor
5764977|NCT02947347|Rituximab|rituximab|mesh-list
5764978|NCT02947347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5764979|NCT02947347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5764980|NCT02947347|Immunologic Factors|immunologic factors|mesh-ancestor
5764981|NCT02947347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5764982|NCT02947347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5764983|NCT02947113|Etoposide|etoposide|mesh-list
5764984|NCT02947113|Pemetrexed|pemetrexed|mesh-list
5764985|NCT02947113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5638695|NCT03217097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5638696|NCT03205423|Gabapentin|gabapentin|mesh-list
5638697|NCT03205423|Analgesics|analgesics|mesh-ancestor
5764986|NCT02947113|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5764987|NCT02947113|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5638698|NCT03205423|Sensory System Agents|sensory system agents|mesh-ancestor
5638699|NCT03205423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5638700|NCT03205423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5638701|NCT03205423|Anticonvulsants|anticonvulsants|mesh-ancestor
5638702|NCT03205423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5638703|NCT03205423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5638704|NCT03205423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5638705|NCT03205423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5638706|NCT03205423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5638707|NCT03205423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5638708|NCT03205423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5638709|NCT03205423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5638710|NCT03205423|Antimanic Agents|antimanic agents|mesh-ancestor
6209788|NCT02151877|Antioxidants|antioxidants|mesh-ancestor
6209789|NCT02151877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209790|NCT02151877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6209791|NCT02151877|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6209792|NCT02151877|Vasodilator Agents|vasodilator agents|mesh-ancestor
6209793|NCT02151877|Gasotransmitters|gasotransmitters|mesh-ancestor
5764988|NCT02947113|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5764989|NCT02947113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5764990|NCT02947113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764991|NCT02947113|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5764992|NCT02947113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5764993|NCT02947334|Bococizumab|bococizumab|mesh-list
5764994|NCT02947334|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5764995|NCT02947334|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5764996|NCT02947334|Antimetabolites|antimetabolites|mesh-ancestor
6209794|NCT02151877|Protective Agents|protective agents|mesh-ancestor
6209795|NCT02151981|Osimertinib|osimertinib|mesh-list
6209796|NCT02151981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5764997|NCT02947334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5764998|NCT02947334|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5764999|NCT02947269|Prucalopride|prucalopride|mesh-list
5765000|NCT02947269|Laxatives|laxatives|mesh-ancestor
5765001|NCT02947269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5765002|NCT02947269|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
5765003|NCT02947269|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5765004|NCT02947269|Serotonin Agents|serotonin agents|mesh-ancestor
5765005|NCT02947269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5765006|NCT02947269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765007|NCT02947269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765008|NCT02947243|Morphine|morphine|mesh-list
5765009|NCT02947243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5765010|NCT02947243|Narcotics|narcotics|mesh-ancestor
6209797|NCT02151981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6209798|NCT02151981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6209799|NCT02151981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209800|NCT02151994|Zamicastat|zamicastat|mesh-list
6209801|NCT02151994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6209802|NCT02151994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209803|NCT02152007|Sirolimus|sirolimus|mesh-list
6209804|NCT02152007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6209805|NCT02152007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6209806|NCT02152007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6209807|NCT02152007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5765011|NCT02947243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5765012|NCT02947243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765013|NCT02947243|Analgesics|analgesics|mesh-ancestor
5765014|NCT02947243|Sensory System Agents|sensory system agents|mesh-ancestor
5895774|NCT04983589|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6209808|NCT02152007|Antifungal Agents|antifungal agents|mesh-ancestor
5638733|NCT03187379|Bupivacaine|bupivacaine|mesh-list
5638734|NCT03187379|Anesthetics, Local|anesthetics, local|mesh-ancestor
5638735|NCT03187379|Anesthetics|anesthetics|mesh-ancestor
5638736|NCT03187379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5638737|NCT03187379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5638738|NCT03187379|Sensory System Agents|sensory system agents|mesh-ancestor
5638739|NCT03187379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5638740|NCT03180034|Vaccines|vaccines|mesh-list
5638741|NCT03180034|Immunologic Factors|immunologic factors|mesh-ancestor
5638742|NCT03180034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5638743|NCT03163992|Pembrolizumab|pembrolizumab|mesh-list
5638744|NCT03163992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5638745|NCT03163992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5638746|NCT03150914|Sirolimus|sirolimus|mesh-list
5638747|NCT03150914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5638748|NCT03150914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5638749|NCT03150914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5638750|NCT03150914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5638751|NCT03150914|Antifungal Agents|antifungal agents|mesh-ancestor
5638752|NCT03150914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5765015|NCT02947243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5765016|NCT02947126|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
5765017|NCT02947126|Pentetic Acid|pentetic acid|mesh-list
5765018|NCT02947126|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5765019|NCT02947126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765020|NCT02947126|Antidotes|antidotes|mesh-ancestor
5765021|NCT02947126|Protective Agents|protective agents|mesh-ancestor
5765022|NCT02947126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765023|NCT02947126|Chelating Agents|chelating agents|mesh-ancestor
5765024|NCT02947126|Sequestering Agents|sequestering agents|mesh-ancestor
5765025|NCT02947126|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5765026|NCT02947087|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
5765027|NCT02947087|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5765028|NCT02947087|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5765029|NCT02947087|Protease Inhibitors|protease inhibitors|mesh-ancestor
5765030|NCT02947087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5765031|NCT02947087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765032|NCT02946944|Sildenafil Citrate|sildenafil citrate|mesh-list
5765033|NCT02946944|Apixaban|apixaban|mesh-list
5765034|NCT02946944|Vasodilator Agents|vasodilator agents|mesh-ancestor
5765035|NCT02946944|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5765036|NCT02946944|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5638753|NCT03150914|Immunologic Factors|immunologic factors|mesh-ancestor
5638754|NCT03150914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5638755|NCT03148795|Talazoparib|talazoparib|mesh-list
5638756|NCT03148795|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5638757|NCT03148795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5638758|NCT03148795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5638759|NCT03148795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5638760|NCT03098485|Azithromycin|azithromycin|mesh-list
5638761|NCT03098485|Levofloxacin|levofloxacin|mesh-list
5638762|NCT03098485|Ofloxacin|ofloxacin|mesh-list
5638763|NCT03098485|Cefpodoxime|cefpodoxime|mesh-list
5765037|NCT02946944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5765038|NCT02946944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765039|NCT02946944|Urological Agents|urological agents|mesh-ancestor
5765040|NCT02946944|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5765041|NCT02946944|Antithrombins|antithrombins|mesh-ancestor
5765042|NCT02946944|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5765043|NCT02946944|Protease Inhibitors|protease inhibitors|mesh-ancestor
5765044|NCT02946944|Anticoagulants|anticoagulants|mesh-ancestor
5765045|NCT02946970|Quinine|quinine|mesh-list
5765046|NCT02946970|Antimalarials|antimalarials|mesh-ancestor
5765047|NCT02946970|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5765048|NCT02946970|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5765049|NCT02946970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5765050|NCT02946970|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5765051|NCT02946970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765052|NCT02946970|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5765053|NCT02946970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5765054|NCT02946970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5765055|NCT02946970|Analgesics|analgesics|mesh-ancestor
5765056|NCT02946970|Sensory System Agents|sensory system agents|mesh-ancestor
5638764|NCT03098485|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
5638765|NCT03098485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5638766|NCT03098485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5765057|NCT02947061|Docetaxel|docetaxel|mesh-list
5765058|NCT02947061|Capecitabine|capecitabine|mesh-list
5765059|NCT02947061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5765060|NCT02947061|Tubulin Modulators|tubulin modulators|mesh-ancestor
5765061|NCT02947061|Antimitotic Agents|antimitotic agents|mesh-ancestor
5765062|NCT02947061|Mitosis Modulators|mitosis modulators|mesh-ancestor
5765063|NCT02947061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765064|NCT02947061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5765065|NCT02947061|Antimetabolites|antimetabolites|mesh-ancestor
5765066|NCT02946671|Nivolumab|nivolumab|mesh-list
5765067|NCT02946671|Mogamulizumab|mogamulizumab|mesh-list
5765068|NCT02946671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5765069|NCT02946671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5765070|NCT02946671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5765071|NCT02946671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765072|NCT02946684|Letrozole|letrozole|mesh-list
5765073|NCT02946684|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5765074|NCT02946684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5765075|NCT02946684|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5765076|NCT02946684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5765077|NCT02946684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765078|NCT02946684|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5638767|NCT03098485|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5638768|NCT03098485|Renal Agents|renal agents|mesh-ancestor
5638769|NCT03098485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5638770|NCT03098485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5638771|NCT03098485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5638772|NCT03098485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5638773|NCT03098485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5638774|NCT03098485|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5638775|NCT03098485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5638776|NCT03092674|Cytarabine|cytarabine|mesh-list
5638777|NCT03092674|Nivolumab|nivolumab|mesh-list
5638778|NCT03092674|Azacitidine|azacitidine|mesh-list
5638779|NCT03092674|Decitabine|decitabine|mesh-list
5638780|NCT03092674|Midostaurin|midostaurin|mesh-list
5638781|NCT03092674|Staurosporine|staurosporine|mesh-list
5638782|NCT03092674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5638783|NCT03092674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5638784|NCT03092674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5765079|NCT02946684|Hormone Antagonists|hormone antagonists|mesh-ancestor
5765080|NCT02946684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5765081|NCT02946684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765082|NCT02946801|Listerine|listerine|mesh-list
5765083|NCT02946801|Sodium Fluoride|sodium fluoride|mesh-list
5638785|NCT03092674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5638786|NCT03092674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5638787|NCT03092674|Antimetabolites|antimetabolites|mesh-ancestor
5638788|NCT03092674|Antiviral Agents|antiviral agents|mesh-ancestor
5638789|NCT03092674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5765084|NCT02946801|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5765085|NCT02946801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5765086|NCT02946801|Cariostatic Agents|cariostatic agents|mesh-ancestor
5765087|NCT02946801|Protective Agents|protective agents|mesh-ancestor
5765088|NCT02946801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765089|NCT02946359|Bevacizumab|bevacizumab|mesh-list
5638790|NCT03092674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5638791|NCT03092674|Immunologic Factors|immunologic factors|mesh-ancestor
5638792|NCT03092674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5638793|NCT03092674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5638794|NCT03092674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5638795|NCT03086486|Linezolid|linezolid|mesh-list
5638796|NCT03086486|Bedaquiline|bedaquiline|mesh-list
5638797|NCT03086486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5638798|NCT03086486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5638799|NCT03086486|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5638800|NCT03086486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5638801|NCT03086486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5638802|NCT03086486|Antitubercular Agents|antitubercular agents|mesh-ancestor
5638803|NCT03077243|Cisplatin|cisplatin|mesh-list
5638804|NCT03077243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5638805|NCT03064867|Rituximab|rituximab|mesh-list
5638806|NCT03064867|Carboplatin|carboplatin|mesh-list
5765090|NCT02946359|Crizotinib|crizotinib|mesh-list
5638807|NCT03064867|Etoposide|etoposide|mesh-list
5638808|NCT03064867|Ifosfamide|ifosfamide|mesh-list
5638809|NCT03064867|Venetoclax|venetoclax|mesh-list
5765091|NCT02946359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5765092|NCT02946359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5765093|NCT02946359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5765094|NCT02946359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5765095|NCT02946359|Growth Substances|growth substances|mesh-ancestor
5765096|NCT02946359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765097|NCT02946359|Growth Inhibitors|growth inhibitors|mesh-ancestor
5765098|NCT02946359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5765099|NCT02946359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5765100|NCT02946359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765101|NCT02946437|Midazolam|midazolam|mesh-list
5765102|NCT02946437|Propofol|propofol|mesh-list
5765103|NCT02946437|Sevoflurane|sevoflurane|mesh-list
5765104|NCT02946437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5765105|NCT02946437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5765106|NCT02946437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765107|NCT02946437|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5765108|NCT02946437|Anesthetics, General|anesthetics, general|mesh-ancestor
5765109|NCT02946437|Anesthetics|anesthetics|mesh-ancestor
5765110|NCT02946437|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5765111|NCT02946437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5765112|NCT02946437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5765113|NCT02946437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5765114|NCT02946437|GABA Modulators|gaba modulators|mesh-ancestor
5765115|NCT02946437|GABA Agents|gaba agents|mesh-ancestor
5765116|NCT02946437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5765117|NCT02946437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765118|NCT02946437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5765119|NCT02946437|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5765120|NCT02946814|Listerine|listerine|mesh-list
5765121|NCT02946814|Sodium Fluoride|sodium fluoride|mesh-list
5765122|NCT02946814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5765123|NCT02946814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5765124|NCT02946814|Cariostatic Agents|cariostatic agents|mesh-ancestor
5765125|NCT02946814|Protective Agents|protective agents|mesh-ancestor
5765126|NCT02946814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765127|NCT02946632|Metformin|metformin|mesh-list
5765128|NCT02946632|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5765129|NCT02946632|Dapagliflozin|dapagliflozin|mesh-list
5765130|NCT02946632|Glimepiride|glimepiride|mesh-list
5765131|NCT02946632|Saxagliptin|saxagliptin|mesh-list
5765132|NCT02946632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5765133|NCT02946632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765134|NCT02946632|Incretins|incretins|mesh-ancestor
5765135|NCT02946632|Hormones|hormones|mesh-ancestor
5765136|NCT02946632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5765137|NCT02946632|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5638810|NCT03064867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5638811|NCT03064867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5638812|NCT03064867|Immunologic Factors|immunologic factors|mesh-ancestor
5638813|NCT03064867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5638814|NCT03064867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5638815|NCT03064867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5638816|NCT03064867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5638817|NCT03064867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5638818|NCT03064867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5638819|NCT03064867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5638820|NCT03064867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5638821|NCT03064867|Alkylating Agents|alkylating agents|mesh-ancestor
5765138|NCT02946632|Protease Inhibitors|protease inhibitors|mesh-ancestor
5765139|NCT02946632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6673399|NCT01562704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6673400|NCT01562704|Analgesics|analgesics|mesh-ancestor
5638822|NCT03052608|Crizotinib|crizotinib|mesh-list
5638823|NCT03052608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5638824|NCT03052608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5638825|NCT03052608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5638826|NCT03052608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5638827|NCT03049449|Cyclophosphamide|cyclophosphamide|mesh-list
5638828|NCT03049449|Fludarabine|fludarabine|mesh-list
5638829|NCT03049449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5638830|NCT03049449|Immunologic Factors|immunologic factors|mesh-ancestor
5638831|NCT03049449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5638832|NCT03049449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5638833|NCT03049449|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5638834|NCT03049449|Alkylating Agents|alkylating agents|mesh-ancestor
5638835|NCT03049449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5638836|NCT03049449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5638837|NCT03049449|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5638838|NCT03000569|Levodopa|levodopa|mesh-list
5638839|NCT03000569|Antiparkinson Agents|antiparkinson agents|mesh-list
5638840|NCT03000569|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5638841|NCT03000569|Dopamine Agents|dopamine agents|mesh-ancestor
5638842|NCT03000569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5638843|NCT03000569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5638844|NCT03000569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5638845|NCT02994784|Melphalan|melphalan|mesh-list
5638846|NCT02994784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5638847|NCT02994784|Alkylating Agents|alkylating agents|mesh-ancestor
5638848|NCT02994784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5638849|NCT02994784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5638850|NCT02994784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5638851|NCT02994784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5638852|NCT02994784|Immunologic Factors|immunologic factors|mesh-ancestor
5638853|NCT02994784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765140|NCT02946632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765141|NCT02946632|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5765142|NCT02946632|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5765143|NCT02946632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5765144|NCT02946632|Immunologic Factors|immunologic factors|mesh-ancestor
5765145|NCT02946788|Minocycline|minocycline|mesh-list
5765146|NCT02946788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5765147|NCT02946788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5895775|NCT04983589|Cholinergic Agents|cholinergic agents|mesh-ancestor
5895776|NCT04983589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5895777|NCT04983589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895778|NCT04968015|Cytarabine|cytarabine|mesh-list
5895779|NCT04968015|Venetoclax|venetoclax|mesh-list
5895780|NCT04968015|Idarubicin|idarubicin|mesh-list
5895781|NCT04968015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5895782|NCT04968015|Antimetabolites|antimetabolites|mesh-ancestor
5895783|NCT04968015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895784|NCT04968015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5895785|NCT04968015|Antiviral Agents|antiviral agents|mesh-ancestor
5895786|NCT04968015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5895787|NCT04968015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5895788|NCT04968015|Immunologic Factors|immunologic factors|mesh-ancestor
5895789|NCT04968015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895790|NCT04968015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5895791|NCT04968015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5895792|NCT04968015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5895793|NCT04968015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5895794|NCT04965935|Dapagliflozin|dapagliflozin|mesh-list
5895795|NCT04965935|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5895796|NCT04965935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895797|NCT04965935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5895798|NCT04965935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895799|NCT04964934|Letrozole|letrozole|mesh-list
5895800|NCT04964934|Palbociclib|palbociclib|mesh-list
5895801|NCT04964934|Anastrozole|anastrozole|mesh-list
5895802|NCT04964934|Hormones|hormones|mesh-list
5638854|NCT02964507|Fulvestrant|fulvestrant|mesh-list
5638855|NCT02964507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5638856|NCT02964507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5638857|NCT02964507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5638858|NCT02964507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5638859|NCT02964507|Hormone Antagonists|hormone antagonists|mesh-ancestor
5765148|NCT02946294|Epinephrine|epinephrine|mesh-list
5765149|NCT02946294|Racepinephrine|racepinephrine|mesh-list
5765150|NCT02946294|Bupivacaine|bupivacaine|mesh-list
5765151|NCT02946294|Epinephryl borate|epinephryl borate|mesh-list
5765152|NCT02946294|Anesthetics, Local|anesthetics, local|mesh-ancestor
5765153|NCT02946294|Anesthetics|anesthetics|mesh-ancestor
5765154|NCT02946294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5765155|NCT02946294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765156|NCT02946294|Sensory System Agents|sensory system agents|mesh-ancestor
5765157|NCT02946294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6490424|NCT00598234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6490425|NCT00598234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6490426|NCT00598234|Analgesics|analgesics|mesh-ancestor
5765158|NCT02946294|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5765159|NCT02946294|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5638860|NCT02964507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5638861|NCT02964507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5638862|NCT02964078|Aldesleukin|aldesleukin|mesh-list
5638863|NCT02964078|Pembrolizumab|pembrolizumab|mesh-list
5638864|NCT02964078|Interleukin-2|interleukin-2|mesh-list
5638865|NCT02964078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5638866|NCT02964078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5638867|NCT02964078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5638868|NCT02964078|Analgesics|analgesics|mesh-ancestor
5638869|NCT02964078|Sensory System Agents|sensory system agents|mesh-ancestor
5638870|NCT02964078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5638871|NCT02964078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765160|NCT02946294|Adrenergic Agents|adrenergic agents|mesh-ancestor
5765161|NCT02946294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5765162|NCT02946294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765163|NCT02946294|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5765164|NCT02946294|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5765165|NCT02946294|Autonomic Agents|autonomic agents|mesh-ancestor
5638872|NCT02964078|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5638873|NCT02964078|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5638874|NCT02964078|Antiviral Agents|antiviral agents|mesh-ancestor
5638875|NCT02964078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5638876|NCT02955394|Fulvestrant|fulvestrant|mesh-list
5638877|NCT02955394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5638878|NCT02955394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5638879|NCT02955394|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5638880|NCT02955394|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5638881|NCT02955394|Hormone Antagonists|hormone antagonists|mesh-ancestor
5638882|NCT02955394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5638883|NCT02955394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5638884|NCT02942277|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
5638885|NCT02942277|Antimalarials|antimalarials|mesh-ancestor
5638886|NCT02942277|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5638887|NCT02942277|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5638888|NCT02942277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5638889|NCT02942017|Brexanolone|brexanolone|mesh-list
5638890|NCT02942017|Neurosteroids|neurosteroids|mesh-ancestor
5638891|NCT02942017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5638892|NCT02942017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5638893|NCT02942017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5638894|NCT02942017|GABA Modulators|gaba modulators|mesh-ancestor
5638895|NCT02942017|GABA Agents|gaba agents|mesh-ancestor
5638896|NCT02942004|Pregnanolone|pregnanolone|mesh-list
5638897|NCT02942004|Brexanolone|brexanolone|mesh-list
5765166|NCT02946294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5765167|NCT02946294|Respiratory System Agents|respiratory system agents|mesh-ancestor
5765168|NCT02946294|Mydriatics|mydriatics|mesh-ancestor
5765169|NCT02946294|Sympathomimetics|sympathomimetics|mesh-ancestor
5765170|NCT02946294|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5765171|NCT02946268|Ropivacaine|ropivacaine|mesh-list
5765172|NCT02946268|Anesthetics, Local|anesthetics, local|mesh-ancestor
5765173|NCT02946268|Anesthetics|anesthetics|mesh-ancestor
5765174|NCT02946268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5765175|NCT02946268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765176|NCT02946268|Sensory System Agents|sensory system agents|mesh-ancestor
5765177|NCT02946268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5765178|NCT02946060|TEMPO|tempo|mesh-list
5765179|NCT02946060|Antioxidants|antioxidants|mesh-ancestor
5765180|NCT02946060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765181|NCT02946060|Protective Agents|protective agents|mesh-ancestor
5765182|NCT02946060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5638898|NCT02942004|Neurosteroids|neurosteroids|mesh-ancestor
5638899|NCT02942004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5638900|NCT02942004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5638901|NCT02942004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5638902|NCT02942004|GABA Modulators|gaba modulators|mesh-ancestor
5638903|NCT02942004|GABA Agents|gaba agents|mesh-ancestor
5638904|NCT02942004|Anesthetics|anesthetics|mesh-ancestor
5638905|NCT02942004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5638906|NCT02939573|Dapsone|dapsone|mesh-list
5638907|NCT02939573|Colchicine|colchicine|mesh-list
5638908|NCT02939573|Azathioprine|azathioprine|mesh-list
5638909|NCT02939573|Gout Suppressants|gout suppressants|mesh-ancestor
5638910|NCT02939573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5638911|NCT02939573|Tubulin Modulators|tubulin modulators|mesh-ancestor
5638912|NCT02939573|Antimitotic Agents|antimitotic agents|mesh-ancestor
5638913|NCT02939573|Mitosis Modulators|mitosis modulators|mesh-ancestor
5765183|NCT02945982|Entecavir|entecavir|mesh-list
5765184|NCT02945982|Carvedilol|carvedilol|mesh-list
5765185|NCT02945982|Antiviral Agents|antiviral agents|mesh-ancestor
5765186|NCT02945982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5765187|NCT02945982|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5765188|NCT02945982|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5765189|NCT02945982|Adrenergic Agents|adrenergic agents|mesh-ancestor
5765190|NCT02945982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5765191|NCT02945982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765192|NCT02945982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765193|NCT02945982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5765194|NCT02945982|Antioxidants|antioxidants|mesh-ancestor
5765195|NCT02945982|Protective Agents|protective agents|mesh-ancestor
5765196|NCT02945982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5765197|NCT02945982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5765198|NCT02945982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5765199|NCT02945982|Vasodilator Agents|vasodilator agents|mesh-ancestor
5638914|NCT02939573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5638915|NCT02939573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5638916|NCT02939573|Antimetabolites|antimetabolites|mesh-ancestor
5638917|NCT02939573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5765200|NCT02945982|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5765201|NCT02945982|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5765202|NCT02945956|Entecavir|entecavir|mesh-list
5765203|NCT02945956|Antiviral Agents|antiviral agents|mesh-ancestor
5765204|NCT02945956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5765205|NCT02945696|Ropivacaine|ropivacaine|mesh-list
5765206|NCT02945696|Anesthetics, Local|anesthetics, local|mesh-ancestor
5765207|NCT02945696|Anesthetics|anesthetics|mesh-ancestor
5765208|NCT02945696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5765209|NCT02945696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765210|NCT02945696|Sensory System Agents|sensory system agents|mesh-ancestor
5765211|NCT02945696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5765212|NCT02945839|Topiramate|topiramate|mesh-list
5765213|NCT02945839|Anticonvulsants|anticonvulsants|mesh-ancestor
5765214|NCT02945839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5765215|NCT02945839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765216|NCT02945852|Apatinib|apatinib|mesh-list
5765217|NCT02945852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5765218|NCT02945852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5765219|NCT02945852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5765220|NCT02945852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765221|NCT02945813|Metformin|metformin|mesh-list
5765222|NCT02945813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5765223|NCT02945813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765224|NCT02945644|Trazodone|trazodone|mesh-list
5765225|NCT02945644|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5765226|NCT02945644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5765227|NCT02945644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5765228|NCT02945644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765229|NCT02945644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5765230|NCT02945644|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5765231|NCT02945644|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5765232|NCT02945644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5765233|NCT02945644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765234|NCT02945644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5765235|NCT02945644|Serotonin Agents|serotonin agents|mesh-ancestor
5765236|NCT02945644|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5765237|NCT02945644|Antidepressive Agents|antidepressive agents|mesh-ancestor
5765238|NCT02945527|Dexamethasone|dexamethasone|mesh-list
5638918|NCT02939573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5638919|NCT02939573|Immunologic Factors|immunologic factors|mesh-ancestor
5638920|NCT02939573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5638921|NCT02939573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5638922|NCT02939573|Antimalarials|antimalarials|mesh-ancestor
5638923|NCT02939573|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5638924|NCT02939573|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5638925|NCT02939573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5638926|NCT02939573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5638927|NCT02939573|Leprostatic Agents|leprostatic agents|mesh-ancestor
5638928|NCT02939573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5693758|NCT03399526|Calcitriol|calcitriol|mesh-list
5693759|NCT03399526|Betamethasone|betamethasone|mesh-list
5693760|NCT03399526|Betamethasone Valerate|betamethasone valerate|mesh-list
5693761|NCT03399526|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5693762|NCT03399526|Betamethasone benzoate|betamethasone benzoate|mesh-list
5693763|NCT03399526|Clobetasol|clobetasol|mesh-list
5693764|NCT03399526|Prednicarbate|prednicarbate|mesh-list
5693765|NCT03399526|Calcipotriene|calcipotriene|mesh-list
5693766|NCT03399526|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
5693767|NCT03399526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5693768|NCT03399526|Glucocorticoids|glucocorticoids|mesh-ancestor
5765239|NCT02945527|Acetazolamide|acetazolamide|mesh-list
5765240|NCT02945527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5765241|NCT02945527|Antiemetics|antiemetics|mesh-ancestor
5765242|NCT02945527|Autonomic Agents|autonomic agents|mesh-ancestor
5765243|NCT02945527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5765244|NCT02945527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765245|NCT02945527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5765246|NCT02945527|Glucocorticoids|glucocorticoids|mesh-ancestor
5765247|NCT02945527|Hormones|hormones|mesh-ancestor
5765248|NCT02945527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5765249|NCT02945527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5765250|NCT02945527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5765251|NCT02945527|Anticonvulsants|anticonvulsants|mesh-ancestor
5765252|NCT02945527|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5765253|NCT02945527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5765254|NCT02945527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765255|NCT02945527|Diuretics|diuretics|mesh-ancestor
5765256|NCT02945527|Natriuretic Agents|natriuretic agents|mesh-ancestor
5765257|NCT02945293|Oxycodone|oxycodone|mesh-list
5765258|NCT02945293|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5765259|NCT02945293|Narcotics|narcotics|mesh-ancestor
5765260|NCT02945293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5693769|NCT03399526|Hormones|hormones|mesh-ancestor
5693770|NCT03399526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5693771|NCT03399526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693772|NCT03399526|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5693773|NCT03399526|Respiratory System Agents|respiratory system agents|mesh-ancestor
5693774|NCT03399526|Dermatologic Agents|dermatologic agents|mesh-ancestor
5693775|NCT03399526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5693776|NCT03399526|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
5693777|NCT03399526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5693778|NCT03399526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765261|NCT02945293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765262|NCT02945293|Analgesics|analgesics|mesh-ancestor
5765263|NCT02945293|Sensory System Agents|sensory system agents|mesh-ancestor
5765264|NCT02945293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5765265|NCT02945280|Apixaban|apixaban|mesh-list
5765266|NCT02945280|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5765267|NCT02945280|Antithrombins|antithrombins|mesh-ancestor
5765268|NCT02945280|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5765269|NCT02945280|Protease Inhibitors|protease inhibitors|mesh-ancestor
5765270|NCT02945280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5765271|NCT02945280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693779|NCT03399526|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5693780|NCT03399526|Vitamins|vitamins|mesh-ancestor
5693781|NCT03399526|Micronutrients|micronutrients|mesh-ancestor
5765272|NCT02945280|Anticoagulants|anticoagulants|mesh-ancestor
5765273|NCT02945267|Tegafur|tegafur|mesh-list
5765274|NCT02945267|Nimotuzumab|nimotuzumab|mesh-list
5765275|NCT02945267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5693782|NCT03399526|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5693783|NCT03399487|Ceritinib|ceritinib|mesh-list
5693784|NCT03399487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5693785|NCT03399487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5765276|NCT02945267|Antimetabolites|antimetabolites|mesh-ancestor
5765277|NCT02945267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765278|NCT02945267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5765279|NCT02945267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5765280|NCT02945241|Vancomycin|vancomycin|mesh-list
5765281|NCT02945241|Cystatins|cystatins|mesh-list
5765282|NCT02945241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5765283|NCT02945241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5765284|NCT02945241|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
5765285|NCT02945241|Protease Inhibitors|protease inhibitors|mesh-ancestor
5765286|NCT02945241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5765287|NCT02945241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765288|NCT02945163|Tenofovir|tenofovir|mesh-list
5765289|NCT02945163|Lamivudine|lamivudine|mesh-list
5765290|NCT02945163|Efavirenz|efavirenz|mesh-list
5765291|NCT02945163|Antiviral Agents|antiviral agents|mesh-ancestor
5765292|NCT02945163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5765293|NCT02945163|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5765294|NCT02945163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5765295|NCT02945163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5765296|NCT02945163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765297|NCT02945163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5638929|NCT02929589|Ibuprofen|ibuprofen|mesh-list
5638930|NCT02929589|Analgesics, Opioid|analgesics, opioid|mesh-list
5638931|NCT02929589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5765298|NCT02945163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5765299|NCT02945163|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5765300|NCT02945163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5765301|NCT02945163|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5765302|NCT02945163|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5765303|NCT02945163|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5765304|NCT02945163|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5765305|NCT02945215|Rituximab|rituximab|mesh-list
5765306|NCT02945215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5765307|NCT02945215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5765308|NCT02945215|Immunologic Factors|immunologic factors|mesh-ancestor
5765309|NCT02945215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5638932|NCT02929589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5638933|NCT02929589|Analgesics|analgesics|mesh-ancestor
5638934|NCT02929589|Sensory System Agents|sensory system agents|mesh-ancestor
5638935|NCT02929589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5638936|NCT02929589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5638937|NCT02929589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5638938|NCT02929589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5638939|NCT02929589|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5765310|NCT02945215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5765311|NCT02945072|Sevoflurane|sevoflurane|mesh-list
5638940|NCT02929589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5638941|NCT02929589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5638942|NCT02929589|Narcotics|narcotics|mesh-ancestor
5638943|NCT02929589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5638944|NCT02924064|Metformin|metformin|mesh-list
5638945|NCT02924064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5638946|NCT02924064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5638947|NCT02921256|Leucovorin|leucovorin|mesh-list
5638948|NCT02921256|Fluorouracil|fluorouracil|mesh-list
5638949|NCT02921256|Capecitabine|capecitabine|mesh-list
5638950|NCT02921256|Pembrolizumab|pembrolizumab|mesh-list
5638951|NCT02921256|Oxaliplatin|oxaliplatin|mesh-list
5638952|NCT02921256|Veliparib|veliparib|mesh-list
5638953|NCT02921256|Antimetabolites|antimetabolites|mesh-ancestor
5638954|NCT02921256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5638955|NCT02921256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5638956|NCT02921256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5638957|NCT02921256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5638958|NCT02921256|Immunologic Factors|immunologic factors|mesh-ancestor
5638959|NCT02921256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5638960|NCT02921256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5638961|NCT02921256|Antidotes|antidotes|mesh-ancestor
5638962|NCT02921256|Protective Agents|protective agents|mesh-ancestor
5638963|NCT02921256|Vitamin B Complex|vitamin b complex|mesh-ancestor
5638964|NCT02921256|Vitamins|vitamins|mesh-ancestor
5638965|NCT02921256|Micronutrients|micronutrients|mesh-ancestor
5638966|NCT02921256|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5638967|NCT02921256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5638968|NCT02910635|Moxifloxacin|moxifloxacin|mesh-list
5638969|NCT02910635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5638970|NCT02910635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5638971|NCT02910635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5638972|NCT02910635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5638973|NCT02910635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5638974|NCT02910635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5638975|NCT02910635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5638976|NCT02890355|Calcium, Dietary|calcium, dietary|mesh-list
5638977|NCT02890355|Leucovorin|leucovorin|mesh-list
5638978|NCT02890355|Folic Acid|folic acid|mesh-list
5765312|NCT02945072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5765313|NCT02945072|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5765314|NCT02945072|Anesthetics, General|anesthetics, general|mesh-ancestor
5765315|NCT02945072|Anesthetics|anesthetics|mesh-ancestor
5765316|NCT02945072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5765317|NCT02945072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765318|NCT02944942|Anesthetics|anesthetics|mesh-list
5765319|NCT02944942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5638979|NCT02890355|Fluorouracil|fluorouracil|mesh-list
5638980|NCT02890355|Irinotecan|irinotecan|mesh-list
5638981|NCT02890355|Veliparib|veliparib|mesh-list
5638982|NCT02890355|Camptothecin|camptothecin|mesh-list
5638983|NCT02890355|Calcium|calcium|mesh-list
5765320|NCT02944942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765321|NCT02945020|Simeprevir|simeprevir|mesh-list
5765322|NCT02945020|Odalasvir|odalasvir|mesh-list
5765323|NCT02945020|Dabigatran|dabigatran|mesh-list
5765324|NCT02945020|Antithrombins|antithrombins|mesh-ancestor
5765325|NCT02945020|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5765326|NCT02945020|Protease Inhibitors|protease inhibitors|mesh-ancestor
5765327|NCT02945020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5765328|NCT02945020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765329|NCT02945020|Anticoagulants|anticoagulants|mesh-ancestor
5765330|NCT02945020|Antiviral Agents|antiviral agents|mesh-ancestor
5765331|NCT02945020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5765332|NCT02944981|Gabapentin|gabapentin|mesh-list
5765333|NCT02944981|Analgesics|analgesics|mesh-ancestor
5765334|NCT02944981|Sensory System Agents|sensory system agents|mesh-ancestor
5765335|NCT02944981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5765336|NCT02944981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765337|NCT02944981|Anticonvulsants|anticonvulsants|mesh-ancestor
5765338|NCT02944981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5765339|NCT02944981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5765340|NCT02944981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5765341|NCT02944981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5638984|NCT02890355|Levoleucovorin|levoleucovorin|mesh-list
5638985|NCT02890355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5638986|NCT02890355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5638987|NCT02890355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5638988|NCT02890355|Antimetabolites|antimetabolites|mesh-ancestor
5638989|NCT02890355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5638990|NCT02890355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5638991|NCT02890355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5638992|NCT02890355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5638993|NCT02890355|Immunologic Factors|immunologic factors|mesh-ancestor
5638994|NCT02890355|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5638995|NCT02890355|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5765342|NCT02944981|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5765343|NCT02944981|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5765344|NCT02944981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5765345|NCT02944981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765346|NCT02944981|Antimanic Agents|antimanic agents|mesh-ancestor
5895803|NCT04964934|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
5895804|NCT04964934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5895805|NCT04964934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895806|NCT04964934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5895807|NCT04964934|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5895808|NCT04964934|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5895809|NCT04964934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5895810|NCT04964934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895811|NCT04964934|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5895812|NCT04964934|Hormone Antagonists|hormone antagonists|mesh-ancestor
5638996|NCT02890355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5638997|NCT02890355|Antidotes|antidotes|mesh-ancestor
5638998|NCT02890355|Protective Agents|protective agents|mesh-ancestor
5638999|NCT02890355|Vitamin B Complex|vitamin b complex|mesh-ancestor
5639000|NCT02890355|Vitamins|vitamins|mesh-ancestor
5639001|NCT02890355|Micronutrients|micronutrients|mesh-ancestor
5639002|NCT02890355|Hematinics|hematinics|mesh-ancestor
5639003|NCT02890355|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5639004|NCT02890355|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5639005|NCT02878798|Topiramate|topiramate|mesh-list
5639006|NCT02878798|Anticonvulsants|anticonvulsants|mesh-ancestor
5639007|NCT02878798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5639008|NCT02878798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209809|NCT02152007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6209810|NCT02152007|Immunologic Factors|immunologic factors|mesh-ancestor
6209811|NCT02152007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209812|NCT02152137|Paclitaxel|paclitaxel|mesh-list
6209813|NCT02152137|Efatutazone|efatutazone|mesh-list
6209814|NCT02152137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6209815|NCT02152137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6209816|NCT02152137|Tubulin Modulators|tubulin modulators|mesh-ancestor
5765347|NCT02945033|Aspirin|aspirin|mesh-list
5765348|NCT02945033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5765349|NCT02945033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5765350|NCT02945033|Analgesics|analgesics|mesh-ancestor
5765351|NCT02945033|Sensory System Agents|sensory system agents|mesh-ancestor
5765352|NCT02945033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5765353|NCT02945033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765354|NCT02945033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5765355|NCT02945033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6209817|NCT02152137|Antimitotic Agents|antimitotic agents|mesh-ancestor
6209818|NCT02152137|Mitosis Modulators|mitosis modulators|mesh-ancestor
6209819|NCT02152137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765356|NCT02945033|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6209820|NCT02152163|Ibuprofen|ibuprofen|mesh-list
6209821|NCT02152163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6209822|NCT02152163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5765357|NCT02945033|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5765358|NCT02945033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765359|NCT02945033|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5765360|NCT02945033|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5765361|NCT02945033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5765362|NCT02945033|Antipyretics|antipyretics|mesh-ancestor
5765363|NCT02944825|Ciprofloxacin|ciprofloxacin|mesh-list
5765364|NCT02944825|Trimethoprim|trimethoprim|mesh-list
5765365|NCT02944825|Sulfamethoxazole|sulfamethoxazole|mesh-list
5765366|NCT02944825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5765367|NCT02944825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5765368|NCT02944825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5765369|NCT02944825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6209823|NCT02152163|Analgesics|analgesics|mesh-ancestor
6209824|NCT02152163|Sensory System Agents|sensory system agents|mesh-ancestor
6209825|NCT02152163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6209826|NCT02152163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209827|NCT02152163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5639029|NCT02861300|Capecitabine|capecitabine|mesh-list
5639030|NCT02861300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5639031|NCT02861300|Antimetabolites|antimetabolites|mesh-ancestor
5639032|NCT02861300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5639033|NCT02861300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5639034|NCT02861014|Ocrelizumab|ocrelizumab|mesh-list
5765370|NCT02944825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5639035|NCT02861014|Immunologic Factors|immunologic factors|mesh-ancestor
5639036|NCT02861014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5639037|NCT02840227|Anesthetics|anesthetics|mesh-list
5639038|NCT02840227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5639039|NCT02840227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5639040|NCT02839707|Bevacizumab|bevacizumab|mesh-list
5639041|NCT02839707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5639042|NCT02839707|Doxorubicin|doxorubicin|mesh-list
5639043|NCT02839707|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5639044|NCT02839707|Atezolizumab|atezolizumab|mesh-list
5765371|NCT02944825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765372|NCT02944825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5765373|NCT02944825|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5765374|NCT02944825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5765375|NCT02944825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5765376|NCT02944825|Renal Agents|renal agents|mesh-ancestor
5765377|NCT02944825|Antimalarials|antimalarials|mesh-ancestor
5765378|NCT02944825|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5765379|NCT02944825|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5765380|NCT02944825|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5639045|NCT02839707|Endothelial Growth Factors|endothelial growth factors|mesh-list
5639046|NCT02839707|Antibodies|antibodies|mesh-list
5639047|NCT02839707|Immunoglobulins|immunoglobulins|mesh-list
5639048|NCT02839707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5639049|NCT02839707|Immunoglobulin G|immunoglobulin g|mesh-list
5639050|NCT02839707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5639051|NCT02839707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5639052|NCT02839707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5639053|NCT02839707|Growth Substances|growth substances|mesh-ancestor
5639054|NCT02839707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5639055|NCT02839707|Growth Inhibitors|growth inhibitors|mesh-ancestor
5639056|NCT02839707|Immunologic Factors|immunologic factors|mesh-ancestor
5639057|NCT02839707|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5639058|NCT02839707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5639059|NCT02839707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5639060|NCT02839707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5639061|NCT02839707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5639062|NCT02821832|Rifampin|rifampin|mesh-list
5639063|NCT02821832|Isoniazid|isoniazid|mesh-list
5639064|NCT02821832|Pyrazinamide|pyrazinamide|mesh-list
5639065|NCT02821832|Ethambutol|ethambutol|mesh-list
5639066|NCT02821832|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5639067|NCT02821832|Antitubercular Agents|antitubercular agents|mesh-ancestor
5639068|NCT02821832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5639069|NCT02821832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5639070|NCT02821832|Leprostatic Agents|leprostatic agents|mesh-ancestor
5639071|NCT02821832|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5639072|NCT02821832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5639073|NCT02821832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5639074|NCT02821832|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5639075|NCT02821832|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5639076|NCT02821832|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5765381|NCT02944825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5765382|NCT02944825|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
5765383|NCT02944734|Amlodipine|amlodipine|mesh-list
5765384|NCT02944734|Candesartan|candesartan|mesh-list
5765385|NCT02944734|Candesartan cilexetil|candesartan cilexetil|mesh-list
5765386|NCT02944734|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5765387|NCT02944734|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5765388|NCT02944734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5765389|NCT02944734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765390|NCT02944734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5765391|NCT02944734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765392|NCT02944734|Vasodilator Agents|vasodilator agents|mesh-ancestor
5765393|NCT02944734|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5765394|NCT02944734|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5765395|NCT02944227|Ranibizumab|ranibizumab|mesh-list
5765396|NCT02944227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5765397|NCT02944227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5765398|NCT02944227|Growth Substances|growth substances|mesh-ancestor
5765399|NCT02944227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765400|NCT02944227|Growth Inhibitors|growth inhibitors|mesh-ancestor
5765401|NCT02944227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5765402|NCT02944292|Propofol|propofol|mesh-list
5639077|NCT02821832|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5765403|NCT02944292|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5639078|NCT02821832|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5639079|NCT02821832|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5639080|NCT02821832|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5639081|NCT02821832|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5639082|NCT02821832|Antimetabolites|antimetabolites|mesh-ancestor
5639083|NCT02821832|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5639084|NCT02820857|Bevacizumab|bevacizumab|mesh-list
5639085|NCT02820857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5639086|NCT02820857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5639087|NCT02820857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5639088|NCT02820857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5639089|NCT02820857|Growth Substances|growth substances|mesh-ancestor
5639090|NCT02820857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765404|NCT02944292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5765405|NCT02944292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765406|NCT02944292|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5765407|NCT02944292|Anesthetics, General|anesthetics, general|mesh-ancestor
5765408|NCT02944292|Anesthetics|anesthetics|mesh-ancestor
5765409|NCT02944357|Gemcitabine|gemcitabine|mesh-list
5765410|NCT02944357|Cisplatin|cisplatin|mesh-list
5765411|NCT02944357|Vaccines|vaccines|mesh-list
5765412|NCT02944357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5765413|NCT02944357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5765414|NCT02944357|Antimetabolites|antimetabolites|mesh-ancestor
5765415|NCT02944357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765416|NCT02944357|Antiviral Agents|antiviral agents|mesh-ancestor
5765417|NCT02944357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5765418|NCT02944357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5765419|NCT02944357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5765420|NCT02944357|Immunologic Factors|immunologic factors|mesh-ancestor
5765421|NCT02944357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765422|NCT02944214|Febuxostat|febuxostat|mesh-list
5765423|NCT02944214|Benzbromarone|benzbromarone|mesh-list
5765424|NCT02944214|Gout Suppressants|gout suppressants|mesh-ancestor
5765425|NCT02944214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5765426|NCT02944214|Uricosuric Agents|uricosuric agents|mesh-ancestor
5765427|NCT02944214|Renal Agents|renal agents|mesh-ancestor
5765428|NCT02944396|Paclitaxel|paclitaxel|mesh-list
5639091|NCT02820857|Growth Inhibitors|growth inhibitors|mesh-ancestor
5639092|NCT02796391|Nicotine|nicotine|mesh-list
5639093|NCT02796391|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5639094|NCT02796391|Autonomic Agents|autonomic agents|mesh-ancestor
5639095|NCT02796391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5639096|NCT02796391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5639097|NCT02796391|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5639098|NCT02796391|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5639099|NCT02796391|Cholinergic Agents|cholinergic agents|mesh-ancestor
5639100|NCT02796391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5639101|NCT02796391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765429|NCT02944396|Carboplatin|carboplatin|mesh-list
5765430|NCT02944396|Nivolumab|nivolumab|mesh-list
5765431|NCT02944396|Pemetrexed|pemetrexed|mesh-list
5765432|NCT02944396|Veliparib|veliparib|mesh-list
5765433|NCT02944396|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5765434|NCT02944396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5765435|NCT02944396|Tubulin Modulators|tubulin modulators|mesh-ancestor
5639102|NCT02784210|Prednisone|prednisone|mesh-list
5639103|NCT02784210|Methylprednisolone|methylprednisolone|mesh-list
5639104|NCT02784210|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5639105|NCT02784210|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5639106|NCT02784210|Prednisolone|prednisolone|mesh-list
5639107|NCT02784210|Prednisolone acetate|prednisolone acetate|mesh-list
5639108|NCT02784210|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5639109|NCT02784210|Prednisolone phosphate|prednisolone phosphate|mesh-list
5639110|NCT02784210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5639111|NCT02784210|Glucocorticoids|glucocorticoids|mesh-ancestor
6209828|NCT02152163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6209829|NCT02152163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6209830|NCT02152163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6209831|NCT02152163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209832|NCT02152345|Methylprednisolone|methylprednisolone|mesh-list
6209833|NCT02152345|Abatacept|abatacept|mesh-list
6209834|NCT02152345|Tacrolimus|tacrolimus|mesh-list
5639112|NCT02784210|Hormones|hormones|mesh-ancestor
5765436|NCT02944396|Antimitotic Agents|antimitotic agents|mesh-ancestor
5765437|NCT02944396|Mitosis Modulators|mitosis modulators|mesh-ancestor
5765438|NCT02944396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209835|NCT02152345|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6209836|NCT02152345|Thymoglobulin|thymoglobulin|mesh-list
6209837|NCT02152345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6209838|NCT02152345|Immunologic Factors|immunologic factors|mesh-ancestor
6209839|NCT02152345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765439|NCT02944396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5765440|NCT02944396|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5639113|NCT02784210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5639114|NCT02784210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5639115|NCT02784210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5639116|NCT02784210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5639117|NCT02784210|Antiemetics|antiemetics|mesh-ancestor
5639118|NCT02784210|Autonomic Agents|autonomic agents|mesh-ancestor
5639119|NCT02784210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5765441|NCT02944396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5765442|NCT02944396|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5765443|NCT02944396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5765444|NCT02944396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5765445|NCT02944552|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
5765446|NCT02944552|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5765447|NCT02944552|Antimetabolites|antimetabolites|mesh-ancestor
5765448|NCT02944552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765449|NCT02944552|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5765450|NCT02944526|Ropivacaine|ropivacaine|mesh-list
5765451|NCT02944526|Anesthetics, Local|anesthetics, local|mesh-ancestor
5765452|NCT02944526|Anesthetics|anesthetics|mesh-ancestor
5765453|NCT02944526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5765454|NCT02944526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765455|NCT02944526|Sensory System Agents|sensory system agents|mesh-ancestor
5765456|NCT02944526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5765457|NCT02944500|Liraglutide|liraglutide|mesh-list
5765458|NCT02944500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5765459|NCT02944500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765460|NCT02944500|Incretins|incretins|mesh-ancestor
5765461|NCT02944500|Hormones|hormones|mesh-ancestor
5765462|NCT02944500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5639120|NCT02784210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5639121|NCT02784210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5639122|NCT02784210|Protective Agents|protective agents|mesh-ancestor
5639123|NCT02775851|Pembrolizumab|pembrolizumab|mesh-list
5639124|NCT02775851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5639125|NCT02775851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5639126|NCT02775435|Paclitaxel|paclitaxel|mesh-list
5639127|NCT02775435|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5639128|NCT02775435|Carboplatin|carboplatin|mesh-list
5639129|NCT02775435|Pembrolizumab|pembrolizumab|mesh-list
5639130|NCT02775435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5639131|NCT02775435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5639132|NCT02775435|Tubulin Modulators|tubulin modulators|mesh-ancestor
5639133|NCT02775435|Antimitotic Agents|antimitotic agents|mesh-ancestor
5639134|NCT02775435|Mitosis Modulators|mitosis modulators|mesh-ancestor
5765463|NCT02944201|Carvedilol|carvedilol|mesh-list
5765464|NCT02944201|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5765465|NCT02944201|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5765466|NCT02944201|Adrenergic Agents|adrenergic agents|mesh-ancestor
5765467|NCT02944201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5765468|NCT02944201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765469|NCT02944201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765470|NCT02944201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5765471|NCT02944201|Antioxidants|antioxidants|mesh-ancestor
5765472|NCT02944201|Protective Agents|protective agents|mesh-ancestor
5765473|NCT02944201|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5765474|NCT02944201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5765475|NCT02944201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5765476|NCT02944201|Vasodilator Agents|vasodilator agents|mesh-ancestor
5765477|NCT02944201|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5765478|NCT02944201|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5765479|NCT02944123|Clopidogrel|clopidogrel|mesh-list
5765480|NCT02944123|Ticagrelor|ticagrelor|mesh-list
5765481|NCT02944123|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
5639135|NCT02775435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5639136|NCT02775435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5639137|NCT02769962|Olaparib|olaparib|mesh-list
5639138|NCT02769962|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5765482|NCT02944123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5765483|NCT02944123|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5765484|NCT02944123|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5765485|NCT02944123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5765486|NCT02944123|Purinergic Agents|purinergic agents|mesh-ancestor
5765487|NCT02944123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5765488|NCT02944123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765489|NCT02944123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765490|NCT02944019|Edoxaban|edoxaban|mesh-list
5765491|NCT02944019|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5765492|NCT02944019|Antithrombins|antithrombins|mesh-ancestor
5765493|NCT02944019|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5765494|NCT02944019|Protease Inhibitors|protease inhibitors|mesh-ancestor
5765495|NCT02944019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5765496|NCT02944019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765497|NCT02944019|Anticoagulants|anticoagulants|mesh-ancestor
5765498|NCT02944175|Neostigmine|neostigmine|mesh-list
5765499|NCT02944175|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5765500|NCT02944175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5765501|NCT02944175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765502|NCT02944175|Cholinergic Agents|cholinergic agents|mesh-ancestor
5765503|NCT02944175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5765504|NCT02944175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765505|NCT02944175|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5765506|NCT02944175|Autonomic Agents|autonomic agents|mesh-ancestor
5765507|NCT02944175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5765508|NCT02944045|Methylprednisolone|methylprednisolone|mesh-list
5765509|NCT02944045|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5765510|NCT02944045|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5639139|NCT02769962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5639140|NCT02769962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5639141|NCT02769962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5639142|NCT02767531|Orlistat|orlistat|mesh-list
5639143|NCT02767531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5639144|NCT02767531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5639145|NCT02767531|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5639146|NCT02767531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5639147|NCT02757898|Biotin|biotin|mesh-list
5639148|NCT02757898|Vitamin B Complex|vitamin b complex|mesh-ancestor
5639149|NCT02757898|Vitamins|vitamins|mesh-ancestor
5639150|NCT02757898|Micronutrients|micronutrients|mesh-ancestor
5639151|NCT02757898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5639152|NCT02740335|Protein C|protein c|mesh-list
5639153|NCT02740335|Protein S|protein s|mesh-list
5639154|NCT02740335|Thrombin|thrombin|mesh-list
5639155|NCT02740335|Hemostatics|hemostatics|mesh-ancestor
5639156|NCT02740335|Coagulants|coagulants|mesh-ancestor
5639157|NCT02740335|Anticoagulants|anticoagulants|mesh-ancestor
5639158|NCT02740335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5639159|NCT02740335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5639160|NCT02740335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765511|NCT02944045|Prednisolone|prednisolone|mesh-list
5765512|NCT02944045|Prednisolone acetate|prednisolone acetate|mesh-list
5765513|NCT02944045|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5765514|NCT02944045|Prednisolone phosphate|prednisolone phosphate|mesh-list
5765515|NCT02944045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5765516|NCT02944045|Antiemetics|antiemetics|mesh-ancestor
5765517|NCT02944045|Autonomic Agents|autonomic agents|mesh-ancestor
5765518|NCT02944045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5765519|NCT02944045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765520|NCT02944045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5765521|NCT02944045|Glucocorticoids|glucocorticoids|mesh-ancestor
5765522|NCT02944045|Hormones|hormones|mesh-ancestor
5765523|NCT02944045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5765524|NCT02944045|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5765525|NCT02944045|Protective Agents|protective agents|mesh-ancestor
5765526|NCT02944045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5765527|NCT02944045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5765528|NCT02943759|Chlorhexidine|chlorhexidine|mesh-list
5765529|NCT02943759|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5765530|NCT02943759|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5765531|NCT02943759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5765532|NCT02943759|Disinfectants|disinfectants|mesh-ancestor
5639161|NCT02737306|Leronlimab|leronlimab|mesh-list
5765533|NCT02943759|Dermatologic Agents|dermatologic agents|mesh-ancestor
5765534|NCT02943707|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
5639162|NCT02737306|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5765535|NCT02943707|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5765536|NCT02943707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5765537|NCT02944110|Glucagon|glucagon|mesh-list
5765538|NCT02944110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5765539|NCT02944110|Hormones|hormones|mesh-ancestor
5765540|NCT02944110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5765541|NCT02944110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765542|NCT02943993|Edoxaban|edoxaban|mesh-list
5765543|NCT02943993|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5765544|NCT02943993|Antithrombins|antithrombins|mesh-ancestor
5765545|NCT02943993|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5765546|NCT02943993|Protease Inhibitors|protease inhibitors|mesh-ancestor
5765547|NCT02943993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5765548|NCT02943993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765549|NCT02943993|Anticoagulants|anticoagulants|mesh-ancestor
5765550|NCT02943798|Paclitaxel|paclitaxel|mesh-list
5765551|NCT02943798|Etoposide|etoposide|mesh-list
5639163|NCT02737306|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5639164|NCT02737306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5639165|NCT02737306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5639166|NCT02737306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5639167|NCT02737306|Antiviral Agents|antiviral agents|mesh-ancestor
5639168|NCT02737306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5639169|NCT02728648|Oxycodone|oxycodone|mesh-list
5639170|NCT02728648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5639171|NCT02728648|Narcotics|narcotics|mesh-ancestor
5639172|NCT02728648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5639173|NCT02728648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5639174|NCT02728648|Analgesics|analgesics|mesh-ancestor
5639175|NCT02728648|Sensory System Agents|sensory system agents|mesh-ancestor
5639176|NCT02728648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5639177|NCT02724228|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
5639178|NCT02724228|Natriuretic Agents|natriuretic agents|mesh-ancestor
5639179|NCT02724228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5639180|NCT02684058|Carboplatin|carboplatin|mesh-list
5639181|NCT02684058|Vincristine|vincristine|mesh-list
5639182|NCT02684058|Trametinib|trametinib|mesh-list
5639183|NCT02684058|Dabrafenib|dabrafenib|mesh-list
5639184|NCT02684058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5639185|NCT02684058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5639186|NCT02684058|Tubulin Modulators|tubulin modulators|mesh-ancestor
5639187|NCT02684058|Antimitotic Agents|antimitotic agents|mesh-ancestor
5639188|NCT02684058|Mitosis Modulators|mitosis modulators|mesh-ancestor
5639189|NCT02684058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5639190|NCT02684058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5639191|NCT02684058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5639192|NCT02679170|Crizotinib|crizotinib|mesh-list
5639193|NCT02679170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5639194|NCT02679170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5639195|NCT02679170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5639196|NCT02679170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765552|NCT02943798|Carboplatin|carboplatin|mesh-list
5765553|NCT02943798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5765554|NCT02943798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5765555|NCT02943798|Tubulin Modulators|tubulin modulators|mesh-ancestor
5765556|NCT02943798|Antimitotic Agents|antimitotic agents|mesh-ancestor
5765557|NCT02943798|Mitosis Modulators|mitosis modulators|mesh-ancestor
5765558|NCT02943798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765559|NCT02943798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5765560|NCT02943798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5765561|NCT02943798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5765562|NCT02943902|Vaccines|vaccines|mesh-list
5765563|NCT02943902|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5765564|NCT02943902|Immunologic Factors|immunologic factors|mesh-ancestor
5765565|NCT02943902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5639197|NCT02649790|Dexamethasone|dexamethasone|mesh-list
5639198|NCT02649790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5639199|NCT02649790|Antiemetics|antiemetics|mesh-ancestor
5639200|NCT02649790|Autonomic Agents|autonomic agents|mesh-ancestor
5639201|NCT02649790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5639202|NCT02649790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5639203|NCT02649790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5639204|NCT02649790|Glucocorticoids|glucocorticoids|mesh-ancestor
5765566|NCT02943785|Edoxaban|edoxaban|mesh-list
5765567|NCT02943785|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5639205|NCT02649790|Hormones|hormones|mesh-ancestor
5765568|NCT02943785|Antithrombins|antithrombins|mesh-ancestor
5639206|NCT02649790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5639207|NCT02649790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5639208|NCT02649790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5765569|NCT02943785|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5765570|NCT02943785|Protease Inhibitors|protease inhibitors|mesh-ancestor
5765571|NCT02943785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5765572|NCT02943785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765573|NCT02943785|Anticoagulants|anticoagulants|mesh-ancestor
5765574|NCT02943655|Mefenamic Acid|mefenamic acid|mesh-list
6490427|NCT00598234|Sensory System Agents|sensory system agents|mesh-ancestor
6490428|NCT00598234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6490429|NCT00598234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490430|NCT00598234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6490431|NCT00598234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6490432|NCT00598234|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6490433|NCT00598234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5639209|NCT02642042|Docetaxel|docetaxel|mesh-list
5765575|NCT02943655|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
5765576|NCT02943655|Contraceptive Agents|contraceptive agents|mesh-list
5765577|NCT02943655|Medroxyprogesterone|medroxyprogesterone|mesh-list
5765578|NCT02943655|Progesterone|progesterone|mesh-list
5765579|NCT02943655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5765580|NCT02943655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765581|NCT02943655|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5765582|NCT02943655|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5765583|NCT02943655|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5765584|NCT02943655|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5765585|NCT02943655|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5765586|NCT02943655|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5765587|NCT02943655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5765588|NCT02943655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5765589|NCT02943655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5765590|NCT02943655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5765591|NCT02943655|Analgesics|analgesics|mesh-ancestor
5765592|NCT02943655|Sensory System Agents|sensory system agents|mesh-ancestor
5765593|NCT02943655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5765594|NCT02943655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5765595|NCT02943655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5765596|NCT02943655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5765597|NCT02943655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5765598|NCT02943655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765599|NCT02943655|Progestins|progestins|mesh-ancestor
5765600|NCT02943655|Hormones|hormones|mesh-ancestor
5765601|NCT02943655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5765602|NCT02943603|Pembrolizumab|pembrolizumab|mesh-list
5765603|NCT02943603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5765604|NCT02943603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5639210|NCT02642042|Trametinib|trametinib|mesh-list
5639211|NCT02642042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5639212|NCT02642042|Tubulin Modulators|tubulin modulators|mesh-ancestor
5639213|NCT02642042|Antimitotic Agents|antimitotic agents|mesh-ancestor
5639214|NCT02642042|Mitosis Modulators|mitosis modulators|mesh-ancestor
5639215|NCT02642042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5639216|NCT02642042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5639217|NCT02642042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5639218|NCT02614547|Brexanolone|brexanolone|mesh-list
5639219|NCT02614547|Neurosteroids|neurosteroids|mesh-ancestor
5639220|NCT02614547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5639221|NCT02614547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5639222|NCT02614547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5639223|NCT02614547|GABA Modulators|gaba modulators|mesh-ancestor
5639224|NCT02614547|GABA Agents|gaba agents|mesh-ancestor
6209840|NCT02152345|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6209841|NCT02152345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6209842|NCT02152345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209843|NCT02152345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6209844|NCT02152345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6209845|NCT02152345|Antiemetics|antiemetics|mesh-ancestor
6209846|NCT02152345|Autonomic Agents|autonomic agents|mesh-ancestor
6209847|NCT02152345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6209848|NCT02152345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6209849|NCT02152345|Glucocorticoids|glucocorticoids|mesh-ancestor
6209850|NCT02152345|Hormones|hormones|mesh-ancestor
5765605|NCT02943369|Ticagrelor|ticagrelor|mesh-list
5765606|NCT02943369|Cangrelor|cangrelor|mesh-list
5765607|NCT02943369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5765608|NCT02943369|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5765609|NCT02943369|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5765610|NCT02943369|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5765611|NCT02943369|Purinergic Agents|purinergic agents|mesh-ancestor
5765612|NCT02943369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5765613|NCT02943369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765614|NCT02943369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765615|NCT02943317|Avelumab|avelumab|mesh-list
5765616|NCT02943317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5765617|NCT02943317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5765618|NCT02943642|Vorinostat|vorinostat|mesh-list
5765619|NCT02943642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5765620|NCT02943642|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5765621|NCT02943642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5765622|NCT02943642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765623|NCT02943356|Tadalafil|tadalafil|mesh-list
5765624|NCT02943356|Vasodilator Agents|vasodilator agents|mesh-ancestor
5765625|NCT02943356|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5765626|NCT02943356|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5765627|NCT02943356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5765628|NCT02943356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765629|NCT02943356|Urological Agents|urological agents|mesh-ancestor
5765630|NCT02943252|Apatinib|apatinib|mesh-list
5765631|NCT02943252|Tegafur|tegafur|mesh-list
5765632|NCT02943252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5765633|NCT02943252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5765634|NCT02943252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5765635|NCT02943252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765636|NCT02943252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5765637|NCT02943252|Antimetabolites|antimetabolites|mesh-ancestor
5895813|NCT04964934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5895814|NCT04964934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5895815|NCT04959812|Sufentanil|sufentanil|mesh-list
5895816|NCT04959812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5895817|NCT04959812|Narcotics|narcotics|mesh-ancestor
5895818|NCT04959812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5895819|NCT04959812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895820|NCT04959812|Analgesics|analgesics|mesh-ancestor
5895821|NCT04959812|Sensory System Agents|sensory system agents|mesh-ancestor
5895822|NCT04959812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5895823|NCT04959812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5895824|NCT04959812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5895825|NCT04959812|Anesthetics, General|anesthetics, general|mesh-ancestor
5895826|NCT04959812|Anesthetics|anesthetics|mesh-ancestor
5907871|NCT05155007|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5907872|NCT05154903|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
5907873|NCT05154903|Nootropic Agents|nootropic agents|mesh-ancestor
5907874|NCT05129475|Ritonavir|ritonavir|mesh-list
5907875|NCT05129475|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5907876|NCT05129475|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5907877|NCT05129475|Protease Inhibitors|protease inhibitors|mesh-ancestor
5907878|NCT05129475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5907879|NCT05129475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907880|NCT05129475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5907881|NCT05129475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5907882|NCT05129475|Antiviral Agents|antiviral agents|mesh-ancestor
5907883|NCT05129475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5907884|NCT05129475|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5907885|NCT05129475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5907886|NCT05123599|Tenofovir|tenofovir|mesh-list
5907887|NCT05123599|Antiviral Agents|antiviral agents|mesh-ancestor
5907888|NCT05123599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5907889|NCT05123599|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5907890|NCT05123599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5907891|NCT05123599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5907892|NCT05123599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907893|NCT05123599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5907894|NCT05123599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5907895|NCT05119296|Pembrolizumab|pembrolizumab|mesh-list
5907896|NCT05119296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5907897|NCT05119296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5907898|NCT05098132|Pembrolizumab|pembrolizumab|mesh-list
5765638|NCT02942914|Insulin Glargine|insulin glargine|mesh-list
5765639|NCT02942914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5765640|NCT02942914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765641|NCT02943135|Lidocaine|lidocaine|mesh-list
5765642|NCT02943135|Anesthetics, Local|anesthetics, local|mesh-ancestor
5765643|NCT02943135|Anesthetics|anesthetics|mesh-ancestor
5765644|NCT02943135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5765645|NCT02943135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765646|NCT02943135|Sensory System Agents|sensory system agents|mesh-ancestor
5765647|NCT02943135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5765648|NCT02943135|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5765649|NCT02943135|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5765650|NCT02943135|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5765651|NCT02943135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5765652|NCT02943135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765653|NCT02943057|Ganciclovir|ganciclovir|mesh-list
5765654|NCT02943057|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
5765655|NCT02943057|Antiviral Agents|antiviral agents|mesh-ancestor
5765656|NCT02943057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5765657|NCT02943057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5765658|NCT02943057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5765659|NCT02943057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765660|NCT02942888|Niacinamide|niacinamide|mesh-list
5765661|NCT02942888|Niacin|niacin|mesh-list
6209851|NCT02152345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6209852|NCT02152345|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6209853|NCT02152345|Protective Agents|protective agents|mesh-ancestor
6209854|NCT02152345|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6209855|NCT02152345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6209856|NCT02152371|Metformin|metformin|mesh-list
6209857|NCT02152371|Insulin Glargine|insulin glargine|mesh-list
6209858|NCT02152371|Dulaglutide|dulaglutide|mesh-list
6209859|NCT02152371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6209860|NCT02152371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209861|NCT02152384|Insulin|insulin|mesh-list
6209862|NCT02152384|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5639248|NCT02599454|Atezolizumab|atezolizumab|mesh-list
5639249|NCT02599454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5639250|NCT02595944|Nivolumab|nivolumab|mesh-list
5639251|NCT02595944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5639252|NCT02595944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5639253|NCT02595944|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5639254|NCT02595944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5639255|NCT02595931|Irinotecan|irinotecan|mesh-list
5639256|NCT02595931|Camptothecin|camptothecin|mesh-list
5639257|NCT02595931|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5639258|NCT02595931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5765662|NCT02942888|Nicotinic Acids|nicotinic acids|mesh-list
5765663|NCT02942888|Vitamin B Complex|vitamin b complex|mesh-ancestor
5765664|NCT02942888|Vitamins|vitamins|mesh-ancestor
5765665|NCT02942888|Micronutrients|micronutrients|mesh-ancestor
5765666|NCT02942888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765667|NCT02942888|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5765668|NCT02942888|Antimetabolites|antimetabolites|mesh-ancestor
5765669|NCT02942888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765670|NCT02942888|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5765671|NCT02942888|Vasodilator Agents|vasodilator agents|mesh-ancestor
5765672|NCT02942810|Cefepime|cefepime|mesh-list
5765673|NCT02942810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5765674|NCT02942810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5765675|NCT02942680|Aspirin|aspirin|mesh-list
5765676|NCT02942680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6673401|NCT01562704|Sensory System Agents|sensory system agents|mesh-ancestor
6673402|NCT01562704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6673403|NCT01562704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765677|NCT02942680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5765678|NCT02942680|Analgesics|analgesics|mesh-ancestor
5765679|NCT02942680|Sensory System Agents|sensory system agents|mesh-ancestor
5765680|NCT02942680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5765681|NCT02942680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765682|NCT02942680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5765683|NCT02942680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5765684|NCT02942680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5765685|NCT02942680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6209863|NCT02152384|Insulin Glargine|insulin glargine|mesh-list
6209864|NCT02152384|Insulin Lispro|insulin lispro|mesh-list
5765686|NCT02942680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765687|NCT02942680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5765688|NCT02942680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5765689|NCT02942680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5765690|NCT02942680|Antipyretics|antipyretics|mesh-ancestor
5765691|NCT02942693|Apatinib|apatinib|mesh-list
5765692|NCT02942693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5765693|NCT02942693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5765694|NCT02942693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5765695|NCT02942693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765696|NCT02942732|Cholecalciferol|cholecalciferol|mesh-list
5765697|NCT02942732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5639259|NCT02595931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5639260|NCT02595931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5639261|NCT02595931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5639262|NCT02595931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5639263|NCT02595905|Cisplatin|cisplatin|mesh-list
5639264|NCT02595905|Veliparib|veliparib|mesh-list
5639265|NCT02595905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5639266|NCT02595905|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5639267|NCT02595905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5639268|NCT02595905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5639269|NCT02592551|Durvalumab|durvalumab|mesh-list
5639270|NCT02592551|Tremelimumab|tremelimumab|mesh-list
5639271|NCT02592551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5639272|NCT02592551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6209865|NCT02152384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6209866|NCT02152384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209867|NCT02152631|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6209868|NCT02152631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6209869|NCT02152631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6209870|NCT02152631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6209871|NCT02152631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209872|NCT02152696|Methotrexate|methotrexate|mesh-list
6209873|NCT02152696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5765698|NCT02942732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765699|NCT02942732|Vitamins|vitamins|mesh-ancestor
5765700|NCT02942732|Micronutrients|micronutrients|mesh-ancestor
5765701|NCT02942732|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5765702|NCT02942758|Pioglitazone|pioglitazone|mesh-list
5765703|NCT02942758|Azacitidine|azacitidine|mesh-list
5765704|NCT02942758|Tretinoin|tretinoin|mesh-list
5765705|NCT02942758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5765706|NCT02942758|Antimetabolites|antimetabolites|mesh-ancestor
5765707|NCT02942758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765708|NCT02942758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5765709|NCT02942758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5765710|NCT02942758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6209874|NCT02152696|Abortifacient Agents|abortifacient agents|mesh-ancestor
6209875|NCT02152696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5639284|NCT02589691|Rocuronium|rocuronium|mesh-list
5639285|NCT02589691|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5639286|NCT02589691|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5639287|NCT02589691|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5639288|NCT02589691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5639289|NCT02589691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5639290|NCT02584933|Ceritinib|ceritinib|mesh-list
5639291|NCT02584933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5639292|NCT02584933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5639293|NCT02584933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5639294|NCT02584933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5639295|NCT02583048|Dolutegravir|dolutegravir|mesh-list
5639296|NCT02583048|Bedaquiline|bedaquiline|mesh-list
5639297|NCT02583048|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5639298|NCT02583048|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5639299|NCT02583048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5639300|NCT02583048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5639301|NCT02583048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5639302|NCT02583048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5639303|NCT02583048|Antiviral Agents|antiviral agents|mesh-ancestor
5639304|NCT02583048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5639305|NCT02583048|Antitubercular Agents|antitubercular agents|mesh-ancestor
5765711|NCT02942758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5639306|NCT02583048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5765712|NCT02942758|Keratolytic Agents|keratolytic agents|mesh-ancestor
5765713|NCT02942758|Dermatologic Agents|dermatologic agents|mesh-ancestor
5765714|NCT02942563|Capecitabine|capecitabine|mesh-list
5765715|NCT02942563|Oxaliplatin|oxaliplatin|mesh-list
5765716|NCT02942563|Irinotecan|irinotecan|mesh-list
5765717|NCT02942563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5765718|NCT02942563|Antimetabolites|antimetabolites|mesh-ancestor
5765719|NCT02942563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765720|NCT02942563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5765721|NCT02942563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5765722|NCT02942563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5765723|NCT02942563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5765724|NCT02942420|Bucillamine|bucillamine|mesh-list
5765725|NCT02942420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5765726|NCT02942420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5765727|NCT02942420|Analgesics|analgesics|mesh-ancestor
5765728|NCT02942420|Sensory System Agents|sensory system agents|mesh-ancestor
5765729|NCT02942420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5765730|NCT02942420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765731|NCT02942420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5765732|NCT02942420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5765733|NCT02942420|Antioxidants|antioxidants|mesh-ancestor
5765734|NCT02942420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765735|NCT02942420|Protective Agents|protective agents|mesh-ancestor
5765736|NCT02942706|Cetuximab|cetuximab|mesh-list
5765737|NCT02942706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5765738|NCT02942706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5765739|NCT02942498|Vitamins|vitamins|mesh-list
5765740|NCT02942498|Ascorbic Acid|ascorbic acid|mesh-list
5765741|NCT02942498|Vitamin E|vitamin e|mesh-list
5765742|NCT02942498|Micronutrients|micronutrients|mesh-ancestor
5765743|NCT02942498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765744|NCT02942498|Antioxidants|antioxidants|mesh-ancestor
5765745|NCT02942498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765746|NCT02942498|Protective Agents|protective agents|mesh-ancestor
5765747|NCT02942381|Hydroxychloroquine|hydroxychloroquine|mesh-list
5765748|NCT02942381|Antimalarials|antimalarials|mesh-ancestor
5765749|NCT02942381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5765750|NCT02942381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5765751|NCT02942381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5765752|NCT02942381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5765753|NCT02942381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765754|NCT02942381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5765755|NCT02942550|Bromides|bromides|mesh-list
5765756|NCT02942550|Methylnaltrexone|methylnaltrexone|mesh-list
5765757|NCT02942550|Anticonvulsants|anticonvulsants|mesh-ancestor
5765758|NCT02942550|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5765759|NCT02942550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765760|NCT02942550|Sensory System Agents|sensory system agents|mesh-ancestor
5765761|NCT02942550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5765762|NCT02942602|Atorvastatin|atorvastatin|mesh-list
5765763|NCT02942602|Ezetimibe|ezetimibe|mesh-list
5765764|NCT02942602|Cholestyramine Resin|cholestyramine resin|mesh-list
5765765|NCT02942602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5765766|NCT02942602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5765767|NCT02942602|Antimetabolites|antimetabolites|mesh-ancestor
5765768|NCT02942602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765769|NCT02942602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5765770|NCT02942602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5639307|NCT02546986|Pembrolizumab|pembrolizumab|mesh-list
5639308|NCT02546986|Azacitidine|azacitidine|mesh-list
5639309|NCT02546986|Cc-486|cc-486|mesh-list
5639310|NCT02546986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5639311|NCT02546986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5639312|NCT02546986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5639313|NCT02546986|Antimetabolites|antimetabolites|mesh-ancestor
5639314|NCT02546986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5639315|NCT02546986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5639316|NCT02539160|Ticagrelor|ticagrelor|mesh-list
5639317|NCT02539160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5639318|NCT02539160|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5693786|NCT03399487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5765771|NCT02942602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5765772|NCT02942329|Apatinib|apatinib|mesh-list
5765773|NCT02942329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5765774|NCT02942329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5765775|NCT02942329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5765776|NCT02942329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765777|NCT02942303|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5765778|NCT02942303|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5765779|NCT02942303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5765780|NCT02942303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765781|NCT02942303|Cholinergic Agents|cholinergic agents|mesh-ancestor
5765782|NCT02942303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5765783|NCT02942303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765784|NCT02942212|Nicotine|nicotine|mesh-list
5639319|NCT02539160|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5639320|NCT02539160|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5639321|NCT02539160|Purinergic Agents|purinergic agents|mesh-ancestor
5639322|NCT02539160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5639323|NCT02539160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5639324|NCT02539160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5639325|NCT02536300|Idelalisib|idelalisib|mesh-list
5639326|NCT02536300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5639327|NCT02536300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5639328|NCT02536300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209876|NCT02152696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209877|NCT02152696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5765785|NCT02942212|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5765786|NCT02942212|Autonomic Agents|autonomic agents|mesh-ancestor
5765787|NCT02942212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5765788|NCT02942212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765789|NCT02942212|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5765790|NCT02942212|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5765791|NCT02942212|Cholinergic Agents|cholinergic agents|mesh-ancestor
5765792|NCT02942212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5765793|NCT02942212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765794|NCT02942043|Bevacizumab|bevacizumab|mesh-list
5765795|NCT02942043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5765796|NCT02942043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5765797|NCT02942043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5765798|NCT02942043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5765799|NCT02942043|Growth Substances|growth substances|mesh-ancestor
5765800|NCT02942043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765801|NCT02942043|Growth Inhibitors|growth inhibitors|mesh-ancestor
5765802|NCT02941913|Palonosetron|palonosetron|mesh-list
5765803|NCT02941913|Antiemetics|antiemetics|mesh-ancestor
5765804|NCT02941913|Autonomic Agents|autonomic agents|mesh-ancestor
5765805|NCT02941913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5765806|NCT02941913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765807|NCT02941913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5765808|NCT02941913|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5765809|NCT02941913|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5765810|NCT02941913|Serotonin Agents|serotonin agents|mesh-ancestor
5765811|NCT02941913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5765812|NCT02941913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765813|NCT02941575|Methamphetamine|methamphetamine|mesh-list
5765814|NCT02941575|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5765815|NCT02941575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765816|NCT02941575|Sympathomimetics|sympathomimetics|mesh-ancestor
5765817|NCT02941575|Autonomic Agents|autonomic agents|mesh-ancestor
5765818|NCT02941575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5765819|NCT02941575|Dopamine Agents|dopamine agents|mesh-ancestor
5765820|NCT02941575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5765821|NCT02941575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765822|NCT02941575|Adrenergic Agents|adrenergic agents|mesh-ancestor
5765823|NCT02941575|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5765824|NCT02941575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5765825|NCT02941575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5765826|NCT02941575|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5765827|NCT02941562|Leucovorin|leucovorin|mesh-list
5765828|NCT02941562|Fluorouracil|fluorouracil|mesh-list
5765829|NCT02941562|Oxaliplatin|oxaliplatin|mesh-list
5765830|NCT02941562|Antimetabolites|antimetabolites|mesh-ancestor
5765831|NCT02941562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209878|NCT02152696|Antimetabolites|antimetabolites|mesh-ancestor
6209879|NCT02152696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209880|NCT02152696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6209881|NCT02152696|Dermatologic Agents|dermatologic agents|mesh-ancestor
5765832|NCT02941562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5765833|NCT02941562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5765834|NCT02941562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5765835|NCT02941562|Immunologic Factors|immunologic factors|mesh-ancestor
5765836|NCT02941562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765837|NCT02941562|Antidotes|antidotes|mesh-ancestor
5765838|NCT02941562|Protective Agents|protective agents|mesh-ancestor
5765839|NCT02941562|Vitamin B Complex|vitamin b complex|mesh-ancestor
5765840|NCT02941562|Vitamins|vitamins|mesh-ancestor
5765841|NCT02941562|Micronutrients|micronutrients|mesh-ancestor
5765842|NCT02941731|Oseltamivir|oseltamivir|mesh-list
5765843|NCT02941731|Antiviral Agents|antiviral agents|mesh-ancestor
5765844|NCT02941731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5765845|NCT02941731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5765846|NCT02941731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765847|NCT02941744|Nivolumab|nivolumab|mesh-list
5765848|NCT02941744|Ipilimumab|ipilimumab|mesh-list
5765849|NCT02941744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5765850|NCT02941744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6673404|NCT01562704|Antipyretics|antipyretics|mesh-ancestor
6673405|NCT01562717|Ibuprofen|ibuprofen|mesh-list
6673406|NCT01562717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6673407|NCT01562717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6673408|NCT01562717|Analgesics|analgesics|mesh-ancestor
6673409|NCT01562717|Sensory System Agents|sensory system agents|mesh-ancestor
6673410|NCT01562717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6673411|NCT01562717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673412|NCT01562717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6673413|NCT01562717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6673414|NCT01562717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6673415|NCT01562717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6673416|NCT01562717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673417|NCT01562795|Fluorometholone|fluorometholone|mesh-list
6673418|NCT01562795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
6673419|NCT01562795|Lubricant Eye Drops|lubricant eye drops|mesh-list
6673420|NCT01562795|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6673421|NCT01562795|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6673422|NCT01562795|Glucocorticoids|glucocorticoids|mesh-ancestor
6673423|NCT01562795|Hormones|hormones|mesh-ancestor
6673424|NCT01562795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6209882|NCT02152696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6209883|NCT02152696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5639337|NCT02506153|Interferons|interferons|mesh-list
5765851|NCT02941744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5639338|NCT02506153|Interferon-alpha|interferon-alpha|mesh-list
5639339|NCT02506153|Interferon alpha-2|interferon alpha-2|mesh-list
5639340|NCT02506153|Pembrolizumab|pembrolizumab|mesh-list
5639341|NCT02506153|Ipilimumab|ipilimumab|mesh-list
5639342|NCT02506153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5639343|NCT02506153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5639344|NCT02506153|Antiviral Agents|antiviral agents|mesh-ancestor
5639345|NCT02506153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5639346|NCT02506153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5639347|NCT02506153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5639348|NCT02506153|Immunologic Factors|immunologic factors|mesh-ancestor
5765852|NCT02941744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765853|NCT02941822|Ambroxol|ambroxol|mesh-list
5765854|NCT02941822|Expectorants|expectorants|mesh-ancestor
5765855|NCT02941822|Respiratory System Agents|respiratory system agents|mesh-ancestor
5895827|NCT04924660|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
5895828|NCT04924660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5895829|NCT04924660|Vasodilator Agents|vasodilator agents|mesh-ancestor
5895830|NCT04884035|Prednisone|prednisone|mesh-list
5895831|NCT04884035|Prednisolone|prednisolone|mesh-list
5895832|NCT04884035|Cyclophosphamide|cyclophosphamide|mesh-list
5895833|NCT04884035|Rituximab|rituximab|mesh-list
5895834|NCT04884035|Doxorubicin|doxorubicin|mesh-list
5895835|NCT04884035|Vincristine|vincristine|mesh-list
5895836|NCT04884035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5639349|NCT02506153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5639350|NCT02500797|Nivolumab|nivolumab|mesh-list
5639351|NCT02500797|Ipilimumab|ipilimumab|mesh-list
5639352|NCT02500797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5895837|NCT04884035|Immunologic Factors|immunologic factors|mesh-ancestor
5895838|NCT04884035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895839|NCT04884035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5895840|NCT04884035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6673425|NCT01562795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5639353|NCT02500797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5639354|NCT02500797|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5639355|NCT02500797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209884|NCT02152696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6209885|NCT02152696|Immunologic Factors|immunologic factors|mesh-ancestor
6209886|NCT02152696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5765856|NCT02941445|Metformin|metformin|mesh-list
5765857|NCT02941445|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5765858|NCT02941445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5765859|NCT02941445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765860|NCT02941445|Incretins|incretins|mesh-ancestor
5765861|NCT02941445|Hormones|hormones|mesh-ancestor
5765862|NCT02941445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5765863|NCT02941445|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5765864|NCT02941445|Protease Inhibitors|protease inhibitors|mesh-ancestor
5765865|NCT02941445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5765866|NCT02941445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765867|NCT02941510|Budesonide|budesonide|mesh-list
5765868|NCT02941510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5765869|NCT02941510|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5765870|NCT02941510|Autonomic Agents|autonomic agents|mesh-ancestor
5765871|NCT02941510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5765872|NCT02941510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765873|NCT02941510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5765874|NCT02941510|Respiratory System Agents|respiratory system agents|mesh-ancestor
5765875|NCT02941510|Glucocorticoids|glucocorticoids|mesh-ancestor
5765876|NCT02941510|Hormones|hormones|mesh-ancestor
5765877|NCT02941510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6209887|NCT02152696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5639360|NCT02477696|Acalabrutinib|acalabrutinib|mesh-list
5639361|NCT02477696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5639362|NCT02477618|Brexanolone|brexanolone|mesh-list
5639363|NCT02477618|Neurosteroids|neurosteroids|mesh-ancestor
5639364|NCT02477618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5639365|NCT02477618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5639366|NCT02477618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5639367|NCT02477618|GABA Modulators|gaba modulators|mesh-ancestor
5639368|NCT02477618|GABA Agents|gaba agents|mesh-ancestor
5639369|NCT02473497|Crizotinib|crizotinib|mesh-list
5639370|NCT02473497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5639371|NCT02473497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5639372|NCT02473497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5765878|NCT02941601|Gemcitabine|gemcitabine|mesh-list
5765879|NCT02941601|Carboplatin|carboplatin|mesh-list
5765880|NCT02941601|Necitumumab|necitumumab|mesh-list
5765881|NCT02941601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5765882|NCT02941601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5765883|NCT02941601|Antimetabolites|antimetabolites|mesh-ancestor
5765884|NCT02941601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765885|NCT02941601|Antiviral Agents|antiviral agents|mesh-ancestor
5765886|NCT02941601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5639373|NCT02473497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5639374|NCT02444741|Pembrolizumab|pembrolizumab|mesh-list
5639375|NCT02444741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5639376|NCT02444741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5639377|NCT02444429|Methylprednisolone|methylprednisolone|mesh-list
5639378|NCT02444429|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5639379|NCT02444429|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5639380|NCT02444429|Prednisolone|prednisolone|mesh-list
5639381|NCT02444429|Prednisolone acetate|prednisolone acetate|mesh-list
5639382|NCT02444429|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5639383|NCT02444429|Prednisolone phosphate|prednisolone phosphate|mesh-list
5639384|NCT02444429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5639385|NCT02444429|Antiemetics|antiemetics|mesh-ancestor
5765887|NCT02941601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5765888|NCT02941601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5765889|NCT02941601|Immunologic Factors|immunologic factors|mesh-ancestor
5765890|NCT02941601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765891|NCT02941601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5639386|NCT02444429|Autonomic Agents|autonomic agents|mesh-ancestor
5639387|NCT02444429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5639388|NCT02444429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5639389|NCT02444429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5765892|NCT02941367|Metformin|metformin|mesh-list
6209888|NCT02153489|Bromides|bromides|mesh-list
6209889|NCT02153489|Anticonvulsants|anticonvulsants|mesh-ancestor
5639390|NCT02444429|Glucocorticoids|glucocorticoids|mesh-ancestor
5639391|NCT02444429|Hormones|hormones|mesh-ancestor
5639392|NCT02444429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5639393|NCT02444429|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5639394|NCT02444429|Protective Agents|protective agents|mesh-ancestor
5639395|NCT02444429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5639396|NCT02444429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5693787|NCT03399487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693788|NCT03399474|Lidocaine|lidocaine|mesh-list
5693789|NCT03399474|Dexmedetomidine|dexmedetomidine|mesh-list
5693790|NCT03399474|Anesthetics, Local|anesthetics, local|mesh-ancestor
5693791|NCT03399474|Anesthetics|anesthetics|mesh-ancestor
5693792|NCT03399474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5693793|NCT03399474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693794|NCT03399474|Sensory System Agents|sensory system agents|mesh-ancestor
5693795|NCT03399474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5693796|NCT03399474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5693797|NCT03399474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5693798|NCT03399474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5693799|NCT03399474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5765893|NCT02941367|Lixisenatide|lixisenatide|mesh-list
5765894|NCT02941367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5765895|NCT02941367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765896|NCT02941328|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
5765897|NCT02941328|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5765898|NCT02941328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5765899|NCT02941328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765900|NCT02941328|Cholinergic Agents|cholinergic agents|mesh-ancestor
5765901|NCT02941328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5765902|NCT02941328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765903|NCT02941315|Captopril|captopril|mesh-list
5765904|NCT02941315|Spironolactone|spironolactone|mesh-list
5765905|NCT02941315|Furosemide|furosemide|mesh-list
5765906|NCT02941315|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
5765907|NCT02941315|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5765908|NCT02941315|Hormone Antagonists|hormone antagonists|mesh-ancestor
5765909|NCT02941315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5765910|NCT02941315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765911|NCT02941315|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5765912|NCT02941315|Diuretics|diuretics|mesh-ancestor
5693800|NCT03399474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693801|NCT03399474|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5693802|NCT03399474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5693803|NCT03399474|Analgesics|analgesics|mesh-ancestor
5693804|NCT03399474|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5693805|NCT03399474|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5693806|NCT03399474|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5693807|NCT03399474|Adrenergic Agents|adrenergic agents|mesh-ancestor
5693808|NCT03399474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5693809|NCT03399448|Cyclophosphamide|cyclophosphamide|mesh-list
5765913|NCT02941315|Natriuretic Agents|natriuretic agents|mesh-ancestor
5765914|NCT02941315|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5765915|NCT02941315|Adrenergic Agents|adrenergic agents|mesh-ancestor
5765916|NCT02941315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5765917|NCT02941315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765918|NCT02941315|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5765919|NCT02941315|Protease Inhibitors|protease inhibitors|mesh-ancestor
5765920|NCT02941315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5765921|NCT02941315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5765922|NCT02941315|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5765923|NCT02941315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5765924|NCT02941224|Sirolimus|sirolimus|mesh-list
5765925|NCT02941224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5765926|NCT02941224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5765927|NCT02941224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5765928|NCT02941224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5765929|NCT02941224|Antifungal Agents|antifungal agents|mesh-ancestor
5765930|NCT02941224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5765931|NCT02941224|Immunologic Factors|immunologic factors|mesh-ancestor
5765932|NCT02941224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765933|NCT02941198|Copper|copper|mesh-list
5765934|NCT02941198|Trace Elements|trace elements|mesh-ancestor
5765935|NCT02941198|Micronutrients|micronutrients|mesh-ancestor
5693810|NCT03399448|Fludarabine|fludarabine|mesh-list
5765936|NCT02941198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765937|NCT02940990|Gemcitabine|gemcitabine|mesh-list
5765938|NCT02940990|Paclitaxel|paclitaxel|mesh-list
5639397|NCT02424851|Thalidomide|thalidomide|mesh-list
5639398|NCT02424851|Dexamethasone|dexamethasone|mesh-list
5639399|NCT02424851|Bortezomib|bortezomib|mesh-list
5639400|NCT02424851|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5639401|NCT02424851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5639402|NCT02424851|Antiemetics|antiemetics|mesh-ancestor
5639403|NCT02424851|Autonomic Agents|autonomic agents|mesh-ancestor
5639404|NCT02424851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5639405|NCT02424851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5639406|NCT02424851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5639407|NCT02424851|Glucocorticoids|glucocorticoids|mesh-ancestor
5639408|NCT02424851|Hormones|hormones|mesh-ancestor
5639409|NCT02424851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5639410|NCT02424851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5639411|NCT02424851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5639412|NCT02424851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5639413|NCT02424851|Alkylating Agents|alkylating agents|mesh-ancestor
5639414|NCT02424851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5639415|NCT02424851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5639416|NCT02424851|Immunologic Factors|immunologic factors|mesh-ancestor
5639417|NCT02424851|Leprostatic Agents|leprostatic agents|mesh-ancestor
5639418|NCT02424851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5639419|NCT02424851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5639420|NCT02424851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5639421|NCT02424851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5639422|NCT02424851|Growth Substances|growth substances|mesh-ancestor
5639423|NCT02424851|Growth Inhibitors|growth inhibitors|mesh-ancestor
5639424|NCT02423876|Hydromorphone|hydromorphone|mesh-list
5639425|NCT02423876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5639426|NCT02423876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5639427|NCT02423876|Sensory System Agents|sensory system agents|mesh-ancestor
5639428|NCT02423876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5639429|NCT02423876|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5639430|NCT02423876|Narcotics|narcotics|mesh-ancestor
5639431|NCT02423876|Analgesics|analgesics|mesh-ancestor
5639432|NCT02404870|Canagliflozin|canagliflozin|mesh-list
5639433|NCT02404870|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5639434|NCT02404870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5639435|NCT02404870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5639436|NCT02404870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5639437|NCT02400814|Atezolizumab|atezolizumab|mesh-list
5639438|NCT02400814|Antibodies|antibodies|mesh-list
5639439|NCT02400814|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5639440|NCT02400814|Immunologic Factors|immunologic factors|mesh-ancestor
5639441|NCT02400814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5639442|NCT02400814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5639443|NCT02368301|Dexamethasone|dexamethasone|mesh-list
5639444|NCT02368301|Lenalidomide|lenalidomide|mesh-list
5639445|NCT02368301|Elotuzumab|elotuzumab|mesh-list
5639446|NCT02368301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5639447|NCT02368301|Antiemetics|antiemetics|mesh-ancestor
5639448|NCT02368301|Autonomic Agents|autonomic agents|mesh-ancestor
5639449|NCT02368301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5639450|NCT02368301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5639451|NCT02368301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5639452|NCT02368301|Glucocorticoids|glucocorticoids|mesh-ancestor
5639453|NCT02368301|Hormones|hormones|mesh-ancestor
5639454|NCT02368301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5765939|NCT02940990|Etoposide|etoposide|mesh-list
5765940|NCT02940990|Vinorelbine|vinorelbine|mesh-list
5765941|NCT02940990|Docetaxel|docetaxel|mesh-list
5765942|NCT02940990|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5765943|NCT02940990|Carboplatin|carboplatin|mesh-list
5765944|NCT02940990|Pemetrexed|pemetrexed|mesh-list
5765945|NCT02940990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5765946|NCT02940990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5765947|NCT02940990|Tubulin Modulators|tubulin modulators|mesh-ancestor
5765948|NCT02940990|Antimitotic Agents|antimitotic agents|mesh-ancestor
5765949|NCT02940990|Mitosis Modulators|mitosis modulators|mesh-ancestor
5765950|NCT02940990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765951|NCT02940990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5765952|NCT02940990|Antimetabolites|antimetabolites|mesh-ancestor
5639455|NCT02368301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5765953|NCT02940990|Antiviral Agents|antiviral agents|mesh-ancestor
5765954|NCT02940990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5765955|NCT02940990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5765956|NCT02940990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5765957|NCT02940990|Immunologic Factors|immunologic factors|mesh-ancestor
5765958|NCT02940990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765959|NCT02940990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5765960|NCT02940990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5765961|NCT02940990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5765962|NCT02940990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5765963|NCT02940925|Cisplatin|cisplatin|mesh-list
5765964|NCT02940925|Fluorouracil|fluorouracil|mesh-list
5765965|NCT02940925|Capecitabine|capecitabine|mesh-list
5765966|NCT02940925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5765967|NCT02940925|Antimetabolites|antimetabolites|mesh-ancestor
5765968|NCT02940925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765969|NCT02940925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5765970|NCT02940925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5765971|NCT02940925|Immunologic Factors|immunologic factors|mesh-ancestor
5765972|NCT02940925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765973|NCT02941016|Evolocumab|evolocumab|mesh-list
5765974|NCT02941016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5765975|NCT02941016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5765976|NCT02941016|Antimetabolites|antimetabolites|mesh-ancestor
5765977|NCT02941016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765978|NCT02941016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5765979|NCT02940912|Apomorphine|apomorphine|mesh-list
5765980|NCT02940912|Emetics|emetics|mesh-ancestor
5765981|NCT02940912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765982|NCT02940912|Autonomic Agents|autonomic agents|mesh-ancestor
5765983|NCT02940912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5639456|NCT02368301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5639457|NCT02368301|Immunologic Factors|immunologic factors|mesh-ancestor
5639458|NCT02368301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5765984|NCT02940912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5765985|NCT02940912|Dopamine Agonists|dopamine agonists|mesh-ancestor
6490434|NCT00598234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6490435|NCT00598234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490436|NCT00598247|Paclitaxel|paclitaxel|mesh-list
6490437|NCT00598247|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
6490438|NCT00598247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6490439|NCT00598247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6490440|NCT00598247|Tubulin Modulators|tubulin modulators|mesh-ancestor
6490441|NCT00598247|Antimitotic Agents|antimitotic agents|mesh-ancestor
6490442|NCT00598247|Mitosis Modulators|mitosis modulators|mesh-ancestor
5765986|NCT02940912|Dopamine Agents|dopamine agents|mesh-ancestor
5765987|NCT02940912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5765988|NCT02940912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5765989|NCT02940821|Hydrogen Peroxide|hydrogen peroxide|mesh-list
5765990|NCT02940821|Fluorides|fluorides|mesh-list
5765991|NCT02940821|Tin Fluorides|tin fluorides|mesh-list
5765992|NCT02940821|Fluorophosphate|fluorophosphate|mesh-list
5765993|NCT02940821|Cariostatic Agents|cariostatic agents|mesh-ancestor
5765994|NCT02940821|Protective Agents|protective agents|mesh-ancestor
5765995|NCT02940821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5765996|NCT02940821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5765997|NCT02940821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5765998|NCT02940808|Caffeine|caffeine|mesh-list
5765999|NCT02940808|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5766000|NCT02940808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766001|NCT02940808|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5766002|NCT02940808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5766003|NCT02940808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766004|NCT02940808|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5639459|NCT02368301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5639460|NCT02368301|Growth Substances|growth substances|mesh-ancestor
5639461|NCT02368301|Growth Inhibitors|growth inhibitors|mesh-ancestor
6209890|NCT02153671|Vaccines|vaccines|mesh-list
6209891|NCT02153671|Immunologic Factors|immunologic factors|mesh-ancestor
6209892|NCT02153671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209893|NCT02153723|Glatiramer Acetate|glatiramer acetate|mesh-list
6209894|NCT02153723|(T,G)-A-L|(t,g)-a-l|mesh-list
6209895|NCT02153723|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6209896|NCT02153723|Immunologic Factors|immunologic factors|mesh-ancestor
6209897|NCT02153723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209898|NCT02153723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5766005|NCT02940808|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6209899|NCT02153723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6209900|NCT02153788|Temazepam|temazepam|mesh-list
6209901|NCT02153788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6209902|NCT02153788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6209903|NCT02153788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209904|NCT02153788|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6209905|NCT02153788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6209906|NCT02153788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5766006|NCT02940808|Purinergic Agents|purinergic agents|mesh-ancestor
5766007|NCT02940808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5766008|NCT02940717|Lithium Carbonate|lithium carbonate|mesh-list
5766009|NCT02940717|Antidepressive Agents|antidepressive agents|mesh-ancestor
5766010|NCT02940717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5766011|NCT02940717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5766012|NCT02940717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766013|NCT02940717|Antimanic Agents|antimanic agents|mesh-ancestor
5639479|NCT02332668|Pembrolizumab|pembrolizumab|mesh-list
5639480|NCT02332668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5639481|NCT02332668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6209907|NCT02153788|GABA Modulators|gaba modulators|mesh-ancestor
6209908|NCT02153788|GABA Agents|gaba agents|mesh-ancestor
6209909|NCT02153788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6209910|NCT02153788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209911|NCT02153905|Aldesleukin|aldesleukin|mesh-list
5639487|NCT02319837|Leuprolide|leuprolide|mesh-list
5766014|NCT02940717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5766015|NCT02940717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5766016|NCT02940717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766017|NCT02940756|Artesunate|artesunate|mesh-list
5766018|NCT02940756|Lumefantrine|lumefantrine|mesh-list
5766019|NCT02940756|Artemether|artemether|mesh-list
5766020|NCT02940756|Piperaquine|piperaquine|mesh-list
5766021|NCT02940756|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
5766022|NCT02940756|Amodiaquine|amodiaquine|mesh-list
5766023|NCT02940756|Artenimol|artenimol|mesh-list
5766024|NCT02940756|Antimalarials|antimalarials|mesh-ancestor
5766025|NCT02940756|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5766026|NCT02940756|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5766027|NCT02940756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5766028|NCT02940756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5766029|NCT02940756|Antiviral Agents|antiviral agents|mesh-ancestor
5766030|NCT02940756|Schistosomicides|schistosomicides|mesh-ancestor
5766031|NCT02940756|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5766032|NCT02940756|Anthelmintics|anthelmintics|mesh-ancestor
5766033|NCT02941068|Fluconazole|fluconazole|mesh-list
5766034|NCT02941068|Caspofungin|caspofungin|mesh-list
5766035|NCT02941068|Antifungal Agents|antifungal agents|mesh-ancestor
5766036|NCT02941068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5766037|NCT02941068|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5766038|NCT02941068|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5766039|NCT02941068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5766040|NCT02941068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766041|NCT02941068|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5766042|NCT02941068|Hormone Antagonists|hormone antagonists|mesh-ancestor
5766043|NCT02941068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5766044|NCT02941068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766045|NCT02941068|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5639488|NCT02319837|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5639489|NCT02319837|Fertility Agents|fertility agents|mesh-ancestor
5639490|NCT02319837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5639491|NCT02319837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5639492|NCT02319837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5639493|NCT02319837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6209912|NCT02153905|Cyclophosphamide|cyclophosphamide|mesh-list
6209913|NCT02153905|Fludarabine|fludarabine|mesh-list
6209914|NCT02153905|Interleukin-2|interleukin-2|mesh-list
6209915|NCT02153905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6209916|NCT02153905|Immunologic Factors|immunologic factors|mesh-ancestor
5639499|NCT02285504|Brexanolone|brexanolone|mesh-list
5639500|NCT02285504|Neurosteroids|neurosteroids|mesh-ancestor
5639501|NCT02285504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5639502|NCT02285504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5639503|NCT02285504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5639504|NCT02285504|GABA Modulators|gaba modulators|mesh-ancestor
5766046|NCT02941068|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5639505|NCT02285504|GABA Agents|gaba agents|mesh-ancestor
6209917|NCT02153905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209918|NCT02153905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5766047|NCT02940548|Amlodipine|amlodipine|mesh-list
5766048|NCT02940548|Nifedipine|nifedipine|mesh-list
5766049|NCT02940548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5766050|NCT02940548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5766051|NCT02940548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5766052|NCT02940548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766053|NCT02940548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5766054|NCT02940548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766055|NCT02940548|Vasodilator Agents|vasodilator agents|mesh-ancestor
5766056|NCT02940548|Tocolytic Agents|tocolytic agents|mesh-ancestor
5766057|NCT02940548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5766058|NCT02940301|Nivolumab|nivolumab|mesh-list
5766059|NCT02940301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5766060|NCT02940301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5766061|NCT02940301|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5766062|NCT02940301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766063|NCT02940379|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
5766064|NCT02940379|Metoprolol|metoprolol|mesh-list
5766065|NCT02940379|Midazolam|midazolam|mesh-list
5766066|NCT02940379|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5766067|NCT02940379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5766068|NCT02940379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5766069|NCT02940379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766070|NCT02940379|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5766071|NCT02940379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5766072|NCT02940379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5766073|NCT02940379|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5766074|NCT02940379|Anesthetics, General|anesthetics, general|mesh-ancestor
5766075|NCT02940379|Anesthetics|anesthetics|mesh-ancestor
5766076|NCT02940379|GABA Modulators|gaba modulators|mesh-ancestor
5766077|NCT02940379|GABA Agents|gaba agents|mesh-ancestor
5766078|NCT02940379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5766079|NCT02940379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209919|NCT02153905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6209920|NCT02153905|Alkylating Agents|alkylating agents|mesh-ancestor
6209921|NCT02153905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209922|NCT02153905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6209923|NCT02153905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6209924|NCT02153905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6209925|NCT02153905|Analgesics|analgesics|mesh-ancestor
6209926|NCT02153905|Sensory System Agents|sensory system agents|mesh-ancestor
6209927|NCT02153905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6209928|NCT02153905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6209929|NCT02153905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6209930|NCT02153905|Antiviral Agents|antiviral agents|mesh-ancestor
5766080|NCT02940379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5766081|NCT02940379|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5766082|NCT02940379|Sympatholytics|sympatholytics|mesh-ancestor
5766083|NCT02940379|Autonomic Agents|autonomic agents|mesh-ancestor
5766084|NCT02940379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5766085|NCT02940379|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5766086|NCT02940379|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5766087|NCT02940379|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5766088|NCT02940379|Adrenergic Agents|adrenergic agents|mesh-ancestor
5766089|NCT02940379|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5766090|NCT02940379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5766091|NCT02940535|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5766092|NCT02940535|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5766093|NCT02940535|Menotropins|menotropins|mesh-list
5766094|NCT02940535|Luteolytic Agents|luteolytic agents|mesh-ancestor
5766095|NCT02940535|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5766096|NCT02940535|Contraceptive Agents|contraceptive agents|mesh-ancestor
5766097|NCT02940535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5766098|NCT02940535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766099|NCT02940535|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5766100|NCT02940535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5766101|NCT02940535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5766102|NCT02940535|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5766103|NCT02940535|Fertility Agents|fertility agents|mesh-ancestor
5766104|NCT02940509|Magnesium Sulfate|magnesium sulfate|mesh-list
5766105|NCT02940509|Ketamine|ketamine|mesh-list
5766106|NCT02940509|Analgesics|analgesics|mesh-ancestor
6209931|NCT02153905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6209932|NCT02153918|Metronidazole|metronidazole|mesh-list
6209933|NCT02153918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6209934|NCT02153918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6209935|NCT02153918|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6209936|NCT02153918|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5639525|NCT02257528|Nivolumab|nivolumab|mesh-list
5639526|NCT02257528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5639527|NCT02257528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5639528|NCT02257528|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5766107|NCT02940509|Sensory System Agents|sensory system agents|mesh-ancestor
5766108|NCT02940509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5766109|NCT02940509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766110|NCT02940509|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5766111|NCT02940509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5766112|NCT02940509|Anesthetics, General|anesthetics, general|mesh-ancestor
5766113|NCT02940509|Anesthetics|anesthetics|mesh-ancestor
5766114|NCT02940509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5766115|NCT02940509|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5766116|NCT02940509|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5766117|NCT02940509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5766118|NCT02940509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766119|NCT02940509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5639529|NCT02257528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209937|NCT02153983|Colchicine|colchicine|mesh-list
6209938|NCT02153983|Gout Suppressants|gout suppressants|mesh-ancestor
6209939|NCT02153983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6209940|NCT02153983|Tubulin Modulators|tubulin modulators|mesh-ancestor
6209941|NCT02153983|Antimitotic Agents|antimitotic agents|mesh-ancestor
6209942|NCT02153983|Mitosis Modulators|mitosis modulators|mesh-ancestor
6209943|NCT02153983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209944|NCT02153983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6209945|NCT02154048|Dexamethasone|dexamethasone|mesh-list
6209946|NCT02154048|Ropivacaine|ropivacaine|mesh-list
6209947|NCT02154048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6209948|NCT02154048|Antiemetics|antiemetics|mesh-ancestor
6209949|NCT02154048|Autonomic Agents|autonomic agents|mesh-ancestor
6209950|NCT02154048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6209951|NCT02154048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209952|NCT02154048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6209953|NCT02154048|Glucocorticoids|glucocorticoids|mesh-ancestor
6209954|NCT02154048|Hormones|hormones|mesh-ancestor
6209955|NCT02154048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6209956|NCT02154048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5639550|NCT02233829|Dopamine|dopamine|mesh-list
5639551|NCT02233829|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5639552|NCT02233829|Sympathomimetics|sympathomimetics|mesh-ancestor
5639553|NCT02233829|Autonomic Agents|autonomic agents|mesh-ancestor
5639554|NCT02233829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5639555|NCT02233829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5639556|NCT02233829|Dopamine Agents|dopamine agents|mesh-ancestor
5639557|NCT02233829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5639558|NCT02233829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5639559|NCT02233829|Protective Agents|protective agents|mesh-ancestor
5639560|NCT02227394|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
5639561|NCT02227394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5766120|NCT02940509|Anticonvulsants|anticonvulsants|mesh-ancestor
5766121|NCT02940509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5766122|NCT02940509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5766123|NCT02940509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5766124|NCT02940509|Tocolytic Agents|tocolytic agents|mesh-ancestor
5766125|NCT02940509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5766126|NCT02940561|Methotrexate|methotrexate|mesh-list
5766127|NCT02940561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5766128|NCT02940561|Abortifacient Agents|abortifacient agents|mesh-ancestor
5766129|NCT02940561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5766130|NCT02940561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766131|NCT02940561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5766132|NCT02940561|Antimetabolites|antimetabolites|mesh-ancestor
5766133|NCT02940561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766134|NCT02940561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5766135|NCT02940561|Dermatologic Agents|dermatologic agents|mesh-ancestor
6209957|NCT02154048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5639562|NCT02227394|Respiratory System Agents|respiratory system agents|mesh-ancestor
5639563|NCT02196181|Trametinib|trametinib|mesh-list
5766136|NCT02940561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5766137|NCT02940561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5766138|NCT02940561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5766139|NCT02940561|Immunologic Factors|immunologic factors|mesh-ancestor
5766140|NCT02940561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5766141|NCT02940561|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5766142|NCT02940314|Solifenacin Succinate|solifenacin succinate|mesh-list
5766143|NCT02940314|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5766144|NCT02940314|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5766145|NCT02940314|Cholinergic Agents|cholinergic agents|mesh-ancestor
5766146|NCT02940314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5766147|NCT02940314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766148|NCT02940314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766149|NCT02940314|Urological Agents|urological agents|mesh-ancestor
5766150|NCT02940366|Atorvastatin|atorvastatin|mesh-list
5766151|NCT02940366|Pitavastatin|pitavastatin|mesh-list
5766152|NCT02940366|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5766153|NCT02940366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5766154|NCT02940366|Antimetabolites|antimetabolites|mesh-ancestor
5766155|NCT02940366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766156|NCT02940366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5766157|NCT02940366|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5766158|NCT02940366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5766159|NCT02940405|Ketorolac|ketorolac|mesh-list
5766160|NCT02940405|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
5766161|NCT02940405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5766162|NCT02940405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5766163|NCT02940405|Analgesics|analgesics|mesh-ancestor
5766164|NCT02940405|Sensory System Agents|sensory system agents|mesh-ancestor
5766165|NCT02940405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5766166|NCT02940405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766167|NCT02940405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5766168|NCT02940405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5766169|NCT02940405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5766170|NCT02940405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5766171|NCT02940405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766172|NCT02940444|Heparin|heparin|mesh-list
5766173|NCT02940444|Anticoagulants|anticoagulants|mesh-ancestor
5766174|NCT02940444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5766175|NCT02940444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5766176|NCT02940444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766177|NCT02940483|Azacitidine|azacitidine|mesh-list
5766178|NCT02940483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5766179|NCT02940483|Antimetabolites|antimetabolites|mesh-ancestor
5766180|NCT02940483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766181|NCT02940483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5766182|NCT02940483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5766183|NCT02940262|Edetic Acid|edetic acid|mesh-list
5766184|NCT02940262|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5766185|NCT02940262|Chelating Agents|chelating agents|mesh-ancestor
5639564|NCT02196181|Dabrafenib|dabrafenib|mesh-list
5639565|NCT02196181|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
5639566|NCT02196181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5639567|NCT02196181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5639568|NCT02196181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5639569|NCT02196181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5639570|NCT02196181|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
5639571|NCT02196181|Protective Agents|protective agents|mesh-ancestor
5639572|NCT02196181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5639573|NCT02196181|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5639574|NCT02196181|Antioxidants|antioxidants|mesh-ancestor
6209958|NCT02154048|Anesthetics, Local|anesthetics, local|mesh-ancestor
6209959|NCT02154048|Anesthetics|anesthetics|mesh-ancestor
6209960|NCT02154048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6209961|NCT02154048|Sensory System Agents|sensory system agents|mesh-ancestor
5766186|NCT02940262|Sequestering Agents|sequestering agents|mesh-ancestor
5766187|NCT02940262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766188|NCT02940262|Anticoagulants|anticoagulants|mesh-ancestor
5766189|NCT02940262|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5766190|NCT02940262|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5766191|NCT02940184|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5766192|NCT02940184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6209962|NCT02154061|Metronidazole|metronidazole|mesh-list
6209963|NCT02154061|Vancomycin|vancomycin|mesh-list
6209964|NCT02154061|Neomycin|neomycin|mesh-list
5895841|NCT04884035|Alkylating Agents|alkylating agents|mesh-ancestor
6209965|NCT02154061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6209966|NCT02154061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6209967|NCT02154061|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6209968|NCT02154061|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6209969|NCT02154061|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6209970|NCT02154061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6209971|NCT02154061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209972|NCT02154139|Leuprolide|leuprolide|mesh-list
6209973|NCT02154139|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6209974|NCT02154139|Fertility Agents|fertility agents|mesh-ancestor
6209975|NCT02154139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6209976|NCT02154139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766193|NCT02940184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766194|NCT02940184|Incretins|incretins|mesh-ancestor
5766195|NCT02940184|Hormones|hormones|mesh-ancestor
5766196|NCT02940184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5766197|NCT02940184|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6209977|NCT02154139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6209978|NCT02154139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6209979|NCT02154243|Midodrine|midodrine|mesh-list
5639598|NCT02193282|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5639599|NCT02193282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5639600|NCT02193282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5639601|NCT02193282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5639602|NCT02193282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5639603|NCT02184741|Immunoglobulins|immunoglobulins|mesh-list
5639604|NCT02184741|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5639605|NCT02184741|gamma-Globulins|gamma-globulins|mesh-list
5639606|NCT02184741|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5639607|NCT02184741|Immunologic Factors|immunologic factors|mesh-ancestor
5639608|NCT02184741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5639609|NCT02176863|Immunoglobulins|immunoglobulins|mesh-list
5639610|NCT02176863|gamma-Globulins|gamma-globulins|mesh-list
5639611|NCT02176863|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5639612|NCT02176863|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5639613|NCT02176863|Immunologic Factors|immunologic factors|mesh-ancestor
5639614|NCT02176863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209980|NCT02154243|Sympathomimetics|sympathomimetics|mesh-ancestor
6209981|NCT02154243|Autonomic Agents|autonomic agents|mesh-ancestor
6209982|NCT02154243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6209983|NCT02154243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209984|NCT02154243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6209985|NCT02154243|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6209986|NCT02154243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5766198|NCT02940184|Protease Inhibitors|protease inhibitors|mesh-ancestor
5766199|NCT02940184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5766200|NCT02940184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895842|NCT04884035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895843|NCT04884035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5895844|NCT04884035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5895845|NCT04884035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5895846|NCT04884035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5895847|NCT04884035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5895848|NCT04884035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5895849|NCT04884035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5895850|NCT04884035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5895851|NCT04884035|Glucocorticoids|glucocorticoids|mesh-ancestor
6209987|NCT02154243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6209988|NCT02154243|Adrenergic Agents|adrenergic agents|mesh-ancestor
6209989|NCT02154243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6209990|NCT02154243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6209991|NCT02154347|Mitiglinide|mitiglinide|mesh-list
6209992|NCT02154347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6209993|NCT02154347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209994|NCT02154425|Certolizumab Pegol|certolizumab pegol|mesh-list
6209995|NCT02154425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6209996|NCT02154425|Immunologic Factors|immunologic factors|mesh-ancestor
6209997|NCT02154425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6209998|NCT02154425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6209999|NCT02154477|Insulin|insulin|mesh-list
6210000|NCT02154477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6210001|NCT02154477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210002|NCT02154763|Ropivacaine|ropivacaine|mesh-list
6210003|NCT02154763|Anesthetics, Local|anesthetics, local|mesh-ancestor
5766201|NCT02940002|Betamethasone|betamethasone|mesh-list
5766202|NCT02940002|Clobetasol|clobetasol|mesh-list
5766203|NCT02940002|Calcipotriene|calcipotriene|mesh-list
5766204|NCT02940002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5766205|NCT02940002|Glucocorticoids|glucocorticoids|mesh-ancestor
5766206|NCT02940002|Hormones|hormones|mesh-ancestor
5766207|NCT02940002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5766208|NCT02940002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766209|NCT02940002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5766210|NCT02940002|Respiratory System Agents|respiratory system agents|mesh-ancestor
5766211|NCT02940002|Dermatologic Agents|dermatologic agents|mesh-ancestor
5766212|NCT02939833|Ropivacaine|ropivacaine|mesh-list
5766213|NCT02939833|Anesthetics, Local|anesthetics, local|mesh-ancestor
5766214|NCT02939833|Anesthetics|anesthetics|mesh-ancestor
5766215|NCT02939833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5766216|NCT02939833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766217|NCT02939833|Sensory System Agents|sensory system agents|mesh-ancestor
5766218|NCT02939833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5766219|NCT02939872|Aspirin|aspirin|mesh-list
5766220|NCT02939872|Clopidogrel|clopidogrel|mesh-list
5766221|NCT02939872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5766222|NCT02939872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6210004|NCT02154763|Anesthetics|anesthetics|mesh-ancestor
6210005|NCT02154763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6210006|NCT02154763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210007|NCT02154763|Sensory System Agents|sensory system agents|mesh-ancestor
6210008|NCT02154763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6210009|NCT02155010|Dexmedetomidine|dexmedetomidine|mesh-list
6210010|NCT02155010|Bupivacaine|bupivacaine|mesh-list
6210011|NCT02155010|Anesthetics, Local|anesthetics, local|mesh-ancestor
6210012|NCT02155010|Anesthetics|anesthetics|mesh-ancestor
6210013|NCT02155010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6210014|NCT02155010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210015|NCT02155010|Sensory System Agents|sensory system agents|mesh-ancestor
6210016|NCT02155010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6210017|NCT02155010|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6210018|NCT02155010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6210019|NCT02155010|Analgesics|analgesics|mesh-ancestor
6210020|NCT02155010|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6210021|NCT02155010|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6210022|NCT02155010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6210023|NCT02155010|Adrenergic Agents|adrenergic agents|mesh-ancestor
6210024|NCT02155010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6210025|NCT02155010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210026|NCT02155101|Ritonavir|ritonavir|mesh-list
6210027|NCT02155101|Lopinavir|lopinavir|mesh-list
5639662|NCT02073968|Paclitaxel|paclitaxel|mesh-list
5639663|NCT02073968|Carboplatin|carboplatin|mesh-list
5639664|NCT02073968|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5639665|NCT02073968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5639666|NCT02073968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5639667|NCT02073968|Tubulin Modulators|tubulin modulators|mesh-ancestor
5639668|NCT02073968|Antimitotic Agents|antimitotic agents|mesh-ancestor
5639669|NCT02073968|Mitosis Modulators|mitosis modulators|mesh-ancestor
5639670|NCT02073968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210028|NCT02155101|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6210029|NCT02155101|Darunavir|darunavir|mesh-list
6210030|NCT02155101|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6210031|NCT02155101|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6210032|NCT02155101|Protease Inhibitors|protease inhibitors|mesh-ancestor
6210033|NCT02155101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6210034|NCT02155101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210035|NCT02155101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6210036|NCT02155101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6210037|NCT02155101|Antiviral Agents|antiviral agents|mesh-ancestor
6210038|NCT02155101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6210039|NCT02155101|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6210040|NCT02155101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6210041|NCT02155257|Gabapentin|gabapentin|mesh-list
6210042|NCT02155257|Modafinil|modafinil|mesh-list
5766223|NCT02939872|Analgesics|analgesics|mesh-ancestor
5766224|NCT02939872|Sensory System Agents|sensory system agents|mesh-ancestor
5766225|NCT02939872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5766226|NCT02939872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210043|NCT02155257|Analgesics|analgesics|mesh-ancestor
6210044|NCT02155257|Sensory System Agents|sensory system agents|mesh-ancestor
6673426|NCT01562795|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6210045|NCT02155257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6210046|NCT02155257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766227|NCT02939872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5766228|NCT02939872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5766229|NCT02939872|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5766230|NCT02939872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5766231|NCT02939872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766232|NCT02939872|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5766233|NCT02939872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5766234|NCT02939872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5766235|NCT02939872|Antipyretics|antipyretics|mesh-ancestor
5766236|NCT02939872|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5766237|NCT02939872|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5766238|NCT02939872|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5766239|NCT02939872|Purinergic Agents|purinergic agents|mesh-ancestor
5766240|NCT02939872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5766241|NCT02939898|Letrozole|letrozole|mesh-list
5766242|NCT02939898|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5766243|NCT02939898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5766244|NCT02939898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5766245|NCT02939898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5766246|NCT02939898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766247|NCT02939898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5766248|NCT02939898|Hormone Antagonists|hormone antagonists|mesh-ancestor
5766249|NCT02939898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5766250|NCT02939898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766251|NCT02939846|Trametinib|trametinib|mesh-list
5766252|NCT02939846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5766253|NCT02939846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5766254|NCT02939846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5766255|NCT02939846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766256|NCT02939495|Sildenafil Citrate|sildenafil citrate|mesh-list
5766257|NCT02939495|Vasodilator Agents|vasodilator agents|mesh-ancestor
5766258|NCT02939495|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5766259|NCT02939495|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6210047|NCT02155257|Anticonvulsants|anticonvulsants|mesh-ancestor
6210048|NCT02155257|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6210049|NCT02155257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6210050|NCT02155257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6210051|NCT02155257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6210052|NCT02155257|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6210053|NCT02155257|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6210054|NCT02155257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6210055|NCT02155257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210056|NCT02155257|Antimanic Agents|antimanic agents|mesh-ancestor
5766260|NCT02939495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5766261|NCT02939495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766262|NCT02939495|Urological Agents|urological agents|mesh-ancestor
5766263|NCT02939482|Triamcinolone|triamcinolone|mesh-list
5766264|NCT02939482|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5766265|NCT02939482|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5766266|NCT02939482|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5766267|NCT02939482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5766268|NCT02939482|Glucocorticoids|glucocorticoids|mesh-ancestor
5766269|NCT02939482|Hormones|hormones|mesh-ancestor
5766270|NCT02939482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5766271|NCT02939482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766272|NCT02939482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5639700|NCT01971970|Adalimumab|adalimumab|mesh-list
5639701|NCT01971970|Infliximab|infliximab|mesh-list
5639702|NCT01971970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5639703|NCT01971970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5639704|NCT01971970|Dermatologic Agents|dermatologic agents|mesh-ancestor
5639705|NCT01971970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5639706|NCT01969409|Rituximab|rituximab|mesh-list
5639707|NCT01969409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5639708|NCT01969409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5639709|NCT01969409|Immunologic Factors|immunologic factors|mesh-ancestor
5639710|NCT01969409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766273|NCT02939482|Immunologic Factors|immunologic factors|mesh-ancestor
5766274|NCT02939482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5895852|NCT04884035|Hormones|hormones|mesh-ancestor
6210057|NCT02155257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5766275|NCT02939482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766276|NCT02939430|Atropine|atropine|mesh-list
5766277|NCT02939430|Neostigmine|neostigmine|mesh-list
5766278|NCT02939430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5639711|NCT01969409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5639712|NCT01942122|Mefenamic Acid|mefenamic acid|mesh-list
5639713|NCT01942122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5639714|NCT01942122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5639715|NCT01942122|Analgesics|analgesics|mesh-ancestor
5639716|NCT01942122|Sensory System Agents|sensory system agents|mesh-ancestor
5639717|NCT01942122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5639718|NCT01942122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5639719|NCT01942122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5639720|NCT01942122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5639721|NCT01942122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5766279|NCT02939430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5766280|NCT02939430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5766281|NCT02939430|Autonomic Agents|autonomic agents|mesh-ancestor
5766282|NCT02939430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5766283|NCT02939430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766284|NCT02939430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5766285|NCT02939430|Respiratory System Agents|respiratory system agents|mesh-ancestor
5766286|NCT02939430|Mydriatics|mydriatics|mesh-ancestor
5766287|NCT02939430|Parasympatholytics|parasympatholytics|mesh-ancestor
5766288|NCT02939430|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5766289|NCT02939430|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5766290|NCT02939430|Cholinergic Agents|cholinergic agents|mesh-ancestor
5766291|NCT02939430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5766292|NCT02939430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766293|NCT02939430|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5766294|NCT02939430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5766295|NCT02939430|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5766296|NCT02939365|Abatacept|abatacept|mesh-list
5766297|NCT02939365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5766298|NCT02939365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766299|NCT02939365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5766300|NCT02939365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5766301|NCT02939365|Immunologic Factors|immunologic factors|mesh-ancestor
5766302|NCT02939365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766303|NCT02939365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5766304|NCT02939547|Betadex|betadex|mesh-list
5766305|NCT02939547|Sequestering Agents|sequestering agents|mesh-ancestor
5766306|NCT02939547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766307|NCT02939417|Grape Seed Extract|grape seed extract|mesh-list
5766308|NCT02939417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5639722|NCT01942122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5639723|NCT01942122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5639724|NCT01940094|Prednisone|prednisone|mesh-list
5639725|NCT01940094|Glucocorticoids|glucocorticoids|mesh-list
5639726|NCT01940094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5639727|NCT01940094|Hormones|hormones|mesh-ancestor
5639728|NCT01940094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5639729|NCT01940094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5639730|NCT01940094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5639731|NCT01940094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6210058|NCT02155257|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6210059|NCT02155257|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6210060|NCT02155257|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6210061|NCT02155309|Scopolamine|scopolamine|mesh-list
6210062|NCT02155309|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
5766309|NCT02939417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5766310|NCT02939417|Antioxidants|antioxidants|mesh-ancestor
5766311|NCT02939417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766312|NCT02939417|Protective Agents|protective agents|mesh-ancestor
5766313|NCT02939417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766314|NCT02939274|Verteporfin|verteporfin|mesh-list
5639738|NCT01898793|Vidarabine|vidarabine|mesh-list
5639739|NCT01898793|Aldesleukin|aldesleukin|mesh-list
5639740|NCT01898793|Cyclophosphamide|cyclophosphamide|mesh-list
5639741|NCT01898793|Fludarabine|fludarabine|mesh-list
5639742|NCT01898793|Fludarabine phosphate|fludarabine phosphate|mesh-list
5639743|NCT01898793|Interleukin-2|interleukin-2|mesh-list
5766315|NCT02939274|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5766316|NCT02939274|Dermatologic Agents|dermatologic agents|mesh-ancestor
5766317|NCT02939287|Olanzapine|olanzapine|mesh-list
5766318|NCT02939287|Aprepitant|aprepitant|mesh-list
5766319|NCT02939287|Fosaprepitant|fosaprepitant|mesh-list
5766320|NCT02939287|Antiemetics|antiemetics|mesh-ancestor
5766321|NCT02939287|Autonomic Agents|autonomic agents|mesh-ancestor
5766322|NCT02939287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5766323|NCT02939287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766324|NCT02939287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5639744|NCT01898793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5639745|NCT01898793|Immunologic Factors|immunologic factors|mesh-ancestor
5639746|NCT01898793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5639747|NCT01898793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5639748|NCT01898793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5639749|NCT01898793|Alkylating Agents|alkylating agents|mesh-ancestor
5639750|NCT01898793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5639751|NCT01898793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5639752|NCT01898793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5639753|NCT01898793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5639754|NCT01898793|Antimetabolites|antimetabolites|mesh-ancestor
5639755|NCT01898793|Antiviral Agents|antiviral agents|mesh-ancestor
5766325|NCT02939287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5766326|NCT02939287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5766327|NCT02939287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5766328|NCT02939287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5766329|NCT02939287|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5639756|NCT01898793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5639757|NCT01898793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5639758|NCT01898793|Analgesics|analgesics|mesh-ancestor
5639759|NCT01898793|Sensory System Agents|sensory system agents|mesh-ancestor
5639760|NCT01898793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5639761|NCT01898793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5639762|NCT01898793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5639763|NCT01882933|Oxaliplatin|oxaliplatin|mesh-list
5639764|NCT01882933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5766330|NCT02939287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5766331|NCT02939287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5766332|NCT02939287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766333|NCT02939287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5766334|NCT02939287|Serotonin Agents|serotonin agents|mesh-ancestor
5766335|NCT02939287|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5766336|NCT02939300|Nivolumab|nivolumab|mesh-list
5766337|NCT02939300|Ipilimumab|ipilimumab|mesh-list
5766338|NCT02939300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5766339|NCT02939300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5766340|NCT02939300|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5766341|NCT02939300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766342|NCT02939248|Morphine|morphine|mesh-list
5766343|NCT02939248|Naloxone|naloxone|mesh-list
5766344|NCT02939248|Ticagrelor|ticagrelor|mesh-list
5766345|NCT02939248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5766346|NCT02939248|Narcotics|narcotics|mesh-ancestor
5766347|NCT02939248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5766348|NCT02939248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766349|NCT02939248|Analgesics|analgesics|mesh-ancestor
6673427|NCT01562808|Aripiprazole|aripiprazole|mesh-list
6673428|NCT01562808|Antidepressive Agents|antidepressive agents|mesh-ancestor
6673429|NCT01562808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6673430|NCT01562808|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6673431|NCT01562808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6673432|NCT01562808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6673433|NCT01562808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766350|NCT02939248|Sensory System Agents|sensory system agents|mesh-ancestor
5766351|NCT02939248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5766352|NCT02939248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5766353|NCT02939248|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5766354|NCT02939248|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5766355|NCT02939248|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5766356|NCT02939248|Purinergic Agents|purinergic agents|mesh-ancestor
5766357|NCT02939248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5766358|NCT02939248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766359|NCT02939248|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5766360|NCT02938988|Anti-Infective Agents|anti-infective agents|mesh-list
5766361|NCT02938988|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5766362|NCT02938988|Methylene Blue|methylene blue|mesh-list
5766363|NCT02938988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5766364|NCT02938988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766365|NCT02939235|Morphine|morphine|mesh-list
5766366|NCT02939235|Metoclopramide|metoclopramide|mesh-list
5766367|NCT02939235|Ticagrelor|ticagrelor|mesh-list
5766368|NCT02939235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5766369|NCT02939235|Narcotics|narcotics|mesh-ancestor
5766370|NCT02939235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5766371|NCT02939235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766372|NCT02939235|Analgesics|analgesics|mesh-ancestor
5766373|NCT02939235|Sensory System Agents|sensory system agents|mesh-ancestor
5766374|NCT02939235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5766375|NCT02939235|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5766376|NCT02939235|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5766377|NCT02939235|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5766378|NCT02939235|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5766379|NCT02939235|Purinergic Agents|purinergic agents|mesh-ancestor
5766380|NCT02939235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5766381|NCT02939235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766382|NCT02939235|Antiemetics|antiemetics|mesh-ancestor
5766383|NCT02939235|Autonomic Agents|autonomic agents|mesh-ancestor
5766384|NCT02939235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5766385|NCT02939235|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5766386|NCT02939235|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5766387|NCT02939235|Dopamine Agents|dopamine agents|mesh-ancestor
5766388|NCT02938962|Tranexamic Acid|tranexamic acid|mesh-list
5766389|NCT02938962|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5766390|NCT02938962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5766391|NCT02938962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766392|NCT02938962|Hemostatics|hemostatics|mesh-ancestor
5766393|NCT02938962|Coagulants|coagulants|mesh-ancestor
5766394|NCT02938975|Permethrin|permethrin|mesh-list
5766395|NCT02938975|Insect Repellents|insect repellents|mesh-list
5766396|NCT02938975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5766397|NCT02938975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766398|NCT02938975|Protective Agents|protective agents|mesh-ancestor
5766399|NCT02938975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5639765|NCT01869829|Antifungal Agents|antifungal agents|mesh-list
5639766|NCT01869829|Clotrimazole|clotrimazole|mesh-list
5639767|NCT01869829|Miconazole|miconazole|mesh-list
5639768|NCT01869829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5639769|NCT01869829|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5639770|NCT01869829|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5639771|NCT01869829|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5766400|NCT02939209|Hydromorphone|hydromorphone|mesh-list
5766401|NCT02939209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5766402|NCT02939209|Narcotics|narcotics|mesh-ancestor
5766403|NCT02939209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5766404|NCT02939209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766405|NCT02939209|Analgesics|analgesics|mesh-ancestor
5766406|NCT02939209|Sensory System Agents|sensory system agents|mesh-ancestor
5766407|NCT02939209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5766408|NCT02939092|Chlorhexidine|chlorhexidine|mesh-list
6673434|NCT01562808|Dopamine Agonists|dopamine agonists|mesh-ancestor
5639772|NCT01869829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5639773|NCT01869829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5639774|NCT01869829|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5639775|NCT01869829|Hormone Antagonists|hormone antagonists|mesh-ancestor
5639776|NCT01869829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5639777|NCT01869829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5639778|NCT01869829|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5766409|NCT02939092|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5766410|NCT02939092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5766411|NCT02939092|Disinfectants|disinfectants|mesh-ancestor
5639779|NCT01869829|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5639780|NCT01860937|Cyclophosphamide|cyclophosphamide|mesh-list
5639781|NCT01860937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5639782|NCT01860937|Immunologic Factors|immunologic factors|mesh-ancestor
5639783|NCT01860937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5639784|NCT01860937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5639785|NCT01860937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5639786|NCT01860937|Alkylating Agents|alkylating agents|mesh-ancestor
5639787|NCT01860937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5639788|NCT01860937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5639789|NCT01860937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5639790|NCT01853748|Paclitaxel|paclitaxel|mesh-list
5639791|NCT01853748|Maytansine|maytansine|mesh-list
5639792|NCT01853748|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
5639793|NCT01853748|Trastuzumab|trastuzumab|mesh-list
5639794|NCT01853748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5766412|NCT02938741|Thymoglobulin|thymoglobulin|mesh-list
5766413|NCT02938741|Immunologic Factors|immunologic factors|mesh-ancestor
5766414|NCT02938741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766415|NCT02938741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5766416|NCT02938546|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5766417|NCT02938546|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5766418|NCT02938546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766419|NCT02938572|Insulin Aspart|insulin aspart|mesh-list
5766420|NCT02938572|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5766421|NCT02938572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766422|NCT02938442|Paclitaxel|paclitaxel|mesh-list
5766423|NCT02938442|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5766424|NCT02938442|Cyclophosphamide|cyclophosphamide|mesh-list
5766425|NCT02938442|Doxorubicin|doxorubicin|mesh-list
5766426|NCT02938442|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5639795|NCT01853748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5639796|NCT01853748|Tubulin Modulators|tubulin modulators|mesh-ancestor
5639797|NCT01853748|Antimitotic Agents|antimitotic agents|mesh-ancestor
5639798|NCT01853748|Mitosis Modulators|mitosis modulators|mesh-ancestor
5639799|NCT01853748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5639800|NCT01853748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5766427|NCT02938442|Freund's Adjuvant|freund's adjuvant|mesh-list
5766428|NCT02938442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5766429|NCT02938442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5766430|NCT02938442|Tubulin Modulators|tubulin modulators|mesh-ancestor
5766431|NCT02938442|Antimitotic Agents|antimitotic agents|mesh-ancestor
5766432|NCT02938442|Mitosis Modulators|mitosis modulators|mesh-ancestor
5766433|NCT02938442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766434|NCT02938442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5766435|NCT02938442|Immunologic Factors|immunologic factors|mesh-ancestor
5766436|NCT02938442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5639801|NCT01842399|Resveratrol|resveratrol|mesh-list
5639802|NCT01842399|Antioxidants|antioxidants|mesh-ancestor
5639803|NCT01842399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5639804|NCT01842399|Protective Agents|protective agents|mesh-ancestor
5766437|NCT02938442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5766438|NCT02938442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5766439|NCT02938442|Alkylating Agents|alkylating agents|mesh-ancestor
5766440|NCT02938442|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5766441|NCT02938442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5766442|NCT02938442|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5766443|NCT02938442|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5766444|NCT02938442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5766445|NCT02938442|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5766446|NCT02938468|Dexamethasone|dexamethasone|mesh-list
5766447|NCT02938468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5766448|NCT02938468|Antiemetics|antiemetics|mesh-ancestor
5766449|NCT02938468|Autonomic Agents|autonomic agents|mesh-ancestor
5766450|NCT02938468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5766451|NCT02938468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766452|NCT02938468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5766453|NCT02938468|Glucocorticoids|glucocorticoids|mesh-ancestor
5766454|NCT02938468|Hormones|hormones|mesh-ancestor
5766455|NCT02938468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5766456|NCT02938468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5639805|NCT01842399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766457|NCT02938468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5766458|NCT02938507|Solabegron|solabegron|mesh-list
5766459|NCT02938507|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
5766460|NCT02938507|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5766461|NCT02938507|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5766462|NCT02938507|Adrenergic Agents|adrenergic agents|mesh-ancestor
5766463|NCT02938507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5766464|NCT02938507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766465|NCT02938507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766466|NCT02938793|Durvalumab|durvalumab|mesh-list
5766467|NCT02938793|Tremelimumab|tremelimumab|mesh-list
5766468|NCT02938793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5766469|NCT02938793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5895853|NCT04884035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5895854|NCT04884035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5895855|NCT04884035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5895856|NCT04884035|Tubulin Modulators|tubulin modulators|mesh-ancestor
5895857|NCT04884035|Antimitotic Agents|antimitotic agents|mesh-ancestor
5895858|NCT04884035|Mitosis Modulators|mitosis modulators|mesh-ancestor
5895859|NCT04848688|Ivermectin|ivermectin|mesh-list
5895860|NCT04848688|Moxidectin|moxidectin|mesh-list
5895861|NCT04848688|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5895862|NCT04848688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5895863|NCT04848688|Anthelmintics|anthelmintics|mesh-ancestor
5895864|NCT04848688|Antinematodal Agents|antinematodal agents|mesh-ancestor
5895865|NCT04840589|Nivolumab|nivolumab|mesh-list
5895866|NCT04840589|Ipilimumab|ipilimumab|mesh-list
5895867|NCT04840589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5895868|NCT04840589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5895869|NCT04840589|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5895870|NCT04840589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895871|NCT04833946|Andrographolide|andrographolide|mesh-list
5895872|NCT04833946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5895873|NCT04833946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5895874|NCT04833946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5895875|NCT04833946|Analgesics|analgesics|mesh-ancestor
5895876|NCT04833946|Sensory System Agents|sensory system agents|mesh-ancestor
5895877|NCT04833946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5895878|NCT04833946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895879|NCT04833946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5895880|NCT04833946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5895881|NCT04833946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5895882|NCT04833946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5895883|NCT04833946|Antiviral Agents|antiviral agents|mesh-ancestor
5895884|NCT04833946|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5895885|NCT04804540|Vedolizumab|vedolizumab|mesh-list
5895886|NCT04804540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5895887|NCT04795869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5895888|NCT04795869|Pembrolizumab|pembrolizumab|mesh-list
5895889|NCT04795869|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5895890|NCT04795869|Antibodies|antibodies|mesh-list
5895891|NCT04795869|Immunoglobulins|immunoglobulins|mesh-list
5895892|NCT04795869|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5895893|NCT04795869|Immunoconjugates|immunoconjugates|mesh-list
5895894|NCT04795869|Immunologic Factors|immunologic factors|mesh-ancestor
5895895|NCT04795869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895896|NCT04795869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5895897|NCT04795245|Afatinib|afatinib|mesh-list
5639806|NCT01842399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5639807|NCT01842399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6210063|NCT02155309|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6210064|NCT02155309|Antiemetics|antiemetics|mesh-ancestor
6210065|NCT02155309|Autonomic Agents|autonomic agents|mesh-ancestor
6210066|NCT02155309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6210067|NCT02155309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210068|NCT02155309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6210069|NCT02155309|Mydriatics|mydriatics|mesh-ancestor
6210070|NCT02155309|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6210071|NCT02155309|Cholinergic Agents|cholinergic agents|mesh-ancestor
6210072|NCT02155309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6210073|NCT02155309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210074|NCT02155309|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6210075|NCT02155309|Parasympatholytics|parasympatholytics|mesh-ancestor
5895898|NCT04795245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5895899|NCT04795245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5895900|NCT04795245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6210076|NCT02155322|Interferons|interferons|mesh-list
5639822|NCT01754779|Indapamide|indapamide|mesh-list
5639823|NCT01754779|Potassium Citrate|potassium citrate|mesh-list
5639824|NCT01754779|Citric Acid|citric acid|mesh-list
5639825|NCT01754779|Sodium Citrate|sodium citrate|mesh-list
5639826|NCT01754779|Anticoagulants|anticoagulants|mesh-ancestor
5639827|NCT01754779|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5639828|NCT01754779|Chelating Agents|chelating agents|mesh-ancestor
5639829|NCT01754779|Sequestering Agents|sequestering agents|mesh-ancestor
5639830|NCT01754779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5639831|NCT01754779|Diuretics|diuretics|mesh-ancestor
5639832|NCT01754779|Natriuretic Agents|natriuretic agents|mesh-ancestor
5639833|NCT01754779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5639834|NCT01754779|Expectorants|expectorants|mesh-ancestor
5766470|NCT02938260|Metoprolol|metoprolol|mesh-list
5766471|NCT02938260|Diltiazem|diltiazem|mesh-list
5766472|NCT02938260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5766473|NCT02938260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5766474|NCT02938260|Sympatholytics|sympatholytics|mesh-ancestor
5766475|NCT02938260|Autonomic Agents|autonomic agents|mesh-ancestor
5766476|NCT02938260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5766477|NCT02938260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5639835|NCT01754779|Respiratory System Agents|respiratory system agents|mesh-ancestor
5639836|NCT01754779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5639837|NCT01754779|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5639838|NCT01754779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5639839|NCT01752491|Ascorbic Acid|ascorbic acid|mesh-list
5639840|NCT01752491|Temozolomide|temozolomide|mesh-list
5639841|NCT01752491|Vitamins|vitamins|mesh-ancestor
5639842|NCT01752491|Micronutrients|micronutrients|mesh-ancestor
5639843|NCT01752491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5639844|NCT01752491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5766478|NCT02938260|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5766479|NCT02938260|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5766480|NCT02938260|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5766481|NCT02938260|Adrenergic Agents|adrenergic agents|mesh-ancestor
5766482|NCT02938260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5766483|NCT02938260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766484|NCT02938260|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5766485|NCT02938260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5766486|NCT02938260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5766487|NCT02938260|Vasodilator Agents|vasodilator agents|mesh-ancestor
5766488|NCT02938273|Cetuximab|cetuximab|mesh-list
5766489|NCT02938273|Avelumab|avelumab|mesh-list
5639845|NCT01752491|Alkylating Agents|alkylating agents|mesh-ancestor
5639846|NCT01752491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5639847|NCT01752491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5639848|NCT01752491|Antioxidants|antioxidants|mesh-ancestor
5639849|NCT01752491|Protective Agents|protective agents|mesh-ancestor
5639850|NCT01723202|Trametinib|trametinib|mesh-list
5639851|NCT01723202|Dabrafenib|dabrafenib|mesh-list
5639852|NCT01723202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5639853|NCT01723202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5639854|NCT01723202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5639855|NCT01723202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490443|NCT00598247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490444|NCT00598338|Prucalopride|prucalopride|mesh-list
6490445|NCT00598338|Laxatives|laxatives|mesh-ancestor
6490446|NCT00598338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6490447|NCT00598338|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
6490448|NCT00598338|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6490449|NCT00598338|Serotonin Agents|serotonin agents|mesh-ancestor
6490450|NCT00598338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6496392|NCT00627887|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6210077|NCT02155322|Interferon-alpha|interferon-alpha|mesh-list
5766490|NCT02938273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5766491|NCT02938273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5766492|NCT02938286|Epinephrine|epinephrine|mesh-list
5766493|NCT02938286|Carticaine|carticaine|mesh-list
5766494|NCT02938286|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5766495|NCT02938286|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5766496|NCT02938286|Adrenergic Agents|adrenergic agents|mesh-ancestor
5639856|NCT01665144|Siponimod|siponimod|mesh-list
5639857|NCT01665144|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5766497|NCT02938286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5766498|NCT02938286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210078|NCT02155322|Interferon alpha-2|interferon alpha-2|mesh-list
5766499|NCT02938286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766500|NCT02938286|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5766501|NCT02938286|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5766502|NCT02938286|Autonomic Agents|autonomic agents|mesh-ancestor
5766503|NCT02938286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5766504|NCT02938286|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5766505|NCT02938286|Respiratory System Agents|respiratory system agents|mesh-ancestor
5766506|NCT02938286|Mydriatics|mydriatics|mesh-ancestor
5766507|NCT02938286|Sympathomimetics|sympathomimetics|mesh-ancestor
5766508|NCT02938286|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5766509|NCT02938286|Anesthetics, Local|anesthetics, local|mesh-ancestor
5766510|NCT02938286|Anesthetics|anesthetics|mesh-ancestor
5766511|NCT02938286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5766512|NCT02938286|Sensory System Agents|sensory system agents|mesh-ancestor
5766513|NCT02938182|Clopidogrel|clopidogrel|mesh-list
5766514|NCT02938182|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5766515|NCT02938182|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5766516|NCT02938182|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5766517|NCT02938182|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5766518|NCT02938182|Purinergic Agents|purinergic agents|mesh-ancestor
5766519|NCT02938182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5639858|NCT01665144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5639859|NCT01665144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5639860|NCT01665144|Immunologic Factors|immunologic factors|mesh-ancestor
5639861|NCT01665144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210079|NCT02155322|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6210080|NCT02155322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6210081|NCT02155322|Antiviral Agents|antiviral agents|mesh-ancestor
6210082|NCT02155322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6210083|NCT02155322|Immunologic Factors|immunologic factors|mesh-ancestor
6210084|NCT02155322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210085|NCT02155335|Golimumab|golimumab|mesh-list
6210086|NCT02155335|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6210087|NCT02155335|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6210088|NCT02155335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6210089|NCT02155335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6210090|NCT02155335|Immunologic Factors|immunologic factors|mesh-ancestor
6210091|NCT02155335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210092|NCT02155465|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6210093|NCT02155465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6210094|NCT02155465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6210095|NCT02155465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6210096|NCT02155465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210097|NCT02155647|Avelumab|avelumab|mesh-list
6210098|NCT02155647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5639882|NCT01578954|Lenalidomide|lenalidomide|mesh-list
5639883|NCT01578954|Immunologic Factors|immunologic factors|mesh-ancestor
5766520|NCT02938182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766521|NCT02938182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766522|NCT02937662|Cytarabine|cytarabine|mesh-list
5766523|NCT02937662|Cyclophosphamide|cyclophosphamide|mesh-list
5766524|NCT02937662|Idarubicin|idarubicin|mesh-list
5766525|NCT02937662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5766526|NCT02937662|Immunologic Factors|immunologic factors|mesh-ancestor
5766527|NCT02937662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5639884|NCT01578954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5639885|NCT01578954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5639886|NCT01578954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5639887|NCT01578954|Growth Substances|growth substances|mesh-ancestor
5639888|NCT01578954|Growth Inhibitors|growth inhibitors|mesh-ancestor
5639889|NCT01578954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5693811|NCT03399448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5693812|NCT03399448|Immunologic Factors|immunologic factors|mesh-ancestor
5693813|NCT03399448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693814|NCT03399448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5693815|NCT03399448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5693816|NCT03399448|Alkylating Agents|alkylating agents|mesh-ancestor
5693817|NCT03399448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693818|NCT03399448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5693819|NCT03399448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5693820|NCT03399435|Epinephrine|epinephrine|mesh-list
5693821|NCT03399435|Racepinephrine|racepinephrine|mesh-list
5693822|NCT03399435|Bupivacaine|bupivacaine|mesh-list
6673435|NCT01562808|Dopamine Agents|dopamine agents|mesh-ancestor
5693823|NCT03399435|Epinephryl borate|epinephryl borate|mesh-list
6210099|NCT02155647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6210100|NCT02155660|Benralizumab|benralizumab|mesh-list
6210101|NCT02155660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6210102|NCT02155660|Respiratory System Agents|respiratory system agents|mesh-ancestor
6210103|NCT02155738|Acetaminophen|acetaminophen|mesh-list
6210104|NCT02155738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6210105|NCT02155738|Analgesics|analgesics|mesh-ancestor
6210106|NCT02155738|Sensory System Agents|sensory system agents|mesh-ancestor
6210107|NCT02155738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6210108|NCT02155738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766528|NCT02937662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5766529|NCT02937662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5766530|NCT02937662|Alkylating Agents|alkylating agents|mesh-ancestor
5766531|NCT02937662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766532|NCT02937662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5766533|NCT02937662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5766534|NCT02937662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5766535|NCT02937662|Antimetabolites|antimetabolites|mesh-ancestor
5766536|NCT02937662|Antiviral Agents|antiviral agents|mesh-ancestor
5766537|NCT02937662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5766538|NCT02937662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5766539|NCT02937662|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5766540|NCT02937662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5766541|NCT02937662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5766542|NCT02937857|Antipyretics|antipyretics|mesh-list
5766543|NCT02937857|Expectorants|expectorants|mesh-list
5766544|NCT02937857|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-list
5766545|NCT02937857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766546|NCT02937857|Respiratory System Agents|respiratory system agents|mesh-ancestor
5766547|NCT02937844|Cyclophosphamide|cyclophosphamide|mesh-list
5766548|NCT02937844|Fludarabine|fludarabine|mesh-list
5766549|NCT02937844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5766550|NCT02937844|Immunologic Factors|immunologic factors|mesh-ancestor
5766551|NCT02937844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766552|NCT02937844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5766553|NCT02937844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5766554|NCT02937844|Alkylating Agents|alkylating agents|mesh-ancestor
5766555|NCT02937844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766556|NCT02937844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5766557|NCT02937844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5766558|NCT02937896|Ketorolac|ketorolac|mesh-list
5766559|NCT02937896|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
5766560|NCT02937896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5766561|NCT02937896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5766562|NCT02937896|Analgesics|analgesics|mesh-ancestor
6210109|NCT02155738|Antipyretics|antipyretics|mesh-ancestor
6210110|NCT02155829|Riluzole|riluzole|mesh-list
6210111|NCT02155829|Anticonvulsants|anticonvulsants|mesh-ancestor
6210112|NCT02155829|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5639904|NCT01275677|Paclitaxel|paclitaxel|mesh-list
5639905|NCT01275677|Docetaxel|docetaxel|mesh-list
5639906|NCT01275677|Cyclophosphamide|cyclophosphamide|mesh-list
5639907|NCT01275677|Doxorubicin|doxorubicin|mesh-list
5639908|NCT01275677|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5639909|NCT01275677|Trastuzumab|trastuzumab|mesh-list
5639910|NCT01275677|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5639911|NCT01275677|Daunorubicin|daunorubicin|mesh-list
5639912|NCT01275677|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
5639913|NCT01275677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5639914|NCT01275677|Antibodies|antibodies|mesh-list
5766563|NCT02937896|Sensory System Agents|sensory system agents|mesh-ancestor
5766564|NCT02937896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5766565|NCT02937896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766566|NCT02937896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5766567|NCT02937896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6210113|NCT02155829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5639915|NCT01275677|Immunoglobulins|immunoglobulins|mesh-list
5639916|NCT01275677|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5639917|NCT01275677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5639918|NCT01275677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5639919|NCT01275677|Tubulin Modulators|tubulin modulators|mesh-ancestor
5639920|NCT01275677|Antimitotic Agents|antimitotic agents|mesh-ancestor
5639921|NCT01275677|Mitosis Modulators|mitosis modulators|mesh-ancestor
5639922|NCT01275677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5639923|NCT01275677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5639924|NCT01275677|Immunologic Factors|immunologic factors|mesh-ancestor
6210114|NCT02155829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5766568|NCT02937896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5766569|NCT02937896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5766570|NCT02937896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766571|NCT02937896|Hemostatics|hemostatics|mesh-ancestor
5766572|NCT02937896|Coagulants|coagulants|mesh-ancestor
5766573|NCT02937896|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5639925|NCT01275677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5639926|NCT01275677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5639927|NCT01275677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5766574|NCT02937896|Natriuretic Agents|natriuretic agents|mesh-ancestor
5766575|NCT02937792|Bupivacaine|bupivacaine|mesh-list
5766576|NCT02937792|Anesthetics, Local|anesthetics, local|mesh-ancestor
5766577|NCT02937792|Anesthetics|anesthetics|mesh-ancestor
5766578|NCT02937792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5766579|NCT02937792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766580|NCT02937792|Sensory System Agents|sensory system agents|mesh-ancestor
5766581|NCT02937792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5766582|NCT02937779|Tenofovir|tenofovir|mesh-list
5766583|NCT02937779|Antiviral Agents|antiviral agents|mesh-ancestor
5639928|NCT01275677|Alkylating Agents|alkylating agents|mesh-ancestor
5639929|NCT01275677|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5639930|NCT01275677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5639931|NCT01275677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5639932|NCT01275677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5639933|NCT01275677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5639934|NCT01250912|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
5639935|NCT01250912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5639936|NCT01250912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5639937|NCT01250912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5639938|NCT01250912|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5639939|NCT01218555|Lenalidomide|lenalidomide|mesh-list
5639940|NCT01218555|Everolimus|everolimus|mesh-list
5639941|NCT01218555|Immunologic Factors|immunologic factors|mesh-ancestor
5766584|NCT02937779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5766585|NCT02937779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5766586|NCT02937779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5766587|NCT02937779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5766588|NCT02937779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766589|NCT02937779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5766590|NCT02937779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5766591|NCT02937519|Cisplatin|cisplatin|mesh-list
5766592|NCT02937519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5766593|NCT02937415|Antioxidants|antioxidants|mesh-list
5766594|NCT02937415|Carbon Monoxide|carbon monoxide|mesh-list
5766595|NCT02937415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766596|NCT02937415|Protective Agents|protective agents|mesh-ancestor
5766597|NCT02937415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766598|NCT02937415|Antimetabolites|antimetabolites|mesh-ancestor
5639942|NCT01218555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5639943|NCT01218555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5639944|NCT01218555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5639945|NCT01218555|Growth Substances|growth substances|mesh-ancestor
5639946|NCT01218555|Growth Inhibitors|growth inhibitors|mesh-ancestor
5639947|NCT01218555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5766599|NCT02937415|Gasotransmitters|gasotransmitters|mesh-ancestor
5766600|NCT02937415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5766601|NCT02937363|Thioctic Acid|thioctic acid|mesh-list
5766602|NCT02937363|Antioxidants|antioxidants|mesh-ancestor
5766603|NCT02937363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766604|NCT02937363|Protective Agents|protective agents|mesh-ancestor
5766605|NCT02937363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766606|NCT02937363|Vitamin B Complex|vitamin b complex|mesh-ancestor
5766607|NCT02937363|Vitamins|vitamins|mesh-ancestor
5766608|NCT02937363|Micronutrients|micronutrients|mesh-ancestor
5766609|NCT02937285|Interferons|interferons|mesh-list
5766610|NCT02937285|Interferon-beta|interferon-beta|mesh-list
5766611|NCT02937285|Interferon beta-1a|interferon beta-1a|mesh-list
5766612|NCT02937285|Mitoxantrone|mitoxantrone|mesh-list
5639948|NCT01218555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5639949|NCT01161394|Pioglitazone|pioglitazone|mesh-list
5639950|NCT01161394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5639951|NCT01161394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5639952|NCT01141712|Cytarabine|cytarabine|mesh-list
5766613|NCT02937285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5766614|NCT02937285|Antiviral Agents|antiviral agents|mesh-ancestor
5639953|NCT01141712|Etoposide|etoposide|mesh-list
5766615|NCT02937285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5766616|NCT02937285|Analgesics|analgesics|mesh-ancestor
5766617|NCT02937285|Sensory System Agents|sensory system agents|mesh-ancestor
5766618|NCT02937285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6673436|NCT01562808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6673437|NCT01562808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673438|NCT01562808|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6673439|NCT01562808|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6673440|NCT01562808|Serotonin Agents|serotonin agents|mesh-ancestor
6673441|NCT01562808|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6673442|NCT01562808|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6673443|NCT01562808|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5639954|NCT01141712|Melphalan|melphalan|mesh-list
5639955|NCT01141712|Carmustine|carmustine|mesh-list
5639956|NCT01141712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5639957|NCT01141712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5639958|NCT01141712|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5639959|NCT01141712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5639960|NCT01141712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5639961|NCT01141712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5639962|NCT01141712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5639963|NCT01141712|Antimetabolites|antimetabolites|mesh-ancestor
5639964|NCT01141712|Antiviral Agents|antiviral agents|mesh-ancestor
5639965|NCT01141712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5639966|NCT01141712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5639967|NCT01141712|Immunologic Factors|immunologic factors|mesh-ancestor
5639968|NCT01141712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5639969|NCT01141712|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6673444|NCT01562808|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6673445|NCT01562951|Adalimumab|adalimumab|mesh-list
6673446|NCT01562951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6673447|NCT01562951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6673448|NCT01562977|Gemcitabine|gemcitabine|mesh-list
6673449|NCT01562977|Rituximab|rituximab|mesh-list
6673450|NCT01562977|Oxaliplatin|oxaliplatin|mesh-list
6673451|NCT01562977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6673452|NCT01562977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5766619|NCT02937285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766620|NCT02937285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5766621|NCT02937285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5766622|NCT02937285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5766623|NCT02937285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766624|NCT02937285|Immunologic Factors|immunologic factors|mesh-ancestor
5766625|NCT02937285|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5639970|NCT01141712|Alkylating Agents|alkylating agents|mesh-ancestor
5639971|NCT01141712|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5639972|NCT01111305|Diethylcarbamazine|diethylcarbamazine|mesh-list
5639973|NCT01111305|Reslizumab|reslizumab|mesh-list
5639974|NCT01111305|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5639975|NCT01111305|Respiratory System Agents|respiratory system agents|mesh-ancestor
5639976|NCT01111305|Filaricides|filaricides|mesh-ancestor
5639977|NCT01111305|Antinematodal Agents|antinematodal agents|mesh-ancestor
5766626|NCT02937272|Gemcitabine|gemcitabine|mesh-list
6210115|NCT02155829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210116|NCT02155829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210117|NCT02155829|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5639978|NCT01111305|Anthelmintics|anthelmintics|mesh-ancestor
5766627|NCT02937272|Paclitaxel|paclitaxel|mesh-list
5766628|NCT02937272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5766629|NCT02937272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5766630|NCT02937272|Tubulin Modulators|tubulin modulators|mesh-ancestor
5766631|NCT02937272|Antimitotic Agents|antimitotic agents|mesh-ancestor
5766632|NCT02937272|Mitosis Modulators|mitosis modulators|mesh-ancestor
5766633|NCT02937272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766634|NCT02937272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5766635|NCT02937272|Antimetabolites|antimetabolites|mesh-ancestor
5766636|NCT02937272|Antiviral Agents|antiviral agents|mesh-ancestor
5766637|NCT02937272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5766638|NCT02937272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5766639|NCT02937272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5766640|NCT02937272|Immunologic Factors|immunologic factors|mesh-ancestor
5766641|NCT02937272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766642|NCT02936934|Morphine|morphine|mesh-list
5766643|NCT02936934|Oxycodone|oxycodone|mesh-list
5766644|NCT02936934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5766645|NCT02936934|Narcotics|narcotics|mesh-ancestor
5766646|NCT02936934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5766647|NCT02936934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766648|NCT02936934|Analgesics|analgesics|mesh-ancestor
5766649|NCT02936934|Sensory System Agents|sensory system agents|mesh-ancestor
5766650|NCT02936934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5766651|NCT02937181|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
6210118|NCT02155829|Protective Agents|protective agents|mesh-ancestor
6210119|NCT02155881|Ciclesonide|ciclesonide|mesh-list
6210120|NCT02155881|Glucocorticoids|glucocorticoids|mesh-ancestor
6210121|NCT02155881|Hormones|hormones|mesh-ancestor
6210122|NCT02155881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6210123|NCT02155881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210124|NCT02155881|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6210125|NCT02155985|Aspirin|aspirin|mesh-list
6210126|NCT02155985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6210127|NCT02155985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6210128|NCT02155985|Analgesics|analgesics|mesh-ancestor
5766652|NCT02937181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5766653|NCT02937181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5766654|NCT02937012|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
5766655|NCT02937012|Bezafibrate|bezafibrate|mesh-list
5639979|NCT01111305|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5639980|NCT01111305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5639981|NCT01111305|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
5639982|NCT01111305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5639983|NCT01111305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5639984|NCT00921856|Acetylcholine|acetylcholine|mesh-list
5639985|NCT00921856|Vasodilator Agents|vasodilator agents|mesh-ancestor
5639986|NCT00921856|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5639987|NCT00921856|Cholinergic Agents|cholinergic agents|mesh-ancestor
5639988|NCT00921856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5639989|NCT00921856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5639990|NCT00921856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5639991|NCT00843882|Lenalidomide|lenalidomide|mesh-list
5639992|NCT00843882|Epoetin Alfa|epoetin alfa|mesh-list
5639993|NCT00843882|Immunologic Factors|immunologic factors|mesh-ancestor
5639994|NCT00843882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5639995|NCT00843882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5639996|NCT00843882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5639997|NCT00843882|Growth Substances|growth substances|mesh-ancestor
5639998|NCT00843882|Growth Inhibitors|growth inhibitors|mesh-ancestor
5639999|NCT00843882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5640000|NCT00843882|Hematinics|hematinics|mesh-ancestor
5640001|NCT00792831|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
5640002|NCT00792831|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5640003|NCT00792831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5640004|NCT00792831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640005|NCT00659646|Levofloxacin|levofloxacin|mesh-list
5640006|NCT00659646|Ofloxacin|ofloxacin|mesh-list
5640007|NCT00659646|Gentamicins|gentamicins|mesh-list
5640008|NCT00659646|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5640009|NCT00659646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5640010|NCT00659646|Renal Agents|renal agents|mesh-ancestor
5766656|NCT02937012|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5766657|NCT02937012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5640011|NCT00659646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5640012|NCT00659646|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5766658|NCT02937012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5766659|NCT02937012|Antimetabolites|antimetabolites|mesh-ancestor
5766660|NCT02937012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766661|NCT02937012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5766662|NCT02936895|Vitamin D|vitamin d|mesh-list
5766663|NCT02936895|Cholecalciferol|cholecalciferol|mesh-list
5766664|NCT02936895|Vitamins|vitamins|mesh-ancestor
5766665|NCT02936895|Micronutrients|micronutrients|mesh-ancestor
5766666|NCT02936895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766667|NCT02936895|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5766668|NCT02936895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5766669|NCT02936830|Listerine|listerine|mesh-list
5766670|NCT02936830|Fluorides|fluorides|mesh-list
5766671|NCT02936830|Sodium Fluoride|sodium fluoride|mesh-list
5766672|NCT02936830|Fluorides, Topical|fluorides, topical|mesh-list
5640013|NCT00659646|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5640014|NCT00659646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5640015|NCT00659646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640016|NCT00659646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5640017|NCT00659646|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5640018|NCT00659646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5640019|NCT00659646|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5640020|NCT00567580|Leuprolide|leuprolide|mesh-list
5640021|NCT00567580|Goserelin|goserelin|mesh-list
5766673|NCT02936830|Glycerol|glycerol|mesh-list
5766674|NCT02936830|Cariostatic Agents|cariostatic agents|mesh-ancestor
5766675|NCT02936830|Protective Agents|protective agents|mesh-ancestor
5766676|NCT02936830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766677|NCT02936830|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5766678|NCT02936830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5766679|NCT02936830|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
5766680|NCT02936661|Tranexamic Acid|tranexamic acid|mesh-list
5766681|NCT02936661|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5766682|NCT02936661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5766683|NCT02936661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766684|NCT02936661|Hemostatics|hemostatics|mesh-ancestor
5766685|NCT02936661|Coagulants|coagulants|mesh-ancestor
5766686|NCT02936622|Paclitaxel|paclitaxel|mesh-list
5766687|NCT02936622|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5766688|NCT02936622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5766689|NCT02936622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5766690|NCT02936622|Tubulin Modulators|tubulin modulators|mesh-ancestor
5766691|NCT02936622|Antimitotic Agents|antimitotic agents|mesh-ancestor
5766692|NCT02936622|Mitosis Modulators|mitosis modulators|mesh-ancestor
5766693|NCT02936622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895901|NCT04795245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895902|NCT04794790|Buprenorphine|buprenorphine|mesh-list
5895903|NCT04794790|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
5895904|NCT04794790|Naloxone|naloxone|mesh-list
5895905|NCT04794790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5895906|NCT04794790|Narcotics|narcotics|mesh-ancestor
5895907|NCT04794790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5895908|NCT04794790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895909|NCT04794790|Analgesics|analgesics|mesh-ancestor
5895910|NCT04794790|Sensory System Agents|sensory system agents|mesh-ancestor
5895911|NCT04794790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5895912|NCT04794790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5895913|NCT04772209|Heparin|heparin|mesh-list
5895914|NCT04772209|Anticoagulants|anticoagulants|mesh-ancestor
5895915|NCT04772209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5895916|NCT04772209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5895917|NCT04772209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895918|NCT04763408|Sorafenib|sorafenib|mesh-list
5895919|NCT04763408|Lenvatinib|lenvatinib|mesh-list
5895920|NCT04763408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5895921|NCT04763408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5895922|NCT04763408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5895923|NCT04763408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895924|NCT04756037|Relugolix|relugolix|mesh-list
5895925|NCT04756037|Androgen Antagonists|androgen antagonists|mesh-ancestor
5895926|NCT04756037|Hormone Antagonists|hormone antagonists|mesh-ancestor
5640022|NCT00567580|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5895927|NCT04756037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5895928|NCT04756037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895929|NCT04746495|Eplerenone|eplerenone|mesh-list
5895930|NCT04746495|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5766694|NCT02936492|Clobetasol|clobetasol|mesh-list
5766695|NCT02936492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5766696|NCT02936492|Glucocorticoids|glucocorticoids|mesh-ancestor
5766697|NCT02936492|Hormones|hormones|mesh-ancestor
5766698|NCT02936492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5766699|NCT02936492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766700|NCT02936505|Cyclosporine|cyclosporine|mesh-list
5766701|NCT02936505|Mycophenolic Acid|mycophenolic acid|mesh-list
5766702|NCT02936505|Tacrolimus|tacrolimus|mesh-list
5766703|NCT02936505|Cyclosporins|cyclosporins|mesh-list
5766704|NCT02936505|Thymoglobulin|thymoglobulin|mesh-list
5766705|NCT02936505|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5766706|NCT02936505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5766707|NCT02936505|Immunologic Factors|immunologic factors|mesh-ancestor
5766708|NCT02936505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766709|NCT02936505|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5766710|NCT02936505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5766711|NCT02936505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766712|NCT02936505|Antifungal Agents|antifungal agents|mesh-ancestor
5766713|NCT02936505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5766714|NCT02936505|Dermatologic Agents|dermatologic agents|mesh-ancestor
5766715|NCT02936505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5766716|NCT02936505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5766717|NCT02936505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5766718|NCT02936505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5766719|NCT02936505|Antitubercular Agents|antitubercular agents|mesh-ancestor
5766720|NCT02936505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5766721|NCT02936427|Dexamethasone|dexamethasone|mesh-list
5766722|NCT02936427|Dexamethasone acetate|dexamethasone acetate|mesh-list
5766723|NCT02936427|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
5766724|NCT02936427|BB 1101|bb 1101|mesh-list
5766725|NCT02936427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5766726|NCT02936427|Antiemetics|antiemetics|mesh-ancestor
5766727|NCT02936427|Autonomic Agents|autonomic agents|mesh-ancestor
5766728|NCT02936427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5766729|NCT02936427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766730|NCT02936427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5766731|NCT02936427|Glucocorticoids|glucocorticoids|mesh-ancestor
5766732|NCT02936427|Hormones|hormones|mesh-ancestor
5766733|NCT02936427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5766734|NCT02936427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5766735|NCT02936427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5766736|NCT02936427|Protease Inhibitors|protease inhibitors|mesh-ancestor
5766737|NCT02936427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5766738|NCT02936427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766739|NCT02936375|Cyclophosphamide|cyclophosphamide|mesh-list
5766740|NCT02936375|Azathioprine|azathioprine|mesh-list
5766741|NCT02936375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5766742|NCT02936375|Immunologic Factors|immunologic factors|mesh-ancestor
5766743|NCT02936375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766744|NCT02936375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5766745|NCT02936375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5640023|NCT00567580|Flutamide|flutamide|mesh-list
5640024|NCT00567580|Bicalutamide|bicalutamide|mesh-list
5640025|NCT00567580|Buserelin|buserelin|mesh-list
5640026|NCT00567580|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5640027|NCT00567580|Fertility Agents|fertility agents|mesh-ancestor
5640028|NCT00567580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5640029|NCT00567580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640030|NCT00567580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5640031|NCT00567580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5640032|NCT00567580|Androgen Antagonists|androgen antagonists|mesh-ancestor
5640033|NCT00567580|Hormone Antagonists|hormone antagonists|mesh-ancestor
5640034|NCT00567580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5640035|NCT00567580|Luteolytic Agents|luteolytic agents|mesh-ancestor
5640036|NCT00567580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5640037|NCT00567580|Contraceptive Agents|contraceptive agents|mesh-ancestor
5640038|NCT00567580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5640039|NCT00496431|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
5640040|NCT00496431|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
5640041|NCT00496431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5640042|NCT00496431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640043|NCT00477412|Cytarabine|cytarabine|mesh-list
5640044|NCT00477412|Dexamethasone|dexamethasone|mesh-list
5766746|NCT02936375|Alkylating Agents|alkylating agents|mesh-ancestor
5766747|NCT02936375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673453|NCT01562977|Immunologic Factors|immunologic factors|mesh-ancestor
6673454|NCT01562977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673455|NCT01562977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5640045|NCT00477412|Dexamethasone acetate|dexamethasone acetate|mesh-list
5640046|NCT00477412|Cyclophosphamide|cyclophosphamide|mesh-list
5640047|NCT00477412|Rituximab|rituximab|mesh-list
5640048|NCT00477412|Doxorubicin|doxorubicin|mesh-list
5640049|NCT00477412|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5640050|NCT00477412|Methotrexate|methotrexate|mesh-list
5640051|NCT00477412|Vincristine|vincristine|mesh-list
5640052|NCT00477412|Bortezomib|bortezomib|mesh-list
5640053|NCT00477412|Daunorubicin|daunorubicin|mesh-list
5640054|NCT00477412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5640055|NCT00477412|Antibodies|antibodies|mesh-list
6673456|NCT01562977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6673457|NCT01562977|Antimetabolites|antimetabolites|mesh-ancestor
6673458|NCT01562977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673459|NCT01562977|Antiviral Agents|antiviral agents|mesh-ancestor
6673460|NCT01562977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6673461|NCT01562977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6673462|NCT01562977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6673463|NCT01562990|Gemcitabine|gemcitabine|mesh-list
6673464|NCT01562990|Rituximab|rituximab|mesh-list
6673465|NCT01562990|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
6673466|NCT01562990|Oxaliplatin|oxaliplatin|mesh-list
5640056|NCT00477412|Immunoglobulins|immunoglobulins|mesh-list
5640057|NCT00477412|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5640058|NCT00477412|BB 1101|bb 1101|mesh-list
5640059|NCT00477412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5640060|NCT00477412|Immunologic Factors|immunologic factors|mesh-ancestor
5640061|NCT00477412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640062|NCT00477412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5640063|NCT00477412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5640064|NCT00477412|Alkylating Agents|alkylating agents|mesh-ancestor
5640065|NCT00477412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640066|NCT00477412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5640067|NCT00477412|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5640068|NCT00477412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5640069|NCT00477412|Antiemetics|antiemetics|mesh-ancestor
5640070|NCT00477412|Autonomic Agents|autonomic agents|mesh-ancestor
5640071|NCT00477412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5640072|NCT00477412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5640073|NCT00477412|Glucocorticoids|glucocorticoids|mesh-ancestor
5640074|NCT00477412|Hormones|hormones|mesh-ancestor
5640075|NCT00477412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5640076|NCT00477412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5640077|NCT00477412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5640078|NCT00477412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5640079|NCT00477412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5640080|NCT00477412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5640081|NCT00477412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5640082|NCT00477412|Abortifacient Agents|abortifacient agents|mesh-ancestor
5640083|NCT00477412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5640084|NCT00477412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5640085|NCT00477412|Antimetabolites|antimetabolites|mesh-ancestor
5640086|NCT00477412|Dermatologic Agents|dermatologic agents|mesh-ancestor
5640087|NCT00477412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5640088|NCT00477412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5640089|NCT00477412|Antiviral Agents|antiviral agents|mesh-ancestor
5640090|NCT00477412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5766748|NCT02936375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5766749|NCT02936375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5766750|NCT02936375|Antimetabolites|antimetabolites|mesh-ancestor
5766751|NCT02936375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5766752|NCT02936167|Plasma-lyte 148|plasma-lyte 148|mesh-list
5640091|NCT00477412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5640092|NCT00477412|Tubulin Modulators|tubulin modulators|mesh-ancestor
5766753|NCT02936167|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5766754|NCT02936167|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5766755|NCT02935933|Dexmedetomidine|dexmedetomidine|mesh-list
5766756|NCT02935933|Morphine|morphine|mesh-list
5766757|NCT02935933|Bupivacaine|bupivacaine|mesh-list
5766758|NCT02935933|Anesthetics, Local|anesthetics, local|mesh-ancestor
5766759|NCT02935933|Anesthetics|anesthetics|mesh-ancestor
5766760|NCT02935933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5766761|NCT02935933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895931|NCT04746495|Hormone Antagonists|hormone antagonists|mesh-ancestor
5766762|NCT02935933|Sensory System Agents|sensory system agents|mesh-ancestor
5766763|NCT02935933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5766764|NCT02935933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5766765|NCT02935933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5766766|NCT02935933|Analgesics|analgesics|mesh-ancestor
5766767|NCT02935933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5766768|NCT02935933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5766769|NCT02935933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5766770|NCT02935933|Adrenergic Agents|adrenergic agents|mesh-ancestor
5766771|NCT02935933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5766772|NCT02935933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766773|NCT02935933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5766774|NCT02935933|Narcotics|narcotics|mesh-ancestor
5766775|NCT02935725|Ketamine|ketamine|mesh-list
5766776|NCT02935725|Analgesics|analgesics|mesh-ancestor
5766777|NCT02935725|Sensory System Agents|sensory system agents|mesh-ancestor
5640093|NCT00477412|Antimitotic Agents|antimitotic agents|mesh-ancestor
5640094|NCT00477412|Mitosis Modulators|mitosis modulators|mesh-ancestor
5640095|NCT00477412|Protease Inhibitors|protease inhibitors|mesh-ancestor
5640096|NCT00369317|Cytarabine|cytarabine|mesh-list
5640097|NCT00369317|Etoposide|etoposide|mesh-list
5640098|NCT00369317|Daunorubicin|daunorubicin|mesh-list
5640099|NCT00369317|Etoposide phosphate|etoposide phosphate|mesh-list
5640100|NCT00369317|Asparaginase|asparaginase|mesh-list
5766778|NCT02935725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5766779|NCT02935725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766780|NCT02935725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5766781|NCT02935725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5766782|NCT02935725|Anesthetics, General|anesthetics, general|mesh-ancestor
5766783|NCT02935725|Anesthetics|anesthetics|mesh-ancestor
5766784|NCT02935725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5766785|NCT02935725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5766786|NCT02935725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5766787|NCT02935725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5640101|NCT00369317|Thioguanine|thioguanine|mesh-list
5640102|NCT00369317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5640103|NCT00369317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5640104|NCT00369317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5640105|NCT00369317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5640106|NCT00369317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5640107|NCT00369317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640108|NCT00369317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5640109|NCT00369317|Antimetabolites|antimetabolites|mesh-ancestor
5640110|NCT00369317|Antiviral Agents|antiviral agents|mesh-ancestor
5640111|NCT00369317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5640112|NCT00369317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5640113|NCT00369317|Immunologic Factors|immunologic factors|mesh-ancestor
5693824|NCT03399435|Neosaxitoxin|neosaxitoxin|mesh-list
5693825|NCT03399435|Anesthetics, Local|anesthetics, local|mesh-ancestor
5693826|NCT03399435|Anesthetics|anesthetics|mesh-ancestor
5693827|NCT03399435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5693828|NCT03399435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693829|NCT03399435|Sensory System Agents|sensory system agents|mesh-ancestor
5693830|NCT03399435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5693831|NCT03399435|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5693832|NCT03399435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5693833|NCT03399435|Adrenergic Agents|adrenergic agents|mesh-ancestor
5693834|NCT03399435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5693835|NCT03399435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693836|NCT03399435|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5693837|NCT03399435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5693838|NCT03399435|Autonomic Agents|autonomic agents|mesh-ancestor
5693839|NCT03399435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5693840|NCT03399435|Respiratory System Agents|respiratory system agents|mesh-ancestor
5693841|NCT03399435|Mydriatics|mydriatics|mesh-ancestor
5693842|NCT03399435|Sympathomimetics|sympathomimetics|mesh-ancestor
5693843|NCT03399435|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5693844|NCT03399435|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5693845|NCT03399435|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5693846|NCT03399409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
5693847|NCT03399318|Acetaminophen|acetaminophen|mesh-list
5693848|NCT03399318|Ibuprofen|ibuprofen|mesh-list
5693849|NCT03399318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5693850|NCT03399318|Analgesics|analgesics|mesh-ancestor
5693851|NCT03399318|Sensory System Agents|sensory system agents|mesh-ancestor
5766788|NCT02935725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766789|NCT02935764|Leucovorin|leucovorin|mesh-list
5766790|NCT02935764|Fluorouracil|fluorouracil|mesh-list
5766791|NCT02935764|Irinotecan|irinotecan|mesh-list
5766792|NCT02935764|Antimetabolites|antimetabolites|mesh-ancestor
5766793|NCT02935764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766794|NCT02935764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5766795|NCT02935764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5766796|NCT02935764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5766797|NCT02935764|Immunologic Factors|immunologic factors|mesh-ancestor
5766798|NCT02935764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766799|NCT02935764|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5766800|NCT02935764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5766801|NCT02935764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5766802|NCT02935764|Antidotes|antidotes|mesh-ancestor
5766803|NCT02935764|Protective Agents|protective agents|mesh-ancestor
5766804|NCT02935764|Vitamin B Complex|vitamin b complex|mesh-ancestor
5766805|NCT02935764|Vitamins|vitamins|mesh-ancestor
5766806|NCT02935764|Micronutrients|micronutrients|mesh-ancestor
5640114|NCT00369317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640115|NCT00369317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5640116|NCT00353158|Doxycycline|doxycycline|mesh-list
5640117|NCT00353158|Voriconazole|voriconazole|mesh-list
5640118|NCT00353158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5640119|NCT00353158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5640120|NCT00353158|Antimalarials|antimalarials|mesh-ancestor
5640121|NCT00353158|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5640122|NCT00353158|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5640123|NCT00353158|Antifungal Agents|antifungal agents|mesh-ancestor
5766807|NCT02935751|Apixaban|apixaban|mesh-list
5766808|NCT02935751|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5766809|NCT02935751|Antithrombins|antithrombins|mesh-ancestor
5766810|NCT02935751|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5766811|NCT02935751|Protease Inhibitors|protease inhibitors|mesh-ancestor
5766812|NCT02935751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5766813|NCT02935751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766814|NCT02935751|Anticoagulants|anticoagulants|mesh-ancestor
5766815|NCT02935998|Ziprasidone|ziprasidone|mesh-list
5766816|NCT02935998|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5766817|NCT02935998|Serotonin Agents|serotonin agents|mesh-ancestor
5766818|NCT02935998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5766819|NCT02935998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766820|NCT02935998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766821|NCT02935998|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5766822|NCT02935998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5766823|NCT02935998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5766824|NCT02935998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5766825|NCT02935998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5766826|NCT02935998|Dopamine Agents|dopamine agents|mesh-ancestor
5766827|NCT02935790|Nivolumab|nivolumab|mesh-list
5766828|NCT02935790|Ipilimumab|ipilimumab|mesh-list
5766829|NCT02935790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5766830|NCT02935790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5766831|NCT02935790|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5766832|NCT02935790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766833|NCT02935829|Locust bean gum|locust bean gum|mesh-list
5766834|NCT02935829|Antidiarrheals|antidiarrheals|mesh-ancestor
5766835|NCT02935829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5766836|NCT02935959|Midazolam|midazolam|mesh-list
5766837|NCT02935959|Dexmedetomidine|dexmedetomidine|mesh-list
5766838|NCT02935959|Ketamine|ketamine|mesh-list
5766839|NCT02935959|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5766840|NCT02935959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5766841|NCT02935959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766842|NCT02935959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5766843|NCT02935959|Analgesics|analgesics|mesh-ancestor
5640124|NCT00353158|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5640125|NCT00353158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5640126|NCT00353158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5640127|NCT00353158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640128|NCT00353158|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5640129|NCT00353158|Hormone Antagonists|hormone antagonists|mesh-ancestor
5640130|NCT00353158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5640131|NCT00353158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766844|NCT02935959|Sensory System Agents|sensory system agents|mesh-ancestor
5766845|NCT02935959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5640132|NCT00353158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5640133|NCT00261807|Daptomycin|daptomycin|mesh-list
5640134|NCT00261807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5640135|NCT00261807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5640136|NCT05216744|Doxycycline|doxycycline|mesh-list
5640137|NCT05216744|Ceftriaxone|ceftriaxone|mesh-list
5640138|NCT05216744|Cefixime|cefixime|mesh-list
5640139|NCT05216744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5640140|NCT05216744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5640141|NCT05216744|Antimalarials|antimalarials|mesh-ancestor
5640142|NCT05216744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5640143|NCT05216744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5640144|NCT05216653|Capecitabine|capecitabine|mesh-list
5640145|NCT05216653|Oxaliplatin|oxaliplatin|mesh-list
5766846|NCT02935959|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5766847|NCT02935959|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5766848|NCT02935959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5766849|NCT02935959|Adrenergic Agents|adrenergic agents|mesh-ancestor
5766850|NCT02935959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5766851|NCT02935959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766852|NCT02935959|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5766853|NCT02935959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5766854|NCT02935959|Anesthetics, General|anesthetics, general|mesh-ancestor
5766855|NCT02935959|Anesthetics|anesthetics|mesh-ancestor
5640146|NCT05216653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5640147|NCT05216653|Antimetabolites|antimetabolites|mesh-ancestor
5640148|NCT05216653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640149|NCT05216653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5693852|NCT03399318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5693853|NCT03399318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693854|NCT03399318|Antipyretics|antipyretics|mesh-ancestor
5693855|NCT03399318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5693856|NCT03399318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5693857|NCT03399318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5693858|NCT03399318|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5693859|NCT03399318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5693860|NCT03399318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693861|NCT03399292|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5693862|NCT03399292|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5693863|NCT03399201|Anesthetics|anesthetics|mesh-list
5766856|NCT02935959|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5766857|NCT02935959|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5766858|NCT02935959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5766859|NCT02935959|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5766860|NCT02935959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5766861|NCT02935959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5766862|NCT02935959|GABA Modulators|gaba modulators|mesh-ancestor
5766863|NCT02935959|GABA Agents|gaba agents|mesh-ancestor
5766864|NCT02935972|Lidocaine|lidocaine|mesh-list
5766865|NCT02935972|Diazepam|diazepam|mesh-list
5766866|NCT02935972|Anesthetics, Local|anesthetics, local|mesh-ancestor
5766867|NCT02935972|Anesthetics|anesthetics|mesh-ancestor
5766868|NCT02935972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5766869|NCT02935972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766870|NCT02935972|Sensory System Agents|sensory system agents|mesh-ancestor
5766871|NCT02935972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5766872|NCT02935972|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5766873|NCT02935972|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5766874|NCT02935972|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5766875|NCT02935972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5693864|NCT03399201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5693865|NCT03399201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693866|NCT03399110|Capecitabine|capecitabine|mesh-list
5693867|NCT03399110|Oxaliplatin|oxaliplatin|mesh-list
5693868|NCT03399110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5693869|NCT03399110|Antimetabolites|antimetabolites|mesh-ancestor
5693870|NCT03399110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693871|NCT03399110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5693872|NCT03399032|Caspofungin|caspofungin|mesh-list
5693873|NCT03399032|Antifungal Agents|antifungal agents|mesh-ancestor
5693874|NCT03399032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5693875|NCT03399032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5693876|NCT03399032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693877|NCT03399019|Midazolam|midazolam|mesh-list
5766876|NCT02935972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766877|NCT02935972|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5766878|NCT02935972|Anticonvulsants|anticonvulsants|mesh-ancestor
5766879|NCT02935972|Antiemetics|antiemetics|mesh-ancestor
5766880|NCT02935972|Autonomic Agents|autonomic agents|mesh-ancestor
5766881|NCT02935972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5766882|NCT02935972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5766883|NCT02935972|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5766884|NCT02935972|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5766885|NCT02935972|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5766886|NCT02935972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5766887|NCT02935972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5766888|NCT02935972|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5766889|NCT02935972|Anesthetics, General|anesthetics, general|mesh-ancestor
5766890|NCT02935972|GABA Modulators|gaba modulators|mesh-ancestor
5766891|NCT02935972|GABA Agents|gaba agents|mesh-ancestor
5766892|NCT02935972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5766893|NCT02935855|Warfarin|warfarin|mesh-list
5766894|NCT02935855|Rivaroxaban|rivaroxaban|mesh-list
5766895|NCT02935855|Dabigatran|dabigatran|mesh-list
5766896|NCT02935855|Apixaban|apixaban|mesh-list
5766897|NCT02935855|Edoxaban|edoxaban|mesh-list
5766898|NCT02935855|Anticoagulants|anticoagulants|mesh-ancestor
5766899|NCT02935855|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5766900|NCT02935855|Antithrombins|antithrombins|mesh-ancestor
5766901|NCT02935855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5766902|NCT02935855|Protease Inhibitors|protease inhibitors|mesh-ancestor
5766903|NCT02935855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5766904|NCT02935855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766905|NCT02935985|Fibrin fragment D|fibrin fragment d|mesh-list
5766906|NCT02935985|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5766907|NCT02935985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5766908|NCT02935985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766909|NCT02935985|Hemostatics|hemostatics|mesh-ancestor
5766910|NCT02935985|Coagulants|coagulants|mesh-ancestor
5766911|NCT02935647|Propofol|propofol|mesh-list
5766912|NCT02935647|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5766913|NCT02935647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5766914|NCT02935647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766915|NCT02935647|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5766916|NCT02935647|Anesthetics, General|anesthetics, general|mesh-ancestor
5766917|NCT02935647|Anesthetics|anesthetics|mesh-ancestor
5766918|NCT02935582|Betamethasone|betamethasone|mesh-list
5766919|NCT02935582|Betamethasone Valerate|betamethasone valerate|mesh-list
5766920|NCT02935582|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5766921|NCT02935582|Betamethasone benzoate|betamethasone benzoate|mesh-list
5766922|NCT02935582|Calcipotriene|calcipotriene|mesh-list
5766923|NCT02935582|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
5766924|NCT02935582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5766925|NCT02935582|Glucocorticoids|glucocorticoids|mesh-ancestor
5766926|NCT02935582|Hormones|hormones|mesh-ancestor
5766927|NCT02935582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6210129|NCT02155985|Sensory System Agents|sensory system agents|mesh-ancestor
6210130|NCT02155985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6210131|NCT02155985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640152|NCT05216419|Cholecalciferol|cholecalciferol|mesh-list
5640153|NCT05216419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5640154|NCT05216419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640155|NCT05216419|Vitamins|vitamins|mesh-ancestor
5640156|NCT05216419|Micronutrients|micronutrients|mesh-ancestor
5640157|NCT05216419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5640158|NCT05216250|Botulinum Toxins|botulinum toxins|mesh-list
5640159|NCT05216250|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5640160|NCT05216250|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5640161|NCT05216250|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5640162|NCT05216250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5766928|NCT02935582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766929|NCT02935582|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5766930|NCT02935582|Respiratory System Agents|respiratory system agents|mesh-ancestor
5766931|NCT02935582|Dermatologic Agents|dermatologic agents|mesh-ancestor
5766932|NCT02935530|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5766933|NCT02935530|Tinzaparin|tinzaparin|mesh-list
5766934|NCT02935530|Dalteparin|dalteparin|mesh-list
5766935|NCT02935530|Argatroban|argatroban|mesh-list
5766936|NCT02935530|Anticoagulants|anticoagulants|mesh-ancestor
5766937|NCT02935530|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5766938|NCT02935530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5766939|NCT02935530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766940|NCT02935530|Antithrombins|antithrombins|mesh-ancestor
5766941|NCT02935530|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5766942|NCT02935530|Protease Inhibitors|protease inhibitors|mesh-ancestor
5640163|NCT05216250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640164|NCT05216250|Cholinergic Agents|cholinergic agents|mesh-ancestor
5640165|NCT05216250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5640166|NCT05216250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640167|NCT05216250|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5640168|NCT05216250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5640169|NCT05216237|Oxaliplatin|oxaliplatin|mesh-list
5640170|NCT05216237|Apatinib|apatinib|mesh-list
5766943|NCT02935530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5766944|NCT02935530|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5766945|NCT02935205|Indomethacin|indomethacin|mesh-list
5766946|NCT02935205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5766947|NCT02935205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5766948|NCT02935205|Analgesics|analgesics|mesh-ancestor
5766949|NCT02935205|Sensory System Agents|sensory system agents|mesh-ancestor
5766950|NCT02935205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5766951|NCT02935205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766952|NCT02935205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5766953|NCT02935205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5766954|NCT02935205|Gout Suppressants|gout suppressants|mesh-ancestor
5766955|NCT02935205|Tocolytic Agents|tocolytic agents|mesh-ancestor
5766956|NCT02935205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5766957|NCT02935205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5766958|NCT02935205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5766959|NCT02935205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766960|NCT02935114|Hydrogen Peroxide|hydrogen peroxide|mesh-list
5766961|NCT02935114|Carbamide Peroxide|carbamide peroxide|mesh-list
5766962|NCT02935114|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5766963|NCT02935114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5766964|NCT02935231|Nicotine|nicotine|mesh-list
5766965|NCT02935231|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5766966|NCT02935231|Autonomic Agents|autonomic agents|mesh-ancestor
5766967|NCT02935231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5766968|NCT02935231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766969|NCT02935231|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5766970|NCT02935231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5766971|NCT02935231|Cholinergic Agents|cholinergic agents|mesh-ancestor
5766972|NCT02935231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5766973|NCT02935231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766974|NCT02935374|Amoxicillin|amoxicillin|mesh-list
5766975|NCT02935374|Clavulanic Acid|clavulanic acid|mesh-list
5766976|NCT02935374|Clavulanic Acids|clavulanic acids|mesh-list
5766977|NCT02935374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5766978|NCT02935374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5766979|NCT02935374|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5766980|NCT02935374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5766981|NCT02935374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766982|NCT02935361|Atezolizumab|atezolizumab|mesh-list
5766983|NCT02935361|Guadecitabine|guadecitabine|mesh-list
5766984|NCT02935361|Azacitidine|azacitidine|mesh-list
5766985|NCT02935361|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5766986|NCT02935361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5766987|NCT02935361|Immunologic Factors|immunologic factors|mesh-ancestor
5766988|NCT02935361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5766989|NCT02935361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5766990|NCT02935361|Antimetabolites|antimetabolites|mesh-ancestor
5766991|NCT02935361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5766992|NCT02935361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5766993|NCT02935322|Chlorhexidine|chlorhexidine|mesh-list
5766994|NCT02935322|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5640171|NCT05216237|Tegafur|tegafur|mesh-list
5766995|NCT02935322|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5766996|NCT02935322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5766997|NCT02935322|Disinfectants|disinfectants|mesh-ancestor
5766998|NCT02935322|Dermatologic Agents|dermatologic agents|mesh-ancestor
5766999|NCT02935335|Menotropins|menotropins|mesh-list
5767000|NCT02935335|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5767001|NCT02935335|Fertility Agents|fertility agents|mesh-ancestor
5767002|NCT02935335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5767003|NCT02935335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767004|NCT02935075|Tenofovir|tenofovir|mesh-list
5767005|NCT02935075|Lamivudine|lamivudine|mesh-list
5767006|NCT02935075|Efavirenz|efavirenz|mesh-list
5767007|NCT02935075|Antiviral Agents|antiviral agents|mesh-ancestor
5767008|NCT02935075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5767009|NCT02935075|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5767010|NCT02935075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6210132|NCT02155985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6210133|NCT02155985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6210134|NCT02155985|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6210135|NCT02155985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6210136|NCT02155985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210137|NCT02155985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6210138|NCT02155985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6210139|NCT02155985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5640172|NCT05216237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5640173|NCT05216237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5640174|NCT05216237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5640175|NCT05216237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640176|NCT05216237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5640177|NCT05216237|Antimetabolites|antimetabolites|mesh-ancestor
5640178|NCT05216211|Bupivacaine|bupivacaine|mesh-list
5640179|NCT05216211|Anesthetics, Local|anesthetics, local|mesh-ancestor
5640180|NCT05216211|Anesthetics|anesthetics|mesh-ancestor
5640181|NCT05216211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5640182|NCT05216211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640183|NCT05216211|Sensory System Agents|sensory system agents|mesh-ancestor
5640184|NCT05216211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5640185|NCT05216055|Dexamethasone|dexamethasone|mesh-list
5640186|NCT05216055|Dexamethasone acetate|dexamethasone acetate|mesh-list
5640187|NCT05216055|Dexmedetomidine|dexmedetomidine|mesh-list
5640188|NCT05216055|Bupivacaine|bupivacaine|mesh-list
5640189|NCT05216055|Ropivacaine|ropivacaine|mesh-list
5640190|NCT05216055|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
5640191|NCT05216055|BB 1101|bb 1101|mesh-list
5640192|NCT05216055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5640193|NCT05216055|Antiemetics|antiemetics|mesh-ancestor
5640194|NCT05216055|Autonomic Agents|autonomic agents|mesh-ancestor
5640195|NCT05216055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5640196|NCT05216055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640197|NCT05216055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5640198|NCT05216055|Glucocorticoids|glucocorticoids|mesh-ancestor
5640199|NCT05216055|Hormones|hormones|mesh-ancestor
5640200|NCT05216055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5640201|NCT05216055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6210140|NCT02155985|Antipyretics|antipyretics|mesh-ancestor
6210141|NCT02156154|Acetaminophen|acetaminophen|mesh-list
6210142|NCT02156154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6210143|NCT02156154|Analgesics|analgesics|mesh-ancestor
6210144|NCT02156154|Sensory System Agents|sensory system agents|mesh-ancestor
6210145|NCT02156154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5640202|NCT05216055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5767011|NCT02935075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5767012|NCT02935075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640203|NCT05216055|Anesthetics, Local|anesthetics, local|mesh-ancestor
5640204|NCT05216055|Anesthetics|anesthetics|mesh-ancestor
5640205|NCT05216055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5640206|NCT05216055|Sensory System Agents|sensory system agents|mesh-ancestor
5640207|NCT05216055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5640208|NCT05216055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5640209|NCT05216055|Analgesics|analgesics|mesh-ancestor
5640210|NCT05216055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5640211|NCT05216055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5640212|NCT05216055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5767013|NCT02935075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5767014|NCT02935075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5767015|NCT02935075|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5767016|NCT02935075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6210146|NCT02156154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640213|NCT05216055|Adrenergic Agents|adrenergic agents|mesh-ancestor
5640214|NCT05216055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5640215|NCT05216055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640216|NCT05216055|Protease Inhibitors|protease inhibitors|mesh-ancestor
5640217|NCT05216055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5640218|NCT05215925|Cetuximab|cetuximab|mesh-list
5640219|NCT05215925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5640220|NCT05215925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5640221|NCT05215873|Misoprostol|misoprostol|mesh-list
5640222|NCT05215873|Oxytocin|oxytocin|mesh-list
5640223|NCT05215873|Oxytocics|oxytocics|mesh-ancestor
5640224|NCT05215873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5640225|NCT05215873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640226|NCT05215873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5640227|NCT05215873|Abortifacient Agents|abortifacient agents|mesh-ancestor
5640228|NCT05215873|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5640229|NCT05215873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5640230|NCT05215743|Acetylcysteine|acetylcysteine|mesh-list
5767017|NCT02935075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5767018|NCT02935075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5767019|NCT02935075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5767020|NCT02935075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5767021|NCT02935101|Prednisolone|prednisolone|mesh-list
5767022|NCT02935101|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5767023|NCT02935101|Methylprednisolone|methylprednisolone|mesh-list
5767024|NCT02935101|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5767025|NCT02935101|Prednisolone acetate|prednisolone acetate|mesh-list
5767026|NCT02935101|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5767027|NCT02935101|Prednisolone phosphate|prednisolone phosphate|mesh-list
5767028|NCT02935101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5767029|NCT02935101|Glucocorticoids|glucocorticoids|mesh-ancestor
5767030|NCT02935101|Hormones|hormones|mesh-ancestor
5767031|NCT02935101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5767032|NCT02935101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767033|NCT02935101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5767034|NCT02935101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5767035|NCT02935101|Antiemetics|antiemetics|mesh-ancestor
5767036|NCT02935101|Autonomic Agents|autonomic agents|mesh-ancestor
5767037|NCT02935101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5767038|NCT02935101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5767039|NCT02935101|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5767040|NCT02935101|Protective Agents|protective agents|mesh-ancestor
5767041|NCT02934945|Budesonide|budesonide|mesh-list
5767042|NCT02934945|Formoterol Fumarate|formoterol fumarate|mesh-list
5767043|NCT02934945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5767044|NCT02934945|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5640231|NCT05215743|Antioxidants|antioxidants|mesh-list
5640232|NCT05215743|Deferoxamine|deferoxamine|mesh-list
5640233|NCT05215743|Antiviral Agents|antiviral agents|mesh-ancestor
5640234|NCT05215743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5640235|NCT05215743|Expectorants|expectorants|mesh-ancestor
5640236|NCT05215743|Respiratory System Agents|respiratory system agents|mesh-ancestor
5640237|NCT05215743|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5640238|NCT05215743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640239|NCT05215743|Protective Agents|protective agents|mesh-ancestor
5640240|NCT05215743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640241|NCT05215743|Siderophores|siderophores|mesh-ancestor
5640242|NCT05215743|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5767045|NCT02934945|Autonomic Agents|autonomic agents|mesh-ancestor
5767046|NCT02934945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5767047|NCT02934945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767048|NCT02934945|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5767049|NCT02934945|Respiratory System Agents|respiratory system agents|mesh-ancestor
5767050|NCT02934945|Glucocorticoids|glucocorticoids|mesh-ancestor
5767051|NCT02934945|Hormones|hormones|mesh-ancestor
5767052|NCT02934945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5767053|NCT02934945|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5640243|NCT05215743|Chelating Agents|chelating agents|mesh-ancestor
5640244|NCT05215743|Sequestering Agents|sequestering agents|mesh-ancestor
5640245|NCT05215730|Copper|copper|mesh-list
5640246|NCT05215730|Trace Elements|trace elements|mesh-ancestor
5640247|NCT05215730|Micronutrients|micronutrients|mesh-ancestor
5640248|NCT05215730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640249|NCT05215665|Lenvatinib|lenvatinib|mesh-list
5640250|NCT05215665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5640251|NCT05215665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5640252|NCT05215665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5640253|NCT05215665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5767054|NCT02934945|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5767055|NCT02934945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5767056|NCT02934945|Adrenergic Agents|adrenergic agents|mesh-ancestor
5767057|NCT02934945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5767058|NCT02934945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5767059|NCT02934919|Nalmefene|nalmefene|mesh-list
5767060|NCT02934919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5767061|NCT02934919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767062|NCT02934919|Sensory System Agents|sensory system agents|mesh-ancestor
5767063|NCT02934919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5895932|NCT04746495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5895933|NCT04746495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895934|NCT04746495|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5895935|NCT04746495|Diuretics|diuretics|mesh-ancestor
5895936|NCT04746495|Natriuretic Agents|natriuretic agents|mesh-ancestor
5895937|NCT04746495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5640254|NCT05215548|Afatinib|afatinib|mesh-list
5640255|NCT05215548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5640256|NCT05215548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5640257|NCT05215548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5640258|NCT05215548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640259|NCT05215535|Liver Extracts|liver extracts|mesh-list
5640260|NCT05215535|Hematinics|hematinics|mesh-ancestor
5640261|NCT05215418|Topiramate|topiramate|mesh-list
5640262|NCT05215418|Phentermine|phentermine|mesh-list
5640263|NCT05215418|Anticonvulsants|anticonvulsants|mesh-ancestor
5640264|NCT05215418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5640265|NCT05215418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640266|NCT05215418|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5640267|NCT05215418|Appetite Depressants|appetite depressants|mesh-ancestor
5640268|NCT05215418|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5640269|NCT05215418|Sympathomimetics|sympathomimetics|mesh-ancestor
5640270|NCT05215418|Autonomic Agents|autonomic agents|mesh-ancestor
5640271|NCT05215418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5640272|NCT05215418|Adrenergic Agents|adrenergic agents|mesh-ancestor
5640273|NCT05215418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5640274|NCT05215418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640275|NCT05215405|Venetoclax|venetoclax|mesh-list
5640276|NCT05215405|Navitoclax|navitoclax|mesh-list
5640277|NCT05215405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5640278|NCT05215366|Arginine Vasopressin|arginine vasopressin|mesh-list
5640279|NCT05215366|Hemostatics|hemostatics|mesh-ancestor
5640280|NCT05215366|Coagulants|coagulants|mesh-ancestor
5640281|NCT05215366|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5640282|NCT05215366|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5640283|NCT05215366|Natriuretic Agents|natriuretic agents|mesh-ancestor
5640284|NCT05215366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640285|NCT05215327|Vaccines|vaccines|mesh-list
5640286|NCT05215327|Immunologic Factors|immunologic factors|mesh-ancestor
5640287|NCT05215327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640288|NCT05215106|Durvalumab|durvalumab|mesh-list
5640289|NCT05215106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5640290|NCT05215106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5640291|NCT05215067|Docetaxel|docetaxel|mesh-list
5640292|NCT05215067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5640293|NCT05215067|Tubulin Modulators|tubulin modulators|mesh-ancestor
5640294|NCT05215067|Antimitotic Agents|antimitotic agents|mesh-ancestor
5640295|NCT05215067|Mitosis Modulators|mitosis modulators|mesh-ancestor
5640296|NCT05215067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640297|NCT05214976|Paclitaxel|paclitaxel|mesh-list
5640298|NCT05214976|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5640299|NCT05214976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5640300|NCT05214976|Tubulin Modulators|tubulin modulators|mesh-ancestor
5895938|NCT04741698|Propranolol|propranolol|mesh-list
5895939|NCT04741698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5895940|NCT04741698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5640301|NCT05214976|Antimitotic Agents|antimitotic agents|mesh-ancestor
5640302|NCT05214976|Mitosis Modulators|mitosis modulators|mesh-ancestor
5640303|NCT05214976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640304|NCT05214911|Loratadine|loratadine|mesh-list
5640305|NCT05214911|Prednisolone|prednisolone|mesh-list
5640306|NCT05214911|Desloratadine|desloratadine|mesh-list
5640307|NCT05214911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5640308|NCT05214911|Glucocorticoids|glucocorticoids|mesh-ancestor
5640309|NCT05214911|Hormones|hormones|mesh-ancestor
5640310|NCT05214911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5640311|NCT05214911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767064|NCT02934789|Contraceptive Agents|contraceptive agents|mesh-list
5767065|NCT02934789|Contraceptives, Oral|contraceptives, oral|mesh-list
5767066|NCT02934789|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
5767067|NCT02934789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5640312|NCT05214911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5640313|NCT05214911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5767068|NCT02934789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640314|NCT05214911|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5640315|NCT05214911|Cholinergic Agents|cholinergic agents|mesh-ancestor
5640316|NCT05214911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5640317|NCT05214911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640318|NCT05214911|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5640319|NCT05214911|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5767069|NCT02934789|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5767070|NCT02934906|Immunoglobulins|immunoglobulins|mesh-list
5767071|NCT02934906|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5767072|NCT02934906|Antibodies|antibodies|mesh-list
5767073|NCT02934906|gamma-Globulins|gamma-globulins|mesh-list
5767074|NCT02934906|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5767075|NCT02934906|Immunologic Factors|immunologic factors|mesh-ancestor
5640320|NCT05214911|Histamine Antagonists|histamine antagonists|mesh-ancestor
5640321|NCT05214911|Histamine Agents|histamine agents|mesh-ancestor
5640322|NCT05214911|Antipruritics|antipruritics|mesh-ancestor
5640323|NCT05214911|Dermatologic Agents|dermatologic agents|mesh-ancestor
5640324|NCT05214911|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5640325|NCT05214872|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
5640326|NCT05214872|Calcium|calcium|mesh-list
5640327|NCT05214872|Mitogens|mitogens|mesh-list
5640328|NCT05214872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5640329|NCT05214872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640330|NCT05214872|Mitosis Modulators|mitosis modulators|mesh-ancestor
5767076|NCT02934906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767077|NCT02935010|Amoxicillin|amoxicillin|mesh-list
5767078|NCT02935010|Metronidazole|metronidazole|mesh-list
5767079|NCT02935010|Clarithromycin|clarithromycin|mesh-list
5767080|NCT02935010|Levofloxacin|levofloxacin|mesh-list
5767081|NCT02935010|Ofloxacin|ofloxacin|mesh-list
5767082|NCT02935010|Potassium Citrate|potassium citrate|mesh-list
5767083|NCT02935010|Esomeprazole|esomeprazole|mesh-list
5767084|NCT02935010|Bismuth|bismuth|mesh-list
5767085|NCT02935010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5767086|NCT02935010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5767087|NCT02935010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5767088|NCT02935010|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5767089|NCT02935010|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5767090|NCT02935010|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5767091|NCT02935010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5767092|NCT02935010|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5767093|NCT02935010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5767094|NCT02935010|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5767095|NCT02935010|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5767096|NCT02935010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5767097|NCT02935010|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5767098|NCT02935010|Renal Agents|renal agents|mesh-ancestor
5767099|NCT02935010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5767100|NCT02935010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5767101|NCT02935010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5767102|NCT02935010|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5767103|NCT02935010|Antacids|antacids|mesh-ancestor
5767104|NCT02935010|Diuretics|diuretics|mesh-ancestor
5767105|NCT02935010|Natriuretic Agents|natriuretic agents|mesh-ancestor
5767106|NCT02935010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767107|NCT02935010|Expectorants|expectorants|mesh-ancestor
5767108|NCT02935010|Respiratory System Agents|respiratory system agents|mesh-ancestor
5767109|NCT02934763|Propranolol|propranolol|mesh-list
5767110|NCT02934763|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5767111|NCT02934763|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5767112|NCT02934763|Adrenergic Agents|adrenergic agents|mesh-ancestor
5767113|NCT02934763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5767114|NCT02934763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5767115|NCT02934763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767116|NCT02934763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5767117|NCT02934763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5767118|NCT02934763|Vasodilator Agents|vasodilator agents|mesh-ancestor
5640331|NCT05214872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5767119|NCT02934464|Leucovorin|leucovorin|mesh-list
5767120|NCT02934464|Paclitaxel|paclitaxel|mesh-list
5767121|NCT02934464|Ramucirumab|ramucirumab|mesh-list
5767122|NCT02934464|Oxaliplatin|oxaliplatin|mesh-list
5767123|NCT02934464|Levoleucovorin|levoleucovorin|mesh-list
5767124|NCT02934464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5640332|NCT05214872|Natriuretic Agents|natriuretic agents|mesh-ancestor
5640333|NCT05214820|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5640334|NCT05214820|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
5640335|NCT05214820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640336|NCT05214807|Chitosan|chitosan|mesh-list
5767125|NCT02934464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5767126|NCT02934464|Tubulin Modulators|tubulin modulators|mesh-ancestor
5767127|NCT02934464|Antimitotic Agents|antimitotic agents|mesh-ancestor
5767128|NCT02934464|Mitosis Modulators|mitosis modulators|mesh-ancestor
5767129|NCT02934464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5767130|NCT02934464|Antidotes|antidotes|mesh-ancestor
5767131|NCT02934464|Protective Agents|protective agents|mesh-ancestor
5767132|NCT02934464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767133|NCT02934464|Vitamin B Complex|vitamin b complex|mesh-ancestor
5767134|NCT02934464|Vitamins|vitamins|mesh-ancestor
5767135|NCT02934464|Micronutrients|micronutrients|mesh-ancestor
5767136|NCT02934607|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
5767137|NCT02934607|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5767138|NCT02934607|Respiratory System Agents|respiratory system agents|mesh-ancestor
5767139|NCT02934321|Erythritol|erythritol|mesh-list
5767140|NCT02934321|Vasodilator Agents|vasodilator agents|mesh-ancestor
5767141|NCT02934035|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5767142|NCT02934035|Citalopram|citalopram|mesh-list
5767143|NCT02934035|Fluoxetine|fluoxetine|mesh-list
5767144|NCT02934035|Paroxetine|paroxetine|mesh-list
5767145|NCT02934035|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
5767146|NCT02934035|Antidepressive Agents|antidepressive agents|mesh-list
5767147|NCT02934035|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5767148|NCT02934035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5767149|NCT02934035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5767150|NCT02934035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5767151|NCT02934035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5767152|NCT02934035|Serotonin Agents|serotonin agents|mesh-ancestor
5767153|NCT02934035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767154|NCT02934035|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5767155|NCT02934035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5767156|NCT02934035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5767157|NCT02934035|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5767158|NCT02934035|Analgesics|analgesics|mesh-ancestor
5767159|NCT02934035|Sensory System Agents|sensory system agents|mesh-ancestor
5767160|NCT02934035|Dopamine Agents|dopamine agents|mesh-ancestor
5767161|NCT02934035|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5767162|NCT02934035|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5640337|NCT05214807|Hylan|hylan|mesh-list
5640338|NCT05214807|Viscosupplements|viscosupplements|mesh-ancestor
5640339|NCT05214807|Protective Agents|protective agents|mesh-ancestor
5640340|NCT05214807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640341|NCT05214807|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5640342|NCT05214807|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5640343|NCT05214807|Antimetabolites|antimetabolites|mesh-ancestor
5640344|NCT05214807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640345|NCT05214807|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5640346|NCT05214807|Chelating Agents|chelating agents|mesh-ancestor
5640347|NCT05214807|Sequestering Agents|sequestering agents|mesh-ancestor
5640348|NCT05214807|Hemostatics|hemostatics|mesh-ancestor
5640349|NCT05214807|Coagulants|coagulants|mesh-ancestor
5693878|NCT03399019|Dexmedetomidine|dexmedetomidine|mesh-list
5693879|NCT03399019|Propofol|propofol|mesh-list
5767163|NCT02934035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5767164|NCT02934152|Amoxicillin|amoxicillin|mesh-list
5767165|NCT02934152|Clarithromycin|clarithromycin|mesh-list
5767166|NCT02934152|Rabeprazole|rabeprazole|mesh-list
5767167|NCT02934152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5693880|NCT03399019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5693881|NCT03399019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5693882|NCT03399019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693883|NCT03399019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5693884|NCT03399019|Anesthetics, General|anesthetics, general|mesh-ancestor
5693885|NCT03399019|Anesthetics|anesthetics|mesh-ancestor
5693886|NCT03399019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5693887|NCT03399019|Analgesics|analgesics|mesh-ancestor
5693888|NCT03399019|Sensory System Agents|sensory system agents|mesh-ancestor
5693889|NCT03399019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5767168|NCT02934152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5767169|NCT02934152|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5767170|NCT02934152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5767171|NCT02934152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5767172|NCT02934152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5767173|NCT02934152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5767174|NCT02934152|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5767175|NCT02934152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5767176|NCT02934152|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5767177|NCT02934295|Antibodies|antibodies|mesh-list
5767178|NCT02934295|Immunologic Factors|immunologic factors|mesh-ancestor
5767179|NCT02934295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767180|NCT02934022|Maraviroc|maraviroc|mesh-list
5767181|NCT02934022|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5767182|NCT02934022|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5767183|NCT02934022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5767184|NCT02934022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5767185|NCT02934022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5767186|NCT02934022|Antiviral Agents|antiviral agents|mesh-ancestor
5767187|NCT02934022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5767188|NCT02934022|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
5767189|NCT02934204|Methotrexate|methotrexate|mesh-list
5767190|NCT02934204|Temozolomide|temozolomide|mesh-list
5767191|NCT02934204|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5767192|NCT02934204|Abortifacient Agents|abortifacient agents|mesh-ancestor
5767193|NCT02934204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5767194|NCT02934204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767195|NCT02934204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5767196|NCT02934204|Antimetabolites|antimetabolites|mesh-ancestor
5767197|NCT02934204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5767198|NCT02934204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5767199|NCT02934204|Dermatologic Agents|dermatologic agents|mesh-ancestor
5767200|NCT02934204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5640350|NCT05214664|Anesthetics|anesthetics|mesh-list
5640351|NCT05214664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5640352|NCT05214664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640353|NCT05208047|Sunitinib|sunitinib|mesh-list
5640354|NCT05208047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5640355|NCT05208047|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5640356|NCT05208047|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5640357|NCT05208047|Growth Substances|growth substances|mesh-ancestor
5640358|NCT05208047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640359|NCT05208047|Growth Inhibitors|growth inhibitors|mesh-ancestor
5640360|NCT05208047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5640361|NCT05208047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5640362|NCT05208047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640363|NCT05201170|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5640364|NCT05198934|Trifluridine|trifluridine|mesh-list
5640365|NCT05198934|Panitumumab|panitumumab|mesh-list
5767201|NCT02934204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5767202|NCT02934204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5767203|NCT02934204|Immunologic Factors|immunologic factors|mesh-ancestor
5767204|NCT02934204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5767205|NCT02934204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5767206|NCT02934204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5767207|NCT02934204|Alkylating Agents|alkylating agents|mesh-ancestor
5767208|NCT02934061|Tizanidine|tizanidine|mesh-list
5767209|NCT02934061|Analgesics|analgesics|mesh-ancestor
5767210|NCT02934061|Sensory System Agents|sensory system agents|mesh-ancestor
5767211|NCT02934061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6210147|NCT02156154|Antipyretics|antipyretics|mesh-ancestor
5767212|NCT02934061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767213|NCT02934061|Anticonvulsants|anticonvulsants|mesh-ancestor
5767214|NCT02934061|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5767215|NCT02934061|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5767216|NCT02934061|Parasympatholytics|parasympatholytics|mesh-ancestor
5767217|NCT02934061|Autonomic Agents|autonomic agents|mesh-ancestor
5767218|NCT02934061|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5767219|NCT02934061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5767220|NCT02934061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5767221|NCT02934061|Adrenergic Agents|adrenergic agents|mesh-ancestor
5767222|NCT02934061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5767223|NCT02934061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5767224|NCT02934217|Cyclosporine|cyclosporine|mesh-list
5767225|NCT02934217|Cyclosporins|cyclosporins|mesh-list
5767226|NCT02934217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5767227|NCT02934217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5767228|NCT02934217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5767229|NCT02934217|Immunologic Factors|immunologic factors|mesh-ancestor
5767230|NCT02934217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767231|NCT02934217|Antifungal Agents|antifungal agents|mesh-ancestor
5767232|NCT02934217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5640366|NCT05198934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5640367|NCT05198934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5640368|NCT05198934|Antimetabolites|antimetabolites|mesh-ancestor
5640369|NCT05198934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5767233|NCT02934217|Dermatologic Agents|dermatologic agents|mesh-ancestor
5767234|NCT02934217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5767235|NCT02934217|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5767236|NCT02933905|Ranibizumab|ranibizumab|mesh-list
5767237|NCT02933905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5767238|NCT02933905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5767239|NCT02933905|Growth Substances|growth substances|mesh-ancestor
5767240|NCT02933905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767241|NCT02933905|Growth Inhibitors|growth inhibitors|mesh-ancestor
5767242|NCT02933905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5767243|NCT02933697|Apixaban|apixaban|mesh-list
5767244|NCT02933697|Phenprocoumon|phenprocoumon|mesh-list
5767245|NCT02933697|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5767246|NCT02933697|Antithrombins|antithrombins|mesh-ancestor
5767247|NCT02933697|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5767248|NCT02933697|Protease Inhibitors|protease inhibitors|mesh-ancestor
5767249|NCT02933697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5767250|NCT02933697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5767251|NCT02933697|Anticoagulants|anticoagulants|mesh-ancestor
5767252|NCT02933814|Bupivacaine|bupivacaine|mesh-list
5767253|NCT02933814|Anesthetics, Local|anesthetics, local|mesh-ancestor
5767254|NCT02933814|Anesthetics|anesthetics|mesh-ancestor
5767255|NCT02933814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5767256|NCT02933814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767257|NCT02933814|Sensory System Agents|sensory system agents|mesh-ancestor
5767258|NCT02933814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5767259|NCT02933775|Cyclophosphamide|cyclophosphamide|mesh-list
5767260|NCT02933775|Fludarabine|fludarabine|mesh-list
5767261|NCT02933775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5767262|NCT02933775|Immunologic Factors|immunologic factors|mesh-ancestor
5767263|NCT02933775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767264|NCT02933775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5767265|NCT02933775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5767266|NCT02933775|Alkylating Agents|alkylating agents|mesh-ancestor
5767267|NCT02933775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5767268|NCT02933775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5767269|NCT02933775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5640370|NCT05198934|Antiviral Agents|antiviral agents|mesh-ancestor
5640371|NCT05198934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5640372|NCT05193591|Autoantibodies|autoantibodies|mesh-list
5640373|NCT05193591|Immunologic Factors|immunologic factors|mesh-ancestor
5640374|NCT05193591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640375|NCT05193487|Anesthetics|anesthetics|mesh-list
5640376|NCT05193487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5640377|NCT05193487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640378|NCT05189145|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5640379|NCT05189145|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5640380|NCT05189145|Hormones|hormones|mesh-list
5640381|NCT05189145|Estradiol|estradiol|mesh-list
5767270|NCT02933788|Aspirin|aspirin|mesh-list
5767271|NCT02933788|Cilostazol|cilostazol|mesh-list
5767272|NCT02933788|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5767273|NCT02933788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5767274|NCT02933788|Analgesics|analgesics|mesh-ancestor
5767275|NCT02933788|Sensory System Agents|sensory system agents|mesh-ancestor
5767276|NCT02933788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5767277|NCT02933788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767278|NCT02933788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5767279|NCT02933788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5767280|NCT02933788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5767281|NCT02933788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5767282|NCT02933788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5767283|NCT02933788|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5640382|NCT05189145|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5640383|NCT05189145|Progesterone|progesterone|mesh-list
5640384|NCT05189145|Dydrogesterone|dydrogesterone|mesh-list
5640385|NCT05189145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5640386|NCT05189145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640387|NCT05189145|Estrogens|estrogens|mesh-ancestor
5640388|NCT05189145|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5640389|NCT05189145|Contraceptive Agents|contraceptive agents|mesh-ancestor
5640390|NCT05189145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5640391|NCT05189145|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5640392|NCT05189145|Progestins|progestins|mesh-ancestor
5640393|NCT05186571|Vaccines|vaccines|mesh-list
5640394|NCT05186571|Immunologic Factors|immunologic factors|mesh-ancestor
5640395|NCT05186571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640396|NCT05183854|Vaccines|vaccines|mesh-list
5640397|NCT05183854|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5640398|NCT05183854|Immunologic Factors|immunologic factors|mesh-ancestor
5640399|NCT05183854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640400|NCT05166967|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5767284|NCT02933788|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5767285|NCT02933788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5767286|NCT02933788|Antipyretics|antipyretics|mesh-ancestor
5767287|NCT02933788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5767288|NCT02933788|Autonomic Agents|autonomic agents|mesh-ancestor
5767289|NCT02933788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5767290|NCT02933788|Respiratory System Agents|respiratory system agents|mesh-ancestor
5767291|NCT02933788|Vasodilator Agents|vasodilator agents|mesh-ancestor
5640401|NCT05166967|Immunologic Factors|immunologic factors|mesh-ancestor
5640402|NCT05166967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640403|NCT05166967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5640404|NCT05160922|Crizotinib|crizotinib|mesh-list
5640405|NCT05160922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5640406|NCT05160922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5640407|NCT05160922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5640408|NCT05160922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640409|NCT05154994|Durvalumab|durvalumab|mesh-list
5640410|NCT05154994|Ipilimumab|ipilimumab|mesh-list
5640411|NCT05154994|Tremelimumab|tremelimumab|mesh-list
5640412|NCT05154994|Belinostat|belinostat|mesh-list
5640413|NCT05154994|Immunoglobulins|immunoglobulins|mesh-list
5640414|NCT05154994|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5640415|NCT05154994|Immunoglobulin G|immunoglobulin g|mesh-list
5640416|NCT05154994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5640417|NCT05154994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5767292|NCT02933788|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5767293|NCT02933788|Protective Agents|protective agents|mesh-ancestor
5767294|NCT02933788|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5767295|NCT02933788|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5767296|NCT02933658|Amlodipine|amlodipine|mesh-list
5767297|NCT02933658|Telmisartan|telmisartan|mesh-list
5767298|NCT02933658|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5767299|NCT02933658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5767300|NCT02933658|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5767301|NCT02933658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5767302|NCT02933658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5767303|NCT02933658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5767304|NCT02933658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767305|NCT02933658|Vasodilator Agents|vasodilator agents|mesh-ancestor
5767306|NCT02933658|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5767307|NCT02933658|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5767308|NCT02933658|Antimetabolites|antimetabolites|mesh-ancestor
5767309|NCT02933658|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5767310|NCT02933658|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5767311|NCT02933658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5767312|NCT02933658|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5767313|NCT02933658|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5640418|NCT05154994|Immunologic Factors|immunologic factors|mesh-ancestor
5640419|NCT05154994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640420|NCT05154994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5640421|NCT05154994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640422|NCT05154994|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5640423|NCT05154994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5767314|NCT02933593|Hydralazine|hydralazine|mesh-list
5640424|NCT05147402|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
5640425|NCT05147402|Hallucinogens|hallucinogens|mesh-ancestor
5640426|NCT05147402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640427|NCT05147402|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5640428|NCT05147402|Serotonin Agents|serotonin agents|mesh-ancestor
5640429|NCT05147402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5767315|NCT02933593|Labetalol|labetalol|mesh-list
5767316|NCT02933593|Nifedipine|nifedipine|mesh-list
5767317|NCT02933593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5767318|NCT02933593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5767319|NCT02933593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5767320|NCT02933593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5767321|NCT02933593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767322|NCT02933593|Vasodilator Agents|vasodilator agents|mesh-ancestor
5767323|NCT02933593|Tocolytic Agents|tocolytic agents|mesh-ancestor
5767324|NCT02933593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5767325|NCT02933593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5767326|NCT02933593|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5767327|NCT02933593|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5767328|NCT02933593|Adrenergic Agents|adrenergic agents|mesh-ancestor
5767329|NCT02933593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5767330|NCT02933593|Sympathomimetics|sympathomimetics|mesh-ancestor
5767331|NCT02933593|Autonomic Agents|autonomic agents|mesh-ancestor
5767332|NCT02933593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5767333|NCT02933593|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5767334|NCT02933593|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5767335|NCT02933853|Insulin|insulin|mesh-list
5767336|NCT02933853|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5767337|NCT02933853|Insulin Aspart|insulin aspart|mesh-list
5767338|NCT02933853|Insulin, Long-Acting|insulin, long-acting|mesh-list
5640430|NCT05147402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640431|NCT05147402|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5640432|NCT05147402|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5640433|NCT05147402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5640434|NCT05147402|Adrenergic Agents|adrenergic agents|mesh-ancestor
5640435|NCT05130788|Nicotine|nicotine|mesh-list
5640436|NCT05130788|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5640437|NCT05130788|Autonomic Agents|autonomic agents|mesh-ancestor
5640438|NCT05130788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5640439|NCT05130788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640440|NCT05130788|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5640441|NCT05130788|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5640442|NCT05130788|Cholinergic Agents|cholinergic agents|mesh-ancestor
5640443|NCT05130788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5640444|NCT05130788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640445|NCT05114915|Docetaxel|docetaxel|mesh-list
5767339|NCT02933853|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
5767340|NCT02933853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5767341|NCT02933853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767342|NCT02933645|Insulin|insulin|mesh-list
5767343|NCT02933645|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5767344|NCT02933645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5767345|NCT02933645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673467|NCT01562990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6673468|NCT01562990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6673469|NCT01562990|Immunologic Factors|immunologic factors|mesh-ancestor
5767346|NCT02933684|Cycloserine|cycloserine|mesh-list
5767347|NCT02933684|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5767348|NCT02933684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5767349|NCT02933684|Renal Agents|renal agents|mesh-ancestor
5767350|NCT02933684|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5640446|NCT05114915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5640447|NCT05114915|Tubulin Modulators|tubulin modulators|mesh-ancestor
5640448|NCT05114915|Antimitotic Agents|antimitotic agents|mesh-ancestor
5640449|NCT05114915|Mitosis Modulators|mitosis modulators|mesh-ancestor
5640450|NCT05114915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640451|NCT05108649|Nicotine|nicotine|mesh-list
5640452|NCT05108649|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5640453|NCT05108649|Autonomic Agents|autonomic agents|mesh-ancestor
5640454|NCT05108649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5640455|NCT05108649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640456|NCT05108649|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5640457|NCT05108649|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5640458|NCT05108649|Cholinergic Agents|cholinergic agents|mesh-ancestor
5640459|NCT05108649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5767351|NCT02933684|Antitubercular Agents|antitubercular agents|mesh-ancestor
5640460|NCT05108649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640461|NCT05096481|Temozolomide|temozolomide|mesh-list
5640462|NCT05096481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5640463|NCT05096481|Alkylating Agents|alkylating agents|mesh-ancestor
5767352|NCT02933684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5767353|NCT02933684|Antimetabolites|antimetabolites|mesh-ancestor
5767354|NCT02933684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5767355|NCT02933333|Molgramostim|molgramostim|mesh-list
5767356|NCT02933333|Lenograstim|lenograstim|mesh-list
5640464|NCT05096481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640465|NCT05096481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5640466|NCT05071833|Peppermint oil|peppermint oil|mesh-list
5640467|NCT05071833|Antiemetics|antiemetics|mesh-ancestor
5640468|NCT05071833|Autonomic Agents|autonomic agents|mesh-ancestor
5640469|NCT05071833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5640470|NCT05071833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640471|NCT05071833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5640472|NCT05071833|Parasympatholytics|parasympatholytics|mesh-ancestor
5640473|NCT05064280|Pembrolizumab|pembrolizumab|mesh-list
5640474|NCT05064280|Lenvatinib|lenvatinib|mesh-list
5640475|NCT05064280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5640476|NCT05064280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5640477|NCT05064280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5640478|NCT05064280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5640479|NCT05064280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640480|NCT05059600|Pregnanolone|pregnanolone|mesh-list
5640481|NCT05059600|Brexanolone|brexanolone|mesh-list
5767357|NCT02933333|Sargramostim|sargramostim|mesh-list
5767358|NCT02933333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5767359|NCT02933333|Immunologic Factors|immunologic factors|mesh-ancestor
5767360|NCT02933333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767361|NCT02933333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5895941|NCT04741698|Adrenergic Agents|adrenergic agents|mesh-ancestor
5895942|NCT04741698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5895943|NCT04741698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895944|NCT04741698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895945|NCT04741698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5895946|NCT04741698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5895947|NCT04741698|Vasodilator Agents|vasodilator agents|mesh-ancestor
5895948|NCT04717414|Luspatercept|luspatercept|mesh-list
5895949|NCT04717414|Hematinics|hematinics|mesh-ancestor
5895950|NCT04715646|Brivaracetam|brivaracetam|mesh-list
5895951|NCT04715646|Anticonvulsants|anticonvulsants|mesh-ancestor
5895952|NCT04701424|Insulin|insulin|mesh-list
5895953|NCT04701424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5895954|NCT04701424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895955|NCT04680988|Gemcitabine|gemcitabine|mesh-list
5895956|NCT04680988|Paclitaxel|paclitaxel|mesh-list
5895957|NCT04680988|Pemetrexed|pemetrexed|mesh-list
5895958|NCT04680988|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5895959|NCT04680988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5895960|NCT04680988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5895961|NCT04680988|Tubulin Modulators|tubulin modulators|mesh-ancestor
5895962|NCT04680988|Antimitotic Agents|antimitotic agents|mesh-ancestor
5895963|NCT04680988|Mitosis Modulators|mitosis modulators|mesh-ancestor
5895964|NCT04680988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895965|NCT04680988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5895966|NCT04680988|Antimetabolites|antimetabolites|mesh-ancestor
5895967|NCT04680988|Antiviral Agents|antiviral agents|mesh-ancestor
5895968|NCT04680988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5895969|NCT04680988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5895970|NCT04680988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5895971|NCT04680988|Immunologic Factors|immunologic factors|mesh-ancestor
5895972|NCT04680988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895973|NCT04680988|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5895974|NCT04680988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5895975|NCT04672941|Bromides|bromides|mesh-list
5895976|NCT04672941|Tiotropium Bromide|tiotropium bromide|mesh-list
5895977|NCT04672941|Olodaterol|olodaterol|mesh-list
5895978|NCT04672941|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5895979|NCT04672941|Autonomic Agents|autonomic agents|mesh-ancestor
5895980|NCT04672941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5895981|NCT04672941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5895982|NCT04672941|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5895983|NCT04672941|Respiratory System Agents|respiratory system agents|mesh-ancestor
5895984|NCT04672941|Parasympatholytics|parasympatholytics|mesh-ancestor
5895985|NCT04672941|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5895986|NCT04672941|Cholinergic Agents|cholinergic agents|mesh-ancestor
5895987|NCT04672941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5895988|NCT04672941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895989|NCT04672941|Anticonvulsants|anticonvulsants|mesh-ancestor
5895990|NCT04627142|Irinotecan|irinotecan|mesh-list
5895991|NCT04627142|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5895992|NCT04627142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5640482|NCT05059600|Anesthetics|anesthetics|mesh-ancestor
5640483|NCT05059600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5895993|NCT04627142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5895994|NCT04627142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5895995|NCT04627142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6210148|NCT02156492|Atorvastatin|atorvastatin|mesh-list
5767362|NCT02933437|Ajmaline|ajmaline|mesh-list
5767363|NCT02933437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5767364|NCT02933437|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5767365|NCT02933437|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5767366|NCT02933437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5767367|NCT02933437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5767368|NCT02932930|Ropivacaine|ropivacaine|mesh-list
5767369|NCT02932930|Anesthetics, Local|anesthetics, local|mesh-ancestor
5767370|NCT02932930|Anesthetics|anesthetics|mesh-ancestor
5767371|NCT02932930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5767372|NCT02932930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767373|NCT02932930|Sensory System Agents|sensory system agents|mesh-ancestor
5767374|NCT02932930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5767375|NCT02932826|Insulin|insulin|mesh-list
6210149|NCT02156492|Simvastatin|simvastatin|mesh-list
6490451|NCT00598338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490452|NCT00598338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490453|NCT00598377|Cosyntropin|cosyntropin|mesh-list
5640484|NCT05059600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640485|NCT05059600|Neurosteroids|neurosteroids|mesh-ancestor
5640486|NCT05059600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5640487|NCT05059600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640488|NCT05059600|GABA Modulators|gaba modulators|mesh-ancestor
5640489|NCT05059600|GABA Agents|gaba agents|mesh-ancestor
5640490|NCT05050136|Volixibat|volixibat|mesh-list
5640491|NCT05050136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5640492|NCT05048849|Somatomedin B|somatomedin b|mesh-list
5640493|NCT05048849|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5640494|NCT05048849|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5640495|NCT05048849|Protease Inhibitors|protease inhibitors|mesh-ancestor
5640496|NCT05048849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5640497|NCT05048849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640498|NCT05047640|Vaccines|vaccines|mesh-list
5640499|NCT05047640|Immunologic Factors|immunologic factors|mesh-ancestor
5640500|NCT05047640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640501|NCT05047601|Ritonavir|ritonavir|mesh-list
5640502|NCT05047601|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5640503|NCT05047601|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5640504|NCT05047601|Protease Inhibitors|protease inhibitors|mesh-ancestor
5640505|NCT05047601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5640506|NCT05047601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490454|NCT00598377|Hormones|hormones|mesh-ancestor
6490455|NCT00598377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6490456|NCT00598377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490457|NCT00598403|Ciprofloxacin|ciprofloxacin|mesh-list
6490458|NCT00598403|Cefditoren pivoxil|cefditoren pivoxil|mesh-list
6490459|NCT00598403|Cefditoren|cefditoren|mesh-list
6490460|NCT00598403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5767376|NCT02932826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5767377|NCT02932826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767378|NCT02933099|Dexamethasone|dexamethasone|mesh-list
5767379|NCT02933099|Dexamethasone acetate|dexamethasone acetate|mesh-list
5767380|NCT02933099|Aprepitant|aprepitant|mesh-list
5767381|NCT02933099|Palonosetron|palonosetron|mesh-list
5767382|NCT02933099|BB 1101|bb 1101|mesh-list
5767383|NCT02933099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5767384|NCT02933099|Antiemetics|antiemetics|mesh-ancestor
5767385|NCT02933099|Autonomic Agents|autonomic agents|mesh-ancestor
5767386|NCT02933099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5640507|NCT05047601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5640508|NCT05047601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5640509|NCT05047601|Antiviral Agents|antiviral agents|mesh-ancestor
5640510|NCT05047601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5640511|NCT05047601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5640512|NCT05047601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5640513|NCT05038618|Somatomedin B|somatomedin b|mesh-list
5640514|NCT05038618|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5640515|NCT05038618|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5640516|NCT05038618|Protease Inhibitors|protease inhibitors|mesh-ancestor
5640517|NCT05038618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5767387|NCT02933099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490461|NCT00598403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5640518|NCT05038618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693890|NCT03399019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5767388|NCT02933099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5767389|NCT02933099|Glucocorticoids|glucocorticoids|mesh-ancestor
5767390|NCT02933099|Hormones|hormones|mesh-ancestor
5767391|NCT02933099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5767392|NCT02933099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5767393|NCT02933099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5767394|NCT02933099|Protease Inhibitors|protease inhibitors|mesh-ancestor
5767395|NCT02933099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5767396|NCT02933099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5767397|NCT02933099|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5640519|NCT05020236|Dexamethasone|dexamethasone|mesh-list
5640520|NCT05020236|Daratumumab|daratumumab|mesh-list
5640521|NCT05020236|Pomalidomide|pomalidomide|mesh-list
5640522|NCT05020236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5640523|NCT05020236|Antiemetics|antiemetics|mesh-ancestor
5640524|NCT05020236|Autonomic Agents|autonomic agents|mesh-ancestor
5767398|NCT02933099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5767399|NCT02933099|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5767400|NCT02933099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5767401|NCT02933099|Serotonin Agents|serotonin agents|mesh-ancestor
5767402|NCT02932722|Anesthetics|anesthetics|mesh-list
5767403|NCT02932722|Propofol|propofol|mesh-list
5767404|NCT02932722|Sevoflurane|sevoflurane|mesh-list
5767405|NCT02932722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5767406|NCT02932722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767407|NCT02932722|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5767408|NCT02932722|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5767409|NCT02932722|Anesthetics, General|anesthetics, general|mesh-ancestor
5767410|NCT02932722|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5767411|NCT02932722|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5767412|NCT02932761|Goserelin|goserelin|mesh-list
5767413|NCT02932761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5767414|NCT02932761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5767415|NCT02932774|Cetirizine|cetirizine|mesh-list
5767416|NCT02932774|Loratadine|loratadine|mesh-list
5767417|NCT02932774|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5767418|NCT02932774|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5767419|NCT02932774|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5767420|NCT02932774|Histamine Antagonists|histamine antagonists|mesh-ancestor
5767421|NCT02932774|Histamine Agents|histamine agents|mesh-ancestor
5767422|NCT02932774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5767423|NCT02932774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5767424|NCT02932774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767425|NCT02932774|Antipruritics|antipruritics|mesh-ancestor
5640525|NCT05020236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5640526|NCT05020236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640527|NCT05020236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5767426|NCT02932774|Dermatologic Agents|dermatologic agents|mesh-ancestor
5767427|NCT02932605|Cannabidiol|cannabidiol|mesh-list
5640528|NCT05020236|Glucocorticoids|glucocorticoids|mesh-ancestor
5640529|NCT05020236|Hormones|hormones|mesh-ancestor
5640530|NCT05020236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5640531|NCT05020236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5640532|NCT05020236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5640533|NCT05020236|Immunologic Factors|immunologic factors|mesh-ancestor
5640534|NCT05020236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5640535|NCT05020236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5640536|NCT05020236|Growth Substances|growth substances|mesh-ancestor
5640537|NCT05020236|Growth Inhibitors|growth inhibitors|mesh-ancestor
5640538|NCT05011513|Ritonavir|ritonavir|mesh-list
5640539|NCT05011513|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5640540|NCT05011513|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5640541|NCT05011513|Protease Inhibitors|protease inhibitors|mesh-ancestor
5640542|NCT05011513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5640543|NCT05011513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5767428|NCT02932605|Anticonvulsants|anticonvulsants|mesh-ancestor
5640544|NCT05011513|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5640545|NCT05011513|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5640546|NCT05011513|Antiviral Agents|antiviral agents|mesh-ancestor
5640547|NCT05011513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5640548|NCT05011513|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5640549|NCT05011513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5640550|NCT05007821|Linezolid|linezolid|mesh-list
5640551|NCT05007821|Bedaquiline|bedaquiline|mesh-list
5640552|NCT05007821|Diarylquinolines|diarylquinolines|mesh-list
5640553|NCT05007821|Clofazimine|clofazimine|mesh-list
5640554|NCT05007821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5640555|NCT05007821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5640556|NCT05007821|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5640557|NCT05007821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5640558|NCT05007821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640559|NCT05007821|Antitubercular Agents|antitubercular agents|mesh-ancestor
5767429|NCT02932488|Sumatriptan|sumatriptan|mesh-list
5767430|NCT02932488|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5767431|NCT02932488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5767432|NCT02932488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5767433|NCT02932488|Serotonin Agents|serotonin agents|mesh-ancestor
5767434|NCT02932488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5767435|NCT02932488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5767436|NCT02932488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767437|NCT02932397|Propofol|propofol|mesh-list
5767438|NCT02932397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5767439|NCT02932397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5640560|NCT05007821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5640561|NCT05007821|Leprostatic Agents|leprostatic agents|mesh-ancestor
5640562|NCT04992013|Niraparib|niraparib|mesh-list
5640563|NCT04992013|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5640564|NCT04992013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5640565|NCT04992013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640566|NCT04992013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5767440|NCT02932397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767441|NCT02932397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5767442|NCT02932397|Anesthetics, General|anesthetics, general|mesh-ancestor
5767443|NCT02932397|Anesthetics|anesthetics|mesh-ancestor
5767444|NCT02932566|Pirfenidone|pirfenidone|mesh-list
5767445|NCT02932566|Analgesics|analgesics|mesh-ancestor
5767446|NCT02932566|Sensory System Agents|sensory system agents|mesh-ancestor
5767447|NCT02932566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5767448|NCT02932566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767449|NCT02932566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5767450|NCT02932566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5767451|NCT02932566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5767452|NCT02932566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5640567|NCT04967443|Prazosin|prazosin|mesh-list
5640568|NCT04967443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5640569|NCT04967443|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5640570|NCT04967443|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5640571|NCT04967443|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5640572|NCT04967443|Adrenergic Agents|adrenergic agents|mesh-ancestor
5640573|NCT04967443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5640574|NCT04967443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640575|NCT04967443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640576|NCT04967079|Trametinib|trametinib|mesh-list
5640577|NCT04967079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5640578|NCT04967079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5640579|NCT04967079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5640580|NCT04967079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640581|NCT04964193|Cyproterone Acetate|cyproterone acetate|mesh-list
5640582|NCT04964193|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5640583|NCT04964193|Cyproterone|cyproterone|mesh-list
5640584|NCT04964193|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
5640585|NCT04964193|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5640586|NCT04964193|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5640587|NCT04964193|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5640588|NCT04964193|Contraceptive Agents|contraceptive agents|mesh-ancestor
5640589|NCT04964193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5640590|NCT04964193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640591|NCT04964193|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5640592|NCT04964193|Estrogens|estrogens|mesh-ancestor
5640593|NCT04964193|Hormones|hormones|mesh-ancestor
5640594|NCT04964193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5640595|NCT04964193|Androgen Antagonists|androgen antagonists|mesh-ancestor
5640596|NCT04964193|Hormone Antagonists|hormone antagonists|mesh-ancestor
5640597|NCT04964193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5640598|NCT04964193|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5640599|NCT04958876|Naltrexone|naltrexone|mesh-list
5640600|NCT04958876|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5640601|NCT04958876|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5767453|NCT02932566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5767454|NCT02932644|Vitamin D|vitamin d|mesh-list
5767455|NCT02932644|Ergocalciferols|ergocalciferols|mesh-list
5767456|NCT02932644|Vitamins|vitamins|mesh-list
5767457|NCT02932644|Micronutrients|micronutrients|mesh-ancestor
5767458|NCT02932644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767459|NCT02932644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5767460|NCT02932644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5767461|NCT02932579|Acetaminophen|acetaminophen|mesh-list
5767462|NCT02932579|Ibuprofen|ibuprofen|mesh-list
5767463|NCT02932579|Oxycodone|oxycodone|mesh-list
5767464|NCT02932579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5767465|NCT02932579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5767466|NCT02932579|Analgesics|analgesics|mesh-ancestor
5767467|NCT02932579|Sensory System Agents|sensory system agents|mesh-ancestor
5767468|NCT02932579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5767469|NCT02932579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767470|NCT02932579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5767471|NCT02932579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5767472|NCT02932579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5767473|NCT02932579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5640602|NCT04958876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640603|NCT04958876|Sensory System Agents|sensory system agents|mesh-ancestor
5640604|NCT04958876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5767474|NCT02932579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5767475|NCT02932579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5767476|NCT02932579|Narcotics|narcotics|mesh-ancestor
5767477|NCT02932579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5767478|NCT02932579|Antipyretics|antipyretics|mesh-ancestor
5767479|NCT02932436|Empagliflozin|empagliflozin|mesh-list
5767480|NCT02932436|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5767481|NCT02932436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5767482|NCT02932436|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5767483|NCT02932436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767484|NCT02932007|Chloroquine|chloroquine|mesh-list
5767485|NCT02932007|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
5767486|NCT02932007|Amebicides|amebicides|mesh-ancestor
5767487|NCT02932007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5767488|NCT02932007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5767489|NCT02932007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5767490|NCT02932007|Antimalarials|antimalarials|mesh-ancestor
5767491|NCT02932007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5767492|NCT02932007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5767493|NCT02932007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5767494|NCT02932007|Analgesics|analgesics|mesh-ancestor
5767495|NCT02932007|Sensory System Agents|sensory system agents|mesh-ancestor
5767496|NCT02932007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5767497|NCT02932007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767498|NCT02932007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5767499|NCT02932007|Filaricides|filaricides|mesh-ancestor
5767500|NCT02932007|Antinematodal Agents|antinematodal agents|mesh-ancestor
5767501|NCT02932007|Anthelmintics|anthelmintics|mesh-ancestor
5767502|NCT02932020|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5767503|NCT02932020|Methylprednisolone|methylprednisolone|mesh-list
5767504|NCT02932020|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5767505|NCT02932020|Prednisolone|prednisolone|mesh-list
5767506|NCT02932020|Prednisolone acetate|prednisolone acetate|mesh-list
5767507|NCT02932020|Bupivacaine|bupivacaine|mesh-list
5767508|NCT02932020|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5767509|NCT02932020|Prednisolone phosphate|prednisolone phosphate|mesh-list
5767510|NCT02932020|Anesthetics, Local|anesthetics, local|mesh-ancestor
5767511|NCT02932020|Anesthetics|anesthetics|mesh-ancestor
5767512|NCT02932020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5767513|NCT02932020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767514|NCT02932020|Sensory System Agents|sensory system agents|mesh-ancestor
5767515|NCT02932020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5767516|NCT02932020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5767517|NCT02932020|Antiemetics|antiemetics|mesh-ancestor
5767518|NCT02932020|Autonomic Agents|autonomic agents|mesh-ancestor
5767519|NCT02932020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5767520|NCT02932020|Glucocorticoids|glucocorticoids|mesh-ancestor
5767521|NCT02932020|Hormones|hormones|mesh-ancestor
5767522|NCT02932020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5767523|NCT02932020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5767524|NCT02932020|Protective Agents|protective agents|mesh-ancestor
5767525|NCT02932020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5767526|NCT02932020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5767527|NCT02932137|Interleukin-2|interleukin-2|mesh-list
5767528|NCT02932137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5640605|NCT04954820|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
5640606|NCT04954820|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5640607|NCT04954820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640608|NCT04951388|Somatomedin B|somatomedin b|mesh-list
5640609|NCT04951388|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5640610|NCT04951388|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5640611|NCT04951388|Protease Inhibitors|protease inhibitors|mesh-ancestor
5640612|NCT04951388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5640613|NCT04951388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640614|NCT04946006|Oxytocin|oxytocin|mesh-list
5767529|NCT02932137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5767530|NCT02932137|Analgesics|analgesics|mesh-ancestor
5767531|NCT02932137|Sensory System Agents|sensory system agents|mesh-ancestor
5767532|NCT02932137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5767533|NCT02932137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767534|NCT02932254|Magnesium Sulfate|magnesium sulfate|mesh-list
5767535|NCT02932254|Analgesics|analgesics|mesh-ancestor
5767536|NCT02932254|Sensory System Agents|sensory system agents|mesh-ancestor
5767537|NCT02932254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5767538|NCT02932254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767539|NCT02932254|Anesthetics|anesthetics|mesh-ancestor
5767540|NCT02932254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5767541|NCT02932254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5767542|NCT02932254|Anticonvulsants|anticonvulsants|mesh-ancestor
5767543|NCT02932254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5767544|NCT02932254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5767545|NCT02932254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5767546|NCT02932254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5767547|NCT02932254|Tocolytic Agents|tocolytic agents|mesh-ancestor
5767548|NCT02932254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5767549|NCT02931903|Lithium Carbonate|lithium carbonate|mesh-list
5767550|NCT02931903|Antidepressive Agents|antidepressive agents|mesh-ancestor
5767551|NCT02931903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5767552|NCT02931903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5767553|NCT02931903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5767554|NCT02931903|Antimanic Agents|antimanic agents|mesh-ancestor
5767555|NCT02931903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5767556|NCT02931903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5767557|NCT02931903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767558|NCT02931786|Ketamine|ketamine|mesh-list
5767559|NCT02931786|Propofol|propofol|mesh-list
5767560|NCT02931786|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5767561|NCT02931786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5767562|NCT02931786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767563|NCT02931786|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5767564|NCT02931786|Anesthetics, General|anesthetics, general|mesh-ancestor
5767565|NCT02931786|Anesthetics|anesthetics|mesh-ancestor
5767566|NCT02931786|Analgesics|analgesics|mesh-ancestor
5767567|NCT02931786|Sensory System Agents|sensory system agents|mesh-ancestor
5767568|NCT02931786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5767569|NCT02931786|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5767570|NCT02931786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5767571|NCT02931786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5767572|NCT02931786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5767573|NCT02931786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5767574|NCT02931877|Propofol|propofol|mesh-list
5767575|NCT02931877|Sevoflurane|sevoflurane|mesh-list
5767576|NCT02931877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5767577|NCT02931877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5767578|NCT02931877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767579|NCT02931877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5767580|NCT02931877|Anesthetics, General|anesthetics, general|mesh-ancestor
5767581|NCT02931877|Anesthetics|anesthetics|mesh-ancestor
5767582|NCT02931877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6210150|NCT02156492|Evacetrapib|evacetrapib|mesh-list
5640615|NCT04946006|Oxytocics|oxytocics|mesh-ancestor
5640616|NCT04946006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5640617|NCT04946006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640618|NCT04926285|Venetoclax|venetoclax|mesh-list
5640619|NCT04926285|Homoharringtonine|homoharringtonine|mesh-list
5640620|NCT04926285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5640621|NCT04926285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5640622|NCT04926285|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5640623|NCT04926285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5767583|NCT02931877|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5895996|NCT04604132|Paclitaxel|paclitaxel|mesh-list
5895997|NCT04604132|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5895998|NCT04604132|Atezolizumab|atezolizumab|mesh-list
5895999|NCT04604132|Ramucirumab|ramucirumab|mesh-list
5896000|NCT04604132|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5896001|NCT04604132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5896002|NCT04604132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5896003|NCT04604132|Tubulin Modulators|tubulin modulators|mesh-ancestor
5896004|NCT04604132|Antimitotic Agents|antimitotic agents|mesh-ancestor
5896005|NCT04604132|Mitosis Modulators|mitosis modulators|mesh-ancestor
5896006|NCT04604132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896007|NCT04604132|Immunologic Factors|immunologic factors|mesh-ancestor
5896008|NCT04604132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896009|NCT04602221|Lamotrigine|lamotrigine|mesh-list
5896010|NCT04602221|BI 425809|bi 425809|mesh-list
5896011|NCT04602221|BI 409306|bi 409306|mesh-list
5896012|NCT04602221|Anticonvulsants|anticonvulsants|mesh-ancestor
5896013|NCT04602221|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5896014|NCT04602221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5896015|NCT04602221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896016|NCT04602221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5896017|NCT04602221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896018|NCT04602221|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5896019|NCT04602221|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5896020|NCT04602221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5896021|NCT04602221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5896022|NCT04602221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5896023|NCT04602221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5896024|NCT04602221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5896025|NCT04602221|Nootropic Agents|nootropic agents|mesh-ancestor
5896026|NCT04582591|Cannabidiol|cannabidiol|mesh-list
5896027|NCT04582591|Anticonvulsants|anticonvulsants|mesh-ancestor
5896028|NCT04569747|Tamoxifen|tamoxifen|mesh-list
5896029|NCT04569747|Trastuzumab|trastuzumab|mesh-list
5896030|NCT04569747|Pertuzumab|pertuzumab|mesh-list
5896031|NCT04569747|Letrozole|letrozole|mesh-list
5896032|NCT04569747|Anastrozole|anastrozole|mesh-list
5896033|NCT04569747|Leuprolide|leuprolide|mesh-list
5896034|NCT04569747|Exemestane|exemestane|mesh-list
5896035|NCT04569747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5896036|NCT04569747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5896037|NCT04569747|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5896038|NCT04569747|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5896039|NCT04569747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5896040|NCT04569747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896041|NCT04569747|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5896042|NCT04569747|Hormone Antagonists|hormone antagonists|mesh-ancestor
5896043|NCT04569747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5896044|NCT04569747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896045|NCT04569747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5896046|NCT04569747|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5896047|NCT04569747|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5896048|NCT04569747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5896049|NCT04569747|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5896050|NCT04569747|Fertility Agents|fertility agents|mesh-ancestor
5896051|NCT04569747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5896052|NCT04542200|Antibodies|antibodies|mesh-list
5896053|NCT04542200|Immunologic Factors|immunologic factors|mesh-ancestor
5896054|NCT04542200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896055|NCT04538534|Nicardipine|nicardipine|mesh-list
5896056|NCT04538534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5896057|NCT04538534|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5896058|NCT04538534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5896059|NCT04538534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896060|NCT04538534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5896061|NCT04538534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767584|NCT02931591|Metformin|metformin|mesh-list
5767585|NCT02931591|Hormones|hormones|mesh-list
5767586|NCT02931591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5767587|NCT02931591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767588|NCT02931591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5767589|NCT02931383|Liraglutide|liraglutide|mesh-list
5767590|NCT02931383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5767591|NCT02931383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767592|NCT02931383|Incretins|incretins|mesh-ancestor
5767593|NCT02931383|Hormones|hormones|mesh-ancestor
5767594|NCT02931383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5767595|NCT02931474|Tesamorelin|tesamorelin|mesh-list
5767596|NCT02931474|Growth Substances|growth substances|mesh-ancestor
5767597|NCT02931474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767598|NCT02931695|Hormones|hormones|mesh-list
5767599|NCT02931695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5767600|NCT02931695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767601|NCT02931357|Cetylpyridinium|cetylpyridinium|mesh-list
5767602|NCT02931357|Lidocaine|lidocaine|mesh-list
5767603|NCT02931357|Hyaluronic Acid|hyaluronic acid|mesh-list
5767604|NCT02931357|Anesthetics, Local|anesthetics, local|mesh-ancestor
5767605|NCT02931357|Anesthetics|anesthetics|mesh-ancestor
5767606|NCT02931357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5767607|NCT02931357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767608|NCT02931357|Sensory System Agents|sensory system agents|mesh-ancestor
5767609|NCT02931357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5767610|NCT02931357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5767611|NCT02931357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5767612|NCT02931357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5767613|NCT02931357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5767614|NCT02931357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5767615|NCT02931357|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5767616|NCT02931357|Immunologic Factors|immunologic factors|mesh-ancestor
5767617|NCT02931357|Viscosupplements|viscosupplements|mesh-ancestor
5767618|NCT02931357|Protective Agents|protective agents|mesh-ancestor
5767619|NCT02931357|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5767620|NCT02931357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5767621|NCT02931526|Tigecycline|tigecycline|mesh-list
5767622|NCT02931526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5767623|NCT02931526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5767624|NCT02931526|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5767625|NCT02931526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5767626|NCT02931526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5767627|NCT02931123|Rifaximin|rifaximin|mesh-list
5767628|NCT02931123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5767629|NCT02931123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5767630|NCT02931123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5767631|NCT02931136|Huperzine A|huperzine a|mesh-list
5767632|NCT02931136|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5767633|NCT02931136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5767634|NCT02931136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5767635|NCT02931136|Cholinergic Agents|cholinergic agents|mesh-ancestor
5767636|NCT02931136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5767637|NCT02931136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767638|NCT02931136|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5767639|NCT02931136|Protective Agents|protective agents|mesh-ancestor
5767640|NCT02931188|Anacetrapib|anacetrapib|mesh-list
5767641|NCT02931188|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5767642|NCT02931188|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5767643|NCT02931188|Antimetabolites|antimetabolites|mesh-ancestor
5767644|NCT02931188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5767645|NCT02931188|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5767646|NCT02931175|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
5767647|NCT02931175|Hormones|hormones|mesh-ancestor
5767648|NCT02931175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5767649|NCT02931175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767650|NCT02931071|Plerixafor|plerixafor|mesh-list
5767651|NCT02931071|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5767652|NCT02931071|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5767653|NCT02931071|Antiviral Agents|antiviral agents|mesh-ancestor
5767654|NCT02931071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5767655|NCT02930733|Bupivacaine|bupivacaine|mesh-list
5767656|NCT02930733|Anesthetics, Local|anesthetics, local|mesh-ancestor
5767657|NCT02930733|Anesthetics|anesthetics|mesh-ancestor
5767658|NCT02930733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5767659|NCT02930733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767660|NCT02930733|Sensory System Agents|sensory system agents|mesh-ancestor
5767661|NCT02930733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5767662|NCT02930811|Sildenafil Citrate|sildenafil citrate|mesh-list
5767663|NCT02930811|Vasodilator Agents|vasodilator agents|mesh-ancestor
5767664|NCT02930811|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5767665|NCT02930811|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5767666|NCT02930811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5767667|NCT02930811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5767668|NCT02930811|Urological Agents|urological agents|mesh-ancestor
5767669|NCT02930954|Gemcitabine|gemcitabine|mesh-list
5767670|NCT02930954|Bevacizumab|bevacizumab|mesh-list
5767671|NCT02930954|Carboplatin|carboplatin|mesh-list
5767672|NCT02930954|Pemetrexed|pemetrexed|mesh-list
5767673|NCT02930954|Gefitinib|gefitinib|mesh-list
5767674|NCT02930954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5767675|NCT02930954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5767676|NCT02930954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5767677|NCT02930954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5767678|NCT02930954|Growth Substances|growth substances|mesh-ancestor
5767679|NCT02930954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767680|NCT02930954|Growth Inhibitors|growth inhibitors|mesh-ancestor
5767681|NCT02930954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5767682|NCT02930954|Antimetabolites|antimetabolites|mesh-ancestor
5767683|NCT02930954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5767684|NCT02930954|Antiviral Agents|antiviral agents|mesh-ancestor
5767685|NCT02930954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5767686|NCT02930954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5767687|NCT02930954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5767688|NCT02930954|Immunologic Factors|immunologic factors|mesh-ancestor
5767689|NCT02930954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5767690|NCT02930954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5767691|NCT02930954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5767692|NCT02931201|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5767693|NCT02931201|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5767694|NCT02931201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5767695|NCT02930551|Lidocaine|lidocaine|mesh-list
5767696|NCT02930551|Anesthetics, Local|anesthetics, local|mesh-ancestor
5767697|NCT02930551|Anesthetics|anesthetics|mesh-ancestor
5767698|NCT02930551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5767699|NCT02930551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767700|NCT02930551|Sensory System Agents|sensory system agents|mesh-ancestor
5767701|NCT02930551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5767702|NCT02930551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5767703|NCT02930551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5767704|NCT02930551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5767705|NCT02930551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5767706|NCT02930551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5767707|NCT02930707|Magnesium Sulfate|magnesium sulfate|mesh-list
5767708|NCT02930707|Bupivacaine|bupivacaine|mesh-list
5767709|NCT02930707|Anesthetics, Local|anesthetics, local|mesh-ancestor
5767710|NCT02930707|Anesthetics|anesthetics|mesh-ancestor
5767711|NCT02930707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5767712|NCT02930707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767713|NCT02930707|Sensory System Agents|sensory system agents|mesh-ancestor
5767714|NCT02930707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5767715|NCT02930707|Analgesics|analgesics|mesh-ancestor
5767716|NCT02930707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5767717|NCT02930707|Anticonvulsants|anticonvulsants|mesh-ancestor
5767718|NCT02930707|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5767719|NCT02930707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5767720|NCT02930707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5767721|NCT02930707|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5767722|NCT02930707|Tocolytic Agents|tocolytic agents|mesh-ancestor
5767723|NCT02930707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5767724|NCT02930473|Psychotropic Drugs|psychotropic drugs|mesh-list
5767725|NCT02930434|Vitamin D|vitamin d|mesh-list
5767726|NCT02930434|Cholecalciferol|cholecalciferol|mesh-list
5767727|NCT02930434|Vitamins|vitamins|mesh-ancestor
5767728|NCT02930434|Micronutrients|micronutrients|mesh-ancestor
5767729|NCT02930434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767730|NCT02930434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5767731|NCT02930434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5767732|NCT02930317|Factor VIII|factor viii|mesh-list
5767733|NCT02930317|Coagulants|coagulants|mesh-ancestor
5767734|NCT02930057|Betamethasone|betamethasone|mesh-list
5767735|NCT02930057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5767736|NCT02930057|Glucocorticoids|glucocorticoids|mesh-ancestor
5767737|NCT02930057|Hormones|hormones|mesh-ancestor
5767738|NCT02930057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5767739|NCT02930057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767740|NCT02930057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5767741|NCT02930057|Respiratory System Agents|respiratory system agents|mesh-ancestor
5767742|NCT02930109|Cytarabine|cytarabine|mesh-list
5767743|NCT02930109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5767744|NCT02930109|Antimetabolites|antimetabolites|mesh-ancestor
5767745|NCT02930109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5767746|NCT02930109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5767747|NCT02930109|Antiviral Agents|antiviral agents|mesh-ancestor
5767748|NCT02930109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5767749|NCT02930109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5767750|NCT02930109|Immunologic Factors|immunologic factors|mesh-ancestor
5767751|NCT02930109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767752|NCT02930031|Acetylcysteine|acetylcysteine|mesh-list
5767753|NCT02930031|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5767754|NCT02930031|Antiviral Agents|antiviral agents|mesh-ancestor
5767755|NCT02930031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5767756|NCT02930031|Expectorants|expectorants|mesh-ancestor
5767757|NCT02930031|Respiratory System Agents|respiratory system agents|mesh-ancestor
5767758|NCT02930031|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5767759|NCT02930031|Antioxidants|antioxidants|mesh-ancestor
5767760|NCT02930031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5767761|NCT02930031|Protective Agents|protective agents|mesh-ancestor
6673470|NCT01562990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673471|NCT01562990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6673472|NCT01562990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6673473|NCT01562990|Antimetabolites|antimetabolites|mesh-ancestor
6673474|NCT01562990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673475|NCT01562990|Antiviral Agents|antiviral agents|mesh-ancestor
6673476|NCT01562990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6673477|NCT01562990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5767762|NCT02930031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767763|NCT02930031|Antidotes|antidotes|mesh-ancestor
5767764|NCT02930044|Insulin|insulin|mesh-list
5767765|NCT02930044|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5767766|NCT02930044|Insulin Glargine|insulin glargine|mesh-list
5767767|NCT02930044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5767768|NCT02930044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896062|NCT04538534|Vasodilator Agents|vasodilator agents|mesh-ancestor
5896063|NCT04538378|Durvalumab|durvalumab|mesh-list
5896064|NCT04538378|Olaparib|olaparib|mesh-list
5896065|NCT04538378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5896066|NCT04538378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5896067|NCT04538378|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5896068|NCT04538378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5896069|NCT04538378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896070|NCT04529538|Vaccines|vaccines|mesh-list
5896071|NCT04529538|Immunologic Factors|immunologic factors|mesh-ancestor
5896072|NCT04529538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896073|NCT04498832|Vaccines|vaccines|mesh-list
5896074|NCT04498832|Immunologic Factors|immunologic factors|mesh-ancestor
5896075|NCT04498832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896076|NCT04497883|Maribavir|maribavir|mesh-list
5896077|NCT04497883|Antiviral Agents|antiviral agents|mesh-ancestor
5896078|NCT04497883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5896079|NCT04469075|Clindamycin|clindamycin|mesh-list
5896080|NCT04469075|Clindamycin palmitate|clindamycin palmitate|mesh-list
5896081|NCT04469075|Clindamycin phosphate|clindamycin phosphate|mesh-list
5896082|NCT04469075|Triamcinolone|triamcinolone|mesh-list
5896083|NCT04469075|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5896084|NCT04469075|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5896085|NCT04469075|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5896086|NCT04469075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5896087|NCT04469075|Glucocorticoids|glucocorticoids|mesh-ancestor
5896088|NCT04469075|Hormones|hormones|mesh-ancestor
5896089|NCT04469075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5896090|NCT04469075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896091|NCT04469075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5896092|NCT04469075|Immunologic Factors|immunologic factors|mesh-ancestor
5896093|NCT04469075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5907899|NCT05098132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5767769|NCT02930265|Liraglutide|liraglutide|mesh-list
5767770|NCT02930265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5767771|NCT02930265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767772|NCT02930265|Incretins|incretins|mesh-ancestor
5767773|NCT02930265|Hormones|hormones|mesh-ancestor
5767774|NCT02930265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5767775|NCT02929927|Sodium Hypochlorite|sodium hypochlorite|mesh-list
5767776|NCT02929927|Eusol|eusol|mesh-list
5767777|NCT02929927|Disinfectants|disinfectants|mesh-ancestor
5767778|NCT02929927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5767779|NCT02929797|Gemcitabine|gemcitabine|mesh-list
5767780|NCT02929797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5767781|NCT02929797|Antimetabolites|antimetabolites|mesh-ancestor
5767782|NCT02929797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5767783|NCT02929797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5767784|NCT02929797|Antiviral Agents|antiviral agents|mesh-ancestor
5767785|NCT02929797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5767786|NCT02929797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5767787|NCT02929797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5767788|NCT02929797|Immunologic Factors|immunologic factors|mesh-ancestor
5767789|NCT02929797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767790|NCT02929901|Caffeine|caffeine|mesh-list
5767791|NCT02929901|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5767792|NCT02929901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767793|NCT02929901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5767794|NCT02929901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5767795|NCT02929901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5767796|NCT02929901|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5767797|NCT02929901|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5767798|NCT02929901|Purinergic Agents|purinergic agents|mesh-ancestor
5767799|NCT02929901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5767800|NCT02929914|Anti-Infective Agents|anti-infective agents|mesh-list
5767801|NCT02929914|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5767802|NCT02929706|Azathioprine|azathioprine|mesh-list
5767803|NCT02929706|Antimetabolites|antimetabolites|mesh-ancestor
5767804|NCT02929706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5767805|NCT02929706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5767806|NCT02929706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5767807|NCT02929706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5767808|NCT02929706|Immunologic Factors|immunologic factors|mesh-ancestor
5767809|NCT02929706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767810|NCT02929706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5767811|NCT02929693|Gefitinib|gefitinib|mesh-list
5767812|NCT02929693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5767813|NCT02929693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5767814|NCT02929693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5767815|NCT02929693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5767816|NCT02929719|Dapsone|dapsone|mesh-list
5767817|NCT02929719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5767818|NCT02929719|Antimalarials|antimalarials|mesh-ancestor
5767819|NCT02929719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5767820|NCT02929719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5767821|NCT02929719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5767822|NCT02929719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5767823|NCT02929719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5767824|NCT02929719|Leprostatic Agents|leprostatic agents|mesh-ancestor
5767825|NCT02929719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5767826|NCT02929524|Ketamine|ketamine|mesh-list
5767827|NCT02929524|Analgesics|analgesics|mesh-ancestor
5767828|NCT02929524|Sensory System Agents|sensory system agents|mesh-ancestor
5767829|NCT02929524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5767830|NCT02929524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767831|NCT02929524|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5767832|NCT02929524|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5767833|NCT02929524|Anesthetics, General|anesthetics, general|mesh-ancestor
5767834|NCT02929524|Anesthetics|anesthetics|mesh-ancestor
5767835|NCT02929524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5767836|NCT02929524|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5767837|NCT02929524|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5767838|NCT02929524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5767839|NCT02929524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5767840|NCT02929888|Aspirin|aspirin|mesh-list
5767841|NCT02929888|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5767842|NCT02929888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5767843|NCT02929888|Analgesics|analgesics|mesh-ancestor
5767844|NCT02929888|Sensory System Agents|sensory system agents|mesh-ancestor
5767845|NCT02929888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5767846|NCT02929888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767847|NCT02929888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5767848|NCT02929888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5767849|NCT02929888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5767850|NCT02929888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5767851|NCT02929888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5767852|NCT02929888|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5767853|NCT02929888|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5767854|NCT02929888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5767855|NCT02929888|Antipyretics|antipyretics|mesh-ancestor
5767856|NCT02929563|Pantoprazole|pantoprazole|mesh-list
5767857|NCT02929563|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5767858|NCT02929563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5767859|NCT02929563|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5767860|NCT02929563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5767861|NCT02929563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5767862|NCT02929459|Vitamins|vitamins|mesh-list
5767863|NCT02929459|Riboflavin|riboflavin|mesh-list
5767864|NCT02929459|Vitamin B Complex|vitamin b complex|mesh-list
5767865|NCT02929459|Micronutrients|micronutrients|mesh-ancestor
5767866|NCT02929459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767867|NCT02929459|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5767868|NCT02929459|Dermatologic Agents|dermatologic agents|mesh-ancestor
5767869|NCT02929576|Paclitaxel|paclitaxel|mesh-list
5767870|NCT02929576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5767871|NCT02929576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5767872|NCT02929576|Tubulin Modulators|tubulin modulators|mesh-ancestor
5767873|NCT02929576|Antimitotic Agents|antimitotic agents|mesh-ancestor
5767874|NCT02929576|Mitosis Modulators|mitosis modulators|mesh-ancestor
5767875|NCT02929576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5767876|NCT02929121|Doxycycline|doxycycline|mesh-list
5767877|NCT02929121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5767878|NCT02929121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5767879|NCT02929121|Antimalarials|antimalarials|mesh-ancestor
5767880|NCT02929121|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5767881|NCT02929121|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5767882|NCT02929134|Doxycycline|doxycycline|mesh-list
5767883|NCT02929134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5767884|NCT02929134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5767885|NCT02929134|Antimalarials|antimalarials|mesh-ancestor
5767886|NCT02929134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5767887|NCT02929134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5767888|NCT02929147|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
5767889|NCT02929147|Morphine|morphine|mesh-list
5767890|NCT02929147|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5767891|NCT02929147|Narcotics|narcotics|mesh-ancestor
5767892|NCT02929147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5767893|NCT02929147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767894|NCT02929147|Analgesics|analgesics|mesh-ancestor
5767895|NCT02929147|Sensory System Agents|sensory system agents|mesh-ancestor
5767896|NCT02929147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5767897|NCT02929147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5767898|NCT02929147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5767899|NCT02929147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5767900|NCT02929147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5767901|NCT02929212|Acetaminophen|acetaminophen|mesh-list
5767902|NCT02929212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5767903|NCT02929212|Analgesics|analgesics|mesh-ancestor
5767904|NCT02929212|Sensory System Agents|sensory system agents|mesh-ancestor
5767905|NCT02929212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5767906|NCT02929212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767907|NCT02929212|Antipyretics|antipyretics|mesh-ancestor
5767908|NCT02929251|Adalimumab|adalimumab|mesh-list
5767909|NCT02929251|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5767910|NCT02929251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5767911|NCT02929251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5767912|NCT02929394|Trabectedin|trabectedin|mesh-list
5767913|NCT02929394|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5767914|NCT02929394|Alkylating Agents|alkylating agents|mesh-ancestor
5767915|NCT02929394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5767916|NCT02929394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5767917|NCT02929316|Vedolizumab|vedolizumab|mesh-list
5767918|NCT02929316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5767919|NCT02929095|Midazolam|midazolam|mesh-list
5767920|NCT02929095|Dexmedetomidine|dexmedetomidine|mesh-list
5767921|NCT02929095|Remifentanil|remifentanil|mesh-list
5767922|NCT02929095|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5767923|NCT02929095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5767924|NCT02929095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767925|NCT02929095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5767926|NCT02929095|Analgesics|analgesics|mesh-ancestor
5767927|NCT02929095|Sensory System Agents|sensory system agents|mesh-ancestor
5767928|NCT02929095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5767929|NCT02929095|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5767930|NCT02929095|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5767931|NCT02929095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5767932|NCT02929095|Adrenergic Agents|adrenergic agents|mesh-ancestor
5767933|NCT02929095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5767934|NCT02929095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5767935|NCT02929095|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5767936|NCT02929095|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5767937|NCT02929095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5767938|NCT02929095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5767939|NCT02929095|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5767940|NCT02929095|Anesthetics, General|anesthetics, general|mesh-ancestor
5767941|NCT02929095|Anesthetics|anesthetics|mesh-ancestor
5767942|NCT02929095|GABA Modulators|gaba modulators|mesh-ancestor
5767943|NCT02929095|GABA Agents|gaba agents|mesh-ancestor
5767944|NCT02929095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5767945|NCT02929095|Narcotics|narcotics|mesh-ancestor
5767946|NCT02928861|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5767947|NCT02928861|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5767948|NCT02928861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5767949|NCT02928965|Minocycline|minocycline|mesh-list
5767950|NCT02928965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5767951|NCT02928965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5767952|NCT02928692|Minocycline|minocycline|mesh-list
5767953|NCT02928692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5767954|NCT02928692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5767955|NCT02928991|Vidarabine|vidarabine|mesh-list
5767956|NCT02928991|Fludarabine|fludarabine|mesh-list
5767957|NCT02928991|Fludarabine phosphate|fludarabine phosphate|mesh-list
5767958|NCT02928991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5767959|NCT02928991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5767960|NCT02928991|Antimetabolites|antimetabolites|mesh-ancestor
5767961|NCT02928991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5767962|NCT02928991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5767963|NCT02928991|Immunologic Factors|immunologic factors|mesh-ancestor
5767964|NCT02928991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767965|NCT02928991|Antiviral Agents|antiviral agents|mesh-ancestor
5767966|NCT02928991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5767967|NCT02928679|Liraglutide|liraglutide|mesh-list
5767968|NCT02928679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5767969|NCT02928679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767970|NCT02928679|Incretins|incretins|mesh-ancestor
5767971|NCT02928679|Hormones|hormones|mesh-ancestor
5767972|NCT02928679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5767973|NCT02928510|Idelalisib|idelalisib|mesh-list
5767974|NCT02928510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5767975|NCT02928510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5767976|NCT02928510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5767977|NCT02928419|Lenalidomide|lenalidomide|mesh-list
5767978|NCT02928419|Immunologic Factors|immunologic factors|mesh-ancestor
5767979|NCT02928419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767980|NCT02928419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5767981|NCT02928419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5767982|NCT02928419|Growth Substances|growth substances|mesh-ancestor
5767983|NCT02928419|Growth Inhibitors|growth inhibitors|mesh-ancestor
5767984|NCT02928419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5767985|NCT02928614|Liraglutide|liraglutide|mesh-list
5767986|NCT02928614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5767987|NCT02928614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767988|NCT02928614|Incretins|incretins|mesh-ancestor
5767989|NCT02928614|Hormones|hormones|mesh-ancestor
5767990|NCT02928614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5896094|NCT04469075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896095|NCT04469075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5896096|NCT04469075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5896097|NCT04469075|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5896098|NCT04441762|Ketorolac|ketorolac|mesh-list
5896099|NCT04441762|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
5896100|NCT04441762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5896101|NCT04441762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5896102|NCT04441762|Analgesics|analgesics|mesh-ancestor
5896103|NCT04441762|Sensory System Agents|sensory system agents|mesh-ancestor
5896104|NCT04441762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5896105|NCT04441762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896106|NCT04441762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5896107|NCT04441762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5896108|NCT04441762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5896109|NCT04441762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5896110|NCT04441762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896111|NCT04435600|Ustekinumab|ustekinumab|mesh-list
5896112|NCT04435600|Dermatologic Agents|dermatologic agents|mesh-ancestor
5896113|NCT04412694|Dexamethasone|dexamethasone|mesh-list
5896114|NCT04412694|Dexamethasone acetate|dexamethasone acetate|mesh-list
5896115|NCT04412694|BB 1101|bb 1101|mesh-list
5896116|NCT04412694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5896117|NCT04412694|Antiemetics|antiemetics|mesh-ancestor
5896118|NCT04412694|Autonomic Agents|autonomic agents|mesh-ancestor
5896119|NCT04412694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5896120|NCT04412694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896121|NCT04412694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5896122|NCT04412694|Glucocorticoids|glucocorticoids|mesh-ancestor
5896123|NCT04412694|Hormones|hormones|mesh-ancestor
5896124|NCT04412694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5896125|NCT04412694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5896126|NCT04412694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5896127|NCT04412694|Protease Inhibitors|protease inhibitors|mesh-ancestor
5896128|NCT04412694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5896129|NCT04412694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896130|NCT04359784|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5896131|NCT04359784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5896132|NCT04351438|Heparin|heparin|mesh-list
5896133|NCT04351438|Citric Acid|citric acid|mesh-list
5896134|NCT04351438|Sodium Citrate|sodium citrate|mesh-list
5896135|NCT04351438|Anticoagulants|anticoagulants|mesh-ancestor
5896136|NCT04351438|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5896137|NCT04351438|Chelating Agents|chelating agents|mesh-ancestor
5896138|NCT04351438|Sequestering Agents|sequestering agents|mesh-ancestor
5896139|NCT04351438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896140|NCT04351438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5896141|NCT04351438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5896142|NCT04329065|Paclitaxel|paclitaxel|mesh-list
5896143|NCT04329065|Trastuzumab|trastuzumab|mesh-list
5896144|NCT04329065|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5896145|NCT04329065|Pertuzumab|pertuzumab|mesh-list
5896146|NCT04329065|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
5896147|NCT04329065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5896148|NCT04329065|Vaccines|vaccines|mesh-list
5896149|NCT04329065|Antibodies|antibodies|mesh-list
5896150|NCT04329065|Immunoglobulins|immunoglobulins|mesh-list
5896151|NCT04329065|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5896152|NCT04329065|Immunoglobulin G|immunoglobulin g|mesh-list
5896153|NCT04329065|Immunologic Factors|immunologic factors|mesh-ancestor
5896154|NCT04329065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896155|NCT04329065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5896156|NCT04329065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5896157|NCT04329065|Tubulin Modulators|tubulin modulators|mesh-ancestor
5896158|NCT04329065|Antimitotic Agents|antimitotic agents|mesh-ancestor
5896159|NCT04329065|Mitosis Modulators|mitosis modulators|mesh-ancestor
5896160|NCT04329065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896161|NCT04325217|Nintedanib|nintedanib|mesh-list
5896162|NCT04325217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5767991|NCT02928601|Ondansetron|ondansetron|mesh-list
5767992|NCT02928601|Antiemetics|antiemetics|mesh-ancestor
5767993|NCT02928601|Autonomic Agents|autonomic agents|mesh-ancestor
5767994|NCT02928601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5767995|NCT02928601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5767996|NCT02928601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5767997|NCT02928601|Antipruritics|antipruritics|mesh-ancestor
5767998|NCT02928601|Dermatologic Agents|dermatologic agents|mesh-ancestor
5767999|NCT02928601|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5768000|NCT02928601|Serotonin Agents|serotonin agents|mesh-ancestor
5768001|NCT02928601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5768002|NCT02928601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768003|NCT02928601|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5768004|NCT02928601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5768005|NCT02928601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5768006|NCT02928601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5768007|NCT02928601|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5768008|NCT02928575|Temozolomide|temozolomide|mesh-list
5768009|NCT02928575|Sunitinib|sunitinib|mesh-list
5768010|NCT02928575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5768011|NCT02928575|Alkylating Agents|alkylating agents|mesh-ancestor
5768012|NCT02928575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768013|NCT02928575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5768014|NCT02928575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5768015|NCT02928575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5768016|NCT02928575|Growth Substances|growth substances|mesh-ancestor
5768017|NCT02928575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768018|NCT02928575|Growth Inhibitors|growth inhibitors|mesh-ancestor
5768019|NCT02928575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5768020|NCT02928575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5768021|NCT02928328|Lidocaine|lidocaine|mesh-list
5768022|NCT02928328|Lorazepam|lorazepam|mesh-list
5768023|NCT02928328|Capsaicin|capsaicin|mesh-list
5768024|NCT02928328|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
5768025|NCT02928328|Butyric Acid|butyric acid|mesh-list
5768026|NCT02928328|Anesthetics, Local|anesthetics, local|mesh-ancestor
5768027|NCT02928328|Anesthetics|anesthetics|mesh-ancestor
5768028|NCT02928328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5768029|NCT02928328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768030|NCT02928328|Sensory System Agents|sensory system agents|mesh-ancestor
5768031|NCT02928328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5768032|NCT02928328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5768033|NCT02928328|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5768034|NCT02928328|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5768035|NCT02928328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5768036|NCT02928328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768037|NCT02928328|Antipruritics|antipruritics|mesh-ancestor
5768038|NCT02928328|Dermatologic Agents|dermatologic agents|mesh-ancestor
5768039|NCT02928328|Anticonvulsants|anticonvulsants|mesh-ancestor
5768040|NCT02928328|Antiemetics|antiemetics|mesh-ancestor
5768041|NCT02928328|Autonomic Agents|autonomic agents|mesh-ancestor
5768042|NCT02928328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5768043|NCT02928328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5768044|NCT02928328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5768045|NCT02928328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5768046|NCT02928328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5768047|NCT02928328|GABA Modulators|gaba modulators|mesh-ancestor
5768048|NCT02928328|GABA Agents|gaba agents|mesh-ancestor
5768049|NCT02928328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5768050|NCT02928328|Histamine Antagonists|histamine antagonists|mesh-ancestor
5768051|NCT02928328|Histamine Agents|histamine agents|mesh-ancestor
5768052|NCT02928315|Magnesium Sulfate|magnesium sulfate|mesh-list
5768053|NCT02928315|Analgesics|analgesics|mesh-ancestor
5768054|NCT02928315|Sensory System Agents|sensory system agents|mesh-ancestor
5768055|NCT02928315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5768056|NCT02928315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768057|NCT02928315|Anesthetics|anesthetics|mesh-ancestor
5768058|NCT02928315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5768059|NCT02928315|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5768060|NCT02928315|Anticonvulsants|anticonvulsants|mesh-ancestor
5768061|NCT02928315|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5768062|NCT02928315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5768063|NCT02928315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768064|NCT02928315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5768065|NCT02928315|Tocolytic Agents|tocolytic agents|mesh-ancestor
5768066|NCT02928315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5768067|NCT02927951|Pregabalin|pregabalin|mesh-list
5768068|NCT02927951|Analgesics|analgesics|mesh-ancestor
5768069|NCT02927951|Sensory System Agents|sensory system agents|mesh-ancestor
5768070|NCT02927951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5768071|NCT02927951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768072|NCT02927951|Anticonvulsants|anticonvulsants|mesh-ancestor
5768073|NCT02927951|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5768074|NCT02927951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5768075|NCT02927951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768076|NCT02927951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5768077|NCT02927951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5768078|NCT02927951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5768079|NCT02927951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5768080|NCT02927951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5768081|NCT02927847|Nicotine|nicotine|mesh-list
5768082|NCT02927847|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5768083|NCT02927847|Autonomic Agents|autonomic agents|mesh-ancestor
5768084|NCT02927847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5768085|NCT02927847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768086|NCT02927847|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5768087|NCT02927847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5768088|NCT02927847|Cholinergic Agents|cholinergic agents|mesh-ancestor
5768089|NCT02927847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5768090|NCT02927847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768091|NCT02927769|Nivolumab|nivolumab|mesh-list
5768092|NCT02927769|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5768093|NCT02927769|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5768094|NCT02927769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5768095|NCT02927769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5768096|NCT02927769|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5768097|NCT02927769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768098|NCT02927769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5768099|NCT02927769|Alkylating Agents|alkylating agents|mesh-ancestor
5768100|NCT02927886|Botulinum Toxins|botulinum toxins|mesh-list
5768101|NCT02927886|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5768102|NCT02927886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5768103|NCT02927886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768104|NCT02927886|Cholinergic Agents|cholinergic agents|mesh-ancestor
5768105|NCT02927886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5768106|NCT02927886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768107|NCT02927587|Propofol|propofol|mesh-list
5768108|NCT02927587|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5768109|NCT02927587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5768110|NCT02927587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768111|NCT02927587|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5768112|NCT02927587|Anesthetics, General|anesthetics, general|mesh-ancestor
5768113|NCT02927587|Anesthetics|anesthetics|mesh-ancestor
5768114|NCT02927392|Leuprolide|leuprolide|mesh-list
5768115|NCT02927392|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5768116|NCT02927392|Fertility Agents|fertility agents|mesh-ancestor
5768117|NCT02927392|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5768118|NCT02927392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768119|NCT02927392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5768120|NCT02927392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5768121|NCT02927405|Gabapentin|gabapentin|mesh-list
5768122|NCT02927405|Analgesics|analgesics|mesh-ancestor
5768123|NCT02927405|Sensory System Agents|sensory system agents|mesh-ancestor
5768124|NCT02927405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5768125|NCT02927405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768126|NCT02927405|Anticonvulsants|anticonvulsants|mesh-ancestor
5768127|NCT02927405|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5768128|NCT02927405|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5768129|NCT02927405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5768130|NCT02927405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5768131|NCT02927405|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5768132|NCT02927405|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5768133|NCT02927405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5768134|NCT02927405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768135|NCT02927405|Antimanic Agents|antimanic agents|mesh-ancestor
5768136|NCT02927379|Dexmedetomidine|dexmedetomidine|mesh-list
5768137|NCT02927379|Ketamine|ketamine|mesh-list
5768138|NCT02927379|Bupivacaine|bupivacaine|mesh-list
5768139|NCT02927379|Anesthetics, Local|anesthetics, local|mesh-ancestor
5768140|NCT02927379|Anesthetics|anesthetics|mesh-ancestor
5768141|NCT02927379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5768142|NCT02927379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768143|NCT02927379|Sensory System Agents|sensory system agents|mesh-ancestor
5768144|NCT02927379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5768145|NCT02927379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5768146|NCT02927379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5768147|NCT02927379|Analgesics|analgesics|mesh-ancestor
5640624|NCT04926285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640625|NCT04912063|Azacitidine|azacitidine|mesh-list
5640626|NCT04912063|Venetoclax|venetoclax|mesh-list
5640627|NCT04912063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5768148|NCT02927379|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5768149|NCT02927379|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5768150|NCT02927379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5768151|NCT02927379|Adrenergic Agents|adrenergic agents|mesh-ancestor
5768152|NCT02927379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5768153|NCT02927379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768154|NCT02927379|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5768155|NCT02927379|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5768156|NCT02927379|Anesthetics, General|anesthetics, general|mesh-ancestor
5768157|NCT02927379|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5768158|NCT02927379|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5768159|NCT02927496|Doxycycline|doxycycline|mesh-list
6490462|NCT00598403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6490463|NCT00598403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6490464|NCT00598403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6490465|NCT00598403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490466|NCT00598403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5768160|NCT02927496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5768161|NCT02927496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5768162|NCT02927496|Antimalarials|antimalarials|mesh-ancestor
5768163|NCT02927496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5768164|NCT02927496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5768165|NCT02927535|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
5768166|NCT02927535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5768167|NCT02927353|Adalimumab|adalimumab|mesh-list
5768168|NCT02927353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5768169|NCT02927353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5768170|NCT02927444|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5768171|NCT02927444|Immunologic Factors|immunologic factors|mesh-ancestor
5768172|NCT02927444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768173|NCT02927509|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
5768174|NCT02927509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5768175|NCT02927509|Adrenergic Agents|adrenergic agents|mesh-ancestor
5768176|NCT02927509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5768177|NCT02927509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768178|NCT02927509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768179|NCT02927522|Donepezil|donepezil|mesh-list
5768180|NCT02927522|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5768181|NCT02927522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5640628|NCT04912063|Antimetabolites|antimetabolites|mesh-ancestor
5640629|NCT04912063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640630|NCT04912063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5640631|NCT04912063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5640632|NCT04899986|Chlorhexidine|chlorhexidine|mesh-list
5640633|NCT04899986|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5640634|NCT04899986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5768182|NCT02927522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768183|NCT02927522|Cholinergic Agents|cholinergic agents|mesh-ancestor
5768184|NCT02927522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5768185|NCT02927522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768186|NCT02927522|Nootropic Agents|nootropic agents|mesh-ancestor
5768187|NCT02926976|Valproic Acid|valproic acid|mesh-list
5768188|NCT02926976|Risperidone|risperidone|mesh-list
5768189|NCT02926976|Aripiprazole|aripiprazole|mesh-list
5768190|NCT02926976|Clozapine|clozapine|mesh-list
5768191|NCT02926976|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5768192|NCT02926976|Serotonin Agents|serotonin agents|mesh-ancestor
5768193|NCT02926976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5768194|NCT02926976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768195|NCT02926976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768196|NCT02926976|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5768197|NCT02926976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5768198|NCT02926976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5768199|NCT02926976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5768200|NCT02926976|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5768201|NCT02926976|Dopamine Agents|dopamine agents|mesh-ancestor
5768202|NCT02926976|Antidepressive Agents|antidepressive agents|mesh-ancestor
5768203|NCT02926976|Dopamine Agonists|dopamine agonists|mesh-ancestor
5768204|NCT02926976|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5768205|NCT02926976|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5768206|NCT02926976|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5768207|NCT02926976|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5768208|NCT02926976|Anticonvulsants|anticonvulsants|mesh-ancestor
5768209|NCT02926976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5768210|NCT02926976|GABA Agents|gaba agents|mesh-ancestor
5768211|NCT02926976|Antimanic Agents|antimanic agents|mesh-ancestor
5768212|NCT02926976|GABA Antagonists|gaba antagonists|mesh-ancestor
5768213|NCT02926989|Plasma-lyte 148|plasma-lyte 148|mesh-list
5768214|NCT02926989|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5768215|NCT02926989|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5768216|NCT02926885|Liver Extracts|liver extracts|mesh-list
5768217|NCT02926885|Hematinics|hematinics|mesh-ancestor
5768218|NCT02926859|Cannabidiol|cannabidiol|mesh-list
5768219|NCT02926859|Anticonvulsants|anticonvulsants|mesh-ancestor
5768220|NCT02927015|Iproplatin|iproplatin|mesh-list
5768221|NCT02927015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5768222|NCT02926846|Vancomycin|vancomycin|mesh-list
5768223|NCT02926846|Gentamicins|gentamicins|mesh-list
5768224|NCT02926846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5768225|NCT02926846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5768226|NCT02926846|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5768227|NCT02926846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5768228|NCT02926846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896163|NCT04325217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5896164|NCT04325217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5896165|NCT04325217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896166|NCT04278651|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
5896167|NCT04278651|Hematinics|hematinics|mesh-ancestor
5896168|NCT04278651|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5896169|NCT04278651|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5896170|NCT04270643|Vitamin D|vitamin d|mesh-list
5896171|NCT04270643|Cholecalciferol|cholecalciferol|mesh-list
5896172|NCT04270643|Vitamins|vitamins|mesh-ancestor
5896173|NCT04270643|Micronutrients|micronutrients|mesh-ancestor
5896174|NCT04270643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896175|NCT04270643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5896176|NCT04270643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5896177|NCT04266275|Curcumin|curcumin|mesh-list
5896178|NCT04266275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5896179|NCT04266275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5896180|NCT04266275|Analgesics|analgesics|mesh-ancestor
5896181|NCT04266275|Sensory System Agents|sensory system agents|mesh-ancestor
5896182|NCT04266275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5896183|NCT04266275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896184|NCT04266275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5896185|NCT04266275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5896186|NCT04266275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5896187|NCT04266275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5896188|NCT04266275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896189|NCT04260347|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5896190|NCT04260347|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5896191|NCT04260347|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5768229|NCT02926690|OTS167|ots167|mesh-list
5768230|NCT02926690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5768231|NCT02926690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5768232|NCT02926690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768233|NCT02926586|Cytarabine|cytarabine|mesh-list
5768234|NCT02926586|Fludarabine|fludarabine|mesh-list
5768235|NCT02926586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5768236|NCT02926586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5768237|NCT02926586|Antimetabolites|antimetabolites|mesh-ancestor
5768238|NCT02926586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768239|NCT02926586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5768240|NCT02926586|Immunologic Factors|immunologic factors|mesh-ancestor
5768241|NCT02926586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768242|NCT02926586|Antiviral Agents|antiviral agents|mesh-ancestor
5768243|NCT02926586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5768244|NCT02926222|Lomustine|lomustine|mesh-list
5768245|NCT02926222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5768246|NCT02926222|Alkylating Agents|alkylating agents|mesh-ancestor
5768247|NCT02926222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768248|NCT02926222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5768249|NCT02926248|Colchicine|colchicine|mesh-list
5768250|NCT02926248|Gout Suppressants|gout suppressants|mesh-ancestor
5768251|NCT02926248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5768252|NCT02926248|Tubulin Modulators|tubulin modulators|mesh-ancestor
5768253|NCT02926248|Antimitotic Agents|antimitotic agents|mesh-ancestor
5768254|NCT02926248|Mitosis Modulators|mitosis modulators|mesh-ancestor
5768255|NCT02926248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768256|NCT02926248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5768257|NCT02926326|Azithromycin|azithromycin|mesh-list
5768258|NCT02926326|Acumapimod|acumapimod|mesh-list
5768259|NCT02926326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5768260|NCT02926326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5768261|NCT02926326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5768262|NCT02926326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5768263|NCT02926326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768264|NCT02926183|Gemcitabine|gemcitabine|mesh-list
5768265|NCT02926183|Paclitaxel|paclitaxel|mesh-list
5768266|NCT02926183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5768267|NCT02926183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5768268|NCT02926183|Tubulin Modulators|tubulin modulators|mesh-ancestor
5768269|NCT02926183|Antimitotic Agents|antimitotic agents|mesh-ancestor
5768270|NCT02926183|Mitosis Modulators|mitosis modulators|mesh-ancestor
5768271|NCT02926183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768272|NCT02926183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5768273|NCT02926183|Antimetabolites|antimetabolites|mesh-ancestor
5768274|NCT02926183|Antiviral Agents|antiviral agents|mesh-ancestor
5768275|NCT02926183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5768276|NCT02926183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5768277|NCT02926183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5768278|NCT02926183|Immunologic Factors|immunologic factors|mesh-ancestor
5768279|NCT02926183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768280|NCT02926196|Avelumab|avelumab|mesh-list
5768281|NCT02926196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5768282|NCT02926196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5768283|NCT02926170|Rivaroxaban|rivaroxaban|mesh-list
5768284|NCT02926170|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5768285|NCT02926170|Antithrombins|antithrombins|mesh-ancestor
5768286|NCT02926170|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5768287|NCT02926170|Protease Inhibitors|protease inhibitors|mesh-ancestor
5768288|NCT02926170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5768289|NCT02926170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768290|NCT02926170|Anticoagulants|anticoagulants|mesh-ancestor
5768291|NCT02926053|Cyclophosphamide|cyclophosphamide|mesh-list
5768292|NCT02926053|Fludarabine|fludarabine|mesh-list
5768293|NCT02926053|Interleukin-2|interleukin-2|mesh-list
5768294|NCT02926053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5768295|NCT02926053|Immunologic Factors|immunologic factors|mesh-ancestor
5768296|NCT02926053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768297|NCT02926053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5768298|NCT02926053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5768299|NCT02926053|Alkylating Agents|alkylating agents|mesh-ancestor
5768300|NCT02926053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768301|NCT02926053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5768302|NCT02926053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5768303|NCT02926053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5768304|NCT02926053|Analgesics|analgesics|mesh-ancestor
5768305|NCT02926053|Sensory System Agents|sensory system agents|mesh-ancestor
5768306|NCT02926053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5768307|NCT02925832|Bupivacaine|bupivacaine|mesh-list
5768308|NCT02925832|Ropivacaine|ropivacaine|mesh-list
5768309|NCT02925832|Anesthetics, Local|anesthetics, local|mesh-list
5768310|NCT02925832|Proxymetacaine|proxymetacaine|mesh-list
5768311|NCT02925832|Anesthetics|anesthetics|mesh-list
5768312|NCT02925832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5768313|NCT02925832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768314|NCT02925832|Sensory System Agents|sensory system agents|mesh-ancestor
5768315|NCT02925832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5768316|NCT02925975|Carvedilol|carvedilol|mesh-list
5768317|NCT02925975|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5768318|NCT02925975|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5768319|NCT02925975|Adrenergic Agents|adrenergic agents|mesh-ancestor
5768320|NCT02925975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5768321|NCT02925975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768322|NCT02925975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768323|NCT02925975|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5768324|NCT02925975|Antioxidants|antioxidants|mesh-ancestor
5768325|NCT02925975|Protective Agents|protective agents|mesh-ancestor
5768326|NCT02925975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5768327|NCT02925975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5768328|NCT02925975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5768329|NCT02925975|Vasodilator Agents|vasodilator agents|mesh-ancestor
5768330|NCT02925975|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5768331|NCT02925975|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5768332|NCT02925702|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
5768333|NCT02925702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5768334|NCT02925351|Clofarabine|clofarabine|mesh-list
5768335|NCT02925351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5768336|NCT02925351|Antimetabolites|antimetabolites|mesh-ancestor
5768337|NCT02925351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768338|NCT02925351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5768339|NCT02925299|Insulin|insulin|mesh-list
5768340|NCT02925299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5768341|NCT02925299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768342|NCT02925559|Dapagliflozin|dapagliflozin|mesh-list
5768343|NCT02925559|Gliclazide|gliclazide|mesh-list
5768344|NCT02925559|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5768345|NCT02925559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768346|NCT02925559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5768347|NCT02925559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768348|NCT02925247|Anticoagulants|anticoagulants|mesh-list
5768349|NCT02925416|Oritavancin|oritavancin|mesh-list
5768350|NCT02925416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5768351|NCT02925416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5768352|NCT02925533|Pembrolizumab|pembrolizumab|mesh-list
5768353|NCT02925533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5768354|NCT02925533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5768355|NCT02925195|Vitamin D|vitamin d|mesh-list
5768356|NCT02925195|Cholecalciferol|cholecalciferol|mesh-list
5768357|NCT02925195|Vitamins|vitamins|mesh-ancestor
5768358|NCT02925195|Micronutrients|micronutrients|mesh-ancestor
5768359|NCT02925195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768360|NCT02925195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5768361|NCT02925195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5768362|NCT02924922|Mannitol|mannitol|mesh-list
5768363|NCT02924922|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5768364|NCT02924922|Diuretics|diuretics|mesh-ancestor
5768365|NCT02924922|Natriuretic Agents|natriuretic agents|mesh-ancestor
5768366|NCT02924922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768367|NCT02925026|Lactoferrin|lactoferrin|mesh-list
5768368|NCT02925026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5768369|NCT02925130|Albuterol|albuterol|mesh-list
5768370|NCT02925130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5768371|NCT02925130|Autonomic Agents|autonomic agents|mesh-ancestor
5768372|NCT02925130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5768373|NCT02925130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768374|NCT02925130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5768375|NCT02925130|Respiratory System Agents|respiratory system agents|mesh-ancestor
5768376|NCT02925130|Tocolytic Agents|tocolytic agents|mesh-ancestor
5768377|NCT02925130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5768378|NCT02925130|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5768379|NCT02925130|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5768380|NCT02925130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5768381|NCT02925130|Adrenergic Agents|adrenergic agents|mesh-ancestor
5768382|NCT02925130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5768383|NCT02925130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896192|NCT04260347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896193|NCT04203498|Nabiximols|nabiximols|mesh-list
5896194|NCT04203498|Analgesics|analgesics|mesh-ancestor
5896195|NCT04203498|Sensory System Agents|sensory system agents|mesh-ancestor
5896196|NCT04203498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5896197|NCT04203498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907900|NCT05098132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5907901|NCT05086692|Interleukin-2|interleukin-2|mesh-list
5907902|NCT05086692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5907903|NCT05086692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5907904|NCT05086692|Analgesics|analgesics|mesh-ancestor
5907905|NCT05086692|Sensory System Agents|sensory system agents|mesh-ancestor
5907906|NCT05086692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5907907|NCT05086692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907908|NCT05084508|Vaccines|vaccines|mesh-list
5907909|NCT05084508|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5907910|NCT05084508|Immunologic Factors|immunologic factors|mesh-ancestor
5907911|NCT05084508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907912|NCT05083845|Anesthetics|anesthetics|mesh-list
5907913|NCT05083845|Anesthetics, Local|anesthetics, local|mesh-list
5907914|NCT05083845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5907915|NCT05083845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907916|NCT05083845|Sensory System Agents|sensory system agents|mesh-ancestor
5907917|NCT05083845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5907918|NCT05071612|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6673478|NCT01562990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6673479|NCT01562990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6673480|NCT01563068|Calcipotriene|calcipotriene|mesh-list
6673481|NCT01563068|Dermatologic Agents|dermatologic agents|mesh-ancestor
6673482|NCT01563120|Metformin|metformin|mesh-list
6673483|NCT01563120|Glyburide|glyburide|mesh-list
6673484|NCT01563120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6673485|NCT01563120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673486|NCT01563224|Baclofen|baclofen|mesh-list
5907919|NCT05071612|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5907920|NCT05071612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5907921|NCT05071612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5907922|NCT05071612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907923|NCT05071612|Adrenergic Agents|adrenergic agents|mesh-ancestor
5907924|NCT05071612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5907925|NCT05071612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907929|NCT05062577|Buprenorphine|buprenorphine|mesh-list
5907930|NCT05062577|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
5907931|NCT05062577|Naloxone|naloxone|mesh-list
5907932|NCT05062577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5907933|NCT05062577|Narcotics|narcotics|mesh-ancestor
5907934|NCT05062577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5907935|NCT05062577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907936|NCT05062577|Analgesics|analgesics|mesh-ancestor
5907937|NCT05062577|Sensory System Agents|sensory system agents|mesh-ancestor
5907938|NCT05062577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5907939|NCT05062577|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5907940|NCT05047250|Gemcitabine|gemcitabine|mesh-list
5907941|NCT05047250|Paclitaxel|paclitaxel|mesh-list
5907942|NCT05047250|Carboplatin|carboplatin|mesh-list
5907943|NCT05047250|Pemetrexed|pemetrexed|mesh-list
5907944|NCT05047250|Atezolizumab|atezolizumab|mesh-list
5907945|NCT05047250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5907946|NCT05047250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5907947|NCT05047250|Tubulin Modulators|tubulin modulators|mesh-ancestor
5907948|NCT05047250|Antimitotic Agents|antimitotic agents|mesh-ancestor
5907949|NCT05047250|Mitosis Modulators|mitosis modulators|mesh-ancestor
5907950|NCT05047250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907951|NCT05047250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5907952|NCT05047250|Antimetabolites|antimetabolites|mesh-ancestor
5907953|NCT05047250|Antiviral Agents|antiviral agents|mesh-ancestor
5907954|NCT05047250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6673487|NCT01563224|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5768384|NCT02925000|Vinorelbine|vinorelbine|mesh-list
5768385|NCT02925000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5768386|NCT02925000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5768387|NCT02925000|Tubulin Modulators|tubulin modulators|mesh-ancestor
5768388|NCT02925000|Antimitotic Agents|antimitotic agents|mesh-ancestor
5768389|NCT02925000|Mitosis Modulators|mitosis modulators|mesh-ancestor
5768390|NCT02925000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768391|NCT02924987|Aflibercept|aflibercept|mesh-list
5768392|NCT02924987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5768393|NCT02924987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5768394|NCT02924987|Growth Substances|growth substances|mesh-ancestor
5768395|NCT02924987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768396|NCT02924987|Growth Inhibitors|growth inhibitors|mesh-ancestor
5768397|NCT02924987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5768398|NCT02924974|Lidocaine|lidocaine|mesh-list
5768399|NCT02924974|Morphine|morphine|mesh-list
5768400|NCT02924974|Anesthetics, Local|anesthetics, local|mesh-ancestor
5768401|NCT02924974|Anesthetics|anesthetics|mesh-ancestor
5768402|NCT02924974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5768403|NCT02924974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768404|NCT02924974|Sensory System Agents|sensory system agents|mesh-ancestor
5768405|NCT02924974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5768406|NCT02924974|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5768407|NCT02924974|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5768408|NCT02924974|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5768409|NCT02924974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5768410|NCT02924974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768411|NCT02924974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5768412|NCT02924974|Narcotics|narcotics|mesh-ancestor
5768413|NCT02924974|Analgesics|analgesics|mesh-ancestor
5768414|NCT02924909|Paclitaxel|paclitaxel|mesh-list
5768415|NCT02924909|Carboplatin|carboplatin|mesh-list
5768416|NCT02924909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5768417|NCT02924909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5768418|NCT02924909|Tubulin Modulators|tubulin modulators|mesh-ancestor
5768419|NCT02924909|Antimitotic Agents|antimitotic agents|mesh-ancestor
5768420|NCT02924909|Mitosis Modulators|mitosis modulators|mesh-ancestor
5768421|NCT02924909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768422|NCT02924857|Paclitaxel|paclitaxel|mesh-list
5768423|NCT02924857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5768424|NCT02924857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5768425|NCT02924857|Tubulin Modulators|tubulin modulators|mesh-ancestor
5768426|NCT02924857|Antimitotic Agents|antimitotic agents|mesh-ancestor
5768427|NCT02924857|Mitosis Modulators|mitosis modulators|mesh-ancestor
5768428|NCT02924857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768429|NCT02924753|Cyclophosphamide|cyclophosphamide|mesh-list
5768430|NCT02924753|Fludarabine|fludarabine|mesh-list
5768431|NCT02924753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6210151|NCT02156492|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6210152|NCT02156492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5768432|NCT02924753|Immunologic Factors|immunologic factors|mesh-ancestor
5768433|NCT02924753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768434|NCT02924753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5768435|NCT02924753|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5768436|NCT02924753|Alkylating Agents|alkylating agents|mesh-ancestor
5768437|NCT02924753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768438|NCT02924753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5768439|NCT02924753|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5768440|NCT02924766|Prednisone|prednisone|mesh-list
5768441|NCT02924766|Abiraterone Acetate|abiraterone acetate|mesh-list
5768442|NCT02924766|Niraparib|niraparib|mesh-list
5768443|NCT02924766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5768444|NCT02924766|Glucocorticoids|glucocorticoids|mesh-ancestor
5768445|NCT02924766|Hormones|hormones|mesh-ancestor
5768446|NCT02924766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5768447|NCT02924766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768448|NCT02924766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5768449|NCT02924766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5768450|NCT02924766|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5768451|NCT02924766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5768452|NCT02924766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768453|NCT02924766|Hormone Antagonists|hormone antagonists|mesh-ancestor
5768454|NCT02924766|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5768455|NCT02924766|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5768456|NCT02924675|Pregabalin|pregabalin|mesh-list
5768457|NCT02924675|Analgesics|analgesics|mesh-ancestor
5768458|NCT02924675|Sensory System Agents|sensory system agents|mesh-ancestor
5768459|NCT02924675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5768460|NCT02924675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768461|NCT02924675|Anticonvulsants|anticonvulsants|mesh-ancestor
5768462|NCT02924675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5768463|NCT02924675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5768464|NCT02924675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768465|NCT02924675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5768466|NCT02924675|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5768467|NCT02924675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5768468|NCT02924675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5768469|NCT02924675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5768470|NCT02924532|Hormones|hormones|mesh-list
5768471|NCT02924532|Parathyroid Hormone|parathyroid hormone|mesh-list
5768472|NCT02924532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5768473|NCT02924532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768474|NCT02924532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5768475|NCT02924506|Meloxicam|meloxicam|mesh-list
5768476|NCT02924506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5768477|NCT02924506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5768478|NCT02924506|Analgesics|analgesics|mesh-ancestor
5768479|NCT02924506|Sensory System Agents|sensory system agents|mesh-ancestor
5768480|NCT02924506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5768481|NCT02924506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768482|NCT02924506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5768483|NCT02924506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5768484|NCT02924506|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5768485|NCT02924506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5768486|NCT02924506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5768487|NCT02924506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768488|NCT02924727|Valsartan|valsartan|mesh-list
5768489|NCT02924727|Ramipril|ramipril|mesh-list
5768490|NCT02924727|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5768491|NCT02924727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5768492|NCT02924727|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5768493|NCT02924727|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5768494|NCT02924727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768495|NCT02924727|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5768496|NCT02924727|Protease Inhibitors|protease inhibitors|mesh-ancestor
5768497|NCT02924727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5768498|NCT02924324|Propofol|propofol|mesh-list
5768499|NCT02924324|Ropivacaine|ropivacaine|mesh-list
5768500|NCT02924324|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5768501|NCT02924324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5768502|NCT02924324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768503|NCT02924324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5768504|NCT02924324|Anesthetics, General|anesthetics, general|mesh-ancestor
5768505|NCT02924324|Anesthetics|anesthetics|mesh-ancestor
5768506|NCT02924324|Anesthetics, Local|anesthetics, local|mesh-ancestor
5768507|NCT02924324|Sensory System Agents|sensory system agents|mesh-ancestor
5768508|NCT02924324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5768509|NCT02924311|Aflibercept|aflibercept|mesh-list
5768510|NCT02924311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5768511|NCT02924311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5768512|NCT02924311|Growth Substances|growth substances|mesh-ancestor
5768513|NCT02924311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768514|NCT02924311|Growth Inhibitors|growth inhibitors|mesh-ancestor
5768515|NCT02924311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5768516|NCT02924285|Amiodarone|amiodarone|mesh-list
5768517|NCT02924285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5768518|NCT02924285|Vasodilator Agents|vasodilator agents|mesh-ancestor
5768519|NCT02924285|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5768520|NCT02924285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5768521|NCT02924285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768522|NCT02924285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5768523|NCT02924285|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5768524|NCT02924285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5768525|NCT02924285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5768526|NCT02924285|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5768527|NCT02924285|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5768528|NCT02924285|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5768529|NCT02924480|Lidocaine|lidocaine|mesh-list
5768530|NCT02924480|Anesthetics, Local|anesthetics, local|mesh-ancestor
5768531|NCT02924480|Anesthetics|anesthetics|mesh-ancestor
5768532|NCT02924480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5768533|NCT02924480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768534|NCT02924480|Sensory System Agents|sensory system agents|mesh-ancestor
5768535|NCT02924480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5768536|NCT02924480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5768537|NCT02924480|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5768538|NCT02924480|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5768539|NCT02924480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5768540|NCT02924480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768541|NCT02924454|Metoprolol|metoprolol|mesh-list
5768542|NCT02924454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5768543|NCT02924454|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
5768544|NCT02924454|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
5768545|NCT02924454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5768546|NCT02924454|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5768547|NCT02924454|Sympatholytics|sympatholytics|mesh-ancestor
5768548|NCT02924454|Autonomic Agents|autonomic agents|mesh-ancestor
5768549|NCT02924454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5768550|NCT02924454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768551|NCT02924454|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5768552|NCT02924454|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5768553|NCT02924454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5768554|NCT02924454|Adrenergic Agents|adrenergic agents|mesh-ancestor
5768555|NCT02924454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5768556|NCT02924454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768557|NCT02924454|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5768558|NCT02924337|Moxifloxacin|moxifloxacin|mesh-list
5768559|NCT02924337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5768560|NCT02924337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5768561|NCT02924337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5768562|NCT02924337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5768563|NCT02924337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5768564|NCT02924337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768565|NCT02924337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5768566|NCT02924246|Vaccines|vaccines|mesh-list
5768567|NCT02924246|Immunologic Factors|immunologic factors|mesh-ancestor
5768568|NCT02924246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768569|NCT02924233|Nivolumab|nivolumab|mesh-list
5768570|NCT02924233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5768571|NCT02924233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5768572|NCT02924233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5768573|NCT02924233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768574|NCT02923986|Dasatinib|dasatinib|mesh-list
5768575|NCT02923986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5768576|NCT02923986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5768577|NCT02923986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5768578|NCT02923986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768579|NCT02923934|Nivolumab|nivolumab|mesh-list
5768580|NCT02923934|Ipilimumab|ipilimumab|mesh-list
5768581|NCT02923934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5768582|NCT02923934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5768583|NCT02923934|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5768584|NCT02923934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768585|NCT02924038|Poly ICLC|poly iclc|mesh-list
5768586|NCT02924038|Interferon Inducers|interferon inducers|mesh-ancestor
5768587|NCT02924038|Immunologic Factors|immunologic factors|mesh-ancestor
5768588|NCT02924038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768589|NCT02924090|Ketamine|ketamine|mesh-list
5768590|NCT02924090|Etomidate|etomidate|mesh-list
5768591|NCT02924090|Analgesics|analgesics|mesh-ancestor
5768592|NCT02924090|Sensory System Agents|sensory system agents|mesh-ancestor
5768593|NCT02924090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5768594|NCT02924090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768595|NCT02924090|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5768596|NCT02924090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5768597|NCT02924090|Anesthetics, General|anesthetics, general|mesh-ancestor
5768598|NCT02924090|Anesthetics|anesthetics|mesh-ancestor
5768599|NCT02924090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5768600|NCT02924090|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5768601|NCT02924090|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5768602|NCT02924090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5768603|NCT02924090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768604|NCT02924090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5768605|NCT02923999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5768606|NCT02923999|Antibodies|antibodies|mesh-list
5768607|NCT02923999|Immunoglobulins|immunoglobulins|mesh-list
5768608|NCT02923999|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5768609|NCT02923999|Immunologic Factors|immunologic factors|mesh-ancestor
5768610|NCT02923999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768611|NCT02923999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5768612|NCT02923856|Clarithromycin|clarithromycin|mesh-list
5768613|NCT02923856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5768614|NCT02923856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5768615|NCT02923856|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5768616|NCT02923856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5768617|NCT02923856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768618|NCT02923856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5768619|NCT02923856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5768620|NCT02923869|Bupivacaine|bupivacaine|mesh-list
5768621|NCT02923869|Levobupivacaine|levobupivacaine|mesh-list
5768622|NCT02923869|Anesthetics, Local|anesthetics, local|mesh-ancestor
5768623|NCT02923869|Anesthetics|anesthetics|mesh-ancestor
5768624|NCT02923869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5768625|NCT02923869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768626|NCT02923869|Sensory System Agents|sensory system agents|mesh-ancestor
5768627|NCT02923869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5768628|NCT02923791|Lenograstim|lenograstim|mesh-list
5768629|NCT02923791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5768630|NCT02923791|Immunologic Factors|immunologic factors|mesh-ancestor
6673488|NCT01563224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673489|NCT01563224|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6673490|NCT01563224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6673491|NCT01563224|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6673492|NCT01563224|GABA Agonists|gaba agonists|mesh-ancestor
5768631|NCT02923791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768632|NCT02923687|Ketorolac|ketorolac|mesh-list
5768633|NCT02923687|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
5768634|NCT02923687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5768635|NCT02923687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5768636|NCT02923687|Analgesics|analgesics|mesh-ancestor
5768637|NCT02923687|Sensory System Agents|sensory system agents|mesh-ancestor
5768638|NCT02923687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6673493|NCT01563224|GABA Agents|gaba agents|mesh-ancestor
6673494|NCT01563224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6673495|NCT01563224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673496|NCT01563289|Ibuprofen|ibuprofen|mesh-list
6673497|NCT01563289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5768639|NCT02923687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768640|NCT02923687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5768641|NCT02923687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5768642|NCT02923687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5768643|NCT02923687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5768644|NCT02923687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768645|NCT02923557|Pirarubicin|pirarubicin|mesh-list
5768646|NCT02923557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5768647|NCT02923583|Abatacept|abatacept|mesh-list
5768648|NCT02923583|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5768649|NCT02923583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768650|NCT02923583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5768651|NCT02923583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5768652|NCT02923583|Immunologic Factors|immunologic factors|mesh-ancestor
5768653|NCT02923583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768654|NCT02923583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5768655|NCT02923466|Interferon-beta|interferon-beta|mesh-list
5768656|NCT02923466|Avelumab|avelumab|mesh-list
5768657|NCT02923466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5768658|NCT02923466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5768659|NCT02923466|Antiviral Agents|antiviral agents|mesh-ancestor
5768660|NCT02923466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5768661|NCT02923466|Immunologic Factors|immunologic factors|mesh-ancestor
5768662|NCT02923466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768663|NCT02923388|Vitamins|vitamins|mesh-list
5768664|NCT02923388|Vitamin B 12|vitamin b 12|mesh-list
5768665|NCT02923388|Pyridoxine|pyridoxine|mesh-list
5768666|NCT02923388|Vitamin B 6|vitamin b 6|mesh-list
5768667|NCT02923388|Vitamin B Complex|vitamin b complex|mesh-list
5768668|NCT02923388|Micronutrients|micronutrients|mesh-ancestor
5768669|NCT02923388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896198|NCT04200248|Aflibercept|aflibercept|mesh-list
5896199|NCT04200248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5896200|NCT04200248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5896201|NCT04200248|Growth Substances|growth substances|mesh-ancestor
5896202|NCT04200248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896203|NCT04200248|Growth Inhibitors|growth inhibitors|mesh-ancestor
5896204|NCT04200248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5896205|NCT04169191|Sildenafil Citrate|sildenafil citrate|mesh-list
5896206|NCT04169191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896207|NCT04169191|Vasodilator Agents|vasodilator agents|mesh-ancestor
5896208|NCT04169191|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5896209|NCT04169191|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5896210|NCT04169191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5896211|NCT04169191|Urological Agents|urological agents|mesh-ancestor
5896212|NCT04164732|Valsartan|valsartan|mesh-list
5896213|NCT04164732|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5896214|NCT04164732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5896215|NCT04164732|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5896216|NCT04164732|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5896217|NCT04164732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896218|NCT04157517|Pembrolizumab|pembrolizumab|mesh-list
5896219|NCT04157517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5896220|NCT04157517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5896221|NCT04138615|Morphine|morphine|mesh-list
5896222|NCT04138615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5896223|NCT04138615|Narcotics|narcotics|mesh-ancestor
5896224|NCT04138615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5896225|NCT04138615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896226|NCT04138615|Analgesics|analgesics|mesh-ancestor
5896227|NCT04138615|Sensory System Agents|sensory system agents|mesh-ancestor
5896228|NCT04138615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5896229|NCT04119830|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
5896230|NCT04119830|Pembrolizumab|pembrolizumab|mesh-list
5896231|NCT04119830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5896232|NCT04119830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5896233|NCT04119830|Antiviral Agents|antiviral agents|mesh-ancestor
5896234|NCT04119830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5896235|NCT04091750|Nivolumab|nivolumab|mesh-list
5896236|NCT04091750|Ipilimumab|ipilimumab|mesh-list
5896237|NCT04091750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5896238|NCT04091750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5896239|NCT04091750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5896240|NCT04091750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896241|NCT04084314|Erenumab|erenumab|mesh-list
5896242|NCT04084314|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
5896243|NCT04084314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896244|NCT04084314|Analgesics|analgesics|mesh-ancestor
6490467|NCT00598403|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6490468|NCT00598403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6490469|NCT00598429|Alprostadil|alprostadil|mesh-list
5640635|NCT04899986|Disinfectants|disinfectants|mesh-ancestor
5640636|NCT04896320|Tucatinib|tucatinib|mesh-list
5640637|NCT04896320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5640638|NCT04896320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5640639|NCT04896320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5640640|NCT04896320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640641|NCT04895436|Venetoclax|venetoclax|mesh-list
5640642|NCT04895436|Obinutuzumab|obinutuzumab|mesh-list
5640643|NCT04895436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5640644|NCT04895436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5640645|NCT04881240|Cyclophosphamide|cyclophosphamide|mesh-list
5640646|NCT04881240|Fludarabine|fludarabine|mesh-list
5640647|NCT04881240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5640648|NCT04881240|Immunologic Factors|immunologic factors|mesh-ancestor
5640649|NCT04881240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640650|NCT04881240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5768670|NCT02923258|Docetaxel|docetaxel|mesh-list
5768671|NCT02923258|Cisplatin|cisplatin|mesh-list
5768672|NCT02923258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5768673|NCT02923258|Tubulin Modulators|tubulin modulators|mesh-ancestor
5768674|NCT02923258|Antimitotic Agents|antimitotic agents|mesh-ancestor
5768675|NCT02923258|Mitosis Modulators|mitosis modulators|mesh-ancestor
5768676|NCT02923258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768677|NCT02923336|Propranolol|propranolol|mesh-list
5768678|NCT02923336|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
5768679|NCT02923336|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5768680|NCT02923336|Adrenergic Agents|adrenergic agents|mesh-ancestor
5768681|NCT02923336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5768682|NCT02923336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768683|NCT02923336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768684|NCT02923336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5768685|NCT02923336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5768686|NCT02923336|Vasodilator Agents|vasodilator agents|mesh-ancestor
5768687|NCT02923128|Sufentanil|sufentanil|mesh-list
5768688|NCT02923128|Dexmedetomidine|dexmedetomidine|mesh-list
5768689|NCT02923128|Dsuvia|dsuvia|mesh-list
5768690|NCT02923128|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5768691|NCT02923128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5768692|NCT02923128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768693|NCT02923128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5768694|NCT02923128|Analgesics|analgesics|mesh-ancestor
5768695|NCT02923128|Sensory System Agents|sensory system agents|mesh-ancestor
5768696|NCT02923128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5768697|NCT02923128|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5768698|NCT02923128|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5768699|NCT02923128|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5768700|NCT02923128|Adrenergic Agents|adrenergic agents|mesh-ancestor
5768701|NCT02923128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5768702|NCT02923128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768703|NCT02923128|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5768704|NCT02923128|Narcotics|narcotics|mesh-ancestor
5768705|NCT02923128|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5768706|NCT02923128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5768707|NCT02923128|Anesthetics, General|anesthetics, general|mesh-ancestor
5768708|NCT02923128|Anesthetics|anesthetics|mesh-ancestor
5768709|NCT02922894|Trazodone|trazodone|mesh-list
5768710|NCT02922894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5768711|NCT02922894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5768712|NCT02922894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5768713|NCT02922894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768714|NCT02922894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5768715|NCT02922894|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5768716|NCT02922894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5768717|NCT02922894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5768718|NCT02922894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768719|NCT02922894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5768720|NCT02922894|Serotonin Agents|serotonin agents|mesh-ancestor
5768721|NCT02922894|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5768722|NCT02922894|Antidepressive Agents|antidepressive agents|mesh-ancestor
5768723|NCT02922933|Entinostat|entinostat|mesh-list
5768724|NCT02922933|Omeprazole|omeprazole|mesh-list
5768725|NCT02922933|Famotidine|famotidine|mesh-list
5768726|NCT02922933|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5768727|NCT02922933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5768728|NCT02922933|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5768729|NCT02922933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5768730|NCT02922933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768731|NCT02922933|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5768732|NCT02922933|Histamine Antagonists|histamine antagonists|mesh-ancestor
5768733|NCT02922933|Histamine Agents|histamine agents|mesh-ancestor
5768734|NCT02922933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5768735|NCT02922933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768736|NCT02922933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5768737|NCT02922933|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5768738|NCT02922946|Entinostat|entinostat|mesh-list
5768739|NCT02922946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5768740|NCT02922946|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5768741|NCT02922946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5768742|NCT02922946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768743|NCT02922803|Calcium, Dietary|calcium, dietary|mesh-list
5768744|NCT02922803|Vitamin D|vitamin d|mesh-list
5768745|NCT02922803|Ergocalciferols|ergocalciferols|mesh-list
5768746|NCT02922803|Cholecalciferol|cholecalciferol|mesh-list
5768747|NCT02922803|Vitamins|vitamins|mesh-list
5768748|NCT02922803|Calcium|calcium|mesh-list
5768749|NCT02922803|Micronutrients|micronutrients|mesh-ancestor
5768750|NCT02922803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768751|NCT02922803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5768752|NCT02922803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5768753|NCT02922725|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
5768754|NCT02922725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5768755|NCT02922725|Antidepressive Agents|antidepressive agents|mesh-ancestor
5768756|NCT02922725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5768757|NCT02922686|Floxacillin|floxacillin|mesh-list
5768758|NCT02922686|Penicillin V|penicillin v|mesh-list
5768759|NCT02922686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5768760|NCT02922686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5768761|NCT02922712|Nimesulide|nimesulide|mesh-list
5768762|NCT02922712|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5768763|NCT02922712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5768764|NCT02922712|Analgesics|analgesics|mesh-ancestor
5768765|NCT02922712|Sensory System Agents|sensory system agents|mesh-ancestor
5768766|NCT02922712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5768767|NCT02922712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768768|NCT02922712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5768769|NCT02922712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5768770|NCT02922712|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5768771|NCT02922712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5768772|NCT02922712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768773|NCT02922777|Docetaxel|docetaxel|mesh-list
5768774|NCT02922777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5768775|NCT02922777|Tubulin Modulators|tubulin modulators|mesh-ancestor
5768776|NCT02922777|Antimitotic Agents|antimitotic agents|mesh-ancestor
5768777|NCT02922777|Mitosis Modulators|mitosis modulators|mesh-ancestor
5768778|NCT02922777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768779|NCT02922699|Omeprazole|omeprazole|mesh-list
5768780|NCT02922699|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5768781|NCT02922699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5768782|NCT02922699|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5768783|NCT02922699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5768784|NCT02922699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768785|NCT02922673|Aspirin|aspirin|mesh-list
5768786|NCT02922673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5768787|NCT02922673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5768788|NCT02922673|Analgesics|analgesics|mesh-ancestor
5768789|NCT02922673|Sensory System Agents|sensory system agents|mesh-ancestor
5768790|NCT02922673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5768791|NCT02922673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768792|NCT02922673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5768793|NCT02922673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5768794|NCT02922673|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5768795|NCT02922673|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5768796|NCT02922673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768797|NCT02922673|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5768798|NCT02922673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5640651|NCT04881240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5640652|NCT04881240|Alkylating Agents|alkylating agents|mesh-ancestor
5640653|NCT04881240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640654|NCT04881240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5640655|NCT04881240|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5640656|NCT04865796|Lactoferrin|lactoferrin|mesh-list
5640657|NCT04865796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5640658|NCT04858269|Paclitaxel|paclitaxel|mesh-list
5640659|NCT04858269|Carboplatin|carboplatin|mesh-list
5640660|NCT04858269|Pembrolizumab|pembrolizumab|mesh-list
5640661|NCT04858269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6210153|NCT02156492|Antimetabolites|antimetabolites|mesh-ancestor
6490470|NCT00598429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5768799|NCT02922673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5768800|NCT02922673|Antipyretics|antipyretics|mesh-ancestor
5768801|NCT02922660|Remifentanil|remifentanil|mesh-list
5768802|NCT02922660|Anesthetics|anesthetics|mesh-list
5768803|NCT02922660|Propofol|propofol|mesh-list
5768804|NCT02922660|Desflurane|desflurane|mesh-list
5768805|NCT02922660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5768806|NCT02922660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768807|NCT02922660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5768808|NCT02922660|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5768809|NCT02922660|Anesthetics, General|anesthetics, general|mesh-ancestor
5768810|NCT02922660|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5768811|NCT02922660|Narcotics|narcotics|mesh-ancestor
5768812|NCT02922660|Analgesics|analgesics|mesh-ancestor
5768813|NCT02922660|Sensory System Agents|sensory system agents|mesh-ancestor
5768814|NCT02922660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5768815|NCT02922660|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5768816|NCT02922465|Clopidogrel|clopidogrel|mesh-list
5768817|NCT02922465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5768818|NCT02922465|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5768819|NCT02922465|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5768820|NCT02922465|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5768821|NCT02922465|Purinergic Agents|purinergic agents|mesh-ancestor
5768822|NCT02922465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5768823|NCT02922465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768824|NCT02922465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768825|NCT02922426|Olanzapine|olanzapine|mesh-list
5768826|NCT02922426|Antiemetics|antiemetics|mesh-ancestor
5768827|NCT02922426|Autonomic Agents|autonomic agents|mesh-ancestor
5768828|NCT02922426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5768829|NCT02922426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768830|NCT02922426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5768831|NCT02922426|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5768832|NCT02922426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5768833|NCT02922426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5768834|NCT02922426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5768835|NCT02922426|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5768836|NCT02922426|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5768837|NCT02922426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5768838|NCT02922426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768839|NCT02922426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5768840|NCT02922426|Serotonin Agents|serotonin agents|mesh-ancestor
5768841|NCT02922491|Vitamin E|vitamin e|mesh-list
5768842|NCT02922491|Vitamins|vitamins|mesh-ancestor
5768843|NCT02922491|Micronutrients|micronutrients|mesh-ancestor
5768844|NCT02922491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768845|NCT02922491|Antioxidants|antioxidants|mesh-ancestor
5768846|NCT02922491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768847|NCT02922491|Protective Agents|protective agents|mesh-ancestor
5768848|NCT02922179|Insulin|insulin|mesh-list
5768849|NCT02922179|Insulin Detemir|insulin detemir|mesh-list
5768850|NCT02922179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5768851|NCT02922179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768852|NCT02922283|Interleukin-2|interleukin-2|mesh-list
5768853|NCT02922283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5768854|NCT02922283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5768855|NCT02922283|Analgesics|analgesics|mesh-ancestor
5768856|NCT02922283|Sensory System Agents|sensory system agents|mesh-ancestor
5768857|NCT02922283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5768858|NCT02922283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768859|NCT02922192|Antirheumatic Agents|antirheumatic agents|mesh-list
5768860|NCT02922075|Amoxicillin|amoxicillin|mesh-list
5768861|NCT02922075|Chlorhexidine|chlorhexidine|mesh-list
5768862|NCT02922075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5768863|NCT02922075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5768864|NCT02922075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5768865|NCT02922075|Disinfectants|disinfectants|mesh-ancestor
5768866|NCT02922166|SRX246|srx246|mesh-list
5768867|NCT02922166|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
5768868|NCT02922166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768869|NCT02922166|Natriuretic Agents|natriuretic agents|mesh-ancestor
5768870|NCT02922166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768871|NCT02922348|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5768872|NCT02922348|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5768873|NCT02922348|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5768874|NCT02922348|Medroxyprogesterone|medroxyprogesterone|mesh-list
5768875|NCT02922348|Norgestimate|norgestimate|mesh-list
5768876|NCT02922348|Contraceptive Agents|contraceptive agents|mesh-list
5768877|NCT02922348|Contraceptives, Oral|contraceptives, oral|mesh-list
5768878|NCT02922348|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
5768879|NCT02922348|Hormones|hormones|mesh-list
5768880|NCT02922348|Estradiol|estradiol|mesh-list
5768881|NCT02922348|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5768882|NCT02922348|Progestins|progestins|mesh-list
5768883|NCT02922348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5768884|NCT02922348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768885|NCT02922348|Estrogens|estrogens|mesh-ancestor
5768886|NCT02922348|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5768887|NCT02922348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5768888|NCT02922348|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5768889|NCT02922348|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5768890|NCT02922348|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5768891|NCT02922387|Varenicline|varenicline|mesh-list
5768892|NCT02922387|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5768893|NCT02922387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5768894|NCT02922387|Cholinergic Agents|cholinergic agents|mesh-ancestor
5768895|NCT02922387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5768896|NCT02922387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768897|NCT02922387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768898|NCT02922127|Contraceptive Agents|contraceptive agents|mesh-list
5768899|NCT02922127|Ulipristal acetate|ulipristal acetate|mesh-list
5768900|NCT02922127|Contraceptives, Oral|contraceptives, oral|mesh-list
5768901|NCT02922127|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
5768902|NCT02922127|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5768903|NCT02922127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768904|NCT02922127|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5768905|NCT02922127|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5768906|NCT02921984|Docetaxel|docetaxel|mesh-list
5768907|NCT02921984|Pemetrexed|pemetrexed|mesh-list
5768908|NCT02921984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5768909|NCT02921984|Tubulin Modulators|tubulin modulators|mesh-ancestor
5768910|NCT02921984|Antimitotic Agents|antimitotic agents|mesh-ancestor
5768911|NCT02921984|Mitosis Modulators|mitosis modulators|mesh-ancestor
5768912|NCT02921984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768913|NCT02921984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5768914|NCT02921984|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5768915|NCT02921984|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5768916|NCT02921906|Acetaminophen|acetaminophen|mesh-list
5768917|NCT02921906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5768918|NCT02921906|Analgesics|analgesics|mesh-ancestor
5768919|NCT02921906|Sensory System Agents|sensory system agents|mesh-ancestor
5768920|NCT02921906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5768921|NCT02921906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768922|NCT02921906|Antipyretics|antipyretics|mesh-ancestor
5768923|NCT02921763|Dydrogesterone|dydrogesterone|mesh-list
5768924|NCT02921763|Progestins|progestins|mesh-ancestor
5768925|NCT02921763|Hormones|hormones|mesh-ancestor
5768926|NCT02921763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5768927|NCT02921763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768928|NCT02921659|Niacinamide|niacinamide|mesh-list
5768929|NCT02921659|Vitamin B Complex|vitamin b complex|mesh-ancestor
5768930|NCT02921659|Vitamins|vitamins|mesh-ancestor
5768931|NCT02921659|Micronutrients|micronutrients|mesh-ancestor
5768932|NCT02921659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768933|NCT02921919|Talazoparib|talazoparib|mesh-list
5768934|NCT02921919|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5768935|NCT02921919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5768936|NCT02921919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768937|NCT02921919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5896245|NCT04084314|Sensory System Agents|sensory system agents|mesh-ancestor
5896246|NCT04084314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5896247|NCT04084314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896248|NCT04082728|Dipyrone|dipyrone|mesh-list
5896249|NCT04082728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5896250|NCT04082728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5896251|NCT04082728|Analgesics|analgesics|mesh-ancestor
5896252|NCT04082728|Sensory System Agents|sensory system agents|mesh-ancestor
5896253|NCT04082728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5896254|NCT04082728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768938|NCT02921269|Bevacizumab|bevacizumab|mesh-list
5768939|NCT02921269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5768940|NCT02921269|Atezolizumab|atezolizumab|mesh-list
5768941|NCT02921269|Endothelial Growth Factors|endothelial growth factors|mesh-list
5768942|NCT02921269|Antibodies|antibodies|mesh-list
5768943|NCT02921269|Immunoglobulins|immunoglobulins|mesh-list
5768944|NCT02921269|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5768945|NCT02921269|Immunoglobulin G|immunoglobulin g|mesh-list
5768946|NCT02921269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5768947|NCT02921269|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5768948|NCT02921269|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5768949|NCT02921269|Growth Substances|growth substances|mesh-ancestor
5768950|NCT02921269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768951|NCT02921269|Growth Inhibitors|growth inhibitors|mesh-ancestor
5768952|NCT02921269|Immunologic Factors|immunologic factors|mesh-ancestor
5768953|NCT02921282|Dopamine|dopamine|mesh-list
5768954|NCT02921282|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5768955|NCT02921282|Sympathomimetics|sympathomimetics|mesh-ancestor
5768956|NCT02921282|Autonomic Agents|autonomic agents|mesh-ancestor
5768957|NCT02921282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5768958|NCT02921282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768959|NCT02921282|Dopamine Agents|dopamine agents|mesh-ancestor
5768960|NCT02921282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5768961|NCT02921282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768962|NCT02921282|Protective Agents|protective agents|mesh-ancestor
5768963|NCT02921360|Aspirin|aspirin|mesh-list
5768964|NCT02921360|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5768965|NCT02921360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5768966|NCT02921360|Analgesics|analgesics|mesh-ancestor
5768967|NCT02921360|Sensory System Agents|sensory system agents|mesh-ancestor
5768968|NCT02921360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5768969|NCT02921360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768970|NCT02921360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5768971|NCT02921360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5768972|NCT02921360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5768973|NCT02921360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5768974|NCT02921360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5768975|NCT02921360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5768976|NCT02921360|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5768977|NCT02921360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5768978|NCT02921360|Antipyretics|antipyretics|mesh-ancestor
5768979|NCT02921204|Vitamin D|vitamin d|mesh-list
5768980|NCT02921204|Vitamins|vitamins|mesh-ancestor
5768981|NCT02921204|Micronutrients|micronutrients|mesh-ancestor
5768982|NCT02921204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768983|NCT02921204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5768984|NCT02921191|Lenograstim|lenograstim|mesh-list
5768985|NCT02921191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5768986|NCT02921191|Immunologic Factors|immunologic factors|mesh-ancestor
5768987|NCT02921191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768988|NCT02921178|Omalizumab|omalizumab|mesh-list
5768989|NCT02921178|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5768990|NCT02921178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5768991|NCT02921178|Respiratory System Agents|respiratory system agents|mesh-ancestor
5768992|NCT02921165|Aspirin|aspirin|mesh-list
5768993|NCT02921165|Analgesics|analgesics|mesh-list
5768994|NCT02921165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5768995|NCT02921165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5768996|NCT02921165|Sensory System Agents|sensory system agents|mesh-ancestor
5768997|NCT02921165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5768998|NCT02921165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5768999|NCT02921165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5769000|NCT02921165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5769001|NCT02921165|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5769002|NCT02921165|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5769003|NCT02921165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5769004|NCT02921165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5769005|NCT02921165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5769006|NCT02921165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5769007|NCT02921165|Antipyretics|antipyretics|mesh-ancestor
5769008|NCT02920931|Tenofovir|tenofovir|mesh-list
5769009|NCT02920931|Antiviral Agents|antiviral agents|mesh-ancestor
5769010|NCT02920931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5769011|NCT02920931|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6490471|NCT00598429|Vasodilator Agents|vasodilator agents|mesh-ancestor
5769012|NCT02920931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5769013|NCT02920931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5769014|NCT02920931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5769015|NCT02920931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5769016|NCT02920931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5769017|NCT02920827|Dapivirine|dapivirine|mesh-list
5769018|NCT02920827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5769019|NCT02920827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5769020|NCT02920827|Antiviral Agents|antiviral agents|mesh-ancestor
5769021|NCT02920827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5769022|NCT02920801|Metformin|metformin|mesh-list
5769023|NCT02920801|Saxagliptin|saxagliptin|mesh-list
5769024|NCT02920801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5769025|NCT02920801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769026|NCT02920801|Incretins|incretins|mesh-ancestor
5769027|NCT02920801|Hormones|hormones|mesh-ancestor
5769028|NCT02920801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5769029|NCT02920801|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5769030|NCT02920801|Protease Inhibitors|protease inhibitors|mesh-ancestor
5769031|NCT02920801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5769032|NCT02920801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5769033|NCT02921035|Interferons|interferons|mesh-list
5769034|NCT02921035|Interferon-beta|interferon-beta|mesh-list
5769035|NCT02921035|Interferon beta-1a|interferon beta-1a|mesh-list
5769036|NCT02921035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5769037|NCT02921035|Antiviral Agents|antiviral agents|mesh-ancestor
5769038|NCT02921035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5769039|NCT02921035|Immunologic Factors|immunologic factors|mesh-ancestor
5769040|NCT02921035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769041|NCT02921035|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5769042|NCT02921022|Gemcitabine|gemcitabine|mesh-list
5769043|NCT02921022|Paclitaxel|paclitaxel|mesh-list
5769044|NCT02921022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5769045|NCT02921022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5769046|NCT02921022|Tubulin Modulators|tubulin modulators|mesh-ancestor
5769047|NCT02921022|Antimitotic Agents|antimitotic agents|mesh-ancestor
5769048|NCT02921022|Mitosis Modulators|mitosis modulators|mesh-ancestor
5769049|NCT02921022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5769050|NCT02921022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5769051|NCT02921022|Antimetabolites|antimetabolites|mesh-ancestor
5769052|NCT02921022|Antiviral Agents|antiviral agents|mesh-ancestor
5769053|NCT02921022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5769054|NCT02921022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5769055|NCT02921022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5769056|NCT02921022|Immunologic Factors|immunologic factors|mesh-ancestor
5769057|NCT02921022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769058|NCT02920905|Lidocaine|lidocaine|mesh-list
5769059|NCT02920905|Atracurium|atracurium|mesh-list
5769060|NCT02920905|Anesthetics, Local|anesthetics, local|mesh-ancestor
5769061|NCT02920905|Anesthetics|anesthetics|mesh-ancestor
5769062|NCT02920905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5769063|NCT02920905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769064|NCT02920905|Sensory System Agents|sensory system agents|mesh-ancestor
5769065|NCT02920905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5769066|NCT02920905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5769067|NCT02920905|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5769068|NCT02920905|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5769069|NCT02920905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5769070|NCT02920905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5769071|NCT02920905|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5769072|NCT02920905|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5769073|NCT02920905|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5769074|NCT02920905|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
5769075|NCT02920905|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5769076|NCT02920905|Cholinergic Agents|cholinergic agents|mesh-ancestor
5769077|NCT02920905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5769078|NCT02920567|Octreotide|octreotide|mesh-list
5769079|NCT02920567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5769080|NCT02920567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5769081|NCT02920567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5769082|NCT02920515|Leuprolide|leuprolide|mesh-list
5769083|NCT02920515|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5769084|NCT02920515|Fertility Agents|fertility agents|mesh-ancestor
5769085|NCT02920515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5769086|NCT02920515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769087|NCT02920515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5769088|NCT02920515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5907955|NCT05047250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5769089|NCT02920710|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
5769090|NCT02920710|Hormones|hormones|mesh-ancestor
5769091|NCT02920710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5769092|NCT02920710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769093|NCT02920502|Cholecalciferol|cholecalciferol|mesh-list
5769094|NCT02920502|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5769095|NCT02920502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769096|NCT02920502|Vitamins|vitamins|mesh-ancestor
5769097|NCT02920502|Micronutrients|micronutrients|mesh-ancestor
5769098|NCT02920502|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5769099|NCT02920593|Vitamin D|vitamin d|mesh-list
5769100|NCT02920593|Ergocalciferols|ergocalciferols|mesh-list
5769101|NCT02920593|Cholecalciferol|cholecalciferol|mesh-list
5769102|NCT02920593|Vitamins|vitamins|mesh-list
5769103|NCT02920593|Micronutrients|micronutrients|mesh-ancestor
5769104|NCT02920593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769105|NCT02920593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5769106|NCT02920593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5769107|NCT02920658|Betamethasone|betamethasone|mesh-list
5769108|NCT02920658|Betamethasone Valerate|betamethasone valerate|mesh-list
5769109|NCT02920658|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5769110|NCT02920658|Betamethasone benzoate|betamethasone benzoate|mesh-list
5769111|NCT02920658|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
5769112|NCT02920658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5769113|NCT02920658|Glucocorticoids|glucocorticoids|mesh-ancestor
5769114|NCT02920658|Hormones|hormones|mesh-ancestor
5769115|NCT02920658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5769116|NCT02920658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769117|NCT02920658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5769118|NCT02920658|Respiratory System Agents|respiratory system agents|mesh-ancestor
5769119|NCT02920359|Leuprolide|leuprolide|mesh-list
5769120|NCT02920359|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5769121|NCT02920359|Fertility Agents|fertility agents|mesh-ancestor
5769122|NCT02920359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5769123|NCT02920359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769124|NCT02920359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5769125|NCT02920359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5769126|NCT02920489|Sufentanil|sufentanil|mesh-list
5769127|NCT02920489|Dsuvia|dsuvia|mesh-list
5769128|NCT02920489|Ropivacaine|ropivacaine|mesh-list
5769129|NCT02920489|Anesthetics, Local|anesthetics, local|mesh-ancestor
5769130|NCT02920489|Anesthetics|anesthetics|mesh-ancestor
5769131|NCT02920489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5769132|NCT02920489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769133|NCT02920489|Sensory System Agents|sensory system agents|mesh-ancestor
5769134|NCT02920489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5769135|NCT02920489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5769136|NCT02920489|Narcotics|narcotics|mesh-ancestor
5769137|NCT02920489|Analgesics|analgesics|mesh-ancestor
5769138|NCT02920489|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5769139|NCT02920489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5769140|NCT02920489|Anesthetics, General|anesthetics, general|mesh-ancestor
5769141|NCT02920372|Epoetin Alfa|epoetin alfa|mesh-list
5769142|NCT02920372|Hematinics|hematinics|mesh-ancestor
5769143|NCT02920229|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5769144|NCT02920229|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5769145|NCT02920229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896255|NCT04082728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5896256|NCT04082728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5896257|NCT04082728|Antipyretics|antipyretics|mesh-ancestor
5896258|NCT04049786|Metoprolol|metoprolol|mesh-list
5896259|NCT04049786|Carvedilol|carvedilol|mesh-list
5896260|NCT04049786|Midazolam|midazolam|mesh-list
5896261|NCT04049786|Simvastatin|simvastatin|mesh-list
5896262|NCT04049786|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5896263|NCT04049786|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5896264|NCT04049786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5896265|NCT04049786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896266|NCT04049786|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5896267|NCT04049786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5896268|NCT04049786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5896269|NCT04049786|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5896270|NCT04049786|Anesthetics, General|anesthetics, general|mesh-ancestor
5896271|NCT04049786|Anesthetics|anesthetics|mesh-ancestor
5896272|NCT04049786|GABA Modulators|gaba modulators|mesh-ancestor
5896273|NCT04049786|GABA Agents|gaba agents|mesh-ancestor
5896274|NCT04049786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5896275|NCT04049786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5769146|NCT02919917|Midodrine|midodrine|mesh-list
5769147|NCT02919917|Sympathomimetics|sympathomimetics|mesh-ancestor
5769148|NCT02919917|Autonomic Agents|autonomic agents|mesh-ancestor
5769149|NCT02919917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5769150|NCT02919917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769151|NCT02919917|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5769152|NCT02919917|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5769153|NCT02919917|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5769154|NCT02919917|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5769155|NCT02919917|Adrenergic Agents|adrenergic agents|mesh-ancestor
5769156|NCT02919917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5640662|NCT04858269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5640663|NCT04858269|Tubulin Modulators|tubulin modulators|mesh-ancestor
5640664|NCT04858269|Antimitotic Agents|antimitotic agents|mesh-ancestor
5769157|NCT02919917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5769158|NCT02920047|Amlodipine|amlodipine|mesh-list
5769159|NCT02920047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5769160|NCT02920047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5769161|NCT02920047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5769162|NCT02920047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5769163|NCT02920047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5769164|NCT02920047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769165|NCT02920047|Vasodilator Agents|vasodilator agents|mesh-ancestor
5769166|NCT02920190|Liraglutide|liraglutide|mesh-list
5769167|NCT02920190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5769168|NCT02920190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769169|NCT02920190|Incretins|incretins|mesh-ancestor
5769170|NCT02920190|Hormones|hormones|mesh-ancestor
5769171|NCT02920190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5769172|NCT02919969|Pembrolizumab|pembrolizumab|mesh-list
5769173|NCT02919969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5769174|NCT02919969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5769175|NCT02920060|Levetiracetam|levetiracetam|mesh-list
5769176|NCT02920060|Valproic Acid|valproic acid|mesh-list
5769177|NCT02920060|Anticonvulsants|anticonvulsants|mesh-ancestor
5769178|NCT02920060|Nootropic Agents|nootropic agents|mesh-ancestor
5769179|NCT02920060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5769180|NCT02920060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5769181|NCT02920060|GABA Agents|gaba agents|mesh-ancestor
5769182|NCT02920060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5769183|NCT02920060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769184|NCT02920060|Antimanic Agents|antimanic agents|mesh-ancestor
6490472|NCT00598429|Urological Agents|urological agents|mesh-ancestor
5769185|NCT02920060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5769186|NCT02920060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5769187|NCT02920060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5769188|NCT02919878|Gemcitabine|gemcitabine|mesh-list
5769189|NCT02919878|Capecitabine|capecitabine|mesh-list
5769190|NCT02919878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5769191|NCT02919878|Antimetabolites|antimetabolites|mesh-ancestor
5769192|NCT02919878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5769193|NCT02919878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5769194|NCT02919878|Antiviral Agents|antiviral agents|mesh-ancestor
6490473|NCT00598533|Sirolimus|sirolimus|mesh-list
6490474|NCT00598533|Probucol|probucol|mesh-list
6490475|NCT00598533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6490476|NCT00598533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6490477|NCT00598533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6490478|NCT00598533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6490479|NCT00598533|Antifungal Agents|antifungal agents|mesh-ancestor
6490480|NCT00598533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6490481|NCT00598533|Immunologic Factors|immunologic factors|mesh-ancestor
6490482|NCT00598533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490483|NCT00598533|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6490484|NCT00598533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5640665|NCT04858269|Mitosis Modulators|mitosis modulators|mesh-ancestor
5640666|NCT04858269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640667|NCT04858269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5640668|NCT04844528|Niacinamide|niacinamide|mesh-list
5640669|NCT04844528|Niacin|niacin|mesh-list
5640670|NCT04844528|Nicotinic Acids|nicotinic acids|mesh-list
5640671|NCT04844528|Vitamin B Complex|vitamin b complex|mesh-ancestor
5640672|NCT04844528|Vitamins|vitamins|mesh-ancestor
5640673|NCT04844528|Micronutrients|micronutrients|mesh-ancestor
5640674|NCT04844528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640675|NCT04844528|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6490485|NCT00598533|Antimetabolites|antimetabolites|mesh-ancestor
5769195|NCT02919878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5769196|NCT02919878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5769197|NCT02919878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5769198|NCT02919878|Immunologic Factors|immunologic factors|mesh-ancestor
5769199|NCT02919878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769200|NCT02919605|Pentamidine|pentamidine|mesh-list
5769201|NCT02919605|Antifungal Agents|antifungal agents|mesh-ancestor
5769202|NCT02919605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5769203|NCT02919605|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5769204|NCT02919605|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5769205|NCT02919605|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5769206|NCT02919735|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5769207|NCT02919787|Irinotecan|irinotecan|mesh-list
5769208|NCT02919787|Fluorouracil|fluorouracil|mesh-list
6490486|NCT00598533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490487|NCT00598533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6490488|NCT00598533|Antioxidants|antioxidants|mesh-ancestor
6490489|NCT00598533|Protective Agents|protective agents|mesh-ancestor
6490490|NCT00598572|Deferoxamine|deferoxamine|mesh-list
6490491|NCT00598572|Siderophores|siderophores|mesh-ancestor
6490492|NCT00598572|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6490493|NCT00598572|Chelating Agents|chelating agents|mesh-ancestor
6490494|NCT00598572|Sequestering Agents|sequestering agents|mesh-ancestor
6490495|NCT00598572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490496|NCT00598611|Loratadine|loratadine|mesh-list
5640676|NCT04844528|Antimetabolites|antimetabolites|mesh-ancestor
5769209|NCT02919787|Oxaliplatin|oxaliplatin|mesh-list
5769210|NCT02919787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5769211|NCT02919787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5769212|NCT02919787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5769213|NCT02919787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5769214|NCT02919787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5769215|NCT02919787|Antimetabolites|antimetabolites|mesh-ancestor
5769216|NCT02919787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5769217|NCT02919787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5769218|NCT02919787|Immunologic Factors|immunologic factors|mesh-ancestor
5769219|NCT02919787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769220|NCT02919501|Vortioxetine|vortioxetine|mesh-list
5769221|NCT02919501|Antidepressive Agents|antidepressive agents|mesh-ancestor
5769222|NCT02919501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5769223|NCT02919501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5769224|NCT02919501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5769225|NCT02919501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5769226|NCT02919501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769227|NCT02919501|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5769228|NCT02919501|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5769229|NCT02919501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5769230|NCT02919501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5769231|NCT02919501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5769232|NCT02919501|Serotonin Agents|serotonin agents|mesh-ancestor
5769233|NCT02919501|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5769234|NCT02919501|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5769235|NCT02919501|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5769236|NCT02919501|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5769237|NCT02919579|Esketamine|esketamine|mesh-list
5769238|NCT02919579|Antidepressive Agents|antidepressive agents|mesh-ancestor
5769239|NCT02919579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5769240|NCT02919462|Cisplatin|cisplatin|mesh-list
5769241|NCT02919462|Pemetrexed|pemetrexed|mesh-list
5769242|NCT02919462|Vinorelbine|vinorelbine|mesh-list
5769243|NCT02919462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5769244|NCT02919462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5769245|NCT02919462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5769246|NCT02919462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5769247|NCT02919462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6490497|NCT00598611|Desloratadine|desloratadine|mesh-list
5640677|NCT04844528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640678|NCT04844528|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5640679|NCT04844528|Vasodilator Agents|vasodilator agents|mesh-ancestor
5640680|NCT04818086|Buprenorphine|buprenorphine|mesh-list
5640681|NCT04818086|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
5640682|NCT04818086|Lemborexant|lemborexant|mesh-list
5640683|NCT04818086|Naloxone|naloxone|mesh-list
5640684|NCT04818086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5640685|NCT04818086|Narcotics|narcotics|mesh-ancestor
5769248|NCT02919462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5769249|NCT02919462|Tubulin Modulators|tubulin modulators|mesh-ancestor
5769250|NCT02919462|Antimitotic Agents|antimitotic agents|mesh-ancestor
5769251|NCT02919462|Mitosis Modulators|mitosis modulators|mesh-ancestor
5769252|NCT02919332|Deoxyglucose|deoxyglucose|mesh-list
5769253|NCT02919332|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5769254|NCT02919332|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5769255|NCT02919332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5769256|NCT02919332|Antimetabolites|antimetabolites|mesh-ancestor
5769257|NCT02919332|Antiviral Agents|antiviral agents|mesh-ancestor
5769258|NCT02919332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5769259|NCT02919293|Vaccines|vaccines|mesh-list
5769260|NCT02919293|Immunologic Factors|immunologic factors|mesh-ancestor
5769261|NCT02919293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769262|NCT02919371|Bevacizumab|bevacizumab|mesh-list
5769263|NCT02919371|Sunitinib|sunitinib|mesh-list
5769264|NCT02919371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5769265|NCT02919371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5769266|NCT02919371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5769267|NCT02919371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5769268|NCT02919371|Growth Substances|growth substances|mesh-ancestor
5769269|NCT02919371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769270|NCT02919371|Growth Inhibitors|growth inhibitors|mesh-ancestor
5769271|NCT02919371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5769272|NCT02919371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5769273|NCT02919371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5769274|NCT02919202|Listerine|listerine|mesh-list
5769275|NCT02919202|Fluorides|fluorides|mesh-list
5769276|NCT02919202|Sodium Fluoride|sodium fluoride|mesh-list
5769277|NCT02919202|Fluorides, Topical|fluorides, topical|mesh-list
5769278|NCT02919202|Cariostatic Agents|cariostatic agents|mesh-ancestor
5769279|NCT02919202|Protective Agents|protective agents|mesh-ancestor
5769280|NCT02919202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769281|NCT02919202|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5769282|NCT02919202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5769283|NCT02919345|Dapagliflozin|dapagliflozin|mesh-list
5769284|NCT02919345|Glyburide|glyburide|mesh-list
5769285|NCT02919345|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5769286|NCT02919345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5769287|NCT02919345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5769288|NCT02919345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769289|NCT02919449|Atezolizumab|atezolizumab|mesh-list
5769290|NCT02919449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5769291|NCT02919176|Pioglitazone|pioglitazone|mesh-list
5769292|NCT02919176|Mirabegron|mirabegron|mesh-list
5769293|NCT02919176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5769294|NCT02919176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769295|NCT02919176|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
5769296|NCT02919176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5769297|NCT02919176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5769298|NCT02919176|Adrenergic Agents|adrenergic agents|mesh-ancestor
5769299|NCT02919176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5769300|NCT02919176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5769301|NCT02919176|Urological Agents|urological agents|mesh-ancestor
5769302|NCT02919072|Ropivacaine|ropivacaine|mesh-list
5769303|NCT02919072|Chloroprocaine|chloroprocaine|mesh-list
5769304|NCT02919072|Anesthetics, Local|anesthetics, local|mesh-ancestor
5769305|NCT02919072|Anesthetics|anesthetics|mesh-ancestor
5640686|NCT04818086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5640687|NCT04818086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640688|NCT04818086|Analgesics|analgesics|mesh-ancestor
5640689|NCT04818086|Sensory System Agents|sensory system agents|mesh-ancestor
5640690|NCT04818086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5640691|NCT04818086|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5769306|NCT02919072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5769307|NCT02919072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769308|NCT02919072|Sensory System Agents|sensory system agents|mesh-ancestor
5769309|NCT02919072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5769310|NCT02919059|Dapagliflozin|dapagliflozin|mesh-list
5769311|NCT02919059|Glimepiride|glimepiride|mesh-list
5769312|NCT02919059|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5769313|NCT02919059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640692|NCT04818086|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
5640693|NCT04818086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5640694|NCT04818086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5769314|NCT02919059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5769315|NCT02919059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769316|NCT02919059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5769317|NCT02919059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5769318|NCT02919059|Immunologic Factors|immunologic factors|mesh-ancestor
5769319|NCT02918955|Cisplatin|cisplatin|mesh-list
5769320|NCT02918955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5769321|NCT02918812|Diclofenac|diclofenac|mesh-list
5769322|NCT02918812|Lidocaine|lidocaine|mesh-list
5769323|NCT02918812|Anesthetics, Local|anesthetics, local|mesh-ancestor
5769324|NCT02918812|Anesthetics|anesthetics|mesh-ancestor
5769325|NCT02918812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5769326|NCT02918812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769327|NCT02918812|Sensory System Agents|sensory system agents|mesh-ancestor
5769328|NCT02918812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5769329|NCT02918812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5769330|NCT02918812|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5769331|NCT02918812|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5769332|NCT02918812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5769333|NCT02918812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5769334|NCT02918812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5769335|NCT02918812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5769336|NCT02918812|Analgesics|analgesics|mesh-ancestor
5769337|NCT02918812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5769338|NCT02918812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5769339|NCT02918812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5769340|NCT02918812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5769341|NCT02918864|Oxytocin|oxytocin|mesh-list
5769342|NCT02918864|Oxytocics|oxytocics|mesh-ancestor
5769343|NCT02918864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5769344|NCT02918864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769345|NCT02918825|Olanzapine|olanzapine|mesh-list
5769346|NCT02918825|Paliperidone Palmitate|paliperidone palmitate|mesh-list
5769347|NCT02918825|Antiemetics|antiemetics|mesh-ancestor
5769348|NCT02918825|Autonomic Agents|autonomic agents|mesh-ancestor
5769349|NCT02918825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5769350|NCT02918825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769351|NCT02918825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5769352|NCT02918825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5769353|NCT02918825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5769354|NCT02918825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5769355|NCT02918825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5769356|NCT02918825|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5769357|NCT02918825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5769358|NCT02918825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5769359|NCT02918825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5769360|NCT02918825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5769361|NCT02918825|Serotonin Agents|serotonin agents|mesh-ancestor
5769362|NCT02918825|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5769363|NCT02918825|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5769364|NCT02918825|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5769365|NCT02918825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5769366|NCT02918825|Dopamine Agents|dopamine agents|mesh-ancestor
5769367|NCT02918760|Gabapentin|gabapentin|mesh-list
5769368|NCT02918760|Analgesics|analgesics|mesh-ancestor
5769369|NCT02918760|Sensory System Agents|sensory system agents|mesh-ancestor
5769370|NCT02918760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5769371|NCT02918760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769372|NCT02918760|Anticonvulsants|anticonvulsants|mesh-ancestor
5769373|NCT02918760|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5769374|NCT02918760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5769375|NCT02918760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5769376|NCT02918760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5769377|NCT02918760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5769378|NCT02918760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5769379|NCT02918760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5769380|NCT02918760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5769381|NCT02918760|Antimanic Agents|antimanic agents|mesh-ancestor
5769382|NCT02918747|Gemcitabine|gemcitabine|mesh-list
5769383|NCT02918747|Dexamethasone|dexamethasone|mesh-list
5769384|NCT02918747|Prednisone|prednisone|mesh-list
5769385|NCT02918747|Cyclophosphamide|cyclophosphamide|mesh-list
5769386|NCT02918747|Doxorubicin|doxorubicin|mesh-list
5769387|NCT02918747|Oxaliplatin|oxaliplatin|mesh-list
5769388|NCT02918747|Vincristine|vincristine|mesh-list
5769389|NCT02918747|Pegaspargase|pegaspargase|mesh-list
5769390|NCT02918747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5769391|NCT02918747|Immunologic Factors|immunologic factors|mesh-ancestor
5769392|NCT02918747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769393|NCT02918747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5769394|NCT02918747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5769395|NCT02918747|Alkylating Agents|alkylating agents|mesh-ancestor
5769396|NCT02918747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5769397|NCT02918747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5769398|NCT02918747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5769399|NCT02918747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5769400|NCT02918747|Antiemetics|antiemetics|mesh-ancestor
5769401|NCT02918747|Autonomic Agents|autonomic agents|mesh-ancestor
5769402|NCT02918747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5769403|NCT02918747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5769404|NCT02918747|Glucocorticoids|glucocorticoids|mesh-ancestor
5769405|NCT02918747|Hormones|hormones|mesh-ancestor
5769406|NCT02918747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5769407|NCT02918747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5769408|NCT02918747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5769409|NCT02918747|Antimetabolites|antimetabolites|mesh-ancestor
5769410|NCT02918747|Antiviral Agents|antiviral agents|mesh-ancestor
5769411|NCT02918747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5769412|NCT02918747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5769413|NCT02918747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5769414|NCT02918747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5769415|NCT02918747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5769416|NCT02918747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5769417|NCT02918747|Tubulin Modulators|tubulin modulators|mesh-ancestor
5769418|NCT02918747|Antimitotic Agents|antimitotic agents|mesh-ancestor
5769419|NCT02918747|Mitosis Modulators|mitosis modulators|mesh-ancestor
5769420|NCT02918708|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5769421|NCT02918708|Immunologic Factors|immunologic factors|mesh-ancestor
5769422|NCT02918708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769423|NCT02918591|Empagliflozin|empagliflozin|mesh-list
5769424|NCT02918591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5769425|NCT02918591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5769426|NCT02918591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5769427|NCT02918591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896276|NCT04049786|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5896277|NCT04049786|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5896278|NCT04049786|Antimetabolites|antimetabolites|mesh-ancestor
5896279|NCT04049786|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5896280|NCT04049786|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5896281|NCT04049786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5896282|NCT04049786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5896283|NCT04049786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5896284|NCT04049786|Sympatholytics|sympatholytics|mesh-ancestor
5896285|NCT04049786|Autonomic Agents|autonomic agents|mesh-ancestor
5896286|NCT04049786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5896287|NCT04049786|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5896288|NCT04049786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5896289|NCT04049786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5896290|NCT04049786|Adrenergic Agents|adrenergic agents|mesh-ancestor
5896291|NCT04049786|Antioxidants|antioxidants|mesh-ancestor
5896292|NCT04049786|Protective Agents|protective agents|mesh-ancestor
5896293|NCT04049786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5896294|NCT04049786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5896295|NCT04049786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5896296|NCT04049786|Vasodilator Agents|vasodilator agents|mesh-ancestor
5896297|NCT04049786|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5896298|NCT04049786|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5896299|NCT04045613|Atezolizumab|atezolizumab|mesh-list
5896300|NCT04045613|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5896301|NCT04045613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5896302|NCT04045613|Immunologic Factors|immunologic factors|mesh-ancestor
5896303|NCT04045613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896304|NCT04034238|Tofacitinib|tofacitinib|mesh-list
5896305|NCT04034238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5896306|NCT04034238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5896307|NCT04034238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896308|NCT04027946|Pembrolizumab|pembrolizumab|mesh-list
5896309|NCT04027946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5896310|NCT04027946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5769428|NCT02918409|Tobramycin|tobramycin|mesh-list
5769429|NCT02918409|Colistin|colistin|mesh-list
5769430|NCT02918409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5769431|NCT02918409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5769432|NCT02918331|Dexamethasone|dexamethasone|mesh-list
5769433|NCT02918331|Lenalidomide|lenalidomide|mesh-list
5769434|NCT02918331|Daratumumab|daratumumab|mesh-list
5769435|NCT02918331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5769436|NCT02918331|Antiemetics|antiemetics|mesh-ancestor
5769437|NCT02918331|Autonomic Agents|autonomic agents|mesh-ancestor
5769438|NCT02918331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5769439|NCT02918331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769440|NCT02918331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5769441|NCT02918331|Glucocorticoids|glucocorticoids|mesh-ancestor
5769442|NCT02918331|Hormones|hormones|mesh-ancestor
5769443|NCT02918331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5769444|NCT02918331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5769445|NCT02918331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5769446|NCT02918331|Immunologic Factors|immunologic factors|mesh-ancestor
5769447|NCT02918331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5769448|NCT02918331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5769449|NCT02918331|Growth Substances|growth substances|mesh-ancestor
5769450|NCT02918331|Growth Inhibitors|growth inhibitors|mesh-ancestor
5769451|NCT02918045|Cellulose, Oxidized|cellulose, oxidized|mesh-list
5769452|NCT02918045|Hemostatics|hemostatics|mesh-ancestor
5769453|NCT02918045|Coagulants|coagulants|mesh-ancestor
5769454|NCT02918136|Cortisone|cortisone|mesh-list
5769455|NCT02918136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5769456|NCT02918110|Misoprostol|misoprostol|mesh-list
5769457|NCT02918110|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5769458|NCT02918110|Abortifacient Agents|abortifacient agents|mesh-ancestor
5769459|NCT02918110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5769460|NCT02918110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769461|NCT02918110|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5769462|NCT02918110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5769463|NCT02918110|Oxytocics|oxytocics|mesh-ancestor
5769464|NCT02917889|Caffeine|caffeine|mesh-list
5769465|NCT02917889|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5769466|NCT02917889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769467|NCT02917889|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5769468|NCT02917889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5769469|NCT02917889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5769470|NCT02917889|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5769471|NCT02917889|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5769472|NCT02917889|Purinergic Agents|purinergic agents|mesh-ancestor
5769473|NCT02917889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5769474|NCT02918084|Letrozole|letrozole|mesh-list
5769475|NCT02918084|Anastrozole|anastrozole|mesh-list
5769476|NCT02918084|Exemestane|exemestane|mesh-list
5769477|NCT02918084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5769478|NCT02918084|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5769479|NCT02918084|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5769480|NCT02918084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5769481|NCT02918084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5769482|NCT02918084|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5769483|NCT02918084|Hormone Antagonists|hormone antagonists|mesh-ancestor
5769484|NCT02918084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5769485|NCT02918084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769486|NCT02918084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5769487|NCT02917967|Botulinum Toxins|botulinum toxins|mesh-list
5769488|NCT02917967|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5769489|NCT02917967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5769490|NCT02917967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5769491|NCT02917967|Cholinergic Agents|cholinergic agents|mesh-ancestor
5769492|NCT02917967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5769493|NCT02917967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769494|NCT02917772|Nivolumab|nivolumab|mesh-list
5769495|NCT02917772|Ipilimumab|ipilimumab|mesh-list
5769496|NCT02917772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5769497|NCT02917772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5769498|NCT02917772|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5769499|NCT02917772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5769500|NCT02917746|Imiquimod|imiquimod|mesh-list
6490498|NCT00598611|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5769501|NCT02917746|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5769502|NCT02917746|Immunologic Factors|immunologic factors|mesh-ancestor
5769503|NCT02917746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769504|NCT02917746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5769505|NCT02917746|Interferon Inducers|interferon inducers|mesh-ancestor
5769506|NCT02917551|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5769507|NCT02917551|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5769508|NCT02917551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5769509|NCT02917551|Antitubercular Agents|antitubercular agents|mesh-ancestor
5769510|NCT02917512|Cyclosporine|cyclosporine|mesh-list
5769511|NCT02917512|Cyclosporins|cyclosporins|mesh-list
5769512|NCT02917512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5769513|NCT02917512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5769514|NCT02917512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5769515|NCT02917512|Immunologic Factors|immunologic factors|mesh-ancestor
5769516|NCT02917512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769517|NCT02917512|Antifungal Agents|antifungal agents|mesh-ancestor
5769518|NCT02917512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5769519|NCT02917512|Dermatologic Agents|dermatologic agents|mesh-ancestor
5769520|NCT02917512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5769521|NCT02917512|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5769522|NCT02917525|Vitamin K|vitamin k|mesh-list
5769523|NCT02917525|Vitamin K 2|vitamin k 2|mesh-list
5769524|NCT02917525|Vitamins|vitamins|mesh-ancestor
5769525|NCT02917525|Micronutrients|micronutrients|mesh-ancestor
5769526|NCT02917525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769527|NCT02917525|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5769528|NCT02917525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5769529|NCT02917525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5769530|NCT02917525|Hemostatics|hemostatics|mesh-ancestor
5640695|NCT04818086|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5640696|NCT04818086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5640697|NCT04813991|Ibuprofen|ibuprofen|mesh-list
5640698|NCT04813991|Oxycodone|oxycodone|mesh-list
5640699|NCT04813991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5640700|NCT04813991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5640701|NCT04813991|Analgesics|analgesics|mesh-ancestor
5640702|NCT04813991|Sensory System Agents|sensory system agents|mesh-ancestor
5640703|NCT04813991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5640704|NCT04813991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640705|NCT04813991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5769531|NCT02917525|Coagulants|coagulants|mesh-ancestor
5769532|NCT02917564|Triamcinolone|triamcinolone|mesh-list
5769533|NCT02917564|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5769534|NCT02917564|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5769535|NCT02917564|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5769536|NCT02917564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5769537|NCT02917564|Glucocorticoids|glucocorticoids|mesh-ancestor
5769538|NCT02917564|Hormones|hormones|mesh-ancestor
5769539|NCT02917564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5769540|NCT02917564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769541|NCT02917564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5769542|NCT02917564|Immunologic Factors|immunologic factors|mesh-ancestor
5769543|NCT02917564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5769544|NCT02917564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5769545|NCT02917200|Moxifloxacin|moxifloxacin|mesh-list
5769546|NCT02917200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5769547|NCT02917200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5769548|NCT02917200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5769549|NCT02917200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5769550|NCT02917200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5769551|NCT02917200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5769552|NCT02917200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5769553|NCT02917005|Palbociclib|palbociclib|mesh-list
5769554|NCT02917005|Exemestane|exemestane|mesh-list
5769555|NCT02917005|Goserelin|goserelin|mesh-list
5769556|NCT02917005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5769557|NCT02917005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5769558|NCT02917005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5769559|NCT02917005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5769560|NCT02917005|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5769561|NCT02917005|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5769562|NCT02917005|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5769563|NCT02917005|Hormone Antagonists|hormone antagonists|mesh-ancestor
5769564|NCT02917005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5769565|NCT02917005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769566|NCT02917005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5769567|NCT02917018|Dexmedetomidine|dexmedetomidine|mesh-list
5769568|NCT02917018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5769569|NCT02917018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5769570|NCT02917018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769571|NCT02917018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5769572|NCT02917018|Analgesics|analgesics|mesh-ancestor
5769573|NCT02917018|Sensory System Agents|sensory system agents|mesh-ancestor
5769574|NCT02917018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5769575|NCT02917018|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5769576|NCT02917018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5769577|NCT02917018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5769578|NCT02917018|Adrenergic Agents|adrenergic agents|mesh-ancestor
5769579|NCT02917018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5769580|NCT02917018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5769581|NCT02917057|Exenatide|exenatide|mesh-list
5769582|NCT02917057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5769583|NCT02917057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769584|NCT02917057|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5769585|NCT02917057|Incretins|incretins|mesh-ancestor
5769586|NCT02917057|Hormones|hormones|mesh-ancestor
5769587|NCT02917057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5769588|NCT02916940|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
5769589|NCT02916940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5769590|NCT02916940|Glucocorticoids|glucocorticoids|mesh-ancestor
5769591|NCT02916940|Hormones|hormones|mesh-ancestor
5769592|NCT02916940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5769593|NCT02916940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769594|NCT02916862|Calcium, Dietary|calcium, dietary|mesh-list
5769595|NCT02916862|Calcium|calcium|mesh-list
5769596|NCT02916862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5769597|NCT02916862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769598|NCT02916862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5769599|NCT02916979|Methotrexate|methotrexate|mesh-list
5769600|NCT02916979|Fludarabine|fludarabine|mesh-list
5769601|NCT02916979|Busulfan|busulfan|mesh-list
5769602|NCT02916979|Thymoglobulin|thymoglobulin|mesh-list
5769603|NCT02916979|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6490499|NCT00598611|Cholinergic Agents|cholinergic agents|mesh-ancestor
6490500|NCT00598611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6490501|NCT00598611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5769604|NCT02916979|Abortifacient Agents|abortifacient agents|mesh-ancestor
5769605|NCT02916979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5769606|NCT02916979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769607|NCT02916979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5769608|NCT02916979|Antimetabolites|antimetabolites|mesh-ancestor
5769609|NCT02916979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5769610|NCT02916979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5769611|NCT02916979|Dermatologic Agents|dermatologic agents|mesh-ancestor
5769612|NCT02916979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6673498|NCT01563289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6673499|NCT01563289|Analgesics|analgesics|mesh-ancestor
6673500|NCT01563289|Sensory System Agents|sensory system agents|mesh-ancestor
6673501|NCT01563289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6673502|NCT01563289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673503|NCT01563289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5769613|NCT02916979|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5769614|NCT02916979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5769615|NCT02916979|Immunologic Factors|immunologic factors|mesh-ancestor
5769616|NCT02916979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5769617|NCT02916979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5769618|NCT02916979|Alkylating Agents|alkylating agents|mesh-ancestor
6490502|NCT00598611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769619|NCT02916979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5769620|NCT02916979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5769621|NCT02916771|Dexamethasone|dexamethasone|mesh-list
5769622|NCT02916771|Lenalidomide|lenalidomide|mesh-list
5769623|NCT02916771|Ixazomib|ixazomib|mesh-list
5769624|NCT02916771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5769625|NCT02916771|Antiemetics|antiemetics|mesh-ancestor
5769626|NCT02916771|Autonomic Agents|autonomic agents|mesh-ancestor
5769627|NCT02916771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5769628|NCT02916771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769629|NCT02916771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5769630|NCT02916771|Glucocorticoids|glucocorticoids|mesh-ancestor
5769631|NCT02916771|Hormones|hormones|mesh-ancestor
5769632|NCT02916771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5769633|NCT02916771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5769634|NCT02916771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5769635|NCT02916771|Immunologic Factors|immunologic factors|mesh-ancestor
5769636|NCT02916771|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5769637|NCT02916771|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5769638|NCT02916771|Growth Substances|growth substances|mesh-ancestor
5769639|NCT02916771|Growth Inhibitors|growth inhibitors|mesh-ancestor
5769640|NCT02916771|Protease Inhibitors|protease inhibitors|mesh-ancestor
5769641|NCT02916771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5769642|NCT02916771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5769643|NCT02916654|Iron|iron|mesh-list
5769644|NCT02916654|Trace Elements|trace elements|mesh-ancestor
5769645|NCT02916654|Micronutrients|micronutrients|mesh-ancestor
5769646|NCT02916654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769647|NCT02916355|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5769648|NCT02916355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5769649|NCT02916420|Dexamethasone|dexamethasone|mesh-list
5769650|NCT02916420|Pomalidomide|pomalidomide|mesh-list
5769651|NCT02916420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5769652|NCT02916420|Antiemetics|antiemetics|mesh-ancestor
5769653|NCT02916420|Autonomic Agents|autonomic agents|mesh-ancestor
5769654|NCT02916420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5769655|NCT02916420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769656|NCT02916420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5769657|NCT02916420|Glucocorticoids|glucocorticoids|mesh-ancestor
5769658|NCT02916420|Hormones|hormones|mesh-ancestor
5769659|NCT02916420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5769660|NCT02916420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5769661|NCT02916420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5769662|NCT02916420|Immunologic Factors|immunologic factors|mesh-ancestor
5769663|NCT02916420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5769664|NCT02916420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5769665|NCT02916420|Growth Substances|growth substances|mesh-ancestor
5769666|NCT02916420|Growth Inhibitors|growth inhibitors|mesh-ancestor
5896311|NCT04023253|Solifenacin Succinate|solifenacin succinate|mesh-list
5896312|NCT04023253|Mirabegron|mirabegron|mesh-list
5896313|NCT04023253|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5896314|NCT04023253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5896315|NCT04023253|Cholinergic Agents|cholinergic agents|mesh-ancestor
6490503|NCT00598611|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6490504|NCT00598611|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6490505|NCT00598611|Histamine Antagonists|histamine antagonists|mesh-ancestor
6490506|NCT00598611|Histamine Agents|histamine agents|mesh-ancestor
5896316|NCT04023253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5896317|NCT04023253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896318|NCT04023253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896319|NCT04023253|Urological Agents|urological agents|mesh-ancestor
5896320|NCT04023253|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
5896321|NCT04023253|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5896322|NCT04023253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5896323|NCT04023253|Adrenergic Agents|adrenergic agents|mesh-ancestor
5896324|NCT04005053|Acetylcysteine|acetylcysteine|mesh-list
6210154|NCT02156492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210155|NCT02156492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5896325|NCT04005053|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5896326|NCT04005053|Antiviral Agents|antiviral agents|mesh-ancestor
5896327|NCT04005053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5896328|NCT04005053|Expectorants|expectorants|mesh-ancestor
5896329|NCT04005053|Respiratory System Agents|respiratory system agents|mesh-ancestor
5896330|NCT04005053|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5896331|NCT04005053|Antioxidants|antioxidants|mesh-ancestor
5896332|NCT04005053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896333|NCT04005053|Protective Agents|protective agents|mesh-ancestor
5896334|NCT04005053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896335|NCT04005053|Antidotes|antidotes|mesh-ancestor
5896336|NCT03993132|Empagliflozin|empagliflozin|mesh-list
5896337|NCT03993132|Glucagon|glucagon|mesh-list
5896338|NCT03993132|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5896339|NCT03993132|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5896340|NCT03993132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212587|NCT02190903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896341|NCT03993132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5769667|NCT02916511|Paclitaxel|paclitaxel|mesh-list
5769668|NCT02916511|Carboplatin|carboplatin|mesh-list
5769669|NCT02916511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5769670|NCT02916511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5769671|NCT02916511|Tubulin Modulators|tubulin modulators|mesh-ancestor
5769672|NCT02916511|Antimitotic Agents|antimitotic agents|mesh-ancestor
5769673|NCT02916511|Mitosis Modulators|mitosis modulators|mesh-ancestor
5769674|NCT02916511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5769675|NCT02916485|Sirolimus|sirolimus|mesh-list
5769676|NCT02916485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5769677|NCT02916485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5769678|NCT02916485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5769679|NCT02916485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5769680|NCT02916485|Antifungal Agents|antifungal agents|mesh-ancestor
5769681|NCT02916485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5769682|NCT02916485|Immunologic Factors|immunologic factors|mesh-ancestor
5769683|NCT02916485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769684|NCT02916602|Losartan|losartan|mesh-list
5769685|NCT02916602|Amlodipine|amlodipine|mesh-list
5769686|NCT02916602|Chlorthalidone|chlorthalidone|mesh-list
5769687|NCT02916602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5769688|NCT02916602|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5769689|NCT02916602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5769690|NCT02916602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5769691|NCT02916602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5769692|NCT02916602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769693|NCT02916602|Vasodilator Agents|vasodilator agents|mesh-ancestor
5769694|NCT02916602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5769695|NCT02916602|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5769696|NCT02916602|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5769697|NCT02916602|Diuretics|diuretics|mesh-ancestor
5769698|NCT02916602|Natriuretic Agents|natriuretic agents|mesh-ancestor
5769699|NCT02916602|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5769700|NCT02916381|Anesthetics|anesthetics|mesh-list
5769701|NCT02916381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5769702|NCT02916381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769703|NCT02916251|Glucagon|glucagon|mesh-list
5769704|NCT02916251|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5769705|NCT02916251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5769706|NCT02916251|Hormones|hormones|mesh-ancestor
5769707|NCT02916251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5769708|NCT02916251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769709|NCT02916251|Incretins|incretins|mesh-ancestor
5769710|NCT02916173|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5769711|NCT02916173|Hormones|hormones|mesh-list
5769712|NCT02916173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5769713|NCT02916173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769714|NCT02916173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5769715|NCT02916238|Fluoxetine|fluoxetine|mesh-list
5769716|NCT02916238|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5769717|NCT02916238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5769718|NCT02916238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5769719|NCT02916238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5769720|NCT02916238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5769721|NCT02916238|Serotonin Agents|serotonin agents|mesh-ancestor
5769722|NCT02916238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769723|NCT02916238|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5769724|NCT02916238|Antidepressive Agents|antidepressive agents|mesh-ancestor
5769725|NCT02916238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5769726|NCT02916238|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5769727|NCT02916238|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5769728|NCT02916238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5769729|NCT02916134|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5769730|NCT02916134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5769731|NCT02916160|Valsartan|valsartan|mesh-list
5769732|NCT02916160|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5769733|NCT02916160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5769734|NCT02916160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5769735|NCT02916160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5769736|NCT02916160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5769737|NCT02916121|Folic Acid|folic acid|mesh-list
6210156|NCT02156492|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5769738|NCT02916121|Vitamin B 12|vitamin b 12|mesh-list
5769739|NCT02916121|Vitamins|vitamins|mesh-ancestor
5769740|NCT02916121|Micronutrients|micronutrients|mesh-ancestor
5769741|NCT02916121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769742|NCT02916121|Hematinics|hematinics|mesh-ancestor
5769743|NCT02916121|Vitamin B Complex|vitamin b complex|mesh-ancestor
5769744|NCT02916147|Propofol|propofol|mesh-list
5769745|NCT02916147|Sevoflurane|sevoflurane|mesh-list
5769746|NCT02916147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5769747|NCT02916147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5769748|NCT02916147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769749|NCT02916147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5769750|NCT02916147|Anesthetics, General|anesthetics, general|mesh-ancestor
5769751|NCT02916147|Anesthetics|anesthetics|mesh-ancestor
5769752|NCT02916147|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5769753|NCT02916147|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5769754|NCT02915731|Vitamin A|vitamin a|mesh-list
5769755|NCT02915731|Vitamins|vitamins|mesh-ancestor
5769756|NCT02915731|Micronutrients|micronutrients|mesh-ancestor
5769757|NCT02915731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769758|NCT02915666|Trametinib|trametinib|mesh-list
5769759|NCT02915666|Dabrafenib|dabrafenib|mesh-list
5769760|NCT02915666|Digoxin|digoxin|mesh-list
5769761|NCT02915666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5769762|NCT02915666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5769763|NCT02915666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5769764|NCT02915666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5769765|NCT02915666|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5769766|NCT02915666|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5769767|NCT02915666|Protective Agents|protective agents|mesh-ancestor
5769768|NCT02915666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769769|NCT02915809|Vaccines|vaccines|mesh-list
5769770|NCT02915809|Immunologic Factors|immunologic factors|mesh-ancestor
5769771|NCT02915809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769772|NCT02915523|Avelumab|avelumab|mesh-list
5769773|NCT02915523|Entinostat|entinostat|mesh-list
5769774|NCT02915523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5769775|NCT02915523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5769776|NCT02915523|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5769777|NCT02915523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5769778|NCT02915523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5769779|NCT02915796|Lenograstim|lenograstim|mesh-list
5769780|NCT02915796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5769781|NCT02915796|Immunologic Factors|immunologic factors|mesh-ancestor
5769782|NCT02915796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769783|NCT02915263|Immunoglobulins|immunoglobulins|mesh-list
5769784|NCT02915263|Immunologic Factors|immunologic factors|mesh-ancestor
5769785|NCT02915263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769786|NCT02915250|Insulin Lispro|insulin lispro|mesh-list
5769787|NCT02915250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5769788|NCT02915250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769789|NCT02915198|Metformin|metformin|mesh-list
5769790|NCT02915198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5769791|NCT02915198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769792|NCT02915289|Chlorhexidine|chlorhexidine|mesh-list
5769793|NCT02915289|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5769794|NCT02915289|Povidone-Iodine|povidone-iodine|mesh-list
5769795|NCT02915289|Povidone|povidone|mesh-list
5769796|NCT02915289|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5769797|NCT02915289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5769798|NCT02915289|Disinfectants|disinfectants|mesh-ancestor
5769799|NCT02915289|Dermatologic Agents|dermatologic agents|mesh-ancestor
5769800|NCT02915289|Plasma Substitutes|plasma substitutes|mesh-ancestor
5769801|NCT02915289|Blood Substitutes|blood substitutes|mesh-ancestor
5769802|NCT02915224|Obinutuzumab|obinutuzumab|mesh-list
5769803|NCT02915224|Chlorambucil|chlorambucil|mesh-list
5769804|NCT02915224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5769805|NCT02915224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5769806|NCT02915224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5769807|NCT02915224|Alkylating Agents|alkylating agents|mesh-ancestor
6210157|NCT02156492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6210158|NCT02156804|Nivolumab|nivolumab|mesh-list
6210159|NCT02156804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5769808|NCT02915224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210160|NCT02156804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5769809|NCT02915354|Etanercept|etanercept|mesh-list
5769810|NCT02915354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5769811|NCT02915354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5769812|NCT02915354|Analgesics|analgesics|mesh-ancestor
5769813|NCT02915354|Sensory System Agents|sensory system agents|mesh-ancestor
5769814|NCT02915354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5769815|NCT02915354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769816|NCT02915354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5769817|NCT02915354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5769818|NCT02915354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5769819|NCT02915354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5769820|NCT02915354|Immunologic Factors|immunologic factors|mesh-ancestor
5769821|NCT02915094|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5769822|NCT02915094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5769823|NCT02915172|Capecitabine|capecitabine|mesh-list
5769824|NCT02915172|Lenvatinib|lenvatinib|mesh-list
5769825|NCT02915172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5769826|NCT02915172|Antimetabolites|antimetabolites|mesh-ancestor
5769827|NCT02915172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5769828|NCT02915172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5769829|NCT02915172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5769830|NCT02915172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5769831|NCT02915055|Acetaminophen|acetaminophen|mesh-list
5769832|NCT02915055|Ibuprofen|ibuprofen|mesh-list
5769833|NCT02915055|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
5769834|NCT02915055|Oxycodone|oxycodone|mesh-list
5769835|NCT02915055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5769836|NCT02915055|Analgesics|analgesics|mesh-ancestor
5769837|NCT02915055|Sensory System Agents|sensory system agents|mesh-ancestor
5769838|NCT02915055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5769839|NCT02915055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769840|NCT02915055|Antipyretics|antipyretics|mesh-ancestor
5769841|NCT02915055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5769842|NCT02915055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5769843|NCT02915055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5769844|NCT02915055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5769845|NCT02915055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5769846|NCT02915055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5769847|NCT02915055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5769848|NCT02915055|Narcotics|narcotics|mesh-ancestor
5769849|NCT02915055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5896342|NCT03993132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896343|NCT03993132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5896344|NCT03993132|Hormones|hormones|mesh-ancestor
5896345|NCT03993132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5896346|NCT03993132|Incretins|incretins|mesh-ancestor
5896347|NCT03975647|Tucatinib|tucatinib|mesh-list
5896348|NCT03975647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5896349|NCT03975647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896350|NCT03975647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5896351|NCT03975647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5896352|NCT03972657|Cemiplimab|cemiplimab|mesh-list
5896353|NCT03972657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5896354|NCT03972657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5896355|NCT03970382|Aldesleukin|aldesleukin|mesh-list
5896356|NCT03970382|Nivolumab|nivolumab|mesh-list
5896357|NCT03970382|Interleukin-2|interleukin-2|mesh-list
5896358|NCT03970382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5896359|NCT03970382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5896360|NCT03970382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5896361|NCT03970382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896362|NCT03970382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5896363|NCT03970382|Analgesics|analgesics|mesh-ancestor
5896364|NCT03970382|Sensory System Agents|sensory system agents|mesh-ancestor
5896365|NCT03970382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5896366|NCT03970382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896367|NCT03970382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5896368|NCT03970382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5896369|NCT03970382|Antiviral Agents|antiviral agents|mesh-ancestor
5896370|NCT03970382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5896371|NCT03965689|Paclitaxel|paclitaxel|mesh-list
5896372|NCT03965689|Carboplatin|carboplatin|mesh-list
5896373|NCT03965689|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5896374|NCT03965689|Enzyme Inhibitors|enzyme inhibitors|mesh-list
5896375|NCT03965689|Pevonedistat|pevonedistat|mesh-list
5896376|NCT03965689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5896377|NCT03965689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5896378|NCT03965689|Tubulin Modulators|tubulin modulators|mesh-ancestor
5896379|NCT03965689|Antimitotic Agents|antimitotic agents|mesh-ancestor
5896380|NCT03965689|Mitosis Modulators|mitosis modulators|mesh-ancestor
5769850|NCT02915042|Dexmedetomidine|dexmedetomidine|mesh-list
5769851|NCT02915042|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5769852|NCT02915042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5769853|NCT02915042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769854|NCT02915042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5769855|NCT02915042|Analgesics|analgesics|mesh-ancestor
5769856|NCT02915042|Sensory System Agents|sensory system agents|mesh-ancestor
5769857|NCT02915042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5769858|NCT02915042|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5769859|NCT02915042|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5769860|NCT02915042|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5769861|NCT02915042|Adrenergic Agents|adrenergic agents|mesh-ancestor
5769862|NCT02915042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5769863|NCT02915042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5769864|NCT02914886|Insulin|insulin|mesh-list
5769865|NCT02914886|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5769866|NCT02914886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5769867|NCT02914886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769868|NCT02914652|Albuterol|albuterol|mesh-list
5769869|NCT02914652|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5769870|NCT02914652|Autonomic Agents|autonomic agents|mesh-ancestor
5769871|NCT02914652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5769872|NCT02914652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769873|NCT02914652|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5769874|NCT02914652|Respiratory System Agents|respiratory system agents|mesh-ancestor
5769875|NCT02914652|Tocolytic Agents|tocolytic agents|mesh-ancestor
5769876|NCT02914652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5769877|NCT02914652|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5769878|NCT02914652|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5769879|NCT02914652|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5769880|NCT02914652|Adrenergic Agents|adrenergic agents|mesh-ancestor
5769881|NCT02914652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5769882|NCT02914652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5769883|NCT02914678|Fentanyl|fentanyl|mesh-list
5769884|NCT02914678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5769885|NCT02914678|Narcotics|narcotics|mesh-ancestor
5769886|NCT02914678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5769887|NCT02914678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769888|NCT02914678|Analgesics|analgesics|mesh-ancestor
5769889|NCT02914678|Sensory System Agents|sensory system agents|mesh-ancestor
5769890|NCT02914678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5769891|NCT02914678|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5769892|NCT02914678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5769893|NCT02914678|Anesthetics, General|anesthetics, general|mesh-ancestor
5769894|NCT02914678|Anesthetics|anesthetics|mesh-ancestor
5769895|NCT02914639|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5769896|NCT02914639|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5769897|NCT02914613|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5769898|NCT02914613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5769899|NCT02914626|Ranibizumab|ranibizumab|mesh-list
5769900|NCT02914626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5769901|NCT02914626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5769902|NCT02914626|Growth Substances|growth substances|mesh-ancestor
5769903|NCT02914626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769904|NCT02914626|Growth Inhibitors|growth inhibitors|mesh-ancestor
5769905|NCT02914626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5769906|NCT02914405|Nivolumab|nivolumab|mesh-list
5769907|NCT02914405|Dinutuximab|dinutuximab|mesh-list
5769908|NCT02914405|Immunoglobulins|immunoglobulins|mesh-list
5769909|NCT02914405|Immunoglobulin G|immunoglobulin g|mesh-list
5769910|NCT02914405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5769911|NCT02914405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5769912|NCT02914405|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5769913|NCT02914405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5769914|NCT02914405|Immunologic Factors|immunologic factors|mesh-ancestor
5769915|NCT02914405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769916|NCT02914366|Ambroxol|ambroxol|mesh-list
5769917|NCT02914366|Expectorants|expectorants|mesh-ancestor
5769918|NCT02914366|Respiratory System Agents|respiratory system agents|mesh-ancestor
5769919|NCT02914158|Tamoxifen|tamoxifen|mesh-list
5769920|NCT02914158|Goserelin|goserelin|mesh-list
5769921|NCT02914158|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5769922|NCT02914158|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5769923|NCT02914158|Hormone Antagonists|hormone antagonists|mesh-ancestor
6210161|NCT02156804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5769924|NCT02914158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5769925|NCT02914158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769926|NCT02914158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5769927|NCT02914158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5769928|NCT02914158|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5769929|NCT02914158|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5769930|NCT02914158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5769931|NCT02914158|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5769932|NCT02914158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5769933|NCT02914158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5769934|NCT02914015|Morphine|morphine|mesh-list
5769935|NCT02914015|Ropivacaine|ropivacaine|mesh-list
5769936|NCT02914015|Anesthetics, Local|anesthetics, local|mesh-list
5769937|NCT02914015|Anesthetics|anesthetics|mesh-list
5769938|NCT02914015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5769939|NCT02914015|Narcotics|narcotics|mesh-ancestor
5769940|NCT02914015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5769941|NCT02914015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769942|NCT02914015|Analgesics|analgesics|mesh-ancestor
5769943|NCT02914015|Sensory System Agents|sensory system agents|mesh-ancestor
5769944|NCT02914015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5769945|NCT02914054|Dexamethasone|dexamethasone|mesh-list
5769946|NCT02914054|Prednisone|prednisone|mesh-list
5769947|NCT02914054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5769948|NCT02914054|Antiemetics|antiemetics|mesh-ancestor
5769949|NCT02914054|Autonomic Agents|autonomic agents|mesh-ancestor
5769950|NCT02914054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5769951|NCT02914054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769952|NCT02914054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5769953|NCT02914054|Glucocorticoids|glucocorticoids|mesh-ancestor
5769954|NCT02914054|Hormones|hormones|mesh-ancestor
5769955|NCT02914054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5769956|NCT02914054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5769957|NCT02914054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5769958|NCT02914145|Piperaquine|piperaquine|mesh-list
5769959|NCT02914145|Artenimol|artenimol|mesh-list
5769960|NCT02914145|Antimalarials|antimalarials|mesh-ancestor
5769961|NCT02914145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5769962|NCT02914145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5769963|NCT02914145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5769964|NCT02913885|Fluorides|fluorides|mesh-list
5769965|NCT02913885|Fluorides, Topical|fluorides, topical|mesh-list
5769966|NCT02913885|Cariostatic Agents|cariostatic agents|mesh-ancestor
5769967|NCT02913885|Protective Agents|protective agents|mesh-ancestor
5769968|NCT02913885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769969|NCT02914028|Acetaminophen|acetaminophen|mesh-list
5769970|NCT02914028|Tramadol|tramadol|mesh-list
5769971|NCT02914028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5769972|NCT02914028|Analgesics|analgesics|mesh-ancestor
5769973|NCT02914028|Sensory System Agents|sensory system agents|mesh-ancestor
5769974|NCT02914028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5769975|NCT02914028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769976|NCT02914028|Antipyretics|antipyretics|mesh-ancestor
5769977|NCT02914028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5769978|NCT02914028|Narcotics|narcotics|mesh-ancestor
5769979|NCT02914028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5769980|NCT02913859|Androgen Antagonists|androgen antagonists|mesh-list
5769981|NCT02913859|Hormone Antagonists|hormone antagonists|mesh-ancestor
6210162|NCT02156804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5769982|NCT02913859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5769983|NCT02913859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769984|NCT02913768|Ondansetron|ondansetron|mesh-list
5769985|NCT02913768|Antiemetics|antiemetics|mesh-ancestor
5769986|NCT02913768|Autonomic Agents|autonomic agents|mesh-ancestor
5769987|NCT02913768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5769988|NCT02913768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5769989|NCT02913768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5769990|NCT02913768|Antipruritics|antipruritics|mesh-ancestor
5769991|NCT02913768|Dermatologic Agents|dermatologic agents|mesh-ancestor
5769992|NCT02913768|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5769993|NCT02913768|Serotonin Agents|serotonin agents|mesh-ancestor
5769994|NCT02913768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5769995|NCT02913768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5769996|NCT02913768|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5769997|NCT02913768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5769998|NCT02913768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5769999|NCT02913768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5770000|NCT02913768|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5770001|NCT02913417|Nivolumab|nivolumab|mesh-list
5770002|NCT02913417|Ipilimumab|ipilimumab|mesh-list
5770003|NCT02913417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5770004|NCT02913417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5770005|NCT02913417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5770006|NCT02913417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5770007|NCT02913573|Bupivacaine|bupivacaine|mesh-list
5770008|NCT02913573|Anesthetics, Local|anesthetics, local|mesh-ancestor
6210163|NCT02157103|Bevacizumab|bevacizumab|mesh-list
6210164|NCT02157103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6210165|NCT02157103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6210166|NCT02157103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6210167|NCT02157103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6210168|NCT02157103|Growth Substances|growth substances|mesh-ancestor
6210169|NCT02157103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210170|NCT02157103|Growth Inhibitors|growth inhibitors|mesh-ancestor
6210171|NCT02157298|Dapagliflozin|dapagliflozin|mesh-list
5770009|NCT02913573|Anesthetics|anesthetics|mesh-ancestor
5770010|NCT02913573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5770011|NCT02913573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770012|NCT02913573|Sensory System Agents|sensory system agents|mesh-ancestor
5770013|NCT02913573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5770014|NCT02913430|Tamoxifen|tamoxifen|mesh-list
5770015|NCT02913430|Fulvestrant|fulvestrant|mesh-list
5770016|NCT02913430|Palbociclib|palbociclib|mesh-list
5770017|NCT02913430|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5770018|NCT02913430|Hormone Antagonists|hormone antagonists|mesh-ancestor
5770019|NCT02913430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5770020|NCT02913430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770021|NCT02913430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5770022|NCT02913430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5770023|NCT02913430|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5770024|NCT02913430|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5770025|NCT02913430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5770026|NCT02913430|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5770027|NCT02913430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5770028|NCT02913430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5770029|NCT02913430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5770030|NCT02913469|Morphine|morphine|mesh-list
6210172|NCT02157298|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5640706|NCT04813991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5770031|NCT02913469|Metoclopramide|metoclopramide|mesh-list
5770032|NCT02913469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5770033|NCT02913469|Narcotics|narcotics|mesh-ancestor
5770034|NCT02913469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5770035|NCT02913469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770036|NCT02913469|Analgesics|analgesics|mesh-ancestor
5770037|NCT02913469|Sensory System Agents|sensory system agents|mesh-ancestor
5770038|NCT02913469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5770039|NCT02913469|Antiemetics|antiemetics|mesh-ancestor
5770040|NCT02913469|Autonomic Agents|autonomic agents|mesh-ancestor
5770041|NCT02913469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5770042|NCT02913469|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5640707|NCT04813991|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5640708|NCT04813991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5640709|NCT04813991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640710|NCT04813991|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5640711|NCT04813991|Narcotics|narcotics|mesh-ancestor
5640712|NCT04813991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5640713|NCT04811118|Docetaxel|docetaxel|mesh-list
5640714|NCT04811118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5640715|NCT04811118|Tubulin Modulators|tubulin modulators|mesh-ancestor
5640716|NCT04811118|Antimitotic Agents|antimitotic agents|mesh-ancestor
5640717|NCT04811118|Mitosis Modulators|mitosis modulators|mesh-ancestor
5770043|NCT02913469|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5770044|NCT02913469|Dopamine Agents|dopamine agents|mesh-ancestor
5770045|NCT02913469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5770046|NCT02913469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5770047|NCT02913508|Vedolizumab|vedolizumab|mesh-list
5770048|NCT02913508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5770049|NCT02913300|Lidocaine|lidocaine|mesh-list
5770050|NCT02913300|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5770051|NCT02913300|Anesthetics, Local|anesthetics, local|mesh-ancestor
6210173|NCT02157298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5770052|NCT02913300|Anesthetics|anesthetics|mesh-ancestor
5770053|NCT02913300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5770054|NCT02913300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770055|NCT02913300|Sensory System Agents|sensory system agents|mesh-ancestor
5770056|NCT02913300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5770057|NCT02913300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5770058|NCT02913300|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5770059|NCT02913300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5770060|NCT02913300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5770061|NCT02913300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5770062|NCT02913690|Vitamin E|vitamin e|mesh-list
5770063|NCT02913690|Vitamins|vitamins|mesh-ancestor
5770064|NCT02913690|Micronutrients|micronutrients|mesh-ancestor
5770065|NCT02913690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770066|NCT02913690|Antioxidants|antioxidants|mesh-ancestor
5770067|NCT02913690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5770068|NCT02913690|Protective Agents|protective agents|mesh-ancestor
5896381|NCT03965689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896382|NCT03952143|Insulin|insulin|mesh-list
5896383|NCT03952143|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5896384|NCT03952143|Insulin Glargine|insulin glargine|mesh-list
5896385|NCT03952143|Insulin Lispro|insulin lispro|mesh-list
5896386|NCT03952143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5896387|NCT03952143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896388|NCT03934372|Ponatinib|ponatinib|mesh-list
5896389|NCT03934372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5896390|NCT03934372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5896391|NCT03934372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5896392|NCT03934372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896393|NCT03934307|Irbesartan|irbesartan|mesh-list
5896394|NCT03934307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5896395|NCT03934307|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5896396|NCT03934307|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5896397|NCT03934307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896398|NCT03933202|Cladribine|cladribine|mesh-list
5896399|NCT03933202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5896400|NCT03933202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5896401|NCT03933202|Immunologic Factors|immunologic factors|mesh-ancestor
5896402|NCT03933202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896403|NCT03932643|TIC10 compound|tic10 compound|mesh-list
5896404|NCT03932643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5896405|NCT03931642|Blinatumomab|blinatumomab|mesh-list
5896406|NCT03931642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5896407|NCT03930953|Rituximab|rituximab|mesh-list
5896408|NCT03930953|Obinutuzumab|obinutuzumab|mesh-list
5896409|NCT03930953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5896410|NCT03930953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5896411|NCT03930953|Immunologic Factors|immunologic factors|mesh-ancestor
5896412|NCT03930953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896413|NCT03930953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5896414|NCT03915769|Ozanimod|ozanimod|mesh-list
5896415|NCT03915769|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5896416|NCT03915769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896417|NCT03915769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5896418|NCT03915769|Immunologic Factors|immunologic factors|mesh-ancestor
5896419|NCT03915769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896420|NCT03890666|Albuterol|albuterol|mesh-list
5896421|NCT03890666|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5896422|NCT03890666|Autonomic Agents|autonomic agents|mesh-ancestor
5896423|NCT03890666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5896424|NCT03890666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896425|NCT03890666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5896426|NCT03890666|Respiratory System Agents|respiratory system agents|mesh-ancestor
5896427|NCT03890666|Tocolytic Agents|tocolytic agents|mesh-ancestor
5896428|NCT03890666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5896429|NCT03890666|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5896430|NCT03890666|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5896431|NCT03890666|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5896432|NCT03890666|Adrenergic Agents|adrenergic agents|mesh-ancestor
5896433|NCT03890666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5896434|NCT03890666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896435|NCT03863288|Oxytocin|oxytocin|mesh-list
5896436|NCT03863288|Oxytocics|oxytocics|mesh-ancestor
5896437|NCT03863288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5770069|NCT02913196|Prednisone|prednisone|mesh-list
5770070|NCT02913196|Docetaxel|docetaxel|mesh-list
5770071|NCT02913196|Abiraterone Acetate|abiraterone acetate|mesh-list
5770072|NCT02913196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5770073|NCT02913196|Tubulin Modulators|tubulin modulators|mesh-ancestor
5770074|NCT02913196|Antimitotic Agents|antimitotic agents|mesh-ancestor
5770075|NCT02913196|Mitosis Modulators|mitosis modulators|mesh-ancestor
5770076|NCT02913196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5770077|NCT02913196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5770078|NCT02913196|Glucocorticoids|glucocorticoids|mesh-ancestor
5770079|NCT02913196|Hormones|hormones|mesh-ancestor
5770080|NCT02913196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5770081|NCT02913196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770082|NCT02913196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5770083|NCT02913196|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5770084|NCT02913196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5770085|NCT02913196|Hormone Antagonists|hormone antagonists|mesh-ancestor
5770086|NCT02913196|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5770087|NCT02913157|Hydroxychloroquine|hydroxychloroquine|mesh-list
5770088|NCT02913157|Antimalarials|antimalarials|mesh-ancestor
5770089|NCT02913157|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5770090|NCT02913157|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5770091|NCT02913157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5770092|NCT02913157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5770093|NCT02913157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5770094|NCT02913157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5770095|NCT02913118|Amoxicillin|amoxicillin|mesh-list
5770096|NCT02913118|Azithromycin|azithromycin|mesh-list
5770097|NCT02913118|Doxycycline|doxycycline|mesh-list
5770098|NCT02913118|Minocycline|minocycline|mesh-list
5770099|NCT02913118|Cephalosporins|cephalosporins|mesh-list
5770100|NCT02913118|Fluoroquinolones|fluoroquinolones|mesh-list
5770101|NCT02913118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5770102|NCT02913118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5770103|NCT02913118|Antimalarials|antimalarials|mesh-ancestor
5770104|NCT02913118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5770105|NCT02913118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5770106|NCT02913118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5770107|NCT02913118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5770108|NCT02913118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5770109|NCT02912988|Letrozole|letrozole|mesh-list
5770110|NCT02912988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5770111|NCT02912988|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5770112|NCT02912988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5770113|NCT02912988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5770114|NCT02912988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5770115|NCT02912988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5770116|NCT02912988|Hormone Antagonists|hormone antagonists|mesh-ancestor
5770117|NCT02912988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6490507|NCT00598611|Antipruritics|antipruritics|mesh-ancestor
6490508|NCT00598611|Dermatologic Agents|dermatologic agents|mesh-ancestor
6490509|NCT00598611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6490510|NCT00598624|Treosulfan|treosulfan|mesh-list
6490511|NCT00598624|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5640718|NCT04811118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640719|NCT04811027|Pembrolizumab|pembrolizumab|mesh-list
5640720|NCT04811027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5640721|NCT04811027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5640722|NCT04793685|Prazosin|prazosin|mesh-list
5640723|NCT04793685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5640724|NCT04793685|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5640725|NCT04793685|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5640726|NCT04793685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5640727|NCT04793685|Adrenergic Agents|adrenergic agents|mesh-ancestor
5640728|NCT04793685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5640729|NCT04793685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640730|NCT04793685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640731|NCT04785287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5640732|NCT04785287|Nivolumab|nivolumab|mesh-list
5640733|NCT04785287|Antibodies|antibodies|mesh-list
5640734|NCT04785287|Immunoglobulins|immunoglobulins|mesh-list
5640735|NCT04785287|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5640736|NCT04785287|Immunologic Factors|immunologic factors|mesh-ancestor
5640737|NCT04785287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640738|NCT04785287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5770118|NCT02912988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770119|NCT02913066|Cisplatin|cisplatin|mesh-list
5770120|NCT02913066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5770121|NCT02912793|Betadex|betadex|mesh-list
5770122|NCT02912793|Sequestering Agents|sequestering agents|mesh-ancestor
6210174|NCT02157298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6210175|NCT02157298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210176|NCT02157376|Esomeprazole|esomeprazole|mesh-list
5770123|NCT02912793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5770124|NCT02912663|Magnesium Sulfate|magnesium sulfate|mesh-list
5770125|NCT02912663|Verapamil|verapamil|mesh-list
5770126|NCT02912663|Analgesics|analgesics|mesh-ancestor
5770127|NCT02912663|Sensory System Agents|sensory system agents|mesh-ancestor
5770128|NCT02912663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5770129|NCT02912663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770130|NCT02912663|Anesthetics|anesthetics|mesh-ancestor
5770131|NCT02912663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5770132|NCT02912663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5770133|NCT02912663|Anticonvulsants|anticonvulsants|mesh-ancestor
5770134|NCT02912663|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5770135|NCT02912663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5770136|NCT02912663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5770137|NCT02912663|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5770138|NCT02912663|Tocolytic Agents|tocolytic agents|mesh-ancestor
5770139|NCT02912663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5770140|NCT02912663|Vasodilator Agents|vasodilator agents|mesh-ancestor
5770141|NCT02912637|Xenon|xenon|mesh-list
5770142|NCT02912637|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5770143|NCT02912637|Anesthetics, General|anesthetics, general|mesh-ancestor
5770144|NCT02912637|Anesthetics|anesthetics|mesh-ancestor
5770145|NCT02912637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5770146|NCT02912637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770147|NCT02912715|Paclitaxel|paclitaxel|mesh-list
5770148|NCT02912715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5770149|NCT02912715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5770150|NCT02912715|Tubulin Modulators|tubulin modulators|mesh-ancestor
5770151|NCT02912715|Antimitotic Agents|antimitotic agents|mesh-ancestor
5770152|NCT02912715|Mitosis Modulators|mitosis modulators|mesh-ancestor
5770153|NCT02912715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5770154|NCT02912910|Labetalol|labetalol|mesh-list
5770155|NCT02912910|Nifedipine|nifedipine|mesh-list
5770156|NCT02912910|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5770157|NCT02912910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5770158|NCT02912910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5770159|NCT02912910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5770160|NCT02912910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770161|NCT02912910|Vasodilator Agents|vasodilator agents|mesh-ancestor
5770162|NCT02912910|Tocolytic Agents|tocolytic agents|mesh-ancestor
5770163|NCT02912910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5770164|NCT02912910|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5770165|NCT02912910|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5770166|NCT02912910|Adrenergic Agents|adrenergic agents|mesh-ancestor
5770167|NCT02912910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5770168|NCT02912910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5770169|NCT02912910|Sympathomimetics|sympathomimetics|mesh-ancestor
5770170|NCT02912910|Autonomic Agents|autonomic agents|mesh-ancestor
5770171|NCT02912910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5770172|NCT02912910|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5770173|NCT02912910|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5770174|NCT02912702|Dexamethasone|dexamethasone|mesh-list
5770175|NCT02912702|Methylprednisolone|methylprednisolone|mesh-list
5770176|NCT02912702|Doxorubicin|doxorubicin|mesh-list
5770177|NCT02912702|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5770178|NCT02912702|Etoposide|etoposide|mesh-list
5770179|NCT02912702|Etoposide phosphate|etoposide phosphate|mesh-list
5770180|NCT02912702|Pegaspargase|pegaspargase|mesh-list
5770181|NCT02912702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5770182|NCT02912702|Antiemetics|antiemetics|mesh-ancestor
5770183|NCT02912702|Autonomic Agents|autonomic agents|mesh-ancestor
5770184|NCT02912702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5770185|NCT02912702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770186|NCT02912702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5770187|NCT02912702|Glucocorticoids|glucocorticoids|mesh-ancestor
5770188|NCT02912702|Hormones|hormones|mesh-ancestor
5770189|NCT02912702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5770190|NCT02912702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5770191|NCT02912702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5770192|NCT02912702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5770193|NCT02912702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5770194|NCT02912702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5770195|NCT02912702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5770196|NCT02912702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5770197|NCT02912702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5770198|NCT02912702|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5770199|NCT02912702|Protective Agents|protective agents|mesh-ancestor
5770200|NCT02912572|Avelumab|avelumab|mesh-list
5770201|NCT02912572|Axitinib|axitinib|mesh-list
5770202|NCT02912572|Talazoparib|talazoparib|mesh-list
5770203|NCT02912572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5770204|NCT02912572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5770205|NCT02912572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5770206|NCT02912572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5770207|NCT02912572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5770208|NCT02912572|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5770209|NCT02912676|Methotrexate|methotrexate|mesh-list
5770210|NCT02912676|Mercaptopurine|mercaptopurine|mesh-list
5770211|NCT02912676|Thioguanine|thioguanine|mesh-list
5770212|NCT02912676|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5770213|NCT02912676|Abortifacient Agents|abortifacient agents|mesh-ancestor
5770214|NCT02912676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5770215|NCT02912676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770216|NCT02912676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5770217|NCT02912676|Antimetabolites|antimetabolites|mesh-ancestor
5770218|NCT02912676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5770219|NCT02912676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5770220|NCT02912676|Dermatologic Agents|dermatologic agents|mesh-ancestor
5770221|NCT02912676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5770222|NCT02912676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5770223|NCT02912676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5770224|NCT02912676|Immunologic Factors|immunologic factors|mesh-ancestor
5770225|NCT02912676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5770226|NCT02912676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5770227|NCT02912494|Darbepoetin alfa|darbepoetin alfa|mesh-list
5770228|NCT02912494|Hematinics|hematinics|mesh-ancestor
5770229|NCT02912156|Voriconazole|voriconazole|mesh-list
5770230|NCT02912156|Antifungal Agents|antifungal agents|mesh-ancestor
5770231|NCT02912156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5770232|NCT02912156|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5770233|NCT02912156|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5770234|NCT02912156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5770235|NCT02912156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5770236|NCT02912156|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5770237|NCT02912156|Hormone Antagonists|hormone antagonists|mesh-ancestor
5770238|NCT02912156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5770239|NCT02912156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770240|NCT02912156|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5770241|NCT02912169|Anesthetics|anesthetics|mesh-list
5770242|NCT02912169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5770243|NCT02912169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770244|NCT02912520|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5770245|NCT02912520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5770246|NCT02912182|Prednisolone|prednisolone|mesh-list
5770247|NCT02912182|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5770248|NCT02912182|Methylprednisolone|methylprednisolone|mesh-list
5770249|NCT02912182|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5770250|NCT02912182|Prednisolone acetate|prednisolone acetate|mesh-list
5770251|NCT02912182|Betamethasone|betamethasone|mesh-list
5770252|NCT02912182|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5770253|NCT02912182|Prednisolone phosphate|prednisolone phosphate|mesh-list
5770254|NCT02912182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5770255|NCT02912182|Glucocorticoids|glucocorticoids|mesh-ancestor
5770256|NCT02912182|Hormones|hormones|mesh-ancestor
5770257|NCT02912182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5770258|NCT02912182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770259|NCT02912182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5770260|NCT02912182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5770261|NCT02912182|Antiemetics|antiemetics|mesh-ancestor
5770262|NCT02912182|Autonomic Agents|autonomic agents|mesh-ancestor
5770263|NCT02912182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5770264|NCT02912182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5770265|NCT02912182|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5770266|NCT02912182|Protective Agents|protective agents|mesh-ancestor
5770267|NCT02912182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5770268|NCT02912182|Respiratory System Agents|respiratory system agents|mesh-ancestor
5770269|NCT02912247|Adalimumab|adalimumab|mesh-list
5770270|NCT02912247|Antibodies|antibodies|mesh-list
5770271|NCT02912247|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5770272|NCT02912247|Immunologic Factors|immunologic factors|mesh-ancestor
5770273|NCT02912247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770274|NCT02912247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5770275|NCT02912247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5770276|NCT02912234|Clarithromycin|clarithromycin|mesh-list
5770277|NCT02912234|Apixaban|apixaban|mesh-list
5770278|NCT02912234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5770279|NCT02912234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5770280|NCT02912234|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5770281|NCT02912234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5770282|NCT02912234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5770283|NCT02912234|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5770284|NCT02912234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5770285|NCT02912234|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5770286|NCT02912234|Antithrombins|antithrombins|mesh-ancestor
5770287|NCT02912234|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5770288|NCT02912234|Protease Inhibitors|protease inhibitors|mesh-ancestor
5770289|NCT02912234|Anticoagulants|anticoagulants|mesh-ancestor
5770290|NCT02912026|Olorofim|olorofim|mesh-list
5770291|NCT02912026|Antifungal Agents|antifungal agents|mesh-ancestor
5770292|NCT02912026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5770293|NCT02911961|Acetaminophen|acetaminophen|mesh-list
5770294|NCT02911961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5770295|NCT02911961|Analgesics|analgesics|mesh-ancestor
5770296|NCT02911961|Sensory System Agents|sensory system agents|mesh-ancestor
5770297|NCT02911961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5770298|NCT02911961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770299|NCT02911961|Antipyretics|antipyretics|mesh-ancestor
5770300|NCT02911870|Moxifloxacin|moxifloxacin|mesh-list
5770301|NCT02911870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5770302|NCT02911870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5770303|NCT02911870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5770304|NCT02911870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5770305|NCT02911870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5770306|NCT02911870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5770307|NCT02911870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5770308|NCT02911766|Chlorhexidine|chlorhexidine|mesh-list
5770309|NCT02911766|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5770310|NCT02911766|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5770311|NCT02911766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5770312|NCT02911766|Disinfectants|disinfectants|mesh-ancestor
5770313|NCT02911766|Dermatologic Agents|dermatologic agents|mesh-ancestor
5770314|NCT02911831|Tranexamic Acid|tranexamic acid|mesh-list
5770315|NCT02911831|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5770316|NCT02911831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5770317|NCT02911831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5770318|NCT02911831|Hemostatics|hemostatics|mesh-ancestor
5770319|NCT02911831|Coagulants|coagulants|mesh-ancestor
6490512|NCT00598624|Alkylating Agents|alkylating agents|mesh-ancestor
6490513|NCT00598624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490514|NCT00598624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6490515|NCT00598637|Everolimus|everolimus|mesh-list
6490516|NCT00598637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6490517|NCT00598637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6490518|NCT00598637|Immunologic Factors|immunologic factors|mesh-ancestor
5770320|NCT02911792|Metformin|metformin|mesh-list
5770321|NCT02911792|Dapagliflozin|dapagliflozin|mesh-list
5770322|NCT02911792|Glipizide|glipizide|mesh-list
5770323|NCT02911792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5770324|NCT02911792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770325|NCT02911792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5770326|NCT02911792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5770327|NCT02911662|Cephalexin|cephalexin|mesh-list
5770328|NCT02911662|Nitrofurantoin|nitrofurantoin|mesh-list
5770329|NCT02911662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5770330|NCT02911662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5770331|NCT02911662|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5770332|NCT02911662|Renal Agents|renal agents|mesh-ancestor
5896438|NCT03863288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770333|NCT02911701|Acetaminophen|acetaminophen|mesh-list
5770334|NCT02911701|Ibuprofen|ibuprofen|mesh-list
5770335|NCT02911701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5770336|NCT02911701|Analgesics|analgesics|mesh-ancestor
5770337|NCT02911701|Sensory System Agents|sensory system agents|mesh-ancestor
5770338|NCT02911701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5770339|NCT02911701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770340|NCT02911701|Antipyretics|antipyretics|mesh-ancestor
5770341|NCT02911701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6490519|NCT00598637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490520|NCT00598676|Sirolimus|sirolimus|mesh-list
6490521|NCT00598676|Everolimus|everolimus|mesh-list
6490522|NCT00598676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6490523|NCT00598676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6490524|NCT00598676|Immunologic Factors|immunologic factors|mesh-ancestor
6490525|NCT00598676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490526|NCT00598676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6490527|NCT00598676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6490528|NCT00598676|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6490529|NCT00598676|Antifungal Agents|antifungal agents|mesh-ancestor
6490530|NCT00598715|Sirolimus|sirolimus|mesh-list
6490531|NCT00598715|Paclitaxel|paclitaxel|mesh-list
6490532|NCT00598715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6490533|NCT00598715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5770342|NCT02911701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5770343|NCT02911701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5770344|NCT02911701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5770345|NCT02911701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5770346|NCT02911701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5770347|NCT02911597|Naltrexone|naltrexone|mesh-list
5770348|NCT02911597|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5770349|NCT02911597|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5770350|NCT02911597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770351|NCT02911597|Sensory System Agents|sensory system agents|mesh-ancestor
5770352|NCT02911597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5770353|NCT02911298|Metronidazole|metronidazole|mesh-list
5770354|NCT02911298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5770355|NCT02911298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5770356|NCT02911298|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5770357|NCT02911298|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5770358|NCT02911350|Paclitaxel|paclitaxel|mesh-list
5770359|NCT02911350|Hormones|hormones|mesh-list
5770360|NCT02911350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5770361|NCT02911350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5770362|NCT02911350|Tubulin Modulators|tubulin modulators|mesh-ancestor
5770363|NCT02911350|Antimitotic Agents|antimitotic agents|mesh-ancestor
5770364|NCT02911350|Mitosis Modulators|mitosis modulators|mesh-ancestor
5770365|NCT02911350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5770366|NCT02911350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5770367|NCT02911350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770368|NCT02911480|Oxytocin|oxytocin|mesh-list
5770369|NCT02911480|Oxytocics|oxytocics|mesh-ancestor
5770370|NCT02911480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5770371|NCT02911480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770372|NCT02911272|Oxytocin|oxytocin|mesh-list
5770373|NCT02911272|Oxytocics|oxytocics|mesh-ancestor
5770374|NCT02911272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5770375|NCT02911272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770376|NCT02910778|Ticagrelor|ticagrelor|mesh-list
5770377|NCT02910778|Atorvastatin|atorvastatin|mesh-list
5770378|NCT02910778|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5770379|NCT02910778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5770380|NCT02910778|Antimetabolites|antimetabolites|mesh-ancestor
5770381|NCT02910778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5770382|NCT02910778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5770383|NCT02910778|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5770384|NCT02910778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5770385|NCT02910778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5770386|NCT02910778|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5770387|NCT02910778|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5770388|NCT02910778|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5770389|NCT02910778|Purinergic Agents|purinergic agents|mesh-ancestor
5770390|NCT02910778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5770391|NCT02910778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490534|NCT00598715|Tubulin Modulators|tubulin modulators|mesh-ancestor
5770392|NCT02910882|Gemcitabine|gemcitabine|mesh-list
5770393|NCT02910882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5770394|NCT02910882|Antimetabolites|antimetabolites|mesh-ancestor
5770395|NCT02910882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5770396|NCT02910882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5770397|NCT02910882|Antiviral Agents|antiviral agents|mesh-ancestor
5770398|NCT02910882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5770399|NCT02910882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5770400|NCT02910882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5770401|NCT02910882|Immunologic Factors|immunologic factors|mesh-ancestor
5770402|NCT02910882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770403|NCT02910817|Metformin|metformin|mesh-list
5770404|NCT02910817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5770405|NCT02910817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770406|NCT02910765|Methylene Blue|methylene blue|mesh-list
5770407|NCT02910765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5770408|NCT02910765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5770409|NCT02910518|Insulin|insulin|mesh-list
5770410|NCT02910518|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5770411|NCT02910518|Insulin Aspart|insulin aspart|mesh-list
5770412|NCT02910518|Insulin glulisine|insulin glulisine|mesh-list
5770413|NCT02910518|Insulin, Isophane|insulin, isophane|mesh-list
5770414|NCT02910518|Isophane Insulin, Human|isophane insulin, human|mesh-list
5770415|NCT02910518|Isophane insulin, beef|isophane insulin, beef|mesh-list
5770416|NCT02910518|Heparin|heparin|mesh-list
5770417|NCT02910518|Calcium heparin|calcium heparin|mesh-list
5770418|NCT02910518|Glucagon|glucagon|mesh-list
5770419|NCT02910518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5770420|NCT02910518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770421|NCT02910518|Anticoagulants|anticoagulants|mesh-ancestor
5770422|NCT02910518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5770423|NCT02910518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5770424|NCT02910518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5770425|NCT02910518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5770426|NCT02910518|Hormones|hormones|mesh-ancestor
5770427|NCT02910518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5770428|NCT02910414|Ethanol|ethanol|mesh-list
5770429|NCT02910414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5770430|NCT02910414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5770431|NCT02910414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5770432|NCT02910414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770433|NCT02910596|Bethanechol|bethanechol|mesh-list
5770434|NCT02910596|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5770435|NCT02910596|Autonomic Agents|autonomic agents|mesh-ancestor
5770436|NCT02910596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5770437|NCT02910596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770438|NCT02910596|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
5770439|NCT02910596|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5770440|NCT02910596|Cholinergic Agents|cholinergic agents|mesh-ancestor
5770441|NCT02910596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5770442|NCT02910596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5770443|NCT02910570|Liraglutide|liraglutide|mesh-list
5770444|NCT02910570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5770445|NCT02910570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770446|NCT02910570|Incretins|incretins|mesh-ancestor
5770447|NCT02910570|Hormones|hormones|mesh-ancestor
5770448|NCT02910570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5770449|NCT02910531|Thioctic Acid|thioctic acid|mesh-list
5770450|NCT02910531|Antioxidants|antioxidants|mesh-ancestor
5770451|NCT02910531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5770452|NCT02910531|Protective Agents|protective agents|mesh-ancestor
5770453|NCT02910531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770454|NCT02910531|Vitamin B Complex|vitamin b complex|mesh-ancestor
5770455|NCT02910531|Vitamins|vitamins|mesh-ancestor
5770456|NCT02910531|Micronutrients|micronutrients|mesh-ancestor
5770457|NCT02910076|Hydroxychloroquine|hydroxychloroquine|mesh-list
5770458|NCT02910076|Antimalarials|antimalarials|mesh-ancestor
5770459|NCT02910076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5770460|NCT02910076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5770461|NCT02910076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5770462|NCT02910076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5770463|NCT02910076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5770464|NCT02910076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5770465|NCT02910141|Insulin|insulin|mesh-list
5770466|NCT02910141|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5770467|NCT02910141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5770468|NCT02910141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770469|NCT02910115|Oxytocin|oxytocin|mesh-list
5770470|NCT02910115|Oxytocics|oxytocics|mesh-ancestor
5770471|NCT02910115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5770472|NCT02910115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770473|NCT02910206|Sufentanil|sufentanil|mesh-list
5770474|NCT02910206|Propofol|propofol|mesh-list
5770475|NCT02910206|Etomidate|etomidate|mesh-list
5770476|NCT02910206|Cisatracurium|cisatracurium|mesh-list
5770477|NCT02910206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5770478|NCT02910206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5770479|NCT02910206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770480|NCT02910206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5770481|NCT02910206|Anesthetics, General|anesthetics, general|mesh-ancestor
5770482|NCT02910206|Anesthetics|anesthetics|mesh-ancestor
5770483|NCT02910206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5770484|NCT02910206|Narcotics|narcotics|mesh-ancestor
5770485|NCT02910206|Analgesics|analgesics|mesh-ancestor
5770486|NCT02910206|Sensory System Agents|sensory system agents|mesh-ancestor
5770487|NCT02910206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5770488|NCT02910206|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5770489|NCT02910206|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5770490|NCT02910206|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6490535|NCT00598715|Antimitotic Agents|antimitotic agents|mesh-ancestor
6490536|NCT00598715|Mitosis Modulators|mitosis modulators|mesh-ancestor
5770491|NCT02909972|Cytarabine|cytarabine|mesh-list
5770492|NCT02909972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5770493|NCT02909972|Antimetabolites|antimetabolites|mesh-ancestor
5770494|NCT02909972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5770495|NCT02909972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5770496|NCT02909972|Antiviral Agents|antiviral agents|mesh-ancestor
5770497|NCT02909972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5770498|NCT02909972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5770499|NCT02909972|Immunologic Factors|immunologic factors|mesh-ancestor
5770500|NCT02909972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770501|NCT02910050|Letrozole|letrozole|mesh-list
5770502|NCT02910050|Anastrozole|anastrozole|mesh-list
5770503|NCT02910050|Exemestane|exemestane|mesh-list
5770504|NCT02910050|Bicalutamide|bicalutamide|mesh-list
5770505|NCT02910050|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5770506|NCT02910050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5770507|NCT02910050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5770508|NCT02910050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5770509|NCT02910050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5770510|NCT02910050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5770511|NCT02910050|Hormone Antagonists|hormone antagonists|mesh-ancestor
5770512|NCT02910050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5770513|NCT02910050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770514|NCT02910050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5770515|NCT02910050|Androgen Antagonists|androgen antagonists|mesh-ancestor
5770516|NCT02909933|Metformin|metformin|mesh-list
5770517|NCT02909933|Liraglutide|liraglutide|mesh-list
5770518|NCT02909933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5770519|NCT02909933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770520|NCT02909933|Incretins|incretins|mesh-ancestor
5770521|NCT02909933|Hormones|hormones|mesh-ancestor
5770522|NCT02909933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5770523|NCT02910245|Prednisone|prednisone|mesh-list
5770524|NCT02910245|Mesalamine|mesalamine|mesh-list
5770525|NCT02910245|Mercaptopurine|mercaptopurine|mesh-list
5770526|NCT02910245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5770527|NCT02910245|Glucocorticoids|glucocorticoids|mesh-ancestor
5770528|NCT02910245|Hormones|hormones|mesh-ancestor
5770529|NCT02910245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5770530|NCT02910245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770531|NCT02910245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5770532|NCT02910245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5770533|NCT02910245|Antimetabolites|antimetabolites|mesh-ancestor
5770534|NCT02910245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5770535|NCT02910245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5770536|NCT02910245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5770537|NCT02910245|Immunologic Factors|immunologic factors|mesh-ancestor
5770538|NCT02910245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5770539|NCT02910245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5770540|NCT02910245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5770541|NCT02910245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5770542|NCT02910245|Analgesics|analgesics|mesh-ancestor
5770543|NCT02910245|Sensory System Agents|sensory system agents|mesh-ancestor
6673504|NCT01563289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5770544|NCT02910245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5770545|NCT02910245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5896439|NCT03861091|Risedronic Acid|risedronic acid|mesh-list
5896440|NCT03861091|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5896441|NCT03861091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5896442|NCT03861091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896443|NCT03861091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5896444|NCT03861091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896445|NCT03861091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6210177|NCT02157376|Cimetidine|cimetidine|mesh-list
6210178|NCT02157376|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6210179|NCT02157376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6210180|NCT02157376|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6210181|NCT02157376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6210182|NCT02157376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210183|NCT02157376|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6210184|NCT02157376|Histamine Antagonists|histamine antagonists|mesh-ancestor
5896446|NCT03829514|Fenofibrate|fenofibrate|mesh-list
5896447|NCT03829514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5896448|NCT03829514|Antimetabolites|antimetabolites|mesh-ancestor
5896449|NCT03829514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896450|NCT03829514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5896451|NCT03808090|Calcium|calcium|mesh-list
5896452|NCT03808090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5896453|NCT03808090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896454|NCT03803761|Fulvestrant|fulvestrant|mesh-list
5896455|NCT03803761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5896456|NCT03803761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5896457|NCT03803761|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5896458|NCT03803761|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5896459|NCT03803761|Hormone Antagonists|hormone antagonists|mesh-ancestor
5896460|NCT03803761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5896461|NCT03803761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896462|NCT03801200|Apatinib|apatinib|mesh-list
5896463|NCT03801200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5896464|NCT03801200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5896465|NCT03801200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5896466|NCT03801200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896467|NCT03801122|Tranexamic Acid|tranexamic acid|mesh-list
5896468|NCT03801122|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5896469|NCT03801122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5896470|NCT03801122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896471|NCT03801122|Hemostatics|hemostatics|mesh-ancestor
5896472|NCT03801122|Coagulants|coagulants|mesh-ancestor
6210185|NCT02157376|Histamine Agents|histamine agents|mesh-ancestor
6210186|NCT02157376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6210187|NCT02157376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210188|NCT02157376|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6210189|NCT02157376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5896473|NCT03794583|Treprostinil|treprostinil|mesh-list
5896474|NCT03794583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5896475|NCT03788291|Rituximab|rituximab|mesh-list
5896476|NCT03788291|Acalabrutinib|acalabrutinib|mesh-list
5896477|NCT03788291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5896478|NCT03788291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5896479|NCT03788291|Immunologic Factors|immunologic factors|mesh-ancestor
5896480|NCT03788291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896481|NCT03788291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5896482|NCT03785405|Valsartan|valsartan|mesh-list
5896483|NCT03785405|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5896484|NCT03785405|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5896485|NCT03785405|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5896486|NCT03785405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896487|NCT03771157|Vaccines|vaccines|mesh-list
5896488|NCT03771157|Immunologic Factors|immunologic factors|mesh-ancestor
6210190|NCT02157623|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6210191|NCT02157623|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6210192|NCT02157623|Dermatologic Agents|dermatologic agents|mesh-ancestor
6210193|NCT02157935|Formoterol Fumarate|formoterol fumarate|mesh-list
6210194|NCT02157935|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6210195|NCT02157935|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6210196|NCT02157935|Autonomic Agents|autonomic agents|mesh-ancestor
6210197|NCT02157935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6210198|NCT02157935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210199|NCT02157935|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6210200|NCT02157935|Respiratory System Agents|respiratory system agents|mesh-ancestor
6210201|NCT02157935|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6210202|NCT02157935|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6210203|NCT02157935|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6210204|NCT02157935|Adrenergic Agents|adrenergic agents|mesh-ancestor
6210205|NCT02157935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5770546|NCT02909751|Tocotrienols|tocotrienols|mesh-list
5770547|NCT02909751|Vitamin E|vitamin e|mesh-list
5770548|NCT02909751|Tocopherols|tocopherols|mesh-list
5770549|NCT02909751|Docetaxel|docetaxel|mesh-list
5770550|NCT02909751|Cyclophosphamide|cyclophosphamide|mesh-list
5770551|NCT02909751|Trastuzumab|trastuzumab|mesh-list
5770552|NCT02909751|Epirubicin|epirubicin|mesh-list
5770553|NCT02909751|Pertuzumab|pertuzumab|mesh-list
5770554|NCT02909751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5770555|NCT02909751|Tubulin Modulators|tubulin modulators|mesh-ancestor
5770556|NCT02909751|Antimitotic Agents|antimitotic agents|mesh-ancestor
5770557|NCT02909751|Mitosis Modulators|mitosis modulators|mesh-ancestor
5770558|NCT02909751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5770559|NCT02909751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5770560|NCT02909751|Immunologic Factors|immunologic factors|mesh-ancestor
5770561|NCT02909751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770562|NCT02909751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5770563|NCT02909751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5770564|NCT02909751|Alkylating Agents|alkylating agents|mesh-ancestor
5770565|NCT02909751|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5770566|NCT02909751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5770567|NCT02909751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5770568|NCT02909751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5770569|NCT02909751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5770570|NCT02909751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5770571|NCT02909751|Antioxidants|antioxidants|mesh-ancestor
5770572|NCT02909751|Protective Agents|protective agents|mesh-ancestor
5770573|NCT02909751|Vitamins|vitamins|mesh-ancestor
5770574|NCT02909751|Micronutrients|micronutrients|mesh-ancestor
5770575|NCT02909712|Pyrimethamine|pyrimethamine|mesh-list
5770576|NCT02909712|Piperaquine|piperaquine|mesh-list
5770577|NCT02909712|Sulfadoxine|sulfadoxine|mesh-list
5770578|NCT02909712|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
5770579|NCT02909712|Artenimol|artenimol|mesh-list
5770580|NCT02909712|Antimalarials|antimalarials|mesh-ancestor
5770581|NCT02909712|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5770582|NCT02909712|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5770583|NCT02909712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5770584|NCT02909712|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5770585|NCT02909712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5770586|NCT02909712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5770587|NCT02909712|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5770588|NCT02909712|Renal Agents|renal agents|mesh-ancestor
5770589|NCT02909465|Midazolam|midazolam|mesh-list
5770590|NCT02909465|Ketamine|ketamine|mesh-list
5770591|NCT02909465|Haloperidol|haloperidol|mesh-list
5770592|NCT02909465|Haloperidol decanoate|haloperidol decanoate|mesh-list
5770593|NCT02909465|Analgesics|analgesics|mesh-ancestor
5770594|NCT02909465|Sensory System Agents|sensory system agents|mesh-ancestor
5770595|NCT02909465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5770596|NCT02909465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770597|NCT02909465|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5770598|NCT02909465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5770599|NCT02909465|Anesthetics, General|anesthetics, general|mesh-ancestor
5770600|NCT02909465|Anesthetics|anesthetics|mesh-ancestor
5770601|NCT02909465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5770602|NCT02909465|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5770603|NCT02909465|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5770604|NCT02909465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5770605|NCT02909465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5770606|NCT02909465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5770607|NCT02909465|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5770608|NCT02909465|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5770609|NCT02909465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5770610|NCT02909465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5770611|NCT02909465|GABA Modulators|gaba modulators|mesh-ancestor
5770612|NCT02909465|GABA Agents|gaba agents|mesh-ancestor
5770613|NCT02909465|Antiemetics|antiemetics|mesh-ancestor
5770614|NCT02909465|Autonomic Agents|autonomic agents|mesh-ancestor
5770615|NCT02909465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5770616|NCT02909465|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5770617|NCT02909465|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5770618|NCT02909465|Dopamine Agents|dopamine agents|mesh-ancestor
5770619|NCT02909465|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5770620|NCT02909322|Hydromorphone|hydromorphone|mesh-list
5770621|NCT02909322|Bupivacaine|bupivacaine|mesh-list
5770622|NCT02909322|Ropivacaine|ropivacaine|mesh-list
5770623|NCT02909322|Anesthetics, Local|anesthetics, local|mesh-ancestor
5770624|NCT02909322|Anesthetics|anesthetics|mesh-ancestor
5770625|NCT02909322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5770626|NCT02909322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770627|NCT02909322|Sensory System Agents|sensory system agents|mesh-ancestor
5770628|NCT02909322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5770629|NCT02909322|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5770630|NCT02909322|Narcotics|narcotics|mesh-ancestor
5770631|NCT02909322|Analgesics|analgesics|mesh-ancestor
5770632|NCT02909413|Sevoflurane|sevoflurane|mesh-list
5770633|NCT02909413|Desflurane|desflurane|mesh-list
5770634|NCT02909413|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5770635|NCT02909413|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5770636|NCT02909413|Anesthetics, General|anesthetics, general|mesh-ancestor
5770637|NCT02909413|Anesthetics|anesthetics|mesh-ancestor
5770638|NCT02909413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5770639|NCT02909413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770640|NCT02909400|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
5770641|NCT02909400|Antioxidants|antioxidants|mesh-ancestor
5770642|NCT02909400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5770643|NCT02909400|Protective Agents|protective agents|mesh-ancestor
5770644|NCT02909400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770645|NCT02909257|Bupivacaine|bupivacaine|mesh-list
5770646|NCT02909257|Anesthetics, Local|anesthetics, local|mesh-ancestor
5770647|NCT02909257|Anesthetics|anesthetics|mesh-ancestor
5770648|NCT02909257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5770649|NCT02909257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770650|NCT02909257|Sensory System Agents|sensory system agents|mesh-ancestor
5770651|NCT02909257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5770652|NCT02909478|Dexamethasone|dexamethasone|mesh-list
5770653|NCT02909478|Aprepitant|aprepitant|mesh-list
5770654|NCT02909478|Tropisetron|tropisetron|mesh-list
5770655|NCT02909478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5770656|NCT02909478|Antiemetics|antiemetics|mesh-ancestor
5770657|NCT02909478|Autonomic Agents|autonomic agents|mesh-ancestor
5770658|NCT02909478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5770659|NCT02909478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770660|NCT02909478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5770661|NCT02909478|Glucocorticoids|glucocorticoids|mesh-ancestor
5770662|NCT02909478|Hormones|hormones|mesh-ancestor
5770663|NCT02909478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5770664|NCT02909478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5770665|NCT02909478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5770666|NCT02909478|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5770667|NCT02909478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5770668|NCT02909478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5770669|NCT02909478|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5770670|NCT02909478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5770671|NCT02909478|Serotonin Agents|serotonin agents|mesh-ancestor
5770672|NCT02909335|Mycophenolic Acid|mycophenolic acid|mesh-list
5770673|NCT02909335|Prednisone|prednisone|mesh-list
5770674|NCT02909335|Methylprednisolone|methylprednisolone|mesh-list
5770675|NCT02909335|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5770676|NCT02909335|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5770677|NCT02909335|Prednisolone|prednisolone|mesh-list
5770678|NCT02909335|Prednisolone acetate|prednisolone acetate|mesh-list
5770679|NCT02909335|Everolimus|everolimus|mesh-list
5770680|NCT02909335|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5770681|NCT02909335|Prednisolone phosphate|prednisolone phosphate|mesh-list
5770682|NCT02909335|Tacrolimus|tacrolimus|mesh-list
5770683|NCT02909335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5770684|NCT02909335|Glucocorticoids|glucocorticoids|mesh-ancestor
5770685|NCT02909335|Hormones|hormones|mesh-ancestor
5770686|NCT02909335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5770687|NCT02909335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770688|NCT02909335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5770689|NCT02909335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5770690|NCT02909335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5770691|NCT02909335|Immunologic Factors|immunologic factors|mesh-ancestor
5770692|NCT02909335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5770693|NCT02909335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5770694|NCT02909335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5770695|NCT02909335|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5770696|NCT02909335|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5770697|NCT02909335|Antitubercular Agents|antitubercular agents|mesh-ancestor
5770698|NCT02909335|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5770699|NCT02909335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5770700|NCT02909335|Antiemetics|antiemetics|mesh-ancestor
5770701|NCT02909335|Autonomic Agents|autonomic agents|mesh-ancestor
5770702|NCT02909335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5770703|NCT02909335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5770704|NCT02909335|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5770705|NCT02909335|Protective Agents|protective agents|mesh-ancestor
5770706|NCT02909348|Pembrolizumab|pembrolizumab|mesh-list
5770707|NCT02909348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5770708|NCT02909348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5770709|NCT02909361|Fulvestrant|fulvestrant|mesh-list
5770710|NCT02909361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5770711|NCT02909361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5770712|NCT02909361|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5770713|NCT02909361|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5770714|NCT02909361|Hormone Antagonists|hormone antagonists|mesh-ancestor
5770715|NCT02909361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5770716|NCT02909361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770717|NCT02908945|Ketamine|ketamine|mesh-list
5770718|NCT02908945|Analgesics|analgesics|mesh-ancestor
5770719|NCT02908945|Sensory System Agents|sensory system agents|mesh-ancestor
5770720|NCT02908945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5770721|NCT02908945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770722|NCT02908945|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5770723|NCT02908945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5770724|NCT02908945|Anesthetics, General|anesthetics, general|mesh-ancestor
5770725|NCT02908945|Anesthetics|anesthetics|mesh-ancestor
5770726|NCT02908945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5770727|NCT02908945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5770728|NCT02908945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5770729|NCT02908945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5770730|NCT02908945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5770731|NCT02909088|Ecopipam|ecopipam|mesh-list
5770732|NCT02909088|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5770733|NCT02909088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5770734|NCT02909088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5770735|NCT02909088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770736|NCT02909088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5770737|NCT02909088|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5770738|NCT02909088|Dopamine Agents|dopamine agents|mesh-ancestor
5770739|NCT02909088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5770740|NCT02909088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5770741|NCT02909049|Midazolam|midazolam|mesh-list
5770742|NCT02909049|Ketamine|ketamine|mesh-list
5770743|NCT02909049|Mepivacaine|mepivacaine|mesh-list
5770744|NCT02909049|Analgesics|analgesics|mesh-ancestor
5770745|NCT02909049|Sensory System Agents|sensory system agents|mesh-ancestor
5770746|NCT02909049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5770747|NCT02909049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770748|NCT02909049|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5770749|NCT02909049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5770750|NCT02909049|Anesthetics, General|anesthetics, general|mesh-ancestor
5770751|NCT02909049|Anesthetics|anesthetics|mesh-ancestor
5770752|NCT02909049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5770753|NCT02909049|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5770754|NCT02909049|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5770755|NCT02909049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5770756|NCT02909049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5770757|NCT02909049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5770758|NCT02909049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5770759|NCT02909049|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5770760|NCT02909049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5770761|NCT02909049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5770762|NCT02909049|GABA Modulators|gaba modulators|mesh-ancestor
5770763|NCT02909049|GABA Agents|gaba agents|mesh-ancestor
5770764|NCT02909049|Anesthetics, Local|anesthetics, local|mesh-ancestor
5770765|NCT02908581|Folic Acid|folic acid|mesh-list
5770766|NCT02908581|Vitamin B Complex|vitamin b complex|mesh-list
5770767|NCT02908581|Hematinics|hematinics|mesh-ancestor
6490537|NCT00598715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490538|NCT00598715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5770768|NCT02908581|Vitamins|vitamins|mesh-ancestor
5770769|NCT02908581|Micronutrients|micronutrients|mesh-ancestor
5770770|NCT02908581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770771|NCT02908789|Anti-Infective Agents|anti-infective agents|mesh-list
5770772|NCT02908789|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5770773|NCT02908711|Ropivacaine|ropivacaine|mesh-list
5770774|NCT02908711|Anesthetics, Local|anesthetics, local|mesh-ancestor
5770775|NCT02908711|Anesthetics|anesthetics|mesh-ancestor
5770776|NCT02908711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5770777|NCT02908711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770778|NCT02908711|Sensory System Agents|sensory system agents|mesh-ancestor
5770779|NCT02908711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5770780|NCT02908763|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5770781|NCT02908763|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
5770782|NCT02908763|Antiviral Agents|antiviral agents|mesh-ancestor
5770783|NCT02908763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5770784|NCT02908698|Prednisone|prednisone|mesh-list
5770785|NCT02908698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5770786|NCT02908698|Glucocorticoids|glucocorticoids|mesh-ancestor
5770787|NCT02908698|Hormones|hormones|mesh-ancestor
5770788|NCT02908698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5770789|NCT02908698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770790|NCT02908698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5770791|NCT02908698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5770792|NCT02908438|Hormones|hormones|mesh-list
5770793|NCT02908438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5770794|NCT02908438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770795|NCT02908412|Bupivacaine|bupivacaine|mesh-list
5770796|NCT02908412|Anesthetics, Local|anesthetics, local|mesh-ancestor
5770797|NCT02908412|Anesthetics|anesthetics|mesh-ancestor
5770798|NCT02908412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5770799|NCT02908412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770800|NCT02908412|Sensory System Agents|sensory system agents|mesh-ancestor
5770801|NCT02908412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5770802|NCT02908191|Tenofovir|tenofovir|mesh-list
5770803|NCT02908191|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5770804|NCT02908191|Entecavir|entecavir|mesh-list
5770805|NCT02908191|Antiviral Agents|antiviral agents|mesh-ancestor
5770806|NCT02908191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5770807|NCT02908191|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5770808|NCT02908191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5770809|NCT02908191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5770810|NCT02908191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5770811|NCT02908191|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5770812|NCT02908191|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5896489|NCT03771157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896490|NCT03752918|Niacin|niacin|mesh-list
5896491|NCT03752918|Nicotinic Acids|nicotinic acids|mesh-list
5896492|NCT03752918|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
5896493|NCT03752918|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5896494|NCT03752918|Antimetabolites|antimetabolites|mesh-ancestor
5896495|NCT03752918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896496|NCT03752918|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5896497|NCT03752918|Vasodilator Agents|vasodilator agents|mesh-ancestor
5896498|NCT03752918|Vitamin B Complex|vitamin b complex|mesh-ancestor
5896499|NCT03752918|Vitamins|vitamins|mesh-ancestor
5896500|NCT03752918|Micronutrients|micronutrients|mesh-ancestor
5896501|NCT03752918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896502|NCT03752918|Hallucinogens|hallucinogens|mesh-ancestor
5896503|NCT03752918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5896504|NCT03752918|Serotonin Agents|serotonin agents|mesh-ancestor
5896505|NCT03752918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5896506|NCT03752918|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5896507|NCT03752918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5896508|NCT03752918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5896509|NCT03752918|Adrenergic Agents|adrenergic agents|mesh-ancestor
5907956|NCT05047250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5907957|NCT05047250|Immunologic Factors|immunologic factors|mesh-ancestor
5907958|NCT05047250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907959|NCT05047250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5907960|NCT05047250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5770813|NCT02908295|Misoprostol|misoprostol|mesh-list
5770814|NCT02908295|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5770815|NCT02908295|Abortifacient Agents|abortifacient agents|mesh-ancestor
5770816|NCT02908295|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5770817|NCT02908295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770818|NCT02908295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5770819|NCT02908295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5770820|NCT02908295|Oxytocics|oxytocics|mesh-ancestor
5770821|NCT02908334|Sertraline|sertraline|mesh-list
5770822|NCT02908334|Antidepressive Agents|antidepressive agents|mesh-ancestor
5770823|NCT02908334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5770824|NCT02908334|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5770825|NCT02908334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5770826|NCT02908334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5770827|NCT02908334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5770828|NCT02908334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5770829|NCT02908334|Serotonin Agents|serotonin agents|mesh-ancestor
5770830|NCT02908334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770831|NCT02908165|Sorafenib|sorafenib|mesh-list
5770832|NCT02908165|Chlorotrianisene|chlorotrianisene|mesh-list
5770833|NCT02908165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5770834|NCT02908165|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5770835|NCT02908165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5770836|NCT02908165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5770837|NCT02908165|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
5770838|NCT02908165|Estrogens|estrogens|mesh-ancestor
5770839|NCT02908165|Hormones|hormones|mesh-ancestor
5770840|NCT02908165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5770841|NCT02908165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770842|NCT02908165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5770843|NCT02908282|Povidone|povidone|mesh-list
5770844|NCT02908282|Plasma Substitutes|plasma substitutes|mesh-ancestor
5770845|NCT02908282|Blood Substitutes|blood substitutes|mesh-ancestor
5770846|NCT02908152|Curcumin|curcumin|mesh-list
5770847|NCT02908152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5770848|NCT02908152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5770849|NCT02908152|Analgesics|analgesics|mesh-ancestor
5770850|NCT02908152|Sensory System Agents|sensory system agents|mesh-ancestor
5770851|NCT02908152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5770852|NCT02908152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770853|NCT02908152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5770854|NCT02908152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5770855|NCT02908152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5770856|NCT02908152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5770857|NCT02908152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5770858|NCT02908126|Oxytocin|oxytocin|mesh-list
5770859|NCT02908126|Oxytocics|oxytocics|mesh-ancestor
5770860|NCT02908126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5770861|NCT02908126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770862|NCT02907957|Anesthetics|anesthetics|mesh-list
5770863|NCT02907957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5770864|NCT02907957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770865|NCT02908035|Sirolimus|sirolimus|mesh-list
5770866|NCT02908035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5770867|NCT02908035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5770868|NCT02908035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5770869|NCT02908035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5770870|NCT02908035|Antifungal Agents|antifungal agents|mesh-ancestor
5770871|NCT02908035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5770872|NCT02908035|Immunologic Factors|immunologic factors|mesh-ancestor
5770873|NCT02908035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770874|NCT02907749|Carvedilol|carvedilol|mesh-list
5770875|NCT02907749|Spironolactone|spironolactone|mesh-list
5770876|NCT02907749|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5770877|NCT02907749|Hormone Antagonists|hormone antagonists|mesh-ancestor
5770878|NCT02907749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5770879|NCT02907749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770880|NCT02907749|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5770881|NCT02907749|Diuretics|diuretics|mesh-ancestor
5770882|NCT02907749|Natriuretic Agents|natriuretic agents|mesh-ancestor
5770883|NCT02907749|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5770884|NCT02907749|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5770885|NCT02907749|Adrenergic Agents|adrenergic agents|mesh-ancestor
5770886|NCT02907749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5896510|NCT03751124|Norethindrone|norethindrone|mesh-list
5770887|NCT02907749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5770888|NCT02907749|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5770889|NCT02907749|Antioxidants|antioxidants|mesh-ancestor
5770890|NCT02907749|Protective Agents|protective agents|mesh-ancestor
5770891|NCT02907749|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5770892|NCT02907749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5770893|NCT02907749|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5770894|NCT02907749|Vasodilator Agents|vasodilator agents|mesh-ancestor
5770895|NCT02907749|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5770896|NCT02907749|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5770897|NCT02907593|Budesonide|budesonide|mesh-list
5770898|NCT02907593|Calfactant|calfactant|mesh-list
5770899|NCT02907593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5770900|NCT02907593|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5770901|NCT02907593|Autonomic Agents|autonomic agents|mesh-ancestor
5770902|NCT02907593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5770903|NCT02907593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770904|NCT02907593|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5770905|NCT02907593|Respiratory System Agents|respiratory system agents|mesh-ancestor
5770906|NCT02907593|Glucocorticoids|glucocorticoids|mesh-ancestor
5770907|NCT02907593|Hormones|hormones|mesh-ancestor
5770908|NCT02907593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5770909|NCT02907593|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
5770910|NCT02907710|Endostar protein|endostar protein|mesh-list
5770911|NCT02907710|Endostatins|endostatins|mesh-list
5770912|NCT02907710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5770913|NCT02907710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5770914|NCT02907710|Growth Substances|growth substances|mesh-ancestor
5770915|NCT02907710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770916|NCT02907710|Growth Inhibitors|growth inhibitors|mesh-ancestor
5770917|NCT02907710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5770918|NCT02907554|Cyclosporine|cyclosporine|mesh-list
5770919|NCT02907554|Cyclosporins|cyclosporins|mesh-list
5770920|NCT02907554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5770921|NCT02907554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5770922|NCT02907554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5770923|NCT02907554|Immunologic Factors|immunologic factors|mesh-ancestor
5770924|NCT02907554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770925|NCT02907554|Antifungal Agents|antifungal agents|mesh-ancestor
5770926|NCT02907554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5770927|NCT02907554|Dermatologic Agents|dermatologic agents|mesh-ancestor
5770928|NCT02907554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5770929|NCT02907554|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5770930|NCT02907632|Metoclopramide|metoclopramide|mesh-list
5770931|NCT02907632|Antiemetics|antiemetics|mesh-ancestor
5770932|NCT02907632|Autonomic Agents|autonomic agents|mesh-ancestor
5770933|NCT02907632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5770934|NCT02907632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770935|NCT02907632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5770936|NCT02907632|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5770937|NCT02907632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5770938|NCT02907632|Dopamine Agents|dopamine agents|mesh-ancestor
5770939|NCT02907632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5770940|NCT02907632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5770941|NCT02907437|Minocycline|minocycline|mesh-list
5770942|NCT02907437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5770943|NCT02907437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5770944|NCT02907307|Clotrimazole|clotrimazole|mesh-list
5770945|NCT02907307|Miconazole|miconazole|mesh-list
5770946|NCT02907307|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5770947|NCT02907307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5770948|NCT02907307|Antifungal Agents|antifungal agents|mesh-ancestor
5770949|NCT02907307|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5770950|NCT02907307|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5770951|NCT02907307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5770952|NCT02907307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5770953|NCT02907307|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5770954|NCT02907307|Hormone Antagonists|hormone antagonists|mesh-ancestor
5770955|NCT02907307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5770956|NCT02907307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770957|NCT02907307|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5770958|NCT02907307|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5770959|NCT02907021|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
5896511|NCT03751124|Norethindrone Acetate|norethindrone acetate|mesh-list
5770960|NCT02907021|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5770961|NCT02907021|Adrenergic Agents|adrenergic agents|mesh-ancestor
5770962|NCT02907021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5770963|NCT02907021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5770964|NCT02907021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770965|NCT02906722|Colistin|colistin|mesh-list
5770966|NCT02906722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5770967|NCT02906722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5770968|NCT02906748|Parathyroid Hormone|parathyroid hormone|mesh-list
5770969|NCT02906748|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5770970|NCT02906748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770971|NCT02906995|Nicotine|nicotine|mesh-list
5770972|NCT02906995|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5770973|NCT02906995|Autonomic Agents|autonomic agents|mesh-ancestor
5770974|NCT02906995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5770975|NCT02906995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5770976|NCT02906995|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5770977|NCT02906995|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5770978|NCT02906995|Cholinergic Agents|cholinergic agents|mesh-ancestor
5770979|NCT02906995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5770980|NCT02906995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5770981|NCT02906800|Digoxin|digoxin|mesh-list
5770982|NCT02906800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5770983|NCT02906800|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5770984|NCT02906800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5770985|NCT02906800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5770986|NCT02906800|Protective Agents|protective agents|mesh-ancestor
5770987|NCT02906800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896512|NCT03751124|Estradiol|estradiol|mesh-list
5896513|NCT03751124|Relugolix|relugolix|mesh-list
5896514|NCT03751124|Estrogens|estrogens|mesh-ancestor
5896515|NCT03751124|Hormones|hormones|mesh-ancestor
5896516|NCT03751124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5896517|NCT03751124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896518|NCT03751124|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5896519|NCT03751124|Contraceptive Agents|contraceptive agents|mesh-ancestor
5896520|NCT03751124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5896521|NCT03751124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5896522|NCT03751124|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5896523|NCT03751124|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5896524|NCT03751124|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5896525|NCT03751124|Androgen Antagonists|androgen antagonists|mesh-ancestor
5896526|NCT03751124|Hormone Antagonists|hormone antagonists|mesh-ancestor
5896527|NCT03728426|Letermovir|letermovir|mesh-list
5896528|NCT03728426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5896529|NCT03728426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5896530|NCT03728426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896531|NCT03728426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5896532|NCT03728426|Antiviral Agents|antiviral agents|mesh-ancestor
5896533|NCT03728426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5896534|NCT03724149|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
5896535|NCT03724149|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
5896536|NCT03724149|Antiviral Agents|antiviral agents|mesh-ancestor
5896537|NCT03724149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5896538|NCT03716180|Paclitaxel|paclitaxel|mesh-list
5896539|NCT03716180|Trastuzumab|trastuzumab|mesh-list
5896540|NCT03716180|Pertuzumab|pertuzumab|mesh-list
5896541|NCT03716180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5896542|NCT03716180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5896543|NCT03716180|Tubulin Modulators|tubulin modulators|mesh-ancestor
5896544|NCT03716180|Antimitotic Agents|antimitotic agents|mesh-ancestor
5896545|NCT03716180|Mitosis Modulators|mitosis modulators|mesh-ancestor
5896546|NCT03716180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896547|NCT03716180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5896548|NCT03713801|Metformin|metformin|mesh-list
5896549|NCT03713801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5896550|NCT03713801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896551|NCT03704688|Trametinib|trametinib|mesh-list
5770988|NCT02906514|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
5770989|NCT02906514|Plasma Substitutes|plasma substitutes|mesh-ancestor
5770990|NCT02906514|Blood Substitutes|blood substitutes|mesh-ancestor
5770991|NCT02906553|Nitroglycerin|nitroglycerin|mesh-list
5770992|NCT02906553|Vasodilator Agents|vasodilator agents|mesh-ancestor
5770993|NCT02906254|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5770994|NCT02906254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5770995|NCT02906150|Cisplatin|cisplatin|mesh-list
5770996|NCT02906150|Carboplatin|carboplatin|mesh-list
5770997|NCT02906150|Pemetrexed|pemetrexed|mesh-list
5770998|NCT02906150|Thymalfasin|thymalfasin|mesh-list
5770999|NCT02906150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5771000|NCT02906150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5771001|NCT02906150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771002|NCT02906150|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5771003|NCT02906150|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5771004|NCT02906150|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5771005|NCT02906150|Immunologic Factors|immunologic factors|mesh-ancestor
5771006|NCT02906150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771007|NCT02906059|Irinotecan|irinotecan|mesh-list
5771008|NCT02906059|Adavosertib|adavosertib|mesh-list
5771009|NCT02906059|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5771010|NCT02906059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5771011|NCT02906059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5771012|NCT02906059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771013|NCT02906059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5771014|NCT02906176|Voriconazole|voriconazole|mesh-list
5771015|NCT02906176|Antifungal Agents|antifungal agents|mesh-ancestor
5771016|NCT02906176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5771017|NCT02906176|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5771018|NCT02906176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5771019|NCT02906176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5771020|NCT02906176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771021|NCT02906176|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5771022|NCT02906176|Hormone Antagonists|hormone antagonists|mesh-ancestor
5771023|NCT02906176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5771024|NCT02906176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771025|NCT02906176|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5771026|NCT02905994|Cytarabine|cytarabine|mesh-list
5771027|NCT02905994|Idarubicin|idarubicin|mesh-list
5771028|NCT02905994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5771029|NCT02905994|Antimetabolites|antimetabolites|mesh-ancestor
5771030|NCT02905994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771031|NCT02905994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5771032|NCT02905994|Antiviral Agents|antiviral agents|mesh-ancestor
5771033|NCT02905994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5771034|NCT02905994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5771035|NCT02905994|Immunologic Factors|immunologic factors|mesh-ancestor
5771036|NCT02905994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771037|NCT02905994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5771038|NCT02905994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5771039|NCT02905994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5771040|NCT02905994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5771041|NCT02905890|Norethindrone|norethindrone|mesh-list
5771042|NCT02905890|Norethindrone enanthate|norethindrone enanthate|mesh-list
5771043|NCT02905890|Norethindrone Acetate|norethindrone acetate|mesh-list
5771044|NCT02905890|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5771045|NCT02905890|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5771046|NCT02905890|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5771047|NCT02905890|Contraceptive Agents|contraceptive agents|mesh-ancestor
5771048|NCT02905890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5771049|NCT02905890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771050|NCT02905890|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5771051|NCT02905890|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5771052|NCT02906163|Gefitinib|gefitinib|mesh-list
5771053|NCT02906163|Afatinib|afatinib|mesh-list
5771054|NCT02906163|Thymalfasin|thymalfasin|mesh-list
5771055|NCT02906163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5771056|NCT02906163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5771057|NCT02906163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5771058|NCT02906163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771059|NCT02906163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5771060|NCT02906163|Immunologic Factors|immunologic factors|mesh-ancestor
5771061|NCT02906163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771062|NCT02905864|Liraglutide|liraglutide|mesh-list
5771063|NCT02905864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5771064|NCT02905864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771065|NCT02905864|Incretins|incretins|mesh-ancestor
5771066|NCT02905864|Hormones|hormones|mesh-ancestor
5771067|NCT02905864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5771068|NCT02905695|Levobupivacaine|levobupivacaine|mesh-list
5771069|NCT02905695|Anesthetics, Local|anesthetics, local|mesh-ancestor
5771070|NCT02905695|Anesthetics|anesthetics|mesh-ancestor
5771071|NCT02905695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5771072|NCT02905695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771073|NCT02905695|Sensory System Agents|sensory system agents|mesh-ancestor
5771074|NCT02905695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5771075|NCT02905682|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
5771076|NCT02905682|Hemostatics|hemostatics|mesh-ancestor
5771077|NCT02905682|Coagulants|coagulants|mesh-ancestor
5771078|NCT02905682|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5771079|NCT02905682|Natriuretic Agents|natriuretic agents|mesh-ancestor
5771080|NCT02905682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771081|NCT02905708|Charcoal|charcoal|mesh-list
5771082|NCT02905708|Antidotes|antidotes|mesh-ancestor
5771083|NCT02905708|Protective Agents|protective agents|mesh-ancestor
5771084|NCT02905708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771085|NCT02905591|Ascorbic Acid|ascorbic acid|mesh-list
5771086|NCT02905591|Paclitaxel|paclitaxel|mesh-list
5771087|NCT02905591|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5771088|NCT02905591|Carboplatin|carboplatin|mesh-list
5771089|NCT02905591|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5771090|NCT02905591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5771091|NCT02905591|Tubulin Modulators|tubulin modulators|mesh-ancestor
5771092|NCT02905591|Antimitotic Agents|antimitotic agents|mesh-ancestor
5771093|NCT02905591|Mitosis Modulators|mitosis modulators|mesh-ancestor
5771094|NCT02905591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771095|NCT02905591|Vitamins|vitamins|mesh-ancestor
5771096|NCT02905591|Micronutrients|micronutrients|mesh-ancestor
5771097|NCT02905591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771098|NCT02905591|Antioxidants|antioxidants|mesh-ancestor
5771099|NCT02905591|Protective Agents|protective agents|mesh-ancestor
5771100|NCT02905799|Resveratrol|resveratrol|mesh-list
5771101|NCT02905799|Antioxidants|antioxidants|mesh-ancestor
5771102|NCT02905799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771103|NCT02905799|Protective Agents|protective agents|mesh-ancestor
5771104|NCT02905799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771105|NCT02905799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5771106|NCT02905799|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5771107|NCT02905539|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
5771108|NCT02905539|Hematinics|hematinics|mesh-ancestor
5771109|NCT02905578|Ascorbic Acid|ascorbic acid|mesh-list
5771110|NCT02905578|Gemcitabine|gemcitabine|mesh-list
5771111|NCT02905578|Paclitaxel|paclitaxel|mesh-list
5771112|NCT02905578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5771113|NCT02905578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5771114|NCT02905578|Tubulin Modulators|tubulin modulators|mesh-ancestor
5771115|NCT02905578|Antimitotic Agents|antimitotic agents|mesh-ancestor
5771116|NCT02905578|Mitosis Modulators|mitosis modulators|mesh-ancestor
5771117|NCT02905578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771118|NCT02905578|Vitamins|vitamins|mesh-ancestor
5771119|NCT02905578|Micronutrients|micronutrients|mesh-ancestor
5771120|NCT02905578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771121|NCT02905578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5771122|NCT02905578|Antimetabolites|antimetabolites|mesh-ancestor
5771123|NCT02905578|Antiviral Agents|antiviral agents|mesh-ancestor
5771124|NCT02905578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5771125|NCT02905578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5771126|NCT02905578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5771127|NCT02905578|Immunologic Factors|immunologic factors|mesh-ancestor
5771128|NCT02905578|Antioxidants|antioxidants|mesh-ancestor
5771129|NCT02905578|Protective Agents|protective agents|mesh-ancestor
5771130|NCT02905734|Nicotine|nicotine|mesh-list
5771131|NCT02905734|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5771132|NCT02905734|Autonomic Agents|autonomic agents|mesh-ancestor
5771133|NCT02905734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5771134|NCT02905734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771135|NCT02905734|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5771136|NCT02905734|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5771137|NCT02905734|Cholinergic Agents|cholinergic agents|mesh-ancestor
5771138|NCT02905734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5771139|NCT02905734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771140|NCT02905760|Furosemide|furosemide|mesh-list
5771141|NCT02905760|Diuretics|diuretics|mesh-list
5771142|NCT02905760|Natriuretic Agents|natriuretic agents|mesh-ancestor
5771143|NCT02905760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771144|NCT02905760|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5771145|NCT02905760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5771146|NCT02905760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771147|NCT02905513|Contraceptive Agents|contraceptive agents|mesh-list
5771148|NCT02905513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5771149|NCT02905513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771150|NCT02905526|Contraceptive Agents|contraceptive agents|mesh-list
5771151|NCT02905526|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5771152|NCT02905526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771153|NCT02905461|Contraceptive Agents|contraceptive agents|mesh-list
5771154|NCT02905461|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5771155|NCT02905461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771156|NCT02905188|Cyclophosphamide|cyclophosphamide|mesh-list
5771157|NCT02905188|Fludarabine|fludarabine|mesh-list
5771158|NCT02905188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5771159|NCT02905188|Immunologic Factors|immunologic factors|mesh-ancestor
5771160|NCT02905188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771161|NCT02905188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5771162|NCT02905188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5771163|NCT02905188|Alkylating Agents|alkylating agents|mesh-ancestor
5771164|NCT02905188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771165|NCT02905188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5771166|NCT02905188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5771167|NCT02905305|Dexamethasone|dexamethasone|mesh-list
5771168|NCT02905305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5771169|NCT02905305|Antiemetics|antiemetics|mesh-ancestor
5771170|NCT02905305|Autonomic Agents|autonomic agents|mesh-ancestor
5771171|NCT02905305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5771172|NCT02905305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771173|NCT02905305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5771174|NCT02905305|Glucocorticoids|glucocorticoids|mesh-ancestor
5771175|NCT02905305|Hormones|hormones|mesh-ancestor
5771176|NCT02905305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5771177|NCT02905305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5771178|NCT02905305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5771179|NCT02905227|Zolmitriptan|zolmitriptan|mesh-list
5771180|NCT02905227|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5771181|NCT02905227|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5771182|NCT02905227|Serotonin Agents|serotonin agents|mesh-ancestor
5771183|NCT02905227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5771184|NCT02905227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771185|NCT02905227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771186|NCT02905058|Ketoprofen|ketoprofen|mesh-list
5771187|NCT02905058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5771188|NCT02905058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5771189|NCT02905058|Analgesics|analgesics|mesh-ancestor
5771190|NCT02905058|Sensory System Agents|sensory system agents|mesh-ancestor
5771191|NCT02905058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5771192|NCT02905058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771193|NCT02905058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5771194|NCT02905058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5771195|NCT02905058|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5771196|NCT02905058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5771197|NCT02905058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771198|NCT02905045|Ketoprofen|ketoprofen|mesh-list
5771199|NCT02905045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5771200|NCT02905045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5771201|NCT02905045|Analgesics|analgesics|mesh-ancestor
5771202|NCT02905045|Sensory System Agents|sensory system agents|mesh-ancestor
5771203|NCT02905045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5771204|NCT02905045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771205|NCT02905045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5771206|NCT02905045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5771207|NCT02905045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5771208|NCT02905045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5771209|NCT02905045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896552|NCT03704688|Ponatinib|ponatinib|mesh-list
5896553|NCT03704688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5896554|NCT03704688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5771210|NCT02904772|Cyclosporine|cyclosporine|mesh-list
5771211|NCT02904772|Mycophenolic Acid|mycophenolic acid|mesh-list
5771212|NCT02904772|Prednisolone|prednisolone|mesh-list
5771213|NCT02904772|Cyclosporins|cyclosporins|mesh-list
5771214|NCT02904772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5771215|NCT02904772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771216|NCT02904772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5771217|NCT02904772|Immunologic Factors|immunologic factors|mesh-ancestor
5771218|NCT02904772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771219|NCT02904772|Antifungal Agents|antifungal agents|mesh-ancestor
5771220|NCT02904772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5771221|NCT02904772|Dermatologic Agents|dermatologic agents|mesh-ancestor
5771222|NCT02904772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5771223|NCT02904772|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5771224|NCT02904772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5771225|NCT02904772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5771226|NCT02904772|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5771227|NCT02904772|Antitubercular Agents|antitubercular agents|mesh-ancestor
5771228|NCT02904772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5771229|NCT02904772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5771230|NCT02904772|Glucocorticoids|glucocorticoids|mesh-ancestor
5771231|NCT02904772|Hormones|hormones|mesh-ancestor
5771232|NCT02904772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5771233|NCT02904772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5771234|NCT02904759|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
5771235|NCT02904759|Hemostatics|hemostatics|mesh-ancestor
5771236|NCT02904759|Coagulants|coagulants|mesh-ancestor
5771237|NCT02904759|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5771238|NCT02904759|Natriuretic Agents|natriuretic agents|mesh-ancestor
5771239|NCT02904759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771240|NCT02904564|Fluorouracil|fluorouracil|mesh-list
5771241|NCT02904564|Antimetabolites|antimetabolites|mesh-ancestor
5771242|NCT02904564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771243|NCT02904564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5771244|NCT02904564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5771245|NCT02904564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5771246|NCT02904564|Immunologic Factors|immunologic factors|mesh-ancestor
5771247|NCT02904564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771248|NCT02904538|Dexamethasone|dexamethasone|mesh-list
5771249|NCT02904538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5771250|NCT02904538|Antiemetics|antiemetics|mesh-ancestor
5771251|NCT02904538|Autonomic Agents|autonomic agents|mesh-ancestor
5771252|NCT02904538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5771253|NCT02904538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771254|NCT02904538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5771255|NCT02904538|Glucocorticoids|glucocorticoids|mesh-ancestor
5771256|NCT02904538|Hormones|hormones|mesh-ancestor
5771257|NCT02904538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5771258|NCT02904538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5771259|NCT02904538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5771260|NCT02904499|Dabigatran|dabigatran|mesh-list
5771261|NCT02904499|Antithrombins|antithrombins|mesh-ancestor
5771262|NCT02904499|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5771263|NCT02904499|Protease Inhibitors|protease inhibitors|mesh-ancestor
5771264|NCT02904499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5771265|NCT02904499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771266|NCT02904499|Anticoagulants|anticoagulants|mesh-ancestor
5771267|NCT02904369|Tenofovir|tenofovir|mesh-list
5771268|NCT02904369|Emtricitabine|emtricitabine|mesh-list
5771269|NCT02904369|Antiviral Agents|antiviral agents|mesh-ancestor
5771270|NCT02904369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5771271|NCT02904369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5771272|NCT02904369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5771273|NCT02904369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5771274|NCT02904369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771275|NCT02904369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5771276|NCT02904369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5771277|NCT02904291|Amlodipine|amlodipine|mesh-list
5771278|NCT02904291|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5771279|NCT02904291|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5771280|NCT02904291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5771281|NCT02904291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771282|NCT02904291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5771283|NCT02904291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212588|NCT02191033|Nicotine|nicotine|mesh-list
5771284|NCT02904291|Vasodilator Agents|vasodilator agents|mesh-ancestor
5771285|NCT02904304|Ibuprofen|ibuprofen|mesh-list
5771286|NCT02904304|Phenylephrine|phenylephrine|mesh-list
5771287|NCT02904304|Oxymetazoline|oxymetazoline|mesh-list
5771288|NCT02904304|Desloratadine|desloratadine|mesh-list
5771289|NCT02904304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5771290|NCT02904304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5771291|NCT02904304|Analgesics|analgesics|mesh-ancestor
5771292|NCT02904304|Sensory System Agents|sensory system agents|mesh-ancestor
5771293|NCT02904304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5771294|NCT02904304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771295|NCT02904304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5771296|NCT02904304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5771297|NCT02904304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5771298|NCT02904304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5771299|NCT02904304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771300|NCT02904304|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5771301|NCT02904304|Mydriatics|mydriatics|mesh-ancestor
5771302|NCT02904304|Autonomic Agents|autonomic agents|mesh-ancestor
5771303|NCT02904304|Sympathomimetics|sympathomimetics|mesh-ancestor
5771304|NCT02904304|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5771305|NCT02904304|Nasal Decongestants|nasal decongestants|mesh-ancestor
5771306|NCT02904304|Respiratory System Agents|respiratory system agents|mesh-ancestor
5771307|NCT02904304|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5771308|NCT02904304|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5771309|NCT02904304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5771310|NCT02904304|Adrenergic Agents|adrenergic agents|mesh-ancestor
5771311|NCT02904304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5771312|NCT02904304|Protective Agents|protective agents|mesh-ancestor
5771313|NCT02904304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5771314|NCT02904304|Cholinergic Agents|cholinergic agents|mesh-ancestor
5771315|NCT02904304|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5771316|NCT02904304|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5771317|NCT02904304|Histamine Antagonists|histamine antagonists|mesh-ancestor
5771318|NCT02904304|Histamine Agents|histamine agents|mesh-ancestor
5771319|NCT02904031|Leucovorin|leucovorin|mesh-list
5771320|NCT02904031|Fluorouracil|fluorouracil|mesh-list
5771321|NCT02904031|Oxaliplatin|oxaliplatin|mesh-list
5771322|NCT02904031|Panitumumab|panitumumab|mesh-list
5771323|NCT02904031|Levoleucovorin|levoleucovorin|mesh-list
5771324|NCT02904031|Antimetabolites|antimetabolites|mesh-ancestor
5771325|NCT02904031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771326|NCT02904031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5771327|NCT02904031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5771328|NCT02904031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5771329|NCT02904031|Immunologic Factors|immunologic factors|mesh-ancestor
5771330|NCT02904031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771331|NCT02904031|Antidotes|antidotes|mesh-ancestor
5771332|NCT02904031|Protective Agents|protective agents|mesh-ancestor
5771333|NCT02904031|Vitamin B Complex|vitamin b complex|mesh-ancestor
5771334|NCT02904031|Vitamins|vitamins|mesh-ancestor
5771335|NCT02904031|Micronutrients|micronutrients|mesh-ancestor
5771336|NCT02904031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5771337|NCT02903888|Levonorgestrel|levonorgestrel|mesh-list
5771338|NCT02903888|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5771339|NCT02903888|Contraceptive Agents|contraceptive agents|mesh-ancestor
5771340|NCT02903888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5771341|NCT02903888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771342|NCT02903888|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5771343|NCT02903888|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5771344|NCT02903888|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5771345|NCT02904109|Mannitol|mannitol|mesh-list
5771346|NCT02904109|Triflusal|triflusal|mesh-list
5771347|NCT02904109|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5771348|NCT02904109|Diuretics|diuretics|mesh-ancestor
5771349|NCT02904109|Natriuretic Agents|natriuretic agents|mesh-ancestor
5771350|NCT02904109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771351|NCT02904109|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5771352|NCT02903901|Melatonin|melatonin|mesh-list
5771353|NCT02903901|Antioxidants|antioxidants|mesh-ancestor
5771354|NCT02903901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771355|NCT02903901|Protective Agents|protective agents|mesh-ancestor
5771356|NCT02903901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771357|NCT02903901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5771358|NCT02903498|Tegafur|tegafur|mesh-list
5771359|NCT02903498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5771360|NCT02903498|Antimetabolites|antimetabolites|mesh-ancestor
5896555|NCT03704688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5771361|NCT02903498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771362|NCT02903498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5771363|NCT02903524|Cyclophosphamide|cyclophosphamide|mesh-list
5640739|NCT04785287|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5640740|NCT04785287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640741|NCT04733534|Dasatinib|dasatinib|mesh-list
5640742|NCT04733534|Quercetin|quercetin|mesh-list
5640743|NCT04733534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5640744|NCT04733534|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5640745|NCT04733534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5640746|NCT04733534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640747|NCT04733534|Antioxidants|antioxidants|mesh-ancestor
5640748|NCT04733534|Protective Agents|protective agents|mesh-ancestor
5640749|NCT04733534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640750|NCT04718961|Volixibat|volixibat|mesh-list
5640751|NCT04718961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5640752|NCT04711252|Palbociclib|palbociclib|mesh-list
5640753|NCT04711252|Anastrozole|anastrozole|mesh-list
5640754|NCT04711252|Hormones|hormones|mesh-list
5640755|NCT04711252|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
5640756|NCT04711252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5640757|NCT04711252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640758|NCT04711252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5640759|NCT04711252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5640760|NCT04711252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5640761|NCT04711252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640762|NCT04711252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5640763|NCT04711252|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5640764|NCT04711252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5640765|NCT04711252|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5640766|NCT04711252|Hormone Antagonists|hormone antagonists|mesh-ancestor
5640767|NCT04703036|Acetylcysteine|acetylcysteine|mesh-list
5640768|NCT04703036|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5640769|NCT04703036|Glycine|glycine|mesh-list
5640770|NCT04703036|Antiviral Agents|antiviral agents|mesh-ancestor
5640771|NCT04703036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5640772|NCT04703036|Expectorants|expectorants|mesh-ancestor
5640773|NCT04703036|Respiratory System Agents|respiratory system agents|mesh-ancestor
5640774|NCT04703036|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5640775|NCT04703036|Antioxidants|antioxidants|mesh-ancestor
5640776|NCT04703036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640777|NCT04703036|Protective Agents|protective agents|mesh-ancestor
5640778|NCT04703036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640779|NCT04703036|Antidotes|antidotes|mesh-ancestor
5640780|NCT04703036|Glycine Agents|glycine agents|mesh-ancestor
5640781|NCT04703036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5693891|NCT03399019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5693892|NCT03399019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5693893|NCT03399019|Adrenergic Agents|adrenergic agents|mesh-ancestor
5693894|NCT03399019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5693895|NCT03399019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693896|NCT03399019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5693897|NCT03399019|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5693898|NCT03399019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5693899|NCT03399019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5693900|NCT03399019|GABA Modulators|gaba modulators|mesh-ancestor
5693901|NCT03399019|GABA Agents|gaba agents|mesh-ancestor
5693902|NCT03398993|Clomiphene|clomiphene|mesh-list
5693903|NCT03398993|Enclomiphene|enclomiphene|mesh-list
5693904|NCT03398993|Zuclomiphene|zuclomiphene|mesh-list
5693905|NCT03398993|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5693906|NCT03398993|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5693907|NCT03398993|Hormone Antagonists|hormone antagonists|mesh-ancestor
5693908|NCT03398993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5693909|NCT03398993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693910|NCT03398993|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5693911|NCT03398993|Fertility Agents|fertility agents|mesh-ancestor
5693912|NCT03398993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5693913|NCT03398993|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5693914|NCT03398993|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5693915|NCT03398941|Octreotide|octreotide|mesh-list
5693916|NCT03398941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5693917|NCT03398941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5771364|NCT02903524|Doxorubicin|doxorubicin|mesh-list
5771365|NCT02903524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5771366|NCT02903524|Pirarubicin|pirarubicin|mesh-list
5771367|NCT02903524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5771368|NCT02903524|Immunologic Factors|immunologic factors|mesh-ancestor
5771369|NCT02903524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771370|NCT02903524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5771371|NCT02903524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5771372|NCT02903524|Alkylating Agents|alkylating agents|mesh-ancestor
5771373|NCT02903524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771374|NCT02903524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5771375|NCT02903524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5771376|NCT02903524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5771377|NCT02903524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5771378|NCT02903524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5771379|NCT02903524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5771380|NCT02903680|Dexamethasone|dexamethasone|mesh-list
5771381|NCT02903680|Dexamethasone acetate|dexamethasone acetate|mesh-list
5771382|NCT02903680|BB 1101|bb 1101|mesh-list
5771383|NCT02903680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5771384|NCT02903680|Antiemetics|antiemetics|mesh-ancestor
5771385|NCT02903680|Autonomic Agents|autonomic agents|mesh-ancestor
5771386|NCT02903680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5771387|NCT02903680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771388|NCT02903680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5771389|NCT02903680|Glucocorticoids|glucocorticoids|mesh-ancestor
5771390|NCT02903680|Hormones|hormones|mesh-ancestor
5771391|NCT02903680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5771392|NCT02903680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5771393|NCT02903680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5771394|NCT02903680|Protease Inhibitors|protease inhibitors|mesh-ancestor
5771395|NCT02903680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5771396|NCT02903680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771397|NCT02903485|Anesthetics|anesthetics|mesh-list
5771398|NCT02903485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5771399|NCT02903485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771400|NCT02903719|Ropivacaine|ropivacaine|mesh-list
5771401|NCT02903719|Anesthetics, Local|anesthetics, local|mesh-ancestor
5771402|NCT02903719|Anesthetics|anesthetics|mesh-ancestor
5771403|NCT02903719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5771404|NCT02903719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771405|NCT02903719|Sensory System Agents|sensory system agents|mesh-ancestor
5771406|NCT02903719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5771407|NCT02903537|Cholecalciferol|cholecalciferol|mesh-list
5771408|NCT02903537|Interferons|interferons|mesh-list
5771409|NCT02903537|Interferon-beta|interferon-beta|mesh-list
5771410|NCT02903537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5771411|NCT02903537|Antiviral Agents|antiviral agents|mesh-ancestor
5771412|NCT02903537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5771413|NCT02903537|Immunologic Factors|immunologic factors|mesh-ancestor
5771414|NCT02903537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771415|NCT02903537|Vitamins|vitamins|mesh-ancestor
5771416|NCT02903537|Micronutrients|micronutrients|mesh-ancestor
5771417|NCT02903537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5771418|NCT02903537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5896556|NCT03704688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896557|NCT03684213|Ascorbic Acid|ascorbic acid|mesh-list
5896558|NCT03684213|Norepinephrine|norepinephrine|mesh-list
5896559|NCT03684213|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
5896560|NCT03684213|Antioxidants|antioxidants|mesh-ancestor
6673505|NCT01563289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6673506|NCT01563289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6673507|NCT01563289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896561|NCT03684213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896562|NCT03684213|Protective Agents|protective agents|mesh-ancestor
5896563|NCT03684213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896564|NCT03684213|Vitamins|vitamins|mesh-ancestor
5896565|NCT03684213|Micronutrients|micronutrients|mesh-ancestor
5896566|NCT03684213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5896567|NCT03684213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5896568|NCT03684213|Adrenergic Agents|adrenergic agents|mesh-ancestor
5896569|NCT03684213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5896570|NCT03684213|Sympathomimetics|sympathomimetics|mesh-ancestor
5896571|NCT03684213|Autonomic Agents|autonomic agents|mesh-ancestor
5896572|NCT03684213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5771419|NCT02903251|Oxytocin|oxytocin|mesh-list
5771420|NCT02903251|Oxytocics|oxytocics|mesh-ancestor
5771421|NCT02903251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5771422|NCT02903251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771423|NCT02903004|Gemcitabine|gemcitabine|mesh-list
5771424|NCT02903004|Paclitaxel|paclitaxel|mesh-list
5771425|NCT02903004|Carboplatin|carboplatin|mesh-list
5771426|NCT02903004|Doxorubicin|doxorubicin|mesh-list
5771427|NCT02903004|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5771428|NCT02903004|Topotecan|topotecan|mesh-list
5771429|NCT02903004|Trabectedin|trabectedin|mesh-list
5771430|NCT02903004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5771431|NCT02903004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5771432|NCT02903004|Tubulin Modulators|tubulin modulators|mesh-ancestor
5771433|NCT02903004|Antimitotic Agents|antimitotic agents|mesh-ancestor
5771434|NCT02903004|Mitosis Modulators|mitosis modulators|mesh-ancestor
5771435|NCT02903004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771436|NCT02903004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5771437|NCT02903004|Antimetabolites|antimetabolites|mesh-ancestor
5771438|NCT02903004|Antiviral Agents|antiviral agents|mesh-ancestor
5771439|NCT02903004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5771440|NCT02903004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5771441|NCT02903004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5771442|NCT02903004|Immunologic Factors|immunologic factors|mesh-ancestor
5771443|NCT02903004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771444|NCT02903004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5771445|NCT02903004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5771446|NCT02903004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5771447|NCT02903004|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5771448|NCT02903004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5771449|NCT02903004|Alkylating Agents|alkylating agents|mesh-ancestor
5771450|NCT02902861|Methotrexate|methotrexate|mesh-list
5771451|NCT02902861|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5771452|NCT02902861|Abortifacient Agents|abortifacient agents|mesh-ancestor
5771453|NCT02902861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5771454|NCT02902861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771455|NCT02902861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5771456|NCT02902861|Antimetabolites|antimetabolites|mesh-ancestor
5771457|NCT02902861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771458|NCT02902861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5771459|NCT02902861|Dermatologic Agents|dermatologic agents|mesh-ancestor
5771460|NCT02902861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5771461|NCT02902861|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5771462|NCT02902861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5771463|NCT02902861|Immunologic Factors|immunologic factors|mesh-ancestor
5771464|NCT02902861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5771465|NCT02902861|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5771466|NCT02903017|Tranexamic Acid|tranexamic acid|mesh-list
5771467|NCT02903017|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5771468|NCT02903017|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5771469|NCT02903017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771470|NCT02903017|Hemostatics|hemostatics|mesh-ancestor
5771471|NCT02903017|Coagulants|coagulants|mesh-ancestor
5771472|NCT02902731|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5771473|NCT02902731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5771474|NCT02903069|Temozolomide|temozolomide|mesh-list
5771475|NCT02903069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5771476|NCT02903069|Alkylating Agents|alkylating agents|mesh-ancestor
5771477|NCT02903069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771478|NCT02903069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5771479|NCT02902744|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
5771480|NCT02902744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5771481|NCT02902744|Glucocorticoids|glucocorticoids|mesh-ancestor
5771482|NCT02902744|Hormones|hormones|mesh-ancestor
5771483|NCT02902744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5771484|NCT02902744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771485|NCT02902666|Acetaminophen|acetaminophen|mesh-list
5771486|NCT02902666|Codeine|codeine|mesh-list
5771487|NCT02902666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5771488|NCT02902666|Analgesics|analgesics|mesh-ancestor
5771489|NCT02902666|Sensory System Agents|sensory system agents|mesh-ancestor
5771490|NCT02902666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5771491|NCT02902666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771492|NCT02902666|Antipyretics|antipyretics|mesh-ancestor
5771493|NCT02902666|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5771494|NCT02902666|Narcotics|narcotics|mesh-ancestor
5771495|NCT02902666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5771496|NCT02902666|Antitussive Agents|antitussive agents|mesh-ancestor
5771497|NCT02902666|Respiratory System Agents|respiratory system agents|mesh-ancestor
5771498|NCT02902653|Misoprostol|misoprostol|mesh-list
5771499|NCT02902653|Dinoprostone|dinoprostone|mesh-list
5771500|NCT02902653|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5771501|NCT02902653|Abortifacient Agents|abortifacient agents|mesh-ancestor
5771502|NCT02902653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5771503|NCT02902653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771504|NCT02902653|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5771505|NCT02902653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5771506|NCT02902653|Oxytocics|oxytocics|mesh-ancestor
5771507|NCT02902640|Trimethoprim|trimethoprim|mesh-list
5771508|NCT02902640|Sulfamethoxazole|sulfamethoxazole|mesh-list
5771509|NCT02902640|Phenylpropanolamine|phenylpropanolamine|mesh-list
5771510|NCT02902640|Guaifenesin|guaifenesin|mesh-list
5771511|NCT02902640|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
5771512|NCT02902640|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5771513|NCT02902640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5771514|NCT02902640|Renal Agents|renal agents|mesh-ancestor
5771515|NCT02902640|Antimalarials|antimalarials|mesh-ancestor
5771516|NCT02902640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5771517|NCT02902640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5771518|NCT02902640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5771519|NCT02902640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5771520|NCT02902640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771521|NCT02902640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5771522|NCT02902640|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
5771523|NCT02902640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5771524|NCT02902640|Expectorants|expectorants|mesh-ancestor
5771525|NCT02902640|Respiratory System Agents|respiratory system agents|mesh-ancestor
5771526|NCT02902640|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5771527|NCT02902640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5771528|NCT02902640|Adrenergic Agents|adrenergic agents|mesh-ancestor
5771529|NCT02902640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5771530|NCT02902640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771531|NCT02902640|Appetite Depressants|appetite depressants|mesh-ancestor
5771532|NCT02902640|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5771533|NCT02902640|Sympathomimetics|sympathomimetics|mesh-ancestor
5771534|NCT02902640|Autonomic Agents|autonomic agents|mesh-ancestor
5771535|NCT02902640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5771536|NCT02902640|Nasal Decongestants|nasal decongestants|mesh-ancestor
5771537|NCT02902640|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5771538|NCT02902354|Nifedipine|nifedipine|mesh-list
5771539|NCT02902354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5771540|NCT02902354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5771541|NCT02902354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771542|NCT02902354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5771543|NCT02902354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771544|NCT02902354|Vasodilator Agents|vasodilator agents|mesh-ancestor
5771545|NCT02902354|Tocolytic Agents|tocolytic agents|mesh-ancestor
5771546|NCT02902354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5771547|NCT02902315|Vitamins|vitamins|mesh-list
5771548|NCT02902315|Ascorbic Acid|ascorbic acid|mesh-list
5771549|NCT02902315|Tocopherols|tocopherols|mesh-list
5771550|NCT02902315|alpha-Tocopherol|alpha-tocopherol|mesh-list
5771551|NCT02902315|Micronutrients|micronutrients|mesh-ancestor
5771552|NCT02902315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771553|NCT02902315|Antioxidants|antioxidants|mesh-ancestor
5771554|NCT02902315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771555|NCT02902315|Protective Agents|protective agents|mesh-ancestor
5771556|NCT02902302|Ibuprofen|ibuprofen|mesh-list
5771557|NCT02902302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5771558|NCT02902302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5771559|NCT02902302|Analgesics|analgesics|mesh-ancestor
5771560|NCT02902302|Sensory System Agents|sensory system agents|mesh-ancestor
5771561|NCT02902302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5771562|NCT02902302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771563|NCT02902302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5771564|NCT02902302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5771565|NCT02902302|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5771566|NCT02902302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5771567|NCT02902302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771568|NCT02902523|Tenofovir|tenofovir|mesh-list
5771569|NCT02902523|Antiviral Agents|antiviral agents|mesh-ancestor
5771570|NCT02902523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5771571|NCT02902523|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5771572|NCT02902523|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5771573|NCT02902523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5771574|NCT02902523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771575|NCT02902523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5771576|NCT02902523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5771577|NCT02902432|Endostar protein|endostar protein|mesh-list
5771578|NCT02902432|Endostatins|endostatins|mesh-list
5771579|NCT02902432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5771580|NCT02902432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5771581|NCT02902432|Growth Substances|growth substances|mesh-ancestor
5771582|NCT02902432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771583|NCT02902432|Growth Inhibitors|growth inhibitors|mesh-ancestor
5771584|NCT02902432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5771585|NCT02902484|Nintedanib|nintedanib|mesh-list
5771586|NCT02902484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5771587|NCT02902484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5771588|NCT02902484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5771589|NCT02902484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771590|NCT02902380|Dexmedetomidine|dexmedetomidine|mesh-list
5771591|NCT02902380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5771592|NCT02902380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5771593|NCT02902380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771594|NCT02902380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5771595|NCT02902380|Analgesics|analgesics|mesh-ancestor
5771596|NCT02902380|Sensory System Agents|sensory system agents|mesh-ancestor
5771597|NCT02902380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5771598|NCT02902380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5771599|NCT02902380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5771600|NCT02902380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5771601|NCT02902380|Adrenergic Agents|adrenergic agents|mesh-ancestor
5771602|NCT02902380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5771603|NCT02902380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771604|NCT02902289|Ibuprofen|ibuprofen|mesh-list
5771605|NCT02902289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5771606|NCT02902289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5771607|NCT02902289|Analgesics|analgesics|mesh-ancestor
5771608|NCT02902289|Sensory System Agents|sensory system agents|mesh-ancestor
5771609|NCT02902289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5771610|NCT02902289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771611|NCT02902289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5771612|NCT02902289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5771613|NCT02902289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5771614|NCT02902289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5771615|NCT02902289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771616|NCT02902042|Pembrolizumab|pembrolizumab|mesh-list
5771617|NCT02902042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5771618|NCT02902042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5771619|NCT02902029|Atezolizumab|atezolizumab|mesh-list
5771620|NCT02902029|Vemurafenib|vemurafenib|mesh-list
5771621|NCT02902029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5771622|NCT02902029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5771623|NCT02902029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5771624|NCT02902029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771625|NCT02902133|Acetazolamide|acetazolamide|mesh-list
5771626|NCT02902133|Anticonvulsants|anticonvulsants|mesh-ancestor
5771627|NCT02902133|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5771628|NCT02902133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5771629|NCT02902133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771630|NCT02902133|Diuretics|diuretics|mesh-ancestor
5771631|NCT02902133|Natriuretic Agents|natriuretic agents|mesh-ancestor
5771632|NCT02902133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771633|NCT02902055|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
5771634|NCT02902055|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5771635|NCT02902055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5771636|NCT02902055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771637|NCT02901977|Ramipril|ramipril|mesh-list
5771638|NCT02901977|Doxazosin|doxazosin|mesh-list
5771639|NCT02901977|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5771640|NCT02901977|Protease Inhibitors|protease inhibitors|mesh-ancestor
5771641|NCT02901977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5771642|NCT02901977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490539|NCT00598715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5771643|NCT02901977|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5771644|NCT02901977|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5771645|NCT02901977|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5771646|NCT02901977|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5771647|NCT02901977|Adrenergic Agents|adrenergic agents|mesh-ancestor
5771648|NCT02901977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5771649|NCT02901977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896573|NCT03684213|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5896574|NCT03684213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5896575|NCT03679780|Nitroprusside|nitroprusside|mesh-list
5896576|NCT03679780|BQ 788|bq 788|mesh-list
5896577|NCT03679780|Nitroarginine|nitroarginine|mesh-list
5896578|NCT03679780|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
5896579|NCT03679780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5896580|NCT03679780|Vasodilator Agents|vasodilator agents|mesh-ancestor
5896581|NCT03679780|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5896582|NCT03679780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896583|NCT03679780|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5896584|NCT03679780|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
5896585|NCT03679780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5896586|NCT03672773|Temozolomide|temozolomide|mesh-list
5896587|NCT03672773|Talazoparib|talazoparib|mesh-list
5896588|NCT03672773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5896589|NCT03672773|Alkylating Agents|alkylating agents|mesh-ancestor
5896590|NCT03672773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896591|NCT03672773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5896592|NCT03672773|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5896593|NCT03672773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5896594|NCT03667690|Fluconazole|fluconazole|mesh-list
5896595|NCT03667690|Caspofungin|caspofungin|mesh-list
5896596|NCT03667690|Rezafungin|rezafungin|mesh-list
5896597|NCT03667690|Antifungal Agents|antifungal agents|mesh-ancestor
5896598|NCT03667690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5896599|NCT03667690|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5896600|NCT03667690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5896601|NCT03667690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5896602|NCT03667690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896603|NCT03667690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5896604|NCT03667690|Hormone Antagonists|hormone antagonists|mesh-ancestor
5896605|NCT03667690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5896606|NCT03667690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896607|NCT03667690|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5896608|NCT03667690|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5896609|NCT03641560|Androgens|androgens|mesh-list
5896610|NCT03641560|Hormones|hormones|mesh-ancestor
5896611|NCT03641560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5896612|NCT03641560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896613|NCT03625349|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
5896614|NCT03625349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5896615|NCT03625349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896616|NCT03624101|Ivacaftor|ivacaftor|mesh-list
5896617|NCT03624101|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
5896618|NCT03624101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5896619|NCT03624101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896620|NCT03600350|Nivolumab|nivolumab|mesh-list
5896621|NCT03600350|Sargramostim|sargramostim|mesh-list
5896622|NCT03600350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5896623|NCT03600350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5896624|NCT03600350|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5896625|NCT03600350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896626|NCT03600350|Immunologic Factors|immunologic factors|mesh-ancestor
5896627|NCT03600350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896628|NCT03598270|Gemcitabine|gemcitabine|mesh-list
5896629|NCT03598270|Paclitaxel|paclitaxel|mesh-list
5896630|NCT03598270|Carboplatin|carboplatin|mesh-list
5896631|NCT03598270|Doxorubicin|doxorubicin|mesh-list
5896632|NCT03598270|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5896633|NCT03598270|Atezolizumab|atezolizumab|mesh-list
5896634|NCT03598270|Niraparib|niraparib|mesh-list
5896635|NCT03598270|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5896636|NCT03598270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5896637|NCT03598270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5896638|NCT03598270|Tubulin Modulators|tubulin modulators|mesh-ancestor
5896639|NCT03598270|Antimitotic Agents|antimitotic agents|mesh-ancestor
5771650|NCT02902198|Quinine|quinine|mesh-list
5771651|NCT02902198|Antimalarials|antimalarials|mesh-ancestor
5771652|NCT02902198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5771653|NCT02902198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5771654|NCT02902198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5771655|NCT02902198|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5771656|NCT02902198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771657|NCT02902198|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5771658|NCT02902198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5771659|NCT02902198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5771660|NCT02902198|Analgesics|analgesics|mesh-ancestor
5771661|NCT02902198|Sensory System Agents|sensory system agents|mesh-ancestor
5771662|NCT02901587|Quetiapine Fumarate|quetiapine fumarate|mesh-list
5771663|NCT02901587|Antidepressive Agents|antidepressive agents|mesh-ancestor
5771664|NCT02901587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5771665|NCT02901587|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5771666|NCT02901587|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5771667|NCT02901587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5771668|NCT02901587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771669|NCT02901561|Misoprostol|misoprostol|mesh-list
5771670|NCT02901561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5771671|NCT02901561|Abortifacient Agents|abortifacient agents|mesh-ancestor
5771672|NCT02901561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5771673|NCT02901561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771674|NCT02901561|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5771675|NCT02901561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5771676|NCT02901561|Oxytocics|oxytocics|mesh-ancestor
5771677|NCT02901717|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5771678|NCT02901717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5771679|NCT02901717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5771680|NCT02901717|Antitubercular Agents|antitubercular agents|mesh-ancestor
5771681|NCT02901418|Immunoglobulins|immunoglobulins|mesh-list
5771682|NCT02901418|Immunologic Factors|immunologic factors|mesh-ancestor
5771683|NCT02901418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771684|NCT02901366|Dotinurad|dotinurad|mesh-list
5771685|NCT02901366|Uricosuric Agents|uricosuric agents|mesh-ancestor
5771686|NCT02901366|Gout Suppressants|gout suppressants|mesh-ancestor
5771687|NCT02901366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5771688|NCT02901366|Renal Agents|renal agents|mesh-ancestor
5771689|NCT02901379|Atorvastatin|atorvastatin|mesh-list
5771690|NCT02901379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5771691|NCT02901379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5771692|NCT02901379|Antimetabolites|antimetabolites|mesh-ancestor
5771693|NCT02901379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771694|NCT02901379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5771695|NCT02901379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5771696|NCT02901379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5771697|NCT02901353|Sirolimus|sirolimus|mesh-list
5771698|NCT02901353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5771699|NCT02901353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5771700|NCT02901353|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5771701|NCT02901353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5771702|NCT02901353|Antifungal Agents|antifungal agents|mesh-ancestor
5771703|NCT02901353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5771704|NCT02901353|Immunologic Factors|immunologic factors|mesh-ancestor
5771705|NCT02901353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771706|NCT02901106|Dimethyl Fumarate|dimethyl fumarate|mesh-list
5771707|NCT02901106|Dermatologic Agents|dermatologic agents|mesh-ancestor
5771708|NCT02901106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5771709|NCT02901106|Immunologic Factors|immunologic factors|mesh-ancestor
5771710|NCT02901106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771711|NCT02901288|Levofloxacin|levofloxacin|mesh-list
5771712|NCT02901288|Ofloxacin|ofloxacin|mesh-list
5771713|NCT02901288|Rifampin|rifampin|mesh-list
5771714|NCT02901288|Isoniazid|isoniazid|mesh-list
5771715|NCT02901288|Pyrazinamide|pyrazinamide|mesh-list
5771716|NCT02901288|Ethambutol|ethambutol|mesh-list
5771717|NCT02901288|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5771718|NCT02901288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5771719|NCT02901288|Renal Agents|renal agents|mesh-ancestor
5771720|NCT02901288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5771721|NCT02901288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5771722|NCT02901288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5771723|NCT02901288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5771724|NCT02901288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771725|NCT02901288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5771726|NCT02901288|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5896640|NCT03598270|Mitosis Modulators|mitosis modulators|mesh-ancestor
5771727|NCT02901288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5771728|NCT02901288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5771729|NCT02901288|Antitubercular Agents|antitubercular agents|mesh-ancestor
5771730|NCT02901288|Leprostatic Agents|leprostatic agents|mesh-ancestor
5771731|NCT02901288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5771732|NCT02901288|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5771733|NCT02901288|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5771734|NCT02901288|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5771735|NCT02901288|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5771736|NCT02901288|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5771737|NCT02901288|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5771738|NCT02901288|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5771739|NCT02901288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5771740|NCT02901288|Antimetabolites|antimetabolites|mesh-ancestor
5771741|NCT02901288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5771742|NCT02901184|Spironolactone|spironolactone|mesh-list
5771743|NCT02901184|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5771744|NCT02901184|Hormone Antagonists|hormone antagonists|mesh-ancestor
5771745|NCT02901184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5771746|NCT02901184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771747|NCT02901184|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5771748|NCT02901184|Diuretics|diuretics|mesh-ancestor
5771749|NCT02901184|Natriuretic Agents|natriuretic agents|mesh-ancestor
5771750|NCT02901067|Aspirin|aspirin|mesh-list
5771751|NCT02901067|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5771752|NCT02901067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5771753|NCT02901067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5771754|NCT02901067|Analgesics|analgesics|mesh-ancestor
5771755|NCT02901067|Sensory System Agents|sensory system agents|mesh-ancestor
5771756|NCT02901067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5771757|NCT02901067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771758|NCT02901067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5771759|NCT02901067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5771760|NCT02901067|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5771761|NCT02901067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5771762|NCT02901067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771763|NCT02901067|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5771764|NCT02901067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5771765|NCT02901067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5771766|NCT02901067|Antipyretics|antipyretics|mesh-ancestor
5771767|NCT02901067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5771768|NCT02901067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5771769|NCT02901067|Antimetabolites|antimetabolites|mesh-ancestor
5771770|NCT02901067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5771771|NCT02901067|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5771772|NCT02901145|Cyclophosphamide|cyclophosphamide|mesh-list
5771773|NCT02901145|Nivolumab|nivolumab|mesh-list
5771774|NCT02901145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5771775|NCT02901145|Immunologic Factors|immunologic factors|mesh-ancestor
5771776|NCT02901145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771777|NCT02901145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5771778|NCT02901145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5771779|NCT02901145|Alkylating Agents|alkylating agents|mesh-ancestor
5771780|NCT02901145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771781|NCT02901145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5771782|NCT02901145|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5771783|NCT02901145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5771784|NCT02901145|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5771785|NCT02901301|Pembrolizumab|pembrolizumab|mesh-list
5771786|NCT02901301|Capecitabine|capecitabine|mesh-list
5771787|NCT02901301|Trastuzumab|trastuzumab|mesh-list
5771788|NCT02901301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5771789|NCT02901301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5771790|NCT02901301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5771791|NCT02901301|Antimetabolites|antimetabolites|mesh-ancestor
5771792|NCT02901301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771793|NCT02901041|Zonisamide|zonisamide|mesh-list
5771794|NCT02901041|Anticonvulsants|anticonvulsants|mesh-ancestor
5771795|NCT02901041|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5771796|NCT02901041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5771797|NCT02901041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771798|NCT02901041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5771799|NCT02901041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771800|NCT02901236|Bevacizumab|bevacizumab|mesh-list
5771801|NCT02901236|Mitomycins|mitomycins|mesh-list
5771802|NCT02901236|Mitomycin|mitomycin|mesh-list
5771803|NCT02901236|Antimetabolites|antimetabolites|mesh-list
5771804|NCT02901236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5771805|NCT02901236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5771806|NCT02901236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5771807|NCT02901236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5771808|NCT02901236|Growth Substances|growth substances|mesh-ancestor
5771809|NCT02901236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771810|NCT02901236|Growth Inhibitors|growth inhibitors|mesh-ancestor
5771811|NCT02901236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5771812|NCT02901236|Alkylating Agents|alkylating agents|mesh-ancestor
5771813|NCT02901236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771814|NCT02901236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5771815|NCT02901236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5771816|NCT02900976|Rituximab|rituximab|mesh-list
5771817|NCT02900976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5771818|NCT02900976|Antibodies|antibodies|mesh-list
5771819|NCT02900976|Immunoglobulins|immunoglobulins|mesh-list
5771820|NCT02900976|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5771821|NCT02900976|Immunologic Factors|immunologic factors|mesh-ancestor
5771822|NCT02900976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771823|NCT02900976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5771824|NCT02900976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5771825|NCT02900820|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5771826|NCT02900820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5771827|NCT02900820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5771828|NCT02900820|Antitubercular Agents|antitubercular agents|mesh-ancestor
5771829|NCT02900729|Losartan|losartan|mesh-list
5771830|NCT02900729|Amlodipine|amlodipine|mesh-list
5771831|NCT02900729|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5771832|NCT02900729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5771833|NCT02900729|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5771834|NCT02900729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5771835|NCT02900729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771836|NCT02900729|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5771837|NCT02900729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771838|NCT02900729|Vasodilator Agents|vasodilator agents|mesh-ancestor
5771839|NCT02900729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5771840|NCT02900729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5771841|NCT02900729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5771842|NCT02900729|Diuretics|diuretics|mesh-ancestor
5771843|NCT02900729|Natriuretic Agents|natriuretic agents|mesh-ancestor
5771844|NCT02900729|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5771845|NCT02900664|Trametinib|trametinib|mesh-list
5771846|NCT02900664|Spartalizumab|spartalizumab|mesh-list
5771847|NCT02900664|Nazartinib|nazartinib|mesh-list
5771848|NCT02900664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5771849|NCT02900664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5771850|NCT02900664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5771851|NCT02900664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771852|NCT02900664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5771853|NCT02900560|Pembrolizumab|pembrolizumab|mesh-list
5771854|NCT02900560|Azacitidine|azacitidine|mesh-list
5771855|NCT02900560|Cc-486|cc-486|mesh-list
5771856|NCT02900560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5771857|NCT02900560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5771858|NCT02900560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5771859|NCT02900560|Antimetabolites|antimetabolites|mesh-ancestor
5771860|NCT02900560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771861|NCT02900560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5771862|NCT02900742|Gemcitabine|gemcitabine|mesh-list
5771863|NCT02900742|Docetaxel|docetaxel|mesh-list
5771864|NCT02900742|Pemetrexed|pemetrexed|mesh-list
6673508|NCT01563328|Dolutegravir|dolutegravir|mesh-list
6673509|NCT01563328|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6673510|NCT01563328|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6673511|NCT01563328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6673512|NCT01563328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673513|NCT01563328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6673514|NCT01563328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5771865|NCT02900742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5771866|NCT02900742|Antimetabolites|antimetabolites|mesh-ancestor
6673515|NCT01563328|Antiviral Agents|antiviral agents|mesh-ancestor
5771867|NCT02900742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771868|NCT02900742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5771869|NCT02900742|Antiviral Agents|antiviral agents|mesh-ancestor
5771870|NCT02900742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5771871|NCT02900742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5771872|NCT02900742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5771873|NCT02900742|Immunologic Factors|immunologic factors|mesh-ancestor
5771874|NCT02900742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771875|NCT02900742|Tubulin Modulators|tubulin modulators|mesh-ancestor
5771876|NCT02900742|Antimitotic Agents|antimitotic agents|mesh-ancestor
5771877|NCT02900742|Mitosis Modulators|mitosis modulators|mesh-ancestor
5771878|NCT02900742|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5771879|NCT02900742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5771880|NCT02900209|Vaccines|vaccines|mesh-list
5771881|NCT02900209|Immunologic Factors|immunologic factors|mesh-ancestor
5771882|NCT02900209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771883|NCT02900352|Zonisamide|zonisamide|mesh-list
5771884|NCT02900352|Anticonvulsants|anticonvulsants|mesh-ancestor
5771885|NCT02900352|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5771886|NCT02900352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5771887|NCT02900352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771888|NCT02900352|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5771889|NCT02900352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771890|NCT02900469|Denosumab|denosumab|mesh-list
5771891|NCT02900469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5771892|NCT02900469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771893|NCT02900443|Mycophenolic Acid|mycophenolic acid|mesh-list
5771894|NCT02900443|Azathioprine|azathioprine|mesh-list
5771895|NCT02900443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5771896|NCT02900443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5771897|NCT02900443|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5771898|NCT02900443|Antitubercular Agents|antitubercular agents|mesh-ancestor
5771899|NCT02900443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5771900|NCT02900443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6673516|NCT01563328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6673517|NCT01563367|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
6673518|NCT01563367|Hematinics|hematinics|mesh-ancestor
6673519|NCT01563601|Carboplatin|carboplatin|mesh-list
5771901|NCT02900443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5771902|NCT02900443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771903|NCT02900443|Antimetabolites|antimetabolites|mesh-ancestor
5771904|NCT02900443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5771905|NCT02900443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5771906|NCT02900443|Immunologic Factors|immunologic factors|mesh-ancestor
5771907|NCT02900443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771908|NCT02900443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5896641|NCT03598270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896642|NCT03598270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5896643|NCT03598270|Antimetabolites|antimetabolites|mesh-ancestor
5896644|NCT03598270|Antiviral Agents|antiviral agents|mesh-ancestor
5896645|NCT03598270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5896646|NCT03598270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5896647|NCT03598270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5896648|NCT03598270|Immunologic Factors|immunologic factors|mesh-ancestor
5896649|NCT03598270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896650|NCT03598270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5896651|NCT03598270|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5896652|NCT03598270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5896653|NCT03598270|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5896654|NCT03580525|Nicotine|nicotine|mesh-list
5896655|NCT03580525|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5896656|NCT03580525|Autonomic Agents|autonomic agents|mesh-ancestor
5896657|NCT03580525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5896658|NCT03580525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896659|NCT03580525|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5896660|NCT03580525|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5896661|NCT03580525|Cholinergic Agents|cholinergic agents|mesh-ancestor
5896662|NCT03580525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5896663|NCT03580525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896664|NCT03560297|Nitrazepam|nitrazepam|mesh-list
5896665|NCT03560297|Anticonvulsants|anticonvulsants|mesh-ancestor
5896666|NCT03560297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5896667|NCT03560297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6673520|NCT01563601|Etoposide|etoposide|mesh-list
6673521|NCT01563601|Etoposide phosphate|etoposide phosphate|mesh-list
5771909|NCT02900417|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5771910|NCT02900417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5771911|NCT02900417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771912|NCT02900417|Incretins|incretins|mesh-ancestor
5771913|NCT02900417|Hormones|hormones|mesh-ancestor
5771914|NCT02900417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5771915|NCT02900417|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5771916|NCT02900417|Protease Inhibitors|protease inhibitors|mesh-ancestor
5771917|NCT02900417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5771918|NCT02900417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771919|NCT02900157|Durvalumab|durvalumab|mesh-list
5771920|NCT02900157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5771921|NCT02900157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5771922|NCT02900430|Antifungal Agents|antifungal agents|mesh-list
5771923|NCT02900430|Clotrimazole|clotrimazole|mesh-list
5771924|NCT02900430|Miconazole|miconazole|mesh-list
5771925|NCT02900430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5771926|NCT02900430|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5771927|NCT02900430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5771928|NCT02900430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5771929|NCT02900430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5771930|NCT02900430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771931|NCT02900430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5771932|NCT02900430|Hormone Antagonists|hormone antagonists|mesh-ancestor
5771933|NCT02900430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5771934|NCT02900430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771935|NCT02900430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5771936|NCT02900430|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5771937|NCT02900105|Letrozole|letrozole|mesh-list
5771938|NCT02900105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5771939|NCT02900105|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5771940|NCT02900105|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5771941|NCT02900105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5771942|NCT02900105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771943|NCT02900105|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5771944|NCT02900105|Hormone Antagonists|hormone antagonists|mesh-ancestor
5771945|NCT02900105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5771946|NCT02900105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771947|NCT02899702|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5771948|NCT02899702|Immunologic Factors|immunologic factors|mesh-ancestor
5771949|NCT02899702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771950|NCT02899793|Pembrolizumab|pembrolizumab|mesh-list
5771951|NCT02899793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5771952|NCT02899793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5771953|NCT02899611|Valproic Acid|valproic acid|mesh-list
5771954|NCT02899611|Anticonvulsants|anticonvulsants|mesh-ancestor
5771955|NCT02899611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5771956|NCT02899611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771957|NCT02899611|GABA Agents|gaba agents|mesh-ancestor
5771958|NCT02899611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5771959|NCT02899611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771960|NCT02899611|Antimanic Agents|antimanic agents|mesh-ancestor
5771961|NCT02899611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5771962|NCT02899611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5771963|NCT02899611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5771964|NCT02899507|Amoxicillin|amoxicillin|mesh-list
5771965|NCT02899507|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5771966|NCT02899507|Clavulanic Acids|clavulanic acids|mesh-list
5771967|NCT02899507|Clavulanic Acid|clavulanic acid|mesh-list
5771968|NCT02899507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5771969|NCT02899507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5771970|NCT02899507|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5771971|NCT02899507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5771972|NCT02899507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771973|NCT02899325|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5771974|NCT02899325|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5771975|NCT02899325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771976|NCT02899364|Sodium thiosulfate|sodium thiosulfate|mesh-list
5771977|NCT02899364|Antidotes|antidotes|mesh-ancestor
5771978|NCT02899364|Protective Agents|protective agents|mesh-ancestor
5771979|NCT02899364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771980|NCT02899364|Antioxidants|antioxidants|mesh-ancestor
5771981|NCT02899364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5771982|NCT02899364|Antitubercular Agents|antitubercular agents|mesh-ancestor
5771983|NCT02899364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5771984|NCT02899364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5771985|NCT02899364|Chelating Agents|chelating agents|mesh-ancestor
5771986|NCT02899364|Sequestering Agents|sequestering agents|mesh-ancestor
5771987|NCT02899286|BCT-100|bct-100|mesh-list
5771988|NCT02899286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5771989|NCT02899182|Nitrous Oxide|nitrous oxide|mesh-list
5771990|NCT02899182|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5771991|NCT02899182|Anesthetics, General|anesthetics, general|mesh-ancestor
5771992|NCT02899182|Anesthetics|anesthetics|mesh-ancestor
5771993|NCT02899182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5771994|NCT02899182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5771995|NCT02899182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5771996|NCT02899182|Analgesics|analgesics|mesh-ancestor
5771997|NCT02899182|Sensory System Agents|sensory system agents|mesh-ancestor
5771998|NCT02899182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5771999|NCT02899169|Tretinoin|tretinoin|mesh-list
5772000|NCT02899169|Hydroxyurea|hydroxyurea|mesh-list
5772001|NCT02899169|Arsenic Trioxide|arsenic trioxide|mesh-list
5772002|NCT02899169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5772003|NCT02899169|Keratolytic Agents|keratolytic agents|mesh-ancestor
5772004|NCT02899169|Dermatologic Agents|dermatologic agents|mesh-ancestor
5772005|NCT02899169|Antisickling Agents|antisickling agents|mesh-ancestor
5772006|NCT02899169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5772007|NCT02899169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772008|NCT02899169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5772009|NCT02899104|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
5772010|NCT02899104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6490540|NCT00598715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6490541|NCT00598715|Antifungal Agents|antifungal agents|mesh-ancestor
6490542|NCT00598715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6490543|NCT00598715|Immunologic Factors|immunologic factors|mesh-ancestor
6490544|NCT00598715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490545|NCT00598793|Insulin|insulin|mesh-list
6490546|NCT00598793|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6490547|NCT00598793|Metformin|metformin|mesh-list
6490548|NCT00598793|Insulin Glargine|insulin glargine|mesh-list
6490549|NCT00598793|Pioglitazone|pioglitazone|mesh-list
6490550|NCT00598793|Insulin Aspart|insulin aspart|mesh-list
6490551|NCT00598793|Biphasic Insulins|biphasic insulins|mesh-list
6490552|NCT00598793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6490553|NCT00598793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490554|NCT00598858|Prednisone|prednisone|mesh-list
6490555|NCT00598858|Cortisone|cortisone|mesh-list
6490556|NCT00598858|Docetaxel|docetaxel|mesh-list
5772011|NCT02899000|Doxycycline|doxycycline|mesh-list
5772012|NCT02899000|Adapalene|adapalene|mesh-list
5772013|NCT02899000|Benzoyl Peroxide|benzoyl peroxide|mesh-list
5772014|NCT02899000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5772015|NCT02899000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5772016|NCT02899000|Antimalarials|antimalarials|mesh-ancestor
5772017|NCT02899000|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5772018|NCT02899000|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5772019|NCT02899000|Dermatologic Agents|dermatologic agents|mesh-ancestor
5772020|NCT02899000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5772021|NCT02899000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5772022|NCT02899000|Analgesics|analgesics|mesh-ancestor
5772023|NCT02899000|Sensory System Agents|sensory system agents|mesh-ancestor
5772024|NCT02899000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5772025|NCT02899000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5772026|NCT02899000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5772027|NCT02899000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5772028|NCT02899143|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5772029|NCT02899143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5772030|NCT02899026|Prednisone|prednisone|mesh-list
5772031|NCT02899026|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5772032|NCT02899026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5772033|NCT02899026|Glucocorticoids|glucocorticoids|mesh-ancestor
5772034|NCT02899026|Hormones|hormones|mesh-ancestor
5772035|NCT02899026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5772036|NCT02899026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490557|NCT00598858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6490558|NCT00598858|Tubulin Modulators|tubulin modulators|mesh-ancestor
6490559|NCT00598858|Antimitotic Agents|antimitotic agents|mesh-ancestor
5772037|NCT02899026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5772038|NCT02899026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5772039|NCT02899026|Immunologic Factors|immunologic factors|mesh-ancestor
5772040|NCT02898961|Gentamicins|gentamicins|mesh-list
5772041|NCT02898961|Amikacin|amikacin|mesh-list
5772042|NCT02898961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5772043|NCT02898961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5772044|NCT02898961|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5772045|NCT02898961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5772046|NCT02898961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772047|NCT02898792|Remifentanil|remifentanil|mesh-list
5772048|NCT02898792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5772049|NCT02898792|Narcotics|narcotics|mesh-ancestor
5772050|NCT02898792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5772051|NCT02898792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5772052|NCT02898792|Analgesics|analgesics|mesh-ancestor
5772053|NCT02898792|Sensory System Agents|sensory system agents|mesh-ancestor
5772054|NCT02898792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5772055|NCT02898779|Primaquine|primaquine|mesh-list
5772056|NCT02898779|Antimalarials|antimalarials|mesh-ancestor
5772057|NCT02898779|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5772058|NCT02898779|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5772059|NCT02898779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5896668|NCT03560297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896669|NCT03560297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5896670|NCT03560297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5896671|NCT03560297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5896672|NCT03560297|GABA Modulators|gaba modulators|mesh-ancestor
5896673|NCT03560297|GABA Agents|gaba agents|mesh-ancestor
5896674|NCT03560297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5896675|NCT03560297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896676|NCT03556800|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5896677|NCT03556800|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5896678|NCT03556800|Estradiol|estradiol|mesh-list
5896679|NCT03556800|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5896680|NCT03556800|Estrogens|estrogens|mesh-ancestor
5896681|NCT03556800|Hormones|hormones|mesh-ancestor
5896682|NCT03556800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5896683|NCT03556800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896684|NCT03556800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5896685|NCT03556800|Contraceptive Agents|contraceptive agents|mesh-ancestor
5896686|NCT03556800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5896687|NCT03556800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5896688|NCT03554707|Bevacizumab|bevacizumab|mesh-list
5896689|NCT03554707|Irinotecan|irinotecan|mesh-list
5896690|NCT03554707|Temozolomide|temozolomide|mesh-list
5896691|NCT03554707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5896692|NCT03554707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5896693|NCT03554707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5896694|NCT03554707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5896695|NCT03554707|Growth Substances|growth substances|mesh-ancestor
5896696|NCT03554707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896697|NCT03554707|Growth Inhibitors|growth inhibitors|mesh-ancestor
5896698|NCT03554707|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5896699|NCT03554707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5896700|NCT03554707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5896701|NCT03554707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896702|NCT03554707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5896703|NCT03554707|Alkylating Agents|alkylating agents|mesh-ancestor
5896704|NCT03505723|Tranexamic Acid|tranexamic acid|mesh-list
5896705|NCT03505723|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5896706|NCT03505723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5896707|NCT03505723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896708|NCT03505723|Hemostatics|hemostatics|mesh-ancestor
5896709|NCT03505723|Coagulants|coagulants|mesh-ancestor
5896710|NCT03496623|Treprostinil|treprostinil|mesh-list
5896711|NCT03496623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5896712|NCT03496623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5896713|NCT03474107|Paclitaxel|paclitaxel|mesh-list
5896714|NCT03474107|Docetaxel|docetaxel|mesh-list
5896715|NCT03474107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5896716|NCT03474107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5896717|NCT03474107|Tubulin Modulators|tubulin modulators|mesh-ancestor
5896718|NCT03474107|Antimitotic Agents|antimitotic agents|mesh-ancestor
5896719|NCT03474107|Mitosis Modulators|mitosis modulators|mesh-ancestor
5896720|NCT03474107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772060|NCT02898571|Ascorbic Acid|ascorbic acid|mesh-list
5772061|NCT02898571|Vitamins|vitamins|mesh-ancestor
5772062|NCT02898571|Micronutrients|micronutrients|mesh-ancestor
5772063|NCT02898571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5772064|NCT02898571|Antioxidants|antioxidants|mesh-ancestor
5772065|NCT02898571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772066|NCT02898571|Protective Agents|protective agents|mesh-ancestor
5772067|NCT02898376|Tocopherols|tocopherols|mesh-list
5772068|NCT02898376|Vitamin E|vitamin e|mesh-list
5772069|NCT02898376|Tocotrienols|tocotrienols|mesh-list
5772070|NCT02898376|alpha-Tocopherol|alpha-tocopherol|mesh-list
5772071|NCT02898376|Pentoxifylline|pentoxifylline|mesh-list
5772072|NCT02898376|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5772073|NCT02898376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5772074|NCT02898376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772075|NCT02898376|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5772076|NCT02898376|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5772077|NCT02898376|Protective Agents|protective agents|mesh-ancestor
5772078|NCT02898376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5772079|NCT02898376|Vasodilator Agents|vasodilator agents|mesh-ancestor
5772080|NCT02898376|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5772081|NCT02898376|Antioxidants|antioxidants|mesh-ancestor
6210206|NCT02157935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210207|NCT02157948|Denosumab|denosumab|mesh-list
6210208|NCT02157948|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6210209|NCT02157948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210210|NCT02158039|Ethanol|ethanol|mesh-list
5772082|NCT02898376|Vitamins|vitamins|mesh-ancestor
5772083|NCT02898376|Micronutrients|micronutrients|mesh-ancestor
5772084|NCT02898610|Colchicine|colchicine|mesh-list
5772085|NCT02898610|Gout Suppressants|gout suppressants|mesh-ancestor
5772086|NCT02898610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5772087|NCT02898610|Tubulin Modulators|tubulin modulators|mesh-ancestor
5772088|NCT02898610|Antimitotic Agents|antimitotic agents|mesh-ancestor
5772089|NCT02898610|Mitosis Modulators|mitosis modulators|mesh-ancestor
5772090|NCT02898610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772091|NCT02898610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5772092|NCT02897934|Bupivacaine|bupivacaine|mesh-list
5772093|NCT02897934|Anesthetics, Local|anesthetics, local|mesh-ancestor
5772094|NCT02897934|Anesthetics|anesthetics|mesh-ancestor
5772095|NCT02897934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5772096|NCT02897934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5772097|NCT02897934|Sensory System Agents|sensory system agents|mesh-ancestor
5772098|NCT02897934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5772099|NCT02897986|Vinorelbine|vinorelbine|mesh-list
5772100|NCT02897986|Propranolol|propranolol|mesh-list
5772101|NCT02897986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5772102|NCT02897986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5772103|NCT02897986|Tubulin Modulators|tubulin modulators|mesh-ancestor
5772104|NCT02897986|Antimitotic Agents|antimitotic agents|mesh-ancestor
5772105|NCT02897986|Mitosis Modulators|mitosis modulators|mesh-ancestor
5772106|NCT02897986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772107|NCT02897986|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5772108|NCT02897986|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5772109|NCT02897986|Adrenergic Agents|adrenergic agents|mesh-ancestor
5772110|NCT02897986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5772111|NCT02897986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5772112|NCT02897986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5772113|NCT02897986|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5772114|NCT02897986|Vasodilator Agents|vasodilator agents|mesh-ancestor
5772115|NCT02898012|Bevacizumab|bevacizumab|mesh-list
5772116|NCT02898012|Temozolomide|temozolomide|mesh-list
5772117|NCT02898012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5772118|NCT02898012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5772119|NCT02898012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5772120|NCT02898012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5772121|NCT02898012|Growth Substances|growth substances|mesh-ancestor
5772122|NCT02898012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5772123|NCT02898012|Growth Inhibitors|growth inhibitors|mesh-ancestor
5772124|NCT02898012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5772125|NCT02898012|Alkylating Agents|alkylating agents|mesh-ancestor
5772126|NCT02898012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772127|NCT02897778|Entinostat|entinostat|mesh-list
5772128|NCT02897778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5772129|NCT02897778|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5772130|NCT02897778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6210211|NCT02158039|Lidocaine|lidocaine|mesh-list
5772131|NCT02897778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772132|NCT02897869|Amikacin|amikacin|mesh-list
5772133|NCT02897869|Murepavadin|murepavadin|mesh-list
5772134|NCT02897869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5772135|NCT02897869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5772136|NCT02897856|Midazolam|midazolam|mesh-list
5772137|NCT02897856|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5772138|NCT02897856|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5772139|NCT02897856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5772140|NCT02897856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5772141|NCT02897856|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5772142|NCT02897856|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5772143|NCT02897856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5772144|NCT02897856|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5772145|NCT02897856|Anesthetics, General|anesthetics, general|mesh-ancestor
5772146|NCT02897856|Anesthetics|anesthetics|mesh-ancestor
5772147|NCT02897856|GABA Modulators|gaba modulators|mesh-ancestor
5772148|NCT02897856|GABA Agents|gaba agents|mesh-ancestor
5772149|NCT02897856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5772150|NCT02897856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772151|NCT02897830|Dexamethasone|dexamethasone|mesh-list
5772152|NCT02897830|Lenalidomide|lenalidomide|mesh-list
5772153|NCT02897830|Ixazomib|ixazomib|mesh-list
5772154|NCT02897830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5772155|NCT02897830|Antiemetics|antiemetics|mesh-ancestor
5772156|NCT02897830|Autonomic Agents|autonomic agents|mesh-ancestor
5772157|NCT02897830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5772158|NCT02897830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5772159|NCT02897830|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5772160|NCT02897830|Glucocorticoids|glucocorticoids|mesh-ancestor
5772161|NCT02897830|Hormones|hormones|mesh-ancestor
5772162|NCT02897830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5772163|NCT02897830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5772164|NCT02897830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5772165|NCT02897830|Immunologic Factors|immunologic factors|mesh-ancestor
5772166|NCT02897830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5772167|NCT02897830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5772168|NCT02897830|Growth Substances|growth substances|mesh-ancestor
5772169|NCT02897830|Growth Inhibitors|growth inhibitors|mesh-ancestor
5772170|NCT02897830|Protease Inhibitors|protease inhibitors|mesh-ancestor
5772171|NCT02897830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5772172|NCT02897830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772173|NCT02897765|Nivolumab|nivolumab|mesh-list
5772174|NCT02897765|Poly ICLC|poly iclc|mesh-list
5772175|NCT02897765|Immunologic Factors|immunologic factors|mesh-ancestor
5772176|NCT02897765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5772177|NCT02897765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5772178|NCT02897765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5772179|NCT02897765|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5772180|NCT02897765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772181|NCT02897765|Interferon Inducers|interferon inducers|mesh-ancestor
5772182|NCT02897557|Pancrelipase|pancrelipase|mesh-list
5772183|NCT02897557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5772184|NCT02897700|Cyclophosphamide|cyclophosphamide|mesh-list
5772185|NCT02897700|Doxorubicin|doxorubicin|mesh-list
5772186|NCT02897700|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5772187|NCT02897700|Fluorouracil|fluorouracil|mesh-list
5772188|NCT02897700|Methotrexate|methotrexate|mesh-list
5772189|NCT02897700|Epirubicin|epirubicin|mesh-list
5772190|NCT02897700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5772191|NCT02897700|Immunologic Factors|immunologic factors|mesh-ancestor
5772192|NCT02897700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5772193|NCT02897700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5772194|NCT02897700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5772195|NCT02897700|Alkylating Agents|alkylating agents|mesh-ancestor
5772196|NCT02897700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772197|NCT02897700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5772198|NCT02897700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5772199|NCT02897700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5772200|NCT02897700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5772201|NCT02897700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5772202|NCT02897700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5772203|NCT02897700|Antimetabolites|antimetabolites|mesh-ancestor
5772204|NCT02897700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5772205|NCT02897700|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5772206|NCT02897700|Abortifacient Agents|abortifacient agents|mesh-ancestor
6210212|NCT02158039|Anesthetics, Local|anesthetics, local|mesh-ancestor
6210213|NCT02158039|Anesthetics|anesthetics|mesh-ancestor
6210214|NCT02158039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6210215|NCT02158039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210216|NCT02158039|Sensory System Agents|sensory system agents|mesh-ancestor
6210217|NCT02158039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6210218|NCT02158039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6210219|NCT02158039|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6210220|NCT02158039|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6210221|NCT02158039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6490560|NCT00598858|Mitosis Modulators|mitosis modulators|mesh-ancestor
6490561|NCT00598858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772207|NCT02897700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5772208|NCT02897700|Dermatologic Agents|dermatologic agents|mesh-ancestor
5772209|NCT02897700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6490562|NCT00598858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6490563|NCT00598858|Glucocorticoids|glucocorticoids|mesh-ancestor
6490564|NCT00598858|Hormones|hormones|mesh-ancestor
6490565|NCT00598858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6490566|NCT00598858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5772210|NCT02897700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5772211|NCT02897596|Grazoprevir|grazoprevir|mesh-list
5772212|NCT02897596|Antiviral Agents|antiviral agents|mesh-ancestor
5772213|NCT02897596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5772214|NCT02897466|Anti-Infective Agents|anti-infective agents|mesh-list
5772215|NCT02897466|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5772216|NCT02897375|Carboplatin|carboplatin|mesh-list
5772217|NCT02897375|Palbociclib|palbociclib|mesh-list
5772218|NCT02897375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5772219|NCT02897375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5772220|NCT02897375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5772221|NCT02897375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772222|NCT02897206|Imipenem|imipenem|mesh-list
5772223|NCT02897206|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
5772224|NCT02897206|Cilastatin|cilastatin|mesh-list
5772225|NCT02897206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5772226|NCT02897206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5772227|NCT02897206|Protease Inhibitors|protease inhibitors|mesh-ancestor
5772228|NCT02897206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5772229|NCT02897206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896721|NCT03472092|Amitriptyline|amitriptyline|mesh-list
5896722|NCT03472092|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
5896723|NCT03472092|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5896724|NCT03472092|Antidepressive Agents|antidepressive agents|mesh-ancestor
5896725|NCT03472092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5896726|NCT03472092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5896727|NCT03472092|Analgesics|analgesics|mesh-ancestor
5896728|NCT03472092|Sensory System Agents|sensory system agents|mesh-ancestor
5896729|NCT03472092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5896730|NCT03472092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896731|NCT03472092|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5896732|NCT03472092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5896733|NCT03472092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5896734|NCT03472092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896735|NCT03472092|Adrenergic Agents|adrenergic agents|mesh-ancestor
5896736|NCT03472092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5896737|NCT03472092|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5896738|NCT03472092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5896739|NCT03472092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5896740|NCT03464045|Empagliflozin|empagliflozin|mesh-list
5896741|NCT03464045|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
5896742|NCT03464045|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
5896743|NCT03464045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896744|NCT03464045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5896745|NCT03464045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896746|NCT03464045|Protease Inhibitors|protease inhibitors|mesh-ancestor
5896747|NCT03464045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5896748|NCT03436862|Nivolumab|nivolumab|mesh-list
5896749|NCT03436862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5896750|NCT03436862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5896751|NCT03436862|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5896752|NCT03436862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772230|NCT02897401|Carbon Monoxide|carbon monoxide|mesh-list
5772231|NCT02897401|Antimetabolites|antimetabolites|mesh-ancestor
5772232|NCT02897401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772233|NCT02897401|Gasotransmitters|gasotransmitters|mesh-ancestor
5772234|NCT02897401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5772235|NCT02897401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5772236|NCT02897219|Ipragliflozin|ipragliflozin|mesh-list
5772237|NCT02897219|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5772238|NCT02897219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5772239|NCT02897219|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5772240|NCT02897219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772241|NCT02897063|Midodrine|midodrine|mesh-list
5772242|NCT02897063|Droxidopa|droxidopa|mesh-list
5772243|NCT02897063|Sympathomimetics|sympathomimetics|mesh-ancestor
5772244|NCT02897063|Autonomic Agents|autonomic agents|mesh-ancestor
5772245|NCT02897063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5772246|NCT02897063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5772247|NCT02897063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5772248|NCT02897063|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5772249|NCT02897063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5772250|NCT02897063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5772251|NCT02897063|Adrenergic Agents|adrenergic agents|mesh-ancestor
5772252|NCT02897063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5772253|NCT02897063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772254|NCT02897063|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5772255|NCT02897063|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5772256|NCT02897076|Betamethasone|betamethasone|mesh-list
5772257|NCT02897076|Betamethasone Valerate|betamethasone valerate|mesh-list
5772258|NCT02897076|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5772259|NCT02897076|Betamethasone benzoate|betamethasone benzoate|mesh-list
5772260|NCT02897076|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
5772261|NCT02897076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5772262|NCT02897076|Glucocorticoids|glucocorticoids|mesh-ancestor
5772263|NCT02897076|Hormones|hormones|mesh-ancestor
5772264|NCT02897076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5772265|NCT02897076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5772266|NCT02897076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5772267|NCT02897076|Respiratory System Agents|respiratory system agents|mesh-ancestor
5772268|NCT02896829|Imatinib Mesylate|imatinib mesylate|mesh-list
5772269|NCT02896829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5772270|NCT02896829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5772271|NCT02896829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5772272|NCT02896829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772273|NCT02897050|Cyclophosphamide|cyclophosphamide|mesh-list
5772274|NCT02897050|Docetaxel|docetaxel|mesh-list
5772275|NCT02897050|Fluorouracil|fluorouracil|mesh-list
5772276|NCT02897050|Capecitabine|capecitabine|mesh-list
5772277|NCT02897050|Epirubicin|epirubicin|mesh-list
5772278|NCT02897050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5772279|NCT02897050|Immunologic Factors|immunologic factors|mesh-ancestor
5772280|NCT02897050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5772281|NCT02897050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5640782|NCT04695652|Somatomedin B|somatomedin b|mesh-list
5640783|NCT04695652|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5640784|NCT04695652|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5640785|NCT04695652|Protease Inhibitors|protease inhibitors|mesh-ancestor
5640786|NCT04695652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5640787|NCT04695652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640788|NCT04647084|Lidocaine|lidocaine|mesh-list
5640789|NCT04647084|Anesthetics, Local|anesthetics, local|mesh-ancestor
5640790|NCT04647084|Anesthetics|anesthetics|mesh-ancestor
5640791|NCT04647084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5640792|NCT04647084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640793|NCT04647084|Sensory System Agents|sensory system agents|mesh-ancestor
5640794|NCT04647084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5640795|NCT04647084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5640796|NCT04647084|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5640797|NCT04647084|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5640798|NCT04647084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5640799|NCT04647084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640800|NCT04632927|Ustekinumab|ustekinumab|mesh-list
5640801|NCT04632927|Dermatologic Agents|dermatologic agents|mesh-ancestor
5640802|NCT04620798|Antibodies|antibodies|mesh-list
5640803|NCT04620798|Immunologic Factors|immunologic factors|mesh-ancestor
5772282|NCT02897050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5772283|NCT02897050|Alkylating Agents|alkylating agents|mesh-ancestor
5772284|NCT02897050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772285|NCT02897050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5772286|NCT02897050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5772287|NCT02897050|Tubulin Modulators|tubulin modulators|mesh-ancestor
5772288|NCT02897050|Antimitotic Agents|antimitotic agents|mesh-ancestor
5772289|NCT02897050|Mitosis Modulators|mitosis modulators|mesh-ancestor
5772290|NCT02897050|Antimetabolites|antimetabolites|mesh-ancestor
5772291|NCT02897050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5772292|NCT02897050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5772293|NCT02897050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5772294|NCT02897050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5772295|NCT02897050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5772296|NCT02896842|Imatinib Mesylate|imatinib mesylate|mesh-list
5772297|NCT02896842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5772298|NCT02896842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5772299|NCT02896842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5772300|NCT02896842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490567|NCT00598858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6490568|NCT00598897|Clarithromycin|clarithromycin|mesh-list
6490569|NCT00598897|Rifabutin|rifabutin|mesh-list
6490570|NCT00598897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6490571|NCT00598897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6490572|NCT00598897|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6490573|NCT00598897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6490574|NCT00598897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490575|NCT00598897|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6490576|NCT00598897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5772301|NCT02896803|Fluorouracil|fluorouracil|mesh-list
5772302|NCT02896803|Oxaliplatin|oxaliplatin|mesh-list
5772303|NCT02896803|Antimetabolites|antimetabolites|mesh-ancestor
5772304|NCT02896803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772305|NCT02896803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5772306|NCT02896803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5772307|NCT02896803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5772308|NCT02896803|Immunologic Factors|immunologic factors|mesh-ancestor
5772309|NCT02896803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5772310|NCT02897037|Heparin|heparin|mesh-list
5772311|NCT02897037|Bivalirudin|bivalirudin|mesh-list
5772312|NCT02897037|Anticoagulants|anticoagulants|mesh-ancestor
5772313|NCT02897037|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5772314|NCT02897037|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5772315|NCT02897037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772316|NCT02897037|Antithrombins|antithrombins|mesh-ancestor
5772317|NCT02897037|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5772318|NCT02897037|Protease Inhibitors|protease inhibitors|mesh-ancestor
5772319|NCT02897037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5772320|NCT02897011|Methotrexate|methotrexate|mesh-list
5772321|NCT02897011|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5772322|NCT02897011|Abortifacient Agents|abortifacient agents|mesh-ancestor
5772323|NCT02897011|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5772324|NCT02897011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5772325|NCT02897011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5772326|NCT02897011|Antimetabolites|antimetabolites|mesh-ancestor
5772327|NCT02897011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772328|NCT02897011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5772329|NCT02897011|Dermatologic Agents|dermatologic agents|mesh-ancestor
5772330|NCT02897011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5772331|NCT02897011|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6490577|NCT00598897|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6490578|NCT00598897|Antitubercular Agents|antitubercular agents|mesh-ancestor
6490579|NCT00598923|Topiramate|topiramate|mesh-list
6490580|NCT00598923|Phenytoin|phenytoin|mesh-list
6490581|NCT00598923|Anticonvulsants|anticonvulsants|mesh-ancestor
6490582|NCT00598923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6490583|NCT00598923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490584|NCT00598923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6490585|NCT00598923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6490586|NCT00598923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6490587|NCT00598923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772332|NCT02897011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5772333|NCT02897011|Immunologic Factors|immunologic factors|mesh-ancestor
5772334|NCT02897011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6673522|NCT01563601|Obatoclax|obatoclax|mesh-list
6673523|NCT01563601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6673524|NCT01563601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6673525|NCT01563601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6673526|NCT01563601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6673527|NCT01563601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6673528|NCT01563601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673529|NCT01563614|Cytarabine|cytarabine|mesh-list
6673530|NCT01563614|Lomustine|lomustine|mesh-list
6673531|NCT01563614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5772335|NCT02897011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5772336|NCT02896621|Amlodipine|amlodipine|mesh-list
5772337|NCT02896621|Chlorthalidone|chlorthalidone|mesh-list
5772338|NCT02896621|Amiloride|amiloride|mesh-list
5772339|NCT02896621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5772340|NCT02896621|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5772341|NCT02896621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5772342|NCT02896621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772343|NCT02896621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5772344|NCT02896621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5772345|NCT02896621|Vasodilator Agents|vasodilator agents|mesh-ancestor
5772346|NCT02896621|Diuretics|diuretics|mesh-ancestor
5772347|NCT02896621|Natriuretic Agents|natriuretic agents|mesh-ancestor
5772348|NCT02896621|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5772349|NCT02896621|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
5772350|NCT02896621|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5772351|NCT02896621|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
5772352|NCT02896621|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5772353|NCT02896582|Cytarabine|cytarabine|mesh-list
5772354|NCT02896582|Dexamethasone|dexamethasone|mesh-list
5772355|NCT02896582|Etoposide|etoposide|mesh-list
5772356|NCT02896582|Melphalan|melphalan|mesh-list
5772357|NCT02896582|Cisplatin|cisplatin|mesh-list
5772358|NCT02896582|Obinutuzumab|obinutuzumab|mesh-list
5772359|NCT02896582|Carmustine|carmustine|mesh-list
5772360|NCT02896582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5772361|NCT02896582|Antiemetics|antiemetics|mesh-ancestor
5772362|NCT02896582|Autonomic Agents|autonomic agents|mesh-ancestor
5772363|NCT02896582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5772364|NCT02896582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5772365|NCT02896582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5772366|NCT02896582|Glucocorticoids|glucocorticoids|mesh-ancestor
5772367|NCT02896582|Hormones|hormones|mesh-ancestor
5772368|NCT02896582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5772369|NCT02896582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5772370|NCT02896582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5772371|NCT02896582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5772372|NCT02896582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5772373|NCT02896582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5772374|NCT02896582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5772375|NCT02896582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772376|NCT02896582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5772377|NCT02896582|Antimetabolites|antimetabolites|mesh-ancestor
5772378|NCT02896582|Antiviral Agents|antiviral agents|mesh-ancestor
5772379|NCT02896582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5772380|NCT02896582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5772381|NCT02896582|Immunologic Factors|immunologic factors|mesh-ancestor
5772382|NCT02896582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5772383|NCT02896582|Alkylating Agents|alkylating agents|mesh-ancestor
5772384|NCT02896582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5772385|NCT02896582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5772386|NCT02896413|Dexmedetomidine|dexmedetomidine|mesh-list
5772387|NCT02896413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5772388|NCT02896413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5772389|NCT02896413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5772390|NCT02896413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5772391|NCT02896413|Analgesics|analgesics|mesh-ancestor
5772392|NCT02896413|Sensory System Agents|sensory system agents|mesh-ancestor
5772393|NCT02896413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5772394|NCT02896413|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5772395|NCT02896413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5772396|NCT02896413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5772397|NCT02896413|Adrenergic Agents|adrenergic agents|mesh-ancestor
5772398|NCT02896413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5772399|NCT02896413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772400|NCT02896270|Valproic Acid|valproic acid|mesh-list
5772401|NCT02896270|Anticonvulsants|anticonvulsants|mesh-ancestor
5772402|NCT02896270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5772403|NCT02896270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772404|NCT02896270|GABA Agents|gaba agents|mesh-ancestor
5772405|NCT02896270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5772406|NCT02896270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5772407|NCT02896270|Antimanic Agents|antimanic agents|mesh-ancestor
5772408|NCT02896270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5772409|NCT02896270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5772410|NCT02896270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5772411|NCT02896205|Mycophenolic Acid|mycophenolic acid|mesh-list
5772412|NCT02896205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5772413|NCT02896205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5772414|NCT02896205|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5772415|NCT02896205|Antitubercular Agents|antitubercular agents|mesh-ancestor
5772416|NCT02896205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5772417|NCT02896205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5772418|NCT02896205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5772419|NCT02896205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772420|NCT02896101|Pimecrolimus|pimecrolimus|mesh-list
5772421|NCT02896101|Tacrolimus|tacrolimus|mesh-list
5772422|NCT02896101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5772423|NCT02896101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5772424|NCT02896101|Analgesics|analgesics|mesh-ancestor
5772425|NCT02896101|Sensory System Agents|sensory system agents|mesh-ancestor
5772426|NCT02896101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5772427|NCT02896101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5772428|NCT02896101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5772429|NCT02896101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5772430|NCT02896101|Dermatologic Agents|dermatologic agents|mesh-ancestor
5772431|NCT02896101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5772432|NCT02896101|Immunologic Factors|immunologic factors|mesh-ancestor
5772433|NCT02896101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5772434|NCT02896101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5772435|NCT02896101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772436|NCT02895958|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
5772437|NCT02895958|Antiviral Agents|antiviral agents|mesh-ancestor
5772438|NCT02895958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5772439|NCT02896023|Menotropins|menotropins|mesh-list
5772440|NCT02896023|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5772441|NCT02896023|Fertility Agents|fertility agents|mesh-ancestor
5772442|NCT02896023|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5772443|NCT02896023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5772444|NCT02895659|Norepinephrine|norepinephrine|mesh-list
5772445|NCT02895659|Epinephrine|epinephrine|mesh-list
5772446|NCT02895659|Racepinephrine|racepinephrine|mesh-list
5772447|NCT02895659|Epinephryl borate|epinephryl borate|mesh-list
5772448|NCT02895659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5772449|NCT02895659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5772450|NCT02895659|Adrenergic Agents|adrenergic agents|mesh-ancestor
5772451|NCT02895659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5772452|NCT02895659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772453|NCT02895659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5772454|NCT02895659|Sympathomimetics|sympathomimetics|mesh-ancestor
5772455|NCT02895659|Autonomic Agents|autonomic agents|mesh-ancestor
5772456|NCT02895659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5772457|NCT02895659|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5772458|NCT02895659|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5772459|NCT02895659|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5772460|NCT02895659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5772461|NCT02895659|Respiratory System Agents|respiratory system agents|mesh-ancestor
5772462|NCT02895659|Mydriatics|mydriatics|mesh-ancestor
5772463|NCT02895529|Itraconazole|itraconazole|mesh-list
5772464|NCT02895529|Caspofungin|caspofungin|mesh-list
5772465|NCT02895529|Antifungal Agents|antifungal agents|mesh-ancestor
5772466|NCT02895529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5772467|NCT02895529|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5772468|NCT02895529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5772469|NCT02895529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5772470|NCT02895529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772471|NCT02895529|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5772472|NCT02895529|Hormone Antagonists|hormone antagonists|mesh-ancestor
5772473|NCT02895529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6673532|NCT01563614|Antimetabolites|antimetabolites|mesh-ancestor
5772474|NCT02895529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5772475|NCT02895529|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5772476|NCT02895672|Exenatide|exenatide|mesh-list
5772477|NCT02895672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5772478|NCT02895672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5772479|NCT02895672|Incretins|incretins|mesh-ancestor
5772480|NCT02895672|Hormones|hormones|mesh-ancestor
5772481|NCT02895672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5772482|NCT02895672|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5896753|NCT03431584|Hyaluronic Acid|hyaluronic acid|mesh-list
5896754|NCT03431584|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5896755|NCT03431584|Immunologic Factors|immunologic factors|mesh-ancestor
5896756|NCT03431584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896757|NCT03431584|Viscosupplements|viscosupplements|mesh-ancestor
5896758|NCT03431584|Protective Agents|protective agents|mesh-ancestor
5896759|NCT03410875|Obinutuzumab|obinutuzumab|mesh-list
5896760|NCT03410875|Vemurafenib|vemurafenib|mesh-list
5896761|NCT03410875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5896762|NCT03410875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5896763|NCT03410875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5896764|NCT03410875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5896765|NCT03410875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896766|NCT03401320|Letrozole|letrozole|mesh-list
5896767|NCT03401320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5896768|NCT03401320|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5896769|NCT03401320|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5896770|NCT03401320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5896771|NCT03401320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896772|NCT03401320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5896773|NCT03401320|Hormone Antagonists|hormone antagonists|mesh-ancestor
5896774|NCT03401320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5896775|NCT03401320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896776|NCT03343301|Bemarituzumab|bemarituzumab|mesh-list
5896777|NCT03343301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5896778|NCT03343301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5896779|NCT03321019|Capsaicin|capsaicin|mesh-list
5896780|NCT03321019|Antipruritics|antipruritics|mesh-ancestor
5896781|NCT03321019|Dermatologic Agents|dermatologic agents|mesh-ancestor
5896782|NCT03321019|Sensory System Agents|sensory system agents|mesh-ancestor
5896783|NCT03321019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5896784|NCT03321019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896785|NCT03317613|Capsaicin|capsaicin|mesh-list
5896786|NCT03317613|Antipruritics|antipruritics|mesh-ancestor
5896787|NCT03317613|Dermatologic Agents|dermatologic agents|mesh-ancestor
5896788|NCT03317613|Sensory System Agents|sensory system agents|mesh-ancestor
5896789|NCT03317613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5896790|NCT03317613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896791|NCT03310619|Nivolumab|nivolumab|mesh-list
5896792|NCT03310619|Durvalumab|durvalumab|mesh-list
5896793|NCT03310619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5896794|NCT03310619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5896795|NCT03310619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5896796|NCT03310619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896797|NCT03302910|Torsemide|torsemide|mesh-list
5896798|NCT03302910|Furosemide|furosemide|mesh-list
5896799|NCT03302910|Bumetanide|bumetanide|mesh-list
5896800|NCT03302910|Nitroglycerin|nitroglycerin|mesh-list
5896801|NCT03302910|Diuretics|diuretics|mesh-list
5896802|NCT03302910|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
5896803|NCT03302910|Natriuretic Agents|natriuretic agents|mesh-ancestor
5896804|NCT03302910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896805|NCT03302910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5896806|NCT03302910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896807|NCT03302910|Vasodilator Agents|vasodilator agents|mesh-ancestor
5896808|NCT03302910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5896809|NCT03301506|Seladelpar|seladelpar|mesh-list
5896810|NCT03301506|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5896811|NCT03301506|Antimetabolites|antimetabolites|mesh-ancestor
5896812|NCT03301506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896813|NCT03301506|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5896814|NCT03267498|Nivolumab|nivolumab|mesh-list
5896815|NCT03267498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5896816|NCT03267498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5896817|NCT03267498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5896818|NCT03267498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772483|NCT02895750|Metformin|metformin|mesh-list
5772484|NCT02895750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5772485|NCT02895750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5772486|NCT02895191|Urinastatin|urinastatin|mesh-list
5772487|NCT02895191|Trypsin Inhibitors|trypsin inhibitors|mesh-list
5772488|NCT02895191|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5772489|NCT02895191|Protease Inhibitors|protease inhibitors|mesh-ancestor
5772490|NCT02895191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5772491|NCT02895191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772492|NCT02895061|Alfacalcidol|alfacalcidol|mesh-list
5772493|NCT02895061|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
5772494|NCT02895061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5772495|NCT02895061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5772496|NCT02895061|Vitamins|vitamins|mesh-ancestor
5772497|NCT02895061|Micronutrients|micronutrients|mesh-ancestor
5772498|NCT02895113|Aspirin|aspirin|mesh-list
5772499|NCT02895113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5772500|NCT02895113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5772501|NCT02895113|Analgesics|analgesics|mesh-ancestor
5772502|NCT02895113|Sensory System Agents|sensory system agents|mesh-ancestor
5772503|NCT02895113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5772504|NCT02895113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5772505|NCT02895113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5772506|NCT02895113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5772507|NCT02895113|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5772508|NCT02895113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5772509|NCT02895113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772510|NCT02895113|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5772511|NCT02895113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5772512|NCT02895113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5772513|NCT02895113|Antipyretics|antipyretics|mesh-ancestor
5772514|NCT02895321|Listerine|listerine|mesh-list
5772515|NCT02895321|Sodium Fluoride|sodium fluoride|mesh-list
5772516|NCT02895321|Cariostatic Agents|cariostatic agents|mesh-ancestor
5772517|NCT02895321|Protective Agents|protective agents|mesh-ancestor
5772518|NCT02895321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5772519|NCT02895321|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5772520|NCT02895321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5772521|NCT02894983|Calpastatin|calpastatin|mesh-list
5772522|NCT02894983|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
5772523|NCT02894983|Protease Inhibitors|protease inhibitors|mesh-ancestor
5772524|NCT02894983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5772525|NCT02894983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772526|NCT02895022|Lidocaine|lidocaine|mesh-list
5772527|NCT02895022|Anesthetics, Local|anesthetics, local|mesh-ancestor
5772528|NCT02895022|Anesthetics|anesthetics|mesh-ancestor
5772529|NCT02895022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5772530|NCT02895022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5772531|NCT02895022|Sensory System Agents|sensory system agents|mesh-ancestor
5772532|NCT02895022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5772533|NCT02895022|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5772534|NCT02895022|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5772535|NCT02895022|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5772536|NCT02895022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5772537|NCT02895022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673533|NCT01563614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673534|NCT01563614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6673535|NCT01563614|Antiviral Agents|antiviral agents|mesh-ancestor
6673536|NCT01563614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6673537|NCT01563614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5772538|NCT02894957|Varenicline|varenicline|mesh-list
5772539|NCT02894957|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5772540|NCT02894957|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5772541|NCT02894957|Cholinergic Agents|cholinergic agents|mesh-ancestor
5772542|NCT02894957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5772543|NCT02894957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772544|NCT02894957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5772545|NCT02895074|Proxymetacaine|proxymetacaine|mesh-list
5772546|NCT02895074|Tropicamide|tropicamide|mesh-list
5772547|NCT02895074|Mydriatics|mydriatics|mesh-ancestor
5772548|NCT02895074|Autonomic Agents|autonomic agents|mesh-ancestor
5772549|NCT02895074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5772550|NCT02895074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5772551|NCT02895074|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5772552|NCT02895074|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5772553|NCT02895074|Cholinergic Agents|cholinergic agents|mesh-ancestor
5772554|NCT02895074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5772555|NCT02895074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772556|NCT02895074|Anesthetics, Local|anesthetics, local|mesh-ancestor
5772557|NCT02895074|Anesthetics|anesthetics|mesh-ancestor
5772558|NCT02895074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5772559|NCT02895074|Sensory System Agents|sensory system agents|mesh-ancestor
5772560|NCT02894892|Esomeprazole|esomeprazole|mesh-list
5772561|NCT02894892|Bismuth|bismuth|mesh-list
5772562|NCT02894892|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5772563|NCT02894892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5772564|NCT02894892|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5772565|NCT02894892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5772566|NCT02894892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772567|NCT02894892|Antacids|antacids|mesh-ancestor
5772568|NCT02894905|Adafosbuvir|adafosbuvir|mesh-list
5772569|NCT02894905|Antiviral Agents|antiviral agents|mesh-ancestor
5772570|NCT02894905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5772571|NCT02894918|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5772572|NCT02894918|Antiviral Agents|antiviral agents|mesh-ancestor
5772573|NCT02894918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5772574|NCT02894593|Ethanol|ethanol|mesh-list
5772575|NCT02894593|Chlorhexidine|chlorhexidine|mesh-list
5772576|NCT02894593|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5772577|NCT02894593|Listerine|listerine|mesh-list
5772578|NCT02894593|Sodium Fluoride|sodium fluoride|mesh-list
5772579|NCT02894593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5772580|NCT02894593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5772581|NCT02894593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5772582|NCT02894593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5772583|NCT02894593|Disinfectants|disinfectants|mesh-ancestor
5772584|NCT02894593|Dermatologic Agents|dermatologic agents|mesh-ancestor
5772585|NCT02894593|Cariostatic Agents|cariostatic agents|mesh-ancestor
5772586|NCT02894593|Protective Agents|protective agents|mesh-ancestor
5772587|NCT02894554|Lamivudine|lamivudine|mesh-list
5772588|NCT02894554|Telbivudine|telbivudine|mesh-list
5772589|NCT02894554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5772590|NCT02894554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5772591|NCT02894554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5772592|NCT02894554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772593|NCT02894554|Antiviral Agents|antiviral agents|mesh-ancestor
5772594|NCT02894554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5772595|NCT02894554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5772596|NCT02894554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5772597|NCT02894606|Thymoglobulin|thymoglobulin|mesh-list
5772598|NCT02894606|Basiliximab|basiliximab|mesh-list
5772599|NCT02894606|Immunologic Factors|immunologic factors|mesh-ancestor
5772600|NCT02894606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5772601|NCT02894606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5772602|NCT02894684|Aztreonam|aztreonam|mesh-list
5772603|NCT02894684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5772604|NCT02894684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5772605|NCT02894710|Lidocaine|lidocaine|mesh-list
5772606|NCT02894710|Anesthetics, Local|anesthetics, local|mesh-ancestor
5772607|NCT02894710|Anesthetics|anesthetics|mesh-ancestor
5772608|NCT02894710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5772609|NCT02894710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5772610|NCT02894710|Sensory System Agents|sensory system agents|mesh-ancestor
5772611|NCT02894710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5772612|NCT02894710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5772613|NCT02894710|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5772614|NCT02894710|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5772615|NCT02894710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5772616|NCT02894710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772617|NCT02894645|Cytarabine|cytarabine|mesh-list
5772618|NCT02894645|Dexamethasone|dexamethasone|mesh-list
5772619|NCT02894645|Prednisolone|prednisolone|mesh-list
5772620|NCT02894645|Cyclophosphamide|cyclophosphamide|mesh-list
5772621|NCT02894645|Doxorubicin|doxorubicin|mesh-list
5772622|NCT02894645|Methotrexate|methotrexate|mesh-list
5772623|NCT02894645|Fludarabine|fludarabine|mesh-list
5772624|NCT02894645|Vincristine|vincristine|mesh-list
5772625|NCT02894645|Daunorubicin|daunorubicin|mesh-list
5772626|NCT02894645|Asparaginase|asparaginase|mesh-list
5772627|NCT02894645|Mercaptopurine|mercaptopurine|mesh-list
5772628|NCT02894645|Thioguanine|thioguanine|mesh-list
5772629|NCT02894645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5772630|NCT02894645|Immunologic Factors|immunologic factors|mesh-ancestor
5772631|NCT02894645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5772632|NCT02894645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5772633|NCT02894645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5772634|NCT02894645|Alkylating Agents|alkylating agents|mesh-ancestor
5772635|NCT02894645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772636|NCT02894645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5772637|NCT02894645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5772638|NCT02894645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5772639|NCT02894645|Antiemetics|antiemetics|mesh-ancestor
5772640|NCT02894645|Autonomic Agents|autonomic agents|mesh-ancestor
5772641|NCT02894645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5772642|NCT02894645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5772643|NCT02894645|Glucocorticoids|glucocorticoids|mesh-ancestor
5772644|NCT02894645|Hormones|hormones|mesh-ancestor
5772645|NCT02894645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5772646|NCT02894645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5772647|NCT02894645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5772648|NCT02894645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5772649|NCT02894645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5772650|NCT02894645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5772651|NCT02894645|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5772652|NCT02894645|Abortifacient Agents|abortifacient agents|mesh-ancestor
5772653|NCT02894645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5772654|NCT02894645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5772655|NCT02894645|Antimetabolites|antimetabolites|mesh-ancestor
5772656|NCT02894645|Dermatologic Agents|dermatologic agents|mesh-ancestor
5772657|NCT02894645|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5772658|NCT02894645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5772659|NCT02894645|Antiviral Agents|antiviral agents|mesh-ancestor
5772660|NCT02894645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5772661|NCT02894645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5772662|NCT02894645|Tubulin Modulators|tubulin modulators|mesh-ancestor
5772663|NCT02894645|Antimitotic Agents|antimitotic agents|mesh-ancestor
5772664|NCT02894645|Mitosis Modulators|mitosis modulators|mesh-ancestor
5772665|NCT02894138|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5772666|NCT02894138|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5772667|NCT02894138|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5772668|NCT02894138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772669|NCT02894307|Rivaroxaban|rivaroxaban|mesh-list
5772670|NCT02894307|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5772671|NCT02894307|Antithrombins|antithrombins|mesh-ancestor
5772672|NCT02894307|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5772673|NCT02894307|Protease Inhibitors|protease inhibitors|mesh-ancestor
5772674|NCT02894307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5772675|NCT02894307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772676|NCT02894307|Anticoagulants|anticoagulants|mesh-ancestor
5772677|NCT02894151|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
5772678|NCT02894151|Medroxyprogesterone|medroxyprogesterone|mesh-list
5772679|NCT02894151|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5772680|NCT02894151|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5772681|NCT02894151|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5772682|NCT02894151|Contraceptive Agents|contraceptive agents|mesh-ancestor
5772683|NCT02894151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5772684|NCT02894151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5772685|NCT02894151|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5772686|NCT02894151|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5772687|NCT02894151|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5772688|NCT02894151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5772689|NCT02894151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5896819|NCT03251729|Progesterone|progesterone|mesh-list
5896820|NCT03251729|Progestins|progestins|mesh-ancestor
5896821|NCT03251729|Hormones|hormones|mesh-ancestor
5896822|NCT03251729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5896823|NCT03251729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896824|NCT03206073|Durvalumab|durvalumab|mesh-list
5896825|NCT03206073|Tremelimumab|tremelimumab|mesh-list
5896826|NCT03206073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5896827|NCT03206073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5896828|NCT03205137|Amlodipine|amlodipine|mesh-list
5896829|NCT03205137|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5896830|NCT03205137|Telmisartan|telmisartan|mesh-list
5896831|NCT03205137|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
5896832|NCT03205137|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
5896833|NCT03205137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5772690|NCT02893995|Treprostinil|treprostinil|mesh-list
5772691|NCT02893995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5772692|NCT02894268|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5772693|NCT02894268|Doxycycline|doxycycline|mesh-list
5772694|NCT02894268|Furazolidone|furazolidone|mesh-list
5772695|NCT02894268|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
5772696|NCT02894268|Esomeprazole|esomeprazole|mesh-list
5772697|NCT02894268|Bismuth|bismuth|mesh-list
5772698|NCT02894268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5772699|NCT02894268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5772700|NCT02894268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5772701|NCT02894268|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5772702|NCT02894268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5772703|NCT02894268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772704|NCT02894268|Antimalarials|antimalarials|mesh-ancestor
5772705|NCT02894268|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5772706|NCT02894268|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5772707|NCT02894268|Antacids|antacids|mesh-ancestor
5772708|NCT02894268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5772709|NCT02894268|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5772710|NCT02894268|Renal Agents|renal agents|mesh-ancestor
5772711|NCT02894268|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
5772712|NCT02894268|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
5772713|NCT02893618|Diazoxide|diazoxide|mesh-list
5772714|NCT02893618|Choline|choline|mesh-list
5772715|NCT02893618|Lipotropic Agents|lipotropic agents|mesh-ancestor
5772716|NCT02893618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5772717|NCT02893618|Antimetabolites|antimetabolites|mesh-ancestor
5772718|NCT02893618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772719|NCT02893618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5772720|NCT02893618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5772721|NCT02893618|Nootropic Agents|nootropic agents|mesh-ancestor
5772722|NCT02893618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5772723|NCT02893618|Vasodilator Agents|vasodilator agents|mesh-ancestor
5772724|NCT02893722|Oxytocin|oxytocin|mesh-list
5772725|NCT02893722|Atosiban|atosiban|mesh-list
5772726|NCT02893722|Oxytocics|oxytocics|mesh-ancestor
5772727|NCT02893722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5772728|NCT02893722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5772729|NCT02893722|Hormone Antagonists|hormone antagonists|mesh-ancestor
5772730|NCT02893722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5772731|NCT02893722|Tocolytic Agents|tocolytic agents|mesh-ancestor
5772732|NCT02893709|Omeprazole|omeprazole|mesh-list
5772733|NCT02893709|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5772734|NCT02893709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5772735|NCT02893709|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5772736|NCT02893709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5772737|NCT02893709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772738|NCT02893826|Nimodipine|nimodipine|mesh-list
5772739|NCT02893826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5772740|NCT02893826|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5772741|NCT02893826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5772742|NCT02893826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772743|NCT02893826|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5772744|NCT02893826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5772745|NCT02893826|Vasodilator Agents|vasodilator agents|mesh-ancestor
5772746|NCT02893332|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5772747|NCT02893332|Gefitinib|gefitinib|mesh-list
5772748|NCT02893332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5772749|NCT02893332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5772750|NCT02893332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5772751|NCT02893332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772752|NCT02893280|Aspirin|aspirin|mesh-list
5772753|NCT02893280|Enoxaparin|enoxaparin|mesh-list
5772754|NCT02893280|Streptokinase|streptokinase|mesh-list
5772755|NCT02893280|Clopidogrel|clopidogrel|mesh-list
5772756|NCT02893280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5772757|NCT02893280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5772758|NCT02893280|Analgesics|analgesics|mesh-ancestor
5772759|NCT02893280|Sensory System Agents|sensory system agents|mesh-ancestor
5772760|NCT02893280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5772761|NCT02893280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5772762|NCT02893280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5772763|NCT02893280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5772764|NCT02893280|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5772765|NCT02893280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5772766|NCT02893280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772767|NCT02893280|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5772768|NCT02893280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5772769|NCT02893280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5772770|NCT02893280|Antipyretics|antipyretics|mesh-ancestor
5772771|NCT02893280|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5772772|NCT02893280|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5772773|NCT02893280|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5772774|NCT02893280|Purinergic Agents|purinergic agents|mesh-ancestor
5772775|NCT02893280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5772776|NCT02893280|Anticoagulants|anticoagulants|mesh-ancestor
5772777|NCT02893553|Midodrine|midodrine|mesh-list
5772778|NCT02893553|Bromides|bromides|mesh-list
5772779|NCT02893553|Mirabegron|mirabegron|mesh-list
5772780|NCT02893553|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
5772781|NCT02893553|Anticonvulsants|anticonvulsants|mesh-ancestor
5772782|NCT02893553|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
5772783|NCT02893553|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5772784|NCT02893553|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5772785|NCT02893553|Adrenergic Agents|adrenergic agents|mesh-ancestor
5772786|NCT02893553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5772787|NCT02893553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772788|NCT02893553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5772789|NCT02893553|Urological Agents|urological agents|mesh-ancestor
5772790|NCT02893553|Sympathomimetics|sympathomimetics|mesh-ancestor
5772791|NCT02893553|Autonomic Agents|autonomic agents|mesh-ancestor
5772792|NCT02893553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5772793|NCT02893553|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5772794|NCT02893553|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5772795|NCT02893553|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5772796|NCT02893553|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5772797|NCT02893553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5772798|NCT02893553|Cholinergic Agents|cholinergic agents|mesh-ancestor
5772799|NCT02893540|Capecitabine|capecitabine|mesh-list
5772800|NCT02893540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5772801|NCT02893540|Antimetabolites|antimetabolites|mesh-ancestor
5772802|NCT02893540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772803|NCT02893540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5772804|NCT02893371|Lamotrigine|lamotrigine|mesh-list
5772805|NCT02893371|Carbamazepine|carbamazepine|mesh-list
5772806|NCT02893371|Oxcarbazepine|oxcarbazepine|mesh-list
5772807|NCT02893371|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5772808|NCT02893371|Valproic Acid|valproic acid|mesh-list
5772809|NCT02893371|Haloperidol|haloperidol|mesh-list
5772810|NCT02893371|Olanzapine|olanzapine|mesh-list
5772811|NCT02893371|Risperidone|risperidone|mesh-list
5772812|NCT02893371|Quetiapine Fumarate|quetiapine fumarate|mesh-list
5772813|NCT02893371|Aripiprazole|aripiprazole|mesh-list
5772814|NCT02893371|Paliperidone Palmitate|paliperidone palmitate|mesh-list
5772815|NCT02893371|Ziprasidone|ziprasidone|mesh-list
5772816|NCT02893371|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
5772817|NCT02893371|Clozapine|clozapine|mesh-list
5772818|NCT02893371|Asenapine|asenapine|mesh-list
5772819|NCT02893371|Perphenazine|perphenazine|mesh-list
5772820|NCT02893371|Lithium Carbonate|lithium carbonate|mesh-list
5772821|NCT02893371|Mirtazapine|mirtazapine|mesh-list
5772822|NCT02893371|Fluvoxamine|fluvoxamine|mesh-list
5772823|NCT02893371|Doxepin|doxepin|mesh-list
5772824|NCT02893371|Citalopram|citalopram|mesh-list
5772825|NCT02893371|Bupropion|bupropion|mesh-list
5772826|NCT02893371|Sertraline|sertraline|mesh-list
5772827|NCT02893371|Fluoxetine|fluoxetine|mesh-list
5772828|NCT02893371|Paroxetine|paroxetine|mesh-list
5772829|NCT02893371|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
5772830|NCT02893371|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
5772831|NCT02893371|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
5772832|NCT02893371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5772833|NCT02893371|Serotonin Agents|serotonin agents|mesh-ancestor
5772834|NCT02893371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5772835|NCT02893371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772836|NCT02893371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5772837|NCT02893371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5772838|NCT02893371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5772839|NCT02893371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5772840|NCT02893371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5772841|NCT02893371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5772842|NCT02893371|Dopamine Agents|dopamine agents|mesh-ancestor
5772843|NCT02893371|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5772844|NCT02893371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5772845|NCT02893371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5772846|NCT02893371|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5772847|NCT02893371|Antidepressive Agents|antidepressive agents|mesh-ancestor
5772848|NCT02893371|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5772849|NCT02893371|Autonomic Agents|autonomic agents|mesh-ancestor
5772850|NCT02893371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5772851|NCT02893371|Antiemetics|antiemetics|mesh-ancestor
5772852|NCT02893371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5772853|NCT02893371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5772854|NCT02893371|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5772855|NCT02893371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5772856|NCT02893371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5772857|NCT02893371|Dopamine Agonists|dopamine agonists|mesh-ancestor
5772858|NCT02893371|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5772859|NCT02893371|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5772860|NCT02893371|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5772861|NCT02893371|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5772862|NCT02893371|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5772863|NCT02893371|Analgesics|analgesics|mesh-ancestor
5772864|NCT02893371|Sensory System Agents|sensory system agents|mesh-ancestor
5772865|NCT02893371|Antimanic Agents|antimanic agents|mesh-ancestor
5772866|NCT02893371|Anticonvulsants|anticonvulsants|mesh-ancestor
5772867|NCT02893371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5772868|NCT02893371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5772869|NCT02893371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5772870|NCT02893371|GABA Agents|gaba agents|mesh-ancestor
5772871|NCT02893371|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5772872|NCT02893371|Histamine Antagonists|histamine antagonists|mesh-ancestor
5772873|NCT02893371|Histamine Agents|histamine agents|mesh-ancestor
5772874|NCT02893371|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5772875|NCT02893371|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5772876|NCT02893371|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5772877|NCT02893371|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5772878|NCT02893371|Adrenergic Agents|adrenergic agents|mesh-ancestor
5772879|NCT02893371|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5772880|NCT02893371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5772881|NCT02893371|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5772882|NCT02893371|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5772883|NCT02893371|GABA Antagonists|gaba antagonists|mesh-ancestor
5772884|NCT02893371|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5772885|NCT02893371|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5772886|NCT02893371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5772887|NCT02893371|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5772888|NCT02893371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5772889|NCT02893371|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5772890|NCT02893293|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
5772891|NCT02893293|Hematinics|hematinics|mesh-ancestor
5772892|NCT02893293|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5772893|NCT02893293|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5772894|NCT02893423|Ropivacaine|ropivacaine|mesh-list
5772895|NCT02893423|Anesthetics, Local|anesthetics, local|mesh-ancestor
5772896|NCT02893423|Anesthetics|anesthetics|mesh-ancestor
5772897|NCT02893423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5772898|NCT02893423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5772899|NCT02893423|Sensory System Agents|sensory system agents|mesh-ancestor
5772900|NCT02893423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5772901|NCT02893176|Macitentan|macitentan|mesh-list
5772902|NCT02893176|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
5772903|NCT02893176|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5772904|NCT02893176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772905|NCT02893176|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
5772906|NCT02893384|Anesthetics|anesthetics|mesh-list
5772907|NCT02893384|Anesthetics, Local|anesthetics, local|mesh-list
5772908|NCT02893384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5772909|NCT02893384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5772910|NCT02893384|Sensory System Agents|sensory system agents|mesh-ancestor
5772911|NCT02893384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5772912|NCT02893228|Levobupivacaine|levobupivacaine|mesh-list
5772913|NCT02893228|Anesthetics, Local|anesthetics, local|mesh-ancestor
5772914|NCT02893228|Anesthetics|anesthetics|mesh-ancestor
5772915|NCT02893228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5772916|NCT02893228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5772917|NCT02893228|Sensory System Agents|sensory system agents|mesh-ancestor
5772918|NCT02893228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5772919|NCT02893488|Lamivudine|lamivudine|mesh-list
5772920|NCT02893488|Dolutegravir|dolutegravir|mesh-list
5772921|NCT02893488|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5772922|NCT02893488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5772923|NCT02893488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5772924|NCT02893488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772925|NCT02893488|Antiviral Agents|antiviral agents|mesh-ancestor
5772926|NCT02893488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5772927|NCT02893488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5772928|NCT02893488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5772929|NCT02893488|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5772930|NCT02893488|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5772931|NCT02893254|Adalimumab|adalimumab|mesh-list
5772932|NCT02893254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5772933|NCT02893254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5772934|NCT02893111|Bortezomib|bortezomib|mesh-list
5772935|NCT02893111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5772936|NCT02893124|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5772937|NCT02893124|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
5772938|NCT02893124|Antiviral Agents|antiviral agents|mesh-ancestor
5772939|NCT02893124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5772940|NCT02892916|Ketamine|ketamine|mesh-list
5772941|NCT02892916|Analgesics|analgesics|mesh-ancestor
5772942|NCT02892916|Sensory System Agents|sensory system agents|mesh-ancestor
5772943|NCT02892916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5772944|NCT02892916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5772945|NCT02892916|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5772946|NCT02892916|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5772947|NCT02892916|Anesthetics, General|anesthetics, general|mesh-ancestor
5772948|NCT02892916|Anesthetics|anesthetics|mesh-ancestor
5772949|NCT02892916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5772950|NCT02892916|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5772951|NCT02892916|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5772952|NCT02892916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5772953|NCT02892916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772954|NCT02892942|Cetrorelix|cetrorelix|mesh-list
5772955|NCT02892942|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5772956|NCT02892942|Fertility Agents|fertility agents|mesh-ancestor
5772957|NCT02892942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5772958|NCT02892942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5772959|NCT02892942|Hormone Antagonists|hormone antagonists|mesh-ancestor
5772960|NCT02892942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5772961|NCT02892812|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5772962|NCT02892812|Immunologic Factors|immunologic factors|mesh-ancestor
5772963|NCT02892812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896834|NCT03205137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5896835|NCT03205137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5896836|NCT03205137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896837|NCT03205137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5896838|NCT03205137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896839|NCT03205137|Vasodilator Agents|vasodilator agents|mesh-ancestor
5896840|NCT03205137|Diuretics|diuretics|mesh-ancestor
5896841|NCT03205137|Natriuretic Agents|natriuretic agents|mesh-ancestor
5896842|NCT03205137|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5896843|NCT03205137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5896844|NCT03205137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5896845|NCT03190915|Trametinib|trametinib|mesh-list
5896846|NCT03190915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5896847|NCT03190915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5896848|NCT03190915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5896849|NCT03190915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896850|NCT03186404|Atorvastatin|atorvastatin|mesh-list
5896851|NCT03186404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5896852|NCT03186404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5896853|NCT03186404|Antimetabolites|antimetabolites|mesh-ancestor
5896854|NCT03186404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896855|NCT03186404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5896856|NCT03186404|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5896857|NCT03186404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5907964|NCT04992065|Evolocumab|evolocumab|mesh-list
5907965|NCT04992065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5907966|NCT04992065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5772964|NCT02892591|Oxycodone|oxycodone|mesh-list
5772965|NCT02892591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5772966|NCT02892591|Narcotics|narcotics|mesh-ancestor
5772967|NCT02892591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5772968|NCT02892591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5772969|NCT02892591|Analgesics|analgesics|mesh-ancestor
5772970|NCT02892591|Sensory System Agents|sensory system agents|mesh-ancestor
5772971|NCT02892591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5772972|NCT02892357|Omeprazole|omeprazole|mesh-list
5772973|NCT02892357|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5772974|NCT02892357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5772975|NCT02892357|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5772976|NCT02892357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5772977|NCT02892357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772978|NCT02892318|Atezolizumab|atezolizumab|mesh-list
5772979|NCT02892318|Guadecitabine|guadecitabine|mesh-list
5772980|NCT02892318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5772981|NCT02892201|Pembrolizumab|pembrolizumab|mesh-list
5772982|NCT02892201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5772983|NCT02892201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5772984|NCT02892123|Paclitaxel|paclitaxel|mesh-list
5772985|NCT02892123|Vinorelbine|vinorelbine|mesh-list
5772986|NCT02892123|Capecitabine|capecitabine|mesh-list
5772987|NCT02892123|Tucatinib|tucatinib|mesh-list
5772988|NCT02892123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5772989|NCT02892123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5772990|NCT02892123|Tubulin Modulators|tubulin modulators|mesh-ancestor
5772991|NCT02892123|Antimitotic Agents|antimitotic agents|mesh-ancestor
5772992|NCT02892123|Mitosis Modulators|mitosis modulators|mesh-ancestor
5772993|NCT02892123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5772994|NCT02892123|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5772995|NCT02892123|Antimetabolites|antimetabolites|mesh-ancestor
5772996|NCT02892123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5772997|NCT02892123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5772998|NCT02891967|Z 350|z 350|mesh-list
5772999|NCT02891967|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
5773000|NCT02891967|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5773001|NCT02891967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5773002|NCT02891967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773003|NCT02891967|Hormone Antagonists|hormone antagonists|mesh-ancestor
5773004|NCT02891967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5773005|NCT02891967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773006|NCT02891980|Vaccines|vaccines|mesh-list
5773007|NCT02891980|Immunologic Factors|immunologic factors|mesh-ancestor
5773008|NCT02891980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773009|NCT02891785|Antipain|antipain|mesh-list
5773010|NCT02891785|Protease Inhibitors|protease inhibitors|mesh-ancestor
5773011|NCT02891785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5773012|NCT02891785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773013|NCT02891603|Sirolimus|sirolimus|mesh-list
5773014|NCT02891603|Tacrolimus|tacrolimus|mesh-list
5773015|NCT02891603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5773016|NCT02891603|Immunologic Factors|immunologic factors|mesh-ancestor
5773017|NCT02891603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773018|NCT02891603|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5773019|NCT02891603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5773020|NCT02891603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773021|NCT02891603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5773022|NCT02891603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5773023|NCT02891603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5773024|NCT02891603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5773025|NCT02891603|Antifungal Agents|antifungal agents|mesh-ancestor
5773026|NCT02891616|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5773027|NCT02891616|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5773028|NCT02891616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773038|NCT02891395|Imatinib Mesylate|imatinib mesylate|mesh-list
5773039|NCT02891395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5773040|NCT02891395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5773041|NCT02891395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5773042|NCT02891395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773043|NCT02891161|Durvalumab|durvalumab|mesh-list
5773044|NCT02891161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5773045|NCT02891161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5773046|NCT02891278|Cytarabine|cytarabine|mesh-list
5773047|NCT02891278|Sertraline|sertraline|mesh-list
5773048|NCT02891278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5773049|NCT02891278|Antimetabolites|antimetabolites|mesh-ancestor
5773050|NCT02891278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773051|NCT02891278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5773052|NCT02891278|Antiviral Agents|antiviral agents|mesh-ancestor
5773053|NCT02891278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5773054|NCT02891278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5773055|NCT02891278|Immunologic Factors|immunologic factors|mesh-ancestor
5773056|NCT02891278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773057|NCT02891278|Antidepressive Agents|antidepressive agents|mesh-ancestor
5773058|NCT02891278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5773059|NCT02891278|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5773060|NCT02891278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5773061|NCT02891278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5773062|NCT02891278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5773063|NCT02891278|Serotonin Agents|serotonin agents|mesh-ancestor
5773064|NCT02891018|Paclitaxel|paclitaxel|mesh-list
5773065|NCT02891018|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5773066|NCT02891018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5773067|NCT02891018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5773068|NCT02891018|Tubulin Modulators|tubulin modulators|mesh-ancestor
5773069|NCT02891018|Antimitotic Agents|antimitotic agents|mesh-ancestor
5773070|NCT02891018|Mitosis Modulators|mitosis modulators|mesh-ancestor
5773071|NCT02891018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896858|NCT03099174|Letrozole|letrozole|mesh-list
5896859|NCT03099174|Fulvestrant|fulvestrant|mesh-list
5896860|NCT03099174|Anastrozole|anastrozole|mesh-list
5896861|NCT03099174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5896862|NCT03099174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5896863|NCT03099174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5896864|NCT03099174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5896865|NCT03099174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896866|NCT03099174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5896867|NCT03099174|Hormone Antagonists|hormone antagonists|mesh-ancestor
5896868|NCT03099174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5896869|NCT03099174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896870|NCT03099174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5896871|NCT03099174|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5896872|NCT03098836|Prednisone|prednisone|mesh-list
5896873|NCT03098836|Abiraterone Acetate|abiraterone acetate|mesh-list
5896874|NCT03098836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5896875|NCT03098836|Glucocorticoids|glucocorticoids|mesh-ancestor
5896876|NCT03098836|Hormones|hormones|mesh-ancestor
5896877|NCT03098836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5896878|NCT03098836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896879|NCT03098836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5896880|NCT03098836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5896881|NCT03098836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5896882|NCT03098836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5896883|NCT03098836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896884|NCT03098836|Hormone Antagonists|hormone antagonists|mesh-ancestor
5896885|NCT03098836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5896886|NCT03095781|Pembrolizumab|pembrolizumab|mesh-list
5896887|NCT03095781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5896888|NCT03095781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5896889|NCT03076164|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5896890|NCT03076164|Trametinib|trametinib|mesh-list
5896891|NCT03076164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5896892|NCT03076164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5896893|NCT03076164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5896894|NCT03076164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896895|NCT03073070|Biotin|biotin|mesh-list
5896896|NCT03073070|Vitamin B Complex|vitamin b complex|mesh-ancestor
5896897|NCT03073070|Vitamins|vitamins|mesh-ancestor
5896898|NCT03073070|Micronutrients|micronutrients|mesh-ancestor
5896899|NCT03073070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773072|NCT02891083|Paclitaxel|paclitaxel|mesh-list
5773073|NCT02891083|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5773074|NCT02891083|Cisplatin|cisplatin|mesh-list
5773075|NCT02891083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5773076|NCT02891083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5773077|NCT02891083|Tubulin Modulators|tubulin modulators|mesh-ancestor
5773078|NCT02891083|Antimitotic Agents|antimitotic agents|mesh-ancestor
5773079|NCT02891083|Mitosis Modulators|mitosis modulators|mesh-ancestor
5773080|NCT02891083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773081|NCT02891005|Paclitaxel|paclitaxel|mesh-list
5773082|NCT02891005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5773083|NCT02891005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5773084|NCT02891005|Tubulin Modulators|tubulin modulators|mesh-ancestor
5773085|NCT02891005|Antimitotic Agents|antimitotic agents|mesh-ancestor
5773086|NCT02891005|Mitosis Modulators|mitosis modulators|mesh-ancestor
5773087|NCT02891005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773088|NCT02890875|Ethanol|ethanol|mesh-list
5773089|NCT02890875|Heparin|heparin|mesh-list
5773090|NCT02890875|Anticoagulants|anticoagulants|mesh-ancestor
5773091|NCT02890875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5773092|NCT02890875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5773093|NCT02890875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773094|NCT02890875|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5773095|NCT02890875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5773096|NCT02890875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5773097|NCT02890875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773098|NCT02890719|Ribavirin|ribavirin|mesh-list
5773099|NCT02890719|Grazoprevir|grazoprevir|mesh-list
5773100|NCT02890719|Antimetabolites|antimetabolites|mesh-ancestor
5773101|NCT02890719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490588|NCT00598923|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6490589|NCT00598923|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6490590|NCT00598962|Azithromycin|azithromycin|mesh-list
6490591|NCT00598962|Rifampin|rifampin|mesh-list
6490592|NCT00598962|Rifabutin|rifabutin|mesh-list
6490593|NCT00598962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6490594|NCT00598962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6490595|NCT00598962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6490596|NCT00598962|Antitubercular Agents|antitubercular agents|mesh-ancestor
5773102|NCT02890719|Antiviral Agents|antiviral agents|mesh-ancestor
5773103|NCT02890719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5773104|NCT02890745|Empagliflozin|empagliflozin|mesh-list
5773105|NCT02890745|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5773106|NCT02890745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773107|NCT02890745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5773108|NCT02890745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773109|NCT02890771|Turmeric extract|turmeric extract|mesh-list
5773110|NCT02890771|Antioxidants|antioxidants|mesh-ancestor
5773111|NCT02890771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773112|NCT02890771|Protective Agents|protective agents|mesh-ancestor
5773113|NCT02890771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773114|NCT02890823|Cholecalciferol|cholecalciferol|mesh-list
5773115|NCT02890823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5773116|NCT02890823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773117|NCT02890823|Vitamins|vitamins|mesh-ancestor
5773118|NCT02890823|Micronutrients|micronutrients|mesh-ancestor
5773119|NCT02890823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5773120|NCT02890602|Prednisolone|prednisolone|mesh-list
5773121|NCT02890602|Cyclophosphamide|cyclophosphamide|mesh-list
5773122|NCT02890602|Vincristine|vincristine|mesh-list
5773123|NCT02890602|Darbepoetin alfa|darbepoetin alfa|mesh-list
5773124|NCT02890602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5773125|NCT02890602|Immunologic Factors|immunologic factors|mesh-ancestor
5773126|NCT02890602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773127|NCT02890602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5773128|NCT02890602|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5773129|NCT02890602|Alkylating Agents|alkylating agents|mesh-ancestor
5773130|NCT02890602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773131|NCT02890602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5773132|NCT02890602|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5773133|NCT02890602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5773134|NCT02890602|Tubulin Modulators|tubulin modulators|mesh-ancestor
5773135|NCT02890602|Antimitotic Agents|antimitotic agents|mesh-ancestor
5773136|NCT02890602|Mitosis Modulators|mitosis modulators|mesh-ancestor
5773137|NCT02890602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5773138|NCT02890602|Glucocorticoids|glucocorticoids|mesh-ancestor
5773139|NCT02890602|Hormones|hormones|mesh-ancestor
5773140|NCT02890602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5773141|NCT02890602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5773142|NCT02890602|Hematinics|hematinics|mesh-ancestor
5773143|NCT02890784|Dasatinib|dasatinib|mesh-list
5773144|NCT02890784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5773145|NCT02890784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5773146|NCT02890784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5773147|NCT02890784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773148|NCT02890589|Chromium|chromium|mesh-list
5773149|NCT02890589|Everolimus|everolimus|mesh-list
5773150|NCT02890589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5773151|NCT02890589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5773152|NCT02890589|Immunologic Factors|immunologic factors|mesh-ancestor
5773153|NCT02890589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773154|NCT02890589|Trace Elements|trace elements|mesh-ancestor
5773155|NCT02890589|Micronutrients|micronutrients|mesh-ancestor
5773156|NCT02890173|Eplerenone|eplerenone|mesh-list
5773157|NCT02890173|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5773158|NCT02890173|Hormone Antagonists|hormone antagonists|mesh-ancestor
5773159|NCT02890173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5773160|NCT02890173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773161|NCT02890173|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5773162|NCT02890173|Diuretics|diuretics|mesh-ancestor
5773163|NCT02890173|Natriuretic Agents|natriuretic agents|mesh-ancestor
5773164|NCT02890173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5773165|NCT02890238|Sildenafil Citrate|sildenafil citrate|mesh-list
5773166|NCT02890238|Citric Acid|citric acid|mesh-list
5773167|NCT02890238|Sodium Citrate|sodium citrate|mesh-list
5773168|NCT02890238|Clomiphene|clomiphene|mesh-list
5773169|NCT02890238|Enclomiphene|enclomiphene|mesh-list
5773170|NCT02890238|Zuclomiphene|zuclomiphene|mesh-list
5773171|NCT02890238|Anticoagulants|anticoagulants|mesh-ancestor
5773172|NCT02890238|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5773173|NCT02890238|Chelating Agents|chelating agents|mesh-ancestor
5773174|NCT02890238|Sequestering Agents|sequestering agents|mesh-ancestor
5773175|NCT02890238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773176|NCT02890238|Vasodilator Agents|vasodilator agents|mesh-ancestor
5773177|NCT02890238|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5773178|NCT02890238|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5773179|NCT02890238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5773180|NCT02890238|Urological Agents|urological agents|mesh-ancestor
5773181|NCT02890238|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5773182|NCT02890238|Hormone Antagonists|hormone antagonists|mesh-ancestor
5773183|NCT02890238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5773184|NCT02890238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773185|NCT02890238|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5773186|NCT02890238|Fertility Agents|fertility agents|mesh-ancestor
5773187|NCT02890238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5773188|NCT02890238|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5773189|NCT02890238|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5773190|NCT02890511|Paclitaxel|paclitaxel|mesh-list
5773191|NCT02890511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5773192|NCT02890511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5773193|NCT02890511|Tubulin Modulators|tubulin modulators|mesh-ancestor
5773194|NCT02890511|Antimitotic Agents|antimitotic agents|mesh-ancestor
5773195|NCT02890511|Mitosis Modulators|mitosis modulators|mesh-ancestor
5773196|NCT02890511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773197|NCT02890212|Selenium|selenium|mesh-list
5773198|NCT02890212|Antioxidants|antioxidants|mesh-ancestor
5773199|NCT02890212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773200|NCT02890212|Protective Agents|protective agents|mesh-ancestor
5773201|NCT02890212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773202|NCT02890212|Trace Elements|trace elements|mesh-ancestor
5773203|NCT02890212|Micronutrients|micronutrients|mesh-ancestor
5773204|NCT02890277|Anti-Infective Agents|anti-infective agents|mesh-list
5773205|NCT02890277|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5773206|NCT02890277|Chitosan|chitosan|mesh-list
5773207|NCT02890277|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5773208|NCT02890277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5773209|NCT02890277|Antimetabolites|antimetabolites|mesh-ancestor
5773210|NCT02890277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773211|NCT02890277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5773212|NCT02890277|Chelating Agents|chelating agents|mesh-ancestor
5773213|NCT02890277|Sequestering Agents|sequestering agents|mesh-ancestor
5773214|NCT02890277|Hemostatics|hemostatics|mesh-ancestor
5773215|NCT02890277|Coagulants|coagulants|mesh-ancestor
5773216|NCT02890186|Remifentanil|remifentanil|mesh-list
5773217|NCT02890186|Propofol|propofol|mesh-list
5773218|NCT02890186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5773219|NCT02890186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5773220|NCT02890186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773221|NCT02890186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5773222|NCT02890186|Anesthetics, General|anesthetics, general|mesh-ancestor
5773223|NCT02890186|Anesthetics|anesthetics|mesh-ancestor
5773224|NCT02890186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5773225|NCT02890186|Narcotics|narcotics|mesh-ancestor
5773226|NCT02890186|Analgesics|analgesics|mesh-ancestor
5773227|NCT02890186|Sensory System Agents|sensory system agents|mesh-ancestor
5773228|NCT02890186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5773229|NCT02890199|Lidocaine|lidocaine|mesh-list
5773230|NCT02890199|Bupivacaine|bupivacaine|mesh-list
5773231|NCT02890199|Anesthetics, Local|anesthetics, local|mesh-ancestor
5773232|NCT02890199|Anesthetics|anesthetics|mesh-ancestor
5773233|NCT02890199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5773234|NCT02890199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773235|NCT02890199|Sensory System Agents|sensory system agents|mesh-ancestor
5773236|NCT02890199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5773237|NCT02890199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5773238|NCT02890199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5773239|NCT02890199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5773240|NCT02890199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5773241|NCT02890199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773242|NCT02890082|Tamoxifen|tamoxifen|mesh-list
5773243|NCT02890082|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5773244|NCT02890082|Hormone Antagonists|hormone antagonists|mesh-ancestor
5773245|NCT02890082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5773246|NCT02890082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773247|NCT02890082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5773248|NCT02890082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5773249|NCT02890082|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5773250|NCT02890082|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5773251|NCT02890082|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5773252|NCT02890368|Interferons|interferons|mesh-list
5773253|NCT02890368|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
5773254|NCT02890368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5773255|NCT02890368|Immunoglobulin G|immunoglobulin g|mesh-list
5773256|NCT02890368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5773257|NCT02890368|Antiviral Agents|antiviral agents|mesh-ancestor
5773258|NCT02890368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5773259|NCT02890368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5773260|NCT02890368|Immunologic Factors|immunologic factors|mesh-ancestor
5773261|NCT02890368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773262|NCT02890368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773263|NCT02889666|Gemcitabine|gemcitabine|mesh-list
5773264|NCT02889666|Cisplatin|cisplatin|mesh-list
5773265|NCT02889666|Carboplatin|carboplatin|mesh-list
5773266|NCT02889666|Docetaxel|docetaxel|mesh-list
5773267|NCT02889666|Oxaliplatin|oxaliplatin|mesh-list
5773268|NCT02889666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5773269|NCT02889666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5773270|NCT02889666|Antimetabolites|antimetabolites|mesh-ancestor
5773271|NCT02889666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773272|NCT02889666|Antiviral Agents|antiviral agents|mesh-ancestor
5773273|NCT02889666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5773274|NCT02889666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5773275|NCT02889666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5773276|NCT02889666|Immunologic Factors|immunologic factors|mesh-ancestor
5773277|NCT02889666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773278|NCT02889666|Tubulin Modulators|tubulin modulators|mesh-ancestor
5773279|NCT02889666|Antimitotic Agents|antimitotic agents|mesh-ancestor
5773280|NCT02889666|Mitosis Modulators|mitosis modulators|mesh-ancestor
5773281|NCT02889835|Chlorhexidine|chlorhexidine|mesh-list
5773282|NCT02889835|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5773283|NCT02889835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5773284|NCT02889835|Disinfectants|disinfectants|mesh-ancestor
5773285|NCT02889692|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5773286|NCT02889692|Gefitinib|gefitinib|mesh-list
5773287|NCT02889692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5773288|NCT02889692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5773289|NCT02889692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5773290|NCT02889692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773291|NCT02889822|Alprostadil|alprostadil|mesh-list
5773292|NCT02889822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5773293|NCT02889822|Vasodilator Agents|vasodilator agents|mesh-ancestor
5773294|NCT02889822|Urological Agents|urological agents|mesh-ancestor
5773295|NCT02889653|Anticoagulants|anticoagulants|mesh-list
5773296|NCT02889523|Prednisolone|prednisolone|mesh-list
5773297|NCT02889523|Cyclophosphamide|cyclophosphamide|mesh-list
5773298|NCT02889523|Rituximab|rituximab|mesh-list
5773299|NCT02889523|Doxorubicin|doxorubicin|mesh-list
5773300|NCT02889523|Vincristine|vincristine|mesh-list
5773301|NCT02889523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5773302|NCT02889523|Immunologic Factors|immunologic factors|mesh-ancestor
5773303|NCT02889523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773304|NCT02889523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5773305|NCT02889523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5773306|NCT02889523|Alkylating Agents|alkylating agents|mesh-ancestor
5773307|NCT02889523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773308|NCT02889523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5773309|NCT02889523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5773310|NCT02889523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5773311|NCT02889523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5773312|NCT02889523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5773313|NCT02889523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5773314|NCT02889523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5773315|NCT02889523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5773316|NCT02889523|Tubulin Modulators|tubulin modulators|mesh-ancestor
5773317|NCT02889523|Antimitotic Agents|antimitotic agents|mesh-ancestor
5773318|NCT02889523|Mitosis Modulators|mitosis modulators|mesh-ancestor
5773319|NCT02889523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5773320|NCT02889523|Glucocorticoids|glucocorticoids|mesh-ancestor
5773321|NCT02889523|Hormones|hormones|mesh-ancestor
5773322|NCT02889523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5773323|NCT02889523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5896900|NCT03063944|Azacitidine|azacitidine|mesh-list
5896901|NCT03063944|Decitabine|decitabine|mesh-list
5896902|NCT03063944|Venetoclax|venetoclax|mesh-list
5896903|NCT03063944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5896904|NCT03063944|Antimetabolites|antimetabolites|mesh-ancestor
5896905|NCT03063944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896906|NCT03063944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5896907|NCT03063944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5896908|NCT03060577|Evolocumab|evolocumab|mesh-list
5896909|NCT03060577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5896910|NCT03060577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5896911|NCT03060577|Antimetabolites|antimetabolites|mesh-ancestor
5896912|NCT03060577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896913|NCT03060577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5896914|NCT03025087|Hydroxychloroquine|hydroxychloroquine|mesh-list
5896915|NCT03025087|Antimalarials|antimalarials|mesh-ancestor
5896916|NCT03025087|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5896917|NCT03025087|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5896918|NCT03025087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5896919|NCT03025087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5896920|NCT03025087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896921|NCT03025087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5896927|NCT02987257|Cyclosporine|cyclosporine|mesh-list
5896928|NCT02987257|Etanercept|etanercept|mesh-list
5896929|NCT02987257|Cyclosporins|cyclosporins|mesh-list
5896930|NCT02987257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5896931|NCT02987257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896932|NCT02987257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5896933|NCT02987257|Immunologic Factors|immunologic factors|mesh-ancestor
5896934|NCT02987257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896935|NCT02987257|Antifungal Agents|antifungal agents|mesh-ancestor
5896936|NCT02987257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5896937|NCT02987257|Dermatologic Agents|dermatologic agents|mesh-ancestor
5896938|NCT02987257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5896939|NCT02987257|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5896940|NCT02987257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5773324|NCT02889549|Clopidogrel|clopidogrel|mesh-list
5773325|NCT02889549|Ticagrelor|ticagrelor|mesh-list
5773326|NCT02889549|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5773327|NCT02889549|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5773328|NCT02889549|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5773329|NCT02889549|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5773330|NCT02889549|Purinergic Agents|purinergic agents|mesh-ancestor
5773331|NCT02889549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5773332|NCT02889549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773333|NCT02889549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773334|NCT02889432|Melatonin|melatonin|mesh-list
5773335|NCT02889432|Antioxidants|antioxidants|mesh-ancestor
5773336|NCT02889432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773337|NCT02889432|Protective Agents|protective agents|mesh-ancestor
5773338|NCT02889432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773339|NCT02889432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5773340|NCT02889497|Vaccines|vaccines|mesh-list
5773341|NCT02889497|Immunologic Factors|immunologic factors|mesh-ancestor
5773342|NCT02889497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773343|NCT02889367|Odalasvir|odalasvir|mesh-list
5773344|NCT02889367|Antiviral Agents|antiviral agents|mesh-ancestor
5773345|NCT02889367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5773346|NCT02889081|Vitamin D|vitamin d|mesh-list
5773347|NCT02889081|Vitamins|vitamins|mesh-ancestor
5773348|NCT02889081|Micronutrients|micronutrients|mesh-ancestor
5773349|NCT02889081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773350|NCT02889081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5773351|NCT02889159|Imiquimod|imiquimod|mesh-list
5773352|NCT02889159|Histamine|histamine|mesh-list
5773353|NCT02889159|Histamine phosphate|histamine phosphate|mesh-list
5773354|NCT02889159|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5773355|NCT02889159|Immunologic Factors|immunologic factors|mesh-ancestor
5773356|NCT02889159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773357|NCT02889159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5773358|NCT02889159|Interferon Inducers|interferon inducers|mesh-ancestor
5773359|NCT02889159|Histamine Agonists|histamine agonists|mesh-ancestor
5773360|NCT02889159|Histamine Agents|histamine agents|mesh-ancestor
5773361|NCT02889159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5773362|NCT02889159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773363|NCT02889224|Hydrocortisone|hydrocortisone|mesh-list
5773364|NCT02889224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5773365|NCT02888990|Dasatinib|dasatinib|mesh-list
5773366|NCT02888990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5773367|NCT02888990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5773368|NCT02888990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5773369|NCT02888990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773370|NCT02888899|Loperamide|loperamide|mesh-list
5773371|NCT02888899|Antidiarrheals|antidiarrheals|mesh-list
5773372|NCT02888899|Calcium polycarbophil|calcium polycarbophil|mesh-list
5773373|NCT02888899|Psyllium|psyllium|mesh-list
5773374|NCT02888899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5773375|NCT02888899|Cathartics|cathartics|mesh-ancestor
5773376|NCT02889003|Pioglitazone|pioglitazone|mesh-list
5773377|NCT02889003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5773378|NCT02889003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773379|NCT02888704|Remestemcel-l|remestemcel-l|mesh-list
5773380|NCT02888704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5773381|NCT02888704|Antiviral Agents|antiviral agents|mesh-ancestor
5773382|NCT02888704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5773383|NCT02888730|Tobramycin|tobramycin|mesh-list
5773384|NCT02888730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5773385|NCT02888730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5773386|NCT02888652|Clopidogrel|clopidogrel|mesh-list
5773387|NCT02888652|Ticagrelor|ticagrelor|mesh-list
5773388|NCT02888652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
5773389|NCT02888652|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5773390|NCT02888652|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5773391|NCT02888652|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5773392|NCT02888652|Purinergic Agents|purinergic agents|mesh-ancestor
5773393|NCT02888652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5773394|NCT02888652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773395|NCT02888652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773396|NCT02888574|Oxytocin|oxytocin|mesh-list
5773397|NCT02888574|Oxytocics|oxytocics|mesh-ancestor
5773398|NCT02888574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5773399|NCT02888574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773400|NCT02888301|Clofarabine|clofarabine|mesh-list
5773401|NCT02888301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5773402|NCT02888301|Antimetabolites|antimetabolites|mesh-ancestor
5773403|NCT02888301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773404|NCT02888301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5773405|NCT02888548|Botulinum Toxins|botulinum toxins|mesh-list
5773406|NCT02888548|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5773407|NCT02888548|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5773408|NCT02888548|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5773409|NCT02888548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5773410|NCT02888548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773411|NCT02888548|Cholinergic Agents|cholinergic agents|mesh-ancestor
5773412|NCT02888548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5773413|NCT02888548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773414|NCT02888548|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5773415|NCT02888548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5773416|NCT02888327|Oseltamivir|oseltamivir|mesh-list
5773417|NCT02888327|Digoxin|digoxin|mesh-list
5773418|NCT02888327|Midazolam|midazolam|mesh-list
5773419|NCT02888327|Pitavastatin|pitavastatin|mesh-list
5773420|NCT02888327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5773421|NCT02888327|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5773422|NCT02888327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5773423|NCT02888327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773424|NCT02888327|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5773425|NCT02888327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5773426|NCT02888327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5773427|NCT02888327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5773428|NCT02888327|Anesthetics, General|anesthetics, general|mesh-ancestor
5773429|NCT02888327|Anesthetics|anesthetics|mesh-ancestor
5773430|NCT02888327|GABA Modulators|gaba modulators|mesh-ancestor
5773431|NCT02888327|GABA Agents|gaba agents|mesh-ancestor
5773432|NCT02888327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5773433|NCT02888327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773434|NCT02888327|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5773435|NCT02888327|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5773436|NCT02888327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5773437|NCT02888327|Protective Agents|protective agents|mesh-ancestor
5773438|NCT02888327|Antiviral Agents|antiviral agents|mesh-ancestor
5773439|NCT02888327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5773440|NCT02888327|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5773441|NCT02888327|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5773442|NCT02888327|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5773443|NCT02888327|Antimetabolites|antimetabolites|mesh-ancestor
5773444|NCT02888327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5773445|NCT02888275|Dexmedetomidine|dexmedetomidine|mesh-list
5773446|NCT02888275|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5773447|NCT02888275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5773448|NCT02888275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773449|NCT02888275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5773450|NCT02888275|Analgesics|analgesics|mesh-ancestor
5773451|NCT02888275|Sensory System Agents|sensory system agents|mesh-ancestor
5773452|NCT02888275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5773453|NCT02888275|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5773454|NCT02888275|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5773455|NCT02888275|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5773456|NCT02888275|Adrenergic Agents|adrenergic agents|mesh-ancestor
5773457|NCT02888275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5773458|NCT02888275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773459|NCT02888561|Dobutamine|dobutamine|mesh-list
5773460|NCT02888561|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5773461|NCT02888561|Sympathomimetics|sympathomimetics|mesh-ancestor
5773462|NCT02888561|Autonomic Agents|autonomic agents|mesh-ancestor
5773463|NCT02888561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5773464|NCT02888561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773465|NCT02888561|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5773466|NCT02888561|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5773467|NCT02888561|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5773468|NCT02888561|Adrenergic Agents|adrenergic agents|mesh-ancestor
5773469|NCT02888561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5773470|NCT02888561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773471|NCT02888561|Protective Agents|protective agents|mesh-ancestor
5773472|NCT02888444|Varenicline|varenicline|mesh-list
5773473|NCT02888444|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5773474|NCT02888444|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5773475|NCT02888444|Cholinergic Agents|cholinergic agents|mesh-ancestor
5773476|NCT02888444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5773477|NCT02888444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773478|NCT02888444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773479|NCT02888054|Allopurinol|allopurinol|mesh-list
5773480|NCT02888054|Lesinurad|lesinurad|mesh-list
5773481|NCT02888054|Antimetabolites|antimetabolites|mesh-ancestor
5773482|NCT02888054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773483|NCT02888054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5773484|NCT02888054|Gout Suppressants|gout suppressants|mesh-ancestor
5773485|NCT02888054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5773486|NCT02888054|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5773487|NCT02888054|Antioxidants|antioxidants|mesh-ancestor
5773488|NCT02888054|Protective Agents|protective agents|mesh-ancestor
5773489|NCT02888054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773490|NCT02888054|Uricosuric Agents|uricosuric agents|mesh-ancestor
5773491|NCT02888054|Renal Agents|renal agents|mesh-ancestor
5773492|NCT02888392|Psyllium|psyllium|mesh-list
5773493|NCT02888392|Cathartics|cathartics|mesh-ancestor
5773494|NCT02888392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5773495|NCT02888223|Factor VIII|factor viii|mesh-list
5773496|NCT02888223|Coagulants|coagulants|mesh-ancestor
5773497|NCT02887976|Methylprednisolone|methylprednisolone|mesh-list
5773498|NCT02887976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5773499|NCT02887976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5773500|NCT02887976|Prednisolone|prednisolone|mesh-list
5773501|NCT02887976|Prednisolone acetate|prednisolone acetate|mesh-list
5773502|NCT02887976|Abiraterone Acetate|abiraterone acetate|mesh-list
5773503|NCT02887976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5773504|NCT02887976|Prednisolone phosphate|prednisolone phosphate|mesh-list
5773505|NCT02887976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5773506|NCT02887976|Antiemetics|antiemetics|mesh-ancestor
5773507|NCT02887976|Autonomic Agents|autonomic agents|mesh-ancestor
5773508|NCT02887976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5773509|NCT02887976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773510|NCT02887976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5773511|NCT02887976|Glucocorticoids|glucocorticoids|mesh-ancestor
5773512|NCT02887976|Hormones|hormones|mesh-ancestor
5773513|NCT02887976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5773514|NCT02887976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5773515|NCT02887976|Protective Agents|protective agents|mesh-ancestor
5773516|NCT02887976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5773517|NCT02887976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5773518|NCT02887976|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5773519|NCT02887976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5773520|NCT02887976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773521|NCT02887976|Hormone Antagonists|hormone antagonists|mesh-ancestor
5773522|NCT02887976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5896941|NCT02987257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5896942|NCT02987257|Analgesics|analgesics|mesh-ancestor
5896943|NCT02987257|Sensory System Agents|sensory system agents|mesh-ancestor
5896944|NCT02987257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5896945|NCT02987257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5896946|NCT02987257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5896947|NCT02939742|Betamethasone|betamethasone|mesh-list
5896948|NCT02939742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5896949|NCT02939742|Glucocorticoids|glucocorticoids|mesh-ancestor
5896950|NCT02939742|Hormones|hormones|mesh-ancestor
5896951|NCT02939742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5896952|NCT02939742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896953|NCT02939742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5896954|NCT02939742|Respiratory System Agents|respiratory system agents|mesh-ancestor
5896955|NCT02905214|Sirolimus|sirolimus|mesh-list
5896956|NCT02905214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5896957|NCT02905214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5896958|NCT02905214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5896959|NCT02905214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5896960|NCT02905214|Antifungal Agents|antifungal agents|mesh-ancestor
5896961|NCT02905214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5896962|NCT02905214|Immunologic Factors|immunologic factors|mesh-ancestor
5896963|NCT02905214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5896964|NCT02816021|Pembrolizumab|pembrolizumab|mesh-list
5896965|NCT02816021|Azacitidine|azacitidine|mesh-list
5896966|NCT02816021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5896967|NCT02816021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5896968|NCT02816021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5896969|NCT02816021|Antimetabolites|antimetabolites|mesh-ancestor
5896970|NCT02816021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773523|NCT02888067|Bromides|bromides|mesh-list
5773524|NCT02888067|Rocuronium|rocuronium|mesh-list
5773525|NCT02888067|Anticonvulsants|anticonvulsants|mesh-ancestor
5773526|NCT02888067|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5773527|NCT02888067|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5773528|NCT02888067|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5773529|NCT02888067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5773530|NCT02888067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773531|NCT02888041|Dinoprostone|dinoprostone|mesh-list
5773532|NCT02888041|Oxytocics|oxytocics|mesh-ancestor
5773533|NCT02888041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5773534|NCT02888041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773535|NCT02887807|Cyclosporine|cyclosporine|mesh-list
5773536|NCT02887807|Cyclosporins|cyclosporins|mesh-list
5773537|NCT02887807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5773538|NCT02887807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773539|NCT02887807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5773540|NCT02887807|Immunologic Factors|immunologic factors|mesh-ancestor
5773541|NCT02887807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773542|NCT02887807|Antifungal Agents|antifungal agents|mesh-ancestor
5773543|NCT02887807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5773544|NCT02887807|Dermatologic Agents|dermatologic agents|mesh-ancestor
5773545|NCT02887807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5773546|NCT02887807|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5773547|NCT02887677|Dapagliflozin|dapagliflozin|mesh-list
5773548|NCT02887677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5773549|NCT02887677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773550|NCT02887677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5773551|NCT02887677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773552|NCT02887573|Mosapride|mosapride|mesh-list
5773553|NCT02887573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773554|NCT02887573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5773555|NCT02887573|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5773556|NCT02887573|Serotonin Agents|serotonin agents|mesh-ancestor
5773557|NCT02887573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5773558|NCT02887573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773559|NCT02887534|Tizanidine|tizanidine|mesh-list
5773560|NCT02887534|Analgesics|analgesics|mesh-ancestor
5773561|NCT02887534|Sensory System Agents|sensory system agents|mesh-ancestor
5773562|NCT02887534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5773563|NCT02887534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773564|NCT02887534|Anticonvulsants|anticonvulsants|mesh-ancestor
5773565|NCT02887534|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5773566|NCT02887534|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5773567|NCT02887534|Parasympatholytics|parasympatholytics|mesh-ancestor
5773568|NCT02887534|Autonomic Agents|autonomic agents|mesh-ancestor
5773569|NCT02887534|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5773570|NCT02887534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5773571|NCT02887534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5773572|NCT02887534|Adrenergic Agents|adrenergic agents|mesh-ancestor
5773573|NCT02887534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5773574|NCT02887534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773575|NCT02887443|Midazolam|midazolam|mesh-list
5773576|NCT02887443|Idebenone|idebenone|mesh-list
5773577|NCT02887443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5773578|NCT02887443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5773579|NCT02887443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5773580|NCT02887443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773581|NCT02887443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5773582|NCT02887443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5773583|NCT02887443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5773584|NCT02887443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5773585|NCT02887443|Anesthetics, General|anesthetics, general|mesh-ancestor
5773586|NCT02887443|Anesthetics|anesthetics|mesh-ancestor
5773587|NCT02887443|GABA Modulators|gaba modulators|mesh-ancestor
5773588|NCT02887443|GABA Agents|gaba agents|mesh-ancestor
5773589|NCT02887443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5773590|NCT02887443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773591|NCT02887443|Antioxidants|antioxidants|mesh-ancestor
5773592|NCT02887443|Protective Agents|protective agents|mesh-ancestor
5773593|NCT02887365|Tegafur|tegafur|mesh-list
5773594|NCT02887365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5773595|NCT02887365|Antimetabolites|antimetabolites|mesh-ancestor
5773596|NCT02887365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773597|NCT02887365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5773598|NCT02887625|Insulin|insulin|mesh-list
5773599|NCT02887625|Insulin Glargine|insulin glargine|mesh-list
5773600|NCT02887625|Pioglitazone|pioglitazone|mesh-list
5773601|NCT02887625|Insulin Aspart|insulin aspart|mesh-list
5773602|NCT02887625|Exenatide|exenatide|mesh-list
5773603|NCT02887625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5773604|NCT02887625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773605|NCT02887625|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5773606|NCT02887625|Incretins|incretins|mesh-ancestor
5773607|NCT02887625|Hormones|hormones|mesh-ancestor
5773608|NCT02887625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5773609|NCT02887222|Bupivacaine|bupivacaine|mesh-list
5773610|NCT02887222|Anesthetics, Local|anesthetics, local|mesh-ancestor
5773611|NCT02887222|Anesthetics|anesthetics|mesh-ancestor
5773612|NCT02887222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5773613|NCT02887222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773614|NCT02887222|Sensory System Agents|sensory system agents|mesh-ancestor
5773615|NCT02887222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5773616|NCT02887313|Leucovorin|leucovorin|mesh-list
5773617|NCT02887313|Fluorouracil|fluorouracil|mesh-list
5773618|NCT02887313|Oxaliplatin|oxaliplatin|mesh-list
5773619|NCT02887313|Antimetabolites|antimetabolites|mesh-ancestor
5773620|NCT02887313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773621|NCT02887313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5773622|NCT02887313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5773623|NCT02887313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5773624|NCT02887313|Immunologic Factors|immunologic factors|mesh-ancestor
5773625|NCT02887313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773626|NCT02887313|Antidotes|antidotes|mesh-ancestor
5773627|NCT02887313|Protective Agents|protective agents|mesh-ancestor
5773628|NCT02887313|Vitamin B Complex|vitamin b complex|mesh-ancestor
5773629|NCT02887313|Vitamins|vitamins|mesh-ancestor
5773630|NCT02887313|Micronutrients|micronutrients|mesh-ancestor
5773631|NCT02886988|Botulinum Toxins|botulinum toxins|mesh-list
5773632|NCT02886988|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5773633|NCT02886988|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5773634|NCT02886988|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5773635|NCT02886988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5773636|NCT02886988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773637|NCT02886988|Cholinergic Agents|cholinergic agents|mesh-ancestor
5773638|NCT02886988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5773639|NCT02886988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773640|NCT02886988|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5773641|NCT02886988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5773642|NCT02886897|Antibodies|antibodies|mesh-list
5773643|NCT02886897|Immunologic Factors|immunologic factors|mesh-ancestor
5773644|NCT02886897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773645|NCT02886962|Vitamin K|vitamin k|mesh-list
5773646|NCT02886962|Vitamins|vitamins|mesh-ancestor
5773647|NCT02886962|Micronutrients|micronutrients|mesh-ancestor
5773648|NCT02886962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773649|NCT02886962|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5773650|NCT02886962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5773651|NCT02886962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773652|NCT02886962|Hemostatics|hemostatics|mesh-ancestor
5773653|NCT02886962|Coagulants|coagulants|mesh-ancestor
5896971|NCT02816021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5896972|NCT02812433|Sildenafil Citrate|sildenafil citrate|mesh-list
5896973|NCT02812433|Vasodilator Agents|vasodilator agents|mesh-ancestor
5896974|NCT02812433|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5896975|NCT02812433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5896976|NCT02812433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5896977|NCT02812433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896978|NCT02812433|Urological Agents|urological agents|mesh-ancestor
5896979|NCT02743897|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
5896980|NCT02743897|Antiviral Agents|antiviral agents|mesh-ancestor
5896981|NCT02743897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5896982|NCT02737046|Interferons|interferons|mesh-list
5896983|NCT02737046|Interferon-alpha|interferon-alpha|mesh-list
5896984|NCT02737046|Interferon alpha-2|interferon alpha-2|mesh-list
5896985|NCT02737046|Zidovudine|zidovudine|mesh-list
5896986|NCT02737046|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
5896987|NCT02737046|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
5896988|NCT02737046|Belinostat|belinostat|mesh-list
5896989|NCT02737046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5896990|NCT02737046|Antiviral Agents|antiviral agents|mesh-ancestor
5896991|NCT02737046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5896992|NCT02737046|Immunologic Factors|immunologic factors|mesh-ancestor
5896993|NCT02737046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773654|NCT02886585|Pembrolizumab|pembrolizumab|mesh-list
5773655|NCT02886585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5773656|NCT02886585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5773657|NCT02886429|Dexmedetomidine|dexmedetomidine|mesh-list
5773658|NCT02886429|Bupivacaine|bupivacaine|mesh-list
5773659|NCT02886429|Anesthetics, Local|anesthetics, local|mesh-ancestor
5773660|NCT02886429|Anesthetics|anesthetics|mesh-ancestor
5773661|NCT02886429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5773662|NCT02886429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773663|NCT02886429|Sensory System Agents|sensory system agents|mesh-ancestor
5773664|NCT02886429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5773665|NCT02886429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5773666|NCT02886429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5773667|NCT02886429|Analgesics|analgesics|mesh-ancestor
5773668|NCT02886429|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5773669|NCT02886429|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5773670|NCT02886429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5773671|NCT02886429|Adrenergic Agents|adrenergic agents|mesh-ancestor
5773672|NCT02886429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5773673|NCT02886429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773674|NCT02886377|Antibodies|antibodies|mesh-list
5773675|NCT02886377|Immunologic Factors|immunologic factors|mesh-ancestor
5773676|NCT02886377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773677|NCT02886351|Nitrous Oxide|nitrous oxide|mesh-list
5773678|NCT02886351|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5773679|NCT02886351|Anesthetics, General|anesthetics, general|mesh-ancestor
5773680|NCT02886351|Anesthetics|anesthetics|mesh-ancestor
5773681|NCT02886351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5773682|NCT02886351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773683|NCT02886351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5773684|NCT02886351|Analgesics|analgesics|mesh-ancestor
5773685|NCT02886351|Sensory System Agents|sensory system agents|mesh-ancestor
5773686|NCT02886351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5773687|NCT02886195|Pemetrexed|pemetrexed|mesh-list
5773688|NCT02886195|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5773689|NCT02886195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5773690|NCT02886195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5773691|NCT02886195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773692|NCT02886195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5773693|NCT02886195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5773694|NCT02886195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5773695|NCT02886299|Simvastatin|simvastatin|mesh-list
5773696|NCT02886299|Fenofibrate|fenofibrate|mesh-list
5773697|NCT02886299|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5773698|NCT02886299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5773699|NCT02886299|Antimetabolites|antimetabolites|mesh-ancestor
5773700|NCT02886299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773701|NCT02886299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5773702|NCT02886299|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5773703|NCT02886299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5773704|NCT02886286|Fentanyl|fentanyl|mesh-list
5773705|NCT02886286|Morphine|morphine|mesh-list
5773706|NCT02886286|Hydromorphone|hydromorphone|mesh-list
5773707|NCT02886286|Bupivacaine|bupivacaine|mesh-list
6673538|NCT01563614|Immunologic Factors|immunologic factors|mesh-ancestor
5773708|NCT02886286|Anesthetics, Local|anesthetics, local|mesh-ancestor
5773709|NCT02886286|Anesthetics|anesthetics|mesh-ancestor
5773710|NCT02886286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5773711|NCT02886286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773712|NCT02886286|Sensory System Agents|sensory system agents|mesh-ancestor
5773713|NCT02886286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5773714|NCT02886286|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5773715|NCT02886286|Narcotics|narcotics|mesh-ancestor
5773716|NCT02886286|Analgesics|analgesics|mesh-ancestor
5773717|NCT02886286|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5773718|NCT02886286|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5773719|NCT02886286|Anesthetics, General|anesthetics, general|mesh-ancestor
5773720|NCT02886065|Lenalidomide|lenalidomide|mesh-list
5773721|NCT02886065|Poly ICLC|poly iclc|mesh-list
5773722|NCT02886065|Citarinostat|citarinostat|mesh-list
5773723|NCT02886065|Immunologic Factors|immunologic factors|mesh-ancestor
5773724|NCT02886065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773725|NCT02886065|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5773726|NCT02886065|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5773727|NCT02886065|Growth Substances|growth substances|mesh-ancestor
5773728|NCT02886065|Growth Inhibitors|growth inhibitors|mesh-ancestor
5773729|NCT02886065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5773730|NCT02886065|Interferon Inducers|interferon inducers|mesh-ancestor
5773731|NCT02886065|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5773732|NCT02886065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5773733|NCT02886065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773734|NCT02885974|Gemcitabine|gemcitabine|mesh-list
5773735|NCT02885974|Celecoxib|celecoxib|mesh-list
5773736|NCT02885974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5773737|NCT02885974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5773738|NCT02885974|Antimetabolites|antimetabolites|mesh-ancestor
5773739|NCT02885974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773740|NCT02885974|Antiviral Agents|antiviral agents|mesh-ancestor
5773741|NCT02885974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5773742|NCT02885974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5773743|NCT02885974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5773744|NCT02885974|Immunologic Factors|immunologic factors|mesh-ancestor
5773745|NCT02885974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773746|NCT02885974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5773747|NCT02885974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5773748|NCT02885974|Analgesics|analgesics|mesh-ancestor
5773749|NCT02885974|Sensory System Agents|sensory system agents|mesh-ancestor
5773750|NCT02885974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5773751|NCT02885974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5773752|NCT02885974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5773753|NCT02885974|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5773754|NCT02885974|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5773755|NCT02885961|Dabigatran|dabigatran|mesh-list
5773756|NCT02885961|Antithrombins|antithrombins|mesh-ancestor
5773757|NCT02885961|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5773758|NCT02885961|Protease Inhibitors|protease inhibitors|mesh-ancestor
5773759|NCT02885961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5773760|NCT02885961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773761|NCT02885961|Anticoagulants|anticoagulants|mesh-ancestor
5773762|NCT02885727|Durvalumab|durvalumab|mesh-list
5773763|NCT02885727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5773764|NCT02885727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5773765|NCT02885909|Insulin|insulin|mesh-list
5773766|NCT02885909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5773767|NCT02885909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773768|NCT02885740|Adenosine|adenosine|mesh-list
5773769|NCT02885740|Analgesics|analgesics|mesh-ancestor
5773770|NCT02885740|Sensory System Agents|sensory system agents|mesh-ancestor
5773771|NCT02885740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5773772|NCT02885740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773773|NCT02885740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5773774|NCT02885740|Vasodilator Agents|vasodilator agents|mesh-ancestor
5773775|NCT02885740|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5773776|NCT02885740|Purinergic Agonists|purinergic agonists|mesh-ancestor
5773777|NCT02885740|Purinergic Agents|purinergic agents|mesh-ancestor
5773778|NCT02885740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5773779|NCT02885740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773780|NCT02885948|Naloxone|naloxone|mesh-list
5773781|NCT02885948|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5773782|NCT02885948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773783|NCT02885948|Sensory System Agents|sensory system agents|mesh-ancestor
5773784|NCT02885948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5773785|NCT02885922|Hypoglycemic Agents|hypoglycemic agents|mesh-list
5773786|NCT02885922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773787|NCT02885753|Leucovorin|leucovorin|mesh-list
5773788|NCT02885753|Folic Acid|folic acid|mesh-list
5773789|NCT02885753|Bevacizumab|bevacizumab|mesh-list
5773790|NCT02885753|Panitumumab|panitumumab|mesh-list
5773791|NCT02885753|Oxaliplatin|oxaliplatin|mesh-list
5773792|NCT02885753|Levoleucovorin|levoleucovorin|mesh-list
5773793|NCT02885753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5773794|NCT02885753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5773795|NCT02885753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5773796|NCT02885753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5773797|NCT02885753|Growth Substances|growth substances|mesh-ancestor
5773798|NCT02885753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773799|NCT02885753|Growth Inhibitors|growth inhibitors|mesh-ancestor
5773800|NCT02885753|Antidotes|antidotes|mesh-ancestor
5773801|NCT02885753|Protective Agents|protective agents|mesh-ancestor
5773802|NCT02885753|Vitamin B Complex|vitamin b complex|mesh-ancestor
5773803|NCT02885753|Vitamins|vitamins|mesh-ancestor
5773804|NCT02885753|Micronutrients|micronutrients|mesh-ancestor
5773805|NCT02885753|Hematinics|hematinics|mesh-ancestor
5773806|NCT02885441|Ketorolac|ketorolac|mesh-list
5896994|NCT02737046|Antimetabolites|antimetabolites|mesh-ancestor
5773807|NCT02885441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5773808|NCT02885441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5773809|NCT02885441|Analgesics|analgesics|mesh-ancestor
5773810|NCT02885441|Sensory System Agents|sensory system agents|mesh-ancestor
5773811|NCT02885441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5773812|NCT02885441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773813|NCT02885441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5773814|NCT02885441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5773815|NCT02885441|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5773816|NCT02885441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5773817|NCT02885441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773818|NCT02885688|Insulin|insulin|mesh-list
5773819|NCT02885688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5773820|NCT02885688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773821|NCT02885597|Methotrexate|methotrexate|mesh-list
5773822|NCT02885597|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5773823|NCT02885597|Abortifacient Agents|abortifacient agents|mesh-ancestor
5773824|NCT02885597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5773825|NCT02885597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773826|NCT02885597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5773827|NCT02885597|Antimetabolites|antimetabolites|mesh-ancestor
5773828|NCT02885597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773829|NCT02885597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5773830|NCT02885597|Dermatologic Agents|dermatologic agents|mesh-ancestor
5773831|NCT02885597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5773832|NCT02885597|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5773833|NCT02885597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5773834|NCT02885597|Immunologic Factors|immunologic factors|mesh-ancestor
5773835|NCT02885597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5773836|NCT02885597|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5773837|NCT02885558|Efonidipine|efonidipine|mesh-list
5773838|NCT02885558|Nifedipine|nifedipine|mesh-list
5773839|NCT02885558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5773840|NCT02885558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5773841|NCT02885558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773842|NCT02885558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5773843|NCT02885558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773844|NCT02885558|Vasodilator Agents|vasodilator agents|mesh-ancestor
5773845|NCT02885558|Tocolytic Agents|tocolytic agents|mesh-ancestor
5773846|NCT02885558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5773847|NCT02885558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5773848|NCT02885558|Diuretics|diuretics|mesh-ancestor
5773849|NCT02885558|Natriuretic Agents|natriuretic agents|mesh-ancestor
5773850|NCT02885545|Anticoagulants|anticoagulants|mesh-list
5773851|NCT02885454|Simeprevir|simeprevir|mesh-list
5773852|NCT02885454|Odalasvir|odalasvir|mesh-list
5773853|NCT02885454|Drospirenone|drospirenone|mesh-list
5773854|NCT02885454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5773855|NCT02885454|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
5773856|NCT02885454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5773857|NCT02885454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5773858|NCT02885454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5773859|NCT02885454|Contraceptive Agents|contraceptive agents|mesh-ancestor
5773860|NCT02885454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5773861|NCT02885454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773862|NCT02885454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5773863|NCT02885454|Estrogens|estrogens|mesh-ancestor
5773864|NCT02885454|Hormones|hormones|mesh-ancestor
5773865|NCT02885454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5773866|NCT02885454|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5773867|NCT02885454|Hormone Antagonists|hormone antagonists|mesh-ancestor
5773868|NCT02885454|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5773869|NCT02885454|Diuretics|diuretics|mesh-ancestor
5773870|NCT02885454|Natriuretic Agents|natriuretic agents|mesh-ancestor
6673539|NCT01563614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673540|NCT01563614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6673541|NCT01563614|Alkylating Agents|alkylating agents|mesh-ancestor
6673542|NCT01563640|Permethrin|permethrin|mesh-list
5773871|NCT02885454|Antiviral Agents|antiviral agents|mesh-ancestor
5773872|NCT02885454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5773873|NCT02885454|Protease Inhibitors|protease inhibitors|mesh-ancestor
5773874|NCT02885454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5907967|NCT04992065|Antimetabolites|antimetabolites|mesh-ancestor
5773875|NCT02885454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773876|NCT02885168|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
5773877|NCT02885168|Phenylephrine|phenylephrine|mesh-list
5773878|NCT02885168|Protein C|protein c|mesh-list
5773879|NCT02885168|Oxymetazoline|oxymetazoline|mesh-list
5773880|NCT02885168|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5773881|NCT02885168|Mydriatics|mydriatics|mesh-ancestor
5773882|NCT02885168|Autonomic Agents|autonomic agents|mesh-ancestor
5773883|NCT02885168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5773884|NCT02885168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773885|NCT02885168|Sympathomimetics|sympathomimetics|mesh-ancestor
5773886|NCT02885168|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5773887|NCT02885168|Nasal Decongestants|nasal decongestants|mesh-ancestor
5773888|NCT02885168|Respiratory System Agents|respiratory system agents|mesh-ancestor
5773889|NCT02885168|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5773890|NCT02885168|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5773891|NCT02885168|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5773892|NCT02885168|Adrenergic Agents|adrenergic agents|mesh-ancestor
5773893|NCT02885168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5773894|NCT02885168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773895|NCT02885168|Protective Agents|protective agents|mesh-ancestor
5773896|NCT02885168|Anticoagulants|anticoagulants|mesh-ancestor
5773897|NCT02885168|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5773898|NCT02885168|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5773899|NCT02885168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5773900|NCT02885272|Deoxyglucose|deoxyglucose|mesh-list
5773901|NCT02885272|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5773902|NCT02885272|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5773903|NCT02885272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773904|NCT02885272|Antimetabolites|antimetabolites|mesh-ancestor
5773905|NCT02885272|Antiviral Agents|antiviral agents|mesh-ancestor
5773906|NCT02885272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5773907|NCT02885311|Naltrexone|naltrexone|mesh-list
5773908|NCT02885311|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5773909|NCT02885311|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5773910|NCT02885311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773911|NCT02885311|Sensory System Agents|sensory system agents|mesh-ancestor
5773912|NCT02885311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5896995|NCT02737046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5896996|NCT02737046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5896997|NCT02737046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5896998|NCT02737046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5896999|NCT02737046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5897000|NCT02737046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5897001|NCT02737046|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5897002|NCT02723864|Veliparib|veliparib|mesh-list
5897003|NCT02723864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5897004|NCT02723864|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5897005|NCT02723864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5897006|NCT02723864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897007|NCT02676791|Povidone-Iodine|povidone-iodine|mesh-list
5897008|NCT02676791|Povidone|povidone|mesh-list
5897009|NCT02676791|Plasma Substitutes|plasma substitutes|mesh-ancestor
5897010|NCT02676791|Blood Substitutes|blood substitutes|mesh-ancestor
5897011|NCT02676791|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5897012|NCT02676791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5897013|NCT02673996|Phenylephrine|phenylephrine|mesh-list
5897014|NCT02673996|Isoproterenol|isoproterenol|mesh-list
5897015|NCT02673996|Oxymetazoline|oxymetazoline|mesh-list
5897016|NCT02673996|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5897017|NCT02673996|Mydriatics|mydriatics|mesh-ancestor
5897018|NCT02673996|Autonomic Agents|autonomic agents|mesh-ancestor
5897019|NCT02673996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5897020|NCT02673996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897021|NCT02673996|Sympathomimetics|sympathomimetics|mesh-ancestor
5897022|NCT02673996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5897023|NCT02673996|Nasal Decongestants|nasal decongestants|mesh-ancestor
5897024|NCT02673996|Respiratory System Agents|respiratory system agents|mesh-ancestor
5897025|NCT02673996|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5897026|NCT02673996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5897027|NCT02673996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5897028|NCT02673996|Adrenergic Agents|adrenergic agents|mesh-ancestor
5897029|NCT02673996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5897030|NCT02673996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897031|NCT02673996|Protective Agents|protective agents|mesh-ancestor
5897032|NCT02673996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6673543|NCT01563640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6673544|NCT01563640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773913|NCT02884986|Etoricoxib|etoricoxib|mesh-list
5773914|NCT02884986|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5773915|NCT02884986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5773916|NCT02884986|Analgesics|analgesics|mesh-ancestor
5773917|NCT02884986|Sensory System Agents|sensory system agents|mesh-ancestor
5773918|NCT02884986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5773919|NCT02884986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773920|NCT02884986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5773921|NCT02884986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5773922|NCT02884986|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5773923|NCT02884986|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5773924|NCT02884986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5773925|NCT02884986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773926|NCT02884921|Acetaminophen|acetaminophen|mesh-list
5773927|NCT02884921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5773928|NCT02884921|Analgesics|analgesics|mesh-ancestor
5773929|NCT02884921|Sensory System Agents|sensory system agents|mesh-ancestor
5773930|NCT02884921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5773931|NCT02884921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773932|NCT02884921|Antipyretics|antipyretics|mesh-ancestor
5773933|NCT02884596|Serotonin|serotonin|mesh-list
5773934|NCT02884596|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
5773935|NCT02884596|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5773936|NCT02884596|Serotonin Agents|serotonin agents|mesh-ancestor
5773937|NCT02884596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5773938|NCT02884596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773939|NCT02884596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773940|NCT02884596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5773941|NCT02884596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5773942|NCT02884817|Listerine|listerine|mesh-list
5773943|NCT02884817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5773944|NCT02884817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5773945|NCT02884713|Doxycycline|doxycycline|mesh-list
5773946|NCT02884713|Levofloxacin|levofloxacin|mesh-list
5773947|NCT02884713|Ofloxacin|ofloxacin|mesh-list
5773948|NCT02884713|Esomeprazole|esomeprazole|mesh-list
5773949|NCT02884713|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5773950|NCT02884713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5773951|NCT02884713|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5773952|NCT02884713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5773953|NCT02884713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773954|NCT02884713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5773955|NCT02884713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5773956|NCT02884713|Antimalarials|antimalarials|mesh-ancestor
5773957|NCT02884713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5773958|NCT02884713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5773959|NCT02884713|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5773960|NCT02884713|Renal Agents|renal agents|mesh-ancestor
5773961|NCT02884713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5773962|NCT02884713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5773963|NCT02884713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5773964|NCT02884713|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5773965|NCT02884713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5773966|NCT02884388|Anesthetics|anesthetics|mesh-list
5773967|NCT02884388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5773968|NCT02884388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773969|NCT02884440|Ropivacaine|ropivacaine|mesh-list
5773970|NCT02884440|Anesthetics|anesthetics|mesh-ancestor
5773971|NCT02884440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5773972|NCT02884440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773973|NCT02884440|Anesthetics, Local|anesthetics, local|mesh-ancestor
5773974|NCT02884440|Sensory System Agents|sensory system agents|mesh-ancestor
5773975|NCT02884440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5773976|NCT02884635|Methotrexate|methotrexate|mesh-list
5773977|NCT02884635|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5773978|NCT02884635|Abortifacient Agents|abortifacient agents|mesh-ancestor
5773979|NCT02884635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5773980|NCT02884635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5773981|NCT02884635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5773982|NCT02884635|Antimetabolites|antimetabolites|mesh-ancestor
5773983|NCT02884635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773984|NCT02884635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5773985|NCT02884635|Dermatologic Agents|dermatologic agents|mesh-ancestor
5773986|NCT02884635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5773987|NCT02884635|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5773988|NCT02884635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5773989|NCT02884635|Immunologic Factors|immunologic factors|mesh-ancestor
5773990|NCT02884635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5773991|NCT02884635|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5773992|NCT02884479|Docetaxel|docetaxel|mesh-list
5773993|NCT02884479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5773994|NCT02884479|Tubulin Modulators|tubulin modulators|mesh-ancestor
5773995|NCT02884479|Antimitotic Agents|antimitotic agents|mesh-ancestor
5773996|NCT02884479|Mitosis Modulators|mitosis modulators|mesh-ancestor
5773997|NCT02884479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5773998|NCT02884310|Remifentanil|remifentanil|mesh-list
5773999|NCT02884310|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5774000|NCT02884310|Narcotics|narcotics|mesh-ancestor
5774001|NCT02884310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5774002|NCT02884310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774003|NCT02884310|Analgesics|analgesics|mesh-ancestor
5774004|NCT02884310|Sensory System Agents|sensory system agents|mesh-ancestor
5774005|NCT02884310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5774006|NCT02884219|Ibuprofen|ibuprofen|mesh-list
5774007|NCT02884219|Indomethacin|indomethacin|mesh-list
5774008|NCT02884219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
5774009|NCT02884219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5774010|NCT02884219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5774011|NCT02884219|Analgesics|analgesics|mesh-ancestor
5774012|NCT02884219|Sensory System Agents|sensory system agents|mesh-ancestor
5774013|NCT02884219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5774014|NCT02884219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774015|NCT02884219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5774016|NCT02884219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5774017|NCT02884219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5774018|NCT02884219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5774019|NCT02884219|Gout Suppressants|gout suppressants|mesh-ancestor
5774020|NCT02884219|Tocolytic Agents|tocolytic agents|mesh-ancestor
5774021|NCT02884219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5774022|NCT02884245|Estrogens|estrogens|mesh-list
5774023|NCT02884245|Hormones|hormones|mesh-ancestor
5774024|NCT02884245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5774025|NCT02884245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774026|NCT02884050|Topiramate|topiramate|mesh-list
5774027|NCT02884050|Anticonvulsants|anticonvulsants|mesh-ancestor
5774028|NCT02884050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5774029|NCT02884050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774030|NCT02884115|Penicillins|penicillins|mesh-list
5774031|NCT02884115|Penicillin G Benzathine|penicillin g benzathine|mesh-list
5774032|NCT02884115|Penicillin G|penicillin g|mesh-list
5774033|NCT02884115|Penicillin G Procaine|penicillin g procaine|mesh-list
5774034|NCT02884115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5774035|NCT02884115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5774036|NCT02884128|Leucovorin|leucovorin|mesh-list
5774037|NCT02884128|Fluorouracil|fluorouracil|mesh-list
5774038|NCT02884128|Irinotecan|irinotecan|mesh-list
5774039|NCT02884128|Antimetabolites|antimetabolites|mesh-ancestor
5774040|NCT02884128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5774041|NCT02884128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5774042|NCT02884128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5774043|NCT02884128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5774044|NCT02884128|Immunologic Factors|immunologic factors|mesh-ancestor
5774045|NCT02884128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774046|NCT02884128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5774047|NCT02884128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5774048|NCT02884128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5774049|NCT02884128|Antidotes|antidotes|mesh-ancestor
5774050|NCT02884128|Protective Agents|protective agents|mesh-ancestor
5774051|NCT02884128|Vitamin B Complex|vitamin b complex|mesh-ancestor
5774052|NCT02884128|Vitamins|vitamins|mesh-ancestor
5774053|NCT02884128|Micronutrients|micronutrients|mesh-ancestor
5774054|NCT02884037|Rifaximin|rifaximin|mesh-list
5774055|NCT02884037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5774056|NCT02884037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5774057|NCT02884037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5774058|NCT02884180|Dexamethasone|dexamethasone|mesh-list
5774059|NCT02884180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5774060|NCT02884180|Antiemetics|antiemetics|mesh-ancestor
5774061|NCT02884180|Autonomic Agents|autonomic agents|mesh-ancestor
5774062|NCT02884180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5774063|NCT02884180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774064|NCT02884180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5774065|NCT02884180|Glucocorticoids|glucocorticoids|mesh-ancestor
5774066|NCT02884180|Hormones|hormones|mesh-ancestor
5774067|NCT02884180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5774068|NCT02884180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5774069|NCT02884180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5774070|NCT02883647|Tenofovir|tenofovir|mesh-list
5774071|NCT02883647|Entecavir|entecavir|mesh-list
5774072|NCT02883647|Antiviral Agents|antiviral agents|mesh-ancestor
5774073|NCT02883647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5774074|NCT02883647|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5774075|NCT02883647|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5774076|NCT02883647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5774077|NCT02883647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5774078|NCT02883647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5774079|NCT02883647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5774080|NCT02883595|Thymalfasin|thymalfasin|mesh-list
5774081|NCT02883595|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5774082|NCT02883595|Immunologic Factors|immunologic factors|mesh-ancestor
5774083|NCT02883595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774084|NCT02883556|Pembrolizumab|pembrolizumab|mesh-list
5774085|NCT02883556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5774086|NCT02883556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5774087|NCT02883569|Ibuprofen|ibuprofen|mesh-list
5774088|NCT02883569|Aceclofenac|aceclofenac|mesh-list
5774089|NCT02883569|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
5774090|NCT02883569|Tramadol|tramadol|mesh-list
5774091|NCT02883569|Codeine|codeine|mesh-list
5774092|NCT02883569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5774093|NCT02883569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5774094|NCT02883569|Analgesics|analgesics|mesh-ancestor
5774095|NCT02883569|Sensory System Agents|sensory system agents|mesh-ancestor
5774096|NCT02883569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5774097|NCT02883569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774098|NCT02883569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5774099|NCT02883569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5774100|NCT02883569|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5774101|NCT02883569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5774102|NCT02883569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5774103|NCT02883569|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5774104|NCT02883569|Narcotics|narcotics|mesh-ancestor
5774105|NCT02883569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5774106|NCT02883569|Antitussive Agents|antitussive agents|mesh-ancestor
5774107|NCT02883569|Respiratory System Agents|respiratory system agents|mesh-ancestor
5897033|NCT02673996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5897034|NCT02673996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5897035|NCT02600949|Pembrolizumab|pembrolizumab|mesh-list
5897036|NCT02600949|Imiquimod|imiquimod|mesh-list
5897037|NCT02600949|Vaccines|vaccines|mesh-list
5897038|NCT02600949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5897039|NCT02600949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5897040|NCT02600949|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6490597|NCT00598962|Leprostatic Agents|leprostatic agents|mesh-ancestor
6490598|NCT00598962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6490599|NCT00598962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6490600|NCT00598962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490601|NCT00598962|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6490602|NCT00598962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6490603|NCT00598962|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6490604|NCT00598962|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6490605|NCT00598962|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6490606|NCT00598962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6490607|NCT00599079|Azithromycin|azithromycin|mesh-list
6490608|NCT00599079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6490609|NCT00599079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6490610|NCT00599222|Ranibizumab|ranibizumab|mesh-list
6490611|NCT00599222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6490612|NCT00599222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6490613|NCT00599222|Growth Substances|growth substances|mesh-ancestor
6490614|NCT00599222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490615|NCT00599222|Growth Inhibitors|growth inhibitors|mesh-ancestor
6490616|NCT00599222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5897041|NCT02600949|Immunologic Factors|immunologic factors|mesh-ancestor
5897042|NCT02600949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640804|NCT04620798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640805|NCT04609046|Rituximab|rituximab|mesh-list
5640806|NCT04609046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5640807|NCT04609046|Nivolumab|nivolumab|mesh-list
5640808|NCT04609046|Methotrexate|methotrexate|mesh-list
5774108|NCT02883478|Riboflavin|riboflavin|mesh-list
5774109|NCT02883478|Vitamin B Complex|vitamin b complex|mesh-ancestor
5774110|NCT02883478|Vitamins|vitamins|mesh-ancestor
5774111|NCT02883478|Micronutrients|micronutrients|mesh-ancestor
5774112|NCT02883478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774113|NCT02883478|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6490617|NCT00599235|Hydralazine|hydralazine|mesh-list
5774114|NCT02883478|Dermatologic Agents|dermatologic agents|mesh-ancestor
5774115|NCT02883179|Lidocaine|lidocaine|mesh-list
5774116|NCT02883179|Prilocaine|prilocaine|mesh-list
5774117|NCT02883179|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
5774118|NCT02883179|Anesthetics, Local|anesthetics, local|mesh-ancestor
5774119|NCT02883179|Anesthetics|anesthetics|mesh-ancestor
5774120|NCT02883179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5774121|NCT02883179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774122|NCT02883179|Sensory System Agents|sensory system agents|mesh-ancestor
5774123|NCT02883179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5774124|NCT02883179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5774125|NCT02883179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5774126|NCT02883179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5774127|NCT02883179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5774128|NCT02883179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5774129|NCT02883179|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
5774130|NCT02883192|Ondansetron|ondansetron|mesh-list
5774131|NCT02883192|Antiemetics|antiemetics|mesh-ancestor
5774132|NCT02883192|Autonomic Agents|autonomic agents|mesh-ancestor
5774133|NCT02883192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5774134|NCT02883192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774135|NCT02883192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5774136|NCT02883192|Antipruritics|antipruritics|mesh-ancestor
5774137|NCT02883192|Dermatologic Agents|dermatologic agents|mesh-ancestor
5774138|NCT02883192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5774139|NCT02883192|Serotonin Agents|serotonin agents|mesh-ancestor
5774140|NCT02883192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5774141|NCT02883192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5774142|NCT02883192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5774143|NCT02883192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5774144|NCT02883192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5774145|NCT02883192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5774146|NCT02883192|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5774147|NCT02883439|Fluticasone|fluticasone|mesh-list
5774148|NCT02883439|Xhance|xhance|mesh-list
5774149|NCT02883439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5774150|NCT02883439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5774151|NCT02883439|Autonomic Agents|autonomic agents|mesh-ancestor
5774152|NCT02883439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5774153|NCT02883439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774154|NCT02883439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5774155|NCT02883439|Respiratory System Agents|respiratory system agents|mesh-ancestor
5774156|NCT02883439|Dermatologic Agents|dermatologic agents|mesh-ancestor
5774157|NCT02883439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5774158|NCT02883426|Vaccines|vaccines|mesh-list
5774159|NCT02883426|Immunologic Factors|immunologic factors|mesh-ancestor
5774160|NCT02883426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774161|NCT02883114|Itraconazole|itraconazole|mesh-list
5774162|NCT02883114|Antifungal Agents|antifungal agents|mesh-ancestor
5774163|NCT02883114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5774164|NCT02883114|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5774165|NCT02883114|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5774166|NCT02883114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5774167|NCT02883114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5774168|NCT02883114|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5774169|NCT02883114|Hormone Antagonists|hormone antagonists|mesh-ancestor
5774170|NCT02883114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5774171|NCT02883114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774172|NCT02883114|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5774173|NCT02883023|Bleomycin|bleomycin|mesh-list
6490618|NCT00599235|Sildenafil Citrate|sildenafil citrate|mesh-list
5640809|NCT04609046|Lenalidomide|lenalidomide|mesh-list
5640810|NCT04609046|Antibodies|antibodies|mesh-list
5640811|NCT04609046|Immunoglobulins|immunoglobulins|mesh-list
5640812|NCT04609046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5774174|NCT02883023|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5774175|NCT02883023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5774176|NCT02883049|Calcium, Dietary|calcium, dietary|mesh-list
5774177|NCT02883049|Leucovorin|leucovorin|mesh-list
5774178|NCT02883049|Folic Acid|folic acid|mesh-list
5774179|NCT02883049|Cytarabine|cytarabine|mesh-list
5774180|NCT02883049|Dexamethasone|dexamethasone|mesh-list
5774181|NCT02883049|Dexamethasone acetate|dexamethasone acetate|mesh-list
5774182|NCT02883049|Prednisone|prednisone|mesh-list
5774183|NCT02883049|Hydrocortisone|hydrocortisone|mesh-list
5774184|NCT02883049|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
5774185|NCT02883049|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
5774186|NCT02883049|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
5774187|NCT02883049|Cortisone|cortisone|mesh-list
5774188|NCT02883049|Cyclophosphamide|cyclophosphamide|mesh-list
5774189|NCT02883049|Doxorubicin|doxorubicin|mesh-list
5774190|NCT02883049|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5774191|NCT02883049|Methotrexate|methotrexate|mesh-list
5774192|NCT02883049|Etoposide|etoposide|mesh-list
5774193|NCT02883049|Vincristine|vincristine|mesh-list
5774194|NCT02883049|Etoposide phosphate|etoposide phosphate|mesh-list
5774195|NCT02883049|Daunorubicin|daunorubicin|mesh-list
5774196|NCT02883049|Asparaginase|asparaginase|mesh-list
5774197|NCT02883049|Dasatinib|dasatinib|mesh-list
5774198|NCT02883049|Mercaptopurine|mercaptopurine|mesh-list
5774199|NCT02883049|Clofarabine|clofarabine|mesh-list
5774200|NCT02883049|Podophyllotoxin|podophyllotoxin|mesh-list
5774201|NCT02883049|Pegaspargase|pegaspargase|mesh-list
5774202|NCT02883049|Thioguanine|thioguanine|mesh-list
5774203|NCT02883049|BB 1101|bb 1101|mesh-list
5774204|NCT02883049|Calcium|calcium|mesh-list
5774205|NCT02883049|2-Aminopurine|2-aminopurine|mesh-list
5774206|NCT02883049|Levoleucovorin|levoleucovorin|mesh-list
5774207|NCT02883049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5774208|NCT02883049|Immunologic Factors|immunologic factors|mesh-ancestor
5774209|NCT02883049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774210|NCT02883049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5774211|NCT02883049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5774212|NCT02883049|Alkylating Agents|alkylating agents|mesh-ancestor
5774213|NCT02883049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5774214|NCT02883049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5774215|NCT02883049|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5774216|NCT02883049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5774217|NCT02883049|Antiemetics|antiemetics|mesh-ancestor
5774218|NCT02883049|Autonomic Agents|autonomic agents|mesh-ancestor
5774219|NCT02883049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5774220|NCT02883049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5774221|NCT02883049|Glucocorticoids|glucocorticoids|mesh-ancestor
5774222|NCT02883049|Hormones|hormones|mesh-ancestor
5774223|NCT02883049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5774224|NCT02883049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5774225|NCT02883049|Protease Inhibitors|protease inhibitors|mesh-ancestor
5774226|NCT02883049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5774227|NCT02883049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5774228|NCT02883049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5774229|NCT02883049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5774230|NCT02883049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5774231|NCT02883049|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5774232|NCT02883049|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5774233|NCT02883049|Abortifacient Agents|abortifacient agents|mesh-ancestor
5774234|NCT02883049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5774235|NCT02883049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5774236|NCT02883049|Antimetabolites|antimetabolites|mesh-ancestor
5774237|NCT02883049|Dermatologic Agents|dermatologic agents|mesh-ancestor
5774238|NCT02883049|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5774239|NCT02883049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5774240|NCT02883049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5774241|NCT02883049|Antiviral Agents|antiviral agents|mesh-ancestor
5774242|NCT02883049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5774243|NCT02883049|Antidotes|antidotes|mesh-ancestor
5774244|NCT02883049|Protective Agents|protective agents|mesh-ancestor
5774245|NCT02883049|Vitamin B Complex|vitamin b complex|mesh-ancestor
5774246|NCT02883049|Vitamins|vitamins|mesh-ancestor
5774247|NCT02883049|Micronutrients|micronutrients|mesh-ancestor
5774248|NCT02883049|Tubulin Modulators|tubulin modulators|mesh-ancestor
5774249|NCT02883049|Antimitotic Agents|antimitotic agents|mesh-ancestor
5774250|NCT02883049|Mitosis Modulators|mitosis modulators|mesh-ancestor
5774251|NCT02883049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5774252|NCT02883049|Hematinics|hematinics|mesh-ancestor
5774253|NCT02883049|Keratolytic Agents|keratolytic agents|mesh-ancestor
5774254|NCT02882893|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5774255|NCT02882893|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5774256|NCT02882893|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5774257|NCT02882893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5774258|NCT02882893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774259|NCT02882893|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5774260|NCT02882893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5774261|NCT02882893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5774262|NCT02882893|Cholinergic Agents|cholinergic agents|mesh-ancestor
5774263|NCT02882893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5774264|NCT02882828|Tacrolimus|tacrolimus|mesh-list
5774265|NCT02882828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5774266|NCT02882828|Immunologic Factors|immunologic factors|mesh-ancestor
5774267|NCT02882828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774268|NCT02882828|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5774269|NCT02882828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5774270|NCT02882828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5774271|NCT02882984|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5774272|NCT02882984|Gefitinib|gefitinib|mesh-list
5774273|NCT02882984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5774274|NCT02882984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5774275|NCT02882984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5774276|NCT02882984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5774277|NCT02882789|Delpazolid|delpazolid|mesh-list
5774278|NCT02882789|Oxazolidinones|oxazolidinones|mesh-list
5774279|NCT02882789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5774280|NCT02882789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5774281|NCT02882789|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5774282|NCT02882789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5774283|NCT02882789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5774284|NCT02882737|Glucagon|glucagon|mesh-list
5774285|NCT02882737|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5774286|NCT02882737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5774287|NCT02882737|Hormones|hormones|mesh-ancestor
5774288|NCT02882737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5774289|NCT02882737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774290|NCT02882737|Incretins|incretins|mesh-ancestor
5774291|NCT02882555|Capsaicin|capsaicin|mesh-list
5774292|NCT02882555|Antipruritics|antipruritics|mesh-ancestor
5774293|NCT02882555|Dermatologic Agents|dermatologic agents|mesh-ancestor
5774294|NCT02882555|Sensory System Agents|sensory system agents|mesh-ancestor
5774295|NCT02882555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5774296|NCT02882555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774297|NCT02882932|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5774298|NCT02882308|Durvalumab|durvalumab|mesh-list
5774299|NCT02882308|Olaparib|olaparib|mesh-list
5774300|NCT02882308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5774301|NCT02882308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5774302|NCT02882308|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5774303|NCT02882308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5774304|NCT02882308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5774305|NCT02882581|Metformin|metformin|mesh-list
5774306|NCT02882581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5774307|NCT02882581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774308|NCT02882347|Somatostatin|somatostatin|mesh-list
5774309|NCT02882347|Hormones|hormones|mesh-ancestor
5774310|NCT02882347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5774311|NCT02882347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774312|NCT02882477|Metformin|metformin|mesh-list
5774313|NCT02882477|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5774314|NCT02882477|Acetylcysteine|acetylcysteine|mesh-list
5774315|NCT02882477|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5774316|NCT02882477|Deferiprone|deferiprone|mesh-list
5774317|NCT02882477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5774318|NCT02882477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774319|NCT02882477|Incretins|incretins|mesh-ancestor
5774320|NCT02882477|Hormones|hormones|mesh-ancestor
5774321|NCT02882477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5774322|NCT02882477|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5774323|NCT02882477|Protease Inhibitors|protease inhibitors|mesh-ancestor
5774324|NCT02882477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5774325|NCT02882477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5774326|NCT02882477|Antiviral Agents|antiviral agents|mesh-ancestor
5774327|NCT02882477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5774328|NCT02882477|Expectorants|expectorants|mesh-ancestor
5774329|NCT02882477|Respiratory System Agents|respiratory system agents|mesh-ancestor
5774330|NCT02882477|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5774331|NCT02882477|Antioxidants|antioxidants|mesh-ancestor
5774332|NCT02882477|Protective Agents|protective agents|mesh-ancestor
5774333|NCT02882477|Antidotes|antidotes|mesh-ancestor
5774334|NCT02882477|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5774335|NCT02882477|Chelating Agents|chelating agents|mesh-ancestor
5774336|NCT02882477|Sequestering Agents|sequestering agents|mesh-ancestor
5774337|NCT02882425|Selexipag|selexipag|mesh-list
5774338|NCT02882425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5774339|NCT02882451|Ascorbic Acid|ascorbic acid|mesh-list
5774340|NCT02882451|Pinaverium|pinaverium|mesh-list
5774341|NCT02882451|Bromides|bromides|mesh-list
5774342|NCT02882451|Vitamins|vitamins|mesh-ancestor
5774343|NCT02882451|Micronutrients|micronutrients|mesh-ancestor
5774344|NCT02882451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774345|NCT02882451|Antioxidants|antioxidants|mesh-ancestor
5774346|NCT02882451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5774347|NCT02882451|Protective Agents|protective agents|mesh-ancestor
5774348|NCT02882451|Anticonvulsants|anticonvulsants|mesh-ancestor
5774349|NCT02882451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5774350|NCT02882451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5774351|NCT02882451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5774352|NCT02882451|Parasympatholytics|parasympatholytics|mesh-ancestor
5774353|NCT02882451|Autonomic Agents|autonomic agents|mesh-ancestor
5774354|NCT02882451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5774355|NCT02882269|Capecitabine|capecitabine|mesh-list
5774356|NCT02882269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5774357|NCT02882269|Antimetabolites|antimetabolites|mesh-ancestor
5774358|NCT02882269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5774359|NCT02882269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5774360|NCT02882594|Anesthetics|anesthetics|mesh-list
5774361|NCT02882594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5774362|NCT02882594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774363|NCT02882100|Vaccines|vaccines|mesh-list
5774364|NCT02882100|Immunologic Factors|immunologic factors|mesh-ancestor
5774365|NCT02882100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774366|NCT02882113|Tacrolimus|tacrolimus|mesh-list
5774367|NCT02882113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5774368|NCT02882113|Immunologic Factors|immunologic factors|mesh-ancestor
5774369|NCT02882113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774370|NCT02882113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5774371|NCT02882113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5774372|NCT02882113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5774373|NCT02882217|Histamine|histamine|mesh-list
5774374|NCT02882217|Glutarimide|glutarimide|mesh-list
5774375|NCT02882217|Histamine Agonists|histamine agonists|mesh-ancestor
5774376|NCT02882217|Histamine Agents|histamine agents|mesh-ancestor
5774377|NCT02882217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5774378|NCT02882217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5774379|NCT02882217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774380|NCT02882217|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5774381|NCT02882217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5774382|NCT02881866|Furosemide|furosemide|mesh-list
5774383|NCT02881866|Diuretics|diuretics|mesh-ancestor
5774384|NCT02881866|Natriuretic Agents|natriuretic agents|mesh-ancestor
5774385|NCT02881866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774386|NCT02881866|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5774387|NCT02881866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5774388|NCT02881866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897043|NCT02600949|Interferon Inducers|interferon inducers|mesh-ancestor
5897044|NCT02597062|Dexamethasone|dexamethasone|mesh-list
5897045|NCT02597062|Cyclophosphamide|cyclophosphamide|mesh-list
5897046|NCT02597062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5897047|NCT02597062|Immunologic Factors|immunologic factors|mesh-ancestor
5897048|NCT02597062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897049|NCT02597062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5897050|NCT02597062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5897051|NCT02597062|Alkylating Agents|alkylating agents|mesh-ancestor
5897052|NCT02597062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897053|NCT02597062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5897054|NCT02597062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5897055|NCT02597062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5897056|NCT02597062|Antiemetics|antiemetics|mesh-ancestor
5897057|NCT02597062|Autonomic Agents|autonomic agents|mesh-ancestor
5897058|NCT02597062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5897059|NCT02597062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5774389|NCT02881892|Dialysis Solutions|dialysis solutions|mesh-list
5774390|NCT02881892|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5774391|NCT02882191|Levonorgestrel|levonorgestrel|mesh-list
5774392|NCT02882191|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5774393|NCT02882191|Contraceptive Agents|contraceptive agents|mesh-ancestor
5774394|NCT02882191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5774395|NCT02882191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774396|NCT02882191|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5774397|NCT02882191|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5774398|NCT02882191|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5774399|NCT02882126|Treprostinil|treprostinil|mesh-list
5774400|NCT02882126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5774401|NCT02882230|Dolutegravir|dolutegravir|mesh-list
5774402|NCT02882230|Rilpivirine|rilpivirine|mesh-list
5774403|NCT02882230|Elvitegravir|elvitegravir|mesh-list
5774404|NCT02882230|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5774405|NCT02882230|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5774406|NCT02882230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5774407|NCT02882230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5774408|NCT02882230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5774409|NCT02882230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5774410|NCT02882230|Antiviral Agents|antiviral agents|mesh-ancestor
5774411|NCT02882230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5774412|NCT02882230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5774413|NCT02882230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5774414|NCT02881749|Mechlorethamine|mechlorethamine|mesh-list
5774415|NCT02881749|Alkylating Agents|alkylating agents|mesh-ancestor
5774416|NCT02881749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5774417|NCT02881749|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5774418|NCT02881749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5774419|NCT02881762|Maraviroc|maraviroc|mesh-list
5774420|NCT02881762|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5774421|NCT02881762|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5774422|NCT02881762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5774423|NCT02881762|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5774424|NCT02881762|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5774425|NCT02881762|Antiviral Agents|antiviral agents|mesh-ancestor
5774426|NCT02881762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5774427|NCT02881762|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
5774428|NCT02882087|Methotrexate|methotrexate|mesh-list
5774429|NCT02882087|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5774430|NCT02882087|Abortifacient Agents|abortifacient agents|mesh-ancestor
5774431|NCT02882087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5774432|NCT02882087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774433|NCT02882087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5774434|NCT02882087|Antimetabolites|antimetabolites|mesh-ancestor
5774435|NCT02882087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5774436|NCT02882087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5774437|NCT02882087|Dermatologic Agents|dermatologic agents|mesh-ancestor
6490619|NCT00599235|Vasodilator Agents|vasodilator agents|mesh-ancestor
5774438|NCT02882087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5774439|NCT02882087|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5774440|NCT02882087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5774441|NCT02882087|Immunologic Factors|immunologic factors|mesh-ancestor
5774442|NCT02882087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5774443|NCT02882087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5774444|NCT02881346|Betamethasone|betamethasone|mesh-list
5774445|NCT02881346|Betamethasone Valerate|betamethasone valerate|mesh-list
5774446|NCT02881346|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5774447|NCT02881346|Betamethasone benzoate|betamethasone benzoate|mesh-list
5774448|NCT02881346|Calcipotriene|calcipotriene|mesh-list
5774449|NCT02881346|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
5774450|NCT02881346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5774451|NCT02881346|Glucocorticoids|glucocorticoids|mesh-ancestor
5774452|NCT02881346|Hormones|hormones|mesh-ancestor
5774453|NCT02881346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5774454|NCT02881346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774455|NCT02881346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5774456|NCT02881346|Respiratory System Agents|respiratory system agents|mesh-ancestor
5774457|NCT02881346|Dermatologic Agents|dermatologic agents|mesh-ancestor
5774458|NCT02881528|Metformin|metformin|mesh-list
6210222|NCT02158039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210223|NCT02158039|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6210224|NCT02158039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5774459|NCT02881528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5774460|NCT02881528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774461|NCT02881554|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
5774462|NCT02881554|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5774463|NCT02881554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5774464|NCT02881619|Etodolac|etodolac|mesh-list
5774465|NCT02881619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5774466|NCT02881619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5774467|NCT02881619|Analgesics|analgesics|mesh-ancestor
5774468|NCT02881619|Sensory System Agents|sensory system agents|mesh-ancestor
5774469|NCT02881619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5774470|NCT02881619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774471|NCT02881619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5774472|NCT02881619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5774473|NCT02881619|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5774474|NCT02881619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5774475|NCT02881619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5774476|NCT02881619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5774477|NCT02881242|Trametinib|trametinib|mesh-list
5774478|NCT02881242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5774479|NCT02881242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5774480|NCT02881242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5774481|NCT02881242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5774482|NCT02880995|Amisulpride|amisulpride|mesh-list
5774483|NCT02880995|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5774484|NCT02880995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5774485|NCT02880995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5774486|NCT02880995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774487|NCT02880995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5774488|NCT02880995|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5774489|NCT02880995|Dopamine Agents|dopamine agents|mesh-ancestor
5774490|NCT02880995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5774491|NCT02880995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5774492|NCT02880995|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5774493|NCT02880995|Antidepressive Agents|antidepressive agents|mesh-ancestor
5774494|NCT02880943|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
5774495|NCT02880943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5774496|NCT02881177|Oxytocin|oxytocin|mesh-list
5774497|NCT02881177|Oxytocics|oxytocics|mesh-ancestor
5774498|NCT02881177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5774499|NCT02881177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774500|NCT02881125|Paclitaxel|paclitaxel|mesh-list
5774501|NCT02881125|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5774502|NCT02881125|Nortriptyline|nortriptyline|mesh-list
5774503|NCT02881125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5774504|NCT02881125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5774505|NCT02881125|Tubulin Modulators|tubulin modulators|mesh-ancestor
5774506|NCT02881125|Antimitotic Agents|antimitotic agents|mesh-ancestor
5774507|NCT02881125|Mitosis Modulators|mitosis modulators|mesh-ancestor
5774508|NCT02881125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5774509|NCT02881125|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5774510|NCT02881125|Antidepressive Agents|antidepressive agents|mesh-ancestor
5774511|NCT02881125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5774512|NCT02881125|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5774513|NCT02881125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5774514|NCT02881125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5774515|NCT02881125|Adrenergic Agents|adrenergic agents|mesh-ancestor
5774516|NCT02881125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5774517|NCT02881125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774518|NCT02880787|Rocuronium|rocuronium|mesh-list
5774519|NCT02880787|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5774520|NCT02880787|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5774521|NCT02880787|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5774522|NCT02880787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5774523|NCT02880787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774524|NCT02880800|Morphine|morphine|mesh-list
5774525|NCT02880800|Hydromorphone|hydromorphone|mesh-list
5774526|NCT02880800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5774527|NCT02880800|Narcotics|narcotics|mesh-ancestor
5897060|NCT02597062|Glucocorticoids|glucocorticoids|mesh-ancestor
5774528|NCT02880800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5774529|NCT02880800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774530|NCT02880800|Analgesics|analgesics|mesh-ancestor
5774531|NCT02880800|Sensory System Agents|sensory system agents|mesh-ancestor
5774532|NCT02880800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5774533|NCT02880462|Sulforaphane|sulforaphane|mesh-list
5774534|NCT02880462|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5774535|NCT02880462|Protective Agents|protective agents|mesh-ancestor
5774536|NCT02880462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774537|NCT02880462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5897061|NCT02597062|Hormones|hormones|mesh-ancestor
5897062|NCT02597062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5897063|NCT02597062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5897064|NCT02549170|Immunoglobulins|immunoglobulins|mesh-list
5897065|NCT02549170|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5897066|NCT02549170|Antibodies|antibodies|mesh-list
5897067|NCT02549170|Immunoglobulin G|immunoglobulin g|mesh-list
5897068|NCT02549170|gamma-Globulins|gamma-globulins|mesh-list
5897069|NCT02549170|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5897070|NCT02549170|Immunologic Factors|immunologic factors|mesh-ancestor
5897071|NCT02549170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897072|NCT02498912|Cyclophosphamide|cyclophosphamide|mesh-list
5897073|NCT02498912|Fludarabine|fludarabine|mesh-list
5897074|NCT02498912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5897075|NCT02498912|Immunologic Factors|immunologic factors|mesh-ancestor
5897076|NCT02498912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897077|NCT02498912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5897078|NCT02498912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5897079|NCT02498912|Alkylating Agents|alkylating agents|mesh-ancestor
5897080|NCT02498912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897081|NCT02498912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5897082|NCT02498912|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5897083|NCT02483247|Paclitaxel|paclitaxel|mesh-list
5897084|NCT02483247|Doxorubicin|doxorubicin|mesh-list
5897085|NCT02483247|Pembrolizumab|pembrolizumab|mesh-list
5897086|NCT02483247|Capecitabine|capecitabine|mesh-list
5897087|NCT02483247|Nivolumab|nivolumab|mesh-list
5897088|NCT02483247|Sunitinib|sunitinib|mesh-list
5897089|NCT02483247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5897090|NCT02483247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5897091|NCT02483247|Tubulin Modulators|tubulin modulators|mesh-ancestor
5897092|NCT02483247|Antimitotic Agents|antimitotic agents|mesh-ancestor
5897093|NCT02483247|Mitosis Modulators|mitosis modulators|mesh-ancestor
5897094|NCT02483247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897095|NCT02483247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5897096|NCT02483247|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5897097|NCT02483247|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5897098|NCT02483247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5897099|NCT02483247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5897100|NCT02483247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5897101|NCT02483247|Antimetabolites|antimetabolites|mesh-ancestor
5897102|NCT02483247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5897103|NCT02483247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5897104|NCT02483247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5897105|NCT02483247|Growth Substances|growth substances|mesh-ancestor
5897106|NCT02483247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897107|NCT02483247|Growth Inhibitors|growth inhibitors|mesh-ancestor
5897108|NCT02483247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5897109|NCT02467361|Pembrolizumab|pembrolizumab|mesh-list
5897110|NCT02467361|Nivolumab|nivolumab|mesh-list
5897111|NCT02467361|Ipilimumab|ipilimumab|mesh-list
5897112|NCT02467361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5897113|NCT02467361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5897114|NCT02467361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5897115|NCT02467361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897116|NCT02359565|Pembrolizumab|pembrolizumab|mesh-list
5897117|NCT02359565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5897118|NCT02359565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5897119|NCT02169310|Raclopride|raclopride|mesh-list
5897120|NCT02169310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5897121|NCT02169310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5897122|NCT02169310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5897123|NCT02169310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897124|NCT02169310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5897125|NCT02169310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5897126|NCT02169310|Dopamine Agents|dopamine agents|mesh-ancestor
5774538|NCT02880410|Temozolomide|temozolomide|mesh-list
5774539|NCT02880410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5774540|NCT02880410|Alkylating Agents|alkylating agents|mesh-ancestor
5774541|NCT02880410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5774542|NCT02880410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5774543|NCT02880345|Pembrolizumab|pembrolizumab|mesh-list
5774544|NCT02880345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5774545|NCT02880345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5774546|NCT02880371|Pembrolizumab|pembrolizumab|mesh-list
5774547|NCT02880371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5774548|NCT02880371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5774549|NCT02880280|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5774550|NCT02880280|Menotropins|menotropins|mesh-list
5774551|NCT02880280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5774552|NCT02880280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774553|NCT02880280|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5774554|NCT02880280|Fertility Agents|fertility agents|mesh-ancestor
5774555|NCT02879955|Acarbose|acarbose|mesh-list
5774556|NCT02879955|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
5774557|NCT02879955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5774558|NCT02879955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5774559|NCT02879955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5774560|NCT02879955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774561|NCT02880033|Deferiprone|deferiprone|mesh-list
5774562|NCT02880033|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5774563|NCT02880033|Chelating Agents|chelating agents|mesh-ancestor
5774564|NCT02880033|Sequestering Agents|sequestering agents|mesh-ancestor
5774565|NCT02880033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5774566|NCT02879981|Trimethoprim|trimethoprim|mesh-list
5774567|NCT02879981|Sulfamethoxazole|sulfamethoxazole|mesh-list
5774568|NCT02879981|Phenylpropanolamine|phenylpropanolamine|mesh-list
5774569|NCT02879981|Guaifenesin|guaifenesin|mesh-list
5774570|NCT02879981|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
5774571|NCT02879981|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5774572|NCT02879981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5774573|NCT02879981|Renal Agents|renal agents|mesh-ancestor
5774574|NCT02879981|Antimalarials|antimalarials|mesh-ancestor
5774575|NCT02879981|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5774576|NCT02879981|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5774577|NCT02879981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5774578|NCT02879981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5774579|NCT02879981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5774580|NCT02879981|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5774581|NCT02879981|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
5774582|NCT02879981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5774583|NCT02879981|Expectorants|expectorants|mesh-ancestor
5774584|NCT02879981|Respiratory System Agents|respiratory system agents|mesh-ancestor
5774585|NCT02879981|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5774586|NCT02879981|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5774587|NCT02879981|Adrenergic Agents|adrenergic agents|mesh-ancestor
5774588|NCT02879981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5774589|NCT02879981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774590|NCT02879981|Appetite Depressants|appetite depressants|mesh-ancestor
5774591|NCT02879981|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5774592|NCT02879981|Sympathomimetics|sympathomimetics|mesh-ancestor
5774593|NCT02879981|Autonomic Agents|autonomic agents|mesh-ancestor
5774594|NCT02879981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5774595|NCT02879981|Nasal Decongestants|nasal decongestants|mesh-ancestor
5774596|NCT02879981|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5774597|NCT02880007|Cisplatin|cisplatin|mesh-list
5774598|NCT02880007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5774599|NCT02880085|Lidocaine|lidocaine|mesh-list
5774600|NCT02880085|Anesthetics, Local|anesthetics, local|mesh-list
5774601|NCT02880085|Anesthetics|anesthetics|mesh-list
5774602|NCT02880085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5774603|NCT02880085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774604|NCT02880085|Sensory System Agents|sensory system agents|mesh-ancestor
5774605|NCT02880085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5774606|NCT02880085|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5774607|NCT02880085|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5774608|NCT02880085|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5774609|NCT02880085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5774610|NCT02880085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5774611|NCT02879916|Levobupivacaine|levobupivacaine|mesh-list
5774612|NCT02879916|Anesthetics, Local|anesthetics, local|mesh-ancestor
5774613|NCT02879916|Anesthetics|anesthetics|mesh-ancestor
5774614|NCT02879916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5774615|NCT02879916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774616|NCT02879916|Sensory System Agents|sensory system agents|mesh-ancestor
5774617|NCT02879916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5774618|NCT02879942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
5774619|NCT02879942|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-list
5774620|NCT02879942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5774621|NCT02879942|Growth Substances|growth substances|mesh-ancestor
5774622|NCT02879942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774623|NCT02879942|Growth Inhibitors|growth inhibitors|mesh-ancestor
5774624|NCT02879942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5774625|NCT02879669|Cyclophosphamide|cyclophosphamide|mesh-list
5774626|NCT02879669|Carboplatin|carboplatin|mesh-list
5774627|NCT02879669|Pemetrexed|pemetrexed|mesh-list
5774628|NCT02879669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5774629|NCT02879669|Immunologic Factors|immunologic factors|mesh-ancestor
5774630|NCT02879669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774631|NCT02879669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5774632|NCT02879669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5774633|NCT02879669|Alkylating Agents|alkylating agents|mesh-ancestor
5774634|NCT02879669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5774635|NCT02879669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5774636|NCT02879669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5774637|NCT02879669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5774638|NCT02879669|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5774639|NCT02879669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5774640|NCT02879435|Bupivacaine|bupivacaine|mesh-list
5774641|NCT02879435|Anesthetics, Local|anesthetics, local|mesh-ancestor
5774642|NCT02879435|Anesthetics|anesthetics|mesh-ancestor
5774643|NCT02879435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5774644|NCT02879435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774645|NCT02879435|Sensory System Agents|sensory system agents|mesh-ancestor
6490620|NCT00599235|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6490621|NCT00599235|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6490622|NCT00599235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6490623|NCT00599235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490624|NCT00599235|Urological Agents|urological agents|mesh-ancestor
5774646|NCT02879435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5774647|NCT02879760|Pembrolizumab|pembrolizumab|mesh-list
5774648|NCT02879760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5774649|NCT02879760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5774650|NCT02879513|Paclitaxel|paclitaxel|mesh-list
5774651|NCT02879513|Cyclophosphamide|cyclophosphamide|mesh-list
5774652|NCT02879513|Epirubicin|epirubicin|mesh-list
5774653|NCT02879513|Fluorouracil|fluorouracil|mesh-list
5774654|NCT02879513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5774655|NCT02879513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5774656|NCT02879513|Tubulin Modulators|tubulin modulators|mesh-ancestor
5774657|NCT02879513|Antimitotic Agents|antimitotic agents|mesh-ancestor
5774658|NCT02879513|Mitosis Modulators|mitosis modulators|mesh-ancestor
5774659|NCT02879513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5774660|NCT02879513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5774661|NCT02879513|Immunologic Factors|immunologic factors|mesh-ancestor
5774662|NCT02879513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774663|NCT02879513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5774664|NCT02879513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5774665|NCT02879513|Alkylating Agents|alkylating agents|mesh-ancestor
5774666|NCT02879513|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5774667|NCT02879513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5774668|NCT02879513|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5774669|NCT02879513|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5774670|NCT02879513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5774671|NCT02879513|Antimetabolites|antimetabolites|mesh-ancestor
5774672|NCT02879513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5774673|NCT02879643|Vincristine|vincristine|mesh-list
5774674|NCT02879643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5774675|NCT02879643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5774676|NCT02879643|Tubulin Modulators|tubulin modulators|mesh-ancestor
5774677|NCT02879643|Antimitotic Agents|antimitotic agents|mesh-ancestor
5774678|NCT02879643|Mitosis Modulators|mitosis modulators|mesh-ancestor
5774679|NCT02879643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5774680|NCT02879617|Durvalumab|durvalumab|mesh-list
5774681|NCT02879617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6673545|NCT01563718|Naltrexone|naltrexone|mesh-list
6673546|NCT01563718|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6673547|NCT01563718|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6673548|NCT01563718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673549|NCT01563718|Sensory System Agents|sensory system agents|mesh-ancestor
5774682|NCT02879617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5774683|NCT02879721|Candesartan|candesartan|mesh-list
5774684|NCT02879721|Enalapril|enalapril|mesh-list
5774685|NCT02879721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5774686|NCT02879721|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5774687|NCT02879721|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5774688|NCT02879721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5774689|NCT02879721|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5774690|NCT02879721|Protease Inhibitors|protease inhibitors|mesh-ancestor
5774691|NCT02879721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5774692|NCT02879409|Insulin|insulin|mesh-list
5774693|NCT02879409|Metformin|metformin|mesh-list
6490625|NCT00599235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6490626|NCT00599274|Interferons|interferons|mesh-list
6490627|NCT00599274|Interferon-beta|interferon-beta|mesh-list
6490628|NCT00599274|Interferon beta-1a|interferon beta-1a|mesh-list
6490629|NCT00599274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6490630|NCT00599274|Antiviral Agents|antiviral agents|mesh-ancestor
6490631|NCT00599274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6490632|NCT00599274|Immunologic Factors|immunologic factors|mesh-ancestor
6490633|NCT00599274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490634|NCT00599274|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6490635|NCT00599287|Haloperidol|haloperidol|mesh-list
5774694|NCT02879409|Pioglitazone|pioglitazone|mesh-list
5774695|NCT02879409|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5774696|NCT02879409|Liraglutide|liraglutide|mesh-list
5774697|NCT02879409|Dapagliflozin|dapagliflozin|mesh-list
5774698|NCT02879409|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5774699|NCT02879409|Gliclazide|gliclazide|mesh-list
5774700|NCT02879409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6490636|NCT00599287|Haloperidol decanoate|haloperidol decanoate|mesh-list
6490637|NCT00599287|Methylphenidate|methylphenidate|mesh-list
6490638|NCT00599287|Rivastigmine|rivastigmine|mesh-list
6490639|NCT00599287|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6490640|NCT00599287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490641|NCT00599287|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6490642|NCT00599287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5774701|NCT02879409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774702|NCT02879409|Incretins|incretins|mesh-ancestor
5774703|NCT02879409|Hormones|hormones|mesh-ancestor
5774704|NCT02879409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5774705|NCT02879409|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5774706|NCT02879409|Protease Inhibitors|protease inhibitors|mesh-ancestor
5774707|NCT02879409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5774708|NCT02879409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5774709|NCT02879409|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5774710|NCT02879292|Anesthetics|anesthetics|mesh-list
5774711|NCT02879292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5774712|NCT02879292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774713|NCT02879227|Cisplatin|cisplatin|mesh-list
5774714|NCT02879227|Oxaliplatin|oxaliplatin|mesh-list
5774715|NCT02879227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5774716|NCT02879110|Sulforaphane|sulforaphane|mesh-list
5774717|NCT02879110|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5774718|NCT02879110|Protective Agents|protective agents|mesh-ancestor
5774719|NCT02879110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774720|NCT02879110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6490643|NCT00599287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6490644|NCT00599287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5774721|NCT02879097|Paclitaxel|paclitaxel|mesh-list
5774722|NCT02879097|Carboplatin|carboplatin|mesh-list
5774723|NCT02879097|Bevacizumab|bevacizumab|mesh-list
5774724|NCT02879097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5774725|NCT02879097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5774726|NCT02879097|Tubulin Modulators|tubulin modulators|mesh-ancestor
5774727|NCT02879097|Antimitotic Agents|antimitotic agents|mesh-ancestor
5774728|NCT02879097|Mitosis Modulators|mitosis modulators|mesh-ancestor
5774729|NCT02879097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5774730|NCT02879097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5774731|NCT02879097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5774732|NCT02879097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5774733|NCT02879097|Growth Substances|growth substances|mesh-ancestor
5774734|NCT02879097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774735|NCT02879097|Growth Inhibitors|growth inhibitors|mesh-ancestor
5774736|NCT02879006|Omalizumab|omalizumab|mesh-list
5774737|NCT02879006|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5774738|NCT02879006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5774739|NCT02879006|Respiratory System Agents|respiratory system agents|mesh-ancestor
5774740|NCT02878837|Midazolam|midazolam|mesh-list
5774741|NCT02878837|Dexmedetomidine|dexmedetomidine|mesh-list
5774742|NCT02878837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5774743|NCT02878837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5774744|NCT02878837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774745|NCT02878837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5774746|NCT02878837|Analgesics|analgesics|mesh-ancestor
5774747|NCT02878837|Sensory System Agents|sensory system agents|mesh-ancestor
5774748|NCT02878837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5774749|NCT02878837|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5774750|NCT02878837|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5774751|NCT02878837|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5774752|NCT02878837|Adrenergic Agents|adrenergic agents|mesh-ancestor
5774753|NCT02878837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5774754|NCT02878837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5774755|NCT02878837|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5774756|NCT02878837|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5774757|NCT02878837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5774758|NCT02878837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5774759|NCT02878837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5774760|NCT02878837|Anesthetics, General|anesthetics, general|mesh-ancestor
5774761|NCT02878837|Anesthetics|anesthetics|mesh-ancestor
6210225|NCT02158091|Cyclophosphamide|cyclophosphamide|mesh-list
6210226|NCT02158091|Rituximab|rituximab|mesh-list
6210227|NCT02158091|Fludarabine|fludarabine|mesh-list
6210228|NCT02158091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6210229|NCT02158091|Immunologic Factors|immunologic factors|mesh-ancestor
6210230|NCT02158091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210231|NCT02158091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6210232|NCT02158091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6210233|NCT02158091|Alkylating Agents|alkylating agents|mesh-ancestor
5774762|NCT02878837|GABA Modulators|gaba modulators|mesh-ancestor
5774763|NCT02878837|GABA Agents|gaba agents|mesh-ancestor
5774764|NCT02878785|Decitabine|decitabine|mesh-list
5774765|NCT02878785|Talazoparib|talazoparib|mesh-list
5774766|NCT02878785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5774767|NCT02878785|Antimetabolites|antimetabolites|mesh-ancestor
5774768|NCT02878785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5774769|NCT02878785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5774770|NCT02878785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5774771|NCT02878785|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5897127|NCT02169310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5897128|NCT02169310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897129|NCT02130882|Benralizumab|benralizumab|mesh-list
5897130|NCT02130882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5897131|NCT02130882|Respiratory System Agents|respiratory system agents|mesh-ancestor
5897132|NCT02130453|Regadenoson|regadenoson|mesh-list
5897133|NCT02130453|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
5897134|NCT02130453|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5897135|NCT02130453|Purinergic Agonists|purinergic agonists|mesh-ancestor
5897136|NCT02130453|Purinergic Agents|purinergic agents|mesh-ancestor
5897137|NCT02130453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5897138|NCT02130453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897139|NCT02130453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897140|NCT02101775|Gemcitabine|gemcitabine|mesh-list
5897141|NCT02101775|Adavosertib|adavosertib|mesh-list
5897142|NCT02101775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5897143|NCT02101775|Antimetabolites|antimetabolites|mesh-ancestor
5897144|NCT02101775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897145|NCT02101775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5897146|NCT02101775|Antiviral Agents|antiviral agents|mesh-ancestor
5897147|NCT02101775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5897148|NCT02101775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5897149|NCT02101775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5897150|NCT02101775|Immunologic Factors|immunologic factors|mesh-ancestor
5897151|NCT02101775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897152|NCT02055963|Minocycline|minocycline|mesh-list
5897153|NCT02055963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6212589|NCT02191033|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5774772|NCT02878863|Peoniflorin|peoniflorin|mesh-list
5774773|NCT02878863|Silymarin|silymarin|mesh-list
5774774|NCT02878863|Antioxidants|antioxidants|mesh-ancestor
5774775|NCT02878863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5774776|NCT02878863|Protective Agents|protective agents|mesh-ancestor
5774777|NCT02878863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774778|NCT02878863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5774779|NCT02878863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5774780|NCT02878863|Analgesics|analgesics|mesh-ancestor
5774781|NCT02878863|Sensory System Agents|sensory system agents|mesh-ancestor
5774782|NCT02878863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5774783|NCT02878863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5774784|NCT02878863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5774785|NCT02878772|Aspirin|aspirin|mesh-list
5774786|NCT02878772|Vinpocetine|vinpocetine|mesh-list
5774787|NCT02878772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5774788|NCT02878772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5774789|NCT02878772|Analgesics|analgesics|mesh-ancestor
5774790|NCT02878772|Sensory System Agents|sensory system agents|mesh-ancestor
5774791|NCT02878772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5774792|NCT02878772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774793|NCT02878772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5774794|NCT02878772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5774795|NCT02878772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5774796|NCT02878772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5774797|NCT02878772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5774798|NCT02878772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5774799|NCT02878772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5774800|NCT02878772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5774801|NCT02878772|Antipyretics|antipyretics|mesh-ancestor
5774802|NCT02878772|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5774803|NCT02878772|Vasodilator Agents|vasodilator agents|mesh-ancestor
5774804|NCT02878772|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5774805|NCT02878772|Protective Agents|protective agents|mesh-ancestor
5774806|NCT02878772|Nootropic Agents|nootropic agents|mesh-ancestor
5774807|NCT02878564|Praziquantel|praziquantel|mesh-list
5774808|NCT02878564|Anthelmintics|anthelmintics|mesh-ancestor
5774809|NCT02878564|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5774810|NCT02878564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5774811|NCT02878512|Anesthetics|anesthetics|mesh-list
5774812|NCT02878512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5774813|NCT02878512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774814|NCT02878707|Dexmedetomidine|dexmedetomidine|mesh-list
5774815|NCT02878707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5774816|NCT02878707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5774817|NCT02878707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774818|NCT02878707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5774819|NCT02878707|Analgesics|analgesics|mesh-ancestor
5774820|NCT02878707|Sensory System Agents|sensory system agents|mesh-ancestor
5774821|NCT02878707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5774822|NCT02878707|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5774823|NCT02878707|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5774824|NCT02878707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5774825|NCT02878707|Adrenergic Agents|adrenergic agents|mesh-ancestor
5774826|NCT02878707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5774827|NCT02878707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5774828|NCT02878681|Ranibizumab|ranibizumab|mesh-list
5774829|NCT02878681|Aflibercept|aflibercept|mesh-list
5774830|NCT02878681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5774831|NCT02878681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5774832|NCT02878681|Growth Substances|growth substances|mesh-ancestor
5774833|NCT02878681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774834|NCT02878681|Growth Inhibitors|growth inhibitors|mesh-ancestor
5774835|NCT02878681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5774836|NCT02878421|Nicotine|nicotine|mesh-list
5774837|NCT02878421|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5774838|NCT02878421|Autonomic Agents|autonomic agents|mesh-ancestor
5774839|NCT02878421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5774840|NCT02878421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774841|NCT02878421|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5774842|NCT02878421|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5774843|NCT02878421|Cholinergic Agents|cholinergic agents|mesh-ancestor
5774844|NCT02878421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5774845|NCT02878421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5774846|NCT02878538|Deferiprone|deferiprone|mesh-list
5774847|NCT02878538|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5774848|NCT02878538|Chelating Agents|chelating agents|mesh-ancestor
5774849|NCT02878538|Sequestering Agents|sequestering agents|mesh-ancestor
5774850|NCT02878538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5774851|NCT02878200|Piperaquine|piperaquine|mesh-list
5774852|NCT02878200|Artenimol|artenimol|mesh-list
5774853|NCT02878200|Antimalarials|antimalarials|mesh-ancestor
5774854|NCT02878200|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5774855|NCT02878200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5774856|NCT02878200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5774857|NCT02878291|Vaccines|vaccines|mesh-list
5774858|NCT02878291|Immunologic Factors|immunologic factors|mesh-ancestor
5774859|NCT02878291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774860|NCT02878083|Adalimumab|adalimumab|mesh-list
5774861|NCT02878083|Vedolizumab|vedolizumab|mesh-list
5774862|NCT02878083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5774863|NCT02878083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5774864|NCT02878083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5774865|NCT02878265|Vitamins|vitamins|mesh-list
5774866|NCT02878265|Vitamin A|vitamin a|mesh-list
5774867|NCT02878265|Zinc|zinc|mesh-list
5774868|NCT02878265|Retinol palmitate|retinol palmitate|mesh-list
5774869|NCT02878265|Micronutrients|micronutrients|mesh-ancestor
5774870|NCT02878265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774871|NCT02878265|Trace Elements|trace elements|mesh-ancestor
5774872|NCT02878265|Antioxidants|antioxidants|mesh-ancestor
5774873|NCT02878265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5774874|NCT02878265|Protective Agents|protective agents|mesh-ancestor
5774875|NCT02878265|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5774876|NCT02878265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5774877|NCT02878161|Prednisone|prednisone|mesh-list
5774878|NCT02878161|Methylprednisolone|methylprednisolone|mesh-list
5774879|NCT02878161|Adalimumab|adalimumab|mesh-list
5774880|NCT02878161|Etanercept|etanercept|mesh-list
5774881|NCT02878161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
5774882|NCT02878161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
5774883|NCT02878161|Methotrexate|methotrexate|mesh-list
5774884|NCT02878161|Infliximab|infliximab|mesh-list
5774885|NCT02878161|Glucocorticoids|glucocorticoids|mesh-list
5774886|NCT02878161|Leflunomide|leflunomide|mesh-list
5774887|NCT02878161|Hormones|hormones|mesh-ancestor
5774888|NCT02878161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5774889|NCT02878161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774890|NCT02878161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5774891|NCT02878161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5774892|NCT02878161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5774893|NCT02878161|Abortifacient Agents|abortifacient agents|mesh-ancestor
5774894|NCT02878161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5774895|NCT02878161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5774896|NCT02878161|Antimetabolites|antimetabolites|mesh-ancestor
5774897|NCT02878161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5774898|NCT02878161|Dermatologic Agents|dermatologic agents|mesh-ancestor
5774899|NCT02878161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5774900|NCT02878161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5774901|NCT02878161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5774902|NCT02878161|Immunologic Factors|immunologic factors|mesh-ancestor
5774903|NCT02878161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5774904|NCT02878161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5774905|NCT02878161|Antiemetics|antiemetics|mesh-ancestor
5774906|NCT02878161|Autonomic Agents|autonomic agents|mesh-ancestor
5774907|NCT02878161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5774908|NCT02878161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5774909|NCT02878161|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5774910|NCT02878161|Protective Agents|protective agents|mesh-ancestor
5774911|NCT02878161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5774912|NCT02878161|Analgesics|analgesics|mesh-ancestor
5774913|NCT02878161|Sensory System Agents|sensory system agents|mesh-ancestor
5774914|NCT02878018|Hormones|hormones|mesh-list
5774915|NCT02878018|Adrenergic Agents|adrenergic agents|mesh-list
5774916|NCT02878018|Immunosuppressive Agents|immunosuppressive agents|mesh-list
5774917|NCT02878018|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
5774918|NCT02878018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5774919|NCT02878018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774920|NCT02878018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5774921|NCT02878018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5774922|NCT02878018|Immunologic Factors|immunologic factors|mesh-ancestor
5774923|NCT02878018|Protease Inhibitors|protease inhibitors|mesh-ancestor
5774924|NCT02878018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5774925|NCT02878031|Amoxicillin|amoxicillin|mesh-list
5774926|NCT02878031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5774927|NCT02878031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5774928|NCT02878122|Carboplatin|carboplatin|mesh-list
5774929|NCT02878122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5774930|NCT02877901|Tolterodine Tartrate|tolterodine tartrate|mesh-list
5774931|NCT02877901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5774932|NCT02877901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5774933|NCT02877901|Cholinergic Agents|cholinergic agents|mesh-ancestor
5774934|NCT02877901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5774935|NCT02877901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5774936|NCT02877901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774937|NCT02877901|Urological Agents|urological agents|mesh-ancestor
5774938|NCT02877888|Fluorides|fluorides|mesh-list
5774939|NCT02877888|Fluorides, Topical|fluorides, topical|mesh-list
5774940|NCT02877888|Cariostatic Agents|cariostatic agents|mesh-ancestor
5774941|NCT02877888|Protective Agents|protective agents|mesh-ancestor
5774942|NCT02877888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774943|NCT02877615|S44819|s44819|mesh-list
5774944|NCT02877615|GABA-A Receptor Antagonists|gaba-a receptor antagonists|mesh-ancestor
5774945|NCT02877615|GABA Antagonists|gaba antagonists|mesh-ancestor
5774946|NCT02877615|GABA Agents|gaba agents|mesh-ancestor
5774947|NCT02877615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5774948|NCT02877615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5774949|NCT02877615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774950|NCT02877771|Insulin|insulin|mesh-list
5774951|NCT02877771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5774952|NCT02877771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774953|NCT02877537|Albuterol|albuterol|mesh-list
5774954|NCT02877537|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5774955|NCT02877537|Autonomic Agents|autonomic agents|mesh-ancestor
5774956|NCT02877537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5774957|NCT02877537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774958|NCT02877537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5774959|NCT02877537|Respiratory System Agents|respiratory system agents|mesh-ancestor
5774960|NCT02877537|Tocolytic Agents|tocolytic agents|mesh-ancestor
5774961|NCT02877537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5774962|NCT02877537|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5774963|NCT02877537|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5774964|NCT02877537|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5774965|NCT02877537|Adrenergic Agents|adrenergic agents|mesh-ancestor
5774966|NCT02877537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5774967|NCT02877537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210234|NCT02158091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210235|NCT02158091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6210236|NCT02158091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6490645|NCT00599287|Dopamine Agents|dopamine agents|mesh-ancestor
5774972|NCT02877511|Sunscreening Agents|sunscreening agents|mesh-list
5774973|NCT02877511|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5774974|NCT02877511|Protective Agents|protective agents|mesh-ancestor
5774975|NCT02877511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774976|NCT02877511|Dermatologic Agents|dermatologic agents|mesh-ancestor
5774977|NCT02877641|Vitamin D|vitamin d|mesh-list
5774978|NCT02877641|Cholecalciferol|cholecalciferol|mesh-list
5774979|NCT02877641|Vitamins|vitamins|mesh-list
5774980|NCT02877641|Micronutrients|micronutrients|mesh-ancestor
5774981|NCT02877641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774982|NCT02877641|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5774983|NCT02877641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5774984|NCT02877238|Sevoflurane|sevoflurane|mesh-list
5774985|NCT02877238|Anesthetics|anesthetics|mesh-ancestor
5774986|NCT02877238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5774987|NCT02877238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774988|NCT02877238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5774989|NCT02877238|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5774990|NCT02877238|Anesthetics, General|anesthetics, general|mesh-ancestor
5897154|NCT02055963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5897155|NCT01976169|Palbociclib|palbociclib|mesh-list
5897156|NCT01976169|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
5897157|NCT01976169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5897158|NCT01976169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5897159|NCT01976169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5897160|NCT01976169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897161|NCT01976169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5897162|NCT01976169|Tubulin Modulators|tubulin modulators|mesh-ancestor
5774991|NCT02877173|Alprostadil|alprostadil|mesh-list
5774992|NCT02877173|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5774993|NCT02877173|Vasodilator Agents|vasodilator agents|mesh-ancestor
5774994|NCT02877173|Urological Agents|urological agents|mesh-ancestor
5774995|NCT02877277|Ascorbic Acid|ascorbic acid|mesh-list
5774996|NCT02877277|Vitamins|vitamins|mesh-ancestor
5774997|NCT02877277|Micronutrients|micronutrients|mesh-ancestor
5774998|NCT02877277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5774999|NCT02877277|Antioxidants|antioxidants|mesh-ancestor
5775000|NCT02877277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5775001|NCT02877277|Protective Agents|protective agents|mesh-ancestor
5775002|NCT02877303|Cytarabine|cytarabine|mesh-list
5775003|NCT02877303|Dexamethasone|dexamethasone|mesh-list
5775004|NCT02877303|Dexamethasone acetate|dexamethasone acetate|mesh-list
5775005|NCT02877303|Prednisone|prednisone|mesh-list
5775006|NCT02877303|Cortisone|cortisone|mesh-list
5775007|NCT02877303|Cyclophosphamide|cyclophosphamide|mesh-list
5775008|NCT02877303|Rituximab|rituximab|mesh-list
5775009|NCT02877303|Doxorubicin|doxorubicin|mesh-list
5775010|NCT02877303|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5775011|NCT02877303|Methotrexate|methotrexate|mesh-list
5775012|NCT02877303|Vincristine|vincristine|mesh-list
5775013|NCT02877303|Mercaptopurine|mercaptopurine|mesh-list
5775014|NCT02877303|Ofatumumab|ofatumumab|mesh-list
5775015|NCT02877303|Blinatumomab|blinatumomab|mesh-list
5775016|NCT02877303|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
5775017|NCT02877303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5775018|NCT02877303|Muromonab-CD3|muromonab-cd3|mesh-list
5775019|NCT02877303|Antibodies|antibodies|mesh-list
5775020|NCT02877303|Immunoglobulins|immunoglobulins|mesh-list
5775021|NCT02877303|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5775022|NCT02877303|Antibodies, Bispecific|antibodies, bispecific|mesh-list
5775023|NCT02877303|BB 1101|bb 1101|mesh-list
5775024|NCT02877303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5775025|NCT02877303|Immunologic Factors|immunologic factors|mesh-ancestor
5775026|NCT02877303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775027|NCT02877303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5775028|NCT02877303|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5775029|NCT02877303|Alkylating Agents|alkylating agents|mesh-ancestor
5775030|NCT02877303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5775031|NCT02877303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5775032|NCT02877303|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5775033|NCT02877303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5775034|NCT02877303|Antiemetics|antiemetics|mesh-ancestor
5775035|NCT02877303|Autonomic Agents|autonomic agents|mesh-ancestor
5775036|NCT02877303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5775037|NCT02877303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5775038|NCT02877303|Glucocorticoids|glucocorticoids|mesh-ancestor
5775039|NCT02877303|Hormones|hormones|mesh-ancestor
5775040|NCT02877303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5775041|NCT02877303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5775042|NCT02877303|Protease Inhibitors|protease inhibitors|mesh-ancestor
5775043|NCT02877303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5775044|NCT02877303|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5775045|NCT02877303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5775046|NCT02877303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5775047|NCT02877303|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5775048|NCT02877303|Abortifacient Agents|abortifacient agents|mesh-ancestor
5775049|NCT02877303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5775050|NCT02877303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5775051|NCT02877303|Antimetabolites|antimetabolites|mesh-ancestor
5775052|NCT02877303|Dermatologic Agents|dermatologic agents|mesh-ancestor
5775053|NCT02877303|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5775054|NCT02877303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5775055|NCT02877303|Antiviral Agents|antiviral agents|mesh-ancestor
5775056|NCT02877303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5775057|NCT02877303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5775058|NCT02877303|Tubulin Modulators|tubulin modulators|mesh-ancestor
5775059|NCT02877303|Antimitotic Agents|antimitotic agents|mesh-ancestor
5775060|NCT02877303|Mitosis Modulators|mitosis modulators|mesh-ancestor
5775061|NCT02876991|Listerine|listerine|mesh-list
5775062|NCT02876991|Fluorides|fluorides|mesh-list
5775063|NCT02876991|Sodium Fluoride|sodium fluoride|mesh-list
6490646|NCT00599287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5775064|NCT02876991|Cariostatic Agents|cariostatic agents|mesh-ancestor
5775065|NCT02876991|Protective Agents|protective agents|mesh-ancestor
5775066|NCT02876991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775067|NCT02876991|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5775068|NCT02876991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5775069|NCT02876770|Melatonin|melatonin|mesh-list
5775070|NCT02876770|Antioxidants|antioxidants|mesh-ancestor
5775071|NCT02876770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5775072|NCT02876770|Protective Agents|protective agents|mesh-ancestor
5775073|NCT02876770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775074|NCT02876770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5775075|NCT02876822|Vitamin D|vitamin d|mesh-list
5775076|NCT02876822|Cholecalciferol|cholecalciferol|mesh-list
5775077|NCT02876822|Vitamins|vitamins|mesh-ancestor
5775078|NCT02876822|Micronutrients|micronutrients|mesh-ancestor
5775079|NCT02876822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775080|NCT02876822|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5775081|NCT02876822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5775082|NCT02876718|Rivaroxaban|rivaroxaban|mesh-list
5775083|NCT02876718|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5775084|NCT02876718|Antithrombins|antithrombins|mesh-ancestor
5775085|NCT02876718|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5775086|NCT02876718|Protease Inhibitors|protease inhibitors|mesh-ancestor
5775087|NCT02876718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5775088|NCT02876718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5775089|NCT02876718|Anticoagulants|anticoagulants|mesh-ancestor
5775090|NCT02876978|Cyclophosphamide|cyclophosphamide|mesh-list
5775091|NCT02876978|Fludarabine|fludarabine|mesh-list
5775092|NCT02876978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5775093|NCT02876978|Immunologic Factors|immunologic factors|mesh-ancestor
5775094|NCT02876978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210237|NCT02158091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6210238|NCT02158273|Fenofibrate|fenofibrate|mesh-list
5775095|NCT02876978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5775096|NCT02876978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5775097|NCT02876978|Alkylating Agents|alkylating agents|mesh-ancestor
5775098|NCT02876978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5775099|NCT02876978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5775100|NCT02876978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5775101|NCT02876679|Cyclosporine|cyclosporine|mesh-list
5775102|NCT02876679|Mycophenolic Acid|mycophenolic acid|mesh-list
5775103|NCT02876679|Cyclophosphamide|cyclophosphamide|mesh-list
5775104|NCT02876679|Cyclosporins|cyclosporins|mesh-list
5775105|NCT02876679|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5775106|NCT02876679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5775107|NCT02876679|Immunologic Factors|immunologic factors|mesh-ancestor
5775108|NCT02876679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775109|NCT02876679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5775110|NCT02876679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5775111|NCT02876679|Alkylating Agents|alkylating agents|mesh-ancestor
5775112|NCT02876679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5775113|NCT02876679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5775114|NCT02876679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5775115|NCT02876679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5775116|NCT02876679|Antifungal Agents|antifungal agents|mesh-ancestor
5775117|NCT02876679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5775118|NCT02876679|Dermatologic Agents|dermatologic agents|mesh-ancestor
5775119|NCT02876679|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5775120|NCT02876679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5775121|NCT02876679|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5775122|NCT02876679|Antitubercular Agents|antitubercular agents|mesh-ancestor
5775123|NCT02876679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5775124|NCT02876796|Firsocostat|firsocostat|mesh-list
5775125|NCT02876796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5775126|NCT02876796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5775127|NCT02876835|Darbepoetin alfa|darbepoetin alfa|mesh-list
5775128|NCT02876835|Hematinics|hematinics|mesh-ancestor
5775129|NCT02876549|Chloroquine|chloroquine|mesh-list
5775130|NCT02876549|Primaquine|primaquine|mesh-list
5775131|NCT02876549|Amebicides|amebicides|mesh-ancestor
5775132|NCT02876549|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5775133|NCT02876549|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6210239|NCT02158273|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6210240|NCT02158273|Antimetabolites|antimetabolites|mesh-ancestor
6210241|NCT02158273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210242|NCT02158273|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6210243|NCT02158364|Vaccines|vaccines|mesh-list
6210244|NCT02158364|Immunologic Factors|immunologic factors|mesh-ancestor
6210245|NCT02158364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210246|NCT02158442|Clavulanic Acid|clavulanic acid|mesh-list
6210247|NCT02158442|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
6210248|NCT02158442|Ticarcillin|ticarcillin|mesh-list
5775134|NCT02876549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5775135|NCT02876549|Antimalarials|antimalarials|mesh-ancestor
5775136|NCT02876549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5775137|NCT02876432|Diclofenac|diclofenac|mesh-list
5775138|NCT02876432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5775139|NCT02876432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5775140|NCT02876432|Analgesics|analgesics|mesh-ancestor
5775141|NCT02876432|Sensory System Agents|sensory system agents|mesh-ancestor
5775142|NCT02876432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5775143|NCT02876432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775144|NCT02876432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5775145|NCT02876432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5775146|NCT02876432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5775147|NCT02876432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5775148|NCT02876432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5775149|NCT02876276|Hyaluronic Acid|hyaluronic acid|mesh-list
5775150|NCT02876276|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5775151|NCT02876276|Immunologic Factors|immunologic factors|mesh-ancestor
5775152|NCT02876276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775153|NCT02876276|Viscosupplements|viscosupplements|mesh-ancestor
5775154|NCT02876276|Protective Agents|protective agents|mesh-ancestor
5775155|NCT02876354|Vitamin K|vitamin k|mesh-list
5775156|NCT02876354|Vitamin K 2|vitamin k 2|mesh-list
5775157|NCT02876354|Vitamins|vitamins|mesh-ancestor
5775158|NCT02876354|Micronutrients|micronutrients|mesh-ancestor
5775159|NCT02876354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775160|NCT02876354|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5775161|NCT02876354|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5775162|NCT02876354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5775163|NCT02876354|Hemostatics|hemostatics|mesh-ancestor
5775164|NCT02876354|Coagulants|coagulants|mesh-ancestor
5775165|NCT02876224|Bevacizumab|bevacizumab|mesh-list
5775166|NCT02876224|Atezolizumab|atezolizumab|mesh-list
5775167|NCT02876224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5775168|NCT02876224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5775169|NCT02876224|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5775170|NCT02876224|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5775171|NCT02876224|Growth Substances|growth substances|mesh-ancestor
5775172|NCT02876224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775173|NCT02876224|Growth Inhibitors|growth inhibitors|mesh-ancestor
5775174|NCT02876250|Cyclosporine|cyclosporine|mesh-list
5775175|NCT02876250|Cyclosporins|cyclosporins|mesh-list
5775176|NCT02876250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5775177|NCT02876250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5775178|NCT02876250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5775179|NCT02876250|Immunologic Factors|immunologic factors|mesh-ancestor
5775180|NCT02876250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775181|NCT02876250|Antifungal Agents|antifungal agents|mesh-ancestor
5775182|NCT02876250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5775183|NCT02876250|Dermatologic Agents|dermatologic agents|mesh-ancestor
5775184|NCT02876250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5775185|NCT02876250|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5775186|NCT02876484|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
5775187|NCT02876484|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
5775188|NCT02876484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5775189|NCT02876484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5775190|NCT02876484|Antimetabolites|antimetabolites|mesh-ancestor
5775191|NCT02876484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5775192|NCT02876484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5775193|NCT02876484|Cathartics|cathartics|mesh-ancestor
5775194|NCT02876484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5775195|NCT02876211|Vitamin D|vitamin d|mesh-list
5775196|NCT02876211|Vitamins|vitamins|mesh-ancestor
5775197|NCT02876211|Micronutrients|micronutrients|mesh-ancestor
5775198|NCT02876211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775199|NCT02876211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5775200|NCT02876094|Celecoxib|celecoxib|mesh-list
5775201|NCT02876094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5775202|NCT02876094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5775203|NCT02876094|Analgesics|analgesics|mesh-ancestor
5775204|NCT02876094|Sensory System Agents|sensory system agents|mesh-ancestor
5775205|NCT02876094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5775206|NCT02876094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775207|NCT02876094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5775208|NCT02876094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5775209|NCT02876094|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5775210|NCT02876094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5775211|NCT02876094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5775212|NCT02876094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5775213|NCT02876081|Afatinib|afatinib|mesh-list
5775214|NCT02876081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5775215|NCT02876081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5775216|NCT02876081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5775217|NCT02876081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5775218|NCT02876146|Albendazole|albendazole|mesh-list
5775219|NCT02876146|Benzimidazole|benzimidazole|mesh-list
5775220|NCT02876146|Anthelmintics|anthelmintics|mesh-ancestor
5775221|NCT02876146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5775222|NCT02876146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5775223|NCT02876146|Anticestodal Agents|anticestodal agents|mesh-ancestor
5775224|NCT02876146|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5775225|NCT02876146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5775226|NCT02876146|Tubulin Modulators|tubulin modulators|mesh-ancestor
5775227|NCT02876146|Antimitotic Agents|antimitotic agents|mesh-ancestor
5775228|NCT02876146|Mitosis Modulators|mitosis modulators|mesh-ancestor
6673550|NCT01563718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6673551|NCT01563731|Antihypertensive Agents|antihypertensive agents|mesh-list
6673552|NCT01563731|Calcium Channel Blockers|calcium channel blockers|mesh-list
6673553|NCT01563731|Atorvastatin|atorvastatin|mesh-list
6673554|NCT01563731|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6673555|NCT01563731|Simvastatin|simvastatin|mesh-list
6673556|NCT01563731|Pravastatin|pravastatin|mesh-list
6673557|NCT01563731|Enzyme Inhibitors|enzyme inhibitors|mesh-list
6673558|NCT01563731|Diuretics|diuretics|mesh-list
6673559|NCT01563731|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6673560|NCT01563731|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
6673561|NCT01563731|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
6673562|NCT01563731|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
6673563|NCT01563731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5775229|NCT02876146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5775230|NCT02876146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5775231|NCT02875756|Ivermectin|ivermectin|mesh-list
5775232|NCT02875756|Selamectin|selamectin|mesh-list
5775233|NCT02875756|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5775234|NCT02875756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5775235|NCT02875743|Posaconazole|posaconazole|mesh-list
5775236|NCT02875743|Antifungal Agents|antifungal agents|mesh-ancestor
5775237|NCT02875743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5775238|NCT02875743|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5775239|NCT02875743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5775240|NCT02875743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5775241|NCT02875743|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5775242|NCT02875743|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5775243|NCT02875743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5775244|NCT02875743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5775245|NCT02875743|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5775246|NCT02875743|Hormone Antagonists|hormone antagonists|mesh-ancestor
5775247|NCT02875743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5775248|NCT02875743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775249|NCT02875821|Metformin|metformin|mesh-list
5775250|NCT02875821|Pioglitazone|pioglitazone|mesh-list
5775251|NCT02875821|Ipragliflozin|ipragliflozin|mesh-list
5775252|NCT02875821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5775253|NCT02875821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775254|NCT02875821|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5775255|NCT02875821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5775256|NCT02875886|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5775257|NCT02875886|Amiloride|amiloride|mesh-list
5775258|NCT02875886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5775259|NCT02875886|Diuretics|diuretics|mesh-ancestor
5775260|NCT02875886|Natriuretic Agents|natriuretic agents|mesh-ancestor
5775261|NCT02875886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775262|NCT02875886|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5775263|NCT02875886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5775264|NCT02875886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5775265|NCT02875886|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
5775266|NCT02875886|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5775267|NCT02875886|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
6673564|NCT01563731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673565|NCT01563731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5775268|NCT02875886|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5775269|NCT02875873|Methamphetamine|methamphetamine|mesh-list
5775270|NCT02875873|Plasma-lyte 148|plasma-lyte 148|mesh-list
5775271|NCT02875873|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5775272|NCT02875873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775273|NCT02875873|Sympathomimetics|sympathomimetics|mesh-ancestor
5775274|NCT02875873|Autonomic Agents|autonomic agents|mesh-ancestor
5775275|NCT02875873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5775276|NCT02875873|Dopamine Agents|dopamine agents|mesh-ancestor
5775277|NCT02875873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5775278|NCT02875873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5775279|NCT02875873|Adrenergic Agents|adrenergic agents|mesh-ancestor
5775280|NCT02875873|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5775281|NCT02875873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5775282|NCT02875873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5775283|NCT02875873|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5775284|NCT02875873|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5775285|NCT02875873|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5897163|NCT01976169|Antimitotic Agents|antimitotic agents|mesh-ancestor
5897164|NCT01976169|Mitosis Modulators|mitosis modulators|mesh-ancestor
5897165|NCT01920932|Prednisone|prednisone|mesh-list
5897166|NCT01920932|Prednisolone|prednisolone|mesh-list
5897167|NCT01920932|Cyclophosphamide|cyclophosphamide|mesh-list
5897168|NCT01920932|Dacarbazine|dacarbazine|mesh-list
5897169|NCT01920932|Doxorubicin|doxorubicin|mesh-list
5897170|NCT01920932|Etoposide|etoposide|mesh-list
5897171|NCT01920932|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5897172|NCT01920932|Imidazole|imidazole|mesh-list
5897173|NCT01920932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5897174|NCT01920932|Immunologic Factors|immunologic factors|mesh-ancestor
5897175|NCT01920932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897176|NCT01920932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5897177|NCT01920932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5897178|NCT01920932|Alkylating Agents|alkylating agents|mesh-ancestor
5897179|NCT01920932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897180|NCT01920932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5897181|NCT01920932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5897182|NCT01920932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5897183|NCT01920932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5897184|NCT01920932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5897185|NCT01920932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5897186|NCT01920932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5897187|NCT01920932|Glucocorticoids|glucocorticoids|mesh-ancestor
5897188|NCT01920932|Hormones|hormones|mesh-ancestor
5897189|NCT01920932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5897190|NCT01920932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5897191|NCT01920932|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5897192|NCT01920932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5897193|NCT01856478|Methotrexate|methotrexate|mesh-list
5897194|NCT01856478|Afatinib|afatinib|mesh-list
5897195|NCT01856478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5897196|NCT01856478|Abortifacient Agents|abortifacient agents|mesh-ancestor
5897197|NCT01856478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5897198|NCT01856478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897199|NCT01856478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5897200|NCT01856478|Antimetabolites|antimetabolites|mesh-ancestor
5775286|NCT02875457|Cisplatin|cisplatin|mesh-list
5775287|NCT02875457|Etoposide|etoposide|mesh-list
5775288|NCT02875457|Etoposide phosphate|etoposide phosphate|mesh-list
5775289|NCT02875457|Apatinib|apatinib|mesh-list
5775290|NCT02875457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5775291|NCT02875457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5775292|NCT02875457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5775293|NCT02875457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5775294|NCT02875457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5775295|NCT02875457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5775296|NCT02875457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5775297|NCT02875587|Cabergoline|cabergoline|mesh-list
5775298|NCT02875587|Calcium|calcium|mesh-list
5775299|NCT02875587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5775300|NCT02875587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775301|NCT02875587|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5775302|NCT02875587|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5775303|NCT02875587|Dopamine Agonists|dopamine agonists|mesh-ancestor
5775304|NCT02875587|Dopamine Agents|dopamine agents|mesh-ancestor
5775305|NCT02875587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5775306|NCT02875587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5775307|NCT02876107|Paclitaxel|paclitaxel|mesh-list
5775308|NCT02876107|Carboplatin|carboplatin|mesh-list
5775309|NCT02876107|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5775310|NCT02876107|Panitumumab|panitumumab|mesh-list
5775311|NCT02876107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5775312|NCT02876107|Antibodies|antibodies|mesh-list
5775313|NCT02876107|Immunoglobulins|immunoglobulins|mesh-list
5775314|NCT02876107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5775315|NCT02876107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5775316|NCT02876107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5775317|NCT02876107|Tubulin Modulators|tubulin modulators|mesh-ancestor
5775318|NCT02876107|Antimitotic Agents|antimitotic agents|mesh-ancestor
5775319|NCT02876107|Mitosis Modulators|mitosis modulators|mesh-ancestor
5775320|NCT02876107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5775321|NCT02876107|Immunologic Factors|immunologic factors|mesh-ancestor
5775322|NCT02876107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775323|NCT02875717|Aspirin|aspirin|mesh-list
5775324|NCT02875717|Heparin|heparin|mesh-list
5775325|NCT02875717|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5775326|NCT02875717|Tinzaparin|tinzaparin|mesh-list
5775327|NCT02875717|Dalteparin|dalteparin|mesh-list
5775328|NCT02875717|Anticoagulants|anticoagulants|mesh-ancestor
5775329|NCT02875717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5775330|NCT02875717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5775331|NCT02875717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5775332|NCT02875717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5775333|NCT02875717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5775334|NCT02875717|Analgesics|analgesics|mesh-ancestor
5775335|NCT02875717|Sensory System Agents|sensory system agents|mesh-ancestor
5775336|NCT02875717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5775337|NCT02875717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775338|NCT02875717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5775339|NCT02875717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5775340|NCT02875717|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5775341|NCT02875717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5775342|NCT02875717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5775343|NCT02875717|Antipyretics|antipyretics|mesh-ancestor
5775344|NCT02875262|Deferoxamine|deferoxamine|mesh-list
5775345|NCT02875262|Siderophores|siderophores|mesh-ancestor
5775346|NCT02875262|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5775347|NCT02875262|Chelating Agents|chelating agents|mesh-ancestor
5775348|NCT02875262|Sequestering Agents|sequestering agents|mesh-ancestor
5775349|NCT02875262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5775350|NCT02875093|Cytarabine|cytarabine|mesh-list
6490647|NCT00599287|Antiemetics|antiemetics|mesh-ancestor
6490648|NCT00599287|Autonomic Agents|autonomic agents|mesh-ancestor
6490649|NCT00599287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6490650|NCT00599287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6490651|NCT00599287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6490652|NCT00599287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6490653|NCT00599287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6490654|NCT00599287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5775351|NCT02875093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5775352|NCT02875093|Antimetabolites|antimetabolites|mesh-ancestor
5775353|NCT02875093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490655|NCT00599287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5775354|NCT02875093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5775355|NCT02875093|Antiviral Agents|antiviral agents|mesh-ancestor
5775356|NCT02875093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5775357|NCT02875093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5775358|NCT02875093|Immunologic Factors|immunologic factors|mesh-ancestor
5775359|NCT02875093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775360|NCT02875288|Bupivacaine|bupivacaine|mesh-list
5775361|NCT02875288|Anesthetics, Local|anesthetics, local|mesh-ancestor
5775362|NCT02875288|Anesthetics|anesthetics|mesh-ancestor
5775363|NCT02875288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5775364|NCT02875288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775365|NCT02875288|Sensory System Agents|sensory system agents|mesh-ancestor
5775366|NCT02875288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5775367|NCT02875015|Lidocaine|lidocaine|mesh-list
5775368|NCT02875015|Bupivacaine|bupivacaine|mesh-list
5775369|NCT02875015|Anesthetics, Local|anesthetics, local|mesh-ancestor
5775370|NCT02875015|Anesthetics|anesthetics|mesh-ancestor
5775371|NCT02875015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5640813|NCT04609046|Immunologic Factors|immunologic factors|mesh-ancestor
5640814|NCT04609046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640815|NCT04609046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5640816|NCT04609046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5640817|NCT04609046|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5640818|NCT04609046|Abortifacient Agents|abortifacient agents|mesh-ancestor
5775372|NCT02875015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775373|NCT02875015|Sensory System Agents|sensory system agents|mesh-ancestor
5775374|NCT02875015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5775375|NCT02875015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5775376|NCT02875015|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5775377|NCT02875015|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5775378|NCT02875015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5775379|NCT02875015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5775380|NCT02875002|Belinostat|belinostat|mesh-list
5775381|NCT02875002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5775382|NCT02875002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5775383|NCT02875002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5775384|NCT02875002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5775385|NCT02874989|Dasatinib|dasatinib|mesh-list
5775386|NCT02874989|Quercetin|quercetin|mesh-list
5775387|NCT02874989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5775388|NCT02874989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5775389|NCT02874989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5775390|NCT02874989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5775391|NCT02874989|Antioxidants|antioxidants|mesh-ancestor
5775392|NCT02874989|Protective Agents|protective agents|mesh-ancestor
5775393|NCT02874989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775394|NCT02874963|Ethanol|ethanol|mesh-list
5775395|NCT02874963|Listerine|listerine|mesh-list
5775396|NCT02874963|Eucalyptol|eucalyptol|mesh-list
5775397|NCT02874963|Salicylates|salicylates|mesh-list
5775398|NCT02874963|Methyl salicylate|methyl salicylate|mesh-list
5775399|NCT02874963|Menthol|menthol|mesh-list
5775400|NCT02874963|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5775401|NCT02874963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5775402|NCT02874963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5775403|NCT02874963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775404|NCT02874963|Antipruritics|antipruritics|mesh-ancestor
5775405|NCT02874963|Dermatologic Agents|dermatologic agents|mesh-ancestor
5775406|NCT02874963|Protective Agents|protective agents|mesh-ancestor
5775407|NCT02874963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5775408|NCT02874963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5775409|NCT02874963|Analgesics|analgesics|mesh-ancestor
5775410|NCT02874963|Sensory System Agents|sensory system agents|mesh-ancestor
5775411|NCT02874963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5775412|NCT02874963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5775413|NCT02874963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5775414|NCT02874963|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5775415|NCT02874963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5775416|NCT02874963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640819|NCT04609046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5640820|NCT04609046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5640821|NCT04609046|Antimetabolites|antimetabolites|mesh-ancestor
5640822|NCT04609046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640823|NCT04609046|Dermatologic Agents|dermatologic agents|mesh-ancestor
5640824|NCT04609046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5775417|NCT02874963|Antitussive Agents|antitussive agents|mesh-ancestor
5775418|NCT02874963|Respiratory System Agents|respiratory system agents|mesh-ancestor
5775419|NCT02874963|Insect Repellents|insect repellents|mesh-ancestor
5775420|NCT02874768|Dexmedetomidine|dexmedetomidine|mesh-list
5775421|NCT02874768|Propofol|propofol|mesh-list
5775422|NCT02874768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5775423|NCT02874768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5775424|NCT02874768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775425|NCT02874768|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5775426|NCT02874768|Anesthetics, General|anesthetics, general|mesh-ancestor
5775427|NCT02874768|Anesthetics|anesthetics|mesh-ancestor
5775428|NCT02874768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5775429|NCT02874768|Analgesics|analgesics|mesh-ancestor
5775430|NCT02874768|Sensory System Agents|sensory system agents|mesh-ancestor
5775431|NCT02874768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5775432|NCT02874768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5775433|NCT02874768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5775434|NCT02874768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6490656|NCT00599287|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6490657|NCT00599287|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5775435|NCT02874768|Adrenergic Agents|adrenergic agents|mesh-ancestor
5775436|NCT02874768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5775437|NCT02874768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5775438|NCT02874586|Immunosuppressive Agents|immunosuppressive agents|mesh-list
5775439|NCT02874586|Immunologic Factors|immunologic factors|mesh-ancestor
5775440|NCT02874586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775441|NCT02874690|Methylphenidate|methylphenidate|mesh-list
5775442|NCT02874690|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5775443|NCT02874690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775444|NCT02874690|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5775445|NCT02874690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5775446|NCT02874690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5775447|NCT02874690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5775448|NCT02874690|Dopamine Agents|dopamine agents|mesh-ancestor
5775449|NCT02874690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5775450|NCT02874807|Empagliflozin|empagliflozin|mesh-list
5775451|NCT02874807|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5775452|NCT02874807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5775453|NCT02874807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5775454|NCT02874807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775455|NCT02874820|Idazoxan|idazoxan|mesh-list
5775456|NCT02874820|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5775457|NCT02874820|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5775458|NCT02874820|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5775459|NCT02874820|Adrenergic Agents|adrenergic agents|mesh-ancestor
5775460|NCT02874820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5775461|NCT02874820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5775462|NCT02874820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775463|NCT02874378|Dexmedetomidine|dexmedetomidine|mesh-list
5775464|NCT02874378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5775465|NCT02874378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5775466|NCT02874378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775467|NCT02874378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5775468|NCT02874378|Analgesics|analgesics|mesh-ancestor
5775469|NCT02874378|Sensory System Agents|sensory system agents|mesh-ancestor
5775470|NCT02874378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5775471|NCT02874378|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5775472|NCT02874378|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5775473|NCT02874378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5775474|NCT02874378|Adrenergic Agents|adrenergic agents|mesh-ancestor
5775475|NCT02874378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5775476|NCT02874378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5775477|NCT02874430|Metformin|metformin|mesh-list
5775478|NCT02874430|Doxycycline|doxycycline|mesh-list
5775479|NCT02874430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5775480|NCT02874430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775481|NCT02874430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5775482|NCT02874430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5775483|NCT02874430|Antimalarials|antimalarials|mesh-ancestor
5775484|NCT02874430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5775485|NCT02874430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5775486|NCT02874144|Mometasone Furoate|mometasone furoate|mesh-list
5775487|NCT02874144|Fluticasone|fluticasone|mesh-list
6210249|NCT02158442|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6210250|NCT02158442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6210251|NCT02158442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210252|NCT02158442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6210253|NCT02158442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6210254|NCT02158520|Paclitaxel|paclitaxel|mesh-list
6210255|NCT02158520|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6210256|NCT02158520|Bevacizumab|bevacizumab|mesh-list
6210257|NCT02158520|Ipilimumab|ipilimumab|mesh-list
6210258|NCT02158520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6210259|NCT02158520|Endothelial Growth Factors|endothelial growth factors|mesh-list
6210260|NCT02158520|Antibodies|antibodies|mesh-list
6210261|NCT02158520|Immunoglobulins|immunoglobulins|mesh-list
6210262|NCT02158520|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6210263|NCT02158520|Immunoglobulin G|immunoglobulin g|mesh-list
6673566|NCT01563731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6673567|NCT01563731|Antimetabolites|antimetabolites|mesh-ancestor
6673568|NCT01563731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5775488|NCT02874144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5775489|NCT02874144|Dermatologic Agents|dermatologic agents|mesh-ancestor
5775490|NCT02874144|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5775491|NCT02874144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5775492|NCT02874144|Autonomic Agents|autonomic agents|mesh-ancestor
5775493|NCT02874144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5775494|NCT02874144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775495|NCT02874144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5775496|NCT02874144|Respiratory System Agents|respiratory system agents|mesh-ancestor
5775497|NCT02874326|Octreotide|octreotide|mesh-list
5775498|NCT02874326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5775499|NCT02874326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5775500|NCT02874326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5775501|NCT02874287|Hydroxychloroquine|hydroxychloroquine|mesh-list
5775502|NCT02874287|Antimalarials|antimalarials|mesh-ancestor
5775503|NCT02874287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5775504|NCT02874287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5775505|NCT02874287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5775506|NCT02874287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5775507|NCT02874287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5775508|NCT02874287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5897201|NCT01856478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897202|NCT01856478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5897203|NCT01856478|Dermatologic Agents|dermatologic agents|mesh-ancestor
5897204|NCT01856478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5897205|NCT01856478|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5897206|NCT01856478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5897207|NCT01856478|Immunologic Factors|immunologic factors|mesh-ancestor
5897208|NCT01856478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5897209|NCT01856478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5897210|NCT01856478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5897211|NCT01827111|Paclitaxel|paclitaxel|mesh-list
5897212|NCT01827111|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5897213|NCT01827111|Ipilimumab|ipilimumab|mesh-list
5897214|NCT01827111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5897215|NCT01827111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5897216|NCT01827111|Tubulin Modulators|tubulin modulators|mesh-ancestor
5897217|NCT01827111|Antimitotic Agents|antimitotic agents|mesh-ancestor
5897218|NCT01827111|Mitosis Modulators|mitosis modulators|mesh-ancestor
5897219|NCT01827111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897220|NCT01827111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5897221|NCT01827111|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5897222|NCT01729754|Etanercept|etanercept|mesh-list
5897223|NCT01729754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5897224|NCT01729754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5897225|NCT01729754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5897226|NCT01729754|Analgesics|analgesics|mesh-ancestor
5897227|NCT01729754|Sensory System Agents|sensory system agents|mesh-ancestor
5897228|NCT01729754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5897229|NCT01729754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897230|NCT01729754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5897231|NCT01729754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5897232|NCT01729754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5897233|NCT01729754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5897234|NCT01729754|Immunologic Factors|immunologic factors|mesh-ancestor
5897235|NCT01631292|Vitamin D|vitamin d|mesh-list
5897236|NCT01631292|Ergocalciferols|ergocalciferols|mesh-list
6210264|NCT02158520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5775509|NCT02874248|Drospirenone|drospirenone|mesh-list
5775510|NCT02874248|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5775511|NCT02874248|Hormone Antagonists|hormone antagonists|mesh-ancestor
5775512|NCT02874248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5775513|NCT02874248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775514|NCT02874248|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5775515|NCT02874248|Diuretics|diuretics|mesh-ancestor
5775516|NCT02874248|Natriuretic Agents|natriuretic agents|mesh-ancestor
5775517|NCT02873819|Cyclophosphamide|cyclophosphamide|mesh-list
5775518|NCT02873819|Sargramostim|sargramostim|mesh-list
5775519|NCT02873819|Poly ICLC|poly iclc|mesh-list
5775520|NCT02873819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5775521|NCT02873819|Immunologic Factors|immunologic factors|mesh-ancestor
5775522|NCT02873819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775523|NCT02873819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5775524|NCT02873819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5775525|NCT02873819|Alkylating Agents|alkylating agents|mesh-ancestor
5775526|NCT02873819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5775527|NCT02873819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5775528|NCT02873819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5775529|NCT02873819|Interferon Inducers|interferon inducers|mesh-ancestor
5775530|NCT02873598|Gemcitabine|gemcitabine|mesh-list
5775531|NCT02873598|Paclitaxel|paclitaxel|mesh-list
5775532|NCT02873598|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5775533|NCT02873598|Folfirinox|folfirinox|mesh-list
5775534|NCT02873598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5775535|NCT02873598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5775536|NCT02873598|Tubulin Modulators|tubulin modulators|mesh-ancestor
5775537|NCT02873598|Antimitotic Agents|antimitotic agents|mesh-ancestor
5775538|NCT02873598|Mitosis Modulators|mitosis modulators|mesh-ancestor
5775539|NCT02873598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5775540|NCT02873598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5775541|NCT02873598|Antimetabolites|antimetabolites|mesh-ancestor
5775542|NCT02873598|Antiviral Agents|antiviral agents|mesh-ancestor
5775543|NCT02873598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5775544|NCT02873598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5775545|NCT02873598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5775546|NCT02873598|Immunologic Factors|immunologic factors|mesh-ancestor
5775547|NCT02873598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775548|NCT02873650|Dabrafenib|dabrafenib|mesh-list
5775549|NCT02873650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5775550|NCT02873650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5775551|NCT02873650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5775552|NCT02873650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5775553|NCT02873806|Tobramycin|tobramycin|mesh-list
5775554|NCT02873806|Dexamethasone|dexamethasone|mesh-list
5775555|NCT02873806|Travoprost|travoprost|mesh-list
5775556|NCT02873806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5775557|NCT02873806|Antiemetics|antiemetics|mesh-ancestor
5775558|NCT02873806|Autonomic Agents|autonomic agents|mesh-ancestor
5775559|NCT02873806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5775560|NCT02873806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775561|NCT02873806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5775562|NCT02873806|Glucocorticoids|glucocorticoids|mesh-ancestor
5775563|NCT02873806|Hormones|hormones|mesh-ancestor
5775564|NCT02873806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5775565|NCT02873806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5775566|NCT02873806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5775567|NCT02873806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5775568|NCT02873806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5775569|NCT02873806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5775570|NCT02873559|Testosterone|testosterone|mesh-list
5775571|NCT02873559|Androgens|androgens|mesh-ancestor
5775572|NCT02873559|Hormones|hormones|mesh-ancestor
5775573|NCT02873559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5775574|NCT02873559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775575|NCT02874313|Hypoglycemic Agents|hypoglycemic agents|mesh-list
5775576|NCT02874313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775577|NCT02873871|Hemostatics|hemostatics|mesh-list
5775578|NCT02873871|Coagulants|coagulants|mesh-ancestor
5775579|NCT02873273|Dexamethasone|dexamethasone|mesh-list
5775580|NCT02873273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5775581|NCT02873273|Antiemetics|antiemetics|mesh-ancestor
5775582|NCT02873273|Autonomic Agents|autonomic agents|mesh-ancestor
5775583|NCT02873273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5775584|NCT02873273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775585|NCT02873273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5775586|NCT02873273|Glucocorticoids|glucocorticoids|mesh-ancestor
5775587|NCT02873273|Hormones|hormones|mesh-ancestor
5775588|NCT02873273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5775589|NCT02873273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5775590|NCT02873273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5775591|NCT02873325|Antiviral Agents|antiviral agents|mesh-list
5775592|NCT02873325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5775593|NCT02873234|Antidepressive Agents|antidepressive agents|mesh-list
5775594|NCT02873234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5775595|NCT02873364|Vitamin D|vitamin d|mesh-list
5775596|NCT02873364|Ergocalciferols|ergocalciferols|mesh-list
5775597|NCT02873364|Cholecalciferol|cholecalciferol|mesh-list
5775598|NCT02873364|Vitamins|vitamins|mesh-list
5775599|NCT02873364|Micronutrients|micronutrients|mesh-ancestor
5775600|NCT02873364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775601|NCT02873364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5775602|NCT02873364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5775603|NCT02873351|Levodopa|levodopa|mesh-list
5775604|NCT02873351|Carbidopa|carbidopa|mesh-list
5775605|NCT02873351|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
5775606|NCT02873351|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5775607|NCT02873351|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5775608|NCT02873351|Dopamine Agents|dopamine agents|mesh-ancestor
5775609|NCT02873351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5775610|NCT02873351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5775611|NCT02873351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775612|NCT02873351|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5775613|NCT02873351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5775614|NCT02873351|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5775615|NCT02873351|Immunologic Factors|immunologic factors|mesh-ancestor
5775616|NCT02873351|Dopamine Agonists|dopamine agonists|mesh-ancestor
5775617|NCT02873091|Sufentanil|sufentanil|mesh-list
5775618|NCT02873091|Ropivacaine|ropivacaine|mesh-list
5775619|NCT02873091|Anesthetics, Local|anesthetics, local|mesh-ancestor
5775620|NCT02873091|Anesthetics|anesthetics|mesh-ancestor
5775621|NCT02873091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5775622|NCT02873091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775623|NCT02873091|Sensory System Agents|sensory system agents|mesh-ancestor
5775624|NCT02873091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5775625|NCT02873091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5775626|NCT02873091|Narcotics|narcotics|mesh-ancestor
5775627|NCT02873091|Analgesics|analgesics|mesh-ancestor
5775628|NCT02873091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5775629|NCT02873091|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5775630|NCT02873091|Anesthetics, General|anesthetics, general|mesh-ancestor
5775631|NCT02873065|Amoxicillin|amoxicillin|mesh-list
5775632|NCT02873065|Clarithromycin|clarithromycin|mesh-list
5775633|NCT02873065|Potassium Citrate|potassium citrate|mesh-list
5775634|NCT02873065|Bismuth|bismuth|mesh-list
5775635|NCT02873065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5775636|NCT02873065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5775637|NCT02873065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5775638|NCT02873065|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5775639|NCT02873065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5775640|NCT02873065|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5775641|NCT02873065|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5775642|NCT02873065|Antacids|antacids|mesh-ancestor
5775643|NCT02873065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5775644|NCT02873065|Diuretics|diuretics|mesh-ancestor
5775645|NCT02873065|Natriuretic Agents|natriuretic agents|mesh-ancestor
5775646|NCT02873065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775647|NCT02873065|Expectorants|expectorants|mesh-ancestor
5775648|NCT02873065|Respiratory System Agents|respiratory system agents|mesh-ancestor
5775649|NCT02872818|Metformin|metformin|mesh-list
5775650|NCT02872818|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
5775651|NCT02872818|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5775652|NCT02872818|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5775653|NCT02872818|Medroxyprogesterone|medroxyprogesterone|mesh-list
5775654|NCT02872818|Estradiol|estradiol|mesh-list
5775655|NCT02872818|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5775656|NCT02872818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5775657|NCT02872818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775658|NCT02872818|Estrogens|estrogens|mesh-ancestor
5775659|NCT02872818|Hormones|hormones|mesh-ancestor
5775660|NCT02872818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5775661|NCT02872818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5775662|NCT02872818|Contraceptive Agents|contraceptive agents|mesh-ancestor
5775663|NCT02872818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5775664|NCT02872818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6490658|NCT00599287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6490659|NCT00599287|Cholinergic Agents|cholinergic agents|mesh-ancestor
6490660|NCT00599287|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6490661|NCT00599287|Protective Agents|protective agents|mesh-ancestor
6210265|NCT02158520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6210266|NCT02158520|Tubulin Modulators|tubulin modulators|mesh-ancestor
6210267|NCT02158520|Antimitotic Agents|antimitotic agents|mesh-ancestor
6210268|NCT02158520|Mitosis Modulators|mitosis modulators|mesh-ancestor
6210269|NCT02158520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210270|NCT02158520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6210271|NCT02158520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6490662|NCT00599417|Broncho-Vaxom|broncho-vaxom|mesh-list
6490663|NCT00599417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6490664|NCT00599417|Immunologic Factors|immunologic factors|mesh-ancestor
6490665|NCT00599417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490666|NCT00599534|Montelukast|montelukast|mesh-list
6490667|NCT00599534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6490668|NCT00599534|Respiratory System Agents|respiratory system agents|mesh-ancestor
6673569|NCT01563731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5775665|NCT02872818|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5775666|NCT02872818|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5775667|NCT02872818|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5775668|NCT02872818|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5775669|NCT02872818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5775670|NCT02872818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5775671|NCT02873026|Triamcinolone|triamcinolone|mesh-list
5775672|NCT02873026|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5775673|NCT02873026|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5775674|NCT02873026|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5775675|NCT02873026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5775676|NCT02873026|Glucocorticoids|glucocorticoids|mesh-ancestor
5775677|NCT02873026|Hormones|hormones|mesh-ancestor
5775678|NCT02873026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5775679|NCT02873026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775680|NCT02873026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5775681|NCT02873026|Immunologic Factors|immunologic factors|mesh-ancestor
5775682|NCT02873026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5775683|NCT02873026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5775684|NCT02872584|Prednisone|prednisone|mesh-list
5775685|NCT02872584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6673570|NCT01563731|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6673571|NCT01563731|Natriuretic Agents|natriuretic agents|mesh-ancestor
6673572|NCT01563731|Protease Inhibitors|protease inhibitors|mesh-ancestor
6673573|NCT01563731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6673574|NCT01563731|Hormone Antagonists|hormone antagonists|mesh-ancestor
6673575|NCT01563731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6673576|NCT01563731|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6673577|NCT01563835|Fentanyl|fentanyl|mesh-list
6673578|NCT01563835|Bupivacaine|bupivacaine|mesh-list
6673579|NCT01563835|Citric Acid|citric acid|mesh-list
6673580|NCT01563835|Sodium Citrate|sodium citrate|mesh-list
6673581|NCT01563835|Anesthetics, Local|anesthetics, local|mesh-ancestor
6673582|NCT01563835|Anesthetics|anesthetics|mesh-ancestor
6673583|NCT01563835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5775686|NCT02872584|Glucocorticoids|glucocorticoids|mesh-ancestor
5775687|NCT02872584|Hormones|hormones|mesh-ancestor
5775688|NCT02872584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5775689|NCT02872584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775690|NCT02872584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5775691|NCT02872584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5775692|NCT02872597|Dexamethasone|dexamethasone|mesh-list
5775693|NCT02872597|Prednisone|prednisone|mesh-list
5775694|NCT02872597|Methylprednisolone|methylprednisolone|mesh-list
5775695|NCT02872597|Prednisolone|prednisolone|mesh-list
5775696|NCT02872597|Albuterol|albuterol|mesh-list
5775697|NCT02872597|Ipratropium|ipratropium|mesh-list
5775698|NCT02872597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5775699|NCT02872597|Antiemetics|antiemetics|mesh-ancestor
5775700|NCT02872597|Autonomic Agents|autonomic agents|mesh-ancestor
5775701|NCT02872597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5775702|NCT02872597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775703|NCT02872597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5775704|NCT02872597|Glucocorticoids|glucocorticoids|mesh-ancestor
5775705|NCT02872597|Hormones|hormones|mesh-ancestor
5775706|NCT02872597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5775707|NCT02872597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5775708|NCT02872597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5775709|NCT02872597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5775710|NCT02872597|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5775711|NCT02872597|Protective Agents|protective agents|mesh-ancestor
5775712|NCT02872597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5775713|NCT02872597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5775714|NCT02872597|Respiratory System Agents|respiratory system agents|mesh-ancestor
5775715|NCT02872597|Tocolytic Agents|tocolytic agents|mesh-ancestor
5775716|NCT02872597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5775717|NCT02872597|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5775718|NCT02872597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5775719|NCT02872597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5775720|NCT02872597|Adrenergic Agents|adrenergic agents|mesh-ancestor
5775721|NCT02872597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5775722|NCT02872597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5775723|NCT02872597|Cholinergic Agents|cholinergic agents|mesh-ancestor
5775724|NCT02872649|Warfarin|warfarin|mesh-list
5775725|NCT02872649|Dabigatran|dabigatran|mesh-list
5775726|NCT02872649|Phenprocoumon|phenprocoumon|mesh-list
5775727|NCT02872649|Anticoagulants|anticoagulants|mesh-ancestor
5775728|NCT02872649|Antithrombins|antithrombins|mesh-ancestor
5775729|NCT02872649|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5775730|NCT02872649|Protease Inhibitors|protease inhibitors|mesh-ancestor
5775731|NCT02872649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5775732|NCT02872649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897237|NCT01631292|Cholecalciferol|cholecalciferol|mesh-list
5897238|NCT01631292|Vitamins|vitamins|mesh-list
5897239|NCT01631292|Micronutrients|micronutrients|mesh-ancestor
5897240|NCT01631292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897241|NCT01631292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5897242|NCT01631292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5897243|NCT01553149|Lenalidomide|lenalidomide|mesh-list
5897244|NCT01553149|Immunologic Factors|immunologic factors|mesh-ancestor
5897245|NCT01553149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897246|NCT01553149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5897247|NCT01553149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5897248|NCT01553149|Growth Substances|growth substances|mesh-ancestor
5897249|NCT01553149|Growth Inhibitors|growth inhibitors|mesh-ancestor
5897250|NCT01553149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5897251|NCT01437111|Vitamin D|vitamin d|mesh-list
5897252|NCT01437111|Cholecalciferol|cholecalciferol|mesh-list
5897253|NCT01437111|Alendronate|alendronate|mesh-list
5897254|NCT01437111|Vitamins|vitamins|mesh-ancestor
5897255|NCT01437111|Micronutrients|micronutrients|mesh-ancestor
5897256|NCT01437111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897257|NCT01437111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5897258|NCT01437111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5897259|NCT01386385|Paclitaxel|paclitaxel|mesh-list
5897260|NCT01386385|Carboplatin|carboplatin|mesh-list
5897261|NCT01386385|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5897262|NCT01386385|Veliparib|veliparib|mesh-list
5897263|NCT01386385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5897264|NCT01386385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5897265|NCT01386385|Tubulin Modulators|tubulin modulators|mesh-ancestor
5897266|NCT01386385|Antimitotic Agents|antimitotic agents|mesh-ancestor
5897267|NCT01386385|Mitosis Modulators|mitosis modulators|mesh-ancestor
5897268|NCT01386385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897269|NCT01386385|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5897270|NCT01386385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5897271|NCT01364597|Brivaracetam|brivaracetam|mesh-list
5897272|NCT01364597|Anticonvulsants|anticonvulsants|mesh-ancestor
5897273|NCT01349101|Vidarabine|vidarabine|mesh-list
5897274|NCT01349101|Mycophenolic Acid|mycophenolic acid|mesh-list
6490669|NCT00599534|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6490670|NCT00599534|Hormone Antagonists|hormone antagonists|mesh-ancestor
6490671|NCT00599534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6490672|NCT00599534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897275|NCT01349101|Cyclophosphamide|cyclophosphamide|mesh-list
5897276|NCT01349101|Busulfan|busulfan|mesh-list
5897277|NCT01349101|Fludarabine|fludarabine|mesh-list
5897278|NCT01349101|Fludarabine phosphate|fludarabine phosphate|mesh-list
5897279|NCT01349101|Tacrolimus|tacrolimus|mesh-list
5897280|NCT01349101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5897281|NCT01349101|Immunologic Factors|immunologic factors|mesh-ancestor
5775733|NCT02872389|Sevoflurane|sevoflurane|mesh-list
5775734|NCT02872389|Desflurane|desflurane|mesh-list
5775735|NCT02872389|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5775736|NCT02872389|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5775737|NCT02872389|Anesthetics, General|anesthetics, general|mesh-ancestor
5775738|NCT02872389|Anesthetics|anesthetics|mesh-ancestor
5775739|NCT02872389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5775740|NCT02872389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775741|NCT02872272|Amikacin|amikacin|mesh-list
5775742|NCT02872272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5775743|NCT02872272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5775744|NCT02872259|Pembrolizumab|pembrolizumab|mesh-list
5775745|NCT02872259|Trametinib|trametinib|mesh-list
5775746|NCT02872259|Dabrafenib|dabrafenib|mesh-list
5775747|NCT02872259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5775748|NCT02872259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5775749|NCT02872259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5775750|NCT02872259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5775751|NCT02872259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5775752|NCT02872467|Oxytocin|oxytocin|mesh-list
5775753|NCT02872467|Oxytocics|oxytocics|mesh-ancestor
5775754|NCT02872467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5775755|NCT02872467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775756|NCT02872428|Valproic Acid|valproic acid|mesh-list
5775757|NCT02872428|Anticonvulsants|anticonvulsants|mesh-ancestor
5775758|NCT02872428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5775759|NCT02872428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5775760|NCT02872428|GABA Agents|gaba agents|mesh-ancestor
5775761|NCT02872428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5775762|NCT02872428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775763|NCT02872428|Antimanic Agents|antimanic agents|mesh-ancestor
5775764|NCT02872428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5775765|NCT02872428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5775766|NCT02872428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5775767|NCT02871882|Bile Acids and Salts|bile acids and salts|mesh-list
5775768|NCT02871882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5775769|NCT02871869|Buformin|buformin|mesh-list
5775770|NCT02871869|Prednisone|prednisone|mesh-list
5775771|NCT02871869|Cyclophosphamide|cyclophosphamide|mesh-list
5775772|NCT02871869|Rituximab|rituximab|mesh-list
5775773|NCT02871869|Epirubicin|epirubicin|mesh-list
5775774|NCT02871869|Vindesine|vindesine|mesh-list
5775775|NCT02871869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5775776|NCT02871869|Immunologic Factors|immunologic factors|mesh-ancestor
5775777|NCT02871869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775778|NCT02871869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5775779|NCT02871869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5775780|NCT02871869|Alkylating Agents|alkylating agents|mesh-ancestor
5775781|NCT02871869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5775782|NCT02871869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5775783|NCT02871869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5775784|NCT02871869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5775785|NCT02871869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5775786|NCT02871869|Glucocorticoids|glucocorticoids|mesh-ancestor
5775787|NCT02871869|Hormones|hormones|mesh-ancestor
5775788|NCT02871869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5775789|NCT02871869|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5775790|NCT02871869|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5775791|NCT02871869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5775792|NCT02871869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5775793|NCT02871869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5775794|NCT02871869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5775795|NCT02871869|Tubulin Modulators|tubulin modulators|mesh-ancestor
5775796|NCT02871869|Antimitotic Agents|antimitotic agents|mesh-ancestor
5775797|NCT02871869|Mitosis Modulators|mitosis modulators|mesh-ancestor
5775798|NCT02871869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5775799|NCT02872090|Glycopyrrolate|glycopyrrolate|mesh-list
5775800|NCT02872090|Tiotropium Bromide|tiotropium bromide|mesh-list
5775801|NCT02872090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5775802|NCT02872090|Autonomic Agents|autonomic agents|mesh-ancestor
5775803|NCT02872090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5775804|NCT02872090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775805|NCT02872090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5775806|NCT02872090|Respiratory System Agents|respiratory system agents|mesh-ancestor
5775807|NCT02872090|Parasympatholytics|parasympatholytics|mesh-ancestor
5775808|NCT02872090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5775809|NCT02872090|Cholinergic Agents|cholinergic agents|mesh-ancestor
5775810|NCT02872090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5775811|NCT02872090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5775812|NCT02872090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5775813|NCT02872090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5775814|NCT02871791|Everolimus|everolimus|mesh-list
5775815|NCT02871791|Palbociclib|palbociclib|mesh-list
5775816|NCT02871791|Exemestane|exemestane|mesh-list
5775817|NCT02871791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5775818|NCT02871791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5775819|NCT02871791|Immunologic Factors|immunologic factors|mesh-ancestor
5775820|NCT02871791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775821|NCT02871791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5775822|NCT02871791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5775823|NCT02871791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5775824|NCT02871791|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5775825|NCT02871791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5775826|NCT02871791|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5775827|NCT02871791|Hormone Antagonists|hormone antagonists|mesh-ancestor
5775828|NCT02871791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5775829|NCT02872064|Verteporfin|verteporfin|mesh-list
5775830|NCT02872064|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5775831|NCT02872064|Dermatologic Agents|dermatologic agents|mesh-ancestor
5775832|NCT02871843|Temozolomide|temozolomide|mesh-list
5775833|NCT02871843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5775834|NCT02871843|Alkylating Agents|alkylating agents|mesh-ancestor
5775835|NCT02871843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5775836|NCT02871843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5775837|NCT02871661|Amitriptyline|amitriptyline|mesh-list
5775838|NCT02871661|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
5775839|NCT02871661|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5775840|NCT02871661|Antidepressive Agents|antidepressive agents|mesh-ancestor
5775841|NCT02871661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5775842|NCT02871661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5775843|NCT02871661|Analgesics|analgesics|mesh-ancestor
5775844|NCT02871661|Sensory System Agents|sensory system agents|mesh-ancestor
5775845|NCT02871661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5775846|NCT02871661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775847|NCT02871661|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5775848|NCT02871661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5775849|NCT02871661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5775850|NCT02871661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5775851|NCT02871661|Adrenergic Agents|adrenergic agents|mesh-ancestor
5775852|NCT02871661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5775853|NCT02871661|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5775854|NCT02871661|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5775855|NCT02871661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5775856|NCT02871986|Estrogens|estrogens|mesh-list
5775857|NCT02871986|Hormones|hormones|mesh-ancestor
5775858|NCT02871986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5775859|NCT02871986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775860|NCT02871713|Morphine|morphine|mesh-list
5775861|NCT02871713|Ropivacaine|ropivacaine|mesh-list
5775862|NCT02871713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6490673|NCT00599534|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6490674|NCT00599534|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6490675|NCT00599534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490676|NCT00599560|Vasopressins|vasopressins|mesh-list
6490677|NCT00599560|Arginine Vasopressin|arginine vasopressin|mesh-list
6490678|NCT00599560|Hemostatics|hemostatics|mesh-ancestor
6490679|NCT00599560|Coagulants|coagulants|mesh-ancestor
6490680|NCT00599560|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6490681|NCT00599560|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6490682|NCT00599560|Natriuretic Agents|natriuretic agents|mesh-ancestor
6490683|NCT00599560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490684|NCT00599573|Ondansetron|ondansetron|mesh-list
6490685|NCT00599573|Antiemetics|antiemetics|mesh-ancestor
6490686|NCT00599573|Autonomic Agents|autonomic agents|mesh-ancestor
6490687|NCT00599573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6490688|NCT00599573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775863|NCT02871713|Narcotics|narcotics|mesh-ancestor
6210272|NCT02158520|Growth Substances|growth substances|mesh-ancestor
6490689|NCT00599573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6490690|NCT00599573|Antipruritics|antipruritics|mesh-ancestor
6490691|NCT00599573|Dermatologic Agents|dermatologic agents|mesh-ancestor
6490692|NCT00599573|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5775864|NCT02871713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5775865|NCT02871713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775866|NCT02871713|Analgesics|analgesics|mesh-ancestor
5775867|NCT02871713|Sensory System Agents|sensory system agents|mesh-ancestor
5775868|NCT02871713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5775869|NCT02871713|Anesthetics, Local|anesthetics, local|mesh-ancestor
5775870|NCT02871713|Anesthetics|anesthetics|mesh-ancestor
5775871|NCT02871765|Warfarin|warfarin|mesh-list
5775872|NCT02871765|Anticoagulants|anticoagulants|mesh-ancestor
5775873|NCT02871687|Simvastatin|simvastatin|mesh-list
5775874|NCT02871687|Pravastatin|pravastatin|mesh-list
5775875|NCT02871687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5775876|NCT02871687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5775877|NCT02871687|Antimetabolites|antimetabolites|mesh-ancestor
5775878|NCT02871687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5775879|NCT02871687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5775880|NCT02871687|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5775881|NCT02871687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5775882|NCT02872038|Cefazolin|cefazolin|mesh-list
5775883|NCT02872038|Ceftazidime|ceftazidime|mesh-list
5775884|NCT02872038|Cefepime|cefepime|mesh-list
5775885|NCT02872038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5775886|NCT02872038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5775887|NCT02871648|Fludrocortisone|fludrocortisone|mesh-list
5775888|NCT02871648|Eplerenone|eplerenone|mesh-list
5775889|NCT02871648|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5775890|NCT02871648|Hormone Antagonists|hormone antagonists|mesh-ancestor
5775891|NCT02871648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5775892|NCT02871648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775893|NCT02871648|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5775894|NCT02871648|Diuretics|diuretics|mesh-ancestor
5775895|NCT02871648|Natriuretic Agents|natriuretic agents|mesh-ancestor
5775896|NCT02871648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5775897|NCT02871648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5775898|NCT02871401|Valganciclovir|valganciclovir|mesh-list
5775899|NCT02871401|Antiviral Agents|antiviral agents|mesh-ancestor
5775900|NCT02871401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5775901|NCT02871323|Durvalumab|durvalumab|mesh-list
5775902|NCT02871323|Immunoglobulins|immunoglobulins|mesh-list
5775903|NCT02871323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5775904|NCT02871323|Immunoglobulin G|immunoglobulin g|mesh-list
5775905|NCT02871323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5775906|NCT02871323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5775907|NCT02871323|Immunologic Factors|immunologic factors|mesh-ancestor
5775908|NCT02871323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775909|NCT02871518|Cisplatin|cisplatin|mesh-list
5775910|NCT02871518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5775911|NCT02871219|Lenalidomide|lenalidomide|mesh-list
5775912|NCT02871219|Obinutuzumab|obinutuzumab|mesh-list
5775913|NCT02871219|Immunologic Factors|immunologic factors|mesh-ancestor
5775914|NCT02871219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775915|NCT02871219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5775916|NCT02871219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5775917|NCT02871219|Growth Substances|growth substances|mesh-ancestor
5775918|NCT02871219|Growth Inhibitors|growth inhibitors|mesh-ancestor
5775919|NCT02871219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5775920|NCT02871219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5775921|NCT02871505|Penicillins|penicillins|mesh-list
5775922|NCT02871505|Penicillin G|penicillin g|mesh-list
5775923|NCT02871505|Penicillin G Benzathine|penicillin g benzathine|mesh-list
5775924|NCT02871505|Penicillin G Procaine|penicillin g procaine|mesh-list
5775925|NCT02871505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5775926|NCT02871505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5775927|NCT02871349|Propranolol|propranolol|mesh-list
5775928|NCT02871349|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5775929|NCT02871349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5775930|NCT02871349|Adrenergic Agents|adrenergic agents|mesh-ancestor
5775931|NCT02871349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5775932|NCT02871349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5775933|NCT02871349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775934|NCT02871349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5775935|NCT02871349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5775936|NCT02871349|Vasodilator Agents|vasodilator agents|mesh-ancestor
6490693|NCT00599573|Serotonin Agents|serotonin agents|mesh-ancestor
5775937|NCT02871193|Dexamethasone|dexamethasone|mesh-list
5775938|NCT02871193|Ropivacaine|ropivacaine|mesh-list
5775939|NCT02871193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5775940|NCT02871193|Antiemetics|antiemetics|mesh-ancestor
5775941|NCT02871193|Autonomic Agents|autonomic agents|mesh-ancestor
5775942|NCT02871193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5775943|NCT02871193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775944|NCT02871193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5775945|NCT02871193|Glucocorticoids|glucocorticoids|mesh-ancestor
5775946|NCT02871193|Hormones|hormones|mesh-ancestor
5775947|NCT02871193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5775948|NCT02871193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5775949|NCT02871193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5775950|NCT02871193|Anesthetics, Local|anesthetics, local|mesh-ancestor
5775951|NCT02871193|Anesthetics|anesthetics|mesh-ancestor
5775952|NCT02871193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5775953|NCT02871193|Sensory System Agents|sensory system agents|mesh-ancestor
5775954|NCT02871141|Antidepressive Agents|antidepressive agents|mesh-list
5775955|NCT02871141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5775956|NCT02870829|Vitamin K 2|vitamin k 2|mesh-list
5775957|NCT02870829|Vitamin K|vitamin k|mesh-list
5775958|NCT02870829|Vitamin MK 7|vitamin mk 7|mesh-list
5775959|NCT02870829|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5775960|NCT02870829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5775961|NCT02870829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5775962|NCT02870829|Hemostatics|hemostatics|mesh-ancestor
5775963|NCT02870829|Coagulants|coagulants|mesh-ancestor
5775964|NCT02870829|Vitamins|vitamins|mesh-ancestor
5775965|NCT02870829|Micronutrients|micronutrients|mesh-ancestor
5775966|NCT02870829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897282|NCT01349101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897283|NCT01349101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5897284|NCT01349101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5897285|NCT01349101|Alkylating Agents|alkylating agents|mesh-ancestor
5897286|NCT01349101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897287|NCT01349101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5897288|NCT01349101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5897289|NCT01349101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5897290|NCT01349101|Antimetabolites|antimetabolites|mesh-ancestor
5897291|NCT01349101|Antiviral Agents|antiviral agents|mesh-ancestor
5897292|NCT01349101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5897293|NCT01349101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5897294|NCT01349101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5897295|NCT01349101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5897296|NCT01349101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5897297|NCT01349101|Antitubercular Agents|antitubercular agents|mesh-ancestor
5897298|NCT01349101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5897299|NCT01333046|Azacitidine|azacitidine|mesh-list
5897300|NCT01333046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5897301|NCT01333046|Antimetabolites|antimetabolites|mesh-ancestor
5897302|NCT01333046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897303|NCT01333046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5897304|NCT01333046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5897305|NCT01163383|Iodine|iodine|mesh-list
5897306|NCT01163383|Cadexomer iodine|cadexomer iodine|mesh-list
5897307|NCT01163383|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
5897308|NCT01163383|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5897309|NCT01163383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5897310|NCT01163383|Trace Elements|trace elements|mesh-ancestor
5897311|NCT01163383|Micronutrients|micronutrients|mesh-ancestor
5897312|NCT01163383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897313|NCT01163383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5897314|NCT01163383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5897315|NCT01163383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897316|NCT01163383|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5897317|NCT01057121|Lenalidomide|lenalidomide|mesh-list
5897318|NCT01057121|Immunologic Factors|immunologic factors|mesh-ancestor
5897319|NCT01057121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897320|NCT01057121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5897321|NCT01057121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5897322|NCT01057121|Growth Substances|growth substances|mesh-ancestor
5897323|NCT01057121|Growth Inhibitors|growth inhibitors|mesh-ancestor
5897324|NCT01057121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5897325|NCT01004263|Rizatriptan|rizatriptan|mesh-list
5897326|NCT01004263|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5897327|NCT01004263|Serotonin Agents|serotonin agents|mesh-ancestor
5897328|NCT01004263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5775967|NCT02870907|Cyclophosphamide|cyclophosphamide|mesh-list
5775968|NCT02870907|Thiotepa|thiotepa|mesh-list
5775969|NCT02870907|Carboplatin|carboplatin|mesh-list
5775970|NCT02870907|Etoposide|etoposide|mesh-list
5775971|NCT02870907|Etoposide phosphate|etoposide phosphate|mesh-list
5775972|NCT02870907|Vincristine|vincristine|mesh-list
5775973|NCT02870907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5775974|NCT02870907|Immunologic Factors|immunologic factors|mesh-ancestor
5775975|NCT02870907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775976|NCT02870907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5775977|NCT02870907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5775978|NCT02870907|Alkylating Agents|alkylating agents|mesh-ancestor
5775979|NCT02870907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5775980|NCT02870907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5775981|NCT02870907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5775982|NCT02870907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5775983|NCT02870907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5775984|NCT02870907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5775985|NCT02870907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5775986|NCT02870907|Tubulin Modulators|tubulin modulators|mesh-ancestor
5775987|NCT02870907|Antimitotic Agents|antimitotic agents|mesh-ancestor
5775988|NCT02870907|Mitosis Modulators|mitosis modulators|mesh-ancestor
5775989|NCT02870634|Copper|copper|mesh-list
5775990|NCT02870634|Trace Elements|trace elements|mesh-ancestor
5775991|NCT02870634|Micronutrients|micronutrients|mesh-ancestor
5775992|NCT02870634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5775993|NCT02870478|Atropine|atropine|mesh-list
5775994|NCT02870478|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5775995|NCT02870478|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5775996|NCT02870478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5775997|NCT02870478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5775998|NCT02870478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5775999|NCT02870478|Autonomic Agents|autonomic agents|mesh-ancestor
5776000|NCT02870478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5776001|NCT02870478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776002|NCT02870478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5776003|NCT02870478|Respiratory System Agents|respiratory system agents|mesh-ancestor
5776004|NCT02870478|Mydriatics|mydriatics|mesh-ancestor
5776005|NCT02870478|Parasympatholytics|parasympatholytics|mesh-ancestor
5776006|NCT02870478|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5776007|NCT02870478|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5776008|NCT02870478|Cholinergic Agents|cholinergic agents|mesh-ancestor
5776009|NCT02870478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5776010|NCT02870478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5776011|NCT02870673|Triamcinolone|triamcinolone|mesh-list
5776012|NCT02870673|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5776013|NCT02870673|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5776014|NCT02870673|Lidocaine|lidocaine|mesh-list
5776015|NCT02870673|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5776016|NCT02870673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5776017|NCT02870673|Glucocorticoids|glucocorticoids|mesh-ancestor
5776018|NCT02870673|Hormones|hormones|mesh-ancestor
5776019|NCT02870673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5776020|NCT02870673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776021|NCT02870673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5776022|NCT02870673|Immunologic Factors|immunologic factors|mesh-ancestor
5776023|NCT02870673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5776024|NCT02870673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5776025|NCT02870673|Anesthetics, Local|anesthetics, local|mesh-ancestor
5776026|NCT02870673|Anesthetics|anesthetics|mesh-ancestor
5776027|NCT02870673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5776028|NCT02870673|Sensory System Agents|sensory system agents|mesh-ancestor
5776029|NCT02870673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5776030|NCT02870673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5776031|NCT02870673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5776032|NCT02870673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5776033|NCT02870673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5776034|NCT02870361|Insulin|insulin|mesh-list
5776035|NCT02870361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5776036|NCT02870361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490694|NCT00599573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6490695|NCT00599573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490696|NCT00599573|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6490697|NCT00599573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6490698|NCT00599573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6490699|NCT00599573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5776037|NCT02870790|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5776038|NCT02870790|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5776039|NCT02870790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5776040|NCT02870790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5776041|NCT02870790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5776042|NCT02870790|Antiviral Agents|antiviral agents|mesh-ancestor
5776043|NCT02870790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5776044|NCT02870790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5776045|NCT02870790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5776046|NCT02870231|Liraglutide|liraglutide|mesh-list
5776047|NCT02870231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5776048|NCT02870231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776049|NCT02870231|Incretins|incretins|mesh-ancestor
5776050|NCT02870231|Hormones|hormones|mesh-ancestor
5776051|NCT02870231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5776052|NCT02870348|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
5776053|NCT02870348|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5776054|NCT02870348|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5776055|NCT02870348|Protease Inhibitors|protease inhibitors|mesh-ancestor
5776056|NCT02870348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5776057|NCT02870348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5776058|NCT02869984|Ramosetron|ramosetron|mesh-list
5776059|NCT02869984|Antiemetics|antiemetics|mesh-ancestor
5776060|NCT02869984|Autonomic Agents|autonomic agents|mesh-ancestor
5776061|NCT02869984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5776062|NCT02869984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776063|NCT02869984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5776064|NCT02869984|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5776065|NCT02869984|Serotonin Agents|serotonin agents|mesh-ancestor
5776066|NCT02869984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5776067|NCT02869984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5776068|NCT02870153|Oxaliplatin|oxaliplatin|mesh-list
5776069|NCT02870153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5776070|NCT02869841|Levobupivacaine|levobupivacaine|mesh-list
5776071|NCT02869841|Anesthetics, Local|anesthetics, local|mesh-ancestor
5776072|NCT02869841|Anesthetics|anesthetics|mesh-ancestor
5776073|NCT02869841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5776074|NCT02869841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776075|NCT02869841|Sensory System Agents|sensory system agents|mesh-ancestor
5776076|NCT02869841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5776077|NCT02870036|Leucovorin|leucovorin|mesh-list
5776078|NCT02870036|Thalidomide|thalidomide|mesh-list
5776079|NCT02870036|Fluorouracil|fluorouracil|mesh-list
5776080|NCT02870036|Calcium|calcium|mesh-list
5776081|NCT02870036|Levoleucovorin|levoleucovorin|mesh-list
5776082|NCT02870036|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5776083|NCT02870036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776084|NCT02870036|Antimetabolites|antimetabolites|mesh-ancestor
5776085|NCT02870036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5776086|NCT02870036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5776087|NCT02870036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5776088|NCT02870036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5776089|NCT02870036|Immunologic Factors|immunologic factors|mesh-ancestor
5776090|NCT02870036|Antidotes|antidotes|mesh-ancestor
5776091|NCT02870036|Protective Agents|protective agents|mesh-ancestor
5776092|NCT02870036|Vitamin B Complex|vitamin b complex|mesh-ancestor
5776093|NCT02870036|Vitamins|vitamins|mesh-ancestor
5776094|NCT02870036|Micronutrients|micronutrients|mesh-ancestor
5776095|NCT02870036|Leprostatic Agents|leprostatic agents|mesh-ancestor
5776096|NCT02870036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5776097|NCT02870036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5776098|NCT02870036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5776099|NCT02870036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5776100|NCT02870036|Growth Substances|growth substances|mesh-ancestor
5776101|NCT02870036|Growth Inhibitors|growth inhibitors|mesh-ancestor
5776102|NCT02869815|Methylene Blue|methylene blue|mesh-list
5776103|NCT02869815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5776104|NCT02869815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5776105|NCT02869763|Ethanol|ethanol|mesh-list
5776106|NCT02869763|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5776107|NCT02869763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5776108|NCT02869763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5776109|NCT02869763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776110|NCT02869672|Vaccines|vaccines|mesh-list
5776111|NCT02869672|Immunologic Factors|immunologic factors|mesh-ancestor
6212590|NCT02191033|Autonomic Agents|autonomic agents|mesh-ancestor
5776112|NCT02869672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776113|NCT02869347|Complement C1s|complement c1s|mesh-list
5776114|NCT02869347|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
5776115|NCT02869347|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
5776116|NCT02869347|Immunologic Factors|immunologic factors|mesh-ancestor
5776117|NCT02869347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776118|NCT02869347|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5776119|NCT02869347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5776120|NCT02870062|Chlorhexidine|chlorhexidine|mesh-list
5776121|NCT02870062|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5776122|NCT02870062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5776123|NCT02870062|Disinfectants|disinfectants|mesh-ancestor
5776124|NCT02869204|Ascorbic Acid|ascorbic acid|mesh-list
5776125|NCT02869204|Vitamins|vitamins|mesh-ancestor
5776126|NCT02869204|Micronutrients|micronutrients|mesh-ancestor
5776127|NCT02869204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776128|NCT02869204|Antioxidants|antioxidants|mesh-ancestor
5776129|NCT02869204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5776130|NCT02869204|Protective Agents|protective agents|mesh-ancestor
5776131|NCT02869321|Fentanyl|fentanyl|mesh-list
5776132|NCT02869321|Morphine|morphine|mesh-list
5776133|NCT02869321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5776134|NCT02869321|Narcotics|narcotics|mesh-ancestor
5776135|NCT02869321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5776136|NCT02869321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776137|NCT02869321|Analgesics|analgesics|mesh-ancestor
5776138|NCT02869321|Sensory System Agents|sensory system agents|mesh-ancestor
5776139|NCT02869321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5776140|NCT02869321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5776141|NCT02869321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5776142|NCT02869321|Anesthetics, General|anesthetics, general|mesh-ancestor
5776143|NCT02869321|Anesthetics|anesthetics|mesh-ancestor
5897329|NCT01004263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897330|NCT01004263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897331|NCT01001234|Rizatriptan|rizatriptan|mesh-list
5897332|NCT01001234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5897333|NCT01001234|Serotonin Agents|serotonin agents|mesh-ancestor
5897334|NCT01001234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5897335|NCT01001234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897336|NCT01001234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897337|NCT00961792|Diphenhydramine|diphenhydramine|mesh-list
5897338|NCT00961792|Promethazine|promethazine|mesh-list
5897339|NCT00961792|Ethanol|ethanol|mesh-list
6490700|NCT00599573|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6490701|NCT00599625|Pravastatin|pravastatin|mesh-list
6490702|NCT00599625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6490703|NCT00599625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6490704|NCT00599625|Antimetabolites|antimetabolites|mesh-ancestor
6490705|NCT00599625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490706|NCT00599625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6673584|NCT01563835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673585|NCT01563835|Sensory System Agents|sensory system agents|mesh-ancestor
6673586|NCT01563835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5897340|NCT00961792|Caffeine|caffeine|mesh-list
5897341|NCT00961792|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5897342|NCT00961792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897343|NCT00961792|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5897344|NCT00961792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5897345|NCT00961792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897346|NCT00961792|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5897347|NCT00961792|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5897348|NCT00961792|Purinergic Agents|purinergic agents|mesh-ancestor
5897349|NCT00961792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5897350|NCT00961792|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5897351|NCT00961792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5897352|NCT00961792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5897353|NCT00961792|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5897354|NCT00961792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5897355|NCT00961792|Anesthetics, Local|anesthetics, local|mesh-ancestor
5897356|NCT00961792|Anesthetics|anesthetics|mesh-ancestor
5897357|NCT00961792|Sensory System Agents|sensory system agents|mesh-ancestor
5897358|NCT00961792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6490707|NCT00599625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5776144|NCT02869165|Estrogens|estrogens|mesh-list
5776145|NCT02869165|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
5776146|NCT02869165|Hormones|hormones|mesh-ancestor
5776147|NCT02869165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5776148|NCT02869165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776149|NCT02869217|Cyclophosphamide|cyclophosphamide|mesh-list
5776150|NCT02869217|Fludarabine|fludarabine|mesh-list
5776151|NCT02869217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5776152|NCT02869217|Immunologic Factors|immunologic factors|mesh-ancestor
5776153|NCT02869217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776154|NCT02869217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5776155|NCT02869217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5776156|NCT02869217|Alkylating Agents|alkylating agents|mesh-ancestor
5776157|NCT02869217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5776158|NCT02869217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5776159|NCT02869217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5776160|NCT02869126|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
5776161|NCT02869126|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5776162|NCT02869126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5776163|NCT02869100|Listerine|listerine|mesh-list
5776164|NCT02869100|Fluorides|fluorides|mesh-list
5776165|NCT02869100|Sodium Fluoride|sodium fluoride|mesh-list
5776166|NCT02869100|Cariostatic Agents|cariostatic agents|mesh-ancestor
5776167|NCT02869100|Protective Agents|protective agents|mesh-ancestor
5776168|NCT02869100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776169|NCT02869100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5776170|NCT02869100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5776171|NCT02868944|Sufentanil|sufentanil|mesh-list
5776172|NCT02868944|Morphine|morphine|mesh-list
5776173|NCT02868944|Levobupivacaine|levobupivacaine|mesh-list
5776174|NCT02868944|Anesthetics|anesthetics|mesh-list
5776175|NCT02868944|Anesthetics, Local|anesthetics, local|mesh-list
5776176|NCT02868944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5776177|NCT02868944|Narcotics|narcotics|mesh-ancestor
5776178|NCT02868944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5776179|NCT02868944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776180|NCT02868944|Analgesics|analgesics|mesh-ancestor
5776181|NCT02868944|Sensory System Agents|sensory system agents|mesh-ancestor
5776182|NCT02868944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5776183|NCT02868944|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5776184|NCT02868944|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5776185|NCT02868944|Anesthetics, General|anesthetics, general|mesh-ancestor
5776186|NCT02868931|Insulin|insulin|mesh-list
5776187|NCT02868931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5776188|NCT02868931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776189|NCT02868749|Hyaluronic Acid|hyaluronic acid|mesh-list
5776190|NCT02868749|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5776191|NCT02868749|Immunologic Factors|immunologic factors|mesh-ancestor
5776192|NCT02868749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776193|NCT02868749|Viscosupplements|viscosupplements|mesh-ancestor
5776194|NCT02868749|Protective Agents|protective agents|mesh-ancestor
5776195|NCT02869035|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5776196|NCT02869035|Citalopram|citalopram|mesh-list
5776197|NCT02869035|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5776198|NCT02869035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5776199|NCT02869035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5776200|NCT02869035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5776201|NCT02869035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5776202|NCT02869035|Serotonin Agents|serotonin agents|mesh-ancestor
5776203|NCT02869035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776204|NCT02869035|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5776205|NCT02869035|Antidepressive Agents|antidepressive agents|mesh-ancestor
5776206|NCT02869035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5776207|NCT02869035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5776208|NCT02869035|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5776209|NCT02869035|Analgesics|analgesics|mesh-ancestor
5776210|NCT02869035|Sensory System Agents|sensory system agents|mesh-ancestor
5776211|NCT02869035|Dopamine Agents|dopamine agents|mesh-ancestor
5776212|NCT02868996|Kallikreins|kallikreins|mesh-list
5776213|NCT02868996|Coagulants|coagulants|mesh-ancestor
5776214|NCT02868996|Fertility Agents, Male|fertility agents, male|mesh-ancestor
5776215|NCT02868996|Fertility Agents|fertility agents|mesh-ancestor
5776216|NCT02868996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5776217|NCT02868996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776218|NCT02868814|Pregabalin|pregabalin|mesh-list
5776219|NCT02868814|Analgesics|analgesics|mesh-ancestor
5897359|NCT00961792|Antiemetics|antiemetics|mesh-ancestor
5776220|NCT02868814|Sensory System Agents|sensory system agents|mesh-ancestor
5776221|NCT02868814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5776222|NCT02868814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776223|NCT02868814|Anticonvulsants|anticonvulsants|mesh-ancestor
5776224|NCT02868814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5776225|NCT02868814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5776226|NCT02868814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5776227|NCT02868814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5776228|NCT02868814|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5776229|NCT02868814|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5776230|NCT02868814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5776231|NCT02868814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5776232|NCT02868801|Pregabalin|pregabalin|mesh-list
5776233|NCT02868801|Analgesics|analgesics|mesh-ancestor
5776234|NCT02868801|Sensory System Agents|sensory system agents|mesh-ancestor
5776235|NCT02868801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5776236|NCT02868801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776237|NCT02868801|Anticonvulsants|anticonvulsants|mesh-ancestor
5776238|NCT02868801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5776239|NCT02868801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5776240|NCT02868801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5776241|NCT02868801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5776242|NCT02868801|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5776243|NCT02868801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5776244|NCT02868801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5776245|NCT02868801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5776246|NCT02868580|Lamivudine|lamivudine|mesh-list
5776247|NCT02868580|Abacavir|abacavir|mesh-list
5776248|NCT02868580|Dolutegravir|dolutegravir|mesh-list
5776249|NCT02868580|Triumeq|triumeq|mesh-list
5776250|NCT02868580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5776251|NCT02868580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5776252|NCT02868580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5776253|NCT02868580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5776254|NCT02868580|Antiviral Agents|antiviral agents|mesh-ancestor
5776255|NCT02868580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5776256|NCT02868580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5776257|NCT02868580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5776258|NCT02868580|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5776259|NCT02868580|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5776260|NCT02868827|Vitamin D|vitamin d|mesh-list
5776261|NCT02868827|Cholecalciferol|cholecalciferol|mesh-list
5776262|NCT02868827|Vitamins|vitamins|mesh-ancestor
5776263|NCT02868827|Micronutrients|micronutrients|mesh-ancestor
5776264|NCT02868827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776265|NCT02868827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5776266|NCT02868827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5776267|NCT02868606|Insulin|insulin|mesh-list
5776268|NCT02868606|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5776269|NCT02868606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5776270|NCT02868606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776271|NCT02868385|Praziquantel|praziquantel|mesh-list
5776272|NCT02868385|Anthelmintics|anthelmintics|mesh-ancestor
5776273|NCT02868385|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5776274|NCT02868385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5776275|NCT02868632|Durvalumab|durvalumab|mesh-list
5776276|NCT02868632|Tremelimumab|tremelimumab|mesh-list
5776277|NCT02868632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5776278|NCT02868632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5776279|NCT02868372|Povidone-Iodine|povidone-iodine|mesh-list
5776280|NCT02868372|Povidone|povidone|mesh-list
5776281|NCT02868372|Plasma Substitutes|plasma substitutes|mesh-ancestor
5776282|NCT02868372|Blood Substitutes|blood substitutes|mesh-ancestor
5776283|NCT02868372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5776284|NCT02868372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5776285|NCT02868437|Hyaluronic Acid|hyaluronic acid|mesh-list
5776286|NCT02868437|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5776287|NCT02868437|Immunologic Factors|immunologic factors|mesh-ancestor
5776288|NCT02868437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776289|NCT02868437|Viscosupplements|viscosupplements|mesh-ancestor
5776290|NCT02868437|Protective Agents|protective agents|mesh-ancestor
5776291|NCT02868567|4-Aminopyridine|4-aminopyridine|mesh-list
5776292|NCT02868567|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5776293|NCT02868567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5776294|NCT02868567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5776295|NCT02868151|Ascorbic Acid|ascorbic acid|mesh-list
5776296|NCT02868151|Vitamins|vitamins|mesh-ancestor
5776297|NCT02868151|Micronutrients|micronutrients|mesh-ancestor
5776298|NCT02868151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776299|NCT02868151|Antioxidants|antioxidants|mesh-ancestor
5776300|NCT02868151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5776301|NCT02868151|Protective Agents|protective agents|mesh-ancestor
5776302|NCT02868073|Vaccines|vaccines|mesh-list
5776303|NCT02868073|Immunologic Factors|immunologic factors|mesh-ancestor
5776304|NCT02868073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776305|NCT02867982|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5776306|NCT02867982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5776307|NCT02867956|Etoposide|etoposide|mesh-list
5776308|NCT02867956|Apatinib|apatinib|mesh-list
5776309|NCT02867956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5776310|NCT02867956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5776311|NCT02867956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5776312|NCT02867956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5776313|NCT02867956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5776314|NCT02867956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5776315|NCT02867956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5776316|NCT02867930|Dexmedetomidine|dexmedetomidine|mesh-list
5776317|NCT02867930|Ketamine|ketamine|mesh-list
5776318|NCT02867930|Propofol|propofol|mesh-list
5776319|NCT02867930|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5776320|NCT02867930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5776321|NCT02867930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776322|NCT02867930|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5776323|NCT02867930|Anesthetics, General|anesthetics, general|mesh-ancestor
5776324|NCT02867930|Anesthetics|anesthetics|mesh-ancestor
5776325|NCT02867930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5776326|NCT02867930|Analgesics|analgesics|mesh-ancestor
5776327|NCT02867930|Sensory System Agents|sensory system agents|mesh-ancestor
5776328|NCT02867930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5776329|NCT02867930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5776330|NCT02867930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5776331|NCT02867930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5776332|NCT02867930|Adrenergic Agents|adrenergic agents|mesh-ancestor
5776333|NCT02867930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5776334|NCT02867930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5776335|NCT02867930|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5776336|NCT02867930|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5776337|NCT02867930|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5776338|NCT02867904|Methylprednisolone|methylprednisolone|mesh-list
5776339|NCT02867904|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5776340|NCT02867904|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5776341|NCT02867904|Prednisolone|prednisolone|mesh-list
5776342|NCT02867904|Prednisolone acetate|prednisolone acetate|mesh-list
5776343|NCT02867904|Bupivacaine|bupivacaine|mesh-list
5776344|NCT02867904|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5776345|NCT02867904|Prednisolone phosphate|prednisolone phosphate|mesh-list
5776346|NCT02867904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5776347|NCT02867904|Antiemetics|antiemetics|mesh-ancestor
5776348|NCT02867904|Autonomic Agents|autonomic agents|mesh-ancestor
5776349|NCT02867904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5776350|NCT02867904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776351|NCT02867904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5776352|NCT02867904|Glucocorticoids|glucocorticoids|mesh-ancestor
5776353|NCT02867904|Hormones|hormones|mesh-ancestor
5776354|NCT02867904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5776355|NCT02867904|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5776356|NCT02867904|Protective Agents|protective agents|mesh-ancestor
5776357|NCT02867904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5776358|NCT02867904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5776359|NCT02867904|Anesthetics, Local|anesthetics, local|mesh-ancestor
5776360|NCT02867904|Anesthetics|anesthetics|mesh-ancestor
5776361|NCT02867904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5776362|NCT02867904|Sensory System Agents|sensory system agents|mesh-ancestor
5776363|NCT02867878|Adenosine|adenosine|mesh-list
5776364|NCT02867878|Analgesics|analgesics|mesh-ancestor
5776365|NCT02867878|Sensory System Agents|sensory system agents|mesh-ancestor
5776366|NCT02867878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5776367|NCT02867878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776368|NCT02867878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6490708|NCT00599625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6490709|NCT00599651|Pulmonary Surfactants|pulmonary surfactants|mesh-list
5776369|NCT02867878|Vasodilator Agents|vasodilator agents|mesh-ancestor
5776370|NCT02867878|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5776371|NCT02867878|Purinergic Agonists|purinergic agonists|mesh-ancestor
5776372|NCT02867878|Purinergic Agents|purinergic agents|mesh-ancestor
5776373|NCT02867878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5776374|NCT02867878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5776375|NCT02867865|Gemcitabine|gemcitabine|mesh-list
5776376|NCT02867865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5776377|NCT02867865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5776378|NCT02867865|Antimetabolites|antimetabolites|mesh-ancestor
5776379|NCT02867865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5776380|NCT02867865|Antiviral Agents|antiviral agents|mesh-ancestor
5776381|NCT02867865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5776382|NCT02867865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5776383|NCT02867865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5776384|NCT02867865|Immunologic Factors|immunologic factors|mesh-ancestor
5776385|NCT02867865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897360|NCT00961792|Autonomic Agents|autonomic agents|mesh-ancestor
5897361|NCT00961792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5897362|NCT00961792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5897363|NCT00961792|Histamine Antagonists|histamine antagonists|mesh-ancestor
5897364|NCT00961792|Histamine Agents|histamine agents|mesh-ancestor
5897365|NCT00961792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5897366|NCT00961792|Antipruritics|antipruritics|mesh-ancestor
5897367|NCT00961792|Dermatologic Agents|dermatologic agents|mesh-ancestor
5897368|NCT00950846|Cyclophosphamide|cyclophosphamide|mesh-list
5897369|NCT00950846|Busulfan|busulfan|mesh-list
5897370|NCT00950846|Fludarabine|fludarabine|mesh-list
5897371|NCT00950846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5897372|NCT00950846|Immunologic Factors|immunologic factors|mesh-ancestor
5897373|NCT00950846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897374|NCT00950846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5897375|NCT00950846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5897376|NCT00950846|Alkylating Agents|alkylating agents|mesh-ancestor
5897377|NCT00950846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897378|NCT00950846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5897379|NCT00950846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5897380|NCT00924170|Cyclophosphamide|cyclophosphamide|mesh-list
5897381|NCT00924170|Fludarabine|fludarabine|mesh-list
5897382|NCT00924170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5897383|NCT00924170|Immunologic Factors|immunologic factors|mesh-ancestor
5897384|NCT00924170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897385|NCT00924170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5897386|NCT00924170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5897387|NCT00924170|Alkylating Agents|alkylating agents|mesh-ancestor
5897388|NCT00924170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897389|NCT00924170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5897390|NCT00924170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5897391|NCT00894556|Sumatriptan|sumatriptan|mesh-list
5897392|NCT00894556|Rizatriptan|rizatriptan|mesh-list
5897393|NCT00894556|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5897394|NCT00894556|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5897395|NCT00894556|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5897396|NCT00894556|Serotonin Agents|serotonin agents|mesh-ancestor
5897397|NCT00894556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5897398|NCT00894556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897399|NCT00894556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897400|NCT00840177|Cytarabine|cytarabine|mesh-list
5897401|NCT00840177|Idarubicin|idarubicin|mesh-list
5897402|NCT00840177|Pravastatin|pravastatin|mesh-list
5897403|NCT00840177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5897404|NCT00840177|Antimetabolites|antimetabolites|mesh-ancestor
5897405|NCT00840177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897406|NCT00840177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6490710|NCT00599651|Respiratory System Agents|respiratory system agents|mesh-ancestor
6490711|NCT00599716|Hyaluronic Acid|hyaluronic acid|mesh-list
6490712|NCT00599716|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6490713|NCT00599716|Immunologic Factors|immunologic factors|mesh-ancestor
6490714|NCT00599716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776386|NCT02867917|Psyllium|psyllium|mesh-list
5776387|NCT02867917|Cathartics|cathartics|mesh-ancestor
5776388|NCT02867917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5776389|NCT02867566|Rituximab|rituximab|mesh-list
5776390|NCT02867566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5776391|NCT02867566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5776392|NCT02867566|Immunologic Factors|immunologic factors|mesh-ancestor
5776393|NCT02867566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776394|NCT02867566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5776395|NCT02867852|Abiraterone Acetate|abiraterone acetate|mesh-list
5776396|NCT02867852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5776397|NCT02867852|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5776398|NCT02867852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5776399|NCT02867852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5776400|NCT02867852|Hormone Antagonists|hormone antagonists|mesh-ancestor
5776401|NCT02867852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5776402|NCT02867852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776403|NCT02867852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5776404|NCT02867722|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5776405|NCT02867722|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5776406|NCT02867722|Dermatologic Agents|dermatologic agents|mesh-ancestor
5776407|NCT02867553|Rituximab|rituximab|mesh-list
5776408|NCT02867553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5776409|NCT02867553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5776410|NCT02867553|Immunologic Factors|immunologic factors|mesh-ancestor
5776411|NCT02867553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776412|NCT02867553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5776413|NCT02867800|Acetaminophen|acetaminophen|mesh-list
5776414|NCT02867800|Diphenhydramine|diphenhydramine|mesh-list
5776415|NCT02867800|Promethazine|promethazine|mesh-list
5776416|NCT02867800|Cyclosporine|cyclosporine|mesh-list
5776417|NCT02867800|Sirolimus|sirolimus|mesh-list
5776418|NCT02867800|Mycophenolic Acid|mycophenolic acid|mesh-list
5776419|NCT02867800|Methylprednisolone|methylprednisolone|mesh-list
5776420|NCT02867800|Methotrexate|methotrexate|mesh-list
5776421|NCT02867800|Fludarabine|fludarabine|mesh-list
5776422|NCT02867800|Melphalan|melphalan|mesh-list
5776423|NCT02867800|Alemtuzumab|alemtuzumab|mesh-list
5776424|NCT02867800|Thiotepa|thiotepa|mesh-list
5776425|NCT02867800|Abatacept|abatacept|mesh-list
5776426|NCT02867800|Meperidine|meperidine|mesh-list
5776427|NCT02867800|Tacrolimus|tacrolimus|mesh-list
5776428|NCT02867800|Cyclosporins|cyclosporins|mesh-list
5776429|NCT02867800|Thymoglobulin|thymoglobulin|mesh-list
5776430|NCT02867800|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5776431|NCT02867800|Abortifacient Agents|abortifacient agents|mesh-ancestor
5776432|NCT02867800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5776433|NCT02867800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776434|NCT02867800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5776435|NCT02867800|Antimetabolites|antimetabolites|mesh-ancestor
5776436|NCT02867800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5776437|NCT02867800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5776438|NCT02867800|Dermatologic Agents|dermatologic agents|mesh-ancestor
5776439|NCT02867800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5776440|NCT02867800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5776441|NCT02867800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5776442|NCT02867800|Immunologic Factors|immunologic factors|mesh-ancestor
5776443|NCT02867800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5776444|NCT02867800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5776445|NCT02867800|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5776446|NCT02867800|Antifungal Agents|antifungal agents|mesh-ancestor
5776447|NCT02867800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5776448|NCT02867800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5776449|NCT02867800|Analgesics|analgesics|mesh-ancestor
5776450|NCT02867800|Sensory System Agents|sensory system agents|mesh-ancestor
5776451|NCT02867800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5776452|NCT02867800|Antipyretics|antipyretics|mesh-ancestor
5776453|NCT02867800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5776454|NCT02867800|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5776455|NCT02867800|Antitubercular Agents|antitubercular agents|mesh-ancestor
5776456|NCT02867800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5776457|NCT02867800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5776458|NCT02867800|Alkylating Agents|alkylating agents|mesh-ancestor
5776459|NCT02867800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5776460|NCT02867800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5776461|NCT02867800|Antiemetics|antiemetics|mesh-ancestor
5776462|NCT02867800|Autonomic Agents|autonomic agents|mesh-ancestor
5640825|NCT04609046|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5640826|NCT04609046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5640827|NCT04609046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5640828|NCT04609046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5640829|NCT04609046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5640830|NCT04609046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5640831|NCT04609046|Growth Substances|growth substances|mesh-ancestor
5640832|NCT04609046|Growth Inhibitors|growth inhibitors|mesh-ancestor
5640833|NCT04598477|Prednisone|prednisone|mesh-list
5640834|NCT04598477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5640835|NCT04598477|Glucocorticoids|glucocorticoids|mesh-ancestor
5640836|NCT04598477|Hormones|hormones|mesh-ancestor
5640837|NCT04598477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5640838|NCT04598477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776463|NCT02867800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5776464|NCT02867800|Glucocorticoids|glucocorticoids|mesh-ancestor
5776465|NCT02867800|Hormones|hormones|mesh-ancestor
5776466|NCT02867800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5776467|NCT02867800|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5776468|NCT02867800|Protective Agents|protective agents|mesh-ancestor
5776469|NCT02867800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5776470|NCT02867800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5776471|NCT02867800|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5776472|NCT02867800|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5776473|NCT02867800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5776474|NCT02867800|Anesthetics, Local|anesthetics, local|mesh-ancestor
5776475|NCT02867800|Anesthetics|anesthetics|mesh-ancestor
5776476|NCT02867800|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5776477|NCT02867800|Histamine Antagonists|histamine antagonists|mesh-ancestor
5776478|NCT02867800|Histamine Agents|histamine agents|mesh-ancestor
5776479|NCT02867800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5776480|NCT02867800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5776481|NCT02867800|Antipruritics|antipruritics|mesh-ancestor
5776482|NCT02867800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6490715|NCT00599716|Viscosupplements|viscosupplements|mesh-ancestor
6490716|NCT00599716|Protective Agents|protective agents|mesh-ancestor
6490717|NCT00599807|Vitamin D|vitamin d|mesh-list
6490718|NCT00599807|Cholecalciferol|cholecalciferol|mesh-list
6490719|NCT00599807|Vitamins|vitamins|mesh-ancestor
6490720|NCT00599807|Micronutrients|micronutrients|mesh-ancestor
6490721|NCT00599807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490722|NCT00599807|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6490723|NCT00599807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6490724|NCT00599820|Bevacizumab|bevacizumab|mesh-list
6490725|NCT00599820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6490726|NCT00599820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6490727|NCT00599820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6490728|NCT00599820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6490729|NCT00599820|Growth Substances|growth substances|mesh-ancestor
6490730|NCT00599820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490731|NCT00599820|Growth Inhibitors|growth inhibitors|mesh-ancestor
6490732|NCT00599833|Cetuximab|cetuximab|mesh-list
6490733|NCT00599833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6490734|NCT00599833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5776483|NCT02867800|Narcotics|narcotics|mesh-ancestor
5776484|NCT02867800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5776485|NCT02867839|Oxaliplatin|oxaliplatin|mesh-list
5776486|NCT02867839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5776487|NCT02867176|Ketorolac|ketorolac|mesh-list
5776488|NCT02867176|Gabapentin|gabapentin|mesh-list
5776489|NCT02867176|Analgesics|analgesics|mesh-ancestor
5776490|NCT02867176|Sensory System Agents|sensory system agents|mesh-ancestor
5776491|NCT02867176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5776492|NCT02867176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776493|NCT02867176|Anticonvulsants|anticonvulsants|mesh-ancestor
5776494|NCT02867176|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5776495|NCT02867176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5776496|NCT02867176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5776497|NCT02867176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5776498|NCT02867176|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6490735|NCT00599885|Valsartan|valsartan|mesh-list
6490736|NCT00599885|Telmisartan|telmisartan|mesh-list
6490737|NCT00599885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5776499|NCT02867176|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6490738|NCT00599885|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6490739|NCT00599885|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6490740|NCT00599885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490741|NCT00599898|Nifedipine|nifedipine|mesh-list
6490742|NCT00599898|Atosiban|atosiban|mesh-list
6490743|NCT00599898|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6490744|NCT00599898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6490745|NCT00599898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490746|NCT00599898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6490747|NCT00599898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490748|NCT00599898|Vasodilator Agents|vasodilator agents|mesh-ancestor
6490749|NCT00599898|Tocolytic Agents|tocolytic agents|mesh-ancestor
6490750|NCT00599898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6490751|NCT00599898|Hormone Antagonists|hormone antagonists|mesh-ancestor
6496393|NCT00627887|Antidepressive Agents|antidepressive agents|mesh-ancestor
5776500|NCT02867176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5776501|NCT02867176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5776502|NCT02867176|Antimanic Agents|antimanic agents|mesh-ancestor
5776503|NCT02867176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5776504|NCT02867176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5776505|NCT02867176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5776506|NCT02867176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5776507|NCT02867176|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5776508|NCT02867176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5776509|NCT02867293|Anesthetics|anesthetics|mesh-list
5776510|NCT02867293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5776511|NCT02867293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776512|NCT02867306|Methotrexate|methotrexate|mesh-list
5776513|NCT02867306|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5776514|NCT02867306|Abortifacient Agents|abortifacient agents|mesh-ancestor
5776515|NCT02867306|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5776516|NCT02867306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776517|NCT02867306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5776518|NCT02867306|Antimetabolites|antimetabolites|mesh-ancestor
5776519|NCT02867306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5776520|NCT02867306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5776521|NCT02867306|Dermatologic Agents|dermatologic agents|mesh-ancestor
5776522|NCT02867306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5776523|NCT02867306|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5776524|NCT02867306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5776525|NCT02867306|Immunologic Factors|immunologic factors|mesh-ancestor
5776526|NCT02867306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5776527|NCT02867306|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5776528|NCT02867267|Thymalfasin|thymalfasin|mesh-list
5776529|NCT02867267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5776530|NCT02867267|Immunologic Factors|immunologic factors|mesh-ancestor
5776531|NCT02867267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776532|NCT02867397|Oxaliplatin|oxaliplatin|mesh-list
5776533|NCT02867397|Epirubicin|epirubicin|mesh-list
5776534|NCT02867397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5776535|NCT02867397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5776536|NCT02867397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5776537|NCT02867397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5776538|NCT02867397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5776539|NCT02867397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5776540|NCT02867280|Sorafenib|sorafenib|mesh-list
5776541|NCT02867280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5776542|NCT02867280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5776543|NCT02867280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5776544|NCT02867280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5776545|NCT02867124|Naltrexone|naltrexone|mesh-list
5776546|NCT02867124|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5776547|NCT02867124|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5776548|NCT02867124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776549|NCT02867124|Sensory System Agents|sensory system agents|mesh-ancestor
5776550|NCT02867124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5776551|NCT02867332|Cyclophosphamide|cyclophosphamide|mesh-list
5776552|NCT02867332|Interleukin-2|interleukin-2|mesh-list
5776553|NCT02867332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5776554|NCT02867332|Immunologic Factors|immunologic factors|mesh-ancestor
5776555|NCT02867332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776556|NCT02867332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5776557|NCT02867332|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5776558|NCT02867332|Alkylating Agents|alkylating agents|mesh-ancestor
5776559|NCT02867332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5776560|NCT02867332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5776561|NCT02867332|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5776562|NCT02867332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5776563|NCT02867332|Analgesics|analgesics|mesh-ancestor
5776564|NCT02867332|Sensory System Agents|sensory system agents|mesh-ancestor
5776565|NCT02867332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5776566|NCT02867345|Cyclophosphamide|cyclophosphamide|mesh-list
5776567|NCT02867345|Interleukin-2|interleukin-2|mesh-list
5776568|NCT02867345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5776569|NCT02867345|Immunologic Factors|immunologic factors|mesh-ancestor
5776570|NCT02867345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776571|NCT02867345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5776572|NCT02867345|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5776573|NCT02867345|Alkylating Agents|alkylating agents|mesh-ancestor
5776574|NCT02867345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5776575|NCT02867345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5776576|NCT02867345|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5776577|NCT02867345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5776578|NCT02867345|Analgesics|analgesics|mesh-ancestor
5776579|NCT02867345|Sensory System Agents|sensory system agents|mesh-ancestor
5776580|NCT02867345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5776581|NCT02866747|Durvalumab|durvalumab|mesh-list
5776582|NCT02866747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5776583|NCT02866747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5776584|NCT02866903|Bevacizumab|bevacizumab|mesh-list
5776585|NCT02866903|Oxaliplatin|oxaliplatin|mesh-list
5776586|NCT02866903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5776587|NCT02866903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5776588|NCT02866903|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5776589|NCT02866903|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5776590|NCT02866903|Growth Substances|growth substances|mesh-ancestor
5776591|NCT02866903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776592|NCT02866903|Growth Inhibitors|growth inhibitors|mesh-ancestor
5776593|NCT02867046|Dexamethasone|dexamethasone|mesh-list
5776594|NCT02867046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5776595|NCT02867046|Antiemetics|antiemetics|mesh-ancestor
5776596|NCT02867046|Autonomic Agents|autonomic agents|mesh-ancestor
5776597|NCT02867046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5776598|NCT02867046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776599|NCT02867046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5776600|NCT02867046|Glucocorticoids|glucocorticoids|mesh-ancestor
5776601|NCT02867046|Hormones|hormones|mesh-ancestor
5776602|NCT02867046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5776603|NCT02867046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5776604|NCT02867046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5776605|NCT02867020|Prednisone|prednisone|mesh-list
5776606|NCT02867020|Goserelin|goserelin|mesh-list
5776607|NCT02867020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5776608|NCT02867020|Glucocorticoids|glucocorticoids|mesh-ancestor
5776609|NCT02867020|Hormones|hormones|mesh-ancestor
5776610|NCT02867020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5776611|NCT02867020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776612|NCT02867020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5776613|NCT02867020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5776614|NCT02867007|Mogamulizumab|mogamulizumab|mesh-list
5776615|NCT02867007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5776616|NCT02866955|Tamoxifen|tamoxifen|mesh-list
5776617|NCT02866955|Estramustine|estramustine|mesh-list
5776618|NCT02866955|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5776619|NCT02866955|Hormone Antagonists|hormone antagonists|mesh-ancestor
5776620|NCT02866955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5776621|NCT02866955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776622|NCT02866955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5776623|NCT02866955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5776624|NCT02866955|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5776625|NCT02866955|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5776626|NCT02866955|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5776627|NCT02866955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5776628|NCT02866955|Alkylating Agents|alkylating agents|mesh-ancestor
5776629|NCT02866955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5776630|NCT02866786|Metformin|metformin|mesh-list
5776631|NCT02866786|Cyproterone Acetate|cyproterone acetate|mesh-list
5776632|NCT02866786|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5776633|NCT02866786|Estradiol|estradiol|mesh-list
6490752|NCT00599898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6490753|NCT00599911|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6496394|NCT00627887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5776634|NCT02866786|Cyproterone|cyproterone|mesh-list
5776635|NCT02866786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5776636|NCT02866786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776637|NCT02866786|Estrogens|estrogens|mesh-ancestor
5776638|NCT02866786|Hormones|hormones|mesh-ancestor
5776639|NCT02866786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5776640|NCT02866786|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5776641|NCT02866786|Contraceptive Agents|contraceptive agents|mesh-ancestor
5776642|NCT02866786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5776643|NCT02866786|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5776644|NCT02866786|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5776645|NCT02866786|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5776646|NCT02866786|Androgen Antagonists|androgen antagonists|mesh-ancestor
5776647|NCT02866786|Hormone Antagonists|hormone antagonists|mesh-ancestor
5776648|NCT02866786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5776649|NCT02866786|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5776650|NCT02866409|Dexmedetomidine|dexmedetomidine|mesh-list
5776651|NCT02866409|Bupivacaine|bupivacaine|mesh-list
5776652|NCT02866409|Anesthetics, Local|anesthetics, local|mesh-ancestor
5776653|NCT02866409|Anesthetics|anesthetics|mesh-ancestor
5776654|NCT02866409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5776655|NCT02866409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776656|NCT02866409|Sensory System Agents|sensory system agents|mesh-ancestor
5776657|NCT02866409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5776658|NCT02866409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5776659|NCT02866409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5776660|NCT02866409|Analgesics|analgesics|mesh-ancestor
5776661|NCT02866409|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5776662|NCT02866409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5776663|NCT02866409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5776664|NCT02866409|Adrenergic Agents|adrenergic agents|mesh-ancestor
5776665|NCT02866409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5776666|NCT02866409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5776667|NCT02866214|Febuxostat|febuxostat|mesh-list
5776668|NCT02866214|Gout Suppressants|gout suppressants|mesh-ancestor
5776669|NCT02866214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5776670|NCT02866448|Aspirin|aspirin|mesh-list
5776671|NCT02866448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5776672|NCT02866448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5776673|NCT02866448|Analgesics|analgesics|mesh-ancestor
5776674|NCT02866448|Sensory System Agents|sensory system agents|mesh-ancestor
5776675|NCT02866448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5776676|NCT02866448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776677|NCT02866448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5776678|NCT02866448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5776679|NCT02866448|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5776680|NCT02866448|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5776681|NCT02866448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5776682|NCT02866448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5776683|NCT02866448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5776684|NCT02866448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5776685|NCT02866448|Antipyretics|antipyretics|mesh-ancestor
5776686|NCT02866435|Potassium phosphate|potassium phosphate|mesh-list
5776687|NCT02866435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776688|NCT02866435|Cariostatic Agents|cariostatic agents|mesh-ancestor
5776689|NCT02866435|Protective Agents|protective agents|mesh-ancestor
5776690|NCT02866383|Nivolumab|nivolumab|mesh-list
5776691|NCT02866383|Ipilimumab|ipilimumab|mesh-list
5776692|NCT02866383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5776693|NCT02866383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5776694|NCT02866383|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5776695|NCT02866383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5776696|NCT02866370|Paclitaxel|paclitaxel|mesh-list
5776697|NCT02866370|Carboplatin|carboplatin|mesh-list
5776698|NCT02866370|Doxorubicin|doxorubicin|mesh-list
5776699|NCT02866370|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5776700|NCT02866370|Topotecan|topotecan|mesh-list
5776701|NCT02866370|Nintedanib|nintedanib|mesh-list
5776702|NCT02866370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5776703|NCT02866370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5776704|NCT02866370|Tubulin Modulators|tubulin modulators|mesh-ancestor
5776705|NCT02866370|Antimitotic Agents|antimitotic agents|mesh-ancestor
5776706|NCT02866370|Mitosis Modulators|mitosis modulators|mesh-ancestor
5776707|NCT02866370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5776708|NCT02866370|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5776709|NCT02866370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5776710|NCT02866370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5776711|NCT02866370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5776712|NCT02866370|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5776713|NCT02866370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5897407|NCT00840177|Antiviral Agents|antiviral agents|mesh-ancestor
5897408|NCT00840177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5897409|NCT00840177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5897410|NCT00840177|Immunologic Factors|immunologic factors|mesh-ancestor
5897411|NCT00840177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897412|NCT00840177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5897413|NCT00840177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5897414|NCT00840177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5897415|NCT00840177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5897416|NCT00840177|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5897417|NCT00840177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5897418|NCT00840177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5897419|NCT00840177|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5897420|NCT00820950|Betamethasone|betamethasone|mesh-list
5897421|NCT00820950|Betamethasone Valerate|betamethasone valerate|mesh-list
5897422|NCT00820950|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5897423|NCT00820950|Betamethasone benzoate|betamethasone benzoate|mesh-list
5897424|NCT00820950|Calcipotriene|calcipotriene|mesh-list
5897425|NCT00820950|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
5897426|NCT00820950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5897427|NCT00820950|Glucocorticoids|glucocorticoids|mesh-ancestor
5897428|NCT00820950|Hormones|hormones|mesh-ancestor
5897429|NCT00820950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5897430|NCT00820950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897431|NCT00820950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5897432|NCT00820950|Respiratory System Agents|respiratory system agents|mesh-ancestor
5897433|NCT00820950|Dermatologic Agents|dermatologic agents|mesh-ancestor
5897434|NCT00806416|Vitamin D|vitamin d|mesh-list
5897435|NCT00806416|Cholecalciferol|cholecalciferol|mesh-list
5897436|NCT00806416|Alendronate|alendronate|mesh-list
5897437|NCT00806416|Vitamins|vitamins|mesh-ancestor
5897438|NCT00806416|Micronutrients|micronutrients|mesh-ancestor
5897439|NCT00806416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897440|NCT00806416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5897441|NCT00806416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5907968|NCT04992065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907969|NCT04992065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5907970|NCT04988308|Adalimumab|adalimumab|mesh-list
5907971|NCT04988308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5907972|NCT04988308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5907973|NCT04986852|Pembrolizumab|pembrolizumab|mesh-list
5907974|NCT04986852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5907975|NCT04986852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5907976|NCT04979442|Trabectedin|trabectedin|mesh-list
5907977|NCT04979442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5907978|NCT04979442|Alkylating Agents|alkylating agents|mesh-ancestor
5907979|NCT04979442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907980|NCT04979442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5908773|NCT04128696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5908774|NCT04128696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5908775|NCT04126135|Nicotine|nicotine|mesh-list
5908776|NCT04126135|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5908777|NCT04126135|Autonomic Agents|autonomic agents|mesh-ancestor
5908778|NCT04126135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5908779|NCT04126135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5908780|NCT04126135|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5908781|NCT04126135|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5908782|NCT04126135|Cholinergic Agents|cholinergic agents|mesh-ancestor
5908783|NCT04126135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5908784|NCT04126135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908785|NCT04115319|Quetiapine Fumarate|quetiapine fumarate|mesh-list
5908786|NCT04115319|Antidepressive Agents|antidepressive agents|mesh-ancestor
5908787|NCT04115319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5908788|NCT04115319|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5776714|NCT02866253|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
5776715|NCT02866253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5776716|NCT02866253|Immunologic Factors|immunologic factors|mesh-ancestor
5776717|NCT02866253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776718|NCT02866396|Pregabalin|pregabalin|mesh-list
5776719|NCT02866396|Analgesics|analgesics|mesh-ancestor
5776720|NCT02866396|Sensory System Agents|sensory system agents|mesh-ancestor
5776721|NCT02866396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5776722|NCT02866396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776723|NCT02866396|Anticonvulsants|anticonvulsants|mesh-ancestor
5776724|NCT02866396|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5776725|NCT02866396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5776726|NCT02866396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5776727|NCT02866396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5776728|NCT02866396|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5776729|NCT02866396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5776730|NCT02866396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5776731|NCT02866396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5776732|NCT02866136|Carboplatin|carboplatin|mesh-list
5776733|NCT02866136|Etoposide|etoposide|mesh-list
5776734|NCT02866136|Etoposide phosphate|etoposide phosphate|mesh-list
5776735|NCT02866136|Melphalan|melphalan|mesh-list
5776736|NCT02866136|Vincristine|vincristine|mesh-list
5776737|NCT02866136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5776738|NCT02866136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5776739|NCT02866136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5776740|NCT02866136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5776741|NCT02866136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5776742|NCT02866136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5776743|NCT02866136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5776744|NCT02866136|Alkylating Agents|alkylating agents|mesh-ancestor
5776745|NCT02866136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5776746|NCT02866136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5776747|NCT02866136|Immunologic Factors|immunologic factors|mesh-ancestor
5776748|NCT02866136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776749|NCT02866136|Tubulin Modulators|tubulin modulators|mesh-ancestor
5776750|NCT02866136|Antimitotic Agents|antimitotic agents|mesh-ancestor
5776751|NCT02866136|Mitosis Modulators|mitosis modulators|mesh-ancestor
5776752|NCT02865824|Aspirin|aspirin|mesh-list
5776753|NCT02865824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5776754|NCT02865824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5776755|NCT02865824|Analgesics|analgesics|mesh-ancestor
5776756|NCT02865824|Sensory System Agents|sensory system agents|mesh-ancestor
5776757|NCT02865824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5776758|NCT02865824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776759|NCT02865824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5776760|NCT02865824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5776761|NCT02865824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5776762|NCT02865824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5776763|NCT02865824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5776764|NCT02865824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5776765|NCT02865824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5776766|NCT02865824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5776767|NCT02865824|Antipyretics|antipyretics|mesh-ancestor
5776768|NCT02865980|Povidone-Iodine|povidone-iodine|mesh-list
5776769|NCT02865980|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5776770|NCT02865980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5776771|NCT02865785|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
5776772|NCT02865785|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
5776773|NCT02865785|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5776774|NCT02865785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5776775|NCT02866032|Ciclopirox|ciclopirox|mesh-list
5776776|NCT02866032|Antifungal Agents|antifungal agents|mesh-ancestor
5776777|NCT02866032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5776778|NCT02866006|Topotecan|topotecan|mesh-list
5776779|NCT02866006|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5776780|NCT02866006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5776781|NCT02866006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5776782|NCT02866006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5776783|NCT02866006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5776784|NCT02865993|Povidone-Iodine|povidone-iodine|mesh-list
5776785|NCT02865993|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5776786|NCT02865993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5776787|NCT02866071|Ketamine|ketamine|mesh-list
5776788|NCT02866071|Analgesics|analgesics|mesh-ancestor
5776789|NCT02866071|Sensory System Agents|sensory system agents|mesh-ancestor
5776790|NCT02866071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5776791|NCT02866071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776792|NCT02866071|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5776793|NCT02866071|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5776794|NCT02866071|Anesthetics, General|anesthetics, general|mesh-ancestor
5776795|NCT02866071|Anesthetics|anesthetics|mesh-ancestor
5776796|NCT02866071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5776797|NCT02866071|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5776798|NCT02866071|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5776799|NCT02866071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5776800|NCT02866071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5776801|NCT02865733|Treprostinil|treprostinil|mesh-list
5776802|NCT02865733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5776803|NCT02865629|Acetylcysteine|acetylcysteine|mesh-list
5776804|NCT02865629|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5776805|NCT02865629|Antiviral Agents|antiviral agents|mesh-ancestor
5776806|NCT02865629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5776807|NCT02865629|Expectorants|expectorants|mesh-ancestor
5776808|NCT02865629|Respiratory System Agents|respiratory system agents|mesh-ancestor
5776809|NCT02865629|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5776810|NCT02865629|Antioxidants|antioxidants|mesh-ancestor
5776811|NCT02865629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5776812|NCT02865629|Protective Agents|protective agents|mesh-ancestor
5776813|NCT02865629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776814|NCT02865629|Antidotes|antidotes|mesh-ancestor
5776815|NCT02865681|Letrozole|letrozole|mesh-list
5776816|NCT02865681|Clomiphene|clomiphene|mesh-list
5776817|NCT02865681|Enclomiphene|enclomiphene|mesh-list
5776818|NCT02865681|Zuclomiphene|zuclomiphene|mesh-list
5776819|NCT02865681|Menotropins|menotropins|mesh-list
5776820|NCT02865681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5776821|NCT02865681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5776822|NCT02865681|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5776823|NCT02865681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5776824|NCT02865681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5776825|NCT02865681|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5776826|NCT02865681|Hormone Antagonists|hormone antagonists|mesh-ancestor
5776827|NCT02865681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5776828|NCT02865681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776829|NCT02865681|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5776830|NCT02865681|Fertility Agents|fertility agents|mesh-ancestor
5776831|NCT02865681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5776832|NCT02865681|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5776833|NCT02865681|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5776834|NCT02865642|Citalopram|citalopram|mesh-list
5776835|NCT02865642|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
5776836|NCT02865642|Serotonin|serotonin|mesh-list
5776837|NCT02865642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5776838|NCT02865642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5776839|NCT02865642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5776840|NCT02865642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5776841|NCT02865642|Serotonin Agents|serotonin agents|mesh-ancestor
5776842|NCT02865642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776843|NCT02865642|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5776844|NCT02865642|Antidepressive Agents|antidepressive agents|mesh-ancestor
5776845|NCT02865642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5776846|NCT02865642|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5776847|NCT02865668|Metformin|metformin|mesh-list
5776848|NCT02865668|Canagliflozin|canagliflozin|mesh-list
5776849|NCT02865668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5776850|NCT02865668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776851|NCT02865668|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5776852|NCT02865668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5776853|NCT02865564|Gentamicins|gentamicins|mesh-list
5776854|NCT02865564|Ampicillin|ampicillin|mesh-list
5776855|NCT02865564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5776856|NCT02865564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5776857|NCT02865564|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5776858|NCT02865564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5776859|NCT02865564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5776860|NCT02865473|Pilocarpine|pilocarpine|mesh-list
5776861|NCT02865473|Miotics|miotics|mesh-ancestor
5776862|NCT02865473|Autonomic Agents|autonomic agents|mesh-ancestor
5897442|NCT00748904|Rifaximin|rifaximin|mesh-list
5776863|NCT02865473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5776864|NCT02865473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776865|NCT02865473|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
5776866|NCT02865473|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5776867|NCT02865473|Cholinergic Agents|cholinergic agents|mesh-ancestor
5776868|NCT02865473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5776869|NCT02865473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5776870|NCT02865551|Anesthetics|anesthetics|mesh-list
5776871|NCT02865551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5776872|NCT02865551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776873|NCT02865616|Vancomycin|vancomycin|mesh-list
5776874|NCT02865616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5776875|NCT02865616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5776876|NCT02865460|Coenzyme Q10|coenzyme q10|mesh-list
5776877|NCT02865460|Micronutrients|micronutrients|mesh-ancestor
5776878|NCT02865460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776879|NCT02865460|Vitamins|vitamins|mesh-ancestor
5776880|NCT02865369|Asunaprevir|asunaprevir|mesh-list
5776881|NCT02865369|Protease Inhibitors|protease inhibitors|mesh-ancestor
5776882|NCT02865369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5776883|NCT02865369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210273|NCT02158520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210274|NCT02158520|Growth Inhibitors|growth inhibitors|mesh-ancestor
6210275|NCT02158520|Immunologic Factors|immunologic factors|mesh-ancestor
6210276|NCT02158520|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6210277|NCT02158533|Naltrexone|naltrexone|mesh-list
6210278|NCT02158533|Buprenorphine|buprenorphine|mesh-list
6210279|NCT02158533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6210280|NCT02158533|Narcotics|narcotics|mesh-ancestor
6210281|NCT02158533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6210282|NCT02158533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210283|NCT02158533|Analgesics|analgesics|mesh-ancestor
5776884|NCT02865356|Cyclosporine|cyclosporine|mesh-list
5776885|NCT02865356|Cyclosporins|cyclosporins|mesh-list
5776886|NCT02865356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5776887|NCT02865356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5776888|NCT02865356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5776889|NCT02865356|Immunologic Factors|immunologic factors|mesh-ancestor
5776890|NCT02865356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776891|NCT02865356|Antifungal Agents|antifungal agents|mesh-ancestor
5776892|NCT02865356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5776893|NCT02865356|Dermatologic Agents|dermatologic agents|mesh-ancestor
5776894|NCT02865356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5776895|NCT02865356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5776896|NCT02865304|Endostar protein|endostar protein|mesh-list
5776897|NCT02865304|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5776898|NCT02865304|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5776899|NCT02865304|Growth Substances|growth substances|mesh-ancestor
5776900|NCT02865304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776901|NCT02865304|Growth Inhibitors|growth inhibitors|mesh-ancestor
5776902|NCT02865304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5776903|NCT02865174|Heparin|heparin|mesh-list
5776904|NCT02865174|Enoxaparin|enoxaparin|mesh-list
5776905|NCT02865174|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5776906|NCT02865174|Tinzaparin|tinzaparin|mesh-list
5776907|NCT02865174|Dalteparin|dalteparin|mesh-list
5776908|NCT02865174|Tranylcypromine|tranylcypromine|mesh-list
5776909|NCT02865174|Tranexamic Acid|tranexamic acid|mesh-list
5776910|NCT02865174|Thrombin|thrombin|mesh-list
5776911|NCT02865174|Anticoagulants|anticoagulants|mesh-ancestor
5776912|NCT02865174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5776913|NCT02865174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5776914|NCT02865174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5776915|NCT02865174|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5776916|NCT02865174|Hemostatics|hemostatics|mesh-ancestor
5776917|NCT02865174|Coagulants|coagulants|mesh-ancestor
5776918|NCT02865174|Antidepressive Agents|antidepressive agents|mesh-ancestor
5776919|NCT02865174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5776920|NCT02865174|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
5776921|NCT02865174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5776922|NCT02865174|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5776923|NCT02865174|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5776924|NCT02865174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5776925|NCT02865174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776926|NCT02865005|Dapsone|dapsone|mesh-list
5776927|NCT02865005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5776928|NCT02865005|Antimalarials|antimalarials|mesh-ancestor
6210284|NCT02158533|Sensory System Agents|sensory system agents|mesh-ancestor
5776929|NCT02865005|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5776930|NCT02865005|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5776931|NCT02865005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5776932|NCT02865005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5776933|NCT02865005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5776934|NCT02865005|Leprostatic Agents|leprostatic agents|mesh-ancestor
5776935|NCT02865005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5776936|NCT02864927|Vaccines|vaccines|mesh-list
5776937|NCT02864927|Immunologic Factors|immunologic factors|mesh-ancestor
5776938|NCT02864927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776939|NCT02864849|Capecitabine|capecitabine|mesh-list
5776940|NCT02864849|Oxaliplatin|oxaliplatin|mesh-list
5776941|NCT02864849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5776942|NCT02864849|Antimetabolites|antimetabolites|mesh-ancestor
5776943|NCT02864849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5776944|NCT02864849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5776945|NCT02865018|Cetirizine|cetirizine|mesh-list
5776946|NCT02865018|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5776947|NCT02865018|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5776948|NCT02865018|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5776949|NCT02865018|Histamine Antagonists|histamine antagonists|mesh-ancestor
5776950|NCT02865018|Histamine Agents|histamine agents|mesh-ancestor
5776951|NCT02865018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5776952|NCT02865018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5776953|NCT02865018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776954|NCT02864758|Vitamin K|vitamin k|mesh-list
5776955|NCT02864758|Rivaroxaban|rivaroxaban|mesh-list
5776956|NCT02864758|Dabigatran|dabigatran|mesh-list
5776957|NCT02864758|Vitamins|vitamins|mesh-ancestor
5776958|NCT02864758|Micronutrients|micronutrients|mesh-ancestor
5776959|NCT02864758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776960|NCT02864758|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5776961|NCT02864758|Antithrombins|antithrombins|mesh-ancestor
5776962|NCT02864758|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5776963|NCT02864758|Protease Inhibitors|protease inhibitors|mesh-ancestor
5776964|NCT02864758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5776965|NCT02864758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5776966|NCT02864758|Anticoagulants|anticoagulants|mesh-ancestor
5776967|NCT02864758|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5776968|NCT02864758|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5776969|NCT02864758|Hemostatics|hemostatics|mesh-ancestor
5776970|NCT02864758|Coagulants|coagulants|mesh-ancestor
5776971|NCT02864784|Calcium Carbonate|calcium carbonate|mesh-list
5776972|NCT02864784|Calcium|calcium|mesh-list
5776973|NCT02864784|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5776974|NCT02864784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776975|NCT02864784|Antacids|antacids|mesh-ancestor
5776976|NCT02864784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5776977|NCT02864784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5897443|NCT00748904|Lactulose|lactulose|mesh-list
5897444|NCT00748904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5897445|NCT00748904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5897446|NCT00748904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5897447|NCT00729651|Cholecalciferol|cholecalciferol|mesh-list
5897448|NCT00729651|Alendronate|alendronate|mesh-list
5897449|NCT00729651|Calcium|calcium|mesh-list
5897450|NCT00729651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5897451|NCT00729651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897452|NCT00729651|Vitamins|vitamins|mesh-ancestor
5897453|NCT00729651|Micronutrients|micronutrients|mesh-ancestor
5897454|NCT00729651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5897455|NCT00698815|Pemetrexed|pemetrexed|mesh-list
5897456|NCT00698815|Sunitinib|sunitinib|mesh-list
5897457|NCT00698815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5897458|NCT00698815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5897459|NCT00698815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897460|NCT00698815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5897461|NCT00698815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5897462|NCT00698815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5897463|NCT00698815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5897464|NCT00698815|Growth Substances|growth substances|mesh-ancestor
5897465|NCT00698815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897466|NCT00698815|Growth Inhibitors|growth inhibitors|mesh-ancestor
5897467|NCT00698815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5897468|NCT00698022|Risperidone|risperidone|mesh-list
5897469|NCT00698022|Mifepristone|mifepristone|mesh-list
5897470|NCT00698022|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5776978|NCT02864602|Dexamethasone|dexamethasone|mesh-list
5776979|NCT02864602|Dexamethasone acetate|dexamethasone acetate|mesh-list
5776980|NCT02864602|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
5776981|NCT02864602|BB 1101|bb 1101|mesh-list
5776982|NCT02864602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5776983|NCT02864602|Antiemetics|antiemetics|mesh-ancestor
5776984|NCT02864602|Autonomic Agents|autonomic agents|mesh-ancestor
5776985|NCT02864602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5776986|NCT02864602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5776987|NCT02864602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5776988|NCT02864602|Glucocorticoids|glucocorticoids|mesh-ancestor
5776989|NCT02864602|Hormones|hormones|mesh-ancestor
5776990|NCT02864602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5776991|NCT02864602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5776992|NCT02864602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5776993|NCT02864602|Protease Inhibitors|protease inhibitors|mesh-ancestor
5776994|NCT02864602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5776995|NCT02864602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5776996|NCT02864472|Ranibizumab|ranibizumab|mesh-list
5776997|NCT02864472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5776998|NCT02864472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5776999|NCT02864472|Growth Substances|growth substances|mesh-ancestor
5777000|NCT02864472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777001|NCT02864472|Growth Inhibitors|growth inhibitors|mesh-ancestor
5777002|NCT02864472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5777003|NCT02864550|Doxycycline|doxycycline|mesh-list
5777004|NCT02864550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5777005|NCT02864550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5777006|NCT02864550|Antimalarials|antimalarials|mesh-ancestor
5777007|NCT02864550|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5777008|NCT02864550|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5777009|NCT02864264|Interferons|interferons|mesh-list
5777010|NCT02864264|Interferon-gamma|interferon-gamma|mesh-list
5777011|NCT02864264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5777012|NCT02864264|Antiviral Agents|antiviral agents|mesh-ancestor
5777013|NCT02864264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5777014|NCT02864199|Ribavirin|ribavirin|mesh-list
5777015|NCT02864199|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5777016|NCT02864199|Antimetabolites|antimetabolites|mesh-ancestor
5777017|NCT02864199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777018|NCT02864199|Antiviral Agents|antiviral agents|mesh-ancestor
5777019|NCT02864199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5777020|NCT02863861|Dexmedetomidine|dexmedetomidine|mesh-list
5777021|NCT02863861|Ketamine|ketamine|mesh-list
5777022|NCT02863861|Propofol|propofol|mesh-list
5777023|NCT02863861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5777024|NCT02863861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5777025|NCT02863861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777026|NCT02863861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5777027|NCT02863861|Anesthetics, General|anesthetics, general|mesh-ancestor
5777028|NCT02863861|Anesthetics|anesthetics|mesh-ancestor
5777029|NCT02863861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5777030|NCT02863861|Analgesics|analgesics|mesh-ancestor
5777031|NCT02863861|Sensory System Agents|sensory system agents|mesh-ancestor
5777032|NCT02863861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5777033|NCT02863861|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5777034|NCT02863861|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5777035|NCT02863861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5777036|NCT02863861|Adrenergic Agents|adrenergic agents|mesh-ancestor
5777037|NCT02863861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5777038|NCT02863861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777039|NCT02863861|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5777040|NCT02863861|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5777041|NCT02863861|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5777042|NCT02864147|Imiquimod|imiquimod|mesh-list
5777043|NCT02864147|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5777044|NCT02864147|Immunologic Factors|immunologic factors|mesh-ancestor
5777045|NCT02864147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777046|NCT02864147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5777047|NCT02864147|Interferon Inducers|interferon inducers|mesh-ancestor
5777048|NCT02864095|Epinephrine|epinephrine|mesh-list
5777049|NCT02864095|Tranexamic Acid|tranexamic acid|mesh-list
5777050|NCT02864095|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5777051|NCT02864095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5777052|NCT02864095|Adrenergic Agents|adrenergic agents|mesh-ancestor
5777053|NCT02864095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5777054|NCT02864095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777055|NCT02864095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777056|NCT02864095|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5777057|NCT02864095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5777058|NCT02864095|Autonomic Agents|autonomic agents|mesh-ancestor
5777059|NCT02864095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5777060|NCT02864095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5777061|NCT02864095|Respiratory System Agents|respiratory system agents|mesh-ancestor
5777062|NCT02864095|Mydriatics|mydriatics|mesh-ancestor
5777063|NCT02864095|Sympathomimetics|sympathomimetics|mesh-ancestor
5777064|NCT02864095|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5777065|NCT02864095|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5777066|NCT02864095|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5777067|NCT02864095|Hemostatics|hemostatics|mesh-ancestor
5777068|NCT02864095|Coagulants|coagulants|mesh-ancestor
5777069|NCT02863835|Albuterol|albuterol|mesh-list
5777070|NCT02863835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5777071|NCT02863835|Autonomic Agents|autonomic agents|mesh-ancestor
5777072|NCT02863835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6673587|NCT01563835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6673588|NCT01563835|Narcotics|narcotics|mesh-ancestor
6673589|NCT01563835|Analgesics|analgesics|mesh-ancestor
6673590|NCT01563835|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6673591|NCT01563835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6673592|NCT01563835|Anesthetics, General|anesthetics, general|mesh-ancestor
5777073|NCT02863835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777074|NCT02863835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5777075|NCT02863835|Respiratory System Agents|respiratory system agents|mesh-ancestor
5777076|NCT02863835|Tocolytic Agents|tocolytic agents|mesh-ancestor
5777077|NCT02863835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5777078|NCT02863835|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5777079|NCT02863835|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5777080|NCT02863835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5777081|NCT02863835|Adrenergic Agents|adrenergic agents|mesh-ancestor
5777082|NCT02863835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5777083|NCT02863835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777084|NCT02863913|Cyclophosphamide|cyclophosphamide|mesh-list
5777085|NCT02863913|Interleukin-2|interleukin-2|mesh-list
5777086|NCT02863913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5777087|NCT02863913|Immunologic Factors|immunologic factors|mesh-ancestor
5777088|NCT02863913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777089|NCT02863913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5777090|NCT02863913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5777091|NCT02863913|Alkylating Agents|alkylating agents|mesh-ancestor
5777092|NCT02863913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777093|NCT02863913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5777094|NCT02863913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5777095|NCT02863913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5777096|NCT02863913|Analgesics|analgesics|mesh-ancestor
5777097|NCT02863913|Sensory System Agents|sensory system agents|mesh-ancestor
5777098|NCT02863913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5777099|NCT02863614|Ibuprofen|ibuprofen|mesh-list
5777100|NCT02863614|Lorazepam|lorazepam|mesh-list
5777101|NCT02863614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5777102|NCT02863614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5777103|NCT02863614|Analgesics|analgesics|mesh-ancestor
5777104|NCT02863614|Sensory System Agents|sensory system agents|mesh-ancestor
5777105|NCT02863614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5777106|NCT02863614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777107|NCT02863614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5777108|NCT02863614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5777109|NCT02863614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5777110|NCT02863614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5777111|NCT02863614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777112|NCT02863614|Anticonvulsants|anticonvulsants|mesh-ancestor
5777113|NCT02863614|Antiemetics|antiemetics|mesh-ancestor
5777114|NCT02863614|Autonomic Agents|autonomic agents|mesh-ancestor
5777115|NCT02863614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5777116|NCT02863614|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5777117|NCT02863614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5777118|NCT02863614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5777119|NCT02863614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5777120|NCT02863614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5777121|NCT02863614|GABA Modulators|gaba modulators|mesh-ancestor
5777122|NCT02863614|GABA Agents|gaba agents|mesh-ancestor
5777123|NCT02863614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5777124|NCT02863809|Riboflavin|riboflavin|mesh-list
5777125|NCT02863809|Dextrans|dextrans|mesh-list
5777126|NCT02863809|Vitamins|vitamins|mesh-ancestor
5777127|NCT02863809|Micronutrients|micronutrients|mesh-ancestor
5777128|NCT02863809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777129|NCT02863809|Vitamin B Complex|vitamin b complex|mesh-ancestor
5777130|NCT02863809|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5777131|NCT02863809|Dermatologic Agents|dermatologic agents|mesh-ancestor
5777132|NCT02863809|Anticoagulants|anticoagulants|mesh-ancestor
5777133|NCT02863809|Plasma Substitutes|plasma substitutes|mesh-ancestor
5777134|NCT02863809|Blood Substitutes|blood substitutes|mesh-ancestor
5777135|NCT02863367|Gemcitabine|gemcitabine|mesh-list
5777136|NCT02863367|Apatinib|apatinib|mesh-list
5777137|NCT02863367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5777138|NCT02863367|Antimetabolites|antimetabolites|mesh-ancestor
5777139|NCT02863367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777140|NCT02863367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5777141|NCT02863367|Antiviral Agents|antiviral agents|mesh-ancestor
5777142|NCT02863367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5777143|NCT02863367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6490754|NCT00599911|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6490755|NCT00599911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6490756|NCT00599911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6490757|NCT00599911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490758|NCT00599911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6490759|NCT00599911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490760|NCT00599911|Analgesics|analgesics|mesh-ancestor
6490761|NCT00599911|Sensory System Agents|sensory system agents|mesh-ancestor
6490762|NCT00599911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6490763|NCT00599911|Antidepressive Agents|antidepressive agents|mesh-ancestor
6490764|NCT00599911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5777144|NCT02863367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5777145|NCT02863367|Immunologic Factors|immunologic factors|mesh-ancestor
5777146|NCT02863367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777147|NCT02863367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5777148|NCT02863679|Tetracaine|tetracaine|mesh-list
5777149|NCT02863679|Anesthetics, Local|anesthetics, local|mesh-ancestor
5777150|NCT02863679|Anesthetics|anesthetics|mesh-ancestor
5777151|NCT02863679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5777152|NCT02863679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777153|NCT02863679|Sensory System Agents|sensory system agents|mesh-ancestor
5777154|NCT02863679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5777155|NCT02863705|Timolol|timolol|mesh-list
5777156|NCT02863705|Brimonidine Tartrate|brimonidine tartrate|mesh-list
5777157|NCT02863705|Bimatoprost|bimatoprost|mesh-list
5777158|NCT02863705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5777159|NCT02863705|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5777160|NCT02863705|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5777161|NCT02863705|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5777162|NCT02863705|Adrenergic Agents|adrenergic agents|mesh-ancestor
5777163|NCT02863705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5777164|NCT02863705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777165|NCT02863705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777166|NCT02863705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5777167|NCT02863705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5777168|NCT02863705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5777169|NCT02863705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5777170|NCT02863705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5777171|NCT02863471|Gemcitabine|gemcitabine|mesh-list
5777172|NCT02863471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5777173|NCT02863471|Antimetabolites|antimetabolites|mesh-ancestor
5777174|NCT02863471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777175|NCT02863471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5777176|NCT02863471|Antiviral Agents|antiviral agents|mesh-ancestor
5777177|NCT02863471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5777178|NCT02863471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5777179|NCT02863471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5777180|NCT02863471|Immunologic Factors|immunologic factors|mesh-ancestor
5777181|NCT02863471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777182|NCT02863276|Insulin|insulin|mesh-list
5777183|NCT02863276|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5777184|NCT02863276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5777185|NCT02863276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777186|NCT02863055|Nintedanib|nintedanib|mesh-list
5777187|NCT02863055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5777188|NCT02863055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5777189|NCT02863055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5777190|NCT02863055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777191|NCT02862977|Ketoprofen|ketoprofen|mesh-list
5777192|NCT02862977|Amitriptyline|amitriptyline|mesh-list
5777193|NCT02862977|Cyclobenzaprine|cyclobenzaprine|mesh-list
5777194|NCT02862977|Caffeine|caffeine|mesh-list
5777195|NCT02862977|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5777196|NCT02862977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777197|NCT02862977|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5777198|NCT02862977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5777199|NCT02862977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777200|NCT02862977|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5777201|NCT02862977|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5777202|NCT02862977|Purinergic Agents|purinergic agents|mesh-ancestor
5777203|NCT02862977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5777204|NCT02862977|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5777205|NCT02862977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5777206|NCT02862977|Analgesics|analgesics|mesh-ancestor
5777207|NCT02862977|Sensory System Agents|sensory system agents|mesh-ancestor
5777208|NCT02862977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5777209|NCT02862977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5777210|NCT02862977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5777211|NCT02862977|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5777212|NCT02862977|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5777213|NCT02862977|Antidepressive Agents|antidepressive agents|mesh-ancestor
5777214|NCT02862977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5777215|NCT02862977|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5777216|NCT02862977|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5777217|NCT02862977|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5777218|NCT02862977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5777219|NCT02862977|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5777220|NCT02862977|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5777221|NCT02862977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5777222|NCT02862977|Adrenergic Agents|adrenergic agents|mesh-ancestor
5777223|NCT02863120|Bupivacaine|bupivacaine|mesh-list
5777224|NCT02863120|Ropivacaine|ropivacaine|mesh-list
5777225|NCT02863120|Anesthetics, Local|anesthetics, local|mesh-ancestor
5777226|NCT02863120|Anesthetics|anesthetics|mesh-ancestor
5777227|NCT02863120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5777228|NCT02863120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777229|NCT02863120|Sensory System Agents|sensory system agents|mesh-ancestor
5777230|NCT02863120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5897471|NCT00698022|Serotonin Agents|serotonin agents|mesh-ancestor
5897472|NCT00698022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5897473|NCT00698022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897474|NCT00698022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897475|NCT00698022|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5897476|NCT00698022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5897477|NCT00698022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5897478|NCT00698022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5897479|NCT00698022|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5897480|NCT00698022|Dopamine Agents|dopamine agents|mesh-ancestor
5897481|NCT00698022|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5897482|NCT00698022|Abortifacient Agents|abortifacient agents|mesh-ancestor
5897483|NCT00698022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5897484|NCT00698022|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5897485|NCT00698022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6490765|NCT00599911|Dopamine Agents|dopamine agents|mesh-ancestor
6490766|NCT00599937|Tretinoin|tretinoin|mesh-list
6490767|NCT00599937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6490768|NCT00599937|Keratolytic Agents|keratolytic agents|mesh-ancestor
6490769|NCT00599937|Dermatologic Agents|dermatologic agents|mesh-ancestor
6490770|NCT00599950|Mitomycins|mitomycins|mesh-list
6490771|NCT00599950|Mitomycin|mitomycin|mesh-list
5897486|NCT00698022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5897487|NCT00698022|Contraceptive Agents|contraceptive agents|mesh-ancestor
5897488|NCT00698022|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5897489|NCT00698022|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5897490|NCT00698022|Hormone Antagonists|hormone antagonists|mesh-ancestor
5897491|NCT00698022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5897492|NCT00698022|Luteolytic Agents|luteolytic agents|mesh-ancestor
6490772|NCT00599950|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6673593|NCT01563835|Anticoagulants|anticoagulants|mesh-ancestor
6490773|NCT00599950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6490774|NCT00599950|Alkylating Agents|alkylating agents|mesh-ancestor
5777231|NCT02863185|Atorvastatin|atorvastatin|mesh-list
5777232|NCT02863185|Pitavastatin|pitavastatin|mesh-list
5777233|NCT02863185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5777234|NCT02863185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5777235|NCT02863185|Antimetabolites|antimetabolites|mesh-ancestor
5777236|NCT02863185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777237|NCT02863185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5777238|NCT02863185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5777239|NCT02863185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5777240|NCT02862665|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
5777241|NCT02862665|Hematinics|hematinics|mesh-ancestor
5777242|NCT02862782|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5777243|NCT02862782|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5777244|NCT02862782|Luteolytic Agents|luteolytic agents|mesh-ancestor
5777245|NCT02862782|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5777246|NCT02862782|Contraceptive Agents|contraceptive agents|mesh-ancestor
5777247|NCT02862782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5777248|NCT02862782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777249|NCT02862782|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5777250|NCT02862782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5777251|NCT02862782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5777252|NCT02862873|Ondansetron|ondansetron|mesh-list
5777253|NCT02862873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5777254|NCT02862873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777255|NCT02862873|Antiemetics|antiemetics|mesh-ancestor
5777256|NCT02862873|Autonomic Agents|autonomic agents|mesh-ancestor
5777257|NCT02862873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5777258|NCT02862873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5777259|NCT02862873|Antipruritics|antipruritics|mesh-ancestor
5777260|NCT02862873|Dermatologic Agents|dermatologic agents|mesh-ancestor
5777261|NCT02862873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5777262|NCT02862873|Serotonin Agents|serotonin agents|mesh-ancestor
5777263|NCT02862873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5777264|NCT02862873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777265|NCT02862873|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5777266|NCT02862873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5777267|NCT02862873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5777268|NCT02862873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5777269|NCT02862691|Acetaminophen|acetaminophen|mesh-list
5777270|NCT02862691|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
5777271|NCT02862691|Oxycodone|oxycodone|mesh-list
5777272|NCT02862691|Analgesics|analgesics|mesh-list
5777273|NCT02862691|Bupivacaine|bupivacaine|mesh-list
5777274|NCT02862691|Anesthetics, Local|anesthetics, local|mesh-list
5777275|NCT02862691|Anesthetics|anesthetics|mesh-list
5777276|NCT02862691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5777277|NCT02862691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777278|NCT02862691|Sensory System Agents|sensory system agents|mesh-ancestor
5777279|NCT02862691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5777280|NCT02862691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5777281|NCT02862691|Antipyretics|antipyretics|mesh-ancestor
5777282|NCT02862691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5777283|NCT02862691|Narcotics|narcotics|mesh-ancestor
5777284|NCT02862691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5777285|NCT02862691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5777286|NCT02862691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5777287|NCT02862769|Lidocaine|lidocaine|mesh-list
5777288|NCT02862769|Anesthetics, Local|anesthetics, local|mesh-ancestor
5777289|NCT02862769|Anesthetics|anesthetics|mesh-ancestor
5777290|NCT02862769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5777291|NCT02862769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777292|NCT02862769|Sensory System Agents|sensory system agents|mesh-ancestor
5777293|NCT02862769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5777294|NCT02862769|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5777295|NCT02862769|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5777296|NCT02862769|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5777297|NCT02862769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5777298|NCT02862769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777299|NCT02862483|Tadalafil|tadalafil|mesh-list
5777300|NCT02862483|Tamsulosin|tamsulosin|mesh-list
5777301|NCT02862483|Vasodilator Agents|vasodilator agents|mesh-ancestor
5777302|NCT02862483|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5777303|NCT02862483|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6496495|NCT00628238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5777304|NCT02862483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5777305|NCT02862483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777306|NCT02862483|Urological Agents|urological agents|mesh-ancestor
5777307|NCT02862483|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5777308|NCT02862483|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5777309|NCT02862483|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5777310|NCT02862483|Adrenergic Agents|adrenergic agents|mesh-ancestor
5777311|NCT02862483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5777312|NCT02862483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777313|NCT02862509|Budesonide|budesonide|mesh-list
5777314|NCT02862509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5777315|NCT02862509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5777316|NCT02862509|Autonomic Agents|autonomic agents|mesh-ancestor
5777317|NCT02862509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5777318|NCT02862509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777319|NCT02862509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5777320|NCT02862509|Respiratory System Agents|respiratory system agents|mesh-ancestor
5777321|NCT02862509|Glucocorticoids|glucocorticoids|mesh-ancestor
5777322|NCT02862509|Hormones|hormones|mesh-ancestor
5777323|NCT02862509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5777324|NCT02862145|Dexamethasone|dexamethasone|mesh-list
5777325|NCT02862145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5777326|NCT02862145|Antiemetics|antiemetics|mesh-ancestor
5777327|NCT02862145|Autonomic Agents|autonomic agents|mesh-ancestor
5777328|NCT02862145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5777329|NCT02862145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777330|NCT02862145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5777331|NCT02862145|Glucocorticoids|glucocorticoids|mesh-ancestor
5777332|NCT02862145|Hormones|hormones|mesh-ancestor
5777333|NCT02862145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5777334|NCT02862145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5777335|NCT02862145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5777336|NCT02862327|Dexamethasone|dexamethasone|mesh-list
5777337|NCT02862327|Dexamethasone acetate|dexamethasone acetate|mesh-list
5777338|NCT02862327|Ropivacaine|ropivacaine|mesh-list
5777339|NCT02862327|BB 1101|bb 1101|mesh-list
5777340|NCT02862327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5777341|NCT02862327|Antiemetics|antiemetics|mesh-ancestor
5777342|NCT02862327|Autonomic Agents|autonomic agents|mesh-ancestor
5777343|NCT02862327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5777344|NCT02862327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777345|NCT02862327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5777346|NCT02862327|Glucocorticoids|glucocorticoids|mesh-ancestor
5777347|NCT02862327|Hormones|hormones|mesh-ancestor
5777348|NCT02862327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5777349|NCT02862327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5777350|NCT02862327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5777351|NCT02862327|Protease Inhibitors|protease inhibitors|mesh-ancestor
5777352|NCT02862327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5777353|NCT02862327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777354|NCT02862327|Anesthetics, Local|anesthetics, local|mesh-ancestor
5777355|NCT02862327|Anesthetics|anesthetics|mesh-ancestor
5777356|NCT02862327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5777357|NCT02862327|Sensory System Agents|sensory system agents|mesh-ancestor
5777358|NCT02862210|Lithium Carbonate|lithium carbonate|mesh-list
5777359|NCT02862210|Antidepressive Agents|antidepressive agents|mesh-ancestor
5777360|NCT02862210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5777361|NCT02862210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5777362|NCT02862210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777363|NCT02862210|Antimanic Agents|antimanic agents|mesh-ancestor
5777364|NCT02862210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5777365|NCT02862210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5777366|NCT02862210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777367|NCT02861950|Bupivacaine|bupivacaine|mesh-list
5777368|NCT02861950|Ropivacaine|ropivacaine|mesh-list
5777369|NCT02861950|Anesthetics, Local|anesthetics, local|mesh-ancestor
5777370|NCT02861950|Anesthetics|anesthetics|mesh-ancestor
5777371|NCT02861950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5777372|NCT02861950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777373|NCT02861950|Sensory System Agents|sensory system agents|mesh-ancestor
5777374|NCT02861950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5777375|NCT02862015|Gemcitabine|gemcitabine|mesh-list
5777376|NCT02862015|Folfirinox|folfirinox|mesh-list
5777377|NCT02862015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5777378|NCT02862015|Antimetabolites|antimetabolites|mesh-ancestor
5777379|NCT02862015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777380|NCT02862015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5777381|NCT02862015|Antiviral Agents|antiviral agents|mesh-ancestor
5777382|NCT02862015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5777383|NCT02862015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5777384|NCT02862015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5777385|NCT02862015|Immunologic Factors|immunologic factors|mesh-ancestor
5777386|NCT02862015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777387|NCT02861976|Analgesics, Opioid|analgesics, opioid|mesh-list
5777388|NCT02861976|Narcotics|narcotics|mesh-ancestor
5777389|NCT02861976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5777390|NCT02861976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777391|NCT02861976|Analgesics|analgesics|mesh-ancestor
5777392|NCT02861976|Sensory System Agents|sensory system agents|mesh-ancestor
5777393|NCT02861976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5777394|NCT02861859|Olanzapine|olanzapine|mesh-list
5777395|NCT02861859|Antiemetics|antiemetics|mesh-ancestor
5777396|NCT02861859|Autonomic Agents|autonomic agents|mesh-ancestor
5777397|NCT02861859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5777398|NCT02861859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777399|NCT02861859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5777400|NCT02861859|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5777401|NCT02861859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5777402|NCT02861859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5777403|NCT02861859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5777404|NCT02861859|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5777405|NCT02861859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5777406|NCT02861859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5777407|NCT02861859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777408|NCT02861859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5777409|NCT02861859|Serotonin Agents|serotonin agents|mesh-ancestor
5777410|NCT02861482|Oxytocin|oxytocin|mesh-list
5777411|NCT02861482|Carboprost tromethamine|carboprost tromethamine|mesh-list
5777412|NCT02861482|Oxytocics|oxytocics|mesh-ancestor
5777413|NCT02861482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5777414|NCT02861482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777415|NCT02861716|Fentanyl|fentanyl|mesh-list
5777416|NCT02861716|Dexmedetomidine|dexmedetomidine|mesh-list
5777417|NCT02861716|Bupivacaine|bupivacaine|mesh-list
5777418|NCT02861716|Anesthetics, Local|anesthetics, local|mesh-ancestor
5777419|NCT02861716|Anesthetics|anesthetics|mesh-ancestor
5777420|NCT02861716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5777421|NCT02861716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777422|NCT02861716|Sensory System Agents|sensory system agents|mesh-ancestor
5777423|NCT02861716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5777424|NCT02861716|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5777425|NCT02861716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5777426|NCT02861716|Analgesics|analgesics|mesh-ancestor
5777427|NCT02861716|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5777428|NCT02861716|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5777429|NCT02861716|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5777430|NCT02861716|Adrenergic Agents|adrenergic agents|mesh-ancestor
5777431|NCT02861716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5777432|NCT02861716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777433|NCT02861716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5777434|NCT02861716|Narcotics|narcotics|mesh-ancestor
5777435|NCT02861716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5777436|NCT02861716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5777437|NCT02861716|Anesthetics, General|anesthetics, general|mesh-ancestor
5777438|NCT02861690|Paclitaxel|paclitaxel|mesh-list
5777439|NCT02861690|Nedaplatin|nedaplatin|mesh-list
5777440|NCT02861690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5777441|NCT02861690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5777442|NCT02861690|Tubulin Modulators|tubulin modulators|mesh-ancestor
5777443|NCT02861690|Antimitotic Agents|antimitotic agents|mesh-ancestor
5777444|NCT02861690|Mitosis Modulators|mitosis modulators|mesh-ancestor
5777445|NCT02861690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897493|NCT00698022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5777446|NCT02861261|Promethazine|promethazine|mesh-list
5777447|NCT02861261|Diphenhydramine|diphenhydramine|mesh-list
5777448|NCT02861261|Antipruritics|antipruritics|mesh-ancestor
5777449|NCT02861261|Dermatologic Agents|dermatologic agents|mesh-ancestor
5777450|NCT02861261|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5777451|NCT02861261|Histamine Antagonists|histamine antagonists|mesh-ancestor
5777452|NCT02861261|Histamine Agents|histamine agents|mesh-ancestor
5777453|NCT02861261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5777454|NCT02861261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777455|NCT02861261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777456|NCT02861261|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5777457|NCT02861261|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5777458|NCT02861261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5777459|NCT02861261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5777460|NCT02861261|Anesthetics, Local|anesthetics, local|mesh-ancestor
5777461|NCT02861261|Anesthetics|anesthetics|mesh-ancestor
5777462|NCT02861261|Sensory System Agents|sensory system agents|mesh-ancestor
5777463|NCT02861261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5777464|NCT02861261|Antiemetics|antiemetics|mesh-ancestor
5777465|NCT02861261|Autonomic Agents|autonomic agents|mesh-ancestor
5777466|NCT02861261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5777467|NCT02861222|Doxorubicin|doxorubicin|mesh-list
5777468|NCT02861222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5777469|NCT02861222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5777470|NCT02861222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5777471|NCT02861222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5777472|NCT02861222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5777473|NCT02861222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777474|NCT02861378|Phentolamine|phentolamine|mesh-list
5777475|NCT02861378|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5777476|NCT02861378|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5777477|NCT02861378|Adrenergic Agents|adrenergic agents|mesh-ancestor
5777478|NCT02861378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5777479|NCT02861378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777480|NCT02861378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777481|NCT02861378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5777482|NCT02861105|Enoxaparin|enoxaparin|mesh-list
5777483|NCT02861105|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5777484|NCT02861105|Anticoagulants|anticoagulants|mesh-ancestor
5777485|NCT02861105|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5777486|NCT02861105|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5777487|NCT02861105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777488|NCT02860936|Lenvatinib|lenvatinib|mesh-list
5777489|NCT02860936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5777490|NCT02860936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5777491|NCT02860936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5777492|NCT02860936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777493|NCT02860949|Ketorolac|ketorolac|mesh-list
5777494|NCT02860949|Epinephrine|epinephrine|mesh-list
5777495|NCT02860949|Morphine|morphine|mesh-list
5777496|NCT02860949|Bupivacaine|bupivacaine|mesh-list
5777497|NCT02860949|Anesthetics, Local|anesthetics, local|mesh-ancestor
5777498|NCT02860949|Anesthetics|anesthetics|mesh-ancestor
5777499|NCT02860949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5777500|NCT02860949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777501|NCT02860949|Sensory System Agents|sensory system agents|mesh-ancestor
5777502|NCT02860949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5777503|NCT02860949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5777504|NCT02860949|Narcotics|narcotics|mesh-ancestor
5777505|NCT02860949|Analgesics|analgesics|mesh-ancestor
5777506|NCT02860949|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5777507|NCT02860949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5777508|NCT02860949|Adrenergic Agents|adrenergic agents|mesh-ancestor
5777509|NCT02860949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5777510|NCT02860949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777511|NCT02860949|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5777512|NCT02860949|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5777513|NCT02860949|Autonomic Agents|autonomic agents|mesh-ancestor
5777514|NCT02860949|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5777515|NCT02860949|Respiratory System Agents|respiratory system agents|mesh-ancestor
5777516|NCT02860949|Mydriatics|mydriatics|mesh-ancestor
5777517|NCT02860949|Sympathomimetics|sympathomimetics|mesh-ancestor
5777518|NCT02860949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5777519|NCT02860949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5777520|NCT02860949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5777521|NCT02860949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5777522|NCT02860949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5777523|NCT02860949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5777524|NCT02860949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5777525|NCT02860923|Exenatide|exenatide|mesh-list
5777526|NCT02860923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5777527|NCT02860923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777528|NCT02860923|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5777529|NCT02860923|Incretins|incretins|mesh-ancestor
5777530|NCT02860923|Hormones|hormones|mesh-ancestor
5777531|NCT02860923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5777532|NCT02861040|Vincristine|vincristine|mesh-list
5777533|NCT02861040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5777534|NCT02861040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5777535|NCT02861040|Tubulin Modulators|tubulin modulators|mesh-ancestor
5777536|NCT02861040|Antimitotic Agents|antimitotic agents|mesh-ancestor
5777537|NCT02861040|Mitosis Modulators|mitosis modulators|mesh-ancestor
5777538|NCT02861040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777539|NCT02860962|Dextromethorphan|dextromethorphan|mesh-list
5777540|NCT02860962|Antitussive Agents|antitussive agents|mesh-ancestor
5777541|NCT02860962|Respiratory System Agents|respiratory system agents|mesh-ancestor
5777542|NCT02860962|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5777543|NCT02860962|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5777544|NCT02860962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5777545|NCT02860962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777546|NCT02860962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777547|NCT02860858|Aflibercept|aflibercept|mesh-list
5777548|NCT02860858|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5777549|NCT02860858|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5777550|NCT02860858|Growth Substances|growth substances|mesh-ancestor
5777551|NCT02860858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777552|NCT02860858|Growth Inhibitors|growth inhibitors|mesh-ancestor
5777553|NCT02860858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5777554|NCT02861183|Hyaluronic Acid|hyaluronic acid|mesh-list
5777555|NCT02861183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5777556|NCT02861183|Immunologic Factors|immunologic factors|mesh-ancestor
5777557|NCT02861183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777558|NCT02861183|Viscosupplements|viscosupplements|mesh-ancestor
5777559|NCT02861183|Protective Agents|protective agents|mesh-ancestor
5777560|NCT02860897|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
5777561|NCT02860897|Estrogens|estrogens|mesh-ancestor
5777562|NCT02860897|Hormones|hormones|mesh-ancestor
5777563|NCT02860897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5777564|NCT02860897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777565|NCT02860819|Gemcitabine|gemcitabine|mesh-list
5777566|NCT02860819|Carboplatin|carboplatin|mesh-list
5777567|NCT02860819|Veliparib|veliparib|mesh-list
5777568|NCT02860819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5777569|NCT02860819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5777570|NCT02860819|Antimetabolites|antimetabolites|mesh-ancestor
5777571|NCT02860819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777572|NCT02860819|Antiviral Agents|antiviral agents|mesh-ancestor
5777573|NCT02860819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5777574|NCT02860819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5777575|NCT02860819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5777576|NCT02860819|Immunologic Factors|immunologic factors|mesh-ancestor
5777577|NCT02860819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777578|NCT02860819|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5777579|NCT02860663|Vitamin D|vitamin d|mesh-list
5777580|NCT02860663|Ergocalciferols|ergocalciferols|mesh-list
5777581|NCT02860663|Cholecalciferol|cholecalciferol|mesh-list
5777582|NCT02860663|Vitamins|vitamins|mesh-list
5777583|NCT02860663|Micronutrients|micronutrients|mesh-ancestor
5777584|NCT02860663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777585|NCT02860663|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5777586|NCT02860663|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5777587|NCT02860624|Esomeprazole|esomeprazole|mesh-list
5777588|NCT02860624|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5777589|NCT02860624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5777590|NCT02860624|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5777591|NCT02860624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5777592|NCT02860624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777593|NCT02860494|Everolimus|everolimus|mesh-list
5777594|NCT02860494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5777595|NCT02860494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5777596|NCT02860494|Immunologic Factors|immunologic factors|mesh-ancestor
5777597|NCT02860494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777598|NCT02860234|Capecitabine|capecitabine|mesh-list
5777599|NCT02860234|Oxaliplatin|oxaliplatin|mesh-list
5777600|NCT02860234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5777601|NCT02860234|Antimetabolites|antimetabolites|mesh-ancestor
5777602|NCT02860234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777603|NCT02860234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5777604|NCT02860299|Heparin|heparin|mesh-list
5777605|NCT02860299|Calcium heparin|calcium heparin|mesh-list
5777606|NCT02860299|Anticoagulants|anticoagulants|mesh-ancestor
5777607|NCT02860299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777608|NCT02860299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5777609|NCT02860299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5777610|NCT02860117|Ketamine|ketamine|mesh-list
5777611|NCT02860117|Analgesics|analgesics|mesh-ancestor
5777612|NCT02860117|Sensory System Agents|sensory system agents|mesh-ancestor
5777613|NCT02860117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5777614|NCT02860117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777615|NCT02860117|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5777616|NCT02860117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5777617|NCT02860117|Anesthetics, General|anesthetics, general|mesh-ancestor
5777618|NCT02860117|Anesthetics|anesthetics|mesh-ancestor
5777619|NCT02860117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5777620|NCT02860117|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5777621|NCT02860117|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5777622|NCT02860117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5777623|NCT02860117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777624|NCT02860221|Epinephrine|epinephrine|mesh-list
5777625|NCT02860221|Tranexamic Acid|tranexamic acid|mesh-list
5777626|NCT02860221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5777627|NCT02860221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5777628|NCT02860221|Adrenergic Agents|adrenergic agents|mesh-ancestor
5777629|NCT02860221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5777630|NCT02860221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777631|NCT02860221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777632|NCT02860221|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5777633|NCT02860221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5777634|NCT02860221|Autonomic Agents|autonomic agents|mesh-ancestor
5777635|NCT02860221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5777636|NCT02860221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5777637|NCT02860221|Respiratory System Agents|respiratory system agents|mesh-ancestor
5777638|NCT02860221|Mydriatics|mydriatics|mesh-ancestor
5777639|NCT02860221|Sympathomimetics|sympathomimetics|mesh-ancestor
5777640|NCT02860221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5777641|NCT02860221|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5777642|NCT02860221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5777643|NCT02860221|Hemostatics|hemostatics|mesh-ancestor
5777644|NCT02860221|Coagulants|coagulants|mesh-ancestor
5777645|NCT02860039|Vaccines|vaccines|mesh-list
5777646|NCT02860039|Immunologic Factors|immunologic factors|mesh-ancestor
5777647|NCT02860039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777648|NCT02859792|Riluzole|riluzole|mesh-list
5777649|NCT02859792|Anticonvulsants|anticonvulsants|mesh-ancestor
5777650|NCT02859792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5777651|NCT02859792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5777652|NCT02859792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5777653|NCT02859792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777654|NCT02859792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777655|NCT02859792|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5777656|NCT02859792|Protective Agents|protective agents|mesh-ancestor
5897494|NCT00698022|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5897495|NCT00692913|Cholecalciferol|cholecalciferol|mesh-list
5897496|NCT00692913|Alendronate|alendronate|mesh-list
5897497|NCT00692913|Calcium|calcium|mesh-list
5897498|NCT00692913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5897499|NCT00692913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897500|NCT00692913|Vitamins|vitamins|mesh-ancestor
5897501|NCT00692913|Micronutrients|micronutrients|mesh-ancestor
5897502|NCT00692913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5897503|NCT00617708|Gemcitabine|gemcitabine|mesh-list
5897504|NCT00617708|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5897505|NCT00617708|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5897506|NCT00617708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5897507|NCT00617708|Antimetabolites|antimetabolites|mesh-ancestor
5897508|NCT00617708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777657|NCT02859909|Immunoglobulins|immunoglobulins|mesh-list
5777658|NCT02859909|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5777659|NCT02859909|Immunologic Factors|immunologic factors|mesh-ancestor
5777660|NCT02859909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777661|NCT02859480|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5777662|NCT02859480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5777663|NCT02859480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5777664|NCT02859480|Antimetabolites|antimetabolites|mesh-ancestor
5777665|NCT02859480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777666|NCT02859480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5777667|NCT02859480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5777668|NCT02859480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5777669|NCT02859402|Fludarabine|fludarabine|mesh-list
5777670|NCT02859402|Busulfan|busulfan|mesh-list
5777671|NCT02859402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5777672|NCT02859402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777673|NCT02859402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5777674|NCT02859402|Immunologic Factors|immunologic factors|mesh-ancestor
5777675|NCT02859402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777676|NCT02859402|Alkylating Agents|alkylating agents|mesh-ancestor
5777677|NCT02859402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5777678|NCT02859402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5777679|NCT02859584|Hydrocortisone|hydrocortisone|mesh-list
5777680|NCT02859584|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
5777681|NCT02859584|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
5777682|NCT02859584|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
5777683|NCT02859584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5777684|NCT02859571|Oxytocin|oxytocin|mesh-list
5777685|NCT02859571|Oxytocics|oxytocics|mesh-ancestor
5777686|NCT02859571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5777687|NCT02859571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777688|NCT02859285|Estradiol|estradiol|mesh-list
5777689|NCT02859285|Estrogens|estrogens|mesh-ancestor
5777690|NCT02859285|Hormones|hormones|mesh-ancestor
5777691|NCT02859285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5777692|NCT02859285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777693|NCT02859012|Axitinib|axitinib|mesh-list
5777694|NCT02859012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5777695|NCT02859012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5777696|NCT02859012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5777697|NCT02859012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777698|NCT02859129|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
5777699|NCT02859129|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5777700|NCT02859129|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5777701|NCT02859129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5777702|NCT02859129|Antimetabolites|antimetabolites|mesh-ancestor
5777703|NCT02859129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777704|NCT02859129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5777705|NCT02859129|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5777706|NCT02859129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5777707|NCT02859129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5777708|NCT02859103|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
5777709|NCT02859103|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5777710|NCT02859103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5777711|NCT02859103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5777712|NCT02859103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777713|NCT02859103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5777714|NCT02859103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777715|NCT02859103|Antidepressive Agents|antidepressive agents|mesh-ancestor
5777716|NCT02859103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5777717|NCT02859259|Fostemsavir|fostemsavir|mesh-list
5777718|NCT02859259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5777719|NCT02859259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5777720|NCT02859259|Antiviral Agents|antiviral agents|mesh-ancestor
5777721|NCT02859259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5777722|NCT02859259|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5777723|NCT02859259|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5777724|NCT02859259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777725|NCT02859077|Gemcitabine|gemcitabine|mesh-list
5777726|NCT02859077|Carboplatin|carboplatin|mesh-list
5777727|NCT02859077|Pemetrexed|pemetrexed|mesh-list
5777728|NCT02859077|Gefitinib|gefitinib|mesh-list
5777729|NCT02859077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5777730|NCT02859077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5777731|NCT02859077|Antimetabolites|antimetabolites|mesh-ancestor
5777732|NCT02859077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777733|NCT02859077|Antiviral Agents|antiviral agents|mesh-ancestor
5777734|NCT02859077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5777735|NCT02859077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5777736|NCT02859077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5777737|NCT02859077|Immunologic Factors|immunologic factors|mesh-ancestor
5777738|NCT02859077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777739|NCT02859077|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5777740|NCT02859077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5777741|NCT02859077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5777742|NCT02858921|Pembrolizumab|pembrolizumab|mesh-list
5777743|NCT02858921|Trametinib|trametinib|mesh-list
5777744|NCT02858921|Dabrafenib|dabrafenib|mesh-list
5777745|NCT02858921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5777746|NCT02858921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5777747|NCT02858921|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5777748|NCT02858921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5777749|NCT02858921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777750|NCT02858843|Ivacaftor|ivacaftor|mesh-list
5777751|NCT02858843|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
5777752|NCT02858843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5777753|NCT02858843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777754|NCT02858817|Atovaquone|atovaquone|mesh-list
5777755|NCT02858817|Proguanil|proguanil|mesh-list
5777756|NCT02858817|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
5777757|NCT02858817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5777758|NCT02858817|Antimalarials|antimalarials|mesh-ancestor
5777759|NCT02858817|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5777760|NCT02858817|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5777761|NCT02858817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5777762|NCT02858817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777763|NCT02858817|Antimetabolites|antimetabolites|mesh-ancestor
5777764|NCT02858856|Juzentaihoto|juzentaihoto|mesh-list
5777765|NCT02858856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5777766|NCT02858856|Mitogens|mitogens|mesh-ancestor
5777767|NCT02858856|Mitosis Modulators|mitosis modulators|mesh-ancestor
5777768|NCT02858856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777769|NCT02858622|Fentanyl|fentanyl|mesh-list
5777770|NCT02858622|Meperidine|meperidine|mesh-list
5777771|NCT02858622|Bupivacaine|bupivacaine|mesh-list
5777772|NCT02858622|Anesthetics, Local|anesthetics, local|mesh-ancestor
5777773|NCT02858622|Anesthetics|anesthetics|mesh-ancestor
5777774|NCT02858622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5777775|NCT02858622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777776|NCT02858622|Sensory System Agents|sensory system agents|mesh-ancestor
5777777|NCT02858622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5777778|NCT02858622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5777779|NCT02858622|Narcotics|narcotics|mesh-ancestor
5777780|NCT02858622|Analgesics|analgesics|mesh-ancestor
5777781|NCT02858622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5777782|NCT02858622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5777783|NCT02858622|Anesthetics, General|anesthetics, general|mesh-ancestor
5777784|NCT02858804|Cytarabine|cytarabine|mesh-list
5777785|NCT02858804|Thalidomide|thalidomide|mesh-list
5777786|NCT02858804|Dexamethasone|dexamethasone|mesh-list
5777787|NCT02858804|Prednisone|prednisone|mesh-list
5777788|NCT02858804|Cyclophosphamide|cyclophosphamide|mesh-list
5777789|NCT02858804|Rituximab|rituximab|mesh-list
5777790|NCT02858804|Doxorubicin|doxorubicin|mesh-list
5777791|NCT02858804|Etoposide|etoposide|mesh-list
5777792|NCT02858804|Vincristine|vincristine|mesh-list
5777793|NCT02858804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5777794|NCT02858804|Immunologic Factors|immunologic factors|mesh-ancestor
5777795|NCT02858804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777796|NCT02858804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5777797|NCT02858804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5777798|NCT02858804|Alkylating Agents|alkylating agents|mesh-ancestor
5777799|NCT02858804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777800|NCT02858804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5777801|NCT02858804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5777802|NCT02858804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5777803|NCT02858804|Antiemetics|antiemetics|mesh-ancestor
6496496|NCT00628238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5777804|NCT02858804|Autonomic Agents|autonomic agents|mesh-ancestor
5777805|NCT02858804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5777806|NCT02858804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5777807|NCT02858804|Glucocorticoids|glucocorticoids|mesh-ancestor
5777808|NCT02858804|Hormones|hormones|mesh-ancestor
5777809|NCT02858804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5777810|NCT02858804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5777811|NCT02858804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5777812|NCT02858804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5777813|NCT02858804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5777814|NCT02858804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5777815|NCT02858804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5777816|NCT02858804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5777817|NCT02858804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5777818|NCT02858804|Antimetabolites|antimetabolites|mesh-ancestor
5777819|NCT02858804|Antiviral Agents|antiviral agents|mesh-ancestor
5777820|NCT02858804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5777821|NCT02858804|Tubulin Modulators|tubulin modulators|mesh-ancestor
5777822|NCT02858804|Antimitotic Agents|antimitotic agents|mesh-ancestor
5777823|NCT02858804|Mitosis Modulators|mitosis modulators|mesh-ancestor
5777824|NCT02858804|Leprostatic Agents|leprostatic agents|mesh-ancestor
5777825|NCT02858804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5777826|NCT02858804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5777827|NCT02858804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5777828|NCT02858804|Growth Substances|growth substances|mesh-ancestor
5777829|NCT02858804|Growth Inhibitors|growth inhibitors|mesh-ancestor
5777830|NCT02858505|Iron|iron|mesh-list
5777831|NCT02858505|Trace Elements|trace elements|mesh-ancestor
5777832|NCT02858505|Micronutrients|micronutrients|mesh-ancestor
5777833|NCT02858505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777834|NCT02858258|Rituximab|rituximab|mesh-list
5777835|NCT02858258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5777836|NCT02858258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5777837|NCT02858258|Immunologic Factors|immunologic factors|mesh-ancestor
5777838|NCT02858258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777839|NCT02858258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5777840|NCT02858219|Botulinum Toxins|botulinum toxins|mesh-list
5777841|NCT02858219|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5777842|NCT02858219|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5777843|NCT02858219|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5777844|NCT02858219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5777845|NCT02858219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777846|NCT02858219|Cholinergic Agents|cholinergic agents|mesh-ancestor
5777847|NCT02858219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5777848|NCT02858219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777849|NCT02858219|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5777850|NCT02858219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5777851|NCT02858297|Triamcinolone|triamcinolone|mesh-list
5777852|NCT02858297|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5777853|NCT02858297|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5777854|NCT02858297|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5777855|NCT02858297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5777856|NCT02858297|Glucocorticoids|glucocorticoids|mesh-ancestor
5777857|NCT02858297|Hormones|hormones|mesh-ancestor
5777858|NCT02858297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5777859|NCT02858297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777860|NCT02858297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5777861|NCT02858297|Immunologic Factors|immunologic factors|mesh-ancestor
5777862|NCT02858297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5777863|NCT02858297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777864|NCT02858193|Carbocysteine|carbocysteine|mesh-list
5777865|NCT02858193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5777866|NCT02858193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5777867|NCT02858193|Expectorants|expectorants|mesh-ancestor
5777868|NCT02858193|Respiratory System Agents|respiratory system agents|mesh-ancestor
5897509|NCT00617708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5897510|NCT00617708|Antiviral Agents|antiviral agents|mesh-ancestor
5897511|NCT00617708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5897512|NCT00617708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5897513|NCT00617708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5897514|NCT00617708|Immunologic Factors|immunologic factors|mesh-ancestor
5897515|NCT00617708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897516|NCT00617708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5897517|NCT00516737|Rizatriptan|rizatriptan|mesh-list
5897518|NCT00516737|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5897519|NCT00516737|Serotonin Agents|serotonin agents|mesh-ancestor
5897520|NCT00516737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5897521|NCT00516737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777869|NCT02858024|Dapivirine|dapivirine|mesh-list
5777870|NCT02858024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5777871|NCT02858024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5777872|NCT02858024|Antiviral Agents|antiviral agents|mesh-ancestor
5777873|NCT02858024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5777874|NCT02858206|Paclitaxel|paclitaxel|mesh-list
5777875|NCT02858206|Nimotuzumab|nimotuzumab|mesh-list
5777876|NCT02858206|Nedaplatin|nedaplatin|mesh-list
5777877|NCT02858206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5777878|NCT02858206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5777879|NCT02858206|Tubulin Modulators|tubulin modulators|mesh-ancestor
5777880|NCT02858206|Antimitotic Agents|antimitotic agents|mesh-ancestor
5777881|NCT02858206|Mitosis Modulators|mitosis modulators|mesh-ancestor
5777882|NCT02858206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777883|NCT02858206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5777884|NCT02857959|Penicillins|penicillins|mesh-list
5777885|NCT02857959|Penicillin G|penicillin g|mesh-list
5777886|NCT02857959|Penicillin G Benzathine|penicillin g benzathine|mesh-list
5777887|NCT02857959|Penicillin G Procaine|penicillin g procaine|mesh-list
5777888|NCT02857959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5777889|NCT02857959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5777890|NCT02857946|Linagliptin|linagliptin|mesh-list
5777891|NCT02857946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5777892|NCT02857946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777893|NCT02857946|Incretins|incretins|mesh-ancestor
5777894|NCT02857946|Hormones|hormones|mesh-ancestor
5777895|NCT02857946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5777896|NCT02857946|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5777897|NCT02857946|Protease Inhibitors|protease inhibitors|mesh-ancestor
5777898|NCT02857946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5777899|NCT02857946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777900|NCT02857712|Axitinib|axitinib|mesh-list
5777901|NCT02857712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5777902|NCT02857712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6490775|NCT00599950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490776|NCT00599950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6490777|NCT00599950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6496395|NCT00627887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496396|NCT00627887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496397|NCT00627887|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6496398|NCT00627887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6496399|NCT00627887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6496400|NCT00627887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5777903|NCT02857712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5777904|NCT02857712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777905|NCT02857920|Bevacizumab|bevacizumab|mesh-list
5777906|NCT02857920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5777907|NCT02857920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5777908|NCT02857920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5777909|NCT02857920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5777910|NCT02857920|Growth Substances|growth substances|mesh-ancestor
5777911|NCT02857920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777912|NCT02857920|Growth Inhibitors|growth inhibitors|mesh-ancestor
5777913|NCT02857829|Caffeine|caffeine|mesh-list
5777914|NCT02857829|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5777915|NCT02857829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777916|NCT02857829|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5777917|NCT02857829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5777918|NCT02857829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777919|NCT02857829|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5777920|NCT02857829|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5777921|NCT02857829|Purinergic Agents|purinergic agents|mesh-ancestor
5777922|NCT02857829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5777923|NCT02857842|Prednisolone|prednisolone|mesh-list
5777924|NCT02857842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5777925|NCT02857842|Glucocorticoids|glucocorticoids|mesh-ancestor
5777926|NCT02857842|Hormones|hormones|mesh-ancestor
5777927|NCT02857842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5777928|NCT02857842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777929|NCT02857842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5777930|NCT02857842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5777931|NCT02857777|Esketamine|esketamine|mesh-list
5777932|NCT02857777|Antidepressive Agents|antidepressive agents|mesh-ancestor
5777933|NCT02857777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5777934|NCT02857686|Anesthetics|anesthetics|mesh-list
5777935|NCT02857686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5777936|NCT02857686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777937|NCT02857582|Metronidazole|metronidazole|mesh-list
5777938|NCT02857582|Vancomycin|vancomycin|mesh-list
5777939|NCT02857582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5777940|NCT02857582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5777941|NCT02857582|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5777942|NCT02857582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5777943|NCT02857569|Nivolumab|nivolumab|mesh-list
5777944|NCT02857569|Ipilimumab|ipilimumab|mesh-list
5777945|NCT02857569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5777946|NCT02857569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5777947|NCT02857569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5777948|NCT02857569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777949|NCT02857491|Ranibizumab|ranibizumab|mesh-list
5777950|NCT02857491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5777951|NCT02857491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5777952|NCT02857491|Growth Substances|growth substances|mesh-ancestor
5777953|NCT02857491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777954|NCT02857491|Growth Inhibitors|growth inhibitors|mesh-ancestor
5777955|NCT02857491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5777956|NCT02857309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
5777957|NCT02857309|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
5777958|NCT02857309|Mineralocorticoids|mineralocorticoids|mesh-list
5777959|NCT02857309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777960|NCT02857309|Hormone Antagonists|hormone antagonists|mesh-ancestor
5777961|NCT02857309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5777962|NCT02857309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777963|NCT02857309|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5777964|NCT02857309|Diuretics|diuretics|mesh-ancestor
5777965|NCT02857309|Natriuretic Agents|natriuretic agents|mesh-ancestor
5777966|NCT02857309|Hormones|hormones|mesh-ancestor
5777967|NCT02857465|Dexamethasone|dexamethasone|mesh-list
5777968|NCT02857465|Dexamethasone acetate|dexamethasone acetate|mesh-list
5777969|NCT02857465|Sufentanil|sufentanil|mesh-list
5777970|NCT02857465|Dsuvia|dsuvia|mesh-list
5777971|NCT02857465|Ropivacaine|ropivacaine|mesh-list
5777972|NCT02857465|BB 1101|bb 1101|mesh-list
5777973|NCT02857465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5777974|NCT02857465|Antiemetics|antiemetics|mesh-ancestor
5777975|NCT02857465|Autonomic Agents|autonomic agents|mesh-ancestor
5777976|NCT02857465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5777977|NCT02857465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5777978|NCT02857465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5777979|NCT02857465|Glucocorticoids|glucocorticoids|mesh-ancestor
5777980|NCT02857465|Hormones|hormones|mesh-ancestor
5777981|NCT02857465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5777982|NCT02857465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5777983|NCT02857465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5777984|NCT02857465|Protease Inhibitors|protease inhibitors|mesh-ancestor
5777985|NCT02857465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5777986|NCT02857465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5777987|NCT02857465|Anesthetics, Local|anesthetics, local|mesh-ancestor
5777988|NCT02857465|Anesthetics|anesthetics|mesh-ancestor
5777989|NCT02857465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5777990|NCT02857465|Sensory System Agents|sensory system agents|mesh-ancestor
5777991|NCT02857465|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5777992|NCT02857465|Narcotics|narcotics|mesh-ancestor
5777993|NCT02857465|Analgesics|analgesics|mesh-ancestor
5777994|NCT02857465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5777995|NCT02857465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5777996|NCT02857465|Anesthetics, General|anesthetics, general|mesh-ancestor
5777997|NCT02857218|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
5777998|NCT02857218|Hematinics|hematinics|mesh-ancestor
5777999|NCT02857218|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5778000|NCT02857218|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5778001|NCT02857244|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5778002|NCT02857244|Modafinil|modafinil|mesh-list
5778003|NCT02857244|Donepezil|donepezil|mesh-list
5778004|NCT02857244|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5778005|NCT02857244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5778006|NCT02857244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5778007|NCT02857244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778008|NCT02857244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5778009|NCT02857244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778010|NCT02857244|Analgesics|analgesics|mesh-ancestor
5778011|NCT02857244|Sensory System Agents|sensory system agents|mesh-ancestor
5778012|NCT02857244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5778013|NCT02857244|Antidepressive Agents|antidepressive agents|mesh-ancestor
5778014|NCT02857244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5778015|NCT02857244|Dopamine Agents|dopamine agents|mesh-ancestor
5778016|NCT02857244|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5778017|NCT02857244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5778018|NCT02857244|Cholinergic Agents|cholinergic agents|mesh-ancestor
5778019|NCT02857244|Nootropic Agents|nootropic agents|mesh-ancestor
5778020|NCT02857244|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5778021|NCT02857244|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
5778022|NCT02857244|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5778023|NCT02857244|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5778024|NCT02857361|Ketamine|ketamine|mesh-list
5778025|NCT02857361|Analgesics|analgesics|mesh-ancestor
5778026|NCT02857361|Sensory System Agents|sensory system agents|mesh-ancestor
5778027|NCT02857361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5778028|NCT02857361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778029|NCT02857361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5778030|NCT02857361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5778031|NCT02857361|Anesthetics, General|anesthetics, general|mesh-ancestor
5778032|NCT02857361|Anesthetics|anesthetics|mesh-ancestor
5778033|NCT02857361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5778034|NCT02857361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5778035|NCT02857361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5778036|NCT02857361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5778037|NCT02857361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778038|NCT02857270|Gemcitabine|gemcitabine|mesh-list
5778039|NCT02857270|Paclitaxel|paclitaxel|mesh-list
5778040|NCT02857270|Cetuximab|cetuximab|mesh-list
5778041|NCT02857270|Midazolam|midazolam|mesh-list
5778042|NCT02857270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5778043|NCT02857270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5778044|NCT02857270|Tubulin Modulators|tubulin modulators|mesh-ancestor
5778045|NCT02857270|Antimitotic Agents|antimitotic agents|mesh-ancestor
5778046|NCT02857270|Mitosis Modulators|mitosis modulators|mesh-ancestor
5778047|NCT02857270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778048|NCT02857270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5778049|NCT02857270|Antimetabolites|antimetabolites|mesh-ancestor
5778050|NCT02857270|Antiviral Agents|antiviral agents|mesh-ancestor
5778051|NCT02857270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5778052|NCT02857270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5778053|NCT02857270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5778054|NCT02857270|Immunologic Factors|immunologic factors|mesh-ancestor
5778055|NCT02857270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778056|NCT02857270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5778057|NCT02857270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5778058|NCT02857270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5778059|NCT02857270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5778060|NCT02857270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5778061|NCT02857270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5778062|NCT02857270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5778063|NCT02857270|Anesthetics, General|anesthetics, general|mesh-ancestor
5778064|NCT02857270|Anesthetics|anesthetics|mesh-ancestor
5778065|NCT02857270|GABA Modulators|gaba modulators|mesh-ancestor
5778066|NCT02857270|GABA Agents|gaba agents|mesh-ancestor
5778067|NCT02857270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5778068|NCT02857270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5778069|NCT02856919|Brimonidine Tartrate|brimonidine tartrate|mesh-list
5778070|NCT02856919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5778071|NCT02856919|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5778072|NCT02856919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5778073|NCT02856919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5778074|NCT02856919|Adrenergic Agents|adrenergic agents|mesh-ancestor
5778075|NCT02856919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5778076|NCT02856919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778077|NCT02856919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778078|NCT02856854|Cocaine|cocaine|mesh-list
5778079|NCT02856854|Oxazepam|oxazepam|mesh-list
5778080|NCT02856854|Metyrapone|metyrapone|mesh-list
5778081|NCT02856854|Anesthetics, Local|anesthetics, local|mesh-ancestor
5778082|NCT02856854|Anesthetics|anesthetics|mesh-ancestor
5778083|NCT02856854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5778084|NCT02856854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778085|NCT02856854|Sensory System Agents|sensory system agents|mesh-ancestor
5778086|NCT02856854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5778087|NCT02856854|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5778088|NCT02856854|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5778089|NCT02856854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5778090|NCT02856854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5778091|NCT02856854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778092|NCT02856854|Dopamine Agents|dopamine agents|mesh-ancestor
5778093|NCT02856854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5778094|NCT02856854|Antimetabolites|antimetabolites|mesh-ancestor
5778095|NCT02856854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5778096|NCT02856854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5778097|NCT02856854|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5778098|NCT02856854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5778099|NCT02856854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5778100|NCT02856854|GABA Modulators|gaba modulators|mesh-ancestor
5778101|NCT02856854|GABA Agents|gaba agents|mesh-ancestor
5778102|NCT02857062|Emollients|emollients|mesh-list
5778103|NCT02857062|Dermatologic Agents|dermatologic agents|mesh-ancestor
5778104|NCT02856893|Gefitinib|gefitinib|mesh-list
5778105|NCT02856893|Osimertinib|osimertinib|mesh-list
5778106|NCT02856893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5778107|NCT02856893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5778108|NCT02856893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5778109|NCT02856893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778110|NCT02857166|Antibodies|antibodies|mesh-list
5778111|NCT02857166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5778112|NCT02857166|Immunologic Factors|immunologic factors|mesh-ancestor
5778113|NCT02857166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778114|NCT02856932|Methamphetamine|methamphetamine|mesh-list
5778115|NCT02856932|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5778116|NCT02856932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778117|NCT02856932|Sympathomimetics|sympathomimetics|mesh-ancestor
5778118|NCT02856932|Autonomic Agents|autonomic agents|mesh-ancestor
5778119|NCT02856932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5778120|NCT02856932|Dopamine Agents|dopamine agents|mesh-ancestor
5778121|NCT02856932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5778122|NCT02856932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778123|NCT02856932|Adrenergic Agents|adrenergic agents|mesh-ancestor
5778124|NCT02856932|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5778125|NCT02856932|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5778126|NCT02856932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6490778|NCT00600041|Pantoprazole|pantoprazole|mesh-list
6490779|NCT00600041|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6490780|NCT00600041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5778127|NCT02856932|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5778128|NCT02856867|Leucovorin|leucovorin|mesh-list
5778129|NCT02856867|Fluorouracil|fluorouracil|mesh-list
5778130|NCT02856867|Oxaliplatin|oxaliplatin|mesh-list
5778131|NCT02856867|Nintedanib|nintedanib|mesh-list
5778132|NCT02856867|Antimetabolites|antimetabolites|mesh-ancestor
5778133|NCT02856867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778134|NCT02856867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5778135|NCT02856867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5778136|NCT02856867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5778137|NCT02856867|Immunologic Factors|immunologic factors|mesh-ancestor
5778138|NCT02856867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778139|NCT02856867|Antidotes|antidotes|mesh-ancestor
5778140|NCT02856867|Protective Agents|protective agents|mesh-ancestor
5778141|NCT02856867|Vitamin B Complex|vitamin b complex|mesh-ancestor
5778142|NCT02856867|Vitamins|vitamins|mesh-ancestor
5778143|NCT02856867|Micronutrients|micronutrients|mesh-ancestor
5778144|NCT02856867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5778145|NCT02856867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5778146|NCT02856906|Salicylic Acid|salicylic acid|mesh-list
5778147|NCT02856906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5778148|NCT02856906|Antifungal Agents|antifungal agents|mesh-ancestor
5778149|NCT02856906|Keratolytic Agents|keratolytic agents|mesh-ancestor
5778150|NCT02856906|Dermatologic Agents|dermatologic agents|mesh-ancestor
5778151|NCT02857153|Urapidil|urapidil|mesh-list
5778152|NCT02857153|Phenylephrine|phenylephrine|mesh-list
5778153|NCT02857153|Oxymetazoline|oxymetazoline|mesh-list
5778154|NCT02857153|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5778155|NCT02857153|Mydriatics|mydriatics|mesh-ancestor
5778156|NCT02857153|Autonomic Agents|autonomic agents|mesh-ancestor
5778157|NCT02857153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5778158|NCT02857153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778159|NCT02857153|Sympathomimetics|sympathomimetics|mesh-ancestor
5778160|NCT02857153|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5778161|NCT02857153|Nasal Decongestants|nasal decongestants|mesh-ancestor
5778162|NCT02857153|Respiratory System Agents|respiratory system agents|mesh-ancestor
5778163|NCT02857153|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5778164|NCT02857153|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5778165|NCT02857153|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5778166|NCT02857153|Adrenergic Agents|adrenergic agents|mesh-ancestor
5778167|NCT02857153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5778168|NCT02857153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778169|NCT02857153|Protective Agents|protective agents|mesh-ancestor
5778170|NCT02857153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5778171|NCT02857153|Vasodilator Agents|vasodilator agents|mesh-ancestor
5778172|NCT02857153|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5778173|NCT02857153|Serotonin Agents|serotonin agents|mesh-ancestor
5778174|NCT02857153|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5778175|NCT02857153|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5778176|NCT02857153|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5778177|NCT02856698|Midazolam|midazolam|mesh-list
5778178|NCT02856698|Morphine|morphine|mesh-list
5778179|NCT02856698|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5778180|NCT02856698|Narcotics|narcotics|mesh-ancestor
5778181|NCT02856698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5778182|NCT02856698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778183|NCT02856698|Analgesics|analgesics|mesh-ancestor
5778184|NCT02856698|Sensory System Agents|sensory system agents|mesh-ancestor
5778185|NCT02856698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5778186|NCT02856698|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5778187|NCT02856698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5778188|NCT02856698|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5778189|NCT02856698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6490781|NCT00600041|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6490782|NCT00600041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6490783|NCT00600041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490784|NCT00600054|Nimotuzumab|nimotuzumab|mesh-list
6490785|NCT00600054|Antibodies|antibodies|mesh-list
6490786|NCT00600054|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6490787|NCT00600054|Immunologic Factors|immunologic factors|mesh-ancestor
6490788|NCT00600054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490789|NCT00600054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6490790|NCT00600054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6490791|NCT00600093|Amantadine|amantadine|mesh-list
6490792|NCT00600093|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6490793|NCT00600093|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6490794|NCT00600093|Antiviral Agents|antiviral agents|mesh-ancestor
6490795|NCT00600093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6490796|NCT00600093|Dopamine Agents|dopamine agents|mesh-ancestor
6490797|NCT00600093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6490798|NCT00600093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490799|NCT00600093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490800|NCT00600093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6490801|NCT00600093|Analgesics|analgesics|mesh-ancestor
6490802|NCT00600093|Sensory System Agents|sensory system agents|mesh-ancestor
5778190|NCT02856698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5778191|NCT02856698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5778192|NCT02856698|Anesthetics, General|anesthetics, general|mesh-ancestor
5778193|NCT02856698|Anesthetics|anesthetics|mesh-ancestor
5778194|NCT02856698|GABA Modulators|gaba modulators|mesh-ancestor
5778195|NCT02856698|GABA Agents|gaba agents|mesh-ancestor
5778196|NCT02856698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5778197|NCT02856698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778198|NCT02856789|Hemostatics|hemostatics|mesh-list
5778199|NCT02856789|Coagulants|coagulants|mesh-ancestor
5778200|NCT02856724|Dinoprostone|dinoprostone|mesh-list
5778201|NCT02856724|Oxytocics|oxytocics|mesh-ancestor
5778202|NCT02856724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5778203|NCT02856724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897522|NCT00516737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897523|NCT00358527|Mometasone Furoate|mometasone furoate|mesh-list
5897524|NCT00358527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5897525|NCT00358527|Dermatologic Agents|dermatologic agents|mesh-ancestor
5897526|NCT00358527|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5897527|NCT00326898|Sorafenib|sorafenib|mesh-list
5897528|NCT00326898|Sunitinib|sunitinib|mesh-list
5897529|NCT00326898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5897530|NCT00326898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6490803|NCT00600093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5897531|NCT00326898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5778204|NCT02856776|Vitamin D|vitamin d|mesh-list
5778205|NCT02856776|Cholecalciferol|cholecalciferol|mesh-list
5778206|NCT02856776|Vitamins|vitamins|mesh-ancestor
5778207|NCT02856776|Micronutrients|micronutrients|mesh-ancestor
5778208|NCT02856776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778209|NCT02856776|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5778210|NCT02856776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5778211|NCT02856750|Gabapentin|gabapentin|mesh-list
5778212|NCT02856750|Analgesics|analgesics|mesh-ancestor
5778213|NCT02856750|Sensory System Agents|sensory system agents|mesh-ancestor
5778214|NCT02856750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5778215|NCT02856750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778216|NCT02856750|Anticonvulsants|anticonvulsants|mesh-ancestor
5778217|NCT02856750|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5778218|NCT02856750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5778219|NCT02856750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5778220|NCT02856750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5778221|NCT02856750|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5778222|NCT02856750|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5778223|NCT02856750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5778224|NCT02856750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778225|NCT02856750|Antimanic Agents|antimanic agents|mesh-ancestor
5778226|NCT02856581|Varenicline|varenicline|mesh-list
5778227|NCT02856581|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5778228|NCT02856581|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5778229|NCT02856581|Cholinergic Agents|cholinergic agents|mesh-ancestor
5778230|NCT02856581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5778231|NCT02856581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778232|NCT02856581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778233|NCT02856685|Mitoxantrone|mitoxantrone|mesh-list
5778234|NCT02856685|Analgesics|analgesics|mesh-ancestor
5778235|NCT02856685|Sensory System Agents|sensory system agents|mesh-ancestor
5778236|NCT02856685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5778237|NCT02856685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778238|NCT02856685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5778239|NCT02856685|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5778240|NCT02856685|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5778241|NCT02856685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5778242|NCT02856685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778243|NCT02856568|Gemcitabine|gemcitabine|mesh-list
5778244|NCT02856568|Cisplatin|cisplatin|mesh-list
5778245|NCT02856568|Ricolinostat|ricolinostat|mesh-list
5778246|NCT02856568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5778247|NCT02856568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5778248|NCT02856568|Antimetabolites|antimetabolites|mesh-ancestor
5778249|NCT02856568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778250|NCT02856568|Antiviral Agents|antiviral agents|mesh-ancestor
5778251|NCT02856568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5778252|NCT02856568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5778253|NCT02856568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5778254|NCT02856568|Immunologic Factors|immunologic factors|mesh-ancestor
5778255|NCT02856568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778256|NCT02856568|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5778257|NCT02856594|Dexmedetomidine|dexmedetomidine|mesh-list
5778258|NCT02856594|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5778259|NCT02856594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5778260|NCT02856594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778261|NCT02856594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5778262|NCT02856594|Analgesics|analgesics|mesh-ancestor
5778263|NCT02856594|Sensory System Agents|sensory system agents|mesh-ancestor
5778264|NCT02856594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5778265|NCT02856594|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5778266|NCT02856594|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5778267|NCT02856594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5778268|NCT02856594|Adrenergic Agents|adrenergic agents|mesh-ancestor
5778269|NCT02856594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5778270|NCT02856594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778271|NCT02856451|Nivolumab|nivolumab|mesh-list
5778272|NCT02856451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5778273|NCT02856451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5778274|NCT02856451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5778275|NCT02856451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778276|NCT02856295|Enoxaparin|enoxaparin|mesh-list
5778277|NCT02856295|Anticoagulants|anticoagulants|mesh-ancestor
5778278|NCT02856295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5778279|NCT02856295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5778280|NCT02856295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778281|NCT02856243|Antiviral Agents|antiviral agents|mesh-list
5778282|NCT02856243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5778283|NCT02856503|Vitamin D|vitamin d|mesh-list
5778284|NCT02856503|Cholecalciferol|cholecalciferol|mesh-list
5778285|NCT02856503|Vitamins|vitamins|mesh-ancestor
5778286|NCT02856503|Micronutrients|micronutrients|mesh-ancestor
5778287|NCT02856503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778288|NCT02856503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5778289|NCT02856503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5778290|NCT02856178|Caspofungin|caspofungin|mesh-list
5778291|NCT02856178|Olorofim|olorofim|mesh-list
5778292|NCT02856178|Antifungal Agents|antifungal agents|mesh-ancestor
5778293|NCT02856178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5778294|NCT02856178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5778295|NCT02856178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778296|NCT02856542|Betamethasone|betamethasone|mesh-list
6490804|NCT00600145|Mirtazapine|mirtazapine|mesh-list
6490805|NCT00600145|Antidepressive Agents|antidepressive agents|mesh-ancestor
6490806|NCT00600145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6210285|NCT02158533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6210286|NCT02158533|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6210287|NCT02158533|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6210288|NCT02158572|Contraceptive Agents|contraceptive agents|mesh-list
6210289|NCT02158572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6210290|NCT02158572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210291|NCT02158806|Aspirin|aspirin|mesh-list
6490807|NCT00600145|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5778297|NCT02856542|Betamethasone Valerate|betamethasone valerate|mesh-list
5778298|NCT02856542|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5778299|NCT02856542|Betamethasone benzoate|betamethasone benzoate|mesh-list
5778300|NCT02856542|Calcipotriene|calcipotriene|mesh-list
5778301|NCT02856542|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
5778302|NCT02856542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5778303|NCT02856542|Glucocorticoids|glucocorticoids|mesh-ancestor
5778304|NCT02856542|Hormones|hormones|mesh-ancestor
5778305|NCT02856542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5778306|NCT02856542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778307|NCT02856542|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5778308|NCT02856542|Respiratory System Agents|respiratory system agents|mesh-ancestor
5778309|NCT02856542|Dermatologic Agents|dermatologic agents|mesh-ancestor
5778310|NCT02856425|Pembrolizumab|pembrolizumab|mesh-list
5778311|NCT02856425|Nintedanib|nintedanib|mesh-list
5778312|NCT02856425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5778313|NCT02856425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5778314|NCT02856425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5778315|NCT02856425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5778316|NCT02856425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778317|NCT02856100|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
5778318|NCT02856100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778319|NCT02856048|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5778320|NCT02856048|Luteolytic Agents|luteolytic agents|mesh-ancestor
5778321|NCT02856048|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5778322|NCT02856048|Contraceptive Agents|contraceptive agents|mesh-ancestor
5778323|NCT02856048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5778324|NCT02856048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778325|NCT02856048|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5778326|NCT02856048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5778327|NCT02856048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5778328|NCT02856113|Alogliptin|alogliptin|mesh-list
5778329|NCT02856113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5778330|NCT02856113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778331|NCT02856113|Incretins|incretins|mesh-ancestor
5778332|NCT02856113|Hormones|hormones|mesh-ancestor
5778333|NCT02856113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5778334|NCT02856113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5778335|NCT02856113|Protease Inhibitors|protease inhibitors|mesh-ancestor
5778336|NCT02856113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5778337|NCT02856113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778338|NCT02856230|Paclitaxel|paclitaxel|mesh-list
5778339|NCT02856230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5778340|NCT02856230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6490808|NCT00600145|Histamine Antagonists|histamine antagonists|mesh-ancestor
5778341|NCT02856230|Tubulin Modulators|tubulin modulators|mesh-ancestor
5778342|NCT02856230|Antimitotic Agents|antimitotic agents|mesh-ancestor
5778343|NCT02856230|Mitosis Modulators|mitosis modulators|mesh-ancestor
5778344|NCT02856230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778345|NCT02856126|Sorafenib|sorafenib|mesh-list
5778346|NCT02856126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5778347|NCT02856126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5778348|NCT02856126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5778349|NCT02856126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778350|NCT02856087|Remifentanil|remifentanil|mesh-list
5778351|NCT02856087|Naloxone|naloxone|mesh-list
5778352|NCT02856087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5778353|NCT02856087|Narcotics|narcotics|mesh-ancestor
5778354|NCT02856087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5778355|NCT02856087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778356|NCT02856087|Analgesics|analgesics|mesh-ancestor
5778357|NCT02856087|Sensory System Agents|sensory system agents|mesh-ancestor
5778358|NCT02856087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5778359|NCT02856087|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5778360|NCT02855632|Hormones|hormones|mesh-list
5778361|NCT02855632|Progesterone|progesterone|mesh-list
5778362|NCT02855632|Sargramostim|sargramostim|mesh-list
5778363|NCT02855632|Lenograstim|lenograstim|mesh-list
5778364|NCT02855632|Estrogens|estrogens|mesh-list
5778365|NCT02855632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5778366|NCT02855632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778367|NCT02855632|Progestins|progestins|mesh-ancestor
5778368|NCT02855632|Immunologic Factors|immunologic factors|mesh-ancestor
5778369|NCT02855632|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5778370|NCT02855684|Insulin|insulin|mesh-list
5778371|NCT02855684|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5778372|NCT02855684|Insulin Glargine|insulin glargine|mesh-list
5778373|NCT02855684|Hypoglycemic Agents|hypoglycemic agents|mesh-list
5778374|NCT02855684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778375|NCT02855866|Acetaminophen|acetaminophen|mesh-list
5778376|NCT02855866|Dexamethasone|dexamethasone|mesh-list
5778377|NCT02855866|Cortisone|cortisone|mesh-list
5778378|NCT02855866|Dexamethasone acetate|dexamethasone acetate|mesh-list
5778379|NCT02855866|BB 1101|bb 1101|mesh-list
5778380|NCT02855866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5778381|NCT02855866|Antiemetics|antiemetics|mesh-ancestor
5778382|NCT02855866|Autonomic Agents|autonomic agents|mesh-ancestor
5778383|NCT02855866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5778384|NCT02855866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778385|NCT02855866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5778386|NCT02855866|Glucocorticoids|glucocorticoids|mesh-ancestor
5778387|NCT02855866|Hormones|hormones|mesh-ancestor
5778388|NCT02855866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5778389|NCT02855866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5778390|NCT02855866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5778391|NCT02855866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5778392|NCT02855866|Analgesics|analgesics|mesh-ancestor
5778393|NCT02855866|Sensory System Agents|sensory system agents|mesh-ancestor
5778394|NCT02855866|Antipyretics|antipyretics|mesh-ancestor
5778395|NCT02855866|Protease Inhibitors|protease inhibitors|mesh-ancestor
5778396|NCT02855866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5778397|NCT02855866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778398|NCT02855788|Leucovorin|leucovorin|mesh-list
5778399|NCT02855788|Paclitaxel|paclitaxel|mesh-list
5778400|NCT02855788|Oxaliplatin|oxaliplatin|mesh-list
5778401|NCT02855788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5778402|NCT02855788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5778403|NCT02855788|Tubulin Modulators|tubulin modulators|mesh-ancestor
5778404|NCT02855788|Antimitotic Agents|antimitotic agents|mesh-ancestor
5778405|NCT02855788|Mitosis Modulators|mitosis modulators|mesh-ancestor
5778406|NCT02855788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778407|NCT02855788|Antidotes|antidotes|mesh-ancestor
5778408|NCT02855788|Protective Agents|protective agents|mesh-ancestor
5778409|NCT02855788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778410|NCT02855788|Vitamin B Complex|vitamin b complex|mesh-ancestor
5778411|NCT02855788|Vitamins|vitamins|mesh-ancestor
5778412|NCT02855788|Micronutrients|micronutrients|mesh-ancestor
5778413|NCT02855502|Prednisolone|prednisolone|mesh-list
5778414|NCT02855502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6490809|NCT00600145|Histamine Agents|histamine agents|mesh-ancestor
6490810|NCT00600145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5778415|NCT02855502|Glucocorticoids|glucocorticoids|mesh-ancestor
5778416|NCT02855502|Hormones|hormones|mesh-ancestor
5778417|NCT02855502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5778418|NCT02855502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778419|NCT02855502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5778420|NCT02855502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5778421|NCT02855515|Anesthetics|anesthetics|mesh-list
5778422|NCT02855515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5778423|NCT02855515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778424|NCT02855346|Dapivirine|dapivirine|mesh-list
5778425|NCT02855346|Levonorgestrel|levonorgestrel|mesh-list
5778426|NCT02855346|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5778427|NCT02855346|Contraceptive Agents|contraceptive agents|mesh-ancestor
5778428|NCT02855346|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5778429|NCT02855346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778430|NCT02855346|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5778431|NCT02855346|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5778432|NCT02855346|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5778433|NCT02855346|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5778434|NCT02855346|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5778435|NCT02855346|Antiviral Agents|antiviral agents|mesh-ancestor
5778436|NCT02855346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5778437|NCT02855307|Insulin|insulin|mesh-list
5778438|NCT02855307|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5778439|NCT02855307|Hormones|hormones|mesh-list
5778440|NCT02855307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5778441|NCT02855307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778442|NCT02855307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5778443|NCT02855294|Drospirenone|drospirenone|mesh-list
5778444|NCT02855294|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5778445|NCT02855294|Hormone Antagonists|hormone antagonists|mesh-ancestor
5778446|NCT02855294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5778447|NCT02855294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778448|NCT02855294|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5778449|NCT02855294|Diuretics|diuretics|mesh-ancestor
5778450|NCT02855294|Natriuretic Agents|natriuretic agents|mesh-ancestor
5778451|NCT02855203|Pembrolizumab|pembrolizumab|mesh-list
5778452|NCT02855203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5778453|NCT02855203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5778454|NCT02855138|Isotretinoin|isotretinoin|mesh-list
5778455|NCT02855138|Dermatologic Agents|dermatologic agents|mesh-ancestor
5778456|NCT02855073|Hyaluronic Acid|hyaluronic acid|mesh-list
5778457|NCT02855073|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5778458|NCT02855073|Immunologic Factors|immunologic factors|mesh-ancestor
5778459|NCT02855073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778460|NCT02855073|Viscosupplements|viscosupplements|mesh-ancestor
5778461|NCT02855073|Protective Agents|protective agents|mesh-ancestor
5897532|NCT00326898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897533|NCT00326898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5897534|NCT00326898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5897535|NCT00326898|Growth Substances|growth substances|mesh-ancestor
5897536|NCT00326898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897537|NCT00326898|Growth Inhibitors|growth inhibitors|mesh-ancestor
5897538|NCT00156065|Haloperidol|haloperidol|mesh-list
5897539|NCT00156065|Haloperidol decanoate|haloperidol decanoate|mesh-list
5897540|NCT00156065|Asenapine|asenapine|mesh-list
5897541|NCT00156065|Antiemetics|antiemetics|mesh-ancestor
5897542|NCT00156065|Autonomic Agents|autonomic agents|mesh-ancestor
5897543|NCT00156065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5897544|NCT00156065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897545|NCT00156065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5897546|NCT00156065|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5897547|NCT00156065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5897548|NCT00156065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5897549|NCT00156065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5897550|NCT00156065|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5897551|NCT00156065|Dopamine Agents|dopamine agents|mesh-ancestor
5897552|NCT00156065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5897553|NCT00156065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897554|NCT00156065|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5897555|NCT00150176|Asenapine|asenapine|mesh-list
5897556|NCT00150176|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5897557|NCT00150176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5897558|NCT00150176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5897559|NCT00150176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897560|NCT00150176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5897561|NCT00148629|Mebendazole|mebendazole|mesh-list
5897562|NCT00148629|Piperazine|piperazine|mesh-list
5897563|NCT00148629|Piperazine citrate|piperazine citrate|mesh-list
5778462|NCT02854995|Triamcinolone|triamcinolone|mesh-list
5778463|NCT02854995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5778464|NCT02854995|Glucocorticoids|glucocorticoids|mesh-ancestor
5778465|NCT02854995|Hormones|hormones|mesh-ancestor
6210292|NCT02158806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6210293|NCT02158806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6210294|NCT02158806|Analgesics|analgesics|mesh-ancestor
5778466|NCT02854995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5778467|NCT02854995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778468|NCT02854904|Dexmedetomidine|dexmedetomidine|mesh-list
5778469|NCT02854904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5778470|NCT02854904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5778471|NCT02854904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778472|NCT02854904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5778473|NCT02854904|Analgesics|analgesics|mesh-ancestor
5778474|NCT02854904|Sensory System Agents|sensory system agents|mesh-ancestor
5778475|NCT02854904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5778476|NCT02854904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5778477|NCT02854904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5778478|NCT02854904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5778479|NCT02854904|Adrenergic Agents|adrenergic agents|mesh-ancestor
5778480|NCT02854904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5778481|NCT02854904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778482|NCT02854670|Capsaicin|capsaicin|mesh-list
5778483|NCT02854670|Antipruritics|antipruritics|mesh-ancestor
5778484|NCT02854670|Dermatologic Agents|dermatologic agents|mesh-ancestor
5778485|NCT02854670|Sensory System Agents|sensory system agents|mesh-ancestor
5778486|NCT02854670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5778487|NCT02854670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778488|NCT02854761|Vitamin D|vitamin d|mesh-list
5778489|NCT02854761|Vitamins|vitamins|mesh-ancestor
5778490|NCT02854761|Micronutrients|micronutrients|mesh-ancestor
5778491|NCT02854761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778492|NCT02854761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5778493|NCT02854748|Empagliflozin|empagliflozin|mesh-list
5778494|NCT02854748|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5778495|NCT02854748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778496|NCT02854748|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5778497|NCT02854748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778498|NCT02854592|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5778499|NCT02854592|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5778500|NCT02854592|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5778501|NCT02854592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778502|NCT02854488|Ipilimumab|ipilimumab|mesh-list
5778503|NCT02854488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5778504|NCT02854488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5778505|NCT02854488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5778506|NCT02854488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778507|NCT02854722|Calcium, Dietary|calcium, dietary|mesh-list
5778508|NCT02854722|Vitamin D|vitamin d|mesh-list
5778509|NCT02854722|Ergocalciferols|ergocalciferols|mesh-list
5778510|NCT02854722|Cholecalciferol|cholecalciferol|mesh-list
5778511|NCT02854722|Vitamins|vitamins|mesh-list
5778512|NCT02854722|Calcium|calcium|mesh-list
5778513|NCT02854722|Deferasirox|deferasirox|mesh-list
5778514|NCT02854722|Micronutrients|micronutrients|mesh-ancestor
5778515|NCT02854722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778516|NCT02854722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5778517|NCT02854722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5778518|NCT02854722|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5778519|NCT02854722|Chelating Agents|chelating agents|mesh-ancestor
5778520|NCT02854722|Sequestering Agents|sequestering agents|mesh-ancestor
5778521|NCT02854722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778522|NCT02854696|Insulin|insulin|mesh-list
5778523|NCT02854696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5778524|NCT02854696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778525|NCT02854787|Phenylephrine|phenylephrine|mesh-list
5778526|NCT02854787|Oxymetazoline|oxymetazoline|mesh-list
5778527|NCT02854787|Norepinephrine|norepinephrine|mesh-list
6210295|NCT02158806|Sensory System Agents|sensory system agents|mesh-ancestor
6210296|NCT02158806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6210297|NCT02158806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210298|NCT02158806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6210299|NCT02158806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6210300|NCT02158806|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5778528|NCT02854787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5778529|NCT02854787|Mydriatics|mydriatics|mesh-ancestor
5778530|NCT02854787|Autonomic Agents|autonomic agents|mesh-ancestor
5778531|NCT02854787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5778532|NCT02854787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778533|NCT02854787|Sympathomimetics|sympathomimetics|mesh-ancestor
5778534|NCT02854787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5778535|NCT02854787|Nasal Decongestants|nasal decongestants|mesh-ancestor
5778536|NCT02854787|Respiratory System Agents|respiratory system agents|mesh-ancestor
5778537|NCT02854787|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5778538|NCT02854787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5778539|NCT02854787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5778540|NCT02854787|Adrenergic Agents|adrenergic agents|mesh-ancestor
5778541|NCT02854787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5778542|NCT02854787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778543|NCT02854787|Protective Agents|protective agents|mesh-ancestor
5778544|NCT02854241|Liver Extracts|liver extracts|mesh-list
5778545|NCT02854241|Hematinics|hematinics|mesh-ancestor
5778546|NCT02854345|Parathyroid Hormone|parathyroid hormone|mesh-list
5778547|NCT02854345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5778548|NCT02854345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778549|NCT02853864|Dexmedetomidine|dexmedetomidine|mesh-list
5778550|NCT02853864|Propofol|propofol|mesh-list
5778551|NCT02853864|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5778552|NCT02853864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5778553|NCT02853864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778554|NCT02853864|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5778555|NCT02853864|Anesthetics, General|anesthetics, general|mesh-ancestor
5778556|NCT02853864|Anesthetics|anesthetics|mesh-ancestor
5778557|NCT02853864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5778558|NCT02853864|Analgesics|analgesics|mesh-ancestor
5778559|NCT02853864|Sensory System Agents|sensory system agents|mesh-ancestor
5778560|NCT02853864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5778561|NCT02853864|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5778562|NCT02853864|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5778563|NCT02853864|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5778564|NCT02853864|Adrenergic Agents|adrenergic agents|mesh-ancestor
5778565|NCT02853864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5778566|NCT02853864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778567|NCT02854072|Gemcitabine|gemcitabine|mesh-list
5778568|NCT02854072|Capecitabine|capecitabine|mesh-list
5778569|NCT02854072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5778570|NCT02854072|Antimetabolites|antimetabolites|mesh-ancestor
5778571|NCT02854072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778572|NCT02854072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5778573|NCT02854072|Antiviral Agents|antiviral agents|mesh-ancestor
5778574|NCT02854072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5778575|NCT02854072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5778576|NCT02854072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5778577|NCT02854072|Immunologic Factors|immunologic factors|mesh-ancestor
5778578|NCT02854072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778579|NCT02853799|Insulin|insulin|mesh-list
5778580|NCT02853799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5778581|NCT02853799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778582|NCT02853630|Metformin|metformin|mesh-list
5778583|NCT02853630|Vildagliptin|vildagliptin|mesh-list
5778584|NCT02853630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5778585|NCT02853630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778586|NCT02853630|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5778587|NCT02853630|Protease Inhibitors|protease inhibitors|mesh-ancestor
5778588|NCT02853630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5778589|NCT02853630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778590|NCT02853539|Denosumab|denosumab|mesh-list
5778591|NCT02853539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5778592|NCT02853539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778593|NCT02853526|Propranolol|propranolol|mesh-list
5778594|NCT02853526|Warfarin|warfarin|mesh-list
5778595|NCT02853526|Anticoagulants|anticoagulants|mesh-ancestor
5778596|NCT02853526|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5778597|NCT02853526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5778598|NCT02853526|Adrenergic Agents|adrenergic agents|mesh-ancestor
5778599|NCT02853526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5897564|NCT00148629|DMP 777|dmp 777|mesh-list
6210301|NCT02158806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6210302|NCT02158806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496497|NCT00628238|Immunologic Factors|immunologic factors|mesh-ancestor
6210303|NCT02158806|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6210304|NCT02158806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6210305|NCT02158806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6210306|NCT02158806|Antipyretics|antipyretics|mesh-ancestor
6210307|NCT02158936|Azacitidine|azacitidine|mesh-list
6210308|NCT02158936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6210309|NCT02158936|Antimetabolites|antimetabolites|mesh-ancestor
6210310|NCT02158936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210311|NCT02158936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6210312|NCT02158936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6210313|NCT02158975|Ixazomib|ixazomib|mesh-list
6210314|NCT02158975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6210315|NCT02158975|Protease Inhibitors|protease inhibitors|mesh-ancestor
6210316|NCT02158975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6210317|NCT02158975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778600|NCT02853526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778601|NCT02853526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778602|NCT02853526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5778603|NCT02853526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5778604|NCT02853526|Vasodilator Agents|vasodilator agents|mesh-ancestor
5897565|NCT00148629|Antinematodal Agents|antinematodal agents|mesh-ancestor
5897566|NCT00148629|Anthelmintics|anthelmintics|mesh-ancestor
5897567|NCT00148629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5897568|NCT00148629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5897569|NCT00148629|Tubulin Modulators|tubulin modulators|mesh-ancestor
5897570|NCT00148629|Antimitotic Agents|antimitotic agents|mesh-ancestor
5897571|NCT00148629|Mitosis Modulators|mitosis modulators|mesh-ancestor
6210318|NCT02159053|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6210319|NCT02159053|Immunologic Factors|immunologic factors|mesh-ancestor
6210320|NCT02159053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210321|NCT02159352|Ritonavir|ritonavir|mesh-list
6210322|NCT02159352|Lopinavir|lopinavir|mesh-list
6210323|NCT02159352|Darunavir|darunavir|mesh-list
6210324|NCT02159352|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6673594|NCT01563835|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6673595|NCT01563835|Chelating Agents|chelating agents|mesh-ancestor
6673596|NCT01563835|Sequestering Agents|sequestering agents|mesh-ancestor
6673597|NCT01563835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673598|NCT01563939|Remifentanil|remifentanil|mesh-list
6673599|NCT01563939|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6673600|NCT01563939|Narcotics|narcotics|mesh-ancestor
6673601|NCT01563939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6673602|NCT01563939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673603|NCT01563939|Analgesics|analgesics|mesh-ancestor
6673604|NCT01563939|Sensory System Agents|sensory system agents|mesh-ancestor
6673605|NCT01563939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5897572|NCT00148629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897573|NCT00148629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5897574|NCT00148629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5897575|NCT00145509|Asenapine|asenapine|mesh-list
5897576|NCT00145509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5897577|NCT00145509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5897578|NCT00145509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5897579|NCT00145509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897580|NCT00145509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5897581|NCT00145496|Olanzapine|olanzapine|mesh-list
5897582|NCT00145496|Asenapine|asenapine|mesh-list
5897583|NCT00145496|Antiemetics|antiemetics|mesh-ancestor
5897584|NCT00145496|Autonomic Agents|autonomic agents|mesh-ancestor
5897585|NCT00145496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6210325|NCT02159352|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6210326|NCT02159352|Protease Inhibitors|protease inhibitors|mesh-ancestor
6210327|NCT02159352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5897586|NCT00145496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897587|NCT00145496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5897588|NCT00145496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6210328|NCT02159352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210329|NCT02159352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6210330|NCT02159352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6210331|NCT02159352|Antiviral Agents|antiviral agents|mesh-ancestor
6210332|NCT02159352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6210333|NCT02159352|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6210334|NCT02159352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6210335|NCT02159365|Dexamethasone|dexamethasone|mesh-list
5897589|NCT00145496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5907981|NCT04977986|Cannabidiol|cannabidiol|mesh-list
6673606|NCT01563952|Sirolimus|sirolimus|mesh-list
6210336|NCT02159365|Lenalidomide|lenalidomide|mesh-list
6210337|NCT02159365|Elotuzumab|elotuzumab|mesh-list
6210338|NCT02159365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6210339|NCT02159365|Antiemetics|antiemetics|mesh-ancestor
6210340|NCT02159365|Autonomic Agents|autonomic agents|mesh-ancestor
6210341|NCT02159365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6210342|NCT02159365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210343|NCT02159365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5778605|NCT02853552|Misoprostol|misoprostol|mesh-list
5778606|NCT02853552|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5778607|NCT02853552|Abortifacient Agents|abortifacient agents|mesh-ancestor
5778608|NCT02853552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5778609|NCT02853552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778610|NCT02853552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5778611|NCT02853552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5778612|NCT02853552|Oxytocics|oxytocics|mesh-ancestor
5778613|NCT02853253|SMOFlipid|smoflipid|mesh-list
5778614|NCT02853253|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
5778615|NCT02853253|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6210344|NCT02159365|Glucocorticoids|glucocorticoids|mesh-ancestor
6210345|NCT02159365|Hormones|hormones|mesh-ancestor
6210346|NCT02159365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6210347|NCT02159365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5778616|NCT02853253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5778617|NCT02853370|Rituximab|rituximab|mesh-list
5778618|NCT02853370|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5778619|NCT02853370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5778620|NCT02853370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5778621|NCT02853370|Immunologic Factors|immunologic factors|mesh-ancestor
5778622|NCT02853370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778623|NCT02853370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5778624|NCT02853370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5778625|NCT02853370|Alkylating Agents|alkylating agents|mesh-ancestor
5778626|NCT02853370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778627|NCT02853578|Budesonide|budesonide|mesh-list
5778628|NCT02853578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5778629|NCT02853578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5778630|NCT02853578|Autonomic Agents|autonomic agents|mesh-ancestor
5778631|NCT02853578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5778632|NCT02853578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778633|NCT02853578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5778634|NCT02853578|Respiratory System Agents|respiratory system agents|mesh-ancestor
5778635|NCT02853578|Glucocorticoids|glucocorticoids|mesh-ancestor
5778636|NCT02853578|Hormones|hormones|mesh-ancestor
5778637|NCT02853578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5778638|NCT02853136|Fluvoxamine|fluvoxamine|mesh-list
5778639|NCT02853136|BI 409306|bi 409306|mesh-list
5778640|NCT02853136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5778641|NCT02853136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5778642|NCT02853136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5778643|NCT02853136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778644|NCT02853136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5778645|NCT02853136|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5778646|NCT02853136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5778647|NCT02853136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5778648|NCT02853136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778649|NCT02853136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5778650|NCT02853136|Serotonin Agents|serotonin agents|mesh-ancestor
5778651|NCT02853136|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5778652|NCT02853136|Antidepressive Agents|antidepressive agents|mesh-ancestor
5778653|NCT02853136|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5778654|NCT02853136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5778655|NCT02853136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6490811|NCT00600145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490812|NCT00600145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490813|NCT00600145|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6490814|NCT00600145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6490815|NCT00600145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6490816|NCT00600145|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5778656|NCT02853136|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5778657|NCT02853136|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5778658|NCT02853071|Estramustine|estramustine|mesh-list
5907982|NCT04977986|Anticonvulsants|anticonvulsants|mesh-ancestor
5778659|NCT02853071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5778660|NCT02853071|Alkylating Agents|alkylating agents|mesh-ancestor
5778661|NCT02853071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778662|NCT02853071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5778663|NCT02853071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5778664|NCT02852837|Daratumumab|daratumumab|mesh-list
5778665|NCT02852837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5778666|NCT02852798|Docetaxel|docetaxel|mesh-list
5778667|NCT02852798|Apatinib|apatinib|mesh-list
5778668|NCT02852798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5778669|NCT02852798|Tubulin Modulators|tubulin modulators|mesh-ancestor
5778670|NCT02852798|Antimitotic Agents|antimitotic agents|mesh-ancestor
5778671|NCT02852798|Mitosis Modulators|mitosis modulators|mesh-ancestor
5778672|NCT02852798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778673|NCT02852798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5778674|NCT02852798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5778675|NCT02852681|Drospirenone|drospirenone|mesh-list
5778676|NCT02852681|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5778677|NCT02852681|Hormone Antagonists|hormone antagonists|mesh-ancestor
5778678|NCT02852681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5778679|NCT02852681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778680|NCT02852681|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5778681|NCT02852681|Diuretics|diuretics|mesh-ancestor
5778682|NCT02852681|Natriuretic Agents|natriuretic agents|mesh-ancestor
5778683|NCT02852694|Adalimumab|adalimumab|mesh-list
5778684|NCT02852694|Methotrexate|methotrexate|mesh-list
5778685|NCT02852694|Mercaptopurine|mercaptopurine|mesh-list
5778686|NCT02852694|Azathioprine|azathioprine|mesh-list
5778687|NCT02852694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5778688|NCT02852694|Abortifacient Agents|abortifacient agents|mesh-ancestor
6673607|NCT01563952|Umirolimus|umirolimus|mesh-list
6673608|NCT01563952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6673609|NCT01563952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6210348|NCT02159365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6210349|NCT02159365|Immunologic Factors|immunologic factors|mesh-ancestor
6210350|NCT02159365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6210351|NCT02159365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6210352|NCT02159365|Growth Substances|growth substances|mesh-ancestor
5778689|NCT02852694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5778690|NCT02852694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778691|NCT02852694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5778692|NCT02852694|Antimetabolites|antimetabolites|mesh-ancestor
5778693|NCT02852694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778694|NCT02852694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6210353|NCT02159365|Growth Inhibitors|growth inhibitors|mesh-ancestor
6210354|NCT02159469|Methyltestosterone|methyltestosterone|mesh-list
6210355|NCT02159469|Testosterone|testosterone|mesh-list
6210356|NCT02159469|Testosterone undecanoate|testosterone undecanoate|mesh-list
6210357|NCT02159469|Testosterone enanthate|testosterone enanthate|mesh-list
6210358|NCT02159469|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6210359|NCT02159469|Androgens|androgens|mesh-ancestor
6210360|NCT02159469|Hormones|hormones|mesh-ancestor
6210361|NCT02159469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6210362|NCT02159469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210363|NCT02159469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6210364|NCT02159469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6210365|NCT02159469|Anabolic Agents|anabolic agents|mesh-ancestor
6210366|NCT02159482|Interferons|interferons|mesh-list
6210367|NCT02159482|Interferon-alpha|interferon-alpha|mesh-list
6210368|NCT02159482|Interferon alpha-2|interferon alpha-2|mesh-list
6210369|NCT02159482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6210370|NCT02159482|Antiviral Agents|antiviral agents|mesh-ancestor
6210371|NCT02159482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6210372|NCT02159482|Immunologic Factors|immunologic factors|mesh-ancestor
6210373|NCT02159482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210374|NCT02159521|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6210375|NCT02159521|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6210376|NCT02159521|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6210377|NCT02159521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210378|NCT02159547|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
6210379|NCT02159547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6210380|NCT02159547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6673610|NCT01563952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6210381|NCT02159547|Analgesics|analgesics|mesh-ancestor
6210382|NCT02159547|Sensory System Agents|sensory system agents|mesh-ancestor
6210383|NCT02159547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6210384|NCT02159547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210385|NCT02159547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6210386|NCT02159547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6210387|NCT02159807|Fentanyl|fentanyl|mesh-list
6210388|NCT02159807|Bupivacaine|bupivacaine|mesh-list
5778695|NCT02852694|Dermatologic Agents|dermatologic agents|mesh-ancestor
5778696|NCT02852694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5778697|NCT02852694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5778698|NCT02852694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5778699|NCT02852694|Immunologic Factors|immunologic factors|mesh-ancestor
5778700|NCT02852694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5778701|NCT02852694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5778702|NCT02852694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5778703|NCT02852655|Pembrolizumab|pembrolizumab|mesh-list
5778704|NCT02852655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5778705|NCT02852655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5778706|NCT02852720|Anesthetics|anesthetics|mesh-list
5778707|NCT02852720|Levobupivacaine|levobupivacaine|mesh-list
5778708|NCT02852720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5778709|NCT02852720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778710|NCT02852720|Anesthetics, Local|anesthetics, local|mesh-ancestor
5778711|NCT02852720|Sensory System Agents|sensory system agents|mesh-ancestor
5778712|NCT02852720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5778713|NCT02852564|Ethacrynic Acid|ethacrynic acid|mesh-list
5778714|NCT02852564|Diuretics|diuretics|mesh-ancestor
6210389|NCT02159807|Anesthetics, Local|anesthetics, local|mesh-ancestor
6210390|NCT02159807|Anesthetics|anesthetics|mesh-ancestor
6210391|NCT02159807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5778715|NCT02852564|Natriuretic Agents|natriuretic agents|mesh-ancestor
5778716|NCT02852564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778717|NCT02852564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5778718|NCT02852564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778719|NCT02852577|Clonazepam|clonazepam|mesh-list
5778720|NCT02852577|Paroxetine|paroxetine|mesh-list
5778721|NCT02852577|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5778722|NCT02852577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5778723|NCT02852577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5778724|NCT02852577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778725|NCT02852577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5778726|NCT02852577|Serotonin Agents|serotonin agents|mesh-ancestor
5778727|NCT02852577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778728|NCT02852577|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5778729|NCT02852577|Antidepressive Agents|antidepressive agents|mesh-ancestor
5778730|NCT02852577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5778731|NCT02852577|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5778732|NCT02852577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6673611|NCT01563952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6673612|NCT01563952|Antifungal Agents|antifungal agents|mesh-ancestor
6673613|NCT01563952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5778733|NCT02852577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5778734|NCT02852577|Anticonvulsants|anticonvulsants|mesh-ancestor
5778735|NCT02852577|GABA Modulators|gaba modulators|mesh-ancestor
5778736|NCT02852577|GABA Agents|gaba agents|mesh-ancestor
5778737|NCT02852486|Pioglitazone|pioglitazone|mesh-list
5778738|NCT02852486|Imatinib Mesylate|imatinib mesylate|mesh-list
5778739|NCT02852486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5778740|NCT02852486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778741|NCT02852486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5778742|NCT02852486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5778743|NCT02852486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5778744|NCT02852486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778745|NCT02852083|Pioglitazone|pioglitazone|mesh-list
5778746|NCT02852083|Clarithromycin|clarithromycin|mesh-list
6673614|NCT01563952|Immunologic Factors|immunologic factors|mesh-ancestor
6673615|NCT01563952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673616|NCT01563952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6673617|NCT01564095|Tryptophan|tryptophan|mesh-list
5778747|NCT02852083|Nivolumab|nivolumab|mesh-list
5778748|NCT02852083|Treosulfan|treosulfan|mesh-list
5778749|NCT02852083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5778750|NCT02852083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5778751|NCT02852083|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5897590|NCT00145496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6673618|NCT01564095|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6673619|NCT01564095|Tacrolimus|tacrolimus|mesh-list
5778752|NCT02852083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778753|NCT02852083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5778754|NCT02852083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778755|NCT02852083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6210392|NCT02159807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210393|NCT02159807|Sensory System Agents|sensory system agents|mesh-ancestor
6210394|NCT02159807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6210395|NCT02159807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6210396|NCT02159807|Narcotics|narcotics|mesh-ancestor
6210397|NCT02159807|Analgesics|analgesics|mesh-ancestor
6210398|NCT02159807|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6210399|NCT02159807|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6210400|NCT02159807|Anesthetics, General|anesthetics, general|mesh-ancestor
6210401|NCT02159859|Ertapenem|ertapenem|mesh-list
6210402|NCT02159859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6210403|NCT02159859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6210404|NCT02159872|Homoharringtonine|homoharringtonine|mesh-list
6210405|NCT02159872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6210406|NCT02159872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6210407|NCT02159872|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6210408|NCT02159872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5778756|NCT02852083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5778757|NCT02852083|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5778758|NCT02852083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5778759|NCT02852083|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5778760|NCT02852083|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5778761|NCT02852083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5778762|NCT02852083|Alkylating Agents|alkylating agents|mesh-ancestor
5778763|NCT02852239|Dabrafenib|dabrafenib|mesh-list
5778764|NCT02852239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5778765|NCT02852239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5778766|NCT02852239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5778767|NCT02852239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778768|NCT02852122|Choline|choline|mesh-list
6210409|NCT02159872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210410|NCT02159950|Vaccines|vaccines|mesh-list
6210411|NCT02159950|Immunologic Factors|immunologic factors|mesh-ancestor
6210412|NCT02159950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210413|NCT02159976|Amoxicillin|amoxicillin|mesh-list
6210414|NCT02159976|Metronidazole|metronidazole|mesh-list
6210415|NCT02159976|Clarithromycin|clarithromycin|mesh-list
6210416|NCT02159976|Tetracycline|tetracycline|mesh-list
6210417|NCT02159976|Pantoprazole|pantoprazole|mesh-list
6210418|NCT02159976|Bismuth|bismuth|mesh-list
6210419|NCT02159976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6210420|NCT02159976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6210421|NCT02159976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6210422|NCT02159976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6210423|NCT02159976|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6210424|NCT02159976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6210425|NCT02159976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210426|NCT02159976|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6210427|NCT02159976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6210428|NCT02159976|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6210429|NCT02159976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6210430|NCT02159976|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6210431|NCT02159976|Antacids|antacids|mesh-ancestor
6210432|NCT02160041|Infigratinib|infigratinib|mesh-list
6210433|NCT02160041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6210434|NCT02160145|Tolvaptan|tolvaptan|mesh-list
6210435|NCT02160145|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6210436|NCT02160145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210437|NCT02160145|Natriuretic Agents|natriuretic agents|mesh-ancestor
6210438|NCT02160145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210439|NCT02160288|Botulinum Toxins|botulinum toxins|mesh-list
6210440|NCT02160288|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6210441|NCT02160288|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6210442|NCT02160288|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6210443|NCT02160288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6210444|NCT02160288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210445|NCT02160288|Cholinergic Agents|cholinergic agents|mesh-ancestor
6210446|NCT02160288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6210447|NCT02160288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210448|NCT02160288|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6210449|NCT02160288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6673620|NCT01564095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6673621|NCT01564095|Immunologic Factors|immunologic factors|mesh-ancestor
6673622|NCT01564095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673623|NCT01564095|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6673624|NCT01564095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6673625|NCT01564095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673626|NCT01564095|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6673627|NCT01564095|Antidepressive Agents|antidepressive agents|mesh-ancestor
6673628|NCT01564095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6673629|NCT01564108|Ranibizumab|ranibizumab|mesh-list
6210450|NCT02160535|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6210451|NCT02160535|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6210452|NCT02160535|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6210453|NCT02160535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6210454|NCT02160535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210455|NCT02160535|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6210456|NCT02160535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6210457|NCT02160535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778769|NCT02852122|Lipotropic Agents|lipotropic agents|mesh-ancestor
5778770|NCT02852122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5778771|NCT02852122|Antimetabolites|antimetabolites|mesh-ancestor
6210458|NCT02160535|Cholinergic Agents|cholinergic agents|mesh-ancestor
6210459|NCT02160535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6210460|NCT02160626|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6210461|NCT02160730|Roscovitine|roscovitine|mesh-list
6210462|NCT02160730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6210463|NCT02160730|Antiviral Agents|antiviral agents|mesh-ancestor
6210464|NCT02160730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6210465|NCT02160730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6210466|NCT02160730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6210467|NCT02160730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210468|NCT02160808|Secretin|secretin|mesh-list
6210469|NCT02160808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6210470|NCT02160808|Hormones|hormones|mesh-ancestor
6210471|NCT02160808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6210472|NCT02160808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778772|NCT02852122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778773|NCT02852122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5778774|NCT02852122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5778775|NCT02852122|Nootropic Agents|nootropic agents|mesh-ancestor
5778776|NCT02852382|Morphine|morphine|mesh-list
5778777|NCT02852382|Bupivacaine|bupivacaine|mesh-list
5778778|NCT02852382|Anesthetics, Local|anesthetics, local|mesh-ancestor
5778779|NCT02852382|Anesthetics|anesthetics|mesh-ancestor
5778780|NCT02852382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5778781|NCT02852382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778782|NCT02852382|Sensory System Agents|sensory system agents|mesh-ancestor
5778783|NCT02852382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5778784|NCT02852382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5778785|NCT02852382|Narcotics|narcotics|mesh-ancestor
5778786|NCT02852382|Analgesics|analgesics|mesh-ancestor
5897591|NCT00145496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5897592|NCT00145496|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5897593|NCT00145496|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5897594|NCT00145496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5897595|NCT00145496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897596|NCT00145496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5897597|NCT00145496|Serotonin Agents|serotonin agents|mesh-ancestor
5897598|NCT00145470|Asenapine|asenapine|mesh-list
5897599|NCT00145470|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5897600|NCT00145470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5897601|NCT00145470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5897602|NCT00145470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897603|NCT00145470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5897604|NCT00129402|Simvastatin|simvastatin|mesh-list
5897605|NCT00129402|Ezetimibe|ezetimibe|mesh-list
5897606|NCT00129402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5897607|NCT00129402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5897608|NCT00129402|Antimetabolites|antimetabolites|mesh-ancestor
5897609|NCT00129402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897610|NCT00129402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5897611|NCT00129402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5897612|NCT00129402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5778787|NCT02851888|Ropivacaine|ropivacaine|mesh-list
5778788|NCT02851888|Anesthetics|anesthetics|mesh-ancestor
5778789|NCT02851888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5778790|NCT02851888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778791|NCT02851888|Anesthetics, Local|anesthetics, local|mesh-ancestor
5778792|NCT02851888|Sensory System Agents|sensory system agents|mesh-ancestor
5778793|NCT02851888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5778794|NCT02851914|Antidepressive Agents|antidepressive agents|mesh-list
5778795|NCT02851914|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
5778796|NCT02851914|Serotonin|serotonin|mesh-list
5778797|NCT02851914|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
5778798|NCT02851914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5778799|NCT02851914|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5778800|NCT02851914|Serotonin Agents|serotonin agents|mesh-ancestor
5778801|NCT02851914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5778802|NCT02851914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778803|NCT02851914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778804|NCT02851914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5778805|NCT02851914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5778806|NCT02851745|Linagliptin|linagliptin|mesh-list
5778807|NCT02851745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5778808|NCT02851745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778809|NCT02851745|Incretins|incretins|mesh-ancestor
5778810|NCT02851745|Hormones|hormones|mesh-ancestor
5778811|NCT02851745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5778812|NCT02851745|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5778813|NCT02851745|Protease Inhibitors|protease inhibitors|mesh-ancestor
5778814|NCT02851745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5778815|NCT02851745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778816|NCT02851472|Nitric Oxide|nitric oxide|mesh-list
5778817|NCT02851472|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5778818|NCT02851472|Autonomic Agents|autonomic agents|mesh-ancestor
5778819|NCT02851472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5778820|NCT02851472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778821|NCT02851472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5778822|NCT02851472|Respiratory System Agents|respiratory system agents|mesh-ancestor
5778823|NCT02851472|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5778824|NCT02851472|Antioxidants|antioxidants|mesh-ancestor
5778825|NCT02851472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778826|NCT02851472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5778827|NCT02851472|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5778828|NCT02851472|Vasodilator Agents|vasodilator agents|mesh-ancestor
5778829|NCT02851472|Gasotransmitters|gasotransmitters|mesh-ancestor
5778830|NCT02851472|Protective Agents|protective agents|mesh-ancestor
5778831|NCT02851459|Vaccines|vaccines|mesh-list
5778832|NCT02851459|Immunologic Factors|immunologic factors|mesh-ancestor
5778833|NCT02851459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778834|NCT02851433|Anesthetics|anesthetics|mesh-list
5778835|NCT02851433|Propofol|propofol|mesh-list
5778836|NCT02851433|Sevoflurane|sevoflurane|mesh-list
5778837|NCT02851433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5778838|NCT02851433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778839|NCT02851433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5778840|NCT02851433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5778841|NCT02851433|Anesthetics, General|anesthetics, general|mesh-ancestor
5778842|NCT02851433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5778843|NCT02851433|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5778844|NCT02851095|Metformin|metformin|mesh-list
5778845|NCT02851095|Canagliflozin|canagliflozin|mesh-list
5778846|NCT02851095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5778847|NCT02851095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778848|NCT02851095|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5778849|NCT02851095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778850|NCT02851394|Tramadol|tramadol|mesh-list
5778851|NCT02851394|Levobupivacaine|levobupivacaine|mesh-list
5778852|NCT02851394|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5778853|NCT02851394|Narcotics|narcotics|mesh-ancestor
5778854|NCT02851394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5778855|NCT02851394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778856|NCT02851394|Analgesics|analgesics|mesh-ancestor
5778857|NCT02851394|Sensory System Agents|sensory system agents|mesh-ancestor
5778858|NCT02851394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5778859|NCT02851394|Anesthetics, Local|anesthetics, local|mesh-ancestor
5778860|NCT02851394|Anesthetics|anesthetics|mesh-ancestor
5778861|NCT02851303|Morphine|morphine|mesh-list
5778862|NCT02851303|Methadone|methadone|mesh-list
5778863|NCT02851303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5778864|NCT02851303|Narcotics|narcotics|mesh-ancestor
5778865|NCT02851303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5778866|NCT02851303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778867|NCT02851303|Analgesics|analgesics|mesh-ancestor
5778868|NCT02851303|Sensory System Agents|sensory system agents|mesh-ancestor
5778869|NCT02851303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6490817|NCT00600145|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6490818|NCT00600145|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6490819|NCT00600145|Adrenergic Agents|adrenergic agents|mesh-ancestor
6490820|NCT00600145|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6490821|NCT00600145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6490822|NCT00600145|Serotonin Agents|serotonin agents|mesh-ancestor
6490823|NCT00600145|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6490824|NCT00600158|Lidocaine|lidocaine|mesh-list
6490825|NCT00600158|Hydromorphone|hydromorphone|mesh-list
6490826|NCT00600158|Bupivacaine|bupivacaine|mesh-list
6490827|NCT00600158|Anesthetics, Local|anesthetics, local|mesh-ancestor
6490828|NCT00600158|Anesthetics|anesthetics|mesh-ancestor
6490829|NCT00600158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6490830|NCT00600158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490831|NCT00600158|Sensory System Agents|sensory system agents|mesh-ancestor
6490832|NCT00600158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6490833|NCT00600158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6490834|NCT00600158|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6490835|NCT00600158|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6490836|NCT00600158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6490837|NCT00600158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490838|NCT00600158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6490839|NCT00600158|Narcotics|narcotics|mesh-ancestor
6490840|NCT00600158|Analgesics|analgesics|mesh-ancestor
6490841|NCT00600210|Bevacizumab|bevacizumab|mesh-list
6490842|NCT00600210|Carboplatin|carboplatin|mesh-list
6490843|NCT00600210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6490844|NCT00600210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6490845|NCT00600210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6490846|NCT00600210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6490847|NCT00600210|Growth Substances|growth substances|mesh-ancestor
6490848|NCT00600210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490849|NCT00600210|Growth Inhibitors|growth inhibitors|mesh-ancestor
6490850|NCT00600249|Docetaxel|docetaxel|mesh-list
6490851|NCT00600249|Cetuximab|cetuximab|mesh-list
6490852|NCT00600249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6210473|NCT02160990|Exenatide|exenatide|mesh-list
6210474|NCT02160990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6210475|NCT02160990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210476|NCT02160990|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6210477|NCT02160990|Incretins|incretins|mesh-ancestor
6210478|NCT02160990|Hormones|hormones|mesh-ancestor
6210479|NCT02160990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6210480|NCT02161146|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
6210481|NCT02161146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6210482|NCT02161146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6210483|NCT02161146|Analgesics|analgesics|mesh-ancestor
6210484|NCT02161146|Sensory System Agents|sensory system agents|mesh-ancestor
6210485|NCT02161146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6210486|NCT02161146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210487|NCT02161146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6210488|NCT02161146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6210489|NCT02161146|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5778870|NCT02851303|Antitussive Agents|antitussive agents|mesh-ancestor
5778871|NCT02851303|Respiratory System Agents|respiratory system agents|mesh-ancestor
5778872|NCT02851407|Defibrotide|defibrotide|mesh-list
5778873|NCT02851407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5778874|NCT02851407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5778875|NCT02851407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778876|NCT02851407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5778877|NCT02851290|Anesthetics|anesthetics|mesh-list
5778878|NCT02851290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5778879|NCT02851290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778880|NCT02851212|Metformin|metformin|mesh-list
5778881|NCT02851212|Canagliflozin|canagliflozin|mesh-list
5778882|NCT02851212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5778883|NCT02851212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490853|NCT00600249|Tubulin Modulators|tubulin modulators|mesh-ancestor
5778884|NCT02851212|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5778885|NCT02851212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778886|NCT02851004|Pembrolizumab|pembrolizumab|mesh-list
5778887|NCT02851004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5778888|NCT02851004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5778889|NCT02850718|Sildenafil Citrate|sildenafil citrate|mesh-list
5778890|NCT02850718|Vasodilator Agents|vasodilator agents|mesh-ancestor
5778891|NCT02850718|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5778892|NCT02850718|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5778893|NCT02850718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5778894|NCT02850718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778895|NCT02850718|Urological Agents|urological agents|mesh-ancestor
5778896|NCT02850744|Temozolomide|temozolomide|mesh-list
5778897|NCT02850744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5778898|NCT02850744|Alkylating Agents|alkylating agents|mesh-ancestor
5778899|NCT02850744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778900|NCT02850744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5778901|NCT02850887|Anesthetics|anesthetics|mesh-list
5778902|NCT02850887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5778903|NCT02850887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778904|NCT02850913|Doxycycline|doxycycline|mesh-list
5778905|NCT02850913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5778906|NCT02850913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5778907|NCT02850913|Antimalarials|antimalarials|mesh-ancestor
5778908|NCT02850913|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6673630|NCT01564108|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6673631|NCT01564108|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6673632|NCT01564108|Growth Substances|growth substances|mesh-ancestor
6673633|NCT01564108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673634|NCT01564108|Growth Inhibitors|growth inhibitors|mesh-ancestor
6673635|NCT01564108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6673636|NCT01564199|Fluticasone|fluticasone|mesh-list
6673637|NCT01564199|Xhance|xhance|mesh-list
6673638|NCT01564199|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6673639|NCT01564199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6673640|NCT01564199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6673641|NCT01564199|Autonomic Agents|autonomic agents|mesh-ancestor
6673642|NCT01564199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6210490|NCT02161146|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6210491|NCT02161146|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6210492|NCT02161146|Histamine Antagonists|histamine antagonists|mesh-ancestor
6210493|NCT02161146|Histamine Agents|histamine agents|mesh-ancestor
5778909|NCT02850913|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5778910|NCT02850848|Entecavir|entecavir|mesh-list
5778911|NCT02850848|Antiviral Agents|antiviral agents|mesh-ancestor
5778912|NCT02850848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5778913|NCT02850874|Gemcitabine|gemcitabine|mesh-list
5778914|NCT02850874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5778915|NCT02850874|Antimetabolites|antimetabolites|mesh-ancestor
5778916|NCT02850874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778917|NCT02850874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5778918|NCT02850874|Antiviral Agents|antiviral agents|mesh-ancestor
5778919|NCT02850874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5778920|NCT02850874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5778921|NCT02850874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5778922|NCT02850874|Immunologic Factors|immunologic factors|mesh-ancestor
5778923|NCT02850874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897613|NCT00101439|Ezetimibe|ezetimibe|mesh-list
5897614|NCT00101439|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5897615|NCT00101439|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5897616|NCT00101439|Antimetabolites|antimetabolites|mesh-ancestor
6673643|NCT01564199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897617|NCT00101439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897618|NCT00101439|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5897619|NCT00096200|Paclitaxel|paclitaxel|mesh-list
5897620|NCT00096200|Carboplatin|carboplatin|mesh-list
5897621|NCT00096200|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5897622|NCT00096200|Sorafenib|sorafenib|mesh-list
5897623|NCT00096200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5897624|NCT00096200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5897625|NCT00096200|Tubulin Modulators|tubulin modulators|mesh-ancestor
5897626|NCT00096200|Antimitotic Agents|antimitotic agents|mesh-ancestor
5897627|NCT00096200|Mitosis Modulators|mitosis modulators|mesh-ancestor
5897628|NCT00096200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673644|NCT01564199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6673645|NCT01564199|Respiratory System Agents|respiratory system agents|mesh-ancestor
6673646|NCT01564199|Dermatologic Agents|dermatologic agents|mesh-ancestor
6673647|NCT01564199|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6673648|NCT01564199|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6673649|NCT01564199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6673650|NCT01564199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6673651|NCT01564199|Adrenergic Agents|adrenergic agents|mesh-ancestor
6673652|NCT01564199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6673653|NCT01564199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673654|NCT01564238|Calcium, Dietary|calcium, dietary|mesh-list
6673655|NCT01564238|Calcium|calcium|mesh-list
6673656|NCT01564238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6673657|NCT01564238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673658|NCT01564238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5778924|NCT02850419|Doxorubicin|doxorubicin|mesh-list
5778925|NCT02850419|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6210494|NCT02161146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6490854|NCT00600249|Antimitotic Agents|antimitotic agents|mesh-ancestor
6490855|NCT00600249|Mitosis Modulators|mitosis modulators|mesh-ancestor
6490856|NCT00600249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490857|NCT00600249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5778926|NCT02850419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5778927|NCT02850419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5778928|NCT02850419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5778929|NCT02850419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5778930|NCT02850419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5778931|NCT02850419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778932|NCT02850250|Cefuroxime|cefuroxime|mesh-list
5778933|NCT02850250|Cefuroxime axetil|cefuroxime axetil|mesh-list
5778934|NCT02850250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5778935|NCT02850250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5778936|NCT02850445|Olanzapine|olanzapine|mesh-list
5778937|NCT02850445|Antiemetics|antiemetics|mesh-ancestor
5778938|NCT02850445|Autonomic Agents|autonomic agents|mesh-ancestor
5778939|NCT02850445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5778940|NCT02850445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778941|NCT02850445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5778942|NCT02850445|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5778943|NCT02850445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5778944|NCT02850445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5778945|NCT02850445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5778946|NCT02850445|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5778947|NCT02850445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5778948|NCT02850445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5778949|NCT02850445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778950|NCT02850445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5778951|NCT02850445|Serotonin Agents|serotonin agents|mesh-ancestor
5778952|NCT02850211|Ibuprofen|ibuprofen|mesh-list
5778953|NCT02850211|Celecoxib|celecoxib|mesh-list
5778954|NCT02850211|Tramadol|tramadol|mesh-list
5778955|NCT02850211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5778956|NCT02850211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5778957|NCT02850211|Analgesics|analgesics|mesh-ancestor
5778958|NCT02850211|Sensory System Agents|sensory system agents|mesh-ancestor
5778959|NCT02850211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5778960|NCT02850211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778961|NCT02850211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6210495|NCT02161146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210496|NCT02161185|Midazolam|midazolam|mesh-list
6210497|NCT02161185|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6210498|NCT02161185|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6210499|NCT02161185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6210500|NCT02161185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210501|NCT02161185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6210502|NCT02161185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6210503|NCT02161185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6210504|NCT02161185|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6210505|NCT02161185|Anesthetics, General|anesthetics, general|mesh-ancestor
6210506|NCT02161185|Anesthetics|anesthetics|mesh-ancestor
6490858|NCT00600262|Bevacizumab|bevacizumab|mesh-list
6490859|NCT00600262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6490860|NCT00600262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6490861|NCT00600262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6490862|NCT00600262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6490863|NCT00600262|Growth Substances|growth substances|mesh-ancestor
6490864|NCT00600262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490865|NCT00600262|Growth Inhibitors|growth inhibitors|mesh-ancestor
6490866|NCT00600301|Triamcinolone|triamcinolone|mesh-list
6490867|NCT00600301|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6490868|NCT00600301|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5778962|NCT02850211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5778963|NCT02850211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5778964|NCT02850211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5778965|NCT02850211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778966|NCT02850211|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5778967|NCT02850211|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5778968|NCT02850211|Narcotics|narcotics|mesh-ancestor
5778969|NCT02850211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5778970|NCT02850289|Interferons|interferons|mesh-list
5778971|NCT02850289|Ribavirin|ribavirin|mesh-list
5778972|NCT02850289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5778973|NCT02850289|Antiviral Agents|antiviral agents|mesh-ancestor
5778974|NCT02850289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5778975|NCT02850289|Antimetabolites|antimetabolites|mesh-ancestor
5778976|NCT02850289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778977|NCT02850484|Budesonide|budesonide|mesh-list
5778978|NCT02850484|Formoterol Fumarate|formoterol fumarate|mesh-list
5778979|NCT02850484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5778980|NCT02850484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5778981|NCT02850484|Autonomic Agents|autonomic agents|mesh-ancestor
5778982|NCT02850484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5778983|NCT02850484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5778984|NCT02850484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5778985|NCT02850484|Respiratory System Agents|respiratory system agents|mesh-ancestor
5640839|NCT04598477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5640840|NCT04598477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5640841|NCT04598451|Prednisone|prednisone|mesh-list
5640842|NCT04598451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5640843|NCT04598451|Glucocorticoids|glucocorticoids|mesh-ancestor
5640844|NCT04598451|Hormones|hormones|mesh-ancestor
5640845|NCT04598451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5640846|NCT04598451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640847|NCT04598451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5640848|NCT04598451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5640849|NCT04597125|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
5640850|NCT04597125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5640851|NCT04582383|Doxycycline|doxycycline|mesh-list
5640852|NCT04582383|Spironolactone|spironolactone|mesh-list
5640853|NCT04582383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5640854|NCT04582383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5640855|NCT04582383|Antimalarials|antimalarials|mesh-ancestor
5640856|NCT04582383|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5640857|NCT04582383|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5640858|NCT04582383|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5640859|NCT04582383|Hormone Antagonists|hormone antagonists|mesh-ancestor
5640860|NCT04582383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5640861|NCT04582383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640862|NCT04582383|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5640863|NCT04582383|Diuretics|diuretics|mesh-ancestor
5640864|NCT04582383|Natriuretic Agents|natriuretic agents|mesh-ancestor
5640865|NCT04576078|Nefopam|nefopam|mesh-list
5640866|NCT04576078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5640867|NCT04576078|Analgesics|analgesics|mesh-ancestor
5640868|NCT04576078|Sensory System Agents|sensory system agents|mesh-ancestor
5640869|NCT04576078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5640870|NCT04576078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640871|NCT04557449|Letrozole|letrozole|mesh-list
5640872|NCT04557449|Fulvestrant|fulvestrant|mesh-list
5640873|NCT04557449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5640874|NCT04557449|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5778986|NCT02850484|Glucocorticoids|glucocorticoids|mesh-ancestor
5778987|NCT02850484|Hormones|hormones|mesh-ancestor
5778988|NCT02850484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5778989|NCT02850484|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5778990|NCT02850484|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5778991|NCT02850484|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5778992|NCT02850484|Adrenergic Agents|adrenergic agents|mesh-ancestor
5778993|NCT02850484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5778994|NCT02850484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5778995|NCT02850081|Atorvastatin|atorvastatin|mesh-list
5778996|NCT02850081|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
5778997|NCT02850081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5778998|NCT02850081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5778999|NCT02850081|Antimetabolites|antimetabolites|mesh-ancestor
5779000|NCT02850081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779001|NCT02850081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5779002|NCT02850081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5779003|NCT02849873|Tazarotene|tazarotene|mesh-list
5779004|NCT02849873|Dermatologic Agents|dermatologic agents|mesh-ancestor
5779005|NCT02849873|Keratolytic Agents|keratolytic agents|mesh-ancestor
5779006|NCT02850016|Romidepsin|romidepsin|mesh-list
5779007|NCT02850016|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
5779008|NCT02850016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5779009|NCT02850016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5779010|NCT02850016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5779011|NCT02850016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490869|NCT00600301|Bevacizumab|bevacizumab|mesh-list
6490870|NCT00600301|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6490871|NCT00600301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6490872|NCT00600301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6490873|NCT00600301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6490874|NCT00600301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5779012|NCT02849782|4-Aminopyridine|4-aminopyridine|mesh-list
5779013|NCT02849782|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5779014|NCT02849782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5779015|NCT02849782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779016|NCT02849899|Vildagliptin|vildagliptin|mesh-list
6673659|NCT01564251|Gemcitabine|gemcitabine|mesh-list
6673660|NCT01564251|GDC-0575|gdc-0575|mesh-list
6673661|NCT01564251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6673662|NCT01564251|Antimetabolites|antimetabolites|mesh-ancestor
5779017|NCT02849899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6210507|NCT02161185|GABA Modulators|gaba modulators|mesh-ancestor
6210508|NCT02161185|GABA Agents|gaba agents|mesh-ancestor
6210509|NCT02161185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6210510|NCT02161185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210511|NCT02161406|Abatacept|abatacept|mesh-list
6210512|NCT02161406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6210513|NCT02161406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210514|NCT02161406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5779018|NCT02849899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779019|NCT02849899|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5779020|NCT02849899|Protease Inhibitors|protease inhibitors|mesh-ancestor
5779021|NCT02849899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5779022|NCT02849899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779023|NCT02849743|Oxytocin|oxytocin|mesh-list
5779024|NCT02849743|Oxytocics|oxytocics|mesh-ancestor
5779025|NCT02849743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5779026|NCT02849743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779027|NCT02849483|Ramosetron|ramosetron|mesh-list
5779028|NCT02849483|Antiemetics|antiemetics|mesh-ancestor
5779029|NCT02849483|Autonomic Agents|autonomic agents|mesh-ancestor
5779030|NCT02849483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5779031|NCT02849483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210515|NCT02161406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6210516|NCT02161406|Immunologic Factors|immunologic factors|mesh-ancestor
6210517|NCT02161406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210518|NCT02161406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6210519|NCT02161458|Dexetimide|dexetimide|mesh-list
6210520|NCT02161458|Citalopram|citalopram|mesh-list
6210521|NCT02161458|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6210522|NCT02161458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6210523|NCT02161458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6210524|NCT02161458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779032|NCT02849483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5779033|NCT02849483|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6490875|NCT00600301|Growth Substances|growth substances|mesh-ancestor
6490876|NCT00600301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490877|NCT00600301|Growth Inhibitors|growth inhibitors|mesh-ancestor
6490878|NCT00600301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6490879|NCT00600301|Glucocorticoids|glucocorticoids|mesh-ancestor
6490880|NCT00600301|Hormones|hormones|mesh-ancestor
6490881|NCT00600301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5779034|NCT02849483|Serotonin Agents|serotonin agents|mesh-ancestor
5779035|NCT02849483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5779036|NCT02849483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779037|NCT02849730|Fentanyl|fentanyl|mesh-list
5779038|NCT02849730|Analgesics|analgesics|mesh-list
5779039|NCT02849730|Ropivacaine|ropivacaine|mesh-list
5779040|NCT02849730|Anesthetics, Local|anesthetics, local|mesh-ancestor
5779041|NCT02849730|Anesthetics|anesthetics|mesh-ancestor
5779042|NCT02849730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5779043|NCT02849730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779044|NCT02849730|Sensory System Agents|sensory system agents|mesh-ancestor
5779045|NCT02849730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5779046|NCT02849730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5779047|NCT02849730|Narcotics|narcotics|mesh-ancestor
5779048|NCT02849730|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5779049|NCT02849730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5779050|NCT02849730|Anesthetics, General|anesthetics, general|mesh-ancestor
5779051|NCT02849457|Vigabatrin|vigabatrin|mesh-list
5779052|NCT02849457|Anticonvulsants|anticonvulsants|mesh-ancestor
5779053|NCT02849457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5779054|NCT02849457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779055|NCT02849457|GABA Agents|gaba agents|mesh-ancestor
5779056|NCT02849457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5779057|NCT02849457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779058|NCT02849470|Complement Factor H|complement factor h|mesh-list
5779059|NCT02849470|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5779060|NCT02849470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5779061|NCT02849470|Immunologic Factors|immunologic factors|mesh-ancestor
5779062|NCT02849470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779063|NCT02849548|Suvorexant|suvorexant|mesh-list
5779064|NCT02849548|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5779065|NCT02849548|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5779066|NCT02849548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5779067|NCT02849548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779068|NCT02849548|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
5779069|NCT02849548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5779070|NCT02849548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779071|NCT02849236|Ropivacaine|ropivacaine|mesh-list
5779072|NCT02849236|Anesthetics, Local|anesthetics, local|mesh-ancestor
5779073|NCT02849236|Anesthetics|anesthetics|mesh-ancestor
5779074|NCT02849236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5779075|NCT02849236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779076|NCT02849236|Sensory System Agents|sensory system agents|mesh-ancestor
5779077|NCT02849236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5779078|NCT02848963|Ketamine|ketamine|mesh-list
5779079|NCT02848963|Propofol|propofol|mesh-list
5779080|NCT02848963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5779081|NCT02848963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5779082|NCT02848963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779083|NCT02848963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5779084|NCT02848963|Anesthetics, General|anesthetics, general|mesh-ancestor
5779085|NCT02848963|Anesthetics|anesthetics|mesh-ancestor
5779086|NCT02848963|Analgesics|analgesics|mesh-ancestor
5779087|NCT02848963|Sensory System Agents|sensory system agents|mesh-ancestor
5779088|NCT02848963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5779089|NCT02848963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5779090|NCT02848963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5779091|NCT02848963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5779092|NCT02848963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5779093|NCT02848963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779094|NCT02848937|Citric Acid|citric acid|mesh-list
5779095|NCT02848937|Sodium Citrate|sodium citrate|mesh-list
5779096|NCT02848937|Anticoagulants|anticoagulants|mesh-ancestor
5779097|NCT02848937|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5779098|NCT02848937|Chelating Agents|chelating agents|mesh-ancestor
5779099|NCT02848937|Sequestering Agents|sequestering agents|mesh-ancestor
5779100|NCT02848937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897629|NCT00096200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5897630|NCT00096200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5897631|NCT00089245|Iodine|iodine|mesh-list
5897632|NCT00089245|Cadexomer iodine|cadexomer iodine|mesh-list
5897633|NCT00089245|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5897634|NCT00089245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5897635|NCT00089245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5897636|NCT00089245|Trace Elements|trace elements|mesh-ancestor
5897637|NCT00089245|Micronutrients|micronutrients|mesh-ancestor
5779101|NCT02848950|Metformin|metformin|mesh-list
5779102|NCT02848950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5779103|NCT02848950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779104|NCT02849132|Entecavir|entecavir|mesh-list
5779105|NCT02849132|Antiviral Agents|antiviral agents|mesh-ancestor
5779106|NCT02849132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5779107|NCT02849171|Choline|choline|mesh-list
5779108|NCT02849171|Lipotropic Agents|lipotropic agents|mesh-ancestor
5779109|NCT02849171|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5779110|NCT02849171|Antimetabolites|antimetabolites|mesh-ancestor
5779111|NCT02849171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779112|NCT02849171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5779113|NCT02849171|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5779114|NCT02849171|Nootropic Agents|nootropic agents|mesh-ancestor
5779115|NCT02848612|Heparin|heparin|mesh-list
5779116|NCT02848612|Calcium heparin|calcium heparin|mesh-list
5779117|NCT02848612|Anticoagulants|anticoagulants|mesh-ancestor
5779118|NCT02848612|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5779119|NCT02848612|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5779120|NCT02848612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779121|NCT02848794|Irinotecan|irinotecan|mesh-list
5779122|NCT02848794|Apatinib|apatinib|mesh-list
5779123|NCT02848794|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5779124|NCT02848794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5779125|NCT02848794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5779126|NCT02848794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779127|NCT02848794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5779128|NCT02848794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5779129|NCT02848820|Amoxicillin|amoxicillin|mesh-list
5779130|NCT02848820|Gentamicins|gentamicins|mesh-list
5779131|NCT02848820|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5779132|NCT02848820|Clavulanic Acids|clavulanic acids|mesh-list
5779133|NCT02848820|Clavulanic Acid|clavulanic acid|mesh-list
5779134|NCT02848820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5779135|NCT02848820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5779136|NCT02848820|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5779137|NCT02848820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5779138|NCT02848820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779139|NCT02848820|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5779140|NCT02848560|Xenon|xenon|mesh-list
5779141|NCT02848560|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5779142|NCT02848560|Anesthetics, General|anesthetics, general|mesh-ancestor
5779143|NCT02848560|Anesthetics|anesthetics|mesh-ancestor
5779144|NCT02848560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5779145|NCT02848560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779146|NCT02848768|Sunitinib|sunitinib|mesh-list
5779147|NCT02848768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5779148|NCT02848768|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5779149|NCT02848768|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5779150|NCT02848768|Growth Substances|growth substances|mesh-ancestor
5779151|NCT02848768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779152|NCT02848768|Growth Inhibitors|growth inhibitors|mesh-ancestor
5779153|NCT02848768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5779154|NCT02848768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5779155|NCT02848768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779156|NCT02848508|Metformin|metformin|mesh-list
6210525|NCT02161458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6210526|NCT02161458|Serotonin Agents|serotonin agents|mesh-ancestor
6210527|NCT02161458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210528|NCT02161458|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6210529|NCT02161458|Antidepressive Agents|antidepressive agents|mesh-ancestor
6210530|NCT02161458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6210531|NCT02161458|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6210532|NCT02161458|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6210533|NCT02161458|Parasympatholytics|parasympatholytics|mesh-ancestor
6210534|NCT02161458|Autonomic Agents|autonomic agents|mesh-ancestor
6210535|NCT02161458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6210536|NCT02161458|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6210537|NCT02161458|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5779157|NCT02848508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5779158|NCT02848508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779159|NCT02848443|Trifluridine|trifluridine|mesh-list
5779160|NCT02848443|Bevacizumab|bevacizumab|mesh-list
5779161|NCT02848443|Nivolumab|nivolumab|mesh-list
5779162|NCT02848443|Oxaliplatin|oxaliplatin|mesh-list
5779163|NCT02848443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5779164|NCT02848443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5779165|NCT02848443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6210538|NCT02161458|Cholinergic Agents|cholinergic agents|mesh-ancestor
6210539|NCT02161484|Bupivacaine|bupivacaine|mesh-list
6210540|NCT02161484|Anesthetics, Local|anesthetics, local|mesh-ancestor
6210541|NCT02161484|Anesthetics|anesthetics|mesh-ancestor
6210542|NCT02161484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6210543|NCT02161484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210544|NCT02161484|Sensory System Agents|sensory system agents|mesh-ancestor
6210545|NCT02161484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6210546|NCT02161562|Omalizumab|omalizumab|mesh-list
6210547|NCT02161562|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6210548|NCT02161562|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6210549|NCT02161562|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6210550|NCT02161562|Respiratory System Agents|respiratory system agents|mesh-ancestor
6210551|NCT02161562|Immunologic Factors|immunologic factors|mesh-ancestor
5779166|NCT02848443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5779167|NCT02848443|Growth Substances|growth substances|mesh-ancestor
5779168|NCT02848443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779169|NCT02848443|Growth Inhibitors|growth inhibitors|mesh-ancestor
5779170|NCT02848443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5779171|NCT02848443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779172|NCT02848443|Antimetabolites|antimetabolites|mesh-ancestor
5779173|NCT02848443|Antiviral Agents|antiviral agents|mesh-ancestor
5779174|NCT02848443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5779175|NCT02848183|Cytarabine|cytarabine|mesh-list
5779176|NCT02848183|Etoposide|etoposide|mesh-list
5779177|NCT02848183|Mitoxantrone|mitoxantrone|mesh-list
5779178|NCT02848183|Idarubicin|idarubicin|mesh-list
5779179|NCT02848183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5779180|NCT02848183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5779181|NCT02848183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6210552|NCT02161562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210553|NCT02161575|Ranibizumab|ranibizumab|mesh-list
6210554|NCT02161575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6210555|NCT02161575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5779182|NCT02848183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5779183|NCT02848183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5779184|NCT02848183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779185|NCT02848183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5779186|NCT02848183|Antimetabolites|antimetabolites|mesh-ancestor
5779187|NCT02848183|Antiviral Agents|antiviral agents|mesh-ancestor
5779188|NCT02848183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5779189|NCT02848183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5779190|NCT02848183|Immunologic Factors|immunologic factors|mesh-ancestor
5779191|NCT02848183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779192|NCT02848183|Analgesics|analgesics|mesh-ancestor
5779193|NCT02848183|Sensory System Agents|sensory system agents|mesh-ancestor
5779194|NCT02848183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5779195|NCT02848183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5779196|NCT02848417|Curcumin|curcumin|mesh-list
5779197|NCT02848417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5779198|NCT02848417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5779199|NCT02848417|Analgesics|analgesics|mesh-ancestor
5779200|NCT02848417|Sensory System Agents|sensory system agents|mesh-ancestor
5779201|NCT02848417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5779202|NCT02848417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779203|NCT02848417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5779204|NCT02848417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5779205|NCT02848417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5779206|NCT02848417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5779207|NCT02848417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779208|NCT02848209|Phenol|phenol|mesh-list
5779209|NCT02848209|Croton Oil|croton oil|mesh-list
5779210|NCT02848209|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5779211|NCT02848209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5779212|NCT02848209|Disinfectants|disinfectants|mesh-ancestor
5779213|NCT02848209|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
5779214|NCT02848209|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5779215|NCT02848209|Dermatologic Agents|dermatologic agents|mesh-ancestor
5779216|NCT02848300|Bimatoprost|bimatoprost|mesh-list
5779217|NCT02848300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5779218|NCT02848131|Dasatinib|dasatinib|mesh-list
5779219|NCT02848131|Quercetin|quercetin|mesh-list
5779220|NCT02848131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5779221|NCT02848131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6210556|NCT02161575|Growth Substances|growth substances|mesh-ancestor
6210557|NCT02161575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210558|NCT02161575|Growth Inhibitors|growth inhibitors|mesh-ancestor
6210559|NCT02161575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6210560|NCT02161705|Ropivacaine|ropivacaine|mesh-list
6210561|NCT02161705|Anesthetics, Local|anesthetics, local|mesh-ancestor
6210562|NCT02161705|Anesthetics|anesthetics|mesh-ancestor
6210563|NCT02161705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6210564|NCT02161705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210565|NCT02161705|Sensory System Agents|sensory system agents|mesh-ancestor
6210566|NCT02161705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6210567|NCT02161718|Olanzapine|olanzapine|mesh-list
6210568|NCT02161718|Antiemetics|antiemetics|mesh-ancestor
6210569|NCT02161718|Autonomic Agents|autonomic agents|mesh-ancestor
6210570|NCT02161718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6210571|NCT02161718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210572|NCT02161718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6210573|NCT02161718|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6210574|NCT02161718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6210575|NCT02161718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6210576|NCT02161718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6210577|NCT02161718|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6210578|NCT02161718|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6210579|NCT02161718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5779222|NCT02848131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5779223|NCT02848131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779224|NCT02848131|Antioxidants|antioxidants|mesh-ancestor
5779225|NCT02848131|Protective Agents|protective agents|mesh-ancestor
5779226|NCT02848131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779227|NCT02848170|Olmesartan|olmesartan|mesh-list
5779228|NCT02848170|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
5779229|NCT02848170|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5779230|NCT02848170|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5779231|NCT02848170|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5779232|NCT02848170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779233|NCT02848339|Aspirin|aspirin|mesh-list
5779234|NCT02848339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5779235|NCT02848339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5779236|NCT02848339|Analgesics|analgesics|mesh-ancestor
5779237|NCT02848339|Sensory System Agents|sensory system agents|mesh-ancestor
5779238|NCT02848339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5779239|NCT02848339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779240|NCT02848339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5640875|NCT04557449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5640876|NCT04557449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5640877|NCT04557449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640878|NCT04557449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5640879|NCT04557449|Hormone Antagonists|hormone antagonists|mesh-ancestor
6490882|NCT00600301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6490883|NCT00600301|Immunologic Factors|immunologic factors|mesh-ancestor
6490884|NCT00600301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6490885|NCT00600301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640880|NCT04557449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5640881|NCT04557449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640882|NCT04557449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5640883|NCT04557449|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5640884|NCT04530409|Dexamethasone|dexamethasone|mesh-list
5640885|NCT04530409|Methylprednisolone|methylprednisolone|mesh-list
5640886|NCT04530409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5779241|NCT02848339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5779242|NCT02848339|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5640887|NCT04530409|Antiemetics|antiemetics|mesh-ancestor
5640888|NCT04530409|Autonomic Agents|autonomic agents|mesh-ancestor
5640889|NCT04530409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5640890|NCT04530409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640891|NCT04530409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5779243|NCT02848339|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5779244|NCT02848339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490886|NCT00600366|Insulin Aspart|insulin aspart|mesh-list
6490887|NCT00600366|Biphasic Insulins|biphasic insulins|mesh-list
6490888|NCT00600366|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6490889|NCT00600366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6490890|NCT00600366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673663|NCT01564251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673664|NCT01564251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6673665|NCT01564251|Antiviral Agents|antiviral agents|mesh-ancestor
6673666|NCT01564251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6673667|NCT01564251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6673668|NCT01564251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6673669|NCT01564251|Immunologic Factors|immunologic factors|mesh-ancestor
6673670|NCT01564251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673671|NCT01564251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6673672|NCT01564303|Acetylcysteine|acetylcysteine|mesh-list
6210580|NCT02161718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210581|NCT02161718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5779245|NCT02848339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5779246|NCT02848339|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5779247|NCT02848339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5779248|NCT02848339|Antipyretics|antipyretics|mesh-ancestor
5779249|NCT02848157|Dexmedetomidine|dexmedetomidine|mesh-list
5779250|NCT02848157|Ropivacaine|ropivacaine|mesh-list
5779251|NCT02848157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5779252|NCT02848157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5779253|NCT02848157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779254|NCT02848157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5779255|NCT02848157|Analgesics|analgesics|mesh-ancestor
5779256|NCT02848157|Sensory System Agents|sensory system agents|mesh-ancestor
5779257|NCT02848157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5779258|NCT02848157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5779259|NCT02848157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5779260|NCT02848157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5779261|NCT02848157|Adrenergic Agents|adrenergic agents|mesh-ancestor
5779262|NCT02848157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5779263|NCT02848157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779264|NCT02848157|Anesthetics, Local|anesthetics, local|mesh-ancestor
5779265|NCT02848157|Anesthetics|anesthetics|mesh-ancestor
5779266|NCT02848287|Ropivacaine|ropivacaine|mesh-list
5779267|NCT02848287|Anesthetics, Local|anesthetics, local|mesh-ancestor
5779268|NCT02848287|Anesthetics|anesthetics|mesh-ancestor
5779269|NCT02848287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5779270|NCT02848287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779271|NCT02848287|Sensory System Agents|sensory system agents|mesh-ancestor
5779272|NCT02848287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5779273|NCT02847884|Infliximab|infliximab|mesh-list
5779274|NCT02847884|Dermatologic Agents|dermatologic agents|mesh-ancestor
5779275|NCT02847884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5779276|NCT02847884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5779277|NCT02848040|Bile Acids and Salts|bile acids and salts|mesh-list
5779278|NCT02848040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5779279|NCT02847806|Insulin|insulin|mesh-list
5779280|NCT02847806|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5779281|NCT02847806|Estradiol|estradiol|mesh-list
5779282|NCT02847806|Testosterone|testosterone|mesh-list
5779283|NCT02847806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5779284|NCT02847806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779285|NCT02847806|Estrogens|estrogens|mesh-ancestor
5779286|NCT02847806|Hormones|hormones|mesh-ancestor
5779287|NCT02847806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5779288|NCT02847806|Androgens|androgens|mesh-ancestor
5779289|NCT02847702|Naproxen|naproxen|mesh-list
5779290|NCT02847702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5779291|NCT02847702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5779292|NCT02847702|Analgesics|analgesics|mesh-ancestor
5779293|NCT02847702|Sensory System Agents|sensory system agents|mesh-ancestor
5779294|NCT02847702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5779295|NCT02847702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779296|NCT02847702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5779297|NCT02847702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5779298|NCT02847702|Gout Suppressants|gout suppressants|mesh-ancestor
5779299|NCT02847702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5779300|NCT02847702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5779301|NCT02847702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779302|NCT02847442|Levodopa|levodopa|mesh-list
5779303|NCT02847442|Opicapone|opicapone|mesh-list
5779304|NCT02847442|Dopa Decarboxylase|dopa decarboxylase|mesh-list
5779305|NCT02847442|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-list
5779306|NCT02847442|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5779307|NCT02847442|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5779308|NCT02847442|Dopamine Agents|dopamine agents|mesh-ancestor
5779309|NCT02847442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5779310|NCT02847442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779311|NCT02847442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779312|NCT02847442|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
5779313|NCT02847442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5779314|NCT02847455|Rabeprazole|rabeprazole|mesh-list
5779315|NCT02847455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5779316|NCT02847455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5779317|NCT02847455|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5779318|NCT02847455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5779319|NCT02847455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779320|NCT02847559|Bevacizumab|bevacizumab|mesh-list
5779321|NCT02847559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5779322|NCT02847559|Endothelial Growth Factors|endothelial growth factors|mesh-list
5779323|NCT02847559|Antibodies|antibodies|mesh-list
5779324|NCT02847559|Immunoglobulins|immunoglobulins|mesh-list
5779325|NCT02847559|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5779326|NCT02847559|Immunoglobulin G|immunoglobulin g|mesh-list
5779327|NCT02847559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5779328|NCT02847559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5779329|NCT02847559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5779330|NCT02847559|Growth Substances|growth substances|mesh-ancestor
5779331|NCT02847559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779332|NCT02847559|Growth Inhibitors|growth inhibitors|mesh-ancestor
5779333|NCT02847559|Immunologic Factors|immunologic factors|mesh-ancestor
5779334|NCT02847429|Crenolanib|crenolanib|mesh-list
5779335|NCT02847429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5779336|NCT02847403|Exenatide|exenatide|mesh-list
5779337|NCT02847403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5779338|NCT02847403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779339|NCT02847403|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5779340|NCT02847403|Incretins|incretins|mesh-ancestor
5779341|NCT02847403|Hormones|hormones|mesh-ancestor
5779342|NCT02847403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5897638|NCT00089245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897639|NCT00089245|Immunologic Factors|immunologic factors|mesh-ancestor
5897640|NCT05065970|Felzartamab|felzartamab|mesh-list
5897641|NCT05065970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5897642|NCT05065970|Immunologic Factors|immunologic factors|mesh-ancestor
5897643|NCT05065970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897644|NCT05037994|Prednisolone|prednisolone|mesh-list
5897645|NCT05037994|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5897646|NCT05037994|Methylprednisolone|methylprednisolone|mesh-list
5897647|NCT05037994|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5897648|NCT05037994|Prednisolone acetate|prednisolone acetate|mesh-list
5897649|NCT05037994|Gabapentin|gabapentin|mesh-list
5897650|NCT05037994|Bupivacaine|bupivacaine|mesh-list
5897651|NCT05037994|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5897652|NCT05037994|Prednisolone phosphate|prednisolone phosphate|mesh-list
5897653|NCT05037994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5897654|NCT05037994|Glucocorticoids|glucocorticoids|mesh-ancestor
5897655|NCT05037994|Hormones|hormones|mesh-ancestor
5897656|NCT05037994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5897657|NCT05037994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897658|NCT05037994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5897659|NCT05037994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5897660|NCT05037994|Antiemetics|antiemetics|mesh-ancestor
5897661|NCT05037994|Autonomic Agents|autonomic agents|mesh-ancestor
5897662|NCT05037994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5897663|NCT05037994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5897664|NCT05037994|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6210582|NCT02161718|Serotonin Agents|serotonin agents|mesh-ancestor
6210583|NCT02161731|Warfarin|warfarin|mesh-list
6210584|NCT02161731|Evacetrapib|evacetrapib|mesh-list
6210585|NCT02161731|Anticoagulants|anticoagulants|mesh-ancestor
6210586|NCT02161731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6210587|NCT02161731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6210588|NCT02161731|Antimetabolites|antimetabolites|mesh-ancestor
6210589|NCT02161731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210590|NCT02161731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6210591|NCT02162433|Dexmedetomidine|dexmedetomidine|mesh-list
6210592|NCT02162433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6210593|NCT02162433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6210594|NCT02162433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210595|NCT02162433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6210596|NCT02162433|Analgesics|analgesics|mesh-ancestor
6490891|NCT00600405|Ibuprofen|ibuprofen|mesh-list
6490892|NCT00600405|Oxycodone|oxycodone|mesh-list
6490893|NCT00600405|Tamsulosin|tamsulosin|mesh-list
6490894|NCT00600405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6490895|NCT00600405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6210597|NCT02162433|Sensory System Agents|sensory system agents|mesh-ancestor
6210598|NCT02162433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6210599|NCT02162433|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6210600|NCT02162433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6210601|NCT02162433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6210602|NCT02162433|Adrenergic Agents|adrenergic agents|mesh-ancestor
6210603|NCT02162433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6490896|NCT00600405|Analgesics|analgesics|mesh-ancestor
6490897|NCT00600405|Sensory System Agents|sensory system agents|mesh-ancestor
6490898|NCT00600405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5640892|NCT04530409|Glucocorticoids|glucocorticoids|mesh-ancestor
5640893|NCT04530409|Hormones|hormones|mesh-ancestor
5640894|NCT04530409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6490899|NCT00600405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779343|NCT02847624|Tolvaptan|tolvaptan|mesh-list
5779344|NCT02847624|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
5779345|NCT02847624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779346|NCT02847624|Natriuretic Agents|natriuretic agents|mesh-ancestor
5779347|NCT02847624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779348|NCT02847481|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5779349|NCT02847481|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5779350|NCT02847481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5779351|NCT02847481|Antitubercular Agents|antitubercular agents|mesh-ancestor
6490900|NCT00600405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6490901|NCT00600405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6490902|NCT00600405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6490903|NCT00600405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6490904|NCT00600405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490905|NCT00600405|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6490906|NCT00600405|Narcotics|narcotics|mesh-ancestor
6490907|NCT00600405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6490908|NCT00600405|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6490909|NCT00600405|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6490910|NCT00600405|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6490911|NCT00600405|Adrenergic Agents|adrenergic agents|mesh-ancestor
6490912|NCT00600405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5640895|NCT04530409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5779352|NCT02847338|Amlodipine|amlodipine|mesh-list
5779353|NCT02847338|Lisinopril|lisinopril|mesh-list
5779354|NCT02847338|Chlorthalidone|chlorthalidone|mesh-list
5779355|NCT02847338|Amiloride|amiloride|mesh-list
5779356|NCT02847338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5779357|NCT02847338|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5779358|NCT02847338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5779359|NCT02847338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779360|NCT02847338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5779361|NCT02847338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779362|NCT02847338|Vasodilator Agents|vasodilator agents|mesh-ancestor
5779363|NCT02847338|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5779364|NCT02847338|Protease Inhibitors|protease inhibitors|mesh-ancestor
5779365|NCT02847338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5779366|NCT02847338|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5779367|NCT02847338|Protective Agents|protective agents|mesh-ancestor
5779368|NCT02847338|Diuretics|diuretics|mesh-ancestor
5779369|NCT02847338|Natriuretic Agents|natriuretic agents|mesh-ancestor
5779370|NCT02847338|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5779371|NCT02847338|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
5779372|NCT02847338|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5779373|NCT02847338|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
5779374|NCT02847338|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6490913|NCT00600405|Urological Agents|urological agents|mesh-ancestor
5640896|NCT04530409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5640897|NCT04530409|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5640898|NCT04530409|Protective Agents|protective agents|mesh-ancestor
5640899|NCT04521231|Blinatumomab|blinatumomab|mesh-list
5640900|NCT04521231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5640901|NCT04520217|Imipramine|imipramine|mesh-list
5640902|NCT04520217|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5640903|NCT04520217|Antidepressive Agents|antidepressive agents|mesh-ancestor
6490914|NCT00600483|Gentamicins|gentamicins|mesh-list
6490915|NCT00600483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6490916|NCT00600483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6490917|NCT00600483|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6490918|NCT00600483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6490919|NCT00600483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490920|NCT00600509|Levetiracetam|levetiracetam|mesh-list
6490921|NCT00600509|Anticonvulsants|anticonvulsants|mesh-ancestor
6490922|NCT00600509|Nootropic Agents|nootropic agents|mesh-ancestor
6490923|NCT00600535|Abiraterone Acetate|abiraterone acetate|mesh-list
6490924|NCT00600535|Glucocorticoids|glucocorticoids|mesh-list
6490925|NCT00600535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6490926|NCT00600535|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6490927|NCT00600535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6490928|NCT00600535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490929|NCT00600535|Hormone Antagonists|hormone antagonists|mesh-ancestor
6490930|NCT00600535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6490931|NCT00600535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490932|NCT00600535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6490933|NCT00600535|Hormones|hormones|mesh-ancestor
5779375|NCT02847104|Insulin|insulin|mesh-list
5779376|NCT02847104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5779377|NCT02847104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5779378|NCT02847104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779379|NCT02847013|Bupivacaine|bupivacaine|mesh-list
5779380|NCT02847013|Anesthetics, Local|anesthetics, local|mesh-ancestor
5779381|NCT02847013|Anesthetics|anesthetics|mesh-ancestor
5779382|NCT02847013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5779383|NCT02847013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779384|NCT02847013|Sensory System Agents|sensory system agents|mesh-ancestor
5779385|NCT02847013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5779386|NCT02847091|Ipragliflozin|ipragliflozin|mesh-list
5779387|NCT02847091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5779388|NCT02847091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779389|NCT02847091|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6490934|NCT00600548|Miltefosine|miltefosine|mesh-list
6490935|NCT00600548|Meglumine Antimoniate|meglumine antimoniate|mesh-list
6490936|NCT00600548|Antifungal Agents|antifungal agents|mesh-ancestor
6490937|NCT00600548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6490938|NCT00600548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6490939|NCT00600548|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6490940|NCT00600548|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6490941|NCT00600587|Gemcitabine|gemcitabine|mesh-list
6490942|NCT00600587|Carboplatin|carboplatin|mesh-list
6490943|NCT00600587|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6490944|NCT00600587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6490945|NCT00600587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6490946|NCT00600587|Antimetabolites|antimetabolites|mesh-ancestor
6490947|NCT00600587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490948|NCT00600587|Antiviral Agents|antiviral agents|mesh-ancestor
6490949|NCT00600587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6490950|NCT00600587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6490951|NCT00600587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6490952|NCT00600587|Immunologic Factors|immunologic factors|mesh-ancestor
6490953|NCT00600587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779390|NCT02847091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779391|NCT02846909|Progesterone|progesterone|mesh-list
6210604|NCT02162433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210605|NCT02162667|Trastuzumab|trastuzumab|mesh-list
6210606|NCT02162667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6210607|NCT02162667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6210608|NCT02162680|Lidocaine|lidocaine|mesh-list
6210609|NCT02162680|Anesthetics, Local|anesthetics, local|mesh-ancestor
6210610|NCT02162680|Anesthetics|anesthetics|mesh-ancestor
6210611|NCT02162680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5779392|NCT02846909|Progestins|progestins|mesh-ancestor
5779393|NCT02846909|Hormones|hormones|mesh-ancestor
5779394|NCT02846909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5779395|NCT02846909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779396|NCT02846935|Decitabine|decitabine|mesh-list
5779397|NCT02846935|Tetrahydrouridine|tetrahydrouridine|mesh-list
5779398|NCT02846935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6490954|NCT00600587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6490955|NCT00600600|Tigecycline|tigecycline|mesh-list
5779399|NCT02846935|Antimetabolites|antimetabolites|mesh-ancestor
6673673|NCT01564303|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6490956|NCT00600600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6490957|NCT00600600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5779400|NCT02846935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779401|NCT02846935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5779402|NCT02846935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5779403|NCT02847286|Dapivirine|dapivirine|mesh-list
5779404|NCT02847286|Clotrimazole|clotrimazole|mesh-list
5779405|NCT02847286|Miconazole|miconazole|mesh-list
5779406|NCT02847286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5779407|NCT02847286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5779408|NCT02847286|Antiviral Agents|antiviral agents|mesh-ancestor
5779409|NCT02847286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5779410|NCT02847286|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5779411|NCT02847286|Antifungal Agents|antifungal agents|mesh-ancestor
5779412|NCT02847286|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5779413|NCT02847286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5779414|NCT02847286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5779415|NCT02847286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779416|NCT02847286|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5779417|NCT02847286|Hormone Antagonists|hormone antagonists|mesh-ancestor
5779418|NCT02847286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5779419|NCT02847286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779420|NCT02847286|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5779421|NCT02847286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5779422|NCT02847000|Decitabine|decitabine|mesh-list
5779423|NCT02847000|Tetrahydrouridine|tetrahydrouridine|mesh-list
5779424|NCT02847000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5779425|NCT02847000|Antimetabolites|antimetabolites|mesh-ancestor
5779426|NCT02847000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779427|NCT02847000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6673674|NCT01564303|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
6673675|NCT01564303|Antiviral Agents|antiviral agents|mesh-ancestor
6673676|NCT01564303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5779428|NCT02847000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5779429|NCT02847143|Oxytocin|oxytocin|mesh-list
5779430|NCT02847143|Oxytocics|oxytocics|mesh-ancestor
5779431|NCT02847143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5779432|NCT02847143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779433|NCT02846857|Insulin|insulin|mesh-list
5779434|NCT02846857|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5779435|NCT02846857|Glucagon|glucagon|mesh-list
5779436|NCT02846857|Hormones|hormones|mesh-list
6673677|NCT01564303|Expectorants|expectorants|mesh-ancestor
6673678|NCT01564303|Respiratory System Agents|respiratory system agents|mesh-ancestor
6673679|NCT01564303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6673680|NCT01564303|Antioxidants|antioxidants|mesh-ancestor
6673681|NCT01564303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779437|NCT02846857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5779438|NCT02846857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779439|NCT02846857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5779440|NCT02846857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5779441|NCT02846623|Atezolizumab|atezolizumab|mesh-list
5779442|NCT02846623|Venetoclax|venetoclax|mesh-list
5779443|NCT02846623|Obinutuzumab|obinutuzumab|mesh-list
5779444|NCT02846623|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5779445|NCT02846623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5779446|NCT02846623|Immunologic Factors|immunologic factors|mesh-ancestor
5779447|NCT02846623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779448|NCT02846623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5779449|NCT02846701|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6490958|NCT00600600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6490959|NCT00600600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6490960|NCT00600600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6490961|NCT00600626|Insulin|insulin|mesh-list
6490962|NCT00600626|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6490963|NCT00600626|Insulin Aspart|insulin aspart|mesh-list
6490964|NCT00600626|Insulin, Long-Acting|insulin, long-acting|mesh-list
6490965|NCT00600626|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6490966|NCT00600626|Biphasic Insulins|biphasic insulins|mesh-list
6490967|NCT00600626|Isophane Insulin, Human|isophane insulin, human|mesh-list
6490968|NCT00600626|Insulin, Isophane|insulin, isophane|mesh-list
6490969|NCT00600626|Isophane insulin, beef|isophane insulin, beef|mesh-list
6490970|NCT00600626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6490971|NCT00600626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490972|NCT00600639|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5640904|NCT04520217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5640905|NCT04520217|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5640906|NCT04520217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5640907|NCT04520217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5640908|NCT04520217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640909|NCT04520217|Adrenergic Agents|adrenergic agents|mesh-ancestor
5640910|NCT04520217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5640911|NCT04520217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640912|NCT04514484|Nivolumab|nivolumab|mesh-list
5779450|NCT02846701|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5779451|NCT02846701|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5779452|NCT02846701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5779453|NCT02846701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779454|NCT02846701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5779455|NCT02846701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779456|NCT02846701|Analgesics|analgesics|mesh-ancestor
5779457|NCT02846701|Sensory System Agents|sensory system agents|mesh-ancestor
5779458|NCT02846701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5779459|NCT02846701|Antidepressive Agents|antidepressive agents|mesh-ancestor
5779460|NCT02846701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5779461|NCT02846701|Dopamine Agents|dopamine agents|mesh-ancestor
5779462|NCT02846831|Insulin|insulin|mesh-list
5779463|NCT02846831|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5779464|NCT02846831|Hormones|hormones|mesh-list
5779465|NCT02846831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5779466|NCT02846831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779467|NCT02846831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5779468|NCT02846766|Lenvatinib|lenvatinib|mesh-list
5779469|NCT02846766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5779470|NCT02846766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5779471|NCT02846766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5779472|NCT02846766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779473|NCT02846493|Dexamethasone|dexamethasone|mesh-list
5779474|NCT02846493|Bromocriptine|bromocriptine|mesh-list
5779475|NCT02846493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5779476|NCT02846493|Antiemetics|antiemetics|mesh-ancestor
5779477|NCT02846493|Autonomic Agents|autonomic agents|mesh-ancestor
5779478|NCT02846493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5779479|NCT02846493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779480|NCT02846493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5779481|NCT02846493|Glucocorticoids|glucocorticoids|mesh-ancestor
5779482|NCT02846493|Hormones|hormones|mesh-ancestor
5779483|NCT02846493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5779484|NCT02846493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5779485|NCT02846493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5779486|NCT02846493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5779487|NCT02846493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5779488|NCT02846493|Hormone Antagonists|hormone antagonists|mesh-ancestor
5779489|NCT02846493|Dopamine Agonists|dopamine agonists|mesh-ancestor
5779490|NCT02846493|Dopamine Agents|dopamine agents|mesh-ancestor
5779491|NCT02846493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5779492|NCT02846493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779493|NCT02846519|Rifampin|rifampin|mesh-list
5779494|NCT02846519|Esketamine|esketamine|mesh-list
5779495|NCT02846519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5779496|NCT02846519|Antitubercular Agents|antitubercular agents|mesh-ancestor
6490973|NCT00600639|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6490974|NCT00600639|Prednisolone|prednisolone|mesh-list
6490975|NCT00600639|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6490976|NCT00600639|Methylprednisolone|methylprednisolone|mesh-list
6490977|NCT00600639|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6490978|NCT00600639|Prednisolone acetate|prednisolone acetate|mesh-list
6490979|NCT00600639|Albuterol|albuterol|mesh-list
6490980|NCT00600639|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5779497|NCT02846519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5779498|NCT02846519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5779499|NCT02846519|Leprostatic Agents|leprostatic agents|mesh-ancestor
5779500|NCT02846519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5779501|NCT02846519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5897665|NCT05037994|Protective Agents|protective agents|mesh-ancestor
6490981|NCT00600639|Prednisolone phosphate|prednisolone phosphate|mesh-list
6490982|NCT00600639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6490983|NCT00600639|Antitubercular Agents|antitubercular agents|mesh-ancestor
6490984|NCT00600639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6490985|NCT00600639|Glucocorticoids|glucocorticoids|mesh-ancestor
5779502|NCT02846519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779503|NCT02846519|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5779504|NCT02846519|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5779505|NCT02846519|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5779506|NCT02846519|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5779507|NCT02846519|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5779508|NCT02846519|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5779509|NCT02846519|Antidepressive Agents|antidepressive agents|mesh-ancestor
5779510|NCT02846519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5779511|NCT02846506|Metformin|metformin|mesh-list
5779512|NCT02846506|Canagliflozin|canagliflozin|mesh-list
5779513|NCT02846506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5779514|NCT02846506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779515|NCT02846506|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5779516|NCT02846506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779517|NCT02846428|Cyclophosphamide|cyclophosphamide|mesh-list
5779518|NCT02846428|Docetaxel|docetaxel|mesh-list
5779519|NCT02846428|Fluorouracil|fluorouracil|mesh-list
5779520|NCT02846428|Capecitabine|capecitabine|mesh-list
5779521|NCT02846428|Epirubicin|epirubicin|mesh-list
5779522|NCT02846428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5779523|NCT02846428|Immunologic Factors|immunologic factors|mesh-ancestor
5779524|NCT02846428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779525|NCT02846428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5779526|NCT02846428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5779527|NCT02846428|Alkylating Agents|alkylating agents|mesh-ancestor
5779528|NCT02846428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779529|NCT02846428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5779530|NCT02846428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5779531|NCT02846428|Tubulin Modulators|tubulin modulators|mesh-ancestor
5779532|NCT02846428|Antimitotic Agents|antimitotic agents|mesh-ancestor
5779533|NCT02846428|Mitosis Modulators|mitosis modulators|mesh-ancestor
5779534|NCT02846428|Antimetabolites|antimetabolites|mesh-ancestor
5779535|NCT02846428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5779536|NCT02846428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5779537|NCT02846428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5779538|NCT02846428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5779539|NCT02846428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5779540|NCT02846376|Nivolumab|nivolumab|mesh-list
5779541|NCT02846376|Ipilimumab|ipilimumab|mesh-list
5779542|NCT02846376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5779543|NCT02846376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5779544|NCT02846376|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5779545|NCT02846376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779546|NCT02846155|Simethicone|simethicone|mesh-list
5779547|NCT02846155|Antifoaming Agents|antifoaming agents|mesh-ancestor
5779548|NCT02846155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779549|NCT02846155|Emollients|emollients|mesh-ancestor
5779550|NCT02846155|Dermatologic Agents|dermatologic agents|mesh-ancestor
5779551|NCT02846090|Dexmedetomidine|dexmedetomidine|mesh-list
5779552|NCT02846090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5779553|NCT02846090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5779554|NCT02846090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779555|NCT02846090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5779556|NCT02846090|Analgesics|analgesics|mesh-ancestor
5779557|NCT02846090|Sensory System Agents|sensory system agents|mesh-ancestor
5779558|NCT02846090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5779559|NCT02846090|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5779560|NCT02846090|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5779561|NCT02846090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5779562|NCT02846090|Adrenergic Agents|adrenergic agents|mesh-ancestor
5779563|NCT02846090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5779564|NCT02846090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779565|NCT02846142|Levonorgestrel|levonorgestrel|mesh-list
5779566|NCT02846142|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5779567|NCT02846142|Estradiol|estradiol|mesh-list
5779568|NCT02846142|Estrogens|estrogens|mesh-ancestor
5779569|NCT02846142|Hormones|hormones|mesh-ancestor
5779570|NCT02846142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5779571|NCT02846142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779572|NCT02846142|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5779573|NCT02846142|Contraceptive Agents|contraceptive agents|mesh-ancestor
5779574|NCT02846142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5779575|NCT02846142|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5779576|NCT02846142|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5779577|NCT02846142|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5779578|NCT02846142|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5779579|NCT02846025|Folic Acid|folic acid|mesh-list
6210612|NCT02162680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210613|NCT02162680|Sensory System Agents|sensory system agents|mesh-ancestor
6210614|NCT02162680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6210615|NCT02162680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6210616|NCT02162680|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5779580|NCT02846025|Vitamin B Complex|vitamin b complex|mesh-list
5779581|NCT02846025|Antioxidants|antioxidants|mesh-list
5779582|NCT02846025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779583|NCT02846025|Protective Agents|protective agents|mesh-ancestor
5779584|NCT02846025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779585|NCT02846025|Hematinics|hematinics|mesh-ancestor
5779586|NCT02846025|Vitamins|vitamins|mesh-ancestor
5779587|NCT02846025|Micronutrients|micronutrients|mesh-ancestor
5897666|NCT05037994|Analgesics|analgesics|mesh-ancestor
5897667|NCT05037994|Sensory System Agents|sensory system agents|mesh-ancestor
5897668|NCT05037994|Anticonvulsants|anticonvulsants|mesh-ancestor
5897669|NCT05037994|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5897670|NCT05037994|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5897671|NCT05037994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5897672|NCT05037994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5897673|NCT05037994|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5897674|NCT05037994|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5897675|NCT05037994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5897676|NCT05037994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897677|NCT05037994|Antimanic Agents|antimanic agents|mesh-ancestor
5897678|NCT05037994|Anesthetics, Local|anesthetics, local|mesh-ancestor
5897679|NCT05037994|Anesthetics|anesthetics|mesh-ancestor
5897680|NCT05036434|Pembrolizumab|pembrolizumab|mesh-list
5897681|NCT05036434|Lenvatinib|lenvatinib|mesh-list
5897682|NCT05036434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5897683|NCT05036434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5897684|NCT05036434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5897685|NCT05036434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5897686|NCT05036434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897687|NCT05018117|Nicotine|nicotine|mesh-list
5897688|NCT05018117|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5897689|NCT05018117|Autonomic Agents|autonomic agents|mesh-ancestor
5897690|NCT05018117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5897691|NCT05018117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897692|NCT05018117|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5897693|NCT05018117|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5897694|NCT05018117|Cholinergic Agents|cholinergic agents|mesh-ancestor
5897695|NCT05018117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5907983|NCT04973566|Hydroxychloroquine|hydroxychloroquine|mesh-list
6490986|NCT00600639|Hormones|hormones|mesh-ancestor
6210617|NCT02162680|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6210618|NCT02162680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6210619|NCT02162680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210620|NCT02162719|Paclitaxel|paclitaxel|mesh-list
6210621|NCT02162719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6210622|NCT02162719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6210623|NCT02162719|Tubulin Modulators|tubulin modulators|mesh-ancestor
6210624|NCT02162719|Antimitotic Agents|antimitotic agents|mesh-ancestor
6210625|NCT02162719|Mitosis Modulators|mitosis modulators|mesh-ancestor
6210626|NCT02162719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210627|NCT02162758|Dexlansoprazole|dexlansoprazole|mesh-list
6210628|NCT02162758|Lansoprazole|lansoprazole|mesh-list
6210629|NCT02162758|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6210630|NCT02162758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6210631|NCT02162758|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6210632|NCT02162758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6210633|NCT02162758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210634|NCT02162771|Prednisone|prednisone|mesh-list
6210635|NCT02162771|Prednisolone|prednisolone|mesh-list
6210636|NCT02162771|Cyclophosphamide|cyclophosphamide|mesh-list
6210637|NCT02162771|Rituximab|rituximab|mesh-list
6210638|NCT02162771|Vincristine|vincristine|mesh-list
6210639|NCT02162771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6210640|NCT02162771|Immunologic Factors|immunologic factors|mesh-ancestor
6210641|NCT02162771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210642|NCT02162771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6490987|NCT00600639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6490988|NCT00600639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6490989|NCT00600639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6490990|NCT00600639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6490991|NCT00600639|Antiemetics|antiemetics|mesh-ancestor
6490992|NCT00600639|Autonomic Agents|autonomic agents|mesh-ancestor
6490993|NCT00600639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6490994|NCT00600639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5779588|NCT02845804|Everolimus|everolimus|mesh-list
5779589|NCT02845804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5779590|NCT02845804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5779591|NCT02845804|Immunologic Factors|immunologic factors|mesh-ancestor
5779592|NCT02845804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779593|NCT02845856|Cetuximab|cetuximab|mesh-list
5779594|NCT02845856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5779595|NCT02845856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5779596|NCT02845843|Interferons|interferons|mesh-list
5779597|NCT02845843|Ritonavir|ritonavir|mesh-list
5779598|NCT02845843|Lopinavir|lopinavir|mesh-list
5779599|NCT02845843|Interferon-beta|interferon-beta|mesh-list
5779600|NCT02845843|Interferon beta-1b|interferon beta-1b|mesh-list
5779601|NCT02845843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5779602|NCT02845843|Antiviral Agents|antiviral agents|mesh-ancestor
5779603|NCT02845843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5779604|NCT02845843|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5779605|NCT02845843|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5779606|NCT02845843|Protease Inhibitors|protease inhibitors|mesh-ancestor
5779607|NCT02845843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5779608|NCT02845843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779609|NCT02845843|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5779610|NCT02845843|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5779611|NCT02845843|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5779612|NCT02845843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5779613|NCT02845843|Immunologic Factors|immunologic factors|mesh-ancestor
5779614|NCT02845843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779615|NCT02845843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5779616|NCT02845661|Dexmedetomidine|dexmedetomidine|mesh-list
5779617|NCT02845661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5779618|NCT02845661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5779619|NCT02845661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779620|NCT02845661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5779621|NCT02845661|Analgesics|analgesics|mesh-ancestor
5779622|NCT02845661|Sensory System Agents|sensory system agents|mesh-ancestor
6490995|NCT00600639|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6490996|NCT00600639|Protective Agents|protective agents|mesh-ancestor
5779623|NCT02845661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5779624|NCT02845661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5779625|NCT02845661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5779626|NCT02845661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5779627|NCT02845661|Adrenergic Agents|adrenergic agents|mesh-ancestor
5779628|NCT02845661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5779629|NCT02845661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779630|NCT02845908|Leucovorin|leucovorin|mesh-list
5779631|NCT02845908|Fluorouracil|fluorouracil|mesh-list
5779632|NCT02845908|Oxaliplatin|oxaliplatin|mesh-list
5779633|NCT02845908|Antimetabolites|antimetabolites|mesh-ancestor
5779634|NCT02845908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779635|NCT02845908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5779636|NCT02845908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5779637|NCT02845908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5779638|NCT02845908|Immunologic Factors|immunologic factors|mesh-ancestor
5779639|NCT02845908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779640|NCT02845908|Antidotes|antidotes|mesh-ancestor
5779641|NCT02845908|Protective Agents|protective agents|mesh-ancestor
5779642|NCT02845908|Vitamin B Complex|vitamin b complex|mesh-ancestor
5779643|NCT02845908|Vitamins|vitamins|mesh-ancestor
5779644|NCT02845908|Micronutrients|micronutrients|mesh-ancestor
5779645|NCT02845999|Cyclophosphamide|cyclophosphamide|mesh-list
5779646|NCT02845999|Fludarabine|fludarabine|mesh-list
5779647|NCT02845999|Cetuximab|cetuximab|mesh-list
5779648|NCT02845999|Interleukin-2|interleukin-2|mesh-list
5779649|NCT02845999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5779650|NCT02845999|Immunologic Factors|immunologic factors|mesh-ancestor
5779651|NCT02845999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779652|NCT02845999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5779653|NCT02845999|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5779654|NCT02845999|Alkylating Agents|alkylating agents|mesh-ancestor
5779655|NCT02845999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779656|NCT02845999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5779657|NCT02845999|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5779658|NCT02845999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5779659|NCT02845999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5779660|NCT02845999|Analgesics|analgesics|mesh-ancestor
5779661|NCT02845999|Sensory System Agents|sensory system agents|mesh-ancestor
5779662|NCT02845999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5779663|NCT02845882|Cytarabine|cytarabine|mesh-list
5779664|NCT02845882|Dexamethasone|dexamethasone|mesh-list
5779665|NCT02845882|Dexamethasone acetate|dexamethasone acetate|mesh-list
5779666|NCT02845882|Prednisone|prednisone|mesh-list
5779667|NCT02845882|Cyclophosphamide|cyclophosphamide|mesh-list
5779668|NCT02845882|Ifosfamide|ifosfamide|mesh-list
5779669|NCT02845882|Doxorubicin|doxorubicin|mesh-list
5779670|NCT02845882|Methotrexate|methotrexate|mesh-list
5779671|NCT02845882|Etoposide|etoposide|mesh-list
5779672|NCT02845882|Vincristine|vincristine|mesh-list
5779673|NCT02845882|Daunorubicin|daunorubicin|mesh-list
5779674|NCT02845882|Asparaginase|asparaginase|mesh-list
5779675|NCT02845882|Mercaptopurine|mercaptopurine|mesh-list
5779676|NCT02845882|Vindesine|vindesine|mesh-list
5779677|NCT02845882|Pegaspargase|pegaspargase|mesh-list
5779678|NCT02845882|BB 1101|bb 1101|mesh-list
5779679|NCT02845882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5779680|NCT02845882|Immunologic Factors|immunologic factors|mesh-ancestor
5779681|NCT02845882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779682|NCT02845882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5779683|NCT02845882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5779684|NCT02845882|Alkylating Agents|alkylating agents|mesh-ancestor
5779685|NCT02845882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779686|NCT02845882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6673682|NCT01564303|Protective Agents|protective agents|mesh-ancestor
6673683|NCT01564303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673684|NCT01564303|Antidotes|antidotes|mesh-ancestor
6673685|NCT01564303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6673686|NCT01564303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5779687|NCT02845882|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5779688|NCT02845882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5779689|NCT02845882|Antiemetics|antiemetics|mesh-ancestor
5779690|NCT02845882|Autonomic Agents|autonomic agents|mesh-ancestor
5779691|NCT02845882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5779692|NCT02845882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6210643|NCT02162771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6210644|NCT02162771|Alkylating Agents|alkylating agents|mesh-ancestor
6210645|NCT02162771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210646|NCT02162771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6210647|NCT02162771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6210648|NCT02162771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6210649|NCT02162771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6210650|NCT02162771|Glucocorticoids|glucocorticoids|mesh-ancestor
6210651|NCT02162771|Hormones|hormones|mesh-ancestor
6210652|NCT02162771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6210653|NCT02162771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6210654|NCT02162771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6210655|NCT02162771|Tubulin Modulators|tubulin modulators|mesh-ancestor
6210656|NCT02162771|Antimitotic Agents|antimitotic agents|mesh-ancestor
6210657|NCT02162771|Mitosis Modulators|mitosis modulators|mesh-ancestor
6210658|NCT02162862|Bupropion|bupropion|mesh-list
6675580|NCT01576419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5779693|NCT02845882|Glucocorticoids|glucocorticoids|mesh-ancestor
5779694|NCT02845882|Hormones|hormones|mesh-ancestor
5779695|NCT02845882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5779696|NCT02845882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6210659|NCT02162862|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6210660|NCT02162862|Antidepressive Agents|antidepressive agents|mesh-ancestor
6210661|NCT02162862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6490997|NCT00600639|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6673687|NCT01564329|Endostar protein|endostar protein|mesh-list
5779697|NCT02845882|Protease Inhibitors|protease inhibitors|mesh-ancestor
5779698|NCT02845882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5779699|NCT02845882|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5779700|NCT02845882|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5779701|NCT02845882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5779702|NCT02845882|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5779703|NCT02845882|Abortifacient Agents|abortifacient agents|mesh-ancestor
5779704|NCT02845882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5779705|NCT02845882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5779706|NCT02845882|Antimetabolites|antimetabolites|mesh-ancestor
5779707|NCT02845882|Dermatologic Agents|dermatologic agents|mesh-ancestor
5779708|NCT02845882|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5779709|NCT02845882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5779710|NCT02845882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5779711|NCT02845882|Antiviral Agents|antiviral agents|mesh-ancestor
5779712|NCT02845882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5779713|NCT02845882|Tubulin Modulators|tubulin modulators|mesh-ancestor
5779714|NCT02845882|Antimitotic Agents|antimitotic agents|mesh-ancestor
5779715|NCT02845882|Mitosis Modulators|mitosis modulators|mesh-ancestor
5779716|NCT02845648|Cholinergic Antagonists|cholinergic antagonists|mesh-list
5779717|NCT02845648|Cholinergic Agents|cholinergic agents|mesh-ancestor
5779718|NCT02845648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5779719|NCT02845648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779720|NCT02845648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779721|NCT02845986|Oxaliplatin|oxaliplatin|mesh-list
5779722|NCT02845986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5779723|NCT02845778|Melatonin|melatonin|mesh-list
5779724|NCT02845778|Antioxidants|antioxidants|mesh-ancestor
5779725|NCT02845778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779726|NCT02845778|Protective Agents|protective agents|mesh-ancestor
5779727|NCT02845778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779728|NCT02845778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6673688|NCT01564329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6673689|NCT01564329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6673690|NCT01564329|Growth Substances|growth substances|mesh-ancestor
6673691|NCT01564329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779729|NCT02845713|Ivermectin|ivermectin|mesh-list
5779730|NCT02845713|Albendazole|albendazole|mesh-list
5779731|NCT02845713|Diethylcarbamazine|diethylcarbamazine|mesh-list
5779732|NCT02845713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5779733|NCT02845713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5779734|NCT02845713|Anthelmintics|anthelmintics|mesh-ancestor
5779735|NCT02845713|Anticestodal Agents|anticestodal agents|mesh-ancestor
5779736|NCT02845713|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5779737|NCT02845713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5779738|NCT02845713|Tubulin Modulators|tubulin modulators|mesh-ancestor
5779739|NCT02845713|Antimitotic Agents|antimitotic agents|mesh-ancestor
5779740|NCT02845713|Mitosis Modulators|mitosis modulators|mesh-ancestor
5779741|NCT02845713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779742|NCT02845713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5779743|NCT02845713|Filaricides|filaricides|mesh-ancestor
5779744|NCT02845713|Antinematodal Agents|antinematodal agents|mesh-ancestor
5779745|NCT02845713|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
5779746|NCT02845713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5779747|NCT02845765|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
5779748|NCT02845765|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5779749|NCT02845765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5779750|NCT02845765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779751|NCT02845570|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5779752|NCT02845570|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5779753|NCT02845570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779754|NCT02845271|Acetaminophen|acetaminophen|mesh-list
5779755|NCT02845271|Tramadol|tramadol|mesh-list
5779756|NCT02845271|Codeine|codeine|mesh-list
5779757|NCT02845271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5779758|NCT02845271|Analgesics|analgesics|mesh-ancestor
5779759|NCT02845271|Sensory System Agents|sensory system agents|mesh-ancestor
5779760|NCT02845271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5779761|NCT02845271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779762|NCT02845271|Antipyretics|antipyretics|mesh-ancestor
5779763|NCT02845271|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5779764|NCT02845271|Narcotics|narcotics|mesh-ancestor
5779765|NCT02845271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5779766|NCT02845271|Antitussive Agents|antitussive agents|mesh-ancestor
5779767|NCT02845271|Respiratory System Agents|respiratory system agents|mesh-ancestor
5779768|NCT02845388|Sildenafil Citrate|sildenafil citrate|mesh-list
5779769|NCT02845388|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5779770|NCT02845388|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5779771|NCT02845388|Estradiol|estradiol|mesh-list
5779772|NCT02845388|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5779773|NCT02845388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779774|NCT02845388|Estrogens|estrogens|mesh-ancestor
5779775|NCT02845388|Hormones|hormones|mesh-ancestor
5779776|NCT02845388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5779777|NCT02845388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779778|NCT02845388|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5779779|NCT02845388|Contraceptive Agents|contraceptive agents|mesh-ancestor
5779780|NCT02845388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5779781|NCT02845388|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5779782|NCT02845388|Vasodilator Agents|vasodilator agents|mesh-ancestor
5779783|NCT02845388|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5779784|NCT02845388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5779785|NCT02845388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5779786|NCT02845388|Urological Agents|urological agents|mesh-ancestor
5779787|NCT02845466|Becaplermin|becaplermin|mesh-list
5779788|NCT02845466|Anticoagulants|anticoagulants|mesh-ancestor
5779789|NCT02845466|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
5779790|NCT02845466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5779791|NCT02845466|Growth Substances|growth substances|mesh-ancestor
5779792|NCT02845466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779793|NCT02845349|Vortioxetine|vortioxetine|mesh-list
5779794|NCT02845349|Antidepressive Agents|antidepressive agents|mesh-ancestor
5779795|NCT02845349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5779796|NCT02845349|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5779797|NCT02845349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5779798|NCT02845349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5779799|NCT02845349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779800|NCT02845349|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5779801|NCT02845349|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5779802|NCT02845349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5779803|NCT02845349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779804|NCT02845349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5779805|NCT02845349|Serotonin Agents|serotonin agents|mesh-ancestor
5779806|NCT02845349|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5779807|NCT02845349|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5779808|NCT02845349|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5779809|NCT02845349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5779810|NCT02845453|Quetiapine Fumarate|quetiapine fumarate|mesh-list
5779811|NCT02845453|Antidepressive Agents|antidepressive agents|mesh-ancestor
5779812|NCT02845453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5779813|NCT02845453|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5779814|NCT02845453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5779815|NCT02845453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5779816|NCT02845453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779817|NCT02845219|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
5779818|NCT02845219|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
5779819|NCT02845219|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5779820|NCT02845219|Contraceptive Agents|contraceptive agents|mesh-ancestor
5779821|NCT02845219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5779822|NCT02845219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779823|NCT02845219|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5779824|NCT02845219|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5779825|NCT02845219|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5779826|NCT02845219|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5779827|NCT02845219|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5779828|NCT02845219|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
5779829|NCT02845219|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5779830|NCT02845219|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5779831|NCT02845024|Doxycycline|doxycycline|mesh-list
5779832|NCT02845024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5779833|NCT02845024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5779834|NCT02845024|Antimalarials|antimalarials|mesh-ancestor
5779835|NCT02845024|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5779836|NCT02845024|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5779837|NCT02844894|Dexmedetomidine|dexmedetomidine|mesh-list
5779838|NCT02844894|Esmolol|esmolol|mesh-list
5779839|NCT02844894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5779840|NCT02844894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5779841|NCT02844894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779842|NCT02844894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5779843|NCT02844894|Analgesics|analgesics|mesh-ancestor
5779844|NCT02844894|Sensory System Agents|sensory system agents|mesh-ancestor
5779845|NCT02844894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5779846|NCT02844894|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5779847|NCT02844894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5779848|NCT02844894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5779849|NCT02844894|Adrenergic Agents|adrenergic agents|mesh-ancestor
5779850|NCT02844894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5779851|NCT02844894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779852|NCT02844894|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5779853|NCT02844894|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5779854|NCT02844894|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5779855|NCT02844907|Dexamethasone|dexamethasone|mesh-list
5779856|NCT02844907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5779857|NCT02844907|Antiemetics|antiemetics|mesh-ancestor
5779858|NCT02844907|Autonomic Agents|autonomic agents|mesh-ancestor
5779859|NCT02844907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5779860|NCT02844907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779861|NCT02844907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5779862|NCT02844907|Glucocorticoids|glucocorticoids|mesh-ancestor
5779863|NCT02844907|Hormones|hormones|mesh-ancestor
5779864|NCT02844907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5779865|NCT02844907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5779866|NCT02844907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5779867|NCT02844790|Insulin|insulin|mesh-list
5779868|NCT02844790|Insulin Aspart|insulin aspart|mesh-list
5779869|NCT02844790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5779870|NCT02844790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779871|NCT02844933|Cannabidiol|cannabidiol|mesh-list
5779872|NCT02844933|Anticonvulsants|anticonvulsants|mesh-ancestor
5779873|NCT02844881|Apatinib|apatinib|mesh-list
5779874|NCT02844881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5779875|NCT02844881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5779876|NCT02844881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5779877|NCT02844881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779878|NCT02844712|beta-Lactams|beta-lactams|mesh-list
5779879|NCT02844712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5779880|NCT02844712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5779881|NCT02845050|Cisplatin|cisplatin|mesh-list
5779882|NCT02845050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5779883|NCT02844621|Omeprazole|omeprazole|mesh-list
5779884|NCT02844621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5779885|NCT02844621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5779886|NCT02844621|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5779887|NCT02844621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5779888|NCT02844621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779889|NCT02844673|Hydroxyurea|hydroxyurea|mesh-list
5779890|NCT02844673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5779891|NCT02844673|Antisickling Agents|antisickling agents|mesh-ancestor
5779892|NCT02844673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5779893|NCT02844673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779894|NCT02844673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5779895|NCT02844803|Metformin|metformin|mesh-list
5779896|NCT02844803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5779897|NCT02844803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779898|NCT02844530|Epratuzumab|epratuzumab|mesh-list
5779899|NCT02844530|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
5779900|NCT02844530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5779901|NCT02844530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5779902|NCT02844530|Chelating Agents|chelating agents|mesh-ancestor
5779903|NCT02844530|Sequestering Agents|sequestering agents|mesh-ancestor
5779904|NCT02844530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779905|NCT02844517|Pancrelipase|pancrelipase|mesh-list
5779906|NCT02844517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5779907|NCT02844634|Tenofovir|tenofovir|mesh-list
5779908|NCT02844634|Emtricitabine|emtricitabine|mesh-list
5779909|NCT02844634|Doxycycline|doxycycline|mesh-list
5779910|NCT02844634|Antiviral Agents|antiviral agents|mesh-ancestor
5779911|NCT02844634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5779912|NCT02844634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5779913|NCT02844634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5779914|NCT02844634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5779915|NCT02844634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779916|NCT02844634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6210662|NCT02162862|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6210663|NCT02162862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6210664|NCT02162862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6210665|NCT02162862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210666|NCT02162862|Dopamine Agents|dopamine agents|mesh-ancestor
6210667|NCT02162862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6210668|NCT02162862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210669|NCT02162862|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6210670|NCT02162862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6210671|NCT02162862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6210672|NCT02163421|Vedolizumab|vedolizumab|mesh-list
6490998|NCT00600639|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5779917|NCT02844634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5779918|NCT02844634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5779919|NCT02844634|Antimalarials|antimalarials|mesh-ancestor
5779920|NCT02844634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5779921|NCT02844634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5897696|NCT05018117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897697|NCT05002738|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5897698|NCT05002738|Desogestrel|desogestrel|mesh-list
5897699|NCT05002738|Estradiol|estradiol|mesh-list
5897700|NCT05002738|Estrogens|estrogens|mesh-ancestor
5897701|NCT05002738|Hormones|hormones|mesh-ancestor
5897702|NCT05002738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5897703|NCT05002738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897704|NCT05002738|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5897705|NCT05002738|Contraceptive Agents|contraceptive agents|mesh-ancestor
5897706|NCT05002738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5897707|NCT05002738|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5897708|NCT05002738|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5897709|NCT05002738|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5897710|NCT05002738|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5897711|NCT05002738|Progestins|progestins|mesh-ancestor
5897712|NCT05000294|Atezolizumab|atezolizumab|mesh-list
5897713|NCT05000294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5897714|NCT04984616|Atorvastatin|atorvastatin|mesh-list
5897715|NCT04984616|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5897716|NCT04984616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5897717|NCT04984616|Antimetabolites|antimetabolites|mesh-ancestor
5897718|NCT04984616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897719|NCT04984616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5897720|NCT04984616|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5897721|NCT04984616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5897722|NCT04972396|Metformin|metformin|mesh-list
5897723|NCT04972396|Digoxin|digoxin|mesh-list
5897724|NCT04972396|Warfarin|warfarin|mesh-list
5897725|NCT04972396|Atorvastatin|atorvastatin|mesh-list
5897726|NCT04972396|Levonorgestrel|levonorgestrel|mesh-list
5897727|NCT04972396|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5897728|NCT04972396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5897729|NCT04972396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897730|NCT04972396|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5897731|NCT04972396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5897732|NCT04972396|Antimetabolites|antimetabolites|mesh-ancestor
5897733|NCT04972396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897734|NCT04972396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5897735|NCT04972396|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5897736|NCT04972396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5897737|NCT04972396|Anticoagulants|anticoagulants|mesh-ancestor
5897738|NCT04972396|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5897739|NCT04972396|Contraceptive Agents|contraceptive agents|mesh-ancestor
5897740|NCT04972396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5897741|NCT04972396|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5897742|NCT04972396|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5897743|NCT04972396|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5897744|NCT04972396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5897745|NCT04972396|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5897746|NCT04972396|Protective Agents|protective agents|mesh-ancestor
5779922|NCT02844153|Metformin|metformin|mesh-list
5779923|NCT02844153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5779924|NCT02844153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779925|NCT02844387|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5779926|NCT02844322|Rituximab|rituximab|mesh-list
5779927|NCT02844322|Bortezomib|bortezomib|mesh-list
5779928|NCT02844322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5779929|NCT02844322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5779930|NCT02844322|Immunologic Factors|immunologic factors|mesh-ancestor
5779931|NCT02844322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779932|NCT02844322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5779933|NCT02844075|Pembrolizumab|pembrolizumab|mesh-list
5779934|NCT02844075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5779935|NCT02844075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5779936|NCT02844309|Thalidomide|thalidomide|mesh-list
5779937|NCT02844309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5779938|NCT02844309|Immunologic Factors|immunologic factors|mesh-ancestor
5779939|NCT02844309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779940|NCT02844309|Leprostatic Agents|leprostatic agents|mesh-ancestor
5779941|NCT02844309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5779942|NCT02844309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5779943|NCT02844309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5779944|NCT02844309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5779945|NCT02844309|Growth Substances|growth substances|mesh-ancestor
5779946|NCT02844309|Growth Inhibitors|growth inhibitors|mesh-ancestor
5779947|NCT02844309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5779948|NCT05243199|Valsartan|valsartan|mesh-list
5779949|NCT05243199|Irbesartan|irbesartan|mesh-list
5779950|NCT05243199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5779951|NCT05243199|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5779952|NCT05243199|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5779953|NCT05243199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779954|NCT05243186|Methylphenidate|methylphenidate|mesh-list
5779955|NCT05243186|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5779956|NCT05243186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779957|NCT05243186|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5779958|NCT05243186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5779959|NCT05243186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5779960|NCT05243186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779961|NCT05243186|Dopamine Agents|dopamine agents|mesh-ancestor
5779962|NCT05243186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5779963|NCT05243147|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
5779964|NCT05243147|Hemostatics|hemostatics|mesh-ancestor
5779965|NCT05243147|Coagulants|coagulants|mesh-ancestor
5779966|NCT05242965|Vaccines|vaccines|mesh-list
5779967|NCT05242965|Sargramostim|sargramostim|mesh-list
5779968|NCT05242965|Immunologic Factors|immunologic factors|mesh-ancestor
5779969|NCT05242965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779970|NCT05242926|Docetaxel|docetaxel|mesh-list
5779971|NCT05242926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5779972|NCT05242926|Tubulin Modulators|tubulin modulators|mesh-ancestor
6673692|NCT01564329|Growth Inhibitors|growth inhibitors|mesh-ancestor
6490999|NCT00600639|Respiratory System Agents|respiratory system agents|mesh-ancestor
6491000|NCT00600639|Tocolytic Agents|tocolytic agents|mesh-ancestor
5640913|NCT04514484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5640914|NCT04514484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5640915|NCT04514484|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5640916|NCT04514484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640917|NCT04505774|Dapagliflozin|dapagliflozin|mesh-list
5640918|NCT04505774|Empagliflozin|empagliflozin|mesh-list
5640919|NCT04505774|Canagliflozin|canagliflozin|mesh-list
5640920|NCT04505774|Ertugliflozin|ertugliflozin|mesh-list
5640921|NCT04505774|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
5640922|NCT04505774|Heparin|heparin|mesh-list
5640923|NCT04505774|Calcium heparin|calcium heparin|mesh-list
5640924|NCT04505774|Enoxaparin|enoxaparin|mesh-list
5640925|NCT04505774|Dalteparin|dalteparin|mesh-list
5640926|NCT04505774|Tinzaparin|tinzaparin|mesh-list
5640927|NCT04505774|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5640928|NCT04505774|Enoxaparin sodium|enoxaparin sodium|mesh-list
5640929|NCT04505774|Clopidogrel|clopidogrel|mesh-list
5640930|NCT04505774|Ticagrelor|ticagrelor|mesh-list
5640931|NCT04505774|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5640932|NCT04505774|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5640933|NCT04505774|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5640934|NCT04505774|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6491001|NCT00600639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5640935|NCT04505774|Purinergic Agents|purinergic agents|mesh-ancestor
5640936|NCT04505774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5640937|NCT04505774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640938|NCT04505774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640939|NCT04505774|Anticoagulants|anticoagulants|mesh-ancestor
5640940|NCT04505774|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5640941|NCT04505774|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5779973|NCT05242926|Antimitotic Agents|antimitotic agents|mesh-ancestor
5779974|NCT05242926|Mitosis Modulators|mitosis modulators|mesh-ancestor
5779975|NCT05242926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779976|NCT05242874|Olanzapine|olanzapine|mesh-list
5779977|NCT05242874|Fosaprepitant|fosaprepitant|mesh-list
5779978|NCT05242874|Aprepitant|aprepitant|mesh-list
5779979|NCT05242874|Tropisetron|tropisetron|mesh-list
5779980|NCT05242874|Antiemetics|antiemetics|mesh-ancestor
5779981|NCT05242874|Autonomic Agents|autonomic agents|mesh-ancestor
5779982|NCT05242874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5779983|NCT05242874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5779984|NCT05242874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5779985|NCT05242874|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5779986|NCT05242874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5779987|NCT05242874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5779988|NCT05242874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5779989|NCT05242874|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5779990|NCT05242874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5779991|NCT05242874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5779992|NCT05242874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5779993|NCT05242874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5779994|NCT05242874|Serotonin Agents|serotonin agents|mesh-ancestor
6491002|NCT00600639|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6491003|NCT00600639|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6491004|NCT00600639|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6491005|NCT00600639|Adrenergic Agents|adrenergic agents|mesh-ancestor
6491006|NCT00600639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6491007|NCT00600639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491008|NCT00600691|Finasteride|finasteride|mesh-list
6491009|NCT00600691|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6491010|NCT00600691|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6491011|NCT00600691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6491012|NCT00600691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491013|NCT00600691|Hormone Antagonists|hormone antagonists|mesh-ancestor
6491014|NCT00600691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6491015|NCT00600691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491016|NCT00600691|Urological Agents|urological agents|mesh-ancestor
6491017|NCT00600730|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6491018|NCT00600730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491019|NCT00600769|Clarithromycin|clarithromycin|mesh-list
6491020|NCT00600769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5640942|NCT04505774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5640943|NCT04504812|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5640944|NCT04504812|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5640945|NCT04504812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5640946|NCT04504812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5640947|NCT04504812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640948|NCT04504812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5779995|NCT05242874|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6491021|NCT00600769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5779996|NCT05242874|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5779997|NCT05242874|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5779998|NCT05242783|Terlipressin|terlipressin|mesh-list
6491022|NCT00600769|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6491023|NCT00600769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6491024|NCT00600769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491025|NCT00600769|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6491026|NCT00600769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6491027|NCT00600847|Loratadine|loratadine|mesh-list
6491028|NCT00600847|Desloratadine|desloratadine|mesh-list
6210673|NCT02163421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6212591|NCT02191033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6212592|NCT02191033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212593|NCT02191033|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5779999|NCT05242783|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5780000|NCT05242783|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5780001|NCT05242718|Acetylcysteine|acetylcysteine|mesh-list
5780002|NCT05242718|Palmidrol|palmidrol|mesh-list
5780003|NCT05242718|Curcumin|curcumin|mesh-list
5780004|NCT05242718|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5780005|NCT05242718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5780006|NCT05242718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5780007|NCT05242718|Analgesics|analgesics|mesh-ancestor
5780008|NCT05242718|Sensory System Agents|sensory system agents|mesh-ancestor
5780009|NCT05242718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5780010|NCT05242718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780011|NCT05242718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5780012|NCT05242718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5780013|NCT05242718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5780014|NCT05242718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5640949|NCT04504812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640950|NCT04504812|Analgesics|analgesics|mesh-ancestor
5640951|NCT04504812|Sensory System Agents|sensory system agents|mesh-ancestor
5640952|NCT04504812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5640953|NCT04504812|Antidepressive Agents|antidepressive agents|mesh-ancestor
5640954|NCT04504812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5640955|NCT04504812|Dopamine Agents|dopamine agents|mesh-ancestor
5780015|NCT05242718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780016|NCT05242718|Antiviral Agents|antiviral agents|mesh-ancestor
5780017|NCT05242718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5780018|NCT05242718|Expectorants|expectorants|mesh-ancestor
5780019|NCT05242718|Respiratory System Agents|respiratory system agents|mesh-ancestor
5780020|NCT05242718|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5780021|NCT05242718|Antioxidants|antioxidants|mesh-ancestor
5780022|NCT05242718|Protective Agents|protective agents|mesh-ancestor
5780023|NCT05242718|Antidotes|antidotes|mesh-ancestor
5780024|NCT05242718|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5780025|NCT05242718|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5780026|NCT05242718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5780027|NCT05242718|Hormones|hormones|mesh-ancestor
5780028|NCT05242718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5780029|NCT05242705|Cystatins|cystatins|mesh-list
5780030|NCT05242705|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
5780031|NCT05242705|Protease Inhibitors|protease inhibitors|mesh-ancestor
5780032|NCT05242705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5780033|NCT05242705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780034|NCT05242692|Dexmedetomidine|dexmedetomidine|mesh-list
5780035|NCT05242692|Ketamine|ketamine|mesh-list
5780036|NCT05242692|Esketamine|esketamine|mesh-list
5780037|NCT05242692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5780038|NCT05242692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5780039|NCT05242692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780040|NCT05242692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5780041|NCT05242692|Analgesics|analgesics|mesh-ancestor
5780042|NCT05242692|Sensory System Agents|sensory system agents|mesh-ancestor
5780043|NCT05242692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5780044|NCT05242692|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5780045|NCT05242692|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5780046|NCT05242692|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5780047|NCT05242692|Adrenergic Agents|adrenergic agents|mesh-ancestor
5780048|NCT05242692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5780049|NCT05242692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780050|NCT05242692|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5780051|NCT05242692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5780052|NCT05242692|Anesthetics, General|anesthetics, general|mesh-ancestor
5780053|NCT05242692|Anesthetics|anesthetics|mesh-ancestor
5780054|NCT05242692|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5780055|NCT05242692|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5780056|NCT05242692|Antidepressive Agents|antidepressive agents|mesh-ancestor
5780057|NCT05242692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5780058|NCT05242484|Golimumab|golimumab|mesh-list
5780059|NCT05242484|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6210674|NCT02163434|Gabapentin|gabapentin|mesh-list
5640956|NCT04489108|Tranexamic Acid|tranexamic acid|mesh-list
5780060|NCT05242484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5780061|NCT05242484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5780062|NCT05242484|Immunologic Factors|immunologic factors|mesh-ancestor
5780063|NCT05242484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780064|NCT05242471|Golimumab|golimumab|mesh-list
6210675|NCT02163434|Metoclopramide|metoclopramide|mesh-list
6210676|NCT02163434|Analgesics|analgesics|mesh-ancestor
5780065|NCT05242471|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
5780066|NCT05242471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5780067|NCT05242471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5780068|NCT05242471|Immunologic Factors|immunologic factors|mesh-ancestor
5640957|NCT04489108|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5640958|NCT04489108|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5640959|NCT04489108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640960|NCT04489108|Hemostatics|hemostatics|mesh-ancestor
5640961|NCT04489108|Coagulants|coagulants|mesh-ancestor
5640962|NCT04480554|Naltrexone|naltrexone|mesh-list
5640963|NCT04480554|Buprenorphine|buprenorphine|mesh-list
5640964|NCT04480554|Methadone|methadone|mesh-list
5640965|NCT04480554|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
5640966|NCT04480554|Naloxone|naloxone|mesh-list
5640967|NCT04480554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5640968|NCT04480554|Narcotics|narcotics|mesh-ancestor
5640969|NCT04480554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5640970|NCT04480554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5640971|NCT04480554|Analgesics|analgesics|mesh-ancestor
5640972|NCT04480554|Sensory System Agents|sensory system agents|mesh-ancestor
6673693|NCT01564329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6673694|NCT01564355|Triamcinolone|triamcinolone|mesh-list
6673695|NCT01564355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6673696|NCT01564355|Glucocorticoids|glucocorticoids|mesh-ancestor
6673697|NCT01564355|Hormones|hormones|mesh-ancestor
6673698|NCT01564355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6673699|NCT01564355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673700|NCT01564381|Resveratrol|resveratrol|mesh-list
6673701|NCT01564381|Antioxidants|antioxidants|mesh-ancestor
5780069|NCT05242471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780070|NCT05242458|Ustekinumab|ustekinumab|mesh-list
5780071|NCT05242458|Dermatologic Agents|dermatologic agents|mesh-ancestor
5780072|NCT05242419|Huperzine A|huperzine a|mesh-list
5780073|NCT05242419|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5780074|NCT05242419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5780075|NCT05242419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780076|NCT05242419|Cholinergic Agents|cholinergic agents|mesh-ancestor
5780077|NCT05242419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5780078|NCT05242419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780079|NCT05242419|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5780080|NCT05242419|Protective Agents|protective agents|mesh-ancestor
5780081|NCT05242315|Tacrolimus|tacrolimus|mesh-list
5780082|NCT05242315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5780083|NCT05242315|Immunologic Factors|immunologic factors|mesh-ancestor
5780084|NCT05242315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780085|NCT05242315|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5780086|NCT05242315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5780087|NCT05242315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897747|NCT04972396|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5897748|NCT04972396|Estrogens|estrogens|mesh-ancestor
5897749|NCT04972396|Hormones|hormones|mesh-ancestor
5897750|NCT04972396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5897751|NCT04944953|Botulinum Toxins|botulinum toxins|mesh-list
5897752|NCT04944953|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5897753|NCT04944953|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5897754|NCT04944953|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5897755|NCT04944953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5897756|NCT04944953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491029|NCT00600847|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5640973|NCT04480554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5640974|NCT04480554|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6491030|NCT00600847|Cholinergic Agents|cholinergic agents|mesh-ancestor
6491031|NCT00600847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6491032|NCT00600847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491033|NCT00600847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491034|NCT00600847|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6491035|NCT00600847|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6491036|NCT00600847|Histamine Antagonists|histamine antagonists|mesh-ancestor
6491037|NCT00600847|Histamine Agents|histamine agents|mesh-ancestor
6491038|NCT00600847|Antipruritics|antipruritics|mesh-ancestor
6491039|NCT00600847|Dermatologic Agents|dermatologic agents|mesh-ancestor
6491040|NCT00600847|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6491041|NCT00600873|Pramipexole|pramipexole|mesh-list
6491042|NCT00600873|Antioxidants|antioxidants|mesh-ancestor
5640975|NCT04480554|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6491043|NCT00600873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491044|NCT00600873|Protective Agents|protective agents|mesh-ancestor
5780088|NCT05242133|Interferons|interferons|mesh-list
5780089|NCT05242133|Interferon-beta|interferon-beta|mesh-list
5780090|NCT05242133|Interferon beta-1a|interferon beta-1a|mesh-list
5780091|NCT05242133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5780092|NCT05242133|Antiviral Agents|antiviral agents|mesh-ancestor
5780093|NCT05242133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5780094|NCT05242133|Immunologic Factors|immunologic factors|mesh-ancestor
5780095|NCT05242133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491045|NCT00600873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491046|NCT00600873|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6491047|NCT00600873|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6491048|NCT00600873|Dopamine Agonists|dopamine agonists|mesh-ancestor
6491049|NCT00600873|Dopamine Agents|dopamine agents|mesh-ancestor
5780096|NCT05242133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5780097|NCT05242120|Anesthetics|anesthetics|mesh-list
5780098|NCT05242120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5780099|NCT05242120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780100|NCT05242081|Fentanyl|fentanyl|mesh-list
5780101|NCT05242081|Ketamine|ketamine|mesh-list
5780102|NCT05242081|Esketamine|esketamine|mesh-list
5780103|NCT05242081|Analgesics|analgesics|mesh-ancestor
5780104|NCT05242081|Sensory System Agents|sensory system agents|mesh-ancestor
5780105|NCT05242081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5780106|NCT05242081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780107|NCT05242081|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5780108|NCT05242081|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5780109|NCT05242081|Anesthetics, General|anesthetics, general|mesh-ancestor
5780110|NCT05242081|Anesthetics|anesthetics|mesh-ancestor
5780111|NCT05242081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5780112|NCT05242081|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5780113|NCT05242081|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5780114|NCT05242081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5780115|NCT05242081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780116|NCT05242081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5780117|NCT05242081|Narcotics|narcotics|mesh-ancestor
5780118|NCT05242081|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5780119|NCT05242081|Antidepressive Agents|antidepressive agents|mesh-ancestor
5780120|NCT05242081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5780125|NCT05241938|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5780126|NCT05241938|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5780127|NCT05241912|Dobutamine|dobutamine|mesh-list
5780128|NCT05241912|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5780129|NCT05241912|Sympathomimetics|sympathomimetics|mesh-ancestor
5780130|NCT05241912|Autonomic Agents|autonomic agents|mesh-ancestor
5780131|NCT05241912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5780132|NCT05241912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780133|NCT05241912|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5780134|NCT05241912|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5780135|NCT05241912|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5780136|NCT05241912|Adrenergic Agents|adrenergic agents|mesh-ancestor
5780137|NCT05241912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5780138|NCT05241912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780139|NCT05241912|Protective Agents|protective agents|mesh-ancestor
5780140|NCT05241821|Fibrinolytic Agents|fibrinolytic agents|mesh-list
5780141|NCT05241821|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5780142|NCT05241821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780143|NCT05239182|Gemcitabine|gemcitabine|mesh-list
5780144|NCT05239182|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5780145|NCT05239182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5780146|NCT05239182|Antimetabolites|antimetabolites|mesh-ancestor
5780147|NCT05239182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780148|NCT05239182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5780149|NCT05239182|Antiviral Agents|antiviral agents|mesh-ancestor
5780150|NCT05239182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5780151|NCT05239182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5780152|NCT05239182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6673702|NCT01564381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780153|NCT05239182|Immunologic Factors|immunologic factors|mesh-ancestor
5780154|NCT05239182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780155|NCT05238597|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5780156|NCT05238597|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5780157|NCT05237726|Heparin|heparin|mesh-list
5780158|NCT05237726|Enoxaparin|enoxaparin|mesh-list
5780159|NCT05237726|Calcium heparin|calcium heparin|mesh-list
5780160|NCT05237726|Enoxaparin sodium|enoxaparin sodium|mesh-list
5780161|NCT05237726|Anticoagulants|anticoagulants|mesh-ancestor
5780162|NCT05237726|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5780163|NCT05237726|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5780164|NCT05237726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780165|NCT05236608|Nivolumab|nivolumab|mesh-list
5780166|NCT05236608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5780167|NCT05236608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5780168|NCT05236608|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5780169|NCT05236608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780170|NCT05219604|Diphenhydramine|diphenhydramine|mesh-list
5780171|NCT05219604|Promethazine|promethazine|mesh-list
5780172|NCT05219604|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5780173|NCT05219604|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5780174|NCT05219604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5780175|NCT05219604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780176|NCT05219604|Anesthetics, Local|anesthetics, local|mesh-ancestor
5780177|NCT05219604|Anesthetics|anesthetics|mesh-ancestor
5780178|NCT05219604|Sensory System Agents|sensory system agents|mesh-ancestor
5780179|NCT05219604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5780180|NCT05219604|Antiemetics|antiemetics|mesh-ancestor
5780181|NCT05219604|Autonomic Agents|autonomic agents|mesh-ancestor
5780182|NCT05219604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5780183|NCT05219604|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5780184|NCT05219604|Histamine Antagonists|histamine antagonists|mesh-ancestor
5780185|NCT05219604|Histamine Agents|histamine agents|mesh-ancestor
5780186|NCT05219604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5780187|NCT05219604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780188|NCT05219604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5780189|NCT05219604|Antipruritics|antipruritics|mesh-ancestor
5780190|NCT05219604|Dermatologic Agents|dermatologic agents|mesh-ancestor
5780191|NCT05217654|Dapagliflozin|dapagliflozin|mesh-list
5780192|NCT05217654|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5780193|NCT05217654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780194|NCT05217654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5780195|NCT05217654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780196|NCT05211635|Vitamin D|vitamin d|mesh-list
5780197|NCT05211635|Vitamins|vitamins|mesh-ancestor
5780198|NCT05211635|Micronutrients|micronutrients|mesh-ancestor
5780199|NCT05211635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780200|NCT05211635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5780201|NCT05201547|Paclitaxel|paclitaxel|mesh-list
5780202|NCT05201547|Carboplatin|carboplatin|mesh-list
5780203|NCT05201547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5780204|NCT05201547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5780205|NCT05201547|Tubulin Modulators|tubulin modulators|mesh-ancestor
5780206|NCT05201547|Antimitotic Agents|antimitotic agents|mesh-ancestor
5780207|NCT05201547|Mitosis Modulators|mitosis modulators|mesh-ancestor
5780208|NCT05201547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780209|NCT05182164|Pembrolizumab|pembrolizumab|mesh-list
5780210|NCT05182164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5780211|NCT05182164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5780212|NCT05168462|Norepinephrine|norepinephrine|mesh-list
5780213|NCT05168462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5780214|NCT05168462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5780215|NCT05168462|Adrenergic Agents|adrenergic agents|mesh-ancestor
5780216|NCT05168462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5780217|NCT05168462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780218|NCT05168462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780219|NCT05168462|Sympathomimetics|sympathomimetics|mesh-ancestor
5780220|NCT05168462|Autonomic Agents|autonomic agents|mesh-ancestor
5780221|NCT05168462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5780222|NCT05168462|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5897757|NCT04944953|Cholinergic Agents|cholinergic agents|mesh-ancestor
5897758|NCT04944953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5897759|NCT04944953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897760|NCT04944953|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5897761|NCT04944953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5897762|NCT04904952|Acetylcysteine|acetylcysteine|mesh-list
5897763|NCT04904952|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5897764|NCT04904952|Antiviral Agents|antiviral agents|mesh-ancestor
5780223|NCT05150236|Nivolumab|nivolumab|mesh-list
5780224|NCT05150236|Ipilimumab|ipilimumab|mesh-list
5780225|NCT05150236|177Lu-PSMA-617|177lu-psma-617|mesh-list
5780226|NCT05150236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5780227|NCT05150236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5780228|NCT05150236|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5780229|NCT05150236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780230|NCT05150236|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5780231|NCT05135104|Palbociclib|palbociclib|mesh-list
5780232|NCT05135104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5780233|NCT05135104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5780234|NCT05135104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5780235|NCT05135104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210677|NCT02163434|Sensory System Agents|sensory system agents|mesh-ancestor
6210678|NCT02163434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6210679|NCT02163434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780239|NCT05114421|Pembrolizumab|pembrolizumab|mesh-list
5780240|NCT05114421|Lenvatinib|lenvatinib|mesh-list
5780241|NCT05114421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5780242|NCT05114421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5780243|NCT05114421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5780244|NCT05114421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5780245|NCT05114421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780246|NCT05112939|Rilpivirine|rilpivirine|mesh-list
5780247|NCT05112939|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5780248|NCT05112939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5780249|NCT05112939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5780250|NCT05112939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780251|NCT05112939|Antiviral Agents|antiviral agents|mesh-ancestor
5780252|NCT05112939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5780253|NCT05112939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5780254|NCT05112939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5780255|NCT05112666|Rivaroxaban|rivaroxaban|mesh-list
5780256|NCT05112666|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5780257|NCT05112666|Antithrombins|antithrombins|mesh-ancestor
5780258|NCT05112666|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5780259|NCT05112666|Protease Inhibitors|protease inhibitors|mesh-ancestor
5780260|NCT05112666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5780261|NCT05112666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780262|NCT05112666|Anticoagulants|anticoagulants|mesh-ancestor
5780263|NCT05111574|Nivolumab|nivolumab|mesh-list
5780264|NCT05111574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5780265|NCT05111574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5780266|NCT05111574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5780267|NCT05111574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780268|NCT05109052|Bevacizumab|bevacizumab|mesh-list
5780269|NCT05109052|Atezolizumab|atezolizumab|mesh-list
5780270|NCT05109052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5780271|NCT05109052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5780272|NCT05109052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5780273|NCT05109052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5780274|NCT05109052|Growth Substances|growth substances|mesh-ancestor
5780275|NCT05109052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780276|NCT05109052|Growth Inhibitors|growth inhibitors|mesh-ancestor
5780277|NCT05104567|Pembrolizumab|pembrolizumab|mesh-list
5780278|NCT05104567|Cetuximab|cetuximab|mesh-list
5780279|NCT05104567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5780280|NCT05104567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5780281|NCT05104047|Lobeline|lobeline|mesh-list
5780282|NCT05104047|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5780283|NCT05104047|Autonomic Agents|autonomic agents|mesh-ancestor
5780284|NCT05104047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5780285|NCT05104047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780286|NCT05104047|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5780287|NCT05104047|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5780288|NCT05104047|Cholinergic Agents|cholinergic agents|mesh-ancestor
5780289|NCT05104047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5780290|NCT05104047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780291|NCT05104047|Respiratory System Agents|respiratory system agents|mesh-ancestor
5780292|NCT05102734|Nitroglycerin|nitroglycerin|mesh-list
5780293|NCT05102734|Vasodilator Agents|vasodilator agents|mesh-ancestor
5780294|NCT05102071|Metformin|metformin|mesh-list
5780295|NCT05102071|Empagliflozin|empagliflozin|mesh-list
5780296|NCT05102071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5780297|NCT05102071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780298|NCT05102071|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5780299|NCT05102071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780300|NCT05100862|Rituximab|rituximab|mesh-list
5780301|NCT05100862|Lenalidomide|lenalidomide|mesh-list
5780302|NCT05100862|Zanubrutinib|zanubrutinib|mesh-list
5780303|NCT05100862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5780304|NCT05100862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5780305|NCT05100862|Immunologic Factors|immunologic factors|mesh-ancestor
5780306|NCT05100862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780307|NCT05100862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5780308|NCT05100862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5780309|NCT05100862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5780310|NCT05100862|Growth Substances|growth substances|mesh-ancestor
5780311|NCT05100862|Growth Inhibitors|growth inhibitors|mesh-ancestor
5780312|NCT05100862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5780313|NCT05100862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5780314|NCT05100862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780315|NCT05083754|Temozolomide|temozolomide|mesh-list
5780316|NCT05083754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5780317|NCT05083754|Alkylating Agents|alkylating agents|mesh-ancestor
5780318|NCT05083754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780319|NCT05083754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5780320|NCT05078502|Vitamin D|vitamin d|mesh-list
5780321|NCT05078502|Cholecalciferol|cholecalciferol|mesh-list
5780322|NCT05078502|Vitamins|vitamins|mesh-ancestor
5780323|NCT05078502|Micronutrients|micronutrients|mesh-ancestor
5780324|NCT05078502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780325|NCT05078502|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5780326|NCT05078502|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5780327|NCT05071053|Ramucirumab|ramucirumab|mesh-list
5780328|NCT05071053|Maytansine|maytansine|mesh-list
5780329|NCT05071053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5780330|NCT05071053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5780331|NCT05071053|Tubulin Modulators|tubulin modulators|mesh-ancestor
5780332|NCT05071053|Antimitotic Agents|antimitotic agents|mesh-ancestor
5780333|NCT05071053|Mitosis Modulators|mitosis modulators|mesh-ancestor
5780334|NCT05071053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780335|NCT05061420|Pembrolizumab|pembrolizumab|mesh-list
5780336|NCT05061420|Cetuximab|cetuximab|mesh-list
5780337|NCT05061420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5780338|NCT05061420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5780339|NCT05050214|Obinutuzumab|obinutuzumab|mesh-list
5780340|NCT05050214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5780341|NCT05050214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5780342|NCT05049057|Erenumab|erenumab|mesh-list
5780343|NCT05049057|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
5780344|NCT05049057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780345|NCT05049057|Analgesics|analgesics|mesh-ancestor
5780346|NCT05049057|Sensory System Agents|sensory system agents|mesh-ancestor
5780347|NCT05049057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5780348|NCT05049057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780349|NCT05040880|Telmisartan|telmisartan|mesh-list
5780350|NCT05040880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5780351|NCT05040880|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5780352|NCT05040880|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5780353|NCT05040880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780354|NCT05020665|Cytarabine|cytarabine|mesh-list
5780355|NCT05020665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5780356|NCT05020665|Antimetabolites|antimetabolites|mesh-ancestor
5780357|NCT05020665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780358|NCT05020665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5780359|NCT05020665|Antiviral Agents|antiviral agents|mesh-ancestor
5780360|NCT05020665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5780361|NCT05020665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5780362|NCT05020665|Immunologic Factors|immunologic factors|mesh-ancestor
5780363|NCT05020665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780364|NCT05017571|Colchicine|colchicine|mesh-list
5780365|NCT05017571|Gout Suppressants|gout suppressants|mesh-ancestor
5780366|NCT05017571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5780367|NCT05017571|Tubulin Modulators|tubulin modulators|mesh-ancestor
5780368|NCT05017571|Antimitotic Agents|antimitotic agents|mesh-ancestor
5780369|NCT05017571|Mitosis Modulators|mitosis modulators|mesh-ancestor
5780370|NCT05017571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907984|NCT04973566|Etanercept|etanercept|mesh-list
5780371|NCT05017571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5780372|NCT05016310|Vitamin D|vitamin d|mesh-list
5780373|NCT05016310|Ergocalciferols|ergocalciferols|mesh-list
5780374|NCT05016310|Vitamins|vitamins|mesh-list
5780375|NCT05016310|Micronutrients|micronutrients|mesh-ancestor
5780376|NCT05016310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780377|NCT05016310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5780378|NCT05016310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5780379|NCT05007509|Vaccines|vaccines|mesh-list
5780380|NCT05007509|Immunologic Factors|immunologic factors|mesh-ancestor
5780381|NCT05007509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780382|NCT04992624|Dronabinol|dronabinol|mesh-list
5780383|NCT04992624|Cannabidiol|cannabidiol|mesh-list
5780384|NCT04992624|Anticonvulsants|anticonvulsants|mesh-ancestor
5780385|NCT04992624|Hallucinogens|hallucinogens|mesh-ancestor
5780386|NCT04992624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780387|NCT04992624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5780388|NCT04992624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5780389|NCT04992624|Analgesics|analgesics|mesh-ancestor
5780390|NCT04992624|Sensory System Agents|sensory system agents|mesh-ancestor
5780391|NCT04992624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5780392|NCT04992624|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5780393|NCT04992624|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5780394|NCT04992624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5780395|NCT04992624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780396|NCT04992624|Hormones|hormones|mesh-ancestor
5780397|NCT04992624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5780398|NCT04985760|Aluminum Hydroxide|aluminum hydroxide|mesh-list
5780399|NCT04985760|Vaccines|vaccines|mesh-list
5780400|NCT04985760|Aluminum sulfate|aluminum sulfate|mesh-list
5780401|NCT04985760|Immunologic Factors|immunologic factors|mesh-ancestor
5780402|NCT04985760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780403|NCT04985760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5780404|NCT04985760|Antacids|antacids|mesh-ancestor
5780405|NCT04985760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780406|NCT04985760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5780407|NCT04974528|Insulin|insulin|mesh-list
5780408|NCT04974528|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5780409|NCT04974528|Insulin Glargine|insulin glargine|mesh-list
5780410|NCT04974528|Insulin Aspart|insulin aspart|mesh-list
5780411|NCT04974528|Insulin Lispro|insulin lispro|mesh-list
5780412|NCT04974528|Insulin, Short-Acting|insulin, short-acting|mesh-list
5780413|NCT04974528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5780414|NCT04974528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780415|NCT04972175|Insulin Lispro|insulin lispro|mesh-list
5780416|NCT04972175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5780417|NCT04972175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780418|NCT04967573|Rivaroxaban|rivaroxaban|mesh-list
5780419|NCT04967573|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5780420|NCT04967573|Antithrombins|antithrombins|mesh-ancestor
5780421|NCT04967573|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5780422|NCT04967573|Protease Inhibitors|protease inhibitors|mesh-ancestor
5780423|NCT04967573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5780424|NCT04967573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780425|NCT04967573|Anticoagulants|anticoagulants|mesh-ancestor
5897765|NCT04904952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5897766|NCT04904952|Expectorants|expectorants|mesh-ancestor
5897767|NCT04904952|Respiratory System Agents|respiratory system agents|mesh-ancestor
5897768|NCT04904952|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5897769|NCT04904952|Antioxidants|antioxidants|mesh-ancestor
5897770|NCT04904952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897771|NCT04904952|Protective Agents|protective agents|mesh-ancestor
5897772|NCT04904952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897773|NCT04904952|Antidotes|antidotes|mesh-ancestor
5897774|NCT04853147|Dexamethasone|dexamethasone|mesh-list
5897775|NCT04853147|Dexamethasone acetate|dexamethasone acetate|mesh-list
5897776|NCT04853147|Fosaprepitant|fosaprepitant|mesh-list
5897777|NCT04853147|Aprepitant|aprepitant|mesh-list
5897778|NCT04853147|BB 1101|bb 1101|mesh-list
5897779|NCT04853147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5897780|NCT04853147|Antiemetics|antiemetics|mesh-ancestor
5897781|NCT04853147|Autonomic Agents|autonomic agents|mesh-ancestor
5897782|NCT04853147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5897783|NCT04853147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897784|NCT04853147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5897785|NCT04853147|Glucocorticoids|glucocorticoids|mesh-ancestor
5897786|NCT04853147|Hormones|hormones|mesh-ancestor
5897787|NCT04853147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5780426|NCT04954365|Amisulpride|amisulpride|mesh-list
5780427|NCT04954365|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5780428|NCT04954365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5780429|NCT04954365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5780430|NCT04954365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780431|NCT04954365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5780432|NCT04954365|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5780433|NCT04954365|Dopamine Agents|dopamine agents|mesh-ancestor
5780434|NCT04954365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5780435|NCT04954365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780436|NCT04954365|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5780437|NCT04954365|Antidepressive Agents|antidepressive agents|mesh-ancestor
5780438|NCT04947527|Fluorides|fluorides|mesh-list
5780439|NCT04947527|Fluorides, Topical|fluorides, topical|mesh-list
5780440|NCT04947527|Cariostatic Agents|cariostatic agents|mesh-ancestor
5780441|NCT04947527|Protective Agents|protective agents|mesh-ancestor
5780442|NCT04947527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780443|NCT04931979|Pembrolizumab|pembrolizumab|mesh-list
5780444|NCT04931979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5780445|NCT04931979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5780446|NCT04930900|Epinephrine|epinephrine|mesh-list
5780447|NCT04930900|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5780448|NCT04930900|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5780449|NCT04930900|Adrenergic Agents|adrenergic agents|mesh-ancestor
5780450|NCT04930900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5780451|NCT04930900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780452|NCT04930900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780453|NCT04930900|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5780454|NCT04930900|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5780455|NCT04930900|Autonomic Agents|autonomic agents|mesh-ancestor
5780456|NCT04930900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5780457|NCT04930900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5780458|NCT04930900|Respiratory System Agents|respiratory system agents|mesh-ancestor
5780459|NCT04930900|Mydriatics|mydriatics|mesh-ancestor
5780460|NCT04930900|Sympathomimetics|sympathomimetics|mesh-ancestor
5780461|NCT04930900|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5780462|NCT04929041|Paclitaxel|paclitaxel|mesh-list
5780463|NCT04929041|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5780464|NCT04929041|Carboplatin|carboplatin|mesh-list
5780465|NCT04929041|Pembrolizumab|pembrolizumab|mesh-list
5780466|NCT04929041|Nivolumab|nivolumab|mesh-list
5780467|NCT04929041|Pemetrexed|pemetrexed|mesh-list
5780468|NCT04929041|Ipilimumab|ipilimumab|mesh-list
5780469|NCT04929041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5780470|NCT04929041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5780471|NCT04929041|Tubulin Modulators|tubulin modulators|mesh-ancestor
5780472|NCT04929041|Antimitotic Agents|antimitotic agents|mesh-ancestor
5780473|NCT04929041|Mitosis Modulators|mitosis modulators|mesh-ancestor
5780474|NCT04929041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780475|NCT04929041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5780476|NCT04929041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5780477|NCT04929041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5780478|NCT04929041|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5780479|NCT04929041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5780480|NCT04928339|Bupivacaine|bupivacaine|mesh-list
5780481|NCT04928339|Anesthetics, Local|anesthetics, local|mesh-ancestor
5780482|NCT04928339|Anesthetics|anesthetics|mesh-ancestor
5780483|NCT04928339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5780484|NCT04928339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780485|NCT04928339|Sensory System Agents|sensory system agents|mesh-ancestor
5780486|NCT04928339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5780487|NCT04918810|Docetaxel|docetaxel|mesh-list
5780488|NCT04918810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5780489|NCT04918810|Tubulin Modulators|tubulin modulators|mesh-ancestor
5780490|NCT04918810|Antimitotic Agents|antimitotic agents|mesh-ancestor
5780491|NCT04918810|Mitosis Modulators|mitosis modulators|mesh-ancestor
5780492|NCT04918810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780493|NCT04905446|Niacinamide|niacinamide|mesh-list
5780494|NCT04905446|Niacin|niacin|mesh-list
5780495|NCT04905446|Nicotinic Acids|nicotinic acids|mesh-list
5780496|NCT04905446|Vitamin B Complex|vitamin b complex|mesh-ancestor
5780497|NCT04905446|Vitamins|vitamins|mesh-ancestor
5780498|NCT04905446|Micronutrients|micronutrients|mesh-ancestor
5780499|NCT04905446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780500|NCT04905446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5780501|NCT04905446|Antimetabolites|antimetabolites|mesh-ancestor
5780502|NCT04905446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780503|NCT04905446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5780504|NCT04905446|Vasodilator Agents|vasodilator agents|mesh-ancestor
5780505|NCT04887402|Clomiphene|clomiphene|mesh-list
5780506|NCT04887402|Enclomiphene|enclomiphene|mesh-list
5780507|NCT04887402|Zuclomiphene|zuclomiphene|mesh-list
5780508|NCT04887402|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5780509|NCT04887402|Hormone Antagonists|hormone antagonists|mesh-ancestor
5780510|NCT04887402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5780511|NCT04887402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780512|NCT04887402|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5780513|NCT04887402|Fertility Agents|fertility agents|mesh-ancestor
5780514|NCT04887402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5780515|NCT04887402|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5780516|NCT04887402|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5780517|NCT04849715|Rituximab|rituximab|mesh-list
5780518|NCT04849715|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5780519|NCT04849715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5780520|NCT04849715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5780521|NCT04849715|Immunologic Factors|immunologic factors|mesh-ancestor
5780522|NCT04849715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780523|NCT04849715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5780524|NCT04849715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5780525|NCT04849715|Alkylating Agents|alkylating agents|mesh-ancestor
5780526|NCT04849715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780527|NCT04799288|Teriflunomide|teriflunomide|mesh-list
5780528|NCT04799288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5780529|NCT04799288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5780530|NCT04799288|Analgesics|analgesics|mesh-ancestor
5780531|NCT04799288|Sensory System Agents|sensory system agents|mesh-ancestor
5780532|NCT04799288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5780533|NCT04799288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780534|NCT04799288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5780535|NCT04799288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5780536|NCT04799288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5780537|NCT04799288|Immunologic Factors|immunologic factors|mesh-ancestor
5780538|NCT04793568|Interferons|interferons|mesh-list
5780539|NCT04793568|Interferon-gamma|interferon-gamma|mesh-list
5780540|NCT04793568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5780541|NCT04793568|Antiviral Agents|antiviral agents|mesh-ancestor
5780542|NCT04793568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5780543|NCT04793490|Acetaminophen|acetaminophen|mesh-list
5780544|NCT04793490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5780545|NCT04793490|Analgesics|analgesics|mesh-ancestor
5780546|NCT04793490|Sensory System Agents|sensory system agents|mesh-ancestor
5780547|NCT04793490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5780548|NCT04793490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780549|NCT04793490|Antipyretics|antipyretics|mesh-ancestor
5780550|NCT04782700|Prednisone|prednisone|mesh-list
5780551|NCT04782700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5780552|NCT04782700|Glucocorticoids|glucocorticoids|mesh-ancestor
5780553|NCT04782700|Hormones|hormones|mesh-ancestor
5780554|NCT04782700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5780555|NCT04782700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780556|NCT04782700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5780557|NCT04782700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5780558|NCT04777357|Cariprazine|cariprazine|mesh-list
5780559|NCT04777357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5780560|NCT04777357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5780561|NCT04777357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5780562|NCT04777357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780563|NCT04777357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5780564|NCT04760782|Abaloparatide|abaloparatide|mesh-list
5780565|NCT04760782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5780566|NCT04760782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780567|NCT04750005|Listerine|listerine|mesh-list
5780568|NCT04750005|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5780569|NCT04750005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5780570|NCT04748783|Listerine|listerine|mesh-list
5780571|NCT04748783|Chlorhexidine|chlorhexidine|mesh-list
6673703|NCT01564381|Protective Agents|protective agents|mesh-ancestor
5780572|NCT04748783|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5780573|NCT04748783|Hydrogen Peroxide|hydrogen peroxide|mesh-list
5780574|NCT04748783|Sodium Fluoride|sodium fluoride|mesh-list
5780575|NCT04748783|Cariostatic Agents|cariostatic agents|mesh-ancestor
5780576|NCT04748783|Protective Agents|protective agents|mesh-ancestor
5780577|NCT04748783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780578|NCT04748783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5780579|NCT04748783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5780580|NCT04748783|Disinfectants|disinfectants|mesh-ancestor
5780581|NCT04748783|Dermatologic Agents|dermatologic agents|mesh-ancestor
5780582|NCT04739384|Ticagrelor|ticagrelor|mesh-list
5780583|NCT04739384|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5780584|NCT04739384|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5780585|NCT04739384|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5780586|NCT04739384|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5780587|NCT04739384|Purinergic Agents|purinergic agents|mesh-ancestor
5780588|NCT04739384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5780589|NCT04739384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780590|NCT04739384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780591|NCT04703075|Rifapentine|rifapentine|mesh-list
5780592|NCT04703075|Rifampin|rifampin|mesh-list
5780593|NCT04703075|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5780594|NCT04703075|Antitubercular Agents|antitubercular agents|mesh-ancestor
5780595|NCT04703075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5780596|NCT04703075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5780597|NCT04703075|Leprostatic Agents|leprostatic agents|mesh-ancestor
5780598|NCT04703075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5780599|NCT04703075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5780600|NCT04703075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780601|NCT04703075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5780602|NCT04703075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5780603|NCT04703075|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5780604|NCT04703075|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5780605|NCT04703075|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5780606|NCT04703075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5780607|NCT04701788|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5780608|NCT04701788|Immunologic Factors|immunologic factors|mesh-ancestor
5780609|NCT04701788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780610|NCT04700618|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5780611|NCT04700618|Immunologic Factors|immunologic factors|mesh-ancestor
5640976|NCT04480554|Antitussive Agents|antitussive agents|mesh-ancestor
5640977|NCT04480554|Respiratory System Agents|respiratory system agents|mesh-ancestor
5640978|NCT04471675|Docetaxel|docetaxel|mesh-list
5640979|NCT04471675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5640980|NCT04471675|Tubulin Modulators|tubulin modulators|mesh-ancestor
5780612|NCT04700618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780613|NCT04699461|Idelalisib|idelalisib|mesh-list
5780614|NCT04699461|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
5780615|NCT04699461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5780616|NCT04699461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6491050|NCT00600873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6491051|NCT00600912|SMOFlipid|smoflipid|mesh-list
6491052|NCT00600912|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6491053|NCT00600912|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5780617|NCT04699461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780618|NCT04699461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5780619|NCT04674410|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5780620|NCT04674410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5897788|NCT04853147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5897789|NCT04853147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5897790|NCT04853147|Protease Inhibitors|protease inhibitors|mesh-ancestor
5897791|NCT04853147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5897792|NCT04853147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897793|NCT04853147|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5897794|NCT04853147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5897795|NCT04810910|Molgramostim|molgramostim|mesh-list
6491054|NCT00600912|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6491055|NCT00600964|Obatoclax|obatoclax|mesh-list
6491056|NCT00600964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5640981|NCT04471675|Antimitotic Agents|antimitotic agents|mesh-ancestor
5640982|NCT04471675|Mitosis Modulators|mitosis modulators|mesh-ancestor
5640983|NCT04471675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640984|NCT04453839|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
5640985|NCT04453839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5640986|NCT04453839|Vasodilator Agents|vasodilator agents|mesh-ancestor
5640987|NCT04453839|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5640988|NCT04453839|Protective Agents|protective agents|mesh-ancestor
5640989|NCT04453839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780621|NCT04665856|Carboplatin|carboplatin|mesh-list
5780622|NCT04665856|Etoposide|etoposide|mesh-list
5780623|NCT04665856|Atezolizumab|atezolizumab|mesh-list
5780624|NCT04665856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5780625|NCT04665856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5780626|NCT04665856|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5780627|NCT04665856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5780628|NCT04665856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5780629|NCT04665856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780630|NCT04658784|Cyclopropane|cyclopropane|mesh-list
5780631|NCT04658784|Anesthetics|anesthetics|mesh-ancestor
5780632|NCT04658784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5780633|NCT04658784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780634|NCT04646967|Acetaminophen|acetaminophen|mesh-list
5780635|NCT04646967|Ibuprofen|ibuprofen|mesh-list
5780636|NCT04646967|Ketorolac|ketorolac|mesh-list
5780637|NCT04646967|Bupivacaine|bupivacaine|mesh-list
5780638|NCT04646967|Sevoflurane|sevoflurane|mesh-list
5780639|NCT04646967|Anesthetics, Local|anesthetics, local|mesh-ancestor
5780640|NCT04646967|Anesthetics|anesthetics|mesh-ancestor
5780641|NCT04646967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5780642|NCT04646967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780643|NCT04646967|Sensory System Agents|sensory system agents|mesh-ancestor
5780644|NCT04646967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5780645|NCT04646967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5780646|NCT04646967|Analgesics|analgesics|mesh-ancestor
5780647|NCT04646967|Antipyretics|antipyretics|mesh-ancestor
5780648|NCT04646967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5780649|NCT04646967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5780650|NCT04646967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5780651|NCT04646967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5780652|NCT04646967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5780653|NCT04646967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780654|NCT04646967|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5780655|NCT04646967|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5780656|NCT04646967|Anesthetics, General|anesthetics, general|mesh-ancestor
5780657|NCT04646655|Enoxaparin|enoxaparin|mesh-list
5780658|NCT04646655|Anticoagulants|anticoagulants|mesh-ancestor
5780659|NCT04646655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5780660|NCT04646655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5780661|NCT04646655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780662|NCT04646356|Tacrolimus|tacrolimus|mesh-list
5640990|NCT04439513|Hemostatics|hemostatics|mesh-list
5640991|NCT04439513|Coagulants|coagulants|mesh-ancestor
5640992|NCT04431375|Tenofovir|tenofovir|mesh-list
5640993|NCT04431375|Antiviral Agents|antiviral agents|mesh-ancestor
5640994|NCT04431375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5780663|NCT04646356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5780664|NCT04646356|Immunologic Factors|immunologic factors|mesh-ancestor
5780665|NCT04646356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780666|NCT04646356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5780667|NCT04646356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5780668|NCT04646356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780669|NCT04635241|Heparin|heparin|mesh-list
5780670|NCT04635241|Calcium heparin|calcium heparin|mesh-list
5780671|NCT04635241|Anticoagulants|anticoagulants|mesh-ancestor
5780672|NCT04635241|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5780673|NCT04635241|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5780674|NCT04635241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780675|NCT04630145|Clarithromycin|clarithromycin|mesh-list
5780676|NCT04630145|Rifampin|rifampin|mesh-list
5780677|NCT04630145|Ethambutol|ethambutol|mesh-list
5780678|NCT04630145|Rifabutin|rifabutin|mesh-list
5780679|NCT04630145|Bedaquiline|bedaquiline|mesh-list
5780680|NCT04630145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5780681|NCT04630145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5780682|NCT04630145|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5780683|NCT04630145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5640995|NCT04431375|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5640996|NCT04431375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5640997|NCT04431375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5640998|NCT04431375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5640999|NCT04431375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5641000|NCT04431375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5641001|NCT04426825|Bevacizumab|bevacizumab|mesh-list
5641002|NCT04426825|Atezolizumab|atezolizumab|mesh-list
5641003|NCT04426825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5641004|NCT04426825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5780684|NCT04630145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780685|NCT04630145|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5780686|NCT04630145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5780687|NCT04630145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5780688|NCT04630145|Antitubercular Agents|antitubercular agents|mesh-ancestor
5780689|NCT04630145|Leprostatic Agents|leprostatic agents|mesh-ancestor
5780690|NCT04630145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5780691|NCT04630145|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5780692|NCT04630145|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5780693|NCT04630145|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5780694|NCT04630145|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5780695|NCT04630145|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5780696|NCT04630145|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5780697|NCT04628663|Dexmedetomidine|dexmedetomidine|mesh-list
5780698|NCT04628663|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5780699|NCT04628663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5780700|NCT04628663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780701|NCT04628663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5780702|NCT04628663|Analgesics|analgesics|mesh-ancestor
5780703|NCT04628663|Sensory System Agents|sensory system agents|mesh-ancestor
5780704|NCT04628663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5780705|NCT04628663|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5780706|NCT04628663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5780707|NCT04628663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5780708|NCT04628663|Adrenergic Agents|adrenergic agents|mesh-ancestor
5780709|NCT04628663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5780710|NCT04628663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780711|NCT04616560|Trastuzumab|trastuzumab|mesh-list
5780712|NCT04616560|Camptothecin|camptothecin|mesh-list
5780713|NCT04616560|Immunoconjugates|immunoconjugates|mesh-list
5780714|NCT04616560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5780715|NCT04616560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5780716|NCT04616560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5780717|NCT04616560|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5780718|NCT04616560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5780719|NCT04616560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5780720|NCT04616560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780721|NCT04616560|Immunologic Factors|immunologic factors|mesh-ancestor
5780722|NCT04616560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780723|NCT04616547|Edetic Acid|edetic acid|mesh-list
5780724|NCT04616547|Pentetic Acid|pentetic acid|mesh-list
5780725|NCT04616547|Antidotes|antidotes|mesh-ancestor
5780726|NCT04616547|Protective Agents|protective agents|mesh-ancestor
5780727|NCT04616547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780728|NCT04616547|Chelating Agents|chelating agents|mesh-ancestor
5780729|NCT04616547|Sequestering Agents|sequestering agents|mesh-ancestor
5780730|NCT04616547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780731|NCT04616547|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5780732|NCT04616547|Anticoagulants|anticoagulants|mesh-ancestor
5780733|NCT04616547|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5780738|NCT04591431|Nivolumab|nivolumab|mesh-list
5780739|NCT04591431|Trastuzumab|trastuzumab|mesh-list
5780740|NCT04591431|Ipilimumab|ipilimumab|mesh-list
5780741|NCT04591431|Pertuzumab|pertuzumab|mesh-list
5780742|NCT04591431|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
5780743|NCT04591431|Everolimus|everolimus|mesh-list
5780744|NCT04591431|Atezolizumab|atezolizumab|mesh-list
5780745|NCT04591431|Lapatinib|lapatinib|mesh-list
5780746|NCT04591431|Palbociclib|palbociclib|mesh-list
5780747|NCT04591431|Vemurafenib|vemurafenib|mesh-list
5780748|NCT04591431|Maytansine|maytansine|mesh-list
5780749|NCT04591431|Ponatinib|ponatinib|mesh-list
5780750|NCT04591431|Entrectinib|entrectinib|mesh-list
5780751|NCT04591431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5780752|NCT04591431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5780753|NCT04591431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5780754|NCT04591431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780755|NCT04591431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5780756|NCT04591431|Immunologic Factors|immunologic factors|mesh-ancestor
5780757|NCT04591431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780758|NCT04591431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5780759|NCT04591431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5780760|NCT04591431|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5780761|NCT04591431|Tubulin Modulators|tubulin modulators|mesh-ancestor
5780762|NCT04591431|Antimitotic Agents|antimitotic agents|mesh-ancestor
5780763|NCT04591431|Mitosis Modulators|mitosis modulators|mesh-ancestor
5780764|NCT04590404|Nicotine|nicotine|mesh-list
5780765|NCT04590404|Varenicline|varenicline|mesh-list
5780766|NCT04590404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5780767|NCT04590404|Autonomic Agents|autonomic agents|mesh-ancestor
5780768|NCT04590404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5780769|NCT04590404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780770|NCT04590404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5780771|NCT04590404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5780772|NCT04590404|Cholinergic Agents|cholinergic agents|mesh-ancestor
5780773|NCT04590404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5780774|NCT04590404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780775|NCT04587427|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
5780776|NCT04587427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5780784|NCT04570176|Epinephrine|epinephrine|mesh-list
5780785|NCT04570176|Racepinephrine|racepinephrine|mesh-list
5780786|NCT04570176|Epinephryl borate|epinephryl borate|mesh-list
5780787|NCT04570176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5780788|NCT04570176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5780789|NCT04570176|Adrenergic Agents|adrenergic agents|mesh-ancestor
5780790|NCT04570176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5780791|NCT04570176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780792|NCT04570176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780793|NCT04570176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5780794|NCT04570176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5780795|NCT04570176|Autonomic Agents|autonomic agents|mesh-ancestor
5780796|NCT04570176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5780797|NCT04570176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5780798|NCT04570176|Respiratory System Agents|respiratory system agents|mesh-ancestor
5780799|NCT04570176|Mydriatics|mydriatics|mesh-ancestor
5780800|NCT04570176|Sympathomimetics|sympathomimetics|mesh-ancestor
5780801|NCT04570176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5780802|NCT04561362|Nivolumab|nivolumab|mesh-list
5780803|NCT04561362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5780804|NCT04561362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5780805|NCT04561362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5780806|NCT04561362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780807|NCT04553133|Letrozole|letrozole|mesh-list
5780808|NCT04553133|Fulvestrant|fulvestrant|mesh-list
5780809|NCT04553133|Palbociclib|palbociclib|mesh-list
5780810|NCT04553133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5780811|NCT04553133|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5780812|NCT04553133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5780813|NCT04553133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5780814|NCT04553133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780815|NCT04553133|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5780816|NCT04553133|Hormone Antagonists|hormone antagonists|mesh-ancestor
5780817|NCT04553133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5780818|NCT04553133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780819|NCT04553133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5780820|NCT04553133|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5780821|NCT04553133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5780822|NCT04549168|Lemborexant|lemborexant|mesh-list
5780823|NCT04549168|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
5780824|NCT04549168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5780825|NCT04549168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780826|NCT04549168|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5780827|NCT04549168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5780828|NCT04549168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5780829|NCT04549168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780830|NCT04545736|Metformin|metformin|mesh-list
5780831|NCT04545736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5780832|NCT04545736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780833|NCT04545541|Heparin|heparin|mesh-list
5780834|NCT04545541|Calcium heparin|calcium heparin|mesh-list
5780835|NCT04545541|Anticoagulants|anticoagulants|mesh-ancestor
5780836|NCT04545541|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5780837|NCT04545541|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5780838|NCT04545541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780839|NCT04528212|Glimepiride|glimepiride|mesh-list
5780840|NCT04528212|Curcumin|curcumin|mesh-list
5780841|NCT04528212|Fenofibrate|fenofibrate|mesh-list
5780842|NCT04528212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5780843|NCT04528212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5780844|NCT04528212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780845|NCT04528212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5780846|NCT04528212|Immunologic Factors|immunologic factors|mesh-ancestor
5780847|NCT04528212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5780848|NCT04528212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5780849|NCT04528212|Analgesics|analgesics|mesh-ancestor
5780850|NCT04528212|Sensory System Agents|sensory system agents|mesh-ancestor
5780851|NCT04528212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5780852|NCT04528212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5780853|NCT04528212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5780854|NCT04528212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5780855|NCT04528212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5780856|NCT04528212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780857|NCT04528212|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5780858|NCT04528212|Antimetabolites|antimetabolites|mesh-ancestor
5780859|NCT04528212|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5780860|NCT04522167|Aflibercept|aflibercept|mesh-list
5780861|NCT04522167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5780862|NCT04522167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5780863|NCT04522167|Growth Substances|growth substances|mesh-ancestor
5780864|NCT04522167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780865|NCT04522167|Growth Inhibitors|growth inhibitors|mesh-ancestor
5780866|NCT04522167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5780867|NCT04516447|Gemcitabine|gemcitabine|mesh-list
5780868|NCT04516447|Paclitaxel|paclitaxel|mesh-list
5780869|NCT04516447|Carboplatin|carboplatin|mesh-list
5780870|NCT04516447|Doxorubicin|doxorubicin|mesh-list
5780871|NCT04516447|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5780872|NCT04516447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5780873|NCT04516447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5780874|NCT04516447|Tubulin Modulators|tubulin modulators|mesh-ancestor
5780875|NCT04516447|Antimitotic Agents|antimitotic agents|mesh-ancestor
5780876|NCT04516447|Mitosis Modulators|mitosis modulators|mesh-ancestor
5780877|NCT04516447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780878|NCT04516447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5780879|NCT04516447|Antimetabolites|antimetabolites|mesh-ancestor
6673704|NCT01564381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780880|NCT04516447|Antiviral Agents|antiviral agents|mesh-ancestor
5780881|NCT04516447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5780882|NCT04516447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5780883|NCT04516447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5780884|NCT04516447|Immunologic Factors|immunologic factors|mesh-ancestor
5780885|NCT04516447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780886|NCT04516447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5780887|NCT04516447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5780888|NCT04516447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5780889|NCT04505878|Ascorbic Acid|ascorbic acid|mesh-list
5780890|NCT04505878|Vitamins|vitamins|mesh-ancestor
5780891|NCT04505878|Micronutrients|micronutrients|mesh-ancestor
5780892|NCT04505878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780893|NCT04505878|Antioxidants|antioxidants|mesh-ancestor
5780894|NCT04505878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780895|NCT04505878|Protective Agents|protective agents|mesh-ancestor
5780896|NCT04504175|Ketamine|ketamine|mesh-list
5780897|NCT04504175|Analgesics|analgesics|mesh-ancestor
5780898|NCT04504175|Sensory System Agents|sensory system agents|mesh-ancestor
5780899|NCT04504175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5780900|NCT04504175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780901|NCT04504175|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5780902|NCT04504175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5780903|NCT04504175|Anesthetics, General|anesthetics, general|mesh-ancestor
5780904|NCT04504175|Anesthetics|anesthetics|mesh-ancestor
5780905|NCT04504175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5780906|NCT04504175|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5780907|NCT04504175|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5780908|NCT04504175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5780909|NCT04504175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780910|NCT04481308|Fentanyl|fentanyl|mesh-list
5780911|NCT04481308|Propofol|propofol|mesh-list
5780912|NCT04481308|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5780913|NCT04481308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5780914|NCT04481308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780915|NCT04481308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5780916|NCT04481308|Anesthetics, General|anesthetics, general|mesh-ancestor
5780917|NCT04481308|Anesthetics|anesthetics|mesh-ancestor
5780918|NCT04481308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5780919|NCT04481308|Narcotics|narcotics|mesh-ancestor
5780920|NCT04481308|Analgesics|analgesics|mesh-ancestor
5780921|NCT04481308|Sensory System Agents|sensory system agents|mesh-ancestor
5780922|NCT04481308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5780923|NCT04481308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5780924|NCT04475848|Midazolam|midazolam|mesh-list
5780925|NCT04475848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5780926|NCT04475848|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5641005|NCT04426825|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5641006|NCT04426825|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5641007|NCT04426825|Growth Substances|growth substances|mesh-ancestor
5641008|NCT04426825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641009|NCT04426825|Growth Inhibitors|growth inhibitors|mesh-ancestor
5780927|NCT04475848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5780928|NCT04475848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780929|NCT04475848|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5780930|NCT04475848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5780931|NCT04475848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5780932|NCT04475848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5780933|NCT04475848|Anesthetics, General|anesthetics, general|mesh-ancestor
5780934|NCT04475848|Anesthetics|anesthetics|mesh-ancestor
5780935|NCT04475848|GABA Modulators|gaba modulators|mesh-ancestor
5780936|NCT04475848|GABA Agents|gaba agents|mesh-ancestor
5780937|NCT04475848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5780938|NCT04475848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780939|NCT04469699|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5780940|NCT04469699|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5780941|NCT04469699|Dermatologic Agents|dermatologic agents|mesh-ancestor
5780942|NCT04454658|Navitoclax|navitoclax|mesh-list
5780943|NCT04454658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5780944|NCT04452565|Atazanavir Sulfate|atazanavir sulfate|mesh-list
5780945|NCT04452565|Dexamethasone|dexamethasone|mesh-list
5780946|NCT04452565|Dexamethasone acetate|dexamethasone acetate|mesh-list
5780947|NCT04452565|BB 1101|bb 1101|mesh-list
5780948|NCT04452565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5780949|NCT04452565|Antiemetics|antiemetics|mesh-ancestor
5780950|NCT04452565|Autonomic Agents|autonomic agents|mesh-ancestor
5780951|NCT04452565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5780952|NCT04452565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780953|NCT04452565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5780954|NCT04452565|Glucocorticoids|glucocorticoids|mesh-ancestor
5780955|NCT04452565|Hormones|hormones|mesh-ancestor
5780956|NCT04452565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5780957|NCT04452565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5780958|NCT04452565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5780959|NCT04452565|Protease Inhibitors|protease inhibitors|mesh-ancestor
5780960|NCT04452565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5780961|NCT04452565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780962|NCT04452565|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5780963|NCT04452565|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5780964|NCT04452565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5780965|NCT04452565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5780966|NCT04452565|Antiviral Agents|antiviral agents|mesh-ancestor
5780967|NCT04452565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5780968|NCT04425018|Paclitaxel|paclitaxel|mesh-list
5780969|NCT04425018|Trastuzumab|trastuzumab|mesh-list
6491057|NCT00600964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491058|NCT00600977|Doxorubicin|doxorubicin|mesh-list
6491059|NCT00600977|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6491060|NCT00600977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5641010|NCT04410913|Psilocybin|psilocybin|mesh-list
5641011|NCT04410913|Hallucinogens|hallucinogens|mesh-ancestor
5641012|NCT04410913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641013|NCT04410913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5641014|NCT04401748|Azacitidine|azacitidine|mesh-list
5641015|NCT04401748|Venetoclax|venetoclax|mesh-list
5641016|NCT04401748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5641017|NCT04401748|Antimetabolites|antimetabolites|mesh-ancestor
5780970|NCT04425018|Pertuzumab|pertuzumab|mesh-list
5780971|NCT04425018|Margetuximab|margetuximab|mesh-list
5780972|NCT04425018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5780973|NCT04425018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5780974|NCT04425018|Tubulin Modulators|tubulin modulators|mesh-ancestor
5780975|NCT04425018|Antimitotic Agents|antimitotic agents|mesh-ancestor
5780976|NCT04425018|Mitosis Modulators|mitosis modulators|mesh-ancestor
5780977|NCT04425018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780978|NCT04425018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5780979|NCT04423718|Aflibercept|aflibercept|mesh-list
5780980|NCT04423718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5780981|NCT04423718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5780982|NCT04423718|Growth Substances|growth substances|mesh-ancestor
5780983|NCT04423718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780984|NCT04423718|Growth Inhibitors|growth inhibitors|mesh-ancestor
5780985|NCT04423718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5780986|NCT04410328|Aspirin|aspirin|mesh-list
5780987|NCT04410328|Dipyridamole|dipyridamole|mesh-list
5780988|NCT04410328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5780989|NCT04410328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5780990|NCT04410328|Analgesics|analgesics|mesh-ancestor
5780991|NCT04410328|Sensory System Agents|sensory system agents|mesh-ancestor
5780992|NCT04410328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5780993|NCT04410328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5780994|NCT04410328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5780995|NCT04410328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5780996|NCT04410328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5780997|NCT04410328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5780998|NCT04410328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5780999|NCT04410328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5781000|NCT04410328|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5781001|NCT04410328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5781002|NCT04410328|Antipyretics|antipyretics|mesh-ancestor
5781003|NCT04410328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5781004|NCT04410328|Vasodilator Agents|vasodilator agents|mesh-ancestor
5781005|NCT04400474|Atezolizumab|atezolizumab|mesh-list
5781006|NCT04400474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5781007|NCT04393285|Letrozole|letrozole|mesh-list
5781008|NCT04393285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5781009|NCT04393285|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5781010|NCT04393285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5781011|NCT04393285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5781012|NCT04393285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781013|NCT04393285|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5781014|NCT04393285|Hormone Antagonists|hormone antagonists|mesh-ancestor
5781015|NCT04393285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5781016|NCT04393285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5781017|NCT04390399|Leucovorin|leucovorin|mesh-list
5781018|NCT04390399|Gemcitabine|gemcitabine|mesh-list
5781019|NCT04390399|Paclitaxel|paclitaxel|mesh-list
5781020|NCT04390399|Cyclophosphamide|cyclophosphamide|mesh-list
5781021|NCT04390399|Fluorouracil|fluorouracil|mesh-list
5781022|NCT04390399|Irinotecan|irinotecan|mesh-list
5781023|NCT04390399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5781024|NCT04390399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5781025|NCT04390399|Tubulin Modulators|tubulin modulators|mesh-ancestor
5781026|NCT04390399|Antimitotic Agents|antimitotic agents|mesh-ancestor
5781027|NCT04390399|Mitosis Modulators|mitosis modulators|mesh-ancestor
5781028|NCT04390399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781029|NCT04390399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5781030|NCT04390399|Immunologic Factors|immunologic factors|mesh-ancestor
5781031|NCT04390399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5781032|NCT04390399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5781033|NCT04390399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5781034|NCT04390399|Alkylating Agents|alkylating agents|mesh-ancestor
5781035|NCT04390399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5781036|NCT04390399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5781037|NCT04390399|Antimetabolites|antimetabolites|mesh-ancestor
5781038|NCT04390399|Antiviral Agents|antiviral agents|mesh-ancestor
5781039|NCT04390399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5781040|NCT04390399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5781041|NCT04390399|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5781042|NCT04390399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5781043|NCT04390399|Antidotes|antidotes|mesh-ancestor
5781044|NCT04390399|Protective Agents|protective agents|mesh-ancestor
5781045|NCT04390399|Vitamin B Complex|vitamin b complex|mesh-ancestor
5781046|NCT04390399|Vitamins|vitamins|mesh-ancestor
5781047|NCT04390399|Micronutrients|micronutrients|mesh-ancestor
5897796|NCT04810910|Sargramostim|sargramostim|mesh-list
5897797|NCT04810910|Immunologic Factors|immunologic factors|mesh-ancestor
5897798|NCT04810910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897799|NCT04810910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5897800|NCT04746989|Allopurinol|allopurinol|mesh-list
5897801|NCT04746989|Probenecid|probenecid|mesh-list
5897802|NCT04746989|Antimetabolites|antimetabolites|mesh-ancestor
5897803|NCT04746989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897804|NCT04746989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5897805|NCT04746989|Gout Suppressants|gout suppressants|mesh-ancestor
5897806|NCT04746989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5897807|NCT04746989|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5897808|NCT04746989|Antioxidants|antioxidants|mesh-ancestor
5897809|NCT04746989|Protective Agents|protective agents|mesh-ancestor
5897810|NCT04746989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897811|NCT04746989|Uricosuric Agents|uricosuric agents|mesh-ancestor
5897812|NCT04746989|Renal Agents|renal agents|mesh-ancestor
5907985|NCT04973566|Antimalarials|antimalarials|mesh-ancestor
5907986|NCT04973566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5907987|NCT04973566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5907988|NCT04973566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5907989|NCT04973566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5907990|NCT04973566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907991|NCT04973566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5907992|NCT04973566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5907993|NCT04973566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5907994|NCT04973566|Analgesics|analgesics|mesh-ancestor
5907995|NCT04973566|Sensory System Agents|sensory system agents|mesh-ancestor
5907996|NCT04973566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5907997|NCT04973566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907998|NCT04973566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5907999|NCT04973566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5908000|NCT04973566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5908001|NCT04973566|Immunologic Factors|immunologic factors|mesh-ancestor
5908002|NCT04960202|Ritonavir|ritonavir|mesh-list
5908003|NCT04960202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5908004|NCT04960202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5908005|NCT04960202|Protease Inhibitors|protease inhibitors|mesh-ancestor
5908006|NCT04960202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5908007|NCT04960202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908008|NCT04960202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5908009|NCT04960202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5908010|NCT04960202|Antiviral Agents|antiviral agents|mesh-ancestor
5908011|NCT04960202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5908012|NCT04960202|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5908013|NCT04960202|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5908014|NCT04957758|Varenicline|varenicline|mesh-list
5908015|NCT04957758|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5908016|NCT04957758|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5908017|NCT04957758|Cholinergic Agents|cholinergic agents|mesh-ancestor
5908018|NCT04957758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5908019|NCT04957758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908020|NCT04957758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5908021|NCT04954287|Vaccines|vaccines|mesh-list
5908022|NCT04954287|Immunologic Factors|immunologic factors|mesh-ancestor
5908023|NCT04954287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5908024|NCT04938765|Magnesium Sulfate|magnesium sulfate|mesh-list
6673705|NCT01564381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6673706|NCT01564381|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6673707|NCT01564550|Insulin|insulin|mesh-list
6673708|NCT01564550|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6673709|NCT01564550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5908025|NCT04938765|Analgesics|analgesics|mesh-ancestor
5908026|NCT04938765|Sensory System Agents|sensory system agents|mesh-ancestor
5908027|NCT04938765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5908028|NCT04938765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5908029|NCT04938765|Anesthetics|anesthetics|mesh-ancestor
5908030|NCT04938765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5908031|NCT04938765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5908032|NCT04938765|Anticonvulsants|anticonvulsants|mesh-ancestor
5908033|NCT04938765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5908034|NCT04938765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5908035|NCT04938765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673710|NCT01564550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5781048|NCT04385589|Dapagliflozin|dapagliflozin|mesh-list
5781049|NCT04385589|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
5781050|NCT04385589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5781051|NCT04385589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5781052|NCT04385589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781053|NCT04375787|Atorvastatin|atorvastatin|mesh-list
5781054|NCT04375787|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5781055|NCT04375787|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5781056|NCT04375787|Antimetabolites|antimetabolites|mesh-ancestor
5781057|NCT04375787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781058|NCT04375787|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5781059|NCT04375787|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5781060|NCT04375787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5781061|NCT04355143|Colchicine|colchicine|mesh-list
5781062|NCT04355143|Gout Suppressants|gout suppressants|mesh-ancestor
5781063|NCT04355143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5781064|NCT04355143|Tubulin Modulators|tubulin modulators|mesh-ancestor
5781065|NCT04355143|Antimitotic Agents|antimitotic agents|mesh-ancestor
5781066|NCT04355143|Mitosis Modulators|mitosis modulators|mesh-ancestor
5781067|NCT04355143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781068|NCT04355143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5781069|NCT04345796|Empagliflozin|empagliflozin|mesh-list
5781070|NCT04345796|Carvedilol|carvedilol|mesh-list
5781071|NCT04345796|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5781072|NCT04345796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781073|NCT04345796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5781074|NCT04345796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5781075|NCT04345796|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5781076|NCT04345796|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5781077|NCT04345796|Adrenergic Agents|adrenergic agents|mesh-ancestor
5781078|NCT04345796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5781079|NCT04345796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5781080|NCT04345796|Antioxidants|antioxidants|mesh-ancestor
5781081|NCT04345796|Protective Agents|protective agents|mesh-ancestor
5781082|NCT04345796|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5781083|NCT04345796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5781084|NCT04345796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5781085|NCT04345796|Vasodilator Agents|vasodilator agents|mesh-ancestor
5781086|NCT04345796|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5781087|NCT04345796|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6210680|NCT02163434|Anticonvulsants|anticonvulsants|mesh-ancestor
6210681|NCT02163434|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6210682|NCT02163434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6210683|NCT02163434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6210684|NCT02163434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6210685|NCT02163434|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6210686|NCT02163434|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6210687|NCT02163434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6210688|NCT02163434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210689|NCT02163434|Antimanic Agents|antimanic agents|mesh-ancestor
6210690|NCT02163434|Antiemetics|antiemetics|mesh-ancestor
5781099|NCT04327063|Ropivacaine|ropivacaine|mesh-list
5781100|NCT04327063|Anesthetics, Local|anesthetics, local|mesh-ancestor
5781101|NCT04327063|Anesthetics|anesthetics|mesh-ancestor
5781102|NCT04327063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5781103|NCT04327063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5781104|NCT04327063|Sensory System Agents|sensory system agents|mesh-ancestor
5781105|NCT04327063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5781106|NCT04307576|Dexamethasone|dexamethasone|mesh-list
5781107|NCT04307576|Doxorubicin|doxorubicin|mesh-list
5781108|NCT04307576|Vincristine|vincristine|mesh-list
5781109|NCT04307576|Imatinib Mesylate|imatinib mesylate|mesh-list
5781110|NCT04307576|Blinatumomab|blinatumomab|mesh-list
5781111|NCT04307576|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
5781112|NCT04307576|Thioguanine|thioguanine|mesh-list
5781113|NCT04307576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5781114|NCT04307576|Antiemetics|antiemetics|mesh-ancestor
5781115|NCT04307576|Autonomic Agents|autonomic agents|mesh-ancestor
5781116|NCT04307576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5781117|NCT04307576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5781118|NCT04307576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5781119|NCT04307576|Glucocorticoids|glucocorticoids|mesh-ancestor
5781120|NCT04307576|Hormones|hormones|mesh-ancestor
5781121|NCT04307576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6673711|NCT01564576|Bromides|bromides|mesh-list
5781122|NCT04307576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5781123|NCT04307576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5781124|NCT04307576|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5781125|NCT04307576|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5781126|NCT04307576|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5781127|NCT04307576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5781128|NCT04307576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781129|NCT04307576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5781130|NCT04307576|Tubulin Modulators|tubulin modulators|mesh-ancestor
5781131|NCT04307576|Antimitotic Agents|antimitotic agents|mesh-ancestor
5781132|NCT04307576|Mitosis Modulators|mitosis modulators|mesh-ancestor
5781133|NCT04307576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5781134|NCT04307576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5781135|NCT04307576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5781136|NCT04307576|Antimetabolites|antimetabolites|mesh-ancestor
5781137|NCT04280601|Vitamin D|vitamin d|mesh-list
5781138|NCT04280601|Vitamins|vitamins|mesh-ancestor
5781139|NCT04280601|Micronutrients|micronutrients|mesh-ancestor
5781140|NCT04280601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5781141|NCT04280601|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6210691|NCT02163434|Autonomic Agents|autonomic agents|mesh-ancestor
6210692|NCT02163434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6210693|NCT02163434|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6210694|NCT02163434|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6210695|NCT02163434|Dopamine Agents|dopamine agents|mesh-ancestor
5781147|NCT04262427|Cyclophosphamide|cyclophosphamide|mesh-list
5781148|NCT04262427|Pembrolizumab|pembrolizumab|mesh-list
5781149|NCT04262427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5781150|NCT04262427|Immunologic Factors|immunologic factors|mesh-ancestor
5781151|NCT04262427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5781152|NCT04262427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5781153|NCT04262427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5781154|NCT04262427|Alkylating Agents|alkylating agents|mesh-ancestor
5781155|NCT04262427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781156|NCT04262427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6491061|NCT00600977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6491062|NCT00600977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6491063|NCT00600977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6491064|NCT00600977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6491065|NCT00600977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491066|NCT00600990|Vestipitant|vestipitant|mesh-list
6491067|NCT00600990|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5781157|NCT04262427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5781158|NCT04262427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5781159|NCT04252612|Pramlintide|pramlintide|mesh-list
5781160|NCT04252612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5781161|NCT04252612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5781162|NCT04231331|Ertugliflozin|ertugliflozin|mesh-list
5781163|NCT04231331|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5781164|NCT04231331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781165|NCT04231331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5781166|NCT04231331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5781167|NCT04224584|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5781168|NCT04224584|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5781169|NCT04224584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5781170|NCT04224584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5781171|NCT04224584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781172|NCT04224584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5781173|NCT04224584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5781174|NCT04224584|Analgesics|analgesics|mesh-ancestor
5781175|NCT04224584|Sensory System Agents|sensory system agents|mesh-ancestor
5781176|NCT04224584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5781177|NCT04224584|Antidepressive Agents|antidepressive agents|mesh-ancestor
5781178|NCT04224584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5781179|NCT04224584|Dopamine Agents|dopamine agents|mesh-ancestor
5781180|NCT04209855|Paclitaxel|paclitaxel|mesh-list
5781181|NCT04209855|Maytansine|maytansine|mesh-list
5781182|NCT04209855|Doxorubicin|doxorubicin|mesh-list
5781183|NCT04209855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5781184|NCT04209855|Topotecan|topotecan|mesh-list
5781185|NCT04209855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5781186|NCT04209855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6210696|NCT02163447|Pyrimethamine|pyrimethamine|mesh-list
5781187|NCT04209855|Tubulin Modulators|tubulin modulators|mesh-ancestor
5781188|NCT04209855|Antimitotic Agents|antimitotic agents|mesh-ancestor
5781189|NCT04209855|Mitosis Modulators|mitosis modulators|mesh-ancestor
5781190|NCT04209855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781191|NCT04209855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5781192|NCT04209855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5781193|NCT04209855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5781194|NCT04209855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5781195|NCT04209855|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5781205|NCT04195568|Calcium Carbonate|calcium carbonate|mesh-list
5781206|NCT04195568|Antacids|antacids|mesh-ancestor
5781207|NCT04195568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781208|NCT04195568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5781209|NCT04191421|Spartalizumab|spartalizumab|mesh-list
5781210|NCT04191421|Siltuximab|siltuximab|mesh-list
5781211|NCT04191421|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5781212|NCT04191421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781213|NCT04191421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5781214|NCT04172532|Peposertib|peposertib|mesh-list
5781215|NCT04172532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5781216|NCT04172532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5781217|NCT04172532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781218|NCT04148911|Paclitaxel|paclitaxel|mesh-list
5781219|NCT04148911|Atezolizumab|atezolizumab|mesh-list
5781220|NCT04148911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5781221|NCT04148911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5781222|NCT04148911|Tubulin Modulators|tubulin modulators|mesh-ancestor
5781223|NCT04148911|Antimitotic Agents|antimitotic agents|mesh-ancestor
5781224|NCT04148911|Mitosis Modulators|mitosis modulators|mesh-ancestor
5781225|NCT04148911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781226|NCT04139434|Azacitidine|azacitidine|mesh-list
5781227|NCT04139434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5781228|NCT04139434|Antimetabolites|antimetabolites|mesh-ancestor
5781229|NCT04139434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781230|NCT04139434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5781231|NCT04139434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5781232|NCT04138394|Ascorbic Acid|ascorbic acid|mesh-list
5781233|NCT04138394|Vitamins|vitamins|mesh-ancestor
5781234|NCT04138394|Micronutrients|micronutrients|mesh-ancestor
5781235|NCT04138394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5781236|NCT04138394|Antioxidants|antioxidants|mesh-ancestor
5781237|NCT04138394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781238|NCT04138394|Protective Agents|protective agents|mesh-ancestor
5781239|NCT04135937|Bupropion|bupropion|mesh-list
5781240|NCT04135937|Nicotine|nicotine|mesh-list
5781241|NCT04135937|Varenicline|varenicline|mesh-list
5781242|NCT04135937|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5781243|NCT04135937|Autonomic Agents|autonomic agents|mesh-ancestor
5781244|NCT04135937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5781245|NCT04135937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5781246|NCT04135937|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5781247|NCT04135937|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5781248|NCT04135937|Cholinergic Agents|cholinergic agents|mesh-ancestor
5781249|NCT04135937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5781250|NCT04135937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781251|NCT04135937|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5781252|NCT04135937|Antidepressive Agents|antidepressive agents|mesh-ancestor
5781253|NCT04135937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5781254|NCT04135937|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5781255|NCT04135937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5781256|NCT04135937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5781257|NCT04135937|Dopamine Agents|dopamine agents|mesh-ancestor
5781258|NCT04135937|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5781259|NCT04135937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5781260|NCT04135937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5781261|NCT04135495|Ivacaftor|ivacaftor|mesh-list
5781262|NCT04135495|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
5781263|NCT04135495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5781264|NCT04135495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781265|NCT04129437|Ibuprofen|ibuprofen|mesh-list
5781266|NCT04129437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5781267|NCT04129437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5781268|NCT04129437|Analgesics|analgesics|mesh-ancestor
5781269|NCT04129437|Sensory System Agents|sensory system agents|mesh-ancestor
5781270|NCT04129437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5781271|NCT04129437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5781272|NCT04129437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5781273|NCT04129437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5781274|NCT04129437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5781275|NCT04129437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5781276|NCT04129437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781277|NCT04119453|Apatinib|apatinib|mesh-list
5781278|NCT04119453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5781279|NCT04119453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5781280|NCT04119453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5781281|NCT04119453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781282|NCT04102436|Aldesleukin|aldesleukin|mesh-list
5781283|NCT04102436|Cyclophosphamide|cyclophosphamide|mesh-list
5781284|NCT04102436|Fludarabine|fludarabine|mesh-list
5781285|NCT04102436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5781286|NCT04102436|Immunologic Factors|immunologic factors|mesh-ancestor
5781287|NCT04102436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5781288|NCT04102436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5781289|NCT04102436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5781290|NCT04102436|Alkylating Agents|alkylating agents|mesh-ancestor
5781291|NCT04102436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781292|NCT04102436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5781293|NCT04102436|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5781294|NCT04102436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5781295|NCT04102436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5781296|NCT04102436|Antiviral Agents|antiviral agents|mesh-ancestor
5781297|NCT04102436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5781307|NCT04073290|Rifaximin|rifaximin|mesh-list
5781308|NCT04073290|Lactulose|lactulose|mesh-list
5781309|NCT04073290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5781310|NCT04073290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5781311|NCT04073290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5781312|NCT04066348|Etanercept|etanercept|mesh-list
5781313|NCT04066348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5781314|NCT04066348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5781315|NCT04066348|Analgesics|analgesics|mesh-ancestor
5781316|NCT04066348|Sensory System Agents|sensory system agents|mesh-ancestor
5781317|NCT04066348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5781318|NCT04066348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5781319|NCT04066348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5781320|NCT04066348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5781321|NCT04066348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5781322|NCT04066348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5781323|NCT04066348|Immunologic Factors|immunologic factors|mesh-ancestor
5781324|NCT04012931|Rilpivirine|rilpivirine|mesh-list
5781325|NCT04012931|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5781326|NCT04012931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5781327|NCT04012931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5781328|NCT04012931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781329|NCT04012931|Antiviral Agents|antiviral agents|mesh-ancestor
5781330|NCT04012931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5781331|NCT04012931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5781332|NCT04012931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5781333|NCT03998488|Psyllium|psyllium|mesh-list
6491068|NCT00600990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5781334|NCT03998488|Calcium polycarbophil|calcium polycarbophil|mesh-list
5781335|NCT03998488|Cathartics|cathartics|mesh-ancestor
5781336|NCT03998488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5781337|NCT03998488|Antidiarrheals|antidiarrheals|mesh-ancestor
5781338|NCT03987685|Topotecan|topotecan|mesh-list
5781339|NCT03987685|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5781340|NCT03987685|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5781341|NCT03987685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5781342|NCT03987685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781343|NCT03987685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5781344|NCT03967223|Cyclophosphamide|cyclophosphamide|mesh-list
5781345|NCT03967223|Fludarabine|fludarabine|mesh-list
5781346|NCT03967223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5781347|NCT03967223|Immunologic Factors|immunologic factors|mesh-ancestor
5781348|NCT03967223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5781349|NCT03967223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5781350|NCT03967223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5781351|NCT03967223|Alkylating Agents|alkylating agents|mesh-ancestor
5781352|NCT03967223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781353|NCT03967223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5781354|NCT03967223|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5781355|NCT03944772|Carboplatin|carboplatin|mesh-list
5781356|NCT03944772|Etoposide|etoposide|mesh-list
5781357|NCT03944772|Pemetrexed|pemetrexed|mesh-list
5781358|NCT03944772|Durvalumab|durvalumab|mesh-list
5781359|NCT03944772|Gefitinib|gefitinib|mesh-list
5781360|NCT03944772|Osimertinib|osimertinib|mesh-list
5781361|NCT03944772|Necitumumab|necitumumab|mesh-list
5781362|NCT03944772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5781363|NCT03944772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5781364|NCT03944772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5781365|NCT03944772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5781366|NCT03944772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5781367|NCT03944772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781368|NCT03944772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5781369|NCT03944772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5781370|NCT03944772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5781371|NCT03944772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5781372|NCT03939767|Aflibercept|aflibercept|mesh-list
5781373|NCT03939767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5781374|NCT03939767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5781375|NCT03939767|Growth Substances|growth substances|mesh-ancestor
5781376|NCT03939767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5781377|NCT03939767|Growth Inhibitors|growth inhibitors|mesh-ancestor
5781378|NCT03939767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5781379|NCT03936790|Fentanyl|fentanyl|mesh-list
5781380|NCT03936790|Ropivacaine|ropivacaine|mesh-list
5781381|NCT03936790|Anesthetics, Local|anesthetics, local|mesh-ancestor
5781382|NCT03936790|Anesthetics|anesthetics|mesh-ancestor
5781383|NCT03936790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5781384|NCT03936790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5781385|NCT03936790|Sensory System Agents|sensory system agents|mesh-ancestor
5781386|NCT03936790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5781387|NCT03936790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5781388|NCT03936790|Narcotics|narcotics|mesh-ancestor
5781389|NCT03936790|Analgesics|analgesics|mesh-ancestor
5781390|NCT03936790|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5781391|NCT03936790|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5781392|NCT03936790|Anesthetics, General|anesthetics, general|mesh-ancestor
5781393|NCT03931057|Midazolam|midazolam|mesh-list
5781394|NCT03931057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5781395|NCT03931057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5781396|NCT03931057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5781397|NCT03931057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5781398|NCT03931057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6491069|NCT00600990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491070|NCT00600990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491071|NCT00601016|Imiquimod|imiquimod|mesh-list
5781399|NCT03931057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5781400|NCT03931057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5781401|NCT03931057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5781402|NCT03931057|Anesthetics, General|anesthetics, general|mesh-ancestor
5781403|NCT03931057|Anesthetics|anesthetics|mesh-ancestor
5781404|NCT03931057|GABA Modulators|gaba modulators|mesh-ancestor
5781405|NCT03931057|GABA Agents|gaba agents|mesh-ancestor
5781406|NCT03931057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5781407|NCT03931057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781408|NCT03912428|Celecoxib|celecoxib|mesh-list
5781409|NCT03912428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6491072|NCT00601016|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6673712|NCT01564576|Rocuronium|rocuronium|mesh-list
5781410|NCT03912428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5781411|NCT03912428|Analgesics|analgesics|mesh-ancestor
5781412|NCT03912428|Sensory System Agents|sensory system agents|mesh-ancestor
5781413|NCT03912428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5781414|NCT03912428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5781415|NCT03912428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5781416|NCT03912428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5781417|NCT03912428|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5781418|NCT03912428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5781419|NCT03912428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5781420|NCT03912428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897813|NCT04729049|Morphine|morphine|mesh-list
5897814|NCT04729049|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5897815|NCT04729049|Narcotics|narcotics|mesh-ancestor
5897816|NCT04729049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5897817|NCT04729049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897818|NCT04729049|Analgesics|analgesics|mesh-ancestor
5897819|NCT04729049|Sensory System Agents|sensory system agents|mesh-ancestor
5897820|NCT04729049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5897821|NCT04723446|Chlorhexidine|chlorhexidine|mesh-list
5897822|NCT04723446|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5897823|NCT04723446|Hydrogen Peroxide|hydrogen peroxide|mesh-list
5897824|NCT04723446|Cetylpyridinium|cetylpyridinium|mesh-list
5897825|NCT04723446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5897826|NCT04723446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5897827|NCT04723446|Disinfectants|disinfectants|mesh-ancestor
5897828|NCT04723446|Dermatologic Agents|dermatologic agents|mesh-ancestor
5897829|NCT04688931|Mitomycins|mitomycins|mesh-list
5897830|NCT04688931|Mitomycin|mitomycin|mesh-list
5897831|NCT04688931|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5897832|NCT04688931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5897833|NCT04688931|Alkylating Agents|alkylating agents|mesh-ancestor
5897834|NCT04688931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897835|NCT04688931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5897836|NCT04688931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5897837|NCT04667585|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5897838|NCT04667585|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5897839|NCT04667585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897840|NCT04663711|Anesthetics|anesthetics|mesh-list
5897841|NCT04663711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5897842|NCT04663711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897843|NCT04639245|Cyclophosphamide|cyclophosphamide|mesh-list
5897844|NCT04639245|Fludarabine|fludarabine|mesh-list
5897845|NCT04639245|Atezolizumab|atezolizumab|mesh-list
5897846|NCT04639245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5897847|NCT04639245|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5897848|NCT04639245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5897849|NCT04639245|Immunologic Factors|immunologic factors|mesh-ancestor
5897850|NCT04639245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897851|NCT04639245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5897852|NCT04639245|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5897853|NCT04639245|Alkylating Agents|alkylating agents|mesh-ancestor
5897854|NCT04639245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897855|NCT04639245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5897856|NCT04639245|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5897857|NCT04616534|Gemcitabine|gemcitabine|mesh-list
5897858|NCT04616534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5897859|NCT04616534|Antimetabolites|antimetabolites|mesh-ancestor
5897860|NCT04616534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897861|NCT04616534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5897862|NCT04616534|Antiviral Agents|antiviral agents|mesh-ancestor
5897863|NCT04616534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5897864|NCT04616534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5897865|NCT04616534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5897866|NCT04616534|Immunologic Factors|immunologic factors|mesh-ancestor
6673713|NCT01564576|Anticonvulsants|anticonvulsants|mesh-ancestor
6673714|NCT01564576|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5897867|NCT04616534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897868|NCT04588259|Insulin|insulin|mesh-list
5897869|NCT04588259|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6491073|NCT00601016|Immunologic Factors|immunologic factors|mesh-ancestor
6491074|NCT00601016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5781421|NCT03904498|Tolcapone|tolcapone|mesh-list
5781422|NCT03904498|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5781423|NCT03904498|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5781424|NCT03904498|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
5781425|NCT03904498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5781426|NCT03904498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781427|NCT03904329|Anticoagulants|anticoagulants|mesh-list
5781428|NCT03896880|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5781429|NCT03896880|Clotrimazole|clotrimazole|mesh-list
5781430|NCT03896880|Miconazole|miconazole|mesh-list
5781431|NCT03896880|Antifungal Agents|antifungal agents|mesh-list
5781432|NCT03896880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5781433|NCT03896880|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5781434|NCT03896880|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5781435|NCT03896880|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5781436|NCT03896880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5781437|NCT03896880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781438|NCT03896880|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5781439|NCT03896880|Hormone Antagonists|hormone antagonists|mesh-ancestor
5781440|NCT03896880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5781441|NCT03896880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5781442|NCT03896880|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5781443|NCT03896880|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5781444|NCT03866668|Esomeprazole|esomeprazole|mesh-list
5781445|NCT03866668|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5781446|NCT03866668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5781447|NCT03866668|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5781448|NCT03866668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5781449|NCT03866668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781450|NCT03845894|Bupivacaine|bupivacaine|mesh-list
5781451|NCT03845894|Anesthetics, Local|anesthetics, local|mesh-ancestor
5781452|NCT03845894|Anesthetics|anesthetics|mesh-ancestor
5781453|NCT03845894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5781454|NCT03845894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5781455|NCT03845894|Sensory System Agents|sensory system agents|mesh-ancestor
5781456|NCT03845894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5781457|NCT03845582|Vitamin A|vitamin a|mesh-list
5781458|NCT03845582|Retinol acetate|retinol acetate|mesh-list
5781459|NCT03845582|Vitamins|vitamins|mesh-ancestor
6491075|NCT00601016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6491076|NCT00601016|Interferon Inducers|interferon inducers|mesh-ancestor
6491077|NCT00601042|Lobeline|lobeline|mesh-list
6491078|NCT00601042|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6491079|NCT00601042|Autonomic Agents|autonomic agents|mesh-ancestor
6491080|NCT00601042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5781460|NCT03845582|Micronutrients|micronutrients|mesh-ancestor
5781461|NCT03845582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5781462|NCT03845582|Protective Agents|protective agents|mesh-ancestor
5781463|NCT03845582|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5781464|NCT03845582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5781465|NCT03845582|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5781466|NCT03845582|Immunologic Factors|immunologic factors|mesh-ancestor
5781467|NCT03819049|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5781468|NCT03819049|Immunologic Factors|immunologic factors|mesh-ancestor
5781469|NCT03819049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5781470|NCT03809481|Danaparoid|danaparoid|mesh-list
5781471|NCT03809481|Argatroban|argatroban|mesh-list
5781472|NCT03809481|Antithrombins|antithrombins|mesh-ancestor
5781473|NCT03809481|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5781474|NCT03809481|Protease Inhibitors|protease inhibitors|mesh-ancestor
5781475|NCT03809481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5781476|NCT03809481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491081|NCT00601042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5781477|NCT03809481|Anticoagulants|anticoagulants|mesh-ancestor
5781478|NCT03809481|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5781479|NCT03809481|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5781480|NCT03809481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5781481|NCT03789240|Rituximab|rituximab|mesh-list
5781482|NCT03789240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5781483|NCT03789240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5781484|NCT03789240|Immunologic Factors|immunologic factors|mesh-ancestor
5781485|NCT03789240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5781486|NCT03789240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5781487|NCT03789110|Nivolumab|nivolumab|mesh-list
5781488|NCT03789110|Ipilimumab|ipilimumab|mesh-list
5781489|NCT03789110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5781490|NCT03789110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5781491|NCT03789110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5781492|NCT03789110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781493|NCT03773237|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
5781494|NCT03773237|SMOFlipid|smoflipid|mesh-list
5781495|NCT03773237|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
5781496|NCT03773237|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5781497|NCT03773237|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5781498|NCT03745326|Aldesleukin|aldesleukin|mesh-list
5781499|NCT03745326|Cyclophosphamide|cyclophosphamide|mesh-list
5781500|NCT03745326|Fludarabine|fludarabine|mesh-list
5781501|NCT03745326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5781502|NCT03745326|Immunologic Factors|immunologic factors|mesh-ancestor
5781503|NCT03745326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5781504|NCT03745326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5781505|NCT03745326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5781506|NCT03745326|Alkylating Agents|alkylating agents|mesh-ancestor
5781507|NCT03745326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781508|NCT03745326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5781509|NCT03745326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5781510|NCT03745326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5781511|NCT03745326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5781512|NCT03745326|Antiviral Agents|antiviral agents|mesh-ancestor
5781513|NCT03745326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5781514|NCT03721406|Ropivacaine|ropivacaine|mesh-list
5781515|NCT03721406|Anesthetics, Local|anesthetics, local|mesh-ancestor
5781516|NCT03721406|Anesthetics|anesthetics|mesh-ancestor
5781517|NCT03721406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5781518|NCT03721406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5781519|NCT03721406|Sensory System Agents|sensory system agents|mesh-ancestor
5781520|NCT03721406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5781521|NCT03708549|Metformin|metformin|mesh-list
5781522|NCT03708549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5781523|NCT03708549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5781524|NCT03673124|Letrozole|letrozole|mesh-list
5781525|NCT03673124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5781526|NCT03673124|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5781527|NCT03673124|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5781528|NCT03673124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5781529|NCT03673124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781530|NCT03673124|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5781531|NCT03673124|Hormone Antagonists|hormone antagonists|mesh-ancestor
5781532|NCT03673124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5781533|NCT03673124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5781534|NCT03635489|Paclitaxel|paclitaxel|mesh-list
5781535|NCT03635489|Bevacizumab|bevacizumab|mesh-list
5781536|NCT03635489|Carboplatin|carboplatin|mesh-list
5781537|NCT03635489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5781538|NCT03635489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5781539|NCT03635489|Tubulin Modulators|tubulin modulators|mesh-ancestor
5781540|NCT03635489|Antimitotic Agents|antimitotic agents|mesh-ancestor
5781541|NCT03635489|Mitosis Modulators|mitosis modulators|mesh-ancestor
5781542|NCT03635489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781543|NCT03635489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5781544|NCT03635489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5781545|NCT03635489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5781546|NCT03635489|Growth Substances|growth substances|mesh-ancestor
5781547|NCT03635489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5781548|NCT03635489|Growth Inhibitors|growth inhibitors|mesh-ancestor
5781549|NCT03628209|Nivolumab|nivolumab|mesh-list
5781550|NCT03628209|Azacitidine|azacitidine|mesh-list
5781551|NCT03628209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5781552|NCT03628209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5781553|NCT03628209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5781554|NCT03628209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781555|NCT03628209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5781556|NCT03628209|Antimetabolites|antimetabolites|mesh-ancestor
5781557|NCT03628209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5781558|NCT03610061|Durvalumab|durvalumab|mesh-list
5781559|NCT03610061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5781560|NCT03610061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5781561|NCT03598257|Olaparib|olaparib|mesh-list
5781562|NCT03598257|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
5781563|NCT03598257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5781564|NCT03598257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781565|NCT03598257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5781566|NCT03582293|Tranexamic Acid|tranexamic acid|mesh-list
5781567|NCT03582293|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5781568|NCT03582293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5781569|NCT03582293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781570|NCT03582293|Hemostatics|hemostatics|mesh-ancestor
5781571|NCT03582293|Coagulants|coagulants|mesh-ancestor
5781572|NCT03574337|Neostigmine|neostigmine|mesh-list
5781573|NCT03574337|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5781574|NCT03574337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5781575|NCT03574337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781576|NCT03574337|Cholinergic Agents|cholinergic agents|mesh-ancestor
5781577|NCT03574337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5781578|NCT03574337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5781579|NCT03574337|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5781580|NCT03574337|Autonomic Agents|autonomic agents|mesh-ancestor
5781581|NCT03574337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5781582|NCT03567876|Venetoclax|venetoclax|mesh-list
5781583|NCT03567876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5781584|NCT03557294|Varenicline|varenicline|mesh-list
5781585|NCT03557294|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5781586|NCT03557294|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5781587|NCT03557294|Cholinergic Agents|cholinergic agents|mesh-ancestor
5781588|NCT03557294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5781589|NCT03557294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781590|NCT03557294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5781591|NCT03530696|Palbociclib|palbociclib|mesh-list
5781592|NCT03530696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5781593|NCT03530696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5781594|NCT03530696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5781595|NCT03530696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781596|NCT03523858|Ocrelizumab|ocrelizumab|mesh-list
5781597|NCT03523858|Immunologic Factors|immunologic factors|mesh-ancestor
5781598|NCT03523858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5781599|NCT03507452|BAY 2287411|bay 2287411|mesh-list
5781600|NCT03507452|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5781601|NCT03507452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781602|NCT03418649|Eplerenone|eplerenone|mesh-list
5781603|NCT03418649|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5781604|NCT03418649|Hormone Antagonists|hormone antagonists|mesh-ancestor
5781605|NCT03418649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5781606|NCT03418649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5781607|NCT03418649|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5781608|NCT03418649|Diuretics|diuretics|mesh-ancestor
5781609|NCT03418649|Natriuretic Agents|natriuretic agents|mesh-ancestor
5781610|NCT03418649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5781611|NCT03414684|Carboplatin|carboplatin|mesh-list
5781612|NCT03414684|Nivolumab|nivolumab|mesh-list
5781613|NCT03414684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5781614|NCT03414684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5781615|NCT03414684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5781616|NCT03414684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781617|NCT03412877|Aldesleukin|aldesleukin|mesh-list
5781618|NCT03412877|Cyclophosphamide|cyclophosphamide|mesh-list
5781619|NCT03412877|Pembrolizumab|pembrolizumab|mesh-list
5781620|NCT03412877|Fludarabine|fludarabine|mesh-list
5781621|NCT03412877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5781622|NCT03412877|Immunologic Factors|immunologic factors|mesh-ancestor
5781623|NCT03412877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5781624|NCT03412877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5781625|NCT03412877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5781626|NCT03412877|Alkylating Agents|alkylating agents|mesh-ancestor
5781627|NCT03412877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781628|NCT03412877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5781629|NCT03412877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5781630|NCT03412877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5781631|NCT03412877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5781632|NCT03412877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5781633|NCT03412877|Antiviral Agents|antiviral agents|mesh-ancestor
5781634|NCT03412877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5781635|NCT03384641|Bedaquiline|bedaquiline|mesh-list
5781636|NCT03384641|Antitubercular Agents|antitubercular agents|mesh-ancestor
5781637|NCT03384641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5781638|NCT03384641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5781639|NCT03213457|Norethindrone|norethindrone|mesh-list
5781640|NCT03213457|Norethindrone Acetate|norethindrone acetate|mesh-list
5781641|NCT03213457|Estradiol|estradiol|mesh-list
5781642|NCT03213457|Estrogens|estrogens|mesh-ancestor
5781643|NCT03213457|Hormones|hormones|mesh-ancestor
5781644|NCT03213457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5781645|NCT03213457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5781646|NCT03213457|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5781647|NCT03213457|Contraceptive Agents|contraceptive agents|mesh-ancestor
5781648|NCT03213457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5781649|NCT03213457|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5781650|NCT03213457|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5781651|NCT03213457|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5781652|NCT03213457|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5781653|NCT03193190|Leucovorin|leucovorin|mesh-list
5781654|NCT03193190|Gemcitabine|gemcitabine|mesh-list
5781655|NCT03193190|Paclitaxel|paclitaxel|mesh-list
5781656|NCT03193190|Bevacizumab|bevacizumab|mesh-list
5781657|NCT03193190|Fluorouracil|fluorouracil|mesh-list
5781658|NCT03193190|Oxaliplatin|oxaliplatin|mesh-list
5781659|NCT03193190|Atezolizumab|atezolizumab|mesh-list
5781660|NCT03193190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5781661|NCT03193190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5781662|NCT03193190|Tubulin Modulators|tubulin modulators|mesh-ancestor
5781663|NCT03193190|Antimitotic Agents|antimitotic agents|mesh-ancestor
5781664|NCT03193190|Mitosis Modulators|mitosis modulators|mesh-ancestor
5781665|NCT03193190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781666|NCT03193190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5781667|NCT03193190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5781668|NCT03193190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5781669|NCT03193190|Growth Substances|growth substances|mesh-ancestor
5781670|NCT03193190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5781671|NCT03193190|Growth Inhibitors|growth inhibitors|mesh-ancestor
5781672|NCT03193190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5781673|NCT03193190|Antimetabolites|antimetabolites|mesh-ancestor
5781674|NCT03193190|Antiviral Agents|antiviral agents|mesh-ancestor
5781675|NCT03193190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5781676|NCT03193190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5781677|NCT03193190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5781678|NCT03193190|Immunologic Factors|immunologic factors|mesh-ancestor
5781679|NCT03193190|Antidotes|antidotes|mesh-ancestor
5781680|NCT03193190|Protective Agents|protective agents|mesh-ancestor
5781681|NCT03193190|Vitamin B Complex|vitamin b complex|mesh-ancestor
5781682|NCT03193190|Vitamins|vitamins|mesh-ancestor
5781683|NCT03193190|Micronutrients|micronutrients|mesh-ancestor
5781684|NCT03191786|Gemcitabine|gemcitabine|mesh-list
5781685|NCT03191786|Atezolizumab|atezolizumab|mesh-list
5781686|NCT03191786|Vinorelbine|vinorelbine|mesh-list
5781687|NCT03191786|Antibodies|antibodies|mesh-list
5781688|NCT03191786|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5781689|NCT03191786|Immunologic Factors|immunologic factors|mesh-ancestor
5781690|NCT03191786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5781691|NCT03191786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5781692|NCT03191786|Antimetabolites|antimetabolites|mesh-ancestor
5781693|NCT03191786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781694|NCT03191786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5781695|NCT03191786|Antiviral Agents|antiviral agents|mesh-ancestor
5781696|NCT03191786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5781697|NCT03191786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5781698|NCT03191786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5781699|NCT03191786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5781700|NCT03191786|Tubulin Modulators|tubulin modulators|mesh-ancestor
5781701|NCT03191786|Antimitotic Agents|antimitotic agents|mesh-ancestor
5781702|NCT03191786|Mitosis Modulators|mitosis modulators|mesh-ancestor
5781703|NCT03186456|Aspirin|aspirin|mesh-list
5781704|NCT03186456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5781705|NCT03186456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5781706|NCT03186456|Analgesics|analgesics|mesh-ancestor
5781707|NCT03186456|Sensory System Agents|sensory system agents|mesh-ancestor
5781708|NCT03186456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5781709|NCT03186456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5781710|NCT03186456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5781711|NCT03186456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5781712|NCT03186456|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5781713|NCT03186456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5781714|NCT03186456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781715|NCT03186456|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5781716|NCT03186456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5781717|NCT03186456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5781718|NCT03186456|Antipyretics|antipyretics|mesh-ancestor
5781719|NCT03184935|Decitabine|decitabine|mesh-list
5781720|NCT03184935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5781721|NCT03184935|Antimetabolites|antimetabolites|mesh-ancestor
5781722|NCT03184935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781723|NCT03184935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5781724|NCT03184935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5781725|NCT03176134|Tedizolid|tedizolid|mesh-list
5781726|NCT03176134|Tedizolid phosphate|tedizolid phosphate|mesh-list
5781727|NCT03176134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5781728|NCT03176134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5781729|NCT03126110|Nivolumab|nivolumab|mesh-list
5781730|NCT03126110|Ipilimumab|ipilimumab|mesh-list
5781731|NCT03126110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5781732|NCT03126110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5781733|NCT03126110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5781734|NCT03126110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781735|NCT03076554|Avelumab|avelumab|mesh-list
5781736|NCT03076554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5781737|NCT03076554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5781738|NCT03038100|Paclitaxel|paclitaxel|mesh-list
5781739|NCT03038100|Bevacizumab|bevacizumab|mesh-list
5781740|NCT03038100|Carboplatin|carboplatin|mesh-list
5781741|NCT03038100|Atezolizumab|atezolizumab|mesh-list
5781742|NCT03038100|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5781743|NCT03038100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5781744|NCT03038100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5781745|NCT03038100|Tubulin Modulators|tubulin modulators|mesh-ancestor
5781746|NCT03038100|Antimitotic Agents|antimitotic agents|mesh-ancestor
5781747|NCT03038100|Mitosis Modulators|mitosis modulators|mesh-ancestor
5781748|NCT03038100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781749|NCT03038100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5781750|NCT03038100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5781751|NCT03038100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5781752|NCT03038100|Growth Substances|growth substances|mesh-ancestor
5781753|NCT03038100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5781754|NCT03038100|Growth Inhibitors|growth inhibitors|mesh-ancestor
5781755|NCT03038100|Immunologic Factors|immunologic factors|mesh-ancestor
5781756|NCT03036930|Vaccines|vaccines|mesh-list
5781757|NCT03036930|Immunologic Factors|immunologic factors|mesh-ancestor
5781758|NCT03036930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5781759|NCT03036098|Gemcitabine|gemcitabine|mesh-list
5781760|NCT03036098|Carboplatin|carboplatin|mesh-list
5781761|NCT03036098|Nivolumab|nivolumab|mesh-list
5781762|NCT03036098|Ipilimumab|ipilimumab|mesh-list
5781763|NCT03036098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5781764|NCT03036098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5781765|NCT03036098|Antimetabolites|antimetabolites|mesh-ancestor
5781766|NCT03036098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781767|NCT03036098|Antiviral Agents|antiviral agents|mesh-ancestor
5781768|NCT03036098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5781769|NCT03036098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5781770|NCT03036098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5781771|NCT03036098|Immunologic Factors|immunologic factors|mesh-ancestor
5781772|NCT03036098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5781773|NCT03036098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5781774|NCT03036098|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5781775|NCT02982720|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
5781776|NCT02982720|Pembrolizumab|pembrolizumab|mesh-list
5781777|NCT02982720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5781778|NCT02982720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5781779|NCT02982720|Antiviral Agents|antiviral agents|mesh-ancestor
5781780|NCT02982720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5781781|NCT02965703|Aspirin|aspirin|mesh-list
5781782|NCT02965703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5781783|NCT02965703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5781784|NCT02965703|Analgesics|analgesics|mesh-ancestor
5781785|NCT02965703|Sensory System Agents|sensory system agents|mesh-ancestor
5781786|NCT02965703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5781787|NCT02965703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5781788|NCT02965703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5781789|NCT02965703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5781790|NCT02965703|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5781791|NCT02965703|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5781792|NCT02965703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781793|NCT02965703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5781794|NCT02965703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5781795|NCT02965703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5781796|NCT02965703|Antipyretics|antipyretics|mesh-ancestor
5781797|NCT02825940|Gemcitabine|gemcitabine|mesh-list
5781798|NCT02825940|Atezolizumab|atezolizumab|mesh-list
5781799|NCT02825940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5781800|NCT02825940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5781801|NCT02825940|Antimetabolites|antimetabolites|mesh-ancestor
5781802|NCT02825940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781803|NCT02825940|Antiviral Agents|antiviral agents|mesh-ancestor
5781804|NCT02825940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5781805|NCT02825940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5781806|NCT02825940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5781807|NCT02825940|Immunologic Factors|immunologic factors|mesh-ancestor
5781808|NCT02825940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897870|NCT04588259|Insulin Aspart|insulin aspart|mesh-list
5897871|NCT04588259|Insulin, Long-Acting|insulin, long-acting|mesh-list
5897872|NCT04588259|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
5897873|NCT04588259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5897874|NCT04588259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897875|NCT04582448|Insulin|insulin|mesh-list
5897876|NCT04582448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5897877|NCT04582448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897878|NCT04582435|Insulin|insulin|mesh-list
5897879|NCT04582435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5897880|NCT04582435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897881|NCT04562558|Leucovorin|leucovorin|mesh-list
5897882|NCT04562558|Dactinomycin|dactinomycin|mesh-list
5897883|NCT04562558|Methotrexate|methotrexate|mesh-list
5897884|NCT04562558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897885|NCT04562558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5897886|NCT04562558|Abortifacient Agents|abortifacient agents|mesh-ancestor
5897887|NCT04562558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5897888|NCT04562558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5897889|NCT04562558|Antimetabolites|antimetabolites|mesh-ancestor
5897890|NCT04562558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641018|NCT04401748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641019|NCT04401748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5641020|NCT04401748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5897891|NCT04562558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5897892|NCT04562558|Dermatologic Agents|dermatologic agents|mesh-ancestor
5897893|NCT04562558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5897894|NCT04562558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5897895|NCT04562558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5897896|NCT04562558|Immunologic Factors|immunologic factors|mesh-ancestor
5897897|NCT04562558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5897898|NCT04562558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5641021|NCT04382664|Nivolumab|nivolumab|mesh-list
5641022|NCT04382664|Ipilimumab|ipilimumab|mesh-list
5641023|NCT04382664|Sargramostim|sargramostim|mesh-list
5641024|NCT04382664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5641025|NCT04382664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5641026|NCT04382664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5781809|NCT02760329|Nitric Oxide|nitric oxide|mesh-list
5781810|NCT02760329|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5781811|NCT02760329|Autonomic Agents|autonomic agents|mesh-ancestor
5781812|NCT02760329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5781813|NCT02760329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5781814|NCT02760329|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5781815|NCT02760329|Respiratory System Agents|respiratory system agents|mesh-ancestor
5781816|NCT02760329|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5781817|NCT02760329|Antioxidants|antioxidants|mesh-ancestor
5781818|NCT02760329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781819|NCT02760329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5781820|NCT02760329|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5781821|NCT02760329|Vasodilator Agents|vasodilator agents|mesh-ancestor
5781822|NCT02760329|Gasotransmitters|gasotransmitters|mesh-ancestor
5781823|NCT02760329|Protective Agents|protective agents|mesh-ancestor
5781824|NCT02721342|Ramipril|ramipril|mesh-list
6491082|NCT00601042|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6491083|NCT00601042|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6491084|NCT00601042|Cholinergic Agents|cholinergic agents|mesh-ancestor
6491085|NCT00601042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6491086|NCT00601042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491087|NCT00601042|Respiratory System Agents|respiratory system agents|mesh-ancestor
6491088|NCT00601159|Gemcitabine|gemcitabine|mesh-list
6491089|NCT00601159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5781825|NCT02721342|Irbesartan|irbesartan|mesh-list
5781826|NCT02721342|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5781827|NCT02721342|Protease Inhibitors|protease inhibitors|mesh-ancestor
5781828|NCT02721342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5781829|NCT02721342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781830|NCT02721342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5781831|NCT02721342|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5781832|NCT02721342|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5781833|NCT02626455|Prednisone|prednisone|mesh-list
5781834|NCT02626455|Cyclophosphamide|cyclophosphamide|mesh-list
5781835|NCT02626455|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5781836|NCT02626455|Rituximab|rituximab|mesh-list
5781837|NCT02626455|Doxorubicin|doxorubicin|mesh-list
6491090|NCT00601159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6491091|NCT00601159|Antimetabolites|antimetabolites|mesh-ancestor
6491092|NCT00601159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491093|NCT00601159|Antiviral Agents|antiviral agents|mesh-ancestor
6491094|NCT00601159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6491095|NCT00601159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6491096|NCT00601159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6491097|NCT00601159|Immunologic Factors|immunologic factors|mesh-ancestor
5781838|NCT02626455|Vincristine|vincristine|mesh-list
5781839|NCT02626455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5781840|NCT02626455|Immunologic Factors|immunologic factors|mesh-ancestor
5781841|NCT02626455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5781842|NCT02626455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5781843|NCT02626455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5781844|NCT02626455|Alkylating Agents|alkylating agents|mesh-ancestor
5641027|NCT04382664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641028|NCT04382664|Immunologic Factors|immunologic factors|mesh-ancestor
5641029|NCT04382664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5781845|NCT02626455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781846|NCT02626455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5781847|NCT02626455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5781848|NCT02626455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5781849|NCT02626455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5781850|NCT02626455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5781851|NCT02626455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5781852|NCT02626455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5781853|NCT02626455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5781854|NCT02626455|Glucocorticoids|glucocorticoids|mesh-ancestor
5781855|NCT02626455|Hormones|hormones|mesh-ancestor
6491098|NCT00601159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641030|NCT04369664|Atorvastatin|atorvastatin|mesh-list
5641031|NCT04369664|Ezetimibe|ezetimibe|mesh-list
5641032|NCT04369664|Evolocumab|evolocumab|mesh-list
5641033|NCT04369664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5641034|NCT04369664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5641035|NCT04369664|Antimetabolites|antimetabolites|mesh-ancestor
5641036|NCT04369664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641037|NCT04369664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5781856|NCT02626455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5781857|NCT02626455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5781858|NCT02626455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5641038|NCT04369664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5641039|NCT04369664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5641040|NCT04345367|Abrocitinib|abrocitinib|mesh-list
5641041|NCT04345367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5641042|NCT04345367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5641043|NCT04345367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641044|NCT04315038|Anesthetics|anesthetics|mesh-list
5641045|NCT04315038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5641046|NCT04315038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641047|NCT04304144|Dexamethasone|dexamethasone|mesh-list
5641048|NCT04304144|Cyclophosphamide|cyclophosphamide|mesh-list
5641049|NCT04304144|Bortezomib|bortezomib|mesh-list
5641050|NCT04304144|Daratumumab|daratumumab|mesh-list
5641051|NCT04304144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5641052|NCT04304144|Immunologic Factors|immunologic factors|mesh-ancestor
5781859|NCT02626455|Tubulin Modulators|tubulin modulators|mesh-ancestor
5781860|NCT02626455|Antimitotic Agents|antimitotic agents|mesh-ancestor
5781861|NCT02626455|Mitosis Modulators|mitosis modulators|mesh-ancestor
5781862|NCT02621021|Aldesleukin|aldesleukin|mesh-list
5781863|NCT02621021|Cyclophosphamide|cyclophosphamide|mesh-list
5781864|NCT02621021|Pembrolizumab|pembrolizumab|mesh-list
5781865|NCT02621021|Fludarabine|fludarabine|mesh-list
5781866|NCT02621021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5781867|NCT02621021|Immunologic Factors|immunologic factors|mesh-ancestor
5781868|NCT02621021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5781869|NCT02621021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5781870|NCT02621021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5781871|NCT02621021|Alkylating Agents|alkylating agents|mesh-ancestor
5781872|NCT02621021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781873|NCT02621021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5781874|NCT02621021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5781875|NCT02621021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5781876|NCT02621021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5781877|NCT02621021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5781878|NCT02621021|Antiviral Agents|antiviral agents|mesh-ancestor
5781879|NCT02621021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5781880|NCT02594371|Paclitaxel|paclitaxel|mesh-list
5781881|NCT02594371|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5781882|NCT02594371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5781883|NCT02594371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5781884|NCT02594371|Tubulin Modulators|tubulin modulators|mesh-ancestor
5781885|NCT02594371|Antimitotic Agents|antimitotic agents|mesh-ancestor
5781886|NCT02594371|Mitosis Modulators|mitosis modulators|mesh-ancestor
5781887|NCT02594371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781888|NCT02498613|Misonidazole|misonidazole|mesh-list
5781889|NCT02498613|Olaparib|olaparib|mesh-list
5781890|NCT02498613|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
5781891|NCT02498613|Cediranib|cediranib|mesh-list
5781892|NCT02498613|Maleic acid|maleic acid|mesh-list
5781893|NCT02498613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5781894|NCT02498613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781895|NCT02498613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5781896|NCT02498613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5781897|NCT02498613|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5781898|NCT02498613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5781899|NCT02498613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5781900|NCT02494986|Rilpivirine|rilpivirine|mesh-list
5781901|NCT02494986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5781902|NCT02494986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5781903|NCT02494986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5781904|NCT02494986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781905|NCT02494986|Antiviral Agents|antiviral agents|mesh-ancestor
5781906|NCT02494986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5781907|NCT02494986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5781908|NCT02494986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5781909|NCT02425904|Clofarabine|clofarabine|mesh-list
5781910|NCT02425904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5781911|NCT02425904|Antimetabolites|antimetabolites|mesh-ancestor
5781912|NCT02425904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781913|NCT02425904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5781914|NCT02421939|Cytarabine|cytarabine|mesh-list
5781915|NCT02421939|Fludarabine|fludarabine|mesh-list
5781916|NCT02421939|Etoposide|etoposide|mesh-list
5781917|NCT02421939|Azacitidine|azacitidine|mesh-list
5781918|NCT02421939|Mitoxantrone|mitoxantrone|mesh-list
5781919|NCT02421939|Idarubicin|idarubicin|mesh-list
5781920|NCT02421939|Sargramostim|sargramostim|mesh-list
5781921|NCT02421939|Lenograstim|lenograstim|mesh-list
5781922|NCT02421939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5781923|NCT02421939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5781924|NCT02421939|Antimetabolites|antimetabolites|mesh-ancestor
5781925|NCT02421939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781926|NCT02421939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5781927|NCT02421939|Immunologic Factors|immunologic factors|mesh-ancestor
6491099|NCT00601198|Leucovorin|leucovorin|mesh-list
6491100|NCT00601198|Oxaliplatin|oxaliplatin|mesh-list
6491101|NCT00601198|Levoleucovorin|levoleucovorin|mesh-list
6491102|NCT00601198|Amifostine|amifostine|mesh-list
6491103|NCT00601198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5781928|NCT02421939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5781929|NCT02421939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5781930|NCT02421939|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5781931|NCT02421939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5781932|NCT02421939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5781933|NCT02421939|Antiviral Agents|antiviral agents|mesh-ancestor
5781934|NCT02421939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5781935|NCT02421939|Analgesics|analgesics|mesh-ancestor
5781936|NCT02421939|Sensory System Agents|sensory system agents|mesh-ancestor
5781937|NCT02421939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5781938|NCT02421939|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5781939|NCT02421939|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5781940|NCT02390869|Rituximab|rituximab|mesh-list
5781941|NCT02390869|Lenalidomide|lenalidomide|mesh-list
5781942|NCT02390869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5781943|NCT02390869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5781944|NCT02390869|Immunologic Factors|immunologic factors|mesh-ancestor
5781945|NCT02390869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5781946|NCT02390869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5781947|NCT02390869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5781948|NCT02390869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5781949|NCT02390869|Growth Substances|growth substances|mesh-ancestor
5781950|NCT02390869|Growth Inhibitors|growth inhibitors|mesh-ancestor
5781951|NCT02375672|Pembrolizumab|pembrolizumab|mesh-list
5781952|NCT02375672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5781953|NCT02375672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5781954|NCT02354014|Bedaquiline|bedaquiline|mesh-list
5781955|NCT02354014|Diarylquinolines|diarylquinolines|mesh-list
5781956|NCT02354014|Antitubercular Agents|antitubercular agents|mesh-ancestor
5781957|NCT02354014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5781958|NCT02354014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5781959|NCT02223208|Prednisone|prednisone|mesh-list
5781960|NCT02223208|Cyclophosphamide|cyclophosphamide|mesh-list
5781961|NCT02223208|Doxorubicin|doxorubicin|mesh-list
5781962|NCT02223208|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5781963|NCT02223208|Etoposide|etoposide|mesh-list
5781964|NCT02223208|Etoposide phosphate|etoposide phosphate|mesh-list
5781965|NCT02223208|Romidepsin|romidepsin|mesh-list
5781966|NCT02223208|Vincristine|vincristine|mesh-list
5781967|NCT02223208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5781968|NCT02223208|Immunologic Factors|immunologic factors|mesh-ancestor
5781969|NCT02223208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5781970|NCT02223208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5781971|NCT02223208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5781972|NCT02223208|Alkylating Agents|alkylating agents|mesh-ancestor
5781973|NCT02223208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5781974|NCT02223208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5781975|NCT02223208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5781976|NCT02223208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5781977|NCT02223208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5781978|NCT02223208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5781979|NCT02223208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5781980|NCT02223208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5781981|NCT02223208|Glucocorticoids|glucocorticoids|mesh-ancestor
5781982|NCT02223208|Hormones|hormones|mesh-ancestor
5781983|NCT02223208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5781984|NCT02223208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5781985|NCT02223208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5781986|NCT02223208|Tubulin Modulators|tubulin modulators|mesh-ancestor
5781987|NCT02223208|Antimitotic Agents|antimitotic agents|mesh-ancestor
5781988|NCT02223208|Mitosis Modulators|mitosis modulators|mesh-ancestor
5781989|NCT02203526|Cytarabine|cytarabine|mesh-list
6491104|NCT00601198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491105|NCT00601198|Antidotes|antidotes|mesh-ancestor
6491106|NCT00601198|Protective Agents|protective agents|mesh-ancestor
6491107|NCT00601198|Vitamin B Complex|vitamin b complex|mesh-ancestor
6491108|NCT00601198|Vitamins|vitamins|mesh-ancestor
6491109|NCT00601198|Micronutrients|micronutrients|mesh-ancestor
6491110|NCT00601198|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6491111|NCT00601211|Pilocarpine|pilocarpine|mesh-list
6491112|NCT00601211|Miotics|miotics|mesh-ancestor
6491113|NCT00601211|Autonomic Agents|autonomic agents|mesh-ancestor
6491114|NCT00601211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6491115|NCT00601211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491116|NCT00601211|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6491117|NCT00601211|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5641053|NCT04304144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641054|NCT04304144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5641055|NCT04304144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5641056|NCT04304144|Alkylating Agents|alkylating agents|mesh-ancestor
5641057|NCT04304144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641058|NCT04304144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5641059|NCT04304144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5641060|NCT04304144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6491118|NCT00601211|Cholinergic Agents|cholinergic agents|mesh-ancestor
6491119|NCT00601211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5781990|NCT02203526|Isavuconazole|isavuconazole|mesh-list
5781991|NCT02203526|Rituximab|rituximab|mesh-list
5781992|NCT02203526|Methotrexate|methotrexate|mesh-list
5781993|NCT02203526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6491120|NCT00601211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491121|NCT00601276|Leuprolide|leuprolide|mesh-list
6491122|NCT00601276|Cyproterone Acetate|cyproterone acetate|mesh-list
6491123|NCT00601276|Cyproterone|cyproterone|mesh-list
5781994|NCT02203526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5781995|NCT02203526|Immunologic Factors|immunologic factors|mesh-ancestor
5781996|NCT02203526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5781997|NCT02203526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5781998|NCT02203526|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5781999|NCT02203526|Abortifacient Agents|abortifacient agents|mesh-ancestor
5782000|NCT02203526|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5782001|NCT02203526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5782002|NCT02203526|Antimetabolites|antimetabolites|mesh-ancestor
5782003|NCT02203526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782004|NCT02203526|Dermatologic Agents|dermatologic agents|mesh-ancestor
5782005|NCT02203526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5782006|NCT02203526|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5782007|NCT02203526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5782008|NCT02203526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5782009|NCT02203526|Antiviral Agents|antiviral agents|mesh-ancestor
5782010|NCT02203526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5782011|NCT02203526|Antifungal Agents|antifungal agents|mesh-ancestor
5782012|NCT02153645|Amantadine|amantadine|mesh-list
5782013|NCT02153645|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5782014|NCT02153645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5782015|NCT02153645|Antiviral Agents|antiviral agents|mesh-ancestor
5782016|NCT02153645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5782017|NCT02153645|Dopamine Agents|dopamine agents|mesh-ancestor
5782018|NCT02153645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5782019|NCT02153645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782020|NCT02153645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5782021|NCT02153645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5782022|NCT02153645|Analgesics|analgesics|mesh-ancestor
5782023|NCT02153645|Sensory System Agents|sensory system agents|mesh-ancestor
5782024|NCT02153645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5782025|NCT02153632|Amantadine|amantadine|mesh-list
5782026|NCT02153632|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5782027|NCT02153632|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5782028|NCT02153632|Antiviral Agents|antiviral agents|mesh-ancestor
5782029|NCT02153632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5782030|NCT02153632|Dopamine Agents|dopamine agents|mesh-ancestor
5782031|NCT02153632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5782032|NCT02153632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782033|NCT02153632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5782034|NCT02153632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5782035|NCT02153632|Analgesics|analgesics|mesh-ancestor
6491124|NCT00601276|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6491125|NCT00601276|Fertility Agents|fertility agents|mesh-ancestor
6491126|NCT00601276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6491127|NCT00601276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491128|NCT00601276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6491129|NCT00601276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6491130|NCT00601276|Androgen Antagonists|androgen antagonists|mesh-ancestor
6491131|NCT00601276|Hormone Antagonists|hormone antagonists|mesh-ancestor
6491132|NCT00601276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6491133|NCT00601276|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6491134|NCT00601276|Contraceptive Agents|contraceptive agents|mesh-ancestor
6491135|NCT00601289|Temozolomide|temozolomide|mesh-list
6491136|NCT00601289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6491137|NCT00601289|Alkylating Agents|alkylating agents|mesh-ancestor
6491138|NCT00601289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491139|NCT00601289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6491140|NCT00601302|Amlodipine|amlodipine|mesh-list
6491141|NCT00601302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6491142|NCT00601302|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6491143|NCT00601302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6491144|NCT00601302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641061|NCT04304144|Antiemetics|antiemetics|mesh-ancestor
5641062|NCT04304144|Autonomic Agents|autonomic agents|mesh-ancestor
5641063|NCT04304144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6491145|NCT00601302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6491146|NCT00601302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491147|NCT00601302|Vasodilator Agents|vasodilator agents|mesh-ancestor
6491148|NCT00601315|Clarithromycin|clarithromycin|mesh-list
6491149|NCT00601315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6491150|NCT00601315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5782036|NCT02153632|Sensory System Agents|sensory system agents|mesh-ancestor
5782037|NCT02153632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5782038|NCT02065362|Cyclophosphamide|cyclophosphamide|mesh-list
5782039|NCT02065362|Fludarabine|fludarabine|mesh-list
5782040|NCT02065362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5782041|NCT02065362|Immunologic Factors|immunologic factors|mesh-ancestor
5782042|NCT02065362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5782043|NCT02065362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5782044|NCT02065362|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5782045|NCT02065362|Alkylating Agents|alkylating agents|mesh-ancestor
5782046|NCT02065362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782047|NCT02065362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5782048|NCT02065362|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5782049|NCT02037529|Paclitaxel|paclitaxel|mesh-list
5782050|NCT02037529|Halichondrin B|halichondrin b|mesh-list
5782051|NCT02037529|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5782052|NCT02037529|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5782053|NCT02037529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5782054|NCT02037529|Tubulin Modulators|tubulin modulators|mesh-ancestor
5782055|NCT02037529|Antimitotic Agents|antimitotic agents|mesh-ancestor
5782056|NCT02037529|Mitosis Modulators|mitosis modulators|mesh-ancestor
5782057|NCT02037529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782058|NCT02016924|Cobicistat|cobicistat|mesh-list
5782059|NCT02016924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5782060|NCT02016924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782061|NCT02016924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5782062|NCT02016924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5782063|NCT02016924|Antiviral Agents|antiviral agents|mesh-ancestor
5782064|NCT02016924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5782065|NCT02016924|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5782066|NCT02016924|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5641064|NCT04304144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5641065|NCT04304144|Glucocorticoids|glucocorticoids|mesh-ancestor
5641066|NCT04304144|Hormones|hormones|mesh-ancestor
5641067|NCT04304144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5641068|NCT04304144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5641069|NCT04256629|Allopurinol|allopurinol|mesh-list
5641070|NCT04256629|Verinurad|verinurad|mesh-list
5641071|NCT04256629|Antimetabolites|antimetabolites|mesh-ancestor
5641072|NCT04256629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641073|NCT04256629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5641074|NCT04256629|Gout Suppressants|gout suppressants|mesh-ancestor
5641075|NCT04256629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5641076|NCT04256629|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5641077|NCT04256629|Antioxidants|antioxidants|mesh-ancestor
5782067|NCT02013141|Telavancin|telavancin|mesh-list
5782068|NCT02013141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5782069|NCT02013141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5782070|NCT01942135|Fulvestrant|fulvestrant|mesh-list
5782071|NCT01942135|Palbociclib|palbociclib|mesh-list
5782072|NCT01942135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5782073|NCT01942135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5782074|NCT01942135|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5782075|NCT01942135|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5782076|NCT01942135|Hormone Antagonists|hormone antagonists|mesh-ancestor
5782077|NCT01942135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5782078|NCT01942135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5782079|NCT01942135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5782080|NCT01942135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5782081|NCT01942135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782082|NCT01934452|Sunitinib|sunitinib|mesh-list
5782083|NCT01934452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5782084|NCT01934452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5782085|NCT01934452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5782086|NCT01934452|Growth Substances|growth substances|mesh-ancestor
5782087|NCT01934452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5782088|NCT01934452|Growth Inhibitors|growth inhibitors|mesh-ancestor
5782089|NCT01934452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5782090|NCT01934452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5782091|NCT01934452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782092|NCT01867333|Metronidazole|metronidazole|mesh-list
5782093|NCT01867333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5782094|NCT01867333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5782095|NCT01867333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5782096|NCT01867333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5782097|NCT01818167|Benzoyl Peroxide|benzoyl peroxide|mesh-list
5782098|NCT01818167|Dermatologic Agents|dermatologic agents|mesh-ancestor
6210697|NCT02163447|Piperaquine|piperaquine|mesh-list
6210698|NCT02163447|Sulfadoxine|sulfadoxine|mesh-list
6210699|NCT02163447|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6210700|NCT02163447|Artenimol|artenimol|mesh-list
6210701|NCT02163447|Artemisinins|artemisinins|mesh-list
6210702|NCT02163447|Antimalarials|antimalarials|mesh-ancestor
6210703|NCT02163447|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6210704|NCT02163447|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6210705|NCT02163447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6210706|NCT02163447|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6210707|NCT02163447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6210708|NCT02163447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210709|NCT02163447|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6210710|NCT02163447|Renal Agents|renal agents|mesh-ancestor
6210711|NCT02163759|Adalimumab|adalimumab|mesh-list
5782114|NCT01776840|Rituximab|rituximab|mesh-list
5782115|NCT01776840|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5782116|NCT01776840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5782117|NCT01776840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5782118|NCT01776840|Immunologic Factors|immunologic factors|mesh-ancestor
5782119|NCT01776840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5782120|NCT01776840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5782121|NCT01776840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5782122|NCT01776840|Alkylating Agents|alkylating agents|mesh-ancestor
5782123|NCT01776840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782124|NCT01773083|Heparin|heparin|mesh-list
5782125|NCT01773083|Calcium heparin|calcium heparin|mesh-list
5782126|NCT01773083|Anticoagulants|anticoagulants|mesh-ancestor
5782127|NCT01773083|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5782128|NCT01773083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5782129|NCT01773083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782130|NCT01723579|Estradiol|estradiol|mesh-list
5782131|NCT01723579|Estrogens|estrogens|mesh-ancestor
5782132|NCT01723579|Hormones|hormones|mesh-ancestor
5782133|NCT01723579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5782134|NCT01723579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5782135|NCT01689909|Zolpidem|zolpidem|mesh-list
5782136|NCT01689909|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5782137|NCT01689909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5782138|NCT01689909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5782139|NCT01689909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5782140|NCT01689909|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
5782141|NCT01689909|GABA Agonists|gaba agonists|mesh-ancestor
5782142|NCT01689909|GABA Agents|gaba agents|mesh-ancestor
5782143|NCT01689909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5782144|NCT01689909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782145|NCT01615874|Prednisone|prednisone|mesh-list
5782146|NCT01615874|Prednisolone|prednisolone|mesh-list
5782147|NCT01615874|Montelukast|montelukast|mesh-list
5782148|NCT01615874|Mometasone Furoate, Formoterol Fumarate Drug Combination|mometasone furoate, formoterol fumarate drug combination|mesh-list
5782149|NCT01615874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5782150|NCT01615874|Glucocorticoids|glucocorticoids|mesh-ancestor
5782151|NCT01615874|Hormones|hormones|mesh-ancestor
5782152|NCT01615874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5782153|NCT01615874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5782154|NCT01615874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5782155|NCT01615874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5782156|NCT01615874|Autonomic Agents|autonomic agents|mesh-ancestor
5782157|NCT01615874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5782158|NCT01615874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5782159|NCT01615874|Respiratory System Agents|respiratory system agents|mesh-ancestor
5782160|NCT01615874|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5782161|NCT01615874|Hormone Antagonists|hormone antagonists|mesh-ancestor
5782162|NCT01615874|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5782163|NCT01615874|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5782164|NCT01615874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782165|NCT01615874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5782166|NCT01566149|Mometasone Furoate|mometasone furoate|mesh-list
5782167|NCT01566149|Formoterol Fumarate|formoterol fumarate|mesh-list
5782168|NCT01566149|Mometasone Furoate, Formoterol Fumarate Drug Combination|mometasone furoate, formoterol fumarate drug combination|mesh-list
5782169|NCT01566149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5782170|NCT01566149|Autonomic Agents|autonomic agents|mesh-ancestor
5782171|NCT01566149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5782172|NCT01566149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5782173|NCT01566149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5782174|NCT01566149|Respiratory System Agents|respiratory system agents|mesh-ancestor
5782175|NCT01566149|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5782176|NCT01566149|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5782177|NCT01566149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5782178|NCT01566149|Adrenergic Agents|adrenergic agents|mesh-ancestor
5782179|NCT01566149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5782180|NCT01566149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782181|NCT01566149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5782182|NCT01566149|Dermatologic Agents|dermatologic agents|mesh-ancestor
5782183|NCT01566149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5782184|NCT01386125|Mometasone Furoate|mometasone furoate|mesh-list
5782185|NCT01386125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5782186|NCT01386125|Dermatologic Agents|dermatologic agents|mesh-ancestor
5782187|NCT01386125|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5782188|NCT01319565|Aldesleukin|aldesleukin|mesh-list
5782189|NCT01319565|Cyclophosphamide|cyclophosphamide|mesh-list
5782190|NCT01319565|Fludarabine|fludarabine|mesh-list
5782191|NCT01319565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5782192|NCT01319565|Immunologic Factors|immunologic factors|mesh-ancestor
5782193|NCT01319565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5782194|NCT01319565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5782195|NCT01319565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5782196|NCT01319565|Alkylating Agents|alkylating agents|mesh-ancestor
5782197|NCT01319565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782198|NCT01319565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5782199|NCT01319565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5782200|NCT01319565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5782201|NCT01319565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5782202|NCT01319565|Antiviral Agents|antiviral agents|mesh-ancestor
5782203|NCT01319565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5782204|NCT01316250|Imatinib Mesylate|imatinib mesylate|mesh-list
5782205|NCT01316250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5782206|NCT01316250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5782207|NCT01316250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5782208|NCT01316250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782209|NCT01236430|Atorvastatin|atorvastatin|mesh-list
5782210|NCT01236430|Ezetimibe|ezetimibe|mesh-list
5782211|NCT01236430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5782212|NCT01236430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5782213|NCT01236430|Antimetabolites|antimetabolites|mesh-ancestor
5782214|NCT01236430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782215|NCT01236430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5782216|NCT01236430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5782217|NCT01236430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5782218|NCT01165424|Mometasone Furoate|mometasone furoate|mesh-list
5782219|NCT01165424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5782220|NCT01165424|Dermatologic Agents|dermatologic agents|mesh-ancestor
5782221|NCT01165424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5782222|NCT01135134|Mometasone Furoate|mometasone furoate|mesh-list
5782223|NCT01135134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5782224|NCT01135134|Dermatologic Agents|dermatologic agents|mesh-ancestor
5782225|NCT01135134|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5782226|NCT01026870|Mometasone Furoate|mometasone furoate|mesh-list
5782227|NCT01026870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5782228|NCT01026870|Dermatologic Agents|dermatologic agents|mesh-ancestor
5782229|NCT01026870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5782230|NCT00903721|Mometasone Furoate|mometasone furoate|mesh-list
5782231|NCT00903721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5782232|NCT00903721|Dermatologic Agents|dermatologic agents|mesh-ancestor
5782233|NCT00903721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5782234|NCT00867165|Ezetimibe|ezetimibe|mesh-list
5782235|NCT00867165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5782236|NCT00867165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5782237|NCT00867165|Antimetabolites|antimetabolites|mesh-ancestor
5782238|NCT00867165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782239|NCT00867165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5782240|NCT00817076|Desloratadine|desloratadine|mesh-list
5782241|NCT00817076|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5782242|NCT00817076|Cholinergic Agents|cholinergic agents|mesh-ancestor
5782243|NCT00817076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5782244|NCT00817076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782245|NCT00817076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5782246|NCT00817076|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5782247|NCT00817076|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5782248|NCT00817076|Histamine Antagonists|histamine antagonists|mesh-ancestor
5782249|NCT00817076|Histamine Agents|histamine agents|mesh-ancestor
5782250|NCT00817050|Fluticasone|fluticasone|mesh-list
5782251|NCT00817050|Mometasone Furoate|mometasone furoate|mesh-list
5782252|NCT00817050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5782253|NCT00817050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5782254|NCT00817050|Autonomic Agents|autonomic agents|mesh-ancestor
5782255|NCT00817050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5782256|NCT00817050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5782257|NCT00817050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5782258|NCT00817050|Respiratory System Agents|respiratory system agents|mesh-ancestor
5782259|NCT00817050|Dermatologic Agents|dermatologic agents|mesh-ancestor
5782260|NCT00817050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5782261|NCT00816972|Loratadine|loratadine|mesh-list
5782262|NCT00816972|Mandelic Acids|mandelic acids|mesh-list
5782263|NCT00816972|Oxybutynin|oxybutynin|mesh-list
5782264|NCT00816972|Desloratadine|desloratadine|mesh-list
5782265|NCT00816972|Parasympatholytics|parasympatholytics|mesh-ancestor
5782266|NCT00816972|Autonomic Agents|autonomic agents|mesh-ancestor
5782267|NCT00816972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5782268|NCT00816972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5782269|NCT00816972|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5782270|NCT00816972|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5782271|NCT00816972|Cholinergic Agents|cholinergic agents|mesh-ancestor
5782272|NCT00816972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5782273|NCT00816972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782274|NCT00816972|Urological Agents|urological agents|mesh-ancestor
5782275|NCT00816972|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5782276|NCT00816972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5782277|NCT00816972|Renal Agents|renal agents|mesh-ancestor
5782278|NCT00816972|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5782279|NCT00816972|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5782280|NCT00816972|Histamine Antagonists|histamine antagonists|mesh-ancestor
5782281|NCT00816972|Histamine Agents|histamine agents|mesh-ancestor
5782282|NCT00816972|Antipruritics|antipruritics|mesh-ancestor
5782283|NCT00816972|Dermatologic Agents|dermatologic agents|mesh-ancestor
5782284|NCT00816972|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5782285|NCT00805324|Desloratadine|desloratadine|mesh-list
5782286|NCT00805324|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5782287|NCT00805324|Cholinergic Agents|cholinergic agents|mesh-ancestor
5782288|NCT00805324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5782289|NCT00805324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782290|NCT00805324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5782291|NCT00805324|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5782292|NCT00805324|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5782293|NCT00805324|Histamine Antagonists|histamine antagonists|mesh-ancestor
5782294|NCT00805324|Histamine Agents|histamine agents|mesh-ancestor
5782295|NCT00794794|Cetirizine|cetirizine|mesh-list
5782296|NCT00794794|Desloratadine|desloratadine|mesh-list
5782297|NCT00794794|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5782298|NCT00794794|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5782299|NCT00794794|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5782300|NCT00794794|Histamine Antagonists|histamine antagonists|mesh-ancestor
5782301|NCT00794794|Histamine Agents|histamine agents|mesh-ancestor
5782302|NCT00794794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5782303|NCT00794794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782304|NCT00794794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5782305|NCT00794794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5782306|NCT00794794|Cholinergic Agents|cholinergic agents|mesh-ancestor
5782307|NCT00794378|Cetirizine|cetirizine|mesh-list
5782308|NCT00794378|Desloratadine|desloratadine|mesh-list
5782309|NCT00794378|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5782310|NCT00794378|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5782311|NCT00794378|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5782312|NCT00794378|Histamine Antagonists|histamine antagonists|mesh-ancestor
5782313|NCT00794378|Histamine Agents|histamine agents|mesh-ancestor
5782314|NCT00794378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5782315|NCT00794378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782316|NCT00794378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5782317|NCT00794378|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5782318|NCT00794378|Cholinergic Agents|cholinergic agents|mesh-ancestor
5782319|NCT00789152|Levocetirizine|levocetirizine|mesh-list
5782320|NCT00789152|Desloratadine|desloratadine|mesh-list
5782321|NCT00789152|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5782322|NCT00789152|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5782323|NCT00789152|Histamine Antagonists|histamine antagonists|mesh-ancestor
5782324|NCT00789152|Histamine Agents|histamine agents|mesh-ancestor
5782325|NCT00789152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5782326|NCT00789152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782327|NCT00789152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5782328|NCT00789152|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5782329|NCT00789152|Cholinergic Agents|cholinergic agents|mesh-ancestor
5782330|NCT00783458|Fluticasone|fluticasone|mesh-list
5782331|NCT00783458|Mometasone Furoate|mometasone furoate|mesh-list
5782332|NCT00783458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5782333|NCT00783458|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5782334|NCT00783458|Autonomic Agents|autonomic agents|mesh-ancestor
5782335|NCT00783458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6491151|NCT00601315|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5782336|NCT00783458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5782337|NCT00783458|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5782338|NCT00783458|Respiratory System Agents|respiratory system agents|mesh-ancestor
5782339|NCT00783458|Dermatologic Agents|dermatologic agents|mesh-ancestor
5782340|NCT00783458|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5782341|NCT00783211|Fexofenadine|fexofenadine|mesh-list
5782342|NCT00783211|Desloratadine|desloratadine|mesh-list
5782343|NCT00783211|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5782344|NCT00783211|Cholinergic Agents|cholinergic agents|mesh-ancestor
5782345|NCT00783211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5782346|NCT00783211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782347|NCT00783211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5782348|NCT00783211|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5782349|NCT00783211|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5782350|NCT00783211|Histamine Antagonists|histamine antagonists|mesh-ancestor
5782351|NCT00783211|Histamine Agents|histamine agents|mesh-ancestor
5782352|NCT00783211|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5782353|NCT00783146|Fexofenadine|fexofenadine|mesh-list
5782354|NCT00783146|Desloratadine|desloratadine|mesh-list
5782355|NCT00783146|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5782356|NCT00783146|Cholinergic Agents|cholinergic agents|mesh-ancestor
5782357|NCT00783146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5782358|NCT00783146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782359|NCT00783146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5782360|NCT00783146|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5782361|NCT00783146|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5782362|NCT00783146|Histamine Antagonists|histamine antagonists|mesh-ancestor
5782363|NCT00783146|Histamine Agents|histamine agents|mesh-ancestor
5782364|NCT00783146|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5782365|NCT00779740|Mometasone Furoate|mometasone furoate|mesh-list
5782366|NCT00779740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5782367|NCT00779740|Dermatologic Agents|dermatologic agents|mesh-ancestor
5782368|NCT00779740|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5782369|NCT00779545|Mometasone Furoate|mometasone furoate|mesh-list
5782370|NCT00779545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5782371|NCT00779545|Dermatologic Agents|dermatologic agents|mesh-ancestor
5782372|NCT00779545|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5782373|NCT00779532|Moxifloxacin|moxifloxacin|mesh-list
5782374|NCT00779532|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
5782375|NCT00779532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5782376|NCT00779532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5782377|NCT00779532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5782378|NCT00779532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5782379|NCT00779532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5782380|NCT00779532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782381|NCT00779532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5782382|NCT00779532|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5782383|NCT00779532|Contraceptive Agents|contraceptive agents|mesh-ancestor
5782384|NCT00779532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5782385|NCT00779532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5782386|NCT00779532|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5782387|NCT00779532|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5782388|NCT00779532|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5782389|NCT00751218|Cetirizine|cetirizine|mesh-list
6491152|NCT00601315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6491153|NCT00601315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491154|NCT00601315|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6491155|NCT00601315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6210712|NCT02163759|Etrolizumab|etrolizumab|mesh-list
6210713|NCT02163759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6210714|NCT02163759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6210715|NCT02163759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6210716|NCT02163759|Immunologic Factors|immunologic factors|mesh-ancestor
6210717|NCT02163759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210718|NCT02163824|Loteprednol Etabonate|loteprednol etabonate|mesh-list
6210719|NCT02163824|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6210720|NCT02163837|Rifaximin|rifaximin|mesh-list
6210721|NCT02163837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6210722|NCT02163837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6210723|NCT02163837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6210724|NCT02164240|Sunitinib|sunitinib|mesh-list
6210725|NCT02164240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6210726|NCT02164240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6491156|NCT00601328|Calcitriol|calcitriol|mesh-list
6491157|NCT00601328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6491158|NCT00601328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5782390|NCT00751218|Desloratadine|desloratadine|mesh-list
5782391|NCT00751218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5782392|NCT00751218|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5782393|NCT00751218|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5782394|NCT00751218|Histamine Antagonists|histamine antagonists|mesh-ancestor
5782395|NCT00751218|Histamine Agents|histamine agents|mesh-ancestor
5782396|NCT00751218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5782397|NCT00751218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782398|NCT00751218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5782399|NCT00751218|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5782400|NCT00751218|Cholinergic Agents|cholinergic agents|mesh-ancestor
5782401|NCT00751166|Cetirizine|cetirizine|mesh-list
5782402|NCT00751166|Desloratadine|desloratadine|mesh-list
5782403|NCT00751166|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5782404|NCT00751166|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5782405|NCT00751166|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5782406|NCT00751166|Histamine Antagonists|histamine antagonists|mesh-ancestor
5782407|NCT00751166|Histamine Agents|histamine agents|mesh-ancestor
5782408|NCT00751166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5782409|NCT00751166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782410|NCT00751166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5782411|NCT00751166|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5782412|NCT00751166|Cholinergic Agents|cholinergic agents|mesh-ancestor
5782413|NCT00733005|Mometasone Furoate|mometasone furoate|mesh-list
5782414|NCT00733005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5782415|NCT00733005|Dermatologic Agents|dermatologic agents|mesh-ancestor
5782416|NCT00733005|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5782417|NCT00732381|Mometasone Furoate|mometasone furoate|mesh-list
5782418|NCT00732381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5782419|NCT00732381|Dermatologic Agents|dermatologic agents|mesh-ancestor
5782420|NCT00732381|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5782421|NCT00732368|Mometasone Furoate|mometasone furoate|mesh-list
5782422|NCT00732368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5782423|NCT00732368|Dermatologic Agents|dermatologic agents|mesh-ancestor
5782424|NCT00732368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5897899|NCT04562558|Antidotes|antidotes|mesh-ancestor
5897900|NCT04562558|Protective Agents|protective agents|mesh-ancestor
5897901|NCT04562558|Vitamin B Complex|vitamin b complex|mesh-ancestor
5897902|NCT04562558|Vitamins|vitamins|mesh-ancestor
5897903|NCT04562558|Micronutrients|micronutrients|mesh-ancestor
5897904|NCT04562558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5897905|NCT04562558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5897906|NCT04562558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5897907|NCT04562558|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5897908|NCT04547166|Bevacizumab|bevacizumab|mesh-list
6491159|NCT00601328|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6491160|NCT00601328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6491161|NCT00601328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897909|NCT04547166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5897910|NCT04547166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5897911|NCT04547166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5897912|NCT04547166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5897913|NCT04547166|Growth Substances|growth substances|mesh-ancestor
5897914|NCT04547166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897915|NCT04547166|Growth Inhibitors|growth inhibitors|mesh-ancestor
5897916|NCT04529876|Abatacept|abatacept|mesh-list
5897917|NCT04529876|Tofacitinib|tofacitinib|mesh-list
5897918|NCT04529876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5897919|NCT04529876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897920|NCT04529876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5897921|NCT04529876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5897922|NCT04529876|Immunologic Factors|immunologic factors|mesh-ancestor
5897923|NCT04529876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897924|NCT04529876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5897925|NCT04529876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5897926|NCT04529876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5897927|NCT04529863|Abatacept|abatacept|mesh-list
5897928|NCT04529863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5897929|NCT04529863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897930|NCT04529863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5897931|NCT04529863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5897932|NCT04529863|Immunologic Factors|immunologic factors|mesh-ancestor
5897933|NCT04529863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897934|NCT04529863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5897935|NCT04527744|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5782425|NCT00726856|Ezetimibe|ezetimibe|mesh-list
5782426|NCT00726856|Fenofibrate|fenofibrate|mesh-list
5782427|NCT00726856|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5782428|NCT00726856|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5782429|NCT00726856|Antimetabolites|antimetabolites|mesh-ancestor
5782430|NCT00726856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782431|NCT00726856|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5782432|NCT00705211|Ezetimibe|ezetimibe|mesh-list
5782433|NCT00705211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5782434|NCT00705211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5782435|NCT00705211|Antimetabolites|antimetabolites|mesh-ancestor
5782436|NCT00705211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782437|NCT00705211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5782438|NCT00704444|Ezetimibe|ezetimibe|mesh-list
5782439|NCT00704444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5782440|NCT00704444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5782441|NCT00704444|Antimetabolites|antimetabolites|mesh-ancestor
5782442|NCT00704444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782443|NCT00704444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5782444|NCT00654095|Atorvastatin|atorvastatin|mesh-list
5782445|NCT00654095|Ezetimibe|ezetimibe|mesh-list
5782446|NCT00654095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5782447|NCT00654095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5782448|NCT00654095|Antimetabolites|antimetabolites|mesh-ancestor
5782449|NCT00654095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782450|NCT00654095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5782451|NCT00654095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5782452|NCT00654095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5782453|NCT00653913|Ezetimibe|ezetimibe|mesh-list
5782454|NCT00653913|Pitavastatin|pitavastatin|mesh-list
5782455|NCT00653913|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5782456|NCT00653913|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5782457|NCT00653913|Antimetabolites|antimetabolites|mesh-ancestor
5782458|NCT00653913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782459|NCT00653913|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5782460|NCT00653913|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5782461|NCT00653913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5782462|NCT00653523|Simvastatin|simvastatin|mesh-list
5782463|NCT00653523|Ezetimibe|ezetimibe|mesh-list
5782464|NCT00653523|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5782465|NCT00653523|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5782466|NCT00653523|Antimetabolites|antimetabolites|mesh-ancestor
5782467|NCT00653523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782468|NCT00653523|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5782469|NCT00653523|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5782470|NCT00653523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5782471|NCT00652431|Niacin|niacin|mesh-list
5782472|NCT00652431|Niacinamide|niacinamide|mesh-list
5782473|NCT00652431|Nicotinic Acids|nicotinic acids|mesh-list
5782474|NCT00652431|Simvastatin|simvastatin|mesh-list
5782475|NCT00652431|Ezetimibe|ezetimibe|mesh-list
5782476|NCT00652431|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
5782477|NCT00652431|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5782478|NCT00652431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5782479|NCT00652431|Antimetabolites|antimetabolites|mesh-ancestor
5782480|NCT00652431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782481|NCT00652431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5782482|NCT00652431|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5782483|NCT00652431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5782484|NCT00652431|Vasodilator Agents|vasodilator agents|mesh-ancestor
5782485|NCT00652431|Vitamin B Complex|vitamin b complex|mesh-ancestor
5782486|NCT00652431|Vitamins|vitamins|mesh-ancestor
5782487|NCT00652431|Micronutrients|micronutrients|mesh-ancestor
5782488|NCT00652431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5782489|NCT00651378|Atorvastatin|atorvastatin|mesh-list
5782490|NCT00651378|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5782491|NCT00651378|Ezetimibe|ezetimibe|mesh-list
5782492|NCT00651378|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5782493|NCT00651378|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5782494|NCT00651378|Antimetabolites|antimetabolites|mesh-ancestor
5782495|NCT00651378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782496|NCT00651378|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5782497|NCT00651378|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5782498|NCT00651378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5782499|NCT00651274|Ezetimibe|ezetimibe|mesh-list
5782500|NCT00651274|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5782501|NCT00651274|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5782502|NCT00651274|Antimetabolites|antimetabolites|mesh-ancestor
5782503|NCT00651274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782504|NCT00651274|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5782505|NCT00650819|Simvastatin|simvastatin|mesh-list
5782506|NCT00650819|Ezetimibe|ezetimibe|mesh-list
5782507|NCT00650819|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5782508|NCT00650819|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5782509|NCT00650819|Antimetabolites|antimetabolites|mesh-ancestor
5782510|NCT00650819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782511|NCT00650819|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5782512|NCT00650819|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5782513|NCT00650819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5782514|NCT00599027|Mometasone Furoate|mometasone furoate|mesh-list
5782515|NCT00599027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5782516|NCT00599027|Dermatologic Agents|dermatologic agents|mesh-ancestor
5782517|NCT00599027|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5782518|NCT00552032|Mometasone Furoate|mometasone furoate|mesh-list
5782519|NCT00552032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5782520|NCT00552032|Dermatologic Agents|dermatologic agents|mesh-ancestor
5782521|NCT00552032|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5782522|NCT00546052|Losartan|losartan|mesh-list
5782523|NCT00546052|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5782524|NCT00546052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5782525|NCT00546052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5782526|NCT00546052|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5782527|NCT00546052|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5782528|NCT00546052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782529|NCT00546052|Diuretics|diuretics|mesh-ancestor
5782530|NCT00546052|Natriuretic Agents|natriuretic agents|mesh-ancestor
5782531|NCT00546052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5782532|NCT00546052|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5782533|NCT00546052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5782534|NCT00442117|Mometasone Furoate|mometasone furoate|mesh-list
5782535|NCT00442117|Budesonide|budesonide|mesh-list
5782536|NCT00442117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5782537|NCT00442117|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5782538|NCT00442117|Autonomic Agents|autonomic agents|mesh-ancestor
5782539|NCT00442117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5782540|NCT00442117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5782541|NCT00442117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5782542|NCT00442117|Respiratory System Agents|respiratory system agents|mesh-ancestor
5782543|NCT00442117|Glucocorticoids|glucocorticoids|mesh-ancestor
5782544|NCT00442117|Hormones|hormones|mesh-ancestor
5782545|NCT00442117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5782546|NCT00442117|Dermatologic Agents|dermatologic agents|mesh-ancestor
5782547|NCT00442117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5782548|NCT00424008|Fluticasone|fluticasone|mesh-list
5782549|NCT00424008|Xhance|xhance|mesh-list
5782550|NCT00424008|Mometasone Furoate|mometasone furoate|mesh-list
5782551|NCT00424008|Formoterol Fumarate|formoterol fumarate|mesh-list
5782552|NCT00424008|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5782553|NCT00424008|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
5782554|NCT00424008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5782555|NCT00424008|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5782556|NCT00424008|Autonomic Agents|autonomic agents|mesh-ancestor
5782557|NCT00424008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5782558|NCT00424008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5782559|NCT00424008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5782560|NCT00424008|Respiratory System Agents|respiratory system agents|mesh-ancestor
5782561|NCT00424008|Dermatologic Agents|dermatologic agents|mesh-ancestor
5782562|NCT00424008|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5782563|NCT00424008|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5782564|NCT00424008|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5782565|NCT00424008|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5782566|NCT00424008|Adrenergic Agents|adrenergic agents|mesh-ancestor
5782567|NCT00424008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5782568|NCT00424008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782569|NCT00424008|Glucocorticoids|glucocorticoids|mesh-ancestor
5782570|NCT00424008|Hormones|hormones|mesh-ancestor
5782571|NCT00424008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5782572|NCT00424008|Sympathomimetics|sympathomimetics|mesh-ancestor
5782573|NCT00423995|Loratadine|loratadine|mesh-list
6491162|NCT00601328|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5782574|NCT00423995|Montelukast|montelukast|mesh-list
6491163|NCT00601328|Vitamins|vitamins|mesh-ancestor
5782575|NCT00423995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5782576|NCT00423995|Respiratory System Agents|respiratory system agents|mesh-ancestor
5782577|NCT00423995|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5782578|NCT00423995|Hormone Antagonists|hormone antagonists|mesh-ancestor
5782579|NCT00423995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5782580|NCT00423995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5782581|NCT00423995|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5782582|NCT00423995|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5782583|NCT00423995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782584|NCT00423995|Antipruritics|antipruritics|mesh-ancestor
5782585|NCT00423995|Dermatologic Agents|dermatologic agents|mesh-ancestor
5782586|NCT00423995|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5782587|NCT00423995|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5782588|NCT00423995|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5782589|NCT00423995|Histamine Antagonists|histamine antagonists|mesh-ancestor
5782590|NCT00423995|Histamine Agents|histamine agents|mesh-ancestor
5782591|NCT00423995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5782592|NCT00423176|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5782593|NCT00423176|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5782594|NCT00423176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5782595|NCT00423176|Antitubercular Agents|antitubercular agents|mesh-ancestor
5782596|NCT00383240|Mometasone Furoate|mometasone furoate|mesh-list
5782597|NCT00383240|Formoterol Fumarate|formoterol fumarate|mesh-list
5782598|NCT00383240|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5782599|NCT00383240|Autonomic Agents|autonomic agents|mesh-ancestor
5782600|NCT00383240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5782601|NCT00383240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5782602|NCT00383240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5782603|NCT00383240|Respiratory System Agents|respiratory system agents|mesh-ancestor
5782604|NCT00383240|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5782605|NCT00383240|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5782606|NCT00383240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5782607|NCT00383240|Adrenergic Agents|adrenergic agents|mesh-ancestor
5782608|NCT00383240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5782609|NCT00383240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782610|NCT00383240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5782611|NCT00383240|Dermatologic Agents|dermatologic agents|mesh-ancestor
5782612|NCT00383240|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5782613|NCT00380627|Etoricoxib|etoricoxib|mesh-list
5782614|NCT00380627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5782615|NCT00380627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5782616|NCT00380627|Analgesics|analgesics|mesh-ancestor
5782617|NCT00380627|Sensory System Agents|sensory system agents|mesh-ancestor
5641078|NCT04256629|Protective Agents|protective agents|mesh-ancestor
5641079|NCT04256629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641080|NCT04236414|Olaparib|olaparib|mesh-list
5641081|NCT04236414|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5641082|NCT04236414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5782618|NCT00380627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5782619|NCT00380627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5782620|NCT00380627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5782621|NCT00380627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5782622|NCT00380627|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5782623|NCT00380627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5782624|NCT00380627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5782625|NCT00380627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782626|NCT00380523|Etoricoxib|etoricoxib|mesh-list
5782627|NCT00380523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5782628|NCT00380523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5782629|NCT00380523|Analgesics|analgesics|mesh-ancestor
5782630|NCT00380523|Sensory System Agents|sensory system agents|mesh-ancestor
5782631|NCT00380523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5782632|NCT00380523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5782633|NCT00380523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5782634|NCT00380523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5782635|NCT00380523|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5782636|NCT00380523|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5641083|NCT04236414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641084|NCT04236414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5641085|NCT04231084|Epoprostenol|epoprostenol|mesh-list
5641086|NCT04231084|Nitric Oxide|nitric oxide|mesh-list
5641087|NCT04231084|Vasodilator Agents|vasodilator agents|mesh-list
5641088|NCT04231084|Tezosentan|tezosentan|mesh-list
5782637|NCT00380523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5782638|NCT00380523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782639|NCT00319995|Loratadine|loratadine|mesh-list
5782640|NCT00319995|Montelukast|montelukast|mesh-list
5782641|NCT00319995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5782642|NCT00319995|Respiratory System Agents|respiratory system agents|mesh-ancestor
5782643|NCT00319995|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5782644|NCT00319995|Hormone Antagonists|hormone antagonists|mesh-ancestor
5782645|NCT00319995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5782646|NCT00319995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5782647|NCT00319995|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5782648|NCT00319995|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5782649|NCT00319995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782650|NCT00319995|Antipruritics|antipruritics|mesh-ancestor
5782651|NCT00319995|Dermatologic Agents|dermatologic agents|mesh-ancestor
5782652|NCT00319995|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5782653|NCT00319995|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5782654|NCT00319995|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5782655|NCT00319995|Histamine Antagonists|histamine antagonists|mesh-ancestor
5782656|NCT00319995|Histamine Agents|histamine agents|mesh-ancestor
5782657|NCT00319995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5782658|NCT00311844|Desloratadine|desloratadine|mesh-list
5782659|NCT00311844|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5782660|NCT00311844|Cholinergic Agents|cholinergic agents|mesh-ancestor
5782661|NCT00311844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5782662|NCT00311844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782663|NCT00311844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5782664|NCT00311844|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5782665|NCT00311844|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5782666|NCT00311844|Histamine Antagonists|histamine antagonists|mesh-ancestor
5782667|NCT00311844|Histamine Agents|histamine agents|mesh-ancestor
5782668|NCT00212836|Olanzapine|olanzapine|mesh-list
5782669|NCT00212836|Asenapine|asenapine|mesh-list
5782670|NCT00212836|Antiemetics|antiemetics|mesh-ancestor
5782671|NCT00212836|Autonomic Agents|autonomic agents|mesh-ancestor
5782672|NCT00212836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5782673|NCT00212836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5782674|NCT00212836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5782675|NCT00212836|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5782676|NCT00212836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5782677|NCT00212836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5782678|NCT00212836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5782679|NCT00212836|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5782680|NCT00212836|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5782681|NCT00212836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5782682|NCT00212836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782683|NCT00212836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5782684|NCT00212836|Serotonin Agents|serotonin agents|mesh-ancestor
5782685|NCT00212784|Olanzapine|olanzapine|mesh-list
5782686|NCT00212784|Asenapine|asenapine|mesh-list
5782687|NCT00212784|Antiemetics|antiemetics|mesh-ancestor
5782688|NCT00212784|Autonomic Agents|autonomic agents|mesh-ancestor
5782689|NCT00212784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5782690|NCT00212784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5782691|NCT00212784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5782692|NCT00212784|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5782693|NCT00212784|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5782694|NCT00212784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5782695|NCT00212784|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5782696|NCT00212784|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5782697|NCT00212784|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5782698|NCT00212784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5782699|NCT00212784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782700|NCT00212784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5782701|NCT00212784|Serotonin Agents|serotonin agents|mesh-ancestor
5782702|NCT00212771|Olanzapine|olanzapine|mesh-list
5782703|NCT00212771|Asenapine|asenapine|mesh-list
5782704|NCT00212771|Antiemetics|antiemetics|mesh-ancestor
5782705|NCT00212771|Autonomic Agents|autonomic agents|mesh-ancestor
5782706|NCT00212771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5782707|NCT00212771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5782708|NCT00212771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5782709|NCT00212771|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5782710|NCT00212771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5782711|NCT00212771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5782712|NCT00212771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5782713|NCT00212771|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5782714|NCT00212771|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5782715|NCT00212771|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5782716|NCT00212771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782717|NCT00212771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5782718|NCT00212771|Serotonin Agents|serotonin agents|mesh-ancestor
5782719|NCT00202904|Ezetimibe|ezetimibe|mesh-list
5782720|NCT00202904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5782721|NCT00202904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5782722|NCT00202904|Antimetabolites|antimetabolites|mesh-ancestor
5782723|NCT00202904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782724|NCT00202904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5782725|NCT00157924|Atorvastatin|atorvastatin|mesh-list
5782726|NCT00157924|Simvastatin|simvastatin|mesh-list
5782727|NCT00157924|Ezetimibe|ezetimibe|mesh-list
5782728|NCT00157924|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5782729|NCT00157924|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5782730|NCT00157924|Antimetabolites|antimetabolites|mesh-ancestor
5782731|NCT00157924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782732|NCT00157924|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5782733|NCT00157924|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5782734|NCT00157924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5782735|NCT00157911|Simvastatin|simvastatin|mesh-list
5782736|NCT00157911|Ezetimibe|ezetimibe|mesh-list
5782737|NCT00157911|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5782738|NCT00157911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5782739|NCT00157911|Antimetabolites|antimetabolites|mesh-ancestor
5782740|NCT00157911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782741|NCT00157911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5782742|NCT00157911|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5782743|NCT00157911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5782744|NCT00156117|Olanzapine|olanzapine|mesh-list
5782745|NCT00156117|Asenapine|asenapine|mesh-list
5782746|NCT00156117|Antiemetics|antiemetics|mesh-ancestor
5782747|NCT00156117|Autonomic Agents|autonomic agents|mesh-ancestor
5782748|NCT00156117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5782749|NCT00156117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5782750|NCT00156117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5782751|NCT00156117|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5782752|NCT00156117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5782753|NCT00156117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5782754|NCT00156117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5782755|NCT00156117|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5782756|NCT00156117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5782757|NCT00156117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5641089|NCT04231084|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5641090|NCT04231084|Autonomic Agents|autonomic agents|mesh-ancestor
5782758|NCT00156117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782759|NCT00156117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5782760|NCT00156117|Serotonin Agents|serotonin agents|mesh-ancestor
5782761|NCT00156104|Haloperidol|haloperidol|mesh-list
5782762|NCT00156104|Haloperidol decanoate|haloperidol decanoate|mesh-list
5782763|NCT00156104|Asenapine|asenapine|mesh-list
5782764|NCT00156104|Antiemetics|antiemetics|mesh-ancestor
6210727|NCT02164240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5641091|NCT04231084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5641092|NCT04231084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641093|NCT04231084|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5641094|NCT04231084|Respiratory System Agents|respiratory system agents|mesh-ancestor
5641095|NCT04231084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5641096|NCT04231084|Antioxidants|antioxidants|mesh-ancestor
5641097|NCT04231084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641098|NCT04231084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5641099|NCT04231084|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5641100|NCT04231084|Gasotransmitters|gasotransmitters|mesh-ancestor
5641101|NCT04231084|Protective Agents|protective agents|mesh-ancestor
5641102|NCT04231084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5641103|NCT04231084|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5641104|NCT04224545|Colchicine|colchicine|mesh-list
5641105|NCT04224545|Gout Suppressants|gout suppressants|mesh-ancestor
5641106|NCT04224545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5641107|NCT04224545|Tubulin Modulators|tubulin modulators|mesh-ancestor
5782765|NCT00156104|Autonomic Agents|autonomic agents|mesh-ancestor
5782766|NCT00156104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5782767|NCT00156104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5782768|NCT00156104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5782769|NCT00156104|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5782770|NCT00156104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5782771|NCT00156104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5782772|NCT00156104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5782773|NCT00156104|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5782774|NCT00156104|Dopamine Agents|dopamine agents|mesh-ancestor
5782775|NCT00156104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5782776|NCT00156104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782777|NCT00156104|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5782778|NCT00156091|Olanzapine|olanzapine|mesh-list
5782779|NCT00156091|Asenapine|asenapine|mesh-list
5782780|NCT00156091|Antiemetics|antiemetics|mesh-ancestor
5782781|NCT00156091|Autonomic Agents|autonomic agents|mesh-ancestor
5782782|NCT00156091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5782783|NCT00156091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5782784|NCT00156091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5782785|NCT00156091|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5782786|NCT00156091|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5782787|NCT00156091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5782788|NCT00156091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5782789|NCT00156091|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5782790|NCT00156091|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5782791|NCT00156091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5782792|NCT00156091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782793|NCT00156091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5782794|NCT00156091|Serotonin Agents|serotonin agents|mesh-ancestor
5782795|NCT00142558|Indomethacin|indomethacin|mesh-list
5782796|NCT00142558|Etoricoxib|etoricoxib|mesh-list
5782797|NCT00142558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782798|NCT00142558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5782799|NCT00142558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5782800|NCT00142558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5782801|NCT00142558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5782802|NCT00142558|Analgesics|analgesics|mesh-ancestor
5782803|NCT00142558|Sensory System Agents|sensory system agents|mesh-ancestor
5782804|NCT00142558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5782805|NCT00142558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5782806|NCT00142558|Gout Suppressants|gout suppressants|mesh-ancestor
5782807|NCT00142558|Tocolytic Agents|tocolytic agents|mesh-ancestor
5782808|NCT00142558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5782809|NCT00142558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5782810|NCT00142558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5782811|NCT00142558|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5782812|NCT00140985|Losartan|losartan|mesh-list
5782813|NCT00140985|Amlodipine|amlodipine|mesh-list
5782814|NCT00140985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5782815|NCT00140985|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5782816|NCT00140985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5782817|NCT00140985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782818|NCT00140985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5782819|NCT00140985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5782820|NCT00140985|Vasodilator Agents|vasodilator agents|mesh-ancestor
5782821|NCT00140985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5782822|NCT00140985|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5782823|NCT00140985|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5782824|NCT00140972|Diclofenac|diclofenac|mesh-list
5782825|NCT00140972|Etoricoxib|etoricoxib|mesh-list
5782826|NCT00140972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5782827|NCT00140972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5782828|NCT00140972|Analgesics|analgesics|mesh-ancestor
5782829|NCT00140972|Sensory System Agents|sensory system agents|mesh-ancestor
5782830|NCT00140972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5782831|NCT00140972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5782832|NCT00140972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5782833|NCT00140972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5782834|NCT00140972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5782835|NCT00140972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5782836|NCT00140972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782837|NCT00140972|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5782838|NCT00140959|Losartan|losartan|mesh-list
5782839|NCT00140959|Atenolol|atenolol|mesh-list
5782840|NCT00140959|Amlodipine|amlodipine|mesh-list
5782841|NCT00140959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5782842|NCT00140959|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5782843|NCT00140959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5782844|NCT00140959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782845|NCT00140959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5782846|NCT00140959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5782847|NCT00140959|Vasodilator Agents|vasodilator agents|mesh-ancestor
5782848|NCT00140959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5782849|NCT00140959|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5782850|NCT00140959|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5782851|NCT00140959|Adrenergic Agents|adrenergic agents|mesh-ancestor
5782852|NCT00140959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5782853|NCT00140959|Autonomic Agents|autonomic agents|mesh-ancestor
5782854|NCT00140959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5782855|NCT00140959|Sympatholytics|sympatholytics|mesh-ancestor
5782856|NCT00140959|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5782857|NCT00140959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5782858|NCT00140959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5782859|NCT00140907|Losartan|losartan|mesh-list
5782860|NCT00140907|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5782861|NCT00140907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5782862|NCT00140907|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5782863|NCT00140907|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5782864|NCT00140907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782865|NCT00132717|Atorvastatin|atorvastatin|mesh-list
5782866|NCT00132717|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5782867|NCT00132717|Simvastatin|simvastatin|mesh-list
5782868|NCT00132717|Ezetimibe|ezetimibe|mesh-list
5782869|NCT00132717|Pravastatin|pravastatin|mesh-list
5782870|NCT00132717|Lovastatin|lovastatin|mesh-list
5782871|NCT00132717|L 647318|l 647318|mesh-list
5782872|NCT00132717|Dihydromevinolin|dihydromevinolin|mesh-list
5782873|NCT00132717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5782874|NCT00132717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5782875|NCT00132717|Antimetabolites|antimetabolites|mesh-ancestor
5782876|NCT00132717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782877|NCT00132717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5782878|NCT00132717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5782879|NCT00132717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5782880|NCT00127179|Finasteride|finasteride|mesh-list
5782881|NCT00127179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782882|NCT00127179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5782883|NCT00127179|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
5782884|NCT00127179|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5782885|NCT00127179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5782886|NCT00127179|Hormone Antagonists|hormone antagonists|mesh-ancestor
5782887|NCT00127179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5782888|NCT00127179|Urological Agents|urological agents|mesh-ancestor
5782889|NCT00110435|Atorvastatin|atorvastatin|mesh-list
5782890|NCT00110435|Simvastatin|simvastatin|mesh-list
5782891|NCT00110435|Ezetimibe|ezetimibe|mesh-list
5782892|NCT00110435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5782893|NCT00110435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5782894|NCT00110435|Antimetabolites|antimetabolites|mesh-ancestor
5782895|NCT00110435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782896|NCT00110435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5782897|NCT00110435|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5782898|NCT00110435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5782899|NCT00095017|Etoricoxib|etoricoxib|mesh-list
5782900|NCT00095017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5782901|NCT00095017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5782902|NCT00095017|Analgesics|analgesics|mesh-ancestor
5782903|NCT00095017|Sensory System Agents|sensory system agents|mesh-ancestor
5782904|NCT00095017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5782905|NCT00095017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5782906|NCT00095017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5782907|NCT00095017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5782908|NCT00095017|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5782909|NCT00095017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5782910|NCT00095017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5782911|NCT00095017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782912|NCT00093899|Simvastatin|simvastatin|mesh-list
5782913|NCT00093899|Ezetimibe|ezetimibe|mesh-list
5782914|NCT00093899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5782915|NCT00093899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5782916|NCT00093899|Antimetabolites|antimetabolites|mesh-ancestor
5782917|NCT00093899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782918|NCT00093899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5782919|NCT00093899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5782920|NCT00093899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5782921|NCT00092898|Ezetimibe|ezetimibe|mesh-list
5782922|NCT00092898|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5782923|NCT00092898|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5782924|NCT00092898|Antimetabolites|antimetabolites|mesh-ancestor
5782925|NCT00092898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782926|NCT00092898|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5782927|NCT00092820|Ezetimibe|ezetimibe|mesh-list
5782928|NCT00092820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5782929|NCT00092820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5782930|NCT00092820|Antimetabolites|antimetabolites|mesh-ancestor
5782931|NCT00092820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782932|NCT00092820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5782933|NCT00092807|Ezetimibe|ezetimibe|mesh-list
5782934|NCT00092807|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5782935|NCT00092807|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5782936|NCT00092807|Antimetabolites|antimetabolites|mesh-ancestor
5782937|NCT00092807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782938|NCT00092807|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5782939|NCT00092781|Celecoxib|celecoxib|mesh-list
5782940|NCT00092781|Etoricoxib|etoricoxib|mesh-list
5782941|NCT00092781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5782942|NCT00092781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5782943|NCT00092781|Analgesics|analgesics|mesh-ancestor
5782944|NCT00092781|Sensory System Agents|sensory system agents|mesh-ancestor
5782945|NCT00092781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5782946|NCT00092781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5782947|NCT00092781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5782948|NCT00092781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5782949|NCT00092781|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5782950|NCT00092781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5782951|NCT00092781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5782952|NCT00092781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782953|NCT00092768|Celecoxib|celecoxib|mesh-list
5782954|NCT00092768|Etoricoxib|etoricoxib|mesh-list
5782955|NCT00092768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5782956|NCT00092768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5782957|NCT00092768|Analgesics|analgesics|mesh-ancestor
5782958|NCT00092768|Sensory System Agents|sensory system agents|mesh-ancestor
5782959|NCT00092768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5782960|NCT00092768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5782961|NCT00092768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5782962|NCT00092768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5782963|NCT00092768|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5782964|NCT00092768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5782965|NCT00092768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5782966|NCT00092768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782967|NCT00092755|Ibuprofen|ibuprofen|mesh-list
5782968|NCT00092755|Etoricoxib|etoricoxib|mesh-list
5782969|NCT00092755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5782970|NCT00092755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5782971|NCT00092755|Analgesics|analgesics|mesh-ancestor
5782972|NCT00092755|Sensory System Agents|sensory system agents|mesh-ancestor
5782973|NCT00092755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5782974|NCT00092755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5782975|NCT00092755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5782976|NCT00092755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5782977|NCT00092755|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5782978|NCT00092755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5782979|NCT00092755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782980|NCT00092755|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5782981|NCT00092742|Diclofenac|diclofenac|mesh-list
5782982|NCT00092742|Etoricoxib|etoricoxib|mesh-list
5782983|NCT00092742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5782984|NCT00092742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5782985|NCT00092742|Analgesics|analgesics|mesh-ancestor
5782986|NCT00092742|Sensory System Agents|sensory system agents|mesh-ancestor
5782987|NCT00092742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5782988|NCT00092742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5782989|NCT00092742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5782990|NCT00092742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5782991|NCT00092742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5782992|NCT00092742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5782993|NCT00092742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5782994|NCT00092742|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5782995|NCT00092729|Naproxen|naproxen|mesh-list
5782996|NCT00092729|Etoricoxib|etoricoxib|mesh-list
5782997|NCT00092729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5782998|NCT00092729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6210728|NCT02164240|Growth Substances|growth substances|mesh-ancestor
6210729|NCT02164240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210730|NCT02164240|Growth Inhibitors|growth inhibitors|mesh-ancestor
6210731|NCT02164240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6210732|NCT02164240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6210733|NCT02164240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210734|NCT02164318|Nitroglycerin|nitroglycerin|mesh-list
6210735|NCT02164318|Vasodilator Agents|vasodilator agents|mesh-ancestor
6210736|NCT02164383|Nicotine|nicotine|mesh-list
5782999|NCT00092729|Analgesics|analgesics|mesh-ancestor
5783000|NCT00092729|Sensory System Agents|sensory system agents|mesh-ancestor
5783001|NCT00092729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5783002|NCT00092729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783003|NCT00092729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6210737|NCT02164383|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6210738|NCT02164383|Autonomic Agents|autonomic agents|mesh-ancestor
6210739|NCT02164383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6210740|NCT02164383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210741|NCT02164383|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6210742|NCT02164383|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6210743|NCT02164383|Cholinergic Agents|cholinergic agents|mesh-ancestor
6210744|NCT02164383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6210745|NCT02164383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210746|NCT02164422|Guanfacine|guanfacine|mesh-list
6210747|NCT02164422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6210748|NCT02164422|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6210749|NCT02164422|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6491164|NCT00601328|Micronutrients|micronutrients|mesh-ancestor
5783004|NCT00092729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5783005|NCT00092729|Gout Suppressants|gout suppressants|mesh-ancestor
5783006|NCT00092729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5783007|NCT00092729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5783008|NCT00092729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783009|NCT00092729|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5783010|NCT00092703|Diclofenac|diclofenac|mesh-list
5783011|NCT00092703|Etoricoxib|etoricoxib|mesh-list
5783012|NCT00092703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5783013|NCT00092703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5783014|NCT00092703|Analgesics|analgesics|mesh-ancestor
5783015|NCT00092703|Sensory System Agents|sensory system agents|mesh-ancestor
5783016|NCT00092703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5783017|NCT00092703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783018|NCT00092703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5783019|NCT00092703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5783020|NCT00092703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5783021|NCT00092703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5783022|NCT00092703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783023|NCT00092703|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5783024|NCT02844270|Sirolimus|sirolimus|mesh-list
5783025|NCT02844270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5783026|NCT02844270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5783027|NCT02844270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5783028|NCT02844270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5783029|NCT02844270|Antifungal Agents|antifungal agents|mesh-ancestor
5783030|NCT02844270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6491165|NCT00601328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6491166|NCT00601432|Levofloxacin|levofloxacin|mesh-list
6491167|NCT00601432|Ofloxacin|ofloxacin|mesh-list
6491168|NCT00601432|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6491169|NCT00601432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6491170|NCT00601432|Renal Agents|renal agents|mesh-ancestor
6491171|NCT00601432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6210750|NCT02164422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6491172|NCT00601432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5783031|NCT02844270|Immunologic Factors|immunologic factors|mesh-ancestor
5783032|NCT02844270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783033|NCT02843984|Lactoferrin|lactoferrin|mesh-list
5783034|NCT02843984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5783035|NCT02844062|Cyclophosphamide|cyclophosphamide|mesh-list
5783036|NCT02844062|Fludarabine|fludarabine|mesh-list
5783037|NCT02844062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5783038|NCT02844062|Immunologic Factors|immunologic factors|mesh-ancestor
5783039|NCT02844062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783040|NCT02844062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5783041|NCT02844062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5783042|NCT02844062|Alkylating Agents|alkylating agents|mesh-ancestor
5783043|NCT02844062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783044|NCT02844062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5783045|NCT02844062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5783046|NCT02844114|Gemcitabine|gemcitabine|mesh-list
5783047|NCT02844114|Cisplatin|cisplatin|mesh-list
5783048|NCT02844114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5783049|NCT02844114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5783050|NCT02844114|Antimetabolites|antimetabolites|mesh-ancestor
5783051|NCT02844114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783052|NCT02844114|Antiviral Agents|antiviral agents|mesh-ancestor
5783053|NCT02844114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5783054|NCT02844114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5783055|NCT02844114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6491173|NCT00601432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6491174|NCT00601432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6491175|NCT00601432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491176|NCT00601432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6491177|NCT00601432|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6491178|NCT00601432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6491179|NCT00601510|Capecitabine|capecitabine|mesh-list
6491180|NCT00601510|Imatinib Mesylate|imatinib mesylate|mesh-list
6491181|NCT00601510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6210751|NCT02164422|Adrenergic Agents|adrenergic agents|mesh-ancestor
6210752|NCT02164422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6210753|NCT02164422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210754|NCT02164422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210755|NCT02164513|Fluticasone|fluticasone|mesh-list
6491182|NCT00601510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6491183|NCT00601510|Antimetabolites|antimetabolites|mesh-ancestor
6491184|NCT00601510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491185|NCT00601510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6491186|NCT00601510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6491187|NCT00601536|Lithium Carbonate|lithium carbonate|mesh-list
6491188|NCT00601536|Antidepressive Agents|antidepressive agents|mesh-ancestor
6491189|NCT00601536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6673715|NCT01564576|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5783056|NCT02844114|Immunologic Factors|immunologic factors|mesh-ancestor
5783057|NCT02844114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783058|NCT02843698|Dexmedetomidine|dexmedetomidine|mesh-list
5783059|NCT02843698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5783060|NCT02843698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5783061|NCT02843698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783062|NCT02843698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5783063|NCT02843698|Analgesics|analgesics|mesh-ancestor
5783064|NCT02843698|Sensory System Agents|sensory system agents|mesh-ancestor
5783065|NCT02843698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5783066|NCT02843698|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5783067|NCT02843698|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5783068|NCT02843698|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5783069|NCT02843698|Adrenergic Agents|adrenergic agents|mesh-ancestor
5783070|NCT02843698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5783071|NCT02843698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783072|NCT02843685|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
5783073|NCT02843685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5897936|NCT04527744|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5897937|NCT04527744|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5897938|NCT04527744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5897939|NCT04527744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897940|NCT04527744|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5897941|NCT04527744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5908789|NCT04115319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5783074|NCT02843321|Vaccines|vaccines|mesh-list
5783075|NCT02843321|Immunologic Factors|immunologic factors|mesh-ancestor
5783076|NCT02843321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783077|NCT02843451|Silymarin|silymarin|mesh-list
5783078|NCT02843451|Antioxidants|antioxidants|mesh-ancestor
5783079|NCT02843451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783080|NCT02843451|Protective Agents|protective agents|mesh-ancestor
5783081|NCT02843451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783082|NCT02843438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
5783083|NCT02843490|Ranibizumab|ranibizumab|mesh-list
5783084|NCT02843490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5783085|NCT02843490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5783086|NCT02843490|Growth Substances|growth substances|mesh-ancestor
5783087|NCT02843490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783088|NCT02843490|Growth Inhibitors|growth inhibitors|mesh-ancestor
5783089|NCT02843490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5783090|NCT02843230|Bevacizumab|bevacizumab|mesh-list
5783091|NCT02843230|Temozolomide|temozolomide|mesh-list
5783092|NCT02843230|Lomustine|lomustine|mesh-list
5783093|NCT02843230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5783094|NCT02843230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5783095|NCT02843230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5783096|NCT02843230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5783097|NCT02843230|Growth Substances|growth substances|mesh-ancestor
5783098|NCT02843230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783099|NCT02843230|Growth Inhibitors|growth inhibitors|mesh-ancestor
5783100|NCT02843230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5783101|NCT02843230|Alkylating Agents|alkylating agents|mesh-ancestor
5783102|NCT02843230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783103|NCT02842983|Esmolol|esmolol|mesh-list
5783104|NCT02842983|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5783105|NCT02842983|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5783106|NCT02842983|Adrenergic Agents|adrenergic agents|mesh-ancestor
5783107|NCT02842983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5783108|NCT02842983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783109|NCT02842983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783110|NCT02842983|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5783111|NCT02843126|Trastuzumab|trastuzumab|mesh-list
5783112|NCT02843126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5783113|NCT02843126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5783114|NCT02843204|Pembrolizumab|pembrolizumab|mesh-list
5783115|NCT02843204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5783116|NCT02843204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5783117|NCT02843061|Rituximab|rituximab|mesh-list
5783118|NCT02843061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5783119|NCT02843061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5783120|NCT02843061|Immunologic Factors|immunologic factors|mesh-ancestor
5783121|NCT02843061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783122|NCT02843061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5783123|NCT02842931|Prednisone|prednisone|mesh-list
5783124|NCT02842931|Cyclophosphamide|cyclophosphamide|mesh-list
5783125|NCT02842931|Doxorubicin|doxorubicin|mesh-list
5783126|NCT02842931|Etoposide|etoposide|mesh-list
5783127|NCT02842931|Vincristine|vincristine|mesh-list
5783128|NCT02842931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5783129|NCT02842931|Immunologic Factors|immunologic factors|mesh-ancestor
5783130|NCT02842931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783131|NCT02842931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5783132|NCT02842931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5783133|NCT02842931|Alkylating Agents|alkylating agents|mesh-ancestor
5783134|NCT02842931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783135|NCT02842931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5783136|NCT02842931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5783137|NCT02842931|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5783138|NCT02842931|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5783139|NCT02842931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5783140|NCT02842931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5783141|NCT02842931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5783142|NCT02842931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5783143|NCT02842931|Glucocorticoids|glucocorticoids|mesh-ancestor
5783144|NCT02842931|Hormones|hormones|mesh-ancestor
5783145|NCT02842931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5783146|NCT02842931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5783147|NCT02842931|Tubulin Modulators|tubulin modulators|mesh-ancestor
5783148|NCT02842931|Antimitotic Agents|antimitotic agents|mesh-ancestor
5783149|NCT02842931|Mitosis Modulators|mitosis modulators|mesh-ancestor
5783150|NCT02842749|Everolimus|everolimus|mesh-list
5783151|NCT02842749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5783152|NCT02842749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5783153|NCT02842749|Immunologic Factors|immunologic factors|mesh-ancestor
5783154|NCT02842749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783155|NCT02842814|Hydroxychloroquine|hydroxychloroquine|mesh-list
5783156|NCT02842814|Glucocorticoids|glucocorticoids|mesh-list
5783157|NCT02842814|Antimalarials|antimalarials|mesh-ancestor
5783158|NCT02842814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5783159|NCT02842814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5783160|NCT02842814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5783161|NCT02842814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5783162|NCT02842814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783163|NCT02842814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5783164|NCT02842814|Hormones|hormones|mesh-ancestor
5783165|NCT02842814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5783166|NCT02842814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783167|NCT02842567|Vitamin E|vitamin e|mesh-list
5783168|NCT02842567|Tocopherols|tocopherols|mesh-list
5783169|NCT02842567|alpha-Tocopherol|alpha-tocopherol|mesh-list
5783170|NCT02842567|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
5783171|NCT02842567|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
5783172|NCT02842567|Vitamins|vitamins|mesh-ancestor
5783173|NCT02842567|Micronutrients|micronutrients|mesh-ancestor
5783174|NCT02842567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783175|NCT02842567|Antioxidants|antioxidants|mesh-ancestor
5783176|NCT02842567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783177|NCT02842567|Protective Agents|protective agents|mesh-ancestor
5783178|NCT02842567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5783179|NCT02842567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5783180|NCT02842567|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5783181|NCT02842567|Disinfectants|disinfectants|mesh-ancestor
5783182|NCT02842580|Leucovorin|leucovorin|mesh-list
5783183|NCT02842580|Bevacizumab|bevacizumab|mesh-list
5783184|NCT02842580|Capecitabine|capecitabine|mesh-list
5783185|NCT02842580|Oxaliplatin|oxaliplatin|mesh-list
5783186|NCT02842580|Irinotecan|irinotecan|mesh-list
5783187|NCT02842580|Levoleucovorin|levoleucovorin|mesh-list
5783188|NCT02842580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5783189|NCT02842580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5783190|NCT02842580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5783191|NCT02842580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5783192|NCT02842580|Growth Substances|growth substances|mesh-ancestor
5783193|NCT02842580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783194|NCT02842580|Growth Inhibitors|growth inhibitors|mesh-ancestor
5783195|NCT02842580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5783196|NCT02842580|Antimetabolites|antimetabolites|mesh-ancestor
5783197|NCT02842580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783198|NCT02842580|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5783199|NCT02842580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5783200|NCT02842580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5783201|NCT02842580|Antidotes|antidotes|mesh-ancestor
5783202|NCT02842580|Protective Agents|protective agents|mesh-ancestor
5783203|NCT02842580|Vitamin B Complex|vitamin b complex|mesh-ancestor
5783204|NCT02842580|Vitamins|vitamins|mesh-ancestor
5783205|NCT02842580|Micronutrients|micronutrients|mesh-ancestor
5783206|NCT02842359|Irbesartan|irbesartan|mesh-list
5783207|NCT02842359|Atorvastatin|atorvastatin|mesh-list
5783208|NCT02842359|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5783209|NCT02842359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5783210|NCT02842359|Antimetabolites|antimetabolites|mesh-ancestor
5783211|NCT02842359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783212|NCT02842359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5783213|NCT02842359|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5783214|NCT02842359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5783215|NCT02842359|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5783216|NCT02842359|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5783217|NCT02842359|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5783218|NCT02842281|Levan|levan|mesh-list
5783219|NCT02842281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5783220|NCT02842294|Bevacizumab|bevacizumab|mesh-list
5783221|NCT02842294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5783222|NCT02842294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5783223|NCT02842294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5783224|NCT02842294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5783225|NCT02842294|Growth Substances|growth substances|mesh-ancestor
6210756|NCT02164513|Xhance|xhance|mesh-list
5783226|NCT02842294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783227|NCT02842294|Growth Inhibitors|growth inhibitors|mesh-ancestor
5783228|NCT02842437|Dexmedetomidine|dexmedetomidine|mesh-list
5783229|NCT02842437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5783230|NCT02842437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5783231|NCT02842437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783232|NCT02842437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5783233|NCT02842437|Analgesics|analgesics|mesh-ancestor
5783234|NCT02842437|Sensory System Agents|sensory system agents|mesh-ancestor
5783235|NCT02842437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5783236|NCT02842437|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5783237|NCT02842437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5783238|NCT02842437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5783239|NCT02842437|Adrenergic Agents|adrenergic agents|mesh-ancestor
5783240|NCT02842437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5783241|NCT02842437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783242|NCT02842424|Ramipril|ramipril|mesh-list
5783243|NCT02842424|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5783244|NCT02842424|Protease Inhibitors|protease inhibitors|mesh-ancestor
5783245|NCT02842424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5783246|NCT02842424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783247|NCT02842424|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5783248|NCT02842125|Pembrolizumab|pembrolizumab|mesh-list
5783249|NCT02842125|Nivolumab|nivolumab|mesh-list
5783250|NCT02842125|Capecitabine|capecitabine|mesh-list
5783251|NCT02842125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5783252|NCT02842125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5783253|NCT02842125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5783254|NCT02842125|Antimetabolites|antimetabolites|mesh-ancestor
5783255|NCT02842125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783256|NCT02842125|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5897942|NCT04527744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897943|NCT04527744|Cholinergic Agents|cholinergic agents|mesh-ancestor
5897944|NCT04527744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5897945|NCT04522323|Lenvatinib|lenvatinib|mesh-list
5897946|NCT04522323|Axitinib|axitinib|mesh-list
5897947|NCT04522323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5897948|NCT04522323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5897949|NCT04522323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5897950|NCT04522323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897951|NCT04465487|Cemiplimab|cemiplimab|mesh-list
5897952|NCT04465487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5897953|NCT04465487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5897954|NCT04443244|Botulinum Toxins|botulinum toxins|mesh-list
5897955|NCT04443244|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5897956|NCT04443244|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5897957|NCT04443244|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5897958|NCT04443244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5897959|NCT04443244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897960|NCT04443244|Cholinergic Agents|cholinergic agents|mesh-ancestor
5897961|NCT04443244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5897962|NCT04443244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897963|NCT04443244|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5897964|NCT04443244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5897965|NCT04442581|Pembrolizumab|pembrolizumab|mesh-list
5897966|NCT04442581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5897967|NCT04442581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5897968|NCT04421092|Lidocaine|lidocaine|mesh-list
5897969|NCT04421092|Anesthetics, Local|anesthetics, local|mesh-ancestor
5897970|NCT04421092|Anesthetics|anesthetics|mesh-ancestor
5897971|NCT04421092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5897972|NCT04421092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897973|NCT04421092|Sensory System Agents|sensory system agents|mesh-ancestor
5897974|NCT04421092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5897975|NCT04421092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5897976|NCT04421092|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5897977|NCT04421092|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5897978|NCT04421092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5897979|NCT04421092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897980|NCT04408898|Pembrolizumab|pembrolizumab|mesh-list
5897981|NCT04408898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5897982|NCT04408898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5897983|NCT04402385|Aspirin|aspirin|mesh-list
5783257|NCT02841982|Morphine|morphine|mesh-list
5783258|NCT02841982|Ropivacaine|ropivacaine|mesh-list
5783259|NCT02841982|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5783260|NCT02841982|Narcotics|narcotics|mesh-ancestor
5783261|NCT02841982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5783262|NCT02841982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783263|NCT02841982|Analgesics|analgesics|mesh-ancestor
5783264|NCT02841982|Sensory System Agents|sensory system agents|mesh-ancestor
5783265|NCT02841982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5783266|NCT02841982|Anesthetics, Local|anesthetics, local|mesh-ancestor
5783267|NCT02841982|Anesthetics|anesthetics|mesh-ancestor
5783268|NCT02841839|Fluorides|fluorides|mesh-list
5783269|NCT02841839|Tin Fluorides|tin fluorides|mesh-list
5783270|NCT02841839|Cariostatic Agents|cariostatic agents|mesh-ancestor
5783271|NCT02841839|Protective Agents|protective agents|mesh-ancestor
5783272|NCT02841839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783273|NCT02841488|Fentanyl|fentanyl|mesh-list
5783274|NCT02841488|Ropivacaine|ropivacaine|mesh-list
5783275|NCT02841488|Anesthetics, Local|anesthetics, local|mesh-ancestor
5783276|NCT02841488|Anesthetics|anesthetics|mesh-ancestor
5783277|NCT02841488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5783278|NCT02841488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783279|NCT02841488|Sensory System Agents|sensory system agents|mesh-ancestor
5783280|NCT02841488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5783281|NCT02841488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5783282|NCT02841488|Narcotics|narcotics|mesh-ancestor
5783283|NCT02841488|Analgesics|analgesics|mesh-ancestor
5783284|NCT02841488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5783285|NCT02841488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5783286|NCT02841488|Anesthetics, General|anesthetics, general|mesh-ancestor
5783287|NCT02841722|Sargramostim|sargramostim|mesh-list
5783288|NCT02841722|Lenograstim|lenograstim|mesh-list
5783289|NCT02841722|Immunologic Factors|immunologic factors|mesh-ancestor
5783290|NCT02841722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783291|NCT02841722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5783292|NCT02841579|Osimertinib|osimertinib|mesh-list
5783293|NCT02841579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5783294|NCT02841579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5783295|NCT02841579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5783296|NCT02841579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783297|NCT02841774|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5783298|NCT02841774|Pravastatin|pravastatin|mesh-list
5783299|NCT02841774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5783300|NCT02841774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5783301|NCT02841774|Antimetabolites|antimetabolites|mesh-ancestor
5783302|NCT02841774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783303|NCT02841774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5783304|NCT02841774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5783305|NCT02841774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5783306|NCT02841800|Phenobarbital|phenobarbital|mesh-list
5783307|NCT02841800|Anticonvulsants|anticonvulsants|mesh-ancestor
5783308|NCT02841800|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5783309|NCT02841800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5783310|NCT02841800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783311|NCT02841800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5783312|NCT02841800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5783313|NCT02841800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5783314|NCT02841800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783315|NCT02841800|GABA Modulators|gaba modulators|mesh-ancestor
5783316|NCT02841800|GABA Agents|gaba agents|mesh-ancestor
5783317|NCT02841800|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5783318|NCT02841800|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5783319|NCT02841800|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5783320|NCT02841371|Edetic Acid|edetic acid|mesh-list
5783321|NCT02841371|Pentetic Acid|pentetic acid|mesh-list
5783322|NCT02841371|Antidotes|antidotes|mesh-ancestor
5783323|NCT02841371|Protective Agents|protective agents|mesh-ancestor
5783324|NCT02841371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783325|NCT02841371|Chelating Agents|chelating agents|mesh-ancestor
5783326|NCT02841371|Sequestering Agents|sequestering agents|mesh-ancestor
5783327|NCT02841371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783328|NCT02841371|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5783329|NCT02841371|Anticoagulants|anticoagulants|mesh-ancestor
5783330|NCT02841371|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5783331|NCT02841280|Chlorthalidone|chlorthalidone|mesh-list
5783332|NCT02841280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5783333|NCT02841280|Diuretics|diuretics|mesh-ancestor
5783334|NCT02841280|Natriuretic Agents|natriuretic agents|mesh-ancestor
5783335|NCT02841280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783336|NCT02841280|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5783337|NCT02841280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5783338|NCT02841280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783339|NCT02841306|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
5783340|NCT02841306|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5783341|NCT02841306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5783342|NCT02841332|Misonidazole|misonidazole|mesh-list
5783343|NCT02841332|Bevacizumab|bevacizumab|mesh-list
5783344|NCT02841332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5783345|NCT02841332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5783346|NCT02841332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5783347|NCT02841332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5783348|NCT02841332|Growth Substances|growth substances|mesh-ancestor
5783349|NCT02841332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783350|NCT02841332|Growth Inhibitors|growth inhibitors|mesh-ancestor
5783351|NCT02841332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5783352|NCT02841332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5783353|NCT02841332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5783354|NCT02840994|Pembrolizumab|pembrolizumab|mesh-list
5783355|NCT02840994|Nivolumab|nivolumab|mesh-list
5783356|NCT02840994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5783357|NCT02840994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5783358|NCT02840994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5783359|NCT02840994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783360|NCT02841202|Contraceptive Agents|contraceptive agents|mesh-list
5783361|NCT02841202|Contraceptives, Oral|contraceptives, oral|mesh-list
5783362|NCT02841202|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
5783363|NCT02841202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5783364|NCT02841202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783365|NCT02841202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5783366|NCT02841137|Progesterone|progesterone|mesh-list
5783367|NCT02841137|Progestins|progestins|mesh-ancestor
5783368|NCT02841137|Hormones|hormones|mesh-ancestor
5783369|NCT02841137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5783370|NCT02841137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783371|NCT02841176|Golimumab|golimumab|mesh-list
5783372|NCT02841176|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
5783373|NCT02841176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5783374|NCT02841176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5783375|NCT02841176|Immunologic Factors|immunologic factors|mesh-ancestor
5783376|NCT02841176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783377|NCT02840929|Esomeprazole|esomeprazole|mesh-list
5783378|NCT02840929|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5783379|NCT02840929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5783380|NCT02840929|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5783381|NCT02840929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5783382|NCT02840929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783383|NCT02840708|Sargramostim|sargramostim|mesh-list
5783384|NCT02840708|Immunologic Factors|immunologic factors|mesh-ancestor
5783385|NCT02840708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783386|NCT02840539|Cytarabine|cytarabine|mesh-list
5783387|NCT02840539|Dexamethasone|dexamethasone|mesh-list
5783388|NCT02840539|Dexamethasone acetate|dexamethasone acetate|mesh-list
5783389|NCT02840539|Bortezomib|bortezomib|mesh-list
5783390|NCT02840539|BB 1101|bb 1101|mesh-list
5783391|NCT02840539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5783392|NCT02840539|Antiemetics|antiemetics|mesh-ancestor
5783393|NCT02840539|Autonomic Agents|autonomic agents|mesh-ancestor
5783394|NCT02840539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5783395|NCT02840539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783396|NCT02840539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5783397|NCT02840539|Glucocorticoids|glucocorticoids|mesh-ancestor
5783398|NCT02840539|Hormones|hormones|mesh-ancestor
5783399|NCT02840539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5783400|NCT02840539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5783401|NCT02840539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5783402|NCT02840539|Protease Inhibitors|protease inhibitors|mesh-ancestor
5783403|NCT02840539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5783404|NCT02840539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783405|NCT02840539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5783406|NCT02840539|Antimetabolites|antimetabolites|mesh-ancestor
5783407|NCT02840539|Antiviral Agents|antiviral agents|mesh-ancestor
5783408|NCT02840539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5783409|NCT02840539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5783410|NCT02840539|Immunologic Factors|immunologic factors|mesh-ancestor
5783411|NCT02840591|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
5783412|NCT02840591|Nootropic Agents|nootropic agents|mesh-ancestor
5897984|NCT04402385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5897985|NCT04402385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5897986|NCT04402385|Analgesics|analgesics|mesh-ancestor
5897987|NCT04402385|Sensory System Agents|sensory system agents|mesh-ancestor
5897988|NCT04402385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5897989|NCT04402385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5897990|NCT04402385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5897991|NCT04402385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5897992|NCT04402385|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5897993|NCT04402385|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5897994|NCT04402385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5897995|NCT04402385|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5897996|NCT04402385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5897997|NCT04402385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5897998|NCT04402385|Antipyretics|antipyretics|mesh-ancestor
5897999|NCT04393103|Atropine|atropine|mesh-list
5898000|NCT04393103|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
5898001|NCT04393103|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5898002|NCT04393103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5898003|NCT04393103|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5898004|NCT04393103|Autonomic Agents|autonomic agents|mesh-ancestor
5898005|NCT04393103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5641108|NCT04224545|Antimitotic Agents|antimitotic agents|mesh-ancestor
5641109|NCT04224545|Mitosis Modulators|mitosis modulators|mesh-ancestor
5641110|NCT04224545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641111|NCT04224545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5641112|NCT04186494|Liraglutide|liraglutide|mesh-list
5641113|NCT04186494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5641114|NCT04186494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641115|NCT04186494|Incretins|incretins|mesh-ancestor
5641116|NCT04186494|Hormones|hormones|mesh-ancestor
5641117|NCT04186494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5641118|NCT04180995|Axitinib|axitinib|mesh-list
5641119|NCT04180995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5641120|NCT04180995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5641121|NCT04180995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5641122|NCT04180995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693918|NCT03398941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5693919|NCT03398876|Nicotine|nicotine|mesh-list
5693920|NCT03398876|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5693921|NCT03398876|Autonomic Agents|autonomic agents|mesh-ancestor
5693922|NCT03398876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5693923|NCT03398876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693924|NCT03398876|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5898006|NCT04393103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898007|NCT04393103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5898008|NCT04393103|Respiratory System Agents|respiratory system agents|mesh-ancestor
5898009|NCT04393103|Mydriatics|mydriatics|mesh-ancestor
5898010|NCT04393103|Parasympatholytics|parasympatholytics|mesh-ancestor
5898011|NCT04393103|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5898012|NCT04393103|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5898013|NCT04393103|Cholinergic Agents|cholinergic agents|mesh-ancestor
5898014|NCT04393103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5898015|NCT04393103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898016|NCT04393103|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
5898017|NCT04393103|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5898018|NCT04393103|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5898019|NCT04347616|Aldesleukin|aldesleukin|mesh-list
5898020|NCT04347616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5783413|NCT02840240|Gabapentin|gabapentin|mesh-list
5783414|NCT02840240|Analgesics|analgesics|mesh-ancestor
5783415|NCT02840240|Sensory System Agents|sensory system agents|mesh-ancestor
5783416|NCT02840240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5783417|NCT02840240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783418|NCT02840240|Anticonvulsants|anticonvulsants|mesh-ancestor
5783419|NCT02840240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5783420|NCT02840240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5783421|NCT02840240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5783422|NCT02840240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5783423|NCT02840240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5783424|NCT02840240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5783425|NCT02840240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5783426|NCT02840240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783427|NCT02840240|Antimanic Agents|antimanic agents|mesh-ancestor
5783428|NCT02840526|Acetaminophen|acetaminophen|mesh-list
5783429|NCT02840526|Fentanyl|fentanyl|mesh-list
5783430|NCT02840526|Bupivacaine|bupivacaine|mesh-list
5783431|NCT02840526|Propofol|propofol|mesh-list
5783432|NCT02840526|Sevoflurane|sevoflurane|mesh-list
5783433|NCT02840526|Anesthetics, Local|anesthetics, local|mesh-ancestor
5783434|NCT02840526|Anesthetics|anesthetics|mesh-ancestor
5783435|NCT02840526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5783436|NCT02840526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783437|NCT02840526|Sensory System Agents|sensory system agents|mesh-ancestor
5783438|NCT02840526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5783439|NCT02840526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5783440|NCT02840526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5783441|NCT02840526|Anesthetics, General|anesthetics, general|mesh-ancestor
5783442|NCT02840526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5783443|NCT02840526|Narcotics|narcotics|mesh-ancestor
5783444|NCT02840526|Analgesics|analgesics|mesh-ancestor
5783445|NCT02840526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5783446|NCT02840526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5783447|NCT02840526|Antipyretics|antipyretics|mesh-ancestor
5783448|NCT02840526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5783449|NCT02840526|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5783450|NCT02840409|Bevacizumab|bevacizumab|mesh-list
5783451|NCT02840409|Vinblastine|vinblastine|mesh-list
5783452|NCT02840409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5783453|NCT02840409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5783454|NCT02840409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5783455|NCT02840409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5783456|NCT02840409|Growth Substances|growth substances|mesh-ancestor
5783457|NCT02840409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783458|NCT02840409|Growth Inhibitors|growth inhibitors|mesh-ancestor
5783459|NCT02840409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5783460|NCT02840409|Tubulin Modulators|tubulin modulators|mesh-ancestor
5783461|NCT02840409|Antimitotic Agents|antimitotic agents|mesh-ancestor
5783462|NCT02840409|Mitosis Modulators|mitosis modulators|mesh-ancestor
5783463|NCT02840409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783464|NCT02840175|Adalimumab|adalimumab|mesh-list
5783465|NCT02840175|Etanercept|etanercept|mesh-list
5783466|NCT02840175|Abatacept|abatacept|mesh-list
5783467|NCT02840175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5783468|NCT02840175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5783469|NCT02840175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5783470|NCT02840175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5783471|NCT02840175|Analgesics|analgesics|mesh-ancestor
5783472|NCT02840175|Sensory System Agents|sensory system agents|mesh-ancestor
5783473|NCT02840175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5783474|NCT02840175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783475|NCT02840175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5783476|NCT02840175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5783477|NCT02840175|Immunologic Factors|immunologic factors|mesh-ancestor
5783478|NCT02840175|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5783479|NCT02840175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783480|NCT02840175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5783481|NCT02840162|Celecoxib|celecoxib|mesh-list
5783482|NCT02840162|Benzenesulfonamide|benzenesulfonamide|mesh-list
5783483|NCT02840162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5783484|NCT02840162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5783485|NCT02840162|Analgesics|analgesics|mesh-ancestor
5783486|NCT02840162|Sensory System Agents|sensory system agents|mesh-ancestor
5783487|NCT02840162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5783488|NCT02840162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783489|NCT02840162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5783490|NCT02840162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5783491|NCT02840162|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5783492|NCT02840162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5783493|NCT02840162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5783494|NCT02840162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783495|NCT02840162|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5783496|NCT02840006|Anesthetics|anesthetics|mesh-list
5783497|NCT02840006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5783498|NCT02840006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783499|NCT02839928|Ketamine|ketamine|mesh-list
5783500|NCT02839928|Analgesics|analgesics|mesh-list
5783501|NCT02839928|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
5783502|NCT02839928|Sensory System Agents|sensory system agents|mesh-ancestor
5783503|NCT02839928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5783504|NCT02839928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783505|NCT02839928|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5783506|NCT02839928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5783507|NCT02839928|Anesthetics, General|anesthetics, general|mesh-ancestor
5783508|NCT02839928|Anesthetics|anesthetics|mesh-ancestor
6673716|NCT01564576|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6673717|NCT01564576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6673718|NCT01564576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673719|NCT01564680|Acetaminophen|acetaminophen|mesh-list
6673720|NCT01564680|Lornoxicam|lornoxicam|mesh-list
6673721|NCT01564680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6673722|NCT01564680|Analgesics|analgesics|mesh-ancestor
6673723|NCT01564680|Sensory System Agents|sensory system agents|mesh-ancestor
6673724|NCT01564680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5783509|NCT02839928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5783510|NCT02839928|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5783511|NCT02839928|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5783512|NCT02839928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5783513|NCT02839928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783514|NCT02839928|Anesthetics, Local|anesthetics, local|mesh-ancestor
5783515|NCT02839928|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
5783516|NCT02839941|Mycophenolic Acid|mycophenolic acid|mesh-list
5783517|NCT02839941|Tacrolimus|tacrolimus|mesh-list
5783518|NCT02839941|Glucocorticoids|glucocorticoids|mesh-list
5783519|NCT02839941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5783520|NCT02839941|Immunologic Factors|immunologic factors|mesh-ancestor
5783521|NCT02839941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783522|NCT02839941|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5783523|NCT02839941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5783524|NCT02839941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783525|NCT02839941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5783526|NCT02839941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5783527|NCT02839941|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5783528|NCT02839941|Antitubercular Agents|antitubercular agents|mesh-ancestor
5783529|NCT02839941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5783530|NCT02839941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5783531|NCT02839941|Hormones|hormones|mesh-ancestor
5783532|NCT02839941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5783533|NCT02839694|Celecoxib|celecoxib|mesh-list
5783534|NCT02839694|Decitabine|decitabine|mesh-list
5783535|NCT02839694|Tetrahydrouridine|tetrahydrouridine|mesh-list
5783536|NCT02839694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5783537|NCT02839694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5783538|NCT02839694|Analgesics|analgesics|mesh-ancestor
6673725|NCT01564680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673726|NCT01564680|Antipyretics|antipyretics|mesh-ancestor
6673727|NCT01564680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6673728|NCT01564680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6673729|NCT01564680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6673730|NCT01564810|Cetuximab|cetuximab|mesh-list
6673731|NCT01564810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6673732|NCT01564810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6673733|NCT01564823|Metronidazole|metronidazole|mesh-list
6673734|NCT01564823|Adalimumab|adalimumab|mesh-list
6673735|NCT01564823|Azathioprine|azathioprine|mesh-list
6673736|NCT01564823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5783539|NCT02839694|Sensory System Agents|sensory system agents|mesh-ancestor
5783540|NCT02839694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6673737|NCT01564823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6673738|NCT01564823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6673739|NCT01564823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6673740|NCT01564823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6673741|NCT01564823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6673742|NCT01564823|Antimetabolites|antimetabolites|mesh-ancestor
5783541|NCT02839694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783542|NCT02839694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5783543|NCT02839694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5783544|NCT02839694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5783545|NCT02839694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5783546|NCT02839694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5783547|NCT02839694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783548|NCT02839694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5783549|NCT02839694|Antimetabolites|antimetabolites|mesh-ancestor
5783550|NCT02839694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5783551|NCT02839785|Ibuprofen|ibuprofen|mesh-list
5783552|NCT02839785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5783553|NCT02839785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5783554|NCT02839785|Analgesics|analgesics|mesh-ancestor
5783555|NCT02839785|Sensory System Agents|sensory system agents|mesh-ancestor
5783556|NCT02839785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5783557|NCT02839785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783558|NCT02839785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5783559|NCT02839785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5783560|NCT02839785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5783561|NCT02839785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5783562|NCT02839785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783563|NCT02839668|Acetaminophen|acetaminophen|mesh-list
5783564|NCT02839668|Lidocaine|lidocaine|mesh-list
5783565|NCT02839668|Atropine|atropine|mesh-list
5783566|NCT02839668|Tramadol|tramadol|mesh-list
5783567|NCT02839668|Sevoflurane|sevoflurane|mesh-list
5783568|NCT02839668|Neostigmine|neostigmine|mesh-list
5783569|NCT02839668|Anesthetics, Local|anesthetics, local|mesh-ancestor
5783570|NCT02839668|Anesthetics|anesthetics|mesh-ancestor
5783571|NCT02839668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5783572|NCT02839668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783573|NCT02839668|Sensory System Agents|sensory system agents|mesh-ancestor
5783574|NCT02839668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5783575|NCT02839668|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5783576|NCT02839668|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5783577|NCT02839668|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5783578|NCT02839668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5783579|NCT02839668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783580|NCT02839668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5783581|NCT02839668|Analgesics|analgesics|mesh-ancestor
5783582|NCT02839668|Antipyretics|antipyretics|mesh-ancestor
5783583|NCT02839668|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5783584|NCT02839668|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5783585|NCT02839668|Anesthetics, General|anesthetics, general|mesh-ancestor
5783586|NCT02839668|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5783587|NCT02839668|Narcotics|narcotics|mesh-ancestor
5783588|NCT02839668|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5783589|NCT02839668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5783590|NCT02839668|Autonomic Agents|autonomic agents|mesh-ancestor
5783591|NCT02839668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5783592|NCT02839668|Respiratory System Agents|respiratory system agents|mesh-ancestor
5783593|NCT02839668|Mydriatics|mydriatics|mesh-ancestor
5783594|NCT02839668|Parasympatholytics|parasympatholytics|mesh-ancestor
5783595|NCT02839668|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5783596|NCT02839668|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5783597|NCT02839668|Cholinergic Agents|cholinergic agents|mesh-ancestor
5783598|NCT02839668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5783599|NCT02839668|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5783600|NCT02839668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5783601|NCT02839668|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5783602|NCT02839642|Rivastigmine|rivastigmine|mesh-list
5783603|NCT02839642|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5783604|NCT02839642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6673743|NCT01564823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673744|NCT01564823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6673745|NCT01564823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6673746|NCT01564823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6673747|NCT01564823|Immunologic Factors|immunologic factors|mesh-ancestor
6673748|NCT01564823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783605|NCT02839642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783606|NCT02839642|Cholinergic Agents|cholinergic agents|mesh-ancestor
5783607|NCT02839642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5783608|NCT02839642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783609|NCT02839642|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5783610|NCT02839642|Protective Agents|protective agents|mesh-ancestor
5783611|NCT02839538|Anesthetics|anesthetics|mesh-list
5783612|NCT02839538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5783613|NCT02839538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783614|NCT02839421|Moxifloxacin|moxifloxacin|mesh-list
5783615|NCT02839421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5783616|NCT02839421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6673749|NCT01564836|Imatinib Mesylate|imatinib mesylate|mesh-list
6673750|NCT01564836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6673751|NCT01564836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6673752|NCT01564836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6675581|NCT01576419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5783617|NCT02839421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5783618|NCT02839421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5783619|NCT02839421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5783620|NCT02839421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783621|NCT02839421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5783622|NCT02839356|Epinephrine|epinephrine|mesh-list
5783623|NCT02839356|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5783624|NCT02839356|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5783625|NCT02839356|Adrenergic Agents|adrenergic agents|mesh-ancestor
5783626|NCT02839356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5783627|NCT02839356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783628|NCT02839356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783629|NCT02839356|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5783630|NCT02839356|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5783631|NCT02839356|Autonomic Agents|autonomic agents|mesh-ancestor
5783632|NCT02839356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5783633|NCT02839356|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5783634|NCT02839356|Respiratory System Agents|respiratory system agents|mesh-ancestor
5783635|NCT02839356|Mydriatics|mydriatics|mesh-ancestor
5783636|NCT02839356|Sympathomimetics|sympathomimetics|mesh-ancestor
5783637|NCT02839356|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5783638|NCT02839408|Azithromycin|azithromycin|mesh-list
5783639|NCT02839408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5783640|NCT02839408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5783641|NCT02839239|Vitamin D|vitamin d|mesh-list
5783642|NCT02839239|Ergocalciferols|ergocalciferols|mesh-list
5783643|NCT02839239|Cholecalciferol|cholecalciferol|mesh-list
5783644|NCT02839239|Vitamins|vitamins|mesh-list
5783645|NCT02839239|Micronutrients|micronutrients|mesh-ancestor
5783646|NCT02839239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783647|NCT02839239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5783648|NCT02839239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5783649|NCT02839213|Scopolamine|scopolamine|mesh-list
5783650|NCT02839213|Bromides|bromides|mesh-list
5783651|NCT02839213|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
5783652|NCT02839213|Anticonvulsants|anticonvulsants|mesh-ancestor
5783653|NCT02839213|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5783654|NCT02839213|Antiemetics|antiemetics|mesh-ancestor
5783655|NCT02839213|Autonomic Agents|autonomic agents|mesh-ancestor
5783656|NCT02839213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5783657|NCT02839213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783658|NCT02839213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5783659|NCT02839213|Mydriatics|mydriatics|mesh-ancestor
5783660|NCT02839213|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5783661|NCT02839213|Cholinergic Agents|cholinergic agents|mesh-ancestor
5783662|NCT02839213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5783663|NCT02839213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783664|NCT02839213|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5783665|NCT02839213|Parasympatholytics|parasympatholytics|mesh-ancestor
5783666|NCT02839161|Aluminum Hydroxide|aluminum hydroxide|mesh-list
5783667|NCT02839161|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5783668|NCT02839161|Immunologic Factors|immunologic factors|mesh-ancestor
5783669|NCT02839161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783670|NCT02839161|Antacids|antacids|mesh-ancestor
5783671|NCT02839161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783672|NCT02839161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5783673|NCT02839486|Vancomycin|vancomycin|mesh-list
5783674|NCT02839486|Cefoxitin|cefoxitin|mesh-list
5783675|NCT02839486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5783676|NCT02839486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5783677|NCT02839122|Tadalafil|tadalafil|mesh-list
5783678|NCT02839122|Dutasteride|dutasteride|mesh-list
5783679|NCT02839122|Vasodilator Agents|vasodilator agents|mesh-ancestor
5783680|NCT02839122|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5783681|NCT02839122|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5783682|NCT02839122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5783683|NCT02839122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783684|NCT02839122|Urological Agents|urological agents|mesh-ancestor
5783685|NCT02839122|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
5783686|NCT02839122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5783687|NCT02839122|Hormone Antagonists|hormone antagonists|mesh-ancestor
5783688|NCT02839122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5783689|NCT02839122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783690|NCT02839135|Scopolamine|scopolamine|mesh-list
5783691|NCT02839135|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
5783692|NCT02839135|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5783693|NCT02839135|Antiemetics|antiemetics|mesh-ancestor
5783694|NCT02839135|Autonomic Agents|autonomic agents|mesh-ancestor
5783695|NCT02839135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5783696|NCT02839135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783697|NCT02839135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5783698|NCT02839135|Mydriatics|mydriatics|mesh-ancestor
5783699|NCT02839135|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5783700|NCT02839135|Cholinergic Agents|cholinergic agents|mesh-ancestor
5783701|NCT02839135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5783702|NCT02839135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783703|NCT02839135|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5783704|NCT02839135|Parasympatholytics|parasympatholytics|mesh-ancestor
5783705|NCT02838823|Antibodies|antibodies|mesh-list
5783706|NCT02838823|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5783707|NCT02838823|Immunologic Factors|immunologic factors|mesh-ancestor
5783708|NCT02838823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783709|NCT02838992|Cyclosporine|cyclosporine|mesh-list
5783710|NCT02838992|Cyclophosphamide|cyclophosphamide|mesh-list
5783711|NCT02838992|Cyclosporins|cyclosporins|mesh-list
5783712|NCT02838992|Thymoglobulin|thymoglobulin|mesh-list
5783713|NCT02838992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5783714|NCT02838992|Immunologic Factors|immunologic factors|mesh-ancestor
5783715|NCT02838992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783716|NCT02838992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5783717|NCT02838992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5783718|NCT02838992|Alkylating Agents|alkylating agents|mesh-ancestor
5783719|NCT02838992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783720|NCT02838992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5783721|NCT02838992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5783722|NCT02838992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5783723|NCT02838992|Antifungal Agents|antifungal agents|mesh-ancestor
5783724|NCT02838992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5783725|NCT02838992|Dermatologic Agents|dermatologic agents|mesh-ancestor
5783726|NCT02838992|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5783727|NCT02838745|Pemetrexed|pemetrexed|mesh-list
5783728|NCT02838745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5783729|NCT02838745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5783730|NCT02838745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783731|NCT02838745|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5783732|NCT02838745|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5783733|NCT02839044|Vitamin K 2|vitamin k 2|mesh-list
5783734|NCT02839044|Vitamin K|vitamin k|mesh-list
5783735|NCT02839044|Vitamin MK 7|vitamin mk 7|mesh-list
5783736|NCT02839044|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5783737|NCT02839044|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5783738|NCT02839044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783739|NCT02839044|Hemostatics|hemostatics|mesh-ancestor
5783740|NCT02839044|Coagulants|coagulants|mesh-ancestor
5783741|NCT02839044|Vitamins|vitamins|mesh-ancestor
5783742|NCT02839044|Micronutrients|micronutrients|mesh-ancestor
5783743|NCT02839044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783744|NCT02838940|Cefazolin|cefazolin|mesh-list
5783745|NCT02838940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5783746|NCT02838940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5898021|NCT04347616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5898022|NCT04347616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5898023|NCT04347616|Antiviral Agents|antiviral agents|mesh-ancestor
5898024|NCT04347616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5898025|NCT04333706|Capecitabine|capecitabine|mesh-list
5898026|NCT04333706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5898027|NCT04333706|Antimetabolites|antimetabolites|mesh-ancestor
6210757|NCT02164513|Bromides|bromides|mesh-list
5783747|NCT02838758|Lidocaine|lidocaine|mesh-list
5783748|NCT02838758|Anesthetics, Local|anesthetics, local|mesh-ancestor
5783749|NCT02838758|Anesthetics|anesthetics|mesh-ancestor
5783750|NCT02838758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5783751|NCT02838758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783752|NCT02838758|Sensory System Agents|sensory system agents|mesh-ancestor
5783753|NCT02838758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5783754|NCT02838758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5783755|NCT02838758|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5783756|NCT02838758|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5783757|NCT02838758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5783758|NCT02838758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783759|NCT02838719|Dexamethasone|dexamethasone|mesh-list
5783760|NCT02838719|Dexamethasone acetate|dexamethasone acetate|mesh-list
5783761|NCT02838719|BB 1101|bb 1101|mesh-list
5783762|NCT02838719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5783763|NCT02838719|Antiemetics|antiemetics|mesh-ancestor
5783764|NCT02838719|Autonomic Agents|autonomic agents|mesh-ancestor
5783765|NCT02838719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5783766|NCT02838719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783767|NCT02838719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5783768|NCT02838719|Glucocorticoids|glucocorticoids|mesh-ancestor
5783769|NCT02838719|Hormones|hormones|mesh-ancestor
5783770|NCT02838719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5783771|NCT02838719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5783772|NCT02838719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5783773|NCT02838719|Protease Inhibitors|protease inhibitors|mesh-ancestor
5783774|NCT02838719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5783775|NCT02838719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783776|NCT02838537|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-list
5783777|NCT02838537|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5783778|NCT02838537|Serotonin Agents|serotonin agents|mesh-ancestor
5783779|NCT02838537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5783780|NCT02838537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783781|NCT02838537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783782|NCT02838589|Exenatide|exenatide|mesh-list
5783783|NCT02838589|Glucagon|glucagon|mesh-list
5783784|NCT02838589|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5783785|NCT02838589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5783786|NCT02838589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783787|NCT02838589|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5783788|NCT02838589|Incretins|incretins|mesh-ancestor
5783789|NCT02838589|Hormones|hormones|mesh-ancestor
5783790|NCT02838589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5783791|NCT02838589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5783792|NCT02838576|Estrogens|estrogens|mesh-list
5783793|NCT02838576|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
5783794|NCT02838576|Hormones|hormones|mesh-ancestor
5783795|NCT02838576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5783796|NCT02838576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783797|NCT02838472|Ascorbic Acid|ascorbic acid|mesh-list
5783798|NCT02838472|Vitamins|vitamins|mesh-ancestor
5783799|NCT02838472|Micronutrients|micronutrients|mesh-ancestor
5783800|NCT02838472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783801|NCT02838472|Antioxidants|antioxidants|mesh-ancestor
5783802|NCT02838472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783803|NCT02838472|Protective Agents|protective agents|mesh-ancestor
5783804|NCT02838238|Capecitabine|capecitabine|mesh-list
5783805|NCT02838238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5783806|NCT02838238|Antimetabolites|antimetabolites|mesh-ancestor
5783807|NCT02838238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783808|NCT02838238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5783809|NCT02838329|Ropivacaine|ropivacaine|mesh-list
5783810|NCT02838329|Anesthetics, Local|anesthetics, local|mesh-ancestor
5783811|NCT02838329|Anesthetics|anesthetics|mesh-ancestor
5783812|NCT02838329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5783813|NCT02838329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783814|NCT02838329|Sensory System Agents|sensory system agents|mesh-ancestor
5783815|NCT02838329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5783816|NCT02838342|Interferons|interferons|mesh-list
5783817|NCT02838342|Interferon-alpha|interferon-alpha|mesh-list
5783818|NCT02838342|Cyclophosphamide|cyclophosphamide|mesh-list
5783819|NCT02838342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5783820|NCT02838342|Immunologic Factors|immunologic factors|mesh-ancestor
5783821|NCT02838342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783822|NCT02838342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5783823|NCT02838342|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5783824|NCT02838342|Alkylating Agents|alkylating agents|mesh-ancestor
5783825|NCT02838342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783826|NCT02838342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5783827|NCT02838342|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5783828|NCT02838342|Antiviral Agents|antiviral agents|mesh-ancestor
5783829|NCT02838342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5783830|NCT02838615|Dexamethasone|dexamethasone|mesh-list
5783831|NCT02838615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5783832|NCT02838615|Antiemetics|antiemetics|mesh-ancestor
5783833|NCT02838615|Autonomic Agents|autonomic agents|mesh-ancestor
5783834|NCT02838615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5783835|NCT02838615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783836|NCT02838615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5783837|NCT02838615|Glucocorticoids|glucocorticoids|mesh-ancestor
5783838|NCT02838615|Hormones|hormones|mesh-ancestor
5783839|NCT02838615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5783840|NCT02838615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5783841|NCT02838615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5783842|NCT02838225|Cyclophosphamide|cyclophosphamide|mesh-list
5783843|NCT02838225|Docetaxel|docetaxel|mesh-list
5783844|NCT02838225|Doxorubicin|doxorubicin|mesh-list
5783845|NCT02838225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5783846|NCT02838225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5783847|NCT02838225|Immunologic Factors|immunologic factors|mesh-ancestor
5783848|NCT02838225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783849|NCT02838225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5783850|NCT02838225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5783851|NCT02838225|Alkylating Agents|alkylating agents|mesh-ancestor
5783852|NCT02838225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783853|NCT02838225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5783854|NCT02838225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5783855|NCT02838225|Tubulin Modulators|tubulin modulators|mesh-ancestor
5783856|NCT02838225|Antimitotic Agents|antimitotic agents|mesh-ancestor
5783857|NCT02838225|Mitosis Modulators|mitosis modulators|mesh-ancestor
5783858|NCT02838225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5783859|NCT02838225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5783860|NCT02838225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5783861|NCT02838225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5783862|NCT02838264|Itraconazole|itraconazole|mesh-list
5783863|NCT02838264|Antifungal Agents|antifungal agents|mesh-ancestor
5783864|NCT02838264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5783865|NCT02838264|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5783866|NCT02838264|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5783867|NCT02838264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5783868|NCT02838264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783869|NCT02838264|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5783870|NCT02838264|Hormone Antagonists|hormone antagonists|mesh-ancestor
5783871|NCT02838264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5783872|NCT02838264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783873|NCT02838264|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5783874|NCT02837978|Methotrexate|methotrexate|mesh-list
5783875|NCT02837978|Tacrolimus|tacrolimus|mesh-list
5783876|NCT02837978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5783877|NCT02837978|Abortifacient Agents|abortifacient agents|mesh-ancestor
5783878|NCT02837978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5783879|NCT02837978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783880|NCT02837978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5783881|NCT02837978|Antimetabolites|antimetabolites|mesh-ancestor
5783882|NCT02837978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783883|NCT02837978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5783884|NCT02837978|Dermatologic Agents|dermatologic agents|mesh-ancestor
5783885|NCT02837978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5783886|NCT02837978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5783887|NCT02837978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5783888|NCT02837978|Immunologic Factors|immunologic factors|mesh-ancestor
5783889|NCT02837978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5783890|NCT02837978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5783891|NCT02837978|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5783892|NCT02838121|Zoledronic Acid|zoledronic acid|mesh-list
5783893|NCT02838121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5783894|NCT02838121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783895|NCT02837965|Doxycycline|doxycycline|mesh-list
5783896|NCT02837965|Prednisone|prednisone|mesh-list
5783897|NCT02837965|Methotrexate|methotrexate|mesh-list
5783898|NCT02837965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5783899|NCT02837965|Glucocorticoids|glucocorticoids|mesh-ancestor
5783900|NCT02837965|Hormones|hormones|mesh-ancestor
5783901|NCT02837965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5783902|NCT02837965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783903|NCT02837965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5783904|NCT02837965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5783905|NCT02837965|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5783906|NCT02837965|Abortifacient Agents|abortifacient agents|mesh-ancestor
5783907|NCT02837965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5783908|NCT02837965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5783909|NCT02837965|Antimetabolites|antimetabolites|mesh-ancestor
5783910|NCT02837965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783911|NCT02837965|Dermatologic Agents|dermatologic agents|mesh-ancestor
5783912|NCT02837965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5783913|NCT02837965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5783914|NCT02837965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5783915|NCT02837965|Immunologic Factors|immunologic factors|mesh-ancestor
5783916|NCT02837965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5783917|NCT02837965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5783918|NCT02837965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5783919|NCT02837965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5783920|NCT02837965|Antimalarials|antimalarials|mesh-ancestor
5783921|NCT02837965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5783922|NCT02837965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5783923|NCT02838173|Ropivacaine|ropivacaine|mesh-list
5783924|NCT02838173|Anesthetics, Local|anesthetics, local|mesh-ancestor
5783925|NCT02838173|Anesthetics|anesthetics|mesh-ancestor
5783926|NCT02838173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5783927|NCT02838173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783928|NCT02838173|Sensory System Agents|sensory system agents|mesh-ancestor
5783929|NCT02838173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5783930|NCT02837874|Antidiarrheals|antidiarrheals|mesh-list
5783931|NCT02837874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5783932|NCT02838030|Aspirin|aspirin|mesh-list
5783933|NCT02838030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5783934|NCT02838030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5783935|NCT02838030|Analgesics|analgesics|mesh-ancestor
5783936|NCT02838030|Sensory System Agents|sensory system agents|mesh-ancestor
5783937|NCT02838030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5783938|NCT02838030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783939|NCT02838030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5783940|NCT02838030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5783941|NCT02838030|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5783942|NCT02838030|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5783943|NCT02838030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783944|NCT02838030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5783945|NCT02838030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6491190|NCT00601536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6491191|NCT00601536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491192|NCT00601536|Antimanic Agents|antimanic agents|mesh-ancestor
6491193|NCT00601536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6491194|NCT00601536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6491195|NCT00601536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491196|NCT00601562|Zidovudine|zidovudine|mesh-list
6491197|NCT00601562|Antimetabolites|antimetabolites|mesh-ancestor
6491198|NCT00601562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675582|NCT01576419|Analgesics|analgesics|mesh-ancestor
5783946|NCT02838030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5783947|NCT02838030|Antipyretics|antipyretics|mesh-ancestor
5783948|NCT02837835|Ceftazidime|ceftazidime|mesh-list
5783949|NCT02837835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5783950|NCT02837835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5783951|NCT02837614|Acetaminophen|acetaminophen|mesh-list
5783952|NCT02837614|Amoxicillin|amoxicillin|mesh-list
6673753|NCT01564836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673754|NCT01564979|Botulinum Toxins|botulinum toxins|mesh-list
6673755|NCT01564979|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6673756|NCT01564979|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6673757|NCT01564979|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6673758|NCT01564979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6673759|NCT01564979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673760|NCT01564979|Cholinergic Agents|cholinergic agents|mesh-ancestor
6673761|NCT01564979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6673762|NCT01564979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783953|NCT02837614|Dexamethasone|dexamethasone|mesh-list
5783954|NCT02837614|Dexamethasone acetate|dexamethasone acetate|mesh-list
5783955|NCT02837614|BB 1101|bb 1101|mesh-list
5783956|NCT02837614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5783957|NCT02837614|Antiemetics|antiemetics|mesh-ancestor
5783958|NCT02837614|Autonomic Agents|autonomic agents|mesh-ancestor
5783959|NCT02837614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5783960|NCT02837614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783961|NCT02837614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5783962|NCT02837614|Glucocorticoids|glucocorticoids|mesh-ancestor
5783963|NCT02837614|Hormones|hormones|mesh-ancestor
5783964|NCT02837614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5783965|NCT02837614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5783966|NCT02837614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5783967|NCT02837614|Protease Inhibitors|protease inhibitors|mesh-ancestor
5783968|NCT02837614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5783969|NCT02837614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783970|NCT02837614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5783971|NCT02837614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5783972|NCT02837614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5783973|NCT02837614|Analgesics|analgesics|mesh-ancestor
5783974|NCT02837614|Sensory System Agents|sensory system agents|mesh-ancestor
5783975|NCT02837614|Antipyretics|antipyretics|mesh-ancestor
5783976|NCT02837640|Levodopa|levodopa|mesh-list
5783977|NCT02837640|Carbidopa|carbidopa|mesh-list
5783978|NCT02837640|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
5783979|NCT02837640|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5783980|NCT02837640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5783981|NCT02837640|Dopamine Agents|dopamine agents|mesh-ancestor
5783982|NCT02837640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5783983|NCT02837640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5783984|NCT02837640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5783985|NCT02837640|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5783986|NCT02837640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5783987|NCT02837640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5783988|NCT02837640|Immunologic Factors|immunologic factors|mesh-ancestor
5783989|NCT02837640|Dopamine Agonists|dopamine agonists|mesh-ancestor
5783990|NCT02837770|Diclofenac|diclofenac|mesh-list
5783991|NCT02837770|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6491199|NCT00601562|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6491200|NCT00601562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6491201|NCT00601562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6491202|NCT00601562|Antiviral Agents|antiviral agents|mesh-ancestor
6491203|NCT00601562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5783992|NCT02837770|Lubricant Eye Drops|lubricant eye drops|mesh-list
5783993|NCT02837770|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5783994|NCT02837770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5783995|NCT02837770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5783996|NCT02837770|Analgesics|analgesics|mesh-ancestor
5783997|NCT02837770|Sensory System Agents|sensory system agents|mesh-ancestor
5783998|NCT02837770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5783999|NCT02837770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491204|NCT00601562|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6491205|NCT00601562|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6491206|NCT00601575|Lithium Carbonate|lithium carbonate|mesh-list
6491207|NCT00601575|Antidepressive Agents|antidepressive agents|mesh-ancestor
6491208|NCT00601575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6491209|NCT00601575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6212594|NCT02191033|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5784000|NCT02837770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5784001|NCT02837770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5784002|NCT02837770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5784003|NCT02837770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5784004|NCT02837770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784005|NCT02837263|Pembrolizumab|pembrolizumab|mesh-list
5784006|NCT02837263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5784007|NCT02837263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5784008|NCT02837146|Methotrexate|methotrexate|mesh-list
5784009|NCT02837146|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5784010|NCT02837146|Abortifacient Agents|abortifacient agents|mesh-ancestor
5784011|NCT02837146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5784012|NCT02837146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784013|NCT02837146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5784014|NCT02837146|Antimetabolites|antimetabolites|mesh-ancestor
5784015|NCT02837146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784016|NCT02837146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5784017|NCT02837146|Dermatologic Agents|dermatologic agents|mesh-ancestor
5784018|NCT02837146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5784019|NCT02837146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5784020|NCT02837146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5784021|NCT02837146|Immunologic Factors|immunologic factors|mesh-ancestor
5784022|NCT02837146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5784023|NCT02837146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5784024|NCT02837081|Anti-Infective Agents|anti-infective agents|mesh-list
5784025|NCT02837081|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5898028|NCT04333706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491210|NCT00601575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898029|NCT04333706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5898030|NCT04331002|Triamcinolone|triamcinolone|mesh-list
5898031|NCT04331002|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5898032|NCT04331002|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5898033|NCT04331002|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5898034|NCT04331002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5898035|NCT04331002|Glucocorticoids|glucocorticoids|mesh-ancestor
5898036|NCT04331002|Hormones|hormones|mesh-ancestor
5898037|NCT04331002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5898038|NCT04331002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898039|NCT04331002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5898040|NCT04331002|Immunologic Factors|immunologic factors|mesh-ancestor
5898041|NCT04331002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5898042|NCT04331002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898043|NCT04273139|Venetoclax|venetoclax|mesh-list
5898044|NCT04273139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5898045|NCT04245839|Cyclophosphamide|cyclophosphamide|mesh-list
5898046|NCT04245839|Fludarabine|fludarabine|mesh-list
5898047|NCT04245839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5898048|NCT04245839|Immunologic Factors|immunologic factors|mesh-ancestor
5898049|NCT04245839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898050|NCT04245839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5898051|NCT04245839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5898052|NCT04245839|Alkylating Agents|alkylating agents|mesh-ancestor
5898053|NCT04245839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898054|NCT04245839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5898055|NCT04245839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5898056|NCT04235205|Cholestyramine Resin|cholestyramine resin|mesh-list
5898057|NCT04235205|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5898058|NCT04235205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5898059|NCT04235205|Antimetabolites|antimetabolites|mesh-ancestor
5898060|NCT04235205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898061|NCT04235205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5898062|NCT04218409|Oxycodone|oxycodone|mesh-list
5898063|NCT04218409|Oxytocin|oxytocin|mesh-list
5898064|NCT04218409|Oxytocics|oxytocics|mesh-ancestor
5898065|NCT04218409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5898066|NCT04218409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898067|NCT04218409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6491211|NCT00601575|Antimanic Agents|antimanic agents|mesh-ancestor
6491212|NCT00601575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6491213|NCT00601575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6491214|NCT00601575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491215|NCT00601588|Sertraline|sertraline|mesh-list
6491216|NCT00601588|Antidepressive Agents|antidepressive agents|mesh-ancestor
6491217|NCT00601588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5784026|NCT02837042|Pembrolizumab|pembrolizumab|mesh-list
5784027|NCT02837042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5784028|NCT02837042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5784029|NCT02837185|Botulinum Toxins|botulinum toxins|mesh-list
5784030|NCT02837185|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5784031|NCT02837185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5784032|NCT02837185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784033|NCT02837185|Cholinergic Agents|cholinergic agents|mesh-ancestor
5784034|NCT02837185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5784035|NCT02837185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784036|NCT02837198|Dotinurad|dotinurad|mesh-list
5784037|NCT02837198|FYX-051|fyx-051|mesh-list
5784038|NCT02837198|Uricosuric Agents|uricosuric agents|mesh-ancestor
5784039|NCT02837198|Gout Suppressants|gout suppressants|mesh-ancestor
5784040|NCT02837198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5784041|NCT02837198|Renal Agents|renal agents|mesh-ancestor
5784042|NCT02837198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5784043|NCT02837198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784044|NCT02837094|Insulin|insulin|mesh-list
5784045|NCT02837094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5784046|NCT02837094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784047|NCT02837003|Aspirin|aspirin|mesh-list
5784048|NCT02837003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5784049|NCT02837003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5784050|NCT02837003|Analgesics|analgesics|mesh-ancestor
5784051|NCT02837003|Sensory System Agents|sensory system agents|mesh-ancestor
5784052|NCT02837003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5784053|NCT02837003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784054|NCT02837003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5784055|NCT02837003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5784056|NCT02837003|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5784057|NCT02837003|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5784058|NCT02837003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784059|NCT02837003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5784060|NCT02837003|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5784061|NCT02837003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5784062|NCT02837003|Antipyretics|antipyretics|mesh-ancestor
5784063|NCT02836977|Tegafur|tegafur|mesh-list
5784064|NCT02836977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5784065|NCT02836977|Antimetabolites|antimetabolites|mesh-ancestor
5784066|NCT02836977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784067|NCT02836977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5784068|NCT02836665|Dermatologic Agents|dermatologic agents|mesh-list
5784069|NCT02836639|Etoposide|etoposide|mesh-list
5784070|NCT02836639|Busulfan|busulfan|mesh-list
5784071|NCT02836639|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5784072|NCT02836639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5784073|NCT02836639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5784074|NCT02836639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5784075|NCT02836639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5784076|NCT02836639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5784077|NCT02836639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784078|NCT02836639|Alkylating Agents|alkylating agents|mesh-ancestor
5784079|NCT02836639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5784080|NCT02836639|Immunologic Factors|immunologic factors|mesh-ancestor
5784081|NCT02836639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784082|NCT02836639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5784083|NCT02836639|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5784084|NCT02836847|Trastuzumab|trastuzumab|mesh-list
5784085|NCT02836847|Cetuximab|cetuximab|mesh-list
5784086|NCT02836847|Everolimus|everolimus|mesh-list
5784087|NCT02836847|Sorafenib|sorafenib|mesh-list
5784088|NCT02836847|Lapatinib|lapatinib|mesh-list
5784089|NCT02836847|Gefitinib|gefitinib|mesh-list
5784090|NCT02836847|Crizotinib|crizotinib|mesh-list
5784091|NCT02836847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5784092|NCT02836847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5784093|NCT02836847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5784094|NCT02836847|Immunologic Factors|immunologic factors|mesh-ancestor
5784095|NCT02836847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784096|NCT02836847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5784097|NCT02836847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5784098|NCT02836847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784099|NCT02836821|Rifampin|rifampin|mesh-list
5784100|NCT02836821|Apatinib|apatinib|mesh-list
5784101|NCT02836821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5898068|NCT04218409|Narcotics|narcotics|mesh-ancestor
5784102|NCT02836821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5784103|NCT02836821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5784104|NCT02836821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784105|NCT02836821|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5784106|NCT02836821|Antitubercular Agents|antitubercular agents|mesh-ancestor
5784107|NCT02836821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5784108|NCT02836821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5784109|NCT02836821|Leprostatic Agents|leprostatic agents|mesh-ancestor
5784110|NCT02836821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5784111|NCT02836821|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5784112|NCT02836821|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5784113|NCT02836821|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5784114|NCT02836821|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5784115|NCT02836821|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5784116|NCT02836821|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5784117|NCT02836548|Vorinostat|vorinostat|mesh-list
5784118|NCT02836548|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
5784119|NCT02836548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5784120|NCT02836548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5784121|NCT02836548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784122|NCT02836743|Melatonin|melatonin|mesh-list
5784123|NCT02836743|Antioxidants|antioxidants|mesh-ancestor
5784124|NCT02836743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784125|NCT02836743|Protective Agents|protective agents|mesh-ancestor
5784126|NCT02836743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784127|NCT02836743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5784128|NCT02836704|Metformin|metformin|mesh-list
5784129|NCT02836704|Insulin Glargine|insulin glargine|mesh-list
5784130|NCT02836704|Acarbose|acarbose|mesh-list
5784131|NCT02836704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5784132|NCT02836704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784133|NCT02836704|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
5784134|NCT02836704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5784135|NCT02836704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784136|NCT02836795|Antibodies|antibodies|mesh-list
5784137|NCT02836795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5784138|NCT02836795|Immunologic Factors|immunologic factors|mesh-ancestor
5784139|NCT02836795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784140|NCT02836509|Acetaminophen|acetaminophen|mesh-list
5784141|NCT02836509|Ibuprofen|ibuprofen|mesh-list
5784142|NCT02836509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5784143|NCT02836509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5784144|NCT02836509|Analgesics|analgesics|mesh-ancestor
5784145|NCT02836509|Sensory System Agents|sensory system agents|mesh-ancestor
5784146|NCT02836509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5784147|NCT02836509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784148|NCT02836509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5784149|NCT02836509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5784150|NCT02836509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5784151|NCT02836509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5784152|NCT02836509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784153|NCT02836509|Antipyretics|antipyretics|mesh-ancestor
5784154|NCT02836899|Nitric Oxide|nitric oxide|mesh-list
5784155|NCT02836899|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5784156|NCT02836899|Autonomic Agents|autonomic agents|mesh-ancestor
5784157|NCT02836899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5784158|NCT02836899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784159|NCT02836899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5784160|NCT02836899|Respiratory System Agents|respiratory system agents|mesh-ancestor
5784161|NCT02836899|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5784162|NCT02836899|Antioxidants|antioxidants|mesh-ancestor
5784163|NCT02836899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784164|NCT02836899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5784165|NCT02836899|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5784166|NCT02836899|Vasodilator Agents|vasodilator agents|mesh-ancestor
5784167|NCT02836899|Gasotransmitters|gasotransmitters|mesh-ancestor
5784168|NCT02836899|Protective Agents|protective agents|mesh-ancestor
5784169|NCT02836483|Linezolid|linezolid|mesh-list
5784170|NCT02836483|Delpazolid|delpazolid|mesh-list
5784171|NCT02836483|Oxazolidinones|oxazolidinones|mesh-list
5784172|NCT02836483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5784173|NCT02836483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5784174|NCT02836483|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5784175|NCT02836483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5784176|NCT02836483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784177|NCT02836171|Itraconazole|itraconazole|mesh-list
5784178|NCT02836171|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
5784179|NCT02836171|Apatinib|apatinib|mesh-list
5784180|NCT02836171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5784181|NCT02836171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5784182|NCT02836171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5784183|NCT02836171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784184|NCT02836171|Antifungal Agents|antifungal agents|mesh-ancestor
5784185|NCT02836171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5784186|NCT02836171|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5784187|NCT02836171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5784188|NCT02836171|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5784189|NCT02836171|Hormone Antagonists|hormone antagonists|mesh-ancestor
5784190|NCT02836171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5784191|NCT02836171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784192|NCT02836171|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5784193|NCT02836288|Ketamine|ketamine|mesh-list
5784194|NCT02836288|Analgesics|analgesics|mesh-ancestor
5784195|NCT02836288|Sensory System Agents|sensory system agents|mesh-ancestor
5784196|NCT02836288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5784197|NCT02836288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784198|NCT02836288|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5784199|NCT02836288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5784200|NCT02836288|Anesthetics, General|anesthetics, general|mesh-ancestor
5784201|NCT02836288|Anesthetics|anesthetics|mesh-ancestor
5784202|NCT02836288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5784203|NCT02836288|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5784204|NCT02836288|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5784205|NCT02836288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5784206|NCT02836288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784207|NCT02836184|Niacin|niacin|mesh-list
5784208|NCT02836184|Nicotinic Acids|nicotinic acids|mesh-list
5784209|NCT02836184|Niacinamide|niacinamide|mesh-list
5784210|NCT02836184|Calcium Carbonate|calcium carbonate|mesh-list
5784211|NCT02836184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784212|NCT02836184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5784213|NCT02836184|Antimetabolites|antimetabolites|mesh-ancestor
5784214|NCT02836184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784215|NCT02836184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5784216|NCT02836184|Vasodilator Agents|vasodilator agents|mesh-ancestor
5784217|NCT02836184|Vitamin B Complex|vitamin b complex|mesh-ancestor
5784218|NCT02836184|Vitamins|vitamins|mesh-ancestor
5784219|NCT02836184|Micronutrients|micronutrients|mesh-ancestor
5784220|NCT02836184|Antacids|antacids|mesh-ancestor
5784221|NCT02836184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5784222|NCT02836353|Rifaximin|rifaximin|mesh-list
5784223|NCT02836353|Somatostatin|somatostatin|mesh-list
5784224|NCT02836353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5784225|NCT02836353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5784226|NCT02836353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5784227|NCT02836353|Hormones|hormones|mesh-ancestor
5784228|NCT02836353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5784229|NCT02836353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784230|NCT02836431|Dexmedetomidine|dexmedetomidine|mesh-list
5784231|NCT02836431|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5784232|NCT02836431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5784233|NCT02836431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784234|NCT02836431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5784235|NCT02836431|Analgesics|analgesics|mesh-ancestor
5784236|NCT02836431|Sensory System Agents|sensory system agents|mesh-ancestor
5784237|NCT02836431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5784238|NCT02836431|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5784239|NCT02836431|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5784240|NCT02836431|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5784241|NCT02836431|Adrenergic Agents|adrenergic agents|mesh-ancestor
5784242|NCT02836431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5784243|NCT02836431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784244|NCT02835794|Azacitidine|azacitidine|mesh-list
5784245|NCT02835794|Homoharringtonine|homoharringtonine|mesh-list
5784246|NCT02835794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5784247|NCT02835794|Antimetabolites|antimetabolites|mesh-ancestor
6491218|NCT00601588|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6491219|NCT00601588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5784248|NCT02835794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784249|NCT02835794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5784250|NCT02835794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5784251|NCT02835794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5784252|NCT02835794|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5784253|NCT02836028|Temozolomide|temozolomide|mesh-list
5784254|NCT02836028|Talazoparib|talazoparib|mesh-list
5784255|NCT02836028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5784256|NCT02836028|Alkylating Agents|alkylating agents|mesh-ancestor
5784257|NCT02836028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784258|NCT02836028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5784259|NCT02836028|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5784260|NCT02836028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5784261|NCT02835833|Bevacizumab|bevacizumab|mesh-list
5784262|NCT02835833|Nintedanib|nintedanib|mesh-list
5784263|NCT02835833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5784264|NCT02835833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5784265|NCT02835833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5784266|NCT02835833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5784267|NCT02835833|Growth Substances|growth substances|mesh-ancestor
5784268|NCT02835833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784269|NCT02835833|Growth Inhibitors|growth inhibitors|mesh-ancestor
5784270|NCT02835833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5784271|NCT02835833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5784272|NCT02835833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784273|NCT02836002|Pyrimethamine|pyrimethamine|mesh-list
5784274|NCT02836002|Piperaquine|piperaquine|mesh-list
5784275|NCT02836002|Sulfadoxine|sulfadoxine|mesh-list
5784276|NCT02836002|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
5784277|NCT02836002|Atovaquone|atovaquone|mesh-list
5784278|NCT02836002|Proguanil|proguanil|mesh-list
5784279|NCT02836002|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
5784280|NCT02836002|Antimalarials|antimalarials|mesh-ancestor
5784281|NCT02836002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5784282|NCT02836002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5784283|NCT02836002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5784284|NCT02836002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5784285|NCT02836002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5784286|NCT02836002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784287|NCT02836002|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5784288|NCT02836002|Renal Agents|renal agents|mesh-ancestor
5784289|NCT02836002|Antimetabolites|antimetabolites|mesh-ancestor
5784290|NCT02835742|Sargramostim|sargramostim|mesh-list
5784291|NCT02835742|Immunologic Factors|immunologic factors|mesh-ancestor
5784292|NCT02835742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898069|NCT04218409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5898070|NCT04218409|Analgesics|analgesics|mesh-ancestor
5898071|NCT04218409|Sensory System Agents|sensory system agents|mesh-ancestor
5898072|NCT04218409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5898073|NCT04209868|Bupivacaine|bupivacaine|mesh-list
5898074|NCT04209868|Levobupivacaine|levobupivacaine|mesh-list
5898075|NCT04209868|Anesthetics, Local|anesthetics, local|mesh-ancestor
5898076|NCT04209868|Anesthetics|anesthetics|mesh-ancestor
5898077|NCT04209868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5898078|NCT04209868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898079|NCT04209868|Sensory System Agents|sensory system agents|mesh-ancestor
5898080|NCT04209868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5898081|NCT04209504|Bupivacaine|bupivacaine|mesh-list
5898082|NCT04209504|Ropivacaine|ropivacaine|mesh-list
5898083|NCT04209504|Anesthetics, Local|anesthetics, local|mesh-ancestor
5898084|NCT04209504|Anesthetics|anesthetics|mesh-ancestor
5898085|NCT04209504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5898086|NCT04209504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898087|NCT04209504|Sensory System Agents|sensory system agents|mesh-ancestor
5898088|NCT04209504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5898089|NCT04167176|Lidocaine|lidocaine|mesh-list
5898090|NCT04167176|Bupivacaine|bupivacaine|mesh-list
5898091|NCT04167176|Anesthetics, Local|anesthetics, local|mesh-ancestor
5898092|NCT04167176|Anesthetics|anesthetics|mesh-ancestor
5898093|NCT04167176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5898094|NCT04167176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898095|NCT04167176|Sensory System Agents|sensory system agents|mesh-ancestor
5898096|NCT04167176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5898097|NCT04167176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5898098|NCT04167176|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5784293|NCT02835729|Cytarabine|cytarabine|mesh-list
5784294|NCT02835729|Idarubicin|idarubicin|mesh-list
5784295|NCT02835729|Tryptophan|tryptophan|mesh-list
5784296|NCT02835729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5784297|NCT02835729|Antimetabolites|antimetabolites|mesh-ancestor
5784298|NCT02835729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784299|NCT02835729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5784300|NCT02835729|Antiviral Agents|antiviral agents|mesh-ancestor
5784301|NCT02835729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5784302|NCT02835729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5784303|NCT02835729|Immunologic Factors|immunologic factors|mesh-ancestor
5784304|NCT02835729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784305|NCT02835729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5784306|NCT02835729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5784307|NCT02835729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5784308|NCT02835729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5784309|NCT02835729|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5784310|NCT02835729|Antidepressive Agents|antidepressive agents|mesh-ancestor
5784311|NCT02835729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5784312|NCT02835716|Ustekinumab|ustekinumab|mesh-list
5784313|NCT02835716|Dermatologic Agents|dermatologic agents|mesh-ancestor
5784314|NCT02835651|Palmitic Acid|palmitic acid|mesh-list
5784315|NCT02835651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5784316|NCT02835651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784317|NCT02835469|Menotropins|menotropins|mesh-list
5784318|NCT02835469|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5784319|NCT02835469|Fertility Agents|fertility agents|mesh-ancestor
5784320|NCT02835469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5784321|NCT02835469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784322|NCT02835664|Niacinamide|niacinamide|mesh-list
5784323|NCT02835664|Niacin|niacin|mesh-list
5784324|NCT02835664|Nicotinic Acids|nicotinic acids|mesh-list
5784325|NCT02835664|Vitamin B Complex|vitamin b complex|mesh-ancestor
5784326|NCT02835664|Vitamins|vitamins|mesh-ancestor
5784327|NCT02835664|Micronutrients|micronutrients|mesh-ancestor
5784328|NCT02835664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784329|NCT02835664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5784330|NCT02835664|Antimetabolites|antimetabolites|mesh-ancestor
5784331|NCT02835664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784332|NCT02835664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5784333|NCT02835664|Vasodilator Agents|vasodilator agents|mesh-ancestor
5784334|NCT02835586|Paclitaxel|paclitaxel|mesh-list
5784335|NCT02835586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5784336|NCT02835586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5784337|NCT02835586|Tubulin Modulators|tubulin modulators|mesh-ancestor
5784338|NCT02835586|Antimitotic Agents|antimitotic agents|mesh-ancestor
5784339|NCT02835586|Mitosis Modulators|mitosis modulators|mesh-ancestor
5784340|NCT02835586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491220|NCT00601588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6491221|NCT00601588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491222|NCT00601588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6491223|NCT00601588|Serotonin Agents|serotonin agents|mesh-ancestor
6491224|NCT00601588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784341|NCT02835521|Triamcinolone|triamcinolone|mesh-list
5784342|NCT02835521|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5784343|NCT02835521|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5784344|NCT02835521|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5784345|NCT02835521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5784346|NCT02835521|Glucocorticoids|glucocorticoids|mesh-ancestor
5784347|NCT02835521|Hormones|hormones|mesh-ancestor
5784348|NCT02835521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5784349|NCT02835521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784350|NCT02835521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5784351|NCT02835521|Immunologic Factors|immunologic factors|mesh-ancestor
5784352|NCT02835521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5784353|NCT02835521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784354|NCT02835534|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5784355|NCT02835534|Plasminogen|plasminogen|mesh-list
5784356|NCT02835534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5784357|NCT02835534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5784358|NCT02835534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784359|NCT02835404|Nedaplatin|nedaplatin|mesh-list
5784360|NCT02835404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5784361|NCT02835391|Surgiflo|surgiflo|mesh-list
6491225|NCT00601614|Temozolomide|temozolomide|mesh-list
5784362|NCT02835391|Hemostatics|hemostatics|mesh-ancestor
5784363|NCT02835391|Coagulants|coagulants|mesh-ancestor
5784364|NCT02835079|Tamoxifen|tamoxifen|mesh-list
5784365|NCT02835079|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5784366|NCT02835079|Hormone Antagonists|hormone antagonists|mesh-ancestor
5784367|NCT02835079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5784368|NCT02835079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784369|NCT02835079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5784370|NCT02835079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5784371|NCT02835079|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5784372|NCT02835079|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5784373|NCT02835079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5784374|NCT02835170|Immunoglobulins|immunoglobulins|mesh-list
5784375|NCT02835170|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5784376|NCT02835170|Antibodies|antibodies|mesh-list
5784377|NCT02835170|Immunologic Factors|immunologic factors|mesh-ancestor
5784378|NCT02835170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784379|NCT02835183|Insulin|insulin|mesh-list
5784380|NCT02835183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5784381|NCT02835183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784382|NCT02835131|Pasireotide|pasireotide|mesh-list
5784383|NCT02835131|Hormones|hormones|mesh-ancestor
5784384|NCT02835131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5784385|NCT02835131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784386|NCT02834676|Ethanol|ethanol|mesh-list
5784387|NCT02834676|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5784388|NCT02834676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5784389|NCT02834676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5784390|NCT02834676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784391|NCT02834637|Vaccines|vaccines|mesh-list
5784392|NCT02834637|Immunologic Factors|immunologic factors|mesh-ancestor
5784393|NCT02834637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784394|NCT02834754|Vedolizumab|vedolizumab|mesh-list
5784395|NCT02834754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5784396|NCT02834845|Sevoflurane|sevoflurane|mesh-list
5784397|NCT02834845|Desflurane|desflurane|mesh-list
5784398|NCT02834845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5784399|NCT02834845|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5784400|NCT02834845|Anesthetics, General|anesthetics, general|mesh-ancestor
5784401|NCT02834845|Anesthetics|anesthetics|mesh-ancestor
5784402|NCT02834845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5784403|NCT02834845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784404|NCT02834559|Fluorouracil|fluorouracil|mesh-list
5784405|NCT02834559|Heparin|heparin|mesh-list
5784406|NCT02834559|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5784407|NCT02834559|Tinzaparin|tinzaparin|mesh-list
5784408|NCT02834559|Dalteparin|dalteparin|mesh-list
5784409|NCT02834559|Antimetabolites|antimetabolites|mesh-ancestor
5784410|NCT02834559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784411|NCT02834559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5784412|NCT02834559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5784413|NCT02834559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5784414|NCT02834559|Immunologic Factors|immunologic factors|mesh-ancestor
5784415|NCT02834559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784416|NCT02834559|Anticoagulants|anticoagulants|mesh-ancestor
5784417|NCT02834559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5784418|NCT02834559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5784419|NCT02834507|Levodopa|levodopa|mesh-list
5784420|NCT02834507|Carbidopa|carbidopa|mesh-list
5784421|NCT02834507|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
5784422|NCT02834507|Entacapone|entacapone|mesh-list
5784423|NCT02834507|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5784424|NCT02834507|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5784425|NCT02834507|Dopamine Agents|dopamine agents|mesh-ancestor
5784426|NCT02834507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5784427|NCT02834507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784428|NCT02834507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784429|NCT02834507|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5784430|NCT02834507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5784431|NCT02834507|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5784432|NCT02834507|Immunologic Factors|immunologic factors|mesh-ancestor
5784433|NCT02834507|Dopamine Agonists|dopamine agonists|mesh-ancestor
5784434|NCT02834507|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
5784435|NCT02834546|Sorafenib|sorafenib|mesh-list
5784436|NCT02834546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5784437|NCT02834546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5784438|NCT02834546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5898099|NCT04167176|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5784439|NCT02834546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784440|NCT02834260|Dexamethasone|dexamethasone|mesh-list
5784441|NCT02834260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5784442|NCT02834260|Antiemetics|antiemetics|mesh-ancestor
5784443|NCT02834260|Autonomic Agents|autonomic agents|mesh-ancestor
5784444|NCT02834260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5784445|NCT02834260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784446|NCT02834260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5784447|NCT02834260|Glucocorticoids|glucocorticoids|mesh-ancestor
5784448|NCT02834260|Hormones|hormones|mesh-ancestor
5784449|NCT02834260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5784450|NCT02834260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5784451|NCT02834260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5898100|NCT04167176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5898101|NCT04167176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898102|NCT04164069|Calcium, Dietary|calcium, dietary|mesh-list
5898103|NCT04164069|Leucovorin|leucovorin|mesh-list
5898104|NCT04164069|Folic Acid|folic acid|mesh-list
5898105|NCT04164069|Bevacizumab|bevacizumab|mesh-list
5898106|NCT04164069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5898107|NCT04164069|Fluorouracil|fluorouracil|mesh-list
5898108|NCT04164069|Oxaliplatin|oxaliplatin|mesh-list
5898109|NCT04164069|Dasatinib|dasatinib|mesh-list
5898110|NCT04164069|Endothelial Growth Factors|endothelial growth factors|mesh-list
5898111|NCT04164069|Antibodies|antibodies|mesh-list
5898112|NCT04164069|Immunoglobulins|immunoglobulins|mesh-list
5898113|NCT04164069|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5898114|NCT04164069|Immunoglobulin G|immunoglobulin g|mesh-list
5898115|NCT04164069|Calcium|calcium|mesh-list
5898116|NCT04164069|Levoleucovorin|levoleucovorin|mesh-list
5898117|NCT04164069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5898118|NCT04164069|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5898119|NCT04164069|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5898120|NCT04164069|Growth Substances|growth substances|mesh-ancestor
5898121|NCT04164069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898122|NCT04164069|Growth Inhibitors|growth inhibitors|mesh-ancestor
5898123|NCT04164069|Immunologic Factors|immunologic factors|mesh-ancestor
5898124|NCT04164069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5898125|NCT04164069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5898126|NCT04164069|Antimetabolites|antimetabolites|mesh-ancestor
5898127|NCT04164069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898128|NCT04164069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5898129|NCT04164069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5898130|NCT04164069|Antidotes|antidotes|mesh-ancestor
5898131|NCT04164069|Protective Agents|protective agents|mesh-ancestor
5898132|NCT04164069|Vitamin B Complex|vitamin b complex|mesh-ancestor
5898133|NCT04164069|Vitamins|vitamins|mesh-ancestor
5898134|NCT04164069|Micronutrients|micronutrients|mesh-ancestor
5898135|NCT04164069|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5898136|NCT04164069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5898137|NCT04164069|Hematinics|hematinics|mesh-ancestor
5898138|NCT04143711|Paclitaxel|paclitaxel|mesh-list
5898139|NCT04143711|Nivolumab|nivolumab|mesh-list
5898140|NCT04143711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5898141|NCT04143711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5898142|NCT04143711|Tubulin Modulators|tubulin modulators|mesh-ancestor
5898143|NCT04143711|Antimitotic Agents|antimitotic agents|mesh-ancestor
5898144|NCT04143711|Mitosis Modulators|mitosis modulators|mesh-ancestor
5898145|NCT04143711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898146|NCT04143711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5898147|NCT04143711|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5898148|NCT04129151|Palbociclib|palbociclib|mesh-list
5898149|NCT04129151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5898150|NCT04129151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5898151|NCT04129151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5898152|NCT04129151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908036|NCT04938765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5908037|NCT04938765|Tocolytic Agents|tocolytic agents|mesh-ancestor
5908038|NCT04938765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5908039|NCT04935359|Gemcitabine|gemcitabine|mesh-list
5908040|NCT04935359|Paclitaxel|paclitaxel|mesh-list
5908041|NCT04935359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5908042|NCT04935359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5908043|NCT04935359|Tubulin Modulators|tubulin modulators|mesh-ancestor
5908044|NCT04935359|Antimitotic Agents|antimitotic agents|mesh-ancestor
5908045|NCT04935359|Mitosis Modulators|mitosis modulators|mesh-ancestor
5908790|NCT04115319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5784452|NCT02834286|Dexamethasone|dexamethasone|mesh-list
5784453|NCT02834286|Rituximab|rituximab|mesh-list
5784454|NCT02834286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5784455|NCT02834286|Antiemetics|antiemetics|mesh-ancestor
5784456|NCT02834286|Autonomic Agents|autonomic agents|mesh-ancestor
5784457|NCT02834286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5784458|NCT02834286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784459|NCT02834286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5784460|NCT02834286|Glucocorticoids|glucocorticoids|mesh-ancestor
5784461|NCT02834286|Hormones|hormones|mesh-ancestor
5784462|NCT02834286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5784463|NCT02834286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5784464|NCT02834286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5784465|NCT02834286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5784466|NCT02834286|Immunologic Factors|immunologic factors|mesh-ancestor
5784467|NCT02834286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5784468|NCT02834052|Poly I-C|poly i-c|mesh-list
5784469|NCT02834052|Pembrolizumab|pembrolizumab|mesh-list
5784470|NCT02834052|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
5784471|NCT02834052|Poly ICLC|poly iclc|mesh-list
5784472|NCT02834052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5784473|NCT02834052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5784474|NCT02834052|Interferon Inducers|interferon inducers|mesh-ancestor
5784475|NCT02834052|Immunologic Factors|immunologic factors|mesh-ancestor
5784476|NCT02834052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784477|NCT02834052|Laxatives|laxatives|mesh-ancestor
5784478|NCT02834052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5784479|NCT02834052|Antiviral Agents|antiviral agents|mesh-ancestor
5784480|NCT02834052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5784481|NCT02833831|Moxifloxacin|moxifloxacin|mesh-list
5784482|NCT02833831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5784483|NCT02833831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5784484|NCT02833831|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5784485|NCT02833831|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5784486|NCT02833831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5784487|NCT02833831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784488|NCT02833831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5784489|NCT02833805|Mycophenolic Acid|mycophenolic acid|mesh-list
5784490|NCT02833805|Cyclophosphamide|cyclophosphamide|mesh-list
5784491|NCT02833805|Fludarabine|fludarabine|mesh-list
5784492|NCT02833805|Tacrolimus|tacrolimus|mesh-list
5784493|NCT02833805|Thymoglobulin|thymoglobulin|mesh-list
5784494|NCT02833805|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5784495|NCT02833805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5784496|NCT02833805|Immunologic Factors|immunologic factors|mesh-ancestor
5784497|NCT02833805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784498|NCT02833805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5784499|NCT02833805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5784500|NCT02833805|Alkylating Agents|alkylating agents|mesh-ancestor
5784501|NCT02833805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784502|NCT02833805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5784503|NCT02833805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5784504|NCT02833805|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5784505|NCT02833805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5784506|NCT02833805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5784507|NCT02833805|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5784508|NCT02833805|Antitubercular Agents|antitubercular agents|mesh-ancestor
5784509|NCT02833805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5784510|NCT02833805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5784511|NCT02833987|Warfarin|warfarin|mesh-list
5784512|NCT02833987|Rivaroxaban|rivaroxaban|mesh-list
5784513|NCT02833987|Dabigatran|dabigatran|mesh-list
5784514|NCT02833987|Apixaban|apixaban|mesh-list
5784515|NCT02833987|Anticoagulants|anticoagulants|mesh-ancestor
5784516|NCT02833987|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5784517|NCT02833987|Antithrombins|antithrombins|mesh-ancestor
5784518|NCT02833987|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5784519|NCT02833987|Protease Inhibitors|protease inhibitors|mesh-ancestor
5784520|NCT02833987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5784521|NCT02833987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784522|NCT02833766|Doxorubicin|doxorubicin|mesh-list
5784523|NCT02833766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5784524|NCT02833766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5784525|NCT02833766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5784526|NCT02833766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5784527|NCT02833766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5784528|NCT02833766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784529|NCT02833753|Oxaliplatin|oxaliplatin|mesh-list
5784530|NCT02833753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5784531|NCT02833610|Denosumab|denosumab|mesh-list
5784532|NCT02833610|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5784533|NCT02833610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784534|NCT02833480|Fluticasone|fluticasone|mesh-list
5784535|NCT02833480|Budesonide|budesonide|mesh-list
5784536|NCT02833480|Formoterol Fumarate|formoterol fumarate|mesh-list
5784537|NCT02833480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5784538|NCT02833480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5784539|NCT02833480|Autonomic Agents|autonomic agents|mesh-ancestor
5784540|NCT02833480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5784541|NCT02833480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784542|NCT02833480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5784543|NCT02833480|Respiratory System Agents|respiratory system agents|mesh-ancestor
5784544|NCT02833480|Dermatologic Agents|dermatologic agents|mesh-ancestor
5784545|NCT02833480|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5784546|NCT02833480|Glucocorticoids|glucocorticoids|mesh-ancestor
5784547|NCT02833480|Hormones|hormones|mesh-ancestor
5784548|NCT02833480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5784549|NCT02833480|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5784550|NCT02833480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5784551|NCT02833480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5784552|NCT02833480|Adrenergic Agents|adrenergic agents|mesh-ancestor
5784553|NCT02833480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5784554|NCT02833480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784555|NCT02833506|Sirolimus|sirolimus|mesh-list
5784556|NCT02833506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5784557|NCT02833506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5784558|NCT02833506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5784559|NCT02833506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5784560|NCT02833506|Antifungal Agents|antifungal agents|mesh-ancestor
5784561|NCT02833506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5784562|NCT02833506|Immunologic Factors|immunologic factors|mesh-ancestor
5784563|NCT02833506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784564|NCT02833701|Vitamins|vitamins|mesh-list
5784565|NCT02833701|Ascorbic Acid|ascorbic acid|mesh-list
5784566|NCT02833701|Bevacizumab|bevacizumab|mesh-list
5784567|NCT02833701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5784568|NCT02833701|Endothelial Growth Factors|endothelial growth factors|mesh-list
5784569|NCT02833701|Antibodies|antibodies|mesh-list
5784570|NCT02833701|Immunoglobulins|immunoglobulins|mesh-list
5784571|NCT02833701|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5784572|NCT02833701|Immunoglobulin G|immunoglobulin g|mesh-list
5784573|NCT02833701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5784574|NCT02833701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5784575|NCT02833701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5784576|NCT02833701|Growth Substances|growth substances|mesh-ancestor
5784577|NCT02833701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784578|NCT02833701|Growth Inhibitors|growth inhibitors|mesh-ancestor
5784579|NCT02833701|Micronutrients|micronutrients|mesh-ancestor
5784580|NCT02833701|Immunologic Factors|immunologic factors|mesh-ancestor
5784581|NCT02833701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784582|NCT02833701|Antioxidants|antioxidants|mesh-ancestor
5784583|NCT02833701|Protective Agents|protective agents|mesh-ancestor
5784584|NCT02833688|Dexmedetomidine|dexmedetomidine|mesh-list
5784585|NCT02833688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5784586|NCT02833688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5784587|NCT02833688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784588|NCT02833688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5784589|NCT02833688|Analgesics|analgesics|mesh-ancestor
5784590|NCT02833688|Sensory System Agents|sensory system agents|mesh-ancestor
5784591|NCT02833688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5784592|NCT02833688|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5784593|NCT02833688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5784594|NCT02833688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5784595|NCT02833688|Adrenergic Agents|adrenergic agents|mesh-ancestor
5784596|NCT02833688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5784597|NCT02833688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784598|NCT02833376|Chlorhexidine|chlorhexidine|mesh-list
5784599|NCT02833376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5784600|NCT02833376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5784601|NCT02833376|Disinfectants|disinfectants|mesh-ancestor
5784602|NCT02833233|Nivolumab|nivolumab|mesh-list
5784603|NCT02833233|Ipilimumab|ipilimumab|mesh-list
5784604|NCT02833233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5784605|NCT02833233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5784606|NCT02833233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5784607|NCT02833233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784608|NCT02833584|Acetaminophen|acetaminophen|mesh-list
5784609|NCT02833584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5784610|NCT02833584|Analgesics|analgesics|mesh-ancestor
5784611|NCT02833584|Sensory System Agents|sensory system agents|mesh-ancestor
5784612|NCT02833584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5784613|NCT02833584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784614|NCT02833584|Antipyretics|antipyretics|mesh-ancestor
5784615|NCT02833025|Thrombin|thrombin|mesh-list
5784616|NCT02833025|Hemostatics|hemostatics|mesh-ancestor
5784617|NCT02833025|Coagulants|coagulants|mesh-ancestor
5784618|NCT02833038|Magnesium Sulfate|magnesium sulfate|mesh-list
5784619|NCT02833038|Analgesics|analgesics|mesh-ancestor
5784620|NCT02833038|Sensory System Agents|sensory system agents|mesh-ancestor
5784621|NCT02833038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5784622|NCT02833038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784623|NCT02833038|Anesthetics|anesthetics|mesh-ancestor
5784624|NCT02833038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5784625|NCT02833038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5784626|NCT02833038|Anticonvulsants|anticonvulsants|mesh-ancestor
5784627|NCT02833038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5784628|NCT02833038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5784629|NCT02833038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784630|NCT02833038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5784631|NCT02833038|Tocolytic Agents|tocolytic agents|mesh-ancestor
5784632|NCT02833038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5784633|NCT02833103|Pinaverium|pinaverium|mesh-list
5784634|NCT02833103|Bromides|bromides|mesh-list
5784635|NCT02833103|Anticonvulsants|anticonvulsants|mesh-ancestor
5784636|NCT02833103|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5784637|NCT02833103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5784638|NCT02833103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784639|NCT02833103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5784640|NCT02833103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784641|NCT02833103|Parasympatholytics|parasympatholytics|mesh-ancestor
5784642|NCT02833103|Autonomic Agents|autonomic agents|mesh-ancestor
5784643|NCT02833103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5784644|NCT02833155|Exemestane|exemestane|mesh-list
5784645|NCT02833155|Entinostat|entinostat|mesh-list
5784646|NCT02833155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5784647|NCT02833155|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5784648|NCT02833155|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5784649|NCT02833155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5784650|NCT02833155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784651|NCT02833155|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5784652|NCT02833155|Hormone Antagonists|hormone antagonists|mesh-ancestor
5784653|NCT02833155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5784654|NCT02833155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784655|NCT02833155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5784656|NCT02833116|Dexamethasone|dexamethasone|mesh-list
5784657|NCT02833116|Betamethasone|betamethasone|mesh-list
5784658|NCT02833116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5784659|NCT02833116|Antiemetics|antiemetics|mesh-ancestor
5784660|NCT02833116|Autonomic Agents|autonomic agents|mesh-ancestor
5784661|NCT02833116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5784662|NCT02833116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784663|NCT02833116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5784664|NCT02833116|Glucocorticoids|glucocorticoids|mesh-ancestor
5784665|NCT02833116|Hormones|hormones|mesh-ancestor
5784666|NCT02833116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5784667|NCT02833116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5784668|NCT02833116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5784669|NCT02833116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5784670|NCT02833116|Respiratory System Agents|respiratory system agents|mesh-ancestor
5784671|NCT02832973|Ramipril|ramipril|mesh-list
5784672|NCT02832973|Bisoprolol|bisoprolol|mesh-list
5784673|NCT02832973|Amiloride|amiloride|mesh-list
5784674|NCT02832973|Furosemide|furosemide|mesh-list
5784675|NCT02832973|Spironolactone|spironolactone|mesh-list
5784676|NCT02832973|Diuretics|diuretics|mesh-list
5784677|NCT02832973|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
5784678|NCT02832973|Natriuretic Agents|natriuretic agents|mesh-ancestor
5784679|NCT02832973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784680|NCT02832973|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5898153|NCT04115059|Dasatinib|dasatinib|mesh-list
5784681|NCT02832973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5784682|NCT02832973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784683|NCT02832973|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5784684|NCT02832973|Hormone Antagonists|hormone antagonists|mesh-ancestor
5784685|NCT02832973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5784686|NCT02832973|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5784687|NCT02832973|Protease Inhibitors|protease inhibitors|mesh-ancestor
5784688|NCT02832973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5784689|NCT02832973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5784690|NCT02832973|Sympatholytics|sympatholytics|mesh-ancestor
5784691|NCT02832973|Autonomic Agents|autonomic agents|mesh-ancestor
5784692|NCT02832973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5784693|NCT02832973|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5784694|NCT02832973|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5784695|NCT02832973|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5784696|NCT02832973|Adrenergic Agents|adrenergic agents|mesh-ancestor
5784697|NCT02832973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5784698|NCT02832973|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
5784699|NCT02832973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5784700|NCT02832973|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
5784701|NCT02832778|Tenofovir|tenofovir|mesh-list
5784702|NCT02832778|Lamivudine|lamivudine|mesh-list
5784703|NCT02832778|Zidovudine|zidovudine|mesh-list
5784704|NCT02832778|Emtricitabine|emtricitabine|mesh-list
5784705|NCT02832778|Efavirenz|efavirenz|mesh-list
5784706|NCT02832778|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
5784707|NCT02832778|Isoniazid|isoniazid|mesh-list
5784708|NCT02832778|Antiviral Agents|antiviral agents|mesh-ancestor
5784709|NCT02832778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5784710|NCT02832778|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5784711|NCT02832778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5784712|NCT02832778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5784713|NCT02832778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784714|NCT02832778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5784715|NCT02832778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5784716|NCT02832778|Antimetabolites|antimetabolites|mesh-ancestor
5784717|NCT02832778|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5784718|NCT02832778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5784719|NCT02832778|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5784720|NCT02832778|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5784721|NCT02832778|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5784722|NCT02832778|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5784723|NCT02832778|Antitubercular Agents|antitubercular agents|mesh-ancestor
5784724|NCT02832778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5784725|NCT02832778|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5784726|NCT02832778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5784727|NCT02832778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5784728|NCT02832947|Rivaroxaban|rivaroxaban|mesh-list
5784729|NCT02832947|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6491226|NCT00601614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6673763|NCT01564979|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5784730|NCT02832947|Antithrombins|antithrombins|mesh-ancestor
5784731|NCT02832947|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5784732|NCT02832947|Protease Inhibitors|protease inhibitors|mesh-ancestor
5784733|NCT02832947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5784734|NCT02832947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784735|NCT02832947|Anticoagulants|anticoagulants|mesh-ancestor
5784736|NCT02832999|Liraglutide|liraglutide|mesh-list
5784737|NCT02832999|Vildagliptin|vildagliptin|mesh-list
5784738|NCT02832999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5784739|NCT02832999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784740|NCT02832999|Incretins|incretins|mesh-ancestor
5784741|NCT02832999|Hormones|hormones|mesh-ancestor
5784742|NCT02832999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5784743|NCT02832999|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5784744|NCT02832999|Protease Inhibitors|protease inhibitors|mesh-ancestor
5784745|NCT02832999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5784746|NCT02832999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784747|NCT02832713|Botulinum Toxins|botulinum toxins|mesh-list
5784748|NCT02832713|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5784749|NCT02832713|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5784750|NCT02832713|Hyaluronic Acid|hyaluronic acid|mesh-list
5784751|NCT02832713|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5784752|NCT02832713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5784753|NCT02832713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784754|NCT02832713|Cholinergic Agents|cholinergic agents|mesh-ancestor
5784755|NCT02832713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5784756|NCT02832713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784757|NCT02832713|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5784758|NCT02832713|Immunologic Factors|immunologic factors|mesh-ancestor
5784759|NCT02832713|Viscosupplements|viscosupplements|mesh-ancestor
5784760|NCT02832713|Protective Agents|protective agents|mesh-ancestor
5784761|NCT02832713|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5784762|NCT02832713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5784763|NCT02832700|Caseins|caseins|mesh-list
5784764|NCT02832700|Chelating Agents|chelating agents|mesh-ancestor
5784765|NCT02832700|Sequestering Agents|sequestering agents|mesh-ancestor
5784766|NCT02832700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898154|NCT04115059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5898155|NCT04115059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5898156|NCT04115059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5898157|NCT04115059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898158|NCT04093167|Pembrolizumab|pembrolizumab|mesh-list
5898159|NCT04093167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5898160|NCT04093167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5898161|NCT04083950|Aspirin|aspirin|mesh-list
5898162|NCT04083950|Vaccines|vaccines|mesh-list
5898163|NCT04083950|Immunologic Factors|immunologic factors|mesh-ancestor
5898164|NCT04083950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898165|NCT04083950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5898166|NCT04083950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5898167|NCT04083950|Analgesics|analgesics|mesh-ancestor
5898168|NCT04083950|Sensory System Agents|sensory system agents|mesh-ancestor
5898169|NCT04083950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5898170|NCT04083950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5898171|NCT04083950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5898172|NCT04083950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5898173|NCT04083950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5898174|NCT04083950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898175|NCT04083950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5898176|NCT04083950|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5898177|NCT04083950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5898178|NCT04083950|Antipyretics|antipyretics|mesh-ancestor
5898179|NCT04083365|Capecitabine|capecitabine|mesh-list
5898180|NCT04083365|Durvalumab|durvalumab|mesh-list
5898181|NCT04083365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5898182|NCT04083365|Antimetabolites|antimetabolites|mesh-ancestor
5898183|NCT04083365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898184|NCT04083365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5898185|NCT04083365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5898186|NCT04068103|Calcium, Dietary|calcium, dietary|mesh-list
5898187|NCT04068103|Leucovorin|leucovorin|mesh-list
5898188|NCT04068103|Folic Acid|folic acid|mesh-list
5898189|NCT04068103|Fluorouracil|fluorouracil|mesh-list
5898190|NCT04068103|Capecitabine|capecitabine|mesh-list
5898191|NCT04068103|Oxaliplatin|oxaliplatin|mesh-list
5898192|NCT04068103|Calcium|calcium|mesh-list
5898193|NCT04068103|Levoleucovorin|levoleucovorin|mesh-list
5898194|NCT04068103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5898195|NCT04068103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898196|NCT04068103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5898197|NCT04068103|Antimetabolites|antimetabolites|mesh-ancestor
5898198|NCT04068103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898199|NCT04068103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5898200|NCT04068103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5898201|NCT04068103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5898202|NCT04068103|Immunologic Factors|immunologic factors|mesh-ancestor
5898203|NCT04068103|Antidotes|antidotes|mesh-ancestor
5898204|NCT04068103|Protective Agents|protective agents|mesh-ancestor
5784767|NCT02832531|Aspirin|aspirin|mesh-list
5784768|NCT02832531|Rivaroxaban|rivaroxaban|mesh-list
5784769|NCT02832531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5784770|NCT02832531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5784771|NCT02832531|Analgesics|analgesics|mesh-ancestor
5784772|NCT02832531|Sensory System Agents|sensory system agents|mesh-ancestor
5784773|NCT02832531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5784774|NCT02832531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784775|NCT02832531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5784776|NCT02832531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5784777|NCT02832531|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5784778|NCT02832531|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5784779|NCT02832531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784780|NCT02832531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5784781|NCT02832531|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5784782|NCT02832531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5784783|NCT02832531|Antipyretics|antipyretics|mesh-ancestor
5784784|NCT02832531|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5784785|NCT02832531|Antithrombins|antithrombins|mesh-ancestor
5784786|NCT02832531|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5784787|NCT02832531|Protease Inhibitors|protease inhibitors|mesh-ancestor
5784788|NCT02832531|Anticoagulants|anticoagulants|mesh-ancestor
5784789|NCT02832726|Vitamin B 12|vitamin b 12|mesh-list
5784790|NCT02832726|Hydroxocobalamin|hydroxocobalamin|mesh-list
5784791|NCT02832726|Vitamins|vitamins|mesh-ancestor
5784792|NCT02832726|Micronutrients|micronutrients|mesh-ancestor
5784793|NCT02832726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784794|NCT02832726|Vitamin B Complex|vitamin b complex|mesh-ancestor
5784795|NCT02832726|Hematinics|hematinics|mesh-ancestor
5784796|NCT02832544|Vitamin K|vitamin k|mesh-list
5784797|NCT02832544|Warfarin|warfarin|mesh-list
5784798|NCT02832544|Rivaroxaban|rivaroxaban|mesh-list
5784799|NCT02832544|Vitamins|vitamins|mesh-ancestor
5784800|NCT02832544|Micronutrients|micronutrients|mesh-ancestor
5784801|NCT02832544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784802|NCT02832544|Anticoagulants|anticoagulants|mesh-ancestor
5784803|NCT02832544|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5784804|NCT02832544|Antithrombins|antithrombins|mesh-ancestor
5784805|NCT02832544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5784806|NCT02832544|Protease Inhibitors|protease inhibitors|mesh-ancestor
5784807|NCT02832544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5784808|NCT02832544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784809|NCT02832544|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5784810|NCT02832544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5784811|NCT02832544|Hemostatics|hemostatics|mesh-ancestor
5784812|NCT02832544|Coagulants|coagulants|mesh-ancestor
5784813|NCT02832635|Temozolomide|temozolomide|mesh-list
5784814|NCT02832635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5784815|NCT02832635|Alkylating Agents|alkylating agents|mesh-ancestor
5784816|NCT02832635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784817|NCT02832635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5784818|NCT02832336|Caffeine|caffeine|mesh-list
5784819|NCT02832336|Caffeine citrate|caffeine citrate|mesh-list
5784820|NCT02832336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784821|NCT02832336|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5784822|NCT02832336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784823|NCT02832336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5784824|NCT02832336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5784825|NCT02832336|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5784826|NCT02832336|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5784827|NCT02832336|Purinergic Agents|purinergic agents|mesh-ancestor
5784828|NCT02832336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5784829|NCT02832596|Norepinephrine|norepinephrine|mesh-list
5784830|NCT02832596|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5784831|NCT02832596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5784832|NCT02832596|Adrenergic Agents|adrenergic agents|mesh-ancestor
5784833|NCT02832596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5784834|NCT02832596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784835|NCT02832596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784836|NCT02832596|Sympathomimetics|sympathomimetics|mesh-ancestor
5784837|NCT02832596|Autonomic Agents|autonomic agents|mesh-ancestor
5784838|NCT02832596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5784839|NCT02832596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5784840|NCT02832570|Sildenafil Citrate|sildenafil citrate|mesh-list
5784841|NCT02832570|Vasodilator Agents|vasodilator agents|mesh-ancestor
5784842|NCT02832570|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5784843|NCT02832570|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5784844|NCT02832570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5784845|NCT02832570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784846|NCT02832570|Urological Agents|urological agents|mesh-ancestor
5784847|NCT02832401|Caffeine|caffeine|mesh-list
5784848|NCT02832401|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5784849|NCT02832401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784850|NCT02832401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5784851|NCT02832401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5784852|NCT02832401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784853|NCT02832401|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5784854|NCT02832401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5784855|NCT02832401|Purinergic Agents|purinergic agents|mesh-ancestor
5784856|NCT02832401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5784857|NCT02832089|Carvedilol|carvedilol|mesh-list
5784858|NCT02832089|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5784859|NCT02832089|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5784860|NCT02832089|Adrenergic Agents|adrenergic agents|mesh-ancestor
5784861|NCT02832089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5784862|NCT02832089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784863|NCT02832089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784864|NCT02832089|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5784865|NCT02832089|Antioxidants|antioxidants|mesh-ancestor
5784866|NCT02832089|Protective Agents|protective agents|mesh-ancestor
5784867|NCT02832089|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5784868|NCT02832089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5784869|NCT02832089|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5784870|NCT02832089|Vasodilator Agents|vasodilator agents|mesh-ancestor
5784871|NCT02832089|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5784872|NCT02832089|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5784873|NCT02831894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
5784874|NCT02831894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5784875|NCT02831894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784876|NCT02831972|Itraconazole|itraconazole|mesh-list
5784877|NCT02831972|Antifungal Agents|antifungal agents|mesh-ancestor
5784878|NCT02831972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5784879|NCT02831972|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5784880|NCT02831972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5784881|NCT02831972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5784882|NCT02831972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784883|NCT02831972|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5784884|NCT02831972|Hormone Antagonists|hormone antagonists|mesh-ancestor
5784885|NCT02831972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5784886|NCT02831972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784887|NCT02831972|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5784888|NCT02831933|Valacyclovir|valacyclovir|mesh-list
5784889|NCT02831933|Nivolumab|nivolumab|mesh-list
5784890|NCT02831933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5784891|NCT02831933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5784892|NCT02831933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5784893|NCT02831933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784894|NCT02831933|Antiviral Agents|antiviral agents|mesh-ancestor
5784895|NCT02831933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5784896|NCT02831842|Bevacizumab|bevacizumab|mesh-list
5784897|NCT02831842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5784898|NCT02831842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5784899|NCT02831842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5784900|NCT02831842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5784901|NCT02831842|Growth Substances|growth substances|mesh-ancestor
5784902|NCT02831842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784903|NCT02831842|Growth Inhibitors|growth inhibitors|mesh-ancestor
5784904|NCT02831751|Vaccines|vaccines|mesh-list
5784905|NCT02831751|Immunologic Factors|immunologic factors|mesh-ancestor
5784906|NCT02831751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784907|NCT02831712|Ferrous fumarate|ferrous fumarate|mesh-list
5784908|NCT02831712|Trace Elements|trace elements|mesh-ancestor
5784909|NCT02831712|Micronutrients|micronutrients|mesh-ancestor
5784910|NCT02831712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784911|NCT02831686|Dexamethasone|dexamethasone|mesh-list
5784912|NCT02831686|Ixazomib|ixazomib|mesh-list
5784913|NCT02831686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5784914|NCT02831686|Antiemetics|antiemetics|mesh-ancestor
5784915|NCT02831686|Autonomic Agents|autonomic agents|mesh-ancestor
5784916|NCT02831686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5784917|NCT02831686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784918|NCT02831686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5784919|NCT02831686|Glucocorticoids|glucocorticoids|mesh-ancestor
5784920|NCT02831686|Hormones|hormones|mesh-ancestor
5784921|NCT02831686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5784922|NCT02831686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5784923|NCT02831686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5784924|NCT02831686|Protease Inhibitors|protease inhibitors|mesh-ancestor
5784925|NCT02831686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5784926|NCT02831686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784927|NCT02831543|Mosapride|mosapride|mesh-list
5784928|NCT02831543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784929|NCT02831543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5784930|NCT02831543|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5784931|NCT02831543|Serotonin Agents|serotonin agents|mesh-ancestor
5784932|NCT02831543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5784933|NCT02831543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784934|NCT02831478|Sunscreening Agents|sunscreening agents|mesh-list
5784935|NCT02831478|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5784936|NCT02831478|Protective Agents|protective agents|mesh-ancestor
5784937|NCT02831478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784938|NCT02831478|Dermatologic Agents|dermatologic agents|mesh-ancestor
5784939|NCT02831361|Metformin|metformin|mesh-list
5784940|NCT02831361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5784941|NCT02831361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784942|NCT02831374|Anesthetics|anesthetics|mesh-list
5784943|NCT02831374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5784944|NCT02831374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784945|NCT02831205|Cobalt|cobalt|mesh-list
5784946|NCT02831205|Chromium|chromium|mesh-list
5784947|NCT02831205|Everolimus|everolimus|mesh-list
5784948|NCT02831205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5784949|NCT02831205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5784950|NCT02831205|Immunologic Factors|immunologic factors|mesh-ancestor
5784951|NCT02831205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784952|NCT02831205|Trace Elements|trace elements|mesh-ancestor
5784953|NCT02831205|Micronutrients|micronutrients|mesh-ancestor
5784954|NCT02831218|Aspirin|aspirin|mesh-list
5784955|NCT02831218|Clopidogrel|clopidogrel|mesh-list
5784956|NCT02831218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5784957|NCT02831218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5784958|NCT02831218|Analgesics|analgesics|mesh-ancestor
5784959|NCT02831218|Sensory System Agents|sensory system agents|mesh-ancestor
5784960|NCT02831218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5784961|NCT02831218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784962|NCT02831218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5784963|NCT02831218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5784964|NCT02831218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5784965|NCT02831218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5784966|NCT02831218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491227|NCT00601614|Alkylating Agents|alkylating agents|mesh-ancestor
6491228|NCT00601614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491229|NCT00601614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6491230|NCT00601666|Zolpidem|zolpidem|mesh-list
5784967|NCT02831218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5784968|NCT02831218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5784969|NCT02831218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5784970|NCT02831218|Antipyretics|antipyretics|mesh-ancestor
5784971|NCT02831218|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5784972|NCT02831218|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5784973|NCT02831218|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5784974|NCT02831218|Purinergic Agents|purinergic agents|mesh-ancestor
5784975|NCT02831218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5784976|NCT02831491|Docetaxel|docetaxel|mesh-list
5784977|NCT02831491|Ramucirumab|ramucirumab|mesh-list
5784978|NCT02831491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5784979|NCT02831491|Tubulin Modulators|tubulin modulators|mesh-ancestor
5784980|NCT02831491|Antimitotic Agents|antimitotic agents|mesh-ancestor
5784981|NCT02831491|Mitosis Modulators|mitosis modulators|mesh-ancestor
5784982|NCT02831491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5784983|NCT02831101|Sufentanil|sufentanil|mesh-list
5784984|NCT02831101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5784985|NCT02831101|Narcotics|narcotics|mesh-ancestor
5784986|NCT02831101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5784987|NCT02831101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5784988|NCT02831101|Analgesics|analgesics|mesh-ancestor
5784989|NCT02831101|Sensory System Agents|sensory system agents|mesh-ancestor
5784990|NCT02831101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5784991|NCT02831101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5784992|NCT02831101|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5784993|NCT02831101|Anesthetics, General|anesthetics, general|mesh-ancestor
5784994|NCT02831101|Anesthetics|anesthetics|mesh-ancestor
5784995|NCT02831088|Salicylates|salicylates|mesh-list
5784996|NCT02831088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5784997|NCT02831088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5784998|NCT02831088|Analgesics|analgesics|mesh-ancestor
5784999|NCT02831088|Sensory System Agents|sensory system agents|mesh-ancestor
5785000|NCT02831088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5785001|NCT02831088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785002|NCT02831088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5785003|NCT02831088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5785004|NCT02831088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5785005|NCT02831088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5785006|NCT02831088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898205|NCT04068103|Vitamin B Complex|vitamin b complex|mesh-ancestor
5898206|NCT04068103|Vitamins|vitamins|mesh-ancestor
5898207|NCT04068103|Micronutrients|micronutrients|mesh-ancestor
5898208|NCT04068103|Hematinics|hematinics|mesh-ancestor
5898209|NCT04012827|Doxorubicin|doxorubicin|mesh-list
5898210|NCT04012827|Apatinib|apatinib|mesh-list
5898211|NCT04012827|Ifosfamide|ifosfamide|mesh-list
5898212|NCT04012827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5898213|NCT04012827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5898214|NCT04012827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5898215|NCT04012827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5898216|NCT04012827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5898217|NCT04012827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898218|NCT04012827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5898219|NCT04012827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5898220|NCT04012827|Alkylating Agents|alkylating agents|mesh-ancestor
5898221|NCT04008797|Lenvatinib|lenvatinib|mesh-list
5898222|NCT04008797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5898223|NCT04008797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5898224|NCT04008797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5898225|NCT04008797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898226|NCT03977194|Paclitaxel|paclitaxel|mesh-list
5898227|NCT03977194|Carboplatin|carboplatin|mesh-list
5898228|NCT03977194|Atezolizumab|atezolizumab|mesh-list
5898229|NCT03977194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5898230|NCT03977194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5898231|NCT03977194|Tubulin Modulators|tubulin modulators|mesh-ancestor
5898232|NCT03977194|Antimitotic Agents|antimitotic agents|mesh-ancestor
5898233|NCT03977194|Mitosis Modulators|mitosis modulators|mesh-ancestor
5898234|NCT03977194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898235|NCT03874091|Epinephrine|epinephrine|mesh-list
5898236|NCT03874091|Racepinephrine|racepinephrine|mesh-list
5898237|NCT03874091|Morphine|morphine|mesh-list
5898238|NCT03874091|Bupivacaine|bupivacaine|mesh-list
5898239|NCT03874091|Epinephryl borate|epinephryl borate|mesh-list
5898240|NCT03874091|Anesthetics, Local|anesthetics, local|mesh-ancestor
5898241|NCT03874091|Anesthetics|anesthetics|mesh-ancestor
5898242|NCT03874091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5898243|NCT03874091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898244|NCT03874091|Sensory System Agents|sensory system agents|mesh-ancestor
5898245|NCT03874091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5898246|NCT03874091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5898247|NCT03874091|Narcotics|narcotics|mesh-ancestor
5898248|NCT03874091|Analgesics|analgesics|mesh-ancestor
5898249|NCT03874091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5898250|NCT03874091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5898251|NCT03874091|Adrenergic Agents|adrenergic agents|mesh-ancestor
5898252|NCT03874091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5898253|NCT03874091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898254|NCT03874091|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5898255|NCT03874091|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5898256|NCT03874091|Autonomic Agents|autonomic agents|mesh-ancestor
5898257|NCT03874091|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5898258|NCT03874091|Respiratory System Agents|respiratory system agents|mesh-ancestor
5898259|NCT03874091|Mydriatics|mydriatics|mesh-ancestor
5898260|NCT03874091|Sympathomimetics|sympathomimetics|mesh-ancestor
5898261|NCT03874091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5898262|NCT03773276|Norepinephrine|norepinephrine|mesh-list
5785007|NCT02831179|Capecitabine|capecitabine|mesh-list
5785008|NCT02831179|Temozolomide|temozolomide|mesh-list
5785009|NCT02831179|Veliparib|veliparib|mesh-list
5785010|NCT02831179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5785011|NCT02831179|Antimetabolites|antimetabolites|mesh-ancestor
5785012|NCT02831179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5785013|NCT02831179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5785014|NCT02831179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5785015|NCT02831179|Alkylating Agents|alkylating agents|mesh-ancestor
5785016|NCT02831179|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5785017|NCT02831179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5785018|NCT02831231|Xanomeline|xanomeline|mesh-list
5785019|NCT02831231|Trospium chloride|trospium chloride|mesh-list
5785020|NCT02831231|Parasympatholytics|parasympatholytics|mesh-ancestor
5785021|NCT02831231|Autonomic Agents|autonomic agents|mesh-ancestor
5785022|NCT02831231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5785023|NCT02831231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785024|NCT02831231|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5785025|NCT02831231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5785026|NCT02831231|Cholinergic Agents|cholinergic agents|mesh-ancestor
5785027|NCT02831231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5785028|NCT02831231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5785029|NCT02831231|Urological Agents|urological agents|mesh-ancestor
5785030|NCT02831231|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5785031|NCT02831231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5785032|NCT02831231|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
5785033|NCT02831231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5785034|NCT02830906|Ondansetron|ondansetron|mesh-list
5785035|NCT02830906|Ramosetron|ramosetron|mesh-list
5785036|NCT02830906|Antiemetics|antiemetics|mesh-ancestor
5785037|NCT02830906|Autonomic Agents|autonomic agents|mesh-ancestor
5785038|NCT02830906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5785039|NCT02830906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785040|NCT02830906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5785041|NCT02830906|Antipruritics|antipruritics|mesh-ancestor
5785042|NCT02830906|Dermatologic Agents|dermatologic agents|mesh-ancestor
5785043|NCT02830906|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5785044|NCT02830906|Serotonin Agents|serotonin agents|mesh-ancestor
5785045|NCT02830906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5785046|NCT02830906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5785047|NCT02830906|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5785048|NCT02830906|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5785049|NCT02830906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5785050|NCT02830906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5785051|NCT02830906|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5785052|NCT02830789|Calcium, Dietary|calcium, dietary|mesh-list
5785053|NCT02830789|Calcium Carbonate|calcium carbonate|mesh-list
5785054|NCT02830789|Calcium|calcium|mesh-list
5785055|NCT02830789|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5785056|NCT02830789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785057|NCT02830789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5785058|NCT02830789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5785059|NCT02830789|Antacids|antacids|mesh-ancestor
5785060|NCT02830789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5785061|NCT02831023|Pyrimethamine|pyrimethamine|mesh-list
5785062|NCT02831023|Piperaquine|piperaquine|mesh-list
5785063|NCT02831023|Primaquine|primaquine|mesh-list
5785064|NCT02831023|Sulfadoxine|sulfadoxine|mesh-list
5785065|NCT02831023|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
5785066|NCT02831023|Amodiaquine|amodiaquine|mesh-list
5785067|NCT02831023|Artenimol|artenimol|mesh-list
5785068|NCT02831023|Methylene Blue|methylene blue|mesh-list
5785069|NCT02831023|Antimalarials|antimalarials|mesh-ancestor
5785070|NCT02831023|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5785071|NCT02831023|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5785072|NCT02831023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5785073|NCT02831023|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5785074|NCT02831023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5785075|NCT02831023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5785076|NCT02831023|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5785077|NCT02831023|Renal Agents|renal agents|mesh-ancestor
5785078|NCT02830932|Vaccines|vaccines|mesh-list
5785079|NCT02830932|Immunologic Factors|immunologic factors|mesh-ancestor
5785080|NCT02830932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785081|NCT02830360|Amiodarone|amiodarone|mesh-list
5785082|NCT02830360|Sotalol|sotalol|mesh-list
5785083|NCT02830360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5785084|NCT02830360|Vasodilator Agents|vasodilator agents|mesh-ancestor
5785085|NCT02830360|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5785086|NCT02830360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5785087|NCT02830360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5785088|NCT02830360|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5785089|NCT02830360|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5785090|NCT02830360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5785091|NCT02830360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5785092|NCT02830360|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5785093|NCT02830360|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5785094|NCT02830360|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5785095|NCT02830360|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5785096|NCT02830360|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5785097|NCT02830360|Adrenergic Agents|adrenergic agents|mesh-ancestor
5785098|NCT02830360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5785099|NCT02830360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785100|NCT02830360|Sympatholytics|sympatholytics|mesh-ancestor
5785101|NCT02830360|Autonomic Agents|autonomic agents|mesh-ancestor
5785102|NCT02830360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5785103|NCT02830594|Pembrolizumab|pembrolizumab|mesh-list
5785104|NCT02830594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5785105|NCT02830594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5785106|NCT02830347|Amoxicillin|amoxicillin|mesh-list
5785107|NCT02830347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5785108|NCT02830347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5785109|NCT02830230|Azithromycin|azithromycin|mesh-list
5785110|NCT02830230|Cefixime|cefixime|mesh-list
5785111|NCT02830230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5785112|NCT02830230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5785113|NCT02829931|Bevacizumab|bevacizumab|mesh-list
5785114|NCT02829931|Nivolumab|nivolumab|mesh-list
5785115|NCT02829931|Ipilimumab|ipilimumab|mesh-list
5785116|NCT02829931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5785117|NCT02829931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5785118|NCT02829931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5785119|NCT02829931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5785120|NCT02829931|Growth Substances|growth substances|mesh-ancestor
5785121|NCT02829931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785122|NCT02829931|Growth Inhibitors|growth inhibitors|mesh-ancestor
5785123|NCT02829931|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5785124|NCT02829931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5785125|NCT02830243|Sevoflurane|sevoflurane|mesh-list
5785126|NCT02830243|Desflurane|desflurane|mesh-list
5785127|NCT02830243|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5785128|NCT02830243|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5785129|NCT02830243|Anesthetics, General|anesthetics, general|mesh-ancestor
5785130|NCT02830243|Anesthetics|anesthetics|mesh-ancestor
5785131|NCT02830243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5785132|NCT02830243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785133|NCT02830048|Glyburide|glyburide|mesh-list
5785134|NCT02830048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5785135|NCT02830048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785136|NCT02830126|Anesthetics|anesthetics|mesh-list
5785137|NCT02830126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5785138|NCT02830126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785139|NCT02829879|Listerine|listerine|mesh-list
5785140|NCT02829879|Fluorides|fluorides|mesh-list
5785141|NCT02829879|Sodium Fluoride|sodium fluoride|mesh-list
5785142|NCT02829879|Fluorophosphate|fluorophosphate|mesh-list
5785143|NCT02829879|Cariostatic Agents|cariostatic agents|mesh-ancestor
5785144|NCT02829879|Protective Agents|protective agents|mesh-ancestor
5785145|NCT02829879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785146|NCT02829879|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5785147|NCT02829879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5785148|NCT02829957|Rivaroxaban|rivaroxaban|mesh-list
5785149|NCT02829957|Apixaban|apixaban|mesh-list
5785150|NCT02829957|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5785151|NCT02829957|Antithrombins|antithrombins|mesh-ancestor
5785152|NCT02829957|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5785153|NCT02829957|Protease Inhibitors|protease inhibitors|mesh-ancestor
5785154|NCT02829957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5785155|NCT02829957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5785156|NCT02829957|Anticoagulants|anticoagulants|mesh-ancestor
5785157|NCT02830139|Capecitabine|capecitabine|mesh-list
5785158|NCT02830139|Oxaliplatin|oxaliplatin|mesh-list
5785159|NCT02830139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5785160|NCT02830139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5785161|NCT02830139|Antimetabolites|antimetabolites|mesh-ancestor
5785162|NCT02830139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5785163|NCT02829840|Azacitidine|azacitidine|mesh-list
5785164|NCT02829840|Ponatinib|ponatinib|mesh-list
5785165|NCT02829840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5785166|NCT02829840|Antimetabolites|antimetabolites|mesh-ancestor
5785167|NCT02829840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5785168|NCT02829840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5785169|NCT02829840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5785170|NCT02829840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5785171|NCT02829385|Apatinib|apatinib|mesh-list
5785172|NCT02829385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5785173|NCT02829385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5785174|NCT02829385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5785175|NCT02829385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898263|NCT03773276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5898264|NCT03773276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5898265|NCT03773276|Adrenergic Agents|adrenergic agents|mesh-ancestor
5898266|NCT03773276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5898267|NCT03773276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898268|NCT03773276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898269|NCT03773276|Sympathomimetics|sympathomimetics|mesh-ancestor
5898270|NCT03773276|Autonomic Agents|autonomic agents|mesh-ancestor
5898271|NCT03773276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5898272|NCT03773276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5898273|NCT03738696|Bupivacaine|bupivacaine|mesh-list
5898274|NCT03738696|Ropivacaine|ropivacaine|mesh-list
5898275|NCT03738696|Anesthetics, Local|anesthetics, local|mesh-ancestor
5898276|NCT03738696|Anesthetics|anesthetics|mesh-ancestor
5898277|NCT03738696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5898278|NCT03738696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898279|NCT03738696|Sensory System Agents|sensory system agents|mesh-ancestor
5898280|NCT03738696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5898281|NCT03719768|Avelumab|avelumab|mesh-list
5898282|NCT03719768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5898283|NCT03719768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5898284|NCT03712787|Tilavonemab|tilavonemab|mesh-list
5898285|NCT03712787|Nootropic Agents|nootropic agents|mesh-ancestor
5898286|NCT03708003|Venetoclax|venetoclax|mesh-list
5898287|NCT03708003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5898288|NCT03704610|Infliximab|infliximab|mesh-list
5898289|NCT03704610|Dermatologic Agents|dermatologic agents|mesh-ancestor
5898290|NCT03704610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5898291|NCT03704610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5898292|NCT03679650|Decitabine|decitabine|mesh-list
5898293|NCT03679650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5898294|NCT03679650|Antimetabolites|antimetabolites|mesh-ancestor
5898295|NCT03679650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898296|NCT03679650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5898297|NCT03679650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5898298|NCT03667482|Cetuximab|cetuximab|mesh-list
5898299|NCT03667482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5898300|NCT03667482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5898301|NCT03662815|Molgramostim|molgramostim|mesh-list
5898302|NCT03662815|Sargramostim|sargramostim|mesh-list
5898303|NCT03662815|Immunologic Factors|immunologic factors|mesh-ancestor
5898304|NCT03662815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898305|NCT03662815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5898306|NCT03645148|Molgramostim|molgramostim|mesh-list
5898307|NCT03645148|Sargramostim|sargramostim|mesh-list
5898308|NCT03645148|Immunologic Factors|immunologic factors|mesh-ancestor
5898309|NCT03645148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898310|NCT03645148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5898311|NCT03612921|Amantadine|amantadine|mesh-list
5898312|NCT03612921|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5898313|NCT03612921|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5898314|NCT03612921|Antiviral Agents|antiviral agents|mesh-ancestor
5898315|NCT03612921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5898316|NCT03612921|Dopamine Agents|dopamine agents|mesh-ancestor
5898317|NCT03612921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5898318|NCT03612921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898319|NCT03612921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898320|NCT03612921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5898321|NCT03612921|Analgesics|analgesics|mesh-ancestor
5898322|NCT03612921|Sensory System Agents|sensory system agents|mesh-ancestor
5898323|NCT03612921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5898324|NCT03611738|Docetaxel|docetaxel|mesh-list
5785176|NCT02829424|Methotrexate|methotrexate|mesh-list
5785177|NCT02829424|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5785178|NCT02829424|Abortifacient Agents|abortifacient agents|mesh-ancestor
5785179|NCT02829424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5785180|NCT02829424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785181|NCT02829424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5785182|NCT02829424|Antimetabolites|antimetabolites|mesh-ancestor
5785183|NCT02829424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5785184|NCT02829424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5785185|NCT02829424|Dermatologic Agents|dermatologic agents|mesh-ancestor
5785186|NCT02829424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5785187|NCT02829424|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5785188|NCT02829424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5785189|NCT02829424|Immunologic Factors|immunologic factors|mesh-ancestor
5785190|NCT02829424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5785191|NCT02829424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5785192|NCT02829359|Entecavir|entecavir|mesh-list
5785193|NCT02829359|Antiviral Agents|antiviral agents|mesh-ancestor
5785194|NCT02829359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5785195|NCT02829372|Antibodies|antibodies|mesh-list
5785196|NCT02829372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5785197|NCT02829372|Antibodies, Bispecific|antibodies, bispecific|mesh-list
5785198|NCT02829372|Immunologic Factors|immunologic factors|mesh-ancestor
5785199|NCT02829372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785200|NCT02829346|Tranexamic Acid|tranexamic acid|mesh-list
5785201|NCT02829346|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5785202|NCT02829346|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5785203|NCT02829346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5785204|NCT02829346|Hemostatics|hemostatics|mesh-ancestor
5785205|NCT02829346|Coagulants|coagulants|mesh-ancestor
5785206|NCT02829333|Anesthetics|anesthetics|mesh-list
5785207|NCT02829333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5785208|NCT02829333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785209|NCT02829697|Ropivacaine|ropivacaine|mesh-list
5785210|NCT02829697|Anesthetics, Local|anesthetics, local|mesh-ancestor
5785211|NCT02829697|Anesthetics|anesthetics|mesh-ancestor
5785212|NCT02829697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5785213|NCT02829697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785214|NCT02829697|Sensory System Agents|sensory system agents|mesh-ancestor
5785215|NCT02829697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5785216|NCT02829151|Aspirin|aspirin|mesh-list
5785217|NCT02829151|Cilostazol|cilostazol|mesh-list
5785218|NCT02829151|Clopidogrel|clopidogrel|mesh-list
5785219|NCT02829151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5785220|NCT02829151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5785221|NCT02829151|Analgesics|analgesics|mesh-ancestor
5785222|NCT02829151|Sensory System Agents|sensory system agents|mesh-ancestor
5785223|NCT02829151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5785224|NCT02829151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785225|NCT02829151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5785226|NCT02829151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5785227|NCT02829151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5785228|NCT02829151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5785229|NCT02829151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5785230|NCT02829151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5785231|NCT02829151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5785232|NCT02829151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5785233|NCT02829151|Antipyretics|antipyretics|mesh-ancestor
5785234|NCT02829151|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5785235|NCT02829151|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5785236|NCT02829151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5785237|NCT02829151|Purinergic Agents|purinergic agents|mesh-ancestor
5785238|NCT02829151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5785239|NCT02829151|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5785240|NCT02829151|Autonomic Agents|autonomic agents|mesh-ancestor
5785241|NCT02829151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5785242|NCT02829151|Respiratory System Agents|respiratory system agents|mesh-ancestor
5785243|NCT02829151|Vasodilator Agents|vasodilator agents|mesh-ancestor
5785244|NCT02829151|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5785245|NCT02829151|Protective Agents|protective agents|mesh-ancestor
5785246|NCT02829151|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5785247|NCT02829151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5785248|NCT02829177|Allopurinol|allopurinol|mesh-list
5785249|NCT02829177|Antimetabolites|antimetabolites|mesh-ancestor
5785250|NCT02829177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5785251|NCT02829177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5785252|NCT02829177|Gout Suppressants|gout suppressants|mesh-ancestor
5785253|NCT02829177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5785254|NCT02829177|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5785255|NCT02829177|Antioxidants|antioxidants|mesh-ancestor
5785256|NCT02829177|Protective Agents|protective agents|mesh-ancestor
5785257|NCT02829177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785258|NCT02829281|Triamcinolone|triamcinolone|mesh-list
5785259|NCT02829281|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5785260|NCT02829281|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5785261|NCT02829281|Botulinum Toxins|botulinum toxins|mesh-list
5785262|NCT02829281|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5785263|NCT02829281|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5785264|NCT02829281|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5785265|NCT02829281|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5785266|NCT02829281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5785267|NCT02829281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5785268|NCT02829281|Cholinergic Agents|cholinergic agents|mesh-ancestor
5785269|NCT02829281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5785270|NCT02829281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785271|NCT02829281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5785272|NCT02829281|Glucocorticoids|glucocorticoids|mesh-ancestor
5785273|NCT02829281|Hormones|hormones|mesh-ancestor
5785274|NCT02829281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5785275|NCT02829281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5785276|NCT02829281|Immunologic Factors|immunologic factors|mesh-ancestor
5785277|NCT02829281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5785278|NCT02829281|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5785279|NCT02829281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5785280|NCT02829060|Gentamicins|gentamicins|mesh-list
5785281|NCT02829060|Ampicillin|ampicillin|mesh-list
5785282|NCT02829060|Nitrofurantoin|nitrofurantoin|mesh-list
5785283|NCT02829060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5785284|NCT02829060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5785285|NCT02829060|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5785286|NCT02829060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5785287|NCT02829060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5785288|NCT02829060|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5785289|NCT02829060|Renal Agents|renal agents|mesh-ancestor
5785290|NCT02829008|Bevacizumab|bevacizumab|mesh-list
5785291|NCT02829008|Pemetrexed|pemetrexed|mesh-list
5785292|NCT02829008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5785293|NCT02829008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5785294|NCT02829008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5785295|NCT02829008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5785296|NCT02829008|Growth Substances|growth substances|mesh-ancestor
5785297|NCT02829008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785298|NCT02829008|Growth Inhibitors|growth inhibitors|mesh-ancestor
5785299|NCT02829008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5785300|NCT02829008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5785301|NCT02829008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5785302|NCT02829008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5785303|NCT02828592|Cyclophosphamide|cyclophosphamide|mesh-list
5785304|NCT02828592|Fludarabine|fludarabine|mesh-list
5785305|NCT02828592|Thymoglobulin|thymoglobulin|mesh-list
5785306|NCT02828592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5785307|NCT02828592|Immunologic Factors|immunologic factors|mesh-ancestor
5785308|NCT02828592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785309|NCT02828592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5785310|NCT02828592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5785311|NCT02828592|Alkylating Agents|alkylating agents|mesh-ancestor
5785312|NCT02828592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5785313|NCT02828592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5785314|NCT02828592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5785315|NCT02828384|Psyllium|psyllium|mesh-list
5785316|NCT02828384|Cathartics|cathartics|mesh-ancestor
5785317|NCT02828384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5785318|NCT02828566|Ketamine|ketamine|mesh-list
5785319|NCT02828566|Analgesics|analgesics|mesh-ancestor
5785320|NCT02828566|Sensory System Agents|sensory system agents|mesh-ancestor
5785321|NCT02828566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5785322|NCT02828566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785323|NCT02828566|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5785324|NCT02828566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5785325|NCT02828566|Anesthetics, General|anesthetics, general|mesh-ancestor
5785326|NCT02828566|Anesthetics|anesthetics|mesh-ancestor
5785327|NCT02828566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5785328|NCT02828566|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5785329|NCT02828566|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5785330|NCT02828566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5785331|NCT02828566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5785332|NCT02828163|Triamcinolone|triamcinolone|mesh-list
5785333|NCT02828163|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5785334|NCT02828163|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5785335|NCT02828163|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5785336|NCT02828163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5785337|NCT02828163|Glucocorticoids|glucocorticoids|mesh-ancestor
5785338|NCT02828163|Hormones|hormones|mesh-ancestor
5785339|NCT02828163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5785340|NCT02828163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785341|NCT02828163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5785342|NCT02828163|Immunologic Factors|immunologic factors|mesh-ancestor
5785343|NCT02828163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5785344|NCT02828163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5785345|NCT02828176|Anesthetics|anesthetics|mesh-list
6491231|NCT00601666|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6491232|NCT00601666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6491233|NCT00601666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6491234|NCT00601666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491235|NCT00601666|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6491236|NCT00601666|GABA Agonists|gaba agonists|mesh-ancestor
6491237|NCT00601666|GABA Agents|gaba agents|mesh-ancestor
6491238|NCT00601666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5785346|NCT02828176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5785347|NCT02828176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785348|NCT02828059|Ropivacaine|ropivacaine|mesh-list
5785349|NCT02828059|Anesthetics, Local|anesthetics, local|mesh-ancestor
5785350|NCT02828059|Anesthetics|anesthetics|mesh-ancestor
5785351|NCT02828059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5785352|NCT02828059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785353|NCT02828059|Sensory System Agents|sensory system agents|mesh-ancestor
5785354|NCT02828059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5785355|NCT02828228|Vitamin D|vitamin d|mesh-list
5785356|NCT02828228|Cholecalciferol|cholecalciferol|mesh-list
5785357|NCT02828228|Vitamins|vitamins|mesh-ancestor
5785358|NCT02828228|Micronutrients|micronutrients|mesh-ancestor
5785359|NCT02828228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785360|NCT02828228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5785361|NCT02828228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5785362|NCT02827903|Metformin|metformin|mesh-list
5785363|NCT02827903|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5785364|NCT02827903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5785365|NCT02827903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785366|NCT02827903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5785367|NCT02827903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5785368|NCT02827903|Antimetabolites|antimetabolites|mesh-ancestor
5785369|NCT02827903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5785370|NCT02827903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5785371|NCT02827903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5785372|NCT02827903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5785373|NCT02828033|Rilonacept|rilonacept|mesh-list
5785374|NCT02828033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5785375|NCT02827890|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5785376|NCT02827890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5785377|NCT02827890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785378|NCT02827890|Incretins|incretins|mesh-ancestor
5785379|NCT02827890|Hormones|hormones|mesh-ancestor
5785380|NCT02827890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5785381|NCT02827890|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5785382|NCT02827890|Protease Inhibitors|protease inhibitors|mesh-ancestor
5785383|NCT02827890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5785384|NCT02827890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898325|NCT03611738|Ceritinib|ceritinib|mesh-list
5898326|NCT03611738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5898327|NCT03611738|Tubulin Modulators|tubulin modulators|mesh-ancestor
5898328|NCT03611738|Antimitotic Agents|antimitotic agents|mesh-ancestor
5898329|NCT03611738|Mitosis Modulators|mitosis modulators|mesh-ancestor
5898330|NCT03611738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898331|NCT03611738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5785385|NCT02827877|Copper|copper|mesh-list
5785386|NCT02827877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5785387|NCT02827877|Trastuzumab|trastuzumab|mesh-list
5785388|NCT02827877|Pertuzumab|pertuzumab|mesh-list
5785389|NCT02827877|Antibodies|antibodies|mesh-list
5785390|NCT02827877|Immunoglobulins|immunoglobulins|mesh-list
5785391|NCT02827877|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5785392|NCT02827877|Immunologic Factors|immunologic factors|mesh-ancestor
5785393|NCT02827877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785394|NCT02827877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5785395|NCT02827877|Trace Elements|trace elements|mesh-ancestor
5785396|NCT02827877|Micronutrients|micronutrients|mesh-ancestor
5785397|NCT02827643|Vitamin D|vitamin d|mesh-list
5785398|NCT02827643|Ergocalciferols|ergocalciferols|mesh-list
5785399|NCT02827643|Lamivudine|lamivudine|mesh-list
5785400|NCT02827643|Calcium|calcium|mesh-list
5785401|NCT02827643|Vitamins|vitamins|mesh-ancestor
5785402|NCT02827643|Micronutrients|micronutrients|mesh-ancestor
5785403|NCT02827643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785404|NCT02827643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5785405|NCT02827643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5785406|NCT02827643|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5785407|NCT02827643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5785408|NCT02827643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5785409|NCT02827643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5785410|NCT02827643|Antiviral Agents|antiviral agents|mesh-ancestor
5785411|NCT02827643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5785412|NCT02827643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5785413|NCT02827643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5785414|NCT02827656|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5785415|NCT02827656|Luteolytic Agents|luteolytic agents|mesh-ancestor
5785416|NCT02827656|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5785417|NCT02827656|Contraceptive Agents|contraceptive agents|mesh-ancestor
5785418|NCT02827656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5785419|NCT02827656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785420|NCT02827656|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5785421|NCT02827656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5785422|NCT02827656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5785423|NCT02827747|Vitamin A|vitamin a|mesh-list
5785424|NCT02827747|Antioxidants|antioxidants|mesh-list
5785425|NCT02827747|Vitamins|vitamins|mesh-ancestor
5785426|NCT02827747|Micronutrients|micronutrients|mesh-ancestor
5785427|NCT02827747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785428|NCT02827747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5785429|NCT02827747|Protective Agents|protective agents|mesh-ancestor
5785430|NCT02827578|Tamsulosin|tamsulosin|mesh-list
5785431|NCT02827578|Solifenacin Succinate|solifenacin succinate|mesh-list
5785432|NCT02827578|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5785433|NCT02827578|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5785434|NCT02827578|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5785435|NCT02827578|Adrenergic Agents|adrenergic agents|mesh-ancestor
5785436|NCT02827578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5785437|NCT02827578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5785438|NCT02827578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785439|NCT02827578|Urological Agents|urological agents|mesh-ancestor
5785440|NCT02827578|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5785441|NCT02827578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5785442|NCT02827578|Cholinergic Agents|cholinergic agents|mesh-ancestor
5785443|NCT02827682|Anesthetics|anesthetics|mesh-list
5785444|NCT02827682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5785445|NCT02827682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785446|NCT02827435|Bromides|bromides|mesh-list
5785447|NCT02827435|Rocuronium|rocuronium|mesh-list
5785448|NCT02827435|Anticonvulsants|anticonvulsants|mesh-ancestor
5785449|NCT02827435|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5785450|NCT02827435|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5785451|NCT02827435|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5785452|NCT02827435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5785453|NCT02827435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785454|NCT02827487|Celecoxib|celecoxib|mesh-list
5785455|NCT02827487|Tramadol|tramadol|mesh-list
5785456|NCT02827487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5785457|NCT02827487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5785458|NCT02827487|Analgesics|analgesics|mesh-ancestor
5785459|NCT02827487|Sensory System Agents|sensory system agents|mesh-ancestor
5785460|NCT02827487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5785461|NCT02827487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785462|NCT02827487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5785463|NCT02827487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5785464|NCT02827487|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5785465|NCT02827487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5785466|NCT02827487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5785467|NCT02827487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5785468|NCT02827487|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5785469|NCT02827487|Narcotics|narcotics|mesh-ancestor
5785470|NCT02827487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5785471|NCT02827266|Epoetin Alfa|epoetin alfa|mesh-list
5785472|NCT02827266|Hematinics|hematinics|mesh-ancestor
5785473|NCT02827331|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
5785474|NCT02827331|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
5785475|NCT02827331|Antidepressive Agents|antidepressive agents|mesh-list
5785476|NCT02827331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5785477|NCT02827331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5785478|NCT02827331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785479|NCT02827331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5785480|NCT02827942|Amoxicillin|amoxicillin|mesh-list
5785481|NCT02827942|Metronidazole|metronidazole|mesh-list
5785482|NCT02827942|Clarithromycin|clarithromycin|mesh-list
5785483|NCT02827942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5785484|NCT02827942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5785485|NCT02827942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5785486|NCT02827942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5785487|NCT02827942|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5785488|NCT02827942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5785489|NCT02827942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5785490|NCT02827942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5785491|NCT02827942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5785492|NCT02827136|Lidocaine|lidocaine|mesh-list
5785493|NCT02827136|Anesthetics, Local|anesthetics, local|mesh-ancestor
5785494|NCT02827136|Anesthetics|anesthetics|mesh-ancestor
5785495|NCT02827136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5785496|NCT02827136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785497|NCT02827136|Sensory System Agents|sensory system agents|mesh-ancestor
5785498|NCT02827136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5785499|NCT02827136|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5785500|NCT02827136|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5785501|NCT02827136|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5785502|NCT02827136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5785503|NCT02827136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5785504|NCT02826902|Remifentanil|remifentanil|mesh-list
5785505|NCT02826902|Propofol|propofol|mesh-list
5785506|NCT02826902|Desflurane|desflurane|mesh-list
5785507|NCT02826902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5785508|NCT02826902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5785509|NCT02826902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785510|NCT02826902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5785511|NCT02826902|Anesthetics, General|anesthetics, general|mesh-ancestor
5785512|NCT02826902|Anesthetics|anesthetics|mesh-ancestor
5785513|NCT02826902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5785514|NCT02826902|Narcotics|narcotics|mesh-ancestor
5785515|NCT02826902|Analgesics|analgesics|mesh-ancestor
5785516|NCT02826902|Sensory System Agents|sensory system agents|mesh-ancestor
5785517|NCT02826902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5785518|NCT02826902|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5785519|NCT02826564|Pembrolizumab|pembrolizumab|mesh-list
5785520|NCT02826564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5785521|NCT02826564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5785522|NCT02826616|Trimetazidine|trimetazidine|mesh-list
5785523|NCT02826616|Vasodilator Agents|vasodilator agents|mesh-ancestor
5785524|NCT02826772|Androgens|androgens|mesh-list
5785525|NCT02826772|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
5785526|NCT02826772|Hormones|hormones|mesh-ancestor
5785527|NCT02826772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5785528|NCT02826772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785529|NCT02826772|Androgen Antagonists|androgen antagonists|mesh-ancestor
5785530|NCT02826772|Hormone Antagonists|hormone antagonists|mesh-ancestor
5785531|NCT02826876|Ropivacaine|ropivacaine|mesh-list
5785532|NCT02826876|Anesthetics, Local|anesthetics, local|mesh-ancestor
5785533|NCT02826876|Anesthetics|anesthetics|mesh-ancestor
5785534|NCT02826876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5785535|NCT02826876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785536|NCT02826876|Sensory System Agents|sensory system agents|mesh-ancestor
5898332|NCT03611738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5785537|NCT02826876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5785538|NCT02826759|Insulin|insulin|mesh-list
5785539|NCT02826759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5785540|NCT02826759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785541|NCT02826746|Magnesium Sulfate|magnesium sulfate|mesh-list
5785542|NCT02826746|Analgesics|analgesics|mesh-ancestor
5785543|NCT02826746|Sensory System Agents|sensory system agents|mesh-ancestor
5785544|NCT02826746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5785545|NCT02826746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785546|NCT02826746|Anesthetics|anesthetics|mesh-ancestor
5785547|NCT02826746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5785548|NCT02826746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5785549|NCT02826746|Anticonvulsants|anticonvulsants|mesh-ancestor
5785550|NCT02826746|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5785551|NCT02826746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5785552|NCT02826746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5785553|NCT02826746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5785554|NCT02826746|Tocolytic Agents|tocolytic agents|mesh-ancestor
5785555|NCT02826746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5785556|NCT02826837|Bevacizumab|bevacizumab|mesh-list
5785557|NCT02826837|Cetuximab|cetuximab|mesh-list
5785558|NCT02826837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5785559|NCT02826837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5785560|NCT02826837|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5785561|NCT02826837|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5785562|NCT02826837|Growth Substances|growth substances|mesh-ancestor
5785563|NCT02826837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785564|NCT02826837|Growth Inhibitors|growth inhibitors|mesh-ancestor
5785565|NCT02826486|Leucovorin|leucovorin|mesh-list
5785566|NCT02826486|Pembrolizumab|pembrolizumab|mesh-list
5785567|NCT02826486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5785568|NCT02826486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5785569|NCT02826486|Antidotes|antidotes|mesh-ancestor
5785570|NCT02826486|Protective Agents|protective agents|mesh-ancestor
5785571|NCT02826486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785572|NCT02826486|Vitamin B Complex|vitamin b complex|mesh-ancestor
5785573|NCT02826486|Vitamins|vitamins|mesh-ancestor
5785574|NCT02826486|Micronutrients|micronutrients|mesh-ancestor
5785575|NCT02826408|Rabeprazole|rabeprazole|mesh-list
5785576|NCT02826408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5785577|NCT02826408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5785578|NCT02826408|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5785579|NCT02826408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5785580|NCT02826408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898333|NCT03603808|Vaccines|vaccines|mesh-list
5898334|NCT03603808|Immunologic Factors|immunologic factors|mesh-ancestor
5898335|NCT03603808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898336|NCT03568383|Pyridoxine|pyridoxine|mesh-list
5898337|NCT03568383|Pyridoxal|pyridoxal|mesh-list
5898338|NCT03568383|Vitamin B 6|vitamin b 6|mesh-list
5898339|NCT03568383|Isoniazid|isoniazid|mesh-list
5898340|NCT03568383|Vitamins|vitamins|mesh-ancestor
5898341|NCT03568383|Micronutrients|micronutrients|mesh-ancestor
5898342|NCT03568383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898343|NCT03568383|Vitamin B Complex|vitamin b complex|mesh-ancestor
5898344|NCT03568383|Antitubercular Agents|antitubercular agents|mesh-ancestor
5898345|NCT03568383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5898346|NCT03568383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5898347|NCT03568383|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5898348|NCT03568383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5898349|NCT03568383|Antimetabolites|antimetabolites|mesh-ancestor
5898350|NCT03568383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898351|NCT03568383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5898352|NCT03534453|Olaparib|olaparib|mesh-list
5898353|NCT03534453|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5898354|NCT03534453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5898355|NCT03534453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898356|NCT03534453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5898357|NCT03501576|Vaccines|vaccines|mesh-list
5898358|NCT03501576|Immunologic Factors|immunologic factors|mesh-ancestor
5898359|NCT03501576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898360|NCT03490903|Fentanyl|fentanyl|mesh-list
5898361|NCT03490903|Midazolam|midazolam|mesh-list
5898362|NCT03490903|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5898363|NCT03490903|Narcotics|narcotics|mesh-ancestor
5898364|NCT03490903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5898365|NCT03490903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898366|NCT03490903|Analgesics|analgesics|mesh-ancestor
5785581|NCT02826434|Durvalumab|durvalumab|mesh-list
5785582|NCT02826434|Poly ICLC|poly iclc|mesh-list
5785583|NCT02826434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5785584|NCT02826434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5785585|NCT02826434|Interferon Inducers|interferon inducers|mesh-ancestor
5785586|NCT02826434|Immunologic Factors|immunologic factors|mesh-ancestor
5785587|NCT02826434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785588|NCT02826343|Xenon|xenon|mesh-list
5785589|NCT02826343|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
5785590|NCT02826343|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5785591|NCT02826343|Anesthetics, General|anesthetics, general|mesh-ancestor
5785592|NCT02826343|Anesthetics|anesthetics|mesh-ancestor
5785593|NCT02826343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5785594|NCT02826343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785595|NCT02826343|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5785596|NCT02826343|Autonomic Agents|autonomic agents|mesh-ancestor
5785597|NCT02826343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5785598|NCT02826343|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5785599|NCT02826343|Respiratory System Agents|respiratory system agents|mesh-ancestor
5785600|NCT02826343|Glucocorticoids|glucocorticoids|mesh-ancestor
5785601|NCT02826343|Hormones|hormones|mesh-ancestor
5785602|NCT02826343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5785603|NCT02826343|Sympathomimetics|sympathomimetics|mesh-ancestor
5785604|NCT02826252|Iloprost|iloprost|mesh-list
5785605|NCT02826252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5785606|NCT02826252|Vasodilator Agents|vasodilator agents|mesh-ancestor
5785607|NCT02826200|Acenocoumarol|acenocoumarol|mesh-list
5785608|NCT02826200|Anticoagulants|anticoagulants|mesh-ancestor
5785609|NCT02825953|Pulmonary Surfactants|pulmonary surfactants|mesh-list
5785610|NCT02825953|Respiratory System Agents|respiratory system agents|mesh-ancestor
5785611|NCT02826070|Adefovir|adefovir|mesh-list
5785612|NCT02826070|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
5785613|NCT02826070|Telbivudine|telbivudine|mesh-list
5785614|NCT02826070|Antiviral Agents|antiviral agents|mesh-ancestor
5785615|NCT02826070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5785616|NCT02826070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5785617|NCT02826070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5785618|NCT02826070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5785619|NCT02826070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5785620|NCT02826226|Bronchodilator Agents|bronchodilator agents|mesh-list
5785621|NCT02826226|Autonomic Agents|autonomic agents|mesh-ancestor
5785622|NCT02826226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5785623|NCT02826226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785624|NCT02826226|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5785625|NCT02826226|Respiratory System Agents|respiratory system agents|mesh-ancestor
5785626|NCT02825979|Sotalol|sotalol|mesh-list
5785627|NCT02825979|Flecainide|flecainide|mesh-list
5785628|NCT02825979|Dronedarone|dronedarone|mesh-list
5785629|NCT02825979|Propafenone|propafenone|mesh-list
5785630|NCT02825979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
5785631|NCT02825979|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5785632|NCT02825979|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5785633|NCT02825979|Adrenergic Agents|adrenergic agents|mesh-ancestor
5785634|NCT02825979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5785635|NCT02825979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5785636|NCT02825979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785637|NCT02825979|Sympatholytics|sympatholytics|mesh-ancestor
5785638|NCT02825979|Autonomic Agents|autonomic agents|mesh-ancestor
5785639|NCT02825979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5785640|NCT02825979|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5785641|NCT02825979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5785642|NCT02825979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5785643|NCT02826174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
5785644|NCT02826174|Anesthetics|anesthetics|mesh-list
5785645|NCT02826174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5785646|NCT02826174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785647|NCT02826031|Hyaluronic Acid|hyaluronic acid|mesh-list
5785648|NCT02826031|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5785649|NCT02826031|Immunologic Factors|immunologic factors|mesh-ancestor
5785650|NCT02826031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785651|NCT02826031|Viscosupplements|viscosupplements|mesh-ancestor
5785652|NCT02826031|Protective Agents|protective agents|mesh-ancestor
5785653|NCT02825719|Tranexamic Acid|tranexamic acid|mesh-list
5785654|NCT02825719|Ulipristal acetate|ulipristal acetate|mesh-list
5785655|NCT02825719|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6212595|NCT02191033|Cholinergic Agents|cholinergic agents|mesh-ancestor
5785656|NCT02825719|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5785657|NCT02825719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491239|NCT00601666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491240|NCT00601692|Docetaxel|docetaxel|mesh-list
6491241|NCT00601692|Irinotecan|irinotecan|mesh-list
6491242|NCT00601692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6491243|NCT00601692|Tubulin Modulators|tubulin modulators|mesh-ancestor
6491244|NCT00601692|Antimitotic Agents|antimitotic agents|mesh-ancestor
6491245|NCT00601692|Mitosis Modulators|mitosis modulators|mesh-ancestor
6491246|NCT00601692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491247|NCT00601692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6491248|NCT00601692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6491249|NCT00601692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6496401|NCT00627887|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6210758|NCT02164513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6210759|NCT02164513|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6210760|NCT02164513|Autonomic Agents|autonomic agents|mesh-ancestor
6496402|NCT00627900|Sirolimus|sirolimus|mesh-list
6496403|NCT00627900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6496404|NCT00627900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6496405|NCT00627900|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6496406|NCT00627900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6496407|NCT00627900|Antifungal Agents|antifungal agents|mesh-ancestor
6496408|NCT00627900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6496409|NCT00627900|Immunologic Factors|immunologic factors|mesh-ancestor
6496410|NCT00627900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496411|NCT00627913|Anesthetics|anesthetics|mesh-list
6496412|NCT00627913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6496413|NCT00627913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496414|NCT00627952|Amlodipine|amlodipine|mesh-list
6496415|NCT00627952|Manidipine|manidipine|mesh-list
6496416|NCT00627952|Delapril|delapril|mesh-list
5785658|NCT02825719|Hemostatics|hemostatics|mesh-ancestor
5785659|NCT02825719|Coagulants|coagulants|mesh-ancestor
5785660|NCT02825719|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5785661|NCT02825719|Contraceptive Agents|contraceptive agents|mesh-ancestor
5785662|NCT02825719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5785663|NCT02825719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785664|NCT02825719|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5785665|NCT02825914|Caseins|caseins|mesh-list
5785666|NCT02825914|Chelating Agents|chelating agents|mesh-ancestor
5785667|NCT02825914|Sequestering Agents|sequestering agents|mesh-ancestor
5785668|NCT02825914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5785669|NCT02825576|Glycopyrrolate|glycopyrrolate|mesh-list
5785670|NCT02825576|Neostigmine|neostigmine|mesh-list
5785671|NCT02825576|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5785672|NCT02825576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5785673|NCT02825576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5785674|NCT02825576|Cholinergic Agents|cholinergic agents|mesh-ancestor
5785675|NCT02825576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5785676|NCT02825576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785677|NCT02825576|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5785678|NCT02825576|Autonomic Agents|autonomic agents|mesh-ancestor
5785679|NCT02825576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5785680|NCT02825576|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5785681|NCT02825576|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5785682|NCT02825576|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5785683|NCT02825797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5785684|NCT02825797|Antibodies|antibodies|mesh-list
5785685|NCT02825797|Immunoglobulins|immunoglobulins|mesh-list
5785686|NCT02825797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5785687|NCT02825797|Immunologic Factors|immunologic factors|mesh-ancestor
5785688|NCT02825797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785689|NCT02825797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5785690|NCT02825394|Ecarin|ecarin|mesh-list
5785691|NCT02825394|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5785692|NCT02825394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6673764|NCT01564979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6673765|NCT01565018|Rotigotine|rotigotine|mesh-list
6673766|NCT01565018|Dopamine Agonists|dopamine agonists|mesh-ancestor
6673767|NCT01565018|Dopamine Agents|dopamine agents|mesh-ancestor
6673768|NCT01565018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5785693|NCT02825394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496417|NCT00627952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5785694|NCT02825147|Dexamethasone|dexamethasone|mesh-list
6496418|NCT00627952|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5785695|NCT02825147|Methotrexate|methotrexate|mesh-list
5785696|NCT02825147|Etoposide|etoposide|mesh-list
5785697|NCT02825147|Pegaspargase|pegaspargase|mesh-list
5785698|NCT02825147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5785699|NCT02825147|Antiemetics|antiemetics|mesh-ancestor
5785700|NCT02825147|Autonomic Agents|autonomic agents|mesh-ancestor
5785701|NCT02825147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5785702|NCT02825147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785703|NCT02825147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5785704|NCT02825147|Glucocorticoids|glucocorticoids|mesh-ancestor
5785705|NCT02825147|Hormones|hormones|mesh-ancestor
5785706|NCT02825147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5785707|NCT02825147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5785708|NCT02825147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5785709|NCT02825147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5785710|NCT02825147|Abortifacient Agents|abortifacient agents|mesh-ancestor
5785711|NCT02825147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5785712|NCT02825147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5785713|NCT02825147|Antimetabolites|antimetabolites|mesh-ancestor
5785714|NCT02825147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5785715|NCT02825147|Dermatologic Agents|dermatologic agents|mesh-ancestor
5785716|NCT02825147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5785717|NCT02825147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5785718|NCT02825147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5785719|NCT02825147|Immunologic Factors|immunologic factors|mesh-ancestor
5785720|NCT02825147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5785721|NCT02825147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5785722|NCT02825147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5785723|NCT02825147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5785724|NCT02825147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5785725|NCT02825290|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5785726|NCT02825290|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5785727|NCT02825290|Luteolytic Agents|luteolytic agents|mesh-ancestor
5785728|NCT02825290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5785729|NCT02825290|Contraceptive Agents|contraceptive agents|mesh-ancestor
5785730|NCT02825290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5785731|NCT02825290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785732|NCT02825290|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5785733|NCT02825290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6673769|NCT01565018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673770|NCT01565018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673771|NCT01565096|Metformin|metformin|mesh-list
6673772|NCT01565096|Glimepiride|glimepiride|mesh-list
6673773|NCT01565096|Vildagliptin|vildagliptin|mesh-list
6673774|NCT01565096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6673775|NCT01565096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785734|NCT02825290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5785735|NCT02825342|Citalopram|citalopram|mesh-list
5785736|NCT02825342|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
5785737|NCT02825342|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5785738|NCT02825342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5785739|NCT02825342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5785740|NCT02825342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5785741|NCT02825342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5785742|NCT02825342|Serotonin Agents|serotonin agents|mesh-ancestor
5785743|NCT02825342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785744|NCT02825342|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5785745|NCT02825342|Antidepressive Agents|antidepressive agents|mesh-ancestor
5785746|NCT02825342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5785747|NCT02825342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5785748|NCT02825225|Anesthetics|anesthetics|mesh-list
5785749|NCT02825225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5785750|NCT02825225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785751|NCT02825186|Dexamethasone|dexamethasone|mesh-list
5785752|NCT02825186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5785753|NCT02825186|Antiemetics|antiemetics|mesh-ancestor
5785754|NCT02825186|Autonomic Agents|autonomic agents|mesh-ancestor
5785755|NCT02825186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5785756|NCT02825186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785757|NCT02825186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5785758|NCT02825186|Glucocorticoids|glucocorticoids|mesh-ancestor
5785759|NCT02825186|Hormones|hormones|mesh-ancestor
5785760|NCT02825186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5785761|NCT02825186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5785762|NCT02825186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5785763|NCT02825095|Lidocaine|lidocaine|mesh-list
5785764|NCT02825095|Anesthetics, Local|anesthetics, local|mesh-ancestor
5785765|NCT02825095|Anesthetics|anesthetics|mesh-ancestor
5785766|NCT02825095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5785767|NCT02825095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785768|NCT02825095|Sensory System Agents|sensory system agents|mesh-ancestor
5785769|NCT02825095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5785770|NCT02825095|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5785771|NCT02825095|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5785772|NCT02825095|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5785773|NCT02825095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5785774|NCT02825095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5785775|NCT02825121|Iodine|iodine|mesh-list
5785776|NCT02825121|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5785777|NCT02825121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5785778|NCT02825121|Trace Elements|trace elements|mesh-ancestor
5785779|NCT02825121|Micronutrients|micronutrients|mesh-ancestor
5785780|NCT02825121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785781|NCT02825199|Caffeine|caffeine|mesh-list
5785782|NCT02825199|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5785783|NCT02825199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785784|NCT02825199|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5785785|NCT02825199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5785786|NCT02825199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5785787|NCT02825199|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5785788|NCT02825199|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5785789|NCT02825199|Purinergic Agents|purinergic agents|mesh-ancestor
5785790|NCT02825199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5785791|NCT02824965|Pembrolizumab|pembrolizumab|mesh-list
5785792|NCT02824965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5785793|NCT02824965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5785794|NCT02825056|Morphine|morphine|mesh-list
5785795|NCT02825056|Bupivacaine|bupivacaine|mesh-list
5785796|NCT02825056|Anesthetics, Local|anesthetics, local|mesh-ancestor
5785797|NCT02825056|Anesthetics|anesthetics|mesh-ancestor
5785798|NCT02825056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5785799|NCT02825056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785800|NCT02825056|Sensory System Agents|sensory system agents|mesh-ancestor
5785801|NCT02825056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5785802|NCT02825056|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5785803|NCT02825056|Narcotics|narcotics|mesh-ancestor
5785804|NCT02825056|Analgesics|analgesics|mesh-ancestor
5785805|NCT02824926|Ketoconazole|ketoconazole|mesh-list
5785806|NCT02824926|Antifungal Agents|antifungal agents|mesh-ancestor
5785807|NCT02824926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6491250|NCT00601874|Pilocarpine|pilocarpine|mesh-list
6491251|NCT00601874|Miotics|miotics|mesh-ancestor
5785808|NCT02824926|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5785809|NCT02824926|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5785810|NCT02824926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5785811|NCT02824926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5785812|NCT02824926|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5785813|NCT02824926|Hormone Antagonists|hormone antagonists|mesh-ancestor
5785814|NCT02824926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5785815|NCT02824926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785816|NCT02824926|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5898367|NCT03490903|Sensory System Agents|sensory system agents|mesh-ancestor
5898368|NCT03490903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5898369|NCT03490903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5898370|NCT03490903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5898371|NCT03490903|Anesthetics, General|anesthetics, general|mesh-ancestor
5898372|NCT03490903|Anesthetics|anesthetics|mesh-ancestor
5898373|NCT03490903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5898374|NCT03490903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5898375|NCT03490903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5898376|NCT03490903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5898377|NCT03490903|GABA Modulators|gaba modulators|mesh-ancestor
5898378|NCT03490903|GABA Agents|gaba agents|mesh-ancestor
5898379|NCT03490903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5898380|NCT03490903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898381|NCT03457701|Iron|iron|mesh-list
6491252|NCT00601874|Autonomic Agents|autonomic agents|mesh-ancestor
5898382|NCT03457701|Trace Elements|trace elements|mesh-ancestor
5898383|NCT03457701|Micronutrients|micronutrients|mesh-ancestor
5785817|NCT02824601|Calcium|calcium|mesh-list
5785818|NCT02824601|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5785819|NCT02824601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785820|NCT02824770|Tramadol|tramadol|mesh-list
5785821|NCT02824770|Bupivacaine|bupivacaine|mesh-list
5785822|NCT02824770|Anesthetics, Local|anesthetics, local|mesh-ancestor
5785823|NCT02824770|Anesthetics|anesthetics|mesh-ancestor
5785824|NCT02824770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5785825|NCT02824770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785826|NCT02824770|Sensory System Agents|sensory system agents|mesh-ancestor
5785827|NCT02824770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5785828|NCT02824770|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5785829|NCT02824770|Narcotics|narcotics|mesh-ancestor
5785830|NCT02824770|Analgesics|analgesics|mesh-ancestor
5785831|NCT02824536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5785832|NCT02824536|Antibodies|antibodies|mesh-list
5785833|NCT02824536|Immunoglobulins|immunoglobulins|mesh-list
5785834|NCT02824536|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5785835|NCT02824536|Immunologic Factors|immunologic factors|mesh-ancestor
5785836|NCT02824536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785837|NCT02824536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5785838|NCT02824666|Fallypride|fallypride|mesh-list
5785839|NCT02824666|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5785840|NCT02824666|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5785841|NCT02824666|Dopamine Agents|dopamine agents|mesh-ancestor
5785842|NCT02824666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5785843|NCT02824666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5785844|NCT02824666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785845|NCT02824718|Teriparatide|teriparatide|mesh-list
5785846|NCT02824718|Alfacalcidol|alfacalcidol|mesh-list
5785847|NCT02824718|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
5785848|NCT02824718|Sodium Channel Blockers|sodium channel blockers|mesh-list
5785849|NCT02824718|Diuretics|diuretics|mesh-list
5785850|NCT02824718|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-list
5785851|NCT02824718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5785852|NCT02824718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785853|NCT02824718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5785854|NCT02824718|Natriuretic Agents|natriuretic agents|mesh-ancestor
5785855|NCT02824718|Vitamins|vitamins|mesh-ancestor
5785856|NCT02824718|Micronutrients|micronutrients|mesh-ancestor
5785857|NCT02824718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5785858|NCT02824718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5785859|NCT02824627|Oxytocin|oxytocin|mesh-list
5785860|NCT02824627|Oxytocics|oxytocics|mesh-ancestor
5785861|NCT02824627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5785862|NCT02824627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785863|NCT02824874|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5785864|NCT02824874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5785865|NCT02824874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785866|NCT02824874|Incretins|incretins|mesh-ancestor
5785867|NCT02824874|Hormones|hormones|mesh-ancestor
5785868|NCT02824874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5785869|NCT02824874|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5785870|NCT02824874|Protease Inhibitors|protease inhibitors|mesh-ancestor
5785871|NCT02824874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5785872|NCT02824874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5785873|NCT02824575|Paclitaxel|paclitaxel|mesh-list
5785874|NCT02824575|Rebastinib|rebastinib|mesh-list
5785875|NCT02824575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5785876|NCT02824575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5785877|NCT02824575|Tubulin Modulators|tubulin modulators|mesh-ancestor
5785878|NCT02824575|Antimitotic Agents|antimitotic agents|mesh-ancestor
5785879|NCT02824575|Mitosis Modulators|mitosis modulators|mesh-ancestor
5785880|NCT02824575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5785881|NCT02824575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5785882|NCT02824575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5785883|NCT02824614|Erythritol|erythritol|mesh-list
5785884|NCT02824614|Vasodilator Agents|vasodilator agents|mesh-ancestor
5785885|NCT02824510|Insulin|insulin|mesh-list
5785886|NCT02824510|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5785887|NCT02824510|Insulin Aspart|insulin aspart|mesh-list
5785888|NCT02824510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5785889|NCT02824510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785890|NCT02824523|Aspirin|aspirin|mesh-list
5785891|NCT02824523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5785892|NCT02824523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5785893|NCT02824523|Analgesics|analgesics|mesh-ancestor
5785894|NCT02824523|Sensory System Agents|sensory system agents|mesh-ancestor
5785895|NCT02824523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5785896|NCT02824523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785897|NCT02824523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5785898|NCT02824523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5785899|NCT02824523|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5785900|NCT02824523|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5785901|NCT02824523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5785902|NCT02824523|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5785903|NCT02824523|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5785904|NCT02824523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5785905|NCT02824523|Antipyretics|antipyretics|mesh-ancestor
5785906|NCT02824458|Apatinib|apatinib|mesh-list
5785907|NCT02824458|Gefitinib|gefitinib|mesh-list
5785908|NCT02824458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5785909|NCT02824458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5785910|NCT02824458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5785911|NCT02824458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5785912|NCT02824094|Crizotinib|crizotinib|mesh-list
5785913|NCT02824094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5785914|NCT02824094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5785915|NCT02824094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5785916|NCT02824094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5785917|NCT02824315|Simeprevir|simeprevir|mesh-list
5785918|NCT02824315|Odalasvir|odalasvir|mesh-list
5785919|NCT02824315|Antiviral Agents|antiviral agents|mesh-ancestor
5785920|NCT02824315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5785921|NCT02824315|Protease Inhibitors|protease inhibitors|mesh-ancestor
5785922|NCT02824315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5785923|NCT02824315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5785924|NCT02824406|Acetazolamide|acetazolamide|mesh-list
5785925|NCT02824406|Anticonvulsants|anticonvulsants|mesh-ancestor
5785926|NCT02824406|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5785927|NCT02824406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5785928|NCT02824406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5785929|NCT02824406|Diuretics|diuretics|mesh-ancestor
5785930|NCT02824406|Natriuretic Agents|natriuretic agents|mesh-ancestor
5785931|NCT02824406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785932|NCT02824354|Nalmefene|nalmefene|mesh-list
5785933|NCT02824354|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5785934|NCT02824354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785935|NCT02824354|Sensory System Agents|sensory system agents|mesh-ancestor
5785936|NCT02824354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5785937|NCT02824276|Morphine|morphine|mesh-list
5785938|NCT02824276|Oxycodone|oxycodone|mesh-list
5785939|NCT02824276|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5785940|NCT02824276|Narcotics|narcotics|mesh-ancestor
5785941|NCT02824276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5785942|NCT02824276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785943|NCT02824276|Analgesics|analgesics|mesh-ancestor
5785944|NCT02824276|Sensory System Agents|sensory system agents|mesh-ancestor
5785945|NCT02824276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5785946|NCT02823977|Dexmedetomidine|dexmedetomidine|mesh-list
5785947|NCT02823977|Ketamine|ketamine|mesh-list
5785948|NCT02823977|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5785949|NCT02823977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5785950|NCT02823977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785951|NCT02823977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5785952|NCT02823977|Analgesics|analgesics|mesh-ancestor
5785953|NCT02823977|Sensory System Agents|sensory system agents|mesh-ancestor
5785954|NCT02823977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5785955|NCT02823977|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5785956|NCT02823977|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5785957|NCT02823977|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5785958|NCT02823977|Adrenergic Agents|adrenergic agents|mesh-ancestor
5785959|NCT02823977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5785960|NCT02823977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5785961|NCT02823977|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5785962|NCT02823977|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5785963|NCT02823977|Anesthetics, General|anesthetics, general|mesh-ancestor
5785964|NCT02823977|Anesthetics|anesthetics|mesh-ancestor
5785965|NCT02823977|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5785966|NCT02823977|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5785967|NCT02823808|Glimepiride|glimepiride|mesh-list
5785968|NCT02823808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5785969|NCT02823808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5785970|NCT02823808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785971|NCT02823808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5785972|NCT02823808|Immunologic Factors|immunologic factors|mesh-ancestor
5785973|NCT02823821|Dialysis Solutions|dialysis solutions|mesh-list
5785974|NCT02823821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5785975|NCT02823951|Dimethyl Fumarate|dimethyl fumarate|mesh-list
5785976|NCT02823951|Dermatologic Agents|dermatologic agents|mesh-ancestor
5785977|NCT02823951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5785978|NCT02823951|Immunologic Factors|immunologic factors|mesh-ancestor
5785979|NCT02823951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785980|NCT02823912|Capsaicin|capsaicin|mesh-list
5785981|NCT02823912|Magnesium Oxide|magnesium oxide|mesh-list
5785982|NCT02823912|Antipruritics|antipruritics|mesh-ancestor
5785983|NCT02823912|Dermatologic Agents|dermatologic agents|mesh-ancestor
5785984|NCT02823912|Sensory System Agents|sensory system agents|mesh-ancestor
5785985|NCT02823912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5785986|NCT02823912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785987|NCT02823912|Antacids|antacids|mesh-ancestor
5785988|NCT02823912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5785989|NCT02823912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5785990|NCT02823743|Aspirin|aspirin|mesh-list
5785991|NCT02823743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5785992|NCT02823743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5785993|NCT02823743|Analgesics|analgesics|mesh-ancestor
5785994|NCT02823743|Sensory System Agents|sensory system agents|mesh-ancestor
5785995|NCT02823743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5785996|NCT02823743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5785997|NCT02823743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5785998|NCT02823743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5785999|NCT02823743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5786000|NCT02823743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5786001|NCT02823743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5786002|NCT02823743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5786003|NCT02823743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5786004|NCT02823743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5786005|NCT02823743|Antipyretics|antipyretics|mesh-ancestor
5786006|NCT02823665|Atropine|atropine|mesh-list
5786007|NCT02823665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5786008|NCT02823665|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5786009|NCT02823665|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5786010|NCT02823665|Autonomic Agents|autonomic agents|mesh-ancestor
5786011|NCT02823665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5786012|NCT02823665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786013|NCT02823665|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5786014|NCT02823665|Respiratory System Agents|respiratory system agents|mesh-ancestor
5786015|NCT02823665|Mydriatics|mydriatics|mesh-ancestor
5786016|NCT02823665|Parasympatholytics|parasympatholytics|mesh-ancestor
5786017|NCT02823665|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5786018|NCT02823665|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5786019|NCT02823665|Cholinergic Agents|cholinergic agents|mesh-ancestor
5786020|NCT02823665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5786021|NCT02823665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5786022|NCT02823626|Spironolactone|spironolactone|mesh-list
5786023|NCT02823626|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5786024|NCT02823626|Hormone Antagonists|hormone antagonists|mesh-ancestor
5786025|NCT02823626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5786026|NCT02823626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786027|NCT02823626|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5786028|NCT02823626|Diuretics|diuretics|mesh-ancestor
5786029|NCT02823626|Natriuretic Agents|natriuretic agents|mesh-ancestor
5786030|NCT02823925|Zoledronic Acid|zoledronic acid|mesh-list
5786031|NCT02823925|Pamidronate|pamidronate|mesh-list
5786032|NCT02823925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5786033|NCT02823925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786034|NCT02823496|Sunscreening Agents|sunscreening agents|mesh-list
5786035|NCT02823496|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5786036|NCT02823496|Protective Agents|protective agents|mesh-ancestor
5786037|NCT02823496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786038|NCT02823496|Dermatologic Agents|dermatologic agents|mesh-ancestor
5786039|NCT02823483|Sunscreening Agents|sunscreening agents|mesh-list
5786040|NCT02823483|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5786041|NCT02823483|Protective Agents|protective agents|mesh-ancestor
5786042|NCT02823483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786043|NCT02823483|Dermatologic Agents|dermatologic agents|mesh-ancestor
5786044|NCT02823691|Metformin|metformin|mesh-list
5786045|NCT02823691|Lanreotide|lanreotide|mesh-list
5786046|NCT02823691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5786047|NCT02823691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786048|NCT02823691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5786049|NCT02824042|Itraconazole|itraconazole|mesh-list
5786050|NCT02824042|Maytansine|maytansine|mesh-list
5786051|NCT02824042|Antifungal Agents|antifungal agents|mesh-ancestor
5786052|NCT02824042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5786053|NCT02824042|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5786054|NCT02824042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5786055|NCT02824042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5786056|NCT02824042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5786057|NCT02824042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5786058|NCT02824042|Hormone Antagonists|hormone antagonists|mesh-ancestor
5786059|NCT02824042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5786060|NCT02824042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673776|NCT01565096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6673777|NCT01565096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6673778|NCT01565096|Immunologic Factors|immunologic factors|mesh-ancestor
6673779|NCT01565096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6673780|NCT01565096|Protease Inhibitors|protease inhibitors|mesh-ancestor
6673781|NCT01565096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6673782|NCT01565096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673783|NCT01565109|Docetaxel|docetaxel|mesh-list
6673784|NCT01565109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5786061|NCT02824042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5786062|NCT02824042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5786063|NCT02824042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5786064|NCT02824042|Tubulin Modulators|tubulin modulators|mesh-ancestor
5786065|NCT02824042|Antimitotic Agents|antimitotic agents|mesh-ancestor
5786066|NCT02824042|Mitosis Modulators|mitosis modulators|mesh-ancestor
5786067|NCT02823405|Pembrolizumab|pembrolizumab|mesh-list
5786068|NCT02823405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5786069|NCT02823405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5786070|NCT02823236|Triamcinolone|triamcinolone|mesh-list
5786071|NCT02823236|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5786072|NCT02823236|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5786073|NCT02823236|Pirfenidone|pirfenidone|mesh-list
5786074|NCT02823236|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5786075|NCT02823236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5786076|NCT02823236|Glucocorticoids|glucocorticoids|mesh-ancestor
5786077|NCT02823236|Hormones|hormones|mesh-ancestor
5786078|NCT02823236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5786079|NCT02823236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786080|NCT02823236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5786081|NCT02823236|Immunologic Factors|immunologic factors|mesh-ancestor
5786082|NCT02823236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5786083|NCT02823236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5786084|NCT02823236|Analgesics|analgesics|mesh-ancestor
5786085|NCT02823236|Sensory System Agents|sensory system agents|mesh-ancestor
5786086|NCT02823236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5786087|NCT02823236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5786088|NCT02823236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5786089|NCT02823236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5786090|NCT02823236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5786091|NCT02823249|Erythritol|erythritol|mesh-list
5786092|NCT02823249|Tryptophan|tryptophan|mesh-list
5786093|NCT02823249|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5786094|NCT02823249|Antidepressive Agents|antidepressive agents|mesh-ancestor
5786095|NCT02823249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5786096|NCT02823249|Vasodilator Agents|vasodilator agents|mesh-ancestor
5898384|NCT03457701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898385|NCT03411031|Thalidomide|thalidomide|mesh-list
5898386|NCT03411031|Dexamethasone|dexamethasone|mesh-list
5898387|NCT03411031|Lenalidomide|lenalidomide|mesh-list
5898388|NCT03411031|Elotuzumab|elotuzumab|mesh-list
5786097|NCT02823353|Fenofibrate|fenofibrate|mesh-list
5786098|NCT02823353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5786099|NCT02823353|Antimetabolites|antimetabolites|mesh-ancestor
5786100|NCT02823353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5786101|NCT02823353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5786102|NCT02823028|Nicotine|nicotine|mesh-list
5786103|NCT02823028|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5786104|NCT02823028|Autonomic Agents|autonomic agents|mesh-ancestor
5786105|NCT02823028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5786106|NCT02823028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786107|NCT02823028|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5786108|NCT02823028|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5786109|NCT02823028|Cholinergic Agents|cholinergic agents|mesh-ancestor
5786110|NCT02823028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5786111|NCT02823028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5786112|NCT02823106|Verapamil|verapamil|mesh-list
5786113|NCT02823106|Choline|choline|mesh-list
5786114|NCT02823106|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
6210761|NCT02164513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6210762|NCT02164513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210763|NCT02164513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5786115|NCT02823106|Lipotropic Agents|lipotropic agents|mesh-ancestor
5786116|NCT02823106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5786117|NCT02823106|Antimetabolites|antimetabolites|mesh-ancestor
5786118|NCT02823106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5786119|NCT02823106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5786120|NCT02823106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5786121|NCT02823106|Nootropic Agents|nootropic agents|mesh-ancestor
5786122|NCT02823106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5786123|NCT02823106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5786124|NCT02823106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5786125|NCT02823106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5786126|NCT02823106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786127|NCT02823106|Vasodilator Agents|vasodilator agents|mesh-ancestor
5786128|NCT02823366|Fenofibrate|fenofibrate|mesh-list
5786129|NCT02823366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5786130|NCT02823366|Antimetabolites|antimetabolites|mesh-ancestor
5786131|NCT02823366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5786132|NCT02823366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5786133|NCT02823145|Fenfluramine|fenfluramine|mesh-list
5786134|NCT02823145|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5786135|NCT02823145|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5786136|NCT02823145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5786137|NCT02823145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5786138|NCT02823145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5786139|NCT02823145|Serotonin Agents|serotonin agents|mesh-ancestor
5786140|NCT02823145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786141|NCT02822729|Timolol|timolol|mesh-list
5786142|NCT02822729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5786143|NCT02822729|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5786144|NCT02822729|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5786145|NCT02822729|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5786146|NCT02822729|Adrenergic Agents|adrenergic agents|mesh-ancestor
5786147|NCT02822729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5786148|NCT02822729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5786149|NCT02822729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786150|NCT02822729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5786151|NCT02822729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5786152|NCT02822742|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5786153|NCT02822742|Latanoprost|latanoprost|mesh-list
5786154|NCT02822742|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5786155|NCT02822937|Triazolam|triazolam|mesh-list
5786156|NCT02822937|Methylphenidate|methylphenidate|mesh-list
5786157|NCT02822937|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5786158|NCT02822937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786159|NCT02822937|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5786160|NCT02822937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5786161|NCT02822937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5786162|NCT02822937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5786163|NCT02822937|Dopamine Agents|dopamine agents|mesh-ancestor
5786164|NCT02822937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5786165|NCT02822937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5786166|NCT02822937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5786167|NCT02822937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5786168|NCT02822937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5786169|NCT02822937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5786170|NCT02822937|GABA Modulators|gaba modulators|mesh-ancestor
5786171|NCT02822937|GABA Agents|gaba agents|mesh-ancestor
5786172|NCT02822625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
5786173|NCT02822625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5786174|NCT02822625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786175|NCT02822378|Vitamin D|vitamin d|mesh-list
5786176|NCT02822378|Calcium|calcium|mesh-list
5786177|NCT02822378|Vitamins|vitamins|mesh-ancestor
5786178|NCT02822378|Micronutrients|micronutrients|mesh-ancestor
5786179|NCT02822378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786180|NCT02822378|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5786181|NCT02822378|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5786182|NCT02822482|Cetuximab|cetuximab|mesh-list
5786183|NCT02822482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5786184|NCT02822482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5786185|NCT02822547|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5786186|NCT02822547|Antiviral Agents|antiviral agents|mesh-ancestor
5786187|NCT02822547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5786188|NCT02822573|Donepezil|donepezil|mesh-list
5786189|NCT02822573|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5786190|NCT02822573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5786191|NCT02822573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5786192|NCT02822573|Cholinergic Agents|cholinergic agents|mesh-ancestor
5786193|NCT02822573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5786194|NCT02822573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786195|NCT02822573|Nootropic Agents|nootropic agents|mesh-ancestor
5786196|NCT02822586|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5786197|NCT02822586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5786198|NCT02822586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5786199|NCT02822131|Sevelamer|sevelamer|mesh-list
5786200|NCT02822131|Chelating Agents|chelating agents|mesh-ancestor
5786201|NCT02822131|Sequestering Agents|sequestering agents|mesh-ancestor
5786202|NCT02822131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5786203|NCT02821923|Erythritol|erythritol|mesh-list
5786204|NCT02821923|Vasodilator Agents|vasodilator agents|mesh-ancestor
5786205|NCT02821897|Anesthetics|anesthetics|mesh-list
5786206|NCT02821897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5786207|NCT02821897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786208|NCT02821858|Odalasvir|odalasvir|mesh-list
5786209|NCT02821858|Antiviral Agents|antiviral agents|mesh-ancestor
5786210|NCT02821858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5786211|NCT02822144|Lidocaine|lidocaine|mesh-list
5786212|NCT02822144|Remifentanil|remifentanil|mesh-list
5786213|NCT02822144|Propofol|propofol|mesh-list
5786214|NCT02822144|Etomidate|etomidate|mesh-list
5786215|NCT02822144|Succinylcholine|succinylcholine|mesh-list
5786216|NCT02822144|Anesthetics, Local|anesthetics, local|mesh-ancestor
5786217|NCT02822144|Anesthetics|anesthetics|mesh-ancestor
5786218|NCT02822144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5786219|NCT02822144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786220|NCT02822144|Sensory System Agents|sensory system agents|mesh-ancestor
5786221|NCT02822144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5786222|NCT02822144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5786223|NCT02822144|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5786224|NCT02822144|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5786225|NCT02822144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5786226|NCT02822144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5786227|NCT02822144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5786228|NCT02822144|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5786229|NCT02822144|Anesthetics, General|anesthetics, general|mesh-ancestor
5786230|NCT02822144|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5786231|NCT02822144|Narcotics|narcotics|mesh-ancestor
5786232|NCT02822144|Analgesics|analgesics|mesh-ancestor
5786233|NCT02822144|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
5786234|NCT02822144|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5786235|NCT02822144|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5786236|NCT02822196|Lidocaine|lidocaine|mesh-list
5786237|NCT02822196|Bupivacaine|bupivacaine|mesh-list
5786238|NCT02822196|Anesthetics, Local|anesthetics, local|mesh-ancestor
5786239|NCT02822196|Anesthetics|anesthetics|mesh-ancestor
5786240|NCT02822196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5786241|NCT02822196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786242|NCT02822196|Sensory System Agents|sensory system agents|mesh-ancestor
5786243|NCT02822196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5786244|NCT02822196|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5786245|NCT02822196|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5786246|NCT02822196|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5786247|NCT02822196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5786248|NCT02822196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5786249|NCT02822027|gamma-Globulins|gamma-globulins|mesh-list
5786250|NCT02822027|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5786251|NCT02822027|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5786252|NCT02822027|Immunologic Factors|immunologic factors|mesh-ancestor
5786253|NCT02822027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786254|NCT02822157|Gemcitabine|gemcitabine|mesh-list
5786255|NCT02822157|Paclitaxel|paclitaxel|mesh-list
5786256|NCT02822157|Carboplatin|carboplatin|mesh-list
5786257|NCT02822157|Doxorubicin|doxorubicin|mesh-list
5786258|NCT02822157|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5786259|NCT02822157|Topotecan|topotecan|mesh-list
5786260|NCT02822157|Olaparib|olaparib|mesh-list
5786261|NCT02822157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5786262|NCT02822157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5786263|NCT02822157|Tubulin Modulators|tubulin modulators|mesh-ancestor
5786264|NCT02822157|Antimitotic Agents|antimitotic agents|mesh-ancestor
5786265|NCT02822157|Mitosis Modulators|mitosis modulators|mesh-ancestor
5786266|NCT02822157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5786267|NCT02822157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5786268|NCT02822157|Antimetabolites|antimetabolites|mesh-ancestor
5786269|NCT02822157|Antiviral Agents|antiviral agents|mesh-ancestor
5786270|NCT02822157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5786271|NCT02822157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5786272|NCT02822157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5786273|NCT02822157|Immunologic Factors|immunologic factors|mesh-ancestor
5786274|NCT02822157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786275|NCT02822157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5786276|NCT02822157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5786277|NCT02822157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5786278|NCT02822157|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5786279|NCT02822157|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5898389|NCT03411031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5898390|NCT03411031|Antiemetics|antiemetics|mesh-ancestor
5898391|NCT03411031|Autonomic Agents|autonomic agents|mesh-ancestor
5898392|NCT03411031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5898393|NCT03411031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898394|NCT03411031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5898395|NCT03411031|Glucocorticoids|glucocorticoids|mesh-ancestor
5898396|NCT03411031|Hormones|hormones|mesh-ancestor
5898397|NCT03411031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5898398|NCT03411031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5898399|NCT03411031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5898400|NCT03411031|Immunologic Factors|immunologic factors|mesh-ancestor
5898401|NCT03411031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5898402|NCT03411031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5898403|NCT03411031|Growth Substances|growth substances|mesh-ancestor
5898404|NCT03411031|Growth Inhibitors|growth inhibitors|mesh-ancestor
5898405|NCT03411031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5898406|NCT03411031|Leprostatic Agents|leprostatic agents|mesh-ancestor
5898407|NCT03411031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5898408|NCT03411031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5898409|NCT03405792|Pembrolizumab|pembrolizumab|mesh-list
5898410|NCT03405792|Temozolomide|temozolomide|mesh-list
5898411|NCT03405792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5898412|NCT03405792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5898413|NCT03405792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5898414|NCT03405792|Alkylating Agents|alkylating agents|mesh-ancestor
5898415|NCT03405792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898416|NCT03396575|Cyclophosphamide|cyclophosphamide|mesh-list
5898417|NCT03396575|Fludarabine|fludarabine|mesh-list
5898418|NCT03396575|Vaccines|vaccines|mesh-list
5898419|NCT03396575|Immunologic Factors|immunologic factors|mesh-ancestor
5898420|NCT03396575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898421|NCT03396575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5898422|NCT03396575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5898423|NCT03396575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5898424|NCT03396575|Alkylating Agents|alkylating agents|mesh-ancestor
5898425|NCT03396575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898426|NCT03396575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5898427|NCT03396575|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5786280|NCT02821689|Pirfenidone|pirfenidone|mesh-list
5786281|NCT02821689|Analgesics|analgesics|mesh-ancestor
5786282|NCT02821689|Sensory System Agents|sensory system agents|mesh-ancestor
5786283|NCT02821689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5786284|NCT02821689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786285|NCT02821689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5786286|NCT02821689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5786287|NCT02821689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5786288|NCT02821689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5786289|NCT02821689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5786290|NCT02821507|Sirolimus|sirolimus|mesh-list
5786291|NCT02821507|Cyclophosphamide|cyclophosphamide|mesh-list
5786292|NCT02821507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5786293|NCT02821507|Immunologic Factors|immunologic factors|mesh-ancestor
5786294|NCT02821507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786295|NCT02821507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5786296|NCT02821507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5786297|NCT02821507|Alkylating Agents|alkylating agents|mesh-ancestor
5786298|NCT02821507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5786299|NCT02821507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5786300|NCT02821507|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5786301|NCT02821507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5786302|NCT02821507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5786303|NCT02821507|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5786304|NCT02821507|Antifungal Agents|antifungal agents|mesh-ancestor
5786305|NCT02821520|Verteporfin|verteporfin|mesh-list
5786306|NCT02821520|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5786307|NCT02821520|Dermatologic Agents|dermatologic agents|mesh-ancestor
5786308|NCT02821533|Cisplatin|cisplatin|mesh-list
5786309|NCT02821533|Antineoplastic Agents|antineoplastic agents|mesh-list
5786310|NCT02821546|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5786311|NCT02821468|Acetaminophen|acetaminophen|mesh-list
5786312|NCT02821468|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
5786313|NCT02821468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5786314|NCT02821468|Analgesics|analgesics|mesh-ancestor
5786315|NCT02821468|Sensory System Agents|sensory system agents|mesh-ancestor
5786316|NCT02821468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5786317|NCT02821468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786318|NCT02821468|Antipyretics|antipyretics|mesh-ancestor
5786319|NCT02821468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5786320|NCT02821468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5786321|NCT02821468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5786322|NCT02821468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5786323|NCT02821468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5786324|NCT02821468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5786325|NCT02821676|Anesthetics|anesthetics|mesh-list
5786326|NCT02821676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5786327|NCT02821676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786328|NCT02821559|Bevacizumab|bevacizumab|mesh-list
5786329|NCT02821559|Oxaliplatin|oxaliplatin|mesh-list
5786330|NCT02821559|Raltitrexed|raltitrexed|mesh-list
5786331|NCT02821559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5786332|NCT02821559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5786333|NCT02821559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5786334|NCT02821559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5786335|NCT02821559|Growth Substances|growth substances|mesh-ancestor
5786336|NCT02821559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786337|NCT02821559|Growth Inhibitors|growth inhibitors|mesh-ancestor
5786338|NCT02821559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5786339|NCT02821559|Antimetabolites|antimetabolites|mesh-ancestor
5786340|NCT02821559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5786341|NCT02821559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5786342|NCT02821559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5786343|NCT02821390|Nepafenac|nepafenac|mesh-list
5786344|NCT02821390|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5786345|NCT02821390|Lubricant Eye Drops|lubricant eye drops|mesh-list
5786346|NCT02821390|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5786347|NCT02821390|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5786348|NCT02821390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5786349|NCT02821390|Analgesics|analgesics|mesh-ancestor
5786350|NCT02821390|Sensory System Agents|sensory system agents|mesh-ancestor
5786351|NCT02821390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5786352|NCT02821390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786353|NCT02821390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5786354|NCT02821390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5786355|NCT02821312|DA-8010|da-8010|mesh-list
5786356|NCT02821312|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5786357|NCT02821312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5786358|NCT02821312|Cholinergic Agents|cholinergic agents|mesh-ancestor
5786359|NCT02821312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5786360|NCT02821312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5786361|NCT02821312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786362|NCT02821377|Furosemide|furosemide|mesh-list
5786363|NCT02821377|Diuretics|diuretics|mesh-ancestor
5786364|NCT02821377|Natriuretic Agents|natriuretic agents|mesh-ancestor
5786365|NCT02821377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786366|NCT02821377|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5786367|NCT02821377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5786368|NCT02821377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5786369|NCT02820987|Meropenem|meropenem|mesh-list
5786370|NCT02820987|Tazobactam|tazobactam|mesh-list
5786371|NCT02820987|Piperacillin|piperacillin|mesh-list
5786372|NCT02820987|Cefepime|cefepime|mesh-list
5786373|NCT02820987|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
5786374|NCT02820987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5786375|NCT02820987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5786376|NCT02820987|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5786377|NCT02820987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5786378|NCT02820987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5786379|NCT02821026|Mycophenolic Acid|mycophenolic acid|mesh-list
5786380|NCT02821026|Sirolimus|sirolimus|mesh-list
5786381|NCT02821026|Etanercept|etanercept|mesh-list
5786382|NCT02821026|Tacrolimus|tacrolimus|mesh-list
5786383|NCT02821026|Thymoglobulin|thymoglobulin|mesh-list
5786384|NCT02821026|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5786385|NCT02821026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5786386|NCT02821026|Immunologic Factors|immunologic factors|mesh-ancestor
5786387|NCT02821026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786388|NCT02821026|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5786389|NCT02821026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5786390|NCT02821026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5786391|NCT02821026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5786392|NCT02821026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5786393|NCT02821026|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5786394|NCT02821026|Antitubercular Agents|antitubercular agents|mesh-ancestor
5786395|NCT02821026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5786396|NCT02821026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5786397|NCT02821026|Antifungal Agents|antifungal agents|mesh-ancestor
5786398|NCT02821026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5786399|NCT02821026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5786400|NCT02821026|Analgesics|analgesics|mesh-ancestor
5786401|NCT02821026|Sensory System Agents|sensory system agents|mesh-ancestor
5786402|NCT02821026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5786403|NCT02821026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5786404|NCT02821026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5786405|NCT02821026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5786406|NCT02821156|Nitric Oxide|nitric oxide|mesh-list
5786407|NCT02821156|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5786408|NCT02821156|Autonomic Agents|autonomic agents|mesh-ancestor
5786409|NCT02821156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5786410|NCT02821156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786411|NCT02821156|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5786412|NCT02821156|Respiratory System Agents|respiratory system agents|mesh-ancestor
5786413|NCT02821156|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5786414|NCT02821156|Antioxidants|antioxidants|mesh-ancestor
5786415|NCT02821156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5786416|NCT02821156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5786417|NCT02821156|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5786418|NCT02821156|Vasodilator Agents|vasodilator agents|mesh-ancestor
5786419|NCT02821156|Gasotransmitters|gasotransmitters|mesh-ancestor
5786420|NCT02821156|Protective Agents|protective agents|mesh-ancestor
5786421|NCT02821169|Ropivacaine|ropivacaine|mesh-list
5786422|NCT02821169|Anesthetics, Local|anesthetics, local|mesh-ancestor
5786423|NCT02821169|Anesthetics|anesthetics|mesh-ancestor
5786424|NCT02821169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5786425|NCT02821169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786426|NCT02821169|Sensory System Agents|sensory system agents|mesh-ancestor
5786427|NCT02821169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5786428|NCT02820935|Itraconazole|itraconazole|mesh-list
5786429|NCT02820935|Rifampin|rifampin|mesh-list
5786430|NCT02820935|Antifungal Agents|antifungal agents|mesh-ancestor
5786431|NCT02820935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5786432|NCT02820935|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5786433|NCT02820935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5786434|NCT02820935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5786435|NCT02820935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5786436|NCT02820935|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5786437|NCT02820935|Hormone Antagonists|hormone antagonists|mesh-ancestor
5786438|NCT02820935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5786439|NCT02820935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786440|NCT02820935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5786441|NCT02820935|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5786442|NCT02820935|Antitubercular Agents|antitubercular agents|mesh-ancestor
5786443|NCT02820935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5786444|NCT02820935|Leprostatic Agents|leprostatic agents|mesh-ancestor
5786445|NCT02820935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5786446|NCT02820935|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5786447|NCT02820935|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5786448|NCT02820935|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5786449|NCT02820935|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5786450|NCT02820935|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5786451|NCT02820935|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5786452|NCT02821052|Insulin|insulin|mesh-list
5786453|NCT02821052|Insulin Aspart|insulin aspart|mesh-list
5786454|NCT02821052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5786455|NCT02821052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786456|NCT02820948|Vitamins|vitamins|mesh-list
5786457|NCT02820948|Vitamin E|vitamin e|mesh-list
5786458|NCT02820948|Tocopherols|tocopherols|mesh-list
5786459|NCT02820948|Tocotrienols|tocotrienols|mesh-list
5786460|NCT02820948|alpha-Tocopherol|alpha-tocopherol|mesh-list
5786461|NCT02820948|Micronutrients|micronutrients|mesh-ancestor
5786462|NCT02820948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786463|NCT02820948|Antioxidants|antioxidants|mesh-ancestor
5786464|NCT02820948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5786465|NCT02820948|Protective Agents|protective agents|mesh-ancestor
5786466|NCT02820922|Anesthetics|anesthetics|mesh-list
5786467|NCT02820922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5786468|NCT02820922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786469|NCT02821247|Aflibercept|aflibercept|mesh-list
5786470|NCT02821247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5786471|NCT02821247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5786472|NCT02821247|Growth Substances|growth substances|mesh-ancestor
5786473|NCT02821247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786474|NCT02821247|Growth Inhibitors|growth inhibitors|mesh-ancestor
5786475|NCT02821247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5786476|NCT02820883|Vaccines|vaccines|mesh-list
5786477|NCT02820883|Immunologic Factors|immunologic factors|mesh-ancestor
5786478|NCT02820883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786479|NCT02820519|Loxapine|loxapine|mesh-list
5786480|NCT02820519|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5786481|NCT02820519|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5786482|NCT02820519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5786483|NCT02820519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786484|NCT02820519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5786485|NCT02820519|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5786486|NCT02820519|Dopamine Agents|dopamine agents|mesh-ancestor
5786487|NCT02820519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5786488|NCT02820519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5786489|NCT02820688|Bupivacaine|bupivacaine|mesh-list
5786490|NCT02820688|Prilocaine|prilocaine|mesh-list
5786491|NCT02820688|Anesthetics, Local|anesthetics, local|mesh-ancestor
5786492|NCT02820688|Anesthetics|anesthetics|mesh-ancestor
5786493|NCT02820688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5786494|NCT02820688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786495|NCT02820688|Sensory System Agents|sensory system agents|mesh-ancestor
5786496|NCT02820688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5786497|NCT02820610|Magnesium Sulfate|magnesium sulfate|mesh-list
5786498|NCT02820610|Dexmedetomidine|dexmedetomidine|mesh-list
5786499|NCT02820610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5786500|NCT02820610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5786501|NCT02820610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786502|NCT02820610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5786503|NCT02820610|Analgesics|analgesics|mesh-ancestor
5786504|NCT02820610|Sensory System Agents|sensory system agents|mesh-ancestor
5786505|NCT02820610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5786506|NCT02820610|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5786507|NCT02820610|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5786508|NCT02820610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5786509|NCT02820610|Adrenergic Agents|adrenergic agents|mesh-ancestor
5786510|NCT02820610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5786511|NCT02820610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5786512|NCT02820610|Anesthetics|anesthetics|mesh-ancestor
5786513|NCT02820610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5786514|NCT02820610|Anticonvulsants|anticonvulsants|mesh-ancestor
5786515|NCT02820610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5786516|NCT02820610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5786517|NCT02820610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5786518|NCT02820610|Tocolytic Agents|tocolytic agents|mesh-ancestor
5786519|NCT02820610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5786520|NCT02820493|Vedolizumab|vedolizumab|mesh-list
5786521|NCT02820493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5786522|NCT02820441|Zopiclone|zopiclone|mesh-list
5786523|NCT02820441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5786524|NCT02820441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5786525|NCT02820441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786526|NCT02820558|Substance P|substance p|mesh-list
5786527|NCT02820558|Neurokinin A|neurokinin a|mesh-list
5786528|NCT02820558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5786529|NCT02820558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5786530|NCT02820558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786531|NCT02820259|Tacrolimus|tacrolimus|mesh-list
5786532|NCT02820259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5786533|NCT02820259|Immunologic Factors|immunologic factors|mesh-ancestor
5786534|NCT02820259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786535|NCT02820259|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5786536|NCT02820259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5786537|NCT02820259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898428|NCT03377023|Nivolumab|nivolumab|mesh-list
5898429|NCT03377023|Ipilimumab|ipilimumab|mesh-list
5898430|NCT03377023|Nintedanib|nintedanib|mesh-list
5898431|NCT03377023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5898432|NCT03377023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5898433|NCT03377023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5898434|NCT03377023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898435|NCT03377023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5898436|NCT03377023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5898437|NCT03200288|Hyaluronic Acid|hyaluronic acid|mesh-list
5898438|NCT03200288|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5898439|NCT03200288|Immunologic Factors|immunologic factors|mesh-ancestor
5786538|NCT02820077|Hemostatics|hemostatics|mesh-list
5786539|NCT02820077|Coagulants|coagulants|mesh-ancestor
5786540|NCT02819999|Etoposide|etoposide|mesh-list
5786541|NCT02819999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5786542|NCT02819999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5786543|NCT02819999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5786544|NCT02819999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5786545|NCT02819999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5786546|NCT02819999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5786547|NCT02820025|Doxapram|doxapram|mesh-list
5786548|NCT02820025|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5786549|NCT02820025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786550|NCT02820025|Respiratory System Agents|respiratory system agents|mesh-ancestor
5786551|NCT02820051|Lidocaine|lidocaine|mesh-list
5786552|NCT02820051|Midazolam|midazolam|mesh-list
5786553|NCT02820051|Nalbuphine|nalbuphine|mesh-list
5786554|NCT02820051|Propofol|propofol|mesh-list
5786555|NCT02820051|Anesthetics, Local|anesthetics, local|mesh-ancestor
5786556|NCT02820051|Anesthetics|anesthetics|mesh-ancestor
5786557|NCT02820051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5786558|NCT02820051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786559|NCT02820051|Sensory System Agents|sensory system agents|mesh-ancestor
5786560|NCT02820051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5786561|NCT02820051|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5786562|NCT02820051|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5786563|NCT02820051|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5786564|NCT02820051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5786565|NCT02820051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5786566|NCT02820051|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5786567|NCT02820051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5786568|NCT02820051|Anesthetics, General|anesthetics, general|mesh-ancestor
5786569|NCT02820051|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5786570|NCT02820051|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5786571|NCT02820051|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5786572|NCT02820051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5786573|NCT02820051|GABA Modulators|gaba modulators|mesh-ancestor
5786574|NCT02820051|GABA Agents|gaba agents|mesh-ancestor
5786575|NCT02820051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5786576|NCT02820051|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5786577|NCT02820051|Narcotics|narcotics|mesh-ancestor
5786578|NCT02820051|Analgesics|analgesics|mesh-ancestor
5786579|NCT02819921|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
5786580|NCT02819921|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5786581|NCT02819921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5786582|NCT02819921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6491253|NCT00601874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6491254|NCT00601874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491255|NCT00601874|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6491256|NCT00601874|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6491257|NCT00601874|Cholinergic Agents|cholinergic agents|mesh-ancestor
6491258|NCT00601874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6491259|NCT00601874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491260|NCT00601887|Meloxicam|meloxicam|mesh-list
6491261|NCT00601887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6491262|NCT00601887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6491263|NCT00601887|Analgesics|analgesics|mesh-ancestor
6491264|NCT00601887|Sensory System Agents|sensory system agents|mesh-ancestor
6491265|NCT00601887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6491266|NCT00601887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491267|NCT00601887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6491268|NCT00601887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5786583|NCT02819921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5786584|NCT02819921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5786585|NCT02819921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786586|NCT02819921|Antidepressive Agents|antidepressive agents|mesh-ancestor
5786587|NCT02819921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5786588|NCT02819856|Ebselen|ebselen|mesh-list
5786589|NCT02819856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5786590|NCT02819856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5786591|NCT02819856|Analgesics|analgesics|mesh-ancestor
5786592|NCT02819856|Sensory System Agents|sensory system agents|mesh-ancestor
5786593|NCT02819856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5786594|NCT02819856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786595|NCT02819856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5786596|NCT02819856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5786597|NCT02819856|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5786598|NCT02819856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5786599|NCT02819856|Antioxidants|antioxidants|mesh-ancestor
5786600|NCT02819856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5786601|NCT02819856|Protective Agents|protective agents|mesh-ancestor
5786602|NCT02819856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5786603|NCT02819856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5786604|NCT02819856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5786605|NCT02819843|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
5786606|NCT02819843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5786607|NCT02819843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5786608|NCT02819661|Morphine|morphine|mesh-list
5786609|NCT02819661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5786610|NCT02819661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786611|NCT02819661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5786612|NCT02819661|Narcotics|narcotics|mesh-ancestor
5786613|NCT02819661|Analgesics|analgesics|mesh-ancestor
5786614|NCT02819661|Sensory System Agents|sensory system agents|mesh-ancestor
5786615|NCT02819661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5786616|NCT02819869|Metformin|metformin|mesh-list
5786617|NCT02819869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5786618|NCT02819869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786619|NCT02819648|Prednisolone|prednisolone|mesh-list
5786620|NCT02819648|Glucocorticoids|glucocorticoids|mesh-list
5786621|NCT02819648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5786622|NCT02819648|Hormones|hormones|mesh-ancestor
5786623|NCT02819648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5786624|NCT02819648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786625|NCT02819648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5786626|NCT02819648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5786627|NCT02819596|Durvalumab|durvalumab|mesh-list
5786628|NCT02819596|Tremelimumab|tremelimumab|mesh-list
5786629|NCT02819596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5786630|NCT02819596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5786631|NCT02819414|Acetaminophen|acetaminophen|mesh-list
5786632|NCT02819414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5786633|NCT02819414|Analgesics|analgesics|mesh-ancestor
5786634|NCT02819414|Sensory System Agents|sensory system agents|mesh-ancestor
5786635|NCT02819414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5786636|NCT02819414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786637|NCT02819414|Antipyretics|antipyretics|mesh-ancestor
5786638|NCT02819544|Ropivacaine|ropivacaine|mesh-list
5786639|NCT02819544|Anesthetics, Local|anesthetics, local|mesh-ancestor
5786640|NCT02819544|Anesthetics|anesthetics|mesh-ancestor
5786641|NCT02819544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5786642|NCT02819544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786643|NCT02819544|Sensory System Agents|sensory system agents|mesh-ancestor
6491269|NCT00601887|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6491270|NCT00601887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6491271|NCT00601887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6491272|NCT00601887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491273|NCT00601913|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6491274|NCT00601913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6491275|NCT00601913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6491276|NCT00601913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6491277|NCT00601913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5786644|NCT02819544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5786645|NCT02819570|Ampicillin|ampicillin|mesh-list
5786646|NCT02819570|Cefuroxime|cefuroxime|mesh-list
5786647|NCT02819570|Cefuroxime axetil|cefuroxime axetil|mesh-list
5786648|NCT02819570|Roxithromycin|roxithromycin|mesh-list
5786649|NCT02819570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5786650|NCT02819570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5786651|NCT02819375|Ketamine|ketamine|mesh-list
5786652|NCT02819375|Remifentanil|remifentanil|mesh-list
5786653|NCT02819375|Propofol|propofol|mesh-list
5786654|NCT02819375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5786655|NCT02819375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5786656|NCT02819375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786657|NCT02819375|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5786658|NCT02819375|Anesthetics, General|anesthetics, general|mesh-ancestor
5786659|NCT02819375|Anesthetics|anesthetics|mesh-ancestor
5786660|NCT02819375|Analgesics|analgesics|mesh-ancestor
5786661|NCT02819375|Sensory System Agents|sensory system agents|mesh-ancestor
5786662|NCT02819375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5786663|NCT02819375|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5786664|NCT02819375|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5786665|NCT02819375|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5786666|NCT02819375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5786667|NCT02819375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5786668|NCT02819375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5786669|NCT02819375|Narcotics|narcotics|mesh-ancestor
5786670|NCT02819388|Contraceptive Agents|contraceptive agents|mesh-list
5786671|NCT02819388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5786672|NCT02819388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786673|NCT02819024|Alovudine|alovudine|mesh-list
5786674|NCT02819024|Dideoxynucleosides|dideoxynucleosides|mesh-list
5786675|NCT02819024|Dexamethasone|dexamethasone|mesh-list
5786676|NCT02819024|Dexamethasone acetate|dexamethasone acetate|mesh-list
5786677|NCT02819024|Ichthammol|ichthammol|mesh-list
5786678|NCT02819024|BB 1101|bb 1101|mesh-list
5786679|NCT02819024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5786680|NCT02819024|Antiemetics|antiemetics|mesh-ancestor
5786681|NCT02819024|Autonomic Agents|autonomic agents|mesh-ancestor
5786682|NCT02819024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5786683|NCT02819024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786684|NCT02819024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5786685|NCT02819024|Glucocorticoids|glucocorticoids|mesh-ancestor
5786686|NCT02819024|Hormones|hormones|mesh-ancestor
5786687|NCT02819024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5786688|NCT02819024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5786689|NCT02819024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5786690|NCT02819024|Protease Inhibitors|protease inhibitors|mesh-ancestor
5786691|NCT02819024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5786692|NCT02819024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5786693|NCT02819024|Dermatologic Agents|dermatologic agents|mesh-ancestor
5786694|NCT02819024|Antiviral Agents|antiviral agents|mesh-ancestor
5786695|NCT02819024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5786696|NCT02819024|Antimetabolites|antimetabolites|mesh-ancestor
5786697|NCT02819024|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5786698|NCT02819024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5786699|NCT02819115|Vaccines|vaccines|mesh-list
5786700|NCT02819115|Immunologic Factors|immunologic factors|mesh-ancestor
5786701|NCT02819115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786702|NCT02819102|Berotralstat|berotralstat|mesh-list
5786703|NCT02819102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5786704|NCT02819102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5786705|NCT02818985|Dexamethasone|dexamethasone|mesh-list
5786706|NCT02818985|Dexmedetomidine|dexmedetomidine|mesh-list
5786707|NCT02818985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5786708|NCT02818985|Antiemetics|antiemetics|mesh-ancestor
5786709|NCT02818985|Autonomic Agents|autonomic agents|mesh-ancestor
5786710|NCT02818985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5786711|NCT02818985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786712|NCT02818985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5786713|NCT02818985|Glucocorticoids|glucocorticoids|mesh-ancestor
5786714|NCT02818985|Hormones|hormones|mesh-ancestor
5786715|NCT02818985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5786716|NCT02818985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5786717|NCT02818985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5786718|NCT02818985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5786719|NCT02818985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5786720|NCT02818985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5786721|NCT02818985|Analgesics|analgesics|mesh-ancestor
5786722|NCT02818985|Sensory System Agents|sensory system agents|mesh-ancestor
5786723|NCT02818985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5786724|NCT02818985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5786725|NCT02818985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5786726|NCT02818985|Adrenergic Agents|adrenergic agents|mesh-ancestor
5786727|NCT02818985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5786728|NCT02818985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5786729|NCT02819180|Vaccines|vaccines|mesh-list
5786730|NCT02819180|Immunologic Factors|immunologic factors|mesh-ancestor
5786731|NCT02819180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786732|NCT02819089|Dexmedetomidine|dexmedetomidine|mesh-list
5786733|NCT02819089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5786734|NCT02819089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5786735|NCT02819089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786736|NCT02819089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5786737|NCT02819089|Analgesics|analgesics|mesh-ancestor
5786738|NCT02819089|Sensory System Agents|sensory system agents|mesh-ancestor
5786739|NCT02819089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5786740|NCT02819089|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5786741|NCT02819089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5786742|NCT02819089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5786743|NCT02819089|Adrenergic Agents|adrenergic agents|mesh-ancestor
5786744|NCT02819089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5786745|NCT02819089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5786746|NCT02818881|Methamphetamine|methamphetamine|mesh-list
5786747|NCT02818881|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5786748|NCT02818881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786749|NCT02818881|Sympathomimetics|sympathomimetics|mesh-ancestor
5786750|NCT02818881|Autonomic Agents|autonomic agents|mesh-ancestor
5786751|NCT02818881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5786752|NCT02818881|Dopamine Agents|dopamine agents|mesh-ancestor
5786753|NCT02818881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5786754|NCT02818881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5786755|NCT02818881|Adrenergic Agents|adrenergic agents|mesh-ancestor
5786756|NCT02818881|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5786757|NCT02818881|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5786758|NCT02818881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5786759|NCT02818881|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5786760|NCT02818725|Cisplatin|cisplatin|mesh-list
5786761|NCT02818725|Doxorubicin|doxorubicin|mesh-list
5786762|NCT02818725|Methotrexate|methotrexate|mesh-list
5786763|NCT02818725|Panitumumab|panitumumab|mesh-list
5786764|NCT02818725|Vinblastine|vinblastine|mesh-list
5786765|NCT02818725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5786766|NCT02818725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5786767|NCT02818725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5786768|NCT02818725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5786769|NCT02818725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5786770|NCT02818725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5786771|NCT02818725|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5786772|NCT02818725|Abortifacient Agents|abortifacient agents|mesh-ancestor
5786773|NCT02818725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5786774|NCT02818725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786775|NCT02818725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5786776|NCT02818725|Antimetabolites|antimetabolites|mesh-ancestor
5786777|NCT02818725|Dermatologic Agents|dermatologic agents|mesh-ancestor
5786778|NCT02818725|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5786779|NCT02818725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5786780|NCT02818725|Immunologic Factors|immunologic factors|mesh-ancestor
5786781|NCT02818725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5786782|NCT02818725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5786783|NCT02818725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5786784|NCT02818725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5786785|NCT02818725|Tubulin Modulators|tubulin modulators|mesh-ancestor
5786786|NCT02818725|Antimitotic Agents|antimitotic agents|mesh-ancestor
5786787|NCT02818725|Mitosis Modulators|mitosis modulators|mesh-ancestor
5786788|NCT02818803|Propolis|propolis|mesh-list
5786789|NCT02818803|Miconazole|miconazole|mesh-list
5786790|NCT02818803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5786791|NCT02818803|Antifungal Agents|antifungal agents|mesh-ancestor
5786792|NCT02818803|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5786793|NCT02818803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5786794|NCT02818803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5786795|NCT02818803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5786796|NCT02818803|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5786797|NCT02818803|Hormone Antagonists|hormone antagonists|mesh-ancestor
5786798|NCT02818803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5786799|NCT02818803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786800|NCT02818803|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5786801|NCT02818803|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5786802|NCT02818816|Brimonidine Tartrate|brimonidine tartrate|mesh-list
5786803|NCT02818816|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
5786804|NCT02818816|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5786805|NCT02818816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5786806|NCT02818816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5786807|NCT02818816|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5786808|NCT02818816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5786809|NCT02818816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5786810|NCT02818816|Adrenergic Agents|adrenergic agents|mesh-ancestor
5786811|NCT02818816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5786812|NCT02818816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5786813|NCT02818816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786814|NCT02818816|Laxatives|laxatives|mesh-ancestor
5786815|NCT02818816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5786816|NCT02818660|Cosyntropin|cosyntropin|mesh-list
5786817|NCT02818660|Hormones|hormones|mesh-ancestor
5786818|NCT02818660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5786819|NCT02818660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786820|NCT02818751|Citalopram|citalopram|mesh-list
5786821|NCT02818751|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5786822|NCT02818751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5786823|NCT02818751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5786824|NCT02818751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5786825|NCT02818751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5786826|NCT02818751|Serotonin Agents|serotonin agents|mesh-ancestor
5786827|NCT02818751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786828|NCT02818751|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5786829|NCT02818751|Antidepressive Agents|antidepressive agents|mesh-ancestor
5786830|NCT02818751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5786831|NCT02818738|Levamisole|levamisole|mesh-list
5786832|NCT02818738|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5786833|NCT02818738|Immunologic Factors|immunologic factors|mesh-ancestor
6491278|NCT00601978|Levodopa|levodopa|mesh-list
6491279|NCT00601978|Carbidopa|carbidopa|mesh-list
6491280|NCT00601978|Entacapone|entacapone|mesh-list
6491281|NCT00601978|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
6491282|NCT00601978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6491283|NCT00601978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6491284|NCT00601978|Dopamine Agents|dopamine agents|mesh-ancestor
6491285|NCT00601978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6491286|NCT00601978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5786834|NCT02818738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786835|NCT02818738|Antinematodal Agents|antinematodal agents|mesh-ancestor
5786836|NCT02818738|Anthelmintics|anthelmintics|mesh-ancestor
5786837|NCT02818738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5786838|NCT02818738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5786839|NCT02818738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5786840|NCT02818621|Dexmedetomidine|dexmedetomidine|mesh-list
5786841|NCT02818621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5786842|NCT02818621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5786843|NCT02818621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786844|NCT02818621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5786845|NCT02818621|Analgesics|analgesics|mesh-ancestor
5786846|NCT02818621|Sensory System Agents|sensory system agents|mesh-ancestor
5786847|NCT02818621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5786848|NCT02818621|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5786849|NCT02818621|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5786850|NCT02818621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5786851|NCT02818621|Adrenergic Agents|adrenergic agents|mesh-ancestor
5786852|NCT02818621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5786853|NCT02818621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5786854|NCT02818556|Hyaluronic Acid|hyaluronic acid|mesh-list
5786855|NCT02818556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5786856|NCT02818556|Immunologic Factors|immunologic factors|mesh-ancestor
5786857|NCT02818556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786858|NCT02818556|Viscosupplements|viscosupplements|mesh-ancestor
5786859|NCT02818556|Protective Agents|protective agents|mesh-ancestor
5786860|NCT02818491|Dexamethasone|dexamethasone|mesh-list
5786861|NCT02818491|Dexamethasone acetate|dexamethasone acetate|mesh-list
5786862|NCT02818491|Ropivacaine|ropivacaine|mesh-list
5786863|NCT02818491|BB 1101|bb 1101|mesh-list
5786864|NCT02818491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5786865|NCT02818491|Antiemetics|antiemetics|mesh-ancestor
5786866|NCT02818491|Autonomic Agents|autonomic agents|mesh-ancestor
5786867|NCT02818491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5786868|NCT02818491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786869|NCT02818491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5786870|NCT02818491|Glucocorticoids|glucocorticoids|mesh-ancestor
5786871|NCT02818491|Hormones|hormones|mesh-ancestor
5786872|NCT02818491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5786873|NCT02818491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5786874|NCT02818491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6491287|NCT00601978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786875|NCT02818491|Protease Inhibitors|protease inhibitors|mesh-ancestor
5786876|NCT02818491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5786877|NCT02818491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5786878|NCT02818491|Anesthetics, Local|anesthetics, local|mesh-ancestor
5786879|NCT02818491|Anesthetics|anesthetics|mesh-ancestor
5786880|NCT02818491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5786881|NCT02818491|Sensory System Agents|sensory system agents|mesh-ancestor
5898440|NCT03200288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898441|NCT03200288|Viscosupplements|viscosupplements|mesh-ancestor
5898442|NCT03200288|Protective Agents|protective agents|mesh-ancestor
5908046|NCT04935359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908047|NCT04935359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5908048|NCT04935359|Antimetabolites|antimetabolites|mesh-ancestor
5908049|NCT04935359|Antiviral Agents|antiviral agents|mesh-ancestor
5908050|NCT04935359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5908051|NCT04935359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5908052|NCT04935359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5908053|NCT04935359|Immunologic Factors|immunologic factors|mesh-ancestor
5908054|NCT04935359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5908055|NCT04927780|Leucovorin|leucovorin|mesh-list
5908056|NCT04927780|Fluorouracil|fluorouracil|mesh-list
5908057|NCT04927780|Oxaliplatin|oxaliplatin|mesh-list
5908058|NCT04927780|Irinotecan|irinotecan|mesh-list
5908059|NCT04927780|Calcium|calcium|mesh-list
5908060|NCT04927780|Levoleucovorin|levoleucovorin|mesh-list
5908061|NCT04927780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5908062|NCT04927780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5908063|NCT04927780|Antimetabolites|antimetabolites|mesh-ancestor
5908064|NCT04927780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908065|NCT04927780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5908066|NCT04927780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5908067|NCT04927780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5908068|NCT04927780|Immunologic Factors|immunologic factors|mesh-ancestor
5908069|NCT04927780|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5908070|NCT04927780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5908071|NCT04927780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5908072|NCT04927780|Antidotes|antidotes|mesh-ancestor
5908073|NCT04927780|Protective Agents|protective agents|mesh-ancestor
5908074|NCT04927780|Vitamin B Complex|vitamin b complex|mesh-ancestor
5908075|NCT04927780|Vitamins|vitamins|mesh-ancestor
5908076|NCT04927780|Micronutrients|micronutrients|mesh-ancestor
5908077|NCT04920344|Cisplatin|cisplatin|mesh-list
5908078|NCT04920344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5908079|NCT04919629|Bevacizumab|bevacizumab|mesh-list
5908080|NCT04919629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5908081|NCT04919629|Pembrolizumab|pembrolizumab|mesh-list
5908082|NCT04919629|Endothelial Growth Factors|endothelial growth factors|mesh-list
5908083|NCT04919629|Antibodies|antibodies|mesh-list
5908084|NCT04919629|Immunoglobulins|immunoglobulins|mesh-list
5908085|NCT04919629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5908086|NCT04919629|Immunoglobulin G|immunoglobulin g|mesh-list
5908087|NCT04919629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5908088|NCT04919629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5908089|NCT04919629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5908090|NCT04919629|Growth Substances|growth substances|mesh-ancestor
5908091|NCT04919629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5908092|NCT04919629|Growth Inhibitors|growth inhibitors|mesh-ancestor
5908093|NCT04919629|Immunologic Factors|immunologic factors|mesh-ancestor
5908094|NCT04912115|Midazolam|midazolam|mesh-list
5908095|NCT04912115|Ketamine|ketamine|mesh-list
5908096|NCT04912115|Analgesics|analgesics|mesh-ancestor
5908097|NCT04912115|Sensory System Agents|sensory system agents|mesh-ancestor
5908098|NCT04912115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5908099|NCT04912115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5908100|NCT04912115|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5908101|NCT04912115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5908102|NCT04912115|Anesthetics, General|anesthetics, general|mesh-ancestor
5908103|NCT04912115|Anesthetics|anesthetics|mesh-ancestor
5908104|NCT04912115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5908105|NCT04912115|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5908106|NCT04912115|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5908107|NCT04912115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6491288|NCT00601978|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5908108|NCT04912115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908109|NCT04912115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5908110|NCT04912115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5908111|NCT04912115|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5786882|NCT02818309|Lesogaberan|lesogaberan|mesh-list
5786883|NCT02818309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5786884|NCT02818309|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
5786885|NCT02818309|GABA Agonists|gaba agonists|mesh-ancestor
5786886|NCT02818309|GABA Agents|gaba agents|mesh-ancestor
5786887|NCT02818309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5786888|NCT02818309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5786889|NCT02818309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786890|NCT02818270|Acetylcysteine|acetylcysteine|mesh-list
5786891|NCT02818270|Albuterol|albuterol|mesh-list
5786892|NCT02818270|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5786893|NCT02818270|Antiviral Agents|antiviral agents|mesh-ancestor
5786894|NCT02818270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5786895|NCT02818270|Expectorants|expectorants|mesh-ancestor
5786896|NCT02818270|Respiratory System Agents|respiratory system agents|mesh-ancestor
5786897|NCT02818270|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5786898|NCT02818270|Antioxidants|antioxidants|mesh-ancestor
5786899|NCT02818270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5786900|NCT02818270|Protective Agents|protective agents|mesh-ancestor
5786901|NCT02818270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786902|NCT02818270|Antidotes|antidotes|mesh-ancestor
5786903|NCT02818270|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5786904|NCT02818270|Autonomic Agents|autonomic agents|mesh-ancestor
5786905|NCT02818270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5786906|NCT02818270|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5786907|NCT02818270|Tocolytic Agents|tocolytic agents|mesh-ancestor
5786908|NCT02818270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5786909|NCT02818270|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5786910|NCT02818270|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5786911|NCT02818270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5786912|NCT02818270|Adrenergic Agents|adrenergic agents|mesh-ancestor
5786913|NCT02818270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5786914|NCT02818387|Midazolam|midazolam|mesh-list
5786915|NCT02818387|Remifentanil|remifentanil|mesh-list
5786916|NCT02818387|Propofol|propofol|mesh-list
5786917|NCT02818387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6491289|NCT00601978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6491290|NCT00601978|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
5786918|NCT02818387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5786919|NCT02818387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786920|NCT02818387|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5786921|NCT02818387|Anesthetics, General|anesthetics, general|mesh-ancestor
5786922|NCT02818387|Anesthetics|anesthetics|mesh-ancestor
6491291|NCT00601978|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6491292|NCT00601978|Immunologic Factors|immunologic factors|mesh-ancestor
6491293|NCT00601978|Dopamine Agonists|dopamine agonists|mesh-ancestor
5786923|NCT02818387|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5786924|NCT02818387|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5786925|NCT02818387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5786926|NCT02818387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5786927|NCT02818387|GABA Modulators|gaba modulators|mesh-ancestor
5786928|NCT02818387|GABA Agents|gaba agents|mesh-ancestor
5786929|NCT02818387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5786930|NCT02818387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5786931|NCT02818387|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5786932|NCT02818387|Narcotics|narcotics|mesh-ancestor
5786933|NCT02818387|Analgesics|analgesics|mesh-ancestor
5786934|NCT02818387|Sensory System Agents|sensory system agents|mesh-ancestor
5786935|NCT02818387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5786936|NCT02818348|Darunavir|darunavir|mesh-list
5786937|NCT02818348|Cobicistat|cobicistat|mesh-list
5786938|NCT02818348|Etravirine|etravirine|mesh-list
5786939|NCT02818348|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5786940|NCT02818348|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5786941|NCT02818348|Protease Inhibitors|protease inhibitors|mesh-ancestor
5786942|NCT02818348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5786943|NCT02818348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5786944|NCT02818348|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5786945|NCT02818348|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5786946|NCT02818348|Antiviral Agents|antiviral agents|mesh-ancestor
5786947|NCT02818348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5786948|NCT02818348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5786949|NCT02818348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5786950|NCT02818348|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5786951|NCT02818348|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5786952|NCT02818140|Ropivacaine|ropivacaine|mesh-list
5786953|NCT02818140|Anesthetics, Local|anesthetics, local|mesh-ancestor
5786954|NCT02818140|Anesthetics|anesthetics|mesh-ancestor
5786955|NCT02818140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5786956|NCT02818140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786957|NCT02818140|Sensory System Agents|sensory system agents|mesh-ancestor
5786958|NCT02818140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5786959|NCT02817932|Ranolazine|ranolazine|mesh-list
5786960|NCT02817932|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5786961|NCT02817932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5786962|NCT02817932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5786963|NCT02817750|Zolpidem|zolpidem|mesh-list
5786964|NCT02817750|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5786965|NCT02817750|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5786966|NCT02817750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5786967|NCT02817750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786968|NCT02817750|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
5786969|NCT02817750|GABA Agonists|gaba agonists|mesh-ancestor
5786970|NCT02817750|GABA Agents|gaba agents|mesh-ancestor
5786971|NCT02817750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5786972|NCT02817750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5786973|NCT02817477|Morphine|morphine|mesh-list
5786974|NCT02817477|Ketamine|ketamine|mesh-list
5786975|NCT02817477|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5786976|NCT02817477|Narcotics|narcotics|mesh-ancestor
5786977|NCT02817477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5786978|NCT02817477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5786979|NCT02817477|Analgesics|analgesics|mesh-ancestor
5786980|NCT02817477|Sensory System Agents|sensory system agents|mesh-ancestor
5786981|NCT02817477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5786982|NCT02817477|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5786983|NCT02817477|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5786984|NCT02817477|Anesthetics, General|anesthetics, general|mesh-ancestor
6673785|NCT01565109|Tubulin Modulators|tubulin modulators|mesh-ancestor
5786985|NCT02817477|Anesthetics|anesthetics|mesh-ancestor
5786986|NCT02817477|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5786987|NCT02817477|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5786988|NCT02817477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5786989|NCT02817477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5786990|NCT02817503|Folic Acid|folic acid|mesh-list
5786991|NCT02817503|Vitamin B Complex|vitamin b complex|mesh-list
5786992|NCT02817503|Amlodipine|amlodipine|mesh-list
5786993|NCT02817503|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5786994|NCT02817503|Enalapril|enalapril|mesh-list
5786995|NCT02817503|Enalaprilat|enalaprilat|mesh-list
5786996|NCT02817503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5786997|NCT02817503|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5786998|NCT02817503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6673786|NCT01565109|Antimitotic Agents|antimitotic agents|mesh-ancestor
5786999|NCT02817503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787000|NCT02817503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5787001|NCT02817503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787002|NCT02817503|Vasodilator Agents|vasodilator agents|mesh-ancestor
5787003|NCT02817503|Diuretics|diuretics|mesh-ancestor
5787004|NCT02817503|Natriuretic Agents|natriuretic agents|mesh-ancestor
5787005|NCT02817503|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5787006|NCT02817503|Hematinics|hematinics|mesh-ancestor
5787007|NCT02817503|Vitamins|vitamins|mesh-ancestor
5787008|NCT02817503|Micronutrients|micronutrients|mesh-ancestor
5787009|NCT02817503|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5787010|NCT02817503|Protease Inhibitors|protease inhibitors|mesh-ancestor
5787011|NCT02817503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5787012|NCT02817451|Vaccines|vaccines|mesh-list
5787013|NCT02817451|Immunologic Factors|immunologic factors|mesh-ancestor
5787014|NCT02817451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787015|NCT02817321|Morphine|morphine|mesh-list
5787016|NCT02817321|Ropivacaine|ropivacaine|mesh-list
5787017|NCT02817321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5787018|NCT02817321|Narcotics|narcotics|mesh-ancestor
5787019|NCT02817321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5787020|NCT02817321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787021|NCT02817321|Analgesics|analgesics|mesh-ancestor
5787022|NCT02817321|Sensory System Agents|sensory system agents|mesh-ancestor
5787023|NCT02817321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5787024|NCT02817321|Anesthetics, Local|anesthetics, local|mesh-ancestor
5787025|NCT02817321|Anesthetics|anesthetics|mesh-ancestor
5787026|NCT02817360|Losartan|losartan|mesh-list
5787027|NCT02817360|Valsartan|valsartan|mesh-list
5787028|NCT02817360|Carvedilol|carvedilol|mesh-list
5787029|NCT02817360|Candesartan|candesartan|mesh-list
5787030|NCT02817360|Ramipril|ramipril|mesh-list
5787031|NCT02817360|Enalapril|enalapril|mesh-list
5787032|NCT02817360|Lisinopril|lisinopril|mesh-list
5787033|NCT02817360|Irbesartan|irbesartan|mesh-list
5787034|NCT02817360|Nebivolol|nebivolol|mesh-list
5787035|NCT02817360|Bisoprolol|bisoprolol|mesh-list
5787036|NCT02817360|Perindopril|perindopril|mesh-list
5787037|NCT02817360|Captopril|captopril|mesh-list
5787038|NCT02817360|Quinapril|quinapril|mesh-list
5787039|NCT02817360|Trandolapril|trandolapril|mesh-list
5787040|NCT02817360|Fosinopril|fosinopril|mesh-list
5787041|NCT02817360|Eprosartan|eprosartan|mesh-list
5787042|NCT02817360|Zofenopril|zofenopril|mesh-list
5787043|NCT02817360|Spirapril|spirapril|mesh-list
6491294|NCT00601991|Aflibercept|aflibercept|mesh-list
6491295|NCT00601991|Endothelial Growth Factors|endothelial growth factors|mesh-list
6491296|NCT00601991|Growth Substances|growth substances|mesh-ancestor
6491297|NCT00601991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491298|NCT00601991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5787044|NCT02817360|Cilazapril|cilazapril|mesh-list
5787045|NCT02817360|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
5787046|NCT02817360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5787047|NCT02817360|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5787048|NCT02817360|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5787049|NCT02817360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787050|NCT02817360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5787051|NCT02817360|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5787052|NCT02817360|Adrenergic Agents|adrenergic agents|mesh-ancestor
5787053|NCT02817360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5787054|NCT02817360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787055|NCT02817360|Antioxidants|antioxidants|mesh-ancestor
5787056|NCT02817360|Protective Agents|protective agents|mesh-ancestor
5787057|NCT02817360|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5787058|NCT02817360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5787059|NCT02817360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5787060|NCT02817360|Vasodilator Agents|vasodilator agents|mesh-ancestor
5787061|NCT02817360|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5787062|NCT02817360|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5787063|NCT02817360|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5787064|NCT02817360|Protease Inhibitors|protease inhibitors|mesh-ancestor
5787065|NCT02817360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5787066|NCT02817360|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5787067|NCT02817360|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5787068|NCT02817360|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5787069|NCT02817360|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5787070|NCT02817360|Sympatholytics|sympatholytics|mesh-ancestor
5787071|NCT02817360|Autonomic Agents|autonomic agents|mesh-ancestor
5787072|NCT02817360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5787073|NCT02817360|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5787074|NCT02817360|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
5787075|NCT02816970|Vildagliptin|vildagliptin|mesh-list
5787076|NCT02816970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5787077|NCT02816970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787078|NCT02816970|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5787079|NCT02816970|Protease Inhibitors|protease inhibitors|mesh-ancestor
5787080|NCT02816970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5787081|NCT02816970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787082|NCT02817191|Tobramycin|tobramycin|mesh-list
5787083|NCT02817191|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
5787084|NCT02817191|Dexamethasone|dexamethasone|mesh-list
5787085|NCT02817191|Dexamethasone acetate|dexamethasone acetate|mesh-list
5787086|NCT02817191|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5787087|NCT02817191|BB 1101|bb 1101|mesh-list
5787088|NCT02817191|Dipivefrin|dipivefrin|mesh-list
5787089|NCT02817191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5787090|NCT02817191|Antiemetics|antiemetics|mesh-ancestor
5787091|NCT02817191|Autonomic Agents|autonomic agents|mesh-ancestor
5787092|NCT02817191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5787093|NCT02817191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787094|NCT02817191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5787095|NCT02817191|Glucocorticoids|glucocorticoids|mesh-ancestor
5787096|NCT02817191|Hormones|hormones|mesh-ancestor
5787097|NCT02817191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5787098|NCT02817191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5787099|NCT02817191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5787100|NCT02817191|Protease Inhibitors|protease inhibitors|mesh-ancestor
5787101|NCT02817191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5787102|NCT02817191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787103|NCT02817191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5787104|NCT02817191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5787105|NCT02817191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5787106|NCT02817191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5787107|NCT02817191|Adrenergic Agents|adrenergic agents|mesh-ancestor
5787108|NCT02817191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5787109|NCT02817217|Valsartan|valsartan|mesh-list
5787110|NCT02817217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5787111|NCT02817217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5787112|NCT02817217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5787113|NCT02817217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787114|NCT02817256|Vitamins|vitamins|mesh-list
5787115|NCT02817256|Micronutrients|micronutrients|mesh-ancestor
5787116|NCT02817256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787117|NCT02817243|Simvastatin|simvastatin|mesh-list
5787118|NCT02817243|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5787119|NCT02817243|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5787120|NCT02817243|Antimetabolites|antimetabolites|mesh-ancestor
5787121|NCT02817243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787122|NCT02817243|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5787123|NCT02817243|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5787124|NCT02817243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5787125|NCT02817100|Itraconazole|itraconazole|mesh-list
5787126|NCT02817100|Antifungal Agents|antifungal agents|mesh-ancestor
5787127|NCT02817100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5787128|NCT02817100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5787129|NCT02817100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5787130|NCT02817100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5787131|NCT02817100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787132|NCT02817100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5787133|NCT02817100|Hormone Antagonists|hormone antagonists|mesh-ancestor
5787134|NCT02817100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5787135|NCT02817100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787136|NCT02817100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5787137|NCT02817113|Fluorouracil|fluorouracil|mesh-list
5787138|NCT02817113|Cetuximab|cetuximab|mesh-list
5787139|NCT02817113|Antimetabolites|antimetabolites|mesh-ancestor
5787140|NCT02817113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787141|NCT02817113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5787142|NCT02817113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5787143|NCT02817113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5787144|NCT02817113|Immunologic Factors|immunologic factors|mesh-ancestor
5898443|NCT03164772|Durvalumab|durvalumab|mesh-list
5787145|NCT02817113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787146|NCT02817113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5787147|NCT02816905|Fluorometholone|fluorometholone|mesh-list
5787148|NCT02816905|Dexamethasone|dexamethasone|mesh-list
5787149|NCT02816905|Rimexolone|rimexolone|mesh-list
5787150|NCT02816905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5787151|NCT02816905|Antiemetics|antiemetics|mesh-ancestor
5787152|NCT02816905|Autonomic Agents|autonomic agents|mesh-ancestor
5787153|NCT02816905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5787154|NCT02816905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787155|NCT02816905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5787156|NCT02816905|Glucocorticoids|glucocorticoids|mesh-ancestor
5787157|NCT02816905|Hormones|hormones|mesh-ancestor
5787158|NCT02816905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5787159|NCT02816905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5787160|NCT02816905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5787161|NCT02816905|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5898444|NCT03164772|Tremelimumab|tremelimumab|mesh-list
5898445|NCT03164772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5898446|NCT03164772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5898447|NCT03132532|Paclitaxel|paclitaxel|mesh-list
5898448|NCT03132532|Carboplatin|carboplatin|mesh-list
5898449|NCT03132532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5898450|NCT03132532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5898451|NCT03132532|Tubulin Modulators|tubulin modulators|mesh-ancestor
5898452|NCT03132532|Antimitotic Agents|antimitotic agents|mesh-ancestor
5898453|NCT03132532|Mitosis Modulators|mitosis modulators|mesh-ancestor
5898454|NCT03132532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898455|NCT03122496|Durvalumab|durvalumab|mesh-list
5898456|NCT03122496|Tremelimumab|tremelimumab|mesh-list
5898457|NCT03122496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5898458|NCT03122496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5898459|NCT03066739|Remifentanil|remifentanil|mesh-list
5898460|NCT03066739|Naloxone|naloxone|mesh-list
5898461|NCT03066739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5898462|NCT03066739|Narcotics|narcotics|mesh-ancestor
5898463|NCT03066739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5898464|NCT03066739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898465|NCT03066739|Analgesics|analgesics|mesh-ancestor
5898466|NCT03066739|Sensory System Agents|sensory system agents|mesh-ancestor
5898467|NCT03066739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5898468|NCT03066739|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5898469|NCT03061474|Niacinamide|niacinamide|mesh-list
5898470|NCT03061474|Niacin|niacin|mesh-list
5898471|NCT03061474|Nicotinic Acids|nicotinic acids|mesh-list
5898472|NCT03061474|Vitamin B Complex|vitamin b complex|mesh-ancestor
5898473|NCT03061474|Vitamins|vitamins|mesh-ancestor
5898474|NCT03061474|Micronutrients|micronutrients|mesh-ancestor
5898475|NCT03061474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898476|NCT03061474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5898477|NCT03061474|Antimetabolites|antimetabolites|mesh-ancestor
5898478|NCT03061474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898479|NCT03061474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5898480|NCT03061474|Vasodilator Agents|vasodilator agents|mesh-ancestor
5898481|NCT02980341|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
5898482|NCT02980341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5898483|NCT02980341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5898484|NCT02963831|Durvalumab|durvalumab|mesh-list
5898485|NCT02963831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5898486|NCT02963831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5898487|NCT02929485|Bromocriptine|bromocriptine|mesh-list
5898488|NCT02929485|Tolcapone|tolcapone|mesh-list
5898489|NCT02929485|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5898490|NCT02929485|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5898491|NCT02929485|Hormone Antagonists|hormone antagonists|mesh-ancestor
5898492|NCT02929485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5898493|NCT02929485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898494|NCT02929485|Dopamine Agonists|dopamine agonists|mesh-ancestor
5898495|NCT02929485|Dopamine Agents|dopamine agents|mesh-ancestor
5898496|NCT02929485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5898497|NCT02929485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898498|NCT02929485|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
5898499|NCT02929485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5898500|NCT02884908|Pregabalin|pregabalin|mesh-list
5898501|NCT02884908|Analgesics|analgesics|mesh-ancestor
5898502|NCT02884908|Sensory System Agents|sensory system agents|mesh-ancestor
5898503|NCT02884908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5787162|NCT02816684|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5787163|NCT02816684|Antiviral Agents|antiviral agents|mesh-ancestor
5787164|NCT02816684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5787165|NCT02816853|Moxifloxacin|moxifloxacin|mesh-list
5787166|NCT02816853|Domperidone|domperidone|mesh-list
5787167|NCT02816853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5787168|NCT02816853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5787169|NCT02816853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5787170|NCT02816853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5787171|NCT02816853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5787172|NCT02816853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787173|NCT02816853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5787174|NCT02816853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787175|NCT02816853|Antiemetics|antiemetics|mesh-ancestor
5787176|NCT02816853|Autonomic Agents|autonomic agents|mesh-ancestor
5787177|NCT02816853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5787178|NCT02816853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5787179|NCT02816853|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5787180|NCT02816853|Dopamine Agents|dopamine agents|mesh-ancestor
5787181|NCT02816853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5787182|NCT02816476|Daratumumab|daratumumab|mesh-list
5787183|NCT02816476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5787184|NCT02816593|Hydrogen Peroxide|hydrogen peroxide|mesh-list
5787185|NCT02816593|Carbamide Peroxide|carbamide peroxide|mesh-list
5787186|NCT02816593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5787187|NCT02816593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5787188|NCT02816567|Sufentanil|sufentanil|mesh-list
5787189|NCT02816567|Propofol|propofol|mesh-list
5787190|NCT02816567|Cisatracurium|cisatracurium|mesh-list
5787191|NCT02816567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5787192|NCT02816567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5787193|NCT02816567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787194|NCT02816567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5787195|NCT02816567|Anesthetics, General|anesthetics, general|mesh-ancestor
5787196|NCT02816567|Anesthetics|anesthetics|mesh-ancestor
5787197|NCT02816567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5787198|NCT02816567|Narcotics|narcotics|mesh-ancestor
5787199|NCT02816567|Analgesics|analgesics|mesh-ancestor
5787200|NCT02816567|Sensory System Agents|sensory system agents|mesh-ancestor
5787201|NCT02816567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5787202|NCT02816567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5787203|NCT02816567|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5787204|NCT02816567|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5787205|NCT02816112|Ciprofloxacin|ciprofloxacin|mesh-list
5787206|NCT02816112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5787207|NCT02816112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5787208|NCT02816112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5787209|NCT02816112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5787210|NCT02816112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5787211|NCT02816112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787212|NCT02816112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5787213|NCT02816112|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5787214|NCT02816112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5787215|NCT02816164|Lenograstim|lenograstim|mesh-list
5787216|NCT02816164|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5787217|NCT02816164|Immunologic Factors|immunologic factors|mesh-ancestor
5787218|NCT02816164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787219|NCT02816411|Caseins|caseins|mesh-list
5787220|NCT02816411|Chelating Agents|chelating agents|mesh-ancestor
5787221|NCT02816411|Sequestering Agents|sequestering agents|mesh-ancestor
5787222|NCT02816411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787223|NCT02816424|TEMPO|tempo|mesh-list
5787224|NCT02816424|Antioxidants|antioxidants|mesh-ancestor
5787225|NCT02816424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787226|NCT02816424|Protective Agents|protective agents|mesh-ancestor
5787227|NCT02816424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787228|NCT02815865|Oxytocin|oxytocin|mesh-list
5787229|NCT02815865|Dinoprostone|dinoprostone|mesh-list
5787230|NCT02815865|Oxytocics|oxytocics|mesh-ancestor
5787231|NCT02815865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5787232|NCT02815865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787233|NCT02815657|Valsartan|valsartan|mesh-list
5787234|NCT02815657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5787235|NCT02815657|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5787236|NCT02815657|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5787237|NCT02815657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787238|NCT02815787|Glyburide|glyburide|mesh-list
5787239|NCT02815787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5787240|NCT02815787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787241|NCT02815722|Simvastatin|simvastatin|mesh-list
5787242|NCT02815722|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5787243|NCT02815722|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5787244|NCT02815722|Antimetabolites|antimetabolites|mesh-ancestor
5787245|NCT02815722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787246|NCT02815722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5787247|NCT02815722|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5787248|NCT02815722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5787249|NCT02816151|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5787250|NCT02816151|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5787251|NCT02816151|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5787252|NCT02816151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5787253|NCT02816151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787254|NCT02816151|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5787255|NCT02816151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5787256|NCT02816151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787257|NCT02816151|Cholinergic Agents|cholinergic agents|mesh-ancestor
5787258|NCT02816151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5787259|NCT02816203|Hemostatics|hemostatics|mesh-list
5787260|NCT02816203|Coagulants|coagulants|mesh-ancestor
5787261|NCT02815566|Tenofovir|tenofovir|mesh-list
5787262|NCT02815566|Emtricitabine|emtricitabine|mesh-list
6210764|NCT02164513|Respiratory System Agents|respiratory system agents|mesh-ancestor
6210765|NCT02164513|Dermatologic Agents|dermatologic agents|mesh-ancestor
6210766|NCT02164513|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6210767|NCT02164513|Anticonvulsants|anticonvulsants|mesh-ancestor
6210768|NCT02164864|Aspirin|aspirin|mesh-list
6210769|NCT02164864|Warfarin|warfarin|mesh-list
6210770|NCT02164864|Dabigatran|dabigatran|mesh-list
6210771|NCT02164864|Clopidogrel|clopidogrel|mesh-list
5787263|NCT02815566|Antiviral Agents|antiviral agents|mesh-ancestor
5787264|NCT02815566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5787265|NCT02815566|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5787266|NCT02815566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5787267|NCT02815566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5787268|NCT02815566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787269|NCT02815566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5787270|NCT02815566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5787271|NCT02815319|Dexamethasone|dexamethasone|mesh-list
5787272|NCT02815319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5787273|NCT02815319|Antiemetics|antiemetics|mesh-ancestor
5787274|NCT02815319|Autonomic Agents|autonomic agents|mesh-ancestor
5787275|NCT02815319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5787276|NCT02815319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787277|NCT02815319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5787278|NCT02815319|Glucocorticoids|glucocorticoids|mesh-ancestor
5787279|NCT02815319|Hormones|hormones|mesh-ancestor
5787280|NCT02815319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5787281|NCT02815319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5787282|NCT02815319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5787283|NCT02815410|Levetiracetam|levetiracetam|mesh-list
5787284|NCT02815410|Anticonvulsants|anticonvulsants|mesh-ancestor
5787285|NCT02815410|Nootropic Agents|nootropic agents|mesh-ancestor
5787286|NCT02815475|Curcumin|curcumin|mesh-list
5787287|NCT02815475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5787288|NCT02815475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5787289|NCT02815475|Analgesics|analgesics|mesh-ancestor
5787290|NCT02815475|Sensory System Agents|sensory system agents|mesh-ancestor
5787291|NCT02815475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5787292|NCT02815475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787293|NCT02815475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5787294|NCT02815475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5787295|NCT02815475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5787296|NCT02815475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5787297|NCT02815475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898504|NCT02884908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898505|NCT02884908|Anticonvulsants|anticonvulsants|mesh-ancestor
5898506|NCT02884908|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5898507|NCT02884908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6673787|NCT01565109|Mitosis Modulators|mitosis modulators|mesh-ancestor
5898508|NCT02884908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898509|NCT02884908|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6210772|NCT02164864|Ticagrelor|ticagrelor|mesh-list
5787298|NCT02815449|Iron|iron|mesh-list
5787299|NCT02815449|Trace Elements|trace elements|mesh-ancestor
5787300|NCT02815449|Micronutrients|micronutrients|mesh-ancestor
5787301|NCT02815449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787302|NCT02815332|Minocycline|minocycline|mesh-list
5787303|NCT02815332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5787304|NCT02815332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5787305|NCT02815189|Acetaminophen|acetaminophen|mesh-list
5787306|NCT02815189|Ibuprofen|ibuprofen|mesh-list
5787307|NCT02815189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5787308|NCT02815189|Analgesics|analgesics|mesh-ancestor
5787309|NCT02815189|Sensory System Agents|sensory system agents|mesh-ancestor
5787310|NCT02815189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5787311|NCT02815189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787312|NCT02815189|Antipyretics|antipyretics|mesh-ancestor
5787313|NCT02815189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5787314|NCT02815189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5787315|NCT02815189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5787316|NCT02815189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5787317|NCT02815189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5787318|NCT02815189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787319|NCT02815111|Acetaminophen|acetaminophen|mesh-list
5787320|NCT02815111|Lidocaine|lidocaine|mesh-list
5787321|NCT02815111|Ketamine|ketamine|mesh-list
5787322|NCT02815111|Gabapentin|gabapentin|mesh-list
5787323|NCT02815111|Anesthetics, Local|anesthetics, local|mesh-ancestor
5787324|NCT02815111|Anesthetics|anesthetics|mesh-ancestor
5787325|NCT02815111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5787326|NCT02815111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787327|NCT02815111|Sensory System Agents|sensory system agents|mesh-ancestor
5787328|NCT02815111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5787329|NCT02815111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5787330|NCT02815111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5787331|NCT02815111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5787332|NCT02815111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5787333|NCT02815111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787334|NCT02815111|Analgesics|analgesics|mesh-ancestor
5787335|NCT02815111|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5787336|NCT02815111|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5787337|NCT02815111|Anesthetics, General|anesthetics, general|mesh-ancestor
5787338|NCT02815111|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5787339|NCT02815111|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5787340|NCT02815111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5787341|NCT02815111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5787342|NCT02815111|Antipyretics|antipyretics|mesh-ancestor
5787343|NCT02815111|Anticonvulsants|anticonvulsants|mesh-ancestor
5787344|NCT02815111|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5787345|NCT02815111|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5787346|NCT02815111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5787347|NCT02815111|Antimanic Agents|antimanic agents|mesh-ancestor
5787348|NCT02814994|Respiratory System Agents|respiratory system agents|mesh-list
5787349|NCT02815046|Botulinum Toxins|botulinum toxins|mesh-list
5787350|NCT02815046|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5787351|NCT02815046|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5787352|NCT02815046|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5787353|NCT02815046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5787354|NCT02815046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787355|NCT02815046|Cholinergic Agents|cholinergic agents|mesh-ancestor
5787356|NCT02815046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5787357|NCT02815046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787358|NCT02815046|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5787359|NCT02815046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5787360|NCT02815033|Choline|choline|mesh-list
5787361|NCT02815033|Lipotropic Agents|lipotropic agents|mesh-ancestor
5787362|NCT02815033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5787363|NCT02815033|Antimetabolites|antimetabolites|mesh-ancestor
5787364|NCT02815033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787365|NCT02815033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5787366|NCT02815033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5787367|NCT02815033|Nootropic Agents|nootropic agents|mesh-ancestor
5787368|NCT02814877|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5787369|NCT02814877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5787370|NCT02814968|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5787371|NCT02814968|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5787372|NCT02814968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787373|NCT02815059|Prednisone|prednisone|mesh-list
5787374|NCT02815059|Dasatinib|dasatinib|mesh-list
5787375|NCT02815059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5787376|NCT02815059|Glucocorticoids|glucocorticoids|mesh-ancestor
5787377|NCT02815059|Hormones|hormones|mesh-ancestor
5787378|NCT02815059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5787379|NCT02815059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787380|NCT02815059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5787381|NCT02815059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5787382|NCT02815059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5787383|NCT02815059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5787384|NCT02815059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787385|NCT02814500|Amlodipine|amlodipine|mesh-list
5787386|NCT02814500|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5787387|NCT02814500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5787388|NCT02814500|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5787389|NCT02814500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5787390|NCT02814500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787391|NCT02814500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5787392|NCT02814500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787393|NCT02814500|Vasodilator Agents|vasodilator agents|mesh-ancestor
5787394|NCT02814500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5787395|NCT02814500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6491299|NCT00601991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6491300|NCT00601991|Growth Inhibitors|growth inhibitors|mesh-ancestor
6491301|NCT00601991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6491302|NCT00602004|Losartan|losartan|mesh-list
6491303|NCT00602004|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6491304|NCT00602004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6491305|NCT00602004|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6491306|NCT00602004|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6491307|NCT00602004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787396|NCT02814500|Antimetabolites|antimetabolites|mesh-ancestor
5787397|NCT02814500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5787398|NCT02814500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5787399|NCT02814500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5787400|NCT02814669|Atezolizumab|atezolizumab|mesh-list
5787401|NCT02814669|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
5787402|NCT02814669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5787403|NCT02814461|Axitinib|axitinib|mesh-list
5787404|NCT02814461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5787405|NCT02814461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5787406|NCT02814461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5787407|NCT02814461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787408|NCT02814409|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5787409|NCT02814409|Plasminogen|plasminogen|mesh-list
5787410|NCT02814409|Tenecteplase|tenecteplase|mesh-list
5787411|NCT02814409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5787412|NCT02814409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5787413|NCT02814409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787414|NCT02814630|Omalizumab|omalizumab|mesh-list
5787415|NCT02814630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5787416|NCT02814630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5787417|NCT02814630|Respiratory System Agents|respiratory system agents|mesh-ancestor
5787418|NCT02814058|Zolpidem|zolpidem|mesh-list
5787419|NCT02814058|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5787420|NCT02814058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5787421|NCT02814058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5787422|NCT02814058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787423|NCT02814058|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6491308|NCT00602017|Amlodipine|amlodipine|mesh-list
6491309|NCT00602017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6491310|NCT00602017|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5787424|NCT02814058|GABA Agonists|gaba agonists|mesh-ancestor
5787425|NCT02814058|GABA Agents|gaba agents|mesh-ancestor
5787426|NCT02814058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5787427|NCT02814058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787428|NCT02814110|Lenograstim|lenograstim|mesh-list
5787429|NCT02814110|Sargramostim|sargramostim|mesh-list
5787430|NCT02814110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5787431|NCT02814110|Immunologic Factors|immunologic factors|mesh-ancestor
5787432|NCT02814110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787433|NCT02813863|Metformin|metformin|mesh-list
5787434|NCT02813863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5787435|NCT02813863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787436|NCT02813824|Aspirin|aspirin|mesh-list
5787437|NCT02813824|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
5787438|NCT02813824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5787439|NCT02813824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5787440|NCT02813824|Analgesics|analgesics|mesh-ancestor
5787441|NCT02813824|Sensory System Agents|sensory system agents|mesh-ancestor
5787442|NCT02813824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5787443|NCT02813824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787444|NCT02813824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5787445|NCT02813824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5787446|NCT02813824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5787447|NCT02813824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5787448|NCT02813824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787449|NCT02813824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5787450|NCT02813824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5787451|NCT02813824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5787452|NCT02813824|Antipyretics|antipyretics|mesh-ancestor
5898510|NCT02884908|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5898511|NCT02884908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5898512|NCT02884908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5898513|NCT02884908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5898514|NCT02867761|Glycopyrrolate|glycopyrrolate|mesh-list
5898515|NCT02867761|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5898516|NCT02867761|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5898517|NCT02867761|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5898518|NCT02867761|Cholinergic Agents|cholinergic agents|mesh-ancestor
5898519|NCT02867761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5898520|NCT02867761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898521|NCT02867761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898522|NCT02863445|Levonorgestrel|levonorgestrel|mesh-list
5898523|NCT02863445|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5898524|NCT02863445|Contraceptive Agents|contraceptive agents|mesh-ancestor
5898525|NCT02863445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5898526|NCT02863445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898527|NCT02863445|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5898528|NCT02863445|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5898529|NCT02863445|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5898530|NCT02859337|Ulipristal acetate|ulipristal acetate|mesh-list
5898531|NCT02859337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5898532|NCT02859337|Contraceptive Agents|contraceptive agents|mesh-ancestor
5898533|NCT02859337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5898534|NCT02859337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898535|NCT02859337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5898536|NCT02849639|Scopolamine|scopolamine|mesh-list
5898537|NCT02849639|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
5898538|NCT02849639|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5898539|NCT02849639|Antiemetics|antiemetics|mesh-ancestor
5898540|NCT02849639|Autonomic Agents|autonomic agents|mesh-ancestor
5898541|NCT02849639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5898542|NCT02849639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898543|NCT02849639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5898544|NCT02849639|Mydriatics|mydriatics|mesh-ancestor
5898545|NCT02849639|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5898546|NCT02849639|Cholinergic Agents|cholinergic agents|mesh-ancestor
5898547|NCT02849639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5898548|NCT02849639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898549|NCT02849639|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5898550|NCT02849639|Parasympatholytics|parasympatholytics|mesh-ancestor
5898551|NCT02829502|Exenatide|exenatide|mesh-list
5898552|NCT02829502|Glucagon|glucagon|mesh-list
5898553|NCT02829502|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5898554|NCT02829502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5898555|NCT02829502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898556|NCT02829502|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5898557|NCT02829502|Incretins|incretins|mesh-ancestor
5898558|NCT02829502|Hormones|hormones|mesh-ancestor
5898559|NCT02829502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5898560|NCT02829502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5898561|NCT02815592|Carboplatin|carboplatin|mesh-list
5898562|NCT02815592|Etoposide|etoposide|mesh-list
5898563|NCT02815592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5898564|NCT02815592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5898565|NCT02815592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5898566|NCT02815592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5898567|NCT02815592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5908112|NCT04912115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5787453|NCT02813642|Mitogens|mitogens|mesh-list
5787454|NCT02813642|Mitosis Modulators|mitosis modulators|mesh-ancestor
5787455|NCT02813642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787456|NCT02813356|Naloxegol|naloxegol|mesh-list
5787457|NCT02813356|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5787458|NCT02813356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787459|NCT02813356|Sensory System Agents|sensory system agents|mesh-ancestor
5787460|NCT02813356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5787461|NCT02813369|Naloxegol|naloxegol|mesh-list
5787462|NCT02813369|Laxatives|laxatives|mesh-list
5787463|NCT02813369|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5787464|NCT02813369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787465|NCT02813369|Sensory System Agents|sensory system agents|mesh-ancestor
5787466|NCT02813369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5787467|NCT02813369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5787468|NCT02813382|Bupivacaine|bupivacaine|mesh-list
5787469|NCT02813382|Prilocaine|prilocaine|mesh-list
5787470|NCT02813382|Chloroprocaine|chloroprocaine|mesh-list
5787471|NCT02813382|Procaine|procaine|mesh-list
5787472|NCT02813382|Anesthetics, Local|anesthetics, local|mesh-ancestor
5787473|NCT02813382|Anesthetics|anesthetics|mesh-ancestor
5787474|NCT02813382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5787475|NCT02813382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787476|NCT02813382|Sensory System Agents|sensory system agents|mesh-ancestor
5787477|NCT02813382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5787478|NCT02813135|Carboplatin|carboplatin|mesh-list
5787479|NCT02813135|Nivolumab|nivolumab|mesh-list
6673788|NCT01565109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673789|NCT01565200|Trastuzumab|trastuzumab|mesh-list
6673790|NCT01565200|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
6673791|NCT01565200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6673792|NCT01565200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6673793|NCT01565200|Tubulin Modulators|tubulin modulators|mesh-ancestor
6673794|NCT01565200|Antimitotic Agents|antimitotic agents|mesh-ancestor
6673795|NCT01565200|Mitosis Modulators|mitosis modulators|mesh-ancestor
6673796|NCT01565200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673797|NCT01565239|Thrombin|thrombin|mesh-list
6673798|NCT01565239|Hemostatics|hemostatics|mesh-ancestor
6673799|NCT01565239|Coagulants|coagulants|mesh-ancestor
6673800|NCT01565265|Cetrorelix|cetrorelix|mesh-list
6673801|NCT01565265|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
6673802|NCT01565265|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5787480|NCT02813135|Irinotecan|irinotecan|mesh-list
5787481|NCT02813135|Temozolomide|temozolomide|mesh-list
5787482|NCT02813135|Topotecan|topotecan|mesh-list
5787483|NCT02813135|Olaparib|olaparib|mesh-list
5787484|NCT02813135|Adavosertib|adavosertib|mesh-list
5787485|NCT02813135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5787486|NCT02813135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5787487|NCT02813135|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5787488|NCT02813135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787489|NCT02813135|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5787490|NCT02813135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5787491|NCT02813135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5787492|NCT02813135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5787493|NCT02813135|Alkylating Agents|alkylating agents|mesh-ancestor
5787494|NCT02813135|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5787495|NCT02813486|Vaccines|vaccines|mesh-list
5787496|NCT02813486|Immunologic Factors|immunologic factors|mesh-ancestor
5787497|NCT02813486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787498|NCT02813239|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5787499|NCT02813239|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5787500|NCT02813239|Luteolytic Agents|luteolytic agents|mesh-ancestor
5787501|NCT02813239|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5787502|NCT02813239|Contraceptive Agents|contraceptive agents|mesh-ancestor
5787503|NCT02813239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5787504|NCT02813239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787505|NCT02813239|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5787506|NCT02813239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5787507|NCT02813239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5787508|NCT02813018|Ropivacaine|ropivacaine|mesh-list
5787509|NCT02813018|Anesthetics, Local|anesthetics, local|mesh-ancestor
5787510|NCT02813018|Anesthetics|anesthetics|mesh-ancestor
5787511|NCT02813018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5787512|NCT02813018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787513|NCT02813018|Sensory System Agents|sensory system agents|mesh-ancestor
5787514|NCT02813018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5787515|NCT02813148|Naloxegol|naloxegol|mesh-list
5787516|NCT02813148|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5787517|NCT02813148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787518|NCT02813148|Sensory System Agents|sensory system agents|mesh-ancestor
5787519|NCT02813148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5787520|NCT02813044|Anesthetics|anesthetics|mesh-list
5787521|NCT02813044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5787522|NCT02813044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787523|NCT02812888|Propranolol|propranolol|mesh-list
5787524|NCT02812888|Methimazole|methimazole|mesh-list
5787525|NCT02812888|Propylthiouracil|propylthiouracil|mesh-list
5787526|NCT02812888|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5787527|NCT02812888|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5787528|NCT02812888|Adrenergic Agents|adrenergic agents|mesh-ancestor
5787529|NCT02812888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5787530|NCT02812888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787531|NCT02812888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787532|NCT02812888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5787533|NCT02812888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5787534|NCT02812888|Vasodilator Agents|vasodilator agents|mesh-ancestor
5787535|NCT02812888|Antithyroid Agents|antithyroid agents|mesh-ancestor
5787536|NCT02812888|Hormone Antagonists|hormone antagonists|mesh-ancestor
5787537|NCT02812888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5787538|NCT02812888|Antimetabolites|antimetabolites|mesh-ancestor
5787539|NCT02812979|Albuterol|albuterol|mesh-list
5787540|NCT02812979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5787541|NCT02812979|Autonomic Agents|autonomic agents|mesh-ancestor
5787542|NCT02812979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5787543|NCT02812979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787544|NCT02812979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5787545|NCT02812979|Respiratory System Agents|respiratory system agents|mesh-ancestor
5787546|NCT02812979|Tocolytic Agents|tocolytic agents|mesh-ancestor
5787547|NCT02812979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5787548|NCT02812979|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5787549|NCT02812979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5787550|NCT02812979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5787551|NCT02812979|Adrenergic Agents|adrenergic agents|mesh-ancestor
5787552|NCT02812979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5787553|NCT02812979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787554|NCT02812940|Everolimus|everolimus|mesh-list
5787555|NCT02812940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5787556|NCT02812940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5787557|NCT02812940|Immunologic Factors|immunologic factors|mesh-ancestor
5787558|NCT02812940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787559|NCT02812654|Doxorubicin|doxorubicin|mesh-list
5787560|NCT02812654|Ifosfamide|ifosfamide|mesh-list
5787561|NCT02812654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5787562|NCT02812654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5787563|NCT02812654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5787564|NCT02812654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5787565|NCT02812654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5787566|NCT02812654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787567|NCT02812654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5787568|NCT02812654|Alkylating Agents|alkylating agents|mesh-ancestor
5787569|NCT02812719|Salicylic Acid|salicylic acid|mesh-list
5787570|NCT02812719|Salicylates|salicylates|mesh-list
5787571|NCT02812719|Glycolic acid|glycolic acid|mesh-list
5787572|NCT02812719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5787573|NCT02812719|Antifungal Agents|antifungal agents|mesh-ancestor
5787574|NCT02812719|Keratolytic Agents|keratolytic agents|mesh-ancestor
5787575|NCT02812719|Dermatologic Agents|dermatologic agents|mesh-ancestor
5787576|NCT02812719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5787577|NCT02812719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5787578|NCT02812719|Analgesics|analgesics|mesh-ancestor
5787579|NCT02812719|Sensory System Agents|sensory system agents|mesh-ancestor
5787580|NCT02812719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5787581|NCT02812719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787582|NCT02812719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5787583|NCT02812719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5787584|NCT02812719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5787585|NCT02812719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5787586|NCT02812719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787587|NCT02812992|Gemcitabine|gemcitabine|mesh-list
5787588|NCT02812992|Paclitaxel|paclitaxel|mesh-list
5787589|NCT02812992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5787590|NCT02812992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5787591|NCT02812992|Tubulin Modulators|tubulin modulators|mesh-ancestor
5787592|NCT02812992|Antimitotic Agents|antimitotic agents|mesh-ancestor
5787593|NCT02812992|Mitosis Modulators|mitosis modulators|mesh-ancestor
5787594|NCT02812992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787595|NCT02812992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5787596|NCT02812992|Antimetabolites|antimetabolites|mesh-ancestor
5787597|NCT02812992|Antiviral Agents|antiviral agents|mesh-ancestor
5787598|NCT02812992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5787599|NCT02812992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5787600|NCT02812992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5787601|NCT02812992|Immunologic Factors|immunologic factors|mesh-ancestor
5787602|NCT02812992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787603|NCT02812693|Pembrolizumab|pembrolizumab|mesh-list
5787604|NCT02812693|Imatinib Mesylate|imatinib mesylate|mesh-list
5787605|NCT02812693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5787606|NCT02812693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5787607|NCT02812693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5787608|NCT02812693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5787609|NCT02812693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787610|NCT02812641|Bevacizumab|bevacizumab|mesh-list
5787611|NCT02812641|Cisplatin|cisplatin|mesh-list
5787612|NCT02812641|Fluorouracil|fluorouracil|mesh-list
5787613|NCT02812641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5787614|NCT02812641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5787615|NCT02812641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5787616|NCT02812641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5787617|NCT02812641|Growth Substances|growth substances|mesh-ancestor
5787618|NCT02812641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787619|NCT02812641|Growth Inhibitors|growth inhibitors|mesh-ancestor
5787620|NCT02812641|Antimetabolites|antimetabolites|mesh-ancestor
5787621|NCT02812641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787622|NCT02812641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5787623|NCT02812641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5787624|NCT02812641|Immunologic Factors|immunologic factors|mesh-ancestor
5787625|NCT02812602|Lidocaine|lidocaine|mesh-list
5787626|NCT02812602|Anesthetics, Local|anesthetics, local|mesh-ancestor
5787627|NCT02812602|Anesthetics|anesthetics|mesh-ancestor
5787628|NCT02812602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5787629|NCT02812602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787630|NCT02812602|Sensory System Agents|sensory system agents|mesh-ancestor
5787631|NCT02812602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5787632|NCT02812602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5787633|NCT02812602|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5787634|NCT02812602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5787635|NCT02812602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5787636|NCT02812602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787637|NCT02812368|Clonidine|clonidine|mesh-list
5787638|NCT02812368|Analgesics|analgesics|mesh-ancestor
5787639|NCT02812368|Sensory System Agents|sensory system agents|mesh-ancestor
5787640|NCT02812368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5787641|NCT02812368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491311|NCT00602017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6491312|NCT00602017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787642|NCT02812368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5787643|NCT02812368|Sympatholytics|sympatholytics|mesh-ancestor
5787644|NCT02812368|Autonomic Agents|autonomic agents|mesh-ancestor
5787645|NCT02812368|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5787646|NCT02812368|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5787647|NCT02812368|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5787648|NCT02812368|Adrenergic Agents|adrenergic agents|mesh-ancestor
5787649|NCT02812368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5787650|NCT02812368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787651|NCT02812394|Levodopa|levodopa|mesh-list
5787652|NCT02812394|Carbidopa|carbidopa|mesh-list
5787653|NCT02812394|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
5787654|NCT02812394|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5787655|NCT02812394|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6491313|NCT00602017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6491314|NCT00602017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491315|NCT00602017|Vasodilator Agents|vasodilator agents|mesh-ancestor
6491316|NCT00602030|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6491317|NCT00602030|Entinostat|entinostat|mesh-list
5787656|NCT02812394|Dopamine Agents|dopamine agents|mesh-ancestor
5787657|NCT02812394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5787658|NCT02812394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787659|NCT02812394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787660|NCT02812394|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5787661|NCT02812394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5787662|NCT02812394|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5787663|NCT02812394|Immunologic Factors|immunologic factors|mesh-ancestor
5787664|NCT02812394|Dopamine Agonists|dopamine agonists|mesh-ancestor
5787665|NCT02812199|Lidocaine|lidocaine|mesh-list
5787666|NCT02812199|Epinephrine|epinephrine|mesh-list
5787667|NCT02812199|Racepinephrine|racepinephrine|mesh-list
5787668|NCT02812199|Epinephryl borate|epinephryl borate|mesh-list
5787669|NCT02812199|Anesthetics, Local|anesthetics, local|mesh-ancestor
5787670|NCT02812199|Anesthetics|anesthetics|mesh-ancestor
5787671|NCT02812199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5787672|NCT02812199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787673|NCT02812199|Sensory System Agents|sensory system agents|mesh-ancestor
5787674|NCT02812199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5787675|NCT02812199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5787676|NCT02812199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5787677|NCT02812199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5787678|NCT02812199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5787679|NCT02812199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787680|NCT02812199|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5787681|NCT02812199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5787682|NCT02812199|Adrenergic Agents|adrenergic agents|mesh-ancestor
5787683|NCT02812199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5787684|NCT02812199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5787685|NCT02812199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5787686|NCT02812199|Autonomic Agents|autonomic agents|mesh-ancestor
5787687|NCT02812199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5787688|NCT02812199|Respiratory System Agents|respiratory system agents|mesh-ancestor
5787689|NCT02812199|Mydriatics|mydriatics|mesh-ancestor
5787690|NCT02812199|Sympathomimetics|sympathomimetics|mesh-ancestor
5787691|NCT02812199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5787692|NCT02812212|Diuretics|diuretics|mesh-list
5787693|NCT02812212|Natriuretic Agents|natriuretic agents|mesh-ancestor
5787694|NCT02812212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787695|NCT02812147|Droxidopa|droxidopa|mesh-list
5787696|NCT02812147|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5787697|NCT02812147|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5787698|NCT02812043|Amorolfine|amorolfine|mesh-list
5787699|NCT02812043|Antifungal Agents|antifungal agents|mesh-ancestor
5787700|NCT02812043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5898568|NCT02815592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898569|NCT02795351|Sildenafil Citrate|sildenafil citrate|mesh-list
5898570|NCT02795351|Vasodilator Agents|vasodilator agents|mesh-ancestor
5898571|NCT02795351|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5898572|NCT02795351|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5898573|NCT02795351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5898574|NCT02795351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898575|NCT02795351|Urological Agents|urological agents|mesh-ancestor
5898576|NCT02735239|Leucovorin|leucovorin|mesh-list
5898577|NCT02735239|Paclitaxel|paclitaxel|mesh-list
5898578|NCT02735239|Docetaxel|docetaxel|mesh-list
5898579|NCT02735239|Carboplatin|carboplatin|mesh-list
5898580|NCT02735239|Fluorouracil|fluorouracil|mesh-list
5898581|NCT02735239|Capecitabine|capecitabine|mesh-list
5898582|NCT02735239|Oxaliplatin|oxaliplatin|mesh-list
5898583|NCT02735239|Durvalumab|durvalumab|mesh-list
5898584|NCT02735239|Tremelimumab|tremelimumab|mesh-list
5898585|NCT02735239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5898586|NCT02735239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5898587|NCT02735239|Tubulin Modulators|tubulin modulators|mesh-ancestor
5898588|NCT02735239|Antimitotic Agents|antimitotic agents|mesh-ancestor
5898589|NCT02735239|Mitosis Modulators|mitosis modulators|mesh-ancestor
5898590|NCT02735239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898591|NCT02735239|Antimetabolites|antimetabolites|mesh-ancestor
5898592|NCT02735239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5898593|NCT02735239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5898594|NCT02735239|Immunologic Factors|immunologic factors|mesh-ancestor
5898595|NCT02735239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898596|NCT02735239|Antidotes|antidotes|mesh-ancestor
5898597|NCT02735239|Protective Agents|protective agents|mesh-ancestor
5898598|NCT02735239|Vitamin B Complex|vitamin b complex|mesh-ancestor
5898599|NCT02735239|Vitamins|vitamins|mesh-ancestor
5898600|NCT02735239|Micronutrients|micronutrients|mesh-ancestor
5787701|NCT02811939|Dronabinol|dronabinol|mesh-list
5787702|NCT02811939|Hallucinogens|hallucinogens|mesh-ancestor
5787703|NCT02811939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787704|NCT02811939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5787705|NCT02811939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5787706|NCT02811939|Analgesics|analgesics|mesh-ancestor
5787707|NCT02811939|Sensory System Agents|sensory system agents|mesh-ancestor
5787708|NCT02811939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5787709|NCT02811939|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5787710|NCT02811939|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5787711|NCT02811939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5787712|NCT02811939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787713|NCT02811939|Hormones|hormones|mesh-ancestor
5787714|NCT02811939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5787715|NCT02811978|Dexamethasone|dexamethasone|mesh-list
5787716|NCT02811978|Bortezomib|bortezomib|mesh-list
5787717|NCT02811978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5787718|NCT02811978|Antiemetics|antiemetics|mesh-ancestor
5787719|NCT02811978|Autonomic Agents|autonomic agents|mesh-ancestor
5787720|NCT02811978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5787721|NCT02811978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787722|NCT02811978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5787723|NCT02811978|Glucocorticoids|glucocorticoids|mesh-ancestor
5787724|NCT02811978|Hormones|hormones|mesh-ancestor
5787725|NCT02811978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5787726|NCT02811978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5787727|NCT02811978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5787728|NCT02812355|Heparin|heparin|mesh-list
5787729|NCT02812355|Anticoagulants|anticoagulants|mesh-ancestor
5787730|NCT02812355|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5787731|NCT02812355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5787732|NCT02812355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787733|NCT02811731|Amlodipine|amlodipine|mesh-list
5787734|NCT02811731|Candesartan|candesartan|mesh-list
5787735|NCT02811731|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5787736|NCT02811731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5787737|NCT02811731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5787738|NCT02811731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787739|NCT02811731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5787740|NCT02811731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787741|NCT02811731|Vasodilator Agents|vasodilator agents|mesh-ancestor
5787742|NCT02811731|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5787743|NCT02811731|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5787744|NCT02811809|Leuprolide|leuprolide|mesh-list
5787745|NCT02811809|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5787746|NCT02811809|Fertility Agents|fertility agents|mesh-ancestor
5787747|NCT02811809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5787748|NCT02811809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787749|NCT02811809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5787750|NCT02811809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5787751|NCT02811991|Acetaminophen|acetaminophen|mesh-list
5787752|NCT02811991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5787753|NCT02811991|Analgesics|analgesics|mesh-ancestor
5787754|NCT02811991|Sensory System Agents|sensory system agents|mesh-ancestor
5787755|NCT02811991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5787756|NCT02811991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787757|NCT02811991|Antipyretics|antipyretics|mesh-ancestor
5787758|NCT02811692|Aflibercept|aflibercept|mesh-list
5787759|NCT02811692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5787760|NCT02811692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5787761|NCT02811692|Growth Substances|growth substances|mesh-ancestor
5787762|NCT02811692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787763|NCT02811692|Growth Inhibitors|growth inhibitors|mesh-ancestor
5787764|NCT02811692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5787765|NCT02811627|Memantine|memantine|mesh-list
5787766|NCT02811627|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5787767|NCT02811627|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5787768|NCT02811627|Dopamine Agents|dopamine agents|mesh-ancestor
5787769|NCT02811627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5787770|NCT02811627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787771|NCT02811627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787772|NCT02811627|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5787773|NCT02811627|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5787774|NCT02811497|Azacitidine|azacitidine|mesh-list
5787775|NCT02811497|Durvalumab|durvalumab|mesh-list
5787776|NCT02811497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5787777|NCT02811497|Antimetabolites|antimetabolites|mesh-ancestor
5787778|NCT02811497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787779|NCT02811497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5787780|NCT02811497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5787781|NCT02811497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5787782|NCT02811523|Doxorubicin|doxorubicin|mesh-list
5787783|NCT02811523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5787784|NCT02811523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5787785|NCT02811523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5787786|NCT02811523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5787787|NCT02811523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5787788|NCT02811523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787789|NCT02811484|Dapagliflozin|dapagliflozin|mesh-list
5787790|NCT02811484|Exenatide|exenatide|mesh-list
5787791|NCT02811484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5787792|NCT02811484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787793|NCT02811484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5787794|NCT02811484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787795|NCT02811484|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5787796|NCT02811484|Incretins|incretins|mesh-ancestor
5787797|NCT02811484|Hormones|hormones|mesh-ancestor
5787798|NCT02811484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5787799|NCT02811289|Mirabegron|mirabegron|mesh-list
5787800|NCT02811289|Glycerol|glycerol|mesh-list
5787801|NCT02811289|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
5787802|NCT02811289|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5787803|NCT02811289|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5787804|NCT02811289|Adrenergic Agents|adrenergic agents|mesh-ancestor
5787805|NCT02811289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5787806|NCT02811289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787807|NCT02811289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787808|NCT02811289|Urological Agents|urological agents|mesh-ancestor
5787809|NCT02811289|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
5787810|NCT02811289|Protective Agents|protective agents|mesh-ancestor
5787811|NCT02811185|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5787812|NCT02811185|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5787813|NCT02811185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787814|NCT02811341|Scopolamine|scopolamine|mesh-list
5787815|NCT02811341|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
5787816|NCT02811341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5787817|NCT02811341|Antiemetics|antiemetics|mesh-ancestor
5787818|NCT02811341|Autonomic Agents|autonomic agents|mesh-ancestor
5787819|NCT02811341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5787820|NCT02811341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787821|NCT02811341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5787822|NCT02811341|Mydriatics|mydriatics|mesh-ancestor
5787823|NCT02811341|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5787824|NCT02811341|Cholinergic Agents|cholinergic agents|mesh-ancestor
5787825|NCT02811341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5787826|NCT02811341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787827|NCT02811341|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5787828|NCT02811341|Parasympatholytics|parasympatholytics|mesh-ancestor
5787829|NCT02811354|Osimertinib|osimertinib|mesh-list
5787830|NCT02811354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5787831|NCT02811354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5787832|NCT02811354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5787833|NCT02811354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787834|NCT02811263|Epoetin Alfa|epoetin alfa|mesh-list
5787835|NCT02811263|Hematinics|hematinics|mesh-ancestor
5787836|NCT02811055|Aprepitant|aprepitant|mesh-list
5787837|NCT02811055|Antiemetics|antiemetics|mesh-ancestor
6491318|NCT00602030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6491319|NCT00602030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6491320|NCT00602030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5787838|NCT02811055|Autonomic Agents|autonomic agents|mesh-ancestor
5787839|NCT02811055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5787840|NCT02811055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787841|NCT02811055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5787842|NCT02811055|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5787843|NCT02811055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5787844|NCT02811055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787845|NCT02811016|Budesonide|budesonide|mesh-list
5787846|NCT02811016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5787847|NCT02811016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5787848|NCT02811016|Autonomic Agents|autonomic agents|mesh-ancestor
6673803|NCT01565265|Hormones|hormones|mesh-ancestor
6673804|NCT01565265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6673805|NCT01565265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673806|NCT01565265|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6673807|NCT01565265|Fertility Agents|fertility agents|mesh-ancestor
6673808|NCT01565265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6673809|NCT01565265|Hormone Antagonists|hormone antagonists|mesh-ancestor
6673810|NCT01565278|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6673811|NCT01565278|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6210773|NCT02164864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6673812|NCT01565278|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6673813|NCT01565278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5787849|NCT02811016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5787850|NCT02811016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787851|NCT02811016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5787852|NCT02811016|Respiratory System Agents|respiratory system agents|mesh-ancestor
5787853|NCT02811016|Glucocorticoids|glucocorticoids|mesh-ancestor
5787854|NCT02811016|Hormones|hormones|mesh-ancestor
5787855|NCT02811016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5787856|NCT02810808|Ranibizumab|ranibizumab|mesh-list
6210774|NCT02164864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6210775|NCT02164864|Analgesics|analgesics|mesh-ancestor
6210776|NCT02164864|Sensory System Agents|sensory system agents|mesh-ancestor
5787857|NCT02810808|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5787858|NCT02810808|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5787859|NCT02810808|Growth Substances|growth substances|mesh-ancestor
5787860|NCT02810808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787861|NCT02810808|Growth Inhibitors|growth inhibitors|mesh-ancestor
5787862|NCT02810808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5787863|NCT02810886|Edetic Acid|edetic acid|mesh-list
5787864|NCT02810886|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5787865|NCT02810886|Anticoagulants|anticoagulants|mesh-ancestor
5787866|NCT02810886|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5787867|NCT02810886|Chelating Agents|chelating agents|mesh-ancestor
5787868|NCT02810886|Sequestering Agents|sequestering agents|mesh-ancestor
5787869|NCT02810886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787870|NCT02810886|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5787871|NCT02810782|Morphine|morphine|mesh-list
5787872|NCT02810782|Phenobarbital|phenobarbital|mesh-list
5787873|NCT02810782|Chlorpromazine|chlorpromazine|mesh-list
5787874|NCT02810782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5787875|NCT02810782|Narcotics|narcotics|mesh-ancestor
5787876|NCT02810782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5787877|NCT02810782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787878|NCT02810782|Analgesics|analgesics|mesh-ancestor
5787879|NCT02810782|Sensory System Agents|sensory system agents|mesh-ancestor
5787880|NCT02810782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5787881|NCT02810782|Anticonvulsants|anticonvulsants|mesh-ancestor
5787882|NCT02810782|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5787883|NCT02810782|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5787884|NCT02810782|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5787885|NCT02810782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5787886|NCT02810782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787887|NCT02810782|GABA Modulators|gaba modulators|mesh-ancestor
5787888|NCT02810782|GABA Agents|gaba agents|mesh-ancestor
5787889|NCT02810782|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5787890|NCT02810782|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5787891|NCT02810782|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5787892|NCT02810782|Antiemetics|antiemetics|mesh-ancestor
6210777|NCT02164864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6210778|NCT02164864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210779|NCT02164864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6210780|NCT02164864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6210781|NCT02164864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6210782|NCT02164864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6210783|NCT02164864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210784|NCT02164864|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5787893|NCT02810782|Autonomic Agents|autonomic agents|mesh-ancestor
6673814|NCT01565512|Bupivacaine|bupivacaine|mesh-list
5787894|NCT02810782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5787895|NCT02810782|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5787896|NCT02810782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5787897|NCT02810782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5787898|NCT02810782|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5787899|NCT02810782|Dopamine Agents|dopamine agents|mesh-ancestor
5787900|NCT02810899|Dexmedetomidine|dexmedetomidine|mesh-list
5787901|NCT02810899|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5787902|NCT02810899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5787903|NCT02810899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787904|NCT02810899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5787905|NCT02810899|Analgesics|analgesics|mesh-ancestor
5787906|NCT02810899|Sensory System Agents|sensory system agents|mesh-ancestor
5787907|NCT02810899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5787908|NCT02810899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5787909|NCT02810899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5787910|NCT02810899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5787911|NCT02810899|Adrenergic Agents|adrenergic agents|mesh-ancestor
5787912|NCT02810899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5787913|NCT02810899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787914|NCT02810587|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5787915|NCT02810587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5787916|NCT02810704|Aspirin|aspirin|mesh-list
5787917|NCT02810704|Warfarin|warfarin|mesh-list
5787918|NCT02810704|Rivaroxaban|rivaroxaban|mesh-list
5787919|NCT02810704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5787920|NCT02810704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5787921|NCT02810704|Analgesics|analgesics|mesh-ancestor
5787922|NCT02810704|Sensory System Agents|sensory system agents|mesh-ancestor
5787923|NCT02810704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5787924|NCT02810704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787925|NCT02810704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5787926|NCT02810704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5787927|NCT02810704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5787928|NCT02810704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5787929|NCT02810704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787930|NCT02810704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5787931|NCT02810704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5787932|NCT02810704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5787933|NCT02810704|Antipyretics|antipyretics|mesh-ancestor
5787934|NCT02810704|Anticoagulants|anticoagulants|mesh-ancestor
5787935|NCT02810704|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5787936|NCT02810704|Antithrombins|antithrombins|mesh-ancestor
5787937|NCT02810704|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5787938|NCT02810704|Protease Inhibitors|protease inhibitors|mesh-ancestor
5787939|NCT02810548|Mitogens|mitogens|mesh-list
5787940|NCT02810548|Mitosis Modulators|mitosis modulators|mesh-ancestor
5787941|NCT02810548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898601|NCT02735239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5898602|NCT02733133|Testosterone|testosterone|mesh-list
5898603|NCT02733133|Androgens|androgens|mesh-ancestor
5898604|NCT02733133|Hormones|hormones|mesh-ancestor
5898605|NCT02733133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5898606|NCT02733133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898607|NCT02721459|Vemurafenib|vemurafenib|mesh-list
5898608|NCT02721459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5898609|NCT02721459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5898610|NCT02721459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5898611|NCT02721459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898612|NCT02697383|Dexamethasone|dexamethasone|mesh-list
5898613|NCT02697383|Ixazomib|ixazomib|mesh-list
5898614|NCT02697383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5898615|NCT02697383|Antiemetics|antiemetics|mesh-ancestor
5898616|NCT02697383|Autonomic Agents|autonomic agents|mesh-ancestor
5898617|NCT02697383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5898618|NCT02697383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898619|NCT02697383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5898620|NCT02697383|Glucocorticoids|glucocorticoids|mesh-ancestor
5898621|NCT02697383|Hormones|hormones|mesh-ancestor
5898622|NCT02697383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5898623|NCT02697383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6673815|NCT01565512|Anesthetics, Local|anesthetics, local|mesh-ancestor
6673816|NCT01565512|Anesthetics|anesthetics|mesh-ancestor
6673817|NCT01565512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6673818|NCT01565512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673819|NCT01565512|Sensory System Agents|sensory system agents|mesh-ancestor
5898624|NCT02697383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5787942|NCT02810275|Leucovorin|leucovorin|mesh-list
5787943|NCT02810275|Folic Acid|folic acid|mesh-list
5787944|NCT02810275|Levoleucovorin|levoleucovorin|mesh-list
5787945|NCT02810275|Antidotes|antidotes|mesh-ancestor
5787946|NCT02810275|Protective Agents|protective agents|mesh-ancestor
5787947|NCT02810275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491321|NCT00602030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491322|NCT00602030|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6491323|NCT00602056|Vaccines|vaccines|mesh-list
6491324|NCT00602056|Immunologic Factors|immunologic factors|mesh-ancestor
6491325|NCT00602056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491326|NCT00602082|Capecitabine|capecitabine|mesh-list
6491327|NCT00602082|Streptozocin|streptozocin|mesh-list
6491328|NCT00602082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6491329|NCT00602082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6491330|NCT00602082|Antimetabolites|antimetabolites|mesh-ancestor
6491331|NCT00602082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491332|NCT00602082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6491333|NCT00602095|Misoprostol|misoprostol|mesh-list
6491334|NCT00602095|Dinoprostone|dinoprostone|mesh-list
6491335|NCT00602095|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6491336|NCT00602095|Abortifacient Agents|abortifacient agents|mesh-ancestor
6673820|NCT01565512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5787948|NCT02810275|Vitamin B Complex|vitamin b complex|mesh-ancestor
5787949|NCT02810275|Vitamins|vitamins|mesh-ancestor
5787950|NCT02810275|Micronutrients|micronutrients|mesh-ancestor
5787951|NCT02810275|Hematinics|hematinics|mesh-ancestor
5787952|NCT02810483|Topiramate|topiramate|mesh-list
5787953|NCT02810483|Anticonvulsants|anticonvulsants|mesh-ancestor
5787954|NCT02810483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5787955|NCT02810483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787956|NCT02810132|Metformin|metformin|mesh-list
5787957|NCT02810132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5787958|NCT02810132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787959|NCT02810015|Botulinum Toxins|botulinum toxins|mesh-list
5787960|NCT02810015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5787961|NCT02810015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5787962|NCT02810015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5787963|NCT02810015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5787964|NCT02810015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787965|NCT02810015|Cholinergic Agents|cholinergic agents|mesh-ancestor
5787966|NCT02810015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5787967|NCT02810015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787968|NCT02810015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5787969|NCT02810015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5787970|NCT02809781|Etanercept|etanercept|mesh-list
6673821|NCT01565590|Dexmedetomidine|dexmedetomidine|mesh-list
6673822|NCT01565590|Propofol|propofol|mesh-list
6673823|NCT01565590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6673824|NCT01565590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6673825|NCT01565590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673826|NCT01565590|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5787971|NCT02809781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5787972|NCT02809781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5787973|NCT02809781|Analgesics|analgesics|mesh-ancestor
5787974|NCT02809781|Sensory System Agents|sensory system agents|mesh-ancestor
5787975|NCT02809781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5787976|NCT02809781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787977|NCT02809781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5787978|NCT02809781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5787979|NCT02809781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5787980|NCT02809781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5787981|NCT02809781|Immunologic Factors|immunologic factors|mesh-ancestor
5787982|NCT02809768|Itraconazole|itraconazole|mesh-list
5787983|NCT02809768|Fluconazole|fluconazole|mesh-list
5787984|NCT02809768|Rifampin|rifampin|mesh-list
5787985|NCT02809768|Antifungal Agents|antifungal agents|mesh-ancestor
5787986|NCT02809768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5787987|NCT02809768|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5787988|NCT02809768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5787989|NCT02809768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5787990|NCT02809768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5787991|NCT02809768|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5787992|NCT02809768|Hormone Antagonists|hormone antagonists|mesh-ancestor
5787993|NCT02809768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5787994|NCT02809768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5787995|NCT02809768|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5787996|NCT02809768|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5787997|NCT02809768|Antitubercular Agents|antitubercular agents|mesh-ancestor
5787998|NCT02809768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5787999|NCT02809768|Leprostatic Agents|leprostatic agents|mesh-ancestor
5788000|NCT02809768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5788001|NCT02809768|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5788002|NCT02809768|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5788003|NCT02809768|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5788004|NCT02809768|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5788005|NCT02809768|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5788006|NCT02809768|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5788007|NCT02809768|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5788008|NCT02809768|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5788009|NCT02809937|Dexmedetomidine|dexmedetomidine|mesh-list
5788010|NCT02809937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5788011|NCT02809937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5788012|NCT02809937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788013|NCT02809937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5788014|NCT02809937|Analgesics|analgesics|mesh-ancestor
5788015|NCT02809937|Sensory System Agents|sensory system agents|mesh-ancestor
5788016|NCT02809937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5788017|NCT02809937|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5788018|NCT02809937|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5788019|NCT02809937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5788020|NCT02809937|Adrenergic Agents|adrenergic agents|mesh-ancestor
5788021|NCT02809937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5788022|NCT02809937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5788023|NCT02809820|Metoprolol|metoprolol|mesh-list
5788024|NCT02809820|Carvedilol|carvedilol|mesh-list
5788025|NCT02809820|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
5788026|NCT02809820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5788027|NCT02809820|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5788028|NCT02809820|Sympatholytics|sympatholytics|mesh-ancestor
5788029|NCT02809820|Autonomic Agents|autonomic agents|mesh-ancestor
5788030|NCT02809820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5788031|NCT02809820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788032|NCT02809820|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5788033|NCT02809820|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5788034|NCT02809820|Adrenergic Agents|adrenergic agents|mesh-ancestor
5788035|NCT02809820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5788036|NCT02809820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5788037|NCT02809820|Antioxidants|antioxidants|mesh-ancestor
5788038|NCT02809820|Protective Agents|protective agents|mesh-ancestor
5788039|NCT02809820|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5788040|NCT02809820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5788041|NCT02809820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5788042|NCT02809820|Vasodilator Agents|vasodilator agents|mesh-ancestor
5788043|NCT02809820|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5788044|NCT02809820|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5788045|NCT02809963|Eplerenone|eplerenone|mesh-list
5788046|NCT02809963|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5788047|NCT02809963|Hormone Antagonists|hormone antagonists|mesh-ancestor
5788048|NCT02809963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5788049|NCT02809963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788050|NCT02809963|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5788051|NCT02809963|Diuretics|diuretics|mesh-ancestor
5788052|NCT02809963|Natriuretic Agents|natriuretic agents|mesh-ancestor
5788053|NCT02809963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5788054|NCT02809742|Ropivacaine|ropivacaine|mesh-list
5788055|NCT02809742|Anesthetics, Local|anesthetics, local|mesh-ancestor
5788056|NCT02809742|Anesthetics|anesthetics|mesh-ancestor
5788057|NCT02809742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5788058|NCT02809742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788059|NCT02809742|Sensory System Agents|sensory system agents|mesh-ancestor
5788060|NCT02809742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5788061|NCT02809755|Lidocaine|lidocaine|mesh-list
5788062|NCT02809755|Anesthetics, Local|anesthetics, local|mesh-ancestor
5788063|NCT02809755|Anesthetics|anesthetics|mesh-ancestor
5788064|NCT02809755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5788065|NCT02809755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788066|NCT02809755|Sensory System Agents|sensory system agents|mesh-ancestor
5788067|NCT02809755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5788068|NCT02809755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5788069|NCT02809755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5788070|NCT02809755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5788071|NCT02809755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5788072|NCT02809755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5788073|NCT02809690|Clevudine|clevudine|mesh-list
5788074|NCT02809690|Antiviral Agents|antiviral agents|mesh-ancestor
5788075|NCT02809690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5788076|NCT02809729|Cefazolin|cefazolin|mesh-list
5788077|NCT02809729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5788078|NCT02809729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5788079|NCT02809573|Prednisone|prednisone|mesh-list
5788080|NCT02809573|Cyclophosphamide|cyclophosphamide|mesh-list
5788081|NCT02809573|Vincristine|vincristine|mesh-list
5788082|NCT02809573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5788083|NCT02809573|Immunologic Factors|immunologic factors|mesh-ancestor
5788084|NCT02809573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788085|NCT02809573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5788086|NCT02809573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5788087|NCT02809573|Alkylating Agents|alkylating agents|mesh-ancestor
5788088|NCT02809573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5788089|NCT02809573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5788090|NCT02809573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5788091|NCT02809573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5788092|NCT02809573|Glucocorticoids|glucocorticoids|mesh-ancestor
5788093|NCT02809573|Hormones|hormones|mesh-ancestor
5788094|NCT02809573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5788095|NCT02809573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5788096|NCT02809573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5788097|NCT02809573|Tubulin Modulators|tubulin modulators|mesh-ancestor
5788098|NCT02809573|Antimitotic Agents|antimitotic agents|mesh-ancestor
5788099|NCT02809573|Mitosis Modulators|mitosis modulators|mesh-ancestor
5788100|NCT02809378|Remifentanil|remifentanil|mesh-list
5788101|NCT02809378|Thiopental|thiopental|mesh-list
5788102|NCT02809378|Palonosetron|palonosetron|mesh-list
5788103|NCT02809378|Propofol|propofol|mesh-list
5788104|NCT02809378|Sevoflurane|sevoflurane|mesh-list
5788105|NCT02809378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5788106|NCT02809378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5788107|NCT02809378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788108|NCT02809378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5788109|NCT02809378|Anesthetics, General|anesthetics, general|mesh-ancestor
5788110|NCT02809378|Anesthetics|anesthetics|mesh-ancestor
5788111|NCT02809378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5788112|NCT02809378|Narcotics|narcotics|mesh-ancestor
5788113|NCT02809378|Analgesics|analgesics|mesh-ancestor
5788114|NCT02809378|Sensory System Agents|sensory system agents|mesh-ancestor
5788115|NCT02809378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5788116|NCT02809378|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5788117|NCT02809378|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5788118|NCT02809378|Antiemetics|antiemetics|mesh-ancestor
5788119|NCT02809378|Autonomic Agents|autonomic agents|mesh-ancestor
5788120|NCT02809378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5788121|NCT02809378|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5788122|NCT02809378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5788123|NCT02809378|Serotonin Agents|serotonin agents|mesh-ancestor
5788124|NCT02809378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5788125|NCT02809378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5788126|NCT02809378|Anticonvulsants|anticonvulsants|mesh-ancestor
5788127|NCT02809378|GABA Modulators|gaba modulators|mesh-ancestor
5788128|NCT02809378|GABA Agents|gaba agents|mesh-ancestor
5788129|NCT02809404|Everolimus|everolimus|mesh-list
5788130|NCT02809404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5788131|NCT02809404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5788132|NCT02809404|Immunologic Factors|immunologic factors|mesh-ancestor
5788133|NCT02809404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788134|NCT02809456|Nicorandil|nicorandil|mesh-list
5788135|NCT02809456|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5788136|NCT02809456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5788137|NCT02809456|Vasodilator Agents|vasodilator agents|mesh-ancestor
5788138|NCT02809456|Vitamin B Complex|vitamin b complex|mesh-ancestor
5788139|NCT02809456|Vitamins|vitamins|mesh-ancestor
5788140|NCT02809456|Micronutrients|micronutrients|mesh-ancestor
5788141|NCT02809456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788142|NCT02809469|Apixaban|apixaban|mesh-list
5788143|NCT02809469|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5788144|NCT02809469|Antithrombins|antithrombins|mesh-ancestor
5788145|NCT02809469|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5788146|NCT02809469|Protease Inhibitors|protease inhibitors|mesh-ancestor
5788147|NCT02809469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5788148|NCT02809469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5788149|NCT02809469|Anticoagulants|anticoagulants|mesh-ancestor
5788150|NCT02809079|Mycophenolic Acid|mycophenolic acid|mesh-list
5788151|NCT02809079|Prednisone|prednisone|mesh-list
5788152|NCT02809079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5788153|NCT02809079|Glucocorticoids|glucocorticoids|mesh-ancestor
5788154|NCT02809079|Hormones|hormones|mesh-ancestor
5788155|NCT02809079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5788156|NCT02809079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788157|NCT02809079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5788158|NCT02809079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5788159|NCT02809079|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5788160|NCT02809079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5788161|NCT02809079|Antitubercular Agents|antitubercular agents|mesh-ancestor
5788162|NCT02809079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5788163|NCT02809079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5788164|NCT02809079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5788165|NCT02809079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5788166|NCT02809105|Linaclotide|linaclotide|mesh-list
5788167|NCT02809105|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
5788168|NCT02809105|Enzyme Activators|enzyme activators|mesh-ancestor
5788169|NCT02809105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5788170|NCT02809105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5788171|NCT02808988|Zoledronic Acid|zoledronic acid|mesh-list
5788172|NCT02808988|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5788173|NCT02808988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788174|NCT02808949|Dapivirine|dapivirine|mesh-list
5788175|NCT02808949|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5788176|NCT02808949|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5788177|NCT02808949|Antiviral Agents|antiviral agents|mesh-ancestor
5788178|NCT02808949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5788179|NCT02809066|Calcium, Dietary|calcium, dietary|mesh-list
5788180|NCT02809066|Calcium|calcium|mesh-list
5788181|NCT02809066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5788182|NCT02809066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788183|NCT02809066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5788184|NCT02808871|Pirfenidone|pirfenidone|mesh-list
5788185|NCT02808871|Analgesics|analgesics|mesh-ancestor
5788186|NCT02808871|Sensory System Agents|sensory system agents|mesh-ancestor
5788187|NCT02808871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5788188|NCT02808871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788189|NCT02808871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5788190|NCT02808871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5788191|NCT02808871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5788192|NCT02808871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5788193|NCT02808871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5898625|NCT02697383|Protease Inhibitors|protease inhibitors|mesh-ancestor
5898626|NCT02697383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5898627|NCT02697383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898628|NCT02683265|Methylphenidate|methylphenidate|mesh-list
5898629|NCT02683265|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5898630|NCT02683265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898631|NCT02683265|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5898632|NCT02683265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6673827|NCT01565590|Anesthetics, General|anesthetics, general|mesh-ancestor
6673828|NCT01565590|Anesthetics|anesthetics|mesh-ancestor
6673829|NCT01565590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6673830|NCT01565590|Analgesics|analgesics|mesh-ancestor
5898633|NCT02683265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5898634|NCT02683265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898635|NCT02683265|Dopamine Agents|dopamine agents|mesh-ancestor
5898636|NCT02683265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5898637|NCT02652455|Aldesleukin|aldesleukin|mesh-list
5898638|NCT02652455|Cyclophosphamide|cyclophosphamide|mesh-list
6673831|NCT01565590|Sensory System Agents|sensory system agents|mesh-ancestor
5898639|NCT02652455|Nivolumab|nivolumab|mesh-list
5898640|NCT02652455|Fludarabine|fludarabine|mesh-list
5898641|NCT02652455|Interleukin-2|interleukin-2|mesh-list
5898642|NCT02652455|Antibodies|antibodies|mesh-list
5898643|NCT02652455|Immunoglobulins|immunoglobulins|mesh-list
5898644|NCT02652455|Antibodies, Blocking|antibodies, blocking|mesh-list
5898645|NCT02652455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6673832|NCT01565590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6673833|NCT01565590|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6673834|NCT01565590|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5788194|NCT02808767|Ticagrelor|ticagrelor|mesh-list
5788195|NCT02808767|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
5788196|NCT02808767|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5788197|NCT02808767|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5788198|NCT02808767|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5788199|NCT02808767|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5788200|NCT02808767|Purinergic Agents|purinergic agents|mesh-ancestor
5788201|NCT02808767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5788202|NCT02808767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5788203|NCT02808767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788204|NCT02808741|Olorofim|olorofim|mesh-list
5788205|NCT02808741|Antifungal Agents|antifungal agents|mesh-ancestor
5788206|NCT02808741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5788207|NCT02808728|Bupivacaine|bupivacaine|mesh-list
5788208|NCT02808728|Ropivacaine|ropivacaine|mesh-list
5788209|NCT02808728|Anesthetics, Local|anesthetics, local|mesh-ancestor
5788210|NCT02808728|Anesthetics|anesthetics|mesh-ancestor
5788211|NCT02808728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5788212|NCT02808728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788213|NCT02808728|Sensory System Agents|sensory system agents|mesh-ancestor
5788214|NCT02808728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5788215|NCT02808676|Vitamin D|vitamin d|mesh-list
5788216|NCT02808676|Cholecalciferol|cholecalciferol|mesh-list
5788217|NCT02808676|Vitamins|vitamins|mesh-ancestor
5788218|NCT02808676|Micronutrients|micronutrients|mesh-ancestor
5788219|NCT02808676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788220|NCT02808676|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5788221|NCT02808676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5788222|NCT02808611|Propranolol|propranolol|mesh-list
5788223|NCT02808611|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5788224|NCT02808611|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5788225|NCT02808611|Adrenergic Agents|adrenergic agents|mesh-ancestor
5788226|NCT02808611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5788227|NCT02808611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5788228|NCT02808611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788229|NCT02808611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5788230|NCT02808611|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5788231|NCT02808611|Vasodilator Agents|vasodilator agents|mesh-ancestor
5788232|NCT02808533|Topiramate|topiramate|mesh-list
5788233|NCT02808533|Anticonvulsants|anticonvulsants|mesh-ancestor
5788234|NCT02808533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5788235|NCT02808533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788236|NCT02808364|Vaccines|vaccines|mesh-list
5788237|NCT02808364|Immunologic Factors|immunologic factors|mesh-ancestor
5788238|NCT02808364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788239|NCT02808325|Polygeline|polygeline|mesh-list
5788240|NCT02808325|Plasma Substitutes|plasma substitutes|mesh-ancestor
5788241|NCT02808325|Blood Substitutes|blood substitutes|mesh-ancestor
5788242|NCT02808247|Ifosfamide|ifosfamide|mesh-list
5788243|NCT02808247|Nintedanib|nintedanib|mesh-list
5788244|NCT02808247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5788245|NCT02808247|Alkylating Agents|alkylating agents|mesh-ancestor
5788246|NCT02808247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5788247|NCT02808247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5788248|NCT02808247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5788249|NCT02808247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6673835|NCT01565590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6673836|NCT01565590|Adrenergic Agents|adrenergic agents|mesh-ancestor
5788250|NCT02808091|Bortezomib|bortezomib|mesh-list
6673837|NCT01565590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6673838|NCT01565590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673839|NCT01565720|Moxifloxacin|moxifloxacin|mesh-list
6673840|NCT01565720|Isavuconazole|isavuconazole|mesh-list
6673841|NCT01565720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6673842|NCT01565720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5788251|NCT02808091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5788252|NCT02808143|Pembrolizumab|pembrolizumab|mesh-list
5788253|NCT02808143|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5788254|NCT02808143|BCG Vaccine|bcg vaccine|mesh-list
5788255|NCT02808143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5788256|NCT02808143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5788257|NCT02808143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5788258|NCT02808143|Immunologic Factors|immunologic factors|mesh-ancestor
5788259|NCT02808143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788260|NCT02808065|Mycophenolic Acid|mycophenolic acid|mesh-list
5788261|NCT02808065|Tacrolimus|tacrolimus|mesh-list
5788262|NCT02808065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5788263|NCT02808065|Immunologic Factors|immunologic factors|mesh-ancestor
5788264|NCT02808065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788265|NCT02808065|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5788266|NCT02808065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5788267|NCT02808065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5788268|NCT02808065|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5788269|NCT02808065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5788270|NCT02808065|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5788271|NCT02808065|Antitubercular Agents|antitubercular agents|mesh-ancestor
5788272|NCT02808065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5788273|NCT02808065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5788274|NCT02808117|Micronutrients|micronutrients|mesh-list
5788275|NCT02808117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788276|NCT02807909|Itraconazole|itraconazole|mesh-list
5788277|NCT02807909|Diltiazem|diltiazem|mesh-list
5788278|NCT02807909|Antifungal Agents|antifungal agents|mesh-ancestor
5788279|NCT02807909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5788280|NCT02807909|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5788281|NCT02807909|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5788282|NCT02807909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5788283|NCT02807909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5788284|NCT02807909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5788285|NCT02807909|Hormone Antagonists|hormone antagonists|mesh-ancestor
5788286|NCT02807909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5788287|NCT02807909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788288|NCT02807909|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5788289|NCT02807909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5788290|NCT02807909|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5788291|NCT02807909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5788292|NCT02807909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5788293|NCT02807909|Vasodilator Agents|vasodilator agents|mesh-ancestor
5788294|NCT02807922|Zopiclone|zopiclone|mesh-list
5788295|NCT02807922|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5788296|NCT02807922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5788297|NCT02807922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788298|NCT02808104|Mazindol|mazindol|mesh-list
5788299|NCT02808104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5788300|NCT02808104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788301|NCT02808104|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5788302|NCT02808104|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5788303|NCT02808104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5788304|NCT02808104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5788305|NCT02808104|Adrenergic Agents|adrenergic agents|mesh-ancestor
5788306|NCT02808104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5788307|NCT02808104|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5788308|NCT02808104|Dopamine Agents|dopamine agents|mesh-ancestor
5788309|NCT02807870|Methylphenidate|methylphenidate|mesh-list
5788310|NCT02807870|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5788311|NCT02807870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788312|NCT02807870|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5788313|NCT02807870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5788314|NCT02807870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5788315|NCT02807870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5788316|NCT02807870|Dopamine Agents|dopamine agents|mesh-ancestor
5788317|NCT02807870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5788318|NCT02807805|Niclosamide|niclosamide|mesh-list
5788319|NCT02807805|Prednisone|prednisone|mesh-list
5788320|NCT02807805|Cortisone|cortisone|mesh-list
5788321|NCT02807805|Abiraterone Acetate|abiraterone acetate|mesh-list
5788322|NCT02807805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5788323|NCT02807805|Glucocorticoids|glucocorticoids|mesh-ancestor
5788324|NCT02807805|Hormones|hormones|mesh-ancestor
5898646|NCT02652455|Immunologic Factors|immunologic factors|mesh-ancestor
5788325|NCT02807805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5788326|NCT02807805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788327|NCT02807805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5788328|NCT02807805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5788329|NCT02807805|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5788330|NCT02807805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5788331|NCT02807805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5788332|NCT02807805|Hormone Antagonists|hormone antagonists|mesh-ancestor
5788333|NCT02807805|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5788334|NCT02807805|Anticestodal Agents|anticestodal agents|mesh-ancestor
5788335|NCT02807805|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5788336|NCT02807805|Anthelmintics|anthelmintics|mesh-ancestor
5788337|NCT02807805|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5788338|NCT02807805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5788339|NCT02807805|Antinematodal Agents|antinematodal agents|mesh-ancestor
5788340|NCT02807727|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
5788341|NCT02807727|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6491337|NCT00602095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5788342|NCT02807727|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5788343|NCT02807727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5788344|NCT02807610|Propofol|propofol|mesh-list
5788345|NCT02807610|Etomidate|etomidate|mesh-list
6491338|NCT00602095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491339|NCT00602095|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6491340|NCT00602095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5788346|NCT02807610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5788347|NCT02807610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5788348|NCT02807610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788349|NCT02807610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5788350|NCT02807610|Anesthetics, General|anesthetics, general|mesh-ancestor
5788351|NCT02807610|Anesthetics|anesthetics|mesh-ancestor
5788352|NCT02807571|Anesthetics|anesthetics|mesh-list
5788353|NCT02807571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5788354|NCT02807571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788355|NCT02807558|Azacitidine|azacitidine|mesh-list
5788356|NCT02807558|Daratumumab|daratumumab|mesh-list
5788357|NCT02807558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5788358|NCT02807558|Antimetabolites|antimetabolites|mesh-ancestor
5788359|NCT02807558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5788360|NCT02807558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5788361|NCT02807558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5788362|NCT02807467|Dexmedetomidine|dexmedetomidine|mesh-list
5788363|NCT02807467|Propofol|propofol|mesh-list
5788364|NCT02807467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5788365|NCT02807467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5788366|NCT02807467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788367|NCT02807467|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5788368|NCT02807467|Anesthetics, General|anesthetics, general|mesh-ancestor
5788369|NCT02807467|Anesthetics|anesthetics|mesh-ancestor
5788370|NCT02807467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5788371|NCT02807467|Analgesics|analgesics|mesh-ancestor
5788372|NCT02807467|Sensory System Agents|sensory system agents|mesh-ancestor
5788373|NCT02807467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5788374|NCT02807467|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5788375|NCT02807467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5788376|NCT02807467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5788377|NCT02807467|Adrenergic Agents|adrenergic agents|mesh-ancestor
5788378|NCT02807467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5788379|NCT02807467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5788380|NCT02807441|Aspirin|aspirin|mesh-list
5788381|NCT02807441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5788382|NCT02807441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5788383|NCT02807441|Analgesics|analgesics|mesh-ancestor
5788384|NCT02807441|Sensory System Agents|sensory system agents|mesh-ancestor
5788385|NCT02807441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5788386|NCT02807441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788387|NCT02807441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5788388|NCT02807441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5788389|NCT02807441|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5788390|NCT02807441|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5788391|NCT02807441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5788392|NCT02807441|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5788393|NCT02807441|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5788394|NCT02807441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5788395|NCT02807441|Antipyretics|antipyretics|mesh-ancestor
5788396|NCT02807454|Dexamethasone|dexamethasone|mesh-list
5788397|NCT02807454|Durvalumab|durvalumab|mesh-list
5788398|NCT02807454|Daratumumab|daratumumab|mesh-list
5788399|NCT02807454|Pomalidomide|pomalidomide|mesh-list
5788400|NCT02807454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5788401|NCT02807454|Antiemetics|antiemetics|mesh-ancestor
5788402|NCT02807454|Autonomic Agents|autonomic agents|mesh-ancestor
5788403|NCT02807454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5788404|NCT02807454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788405|NCT02807454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5788406|NCT02807454|Glucocorticoids|glucocorticoids|mesh-ancestor
5788407|NCT02807454|Hormones|hormones|mesh-ancestor
5788408|NCT02807454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5788409|NCT02807454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5788410|NCT02807454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5788411|NCT02807454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5788412|NCT02807454|Immunologic Factors|immunologic factors|mesh-ancestor
5788413|NCT02807454|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5788414|NCT02807454|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5788415|NCT02807454|Growth Substances|growth substances|mesh-ancestor
5788416|NCT02807454|Growth Inhibitors|growth inhibitors|mesh-ancestor
5788417|NCT02807285|Ocrelizumab|ocrelizumab|mesh-list
5788418|NCT02807285|Immunologic Factors|immunologic factors|mesh-ancestor
5788419|NCT02807285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788420|NCT02807415|Ivacaftor|ivacaftor|mesh-list
5788421|NCT02807415|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
5788422|NCT02807415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5788423|NCT02807415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5788424|NCT02807272|Tipifarnib|tipifarnib|mesh-list
5788425|NCT02807272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5788426|NCT02807298|Lidocaine|lidocaine|mesh-list
5788427|NCT02807298|Epinephrine|epinephrine|mesh-list
5788428|NCT02807298|Carticaine|carticaine|mesh-list
5788429|NCT02807298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5788430|NCT02807298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5788431|NCT02807298|Adrenergic Agents|adrenergic agents|mesh-ancestor
5788432|NCT02807298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5788433|NCT02807298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5788434|NCT02807298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788435|NCT02807298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5788436|NCT02807298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5788437|NCT02807298|Autonomic Agents|autonomic agents|mesh-ancestor
5788438|NCT02807298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5788439|NCT02807298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5788440|NCT02807298|Respiratory System Agents|respiratory system agents|mesh-ancestor
5788441|NCT02807298|Mydriatics|mydriatics|mesh-ancestor
5788442|NCT02807298|Sympathomimetics|sympathomimetics|mesh-ancestor
5788443|NCT02807298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5788444|NCT02807298|Anesthetics, Local|anesthetics, local|mesh-ancestor
5788445|NCT02807298|Anesthetics|anesthetics|mesh-ancestor
5788446|NCT02807298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5788447|NCT02807298|Sensory System Agents|sensory system agents|mesh-ancestor
5788448|NCT02807298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5788449|NCT02807298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5788450|NCT02807298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5788451|NCT02807298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5788452|NCT02807207|Moxifloxacin|moxifloxacin|mesh-list
5788453|NCT02807207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5788454|NCT02807207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5788455|NCT02807207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5788456|NCT02807207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5788457|NCT02807207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5788458|NCT02807207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5788459|NCT02807207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5788460|NCT02806999|Insulin|insulin|mesh-list
5788461|NCT02806999|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5788462|NCT02806999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5788463|NCT02806999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788464|NCT02807103|Cyclophosphamide|cyclophosphamide|mesh-list
5788465|NCT02807103|Rituximab|rituximab|mesh-list
5788466|NCT02807103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5788467|NCT02807103|Immunologic Factors|immunologic factors|mesh-ancestor
5788468|NCT02807103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788469|NCT02807103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5788470|NCT02807103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5788471|NCT02807103|Alkylating Agents|alkylating agents|mesh-ancestor
5788472|NCT02807103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5788473|NCT02807103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5788474|NCT02807103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5788475|NCT02807103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5898647|NCT02652455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898648|NCT02652455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5898649|NCT02652455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5898650|NCT02652455|Alkylating Agents|alkylating agents|mesh-ancestor
5898651|NCT02652455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898652|NCT02652455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5898653|NCT02652455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5898654|NCT02652455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5898655|NCT02652455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5898656|NCT02652455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5898657|NCT02652455|Analgesics|analgesics|mesh-ancestor
5898658|NCT02652455|Sensory System Agents|sensory system agents|mesh-ancestor
5898659|NCT02652455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5898660|NCT02652455|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5898661|NCT02652455|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5898662|NCT02652455|Antiviral Agents|antiviral agents|mesh-ancestor
5898663|NCT02652455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5898664|NCT02643303|Durvalumab|durvalumab|mesh-list
5898665|NCT02643303|Tremelimumab|tremelimumab|mesh-list
5898666|NCT02643303|Poly ICLC|poly iclc|mesh-list
5898667|NCT02643303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5898668|NCT02643303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5898669|NCT02643303|Interferon Inducers|interferon inducers|mesh-ancestor
5898670|NCT02643303|Immunologic Factors|immunologic factors|mesh-ancestor
5898671|NCT02643303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898672|NCT02604446|Oxycodone|oxycodone|mesh-list
5898673|NCT02604446|Tapentadol|tapentadol|mesh-list
5898674|NCT02604446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5898675|NCT02604446|Narcotics|narcotics|mesh-ancestor
5898676|NCT02604446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5898677|NCT02604446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898678|NCT02604446|Analgesics|analgesics|mesh-ancestor
5898679|NCT02604446|Sensory System Agents|sensory system agents|mesh-ancestor
5898680|NCT02604446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5898681|NCT02604446|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5898682|NCT02604446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5898683|NCT02604446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5898684|NCT02604446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898685|NCT02604446|Adrenergic Agents|adrenergic agents|mesh-ancestor
5898686|NCT02604446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5898687|NCT02588326|Mometasone Furoate|mometasone furoate|mesh-list
5898688|NCT02588326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5898689|NCT02588326|Dermatologic Agents|dermatologic agents|mesh-ancestor
5898690|NCT02588326|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5898691|NCT02529813|Cyclophosphamide|cyclophosphamide|mesh-list
5898692|NCT02529813|Fludarabine|fludarabine|mesh-list
5898693|NCT02529813|Fludarabine phosphate|fludarabine phosphate|mesh-list
5898694|NCT02529813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5898695|NCT02529813|Immunologic Factors|immunologic factors|mesh-ancestor
5898696|NCT02529813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788476|NCT02807181|Gemcitabine|gemcitabine|mesh-list
5788477|NCT02807181|Cisplatin|cisplatin|mesh-list
5788478|NCT02807181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5788479|NCT02807181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5788480|NCT02807181|Antimetabolites|antimetabolites|mesh-ancestor
5788481|NCT02807181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5788482|NCT02807181|Antiviral Agents|antiviral agents|mesh-ancestor
5788483|NCT02807181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5788484|NCT02807181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5788485|NCT02807181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5788486|NCT02807181|Immunologic Factors|immunologic factors|mesh-ancestor
5788487|NCT02807181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788488|NCT02807194|Anesthetics|anesthetics|mesh-list
5788489|NCT02807194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5788490|NCT02807194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788491|NCT02807116|Rifampin|rifampin|mesh-list
5788492|NCT02807116|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5788493|NCT02807116|Antitubercular Agents|antitubercular agents|mesh-ancestor
5788494|NCT02807116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5788495|NCT02807116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5788496|NCT02807116|Leprostatic Agents|leprostatic agents|mesh-ancestor
5788497|NCT02807116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5788498|NCT02807116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5788499|NCT02807116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5788500|NCT02807116|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5788501|NCT02807116|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5788502|NCT02807116|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5788503|NCT02807116|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5788504|NCT02807116|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5788505|NCT02807116|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5788506|NCT02807051|Clarithromycin|clarithromycin|mesh-list
5788507|NCT02807051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5788508|NCT02807051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5788509|NCT02807051|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5788510|NCT02807051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5788511|NCT02807051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5788512|NCT02807051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5788513|NCT02807051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5788514|NCT02806882|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
5788515|NCT02806882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5788516|NCT02806882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5788517|NCT02806791|Lenograstim|lenograstim|mesh-list
5788518|NCT02806791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5788519|NCT02806791|Immunologic Factors|immunologic factors|mesh-ancestor
5788520|NCT02806791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788521|NCT02806817|Bevacizumab|bevacizumab|mesh-list
5788522|NCT02806817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5788523|NCT02806817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5788524|NCT02806817|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5788525|NCT02806817|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5788526|NCT02806817|Growth Substances|growth substances|mesh-ancestor
5788527|NCT02806817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788528|NCT02806817|Growth Inhibitors|growth inhibitors|mesh-ancestor
5788529|NCT02806804|Vaccines|vaccines|mesh-list
5788530|NCT02806804|Immunologic Factors|immunologic factors|mesh-ancestor
5788531|NCT02806804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788532|NCT02806648|Palbociclib|palbociclib|mesh-list
5788533|NCT02806648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5788534|NCT02806648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5788535|NCT02806648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5788536|NCT02806648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5788537|NCT02806752|Triamcinolone|triamcinolone|mesh-list
5788538|NCT02806752|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5788539|NCT02806752|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5788540|NCT02806752|Ranibizumab|ranibizumab|mesh-list
5788541|NCT02806752|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5788542|NCT02806752|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5788543|NCT02806752|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5788544|NCT02806752|Growth Substances|growth substances|mesh-ancestor
5788545|NCT02806752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788546|NCT02806752|Growth Inhibitors|growth inhibitors|mesh-ancestor
5788547|NCT02806752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5788548|NCT02806752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5788549|NCT02806752|Glucocorticoids|glucocorticoids|mesh-ancestor
5788550|NCT02806752|Hormones|hormones|mesh-ancestor
5788551|NCT02806752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5788552|NCT02806752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5788553|NCT02806752|Immunologic Factors|immunologic factors|mesh-ancestor
5788554|NCT02806752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5788555|NCT02806752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5788556|NCT02806596|Sevoflurane|sevoflurane|mesh-list
5788557|NCT02806596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5788558|NCT02806596|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5788559|NCT02806596|Anesthetics, General|anesthetics, general|mesh-ancestor
5788560|NCT02806596|Anesthetics|anesthetics|mesh-ancestor
5788561|NCT02806596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5788562|NCT02806596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788563|NCT02806492|Phenylephrine|phenylephrine|mesh-list
5788564|NCT02806492|Oxymetazoline|oxymetazoline|mesh-list
5788565|NCT02806492|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5788566|NCT02806492|Mydriatics|mydriatics|mesh-ancestor
5788567|NCT02806492|Autonomic Agents|autonomic agents|mesh-ancestor
5788568|NCT02806492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5788569|NCT02806492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788570|NCT02806492|Sympathomimetics|sympathomimetics|mesh-ancestor
5788571|NCT02806492|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5788572|NCT02806492|Nasal Decongestants|nasal decongestants|mesh-ancestor
5788573|NCT02806492|Respiratory System Agents|respiratory system agents|mesh-ancestor
5788574|NCT02806492|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5788575|NCT02806492|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5788576|NCT02806492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5788577|NCT02806492|Adrenergic Agents|adrenergic agents|mesh-ancestor
5788578|NCT02806492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5788579|NCT02806492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5788580|NCT02806492|Protective Agents|protective agents|mesh-ancestor
5788581|NCT02806284|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5788582|NCT02806284|Immunologic Factors|immunologic factors|mesh-ancestor
5788583|NCT02806284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788584|NCT02806440|Naltrexone|naltrexone|mesh-list
5788585|NCT02806440|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6210785|NCT02164864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6210786|NCT02164864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6210787|NCT02164864|Antipyretics|antipyretics|mesh-ancestor
6210788|NCT02164864|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6210789|NCT02164864|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6210790|NCT02164864|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6210791|NCT02164864|Purinergic Agents|purinergic agents|mesh-ancestor
6210792|NCT02164864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6210793|NCT02164864|Anticoagulants|anticoagulants|mesh-ancestor
6210794|NCT02164864|Antithrombins|antithrombins|mesh-ancestor
6210795|NCT02164864|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6210796|NCT02164864|Protease Inhibitors|protease inhibitors|mesh-ancestor
6210797|NCT02164916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6210798|NCT02164916|Cetuximab|cetuximab|mesh-list
6210799|NCT02164916|Irinotecan|irinotecan|mesh-list
6210800|NCT02164916|Camptothecin|camptothecin|mesh-list
6210801|NCT02164916|Vemurafenib|vemurafenib|mesh-list
6210802|NCT02164916|Antibodies|antibodies|mesh-list
6210803|NCT02164916|Immunoglobulins|immunoglobulins|mesh-list
6210804|NCT02164916|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6210805|NCT02164916|Immunoglobulin G|immunoglobulin g|mesh-list
5788586|NCT02806440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5788587|NCT02806440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788588|NCT02806440|Sensory System Agents|sensory system agents|mesh-ancestor
5788589|NCT02806440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5788590|NCT02806375|Cyclophosphamide|cyclophosphamide|mesh-list
5788591|NCT02806375|Busulfan|busulfan|mesh-list
5788592|NCT02806375|Fludarabine|fludarabine|mesh-list
5788593|NCT02806375|Fludarabine phosphate|fludarabine phosphate|mesh-list
5788594|NCT02806375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5788595|NCT02806375|Immunologic Factors|immunologic factors|mesh-ancestor
5788596|NCT02806375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788597|NCT02806375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5788598|NCT02806375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5788599|NCT02806375|Alkylating Agents|alkylating agents|mesh-ancestor
5788600|NCT02806375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210806|NCT02164916|Mitogens|mitogens|mesh-list
5788601|NCT02806375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6210807|NCT02164916|Immunologic Factors|immunologic factors|mesh-ancestor
6210808|NCT02164916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210809|NCT02164916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5788602|NCT02806375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5788603|NCT02806375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5788604|NCT02806375|Antimetabolites|antimetabolites|mesh-ancestor
5788605|NCT02806349|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
5788606|NCT02806349|Cathartics|cathartics|mesh-ancestor
5788607|NCT02806349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5788608|NCT02806362|Ritonavir|ritonavir|mesh-list
5788609|NCT02806362|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5788610|NCT02806362|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5788611|NCT02806362|Protease Inhibitors|protease inhibitors|mesh-ancestor
5788612|NCT02806362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5788613|NCT02806362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5788614|NCT02806362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5788615|NCT02806362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5788616|NCT02806362|Antiviral Agents|antiviral agents|mesh-ancestor
5788617|NCT02806362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5788618|NCT02806362|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5788619|NCT02806362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5788620|NCT02806206|Prucalopride|prucalopride|mesh-list
5788621|NCT02806206|Laxatives|laxatives|mesh-ancestor
5788622|NCT02806206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5788623|NCT02806206|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
5788624|NCT02806206|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5788625|NCT02806206|Serotonin Agents|serotonin agents|mesh-ancestor
5788626|NCT02806206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5788627|NCT02806206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5788628|NCT02806206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788629|NCT02806141|Colistin|colistin|mesh-list
5788630|NCT02806141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5788631|NCT02806141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5788632|NCT02806128|Kallikreins|kallikreins|mesh-list
5788633|NCT02806128|Coagulants|coagulants|mesh-ancestor
5788634|NCT02806128|Fertility Agents, Male|fertility agents, male|mesh-ancestor
5788635|NCT02806128|Fertility Agents|fertility agents|mesh-ancestor
5788636|NCT02806128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5788637|NCT02806128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788638|NCT02806115|Acetic Acid|acetic acid|mesh-list
5788639|NCT02806115|Retinol acetate|retinol acetate|mesh-list
5788640|NCT02806115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5788641|NCT02806115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5788642|NCT02806115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5788643|NCT02806115|Immunologic Factors|immunologic factors|mesh-ancestor
5788644|NCT02806115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788645|NCT02806115|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5788646|NCT02806115|Protective Agents|protective agents|mesh-ancestor
5788647|NCT02806115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5788648|NCT02806050|Letrozole|letrozole|mesh-list
5788649|NCT02806050|Palbociclib|palbociclib|mesh-list
5788650|NCT02806050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5788651|NCT02806050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5788652|NCT02806050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5788653|NCT02806050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5788654|NCT02806050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5788655|NCT02806050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5788656|NCT02806050|Hormone Antagonists|hormone antagonists|mesh-ancestor
5788657|NCT02806050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5788658|NCT02806050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788659|NCT02806050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5788660|NCT02805946|Posaconazole|posaconazole|mesh-list
5788661|NCT02805946|Antifungal Agents|antifungal agents|mesh-ancestor
5788662|NCT02805946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5788663|NCT02805946|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5788664|NCT02805946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5788665|NCT02805946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5788666|NCT02805946|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5788667|NCT02805946|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5788668|NCT02805946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5788669|NCT02805946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5788670|NCT02805946|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5788671|NCT02805946|Hormone Antagonists|hormone antagonists|mesh-ancestor
5788672|NCT02805946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5788673|NCT02805946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788674|NCT02805738|Tenofovir|tenofovir|mesh-list
5788675|NCT02805738|Antiviral Agents|antiviral agents|mesh-ancestor
5788676|NCT02805738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5788677|NCT02805738|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5788678|NCT02805738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5788679|NCT02805738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5788680|NCT02805738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5788681|NCT02805738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5788682|NCT02805738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5788683|NCT02805920|Bupivacaine|bupivacaine|mesh-list
5788684|NCT02805920|Anesthetics, Local|anesthetics, local|mesh-ancestor
5788685|NCT02805920|Anesthetics|anesthetics|mesh-ancestor
5788686|NCT02805920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5788687|NCT02805920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788688|NCT02805920|Sensory System Agents|sensory system agents|mesh-ancestor
5788689|NCT02805920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5788690|NCT02805608|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5788691|NCT02805608|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5788692|NCT02805608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5788693|NCT02805842|Tacrolimus|tacrolimus|mesh-list
5788694|NCT02805842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5788695|NCT02805842|Immunologic Factors|immunologic factors|mesh-ancestor
5788696|NCT02805842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788697|NCT02805842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5788698|NCT02805842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5788699|NCT02805842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5788700|NCT02805829|Trastuzumab|trastuzumab|mesh-list
5788701|NCT02805829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5788702|NCT02805829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5788703|NCT02805725|Cyclophosphamide|cyclophosphamide|mesh-list
5788704|NCT02805725|Trabectedin|trabectedin|mesh-list
5788705|NCT02805725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6491341|NCT00602095|Oxytocics|oxytocics|mesh-ancestor
6491342|NCT00602134|Mercaptopurine|mercaptopurine|mesh-list
6491343|NCT00602134|Antimetabolites|antimetabolites|mesh-ancestor
5788706|NCT02805725|Immunologic Factors|immunologic factors|mesh-ancestor
5788707|NCT02805725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788708|NCT02805725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5788709|NCT02805725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5788710|NCT02805725|Alkylating Agents|alkylating agents|mesh-ancestor
5788711|NCT02805725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5788712|NCT02805725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5788713|NCT02805725|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5788714|NCT02805868|Siltuximab|siltuximab|mesh-list
5788715|NCT02805868|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5788716|NCT02805868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5788717|NCT02805868|Immunologic Factors|immunologic factors|mesh-ancestor
5788718|NCT02805868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788719|NCT02805556|Fostemsavir|fostemsavir|mesh-list
5788720|NCT02805556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5788721|NCT02805556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5788722|NCT02805556|Antiviral Agents|antiviral agents|mesh-ancestor
5788723|NCT02805556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5788724|NCT02805556|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5788725|NCT02805556|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5788726|NCT02805556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898697|NCT02529813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5898698|NCT02529813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5898699|NCT02529813|Alkylating Agents|alkylating agents|mesh-ancestor
5898700|NCT02529813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898701|NCT02529813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5898702|NCT02529813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5898703|NCT02529813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5898704|NCT02529813|Antimetabolites|antimetabolites|mesh-ancestor
5898705|NCT02488967|Paclitaxel|paclitaxel|mesh-list
5898706|NCT02488967|Cyclophosphamide|cyclophosphamide|mesh-list
5898707|NCT02488967|Carboplatin|carboplatin|mesh-list
5898708|NCT02488967|Doxorubicin|doxorubicin|mesh-list
5898709|NCT02488967|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5898710|NCT02488967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5898711|NCT02488967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5898712|NCT02488967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5898713|NCT02488967|Tubulin Modulators|tubulin modulators|mesh-ancestor
5898714|NCT02488967|Antimitotic Agents|antimitotic agents|mesh-ancestor
5898715|NCT02488967|Mitosis Modulators|mitosis modulators|mesh-ancestor
5898716|NCT02488967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898717|NCT02488967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5788727|NCT02805426|Misoprostol|misoprostol|mesh-list
5788728|NCT02805426|Tranexamic Acid|tranexamic acid|mesh-list
5788729|NCT02805426|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5788730|NCT02805426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5788731|NCT02805426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5788732|NCT02805426|Hemostatics|hemostatics|mesh-ancestor
5788733|NCT02805426|Coagulants|coagulants|mesh-ancestor
5788734|NCT02805426|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5788735|NCT02805426|Abortifacient Agents|abortifacient agents|mesh-ancestor
5788736|NCT02805426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5788737|NCT02805426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788738|NCT02805426|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5788739|NCT02805426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5788740|NCT02805426|Oxytocics|oxytocics|mesh-ancestor
5788741|NCT02805452|Solifenacin Succinate|solifenacin succinate|mesh-list
5788742|NCT02805452|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5788743|NCT02805452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5788744|NCT02805452|Cholinergic Agents|cholinergic agents|mesh-ancestor
5788745|NCT02805452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5788746|NCT02805452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5788747|NCT02805452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788748|NCT02805452|Urological Agents|urological agents|mesh-ancestor
5788749|NCT02805049|Caspofungin|caspofungin|mesh-list
5788750|NCT02805049|Micafungin|micafungin|mesh-list
5788751|NCT02805049|Echinocandins|echinocandins|mesh-list
5788752|NCT02805049|Antifungal Agents|antifungal agents|mesh-ancestor
5788753|NCT02805049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5788754|NCT02805049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5788755|NCT02805049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5788756|NCT02805153|Lenograstim|lenograstim|mesh-list
5788757|NCT02805153|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5788758|NCT02805153|Immunologic Factors|immunologic factors|mesh-ancestor
5788759|NCT02805153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788760|NCT02805231|Vitamin D|vitamin d|mesh-list
5788761|NCT02805231|Vitamins|vitamins|mesh-ancestor
5788762|NCT02805231|Micronutrients|micronutrients|mesh-ancestor
5788763|NCT02805231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788764|NCT02805231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5788765|NCT02805010|Abatacept|abatacept|mesh-list
5788766|NCT02805010|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5788767|NCT02805010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5788768|NCT02805010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5788769|NCT02805010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5788770|NCT02805010|Immunologic Factors|immunologic factors|mesh-ancestor
5788771|NCT02805010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788772|NCT02805010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5788773|NCT02804815|Aspirin|aspirin|mesh-list
5788774|NCT02804815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5788775|NCT02804815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5788776|NCT02804815|Analgesics|analgesics|mesh-ancestor
5788777|NCT02804815|Sensory System Agents|sensory system agents|mesh-ancestor
5788778|NCT02804815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5788779|NCT02804815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788780|NCT02804815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5788781|NCT02804815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5788782|NCT02804815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5788783|NCT02804815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5788784|NCT02804815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5788785|NCT02804815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5788786|NCT02804815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5788787|NCT02804815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5788788|NCT02804815|Antipyretics|antipyretics|mesh-ancestor
5788789|NCT02804841|Vitamin D|vitamin d|mesh-list
5788790|NCT02804841|Ergocalciferols|ergocalciferols|mesh-list
5788791|NCT02804841|Cholecalciferol|cholecalciferol|mesh-list
5788792|NCT02804841|Vitamins|vitamins|mesh-list
5788793|NCT02804841|Micronutrients|micronutrients|mesh-ancestor
5788794|NCT02804841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788795|NCT02804841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5788796|NCT02804841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5788797|NCT02804711|Vaccines|vaccines|mesh-list
5788798|NCT02804711|Immunologic Factors|immunologic factors|mesh-ancestor
5788799|NCT02804711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788800|NCT02804776|Gefitinib|gefitinib|mesh-list
5788801|NCT02804776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5898718|NCT02488967|Immunologic Factors|immunologic factors|mesh-ancestor
5788802|NCT02804776|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5788803|NCT02804776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5788804|NCT02804776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5788805|NCT02804633|Acetaminophen|acetaminophen|mesh-list
5788806|NCT02804633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5788807|NCT02804633|Analgesics|analgesics|mesh-ancestor
5788808|NCT02804633|Sensory System Agents|sensory system agents|mesh-ancestor
5788809|NCT02804633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5788810|NCT02804633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788811|NCT02804633|Antipyretics|antipyretics|mesh-ancestor
5788812|NCT02804646|Carboplatin|carboplatin|mesh-list
5788813|NCT02804646|Pemetrexed|pemetrexed|mesh-list
5788814|NCT02804646|Endostatins|endostatins|mesh-list
5788815|NCT02804646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5788816|NCT02804646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5788817|NCT02804646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5788818|NCT02804646|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5788819|NCT02804646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5788820|NCT02804646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5788821|NCT02804646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5788822|NCT02804646|Growth Substances|growth substances|mesh-ancestor
5788823|NCT02804646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788824|NCT02804646|Growth Inhibitors|growth inhibitors|mesh-ancestor
5788825|NCT02804490|Vitamin A|vitamin a|mesh-list
5788826|NCT02804490|Beta Carotene|beta carotene|mesh-list
5788827|NCT02804490|Provitamins|provitamins|mesh-list
5788828|NCT02804490|Carotenoids|carotenoids|mesh-list
5788829|NCT02804490|Vitamins|vitamins|mesh-ancestor
5788830|NCT02804490|Micronutrients|micronutrients|mesh-ancestor
5788831|NCT02804490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788832|NCT02804490|Antioxidants|antioxidants|mesh-ancestor
5788833|NCT02804490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5788834|NCT02804490|Protective Agents|protective agents|mesh-ancestor
5788835|NCT02804386|Sofosbuvir|sofosbuvir|mesh-list
5788836|NCT02804386|Antiviral Agents|antiviral agents|mesh-ancestor
5788837|NCT02804386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5788838|NCT02804360|Dexamethasone|dexamethasone|mesh-list
5788839|NCT02804360|Dexamethasone acetate|dexamethasone acetate|mesh-list
5788840|NCT02804360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5788841|NCT02804360|Antiemetics|antiemetics|mesh-ancestor
5788842|NCT02804360|Autonomic Agents|autonomic agents|mesh-ancestor
5788843|NCT02804360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5788844|NCT02804360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788845|NCT02804360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5788846|NCT02804360|Glucocorticoids|glucocorticoids|mesh-ancestor
5788847|NCT02804360|Hormones|hormones|mesh-ancestor
5788848|NCT02804360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5788849|NCT02804360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5788850|NCT02804360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5788851|NCT02804022|Morphine|morphine|mesh-list
5788852|NCT02804022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5788853|NCT02804022|Narcotics|narcotics|mesh-ancestor
5788854|NCT02804022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5788855|NCT02804022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788856|NCT02804022|Analgesics|analgesics|mesh-ancestor
5788857|NCT02804022|Sensory System Agents|sensory system agents|mesh-ancestor
5788858|NCT02804022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5788859|NCT02804373|Oxytocin|oxytocin|mesh-list
5788860|NCT02804373|Oxytocics|oxytocics|mesh-ancestor
5788861|NCT02804373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5788862|NCT02804373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788863|NCT02804165|Vaccines|vaccines|mesh-list
5788864|NCT02804165|Immunologic Factors|immunologic factors|mesh-ancestor
5788865|NCT02804165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788866|NCT02804126|Acetaminophen|acetaminophen|mesh-list
5788867|NCT02804126|Dipyrone|dipyrone|mesh-list
5788868|NCT02804126|Ketoprofen|ketoprofen|mesh-list
5788869|NCT02804126|Morphine|morphine|mesh-list
5788870|NCT02804126|Bupivacaine|bupivacaine|mesh-list
5788871|NCT02804126|Anesthetics, Local|anesthetics, local|mesh-ancestor
5788872|NCT02804126|Anesthetics|anesthetics|mesh-ancestor
5788873|NCT02804126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5788874|NCT02804126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788875|NCT02804126|Sensory System Agents|sensory system agents|mesh-ancestor
5788876|NCT02804126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5788877|NCT02804126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5788878|NCT02804126|Narcotics|narcotics|mesh-ancestor
5788879|NCT02804126|Analgesics|analgesics|mesh-ancestor
5788880|NCT02804126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5788881|NCT02804126|Antipyretics|antipyretics|mesh-ancestor
5788882|NCT02804126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5788883|NCT02804126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5788884|NCT02804126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5788885|NCT02804126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5788886|NCT02804126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5788887|NCT02804126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5788888|NCT02803918|Metformin|metformin|mesh-list
5788889|NCT02803918|Lixisenatide|lixisenatide|mesh-list
5788890|NCT02803918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5788891|NCT02803918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898719|NCT02488967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898720|NCT02488967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5898721|NCT02488967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5898722|NCT02488967|Alkylating Agents|alkylating agents|mesh-ancestor
5898723|NCT02488967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5898724|NCT02488967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5898725|NCT02488967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5898726|NCT02488967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5898727|NCT02488967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5898728|NCT02403310|Cytarabine|cytarabine|mesh-list
5898729|NCT02403310|Daunorubicin|daunorubicin|mesh-list
5898730|NCT02403310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5898731|NCT02403310|Antimetabolites|antimetabolites|mesh-ancestor
5898732|NCT02403310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898733|NCT02403310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5898734|NCT02403310|Antiviral Agents|antiviral agents|mesh-ancestor
5898735|NCT02403310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5898736|NCT02403310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5898737|NCT02403310|Immunologic Factors|immunologic factors|mesh-ancestor
5898738|NCT02403310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898739|NCT02403310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5898740|NCT02403310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5898741|NCT02403310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5898742|NCT02403310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5898743|NCT02341625|Nivolumab|nivolumab|mesh-list
5898744|NCT02341625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5898745|NCT02341625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5898746|NCT02341625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5898747|NCT02341625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898748|NCT02297698|Trastuzumab|trastuzumab|mesh-list
5898749|NCT02297698|Sargramostim|sargramostim|mesh-list
5898750|NCT02297698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5898751|NCT02297698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5898752|NCT02297698|Immunologic Factors|immunologic factors|mesh-ancestor
5898753|NCT02297698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898754|NCT02117076|Gabapentin|gabapentin|mesh-list
5898755|NCT02117076|Analgesics|analgesics|mesh-ancestor
5898756|NCT02117076|Sensory System Agents|sensory system agents|mesh-ancestor
5898757|NCT02117076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5898758|NCT02117076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898759|NCT02117076|Anticonvulsants|anticonvulsants|mesh-ancestor
5898760|NCT02117076|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5898761|NCT02117076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5898762|NCT02117076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5898763|NCT02117076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5898764|NCT02117076|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5898765|NCT02117076|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5898766|NCT02117076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5898767|NCT02117076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898768|NCT02117076|Antimanic Agents|antimanic agents|mesh-ancestor
5898769|NCT02099591|Naloxegol|naloxegol|mesh-list
5898770|NCT02099591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5908113|NCT04912115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5788892|NCT02803944|Azithromycin|azithromycin|mesh-list
5788893|NCT02803944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5788894|NCT02803944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5788895|NCT02803892|Vildagliptin|vildagliptin|mesh-list
5788896|NCT02803892|Sirolimus|sirolimus|mesh-list
5788897|NCT02803892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5788898|NCT02803892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5788899|NCT02803892|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5788900|NCT02803892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5788901|NCT02803892|Antifungal Agents|antifungal agents|mesh-ancestor
5788902|NCT02803892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5788903|NCT02803892|Immunologic Factors|immunologic factors|mesh-ancestor
5788904|NCT02803892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788905|NCT02803892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5788906|NCT02803892|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5788907|NCT02803892|Protease Inhibitors|protease inhibitors|mesh-ancestor
5788908|NCT02803892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5788909|NCT02803892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5788910|NCT02803788|Dexamethasone|dexamethasone|mesh-list
5788911|NCT02803788|Ondansetron|ondansetron|mesh-list
5788912|NCT02803788|Ramosetron|ramosetron|mesh-list
5788913|NCT02803788|Antiemetics|antiemetics|mesh-list
5788914|NCT02803788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5788915|NCT02803788|Autonomic Agents|autonomic agents|mesh-ancestor
5788916|NCT02803788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5788917|NCT02803788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788918|NCT02803788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5788919|NCT02803788|Glucocorticoids|glucocorticoids|mesh-ancestor
5788920|NCT02803788|Hormones|hormones|mesh-ancestor
5788921|NCT02803788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5788922|NCT02803788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5788923|NCT02803788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5788924|NCT02803788|Antipruritics|antipruritics|mesh-ancestor
5788925|NCT02803788|Dermatologic Agents|dermatologic agents|mesh-ancestor
5788926|NCT02803788|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5788927|NCT02803788|Serotonin Agents|serotonin agents|mesh-ancestor
5788928|NCT02803788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5788929|NCT02803788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5788930|NCT02803788|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5788931|NCT02803788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5788932|NCT02803788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5788933|NCT02803788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5788934|NCT02803788|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5788935|NCT02803502|Thrombin|thrombin|mesh-list
5788936|NCT02803502|Hemostatics|hemostatics|mesh-ancestor
5788937|NCT02803502|Coagulants|coagulants|mesh-ancestor
5788938|NCT02803385|Analgesics, Opioid|analgesics, opioid|mesh-list
5788939|NCT02803385|Anesthetics|anesthetics|mesh-list
5788940|NCT02803385|Anesthetics, Local|anesthetics, local|mesh-list
5788941|NCT02803385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5788942|NCT02803385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788943|NCT02803385|Narcotics|narcotics|mesh-ancestor
5788944|NCT02803385|Analgesics|analgesics|mesh-ancestor
5788945|NCT02803385|Sensory System Agents|sensory system agents|mesh-ancestor
5788946|NCT02803385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5788947|NCT02803216|Amoxicillin|amoxicillin|mesh-list
5788948|NCT02803216|Clarithromycin|clarithromycin|mesh-list
5788949|NCT02803216|Omeprazole|omeprazole|mesh-list
5788950|NCT02803216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5788951|NCT02803216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5788952|NCT02803216|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5788953|NCT02803216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5788954|NCT02803216|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5788955|NCT02803216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5788956|NCT02803216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5788957|NCT02803216|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5788958|NCT02803216|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5788959|NCT02803216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5788960|NCT02802995|Thrombin|thrombin|mesh-list
5788961|NCT02802995|Hemostatics|hemostatics|mesh-ancestor
5788962|NCT02802995|Coagulants|coagulants|mesh-ancestor
5788963|NCT02803073|Methyltestosterone|methyltestosterone|mesh-list
5788964|NCT02803073|Testosterone|testosterone|mesh-list
5788965|NCT02803073|Testosterone undecanoate|testosterone undecanoate|mesh-list
5788966|NCT02803073|Testosterone enanthate|testosterone enanthate|mesh-list
5788967|NCT02803073|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5788968|NCT02803073|Androgens|androgens|mesh-ancestor
5788969|NCT02803073|Hormones|hormones|mesh-ancestor
5908114|NCT04912115|GABA Modulators|gaba modulators|mesh-ancestor
5788970|NCT02803073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5788971|NCT02803073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788972|NCT02803073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5788973|NCT02803073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5788974|NCT02803073|Anabolic Agents|anabolic agents|mesh-ancestor
5788975|NCT02802943|Imiquimod|imiquimod|mesh-list
5788976|NCT02802943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5788977|NCT02802943|Immunologic Factors|immunologic factors|mesh-ancestor
5788978|NCT02802943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788979|NCT02802943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5788980|NCT02802943|Interferon Inducers|interferon inducers|mesh-ancestor
5788981|NCT02802748|Letrozole|letrozole|mesh-list
5788982|NCT02802748|Vinorelbine|vinorelbine|mesh-list
5788983|NCT02802748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5788984|NCT02802748|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5788985|NCT02802748|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5788986|NCT02802748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5788987|NCT02802748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5788988|NCT02802748|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5788989|NCT02802748|Hormone Antagonists|hormone antagonists|mesh-ancestor
5788990|NCT02802748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5788991|NCT02802748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5788992|NCT02802748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5788993|NCT02802748|Tubulin Modulators|tubulin modulators|mesh-ancestor
5788994|NCT02802748|Antimitotic Agents|antimitotic agents|mesh-ancestor
5788995|NCT02802748|Mitosis Modulators|mitosis modulators|mesh-ancestor
5788996|NCT02802631|Minocycline|minocycline|mesh-list
5788997|NCT02802631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5788998|NCT02802631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5788999|NCT02802722|Vitamin D|vitamin d|mesh-list
5789000|NCT02802722|Cholecalciferol|cholecalciferol|mesh-list
5789001|NCT02802722|Vitamins|vitamins|mesh-ancestor
5789002|NCT02802722|Micronutrients|micronutrients|mesh-ancestor
5789003|NCT02802722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789004|NCT02802722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5789005|NCT02802722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5789006|NCT02802644|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5789007|NCT02802644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5789008|NCT02802644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789009|NCT02802644|Incretins|incretins|mesh-ancestor
5789010|NCT02802644|Hormones|hormones|mesh-ancestor
6673843|NCT01565720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6673844|NCT01565720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6673845|NCT01565720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5789011|NCT02802644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5789012|NCT02802644|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5789013|NCT02802644|Protease Inhibitors|protease inhibitors|mesh-ancestor
5789014|NCT02802644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5789015|NCT02802644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5789016|NCT02802683|Phenylephrine|phenylephrine|mesh-list
5789017|NCT02802683|Oxymetazoline|oxymetazoline|mesh-list
5789018|NCT02802683|Bupivacaine|bupivacaine|mesh-list
5789019|NCT02802683|Levobupivacaine|levobupivacaine|mesh-list
5789020|NCT02802683|Anesthetics, Local|anesthetics, local|mesh-ancestor
5789021|NCT02802683|Anesthetics|anesthetics|mesh-ancestor
5789022|NCT02802683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5789023|NCT02802683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789024|NCT02802683|Sensory System Agents|sensory system agents|mesh-ancestor
5789025|NCT02802683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5789026|NCT02802683|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5789027|NCT02802683|Mydriatics|mydriatics|mesh-ancestor
5789028|NCT02802683|Autonomic Agents|autonomic agents|mesh-ancestor
5789029|NCT02802683|Sympathomimetics|sympathomimetics|mesh-ancestor
5789030|NCT02802683|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5789031|NCT02802683|Nasal Decongestants|nasal decongestants|mesh-ancestor
5789032|NCT02802683|Respiratory System Agents|respiratory system agents|mesh-ancestor
5789033|NCT02802683|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5789034|NCT02802683|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5789035|NCT02802683|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5789036|NCT02802683|Adrenergic Agents|adrenergic agents|mesh-ancestor
5789037|NCT02802683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5789038|NCT02802683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5789039|NCT02802683|Protective Agents|protective agents|mesh-ancestor
5789040|NCT02802969|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
5789041|NCT02802969|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5789042|NCT02802969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5789043|NCT02802696|Furosemide|furosemide|mesh-list
5789044|NCT02802696|Diuretics|diuretics|mesh-ancestor
5789045|NCT02802696|Natriuretic Agents|natriuretic agents|mesh-ancestor
5789046|NCT02802696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789047|NCT02802696|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5789048|NCT02802696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5789049|NCT02802696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5789050|NCT02802813|Piperaquine|piperaquine|mesh-list
5789051|NCT02802813|Primaquine|primaquine|mesh-list
5789052|NCT02802813|Artenimol|artenimol|mesh-list
5789053|NCT02802813|Artemisinins|artemisinins|mesh-list
5789054|NCT02802813|Antimalarials|antimalarials|mesh-ancestor
5789055|NCT02802813|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5789056|NCT02802813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5789057|NCT02802813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5789058|NCT02802605|Bemiparin|bemiparin|mesh-list
5789059|NCT02802605|Anticoagulants|anticoagulants|mesh-ancestor
5898771|NCT02099591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898772|NCT02099591|Sensory System Agents|sensory system agents|mesh-ancestor
5898773|NCT02099591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5898774|NCT01710176|Gemcitabine|gemcitabine|mesh-list
5898775|NCT01710176|Docetaxel|docetaxel|mesh-list
5898776|NCT01710176|Etoposide|etoposide|mesh-list
5898777|NCT01710176|Epirubicin|epirubicin|mesh-list
5898778|NCT01710176|Ifosfamide|ifosfamide|mesh-list
5898779|NCT01710176|Isophosphamide mustard|isophosphamide mustard|mesh-list
5898780|NCT01710176|Dacarbazine|dacarbazine|mesh-list
5898781|NCT01710176|Trabectedin|trabectedin|mesh-list
5898782|NCT01710176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5898783|NCT01710176|Antimetabolites|antimetabolites|mesh-ancestor
5898784|NCT01710176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898785|NCT01710176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5898786|NCT01710176|Antiviral Agents|antiviral agents|mesh-ancestor
5898787|NCT01710176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5898788|NCT01710176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5898789|NCT01710176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5898790|NCT01710176|Immunologic Factors|immunologic factors|mesh-ancestor
6210810|NCT02164916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6210811|NCT02164916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6210812|NCT02164916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6210813|NCT02164916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210814|NCT02164916|Mitosis Modulators|mitosis modulators|mesh-ancestor
6210815|NCT02164916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6210816|NCT02164916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6210817|NCT02164929|Acetaminophen|acetaminophen|mesh-list
6210818|NCT02164929|Dexamethasone|dexamethasone|mesh-list
6210819|NCT02164929|Lidocaine|lidocaine|mesh-list
6210820|NCT02164929|Epinephrine|epinephrine|mesh-list
6210821|NCT02164929|Midazolam|midazolam|mesh-list
5898791|NCT01710176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898792|NCT01710176|Tubulin Modulators|tubulin modulators|mesh-ancestor
5898793|NCT01710176|Antimitotic Agents|antimitotic agents|mesh-ancestor
5898794|NCT01710176|Mitosis Modulators|mitosis modulators|mesh-ancestor
5898795|NCT01710176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5898796|NCT01710176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6210822|NCT02164929|Hydromorphone|hydromorphone|mesh-list
5898797|NCT01710176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5898798|NCT01710176|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5898799|NCT01710176|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5898800|NCT01710176|Alkylating Agents|alkylating agents|mesh-ancestor
5898801|NCT01176461|Nivolumab|nivolumab|mesh-list
5898802|NCT01176461|Vaccines|vaccines|mesh-list
5898803|NCT01176461|Immunologic Factors|immunologic factors|mesh-ancestor
5898804|NCT01176461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898805|NCT01176461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5898806|NCT01176461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5898807|NCT01176461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5898808|NCT01176461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898809|NCT00816582|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5898810|NCT00816582|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5898811|NCT00816582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898812|NCT00584246|Pregabalin|pregabalin|mesh-list
5898813|NCT00584246|Analgesics|analgesics|mesh-ancestor
5898814|NCT00584246|Sensory System Agents|sensory system agents|mesh-ancestor
5898815|NCT00584246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5898816|NCT00584246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210823|NCT02164929|Ropivacaine|ropivacaine|mesh-list
5789060|NCT02802540|Nabilone|nabilone|mesh-list
5789061|NCT02802540|Antiemetics|antiemetics|mesh-ancestor
5789062|NCT02802540|Autonomic Agents|autonomic agents|mesh-ancestor
5789063|NCT02802540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5789064|NCT02802540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789065|NCT02802540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5789066|NCT02802540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5789067|NCT02802540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5789068|NCT02802540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5789069|NCT02802540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5789070|NCT02802215|Folic Acid|folic acid|mesh-list
5789071|NCT02802215|Metformin|metformin|mesh-list
5789072|NCT02802215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5789073|NCT02802215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789074|NCT02802215|Hematinics|hematinics|mesh-ancestor
5789075|NCT02802215|Vitamin B Complex|vitamin b complex|mesh-ancestor
5789076|NCT02802215|Vitamins|vitamins|mesh-ancestor
5789077|NCT02802215|Micronutrients|micronutrients|mesh-ancestor
5789078|NCT02802163|Dexamethasone|dexamethasone|mesh-list
5789079|NCT02802163|Lenalidomide|lenalidomide|mesh-list
5789080|NCT02802163|Panobinostat|panobinostat|mesh-list
5789081|NCT02802163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5789082|NCT02802163|Antiemetics|antiemetics|mesh-ancestor
5789083|NCT02802163|Autonomic Agents|autonomic agents|mesh-ancestor
5789084|NCT02802163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5789085|NCT02802163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789086|NCT02802163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5789087|NCT02802163|Glucocorticoids|glucocorticoids|mesh-ancestor
5789088|NCT02802163|Hormones|hormones|mesh-ancestor
5789089|NCT02802163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5789090|NCT02802163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5789091|NCT02802163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5789092|NCT02802163|Immunologic Factors|immunologic factors|mesh-ancestor
5789093|NCT02802163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5789094|NCT02802163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5789095|NCT02802163|Growth Substances|growth substances|mesh-ancestor
5789096|NCT02802163|Growth Inhibitors|growth inhibitors|mesh-ancestor
5789097|NCT02802163|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5789098|NCT02802163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5789099|NCT02802163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5789100|NCT02802072|Aspirin|aspirin|mesh-list
5789101|NCT02802072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5789102|NCT02802072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5789103|NCT02802072|Analgesics|analgesics|mesh-ancestor
5789104|NCT02802072|Sensory System Agents|sensory system agents|mesh-ancestor
5789105|NCT02802072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5789106|NCT02802072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789107|NCT02802072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5789108|NCT02802072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5789109|NCT02802072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5789110|NCT02802072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5789111|NCT02802072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5789112|NCT02802072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5789113|NCT02802072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5789114|NCT02802072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5789115|NCT02802072|Antipyretics|antipyretics|mesh-ancestor
5789116|NCT02802137|Timolol|timolol|mesh-list
5789117|NCT02802137|Dorzolamide|dorzolamide|mesh-list
5789118|NCT02802137|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5789119|NCT02802137|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5789120|NCT02802137|Adrenergic Agents|adrenergic agents|mesh-ancestor
5789121|NCT02802137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5789122|NCT02802137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5789123|NCT02802137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789124|NCT02802137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5789125|NCT02802137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5789126|NCT02802137|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5789127|NCT02802137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5789128|NCT02801799|Ropivacaine|ropivacaine|mesh-list
5789129|NCT02801799|Anesthetics, Local|anesthetics, local|mesh-ancestor
5789130|NCT02801799|Anesthetics|anesthetics|mesh-ancestor
5789131|NCT02801799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5789132|NCT02801799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789133|NCT02801799|Sensory System Agents|sensory system agents|mesh-ancestor
5789134|NCT02801799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5789135|NCT02801786|Tamoxifen|tamoxifen|mesh-list
5789136|NCT02801786|Lidocaine|lidocaine|mesh-list
5789137|NCT02801786|Anesthetics, Local|anesthetics, local|mesh-ancestor
5789138|NCT02801786|Anesthetics|anesthetics|mesh-ancestor
5789139|NCT02801786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5789140|NCT02801786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789141|NCT02801786|Sensory System Agents|sensory system agents|mesh-ancestor
5789142|NCT02801786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5789143|NCT02801786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5789144|NCT02801786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5789145|NCT02801786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5789146|NCT02801786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5789147|NCT02801786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5789148|NCT02801786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5789149|NCT02801786|Hormone Antagonists|hormone antagonists|mesh-ancestor
5789150|NCT02801786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5789151|NCT02801786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5789152|NCT02801786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5789153|NCT02801786|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5789154|NCT02801786|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5789155|NCT02801786|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5789156|NCT02801838|Morphine|morphine|mesh-list
5789157|NCT02801838|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5789158|NCT02801838|Narcotics|narcotics|mesh-ancestor
5789159|NCT02801838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5789160|NCT02801838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789161|NCT02801838|Analgesics|analgesics|mesh-ancestor
5789162|NCT02801838|Sensory System Agents|sensory system agents|mesh-ancestor
5789163|NCT02801838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5789164|NCT02802098|Bevacizumab|bevacizumab|mesh-list
5789165|NCT02802098|Durvalumab|durvalumab|mesh-list
5789166|NCT02802098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5789167|NCT02802098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5789168|NCT02802098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5789169|NCT02802098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5789170|NCT02802098|Growth Substances|growth substances|mesh-ancestor
5789171|NCT02802098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789172|NCT02802098|Growth Inhibitors|growth inhibitors|mesh-ancestor
5789173|NCT02801487|Cisplatin|cisplatin|mesh-list
5789174|NCT02801487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5789175|NCT02801526|Amlodipine|amlodipine|mesh-list
5789176|NCT02801526|Candesartan|candesartan|mesh-list
5789177|NCT02801526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5789178|NCT02801526|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5789179|NCT02801526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5789180|NCT02801526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5789181|NCT02801526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5789182|NCT02801526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789183|NCT02801526|Vasodilator Agents|vasodilator agents|mesh-ancestor
5789184|NCT02801526|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5789185|NCT02801526|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5789186|NCT02801357|Lofexidine|lofexidine|mesh-list
5789187|NCT02801357|Buprenorphine|buprenorphine|mesh-list
5789188|NCT02801357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5789189|NCT02801357|Narcotics|narcotics|mesh-ancestor
5789190|NCT02801357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5789191|NCT02801357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789192|NCT02801357|Analgesics|analgesics|mesh-ancestor
5789193|NCT02801357|Sensory System Agents|sensory system agents|mesh-ancestor
5789194|NCT02801357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5789195|NCT02801357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5789196|NCT02801357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5789197|NCT02801357|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5789198|NCT02801357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5789199|NCT02801357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5789200|NCT02801357|Adrenergic Agents|adrenergic agents|mesh-ancestor
5789201|NCT02801357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5789202|NCT02801357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5789203|NCT02801383|Interferons|interferons|mesh-list
5789204|NCT02801383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5789205|NCT02801383|Antiviral Agents|antiviral agents|mesh-ancestor
5789206|NCT02801383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5789207|NCT02801656|Vancomycin|vancomycin|mesh-list
5789208|NCT02801656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5789209|NCT02801656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5789210|NCT02801409|Anesthetics|anesthetics|mesh-list
5789211|NCT02801409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5789212|NCT02801409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789213|NCT02801292|Ketamine|ketamine|mesh-list
5789214|NCT02801292|Analgesics|analgesics|mesh-ancestor
5789215|NCT02801292|Sensory System Agents|sensory system agents|mesh-ancestor
5789216|NCT02801292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5789217|NCT02801292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789218|NCT02801292|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5789219|NCT02801292|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5789220|NCT02801292|Anesthetics, General|anesthetics, general|mesh-ancestor
5789221|NCT02801292|Anesthetics|anesthetics|mesh-ancestor
5789222|NCT02801292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5789223|NCT02801292|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5789224|NCT02801292|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5789225|NCT02801292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5789226|NCT02801292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5789227|NCT02801305|Diltiazem|diltiazem|mesh-list
5789228|NCT02801305|Nitroglycerin|nitroglycerin|mesh-list
5789229|NCT02801305|Petrolatum|petrolatum|mesh-list
5789230|NCT02801305|Vasodilator Agents|vasodilator agents|mesh-ancestor
5789231|NCT02801305|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5789232|NCT02801305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5789233|NCT02801305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5789234|NCT02801305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5789235|NCT02801305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5789236|NCT02801305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789237|NCT02801305|Emollients|emollients|mesh-ancestor
5789238|NCT02801305|Dermatologic Agents|dermatologic agents|mesh-ancestor
5789239|NCT02801227|Oxytocin|oxytocin|mesh-list
5789240|NCT02801227|Dinoprostone|dinoprostone|mesh-list
5789241|NCT02801227|Oxytocics|oxytocics|mesh-ancestor
5789242|NCT02801227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5789243|NCT02801227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789244|NCT02801266|Contraceptive Agents|contraceptive agents|mesh-list
5789245|NCT02801266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5789246|NCT02801266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789247|NCT02801201|Midazolam|midazolam|mesh-list
5789248|NCT02801201|Bupivacaine|bupivacaine|mesh-list
5789249|NCT02801201|Anesthetics, Local|anesthetics, local|mesh-ancestor
5789250|NCT02801201|Anesthetics|anesthetics|mesh-ancestor
5789251|NCT02801201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5789252|NCT02801201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789253|NCT02801201|Sensory System Agents|sensory system agents|mesh-ancestor
5789254|NCT02801201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5789255|NCT02801201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5789256|NCT02801201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5789257|NCT02801201|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5789258|NCT02801201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5789259|NCT02801201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5789260|NCT02801201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5789261|NCT02801201|Anesthetics, General|anesthetics, general|mesh-ancestor
5789262|NCT02801201|GABA Modulators|gaba modulators|mesh-ancestor
5789263|NCT02801201|GABA Agents|gaba agents|mesh-ancestor
5789264|NCT02801201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5789265|NCT02801201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5789266|NCT02801097|Irinotecan|irinotecan|mesh-list
5789267|NCT02801097|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5789268|NCT02801097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5789269|NCT02801097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5789270|NCT02801097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5789271|NCT02801097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5789272|NCT02800941|Warfarin|warfarin|mesh-list
5789273|NCT02800941|Anticoagulants|anticoagulants|mesh-list
5789274|NCT02800941|Acenocoumarol|acenocoumarol|mesh-list
5789275|NCT02800941|Fluindione|fluindione|mesh-list
5789276|NCT02801188|Dexmedetomidine|dexmedetomidine|mesh-list
5789277|NCT02801188|Bupivacaine|bupivacaine|mesh-list
5789278|NCT02801188|Anesthetics, Local|anesthetics, local|mesh-ancestor
5789279|NCT02801188|Anesthetics|anesthetics|mesh-ancestor
5789280|NCT02801188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5789281|NCT02801188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789282|NCT02801188|Sensory System Agents|sensory system agents|mesh-ancestor
5789283|NCT02801188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5789284|NCT02801188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5789285|NCT02801188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5789286|NCT02801188|Analgesics|analgesics|mesh-ancestor
5898817|NCT00584246|Anticonvulsants|anticonvulsants|mesh-ancestor
5789287|NCT02801188|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5789288|NCT02801188|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5789289|NCT02801188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5789290|NCT02801188|Adrenergic Agents|adrenergic agents|mesh-ancestor
5789291|NCT02801188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5789292|NCT02801188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5789293|NCT02800902|Atorvastatin|atorvastatin|mesh-list
5789294|NCT02800902|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5789295|NCT02800902|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5789296|NCT02800902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5789297|NCT02800902|Antimetabolites|antimetabolites|mesh-ancestor
5789298|NCT02800902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5789299|NCT02800902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5789300|NCT02800902|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5789301|NCT02800902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5789302|NCT02801032|Tadalafil|tadalafil|mesh-list
5789303|NCT02801032|Vasodilator Agents|vasodilator agents|mesh-ancestor
5789304|NCT02801032|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5789305|NCT02801032|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5789306|NCT02801032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5789307|NCT02801032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5789308|NCT02801032|Urological Agents|urological agents|mesh-ancestor
5789309|NCT02800785|Moxifloxacin|moxifloxacin|mesh-list
5789310|NCT02800785|Metronidazole|metronidazole|mesh-list
5789311|NCT02800785|Ciprofloxacin|ciprofloxacin|mesh-list
5789312|NCT02800785|Levofloxacin|levofloxacin|mesh-list
5789313|NCT02800785|Cefazolin|cefazolin|mesh-list
5789314|NCT02800785|Ceftriaxone|ceftriaxone|mesh-list
5789315|NCT02800785|Clavulanic Acids|clavulanic acids|mesh-list
5789316|NCT02800785|Clavulanic Acid|clavulanic acid|mesh-list
5789317|NCT02800785|Ertapenem|ertapenem|mesh-list
5789318|NCT02800785|Cefuroxime|cefuroxime|mesh-list
5789319|NCT02800785|Tigecycline|tigecycline|mesh-list
5789320|NCT02800785|Cefotaxime|cefotaxime|mesh-list
5789321|NCT02800785|Cefoxitin|cefoxitin|mesh-list
5789322|NCT02800785|Ticarcillin|ticarcillin|mesh-list
5789323|NCT02800785|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
5789324|NCT02800785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5789325|NCT02800785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5789326|NCT02800785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5789327|NCT02800785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5789328|NCT02800785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5789329|NCT02800785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5789330|NCT02800785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5789331|NCT02800785|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5789332|NCT02800785|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5789333|NCT02800785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5789334|NCT02800785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5789335|NCT02800785|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5789336|NCT02800785|Renal Agents|renal agents|mesh-ancestor
5789337|NCT02800785|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5789338|NCT02800785|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5898818|NCT00584246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5898819|NCT00584246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5898820|NCT00584246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898821|NCT00584246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5898822|NCT00584246|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5898823|NCT00584246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5898824|NCT00584246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5898825|NCT00584246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5898826|NCT00584025|Levetiracetam|levetiracetam|mesh-list
5898827|NCT00584025|Anticonvulsants|anticonvulsants|mesh-ancestor
5898828|NCT00584025|Nootropic Agents|nootropic agents|mesh-ancestor
5898829|NCT05124353|Cerebrolysin|cerebrolysin|mesh-list
5898830|NCT05124353|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5898831|NCT05124353|Protective Agents|protective agents|mesh-ancestor
5898832|NCT05124353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898833|NCT05124353|Nootropic Agents|nootropic agents|mesh-ancestor
5898834|NCT05124314|Misoprostol|misoprostol|mesh-list
5898835|NCT05124314|Mifepristone|mifepristone|mesh-list
5898836|NCT05124314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5898837|NCT05124314|Abortifacient Agents|abortifacient agents|mesh-ancestor
5898838|NCT05124314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5898839|NCT05124314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898840|NCT05124314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5898841|NCT05124314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5789339|NCT02800889|Pixantrone|pixantrone|mesh-list
5789340|NCT02800889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5789341|NCT02800889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5789342|NCT02800889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5789343|NCT02800889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5789344|NCT02800889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5789345|NCT02800447|Procarbazine|procarbazine|mesh-list
5789346|NCT02800447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5789347|NCT02800408|Beta-Cryptoxanthin|beta-cryptoxanthin|mesh-list
5789348|NCT02800408|Provitamins|provitamins|mesh-ancestor
5789349|NCT02800408|Vitamins|vitamins|mesh-ancestor
5789350|NCT02800408|Micronutrients|micronutrients|mesh-ancestor
5789351|NCT02800408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789352|NCT02800772|Acetic Acid|acetic acid|mesh-list
5789353|NCT02800772|Retinol acetate|retinol acetate|mesh-list
5789354|NCT02800772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5789355|NCT02800772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5789356|NCT02800772|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5789357|NCT02800772|Immunologic Factors|immunologic factors|mesh-ancestor
5789358|NCT02800772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789359|NCT02800772|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5789360|NCT02800772|Protective Agents|protective agents|mesh-ancestor
5789361|NCT02800772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5789362|NCT02800590|Abp-700|abp-700|mesh-list
5789363|NCT02800590|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
5789364|NCT02800590|GABA Agonists|gaba agonists|mesh-ancestor
5789365|NCT02800590|GABA Agents|gaba agents|mesh-ancestor
5789366|NCT02800590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5789367|NCT02800590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5789368|NCT02800590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789369|NCT02800694|Fentanyl|fentanyl|mesh-list
5789370|NCT02800694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5789371|NCT02800694|Narcotics|narcotics|mesh-ancestor
5789372|NCT02800694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5789373|NCT02800694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789374|NCT02800694|Analgesics|analgesics|mesh-ancestor
5789375|NCT02800694|Sensory System Agents|sensory system agents|mesh-ancestor
5789376|NCT02800694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5789377|NCT02800694|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5789378|NCT02800694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5789379|NCT02800694|Anesthetics, General|anesthetics, general|mesh-ancestor
5789380|NCT02800694|Anesthetics|anesthetics|mesh-ancestor
5789381|NCT02800486|Cetuximab|cetuximab|mesh-list
5789382|NCT02800486|Mannitol|mannitol|mesh-list
5789383|NCT02800486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5789384|NCT02800486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5789385|NCT02800486|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5789386|NCT02800486|Diuretics|diuretics|mesh-ancestor
5789387|NCT02800486|Natriuretic Agents|natriuretic agents|mesh-ancestor
5789388|NCT02800486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789389|NCT02800252|Aspirin|aspirin|mesh-list
5789390|NCT02800252|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5789391|NCT02800252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5789392|NCT02800252|Analgesics|analgesics|mesh-ancestor
5789393|NCT02800252|Sensory System Agents|sensory system agents|mesh-ancestor
5789394|NCT02800252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5789395|NCT02800252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789396|NCT02800252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5789397|NCT02800252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5789398|NCT02800252|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5789399|NCT02800252|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5789400|NCT02800252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5789401|NCT02800252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5789402|NCT02800252|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5789403|NCT02800252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5789404|NCT02800252|Antipyretics|antipyretics|mesh-ancestor
5789405|NCT02800174|Aspirin|aspirin|mesh-list
5789406|NCT02800174|Clopidogrel|clopidogrel|mesh-list
6491344|NCT00602134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491345|NCT00602134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6491346|NCT00602134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5789407|NCT02800174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
5789408|NCT02800174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5789409|NCT02800174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5789410|NCT02800174|Analgesics|analgesics|mesh-ancestor
5789411|NCT02800174|Sensory System Agents|sensory system agents|mesh-ancestor
5898842|NCT05124314|Oxytocics|oxytocics|mesh-ancestor
6491347|NCT00602134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6491348|NCT00602134|Immunologic Factors|immunologic factors|mesh-ancestor
6491349|NCT00602134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491350|NCT00602134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5789412|NCT02800174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5789413|NCT02800174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789414|NCT02800174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5789415|NCT02800174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5789416|NCT02800174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5789417|NCT02800174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5789418|NCT02800174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5789419|NCT02800174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5789420|NCT02800174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5789421|NCT02800174|Antipyretics|antipyretics|mesh-ancestor
5789422|NCT02800174|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5789423|NCT02800174|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5789424|NCT02800174|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5789425|NCT02800174|Purinergic Agents|purinergic agents|mesh-ancestor
5789426|NCT02800174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5789427|NCT02800330|Esomeprazole|esomeprazole|mesh-list
5789428|NCT02800330|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5789429|NCT02800330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6210824|NCT02164929|Propofol|propofol|mesh-list
5789430|NCT02800330|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6210825|NCT02164929|Sevoflurane|sevoflurane|mesh-list
6210826|NCT02164929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5789431|NCT02800330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5789432|NCT02800330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5789433|NCT02799862|Paclitaxel|paclitaxel|mesh-list
5789434|NCT02799862|Carboplatin|carboplatin|mesh-list
5789435|NCT02799862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5789436|NCT02799862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5789437|NCT02799862|Tubulin Modulators|tubulin modulators|mesh-ancestor
5789438|NCT02799862|Antimitotic Agents|antimitotic agents|mesh-ancestor
5789439|NCT02799862|Mitosis Modulators|mitosis modulators|mesh-ancestor
5789440|NCT02799862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5789441|NCT02799927|Calcium|calcium|mesh-list
5789442|NCT02799927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5789443|NCT02799927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789444|NCT02799888|Cyclosporine|cyclosporine|mesh-list
5789445|NCT02799888|Maraviroc|maraviroc|mesh-list
5789446|NCT02799888|Methotrexate|methotrexate|mesh-list
5789447|NCT02799888|Tacrolimus|tacrolimus|mesh-list
5789448|NCT02799888|Cyclosporins|cyclosporins|mesh-list
5789449|NCT02799888|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5789450|NCT02799888|Abortifacient Agents|abortifacient agents|mesh-ancestor
5789451|NCT02799888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5789452|NCT02799888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789453|NCT02799888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5789454|NCT02799888|Antimetabolites|antimetabolites|mesh-ancestor
5789455|NCT02799888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5789456|NCT02799888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5789457|NCT02799888|Dermatologic Agents|dermatologic agents|mesh-ancestor
5789458|NCT02799888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5789459|NCT02799888|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5789460|NCT02799888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5789461|NCT02799888|Immunologic Factors|immunologic factors|mesh-ancestor
5789462|NCT02799888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5789463|NCT02799888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6210827|NCT02164929|Antiemetics|antiemetics|mesh-ancestor
6210828|NCT02164929|Autonomic Agents|autonomic agents|mesh-ancestor
6210829|NCT02164929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6210830|NCT02164929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210831|NCT02164929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6210832|NCT02164929|Glucocorticoids|glucocorticoids|mesh-ancestor
6210833|NCT02164929|Hormones|hormones|mesh-ancestor
6210834|NCT02164929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6210835|NCT02164929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6210836|NCT02164929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6210837|NCT02164929|Anesthetics, Local|anesthetics, local|mesh-ancestor
6210838|NCT02164929|Anesthetics|anesthetics|mesh-ancestor
6210839|NCT02164929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6210840|NCT02164929|Sensory System Agents|sensory system agents|mesh-ancestor
6210841|NCT02164929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5789464|NCT02799888|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5789465|NCT02799888|Antifungal Agents|antifungal agents|mesh-ancestor
5789466|NCT02799888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5789467|NCT02799888|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5789468|NCT02799888|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5789469|NCT02799888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5789470|NCT02799888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5789471|NCT02799888|Antiviral Agents|antiviral agents|mesh-ancestor
5789472|NCT02799888|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
5789473|NCT02800135|Furosemide|furosemide|mesh-list
5789474|NCT02800135|Diuretics|diuretics|mesh-ancestor
5789475|NCT02800135|Natriuretic Agents|natriuretic agents|mesh-ancestor
5789476|NCT02800135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789477|NCT02800135|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5789478|NCT02800135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5789479|NCT02800135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5789480|NCT02799901|Nivolumab|nivolumab|mesh-list
5789481|NCT02799901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5789482|NCT02799901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5789483|NCT02799901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5789484|NCT02799901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5789485|NCT02800265|Sulforaphane|sulforaphane|mesh-list
5789486|NCT02800265|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5789487|NCT02800265|Protective Agents|protective agents|mesh-ancestor
5789488|NCT02800265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789489|NCT02800265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5789490|NCT02799797|Sufentanil|sufentanil|mesh-list
5789491|NCT02799797|Dsuvia|dsuvia|mesh-list
5789492|NCT02799797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5789493|NCT02799797|Narcotics|narcotics|mesh-ancestor
5789494|NCT02799797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5789495|NCT02799797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789496|NCT02799797|Analgesics|analgesics|mesh-ancestor
5789497|NCT02799797|Sensory System Agents|sensory system agents|mesh-ancestor
5789498|NCT02799797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5789499|NCT02799797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5789500|NCT02799797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5789501|NCT02799797|Anesthetics, General|anesthetics, general|mesh-ancestor
5789502|NCT02799797|Anesthetics|anesthetics|mesh-ancestor
5789503|NCT02799615|Infliximab|infliximab|mesh-list
5789504|NCT02799615|Dermatologic Agents|dermatologic agents|mesh-ancestor
5789505|NCT02799615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5789506|NCT02799615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5789507|NCT02799758|Pitavastatin|pitavastatin|mesh-list
5789508|NCT02799758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5789509|NCT02799758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5789510|NCT02799758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5789511|NCT02799758|Antimetabolites|antimetabolites|mesh-ancestor
5789512|NCT02799758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5789513|NCT02799758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5789514|NCT02799758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5789515|NCT02799589|Dexmedetomidine|dexmedetomidine|mesh-list
5789516|NCT02799589|Remifentanil|remifentanil|mesh-list
5789517|NCT02799589|Ropivacaine|ropivacaine|mesh-list
5789518|NCT02799589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5789519|NCT02799589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5789520|NCT02799589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789521|NCT02799589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5789522|NCT02799589|Analgesics|analgesics|mesh-ancestor
5789523|NCT02799589|Sensory System Agents|sensory system agents|mesh-ancestor
5789524|NCT02799589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5789525|NCT02799589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5789526|NCT02799589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5789527|NCT02799589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5789528|NCT02799589|Adrenergic Agents|adrenergic agents|mesh-ancestor
5789529|NCT02799589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5789530|NCT02799589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5789531|NCT02799589|Anesthetics, Local|anesthetics, local|mesh-ancestor
5789532|NCT02799589|Anesthetics|anesthetics|mesh-ancestor
5789533|NCT02799589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5789534|NCT02799589|Narcotics|narcotics|mesh-ancestor
5789535|NCT02799459|Anesthetics|anesthetics|mesh-list
5789536|NCT02799459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5789537|NCT02799459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789538|NCT02799446|Reslizumab|reslizumab|mesh-list
5789539|NCT02799446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5789540|NCT02799446|Respiratory System Agents|respiratory system agents|mesh-ancestor
5789541|NCT02799355|Interferons|interferons|mesh-list
5789542|NCT02799355|Ribavirin|ribavirin|mesh-list
5789543|NCT02799355|Sofosbuvir|sofosbuvir|mesh-list
5789544|NCT02799355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5789545|NCT02799355|Antiviral Agents|antiviral agents|mesh-ancestor
5789546|NCT02799355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5789547|NCT02799355|Antimetabolites|antimetabolites|mesh-ancestor
6491351|NCT00602134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6491352|NCT00602173|Cilostazol|cilostazol|mesh-list
6491353|NCT00602173|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6491354|NCT00602173|Autonomic Agents|autonomic agents|mesh-ancestor
6491355|NCT00602173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5789548|NCT02799355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5789549|NCT02799498|Etanercept|etanercept|mesh-list
5789550|NCT02799498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5789551|NCT02799498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5789552|NCT02799498|Analgesics|analgesics|mesh-ancestor
5789553|NCT02799498|Sensory System Agents|sensory system agents|mesh-ancestor
5789554|NCT02799498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5789555|NCT02799498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789556|NCT02799498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5789557|NCT02799498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5789558|NCT02799498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5789559|NCT02799498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5789560|NCT02799498|Immunologic Factors|immunologic factors|mesh-ancestor
5898843|NCT05124314|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5898844|NCT05124314|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5898845|NCT05124314|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5898846|NCT05124314|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5898847|NCT05124314|Contraceptive Agents|contraceptive agents|mesh-ancestor
5898848|NCT05124314|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5898849|NCT05124314|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5898850|NCT05124314|Hormone Antagonists|hormone antagonists|mesh-ancestor
5898851|NCT05124314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5898852|NCT05124314|Luteolytic Agents|luteolytic agents|mesh-ancestor
6491356|NCT00602173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898853|NCT05124314|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5898854|NCT05124314|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5898855|NCT05123976|Olanzapine|olanzapine|mesh-list
5898856|NCT05123976|Antiemetics|antiemetics|mesh-ancestor
5898857|NCT05123976|Autonomic Agents|autonomic agents|mesh-ancestor
5898858|NCT05123976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5898859|NCT05123976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898860|NCT05123976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5898861|NCT05123976|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5898862|NCT05123976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5898863|NCT05123976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5898864|NCT05123976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5898865|NCT05123976|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5898866|NCT05123976|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5898867|NCT05123976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5898868|NCT05123976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898869|NCT05123976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5898870|NCT05123976|Serotonin Agents|serotonin agents|mesh-ancestor
5908115|NCT04912115|GABA Agents|gaba agents|mesh-ancestor
5908116|NCT04905693|Treprostinil|treprostinil|mesh-list
5908117|NCT04905693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5908118|NCT04902625|Naltrexone|naltrexone|mesh-list
5908119|NCT04902625|Bupropion|bupropion|mesh-list
5908120|NCT04902625|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5908121|NCT04902625|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5908122|NCT04902625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5908123|NCT04902625|Sensory System Agents|sensory system agents|mesh-ancestor
5908124|NCT04902625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5908125|NCT04902625|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5908126|NCT04902625|Antidepressive Agents|antidepressive agents|mesh-ancestor
5908127|NCT04902625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5908128|NCT04902625|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5908129|NCT04902625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5908130|NCT04902625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5908131|NCT04902625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908132|NCT04902625|Dopamine Agents|dopamine agents|mesh-ancestor
5908133|NCT04902625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5789561|NCT02799316|Antibodies|antibodies|mesh-list
5789562|NCT02799316|Immunologic Factors|immunologic factors|mesh-ancestor
5789563|NCT02799316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789564|NCT02799238|Temozolomide|temozolomide|mesh-list
5789565|NCT02799238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5789566|NCT02799238|Alkylating Agents|alkylating agents|mesh-ancestor
5789567|NCT02799238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5789568|NCT02799238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5789569|NCT02799030|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5789570|NCT02799030|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5789571|NCT02799030|Dermatologic Agents|dermatologic agents|mesh-ancestor
5789572|NCT02799277|Testosterone|testosterone|mesh-list
5789573|NCT02799277|Androgens|androgens|mesh-ancestor
5789574|NCT02799277|Hormones|hormones|mesh-ancestor
5789575|NCT02799277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5789576|NCT02799277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789577|NCT02799147|Fludarabine|fludarabine|mesh-list
5789578|NCT02799147|Fludarabine phosphate|fludarabine phosphate|mesh-list
5789579|NCT02799147|Busulfan|busulfan|mesh-list
5789580|NCT02799147|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5789581|NCT02799147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5789582|NCT02799147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5789583|NCT02799147|Antimetabolites|antimetabolites|mesh-ancestor
5789584|NCT02799147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673846|NCT01565720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673847|NCT01565720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6673848|NCT01565720|Antifungal Agents|antifungal agents|mesh-ancestor
6673849|NCT01565733|Insulin Aspart|insulin aspart|mesh-list
6673850|NCT01565733|Biphasic Insulins|biphasic insulins|mesh-list
6673851|NCT01565733|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6673852|NCT01565733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6673853|NCT01565733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673854|NCT01565746|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
6673855|NCT01565746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6673856|NCT01565759|Lithium Carbonate|lithium carbonate|mesh-list
6673857|NCT01565759|Antidepressive Agents|antidepressive agents|mesh-ancestor
6673858|NCT01565759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6673859|NCT01565759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6673860|NCT01565759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673861|NCT01565759|Antimanic Agents|antimanic agents|mesh-ancestor
6673862|NCT01565759|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6673863|NCT01565759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6673864|NCT01565759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673865|NCT01565772|Etoposide|etoposide|mesh-list
6673866|NCT01565772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6673867|NCT01565772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6673868|NCT01565772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5789585|NCT02799147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5789586|NCT02799147|Immunologic Factors|immunologic factors|mesh-ancestor
5789587|NCT02799147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789588|NCT02799147|Alkylating Agents|alkylating agents|mesh-ancestor
5789589|NCT02799147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5789590|NCT02799147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5789591|NCT02799095|Pembrolizumab|pembrolizumab|mesh-list
5789592|NCT02799095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5789593|NCT02799095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5789594|NCT02799134|Ascorbic Acid|ascorbic acid|mesh-list
5789595|NCT02799134|Dexamethasone|dexamethasone|mesh-list
5789596|NCT02799134|Vitamins|vitamins|mesh-ancestor
5789597|NCT02799134|Micronutrients|micronutrients|mesh-ancestor
5789598|NCT02799134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789599|NCT02799134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5789600|NCT02799134|Antiemetics|antiemetics|mesh-ancestor
5789601|NCT02799134|Autonomic Agents|autonomic agents|mesh-ancestor
5789602|NCT02799134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5789603|NCT02799134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5789604|NCT02799134|Glucocorticoids|glucocorticoids|mesh-ancestor
5789605|NCT02799134|Hormones|hormones|mesh-ancestor
5789606|NCT02799134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5789607|NCT02799134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5789608|NCT02799134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5789609|NCT02799134|Antioxidants|antioxidants|mesh-ancestor
5789610|NCT02799134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5789611|NCT02799134|Protective Agents|protective agents|mesh-ancestor
5789612|NCT02798913|Clopidogrel|clopidogrel|mesh-list
5789613|NCT02798913|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5789614|NCT02798913|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5789615|NCT02798913|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5789616|NCT02798913|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5789617|NCT02798913|Purinergic Agents|purinergic agents|mesh-ancestor
5789618|NCT02798913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5789619|NCT02798913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5789620|NCT02798913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789621|NCT02798874|Clopidogrel|clopidogrel|mesh-list
5789622|NCT02798874|Ticagrelor|ticagrelor|mesh-list
5789623|NCT02798874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5789624|NCT02798874|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5789625|NCT02798874|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5789626|NCT02798874|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5789627|NCT02798874|Purinergic Agents|purinergic agents|mesh-ancestor
5789628|NCT02798874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5789629|NCT02798874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5789630|NCT02798874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789631|NCT02799264|Cabotegravir|cabotegravir|mesh-list
5789632|NCT02799264|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5789633|NCT02799264|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5789634|NCT02799264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5789635|NCT02799264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5789636|NCT02799264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5789637|NCT02799264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5789638|NCT02799264|Antiviral Agents|antiviral agents|mesh-ancestor
5789639|NCT02799264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5789640|NCT02798653|Progesterone|progesterone|mesh-list
5789641|NCT02798653|Progestins|progestins|mesh-ancestor
5789642|NCT02798653|Hormones|hormones|mesh-ancestor
5789643|NCT02798653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5789644|NCT02798653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789645|NCT02798744|Empagliflozin|empagliflozin|mesh-list
5789646|NCT02798744|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5789647|NCT02798744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5789648|NCT02798744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5789649|NCT02798744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789650|NCT02798406|Pembrolizumab|pembrolizumab|mesh-list
5789651|NCT02798406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5789652|NCT02798406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5789653|NCT02798510|Gemcitabine|gemcitabine|mesh-list
5789654|NCT02798510|Capecitabine|capecitabine|mesh-list
5789655|NCT02798510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5789656|NCT02798510|Antimetabolites|antimetabolites|mesh-ancestor
5789657|NCT02798510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5789658|NCT02798510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5789659|NCT02798510|Antiviral Agents|antiviral agents|mesh-ancestor
5789660|NCT02798510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5789661|NCT02798510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5789662|NCT02798510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5789663|NCT02798510|Immunologic Factors|immunologic factors|mesh-ancestor
5789664|NCT02798510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789665|NCT02798757|Dapagliflozin|dapagliflozin|mesh-list
5789666|NCT02798757|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5789667|NCT02798757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5789668|NCT02798757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5789669|NCT02798757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789670|NCT02798367|Melatonin|melatonin|mesh-list
5789671|NCT02798367|Antioxidants|antioxidants|mesh-ancestor
5789672|NCT02798367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5789673|NCT02798367|Protective Agents|protective agents|mesh-ancestor
5789674|NCT02798367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789675|NCT02798367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5789676|NCT02798250|Insulin|insulin|mesh-list
5789677|NCT02798250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5789678|NCT02798250|Glucagon|glucagon|mesh-list
5789679|NCT02798250|Hormones|hormones|mesh-list
5789680|NCT02798250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5789681|NCT02798250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789682|NCT02798250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5789683|NCT02798250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5789684|NCT02798055|Bosentan|bosentan|mesh-list
5789685|NCT02798055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5789686|NCT02798055|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5789687|NCT02798055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5789688|NCT02798159|Sildenafil Citrate|sildenafil citrate|mesh-list
5789689|NCT02798159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5789690|NCT02798159|Vasodilator Agents|vasodilator agents|mesh-ancestor
5789691|NCT02798159|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5789692|NCT02798159|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5789693|NCT02798159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5789694|NCT02798159|Urological Agents|urological agents|mesh-ancestor
5789695|NCT02798172|Metformin|metformin|mesh-list
5789696|NCT02798172|Alogliptin|alogliptin|mesh-list
5789697|NCT02798172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5789698|NCT02798172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789699|NCT02798172|Incretins|incretins|mesh-ancestor
5789700|NCT02798172|Hormones|hormones|mesh-ancestor
5789701|NCT02798172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5789702|NCT02798172|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5789703|NCT02798172|Protease Inhibitors|protease inhibitors|mesh-ancestor
5789704|NCT02798172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5789705|NCT02798172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5789706|NCT02798068|Methylprednisolone|methylprednisolone|mesh-list
5789707|NCT02798068|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5789708|NCT02798068|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5789709|NCT02798068|Prednisolone|prednisolone|mesh-list
5789710|NCT02798068|Prednisolone acetate|prednisolone acetate|mesh-list
5789711|NCT02798068|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5789712|NCT02798068|Prednisolone phosphate|prednisolone phosphate|mesh-list
5789713|NCT02798068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5789714|NCT02798068|Antiemetics|antiemetics|mesh-ancestor
5789715|NCT02798068|Autonomic Agents|autonomic agents|mesh-ancestor
5789716|NCT02798068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5789717|NCT02798068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789718|NCT02798068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5789719|NCT02798068|Glucocorticoids|glucocorticoids|mesh-ancestor
5789720|NCT02798068|Hormones|hormones|mesh-ancestor
5789721|NCT02798068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5789722|NCT02798068|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5789723|NCT02798068|Protective Agents|protective agents|mesh-ancestor
5789724|NCT02798068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5789725|NCT02798068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5789726|NCT02797704|Aflibercept|aflibercept|mesh-list
5789727|NCT02797704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5789728|NCT02797704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5789729|NCT02797704|Growth Substances|growth substances|mesh-ancestor
5789730|NCT02797704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789731|NCT02797704|Growth Inhibitors|growth inhibitors|mesh-ancestor
5789732|NCT02797704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5789733|NCT02797717|Prednisone|prednisone|mesh-list
5789734|NCT02797717|Cyclophosphamide|cyclophosphamide|mesh-list
5789735|NCT02797717|Dacarbazine|dacarbazine|mesh-list
5789736|NCT02797717|Doxorubicin|doxorubicin|mesh-list
5789737|NCT02797717|Etoposide|etoposide|mesh-list
5789738|NCT02797717|Vincristine|vincristine|mesh-list
5789739|NCT02797717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5789740|NCT02797717|Immunologic Factors|immunologic factors|mesh-ancestor
5789741|NCT02797717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789742|NCT02797717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5789743|NCT02797717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5789744|NCT02797717|Alkylating Agents|alkylating agents|mesh-ancestor
5789745|NCT02797717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5789746|NCT02797717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5789747|NCT02797717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5789748|NCT02797717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5789749|NCT02797717|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5789750|NCT02797717|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5789751|NCT02797717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5789752|NCT02797717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5789753|NCT02797717|Glucocorticoids|glucocorticoids|mesh-ancestor
5789754|NCT02797717|Hormones|hormones|mesh-ancestor
5789755|NCT02797717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5789756|NCT02797717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5789757|NCT02797717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5789758|NCT02797717|Tubulin Modulators|tubulin modulators|mesh-ancestor
5789759|NCT02797717|Antimitotic Agents|antimitotic agents|mesh-ancestor
5789760|NCT02797717|Mitosis Modulators|mitosis modulators|mesh-ancestor
5789761|NCT02797860|Rocuronium|rocuronium|mesh-list
5789762|NCT02797860|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5789763|NCT02797860|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5789764|NCT02797860|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5789765|NCT02797860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5789766|NCT02797860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789767|NCT02797782|Antibodies|antibodies|mesh-list
5789768|NCT02797782|Immunologic Factors|immunologic factors|mesh-ancestor
5789769|NCT02797782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789770|NCT02797977|Gemcitabine|gemcitabine|mesh-list
5789771|NCT02797977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5789772|NCT02797977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5789773|NCT02797977|Antimetabolites|antimetabolites|mesh-ancestor
5789774|NCT02797977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5789775|NCT02797977|Antiviral Agents|antiviral agents|mesh-ancestor
5789776|NCT02797977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5789777|NCT02797977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5789778|NCT02797977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5789779|NCT02797977|Immunologic Factors|immunologic factors|mesh-ancestor
5789780|NCT02797977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898871|NCT05123781|Metformin|metformin|mesh-list
5898872|NCT05123781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5898873|NCT05123781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898874|NCT05123287|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5898875|NCT05123287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898876|NCT05123287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5898877|NCT05123092|Morphine|morphine|mesh-list
5898878|NCT05123092|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5898879|NCT05123092|Narcotics|narcotics|mesh-ancestor
5898880|NCT05123092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5898881|NCT05123092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898882|NCT05123092|Analgesics|analgesics|mesh-ancestor
5898883|NCT05123092|Sensory System Agents|sensory system agents|mesh-ancestor
5898884|NCT05123092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5898885|NCT05123053|Amifampridine|amifampridine|mesh-list
5898886|NCT05123053|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5898887|NCT05123053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5898888|NCT05123053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898889|NCT05123053|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5898890|NCT05123053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5898891|NCT05123053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898892|NCT05123040|Prednisone|prednisone|mesh-list
5898893|NCT05123040|Methylprednisolone|methylprednisolone|mesh-list
5898894|NCT05123040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5898895|NCT05123040|Glucocorticoids|glucocorticoids|mesh-ancestor
5898896|NCT05123040|Hormones|hormones|mesh-ancestor
5898897|NCT05123040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5898898|NCT05123040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898899|NCT05123040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5898900|NCT05123040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5898901|NCT05123040|Antiemetics|antiemetics|mesh-ancestor
5898902|NCT05123040|Autonomic Agents|autonomic agents|mesh-ancestor
5898903|NCT05123040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5898904|NCT05123040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5898905|NCT05123040|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5898906|NCT05123040|Protective Agents|protective agents|mesh-ancestor
5898907|NCT05122884|Milrinone|milrinone|mesh-list
5898908|NCT05122884|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5898909|NCT05122884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5898910|NCT05122884|Vasodilator Agents|vasodilator agents|mesh-ancestor
5898911|NCT05122884|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5898912|NCT05122884|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5898913|NCT05122884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5898914|NCT05122884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898915|NCT05122884|Protective Agents|protective agents|mesh-ancestor
5898916|NCT05122884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898917|NCT05122819|Anesthetics|anesthetics|mesh-list
5898918|NCT05122819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5898919|NCT05122819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898920|NCT05122780|Acetylcholine|acetylcholine|mesh-list
5898921|NCT05122780|Anticoagulants|anticoagulants|mesh-list
5898922|NCT05122780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
5898923|NCT05122780|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
5789781|NCT02797587|Nicotine|nicotine|mesh-list
5789782|NCT02797587|Varenicline|varenicline|mesh-list
5789783|NCT02797587|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5789784|NCT02797587|Autonomic Agents|autonomic agents|mesh-ancestor
5789785|NCT02797587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5789786|NCT02797587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789787|NCT02797587|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5789788|NCT02797587|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5789789|NCT02797587|Cholinergic Agents|cholinergic agents|mesh-ancestor
5789790|NCT02797587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5789791|NCT02797587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5789792|NCT02797548|Aspirin|aspirin|mesh-list
5789793|NCT02797548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5789794|NCT02797548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5789795|NCT02797548|Analgesics|analgesics|mesh-ancestor
5789796|NCT02797548|Sensory System Agents|sensory system agents|mesh-ancestor
5789797|NCT02797548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5789798|NCT02797548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789799|NCT02797548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5789800|NCT02797548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5789801|NCT02797548|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5789802|NCT02797548|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5789803|NCT02797548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673869|NCT01565772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6673870|NCT01565772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6673871|NCT01565772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673872|NCT01565798|Copper|copper|mesh-list
6673873|NCT01565798|Trace Elements|trace elements|mesh-ancestor
6673874|NCT01565798|Micronutrients|micronutrients|mesh-ancestor
6673875|NCT01565798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673876|NCT01565837|Ipilimumab|ipilimumab|mesh-list
6673877|NCT01565837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6673878|NCT01565837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6673879|NCT01565837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6673880|NCT01565837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673881|NCT01566006|Mycophenolic Acid|mycophenolic acid|mesh-list
6673882|NCT01566006|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
6673883|NCT01566006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6673884|NCT01566006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6673885|NCT01566006|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6673886|NCT01566006|Antitubercular Agents|antitubercular agents|mesh-ancestor
6673887|NCT01566006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6673888|NCT01566006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6673889|NCT01566006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5789804|NCT02797548|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5789805|NCT02797548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5789806|NCT02797548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5789807|NCT02797548|Antipyretics|antipyretics|mesh-ancestor
5789808|NCT02797470|Cytarabine|cytarabine|mesh-list
5789809|NCT02797470|Etoposide|etoposide|mesh-list
5789810|NCT02797470|Podophyllotoxin|podophyllotoxin|mesh-list
6673890|NCT01566006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673891|NCT01566006|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6675583|NCT01576419|Sensory System Agents|sensory system agents|mesh-ancestor
6675584|NCT01576419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6675585|NCT01576419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675586|NCT01576419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6675587|NCT01576419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6675588|NCT01576419|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6675589|NCT01576419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6675590|NCT01576419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5789811|NCT02797470|Etoposide phosphate|etoposide phosphate|mesh-list
5789812|NCT02797470|Melphalan|melphalan|mesh-list
5789813|NCT02797470|Mechlorethamine|mechlorethamine|mesh-list
5789814|NCT02797470|Carmustine|carmustine|mesh-list
5789815|NCT02797470|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
5789816|NCT02797470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5789817|NCT02797470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5789818|NCT02797470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5789819|NCT02797470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5789820|NCT02797470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5789821|NCT02797470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5789822|NCT02797470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5789823|NCT02797470|Antimetabolites|antimetabolites|mesh-ancestor
5789824|NCT02797470|Antiviral Agents|antiviral agents|mesh-ancestor
5789825|NCT02797470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5789826|NCT02797470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5789827|NCT02797470|Immunologic Factors|immunologic factors|mesh-ancestor
5789828|NCT02797470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789829|NCT02797470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5789830|NCT02797470|Alkylating Agents|alkylating agents|mesh-ancestor
5789831|NCT02797470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5789832|NCT02797470|Keratolytic Agents|keratolytic agents|mesh-ancestor
5789833|NCT02797470|Dermatologic Agents|dermatologic agents|mesh-ancestor
5789834|NCT02797470|Tubulin Modulators|tubulin modulators|mesh-ancestor
5789835|NCT02797470|Antimitotic Agents|antimitotic agents|mesh-ancestor
5789836|NCT02797470|Mitosis Modulators|mitosis modulators|mesh-ancestor
5789837|NCT02797236|Vaccines|vaccines|mesh-list
5789838|NCT02797236|Immunologic Factors|immunologic factors|mesh-ancestor
5789839|NCT02797236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789840|NCT02797249|Aspirin|aspirin|mesh-list
5789841|NCT02797249|Salicylic Acid|salicylic acid|mesh-list
5789842|NCT02797249|Salicylates|salicylates|mesh-list
5789843|NCT02797249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5789844|NCT02797249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5789845|NCT02797249|Analgesics|analgesics|mesh-ancestor
5789846|NCT02797249|Sensory System Agents|sensory system agents|mesh-ancestor
5789847|NCT02797249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5789848|NCT02797249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789849|NCT02797249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5789850|NCT02797249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5789851|NCT02797249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5789852|NCT02797249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5789853|NCT02797249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5789854|NCT02797249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5789855|NCT02797249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5789856|NCT02797249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5789857|NCT02797249|Antipyretics|antipyretics|mesh-ancestor
5789858|NCT02797249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5789859|NCT02797249|Antifungal Agents|antifungal agents|mesh-ancestor
5789860|NCT02797249|Keratolytic Agents|keratolytic agents|mesh-ancestor
5789861|NCT02797249|Dermatologic Agents|dermatologic agents|mesh-ancestor
5789862|NCT02797340|Metformin|metformin|mesh-list
5789863|NCT02797340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5789864|NCT02797340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789865|NCT02797145|Digoxin|digoxin|mesh-list
5789866|NCT02797145|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5789867|NCT02797145|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5789868|NCT02797145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5789869|NCT02797145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5789870|NCT02797145|Protective Agents|protective agents|mesh-ancestor
5789871|NCT02797145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789872|NCT02797119|Tranexamic Acid|tranexamic acid|mesh-list
5789873|NCT02797119|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5789874|NCT02797119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5789875|NCT02797119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5789876|NCT02797119|Hemostatics|hemostatics|mesh-ancestor
5789877|NCT02797119|Coagulants|coagulants|mesh-ancestor
5789878|NCT02797067|Indomethacin|indomethacin|mesh-list
5789879|NCT02797067|Glycerol|glycerol|mesh-list
5789880|NCT02797067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5789881|NCT02797067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5789882|NCT02797067|Analgesics|analgesics|mesh-ancestor
5789883|NCT02797067|Sensory System Agents|sensory system agents|mesh-ancestor
5789884|NCT02797067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5789885|NCT02797067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789886|NCT02797067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5789887|NCT02797067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5789888|NCT02797067|Gout Suppressants|gout suppressants|mesh-ancestor
5789889|NCT02797067|Tocolytic Agents|tocolytic agents|mesh-ancestor
5789890|NCT02797067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5789891|NCT02797067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5789892|NCT02797067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5789893|NCT02797067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673892|NCT01566201|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5789894|NCT02797067|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
5789895|NCT02797067|Protective Agents|protective agents|mesh-ancestor
5789896|NCT02797028|Allopurinol|allopurinol|mesh-list
5789897|NCT02797028|Antimetabolites|antimetabolites|mesh-ancestor
5789898|NCT02797028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5789899|NCT02797028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5789900|NCT02797028|Gout Suppressants|gout suppressants|mesh-ancestor
5789901|NCT02797028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5789902|NCT02797028|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5789903|NCT02797028|Antioxidants|antioxidants|mesh-ancestor
5789904|NCT02797028|Protective Agents|protective agents|mesh-ancestor
5789905|NCT02797028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789906|NCT02797015|Ozanimod|ozanimod|mesh-list
5789907|NCT02797015|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5789908|NCT02797015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5789909|NCT02797015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5789910|NCT02797015|Immunologic Factors|immunologic factors|mesh-ancestor
5789911|NCT02797015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789912|NCT02797041|Bortezomib|bortezomib|mesh-list
5789913|NCT02797041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5789914|NCT02796794|Genistein|genistein|mesh-list
5789915|NCT02796794|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5789916|NCT02796794|Protective Agents|protective agents|mesh-ancestor
5789917|NCT02796794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789918|NCT02796794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5789919|NCT02796794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5789920|NCT02796794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5789921|NCT02796794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5789922|NCT02796794|Phytoestrogens|phytoestrogens|mesh-ancestor
5789923|NCT02796794|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
5789924|NCT02796794|Estrogens|estrogens|mesh-ancestor
5789925|NCT02796794|Hormones|hormones|mesh-ancestor
5789926|NCT02796794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5789927|NCT02796833|SMOFlipid|smoflipid|mesh-list
5789928|NCT02796833|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
5789929|NCT02796833|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5789930|NCT02796833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5789931|NCT02796950|Acipimox|acipimox|mesh-list
5789932|NCT02796950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5789933|NCT02796950|Antimetabolites|antimetabolites|mesh-ancestor
5789934|NCT02796950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5789935|NCT02796950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5789936|NCT02796859|Siltuximab|siltuximab|mesh-list
5789937|NCT02796859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5789938|NCT02796547|Levobupivacaine|levobupivacaine|mesh-list
5789939|NCT02796547|Anesthetics, Local|anesthetics, local|mesh-ancestor
5789940|NCT02796547|Anesthetics|anesthetics|mesh-ancestor
5789941|NCT02796547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5789942|NCT02796547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789943|NCT02796547|Sensory System Agents|sensory system agents|mesh-ancestor
5789944|NCT02796547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5789945|NCT02796469|Pentoxifylline|pentoxifylline|mesh-list
5789946|NCT02796469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5789947|NCT02796469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5789948|NCT02796469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5789949|NCT02796469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5789950|NCT02796469|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5789951|NCT02796469|Protective Agents|protective agents|mesh-ancestor
5789952|NCT02796469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789953|NCT02796469|Vasodilator Agents|vasodilator agents|mesh-ancestor
5789954|NCT02796469|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5789955|NCT02796469|Antioxidants|antioxidants|mesh-ancestor
5789956|NCT02796378|Ubiquinone|ubiquinone|mesh-list
5789957|NCT02796378|Coenzyme Q10|coenzyme q10|mesh-list
5789958|NCT02796378|Simvastatin|simvastatin|mesh-list
5789959|NCT02796378|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5789960|NCT02796378|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5789961|NCT02796378|Antimetabolites|antimetabolites|mesh-ancestor
5789962|NCT02796378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5789963|NCT02796378|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5789964|NCT02796378|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5789965|NCT02796378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5789966|NCT02796378|Micronutrients|micronutrients|mesh-ancestor
5789967|NCT02796378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789968|NCT02796378|Vitamins|vitamins|mesh-ancestor
5789969|NCT02796157|Everolimus|everolimus|mesh-list
5789970|NCT02796157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5789971|NCT02796157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5789972|NCT02796157|Immunologic Factors|immunologic factors|mesh-ancestor
5789973|NCT02796157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212596|NCT02191033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5789974|NCT02796196|Coal Tar|coal tar|mesh-list
5789975|NCT02796196|Keratolytic Agents|keratolytic agents|mesh-ancestor
5789976|NCT02796196|Dermatologic Agents|dermatologic agents|mesh-ancestor
5789977|NCT02796183|Bevacizumab|bevacizumab|mesh-list
5789978|NCT02796183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5789979|NCT02796183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5789980|NCT02796183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5789981|NCT02796183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5789982|NCT02796183|Growth Substances|growth substances|mesh-ancestor
5789983|NCT02796183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789984|NCT02796183|Growth Inhibitors|growth inhibitors|mesh-ancestor
5789985|NCT02796105|Ganirelix|ganirelix|mesh-list
5789986|NCT02796105|Hormone Antagonists|hormone antagonists|mesh-ancestor
5789987|NCT02796105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5789988|NCT02796105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5789989|NCT02795949|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5789990|NCT02795949|Amoxicillin|amoxicillin|mesh-list
5789991|NCT02795949|Ciprofloxacin|ciprofloxacin|mesh-list
5789992|NCT02795949|Meropenem|meropenem|mesh-list
5789993|NCT02795949|Tazobactam|tazobactam|mesh-list
5789994|NCT02795949|Piperacillin|piperacillin|mesh-list
5789995|NCT02795949|Clavulanic Acid|clavulanic acid|mesh-list
5789996|NCT02795949|Imipenem|imipenem|mesh-list
5789997|NCT02795949|Ceftazidime|ceftazidime|mesh-list
5789998|NCT02795949|Ampicillin|ampicillin|mesh-list
5789999|NCT02795949|Ertapenem|ertapenem|mesh-list
5790000|NCT02795949|Cefepime|cefepime|mesh-list
5790001|NCT02795949|Cefuroxime|cefuroxime|mesh-list
5790002|NCT02795949|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
5790003|NCT02795949|Lactams|lactams|mesh-list
5790004|NCT02795949|Aztreonam|aztreonam|mesh-list
5790005|NCT02795949|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5790006|NCT02795949|beta-Lactams|beta-lactams|mesh-list
5790007|NCT02795949|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5790008|NCT02795949|Trimethoprim|trimethoprim|mesh-list
5790009|NCT02795949|Sulfamethoxazole|sulfamethoxazole|mesh-list
5790010|NCT02795949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5790011|NCT02795949|Antitubercular Agents|antitubercular agents|mesh-ancestor
5790012|NCT02795949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5790013|NCT02795949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5790014|NCT02795949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5790015|NCT02795949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790016|NCT02795949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5790017|NCT02795949|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5790018|NCT02795949|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5790019|NCT02795949|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5790020|NCT02795949|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5790021|NCT02795949|Renal Agents|renal agents|mesh-ancestor
5790022|NCT02795949|Antimalarials|antimalarials|mesh-ancestor
5790023|NCT02795949|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5790024|NCT02795949|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5790025|NCT02795949|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5790026|NCT02795949|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5790027|NCT02795949|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
5898924|NCT05122780|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5898925|NCT05122780|Adrenergic Agents|adrenergic agents|mesh-ancestor
5898926|NCT05122780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5898927|NCT05122780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898928|NCT05122780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898929|NCT05122780|Vasodilator Agents|vasodilator agents|mesh-ancestor
5898930|NCT05122780|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5898931|NCT05122780|Cholinergic Agents|cholinergic agents|mesh-ancestor
5898932|NCT05122767|Dolutegravir|dolutegravir|mesh-list
5898933|NCT05122767|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5898934|NCT05122767|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5898935|NCT05122767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5898936|NCT05122767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898937|NCT05122767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5898938|NCT05122767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5898939|NCT05122767|Antiviral Agents|antiviral agents|mesh-ancestor
5898940|NCT05122767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5898941|NCT05122741|Aspirin|aspirin|mesh-list
5898942|NCT05122741|Clopidogrel|clopidogrel|mesh-list
5898943|NCT05122741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5898944|NCT05122741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5898945|NCT05122741|Analgesics|analgesics|mesh-ancestor
5898946|NCT05122741|Sensory System Agents|sensory system agents|mesh-ancestor
5898947|NCT05122741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5898948|NCT05122741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790028|NCT02795884|Cisplatin|cisplatin|mesh-list
5790029|NCT02795884|Pemetrexed|pemetrexed|mesh-list
5790030|NCT02795884|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5790031|NCT02795884|Vinorelbine|vinorelbine|mesh-list
5790032|NCT02795884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5790033|NCT02795884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5790034|NCT02795884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790035|NCT02795884|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5790036|NCT02795884|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5790037|NCT02795884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5790038|NCT02795884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5790039|NCT02795884|Tubulin Modulators|tubulin modulators|mesh-ancestor
5790040|NCT02795884|Antimitotic Agents|antimitotic agents|mesh-ancestor
5790041|NCT02795884|Mitosis Modulators|mitosis modulators|mesh-ancestor
5790042|NCT02795572|Vitamin D|vitamin d|mesh-list
5790043|NCT02795572|Vitamins|vitamins|mesh-list
5790044|NCT02795572|Vitamin B 12|vitamin b 12|mesh-list
5790045|NCT02795572|Hydroxocobalamin|hydroxocobalamin|mesh-list
5790046|NCT02795572|Vitamin B 6|vitamin b 6|mesh-list
5790047|NCT02795572|Pyridoxal|pyridoxal|mesh-list
5790048|NCT02795572|Pyridoxine|pyridoxine|mesh-list
5790049|NCT02795572|Vitamin B Complex|vitamin b complex|mesh-list
5790050|NCT02795572|Micronutrients|micronutrients|mesh-ancestor
5790051|NCT02795572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790052|NCT02795572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5790053|NCT02795572|Hematinics|hematinics|mesh-ancestor
5790054|NCT02795858|Octreotide|octreotide|mesh-list
5790055|NCT02795858|Ramucirumab|ramucirumab|mesh-list
5790056|NCT02795858|Lanreotide|lanreotide|mesh-list
5790057|NCT02795858|Somatostatin|somatostatin|mesh-list
5790058|NCT02795858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5790059|NCT02795858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5790060|NCT02795858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5790061|NCT02795858|Hormones|hormones|mesh-ancestor
5790062|NCT02795858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5790063|NCT02795858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790064|NCT02795754|Ritonavir|ritonavir|mesh-list
5790065|NCT02795754|GSK-2838232|gsk-2838232|mesh-list
5790066|NCT02795754|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5790067|NCT02795754|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5790068|NCT02795754|Protease Inhibitors|protease inhibitors|mesh-ancestor
5790069|NCT02795754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5790070|NCT02795754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790071|NCT02795754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5790072|NCT02795754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5790073|NCT02795754|Antiviral Agents|antiviral agents|mesh-ancestor
5790074|NCT02795754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5790075|NCT02795754|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5790076|NCT02795754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5790077|NCT02795546|Alendronate|alendronate|mesh-list
5790078|NCT02795546|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5790079|NCT02795546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790080|NCT02795156|Afatinib|afatinib|mesh-list
5790081|NCT02795156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5790082|NCT02795156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5790083|NCT02795156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5790084|NCT02795156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790085|NCT02795299|Folic Acid|folic acid|mesh-list
5790086|NCT02795299|Methotrexate|methotrexate|mesh-list
5790087|NCT02795299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5790088|NCT02795299|Abortifacient Agents|abortifacient agents|mesh-ancestor
5790089|NCT02795299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5790090|NCT02795299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790091|NCT02795299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5790092|NCT02795299|Antimetabolites|antimetabolites|mesh-ancestor
5790093|NCT02795299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790094|NCT02795299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5790095|NCT02795299|Dermatologic Agents|dermatologic agents|mesh-ancestor
5790096|NCT02795299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5790097|NCT02795299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5790098|NCT02795299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5790099|NCT02795299|Immunologic Factors|immunologic factors|mesh-ancestor
5790100|NCT02795299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5790101|NCT02795299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5790102|NCT02795299|Hematinics|hematinics|mesh-ancestor
5790103|NCT02795299|Vitamin B Complex|vitamin b complex|mesh-ancestor
5790104|NCT02795299|Vitamins|vitamins|mesh-ancestor
5790105|NCT02795299|Micronutrients|micronutrients|mesh-ancestor
5790106|NCT02795143|Isotretinoin|isotretinoin|mesh-list
5790107|NCT02795143|Dermatologic Agents|dermatologic agents|mesh-ancestor
5790108|NCT02795429|Spartalizumab|spartalizumab|mesh-list
5790109|NCT02795429|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5790110|NCT02795429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790111|NCT02795429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5790112|NCT02795039|Fulvestrant|fulvestrant|mesh-list
5790113|NCT02795039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5790114|NCT02795039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5641123|NCT04165772|Capecitabine|capecitabine|mesh-list
5641124|NCT04165772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5641125|NCT04165772|Antimetabolites|antimetabolites|mesh-ancestor
5641126|NCT04165772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641127|NCT04165772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5641128|NCT04163952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5641129|NCT04163952|Panitumumab|panitumumab|mesh-list
5790115|NCT02795039|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5790116|NCT02795039|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5790117|NCT02795039|Hormone Antagonists|hormone antagonists|mesh-ancestor
5790118|NCT02795039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5790119|NCT02795039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790120|NCT02795182|Zanubrutinib|zanubrutinib|mesh-list
5790121|NCT02795182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5790122|NCT02795182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5790123|NCT02795182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5790124|NCT02795182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790125|NCT02794922|Vitamin B Complex|vitamin b complex|mesh-list
5790126|NCT02794922|Vitamins|vitamins|mesh-ancestor
5790127|NCT02794922|Micronutrients|micronutrients|mesh-ancestor
5790128|NCT02794922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790129|NCT02794896|Fentanyl|fentanyl|mesh-list
5790130|NCT02794896|Propofol|propofol|mesh-list
5790131|NCT02794896|Sevoflurane|sevoflurane|mesh-list
5790132|NCT02794896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5790133|NCT02794896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5790134|NCT02794896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790135|NCT02794896|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6491357|NCT00602173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6491358|NCT00602173|Respiratory System Agents|respiratory system agents|mesh-ancestor
6491359|NCT00602173|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6491360|NCT00602173|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6491361|NCT00602173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491362|NCT00602173|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6491363|NCT00602173|Vasodilator Agents|vasodilator agents|mesh-ancestor
6491364|NCT00602173|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6491365|NCT00602173|Protective Agents|protective agents|mesh-ancestor
6491366|NCT00602173|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6491367|NCT00602173|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6491368|NCT00602173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6491369|NCT00602186|Prazosin|prazosin|mesh-list
6491370|NCT00602186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6491371|NCT00602186|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6491372|NCT00602186|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6491373|NCT00602186|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6491374|NCT00602186|Adrenergic Agents|adrenergic agents|mesh-ancestor
6491375|NCT00602186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6491376|NCT00602186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491377|NCT00602186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491378|NCT00602251|Terbinafine|terbinafine|mesh-list
6491379|NCT00602251|Antifungal Agents|antifungal agents|mesh-ancestor
6491380|NCT00602251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6491381|NCT00602251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5641130|NCT04163952|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
5641131|NCT04163952|Antibodies|antibodies|mesh-list
5641132|NCT04163952|Immunoglobulins|immunoglobulins|mesh-list
6491382|NCT00602251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491383|NCT00602303|Torsemide|torsemide|mesh-list
6491384|NCT00602303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6491385|NCT00602303|Diuretics|diuretics|mesh-ancestor
6491386|NCT00602303|Natriuretic Agents|natriuretic agents|mesh-ancestor
6491387|NCT00602303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491388|NCT00602303|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6491389|NCT00602303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6491390|NCT00602303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491391|NCT00602316|Chelating Agents|chelating agents|mesh-list
6491392|NCT00602316|Sequestering Agents|sequestering agents|mesh-ancestor
6491393|NCT00602316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491394|NCT00602342|Terbinafine|terbinafine|mesh-list
6491395|NCT00602342|Antifungal Agents|antifungal agents|mesh-ancestor
6491396|NCT00602342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6491397|NCT00602342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5790136|NCT02794896|Anesthetics, General|anesthetics, general|mesh-ancestor
5790137|NCT02794896|Anesthetics|anesthetics|mesh-ancestor
5790138|NCT02794896|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5790139|NCT02794896|Narcotics|narcotics|mesh-ancestor
5790140|NCT02794896|Analgesics|analgesics|mesh-ancestor
5790141|NCT02794896|Sensory System Agents|sensory system agents|mesh-ancestor
5790142|NCT02794896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5790143|NCT02794896|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5790144|NCT02794896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5790145|NCT02794896|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5790146|NCT02794948|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
5790147|NCT02794948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5790148|NCT02794948|Immunologic Factors|immunologic factors|mesh-ancestor
5790149|NCT02794948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790150|NCT02795065|Enoxaparin|enoxaparin|mesh-list
5790151|NCT02795065|Bemiparin|bemiparin|mesh-list
5790152|NCT02795065|Anticoagulants|anticoagulants|mesh-ancestor
5790153|NCT02795065|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5790154|NCT02795065|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5790155|NCT02795065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790156|NCT02794883|Durvalumab|durvalumab|mesh-list
5790157|NCT02794883|Ipilimumab|ipilimumab|mesh-list
5790158|NCT02794883|Tremelimumab|tremelimumab|mesh-list
5790159|NCT02794883|Immunoglobulins|immunoglobulins|mesh-list
5790160|NCT02794883|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5790161|NCT02794883|Immunoglobulin G|immunoglobulin g|mesh-list
5790162|NCT02794883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5790163|NCT02794883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5790164|NCT02794883|Immunologic Factors|immunologic factors|mesh-ancestor
5790165|NCT02794883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790166|NCT02794883|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5790167|NCT02794883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790168|NCT02794792|Metformin|metformin|mesh-list
5790169|NCT02794792|Ipragliflozin|ipragliflozin|mesh-list
5790170|NCT02794792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5790171|NCT02794792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790172|NCT02794792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5790173|NCT02794792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790174|NCT02794779|Oxytocin|oxytocin|mesh-list
5790175|NCT02794779|Oxytocics|oxytocics|mesh-ancestor
5790176|NCT02794779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5790177|NCT02794779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491398|NCT00602342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491399|NCT00602381|Lithium Carbonate|lithium carbonate|mesh-list
6491400|NCT00602381|Antidepressive Agents|antidepressive agents|mesh-ancestor
5790178|NCT02794714|Rocuronium|rocuronium|mesh-list
5790179|NCT02794714|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5790180|NCT02794714|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5790181|NCT02794714|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5790182|NCT02794714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5790183|NCT02794714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790184|NCT02794571|Paclitaxel|paclitaxel|mesh-list
5790185|NCT02794571|Etoposide|etoposide|mesh-list
5790186|NCT02794571|Bevacizumab|bevacizumab|mesh-list
5790187|NCT02794571|Carboplatin|carboplatin|mesh-list
5790188|NCT02794571|Pembrolizumab|pembrolizumab|mesh-list
5790189|NCT02794571|Capecitabine|capecitabine|mesh-list
5790190|NCT02794571|Pemetrexed|pemetrexed|mesh-list
5790191|NCT02794571|Atezolizumab|atezolizumab|mesh-list
5790192|NCT02794571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5790193|NCT02794571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6491401|NCT00602381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5790194|NCT02794571|Tubulin Modulators|tubulin modulators|mesh-ancestor
5790195|NCT02794571|Antimitotic Agents|antimitotic agents|mesh-ancestor
5790196|NCT02794571|Mitosis Modulators|mitosis modulators|mesh-ancestor
5790197|NCT02794571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790198|NCT02794571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5790199|NCT02794571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5790200|NCT02794571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5790201|NCT02794571|Growth Substances|growth substances|mesh-ancestor
5790202|NCT02794571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790203|NCT02794571|Growth Inhibitors|growth inhibitors|mesh-ancestor
5790204|NCT02794571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5790205|NCT02794571|Antimetabolites|antimetabolites|mesh-ancestor
5790206|NCT02794571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5790207|NCT02794571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5790208|NCT02794571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5790209|NCT02794571|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5790210|NCT02794571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5790211|NCT02794610|Tacrolimus|tacrolimus|mesh-list
5790212|NCT02794610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5790213|NCT02794610|Immunologic Factors|immunologic factors|mesh-ancestor
5790214|NCT02794610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790215|NCT02794610|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5790216|NCT02794610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5790217|NCT02794610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790218|NCT02794402|Exenatide|exenatide|mesh-list
5790219|NCT02794402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5790220|NCT02794402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790221|NCT02794402|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5790222|NCT02794402|Incretins|incretins|mesh-ancestor
5790223|NCT02794402|Hormones|hormones|mesh-ancestor
5790224|NCT02794402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5790225|NCT02794428|Eflornithine|eflornithine|mesh-list
5790226|NCT02794428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5790227|NCT02794428|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5790228|NCT02794428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5790229|NCT02794428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5790230|NCT02794428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5790231|NCT02794428|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
5790232|NCT02794428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5790233|NCT02794428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790234|NCT02794506|Propolis|propolis|mesh-list
5790235|NCT02794506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5790236|NCT02794584|Sufentanil|sufentanil|mesh-list
5790237|NCT02794584|Dsuvia|dsuvia|mesh-list
5790238|NCT02794584|Anesthetics|anesthetics|mesh-ancestor
5790239|NCT02794584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5790240|NCT02794584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790241|NCT02794584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5790242|NCT02794584|Narcotics|narcotics|mesh-ancestor
5790243|NCT02794584|Analgesics|analgesics|mesh-ancestor
5790244|NCT02794584|Sensory System Agents|sensory system agents|mesh-ancestor
5790245|NCT02794584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5790246|NCT02794584|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5790247|NCT02794584|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5790248|NCT02794584|Anesthetics, General|anesthetics, general|mesh-ancestor
5898949|NCT05122741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5898950|NCT05122741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5898951|NCT05122741|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5898952|NCT05122741|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5898953|NCT05122741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898954|NCT05122741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5898955|NCT05122741|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5898956|NCT05122741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5898957|NCT05122741|Antipyretics|antipyretics|mesh-ancestor
5898958|NCT05122741|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5898959|NCT05122741|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5898960|NCT05122741|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5898961|NCT05122741|Purinergic Agents|purinergic agents|mesh-ancestor
5898962|NCT05122741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5898963|NCT05122598|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
5898964|NCT05122598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491402|NCT00602381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5898965|NCT05115773|Anesthetics|anesthetics|mesh-list
5898966|NCT05115773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5790249|NCT02794389|Acetylcysteine|acetylcysteine|mesh-list
5790250|NCT02794389|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5790251|NCT02794389|Antiviral Agents|antiviral agents|mesh-ancestor
5790252|NCT02794389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5790253|NCT02794389|Expectorants|expectorants|mesh-ancestor
5790254|NCT02794389|Respiratory System Agents|respiratory system agents|mesh-ancestor
5790255|NCT02794389|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5790256|NCT02794389|Antioxidants|antioxidants|mesh-ancestor
5790257|NCT02794389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790258|NCT02794389|Protective Agents|protective agents|mesh-ancestor
5790259|NCT02794389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790260|NCT02794389|Antidotes|antidotes|mesh-ancestor
5790261|NCT02794077|Cyclophosphamide|cyclophosphamide|mesh-list
5790262|NCT02794077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5790263|NCT02794077|Immunologic Factors|immunologic factors|mesh-ancestor
5790264|NCT02794077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790265|NCT02794077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5790266|NCT02794077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5790267|NCT02794077|Alkylating Agents|alkylating agents|mesh-ancestor
5790268|NCT02794077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790269|NCT02794077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5790270|NCT02794077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5790271|NCT02794337|Sorafenib|sorafenib|mesh-list
5790272|NCT02794337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5790273|NCT02794337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5790274|NCT02794337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5790275|NCT02794337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790276|NCT02793986|Dexmedetomidine|dexmedetomidine|mesh-list
5790277|NCT02793986|Propofol|propofol|mesh-list
5790278|NCT02793986|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5790279|NCT02793986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5790280|NCT02793986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790281|NCT02793986|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5790282|NCT02793986|Anesthetics, General|anesthetics, general|mesh-ancestor
5790283|NCT02793986|Anesthetics|anesthetics|mesh-ancestor
5790284|NCT02793986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5790285|NCT02793986|Analgesics|analgesics|mesh-ancestor
5790286|NCT02793986|Sensory System Agents|sensory system agents|mesh-ancestor
5790287|NCT02793986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5790288|NCT02793986|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5790289|NCT02793986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5790290|NCT02793986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5790291|NCT02793986|Adrenergic Agents|adrenergic agents|mesh-ancestor
5790292|NCT02793986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5790293|NCT02793986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790294|NCT02794025|Esmolol|esmolol|mesh-list
5790295|NCT02794025|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5790296|NCT02794025|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5790297|NCT02794025|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5790298|NCT02794025|Adrenergic Agents|adrenergic agents|mesh-ancestor
5790299|NCT02794025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5790300|NCT02794025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790301|NCT02794025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790302|NCT02794220|Nicotine|nicotine|mesh-list
5790303|NCT02794220|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5790304|NCT02794220|Autonomic Agents|autonomic agents|mesh-ancestor
5790305|NCT02794220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5790306|NCT02794220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790307|NCT02794220|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5790308|NCT02794220|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5790309|NCT02794220|Cholinergic Agents|cholinergic agents|mesh-ancestor
5790310|NCT02794220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5790311|NCT02794220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790312|NCT02794155|Insulin|insulin|mesh-list
6491403|NCT00602381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491404|NCT00602381|Antimanic Agents|antimanic agents|mesh-ancestor
6491405|NCT00602381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6491406|NCT00602381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5790313|NCT02794155|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5790314|NCT02794155|Insulin Lispro|insulin lispro|mesh-list
5790315|NCT02794155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5790316|NCT02794155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790317|NCT02793843|Dexamethasone|dexamethasone|mesh-list
5790318|NCT02793843|Ondansetron|ondansetron|mesh-list
6491407|NCT00602381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790319|NCT02793843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5790320|NCT02793843|Antiemetics|antiemetics|mesh-ancestor
5790321|NCT02793843|Autonomic Agents|autonomic agents|mesh-ancestor
5790322|NCT02793843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5790323|NCT02793843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790324|NCT02793843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5790325|NCT02793843|Glucocorticoids|glucocorticoids|mesh-ancestor
5790326|NCT02793843|Hormones|hormones|mesh-ancestor
5790327|NCT02793843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5790328|NCT02793843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5790329|NCT02793843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5790330|NCT02793843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5790331|NCT02793843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790332|NCT02793843|Antipruritics|antipruritics|mesh-ancestor
5790333|NCT02793843|Dermatologic Agents|dermatologic agents|mesh-ancestor
5790334|NCT02793843|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5790335|NCT02793843|Serotonin Agents|serotonin agents|mesh-ancestor
5790336|NCT02793843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5790337|NCT02793843|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5790338|NCT02793843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5790339|NCT02793843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5790340|NCT02793843|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5790341|NCT02793908|Progesterone|progesterone|mesh-list
5790342|NCT02793908|Progestins|progestins|mesh-ancestor
5790343|NCT02793908|Hormones|hormones|mesh-ancestor
5790344|NCT02793908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5790345|NCT02793908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790346|NCT02793687|Emoxypine succinate|emoxypine succinate|mesh-list
5790347|NCT02793687|Antioxidants|antioxidants|mesh-ancestor
5790348|NCT02793687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790349|NCT02793687|Protective Agents|protective agents|mesh-ancestor
5790350|NCT02793687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790351|NCT02793687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5790352|NCT02793687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5790353|NCT02793765|Docetaxel|docetaxel|mesh-list
5790354|NCT02793765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5790355|NCT02793765|Tubulin Modulators|tubulin modulators|mesh-ancestor
5790356|NCT02793765|Antimitotic Agents|antimitotic agents|mesh-ancestor
5790357|NCT02793765|Mitosis Modulators|mitosis modulators|mesh-ancestor
5790358|NCT02793765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790359|NCT02793544|Mycophenolic Acid|mycophenolic acid|mesh-list
5790360|NCT02793544|Sirolimus|sirolimus|mesh-list
5790361|NCT02793544|Cyclophosphamide|cyclophosphamide|mesh-list
5790362|NCT02793544|Busulfan|busulfan|mesh-list
5790363|NCT02793544|Fludarabine|fludarabine|mesh-list
5790364|NCT02793544|Mesna|mesna|mesh-list
5790365|NCT02793544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5790366|NCT02793544|Immunologic Factors|immunologic factors|mesh-ancestor
5790367|NCT02793544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790368|NCT02793544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5790369|NCT02793544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5790370|NCT02793544|Alkylating Agents|alkylating agents|mesh-ancestor
5790371|NCT02793544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790372|NCT02793544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5790373|NCT02793544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5790374|NCT02793544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5790375|NCT02793544|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5790376|NCT02793544|Antitubercular Agents|antitubercular agents|mesh-ancestor
5790377|NCT02793544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5790378|NCT02793544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5790379|NCT02793544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5790380|NCT02793544|Antifungal Agents|antifungal agents|mesh-ancestor
5790381|NCT02793544|Protective Agents|protective agents|mesh-ancestor
5790382|NCT02793388|Primaquine|primaquine|mesh-list
5790383|NCT02793388|Antimalarials|antimalarials|mesh-ancestor
5790384|NCT02793388|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5790385|NCT02793388|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5790386|NCT02793388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5790387|NCT02793648|Vitamins|vitamins|mesh-list
5790388|NCT02793648|Ascorbic Acid|ascorbic acid|mesh-list
5790389|NCT02793648|Vitamin E|vitamin e|mesh-list
5790390|NCT02793648|Tocopherols|tocopherols|mesh-list
5790391|NCT02793648|alpha-Tocopherol|alpha-tocopherol|mesh-list
5790392|NCT02793648|Micronutrients|micronutrients|mesh-ancestor
5790393|NCT02793648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790394|NCT02793648|Antioxidants|antioxidants|mesh-ancestor
5790395|NCT02793648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790396|NCT02793648|Protective Agents|protective agents|mesh-ancestor
5790397|NCT02793739|Hyaluronic Acid|hyaluronic acid|mesh-list
5790398|NCT02793739|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5790399|NCT02793739|Immunologic Factors|immunologic factors|mesh-ancestor
5790400|NCT02793739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790401|NCT02793739|Viscosupplements|viscosupplements|mesh-ancestor
5790402|NCT02793739|Protective Agents|protective agents|mesh-ancestor
5790403|NCT02793323|Anesthetics|anesthetics|mesh-list
5790404|NCT02793323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5790405|NCT02793323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790406|NCT02793375|Montelukast|montelukast|mesh-list
5790407|NCT02793375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5790408|NCT02793375|Respiratory System Agents|respiratory system agents|mesh-ancestor
5790409|NCT02793375|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5790410|NCT02793375|Hormone Antagonists|hormone antagonists|mesh-ancestor
5790411|NCT02793375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5790412|NCT02793375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790413|NCT02793375|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5790414|NCT02793375|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5790415|NCT02793375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790416|NCT02793440|Cortivazol|cortivazol|mesh-list
5790417|NCT02793440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5790418|NCT02793505|Metformin|metformin|mesh-list
5790419|NCT02793505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5790420|NCT02793505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790421|NCT02793193|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5790422|NCT02793193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5790423|NCT02793193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5790424|NCT02793193|Antitubercular Agents|antitubercular agents|mesh-ancestor
5790425|NCT02793466|Durvalumab|durvalumab|mesh-list
5790426|NCT02793466|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5790427|NCT02793466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5790428|NCT02793466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5790429|NCT02793466|Immunologic Factors|immunologic factors|mesh-ancestor
5790430|NCT02793466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790431|NCT02793219|Docetaxel|docetaxel|mesh-list
5790432|NCT02793219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5790433|NCT02793219|Tubulin Modulators|tubulin modulators|mesh-ancestor
5790434|NCT02793219|Antimitotic Agents|antimitotic agents|mesh-ancestor
5790435|NCT02793219|Mitosis Modulators|mitosis modulators|mesh-ancestor
5790436|NCT02793219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790437|NCT02793050|Trabectedin|trabectedin|mesh-list
5790438|NCT02793050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5790439|NCT02793050|Alkylating Agents|alkylating agents|mesh-ancestor
5790440|NCT02793050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790441|NCT02793050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5790442|NCT02793011|Dexamethasone|dexamethasone|mesh-list
5790443|NCT02793011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5790444|NCT02793011|Antiemetics|antiemetics|mesh-ancestor
5790445|NCT02793011|Autonomic Agents|autonomic agents|mesh-ancestor
5790446|NCT02793011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5790447|NCT02793011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790448|NCT02793011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5790449|NCT02793011|Glucocorticoids|glucocorticoids|mesh-ancestor
5790450|NCT02793011|Hormones|hormones|mesh-ancestor
5790451|NCT02793011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5790452|NCT02793011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5790453|NCT02793011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5790454|NCT02792816|Artesunate|artesunate|mesh-list
5790455|NCT02792816|Artemether|artemether|mesh-list
5790456|NCT02792816|Piperaquine|piperaquine|mesh-list
5790457|NCT02792816|Artenimol|artenimol|mesh-list
5790458|NCT02792816|Mefloquine|mefloquine|mesh-list
5790459|NCT02792816|Antimalarials|antimalarials|mesh-list
5790460|NCT02792816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5790461|NCT02792816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5790462|NCT02792816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5790463|NCT02792816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5790464|NCT02792816|Antiviral Agents|antiviral agents|mesh-ancestor
5790465|NCT02792816|Schistosomicides|schistosomicides|mesh-ancestor
5790466|NCT02792816|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5790467|NCT02792816|Anthelmintics|anthelmintics|mesh-ancestor
5790468|NCT02792712|Clopidogrel|clopidogrel|mesh-list
5790469|NCT02792712|Ticagrelor|ticagrelor|mesh-list
5790470|NCT02792712|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5790471|NCT02792712|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6491408|NCT00602394|Lithium Carbonate|lithium carbonate|mesh-list
5790472|NCT02792712|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5790473|NCT02792712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5790474|NCT02792712|Purinergic Agents|purinergic agents|mesh-ancestor
5790475|NCT02792712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5790476|NCT02792712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790477|NCT02792712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898967|NCT05115773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898968|NCT05097326|Mifepristone|mifepristone|mesh-list
5898969|NCT05097326|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5898970|NCT05097326|Abortifacient Agents|abortifacient agents|mesh-ancestor
5898971|NCT05097326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5898972|NCT05097326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898973|NCT05097326|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5898974|NCT05097326|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5898975|NCT05097326|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5898976|NCT05097326|Contraceptive Agents|contraceptive agents|mesh-ancestor
5898977|NCT05097326|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5898978|NCT05097326|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5898979|NCT05097326|Hormone Antagonists|hormone antagonists|mesh-ancestor
5898980|NCT05097326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5898981|NCT05097326|Luteolytic Agents|luteolytic agents|mesh-ancestor
5898982|NCT05097326|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5898983|NCT05097326|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5898984|NCT05089630|Vaccines|vaccines|mesh-list
5898985|NCT05089630|Immunologic Factors|immunologic factors|mesh-ancestor
5898986|NCT05089630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898987|NCT05084404|Guanabenz|guanabenz|mesh-list
5898988|NCT05084404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5898989|NCT05084404|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5898990|NCT05084404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5898991|NCT05084404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5898992|NCT05084404|Adrenergic Agents|adrenergic agents|mesh-ancestor
5898993|NCT05084404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5898994|NCT05084404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5898995|NCT05084404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5898996|NCT05081492|Antibodies|antibodies|mesh-list
5898997|NCT05081492|Immunoglobulins|immunoglobulins|mesh-list
5898998|NCT05081492|Immunologic Factors|immunologic factors|mesh-ancestor
5898999|NCT05081492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899000|NCT05073718|Aspirin|aspirin|mesh-list
5899001|NCT05073718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5899002|NCT05073718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5899003|NCT05073718|Analgesics|analgesics|mesh-ancestor
5899004|NCT05073718|Sensory System Agents|sensory system agents|mesh-ancestor
5899005|NCT05073718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5899006|NCT05073718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899007|NCT05073718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5899008|NCT05073718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5899009|NCT05073718|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5899010|NCT05073718|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5899011|NCT05073718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899012|NCT05073718|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5899013|NCT05073718|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5899014|NCT05073718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5899015|NCT05073718|Antipyretics|antipyretics|mesh-ancestor
5899016|NCT05069974|Linezolid|linezolid|mesh-list
5899017|NCT05069974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5899018|NCT05069974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5899019|NCT05069974|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5899020|NCT05069974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5899021|NCT05069974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908134|NCT04902625|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5908135|NCT04902625|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5908136|NCT04902625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5908140|NCT04884360|Olaparib|olaparib|mesh-list
5908141|NCT04884360|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5908142|NCT04884360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5908143|NCT04884360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908144|NCT04884360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5790478|NCT02792491|Prednisone|prednisone|mesh-list
5790479|NCT02792491|Cyclophosphamide|cyclophosphamide|mesh-list
5790480|NCT02792491|Rituximab|rituximab|mesh-list
5790481|NCT02792491|Doxorubicin|doxorubicin|mesh-list
5790482|NCT02792491|Vincristine|vincristine|mesh-list
5790483|NCT02792491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5790484|NCT02792491|Immunologic Factors|immunologic factors|mesh-ancestor
5790485|NCT02792491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790486|NCT02792491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5790487|NCT02792491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5790488|NCT02792491|Alkylating Agents|alkylating agents|mesh-ancestor
5790489|NCT02792491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790490|NCT02792491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5790491|NCT02792491|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5790492|NCT02792491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5790493|NCT02792491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5790494|NCT02792491|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5790495|NCT02792491|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5790496|NCT02792491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5790497|NCT02792491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5790498|NCT02792491|Glucocorticoids|glucocorticoids|mesh-ancestor
5790499|NCT02792491|Hormones|hormones|mesh-ancestor
5790500|NCT02792491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5790501|NCT02792491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5790502|NCT02792491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5790503|NCT02792491|Tubulin Modulators|tubulin modulators|mesh-ancestor
5790504|NCT02792491|Antimitotic Agents|antimitotic agents|mesh-ancestor
5790505|NCT02792491|Mitosis Modulators|mitosis modulators|mesh-ancestor
5790506|NCT02792803|Latanoprost|latanoprost|mesh-list
5790507|NCT02792803|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5790508|NCT02792803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5790509|NCT02792673|Hyaluronic Acid|hyaluronic acid|mesh-list
5790510|NCT02792673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5790511|NCT02792673|Immunologic Factors|immunologic factors|mesh-ancestor
5790512|NCT02792673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790513|NCT02792673|Viscosupplements|viscosupplements|mesh-ancestor
5790514|NCT02792673|Protective Agents|protective agents|mesh-ancestor
5790515|NCT02792413|Denosumab|denosumab|mesh-list
5790516|NCT02792413|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5790517|NCT02792413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790518|NCT02792621|Acipimox|acipimox|mesh-list
5790519|NCT02792621|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5790520|NCT02792621|Antimetabolites|antimetabolites|mesh-ancestor
5790521|NCT02792621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790522|NCT02792621|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5790523|NCT02792426|Nicotine|nicotine|mesh-list
5790524|NCT02792426|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5790525|NCT02792426|Autonomic Agents|autonomic agents|mesh-ancestor
5790526|NCT02792426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5790527|NCT02792426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790528|NCT02792426|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5790529|NCT02792426|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5790530|NCT02792426|Cholinergic Agents|cholinergic agents|mesh-ancestor
5790531|NCT02792426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5790532|NCT02792426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790533|NCT02792465|Fulvestrant|fulvestrant|mesh-list
5790534|NCT02792465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5790535|NCT02792465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5790536|NCT02792465|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5790537|NCT02792465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5790538|NCT02792465|Hormone Antagonists|hormone antagonists|mesh-ancestor
5790539|NCT02792465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5790540|NCT02792465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790541|NCT02792400|Empagliflozin|empagliflozin|mesh-list
5790542|NCT02792400|Linagliptin|linagliptin|mesh-list
5790543|NCT02792400|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5790544|NCT02792400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790545|NCT02792400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5790546|NCT02792400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790547|NCT02792400|Incretins|incretins|mesh-ancestor
5790548|NCT02792400|Hormones|hormones|mesh-ancestor
5790549|NCT02792400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5790550|NCT02792400|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5790551|NCT02792400|Protease Inhibitors|protease inhibitors|mesh-ancestor
5790552|NCT02792400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5790553|NCT02792335|Warfarin|warfarin|mesh-list
5790554|NCT02792335|Rivaroxaban|rivaroxaban|mesh-list
5790555|NCT02792335|Dabigatran|dabigatran|mesh-list
5790556|NCT02792335|Apixaban|apixaban|mesh-list
5790557|NCT02792335|Anticoagulants|anticoagulants|mesh-ancestor
5790558|NCT02792335|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5790559|NCT02792335|Antithrombins|antithrombins|mesh-ancestor
5790560|NCT02792335|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5790561|NCT02792335|Protease Inhibitors|protease inhibitors|mesh-ancestor
5790562|NCT02792335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5790563|NCT02792335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790564|NCT02792114|Cyclophosphamide|cyclophosphamide|mesh-list
5790565|NCT02792114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5790566|NCT02792114|Immunologic Factors|immunologic factors|mesh-ancestor
5790567|NCT02792114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790568|NCT02792114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5790569|NCT02792114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5790570|NCT02792114|Alkylating Agents|alkylating agents|mesh-ancestor
5790571|NCT02792114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790572|NCT02792114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5790573|NCT02792114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5790574|NCT02792088|Tenofovir|tenofovir|mesh-list
5790575|NCT02792088|Antiviral Agents|antiviral agents|mesh-ancestor
5790576|NCT02792088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5790577|NCT02792088|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5790578|NCT02792088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5790579|NCT02792088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5790580|NCT02792088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790581|NCT02792088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5790582|NCT02792088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5790583|NCT02792036|Carboplatin|carboplatin|mesh-list
5790584|NCT02792036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5790585|NCT02792153|Estradiol|estradiol|mesh-list
5790586|NCT02792153|Estrogens|estrogens|mesh-ancestor
5790587|NCT02792153|Hormones|hormones|mesh-ancestor
5790588|NCT02792153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5790589|NCT02792153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790590|NCT02792257|Dronabinol|dronabinol|mesh-list
5790591|NCT02792257|Hallucinogens|hallucinogens|mesh-ancestor
5790592|NCT02792257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790593|NCT02792257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5790594|NCT02792257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5790595|NCT02792257|Analgesics|analgesics|mesh-ancestor
5790596|NCT02792257|Sensory System Agents|sensory system agents|mesh-ancestor
5790597|NCT02792257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5790598|NCT02792257|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5790599|NCT02792257|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5790600|NCT02792257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5790601|NCT02792257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790602|NCT02792257|Hormones|hormones|mesh-ancestor
5790603|NCT02792257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5790604|NCT02791958|Ramipril|ramipril|mesh-list
5790605|NCT02791958|Atorvastatin|atorvastatin|mesh-list
5790606|NCT02791958|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5790607|NCT02791958|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5790608|NCT02791958|Antimetabolites|antimetabolites|mesh-ancestor
5790609|NCT02791958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790610|NCT02791958|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5790611|NCT02791958|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5790612|NCT02791958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5790613|NCT02791958|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5790614|NCT02791958|Protease Inhibitors|protease inhibitors|mesh-ancestor
5790615|NCT02791958|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5790616|NCT02792140|Naltrexone|naltrexone|mesh-list
5790617|NCT02792140|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5790618|NCT02792140|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5790619|NCT02792140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790620|NCT02792140|Sensory System Agents|sensory system agents|mesh-ancestor
5790621|NCT02792140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5790622|NCT02791919|Cytarabine|cytarabine|mesh-list
5790623|NCT02791919|Fludarabine|fludarabine|mesh-list
5790624|NCT02791919|Fludarabine phosphate|fludarabine phosphate|mesh-list
5790625|NCT02791919|Lenograstim|lenograstim|mesh-list
5790626|NCT02791919|Sargramostim|sargramostim|mesh-list
5790627|NCT02791919|Adavosertib|adavosertib|mesh-list
5899022|NCT05062031|Atropine|atropine|mesh-list
5790628|NCT02791919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5790629|NCT02791919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5790630|NCT02791919|Antimetabolites|antimetabolites|mesh-ancestor
5790631|NCT02791919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790632|NCT02791919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5790633|NCT02791919|Immunologic Factors|immunologic factors|mesh-ancestor
5790634|NCT02791919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790635|NCT02791919|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5790636|NCT02791919|Antiviral Agents|antiviral agents|mesh-ancestor
5790637|NCT02791919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5790638|NCT02791919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5790639|NCT02791737|Coal Tar|coal tar|mesh-list
5790640|NCT02791737|Keratolytic Agents|keratolytic agents|mesh-ancestor
5790641|NCT02791737|Dermatologic Agents|dermatologic agents|mesh-ancestor
5790642|NCT02791815|Selexipag|selexipag|mesh-list
5790643|NCT02791815|Midazolam|midazolam|mesh-list
5790644|NCT02791815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5790645|NCT02791815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5790646|NCT02791815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5790647|NCT02791815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790648|NCT02791815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5790649|NCT02791815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5790650|NCT02791815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5790651|NCT02791815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6491409|NCT00602394|Antidepressive Agents|antidepressive agents|mesh-ancestor
6491410|NCT00602394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6491411|NCT00602394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6491412|NCT00602394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491413|NCT00602394|Antimanic Agents|antimanic agents|mesh-ancestor
6491414|NCT00602394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6491415|NCT00602394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6491416|NCT00602394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491417|NCT00602407|Cilostazol|cilostazol|mesh-list
6491418|NCT00602407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6491419|NCT00602407|Autonomic Agents|autonomic agents|mesh-ancestor
5790652|NCT02791815|Anesthetics, General|anesthetics, general|mesh-ancestor
5790653|NCT02791815|Anesthetics|anesthetics|mesh-ancestor
5790654|NCT02791815|GABA Modulators|gaba modulators|mesh-ancestor
5790655|NCT02791815|GABA Agents|gaba agents|mesh-ancestor
5790656|NCT02791815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5790657|NCT02791815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790658|NCT02791815|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5790659|NCT02791594|Pembrolizumab|pembrolizumab|mesh-list
5790660|NCT02791594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5790661|NCT02791594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5790662|NCT02791243|Finasteride|finasteride|mesh-list
5790663|NCT02791243|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
5790664|NCT02791243|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5790665|NCT02791243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5790666|NCT02791243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790667|NCT02791243|Hormone Antagonists|hormone antagonists|mesh-ancestor
5790668|NCT02791243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5790669|NCT02791243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790670|NCT02791243|Urological Agents|urological agents|mesh-ancestor
5790671|NCT02791334|Ramucirumab|ramucirumab|mesh-list
5790672|NCT02791334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5899023|NCT05062031|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5899024|NCT05062031|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5899025|NCT05062031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5899026|NCT05062031|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5899027|NCT05062031|Autonomic Agents|autonomic agents|mesh-ancestor
5899028|NCT05062031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5899029|NCT05062031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899030|NCT05062031|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5899031|NCT05062031|Respiratory System Agents|respiratory system agents|mesh-ancestor
5899032|NCT05062031|Mydriatics|mydriatics|mesh-ancestor
5899033|NCT05062031|Parasympatholytics|parasympatholytics|mesh-ancestor
5899034|NCT05062031|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5899035|NCT05062031|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5899036|NCT05062031|Cholinergic Agents|cholinergic agents|mesh-ancestor
5899037|NCT05062031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5899038|NCT05062031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899039|NCT05062031|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5899040|NCT05052099|Bevacizumab|bevacizumab|mesh-list
6491420|NCT00602407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5790673|NCT02791373|Gemcitabine|gemcitabine|mesh-list
5790674|NCT02791373|Vinorelbine|vinorelbine|mesh-list
5790675|NCT02791373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5790676|NCT02791373|Antimetabolites|antimetabolites|mesh-ancestor
5790677|NCT02791373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790678|NCT02791373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5790679|NCT02791373|Antiviral Agents|antiviral agents|mesh-ancestor
5790680|NCT02791373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5790681|NCT02791373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5790682|NCT02791373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5790683|NCT02791373|Immunologic Factors|immunologic factors|mesh-ancestor
5790684|NCT02791373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790685|NCT02791373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5790686|NCT02791373|Tubulin Modulators|tubulin modulators|mesh-ancestor
5790687|NCT02791373|Antimitotic Agents|antimitotic agents|mesh-ancestor
5790688|NCT02791373|Mitosis Modulators|mitosis modulators|mesh-ancestor
5790689|NCT02791256|Ribavirin|ribavirin|mesh-list
5790690|NCT02791256|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5790691|NCT02791256|Antimetabolites|antimetabolites|mesh-ancestor
5790692|NCT02791256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790693|NCT02791256|Antiviral Agents|antiviral agents|mesh-ancestor
5790694|NCT02791256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5790695|NCT02790853|Proflavine|proflavine|mesh-list
5790696|NCT02790853|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5790697|NCT02790853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5790698|NCT02790957|Plerixafor|plerixafor|mesh-list
5790699|NCT02790957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5790700|NCT02790957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5790701|NCT02790957|Antiviral Agents|antiviral agents|mesh-ancestor
5790702|NCT02790957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5790703|NCT02790996|Vancomycin|vancomycin|mesh-list
5790704|NCT02790996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5790705|NCT02790996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5790706|NCT02790775|Bevacizumab|bevacizumab|mesh-list
5790707|NCT02790775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5790708|NCT02790775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5790709|NCT02790775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5790710|NCT02790775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5790711|NCT02790775|Growth Substances|growth substances|mesh-ancestor
5790712|NCT02790775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790713|NCT02790775|Growth Inhibitors|growth inhibitors|mesh-ancestor
5790714|NCT02791035|Ipragliflozin|ipragliflozin|mesh-list
5790715|NCT02791035|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5790716|NCT02791035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790717|NCT02791035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5790718|NCT02791035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790719|NCT02790840|Omeprazole|omeprazole|mesh-list
5790720|NCT02790840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5790721|NCT02790840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5790722|NCT02790840|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5790723|NCT02790840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5790724|NCT02790840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790725|NCT02790710|Propranolol|propranolol|mesh-list
5790726|NCT02790710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5790727|NCT02790710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5790728|NCT02790710|Adrenergic Agents|adrenergic agents|mesh-ancestor
5790729|NCT02790710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5790730|NCT02790710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790731|NCT02790710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790732|NCT02790710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5790733|NCT02790710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5790734|NCT02790710|Vasodilator Agents|vasodilator agents|mesh-ancestor
5790735|NCT02790684|Firuglipel|firuglipel|mesh-list
5790736|NCT02790684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5790737|NCT02790684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790738|NCT02790671|Firuglipel|firuglipel|mesh-list
5790739|NCT02790671|Itraconazole|itraconazole|mesh-list
5790740|NCT02790671|Antifungal Agents|antifungal agents|mesh-ancestor
5790741|NCT02790671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5790742|NCT02790671|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5790743|NCT02790671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5790744|NCT02790671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5790745|NCT02790671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790746|NCT02790671|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5790747|NCT02790671|Hormone Antagonists|hormone antagonists|mesh-ancestor
5899041|NCT05052099|Atezolizumab|atezolizumab|mesh-list
5790748|NCT02790671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5790749|NCT02790671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790750|NCT02790671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5790751|NCT02790671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5790752|NCT02790580|Cyclophosphamide|cyclophosphamide|mesh-list
5790753|NCT02790580|Doxorubicin|doxorubicin|mesh-list
5790754|NCT02790580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5790755|NCT02790580|Sunitinib|sunitinib|mesh-list
5790756|NCT02790580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5790757|NCT02790580|Immunologic Factors|immunologic factors|mesh-ancestor
5790758|NCT02790580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790759|NCT02790580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5790760|NCT02790580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5790761|NCT02790580|Alkylating Agents|alkylating agents|mesh-ancestor
5790762|NCT02790580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790763|NCT02790580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5790764|NCT02790580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5790765|NCT02790580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5790766|NCT02790580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5790767|NCT02790580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5790768|NCT02790580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5790769|NCT02790580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5790770|NCT02790580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5790771|NCT02790580|Growth Substances|growth substances|mesh-ancestor
5790772|NCT02790580|Growth Inhibitors|growth inhibitors|mesh-ancestor
5790773|NCT02790580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5790774|NCT02790450|Benzbromarone|benzbromarone|mesh-list
5790775|NCT02790450|Uricosuric Agents|uricosuric agents|mesh-ancestor
5790776|NCT02790450|Gout Suppressants|gout suppressants|mesh-ancestor
5790777|NCT02790450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5790778|NCT02790450|Renal Agents|renal agents|mesh-ancestor
5790779|NCT02790632|Nimodipine|nimodipine|mesh-list
5790780|NCT02790632|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5790781|NCT02790632|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5790782|NCT02790632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5790783|NCT02790632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790784|NCT02790632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5790785|NCT02790632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790786|NCT02790632|Vasodilator Agents|vasodilator agents|mesh-ancestor
5790787|NCT02790528|Atorvastatin|atorvastatin|mesh-list
5790788|NCT02790528|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5790789|NCT02790528|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5790790|NCT02790528|Antimetabolites|antimetabolites|mesh-ancestor
5790791|NCT02790528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790792|NCT02790528|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5790793|NCT02790528|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5790794|NCT02790528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5790795|NCT02790099|Morphine|morphine|mesh-list
5790796|NCT02790099|Bupivacaine|bupivacaine|mesh-list
5790797|NCT02790099|Anesthetics, Local|anesthetics, local|mesh-ancestor
5790798|NCT02790099|Anesthetics|anesthetics|mesh-ancestor
5790799|NCT02790099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5790800|NCT02790099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790801|NCT02790099|Sensory System Agents|sensory system agents|mesh-ancestor
5790802|NCT02790099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5790803|NCT02790099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5790804|NCT02790099|Narcotics|narcotics|mesh-ancestor
5790805|NCT02790099|Analgesics|analgesics|mesh-ancestor
5790806|NCT02790203|Celecoxib|celecoxib|mesh-list
5790807|NCT02790203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5790808|NCT02790203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5790809|NCT02790203|Analgesics|analgesics|mesh-ancestor
5790810|NCT02790203|Sensory System Agents|sensory system agents|mesh-ancestor
5790811|NCT02790203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5790812|NCT02790203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790813|NCT02790203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5790814|NCT02790203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5790815|NCT02790203|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5790816|NCT02790203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5790817|NCT02790203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5790818|NCT02790203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790819|NCT02790177|Hyaluronic Acid|hyaluronic acid|mesh-list
5790820|NCT02790177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5790821|NCT02790177|Immunologic Factors|immunologic factors|mesh-ancestor
5790822|NCT02790177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790823|NCT02790177|Viscosupplements|viscosupplements|mesh-ancestor
5790824|NCT02790177|Protective Agents|protective agents|mesh-ancestor
5790825|NCT02790164|Rocuronium|rocuronium|mesh-list
5790826|NCT02790164|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5790827|NCT02790164|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5790828|NCT02790164|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5790829|NCT02790164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5790830|NCT02790164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790831|NCT02789969|Fentanyl|fentanyl|mesh-list
5790832|NCT02789969|Hydromorphone|hydromorphone|mesh-list
5790833|NCT02789969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5790834|NCT02789969|Narcotics|narcotics|mesh-ancestor
5790835|NCT02789969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5790836|NCT02789969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790837|NCT02789969|Analgesics|analgesics|mesh-ancestor
5790838|NCT02789969|Sensory System Agents|sensory system agents|mesh-ancestor
5790839|NCT02789969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5790840|NCT02789969|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5790841|NCT02789969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5790842|NCT02789969|Anesthetics, General|anesthetics, general|mesh-ancestor
5790843|NCT02789969|Anesthetics|anesthetics|mesh-ancestor
5790844|NCT02789982|Propranolol|propranolol|mesh-list
5790845|NCT02789982|Adrenergic Agents|adrenergic agents|mesh-list
5790846|NCT02789982|Adrenergic Antagonists|adrenergic antagonists|mesh-list
5790847|NCT02789982|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5790848|NCT02789982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5790849|NCT02789982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790850|NCT02789982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790851|NCT02789982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5790852|NCT02789982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5790853|NCT02789982|Vasodilator Agents|vasodilator agents|mesh-ancestor
5790854|NCT02789878|Prednisone|prednisone|mesh-list
5790855|NCT02789878|Goserelin|goserelin|mesh-list
5790856|NCT02789878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5790857|NCT02789878|Glucocorticoids|glucocorticoids|mesh-ancestor
5790858|NCT02789878|Hormones|hormones|mesh-ancestor
5790859|NCT02789878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5790860|NCT02789878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790861|NCT02789878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5790862|NCT02789878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5790863|NCT02789865|Metronidazole|metronidazole|mesh-list
5790864|NCT02789865|Levofloxacin|levofloxacin|mesh-list
5790865|NCT02789865|Ofloxacin|ofloxacin|mesh-list
5790866|NCT02789865|Ertapenem|ertapenem|mesh-list
5790867|NCT02789865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5790868|NCT02789865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5790869|NCT02789865|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5790870|NCT02789865|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5790871|NCT02789865|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5790872|NCT02789865|Renal Agents|renal agents|mesh-ancestor
5790873|NCT02789865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5790874|NCT02789865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5790875|NCT02789865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5790876|NCT02789865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790877|NCT02789865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5790878|NCT02789865|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5790879|NCT02789865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5790880|NCT02789930|Anesthetics|anesthetics|mesh-list
5790881|NCT02789930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5790882|NCT02789930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790883|NCT02789813|Valproic Acid|valproic acid|mesh-list
5790884|NCT02789813|Anticonvulsants|anticonvulsants|mesh-ancestor
5790885|NCT02789813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5790886|NCT02789813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790887|NCT02789813|GABA Agents|gaba agents|mesh-ancestor
5790888|NCT02789813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5790889|NCT02789813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790890|NCT02789813|Antimanic Agents|antimanic agents|mesh-ancestor
5790891|NCT02789813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5790892|NCT02789813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5790893|NCT02789813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5899042|NCT05052099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5899043|NCT05052099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5899044|NCT05052099|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5899045|NCT05052099|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5790894|NCT02789657|Paclitaxel|paclitaxel|mesh-list
5790895|NCT02789657|Carboplatin|carboplatin|mesh-list
5790896|NCT02789657|Trastuzumab|trastuzumab|mesh-list
5790897|NCT02789657|Pertuzumab|pertuzumab|mesh-list
5790898|NCT02789657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5790899|NCT02789657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5790900|NCT02789657|Tubulin Modulators|tubulin modulators|mesh-ancestor
5790901|NCT02789657|Antimitotic Agents|antimitotic agents|mesh-ancestor
5790902|NCT02789657|Mitosis Modulators|mitosis modulators|mesh-ancestor
5790903|NCT02789657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790904|NCT02789657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5790905|NCT02789592|Clonazepam|clonazepam|mesh-list
5790906|NCT02789592|Melatonin|melatonin|mesh-list
5790907|NCT02789592|Antioxidants|antioxidants|mesh-ancestor
5790908|NCT02789592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790909|NCT02789592|Protective Agents|protective agents|mesh-ancestor
5790910|NCT02789592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790911|NCT02789592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5790912|NCT02789592|Anticonvulsants|anticonvulsants|mesh-ancestor
5790913|NCT02789592|GABA Modulators|gaba modulators|mesh-ancestor
5790914|NCT02789592|GABA Agents|gaba agents|mesh-ancestor
5790915|NCT02789592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5790916|NCT02789501|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5790917|NCT02789644|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
5790918|NCT02789644|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5790919|NCT02789644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5790920|NCT02789579|Levofloxacin|levofloxacin|mesh-list
5790921|NCT02789579|Ofloxacin|ofloxacin|mesh-list
5790922|NCT02789579|Nitrofurantoin|nitrofurantoin|mesh-list
5790923|NCT02789579|Cefuroxime|cefuroxime|mesh-list
5790924|NCT02789579|Cefuroxime axetil|cefuroxime axetil|mesh-list
5790925|NCT02789579|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5790926|NCT02789579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5790927|NCT02789579|Renal Agents|renal agents|mesh-ancestor
5790928|NCT02789579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5790929|NCT02789579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5790930|NCT02789579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5790931|NCT02789579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5790932|NCT02789579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790933|NCT02789579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5790934|NCT02789579|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5790935|NCT02789579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5790936|NCT02789150|Norepinephrine|norepinephrine|mesh-list
5790937|NCT02789150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5790938|NCT02789150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5790939|NCT02789150|Adrenergic Agents|adrenergic agents|mesh-ancestor
5790940|NCT02789150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5790941|NCT02789150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790942|NCT02789150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790943|NCT02789150|Sympathomimetics|sympathomimetics|mesh-ancestor
5790944|NCT02789150|Autonomic Agents|autonomic agents|mesh-ancestor
5790945|NCT02789150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5790946|NCT02789150|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5790947|NCT02789358|Adenosine|adenosine|mesh-list
5790948|NCT02789358|Analgesics|analgesics|mesh-ancestor
5790949|NCT02789358|Sensory System Agents|sensory system agents|mesh-ancestor
5790950|NCT02789358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5790951|NCT02789358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790952|NCT02789358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5790953|NCT02789358|Vasodilator Agents|vasodilator agents|mesh-ancestor
5790954|NCT02789358|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5790955|NCT02789358|Purinergic Agonists|purinergic agonists|mesh-ancestor
5790956|NCT02789358|Purinergic Agents|purinergic agents|mesh-ancestor
5790957|NCT02789358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5790958|NCT02789358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790959|NCT02789475|Amlodipine|amlodipine|mesh-list
5790960|NCT02789475|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5790961|NCT02789475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5790962|NCT02789475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5790963|NCT02789475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5790964|NCT02789475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790965|NCT02789475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5790966|NCT02789475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790967|NCT02789475|Vasodilator Agents|vasodilator agents|mesh-ancestor
5790968|NCT02789475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5790969|NCT02789475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5790970|NCT02789475|Antimetabolites|antimetabolites|mesh-ancestor
5790971|NCT02789475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5790972|NCT02789475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5790973|NCT02789475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5790974|NCT02789332|Paclitaxel|paclitaxel|mesh-list
5790975|NCT02789332|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5790976|NCT02789332|Cyclophosphamide|cyclophosphamide|mesh-list
5790977|NCT02789332|Carboplatin|carboplatin|mesh-list
5790978|NCT02789332|Epirubicin|epirubicin|mesh-list
5790979|NCT02789332|Olaparib|olaparib|mesh-list
5790980|NCT02789332|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5790981|NCT02789332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5790982|NCT02789332|Tubulin Modulators|tubulin modulators|mesh-ancestor
5790983|NCT02789332|Antimitotic Agents|antimitotic agents|mesh-ancestor
5790984|NCT02789332|Mitosis Modulators|mitosis modulators|mesh-ancestor
5790985|NCT02789332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5790986|NCT02789332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5790987|NCT02789332|Immunologic Factors|immunologic factors|mesh-ancestor
5790988|NCT02789332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5790989|NCT02789332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5790990|NCT02789332|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5790991|NCT02789332|Alkylating Agents|alkylating agents|mesh-ancestor
5790992|NCT02789332|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5790993|NCT02789332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5790994|NCT02789332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5790995|NCT02789332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5790996|NCT02789332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5790997|NCT02789332|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5790998|NCT02789397|Rituximab|rituximab|mesh-list
5790999|NCT02789397|Azathioprine|azathioprine|mesh-list
5791000|NCT02789397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5791001|NCT02789397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5791002|NCT02789397|Immunologic Factors|immunologic factors|mesh-ancestor
5791003|NCT02789397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791004|NCT02789397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5791005|NCT02789397|Antimetabolites|antimetabolites|mesh-ancestor
5791006|NCT02789397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791007|NCT02789397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5791008|NCT02789397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5791009|NCT02789566|Primaquine|primaquine|mesh-list
5791010|NCT02789566|Antimalarials|antimalarials|mesh-ancestor
5791011|NCT02789566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5791012|NCT02789566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5791013|NCT02789566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5791014|NCT02789202|Fluorides|fluorides|mesh-list
5791015|NCT02789202|Sodium Fluoride|sodium fluoride|mesh-list
5791016|NCT02789202|Fluorides, Topical|fluorides, topical|mesh-list
5791017|NCT02789202|Cariostatic Agents|cariostatic agents|mesh-ancestor
5791018|NCT02789202|Protective Agents|protective agents|mesh-ancestor
5791019|NCT02789202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791020|NCT02789189|Gemcitabine|gemcitabine|mesh-list
5791021|NCT02789189|Nedaplatin|nedaplatin|mesh-list
5791022|NCT02789189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5791023|NCT02789189|Antimetabolites|antimetabolites|mesh-ancestor
5791024|NCT02789189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791025|NCT02789189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5791026|NCT02789189|Antiviral Agents|antiviral agents|mesh-ancestor
5791027|NCT02789189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5791028|NCT02789189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5791029|NCT02789189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5791030|NCT02789189|Immunologic Factors|immunologic factors|mesh-ancestor
5791031|NCT02789189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791032|NCT02788864|Piperaquine|piperaquine|mesh-list
5791033|NCT02788864|Antimalarials|antimalarials|mesh-ancestor
5791034|NCT02788864|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5791035|NCT02788864|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5791036|NCT02788864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5791037|NCT02788851|Guanfacine|guanfacine|mesh-list
5791038|NCT02788851|Methylphenidate|methylphenidate|mesh-list
5791039|NCT02788851|Amphetamine|amphetamine|mesh-list
5791040|NCT02788851|Adderall|adderall|mesh-list
5791041|NCT02788851|Dextroamphetamine|dextroamphetamine|mesh-list
5791042|NCT02788851|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
5791043|NCT02788851|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5791044|NCT02788851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791045|NCT02788851|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5791046|NCT02788851|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5899046|NCT05052099|Growth Substances|growth substances|mesh-ancestor
5791047|NCT02788851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5791048|NCT02788851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791049|NCT02788851|Dopamine Agents|dopamine agents|mesh-ancestor
5791050|NCT02788851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5791051|NCT02788851|Sympathomimetics|sympathomimetics|mesh-ancestor
5791052|NCT02788851|Autonomic Agents|autonomic agents|mesh-ancestor
5791053|NCT02788851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5791054|NCT02788851|Adrenergic Agents|adrenergic agents|mesh-ancestor
5791055|NCT02788851|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5791056|NCT02788851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5791057|NCT02788851|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5791058|NCT02788851|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5791059|NCT02788851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5791060|NCT02788877|Aflibercept|aflibercept|mesh-list
5791061|NCT02788877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5791062|NCT02788877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5791063|NCT02788877|Growth Substances|growth substances|mesh-ancestor
5791064|NCT02788877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791065|NCT02788877|Growth Inhibitors|growth inhibitors|mesh-ancestor
5791066|NCT02788877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5791067|NCT02788786|Chlorhexidine|chlorhexidine|mesh-list
5791068|NCT02788786|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5791069|NCT02788786|Cetylpyridinium|cetylpyridinium|mesh-list
5791070|NCT02788786|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5791071|NCT02788786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5791072|NCT02788786|Disinfectants|disinfectants|mesh-ancestor
5791073|NCT02788786|Dermatologic Agents|dermatologic agents|mesh-ancestor
5791074|NCT02788981|Paclitaxel|paclitaxel|mesh-list
5791075|NCT02788981|Mifepristone|mifepristone|mesh-list
5791076|NCT02788981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5791077|NCT02788981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5791078|NCT02788981|Tubulin Modulators|tubulin modulators|mesh-ancestor
6491421|NCT00602407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491422|NCT00602407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6491423|NCT00602407|Respiratory System Agents|respiratory system agents|mesh-ancestor
5641133|NCT04163952|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5791079|NCT02788981|Antimitotic Agents|antimitotic agents|mesh-ancestor
5791080|NCT02788981|Mitosis Modulators|mitosis modulators|mesh-ancestor
5791081|NCT02788981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791082|NCT02788981|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5791083|NCT02788981|Abortifacient Agents|abortifacient agents|mesh-ancestor
5791084|NCT02788981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5791085|NCT02788981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791086|NCT02788981|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5791087|NCT02788981|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5791088|NCT02788981|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5791089|NCT02788981|Contraceptive Agents|contraceptive agents|mesh-ancestor
5791090|NCT02788981|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5791091|NCT02788981|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5791092|NCT02788981|Hormone Antagonists|hormone antagonists|mesh-ancestor
5791093|NCT02788981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5791094|NCT02788981|Luteolytic Agents|luteolytic agents|mesh-ancestor
5791095|NCT02788981|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5791096|NCT02788981|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5791097|NCT02788552|Vitamins|vitamins|mesh-list
5791098|NCT02788552|Thiamine|thiamine|mesh-list
5791099|NCT02788552|Micronutrients|micronutrients|mesh-ancestor
5791100|NCT02788552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791101|NCT02788552|Vitamin B Complex|vitamin b complex|mesh-ancestor
5791102|NCT02788708|Paclitaxel|paclitaxel|mesh-list
5791103|NCT02788708|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5791104|NCT02788708|Lenvatinib|lenvatinib|mesh-list
5791105|NCT02788708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5791106|NCT02788708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5791107|NCT02788708|Tubulin Modulators|tubulin modulators|mesh-ancestor
5791108|NCT02788708|Antimitotic Agents|antimitotic agents|mesh-ancestor
5791109|NCT02788708|Mitosis Modulators|mitosis modulators|mesh-ancestor
5791110|NCT02788708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641134|NCT04163952|Immunologic Factors|immunologic factors|mesh-ancestor
5641135|NCT04163952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641136|NCT04163952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5641137|NCT04112199|Terlipressin|terlipressin|mesh-list
5641138|NCT04112199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5641139|NCT04112199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5641140|NCT04091867|Cetuximab|cetuximab|mesh-list
5791111|NCT02788708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5791112|NCT02788708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5791113|NCT02788305|Misoprostol|misoprostol|mesh-list
5791114|NCT02788305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5791115|NCT02788305|Abortifacient Agents|abortifacient agents|mesh-ancestor
5791116|NCT02788305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5791117|NCT02788305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791118|NCT02788305|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5791119|NCT02788305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5791120|NCT02788305|Oxytocics|oxytocics|mesh-ancestor
5791121|NCT02788240|Meropenem|meropenem|mesh-list
5791122|NCT02788240|Terlipressin|terlipressin|mesh-list
5791123|NCT02788240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5791124|NCT02788240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5791125|NCT02788240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5791126|NCT02788240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5899047|NCT05052099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899048|NCT05052099|Growth Inhibitors|growth inhibitors|mesh-ancestor
5899049|NCT05041920|Omeprazole|omeprazole|mesh-list
5899050|NCT05041920|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5899051|NCT05041920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5899052|NCT05041920|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5899053|NCT05041920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5899054|NCT05041920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899055|NCT05036317|Empagliflozin|empagliflozin|mesh-list
5899056|NCT05036317|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5899057|NCT05036317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899058|NCT05036317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5899059|NCT05036317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899060|NCT05001802|Ropivacaine|ropivacaine|mesh-list
5899061|NCT05001802|Anesthetics, Local|anesthetics, local|mesh-ancestor
5899062|NCT05001802|Anesthetics|anesthetics|mesh-ancestor
5899063|NCT05001802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5899064|NCT05001802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899065|NCT05001802|Sensory System Agents|sensory system agents|mesh-ancestor
5899066|NCT05001802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5899067|NCT04985916|Botulinum Toxins|botulinum toxins|mesh-list
5899068|NCT04985916|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5641141|NCT04091867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5641142|NCT04091867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5641143|NCT04090567|Olaparib|olaparib|mesh-list
5641144|NCT04090567|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
5641145|NCT04090567|Cediranib|cediranib|mesh-list
5641146|NCT04090567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5641147|NCT04090567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641148|NCT04090567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5641149|NCT04090567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5641150|NCT04083963|Paclitaxel|paclitaxel|mesh-list
5641151|NCT04083963|Cyclophosphamide|cyclophosphamide|mesh-list
5641152|NCT04083963|Carboplatin|carboplatin|mesh-list
5899069|NCT04985916|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5899070|NCT04985916|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5899071|NCT04985916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5899072|NCT04985916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899073|NCT04985916|Cholinergic Agents|cholinergic agents|mesh-ancestor
5899074|NCT04985916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5899075|NCT04985916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899076|NCT04985916|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5899077|NCT04985916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5899078|NCT04977271|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
5899079|NCT04977271|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5899080|NCT04977271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5899081|NCT04977271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5899082|NCT04977271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899083|NCT04977271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5899084|NCT04977271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899085|NCT04977271|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5899086|NCT04977271|Antidepressive Agents|antidepressive agents|mesh-ancestor
5899087|NCT04977271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5899088|NCT04975958|Atezolizumab|atezolizumab|mesh-list
5899089|NCT04975958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5899090|NCT04965493|Rituximab|rituximab|mesh-list
5899091|NCT04965493|Venetoclax|venetoclax|mesh-list
5641153|NCT04083963|Doxorubicin|doxorubicin|mesh-list
5791127|NCT02788292|Acetylcysteine|acetylcysteine|mesh-list
5791128|NCT02788292|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5791129|NCT02788292|Antiviral Agents|antiviral agents|mesh-ancestor
5791130|NCT02788292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5791131|NCT02788292|Expectorants|expectorants|mesh-ancestor
5791132|NCT02788292|Respiratory System Agents|respiratory system agents|mesh-ancestor
5791133|NCT02788292|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5791134|NCT02788292|Antioxidants|antioxidants|mesh-ancestor
5791135|NCT02788292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791136|NCT02788292|Protective Agents|protective agents|mesh-ancestor
5791137|NCT02788292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791138|NCT02788292|Antidotes|antidotes|mesh-ancestor
5791139|NCT02787824|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
5791140|NCT02787824|Hematinics|hematinics|mesh-ancestor
5791141|NCT02787967|Beclomethasone|beclomethasone|mesh-list
5791142|NCT02787967|Formoterol Fumarate|formoterol fumarate|mesh-list
5791143|NCT02787967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5791144|NCT02787967|Autonomic Agents|autonomic agents|mesh-ancestor
5791145|NCT02787967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5791146|NCT02787967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791147|NCT02787967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5791148|NCT02787967|Respiratory System Agents|respiratory system agents|mesh-ancestor
5791149|NCT02787967|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5791150|NCT02787967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5791151|NCT02787967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5791152|NCT02787967|Adrenergic Agents|adrenergic agents|mesh-ancestor
5791153|NCT02787967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5791154|NCT02787967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791155|NCT02787967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5791156|NCT02787967|Glucocorticoids|glucocorticoids|mesh-ancestor
5791157|NCT02787967|Hormones|hormones|mesh-ancestor
5791158|NCT02787967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5791159|NCT02787928|Hydromorphone|hydromorphone|mesh-list
5791160|NCT02787928|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5791161|NCT02787928|Narcotics|narcotics|mesh-ancestor
5791162|NCT02787928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5791163|NCT02787928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791164|NCT02787928|Analgesics|analgesics|mesh-ancestor
5791165|NCT02787928|Sensory System Agents|sensory system agents|mesh-ancestor
5791166|NCT02787928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5791167|NCT02788123|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
5791168|NCT02788123|Pantoprazole|pantoprazole|mesh-list
5791169|NCT02788123|Bismuth|bismuth|mesh-list
5791170|NCT02788123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5791171|NCT02788123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5791172|NCT02788123|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5791173|NCT02788123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5791174|NCT02788123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791175|NCT02788123|Antacids|antacids|mesh-ancestor
5791176|NCT02788123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5791177|NCT02788136|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5791178|NCT02788136|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5791179|NCT02788136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791180|NCT02788058|Gefitinib|gefitinib|mesh-list
5791181|NCT02788058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5791182|NCT02788058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5791183|NCT02788058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5791184|NCT02788058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791185|NCT02787642|Olaparib|olaparib|mesh-list
5791186|NCT02787642|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5791187|NCT02787642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5791188|NCT02787642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791189|NCT02787642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5791190|NCT02787603|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5791191|NCT02787603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5791192|NCT02787746|Donepezil|donepezil|mesh-list
5791193|NCT02787746|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5791194|NCT02787746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5791195|NCT02787746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791196|NCT02787746|Cholinergic Agents|cholinergic agents|mesh-ancestor
5791197|NCT02787746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5791198|NCT02787746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791199|NCT02787746|Nootropic Agents|nootropic agents|mesh-ancestor
5791200|NCT02787798|Valsartan|valsartan|mesh-list
5791201|NCT02787798|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5791202|NCT02787798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5791203|NCT02787798|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5791204|NCT02787798|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5791205|NCT02787798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791206|NCT02787473|Docetaxel|docetaxel|mesh-list
5791207|NCT02787473|Pemetrexed|pemetrexed|mesh-list
5791208|NCT02787473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5791209|NCT02787473|Tubulin Modulators|tubulin modulators|mesh-ancestor
5791210|NCT02787473|Antimitotic Agents|antimitotic agents|mesh-ancestor
5791211|NCT02787473|Mitosis Modulators|mitosis modulators|mesh-ancestor
5791212|NCT02787473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791213|NCT02787473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5791214|NCT02787473|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5791215|NCT02787473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5791216|NCT02787447|Gefitinib|gefitinib|mesh-list
5791217|NCT02787447|Thymalfasin|thymalfasin|mesh-list
5791218|NCT02787447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5791219|NCT02787447|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5791220|NCT02787447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5791221|NCT02787447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791222|NCT02787447|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5791223|NCT02787447|Immunologic Factors|immunologic factors|mesh-ancestor
5791224|NCT02787447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791225|NCT02787369|Idelalisib|idelalisib|mesh-list
5791226|NCT02787369|Ricolinostat|ricolinostat|mesh-list
5791227|NCT02787369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5791228|NCT02787369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5791229|NCT02787369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791230|NCT02787369|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5791231|NCT02787317|Heparin|heparin|mesh-list
5791232|NCT02787317|Bivalirudin|bivalirudin|mesh-list
5791233|NCT02787317|Anticoagulants|anticoagulants|mesh-ancestor
5791234|NCT02787317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5791235|NCT02787317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5791236|NCT02787317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791237|NCT02787317|Antithrombins|antithrombins|mesh-ancestor
5791238|NCT02787317|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5791239|NCT02787317|Protease Inhibitors|protease inhibitors|mesh-ancestor
5791240|NCT02787317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5791241|NCT02787356|Lidocaine|lidocaine|mesh-list
5791242|NCT02787356|Anesthetics, Local|anesthetics, local|mesh-ancestor
5791243|NCT02787356|Anesthetics|anesthetics|mesh-ancestor
5791244|NCT02787356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5791245|NCT02787356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791246|NCT02787356|Sensory System Agents|sensory system agents|mesh-ancestor
5791247|NCT02787356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5791248|NCT02787356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5791249|NCT02787356|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5791250|NCT02787356|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5791251|NCT02787356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5791252|NCT02787356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791253|NCT02787239|Rituximab|rituximab|mesh-list
5791254|NCT02787239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5791255|NCT02787239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5791256|NCT02787239|Immunologic Factors|immunologic factors|mesh-ancestor
5791257|NCT02787239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791258|NCT02787239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5791259|NCT02787278|Otaplimastat|otaplimastat|mesh-list
5791260|NCT02787278|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5791261|NCT02787278|Protective Agents|protective agents|mesh-ancestor
5908145|NCT04860713|Aspirin|aspirin|mesh-list
5791262|NCT02787278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791263|NCT02786979|Aspirin|aspirin|mesh-list
5791264|NCT02786979|Beraprost|beraprost|mesh-list
5791265|NCT02786979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5791266|NCT02786979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5791267|NCT02786979|Analgesics|analgesics|mesh-ancestor
5791268|NCT02786979|Sensory System Agents|sensory system agents|mesh-ancestor
5791269|NCT02786979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5791270|NCT02786979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791271|NCT02786979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5791272|NCT02786979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5791273|NCT02786979|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5791274|NCT02786979|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5791275|NCT02786979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791276|NCT02786979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5791277|NCT02786979|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5791278|NCT02786979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5791279|NCT02786979|Antipyretics|antipyretics|mesh-ancestor
5791280|NCT02786979|Vasodilator Agents|vasodilator agents|mesh-ancestor
5791281|NCT02787226|Bupivacaine|bupivacaine|mesh-list
5791282|NCT02787226|Anesthetics, Local|anesthetics, local|mesh-ancestor
5791283|NCT02787226|Anesthetics|anesthetics|mesh-ancestor
5791284|NCT02787226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5791285|NCT02787226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791286|NCT02787226|Sensory System Agents|sensory system agents|mesh-ancestor
5791287|NCT02787226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5791288|NCT02787018|Dexamethasone|dexamethasone|mesh-list
5791289|NCT02787018|Dexmedetomidine|dexmedetomidine|mesh-list
5791290|NCT02787018|Ropivacaine|ropivacaine|mesh-list
5791291|NCT02787018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5791292|NCT02787018|Antiemetics|antiemetics|mesh-ancestor
5791293|NCT02787018|Autonomic Agents|autonomic agents|mesh-ancestor
5791294|NCT02787018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5791295|NCT02787018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791296|NCT02787018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5791297|NCT02787018|Glucocorticoids|glucocorticoids|mesh-ancestor
5791298|NCT02787018|Hormones|hormones|mesh-ancestor
5791299|NCT02787018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5791300|NCT02787018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5791301|NCT02787018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5791302|NCT02787018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5791303|NCT02787018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5791304|NCT02787018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5791305|NCT02787018|Analgesics|analgesics|mesh-ancestor
5791306|NCT02787018|Sensory System Agents|sensory system agents|mesh-ancestor
5791307|NCT02787018|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5791308|NCT02787018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5791309|NCT02787018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5791310|NCT02787018|Adrenergic Agents|adrenergic agents|mesh-ancestor
5791311|NCT02787018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5791312|NCT02787018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791313|NCT02787018|Anesthetics, Local|anesthetics, local|mesh-ancestor
5791314|NCT02787018|Anesthetics|anesthetics|mesh-ancestor
5791315|NCT02787031|Anesthetics|anesthetics|mesh-list
5791316|NCT02787031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5791317|NCT02787031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791318|NCT02786992|Misoprostol|misoprostol|mesh-list
5791319|NCT02786992|Oxytocin|oxytocin|mesh-list
5791320|NCT02786992|Carbetocin|carbetocin|mesh-list
5791321|NCT02786992|Oxytocics|oxytocics|mesh-ancestor
5791322|NCT02786992|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5791323|NCT02786992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791324|NCT02786992|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5791325|NCT02786992|Abortifacient Agents|abortifacient agents|mesh-ancestor
5791326|NCT02786992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5791327|NCT02786992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5791328|NCT02786875|Vitamin D|vitamin d|mesh-list
5791329|NCT02786875|Ergocalciferols|ergocalciferols|mesh-list
5791330|NCT02786875|Vitamins|vitamins|mesh-list
5791331|NCT02786875|Micronutrients|micronutrients|mesh-ancestor
5791332|NCT02786875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791333|NCT02786875|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5791334|NCT02786875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5791335|NCT02786823|Folic Acid|folic acid|mesh-list
5791336|NCT02786823|Vitamin B 12|vitamin b 12|mesh-list
5791337|NCT02786823|Hydroxocobalamin|hydroxocobalamin|mesh-list
5791338|NCT02786823|Metformin|metformin|mesh-list
5791339|NCT02786823|Hypoglycemic Agents|hypoglycemic agents|mesh-list
5791340|NCT02786823|Vitamins|vitamins|mesh-ancestor
5791341|NCT02786823|Micronutrients|micronutrients|mesh-ancestor
5791342|NCT02786823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791343|NCT02786823|Hematinics|hematinics|mesh-ancestor
5791344|NCT02786823|Vitamin B Complex|vitamin b complex|mesh-ancestor
5791345|NCT02786732|Ustekinumab|ustekinumab|mesh-list
5791346|NCT02786732|Brodalumab|brodalumab|mesh-list
5791347|NCT02786732|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5791348|NCT02786732|Dermatologic Agents|dermatologic agents|mesh-ancestor
5791349|NCT02786732|Immunologic Factors|immunologic factors|mesh-ancestor
5791350|NCT02786732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791351|NCT02786550|Botulinum Toxins|botulinum toxins|mesh-list
5791352|NCT02786550|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5791353|NCT02786550|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5791354|NCT02786550|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5791355|NCT02786550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5791356|NCT02786550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791357|NCT02786550|Cholinergic Agents|cholinergic agents|mesh-ancestor
5791358|NCT02786550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5791359|NCT02786550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791360|NCT02786550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5791361|NCT02786550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5791362|NCT02786667|Rotigotine|rotigotine|mesh-list
5791363|NCT02786667|Dopamine Agonists|dopamine agonists|mesh-ancestor
5791364|NCT02786667|Dopamine Agents|dopamine agents|mesh-ancestor
5791365|NCT02786667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5791366|NCT02786667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791367|NCT02786667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899092|NCT04965493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5899093|NCT04965493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5899094|NCT04965493|Immunologic Factors|immunologic factors|mesh-ancestor
5899095|NCT04965493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899096|NCT04965493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5899097|NCT04965389|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5899098|NCT04942210|Vaccines|vaccines|mesh-list
5899099|NCT04942210|Immunologic Factors|immunologic factors|mesh-ancestor
5899100|NCT04942210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899101|NCT04921189|Ascorbic Acid|ascorbic acid|mesh-list
5899102|NCT04921189|Thiamine|thiamine|mesh-list
5899103|NCT04921189|Hydrocortisone|hydrocortisone|mesh-list
5899104|NCT04921189|Antioxidants|antioxidants|mesh-ancestor
5899105|NCT04921189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899106|NCT04921189|Protective Agents|protective agents|mesh-ancestor
5899107|NCT04921189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899108|NCT04921189|Vitamins|vitamins|mesh-ancestor
5899109|NCT04921189|Micronutrients|micronutrients|mesh-ancestor
5899110|NCT04921189|Vitamin B Complex|vitamin b complex|mesh-ancestor
5899111|NCT04921189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5899112|NCT04875871|Copper|copper|mesh-list
5899113|NCT04875871|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5899114|NCT04875871|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5899115|NCT04875871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899116|NCT04875871|Trace Elements|trace elements|mesh-ancestor
5899117|NCT04875871|Micronutrients|micronutrients|mesh-ancestor
5899118|NCT04875871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899119|NCT04840199|Letermovir|letermovir|mesh-list
5899120|NCT04840199|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5899121|NCT04840199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5899122|NCT04840199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899123|NCT04840199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5899124|NCT04840199|Antiviral Agents|antiviral agents|mesh-ancestor
5899125|NCT04840199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5899126|NCT04828538|Vitamin D|vitamin d|mesh-list
5899127|NCT04828538|Vitamins|vitamins|mesh-list
5899128|NCT04828538|Ascorbic Acid|ascorbic acid|mesh-list
5899129|NCT04828538|Folic Acid|folic acid|mesh-list
5899130|NCT04828538|Vitamin B Complex|vitamin b complex|mesh-list
5899131|NCT04828538|Micronutrients|micronutrients|mesh-ancestor
5899132|NCT04828538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899133|NCT04828538|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5899134|NCT04828538|Antioxidants|antioxidants|mesh-ancestor
5899135|NCT04828538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899136|NCT04828538|Protective Agents|protective agents|mesh-ancestor
5899137|NCT04828538|Hematinics|hematinics|mesh-ancestor
5899138|NCT04827056|Ethanol|ethanol|mesh-list
5899139|NCT04827056|Dexmedetomidine|dexmedetomidine|mesh-list
5899140|NCT04827056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5791368|NCT02786407|Botulinum Toxins|botulinum toxins|mesh-list
5791369|NCT02786407|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5791370|NCT02786407|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5791371|NCT02786407|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5791372|NCT02786407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5791373|NCT02786407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791374|NCT02786407|Cholinergic Agents|cholinergic agents|mesh-ancestor
5791375|NCT02786407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5791376|NCT02786407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791377|NCT02786407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5791378|NCT02786407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5641154|NCT04083963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5641155|NCT04083963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5791379|NCT02786641|Cisplatin|cisplatin|mesh-list
5791380|NCT02786641|Docetaxel|docetaxel|mesh-list
5791381|NCT02786641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5791382|NCT02786641|Tubulin Modulators|tubulin modulators|mesh-ancestor
5791383|NCT02786641|Antimitotic Agents|antimitotic agents|mesh-ancestor
5791384|NCT02786641|Mitosis Modulators|mitosis modulators|mesh-ancestor
5791385|NCT02786641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791386|NCT02786446|Naproxen|naproxen|mesh-list
5791387|NCT02786446|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
5791388|NCT02786446|Lidocaine|lidocaine|mesh-list
5791389|NCT02786446|Anesthetics, Local|anesthetics, local|mesh-ancestor
5791390|NCT02786446|Anesthetics|anesthetics|mesh-ancestor
5791391|NCT02786446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5791392|NCT02786446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791393|NCT02786446|Sensory System Agents|sensory system agents|mesh-ancestor
5791394|NCT02786446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5791395|NCT02786446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5791396|NCT02786446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5791397|NCT02786446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5791398|NCT02786446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5791399|NCT02786446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791400|NCT02786446|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5791401|NCT02786446|Analgesics|analgesics|mesh-ancestor
5791402|NCT02786446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5791403|NCT02786446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5791404|NCT02786446|Gout Suppressants|gout suppressants|mesh-ancestor
5791405|NCT02786446|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5791406|NCT02786446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5791407|NCT02786264|Fentanyl|fentanyl|mesh-list
5791408|NCT02786264|Midazolam|midazolam|mesh-list
5791409|NCT02786264|Dexmedetomidine|dexmedetomidine|mesh-list
5791410|NCT02786264|Propofol|propofol|mesh-list
5791411|NCT02786264|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5791412|NCT02786264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5791413|NCT02786264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791414|NCT02786264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5791415|NCT02786264|Anesthetics, General|anesthetics, general|mesh-ancestor
5791416|NCT02786264|Anesthetics|anesthetics|mesh-ancestor
5791417|NCT02786264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5641156|NCT04083963|Tubulin Modulators|tubulin modulators|mesh-ancestor
5641157|NCT04083963|Antimitotic Agents|antimitotic agents|mesh-ancestor
5791418|NCT02786264|Analgesics|analgesics|mesh-ancestor
5791419|NCT02786264|Sensory System Agents|sensory system agents|mesh-ancestor
5791420|NCT02786264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5791421|NCT02786264|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5791422|NCT02786264|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5791423|NCT02786264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5791424|NCT02786264|Adrenergic Agents|adrenergic agents|mesh-ancestor
5791425|NCT02786264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5791426|NCT02786264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791427|NCT02786264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5791428|NCT02786264|Narcotics|narcotics|mesh-ancestor
5791429|NCT02786264|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5791430|NCT02786264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5791431|NCT02786264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5791432|NCT02786264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5791433|NCT02786264|GABA Modulators|gaba modulators|mesh-ancestor
5791434|NCT02786264|GABA Agents|gaba agents|mesh-ancestor
5641158|NCT04083963|Mitosis Modulators|mitosis modulators|mesh-ancestor
5641159|NCT04083963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641160|NCT04083963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5641161|NCT04083963|Immunologic Factors|immunologic factors|mesh-ancestor
6491424|NCT00602407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6491425|NCT00602407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6491426|NCT00602407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491427|NCT00602407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6491428|NCT00602407|Vasodilator Agents|vasodilator agents|mesh-ancestor
6491429|NCT00602407|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6491430|NCT00602407|Protective Agents|protective agents|mesh-ancestor
6491431|NCT00602407|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6491432|NCT00602407|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6491433|NCT00602407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6491434|NCT00602498|Clarithromycin|clarithromycin|mesh-list
6491435|NCT00602498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6491436|NCT00602498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5791435|NCT02785978|Levodopa|levodopa|mesh-list
5791436|NCT02785978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5791437|NCT02785978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5791438|NCT02785978|Dopamine Agents|dopamine agents|mesh-ancestor
5791439|NCT02785978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5791440|NCT02785978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791441|NCT02785978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791442|NCT02786212|Dexmedetomidine|dexmedetomidine|mesh-list
5791443|NCT02786212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5791444|NCT02786212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5791445|NCT02786212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791446|NCT02786212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5791447|NCT02786212|Analgesics|analgesics|mesh-ancestor
5791448|NCT02786212|Sensory System Agents|sensory system agents|mesh-ancestor
5791449|NCT02786212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5791450|NCT02786212|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5791451|NCT02786212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5791452|NCT02786212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5791453|NCT02786212|Adrenergic Agents|adrenergic agents|mesh-ancestor
5791454|NCT02786212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5791455|NCT02786212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791456|NCT02786082|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
5791457|NCT02786082|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5791458|NCT02786082|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5791459|NCT02786082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791460|NCT02785757|Thrombin|thrombin|mesh-list
5791461|NCT02785757|Hemostatics|hemostatics|mesh-ancestor
5791462|NCT02785757|Coagulants|coagulants|mesh-ancestor
5791463|NCT02785601|Trazodone|trazodone|mesh-list
5791464|NCT02785601|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5791465|NCT02785601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5791466|NCT02785601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5791467|NCT02785601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791468|NCT02785601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5791469|NCT02785601|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5791470|NCT02785601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5791471|NCT02785601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5791472|NCT02785601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791473|NCT02785601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5791474|NCT02785601|Serotonin Agents|serotonin agents|mesh-ancestor
5791475|NCT02785601|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5791476|NCT02785601|Antidepressive Agents|antidepressive agents|mesh-ancestor
5791477|NCT02785705|Vaccines|vaccines|mesh-list
5791478|NCT02785705|Immunologic Factors|immunologic factors|mesh-ancestor
5791479|NCT02785705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791480|NCT02785809|Contraceptive Agents|contraceptive agents|mesh-list
5791481|NCT02785809|Contraceptives, Oral|contraceptives, oral|mesh-list
5791482|NCT02785809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5791483|NCT02785809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791484|NCT02785809|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5791485|NCT02785666|Ribavirin|ribavirin|mesh-list
5791486|NCT02785666|Grazoprevir|grazoprevir|mesh-list
5791487|NCT02785666|Antimetabolites|antimetabolites|mesh-ancestor
5791488|NCT02785666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791489|NCT02785666|Antiviral Agents|antiviral agents|mesh-ancestor
5791490|NCT02785666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5791491|NCT02785614|Trazodone|trazodone|mesh-list
5791492|NCT02785614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5791493|NCT02785614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5791494|NCT02785614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6673893|NCT01566201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5791495|NCT02785614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791496|NCT02785614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5791497|NCT02785614|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5791498|NCT02785614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5791499|NCT02785614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5791500|NCT02785614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791501|NCT02785614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5791502|NCT02785614|Serotonin Agents|serotonin agents|mesh-ancestor
5791503|NCT02785614|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5791504|NCT02785614|Antidepressive Agents|antidepressive agents|mesh-ancestor
5791505|NCT02785653|Sevoflurane|sevoflurane|mesh-list
5791506|NCT02785653|Rocuronium|rocuronium|mesh-list
5791507|NCT02785653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5791508|NCT02785653|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5791509|NCT02785653|Anesthetics, General|anesthetics, general|mesh-ancestor
5791510|NCT02785653|Anesthetics|anesthetics|mesh-ancestor
5791511|NCT02785653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5791512|NCT02785653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791513|NCT02785653|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5791514|NCT02785653|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5791515|NCT02785653|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5791516|NCT02785653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5791517|NCT02785718|Hemostatics|hemostatics|mesh-list
5791518|NCT02785718|Coagulants|coagulants|mesh-ancestor
5791519|NCT02785549|Acetaminophen|acetaminophen|mesh-list
5791520|NCT02785549|Amoxicillin|amoxicillin|mesh-list
5791521|NCT02785549|Clavulanic Acids|clavulanic acids|mesh-list
5791522|NCT02785549|Clavulanic Acid|clavulanic acid|mesh-list
5791523|NCT02785549|Ibuprofen|ibuprofen|mesh-list
5791524|NCT02785549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5791525|NCT02785549|Analgesics|analgesics|mesh-ancestor
5791526|NCT02785549|Sensory System Agents|sensory system agents|mesh-ancestor
5791527|NCT02785549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5791528|NCT02785549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791529|NCT02785549|Antipyretics|antipyretics|mesh-ancestor
5791530|NCT02785549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5791531|NCT02785549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5791532|NCT02785549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5791533|NCT02785549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5791534|NCT02785549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5791535|NCT02785549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791536|NCT02785549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5791537|NCT02785549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5791538|NCT02785549|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5791539|NCT02785250|Cyclophosphamide|cyclophosphamide|mesh-list
5791540|NCT02785250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5791541|NCT02785250|Immunologic Factors|immunologic factors|mesh-ancestor
5791542|NCT02785250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791543|NCT02785250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5791544|NCT02785250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5791545|NCT02785250|Alkylating Agents|alkylating agents|mesh-ancestor
5791546|NCT02785250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791547|NCT02785250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5791548|NCT02785250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5791549|NCT02785146|Calcium, Dietary|calcium, dietary|mesh-list
5791550|NCT02785146|Leucovorin|leucovorin|mesh-list
5791551|NCT02785146|Fluorouracil|fluorouracil|mesh-list
5791552|NCT02785146|Oxaliplatin|oxaliplatin|mesh-list
5791553|NCT02785146|Calcium|calcium|mesh-list
5791554|NCT02785146|Levoleucovorin|levoleucovorin|mesh-list
5791555|NCT02785146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5791556|NCT02785146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791557|NCT02785146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5791558|NCT02785146|Antimetabolites|antimetabolites|mesh-ancestor
5791559|NCT02785146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791560|NCT02785146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5791561|NCT02785146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5791562|NCT02785146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5791563|NCT02785146|Immunologic Factors|immunologic factors|mesh-ancestor
5791564|NCT02785146|Antidotes|antidotes|mesh-ancestor
5791565|NCT02785146|Protective Agents|protective agents|mesh-ancestor
5791566|NCT02785146|Vitamin B Complex|vitamin b complex|mesh-ancestor
5791567|NCT02785146|Vitamins|vitamins|mesh-ancestor
5791568|NCT02785146|Micronutrients|micronutrients|mesh-ancestor
5791569|NCT02785393|Doxazosin|doxazosin|mesh-list
5791570|NCT02785393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5791571|NCT02785393|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5791572|NCT02785393|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5791573|NCT02785393|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5791574|NCT02785393|Adrenergic Agents|adrenergic agents|mesh-ancestor
5791575|NCT02785393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5791576|NCT02785393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791577|NCT02785393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791578|NCT02785276|Ropivacaine|ropivacaine|mesh-list
5791579|NCT02785276|Anesthetics, Local|anesthetics, local|mesh-ancestor
5791580|NCT02785276|Anesthetics|anesthetics|mesh-ancestor
5791581|NCT02785276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5791582|NCT02785276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791583|NCT02785276|Sensory System Agents|sensory system agents|mesh-ancestor
5791584|NCT02785276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5791585|NCT02784899|Iloprost|iloprost|mesh-list
5791586|NCT02784899|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5791587|NCT02784899|Vasodilator Agents|vasodilator agents|mesh-ancestor
5791588|NCT02784860|Lidocaine|lidocaine|mesh-list
5791589|NCT02784860|Anesthetics, Local|anesthetics, local|mesh-ancestor
5791590|NCT02784860|Anesthetics|anesthetics|mesh-ancestor
5791591|NCT02784860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5791592|NCT02784860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791593|NCT02784860|Sensory System Agents|sensory system agents|mesh-ancestor
5791594|NCT02784860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5791595|NCT02784860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5791596|NCT02784860|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5791597|NCT02784860|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5791598|NCT02784860|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5791599|NCT02784860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899141|NCT04827056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5899142|NCT04827056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899143|NCT04827056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5899144|NCT04827056|Analgesics|analgesics|mesh-ancestor
5899145|NCT04827056|Sensory System Agents|sensory system agents|mesh-ancestor
5899146|NCT04827056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5899147|NCT04827056|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5899148|NCT04827056|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5899149|NCT04827056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5899150|NCT04827056|Adrenergic Agents|adrenergic agents|mesh-ancestor
5899151|NCT04827056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5899152|NCT04827056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899153|NCT04827056|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5899154|NCT04827056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5899155|NCT04827030|Ropivacaine|ropivacaine|mesh-list
5899156|NCT04827030|Anesthetics, Local|anesthetics, local|mesh-ancestor
5899157|NCT04827030|Anesthetics|anesthetics|mesh-ancestor
5899158|NCT04827030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5899159|NCT04827030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899160|NCT04827030|Sensory System Agents|sensory system agents|mesh-ancestor
5899161|NCT04827030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5899164|NCT04781725|Cisplatin|cisplatin|mesh-list
5899165|NCT04781725|Vinblastine|vinblastine|mesh-list
5899166|NCT04781725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5899167|NCT04781725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5899168|NCT04781725|Tubulin Modulators|tubulin modulators|mesh-ancestor
5899169|NCT04781725|Antimitotic Agents|antimitotic agents|mesh-ancestor
5899170|NCT04781725|Mitosis Modulators|mitosis modulators|mesh-ancestor
5899171|NCT04781725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899172|NCT04767191|Lumefantrine|lumefantrine|mesh-list
5899173|NCT04767191|Artemether|artemether|mesh-list
5899174|NCT04767191|Piperaquine|piperaquine|mesh-list
5899175|NCT04767191|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
5899176|NCT04767191|Artenimol|artenimol|mesh-list
5899177|NCT04767191|Antimalarials|antimalarials|mesh-ancestor
5899178|NCT04767191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5899179|NCT04767191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5899180|NCT04767191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5899181|NCT04737603|Buprenorphine|buprenorphine|mesh-list
6491437|NCT00602498|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6491438|NCT00602498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6491439|NCT00602498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673894|NCT01566240|Paclitaxel|paclitaxel|mesh-list
5791600|NCT02785055|Hydromorphone|hydromorphone|mesh-list
5791601|NCT02785055|Bupivacaine|bupivacaine|mesh-list
5791602|NCT02785055|Anesthetics, Local|anesthetics, local|mesh-ancestor
5791603|NCT02785055|Anesthetics|anesthetics|mesh-ancestor
5791604|NCT02785055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5791605|NCT02785055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791606|NCT02785055|Sensory System Agents|sensory system agents|mesh-ancestor
5791607|NCT02785055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5791608|NCT02785055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5791609|NCT02785055|Narcotics|narcotics|mesh-ancestor
5791610|NCT02785055|Analgesics|analgesics|mesh-ancestor
5791611|NCT02785003|Acetaminophen|acetaminophen|mesh-list
5791612|NCT02785003|Morphine|morphine|mesh-list
5791613|NCT02785003|Narcotics|narcotics|mesh-list
5791614|NCT02785003|Ketamine|ketamine|mesh-list
5791615|NCT02785003|Alvimopan|alvimopan|mesh-list
5791616|NCT02785003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5791617|NCT02785003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5791618|NCT02785003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791619|NCT02785003|Analgesics|analgesics|mesh-ancestor
5791620|NCT02785003|Sensory System Agents|sensory system agents|mesh-ancestor
5791621|NCT02785003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5791622|NCT02785003|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5791623|NCT02785003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5791624|NCT02785003|Anesthetics, General|anesthetics, general|mesh-ancestor
5791625|NCT02785003|Anesthetics|anesthetics|mesh-ancestor
5791626|NCT02785003|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5791627|NCT02785003|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5791628|NCT02785003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5791629|NCT02785003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791630|NCT02785003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5791631|NCT02785003|Antipyretics|antipyretics|mesh-ancestor
5791632|NCT02785003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5791633|NCT02785068|Leucovorin|leucovorin|mesh-list
5791634|NCT02785068|Fluorouracil|fluorouracil|mesh-list
5791635|NCT02785068|Antimetabolites|antimetabolites|mesh-ancestor
5791636|NCT02785068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791637|NCT02785068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5791638|NCT02785068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5791639|NCT02785068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5791640|NCT02785068|Immunologic Factors|immunologic factors|mesh-ancestor
5791641|NCT02785068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791642|NCT02785068|Antidotes|antidotes|mesh-ancestor
5791643|NCT02785068|Protective Agents|protective agents|mesh-ancestor
5791644|NCT02785068|Vitamin B Complex|vitamin b complex|mesh-ancestor
5791645|NCT02785068|Vitamins|vitamins|mesh-ancestor
5791646|NCT02785068|Micronutrients|micronutrients|mesh-ancestor
5791647|NCT02784821|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5693925|NCT03398876|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5693926|NCT03398876|Cholinergic Agents|cholinergic agents|mesh-ancestor
5693927|NCT03398876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5693928|NCT03398876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693929|NCT03398824|Metformin|metformin|mesh-list
5693930|NCT03398824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5693931|NCT03398824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693932|NCT03398811|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
5693933|NCT03398811|Etonogestrel|etonogestrel|mesh-list
5693934|NCT03398811|Desogestrel|desogestrel|mesh-list
5693935|NCT03398811|Medroxyprogesterone|medroxyprogesterone|mesh-list
5693936|NCT03398811|Progesterone|progesterone|mesh-list
5791648|NCT02784821|Gentamicins|gentamicins|mesh-list
5791649|NCT02784821|Ampicillin|ampicillin|mesh-list
5791650|NCT02784821|Cefotaxime|cefotaxime|mesh-list
5791651|NCT02784821|Cefoxitin|cefoxitin|mesh-list
5791652|NCT02784821|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5791653|NCT02784821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5791654|NCT02784821|Antitubercular Agents|antitubercular agents|mesh-ancestor
5791655|NCT02784821|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5791656|NCT02784821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5791657|NCT02784821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791658|NCT02784717|Rivaroxaban|rivaroxaban|mesh-list
5791659|NCT02784717|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5791660|NCT02784717|Antithrombins|antithrombins|mesh-ancestor
5791661|NCT02784717|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5791662|NCT02784717|Protease Inhibitors|protease inhibitors|mesh-ancestor
5791663|NCT02784717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5791664|NCT02784717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791665|NCT02784717|Anticoagulants|anticoagulants|mesh-ancestor
5791666|NCT02784795|Gemcitabine|gemcitabine|mesh-list
5791667|NCT02784795|Carboplatin|carboplatin|mesh-list
5791668|NCT02784795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5791669|NCT02784795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5791670|NCT02784795|Antimetabolites|antimetabolites|mesh-ancestor
5791671|NCT02784795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791672|NCT02784795|Antiviral Agents|antiviral agents|mesh-ancestor
5791673|NCT02784795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5791674|NCT02784795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5791675|NCT02784795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5791676|NCT02784795|Immunologic Factors|immunologic factors|mesh-ancestor
5791677|NCT02784795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791678|NCT02784808|Antirheumatic Agents|antirheumatic agents|mesh-list
5791679|NCT02784626|Dexmedetomidine|dexmedetomidine|mesh-list
5791680|NCT02784626|Propofol|propofol|mesh-list
5791681|NCT02784626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5791682|NCT02784626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5791683|NCT02784626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791684|NCT02784626|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5791685|NCT02784626|Anesthetics, General|anesthetics, general|mesh-ancestor
5791686|NCT02784626|Anesthetics|anesthetics|mesh-ancestor
5791687|NCT02784626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5791688|NCT02784626|Analgesics|analgesics|mesh-ancestor
5791689|NCT02784626|Sensory System Agents|sensory system agents|mesh-ancestor
5791690|NCT02784626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5791691|NCT02784626|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5791692|NCT02784626|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5791693|NCT02784626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5791694|NCT02784626|Adrenergic Agents|adrenergic agents|mesh-ancestor
5791695|NCT02784626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5791696|NCT02784626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791697|NCT02784652|Zoledronic Acid|zoledronic acid|mesh-list
5791698|NCT02784652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5791699|NCT02784652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791700|NCT02784457|Cetrorelix|cetrorelix|mesh-list
5791701|NCT02784457|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5791702|NCT02784457|Fertility Agents|fertility agents|mesh-ancestor
5791703|NCT02784457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5791704|NCT02784457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791705|NCT02784457|Hormone Antagonists|hormone antagonists|mesh-ancestor
5791706|NCT02784457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5791707|NCT02784743|Ivermectin|ivermectin|mesh-list
5791708|NCT02784743|Albendazole|albendazole|mesh-list
5791709|NCT02784743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5791710|NCT02784743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5791711|NCT02784743|Anthelmintics|anthelmintics|mesh-ancestor
5791712|NCT02784743|Anticestodal Agents|anticestodal agents|mesh-ancestor
5791713|NCT02784743|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5791714|NCT02784743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5791715|NCT02784743|Tubulin Modulators|tubulin modulators|mesh-ancestor
5791716|NCT02784743|Antimitotic Agents|antimitotic agents|mesh-ancestor
5791717|NCT02784743|Mitosis Modulators|mitosis modulators|mesh-ancestor
5791718|NCT02784743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791719|NCT02784743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5791720|NCT02784483|Atezolizumab|atezolizumab|mesh-list
5791721|NCT02784483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5791722|NCT02784561|Vidarabine|vidarabine|mesh-list
5791723|NCT02784561|Cytarabine|cytarabine|mesh-list
5791724|NCT02784561|Fludarabine|fludarabine|mesh-list
5791725|NCT02784561|Fludarabine phosphate|fludarabine phosphate|mesh-list
5791726|NCT02784561|Busulfan|busulfan|mesh-list
5791727|NCT02784561|Thymoglobulin|thymoglobulin|mesh-list
5791728|NCT02784561|Sargramostim|sargramostim|mesh-list
5791729|NCT02784561|Lenograstim|lenograstim|mesh-list
5791730|NCT02784561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5791731|NCT02784561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5791732|NCT02784561|Antimetabolites|antimetabolites|mesh-ancestor
5791733|NCT02784561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791734|NCT02784561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5791735|NCT02784561|Immunologic Factors|immunologic factors|mesh-ancestor
5791736|NCT02784561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791737|NCT02784561|Antiviral Agents|antiviral agents|mesh-ancestor
5791738|NCT02784561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5791739|NCT02784561|Alkylating Agents|alkylating agents|mesh-ancestor
5791740|NCT02784561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5791741|NCT02784561|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5791742|NCT02784561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5791743|NCT02784340|Dexamethasone|dexamethasone|mesh-list
5791744|NCT02784340|Dexamethasone acetate|dexamethasone acetate|mesh-list
5791745|NCT02784340|Bupivacaine|bupivacaine|mesh-list
5791746|NCT02784340|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
5791747|NCT02784340|BB 1101|bb 1101|mesh-list
5791748|NCT02784340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5791749|NCT02784340|Antiemetics|antiemetics|mesh-ancestor
5791750|NCT02784340|Autonomic Agents|autonomic agents|mesh-ancestor
5791751|NCT02784340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5791752|NCT02784340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491440|NCT00602498|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6491441|NCT00602498|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6491442|NCT00602511|Thalidomide|thalidomide|mesh-list
6491443|NCT00602511|Bortezomib|bortezomib|mesh-list
6491444|NCT00602511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6491445|NCT00602511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6491446|NCT00602511|Immunologic Factors|immunologic factors|mesh-ancestor
6491447|NCT00602511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491448|NCT00602511|Leprostatic Agents|leprostatic agents|mesh-ancestor
6491449|NCT00602511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6491450|NCT00602511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6491451|NCT00602511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6673895|NCT01566240|Carboplatin|carboplatin|mesh-list
5791753|NCT02784340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5791754|NCT02784340|Glucocorticoids|glucocorticoids|mesh-ancestor
5791755|NCT02784340|Hormones|hormones|mesh-ancestor
5791756|NCT02784340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5791757|NCT02784340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5791758|NCT02784340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5791759|NCT02784340|Protease Inhibitors|protease inhibitors|mesh-ancestor
5791760|NCT02784340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5791761|NCT02784340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791762|NCT02784340|Anesthetics, Local|anesthetics, local|mesh-ancestor
5791763|NCT02784340|Anesthetics|anesthetics|mesh-ancestor
5791764|NCT02784340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5791765|NCT02784340|Sensory System Agents|sensory system agents|mesh-ancestor
5791766|NCT02784327|Ropivacaine|ropivacaine|mesh-list
5791767|NCT02784327|Anesthetics, Local|anesthetics, local|mesh-ancestor
5791768|NCT02784327|Anesthetics|anesthetics|mesh-ancestor
5791769|NCT02784327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5791770|NCT02784327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791771|NCT02784327|Sensory System Agents|sensory system agents|mesh-ancestor
5791772|NCT02784327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5791773|NCT02784223|Choline|choline|mesh-list
5791774|NCT02784223|Lipotropic Agents|lipotropic agents|mesh-ancestor
5791775|NCT02784223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5791776|NCT02784223|Antimetabolites|antimetabolites|mesh-ancestor
5791777|NCT02784223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791778|NCT02784223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5791779|NCT02784223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5791780|NCT02784223|Nootropic Agents|nootropic agents|mesh-ancestor
5791781|NCT02784392|Metoclopramide|metoclopramide|mesh-list
5791782|NCT02784392|Antiemetics|antiemetics|mesh-ancestor
5791783|NCT02784392|Autonomic Agents|autonomic agents|mesh-ancestor
5791784|NCT02784392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5791785|NCT02784392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791786|NCT02784392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5791787|NCT02784392|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5791788|NCT02784392|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5791789|NCT02784392|Dopamine Agents|dopamine agents|mesh-ancestor
5791790|NCT02784392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5791791|NCT02784392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791792|NCT02784054|Cyclophosphamide|cyclophosphamide|mesh-list
5791793|NCT02784054|Melphalan|melphalan|mesh-list
6491452|NCT00602511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6491453|NCT00602511|Growth Substances|growth substances|mesh-ancestor
6491454|NCT00602511|Growth Inhibitors|growth inhibitors|mesh-ancestor
6491455|NCT00602524|Pilocarpine|pilocarpine|mesh-list
6491456|NCT00602524|Miotics|miotics|mesh-ancestor
6491457|NCT00602524|Autonomic Agents|autonomic agents|mesh-ancestor
6491458|NCT00602524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6491459|NCT00602524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491460|NCT00602524|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6491461|NCT00602524|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5791794|NCT02784054|Thiotepa|thiotepa|mesh-list
5791795|NCT02784054|Carboplatin|carboplatin|mesh-list
5791796|NCT02784054|Etoposide|etoposide|mesh-list
5791797|NCT02784054|Bleomycin|bleomycin|mesh-list
5791798|NCT02784054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5791799|NCT02784054|Immunologic Factors|immunologic factors|mesh-ancestor
5791800|NCT02784054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791801|NCT02784054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5791802|NCT02784054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5791803|NCT02784054|Alkylating Agents|alkylating agents|mesh-ancestor
5791804|NCT02784054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791805|NCT02784054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5791806|NCT02784054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5791807|NCT02784054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5791808|NCT02784054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5791809|NCT02784054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5791810|NCT02784054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5791811|NCT02784054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5791812|NCT02784080|Isoantibodies|isoantibodies|mesh-list
5791813|NCT02784080|Immunologic Factors|immunologic factors|mesh-ancestor
5791814|NCT02784080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791815|NCT02783924|Cholecalciferol|cholecalciferol|mesh-list
5791816|NCT02783924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5791817|NCT02783924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791818|NCT02783924|Vitamins|vitamins|mesh-ancestor
5791819|NCT02783924|Micronutrients|micronutrients|mesh-ancestor
5791820|NCT02783924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5791821|NCT02784015|Cyclophosphamide|cyclophosphamide|mesh-list
5791822|NCT02784015|Melphalan|melphalan|mesh-list
5791823|NCT02784015|Ifosfamide|ifosfamide|mesh-list
5791824|NCT02784015|Thiotepa|thiotepa|mesh-list
5791825|NCT02784015|Carboplatin|carboplatin|mesh-list
6491462|NCT00602524|Cholinergic Agents|cholinergic agents|mesh-ancestor
5693937|NCT03398811|Progestins|progestins|mesh-ancestor
5693938|NCT03398811|Hormones|hormones|mesh-ancestor
5693939|NCT03398811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5693940|NCT03398811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693941|NCT03398811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5693942|NCT03398811|Contraceptive Agents|contraceptive agents|mesh-ancestor
5693943|NCT03398811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5791826|NCT02784015|Doxorubicin|doxorubicin|mesh-list
5791827|NCT02784015|Etoposide|etoposide|mesh-list
5791828|NCT02784015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5791829|NCT02784015|Immunologic Factors|immunologic factors|mesh-ancestor
5791830|NCT02784015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791831|NCT02784015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5791832|NCT02784015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5791833|NCT02784015|Alkylating Agents|alkylating agents|mesh-ancestor
5791834|NCT02784015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791835|NCT02784015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5791836|NCT02784015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5791837|NCT02784015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6491463|NCT00602524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6491464|NCT00602524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491465|NCT00602550|Zidovudine|zidovudine|mesh-list
6491466|NCT00602550|Antimetabolites|antimetabolites|mesh-ancestor
6491467|NCT00602550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491468|NCT00602550|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6491469|NCT00602550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6491470|NCT00602550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5791838|NCT02784015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5791839|NCT02784015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5791840|NCT02784015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6491471|NCT00602550|Antiviral Agents|antiviral agents|mesh-ancestor
6491472|NCT00602550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6491473|NCT00602550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6491474|NCT00602550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6491475|NCT00602589|Levofloxacin|levofloxacin|mesh-list
6491476|NCT00602589|Ofloxacin|ofloxacin|mesh-list
6491477|NCT00602589|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5791841|NCT02784015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5791842|NCT02783989|4-hydroxyphenylethanol|4-hydroxyphenylethanol|mesh-list
5791843|NCT02783989|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5791844|NCT02783989|Antioxidants|antioxidants|mesh-ancestor
5791845|NCT02783989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791846|NCT02783989|Protective Agents|protective agents|mesh-ancestor
5791847|NCT02783989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791848|NCT02783976|Sofosbuvir|sofosbuvir|mesh-list
5791849|NCT02783976|Antiviral Agents|antiviral agents|mesh-ancestor
5791850|NCT02783976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5791851|NCT02783937|Lenograstim|lenograstim|mesh-list
5791852|NCT02783937|Sargramostim|sargramostim|mesh-list
5791853|NCT02783937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5791854|NCT02783937|Immunologic Factors|immunologic factors|mesh-ancestor
5791855|NCT02783937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791856|NCT02783859|Amoxicillin|amoxicillin|mesh-list
5791857|NCT02783859|Clavulanic Acids|clavulanic acids|mesh-list
5791858|NCT02783859|Clavulanic Acid|clavulanic acid|mesh-list
5791859|NCT02783859|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5791860|NCT02783859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5791861|NCT02783859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5791862|NCT02783859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5791863|NCT02783859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791864|NCT02783859|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5791865|NCT02783846|Dexmedetomidine|dexmedetomidine|mesh-list
5791866|NCT02783846|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5791867|NCT02783846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5791868|NCT02783846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791869|NCT02783846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5791870|NCT02783846|Analgesics|analgesics|mesh-ancestor
5791871|NCT02783846|Sensory System Agents|sensory system agents|mesh-ancestor
5791872|NCT02783846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5791873|NCT02783846|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5791874|NCT02783846|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5791875|NCT02783846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6491478|NCT00602589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6491479|NCT00602589|Renal Agents|renal agents|mesh-ancestor
6491480|NCT00602589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6491481|NCT00602589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6491482|NCT00602589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6491483|NCT00602589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6491484|NCT00602589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491485|NCT00602589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6491486|NCT00602589|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5791876|NCT02783846|Adrenergic Agents|adrenergic agents|mesh-ancestor
5791877|NCT02783846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5791878|NCT02783846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791879|NCT02783378|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
5791880|NCT02783378|Antacids|antacids|mesh-ancestor
5791881|NCT02783378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791882|NCT02783378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5791883|NCT02783508|Meperidine|meperidine|mesh-list
5791884|NCT02783508|Nitrous Oxide|nitrous oxide|mesh-list
5791885|NCT02783508|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5791886|NCT02783508|Anesthetics, General|anesthetics, general|mesh-ancestor
5791887|NCT02783508|Anesthetics|anesthetics|mesh-ancestor
5791888|NCT02783508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5791889|NCT02783508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791890|NCT02783508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5791891|NCT02783508|Analgesics|analgesics|mesh-ancestor
5791892|NCT02783508|Sensory System Agents|sensory system agents|mesh-ancestor
5791893|NCT02783508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5791894|NCT02783508|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5791895|NCT02783508|Narcotics|narcotics|mesh-ancestor
5791896|NCT02783508|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5791897|NCT02783482|Immunoglobulins|immunoglobulins|mesh-list
5791898|NCT02783482|gamma-Globulins|gamma-globulins|mesh-list
5791899|NCT02783482|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5791900|NCT02783482|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5791901|NCT02783482|Immunologic Factors|immunologic factors|mesh-ancestor
5791902|NCT02783482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791903|NCT02783586|Bupivacaine|bupivacaine|mesh-list
5791904|NCT02783586|Anesthetics, Local|anesthetics, local|mesh-ancestor
5791905|NCT02783586|Anesthetics|anesthetics|mesh-ancestor
5791906|NCT02783586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5791907|NCT02783586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791908|NCT02783586|Sensory System Agents|sensory system agents|mesh-ancestor
5791909|NCT02783586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5791910|NCT02783547|Azacitidine|azacitidine|mesh-list
5791911|NCT02783547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5791912|NCT02783547|Antimetabolites|antimetabolites|mesh-ancestor
5791913|NCT02783547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791914|NCT02783547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5791915|NCT02783547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5791916|NCT02783430|Ketamine|ketamine|mesh-list
5791917|NCT02783430|Milnacipran|milnacipran|mesh-list
5791918|NCT02783430|Levomilnacipran|levomilnacipran|mesh-list
5791919|NCT02783430|Analgesics|analgesics|mesh-ancestor
5791920|NCT02783430|Sensory System Agents|sensory system agents|mesh-ancestor
5791921|NCT02783430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5791922|NCT02783430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791923|NCT02783430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5791924|NCT02783430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5791925|NCT02783430|Anesthetics, General|anesthetics, general|mesh-ancestor
5791926|NCT02783430|Anesthetics|anesthetics|mesh-ancestor
5791927|NCT02783430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5791928|NCT02783430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5791929|NCT02783430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5791930|NCT02783430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5791931|NCT02783430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791932|NCT02783430|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5791933|NCT02783430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5791934|NCT02783430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5791935|NCT02783430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5791936|NCT02783430|Antidepressive Agents|antidepressive agents|mesh-ancestor
5791937|NCT02783430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5791938|NCT02783638|Pregabalin|pregabalin|mesh-list
5791939|NCT02783638|Analgesics|analgesics|mesh-ancestor
5791940|NCT02783638|Sensory System Agents|sensory system agents|mesh-ancestor
5791941|NCT02783638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5791942|NCT02783638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791943|NCT02783638|Anticonvulsants|anticonvulsants|mesh-ancestor
5791944|NCT02783638|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5791945|NCT02783638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5791946|NCT02783638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791947|NCT02783638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5791948|NCT02783638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5791949|NCT02783638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5791950|NCT02783638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5791951|NCT02783638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5791952|NCT02783404|Amoxicillin|amoxicillin|mesh-list
5791953|NCT02783404|Clavulanic Acid|clavulanic acid|mesh-list
5791954|NCT02783404|Clavulanic Acids|clavulanic acids|mesh-list
5791955|NCT02783404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5791956|NCT02783404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5791957|NCT02783404|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5791958|NCT02783404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5791959|NCT02783404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791960|NCT02783300|Pembrolizumab|pembrolizumab|mesh-list
5791961|NCT02783300|GSK-3326595|gsk-3326595|mesh-list
5791962|NCT02783300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5791963|NCT02783300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5791964|NCT02783300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5791965|NCT02783300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791966|NCT02783053|Metformin|metformin|mesh-list
5791967|NCT02783053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5791968|NCT02783053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899182|NCT04737603|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
5899183|NCT04737603|Naloxone|naloxone|mesh-list
5899184|NCT04737603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5899185|NCT04737603|Narcotics|narcotics|mesh-ancestor
5899186|NCT04737603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5899187|NCT04737603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899188|NCT04737603|Analgesics|analgesics|mesh-ancestor
5899189|NCT04737603|Sensory System Agents|sensory system agents|mesh-ancestor
5899190|NCT04737603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5899191|NCT04737603|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5899192|NCT04655976|Docetaxel|docetaxel|mesh-list
5899193|NCT04655976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5899194|NCT04655976|Tubulin Modulators|tubulin modulators|mesh-ancestor
5899195|NCT04655976|Antimitotic Agents|antimitotic agents|mesh-ancestor
5899196|NCT04655976|Mitosis Modulators|mitosis modulators|mesh-ancestor
5899197|NCT04655976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899198|NCT04651166|Tranexamic Acid|tranexamic acid|mesh-list
5899199|NCT04651166|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5899200|NCT04651166|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5899201|NCT04651166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899202|NCT04651166|Hemostatics|hemostatics|mesh-ancestor
5899203|NCT04651166|Coagulants|coagulants|mesh-ancestor
5899204|NCT04637620|Sertraline|sertraline|mesh-list
5899205|NCT04637620|Antidepressive Agents|antidepressive agents|mesh-ancestor
5899206|NCT04637620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5899207|NCT04637620|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5899208|NCT04637620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5899209|NCT04637620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5899210|NCT04637620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899211|NCT04637620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5899212|NCT04637620|Serotonin Agents|serotonin agents|mesh-ancestor
5899213|NCT04637620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5908146|NCT04860713|Ketamine|ketamine|mesh-list
5908147|NCT04860713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5908148|NCT04860713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5908149|NCT04860713|Analgesics|analgesics|mesh-ancestor
5908150|NCT04860713|Sensory System Agents|sensory system agents|mesh-ancestor
5908151|NCT04860713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5908152|NCT04860713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5908153|NCT04860713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5908154|NCT04860713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5908155|NCT04860713|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5908156|NCT04860713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5908157|NCT04860713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908158|NCT04860713|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5791969|NCT02783144|Dexamethasone|dexamethasone|mesh-list
5791970|NCT02783144|Dexamethasone acetate|dexamethasone acetate|mesh-list
5791971|NCT02783144|BB 1101|bb 1101|mesh-list
5791972|NCT02783144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5791973|NCT02783144|Antiemetics|antiemetics|mesh-ancestor
5791974|NCT02783144|Autonomic Agents|autonomic agents|mesh-ancestor
5791975|NCT02783144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5791976|NCT02783144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791977|NCT02783144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5791978|NCT02783144|Glucocorticoids|glucocorticoids|mesh-ancestor
5791979|NCT02783144|Hormones|hormones|mesh-ancestor
5791980|NCT02783144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5791981|NCT02783144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5791982|NCT02783144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5791983|NCT02783144|Protease Inhibitors|protease inhibitors|mesh-ancestor
5791984|NCT02783144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5791985|NCT02783144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5791986|NCT02783040|Digoxin|digoxin|mesh-list
5791987|NCT02783040|Midazolam|midazolam|mesh-list
5791988|NCT02783040|BI 425809|bi 425809|mesh-list
5791989|NCT02783040|Omeprazole|omeprazole|mesh-list
5791990|NCT02783040|Warfarin|warfarin|mesh-list
5791991|NCT02783040|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5791992|NCT02783040|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5791993|NCT02783040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5791994|NCT02783040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5791995|NCT02783040|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5791996|NCT02783040|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5791997|NCT02783040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5791998|NCT02783040|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5791999|NCT02783040|Anesthetics, General|anesthetics, general|mesh-ancestor
5792000|NCT02783040|Anesthetics|anesthetics|mesh-ancestor
5792001|NCT02783040|GABA Modulators|gaba modulators|mesh-ancestor
5792002|NCT02783040|GABA Agents|gaba agents|mesh-ancestor
5792003|NCT02783040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5792004|NCT02783040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792005|NCT02783040|Anticoagulants|anticoagulants|mesh-ancestor
5792006|NCT02783040|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5792007|NCT02783040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5792008|NCT02783040|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5792009|NCT02783040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5792010|NCT02783040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5792011|NCT02783040|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5792012|NCT02783040|Protective Agents|protective agents|mesh-ancestor
5792013|NCT02783040|Nootropic Agents|nootropic agents|mesh-ancestor
5792014|NCT02783183|Pregabalin|pregabalin|mesh-list
5792015|NCT02783183|Analgesics|analgesics|mesh-ancestor
5792016|NCT02783183|Sensory System Agents|sensory system agents|mesh-ancestor
5792017|NCT02783183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5792018|NCT02783183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792019|NCT02783183|Anticonvulsants|anticonvulsants|mesh-ancestor
5792020|NCT02783183|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5792021|NCT02783183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5792022|NCT02783183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792023|NCT02783183|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5792024|NCT02783183|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5792025|NCT02783183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5792026|NCT02783183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5792027|NCT02783183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5792028|NCT02783092|Cannabidiol|cannabidiol|mesh-list
5792029|NCT02783092|Anticonvulsants|anticonvulsants|mesh-ancestor
5792030|NCT02783196|Liraglutide|liraglutide|mesh-list
5792031|NCT02783196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5792032|NCT02783196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792033|NCT02783196|Incretins|incretins|mesh-ancestor
5792034|NCT02783196|Hormones|hormones|mesh-ancestor
5792035|NCT02783196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5792036|NCT02783222|Paclitaxel|paclitaxel|mesh-list
5792037|NCT02783222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5792038|NCT02783222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5792039|NCT02783222|Tubulin Modulators|tubulin modulators|mesh-ancestor
5792040|NCT02783222|Antimitotic Agents|antimitotic agents|mesh-ancestor
5792041|NCT02783222|Mitosis Modulators|mitosis modulators|mesh-ancestor
5792042|NCT02783222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792043|NCT02782819|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5792044|NCT02782897|Immunoglobulins|immunoglobulins|mesh-list
5792045|NCT02782897|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5792046|NCT02782897|Antibodies|antibodies|mesh-list
5792047|NCT02782897|Immunologic Factors|immunologic factors|mesh-ancestor
6491487|NCT00602589|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6491488|NCT00602615|Torsemide|torsemide|mesh-list
6491489|NCT00602615|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6491490|NCT00602615|Diuretics|diuretics|mesh-ancestor
6491491|NCT00602615|Natriuretic Agents|natriuretic agents|mesh-ancestor
6491492|NCT00602615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491493|NCT00602615|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6491494|NCT00602615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6491495|NCT00602615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491496|NCT00602680|Donepezil|donepezil|mesh-list
6491497|NCT00602680|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6491498|NCT00602680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6491499|NCT00602680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491500|NCT00602680|Cholinergic Agents|cholinergic agents|mesh-ancestor
6491501|NCT00602680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6491502|NCT00602680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491503|NCT00602680|Nootropic Agents|nootropic agents|mesh-ancestor
6491504|NCT00602693|Sirolimus|sirolimus|mesh-list
6491505|NCT00602693|Cyclophosphamide|cyclophosphamide|mesh-list
6491506|NCT00602693|Fludarabine|fludarabine|mesh-list
6491507|NCT00602693|Fludarabine phosphate|fludarabine phosphate|mesh-list
6491508|NCT00602693|Allopurinol|allopurinol|mesh-list
6491509|NCT00602693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6491510|NCT00602693|Immunologic Factors|immunologic factors|mesh-ancestor
6491511|NCT00602693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491512|NCT00602693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6491513|NCT00602693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6491514|NCT00602693|Alkylating Agents|alkylating agents|mesh-ancestor
6491515|NCT00602693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491516|NCT00602693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6491517|NCT00602693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6491518|NCT00602693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6491519|NCT00602693|Antimetabolites|antimetabolites|mesh-ancestor
6491520|NCT00602693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5792048|NCT02782897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792049|NCT02782624|Empagliflozin|empagliflozin|mesh-list
5792050|NCT02782624|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5792051|NCT02782624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792052|NCT02782624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5899214|NCT04595994|Gemcitabine|gemcitabine|mesh-list
5792053|NCT02782624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792054|NCT02782754|Cyclophosphamide|cyclophosphamide|mesh-list
5792055|NCT02782754|Carboplatin|carboplatin|mesh-list
5792056|NCT02782754|Etoposide|etoposide|mesh-list
5792057|NCT02782754|Bleomycin|bleomycin|mesh-list
5792058|NCT02782754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5792059|NCT02782754|Immunologic Factors|immunologic factors|mesh-ancestor
5792060|NCT02782754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792061|NCT02782754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5792062|NCT02782754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5792063|NCT02782754|Alkylating Agents|alkylating agents|mesh-ancestor
5792064|NCT02782754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792065|NCT02782754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5792066|NCT02782754|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5792067|NCT02782754|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5792068|NCT02782754|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5792069|NCT02782754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5792070|NCT02782754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5792071|NCT02782754|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5792072|NCT02782559|Sildenafil Citrate|sildenafil citrate|mesh-list
5792073|NCT02782559|Vasodilator Agents|vasodilator agents|mesh-ancestor
5792074|NCT02782559|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5792075|NCT02782559|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5792076|NCT02782559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5792077|NCT02782559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792078|NCT02782559|Urological Agents|urological agents|mesh-ancestor
5792079|NCT02782338|Diclofenac|diclofenac|mesh-list
5792080|NCT02782338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5792081|NCT02782338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5792082|NCT02782338|Analgesics|analgesics|mesh-ancestor
5792083|NCT02782338|Sensory System Agents|sensory system agents|mesh-ancestor
5792084|NCT02782338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5792085|NCT02782338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792086|NCT02782338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5792087|NCT02782338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5792088|NCT02782338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5792089|NCT02782338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5792090|NCT02782338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792091|NCT02782260|Dipyridamole|dipyridamole|mesh-list
5792092|NCT02782260|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5792093|NCT02782260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5792094|NCT02782260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792095|NCT02782260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5792096|NCT02782260|Vasodilator Agents|vasodilator agents|mesh-ancestor
5792097|NCT02782273|Ketorolac|ketorolac|mesh-list
5792098|NCT02782273|Morphine|morphine|mesh-list
5792099|NCT02782273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5792100|NCT02782273|Narcotics|narcotics|mesh-ancestor
5792101|NCT02782273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5792102|NCT02782273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792103|NCT02782273|Analgesics|analgesics|mesh-ancestor
5792104|NCT02782273|Sensory System Agents|sensory system agents|mesh-ancestor
5792105|NCT02782273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5792106|NCT02782273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5792107|NCT02782273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5792108|NCT02782273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5792109|NCT02782273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5792110|NCT02782273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5792111|NCT02782273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5792112|NCT02782273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792113|NCT02782312|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
5792114|NCT02782312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5792115|NCT02782312|Autonomic Agents|autonomic agents|mesh-ancestor
5792116|NCT02782312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5792117|NCT02782312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792118|NCT02782312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5792119|NCT02782312|Respiratory System Agents|respiratory system agents|mesh-ancestor
5792120|NCT02782312|Glucocorticoids|glucocorticoids|mesh-ancestor
5792121|NCT02782312|Hormones|hormones|mesh-ancestor
5792122|NCT02782312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5792123|NCT02782312|Sympathomimetics|sympathomimetics|mesh-ancestor
5792124|NCT02782403|Axitinib|axitinib|mesh-list
5792125|NCT02782403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5792126|NCT02782403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5792127|NCT02782403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5792128|NCT02782403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792129|NCT02782546|Mycophenolic Acid|mycophenolic acid|mesh-list
5792130|NCT02782546|Tacrolimus|tacrolimus|mesh-list
5792131|NCT02782546|Sargramostim|sargramostim|mesh-list
5792132|NCT02782546|Lenograstim|lenograstim|mesh-list
5792133|NCT02782546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5792134|NCT02782546|Immunologic Factors|immunologic factors|mesh-ancestor
5792135|NCT02782546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792136|NCT02782546|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5792137|NCT02782546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5792138|NCT02782546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792139|NCT02782546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5792140|NCT02782546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5792141|NCT02782546|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5792142|NCT02782546|Antitubercular Agents|antitubercular agents|mesh-ancestor
5792143|NCT02782546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5792144|NCT02782546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5792145|NCT02782546|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5792146|NCT02782481|Levodopa|levodopa|mesh-list
5792147|NCT02782481|Carbidopa|carbidopa|mesh-list
5792148|NCT02782481|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5792149|NCT02782481|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5792150|NCT02782481|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5792151|NCT02782481|Dopamine Agents|dopamine agents|mesh-ancestor
5792152|NCT02782481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5792153|NCT02782481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792154|NCT02782481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792155|NCT02782481|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5792156|NCT02782481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5792157|NCT02782286|Ketorolac|ketorolac|mesh-list
5792158|NCT02782286|Morphine|morphine|mesh-list
5792159|NCT02782286|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5792160|NCT02782286|Narcotics|narcotics|mesh-ancestor
5792161|NCT02782286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5792162|NCT02782286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792163|NCT02782286|Analgesics|analgesics|mesh-ancestor
5792164|NCT02782286|Sensory System Agents|sensory system agents|mesh-ancestor
5792165|NCT02782286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5792166|NCT02782286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5792167|NCT02782286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5792168|NCT02782286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5792169|NCT02782286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5792170|NCT02782286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5792171|NCT02782286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5899215|NCT04595994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6491521|NCT00602693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6491522|NCT00602693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6491523|NCT00602693|Antifungal Agents|antifungal agents|mesh-ancestor
6491524|NCT00602693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6491525|NCT00602693|Gout Suppressants|gout suppressants|mesh-ancestor
6491526|NCT00602693|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6491527|NCT00602693|Antioxidants|antioxidants|mesh-ancestor
6491528|NCT00602693|Protective Agents|protective agents|mesh-ancestor
5792172|NCT02782286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792173|NCT02782429|Ketamine|ketamine|mesh-list
5792174|NCT02782429|Analgesics|analgesics|mesh-ancestor
5792175|NCT02782429|Sensory System Agents|sensory system agents|mesh-ancestor
5792176|NCT02782429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5792177|NCT02782429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792178|NCT02782429|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5792179|NCT02782429|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5792180|NCT02782429|Anesthetics, General|anesthetics, general|mesh-ancestor
5792181|NCT02782429|Anesthetics|anesthetics|mesh-ancestor
5792182|NCT02782429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5792183|NCT02782429|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5792184|NCT02782429|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5792185|NCT02782429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5792186|NCT02782429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792187|NCT02782221|Hormones|hormones|mesh-list
5792188|NCT02782221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5792189|NCT02782221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792190|NCT02782208|Acipimox|acipimox|mesh-list
5792191|NCT02782208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5792192|NCT02782208|Antimetabolites|antimetabolites|mesh-ancestor
5792193|NCT02782208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792194|NCT02782208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5792195|NCT02782182|Leucovorin|leucovorin|mesh-list
6491529|NCT00602706|Melphalan|melphalan|mesh-list
6491530|NCT00602706|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
6491531|NCT00602706|Sargramostim|sargramostim|mesh-list
5792196|NCT02782182|Oxaliplatin|oxaliplatin|mesh-list
5792197|NCT02782182|Irinotecan|irinotecan|mesh-list
5792198|NCT02782182|Folfirinox|folfirinox|mesh-list
5792199|NCT02782182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5792200|NCT02782182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5792201|NCT02782182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5792202|NCT02782182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5792203|NCT02782182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792204|NCT02782182|Antidotes|antidotes|mesh-ancestor
6491532|NCT00602706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6491533|NCT00602706|Alkylating Agents|alkylating agents|mesh-ancestor
6491534|NCT00602706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491535|NCT00602706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6491536|NCT00602706|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6491537|NCT00602706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5792205|NCT02782182|Protective Agents|protective agents|mesh-ancestor
5792206|NCT02782182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792207|NCT02782182|Vitamin B Complex|vitamin b complex|mesh-ancestor
5792208|NCT02782182|Vitamins|vitamins|mesh-ancestor
5792209|NCT02782182|Micronutrients|micronutrients|mesh-ancestor
5792210|NCT02782078|Clindamycin|clindamycin|mesh-list
5792211|NCT02782078|Clindamycin palmitate|clindamycin palmitate|mesh-list
5792212|NCT02782078|Clindamycin phosphate|clindamycin phosphate|mesh-list
5792213|NCT02782078|Rifampin|rifampin|mesh-list
5792214|NCT02782078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5792215|NCT02782078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5792216|NCT02782078|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5792217|NCT02782078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5792218|NCT02782078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792219|NCT02782078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5792220|NCT02782078|Antitubercular Agents|antitubercular agents|mesh-ancestor
5792221|NCT02782078|Leprostatic Agents|leprostatic agents|mesh-ancestor
5792222|NCT02782078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5792223|NCT02782078|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5792224|NCT02782078|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5792225|NCT02782078|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5792226|NCT02782078|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5792227|NCT02782078|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5792228|NCT02782078|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5792229|NCT02782052|Bromides|bromides|mesh-list
5792230|NCT02782052|Albuterol|albuterol|mesh-list
5792231|NCT02782052|Ipratropium|ipratropium|mesh-list
5792232|NCT02782052|Anticonvulsants|anticonvulsants|mesh-ancestor
5792233|NCT02782052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5792234|NCT02782052|Autonomic Agents|autonomic agents|mesh-ancestor
5792235|NCT02782052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5792236|NCT02782052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792237|NCT02782052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5792238|NCT02782052|Respiratory System Agents|respiratory system agents|mesh-ancestor
5792239|NCT02782052|Tocolytic Agents|tocolytic agents|mesh-ancestor
5792240|NCT02782052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5792241|NCT02782052|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5792242|NCT02782052|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5792243|NCT02782052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5792244|NCT02782052|Adrenergic Agents|adrenergic agents|mesh-ancestor
5792245|NCT02782052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5792246|NCT02782052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792247|NCT02782052|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5792248|NCT02782052|Cholinergic Agents|cholinergic agents|mesh-ancestor
5792249|NCT02781909|Ibuprofen|ibuprofen|mesh-list
5792250|NCT02781909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5792251|NCT02781909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5792252|NCT02781909|Analgesics|analgesics|mesh-ancestor
5792253|NCT02781909|Sensory System Agents|sensory system agents|mesh-ancestor
5792254|NCT02781909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5792255|NCT02781909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792256|NCT02781909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5792257|NCT02781909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5792258|NCT02781909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5792259|NCT02781909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5792260|NCT02781909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792261|NCT02781766|Thrombin|thrombin|mesh-list
5792262|NCT02781766|Hemostatics|hemostatics|mesh-ancestor
5792263|NCT02781766|Coagulants|coagulants|mesh-ancestor
5792264|NCT02781597|Tranexamic Acid|tranexamic acid|mesh-list
5792265|NCT02781597|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5792266|NCT02781597|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5792267|NCT02781597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792268|NCT02781597|Hemostatics|hemostatics|mesh-ancestor
5792269|NCT02781597|Coagulants|coagulants|mesh-ancestor
5792270|NCT02781805|Alendronate|alendronate|mesh-list
5792271|NCT02781805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5792272|NCT02781805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792278|NCT02781493|Prucalopride|prucalopride|mesh-list
5792279|NCT02781493|Laxatives|laxatives|mesh-ancestor
5792280|NCT02781493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5792281|NCT02781493|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
5792282|NCT02781493|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5792283|NCT02781493|Serotonin Agents|serotonin agents|mesh-ancestor
5792284|NCT02781493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5792285|NCT02781493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491538|NCT00602706|Immunologic Factors|immunologic factors|mesh-ancestor
6491539|NCT00602706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491540|NCT00602706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6491541|NCT00602706|Analgesics|analgesics|mesh-ancestor
6491542|NCT00602706|Sensory System Agents|sensory system agents|mesh-ancestor
6491543|NCT00602706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6491544|NCT00602719|Zolpidem|zolpidem|mesh-list
6491545|NCT00602719|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6491546|NCT00602719|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6491547|NCT00602719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6491548|NCT00602719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491549|NCT00602719|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6491550|NCT00602719|GABA Agonists|gaba agonists|mesh-ancestor
5792286|NCT02781493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792287|NCT02781753|Interferons|interferons|mesh-list
5792288|NCT02781753|Interferon-alpha|interferon-alpha|mesh-list
5792289|NCT02781753|Interferon alpha-2|interferon alpha-2|mesh-list
5792290|NCT02781753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5792291|NCT02781753|Antiviral Agents|antiviral agents|mesh-ancestor
5792292|NCT02781753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5792293|NCT02781753|Immunologic Factors|immunologic factors|mesh-ancestor
5792294|NCT02781753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792295|NCT02781779|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
5792296|NCT02781779|Laxatives|laxatives|mesh-ancestor
5792297|NCT02781779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5792298|NCT02781467|Cyclophosphamide|cyclophosphamide|mesh-list
5792299|NCT02781467|Fludarabine|fludarabine|mesh-list
5792300|NCT02781467|Interleukin-2|interleukin-2|mesh-list
5792301|NCT02781467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5792302|NCT02781467|Immunologic Factors|immunologic factors|mesh-ancestor
5792303|NCT02781467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792304|NCT02781467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5792305|NCT02781467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5792306|NCT02781467|Alkylating Agents|alkylating agents|mesh-ancestor
5792307|NCT02781467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792308|NCT02781467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5792309|NCT02781467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5792310|NCT02781467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5792311|NCT02781467|Analgesics|analgesics|mesh-ancestor
5792312|NCT02781467|Sensory System Agents|sensory system agents|mesh-ancestor
5792313|NCT02781467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5792314|NCT02781506|Nivolumab|nivolumab|mesh-list
5792315|NCT02781506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5792316|NCT02781506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5792317|NCT02781506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5792318|NCT02781506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899216|NCT04595994|Antimetabolites|antimetabolites|mesh-ancestor
5899217|NCT04595994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899218|NCT04595994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5899219|NCT04595994|Antiviral Agents|antiviral agents|mesh-ancestor
5899220|NCT04595994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5899221|NCT04595994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5899222|NCT04595994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5899223|NCT04595994|Immunologic Factors|immunologic factors|mesh-ancestor
5899224|NCT04595994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899225|NCT04595565|Carboplatin|carboplatin|mesh-list
5899226|NCT04595565|Capecitabine|capecitabine|mesh-list
5899227|NCT04595565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5899228|NCT04595565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5899229|NCT04595565|Antimetabolites|antimetabolites|mesh-ancestor
5899230|NCT04595565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491551|NCT00602719|GABA Agents|gaba agents|mesh-ancestor
6491552|NCT00602719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6491553|NCT00602719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491554|NCT00602849|Sertraline|sertraline|mesh-list
5899231|NCT04584255|Niraparib|niraparib|mesh-list
5899232|NCT04584255|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5899233|NCT04584255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5899234|NCT04584255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899235|NCT04584255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5899236|NCT04563845|Moxifloxacin|moxifloxacin|mesh-list
5899237|NCT04563845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5899238|NCT04563845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5899239|NCT04563845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5899240|NCT04563845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5899241|NCT04563845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5899242|NCT04563845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899243|NCT04563845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5899244|NCT04563559|Prednisolone|prednisolone|mesh-list
5899245|NCT04563559|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5899246|NCT04563559|Methylprednisolone|methylprednisolone|mesh-list
6491555|NCT00602849|Antidepressive Agents|antidepressive agents|mesh-ancestor
6491556|NCT00602849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6491557|NCT00602849|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5792319|NCT02781415|Morphine|morphine|mesh-list
5792320|NCT02781415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5792321|NCT02781415|Narcotics|narcotics|mesh-ancestor
5792322|NCT02781415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5792323|NCT02781415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792324|NCT02781415|Analgesics|analgesics|mesh-ancestor
5792325|NCT02781415|Sensory System Agents|sensory system agents|mesh-ancestor
5792326|NCT02781415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5792327|NCT02781246|Dexmedetomidine|dexmedetomidine|mesh-list
5792328|NCT02781246|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5792329|NCT02781246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5792330|NCT02781246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792331|NCT02781246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5792332|NCT02781246|Analgesics|analgesics|mesh-ancestor
5792333|NCT02781246|Sensory System Agents|sensory system agents|mesh-ancestor
5792334|NCT02781246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5792335|NCT02781246|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5792336|NCT02781246|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5792337|NCT02781246|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5792338|NCT02781246|Adrenergic Agents|adrenergic agents|mesh-ancestor
5792339|NCT02781246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5792340|NCT02781246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792341|NCT02781064|Atorvastatin|atorvastatin|mesh-list
5792342|NCT02781064|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5792343|NCT02781064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5792344|NCT02781064|Antimetabolites|antimetabolites|mesh-ancestor
5792345|NCT02781064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792346|NCT02781064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5792347|NCT02781064|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5792348|NCT02781064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5792349|NCT02780804|Entinostat|entinostat|mesh-list
5792350|NCT02780804|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
5792351|NCT02780804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5792352|NCT02780804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5792353|NCT02780804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792354|NCT02780882|Pasireotide|pasireotide|mesh-list
5792355|NCT02780882|Hormones|hormones|mesh-ancestor
5792356|NCT02780882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5792357|NCT02780882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792358|NCT02780778|Docetaxel|docetaxel|mesh-list
5792359|NCT02780778|Apatinib|apatinib|mesh-list
5792360|NCT02780778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5792361|NCT02780778|Tubulin Modulators|tubulin modulators|mesh-ancestor
5792362|NCT02780778|Antimitotic Agents|antimitotic agents|mesh-ancestor
5792363|NCT02780778|Mitosis Modulators|mitosis modulators|mesh-ancestor
5792364|NCT02780778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792365|NCT02780778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5792366|NCT02780778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5792367|NCT02780427|Dexmedetomidine|dexmedetomidine|mesh-list
5792368|NCT02780427|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5792369|NCT02780427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5792370|NCT02780427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792371|NCT02780427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5792372|NCT02780427|Analgesics|analgesics|mesh-ancestor
5792373|NCT02780427|Sensory System Agents|sensory system agents|mesh-ancestor
5792374|NCT02780427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5792375|NCT02780427|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5792376|NCT02780427|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5792377|NCT02780427|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5792378|NCT02780427|Adrenergic Agents|adrenergic agents|mesh-ancestor
5792379|NCT02780427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5792380|NCT02780427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792381|NCT02780479|Dexamethasone|dexamethasone|mesh-list
5792382|NCT02780479|Prednisone|prednisone|mesh-list
5792383|NCT02780479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6491558|NCT00602849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5792384|NCT02780479|Antiemetics|antiemetics|mesh-ancestor
5792385|NCT02780479|Autonomic Agents|autonomic agents|mesh-ancestor
5792386|NCT02780479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5792387|NCT02780479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792388|NCT02780479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5792389|NCT02780479|Glucocorticoids|glucocorticoids|mesh-ancestor
5792390|NCT02780479|Hormones|hormones|mesh-ancestor
5792391|NCT02780479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5792392|NCT02780479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5792393|NCT02780479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5792394|NCT02780505|Ascorbic Acid|ascorbic acid|mesh-list
5792395|NCT02780505|Vitamins|vitamins|mesh-ancestor
5792396|NCT02780505|Micronutrients|micronutrients|mesh-ancestor
5792397|NCT02780505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792398|NCT02780505|Antioxidants|antioxidants|mesh-ancestor
5792399|NCT02780505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792400|NCT02780505|Protective Agents|protective agents|mesh-ancestor
5792401|NCT02780102|Methylphenidate|methylphenidate|mesh-list
5792402|NCT02780102|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5792403|NCT02780102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792404|NCT02780102|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5792405|NCT02780102|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5792406|NCT02780102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5792407|NCT02780102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792408|NCT02780102|Dopamine Agents|dopamine agents|mesh-ancestor
5792409|NCT02780102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5792410|NCT02780128|Ceritinib|ceritinib|mesh-list
5792411|NCT02780128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5792412|NCT02780128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5792413|NCT02780128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5792414|NCT02780128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792415|NCT02780245|Tranexamic Acid|tranexamic acid|mesh-list
5792416|NCT02780245|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5792417|NCT02780245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5792418|NCT02780245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792419|NCT02780245|Hemostatics|hemostatics|mesh-ancestor
5792420|NCT02780245|Coagulants|coagulants|mesh-ancestor
5792421|NCT02780323|Celecoxib|celecoxib|mesh-list
5792422|NCT02780323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5792423|NCT02780323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5792424|NCT02780323|Analgesics|analgesics|mesh-ancestor
5792425|NCT02780323|Sensory System Agents|sensory system agents|mesh-ancestor
5792426|NCT02780323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5792427|NCT02780323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792428|NCT02780323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5792429|NCT02780323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5792430|NCT02780323|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5792431|NCT02780323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5792432|NCT02780323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5792433|NCT02780323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792434|NCT02780310|Lenvatinib|lenvatinib|mesh-list
5792435|NCT02780310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5792436|NCT02780310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5792437|NCT02780310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5792438|NCT02780310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792439|NCT02780024|Metformin|metformin|mesh-list
5792440|NCT02780024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5792441|NCT02780024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792442|NCT02779751|Pembrolizumab|pembrolizumab|mesh-list
5792443|NCT02779751|Anastrozole|anastrozole|mesh-list
5792444|NCT02779751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5792445|NCT02779751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5792446|NCT02779751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5792447|NCT02779751|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5792448|NCT02779751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5792449|NCT02779751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5792450|NCT02779751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792451|NCT02779751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6491559|NCT00602849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6491560|NCT00602849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491561|NCT00602849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6491562|NCT00602849|Serotonin Agents|serotonin agents|mesh-ancestor
6673896|NCT01566240|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6673897|NCT01566240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5792452|NCT02779751|Hormone Antagonists|hormone antagonists|mesh-ancestor
5792453|NCT02779751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5792454|NCT02779751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792455|NCT02780011|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5792456|NCT02780011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5792457|NCT02780011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5792458|NCT02779881|Caseins|caseins|mesh-list
5792459|NCT02779881|Chelating Agents|chelating agents|mesh-ancestor
5792460|NCT02779881|Sequestering Agents|sequestering agents|mesh-ancestor
5792461|NCT02779881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899247|NCT04563559|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5899248|NCT04563559|Prednisolone acetate|prednisolone acetate|mesh-list
5899249|NCT04563559|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5899250|NCT04563559|Prednisolone phosphate|prednisolone phosphate|mesh-list
5899251|NCT04563559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5899252|NCT04563559|Glucocorticoids|glucocorticoids|mesh-ancestor
5899253|NCT04563559|Hormones|hormones|mesh-ancestor
5899254|NCT04563559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5899255|NCT04563559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899256|NCT04563559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5899257|NCT04563559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5899258|NCT04563559|Antiemetics|antiemetics|mesh-ancestor
5899259|NCT04563559|Autonomic Agents|autonomic agents|mesh-ancestor
5899260|NCT04563559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5899261|NCT04563559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5899262|NCT04563559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5899263|NCT04563559|Protective Agents|protective agents|mesh-ancestor
5641162|NCT04083963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641163|NCT04083963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5899273|NCT04551430|Nivolumab|nivolumab|mesh-list
5899274|NCT04551430|Ipilimumab|ipilimumab|mesh-list
5899275|NCT04551430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5899276|NCT04551430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6673898|NCT01566240|Tubulin Modulators|tubulin modulators|mesh-ancestor
5641164|NCT04083963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5641165|NCT04083963|Alkylating Agents|alkylating agents|mesh-ancestor
5641166|NCT04083963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5641167|NCT04083963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5641168|NCT04083963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5641169|NCT04083963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5641170|NCT04083963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5792462|NCT02779777|Tipifarnib|tipifarnib|mesh-list
5792463|NCT02779777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5792464|NCT02779959|Prochlorperazine|prochlorperazine|mesh-list
5792465|NCT02779959|Antiemetics|antiemetics|mesh-ancestor
5792466|NCT02779959|Autonomic Agents|autonomic agents|mesh-ancestor
5792467|NCT02779959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5792468|NCT02779959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792469|NCT02779959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5792470|NCT02779959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5792471|NCT02779959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5792472|NCT02779959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5792473|NCT02779959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5792474|NCT02779959|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5792475|NCT02779959|Dopamine Agents|dopamine agents|mesh-ancestor
5792476|NCT02779959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5792477|NCT02779959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792478|NCT02779634|Coenzyme Q10|coenzyme q10|mesh-list
5792479|NCT02779634|Micronutrients|micronutrients|mesh-ancestor
5792480|NCT02779634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792481|NCT02779634|Vitamins|vitamins|mesh-ancestor
5792482|NCT02779348|Warfarin|warfarin|mesh-list
5792483|NCT02779348|Anticoagulants|anticoagulants|mesh-ancestor
5792484|NCT02779608|Docetaxel|docetaxel|mesh-list
5792485|NCT02779608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5792486|NCT02779608|Tubulin Modulators|tubulin modulators|mesh-ancestor
5792487|NCT02779608|Antimitotic Agents|antimitotic agents|mesh-ancestor
5792488|NCT02779608|Mitosis Modulators|mitosis modulators|mesh-ancestor
5792489|NCT02779608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792490|NCT02779582|Progesterone|progesterone|mesh-list
5792491|NCT02779582|Progestins|progestins|mesh-ancestor
5792492|NCT02779582|Hormones|hormones|mesh-ancestor
5792493|NCT02779582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5792494|NCT02779582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792495|NCT02779387|Goserelin|goserelin|mesh-list
5792496|NCT02779387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5792497|NCT02779387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5792498|NCT02779257|Diazoxide|diazoxide|mesh-list
5792499|NCT02779257|Pasireotide|pasireotide|mesh-list
5792500|NCT02779257|Hormones|hormones|mesh-ancestor
5792501|NCT02779257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5792502|NCT02779257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792503|NCT02779257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5792504|NCT02779257|Vasodilator Agents|vasodilator agents|mesh-ancestor
5792505|NCT02779283|Calcium, Dietary|calcium, dietary|mesh-list
5792506|NCT02779283|Leucovorin|leucovorin|mesh-list
5792507|NCT02779283|Folic Acid|folic acid|mesh-list
5792508|NCT02779283|Cytarabine|cytarabine|mesh-list
5792509|NCT02779283|Dexamethasone|dexamethasone|mesh-list
5792510|NCT02779283|Methylprednisolone|methylprednisolone|mesh-list
5792511|NCT02779283|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5792512|NCT02779283|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5792513|NCT02779283|Prednisolone|prednisolone|mesh-list
5641171|NCT04075916|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
5641172|NCT04075916|Antiviral Agents|antiviral agents|mesh-ancestor
5792514|NCT02779283|Prednisolone acetate|prednisolone acetate|mesh-list
5792515|NCT02779283|Dexamethasone acetate|dexamethasone acetate|mesh-list
5792516|NCT02779283|Cyclophosphamide|cyclophosphamide|mesh-list
5792517|NCT02779283|Rituximab|rituximab|mesh-list
5792518|NCT02779283|Doxorubicin|doxorubicin|mesh-list
5792519|NCT02779283|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5792520|NCT02779283|Methotrexate|methotrexate|mesh-list
5792521|NCT02779283|Vincristine|vincristine|mesh-list
5792522|NCT02779283|Sorafenib|sorafenib|mesh-list
5792523|NCT02779283|Sunitinib|sunitinib|mesh-list
5792524|NCT02779283|Dasatinib|dasatinib|mesh-list
5792525|NCT02779283|Idarubicin|idarubicin|mesh-list
5792526|NCT02779283|Ponatinib|ponatinib|mesh-list
5792527|NCT02779283|Idelalisib|idelalisib|mesh-list
5792528|NCT02779283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5792529|NCT02779283|Antibodies|antibodies|mesh-list
5792530|NCT02779283|Immunoglobulins|immunoglobulins|mesh-list
5792531|NCT02779283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5641173|NCT04075916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5641174|NCT04028063|Doxorubicin|doxorubicin|mesh-list
5641175|NCT04028063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5641176|NCT04028063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5641177|NCT04028063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5641178|NCT04028063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5641179|NCT04028063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5641180|NCT04028063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641181|NCT04014075|Trastuzumab|trastuzumab|mesh-list
5792532|NCT02779283|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5792533|NCT02779283|Prednisolone phosphate|prednisolone phosphate|mesh-list
5792534|NCT02779283|BB 1101|bb 1101|mesh-list
5792535|NCT02779283|Calcium|calcium|mesh-list
5792536|NCT02779283|Levoleucovorin|levoleucovorin|mesh-list
5792537|NCT02779283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5792538|NCT02779283|Immunologic Factors|immunologic factors|mesh-ancestor
5792539|NCT02779283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792540|NCT02779283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5792541|NCT02779283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5792542|NCT02779283|Alkylating Agents|alkylating agents|mesh-ancestor
5792543|NCT02779283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792544|NCT02779283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5792545|NCT02779283|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5792546|NCT02779283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5792547|NCT02779283|Antiemetics|antiemetics|mesh-ancestor
5792548|NCT02779283|Autonomic Agents|autonomic agents|mesh-ancestor
5792549|NCT02779283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5792550|NCT02779283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5792551|NCT02779283|Glucocorticoids|glucocorticoids|mesh-ancestor
5792552|NCT02779283|Hormones|hormones|mesh-ancestor
5792553|NCT02779283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5792554|NCT02779283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5792555|NCT02779283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5792556|NCT02779283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5792557|NCT02779283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5792558|NCT02779283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5792559|NCT02779283|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5792560|NCT02779283|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5792561|NCT02779283|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5792562|NCT02779283|Abortifacient Agents|abortifacient agents|mesh-ancestor
5792563|NCT02779283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5792564|NCT02779283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5792565|NCT02779283|Antimetabolites|antimetabolites|mesh-ancestor
5792566|NCT02779283|Dermatologic Agents|dermatologic agents|mesh-ancestor
5792567|NCT02779283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5792568|NCT02779283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5792569|NCT02779283|Antiviral Agents|antiviral agents|mesh-ancestor
5792570|NCT02779283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5792571|NCT02779283|Antidotes|antidotes|mesh-ancestor
5792572|NCT02779283|Protective Agents|protective agents|mesh-ancestor
5792573|NCT02779283|Vitamin B Complex|vitamin b complex|mesh-ancestor
5792574|NCT02779283|Vitamins|vitamins|mesh-ancestor
5792575|NCT02779283|Micronutrients|micronutrients|mesh-ancestor
5792576|NCT02779283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5792577|NCT02779283|Tubulin Modulators|tubulin modulators|mesh-ancestor
5792578|NCT02779283|Antimitotic Agents|antimitotic agents|mesh-ancestor
5792579|NCT02779283|Mitosis Modulators|mitosis modulators|mesh-ancestor
5792580|NCT02779283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5792581|NCT02779283|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5792582|NCT02779283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5792583|NCT02779283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5792584|NCT02779283|Growth Substances|growth substances|mesh-ancestor
5792585|NCT02779283|Growth Inhibitors|growth inhibitors|mesh-ancestor
5792586|NCT02779283|Hematinics|hematinics|mesh-ancestor
5792587|NCT02779283|Protease Inhibitors|protease inhibitors|mesh-ancestor
5792588|NCT02779413|Insulin|insulin|mesh-list
5792589|NCT02779413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5792590|NCT02779413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792591|NCT02779270|Sunscreening Agents|sunscreening agents|mesh-list
5792592|NCT02779270|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5792593|NCT02779270|Protective Agents|protective agents|mesh-ancestor
5792594|NCT02779270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792595|NCT02779270|Dermatologic Agents|dermatologic agents|mesh-ancestor
5792596|NCT02779465|Vitamin D|vitamin d|mesh-list
5792597|NCT02779465|Cholecalciferol|cholecalciferol|mesh-list
5792598|NCT02779465|Vitamins|vitamins|mesh-ancestor
5792599|NCT02779465|Micronutrients|micronutrients|mesh-ancestor
5792600|NCT02779465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792601|NCT02779465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5792602|NCT02779465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5792603|NCT02779530|Diclofenac|diclofenac|mesh-list
5792604|NCT02779530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5792605|NCT02779530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5792606|NCT02779530|Analgesics|analgesics|mesh-ancestor
5792607|NCT02779530|Sensory System Agents|sensory system agents|mesh-ancestor
5792608|NCT02779530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5792609|NCT02779530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792610|NCT02779530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5792611|NCT02779530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5792612|NCT02779530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5792613|NCT02779530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5792614|NCT02779530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792615|NCT02779192|Ebselen|ebselen|mesh-list
5792616|NCT02779192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5792617|NCT02779192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5792618|NCT02779192|Analgesics|analgesics|mesh-ancestor
5792619|NCT02779192|Sensory System Agents|sensory system agents|mesh-ancestor
5792620|NCT02779192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5792621|NCT02779192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792622|NCT02779192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5792623|NCT02779192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5792624|NCT02779192|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5792625|NCT02779192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5792626|NCT02779192|Antioxidants|antioxidants|mesh-ancestor
5792627|NCT02779192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792628|NCT02779192|Protective Agents|protective agents|mesh-ancestor
5792629|NCT02779192|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5792630|NCT02779192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5792631|NCT02779192|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5792632|NCT02778906|Abatacept|abatacept|mesh-list
5792633|NCT02778906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5792634|NCT02778906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792635|NCT02778906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5792636|NCT02778906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5792637|NCT02778906|Immunologic Factors|immunologic factors|mesh-ancestor
5792638|NCT02778906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792639|NCT02778906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5792640|NCT02779569|Decitabine|decitabine|mesh-list
5792641|NCT02779569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5792642|NCT02779569|Antimetabolites|antimetabolites|mesh-ancestor
5792643|NCT02779569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792644|NCT02779569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5792645|NCT02779569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5792646|NCT02778828|Linezolid|linezolid|mesh-list
5792647|NCT02778828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5792648|NCT02778828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5792649|NCT02778828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5792650|NCT02778828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5792651|NCT02778828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792652|NCT02778789|Adalimumab|adalimumab|mesh-list
5792653|NCT02778789|Etanercept|etanercept|mesh-list
5792654|NCT02778789|Golimumab|golimumab|mesh-list
5792655|NCT02778789|Infliximab|infliximab|mesh-list
5792656|NCT02778789|Certolizumab Pegol|certolizumab pegol|mesh-list
5792657|NCT02778789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5792658|NCT02778789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5792659|NCT02778789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5792660|NCT02778789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5792661|NCT02778789|Analgesics|analgesics|mesh-ancestor
5792662|NCT02778789|Sensory System Agents|sensory system agents|mesh-ancestor
5792663|NCT02778789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5792664|NCT02778789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792665|NCT02778789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5792666|NCT02778789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5792667|NCT02778789|Immunologic Factors|immunologic factors|mesh-ancestor
5792668|NCT02778789|Dermatologic Agents|dermatologic agents|mesh-ancestor
5792669|NCT02778789|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
5792670|NCT02778958|Acetaminophen|acetaminophen|mesh-list
5792671|NCT02778958|Ibuprofen|ibuprofen|mesh-list
5792672|NCT02778958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5792673|NCT02778958|Analgesics|analgesics|mesh-ancestor
5792674|NCT02778958|Sensory System Agents|sensory system agents|mesh-ancestor
5792675|NCT02778958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5792676|NCT02778958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792677|NCT02778958|Antipyretics|antipyretics|mesh-ancestor
5792678|NCT02778958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5792679|NCT02778958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5792680|NCT02778958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5792681|NCT02778958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5792682|NCT02778958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5792683|NCT02778958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792684|NCT02778971|Flutemetamol|flutemetamol|mesh-list
5792685|NCT02778971|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5792686|NCT02778971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792687|NCT02778945|Rocuronium|rocuronium|mesh-list
5792688|NCT02778945|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5792689|NCT02778945|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5792690|NCT02778945|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5792691|NCT02778945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5792692|NCT02778945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792693|NCT02778776|Metformin|metformin|mesh-list
5792694|NCT02778776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5792695|NCT02778776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792696|NCT02779101|Pembrolizumab|pembrolizumab|mesh-list
5792697|NCT02779101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5792698|NCT02779101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5792699|NCT02778919|Leuprolide|leuprolide|mesh-list
5792700|NCT02778919|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5792701|NCT02778919|Fertility Agents|fertility agents|mesh-ancestor
5792702|NCT02778919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5792703|NCT02778919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792704|NCT02778919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5792705|NCT02778919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5792706|NCT02779153|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
5792707|NCT02779153|Hormones|hormones|mesh-ancestor
5792708|NCT02779153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5792709|NCT02779153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792710|NCT02778893|Thalidomide|thalidomide|mesh-list
5792711|NCT02778893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5792712|NCT02778893|Immunologic Factors|immunologic factors|mesh-ancestor
5792713|NCT02778893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792714|NCT02778893|Leprostatic Agents|leprostatic agents|mesh-ancestor
5792715|NCT02778893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5792716|NCT02778893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5792717|NCT02778893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5792718|NCT02778893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5792719|NCT02778893|Growth Substances|growth substances|mesh-ancestor
5792720|NCT02778893|Growth Inhibitors|growth inhibitors|mesh-ancestor
5792721|NCT02778893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5792722|NCT02778659|Zolpidem|zolpidem|mesh-list
5792723|NCT02778659|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5792724|NCT02778659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5792725|NCT02778659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5792726|NCT02778659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792727|NCT02778659|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
5792728|NCT02778659|GABA Agonists|gaba agonists|mesh-ancestor
5792729|NCT02778659|GABA Agents|gaba agents|mesh-ancestor
5792730|NCT02778659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5792731|NCT02778659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792732|NCT02778594|Levodopa|levodopa|mesh-list
5792733|NCT02778594|Benserazide|benserazide|mesh-list
5792734|NCT02778594|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5792735|NCT02778594|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5792736|NCT02778594|Dopamine Agents|dopamine agents|mesh-ancestor
5792737|NCT02778594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5792738|NCT02778594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792739|NCT02778594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792740|NCT02778594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5792741|NCT02778425|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
5792742|NCT02778425|Somatostatin|somatostatin|mesh-list
5792743|NCT02778425|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5792744|NCT02778425|Adrenergic Agents|adrenergic agents|mesh-ancestor
5792745|NCT02778425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5792746|NCT02778425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792747|NCT02778425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792748|NCT02778425|Hormones|hormones|mesh-ancestor
5792749|NCT02778425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5792750|NCT02778360|Methylphenidate|methylphenidate|mesh-list
5792751|NCT02778360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5792752|NCT02778360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792753|NCT02778360|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5792754|NCT02778360|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5792755|NCT02778360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5792756|NCT02778360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792757|NCT02778360|Dopamine Agents|dopamine agents|mesh-ancestor
5792758|NCT02778360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5899277|NCT04551430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5899278|NCT04551430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899279|NCT04359017|Lidocaine|lidocaine|mesh-list
5899280|NCT04359017|Anesthetics, Local|anesthetics, local|mesh-ancestor
5899281|NCT04359017|Anesthetics|anesthetics|mesh-ancestor
5899282|NCT04359017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5899283|NCT04359017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899284|NCT04359017|Sensory System Agents|sensory system agents|mesh-ancestor
5899285|NCT04359017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5899286|NCT04359017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5899287|NCT04359017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5899288|NCT04359017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5899289|NCT04359017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5899290|NCT04359017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899291|NCT04353310|Curcumin|curcumin|mesh-list
5899292|NCT04353310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5899293|NCT04353310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5899294|NCT04353310|Analgesics|analgesics|mesh-ancestor
5899295|NCT04353310|Sensory System Agents|sensory system agents|mesh-ancestor
5899296|NCT04353310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5899297|NCT04353310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899298|NCT04353310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5899299|NCT04353310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5899300|NCT04353310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5899301|NCT04353310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5899302|NCT04353310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899303|NCT04345341|Bupivacaine|bupivacaine|mesh-list
5792759|NCT02778308|Gemcitabine|gemcitabine|mesh-list
5792760|NCT02778308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5792761|NCT02778308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5792762|NCT02778308|Antimetabolites|antimetabolites|mesh-ancestor
5792763|NCT02778308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792764|NCT02778308|Antiviral Agents|antiviral agents|mesh-ancestor
5792765|NCT02778308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5792766|NCT02778308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5792767|NCT02778308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5792768|NCT02778308|Immunologic Factors|immunologic factors|mesh-ancestor
5792769|NCT02778308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792770|NCT02778178|Clonidine|clonidine|mesh-list
5792771|NCT02778178|Ropivacaine|ropivacaine|mesh-list
5792772|NCT02778178|Anesthetics, Local|anesthetics, local|mesh-ancestor
5792773|NCT02778178|Anesthetics|anesthetics|mesh-ancestor
5792774|NCT02778178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5792775|NCT02778178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792776|NCT02778178|Sensory System Agents|sensory system agents|mesh-ancestor
5792777|NCT02778178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5792778|NCT02778178|Analgesics|analgesics|mesh-ancestor
5792779|NCT02778178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5792780|NCT02778178|Sympatholytics|sympatholytics|mesh-ancestor
5792781|NCT02778178|Autonomic Agents|autonomic agents|mesh-ancestor
5792782|NCT02778178|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5792783|NCT02778178|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5792784|NCT02778178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5792785|NCT02778178|Adrenergic Agents|adrenergic agents|mesh-ancestor
5792786|NCT02778178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5792787|NCT02778178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792788|NCT02778191|Carboplatin|carboplatin|mesh-list
5792789|NCT02778191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5792790|NCT02777814|Entecavir|entecavir|mesh-list
5792791|NCT02777814|Antiviral Agents|antiviral agents|mesh-ancestor
5792792|NCT02777814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5792793|NCT02777866|Bupivacaine|bupivacaine|mesh-list
5792794|NCT02777866|Anesthetics, Local|anesthetics, local|mesh-ancestor
5792795|NCT02777866|Anesthetics|anesthetics|mesh-ancestor
5792796|NCT02777866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5792797|NCT02777866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792798|NCT02777866|Sensory System Agents|sensory system agents|mesh-ancestor
6491563|NCT00602849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491564|NCT00602862|Bevacizumab|bevacizumab|mesh-list
6491565|NCT00602862|Sorafenib|sorafenib|mesh-list
5792799|NCT02777866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5792800|NCT02777801|Entecavir|entecavir|mesh-list
5792801|NCT02777801|Antiviral Agents|antiviral agents|mesh-ancestor
5792802|NCT02777801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5792803|NCT02777788|Gemcitabine|gemcitabine|mesh-list
5792804|NCT02777788|Paclitaxel|paclitaxel|mesh-list
5792805|NCT02777788|Vinorelbine|vinorelbine|mesh-list
5792806|NCT02777788|Docetaxel|docetaxel|mesh-list
5792807|NCT02777788|Carboplatin|carboplatin|mesh-list
5792808|NCT02777788|Pemetrexed|pemetrexed|mesh-list
5792809|NCT02777788|Cisplatin|cisplatin|mesh-list
5792810|NCT02777788|Nedaplatin|nedaplatin|mesh-list
5899304|NCT04345341|Anesthetics, Local|anesthetics, local|mesh-ancestor
6673899|NCT01566240|Antimitotic Agents|antimitotic agents|mesh-ancestor
5792811|NCT02777788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5792812|NCT02777788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5792813|NCT02777788|Tubulin Modulators|tubulin modulators|mesh-ancestor
5792814|NCT02777788|Antimitotic Agents|antimitotic agents|mesh-ancestor
5792815|NCT02777788|Mitosis Modulators|mitosis modulators|mesh-ancestor
5792816|NCT02777788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792817|NCT02777788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5792818|NCT02777788|Antimetabolites|antimetabolites|mesh-ancestor
5792819|NCT02777788|Antiviral Agents|antiviral agents|mesh-ancestor
5792820|NCT02777788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5792821|NCT02777788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5792822|NCT02777788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5792823|NCT02777788|Immunologic Factors|immunologic factors|mesh-ancestor
5792824|NCT02777788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792825|NCT02777788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5792826|NCT02777788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5792827|NCT02777736|Methotrexate|methotrexate|mesh-list
5792828|NCT02777736|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5792829|NCT02777736|Abortifacient Agents|abortifacient agents|mesh-ancestor
5792830|NCT02777736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5792831|NCT02777736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491566|NCT00602862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6491567|NCT00602862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6491568|NCT00602862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6491569|NCT00602862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6491570|NCT00602862|Growth Substances|growth substances|mesh-ancestor
6491571|NCT00602862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491572|NCT00602862|Growth Inhibitors|growth inhibitors|mesh-ancestor
6491573|NCT00602862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6491574|NCT00602862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6491575|NCT00602862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491576|NCT00602901|Naproxen|naproxen|mesh-list
6491577|NCT00602901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6491578|NCT00602901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6491579|NCT00602901|Analgesics|analgesics|mesh-ancestor
6491580|NCT00602901|Sensory System Agents|sensory system agents|mesh-ancestor
6491581|NCT00602901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6491582|NCT00602901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491583|NCT00602901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6491584|NCT00602901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5792832|NCT02777736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5792833|NCT02777736|Antimetabolites|antimetabolites|mesh-ancestor
5792834|NCT02777736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792835|NCT02777736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5792836|NCT02777736|Dermatologic Agents|dermatologic agents|mesh-ancestor
5792837|NCT02777736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5792838|NCT02777736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5792839|NCT02777736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5792840|NCT02777736|Immunologic Factors|immunologic factors|mesh-ancestor
5792841|NCT02777736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5792842|NCT02777736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5792843|NCT02777710|Durvalumab|durvalumab|mesh-list
5792844|NCT02777710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5792845|NCT02777710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5792846|NCT02777723|Hyaluronic Acid|hyaluronic acid|mesh-list
5792847|NCT02777723|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5792848|NCT02777723|Immunologic Factors|immunologic factors|mesh-ancestor
5792849|NCT02777723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792850|NCT02777723|Viscosupplements|viscosupplements|mesh-ancestor
5792851|NCT02777723|Protective Agents|protective agents|mesh-ancestor
5792852|NCT02777411|Vaccines|vaccines|mesh-list
6491585|NCT00602901|Gout Suppressants|gout suppressants|mesh-ancestor
6491586|NCT00602901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6491587|NCT00602901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6491588|NCT00602901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491589|NCT00603031|Glucagon|glucagon|mesh-list
5792853|NCT02777411|Immunologic Factors|immunologic factors|mesh-ancestor
5792854|NCT02777411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792855|NCT02777489|Perindopril|perindopril|mesh-list
5792856|NCT02777489|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5792857|NCT02777489|Protease Inhibitors|protease inhibitors|mesh-ancestor
5792858|NCT02777489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5792859|NCT02777489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792860|NCT02777489|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5792861|NCT02777580|Tenecteplase|tenecteplase|mesh-list
5792862|NCT02777580|Clopidogrel|clopidogrel|mesh-list
5792863|NCT02777580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5792864|NCT02777580|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5792865|NCT02777580|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5792866|NCT02777580|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5792867|NCT02777580|Purinergic Agents|purinergic agents|mesh-ancestor
5792868|NCT02777580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5792869|NCT02777580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792870|NCT02777580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792871|NCT02777580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5792872|NCT02777580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5792873|NCT02777671|Gliclazide|gliclazide|mesh-list
5792874|NCT02777671|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
5792875|NCT02777671|Anticonvulsants|anticonvulsants|mesh-ancestor
5792876|NCT02777671|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5792877|NCT02777671|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5792878|NCT02777671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5792879|NCT02777671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792880|NCT02777671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5792881|NCT02777671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792882|NCT02777619|Dexmedetomidine|dexmedetomidine|mesh-list
5792883|NCT02777619|Propofol|propofol|mesh-list
5792884|NCT02777619|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5792885|NCT02777619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5792886|NCT02777619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792887|NCT02777619|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5792888|NCT02777619|Anesthetics, General|anesthetics, general|mesh-ancestor
5792889|NCT02777619|Anesthetics|anesthetics|mesh-ancestor
5792890|NCT02777619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5792891|NCT02777619|Analgesics|analgesics|mesh-ancestor
5792892|NCT02777619|Sensory System Agents|sensory system agents|mesh-ancestor
5792893|NCT02777619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5792894|NCT02777619|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5792895|NCT02777619|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5792896|NCT02777619|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5792897|NCT02777619|Adrenergic Agents|adrenergic agents|mesh-ancestor
5792898|NCT02777619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5792899|NCT02777619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792900|NCT02777320|Acetaminophen|acetaminophen|mesh-list
5792901|NCT02777320|Ibuprofen|ibuprofen|mesh-list
5792902|NCT02777320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5792903|NCT02777320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5792904|NCT02777320|Analgesics|analgesics|mesh-ancestor
5792905|NCT02777320|Sensory System Agents|sensory system agents|mesh-ancestor
5792906|NCT02777320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5792907|NCT02777320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792908|NCT02777320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5792909|NCT02777320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5792910|NCT02777320|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5792911|NCT02777320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5792912|NCT02777320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792913|NCT02777320|Antipyretics|antipyretics|mesh-ancestor
5792914|NCT02777229|Tenofovir|tenofovir|mesh-list
5792915|NCT02777229|Lamivudine|lamivudine|mesh-list
5792916|NCT02777229|Efavirenz|efavirenz|mesh-list
5792917|NCT02777229|Dolutegravir|dolutegravir|mesh-list
5792918|NCT02777229|Antiviral Agents|antiviral agents|mesh-ancestor
5792919|NCT02777229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5792920|NCT02777229|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5792921|NCT02777229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5792922|NCT02777229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5792923|NCT02777229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792924|NCT02777229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5792925|NCT02777229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5792926|NCT02777229|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5792927|NCT02777229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5792928|NCT02777229|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5792929|NCT02777229|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5792930|NCT02777229|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5792931|NCT02777229|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5792932|NCT02777229|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5792933|NCT02777229|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5792934|NCT02777190|Misoprostol|misoprostol|mesh-list
5792935|NCT02777190|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5792936|NCT02777190|Abortifacient Agents|abortifacient agents|mesh-ancestor
5792937|NCT02777190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5792938|NCT02777190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792939|NCT02777190|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5792940|NCT02777190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5792941|NCT02777190|Oxytocics|oxytocics|mesh-ancestor
5792942|NCT02777073|Liraglutide|liraglutide|mesh-list
5792943|NCT02777073|Dapagliflozin|dapagliflozin|mesh-list
5792944|NCT02777073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5792945|NCT02777073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792946|NCT02777073|Incretins|incretins|mesh-ancestor
5792947|NCT02777073|Hormones|hormones|mesh-ancestor
5792948|NCT02777073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5792949|NCT02777073|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5792950|NCT02777073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792951|NCT02776956|Atorvastatin|atorvastatin|mesh-list
5792952|NCT02776956|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5792953|NCT02776956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5792954|NCT02776956|Antimetabolites|antimetabolites|mesh-ancestor
5792955|NCT02776956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792956|NCT02776956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5792957|NCT02776956|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5792958|NCT02776956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5792959|NCT02776917|Paclitaxel|paclitaxel|mesh-list
5792960|NCT02776917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5792961|NCT02776917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5792962|NCT02776917|Tubulin Modulators|tubulin modulators|mesh-ancestor
5792963|NCT02776917|Antimitotic Agents|antimitotic agents|mesh-ancestor
5792964|NCT02776917|Mitosis Modulators|mitosis modulators|mesh-ancestor
5792965|NCT02776917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792966|NCT02776943|Hyaluronic Acid|hyaluronic acid|mesh-list
5792967|NCT02776943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5792968|NCT02776943|Immunologic Factors|immunologic factors|mesh-ancestor
5792969|NCT02776943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5792970|NCT02776943|Viscosupplements|viscosupplements|mesh-ancestor
5792971|NCT02776943|Protective Agents|protective agents|mesh-ancestor
5792972|NCT02776748|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5792973|NCT02776748|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5792974|NCT02776748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5792975|NCT02776748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5792976|NCT02776748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792977|NCT02776748|Antiviral Agents|antiviral agents|mesh-ancestor
5792978|NCT02776748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5792979|NCT02776748|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5792980|NCT02776748|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5792981|NCT02776891|Citric Acid|citric acid|mesh-list
5792982|NCT02776891|Sodium Citrate|sodium citrate|mesh-list
5792983|NCT02776891|Gallium citrate|gallium citrate|mesh-list
5792984|NCT02776891|Anticoagulants|anticoagulants|mesh-ancestor
5792985|NCT02776891|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5792986|NCT02776891|Chelating Agents|chelating agents|mesh-ancestor
5792987|NCT02776891|Sequestering Agents|sequestering agents|mesh-ancestor
5792988|NCT02776891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792989|NCT02776891|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5792990|NCT02776722|Tagatose|tagatose|mesh-list
5792991|NCT02776722|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5792992|NCT02776722|Chelating Agents|chelating agents|mesh-ancestor
5792993|NCT02776722|Sequestering Agents|sequestering agents|mesh-ancestor
5792994|NCT02776722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5792995|NCT02776813|Rituximab|rituximab|mesh-list
5792996|NCT02776813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5792997|NCT02776813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5792998|NCT02776813|Immunologic Factors|immunologic factors|mesh-ancestor
5792999|NCT02776813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793000|NCT02776813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5793001|NCT02776761|Vaccines|vaccines|mesh-list
5793002|NCT02776761|Immunologic Factors|immunologic factors|mesh-ancestor
5793003|NCT02776761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899305|NCT04345341|Anesthetics|anesthetics|mesh-ancestor
5899306|NCT04345341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5899307|NCT04345341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899308|NCT04345341|Sensory System Agents|sensory system agents|mesh-ancestor
5793004|NCT02776878|Dasatinib|dasatinib|mesh-list
5793005|NCT02776878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5793006|NCT02776878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5793007|NCT02776878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5793008|NCT02776878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5793009|NCT02776865|Lidocaine|lidocaine|mesh-list
5793010|NCT02776865|Anesthetics, Local|anesthetics, local|mesh-ancestor
5793011|NCT02776865|Anesthetics|anesthetics|mesh-ancestor
5793012|NCT02776865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5793013|NCT02776865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793014|NCT02776865|Sensory System Agents|sensory system agents|mesh-ancestor
5793015|NCT02776865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5793016|NCT02776865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5793017|NCT02776865|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5793018|NCT02776865|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5793019|NCT02776865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5793020|NCT02776865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5793021|NCT02776540|Aspirin|aspirin|mesh-list
5793022|NCT02776540|Clopidogrel|clopidogrel|mesh-list
5793023|NCT02776540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5793024|NCT02776540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5793025|NCT02776540|Analgesics|analgesics|mesh-ancestor
5793026|NCT02776540|Sensory System Agents|sensory system agents|mesh-ancestor
5793027|NCT02776540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5793028|NCT02776540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793029|NCT02776540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5793030|NCT02776540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5793031|NCT02776540|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5793032|NCT02776540|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5793033|NCT02776540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5793034|NCT02776540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6673900|NCT01566240|Mitosis Modulators|mitosis modulators|mesh-ancestor
6673901|NCT01566240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673902|NCT01566253|Acetaminophen|acetaminophen|mesh-list
6673903|NCT01566253|Ketoprofen|ketoprofen|mesh-list
6673904|NCT01566253|Morphine|morphine|mesh-list
5793035|NCT02776540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5793036|NCT02776540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5793037|NCT02776540|Antipyretics|antipyretics|mesh-ancestor
5793038|NCT02776540|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5793039|NCT02776540|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5793040|NCT02776540|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5793041|NCT02776540|Purinergic Agents|purinergic agents|mesh-ancestor
5793042|NCT02776540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5793043|NCT02776527|Apatinib|apatinib|mesh-list
5793044|NCT02776527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5793045|NCT02776527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5793046|NCT02776527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5793047|NCT02776527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5793048|NCT02776163|Docetaxel|docetaxel|mesh-list
5793049|NCT02776163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5793050|NCT02776163|Tubulin Modulators|tubulin modulators|mesh-ancestor
5793051|NCT02776163|Antimitotic Agents|antimitotic agents|mesh-ancestor
5793052|NCT02776163|Mitosis Modulators|mitosis modulators|mesh-ancestor
5793053|NCT02776163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5793054|NCT02776202|Mycophenolic Acid|mycophenolic acid|mesh-list
5793055|NCT02776202|Sirolimus|sirolimus|mesh-list
5793056|NCT02776202|Fludarabine|fludarabine|mesh-list
5793057|NCT02776202|Fludarabine phosphate|fludarabine phosphate|mesh-list
5793058|NCT02776202|Melphalan|melphalan|mesh-list
5793059|NCT02776202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5793060|NCT02776202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5793061|NCT02776202|Antimetabolites|antimetabolites|mesh-ancestor
6673905|NCT01566253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5899309|NCT04345341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5793062|NCT02776202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5793063|NCT02776202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5793064|NCT02776202|Immunologic Factors|immunologic factors|mesh-ancestor
5793065|NCT02776202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793066|NCT02776202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5793067|NCT02776202|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5793068|NCT02776202|Antitubercular Agents|antitubercular agents|mesh-ancestor
5793069|NCT02776202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5793070|NCT02776202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5793071|NCT02776202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5793072|NCT02776202|Antifungal Agents|antifungal agents|mesh-ancestor
5793073|NCT02776202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5793074|NCT02776202|Alkylating Agents|alkylating agents|mesh-ancestor
5793075|NCT02776202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5793076|NCT02776189|Midazolam|midazolam|mesh-list
5793077|NCT02776189|Dexmedetomidine|dexmedetomidine|mesh-list
5793078|NCT02776189|Propofol|propofol|mesh-list
5793079|NCT02776189|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5793080|NCT02776189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5793081|NCT02776189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793082|NCT02776189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5793083|NCT02776189|Anesthetics, General|anesthetics, general|mesh-ancestor
5793084|NCT02776189|Anesthetics|anesthetics|mesh-ancestor
5793085|NCT02776189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5793086|NCT02776189|Analgesics|analgesics|mesh-ancestor
5793087|NCT02776189|Sensory System Agents|sensory system agents|mesh-ancestor
5793088|NCT02776189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5793089|NCT02776189|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5793090|NCT02776189|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5793091|NCT02776189|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5793092|NCT02776189|Adrenergic Agents|adrenergic agents|mesh-ancestor
5793093|NCT02776189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5793094|NCT02776189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5793095|NCT02776189|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5793096|NCT02776189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5793097|NCT02776189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5793098|NCT02776189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5793099|NCT02776189|GABA Modulators|gaba modulators|mesh-ancestor
5793100|NCT02776189|GABA Agents|gaba agents|mesh-ancestor
5793101|NCT02776137|Docetaxel|docetaxel|mesh-list
5793102|NCT02776137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5793103|NCT02776137|Tubulin Modulators|tubulin modulators|mesh-ancestor
5793104|NCT02776137|Antimitotic Agents|antimitotic agents|mesh-ancestor
5793105|NCT02776137|Mitosis Modulators|mitosis modulators|mesh-ancestor
5793106|NCT02776137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5793107|NCT02776228|Brotizolam|brotizolam|mesh-list
5793108|NCT02776228|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5793109|NCT02776228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5793110|NCT02776228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793111|NCT02776436|Dexamethasone|dexamethasone|mesh-list
5793112|NCT02776436|Prednisone|prednisone|mesh-list
5793113|NCT02776436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5793114|NCT02776436|Antiemetics|antiemetics|mesh-ancestor
5793115|NCT02776436|Autonomic Agents|autonomic agents|mesh-ancestor
5899310|NCT04330625|Volagidemab|volagidemab|mesh-list
5793116|NCT02776436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5793117|NCT02776436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793118|NCT02776436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5793119|NCT02776436|Glucocorticoids|glucocorticoids|mesh-ancestor
5793120|NCT02776436|Hormones|hormones|mesh-ancestor
5793121|NCT02776436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5793122|NCT02776436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5793123|NCT02776436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5793124|NCT02775773|Tranexamic Acid|tranexamic acid|mesh-list
5793125|NCT02775773|Oxytocin|oxytocin|mesh-list
5793126|NCT02775773|Oxytocics|oxytocics|mesh-ancestor
5793127|NCT02775773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5793128|NCT02775773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793129|NCT02775773|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5793130|NCT02775773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5793131|NCT02775773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5793132|NCT02775773|Hemostatics|hemostatics|mesh-ancestor
5793133|NCT02775773|Coagulants|coagulants|mesh-ancestor
5793134|NCT02775968|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5793135|NCT02775968|Azithromycin|azithromycin|mesh-list
5793136|NCT02775968|Ceftriaxone|ceftriaxone|mesh-list
5793137|NCT02775968|Erythromycin|erythromycin|mesh-list
5793138|NCT02775968|Cephalosporins|cephalosporins|mesh-list
5793139|NCT02775968|Cefamandole|cefamandole|mesh-list
5793140|NCT02775968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5793141|NCT02775968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5793142|NCT02775968|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5793143|NCT02775968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5793144|NCT02775968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5793145|NCT02776059|Prednisolone|prednisolone|mesh-list
5793146|NCT02776059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5793147|NCT02776059|Glucocorticoids|glucocorticoids|mesh-ancestor
5793148|NCT02776059|Hormones|hormones|mesh-ancestor
5793149|NCT02776059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5793150|NCT02776059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793151|NCT02776059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5793152|NCT02776059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5793153|NCT02775734|Acetylcysteine|acetylcysteine|mesh-list
5793154|NCT02775734|Clomiphene|clomiphene|mesh-list
5793155|NCT02775734|Enclomiphene|enclomiphene|mesh-list
5793156|NCT02775734|Zuclomiphene|zuclomiphene|mesh-list
5793157|NCT02775734|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5793158|NCT02775734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5793159|NCT02775734|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5793160|NCT02775734|Hormone Antagonists|hormone antagonists|mesh-ancestor
5793161|NCT02775734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5793162|NCT02775734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793163|NCT02775734|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5793164|NCT02775734|Fertility Agents|fertility agents|mesh-ancestor
5793165|NCT02775734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5793166|NCT02775734|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5793167|NCT02775734|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5793168|NCT02775734|Antiviral Agents|antiviral agents|mesh-ancestor
5793169|NCT02775734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5793170|NCT02775734|Expectorants|expectorants|mesh-ancestor
5793171|NCT02775734|Respiratory System Agents|respiratory system agents|mesh-ancestor
5793172|NCT02775734|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5793173|NCT02775734|Antioxidants|antioxidants|mesh-ancestor
5793174|NCT02775734|Protective Agents|protective agents|mesh-ancestor
5793175|NCT02775734|Antidotes|antidotes|mesh-ancestor
5793176|NCT02776397|Vitamin E|vitamin e|mesh-list
5793177|NCT02776397|Tocopherols|tocopherols|mesh-list
5793178|NCT02776397|alpha-Tocopherol|alpha-tocopherol|mesh-list
5793179|NCT02776397|Vitamins|vitamins|mesh-ancestor
5793180|NCT02776397|Micronutrients|micronutrients|mesh-ancestor
5793181|NCT02776397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793182|NCT02776397|Antioxidants|antioxidants|mesh-ancestor
5793183|NCT02776397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5793184|NCT02776397|Protective Agents|protective agents|mesh-ancestor
5793185|NCT02775695|Doxycycline|doxycycline|mesh-list
5793186|NCT02775695|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5793187|NCT02775695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5793188|NCT02775695|Antimalarials|antimalarials|mesh-ancestor
5793189|NCT02775695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5793190|NCT02775695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5793191|NCT02775877|Letrozole|letrozole|mesh-list
5793192|NCT02775877|Clomiphene|clomiphene|mesh-list
5793193|NCT02775877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5793194|NCT02775877|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5793195|NCT02775877|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5793196|NCT02775877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5793197|NCT02775877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5793198|NCT02775877|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5793199|NCT02775877|Hormone Antagonists|hormone antagonists|mesh-ancestor
5793200|NCT02775877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5793201|NCT02775877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793202|NCT02775877|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5793203|NCT02775877|Fertility Agents|fertility agents|mesh-ancestor
5793204|NCT02775877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5793205|NCT02775877|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5793206|NCT02775877|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5793207|NCT02775474|Fentanyl|fentanyl|mesh-list
5793208|NCT02775474|Methadone|methadone|mesh-list
5793209|NCT02775474|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5793210|NCT02775474|Narcotics|narcotics|mesh-ancestor
5793211|NCT02775474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5793212|NCT02775474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793213|NCT02775474|Analgesics|analgesics|mesh-ancestor
5793214|NCT02775474|Sensory System Agents|sensory system agents|mesh-ancestor
5793215|NCT02775474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5793216|NCT02775474|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5793217|NCT02775474|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5793218|NCT02775474|Anesthetics, General|anesthetics, general|mesh-ancestor
5793219|NCT02775474|Anesthetics|anesthetics|mesh-ancestor
5793220|NCT02775474|Antitussive Agents|antitussive agents|mesh-ancestor
5793221|NCT02775474|Respiratory System Agents|respiratory system agents|mesh-ancestor
5793222|NCT02775539|Mirabegron|mirabegron|mesh-list
5793223|NCT02775539|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
5793224|NCT02775539|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5793225|NCT02775539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5793226|NCT02775539|Adrenergic Agents|adrenergic agents|mesh-ancestor
5793227|NCT02775539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5793228|NCT02775539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5793229|NCT02775539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793230|NCT02775539|Urological Agents|urological agents|mesh-ancestor
5641182|NCT04014075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5641183|NCT04014075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5641184|NCT04003285|Pregnanolone|pregnanolone|mesh-list
5641185|NCT04003285|Anesthetics|anesthetics|mesh-ancestor
5641186|NCT04003285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5641187|NCT04003285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641188|NCT03932162|Insulin|insulin|mesh-list
5641189|NCT03932162|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5641190|NCT03932162|Mitogens|mitogens|mesh-list
5641191|NCT03932162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5641192|NCT03932162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793231|NCT02775500|Apremilast|apremilast|mesh-list
5793232|NCT02775500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5793233|NCT02775500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5793234|NCT02775500|Analgesics|analgesics|mesh-ancestor
5793235|NCT02775500|Sensory System Agents|sensory system agents|mesh-ancestor
5793236|NCT02775500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5793237|NCT02775500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793238|NCT02775500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5793239|NCT02775500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5793240|NCT02775500|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5793241|NCT02775500|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5793242|NCT02775500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5793243|NCT02775500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5793244|NCT02775318|Bupivacaine|bupivacaine|mesh-list
5793245|NCT02775318|Anesthetics, Local|anesthetics, local|mesh-ancestor
5793246|NCT02775318|Anesthetics|anesthetics|mesh-ancestor
5793247|NCT02775318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5793248|NCT02775318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793249|NCT02775318|Sensory System Agents|sensory system agents|mesh-ancestor
5793250|NCT02775318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5793251|NCT02775292|Aldesleukin|aldesleukin|mesh-list
5793252|NCT02775292|Cyclophosphamide|cyclophosphamide|mesh-list
5793253|NCT02775292|Nivolumab|nivolumab|mesh-list
5793254|NCT02775292|Fludarabine|fludarabine|mesh-list
5793255|NCT02775292|Fludarabine phosphate|fludarabine phosphate|mesh-list
5793256|NCT02775292|Interleukin-2|interleukin-2|mesh-list
5793257|NCT02775292|Vaccines|vaccines|mesh-list
5793258|NCT02775292|Immunologic Factors|immunologic factors|mesh-ancestor
5793259|NCT02775292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793260|NCT02775292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5793261|NCT02775292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5793262|NCT02775292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5793263|NCT02775292|Alkylating Agents|alkylating agents|mesh-ancestor
5793264|NCT02775292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5793265|NCT02775292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5793266|NCT02775292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5793267|NCT02775292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5793268|NCT02775292|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5793269|NCT02775292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5793270|NCT02775292|Antimetabolites|antimetabolites|mesh-ancestor
5641193|NCT03932162|Mitosis Modulators|mitosis modulators|mesh-ancestor
5641194|NCT03932162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641195|NCT03925532|Denosumab|denosumab|mesh-list
5641196|NCT03925532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5641197|NCT03925532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641198|NCT03906071|Docetaxel|docetaxel|mesh-list
5641199|NCT03906071|Nivolumab|nivolumab|mesh-list
5641200|NCT03906071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5641201|NCT03906071|Tubulin Modulators|tubulin modulators|mesh-ancestor
5641202|NCT03906071|Antimitotic Agents|antimitotic agents|mesh-ancestor
5641203|NCT03906071|Mitosis Modulators|mitosis modulators|mesh-ancestor
5641204|NCT03906071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641205|NCT03906071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5641206|NCT03906071|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5641207|NCT03790111|Gemcitabine|gemcitabine|mesh-list
5641208|NCT03790111|Cisplatin|cisplatin|mesh-list
5641209|NCT03790111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5641210|NCT03790111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5641211|NCT03790111|Antimetabolites|antimetabolites|mesh-ancestor
5641212|NCT03790111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641213|NCT03790111|Antiviral Agents|antiviral agents|mesh-ancestor
5641214|NCT03790111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5641215|NCT03790111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5793271|NCT02775292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5793272|NCT02775292|Analgesics|analgesics|mesh-ancestor
5793273|NCT02775292|Sensory System Agents|sensory system agents|mesh-ancestor
5793274|NCT02775292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5793275|NCT02775292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5793276|NCT02775292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5793277|NCT02775292|Antiviral Agents|antiviral agents|mesh-ancestor
5793278|NCT02775292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5793279|NCT02775370|Apatinib|apatinib|mesh-list
5793280|NCT02775370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5793281|NCT02775370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5793282|NCT02775370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5793283|NCT02775370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5793284|NCT02775227|Hydrocortisone|hydrocortisone|mesh-list
5793285|NCT02775227|Pasireotide|pasireotide|mesh-list
5793286|NCT02775227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5793287|NCT02775227|Hormones|hormones|mesh-ancestor
5793288|NCT02775227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5793289|NCT02775227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793290|NCT02775110|Natalizumab|natalizumab|mesh-list
5793291|NCT02775110|Immunologic Factors|immunologic factors|mesh-ancestor
5793292|NCT02775110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899311|NCT04330625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5899312|NCT04330625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899313|NCT04234022|Pomalidomide|pomalidomide|mesh-list
5899314|NCT04234022|Immunologic Factors|immunologic factors|mesh-ancestor
5899315|NCT04234022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899316|NCT04234022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5899317|NCT04234022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5899318|NCT04234022|Growth Substances|growth substances|mesh-ancestor
5899319|NCT04234022|Growth Inhibitors|growth inhibitors|mesh-ancestor
5899320|NCT04234022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5899321|NCT04230499|Sirolimus|sirolimus|mesh-list
5899322|NCT04230499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5899323|NCT04230499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5899324|NCT04230499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5899325|NCT04230499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5899326|NCT04230499|Antifungal Agents|antifungal agents|mesh-ancestor
5899327|NCT04230499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5899328|NCT04230499|Immunologic Factors|immunologic factors|mesh-ancestor
5899329|NCT04230499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899330|NCT04167462|BMS-986165|bms-986165|mesh-list
5899331|NCT04167462|Dermatologic Agents|dermatologic agents|mesh-ancestor
5899332|NCT04167462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5899333|NCT04167462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5899334|NCT04167462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899335|NCT04165993|Docetaxel|docetaxel|mesh-list
5899336|NCT04165993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5899337|NCT04165993|Tubulin Modulators|tubulin modulators|mesh-ancestor
5899338|NCT04165993|Antimitotic Agents|antimitotic agents|mesh-ancestor
5899339|NCT04165993|Mitosis Modulators|mitosis modulators|mesh-ancestor
6673906|NCT01566253|Narcotics|narcotics|mesh-ancestor
5793293|NCT02775266|Thioctic Acid|thioctic acid|mesh-list
5793294|NCT02775266|Antioxidants|antioxidants|mesh-ancestor
5793295|NCT02775266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5793296|NCT02775266|Protective Agents|protective agents|mesh-ancestor
5793297|NCT02775266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793298|NCT02775266|Vitamin B Complex|vitamin b complex|mesh-ancestor
5793299|NCT02775266|Vitamins|vitamins|mesh-ancestor
5793300|NCT02775266|Micronutrients|micronutrients|mesh-ancestor
5793301|NCT02774993|Doxycycline|doxycycline|mesh-list
5793302|NCT02774993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5793303|NCT02774993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5793304|NCT02774993|Antimalarials|antimalarials|mesh-ancestor
5793305|NCT02774993|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5793306|NCT02774993|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5793307|NCT02775006|Docetaxel|docetaxel|mesh-list
5793308|NCT02775006|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5793309|NCT02775006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5793310|NCT02775006|Tubulin Modulators|tubulin modulators|mesh-ancestor
5793311|NCT02775006|Antimitotic Agents|antimitotic agents|mesh-ancestor
5793312|NCT02775006|Mitosis Modulators|mitosis modulators|mesh-ancestor
5793313|NCT02775006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5793314|NCT02775006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5793315|NCT02775006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5793316|NCT02774902|Clarithromycin|clarithromycin|mesh-list
5793317|NCT02774902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5793318|NCT02774902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5793319|NCT02774902|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5793320|NCT02774902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5793321|NCT02774902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5793322|NCT02774902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5793323|NCT02774902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5793324|NCT02774837|Tenofovir|tenofovir|mesh-list
5793325|NCT02774837|Telbivudine|telbivudine|mesh-list
5793326|NCT02774837|Antiviral Agents|antiviral agents|mesh-ancestor
5793327|NCT02774837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5793328|NCT02774837|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5793329|NCT02774837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5793330|NCT02774837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5793331|NCT02774837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5793332|NCT02774837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5793333|NCT02774837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5793334|NCT02774876|Insulin|insulin|mesh-list
5793335|NCT02774876|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5793336|NCT02774876|Hormones|hormones|mesh-list
5793337|NCT02774876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5793338|NCT02774876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793339|NCT02774876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5793340|NCT02774811|Bimatoprost|bimatoprost|mesh-list
5793341|NCT02774811|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5793342|NCT02774564|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
5793343|NCT02774564|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5793344|NCT02774564|Immunologic Factors|immunologic factors|mesh-ancestor
5793345|NCT02774564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793346|NCT02774564|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5793347|NCT02774564|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5793348|NCT02774564|Dopamine Agonists|dopamine agonists|mesh-ancestor
5793349|NCT02774564|Dopamine Agents|dopamine agents|mesh-ancestor
5793350|NCT02774564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5793351|NCT02774564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5793352|NCT02774382|Vancomycin|vancomycin|mesh-list
5793353|NCT02774382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5793354|NCT02774382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5793355|NCT02774460|Amlodipine|amlodipine|mesh-list
5793356|NCT02774460|Candesartan|candesartan|mesh-list
5793357|NCT02774460|Candesartan cilexetil|candesartan cilexetil|mesh-list
5793358|NCT02774460|Lisinopril|lisinopril|mesh-list
5793359|NCT02774460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5793360|NCT02774460|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5793361|NCT02774460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5793362|NCT02774460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5793363|NCT02774460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5793364|NCT02774460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793365|NCT02774460|Vasodilator Agents|vasodilator agents|mesh-ancestor
5793366|NCT02774460|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5793367|NCT02774460|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5793368|NCT02774460|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5793369|NCT02774460|Protease Inhibitors|protease inhibitors|mesh-ancestor
5793370|NCT02774460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5793371|NCT02774460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5793372|NCT02774460|Protective Agents|protective agents|mesh-ancestor
5793373|NCT02774499|Methadone|methadone|mesh-list
5793374|NCT02774499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5793375|NCT02774499|Narcotics|narcotics|mesh-ancestor
5793376|NCT02774499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5793377|NCT02774499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793378|NCT02774499|Analgesics|analgesics|mesh-ancestor
5793379|NCT02774499|Sensory System Agents|sensory system agents|mesh-ancestor
5793380|NCT02774499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5793381|NCT02774499|Antitussive Agents|antitussive agents|mesh-ancestor
5793382|NCT02774499|Respiratory System Agents|respiratory system agents|mesh-ancestor
5793383|NCT02774525|Ethanol|ethanol|mesh-list
5793384|NCT02774525|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5793385|NCT02774525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5793386|NCT02774525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5793387|NCT02774525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793388|NCT02774200|Apatinib|apatinib|mesh-list
5793389|NCT02774200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5793390|NCT02774200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5793391|NCT02774200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5793392|NCT02774200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5793393|NCT02774239|Immunoglobulins|immunoglobulins|mesh-list
5793394|NCT02774239|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5793395|NCT02774239|Antibodies|antibodies|mesh-list
5793396|NCT02774239|Immunoglobulin G|immunoglobulin g|mesh-list
5793397|NCT02774239|Immunologic Factors|immunologic factors|mesh-ancestor
5793398|NCT02774239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793399|NCT02774044|Beractant|beractant|mesh-list
5793400|NCT02774044|Goat lung surfactant extract|goat lung surfactant extract|mesh-list
5793401|NCT02774044|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
6210842|NCT02164929|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6210843|NCT02164929|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6210844|NCT02164929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6210845|NCT02164929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210846|NCT02164929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6210847|NCT02164929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5793402|NCT02774044|Respiratory System Agents|respiratory system agents|mesh-ancestor
5793403|NCT02774187|Leucovorin|leucovorin|mesh-list
5793404|NCT02774187|Fluorouracil|fluorouracil|mesh-list
5793405|NCT02774187|Oxaliplatin|oxaliplatin|mesh-list
5793406|NCT02774187|Sorafenib|sorafenib|mesh-list
5793407|NCT02774187|Antimetabolites|antimetabolites|mesh-ancestor
5793408|NCT02774187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5793409|NCT02774187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5793410|NCT02774187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5793411|NCT02774187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5793412|NCT02774187|Immunologic Factors|immunologic factors|mesh-ancestor
5793413|NCT02774187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793414|NCT02774187|Antidotes|antidotes|mesh-ancestor
5793415|NCT02774187|Protective Agents|protective agents|mesh-ancestor
5793416|NCT02774187|Vitamin B Complex|vitamin b complex|mesh-ancestor
5793417|NCT02774187|Vitamins|vitamins|mesh-ancestor
5793418|NCT02774187|Micronutrients|micronutrients|mesh-ancestor
5793419|NCT02774187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5793420|NCT02774187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5793421|NCT02774291|Aldesleukin|aldesleukin|mesh-list
5793422|NCT02774291|Cyclophosphamide|cyclophosphamide|mesh-list
5793423|NCT02774291|Fludarabine|fludarabine|mesh-list
5793424|NCT02774291|Fludarabine phosphate|fludarabine phosphate|mesh-list
5793425|NCT02774291|Interleukin-2|interleukin-2|mesh-list
5793426|NCT02774291|Lenograstim|lenograstim|mesh-list
5793427|NCT02774291|Sargramostim|sargramostim|mesh-list
5793428|NCT02774291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5793429|NCT02774291|Immunologic Factors|immunologic factors|mesh-ancestor
5793430|NCT02774291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793431|NCT02774291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5793432|NCT02774291|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5793433|NCT02774291|Alkylating Agents|alkylating agents|mesh-ancestor
5793434|NCT02774291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5793435|NCT02774291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5793436|NCT02774291|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5793437|NCT02774291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5793438|NCT02774291|Antimetabolites|antimetabolites|mesh-ancestor
5793439|NCT02774291|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5793440|NCT02774291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5793441|NCT02774291|Analgesics|analgesics|mesh-ancestor
5793442|NCT02774291|Sensory System Agents|sensory system agents|mesh-ancestor
5793443|NCT02774291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5793444|NCT02774291|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5793445|NCT02774291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5793446|NCT02774291|Antiviral Agents|antiviral agents|mesh-ancestor
5793447|NCT02774291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5793448|NCT02774096|Xenon|xenon|mesh-list
5793449|NCT02774096|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5793450|NCT02774096|Anesthetics, General|anesthetics, general|mesh-ancestor
5793451|NCT02774096|Anesthetics|anesthetics|mesh-ancestor
5793452|NCT02774096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5793453|NCT02774096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793454|NCT02773979|Chloroquine|chloroquine|mesh-list
5793455|NCT02773979|Amebicides|amebicides|mesh-ancestor
5793456|NCT02773979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5793457|NCT02773979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5793458|NCT02773979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5793459|NCT02773979|Antimalarials|antimalarials|mesh-ancestor
5793460|NCT02773979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5793461|NCT02774005|Idebenone|idebenone|mesh-list
5793462|NCT02774005|Antioxidants|antioxidants|mesh-ancestor
5793463|NCT02774005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5793464|NCT02774005|Protective Agents|protective agents|mesh-ancestor
5793465|NCT02774005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793466|NCT02773797|Dexmedetomidine|dexmedetomidine|mesh-list
5793467|NCT02773797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5793468|NCT02773797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5793469|NCT02773797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793470|NCT02773797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5793471|NCT02773797|Analgesics|analgesics|mesh-ancestor
5793472|NCT02773797|Sensory System Agents|sensory system agents|mesh-ancestor
5793473|NCT02773797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5793474|NCT02773797|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5793475|NCT02773797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5793476|NCT02773797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5793477|NCT02773797|Adrenergic Agents|adrenergic agents|mesh-ancestor
5793478|NCT02773797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5793479|NCT02773797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5793480|NCT02773875|Pancrelipase|pancrelipase|mesh-list
5793481|NCT02773875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5793482|NCT02773927|Metformin|metformin|mesh-list
5793483|NCT02773927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5793484|NCT02773927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793485|NCT02773641|Botulinum Toxins|botulinum toxins|mesh-list
5793486|NCT02773641|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5793487|NCT02773641|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5793488|NCT02773641|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5793489|NCT02773641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5793490|NCT02773641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5793491|NCT02773641|Cholinergic Agents|cholinergic agents|mesh-ancestor
5793492|NCT02773641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5793493|NCT02773641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793494|NCT02773641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5793495|NCT02773641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5793496|NCT02773602|Dexamethasone|dexamethasone|mesh-list
5793497|NCT02773602|Clonidine|clonidine|mesh-list
5793498|NCT02773602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5793499|NCT02773602|Antiemetics|antiemetics|mesh-ancestor
5793500|NCT02773602|Autonomic Agents|autonomic agents|mesh-ancestor
5793501|NCT02773602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5793502|NCT02773602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793503|NCT02773602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5793504|NCT02773602|Glucocorticoids|glucocorticoids|mesh-ancestor
5793505|NCT02773602|Hormones|hormones|mesh-ancestor
5793506|NCT02773602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5793507|NCT02773602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5793508|NCT02773602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5793509|NCT02773602|Analgesics|analgesics|mesh-ancestor
5793510|NCT02773602|Sensory System Agents|sensory system agents|mesh-ancestor
5793511|NCT02773602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5793512|NCT02773602|Sympatholytics|sympatholytics|mesh-ancestor
5793513|NCT02773602|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5793514|NCT02773602|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5793515|NCT02773602|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6210848|NCT02164929|Anesthetics, General|anesthetics, general|mesh-ancestor
6210849|NCT02164929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5793516|NCT02773602|Adrenergic Agents|adrenergic agents|mesh-ancestor
5793517|NCT02773602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5793518|NCT02773602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5793519|NCT02773459|Capecitabine|capecitabine|mesh-list
5793520|NCT02773459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5793521|NCT02773459|Antimetabolites|antimetabolites|mesh-ancestor
5793522|NCT02773459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5793523|NCT02773459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5899340|NCT04165993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899341|NCT04158635|Gemcitabine|gemcitabine|mesh-list
5899342|NCT04158635|Paclitaxel|paclitaxel|mesh-list
5899343|NCT04158635|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5899344|NCT04158635|Bosentan|bosentan|mesh-list
5899345|NCT04158635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5899346|NCT04158635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5899347|NCT04158635|Tubulin Modulators|tubulin modulators|mesh-ancestor
5899348|NCT04158635|Antimitotic Agents|antimitotic agents|mesh-ancestor
5793524|NCT02773316|Morphine|morphine|mesh-list
5793525|NCT02773316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5793526|NCT02773316|Narcotics|narcotics|mesh-ancestor
5793527|NCT02773316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5793528|NCT02773316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793529|NCT02773316|Analgesics|analgesics|mesh-ancestor
5793530|NCT02773316|Sensory System Agents|sensory system agents|mesh-ancestor
5793531|NCT02773316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5793532|NCT02773199|Bupivacaine|bupivacaine|mesh-list
5793533|NCT02773199|Anesthetics, Local|anesthetics, local|mesh-ancestor
5793534|NCT02773199|Anesthetics|anesthetics|mesh-ancestor
5793535|NCT02773199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5793536|NCT02773199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793537|NCT02773199|Sensory System Agents|sensory system agents|mesh-ancestor
5793538|NCT02773199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5793539|NCT02773550|Prednisone|prednisone|mesh-list
5793540|NCT02773550|Bortezomib|bortezomib|mesh-list
5793541|NCT02773550|Melphalan|melphalan|mesh-list
5793542|NCT02773550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5793543|NCT02773550|Glucocorticoids|glucocorticoids|mesh-ancestor
5793544|NCT02773550|Hormones|hormones|mesh-ancestor
5793545|NCT02773550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5793546|NCT02773550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793547|NCT02773550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5793548|NCT02773550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5793549|NCT02773550|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5793550|NCT02773550|Alkylating Agents|alkylating agents|mesh-ancestor
5793551|NCT02773550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5793552|NCT02773550|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5793553|NCT02773550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5793554|NCT02773550|Immunologic Factors|immunologic factors|mesh-ancestor
5793555|NCT02773251|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
5793556|NCT02773251|Hyaluronic Acid|hyaluronic acid|mesh-list
5793557|NCT02773251|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5793558|NCT02773251|Immunologic Factors|immunologic factors|mesh-ancestor
5793559|NCT02773251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793560|NCT02773251|Viscosupplements|viscosupplements|mesh-ancestor
5793561|NCT02773251|Protective Agents|protective agents|mesh-ancestor
5793562|NCT02773251|Laxatives|laxatives|mesh-ancestor
5793563|NCT02773251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5793564|NCT02773407|Azithromycin|azithromycin|mesh-list
5793565|NCT02773407|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
5793566|NCT02773407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5793567|NCT02773407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5793568|NCT02773407|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5793569|NCT02773407|Renal Agents|renal agents|mesh-ancestor
5793570|NCT02773407|Antimalarials|antimalarials|mesh-ancestor
5793571|NCT02773407|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5793572|NCT02773407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5793573|NCT02773472|Morphine|morphine|mesh-list
5793574|NCT02773472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5793575|NCT02773472|Narcotics|narcotics|mesh-ancestor
5793576|NCT02773472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5793577|NCT02773472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793578|NCT02773472|Analgesics|analgesics|mesh-ancestor
5793579|NCT02773472|Sensory System Agents|sensory system agents|mesh-ancestor
5793580|NCT02773472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5793581|NCT02773355|Liraglutide|liraglutide|mesh-list
5793582|NCT02773355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5793583|NCT02773355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793584|NCT02773355|Incretins|incretins|mesh-ancestor
5793585|NCT02773355|Hormones|hormones|mesh-ancestor
5793586|NCT02773355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5793587|NCT02773212|Amphetamine|amphetamine|mesh-list
5793588|NCT02773212|Dextroamphetamine|dextroamphetamine|mesh-list
5793589|NCT02773212|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5793590|NCT02773212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793591|NCT02773212|Sympathomimetics|sympathomimetics|mesh-ancestor
5793592|NCT02773212|Autonomic Agents|autonomic agents|mesh-ancestor
5793593|NCT02773212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5793594|NCT02773212|Dopamine Agents|dopamine agents|mesh-ancestor
5793595|NCT02773212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5793596|NCT02773212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5793597|NCT02773212|Adrenergic Agents|adrenergic agents|mesh-ancestor
5793598|NCT02773212|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5793599|NCT02773212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5793600|NCT02773212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5793601|NCT02773212|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5793602|NCT02773485|Gemcitabine|gemcitabine|mesh-list
5793603|NCT02773485|Cisplatin|cisplatin|mesh-list
5793604|NCT02773485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5793605|NCT02773485|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5793606|NCT02773485|Antimetabolites|antimetabolites|mesh-ancestor
5793607|NCT02773485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5793608|NCT02773485|Antiviral Agents|antiviral agents|mesh-ancestor
5793609|NCT02773485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5793610|NCT02773485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5793611|NCT02773485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5793612|NCT02773485|Immunologic Factors|immunologic factors|mesh-ancestor
5793613|NCT02773485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793614|NCT02773095|Lactitol|lactitol|mesh-list
5793615|NCT02773095|Cathartics|cathartics|mesh-ancestor
5793616|NCT02773095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5793617|NCT02772926|Benphothiamine|benphothiamine|mesh-list
5793618|NCT02772926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5793619|NCT02772926|Immunologic Factors|immunologic factors|mesh-ancestor
5793620|NCT02772926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793621|NCT02772926|Chelating Agents|chelating agents|mesh-ancestor
5793622|NCT02772926|Sequestering Agents|sequestering agents|mesh-ancestor
5793623|NCT02772926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5793624|NCT02773017|Dexmedetomidine|dexmedetomidine|mesh-list
5793625|NCT02773017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5793626|NCT02773017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5793627|NCT02773017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793628|NCT02773017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5793629|NCT02773017|Analgesics|analgesics|mesh-ancestor
5793630|NCT02773017|Sensory System Agents|sensory system agents|mesh-ancestor
5793631|NCT02773017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5793632|NCT02773017|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5793633|NCT02773017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5793634|NCT02773017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5793635|NCT02773017|Adrenergic Agents|adrenergic agents|mesh-ancestor
5793636|NCT02773017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5641216|NCT03790111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5641217|NCT03790111|Immunologic Factors|immunologic factors|mesh-ancestor
5641218|NCT03790111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641219|NCT03786081|Bevacizumab|bevacizumab|mesh-list
5641220|NCT03786081|Pembrolizumab|pembrolizumab|mesh-list
5641221|NCT03786081|Tisotumab vedotin|tisotumab vedotin|mesh-list
5641222|NCT03786081|Carboplatin|carboplatin|mesh-list
5641223|NCT03786081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5641224|NCT03786081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5641225|NCT03786081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6491590|NCT00603031|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
6491591|NCT00603031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5793637|NCT02773017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5793638|NCT02773147|Pyridoxine|pyridoxine|mesh-list
5793639|NCT02773147|Vitamin B 12|vitamin b 12|mesh-list
5793640|NCT02773147|Hydroxocobalamin|hydroxocobalamin|mesh-list
5793641|NCT02773147|Hematinics|hematinics|mesh-ancestor
5793642|NCT02773147|Vitamin B Complex|vitamin b complex|mesh-ancestor
5793643|NCT02773147|Vitamins|vitamins|mesh-ancestor
5793644|NCT02773147|Micronutrients|micronutrients|mesh-ancestor
5793645|NCT02773147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793646|NCT02772965|Methotrexate|methotrexate|mesh-list
5793647|NCT02772965|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5793648|NCT02772965|Abortifacient Agents|abortifacient agents|mesh-ancestor
5793649|NCT02772965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5793650|NCT02772965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793651|NCT02772965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5793652|NCT02772965|Antimetabolites|antimetabolites|mesh-ancestor
5793653|NCT02772965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5793654|NCT02772965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5793655|NCT02772965|Dermatologic Agents|dermatologic agents|mesh-ancestor
5793656|NCT02772965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5793657|NCT02772965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5793658|NCT02772965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5793659|NCT02772965|Immunologic Factors|immunologic factors|mesh-ancestor
5793660|NCT02772965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5793661|NCT02772965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5793662|NCT02772822|Rituximab|rituximab|mesh-list
5793663|NCT02772822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5793664|NCT02772822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5793665|NCT02772822|Immunologic Factors|immunologic factors|mesh-ancestor
5793666|NCT02772822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793667|NCT02772822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5793668|NCT02772640|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5793669|NCT02772640|Ezetimibe|ezetimibe|mesh-list
5793670|NCT02772640|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5793671|NCT02772640|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5793672|NCT02772640|Antimetabolites|antimetabolites|mesh-ancestor
5793673|NCT02772640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5793674|NCT02772640|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5793675|NCT02772640|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5793676|NCT02772640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5793677|NCT02772744|Ribavirin|ribavirin|mesh-list
5793678|NCT02772744|Sofosbuvir|sofosbuvir|mesh-list
5793679|NCT02772744|Antimetabolites|antimetabolites|mesh-ancestor
5793680|NCT02772744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5793681|NCT02772744|Antiviral Agents|antiviral agents|mesh-ancestor
5793682|NCT02772744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5793683|NCT02772653|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
5793684|NCT02772653|Natriuretic Agents|natriuretic agents|mesh-ancestor
5793685|NCT02772653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793686|NCT02772354|Metoprolol|metoprolol|mesh-list
5793687|NCT02772354|Verapamil|verapamil|mesh-list
5793688|NCT02772354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5793689|NCT02772354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5793690|NCT02772354|Sympatholytics|sympatholytics|mesh-ancestor
5793691|NCT02772354|Autonomic Agents|autonomic agents|mesh-ancestor
5793692|NCT02772354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5793693|NCT02772354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793694|NCT02772354|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5793695|NCT02772354|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5793696|NCT02772354|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5793697|NCT02772354|Adrenergic Agents|adrenergic agents|mesh-ancestor
5793698|NCT02772354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5793699|NCT02772354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5793700|NCT02772354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5793701|NCT02772354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5793702|NCT02772354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5793703|NCT02772354|Vasodilator Agents|vasodilator agents|mesh-ancestor
5793704|NCT02772419|Benralizumab|benralizumab|mesh-list
5793705|NCT02772419|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5793706|NCT02772419|Respiratory System Agents|respiratory system agents|mesh-ancestor
5793707|NCT02772497|Aflibercept|aflibercept|mesh-list
5793708|NCT02772497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5793709|NCT02772497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5793710|NCT02772497|Growth Substances|growth substances|mesh-ancestor
5793711|NCT02772497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793712|NCT02772497|Growth Inhibitors|growth inhibitors|mesh-ancestor
5793713|NCT02772497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5793714|NCT02772601|Metoprolol|metoprolol|mesh-list
5793715|NCT02772601|Midazolam|midazolam|mesh-list
5793716|NCT02772601|Caffeine|caffeine|mesh-list
5793717|NCT02772601|Omeprazole|omeprazole|mesh-list
5793718|NCT02772601|Warfarin|warfarin|mesh-list
5793719|NCT02772601|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5793720|NCT02772601|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5793721|NCT02772601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5793722|NCT02772601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793723|NCT02772601|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5793724|NCT02772601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5793725|NCT02772601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5793726|NCT02772601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5793727|NCT02772601|Anesthetics, General|anesthetics, general|mesh-ancestor
5793728|NCT02772601|Anesthetics|anesthetics|mesh-ancestor
5793729|NCT02772601|GABA Modulators|gaba modulators|mesh-ancestor
5793730|NCT02772601|GABA Agents|gaba agents|mesh-ancestor
5793731|NCT02772601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5793732|NCT02772601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5793733|NCT02772601|Anticoagulants|anticoagulants|mesh-ancestor
5793734|NCT02772601|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5793735|NCT02772601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5793736|NCT02772601|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5793737|NCT02772601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5793738|NCT02772601|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5793739|NCT02772601|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5793740|NCT02772601|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5793741|NCT02772601|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5793742|NCT02772601|Purinergic Agents|purinergic agents|mesh-ancestor
5793743|NCT02772601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5793744|NCT02772601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5793745|NCT02772601|Sympatholytics|sympatholytics|mesh-ancestor
5793746|NCT02772601|Autonomic Agents|autonomic agents|mesh-ancestor
5793747|NCT02772601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5793748|NCT02772601|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5793749|NCT02772601|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5793750|NCT02772601|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5793751|NCT02772601|Adrenergic Agents|adrenergic agents|mesh-ancestor
5793752|NCT02772718|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5793753|NCT02772718|Immunologic Factors|immunologic factors|mesh-ancestor
5793754|NCT02772718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793755|NCT02772107|Temozolomide|temozolomide|mesh-list
5793756|NCT02772107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5793757|NCT02772107|Alkylating Agents|alkylating agents|mesh-ancestor
5793758|NCT02772107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5793759|NCT02772107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5793760|NCT02772237|Riboflavin|riboflavin|mesh-list
5793761|NCT02772237|Vitamins|vitamins|mesh-ancestor
5793762|NCT02772237|Micronutrients|micronutrients|mesh-ancestor
5793763|NCT02772237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793764|NCT02772237|Vitamin B Complex|vitamin b complex|mesh-ancestor
5793765|NCT02772237|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5793766|NCT02772237|Dermatologic Agents|dermatologic agents|mesh-ancestor
5793767|NCT02772211|Cycloserine|cycloserine|mesh-list
5793768|NCT02772211|Ketamine|ketamine|mesh-list
5793769|NCT02772211|Analgesics|analgesics|mesh-ancestor
5793770|NCT02772211|Sensory System Agents|sensory system agents|mesh-ancestor
5793771|NCT02772211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5793772|NCT02772211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793773|NCT02772211|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5793774|NCT02772211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5793775|NCT02772211|Anesthetics, General|anesthetics, general|mesh-ancestor
5793776|NCT02772211|Anesthetics|anesthetics|mesh-ancestor
5793777|NCT02772211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5793778|NCT02772211|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5793779|NCT02772211|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5793780|NCT02772211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5793781|NCT02772211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5793782|NCT02772211|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5793783|NCT02772211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5793784|NCT02772211|Renal Agents|renal agents|mesh-ancestor
5793785|NCT02772211|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5793786|NCT02772211|Antitubercular Agents|antitubercular agents|mesh-ancestor
5793787|NCT02772211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5793788|NCT02772211|Antimetabolites|antimetabolites|mesh-ancestor
5793789|NCT02772003|Interleukin-12|interleukin-12|mesh-list
5793790|NCT02772003|Vaccines|vaccines|mesh-list
5793791|NCT02772003|Immunologic Factors|immunologic factors|mesh-ancestor
5793792|NCT02772003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793793|NCT02772003|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5793794|NCT02772003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5793795|NCT02772003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5793796|NCT02772003|Growth Substances|growth substances|mesh-ancestor
5793797|NCT02772003|Growth Inhibitors|growth inhibitors|mesh-ancestor
5793798|NCT02772003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5793799|NCT02772120|Progesterone|progesterone|mesh-list
5793800|NCT02772120|Progestins|progestins|mesh-ancestor
5793801|NCT02772120|Hormones|hormones|mesh-ancestor
5793802|NCT02772120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5793803|NCT02772120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793804|NCT02772029|Apatinib|apatinib|mesh-list
5793805|NCT02772029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5793806|NCT02772029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5793807|NCT02772029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5793808|NCT02772029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899349|NCT04158635|Mitosis Modulators|mitosis modulators|mesh-ancestor
5899350|NCT04158635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899351|NCT04158635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5899352|NCT04158635|Antimetabolites|antimetabolites|mesh-ancestor
5899353|NCT04158635|Antiviral Agents|antiviral agents|mesh-ancestor
5899354|NCT04158635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5899355|NCT04158635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5899356|NCT04158635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5899357|NCT04158635|Immunologic Factors|immunologic factors|mesh-ancestor
5899358|NCT04158635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899359|NCT04158635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5899360|NCT04158635|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5899361|NCT04123262|Tamoxifen|tamoxifen|mesh-list
5899362|NCT04123262|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5899363|NCT04123262|Hormone Antagonists|hormone antagonists|mesh-ancestor
5899364|NCT04123262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5899365|NCT04123262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899366|NCT04123262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5899367|NCT04123262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5899368|NCT04123262|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5899369|NCT04123262|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5899370|NCT04123262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5899371|NCT04070378|Daratumumab|daratumumab|mesh-list
5899372|NCT04070378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5899373|NCT04064294|Levodopa|levodopa|mesh-list
5899374|NCT04064294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5899375|NCT04064294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5899376|NCT04064294|Dopamine Agents|dopamine agents|mesh-ancestor
5899377|NCT04064294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5899378|NCT04064294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899379|NCT04064294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899380|NCT03991988|Montelukast|montelukast|mesh-list
5899381|NCT03991988|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5899382|NCT03991988|Respiratory System Agents|respiratory system agents|mesh-ancestor
5899383|NCT03991988|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5899384|NCT03991988|Hormone Antagonists|hormone antagonists|mesh-ancestor
5899385|NCT03991988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5899386|NCT03991988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899387|NCT03991988|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5899388|NCT03991988|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5899389|NCT03991988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899390|NCT03984045|Lidocaine|lidocaine|mesh-list
5899391|NCT03984045|Prochlorperazine|prochlorperazine|mesh-list
5899392|NCT03984045|Anesthetics, Local|anesthetics, local|mesh-ancestor
5899393|NCT03984045|Anesthetics|anesthetics|mesh-ancestor
5899394|NCT03984045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5899395|NCT03984045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899396|NCT03984045|Sensory System Agents|sensory system agents|mesh-ancestor
5899397|NCT03984045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5899398|NCT03984045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5899399|NCT03984045|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5899400|NCT03984045|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5899401|NCT03984045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5899402|NCT03984045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899403|NCT03984045|Antiemetics|antiemetics|mesh-ancestor
5899404|NCT03984045|Autonomic Agents|autonomic agents|mesh-ancestor
5899405|NCT03984045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5899406|NCT03984045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5899407|NCT03984045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5899408|NCT03984045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5899409|NCT03984045|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5899410|NCT03984045|Dopamine Agents|dopamine agents|mesh-ancestor
5899411|NCT03984045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5899412|NCT03930602|Fluvoxamine|fluvoxamine|mesh-list
5899413|NCT03930602|BMS-986165|bms-986165|mesh-list
5793809|NCT02771925|Gabapentin|gabapentin|mesh-list
5793810|NCT02771925|Analgesics|analgesics|mesh-ancestor
5793811|NCT02771925|Sensory System Agents|sensory system agents|mesh-ancestor
5793812|NCT02771925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5793813|NCT02771925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793814|NCT02771925|Anticonvulsants|anticonvulsants|mesh-ancestor
5793815|NCT02771925|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5793816|NCT02771925|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5793817|NCT02771925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5793818|NCT02771925|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5793819|NCT02771925|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5793820|NCT02771925|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5793821|NCT02771925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5793822|NCT02771925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5793823|NCT02771925|Antimanic Agents|antimanic agents|mesh-ancestor
5793824|NCT02771860|Denosumab|denosumab|mesh-list
5793825|NCT02771860|Calcium|calcium|mesh-list
5793826|NCT02771860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5793827|NCT02771860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793828|NCT02771860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5793829|NCT02771782|Vaccines|vaccines|mesh-list
5793830|NCT02771782|BCG Vaccine|bcg vaccine|mesh-list
5793831|NCT02771782|Immunologic Factors|immunologic factors|mesh-ancestor
5793832|NCT02771782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793833|NCT02771782|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5793834|NCT02771795|Trastuzumab|trastuzumab|mesh-list
5793835|NCT02771795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5793836|NCT02771795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5793837|NCT02771834|Vitamin D|vitamin d|mesh-list
5793838|NCT02771834|Vitamins|vitamins|mesh-ancestor
5793839|NCT02771834|Micronutrients|micronutrients|mesh-ancestor
5793840|NCT02771834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793841|NCT02771834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5793842|NCT02771717|Budesonide|budesonide|mesh-list
5793843|NCT02771717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5793844|NCT02771717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5793845|NCT02771717|Autonomic Agents|autonomic agents|mesh-ancestor
5793846|NCT02771717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5793847|NCT02771717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793848|NCT02771717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5793849|NCT02771717|Respiratory System Agents|respiratory system agents|mesh-ancestor
5793850|NCT02771717|Glucocorticoids|glucocorticoids|mesh-ancestor
5793851|NCT02771717|Hormones|hormones|mesh-ancestor
5793852|NCT02771717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5793853|NCT02771912|Propofol|propofol|mesh-list
5793854|NCT02771912|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
5793855|NCT02771912|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5793856|NCT02771912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5793857|NCT02771912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793858|NCT02771912|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5793859|NCT02771912|Anesthetics, General|anesthetics, general|mesh-ancestor
5793860|NCT02771912|Anesthetics|anesthetics|mesh-ancestor
5793861|NCT02771912|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
5793862|NCT02771912|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5793863|NCT02771912|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5793864|NCT02771457|Infliximab|infliximab|mesh-list
5793865|NCT02771457|Dermatologic Agents|dermatologic agents|mesh-ancestor
5793866|NCT02771457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5793867|NCT02771457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5793868|NCT02771392|Tetracaine|tetracaine|mesh-list
5793869|NCT02771392|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5793870|NCT02771392|Anesthetics, Local|anesthetics, local|mesh-ancestor
5793871|NCT02771392|Anesthetics|anesthetics|mesh-ancestor
5793872|NCT02771392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5793873|NCT02771392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793874|NCT02771392|Sensory System Agents|sensory system agents|mesh-ancestor
5793875|NCT02771392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5793876|NCT02771509|Mitogens|mitogens|mesh-list
5793877|NCT02771509|Mitosis Modulators|mitosis modulators|mesh-ancestor
5793878|NCT02771509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5793879|NCT02771379|Idebenone|idebenone|mesh-list
5793880|NCT02771379|Antioxidants|antioxidants|mesh-ancestor
5793881|NCT02771379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5793882|NCT02771379|Protective Agents|protective agents|mesh-ancestor
5793883|NCT02771379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793884|NCT02771587|Ethanol|ethanol|mesh-list
5793885|NCT02771587|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5793886|NCT02771587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5793887|NCT02771587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5793888|NCT02771587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793889|NCT02771704|Iodine|iodine|mesh-list
5793890|NCT02771704|Chlorhexidine|chlorhexidine|mesh-list
5793891|NCT02771704|Fluorides|fluorides|mesh-list
5793892|NCT02771704|Cariostatic Agents|cariostatic agents|mesh-ancestor
5793893|NCT02771704|Protective Agents|protective agents|mesh-ancestor
5793894|NCT02771704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793895|NCT02771704|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5793896|NCT02771704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5793897|NCT02771704|Disinfectants|disinfectants|mesh-ancestor
5793898|NCT02771704|Trace Elements|trace elements|mesh-ancestor
5793899|NCT02771704|Micronutrients|micronutrients|mesh-ancestor
5793900|NCT02771743|Cyclophosphamide|cyclophosphamide|mesh-list
5793901|NCT02771743|Ifosfamide|ifosfamide|mesh-list
5793902|NCT02771743|Carboplatin|carboplatin|mesh-list
5793903|NCT02771743|Doxorubicin|doxorubicin|mesh-list
5793904|NCT02771743|Etoposide|etoposide|mesh-list
5793905|NCT02771743|Interleukin-2|interleukin-2|mesh-list
5793906|NCT02771743|Isotretinoin|isotretinoin|mesh-list
5793907|NCT02771743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5793908|NCT02771743|Immunologic Factors|immunologic factors|mesh-ancestor
5793909|NCT02771743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793910|NCT02771743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5793911|NCT02771743|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5793912|NCT02771743|Alkylating Agents|alkylating agents|mesh-ancestor
5793913|NCT02771743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5793914|NCT02771743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5793915|NCT02771743|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5793916|NCT02771743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5793917|NCT02771743|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5793918|NCT02771743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5793919|NCT02771743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5793920|NCT02771743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5793921|NCT02771743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5793922|NCT02771743|Analgesics|analgesics|mesh-ancestor
5793923|NCT02771743|Sensory System Agents|sensory system agents|mesh-ancestor
5793924|NCT02771743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5793925|NCT02771743|Dermatologic Agents|dermatologic agents|mesh-ancestor
5793926|NCT02771418|Anesthetics|anesthetics|mesh-list
5793927|NCT02771418|Propofol|propofol|mesh-list
5793928|NCT02771418|Sevoflurane|sevoflurane|mesh-list
5793929|NCT02771418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5793930|NCT02771418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793931|NCT02771418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5793932|NCT02771418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5793933|NCT02771418|Anesthetics, General|anesthetics, general|mesh-ancestor
5793934|NCT02771418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5793935|NCT02771418|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5793936|NCT02771600|Anesthetics|anesthetics|mesh-list
5793937|NCT02771600|Anesthetics, Local|anesthetics, local|mesh-list
5793938|NCT02771600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5793939|NCT02771600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793940|NCT02771600|Sensory System Agents|sensory system agents|mesh-ancestor
5793941|NCT02771600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5793942|NCT02771405|Ribavirin|ribavirin|mesh-list
5793943|NCT02771405|Sofosbuvir|sofosbuvir|mesh-list
5793944|NCT02771405|Simeprevir|simeprevir|mesh-list
5793945|NCT02771405|Ledipasvir|ledipasvir|mesh-list
5793946|NCT02771405|Antimetabolites|antimetabolites|mesh-ancestor
5793947|NCT02771405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5793948|NCT02771405|Antiviral Agents|antiviral agents|mesh-ancestor
5793949|NCT02771405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5793950|NCT02771405|Protease Inhibitors|protease inhibitors|mesh-ancestor
5793951|NCT02771405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5793952|NCT02771314|Osimertinib|osimertinib|mesh-list
5793953|NCT02771314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5793954|NCT02771314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5793955|NCT02771314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5793956|NCT02771314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5793957|NCT02770950|Indomethacin|indomethacin|mesh-list
5793958|NCT02770950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5793959|NCT02770950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5793960|NCT02770950|Analgesics|analgesics|mesh-ancestor
5793961|NCT02770950|Sensory System Agents|sensory system agents|mesh-ancestor
5793962|NCT02770950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5793963|NCT02770950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793964|NCT02770950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5793965|NCT02770950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5793966|NCT02770950|Gout Suppressants|gout suppressants|mesh-ancestor
5793967|NCT02770950|Tocolytic Agents|tocolytic agents|mesh-ancestor
5793968|NCT02770950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5793969|NCT02770950|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5793970|NCT02770950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5793971|NCT02770950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5793972|NCT02771158|Midodrine|midodrine|mesh-list
5793973|NCT02771158|Sympathomimetics|sympathomimetics|mesh-ancestor
5793974|NCT02771158|Autonomic Agents|autonomic agents|mesh-ancestor
5793975|NCT02771158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5793976|NCT02771158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793977|NCT02771158|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5793978|NCT02771158|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5793979|NCT02771158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5793980|NCT02771158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5793981|NCT02771158|Adrenergic Agents|adrenergic agents|mesh-ancestor
5793982|NCT02771158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5793983|NCT02771158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5793984|NCT02771197|Pembrolizumab|pembrolizumab|mesh-list
5793985|NCT02771197|Fludarabine|fludarabine|mesh-list
5793986|NCT02771197|Melphalan|melphalan|mesh-list
5793987|NCT02771197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5793988|NCT02771197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5793989|NCT02771197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5793990|NCT02771197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5793991|NCT02771197|Immunologic Factors|immunologic factors|mesh-ancestor
5793992|NCT02771197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793993|NCT02771197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5793994|NCT02771197|Alkylating Agents|alkylating agents|mesh-ancestor
5793995|NCT02771197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5793996|NCT02770885|Dulaglutide|dulaglutide|mesh-list
5793997|NCT02770885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5793998|NCT02770885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5793999|NCT02770651|Everolimus|everolimus|mesh-list
5794000|NCT02770651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5794001|NCT02770651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5794002|NCT02770651|Immunologic Factors|immunologic factors|mesh-ancestor
5794003|NCT02770651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794004|NCT02770729|Moxifloxacin|moxifloxacin|mesh-list
5794005|NCT02770729|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
5794006|NCT02770729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5794007|NCT02770729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5794008|NCT02770729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5794009|NCT02770729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5794010|NCT02770729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5794011|NCT02770729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5794012|NCT02770729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5794013|NCT02770729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5794014|NCT02770729|Contraceptive Agents|contraceptive agents|mesh-ancestor
5794015|NCT02770729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5794016|NCT02770729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794017|NCT02770729|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5794018|NCT02770729|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5794019|NCT02770729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5794020|NCT02770794|Infliximab|infliximab|mesh-list
5794021|NCT02770794|Dermatologic Agents|dermatologic agents|mesh-ancestor
5794022|NCT02770794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5794023|NCT02770794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5794024|NCT02770690|Lidocaine|lidocaine|mesh-list
5794025|NCT02770690|Ethyl Chloride|ethyl chloride|mesh-list
5794026|NCT02770690|Anesthetics, Local|anesthetics, local|mesh-ancestor
5794027|NCT02770690|Anesthetics|anesthetics|mesh-ancestor
5794028|NCT02770690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5794029|NCT02770690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794030|NCT02770690|Sensory System Agents|sensory system agents|mesh-ancestor
5794031|NCT02770690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5794032|NCT02770690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5794033|NCT02770690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5794034|NCT02770690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5794035|NCT02770690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5794036|NCT02770690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5794037|NCT02770404|Nafithromycin|nafithromycin|mesh-list
5794038|NCT02770404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5794039|NCT02770404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5794040|NCT02770404|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5794041|NCT02770404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5794042|NCT02770404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5794043|NCT02770508|Ritonavir|ritonavir|mesh-list
5794044|NCT02770508|Darunavir|darunavir|mesh-list
5794045|NCT02770508|Tenofovir|tenofovir|mesh-list
5794046|NCT02770508|Lamivudine|lamivudine|mesh-list
5794047|NCT02770508|Emtricitabine|emtricitabine|mesh-list
5794048|NCT02770508|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5794049|NCT02770508|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5794050|NCT02770508|Protease Inhibitors|protease inhibitors|mesh-ancestor
5794051|NCT02770508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5794052|NCT02770508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5794053|NCT02770508|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5794054|NCT02770508|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5794055|NCT02770508|Antiviral Agents|antiviral agents|mesh-ancestor
5794056|NCT02770508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5794057|NCT02770508|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5794058|NCT02770508|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5794059|NCT02770508|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5794060|NCT02770508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5794061|NCT02770378|Ritonavir|ritonavir|mesh-list
5794062|NCT02770378|Itraconazole|itraconazole|mesh-list
5794063|NCT02770378|Minocycline|minocycline|mesh-list
5794064|NCT02770378|Celecoxib|celecoxib|mesh-list
5794065|NCT02770378|Temozolomide|temozolomide|mesh-list
5794066|NCT02770378|Auranofin|auranofin|mesh-list
5794067|NCT02770378|Captopril|captopril|mesh-list
5794068|NCT02770378|Disulfiram|disulfiram|mesh-list
5794069|NCT02770378|Aprepitant|aprepitant|mesh-list
5794070|NCT02770378|Sertraline|sertraline|mesh-list
5794071|NCT02770378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5794072|NCT02770378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5794073|NCT02770378|Protease Inhibitors|protease inhibitors|mesh-ancestor
5794074|NCT02770378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5794075|NCT02770378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5794076|NCT02770378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5794077|NCT02770378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5794078|NCT02770378|Antiviral Agents|antiviral agents|mesh-ancestor
5794079|NCT02770378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5794080|NCT02770378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5794081|NCT02770378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5794082|NCT02770378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5794083|NCT02770378|Alkylating Agents|alkylating agents|mesh-ancestor
5794084|NCT02770378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6491592|NCT00603031|Hormones|hormones|mesh-ancestor
6491593|NCT00603031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5794085|NCT02770378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5794086|NCT02770378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5794087|NCT02770378|Analgesics|analgesics|mesh-ancestor
5794088|NCT02770378|Sensory System Agents|sensory system agents|mesh-ancestor
5794089|NCT02770378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5794090|NCT02770378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794091|NCT02770378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5794092|NCT02770378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5794093|NCT02770378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5794094|NCT02770378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5794095|NCT02770378|Antidepressive Agents|antidepressive agents|mesh-ancestor
5794096|NCT02770378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5794097|NCT02770378|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5794098|NCT02770378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5794099|NCT02770378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5794100|NCT02770378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5794101|NCT02770378|Serotonin Agents|serotonin agents|mesh-ancestor
5794102|NCT02770378|Antifungal Agents|antifungal agents|mesh-ancestor
5794103|NCT02770378|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5794104|NCT02770378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5794105|NCT02770378|Hormone Antagonists|hormone antagonists|mesh-ancestor
5794106|NCT02770378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5794107|NCT02770378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6491594|NCT00603031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210850|NCT02164929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6210851|NCT02164929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6210852|NCT02164929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5794108|NCT02770378|Antiemetics|antiemetics|mesh-ancestor
5794109|NCT02770378|Autonomic Agents|autonomic agents|mesh-ancestor
5794110|NCT02770378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5794111|NCT02770378|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5794112|NCT02770378|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5794113|NCT02770378|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
5794114|NCT02770378|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5794115|NCT02770378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5899414|NCT03930602|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5899415|NCT03930602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5794116|NCT02770261|Candesartan|candesartan|mesh-list
5794117|NCT02770261|Candesartan cilexetil|candesartan cilexetil|mesh-list
5794118|NCT02770261|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5794119|NCT02770261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5794120|NCT02770261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5794121|NCT02770261|Antimetabolites|antimetabolites|mesh-ancestor
5794122|NCT02770261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5794123|NCT02770261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5794124|NCT02770261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5794125|NCT02770261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5794126|NCT02770261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5794127|NCT02770261|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6210853|NCT02164929|GABA Modulators|gaba modulators|mesh-ancestor
6210854|NCT02164929|GABA Agents|gaba agents|mesh-ancestor
5794128|NCT02770261|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5794129|NCT02770430|Infliximab|infliximab|mesh-list
5794130|NCT02770430|Basiliximab|basiliximab|mesh-list
5794131|NCT02770430|Dermatologic Agents|dermatologic agents|mesh-ancestor
5794132|NCT02770430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5794133|NCT02770430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5794134|NCT02770430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5794135|NCT02770430|Immunologic Factors|immunologic factors|mesh-ancestor
5794136|NCT02770430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794137|NCT02770274|Aspirin|aspirin|mesh-list
5794138|NCT02770274|Cilostazol|cilostazol|mesh-list
5794139|NCT02770274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5794140|NCT02770274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5794141|NCT02770274|Analgesics|analgesics|mesh-ancestor
5794142|NCT02770274|Sensory System Agents|sensory system agents|mesh-ancestor
5794143|NCT02770274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5794144|NCT02770274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794145|NCT02770274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5794146|NCT02770274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5794147|NCT02770274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5794148|NCT02770274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5794149|NCT02770274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5794150|NCT02770274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5794151|NCT02770274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5794152|NCT02770274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5794153|NCT02770274|Antipyretics|antipyretics|mesh-ancestor
5794154|NCT02770274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5794155|NCT02770274|Autonomic Agents|autonomic agents|mesh-ancestor
5794156|NCT02770274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5794157|NCT02770274|Respiratory System Agents|respiratory system agents|mesh-ancestor
5794158|NCT02770274|Vasodilator Agents|vasodilator agents|mesh-ancestor
5794159|NCT02770274|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5794160|NCT02770274|Protective Agents|protective agents|mesh-ancestor
5794161|NCT02770274|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6210855|NCT02164929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6210856|NCT02164929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5794162|NCT02770274|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5794163|NCT02770222|Rifampin|rifampin|mesh-list
5794164|NCT02770222|Selexipag|selexipag|mesh-list
5794165|NCT02770222|Gemfibrozil|gemfibrozil|mesh-list
5794166|NCT02770222|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5794167|NCT02770222|Antitubercular Agents|antitubercular agents|mesh-ancestor
5794168|NCT02770222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5794169|NCT02770222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5794170|NCT02770222|Leprostatic Agents|leprostatic agents|mesh-ancestor
5794171|NCT02770222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5794172|NCT02770222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5794173|NCT02770222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210857|NCT02164929|Analgesics|analgesics|mesh-ancestor
6210858|NCT02164929|Antipyretics|antipyretics|mesh-ancestor
6210859|NCT02164929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6210860|NCT02164929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6210861|NCT02164929|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6210862|NCT02164929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6210863|NCT02164929|Adrenergic Agents|adrenergic agents|mesh-ancestor
6210864|NCT02164929|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5794174|NCT02770222|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5794175|NCT02770222|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5794176|NCT02770222|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5794177|NCT02770222|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5794178|NCT02770222|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5794179|NCT02770222|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5794180|NCT02770222|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5794181|NCT02770222|Antimetabolites|antimetabolites|mesh-ancestor
5794182|NCT02770222|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5794183|NCT02770222|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
5794184|NCT02770222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5794185|NCT02770222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5794186|NCT02770443|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
5794187|NCT02770443|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5794188|NCT02770443|Adrenergic Agents|adrenergic agents|mesh-ancestor
5794189|NCT02770443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5794190|NCT02770443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210865|NCT02164929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5794191|NCT02770443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794192|NCT02770105|Caffeine|caffeine|mesh-list
5794193|NCT02770105|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5794194|NCT02770105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794195|NCT02770105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5794196|NCT02770105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5794197|NCT02770105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5794198|NCT02770105|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5794199|NCT02770105|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5794200|NCT02770105|Purinergic Agents|purinergic agents|mesh-ancestor
5794201|NCT02770105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5794202|NCT02769832|Gemcitabine|gemcitabine|mesh-list
5794203|NCT02769832|Paclitaxel|paclitaxel|mesh-list
5794204|NCT02769832|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5794205|NCT02769832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5794206|NCT02769832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5794207|NCT02769832|Tubulin Modulators|tubulin modulators|mesh-ancestor
5794208|NCT02769832|Antimitotic Agents|antimitotic agents|mesh-ancestor
5794209|NCT02769832|Mitosis Modulators|mitosis modulators|mesh-ancestor
5794210|NCT02769832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5794211|NCT02769832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5794212|NCT02769832|Antimetabolites|antimetabolites|mesh-ancestor
5794213|NCT02769832|Antiviral Agents|antiviral agents|mesh-ancestor
5794214|NCT02769832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5794215|NCT02769832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5794216|NCT02769832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5794217|NCT02769832|Immunologic Factors|immunologic factors|mesh-ancestor
5794218|NCT02769832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794219|NCT02769845|Hydroxyurea|hydroxyurea|mesh-list
5794220|NCT02769845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5794221|NCT02769845|Antisickling Agents|antisickling agents|mesh-ancestor
5794222|NCT02769845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5794223|NCT02769845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5794224|NCT02769845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5794225|NCT02769936|Cycloserine|cycloserine|mesh-list
5794226|NCT02769936|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5794227|NCT02769936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5794228|NCT02769936|Renal Agents|renal agents|mesh-ancestor
5794229|NCT02769936|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5794230|NCT02769936|Antitubercular Agents|antitubercular agents|mesh-ancestor
5794231|NCT02769936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5794232|NCT02769936|Antimetabolites|antimetabolites|mesh-ancestor
5794233|NCT02769936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5794234|NCT02769910|Capsaicin|capsaicin|mesh-list
5794235|NCT02769910|Antipruritics|antipruritics|mesh-ancestor
5794236|NCT02769910|Dermatologic Agents|dermatologic agents|mesh-ancestor
5794237|NCT02769910|Sensory System Agents|sensory system agents|mesh-ancestor
5794238|NCT02769910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5794239|NCT02769910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794240|NCT02769884|Pancrelipase|pancrelipase|mesh-list
5794241|NCT02769884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5794242|NCT02769793|Levodopa|levodopa|mesh-list
5794243|NCT02769793|Benserazide|benserazide|mesh-list
5794244|NCT02769793|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
5794245|NCT02769793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5794246|NCT02769793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5794247|NCT02769793|Dopamine Agents|dopamine agents|mesh-ancestor
5794248|NCT02769793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5794249|NCT02769793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5794250|NCT02769793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794251|NCT02769793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5794252|NCT02769494|Riboflavin|riboflavin|mesh-list
5794253|NCT02769494|Flavin Mononucleotide|flavin mononucleotide|mesh-list
6210866|NCT02164929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6210867|NCT02164929|Respiratory System Agents|respiratory system agents|mesh-ancestor
6210868|NCT02164929|Mydriatics|mydriatics|mesh-ancestor
6210869|NCT02164929|Sympathomimetics|sympathomimetics|mesh-ancestor
6210870|NCT02164929|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6210871|NCT02164929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6210872|NCT02164929|Narcotics|narcotics|mesh-ancestor
5794254|NCT02769494|Mesalamine|mesalamine|mesh-list
6210873|NCT02164981|Nitroprusside|nitroprusside|mesh-list
5794255|NCT02769494|Vitamin B Complex|vitamin b complex|mesh-ancestor
5794256|NCT02769494|Vitamins|vitamins|mesh-ancestor
5794257|NCT02769494|Micronutrients|micronutrients|mesh-ancestor
5794258|NCT02769494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794259|NCT02769494|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5794260|NCT02769494|Dermatologic Agents|dermatologic agents|mesh-ancestor
5794261|NCT02769494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5794262|NCT02769494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5794263|NCT02769494|Analgesics|analgesics|mesh-ancestor
5794264|NCT02769494|Sensory System Agents|sensory system agents|mesh-ancestor
5794265|NCT02769494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5794266|NCT02769494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5794267|NCT02769494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5794268|NCT02769689|Methylprednisolone|methylprednisolone|mesh-list
5794269|NCT02769689|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5794270|NCT02769689|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5794271|NCT02769689|Prednisolone|prednisolone|mesh-list
5794272|NCT02769689|Prednisolone acetate|prednisolone acetate|mesh-list
5794273|NCT02769689|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5794274|NCT02769689|Prednisolone phosphate|prednisolone phosphate|mesh-list
5794275|NCT02769689|Natalizumab|natalizumab|mesh-list
5794276|NCT02769689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5794277|NCT02769689|Antiemetics|antiemetics|mesh-ancestor
5794278|NCT02769689|Autonomic Agents|autonomic agents|mesh-ancestor
5794279|NCT02769689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5794280|NCT02769689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794281|NCT02769689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5794282|NCT02769689|Glucocorticoids|glucocorticoids|mesh-ancestor
5794283|NCT02769689|Hormones|hormones|mesh-ancestor
5794284|NCT02769689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5794285|NCT02769689|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5794286|NCT02769689|Protective Agents|protective agents|mesh-ancestor
5794287|NCT02769689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5794288|NCT02769689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5794289|NCT02769689|Immunologic Factors|immunologic factors|mesh-ancestor
5794290|NCT02769572|Diclofenac|diclofenac|mesh-list
5794291|NCT02769572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5794292|NCT02769572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5794293|NCT02769572|Analgesics|analgesics|mesh-ancestor
5794294|NCT02769572|Sensory System Agents|sensory system agents|mesh-ancestor
5794295|NCT02769572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5794296|NCT02769572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794297|NCT02769572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5794298|NCT02769572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5794299|NCT02769572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5794300|NCT02769572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5794301|NCT02769572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5794302|NCT02769325|Ketorolac|ketorolac|mesh-list
5794303|NCT02769325|Atropine|atropine|mesh-list
5794304|NCT02769325|Morphine|morphine|mesh-list
5794305|NCT02769325|Propofol|propofol|mesh-list
5794306|NCT02769325|Sevoflurane|sevoflurane|mesh-list
5794307|NCT02769325|Rocuronium|rocuronium|mesh-list
5794308|NCT02769325|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5794309|NCT02769325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5794310|NCT02769325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794311|NCT02769325|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5794312|NCT02769325|Anesthetics, General|anesthetics, general|mesh-ancestor
5794313|NCT02769325|Anesthetics|anesthetics|mesh-ancestor
5794314|NCT02769325|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5794315|NCT02769325|Narcotics|narcotics|mesh-ancestor
5794316|NCT02769325|Analgesics|analgesics|mesh-ancestor
5794317|NCT02769325|Sensory System Agents|sensory system agents|mesh-ancestor
5794318|NCT02769325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5794319|NCT02769325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5794320|NCT02769325|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5794321|NCT02769325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5794322|NCT02769325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5794323|NCT02769325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5794324|NCT02769325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5794325|NCT02769325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5794326|NCT02769325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5794327|NCT02769325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5794328|NCT02769325|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5794329|NCT02769325|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5794330|NCT02769325|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5794331|NCT02769325|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5794332|NCT02769325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5794333|NCT02769325|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5794334|NCT02769325|Autonomic Agents|autonomic agents|mesh-ancestor
5794335|NCT02769325|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5794336|NCT02769325|Respiratory System Agents|respiratory system agents|mesh-ancestor
5794337|NCT02769325|Mydriatics|mydriatics|mesh-ancestor
5794338|NCT02769325|Parasympatholytics|parasympatholytics|mesh-ancestor
5794339|NCT02769325|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5794340|NCT02769325|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5794341|NCT02769325|Cholinergic Agents|cholinergic agents|mesh-ancestor
5794342|NCT02769325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5794343|NCT02769390|Clonidine|clonidine|mesh-list
5794344|NCT02769390|Diazepam|diazepam|mesh-list
5794345|NCT02769390|Analgesics|analgesics|mesh-ancestor
5794346|NCT02769390|Sensory System Agents|sensory system agents|mesh-ancestor
5794347|NCT02769390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5794348|NCT02769390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794349|NCT02769390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5794350|NCT02769390|Sympatholytics|sympatholytics|mesh-ancestor
5794351|NCT02769390|Autonomic Agents|autonomic agents|mesh-ancestor
5794352|NCT02769390|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5794353|NCT02769390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5794354|NCT02769390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5794355|NCT02769390|Adrenergic Agents|adrenergic agents|mesh-ancestor
5794356|NCT02769390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5794357|NCT02769390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5794358|NCT02769390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5794359|NCT02769390|Anticonvulsants|anticonvulsants|mesh-ancestor
5794360|NCT02769390|Antiemetics|antiemetics|mesh-ancestor
5794361|NCT02769390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5794362|NCT02769390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5794363|NCT02769390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5794364|NCT02769390|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5794365|NCT02769390|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5794366|NCT02769390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5794367|NCT02769390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5794368|NCT02769390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5794369|NCT02769390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5794370|NCT02769390|Anesthetics, General|anesthetics, general|mesh-ancestor
5794371|NCT02769390|Anesthetics|anesthetics|mesh-ancestor
5794372|NCT02769390|GABA Modulators|gaba modulators|mesh-ancestor
5794373|NCT02769390|GABA Agents|gaba agents|mesh-ancestor
5794374|NCT02769611|Ruboxistaurin|ruboxistaurin|mesh-list
5794375|NCT02769611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5794376|NCT02769611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5794377|NCT02769286|Osimertinib|osimertinib|mesh-list
5794378|NCT02769286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5794379|NCT02769286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5794380|NCT02769286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5794381|NCT02769286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5794382|NCT02769130|Losartan|losartan|mesh-list
5794383|NCT02769130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5794384|NCT02769130|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5794385|NCT02769130|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5794386|NCT02769130|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5794387|NCT02769130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5794388|NCT02769104|Docetaxel|docetaxel|mesh-list
5794389|NCT02769104|Letrozole|letrozole|mesh-list
6210874|NCT02164981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6210875|NCT02164981|Vasodilator Agents|vasodilator agents|mesh-ancestor
6210876|NCT02164981|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6210877|NCT02164981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210878|NCT02165111|Botulinum Toxins|botulinum toxins|mesh-list
6210879|NCT02165111|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6210880|NCT02165111|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6210881|NCT02165111|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6210882|NCT02165111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6210883|NCT02165111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210884|NCT02165111|Cholinergic Agents|cholinergic agents|mesh-ancestor
6210885|NCT02165111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6210886|NCT02165111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210887|NCT02165111|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6210888|NCT02165111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6210889|NCT02165202|Rilpivirine|rilpivirine|mesh-list
6210890|NCT02165202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5794390|NCT02769104|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5794391|NCT02769104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5794392|NCT02769104|Tubulin Modulators|tubulin modulators|mesh-ancestor
5794393|NCT02769104|Antimitotic Agents|antimitotic agents|mesh-ancestor
5794394|NCT02769104|Mitosis Modulators|mitosis modulators|mesh-ancestor
5794395|NCT02769104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5794396|NCT02769104|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5794397|NCT02769104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5794398|NCT02769104|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5794399|NCT02769104|Hormone Antagonists|hormone antagonists|mesh-ancestor
5794400|NCT02769104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5794401|NCT02769104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794402|NCT02769169|Ranibizumab|ranibizumab|mesh-list
5794403|NCT02769169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6210891|NCT02165202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5794404|NCT02769169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5794405|NCT02769169|Growth Substances|growth substances|mesh-ancestor
5794406|NCT02769169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794407|NCT02769169|Growth Inhibitors|growth inhibitors|mesh-ancestor
5794408|NCT02769169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5794409|NCT02768948|Losartan|losartan|mesh-list
5794410|NCT02768948|Telmisartan|telmisartan|mesh-list
5794411|NCT02768948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6210892|NCT02165202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5794412|NCT02768948|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5794413|NCT02768948|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5794414|NCT02768948|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5794415|NCT02768948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5794416|NCT02768727|Xenon|xenon|mesh-list
5794417|NCT02768727|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6210893|NCT02165202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210894|NCT02165202|Antiviral Agents|antiviral agents|mesh-ancestor
6491595|NCT00603031|Incretins|incretins|mesh-ancestor
6491596|NCT00603083|Ketorolac|ketorolac|mesh-list
6491597|NCT00603083|Ropivacaine|ropivacaine|mesh-list
6491598|NCT00603083|Anesthetics, Local|anesthetics, local|mesh-ancestor
6491599|NCT00603083|Anesthetics|anesthetics|mesh-ancestor
6491600|NCT00603083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6491601|NCT00603083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794418|NCT02768727|Anesthetics, General|anesthetics, general|mesh-ancestor
5794419|NCT02768727|Anesthetics|anesthetics|mesh-ancestor
5794420|NCT02768727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5794421|NCT02768727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794422|NCT02768740|Hydrocortisone|hydrocortisone|mesh-list
5794423|NCT02768740|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
5794424|NCT02768740|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
5794425|NCT02768740|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
5794426|NCT02768740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5794427|NCT02768961|Sofosbuvir|sofosbuvir|mesh-list
6491602|NCT00603083|Sensory System Agents|sensory system agents|mesh-ancestor
5794428|NCT02768961|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
5794429|NCT02768961|Ledipasvir|ledipasvir|mesh-list
5794430|NCT02768961|Antiviral Agents|antiviral agents|mesh-ancestor
5794431|NCT02768961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5794432|NCT02769013|Praziquantel|praziquantel|mesh-list
5794433|NCT02769013|Anthelmintics|anthelmintics|mesh-ancestor
5794434|NCT02769013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5794435|NCT02769013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5794436|NCT02768688|Dexmedetomidine|dexmedetomidine|mesh-list
5794437|NCT02768688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5794438|NCT02768688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5794439|NCT02768688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794440|NCT02768688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5794441|NCT02768688|Analgesics|analgesics|mesh-ancestor
5794442|NCT02768688|Sensory System Agents|sensory system agents|mesh-ancestor
5794443|NCT02768688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5794444|NCT02768688|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5794445|NCT02768688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5794446|NCT02768688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5794447|NCT02768688|Adrenergic Agents|adrenergic agents|mesh-ancestor
5794448|NCT02768688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5794449|NCT02768688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5794450|NCT02768805|Vaccines|vaccines|mesh-list
5794451|NCT02768805|Immunologic Factors|immunologic factors|mesh-ancestor
5794452|NCT02768805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899416|NCT03930602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5899417|NCT03930602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899418|NCT03930602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5899419|NCT03930602|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5899420|NCT03930602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5899421|NCT03930602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5899422|NCT03930602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899423|NCT03930602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5899424|NCT03930602|Serotonin Agents|serotonin agents|mesh-ancestor
5899425|NCT03930602|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5899426|NCT03930602|Antidepressive Agents|antidepressive agents|mesh-ancestor
5899427|NCT03930602|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5899428|NCT03930602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5899429|NCT03930602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5899430|NCT03930602|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5899431|NCT03930602|Dermatologic Agents|dermatologic agents|mesh-ancestor
5899432|NCT03930602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5899433|NCT03927144|Erenumab|erenumab|mesh-list
5899434|NCT03927144|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
5899435|NCT03927144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899436|NCT03927144|Analgesics|analgesics|mesh-ancestor
5899437|NCT03927144|Sensory System Agents|sensory system agents|mesh-ancestor
5899438|NCT03927144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5899439|NCT03927144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899440|NCT03889795|Metformin|metformin|mesh-list
5899441|NCT03889795|Digoxin|digoxin|mesh-list
5899442|NCT03889795|Simvastatin|simvastatin|mesh-list
5794453|NCT02768649|Risperidone|risperidone|mesh-list
5794454|NCT02768649|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5794455|NCT02768649|Serotonin Agents|serotonin agents|mesh-ancestor
5794456|NCT02768649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5794457|NCT02768649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5794458|NCT02768649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794459|NCT02768649|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5794460|NCT02768649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5794461|NCT02768649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5794462|NCT02768649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5794463|NCT02768649|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5794464|NCT02768649|Dopamine Agents|dopamine agents|mesh-ancestor
5794465|NCT02768545|Ezetimibe|ezetimibe|mesh-list
5794466|NCT02768545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5794467|NCT02768545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5794468|NCT02768545|Antimetabolites|antimetabolites|mesh-ancestor
5794469|NCT02768545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5794470|NCT02768545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5794471|NCT02768532|Vedolizumab|vedolizumab|mesh-list
5794472|NCT02768532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5794473|NCT02768519|OTS167|ots167|mesh-list
6491603|NCT00603083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6491604|NCT00603083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6491605|NCT00603083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6491606|NCT00603083|Analgesics|analgesics|mesh-ancestor
6491607|NCT00603083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6491608|NCT00603083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6491609|NCT00603083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6491610|NCT00603083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6491611|NCT00603083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491612|NCT00603109|Rimonabant|rimonabant|mesh-list
6491613|NCT00603109|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6491614|NCT00603109|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
5794474|NCT02768519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5794475|NCT02768519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5794476|NCT02768519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5794477|NCT02769078|Warfarin|warfarin|mesh-list
5794478|NCT02769078|Rivaroxaban|rivaroxaban|mesh-list
5794479|NCT02769078|Dabigatran|dabigatran|mesh-list
5794480|NCT02769078|Apixaban|apixaban|mesh-list
5794481|NCT02769078|Anticoagulants|anticoagulants|mesh-ancestor
5794482|NCT02769078|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5794483|NCT02769078|Antithrombins|antithrombins|mesh-ancestor
5794484|NCT02769078|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5794485|NCT02769078|Protease Inhibitors|protease inhibitors|mesh-ancestor
5794486|NCT02769078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5794487|NCT02769078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5794488|NCT02768441|Dextroamphetamine|dextroamphetamine|mesh-list
5899443|NCT03889795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5794489|NCT02768441|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5794490|NCT02768441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794491|NCT02768441|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5794492|NCT02768441|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5794493|NCT02768441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5794494|NCT02768441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5794495|NCT02768441|Dopamine Agents|dopamine agents|mesh-ancestor
5794496|NCT02768441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5794497|NCT02768610|Dexmedetomidine|dexmedetomidine|mesh-list
5794498|NCT02768610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5794499|NCT02768610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5794500|NCT02768610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794501|NCT02768610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5794502|NCT02768610|Analgesics|analgesics|mesh-ancestor
5794503|NCT02768610|Sensory System Agents|sensory system agents|mesh-ancestor
5794504|NCT02768610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5794505|NCT02768610|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5794506|NCT02768610|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5794507|NCT02768610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5794508|NCT02768610|Adrenergic Agents|adrenergic agents|mesh-ancestor
5794509|NCT02768610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5794510|NCT02768610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5794511|NCT02768493|Ropivacaine|ropivacaine|mesh-list
5794512|NCT02768493|Anesthetics, Local|anesthetics, local|mesh-ancestor
5794513|NCT02768493|Anesthetics|anesthetics|mesh-ancestor
5794514|NCT02768493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5794515|NCT02768493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794516|NCT02768493|Sensory System Agents|sensory system agents|mesh-ancestor
5794517|NCT02768493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5794518|NCT02768415|Apatinib|apatinib|mesh-list
5794519|NCT02768415|Vinorelbine|vinorelbine|mesh-list
5794520|NCT02768415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5794521|NCT02768415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5794522|NCT02768415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5794523|NCT02768415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5794524|NCT02768415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5794525|NCT02768415|Tubulin Modulators|tubulin modulators|mesh-ancestor
5794526|NCT02768415|Antimitotic Agents|antimitotic agents|mesh-ancestor
5794527|NCT02768415|Mitosis Modulators|mitosis modulators|mesh-ancestor
5794528|NCT02768454|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5794529|NCT02768454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5794530|NCT02768337|Afatinib|afatinib|mesh-list
5794531|NCT02768337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5794532|NCT02768337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5794533|NCT02768337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5794534|NCT02768337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5794535|NCT02768571|Cerebrolysin|cerebrolysin|mesh-list
5794536|NCT02768571|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5794537|NCT02768571|Protective Agents|protective agents|mesh-ancestor
5794538|NCT02768571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794539|NCT02768571|Nootropic Agents|nootropic agents|mesh-ancestor
5794540|NCT02768376|Fentanyl|fentanyl|mesh-list
5794541|NCT02768376|Bupivacaine|bupivacaine|mesh-list
5794542|NCT02768376|Anesthetics|anesthetics|mesh-list
5794543|NCT02768376|Anesthetics, Local|anesthetics, local|mesh-ancestor
5794544|NCT02768376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5794545|NCT02768376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794546|NCT02768376|Sensory System Agents|sensory system agents|mesh-ancestor
5794547|NCT02768376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5794548|NCT02768376|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5794549|NCT02768376|Narcotics|narcotics|mesh-ancestor
5794550|NCT02768376|Analgesics|analgesics|mesh-ancestor
5794551|NCT02768376|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5794552|NCT02768376|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5794553|NCT02768376|Anesthetics, General|anesthetics, general|mesh-ancestor
5794554|NCT02768363|Valacyclovir|valacyclovir|mesh-list
5794555|NCT02768363|Antiviral Agents|antiviral agents|mesh-ancestor
5794556|NCT02768363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5794557|NCT02768077|Melatonin|melatonin|mesh-list
5794558|NCT02768077|Antioxidants|antioxidants|mesh-ancestor
5794559|NCT02768077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5794560|NCT02768077|Protective Agents|protective agents|mesh-ancestor
5794561|NCT02768077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794562|NCT02768077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5794563|NCT02768389|Bevacizumab|bevacizumab|mesh-list
5794564|NCT02768389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5794565|NCT02768389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5794566|NCT02768389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5794567|NCT02768389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5794568|NCT02768389|Growth Substances|growth substances|mesh-ancestor
5794569|NCT02768389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794570|NCT02768389|Growth Inhibitors|growth inhibitors|mesh-ancestor
6491615|NCT00603109|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6491616|NCT00603109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6491617|NCT00603109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491618|NCT00603109|Hormones|hormones|mesh-ancestor
6491619|NCT00603109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6491620|NCT00603109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491621|NCT00603135|Levetiracetam|levetiracetam|mesh-list
6491622|NCT00603135|Anticonvulsants|anticonvulsants|mesh-ancestor
6491623|NCT00603135|Nootropic Agents|nootropic agents|mesh-ancestor
6491624|NCT00603317|Amoxicillin|amoxicillin|mesh-list
6491625|NCT00603317|Clavulanic Acids|clavulanic acids|mesh-list
6491626|NCT00603317|Clavulanic Acid|clavulanic acid|mesh-list
6491627|NCT00603317|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6491628|NCT00603317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6491629|NCT00603317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6491630|NCT00603317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6491631|NCT00603317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5794571|NCT02768220|Empagliflozin|empagliflozin|mesh-list
5794572|NCT02768220|Linagliptin|linagliptin|mesh-list
5794573|NCT02768220|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5794574|NCT02768220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5794575|NCT02768220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5794576|NCT02768220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794577|NCT02768220|Incretins|incretins|mesh-ancestor
5794578|NCT02768220|Hormones|hormones|mesh-ancestor
5794579|NCT02768220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5794580|NCT02768220|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5794581|NCT02768220|Protease Inhibitors|protease inhibitors|mesh-ancestor
5794582|NCT02768220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5794583|NCT02768168|Dezocine|dezocine|mesh-list
5794584|NCT02768168|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5794585|NCT02768168|Narcotics|narcotics|mesh-ancestor
5794586|NCT02768168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6491632|NCT00603317|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5641226|NCT03786081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5641227|NCT03786081|Growth Substances|growth substances|mesh-ancestor
5641228|NCT03786081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641229|NCT03786081|Growth Inhibitors|growth inhibitors|mesh-ancestor
5641230|NCT03771586|Ketamine|ketamine|mesh-list
5641231|NCT03771586|Analgesics|analgesics|mesh-ancestor
5641232|NCT03771586|Sensory System Agents|sensory system agents|mesh-ancestor
5641233|NCT03771586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5641234|NCT03771586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641235|NCT03771586|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5641236|NCT03771586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5641237|NCT03771586|Anesthetics, General|anesthetics, general|mesh-ancestor
5641238|NCT03771586|Anesthetics|anesthetics|mesh-ancestor
5641239|NCT03771586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5641240|NCT03771586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5641241|NCT03771586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5641242|NCT03771586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5794587|NCT02768168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794588|NCT02768168|Analgesics|analgesics|mesh-ancestor
5794589|NCT02768168|Sensory System Agents|sensory system agents|mesh-ancestor
5794590|NCT02768168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5794591|NCT02768207|Vemurafenib|vemurafenib|mesh-list
5794592|NCT02768207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5794593|NCT02768207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5794594|NCT02768207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5794595|NCT02768207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5794596|NCT02768116|Sirolimus|sirolimus|mesh-list
5794597|NCT02768116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5794598|NCT02768116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5794599|NCT02768116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5794600|NCT02768116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5794601|NCT02768116|Antifungal Agents|antifungal agents|mesh-ancestor
5794602|NCT02768116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5794603|NCT02768116|Immunologic Factors|immunologic factors|mesh-ancestor
5794604|NCT02768116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794605|NCT02767999|Fluoxetine|fluoxetine|mesh-list
5794606|NCT02767999|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5794607|NCT02767999|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5794608|NCT02767999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5794609|NCT02767999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5794610|NCT02767999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5794611|NCT02767999|Serotonin Agents|serotonin agents|mesh-ancestor
5794612|NCT02767999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794613|NCT02767999|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5794614|NCT02767999|Antidepressive Agents|antidepressive agents|mesh-ancestor
5794615|NCT02767999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5794616|NCT02767999|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5794617|NCT02767999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5794618|NCT02767999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5794619|NCT02767661|Capecitabine|capecitabine|mesh-list
5794620|NCT02767661|Letrozole|letrozole|mesh-list
5794621|NCT02767661|Anastrozole|anastrozole|mesh-list
5794622|NCT02767661|Exemestane|exemestane|mesh-list
5794623|NCT02767661|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5794624|NCT02767661|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5794625|NCT02767661|Antimetabolites|antimetabolites|mesh-ancestor
5794626|NCT02767661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5794627|NCT02767661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5794628|NCT02767661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5794629|NCT02767661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5794630|NCT02767661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5794631|NCT02767661|Hormone Antagonists|hormone antagonists|mesh-ancestor
5794632|NCT02767661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5794633|NCT02767661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794634|NCT02767661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5794635|NCT02767635|Triamcinolone|triamcinolone|mesh-list
5794636|NCT02767635|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5794637|NCT02767635|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5794638|NCT02767635|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5794639|NCT02767635|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5794640|NCT02767635|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5794641|NCT02767635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5794642|NCT02767635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5794643|NCT02767635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794644|NCT02767635|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5794645|NCT02767635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5794646|NCT02767635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5794647|NCT02767635|Cholinergic Agents|cholinergic agents|mesh-ancestor
5794648|NCT02767635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5794649|NCT02767635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5794650|NCT02767635|Glucocorticoids|glucocorticoids|mesh-ancestor
5794651|NCT02767635|Hormones|hormones|mesh-ancestor
5794652|NCT02767635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5794653|NCT02767635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5794654|NCT02767635|Immunologic Factors|immunologic factors|mesh-ancestor
5794655|NCT02767635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5794656|NCT02767596|Lixisenatide|lixisenatide|mesh-list
5794657|NCT02767596|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5794658|NCT02767596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794659|NCT02767752|Gemcitabine|gemcitabine|mesh-list
5794660|NCT02767752|Capecitabine|capecitabine|mesh-list
5794661|NCT02767752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5794662|NCT02767752|Antimetabolites|antimetabolites|mesh-ancestor
5794663|NCT02767752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5794664|NCT02767752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5794665|NCT02767752|Antiviral Agents|antiviral agents|mesh-ancestor
5794666|NCT02767752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6210895|NCT02165202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6210896|NCT02165202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6210897|NCT02165202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6210898|NCT02165397|Rituximab|rituximab|mesh-list
6210899|NCT02165397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6210900|NCT02165397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6210901|NCT02165397|Immunologic Factors|immunologic factors|mesh-ancestor
5794667|NCT02767752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5794668|NCT02767752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5794669|NCT02767752|Immunologic Factors|immunologic factors|mesh-ancestor
5794670|NCT02767752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794671|NCT02767882|Dexamethasone|dexamethasone|mesh-list
5794672|NCT02767882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5794673|NCT02767882|Antiemetics|antiemetics|mesh-ancestor
5794674|NCT02767882|Autonomic Agents|autonomic agents|mesh-ancestor
5794675|NCT02767882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5794676|NCT02767882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794677|NCT02767882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5794678|NCT02767882|Glucocorticoids|glucocorticoids|mesh-ancestor
5794679|NCT02767882|Hormones|hormones|mesh-ancestor
5794680|NCT02767882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5794681|NCT02767882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5794682|NCT02767882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5794683|NCT02767713|Dexamethasone|dexamethasone|mesh-list
5794684|NCT02767713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5794685|NCT02767713|Antiemetics|antiemetics|mesh-ancestor
5794686|NCT02767713|Autonomic Agents|autonomic agents|mesh-ancestor
5794687|NCT02767713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5794688|NCT02767713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794689|NCT02767713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5794690|NCT02767713|Glucocorticoids|glucocorticoids|mesh-ancestor
5794691|NCT02767713|Hormones|hormones|mesh-ancestor
5794692|NCT02767713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5794693|NCT02767713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5794694|NCT02767713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5794695|NCT02767674|Gemcitabine|gemcitabine|mesh-list
5794696|NCT02767674|Prednisone|prednisone|mesh-list
5794697|NCT02767674|Cyclophosphamide|cyclophosphamide|mesh-list
5794698|NCT02767674|Rituximab|rituximab|mesh-list
5794699|NCT02767674|Oxaliplatin|oxaliplatin|mesh-list
5794700|NCT02767674|Epirubicin|epirubicin|mesh-list
5794701|NCT02767674|Vindesine|vindesine|mesh-list
5794702|NCT02767674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5794703|NCT02767674|Immunologic Factors|immunologic factors|mesh-ancestor
5794704|NCT02767674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794705|NCT02767674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5794706|NCT02767674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5794707|NCT02767674|Alkylating Agents|alkylating agents|mesh-ancestor
5794708|NCT02767674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5794709|NCT02767674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5794710|NCT02767674|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5794711|NCT02767674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5794712|NCT02767674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5794713|NCT02767674|Antimetabolites|antimetabolites|mesh-ancestor
5794714|NCT02767674|Antiviral Agents|antiviral agents|mesh-ancestor
5794715|NCT02767674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5794716|NCT02767674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5794717|NCT02767674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5794718|NCT02767674|Glucocorticoids|glucocorticoids|mesh-ancestor
5794719|NCT02767674|Hormones|hormones|mesh-ancestor
5794720|NCT02767674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5794721|NCT02767674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5794722|NCT02767674|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5794723|NCT02767674|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5794724|NCT02767674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5794725|NCT02767674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5794726|NCT02767674|Tubulin Modulators|tubulin modulators|mesh-ancestor
5794727|NCT02767674|Antimitotic Agents|antimitotic agents|mesh-ancestor
5794728|NCT02767674|Mitosis Modulators|mitosis modulators|mesh-ancestor
5794729|NCT02767557|Gemcitabine|gemcitabine|mesh-list
5794730|NCT02767557|Paclitaxel|paclitaxel|mesh-list
5794731|NCT02767557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5794732|NCT02767557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5794733|NCT02767557|Tubulin Modulators|tubulin modulators|mesh-ancestor
5794734|NCT02767557|Antimitotic Agents|antimitotic agents|mesh-ancestor
5794735|NCT02767557|Mitosis Modulators|mitosis modulators|mesh-ancestor
5794736|NCT02767557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5794737|NCT02767557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6210902|NCT02165397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210903|NCT02165397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5794738|NCT02767557|Antimetabolites|antimetabolites|mesh-ancestor
6673907|NCT01566253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6673908|NCT01566253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673909|NCT01566253|Analgesics|analgesics|mesh-ancestor
6673910|NCT01566253|Sensory System Agents|sensory system agents|mesh-ancestor
6673911|NCT01566253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6673912|NCT01566253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6673913|NCT01566253|Antipyretics|antipyretics|mesh-ancestor
6673914|NCT01566253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6673915|NCT01566253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5794739|NCT02767557|Antiviral Agents|antiviral agents|mesh-ancestor
5794740|NCT02767557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5794741|NCT02767557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5794742|NCT02767557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5794743|NCT02767557|Immunologic Factors|immunologic factors|mesh-ancestor
5794744|NCT02767557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794745|NCT02767258|Lubricant Eye Drops|lubricant eye drops|mesh-list
6673916|NCT01566253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5794746|NCT02767258|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5794747|NCT02767258|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5794748|NCT02767245|Thiamine|thiamine|mesh-list
5794749|NCT02767245|Vitamins|vitamins|mesh-ancestor
5794750|NCT02767245|Micronutrients|micronutrients|mesh-ancestor
5641243|NCT03771586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641244|NCT03769181|Cemiplimab|cemiplimab|mesh-list
5641245|NCT03769181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5641246|NCT03769181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5641247|NCT03767582|Nivolumab|nivolumab|mesh-list
5641248|NCT03767582|Vaccines|vaccines|mesh-list
5641249|NCT03767582|Immunologic Factors|immunologic factors|mesh-ancestor
5641250|NCT03767582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641251|NCT03767582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5641252|NCT03767582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5641253|NCT03767582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5641254|NCT03767582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641255|NCT03743662|Bevacizumab|bevacizumab|mesh-list
5641256|NCT03743662|Nivolumab|nivolumab|mesh-list
5641257|NCT03743662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5641258|NCT03743662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5641259|NCT03743662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5641260|NCT03743662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5641261|NCT03743662|Growth Substances|growth substances|mesh-ancestor
5641262|NCT03743662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641263|NCT03743662|Growth Inhibitors|growth inhibitors|mesh-ancestor
5794751|NCT02767245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794752|NCT02767245|Vitamin B Complex|vitamin b complex|mesh-ancestor
5794753|NCT02767310|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5794754|NCT02767310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5794755|NCT02767310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5794756|NCT02767310|Antimetabolites|antimetabolites|mesh-ancestor
5794757|NCT02767310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5794758|NCT02767310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5794759|NCT02767310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5794760|NCT02767310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5794761|NCT02767375|Fluorouracil|fluorouracil|mesh-list
5794762|NCT02767375|Oxaliplatin|oxaliplatin|mesh-list
5794763|NCT02767375|Antimetabolites|antimetabolites|mesh-ancestor
5794764|NCT02767375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5794765|NCT02767375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5794766|NCT02767375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5794767|NCT02767375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5794768|NCT02767375|Immunologic Factors|immunologic factors|mesh-ancestor
5794769|NCT02767375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210904|NCT02166047|Vesatolimod|vesatolimod|mesh-list
6210905|NCT02166047|Antiviral Agents|antiviral agents|mesh-ancestor
6210906|NCT02166047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5794770|NCT02767362|Atorvastatin|atorvastatin|mesh-list
5794771|NCT02767362|Ezetimibe|ezetimibe|mesh-list
5794772|NCT02767362|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5794773|NCT02767362|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5794774|NCT02767362|Antimetabolites|antimetabolites|mesh-ancestor
5794775|NCT02767362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5794776|NCT02767362|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6210907|NCT02166333|Vitamin D|vitamin d|mesh-list
6210908|NCT02166333|Ergocalciferols|ergocalciferols|mesh-list
5794777|NCT02767362|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5794778|NCT02767362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5794779|NCT02767401|Aspirin|aspirin|mesh-list
5794780|NCT02767401|Metoprolol|metoprolol|mesh-list
5794781|NCT02767401|Clopidogrel|clopidogrel|mesh-list
5794782|NCT02767401|Ticagrelor|ticagrelor|mesh-list
5794783|NCT02767401|Atorvastatin|atorvastatin|mesh-list
5794784|NCT02767401|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5794785|NCT02767401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5794786|NCT02767401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5794787|NCT02767401|Analgesics|analgesics|mesh-ancestor
5794788|NCT02767401|Sensory System Agents|sensory system agents|mesh-ancestor
5794789|NCT02767401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5794790|NCT02767401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794791|NCT02767401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5794792|NCT02767401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5794793|NCT02767401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5794794|NCT02767401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5794795|NCT02767401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5794796|NCT02767401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5794797|NCT02767401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5794798|NCT02767401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5794799|NCT02767401|Antipyretics|antipyretics|mesh-ancestor
5794800|NCT02767401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5794801|NCT02767401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5794802|NCT02767401|Antimetabolites|antimetabolites|mesh-ancestor
5794803|NCT02767401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5794804|NCT02767401|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5794805|NCT02767401|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5794806|NCT02767401|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5794807|NCT02767401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5794808|NCT02767401|Purinergic Agents|purinergic agents|mesh-ancestor
5794809|NCT02767401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5794810|NCT02767401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5794811|NCT02767401|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5794812|NCT02767401|Sympatholytics|sympatholytics|mesh-ancestor
5794813|NCT02767401|Autonomic Agents|autonomic agents|mesh-ancestor
5794814|NCT02767401|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5794815|NCT02767401|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5794816|NCT02767401|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5794817|NCT02767401|Adrenergic Agents|adrenergic agents|mesh-ancestor
5794818|NCT02767154|Mannitol|mannitol|mesh-list
5794819|NCT02767154|Dextrans|dextrans|mesh-list
5794820|NCT02767154|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5794821|NCT02767154|Diuretics|diuretics|mesh-ancestor
5794822|NCT02767154|Natriuretic Agents|natriuretic agents|mesh-ancestor
5794823|NCT02767154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794824|NCT02767154|Anticoagulants|anticoagulants|mesh-ancestor
5794825|NCT02767154|Plasma Substitutes|plasma substitutes|mesh-ancestor
5794826|NCT02767154|Blood Substitutes|blood substitutes|mesh-ancestor
5794827|NCT02767102|Melatonin|melatonin|mesh-list
5794828|NCT02767102|Antioxidants|antioxidants|mesh-ancestor
5794829|NCT02767102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5794830|NCT02767102|Protective Agents|protective agents|mesh-ancestor
5794831|NCT02767102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794832|NCT02767102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5794833|NCT02767232|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5794834|NCT02767232|Plasminogen|plasminogen|mesh-list
5794835|NCT02767232|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5794836|NCT02767232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5794837|NCT02767232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5794838|NCT02767479|Esomeprazole|esomeprazole|mesh-list
5794839|NCT02767479|Rabeprazole|rabeprazole|mesh-list
5794840|NCT02767479|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5794841|NCT02767479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5794842|NCT02767479|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5794843|NCT02767479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5794844|NCT02767479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5794845|NCT02767089|Prednisone|prednisone|mesh-list
5794846|NCT02767089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5794847|NCT02767089|Glucocorticoids|glucocorticoids|mesh-ancestor
5794848|NCT02767089|Hormones|hormones|mesh-ancestor
5794849|NCT02767089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5794850|NCT02767089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794851|NCT02767089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5794852|NCT02767089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5899444|NCT03889795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899445|NCT03889795|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5899446|NCT03889795|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5899447|NCT03889795|Antimetabolites|antimetabolites|mesh-ancestor
5899448|NCT03889795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899449|NCT03889795|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5899450|NCT03889795|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5899451|NCT03889795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5899452|NCT03889795|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5899453|NCT03889795|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5899454|NCT03889795|Protective Agents|protective agents|mesh-ancestor
5899455|NCT03872791|Paclitaxel|paclitaxel|mesh-list
5899456|NCT03872791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5899457|NCT03872791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5899458|NCT03872791|Tubulin Modulators|tubulin modulators|mesh-ancestor
5899459|NCT03872791|Antimitotic Agents|antimitotic agents|mesh-ancestor
5899460|NCT03872791|Mitosis Modulators|mitosis modulators|mesh-ancestor
5899461|NCT03872791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908159|NCT04860713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5908160|NCT04860713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5908161|NCT04860713|Antipyretics|antipyretics|mesh-ancestor
5908162|NCT04860713|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5794853|NCT02767219|Dexamethasone|dexamethasone|mesh-list
5794854|NCT02767219|Bevacizumab|bevacizumab|mesh-list
5794855|NCT02767219|Fluorouracil|fluorouracil|mesh-list
5794856|NCT02767219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5794857|NCT02767219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5794858|NCT02767219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5794859|NCT02767219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5794860|NCT02767219|Growth Substances|growth substances|mesh-ancestor
5794861|NCT02767219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794862|NCT02767219|Growth Inhibitors|growth inhibitors|mesh-ancestor
5794863|NCT02767219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5794864|NCT02767219|Antiemetics|antiemetics|mesh-ancestor
5794865|NCT02767219|Autonomic Agents|autonomic agents|mesh-ancestor
5794866|NCT02767219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5794867|NCT02767219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5794868|NCT02767219|Glucocorticoids|glucocorticoids|mesh-ancestor
5794869|NCT02767219|Hormones|hormones|mesh-ancestor
5794870|NCT02767219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5794871|NCT02767219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5794872|NCT02767219|Antimetabolites|antimetabolites|mesh-ancestor
5794873|NCT02767219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5794874|NCT02767219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5794875|NCT02767219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5794876|NCT02767219|Immunologic Factors|immunologic factors|mesh-ancestor
5794877|NCT02767076|Anesthetics|anesthetics|mesh-list
5794878|NCT02767076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5794879|NCT02767076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794880|NCT02767063|Pioglitazone|pioglitazone|mesh-list
5794881|NCT02767063|Avelumab|avelumab|mesh-list
5794882|NCT02767063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5794883|NCT02767063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794884|NCT02767063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5794885|NCT02767063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5794886|NCT02766764|Hormones|hormones|mesh-list
5794887|NCT02766764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5794888|NCT02766764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794889|NCT02766855|Cysteamine|cysteamine|mesh-list
5794890|NCT02766855|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
5794891|NCT02766855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5794892|NCT02767024|Nitroprusside|nitroprusside|mesh-list
5794893|NCT02767024|Dobutamine|dobutamine|mesh-list
5794894|NCT02767024|Furosemide|furosemide|mesh-list
5794895|NCT02767024|Diuretics|diuretics|mesh-ancestor
5794896|NCT02767024|Natriuretic Agents|natriuretic agents|mesh-ancestor
5794897|NCT02767024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794898|NCT02767024|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5794899|NCT02767024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5794900|NCT02767024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5794901|NCT02767024|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5794902|NCT02767024|Sympathomimetics|sympathomimetics|mesh-ancestor
5794903|NCT02767024|Autonomic Agents|autonomic agents|mesh-ancestor
5794904|NCT02767024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5794905|NCT02767024|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5794906|NCT02767024|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5794907|NCT02767024|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5794908|NCT02767024|Adrenergic Agents|adrenergic agents|mesh-ancestor
5794909|NCT02767024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5794910|NCT02767024|Protective Agents|protective agents|mesh-ancestor
5794911|NCT02767024|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5794912|NCT02767024|Vasodilator Agents|vasodilator agents|mesh-ancestor
5794913|NCT02767024|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5794914|NCT02766803|Resveratrol|resveratrol|mesh-list
5794915|NCT02766803|Simvastatin|simvastatin|mesh-list
5794916|NCT02766803|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5794917|NCT02766803|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5794918|NCT02766803|Antimetabolites|antimetabolites|mesh-ancestor
5794919|NCT02766803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5794920|NCT02766803|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5794921|NCT02766803|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5794922|NCT02766803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5794923|NCT02766803|Antioxidants|antioxidants|mesh-ancestor
5794924|NCT02766803|Protective Agents|protective agents|mesh-ancestor
5794925|NCT02766803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794926|NCT02766803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5794927|NCT02766725|Sildenafil Citrate|sildenafil citrate|mesh-list
5794928|NCT02766725|Vasodilator Agents|vasodilator agents|mesh-ancestor
5794929|NCT02766725|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5794930|NCT02766725|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5794931|NCT02766725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5794932|NCT02766725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5794933|NCT02766725|Urological Agents|urological agents|mesh-ancestor
5794934|NCT02766582|Paclitaxel|paclitaxel|mesh-list
5794935|NCT02766582|Carboplatin|carboplatin|mesh-list
5794936|NCT02766582|Pembrolizumab|pembrolizumab|mesh-list
5794937|NCT02766582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5794938|NCT02766582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5794939|NCT02766582|Tubulin Modulators|tubulin modulators|mesh-ancestor
5794940|NCT02766582|Antimitotic Agents|antimitotic agents|mesh-ancestor
5794941|NCT02766582|Mitosis Modulators|mitosis modulators|mesh-ancestor
5794942|NCT02766582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5794943|NCT02766582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5794944|NCT02766647|Lenograstim|lenograstim|mesh-list
5794945|NCT02766647|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5794946|NCT02766647|Immunologic Factors|immunologic factors|mesh-ancestor
5794947|NCT02766647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794948|NCT02766634|Lenograstim|lenograstim|mesh-list
5794949|NCT02766634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5794950|NCT02766634|Immunologic Factors|immunologic factors|mesh-ancestor
5794951|NCT02766634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794952|NCT02766439|Etanercept|etanercept|mesh-list
5794953|NCT02766439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5794954|NCT02766439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5794955|NCT02766439|Analgesics|analgesics|mesh-ancestor
5794956|NCT02766439|Sensory System Agents|sensory system agents|mesh-ancestor
5794957|NCT02766439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5794958|NCT02766439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794959|NCT02766439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5794960|NCT02766439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5794961|NCT02766439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5794962|NCT02766439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5794963|NCT02766439|Immunologic Factors|immunologic factors|mesh-ancestor
5794964|NCT02766192|Ketamine|ketamine|mesh-list
5794965|NCT02766192|Analgesics|analgesics|mesh-ancestor
5794966|NCT02766192|Sensory System Agents|sensory system agents|mesh-ancestor
5794967|NCT02766192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5794968|NCT02766192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794969|NCT02766192|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5794970|NCT02766192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5794971|NCT02766192|Anesthetics, General|anesthetics, general|mesh-ancestor
5794972|NCT02766192|Anesthetics|anesthetics|mesh-ancestor
5794973|NCT02766192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5794974|NCT02766192|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5794975|NCT02766192|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5794976|NCT02766192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5794977|NCT02766192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5794978|NCT02766270|Temozolomide|temozolomide|mesh-list
5899462|NCT03843151|Itraconazole|itraconazole|mesh-list
5794979|NCT02766270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5794980|NCT02766270|Alkylating Agents|alkylating agents|mesh-ancestor
5794981|NCT02766270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5794982|NCT02766270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5794983|NCT02766556|Dexmedetomidine|dexmedetomidine|mesh-list
5794984|NCT02766556|Ropivacaine|ropivacaine|mesh-list
5794985|NCT02766556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5794986|NCT02766556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5794987|NCT02766556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5794988|NCT02766556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5794989|NCT02766556|Analgesics|analgesics|mesh-ancestor
5794990|NCT02766556|Sensory System Agents|sensory system agents|mesh-ancestor
5794991|NCT02766556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5794992|NCT02766556|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5794993|NCT02766556|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5794994|NCT02766556|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5794995|NCT02766556|Adrenergic Agents|adrenergic agents|mesh-ancestor
5794996|NCT02766556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5794997|NCT02766556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5794998|NCT02766556|Anesthetics, Local|anesthetics, local|mesh-ancestor
5794999|NCT02766556|Anesthetics|anesthetics|mesh-ancestor
5795000|NCT02766348|Gemcitabine|gemcitabine|mesh-list
5795001|NCT02766348|Cisplatin|cisplatin|mesh-list
5795002|NCT02766348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5795003|NCT02766348|Antimetabolites|antimetabolites|mesh-ancestor
5795004|NCT02766348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795005|NCT02766348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5795006|NCT02766348|Antiviral Agents|antiviral agents|mesh-ancestor
5795007|NCT02766348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5795008|NCT02766348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5795009|NCT02766348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5795010|NCT02766348|Immunologic Factors|immunologic factors|mesh-ancestor
5795011|NCT02766348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795012|NCT02766322|Ethanol|ethanol|mesh-list
5795013|NCT02766322|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5795014|NCT02766322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5795015|NCT02766322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5795016|NCT02766322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795017|NCT02766257|Anesthetics|anesthetics|mesh-list
5795018|NCT02766257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5795019|NCT02766257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795020|NCT02766140|Docetaxel|docetaxel|mesh-list
5795021|NCT02766140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5795022|NCT02766140|Tubulin Modulators|tubulin modulators|mesh-ancestor
5795023|NCT02766140|Antimitotic Agents|antimitotic agents|mesh-ancestor
5795024|NCT02766140|Mitosis Modulators|mitosis modulators|mesh-ancestor
5795025|NCT02766140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795026|NCT02766036|Propolis|propolis|mesh-list
5795027|NCT02766036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5795028|NCT02765971|Picosulfate sodium|picosulfate sodium|mesh-list
5795029|NCT02765971|Cathartics|cathartics|mesh-ancestor
5795030|NCT02765971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5795031|NCT02765815|Ketorolac|ketorolac|mesh-list
5795032|NCT02765815|Epinephrine|epinephrine|mesh-list
5795033|NCT02765815|Racepinephrine|racepinephrine|mesh-list
5795034|NCT02765815|Morphine|morphine|mesh-list
5795035|NCT02765815|Bupivacaine|bupivacaine|mesh-list
5795036|NCT02765815|Epinephryl borate|epinephryl borate|mesh-list
5795037|NCT02765815|Anesthetics, Local|anesthetics, local|mesh-ancestor
5795038|NCT02765815|Anesthetics|anesthetics|mesh-ancestor
5795039|NCT02765815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5795040|NCT02765815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795041|NCT02765815|Sensory System Agents|sensory system agents|mesh-ancestor
5795042|NCT02765815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5795043|NCT02765815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5795044|NCT02765815|Narcotics|narcotics|mesh-ancestor
5795045|NCT02765815|Analgesics|analgesics|mesh-ancestor
5795046|NCT02765815|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6210909|NCT02166333|Cholecalciferol|cholecalciferol|mesh-list
6210910|NCT02166333|Vitamins|vitamins|mesh-list
6210911|NCT02166333|Micronutrients|micronutrients|mesh-ancestor
6210912|NCT02166333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210913|NCT02166333|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6210914|NCT02166333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6210915|NCT02166346|4-Aminopyridine|4-aminopyridine|mesh-list
6210916|NCT02166346|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5795047|NCT02765815|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5795048|NCT02765815|Adrenergic Agents|adrenergic agents|mesh-ancestor
5795049|NCT02765815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5795050|NCT02765815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795051|NCT02765815|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5795052|NCT02765815|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5795053|NCT02765815|Autonomic Agents|autonomic agents|mesh-ancestor
5795054|NCT02765815|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5795055|NCT02765815|Respiratory System Agents|respiratory system agents|mesh-ancestor
5795056|NCT02765815|Mydriatics|mydriatics|mesh-ancestor
5795057|NCT02765815|Sympathomimetics|sympathomimetics|mesh-ancestor
5795058|NCT02765815|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5795059|NCT02765815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5795060|NCT02765815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5795061|NCT02765815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5795062|NCT02765815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5795063|NCT02765815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5795064|NCT02765815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5795065|NCT02765633|Cangrelor|cangrelor|mesh-list
5795066|NCT02765633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5795067|NCT02765633|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5795068|NCT02765633|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5795069|NCT02765633|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5795070|NCT02765633|Purinergic Agents|purinergic agents|mesh-ancestor
5795071|NCT02765633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5795072|NCT02765633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795073|NCT02765633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795074|NCT02765594|Hydroxychloroquine|hydroxychloroquine|mesh-list
5795075|NCT02765594|Valsartan|valsartan|mesh-list
5795076|NCT02765594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5795077|NCT02765594|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5795078|NCT02765594|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5795079|NCT02765594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795080|NCT02765594|Antimalarials|antimalarials|mesh-ancestor
5795081|NCT02765594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5795082|NCT02765594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5795083|NCT02765594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5795084|NCT02765594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5795085|NCT02765594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5795086|NCT02765347|Metformin|metformin|mesh-list
5795087|NCT02765347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5795088|NCT02765347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899463|NCT03843151|Antifungal Agents|antifungal agents|mesh-ancestor
5899464|NCT03843151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5899465|NCT03843151|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5899466|NCT03843151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5899467|NCT03843151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5795089|NCT02765399|Liraglutide|liraglutide|mesh-list
5795090|NCT02765399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5795091|NCT02765399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795092|NCT02765399|Incretins|incretins|mesh-ancestor
5795093|NCT02765399|Hormones|hormones|mesh-ancestor
5795094|NCT02765399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5795095|NCT02765373|Letrozole|letrozole|mesh-list
5795096|NCT02765373|Anastrozole|anastrozole|mesh-list
5795097|NCT02765373|Exemestane|exemestane|mesh-list
5795098|NCT02765373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5795099|NCT02765373|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5795100|NCT02765373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6210917|NCT02166346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6210918|NCT02166346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210919|NCT02166476|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6210920|NCT02166476|Levofloxacin|levofloxacin|mesh-list
6210921|NCT02166476|Ofloxacin|ofloxacin|mesh-list
6210922|NCT02166476|Meropenem|meropenem|mesh-list
6210923|NCT02166476|Tazobactam|tazobactam|mesh-list
6210924|NCT02166476|Piperacillin|piperacillin|mesh-list
5795101|NCT02765373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5795102|NCT02765373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795103|NCT02765373|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5795104|NCT02765373|Hormone Antagonists|hormone antagonists|mesh-ancestor
5795105|NCT02765373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5795106|NCT02765373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795107|NCT02765373|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5795108|NCT02765217|Amoxicillin|amoxicillin|mesh-list
5795109|NCT02765217|Clavulanic Acids|clavulanic acids|mesh-list
5795110|NCT02765217|Clavulanic Acid|clavulanic acid|mesh-list
5795111|NCT02765217|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5795112|NCT02765217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5795113|NCT02765217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5795114|NCT02765217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5795115|NCT02765217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795116|NCT02765217|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5795117|NCT02765204|Dapagliflozin|dapagliflozin|mesh-list
5795118|NCT02765204|Saxagliptin|saxagliptin|mesh-list
5795119|NCT02765204|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5795120|NCT02765204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795121|NCT02765204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5795122|NCT02765204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795123|NCT02765204|Incretins|incretins|mesh-ancestor
5795124|NCT02765204|Hormones|hormones|mesh-ancestor
6210925|NCT02166476|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
5795125|NCT02765204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5795126|NCT02765204|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5795127|NCT02765204|Protease Inhibitors|protease inhibitors|mesh-ancestor
5795128|NCT02765204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5795129|NCT02765022|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
5795130|NCT02765022|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
5795131|NCT02765022|beta-Endorphin|beta-endorphin|mesh-list
5795132|NCT02765022|Hormones|hormones|mesh-ancestor
5795133|NCT02765022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5795134|NCT02765022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795135|NCT02765022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5795136|NCT02765022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795137|NCT02765009|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5795138|NCT02765009|Furosemide|furosemide|mesh-list
5795139|NCT02765009|Bumetanide|bumetanide|mesh-list
5795140|NCT02765009|Diuretics|diuretics|mesh-list
5795141|NCT02765009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5795142|NCT02765009|Natriuretic Agents|natriuretic agents|mesh-ancestor
5795143|NCT02765009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795144|NCT02765009|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5795145|NCT02765009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5795146|NCT02765009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795147|NCT02765009|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5795148|NCT02765126|Vaccines|vaccines|mesh-list
5795149|NCT02765126|Immunologic Factors|immunologic factors|mesh-ancestor
5795150|NCT02765126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795151|NCT02764619|Spironolactone|spironolactone|mesh-list
5795152|NCT02764619|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5795153|NCT02764619|Hormone Antagonists|hormone antagonists|mesh-ancestor
5795154|NCT02764619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5795155|NCT02764619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795156|NCT02764619|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5795157|NCT02764619|Diuretics|diuretics|mesh-ancestor
5795158|NCT02764619|Natriuretic Agents|natriuretic agents|mesh-ancestor
5795159|NCT02764515|Methotrexate|methotrexate|mesh-list
5795160|NCT02764515|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5795161|NCT02764515|Abortifacient Agents|abortifacient agents|mesh-ancestor
5795162|NCT02764515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5795163|NCT02764515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795164|NCT02764515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5795165|NCT02764515|Antimetabolites|antimetabolites|mesh-ancestor
5795166|NCT02764515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795167|NCT02764515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5795168|NCT02764515|Dermatologic Agents|dermatologic agents|mesh-ancestor
5795169|NCT02764515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5795170|NCT02764515|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5795171|NCT02764515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5795172|NCT02764515|Immunologic Factors|immunologic factors|mesh-ancestor
5795173|NCT02764515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5795174|NCT02764515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5795175|NCT02764736|Atorvastatin|atorvastatin|mesh-list
5795176|NCT02764736|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5795177|NCT02764736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5795178|NCT02764736|Antimetabolites|antimetabolites|mesh-ancestor
5795179|NCT02764736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795180|NCT02764736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5795181|NCT02764736|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5795182|NCT02764736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5795183|NCT02764723|Bupivacaine|bupivacaine|mesh-list
5795184|NCT02764723|Ropivacaine|ropivacaine|mesh-list
5795185|NCT02764723|Anesthetics, Local|anesthetics, local|mesh-ancestor
5795186|NCT02764723|Anesthetics|anesthetics|mesh-ancestor
5795187|NCT02764723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5795188|NCT02764723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795189|NCT02764723|Sensory System Agents|sensory system agents|mesh-ancestor
5795190|NCT02764723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5795191|NCT02764710|Amoxicillin|amoxicillin|mesh-list
5795192|NCT02764710|Clavulanic Acid|clavulanic acid|mesh-list
5795193|NCT02764710|Clavulanic Acids|clavulanic acids|mesh-list
5795194|NCT02764710|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5795195|NCT02764710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5795196|NCT02764710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5795197|NCT02764710|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5795198|NCT02764710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5795199|NCT02764710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795200|NCT02764749|Phenol|phenol|mesh-list
5795201|NCT02764749|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5795202|NCT02764749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5795203|NCT02764749|Disinfectants|disinfectants|mesh-ancestor
5795204|NCT02764749|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
5795205|NCT02764749|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5795206|NCT02764541|Tamoxifen|tamoxifen|mesh-list
5795207|NCT02764541|Letrozole|letrozole|mesh-list
5795208|NCT02764541|Palbociclib|palbociclib|mesh-list
5795209|NCT02764541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5795210|NCT02764541|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5795211|NCT02764541|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5795212|NCT02764541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5795213|NCT02764541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795214|NCT02764541|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5795215|NCT02764541|Hormone Antagonists|hormone antagonists|mesh-ancestor
5795216|NCT02764541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5795217|NCT02764541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795218|NCT02764541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5795219|NCT02764541|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5795220|NCT02764541|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5795221|NCT02764541|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5795222|NCT02764541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5795223|NCT02764593|Nivolumab|nivolumab|mesh-list
5795224|NCT02764593|Cetuximab|cetuximab|mesh-list
5795225|NCT02764593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5795226|NCT02764593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5795227|NCT02764593|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5795228|NCT02764593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795229|NCT02764359|Vancomycin|vancomycin|mesh-list
5795230|NCT02764359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5795231|NCT02764359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5795232|NCT02764268|Apatinib|apatinib|mesh-list
5795233|NCT02764268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5795234|NCT02764268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5795235|NCT02764268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5795236|NCT02764268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795237|NCT02764125|Levodopa|levodopa|mesh-list
5795238|NCT02764125|Carbidopa|carbidopa|mesh-list
5795239|NCT02764125|Entacapone|entacapone|mesh-list
5795240|NCT02764125|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5795241|NCT02764125|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5795242|NCT02764125|Dopamine Agents|dopamine agents|mesh-ancestor
5795243|NCT02764125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5795244|NCT02764125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795245|NCT02764125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795246|NCT02764125|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5795247|NCT02764125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5795248|NCT02764125|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
5795249|NCT02764281|Dexamethasone|dexamethasone|mesh-list
5795250|NCT02764281|Methotrexate|methotrexate|mesh-list
5795251|NCT02764281|Etoposide|etoposide|mesh-list
5795252|NCT02764281|Pegaspargase|pegaspargase|mesh-list
5795253|NCT02764281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5795254|NCT02764281|Antiemetics|antiemetics|mesh-ancestor
5795255|NCT02764281|Autonomic Agents|autonomic agents|mesh-ancestor
5795256|NCT02764281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5795257|NCT02764281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795258|NCT02764281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5795259|NCT02764281|Glucocorticoids|glucocorticoids|mesh-ancestor
5795260|NCT02764281|Hormones|hormones|mesh-ancestor
5795261|NCT02764281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5795262|NCT02764281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5795263|NCT02764281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5795264|NCT02764281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5795265|NCT02764281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795266|NCT02764281|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5795267|NCT02764281|Abortifacient Agents|abortifacient agents|mesh-ancestor
5795268|NCT02764281|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5795269|NCT02764281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5795270|NCT02764281|Antimetabolites|antimetabolites|mesh-ancestor
5795271|NCT02764281|Dermatologic Agents|dermatologic agents|mesh-ancestor
5795272|NCT02764281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5795273|NCT02764281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5795274|NCT02764281|Immunologic Factors|immunologic factors|mesh-ancestor
5795275|NCT02764281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5795276|NCT02764281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5795277|NCT02764281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5795278|NCT02764281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5795279|NCT02764281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5795280|NCT02764411|Brimonidine Tartrate|brimonidine tartrate|mesh-list
5795281|NCT02764411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5795282|NCT02764411|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5795283|NCT02764411|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5795284|NCT02764411|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5795285|NCT02764411|Adrenergic Agents|adrenergic agents|mesh-ancestor
5795286|NCT02764411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5795287|NCT02764411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795288|NCT02764411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795289|NCT02763969|Interferons|interferons|mesh-list
5795290|NCT02763969|Interferon-alpha|interferon-alpha|mesh-list
5795291|NCT02763969|Interferon alpha-2|interferon alpha-2|mesh-list
5795292|NCT02763969|Ustekinumab|ustekinumab|mesh-list
5795293|NCT02763969|Famotidine|famotidine|mesh-list
5795294|NCT02763969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5795295|NCT02763969|Antiviral Agents|antiviral agents|mesh-ancestor
5795296|NCT02763969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5795297|NCT02763969|Immunologic Factors|immunologic factors|mesh-ancestor
5795298|NCT02763969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795299|NCT02763969|Dermatologic Agents|dermatologic agents|mesh-ancestor
5795300|NCT02763969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5795301|NCT02763969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5795302|NCT02763969|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5795303|NCT02763969|Histamine Antagonists|histamine antagonists|mesh-ancestor
5795304|NCT02763969|Histamine Agents|histamine agents|mesh-ancestor
5795305|NCT02763969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5795306|NCT02763969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795307|NCT02763852|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
5795308|NCT02763852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5795309|NCT02763852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795310|NCT02763852|Dopamine Agents|dopamine agents|mesh-ancestor
5795311|NCT02763852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5795312|NCT02763852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899468|NCT03843151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899469|NCT03843151|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5899470|NCT03843151|Hormone Antagonists|hormone antagonists|mesh-ancestor
5899471|NCT03843151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5899472|NCT03843151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899473|NCT03843151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5899474|NCT03822793|Tranexamic Acid|tranexamic acid|mesh-list
5899475|NCT03822793|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5899476|NCT03822793|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5899477|NCT03822793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899478|NCT03822793|Hemostatics|hemostatics|mesh-ancestor
5899479|NCT03822793|Coagulants|coagulants|mesh-ancestor
5899480|NCT03748134|Paclitaxel|paclitaxel|mesh-list
5899481|NCT03748134|Fluorouracil|fluorouracil|mesh-list
5899482|NCT03748134|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5899483|NCT03748134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5899484|NCT03748134|Tubulin Modulators|tubulin modulators|mesh-ancestor
5899485|NCT03748134|Antimitotic Agents|antimitotic agents|mesh-ancestor
5899486|NCT03748134|Mitosis Modulators|mitosis modulators|mesh-ancestor
5899487|NCT03748134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899488|NCT03748134|Antimetabolites|antimetabolites|mesh-ancestor
5899489|NCT03748134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5899490|NCT03748134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5899491|NCT03748134|Immunologic Factors|immunologic factors|mesh-ancestor
5899492|NCT03748134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899493|NCT03710421|Cyclophosphamide|cyclophosphamide|mesh-list
5899494|NCT03710421|Fludarabine|fludarabine|mesh-list
5899495|NCT03710421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5899496|NCT03710421|Immunologic Factors|immunologic factors|mesh-ancestor
5899497|NCT03710421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899498|NCT03710421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5899499|NCT03710421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5899500|NCT03710421|Alkylating Agents|alkylating agents|mesh-ancestor
5795313|NCT02764021|Hypoglycemic Agents|hypoglycemic agents|mesh-list
5795314|NCT02764021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795315|NCT02763722|Emollients|emollients|mesh-list
5795316|NCT02763722|Dermatologic Agents|dermatologic agents|mesh-ancestor
5795317|NCT02763592|Lidocaine|lidocaine|mesh-list
5795318|NCT02763592|Anesthetics, Local|anesthetics, local|mesh-ancestor
5795319|NCT02763592|Anesthetics|anesthetics|mesh-ancestor
5795320|NCT02763592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5795321|NCT02763592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795322|NCT02763592|Sensory System Agents|sensory system agents|mesh-ancestor
5795323|NCT02763592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5795324|NCT02763592|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5795325|NCT02763592|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5795326|NCT02763592|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5795327|NCT02763592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5795328|NCT02763592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795329|NCT02763761|Prednisone|prednisone|mesh-list
5795330|NCT02763761|Methylprednisolone|methylprednisolone|mesh-list
5795331|NCT02763761|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5795332|NCT02763761|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5795333|NCT02763761|Prednisolone|prednisolone|mesh-list
5795334|NCT02763761|Prednisolone acetate|prednisolone acetate|mesh-list
5795335|NCT02763761|Infliximab|infliximab|mesh-list
5795336|NCT02763761|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5795337|NCT02763761|Prednisolone phosphate|prednisolone phosphate|mesh-list
5795338|NCT02763761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5795339|NCT02763761|Glucocorticoids|glucocorticoids|mesh-ancestor
5795340|NCT02763761|Hormones|hormones|mesh-ancestor
5795341|NCT02763761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5795342|NCT02763761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795343|NCT02763761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5795344|NCT02763761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5795345|NCT02763761|Antiemetics|antiemetics|mesh-ancestor
5795346|NCT02763761|Autonomic Agents|autonomic agents|mesh-ancestor
5795347|NCT02763761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5795348|NCT02763761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5795349|NCT02763761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5795350|NCT02763761|Protective Agents|protective agents|mesh-ancestor
5795351|NCT02763761|Dermatologic Agents|dermatologic agents|mesh-ancestor
5795352|NCT02763761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5795353|NCT02763839|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
5795354|NCT02763839|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5795355|NCT02763839|Immunologic Factors|immunologic factors|mesh-ancestor
5795356|NCT02763839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795357|NCT02763839|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5795358|NCT02763839|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5795359|NCT02763839|Dopamine Agonists|dopamine agonists|mesh-ancestor
5795360|NCT02763839|Dopamine Agents|dopamine agents|mesh-ancestor
5795361|NCT02763839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5795362|NCT02763839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795363|NCT02764008|Bupivacaine|bupivacaine|mesh-list
5795364|NCT02764008|Anesthetics, Local|anesthetics, local|mesh-ancestor
5795365|NCT02764008|Anesthetics|anesthetics|mesh-ancestor
5795366|NCT02764008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5795367|NCT02764008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795368|NCT02764008|Sensory System Agents|sensory system agents|mesh-ancestor
5795369|NCT02764008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5795370|NCT02763475|Cyclophosphamide|cyclophosphamide|mesh-list
5795371|NCT02763475|Fludarabine|fludarabine|mesh-list
5795372|NCT02763475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5795373|NCT02763475|Immunologic Factors|immunologic factors|mesh-ancestor
5795374|NCT02763475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795375|NCT02763475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5795376|NCT02763475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5795377|NCT02763475|Alkylating Agents|alkylating agents|mesh-ancestor
5795378|NCT02763475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795379|NCT02763475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5795380|NCT02763475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5795381|NCT02763137|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
5795382|NCT02763137|Carbidopa|carbidopa|mesh-list
5795383|NCT02763137|Levodopa|levodopa|mesh-list
5795384|NCT02763137|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5795385|NCT02763137|Immunologic Factors|immunologic factors|mesh-ancestor
5795386|NCT02763137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210926|NCT02166476|Vaborbactam|vaborbactam|mesh-list
6210927|NCT02166476|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
6210928|NCT02166476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5795387|NCT02763137|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5795388|NCT02763137|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5795389|NCT02763137|Dopamine Agonists|dopamine agonists|mesh-ancestor
5795390|NCT02763137|Dopamine Agents|dopamine agents|mesh-ancestor
5795391|NCT02763137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5795392|NCT02763137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795393|NCT02763137|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5795394|NCT02763137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5795395|NCT02762955|Adalimumab|adalimumab|mesh-list
5795396|NCT02762955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5795397|NCT02762955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5795398|NCT02763098|Remifentanil|remifentanil|mesh-list
5795399|NCT02763098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5795400|NCT02763098|Narcotics|narcotics|mesh-ancestor
5795401|NCT02763098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5795402|NCT02763098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795403|NCT02763098|Analgesics|analgesics|mesh-ancestor
5795404|NCT02763098|Sensory System Agents|sensory system agents|mesh-ancestor
5795405|NCT02763098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5795406|NCT02763059|Acetaminophen|acetaminophen|mesh-list
5795407|NCT02763059|Dexamethasone|dexamethasone|mesh-list
5795408|NCT02763059|Ibuprofen|ibuprofen|mesh-list
5795409|NCT02763059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5795410|NCT02763059|Antiemetics|antiemetics|mesh-ancestor
5795411|NCT02763059|Autonomic Agents|autonomic agents|mesh-ancestor
5795412|NCT02763059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5795413|NCT02763059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795414|NCT02763059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5795415|NCT02763059|Glucocorticoids|glucocorticoids|mesh-ancestor
5795416|NCT02763059|Hormones|hormones|mesh-ancestor
5795417|NCT02763059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5795418|NCT02763059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5795419|NCT02763059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5795420|NCT02763059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5795421|NCT02763059|Analgesics|analgesics|mesh-ancestor
5795422|NCT02763059|Sensory System Agents|sensory system agents|mesh-ancestor
5795423|NCT02763059|Antipyretics|antipyretics|mesh-ancestor
5795424|NCT02763059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5795425|NCT02763059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5795426|NCT02763059|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5795427|NCT02763059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5795428|NCT02763059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795429|NCT02763007|Pioglitazone|pioglitazone|mesh-list
5795430|NCT02763007|Alogliptin|alogliptin|mesh-list
5795431|NCT02763007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5795432|NCT02763007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795433|NCT02763007|Incretins|incretins|mesh-ancestor
5795434|NCT02763007|Hormones|hormones|mesh-ancestor
5795435|NCT02763007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5795436|NCT02763007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5795437|NCT02763007|Protease Inhibitors|protease inhibitors|mesh-ancestor
5795438|NCT02763007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5795439|NCT02763007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795440|NCT02762838|Folic Acid|folic acid|mesh-list
5795441|NCT02762838|Methotrexate|methotrexate|mesh-list
5795442|NCT02762838|Infliximab|infliximab|mesh-list
5795443|NCT02762838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5795444|NCT02762838|Abortifacient Agents|abortifacient agents|mesh-ancestor
5795445|NCT02762838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5795446|NCT02762838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795447|NCT02762838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5795448|NCT02762838|Antimetabolites|antimetabolites|mesh-ancestor
5795449|NCT02762838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795450|NCT02762838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5795451|NCT02762838|Dermatologic Agents|dermatologic agents|mesh-ancestor
5795452|NCT02762838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5795453|NCT02762838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5795454|NCT02762838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5795455|NCT02762838|Immunologic Factors|immunologic factors|mesh-ancestor
5795456|NCT02762838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5795457|NCT02762838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5795458|NCT02762838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5795459|NCT02762838|Hematinics|hematinics|mesh-ancestor
5795460|NCT02762838|Vitamin B Complex|vitamin b complex|mesh-ancestor
5795461|NCT02762838|Vitamins|vitamins|mesh-ancestor
5795462|NCT02762838|Micronutrients|micronutrients|mesh-ancestor
5795463|NCT02762851|Vaccines|vaccines|mesh-list
5795464|NCT02762851|Immunologic Factors|immunologic factors|mesh-ancestor
5795465|NCT02762851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795466|NCT02762981|Paclitaxel|paclitaxel|mesh-list
5795467|NCT02762981|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5795468|NCT02762981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5795469|NCT02762981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5795470|NCT02762981|Tubulin Modulators|tubulin modulators|mesh-ancestor
5795471|NCT02762981|Antimitotic Agents|antimitotic agents|mesh-ancestor
5795472|NCT02762981|Mitosis Modulators|mitosis modulators|mesh-ancestor
5795473|NCT02762981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795474|NCT02762812|Infliximab|infliximab|mesh-list
5795475|NCT02762812|Dermatologic Agents|dermatologic agents|mesh-ancestor
5795476|NCT02762812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5795477|NCT02762812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5795478|NCT02762864|Aspirin|aspirin|mesh-list
5795479|NCT02762864|Clopidogrel|clopidogrel|mesh-list
5795480|NCT02762864|Ticagrelor|ticagrelor|mesh-list
5795481|NCT02762864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5795482|NCT02762864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5795483|NCT02762864|Analgesics|analgesics|mesh-ancestor
5795484|NCT02762864|Sensory System Agents|sensory system agents|mesh-ancestor
5795485|NCT02762864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5795486|NCT02762864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795487|NCT02762864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5795488|NCT02762864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5795489|NCT02762864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5795490|NCT02762864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5795491|NCT02762864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795492|NCT02762864|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5795493|NCT02762864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5795494|NCT02762864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5795495|NCT02762864|Antipyretics|antipyretics|mesh-ancestor
5795496|NCT02762864|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5795497|NCT02762864|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5795498|NCT02762864|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5795499|NCT02762864|Purinergic Agents|purinergic agents|mesh-ancestor
5795500|NCT02762864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5795501|NCT02762890|Iodine|iodine|mesh-list
5795502|NCT02762890|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5795503|NCT02762890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5795504|NCT02762890|Trace Elements|trace elements|mesh-ancestor
5795505|NCT02762890|Micronutrients|micronutrients|mesh-ancestor
5795506|NCT02762890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795507|NCT02762942|Misoprostol|misoprostol|mesh-list
5795508|NCT02762942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5795509|NCT02762942|Abortifacient Agents|abortifacient agents|mesh-ancestor
5795510|NCT02762942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5795511|NCT02762942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795512|NCT02762942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5795513|NCT02762942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5795514|NCT02762942|Oxytocics|oxytocics|mesh-ancestor
5795515|NCT02762656|Lidocaine|lidocaine|mesh-list
5795516|NCT02762656|Anesthetics, Local|anesthetics, local|mesh-ancestor
5795517|NCT02762656|Anesthetics|anesthetics|mesh-ancestor
5795518|NCT02762656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5795519|NCT02762656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795520|NCT02762656|Sensory System Agents|sensory system agents|mesh-ancestor
5795521|NCT02762656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5795522|NCT02762656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5795523|NCT02762656|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5795524|NCT02762656|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5795525|NCT02762656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5795526|NCT02762656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795527|NCT02762643|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
5795528|NCT02762643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5795529|NCT02762643|Hormone Antagonists|hormone antagonists|mesh-ancestor
5795530|NCT02762643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5795531|NCT02762643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795532|NCT02762643|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5795533|NCT02762643|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5795534|NCT02762643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5795535|NCT02762617|Tenofovir|tenofovir|mesh-list
5795536|NCT02762617|Antiviral Agents|antiviral agents|mesh-ancestor
5795537|NCT02762617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5795538|NCT02762617|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5795539|NCT02762617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5795540|NCT02762617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5795541|NCT02762617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795542|NCT02762617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5795543|NCT02762617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5795544|NCT02762591|Pimavanserin|pimavanserin|mesh-list
5795545|NCT02762591|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5795546|NCT02762591|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5795547|NCT02762591|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5795548|NCT02762591|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5795549|NCT02762591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5795550|NCT02762591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795551|NCT02762591|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5795552|NCT02762591|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5795553|NCT02762591|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5795554|NCT02762591|Serotonin Agents|serotonin agents|mesh-ancestor
5795555|NCT02762591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5795556|NCT02762591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795557|NCT02762344|Heparin|heparin|mesh-list
5795558|NCT02762344|Anticoagulants|anticoagulants|mesh-ancestor
5795559|NCT02762344|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5795560|NCT02762344|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5795561|NCT02762344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795562|NCT02762266|Ethiodized Oil|ethiodized oil|mesh-list
5795563|NCT02762266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5795564|NCT02762474|Paclitaxel|paclitaxel|mesh-list
5795565|NCT02762474|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5795566|NCT02762474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5795567|NCT02762474|Tubulin Modulators|tubulin modulators|mesh-ancestor
5795568|NCT02762474|Antimitotic Agents|antimitotic agents|mesh-ancestor
5795569|NCT02762474|Mitosis Modulators|mitosis modulators|mesh-ancestor
5795570|NCT02762474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795571|NCT02762383|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5795572|NCT02762383|Antiviral Agents|antiviral agents|mesh-ancestor
5795573|NCT02762383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5899501|NCT03710421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899502|NCT03710421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5795574|NCT02762448|Asunaprevir|asunaprevir|mesh-list
5795575|NCT02762448|Protease Inhibitors|protease inhibitors|mesh-ancestor
5795576|NCT02762448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5795577|NCT02762448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795578|NCT02762253|Riboflavin|riboflavin|mesh-list
5795579|NCT02762253|Vitamin B Complex|vitamin b complex|mesh-ancestor
5795580|NCT02762253|Vitamins|vitamins|mesh-ancestor
5795581|NCT02762253|Micronutrients|micronutrients|mesh-ancestor
5795582|NCT02762253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795583|NCT02762253|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5795584|NCT02762253|Dermatologic Agents|dermatologic agents|mesh-ancestor
5795585|NCT02762006|Durvalumab|durvalumab|mesh-list
5795586|NCT02762006|Tremelimumab|tremelimumab|mesh-list
5795587|NCT02762006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5795588|NCT02762006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5795589|NCT02762123|Flurbiprofen|flurbiprofen|mesh-list
5795590|NCT02762123|Digoxin|digoxin|mesh-list
5795591|NCT02762123|Midazolam|midazolam|mesh-list
5795592|NCT02762123|Omeprazole|omeprazole|mesh-list
5795593|NCT02762123|Montelukast|montelukast|mesh-list
5795594|NCT02762123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5795595|NCT02762123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5795596|NCT02762123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5795597|NCT02762123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795598|NCT02762123|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5795599|NCT02762123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5795600|NCT02762123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5795601|NCT02762123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5795602|NCT02762123|Anesthetics, General|anesthetics, general|mesh-ancestor
5795603|NCT02762123|Anesthetics|anesthetics|mesh-ancestor
5795604|NCT02762123|GABA Modulators|gaba modulators|mesh-ancestor
5795605|NCT02762123|GABA Agents|gaba agents|mesh-ancestor
5795606|NCT02762123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5795607|NCT02762123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795608|NCT02762123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5795609|NCT02762123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5795610|NCT02762123|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5795611|NCT02762123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5795612|NCT02762123|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5795613|NCT02762123|Respiratory System Agents|respiratory system agents|mesh-ancestor
5795614|NCT02762123|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5795615|NCT02762123|Hormone Antagonists|hormone antagonists|mesh-ancestor
5795616|NCT02762123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5795617|NCT02762123|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5795618|NCT02762123|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5795619|NCT02762123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5795620|NCT02762123|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5795621|NCT02762123|Protective Agents|protective agents|mesh-ancestor
5795622|NCT02762123|Analgesics|analgesics|mesh-ancestor
5795623|NCT02762123|Sensory System Agents|sensory system agents|mesh-ancestor
5795624|NCT02762123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5795625|NCT02762123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5795626|NCT02762123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5795627|NCT02762123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5795628|NCT02762123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5795629|NCT02762123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5795630|NCT02761512|Lansoprazole|lansoprazole|mesh-list
5795631|NCT02761512|Dexlansoprazole|dexlansoprazole|mesh-list
5795632|NCT02761512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5795633|NCT02761512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5795634|NCT02761512|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5795635|NCT02761512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5795636|NCT02761512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795637|NCT02761486|Aspirin|aspirin|mesh-list
5795638|NCT02761486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5795639|NCT02761486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5795640|NCT02761486|Analgesics|analgesics|mesh-ancestor
5795641|NCT02761486|Sensory System Agents|sensory system agents|mesh-ancestor
5795642|NCT02761486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5795643|NCT02761486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795644|NCT02761486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5795645|NCT02761486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5795646|NCT02761486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5795647|NCT02761486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5795648|NCT02761486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795649|NCT02761486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5795650|NCT02761486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5795651|NCT02761486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5795652|NCT02761486|Antipyretics|antipyretics|mesh-ancestor
5795653|NCT02761577|Acetylcysteine|acetylcysteine|mesh-list
5795654|NCT02761577|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5795655|NCT02761577|Antiviral Agents|antiviral agents|mesh-ancestor
5795656|NCT02761577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5795657|NCT02761577|Expectorants|expectorants|mesh-ancestor
5795658|NCT02761577|Respiratory System Agents|respiratory system agents|mesh-ancestor
5795659|NCT02761577|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5795660|NCT02761577|Antioxidants|antioxidants|mesh-ancestor
5795661|NCT02761577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795662|NCT02761577|Protective Agents|protective agents|mesh-ancestor
5795663|NCT02761577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795664|NCT02761577|Antidotes|antidotes|mesh-ancestor
5795665|NCT02761161|Mianserin|mianserin|mesh-list
5795666|NCT02761161|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5795667|NCT02761161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5795668|NCT02761161|Adrenergic Agents|adrenergic agents|mesh-ancestor
5795669|NCT02761161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5795670|NCT02761161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795671|NCT02761161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795672|NCT02761161|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5795673|NCT02761161|Histamine Antagonists|histamine antagonists|mesh-ancestor
5795674|NCT02761161|Histamine Agents|histamine agents|mesh-ancestor
5795675|NCT02761161|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5795676|NCT02761161|Serotonin Agents|serotonin agents|mesh-ancestor
5795677|NCT02761161|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5795678|NCT02761161|Antidepressive Agents|antidepressive agents|mesh-ancestor
5795679|NCT02761161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5795680|NCT02761174|Brimonidine Tartrate|brimonidine tartrate|mesh-list
5795681|NCT02761174|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5795682|NCT02761174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5795683|NCT02761174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5795684|NCT02761174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5795685|NCT02761174|Adrenergic Agents|adrenergic agents|mesh-ancestor
5795686|NCT02761174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5795687|NCT02761174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795688|NCT02761174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795689|NCT02761395|Deferasirox|deferasirox|mesh-list
5795690|NCT02761395|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5795691|NCT02761395|Chelating Agents|chelating agents|mesh-ancestor
5795692|NCT02761395|Sequestering Agents|sequestering agents|mesh-ancestor
5795693|NCT02761395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795694|NCT02761317|Bisacodyl|bisacodyl|mesh-list
5795695|NCT02761317|Cathartics|cathartics|mesh-ancestor
5795696|NCT02761317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5795697|NCT02761317|Laxatives|laxatives|mesh-ancestor
5795698|NCT02761070|Bevacizumab|bevacizumab|mesh-list
5795699|NCT02761070|Temozolomide|temozolomide|mesh-list
5795700|NCT02761070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5795701|NCT02761070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5795702|NCT02761070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5795703|NCT02761070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5795704|NCT02761070|Growth Substances|growth substances|mesh-ancestor
5795705|NCT02761070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795706|NCT02761070|Growth Inhibitors|growth inhibitors|mesh-ancestor
5795707|NCT02761070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5795708|NCT02761070|Alkylating Agents|alkylating agents|mesh-ancestor
5795709|NCT02761070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795710|NCT02760888|Diclofenac|diclofenac|mesh-list
5795711|NCT02760888|Tramadol|tramadol|mesh-list
5795712|NCT02760888|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5795713|NCT02760888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5795714|NCT02760888|Analgesics|analgesics|mesh-ancestor
5795715|NCT02760888|Sensory System Agents|sensory system agents|mesh-ancestor
5795716|NCT02760888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5795717|NCT02760888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795718|NCT02760888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5795719|NCT02760888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5795720|NCT02760888|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5795721|NCT02760888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5795722|NCT02760888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795723|NCT02760888|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5795724|NCT02760888|Narcotics|narcotics|mesh-ancestor
5795725|NCT02760888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5795726|NCT02761291|Gemcitabine|gemcitabine|mesh-list
5795727|NCT02761291|Valganciclovir|valganciclovir|mesh-list
5795728|NCT02761291|Valproic Acid|valproic acid|mesh-list
5795729|NCT02761291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5795730|NCT02761291|Antimetabolites|antimetabolites|mesh-ancestor
5795731|NCT02761291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795732|NCT02761291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5795733|NCT02761291|Antiviral Agents|antiviral agents|mesh-ancestor
5795734|NCT02761291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5795735|NCT02761291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5795736|NCT02761291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5795737|NCT02761291|Immunologic Factors|immunologic factors|mesh-ancestor
5795738|NCT02761291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795739|NCT02761291|Anticonvulsants|anticonvulsants|mesh-ancestor
5795740|NCT02761291|GABA Agents|gaba agents|mesh-ancestor
5795741|NCT02761291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5795742|NCT02761291|Antimanic Agents|antimanic agents|mesh-ancestor
5795743|NCT02761291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5795744|NCT02761291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5795745|NCT02761291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5795746|NCT02760992|Baclofen|baclofen|mesh-list
5795747|NCT02760992|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5795748|NCT02760992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795749|NCT02760992|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5795750|NCT02760992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5795751|NCT02760992|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
5795752|NCT02760992|GABA Agonists|gaba agonists|mesh-ancestor
5795753|NCT02760992|GABA Agents|gaba agents|mesh-ancestor
5795754|NCT02760992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5795755|NCT02760992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795756|NCT02760979|Denosumab|denosumab|mesh-list
5795757|NCT02760979|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5795758|NCT02760979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795759|NCT02760953|Epirubicin|epirubicin|mesh-list
5795760|NCT02760953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5795761|NCT02760953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5795762|NCT02760953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5795763|NCT02760953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5795764|NCT02760953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5795765|NCT02760953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795766|NCT02760901|Acetylcysteine|acetylcysteine|mesh-list
5795767|NCT02760901|Mannitol|mannitol|mesh-list
5795768|NCT02760901|Acetazolamide|acetazolamide|mesh-list
5795769|NCT02760901|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5795770|NCT02760901|Antiviral Agents|antiviral agents|mesh-ancestor
5795771|NCT02760901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6673917|NCT01566253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6673918|NCT01566253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6673919|NCT01566253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673920|NCT01566266|Amoxicillin|amoxicillin|mesh-list
5795772|NCT02760901|Expectorants|expectorants|mesh-ancestor
5795773|NCT02760901|Respiratory System Agents|respiratory system agents|mesh-ancestor
5795774|NCT02760901|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5795775|NCT02760901|Antioxidants|antioxidants|mesh-ancestor
5795776|NCT02760901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795777|NCT02760901|Protective Agents|protective agents|mesh-ancestor
5795778|NCT02760901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795779|NCT02760901|Antidotes|antidotes|mesh-ancestor
5795780|NCT02760901|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5795781|NCT02760901|Diuretics|diuretics|mesh-ancestor
5795782|NCT02760901|Natriuretic Agents|natriuretic agents|mesh-ancestor
5795783|NCT02760901|Anticonvulsants|anticonvulsants|mesh-ancestor
6491633|NCT00603343|Propiverine|propiverine|mesh-list
5641264|NCT03743662|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5641265|NCT03743662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641266|NCT03711058|Nivolumab|nivolumab|mesh-list
5641267|NCT03711058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5641268|NCT03711058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5641269|NCT03711058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5641270|NCT03711058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641271|NCT03706885|Efavirenz|efavirenz|mesh-list
5641272|NCT03706885|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5641273|NCT03706885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5641274|NCT03706885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5641275|NCT03706885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641276|NCT03706885|Antiviral Agents|antiviral agents|mesh-ancestor
5641277|NCT03706885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5795784|NCT02760901|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5795785|NCT02760901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5795786|NCT02760823|Thioctic Acid|thioctic acid|mesh-list
5795787|NCT02760823|Antioxidants|antioxidants|mesh-ancestor
5795788|NCT02760823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795789|NCT02760823|Protective Agents|protective agents|mesh-ancestor
5795790|NCT02760823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795791|NCT02760823|Vitamin B Complex|vitamin b complex|mesh-ancestor
5795792|NCT02760823|Vitamins|vitamins|mesh-ancestor
5795793|NCT02760823|Micronutrients|micronutrients|mesh-ancestor
5899503|NCT03710421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5899504|NCT03703492|Estradiol|estradiol|mesh-list
5899505|NCT03703492|Estrogens|estrogens|mesh-ancestor
5899506|NCT03703492|Hormones|hormones|mesh-ancestor
5899507|NCT03703492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5899508|NCT03703492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899509|NCT03664024|Carboplatin|carboplatin|mesh-list
5899510|NCT03664024|Pembrolizumab|pembrolizumab|mesh-list
5899511|NCT03664024|Pemetrexed|pemetrexed|mesh-list
5899512|NCT03664024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5899513|NCT03664024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5899514|NCT03664024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5899515|NCT03664024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899516|NCT03664024|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5899517|NCT03664024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5899518|NCT03663166|Nivolumab|nivolumab|mesh-list
5899519|NCT03663166|Ipilimumab|ipilimumab|mesh-list
5899520|NCT03663166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5899521|NCT03663166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5899522|NCT03663166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5899523|NCT03663166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899524|NCT03661047|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
5899525|NCT03661047|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5899526|NCT03661047|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5899527|NCT03554317|Nivolumab|nivolumab|mesh-list
5899528|NCT03554317|Methyltestosterone|methyltestosterone|mesh-list
5899529|NCT03554317|Testosterone|testosterone|mesh-list
5899530|NCT03554317|Testosterone undecanoate|testosterone undecanoate|mesh-list
5899531|NCT03554317|Testosterone enanthate|testosterone enanthate|mesh-list
5899532|NCT03554317|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5899533|NCT03554317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5899534|NCT03554317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5899535|NCT03554317|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5899536|NCT03554317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899537|NCT03554317|Androgens|androgens|mesh-ancestor
5899538|NCT03554317|Hormones|hormones|mesh-ancestor
5899539|NCT03554317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5899540|NCT03554317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899541|NCT03554317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5899542|NCT03554317|Anabolic Agents|anabolic agents|mesh-ancestor
5899543|NCT03434418|Osimertinib|osimertinib|mesh-list
5899544|NCT03434418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5899545|NCT03434418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5899546|NCT03434418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5899547|NCT03434418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899548|NCT03430063|Ipilimumab|ipilimumab|mesh-list
5899549|NCT03430063|Cemiplimab|cemiplimab|mesh-list
5899550|NCT03430063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5899551|NCT03430063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5899552|NCT03430063|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5899553|NCT03430063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899554|NCT03425006|Pembrolizumab|pembrolizumab|mesh-list
5795794|NCT02760667|Cisplatin|cisplatin|mesh-list
5795795|NCT02760667|Carboplatin|carboplatin|mesh-list
5795796|NCT02760667|Docetaxel|docetaxel|mesh-list
5795797|NCT02760667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5795798|NCT02760667|Tubulin Modulators|tubulin modulators|mesh-ancestor
5795799|NCT02760667|Antimitotic Agents|antimitotic agents|mesh-ancestor
5795800|NCT02760667|Mitosis Modulators|mitosis modulators|mesh-ancestor
5795801|NCT02760667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795802|NCT02760420|Amoxicillin|amoxicillin|mesh-list
5795803|NCT02760420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5795804|NCT02760420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5795805|NCT02760342|Metformin|metformin|mesh-list
5795806|NCT02760342|Peficitinib|peficitinib|mesh-list
5795807|NCT02760342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5795808|NCT02760342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795809|NCT02760342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5795810|NCT02760342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795811|NCT02760342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5795812|NCT02760342|Immunologic Factors|immunologic factors|mesh-ancestor
5795813|NCT02760615|Losartan|losartan|mesh-list
5795814|NCT02760615|Midazolam|midazolam|mesh-list
5795815|NCT02760615|Dextromethorphan|dextromethorphan|mesh-list
5795816|NCT02760615|Caffeine|caffeine|mesh-list
5795817|NCT02760615|Omeprazole|omeprazole|mesh-list
5795818|NCT02760615|Vedolizumab|vedolizumab|mesh-list
5795819|NCT02760615|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5795820|NCT02760615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5641278|NCT03706885|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5641279|NCT03706885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5641280|NCT03706885|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5641281|NCT03706885|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5641282|NCT03706885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5641283|NCT03706885|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5641284|NCT03671330|Letrozole|letrozole|mesh-list
5641285|NCT03671330|Goserelin|goserelin|mesh-list
5795821|NCT02760615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5795822|NCT02760615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795823|NCT02760615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5795824|NCT02760615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5795825|NCT02760615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5795826|NCT02760615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5795827|NCT02760615|Anesthetics, General|anesthetics, general|mesh-ancestor
5795828|NCT02760615|Anesthetics|anesthetics|mesh-ancestor
5795829|NCT02760615|GABA Modulators|gaba modulators|mesh-ancestor
5795830|NCT02760615|GABA Agents|gaba agents|mesh-ancestor
5795831|NCT02760615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5795832|NCT02760615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795833|NCT02760615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5795834|NCT02760615|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5795835|NCT02760615|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5795836|NCT02760615|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5795837|NCT02760615|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5795838|NCT02760615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5795839|NCT02760615|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5795840|NCT02760615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5795841|NCT02760615|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5795842|NCT02760615|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5795843|NCT02760615|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5795844|NCT02760615|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5795845|NCT02760615|Purinergic Agents|purinergic agents|mesh-ancestor
5795846|NCT02760615|Antitussive Agents|antitussive agents|mesh-ancestor
5795847|NCT02760615|Respiratory System Agents|respiratory system agents|mesh-ancestor
5795848|NCT02760615|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5795849|NCT02760615|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5795850|NCT02760355|Ribavirin|ribavirin|mesh-list
5795851|NCT02760355|Sofosbuvir|sofosbuvir|mesh-list
5795852|NCT02760355|Ledipasvir|ledipasvir|mesh-list
5795853|NCT02760355|Antimetabolites|antimetabolites|mesh-ancestor
5795854|NCT02760355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795855|NCT02760355|Antiviral Agents|antiviral agents|mesh-ancestor
5795856|NCT02760355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5795857|NCT02760459|Dexamethasone|dexamethasone|mesh-list
5795858|NCT02760459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5795859|NCT02760459|Antiemetics|antiemetics|mesh-ancestor
5795860|NCT02760459|Autonomic Agents|autonomic agents|mesh-ancestor
5795861|NCT02760459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5795862|NCT02760459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795863|NCT02760459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5795864|NCT02760459|Glucocorticoids|glucocorticoids|mesh-ancestor
5795865|NCT02760459|Hormones|hormones|mesh-ancestor
5795866|NCT02760459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5795867|NCT02760459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5795868|NCT02760459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5795869|NCT02760316|Prednisolone|prednisolone|mesh-list
5795870|NCT02760316|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5795871|NCT02760316|Methylprednisolone|methylprednisolone|mesh-list
5795872|NCT02760316|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5795873|NCT02760316|Prednisolone acetate|prednisolone acetate|mesh-list
5795874|NCT02760316|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5795875|NCT02760316|Prednisolone phosphate|prednisolone phosphate|mesh-list
5795876|NCT02760316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5795877|NCT02760316|Glucocorticoids|glucocorticoids|mesh-ancestor
5795878|NCT02760316|Hormones|hormones|mesh-ancestor
5795879|NCT02760316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5795880|NCT02760316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795881|NCT02760316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5795882|NCT02760316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5795883|NCT02760316|Antiemetics|antiemetics|mesh-ancestor
5795884|NCT02760316|Autonomic Agents|autonomic agents|mesh-ancestor
5795885|NCT02760316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5795886|NCT02760316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5795887|NCT02760316|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5795888|NCT02760316|Protective Agents|protective agents|mesh-ancestor
5795889|NCT02760472|SMOFlipid|smoflipid|mesh-list
5795890|NCT02760472|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
5795891|NCT02760472|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5795892|NCT02760472|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5795893|NCT02760381|Acetic Acid|acetic acid|mesh-list
5795894|NCT02760381|Retinol acetate|retinol acetate|mesh-list
5795895|NCT02760381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5795896|NCT02760381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5795897|NCT02760381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5795898|NCT02760381|Immunologic Factors|immunologic factors|mesh-ancestor
5795899|NCT02760381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795900|NCT02760381|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5795901|NCT02760381|Protective Agents|protective agents|mesh-ancestor
5795902|NCT02760381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5795903|NCT02760225|Pembrolizumab|pembrolizumab|mesh-list
5795904|NCT02760225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5795905|NCT02760225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5795906|NCT02760043|Dexamethasone|dexamethasone|mesh-list
5795907|NCT02760043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5795908|NCT02760043|Antiemetics|antiemetics|mesh-ancestor
5795909|NCT02760043|Autonomic Agents|autonomic agents|mesh-ancestor
5795910|NCT02760043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5795911|NCT02760043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795912|NCT02760043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5795913|NCT02760043|Glucocorticoids|glucocorticoids|mesh-ancestor
5795914|NCT02760043|Hormones|hormones|mesh-ancestor
5795915|NCT02760043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5795916|NCT02760043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5795917|NCT02760043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5795918|NCT02759861|Sofosbuvir|sofosbuvir|mesh-list
5795919|NCT02759861|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
5795920|NCT02759861|Ledipasvir|ledipasvir|mesh-list
5795921|NCT02759861|Antiviral Agents|antiviral agents|mesh-ancestor
5795922|NCT02759861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5795923|NCT02760121|Acetazolamide|acetazolamide|mesh-list
5795924|NCT02760121|Methazolamide|methazolamide|mesh-list
5795925|NCT02760121|Anticonvulsants|anticonvulsants|mesh-ancestor
5795926|NCT02760121|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5795927|NCT02760121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5795928|NCT02760121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795929|NCT02760121|Diuretics|diuretics|mesh-ancestor
5795930|NCT02760121|Natriuretic Agents|natriuretic agents|mesh-ancestor
5795931|NCT02760121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795932|NCT02759991|Vaccines|vaccines|mesh-list
5795933|NCT02759991|Immunologic Factors|immunologic factors|mesh-ancestor
5795934|NCT02759991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795935|NCT02759887|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5795936|NCT02759887|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5795937|NCT02759887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795938|NCT02760030|Fulvestrant|fulvestrant|mesh-list
5795939|NCT02760030|Palbociclib|palbociclib|mesh-list
5795940|NCT02760030|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5795941|NCT02760030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5795942|NCT02760030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5795943|NCT02760030|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5795944|NCT02760030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5795945|NCT02760030|Hormone Antagonists|hormone antagonists|mesh-ancestor
5795946|NCT02760030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5795947|NCT02760030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795948|NCT02760030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5795949|NCT02760030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5795950|NCT02760030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795951|NCT02760030|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5795952|NCT02760095|Vitamin A|vitamin a|mesh-list
5795953|NCT02760095|Acetic Acid|acetic acid|mesh-list
5795954|NCT02760095|Retinol acetate|retinol acetate|mesh-list
5795955|NCT02760095|Zinc Sulfate|zinc sulfate|mesh-list
5795956|NCT02760095|Vitamins|vitamins|mesh-ancestor
5795957|NCT02760095|Micronutrients|micronutrients|mesh-ancestor
5795958|NCT02760095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795959|NCT02760095|Protective Agents|protective agents|mesh-ancestor
5795960|NCT02760095|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5795961|NCT02760095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5795962|NCT02760095|Astringents|astringents|mesh-ancestor
5795963|NCT02760095|Dermatologic Agents|dermatologic agents|mesh-ancestor
5795964|NCT02760095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5795965|NCT02760095|Immunologic Factors|immunologic factors|mesh-ancestor
5795966|NCT02760095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5795967|NCT02760095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5795968|NCT02759926|Quinine|quinine|mesh-list
5795969|NCT02759926|Denatonium|denatonium|mesh-list
5795970|NCT02759926|Antimalarials|antimalarials|mesh-ancestor
5795971|NCT02759926|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5795972|NCT02759926|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5795973|NCT02759926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5795974|NCT02759926|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5795975|NCT02759926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795976|NCT02759926|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5795977|NCT02759926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5795978|NCT02759926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5795979|NCT02759926|Analgesics|analgesics|mesh-ancestor
5795980|NCT02759926|Sensory System Agents|sensory system agents|mesh-ancestor
5795981|NCT02759926|Aversive Agents|aversive agents|mesh-ancestor
5641286|NCT03671330|Anastrozole|anastrozole|mesh-list
5641287|NCT03671330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5641288|NCT03671330|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5641289|NCT03671330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5641290|NCT03671330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5641291|NCT03671330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491634|NCT00603343|Parasympatholytics|parasympatholytics|mesh-ancestor
6491635|NCT00603343|Autonomic Agents|autonomic agents|mesh-ancestor
6491636|NCT00603343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5795982|NCT02759926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795983|NCT02759926|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
5795984|NCT02759614|Bevacizumab|bevacizumab|mesh-list
5795985|NCT02759614|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5795986|NCT02759614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6491637|NCT00603343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641292|NCT03671330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5641293|NCT03671330|Hormone Antagonists|hormone antagonists|mesh-ancestor
5795987|NCT02759614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5795988|NCT02759614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5795989|NCT02759614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5795990|NCT02759614|Growth Substances|growth substances|mesh-ancestor
5795991|NCT02759614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5795992|NCT02759614|Growth Inhibitors|growth inhibitors|mesh-ancestor
5795993|NCT02759614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5795994|NCT02759614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5795995|NCT02759614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5795996|NCT02759510|Phenylephrine|phenylephrine|mesh-list
5795997|NCT02759510|Oxymetazoline|oxymetazoline|mesh-list
5795998|NCT02759510|Norepinephrine|norepinephrine|mesh-list
5795999|NCT02759510|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5796000|NCT02759510|Mydriatics|mydriatics|mesh-ancestor
5796001|NCT02759510|Autonomic Agents|autonomic agents|mesh-ancestor
5796002|NCT02759510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5796003|NCT02759510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796004|NCT02759510|Sympathomimetics|sympathomimetics|mesh-ancestor
5796005|NCT02759510|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5796006|NCT02759510|Nasal Decongestants|nasal decongestants|mesh-ancestor
6673921|NCT01566266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6673922|NCT01566266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6673923|NCT01566279|Everolimus|everolimus|mesh-list
6673924|NCT01566279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6673925|NCT01566279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6673926|NCT01566279|Immunologic Factors|immunologic factors|mesh-ancestor
6673927|NCT01566279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796007|NCT02759510|Respiratory System Agents|respiratory system agents|mesh-ancestor
5796008|NCT02759510|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5796009|NCT02759510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5796010|NCT02759510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5796011|NCT02759510|Adrenergic Agents|adrenergic agents|mesh-ancestor
5796012|NCT02759510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5796013|NCT02759510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5796014|NCT02759510|Protective Agents|protective agents|mesh-ancestor
5796015|NCT02759588|Bevacizumab|bevacizumab|mesh-list
5796016|NCT02759588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5796017|NCT02759588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5796018|NCT02759588|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5796019|NCT02759588|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6673928|NCT01566292|Botulinum Toxins|botulinum toxins|mesh-list
6673929|NCT01566292|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6673930|NCT01566292|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6673931|NCT01566292|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5796020|NCT02759588|Growth Substances|growth substances|mesh-ancestor
5796021|NCT02759588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796022|NCT02759588|Growth Inhibitors|growth inhibitors|mesh-ancestor
5796023|NCT02759380|Phytoestrogens|phytoestrogens|mesh-list
5796024|NCT02759380|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
5796025|NCT02759380|Estrogens|estrogens|mesh-ancestor
5796026|NCT02759380|Hormones|hormones|mesh-ancestor
5796027|NCT02759380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5796028|NCT02759380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796029|NCT02759224|Irsogladine|irsogladine|mesh-list
5796030|NCT02759224|Lafutidine|lafutidine|mesh-list
5796031|NCT02759224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5796032|NCT02759224|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5796033|NCT02759224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5796034|NCT02759224|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5796035|NCT02759224|Histamine Antagonists|histamine antagonists|mesh-ancestor
5796036|NCT02759224|Histamine Agents|histamine agents|mesh-ancestor
5796037|NCT02759224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5796038|NCT02759224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796039|NCT02759224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5796040|NCT02759224|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5796041|NCT02759224|Protective Agents|protective agents|mesh-ancestor
5796042|NCT02759224|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5796043|NCT02759393|Lansoprazole|lansoprazole|mesh-list
5796044|NCT02759393|Dexlansoprazole|dexlansoprazole|mesh-list
5796045|NCT02759393|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5796046|NCT02759393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5796047|NCT02759393|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5796048|NCT02759393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5796049|NCT02759393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5796050|NCT02759042|Leronlimab|leronlimab|mesh-list
5796051|NCT02759042|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5796052|NCT02759042|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5899555|NCT03425006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5796053|NCT02759042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5796054|NCT02759042|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5796055|NCT02759042|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5796056|NCT02759042|Antiviral Agents|antiviral agents|mesh-ancestor
5796057|NCT02759042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5796058|NCT02759107|Dulaglutide|dulaglutide|mesh-list
5796059|NCT02759107|Tirzepatide|tirzepatide|mesh-list
5796060|NCT02759107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5796061|NCT02759107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796062|NCT02759107|Incretins|incretins|mesh-ancestor
5796063|NCT02759107|Hormones|hormones|mesh-ancestor
5796064|NCT02759107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5796065|NCT02758951|Bevacizumab|bevacizumab|mesh-list
5796066|NCT02758951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5796067|NCT02758951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5796068|NCT02758951|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5796069|NCT02758951|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5796070|NCT02758951|Growth Substances|growth substances|mesh-ancestor
5796071|NCT02758951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796072|NCT02758951|Growth Inhibitors|growth inhibitors|mesh-ancestor
5796073|NCT02758925|Cytarabine|cytarabine|mesh-list
5796074|NCT02758925|Rituximab|rituximab|mesh-list
5796075|NCT02758925|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5796076|NCT02758925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5796077|NCT02758925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5796078|NCT02758925|Immunologic Factors|immunologic factors|mesh-ancestor
5796079|NCT02758925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796080|NCT02758925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5796081|NCT02758925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5796082|NCT02758925|Antimetabolites|antimetabolites|mesh-ancestor
5796083|NCT02758925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5796084|NCT02758925|Antiviral Agents|antiviral agents|mesh-ancestor
5796085|NCT02758925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5796086|NCT02758925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5796087|NCT02758925|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5796088|NCT02758925|Alkylating Agents|alkylating agents|mesh-ancestor
5899556|NCT03425006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5899557|NCT03422731|Alovudine|alovudine|mesh-list
5899558|NCT03422731|Antiviral Agents|antiviral agents|mesh-ancestor
5899559|NCT03422731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5899560|NCT03377699|Insulin|insulin|mesh-list
5899561|NCT03377699|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5899562|NCT03377699|Insulin Aspart|insulin aspart|mesh-list
5899563|NCT03377699|Insulin Detemir|insulin detemir|mesh-list
5899564|NCT03377699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5899565|NCT03377699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899566|NCT03306394|Trifluridine|trifluridine|mesh-list
5899567|NCT03306394|Antimetabolites|antimetabolites|mesh-ancestor
5899568|NCT03306394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899569|NCT03306394|Antiviral Agents|antiviral agents|mesh-ancestor
5899570|NCT03306394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5899571|NCT03290950|Dexamethasone|dexamethasone|mesh-list
5899572|NCT03290950|Dexamethasone acetate|dexamethasone acetate|mesh-list
5899573|NCT03290950|Lenalidomide|lenalidomide|mesh-list
5899574|NCT03290950|Daratumumab|daratumumab|mesh-list
5899575|NCT03290950|BB 1101|bb 1101|mesh-list
5899576|NCT03290950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5899577|NCT03290950|Antiemetics|antiemetics|mesh-ancestor
5899578|NCT03290950|Autonomic Agents|autonomic agents|mesh-ancestor
5796089|NCT02758990|Vitamin D|vitamin d|mesh-list
5796090|NCT02758990|Cholecalciferol|cholecalciferol|mesh-list
5796091|NCT02758990|Vitamins|vitamins|mesh-list
5796092|NCT02758990|Ascorbic Acid|ascorbic acid|mesh-list
5796093|NCT02758990|Vitamin E|vitamin e|mesh-list
5796094|NCT02758990|Tocopherols|tocopherols|mesh-list
5796095|NCT02758990|Vitamin A|vitamin a|mesh-list
5796096|NCT02758990|Niacinamide|niacinamide|mesh-list
5796097|NCT02758990|Niacin|niacin|mesh-list
5796098|NCT02758990|Nicotinic Acids|nicotinic acids|mesh-list
5796099|NCT02758990|Pyridoxine|pyridoxine|mesh-list
5796100|NCT02758990|Pyridoxal|pyridoxal|mesh-list
5796101|NCT02758990|Vitamin B 6|vitamin b 6|mesh-list
5796102|NCT02758990|Caffeine|caffeine|mesh-list
5796103|NCT02758990|Micronutrients|micronutrients|mesh-ancestor
5796104|NCT02758990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796105|NCT02758990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5796106|NCT02758990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5796107|NCT02758990|Antioxidants|antioxidants|mesh-ancestor
5796108|NCT02758990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5796109|NCT02758990|Protective Agents|protective agents|mesh-ancestor
5796110|NCT02758990|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5796111|NCT02758990|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5796112|NCT02758990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5796113|NCT02758990|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5796114|NCT02758990|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5796115|NCT02758990|Purinergic Agents|purinergic agents|mesh-ancestor
5796116|NCT02758990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5796117|NCT02758990|Vitamin B Complex|vitamin b complex|mesh-ancestor
5796118|NCT02758990|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5796119|NCT02758990|Antimetabolites|antimetabolites|mesh-ancestor
5796120|NCT02758990|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5796121|NCT02758990|Vasodilator Agents|vasodilator agents|mesh-ancestor
5796122|NCT02759198|Celecoxib|celecoxib|mesh-list
5796123|NCT02759198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5796124|NCT02759198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5796125|NCT02759198|Analgesics|analgesics|mesh-ancestor
5796126|NCT02759198|Sensory System Agents|sensory system agents|mesh-ancestor
5796127|NCT02759198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5796128|NCT02759198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796129|NCT02759198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5796130|NCT02759198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5796131|NCT02759198|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5796132|NCT02759198|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5796133|NCT02759198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5796134|NCT02759198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5796135|NCT02758873|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5796136|NCT02758873|Montelukast|montelukast|mesh-list
5796137|NCT02758873|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5796138|NCT02758873|Autonomic Agents|autonomic agents|mesh-ancestor
5796139|NCT02758873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5796140|NCT02758873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796141|NCT02758873|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5796142|NCT02758873|Respiratory System Agents|respiratory system agents|mesh-ancestor
5796143|NCT02758873|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5796144|NCT02758873|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5796145|NCT02758873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5796146|NCT02758873|Adrenergic Agents|adrenergic agents|mesh-ancestor
5796147|NCT02758873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5796148|NCT02758873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5796149|NCT02758873|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5796150|NCT02758873|Hormone Antagonists|hormone antagonists|mesh-ancestor
5796151|NCT02758873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5796152|NCT02758873|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5796153|NCT02758873|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5796154|NCT02758769|Abatacept|abatacept|mesh-list
5796155|NCT02758769|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5796156|NCT02758769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5796157|NCT02758769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5796158|NCT02758769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5796159|NCT02758769|Immunologic Factors|immunologic factors|mesh-ancestor
5796160|NCT02758769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796161|NCT02758769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5796162|NCT02758782|Celecoxib|celecoxib|mesh-list
5796163|NCT02758782|Golimumab|golimumab|mesh-list
5796164|NCT02758782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5796165|NCT02758782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5796166|NCT02758782|Analgesics|analgesics|mesh-ancestor
5796167|NCT02758782|Sensory System Agents|sensory system agents|mesh-ancestor
5796168|NCT02758782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5796169|NCT02758782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796170|NCT02758782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5796171|NCT02758782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5796172|NCT02758782|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5796173|NCT02758782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6491638|NCT00603343|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6491639|NCT00603343|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6491640|NCT00603343|Cholinergic Agents|cholinergic agents|mesh-ancestor
6491641|NCT00603343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5796174|NCT02758782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5796175|NCT02758782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5796176|NCT02758782|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
5796177|NCT02758782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5796178|NCT02758782|Immunologic Factors|immunologic factors|mesh-ancestor
5796179|NCT02758665|Venetoclax|venetoclax|mesh-list
5796180|NCT02758665|Obinutuzumab|obinutuzumab|mesh-list
5796181|NCT02758665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5796182|NCT02758665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5796183|NCT02758522|Insulin|insulin|mesh-list
5796184|NCT02758522|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5796185|NCT02758522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5796186|NCT02758522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796187|NCT02758691|Insulin|insulin|mesh-list
5796188|NCT02758691|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5796189|NCT02758691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5796190|NCT02758691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796191|NCT02758587|Pembrolizumab|pembrolizumab|mesh-list
5796192|NCT02758587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5796193|NCT02758587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5796194|NCT02758509|Interferons|interferons|mesh-list
5796195|NCT02758509|Ritonavir|ritonavir|mesh-list
5796196|NCT02758509|Ribavirin|ribavirin|mesh-list
5796197|NCT02758509|Interferon-alpha|interferon-alpha|mesh-list
5796198|NCT02758509|Interferon alpha-2|interferon alpha-2|mesh-list
5796199|NCT02758509|Sofosbuvir|sofosbuvir|mesh-list
5796200|NCT02758509|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5796201|NCT02758509|Ledipasvir|ledipasvir|mesh-list
5796202|NCT02758509|Simeprevir|simeprevir|mesh-list
5796203|NCT02758509|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
5796204|NCT02758509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5796205|NCT02758509|Antiviral Agents|antiviral agents|mesh-ancestor
5796206|NCT02758509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5796207|NCT02758509|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5796208|NCT02758509|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5796209|NCT02758509|Protease Inhibitors|protease inhibitors|mesh-ancestor
5796210|NCT02758509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5796211|NCT02758509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5796212|NCT02758509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5796213|NCT02758509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5796214|NCT02758509|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5796215|NCT02758509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5796216|NCT02758509|Antimetabolites|antimetabolites|mesh-ancestor
5796217|NCT02758509|Immunologic Factors|immunologic factors|mesh-ancestor
5796218|NCT02758509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796219|NCT02758444|Micronutrients|micronutrients|mesh-list
5796220|NCT02758444|Trace Elements|trace elements|mesh-list
5796221|NCT02758444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796222|NCT02758340|Misoprostol|misoprostol|mesh-list
5796223|NCT02758340|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5796224|NCT02758340|Abortifacient Agents|abortifacient agents|mesh-ancestor
5796225|NCT02758340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5796226|NCT02758340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796227|NCT02758340|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5796228|NCT02758340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5796229|NCT02758340|Oxytocics|oxytocics|mesh-ancestor
5796230|NCT02758249|Propofol|propofol|mesh-list
5796231|NCT02758249|Sevoflurane|sevoflurane|mesh-list
5796232|NCT02758249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5796233|NCT02758249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5796234|NCT02758249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796235|NCT02758249|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5796236|NCT02758249|Anesthetics, General|anesthetics, general|mesh-ancestor
5796237|NCT02758249|Anesthetics|anesthetics|mesh-ancestor
5796238|NCT02758249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5796239|NCT02758249|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5796240|NCT02758366|Doxorubicin|doxorubicin|mesh-list
5796241|NCT02758366|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5796242|NCT02758366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5796243|NCT02758366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5796244|NCT02758366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5796245|NCT02758366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5796246|NCT02758366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5796247|NCT02758405|Fentanyl|fentanyl|mesh-list
5796248|NCT02758405|Bupivacaine|bupivacaine|mesh-list
5796249|NCT02758405|Anesthetics, Local|anesthetics, local|mesh-ancestor
5796250|NCT02758405|Anesthetics|anesthetics|mesh-ancestor
6673932|NCT01566292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6673933|NCT01566292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673934|NCT01566292|Cholinergic Agents|cholinergic agents|mesh-ancestor
5641294|NCT03671330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5641295|NCT03671330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641296|NCT03671330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5641297|NCT03643744|Celecoxib|celecoxib|mesh-list
5641298|NCT03643744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5641299|NCT03643744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5641300|NCT03643744|Analgesics|analgesics|mesh-ancestor
5641301|NCT03643744|Sensory System Agents|sensory system agents|mesh-ancestor
5641302|NCT03643744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5641303|NCT03643744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641304|NCT03643744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5796251|NCT02758405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5796252|NCT02758405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796253|NCT02758405|Sensory System Agents|sensory system agents|mesh-ancestor
5796254|NCT02758405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5796255|NCT02758405|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5796256|NCT02758405|Narcotics|narcotics|mesh-ancestor
5796257|NCT02758405|Analgesics|analgesics|mesh-ancestor
5796258|NCT02758405|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5796259|NCT02758405|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5796260|NCT02758405|Anesthetics, General|anesthetics, general|mesh-ancestor
5796261|NCT02758470|Acetazolamide|acetazolamide|mesh-list
5796262|NCT02758470|Methazolamide|methazolamide|mesh-list
5796263|NCT02758470|Anticonvulsants|anticonvulsants|mesh-ancestor
5796264|NCT02758470|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5796265|NCT02758470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5796266|NCT02758470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673935|NCT01566292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6673936|NCT01566292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673937|NCT01566292|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6673938|NCT01566292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6673939|NCT01566422|Vancomycin|vancomycin|mesh-list
6673940|NCT01566422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6673941|NCT01566422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5796267|NCT02758470|Diuretics|diuretics|mesh-ancestor
5796268|NCT02758470|Natriuretic Agents|natriuretic agents|mesh-ancestor
5796269|NCT02758470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796270|NCT02758327|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
5796271|NCT02758327|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5796272|NCT02758327|Lubricant Eye Drops|lubricant eye drops|mesh-list
5796273|NCT02758327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5796274|NCT02758327|Laxatives|laxatives|mesh-ancestor
5796275|NCT02758327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5796276|NCT02758145|Vaccines|vaccines|mesh-list
5796277|NCT02758145|Immunologic Factors|immunologic factors|mesh-ancestor
5796278|NCT02758145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796279|NCT02758015|Betaine|betaine|mesh-list
5796280|NCT02758015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6210929|NCT02166476|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6210930|NCT02166476|Renal Agents|renal agents|mesh-ancestor
6210931|NCT02166476|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6210932|NCT02166476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6210933|NCT02166476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6210934|NCT02166476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210935|NCT02166476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6210936|NCT02166476|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6210937|NCT02166476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6210938|NCT02166697|Candesartan|candesartan|mesh-list
6210939|NCT02166697|Candesartan cilexetil|candesartan cilexetil|mesh-list
6210940|NCT02166697|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6210941|NCT02166697|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6210942|NCT02166697|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6210943|NCT02166697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210944|NCT02167035|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
6210945|NCT02167035|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5796281|NCT02758015|Lipotropic Agents|lipotropic agents|mesh-ancestor
6210946|NCT02167035|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5796282|NCT02758015|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5796283|NCT02758015|Antimetabolites|antimetabolites|mesh-ancestor
5796284|NCT02758015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5796285|NCT02758015|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5796286|NCT02758067|Risperidone|risperidone|mesh-list
5796287|NCT02758067|Brexpiprazole|brexpiprazole|mesh-list
5796288|NCT02758067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5796289|NCT02758067|Serotonin Agents|serotonin agents|mesh-ancestor
5796290|NCT02758067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5796291|NCT02758067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5796292|NCT02758067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796293|NCT02758067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5796294|NCT02758067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5796295|NCT02758067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5796296|NCT02758067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5796297|NCT02758067|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5796298|NCT02758067|Dopamine Agents|dopamine agents|mesh-ancestor
5796299|NCT02758067|Dopamine Agonists|dopamine agonists|mesh-ancestor
5796300|NCT02757651|Hydrogen Peroxide|hydrogen peroxide|mesh-list
5796301|NCT02757651|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5796302|NCT02757651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5796303|NCT02757703|Terlipressin|terlipressin|mesh-list
5796304|NCT02757703|Pantoprazole|pantoprazole|mesh-list
5796305|NCT02757703|Somatostatin|somatostatin|mesh-list
5796306|NCT02757703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5796307|NCT02757703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5796308|NCT02757703|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5796309|NCT02757703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5796310|NCT02757703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5796311|NCT02757703|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5796312|NCT02757703|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5796313|NCT02757703|Hormones|hormones|mesh-ancestor
5796314|NCT02757703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5796315|NCT02757703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796316|NCT02757885|Cyclophosphamide|cyclophosphamide|mesh-list
5796317|NCT02757885|Thiotepa|thiotepa|mesh-list
5796318|NCT02757885|Fludarabine|fludarabine|mesh-list
5796319|NCT02757885|Fludarabine phosphate|fludarabine phosphate|mesh-list
5796320|NCT02757885|Hydroxyurea|hydroxyurea|mesh-list
5796321|NCT02757885|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5796322|NCT02757885|Thymoglobulin|thymoglobulin|mesh-list
5796323|NCT02757885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5796324|NCT02757885|Immunologic Factors|immunologic factors|mesh-ancestor
5796325|NCT02757885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796326|NCT02757885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5796327|NCT02757885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5796328|NCT02757885|Alkylating Agents|alkylating agents|mesh-ancestor
5796329|NCT02757885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5796330|NCT02757885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5796331|NCT02757885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5796332|NCT02757885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5796333|NCT02757885|Antimetabolites|antimetabolites|mesh-ancestor
5796334|NCT02757885|Antisickling Agents|antisickling agents|mesh-ancestor
5796335|NCT02757885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5796336|NCT02757885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5796337|NCT02757534|Domperidone|domperidone|mesh-list
5796338|NCT02757534|Antiemetics|antiemetics|mesh-ancestor
5796339|NCT02757534|Autonomic Agents|autonomic agents|mesh-ancestor
5796340|NCT02757534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5796341|NCT02757534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796342|NCT02757534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5796343|NCT02757534|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5796344|NCT02757534|Dopamine Agents|dopamine agents|mesh-ancestor
5796345|NCT02757534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5796346|NCT02757534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5796347|NCT02757508|Vitamins|vitamins|mesh-list
5796348|NCT02757508|Micronutrients|micronutrients|mesh-ancestor
5796349|NCT02757508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796350|NCT02757313|Dronabinol|dronabinol|mesh-list
5796351|NCT02757313|Hallucinogens|hallucinogens|mesh-ancestor
5796352|NCT02757313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796353|NCT02757313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5796354|NCT02757313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5796355|NCT02757313|Analgesics|analgesics|mesh-ancestor
5796356|NCT02757313|Sensory System Agents|sensory system agents|mesh-ancestor
5796357|NCT02757313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5796358|NCT02757313|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5796359|NCT02757313|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5796360|NCT02757313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5796361|NCT02757313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5796362|NCT02757313|Hormones|hormones|mesh-ancestor
5796363|NCT02757313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5796364|NCT02757495|Dexmedetomidine|dexmedetomidine|mesh-list
5796365|NCT02757495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5796366|NCT02757495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5796367|NCT02757495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796368|NCT02757495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5796369|NCT02757495|Analgesics|analgesics|mesh-ancestor
5796370|NCT02757495|Sensory System Agents|sensory system agents|mesh-ancestor
5796371|NCT02757495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5796372|NCT02757495|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5796373|NCT02757495|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5796374|NCT02757495|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5796375|NCT02757495|Adrenergic Agents|adrenergic agents|mesh-ancestor
5796376|NCT02757495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5796377|NCT02757495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5796378|NCT02757209|Fluticasone|fluticasone|mesh-list
5796379|NCT02757209|Xhance|xhance|mesh-list
5796380|NCT02757209|Budesonide|budesonide|mesh-list
5796381|NCT02757209|Formoterol Fumarate|formoterol fumarate|mesh-list
5796382|NCT02757209|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5796383|NCT02757209|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
5796384|NCT02757209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5796385|NCT02757209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5796386|NCT02757209|Autonomic Agents|autonomic agents|mesh-ancestor
5796387|NCT02757209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5796388|NCT02757209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796389|NCT02757209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5796390|NCT02757209|Respiratory System Agents|respiratory system agents|mesh-ancestor
5796391|NCT02757209|Dermatologic Agents|dermatologic agents|mesh-ancestor
5796392|NCT02757209|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5796393|NCT02757209|Glucocorticoids|glucocorticoids|mesh-ancestor
5796394|NCT02757209|Hormones|hormones|mesh-ancestor
5796395|NCT02757209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5796396|NCT02757209|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5796397|NCT02757209|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5796398|NCT02757209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5796399|NCT02757209|Adrenergic Agents|adrenergic agents|mesh-ancestor
5796400|NCT02757209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5796401|NCT02757209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210947|NCT02167035|Adrenergic Agents|adrenergic agents|mesh-ancestor
5796402|NCT02757287|Desogestrel|desogestrel|mesh-list
5796403|NCT02757287|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5796404|NCT02757287|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5796405|NCT02757287|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5796406|NCT02757287|Contraceptive Agents|contraceptive agents|mesh-ancestor
5796407|NCT02757287|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5796408|NCT02757287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796409|NCT02757287|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5796410|NCT02757287|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5796411|NCT02757287|Progestins|progestins|mesh-ancestor
5796412|NCT02757287|Hormones|hormones|mesh-ancestor
5796413|NCT02757287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5899579|NCT03290950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5899580|NCT03290950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899581|NCT03290950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5796414|NCT02757365|Aspirin|aspirin|mesh-list
5796415|NCT02757365|Levofloxacin|levofloxacin|mesh-list
5796416|NCT02757365|Ofloxacin|ofloxacin|mesh-list
5796417|NCT02757365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5796418|NCT02757365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5796419|NCT02757365|Analgesics|analgesics|mesh-ancestor
5796420|NCT02757365|Sensory System Agents|sensory system agents|mesh-ancestor
5796421|NCT02757365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5796422|NCT02757365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796423|NCT02757365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5796424|NCT02757365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5796425|NCT02757365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5796426|NCT02757365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5796427|NCT02757365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5796428|NCT02757365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5796429|NCT02757365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5796430|NCT02757365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5796431|NCT02757365|Antipyretics|antipyretics|mesh-ancestor
5796432|NCT02757365|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5796433|NCT02757365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5796434|NCT02757365|Renal Agents|renal agents|mesh-ancestor
5796435|NCT02757365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5796436|NCT02757365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5796437|NCT02757365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5796438|NCT02757365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5796439|NCT02757365|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5796440|NCT02757365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5796441|NCT02757469|Drospirenone|drospirenone|mesh-list
5796442|NCT02757469|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5796443|NCT02757469|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
5796444|NCT02757469|Estradiol|estradiol|mesh-list
5796445|NCT02757469|Estrogens|estrogens|mesh-ancestor
5796446|NCT02757469|Hormones|hormones|mesh-ancestor
5796447|NCT02757469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5796448|NCT02757469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796449|NCT02757469|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5796450|NCT02757469|Contraceptive Agents|contraceptive agents|mesh-ancestor
5796451|NCT02757469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5796452|NCT02757469|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5796453|NCT02757469|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5796454|NCT02757469|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5796455|NCT02757469|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5796456|NCT02757469|Hormone Antagonists|hormone antagonists|mesh-ancestor
5796457|NCT02757469|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5796458|NCT02757469|Diuretics|diuretics|mesh-ancestor
5796459|NCT02757469|Natriuretic Agents|natriuretic agents|mesh-ancestor
5796460|NCT02757404|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5796461|NCT02757404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5796462|NCT02757404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5796463|NCT02757404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796464|NCT02757404|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5796465|NCT02757404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5796466|NCT02757404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5796467|NCT02757404|Cholinergic Agents|cholinergic agents|mesh-ancestor
5796468|NCT02757404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5796469|NCT02757391|Aldesleukin|aldesleukin|mesh-list
5796470|NCT02757391|Cyclophosphamide|cyclophosphamide|mesh-list
5796471|NCT02757391|Pembrolizumab|pembrolizumab|mesh-list
5796472|NCT02757391|Interleukin-2|interleukin-2|mesh-list
5796473|NCT02757391|Immunologic Factors|immunologic factors|mesh-list
5796474|NCT02757391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5796475|NCT02757391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796476|NCT02757391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5796477|NCT02757391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5796478|NCT02757391|Alkylating Agents|alkylating agents|mesh-ancestor
5796479|NCT02757391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5796480|NCT02757391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5796481|NCT02757391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5796482|NCT02757391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5796483|NCT02757391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5796484|NCT02757391|Analgesics|analgesics|mesh-ancestor
5796485|NCT02757391|Sensory System Agents|sensory system agents|mesh-ancestor
5796486|NCT02757391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5796487|NCT02757391|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5796488|NCT02757391|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5796489|NCT02757391|Antiviral Agents|antiviral agents|mesh-ancestor
5796490|NCT02757391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5796491|NCT02757196|Methylprednisolone|methylprednisolone|mesh-list
5796492|NCT02757196|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5796493|NCT02757196|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5796494|NCT02757196|Prednisolone|prednisolone|mesh-list
5796495|NCT02757196|Prednisolone acetate|prednisolone acetate|mesh-list
5796496|NCT02757196|Rituximab|rituximab|mesh-list
5796497|NCT02757196|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5796498|NCT02757196|Prednisolone phosphate|prednisolone phosphate|mesh-list
5796499|NCT02757196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5796500|NCT02757196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5796501|NCT02757196|Immunologic Factors|immunologic factors|mesh-ancestor
5796502|NCT02757196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796503|NCT02757196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5796504|NCT02757196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5796505|NCT02757196|Antiemetics|antiemetics|mesh-ancestor
5796506|NCT02757196|Autonomic Agents|autonomic agents|mesh-ancestor
5796507|NCT02757196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5796508|NCT02757196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5796509|NCT02757196|Glucocorticoids|glucocorticoids|mesh-ancestor
5796510|NCT02757196|Hormones|hormones|mesh-ancestor
5796511|NCT02757196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5796512|NCT02757196|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5796513|NCT02757196|Protective Agents|protective agents|mesh-ancestor
5796514|NCT02757196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5796515|NCT02757144|Esomeprazole|esomeprazole|mesh-list
5796516|NCT02757144|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5796517|NCT02757144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5796518|NCT02757144|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5796519|NCT02757144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5796520|NCT02757144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5796521|NCT02757248|Romidepsin|romidepsin|mesh-list
5796522|NCT02757248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5796523|NCT02757248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5796524|NCT02757443|Phosphocreatine|phosphocreatine|mesh-list
5796525|NCT02757443|Anesthetics|anesthetics|mesh-list
5796526|NCT02757443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5796527|NCT02757443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796528|NCT02757443|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5796529|NCT02757443|Protective Agents|protective agents|mesh-ancestor
5796530|NCT02757261|Salicylic Acid|salicylic acid|mesh-list
5796531|NCT02757261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5796532|NCT02757261|Antifungal Agents|antifungal agents|mesh-ancestor
5796533|NCT02757261|Keratolytic Agents|keratolytic agents|mesh-ancestor
5796534|NCT02757261|Dermatologic Agents|dermatologic agents|mesh-ancestor
5796535|NCT02757040|Arsenic Trioxide|arsenic trioxide|mesh-list
5796536|NCT02757040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5796537|NCT02757066|Melatonin|melatonin|mesh-list
5796538|NCT02757066|Antioxidants|antioxidants|mesh-ancestor
5796539|NCT02757066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5796540|NCT02757066|Protective Agents|protective agents|mesh-ancestor
5796541|NCT02757066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796542|NCT02757066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5796543|NCT02757079|Melatonin|melatonin|mesh-list
5796544|NCT02757079|Antioxidants|antioxidants|mesh-ancestor
5796545|NCT02757079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5796546|NCT02757079|Protective Agents|protective agents|mesh-ancestor
5796547|NCT02757079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796548|NCT02757079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5796549|NCT02756962|Cytarabine|cytarabine|mesh-list
5796550|NCT02756962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5796551|NCT02756962|Antimetabolites|antimetabolites|mesh-ancestor
5796552|NCT02756962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5796553|NCT02756962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5796554|NCT02756962|Antiviral Agents|antiviral agents|mesh-ancestor
5796555|NCT02756962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5796556|NCT02756962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5796557|NCT02756962|Immunologic Factors|immunologic factors|mesh-ancestor
5796558|NCT02756962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796559|NCT02756598|Sufentanil|sufentanil|mesh-list
5796560|NCT02756598|Dsuvia|dsuvia|mesh-list
5796561|NCT02756598|Propofol|propofol|mesh-list
5796562|NCT02756598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5796563|NCT02756598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5796564|NCT02756598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796565|NCT02756598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5796566|NCT02756598|Anesthetics, General|anesthetics, general|mesh-ancestor
5796567|NCT02756598|Anesthetics|anesthetics|mesh-ancestor
5796568|NCT02756598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5796569|NCT02756598|Narcotics|narcotics|mesh-ancestor
5796570|NCT02756598|Analgesics|analgesics|mesh-ancestor
5796571|NCT02756598|Sensory System Agents|sensory system agents|mesh-ancestor
5796572|NCT02756598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5796573|NCT02756598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5796574|NCT02756728|Melphalan|melphalan|mesh-list
5796575|NCT02756728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5796576|NCT02756728|Alkylating Agents|alkylating agents|mesh-ancestor
5796577|NCT02756728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5796578|NCT02756728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5796579|NCT02756728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5796580|NCT02756728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5796581|NCT02756728|Immunologic Factors|immunologic factors|mesh-ancestor
5796582|NCT02756728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796583|NCT02756663|Dexamethasone|dexamethasone|mesh-list
5796584|NCT02756663|Panobinostat|panobinostat|mesh-list
5796585|NCT02756663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5796586|NCT02756663|Antiemetics|antiemetics|mesh-ancestor
5796587|NCT02756663|Autonomic Agents|autonomic agents|mesh-ancestor
5796588|NCT02756663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5796589|NCT02756663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796590|NCT02756663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5796591|NCT02756663|Glucocorticoids|glucocorticoids|mesh-ancestor
5796592|NCT02756663|Hormones|hormones|mesh-ancestor
5796593|NCT02756663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5796594|NCT02756663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5796595|NCT02756663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5796596|NCT02756663|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5796597|NCT02756663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5796598|NCT02756663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5796599|NCT02756715|Propofol|propofol|mesh-list
5796600|NCT02756715|Desflurane|desflurane|mesh-list
5796601|NCT02756715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5796602|NCT02756715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5796603|NCT02756715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210948|NCT02167035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6491642|NCT00603343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5796604|NCT02756715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5796605|NCT02756715|Anesthetics, General|anesthetics, general|mesh-ancestor
5796606|NCT02756715|Anesthetics|anesthetics|mesh-ancestor
5796607|NCT02756715|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5796608|NCT02756546|Hydroxychloroquine|hydroxychloroquine|mesh-list
5796609|NCT02756546|Hydrocortisone|hydrocortisone|mesh-list
5796610|NCT02756546|Cyclophosphamide|cyclophosphamide|mesh-list
5796611|NCT02756546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5796612|NCT02756546|Immunologic Factors|immunologic factors|mesh-ancestor
5796613|NCT02756546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796614|NCT02756546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5796615|NCT02756546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5796616|NCT02756546|Alkylating Agents|alkylating agents|mesh-ancestor
5796617|NCT02756546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5796618|NCT02756546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5796619|NCT02756546|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5796620|NCT02756546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5796621|NCT02756546|Antimalarials|antimalarials|mesh-ancestor
5796622|NCT02756546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5796623|NCT02756546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5796624|NCT02756546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5796625|NCT02756546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5796626|NCT02756312|Anesthetics|anesthetics|mesh-list
5796627|NCT02756312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5796628|NCT02756312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796629|NCT02756377|Chlorhexidine|chlorhexidine|mesh-list
5796630|NCT02756377|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5796631|NCT02756377|Cetylpyridinium|cetylpyridinium|mesh-list
5796632|NCT02756377|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5796633|NCT02756377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5796634|NCT02756377|Disinfectants|disinfectants|mesh-ancestor
5796635|NCT02756377|Dermatologic Agents|dermatologic agents|mesh-ancestor
5796636|NCT02756104|Vitamin D|vitamin d|mesh-list
5796637|NCT02756104|Vitamins|vitamins|mesh-ancestor
5796638|NCT02756104|Micronutrients|micronutrients|mesh-ancestor
5796639|NCT02756104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796640|NCT02756104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5796641|NCT02756130|Carboplatin|carboplatin|mesh-list
5796642|NCT02756130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5796643|NCT02756026|Micronutrients|micronutrients|mesh-list
5796644|NCT02756026|Trace Elements|trace elements|mesh-list
5796645|NCT02756026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796646|NCT02755753|Lansoprazole|lansoprazole|mesh-list
5796647|NCT02755753|Dexlansoprazole|dexlansoprazole|mesh-list
5796648|NCT02755753|Rebamipide|rebamipide|mesh-list
5796649|NCT02755753|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5796650|NCT02755753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5796651|NCT02755753|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5796652|NCT02755753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5796653|NCT02755753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5796654|NCT02755753|Antioxidants|antioxidants|mesh-ancestor
5796655|NCT02755753|Protective Agents|protective agents|mesh-ancestor
5796656|NCT02755753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796657|NCT02755714|Bromides|bromides|mesh-list
5796658|NCT02755714|Ipratropium|ipratropium|mesh-list
5796659|NCT02755714|Anticonvulsants|anticonvulsants|mesh-ancestor
5796660|NCT02755714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5796661|NCT02755714|Autonomic Agents|autonomic agents|mesh-ancestor
5796662|NCT02755714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5796663|NCT02755714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796664|NCT02755714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5796665|NCT02755714|Respiratory System Agents|respiratory system agents|mesh-ancestor
5796666|NCT02755714|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5796667|NCT02755714|Cholinergic Agents|cholinergic agents|mesh-ancestor
5796668|NCT02755714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5796669|NCT02755714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5796670|NCT02755909|Anesthetics|anesthetics|mesh-list
5796671|NCT02755909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5796672|NCT02755909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796673|NCT02756000|Dobutamine|dobutamine|mesh-list
5796674|NCT02756000|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5796675|NCT02756000|Sympathomimetics|sympathomimetics|mesh-ancestor
5796676|NCT02756000|Autonomic Agents|autonomic agents|mesh-ancestor
5796677|NCT02756000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5796678|NCT02756000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796679|NCT02756000|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5796680|NCT02756000|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5796681|NCT02756000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5796682|NCT02756000|Adrenergic Agents|adrenergic agents|mesh-ancestor
5796683|NCT02756000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5796684|NCT02756000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5796685|NCT02756000|Protective Agents|protective agents|mesh-ancestor
5796686|NCT02755857|Itraconazole|itraconazole|mesh-list
5796687|NCT02755857|Antifungal Agents|antifungal agents|mesh-ancestor
5796688|NCT02755857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5796689|NCT02755857|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5796690|NCT02755857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5796691|NCT02755857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5796692|NCT02755857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5796693|NCT02755857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5796694|NCT02755857|Hormone Antagonists|hormone antagonists|mesh-ancestor
5796695|NCT02755857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5796696|NCT02755857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796697|NCT02755857|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5899582|NCT03290950|Glucocorticoids|glucocorticoids|mesh-ancestor
5899583|NCT03290950|Hormones|hormones|mesh-ancestor
5899584|NCT03290950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5899585|NCT03290950|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5899586|NCT03290950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5899587|NCT03290950|Protease Inhibitors|protease inhibitors|mesh-ancestor
5899588|NCT03290950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5899589|NCT03290950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5796698|NCT02755545|Salicylic Acid|salicylic acid|mesh-list
5796699|NCT02755545|Adapalene|adapalene|mesh-list
5796700|NCT02755545|Salicylates|salicylates|mesh-list
5796701|NCT02755545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5796702|NCT02755545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5796703|NCT02755545|Analgesics|analgesics|mesh-ancestor
5796704|NCT02755545|Sensory System Agents|sensory system agents|mesh-ancestor
5796705|NCT02755545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5796706|NCT02755545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796707|NCT02755545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5796708|NCT02755545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5796709|NCT02755545|Dermatologic Agents|dermatologic agents|mesh-ancestor
5796710|NCT02755545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5796711|NCT02755545|Antifungal Agents|antifungal agents|mesh-ancestor
5796712|NCT02755545|Keratolytic Agents|keratolytic agents|mesh-ancestor
5796713|NCT02755545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5796714|NCT02755545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5796715|NCT02755545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5796716|NCT02755532|Bupivacaine|bupivacaine|mesh-list
5796717|NCT02755532|Anesthetics, Local|anesthetics, local|mesh-ancestor
5796718|NCT02755532|Anesthetics|anesthetics|mesh-ancestor
5796719|NCT02755532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5796720|NCT02755532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796721|NCT02755532|Sensory System Agents|sensory system agents|mesh-ancestor
5796722|NCT02755532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5796723|NCT02755376|Hyaluronic Acid|hyaluronic acid|mesh-list
5796724|NCT02755376|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5796725|NCT02755376|Immunologic Factors|immunologic factors|mesh-ancestor
5796726|NCT02755376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796727|NCT02755376|Viscosupplements|viscosupplements|mesh-ancestor
5796728|NCT02755376|Protective Agents|protective agents|mesh-ancestor
5796729|NCT02755298|Acetazolamide|acetazolamide|mesh-list
5796730|NCT02755298|Anticonvulsants|anticonvulsants|mesh-ancestor
5796731|NCT02755298|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5796732|NCT02755298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5796733|NCT02755298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5796734|NCT02755298|Diuretics|diuretics|mesh-ancestor
5796735|NCT02755298|Natriuretic Agents|natriuretic agents|mesh-ancestor
5796736|NCT02755298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796737|NCT02755350|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5796738|NCT02755350|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5796739|NCT02755350|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5796740|NCT02755350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5796741|NCT02755350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5796742|NCT02755350|Antiviral Agents|antiviral agents|mesh-ancestor
5796743|NCT02755350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5796744|NCT02755350|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5796745|NCT02755350|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5796746|NCT02755311|Cisplatin|cisplatin|mesh-list
6491643|NCT00603343|Urological Agents|urological agents|mesh-ancestor
6491644|NCT00603356|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6491645|NCT00603356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6491646|NCT00603356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6491647|NCT00603356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6491648|NCT00603356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491649|NCT00603434|Methylphenidate|methylphenidate|mesh-list
6491650|NCT00603434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6491651|NCT00603434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796747|NCT02755311|Carboplatin|carboplatin|mesh-list
5796748|NCT02755311|Fluorouracil|fluorouracil|mesh-list
5796749|NCT02755311|Epirubicin|epirubicin|mesh-list
5796750|NCT02755311|Ethiodized Oil|ethiodized oil|mesh-list
5796751|NCT02755311|Pirarubicin|pirarubicin|mesh-list
5796752|NCT02755311|Doxorubicin|doxorubicin|mesh-list
5796753|NCT02755311|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
5796754|NCT02755311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5796755|NCT02755311|Antimetabolites|antimetabolites|mesh-ancestor
5796756|NCT02755311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5796757|NCT02755311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5796758|NCT02755311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5796759|NCT02755311|Immunologic Factors|immunologic factors|mesh-ancestor
5796760|NCT02755311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796761|NCT02755311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5796762|NCT02755311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5796763|NCT02755311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5796764|NCT02755311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5796765|NCT02755311|Hemostatics|hemostatics|mesh-ancestor
5796766|NCT02755311|Coagulants|coagulants|mesh-ancestor
5796767|NCT02755259|Acetazolamide|acetazolamide|mesh-list
5796768|NCT02755259|Anticonvulsants|anticonvulsants|mesh-ancestor
5796769|NCT02755259|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5796770|NCT02755259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5796771|NCT02755259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5796772|NCT02755259|Diuretics|diuretics|mesh-ancestor
5796773|NCT02755259|Natriuretic Agents|natriuretic agents|mesh-ancestor
5796774|NCT02755259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796775|NCT02755142|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5796776|NCT02755142|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5796777|NCT02755142|Dermatologic Agents|dermatologic agents|mesh-ancestor
5796778|NCT02754882|Paclitaxel|paclitaxel|mesh-list
5796779|NCT02754882|Bevacizumab|bevacizumab|mesh-list
5796780|NCT02754882|Carboplatin|carboplatin|mesh-list
5796781|NCT02754882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5796782|NCT02754882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5796783|NCT02754882|Tubulin Modulators|tubulin modulators|mesh-ancestor
5796784|NCT02754882|Antimitotic Agents|antimitotic agents|mesh-ancestor
5796785|NCT02754882|Mitosis Modulators|mitosis modulators|mesh-ancestor
5796786|NCT02754882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5796787|NCT02754882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5796788|NCT02754882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5796789|NCT02754882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5796790|NCT02754882|Growth Substances|growth substances|mesh-ancestor
5899590|NCT03290950|Immunologic Factors|immunologic factors|mesh-ancestor
5796791|NCT02754882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796792|NCT02754882|Growth Inhibitors|growth inhibitors|mesh-ancestor
5796793|NCT02754856|Durvalumab|durvalumab|mesh-list
5796794|NCT02754856|Ipilimumab|ipilimumab|mesh-list
5796795|NCT02754856|Tremelimumab|tremelimumab|mesh-list
5796796|NCT02754856|Immunoglobulins|immunoglobulins|mesh-list
5796797|NCT02754856|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5796798|NCT02754856|Immunoglobulin G|immunoglobulin g|mesh-list
5796799|NCT02754856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5796800|NCT02754856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5796801|NCT02754856|Immunologic Factors|immunologic factors|mesh-ancestor
5796802|NCT02754856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796803|NCT02754856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5796804|NCT02754856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210949|NCT02167035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210950|NCT02167035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210951|NCT02167035|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6210952|NCT02167035|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6210953|NCT02167035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6210954|NCT02167139|Adalimumab|adalimumab|mesh-list
6210955|NCT02167139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6210956|NCT02167139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6210957|NCT02167204|Alovudine|alovudine|mesh-list
6491652|NCT00603434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6491653|NCT00603434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5796805|NCT02754765|Moxifloxacin|moxifloxacin|mesh-list
5796806|NCT02754765|Levofloxacin|levofloxacin|mesh-list
5796807|NCT02754765|Ofloxacin|ofloxacin|mesh-list
5796808|NCT02754765|Linezolid|linezolid|mesh-list
5796809|NCT02754765|Pyrazinamide|pyrazinamide|mesh-list
5796810|NCT02754765|Bedaquiline|bedaquiline|mesh-list
5796811|NCT02754765|Clofazimine|clofazimine|mesh-list
5796812|NCT02754765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5796813|NCT02754765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5796814|NCT02754765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5796815|NCT02754765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5796816|NCT02754765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5796817|NCT02754765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5796818|NCT02754765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5796819|NCT02754765|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5796820|NCT02754765|Renal Agents|renal agents|mesh-ancestor
5796821|NCT02754765|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5796822|NCT02754765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5796823|NCT02754765|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5796824|NCT02754765|Antitubercular Agents|antitubercular agents|mesh-ancestor
5796825|NCT02754765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5796826|NCT02754765|Leprostatic Agents|leprostatic agents|mesh-ancestor
5796827|NCT02754817|Liraglutide|liraglutide|mesh-list
5796828|NCT02754817|Xultophy|xultophy|mesh-list
5796829|NCT02754817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5796830|NCT02754817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491654|NCT00603434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5796831|NCT02754817|Incretins|incretins|mesh-ancestor
5796832|NCT02754817|Hormones|hormones|mesh-ancestor
5796833|NCT02754817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5796834|NCT02754960|Thalidomide|thalidomide|mesh-list
5796835|NCT02754960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5796836|NCT02754960|Immunologic Factors|immunologic factors|mesh-ancestor
5796837|NCT02754960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210958|NCT02167204|Antiviral Agents|antiviral agents|mesh-ancestor
5796838|NCT02754960|Leprostatic Agents|leprostatic agents|mesh-ancestor
5796839|NCT02754960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5796840|NCT02754960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5796841|NCT02754960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5796842|NCT02754960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5796843|NCT02754960|Growth Substances|growth substances|mesh-ancestor
5796844|NCT02754960|Growth Inhibitors|growth inhibitors|mesh-ancestor
5796845|NCT02754960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5796846|NCT02755064|Erythromycin|erythromycin|mesh-list
5796847|NCT02755064|Erythromycin Estolate|erythromycin estolate|mesh-list
5796848|NCT02755064|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
5796849|NCT02755064|Erythromycin stearate|erythromycin stearate|mesh-list
5796850|NCT02755064|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
5796851|NCT02755064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6673942|NCT01566474|Melatonin|melatonin|mesh-list
6673943|NCT01566474|Omeprazole|omeprazole|mesh-list
6673944|NCT01566474|Antioxidants|antioxidants|mesh-ancestor
6673945|NCT01566474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673946|NCT01566474|Protective Agents|protective agents|mesh-ancestor
6673947|NCT01566474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673948|NCT01566474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6673949|NCT01566474|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6673950|NCT01566474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6673951|NCT01566474|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6673952|NCT01566474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5796852|NCT02755064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5796853|NCT02755064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5796854|NCT02755064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5796855|NCT02755064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5796856|NCT02755064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5796857|NCT02754726|Gemcitabine|gemcitabine|mesh-list
5796858|NCT02754726|Paclitaxel|paclitaxel|mesh-list
5796859|NCT02754726|Nivolumab|nivolumab|mesh-list
5796860|NCT02754726|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5796861|NCT02754726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5796862|NCT02754726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5796863|NCT02754726|Tubulin Modulators|tubulin modulators|mesh-ancestor
5796864|NCT02754726|Antimitotic Agents|antimitotic agents|mesh-ancestor
5796865|NCT02754726|Mitosis Modulators|mitosis modulators|mesh-ancestor
5796866|NCT02754726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5796867|NCT02754726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5796868|NCT02754726|Antimetabolites|antimetabolites|mesh-ancestor
5796869|NCT02754726|Antiviral Agents|antiviral agents|mesh-ancestor
5796870|NCT02754726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5796871|NCT02754726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5796872|NCT02754726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5796873|NCT02754726|Immunologic Factors|immunologic factors|mesh-ancestor
5796874|NCT02754726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796875|NCT02754726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5796876|NCT02754726|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5796877|NCT02754739|Pravastatin|pravastatin|mesh-list
5796878|NCT02754739|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5796879|NCT02754739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5796880|NCT02754739|Antimetabolites|antimetabolites|mesh-ancestor
5796881|NCT02754739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5796882|NCT02754739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5796883|NCT02754739|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5796884|NCT02754739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5796885|NCT02754583|Azithromycin|azithromycin|mesh-list
5796886|NCT02754583|Tetracycline|tetracycline|mesh-list
5796887|NCT02754583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5796888|NCT02754583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5796889|NCT02754583|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5796890|NCT02754583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5796891|NCT02754583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5796892|NCT02754596|Timolol|timolol|mesh-list
5796893|NCT02754596|Travoprost|travoprost|mesh-list
5796894|NCT02754596|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5796895|NCT02754596|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5796896|NCT02754596|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5796897|NCT02754596|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5796898|NCT02754596|Adrenergic Agents|adrenergic agents|mesh-ancestor
5796899|NCT02754596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5796900|NCT02754596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5796901|NCT02754596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796902|NCT02754596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5796903|NCT02754596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5796904|NCT02754687|Nandrolone Decanoate|nandrolone decanoate|mesh-list
5796905|NCT02754687|Nandrolone|nandrolone|mesh-list
5796906|NCT02754687|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
5796907|NCT02754687|Androgens|androgens|mesh-ancestor
5796908|NCT02754687|Hormones|hormones|mesh-ancestor
5796909|NCT02754687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5796910|NCT02754687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796911|NCT02754687|Anabolic Agents|anabolic agents|mesh-ancestor
5796912|NCT02754687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5796913|NCT02754362|Bevacizumab|bevacizumab|mesh-list
5796914|NCT02754362|Poly ICLC|poly iclc|mesh-list
5796915|NCT02754362|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
5796916|NCT02754362|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
5796917|NCT02754362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5796918|NCT02754362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5796919|NCT02754362|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5796920|NCT02754362|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5796921|NCT02754362|Growth Substances|growth substances|mesh-ancestor
5796922|NCT02754362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796923|NCT02754362|Growth Inhibitors|growth inhibitors|mesh-ancestor
5796924|NCT02754362|Interferon Inducers|interferon inducers|mesh-ancestor
5796925|NCT02754362|Immunologic Factors|immunologic factors|mesh-ancestor
5796926|NCT02754297|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
5796927|NCT02754297|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5796928|NCT02754297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5796929|NCT02754102|Sunscreening Agents|sunscreening agents|mesh-list
5796930|NCT02754102|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5796931|NCT02754102|Protective Agents|protective agents|mesh-ancestor
5796932|NCT02754102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796933|NCT02754102|Dermatologic Agents|dermatologic agents|mesh-ancestor
5796934|NCT02754258|Methylphenidate|methylphenidate|mesh-list
5796935|NCT02754258|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5796936|NCT02754258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796937|NCT02754258|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5796938|NCT02754258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5796939|NCT02754258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5796940|NCT02754258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5796941|NCT02754258|Dopamine Agents|dopamine agents|mesh-ancestor
5796942|NCT02754258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5796943|NCT02754063|3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol|3,4,4a,10b-tetrahydro-4-propyl-2h,5h-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol|mesh-list
5796944|NCT02754063|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5796945|NCT02754063|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6491655|NCT00603434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491656|NCT00603434|Dopamine Agents|dopamine agents|mesh-ancestor
6491657|NCT00603434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6491658|NCT00603759|Celecoxib|celecoxib|mesh-list
6491659|NCT00603759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6491660|NCT00603759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6491661|NCT00603759|Analgesics|analgesics|mesh-ancestor
6491662|NCT00603759|Sensory System Agents|sensory system agents|mesh-ancestor
5796946|NCT02754063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5796947|NCT02754063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491663|NCT00603759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5796948|NCT02754063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5796949|NCT02754063|Dopamine Agonists|dopamine agonists|mesh-ancestor
5796950|NCT02754063|Dopamine Agents|dopamine agents|mesh-ancestor
5796951|NCT02754063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5796952|NCT02754063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899591|NCT03290950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5899592|NCT03290950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5899593|NCT03290950|Growth Substances|growth substances|mesh-ancestor
5899594|NCT03290950|Growth Inhibitors|growth inhibitors|mesh-ancestor
5899595|NCT03249844|Methylprednisolone|methylprednisolone|mesh-list
5899596|NCT03249844|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5899597|NCT03249844|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5899598|NCT03249844|Prednisolone|prednisolone|mesh-list
5899599|NCT03249844|Prednisolone acetate|prednisolone acetate|mesh-list
5899600|NCT03249844|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5899601|NCT03249844|Prednisolone phosphate|prednisolone phosphate|mesh-list
5899602|NCT03249844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5899603|NCT03249844|Antiemetics|antiemetics|mesh-ancestor
5899604|NCT03249844|Autonomic Agents|autonomic agents|mesh-ancestor
5899605|NCT03249844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5899606|NCT03249844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899607|NCT03249844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5899608|NCT03249844|Glucocorticoids|glucocorticoids|mesh-ancestor
5899609|NCT03249844|Hormones|hormones|mesh-ancestor
5899610|NCT03249844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5899611|NCT03249844|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5899612|NCT03249844|Protective Agents|protective agents|mesh-ancestor
5641305|NCT03643744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5641306|NCT03643744|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5641307|NCT03643744|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5641308|NCT03643744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5641309|NCT03643744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641310|NCT03583333|Linezolid|linezolid|mesh-list
5641311|NCT03583333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5641312|NCT03583333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5641313|NCT03583333|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5641314|NCT03583333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5641315|NCT03583333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641316|NCT03568422|Paclitaxel|paclitaxel|mesh-list
5641317|NCT03568422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5641318|NCT03568422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5641319|NCT03568422|Tubulin Modulators|tubulin modulators|mesh-ancestor
5641320|NCT03568422|Antimitotic Agents|antimitotic agents|mesh-ancestor
5641321|NCT03568422|Mitosis Modulators|mitosis modulators|mesh-ancestor
5641322|NCT03568422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641323|NCT03560960|Pramlintide|pramlintide|mesh-list
5641324|NCT03560960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5641325|NCT03560960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641326|NCT03518606|Durvalumab|durvalumab|mesh-list
5641327|NCT03518606|Vinorelbine|vinorelbine|mesh-list
5641328|NCT03518606|Tremelimumab|tremelimumab|mesh-list
5641329|NCT03518606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5641330|NCT03518606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5641331|NCT03518606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5641332|NCT03518606|Tubulin Modulators|tubulin modulators|mesh-ancestor
5641333|NCT03518606|Antimitotic Agents|antimitotic agents|mesh-ancestor
5641334|NCT03518606|Mitosis Modulators|mitosis modulators|mesh-ancestor
5641335|NCT03518606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641336|NCT03504423|Leucovorin|leucovorin|mesh-list
5641337|NCT03504423|Folic Acid|folic acid|mesh-list
5641338|NCT03504423|Oxaliplatin|oxaliplatin|mesh-list
5641339|NCT03504423|Irinotecan|irinotecan|mesh-list
5641340|NCT03504423|Folfirinox|folfirinox|mesh-list
5796953|NCT02754011|Capecitabine|capecitabine|mesh-list
5796954|NCT02754011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5796955|NCT02754011|Antimetabolites|antimetabolites|mesh-ancestor
5796956|NCT02754011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5796957|NCT02754011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5796958|NCT02753803|Pioglitazone|pioglitazone|mesh-list
5796959|NCT02753803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5796960|NCT02753803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796961|NCT02754154|Warfarin|warfarin|mesh-list
5796962|NCT02754154|Rivaroxaban|rivaroxaban|mesh-list
5796963|NCT02754154|Dabigatran|dabigatran|mesh-list
5796964|NCT02754154|Apixaban|apixaban|mesh-list
5796965|NCT02754154|Anticoagulants|anticoagulants|mesh-ancestor
5796966|NCT02754154|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5796967|NCT02754154|Antithrombins|antithrombins|mesh-ancestor
5796968|NCT02754154|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5796969|NCT02754154|Protease Inhibitors|protease inhibitors|mesh-ancestor
5796970|NCT02754154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5796971|NCT02754154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5796972|NCT02753855|Telavancin|telavancin|mesh-list
5796973|NCT02753855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5796974|NCT02753855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5796975|NCT02754180|Gemcitabine|gemcitabine|mesh-list
5796976|NCT02754180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5796977|NCT02754180|Antimetabolites|antimetabolites|mesh-ancestor
5796978|NCT02754180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5796979|NCT02754180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5796980|NCT02754180|Antiviral Agents|antiviral agents|mesh-ancestor
5796981|NCT02754180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5796982|NCT02754180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5796983|NCT02754180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5796984|NCT02754180|Immunologic Factors|immunologic factors|mesh-ancestor
5796985|NCT02754180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796986|NCT02754037|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5796987|NCT02754037|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5796988|NCT02754037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5796989|NCT02753725|Fentanyl|fentanyl|mesh-list
5796990|NCT02753725|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5796991|NCT02753725|Narcotics|narcotics|mesh-ancestor
5796992|NCT02753725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5796993|NCT02753725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5796994|NCT02753725|Analgesics|analgesics|mesh-ancestor
5796995|NCT02753725|Sensory System Agents|sensory system agents|mesh-ancestor
5796996|NCT02753725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5796997|NCT02753725|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5796998|NCT02753725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5796999|NCT02753725|Anesthetics, General|anesthetics, general|mesh-ancestor
5797000|NCT02753725|Anesthetics|anesthetics|mesh-ancestor
5797001|NCT02753764|Prednisone|prednisone|mesh-list
5797002|NCT02753764|AZD7624|azd7624|mesh-list
5797003|NCT02753764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5797004|NCT02753764|Glucocorticoids|glucocorticoids|mesh-ancestor
5797005|NCT02753764|Hormones|hormones|mesh-ancestor
5797006|NCT02753764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5797007|NCT02753764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797008|NCT02753764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5797009|NCT02753764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5797010|NCT02753764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5797011|NCT02753764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5797012|NCT02753764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5797013|NCT02753738|Citalopram|citalopram|mesh-list
5797014|NCT02753738|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5797015|NCT02753738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5797016|NCT02753738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6210959|NCT02167204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6210960|NCT02167217|Prednisolone|prednisolone|mesh-list
6210961|NCT02167217|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6210962|NCT02167217|Methylprednisolone|methylprednisolone|mesh-list
6210963|NCT02167217|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5797017|NCT02753738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5797018|NCT02753738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5797019|NCT02753738|Serotonin Agents|serotonin agents|mesh-ancestor
5797020|NCT02753738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797021|NCT02753738|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5797022|NCT02753738|Antidepressive Agents|antidepressive agents|mesh-ancestor
5797023|NCT02753738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5797024|NCT02753686|Tamoxifen|tamoxifen|mesh-list
5797025|NCT02753686|Everolimus|everolimus|mesh-list
5797026|NCT02753686|Letrozole|letrozole|mesh-list
5797027|NCT02753686|Fulvestrant|fulvestrant|mesh-list
5797028|NCT02753686|Anastrozole|anastrozole|mesh-list
5797029|NCT02753686|Exemestane|exemestane|mesh-list
5797030|NCT02753686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5797031|NCT02753686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5797032|NCT02753686|Immunologic Factors|immunologic factors|mesh-ancestor
5797033|NCT02753686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797034|NCT02753686|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5797035|NCT02753686|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5797036|NCT02753686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5797037|NCT02753686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5797038|NCT02753686|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5797039|NCT02753686|Hormone Antagonists|hormone antagonists|mesh-ancestor
5797040|NCT02753686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5797041|NCT02753686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5797042|NCT02753686|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6210964|NCT02167217|Prednisolone acetate|prednisolone acetate|mesh-list
5797043|NCT02753686|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5797044|NCT02753686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5797045|NCT02753686|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5797046|NCT02753712|Fluticasone|fluticasone|mesh-list
5797047|NCT02753712|Xhance|xhance|mesh-list
5797048|NCT02753712|Formoterol Fumarate|formoterol fumarate|mesh-list
5797049|NCT02753712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5797050|NCT02753712|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5797051|NCT02753712|Autonomic Agents|autonomic agents|mesh-ancestor
5797052|NCT02753712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5797053|NCT02753712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797054|NCT02753712|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5797055|NCT02753712|Respiratory System Agents|respiratory system agents|mesh-ancestor
5797056|NCT02753712|Dermatologic Agents|dermatologic agents|mesh-ancestor
5797057|NCT02753712|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5797058|NCT02753712|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5797059|NCT02753712|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5797060|NCT02753712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5797061|NCT02753712|Adrenergic Agents|adrenergic agents|mesh-ancestor
6210965|NCT02167217|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5797062|NCT02753712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5797063|NCT02753712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5797064|NCT02753647|Prednisone|prednisone|mesh-list
5797065|NCT02753647|Cyclophosphamide|cyclophosphamide|mesh-list
5797066|NCT02753647|Rituximab|rituximab|mesh-list
5797067|NCT02753647|Doxorubicin|doxorubicin|mesh-list
5797068|NCT02753647|Vincristine|vincristine|mesh-list
5797069|NCT02753647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5797070|NCT02753647|Immunologic Factors|immunologic factors|mesh-ancestor
5797071|NCT02753647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797072|NCT02753647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5797073|NCT02753647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5797074|NCT02753647|Alkylating Agents|alkylating agents|mesh-ancestor
5797075|NCT02753647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5797076|NCT02753647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5797077|NCT02753647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5797078|NCT02753647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5797079|NCT02753647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5797080|NCT02753647|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5797081|NCT02753647|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5797082|NCT02753647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5797083|NCT02753647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5797084|NCT02753647|Glucocorticoids|glucocorticoids|mesh-ancestor
5797085|NCT02753647|Hormones|hormones|mesh-ancestor
5797086|NCT02753647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5797087|NCT02753647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5797088|NCT02753647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5797089|NCT02753647|Tubulin Modulators|tubulin modulators|mesh-ancestor
5797090|NCT02753647|Antimitotic Agents|antimitotic agents|mesh-ancestor
5797091|NCT02753647|Mitosis Modulators|mitosis modulators|mesh-ancestor
5797092|NCT02753426|Doxycycline|doxycycline|mesh-list
5797093|NCT02753426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5797094|NCT02753426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5797095|NCT02753426|Antimalarials|antimalarials|mesh-ancestor
5797096|NCT02753426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5797097|NCT02753426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5797098|NCT02753387|Chlorhexidine|chlorhexidine|mesh-list
5797099|NCT02753387|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5797100|NCT02753387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5797101|NCT02753387|Disinfectants|disinfectants|mesh-ancestor
5797102|NCT02753309|Sirolimus|sirolimus|mesh-list
5797103|NCT02753309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5797104|NCT02753309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5797105|NCT02753309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5797106|NCT02753309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5797107|NCT02753309|Antifungal Agents|antifungal agents|mesh-ancestor
5797108|NCT02753309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5797109|NCT02753309|Immunologic Factors|immunologic factors|mesh-ancestor
5797110|NCT02753309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797111|NCT02753283|Vitamin D|vitamin d|mesh-list
5797112|NCT02753283|Zoledronic Acid|zoledronic acid|mesh-list
5797113|NCT02753283|Denosumab|denosumab|mesh-list
5797114|NCT02753283|Calcium|calcium|mesh-list
5797115|NCT02753283|Vitamins|vitamins|mesh-ancestor
5797116|NCT02753283|Micronutrients|micronutrients|mesh-ancestor
6673953|NCT01566487|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6673954|NCT01566487|Antidepressive Agents|antidepressive agents|mesh-ancestor
6673955|NCT01566487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6673956|NCT01566487|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6673957|NCT01566487|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5797117|NCT02753283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797118|NCT02753283|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5797119|NCT02753283|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5797120|NCT02753140|Docetaxel|docetaxel|mesh-list
5797121|NCT02753140|Cetuximab|cetuximab|mesh-list
5797122|NCT02753140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5797123|NCT02753140|Tubulin Modulators|tubulin modulators|mesh-ancestor
5797124|NCT02753140|Antimitotic Agents|antimitotic agents|mesh-ancestor
5797125|NCT02753140|Mitosis Modulators|mitosis modulators|mesh-ancestor
5797126|NCT02753140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5797127|NCT02753140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5797128|NCT02753114|Ketamine|ketamine|mesh-list
5797129|NCT02753114|Analgesics|analgesics|mesh-ancestor
5797130|NCT02753114|Sensory System Agents|sensory system agents|mesh-ancestor
5797131|NCT02753114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5797132|NCT02753114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797133|NCT02753114|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5797134|NCT02753114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5797135|NCT02753114|Anesthetics, General|anesthetics, general|mesh-ancestor
5797136|NCT02753114|Anesthetics|anesthetics|mesh-ancestor
5797137|NCT02753114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5797138|NCT02753114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5797139|NCT02753114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5797140|NCT02753114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5797141|NCT02753114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5797142|NCT02753218|Midazolam|midazolam|mesh-list
5797143|NCT02753218|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5797144|NCT02753218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5797145|NCT02753218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5797146|NCT02753218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210966|NCT02167217|Prednisolone phosphate|prednisolone phosphate|mesh-list
6673958|NCT01566487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5797147|NCT02753218|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5797148|NCT02753218|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6673959|NCT01566487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797149|NCT02753218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5797150|NCT02753218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5797151|NCT02753218|Anesthetics, General|anesthetics, general|mesh-ancestor
5797152|NCT02753218|Anesthetics|anesthetics|mesh-ancestor
5797153|NCT02753218|GABA Modulators|gaba modulators|mesh-ancestor
5797154|NCT02753218|GABA Agents|gaba agents|mesh-ancestor
5797155|NCT02753218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5797156|NCT02753218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5797157|NCT02753205|Dexmedetomidine|dexmedetomidine|mesh-list
5797158|NCT02753205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6491664|NCT00603759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491665|NCT00603759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6491666|NCT00603759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6491667|NCT00603759|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6491668|NCT00603759|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6491669|NCT00603759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6491670|NCT00603759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491671|NCT00603772|Tretinoin|tretinoin|mesh-list
6491672|NCT00603772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6491673|NCT00603772|Keratolytic Agents|keratolytic agents|mesh-ancestor
6491674|NCT00603772|Dermatologic Agents|dermatologic agents|mesh-ancestor
6491675|NCT00603785|Omalizumab|omalizumab|mesh-list
6491676|NCT00603785|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6491677|NCT00603785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6491678|NCT00603785|Respiratory System Agents|respiratory system agents|mesh-ancestor
6491679|NCT00603824|PENTA|penta|mesh-list
6491680|NCT00603824|Lepirudin|lepirudin|mesh-list
6491681|NCT00603824|Fondaparinux|fondaparinux|mesh-list
6491682|NCT00603824|Argatroban|argatroban|mesh-list
6491683|NCT00603824|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6491684|NCT00603824|Antithrombins|antithrombins|mesh-ancestor
6491685|NCT00603824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6491686|NCT00603824|Protease Inhibitors|protease inhibitors|mesh-ancestor
6491687|NCT00603824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6491688|NCT00603824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641341|NCT03504423|Levoleucovorin|levoleucovorin|mesh-list
5641342|NCT03504423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5641343|NCT03504423|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5641344|NCT03504423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5641345|NCT03504423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5641346|NCT03504423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641347|NCT03504423|Antidotes|antidotes|mesh-ancestor
5641348|NCT03504423|Protective Agents|protective agents|mesh-ancestor
5641349|NCT03504423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641350|NCT03504423|Vitamin B Complex|vitamin b complex|mesh-ancestor
5641351|NCT03504423|Vitamins|vitamins|mesh-ancestor
5641352|NCT03504423|Micronutrients|micronutrients|mesh-ancestor
5641353|NCT03504423|Hematinics|hematinics|mesh-ancestor
6673960|NCT01566552|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6673961|NCT01566552|Antifungal Agents|antifungal agents|mesh-ancestor
6673962|NCT01566552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6673963|NCT01566552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5641354|NCT03424525|Trimethoprim|trimethoprim|mesh-list
5641355|NCT03424525|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5641356|NCT03424525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5641357|NCT03424525|Renal Agents|renal agents|mesh-ancestor
5641358|NCT03424525|Antimalarials|antimalarials|mesh-ancestor
5641359|NCT03424525|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5641360|NCT03424525|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5641361|NCT03424525|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5641362|NCT03424525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5641363|NCT03424525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641364|NCT03424525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5641365|NCT03424525|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
5797159|NCT02753205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5797160|NCT02753205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797161|NCT02753205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5797162|NCT02753205|Analgesics|analgesics|mesh-ancestor
5797163|NCT02753205|Sensory System Agents|sensory system agents|mesh-ancestor
5797164|NCT02753205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5797165|NCT02753205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5797166|NCT02753205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5797167|NCT02753205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5797168|NCT02753205|Adrenergic Agents|adrenergic agents|mesh-ancestor
5797169|NCT02753205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5797170|NCT02753205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5797171|NCT02752971|Diclofenac|diclofenac|mesh-list
5797172|NCT02752971|Bupivacaine|bupivacaine|mesh-list
5797173|NCT02752971|Anesthetics, Local|anesthetics, local|mesh-ancestor
5797174|NCT02752971|Anesthetics|anesthetics|mesh-ancestor
5797175|NCT02752971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5797176|NCT02752971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797177|NCT02752971|Sensory System Agents|sensory system agents|mesh-ancestor
5797178|NCT02752971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5797179|NCT02752971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5797180|NCT02752971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5797181|NCT02752971|Analgesics|analgesics|mesh-ancestor
5797182|NCT02752971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5797183|NCT02752971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5797184|NCT02752971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5797185|NCT02752971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5797186|NCT02752971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5797187|NCT02753127|Leucovorin|leucovorin|mesh-list
5797188|NCT02753127|Bevacizumab|bevacizumab|mesh-list
5797189|NCT02753127|Fluorouracil|fluorouracil|mesh-list
5797190|NCT02753127|Irinotecan|irinotecan|mesh-list
5797191|NCT02753127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5797192|NCT02753127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5797193|NCT02753127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5797194|NCT02753127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5797195|NCT02753127|Growth Substances|growth substances|mesh-ancestor
5797196|NCT02753127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797197|NCT02753127|Growth Inhibitors|growth inhibitors|mesh-ancestor
5797198|NCT02753127|Antimetabolites|antimetabolites|mesh-ancestor
5797199|NCT02753127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5797200|NCT02753127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5797201|NCT02753127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5797202|NCT02753127|Immunologic Factors|immunologic factors|mesh-ancestor
5797203|NCT02753127|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5797204|NCT02753127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5797205|NCT02753127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5797206|NCT02753127|Antidotes|antidotes|mesh-ancestor
5797207|NCT02753127|Protective Agents|protective agents|mesh-ancestor
5797208|NCT02753127|Vitamin B Complex|vitamin b complex|mesh-ancestor
6491689|NCT00603824|Anticoagulants|anticoagulants|mesh-ancestor
6491690|NCT00603824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6491691|NCT00603824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6491692|NCT00603824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6496419|NCT00627952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6496420|NCT00627952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496421|NCT00627952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6496422|NCT00627952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496423|NCT00627952|Vasodilator Agents|vasodilator agents|mesh-ancestor
6496424|NCT00627952|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6496425|NCT00627952|Protease Inhibitors|protease inhibitors|mesh-ancestor
6496426|NCT00627952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6496427|NCT00627965|Sildenafil Citrate|sildenafil citrate|mesh-list
6491693|NCT00604006|Spironolactone|spironolactone|mesh-list
5797209|NCT02753127|Vitamins|vitamins|mesh-ancestor
5797210|NCT02753127|Micronutrients|micronutrients|mesh-ancestor
5797211|NCT02753166|Dexamethasone|dexamethasone|mesh-list
5797212|NCT02753166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5797213|NCT02753166|Antiemetics|antiemetics|mesh-ancestor
5797214|NCT02753166|Autonomic Agents|autonomic agents|mesh-ancestor
5797215|NCT02753166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5797216|NCT02753166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797217|NCT02753166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5797218|NCT02753166|Glucocorticoids|glucocorticoids|mesh-ancestor
5797219|NCT02753166|Hormones|hormones|mesh-ancestor
5797220|NCT02753166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5797221|NCT02753166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5797222|NCT02753166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5797223|NCT02752828|Insulin|insulin|mesh-list
5797224|NCT02752828|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5797225|NCT02752828|Insulin Glargine|insulin glargine|mesh-list
5797226|NCT02752828|Lixisenatide|lixisenatide|mesh-list
5797227|NCT02752828|Hypoglycemic Agents|hypoglycemic agents|mesh-list
5797228|NCT02752828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797229|NCT02752815|Prednisone|prednisone|mesh-list
5797230|NCT02752815|Cyclophosphamide|cyclophosphamide|mesh-list
5797231|NCT02752815|Rituximab|rituximab|mesh-list
5797232|NCT02752815|Vincristine|vincristine|mesh-list
5797233|NCT02752815|Epirubicin|epirubicin|mesh-list
5797234|NCT02752815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5797235|NCT02752815|Immunologic Factors|immunologic factors|mesh-ancestor
5797236|NCT02752815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797237|NCT02752815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5797238|NCT02752815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5797239|NCT02752815|Alkylating Agents|alkylating agents|mesh-ancestor
5797240|NCT02752815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5797241|NCT02752815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5797242|NCT02752815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5797243|NCT02752815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5797244|NCT02752815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5797245|NCT02752815|Glucocorticoids|glucocorticoids|mesh-ancestor
5797246|NCT02752815|Hormones|hormones|mesh-ancestor
5797247|NCT02752815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5797248|NCT02752815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5797249|NCT02752815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5797250|NCT02752815|Tubulin Modulators|tubulin modulators|mesh-ancestor
5797251|NCT02752815|Antimitotic Agents|antimitotic agents|mesh-ancestor
5797252|NCT02752815|Mitosis Modulators|mitosis modulators|mesh-ancestor
5797253|NCT02752815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6491694|NCT00604006|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5797254|NCT02752815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5797255|NCT02752815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5797256|NCT02752815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5797257|NCT02752685|Paclitaxel|paclitaxel|mesh-list
5797258|NCT02752685|Pembrolizumab|pembrolizumab|mesh-list
5797259|NCT02752685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5797260|NCT02752685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5797261|NCT02752685|Tubulin Modulators|tubulin modulators|mesh-ancestor
5797262|NCT02752685|Antimitotic Agents|antimitotic agents|mesh-ancestor
5797263|NCT02752685|Mitosis Modulators|mitosis modulators|mesh-ancestor
5797264|NCT02752685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5797265|NCT02752685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5797266|NCT02752763|Dextrans|dextrans|mesh-list
5797267|NCT02752763|Povidone|povidone|mesh-list
5797268|NCT02752763|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5797269|NCT02752763|Lubricant Eye Drops|lubricant eye drops|mesh-list
5797270|NCT02752763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5797271|NCT02752763|Plasma Substitutes|plasma substitutes|mesh-ancestor
5797272|NCT02752763|Blood Substitutes|blood substitutes|mesh-ancestor
5797273|NCT02752763|Anticoagulants|anticoagulants|mesh-ancestor
5797274|NCT02753062|Rituximab|rituximab|mesh-list
5797275|NCT02753062|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5797276|NCT02753062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5797277|NCT02753062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5797278|NCT02753062|Immunologic Factors|immunologic factors|mesh-ancestor
5797279|NCT02753062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797280|NCT02753062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5797281|NCT02753062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5797282|NCT02753062|Alkylating Agents|alkylating agents|mesh-ancestor
5797283|NCT02753062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5797284|NCT02753088|Glatiramer Acetate|glatiramer acetate|mesh-list
5797285|NCT02753088|Mannitol|mannitol|mesh-list
5797286|NCT02753088|(T,G)-A-L|(t,g)-a-l|mesh-list
5797287|NCT02753088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5797288|NCT02753088|Diuretics|diuretics|mesh-ancestor
5797289|NCT02753088|Natriuretic Agents|natriuretic agents|mesh-ancestor
5797290|NCT02753088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797291|NCT02753088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5797292|NCT02753088|Immunologic Factors|immunologic factors|mesh-ancestor
5797293|NCT02753088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5797294|NCT02753088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5797295|NCT02752646|Ketorolac|ketorolac|mesh-list
5797296|NCT02752646|Nepafenac|nepafenac|mesh-list
5797297|NCT02752646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5797298|NCT02752646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5797299|NCT02752646|Analgesics|analgesics|mesh-ancestor
5797300|NCT02752646|Sensory System Agents|sensory system agents|mesh-ancestor
5797301|NCT02752646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5797302|NCT02752646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797303|NCT02752646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5797304|NCT02752646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5797305|NCT02752646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5797306|NCT02752646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5797307|NCT02752646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5797308|NCT02752841|Vitamin D|vitamin d|mesh-list
5797309|NCT02752841|Vitamins|vitamins|mesh-ancestor
5797310|NCT02752841|Micronutrients|micronutrients|mesh-ancestor
5797311|NCT02752841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797312|NCT02752841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5797313|NCT02752503|Nalmefene|nalmefene|mesh-list
5797314|NCT02752503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5797315|NCT02752503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797316|NCT02752503|Sensory System Agents|sensory system agents|mesh-ancestor
5797317|NCT02752503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5797318|NCT02752555|Antioxidants|antioxidants|mesh-list
5797319|NCT02752555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5797320|NCT02752555|Protective Agents|protective agents|mesh-ancestor
5797321|NCT02752555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899613|NCT03249844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5899614|NCT03249844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5899615|NCT03221257|Mycophenolic Acid|mycophenolic acid|mesh-list
5899616|NCT03221257|Pirfenidone|pirfenidone|mesh-list
5899617|NCT03221257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5899618|NCT03221257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5899619|NCT03221257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5899620|NCT03221257|Antitubercular Agents|antitubercular agents|mesh-ancestor
5899621|NCT03221257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5899622|NCT03221257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5899623|NCT03221257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5899624|NCT03221257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899625|NCT03221257|Analgesics|analgesics|mesh-ancestor
5899626|NCT03221257|Sensory System Agents|sensory system agents|mesh-ancestor
5899627|NCT03221257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5899628|NCT03221257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899629|NCT03221257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5899630|NCT03221257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5899631|NCT03221257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5899632|NCT03221257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5899633|NCT03204188|Pembrolizumab|pembrolizumab|mesh-list
5899634|NCT03204188|Fludarabine|fludarabine|mesh-list
5899635|NCT03204188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5899636|NCT03204188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5899637|NCT03172754|Nivolumab|nivolumab|mesh-list
5899638|NCT03172754|Axitinib|axitinib|mesh-list
5899639|NCT03172754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5899640|NCT03172754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5797322|NCT02752724|Ketamine|ketamine|mesh-list
5797323|NCT02752724|Methohexital|methohexital|mesh-list
5797324|NCT02752724|Analgesics|analgesics|mesh-ancestor
5797325|NCT02752724|Sensory System Agents|sensory system agents|mesh-ancestor
5797326|NCT02752724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5797327|NCT02752724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797328|NCT02752724|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5797329|NCT02752724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5797330|NCT02752724|Anesthetics, General|anesthetics, general|mesh-ancestor
5797331|NCT02752724|Anesthetics|anesthetics|mesh-ancestor
5797332|NCT02752724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5797333|NCT02752724|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5797334|NCT02752724|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5797335|NCT02752724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5797336|NCT02752724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5797337|NCT02752529|Tacrolimus|tacrolimus|mesh-list
5797338|NCT02752529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5797339|NCT02752529|Immunologic Factors|immunologic factors|mesh-ancestor
5797340|NCT02752529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797341|NCT02752529|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5797342|NCT02752529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5797343|NCT02752529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5797344|NCT02752191|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
5797345|NCT02752191|Hematinics|hematinics|mesh-ancestor
5797346|NCT02752191|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5797347|NCT02752191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5797348|NCT02752113|Metformin|metformin|mesh-list
5797349|NCT02752113|Empagliflozin|empagliflozin|mesh-list
5797350|NCT02752113|Linagliptin|linagliptin|mesh-list
5797351|NCT02752113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5797352|NCT02752113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797353|NCT02752113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5797354|NCT02752113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5797355|NCT02752113|Incretins|incretins|mesh-ancestor
5797356|NCT02752113|Hormones|hormones|mesh-ancestor
5797357|NCT02752113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5797358|NCT02752113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6210967|NCT02167217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5797359|NCT02752113|Protease Inhibitors|protease inhibitors|mesh-ancestor
5797360|NCT02752113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5797361|NCT02752204|Rituximab|rituximab|mesh-list
5797362|NCT02752204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5797363|NCT02752204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5797364|NCT02752204|Immunologic Factors|immunologic factors|mesh-ancestor
5797365|NCT02752204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797366|NCT02752204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5797367|NCT02752308|Atropine|atropine|mesh-list
5797368|NCT02752308|Epinephrine|epinephrine|mesh-list
5797369|NCT02752308|Fentanyl|fentanyl|mesh-list
5797370|NCT02752308|Bupivacaine|bupivacaine|mesh-list
5797371|NCT02752308|Neostigmine|neostigmine|mesh-list
5797372|NCT02752308|Anesthetics, Local|anesthetics, local|mesh-ancestor
5797373|NCT02752308|Anesthetics|anesthetics|mesh-ancestor
5797374|NCT02752308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5797375|NCT02752308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797376|NCT02752308|Sensory System Agents|sensory system agents|mesh-ancestor
5797377|NCT02752308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5797378|NCT02752308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5797379|NCT02752308|Narcotics|narcotics|mesh-ancestor
5797380|NCT02752308|Analgesics|analgesics|mesh-ancestor
5797381|NCT02752308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5797382|NCT02752308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5797383|NCT02752308|Anesthetics, General|anesthetics, general|mesh-ancestor
5797384|NCT02752308|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5797385|NCT02752308|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6210968|NCT02167217|Glucocorticoids|glucocorticoids|mesh-ancestor
6210969|NCT02167217|Hormones|hormones|mesh-ancestor
6210970|NCT02167217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6210971|NCT02167217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797386|NCT02752308|Adrenergic Agents|adrenergic agents|mesh-ancestor
5797387|NCT02752308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5797388|NCT02752308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5797389|NCT02752308|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5797390|NCT02752308|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5797391|NCT02752308|Autonomic Agents|autonomic agents|mesh-ancestor
5797392|NCT02752308|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5797393|NCT02752308|Respiratory System Agents|respiratory system agents|mesh-ancestor
5797394|NCT02752308|Mydriatics|mydriatics|mesh-ancestor
5797395|NCT02752308|Sympathomimetics|sympathomimetics|mesh-ancestor
5797396|NCT02752308|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5797397|NCT02752308|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5797398|NCT02752308|Parasympatholytics|parasympatholytics|mesh-ancestor
5797399|NCT02752308|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5797400|NCT02752308|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5797401|NCT02752308|Cholinergic Agents|cholinergic agents|mesh-ancestor
5797402|NCT02752308|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5797403|NCT02752308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5797404|NCT02752308|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5797405|NCT02752334|Magnesium Sulfate|magnesium sulfate|mesh-list
5797406|NCT02752334|Bupivacaine|bupivacaine|mesh-list
5797407|NCT02752334|Anesthetics, Local|anesthetics, local|mesh-ancestor
5797408|NCT02752334|Anesthetics|anesthetics|mesh-ancestor
5797409|NCT02752334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5797410|NCT02752334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210972|NCT02167217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5797411|NCT02752334|Sensory System Agents|sensory system agents|mesh-ancestor
5797412|NCT02752334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6210973|NCT02167217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6210974|NCT02167217|Antiemetics|antiemetics|mesh-ancestor
6210975|NCT02167217|Autonomic Agents|autonomic agents|mesh-ancestor
6210976|NCT02167217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6210977|NCT02167217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6210978|NCT02167217|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6210979|NCT02167217|Protective Agents|protective agents|mesh-ancestor
6210980|NCT02167256|Saracatinib|saracatinib|mesh-list
6210981|NCT02167256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6210982|NCT02167256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6210983|NCT02167256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210984|NCT02167451|Maraviroc|maraviroc|mesh-list
5797413|NCT02752334|Analgesics|analgesics|mesh-ancestor
5797414|NCT02752334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5797415|NCT02752334|Anticonvulsants|anticonvulsants|mesh-ancestor
5797416|NCT02752334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5797417|NCT02752334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5797418|NCT02752334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5797419|NCT02752334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5797420|NCT02752334|Tocolytic Agents|tocolytic agents|mesh-ancestor
5797421|NCT02752334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5797422|NCT02751996|Tenofovir|tenofovir|mesh-list
5797423|NCT02751996|Antiviral Agents|antiviral agents|mesh-ancestor
5797424|NCT02751996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5797425|NCT02751996|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5797426|NCT02751996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5797427|NCT02751996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5797428|NCT02751996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5797429|NCT02751996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5797430|NCT02751996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5797431|NCT02751918|Doxorubicin|doxorubicin|mesh-list
5797432|NCT02751918|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5797433|NCT02751918|Maytansine|maytansine|mesh-list
5797434|NCT02751918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5797435|NCT02751918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5797436|NCT02751918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5797437|NCT02751918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5797438|NCT02751918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5797439|NCT02751918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5797440|NCT02751918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5797441|NCT02751918|Tubulin Modulators|tubulin modulators|mesh-ancestor
5797442|NCT02751918|Antimitotic Agents|antimitotic agents|mesh-ancestor
5797443|NCT02751918|Mitosis Modulators|mitosis modulators|mesh-ancestor
5797444|NCT02751840|Caffeine|caffeine|mesh-list
5797445|NCT02751840|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6491695|NCT00604006|Hormone Antagonists|hormone antagonists|mesh-ancestor
5797446|NCT02751840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797447|NCT02751840|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5797448|NCT02751840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5797449|NCT02751840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5797450|NCT02751840|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5797451|NCT02751840|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5797452|NCT02751840|Purinergic Agents|purinergic agents|mesh-ancestor
5797453|NCT02751840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5797454|NCT02752477|Anesthetics|anesthetics|mesh-list
5797455|NCT02752477|Anesthetics, General|anesthetics, general|mesh-list
5797456|NCT02752477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5797457|NCT02752477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797458|NCT02752412|Insulin|insulin|mesh-list
5797459|NCT02752412|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5797460|NCT02752412|Metformin|metformin|mesh-list
5797461|NCT02752412|Insulin Glargine|insulin glargine|mesh-list
5797462|NCT02752412|Lixisenatide|lixisenatide|mesh-list
5797463|NCT02752412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5797464|NCT02752412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797465|NCT02751593|Dexamethasone|dexamethasone|mesh-list
5797466|NCT02751593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5797467|NCT02751593|Antiemetics|antiemetics|mesh-ancestor
5797468|NCT02751593|Autonomic Agents|autonomic agents|mesh-ancestor
5797469|NCT02751593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5797470|NCT02751593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797471|NCT02751593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5797472|NCT02751593|Glucocorticoids|glucocorticoids|mesh-ancestor
5797473|NCT02751593|Hormones|hormones|mesh-ancestor
5797474|NCT02751593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5797475|NCT02751593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5797476|NCT02751593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5797477|NCT02751632|Fluoxetine|fluoxetine|mesh-list
5797478|NCT02751632|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5797479|NCT02751632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5797480|NCT02751632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5899641|NCT03172754|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5797481|NCT02751632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5797482|NCT02751632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5797483|NCT02751632|Serotonin Agents|serotonin agents|mesh-ancestor
5797484|NCT02751632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797485|NCT02751632|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5797486|NCT02751632|Antidepressive Agents|antidepressive agents|mesh-ancestor
5797487|NCT02751632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5797488|NCT02751632|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5797489|NCT02751632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5797490|NCT02751632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5797491|NCT02751619|Lidocaine|lidocaine|mesh-list
5797492|NCT02751619|Anesthetics, Local|anesthetics, local|mesh-ancestor
5797493|NCT02751619|Anesthetics|anesthetics|mesh-ancestor
5797494|NCT02751619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5797495|NCT02751619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797496|NCT02751619|Sensory System Agents|sensory system agents|mesh-ancestor
5797497|NCT02751619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5797498|NCT02751619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5797499|NCT02751619|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5797500|NCT02751619|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5797501|NCT02751619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5797502|NCT02751619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5797503|NCT02751541|Sunscreening Agents|sunscreening agents|mesh-list
5797504|NCT02751541|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5797505|NCT02751541|Protective Agents|protective agents|mesh-ancestor
5797506|NCT02751541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797507|NCT02751541|Dermatologic Agents|dermatologic agents|mesh-ancestor
5797508|NCT02751476|Disinfectants|disinfectants|mesh-list
5797509|NCT02751476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5797510|NCT02751528|Vaccines|vaccines|mesh-list
5797511|NCT02751528|Immunologic Factors|immunologic factors|mesh-ancestor
5797512|NCT02751528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797513|NCT02751398|Dapagliflozin|dapagliflozin|mesh-list
5797514|NCT02751398|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5908163|NCT04860713|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5797515|NCT02751398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5797516|NCT02751398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5797517|NCT02751398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797518|NCT02751294|Tafenoquine|tafenoquine|mesh-list
5797519|NCT02751294|Antimalarials|antimalarials|mesh-ancestor
5797520|NCT02751294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6491696|NCT00604006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6491697|NCT00604006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491698|NCT00604006|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6491699|NCT00604006|Diuretics|diuretics|mesh-ancestor
6491700|NCT00604006|Natriuretic Agents|natriuretic agents|mesh-ancestor
6491701|NCT00604032|Tretinoin|tretinoin|mesh-list
6491702|NCT00604032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5797521|NCT02751294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6491703|NCT00604032|Keratolytic Agents|keratolytic agents|mesh-ancestor
6491704|NCT00604032|Dermatologic Agents|dermatologic agents|mesh-ancestor
6491705|NCT00604058|Vaccines|vaccines|mesh-list
6491706|NCT00604058|Immunologic Factors|immunologic factors|mesh-ancestor
6491707|NCT00604058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491708|NCT00604084|Ivermectin|ivermectin|mesh-list
6491709|NCT00604084|Permethrin|permethrin|mesh-list
5797522|NCT02751294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5797523|NCT02751307|Metformin|metformin|mesh-list
5797524|NCT02751307|Clozapine|clozapine|mesh-list
5797525|NCT02751307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5797526|NCT02751307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797527|NCT02751307|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5797528|NCT02751307|Serotonin Agents|serotonin agents|mesh-ancestor
5797529|NCT02751307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5797530|NCT02751307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5797531|NCT02751307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5797532|NCT02751307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5797533|NCT02751307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5797534|NCT02751307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5797535|NCT02751307|GABA Antagonists|gaba antagonists|mesh-ancestor
5797536|NCT02751307|GABA Agents|gaba agents|mesh-ancestor
5797537|NCT02751268|Ropivacaine|ropivacaine|mesh-list
5797538|NCT02751268|Anesthetics, Local|anesthetics, local|mesh-ancestor
5797539|NCT02751268|Anesthetics|anesthetics|mesh-ancestor
5797540|NCT02751268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5797541|NCT02751268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797542|NCT02751268|Sensory System Agents|sensory system agents|mesh-ancestor
5797543|NCT02751268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5797544|NCT02751255|Tretinoin|tretinoin|mesh-list
5797545|NCT02751255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5797546|NCT02751255|Keratolytic Agents|keratolytic agents|mesh-ancestor
5797547|NCT02751255|Dermatologic Agents|dermatologic agents|mesh-ancestor
5797548|NCT02751151|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5797549|NCT02751151|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5797550|NCT02751151|Dermatologic Agents|dermatologic agents|mesh-ancestor
5797551|NCT02750904|Nicotine|nicotine|mesh-list
5797552|NCT02750904|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5797553|NCT02750904|Autonomic Agents|autonomic agents|mesh-ancestor
5797554|NCT02750904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5797555|NCT02750904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797556|NCT02750904|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5797557|NCT02750904|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5797558|NCT02750904|Cholinergic Agents|cholinergic agents|mesh-ancestor
5797559|NCT02750904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5797560|NCT02750904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491710|NCT00604084|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5797561|NCT02750969|Lidocaine|lidocaine|mesh-list
5797562|NCT02750969|Anesthetics, Local|anesthetics, local|mesh-ancestor
5797563|NCT02750969|Anesthetics|anesthetics|mesh-ancestor
5797564|NCT02750969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5797565|NCT02750969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797566|NCT02750969|Sensory System Agents|sensory system agents|mesh-ancestor
5797567|NCT02750969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5797568|NCT02750969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5797569|NCT02750969|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5797570|NCT02750969|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5797571|NCT02750969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5797572|NCT02750969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5797573|NCT02750917|Etoricoxib|etoricoxib|mesh-list
5797574|NCT02750917|Lornoxicam|lornoxicam|mesh-list
5797575|NCT02750917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5797576|NCT02750917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5797577|NCT02750917|Analgesics|analgesics|mesh-ancestor
5797578|NCT02750917|Sensory System Agents|sensory system agents|mesh-ancestor
5797579|NCT02750917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5797580|NCT02750917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797581|NCT02750917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5797582|NCT02750917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5797583|NCT02750917|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5797584|NCT02750917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5797585|NCT02750917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5797586|NCT02750917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5797587|NCT02751034|Lidocaine|lidocaine|mesh-list
5797588|NCT02751034|Anesthetics, Local|anesthetics, local|mesh-ancestor
5797589|NCT02751034|Anesthetics|anesthetics|mesh-ancestor
5797590|NCT02751034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5797591|NCT02751034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797592|NCT02751034|Sensory System Agents|sensory system agents|mesh-ancestor
5797593|NCT02751034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5797594|NCT02751034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5797595|NCT02751034|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5797596|NCT02751034|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5797597|NCT02751034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5797598|NCT02751034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899642|NCT03172754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899643|NCT03172754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5899644|NCT03172754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5899645|NCT03044977|Octreotide|octreotide|mesh-list
5899646|NCT03044977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5899647|NCT03044977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5899648|NCT03044977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5899649|NCT02977156|Ipilimumab|ipilimumab|mesh-list
5899650|NCT02977156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5899651|NCT02977156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5899652|NCT02977156|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5899653|NCT02977156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899654|NCT02913313|Nivolumab|nivolumab|mesh-list
5899655|NCT02913313|Ipilimumab|ipilimumab|mesh-list
5899656|NCT02913313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5899657|NCT02913313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5899658|NCT02913313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5899659|NCT02913313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899660|NCT02755272|Gemcitabine|gemcitabine|mesh-list
5899661|NCT02755272|Carboplatin|carboplatin|mesh-list
5899662|NCT02755272|Pembrolizumab|pembrolizumab|mesh-list
5797599|NCT02750995|Azacitidine|azacitidine|mesh-list
5797600|NCT02750995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5797601|NCT02750995|Antimetabolites|antimetabolites|mesh-ancestor
5797602|NCT02750995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5797603|NCT02750995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5797604|NCT02750995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5797605|NCT02750748|Naltrexone|naltrexone|mesh-list
5797606|NCT02750748|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5797607|NCT02750748|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5797608|NCT02750748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797609|NCT02750748|Sensory System Agents|sensory system agents|mesh-ancestor
5797610|NCT02750748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5797611|NCT02750696|Acetaminophen|acetaminophen|mesh-list
5797612|NCT02750696|Tramadol|tramadol|mesh-list
5797613|NCT02750696|Codeine|codeine|mesh-list
5797614|NCT02750696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5797615|NCT02750696|Analgesics|analgesics|mesh-ancestor
5797616|NCT02750696|Sensory System Agents|sensory system agents|mesh-ancestor
5797617|NCT02750696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5797618|NCT02750696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797619|NCT02750696|Antipyretics|antipyretics|mesh-ancestor
5797620|NCT02750696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5797621|NCT02750696|Narcotics|narcotics|mesh-ancestor
5797622|NCT02750696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5797623|NCT02750696|Antitussive Agents|antitussive agents|mesh-ancestor
5797624|NCT02750696|Respiratory System Agents|respiratory system agents|mesh-ancestor
5797625|NCT02750670|Gemcitabine|gemcitabine|mesh-list
5797626|NCT02750670|Dexamethasone|dexamethasone|mesh-list
5797627|NCT02750670|Obinutuzumab|obinutuzumab|mesh-list
5797628|NCT02750670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5797629|NCT02750670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5797630|NCT02750670|Antiemetics|antiemetics|mesh-ancestor
5797631|NCT02750670|Autonomic Agents|autonomic agents|mesh-ancestor
5797632|NCT02750670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5797633|NCT02750670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797634|NCT02750670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5797635|NCT02750670|Glucocorticoids|glucocorticoids|mesh-ancestor
5797636|NCT02750670|Hormones|hormones|mesh-ancestor
5797637|NCT02750670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5797638|NCT02750670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5797639|NCT02750670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5797640|NCT02750670|Antimetabolites|antimetabolites|mesh-ancestor
5797641|NCT02750670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5797642|NCT02750670|Antiviral Agents|antiviral agents|mesh-ancestor
5797643|NCT02750670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5797644|NCT02750670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5797645|NCT02750670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5797646|NCT02750670|Immunologic Factors|immunologic factors|mesh-ancestor
5797647|NCT02750670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5797648|NCT02750475|Sunscreening Agents|sunscreening agents|mesh-list
5797649|NCT02750475|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5797650|NCT02750475|Protective Agents|protective agents|mesh-ancestor
5797651|NCT02750475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797652|NCT02750475|Dermatologic Agents|dermatologic agents|mesh-ancestor
5797653|NCT02750319|Acetylcysteine|acetylcysteine|mesh-list
5797654|NCT02750319|Amiodarone|amiodarone|mesh-list
5797655|NCT02750319|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5797656|NCT02750319|Antiviral Agents|antiviral agents|mesh-ancestor
5797657|NCT02750319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5797658|NCT02750319|Expectorants|expectorants|mesh-ancestor
5797659|NCT02750319|Respiratory System Agents|respiratory system agents|mesh-ancestor
5797660|NCT02750319|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5797661|NCT02750319|Antioxidants|antioxidants|mesh-ancestor
5797662|NCT02750319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5797663|NCT02750319|Protective Agents|protective agents|mesh-ancestor
5797664|NCT02750319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797665|NCT02750319|Antidotes|antidotes|mesh-ancestor
5797666|NCT02750319|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5797667|NCT02750319|Vasodilator Agents|vasodilator agents|mesh-ancestor
5797668|NCT02750319|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5797669|NCT02750319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5797670|NCT02750319|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5797671|NCT02750319|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5797672|NCT02750319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5797673|NCT02750319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5797674|NCT02750319|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5797675|NCT02750319|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5797676|NCT02750319|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5797677|NCT02750293|Cholecalciferol|cholecalciferol|mesh-list
5797678|NCT02750293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5797679|NCT02750293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797680|NCT02750293|Vitamins|vitamins|mesh-ancestor
5797681|NCT02750293|Micronutrients|micronutrients|mesh-ancestor
5797682|NCT02750293|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5797683|NCT02750254|Plerixafor|plerixafor|mesh-list
5797684|NCT02750254|Cyclophosphamide|cyclophosphamide|mesh-list
5797685|NCT02750254|Melphalan|melphalan|mesh-list
5797686|NCT02750254|Busulfan|busulfan|mesh-list
5797687|NCT02750254|Fludarabine|fludarabine|mesh-list
5797688|NCT02750254|Azacitidine|azacitidine|mesh-list
5797689|NCT02750254|Lenograstim|lenograstim|mesh-list
5797690|NCT02750254|Sargramostim|sargramostim|mesh-list
5797691|NCT02750254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5797692|NCT02750254|Immunologic Factors|immunologic factors|mesh-ancestor
5797693|NCT02750254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797694|NCT02750254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5797695|NCT02750254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5797696|NCT02750254|Alkylating Agents|alkylating agents|mesh-ancestor
5797697|NCT02750254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5797698|NCT02750254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5797699|NCT02750254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5797700|NCT02750254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5797701|NCT02750254|Antimetabolites|antimetabolites|mesh-ancestor
5797702|NCT02750254|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5797703|NCT02750254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6491711|NCT00604084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6491712|NCT00604084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6491713|NCT00604084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491714|NCT00604253|Insulin|insulin|mesh-list
5797704|NCT02750254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5797705|NCT02750254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5797706|NCT02750254|Antiviral Agents|antiviral agents|mesh-ancestor
5797707|NCT02750254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5797708|NCT02750202|Vaccines|vaccines|mesh-list
5797709|NCT02750202|Immunologic Factors|immunologic factors|mesh-ancestor
5797710|NCT02750202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797711|NCT02749994|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5797712|NCT02749994|Ezetimibe|ezetimibe|mesh-list
5797713|NCT02749994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5797714|NCT02749994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5797715|NCT02749994|Antimetabolites|antimetabolites|mesh-ancestor
5797716|NCT02749994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5797717|NCT02749994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5797718|NCT02749994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5797719|NCT02749994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5797720|NCT02750137|Tetracaine|tetracaine|mesh-list
5797721|NCT02750137|Anesthetics, Local|anesthetics, local|mesh-ancestor
5797722|NCT02750137|Anesthetics|anesthetics|mesh-ancestor
5797723|NCT02750137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5797724|NCT02750137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797725|NCT02750137|Sensory System Agents|sensory system agents|mesh-ancestor
5797726|NCT02750137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5797727|NCT02750059|Tenofovir|tenofovir|mesh-list
5797728|NCT02750059|Lamivudine|lamivudine|mesh-list
5797729|NCT02750059|Efavirenz|efavirenz|mesh-list
5797730|NCT02750059|Telmisartan|telmisartan|mesh-list
5797731|NCT02750059|Antiviral Agents|antiviral agents|mesh-ancestor
5797732|NCT02750059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5797733|NCT02750059|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5797734|NCT02750059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5797735|NCT02750059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5797736|NCT02750059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5797737|NCT02750059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5797738|NCT02750059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5797739|NCT02750059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5797740|NCT02750059|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5797741|NCT02750059|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5797742|NCT02750059|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5797743|NCT02750059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5797744|NCT02750059|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5797745|NCT02750059|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5797746|NCT02750059|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5797747|NCT02750059|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5797748|NCT02749825|Goserelin|goserelin|mesh-list
5797749|NCT02749825|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5797750|NCT02749825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5797751|NCT02749825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6210985|NCT02167451|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5797752|NCT02749825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5797753|NCT02749825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797754|NCT02749825|Luteolytic Agents|luteolytic agents|mesh-ancestor
5797755|NCT02749825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5797756|NCT02749825|Contraceptive Agents|contraceptive agents|mesh-ancestor
5797757|NCT02749825|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5797758|NCT02749968|Bupivacaine|bupivacaine|mesh-list
5797759|NCT02749968|Anesthetics, Local|anesthetics, local|mesh-ancestor
5797760|NCT02749968|Anesthetics|anesthetics|mesh-ancestor
5797761|NCT02749968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5797762|NCT02749968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797763|NCT02749968|Sensory System Agents|sensory system agents|mesh-ancestor
6491715|NCT00604253|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6491716|NCT00604253|Insulin Detemir|insulin detemir|mesh-list
6491717|NCT00604253|Isophane Insulin, Human|isophane insulin, human|mesh-list
6491718|NCT00604253|Insulin, Isophane|insulin, isophane|mesh-list
6491719|NCT00604253|Isophane insulin, beef|isophane insulin, beef|mesh-list
6491720|NCT00604253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6673964|NCT01566552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5797764|NCT02749968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5797765|NCT02749890|Insulin Glargine|insulin glargine|mesh-list
5797766|NCT02749890|Lixisenatide|lixisenatide|mesh-list
5797767|NCT02749890|Hypoglycemic Agents|hypoglycemic agents|mesh-list
5797768|NCT02749890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797769|NCT02750163|Acetaminophen|acetaminophen|mesh-list
5797770|NCT02750163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6673965|NCT01566565|Theophylline|theophylline|mesh-list
5797771|NCT02750163|Analgesics|analgesics|mesh-ancestor
5797772|NCT02750163|Sensory System Agents|sensory system agents|mesh-ancestor
5797773|NCT02750163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5797774|NCT02750163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797775|NCT02750163|Antipyretics|antipyretics|mesh-ancestor
5797776|NCT02749747|Sulpiride|sulpiride|mesh-list
5797777|NCT02749747|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5797778|NCT02749747|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5797779|NCT02749747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5797780|NCT02749747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797781|NCT02749747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5797782|NCT02749747|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5797783|NCT02749747|Dopamine Agents|dopamine agents|mesh-ancestor
5797784|NCT02749747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5797785|NCT02749747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5797786|NCT02749747|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5797787|NCT02749747|Antidepressive Agents|antidepressive agents|mesh-ancestor
5797788|NCT02749526|Tegafur|tegafur|mesh-list
5797789|NCT02749526|Endostar protein|endostar protein|mesh-list
5797790|NCT02749526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5797791|NCT02749526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5797792|NCT02749526|Antimetabolites|antimetabolites|mesh-ancestor
5797793|NCT02749526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5797794|NCT02749526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5797795|NCT02749526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5797796|NCT02749526|Growth Substances|growth substances|mesh-ancestor
5797797|NCT02749526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797798|NCT02749526|Growth Inhibitors|growth inhibitors|mesh-ancestor
5797799|NCT02749578|Atorvastatin|atorvastatin|mesh-list
5797800|NCT02749578|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5797801|NCT02749578|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5797802|NCT02749578|Antimetabolites|antimetabolites|mesh-ancestor
5797803|NCT02749578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5797804|NCT02749578|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5797805|NCT02749578|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5797806|NCT02749578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5797807|NCT02749656|Desoximetasone|desoximetasone|mesh-list
5797808|NCT02749656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5797809|NCT02749656|Glucocorticoids|glucocorticoids|mesh-ancestor
5797810|NCT02749656|Hormones|hormones|mesh-ancestor
5797811|NCT02749656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5797812|NCT02749656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797813|NCT02749591|Botulinum Toxins|botulinum toxins|mesh-list
5797814|NCT02749591|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5797815|NCT02749591|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5797816|NCT02749591|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5797817|NCT02749591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5797818|NCT02749591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5797819|NCT02749591|Cholinergic Agents|cholinergic agents|mesh-ancestor
5641366|NCT03424525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5641367|NCT03404960|Nivolumab|nivolumab|mesh-list
5641368|NCT03404960|Ipilimumab|ipilimumab|mesh-list
5641369|NCT03404960|Niraparib|niraparib|mesh-list
5641370|NCT03404960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5641371|NCT03404960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5641372|NCT03404960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5641373|NCT03404960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641374|NCT03404960|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5641375|NCT03404960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5641376|NCT03352765|Rituximab|rituximab|mesh-list
5641377|NCT03352765|Melphalan|melphalan|mesh-list
5797820|NCT02749591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5797821|NCT02749591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797822|NCT02749591|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5797823|NCT02749591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5797824|NCT02749292|Rituximab|rituximab|mesh-list
5797825|NCT02749292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5797826|NCT02749292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5797827|NCT02749292|Immunologic Factors|immunologic factors|mesh-ancestor
5797828|NCT02749292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797829|NCT02749292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5797830|NCT02749409|Parecoxib|parecoxib|mesh-list
5797831|NCT02749409|Morphine|morphine|mesh-list
5797832|NCT02749409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5797833|NCT02749409|Narcotics|narcotics|mesh-ancestor
5797834|NCT02749409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5797835|NCT02749409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797836|NCT02749409|Analgesics|analgesics|mesh-ancestor
5797837|NCT02749409|Sensory System Agents|sensory system agents|mesh-ancestor
5797838|NCT02749409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5797839|NCT02749409|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5797840|NCT02749409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5797841|NCT02749409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5797842|NCT02749409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5797843|NCT02749409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5797844|NCT02749409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5797845|NCT02749409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5797846|NCT02749409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5899663|NCT02755272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5899664|NCT02755272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5899665|NCT02755272|Antimetabolites|antimetabolites|mesh-ancestor
5899666|NCT02755272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899667|NCT02755272|Antiviral Agents|antiviral agents|mesh-ancestor
5899668|NCT02755272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5899669|NCT02755272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5899670|NCT02755272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5899671|NCT02755272|Immunologic Factors|immunologic factors|mesh-ancestor
5899672|NCT02755272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899673|NCT02755272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5899674|NCT02707042|Amoxicillin|amoxicillin|mesh-list
5899675|NCT02707042|Azithromycin|azithromycin|mesh-list
5899676|NCT02707042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5899677|NCT02707042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5899678|NCT02603146|Hydroxychloroquine|hydroxychloroquine|mesh-list
5899679|NCT02603146|Antimalarials|antimalarials|mesh-ancestor
5899680|NCT02603146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5899681|NCT02603146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5899682|NCT02603146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5899683|NCT02603146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5899684|NCT02603146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5797847|NCT02749396|Interferons|interferons|mesh-list
5797848|NCT02749396|Interferon-beta|interferon-beta|mesh-list
5797849|NCT02749396|Interferon beta-1a|interferon beta-1a|mesh-list
5797850|NCT02749396|Interferon beta-1b|interferon beta-1b|mesh-list
5797851|NCT02749396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5797852|NCT02749396|Antiviral Agents|antiviral agents|mesh-ancestor
5797853|NCT02749396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5797854|NCT02749396|Immunologic Factors|immunologic factors|mesh-ancestor
5797855|NCT02749396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797856|NCT02749396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5797857|NCT02749123|Lidocaine|lidocaine|mesh-list
5797858|NCT02749123|Menthol|menthol|mesh-list
5797859|NCT02749123|Anesthetics, Local|anesthetics, local|mesh-ancestor
5797860|NCT02749123|Anesthetics|anesthetics|mesh-ancestor
5797861|NCT02749123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5797862|NCT02749123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797863|NCT02749123|Sensory System Agents|sensory system agents|mesh-ancestor
5797864|NCT02749123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5797865|NCT02749123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5797866|NCT02749123|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5797867|NCT02749123|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5797868|NCT02749123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5797869|NCT02749123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5797870|NCT02749123|Antipruritics|antipruritics|mesh-ancestor
5797871|NCT02749123|Dermatologic Agents|dermatologic agents|mesh-ancestor
5797872|NCT02749032|Metformin|metformin|mesh-list
5797873|NCT02749032|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5797874|NCT02749032|Vildagliptin|vildagliptin|mesh-list
5797875|NCT02749032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5797876|NCT02749032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797877|NCT02749032|Incretins|incretins|mesh-ancestor
5797878|NCT02749032|Hormones|hormones|mesh-ancestor
5797879|NCT02749032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5797880|NCT02749032|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5797881|NCT02749032|Protease Inhibitors|protease inhibitors|mesh-ancestor
5797882|NCT02749032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5797883|NCT02749032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5797884|NCT02749162|Acetaminophen|acetaminophen|mesh-list
5797885|NCT02749162|Dexamethasone|dexamethasone|mesh-list
5797886|NCT02749162|Lidocaine|lidocaine|mesh-list
5797887|NCT02749162|Morphine|morphine|mesh-list
5797888|NCT02749162|Ropivacaine|ropivacaine|mesh-list
5797889|NCT02749162|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
5797890|NCT02749162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5797891|NCT02749162|Antiemetics|antiemetics|mesh-ancestor
5797892|NCT02749162|Autonomic Agents|autonomic agents|mesh-ancestor
5797893|NCT02749162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5797894|NCT02749162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797895|NCT02749162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5797896|NCT02749162|Glucocorticoids|glucocorticoids|mesh-ancestor
5797897|NCT02749162|Hormones|hormones|mesh-ancestor
5797898|NCT02749162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5797899|NCT02749162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5797900|NCT02749162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5797901|NCT02749162|Anesthetics, Local|anesthetics, local|mesh-ancestor
5797902|NCT02749162|Anesthetics|anesthetics|mesh-ancestor
5797903|NCT02749162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5797904|NCT02749162|Sensory System Agents|sensory system agents|mesh-ancestor
5797905|NCT02749162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5797906|NCT02749162|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5797907|NCT02749162|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5797908|NCT02749162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5797909|NCT02749162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5797910|NCT02749162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5797911|NCT02749162|Narcotics|narcotics|mesh-ancestor
5797912|NCT02749162|Analgesics|analgesics|mesh-ancestor
5797913|NCT02749162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5797914|NCT02749162|Antipyretics|antipyretics|mesh-ancestor
5797915|NCT02749136|Gemcitabine|gemcitabine|mesh-list
5797916|NCT02749136|Folfirinox|folfirinox|mesh-list
5797917|NCT02749136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5797918|NCT02749136|Antimetabolites|antimetabolites|mesh-ancestor
5797919|NCT02749136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5797920|NCT02749136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5797921|NCT02749136|Antiviral Agents|antiviral agents|mesh-ancestor
5797922|NCT02749136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5797923|NCT02749136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5797924|NCT02749136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5797925|NCT02749136|Immunologic Factors|immunologic factors|mesh-ancestor
5797926|NCT02749136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797927|NCT02748707|Celecoxib|celecoxib|mesh-list
5797928|NCT02748707|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5797929|NCT02748707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5797930|NCT02748707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5797931|NCT02748707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5797932|NCT02748707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5797933|NCT02748707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5797934|NCT02748707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5797935|NCT02748707|Analgesics|analgesics|mesh-ancestor
5797936|NCT02748707|Sensory System Agents|sensory system agents|mesh-ancestor
5797937|NCT02748707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5797938|NCT02748707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797939|NCT02748707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5797940|NCT02748707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5797941|NCT02748707|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5797942|NCT02748707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5797943|NCT02748772|Thalidomide|thalidomide|mesh-list
5797944|NCT02748772|Endostar protein|endostar protein|mesh-list
5797945|NCT02748772|Endostatins|endostatins|mesh-list
5797946|NCT02748772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5797947|NCT02748772|Immunologic Factors|immunologic factors|mesh-ancestor
5797948|NCT02748772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797949|NCT02748772|Leprostatic Agents|leprostatic agents|mesh-ancestor
5797950|NCT02748772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5797951|NCT02748772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5797952|NCT02748772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5797953|NCT02748772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5797954|NCT02748772|Growth Substances|growth substances|mesh-ancestor
5797955|NCT02748772|Growth Inhibitors|growth inhibitors|mesh-ancestor
5797956|NCT02748772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5797957|NCT02748564|Aldesleukin|aldesleukin|mesh-list
5797958|NCT02748564|Pembrolizumab|pembrolizumab|mesh-list
5797959|NCT02748564|Interleukin-2|interleukin-2|mesh-list
5797960|NCT02748564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5797961|NCT02748564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5797962|NCT02748564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5797963|NCT02748564|Analgesics|analgesics|mesh-ancestor
5797964|NCT02748564|Sensory System Agents|sensory system agents|mesh-ancestor
5797965|NCT02748564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5797966|NCT02748564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797967|NCT02748564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5797968|NCT02748564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5797969|NCT02748564|Antiviral Agents|antiviral agents|mesh-ancestor
5797970|NCT02748564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5797971|NCT02748265|Epoprostenol|epoprostenol|mesh-list
5797972|NCT02748265|Phenylephrine|phenylephrine|mesh-list
6491721|NCT00604253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491722|NCT00604344|Insulin|insulin|mesh-list
6491723|NCT00604344|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6491724|NCT00604344|Insulin Detemir|insulin detemir|mesh-list
6491725|NCT00604344|Isophane Insulin, Human|isophane insulin, human|mesh-list
5797973|NCT02748265|Oxymetazoline|oxymetazoline|mesh-list
5797974|NCT02748265|Tezosentan|tezosentan|mesh-list
5797975|NCT02748265|Propofol|propofol|mesh-list
5797976|NCT02748265|Sevoflurane|sevoflurane|mesh-list
5797977|NCT02748265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5797978|NCT02748265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5797979|NCT02748265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491726|NCT00604344|Insulin, Isophane|insulin, isophane|mesh-list
6491727|NCT00604344|Isophane insulin, beef|isophane insulin, beef|mesh-list
6491728|NCT00604344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6491729|NCT00604344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491730|NCT00604357|Sirolimus|sirolimus|mesh-list
6491731|NCT00604357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6491732|NCT00604357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6491733|NCT00604357|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6491734|NCT00604357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6491735|NCT00604357|Antifungal Agents|antifungal agents|mesh-ancestor
6491736|NCT00604357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6491737|NCT00604357|Immunologic Factors|immunologic factors|mesh-ancestor
6491738|NCT00604357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491739|NCT00604396|Insulin|insulin|mesh-list
6491740|NCT00604396|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6491741|NCT00604396|Insulin Detemir|insulin detemir|mesh-list
6491742|NCT00604396|Isophane Insulin, Human|isophane insulin, human|mesh-list
6491743|NCT00604396|Insulin, Isophane|insulin, isophane|mesh-list
5797980|NCT02748265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5797981|NCT02748265|Anesthetics, General|anesthetics, general|mesh-ancestor
5797982|NCT02748265|Anesthetics|anesthetics|mesh-ancestor
5797983|NCT02748265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5797984|NCT02748265|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5797985|NCT02748265|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5797986|NCT02748265|Mydriatics|mydriatics|mesh-ancestor
5797987|NCT02748265|Autonomic Agents|autonomic agents|mesh-ancestor
5797988|NCT02748265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6491744|NCT00604396|Isophane insulin, beef|isophane insulin, beef|mesh-list
6491745|NCT00604396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6491746|NCT00604396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797989|NCT02748265|Sympathomimetics|sympathomimetics|mesh-ancestor
5797990|NCT02748265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5797991|NCT02748265|Nasal Decongestants|nasal decongestants|mesh-ancestor
5797992|NCT02748265|Respiratory System Agents|respiratory system agents|mesh-ancestor
5797993|NCT02748265|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5797994|NCT02748265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5797995|NCT02748265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5797996|NCT02748265|Adrenergic Agents|adrenergic agents|mesh-ancestor
5797997|NCT02748265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6491747|NCT00604409|Capecitabine|capecitabine|mesh-list
6491748|NCT00604409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6491749|NCT00604409|Antimetabolites|antimetabolites|mesh-ancestor
6496498|NCT00628238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5797998|NCT02748265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5797999|NCT02748265|Protective Agents|protective agents|mesh-ancestor
5798000|NCT02748265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5798001|NCT02748265|Vasodilator Agents|vasodilator agents|mesh-ancestor
5798002|NCT02748304|Aspirin|aspirin|mesh-list
5798003|NCT02748304|Sorafenib|sorafenib|mesh-list
5798004|NCT02748304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5798005|NCT02748304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5798006|NCT02748304|Analgesics|analgesics|mesh-ancestor
5798007|NCT02748304|Sensory System Agents|sensory system agents|mesh-ancestor
5798008|NCT02748304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5798009|NCT02748304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798010|NCT02748304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5798011|NCT02748304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5798012|NCT02748304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5798013|NCT02748304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5798014|NCT02748304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5798015|NCT02748304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5798016|NCT02748304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5798017|NCT02748304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5798018|NCT02748304|Antipyretics|antipyretics|mesh-ancestor
5798019|NCT02748304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5798020|NCT02748304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5798021|NCT02748395|Triamcinolone|triamcinolone|mesh-list
5798022|NCT02748395|Lidocaine|lidocaine|mesh-list
5798023|NCT02748395|Anesthetics, Local|anesthetics, local|mesh-ancestor
5798024|NCT02748395|Anesthetics|anesthetics|mesh-ancestor
5798025|NCT02748395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5798026|NCT02748395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798027|NCT02748395|Sensory System Agents|sensory system agents|mesh-ancestor
5798028|NCT02748395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5798029|NCT02748395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5798030|NCT02748395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5798031|NCT02748395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5798032|NCT02748395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5798033|NCT02748395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5798034|NCT02748395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5798035|NCT02748395|Glucocorticoids|glucocorticoids|mesh-ancestor
5798036|NCT02748395|Hormones|hormones|mesh-ancestor
5798037|NCT02748395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5798038|NCT02748330|Aspirin|aspirin|mesh-list
5798039|NCT02748330|Clopidogrel|clopidogrel|mesh-list
5798040|NCT02748330|Ticagrelor|ticagrelor|mesh-list
5798041|NCT02748330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5798042|NCT02748330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5798043|NCT02748330|Analgesics|analgesics|mesh-ancestor
5798044|NCT02748330|Sensory System Agents|sensory system agents|mesh-ancestor
5798045|NCT02748330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5798046|NCT02748330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798047|NCT02748330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5798048|NCT02748330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5798049|NCT02748330|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5798050|NCT02748330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5798051|NCT02748330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5798052|NCT02748330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5798053|NCT02748330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5798054|NCT02748330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5798055|NCT02748330|Antipyretics|antipyretics|mesh-ancestor
5798056|NCT02748330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5798057|NCT02748330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5798058|NCT02748330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5798059|NCT02748330|Purinergic Agents|purinergic agents|mesh-ancestor
5798060|NCT02748330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5798061|NCT02748135|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5798062|NCT02748135|Immunologic Factors|immunologic factors|mesh-ancestor
5798063|NCT02748135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798064|NCT02747953|Afatinib|afatinib|mesh-list
5798065|NCT02747953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5798066|NCT02747953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5798067|NCT02747953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5798068|NCT02747953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5798069|NCT02747940|Pregabalin|pregabalin|mesh-list
5798070|NCT02747940|Flunarizine|flunarizine|mesh-list
5798071|NCT02747940|Analgesics|analgesics|mesh-ancestor
5798072|NCT02747940|Sensory System Agents|sensory system agents|mesh-ancestor
5798073|NCT02747940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5798074|NCT02747940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798075|NCT02747940|Anticonvulsants|anticonvulsants|mesh-ancestor
5798076|NCT02747940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5798077|NCT02747940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5798078|NCT02747940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5798079|NCT02747940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5798080|NCT02747940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5798081|NCT02747940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5798082|NCT02747940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5798083|NCT02747940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5798084|NCT02747940|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5798085|NCT02747940|Histamine Antagonists|histamine antagonists|mesh-ancestor
5798086|NCT02747940|Histamine Agents|histamine agents|mesh-ancestor
5798087|NCT02747940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5798088|NCT02747940|Vasodilator Agents|vasodilator agents|mesh-ancestor
5798089|NCT02747732|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5798090|NCT02747732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5798091|NCT02747732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5798092|NCT02747732|Alkylating Agents|alkylating agents|mesh-ancestor
5798093|NCT02747732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5798094|NCT02747823|Bevacizumab|bevacizumab|mesh-list
5798095|NCT02747823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5798096|NCT02747823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5798097|NCT02747823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5798098|NCT02747823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5798099|NCT02747823|Growth Substances|growth substances|mesh-ancestor
5798100|NCT02747823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798101|NCT02747823|Growth Inhibitors|growth inhibitors|mesh-ancestor
5899685|NCT02603146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5899686|NCT02542657|Clarithromycin|clarithromycin|mesh-list
5899687|NCT02542657|Dexamethasone|dexamethasone|mesh-list
5899688|NCT02542657|Pomalidomide|pomalidomide|mesh-list
5899689|NCT02542657|Ixazomib|ixazomib|mesh-list
5899690|NCT02542657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5899691|NCT02542657|Antiemetics|antiemetics|mesh-ancestor
5899692|NCT02542657|Autonomic Agents|autonomic agents|mesh-ancestor
5899693|NCT02542657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5899694|NCT02542657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899695|NCT02542657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5899696|NCT02542657|Glucocorticoids|glucocorticoids|mesh-ancestor
5798102|NCT02747511|Haloperidol|haloperidol|mesh-list
5798103|NCT02747511|Haloperidol decanoate|haloperidol decanoate|mesh-list
5798104|NCT02747511|Antiemetics|antiemetics|mesh-ancestor
5798105|NCT02747511|Autonomic Agents|autonomic agents|mesh-ancestor
5798106|NCT02747511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5798107|NCT02747511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798108|NCT02747511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5798109|NCT02747511|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5798110|NCT02747511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5798111|NCT02747511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5798112|NCT02747511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5798113|NCT02747511|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5798114|NCT02747511|Dopamine Agents|dopamine agents|mesh-ancestor
5798115|NCT02747511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5798116|NCT02747511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5798117|NCT02747511|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5798118|NCT02747537|Irinotecan|irinotecan|mesh-list
5798119|NCT02747537|Sorafenib|sorafenib|mesh-list
5798120|NCT02747537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5798121|NCT02747537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5798122|NCT02747537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5798123|NCT02747537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5798124|NCT02747537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5798125|NCT02747537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5798126|NCT02747381|Alfacalcidol|alfacalcidol|mesh-list
5798127|NCT02747381|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
5798128|NCT02747381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5798129|NCT02747381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798130|NCT02747381|Vitamins|vitamins|mesh-ancestor
5798131|NCT02747381|Micronutrients|micronutrients|mesh-ancestor
5798132|NCT02747316|Iron|iron|mesh-list
5798133|NCT02747316|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5798134|NCT02747316|Trace Elements|trace elements|mesh-ancestor
5798135|NCT02747316|Micronutrients|micronutrients|mesh-ancestor
5798136|NCT02747316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798137|NCT02746848|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5798138|NCT02746848|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5798139|NCT02746744|Rituximab|rituximab|mesh-list
5798140|NCT02746744|Dimethyl Fumarate|dimethyl fumarate|mesh-list
5798141|NCT02746744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5798142|NCT02746744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5798143|NCT02746744|Immunologic Factors|immunologic factors|mesh-ancestor
5798144|NCT02746744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798145|NCT02746744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5798146|NCT02746744|Dermatologic Agents|dermatologic agents|mesh-ancestor
5798147|NCT02746744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5798148|NCT02746796|Capecitabine|capecitabine|mesh-list
5798149|NCT02746796|Tegafur|tegafur|mesh-list
5798150|NCT02746796|Oxaliplatin|oxaliplatin|mesh-list
5798151|NCT02746796|Nivolumab|nivolumab|mesh-list
5798152|NCT02746796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5798153|NCT02746796|Antimetabolites|antimetabolites|mesh-ancestor
5798154|NCT02746796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5798155|NCT02746796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5798156|NCT02746796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5798157|NCT02746796|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5798158|NCT02746783|Vaccines|vaccines|mesh-list
5798159|NCT02746783|Immunologic Factors|immunologic factors|mesh-ancestor
5798160|NCT02746783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798161|NCT02746250|Amitriptyline|amitriptyline|mesh-list
5798162|NCT02746250|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
5798163|NCT02746250|Antidepressive Agents|antidepressive agents|mesh-list
5798164|NCT02746250|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
5798165|NCT02746250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5798166|NCT02746250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5798167|NCT02746250|Analgesics|analgesics|mesh-ancestor
5798168|NCT02746250|Sensory System Agents|sensory system agents|mesh-ancestor
5798169|NCT02746250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5798170|NCT02746250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798171|NCT02746250|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5798172|NCT02746250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5798173|NCT02746250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5798174|NCT02746250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5798175|NCT02746250|Adrenergic Agents|adrenergic agents|mesh-ancestor
5798176|NCT02746250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5798177|NCT02746250|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5798178|NCT02746250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5798179|NCT02746250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5798180|NCT02746185|Heparin|heparin|mesh-list
5798181|NCT02746185|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5798182|NCT02746185|Tinzaparin|tinzaparin|mesh-list
5798183|NCT02746185|Dalteparin|dalteparin|mesh-list
5798184|NCT02746185|Rivaroxaban|rivaroxaban|mesh-list
5798185|NCT02746185|Anticoagulants|anticoagulants|mesh-ancestor
5798186|NCT02746185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5798187|NCT02746185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5798188|NCT02746185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5798189|NCT02746185|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5798190|NCT02746185|Antithrombins|antithrombins|mesh-ancestor
5798191|NCT02746185|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5798192|NCT02746185|Protease Inhibitors|protease inhibitors|mesh-ancestor
5798193|NCT02746185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5798194|NCT02746276|Metronidazole|metronidazole|mesh-list
5798195|NCT02746276|Ceftriaxone|ceftriaxone|mesh-list
5798196|NCT02746276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5798197|NCT02746276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5798198|NCT02746276|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5798199|NCT02746276|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5798200|NCT02746380|Adalimumab|adalimumab|mesh-list
5798201|NCT02746380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5798202|NCT02746380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5798203|NCT02745990|Epoetin Alfa|epoetin alfa|mesh-list
5798204|NCT02745990|Hematinics|hematinics|mesh-ancestor
5899697|NCT02542657|Hormones|hormones|mesh-ancestor
5899698|NCT02542657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5899699|NCT02542657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5899700|NCT02542657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5899701|NCT02542657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899702|NCT02542657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5899703|NCT02542657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5899704|NCT02542657|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5899705|NCT02542657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5899706|NCT02542657|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5899707|NCT02542657|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5899708|NCT02542657|Immunologic Factors|immunologic factors|mesh-ancestor
5899709|NCT02542657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5899710|NCT02542657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5899711|NCT02542657|Growth Substances|growth substances|mesh-ancestor
5899712|NCT02542657|Growth Inhibitors|growth inhibitors|mesh-ancestor
5899713|NCT02542657|Protease Inhibitors|protease inhibitors|mesh-ancestor
5899714|NCT02359513|Fluoxetine|fluoxetine|mesh-list
5899715|NCT02359513|Antidepressive Agents|antidepressive agents|mesh-list
5899716|NCT02359513|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5899717|NCT02359513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5899718|NCT02359513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5899719|NCT02359513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899720|NCT02359513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5899721|NCT02359513|Serotonin Agents|serotonin agents|mesh-ancestor
5899722|NCT02359513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899723|NCT02359513|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5899724|NCT02359513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5899725|NCT02359513|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5899726|NCT02359513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5899727|NCT02359513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5899728|NCT02267343|Nivolumab|nivolumab|mesh-list
5899729|NCT02267343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5899730|NCT02267343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5899731|NCT02267343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5899732|NCT02267343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899733|NCT02261285|Nivolumab|nivolumab|mesh-list
5899734|NCT02261285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5899735|NCT02261285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5899736|NCT02261285|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6496499|NCT00628238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5908164|NCT04860713|Anesthetics, General|anesthetics, general|mesh-ancestor
5798205|NCT02745925|Ibuprofen|ibuprofen|mesh-list
5798206|NCT02745925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5798207|NCT02745925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5798208|NCT02745925|Analgesics|analgesics|mesh-ancestor
5798209|NCT02745925|Sensory System Agents|sensory system agents|mesh-ancestor
5798210|NCT02745925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5798211|NCT02745925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798212|NCT02745925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5798213|NCT02745925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5798214|NCT02745925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5798215|NCT02745925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5798216|NCT02745925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5798217|NCT02745912|Metformin|metformin|mesh-list
5798218|NCT02745912|Naltrexone|naltrexone|mesh-list
5798219|NCT02745912|Bupropion|bupropion|mesh-list
5798220|NCT02745912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5798221|NCT02745912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798222|NCT02745912|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5798223|NCT02745912|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5798224|NCT02745912|Sensory System Agents|sensory system agents|mesh-ancestor
5798225|NCT02745912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5798226|NCT02745912|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5798227|NCT02745912|Antidepressive Agents|antidepressive agents|mesh-ancestor
5798228|NCT02745912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5798229|NCT02745912|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5798230|NCT02745912|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5798231|NCT02745912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5798232|NCT02745912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5798233|NCT02745912|Dopamine Agents|dopamine agents|mesh-ancestor
5798234|NCT02745912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5798235|NCT02745912|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5798236|NCT02745912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5798237|NCT02745912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5798238|NCT02745886|Metformin|metformin|mesh-list
5798239|NCT02745886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5798240|NCT02745886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798241|NCT02745873|Ascorbic Acid|ascorbic acid|mesh-list
5798242|NCT02745873|Vitamins|vitamins|mesh-ancestor
5798243|NCT02745873|Micronutrients|micronutrients|mesh-ancestor
5798244|NCT02745873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798245|NCT02745873|Antioxidants|antioxidants|mesh-ancestor
5798246|NCT02745873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5798247|NCT02745873|Protective Agents|protective agents|mesh-ancestor
5798248|NCT02745860|Selexipag|selexipag|mesh-list
5798249|NCT02745860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5798250|NCT02745639|Capecitabine|capecitabine|mesh-list
5798251|NCT02745639|Oxaliplatin|oxaliplatin|mesh-list
5798252|NCT02745639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5798253|NCT02745639|Antimetabolites|antimetabolites|mesh-ancestor
5798254|NCT02745639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5798255|NCT02745639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5798256|NCT02745756|Vaccines|vaccines|mesh-list
5798257|NCT02745756|Immunologic Factors|immunologic factors|mesh-ancestor
5798258|NCT02745756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798259|NCT02745717|Cyclosporine|cyclosporine|mesh-list
5798260|NCT02745717|Cyclosporins|cyclosporins|mesh-list
5798261|NCT02745717|Thymoglobulin|thymoglobulin|mesh-list
5798262|NCT02745717|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5798263|NCT02745717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5798264|NCT02745717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5798265|NCT02745717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5798266|NCT02745717|Immunologic Factors|immunologic factors|mesh-ancestor
5798267|NCT02745717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798268|NCT02745717|Antifungal Agents|antifungal agents|mesh-ancestor
5798269|NCT02745717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5798270|NCT02745717|Dermatologic Agents|dermatologic agents|mesh-ancestor
5798271|NCT02745717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5798272|NCT02745717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5798273|NCT02745691|Gefitinib|gefitinib|mesh-list
5798274|NCT02745691|Crizotinib|crizotinib|mesh-list
5798275|NCT02745691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5798276|NCT02745691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5798277|NCT02745691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5798278|NCT02745691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5798279|NCT02745561|Oxaliplatin|oxaliplatin|mesh-list
5798280|NCT02745561|Endostatins|endostatins|mesh-list
5798281|NCT02745561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5798282|NCT02745561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5798283|NCT02745561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5798284|NCT02745561|Growth Substances|growth substances|mesh-ancestor
5798285|NCT02745561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798286|NCT02745561|Growth Inhibitors|growth inhibitors|mesh-ancestor
5798287|NCT02745522|Oxytocin|oxytocin|mesh-list
5798288|NCT02745522|Oxytocics|oxytocics|mesh-ancestor
5798289|NCT02745522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5798290|NCT02745522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798291|NCT02745769|Ramucirumab|ramucirumab|mesh-list
5798292|NCT02745769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5798293|NCT02745470|Lixisenatide|lixisenatide|mesh-list
5798294|NCT02745470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5798295|NCT02745470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798296|NCT02745431|Oxytocin|oxytocin|mesh-list
5798297|NCT02745431|Oxytocics|oxytocics|mesh-ancestor
5798298|NCT02745431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5798299|NCT02745431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798300|NCT02745054|Anticoagulants|anticoagulants|mesh-list
5798301|NCT02745093|Misoprostol|misoprostol|mesh-list
5798302|NCT02745093|Mifepristone|mifepristone|mesh-list
5798303|NCT02745093|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5798304|NCT02745093|Abortifacient Agents|abortifacient agents|mesh-ancestor
5798305|NCT02745093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5798306|NCT02745093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798307|NCT02745093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5798308|NCT02745093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5798309|NCT02745093|Oxytocics|oxytocics|mesh-ancestor
5798310|NCT02745093|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5798311|NCT02745093|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5798312|NCT02745093|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5798313|NCT02745093|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5798314|NCT02745093|Contraceptive Agents|contraceptive agents|mesh-ancestor
5798315|NCT02745093|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5798316|NCT02745093|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5798317|NCT02745093|Hormone Antagonists|hormone antagonists|mesh-ancestor
5798318|NCT02745093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5798319|NCT02745093|Luteolytic Agents|luteolytic agents|mesh-ancestor
5798320|NCT02745093|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5798321|NCT02745093|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5798322|NCT02744690|Mitomycins|mitomycins|mesh-list
5798323|NCT02744690|Mitomycin|mitomycin|mesh-list
5798324|NCT02744690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5798325|NCT02744690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5798326|NCT02744690|Alkylating Agents|alkylating agents|mesh-ancestor
5798327|NCT02744690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5798328|NCT02744690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5798329|NCT02744690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5798330|NCT02744976|Metformin|metformin|mesh-list
5798331|NCT02744976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5798332|NCT02744976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798333|NCT02744729|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
5798334|NCT02744729|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5798335|NCT02744729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5798336|NCT02744716|Aspirin|aspirin|mesh-list
5798337|NCT02744716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5798338|NCT02744716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5798339|NCT02744716|Analgesics|analgesics|mesh-ancestor
5798340|NCT02744716|Sensory System Agents|sensory system agents|mesh-ancestor
5798341|NCT02744716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5798342|NCT02744716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798343|NCT02744716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5798344|NCT02744716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5798345|NCT02744716|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5798346|NCT02744716|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5798347|NCT02744716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5798348|NCT02744716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5798349|NCT02744716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5798350|NCT02744716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5798351|NCT02744716|Antipyretics|antipyretics|mesh-ancestor
5798352|NCT02744768|Dasatinib|dasatinib|mesh-list
5798353|NCT02744768|Blinatumomab|blinatumomab|mesh-list
5798354|NCT02744768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5798355|NCT02744768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5798356|NCT02744768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5798357|NCT02744768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5798358|NCT02744872|Felodipine|felodipine|mesh-list
5798359|NCT02744872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5798360|NCT02744872|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5798361|NCT02744872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5798362|NCT02744872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5798363|NCT02744872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5798364|NCT02744872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5798365|NCT02744872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798366|NCT02744872|Vasodilator Agents|vasodilator agents|mesh-ancestor
5798367|NCT02744703|Capecitabine|capecitabine|mesh-list
5798368|NCT02744703|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5798369|NCT02744703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5798370|NCT02744703|Antimetabolites|antimetabolites|mesh-ancestor
5798371|NCT02744703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5798372|NCT02744703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5798373|NCT02744638|Metronidazole|metronidazole|mesh-list
5798374|NCT02744638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5798375|NCT02744638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5798376|NCT02744638|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5798377|NCT02744638|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5798378|NCT02744937|Aspirin|aspirin|mesh-list
5908165|NCT04860713|Anesthetics|anesthetics|mesh-ancestor
5798379|NCT02744937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5798380|NCT02744937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5798381|NCT02744937|Analgesics|analgesics|mesh-ancestor
5798382|NCT02744937|Sensory System Agents|sensory system agents|mesh-ancestor
5798383|NCT02744937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5798384|NCT02744937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798385|NCT02744937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5798386|NCT02744937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5798387|NCT02744937|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5798388|NCT02744937|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5798389|NCT02744937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5798390|NCT02744937|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5798391|NCT02744937|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5798392|NCT02744937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5798393|NCT02744937|Antipyretics|antipyretics|mesh-ancestor
5798394|NCT02744612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5798395|NCT02744612|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5798396|NCT02744612|Antibodies|antibodies|mesh-list
5798397|NCT02744612|Immunoglobulins|immunoglobulins|mesh-list
5798398|NCT02744612|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5798399|NCT02744612|Immunoconjugates|immunoconjugates|mesh-list
5798400|NCT02744612|Immunologic Factors|immunologic factors|mesh-ancestor
5798401|NCT02744612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798402|NCT02744612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5798403|NCT02744625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
5798404|NCT02744625|Propofol|propofol|mesh-list
5798405|NCT02744625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5798406|NCT02744625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5798407|NCT02744625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798408|NCT02744625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5798409|NCT02744625|Anesthetics, General|anesthetics, general|mesh-ancestor
5798410|NCT02744625|Anesthetics|anesthetics|mesh-ancestor
5899737|NCT02261285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899738|NCT02256800|Leucovorin|leucovorin|mesh-list
5899739|NCT02256800|Bevacizumab|bevacizumab|mesh-list
5899740|NCT02256800|Irinotecan|irinotecan|mesh-list
5899741|NCT02256800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5899742|NCT02256800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5899743|NCT02256800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5899744|NCT02256800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5899745|NCT02256800|Growth Substances|growth substances|mesh-ancestor
5899746|NCT02256800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899747|NCT02256800|Growth Inhibitors|growth inhibitors|mesh-ancestor
5899748|NCT02256800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5899749|NCT02256800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5899750|NCT02256800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5798411|NCT02744417|Bupropion|bupropion|mesh-list
5798412|NCT02744417|Nicotine|nicotine|mesh-list
5798413|NCT02744417|Varenicline|varenicline|mesh-list
5798414|NCT02744417|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5798415|NCT02744417|Autonomic Agents|autonomic agents|mesh-ancestor
5798416|NCT02744417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5798417|NCT02744417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798418|NCT02744417|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5798419|NCT02744417|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5798420|NCT02744417|Cholinergic Agents|cholinergic agents|mesh-ancestor
5798421|NCT02744417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5798422|NCT02744417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5798423|NCT02744417|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5798424|NCT02744417|Antidepressive Agents|antidepressive agents|mesh-ancestor
5798425|NCT02744417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5798426|NCT02744417|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5798427|NCT02744417|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5798428|NCT02744417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5798429|NCT02744417|Dopamine Agents|dopamine agents|mesh-ancestor
5798430|NCT02744417|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5798431|NCT02744417|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5798432|NCT02744417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5798433|NCT02744339|Riociguat|riociguat|mesh-list
5798434|NCT02744339|Enzyme Activators|enzyme activators|mesh-ancestor
5798435|NCT02744339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5798436|NCT02744430|Mirabegron|mirabegron|mesh-list
5798437|NCT02744430|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
5798438|NCT02744430|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5798439|NCT02744430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5798440|NCT02744430|Adrenergic Agents|adrenergic agents|mesh-ancestor
5798441|NCT02744430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5798442|NCT02744430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5798443|NCT02744430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798444|NCT02744430|Urological Agents|urological agents|mesh-ancestor
5798445|NCT02744508|Dexamethasone|dexamethasone|mesh-list
5798446|NCT02744508|Palonosetron|palonosetron|mesh-list
5798447|NCT02744508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5798448|NCT02744508|Antiemetics|antiemetics|mesh-ancestor
5798449|NCT02744508|Autonomic Agents|autonomic agents|mesh-ancestor
5798450|NCT02744508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5798451|NCT02744508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798452|NCT02744508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5798453|NCT02744508|Glucocorticoids|glucocorticoids|mesh-ancestor
5798454|NCT02744508|Hormones|hormones|mesh-ancestor
5798455|NCT02744508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5798456|NCT02744508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5798457|NCT02744508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5798458|NCT02744508|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5798459|NCT02744508|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5798460|NCT02744508|Serotonin Agents|serotonin agents|mesh-ancestor
5798461|NCT02744508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5798462|NCT02744508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5798463|NCT02744378|Clobetasol|clobetasol|mesh-list
5798464|NCT02744378|Tacrolimus|tacrolimus|mesh-list
5798465|NCT02744378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5798466|NCT02744378|Immunologic Factors|immunologic factors|mesh-ancestor
5798467|NCT02744378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798468|NCT02744378|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5798469|NCT02744378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5798470|NCT02744378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5798471|NCT02744378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5798472|NCT02744378|Glucocorticoids|glucocorticoids|mesh-ancestor
5798473|NCT02744378|Hormones|hormones|mesh-ancestor
5798474|NCT02744378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5798475|NCT02744456|Losartan|losartan|mesh-list
5798476|NCT02744456|Amlodipine|amlodipine|mesh-list
5798477|NCT02744456|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5798478|NCT02744456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5798479|NCT02744456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5798480|NCT02744456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5798481|NCT02744456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5798482|NCT02744456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5798483|NCT02744456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798484|NCT02744456|Vasodilator Agents|vasodilator agents|mesh-ancestor
5798485|NCT02744456|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5798486|NCT02744456|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5798487|NCT02744456|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5798488|NCT02744456|Diuretics|diuretics|mesh-ancestor
5798489|NCT02744456|Natriuretic Agents|natriuretic agents|mesh-ancestor
5798490|NCT02744456|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5798491|NCT02744222|Interferons|interferons|mesh-list
5798492|NCT02744222|Interferon-beta|interferon-beta|mesh-list
5798493|NCT02744222|Interferon beta-1a|interferon beta-1a|mesh-list
5798494|NCT02744222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5798495|NCT02744222|Antiviral Agents|antiviral agents|mesh-ancestor
5798496|NCT02744222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5798497|NCT02744222|Immunologic Factors|immunologic factors|mesh-ancestor
5798498|NCT02744222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798499|NCT02744222|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5798500|NCT02744482|Risedronic Acid|risedronic acid|mesh-list
5798501|NCT02744482|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5798502|NCT02744482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6673966|NCT01566565|Bambuterol|bambuterol|mesh-list
5798503|NCT02744482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5798504|NCT02744482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5798505|NCT02744482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798506|NCT02744482|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5798507|NCT02744495|Betamethasone|betamethasone|mesh-list
5798508|NCT02744495|Droperidol|droperidol|mesh-list
5798509|NCT02744495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5798510|NCT02744495|Glucocorticoids|glucocorticoids|mesh-ancestor
5798511|NCT02744495|Hormones|hormones|mesh-ancestor
5798512|NCT02744495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5798513|NCT02744495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798514|NCT02744495|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5798515|NCT02744495|Respiratory System Agents|respiratory system agents|mesh-ancestor
5798516|NCT02744495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5798517|NCT02744495|Antiemetics|antiemetics|mesh-ancestor
5798518|NCT02744495|Autonomic Agents|autonomic agents|mesh-ancestor
5798519|NCT02744495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5798520|NCT02744495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5798521|NCT02744495|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6491750|NCT00604409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491751|NCT00604409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6491752|NCT00604435|Docetaxel|docetaxel|mesh-list
6491753|NCT00604435|Epirubicin|epirubicin|mesh-list
6491754|NCT00604435|Endostatins|endostatins|mesh-list
6491755|NCT00604435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5798522|NCT02744495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5798523|NCT02744495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5798524|NCT02744495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5798525|NCT02744495|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5798526|NCT02744495|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5798527|NCT02744495|Dopamine Agents|dopamine agents|mesh-ancestor
5798528|NCT02744495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5798529|NCT02744495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5798530|NCT02744196|Methotrexate|methotrexate|mesh-list
5798531|NCT02744196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5798532|NCT02744196|Immunologic Factors|immunologic factors|mesh-ancestor
5798533|NCT02744196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798534|NCT02744196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5798535|NCT02744196|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5798536|NCT02744196|Abortifacient Agents|abortifacient agents|mesh-ancestor
5798537|NCT02744196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6491756|NCT00604435|Tubulin Modulators|tubulin modulators|mesh-ancestor
6491757|NCT00604435|Antimitotic Agents|antimitotic agents|mesh-ancestor
6491758|NCT00604435|Mitosis Modulators|mitosis modulators|mesh-ancestor
6491759|NCT00604435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491760|NCT00604435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6491761|NCT00604435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6491762|NCT00604435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6491763|NCT00604435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6491764|NCT00604435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5798538|NCT02744196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5798539|NCT02744196|Antimetabolites|antimetabolites|mesh-ancestor
5798540|NCT02744196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5798541|NCT02744196|Dermatologic Agents|dermatologic agents|mesh-ancestor
5798542|NCT02744196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5798543|NCT02744196|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5798544|NCT02744196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6491765|NCT00604435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5798545|NCT02744196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5798546|NCT02744183|Benzocaine|benzocaine|mesh-list
5798547|NCT02744183|Anesthetics, Local|anesthetics, local|mesh-ancestor
5798548|NCT02744183|Anesthetics|anesthetics|mesh-ancestor
5798549|NCT02744183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5798550|NCT02744183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798551|NCT02744183|Sensory System Agents|sensory system agents|mesh-ancestor
5798552|NCT02744183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5798553|NCT02744131|Metformin|metformin|mesh-list
5798554|NCT02744131|Cyproterone Acetate|cyproterone acetate|mesh-list
5798555|NCT02744131|Contraceptive Agents|contraceptive agents|mesh-list
5798556|NCT02744131|Contraceptives, Oral|contraceptives, oral|mesh-list
5798557|NCT02744131|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
5798558|NCT02744131|Estradiol|estradiol|mesh-list
5798559|NCT02744131|Cyproterone|cyproterone|mesh-list
6491766|NCT00604435|Growth Substances|growth substances|mesh-ancestor
6491767|NCT00604435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491768|NCT00604435|Growth Inhibitors|growth inhibitors|mesh-ancestor
6491769|NCT00604578|Pioglitazone|pioglitazone|mesh-list
6491770|NCT00604578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6491771|NCT00604578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491772|NCT00604591|Tolcapone|tolcapone|mesh-list
6491773|NCT00604591|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6491774|NCT00604591|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6491775|NCT00604591|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6491776|NCT00604591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6491777|NCT00604591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491778|NCT00604630|Epoetin Alfa|epoetin alfa|mesh-list
6491779|NCT00604630|Hematinics|hematinics|mesh-ancestor
6491780|NCT00604656|Insulin Aspart|insulin aspart|mesh-list
6491781|NCT00604656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6491782|NCT00604656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491783|NCT00604682|Apremilast|apremilast|mesh-list
6210986|NCT02167451|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6212615|NCT02191397|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5798560|NCT02744131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5798561|NCT02744131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798562|NCT02744131|Estrogens|estrogens|mesh-ancestor
5798563|NCT02744131|Hormones|hormones|mesh-ancestor
5798564|NCT02744131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5798565|NCT02744131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5798566|NCT02744131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5798567|NCT02744131|Androgen Antagonists|androgen antagonists|mesh-ancestor
5798568|NCT02744131|Hormone Antagonists|hormone antagonists|mesh-ancestor
5798569|NCT02744131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5798570|NCT02744131|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5798571|NCT02743975|Bevacizumab|bevacizumab|mesh-list
5798572|NCT02743975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5798573|NCT02743975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5798574|NCT02743975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5798575|NCT02743975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5798576|NCT02743975|Growth Substances|growth substances|mesh-ancestor
5798577|NCT02743975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798578|NCT02743975|Growth Inhibitors|growth inhibitors|mesh-ancestor
5798579|NCT02743741|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
5798580|NCT02743741|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5798581|NCT02743741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5798582|NCT02743819|Pembrolizumab|pembrolizumab|mesh-list
5798583|NCT02743819|Ipilimumab|ipilimumab|mesh-list
5798584|NCT02743819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5798585|NCT02743819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5798586|NCT02743819|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5798587|NCT02743819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5798588|NCT02743663|Albuterol|albuterol|mesh-list
5798589|NCT02743663|Bronchodilator Agents|bronchodilator agents|mesh-list
5798590|NCT02743663|Autonomic Agents|autonomic agents|mesh-ancestor
5798591|NCT02743663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5798592|NCT02743663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798593|NCT02743663|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5798594|NCT02743663|Respiratory System Agents|respiratory system agents|mesh-ancestor
5798595|NCT02743663|Tocolytic Agents|tocolytic agents|mesh-ancestor
5798596|NCT02743663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5798597|NCT02743663|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5798598|NCT02743663|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5798599|NCT02743663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5798600|NCT02743663|Adrenergic Agents|adrenergic agents|mesh-ancestor
5798601|NCT02743663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5798602|NCT02743663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5798603|NCT02743572|Iron|iron|mesh-list
5798604|NCT02743572|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
5798605|NCT02743572|Trace Elements|trace elements|mesh-ancestor
5798606|NCT02743572|Micronutrients|micronutrients|mesh-ancestor
5798607|NCT02743572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798608|NCT02743572|Hematinics|hematinics|mesh-ancestor
5798609|NCT02743806|Vedolizumab|vedolizumab|mesh-list
5798610|NCT02743806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5798611|NCT02743598|Liraglutide|liraglutide|mesh-list
5798612|NCT02743598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5798613|NCT02743598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798614|NCT02743598|Incretins|incretins|mesh-ancestor
5798615|NCT02743598|Hormones|hormones|mesh-ancestor
5798616|NCT02743598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5798617|NCT02743260|Metformin|metformin|mesh-list
5798618|NCT02743260|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5798619|NCT02743260|Adefovir|adefovir|mesh-list
5798620|NCT02743260|Digoxin|digoxin|mesh-list
5798621|NCT02743260|Pitavastatin|pitavastatin|mesh-list
5798622|NCT02743260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5798623|NCT02743260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798624|NCT02743260|Incretins|incretins|mesh-ancestor
5798625|NCT02743260|Hormones|hormones|mesh-ancestor
5798626|NCT02743260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5798627|NCT02743260|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5798628|NCT02743260|Protease Inhibitors|protease inhibitors|mesh-ancestor
5798629|NCT02743260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5798630|NCT02743260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5798631|NCT02743260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5798632|NCT02743260|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5798633|NCT02743260|Protective Agents|protective agents|mesh-ancestor
5798634|NCT02743260|Antiviral Agents|antiviral agents|mesh-ancestor
5798635|NCT02743260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5798636|NCT02743260|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5798637|NCT02743260|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5798638|NCT02743260|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5798639|NCT02743260|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5798640|NCT02743260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5798641|NCT02743260|Antimetabolites|antimetabolites|mesh-ancestor
5798642|NCT02743260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5798643|NCT02743455|Vaccines|vaccines|mesh-list
5798644|NCT02743455|Immunologic Factors|immunologic factors|mesh-ancestor
5798645|NCT02743455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798646|NCT02743182|Interferons|interferons|mesh-list
5798647|NCT02743182|Interferon-alpha|interferon-alpha|mesh-list
5798648|NCT02743182|Interferon alpha-2|interferon alpha-2|mesh-list
5798649|NCT02743182|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5798650|NCT02743182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5798651|NCT02743182|Antiviral Agents|antiviral agents|mesh-ancestor
5798652|NCT02743182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5798653|NCT02743182|Immunologic Factors|immunologic factors|mesh-ancestor
5798654|NCT02743182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798655|NCT02743429|Dinutuximab|dinutuximab|mesh-list
5798656|NCT02743429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5798657|NCT02743234|Vancomycin|vancomycin|mesh-list
5798658|NCT02743234|Fidaxomicin|fidaxomicin|mesh-list
5798659|NCT02743234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5798660|NCT02743234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5798661|NCT02743247|Mycophenolic Acid|mycophenolic acid|mesh-list
5798662|NCT02743247|Tacrolimus|tacrolimus|mesh-list
5798663|NCT02743247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5798664|NCT02743247|Immunologic Factors|immunologic factors|mesh-ancestor
5798665|NCT02743247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798666|NCT02743247|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5798667|NCT02743247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5798668|NCT02743247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5798669|NCT02743247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5798670|NCT02743247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5798671|NCT02743247|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5798672|NCT02743247|Antitubercular Agents|antitubercular agents|mesh-ancestor
5798673|NCT02743247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5798674|NCT02743247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5798675|NCT02743390|Infliximab|infliximab|mesh-list
5798676|NCT02743390|Dermatologic Agents|dermatologic agents|mesh-ancestor
5798677|NCT02743390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5798678|NCT02743390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5798679|NCT02743104|Lidocaine|lidocaine|mesh-list
5798680|NCT02743104|Atropine|atropine|mesh-list
5798681|NCT02743104|Midazolam|midazolam|mesh-list
5798682|NCT02743104|Ketamine|ketamine|mesh-list
5798683|NCT02743104|Propofol|propofol|mesh-list
5798684|NCT02743104|Anesthetics, Local|anesthetics, local|mesh-ancestor
5798685|NCT02743104|Anesthetics|anesthetics|mesh-ancestor
5798686|NCT02743104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5798687|NCT02743104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798688|NCT02743104|Sensory System Agents|sensory system agents|mesh-ancestor
5798689|NCT02743104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5798690|NCT02743104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5798691|NCT02743104|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5798692|NCT02743104|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5798693|NCT02743104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5798694|NCT02743104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5798695|NCT02743104|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5798696|NCT02743104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5798697|NCT02743104|Anesthetics, General|anesthetics, general|mesh-ancestor
5798698|NCT02743104|Analgesics|analgesics|mesh-ancestor
5798699|NCT02743104|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5798700|NCT02743104|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5798701|NCT02743104|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5798702|NCT02743104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5798703|NCT02743104|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5798704|NCT02743104|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5798705|NCT02743104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5798706|NCT02743104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5798707|NCT02743104|GABA Modulators|gaba modulators|mesh-ancestor
5798708|NCT02743104|GABA Agents|gaba agents|mesh-ancestor
5798709|NCT02743104|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5798710|NCT02743104|Autonomic Agents|autonomic agents|mesh-ancestor
5798711|NCT02743104|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5798712|NCT02743104|Respiratory System Agents|respiratory system agents|mesh-ancestor
5798713|NCT02743104|Mydriatics|mydriatics|mesh-ancestor
5798714|NCT02743104|Parasympatholytics|parasympatholytics|mesh-ancestor
5798715|NCT02743104|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5798716|NCT02743104|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5798717|NCT02743104|Cholinergic Agents|cholinergic agents|mesh-ancestor
5798718|NCT02743065|Doxorubicin|doxorubicin|mesh-list
5798719|NCT02743065|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5798720|NCT02743065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5798721|NCT02743065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5798722|NCT02743065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5798723|NCT02743065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5798724|NCT02743065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5798725|NCT02742909|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
5798726|NCT02742909|Natriuretic Agents|natriuretic agents|mesh-ancestor
5798727|NCT02742909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899751|NCT02256800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899752|NCT02256800|Antidotes|antidotes|mesh-ancestor
5899753|NCT02256800|Protective Agents|protective agents|mesh-ancestor
5899754|NCT02256800|Vitamin B Complex|vitamin b complex|mesh-ancestor
5899755|NCT02256800|Vitamins|vitamins|mesh-ancestor
5899756|NCT02256800|Micronutrients|micronutrients|mesh-ancestor
5899757|NCT02203682|Doxycycline|doxycycline|mesh-list
5899758|NCT02203682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5899759|NCT02203682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5899760|NCT02203682|Antimalarials|antimalarials|mesh-ancestor
5899761|NCT02203682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5899762|NCT02203682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5899763|NCT02116335|Bosentan|bosentan|mesh-list
5899764|NCT02116335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5899765|NCT02116335|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5899766|NCT02116335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899767|NCT01903486|Prednisone|prednisone|mesh-list
5899768|NCT01903486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5899769|NCT01903486|Glucocorticoids|glucocorticoids|mesh-ancestor
5899770|NCT01903486|Hormones|hormones|mesh-ancestor
5899771|NCT01903486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5899772|NCT01903486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899773|NCT01903486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5899774|NCT01903486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6673967|NCT01566565|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6673968|NCT01566565|Autonomic Agents|autonomic agents|mesh-ancestor
6673969|NCT01566565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6673970|NCT01566565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673971|NCT01566565|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6673972|NCT01566565|Respiratory System Agents|respiratory system agents|mesh-ancestor
6673973|NCT01566565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6673974|NCT01566565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5899775|NCT01811368|Cyclosporine|cyclosporine|mesh-list
5899776|NCT01811368|Mycophenolic Acid|mycophenolic acid|mesh-list
5899777|NCT01811368|Rituximab|rituximab|mesh-list
5899778|NCT01811368|Cyclosporins|cyclosporins|mesh-list
5899779|NCT01811368|Thymoglobulin|thymoglobulin|mesh-list
5899780|NCT01811368|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5899781|NCT01811368|Immunoglobulins|immunoglobulins|mesh-list
5899782|NCT01811368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5899783|NCT01811368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5899784|NCT01811368|Immunologic Factors|immunologic factors|mesh-ancestor
5899785|NCT01811368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899786|NCT01811368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5899787|NCT01811368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5899788|NCT01811368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899789|NCT01811368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5798728|NCT02742948|Ceftriaxone|ceftriaxone|mesh-list
5798729|NCT02742948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5798730|NCT02742948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5798731|NCT02742675|Leuprolide|leuprolide|mesh-list
5798732|NCT02742675|Goserelin|goserelin|mesh-list
5798733|NCT02742675|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5798734|NCT02742675|Flutamide|flutamide|mesh-list
5798735|NCT02742675|Bicalutamide|bicalutamide|mesh-list
5798736|NCT02742675|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5798737|NCT02742675|Fertility Agents|fertility agents|mesh-ancestor
5798738|NCT02742675|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5798739|NCT02742675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798740|NCT02742675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5798741|NCT02742675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5798742|NCT02742675|Androgen Antagonists|androgen antagonists|mesh-ancestor
5798743|NCT02742675|Hormone Antagonists|hormone antagonists|mesh-ancestor
5798744|NCT02742675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5798745|NCT02742675|Luteolytic Agents|luteolytic agents|mesh-ancestor
5798746|NCT02742675|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5798747|NCT02742675|Contraceptive Agents|contraceptive agents|mesh-ancestor
5798748|NCT02742675|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5798749|NCT02742805|Vitamin D|vitamin d|mesh-list
5798750|NCT02742805|Ergocalciferols|ergocalciferols|mesh-list
5798751|NCT02742805|Vitamins|vitamins|mesh-list
5798752|NCT02742805|Omalizumab|omalizumab|mesh-list
5798753|NCT02742805|Micronutrients|micronutrients|mesh-ancestor
5798754|NCT02742805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798755|NCT02742805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5798756|NCT02742805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5798757|NCT02742805|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5798758|NCT02742805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5798759|NCT02742805|Respiratory System Agents|respiratory system agents|mesh-ancestor
5798760|NCT02742623|Rivaroxaban|rivaroxaban|mesh-list
5798761|NCT02742623|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5798762|NCT02742623|Antithrombins|antithrombins|mesh-ancestor
5798763|NCT02742623|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5798764|NCT02742623|Protease Inhibitors|protease inhibitors|mesh-ancestor
5798765|NCT02742623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5798766|NCT02742623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5798767|NCT02742623|Anticoagulants|anticoagulants|mesh-ancestor
5798768|NCT02742285|Lumefantrine|lumefantrine|mesh-list
5798769|NCT02742285|Artemether|artemether|mesh-list
5798770|NCT02742285|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
5798771|NCT02742285|Antimalarials|antimalarials|mesh-ancestor
5798772|NCT02742285|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5798773|NCT02742285|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5798774|NCT02742285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5798775|NCT02742480|Dabigatran|dabigatran|mesh-list
5798776|NCT02742480|Acenocoumarol|acenocoumarol|mesh-list
5798777|NCT02742480|Antithrombins|antithrombins|mesh-ancestor
5798778|NCT02742480|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5798779|NCT02742480|Protease Inhibitors|protease inhibitors|mesh-ancestor
5798780|NCT02742480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5798781|NCT02742480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5798782|NCT02742480|Anticoagulants|anticoagulants|mesh-ancestor
5798783|NCT02742324|Interferon-alpha|interferon-alpha|mesh-list
6673975|NCT01566565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673976|NCT01566565|Vasodilator Agents|vasodilator agents|mesh-ancestor
6673977|NCT01566565|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6673978|NCT01566565|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6673979|NCT01566565|Purinergic Agents|purinergic agents|mesh-ancestor
6673980|NCT01566565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6673981|NCT01566578|Mitogens|mitogens|mesh-list
6673982|NCT01566578|Mitosis Modulators|mitosis modulators|mesh-ancestor
6673983|NCT01566578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673984|NCT01566643|Metronidazole|metronidazole|mesh-list
6673985|NCT01566643|Rabeprazole|rabeprazole|mesh-list
6673986|NCT01566643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6673987|NCT01566643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6673988|NCT01566643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6673989|NCT01566643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6673990|NCT01566643|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6673991|NCT01566643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5798784|NCT02742324|Interferon alpha-2|interferon alpha-2|mesh-list
5798785|NCT02742324|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
5798786|NCT02742324|Antiviral Agents|antiviral agents|mesh-ancestor
5798787|NCT02742324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5798788|NCT02742324|Immunologic Factors|immunologic factors|mesh-ancestor
5798789|NCT02742324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798790|NCT02742324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5798791|NCT02742233|Saxagliptin|saxagliptin|mesh-list
5798792|NCT02742233|Incretins|incretins|mesh-ancestor
5798793|NCT02742233|Hormones|hormones|mesh-ancestor
5798794|NCT02742233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5798795|NCT02742233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798796|NCT02742233|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5798797|NCT02742233|Protease Inhibitors|protease inhibitors|mesh-ancestor
5798798|NCT02742233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5798799|NCT02742233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5798800|NCT02742233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5798801|NCT02742467|Amlodipine|amlodipine|mesh-list
5798802|NCT02742467|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5798803|NCT02742467|Perindopril|perindopril|mesh-list
5798804|NCT02742467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5798805|NCT02742467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5798806|NCT02742467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5798807|NCT02742467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5798808|NCT02742467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5798809|NCT02742467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798810|NCT02742467|Vasodilator Agents|vasodilator agents|mesh-ancestor
5798811|NCT02742467|Diuretics|diuretics|mesh-ancestor
5798812|NCT02742467|Natriuretic Agents|natriuretic agents|mesh-ancestor
5798813|NCT02742467|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5798814|NCT02742467|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5798815|NCT02742467|Protease Inhibitors|protease inhibitors|mesh-ancestor
5798816|NCT02742467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5798817|NCT02742181|Alvimopan|alvimopan|mesh-list
5798818|NCT02742181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5798819|NCT02742142|Fluorides|fluorides|mesh-list
5798820|NCT02742142|Cariostatic Agents|cariostatic agents|mesh-ancestor
5798821|NCT02742142|Protective Agents|protective agents|mesh-ancestor
5798822|NCT02742142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798823|NCT02742168|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
5798824|NCT02742168|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5798825|NCT02742168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5798826|NCT02742051|Cyclophosphamide|cyclophosphamide|mesh-list
5798827|NCT02742051|Fluorouracil|fluorouracil|mesh-list
5798828|NCT02742051|Everolimus|everolimus|mesh-list
5798829|NCT02742051|Letrozole|letrozole|mesh-list
5798830|NCT02742051|Epirubicin|epirubicin|mesh-list
5798831|NCT02742051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5798832|NCT02742051|Immunologic Factors|immunologic factors|mesh-ancestor
5798833|NCT02742051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798834|NCT02742051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5798835|NCT02742051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5798836|NCT02742051|Alkylating Agents|alkylating agents|mesh-ancestor
6673992|NCT01566643|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6673993|NCT01566643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6673994|NCT01566643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6673995|NCT01566656|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6673996|NCT01566656|Immunologic Factors|immunologic factors|mesh-ancestor
6673997|NCT01566656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6673998|NCT01566656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6673999|NCT01566669|Parecoxib|parecoxib|mesh-list
5798837|NCT02742051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5798838|NCT02742051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5798839|NCT02742051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5798840|NCT02742051|Antimetabolites|antimetabolites|mesh-ancestor
5798841|NCT02742051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5798842|NCT02742051|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5798843|NCT02742051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5798844|NCT02742051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5798845|NCT02742051|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5798846|NCT02742051|Hormone Antagonists|hormone antagonists|mesh-ancestor
5798847|NCT02742051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5798848|NCT02742051|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5798849|NCT02742051|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5798850|NCT02742051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5798851|NCT02742038|Fluorides|fluorides|mesh-list
5798852|NCT02742038|Fluorides, Topical|fluorides, topical|mesh-list
5798853|NCT02742038|Cariostatic Agents|cariostatic agents|mesh-ancestor
5798854|NCT02742038|Protective Agents|protective agents|mesh-ancestor
5798855|NCT02742038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798856|NCT02741947|Levodopa|levodopa|mesh-list
5798857|NCT02741947|Benserazide|benserazide|mesh-list
5798858|NCT02741947|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
5798859|NCT02741947|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5798860|NCT02741947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5798861|NCT02741947|Dopamine Agents|dopamine agents|mesh-ancestor
5798862|NCT02741947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5798863|NCT02741947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5798864|NCT02741947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798865|NCT02741947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5798866|NCT02741960|Metformin|metformin|mesh-list
5798867|NCT02741960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5798868|NCT02741960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798869|NCT02741817|Aspirin|aspirin|mesh-list
5798870|NCT02741817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5798871|NCT02741817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5798872|NCT02741817|Analgesics|analgesics|mesh-ancestor
5798873|NCT02741817|Sensory System Agents|sensory system agents|mesh-ancestor
5798874|NCT02741817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5798875|NCT02741817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798876|NCT02741817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5798877|NCT02741817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5798878|NCT02741817|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5798879|NCT02741817|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5798880|NCT02741817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5798881|NCT02741817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5798882|NCT02741817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5798883|NCT02741817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5798884|NCT02741817|Antipyretics|antipyretics|mesh-ancestor
5798885|NCT02741856|Paclitaxel|paclitaxel|mesh-list
5798886|NCT02741856|Carboplatin|carboplatin|mesh-list
5798887|NCT02741856|Capecitabine|capecitabine|mesh-list
5798888|NCT02741856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5798889|NCT02741856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5798890|NCT02741856|Tubulin Modulators|tubulin modulators|mesh-ancestor
5798891|NCT02741856|Antimitotic Agents|antimitotic agents|mesh-ancestor
5641378|NCT03352765|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5641379|NCT03352765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5641380|NCT03352765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5641381|NCT03352765|Immunologic Factors|immunologic factors|mesh-ancestor
5641382|NCT03352765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641383|NCT03352765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5641384|NCT03352765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5641385|NCT03352765|Alkylating Agents|alkylating agents|mesh-ancestor
5641386|NCT03352765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641387|NCT03352765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5641388|NCT03352765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5641389|NCT03300544|Leucovorin|leucovorin|mesh-list
5641390|NCT03300544|Fluorouracil|fluorouracil|mesh-list
5641391|NCT03300544|Capecitabine|capecitabine|mesh-list
5641392|NCT03300544|Oxaliplatin|oxaliplatin|mesh-list
5641393|NCT03300544|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
5641394|NCT03300544|Antimetabolites|antimetabolites|mesh-ancestor
5641395|NCT03300544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641396|NCT03300544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5641397|NCT03300544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5641398|NCT03300544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5641399|NCT03300544|Immunologic Factors|immunologic factors|mesh-ancestor
5798892|NCT02741856|Mitosis Modulators|mitosis modulators|mesh-ancestor
5798893|NCT02741856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5798894|NCT02741856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5798895|NCT02741856|Antimetabolites|antimetabolites|mesh-ancestor
5798896|NCT02741232|Lidocaine|lidocaine|mesh-list
5798897|NCT02741232|Epinephrine|epinephrine|mesh-list
5798898|NCT02741232|Racepinephrine|racepinephrine|mesh-list
5798899|NCT02741232|Epinephryl borate|epinephryl borate|mesh-list
5798900|NCT02741232|Anesthetics, Local|anesthetics, local|mesh-ancestor
5798901|NCT02741232|Anesthetics|anesthetics|mesh-ancestor
5798902|NCT02741232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5798903|NCT02741232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798904|NCT02741232|Sensory System Agents|sensory system agents|mesh-ancestor
5798905|NCT02741232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5798906|NCT02741232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5798907|NCT02741232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5798908|NCT02741232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5798909|NCT02741232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5798910|NCT02741232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5798911|NCT02741232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5798912|NCT02741232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5798913|NCT02741232|Adrenergic Agents|adrenergic agents|mesh-ancestor
5798914|NCT02741232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5798915|NCT02741232|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5798916|NCT02741232|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5798917|NCT02741232|Autonomic Agents|autonomic agents|mesh-ancestor
5798918|NCT02741232|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5798919|NCT02741232|Respiratory System Agents|respiratory system agents|mesh-ancestor
5798920|NCT02741232|Mydriatics|mydriatics|mesh-ancestor
5798921|NCT02741232|Sympathomimetics|sympathomimetics|mesh-ancestor
5798922|NCT02741232|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5798923|NCT02741427|Carbamide Peroxide|carbamide peroxide|mesh-list
5798924|NCT02741427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5798925|NCT02741427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5798926|NCT02741414|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5798927|NCT02741414|Amoxicillin|amoxicillin|mesh-list
5798928|NCT02741414|Metronidazole|metronidazole|mesh-list
5798929|NCT02741414|Clarithromycin|clarithromycin|mesh-list
5798930|NCT02741414|Levofloxacin|levofloxacin|mesh-list
5798931|NCT02741414|Ofloxacin|ofloxacin|mesh-list
5798932|NCT02741414|Tetracycline|tetracycline|mesh-list
5798933|NCT02741414|Furazolidone|furazolidone|mesh-list
5798934|NCT02741414|Esomeprazole|esomeprazole|mesh-list
5798935|NCT02741414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5798936|NCT02741414|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5798937|NCT02741414|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5798938|NCT02741414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5798939|NCT02741414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5798940|NCT02741414|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5798941|NCT02741414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5798942|NCT02741414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5798943|NCT02741414|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5899790|NCT01811368|Antifungal Agents|antifungal agents|mesh-ancestor
5798944|NCT02741414|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5798945|NCT02741414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5798946|NCT02741414|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5798947|NCT02741414|Renal Agents|renal agents|mesh-ancestor
5798948|NCT02741414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5798949|NCT02741414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5798950|NCT02741414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5798951|NCT02741414|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5798952|NCT02741414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5798953|NCT02741414|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
5798954|NCT02741414|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
5798955|NCT02741531|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5798956|NCT02741219|Sufentanil|sufentanil|mesh-list
5798957|NCT02741219|Dexmedetomidine|dexmedetomidine|mesh-list
5798958|NCT02741219|Dsuvia|dsuvia|mesh-list
5798959|NCT02741219|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5798960|NCT02741219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5798961|NCT02741219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798962|NCT02741219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5798963|NCT02741219|Analgesics|analgesics|mesh-ancestor
5798964|NCT02741219|Sensory System Agents|sensory system agents|mesh-ancestor
5798965|NCT02741219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5798966|NCT02741219|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5798967|NCT02741219|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5798968|NCT02741219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5798969|NCT02741219|Adrenergic Agents|adrenergic agents|mesh-ancestor
5798970|NCT02741219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5798971|NCT02741219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5798972|NCT02741219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5798973|NCT02741219|Narcotics|narcotics|mesh-ancestor
5798974|NCT02741219|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5798975|NCT02741219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5798976|NCT02741219|Anesthetics, General|anesthetics, general|mesh-ancestor
5798977|NCT02741219|Anesthetics|anesthetics|mesh-ancestor
5899791|NCT01811368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5899792|NCT01811368|Dermatologic Agents|dermatologic agents|mesh-ancestor
5899793|NCT01811368|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5899794|NCT01811368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5899795|NCT01811368|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5899796|NCT01811368|Antitubercular Agents|antitubercular agents|mesh-ancestor
5899797|NCT01811368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5899798|NCT01611116|Sirolimus|sirolimus|mesh-list
5899799|NCT01611116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5899800|NCT01611116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5899801|NCT01611116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5899802|NCT01611116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5899803|NCT01611116|Antifungal Agents|antifungal agents|mesh-ancestor
5899804|NCT01611116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5899805|NCT01611116|Immunologic Factors|immunologic factors|mesh-ancestor
5798978|NCT02740933|Demeclocycline|demeclocycline|mesh-list
5798979|NCT02740933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5798980|NCT02740933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5798981|NCT02740894|Gefitinib|gefitinib|mesh-list
5798982|NCT02740894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5798983|NCT02740894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5798984|NCT02740894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5798985|NCT02740894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5798986|NCT02740829|Glucagon|glucagon|mesh-list
5798987|NCT02740829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5798988|NCT02740829|Hormones|hormones|mesh-ancestor
5798989|NCT02740829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5798990|NCT02740829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798991|NCT02741063|Oxytocin|oxytocin|mesh-list
5798992|NCT02741063|Oxytocics|oxytocics|mesh-ancestor
5798993|NCT02741063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5798994|NCT02741063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5798995|NCT02741115|Udenafil|udenafil|mesh-list
5798996|NCT02741115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5798997|NCT02741115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5798998|NCT02741115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5798999|NCT02741115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5799000|NCT02740868|Xenon|xenon|mesh-list
5799001|NCT02740868|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5799002|NCT02740868|Anesthetics, General|anesthetics, general|mesh-ancestor
5799003|NCT02740868|Anesthetics|anesthetics|mesh-ancestor
5799004|NCT02740868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5799005|NCT02740868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799006|NCT02741154|Letrozole|letrozole|mesh-list
5799007|NCT02741154|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5799008|NCT02741154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5799009|NCT02741154|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5799010|NCT02741154|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5799011|NCT02741154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5799012|NCT02741154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5799013|NCT02741154|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5799014|NCT02741154|Hormone Antagonists|hormone antagonists|mesh-ancestor
5799015|NCT02741154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5799016|NCT02741154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799017|NCT02741154|Luteolytic Agents|luteolytic agents|mesh-ancestor
5799018|NCT02741154|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5799019|NCT02741154|Contraceptive Agents|contraceptive agents|mesh-ancestor
5799020|NCT02741154|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5799021|NCT02741154|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5799022|NCT02741154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5799023|NCT02740803|Listerine|listerine|mesh-list
5799024|NCT02740803|Fluorides|fluorides|mesh-list
5799025|NCT02740803|Sodium Fluoride|sodium fluoride|mesh-list
5799026|NCT02740803|Tin Fluorides|tin fluorides|mesh-list
5799027|NCT02740803|Fluorophosphate|fluorophosphate|mesh-list
5799028|NCT02740803|Cariostatic Agents|cariostatic agents|mesh-ancestor
5799029|NCT02740803|Protective Agents|protective agents|mesh-ancestor
5799030|NCT02740803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799031|NCT02740803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5799032|NCT02740803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5799033|NCT02741024|Artesunate|artesunate|mesh-list
5799034|NCT02741024|Lumefantrine|lumefantrine|mesh-list
5799035|NCT02741024|Artemether|artemether|mesh-list
5799036|NCT02741024|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
5799037|NCT02741024|Amodiaquine|amodiaquine|mesh-list
5799038|NCT02741024|Antimalarials|antimalarials|mesh-ancestor
5799039|NCT02741024|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5799040|NCT02741024|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5799041|NCT02741024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5799042|NCT02741024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5799043|NCT02741024|Antiviral Agents|antiviral agents|mesh-ancestor
5799044|NCT02741024|Schistosomicides|schistosomicides|mesh-ancestor
5799045|NCT02741024|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5799046|NCT02741024|Anthelmintics|anthelmintics|mesh-ancestor
5799047|NCT02740595|Nicotine|nicotine|mesh-list
5799048|NCT02740595|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5799049|NCT02740595|Autonomic Agents|autonomic agents|mesh-ancestor
5799050|NCT02740595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5799051|NCT02740595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799052|NCT02740595|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5799053|NCT02740595|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5799054|NCT02740595|Cholinergic Agents|cholinergic agents|mesh-ancestor
5799055|NCT02740595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5799056|NCT02740595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5799057|NCT02740647|Amoxicillin|amoxicillin|mesh-list
5799058|NCT02740647|Clavulanic Acid|clavulanic acid|mesh-list
5799059|NCT02740647|Clavulanic Acids|clavulanic acids|mesh-list
5799060|NCT02740647|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5799061|NCT02740647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5799062|NCT02740647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5799063|NCT02740647|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5799064|NCT02740647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5799065|NCT02740647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5799066|NCT02740712|Vitamin K|vitamin k|mesh-list
5799067|NCT02740712|Rucaparib|rucaparib|mesh-list
5799068|NCT02740712|Digoxin|digoxin|mesh-list
5799069|NCT02740712|Midazolam|midazolam|mesh-list
5799070|NCT02740712|Caffeine|caffeine|mesh-list
5799071|NCT02740712|Omeprazole|omeprazole|mesh-list
5799072|NCT02740712|Warfarin|warfarin|mesh-list
5799073|NCT02740712|Vitamins|vitamins|mesh-ancestor
5799074|NCT02740712|Micronutrients|micronutrients|mesh-ancestor
5799075|NCT02740712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799076|NCT02740712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5799077|NCT02740712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5799078|NCT02740712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5799079|NCT02740712|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5799080|NCT02740712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5799081|NCT02740712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5799082|NCT02740712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5799083|NCT02740712|Anesthetics, General|anesthetics, general|mesh-ancestor
5799084|NCT02740712|Anesthetics|anesthetics|mesh-ancestor
5799085|NCT02740712|GABA Modulators|gaba modulators|mesh-ancestor
5799086|NCT02740712|GABA Agents|gaba agents|mesh-ancestor
5799087|NCT02740712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5799088|NCT02740712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5799089|NCT02740712|Anticoagulants|anticoagulants|mesh-ancestor
5799090|NCT02740712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5799091|NCT02740712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5799092|NCT02740712|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5799093|NCT02740712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5799094|NCT02740712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5799095|NCT02740712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5799096|NCT02740712|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5799097|NCT02740712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5799098|NCT02740712|Purinergic Agents|purinergic agents|mesh-ancestor
5799099|NCT02740712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5799100|NCT02740712|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5799101|NCT02740712|Protective Agents|protective agents|mesh-ancestor
5799102|NCT02740712|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5799103|NCT02740712|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5799104|NCT02740712|Hemostatics|hemostatics|mesh-ancestor
5799105|NCT02740712|Coagulants|coagulants|mesh-ancestor
5799106|NCT02740712|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5799107|NCT02740712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5799108|NCT02740426|Pirarubicin|pirarubicin|mesh-list
5799109|NCT02740426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5799110|NCT02740270|Spartalizumab|spartalizumab|mesh-list
5641400|NCT03300544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799111|NCT02740270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5799112|NCT02740270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5799113|NCT02740270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5799114|NCT02740101|Oxytocin|oxytocin|mesh-list
5799115|NCT02740101|Oxytocics|oxytocics|mesh-ancestor
5799116|NCT02740101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5799117|NCT02740101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799118|NCT02740192|Bupivacaine|bupivacaine|mesh-list
5799119|NCT02740192|Ropivacaine|ropivacaine|mesh-list
5799120|NCT02740192|Anesthetics, Local|anesthetics, local|mesh-ancestor
5799121|NCT02740192|Anesthetics|anesthetics|mesh-ancestor
5641401|NCT03300544|Antidotes|antidotes|mesh-ancestor
5641402|NCT03300544|Protective Agents|protective agents|mesh-ancestor
5641403|NCT03300544|Vitamin B Complex|vitamin b complex|mesh-ancestor
5641404|NCT03300544|Vitamins|vitamins|mesh-ancestor
5641405|NCT03300544|Micronutrients|micronutrients|mesh-ancestor
5641406|NCT03300544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5641407|NCT03284853|Latanoprost|latanoprost|mesh-list
5641408|NCT03284853|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5641409|NCT03284853|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5799122|NCT02740192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5799123|NCT02740192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799124|NCT02740192|Sensory System Agents|sensory system agents|mesh-ancestor
5799125|NCT02740192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5799126|NCT02740179|Eplerenone|eplerenone|mesh-list
5799127|NCT02740179|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5799128|NCT02740179|Hormone Antagonists|hormone antagonists|mesh-ancestor
5799129|NCT02740179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5799130|NCT02740179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799131|NCT02740179|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5799132|NCT02740179|Diuretics|diuretics|mesh-ancestor
5799133|NCT02740179|Natriuretic Agents|natriuretic agents|mesh-ancestor
5799134|NCT02740179|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5799135|NCT02740166|Propranolol|propranolol|mesh-list
5799136|NCT02740166|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5799137|NCT02740166|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5799138|NCT02740166|Adrenergic Agents|adrenergic agents|mesh-ancestor
5799139|NCT02740166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5799140|NCT02740166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5799141|NCT02740166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799142|NCT02740166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5799143|NCT02740166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5799144|NCT02740166|Vasodilator Agents|vasodilator agents|mesh-ancestor
5799145|NCT02739958|Propofol|propofol|mesh-list
5799146|NCT02739958|Isoflurane|isoflurane|mesh-list
5799147|NCT02739958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5799148|NCT02739958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5799149|NCT02739958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799150|NCT02739958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5799151|NCT02739958|Anesthetics, General|anesthetics, general|mesh-ancestor
5799152|NCT02739958|Anesthetics|anesthetics|mesh-ancestor
5799153|NCT02739958|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5799154|NCT02739880|Hyaluronic Acid|hyaluronic acid|mesh-list
5799155|NCT02739880|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5799156|NCT02739880|Immunologic Factors|immunologic factors|mesh-ancestor
5799157|NCT02739880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799158|NCT02739880|Viscosupplements|viscosupplements|mesh-ancestor
5799159|NCT02739880|Protective Agents|protective agents|mesh-ancestor
5799160|NCT02739906|Insulin|insulin|mesh-list
5799161|NCT02739906|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5799162|NCT02739906|Insulin Lispro|insulin lispro|mesh-list
5799163|NCT02739906|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5799164|NCT02739906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799165|NCT02739815|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5799166|NCT02739815|Tranexamic Acid|tranexamic acid|mesh-list
5799167|NCT02739815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5799168|NCT02739815|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5799169|NCT02739815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5899806|NCT01611116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799170|NCT02739815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5799171|NCT02739815|Hemostatics|hemostatics|mesh-ancestor
5799172|NCT02739815|Coagulants|coagulants|mesh-ancestor
5799173|NCT02739711|polysaccharide-K|polysaccharide-k|mesh-list
5799174|NCT02739711|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5799175|NCT02739711|Immunologic Factors|immunologic factors|mesh-ancestor
5799176|NCT02739711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799177|NCT02739711|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5799178|NCT02739711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5799179|NCT02739711|Antiviral Agents|antiviral agents|mesh-ancestor
5799180|NCT02739711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6210987|NCT02167451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6210988|NCT02167451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6210989|NCT02167451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6210990|NCT02167451|Antiviral Agents|antiviral agents|mesh-ancestor
6210991|NCT02167451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6210992|NCT02167451|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6210993|NCT02167893|Leuprolide|leuprolide|mesh-list
6210994|NCT02167893|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6210995|NCT02167893|Fertility Agents|fertility agents|mesh-ancestor
6210996|NCT02167893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6210997|NCT02167893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6210998|NCT02167893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6210999|NCT02167893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5799181|NCT02739711|Interferon Inducers|interferon inducers|mesh-ancestor
5799182|NCT02739711|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5799183|NCT02739711|Protective Agents|protective agents|mesh-ancestor
5799184|NCT02739672|Amlodipine|amlodipine|mesh-list
5799185|NCT02739672|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5799186|NCT02739672|Telmisartan|telmisartan|mesh-list
5799187|NCT02739672|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
5799188|NCT02739672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5799189|NCT02739672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5799190|NCT02739672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5799191|NCT02739672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5799192|NCT02739672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5799193|NCT02739672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799194|NCT02739672|Vasodilator Agents|vasodilator agents|mesh-ancestor
5799195|NCT02739672|Diuretics|diuretics|mesh-ancestor
5799196|NCT02739672|Natriuretic Agents|natriuretic agents|mesh-ancestor
5799197|NCT02739672|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5799198|NCT02739672|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5799199|NCT02739672|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5799200|NCT02739685|Everolimus|everolimus|mesh-list
5799201|NCT02739685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5799202|NCT02739685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5799203|NCT02739685|Immunologic Factors|immunologic factors|mesh-ancestor
6211000|NCT02168062|Leuprolide|leuprolide|mesh-list
5799204|NCT02739685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799205|NCT02739542|Dimethyl Fumarate|dimethyl fumarate|mesh-list
5799206|NCT02739542|Dermatologic Agents|dermatologic agents|mesh-ancestor
5799207|NCT02739542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5799208|NCT02739542|Immunologic Factors|immunologic factors|mesh-ancestor
5799209|NCT02739542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799210|NCT02739633|Gemcitabine|gemcitabine|mesh-list
5799211|NCT02739633|Paclitaxel|paclitaxel|mesh-list
5799212|NCT02739633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5799213|NCT02739633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5799214|NCT02739633|Tubulin Modulators|tubulin modulators|mesh-ancestor
5799215|NCT02739633|Antimitotic Agents|antimitotic agents|mesh-ancestor
5799216|NCT02739633|Mitosis Modulators|mitosis modulators|mesh-ancestor
5799217|NCT02739633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5799218|NCT02739633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5799219|NCT02739633|Antimetabolites|antimetabolites|mesh-ancestor
5799220|NCT02739633|Antiviral Agents|antiviral agents|mesh-ancestor
5799221|NCT02739633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5799222|NCT02739633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5799223|NCT02739633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5799224|NCT02739633|Immunologic Factors|immunologic factors|mesh-ancestor
5799225|NCT02739633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799226|NCT02739477|Favipiravir|favipiravir|mesh-list
5799227|NCT02739477|Antiviral Agents|antiviral agents|mesh-ancestor
5799228|NCT02739477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5799229|NCT02739581|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
5799230|NCT02739581|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5799231|NCT02739581|Adrenergic Agents|adrenergic agents|mesh-ancestor
5799232|NCT02739581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5799233|NCT02739581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5799234|NCT02739581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799235|NCT02739516|Letrozole|letrozole|mesh-list
5799236|NCT02739516|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5799237|NCT02739516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5799238|NCT02739516|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5799239|NCT02739516|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5799240|NCT02739516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5799241|NCT02739516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5799242|NCT02739516|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5799243|NCT02739516|Hormone Antagonists|hormone antagonists|mesh-ancestor
5799244|NCT02739516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5799245|NCT02739516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799246|NCT02739516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5899807|NCT01288625|Amifostine|amifostine|mesh-list
5899808|NCT01288625|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5899809|NCT01288625|Protective Agents|protective agents|mesh-ancestor
5899810|NCT01288625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5908166|NCT04860713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5908167|NCT04860713|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5908168|NCT04860713|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5908169|NCT04860713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5908170|NCT04848480|Insulin|insulin|mesh-list
5908171|NCT04848480|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5908172|NCT04848480|Insulin Aspart|insulin aspart|mesh-list
5908173|NCT04848480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5908174|NCT04848480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5908175|NCT04810078|Nivolumab|nivolumab|mesh-list
5908176|NCT04810078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5908177|NCT04810078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5908178|NCT04810078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5908179|NCT04810078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908180|NCT04809285|Insulin|insulin|mesh-list
5908181|NCT04809285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5908182|NCT04809285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5908183|NCT04803201|Prednisone|prednisone|mesh-list
6674000|NCT01566669|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6674001|NCT01566669|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6674002|NCT01566669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6674003|NCT01566669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674004|NCT01566669|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6674005|NCT01566669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6674006|NCT01566669|Analgesics|analgesics|mesh-ancestor
5908184|NCT04803201|Cyclophosphamide|cyclophosphamide|mesh-list
5908185|NCT04803201|Doxorubicin|doxorubicin|mesh-list
5908186|NCT04803201|Etoposide|etoposide|mesh-list
5908187|NCT04803201|Vincristine|vincristine|mesh-list
5908188|NCT04803201|Azacitidine|azacitidine|mesh-list
5908189|NCT04803201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5908190|NCT04803201|Immunologic Factors|immunologic factors|mesh-ancestor
5908191|NCT04803201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5908192|NCT04803201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5799247|NCT02739399|Phenylephrine|phenylephrine|mesh-list
5799248|NCT02739399|Oxymetazoline|oxymetazoline|mesh-list
5799249|NCT02739399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5799250|NCT02739399|Mydriatics|mydriatics|mesh-ancestor
5799251|NCT02739399|Autonomic Agents|autonomic agents|mesh-ancestor
5799252|NCT02739399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5799253|NCT02739399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799254|NCT02739399|Sympathomimetics|sympathomimetics|mesh-ancestor
5799255|NCT02739399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5799256|NCT02739399|Nasal Decongestants|nasal decongestants|mesh-ancestor
5799257|NCT02739399|Respiratory System Agents|respiratory system agents|mesh-ancestor
5799258|NCT02739399|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5799259|NCT02739399|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5799260|NCT02739399|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5799261|NCT02739399|Adrenergic Agents|adrenergic agents|mesh-ancestor
5799262|NCT02739399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5799263|NCT02739399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5799264|NCT02739399|Protective Agents|protective agents|mesh-ancestor
5799265|NCT02739295|Sargramostim|sargramostim|mesh-list
5799266|NCT02739295|Immunologic Factors|immunologic factors|mesh-ancestor
5799267|NCT02739295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799268|NCT02738983|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6211001|NCT02168062|Goserelin|goserelin|mesh-list
6211002|NCT02168062|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5799269|NCT02738983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5799270|NCT02738983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6211003|NCT02168062|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5799271|NCT02738983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5799272|NCT02738983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5799273|NCT02739412|Aldesleukin|aldesleukin|mesh-list
5799274|NCT02739412|Interleukin-2|interleukin-2|mesh-list
5799275|NCT02739412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5799276|NCT02739412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5799277|NCT02739412|Analgesics|analgesics|mesh-ancestor
5799278|NCT02739412|Sensory System Agents|sensory system agents|mesh-ancestor
5799279|NCT02739412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5799280|NCT02739412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799281|NCT02739412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5799282|NCT02739412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5799283|NCT02739412|Antiviral Agents|antiviral agents|mesh-ancestor
5799284|NCT02739412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5799285|NCT02739204|Celecoxib|celecoxib|mesh-list
5799286|NCT02739204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5799287|NCT02739204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5799288|NCT02739204|Analgesics|analgesics|mesh-ancestor
5799289|NCT02739204|Sensory System Agents|sensory system agents|mesh-ancestor
5799290|NCT02739204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5799291|NCT02739204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799292|NCT02739204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5799293|NCT02739204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5799294|NCT02739204|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5799295|NCT02739204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5799296|NCT02739204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5799297|NCT02739204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5799298|NCT02739061|Fluvoxamine|fluvoxamine|mesh-list
5799299|NCT02739061|Sertraline|sertraline|mesh-list
5799300|NCT02739061|Antidepressive Agents|antidepressive agents|mesh-ancestor
5799301|NCT02739061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5799302|NCT02739061|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5799303|NCT02739061|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5799304|NCT02739061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5799305|NCT02739061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5799306|NCT02739061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5799307|NCT02739061|Serotonin Agents|serotonin agents|mesh-ancestor
5799308|NCT02739061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799309|NCT02739061|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5799310|NCT02739061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5799311|NCT02739061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5799312|NCT02739061|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5799313|NCT02739061|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5799314|NCT02739061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5799315|NCT02739061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5799316|NCT02739061|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5799317|NCT02738970|Trastuzumab|trastuzumab|mesh-list
5799318|NCT02738970|Pertuzumab|pertuzumab|mesh-list
5799319|NCT02738970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5799320|NCT02738970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5799321|NCT02738918|Abatacept|abatacept|mesh-list
5799322|NCT02738918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5799323|NCT02738918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5799324|NCT02738918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5799325|NCT02738918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5799326|NCT02738918|Immunologic Factors|immunologic factors|mesh-ancestor
5799327|NCT02738918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799328|NCT02738918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5799329|NCT02738931|Lamivudine|lamivudine|mesh-list
5799330|NCT02738931|Dolutegravir|dolutegravir|mesh-list
5799331|NCT02738931|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5799332|NCT02738931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5799333|NCT02738931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5799334|NCT02738931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5799335|NCT02738931|Antiviral Agents|antiviral agents|mesh-ancestor
5799336|NCT02738931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5799337|NCT02738931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5799338|NCT02738931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5799339|NCT02738931|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6211004|NCT02168062|Fertility Agents|fertility agents|mesh-ancestor
5799340|NCT02738931|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5799341|NCT02738905|Rifaximin|rifaximin|mesh-list
5799342|NCT02738905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5799343|NCT02738905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6211005|NCT02168062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5799344|NCT02738905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5799345|NCT02738814|Propofol|propofol|mesh-list
5799346|NCT02738814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5799347|NCT02738814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5799348|NCT02738814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799349|NCT02738814|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5799350|NCT02738814|Anesthetics, General|anesthetics, general|mesh-ancestor
5799351|NCT02738814|Anesthetics|anesthetics|mesh-ancestor
5799352|NCT02739386|Ipilimumab|ipilimumab|mesh-list
5799353|NCT02739386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5799354|NCT02739386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5799355|NCT02739386|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5799356|NCT02739386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5799357|NCT02738619|Vitamin D|vitamin d|mesh-list
5799358|NCT02738619|Ergocalciferols|ergocalciferols|mesh-list
5799359|NCT02738619|Cholecalciferol|cholecalciferol|mesh-list
5799360|NCT02738619|Vitamins|vitamins|mesh-list
5799361|NCT02738619|Micronutrients|micronutrients|mesh-ancestor
5799362|NCT02738619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799363|NCT02738619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5799364|NCT02738619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5799365|NCT02738658|Everolimus|everolimus|mesh-list
5799366|NCT02738658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5799367|NCT02738658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5799368|NCT02738658|Immunologic Factors|immunologic factors|mesh-ancestor
5799369|NCT02738658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799370|NCT02738502|Ritonavir|ritonavir|mesh-list
5799371|NCT02738502|Darunavir|darunavir|mesh-list
5799372|NCT02738502|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5799373|NCT02738502|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5799374|NCT02738502|Protease Inhibitors|protease inhibitors|mesh-ancestor
5799375|NCT02738502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5799376|NCT02738502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5799377|NCT02738502|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5799378|NCT02738502|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5799379|NCT02738502|Antiviral Agents|antiviral agents|mesh-ancestor
5799380|NCT02738502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5799381|NCT02738502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5799382|NCT02738502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5799383|NCT02738346|Carboplatin|carboplatin|mesh-list
5799384|NCT02738346|Etoposide|etoposide|mesh-list
5799385|NCT02738346|Topotecan|topotecan|mesh-list
5799386|NCT02738346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5799387|NCT02738346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5799388|NCT02738346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5799389|NCT02738346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5799390|NCT02738346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5799391|NCT02738346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5799392|NCT02738346|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5799393|NCT02738632|Amlodipine|amlodipine|mesh-list
5799394|NCT02738632|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5799395|NCT02738632|Telmisartan|telmisartan|mesh-list
5799396|NCT02738632|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
5799397|NCT02738632|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5799398|NCT02738632|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5799399|NCT02738632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5799400|NCT02738632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5799401|NCT02738632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5799402|NCT02738632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799403|NCT02738632|Vasodilator Agents|vasodilator agents|mesh-ancestor
5799404|NCT02738632|Diuretics|diuretics|mesh-ancestor
5799405|NCT02738632|Natriuretic Agents|natriuretic agents|mesh-ancestor
5799406|NCT02738632|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5799407|NCT02738632|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5799408|NCT02738632|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5799409|NCT02738177|Isosorbide|isosorbide|mesh-list
5799410|NCT02738177|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
5799411|NCT02738177|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
5799412|NCT02738177|Misoprostol|misoprostol|mesh-list
5799413|NCT02738177|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5799414|NCT02738177|Abortifacient Agents|abortifacient agents|mesh-ancestor
5799415|NCT02738177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5799416|NCT02738177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799417|NCT02738177|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5799418|NCT02738177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5799419|NCT02738177|Oxytocics|oxytocics|mesh-ancestor
5799420|NCT02738177|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5799421|NCT02738177|Diuretics|diuretics|mesh-ancestor
5799422|NCT02738177|Natriuretic Agents|natriuretic agents|mesh-ancestor
5799423|NCT02738177|Vasodilator Agents|vasodilator agents|mesh-ancestor
5799424|NCT02738177|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5799425|NCT02738177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5799426|NCT02738073|Tranexamic Acid|tranexamic acid|mesh-list
5799427|NCT02738073|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5799428|NCT02738073|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5799429|NCT02738073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5799430|NCT02738073|Hemostatics|hemostatics|mesh-ancestor
5641410|NCT03267277|Sodium thiosulfate|sodium thiosulfate|mesh-list
5799431|NCT02738073|Coagulants|coagulants|mesh-ancestor
5799432|NCT02737943|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5799433|NCT02737943|Analgesics|analgesics|mesh-list
5799434|NCT02737943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5641411|NCT03267277|Antidotes|antidotes|mesh-ancestor
5641412|NCT03267277|Protective Agents|protective agents|mesh-ancestor
5641413|NCT03267277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641414|NCT03267277|Antioxidants|antioxidants|mesh-ancestor
5641415|NCT03267277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641416|NCT03267277|Antitubercular Agents|antitubercular agents|mesh-ancestor
5641417|NCT03267277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5641418|NCT03267277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5641419|NCT03267277|Chelating Agents|chelating agents|mesh-ancestor
5641420|NCT03267277|Sequestering Agents|sequestering agents|mesh-ancestor
5693944|NCT03398811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5799435|NCT02737943|Sensory System Agents|sensory system agents|mesh-ancestor
5799436|NCT02737943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5799437|NCT02737943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799438|NCT02737709|Paclitaxel|paclitaxel|mesh-list
5799439|NCT02737709|Carboplatin|carboplatin|mesh-list
5799440|NCT02737709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5799441|NCT02737709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5799442|NCT02737709|Tubulin Modulators|tubulin modulators|mesh-ancestor
5799443|NCT02737709|Antimitotic Agents|antimitotic agents|mesh-ancestor
5799444|NCT02737709|Mitosis Modulators|mitosis modulators|mesh-ancestor
5799445|NCT02737709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5799446|NCT02737813|Bupivacaine|bupivacaine|mesh-list
5799447|NCT02737813|Anesthetics, Local|anesthetics, local|mesh-ancestor
5799448|NCT02737813|Anesthetics|anesthetics|mesh-ancestor
5799449|NCT02737813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5799450|NCT02737813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799451|NCT02737813|Sensory System Agents|sensory system agents|mesh-ancestor
5799452|NCT02737813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5799453|NCT02737787|Nivolumab|nivolumab|mesh-list
5799454|NCT02737787|Vaccines|vaccines|mesh-list
5799455|NCT02737787|Immunologic Factors|immunologic factors|mesh-ancestor
5799456|NCT02737787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799457|NCT02737787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5799458|NCT02737787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5799459|NCT02737787|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5799460|NCT02737787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5799461|NCT02737670|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
5799462|NCT02737670|Anticoagulants|anticoagulants|mesh-ancestor
5799463|NCT02737670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5799464|NCT02737670|Antimetabolites|antimetabolites|mesh-ancestor
5799465|NCT02737670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5799466|NCT02737670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5799467|NCT02737670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5799468|NCT02737670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5799469|NCT02737670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5799470|NCT02737670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799471|NCT02737800|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5799472|NCT02737800|Luteolytic Agents|luteolytic agents|mesh-ancestor
5799473|NCT02737800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5799474|NCT02737800|Contraceptive Agents|contraceptive agents|mesh-ancestor
5799475|NCT02737800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5799476|NCT02737800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799477|NCT02737800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5799478|NCT02737800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5799479|NCT02737800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5799480|NCT02737774|Carboplatin|carboplatin|mesh-list
5799481|NCT02737774|Pemetrexed|pemetrexed|mesh-list
5799482|NCT02737774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5799483|NCT02737774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5799484|NCT02737774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5799485|NCT02737774|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5799486|NCT02737774|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5899811|NCT00848328|Rituximab|rituximab|mesh-list
5899812|NCT00848328|Lenalidomide|lenalidomide|mesh-list
5899813|NCT00848328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5899814|NCT00848328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5899815|NCT00848328|Immunologic Factors|immunologic factors|mesh-ancestor
5899816|NCT00848328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899817|NCT00848328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5899818|NCT00848328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5899819|NCT00848328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5899820|NCT00848328|Growth Substances|growth substances|mesh-ancestor
5899821|NCT00848328|Growth Inhibitors|growth inhibitors|mesh-ancestor
5899822|NCT00599170|Rituximab|rituximab|mesh-list
5899823|NCT00599170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5899824|NCT00599170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5899825|NCT00599170|Immunologic Factors|immunologic factors|mesh-ancestor
5899826|NCT00599170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899827|NCT00599170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5899828|NCT05128292|Selenium|selenium|mesh-list
5899829|NCT05128292|Antioxidants|antioxidants|mesh-ancestor
5899830|NCT05128292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899831|NCT05128292|Protective Agents|protective agents|mesh-ancestor
5899832|NCT05128292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799487|NCT02737696|Analgesics, Opioid|analgesics, opioid|mesh-list
5799488|NCT02737696|Narcotics|narcotics|mesh-ancestor
5799489|NCT02737696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5799490|NCT02737696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799491|NCT02737696|Analgesics|analgesics|mesh-ancestor
5799492|NCT02737696|Sensory System Agents|sensory system agents|mesh-ancestor
5799493|NCT02737696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5799494|NCT02738229|Valacyclovir|valacyclovir|mesh-list
5799495|NCT02738229|Antiviral Agents|antiviral agents|mesh-ancestor
5799496|NCT02738229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5799497|NCT02737605|Moxifloxacin|moxifloxacin|mesh-list
5799498|NCT02737605|Esketamine|esketamine|mesh-list
5799499|NCT02737605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5799500|NCT02737605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5799501|NCT02737605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5799502|NCT02737605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5799503|NCT02737605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5799504|NCT02737605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5799505|NCT02737605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5799506|NCT02737605|Antidepressive Agents|antidepressive agents|mesh-ancestor
5799507|NCT02737605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5799508|NCT02737371|Antifungal Agents|antifungal agents|mesh-list
5799509|NCT02737371|Clotrimazole|clotrimazole|mesh-list
5799510|NCT02737371|Miconazole|miconazole|mesh-list
5799511|NCT02737371|Olorofim|olorofim|mesh-list
5799512|NCT02737371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5799513|NCT02737371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5799514|NCT02737371|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5799515|NCT02737371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5799516|NCT02737371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5799517|NCT02737371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5799518|NCT02737371|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5799519|NCT02737371|Hormone Antagonists|hormone antagonists|mesh-ancestor
5799520|NCT02737371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5799521|NCT02737371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799522|NCT02737371|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5799523|NCT02737371|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5799524|NCT02737423|Vitamin D|vitamin d|mesh-list
5799525|NCT02737423|Cholecalciferol|cholecalciferol|mesh-list
5799526|NCT02737423|Vitamins|vitamins|mesh-ancestor
5799527|NCT02737423|Micronutrients|micronutrients|mesh-ancestor
5799528|NCT02737423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799529|NCT02737423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5799530|NCT02737423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5799531|NCT02737527|Levobupivacaine|levobupivacaine|mesh-list
5799532|NCT02737527|Anesthetics, Local|anesthetics, local|mesh-ancestor
5799533|NCT02737527|Anesthetics|anesthetics|mesh-ancestor
5799534|NCT02737527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5799535|NCT02737527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211006|NCT02168062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211007|NCT02168062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6211008|NCT02168062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5799536|NCT02737527|Sensory System Agents|sensory system agents|mesh-ancestor
5799537|NCT02737527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5799538|NCT02737319|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5799539|NCT02737319|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5799540|NCT02737319|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5799541|NCT02737319|Antimetabolites|antimetabolites|mesh-ancestor
5799542|NCT02737319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5799543|NCT02737319|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5799544|NCT02737319|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5799545|NCT02737319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5799546|NCT02737254|Oxytocin|oxytocin|mesh-list
5799547|NCT02737254|Oxytocics|oxytocics|mesh-ancestor
5799548|NCT02737254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5799549|NCT02737254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799550|NCT02737202|Saracatinib|saracatinib|mesh-list
5799551|NCT02737202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5799552|NCT02737202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5799553|NCT02737202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5799554|NCT02737228|Gemcitabine|gemcitabine|mesh-list
5799555|NCT02737228|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5799556|NCT02737228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5799557|NCT02737228|Antimetabolites|antimetabolites|mesh-ancestor
5799558|NCT02737228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5799559|NCT02737228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5799560|NCT02737228|Antiviral Agents|antiviral agents|mesh-ancestor
5799561|NCT02737228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5799562|NCT02737228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5799563|NCT02737228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5799564|NCT02737228|Immunologic Factors|immunologic factors|mesh-ancestor
5799565|NCT02737228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799566|NCT02737228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5799567|NCT02737124|Acetaminophen|acetaminophen|mesh-list
5799568|NCT02737124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5799569|NCT02737124|Analgesics|analgesics|mesh-ancestor
5799570|NCT02737124|Sensory System Agents|sensory system agents|mesh-ancestor
5799571|NCT02737124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5799572|NCT02737124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799573|NCT02737124|Antipyretics|antipyretics|mesh-ancestor
5799574|NCT02737150|Anesthetics|anesthetics|mesh-list
5799575|NCT02737150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5799576|NCT02737150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799577|NCT02737059|Codeine|codeine|mesh-list
5799578|NCT02737059|Naloxegol|naloxegol|mesh-list
5799579|NCT02737059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5799580|NCT02737059|Narcotics|narcotics|mesh-ancestor
5799581|NCT02737059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5799582|NCT02737059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799583|NCT02737059|Analgesics|analgesics|mesh-ancestor
5799584|NCT02737059|Sensory System Agents|sensory system agents|mesh-ancestor
5799585|NCT02737059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5799586|NCT02737059|Antitussive Agents|antitussive agents|mesh-ancestor
5799587|NCT02737059|Respiratory System Agents|respiratory system agents|mesh-ancestor
5799588|NCT02737059|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5799589|NCT02736760|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
5799590|NCT02736760|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5799591|NCT02736760|Dermatologic Agents|dermatologic agents|mesh-ancestor
5799592|NCT02736604|Nitrous Oxide|nitrous oxide|mesh-list
5799593|NCT02736604|Anesthetics|anesthetics|mesh-list
5799594|NCT02736604|Sevoflurane|sevoflurane|mesh-list
5799595|NCT02736604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5799596|NCT02736604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799597|NCT02736604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5799598|NCT02736604|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5799599|NCT02736604|Anesthetics, General|anesthetics, general|mesh-ancestor
5799600|NCT02736604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5799601|NCT02736604|Analgesics|analgesics|mesh-ancestor
5799602|NCT02736604|Sensory System Agents|sensory system agents|mesh-ancestor
5799603|NCT02736604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5799604|NCT02736448|Capecitabine|capecitabine|mesh-list
5799605|NCT02736448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5799606|NCT02736448|Antimetabolites|antimetabolites|mesh-ancestor
5799607|NCT02736448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5799608|NCT02736448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5799609|NCT02736591|Hormones|hormones|mesh-list
5799610|NCT02736591|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
5799611|NCT02736591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5799612|NCT02736591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799613|NCT02736513|Osimertinib|osimertinib|mesh-list
5799614|NCT02736513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5799615|NCT02736513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5799616|NCT02736513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5799617|NCT02736513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5799618|NCT02736500|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
5799619|NCT02736500|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5799620|NCT02736500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5799621|NCT02736435|Leuprolide|leuprolide|mesh-list
5799622|NCT02736435|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5799623|NCT02736435|Fertility Agents|fertility agents|mesh-ancestor
5799624|NCT02736435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5799625|NCT02736435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799626|NCT02736435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5799627|NCT02736435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5799628|NCT02736682|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5799629|NCT02736682|Metronidazole|metronidazole|mesh-list
5799630|NCT02736682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5799631|NCT02736682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5799632|NCT02736682|Antitubercular Agents|antitubercular agents|mesh-ancestor
5799633|NCT02736682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5799634|NCT02736682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5799635|NCT02736279|Dimethyl Fumarate|dimethyl fumarate|mesh-list
5799636|NCT02736279|Dermatologic Agents|dermatologic agents|mesh-ancestor
5799637|NCT02736279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5799638|NCT02736279|Immunologic Factors|immunologic factors|mesh-ancestor
5799639|NCT02736279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799640|NCT02736266|Pembrolizumab|pembrolizumab|mesh-list
5799641|NCT02736266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5799642|NCT02736266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5799643|NCT02736240|Vaccines|vaccines|mesh-list
5799644|NCT02736240|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5799645|NCT02736240|Immunologic Factors|immunologic factors|mesh-ancestor
5799646|NCT02736240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799647|NCT02736227|Everolimus|everolimus|mesh-list
5799648|NCT02736227|Tacrolimus|tacrolimus|mesh-list
5799649|NCT02736227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5799650|NCT02736227|Immunologic Factors|immunologic factors|mesh-ancestor
5799651|NCT02736227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799652|NCT02736227|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5799653|NCT02736227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5799654|NCT02736227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5799655|NCT02736227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5799656|NCT02736032|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5799657|NCT02736032|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5799658|NCT02736032|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5799659|NCT02736032|Estradiol|estradiol|mesh-list
5799660|NCT02736032|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5799661|NCT02736032|Progesterone|progesterone|mesh-list
5799662|NCT02736032|Estrogens|estrogens|mesh-ancestor
5799663|NCT02736032|Hormones|hormones|mesh-ancestor
5799664|NCT02736032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5799665|NCT02736032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799666|NCT02736032|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5799667|NCT02736032|Contraceptive Agents|contraceptive agents|mesh-ancestor
5799668|NCT02736032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5799669|NCT02736032|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5799670|NCT02736032|Progestins|progestins|mesh-ancestor
5799671|NCT02736032|Luteolytic Agents|luteolytic agents|mesh-ancestor
5799672|NCT02736032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5799673|NCT02736032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5799674|NCT02736071|Celecoxib|celecoxib|mesh-list
5799675|NCT02736071|Tramadol|tramadol|mesh-list
5799676|NCT02736071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5799677|NCT02736071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5799678|NCT02736071|Analgesics|analgesics|mesh-ancestor
5799679|NCT02736071|Sensory System Agents|sensory system agents|mesh-ancestor
5799680|NCT02736071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5799681|NCT02736071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799682|NCT02736071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5799683|NCT02736071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5799684|NCT02736071|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5799685|NCT02736071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5799686|NCT02736071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5799687|NCT02736071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5799688|NCT02736071|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5799689|NCT02736071|Narcotics|narcotics|mesh-ancestor
5799690|NCT02736071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5799691|NCT02736123|Nivolumab|nivolumab|mesh-list
5799692|NCT02736123|Ipilimumab|ipilimumab|mesh-list
5799693|NCT02736123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5799694|NCT02736123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5799695|NCT02736123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5799696|NCT02736123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899833|NCT05128292|Trace Elements|trace elements|mesh-ancestor
5899834|NCT05128292|Micronutrients|micronutrients|mesh-ancestor
5899835|NCT05128175|Levodopa|levodopa|mesh-list
5899836|NCT05128175|Carbidopa|carbidopa|mesh-list
5899837|NCT05128175|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
5899838|NCT05128175|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5899839|NCT05128175|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5899840|NCT05128175|Dopamine Agents|dopamine agents|mesh-ancestor
5899841|NCT05128175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5899842|NCT05128175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899843|NCT05128175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899844|NCT05128175|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5899845|NCT05128175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5899846|NCT05128175|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5899847|NCT05128175|Immunologic Factors|immunologic factors|mesh-ancestor
5899848|NCT05128175|Dopamine Agonists|dopamine agonists|mesh-ancestor
5899849|NCT05128162|Psilocybin|psilocybin|mesh-list
5899850|NCT05128162|Hallucinogens|hallucinogens|mesh-ancestor
5899851|NCT05128162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899852|NCT05128162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5899853|NCT05128071|Progesterone|progesterone|mesh-list
5899854|NCT05128071|Progestins|progestins|mesh-ancestor
5899855|NCT05128071|Hormones|hormones|mesh-ancestor
5899856|NCT05128071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5899857|NCT05128071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899858|NCT05127980|Antibodies|antibodies|mesh-list
5899859|NCT05127980|Autoantibodies|autoantibodies|mesh-list
5899860|NCT05127980|Immunologic Factors|immunologic factors|mesh-ancestor
5899861|NCT05127980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899862|NCT05127928|Vitamins|vitamins|mesh-list
5899863|NCT05127928|Ascorbic Acid|ascorbic acid|mesh-list
5899864|NCT05127928|Vitamin E|vitamin e|mesh-list
5899865|NCT05127928|Tocopherols|tocopherols|mesh-list
5899866|NCT05127928|Micronutrients|micronutrients|mesh-ancestor
5899867|NCT05127928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899868|NCT05127928|Antioxidants|antioxidants|mesh-ancestor
5899869|NCT05127928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899870|NCT05127928|Protective Agents|protective agents|mesh-ancestor
5899871|NCT05127746|Donepezil|donepezil|mesh-list
5899872|NCT05127746|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5899873|NCT05127746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5899874|NCT05127746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899875|NCT05127746|Cholinergic Agents|cholinergic agents|mesh-ancestor
5899876|NCT05127746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5899877|NCT05127746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899878|NCT05127746|Nootropic Agents|nootropic agents|mesh-ancestor
5899879|NCT05127707|Analgesics, Opioid|analgesics, opioid|mesh-list
5899880|NCT05127707|Narcotics|narcotics|mesh-ancestor
5899881|NCT05127707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5899882|NCT05127707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899883|NCT05127707|Analgesics|analgesics|mesh-ancestor
5899884|NCT05127707|Sensory System Agents|sensory system agents|mesh-ancestor
5899885|NCT05127707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5899886|NCT05127395|Acyclovir|acyclovir|mesh-list
5899887|NCT05127395|Antiviral Agents|antiviral agents|mesh-ancestor
5899888|NCT05127395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5899889|NCT05127369|Fluoxetine|fluoxetine|mesh-list
5899890|NCT05127369|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5799697|NCT02736019|Celecoxib|celecoxib|mesh-list
5799698|NCT02736019|Tramadol|tramadol|mesh-list
5799699|NCT02736019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5799700|NCT02736019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5799701|NCT02736019|Analgesics|analgesics|mesh-ancestor
5799702|NCT02736019|Sensory System Agents|sensory system agents|mesh-ancestor
5799703|NCT02736019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5799704|NCT02736019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799705|NCT02736019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5799706|NCT02736019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5799707|NCT02736019|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5799708|NCT02736019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5799709|NCT02736019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5799710|NCT02736019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5799711|NCT02736019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5799712|NCT02736019|Narcotics|narcotics|mesh-ancestor
5799713|NCT02736019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5799714|NCT02735837|Doxycycline|doxycycline|mesh-list
5799715|NCT02735837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5799716|NCT02735837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5799717|NCT02735837|Antimalarials|antimalarials|mesh-ancestor
5799718|NCT02735837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5799719|NCT02735837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5799720|NCT02735928|Doxorubicin|doxorubicin|mesh-list
5799721|NCT02735928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5799722|NCT02735928|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5799723|NCT02735928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5799724|NCT02735928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5799725|NCT02735928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5799726|NCT02735928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5799727|NCT02735876|Rituximab|rituximab|mesh-list
5799728|NCT02735876|Acalabrutinib|acalabrutinib|mesh-list
5799729|NCT02735876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5799730|NCT02735876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5799731|NCT02735876|Immunologic Factors|immunologic factors|mesh-ancestor
5799732|NCT02735876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799733|NCT02735876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5799734|NCT02735902|Aspirin|aspirin|mesh-list
5799735|NCT02735902|Vitamin K|vitamin k|mesh-list
5799736|NCT02735902|Anticoagulants|anticoagulants|mesh-list
5799737|NCT02735902|Vitamins|vitamins|mesh-ancestor
5799738|NCT02735902|Micronutrients|micronutrients|mesh-ancestor
5799739|NCT02735902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799740|NCT02735902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5799741|NCT02735902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5799742|NCT02735902|Analgesics|analgesics|mesh-ancestor
5799743|NCT02735902|Sensory System Agents|sensory system agents|mesh-ancestor
5799744|NCT02735902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5799745|NCT02735902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5799746|NCT02735902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5799747|NCT02735902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5799748|NCT02735902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5799749|NCT02735902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5799750|NCT02735902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5799751|NCT02735902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5799752|NCT02735902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5799753|NCT02735902|Antipyretics|antipyretics|mesh-ancestor
5799754|NCT02735902|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5799755|NCT02735902|Hemostatics|hemostatics|mesh-ancestor
5799756|NCT02735902|Coagulants|coagulants|mesh-ancestor
5799757|NCT02735798|Trastuzumab|trastuzumab|mesh-list
5799758|NCT02735798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5799759|NCT02735798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5799760|NCT02735590|Isoniazid|isoniazid|mesh-list
5799761|NCT02735590|Rifapentine|rifapentine|mesh-list
5799762|NCT02735590|Antitubercular Agents|antitubercular agents|mesh-ancestor
5799763|NCT02735590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5799764|NCT02735590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5799765|NCT02735590|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5799766|NCT02735590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5799767|NCT02735590|Antimetabolites|antimetabolites|mesh-ancestor
5641421|NCT03206463|Dronabinol|dronabinol|mesh-list
5641422|NCT03206463|Hallucinogens|hallucinogens|mesh-ancestor
5641423|NCT03206463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641424|NCT03206463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5641425|NCT03206463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5641426|NCT03206463|Analgesics|analgesics|mesh-ancestor
5799768|NCT02735590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5799769|NCT02735590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5799770|NCT02735590|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5799771|NCT02735590|Leprostatic Agents|leprostatic agents|mesh-ancestor
5799772|NCT02735694|Cycloserine|cycloserine|mesh-list
5799773|NCT02735694|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5799774|NCT02735694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5799775|NCT02735694|Renal Agents|renal agents|mesh-ancestor
5799776|NCT02735694|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5799777|NCT02735694|Antitubercular Agents|antitubercular agents|mesh-ancestor
5799778|NCT02735694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5799779|NCT02735694|Antimetabolites|antimetabolites|mesh-ancestor
5799780|NCT02735694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5799781|NCT02735395|Amoxicillin|amoxicillin|mesh-list
5799782|NCT02735395|Metronidazole|metronidazole|mesh-list
5799783|NCT02735395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5799784|NCT02735395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5799785|NCT02735395|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5799786|NCT02735395|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5799787|NCT02735473|Choline|choline|mesh-list
5799788|NCT02735473|Lipotropic Agents|lipotropic agents|mesh-ancestor
5799789|NCT02735473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5799790|NCT02735473|Antimetabolites|antimetabolites|mesh-ancestor
5799791|NCT02735473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5799792|NCT02735473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5799793|NCT02735473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5799794|NCT02735473|Nootropic Agents|nootropic agents|mesh-ancestor
5641427|NCT03206463|Sensory System Agents|sensory system agents|mesh-ancestor
5641428|NCT03206463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5641429|NCT03206463|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5641430|NCT03206463|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5799795|NCT02735343|Ketamine|ketamine|mesh-list
5799796|NCT02735343|Prochlorperazine|prochlorperazine|mesh-list
5799797|NCT02735343|Analgesics|analgesics|mesh-ancestor
5799798|NCT02735343|Sensory System Agents|sensory system agents|mesh-ancestor
5799799|NCT02735343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5799800|NCT02735343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799801|NCT02735343|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5799802|NCT02735343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5641431|NCT03206463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5641432|NCT03206463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641433|NCT03206463|Hormones|hormones|mesh-ancestor
5641434|NCT03206463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5641435|NCT03166761|Dexamethasone|dexamethasone|mesh-list
5641436|NCT03166761|Triamcinolone|triamcinolone|mesh-list
5641437|NCT03166761|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5641438|NCT03166761|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5641439|NCT03166761|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5641440|NCT03166761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5641441|NCT03166761|Antiemetics|antiemetics|mesh-ancestor
5799803|NCT02735343|Anesthetics, General|anesthetics, general|mesh-ancestor
5799804|NCT02735343|Anesthetics|anesthetics|mesh-ancestor
5799805|NCT02735343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5799806|NCT02735343|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5799807|NCT02735343|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5799808|NCT02735343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5799809|NCT02735343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5799810|NCT02735343|Antiemetics|antiemetics|mesh-ancestor
5799811|NCT02735343|Autonomic Agents|autonomic agents|mesh-ancestor
5799812|NCT02735343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5799813|NCT02735343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5799814|NCT02735343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5799815|NCT02735343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5799816|NCT02735343|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5799817|NCT02735343|Dopamine Agents|dopamine agents|mesh-ancestor
5799818|NCT02735356|Itraconazole|itraconazole|mesh-list
5799819|NCT02735356|Antifungal Agents|antifungal agents|mesh-ancestor
5799820|NCT02735356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5799821|NCT02735356|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5799822|NCT02735356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5799823|NCT02735356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5799824|NCT02735356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5799825|NCT02735356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5799826|NCT02735356|Hormone Antagonists|hormone antagonists|mesh-ancestor
5799827|NCT02735356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5799828|NCT02735356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799829|NCT02735356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5799830|NCT02735603|Moxifloxacin|moxifloxacin|mesh-list
5799831|NCT02735603|Naltrexone|naltrexone|mesh-list
5799832|NCT02735603|Bupropion|bupropion|mesh-list
5799833|NCT02735603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5799834|NCT02735603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5799835|NCT02735603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5799836|NCT02735603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5799837|NCT02735603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5799838|NCT02735603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5799839|NCT02735603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5799840|NCT02735603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799841|NCT02735603|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5799842|NCT02735603|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5799843|NCT02735603|Sensory System Agents|sensory system agents|mesh-ancestor
5799844|NCT02735603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5799845|NCT02735603|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5799846|NCT02735603|Antidepressive Agents|antidepressive agents|mesh-ancestor
5799847|NCT02735603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5799848|NCT02735603|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5799849|NCT02735603|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5799850|NCT02735603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5799851|NCT02735603|Dopamine Agents|dopamine agents|mesh-ancestor
5799852|NCT02735603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5799853|NCT02735603|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5799854|NCT02735603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5799855|NCT02735330|Ethanol|ethanol|mesh-list
5799856|NCT02735330|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5799857|NCT02735330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6211009|NCT02168062|Luteolytic Agents|luteolytic agents|mesh-ancestor
5799858|NCT02735330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5799859|NCT02735330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799860|NCT02735317|Vitamin B 12|vitamin b 12|mesh-list
5799861|NCT02735317|Hydroxocobalamin|hydroxocobalamin|mesh-list
5799862|NCT02735317|Gentamicins|gentamicins|mesh-list
5799863|NCT02735317|Dexamethasone|dexamethasone|mesh-list
5799864|NCT02735317|Procaine|procaine|mesh-list
5799865|NCT02735317|Vitamins|vitamins|mesh-ancestor
5799866|NCT02735317|Micronutrients|micronutrients|mesh-ancestor
5799867|NCT02735317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799868|NCT02735317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5799869|NCT02735317|Antiemetics|antiemetics|mesh-ancestor
5799870|NCT02735317|Autonomic Agents|autonomic agents|mesh-ancestor
5799871|NCT02735317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5799872|NCT02735317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5799873|NCT02735317|Glucocorticoids|glucocorticoids|mesh-ancestor
5799874|NCT02735317|Hormones|hormones|mesh-ancestor
5799875|NCT02735317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5799876|NCT02735317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5799877|NCT02735317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5799878|NCT02735317|Vitamin B Complex|vitamin b complex|mesh-ancestor
5799879|NCT02735317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5799880|NCT02735317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5799881|NCT02735317|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5799882|NCT02735317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5799883|NCT02735317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5799884|NCT02735317|Hematinics|hematinics|mesh-ancestor
5799885|NCT02735317|Anesthetics, Local|anesthetics, local|mesh-ancestor
6674007|NCT01566669|Sensory System Agents|sensory system agents|mesh-ancestor
5641442|NCT03166761|Autonomic Agents|autonomic agents|mesh-ancestor
5641443|NCT03166761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5641444|NCT03166761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641445|NCT03166761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5641446|NCT03166761|Glucocorticoids|glucocorticoids|mesh-ancestor
5641447|NCT03166761|Hormones|hormones|mesh-ancestor
5641448|NCT03166761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5641449|NCT03166761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5641450|NCT03166761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5641451|NCT03166761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5641452|NCT03166761|Immunologic Factors|immunologic factors|mesh-ancestor
5641453|NCT03166761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5641454|NCT03166761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641455|NCT03153410|Cyclophosphamide|cyclophosphamide|mesh-list
5641456|NCT03153410|Pembrolizumab|pembrolizumab|mesh-list
5641457|NCT03153410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5641458|NCT03153410|Immunologic Factors|immunologic factors|mesh-ancestor
5641459|NCT03153410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641460|NCT03153410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5641461|NCT03153410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5799886|NCT02735317|Anesthetics|anesthetics|mesh-ancestor
5799887|NCT02735317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5799888|NCT02735317|Sensory System Agents|sensory system agents|mesh-ancestor
5799889|NCT02735031|Exenatide|exenatide|mesh-list
5799890|NCT02735031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5799891|NCT02735031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799892|NCT02735031|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5799893|NCT02735031|Incretins|incretins|mesh-ancestor
5799894|NCT02735031|Hormones|hormones|mesh-ancestor
5799895|NCT02735031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5799896|NCT02735057|Paclitaxel|paclitaxel|mesh-list
5799897|NCT02735057|Carboplatin|carboplatin|mesh-list
5799898|NCT02735057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5799899|NCT02735057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5799900|NCT02735057|Tubulin Modulators|tubulin modulators|mesh-ancestor
5799901|NCT02735057|Antimitotic Agents|antimitotic agents|mesh-ancestor
5799902|NCT02735057|Mitosis Modulators|mitosis modulators|mesh-ancestor
5799903|NCT02735057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5799904|NCT02734875|Anticoagulants|anticoagulants|mesh-list
5799905|NCT02735018|Epinephrine|epinephrine|mesh-list
5799906|NCT02735018|Racepinephrine|racepinephrine|mesh-list
5799907|NCT02735018|Epinephryl borate|epinephryl borate|mesh-list
5799908|NCT02735018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5799909|NCT02735018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5799910|NCT02735018|Adrenergic Agents|adrenergic agents|mesh-ancestor
5799911|NCT02735018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5799912|NCT02735018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5799913|NCT02735018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799914|NCT02735018|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5799915|NCT02735018|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5799916|NCT02735018|Autonomic Agents|autonomic agents|mesh-ancestor
5799917|NCT02735018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5799918|NCT02735018|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5799919|NCT02735018|Respiratory System Agents|respiratory system agents|mesh-ancestor
5799920|NCT02735018|Mydriatics|mydriatics|mesh-ancestor
5799921|NCT02735018|Sympathomimetics|sympathomimetics|mesh-ancestor
5799922|NCT02735018|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5799923|NCT02734771|Prednisone|prednisone|mesh-list
5799924|NCT02734771|Cyclophosphamide|cyclophosphamide|mesh-list
5799925|NCT02734771|Rituximab|rituximab|mesh-list
5799926|NCT02734771|Doxorubicin|doxorubicin|mesh-list
5799927|NCT02734771|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5799928|NCT02734771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5799929|NCT02734771|Immunologic Factors|immunologic factors|mesh-ancestor
5799930|NCT02734771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799931|NCT02734771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5799932|NCT02734771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6491784|NCT00604682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6491785|NCT00604682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6491786|NCT00604682|Analgesics|analgesics|mesh-ancestor
6491787|NCT00604682|Sensory System Agents|sensory system agents|mesh-ancestor
6211010|NCT02168062|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5799933|NCT02734771|Alkylating Agents|alkylating agents|mesh-ancestor
5799934|NCT02734771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5799935|NCT02734771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5799936|NCT02734771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5799937|NCT02734771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5799938|NCT02734771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5799939|NCT02734771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5799940|NCT02734771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5799941|NCT02734771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5799942|NCT02734771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5799943|NCT02734771|Glucocorticoids|glucocorticoids|mesh-ancestor
5799944|NCT02734771|Hormones|hormones|mesh-ancestor
5799945|NCT02734771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5799946|NCT02734771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5799947|NCT02734602|Ketamine|ketamine|mesh-list
5799948|NCT02734602|Analgesics|analgesics|mesh-ancestor
5799949|NCT02734602|Sensory System Agents|sensory system agents|mesh-ancestor
5799950|NCT02734602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5799951|NCT02734602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799952|NCT02734602|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5799953|NCT02734602|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5799954|NCT02734602|Anesthetics, General|anesthetics, general|mesh-ancestor
5799955|NCT02734602|Anesthetics|anesthetics|mesh-ancestor
5799956|NCT02734602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5799957|NCT02734602|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5799958|NCT02734602|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5799959|NCT02734602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5799960|NCT02734602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5799961|NCT02734732|Ciprofloxacin|ciprofloxacin|mesh-list
5799962|NCT02734732|Trimethoprim|trimethoprim|mesh-list
5799963|NCT02734732|Sulfamethoxazole|sulfamethoxazole|mesh-list
5799964|NCT02734732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5799965|NCT02734732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5799966|NCT02734732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5799967|NCT02734732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5799968|NCT02734732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5799969|NCT02734732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5799970|NCT02734732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5799971|NCT02734732|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5799972|NCT02734732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5799973|NCT02734732|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5799974|NCT02734732|Renal Agents|renal agents|mesh-ancestor
5799975|NCT02734732|Antimalarials|antimalarials|mesh-ancestor
5799976|NCT02734732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5799977|NCT02734732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5799978|NCT02734732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5799979|NCT02734732|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5799980|NCT02734732|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
5799981|NCT02734524|Carboplatin|carboplatin|mesh-list
5799982|NCT02734524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5799983|NCT02734511|Propofol|propofol|mesh-list
5799984|NCT02734511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5799985|NCT02734511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5799986|NCT02734511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5799987|NCT02734511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5799988|NCT02734511|Anesthetics, General|anesthetics, general|mesh-ancestor
5799989|NCT02734511|Anesthetics|anesthetics|mesh-ancestor
5799990|NCT02734420|Tolonium Chloride|tolonium chloride|mesh-list
5799991|NCT02734420|Hemostatics|hemostatics|mesh-ancestor
5799992|NCT02734420|Coagulants|coagulants|mesh-ancestor
5799993|NCT02734420|Heparin Antagonists|heparin antagonists|mesh-ancestor
5799994|NCT02734420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899891|NCT05127369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5899892|NCT05127369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5899893|NCT05127369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899894|NCT05127369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5899895|NCT05127369|Serotonin Agents|serotonin agents|mesh-ancestor
5899896|NCT05127369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899897|NCT05127369|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5899898|NCT05127369|Antidepressive Agents|antidepressive agents|mesh-ancestor
5899899|NCT05127369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5799995|NCT02734407|Aflibercept|aflibercept|mesh-list
5799996|NCT02734407|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5799997|NCT02734407|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5799998|NCT02734407|Growth Substances|growth substances|mesh-ancestor
5799999|NCT02734407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800000|NCT02734407|Growth Inhibitors|growth inhibitors|mesh-ancestor
5800001|NCT02734407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5800002|NCT02734173|Ritonavir|ritonavir|mesh-list
5800003|NCT02734173|Ribavirin|ribavirin|mesh-list
5800004|NCT02734173|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5800005|NCT02734173|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5800006|NCT02734173|Protease Inhibitors|protease inhibitors|mesh-ancestor
5800007|NCT02734173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5800008|NCT02734173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800009|NCT02734173|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5800010|NCT02734173|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5800011|NCT02734173|Antiviral Agents|antiviral agents|mesh-ancestor
5800012|NCT02734173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5800013|NCT02734173|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5800014|NCT02734173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5800015|NCT02734173|Antimetabolites|antimetabolites|mesh-ancestor
5800016|NCT02734069|Carboplatin|carboplatin|mesh-list
5800017|NCT02734069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5800018|NCT02734186|Praziquantel|praziquantel|mesh-list
5800019|NCT02734186|Anthelmintics|anthelmintics|mesh-ancestor
5800020|NCT02734186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5800021|NCT02734186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5800022|NCT02734160|Durvalumab|durvalumab|mesh-list
5800023|NCT02734160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5800024|NCT02734160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5800025|NCT02733952|Tranexamic Acid|tranexamic acid|mesh-list
5800026|NCT02733952|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5800027|NCT02733952|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5800028|NCT02733952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800029|NCT02733952|Hemostatics|hemostatics|mesh-ancestor
5800030|NCT02733952|Coagulants|coagulants|mesh-ancestor
5800031|NCT02733809|Sorafenib|sorafenib|mesh-list
5800032|NCT02733809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6211011|NCT02168062|Contraceptive Agents|contraceptive agents|mesh-ancestor
5641462|NCT03153410|Alkylating Agents|alkylating agents|mesh-ancestor
5641463|NCT03153410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641464|NCT03153410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5641465|NCT03153410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5641466|NCT03153410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5641467|NCT03148457|Rivaroxaban|rivaroxaban|mesh-list
5641468|NCT03148457|Apixaban|apixaban|mesh-list
5641469|NCT03148457|Edoxaban|edoxaban|mesh-list
5641470|NCT03148457|Dabigatran|dabigatran|mesh-list
5800033|NCT02733809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5800034|NCT02733809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5800035|NCT02733809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800036|NCT02733640|Pantoprazole|pantoprazole|mesh-list
5800037|NCT02733640|Ranitidine|ranitidine|mesh-list
5800038|NCT02733640|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
5800039|NCT02733640|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6212616|NCT02191397|Parasympatholytics|parasympatholytics|mesh-ancestor
6674008|NCT01566669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6674009|NCT01566669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674010|NCT01566669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6674011|NCT01566669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6674012|NCT01566734|Cefazolin|cefazolin|mesh-list
6674013|NCT01566734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6674014|NCT01566734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6674015|NCT01566760|Fesoterodine|fesoterodine|mesh-list
6674016|NCT01566760|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6674017|NCT01566760|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6674018|NCT01566760|Cholinergic Agents|cholinergic agents|mesh-ancestor
6674019|NCT01566760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6674020|NCT01566760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674021|NCT01566760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674022|NCT01566760|Urological Agents|urological agents|mesh-ancestor
6674023|NCT01566799|Metformin|metformin|mesh-list
6674024|NCT01566799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6674025|NCT01566799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674026|NCT01566825|Amitriptyline|amitriptyline|mesh-list
6674027|NCT01566825|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6674028|NCT01566825|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6674029|NCT01566825|Antidepressive Agents|antidepressive agents|mesh-ancestor
6674030|NCT01566825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6674031|NCT01566825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6674032|NCT01566825|Analgesics|analgesics|mesh-ancestor
6674033|NCT01566825|Sensory System Agents|sensory system agents|mesh-ancestor
6674034|NCT01566825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6674035|NCT01566825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674036|NCT01566825|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6674037|NCT01566825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6674038|NCT01566825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6674039|NCT01566825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674040|NCT01566825|Adrenergic Agents|adrenergic agents|mesh-ancestor
6674041|NCT01566825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6674042|NCT01566825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6674043|NCT01566825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6674044|NCT01566825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6674045|NCT01566890|Regadenoson|regadenoson|mesh-list
6674046|NCT01566890|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
6674047|NCT01566890|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6674048|NCT01566890|Purinergic Agonists|purinergic agonists|mesh-ancestor
6674049|NCT01566890|Purinergic Agents|purinergic agents|mesh-ancestor
6674050|NCT01566890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5800040|NCT02733640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5800041|NCT02733640|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5800042|NCT02733640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5800043|NCT02733640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800044|NCT02733640|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5800045|NCT02733640|Histamine Antagonists|histamine antagonists|mesh-ancestor
5800046|NCT02733640|Histamine Agents|histamine agents|mesh-ancestor
5800047|NCT02733640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5800048|NCT02733640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800049|NCT02733835|Remifentanil|remifentanil|mesh-list
5800050|NCT02733835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5800051|NCT02733835|Narcotics|narcotics|mesh-ancestor
5800052|NCT02733835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5800053|NCT02733835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674051|NCT01566890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674052|NCT01566890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800054|NCT02733835|Analgesics|analgesics|mesh-ancestor
5800055|NCT02733835|Sensory System Agents|sensory system agents|mesh-ancestor
5800056|NCT02733835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5800057|NCT02733887|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5800058|NCT02733887|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5800059|NCT02733887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800060|NCT02733822|Naloxone|naloxone|mesh-list
5800061|NCT02733822|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5800062|NCT02733822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800063|NCT02733822|Sensory System Agents|sensory system agents|mesh-ancestor
5800064|NCT02733822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5800065|NCT02733679|Metformin|metformin|mesh-list
5800066|NCT02733679|Pioglitazone|pioglitazone|mesh-list
5800067|NCT02733679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5800068|NCT02733679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800069|NCT02733874|Betamethasone|betamethasone|mesh-list
5800070|NCT02733874|Clobetasol|clobetasol|mesh-list
5800071|NCT02733874|Calcipotriene|calcipotriene|mesh-list
5800072|NCT02733874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5800073|NCT02733874|Glucocorticoids|glucocorticoids|mesh-ancestor
5641471|NCT03148457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5641472|NCT03148457|Antithrombins|antithrombins|mesh-ancestor
5641473|NCT03148457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5641474|NCT03148457|Protease Inhibitors|protease inhibitors|mesh-ancestor
5641475|NCT03148457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5641476|NCT03148457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641477|NCT03148457|Anticoagulants|anticoagulants|mesh-ancestor
5641478|NCT03072147|Teriparatide|teriparatide|mesh-list
5641479|NCT03072147|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5641480|NCT03072147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641481|NCT03072147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5800074|NCT02733874|Hormones|hormones|mesh-ancestor
5800075|NCT02733874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5800076|NCT02733874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800077|NCT02733874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5800078|NCT02733874|Respiratory System Agents|respiratory system agents|mesh-ancestor
5800079|NCT02733874|Dermatologic Agents|dermatologic agents|mesh-ancestor
5800080|NCT02733705|Fentanyl|fentanyl|mesh-list
5800081|NCT02733705|Propofol|propofol|mesh-list
5800082|NCT02733705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5800083|NCT02733705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5800084|NCT02733705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800085|NCT02733705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5800086|NCT02733705|Anesthetics, General|anesthetics, general|mesh-ancestor
5800087|NCT02733705|Anesthetics|anesthetics|mesh-ancestor
5800088|NCT02733705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5800089|NCT02733705|Narcotics|narcotics|mesh-ancestor
5800090|NCT02733705|Analgesics|analgesics|mesh-ancestor
5800091|NCT02733705|Sensory System Agents|sensory system agents|mesh-ancestor
5800092|NCT02733705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5800093|NCT02733705|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5800094|NCT02733510|Methylprednisolone|methylprednisolone|mesh-list
5800095|NCT02733510|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5800096|NCT02733510|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5800097|NCT02733510|Prednisolone|prednisolone|mesh-list
5800098|NCT02733510|Prednisolone acetate|prednisolone acetate|mesh-list
5800099|NCT02733510|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5800100|NCT02733510|Prednisolone phosphate|prednisolone phosphate|mesh-list
5800101|NCT02733510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5800102|NCT02733510|Antiemetics|antiemetics|mesh-ancestor
5800103|NCT02733510|Autonomic Agents|autonomic agents|mesh-ancestor
5800104|NCT02733510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5800105|NCT02733510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800106|NCT02733510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5800107|NCT02733510|Glucocorticoids|glucocorticoids|mesh-ancestor
5800108|NCT02733510|Hormones|hormones|mesh-ancestor
5800109|NCT02733510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5800110|NCT02733510|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5800111|NCT02733510|Protective Agents|protective agents|mesh-ancestor
5800112|NCT02733510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5800113|NCT02733510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5800114|NCT02733471|Lidocaine|lidocaine|mesh-list
5800115|NCT02733471|Anesthetics, Local|anesthetics, local|mesh-ancestor
5800116|NCT02733471|Anesthetics|anesthetics|mesh-ancestor
5800117|NCT02733471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5800118|NCT02733471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800119|NCT02733471|Sensory System Agents|sensory system agents|mesh-ancestor
5800120|NCT02733471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5800121|NCT02733471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5800122|NCT02733471|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5800123|NCT02733471|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5800124|NCT02733471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5800125|NCT02733471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800126|NCT02733458|Gemcitabine|gemcitabine|mesh-list
5800127|NCT02733458|Dexamethasone|dexamethasone|mesh-list
5800128|NCT02733458|Etoposide|etoposide|mesh-list
5800129|NCT02733458|Pegaspargase|pegaspargase|mesh-list
5800130|NCT02733458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5800131|NCT02733458|Antiemetics|antiemetics|mesh-ancestor
5800132|NCT02733458|Autonomic Agents|autonomic agents|mesh-ancestor
5800133|NCT02733458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5800134|NCT02733458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800135|NCT02733458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5800136|NCT02733458|Glucocorticoids|glucocorticoids|mesh-ancestor
5800137|NCT02733458|Hormones|hormones|mesh-ancestor
5800138|NCT02733458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5800139|NCT02733458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5800140|NCT02733458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5800141|NCT02733458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5800142|NCT02733458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800143|NCT02733458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5800144|NCT02733458|Antimetabolites|antimetabolites|mesh-ancestor
5800145|NCT02733458|Antiviral Agents|antiviral agents|mesh-ancestor
5800146|NCT02733458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6211012|NCT02168062|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6211013|NCT02168101|Ixazomib|ixazomib|mesh-list
6211014|NCT02168101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6211015|NCT02168101|Protease Inhibitors|protease inhibitors|mesh-ancestor
6211016|NCT02168101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6212617|NCT02191397|Autonomic Agents|autonomic agents|mesh-ancestor
5641482|NCT03032250|Hydrocortisone|hydrocortisone|mesh-list
5641483|NCT03032250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5641484|NCT03016533|Lamivudine|lamivudine|mesh-list
5641485|NCT03016533|Dolutegravir|dolutegravir|mesh-list
5641486|NCT03016533|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5641487|NCT03016533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5641488|NCT03016533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5641489|NCT03016533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641490|NCT03016533|Antiviral Agents|antiviral agents|mesh-ancestor
5641491|NCT03016533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5641492|NCT03016533|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5641493|NCT03016533|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5641494|NCT03016533|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5641495|NCT03016533|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5641496|NCT03011814|Lenalidomide|lenalidomide|mesh-list
5641497|NCT03011814|Durvalumab|durvalumab|mesh-list
5641498|NCT03011814|Immunoglobulins|immunoglobulins|mesh-list
5641499|NCT03011814|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5641500|NCT03011814|Immunoglobulin G|immunoglobulin g|mesh-list
5641501|NCT03011814|Immunologic Factors|immunologic factors|mesh-ancestor
5641502|NCT03011814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641503|NCT03011814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5800147|NCT02733458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5800148|NCT02733458|Immunologic Factors|immunologic factors|mesh-ancestor
5800149|NCT02733458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5800150|NCT02733458|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5800151|NCT02733458|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5800152|NCT02733445|Dasatinib|dasatinib|mesh-list
5800153|NCT02733445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5800154|NCT02733445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5800155|NCT02733445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5800156|NCT02733445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800157|NCT02733185|Vitamins|vitamins|mesh-list
5800158|NCT02733185|Edetic Acid|edetic acid|mesh-list
5800159|NCT02733185|Pentetic Acid|pentetic acid|mesh-list
5800160|NCT02733185|Micronutrients|micronutrients|mesh-ancestor
5800161|NCT02733185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800162|NCT02733185|Anticoagulants|anticoagulants|mesh-ancestor
5800163|NCT02733185|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5800164|NCT02733185|Chelating Agents|chelating agents|mesh-ancestor
5800165|NCT02733185|Sequestering Agents|sequestering agents|mesh-ancestor
5800166|NCT02733185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800167|NCT02733185|Antidotes|antidotes|mesh-ancestor
5800168|NCT02733185|Protective Agents|protective agents|mesh-ancestor
5800169|NCT02733185|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5800170|NCT02733159|Pembrolizumab|pembrolizumab|mesh-list
5800171|NCT02733159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5800172|NCT02733159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5800173|NCT02733107|Etoposide|etoposide|mesh-list
5800174|NCT02733107|Apatinib|apatinib|mesh-list
5800175|NCT02733107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5800176|NCT02733107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5800177|NCT02733107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5800178|NCT02733107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5800179|NCT02733107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5800180|NCT02733107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800181|NCT02733107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5800182|NCT02733237|Oxytocin|oxytocin|mesh-list
5800183|NCT02733237|Oxytocics|oxytocics|mesh-ancestor
5800184|NCT02733237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5800185|NCT02733237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800186|NCT02733250|Paclitaxel|paclitaxel|mesh-list
5800187|NCT02733250|Pembrolizumab|pembrolizumab|mesh-list
5800188|NCT02733250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5800189|NCT02733250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5800190|NCT02733250|Tubulin Modulators|tubulin modulators|mesh-ancestor
5800191|NCT02733250|Antimitotic Agents|antimitotic agents|mesh-ancestor
5800192|NCT02733250|Mitosis Modulators|mitosis modulators|mesh-ancestor
5800193|NCT02733250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800194|NCT02733250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5800195|NCT02733419|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
5800196|NCT02733419|Enfuvirtide|enfuvirtide|mesh-list
5800197|NCT02733419|Antiviral Agents|antiviral agents|mesh-ancestor
5800198|NCT02733419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5800199|NCT02733419|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5800200|NCT02733419|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5800201|NCT02733419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800202|NCT02733419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5800203|NCT02733393|Lidocaine|lidocaine|mesh-list
5800204|NCT02733393|Anesthetics, Local|anesthetics, local|mesh-ancestor
5800205|NCT02733393|Anesthetics|anesthetics|mesh-ancestor
5800206|NCT02733393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5800207|NCT02733393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800208|NCT02733393|Sensory System Agents|sensory system agents|mesh-ancestor
5800209|NCT02733393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5800210|NCT02733393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5800211|NCT02733393|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5800212|NCT02733393|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6211017|NCT02168101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211018|NCT02168309|Labetalol|labetalol|mesh-list
6211019|NCT02168309|Nifedipine|nifedipine|mesh-list
6211020|NCT02168309|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6211021|NCT02168309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5800213|NCT02733393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5800214|NCT02733393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800215|NCT02733380|Thalidomide|thalidomide|mesh-list
5800216|NCT02733380|Dexamethasone|dexamethasone|mesh-list
5800217|NCT02733380|Doxorubicin|doxorubicin|mesh-list
5800218|NCT02733380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5800219|NCT02733380|Vinorelbine|vinorelbine|mesh-list
5800220|NCT02733380|Mitoxantrone|mitoxantrone|mesh-list
5800221|NCT02733380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5800222|NCT02733380|Antiemetics|antiemetics|mesh-ancestor
5800223|NCT02733380|Autonomic Agents|autonomic agents|mesh-ancestor
5800224|NCT02733380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5800225|NCT02733380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800226|NCT02733380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5800227|NCT02733380|Glucocorticoids|glucocorticoids|mesh-ancestor
5800228|NCT02733380|Hormones|hormones|mesh-ancestor
5800229|NCT02733380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5800230|NCT02733380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5800231|NCT02733380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5800232|NCT02733380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5800233|NCT02733380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5800234|NCT02733380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5800235|NCT02733380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5800236|NCT02733380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800237|NCT02733380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5800238|NCT02733380|Tubulin Modulators|tubulin modulators|mesh-ancestor
5800239|NCT02733380|Antimitotic Agents|antimitotic agents|mesh-ancestor
5800240|NCT02733380|Mitosis Modulators|mitosis modulators|mesh-ancestor
5800241|NCT02733380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5800242|NCT02733380|Immunologic Factors|immunologic factors|mesh-ancestor
5800243|NCT02733380|Leprostatic Agents|leprostatic agents|mesh-ancestor
5800244|NCT02733380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5800245|NCT02733380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5800246|NCT02733380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5800247|NCT02733380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5800248|NCT02733380|Growth Substances|growth substances|mesh-ancestor
5800249|NCT02733380|Growth Inhibitors|growth inhibitors|mesh-ancestor
5800250|NCT02733380|Analgesics|analgesics|mesh-ancestor
5800251|NCT02733380|Sensory System Agents|sensory system agents|mesh-ancestor
5800252|NCT02733341|Ticagrelor|ticagrelor|mesh-list
5800253|NCT02733341|Cangrelor|cangrelor|mesh-list
5800254|NCT02733341|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5800255|NCT02733341|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5800256|NCT02733341|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5800257|NCT02733341|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5800258|NCT02733341|Purinergic Agents|purinergic agents|mesh-ancestor
5800259|NCT02733341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5800260|NCT02733341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800261|NCT02733341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800262|NCT02732795|Morphine|morphine|mesh-list
5800263|NCT02732795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5800264|NCT02732795|Narcotics|narcotics|mesh-ancestor
5800265|NCT02732795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5800266|NCT02732795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800267|NCT02732795|Analgesics|analgesics|mesh-ancestor
5800268|NCT02732795|Sensory System Agents|sensory system agents|mesh-ancestor
5800269|NCT02732795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5800270|NCT02732730|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5800271|NCT02732730|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5800272|NCT02732730|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5800273|NCT02732730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5800274|NCT02732730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800275|NCT02732730|Antiviral Agents|antiviral agents|mesh-ancestor
5800276|NCT02732730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5800277|NCT02732730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5800278|NCT02732730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5800279|NCT02732756|Oxymetazoline|oxymetazoline|mesh-list
5800280|NCT02732756|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5800281|NCT02732756|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5800282|NCT02732756|Adrenergic Agents|adrenergic agents|mesh-ancestor
5800283|NCT02732756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5800284|NCT02732756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800285|NCT02732756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800286|NCT02732756|Sympathomimetics|sympathomimetics|mesh-ancestor
5800287|NCT02732756|Autonomic Agents|autonomic agents|mesh-ancestor
5800288|NCT02732756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6211022|NCT02168309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211023|NCT02168309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6211024|NCT02168309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211025|NCT02168309|Vasodilator Agents|vasodilator agents|mesh-ancestor
6211026|NCT02168309|Tocolytic Agents|tocolytic agents|mesh-ancestor
6211027|NCT02168309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6211028|NCT02168309|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6211029|NCT02168309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6211030|NCT02168309|Adrenergic Agents|adrenergic agents|mesh-ancestor
6211031|NCT02168309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5800289|NCT02732756|Nasal Decongestants|nasal decongestants|mesh-ancestor
5800290|NCT02732756|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5800291|NCT02732756|Respiratory System Agents|respiratory system agents|mesh-ancestor
5899900|NCT05127369|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5899901|NCT05127369|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5899902|NCT05127369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5899903|NCT05126901|Ferric maltol|ferric maltol|mesh-list
5899904|NCT05126901|Hematinics|hematinics|mesh-ancestor
5899905|NCT05126836|Cilostazol|cilostazol|mesh-list
5899906|NCT05126836|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5899907|NCT05126836|Autonomic Agents|autonomic agents|mesh-ancestor
5899908|NCT05126836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5899909|NCT05126836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899910|NCT05126836|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5899911|NCT05126836|Respiratory System Agents|respiratory system agents|mesh-ancestor
5899912|NCT05126836|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5899913|NCT05126836|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5899914|NCT05126836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899915|NCT05126836|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5899916|NCT05126836|Vasodilator Agents|vasodilator agents|mesh-ancestor
5899917|NCT05126836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5899918|NCT05126836|Protective Agents|protective agents|mesh-ancestor
5800292|NCT02732522|Misoprostol|misoprostol|mesh-list
5800293|NCT02732522|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5800294|NCT02732522|Abortifacient Agents|abortifacient agents|mesh-ancestor
5800295|NCT02732522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5800296|NCT02732522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800297|NCT02732522|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5800298|NCT02732522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5800299|NCT02732522|Oxytocics|oxytocics|mesh-ancestor
5800300|NCT02732678|Propranolol|propranolol|mesh-list
5800301|NCT02732678|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5800302|NCT02732678|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5800303|NCT02732678|Adrenergic Agents|adrenergic agents|mesh-ancestor
5800304|NCT02732678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5800305|NCT02732678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800306|NCT02732678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800307|NCT02732678|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5800308|NCT02732678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5800309|NCT02732678|Vasodilator Agents|vasodilator agents|mesh-ancestor
5800310|NCT02732405|Grazoprevir|grazoprevir|mesh-list
5800311|NCT02732405|Antiviral Agents|antiviral agents|mesh-ancestor
5800312|NCT02732405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5800313|NCT02732418|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
5800314|NCT02732418|Contraceptive Agents|contraceptive agents|mesh-list
5800315|NCT02732418|Medroxyprogesterone|medroxyprogesterone|mesh-list
5800316|NCT02732418|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5800317|NCT02732418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800318|NCT02732418|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5800319|NCT02732418|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5800320|NCT02732418|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5800321|NCT02732418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5800322|NCT02732418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5800323|NCT02732418|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5800324|NCT02732418|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5800325|NCT02732418|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5800326|NCT02732197|Thiopental|thiopental|mesh-list
5800327|NCT02732197|Anticonvulsants|anticonvulsants|mesh-ancestor
5800328|NCT02732197|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5800329|NCT02732197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5800330|NCT02732197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800331|NCT02732197|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5800332|NCT02732197|Anesthetics, General|anesthetics, general|mesh-ancestor
5800333|NCT02732197|Anesthetics|anesthetics|mesh-ancestor
5800334|NCT02732197|GABA Modulators|gaba modulators|mesh-ancestor
5800335|NCT02732197|GABA Agents|gaba agents|mesh-ancestor
5800336|NCT02732197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5800337|NCT02732197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800338|NCT02732067|Anesthetics|anesthetics|mesh-list
5800339|NCT02732067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5800340|NCT02732067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800341|NCT02732262|Oxycodone|oxycodone|mesh-list
5800342|NCT02732262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5800343|NCT02732262|Narcotics|narcotics|mesh-ancestor
5800344|NCT02732262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5800345|NCT02732262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800346|NCT02732262|Analgesics|analgesics|mesh-ancestor
5800347|NCT02732262|Sensory System Agents|sensory system agents|mesh-ancestor
5800348|NCT02732262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5800349|NCT02732132|Fentanyl|fentanyl|mesh-list
5800350|NCT02732132|Midazolam|midazolam|mesh-list
5800351|NCT02732132|Ketamine|ketamine|mesh-list
5800352|NCT02732132|Propofol|propofol|mesh-list
5800353|NCT02732132|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5800354|NCT02732132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6674053|NCT01566942|Oxaliplatin|oxaliplatin|mesh-list
5800355|NCT02732132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800356|NCT02732132|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5800357|NCT02732132|Anesthetics, General|anesthetics, general|mesh-ancestor
5800358|NCT02732132|Anesthetics|anesthetics|mesh-ancestor
5800359|NCT02732132|Analgesics|analgesics|mesh-ancestor
5800360|NCT02732132|Sensory System Agents|sensory system agents|mesh-ancestor
5800361|NCT02732132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5800362|NCT02732132|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5800363|NCT02732132|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5800364|NCT02732132|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5800365|NCT02732132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5800366|NCT02732132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800367|NCT02732132|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5800368|NCT02732132|Narcotics|narcotics|mesh-ancestor
5800369|NCT02732132|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5800370|NCT02732132|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5800371|NCT02732132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5800372|NCT02732132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5800373|NCT02732132|GABA Modulators|gaba modulators|mesh-ancestor
5800374|NCT02732132|GABA Agents|gaba agents|mesh-ancestor
5800375|NCT02732288|Melatonin|melatonin|mesh-list
5800376|NCT02732288|Antioxidants|antioxidants|mesh-ancestor
5800377|NCT02732288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800378|NCT02732288|Protective Agents|protective agents|mesh-ancestor
5800379|NCT02732288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800380|NCT02732288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5800381|NCT02732249|Metronidazole|metronidazole|mesh-list
5800382|NCT02732249|Clarithromycin|clarithromycin|mesh-list
5800383|NCT02732249|Potassium Citrate|potassium citrate|mesh-list
5800384|NCT02732249|Esomeprazole|esomeprazole|mesh-list
5800385|NCT02732249|Bismuth|bismuth|mesh-list
5800386|NCT02732249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800387|NCT02732249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5800388|NCT02732249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5800389|NCT02732249|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5800390|NCT02732249|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5800391|NCT02732249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5800392|NCT02732249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5800393|NCT02732249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5800394|NCT02732249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5800395|NCT02732249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5800396|NCT02732249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5800397|NCT02732249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5800398|NCT02732249|Antacids|antacids|mesh-ancestor
5800399|NCT02732249|Diuretics|diuretics|mesh-ancestor
5800400|NCT02732249|Natriuretic Agents|natriuretic agents|mesh-ancestor
5800401|NCT02732249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211032|NCT02168309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6211033|NCT02168309|Sympathomimetics|sympathomimetics|mesh-ancestor
6211034|NCT02168309|Autonomic Agents|autonomic agents|mesh-ancestor
6211035|NCT02168309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6211036|NCT02168309|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6211037|NCT02168309|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6211038|NCT02168361|Interferons|interferons|mesh-list
5800402|NCT02732249|Expectorants|expectorants|mesh-ancestor
5800403|NCT02732249|Respiratory System Agents|respiratory system agents|mesh-ancestor
5800404|NCT02732314|Desonide|desonide|mesh-list
5800405|NCT02732314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5800406|NCT02732093|Lidocaine|lidocaine|mesh-list
5800407|NCT02732093|Anesthetics, Local|anesthetics, local|mesh-ancestor
5800408|NCT02732093|Anesthetics|anesthetics|mesh-ancestor
5800409|NCT02732093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5800410|NCT02732093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800411|NCT02732093|Sensory System Agents|sensory system agents|mesh-ancestor
5800412|NCT02732093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5800413|NCT02732093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5800414|NCT02732093|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5800415|NCT02732093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5800416|NCT02732093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6211039|NCT02168361|Ribavirin|ribavirin|mesh-list
6211040|NCT02168361|Interferon-alpha|interferon-alpha|mesh-list
6211041|NCT02168361|Interferon alpha-2|interferon alpha-2|mesh-list
6211042|NCT02168361|Sofosbuvir|sofosbuvir|mesh-list
6211043|NCT02168361|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6211044|NCT02168361|Simeprevir|simeprevir|mesh-list
6211045|NCT02168361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6491788|NCT00604682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6491789|NCT00604682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800417|NCT02732093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800418|NCT02732236|Rituximab|rituximab|mesh-list
5800419|NCT02732236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5800420|NCT02732236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5800421|NCT02732236|Immunologic Factors|immunologic factors|mesh-ancestor
5800422|NCT02732236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800423|NCT02732236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5800424|NCT02731950|Magnesium Sulfate|magnesium sulfate|mesh-list
5800425|NCT02731950|Bupivacaine|bupivacaine|mesh-list
5800426|NCT02731950|Anesthetics, Local|anesthetics, local|mesh-ancestor
5800427|NCT02731950|Anesthetics|anesthetics|mesh-ancestor
5800428|NCT02731950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5800429|NCT02731950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800430|NCT02731950|Sensory System Agents|sensory system agents|mesh-ancestor
5800431|NCT02731950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5800432|NCT02731950|Analgesics|analgesics|mesh-ancestor
6491790|NCT00604682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6491791|NCT00604682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6491792|NCT00604682|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6491793|NCT00604682|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5800433|NCT02731950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5800434|NCT02731950|Anticonvulsants|anticonvulsants|mesh-ancestor
5800435|NCT02731950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5800436|NCT02731950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5800437|NCT02731950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800438|NCT02731950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5800439|NCT02731950|Tocolytic Agents|tocolytic agents|mesh-ancestor
5800440|NCT02731950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5800441|NCT02731911|Dexamethasone|dexamethasone|mesh-list
5800442|NCT02731911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5800443|NCT02731911|Antiemetics|antiemetics|mesh-ancestor
5800444|NCT02731911|Autonomic Agents|autonomic agents|mesh-ancestor
6211046|NCT02168361|Antiviral Agents|antiviral agents|mesh-ancestor
6491794|NCT00604682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5800445|NCT02731911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5800446|NCT02731911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800447|NCT02731911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5800448|NCT02731911|Glucocorticoids|glucocorticoids|mesh-ancestor
6491795|NCT00604682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491796|NCT00604864|Infliximab|infliximab|mesh-list
6491797|NCT00604864|Antibodies|antibodies|mesh-list
6491798|NCT00604864|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6491799|NCT00604864|Immunologic Factors|immunologic factors|mesh-ancestor
6491800|NCT00604864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491801|NCT00604864|Dermatologic Agents|dermatologic agents|mesh-ancestor
6491802|NCT00604864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6491803|NCT00604864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6491804|NCT00604942|Domperidone|domperidone|mesh-list
6491805|NCT00604942|Esomeprazole|esomeprazole|mesh-list
5800449|NCT02731911|Hormones|hormones|mesh-ancestor
5800450|NCT02731911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5800451|NCT02731911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5800452|NCT02731911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5800453|NCT02731664|Glucagon|glucagon|mesh-list
5800454|NCT02731664|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5800455|NCT02731664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5800456|NCT02731664|Hormones|hormones|mesh-ancestor
5800457|NCT02731664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5800458|NCT02731664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800459|NCT02731664|Incretins|incretins|mesh-ancestor
5800460|NCT02731846|Fluticasone|fluticasone|mesh-list
5800461|NCT02731846|Xhance|xhance|mesh-list
5800462|NCT02731846|Albuterol|albuterol|mesh-list
5800463|NCT02731846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5800464|NCT02731846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5800465|NCT02731846|Autonomic Agents|autonomic agents|mesh-ancestor
5800466|NCT02731846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6491806|NCT00604942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6491807|NCT00604942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5800467|NCT02731846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800468|NCT02731846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5800469|NCT02731846|Respiratory System Agents|respiratory system agents|mesh-ancestor
5800470|NCT02731846|Dermatologic Agents|dermatologic agents|mesh-ancestor
5800471|NCT02731846|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5800472|NCT02731846|Tocolytic Agents|tocolytic agents|mesh-ancestor
5800473|NCT02731846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5800474|NCT02731846|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5800475|NCT02731846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5800476|NCT02731846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5800477|NCT02731846|Adrenergic Agents|adrenergic agents|mesh-ancestor
5800478|NCT02731846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5800479|NCT02731846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800480|NCT02731612|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
5800481|NCT02731612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5800482|NCT02731612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5800483|NCT02731612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5800484|NCT02731612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800485|NCT02731612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5800486|NCT02731612|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5800487|NCT02731612|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5800488|NCT02731612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5800489|NCT02731612|Adrenergic Agents|adrenergic agents|mesh-ancestor
5800490|NCT02731612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5800491|NCT02731612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800492|NCT02731612|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5800493|NCT02731612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5800494|NCT02731612|Serotonin Agents|serotonin agents|mesh-ancestor
5800495|NCT02731612|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5800496|NCT02731612|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5800497|NCT02731612|Dopamine Agents|dopamine agents|mesh-ancestor
5800498|NCT02731560|Rituximab|rituximab|mesh-list
5800499|NCT02731560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5800500|NCT02731560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5800501|NCT02731560|Immunologic Factors|immunologic factors|mesh-ancestor
5800502|NCT02731560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800503|NCT02731560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5800504|NCT02731378|Iron|iron|mesh-list
5800505|NCT02731378|Dextrans|dextrans|mesh-list
5800506|NCT02731378|Epoetin Alfa|epoetin alfa|mesh-list
5800507|NCT02731378|Iron-Dextran Complex|iron-dextran complex|mesh-list
5800508|NCT02731378|Trace Elements|trace elements|mesh-ancestor
5800509|NCT02731378|Micronutrients|micronutrients|mesh-ancestor
5800510|NCT02731378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800511|NCT02731378|Hematinics|hematinics|mesh-ancestor
5800512|NCT02731378|Anticoagulants|anticoagulants|mesh-ancestor
5800513|NCT02731378|Plasma Substitutes|plasma substitutes|mesh-ancestor
5800514|NCT02731378|Blood Substitutes|blood substitutes|mesh-ancestor
5800515|NCT02731430|Morphine|morphine|mesh-list
5800516|NCT02731430|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5800517|NCT02731430|Narcotics|narcotics|mesh-ancestor
5800518|NCT02731430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5800519|NCT02731430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800520|NCT02731430|Analgesics|analgesics|mesh-ancestor
5800521|NCT02731430|Sensory System Agents|sensory system agents|mesh-ancestor
5800522|NCT02731430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5800523|NCT02731534|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
5800524|NCT02731534|Hematinics|hematinics|mesh-ancestor
5800525|NCT02731287|Timolol|timolol|mesh-list
5800526|NCT02731287|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5800527|NCT02731287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5800528|NCT02731287|Adrenergic Agents|adrenergic agents|mesh-ancestor
5800529|NCT02731287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5800530|NCT02731287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800531|NCT02731287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800532|NCT02731287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5800533|NCT02731287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5800534|NCT02731092|Lactoferrin|lactoferrin|mesh-list
5800535|NCT02731092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5800536|NCT02731105|Clindamycin|clindamycin|mesh-list
5800537|NCT02731105|Clindamycin palmitate|clindamycin palmitate|mesh-list
5800538|NCT02731105|Clindamycin phosphate|clindamycin phosphate|mesh-list
5800539|NCT02731105|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
5800540|NCT02731105|Tretinoin|tretinoin|mesh-list
5800541|NCT02731105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5800542|NCT02731105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5800543|NCT02731105|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5800544|NCT02731105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5800545|NCT02731105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800546|NCT02731105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5800547|NCT02731105|Keratolytic Agents|keratolytic agents|mesh-ancestor
5800548|NCT02731105|Dermatologic Agents|dermatologic agents|mesh-ancestor
5800549|NCT02731105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5800550|NCT02731105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5800551|NCT02731105|Analgesics|analgesics|mesh-ancestor
5800552|NCT02731105|Sensory System Agents|sensory system agents|mesh-ancestor
5800553|NCT02731105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5800554|NCT02731105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800555|NCT02731105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5800556|NCT02731105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5800557|NCT02730936|Anti-Infective Agents|anti-infective agents|mesh-list
5800558|NCT02730936|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5800559|NCT02730949|Folic Acid|folic acid|mesh-list
5800560|NCT02730949|Inositol|inositol|mesh-list
5800561|NCT02730949|Hematinics|hematinics|mesh-ancestor
6491808|NCT00604942|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5800562|NCT02730949|Vitamin B Complex|vitamin b complex|mesh-ancestor
5800563|NCT02730949|Vitamins|vitamins|mesh-ancestor
5800564|NCT02730949|Micronutrients|micronutrients|mesh-ancestor
5800565|NCT02730949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800566|NCT02731040|Ibandronic Acid|ibandronic acid|mesh-list
5800567|NCT02731040|Zoledronic Acid|zoledronic acid|mesh-list
5800568|NCT02731040|Diphosphonates|diphosphonates|mesh-list
5800569|NCT02731040|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5800570|NCT02731040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800571|NCT02730975|Abiraterone Acetate|abiraterone acetate|mesh-list
5800572|NCT02730975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5800573|NCT02730975|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5800574|NCT02730975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5800575|NCT02730975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800576|NCT02730975|Hormone Antagonists|hormone antagonists|mesh-ancestor
5800577|NCT02730975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5800578|NCT02730975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800579|NCT02730975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5899919|NCT05126836|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5899920|NCT05126836|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5899921|NCT05126836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5899922|NCT05126693|Botulinum Toxins|botulinum toxins|mesh-list
5899923|NCT05126693|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5899924|NCT05126693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5899925|NCT05126693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899926|NCT05126693|Cholinergic Agents|cholinergic agents|mesh-ancestor
5899927|NCT05126693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5899928|NCT05126693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899929|NCT05126602|Vitamin D|vitamin d|mesh-list
5899930|NCT05126602|Ergocalciferols|ergocalciferols|mesh-list
5899931|NCT05126602|Cholecalciferol|cholecalciferol|mesh-list
5899932|NCT05126602|Vitamins|vitamins|mesh-list
5899933|NCT05126602|Micronutrients|micronutrients|mesh-ancestor
5899934|NCT05126602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899935|NCT05126602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5899936|NCT05126602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5899937|NCT05126342|Niraparib|niraparib|mesh-list
5899938|NCT05126342|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5899939|NCT05126342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5899940|NCT05126342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899941|NCT05126342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5899942|NCT05126147|Hydroxychloroquine|hydroxychloroquine|mesh-list
5899943|NCT05126147|Antimalarials|antimalarials|mesh-ancestor
5899944|NCT05126147|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5899945|NCT05126147|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5899946|NCT05126147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5899947|NCT05126147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5899948|NCT05126147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800580|NCT02730845|Dexmedetomidine|dexmedetomidine|mesh-list
5800581|NCT02730845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5800582|NCT02730845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5800583|NCT02730845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800584|NCT02730845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5800585|NCT02730845|Analgesics|analgesics|mesh-ancestor
5800586|NCT02730845|Sensory System Agents|sensory system agents|mesh-ancestor
5800587|NCT02730845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6491809|NCT00604942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6491810|NCT00604942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491811|NCT00604942|Antiemetics|antiemetics|mesh-ancestor
6491812|NCT00604942|Autonomic Agents|autonomic agents|mesh-ancestor
6491813|NCT00604942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6491814|NCT00604942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491815|NCT00604942|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6491816|NCT00604942|Dopamine Agents|dopamine agents|mesh-ancestor
5800588|NCT02730845|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5800589|NCT02730845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5800590|NCT02730845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5800591|NCT02730845|Adrenergic Agents|adrenergic agents|mesh-ancestor
5800592|NCT02730845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5800593|NCT02730845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800594|NCT02730923|Anastrozole|anastrozole|mesh-list
5800595|NCT02730923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5800596|NCT02730923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5800597|NCT02730923|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5800598|NCT02730923|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5800599|NCT02730923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5800600|NCT02730923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800601|NCT02730923|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5800602|NCT02730923|Hormone Antagonists|hormone antagonists|mesh-ancestor
5800603|NCT02730923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5800604|NCT02730923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800605|NCT02730715|Thymoglobulin|thymoglobulin|mesh-list
5800606|NCT02730715|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5800607|NCT02730715|Basiliximab|basiliximab|mesh-list
5800608|NCT02730715|Immunologic Factors|immunologic factors|mesh-ancestor
5800609|NCT02730715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800610|NCT02730715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5800611|NCT02730689|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5800612|NCT02730689|Ezetimibe|ezetimibe|mesh-list
5800613|NCT02730689|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5800614|NCT02730689|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5800615|NCT02730689|Antimetabolites|antimetabolites|mesh-ancestor
6491817|NCT00604942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6491818|NCT00604955|Paromomycin|paromomycin|mesh-list
5800616|NCT02730689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800617|NCT02730689|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5800618|NCT02730689|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5800619|NCT02730689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5800620|NCT02730533|Esomeprazole|esomeprazole|mesh-list
5800621|NCT02730533|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5800622|NCT02730533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5800623|NCT02730533|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5800624|NCT02730533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5800625|NCT02730533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800626|NCT02730676|Menthol|menthol|mesh-list
5800627|NCT02730676|Antipruritics|antipruritics|mesh-ancestor
5800628|NCT02730676|Dermatologic Agents|dermatologic agents|mesh-ancestor
5800629|NCT02730624|Tazobactam|tazobactam|mesh-list
5800630|NCT02730624|Piperacillin|piperacillin|mesh-list
5800631|NCT02730624|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
5800632|NCT02730624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5800633|NCT02730624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5800634|NCT02730624|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5800635|NCT02730624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5800636|NCT02730624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800637|NCT02730481|Paclitaxel|paclitaxel|mesh-list
5800638|NCT02730481|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5800639|NCT02730481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5800640|NCT02730481|Tubulin Modulators|tubulin modulators|mesh-ancestor
5800641|NCT02730481|Antimitotic Agents|antimitotic agents|mesh-ancestor
5800642|NCT02730481|Mitosis Modulators|mitosis modulators|mesh-ancestor
5800643|NCT02730481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800644|NCT02730572|Methylphenidate|methylphenidate|mesh-list
5800645|NCT02730572|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5800646|NCT02730572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800647|NCT02730572|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5800648|NCT02730572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5800649|NCT02730572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5800650|NCT02730572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800651|NCT02730572|Dopamine Agents|dopamine agents|mesh-ancestor
5800652|NCT02730572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5800653|NCT02730442|Fluconazole|fluconazole|mesh-list
5800654|NCT02730442|Antifungal Agents|antifungal agents|mesh-list
5800655|NCT02730442|Clotrimazole|clotrimazole|mesh-list
5800656|NCT02730442|Miconazole|miconazole|mesh-list
5800657|NCT02730442|Olorofim|olorofim|mesh-list
5800658|NCT02730442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5800659|NCT02730442|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5800660|NCT02730442|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5800661|NCT02730442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5800662|NCT02730442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800663|NCT02730442|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5800664|NCT02730442|Hormone Antagonists|hormone antagonists|mesh-ancestor
5800665|NCT02730442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5800666|NCT02730442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800667|NCT02730442|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5800668|NCT02730442|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5800669|NCT02730442|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5800670|NCT02730442|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5800671|NCT02730364|Acetaminophen|acetaminophen|mesh-list
5800672|NCT02730364|Ascorbic Acid|ascorbic acid|mesh-list
5800673|NCT02730364|Pheniramine|pheniramine|mesh-list
5800674|NCT02730364|Phenylephrine|phenylephrine|mesh-list
5800675|NCT02730364|Oxymetazoline|oxymetazoline|mesh-list
5800676|NCT02730364|Vitamins|vitamins|mesh-ancestor
5800677|NCT02730364|Micronutrients|micronutrients|mesh-ancestor
5800678|NCT02730364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800679|NCT02730364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5800680|NCT02730364|Analgesics|analgesics|mesh-ancestor
5800681|NCT02730364|Sensory System Agents|sensory system agents|mesh-ancestor
5800682|NCT02730364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5800683|NCT02730364|Antipyretics|antipyretics|mesh-ancestor
5800684|NCT02730364|Antioxidants|antioxidants|mesh-ancestor
5800685|NCT02730364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800686|NCT02730364|Protective Agents|protective agents|mesh-ancestor
5800687|NCT02730364|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5800688|NCT02730364|Mydriatics|mydriatics|mesh-ancestor
5800689|NCT02730364|Autonomic Agents|autonomic agents|mesh-ancestor
5800690|NCT02730364|Sympathomimetics|sympathomimetics|mesh-ancestor
5800691|NCT02730364|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5800692|NCT02730364|Nasal Decongestants|nasal decongestants|mesh-ancestor
5800693|NCT02730364|Respiratory System Agents|respiratory system agents|mesh-ancestor
5800694|NCT02730364|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5800695|NCT02730364|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5800696|NCT02730364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5800697|NCT02730364|Adrenergic Agents|adrenergic agents|mesh-ancestor
5800698|NCT02730364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5800699|NCT02730364|Antipruritics|antipruritics|mesh-ancestor
5800700|NCT02730364|Dermatologic Agents|dermatologic agents|mesh-ancestor
5800701|NCT02730364|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5800702|NCT02730364|Histamine Antagonists|histamine antagonists|mesh-ancestor
5800703|NCT02730364|Histamine Agents|histamine agents|mesh-ancestor
5800704|NCT02730364|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5800705|NCT02730546|Calcium, Dietary|calcium, dietary|mesh-list
5800706|NCT02730546|Leucovorin|leucovorin|mesh-list
5800707|NCT02730546|Folic Acid|folic acid|mesh-list
5800708|NCT02730546|Paclitaxel|paclitaxel|mesh-list
5800709|NCT02730546|Carboplatin|carboplatin|mesh-list
5800710|NCT02730546|Fluorouracil|fluorouracil|mesh-list
5800711|NCT02730546|Pembrolizumab|pembrolizumab|mesh-list
5800712|NCT02730546|Oxaliplatin|oxaliplatin|mesh-list
5800713|NCT02730546|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5800714|NCT02730546|Calcium|calcium|mesh-list
5800715|NCT02730546|Levoleucovorin|levoleucovorin|mesh-list
5800716|NCT02730546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5800717|NCT02730546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5800718|NCT02730546|Tubulin Modulators|tubulin modulators|mesh-ancestor
5800719|NCT02730546|Antimitotic Agents|antimitotic agents|mesh-ancestor
5800720|NCT02730546|Mitosis Modulators|mitosis modulators|mesh-ancestor
5800721|NCT02730546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800722|NCT02730546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5800723|NCT02730546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800724|NCT02730546|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5800725|NCT02730546|Antimetabolites|antimetabolites|mesh-ancestor
5800726|NCT02730546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5800727|NCT02730546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5800728|NCT02730546|Immunologic Factors|immunologic factors|mesh-ancestor
5800729|NCT02730546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5800730|NCT02730546|Antidotes|antidotes|mesh-ancestor
5800731|NCT02730546|Protective Agents|protective agents|mesh-ancestor
5800732|NCT02730546|Vitamin B Complex|vitamin b complex|mesh-ancestor
5800733|NCT02730546|Vitamins|vitamins|mesh-ancestor
5800734|NCT02730546|Micronutrients|micronutrients|mesh-ancestor
5800735|NCT02730546|Hematinics|hematinics|mesh-ancestor
5800736|NCT02730117|Cephalosporins|cephalosporins|mesh-list
5800737|NCT02730117|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5800738|NCT02730117|Dobutamine|dobutamine|mesh-list
5800739|NCT02730117|Dopamine|dopamine|mesh-list
5800740|NCT02730117|Milrinone|milrinone|mesh-list
5800741|NCT02730117|Norepinephrine|norepinephrine|mesh-list
5800742|NCT02730117|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
5800743|NCT02730117|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5800744|NCT02730117|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5800745|NCT02730117|Adrenergic Agents|adrenergic agents|mesh-ancestor
5800746|NCT02730117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5800747|NCT02730117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800748|NCT02730117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800749|NCT02730117|Sympathomimetics|sympathomimetics|mesh-ancestor
5800750|NCT02730117|Autonomic Agents|autonomic agents|mesh-ancestor
5800751|NCT02730117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5800752|NCT02730117|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5800753|NCT02730117|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5800754|NCT02730117|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5800755|NCT02730117|Protective Agents|protective agents|mesh-ancestor
5800756|NCT02730117|Dopamine Agents|dopamine agents|mesh-ancestor
5800757|NCT02730117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5800758|NCT02730117|Vasodilator Agents|vasodilator agents|mesh-ancestor
5800759|NCT02730117|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5800760|NCT02730117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5800761|NCT02730117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5800762|NCT02730117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5800763|NCT02730091|Letrozole|letrozole|mesh-list
5800764|NCT02730091|Vinorelbine|vinorelbine|mesh-list
5800765|NCT02730091|Anastrozole|anastrozole|mesh-list
5800766|NCT02730091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5800767|NCT02730091|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5800768|NCT02730091|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5800769|NCT02730091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5800770|NCT02730091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800771|NCT02730091|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5800772|NCT02730091|Hormone Antagonists|hormone antagonists|mesh-ancestor
5800773|NCT02730091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5800774|NCT02730091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800775|NCT02730091|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5800776|NCT02730091|Tubulin Modulators|tubulin modulators|mesh-ancestor
5800777|NCT02730091|Antimitotic Agents|antimitotic agents|mesh-ancestor
5800778|NCT02730091|Mitosis Modulators|mitosis modulators|mesh-ancestor
5800779|NCT02730091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5800780|NCT02730026|Ketoprofen|ketoprofen|mesh-list
5800781|NCT02730026|Omeprazole|omeprazole|mesh-list
5800782|NCT02730026|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5800783|NCT02730026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5800784|NCT02730026|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5800785|NCT02730026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5800786|NCT02730026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800787|NCT02730026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5800788|NCT02730026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5800789|NCT02730026|Analgesics|analgesics|mesh-ancestor
5800790|NCT02730026|Sensory System Agents|sensory system agents|mesh-ancestor
5800791|NCT02730026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5800792|NCT02730026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800793|NCT02730026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5800794|NCT02730026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5800795|NCT02730026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5800796|NCT02729961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5800797|NCT02729961|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5800798|NCT02729961|Ceritinib|ceritinib|mesh-list
5800799|NCT02729961|Antibodies|antibodies|mesh-list
5800800|NCT02729961|Immunoglobulins|immunoglobulins|mesh-list
5800801|NCT02729961|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5800802|NCT02729961|Immunoconjugates|immunoconjugates|mesh-list
5800803|NCT02729961|Immunologic Factors|immunologic factors|mesh-ancestor
5800804|NCT02729961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800805|NCT02729961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5800806|NCT02729961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5800807|NCT02729961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5800808|NCT02729961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800809|NCT02729662|Tolvaptan|tolvaptan|mesh-list
5800810|NCT02729662|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
5800811|NCT02729662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800812|NCT02729662|Natriuretic Agents|natriuretic agents|mesh-ancestor
5800813|NCT02729662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800814|NCT02729766|Empagliflozin|empagliflozin|mesh-list
6674054|NCT01566942|Irinotecan|irinotecan|mesh-list
6674055|NCT01566942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6674056|NCT01566942|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6674057|NCT01566942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6674058|NCT01566942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6674059|NCT01566942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674060|NCT01567072|Ibuprofen|ibuprofen|mesh-list
6674061|NCT01567072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5800815|NCT02729766|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5800816|NCT02729766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800817|NCT02729766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5800818|NCT02729766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491819|NCT00604955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6491820|NCT00604955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6491821|NCT00604955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6491822|NCT00604955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6491823|NCT00605020|Insulin|insulin|mesh-list
6491824|NCT00605020|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6491825|NCT00605020|Insulin Aspart|insulin aspart|mesh-list
6491826|NCT00605020|Insulin, Long-Acting|insulin, long-acting|mesh-list
6491827|NCT00605020|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
5800819|NCT02729714|Suvorexant|suvorexant|mesh-list
5800820|NCT02729714|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5800821|NCT02729714|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5800822|NCT02729714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5800823|NCT02729714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800824|NCT02729714|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
5800825|NCT02729714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5800826|NCT02729714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800827|NCT02729870|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
5800828|NCT02729870|Laxatives|laxatives|mesh-ancestor
5800829|NCT02729870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5800830|NCT02729701|Bazedoxifene|bazedoxifene|mesh-list
5800831|NCT02729701|Estrogens|estrogens|mesh-list
5800832|NCT02729701|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
5800833|NCT02729701|Hormones|hormones|mesh-ancestor
5800834|NCT02729701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5800835|NCT02729701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800836|NCT02729701|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5800837|NCT02729701|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5800838|NCT02729701|Hormone Antagonists|hormone antagonists|mesh-ancestor
5800839|NCT02729701|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5800840|NCT02729805|Ketamine|ketamine|mesh-list
5800841|NCT02729805|Analgesics|analgesics|mesh-ancestor
5800842|NCT02729805|Sensory System Agents|sensory system agents|mesh-ancestor
5800843|NCT02729805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6491828|NCT00605020|Insulin Detemir|insulin detemir|mesh-list
5800844|NCT02729805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800845|NCT02729805|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5800846|NCT02729805|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5800847|NCT02729805|Anesthetics, General|anesthetics, general|mesh-ancestor
5800848|NCT02729805|Anesthetics|anesthetics|mesh-ancestor
5800849|NCT02729805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5800850|NCT02729805|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5800851|NCT02729805|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5800852|NCT02729805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5800853|NCT02729805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800854|NCT02729935|Parecoxib|parecoxib|mesh-list
5800855|NCT02729935|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5800856|NCT02729935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5800857|NCT02729935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5800858|NCT02729935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800859|NCT02729935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5800860|NCT02729935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5800861|NCT02729935|Analgesics|analgesics|mesh-ancestor
5800862|NCT02729935|Sensory System Agents|sensory system agents|mesh-ancestor
5800863|NCT02729935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5800864|NCT02729935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800865|NCT02729935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5800866|NCT02729935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5800867|NCT02729285|Ketorolac|ketorolac|mesh-list
5800868|NCT02729285|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
5800869|NCT02729285|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5800870|NCT02729285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5800871|NCT02729285|Analgesics|analgesics|mesh-ancestor
5800872|NCT02729285|Sensory System Agents|sensory system agents|mesh-ancestor
5800873|NCT02729285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5800874|NCT02729285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800875|NCT02729285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5800876|NCT02729285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6491829|NCT00605020|Biphasic Insulins|biphasic insulins|mesh-list
6491830|NCT00605020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6491831|NCT00605020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800877|NCT02729285|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5800878|NCT02729285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5800879|NCT02729285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800880|NCT02729441|Ramipril|ramipril|mesh-list
5800881|NCT02729441|Perindopril|perindopril|mesh-list
5800882|NCT02729441|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5800883|NCT02729441|Protease Inhibitors|protease inhibitors|mesh-ancestor
5800884|NCT02729441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5800885|NCT02729441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800886|NCT02729441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5800887|NCT02729376|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
5800888|NCT02729376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5800889|NCT02729376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800890|NCT02729467|Itraconazole|itraconazole|mesh-list
5800891|NCT02729467|Rifampin|rifampin|mesh-list
5800892|NCT02729467|Antifungal Agents|antifungal agents|mesh-ancestor
5800893|NCT02729467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5800894|NCT02729467|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5800895|NCT02729467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5800896|NCT02729467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5800897|NCT02729467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800898|NCT02729467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5800899|NCT02729467|Hormone Antagonists|hormone antagonists|mesh-ancestor
5800900|NCT02729467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5800901|NCT02729467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800902|NCT02729467|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5800903|NCT02729467|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5800904|NCT02729467|Antitubercular Agents|antitubercular agents|mesh-ancestor
5800905|NCT02729467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5800906|NCT02729467|Leprostatic Agents|leprostatic agents|mesh-ancestor
5800907|NCT02729467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5800908|NCT02729467|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5800909|NCT02729467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5800910|NCT02729467|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5800911|NCT02729467|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5800912|NCT02729467|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5800913|NCT02729467|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5800914|NCT02729324|Protective Agents|protective agents|mesh-list
5800915|NCT02729324|Radiation-Protective Agents|radiation-protective agents|mesh-list
5800916|NCT02729324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899949|NCT05126147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5908193|NCT04803201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5908194|NCT04803201|Alkylating Agents|alkylating agents|mesh-ancestor
5908195|NCT04803201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908196|NCT04803201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5908197|NCT04803201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5908198|NCT04803201|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5908199|NCT04803201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5908200|NCT04803201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5908201|NCT04803201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5908202|NCT04803201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5908203|NCT04803201|Glucocorticoids|glucocorticoids|mesh-ancestor
5908204|NCT04803201|Hormones|hormones|mesh-ancestor
5908205|NCT04803201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5908206|NCT04803201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5800917|NCT02729116|Ertapenem|ertapenem|mesh-list
5800918|NCT02729116|Sitafloxacin|sitafloxacin|mesh-list
5800919|NCT02729116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5800920|NCT02729116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5800921|NCT02729116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5800922|NCT02729116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5800923|NCT02729116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5800924|NCT02729116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800925|NCT02729116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5800926|NCT02729064|Insulin|insulin|mesh-list
5800927|NCT02729064|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5800928|NCT02729064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5800929|NCT02729064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800930|NCT02728869|Vaccines|vaccines|mesh-list
5800931|NCT02728869|Immunologic Factors|immunologic factors|mesh-ancestor
5800932|NCT02728869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800933|NCT02729012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5800934|NCT02728856|Sunscreening Agents|sunscreening agents|mesh-list
5800935|NCT02728856|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5800936|NCT02728856|Protective Agents|protective agents|mesh-ancestor
5800937|NCT02728856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800938|NCT02728856|Dermatologic Agents|dermatologic agents|mesh-ancestor
5800939|NCT02728947|Rotigotine|rotigotine|mesh-list
5800940|NCT02728947|Dopamine Agonists|dopamine agonists|mesh-ancestor
5800941|NCT02728947|Dopamine Agents|dopamine agents|mesh-ancestor
5800942|NCT02728947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5800943|NCT02728947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800944|NCT02728947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800945|NCT02728934|Golimumab|golimumab|mesh-list
5800946|NCT02728934|Infliximab|infliximab|mesh-list
5800947|NCT02728934|Dermatologic Agents|dermatologic agents|mesh-ancestor
5800948|NCT02728934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5800949|NCT02728934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5800950|NCT02728934|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
5800951|NCT02728934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5800952|NCT02728934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5800953|NCT02728934|Immunologic Factors|immunologic factors|mesh-ancestor
5800954|NCT02728934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800955|NCT02729103|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
5800956|NCT02729103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5800957|NCT02728843|Deferiprone|deferiprone|mesh-list
5800958|NCT02728843|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5800959|NCT02728843|Chelating Agents|chelating agents|mesh-ancestor
5800960|NCT02728843|Sequestering Agents|sequestering agents|mesh-ancestor
5800961|NCT02728843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800962|NCT02728518|Amikacin|amikacin|mesh-list
5800963|NCT02728518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5800964|NCT02728518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5800965|NCT02728700|Mycophenolic Acid|mycophenolic acid|mesh-list
5800966|NCT02728700|Sirolimus|sirolimus|mesh-list
5800967|NCT02728700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5800968|NCT02728700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5800969|NCT02728700|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5800970|NCT02728700|Antitubercular Agents|antitubercular agents|mesh-ancestor
5800971|NCT02728700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5800972|NCT02728700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5800973|NCT02728700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5800974|NCT02728700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800975|NCT02728700|Antifungal Agents|antifungal agents|mesh-ancestor
5800976|NCT02728700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5800977|NCT02728700|Immunologic Factors|immunologic factors|mesh-ancestor
5800978|NCT02728700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800979|NCT02728453|Empagliflozin|empagliflozin|mesh-list
5800980|NCT02728453|Glimepiride|glimepiride|mesh-list
5800981|NCT02728453|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5800982|NCT02728453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800983|NCT02728453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5800984|NCT02728453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5800985|NCT02728453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5800986|NCT02728453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5800987|NCT02728453|Immunologic Factors|immunologic factors|mesh-ancestor
5800988|NCT02728622|Tamoxifen|tamoxifen|mesh-list
5800989|NCT02728622|Paclitaxel|paclitaxel|mesh-list
5800990|NCT02728622|Doxorubicin|doxorubicin|mesh-list
5800991|NCT02728622|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5800992|NCT02728622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5800993|NCT02728622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5800994|NCT02728622|Tubulin Modulators|tubulin modulators|mesh-ancestor
5800995|NCT02728622|Antimitotic Agents|antimitotic agents|mesh-ancestor
5800996|NCT02728622|Mitosis Modulators|mitosis modulators|mesh-ancestor
5800997|NCT02728622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5800998|NCT02728622|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5800999|NCT02728622|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5801000|NCT02728622|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5801001|NCT02728622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5801002|NCT02728622|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5801003|NCT02728622|Hormone Antagonists|hormone antagonists|mesh-ancestor
5801004|NCT02728622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5801005|NCT02728622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801006|NCT02728622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5801007|NCT02728622|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5801008|NCT02728622|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5801009|NCT02728622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5801010|NCT02728687|Mannitol|mannitol|mesh-list
5801011|NCT02728687|Menthol|menthol|mesh-list
5801012|NCT02728687|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5801013|NCT02728687|Diuretics|diuretics|mesh-ancestor
5801014|NCT02728687|Natriuretic Agents|natriuretic agents|mesh-ancestor
5801015|NCT02728687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801016|NCT02728687|Antipruritics|antipruritics|mesh-ancestor
5801017|NCT02728687|Dermatologic Agents|dermatologic agents|mesh-ancestor
5801018|NCT02728466|Proanthocyanidin|proanthocyanidin|mesh-list
5801019|NCT02728466|Procyanidin|procyanidin|mesh-list
5801020|NCT02728466|Antioxidants|antioxidants|mesh-ancestor
5801021|NCT02728466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801022|NCT02728466|Protective Agents|protective agents|mesh-ancestor
5801023|NCT02728466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801024|NCT02728466|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5801025|NCT02728466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5801026|NCT02728466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5801027|NCT02728531|Cytarabine|cytarabine|mesh-list
5801028|NCT02728531|Rituximab|rituximab|mesh-list
5801029|NCT02728531|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5801030|NCT02728531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5801031|NCT02728531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5801032|NCT02728531|Immunologic Factors|immunologic factors|mesh-ancestor
5801033|NCT02728531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801034|NCT02728531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5801035|NCT02728531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5801036|NCT02728531|Antimetabolites|antimetabolites|mesh-ancestor
5801037|NCT02728531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801038|NCT02728531|Antiviral Agents|antiviral agents|mesh-ancestor
5801039|NCT02728531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5801040|NCT02728531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5801041|NCT02728531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6491832|NCT00605098|Ritonavir|ritonavir|mesh-list
6491833|NCT00605098|Lopinavir|lopinavir|mesh-list
5801042|NCT02728531|Alkylating Agents|alkylating agents|mesh-ancestor
5801043|NCT02728492|Gemcitabine|gemcitabine|mesh-list
5801044|NCT02728492|Paclitaxel|paclitaxel|mesh-list
5801045|NCT02728492|Carboplatin|carboplatin|mesh-list
5801046|NCT02728492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6211047|NCT02168361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6211048|NCT02168361|Antimetabolites|antimetabolites|mesh-ancestor
6211049|NCT02168361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211050|NCT02168361|Immunologic Factors|immunologic factors|mesh-ancestor
6211051|NCT02168361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211052|NCT02168361|Protease Inhibitors|protease inhibitors|mesh-ancestor
6211053|NCT02168361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6211054|NCT02168387|Acetylcysteine|acetylcysteine|mesh-list
6211055|NCT02168387|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6211056|NCT02168387|Antiviral Agents|antiviral agents|mesh-ancestor
6211057|NCT02168387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6211058|NCT02168387|Expectorants|expectorants|mesh-ancestor
6211059|NCT02168387|Respiratory System Agents|respiratory system agents|mesh-ancestor
6211060|NCT02168387|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6211061|NCT02168387|Antioxidants|antioxidants|mesh-ancestor
6674062|NCT01567072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5801047|NCT02728492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5801048|NCT02728492|Tubulin Modulators|tubulin modulators|mesh-ancestor
5801049|NCT02728492|Antimitotic Agents|antimitotic agents|mesh-ancestor
5801050|NCT02728492|Mitosis Modulators|mitosis modulators|mesh-ancestor
5801051|NCT02728492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801052|NCT02728492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5801053|NCT02728492|Antimetabolites|antimetabolites|mesh-ancestor
5801054|NCT02728492|Antiviral Agents|antiviral agents|mesh-ancestor
5801055|NCT02728492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5801056|NCT02728492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5801057|NCT02728492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5801058|NCT02728492|Immunologic Factors|immunologic factors|mesh-ancestor
5801059|NCT02728492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801060|NCT02728440|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5801061|NCT02728440|Menotropins|menotropins|mesh-list
5801062|NCT02728440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5801063|NCT02728440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801064|NCT02728440|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5801065|NCT02728440|Fertility Agents|fertility agents|mesh-ancestor
5801066|NCT02728323|Levobupivacaine|levobupivacaine|mesh-list
5801067|NCT02728323|Anesthetics, Local|anesthetics, local|mesh-ancestor
5801068|NCT02728323|Anesthetics|anesthetics|mesh-ancestor
5801069|NCT02728323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5801070|NCT02728323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801071|NCT02728323|Sensory System Agents|sensory system agents|mesh-ancestor
5801072|NCT02728323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6674063|NCT01567072|Analgesics|analgesics|mesh-ancestor
5801073|NCT02728310|Levobupivacaine|levobupivacaine|mesh-list
5801074|NCT02728310|Anesthetics, Local|anesthetics, local|mesh-ancestor
5801075|NCT02728310|Anesthetics|anesthetics|mesh-ancestor
5801076|NCT02728310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5801077|NCT02728310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801078|NCT02728310|Sensory System Agents|sensory system agents|mesh-ancestor
5801079|NCT02728310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5801080|NCT02728037|Lidocaine|lidocaine|mesh-list
5801081|NCT02728037|Magnesium Sulfate|magnesium sulfate|mesh-list
5801082|NCT02728037|Anesthetics, Local|anesthetics, local|mesh-ancestor
5801083|NCT02728037|Anesthetics|anesthetics|mesh-ancestor
5801084|NCT02728037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5801085|NCT02728037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801086|NCT02728037|Sensory System Agents|sensory system agents|mesh-ancestor
5801087|NCT02728037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5801088|NCT02728037|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5801089|NCT02728037|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5801090|NCT02728037|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5801091|NCT02728037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5801092|NCT02728037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801093|NCT02728037|Analgesics|analgesics|mesh-ancestor
5801094|NCT02728037|Anticonvulsants|anticonvulsants|mesh-ancestor
5801095|NCT02728037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5801096|NCT02728037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5801097|NCT02728037|Tocolytic Agents|tocolytic agents|mesh-ancestor
5801098|NCT02728037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5801099|NCT02728245|Dienogest|dienogest|mesh-list
5801100|NCT02728245|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5801101|NCT02728245|Contraceptive Agents|contraceptive agents|mesh-ancestor
5801102|NCT02728245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5801103|NCT02728245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801104|NCT02728245|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5801105|NCT02728245|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5801106|NCT02728245|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5801107|NCT02728245|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5801108|NCT02728245|Hormone Antagonists|hormone antagonists|mesh-ancestor
5801109|NCT02728245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5801110|NCT02728245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5801111|NCT02728245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5801112|NCT02727803|Cyclophosphamide|cyclophosphamide|mesh-list
5801113|NCT02727803|Melphalan|melphalan|mesh-list
5801114|NCT02727803|Busulfan|busulfan|mesh-list
5801115|NCT02727803|Mechlorethamine|mechlorethamine|mesh-list
5801116|NCT02727803|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
5801117|NCT02727803|Rituximab|rituximab|mesh-list
5801118|NCT02727803|Fludarabine|fludarabine|mesh-list
5801119|NCT02727803|Fludarabine phosphate|fludarabine phosphate|mesh-list
5801120|NCT02727803|Clofarabine|clofarabine|mesh-list
5801121|NCT02727803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5801122|NCT02727803|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5801123|NCT02727803|Antibodies|antibodies|mesh-list
5801124|NCT02727803|Immunoglobulins|immunoglobulins|mesh-list
5801125|NCT02727803|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5801126|NCT02727803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5801127|NCT02727803|Immunologic Factors|immunologic factors|mesh-ancestor
5801128|NCT02727803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801129|NCT02727803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5801130|NCT02727803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5801131|NCT02727803|Alkylating Agents|alkylating agents|mesh-ancestor
5801132|NCT02727803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801133|NCT02727803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5801134|NCT02727803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5801135|NCT02727803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5801136|NCT02727803|Antimetabolites|antimetabolites|mesh-ancestor
5801137|NCT02727712|Anesthetics|anesthetics|mesh-list
5801138|NCT02727712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5801139|NCT02727712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801140|NCT02727647|Factor VIII|factor viii|mesh-list
5801141|NCT02727647|Coagulants|coagulants|mesh-ancestor
5801142|NCT02727881|Squalamine|squalamine|mesh-list
5801143|NCT02727881|Ranibizumab|ranibizumab|mesh-list
5801144|NCT02727881|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5801145|NCT02727881|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5801146|NCT02727881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5801147|NCT02727881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5801148|NCT02727881|Growth Substances|growth substances|mesh-ancestor
5801149|NCT02727881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801150|NCT02727881|Growth Inhibitors|growth inhibitors|mesh-ancestor
5801151|NCT02727881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5801152|NCT02727881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5801153|NCT02727881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5801154|NCT02727881|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5801155|NCT02727881|Protective Agents|protective agents|mesh-ancestor
5801156|NCT02727738|Selenium|selenium|mesh-list
5801157|NCT02727738|Methimazole|methimazole|mesh-list
5801158|NCT02727738|Antioxidants|antioxidants|mesh-ancestor
5801159|NCT02727738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801160|NCT02727738|Protective Agents|protective agents|mesh-ancestor
5801161|NCT02727738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801162|NCT02727738|Trace Elements|trace elements|mesh-ancestor
5801163|NCT02727738|Micronutrients|micronutrients|mesh-ancestor
5801164|NCT02727738|Antithyroid Agents|antithyroid agents|mesh-ancestor
5801165|NCT02727738|Hormone Antagonists|hormone antagonists|mesh-ancestor
5801166|NCT02727738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5801167|NCT02727907|Interferons|interferons|mesh-list
5801168|NCT02727907|Interferon-beta|interferon-beta|mesh-list
5801169|NCT02727907|Interferon beta-1a|interferon beta-1a|mesh-list
5801170|NCT02727907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5801171|NCT02727907|Antiviral Agents|antiviral agents|mesh-ancestor
5801172|NCT02727907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5801173|NCT02727907|Immunologic Factors|immunologic factors|mesh-ancestor
6491834|NCT00605098|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6491835|NCT00605098|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6491836|NCT00605098|Protease Inhibitors|protease inhibitors|mesh-ancestor
5801174|NCT02727907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801175|NCT02727907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5801176|NCT02727621|Dexmedetomidine|dexmedetomidine|mesh-list
5801177|NCT02727621|Propofol|propofol|mesh-list
5801178|NCT02727621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5801179|NCT02727621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5801180|NCT02727621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801181|NCT02727621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5801182|NCT02727621|Anesthetics, General|anesthetics, general|mesh-ancestor
5801183|NCT02727621|Anesthetics|anesthetics|mesh-ancestor
5801184|NCT02727621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5801185|NCT02727621|Analgesics|analgesics|mesh-ancestor
5801186|NCT02727621|Sensory System Agents|sensory system agents|mesh-ancestor
5801187|NCT02727621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5801188|NCT02727621|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5801189|NCT02727621|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5801190|NCT02727621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5801191|NCT02727621|Adrenergic Agents|adrenergic agents|mesh-ancestor
5801192|NCT02727621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5801193|NCT02727621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491837|NCT00605098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5801194|NCT02727608|Eculizumab|eculizumab|mesh-list
6491838|NCT00605098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491839|NCT00605098|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6491840|NCT00605098|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6491841|NCT00605098|Antiviral Agents|antiviral agents|mesh-ancestor
6491842|NCT00605098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6491843|NCT00605098|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6491844|NCT00605098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6491845|NCT00605111|Insulin Aspart|insulin aspart|mesh-list
6491846|NCT00605111|Biphasic Insulins|biphasic insulins|mesh-list
6491847|NCT00605111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6491848|NCT00605111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491849|NCT00605137|Insulin|insulin|mesh-list
6491850|NCT00605137|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6491851|NCT00605137|Insulin Detemir|insulin detemir|mesh-list
6491852|NCT00605137|Isophane Insulin, Human|isophane insulin, human|mesh-list
6491853|NCT00605137|Insulin, Isophane|insulin, isophane|mesh-list
6491854|NCT00605137|Isophane insulin, beef|isophane insulin, beef|mesh-list
6491855|NCT00605137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6491856|NCT00605137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491857|NCT00605371|Lamotrigine|lamotrigine|mesh-list
6491858|NCT00605371|Anticonvulsants|anticonvulsants|mesh-list
6491859|NCT00605371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6491860|NCT00605371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6491861|NCT00605371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491862|NCT00605371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6491863|NCT00605371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801195|NCT02727608|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5801196|NCT02727608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5801197|NCT02727608|Immunologic Factors|immunologic factors|mesh-ancestor
5801198|NCT02727608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899950|NCT05126108|Parathyroid Hormone|parathyroid hormone|mesh-list
5899951|NCT05126108|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5899952|NCT05126108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899953|NCT05126004|Acetylcysteine|acetylcysteine|mesh-list
5899954|NCT05126004|Azacitidine|azacitidine|mesh-list
5899955|NCT05126004|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5899956|NCT05126004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5899957|NCT05126004|Antimetabolites|antimetabolites|mesh-ancestor
5899958|NCT05126004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899959|NCT05126004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5899960|NCT05126004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5899961|NCT05126004|Antiviral Agents|antiviral agents|mesh-ancestor
5899962|NCT05126004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5899963|NCT05126004|Expectorants|expectorants|mesh-ancestor
5899964|NCT05126004|Respiratory System Agents|respiratory system agents|mesh-ancestor
6491864|NCT00605371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6491865|NCT00605371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5801199|NCT02727491|Dextromethorphan|dextromethorphan|mesh-list
5801200|NCT02727491|Antitussive Agents|antitussive agents|mesh-ancestor
5801201|NCT02727491|Respiratory System Agents|respiratory system agents|mesh-ancestor
5801202|NCT02727491|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5801203|NCT02727491|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5801204|NCT02727491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5801205|NCT02727491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801206|NCT02727491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801207|NCT02727504|Dobutamine|dobutamine|mesh-list
5801208|NCT02727504|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5801209|NCT02727504|Sympathomimetics|sympathomimetics|mesh-ancestor
5801210|NCT02727504|Autonomic Agents|autonomic agents|mesh-ancestor
5801211|NCT02727504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5801212|NCT02727504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801213|NCT02727504|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5801214|NCT02727504|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5801215|NCT02727504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5801216|NCT02727504|Adrenergic Agents|adrenergic agents|mesh-ancestor
5801217|NCT02727504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5801218|NCT02727504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801219|NCT02727504|Protective Agents|protective agents|mesh-ancestor
5801220|NCT02727309|Apatinib|apatinib|mesh-list
5801221|NCT02727309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5801222|NCT02727309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5801223|NCT02727309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5801224|NCT02727309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801225|NCT02727296|Propofol|propofol|mesh-list
5801226|NCT02727296|Sevoflurane|sevoflurane|mesh-list
5801227|NCT02727296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5801228|NCT02727296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5801229|NCT02727296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801230|NCT02727296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5801231|NCT02727296|Anesthetics, General|anesthetics, general|mesh-ancestor
5801232|NCT02727296|Anesthetics|anesthetics|mesh-ancestor
5801233|NCT02727296|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5801234|NCT02727296|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5801235|NCT02727348|Anesthetics|anesthetics|mesh-list
5801236|NCT02727348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5801237|NCT02727348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801238|NCT02726919|Clobazam|clobazam|mesh-list
5801239|NCT02726919|Anticonvulsants|anticonvulsants|mesh-ancestor
5641504|NCT03011814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5641505|NCT03011814|Growth Substances|growth substances|mesh-ancestor
5641506|NCT03011814|Growth Inhibitors|growth inhibitors|mesh-ancestor
5801240|NCT02726919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5801241|NCT02726919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5801242|NCT02726919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5801243|NCT02726919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801244|NCT02726919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5801245|NCT02726919|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
5801246|NCT02726919|GABA Agonists|gaba agonists|mesh-ancestor
5801247|NCT02726919|GABA Agents|gaba agents|mesh-ancestor
5801248|NCT02726919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5801249|NCT02726919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801250|NCT02727205|Rotigotine|rotigotine|mesh-list
5801251|NCT02727205|Dopamine Agonists|dopamine agonists|mesh-ancestor
5801252|NCT02727205|Dopamine Agents|dopamine agents|mesh-ancestor
5801253|NCT02727205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5801254|NCT02727205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801255|NCT02727205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641507|NCT03011814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5801256|NCT02726867|Lacosamide|lacosamide|mesh-list
5801257|NCT02726867|Ketamine|ketamine|mesh-list
5801258|NCT02726867|Levetiracetam|levetiracetam|mesh-list
5801259|NCT02726867|Phenobarbital|phenobarbital|mesh-list
5801260|NCT02726867|Analgesics|analgesics|mesh-ancestor
5801261|NCT02726867|Sensory System Agents|sensory system agents|mesh-ancestor
5801262|NCT02726867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5801263|NCT02726867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801264|NCT02726867|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5801265|NCT02726867|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5801266|NCT02726867|Anesthetics, General|anesthetics, general|mesh-ancestor
5801267|NCT02726867|Anesthetics|anesthetics|mesh-ancestor
5801268|NCT02726867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5641508|NCT03011814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5641509|NCT02962414|Everolimus|everolimus|mesh-list
5641510|NCT02962414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5641511|NCT02962414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5641512|NCT02962414|Immunologic Factors|immunologic factors|mesh-ancestor
5801269|NCT02726867|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5801270|NCT02726867|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5801271|NCT02726867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5801272|NCT02726867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801273|NCT02726867|Anticonvulsants|anticonvulsants|mesh-ancestor
5801274|NCT02726867|Nootropic Agents|nootropic agents|mesh-ancestor
5641513|NCT02962414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641514|NCT02947165|Spartalizumab|spartalizumab|mesh-list
5641515|NCT02947165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5641516|NCT02947165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641517|NCT02947165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5641518|NCT02923778|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
5641519|NCT02923778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5641520|NCT02923778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5641521|NCT02905318|Palbociclib|palbociclib|mesh-list
5641522|NCT02905318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5801275|NCT02726867|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5801276|NCT02726867|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5801277|NCT02726867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5801278|NCT02726867|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5801279|NCT02726867|GABA Modulators|gaba modulators|mesh-ancestor
5801280|NCT02726867|GABA Agents|gaba agents|mesh-ancestor
5801281|NCT02726867|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5801282|NCT02726867|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5801283|NCT02726867|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5801284|NCT02726984|Listerine|listerine|mesh-list
5801285|NCT02726984|Fluorides|fluorides|mesh-list
5801286|NCT02726984|Sodium Fluoride|sodium fluoride|mesh-list
5801287|NCT02726984|Cariostatic Agents|cariostatic agents|mesh-ancestor
5801288|NCT02726984|Protective Agents|protective agents|mesh-ancestor
5801289|NCT02726984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801290|NCT02726984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5801291|NCT02726984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5801292|NCT02726854|Apatinib|apatinib|mesh-list
5801293|NCT02726854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5801294|NCT02726854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5801295|NCT02726854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5801296|NCT02726854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801297|NCT02726828|Morphine|morphine|mesh-list
5801298|NCT02726828|Ketamine|ketamine|mesh-list
5801299|NCT02726828|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5801300|NCT02726828|Narcotics|narcotics|mesh-ancestor
5801301|NCT02726828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5801302|NCT02726828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801303|NCT02726828|Analgesics|analgesics|mesh-ancestor
5801304|NCT02726828|Sensory System Agents|sensory system agents|mesh-ancestor
5801305|NCT02726828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5801306|NCT02726828|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5801307|NCT02726828|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5801308|NCT02726828|Anesthetics, General|anesthetics, general|mesh-ancestor
5801309|NCT02726828|Anesthetics|anesthetics|mesh-ancestor
5801310|NCT02726828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5801311|NCT02726828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5801312|NCT02726828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5801313|NCT02726828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801314|NCT02726503|Lenvatinib|lenvatinib|mesh-list
5801315|NCT02726503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5801316|NCT02726503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5801317|NCT02726503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5801318|NCT02726503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801319|NCT02726581|Dexamethasone|dexamethasone|mesh-list
5801320|NCT02726581|Nivolumab|nivolumab|mesh-list
5801321|NCT02726581|Pomalidomide|pomalidomide|mesh-list
5801322|NCT02726581|Elotuzumab|elotuzumab|mesh-list
5801323|NCT02726581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5801324|NCT02726581|Antiemetics|antiemetics|mesh-ancestor
5801325|NCT02726581|Autonomic Agents|autonomic agents|mesh-ancestor
5801326|NCT02726581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5801327|NCT02726581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801328|NCT02726581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5801329|NCT02726581|Glucocorticoids|glucocorticoids|mesh-ancestor
5801330|NCT02726581|Hormones|hormones|mesh-ancestor
5801331|NCT02726581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5801332|NCT02726581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5801333|NCT02726581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5801334|NCT02726581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5801335|NCT02726581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5801336|NCT02726581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801337|NCT02726581|Immunologic Factors|immunologic factors|mesh-ancestor
5801338|NCT02726581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5801339|NCT02726581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5801340|NCT02726581|Growth Substances|growth substances|mesh-ancestor
5801341|NCT02726581|Growth Inhibitors|growth inhibitors|mesh-ancestor
5801342|NCT02726555|Atorvastatin|atorvastatin|mesh-list
5801343|NCT02726555|Red yeast rice|red yeast rice|mesh-list
5801344|NCT02726555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5801345|NCT02726555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5801346|NCT02726555|Antimetabolites|antimetabolites|mesh-ancestor
5801347|NCT02726555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801348|NCT02726555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5801349|NCT02726555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5801350|NCT02726555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5801351|NCT02726490|Metformin|metformin|mesh-list
5801352|NCT02726490|Glyburide|glyburide|mesh-list
5801353|NCT02726490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5801354|NCT02726490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801355|NCT02726737|Lidocaine|lidocaine|mesh-list
5801356|NCT02726737|Anesthetics, Local|anesthetics, local|mesh-ancestor
5801357|NCT02726737|Anesthetics|anesthetics|mesh-ancestor
5801358|NCT02726737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5801359|NCT02726737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801360|NCT02726737|Sensory System Agents|sensory system agents|mesh-ancestor
5801361|NCT02726737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5801362|NCT02726737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5801363|NCT02726737|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5801364|NCT02726737|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5801365|NCT02726737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5801366|NCT02726737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801367|NCT02726711|Trimethaphan|trimethaphan|mesh-list
5801368|NCT02726711|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
5801369|NCT02726711|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5801370|NCT02726711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5801371|NCT02726711|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
5801372|NCT02726711|Autonomic Agents|autonomic agents|mesh-ancestor
5801373|NCT02726711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5801374|NCT02726711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801375|NCT02726711|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
5801376|NCT02726711|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5801377|NCT02726711|Cholinergic Agents|cholinergic agents|mesh-ancestor
5801378|NCT02726711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5801379|NCT02726711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801380|NCT02726711|Vasodilator Agents|vasodilator agents|mesh-ancestor
5801381|NCT02726646|Doxycycline|doxycycline|mesh-list
6674064|NCT01567072|Sensory System Agents|sensory system agents|mesh-ancestor
6674065|NCT01567072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5801382|NCT02726646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5801383|NCT02726646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5801384|NCT02726646|Antimalarials|antimalarials|mesh-ancestor
5801385|NCT02726646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5801386|NCT02726646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5801387|NCT02726308|Dexamethasone|dexamethasone|mesh-list
5801388|NCT02726308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5801389|NCT02726308|Antiemetics|antiemetics|mesh-ancestor
5801390|NCT02726308|Autonomic Agents|autonomic agents|mesh-ancestor
5801391|NCT02726308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5801392|NCT02726308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801393|NCT02726308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5801394|NCT02726308|Glucocorticoids|glucocorticoids|mesh-ancestor
5801395|NCT02726308|Hormones|hormones|mesh-ancestor
5801396|NCT02726308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5801397|NCT02726308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5801398|NCT02726308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5801399|NCT02726269|Ofloxacin|ofloxacin|mesh-list
5801400|NCT02726269|Levofloxacin|levofloxacin|mesh-list
5801401|NCT02726269|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5801402|NCT02726269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5801403|NCT02726269|Renal Agents|renal agents|mesh-ancestor
5801404|NCT02726269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5641523|NCT02905318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5641524|NCT02905318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5641525|NCT02905318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641526|NCT02872025|Pembrolizumab|pembrolizumab|mesh-list
5641527|NCT02872025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5641528|NCT02872025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5641529|NCT02852213|Dopa Decarboxylase|dopa decarboxylase|mesh-list
5641530|NCT02852213|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5641531|NCT02852213|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5801405|NCT02726269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5801406|NCT02726269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5801407|NCT02726269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5801408|NCT02726269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801409|NCT02726269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5801410|NCT02726269|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5801411|NCT02726269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5801412|NCT02726126|Fentanyl|fentanyl|mesh-list
5801413|NCT02726126|Melatonin|melatonin|mesh-list
5801414|NCT02726126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5801415|NCT02726126|Narcotics|narcotics|mesh-ancestor
5801416|NCT02726126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5801417|NCT02726126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801418|NCT02726126|Analgesics|analgesics|mesh-ancestor
5801419|NCT02726126|Sensory System Agents|sensory system agents|mesh-ancestor
5801420|NCT02726126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5801421|NCT02726126|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5801422|NCT02726126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5801423|NCT02726126|Anesthetics, General|anesthetics, general|mesh-ancestor
5801424|NCT02726126|Anesthetics|anesthetics|mesh-ancestor
5801425|NCT02726126|Antioxidants|antioxidants|mesh-ancestor
5801426|NCT02726126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801427|NCT02726126|Protective Agents|protective agents|mesh-ancestor
5899965|NCT05126004|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5899966|NCT05126004|Antioxidants|antioxidants|mesh-ancestor
5899967|NCT05126004|Protective Agents|protective agents|mesh-ancestor
5899968|NCT05126004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899969|NCT05126004|Antidotes|antidotes|mesh-ancestor
5899970|NCT05125718|Anti-Infective Agents|anti-infective agents|mesh-list
5899971|NCT05125718|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5899972|NCT05125640|Progesterone|progesterone|mesh-list
5899973|NCT05125640|Progestins|progestins|mesh-ancestor
5899974|NCT05125640|Hormones|hormones|mesh-ancestor
5899975|NCT05125640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5899976|NCT05125640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899977|NCT05125627|Progesterone|progesterone|mesh-list
5899978|NCT05125627|Progestins|progestins|mesh-ancestor
5641532|NCT02767804|Crizotinib|crizotinib|mesh-list
5641533|NCT02767804|Ensartinib|ensartinib|mesh-list
5641534|NCT02767804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5641535|NCT02767804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5641536|NCT02767804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5641537|NCT02767804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641538|NCT02721069|Diazepam|diazepam|mesh-list
5641539|NCT02721069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5641540|NCT02721069|Anticonvulsants|anticonvulsants|mesh-ancestor
5801428|NCT02726347|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5801429|NCT02726347|Immunologic Factors|immunologic factors|mesh-ancestor
5801430|NCT02726347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801431|NCT02726035|Naltrexone|naltrexone|mesh-list
5801432|NCT02726035|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5801433|NCT02726035|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5801434|NCT02726035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801435|NCT02726035|Sensory System Agents|sensory system agents|mesh-ancestor
5801436|NCT02726035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5899979|NCT05125627|Hormones|hormones|mesh-ancestor
5899980|NCT05125627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5899981|NCT05125627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899982|NCT05125588|Meloxicam|meloxicam|mesh-list
5899983|NCT05125588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5899984|NCT05125588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5899985|NCT05125588|Analgesics|analgesics|mesh-ancestor
5899986|NCT05125588|Sensory System Agents|sensory system agents|mesh-ancestor
5899987|NCT05125588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5899988|NCT05125588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899989|NCT05125588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5899990|NCT05125588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5899991|NCT05125588|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5899992|NCT05125588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5899993|NCT05125588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5899994|NCT05125588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5899995|NCT05125575|Metformin|metformin|mesh-list
5899996|NCT05125575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5899997|NCT05125575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5899998|NCT05125549|Clopidogrel|clopidogrel|mesh-list
5899999|NCT05125549|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5900000|NCT05125549|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5900001|NCT05125549|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5900002|NCT05125549|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5900003|NCT05125549|Purinergic Agents|purinergic agents|mesh-ancestor
5900004|NCT05125549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5900005|NCT05125549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900006|NCT05125549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900007|NCT05125380|Acetic Acid|acetic acid|mesh-list
5900008|NCT05125380|Retinol acetate|retinol acetate|mesh-list
5900009|NCT05125380|Lugol's solution|lugol's solution|mesh-list
5900010|NCT05125380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5900011|NCT05125380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5900012|NCT05125380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5900013|NCT05125380|Immunologic Factors|immunologic factors|mesh-ancestor
5900014|NCT05125380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900015|NCT05125380|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5900016|NCT05125380|Protective Agents|protective agents|mesh-ancestor
5900017|NCT05125380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5900018|NCT05125380|Hemostatics|hemostatics|mesh-ancestor
5900019|NCT05125380|Coagulants|coagulants|mesh-ancestor
5900020|NCT05125328|Remifentanil|remifentanil|mesh-list
5900021|NCT05125328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5900022|NCT05125328|Narcotics|narcotics|mesh-ancestor
5900023|NCT05125328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5900024|NCT05125328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900025|NCT05125328|Analgesics|analgesics|mesh-ancestor
5900026|NCT05125328|Sensory System Agents|sensory system agents|mesh-ancestor
5900027|NCT05125328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5900028|NCT05125276|Aspirin|aspirin|mesh-list
5900029|NCT05125276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5900030|NCT05125276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5900031|NCT05125276|Analgesics|analgesics|mesh-ancestor
5900032|NCT05125276|Sensory System Agents|sensory system agents|mesh-ancestor
5900033|NCT05125276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5900034|NCT05125276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900035|NCT05125276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5900036|NCT05125276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5900037|NCT05125276|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5900038|NCT05125276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5900039|NCT05125276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900040|NCT05125276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5900041|NCT05125276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5801437|NCT02725736|Nifedipine|nifedipine|mesh-list
5801438|NCT02725736|Atosiban|atosiban|mesh-list
5801439|NCT02725736|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5801440|NCT02725736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5801441|NCT02725736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801442|NCT02725736|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5801443|NCT02725736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801444|NCT02725736|Vasodilator Agents|vasodilator agents|mesh-ancestor
5801445|NCT02725736|Tocolytic Agents|tocolytic agents|mesh-ancestor
5801446|NCT02725736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5801447|NCT02725736|Hormone Antagonists|hormone antagonists|mesh-ancestor
5801448|NCT02725736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5801449|NCT02725918|Pemetrexed|pemetrexed|mesh-list
5801450|NCT02725918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5801451|NCT02725918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5801452|NCT02725918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801453|NCT02725918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5801454|NCT02725918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5801455|NCT02725541|Trastuzumab|trastuzumab|mesh-list
5801456|NCT02725541|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
5801457|NCT02725541|Maytansine|maytansine|mesh-list
5801458|NCT02725541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5801459|NCT02725541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5801460|NCT02725541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5801461|NCT02725541|Tubulin Modulators|tubulin modulators|mesh-ancestor
5801462|NCT02725541|Antimitotic Agents|antimitotic agents|mesh-ancestor
5801463|NCT02725541|Mitosis Modulators|mitosis modulators|mesh-ancestor
5801464|NCT02725541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801465|NCT02725502|Linagliptin|linagliptin|mesh-list
5801466|NCT02725502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5801467|NCT02725502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801468|NCT02725502|Incretins|incretins|mesh-ancestor
5801469|NCT02725502|Hormones|hormones|mesh-ancestor
5801470|NCT02725502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5801471|NCT02725502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5801472|NCT02725502|Protease Inhibitors|protease inhibitors|mesh-ancestor
5801473|NCT02725502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5801474|NCT02725502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801475|NCT02725398|Scopolamine|scopolamine|mesh-list
5801476|NCT02725398|Bromides|bromides|mesh-list
5801477|NCT02725398|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
5801478|NCT02725398|Anticonvulsants|anticonvulsants|mesh-ancestor
5801479|NCT02725398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5801480|NCT02725398|Antiemetics|antiemetics|mesh-ancestor
5801481|NCT02725398|Autonomic Agents|autonomic agents|mesh-ancestor
5801482|NCT02725398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5801483|NCT02725398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801484|NCT02725398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5801485|NCT02725398|Mydriatics|mydriatics|mesh-ancestor
5801486|NCT02725398|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5801487|NCT02725398|Cholinergic Agents|cholinergic agents|mesh-ancestor
5801488|NCT02725398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5801489|NCT02725398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801490|NCT02725398|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5801491|NCT02725398|Parasympatholytics|parasympatholytics|mesh-ancestor
5801492|NCT02725372|Nitric Oxide|nitric oxide|mesh-list
5801493|NCT02725372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5801494|NCT02725372|Autonomic Agents|autonomic agents|mesh-ancestor
5801495|NCT02725372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5801496|NCT02725372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801497|NCT02725372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5801498|NCT02725372|Respiratory System Agents|respiratory system agents|mesh-ancestor
5801499|NCT02725372|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5801500|NCT02725372|Antioxidants|antioxidants|mesh-ancestor
5801501|NCT02725372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801502|NCT02725372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5801503|NCT02725372|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6491866|NCT00605371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6491867|NCT00605371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6491868|NCT00605371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6491869|NCT00605397|Trastuzumab|trastuzumab|mesh-list
6491870|NCT00605397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6491871|NCT00605397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5641541|NCT02721069|Antiemetics|antiemetics|mesh-ancestor
5641542|NCT02721069|Autonomic Agents|autonomic agents|mesh-ancestor
5641543|NCT02721069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5641544|NCT02721069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491872|NCT00605410|Bromides|bromides|mesh-list
6491873|NCT00605410|Ipratropium|ipratropium|mesh-list
6491874|NCT00605410|Anticonvulsants|anticonvulsants|mesh-ancestor
6491875|NCT00605410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6491876|NCT00605410|Autonomic Agents|autonomic agents|mesh-ancestor
6491877|NCT00605410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6491878|NCT00605410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491879|NCT00605410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6491880|NCT00605410|Respiratory System Agents|respiratory system agents|mesh-ancestor
6491881|NCT00605410|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6491882|NCT00605410|Cholinergic Agents|cholinergic agents|mesh-ancestor
6491883|NCT00605410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6491884|NCT00605410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491885|NCT00605605|Dextromethorphan|dextromethorphan|mesh-list
6491886|NCT00605605|Antitussive Agents|antitussive agents|mesh-ancestor
6491887|NCT00605605|Respiratory System Agents|respiratory system agents|mesh-ancestor
6491888|NCT00605605|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5641545|NCT02721069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5641546|NCT02721069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5641547|NCT02721069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5641548|NCT02721069|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5641549|NCT02721069|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5641550|NCT02721069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5641551|NCT02721069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5641552|NCT02721069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5641553|NCT02721069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5641554|NCT02721069|Anesthetics, General|anesthetics, general|mesh-ancestor
5641555|NCT02721069|Anesthetics|anesthetics|mesh-ancestor
5641556|NCT02721069|GABA Modulators|gaba modulators|mesh-ancestor
5641557|NCT02721069|GABA Agents|gaba agents|mesh-ancestor
5641558|NCT02721069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5641559|NCT02721069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641560|NCT02719613|Dexamethasone|dexamethasone|mesh-list
5641561|NCT02719613|Dexamethasone acetate|dexamethasone acetate|mesh-list
5641562|NCT02719613|Nivolumab|nivolumab|mesh-list
5641563|NCT02719613|Lenalidomide|lenalidomide|mesh-list
5641564|NCT02719613|Bortezomib|bortezomib|mesh-list
5641565|NCT02719613|Pomalidomide|pomalidomide|mesh-list
5641566|NCT02719613|Elotuzumab|elotuzumab|mesh-list
5641567|NCT02719613|BB 1101|bb 1101|mesh-list
5641568|NCT02719613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5641569|NCT02719613|Antiemetics|antiemetics|mesh-ancestor
5641570|NCT02719613|Autonomic Agents|autonomic agents|mesh-ancestor
5801504|NCT02725372|Vasodilator Agents|vasodilator agents|mesh-ancestor
5801505|NCT02725372|Gasotransmitters|gasotransmitters|mesh-ancestor
5801506|NCT02725372|Protective Agents|protective agents|mesh-ancestor
5801507|NCT02725255|Albendazole|albendazole|mesh-list
5801508|NCT02725255|Anthelmintics|anthelmintics|mesh-ancestor
5801509|NCT02725255|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5801510|NCT02725255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5801511|NCT02725255|Anticestodal Agents|anticestodal agents|mesh-ancestor
5801512|NCT02725255|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5801513|NCT02725255|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5801514|NCT02725255|Tubulin Modulators|tubulin modulators|mesh-ancestor
5801515|NCT02725255|Antimitotic Agents|antimitotic agents|mesh-ancestor
5801516|NCT02725255|Mitosis Modulators|mitosis modulators|mesh-ancestor
5801517|NCT02725255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801518|NCT02725255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5801519|NCT02725424|Docetaxel|docetaxel|mesh-list
5801520|NCT02725424|Oxaliplatin|oxaliplatin|mesh-list
5801521|NCT02725424|Trastuzumab|trastuzumab|mesh-list
5801522|NCT02725424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5801523|NCT02725424|Tubulin Modulators|tubulin modulators|mesh-ancestor
5801524|NCT02725424|Antimitotic Agents|antimitotic agents|mesh-ancestor
5801525|NCT02725424|Mitosis Modulators|mitosis modulators|mesh-ancestor
5801526|NCT02725424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801527|NCT02725424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5801528|NCT02725359|Tizanidine|tizanidine|mesh-list
5801529|NCT02725359|Bupivacaine|bupivacaine|mesh-list
5801530|NCT02725359|Anesthetics, Local|anesthetics, local|mesh-ancestor
5801531|NCT02725359|Anesthetics|anesthetics|mesh-ancestor
5801532|NCT02725359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5801533|NCT02725359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801534|NCT02725359|Sensory System Agents|sensory system agents|mesh-ancestor
5801535|NCT02725359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5801536|NCT02725359|Analgesics|analgesics|mesh-ancestor
5801537|NCT02725359|Anticonvulsants|anticonvulsants|mesh-ancestor
5801538|NCT02725359|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5801539|NCT02725359|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5801540|NCT02725359|Parasympatholytics|parasympatholytics|mesh-ancestor
5801541|NCT02725359|Autonomic Agents|autonomic agents|mesh-ancestor
5801542|NCT02725359|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5801543|NCT02725359|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5801544|NCT02725359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5801545|NCT02725359|Adrenergic Agents|adrenergic agents|mesh-ancestor
5801546|NCT02725359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5801547|NCT02725359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801548|NCT02725489|Durvalumab|durvalumab|mesh-list
5801549|NCT02725489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6674066|NCT01567072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674067|NCT01567072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6674068|NCT01567072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6674069|NCT01567072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5801550|NCT02725489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5801551|NCT02725229|Levobupivacaine|levobupivacaine|mesh-list
5801552|NCT02725229|Anesthetics, Local|anesthetics, local|mesh-ancestor
5801553|NCT02725229|Anesthetics|anesthetics|mesh-ancestor
5801554|NCT02725229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5801555|NCT02725229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801556|NCT02725229|Sensory System Agents|sensory system agents|mesh-ancestor
5801557|NCT02725229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5801558|NCT02725242|Budesonide|budesonide|mesh-list
5801559|NCT02725242|Formoterol Fumarate|formoterol fumarate|mesh-list
5801560|NCT02725242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5801561|NCT02725242|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5801562|NCT02725242|Autonomic Agents|autonomic agents|mesh-ancestor
5801563|NCT02725242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5801564|NCT02725242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801565|NCT02725242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5801566|NCT02725242|Respiratory System Agents|respiratory system agents|mesh-ancestor
5801567|NCT02725242|Glucocorticoids|glucocorticoids|mesh-ancestor
5801568|NCT02725242|Hormones|hormones|mesh-ancestor
5801569|NCT02725242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5801570|NCT02725242|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5801571|NCT02725242|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5801572|NCT02725242|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6674070|NCT01567072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5801573|NCT02725242|Adrenergic Agents|adrenergic agents|mesh-ancestor
5801574|NCT02725242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5801575|NCT02725242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801576|NCT02725177|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
5801577|NCT02725177|Hormones|hormones|mesh-ancestor
5801578|NCT02725177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5801579|NCT02725177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801580|NCT02725164|Nitrous Oxide|nitrous oxide|mesh-list
5801581|NCT02725164|Sevoflurane|sevoflurane|mesh-list
5801582|NCT02725164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5801583|NCT02725164|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5801584|NCT02725164|Anesthetics, General|anesthetics, general|mesh-ancestor
5801585|NCT02725164|Anesthetics|anesthetics|mesh-ancestor
5801586|NCT02725164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5801587|NCT02725164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801588|NCT02725164|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5801589|NCT02725164|Analgesics|analgesics|mesh-ancestor
5801590|NCT02725164|Sensory System Agents|sensory system agents|mesh-ancestor
5801591|NCT02725164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5801592|NCT02725099|Ticagrelor|ticagrelor|mesh-list
5801593|NCT02725099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5801594|NCT02725099|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5801595|NCT02725099|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5801596|NCT02725099|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5801597|NCT02725099|Purinergic Agents|purinergic agents|mesh-ancestor
5801598|NCT02725099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5801599|NCT02725099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801600|NCT02725099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801601|NCT02724904|Methotrexate|methotrexate|mesh-list
5801602|NCT02724904|Fludarabine|fludarabine|mesh-list
5801603|NCT02724904|Thiotepa|thiotepa|mesh-list
5801604|NCT02724904|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5801605|NCT02724904|Abortifacient Agents|abortifacient agents|mesh-ancestor
5801606|NCT02724904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5801607|NCT02724904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801608|NCT02724904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5801609|NCT02724904|Antimetabolites|antimetabolites|mesh-ancestor
5801610|NCT02724904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801611|NCT02724904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5801612|NCT02724904|Dermatologic Agents|dermatologic agents|mesh-ancestor
5801613|NCT02724904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5801614|NCT02724904|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5801615|NCT02724904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5801616|NCT02724904|Immunologic Factors|immunologic factors|mesh-ancestor
5801617|NCT02724904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5801618|NCT02724904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5801619|NCT02724904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5801620|NCT02724904|Alkylating Agents|alkylating agents|mesh-ancestor
5801621|NCT02724904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5801622|NCT02725112|Pregabalin|pregabalin|mesh-list
5801623|NCT02725112|Analgesics|analgesics|mesh-ancestor
5801624|NCT02725112|Sensory System Agents|sensory system agents|mesh-ancestor
5801625|NCT02725112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5801626|NCT02725112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801627|NCT02725112|Anticonvulsants|anticonvulsants|mesh-ancestor
5801628|NCT02725112|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5801629|NCT02725112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5801630|NCT02725112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801631|NCT02725112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5801632|NCT02725112|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5801633|NCT02725112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5801634|NCT02725112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5801635|NCT02725112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5801636|NCT02725060|Phenylephrine|phenylephrine|mesh-list
5801637|NCT02725060|Isoproterenol|isoproterenol|mesh-list
5801638|NCT02725060|Oxymetazoline|oxymetazoline|mesh-list
5801639|NCT02725060|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5801640|NCT02725060|Mydriatics|mydriatics|mesh-ancestor
5801641|NCT02725060|Autonomic Agents|autonomic agents|mesh-ancestor
5801642|NCT02725060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5801643|NCT02725060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801644|NCT02725060|Sympathomimetics|sympathomimetics|mesh-ancestor
5801645|NCT02725060|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5801646|NCT02725060|Nasal Decongestants|nasal decongestants|mesh-ancestor
5801647|NCT02725060|Respiratory System Agents|respiratory system agents|mesh-ancestor
5801648|NCT02725060|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5801649|NCT02725060|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5801650|NCT02725060|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5801651|NCT02725060|Adrenergic Agents|adrenergic agents|mesh-ancestor
5801652|NCT02725060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5801653|NCT02725060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801654|NCT02725060|Protective Agents|protective agents|mesh-ancestor
5801655|NCT02725060|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5801656|NCT02725060|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5801657|NCT02725060|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5801658|NCT02724761|Epinephrine|epinephrine|mesh-list
5801659|NCT02724761|Racepinephrine|racepinephrine|mesh-list
5801660|NCT02724761|Epinephryl borate|epinephryl borate|mesh-list
5801661|NCT02724761|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5801662|NCT02724761|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5801663|NCT02724761|Adrenergic Agents|adrenergic agents|mesh-ancestor
5801664|NCT02724761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5801665|NCT02724761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801666|NCT02724761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801667|NCT02724761|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5801668|NCT02724761|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5801669|NCT02724761|Autonomic Agents|autonomic agents|mesh-ancestor
5801670|NCT02724761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5801671|NCT02724761|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5801672|NCT02724761|Respiratory System Agents|respiratory system agents|mesh-ancestor
5801673|NCT02724761|Mydriatics|mydriatics|mesh-ancestor
5801674|NCT02724761|Sympathomimetics|sympathomimetics|mesh-ancestor
5801675|NCT02724761|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5801676|NCT02724618|Curcumin|curcumin|mesh-list
5801677|NCT02724618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5801678|NCT02724618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5801679|NCT02724618|Analgesics|analgesics|mesh-ancestor
5801680|NCT02724618|Sensory System Agents|sensory system agents|mesh-ancestor
5801681|NCT02724618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5801682|NCT02724618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801683|NCT02724618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5801684|NCT02724618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5801685|NCT02724618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5801686|NCT02724618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5801687|NCT02724618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801688|NCT02724332|Sirolimus|sirolimus|mesh-list
5801689|NCT02724332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5801690|NCT02724332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5801691|NCT02724332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5801692|NCT02724332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5801693|NCT02724332|Antifungal Agents|antifungal agents|mesh-ancestor
5801694|NCT02724332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5801695|NCT02724332|Immunologic Factors|immunologic factors|mesh-ancestor
5801696|NCT02724332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801697|NCT02724358|Chlorotrianisene|chlorotrianisene|mesh-list
6491889|NCT00605605|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6491890|NCT00605605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6491891|NCT00605605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491892|NCT00605605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491893|NCT00605683|Cabergoline|cabergoline|mesh-list
6491894|NCT00605683|Pramipexole|pramipexole|mesh-list
6491895|NCT00605683|Ropinirole|ropinirole|mesh-list
6491896|NCT00605683|Bromocriptine|bromocriptine|mesh-list
5801698|NCT02724358|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
5801699|NCT02724358|Estrogens|estrogens|mesh-ancestor
5801700|NCT02724358|Hormones|hormones|mesh-ancestor
5801701|NCT02724358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5801702|NCT02724358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801703|NCT02724358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5801704|NCT02724358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5801705|NCT02724202|Curcumin|curcumin|mesh-list
5801706|NCT02724202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5801707|NCT02724202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5801708|NCT02724202|Analgesics|analgesics|mesh-ancestor
5801709|NCT02724202|Sensory System Agents|sensory system agents|mesh-ancestor
5801710|NCT02724202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5801711|NCT02724202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801712|NCT02724202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5801713|NCT02724202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5801714|NCT02724202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5801715|NCT02724202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5801716|NCT02724202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801717|NCT02724410|Amoxicillin|amoxicillin|mesh-list
5801718|NCT02724410|Clavulanic Acid|clavulanic acid|mesh-list
5801719|NCT02724410|Clavulanic Acids|clavulanic acids|mesh-list
5801720|NCT02724410|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5801721|NCT02724410|Ertapenem|ertapenem|mesh-list
5801722|NCT02724410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5801723|NCT02724410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5801724|NCT02724410|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5801725|NCT02724410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5801726|NCT02724410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801727|NCT02724150|Omeprazole|omeprazole|mesh-list
5801728|NCT02724150|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5801729|NCT02724150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5801730|NCT02724150|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5801731|NCT02724150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5801732|NCT02724150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900042|NCT05125276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5900043|NCT05125276|Antipyretics|antipyretics|mesh-ancestor
5900044|NCT05125237|Amiloride|amiloride|mesh-list
5900045|NCT05125237|Triamterene|triamterene|mesh-list
6491897|NCT00605683|Lisuride|lisuride|mesh-list
5900046|NCT05125237|Diuretics|diuretics|mesh-ancestor
5900047|NCT05125237|Natriuretic Agents|natriuretic agents|mesh-ancestor
6491898|NCT00605683|Apomorphine|apomorphine|mesh-list
5801733|NCT02723955|Gemcitabine|gemcitabine|mesh-list
5801734|NCT02723955|Paclitaxel|paclitaxel|mesh-list
5801735|NCT02723955|Docetaxel|docetaxel|mesh-list
5801736|NCT02723955|Carboplatin|carboplatin|mesh-list
5801737|NCT02723955|Fluorouracil|fluorouracil|mesh-list
5801738|NCT02723955|Pembrolizumab|pembrolizumab|mesh-list
5801739|NCT02723955|Pemetrexed|pemetrexed|mesh-list
5801740|NCT02723955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5801741|NCT02723955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5801742|NCT02723955|Tubulin Modulators|tubulin modulators|mesh-ancestor
5801743|NCT02723955|Antimitotic Agents|antimitotic agents|mesh-ancestor
5801744|NCT02723955|Mitosis Modulators|mitosis modulators|mesh-ancestor
5801745|NCT02723955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801746|NCT02723955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5801747|NCT02723955|Antimetabolites|antimetabolites|mesh-ancestor
5801748|NCT02723955|Antiviral Agents|antiviral agents|mesh-ancestor
5801749|NCT02723955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5801750|NCT02723955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5801751|NCT02723955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5801752|NCT02723955|Immunologic Factors|immunologic factors|mesh-ancestor
5801753|NCT02723955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801754|NCT02723955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5801755|NCT02723955|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5801756|NCT02723955|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5801757|NCT02724098|Dexmedetomidine|dexmedetomidine|mesh-list
5801758|NCT02724098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5801759|NCT02724098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5801760|NCT02724098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801761|NCT02724098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5801762|NCT02724098|Analgesics|analgesics|mesh-ancestor
5801763|NCT02724098|Sensory System Agents|sensory system agents|mesh-ancestor
5801764|NCT02724098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5801765|NCT02724098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5801766|NCT02724098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5801767|NCT02724098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5801768|NCT02724098|Adrenergic Agents|adrenergic agents|mesh-ancestor
5801769|NCT02724098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5801770|NCT02724098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801771|NCT02724046|Ciprofloxacin|ciprofloxacin|mesh-list
5801772|NCT02724046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5801773|NCT02724046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5801774|NCT02724046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5801775|NCT02724046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5801776|NCT02724046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5801777|NCT02724046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801778|NCT02724046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5801779|NCT02724046|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5801780|NCT02724046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5801781|NCT02724293|Pregabalin|pregabalin|mesh-list
5801782|NCT02724293|Analgesics|analgesics|mesh-ancestor
5801783|NCT02724293|Sensory System Agents|sensory system agents|mesh-ancestor
5801784|NCT02724293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5801785|NCT02724293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801786|NCT02724293|Anticonvulsants|anticonvulsants|mesh-ancestor
5801787|NCT02724293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5801788|NCT02724293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5801789|NCT02724293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801790|NCT02724293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5801791|NCT02724293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5801792|NCT02724293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5801793|NCT02724293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5801794|NCT02724293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5801795|NCT02723968|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5801796|NCT02724163|Cytarabine|cytarabine|mesh-list
5801797|NCT02724163|Cyclophosphamide|cyclophosphamide|mesh-list
5801798|NCT02724163|Busulfan|busulfan|mesh-list
5801799|NCT02724163|Fludarabine|fludarabine|mesh-list
5801800|NCT02724163|Daunorubicin|daunorubicin|mesh-list
5801801|NCT02724163|Mitoxantrone|mitoxantrone|mesh-list
5801802|NCT02724163|Gemtuzumab|gemtuzumab|mesh-list
5801803|NCT02724163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5801804|NCT02724163|Immunologic Factors|immunologic factors|mesh-ancestor
5801805|NCT02724163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801806|NCT02724163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5801807|NCT02724163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5801808|NCT02724163|Alkylating Agents|alkylating agents|mesh-ancestor
5801809|NCT02724163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801810|NCT02724163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5801811|NCT02724163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5801812|NCT02724163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5801813|NCT02724163|Antimetabolites|antimetabolites|mesh-ancestor
5801814|NCT02724163|Antiviral Agents|antiviral agents|mesh-ancestor
5801815|NCT02724163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5801816|NCT02724163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5801817|NCT02724163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6491899|NCT00605683|Pergolide|pergolide|mesh-list
6491900|NCT00605683|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6491901|NCT00605683|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6491902|NCT00605683|Dopamine Agonists|dopamine agonists|mesh-ancestor
6491903|NCT00605683|Dopamine Agents|dopamine agents|mesh-ancestor
6491904|NCT00605683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6491905|NCT00605683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491906|NCT00605683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491907|NCT00605683|Antioxidants|antioxidants|mesh-ancestor
6491908|NCT00605683|Protective Agents|protective agents|mesh-ancestor
5801818|NCT02724163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5801819|NCT02724163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5801820|NCT02724163|Analgesics|analgesics|mesh-ancestor
5801821|NCT02724163|Sensory System Agents|sensory system agents|mesh-ancestor
5801822|NCT02724163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5801823|NCT02724163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5801824|NCT02723981|Vitamins|vitamins|mesh-list
5801825|NCT02723981|Vitamin K|vitamin k|mesh-list
5801826|NCT02723981|Rivaroxaban|rivaroxaban|mesh-list
5801827|NCT02723981|Dabigatran|dabigatran|mesh-list
5801828|NCT02723981|Anticoagulants|anticoagulants|mesh-list
5801829|NCT02723981|Clopidogrel|clopidogrel|mesh-list
5801830|NCT02723981|Micronutrients|micronutrients|mesh-ancestor
5801831|NCT02723981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801832|NCT02723981|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5801833|NCT02723981|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5801834|NCT02723981|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5801835|NCT02723981|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5801836|NCT02723981|Purinergic Agents|purinergic agents|mesh-ancestor
5801837|NCT02723981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5801838|NCT02723981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801839|NCT02723981|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5801840|NCT02723981|Antithrombins|antithrombins|mesh-ancestor
5801841|NCT02723981|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5801842|NCT02723981|Protease Inhibitors|protease inhibitors|mesh-ancestor
5801843|NCT02723981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5801844|NCT02723981|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5801845|NCT02723981|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5801846|NCT02723981|Hemostatics|hemostatics|mesh-ancestor
5801847|NCT02723981|Coagulants|coagulants|mesh-ancestor
5801848|NCT02723903|Fluoxetine|fluoxetine|mesh-list
5801849|NCT02723903|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5801850|NCT02723903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5801851|NCT02723903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5801852|NCT02723903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801853|NCT02723903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5801854|NCT02723903|Serotonin Agents|serotonin agents|mesh-ancestor
5801855|NCT02723903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801856|NCT02723903|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5801857|NCT02723903|Antidepressive Agents|antidepressive agents|mesh-ancestor
5801858|NCT02723903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5801859|NCT02723903|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5801860|NCT02723903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5801861|NCT02723903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5801862|NCT02723760|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
5801863|NCT02723760|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5801864|NCT02723760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801865|NCT02723578|Pemetrexed|pemetrexed|mesh-list
5801866|NCT02723578|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5801867|NCT02723578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6491909|NCT00605683|Hormone Antagonists|hormone antagonists|mesh-ancestor
5801868|NCT02723578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5801869|NCT02723578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801870|NCT02723578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5801871|NCT02723578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5801872|NCT02723578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5801873|NCT02723838|Gemcitabine|gemcitabine|mesh-list
5801874|NCT02723838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5801875|NCT02723838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5801876|NCT02723838|Antimetabolites|antimetabolites|mesh-ancestor
5801877|NCT02723838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801878|NCT02723838|Antiviral Agents|antiviral agents|mesh-ancestor
5801879|NCT02723838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5801880|NCT02723838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5801881|NCT02723838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5801882|NCT02723838|Immunologic Factors|immunologic factors|mesh-ancestor
5801883|NCT02723838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801884|NCT02723500|Xenon|xenon|mesh-list
5801885|NCT02723500|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5801886|NCT02723500|Anesthetics, General|anesthetics, general|mesh-ancestor
5801887|NCT02723500|Anesthetics|anesthetics|mesh-ancestor
5801888|NCT02723500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5801889|NCT02723500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801890|NCT02723669|Acetylcysteine|acetylcysteine|mesh-list
5801891|NCT02723669|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5801892|NCT02723669|Antiviral Agents|antiviral agents|mesh-ancestor
5801893|NCT02723669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5801894|NCT02723669|Expectorants|expectorants|mesh-ancestor
5801895|NCT02723669|Respiratory System Agents|respiratory system agents|mesh-ancestor
5801896|NCT02723669|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5801897|NCT02723669|Antioxidants|antioxidants|mesh-ancestor
5801898|NCT02723669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801899|NCT02723669|Protective Agents|protective agents|mesh-ancestor
5801900|NCT02723669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801901|NCT02723669|Antidotes|antidotes|mesh-ancestor
5801902|NCT02723513|Xenon|xenon|mesh-list
5801903|NCT02723513|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5801904|NCT02723513|Anesthetics, General|anesthetics, general|mesh-ancestor
5801905|NCT02723513|Anesthetics|anesthetics|mesh-ancestor
5801906|NCT02723513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5801907|NCT02723513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801908|NCT02723461|Oxytocin|oxytocin|mesh-list
5801909|NCT02723461|Oxytocics|oxytocics|mesh-ancestor
5801910|NCT02723461|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5801911|NCT02723461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801912|NCT02723487|Bupivacaine|bupivacaine|mesh-list
5801913|NCT02723487|Anesthetics, Local|anesthetics, local|mesh-ancestor
5801914|NCT02723487|Anesthetics|anesthetics|mesh-ancestor
5801915|NCT02723487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5801916|NCT02723487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801917|NCT02723487|Sensory System Agents|sensory system agents|mesh-ancestor
5801918|NCT02723487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5801919|NCT02723448|Aclarubicin|aclarubicin|mesh-list
5801920|NCT02723448|Aclacinomycins|aclacinomycins|mesh-list
5801921|NCT02723448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5801922|NCT02723448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5801923|NCT02723448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5801924|NCT02723448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5801925|NCT02723448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5801926|NCT02723448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801927|NCT02723448|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5801928|NCT02723448|Immunologic Factors|immunologic factors|mesh-ancestor
5801929|NCT02723448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801930|NCT02723279|Tolterodine Tartrate|tolterodine tartrate|mesh-list
5801931|NCT02723279|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5801932|NCT02723279|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5801933|NCT02723279|Cholinergic Agents|cholinergic agents|mesh-ancestor
5801934|NCT02723279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5801935|NCT02723279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801936|NCT02723279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801937|NCT02723279|Urological Agents|urological agents|mesh-ancestor
5801938|NCT02723266|Tin Fluorides|tin fluorides|mesh-list
5801939|NCT02723266|Cariostatic Agents|cariostatic agents|mesh-ancestor
5801940|NCT02723266|Protective Agents|protective agents|mesh-ancestor
5801941|NCT02723266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801942|NCT02723253|Raltitrexed|raltitrexed|mesh-list
5801943|NCT02723253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5801944|NCT02723253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5801945|NCT02723253|Antimetabolites|antimetabolites|mesh-ancestor
5801946|NCT02723253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801947|NCT02723253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5801948|NCT02723253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5801949|NCT02723383|Baclofen|baclofen|mesh-list
5801950|NCT02723383|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5801951|NCT02723383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801952|NCT02723383|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5801953|NCT02723383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5801954|NCT02723383|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
5801955|NCT02723383|GABA Agonists|gaba agonists|mesh-ancestor
5801956|NCT02723383|GABA Agents|gaba agents|mesh-ancestor
5801957|NCT02723383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5801958|NCT02723383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801959|NCT02723435|Midostaurin|midostaurin|mesh-list
5801960|NCT02723435|Staurosporine|staurosporine|mesh-list
5801961|NCT02723435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5801962|NCT02723435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5801963|NCT02723435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5801964|NCT02723435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801965|NCT02723331|Gemcitabine|gemcitabine|mesh-list
5801966|NCT02723331|Paclitaxel|paclitaxel|mesh-list
5801967|NCT02723331|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5801968|NCT02723331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5801969|NCT02723331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5801970|NCT02723331|Tubulin Modulators|tubulin modulators|mesh-ancestor
5801971|NCT02723331|Antimitotic Agents|antimitotic agents|mesh-ancestor
5801972|NCT02723331|Mitosis Modulators|mitosis modulators|mesh-ancestor
5801973|NCT02723331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5801974|NCT02723331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5801975|NCT02723331|Antimetabolites|antimetabolites|mesh-ancestor
5801976|NCT02723331|Antiviral Agents|antiviral agents|mesh-ancestor
5801977|NCT02723331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5801978|NCT02723331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5801979|NCT02723331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5801980|NCT02723331|Immunologic Factors|immunologic factors|mesh-ancestor
5801981|NCT02723331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801982|NCT02722954|Pembrolizumab|pembrolizumab|mesh-list
5801983|NCT02722954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5801984|NCT02722954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5801985|NCT02723071|Ocrelizumab|ocrelizumab|mesh-list
5801986|NCT02723071|Immunologic Factors|immunologic factors|mesh-ancestor
5801987|NCT02723071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801988|NCT02722902|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
5801989|NCT02722902|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
5801990|NCT02722902|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5801991|NCT02722902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5801992|NCT02722811|Etanercept|etanercept|mesh-list
5801993|NCT02722811|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5801994|NCT02722811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5801995|NCT02722811|Analgesics|analgesics|mesh-ancestor
5801996|NCT02722811|Sensory System Agents|sensory system agents|mesh-ancestor
5801997|NCT02722811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5801998|NCT02722811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5801999|NCT02722811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5802000|NCT02722811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5802001|NCT02722811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5802002|NCT02722811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5802003|NCT02722811|Immunologic Factors|immunologic factors|mesh-ancestor
5802004|NCT02722538|Gemcitabine|gemcitabine|mesh-list
5802005|NCT02722538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5802006|NCT02722538|Antimetabolites|antimetabolites|mesh-ancestor
5802007|NCT02722538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5802008|NCT02722538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5802009|NCT02722538|Antiviral Agents|antiviral agents|mesh-ancestor
5802010|NCT02722538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5802011|NCT02722538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5802012|NCT02722538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5802013|NCT02722538|Immunologic Factors|immunologic factors|mesh-ancestor
5802014|NCT02722538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802015|NCT02722746|Epinephrine|epinephrine|mesh-list
5802016|NCT02722746|Ropivacaine|ropivacaine|mesh-list
5802017|NCT02722746|Anesthetics, Local|anesthetics, local|mesh-ancestor
5802018|NCT02722746|Anesthetics|anesthetics|mesh-ancestor
5802019|NCT02722746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5802020|NCT02722746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802021|NCT02722746|Sensory System Agents|sensory system agents|mesh-ancestor
5802022|NCT02722746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5802023|NCT02722746|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5802024|NCT02722746|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5802025|NCT02722746|Adrenergic Agents|adrenergic agents|mesh-ancestor
5802026|NCT02722746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5802027|NCT02722746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5802028|NCT02722746|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5802029|NCT02722746|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5802030|NCT02722746|Autonomic Agents|autonomic agents|mesh-ancestor
5802031|NCT02722746|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5802032|NCT02722746|Respiratory System Agents|respiratory system agents|mesh-ancestor
5802033|NCT02722746|Mydriatics|mydriatics|mesh-ancestor
5802034|NCT02722746|Sympathomimetics|sympathomimetics|mesh-ancestor
5802035|NCT02722746|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5802036|NCT02722616|Pancrelipase|pancrelipase|mesh-list
5802037|NCT02722616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5802038|NCT02722772|Etanercept|etanercept|mesh-list
5802039|NCT02722772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5802040|NCT02722772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5802041|NCT02722772|Analgesics|analgesics|mesh-ancestor
5802042|NCT02722772|Sensory System Agents|sensory system agents|mesh-ancestor
5802043|NCT02722772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5802044|NCT02722772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802045|NCT02722772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5802046|NCT02722772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5802047|NCT02722772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5802048|NCT02722772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5802049|NCT02722772|Immunologic Factors|immunologic factors|mesh-ancestor
5802050|NCT02722733|Cytarabine|cytarabine|mesh-list
5802051|NCT02722733|Lenograstim|lenograstim|mesh-list
5802052|NCT02722733|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5802053|NCT02722733|Immunologic Factors|immunologic factors|mesh-ancestor
5802054|NCT02722733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802055|NCT02722733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5802056|NCT02722733|Antimetabolites|antimetabolites|mesh-ancestor
5802057|NCT02722733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5802058|NCT02722733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5802059|NCT02722733|Antiviral Agents|antiviral agents|mesh-ancestor
5802060|NCT02722733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5802061|NCT02722733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5900048|NCT05125237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900049|NCT05125237|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
5900050|NCT05125237|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5900051|NCT05125237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5900052|NCT05125237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900053|NCT05125237|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
5900054|NCT05125237|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5900055|NCT05125224|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5900056|NCT05125224|Calcium Channel Blockers|calcium channel blockers|mesh-list
5900057|NCT05125224|1,4-dihydropyridine|1,4-dihydropyridine|mesh-list
5900058|NCT05125224|Calcium|calcium|mesh-list
5900059|NCT05125224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5900060|NCT05125224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900061|NCT05125224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5900062|NCT05125224|Diuretics|diuretics|mesh-ancestor
5900063|NCT05125224|Natriuretic Agents|natriuretic agents|mesh-ancestor
5900064|NCT05125224|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5900065|NCT05125224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5900066|NCT05125224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900067|NCT05125055|Paclitaxel|paclitaxel|mesh-list
5900068|NCT05125055|Docetaxel|docetaxel|mesh-list
5900069|NCT05125055|Fluorouracil|fluorouracil|mesh-list
5900070|NCT05125055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5900071|NCT05125055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5900072|NCT05125055|Tubulin Modulators|tubulin modulators|mesh-ancestor
5900073|NCT05125055|Antimitotic Agents|antimitotic agents|mesh-ancestor
5900074|NCT05125055|Mitosis Modulators|mitosis modulators|mesh-ancestor
5900075|NCT05125055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900076|NCT05125055|Antimetabolites|antimetabolites|mesh-ancestor
5900077|NCT05125055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5900078|NCT05125055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5900079|NCT05125055|Immunologic Factors|immunologic factors|mesh-ancestor
5900080|NCT05125055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802062|NCT02722694|Methotrexate|methotrexate|mesh-list
5802063|NCT02722694|Abatacept|abatacept|mesh-list
5802064|NCT02722694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5802065|NCT02722694|Abortifacient Agents|abortifacient agents|mesh-ancestor
5802066|NCT02722694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5802067|NCT02722694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802068|NCT02722694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5802069|NCT02722694|Antimetabolites|antimetabolites|mesh-ancestor
5802070|NCT02722694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5802071|NCT02722694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5802072|NCT02722694|Dermatologic Agents|dermatologic agents|mesh-ancestor
5802073|NCT02722694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5802074|NCT02722694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5802075|NCT02722694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5802076|NCT02722694|Immunologic Factors|immunologic factors|mesh-ancestor
5802077|NCT02722694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5802078|NCT02722694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5802079|NCT02722694|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5802080|NCT02722603|Gabapentin|gabapentin|mesh-list
5802081|NCT02722603|Tramadol|tramadol|mesh-list
5802082|NCT02722603|Analgesics|analgesics|mesh-ancestor
5802083|NCT02722603|Sensory System Agents|sensory system agents|mesh-ancestor
5802084|NCT02722603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5802085|NCT02722603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802086|NCT02722603|Anticonvulsants|anticonvulsants|mesh-ancestor
5802087|NCT02722603|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5802088|NCT02722603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5802089|NCT02722603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5802090|NCT02722603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5802091|NCT02722603|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5802092|NCT02722603|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5802093|NCT02722603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5802094|NCT02722603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5802095|NCT02722603|Antimanic Agents|antimanic agents|mesh-ancestor
5802096|NCT02722603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5802097|NCT02722603|Narcotics|narcotics|mesh-ancestor
5802098|NCT02722447|Rivaroxaban|rivaroxaban|mesh-list
5802099|NCT02722447|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5802100|NCT02722447|Antithrombins|antithrombins|mesh-ancestor
5802101|NCT02722447|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5802102|NCT02722447|Protease Inhibitors|protease inhibitors|mesh-ancestor
5802103|NCT02722447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5802104|NCT02722447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5802105|NCT02722447|Anticoagulants|anticoagulants|mesh-ancestor
5802106|NCT02722421|Efavirenz|efavirenz|mesh-list
5802107|NCT02722421|Levonorgestrel|levonorgestrel|mesh-list
5802108|NCT02722421|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5802109|NCT02722421|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5802110|NCT02722421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5802111|NCT02722421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5802112|NCT02722421|Antiviral Agents|antiviral agents|mesh-ancestor
5802113|NCT02722421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5802114|NCT02722421|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5802115|NCT02722421|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5802116|NCT02722421|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5802117|NCT02722421|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5802118|NCT02722421|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5802119|NCT02722421|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5802120|NCT02722421|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5802121|NCT02722421|Contraceptive Agents|contraceptive agents|mesh-ancestor
5802122|NCT02722421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5802123|NCT02722421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802124|NCT02722421|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5802125|NCT02722421|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5802126|NCT02722421|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5802127|NCT02722369|Gemcitabine|gemcitabine|mesh-list
5802128|NCT02722369|Hydroxychloroquine|hydroxychloroquine|mesh-list
5802129|NCT02722369|Carboplatin|carboplatin|mesh-list
5802130|NCT02722369|Etoposide|etoposide|mesh-list
5802131|NCT02722369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5802132|NCT02722369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5802133|NCT02722369|Antimetabolites|antimetabolites|mesh-ancestor
5802134|NCT02722369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5802135|NCT02722369|Antiviral Agents|antiviral agents|mesh-ancestor
5802136|NCT02722369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5802137|NCT02722369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5802138|NCT02722369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5802139|NCT02722369|Immunologic Factors|immunologic factors|mesh-ancestor
5802140|NCT02722369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802141|NCT02722369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5802142|NCT02722369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5802143|NCT02722369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5802144|NCT02722369|Antimalarials|antimalarials|mesh-ancestor
5802145|NCT02722369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5802146|NCT02722369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5802147|NCT02722369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5802148|NCT02722356|Oxytocin|oxytocin|mesh-list
5802149|NCT02722356|Oxytocics|oxytocics|mesh-ancestor
5802150|NCT02722356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5802151|NCT02722356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802152|NCT02722343|Tenofovir|tenofovir|mesh-list
5802153|NCT02722343|Emtricitabine|emtricitabine|mesh-list
5802154|NCT02722343|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5802155|NCT02722343|Antiviral Agents|antiviral agents|mesh-ancestor
5802156|NCT02722343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5802157|NCT02722343|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5802158|NCT02722343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5802159|NCT02722343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5802160|NCT02722343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5802161|NCT02722343|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5802162|NCT02722343|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5802163|NCT02722200|Hydrocortisone|hydrocortisone|mesh-list
5802164|NCT02722200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5802165|NCT02722083|Chlorpheniramine|chlorpheniramine|mesh-list
5802166|NCT02722083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5802167|NCT02722083|Antipruritics|antipruritics|mesh-ancestor
5802168|NCT02722083|Dermatologic Agents|dermatologic agents|mesh-ancestor
5802169|NCT02722083|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5802170|NCT02722083|Histamine Antagonists|histamine antagonists|mesh-ancestor
5802171|NCT02722083|Histamine Agents|histamine agents|mesh-ancestor
5802172|NCT02722083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5802173|NCT02722083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802174|NCT02722083|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6491910|NCT00605683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6491911|NCT00605683|Emetics|emetics|mesh-ancestor
6491912|NCT00605683|Autonomic Agents|autonomic agents|mesh-ancestor
6491913|NCT00605683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6491914|NCT00605683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6491915|NCT00605683|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6491916|NCT00605683|Serotonin Agents|serotonin agents|mesh-ancestor
5802175|NCT02722096|Lidocaine|lidocaine|mesh-list
5802176|NCT02722096|Ropivacaine|ropivacaine|mesh-list
5802177|NCT02722096|Anesthetics|anesthetics|mesh-list
5802178|NCT02722096|Anesthetics, Local|anesthetics, local|mesh-ancestor
5802179|NCT02722096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5802180|NCT02722096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802181|NCT02722096|Sensory System Agents|sensory system agents|mesh-ancestor
6491917|NCT00605774|Epinephrine|epinephrine|mesh-list
5802182|NCT02722096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5802183|NCT02722096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5802184|NCT02722096|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5802185|NCT02722096|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5802186|NCT02722096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5802187|NCT02722096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5802188|NCT02721940|Zoledronic Acid|zoledronic acid|mesh-list
5802189|NCT02721940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5802190|NCT02721940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802191|NCT02721862|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
5802192|NCT02721862|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5802193|NCT02721862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5802194|NCT02721888|Liraglutide|liraglutide|mesh-list
5802195|NCT02721888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5802196|NCT02721888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802197|NCT02721888|Incretins|incretins|mesh-ancestor
5802198|NCT02721888|Hormones|hormones|mesh-ancestor
5802199|NCT02721888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5802200|NCT02721732|Pembrolizumab|pembrolizumab|mesh-list
5802201|NCT02721732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5802202|NCT02721732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5802203|NCT02721511|Furosemide|furosemide|mesh-list
5802204|NCT02721511|Diuretics|diuretics|mesh-ancestor
5802205|NCT02721511|Natriuretic Agents|natriuretic agents|mesh-ancestor
5802206|NCT02721511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802207|NCT02721511|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5802208|NCT02721511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5802209|NCT02721511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5802210|NCT02721420|Piperaquine|piperaquine|mesh-list
5802211|NCT02721420|Artenimol|artenimol|mesh-list
5802212|NCT02721420|Antimalarials|antimalarials|mesh-ancestor
5802213|NCT02721420|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5802214|NCT02721420|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5802215|NCT02721420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5802216|NCT02721368|Lidocaine|lidocaine|mesh-list
5802217|NCT02721368|Anesthetics, Local|anesthetics, local|mesh-ancestor
5802218|NCT02721368|Anesthetics|anesthetics|mesh-ancestor
5802219|NCT02721368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5802220|NCT02721368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802221|NCT02721368|Sensory System Agents|sensory system agents|mesh-ancestor
5802222|NCT02721368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5802223|NCT02721368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5802224|NCT02721368|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5802225|NCT02721368|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5802226|NCT02721368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5802227|NCT02721368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491918|NCT00605774|Racepinephrine|racepinephrine|mesh-list
6491919|NCT00605774|Epinephryl borate|epinephryl borate|mesh-list
6491920|NCT00605774|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6491921|NCT00605774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6491922|NCT00605774|Adrenergic Agents|adrenergic agents|mesh-ancestor
6491923|NCT00605774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5802228|NCT02721329|Acetaminophen|acetaminophen|mesh-list
5802229|NCT02721329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5802230|NCT02721329|Analgesics|analgesics|mesh-ancestor
5802231|NCT02721329|Sensory System Agents|sensory system agents|mesh-ancestor
5802232|NCT02721329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5802233|NCT02721329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802234|NCT02721329|Antipyretics|antipyretics|mesh-ancestor
5802235|NCT02721433|Denosumab|denosumab|mesh-list
6491924|NCT00605774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491925|NCT00605774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491926|NCT00605774|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6491927|NCT00605774|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6491928|NCT00605774|Autonomic Agents|autonomic agents|mesh-ancestor
6491929|NCT00605774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6491930|NCT00605774|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6491931|NCT00605774|Respiratory System Agents|respiratory system agents|mesh-ancestor
6491932|NCT00605774|Mydriatics|mydriatics|mesh-ancestor
6491933|NCT00605774|Sympathomimetics|sympathomimetics|mesh-ancestor
6491934|NCT00605774|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6491935|NCT00605787|1-(carboxymethylthio)tetradecane|1-(carboxymethylthio)tetradecane|mesh-list
6491936|NCT00605787|Antioxidants|antioxidants|mesh-ancestor
6491937|NCT00605787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491938|NCT00605787|Protective Agents|protective agents|mesh-ancestor
6491939|NCT00605787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491940|NCT00605787|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6491941|NCT00605891|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5802236|NCT02721433|Zoledronic Acid|zoledronic acid|mesh-list
6491942|NCT00605891|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6491943|NCT00605891|Autonomic Agents|autonomic agents|mesh-ancestor
5802237|NCT02721433|Pamidronate|pamidronate|mesh-list
5802238|NCT02721433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5802239|NCT02721433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802240|NCT02721238|Plasma-lyte 148|plasma-lyte 148|mesh-list
5802241|NCT02721238|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5802242|NCT02721238|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5802243|NCT02721043|Lenalidomide|lenalidomide|mesh-list
5802244|NCT02721043|Vaccines|vaccines|mesh-list
5802245|NCT02721043|Poly ICLC|poly iclc|mesh-list
5802246|NCT02721043|Immunologic Factors|immunologic factors|mesh-ancestor
5802247|NCT02721043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802248|NCT02721043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5802249|NCT02721043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5802250|NCT02721043|Growth Substances|growth substances|mesh-ancestor
5802251|NCT02721043|Growth Inhibitors|growth inhibitors|mesh-ancestor
5802252|NCT02721043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5802253|NCT02721043|Interferon Inducers|interferon inducers|mesh-ancestor
5802254|NCT02721290|Ropivacaine|ropivacaine|mesh-list
5802255|NCT02721290|Anesthetics, Local|anesthetics, local|mesh-ancestor
5802256|NCT02721290|Anesthetics|anesthetics|mesh-ancestor
5802257|NCT02721290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5802258|NCT02721290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802259|NCT02721290|Sensory System Agents|sensory system agents|mesh-ancestor
5802260|NCT02721290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5802261|NCT02721082|Nicotine|nicotine|mesh-list
5802262|NCT02721082|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5802263|NCT02721082|Autonomic Agents|autonomic agents|mesh-ancestor
5802264|NCT02721082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5802265|NCT02721082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802266|NCT02721082|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5802267|NCT02721082|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5802268|NCT02721082|Cholinergic Agents|cholinergic agents|mesh-ancestor
5802269|NCT02721082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5802270|NCT02721082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5802271|NCT02721173|Clindamycin|clindamycin|mesh-list
5802272|NCT02721173|Clindamycin palmitate|clindamycin palmitate|mesh-list
5802273|NCT02721173|Clindamycin phosphate|clindamycin phosphate|mesh-list
5802274|NCT02721173|Adapalene|adapalene|mesh-list
5802275|NCT02721173|Tazarotene|tazarotene|mesh-list
5802276|NCT02721173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5802277|NCT02721173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5802278|NCT02721173|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5802279|NCT02721173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5802280|NCT02721173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5802281|NCT02721173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5802282|NCT02721173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5802283|NCT02721173|Analgesics|analgesics|mesh-ancestor
5802284|NCT02721173|Sensory System Agents|sensory system agents|mesh-ancestor
5802285|NCT02721173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5802286|NCT02721173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802287|NCT02721173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5802288|NCT02721173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5802289|NCT02721173|Dermatologic Agents|dermatologic agents|mesh-ancestor
5802290|NCT02721173|Keratolytic Agents|keratolytic agents|mesh-ancestor
5802291|NCT02721186|Piperaquine|piperaquine|mesh-list
5802292|NCT02721186|Primaquine|primaquine|mesh-list
6674071|NCT01567072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674072|NCT01567111|Metomidate|metomidate|mesh-list
6674073|NCT01567111|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6674074|NCT01567111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6674075|NCT01567111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674076|NCT01567124|Moxonidine|moxonidine|mesh-list
6674077|NCT01567124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6674078|NCT01567202|Vaccines|vaccines|mesh-list
6674079|NCT01567202|Immunologic Factors|immunologic factors|mesh-ancestor
6674080|NCT01567202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674081|NCT01567215|Ethanol|ethanol|mesh-list
5802293|NCT02721186|Artenimol|artenimol|mesh-list
5802294|NCT02721186|Antimalarials|antimalarials|mesh-ancestor
5802295|NCT02721186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5802296|NCT02721186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5802297|NCT02721186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5802298|NCT02720978|Oxytocin|oxytocin|mesh-list
5802299|NCT02720978|Oxytocics|oxytocics|mesh-ancestor
5802300|NCT02720978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5802301|NCT02720978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802302|NCT02720991|Misoprostol|misoprostol|mesh-list
5802303|NCT02720991|Mifepristone|mifepristone|mesh-list
5802304|NCT02720991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5802305|NCT02720991|Abortifacient Agents|abortifacient agents|mesh-ancestor
5802306|NCT02720991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5802307|NCT02720991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802308|NCT02720991|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5802309|NCT02720991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5802310|NCT02720991|Oxytocics|oxytocics|mesh-ancestor
5802311|NCT02720991|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5802312|NCT02720991|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5802313|NCT02720991|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5802314|NCT02720991|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5802315|NCT02720991|Contraceptive Agents|contraceptive agents|mesh-ancestor
5802316|NCT02720991|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5802317|NCT02720991|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5802318|NCT02720991|Hormone Antagonists|hormone antagonists|mesh-ancestor
5802319|NCT02720991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5802320|NCT02720991|Luteolytic Agents|luteolytic agents|mesh-ancestor
5802321|NCT02720991|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5802322|NCT02720991|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5802323|NCT02720822|Morphine|morphine|mesh-list
5802324|NCT02720822|Laxatives|laxatives|mesh-list
5802325|NCT02720822|Cathartics|cathartics|mesh-list
5802326|NCT02720822|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5802327|NCT02720822|Narcotics|narcotics|mesh-ancestor
5802328|NCT02720822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6674082|NCT01567215|Silver Nitrate|silver nitrate|mesh-list
6674083|NCT01567215|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5802329|NCT02720822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802330|NCT02720822|Analgesics|analgesics|mesh-ancestor
5802331|NCT02720822|Sensory System Agents|sensory system agents|mesh-ancestor
5802332|NCT02720822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5802333|NCT02720822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5900081|NCT05125042|Amiodarone|amiodarone|mesh-list
5900082|NCT05125042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5900083|NCT05125042|Vasodilator Agents|vasodilator agents|mesh-ancestor
5900084|NCT05125042|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5900085|NCT05125042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5900086|NCT05125042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900087|NCT05125042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5900088|NCT05125042|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5900089|NCT05125042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5900090|NCT05125042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5900091|NCT05125042|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5900092|NCT05125042|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5900093|NCT05125042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5900094|NCT05124977|Anti-Infective Agents|anti-infective agents|mesh-list
5900095|NCT05124977|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5900096|NCT05124951|Carboplatin|carboplatin|mesh-list
5900097|NCT05124951|Etoposide|etoposide|mesh-list
5900098|NCT05124951|Etoposide phosphate|etoposide phosphate|mesh-list
5900099|NCT05124951|Ifosfamide|ifosfamide|mesh-list
5900100|NCT05124951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5900101|NCT05124951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5900102|NCT05124951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5900103|NCT05124951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5900104|NCT05124951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5900105|NCT05124951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900106|NCT05124951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5900107|NCT05124951|Alkylating Agents|alkylating agents|mesh-ancestor
5900108|NCT05124938|Hormones|hormones|mesh-list
5900109|NCT05124938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5900110|NCT05124938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900111|NCT05124730|Metformin|metformin|mesh-list
5900112|NCT05124730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5900113|NCT05124730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900114|NCT05124717|Metformin|metformin|mesh-list
5900115|NCT05124717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5900116|NCT05124717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900117|NCT05124457|Insulin|insulin|mesh-list
5900118|NCT05124457|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5900119|NCT05124457|Insulin Detemir|insulin detemir|mesh-list
5900120|NCT05124457|Isophane Insulin, Human|isophane insulin, human|mesh-list
5900121|NCT05124457|Insulin, Isophane|insulin, isophane|mesh-list
5900122|NCT05124457|Isophane insulin, beef|isophane insulin, beef|mesh-list
5900123|NCT05124457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5900124|NCT05124457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900125|NCT05124431|Everolimus|everolimus|mesh-list
5900126|NCT05124431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5900127|NCT05124431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5900128|NCT05124431|Immunologic Factors|immunologic factors|mesh-ancestor
5900129|NCT05124431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900130|NCT05118620|Bupivacaine|bupivacaine|mesh-list
5900131|NCT05118620|Anesthetics, Local|anesthetics, local|mesh-ancestor
5900132|NCT05118620|Anesthetics|anesthetics|mesh-ancestor
5900133|NCT05118620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5900134|NCT05118620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900135|NCT05118620|Sensory System Agents|sensory system agents|mesh-ancestor
5900136|NCT05118620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5900137|NCT05115591|Anesthetics|anesthetics|mesh-list
5900138|NCT05115591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5900139|NCT05115591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900140|NCT05115201|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5900141|NCT05115201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5900142|NCT05109949|Dapagliflozin|dapagliflozin|mesh-list
5900143|NCT05109949|Empagliflozin|empagliflozin|mesh-list
5900144|NCT05109949|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5900145|NCT05109949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900146|NCT05109949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5900147|NCT05109949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5908207|NCT04803201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5908208|NCT04803201|Tubulin Modulators|tubulin modulators|mesh-ancestor
5802334|NCT02720770|Hormones|hormones|mesh-list
5802335|NCT02720770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5802336|NCT02720770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802337|NCT02720926|Capecitabine|capecitabine|mesh-list
5802338|NCT02720926|Oxaliplatin|oxaliplatin|mesh-list
5802339|NCT02720926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5802340|NCT02720926|Antimetabolites|antimetabolites|mesh-ancestor
5802341|NCT02720926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5802342|NCT02720926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5802343|NCT02720965|Anesthetics|anesthetics|mesh-list
5802344|NCT02720965|Anesthetics, Local|anesthetics, local|mesh-list
5802345|NCT02720965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5802346|NCT02720965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802347|NCT02720965|Sensory System Agents|sensory system agents|mesh-ancestor
5802348|NCT02720965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5802349|NCT02720783|Econazole|econazole|mesh-list
5802350|NCT02720783|Benzydamine|benzydamine|mesh-list
5802351|NCT02720783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5802352|NCT02720783|Antifungal Agents|antifungal agents|mesh-ancestor
5802353|NCT02720783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5802354|NCT02720783|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5802355|NCT02720783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5802356|NCT02720783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5802357|NCT02720783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5802358|NCT02720783|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5802359|NCT02720783|Hormone Antagonists|hormone antagonists|mesh-ancestor
5802360|NCT02720783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5802361|NCT02720783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802362|NCT02720692|Meloxicam|meloxicam|mesh-list
5802363|NCT02720692|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5802364|NCT02720692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5802365|NCT02720692|Analgesics|analgesics|mesh-ancestor
5802366|NCT02720692|Sensory System Agents|sensory system agents|mesh-ancestor
5802367|NCT02720692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5802368|NCT02720692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802369|NCT02720692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5802370|NCT02720692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5802371|NCT02720692|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5802372|NCT02720692|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5802373|NCT02720692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5802374|NCT02720692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5802375|NCT02720705|Dexmedetomidine|dexmedetomidine|mesh-list
5802376|NCT02720705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5802377|NCT02720705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5802378|NCT02720705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802379|NCT02720705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5802380|NCT02720705|Analgesics|analgesics|mesh-ancestor
5802381|NCT02720705|Sensory System Agents|sensory system agents|mesh-ancestor
5802382|NCT02720705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5802383|NCT02720705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5802384|NCT02720705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5802385|NCT02720705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5802386|NCT02720705|Adrenergic Agents|adrenergic agents|mesh-ancestor
5802387|NCT02720705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5802388|NCT02720705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5802389|NCT02720744|Sodium Oxybate|sodium oxybate|mesh-list
5802390|NCT02720744|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5802391|NCT02720744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5802392|NCT02720744|Anesthetics, General|anesthetics, general|mesh-ancestor
5802393|NCT02720744|Anesthetics|anesthetics|mesh-ancestor
5802394|NCT02720744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5802395|NCT02720744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802396|NCT02720471|Anesthetics|anesthetics|mesh-list
5802397|NCT02720471|Anesthetics, Local|anesthetics, local|mesh-list
5802398|NCT02720471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5802399|NCT02720471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802400|NCT02720471|Sensory System Agents|sensory system agents|mesh-ancestor
5802401|NCT02720471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5802402|NCT02720601|Capecitabine|capecitabine|mesh-list
5802403|NCT02720601|Irinotecan|irinotecan|mesh-list
5802404|NCT02720601|Camptothecin|camptothecin|mesh-list
5802405|NCT02720601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5802406|NCT02720601|Antimetabolites|antimetabolites|mesh-ancestor
5802407|NCT02720601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5802408|NCT02720601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5802409|NCT02720601|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5802410|NCT02720601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5802411|NCT02720601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5802412|NCT02720601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5802413|NCT02720458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
5802414|NCT02720458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5802415|NCT02720458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802416|NCT02720575|Vitamin D|vitamin d|mesh-list
5802417|NCT02720575|Vitamins|vitamins|mesh-ancestor
5802418|NCT02720575|Micronutrients|micronutrients|mesh-ancestor
5802419|NCT02720575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802420|NCT02720575|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5802421|NCT02720406|Ketamine|ketamine|mesh-list
5802422|NCT02720406|Analgesics|analgesics|mesh-ancestor
5802423|NCT02720406|Sensory System Agents|sensory system agents|mesh-ancestor
5802424|NCT02720406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6491944|NCT00605891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6491945|NCT00605891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491946|NCT00605891|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6491947|NCT00605891|Respiratory System Agents|respiratory system agents|mesh-ancestor
6491948|NCT00605891|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6491949|NCT00605891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6491950|NCT00605891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5802425|NCT02720406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802426|NCT02720406|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5802427|NCT02720406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5802428|NCT02720406|Anesthetics, General|anesthetics, general|mesh-ancestor
5802429|NCT02720406|Anesthetics|anesthetics|mesh-ancestor
5802430|NCT02720406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5802431|NCT02720406|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5802432|NCT02720406|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5802433|NCT02720406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5802434|NCT02720406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5802435|NCT02720367|Gemcitabine|gemcitabine|mesh-list
5802436|NCT02720367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5802437|NCT02720367|Antimetabolites|antimetabolites|mesh-ancestor
5802438|NCT02720367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5802439|NCT02720367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5802440|NCT02720367|Antiviral Agents|antiviral agents|mesh-ancestor
5802441|NCT02720367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5802442|NCT02720367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5802443|NCT02720367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5802444|NCT02720367|Immunologic Factors|immunologic factors|mesh-ancestor
5802445|NCT02720367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802446|NCT02720120|Ocrelizumab|ocrelizumab|mesh-list
5802447|NCT02720120|Immunologic Factors|immunologic factors|mesh-ancestor
5802448|NCT02720120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802449|NCT02720094|Cabotegravir|cabotegravir|mesh-list
5802450|NCT02720094|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5802451|NCT02720094|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5802452|NCT02720094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5802453|NCT02720094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5802454|NCT02720094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5802455|NCT02720094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5802456|NCT02720094|Antiviral Agents|antiviral agents|mesh-ancestor
5802457|NCT02720094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5802458|NCT02720341|Armin|armin|mesh-list
5802459|NCT02720341|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5802460|NCT02720341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5802461|NCT02720341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5802462|NCT02720341|Cholinergic Agents|cholinergic agents|mesh-ancestor
5802463|NCT02720341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5802464|NCT02720341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802465|NCT02719756|Metformin|metformin|mesh-list
5802466|NCT02719756|Dapagliflozin|dapagliflozin|mesh-list
6491951|NCT00605891|Adrenergic Agents|adrenergic agents|mesh-ancestor
5802467|NCT02719756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5802468|NCT02719756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802469|NCT02719756|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5802470|NCT02719756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5802471|NCT02719795|Ropivacaine|ropivacaine|mesh-list
5802472|NCT02719795|Anesthetics, Local|anesthetics, local|mesh-ancestor
5802473|NCT02719795|Anesthetics|anesthetics|mesh-ancestor
5802474|NCT02719795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5802475|NCT02719795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802476|NCT02719795|Sensory System Agents|sensory system agents|mesh-ancestor
5802477|NCT02719795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5802478|NCT02719834|Acetaminophen|acetaminophen|mesh-list
5802479|NCT02719834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5802480|NCT02719834|Analgesics|analgesics|mesh-ancestor
5802481|NCT02719834|Sensory System Agents|sensory system agents|mesh-ancestor
5802482|NCT02719834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5802483|NCT02719834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802484|NCT02719834|Antipyretics|antipyretics|mesh-ancestor
5802485|NCT02719808|Tenofovir|tenofovir|mesh-list
5802486|NCT02719808|Antiviral Agents|antiviral agents|mesh-ancestor
5802487|NCT02719808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5802488|NCT02719808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5802489|NCT02719808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5802490|NCT02719808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5802491|NCT02719808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5802492|NCT02719808|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5802493|NCT02719808|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5802494|NCT02719574|Cytarabine|cytarabine|mesh-list
5802495|NCT02719574|Azacitidine|azacitidine|mesh-list
5802496|NCT02719574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5802497|NCT02719574|Antimetabolites|antimetabolites|mesh-ancestor
5802498|NCT02719574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5802499|NCT02719574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5802500|NCT02719574|Antiviral Agents|antiviral agents|mesh-ancestor
5802501|NCT02719574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5802502|NCT02719574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5802503|NCT02719574|Immunologic Factors|immunologic factors|mesh-ancestor
5802504|NCT02719574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802505|NCT02719574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5802506|NCT02719405|Caseins|caseins|mesh-list
5802507|NCT02719405|Chelating Agents|chelating agents|mesh-ancestor
5802508|NCT02719405|Sequestering Agents|sequestering agents|mesh-ancestor
5802509|NCT02719405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5802510|NCT02719392|Acetylcysteine|acetylcysteine|mesh-list
5802511|NCT02719392|Minocycline|minocycline|mesh-list
5802512|NCT02719392|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5802513|NCT02719392|Antiviral Agents|antiviral agents|mesh-ancestor
5802514|NCT02719392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5802515|NCT02719392|Expectorants|expectorants|mesh-ancestor
5802516|NCT02719392|Respiratory System Agents|respiratory system agents|mesh-ancestor
5802517|NCT02719392|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5802518|NCT02719392|Antioxidants|antioxidants|mesh-ancestor
5802519|NCT02719392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5802520|NCT02719392|Protective Agents|protective agents|mesh-ancestor
5802521|NCT02719392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802522|NCT02719392|Antidotes|antidotes|mesh-ancestor
5802523|NCT02719392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5802524|NCT02719418|Tinzaparin|tinzaparin|mesh-list
5802525|NCT02719418|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5802526|NCT02719418|Dalteparin|dalteparin|mesh-list
5802527|NCT02719418|Anticoagulants|anticoagulants|mesh-ancestor
5802528|NCT02719418|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5802529|NCT02719418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5802530|NCT02719418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5802531|NCT02719431|Warfarin|warfarin|mesh-list
5802532|NCT02719431|Anticoagulants|anticoagulants|mesh-ancestor
5802533|NCT02719314|Methylprednisolone|methylprednisolone|mesh-list
6491952|NCT00605891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6491953|NCT00605891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491954|NCT00605930|Niacinamide|niacinamide|mesh-list
6491955|NCT00605930|Niacin|niacin|mesh-list
6491956|NCT00605930|Nicotinic Acids|nicotinic acids|mesh-list
6491957|NCT00605930|Vitamin B Complex|vitamin b complex|mesh-ancestor
6491958|NCT00605930|Vitamins|vitamins|mesh-ancestor
6491959|NCT00605930|Micronutrients|micronutrients|mesh-ancestor
6491960|NCT00605930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6491961|NCT00605930|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6491962|NCT00605930|Antimetabolites|antimetabolites|mesh-ancestor
6491963|NCT00605930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491964|NCT00605930|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6491965|NCT00605930|Vasodilator Agents|vasodilator agents|mesh-ancestor
6491966|NCT00605995|Simvastatin|simvastatin|mesh-list
6491967|NCT00605995|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6491968|NCT00605995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6491969|NCT00605995|Antimetabolites|antimetabolites|mesh-ancestor
6491970|NCT00605995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491971|NCT00605995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6491972|NCT00605995|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6491973|NCT00605995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6491974|NCT00606060|Factor VIII|factor viii|mesh-list
6491975|NCT00606060|Coagulants|coagulants|mesh-ancestor
5802534|NCT02719314|Glucocorticoids|glucocorticoids|mesh-list
5802535|NCT02719314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5802536|NCT02719314|Antiemetics|antiemetics|mesh-ancestor
5802537|NCT02719314|Autonomic Agents|autonomic agents|mesh-ancestor
5802538|NCT02719314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5802539|NCT02719314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802540|NCT02719314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5802541|NCT02719314|Hormones|hormones|mesh-ancestor
5802542|NCT02719314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5802543|NCT02719314|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5802544|NCT02719314|Protective Agents|protective agents|mesh-ancestor
5802545|NCT02719379|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5802546|NCT02719379|Immunologic Factors|immunologic factors|mesh-ancestor
5802547|NCT02719379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900148|NCT05104918|Vortioxetine|vortioxetine|mesh-list
5900149|NCT05104918|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
5900150|NCT05104918|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5900151|NCT05104918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5900152|NCT05104918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5900153|NCT05104918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900154|NCT05104918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5900155|NCT05104918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900156|NCT05104918|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5900157|NCT05104918|Antidepressive Agents|antidepressive agents|mesh-ancestor
6491976|NCT00606099|Adefovir|adefovir|mesh-list
6211062|NCT02168387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211063|NCT02168387|Protective Agents|protective agents|mesh-ancestor
6211064|NCT02168387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211065|NCT02168387|Antidotes|antidotes|mesh-ancestor
6211066|NCT02168439|Midazolam|midazolam|mesh-list
6211067|NCT02168439|Dexmedetomidine|dexmedetomidine|mesh-list
6211068|NCT02168439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6211069|NCT02168439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6211070|NCT02168439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211071|NCT02168439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6211072|NCT02168439|Analgesics|analgesics|mesh-ancestor
6211073|NCT02168439|Sensory System Agents|sensory system agents|mesh-ancestor
6211074|NCT02168439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6211075|NCT02168439|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6674084|NCT01567215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5802548|NCT02719327|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
5802549|NCT02719327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5802550|NCT02719327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5802551|NCT02719210|Mannitol|mannitol|mesh-list
5802552|NCT02719210|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5802553|NCT02719210|Diuretics|diuretics|mesh-ancestor
5802554|NCT02719210|Natriuretic Agents|natriuretic agents|mesh-ancestor
5802555|NCT02719210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802556|NCT02719132|Metformin|metformin|mesh-list
5802557|NCT02719132|Dapagliflozin|dapagliflozin|mesh-list
5802558|NCT02719132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5802559|NCT02719132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802560|NCT02719132|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5802561|NCT02719132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5802562|NCT02718820|Docetaxel|docetaxel|mesh-list
5802563|NCT02718820|Pembrolizumab|pembrolizumab|mesh-list
5802564|NCT02718820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5802565|NCT02718820|Tubulin Modulators|tubulin modulators|mesh-ancestor
5802566|NCT02718820|Antimitotic Agents|antimitotic agents|mesh-ancestor
5802567|NCT02718820|Mitosis Modulators|mitosis modulators|mesh-ancestor
5802568|NCT02718820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5802569|NCT02718820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5802570|NCT02718950|Liraglutide|liraglutide|mesh-list
5802571|NCT02718950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5802572|NCT02718950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802573|NCT02718950|Incretins|incretins|mesh-ancestor
5802574|NCT02718950|Hormones|hormones|mesh-ancestor
5802575|NCT02718950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5802576|NCT02719015|Pembrolizumab|pembrolizumab|mesh-list
5802577|NCT02719015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5802578|NCT02719015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5802579|NCT02718911|Durvalumab|durvalumab|mesh-list
5802580|NCT02718911|Tremelimumab|tremelimumab|mesh-list
5802581|NCT02718911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5802582|NCT02718911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5802583|NCT02718755|Vidarabine|vidarabine|mesh-list
5802584|NCT02718755|Cytarabine|cytarabine|mesh-list
5802585|NCT02718755|Fludarabine|fludarabine|mesh-list
5802586|NCT02718755|Fludarabine phosphate|fludarabine phosphate|mesh-list
5802587|NCT02718755|Asparaginase|asparaginase|mesh-list
5802588|NCT02718755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5802589|NCT02718755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5802590|NCT02718755|Antimetabolites|antimetabolites|mesh-ancestor
5802591|NCT02718755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5802592|NCT02718755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5802593|NCT02718755|Immunologic Factors|immunologic factors|mesh-ancestor
5802594|NCT02718755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802595|NCT02718755|Antiviral Agents|antiviral agents|mesh-ancestor
5802596|NCT02718755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5802597|NCT02718976|Lidocaine|lidocaine|mesh-list
5802598|NCT02718976|Epinephrine|epinephrine|mesh-list
5802599|NCT02718976|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
5802600|NCT02718976|Anesthetics, Local|anesthetics, local|mesh-ancestor
5802601|NCT02718976|Anesthetics|anesthetics|mesh-ancestor
5802602|NCT02718976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5802603|NCT02718976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802604|NCT02718976|Sensory System Agents|sensory system agents|mesh-ancestor
5802605|NCT02718976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5802606|NCT02718976|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5802607|NCT02718976|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5802608|NCT02718976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5802609|NCT02718976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5802610|NCT02718976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5802611|NCT02718976|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5802612|NCT02718976|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5802613|NCT02718976|Adrenergic Agents|adrenergic agents|mesh-ancestor
5802614|NCT02718976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5802615|NCT02718976|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5802616|NCT02718976|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5802617|NCT02718976|Autonomic Agents|autonomic agents|mesh-ancestor
5802618|NCT02718976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5802619|NCT02718976|Respiratory System Agents|respiratory system agents|mesh-ancestor
5802620|NCT02718976|Mydriatics|mydriatics|mesh-ancestor
5802621|NCT02718976|Sympathomimetics|sympathomimetics|mesh-ancestor
5802622|NCT02718976|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5802623|NCT02718976|Chelating Agents|chelating agents|mesh-ancestor
5802624|NCT02718976|Sequestering Agents|sequestering agents|mesh-ancestor
5802625|NCT02718677|Factor VIII|factor viii|mesh-list
6491977|NCT00606099|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6491978|NCT00606099|Telbivudine|telbivudine|mesh-list
6491979|NCT00606099|Antiviral Agents|antiviral agents|mesh-ancestor
6491980|NCT00606099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6491981|NCT00606099|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6491982|NCT00606099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6491983|NCT00606099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6491984|NCT00606099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491985|NCT00606125|Sorafenib|sorafenib|mesh-list
6491986|NCT00606125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6491987|NCT00606125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6491988|NCT00606125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6491989|NCT00606125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6491990|NCT00606164|Bryostatin 1|bryostatin 1|mesh-list
6491991|NCT00606164|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6491992|NCT00606164|Immunologic Factors|immunologic factors|mesh-ancestor
6491993|NCT00606164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674085|NCT01567215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5802626|NCT02718677|Coagulants|coagulants|mesh-ancestor
5802627|NCT02718716|Rozanolixizumab|rozanolixizumab|mesh-list
5802628|NCT02718716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5802629|NCT02718716|Immunologic Factors|immunologic factors|mesh-ancestor
5802630|NCT02718716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802631|NCT02718547|Timolol|timolol|mesh-list
5802632|NCT02718547|Brimonidine Tartrate|brimonidine tartrate|mesh-list
5802633|NCT02718547|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5802634|NCT02718547|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
5802635|NCT02718547|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5802636|NCT02718547|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5802637|NCT02718547|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5802638|NCT02718547|Adrenergic Agents|adrenergic agents|mesh-ancestor
5802639|NCT02718547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5802640|NCT02718547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5802641|NCT02718547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802642|NCT02718547|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5802643|NCT02718547|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5802644|NCT02718547|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5802645|NCT02718547|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5802646|NCT02718547|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5802647|NCT02718742|Paclitaxel|paclitaxel|mesh-list
5802648|NCT02718742|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5802649|NCT02718742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5802650|NCT02718742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5802651|NCT02718742|Tubulin Modulators|tubulin modulators|mesh-ancestor
5802652|NCT02718742|Antimitotic Agents|antimitotic agents|mesh-ancestor
5802653|NCT02718742|Mitosis Modulators|mitosis modulators|mesh-ancestor
5802654|NCT02718742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5802655|NCT02718404|Analgesics|analgesics|mesh-list
5802656|NCT02718404|Sensory System Agents|sensory system agents|mesh-ancestor
5802657|NCT02718404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5802658|NCT02718404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802659|NCT02718469|Vaccines|vaccines|mesh-list
5802660|NCT02718469|Immunologic Factors|immunologic factors|mesh-ancestor
5802661|NCT02718469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802662|NCT02718521|Isosorbide|isosorbide|mesh-list
5802663|NCT02718521|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
5802664|NCT02718521|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
5802665|NCT02718521|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5802666|NCT02718521|Diuretics|diuretics|mesh-ancestor
5802667|NCT02718521|Natriuretic Agents|natriuretic agents|mesh-ancestor
5802668|NCT02718521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802669|NCT02718521|Vasodilator Agents|vasodilator agents|mesh-ancestor
5802670|NCT02718521|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5802671|NCT02718521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5802672|NCT02718482|Gemcitabine|gemcitabine|mesh-list
5802673|NCT02718482|Docetaxel|docetaxel|mesh-list
5802674|NCT02718482|Ifosfamide|ifosfamide|mesh-list
5802675|NCT02718482|Isophosphamide mustard|isophosphamide mustard|mesh-list
5802676|NCT02718482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5802677|NCT02718482|Antimetabolites|antimetabolites|mesh-ancestor
5802678|NCT02718482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5802679|NCT02718482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5802680|NCT02718482|Antiviral Agents|antiviral agents|mesh-ancestor
5802681|NCT02718482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5802682|NCT02718482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5802683|NCT02718482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5802684|NCT02718482|Immunologic Factors|immunologic factors|mesh-ancestor
5802685|NCT02718482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802686|NCT02718482|Tubulin Modulators|tubulin modulators|mesh-ancestor
5802687|NCT02718482|Antimitotic Agents|antimitotic agents|mesh-ancestor
5802688|NCT02718482|Mitosis Modulators|mitosis modulators|mesh-ancestor
5802689|NCT02718482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5802690|NCT02718482|Alkylating Agents|alkylating agents|mesh-ancestor
5802691|NCT02718599|Terlipressin|terlipressin|mesh-list
5802692|NCT02718599|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5802693|NCT02718599|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5802694|NCT02718261|Pantoprazole|pantoprazole|mesh-list
5802695|NCT02718261|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5802696|NCT02718261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5802697|NCT02718261|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5802698|NCT02718261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5802699|NCT02718261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5802700|NCT02717884|Cytarabine|cytarabine|mesh-list
5802701|NCT02717884|Tretinoin|tretinoin|mesh-list
5802702|NCT02717884|Tranylcypromine|tranylcypromine|mesh-list
5802703|NCT02717884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5802704|NCT02717884|Antimetabolites|antimetabolites|mesh-ancestor
5802705|NCT02717884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5802706|NCT02717884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5802707|NCT02717884|Antiviral Agents|antiviral agents|mesh-ancestor
5802708|NCT02717884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5802709|NCT02717884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5802710|NCT02717884|Immunologic Factors|immunologic factors|mesh-ancestor
5802711|NCT02717884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802712|NCT02717884|Keratolytic Agents|keratolytic agents|mesh-ancestor
5802713|NCT02717884|Dermatologic Agents|dermatologic agents|mesh-ancestor
5802714|NCT02717884|Antidepressive Agents|antidepressive agents|mesh-ancestor
5802715|NCT02717884|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5802716|NCT02717884|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
5802717|NCT02717884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5802718|NCT02717884|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5802719|NCT02717884|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5802720|NCT02717884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5802721|NCT02718079|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5802722|NCT02718079|Acetylcysteine|acetylcysteine|mesh-list
5802723|NCT02718079|Mannitol|mannitol|mesh-list
5802724|NCT02718079|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5802725|NCT02718079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5802726|NCT02718079|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5802727|NCT02718079|Diuretics|diuretics|mesh-ancestor
5802728|NCT02718079|Natriuretic Agents|natriuretic agents|mesh-ancestor
5802729|NCT02718079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802730|NCT02718079|Antiviral Agents|antiviral agents|mesh-ancestor
5802731|NCT02718079|Expectorants|expectorants|mesh-ancestor
6674086|NCT01567215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674087|NCT01567358|Infliximab|infliximab|mesh-list
6674088|NCT01567358|Dermatologic Agents|dermatologic agents|mesh-ancestor
6674089|NCT01567358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6674090|NCT01567358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6674091|NCT01567384|Pemetrexed|pemetrexed|mesh-list
6674092|NCT01567384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6491994|NCT00606164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6491995|NCT00606203|Milnacipran|milnacipran|mesh-list
6491996|NCT00606203|Levomilnacipran|levomilnacipran|mesh-list
6491997|NCT00606203|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6491998|NCT00606203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6491999|NCT00606203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6492000|NCT00606203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492001|NCT00606203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6492002|NCT00606203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492003|NCT00606203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6492004|NCT00606203|Analgesics|analgesics|mesh-ancestor
6492005|NCT00606203|Sensory System Agents|sensory system agents|mesh-ancestor
6492006|NCT00606203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6674093|NCT01567384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5802732|NCT02718079|Respiratory System Agents|respiratory system agents|mesh-ancestor
5802733|NCT02718079|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5802734|NCT02718079|Antioxidants|antioxidants|mesh-ancestor
5802735|NCT02718079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5802736|NCT02718079|Protective Agents|protective agents|mesh-ancestor
5802737|NCT02718079|Antidotes|antidotes|mesh-ancestor
5802738|NCT02717962|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
5802739|NCT02717962|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5802740|NCT02717962|Alkylating Agents|alkylating agents|mesh-ancestor
5802741|NCT02717962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5802742|NCT02717962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5802743|NCT02718183|Hydrogen Peroxide|hydrogen peroxide|mesh-list
5802744|NCT02718183|Carbamide Peroxide|carbamide peroxide|mesh-list
5802745|NCT02718183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5802746|NCT02718183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5802747|NCT02717923|Capecitabine|capecitabine|mesh-list
5802748|NCT02717923|Cetuximab|cetuximab|mesh-list
5802749|NCT02717923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5802750|NCT02717923|Antimetabolites|antimetabolites|mesh-ancestor
5802751|NCT02717923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5802752|NCT02717923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5802753|NCT02717923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5802754|NCT02717871|Moxifloxacin|moxifloxacin|mesh-list
5802755|NCT02717871|Ciprofloxacin|ciprofloxacin|mesh-list
5802756|NCT02717871|Levofloxacin|levofloxacin|mesh-list
5802757|NCT02717871|Ofloxacin|ofloxacin|mesh-list
5802758|NCT02717871|Gentamicins|gentamicins|mesh-list
5802759|NCT02717871|Cefazolin|cefazolin|mesh-list
5802760|NCT02717871|Tobramycin|tobramycin|mesh-list
5802761|NCT02717871|Gatifloxacin|gatifloxacin|mesh-list
5802762|NCT02717871|Fluoroquinolones|fluoroquinolones|mesh-list
5802763|NCT02717871|Besifloxacin|besifloxacin|mesh-list
5802764|NCT02717871|Prednisolone|prednisolone|mesh-list
5802765|NCT02717871|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5802766|NCT02717871|Methylprednisolone|methylprednisolone|mesh-list
5802767|NCT02717871|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5802768|NCT02717871|Prednisolone acetate|prednisolone acetate|mesh-list
5802769|NCT02717871|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5802770|NCT02717871|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5802771|NCT02717871|Prednisolone phosphate|prednisolone phosphate|mesh-list
5802772|NCT02717871|Cyclopentolate|cyclopentolate|mesh-list
5802773|NCT02717871|Mydriatics|mydriatics|mesh-list
5802774|NCT02717871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5802775|NCT02717871|Glucocorticoids|glucocorticoids|mesh-ancestor
5802776|NCT02717871|Hormones|hormones|mesh-ancestor
5802777|NCT02717871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5802778|NCT02717871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802779|NCT02717871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5802780|NCT02717871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5802781|NCT02717871|Antiemetics|antiemetics|mesh-ancestor
5802782|NCT02717871|Autonomic Agents|autonomic agents|mesh-ancestor
5802783|NCT02717871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5802784|NCT02717871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5802785|NCT02717871|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5802786|NCT02717871|Protective Agents|protective agents|mesh-ancestor
5802787|NCT02717871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5802788|NCT02717871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5802789|NCT02717871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5802790|NCT02717871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5802791|NCT02717871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5802792|NCT02717871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5802793|NCT02717871|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5802794|NCT02717871|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5802795|NCT02717871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5802796|NCT02717871|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5802797|NCT02717871|Renal Agents|renal agents|mesh-ancestor
5802798|NCT02717871|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5802799|NCT02717871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5802800|NCT02717871|Parasympatholytics|parasympatholytics|mesh-ancestor
5802801|NCT02717871|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5802802|NCT02717871|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5802803|NCT02717871|Cholinergic Agents|cholinergic agents|mesh-ancestor
5802804|NCT02717871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5802805|NCT02717858|Liraglutide|liraglutide|mesh-list
5802806|NCT02717858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5802807|NCT02717858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802808|NCT02717858|Incretins|incretins|mesh-ancestor
5802809|NCT02717858|Hormones|hormones|mesh-ancestor
5802810|NCT02717858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5802811|NCT02717572|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5802812|NCT02717572|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5802813|NCT02717572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5802814|NCT02717819|Vitamin D|vitamin d|mesh-list
5802815|NCT02717819|Vitamins|vitamins|mesh-ancestor
5802816|NCT02717819|Micronutrients|micronutrients|mesh-ancestor
5802817|NCT02717819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802818|NCT02717819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5900158|NCT05104918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5900159|NCT05104918|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5900160|NCT05104918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5900161|NCT05104918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5900162|NCT05104918|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5900163|NCT05104918|Serotonin Agents|serotonin agents|mesh-ancestor
5900164|NCT05104918|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5900165|NCT05104918|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5900166|NCT05104918|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5900167|NCT05104918|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5900168|NCT05092412|Carboplatin|carboplatin|mesh-list
5900169|NCT05092412|Etoposide|etoposide|mesh-list
5900170|NCT05092412|Durvalumab|durvalumab|mesh-list
5802819|NCT02717780|Fentanyl|fentanyl|mesh-list
5802820|NCT02717780|Remifentanil|remifentanil|mesh-list
5802821|NCT02717780|Sevoflurane|sevoflurane|mesh-list
5802822|NCT02717780|Desflurane|desflurane|mesh-list
5802823|NCT02717780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5802824|NCT02717780|Narcotics|narcotics|mesh-ancestor
5802825|NCT02717780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5802826|NCT02717780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802827|NCT02717780|Analgesics|analgesics|mesh-ancestor
5802828|NCT02717780|Sensory System Agents|sensory system agents|mesh-ancestor
5802829|NCT02717780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5802830|NCT02717780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5802831|NCT02717780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5802832|NCT02717780|Anesthetics, General|anesthetics, general|mesh-ancestor
5802833|NCT02717780|Anesthetics|anesthetics|mesh-ancestor
5802834|NCT02717780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5802835|NCT02717780|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5802836|NCT02717052|Ketamine|ketamine|mesh-list
5802837|NCT02717052|Esketamine|esketamine|mesh-list
5802838|NCT02717052|Analgesics|analgesics|mesh-ancestor
5802839|NCT02717052|Sensory System Agents|sensory system agents|mesh-ancestor
5802840|NCT02717052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5802841|NCT02717052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802842|NCT02717052|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5802843|NCT02717052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5802844|NCT02717052|Anesthetics, General|anesthetics, general|mesh-ancestor
5802845|NCT02717052|Anesthetics|anesthetics|mesh-ancestor
5802846|NCT02717052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5802847|NCT02717052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5802848|NCT02717052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5802849|NCT02717052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5802850|NCT02717052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5802851|NCT02717052|Antidepressive Agents|antidepressive agents|mesh-ancestor
5802852|NCT02717052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5802858|NCT02717091|Gemcitabine|gemcitabine|mesh-list
5802859|NCT02717091|Paclitaxel|paclitaxel|mesh-list
5802860|NCT02717091|Folfirinox|folfirinox|mesh-list
5802861|NCT02717091|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5802862|NCT02717091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5802863|NCT02717091|Tubulin Modulators|tubulin modulators|mesh-ancestor
5802864|NCT02717091|Antimitotic Agents|antimitotic agents|mesh-ancestor
5802865|NCT02717091|Mitosis Modulators|mitosis modulators|mesh-ancestor
5802866|NCT02717091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5802867|NCT02717091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5802868|NCT02717091|Antimetabolites|antimetabolites|mesh-ancestor
5802869|NCT02717091|Antiviral Agents|antiviral agents|mesh-ancestor
5802870|NCT02717091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5802871|NCT02717091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5802872|NCT02717091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5802873|NCT02717091|Immunologic Factors|immunologic factors|mesh-ancestor
5802874|NCT02717091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802875|NCT02716974|Docetaxel|docetaxel|mesh-list
5802876|NCT02716974|Leuprolide|leuprolide|mesh-list
5802877|NCT02716974|Bicalutamide|bicalutamide|mesh-list
5802878|NCT02716974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5802879|NCT02716974|Tubulin Modulators|tubulin modulators|mesh-ancestor
5802880|NCT02716974|Antimitotic Agents|antimitotic agents|mesh-ancestor
5802881|NCT02716974|Mitosis Modulators|mitosis modulators|mesh-ancestor
5802882|NCT02716974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5802883|NCT02716974|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5802884|NCT02716974|Fertility Agents|fertility agents|mesh-ancestor
5802885|NCT02716974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5802886|NCT02716974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802887|NCT02716974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5802888|NCT02716974|Androgen Antagonists|androgen antagonists|mesh-ancestor
6674094|NCT01567384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674095|NCT01567384|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6674096|NCT01567384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6674097|NCT01567423|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6674098|NCT01567423|Antimalarials|antimalarials|mesh-ancestor
5802889|NCT02716974|Hormone Antagonists|hormone antagonists|mesh-ancestor
5802890|NCT02716974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5802891|NCT02716961|Gemcitabine|gemcitabine|mesh-list
5802892|NCT02716961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5802893|NCT02716961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5802894|NCT02716961|Antimetabolites|antimetabolites|mesh-ancestor
5802895|NCT02716961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5802896|NCT02716961|Antiviral Agents|antiviral agents|mesh-ancestor
5802897|NCT02716961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5802898|NCT02716961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5802899|NCT02716961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5802900|NCT02716961|Immunologic Factors|immunologic factors|mesh-ancestor
5802901|NCT02716961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802902|NCT02716857|Oxycodone|oxycodone|mesh-list
5802903|NCT02716857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5802904|NCT02716857|Narcotics|narcotics|mesh-ancestor
5802905|NCT02716857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5802906|NCT02716857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802907|NCT02716857|Analgesics|analgesics|mesh-ancestor
5802908|NCT02716857|Sensory System Agents|sensory system agents|mesh-ancestor
5802909|NCT02716857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5802910|NCT02716766|Capecitabine|capecitabine|mesh-list
5802911|NCT02716766|Oxaliplatin|oxaliplatin|mesh-list
5802912|NCT02716766|Sorafenib|sorafenib|mesh-list
5802913|NCT02716766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5802914|NCT02716766|Antimetabolites|antimetabolites|mesh-ancestor
5802915|NCT02716766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5802916|NCT02716766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5802917|NCT02716766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5802918|NCT02716766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5802919|NCT02716792|Ibandronic Acid|ibandronic acid|mesh-list
5802920|NCT02716792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5802921|NCT02716792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802922|NCT02716610|Insulin Lispro|insulin lispro|mesh-list
5802923|NCT02716610|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5802924|NCT02716610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802925|NCT02716415|Menthol|menthol|mesh-list
5802926|NCT02716415|Petrolatum|petrolatum|mesh-list
5802927|NCT02716415|Zinc Oxide|zinc oxide|mesh-list
5802928|NCT02716415|Antipruritics|antipruritics|mesh-ancestor
5802929|NCT02716415|Dermatologic Agents|dermatologic agents|mesh-ancestor
5802930|NCT02716415|Emollients|emollients|mesh-ancestor
5802931|NCT02716415|Sunscreening Agents|sunscreening agents|mesh-ancestor
5802932|NCT02716415|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5802933|NCT02716415|Protective Agents|protective agents|mesh-ancestor
5802934|NCT02716415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802935|NCT02716428|Ribavirin|ribavirin|mesh-list
5802936|NCT02716428|Antimetabolites|antimetabolites|mesh-ancestor
5802937|NCT02716428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5802938|NCT02716428|Antiviral Agents|antiviral agents|mesh-ancestor
5802939|NCT02716428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5802940|NCT02716311|Cetuximab|cetuximab|mesh-list
5802941|NCT02716311|Afatinib|afatinib|mesh-list
5802942|NCT02716311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5802943|NCT02716311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5802944|NCT02716311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5802945|NCT02716311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5802946|NCT02716311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5802947|NCT02716285|Peppermint oil|peppermint oil|mesh-list
5802948|NCT02716285|Antiemetics|antiemetics|mesh-ancestor
5802949|NCT02716285|Autonomic Agents|autonomic agents|mesh-ancestor
5802950|NCT02716285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5802951|NCT02716285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802952|NCT02716285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5802953|NCT02716285|Parasympatholytics|parasympatholytics|mesh-ancestor
5802954|NCT02716129|Morphine|morphine|mesh-list
5802955|NCT02716129|Nalbuphine|nalbuphine|mesh-list
5802956|NCT02716129|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5802957|NCT02716129|Narcotics|narcotics|mesh-ancestor
5802958|NCT02716129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5802959|NCT02716129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802960|NCT02716129|Analgesics|analgesics|mesh-ancestor
5802961|NCT02716129|Sensory System Agents|sensory system agents|mesh-ancestor
5802962|NCT02716129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5802963|NCT02716116|Carboplatin|carboplatin|mesh-list
5802964|NCT02716116|Pemetrexed|pemetrexed|mesh-list
5802965|NCT02716116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5802966|NCT02716116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5802967|NCT02716116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5802968|NCT02716116|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5802969|NCT02716116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5802970|NCT02716259|Fluorides|fluorides|mesh-list
5802971|NCT02716259|Sodium Fluoride|sodium fluoride|mesh-list
5802972|NCT02716259|Cariostatic Agents|cariostatic agents|mesh-ancestor
5802973|NCT02716259|Protective Agents|protective agents|mesh-ancestor
5802974|NCT02716259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802975|NCT02716233|Pegaspargase|pegaspargase|mesh-list
5802976|NCT02716233|Asparaginase|asparaginase|mesh-list
5802977|NCT02716233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5802978|NCT02716272|Nivolumab|nivolumab|mesh-list
5802979|NCT02716272|Ipilimumab|ipilimumab|mesh-list
5802980|NCT02716272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5802981|NCT02716272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5802982|NCT02716272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5802983|NCT02716272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5802984|NCT02716142|Misoprostol|misoprostol|mesh-list
5802985|NCT02716142|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5802986|NCT02716142|Abortifacient Agents|abortifacient agents|mesh-ancestor
5802987|NCT02716142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5802988|NCT02716142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5802989|NCT02716142|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5802990|NCT02716142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5802991|NCT02716142|Oxytocics|oxytocics|mesh-ancestor
5802992|NCT02716038|Paclitaxel|paclitaxel|mesh-list
5802993|NCT02716038|Carboplatin|carboplatin|mesh-list
5802994|NCT02716038|Atezolizumab|atezolizumab|mesh-list
5802995|NCT02716038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5802996|NCT02716038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5802997|NCT02716038|Tubulin Modulators|tubulin modulators|mesh-ancestor
5802998|NCT02716038|Antimitotic Agents|antimitotic agents|mesh-ancestor
5802999|NCT02716038|Mitosis Modulators|mitosis modulators|mesh-ancestor
5803000|NCT02716038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5803001|NCT02716090|Adapalene|adapalene|mesh-list
5803002|NCT02716090|Benzoyl Peroxide|benzoyl peroxide|mesh-list
5803003|NCT02716090|Dermatologic Agents|dermatologic agents|mesh-ancestor
5803004|NCT02716090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5803005|NCT02716090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5803006|NCT02716090|Analgesics|analgesics|mesh-ancestor
5803007|NCT02716090|Sensory System Agents|sensory system agents|mesh-ancestor
5803008|NCT02716090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5803009|NCT02716090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803010|NCT02716090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5803011|NCT02716090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5900171|NCT05092412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5900172|NCT05092412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5900173|NCT05092412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5900174|NCT05092412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5900175|NCT05092412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5900176|NCT05092412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900177|NCT05092412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5900178|NCT05089942|Insulin|insulin|mesh-list
5900179|NCT05089942|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5900180|NCT05089942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5900181|NCT05089942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900182|NCT05087914|Naproxen|naproxen|mesh-list
5900183|NCT05087914|Levodopa|levodopa|mesh-list
5803012|NCT02715869|Sevoflurane|sevoflurane|mesh-list
5803013|NCT02715869|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5803014|NCT02715869|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5803015|NCT02715869|Anesthetics, General|anesthetics, general|mesh-ancestor
5803016|NCT02715869|Anesthetics|anesthetics|mesh-ancestor
5803017|NCT02715869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5803018|NCT02715869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803019|NCT02715687|Amiodarone|amiodarone|mesh-list
5803020|NCT02715687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5803021|NCT02715687|Vasodilator Agents|vasodilator agents|mesh-ancestor
5803022|NCT02715687|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5803023|NCT02715687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5803024|NCT02715687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5803025|NCT02715687|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5803026|NCT02715687|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5803027|NCT02715687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5803028|NCT02715687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5803029|NCT02715687|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5803030|NCT02715687|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5803031|NCT02715687|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5803032|NCT02716012|Sorafenib|sorafenib|mesh-list
5803033|NCT02716012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5803034|NCT02716012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5803035|NCT02716012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5803036|NCT02716012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5803037|NCT02715947|Methotrexate|methotrexate|mesh-list
5803038|NCT02715947|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5803039|NCT02715947|Abortifacient Agents|abortifacient agents|mesh-ancestor
5803040|NCT02715947|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5803041|NCT02715947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803042|NCT02715947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5803043|NCT02715947|Antimetabolites|antimetabolites|mesh-ancestor
5803044|NCT02715947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5803045|NCT02715947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5803046|NCT02715947|Dermatologic Agents|dermatologic agents|mesh-ancestor
5803047|NCT02715947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5803048|NCT02715947|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5803049|NCT02715947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5803050|NCT02715947|Immunologic Factors|immunologic factors|mesh-ancestor
5803051|NCT02715947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5803052|NCT02715947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5803053|NCT02715960|Vitamin A|vitamin a|mesh-list
5803054|NCT02715960|Tretinoin|tretinoin|mesh-list
5803055|NCT02715960|Acitretin|acitretin|mesh-list
5803056|NCT02715960|Vitamins|vitamins|mesh-ancestor
5803057|NCT02715960|Micronutrients|micronutrients|mesh-ancestor
5803058|NCT02715960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803059|NCT02715960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5803060|NCT02715960|Keratolytic Agents|keratolytic agents|mesh-ancestor
5803061|NCT02715960|Dermatologic Agents|dermatologic agents|mesh-ancestor
5803062|NCT02715492|Enoxaparin|enoxaparin|mesh-list
5803063|NCT02715492|Anticoagulants|anticoagulants|mesh-ancestor
5803064|NCT02715492|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5803065|NCT02715492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5803066|NCT02715492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5803067|NCT02715531|Leucovorin|leucovorin|mesh-list
5803068|NCT02715531|Gemcitabine|gemcitabine|mesh-list
5803069|NCT02715531|Paclitaxel|paclitaxel|mesh-list
5803070|NCT02715531|Bevacizumab|bevacizumab|mesh-list
5803071|NCT02715531|Capecitabine|capecitabine|mesh-list
5803072|NCT02715531|Oxaliplatin|oxaliplatin|mesh-list
5803073|NCT02715531|Atezolizumab|atezolizumab|mesh-list
5803074|NCT02715531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5803075|NCT02715531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5803076|NCT02715531|Tubulin Modulators|tubulin modulators|mesh-ancestor
5803077|NCT02715531|Antimitotic Agents|antimitotic agents|mesh-ancestor
5803078|NCT02715531|Mitosis Modulators|mitosis modulators|mesh-ancestor
5803079|NCT02715531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5803080|NCT02715531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5803081|NCT02715531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5803082|NCT02715531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5803083|NCT02715531|Growth Substances|growth substances|mesh-ancestor
5803084|NCT02715531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803085|NCT02715531|Growth Inhibitors|growth inhibitors|mesh-ancestor
5803086|NCT02715531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5803087|NCT02715531|Antimetabolites|antimetabolites|mesh-ancestor
5803088|NCT02715531|Antiviral Agents|antiviral agents|mesh-ancestor
5803089|NCT02715531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5803090|NCT02715531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5803091|NCT02715531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5803092|NCT02715531|Immunologic Factors|immunologic factors|mesh-ancestor
5803093|NCT02715531|Antidotes|antidotes|mesh-ancestor
5803094|NCT02715531|Protective Agents|protective agents|mesh-ancestor
5803095|NCT02715531|Vitamin B Complex|vitamin b complex|mesh-ancestor
5803096|NCT02715531|Vitamins|vitamins|mesh-ancestor
5803097|NCT02715531|Micronutrients|micronutrients|mesh-ancestor
5803098|NCT02715479|Dolutegravir|dolutegravir|mesh-list
5803099|NCT02715479|BMS-955176|bms-955176|mesh-list
5803100|NCT02715479|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5803101|NCT02715479|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5803102|NCT02715479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5803103|NCT02715479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5803104|NCT02715479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5803105|NCT02715479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5803106|NCT02715479|Antiviral Agents|antiviral agents|mesh-ancestor
5803107|NCT02715479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5803108|NCT02715336|Leuprolide|leuprolide|mesh-list
5803109|NCT02715336|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5803110|NCT02715336|Fertility Agents|fertility agents|mesh-ancestor
5803111|NCT02715336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5803112|NCT02715336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803113|NCT02715336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5803114|NCT02715336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5803115|NCT02715466|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5803116|NCT02714998|Methotrexate|methotrexate|mesh-list
5803117|NCT02714998|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5803118|NCT02714998|Abortifacient Agents|abortifacient agents|mesh-ancestor
5803119|NCT02714998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5803120|NCT02714998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803121|NCT02714998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5803122|NCT02714998|Antimetabolites|antimetabolites|mesh-ancestor
5803123|NCT02714998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5803124|NCT02714998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5803125|NCT02714998|Dermatologic Agents|dermatologic agents|mesh-ancestor
5803126|NCT02714998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5803127|NCT02714998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5803128|NCT02714998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5803129|NCT02714998|Immunologic Factors|immunologic factors|mesh-ancestor
5803130|NCT02714998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5803131|NCT02714998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5803132|NCT02715024|Tamsulosin|tamsulosin|mesh-list
5803133|NCT02715024|Solifenacin Succinate|solifenacin succinate|mesh-list
5803134|NCT02715024|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5803135|NCT02715024|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5803136|NCT02715024|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5803137|NCT02715024|Adrenergic Agents|adrenergic agents|mesh-ancestor
5803138|NCT02715024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5803139|NCT02715024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5803140|NCT02715024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803141|NCT02715024|Urological Agents|urological agents|mesh-ancestor
5803142|NCT02715024|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5803143|NCT02715024|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5803144|NCT02715024|Cholinergic Agents|cholinergic agents|mesh-ancestor
5803145|NCT02715193|Volagidemab|volagidemab|mesh-list
5803146|NCT02715193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5803147|NCT02715193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803148|NCT02715154|Dexmedetomidine|dexmedetomidine|mesh-list
5803149|NCT02715154|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5803150|NCT02715154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5803151|NCT02715154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803152|NCT02715154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5803153|NCT02715154|Analgesics|analgesics|mesh-ancestor
5803154|NCT02715154|Sensory System Agents|sensory system agents|mesh-ancestor
5803155|NCT02715154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5803156|NCT02715154|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5803157|NCT02715154|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5803158|NCT02715154|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5803159|NCT02715154|Adrenergic Agents|adrenergic agents|mesh-ancestor
5803160|NCT02715154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5803161|NCT02715154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5803162|NCT02715232|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5803163|NCT02715232|Cyproterone Acetate|cyproterone acetate|mesh-list
5803164|NCT02715232|Lynestrenol|lynestrenol|mesh-list
5803165|NCT02715232|Estradiol|estradiol|mesh-list
5803166|NCT02715232|Testosterone|testosterone|mesh-list
5803167|NCT02715232|Cyproterone|cyproterone|mesh-list
5803168|NCT02715232|Estrogens|estrogens|mesh-ancestor
5803169|NCT02715232|Hormones|hormones|mesh-ancestor
5803170|NCT02715232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5803171|NCT02715232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803172|NCT02715232|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6674099|NCT01567423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6674100|NCT01567423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6674101|NCT01567423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6674102|NCT01567475|Rituximab|rituximab|mesh-list
5803173|NCT02715232|Contraceptive Agents|contraceptive agents|mesh-ancestor
5803174|NCT02715232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5803175|NCT02715232|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5803176|NCT02715232|Androgens|androgens|mesh-ancestor
5803177|NCT02715232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5803178|NCT02715232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5803179|NCT02715232|Luteolytic Agents|luteolytic agents|mesh-ancestor
5803180|NCT02715232|Androgen Antagonists|androgen antagonists|mesh-ancestor
5803181|NCT02715232|Hormone Antagonists|hormone antagonists|mesh-ancestor
5803182|NCT02715232|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5803183|NCT02715232|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5803184|NCT02715232|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5803185|NCT02715232|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5803186|NCT02715167|Budesonide|budesonide|mesh-list
5803187|NCT02715167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5803188|NCT02715167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5803189|NCT02715167|Autonomic Agents|autonomic agents|mesh-ancestor
5803190|NCT02715167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5803191|NCT02715167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803192|NCT02715167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5803193|NCT02715167|Respiratory System Agents|respiratory system agents|mesh-ancestor
5803194|NCT02715167|Glucocorticoids|glucocorticoids|mesh-ancestor
5803195|NCT02715167|Hormones|hormones|mesh-ancestor
5803196|NCT02715167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5803197|NCT02714959|Aldesleukin|aldesleukin|mesh-list
5803198|NCT02714959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5803199|NCT02714959|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5803200|NCT02714959|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5803201|NCT02714959|Antiviral Agents|antiviral agents|mesh-ancestor
5803202|NCT02714959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5803203|NCT02714894|Clozapine|clozapine|mesh-list
5803204|NCT02714894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5803205|NCT02714894|Serotonin Agents|serotonin agents|mesh-ancestor
5803206|NCT02714894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6674103|NCT01567475|Everolimus|everolimus|mesh-list
5803207|NCT02714894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5803208|NCT02714894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803209|NCT02714894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5803210|NCT02714894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5803211|NCT02714894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5803212|NCT02714894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5803213|NCT02714894|GABA Antagonists|gaba antagonists|mesh-ancestor
5803214|NCT02714894|GABA Agents|gaba agents|mesh-ancestor
5803215|NCT02714634|Hydroxychloroquine|hydroxychloroquine|mesh-list
5803216|NCT02714634|Methotrexate|methotrexate|mesh-list
5803217|NCT02714634|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5803218|NCT02714634|Abortifacient Agents|abortifacient agents|mesh-ancestor
5803219|NCT02714634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5803220|NCT02714634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803221|NCT02714634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5803222|NCT02714634|Antimetabolites|antimetabolites|mesh-ancestor
5803223|NCT02714634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5803224|NCT02714634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5803225|NCT02714634|Dermatologic Agents|dermatologic agents|mesh-ancestor
5803226|NCT02714634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5803227|NCT02714634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5803228|NCT02714634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5803229|NCT02714634|Immunologic Factors|immunologic factors|mesh-ancestor
5803230|NCT02714634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5803231|NCT02714634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5803232|NCT02714634|Antimalarials|antimalarials|mesh-ancestor
5803233|NCT02714634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5803234|NCT02714634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5803235|NCT02714634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5803236|NCT02714881|Certolizumab Pegol|certolizumab pegol|mesh-list
5803237|NCT02714881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5803238|NCT02714881|Immunologic Factors|immunologic factors|mesh-ancestor
5803239|NCT02714881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803240|NCT02714881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5803241|NCT02714725|Dexmedetomidine|dexmedetomidine|mesh-list
5803242|NCT02714725|Propofol|propofol|mesh-list
5803243|NCT02714725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5803244|NCT02714725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5803245|NCT02714725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803246|NCT02714725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5803247|NCT02714725|Anesthetics, General|anesthetics, general|mesh-ancestor
5803248|NCT02714725|Anesthetics|anesthetics|mesh-ancestor
5803249|NCT02714725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5803250|NCT02714725|Analgesics|analgesics|mesh-ancestor
5803251|NCT02714725|Sensory System Agents|sensory system agents|mesh-ancestor
5803252|NCT02714725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5803253|NCT02714725|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5803254|NCT02714725|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5803255|NCT02714725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5803256|NCT02714725|Adrenergic Agents|adrenergic agents|mesh-ancestor
5803257|NCT02714725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5803258|NCT02714725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5803259|NCT02714842|Diclofenac|diclofenac|mesh-list
5803260|NCT02714842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5803261|NCT02714842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5803262|NCT02714842|Analgesics|analgesics|mesh-ancestor
5803263|NCT02714842|Sensory System Agents|sensory system agents|mesh-ancestor
5803264|NCT02714842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5803265|NCT02714842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803266|NCT02714842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5803267|NCT02714842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5803268|NCT02714842|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5803269|NCT02714842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5803270|NCT02714842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5803271|NCT02714712|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5803272|NCT02714712|Antiviral Agents|antiviral agents|mesh-ancestor
5803273|NCT02714712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5803274|NCT02714699|Diclofenac|diclofenac|mesh-list
5803275|NCT02714699|Scopolamine|scopolamine|mesh-list
5803276|NCT02714699|Bromides|bromides|mesh-list
5803277|NCT02714699|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
5803278|NCT02714699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5803279|NCT02714699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5803280|NCT02714699|Analgesics|analgesics|mesh-ancestor
5803281|NCT02714699|Sensory System Agents|sensory system agents|mesh-ancestor
5803282|NCT02714699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5803283|NCT02714699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803284|NCT02714699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5803285|NCT02714699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5803286|NCT02714699|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5803287|NCT02714699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5803288|NCT02714699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5803289|NCT02714699|Anticonvulsants|anticonvulsants|mesh-ancestor
5803290|NCT02714699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5803291|NCT02714699|Antiemetics|antiemetics|mesh-ancestor
5803292|NCT02714699|Autonomic Agents|autonomic agents|mesh-ancestor
5803293|NCT02714699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5803294|NCT02714699|Mydriatics|mydriatics|mesh-ancestor
5803295|NCT02714699|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5803296|NCT02714699|Cholinergic Agents|cholinergic agents|mesh-ancestor
5803297|NCT02714699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5803298|NCT02714699|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5803299|NCT02714699|Parasympatholytics|parasympatholytics|mesh-ancestor
5803300|NCT02714855|Apixaban|apixaban|mesh-list
5803301|NCT02714855|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5803302|NCT02714855|Antithrombins|antithrombins|mesh-ancestor
5803303|NCT02714855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5803304|NCT02714855|Protease Inhibitors|protease inhibitors|mesh-ancestor
5803305|NCT02714855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5803306|NCT02714855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5803307|NCT02714855|Anticoagulants|anticoagulants|mesh-ancestor
5803308|NCT02714543|Hydrocortisone|hydrocortisone|mesh-list
5803309|NCT02714543|Hyaluronic Acid|hyaluronic acid|mesh-list
5803310|NCT02714543|Antioxidants|antioxidants|mesh-list
5803311|NCT02714543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5803312|NCT02714543|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5803313|NCT02714543|Immunologic Factors|immunologic factors|mesh-ancestor
5803314|NCT02714543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803315|NCT02714543|Viscosupplements|viscosupplements|mesh-ancestor
5803316|NCT02714543|Protective Agents|protective agents|mesh-ancestor
5803317|NCT02714543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5803318|NCT02714530|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5803319|NCT02714530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5803320|NCT02714530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5803321|NCT02714530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5803322|NCT02714530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900184|NCT05087914|Carbidopa|carbidopa|mesh-list
5900185|NCT05087914|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
5900186|NCT05087914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5900187|NCT05087914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5900188|NCT05087914|Analgesics|analgesics|mesh-ancestor
5900189|NCT05087914|Sensory System Agents|sensory system agents|mesh-ancestor
5900190|NCT05087914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5900191|NCT05087914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900192|NCT05087914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5900193|NCT05087914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5900194|NCT05087914|Gout Suppressants|gout suppressants|mesh-ancestor
5900195|NCT05087914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5900196|NCT05087914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5900197|NCT05087914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900198|NCT05087914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5900199|NCT05087914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5900200|NCT05087914|Dopamine Agents|dopamine agents|mesh-ancestor
5900201|NCT05087914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5900202|NCT05087914|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5900203|NCT05087914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5900204|NCT05087914|Immunologic Factors|immunologic factors|mesh-ancestor
5900205|NCT05087914|Dopamine Agonists|dopamine agonists|mesh-ancestor
5900206|NCT05086393|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5900207|NCT05086393|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5900208|NCT05086393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5900209|NCT05086393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5900210|NCT05086393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900211|NCT05086393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5900212|NCT05086393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900213|NCT05086393|Analgesics|analgesics|mesh-ancestor
5900214|NCT05086393|Sensory System Agents|sensory system agents|mesh-ancestor
5900215|NCT05086393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5900216|NCT05086393|Antidepressive Agents|antidepressive agents|mesh-ancestor
5900217|NCT05086393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5900218|NCT05086393|Dopamine Agents|dopamine agents|mesh-ancestor
5900219|NCT05073172|Sulfadiazine|sulfadiazine|mesh-list
5900220|NCT05073172|Silver Sulfadiazine|silver sulfadiazine|mesh-list
5900221|NCT05073172|Petrolatum|petrolatum|mesh-list
5900222|NCT05073172|Mineral Oil|mineral oil|mesh-list
5900223|NCT05073172|Emollients|emollients|mesh-ancestor
5900224|NCT05073172|Dermatologic Agents|dermatologic agents|mesh-ancestor
5900225|NCT05073172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5900226|NCT05073172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5900227|NCT05073172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5900228|NCT05073172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5900229|NCT05073172|Coccidiostats|coccidiostats|mesh-ancestor
5900230|NCT05073172|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5900231|NCT05055323|Pyrvinium|pyrvinium|mesh-list
5900232|NCT05055323|Anthelmintics|anthelmintics|mesh-ancestor
5900233|NCT05055323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5900234|NCT05055323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5900235|NCT05053880|Pembrolizumab|pembrolizumab|mesh-list
5900236|NCT05053880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5900237|NCT05053880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5900238|NCT05047718|Vaccines|vaccines|mesh-list
5900239|NCT05047718|Immunologic Factors|immunologic factors|mesh-ancestor
5900240|NCT05047718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900241|NCT05044936|Cannabidiol|cannabidiol|mesh-list
5900242|NCT05044936|Anticonvulsants|anticonvulsants|mesh-ancestor
5900243|NCT05044611|Amiloride|amiloride|mesh-list
5900244|NCT05044611|Diuretics|diuretics|mesh-ancestor
5900245|NCT05044611|Natriuretic Agents|natriuretic agents|mesh-ancestor
5900246|NCT05044611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900247|NCT05044611|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
5803323|NCT02714439|Proflavine|proflavine|mesh-list
5803324|NCT02714439|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5803325|NCT02714439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5803326|NCT02714166|Sunscreening Agents|sunscreening agents|mesh-list
5803327|NCT02714166|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5803328|NCT02714166|Protective Agents|protective agents|mesh-ancestor
5803329|NCT02714166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803330|NCT02714166|Dermatologic Agents|dermatologic agents|mesh-ancestor
5803331|NCT02714231|Diclofenac|diclofenac|mesh-list
5803332|NCT02714231|Scopolamine|scopolamine|mesh-list
5803333|NCT02714231|Bromides|bromides|mesh-list
5803334|NCT02714231|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
5803335|NCT02714231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5803336|NCT02714231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5803337|NCT02714231|Analgesics|analgesics|mesh-ancestor
5803338|NCT02714231|Sensory System Agents|sensory system agents|mesh-ancestor
5803339|NCT02714231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5803340|NCT02714231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803341|NCT02714231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5803342|NCT02714231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5803343|NCT02714231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5803344|NCT02714231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5803345|NCT02714231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5803346|NCT02714231|Anticonvulsants|anticonvulsants|mesh-ancestor
5803347|NCT02714231|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5803348|NCT02714231|Antiemetics|antiemetics|mesh-ancestor
5803349|NCT02714231|Autonomic Agents|autonomic agents|mesh-ancestor
5803350|NCT02714231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5803351|NCT02714231|Mydriatics|mydriatics|mesh-ancestor
5803352|NCT02714231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5803353|NCT02714231|Cholinergic Agents|cholinergic agents|mesh-ancestor
5803354|NCT02714231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5803355|NCT02714231|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5803356|NCT02714231|Parasympatholytics|parasympatholytics|mesh-ancestor
5803357|NCT02714322|Adalimumab|adalimumab|mesh-list
5803358|NCT02714322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5803359|NCT02714322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5803360|NCT02714179|Acetaminophen|acetaminophen|mesh-list
5803361|NCT02714179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5803362|NCT02714179|Analgesics|analgesics|mesh-ancestor
6674104|NCT01567475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6674105|NCT01567475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6674106|NCT01567475|Immunologic Factors|immunologic factors|mesh-ancestor
5803363|NCT02714179|Sensory System Agents|sensory system agents|mesh-ancestor
5803364|NCT02714179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5803365|NCT02714179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803366|NCT02714179|Antipyretics|antipyretics|mesh-ancestor
5803367|NCT02714361|Vitamin D|vitamin d|mesh-list
5803368|NCT02714361|Cholecalciferol|cholecalciferol|mesh-list
5803369|NCT02714361|Vitamins|vitamins|mesh-ancestor
5803370|NCT02714361|Micronutrients|micronutrients|mesh-ancestor
5803371|NCT02714361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803372|NCT02714361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5803373|NCT02714361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5803374|NCT02713997|Etanercept|etanercept|mesh-list
5803375|NCT02713997|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
5803376|NCT02713997|Protein C Inhibitor|protein c inhibitor|mesh-list
5803377|NCT02713997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5803378|NCT02713997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5803379|NCT02713997|Analgesics|analgesics|mesh-ancestor
5803380|NCT02713997|Sensory System Agents|sensory system agents|mesh-ancestor
5803381|NCT02713997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5803382|NCT02713997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803383|NCT02713997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5803384|NCT02713997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5803385|NCT02713997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5803386|NCT02713997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5803387|NCT02713997|Immunologic Factors|immunologic factors|mesh-ancestor
5803388|NCT02713997|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5803389|NCT02713997|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5803390|NCT02713997|Protease Inhibitors|protease inhibitors|mesh-ancestor
5803391|NCT02713997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5803392|NCT02713997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5803393|NCT02714036|Ibudilast|ibudilast|mesh-list
5803394|NCT02714036|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5803395|NCT02714036|Autonomic Agents|autonomic agents|mesh-ancestor
5803396|NCT02714036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5803397|NCT02714036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803398|NCT02714036|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5803399|NCT02714036|Respiratory System Agents|respiratory system agents|mesh-ancestor
5803400|NCT02714036|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5803401|NCT02714036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5803402|NCT02714036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5803403|NCT02714036|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5803404|NCT02714036|Vasodilator Agents|vasodilator agents|mesh-ancestor
5803405|NCT02713945|Simvastatin|simvastatin|mesh-list
5803406|NCT02713945|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5803407|NCT02713945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5803408|NCT02713945|Antimetabolites|antimetabolites|mesh-ancestor
5803409|NCT02713945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5803410|NCT02713945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5803411|NCT02713945|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5803412|NCT02713945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5803413|NCT02713841|Insulin|insulin|mesh-list
5803414|NCT02713841|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5803415|NCT02713841|Insulin Lispro|insulin lispro|mesh-list
5803416|NCT02713841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5803417|NCT02713841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803418|NCT02713893|Econazole|econazole|mesh-list
5803419|NCT02713893|Benzydamine|benzydamine|mesh-list
5803420|NCT02713893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5803421|NCT02713893|Antifungal Agents|antifungal agents|mesh-ancestor
5803422|NCT02713893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5803423|NCT02713893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5803424|NCT02713893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5641571|NCT02719613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5641572|NCT02719613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641573|NCT02719613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5641574|NCT02719613|Glucocorticoids|glucocorticoids|mesh-ancestor
5641575|NCT02719613|Hormones|hormones|mesh-ancestor
5641576|NCT02719613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5641577|NCT02719613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5641578|NCT02719613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5641579|NCT02719613|Protease Inhibitors|protease inhibitors|mesh-ancestor
5641580|NCT02719613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5641581|NCT02719613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5803425|NCT02713893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5803426|NCT02713893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5803427|NCT02713893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5803428|NCT02713893|Hormone Antagonists|hormone antagonists|mesh-ancestor
5803429|NCT02713893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5803430|NCT02713893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803431|NCT02714010|Gefitinib|gefitinib|mesh-list
5803432|NCT02714010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5803433|NCT02714010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5803434|NCT02714010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5803435|NCT02714010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5803436|NCT02713750|Contraceptive Agents|contraceptive agents|mesh-list
5803437|NCT02713750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5803438|NCT02713750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803439|NCT02714075|Zinc|zinc|mesh-list
5803440|NCT02714075|Iron|iron|mesh-list
5803441|NCT02714075|Zinc Sulfate|zinc sulfate|mesh-list
5803442|NCT02714075|Zinc Oxide|zinc oxide|mesh-list
5803443|NCT02714075|Citric Acid|citric acid|mesh-list
5803444|NCT02714075|Sodium Citrate|sodium citrate|mesh-list
5803445|NCT02714075|Anticoagulants|anticoagulants|mesh-ancestor
5803446|NCT02714075|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5803447|NCT02714075|Chelating Agents|chelating agents|mesh-ancestor
5803448|NCT02714075|Sequestering Agents|sequestering agents|mesh-ancestor
5803449|NCT02714075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5803450|NCT02714075|Trace Elements|trace elements|mesh-ancestor
5803451|NCT02714075|Micronutrients|micronutrients|mesh-ancestor
5803452|NCT02714075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803453|NCT02714075|Astringents|astringents|mesh-ancestor
5803454|NCT02714075|Dermatologic Agents|dermatologic agents|mesh-ancestor
5803455|NCT02714075|Sunscreening Agents|sunscreening agents|mesh-ancestor
5803456|NCT02714075|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5803457|NCT02714075|Protective Agents|protective agents|mesh-ancestor
5803458|NCT02713802|Propofol|propofol|mesh-list
5803459|NCT02713802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5803460|NCT02713802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5803461|NCT02713802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803462|NCT02713802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5803463|NCT02713802|Anesthetics, General|anesthetics, general|mesh-ancestor
5803464|NCT02713802|Anesthetics|anesthetics|mesh-ancestor
5803465|NCT02713776|Pasireotide|pasireotide|mesh-list
5803466|NCT02713776|Somatostatin|somatostatin|mesh-list
5803467|NCT02713776|Hormones|hormones|mesh-ancestor
5803468|NCT02713776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5803469|NCT02713776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803470|NCT02713763|Sunitinib|sunitinib|mesh-list
5803471|NCT02713763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5803472|NCT02713763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5803473|NCT02713763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5803474|NCT02713763|Growth Substances|growth substances|mesh-ancestor
5803475|NCT02713763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803476|NCT02713763|Growth Inhibitors|growth inhibitors|mesh-ancestor
5803477|NCT02713763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5803478|NCT02713763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5803479|NCT02713763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5803480|NCT02713607|Doxycycline|doxycycline|mesh-list
5803481|NCT02713607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5803482|NCT02713607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5803483|NCT02713607|Antimalarials|antimalarials|mesh-ancestor
5803484|NCT02713607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5803485|NCT02713607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5803486|NCT02713282|Paliperidone Palmitate|paliperidone palmitate|mesh-list
5803487|NCT02713282|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5803488|NCT02713282|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5803489|NCT02713282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5803490|NCT02713282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803491|NCT02713282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5803492|NCT02713282|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5803493|NCT02713282|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5803494|NCT02713282|Serotonin Agents|serotonin agents|mesh-ancestor
5803495|NCT02713282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5803496|NCT02713282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5803497|NCT02713282|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5803498|NCT02713282|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5803499|NCT02713282|Dopamine Agents|dopamine agents|mesh-ancestor
5803500|NCT02713477|Insulin|insulin|mesh-list
5803501|NCT02713477|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5803502|NCT02713477|Insulin Glargine|insulin glargine|mesh-list
5803503|NCT02713477|Lixisenatide|lixisenatide|mesh-list
5803504|NCT02713477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5803505|NCT02713477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803506|NCT02713139|Metronidazole|metronidazole|mesh-list
5803507|NCT02713139|Clotrimazole|clotrimazole|mesh-list
5803508|NCT02713139|Miconazole|miconazole|mesh-list
5803509|NCT02713139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5803510|NCT02713139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5803511|NCT02713139|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5803512|NCT02713139|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5803513|NCT02713139|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5803514|NCT02713139|Antifungal Agents|antifungal agents|mesh-ancestor
5803515|NCT02713139|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5803516|NCT02713139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5803517|NCT02713139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5803518|NCT02713139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5803519|NCT02713139|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5803520|NCT02713139|Hormone Antagonists|hormone antagonists|mesh-ancestor
5803521|NCT02713139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5803522|NCT02713139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803523|NCT02713139|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5803524|NCT02713139|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5803525|NCT02713191|Fentanyl|fentanyl|mesh-list
5803526|NCT02713191|Midazolam|midazolam|mesh-list
5803527|NCT02713191|Dexmedetomidine|dexmedetomidine|mesh-list
5803528|NCT02713191|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5803529|NCT02713191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5803530|NCT02713191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803531|NCT02713191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5803532|NCT02713191|Analgesics|analgesics|mesh-ancestor
5803533|NCT02713191|Sensory System Agents|sensory system agents|mesh-ancestor
5803534|NCT02713191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5803535|NCT02713191|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5803536|NCT02713191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5803537|NCT02713191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5803538|NCT02713191|Adrenergic Agents|adrenergic agents|mesh-ancestor
5803539|NCT02713191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5803540|NCT02713191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5803541|NCT02713191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5803542|NCT02713191|Narcotics|narcotics|mesh-ancestor
5803543|NCT02713191|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5803544|NCT02713191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5803545|NCT02713191|Anesthetics, General|anesthetics, general|mesh-ancestor
5803546|NCT02713191|Anesthetics|anesthetics|mesh-ancestor
5803547|NCT02713191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5803548|NCT02713191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5803549|NCT02713191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5803550|NCT02713191|GABA Modulators|gaba modulators|mesh-ancestor
5803551|NCT02713191|GABA Agents|gaba agents|mesh-ancestor
5803552|NCT02713009|Vitamin D|vitamin d|mesh-list
5803553|NCT02713009|Ergocalciferols|ergocalciferols|mesh-list
5803554|NCT02713009|Cholecalciferol|cholecalciferol|mesh-list
5803555|NCT02713009|Vitamins|vitamins|mesh-list
5803556|NCT02713009|Micronutrients|micronutrients|mesh-ancestor
5803557|NCT02713009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803558|NCT02713009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5803559|NCT02713009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5803560|NCT02713074|Povidone-Iodine|povidone-iodine|mesh-list
5803561|NCT02713074|Povidone|povidone|mesh-list
5803562|NCT02713074|Plasma Substitutes|plasma substitutes|mesh-ancestor
5803563|NCT02713074|Blood Substitutes|blood substitutes|mesh-ancestor
5803564|NCT02713074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5803565|NCT02713074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5803566|NCT02713087|Phenylephrine|phenylephrine|mesh-list
5803567|NCT02713087|Oxymetazoline|oxymetazoline|mesh-list
5803568|NCT02713087|Ephedrine|ephedrine|mesh-list
5803569|NCT02713087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5803570|NCT02713087|Mydriatics|mydriatics|mesh-ancestor
5803571|NCT02713087|Autonomic Agents|autonomic agents|mesh-ancestor
5803572|NCT02713087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5803573|NCT02713087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803574|NCT02713087|Sympathomimetics|sympathomimetics|mesh-ancestor
5803575|NCT02713087|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5803576|NCT02713087|Nasal Decongestants|nasal decongestants|mesh-ancestor
5803577|NCT02713087|Respiratory System Agents|respiratory system agents|mesh-ancestor
5803578|NCT02713087|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5803579|NCT02713087|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5803580|NCT02713087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5803581|NCT02713087|Adrenergic Agents|adrenergic agents|mesh-ancestor
5803582|NCT02713087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6674107|NCT01567475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674108|NCT01567475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6674109|NCT01567475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6674110|NCT01567488|Everolimus|everolimus|mesh-list
5803583|NCT02713087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674111|NCT01567488|Octreotide|octreotide|mesh-list
5803584|NCT02713087|Protective Agents|protective agents|mesh-ancestor
5803585|NCT02713087|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5803586|NCT02712957|Naproxen|naproxen|mesh-list
5803587|NCT02712957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5803588|NCT02712957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5803589|NCT02712957|Analgesics|analgesics|mesh-ancestor
5803590|NCT02712957|Sensory System Agents|sensory system agents|mesh-ancestor
5803591|NCT02712957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5803592|NCT02712957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803593|NCT02712957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5803594|NCT02712957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5803595|NCT02712957|Gout Suppressants|gout suppressants|mesh-ancestor
5803596|NCT02712957|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5803597|NCT02712957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5803598|NCT02712957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5803599|NCT02712944|Testosterone|testosterone|mesh-list
5803600|NCT02712944|Androgens|androgens|mesh-ancestor
5803601|NCT02712944|Hormones|hormones|mesh-ancestor
5803602|NCT02712944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5803603|NCT02712944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803604|NCT02712866|Vedolizumab|vedolizumab|mesh-list
5803605|NCT02712866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5803606|NCT02712619|Metformin|metformin|mesh-list
5803607|NCT02712619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5803608|NCT02712619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900248|NCT05044611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5900249|NCT05044611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5900250|NCT05044611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900251|NCT05044611|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
5900252|NCT05044611|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5900253|NCT04979910|Ixekizumab|ixekizumab|mesh-list
5900254|NCT04979910|Dermatologic Agents|dermatologic agents|mesh-ancestor
5900255|NCT04971187|Cisplatin|cisplatin|mesh-list
5900256|NCT04971187|Carboplatin|carboplatin|mesh-list
5900257|NCT04971187|Pemetrexed|pemetrexed|mesh-list
5900258|NCT04971187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5900259|NCT04971187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5900260|NCT04971187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900261|NCT04971187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5900262|NCT04971187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5900263|NCT04960709|Durvalumab|durvalumab|mesh-list
5900264|NCT04960709|Tremelimumab|tremelimumab|mesh-list
5900265|NCT04960709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5900266|NCT04960709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5900267|NCT04943627|Gemcitabine|gemcitabine|mesh-list
5900268|NCT04943627|Irinotecan|irinotecan|mesh-list
5900269|NCT04943627|Pemetrexed|pemetrexed|mesh-list
5900270|NCT04943627|Topotecan|topotecan|mesh-list
5900271|NCT04943627|Vinorelbine|vinorelbine|mesh-list
5900272|NCT04943627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5900273|NCT04943627|Antimetabolites|antimetabolites|mesh-ancestor
5900274|NCT04943627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900275|NCT04943627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5900276|NCT04943627|Antiviral Agents|antiviral agents|mesh-ancestor
5900277|NCT04943627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5900278|NCT04943627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5900279|NCT04943627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5900280|NCT04943627|Immunologic Factors|immunologic factors|mesh-ancestor
5900281|NCT04943627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900282|NCT04943627|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5900283|NCT04943627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5900284|NCT04943627|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5900285|NCT04943627|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5900286|NCT04943627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5900287|NCT04943627|Tubulin Modulators|tubulin modulators|mesh-ancestor
5900288|NCT04943627|Antimitotic Agents|antimitotic agents|mesh-ancestor
5900289|NCT04943627|Mitosis Modulators|mitosis modulators|mesh-ancestor
5900290|NCT04943302|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5900291|NCT04943302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5803609|NCT02712671|Interferons|interferons|mesh-list
5803610|NCT02712671|Interferon-gamma|interferon-gamma|mesh-list
5803611|NCT02712671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5803612|NCT02712671|Antiviral Agents|antiviral agents|mesh-ancestor
5803613|NCT02712671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5803614|NCT02712697|Prednisone|prednisone|mesh-list
5803615|NCT02712697|Hormones|hormones|mesh-list
5803616|NCT02712697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5803617|NCT02712697|Glucocorticoids|glucocorticoids|mesh-ancestor
5803618|NCT02712697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5803619|NCT02712697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803620|NCT02712697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5803621|NCT02712697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5803622|NCT02712775|Minocycline|minocycline|mesh-list
5803623|NCT02712775|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5803624|NCT02712775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5803625|NCT02712658|Terbutaline|terbutaline|mesh-list
5803626|NCT02712658|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5803627|NCT02712658|Autonomic Agents|autonomic agents|mesh-ancestor
5803628|NCT02712658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5803629|NCT02712658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803630|NCT02712658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5803631|NCT02712658|Respiratory System Agents|respiratory system agents|mesh-ancestor
5803632|NCT02712658|Sympathomimetics|sympathomimetics|mesh-ancestor
5803633|NCT02712658|Tocolytic Agents|tocolytic agents|mesh-ancestor
5803634|NCT02712658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5803635|NCT02712658|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5803636|NCT02712658|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5803637|NCT02712658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5803638|NCT02712658|Adrenergic Agents|adrenergic agents|mesh-ancestor
5803639|NCT02712658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5803640|NCT02712658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5803641|NCT02712723|Letrozole|letrozole|mesh-list
5803642|NCT02712723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5803643|NCT02712723|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5803644|NCT02712723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5803645|NCT02712723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5803646|NCT02712723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5803647|NCT02712723|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5803648|NCT02712723|Hormone Antagonists|hormone antagonists|mesh-ancestor
5803649|NCT02712723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5803650|NCT02712723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803651|NCT02712801|Ritonavir|ritonavir|mesh-list
5803652|NCT02712801|Lopinavir|lopinavir|mesh-list
5803653|NCT02712801|Lamivudine|lamivudine|mesh-list
5803654|NCT02712801|Zidovudine|zidovudine|mesh-list
5803655|NCT02712801|Nevirapine|nevirapine|mesh-list
5803656|NCT02712801|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5803657|NCT02712801|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5803658|NCT02712801|Protease Inhibitors|protease inhibitors|mesh-ancestor
5803659|NCT02712801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5900292|NCT04943302|Alkylating Agents|alkylating agents|mesh-ancestor
5803660|NCT02712801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5803661|NCT02712801|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5803662|NCT02712801|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5803663|NCT02712801|Antiviral Agents|antiviral agents|mesh-ancestor
5803664|NCT02712801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5803665|NCT02712801|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5803666|NCT02712801|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5803667|NCT02712801|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5803668|NCT02712801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5803669|NCT02712801|Antimetabolites|antimetabolites|mesh-ancestor
5803670|NCT02712801|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5803671|NCT02712801|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5803672|NCT02712528|Sufentanil|sufentanil|mesh-list
5803673|NCT02712528|Remifentanil|remifentanil|mesh-list
5803674|NCT02712528|Sevoflurane|sevoflurane|mesh-list
5803675|NCT02712528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5803676|NCT02712528|Narcotics|narcotics|mesh-ancestor
5803677|NCT02712528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5803678|NCT02712528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803679|NCT02712528|Analgesics|analgesics|mesh-ancestor
5803680|NCT02712528|Sensory System Agents|sensory system agents|mesh-ancestor
5803681|NCT02712528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5803682|NCT02712528|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5803683|NCT02712528|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5803684|NCT02712528|Anesthetics, General|anesthetics, general|mesh-ancestor
5803685|NCT02712528|Anesthetics|anesthetics|mesh-ancestor
5803686|NCT02712528|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5803687|NCT02712528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5803688|NCT02712814|Estrogens|estrogens|mesh-list
5803689|NCT02712814|Hormones|hormones|mesh-ancestor
5803690|NCT02712814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5803691|NCT02712814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803692|NCT02712502|Amoxicillin|amoxicillin|mesh-list
5803693|NCT02712502|Levofloxacin|levofloxacin|mesh-list
5803694|NCT02712502|Ofloxacin|ofloxacin|mesh-list
5803695|NCT02712502|Clavulanic Acid|clavulanic acid|mesh-list
5803696|NCT02712502|Clavulanic Acids|clavulanic acids|mesh-list
5803697|NCT02712502|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5803698|NCT02712502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5803699|NCT02712502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6674112|NCT01567488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6674113|NCT01567488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6674114|NCT01567488|Immunologic Factors|immunologic factors|mesh-ancestor
6674115|NCT01567488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674116|NCT01567488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6674117|NCT01567488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6674118|NCT01567501|Cetirizine|cetirizine|mesh-list
6674119|NCT01567501|Levocetirizine|levocetirizine|mesh-list
6674120|NCT01567501|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6674121|NCT01567501|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5803700|NCT02712502|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5803701|NCT02712502|Renal Agents|renal agents|mesh-ancestor
5803702|NCT02712502|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5803703|NCT02712502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5803704|NCT02712502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5803705|NCT02712502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5803706|NCT02712502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5803707|NCT02712502|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6674122|NCT01567501|Histamine Antagonists|histamine antagonists|mesh-ancestor
5803708|NCT02712502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5803709|NCT02712502|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5803710|NCT02712346|Ambrisentan|ambrisentan|mesh-list
5803711|NCT02712346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5803712|NCT02712476|Furosemide|furosemide|mesh-list
5803713|NCT02712476|Mannitol|mannitol|mesh-list
5803714|NCT02712476|Diuretics|diuretics|mesh-ancestor
5803715|NCT02712476|Natriuretic Agents|natriuretic agents|mesh-ancestor
5803716|NCT02712476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803717|NCT02712476|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5803718|NCT02712476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5803719|NCT02712476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5803720|NCT02712476|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5803721|NCT02712125|Isosorbide|isosorbide|mesh-list
5803722|NCT02712125|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
5803723|NCT02712125|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
5803724|NCT02712125|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5803725|NCT02712125|Diuretics|diuretics|mesh-ancestor
5803726|NCT02712125|Natriuretic Agents|natriuretic agents|mesh-ancestor
5803727|NCT02712125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803728|NCT02712125|Vasodilator Agents|vasodilator agents|mesh-ancestor
5803729|NCT02712125|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5803730|NCT02712125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5803731|NCT02712177|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5803732|NCT02712177|Immunologic Factors|immunologic factors|mesh-ancestor
5803733|NCT02712177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803734|NCT02712203|Vaccines|vaccines|mesh-list
5803735|NCT02712203|Immunologic Factors|immunologic factors|mesh-ancestor
5803736|NCT02712203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803737|NCT02712307|Penicillins|penicillins|mesh-list
5803738|NCT02712307|Penicillin V|penicillin v|mesh-list
5803739|NCT02712307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5803740|NCT02712307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5803741|NCT02712151|Ropivacaine|ropivacaine|mesh-list
5803742|NCT02712151|Anesthetics, Local|anesthetics, local|mesh-ancestor
5803743|NCT02712151|Anesthetics|anesthetics|mesh-ancestor
5803744|NCT02712151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5803745|NCT02712151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803746|NCT02712151|Sensory System Agents|sensory system agents|mesh-ancestor
5803747|NCT02712151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5803748|NCT02711865|Antibodies|antibodies|mesh-list
5803749|NCT02711865|Immunologic Factors|immunologic factors|mesh-ancestor
5803750|NCT02711865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803751|NCT02711904|Remifentanil|remifentanil|mesh-list
5803752|NCT02711904|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6674123|NCT01567501|Histamine Agents|histamine agents|mesh-ancestor
6674124|NCT01567501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6674125|NCT01567501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674126|NCT01567501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674127|NCT01567501|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6674128|NCT01567540|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6674129|NCT01567540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6674130|NCT01567540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674131|NCT01567540|Incretins|incretins|mesh-ancestor
6674132|NCT01567540|Hormones|hormones|mesh-ancestor
6674133|NCT01567540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6674134|NCT01567540|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6674135|NCT01567540|Protease Inhibitors|protease inhibitors|mesh-ancestor
6674136|NCT01567540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6674137|NCT01567540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674138|NCT01567605|Lidocaine|lidocaine|mesh-list
6674139|NCT01567605|Anesthetics, Local|anesthetics, local|mesh-ancestor
6674140|NCT01567605|Anesthetics|anesthetics|mesh-ancestor
6674141|NCT01567605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6674142|NCT01567605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674143|NCT01567605|Sensory System Agents|sensory system agents|mesh-ancestor
5803753|NCT02711904|Narcotics|narcotics|mesh-ancestor
5803754|NCT02711904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5803755|NCT02711904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803756|NCT02711904|Analgesics|analgesics|mesh-ancestor
5803757|NCT02711904|Sensory System Agents|sensory system agents|mesh-ancestor
5803758|NCT02711904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5803759|NCT02711969|Apatinib|apatinib|mesh-list
5803760|NCT02711969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5803761|NCT02711969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5803762|NCT02711969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5803763|NCT02711969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5803764|NCT02711943|Levofloxacin|levofloxacin|mesh-list
5803765|NCT02711943|Ofloxacin|ofloxacin|mesh-list
5803766|NCT02711943|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5803767|NCT02711943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5803768|NCT02711943|Renal Agents|renal agents|mesh-ancestor
5803769|NCT02711943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5803770|NCT02711943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5803771|NCT02711943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5803772|NCT02711943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5803773|NCT02711943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5803774|NCT02711943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5803775|NCT02711943|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5803776|NCT02711943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5803777|NCT02711982|Methylprednisolone|methylprednisolone|mesh-list
5803778|NCT02711982|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5803779|NCT02711982|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5803780|NCT02711982|Prednisolone|prednisolone|mesh-list
5803781|NCT02711982|Prednisolone acetate|prednisolone acetate|mesh-list
5803782|NCT02711982|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5803783|NCT02711982|Prednisolone phosphate|prednisolone phosphate|mesh-list
5803784|NCT02711982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5803785|NCT02711982|Antiemetics|antiemetics|mesh-ancestor
5803786|NCT02711982|Autonomic Agents|autonomic agents|mesh-ancestor
5803787|NCT02711982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6674144|NCT01567605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6674145|NCT01567605|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6674146|NCT01567605|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6674147|NCT01567605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6674148|NCT01567605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6674149|NCT01567605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674150|NCT01567618|Docetaxel|docetaxel|mesh-list
6674151|NCT01567618|Fluorouracil|fluorouracil|mesh-list
5803788|NCT02711982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803789|NCT02711982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5803790|NCT02711982|Glucocorticoids|glucocorticoids|mesh-ancestor
5803791|NCT02711982|Hormones|hormones|mesh-ancestor
5803792|NCT02711982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5803793|NCT02711982|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5803794|NCT02711982|Protective Agents|protective agents|mesh-ancestor
5803795|NCT02711982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5803796|NCT02711982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5803797|NCT02711891|Loperamide|loperamide|mesh-list
5803798|NCT02711891|Antidiarrheals|antidiarrheals|mesh-list
5803799|NCT02711891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5803800|NCT02711826|Acetaminophen|acetaminophen|mesh-list
5803801|NCT02711826|Diphenhydramine|diphenhydramine|mesh-list
5803802|NCT02711826|Promethazine|promethazine|mesh-list
5803803|NCT02711826|Mycophenolic Acid|mycophenolic acid|mesh-list
5803804|NCT02711826|Everolimus|everolimus|mesh-list
5803805|NCT02711826|Tacrolimus|tacrolimus|mesh-list
5803806|NCT02711826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5803807|NCT02711826|Immunologic Factors|immunologic factors|mesh-ancestor
5803808|NCT02711826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803809|NCT02711826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5803810|NCT02711826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5803811|NCT02711826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5803812|NCT02711826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5803813|NCT02711826|Analgesics|analgesics|mesh-ancestor
5803814|NCT02711826|Sensory System Agents|sensory system agents|mesh-ancestor
5803815|NCT02711826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5803816|NCT02711826|Antipyretics|antipyretics|mesh-ancestor
5803817|NCT02711826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5803818|NCT02711826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5803819|NCT02711826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5803820|NCT02711826|Antitubercular Agents|antitubercular agents|mesh-ancestor
5803821|NCT02711826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5803822|NCT02711826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5803823|NCT02711826|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5803824|NCT02711826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5803825|NCT02711826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5803826|NCT02711826|Anesthetics, Local|anesthetics, local|mesh-ancestor
5803827|NCT02711826|Anesthetics|anesthetics|mesh-ancestor
5803828|NCT02711826|Antiemetics|antiemetics|mesh-ancestor
5803829|NCT02711826|Autonomic Agents|autonomic agents|mesh-ancestor
5803830|NCT02711826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5803831|NCT02711826|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5803832|NCT02711826|Histamine Antagonists|histamine antagonists|mesh-ancestor
5803833|NCT02711826|Histamine Agents|histamine agents|mesh-ancestor
5803834|NCT02711826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5803835|NCT02711826|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5803836|NCT02711826|Antipruritics|antipruritics|mesh-ancestor
5803837|NCT02711826|Dermatologic Agents|dermatologic agents|mesh-ancestor
5803838|NCT02711917|Propofol|propofol|mesh-list
5803839|NCT02711917|Etomidate|etomidate|mesh-list
5803840|NCT02711917|Rocuronium|rocuronium|mesh-list
5803841|NCT02711917|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5803842|NCT02711917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5803843|NCT02711917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803844|NCT02711917|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5803845|NCT02711917|Anesthetics, General|anesthetics, general|mesh-ancestor
5803846|NCT02711917|Anesthetics|anesthetics|mesh-ancestor
5803847|NCT02711917|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5803848|NCT02711917|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5803849|NCT02711917|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5803850|NCT02711917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5803851|NCT02711735|Vaccines|vaccines|mesh-list
5803852|NCT02711735|Immunologic Factors|immunologic factors|mesh-ancestor
5803853|NCT02711735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803854|NCT02711449|Methylprednisolone|methylprednisolone|mesh-list
5803855|NCT02711449|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5803856|NCT02711449|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5803857|NCT02711449|Prednisolone|prednisolone|mesh-list
5803858|NCT02711449|Prednisolone acetate|prednisolone acetate|mesh-list
5803859|NCT02711449|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5803860|NCT02711449|Prednisolone phosphate|prednisolone phosphate|mesh-list
5803861|NCT02711449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5803862|NCT02711449|Antiemetics|antiemetics|mesh-ancestor
5803863|NCT02711449|Autonomic Agents|autonomic agents|mesh-ancestor
5803864|NCT02711449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5803865|NCT02711449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803866|NCT02711449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5803867|NCT02711449|Glucocorticoids|glucocorticoids|mesh-ancestor
5803868|NCT02711449|Hormones|hormones|mesh-ancestor
5803869|NCT02711449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5803870|NCT02711449|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5803871|NCT02711449|Protective Agents|protective agents|mesh-ancestor
5803872|NCT02711449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5803873|NCT02711449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5803874|NCT02711592|Analgesics|analgesics|mesh-list
5803875|NCT02711592|Sensory System Agents|sensory system agents|mesh-ancestor
5803876|NCT02711592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5803877|NCT02711592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803878|NCT02711410|Clopidogrel|clopidogrel|mesh-list
5803879|NCT02711410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5803880|NCT02711410|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5803881|NCT02711410|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5803882|NCT02711410|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5803883|NCT02711410|Purinergic Agents|purinergic agents|mesh-ancestor
5803884|NCT02711410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5803885|NCT02711410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5803886|NCT02711410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803887|NCT02711670|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5803888|NCT02711670|Chlorthalidone|chlorthalidone|mesh-list
5803889|NCT02711670|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5803890|NCT02711670|Diuretics|diuretics|mesh-ancestor
5803891|NCT02711670|Natriuretic Agents|natriuretic agents|mesh-ancestor
5803892|NCT02711670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803893|NCT02711670|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5803894|NCT02711670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5803895|NCT02711670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5803896|NCT02711579|Celecoxib|celecoxib|mesh-list
5803897|NCT02711579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5803898|NCT02711579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5803899|NCT02711579|Analgesics|analgesics|mesh-ancestor
5803900|NCT02711579|Sensory System Agents|sensory system agents|mesh-ancestor
5803901|NCT02711579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5803902|NCT02711579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803903|NCT02711579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5803904|NCT02711579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5803905|NCT02711579|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5803906|NCT02711579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5803907|NCT02711579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5803908|NCT02711579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5803909|NCT02711683|3-n-butylphthalide|3-n-butylphthalide|mesh-list
5803910|NCT02711683|Donepezil|donepezil|mesh-list
5803911|NCT02711683|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5803912|NCT02711683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5803913|NCT02711683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5803914|NCT02711683|Cholinergic Agents|cholinergic agents|mesh-ancestor
5803915|NCT02711683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5803916|NCT02711683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803917|NCT02711683|Nootropic Agents|nootropic agents|mesh-ancestor
5803918|NCT02711683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6211076|NCT02168439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6211077|NCT02168439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6211078|NCT02168439|Adrenergic Agents|adrenergic agents|mesh-ancestor
6211079|NCT02168439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6211080|NCT02168439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5803919|NCT02711683|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5803920|NCT02711683|Protective Agents|protective agents|mesh-ancestor
5803921|NCT02711176|Amoxicillin|amoxicillin|mesh-list
5803922|NCT02711176|Clarithromycin|clarithromycin|mesh-list
5803923|NCT02711176|Tinidazole|tinidazole|mesh-list
5803924|NCT02711176|Esomeprazole|esomeprazole|mesh-list
5803925|NCT02711176|Lansoprazole|lansoprazole|mesh-list
5803926|NCT02711176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5803927|NCT02711176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5803928|NCT02711176|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6211081|NCT02168439|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6211082|NCT02168439|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6211083|NCT02168439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6211084|NCT02168439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6211085|NCT02168439|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6211086|NCT02168439|Anesthetics, General|anesthetics, general|mesh-ancestor
6211087|NCT02168439|Anesthetics|anesthetics|mesh-ancestor
6211088|NCT02168439|GABA Modulators|gaba modulators|mesh-ancestor
6211089|NCT02168439|GABA Agents|gaba agents|mesh-ancestor
6211090|NCT02168478|Neomycin|neomycin|mesh-list
6211091|NCT02168478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6211092|NCT02168478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6211093|NCT02168478|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6211094|NCT02168478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6211095|NCT02168478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211096|NCT02168491|Insulin Glargine|insulin glargine|mesh-list
6211097|NCT02168491|Lixisenatide|lixisenatide|mesh-list
5803929|NCT02711176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5803930|NCT02711176|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5803931|NCT02711176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5803932|NCT02711176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5803933|NCT02711176|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5803934|NCT02711176|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5803935|NCT02711176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5803936|NCT02711176|Alkylating Agents|alkylating agents|mesh-ancestor
5803937|NCT02711176|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
5803938|NCT02711176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5803939|NCT02711176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5803940|NCT02711189|Oxytocin|oxytocin|mesh-list
5803941|NCT02711189|Oxytocics|oxytocics|mesh-ancestor
5803942|NCT02711189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5803943|NCT02711189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803944|NCT02711202|Sirolimus|sirolimus|mesh-list
5803945|NCT02711202|Alemtuzumab|alemtuzumab|mesh-list
5803946|NCT02711202|Infliximab|infliximab|mesh-list
5803947|NCT02711202|Tacrolimus|tacrolimus|mesh-list
5803948|NCT02711202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5803949|NCT02711202|Immunologic Factors|immunologic factors|mesh-ancestor
5803950|NCT02711202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803951|NCT02711202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5803952|NCT02711202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5803953|NCT02711202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5803954|NCT02711202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5803955|NCT02711202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5803956|NCT02711202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5803957|NCT02711202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5803958|NCT02711202|Antifungal Agents|antifungal agents|mesh-ancestor
5803959|NCT02711202|Dermatologic Agents|dermatologic agents|mesh-ancestor
5803960|NCT02711202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5803961|NCT02711202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5803962|NCT02711202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5900293|NCT04943302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900294|NCT04943302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5900295|NCT04941508|Dexmedetomidine|dexmedetomidine|mesh-list
5900296|NCT04941508|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5900297|NCT04941508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5900298|NCT04941508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900299|NCT04941508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5900300|NCT04941508|Analgesics|analgesics|mesh-ancestor
5900301|NCT04941508|Sensory System Agents|sensory system agents|mesh-ancestor
5900302|NCT04941508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5900303|NCT04941508|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5900304|NCT04941508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5900305|NCT04941508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5900306|NCT04941508|Adrenergic Agents|adrenergic agents|mesh-ancestor
5900307|NCT04941508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5900308|NCT04941508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900309|NCT04933331|Silver Nitrate|silver nitrate|mesh-list
5900310|NCT04933331|Fluorides|fluorides|mesh-list
5900311|NCT04933331|Fluorides, Topical|fluorides, topical|mesh-list
5900312|NCT04933331|Cariostatic Agents|cariostatic agents|mesh-ancestor
5900313|NCT04933331|Protective Agents|protective agents|mesh-ancestor
5900314|NCT04933331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900315|NCT04933331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5900316|NCT04933331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5900317|NCT04932213|Tropicamide|tropicamide|mesh-list
5900318|NCT04932213|Mydriatics|mydriatics|mesh-ancestor
5900319|NCT04932213|Autonomic Agents|autonomic agents|mesh-ancestor
5900320|NCT04932213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5900321|NCT04932213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803963|NCT02711228|Immunoglobulins|immunoglobulins|mesh-list
5803964|NCT02711228|Antibodies|antibodies|mesh-list
5803965|NCT02711228|gamma-Globulins|gamma-globulins|mesh-list
5803966|NCT02711228|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5803967|NCT02711228|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5803968|NCT02711228|Immunologic Factors|immunologic factors|mesh-ancestor
5803969|NCT02711228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803970|NCT02711215|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5803971|NCT02711215|Mirtazapine|mirtazapine|mesh-list
5803972|NCT02711215|Citalopram|citalopram|mesh-list
5803973|NCT02711215|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
5803974|NCT02711215|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5803975|NCT02711215|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5803976|NCT02711215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5803977|NCT02711215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5803978|NCT02711215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5803979|NCT02711215|Serotonin Agents|serotonin agents|mesh-ancestor
5803980|NCT02711215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5803981|NCT02711215|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5803982|NCT02711215|Antidepressive Agents|antidepressive agents|mesh-ancestor
5803983|NCT02711215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5803984|NCT02711215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5803985|NCT02711215|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5803986|NCT02711215|Analgesics|analgesics|mesh-ancestor
5803987|NCT02711215|Sensory System Agents|sensory system agents|mesh-ancestor
5803988|NCT02711215|Dopamine Agents|dopamine agents|mesh-ancestor
5803989|NCT02711215|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5803990|NCT02711215|Histamine Antagonists|histamine antagonists|mesh-ancestor
5803991|NCT02711215|Histamine Agents|histamine agents|mesh-ancestor
5803992|NCT02711215|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5803993|NCT02711215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5641582|NCT02719613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5803994|NCT02711215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5803995|NCT02711215|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5803996|NCT02711215|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5803997|NCT02711215|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5803998|NCT02711215|Adrenergic Agents|adrenergic agents|mesh-ancestor
5803999|NCT02711215|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5804000|NCT02711215|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5804001|NCT02711215|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5804002|NCT02711358|Indomethacin|indomethacin|mesh-list
5804003|NCT02711358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5804004|NCT02711358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5804005|NCT02711358|Analgesics|analgesics|mesh-ancestor
5804006|NCT02711358|Sensory System Agents|sensory system agents|mesh-ancestor
5804007|NCT02711358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5804008|NCT02711358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804009|NCT02711358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5804010|NCT02711358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5804011|NCT02711358|Gout Suppressants|gout suppressants|mesh-ancestor
5641583|NCT02719613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5641584|NCT02719613|Immunologic Factors|immunologic factors|mesh-ancestor
5641585|NCT02719613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5641586|NCT02719613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5641587|NCT02719613|Growth Substances|growth substances|mesh-ancestor
5641588|NCT02719613|Growth Inhibitors|growth inhibitors|mesh-ancestor
5641589|NCT02717507|Carvedilol|carvedilol|mesh-list
5804012|NCT02711358|Tocolytic Agents|tocolytic agents|mesh-ancestor
5804013|NCT02711358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5804014|NCT02711358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5804015|NCT02711358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5804016|NCT02711358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5804017|NCT02711267|Acyclovir|acyclovir|mesh-list
5804018|NCT02711267|Antiviral Agents|antiviral agents|mesh-ancestor
5804019|NCT02711267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5804020|NCT02711280|Propofol|propofol|mesh-list
5804021|NCT02711280|Sevoflurane|sevoflurane|mesh-list
5804022|NCT02711280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5804023|NCT02711280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5804024|NCT02711280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804025|NCT02711280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5804026|NCT02711280|Anesthetics, General|anesthetics, general|mesh-ancestor
5804027|NCT02711280|Anesthetics|anesthetics|mesh-ancestor
5804028|NCT02711280|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5804029|NCT02711280|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5804030|NCT02711241|Dipyrone|dipyrone|mesh-list
5804031|NCT02711241|Papaverine|papaverine|mesh-list
5804032|NCT02711241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5804033|NCT02711241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5804034|NCT02711241|Analgesics|analgesics|mesh-ancestor
5804035|NCT02711241|Sensory System Agents|sensory system agents|mesh-ancestor
5804036|NCT02711241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5804037|NCT02711241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804038|NCT02711241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5804039|NCT02711241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5804040|NCT02711241|Antipyretics|antipyretics|mesh-ancestor
5804041|NCT02711241|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5804042|NCT02711241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5804043|NCT02711241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5804044|NCT02711241|Vasodilator Agents|vasodilator agents|mesh-ancestor
5804045|NCT02711241|Urological Agents|urological agents|mesh-ancestor
5804046|NCT02711059|Parathyroid Hormone|parathyroid hormone|mesh-list
5804047|NCT02711059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5804048|NCT02711059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804049|NCT02711007|Apatinib|apatinib|mesh-list
5804050|NCT02711007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5804051|NCT02711007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5804052|NCT02711007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5804053|NCT02711007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5804054|NCT02710877|Sufentanil|sufentanil|mesh-list
5804055|NCT02710877|Dsuvia|dsuvia|mesh-list
5804056|NCT02710877|Levobupivacaine|levobupivacaine|mesh-list
5804057|NCT02710877|Anesthetics, Local|anesthetics, local|mesh-ancestor
5804058|NCT02710877|Anesthetics|anesthetics|mesh-ancestor
5804059|NCT02710877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5908209|NCT04803201|Antimitotic Agents|antimitotic agents|mesh-ancestor
6492007|NCT00606203|Antidepressive Agents|antidepressive agents|mesh-ancestor
6492008|NCT00606203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6496428|NCT00627965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496429|NCT00627965|Vasodilator Agents|vasodilator agents|mesh-ancestor
6496430|NCT00627965|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6496431|NCT00627965|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5804060|NCT02710877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804061|NCT02710877|Sensory System Agents|sensory system agents|mesh-ancestor
5804062|NCT02710877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5804063|NCT02710877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5804064|NCT02710877|Narcotics|narcotics|mesh-ancestor
5804065|NCT02710877|Analgesics|analgesics|mesh-ancestor
5804066|NCT02710877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5804067|NCT02710877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5804068|NCT02710877|Anesthetics, General|anesthetics, general|mesh-ancestor
5804069|NCT02710656|Paclitaxel|paclitaxel|mesh-list
5804070|NCT02710656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5804071|NCT02710656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6496432|NCT00627965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5804072|NCT02710656|Tubulin Modulators|tubulin modulators|mesh-ancestor
5804073|NCT02710656|Antimitotic Agents|antimitotic agents|mesh-ancestor
5804074|NCT02710656|Mitosis Modulators|mitosis modulators|mesh-ancestor
5804075|NCT02710656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5804076|NCT02710539|Amlodipine|amlodipine|mesh-list
5804077|NCT02710539|Perindopril|perindopril|mesh-list
5804078|NCT02710539|Indapamide|indapamide|mesh-list
5804079|NCT02710539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5804080|NCT02710539|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5804081|NCT02710539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5804082|NCT02710539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5804083|NCT02710539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5804084|NCT02710539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804085|NCT02710539|Vasodilator Agents|vasodilator agents|mesh-ancestor
5804086|NCT02710539|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5804087|NCT02710539|Protease Inhibitors|protease inhibitors|mesh-ancestor
5804088|NCT02710539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5804089|NCT02710539|Diuretics|diuretics|mesh-ancestor
5804090|NCT02710539|Natriuretic Agents|natriuretic agents|mesh-ancestor
5804091|NCT02710539|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5804092|NCT02710604|Tenofovir|tenofovir|mesh-list
5804093|NCT02710604|Hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|mesh-list
5804094|NCT02710604|Antiviral Agents|antiviral agents|mesh-ancestor
5804095|NCT02710604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5804096|NCT02710604|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5804097|NCT02710604|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5804098|NCT02710604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5804099|NCT02710604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5804100|NCT02710604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5804101|NCT02710604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5804102|NCT02710552|Amlodipine|amlodipine|mesh-list
5804103|NCT02710552|Antihypertensive Agents|antihypertensive agents|mesh-list
5804104|NCT02710552|Perindopril|perindopril|mesh-list
5804105|NCT02710552|Indapamide|indapamide|mesh-list
5804106|NCT02710552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5804107|NCT02710552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5804108|NCT02710552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5804109|NCT02710552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5804110|NCT02710552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804111|NCT02710552|Vasodilator Agents|vasodilator agents|mesh-ancestor
5804112|NCT02710552|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5804113|NCT02710552|Protease Inhibitors|protease inhibitors|mesh-ancestor
5804114|NCT02710552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5804115|NCT02710552|Diuretics|diuretics|mesh-ancestor
5804116|NCT02710552|Natriuretic Agents|natriuretic agents|mesh-ancestor
5804117|NCT02710552|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5804118|NCT02710448|Metformin|metformin|mesh-list
5804119|NCT02710448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5804120|NCT02710448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804121|NCT02710409|Vaccines|vaccines|mesh-list
5804122|NCT02710409|Immunologic Factors|immunologic factors|mesh-ancestor
5804123|NCT02710409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804124|NCT02710396|Paclitaxel|paclitaxel|mesh-list
5804125|NCT02710396|Carboplatin|carboplatin|mesh-list
5804126|NCT02710396|Pembrolizumab|pembrolizumab|mesh-list
5804127|NCT02710396|Pemetrexed|pemetrexed|mesh-list
5804128|NCT02710396|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5804129|NCT02710396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5804130|NCT02710396|Tubulin Modulators|tubulin modulators|mesh-ancestor
5804131|NCT02710396|Antimitotic Agents|antimitotic agents|mesh-ancestor
5804132|NCT02710396|Mitosis Modulators|mitosis modulators|mesh-ancestor
5804133|NCT02710396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5804134|NCT02710396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5804135|NCT02710396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5804136|NCT02710396|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5804137|NCT02710396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5804138|NCT02710266|Gabexate|gabexate|mesh-list
5804139|NCT02710266|Anticoagulants|anticoagulants|mesh-ancestor
5804140|NCT02710266|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5804141|NCT02710266|Protease Inhibitors|protease inhibitors|mesh-ancestor
5804142|NCT02710266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5804143|NCT02710266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5804144|NCT02710305|Lidocaine|lidocaine|mesh-list
5804145|NCT02710305|Scopolamine|scopolamine|mesh-list
5804146|NCT02710305|Bromides|bromides|mesh-list
5804147|NCT02710305|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
5804148|NCT02710305|Anesthetics, Local|anesthetics, local|mesh-ancestor
5804149|NCT02710305|Anesthetics|anesthetics|mesh-ancestor
5804150|NCT02710305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5804151|NCT02710305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804152|NCT02710305|Sensory System Agents|sensory system agents|mesh-ancestor
5804153|NCT02710305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5804154|NCT02710305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5804155|NCT02710305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5804156|NCT02710305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5804157|NCT02710305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5804158|NCT02710305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5804159|NCT02710305|Anticonvulsants|anticonvulsants|mesh-ancestor
5804160|NCT02710305|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5804161|NCT02710305|Antiemetics|antiemetics|mesh-ancestor
5804162|NCT02710305|Autonomic Agents|autonomic agents|mesh-ancestor
5804163|NCT02710305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5804164|NCT02710305|Mydriatics|mydriatics|mesh-ancestor
5804165|NCT02710305|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5804166|NCT02710305|Cholinergic Agents|cholinergic agents|mesh-ancestor
5804167|NCT02710305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5804168|NCT02710305|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5804169|NCT02710305|Parasympatholytics|parasympatholytics|mesh-ancestor
5804170|NCT02710318|Vaccines|vaccines|mesh-list
5804171|NCT02710318|Immunologic Factors|immunologic factors|mesh-ancestor
5804172|NCT02710318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804173|NCT02710110|Capsaicin|capsaicin|mesh-list
5804174|NCT02710110|Antipruritics|antipruritics|mesh-ancestor
5804175|NCT02710110|Dermatologic Agents|dermatologic agents|mesh-ancestor
5804176|NCT02710110|Sensory System Agents|sensory system agents|mesh-ancestor
5804177|NCT02710110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5804178|NCT02710110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804179|NCT02710162|Capsaicin|capsaicin|mesh-list
5804180|NCT02710162|Antipruritics|antipruritics|mesh-ancestor
5804181|NCT02710162|Dermatologic Agents|dermatologic agents|mesh-ancestor
5804182|NCT02710162|Sensory System Agents|sensory system agents|mesh-ancestor
5804183|NCT02710162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5804184|NCT02710162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804185|NCT02709863|Propofol|propofol|mesh-list
5804186|NCT02709863|Sevoflurane|sevoflurane|mesh-list
5804187|NCT02709863|Desflurane|desflurane|mesh-list
5804188|NCT02709863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5804189|NCT02709863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5804190|NCT02709863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804191|NCT02709863|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5804192|NCT02709863|Anesthetics, General|anesthetics, general|mesh-ancestor
5804193|NCT02709863|Anesthetics|anesthetics|mesh-ancestor
5804194|NCT02709863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5804195|NCT02709863|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5804196|NCT02709902|Adapalene|adapalene|mesh-list
5804197|NCT02709902|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
5804198|NCT02709902|Benzoyl Peroxide|benzoyl peroxide|mesh-list
5804199|NCT02709902|Dermatologic Agents|dermatologic agents|mesh-ancestor
5804200|NCT02709902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5804201|NCT02709902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5804202|NCT02709902|Analgesics|analgesics|mesh-ancestor
5804203|NCT02709902|Sensory System Agents|sensory system agents|mesh-ancestor
5804204|NCT02709902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5804205|NCT02709902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804206|NCT02709902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5804207|NCT02709902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5804208|NCT02709824|Chlorhexidine|chlorhexidine|mesh-list
5804209|NCT02709824|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5804210|NCT02709824|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5804211|NCT02709824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5804212|NCT02709824|Disinfectants|disinfectants|mesh-ancestor
5804213|NCT02709824|Dermatologic Agents|dermatologic agents|mesh-ancestor
5804214|NCT02709720|Cisplatin|cisplatin|mesh-list
5804215|NCT02709720|Vinorelbine|vinorelbine|mesh-list
5804216|NCT02709720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5804217|NCT02709720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5804218|NCT02709720|Tubulin Modulators|tubulin modulators|mesh-ancestor
5804219|NCT02709720|Antimitotic Agents|antimitotic agents|mesh-ancestor
5804220|NCT02709720|Mitosis Modulators|mitosis modulators|mesh-ancestor
5804221|NCT02709720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5804222|NCT02709668|Vitamin B Complex|vitamin b complex|mesh-list
5804223|NCT02709668|Vitamins|vitamins|mesh-ancestor
5804224|NCT02709668|Micronutrients|micronutrients|mesh-ancestor
5804225|NCT02709668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804226|NCT02709616|Vaccines|vaccines|mesh-list
5804227|NCT02709616|Immunologic Factors|immunologic factors|mesh-ancestor
5804228|NCT02709616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804229|NCT02709590|Diclofenac|diclofenac|mesh-list
5804230|NCT02709590|Lidocaine|lidocaine|mesh-list
5804231|NCT02709590|Anesthetics, Local|anesthetics, local|mesh-ancestor
5804232|NCT02709590|Anesthetics|anesthetics|mesh-ancestor
5804233|NCT02709590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5804234|NCT02709590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804235|NCT02709590|Sensory System Agents|sensory system agents|mesh-ancestor
5804236|NCT02709590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5804237|NCT02709590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5804238|NCT02709590|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5804239|NCT02709590|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5804240|NCT02709590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5804241|NCT02709590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5804242|NCT02709590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5804243|NCT02709590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5804244|NCT02709590|Analgesics|analgesics|mesh-ancestor
5804245|NCT02709590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5804246|NCT02709590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5804247|NCT02709590|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5804248|NCT02709590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5804249|NCT02709603|Scopolamine|scopolamine|mesh-list
5804250|NCT02709603|Bromides|bromides|mesh-list
5804251|NCT02709603|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
5804252|NCT02709603|Anticonvulsants|anticonvulsants|mesh-ancestor
5641590|NCT02717507|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5641591|NCT02717507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5641592|NCT02717507|Adrenergic Agents|adrenergic agents|mesh-ancestor
5641593|NCT02717507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5641594|NCT02717507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641595|NCT02717507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641596|NCT02717507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5641597|NCT02717507|Antioxidants|antioxidants|mesh-ancestor
5641598|NCT02717507|Protective Agents|protective agents|mesh-ancestor
5641599|NCT02717507|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5641600|NCT02717507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5804253|NCT02709603|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5804254|NCT02709603|Antiemetics|antiemetics|mesh-ancestor
5804255|NCT02709603|Autonomic Agents|autonomic agents|mesh-ancestor
5804256|NCT02709603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6492009|NCT00606242|Fluticasone|fluticasone|mesh-list
5693945|NCT03398811|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5693946|NCT03398811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5693947|NCT03398811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5693948|NCT03398811|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5693949|NCT03398811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5693950|NCT03398811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5693951|NCT03398785|Epinephrine|epinephrine|mesh-list
5693952|NCT03398785|Racepinephrine|racepinephrine|mesh-list
5693953|NCT03398785|Epinephryl borate|epinephryl borate|mesh-list
5693954|NCT03398785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5693955|NCT03398785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5693956|NCT03398785|Adrenergic Agents|adrenergic agents|mesh-ancestor
5693957|NCT03398785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5693958|NCT03398785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693959|NCT03398785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693960|NCT03398785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5693961|NCT03398785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5693962|NCT03398785|Autonomic Agents|autonomic agents|mesh-ancestor
5693963|NCT03398785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5693964|NCT03398785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5693965|NCT03398785|Respiratory System Agents|respiratory system agents|mesh-ancestor
5693966|NCT03398785|Mydriatics|mydriatics|mesh-ancestor
5693967|NCT03398785|Sympathomimetics|sympathomimetics|mesh-ancestor
5804257|NCT02709603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804258|NCT02709603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5804259|NCT02709603|Mydriatics|mydriatics|mesh-ancestor
5804260|NCT02709603|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5804261|NCT02709603|Cholinergic Agents|cholinergic agents|mesh-ancestor
5804262|NCT02709603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5804263|NCT02709603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5804264|NCT02709603|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5804265|NCT02709603|Parasympatholytics|parasympatholytics|mesh-ancestor
5804266|NCT02709564|Misoprostol|misoprostol|mesh-list
5804267|NCT02709564|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5804268|NCT02709564|Abortifacient Agents|abortifacient agents|mesh-ancestor
5804269|NCT02709564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5804270|NCT02709564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804271|NCT02709564|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5804272|NCT02709564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5804273|NCT02709564|Oxytocics|oxytocics|mesh-ancestor
5900322|NCT04932213|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6492010|NCT00606242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6492011|NCT00606242|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6492012|NCT00606242|Autonomic Agents|autonomic agents|mesh-ancestor
5641601|NCT02717507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5641602|NCT02717507|Vasodilator Agents|vasodilator agents|mesh-ancestor
5641603|NCT02717507|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5641604|NCT02717507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5641605|NCT02658981|Nivolumab|nivolumab|mesh-list
5641606|NCT02658981|Antibodies|antibodies|mesh-list
5641607|NCT02658981|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5900323|NCT04932213|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5900324|NCT04932213|Cholinergic Agents|cholinergic agents|mesh-ancestor
5900325|NCT04932213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5900326|NCT04932213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900327|NCT04909853|Ritonavir|ritonavir|mesh-list
5900328|NCT04909853|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5900329|NCT04909853|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5900330|NCT04909853|Protease Inhibitors|protease inhibitors|mesh-ancestor
5900331|NCT04909853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5900332|NCT04909853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900333|NCT04909853|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6492013|NCT00606242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5641608|NCT02658981|Immunologic Factors|immunologic factors|mesh-ancestor
5641609|NCT02658981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641610|NCT02658981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5641611|NCT02658981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5641612|NCT02658981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5641613|NCT02658981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641614|NCT02575794|Masoprocol|masoprocol|mesh-list
5641615|NCT02575794|Antioxidants|antioxidants|mesh-ancestor
5641616|NCT02575794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641617|NCT02575794|Protective Agents|protective agents|mesh-ancestor
5641618|NCT02575794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641619|NCT02575794|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
5804274|NCT02709265|Amikacin|amikacin|mesh-list
5804275|NCT02709265|Fosfomycin|fosfomycin|mesh-list
5804276|NCT02709265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5804277|NCT02709265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5804278|NCT02709304|Lidocaine|lidocaine|mesh-list
5804279|NCT02709304|Anesthetics, Local|anesthetics, local|mesh-ancestor
5804280|NCT02709304|Anesthetics|anesthetics|mesh-ancestor
5804281|NCT02709304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5804282|NCT02709304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804283|NCT02709304|Sensory System Agents|sensory system agents|mesh-ancestor
5804284|NCT02709304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5804285|NCT02709304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5804286|NCT02709304|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5804287|NCT02709304|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5804288|NCT02709304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5804289|NCT02709304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5804290|NCT02709473|Remifentanil|remifentanil|mesh-list
5804291|NCT02709473|Propofol|propofol|mesh-list
5804292|NCT02709473|Rocuronium|rocuronium|mesh-list
5804293|NCT02709473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5804294|NCT02709473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5804295|NCT02709473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804296|NCT02709473|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5804297|NCT02709473|Anesthetics, General|anesthetics, general|mesh-ancestor
5804298|NCT02709473|Anesthetics|anesthetics|mesh-ancestor
5804299|NCT02709473|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5804300|NCT02709473|Narcotics|narcotics|mesh-ancestor
5804301|NCT02709473|Analgesics|analgesics|mesh-ancestor
5804302|NCT02709473|Sensory System Agents|sensory system agents|mesh-ancestor
5804303|NCT02709473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5804304|NCT02709473|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5804305|NCT02709473|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5804306|NCT02709473|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5804307|NCT02709187|Candesartan|candesartan|mesh-list
5804308|NCT02709187|Candesartan cilexetil|candesartan cilexetil|mesh-list
5804309|NCT02709187|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5804310|NCT02709187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5804311|NCT02709187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5804312|NCT02709187|Antimetabolites|antimetabolites|mesh-ancestor
5804313|NCT02709187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5804314|NCT02709187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5804315|NCT02709187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6674152|NCT01567618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6674153|NCT01567618|Tubulin Modulators|tubulin modulators|mesh-ancestor
5641620|NCT02575794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5641621|NCT02575794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5641622|NCT02575794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5641623|NCT02575794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5641624|NCT02575794|Analgesics|analgesics|mesh-ancestor
5641625|NCT02575794|Sensory System Agents|sensory system agents|mesh-ancestor
5641626|NCT02575794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5641627|NCT02575794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5641628|NCT02575794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5641629|NCT02452268|Spartalizumab|spartalizumab|mesh-list
5641630|NCT02452268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6674154|NCT01567618|Antimitotic Agents|antimitotic agents|mesh-ancestor
6674155|NCT01567618|Mitosis Modulators|mitosis modulators|mesh-ancestor
6674156|NCT01567618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674157|NCT01567618|Antimetabolites|antimetabolites|mesh-ancestor
6674158|NCT01567618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6674159|NCT01567618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6674160|NCT01567618|Immunologic Factors|immunologic factors|mesh-ancestor
6674161|NCT01567618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674162|NCT01567657|Midazolam|midazolam|mesh-list
6674163|NCT01567657|Meperidine|meperidine|mesh-list
6674164|NCT01567657|Propofol|propofol|mesh-list
6674165|NCT01567657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6674166|NCT01567657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6674167|NCT01567657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674168|NCT01567657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6674169|NCT01567657|Anesthetics, General|anesthetics, general|mesh-ancestor
6674170|NCT01567657|Anesthetics|anesthetics|mesh-ancestor
6674171|NCT01567657|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6674172|NCT01567657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6674173|NCT01567657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6674174|NCT01567657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5804316|NCT02709187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5804317|NCT02709187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5804318|NCT02709187|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5804319|NCT02709187|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5804320|NCT02709200|Dexmedetomidine|dexmedetomidine|mesh-list
5804321|NCT02709200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5804322|NCT02709200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5804323|NCT02709200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804324|NCT02709200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5804325|NCT02709200|Analgesics|analgesics|mesh-ancestor
5804326|NCT02709200|Sensory System Agents|sensory system agents|mesh-ancestor
5804327|NCT02709200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5804328|NCT02709200|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5804329|NCT02709200|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5804330|NCT02709200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5804331|NCT02709200|Adrenergic Agents|adrenergic agents|mesh-ancestor
5804332|NCT02709200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5804333|NCT02709200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5804334|NCT02709382|Tazobactam|tazobactam|mesh-list
5804335|NCT02709382|Cefepime|cefepime|mesh-list
5804336|NCT02709382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5804337|NCT02709382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5804338|NCT02709382|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5804339|NCT02709382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5804340|NCT02709382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5804341|NCT02709525|Hyaluronic Acid|hyaluronic acid|mesh-list
5804342|NCT02709525|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5804343|NCT02709525|Immunologic Factors|immunologic factors|mesh-ancestor
5804344|NCT02709525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804345|NCT02709525|Viscosupplements|viscosupplements|mesh-ancestor
5804346|NCT02709525|Protective Agents|protective agents|mesh-ancestor
5804347|NCT02708992|Azithromycin|azithromycin|mesh-list
5804348|NCT02708992|Cefixime|cefixime|mesh-list
5804349|NCT02708992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5804350|NCT02708992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5804351|NCT02709031|Cicletanine|cicletanine|mesh-list
5804352|NCT02709031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5804353|NCT02709031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5804354|NCT02709031|Diuretics|diuretics|mesh-ancestor
5804355|NCT02709031|Natriuretic Agents|natriuretic agents|mesh-ancestor
5804356|NCT02709031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804357|NCT02708836|Anesthetics|anesthetics|mesh-list
5804358|NCT02708836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5804359|NCT02708836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804360|NCT02708628|Heparin|heparin|mesh-list
5804361|NCT02708628|Allantoin|allantoin|mesh-list
5804362|NCT02708628|Anticoagulants|anticoagulants|mesh-ancestor
5804363|NCT02708628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5804364|NCT02708628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5804365|NCT02708628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5804366|NCT02708628|Dermatologic Agents|dermatologic agents|mesh-ancestor
5804367|NCT02708693|Triamcinolone|triamcinolone|mesh-list
5804368|NCT02708693|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5804369|NCT02708693|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5804370|NCT02708693|Lidocaine|lidocaine|mesh-list
5804371|NCT02708693|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5804372|NCT02708693|Anesthetics, Local|anesthetics, local|mesh-ancestor
5804373|NCT02708693|Anesthetics|anesthetics|mesh-ancestor
5804374|NCT02708693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5804375|NCT02708693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804376|NCT02708693|Sensory System Agents|sensory system agents|mesh-ancestor
5804377|NCT02708693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5804378|NCT02708693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5804379|NCT02708693|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5804380|NCT02708693|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5804381|NCT02708693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5804382|NCT02708693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5804383|NCT02708693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5804384|NCT02708693|Glucocorticoids|glucocorticoids|mesh-ancestor
5804385|NCT02708693|Hormones|hormones|mesh-ancestor
5804386|NCT02708693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5804387|NCT02708693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5804388|NCT02708693|Immunologic Factors|immunologic factors|mesh-ancestor
5804389|NCT02708693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5804390|NCT02708706|Hyaluronic Acid|hyaluronic acid|mesh-list
5804391|NCT02708706|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5804392|NCT02708706|Immunologic Factors|immunologic factors|mesh-ancestor
5804393|NCT02708706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804394|NCT02708706|Viscosupplements|viscosupplements|mesh-ancestor
5804395|NCT02708706|Protective Agents|protective agents|mesh-ancestor
5804396|NCT02708680|Atezolizumab|atezolizumab|mesh-list
5804397|NCT02708680|Entinostat|entinostat|mesh-list
5804398|NCT02708680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5804399|NCT02708680|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5804400|NCT02708680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5804401|NCT02708680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5804402|NCT02708511|Copper|copper|mesh-list
5804403|NCT02708511|Trace Elements|trace elements|mesh-ancestor
5804404|NCT02708511|Micronutrients|micronutrients|mesh-ancestor
5804405|NCT02708511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804406|NCT02708394|Olanzapine|olanzapine|mesh-list
5804407|NCT02708394|Antiemetics|antiemetics|mesh-ancestor
5804408|NCT02708394|Autonomic Agents|autonomic agents|mesh-ancestor
5804409|NCT02708394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5804410|NCT02708394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804411|NCT02708394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5804412|NCT02708394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5804413|NCT02708394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5804414|NCT02708394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5804415|NCT02708394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5804416|NCT02708394|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5804417|NCT02708394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5804418|NCT02708394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5804419|NCT02708394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5804420|NCT02708394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5804421|NCT02708394|Serotonin Agents|serotonin agents|mesh-ancestor
5804422|NCT02708160|Fluorides|fluorides|mesh-list
5804423|NCT02708160|Cariostatic Agents|cariostatic agents|mesh-ancestor
5804424|NCT02708160|Protective Agents|protective agents|mesh-ancestor
5804425|NCT02708160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804426|NCT02708446|Misoprostol|misoprostol|mesh-list
5804427|NCT02708446|Mifepristone|mifepristone|mesh-list
5804428|NCT02708446|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5804429|NCT02708446|Abortifacient Agents|abortifacient agents|mesh-ancestor
5804430|NCT02708446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5804431|NCT02708446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804432|NCT02708446|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5804433|NCT02708446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5804434|NCT02708446|Oxytocics|oxytocics|mesh-ancestor
5804435|NCT02708446|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5804436|NCT02708446|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5804437|NCT02708446|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5804438|NCT02708446|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5804439|NCT02708446|Contraceptive Agents|contraceptive agents|mesh-ancestor
5804440|NCT02708446|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5804441|NCT02708446|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5804442|NCT02708446|Hormone Antagonists|hormone antagonists|mesh-ancestor
5804443|NCT02708446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5804444|NCT02708446|Luteolytic Agents|luteolytic agents|mesh-ancestor
5804445|NCT02708446|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5804446|NCT02708446|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5804447|NCT02708251|Lidocaine|lidocaine|mesh-list
5804448|NCT02708251|Nitroglycerin|nitroglycerin|mesh-list
5804449|NCT02708251|Anesthetics, Local|anesthetics, local|mesh-ancestor
5804450|NCT02708251|Anesthetics|anesthetics|mesh-ancestor
5804451|NCT02708251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5804452|NCT02708251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804453|NCT02708251|Sensory System Agents|sensory system agents|mesh-ancestor
5804454|NCT02708251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5804455|NCT02708251|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5804456|NCT02708251|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5804457|NCT02708251|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5804458|NCT02708251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5804459|NCT02708251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5804460|NCT02708251|Vasodilator Agents|vasodilator agents|mesh-ancestor
5804461|NCT02708459|Morphine|morphine|mesh-list
5804462|NCT02708459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5804463|NCT02708459|Narcotics|narcotics|mesh-ancestor
5804464|NCT02708459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5804465|NCT02708459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804466|NCT02708459|Analgesics|analgesics|mesh-ancestor
5804467|NCT02708459|Sensory System Agents|sensory system agents|mesh-ancestor
5804468|NCT02708459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5804469|NCT02708173|Vaccines|vaccines|mesh-list
5804470|NCT02708173|Immunologic Factors|immunologic factors|mesh-ancestor
5804471|NCT02708173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804472|NCT02707809|Dexmedetomidine|dexmedetomidine|mesh-list
5804473|NCT02707809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5804474|NCT02707809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5804475|NCT02707809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804476|NCT02707809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5804477|NCT02707809|Analgesics|analgesics|mesh-ancestor
5804478|NCT02707809|Sensory System Agents|sensory system agents|mesh-ancestor
5804479|NCT02707809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5804480|NCT02707809|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5804481|NCT02707809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5804482|NCT02707809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5804483|NCT02707809|Adrenergic Agents|adrenergic agents|mesh-ancestor
5804484|NCT02707809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5804485|NCT02707809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5804486|NCT02707900|Vorinostat|vorinostat|mesh-list
5804487|NCT02707900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5804488|NCT02707900|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5804489|NCT02707900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5804490|NCT02707900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5804491|NCT02707874|Ropivacaine|ropivacaine|mesh-list
5804492|NCT02707874|Anesthetics, Local|anesthetics, local|mesh-ancestor
5804493|NCT02707874|Anesthetics|anesthetics|mesh-ancestor
5804494|NCT02707874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5804495|NCT02707874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804496|NCT02707874|Sensory System Agents|sensory system agents|mesh-ancestor
5804497|NCT02707874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5804498|NCT02707926|Anti-HIV Agents|anti-hiv agents|mesh-list
5804499|NCT02707926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5804500|NCT02707926|Antiviral Agents|antiviral agents|mesh-ancestor
5804501|NCT02707926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5804502|NCT02707913|Amlodipine|amlodipine|mesh-list
5804503|NCT02707913|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5804504|NCT02707913|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5804505|NCT02707913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5804506|NCT02707913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5804507|NCT02707913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5804508|NCT02707913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804509|NCT02707913|Vasodilator Agents|vasodilator agents|mesh-ancestor
5900334|NCT04909853|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5900335|NCT04909853|Antiviral Agents|antiviral agents|mesh-ancestor
5900336|NCT04909853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5900337|NCT04909853|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5900338|NCT04909853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5900339|NCT04901988|Nivolumab|nivolumab|mesh-list
5900340|NCT04901988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5900341|NCT04901988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5900342|NCT04901988|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5900343|NCT04901988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900344|NCT04880876|Eluxadoline|eluxadoline|mesh-list
5900345|NCT04880876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5900346|NCT04874831|Avelumab|avelumab|mesh-list
5900347|NCT04874831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5900348|NCT04874831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5900349|NCT04869358|Ofatumumab|ofatumumab|mesh-list
5900350|NCT04869358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5900351|NCT04863248|Docetaxel|docetaxel|mesh-list
5900352|NCT04863248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5900353|NCT04863248|Tubulin Modulators|tubulin modulators|mesh-ancestor
5900354|NCT04863248|Antimitotic Agents|antimitotic agents|mesh-ancestor
5900355|NCT04863248|Mitosis Modulators|mitosis modulators|mesh-ancestor
5900356|NCT04863248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900357|NCT04862260|Atorvastatin|atorvastatin|mesh-list
5900358|NCT04862260|Ezetimibe|ezetimibe|mesh-list
5900359|NCT04862260|Evolocumab|evolocumab|mesh-list
5900360|NCT04862260|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6674175|NCT01567657|GABA Modulators|gaba modulators|mesh-ancestor
6674176|NCT01567657|GABA Agents|gaba agents|mesh-ancestor
6674177|NCT01567657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6674178|NCT01567657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674179|NCT01567657|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6674180|NCT01567657|Narcotics|narcotics|mesh-ancestor
6674181|NCT01567657|Analgesics|analgesics|mesh-ancestor
5641631|NCT02452268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641632|NCT02452268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5641633|NCT02415621|Abiraterone Acetate|abiraterone acetate|mesh-list
5641634|NCT02415621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5641635|NCT02415621|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5641636|NCT02415621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5641637|NCT02415621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641638|NCT02415621|Hormone Antagonists|hormone antagonists|mesh-ancestor
5641639|NCT02415621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5641640|NCT02415621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641641|NCT02415621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5641642|NCT02389465|Celecoxib|celecoxib|mesh-list
5900361|NCT04862260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5900362|NCT04862260|Antimetabolites|antimetabolites|mesh-ancestor
6674182|NCT01567657|Sensory System Agents|sensory system agents|mesh-ancestor
5804510|NCT02707666|Pembrolizumab|pembrolizumab|mesh-list
5804511|NCT02707666|Pemetrexed|pemetrexed|mesh-list
5804512|NCT02707666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5804513|NCT02707666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5804514|NCT02707666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5804515|NCT02707666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5804516|NCT02707666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5804517|NCT02707666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5804518|NCT02707653|Misoprostol|misoprostol|mesh-list
5804519|NCT02707653|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5804520|NCT02707653|Abortifacient Agents|abortifacient agents|mesh-ancestor
5804521|NCT02707653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5804522|NCT02707653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804523|NCT02707653|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5804524|NCT02707653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5804525|NCT02707653|Oxytocics|oxytocics|mesh-ancestor
5804526|NCT02707692|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5804527|NCT02707692|Immunologic Factors|immunologic factors|mesh-ancestor
5804528|NCT02707692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804529|NCT02707458|Probucol|probucol|mesh-list
5804530|NCT02707458|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5804531|NCT02707458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5804532|NCT02707458|Antimetabolites|antimetabolites|mesh-ancestor
5804533|NCT02707458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5804534|NCT02707458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5804535|NCT02707458|Antioxidants|antioxidants|mesh-ancestor
5804536|NCT02707458|Protective Agents|protective agents|mesh-ancestor
5804537|NCT02707458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804538|NCT02707484|Thalidomide|thalidomide|mesh-list
5804539|NCT02707484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5804540|NCT02707484|Immunologic Factors|immunologic factors|mesh-ancestor
5804541|NCT02707484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804542|NCT02707484|Leprostatic Agents|leprostatic agents|mesh-ancestor
5804543|NCT02707484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5804544|NCT02707484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5804545|NCT02707484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5804546|NCT02707484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5804547|NCT02707484|Growth Substances|growth substances|mesh-ancestor
5641643|NCT02389465|Dexetimide|dexetimide|mesh-list
5641644|NCT02389465|Citalopram|citalopram|mesh-list
5641645|NCT02389465|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5641646|NCT02389465|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5641647|NCT02389465|Analgesics|analgesics|mesh-ancestor
5641648|NCT02389465|Sensory System Agents|sensory system agents|mesh-ancestor
5641649|NCT02389465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5641650|NCT02389465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641651|NCT02389465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5641652|NCT02389465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5641653|NCT02389465|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5641654|NCT02389465|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5641655|NCT02389465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5641656|NCT02389465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641657|NCT02389465|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5804548|NCT02707484|Growth Inhibitors|growth inhibitors|mesh-ancestor
5804549|NCT02707484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5804550|NCT02707445|Clopidogrel|clopidogrel|mesh-list
5804551|NCT02707445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5804552|NCT02707445|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5804553|NCT02707445|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5804554|NCT02707445|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5804555|NCT02707445|Purinergic Agents|purinergic agents|mesh-ancestor
5804556|NCT02707445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5804557|NCT02707445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5804558|NCT02707445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804559|NCT02707393|Cyclosporine|cyclosporine|mesh-list
5804560|NCT02707393|Mycophenolic Acid|mycophenolic acid|mesh-list
5804561|NCT02707393|Fludarabine|fludarabine|mesh-list
5804562|NCT02707393|Melphalan|melphalan|mesh-list
5804563|NCT02707393|Thiotepa|thiotepa|mesh-list
5804564|NCT02707393|Cyclosporins|cyclosporins|mesh-list
5804565|NCT02707393|Thymoglobulin|thymoglobulin|mesh-list
5804566|NCT02707393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5804567|NCT02707393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5804568|NCT02707393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5804569|NCT02707393|Immunologic Factors|immunologic factors|mesh-ancestor
5804570|NCT02707393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804571|NCT02707393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5804572|NCT02707393|Antifungal Agents|antifungal agents|mesh-ancestor
5804573|NCT02707393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5804574|NCT02707393|Dermatologic Agents|dermatologic agents|mesh-ancestor
5804575|NCT02707393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5804576|NCT02707393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5804577|NCT02707393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5804578|NCT02707393|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5804579|NCT02707393|Antitubercular Agents|antitubercular agents|mesh-ancestor
5804580|NCT02707393|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5804581|NCT02707393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5804582|NCT02707393|Alkylating Agents|alkylating agents|mesh-ancestor
5804583|NCT02707393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5804584|NCT02707588|Pembrolizumab|pembrolizumab|mesh-list
5804585|NCT02707588|Cetuximab|cetuximab|mesh-list
5804586|NCT02707588|Antibodies|antibodies|mesh-list
5804587|NCT02707588|Immunoglobulins|immunoglobulins|mesh-list
5804588|NCT02707588|Immunologic Factors|immunologic factors|mesh-ancestor
5804589|NCT02707588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804590|NCT02707588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5804591|NCT02707588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5804592|NCT02707575|Ranibizumab|ranibizumab|mesh-list
6674183|NCT01567657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6674184|NCT01567670|Naloxone|naloxone|mesh-list
6674185|NCT01567670|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6674186|NCT01567670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674187|NCT01567670|Sensory System Agents|sensory system agents|mesh-ancestor
6674188|NCT01567670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6674189|NCT01567683|Imiquimod|imiquimod|mesh-list
6674190|NCT01567683|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6674191|NCT01567683|Immunologic Factors|immunologic factors|mesh-ancestor
6674192|NCT01567683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674193|NCT01567683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6674194|NCT01567683|Interferon Inducers|interferon inducers|mesh-ancestor
6674195|NCT01567709|Vorinostat|vorinostat|mesh-list
6674196|NCT01567709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6674197|NCT01567709|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6674198|NCT01567709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6674199|NCT01567709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674200|NCT01567735|Simeprevir|simeprevir|mesh-list
5804593|NCT02707575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6674201|NCT01567735|Antiviral Agents|antiviral agents|mesh-ancestor
5804594|NCT02707575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5804595|NCT02707575|Growth Substances|growth substances|mesh-ancestor
5804596|NCT02707575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804597|NCT02707575|Growth Inhibitors|growth inhibitors|mesh-ancestor
5804598|NCT02707575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5804599|NCT02707328|Gemcitabine|gemcitabine|mesh-list
5804600|NCT02707328|Paclitaxel|paclitaxel|mesh-list
5804601|NCT02707328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5804602|NCT02707328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5804603|NCT02707328|Tubulin Modulators|tubulin modulators|mesh-ancestor
5804604|NCT02707328|Antimitotic Agents|antimitotic agents|mesh-ancestor
5804605|NCT02707328|Mitosis Modulators|mitosis modulators|mesh-ancestor
5804606|NCT02707328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5804607|NCT02707328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5804608|NCT02707328|Antimetabolites|antimetabolites|mesh-ancestor
5804609|NCT02707328|Antiviral Agents|antiviral agents|mesh-ancestor
5804610|NCT02707328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5804611|NCT02707328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5804612|NCT02707328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5804613|NCT02707328|Immunologic Factors|immunologic factors|mesh-ancestor
5804614|NCT02707328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804615|NCT02707315|Gemcitabine|gemcitabine|mesh-list
5804616|NCT02707315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5804617|NCT02707315|Antimetabolites|antimetabolites|mesh-ancestor
5804618|NCT02707315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5804619|NCT02707315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5804620|NCT02707315|Antiviral Agents|antiviral agents|mesh-ancestor
5804621|NCT02707315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5804622|NCT02707315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5804623|NCT02707315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5804624|NCT02707315|Immunologic Factors|immunologic factors|mesh-ancestor
5804625|NCT02707315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804626|NCT02706977|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
5804627|NCT02706977|Carbidopa|carbidopa|mesh-list
5804628|NCT02706977|Levodopa|levodopa|mesh-list
5804629|NCT02706977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5804630|NCT02706977|Immunologic Factors|immunologic factors|mesh-ancestor
5804631|NCT02706977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804632|NCT02706977|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5804633|NCT02706977|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5804634|NCT02706977|Dopamine Agonists|dopamine agonists|mesh-ancestor
5804635|NCT02706977|Dopamine Agents|dopamine agents|mesh-ancestor
5804636|NCT02706977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5804637|NCT02706977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5804638|NCT02706977|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5804639|NCT02706977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5804640|NCT02707120|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5804641|NCT02707120|Lubricant Eye Drops|lubricant eye drops|mesh-list
5804642|NCT02707120|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5804643|NCT02707081|Lidocaine|lidocaine|mesh-list
5804644|NCT02707081|Anesthetics, Local|anesthetics, local|mesh-ancestor
5804645|NCT02707081|Anesthetics|anesthetics|mesh-ancestor
5804646|NCT02707081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5804647|NCT02707081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804648|NCT02707081|Sensory System Agents|sensory system agents|mesh-ancestor
5804649|NCT02707081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5804650|NCT02707081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5804651|NCT02707081|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5804652|NCT02707081|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5804653|NCT02707081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5804654|NCT02707081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5804655|NCT02707263|Heparin|heparin|mesh-list
5804656|NCT02707263|Calcium heparin|calcium heparin|mesh-list
5804657|NCT02707263|Anticoagulants|anticoagulants|mesh-ancestor
5804658|NCT02707263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5804659|NCT02707263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5804660|NCT02707263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5804661|NCT02707224|Candesartan|candesartan|mesh-list
5804662|NCT02707224|Candesartan cilexetil|candesartan cilexetil|mesh-list
5804663|NCT02707224|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5804664|NCT02707224|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5804665|NCT02707224|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5804666|NCT02707224|Antimetabolites|antimetabolites|mesh-ancestor
5804667|NCT02707224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5804668|NCT02707224|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6674202|NCT01567735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6674203|NCT01567735|Protease Inhibitors|protease inhibitors|mesh-ancestor
6674204|NCT01567735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5804669|NCT02707224|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5804670|NCT02707224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5804671|NCT02707224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5804672|NCT02707224|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5804673|NCT02707224|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5804674|NCT02707159|Gemcitabine|gemcitabine|mesh-list
5804675|NCT02707159|Paclitaxel|paclitaxel|mesh-list
5804676|NCT02707159|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5804677|NCT02707159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5804678|NCT02707159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5804679|NCT02707159|Tubulin Modulators|tubulin modulators|mesh-ancestor
5804680|NCT02707159|Antimitotic Agents|antimitotic agents|mesh-ancestor
5804681|NCT02707159|Mitosis Modulators|mitosis modulators|mesh-ancestor
5804682|NCT02707159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5804683|NCT02707159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5804684|NCT02707159|Antimetabolites|antimetabolites|mesh-ancestor
5804685|NCT02707159|Antiviral Agents|antiviral agents|mesh-ancestor
5804686|NCT02707159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5804687|NCT02707159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5804688|NCT02707159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5804689|NCT02707159|Immunologic Factors|immunologic factors|mesh-ancestor
5804690|NCT02707159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804691|NCT02707211|Antibodies|antibodies|mesh-list
5804692|NCT02707211|Immunoglobulin M|immunoglobulin m|mesh-list
5804693|NCT02707211|Immunologic Factors|immunologic factors|mesh-ancestor
5804694|NCT02707211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804695|NCT02707250|Meperidine|meperidine|mesh-list
5804696|NCT02707250|Bupivacaine|bupivacaine|mesh-list
5804697|NCT02707250|Anesthetics, Local|anesthetics, local|mesh-ancestor
5804698|NCT02707250|Anesthetics|anesthetics|mesh-ancestor
5804699|NCT02707250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5804700|NCT02707250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804701|NCT02707250|Sensory System Agents|sensory system agents|mesh-ancestor
5804702|NCT02707250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5804703|NCT02707250|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5804704|NCT02707250|Narcotics|narcotics|mesh-ancestor
5804705|NCT02707250|Analgesics|analgesics|mesh-ancestor
5804706|NCT02707250|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5804707|NCT02707094|Immunologic Factors|immunologic factors|mesh-list
5804708|NCT02707094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804709|NCT02707016|Sevoflurane|sevoflurane|mesh-list
5804710|NCT02707016|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5804711|NCT02707016|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5804712|NCT02707016|Anesthetics, General|anesthetics, general|mesh-ancestor
5804713|NCT02707016|Anesthetics|anesthetics|mesh-ancestor
5804714|NCT02707016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5804715|NCT02707016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804716|NCT02706704|Adalimumab|adalimumab|mesh-list
5804717|NCT02706704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5804718|NCT02706704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5804719|NCT02706769|Acetaminophen|acetaminophen|mesh-list
5804720|NCT02706769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5804721|NCT02706769|Analgesics|analgesics|mesh-ancestor
5804722|NCT02706769|Sensory System Agents|sensory system agents|mesh-ancestor
5804723|NCT02706769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5804724|NCT02706769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804725|NCT02706769|Antipyretics|antipyretics|mesh-ancestor
5804726|NCT02706678|Tacrolimus|tacrolimus|mesh-list
5804727|NCT02706678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5804728|NCT02706678|Immunologic Factors|immunologic factors|mesh-ancestor
5804729|NCT02706678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804730|NCT02706678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5804731|NCT02706678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5908210|NCT04803201|Mitosis Modulators|mitosis modulators|mesh-ancestor
5804732|NCT02706678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5804733|NCT02706860|Atorvastatin|atorvastatin|mesh-list
5804734|NCT02706860|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5804735|NCT02706860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5804736|NCT02706860|Antimetabolites|antimetabolites|mesh-ancestor
5804737|NCT02706860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5804738|NCT02706860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5804739|NCT02706860|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5804740|NCT02706860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5804741|NCT02706470|Cyclosporine|cyclosporine|mesh-list
5804742|NCT02706470|Cyclosporins|cyclosporins|mesh-list
5804743|NCT02706470|Dydrogesterone|dydrogesterone|mesh-list
5804744|NCT02706470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5804745|NCT02706470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5804746|NCT02706470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5804747|NCT02706470|Immunologic Factors|immunologic factors|mesh-ancestor
5804748|NCT02706470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804749|NCT02706470|Antifungal Agents|antifungal agents|mesh-ancestor
5804750|NCT02706470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5804751|NCT02706470|Dermatologic Agents|dermatologic agents|mesh-ancestor
5804752|NCT02706470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5804753|NCT02706470|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5804754|NCT02706470|Progestins|progestins|mesh-ancestor
5804755|NCT02706470|Hormones|hormones|mesh-ancestor
5804756|NCT02706470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5804757|NCT02706535|Itraconazole|itraconazole|mesh-list
5804758|NCT02706535|Rifampin|rifampin|mesh-list
5804759|NCT02706535|Antifungal Agents|antifungal agents|mesh-ancestor
5804760|NCT02706535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5804761|NCT02706535|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5804762|NCT02706535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5804763|NCT02706535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5804764|NCT02706535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5804765|NCT02706535|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5804766|NCT02706535|Hormone Antagonists|hormone antagonists|mesh-ancestor
5804767|NCT02706535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5804768|NCT02706535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804769|NCT02706535|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5804770|NCT02706535|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5804771|NCT02706535|Antitubercular Agents|antitubercular agents|mesh-ancestor
5804772|NCT02706535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5804773|NCT02706535|Leprostatic Agents|leprostatic agents|mesh-ancestor
5804774|NCT02706535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5804775|NCT02706535|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5804776|NCT02706535|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5804777|NCT02706535|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5804778|NCT02706535|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5804779|NCT02706535|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5804780|NCT02706535|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6492014|NCT00606242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492015|NCT00606242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6492016|NCT00606242|Respiratory System Agents|respiratory system agents|mesh-ancestor
6492017|NCT00606242|Dermatologic Agents|dermatologic agents|mesh-ancestor
6492018|NCT00606242|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6492019|NCT00606268|Micafungin|micafungin|mesh-list
6492020|NCT00606268|Antifungal Agents|antifungal agents|mesh-ancestor
6492021|NCT00606268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5804781|NCT02706509|Tramadol|tramadol|mesh-list
5804782|NCT02706509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6492022|NCT00606333|Sirolimus|sirolimus|mesh-list
6492023|NCT00606333|Paclitaxel|paclitaxel|mesh-list
6492024|NCT00606333|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6496433|NCT00627965|Urological Agents|urological agents|mesh-ancestor
5804783|NCT02706509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804784|NCT02706509|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5804785|NCT02706509|Narcotics|narcotics|mesh-ancestor
5804786|NCT02706509|Analgesics|analgesics|mesh-ancestor
5804787|NCT02706509|Sensory System Agents|sensory system agents|mesh-ancestor
5804788|NCT02706509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5804789|NCT02706353|Pembrolizumab|pembrolizumab|mesh-list
5804790|NCT02706353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5804791|NCT02706353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5804792|NCT02706236|Pancrelipase|pancrelipase|mesh-list
5804793|NCT02706236|Pancreatin|pancreatin|mesh-list
5804794|NCT02706236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5804795|NCT02706405|Cyclophosphamide|cyclophosphamide|mesh-list
5804796|NCT02706405|Fludarabine|fludarabine|mesh-list
5804797|NCT02706405|Durvalumab|durvalumab|mesh-list
5804798|NCT02706405|Immunoglobulins|immunoglobulins|mesh-list
5804799|NCT02706405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5804800|NCT02706405|Immunoglobulin G|immunoglobulin g|mesh-list
5804801|NCT02706405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5804802|NCT02706405|Immunologic Factors|immunologic factors|mesh-ancestor
5804803|NCT02706405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804804|NCT02706405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5804805|NCT02706405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5804806|NCT02706405|Alkylating Agents|alkylating agents|mesh-ancestor
5804807|NCT02706405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5804808|NCT02706405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5804809|NCT02706405|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5804810|NCT02706405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5804811|NCT02706158|Vitamin D|vitamin d|mesh-list
6674205|NCT01567735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674206|NCT01567774|Atorvastatin|atorvastatin|mesh-list
5804812|NCT02706158|Calcium|calcium|mesh-list
5804813|NCT02706158|Vitamins|vitamins|mesh-ancestor
5804814|NCT02706158|Micronutrients|micronutrients|mesh-ancestor
5804815|NCT02706158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804816|NCT02706158|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5804817|NCT02706158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5804818|NCT02706119|Insulin|insulin|mesh-list
5804819|NCT02706119|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5804820|NCT02706119|Insulin Glargine|insulin glargine|mesh-list
5804821|NCT02706119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5804822|NCT02706119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804823|NCT02705859|Trastuzumab|trastuzumab|mesh-list
5804824|NCT02705859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5804825|NCT02705859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5804826|NCT02705950|Baclofen|baclofen|mesh-list
5804827|NCT02705950|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5804828|NCT02705950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804829|NCT02705950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5804830|NCT02705950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5804831|NCT02705950|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
5804832|NCT02705950|GABA Agonists|gaba agonists|mesh-ancestor
5804833|NCT02705950|GABA Agents|gaba agents|mesh-ancestor
5804834|NCT02705950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5804835|NCT02705950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900363|NCT04862260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900364|NCT04862260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5900365|NCT04862260|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5900366|NCT04862260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5908211|NCT04803201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5908212|NCT04803201|Antimetabolites|antimetabolites|mesh-ancestor
5908213|NCT04799015|Dexamethasone|dexamethasone|mesh-list
5908214|NCT04799015|Metoclopramide|metoclopramide|mesh-list
5908215|NCT04799015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5908216|NCT04799015|Antiemetics|antiemetics|mesh-ancestor
5908217|NCT04799015|Autonomic Agents|autonomic agents|mesh-ancestor
5908218|NCT04799015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5908219|NCT04799015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5908220|NCT04799015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5908221|NCT04799015|Glucocorticoids|glucocorticoids|mesh-ancestor
6211098|NCT02168491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5908222|NCT04799015|Hormones|hormones|mesh-ancestor
6496434|NCT00627991|Valsartan|valsartan|mesh-list
5804836|NCT02705872|Sufentanil|sufentanil|mesh-list
5804837|NCT02705872|Dsuvia|dsuvia|mesh-list
5804838|NCT02705872|Levobupivacaine|levobupivacaine|mesh-list
5804839|NCT02705872|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5804840|NCT02705872|Narcotics|narcotics|mesh-ancestor
5804841|NCT02705872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5804842|NCT02705872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804843|NCT02705872|Analgesics|analgesics|mesh-ancestor
5804844|NCT02705872|Sensory System Agents|sensory system agents|mesh-ancestor
5804845|NCT02705872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5804846|NCT02705872|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5804847|NCT02705872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5804848|NCT02705872|Anesthetics, General|anesthetics, general|mesh-ancestor
5804849|NCT02705872|Anesthetics|anesthetics|mesh-ancestor
5804850|NCT02705872|Anesthetics, Local|anesthetics, local|mesh-ancestor
5804851|NCT02706054|Meloxicam|meloxicam|mesh-list
5804852|NCT02706054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5804853|NCT02706054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5804854|NCT02706054|Analgesics|analgesics|mesh-ancestor
5804855|NCT02706054|Sensory System Agents|sensory system agents|mesh-ancestor
5804856|NCT02706054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5804857|NCT02706054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804858|NCT02706054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5804859|NCT02706054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5804860|NCT02706054|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5804861|NCT02706054|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5804862|NCT02706054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5804863|NCT02706054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5804864|NCT02706015|Dipyrone|dipyrone|mesh-list
5804865|NCT02706015|Dihydroergotamine|dihydroergotamine|mesh-list
5804866|NCT02706015|Caffeine|caffeine|mesh-list
5804867|NCT02706015|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5804868|NCT02706015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804869|NCT02706015|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5804870|NCT02706015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5804871|NCT02706015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5804872|NCT02706015|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5804873|NCT02706015|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5804874|NCT02706015|Purinergic Agents|purinergic agents|mesh-ancestor
5804875|NCT02706015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5804876|NCT02706015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5804877|NCT02706015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5804878|NCT02706015|Analgesics|analgesics|mesh-ancestor
5804879|NCT02706015|Sensory System Agents|sensory system agents|mesh-ancestor
5804880|NCT02706015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5804881|NCT02706015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5804882|NCT02706015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5804883|NCT02706015|Antipyretics|antipyretics|mesh-ancestor
5804884|NCT02706015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5804885|NCT02706015|Dopamine Agonists|dopamine agonists|mesh-ancestor
5804886|NCT02706015|Dopamine Agents|dopamine agents|mesh-ancestor
5804887|NCT02705976|Warfarin|warfarin|mesh-list
5804888|NCT02705976|Anticoagulants|anticoagulants|mesh-ancestor
5804889|NCT02705820|Pembrolizumab|pembrolizumab|mesh-list
5804890|NCT02705820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5804891|NCT02705820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5804892|NCT02705989|Branebrutinib|branebrutinib|mesh-list
5804893|NCT02705989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5804894|NCT02705989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5804895|NCT02705989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5804896|NCT02706067|Orlistat|orlistat|mesh-list
5804897|NCT02706067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5804898|NCT02706067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5804899|NCT02706067|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5804900|NCT02706067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5804901|NCT02705768|Carbamazepine|carbamazepine|mesh-list
5804902|NCT02705768|Oxcarbazepine|oxcarbazepine|mesh-list
5804903|NCT02705768|Anticonvulsants|anticonvulsants|mesh-ancestor
5804904|NCT02705768|Antimanic Agents|antimanic agents|mesh-ancestor
5804905|NCT02705768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5804906|NCT02705768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5804907|NCT02705768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804908|NCT02705768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5804909|NCT02705768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5804910|NCT02705768|Analgesics|analgesics|mesh-ancestor
5804911|NCT02705768|Sensory System Agents|sensory system agents|mesh-ancestor
5804912|NCT02705768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5804913|NCT02705768|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5804914|NCT02705768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5804915|NCT02705768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5804916|NCT02705768|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5804917|NCT02705768|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5804918|NCT02705768|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5804919|NCT02705729|Methamphetamine|methamphetamine|mesh-list
5804920|NCT02705729|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5804921|NCT02705729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804922|NCT02705729|Sympathomimetics|sympathomimetics|mesh-ancestor
5804923|NCT02705729|Autonomic Agents|autonomic agents|mesh-ancestor
5804924|NCT02705729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5804925|NCT02705729|Dopamine Agents|dopamine agents|mesh-ancestor
5804926|NCT02705729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5804927|NCT02705729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5804928|NCT02705729|Adrenergic Agents|adrenergic agents|mesh-ancestor
5804929|NCT02705729|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5804930|NCT02705729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5804931|NCT02705729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5804932|NCT02705729|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5804933|NCT02705534|Ribavirin|ribavirin|mesh-list
5804934|NCT02705534|Sofosbuvir|sofosbuvir|mesh-list
5804935|NCT02705534|Ledipasvir|ledipasvir|mesh-list
5804936|NCT02705534|Antimetabolites|antimetabolites|mesh-ancestor
5804937|NCT02705534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5804938|NCT02705534|Antiviral Agents|antiviral agents|mesh-ancestor
5804939|NCT02705534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5804940|NCT02705547|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5804941|NCT02705547|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5804942|NCT02705547|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5804943|NCT02705547|Antimetabolites|antimetabolites|mesh-ancestor
5804944|NCT02705547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5804945|NCT02705547|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5804946|NCT02705547|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5804947|NCT02705547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5804948|NCT02705573|Mannitol|mannitol|mesh-list
5804949|NCT02705573|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5804950|NCT02705573|Diuretics|diuretics|mesh-ancestor
5804951|NCT02705573|Natriuretic Agents|natriuretic agents|mesh-ancestor
5804952|NCT02705573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804953|NCT02705508|Gemcitabine|gemcitabine|mesh-list
5804954|NCT02705508|Etoposide|etoposide|mesh-list
5804955|NCT02705508|Etoposide phosphate|etoposide phosphate|mesh-list
5804956|NCT02705508|Pegaspargase|pegaspargase|mesh-list
5804957|NCT02705508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5804958|NCT02705508|Antimetabolites|antimetabolites|mesh-ancestor
5804959|NCT02705508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5804960|NCT02705508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5804961|NCT02705508|Antiviral Agents|antiviral agents|mesh-ancestor
5804962|NCT02705508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5804963|NCT02705508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5804964|NCT02705508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5804965|NCT02705508|Immunologic Factors|immunologic factors|mesh-ancestor
5804966|NCT02705508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804967|NCT02705508|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5804968|NCT02705508|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5804969|NCT02705508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5804970|NCT02705482|Durvalumab|durvalumab|mesh-list
5804971|NCT02705482|Tremelimumab|tremelimumab|mesh-list
5804972|NCT02705482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5804973|NCT02705482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5804974|NCT02705612|Nimotuzumab|nimotuzumab|mesh-list
5804975|NCT02705612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5804976|NCT02705612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5804977|NCT02705664|Amorolfine|amorolfine|mesh-list
5804978|NCT02705664|Bifonazole|bifonazole|mesh-list
5804979|NCT02705664|Antifungal Agents|antifungal agents|mesh-ancestor
5804980|NCT02705664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5804981|NCT02705378|Naloxegol|naloxegol|mesh-list
5804982|NCT02705378|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5804983|NCT02705378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804984|NCT02705378|Sensory System Agents|sensory system agents|mesh-ancestor
5804985|NCT02705378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5804986|NCT02705638|Rituximab|rituximab|mesh-list
5804987|NCT02705638|Lenalidomide|lenalidomide|mesh-list
5804988|NCT02705638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5804989|NCT02705638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5804990|NCT02705638|Immunologic Factors|immunologic factors|mesh-ancestor
5804991|NCT02705638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804992|NCT02705638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5804993|NCT02705638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5804994|NCT02705638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6674207|NCT01567774|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6674208|NCT01567774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6674209|NCT01567774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6674210|NCT01567774|Antimetabolites|antimetabolites|mesh-ancestor
6674211|NCT01567774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674212|NCT01567774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6674213|NCT01567774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6674214|NCT01567774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6674215|NCT01567800|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
6674216|NCT01567800|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6674217|NCT01567800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674218|NCT01567930|Sirolimus|sirolimus|mesh-list
6674219|NCT01567930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6674220|NCT01567930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6674221|NCT01567930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6674222|NCT01567930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6674223|NCT01567930|Antifungal Agents|antifungal agents|mesh-ancestor
6674224|NCT01567930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6674225|NCT01567930|Immunologic Factors|immunologic factors|mesh-ancestor
6674226|NCT01567930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5804995|NCT02705638|Growth Substances|growth substances|mesh-ancestor
5804996|NCT02705638|Growth Inhibitors|growth inhibitors|mesh-ancestor
5804997|NCT02705651|Somatostatin|somatostatin|mesh-list
5804998|NCT02705651|Hormones|hormones|mesh-ancestor
5804999|NCT02705651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5805000|NCT02705651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805001|NCT02705287|Vitamin D|vitamin d|mesh-list
5805002|NCT02705287|Ergocalciferols|ergocalciferols|mesh-list
5805003|NCT02705287|Vitamins|vitamins|mesh-list
5805004|NCT02705287|Micronutrients|micronutrients|mesh-ancestor
5805005|NCT02705287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805006|NCT02705287|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5805007|NCT02705287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5805008|NCT02705313|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
5805009|NCT02705313|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5805010|NCT02705313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805011|NCT02705066|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
5805012|NCT02705066|Nootropic Agents|nootropic agents|mesh-ancestor
5805013|NCT02705053|Insulin|insulin|mesh-list
5805014|NCT02705053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5805015|NCT02705053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805016|NCT02705274|Bevacizumab|bevacizumab|mesh-list
5805017|NCT02705274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5805018|NCT02705274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5805019|NCT02705274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5805020|NCT02705274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5805021|NCT02705274|Growth Substances|growth substances|mesh-ancestor
5805022|NCT02705274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805023|NCT02705274|Growth Inhibitors|growth inhibitors|mesh-ancestor
5805024|NCT02705196|Gemcitabine|gemcitabine|mesh-list
5805025|NCT02705196|Paclitaxel|paclitaxel|mesh-list
5805026|NCT02705196|Atezolizumab|atezolizumab|mesh-list
5805027|NCT02705196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5805028|NCT02705196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5805029|NCT02705196|Tubulin Modulators|tubulin modulators|mesh-ancestor
5805030|NCT02705196|Antimitotic Agents|antimitotic agents|mesh-ancestor
5805031|NCT02705196|Mitosis Modulators|mitosis modulators|mesh-ancestor
5805032|NCT02705196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805033|NCT02705196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5805034|NCT02705196|Antimetabolites|antimetabolites|mesh-ancestor
5805035|NCT02705196|Antiviral Agents|antiviral agents|mesh-ancestor
5805036|NCT02705196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5805037|NCT02705196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5805038|NCT02705196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5805039|NCT02705196|Immunologic Factors|immunologic factors|mesh-ancestor
5805040|NCT02705196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805041|NCT02704988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5805042|NCT02705014|Hormones|hormones|mesh-list
5805043|NCT02705014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5805044|NCT02705014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805045|NCT02704962|Olanzapine|olanzapine|mesh-list
5805046|NCT02704962|Antiemetics|antiemetics|mesh-ancestor
5805047|NCT02704962|Autonomic Agents|autonomic agents|mesh-ancestor
5805048|NCT02704962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5805049|NCT02704962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805050|NCT02704962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5805051|NCT02704962|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5805052|NCT02704962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5805053|NCT02704962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5805054|NCT02704962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5805055|NCT02704962|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5805056|NCT02704962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5805057|NCT02704962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5805058|NCT02704962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805059|NCT02704962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5805060|NCT02704962|Serotonin Agents|serotonin agents|mesh-ancestor
5805061|NCT02704715|Anesthetics|anesthetics|mesh-list
5805062|NCT02704715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5805063|NCT02704715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805064|NCT02704624|Vitamin D|vitamin d|mesh-list
5805065|NCT02704624|Vitamins|vitamins|mesh-ancestor
5805066|NCT02704624|Micronutrients|micronutrients|mesh-ancestor
5805067|NCT02704624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805068|NCT02704624|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5805069|NCT02704754|Suvorexant|suvorexant|mesh-list
5805070|NCT02704754|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5805071|NCT02704754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5805072|NCT02704754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5805073|NCT02704754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805074|NCT02704754|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
6492025|NCT00606333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6492026|NCT00606333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6492027|NCT00606333|Tubulin Modulators|tubulin modulators|mesh-ancestor
6492028|NCT00606333|Antimitotic Agents|antimitotic agents|mesh-ancestor
6492029|NCT00606333|Mitosis Modulators|mitosis modulators|mesh-ancestor
6492030|NCT00606333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492031|NCT00606333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6492032|NCT00606333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6492033|NCT00606333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6492034|NCT00606333|Antifungal Agents|antifungal agents|mesh-ancestor
6492035|NCT00606333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6492036|NCT00606333|Immunologic Factors|immunologic factors|mesh-ancestor
6492037|NCT00606333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492038|NCT00606411|Topiramate|topiramate|mesh-list
6492039|NCT00606411|Anticonvulsants|anticonvulsants|mesh-ancestor
6492040|NCT00606411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6492041|NCT00606411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492042|NCT00606437|Fludarabine|fludarabine|mesh-list
6492043|NCT00606437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5641658|NCT02389465|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5641659|NCT02389465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5641660|NCT02389465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5641661|NCT02389465|Serotonin Agents|serotonin agents|mesh-ancestor
5641662|NCT02389465|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5641663|NCT02389465|Antidepressive Agents|antidepressive agents|mesh-ancestor
5641664|NCT02389465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5641665|NCT02389465|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5641666|NCT02389465|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5641667|NCT02389465|Parasympatholytics|parasympatholytics|mesh-ancestor
5641668|NCT02389465|Autonomic Agents|autonomic agents|mesh-ancestor
5641669|NCT02389465|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5641670|NCT02389465|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5641671|NCT02389465|Cholinergic Agents|cholinergic agents|mesh-ancestor
5641672|NCT02367456|Azacitidine|azacitidine|mesh-list
5641673|NCT02367456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5641674|NCT02367456|Antimetabolites|antimetabolites|mesh-ancestor
5641675|NCT02367456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641676|NCT02367456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5641677|NCT02367456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5641678|NCT02335060|Acetylcysteine|acetylcysteine|mesh-list
5641679|NCT02335060|Dronabinol|dronabinol|mesh-list
5641680|NCT02335060|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5641681|NCT02335060|Antiviral Agents|antiviral agents|mesh-ancestor
5641682|NCT02335060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5641683|NCT02335060|Expectorants|expectorants|mesh-ancestor
5805075|NCT02704754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5805076|NCT02704754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805077|NCT02704923|Atropine|atropine|mesh-list
5805078|NCT02704923|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5805079|NCT02704923|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5805080|NCT02704923|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5805081|NCT02704923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5805082|NCT02704923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5805083|NCT02704923|Autonomic Agents|autonomic agents|mesh-ancestor
5805084|NCT02704923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5805085|NCT02704923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805086|NCT02704923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5805087|NCT02704923|Respiratory System Agents|respiratory system agents|mesh-ancestor
5805088|NCT02704923|Mydriatics|mydriatics|mesh-ancestor
5805089|NCT02704923|Parasympatholytics|parasympatholytics|mesh-ancestor
5805090|NCT02704923|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5805091|NCT02704923|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5805092|NCT02704923|Cholinergic Agents|cholinergic agents|mesh-ancestor
5805093|NCT02704923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5805094|NCT02704923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805095|NCT02704598|Warfarin|warfarin|mesh-list
5805096|NCT02704598|Rivaroxaban|rivaroxaban|mesh-list
5805097|NCT02704598|Anticoagulants|anticoagulants|mesh-ancestor
5805098|NCT02704598|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5805099|NCT02704598|Antithrombins|antithrombins|mesh-ancestor
5805100|NCT02704598|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5805101|NCT02704598|Protease Inhibitors|protease inhibitors|mesh-ancestor
5805102|NCT02704598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5805103|NCT02704598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805104|NCT02704767|Apatinib|apatinib|mesh-list
5805105|NCT02704767|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5805106|NCT02704767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5805107|NCT02704767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5805108|NCT02704767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5805109|NCT02704767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805110|NCT02704780|Misoprostol|misoprostol|mesh-list
5805111|NCT02704780|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5805112|NCT02704780|Abortifacient Agents|abortifacient agents|mesh-ancestor
5805113|NCT02704780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5805114|NCT02704780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805115|NCT02704780|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5805116|NCT02704780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5805117|NCT02704780|Oxytocics|oxytocics|mesh-ancestor
5805118|NCT02704546|Methylphenidate|methylphenidate|mesh-list
5805119|NCT02704546|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5805120|NCT02704546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805121|NCT02704546|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5805122|NCT02704546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5805123|NCT02704546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5805124|NCT02704546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805125|NCT02704546|Dopamine Agents|dopamine agents|mesh-ancestor
5805126|NCT02704546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5900367|NCT04846218|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5900368|NCT04846218|Progesterone|progesterone|mesh-list
5900369|NCT04846218|Progestins|progestins|mesh-ancestor
5900370|NCT04846218|Hormones|hormones|mesh-ancestor
5900371|NCT04846218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5805127|NCT02704481|Misoprostol|misoprostol|mesh-list
5805128|NCT02704481|Mifepristone|mifepristone|mesh-list
5805129|NCT02704481|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5805130|NCT02704481|Abortifacient Agents|abortifacient agents|mesh-ancestor
5805131|NCT02704481|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5805132|NCT02704481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805133|NCT02704481|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5805134|NCT02704481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5805135|NCT02704481|Oxytocics|oxytocics|mesh-ancestor
5805136|NCT02704481|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5805137|NCT02704481|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5805138|NCT02704481|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5805139|NCT02704481|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5805140|NCT02704481|Contraceptive Agents|contraceptive agents|mesh-ancestor
5805141|NCT02704481|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5805142|NCT02704481|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5805143|NCT02704481|Hormone Antagonists|hormone antagonists|mesh-ancestor
5805144|NCT02704481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6211099|NCT02168491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211100|NCT02168660|Vitamin D|vitamin d|mesh-list
6211101|NCT02168660|Cholecalciferol|cholecalciferol|mesh-list
6211102|NCT02168660|Vitamins|vitamins|mesh-ancestor
6211103|NCT02168660|Micronutrients|micronutrients|mesh-ancestor
6211104|NCT02168660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211105|NCT02168660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6211106|NCT02168660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6211107|NCT02168803|Evacetrapib|evacetrapib|mesh-list
6211108|NCT02168803|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6211109|NCT02168803|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6211110|NCT02168803|Antimetabolites|antimetabolites|mesh-ancestor
6211111|NCT02168803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211112|NCT02168803|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6211113|NCT02168816|Moxifloxacin|moxifloxacin|mesh-list
6211114|NCT02168816|Metronidazole|metronidazole|mesh-list
6211115|NCT02168816|Vancomycin|vancomycin|mesh-list
6211116|NCT02168816|Ciprofloxacin|ciprofloxacin|mesh-list
6211117|NCT02168816|Clindamycin|clindamycin|mesh-list
5805145|NCT02704481|Luteolytic Agents|luteolytic agents|mesh-ancestor
5805146|NCT02704481|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5805147|NCT02704481|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5805148|NCT02704494|Losartan|losartan|mesh-list
5805149|NCT02704494|Resveratrol|resveratrol|mesh-list
5805150|NCT02704494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5805151|NCT02704494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5805152|NCT02704494|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5805153|NCT02704494|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5805154|NCT02704494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805155|NCT02704494|Antioxidants|antioxidants|mesh-ancestor
5805156|NCT02704494|Protective Agents|protective agents|mesh-ancestor
5805157|NCT02704494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805158|NCT02704494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5805159|NCT02704494|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5805160|NCT02704520|Leucovorin|leucovorin|mesh-list
5805161|NCT02704520|Folic Acid|folic acid|mesh-list
5805162|NCT02704520|Fluorouracil|fluorouracil|mesh-list
6211118|NCT02168816|Meropenem|meropenem|mesh-list
5805163|NCT02704520|Capecitabine|capecitabine|mesh-list
6211119|NCT02168816|Tazobactam|tazobactam|mesh-list
6211120|NCT02168816|Linezolid|linezolid|mesh-list
6211121|NCT02168816|Piperacillin|piperacillin|mesh-list
6211122|NCT02168816|Daptomycin|daptomycin|mesh-list
6492044|NCT00606450|Thalidomide|thalidomide|mesh-list
5805164|NCT02704520|Oxaliplatin|oxaliplatin|mesh-list
5805165|NCT02704520|Levoleucovorin|levoleucovorin|mesh-list
5805166|NCT02704520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805167|NCT02704520|Antimetabolites|antimetabolites|mesh-ancestor
5805168|NCT02704520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805169|NCT02704520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5805170|NCT02704520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5805171|NCT02704520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5805172|NCT02704520|Immunologic Factors|immunologic factors|mesh-ancestor
5805173|NCT02704520|Antidotes|antidotes|mesh-ancestor
5805174|NCT02704520|Protective Agents|protective agents|mesh-ancestor
5805175|NCT02704520|Vitamin B Complex|vitamin b complex|mesh-ancestor
5805176|NCT02704520|Vitamins|vitamins|mesh-ancestor
5805177|NCT02704520|Micronutrients|micronutrients|mesh-ancestor
5805178|NCT02704520|Hematinics|hematinics|mesh-ancestor
5805179|NCT02704208|Nicotine|nicotine|mesh-list
5805180|NCT02704208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5805181|NCT02704208|Autonomic Agents|autonomic agents|mesh-ancestor
5805182|NCT02704208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5805183|NCT02704208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805184|NCT02704208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5805185|NCT02704208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6492045|NCT00606450|Apremilast|apremilast|mesh-list
6492046|NCT00606450|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5641684|NCT02335060|Respiratory System Agents|respiratory system agents|mesh-ancestor
5805186|NCT02704208|Cholinergic Agents|cholinergic agents|mesh-ancestor
5805187|NCT02704208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5805188|NCT02704208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805189|NCT02704507|Triamcinolone|triamcinolone|mesh-list
5805190|NCT02704507|Tretinoin|tretinoin|mesh-list
5805191|NCT02704507|Emollients|emollients|mesh-list
5805192|NCT02704507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5805193|NCT02704507|Glucocorticoids|glucocorticoids|mesh-ancestor
5805194|NCT02704507|Hormones|hormones|mesh-ancestor
5641685|NCT02335060|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5805195|NCT02704507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5805196|NCT02704507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805197|NCT02704507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5805198|NCT02704507|Keratolytic Agents|keratolytic agents|mesh-ancestor
5805199|NCT02704507|Dermatologic Agents|dermatologic agents|mesh-ancestor
5805200|NCT02703857|Cefoxitin|cefoxitin|mesh-list
5805201|NCT02703857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5805202|NCT02703857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5805203|NCT02704052|Enoxaparin|enoxaparin|mesh-list
5805204|NCT02704052|Enoxaparin sodium|enoxaparin sodium|mesh-list
5805205|NCT02704052|Anticoagulants|anticoagulants|mesh-ancestor
5805206|NCT02704052|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5805207|NCT02704052|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5805208|NCT02704052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805209|NCT02703896|Esomeprazole|esomeprazole|mesh-list
5805210|NCT02703896|Omeprazole|omeprazole|mesh-list
5805211|NCT02703896|Pantoprazole|pantoprazole|mesh-list
5805212|NCT02703896|Lansoprazole|lansoprazole|mesh-list
5805213|NCT02703896|Famotidine|famotidine|mesh-list
5805214|NCT02703896|Ranitidine|ranitidine|mesh-list
5805215|NCT02703896|Cimetidine|cimetidine|mesh-list
5805216|NCT02703896|Nizatidine|nizatidine|mesh-list
5805217|NCT02703896|Lafutidine|lafutidine|mesh-list
5641686|NCT02335060|Antioxidants|antioxidants|mesh-ancestor
5641687|NCT02335060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641688|NCT02335060|Protective Agents|protective agents|mesh-ancestor
5641689|NCT02335060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641690|NCT02335060|Antidotes|antidotes|mesh-ancestor
5805218|NCT02703896|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5805219|NCT02703896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6211123|NCT02168816|Cefepime|cefepime|mesh-list
5805220|NCT02703896|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5805221|NCT02703896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5805222|NCT02703896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805223|NCT02703896|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5805224|NCT02703896|Histamine Antagonists|histamine antagonists|mesh-ancestor
5805225|NCT02703896|Histamine Agents|histamine agents|mesh-ancestor
5805226|NCT02703896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5805227|NCT02703896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805228|NCT02703896|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5805229|NCT02703896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5805230|NCT02704013|Oxybutynin|oxybutynin|mesh-list
5805231|NCT02704013|Parasympatholytics|parasympatholytics|mesh-ancestor
5805232|NCT02704013|Autonomic Agents|autonomic agents|mesh-ancestor
5805233|NCT02704013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5805234|NCT02704013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805235|NCT02704013|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5805236|NCT02704013|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5805237|NCT02704013|Cholinergic Agents|cholinergic agents|mesh-ancestor
5805238|NCT02704013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5805239|NCT02704013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805240|NCT02704013|Urological Agents|urological agents|mesh-ancestor
5805241|NCT02703961|Cisplatin|cisplatin|mesh-list
5805242|NCT02703961|Docetaxel|docetaxel|mesh-list
5805243|NCT02703961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5805244|NCT02703961|Tubulin Modulators|tubulin modulators|mesh-ancestor
5805245|NCT02703961|Antimitotic Agents|antimitotic agents|mesh-ancestor
5805246|NCT02703961|Mitosis Modulators|mitosis modulators|mesh-ancestor
5805247|NCT02703961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805248|NCT02703649|Letrozole|letrozole|mesh-list
5805249|NCT02703649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5805250|NCT02703649|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5805251|NCT02703649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5805252|NCT02703649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5805253|NCT02703649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805254|NCT02703649|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5805255|NCT02703649|Hormone Antagonists|hormone antagonists|mesh-ancestor
5805256|NCT02703649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5805257|NCT02703649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805258|NCT02703584|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5805259|NCT02703584|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5805260|NCT02703584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805261|NCT02703571|Trametinib|trametinib|mesh-list
5805262|NCT02703571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5641691|NCT02335060|Hallucinogens|hallucinogens|mesh-ancestor
5641692|NCT02335060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5641693|NCT02335060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5641694|NCT02335060|Analgesics|analgesics|mesh-ancestor
5641695|NCT02335060|Sensory System Agents|sensory system agents|mesh-ancestor
5641696|NCT02335060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5641697|NCT02335060|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5641698|NCT02335060|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5641699|NCT02335060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5641700|NCT02335060|Hormones|hormones|mesh-ancestor
5641701|NCT02335060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5641702|NCT02297438|Letrozole|letrozole|mesh-list
5641703|NCT02297438|Palbociclib|palbociclib|mesh-list
5641704|NCT02297438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5641705|NCT02297438|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5641706|NCT02297438|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5641707|NCT02297438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5641708|NCT02297438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805263|NCT02703571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5805264|NCT02703571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5641709|NCT02297438|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5641710|NCT02297438|Hormone Antagonists|hormone antagonists|mesh-ancestor
5641711|NCT02297438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5641712|NCT02297438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641713|NCT02297438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5641714|NCT02297412|Minocycline|minocycline|mesh-list
5641715|NCT02297412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5641716|NCT02297412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5641717|NCT02292758|Bevacizumab|bevacizumab|mesh-list
6211124|NCT02168816|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
5805265|NCT02703571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805266|NCT02703740|Lidocaine|lidocaine|mesh-list
5805267|NCT02703740|Hyaluronic Acid|hyaluronic acid|mesh-list
5805268|NCT02703740|Anesthetics, Local|anesthetics, local|mesh-ancestor
5805269|NCT02703740|Anesthetics|anesthetics|mesh-ancestor
6211125|NCT02168816|Aztreonam|aztreonam|mesh-list
6211126|NCT02168816|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6211127|NCT02168816|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6211128|NCT02168816|Trimethoprim|trimethoprim|mesh-list
6211129|NCT02168816|Sulfamethoxazole|sulfamethoxazole|mesh-list
6211130|NCT02168816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6211131|NCT02168816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6211132|NCT02168816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6211133|NCT02168816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6211134|NCT02168816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211135|NCT02168816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6211136|NCT02168816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5805270|NCT02703740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5805271|NCT02703740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805272|NCT02703740|Sensory System Agents|sensory system agents|mesh-ancestor
5805273|NCT02703740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5805274|NCT02703740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5805275|NCT02703740|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5805276|NCT02703740|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5805277|NCT02703740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6211137|NCT02168816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6211138|NCT02168816|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6211139|NCT02168816|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6211140|NCT02168816|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6211141|NCT02168816|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6211142|NCT02168816|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6211143|NCT02168816|Renal Agents|renal agents|mesh-ancestor
5805278|NCT02703740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805279|NCT02703740|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5805280|NCT02703740|Immunologic Factors|immunologic factors|mesh-ancestor
5805281|NCT02703740|Viscosupplements|viscosupplements|mesh-ancestor
5805282|NCT02703740|Protective Agents|protective agents|mesh-ancestor
5805283|NCT02703363|Minocycline|minocycline|mesh-list
5805284|NCT02703363|Celecoxib|celecoxib|mesh-list
5805285|NCT02703363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5805286|NCT02703363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5805287|NCT02703363|Analgesics|analgesics|mesh-ancestor
5805288|NCT02703363|Sensory System Agents|sensory system agents|mesh-ancestor
5805289|NCT02703363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5805290|NCT02703363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805291|NCT02703363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5805292|NCT02703363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5805293|NCT02703363|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5805294|NCT02703363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5805295|NCT02703363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5805296|NCT02703363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805297|NCT02703363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5805298|NCT02703363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5805299|NCT02703376|Prednisone|prednisone|mesh-list
5805300|NCT02703376|Prednisolone|prednisolone|mesh-list
5805301|NCT02703376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5805302|NCT02703376|Glucocorticoids|glucocorticoids|mesh-ancestor
5805303|NCT02703376|Hormones|hormones|mesh-ancestor
5805304|NCT02703376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5805305|NCT02703376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805306|NCT02703376|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5805307|NCT02703376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5805308|NCT02703610|Acetaminophen|acetaminophen|mesh-list
5805309|NCT02703610|Ibuprofen|ibuprofen|mesh-list
5805310|NCT02703610|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
5805311|NCT02703610|Oxycodone|oxycodone|mesh-list
5805312|NCT02703610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5805313|NCT02703610|Analgesics|analgesics|mesh-ancestor
5805314|NCT02703610|Sensory System Agents|sensory system agents|mesh-ancestor
5805315|NCT02703610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5805316|NCT02703610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805317|NCT02703610|Antipyretics|antipyretics|mesh-ancestor
5805318|NCT02703610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5805319|NCT02703610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5805320|NCT02703610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5805321|NCT02703610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5805322|NCT02703610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5805323|NCT02703610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805324|NCT02703610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5805325|NCT02703610|Narcotics|narcotics|mesh-ancestor
5805326|NCT02703610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5805327|NCT02703415|Tramadol|tramadol|mesh-list
5805328|NCT02703415|Bupivacaine|bupivacaine|mesh-list
5805329|NCT02703415|Anesthetics, Local|anesthetics, local|mesh-ancestor
5805330|NCT02703415|Anesthetics|anesthetics|mesh-ancestor
5805331|NCT02703415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5805332|NCT02703415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805333|NCT02703415|Sensory System Agents|sensory system agents|mesh-ancestor
5805334|NCT02703415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5805335|NCT02703415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5805336|NCT02703415|Narcotics|narcotics|mesh-ancestor
5805337|NCT02703415|Analgesics|analgesics|mesh-ancestor
5805338|NCT02703181|Diketopiperazines|diketopiperazines|mesh-list
5805339|NCT02703181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5805340|NCT02703181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5805341|NCT02703233|Nitrous Oxide|nitrous oxide|mesh-list
5805342|NCT02703233|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5805343|NCT02703233|Anesthetics, General|anesthetics, general|mesh-ancestor
5805344|NCT02703233|Anesthetics|anesthetics|mesh-ancestor
5805345|NCT02703233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5805346|NCT02703233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805347|NCT02703233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5805348|NCT02703233|Analgesics|analgesics|mesh-ancestor
5805349|NCT02703233|Sensory System Agents|sensory system agents|mesh-ancestor
5805350|NCT02703233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5805351|NCT02703272|Dexamethasone|dexamethasone|mesh-list
5805352|NCT02703272|Rituximab|rituximab|mesh-list
5805353|NCT02703272|Carboplatin|carboplatin|mesh-list
5805354|NCT02703272|Etoposide|etoposide|mesh-list
5805355|NCT02703272|Vincristine|vincristine|mesh-list
5805356|NCT02703272|Ifosfamide|ifosfamide|mesh-list
5805357|NCT02703272|Idarubicin|idarubicin|mesh-list
5805358|NCT02703272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5805359|NCT02703272|Antiemetics|antiemetics|mesh-ancestor
5805360|NCT02703272|Autonomic Agents|autonomic agents|mesh-ancestor
5805361|NCT02703272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5805362|NCT02703272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805363|NCT02703272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5805364|NCT02703272|Glucocorticoids|glucocorticoids|mesh-ancestor
5805365|NCT02703272|Hormones|hormones|mesh-ancestor
5805366|NCT02703272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5805367|NCT02703272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5805368|NCT02703272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5805369|NCT02703272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5805370|NCT02703272|Immunologic Factors|immunologic factors|mesh-ancestor
5805371|NCT02703272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5805372|NCT02703272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5805373|NCT02703272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5805374|NCT02703272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5805375|NCT02703272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5805376|NCT02703272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805377|NCT02703272|Tubulin Modulators|tubulin modulators|mesh-ancestor
5805378|NCT02703272|Antimitotic Agents|antimitotic agents|mesh-ancestor
5805379|NCT02703272|Mitosis Modulators|mitosis modulators|mesh-ancestor
5805380|NCT02703272|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5805381|NCT02703272|Alkylating Agents|alkylating agents|mesh-ancestor
5805382|NCT02703272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5805383|NCT02703194|Prednisone|prednisone|mesh-list
5805384|NCT02703194|Prednisolone|prednisolone|mesh-list
5805385|NCT02703194|Leflunomide|leflunomide|mesh-list
5805386|NCT02703194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5805387|NCT02703194|Glucocorticoids|glucocorticoids|mesh-ancestor
5805388|NCT02703194|Hormones|hormones|mesh-ancestor
5805389|NCT02703194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5805390|NCT02703194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805391|NCT02703194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5805392|NCT02703194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5805393|NCT02703194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5805394|NCT02703194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805395|NCT02703194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5805396|NCT02703194|Immunologic Factors|immunologic factors|mesh-ancestor
5805397|NCT02702960|Mycophenolic Acid|mycophenolic acid|mesh-list
5805398|NCT02702960|Prednisone|prednisone|mesh-list
5805399|NCT02702960|Cyclophosphamide|cyclophosphamide|mesh-list
6674227|NCT01567995|Clobetasone butyrate|clobetasone butyrate|mesh-list
6674228|NCT01567995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6674229|NCT01567995|Glucocorticoids|glucocorticoids|mesh-ancestor
6674230|NCT01567995|Hormones|hormones|mesh-ancestor
6674231|NCT01567995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6674232|NCT01567995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675591|NCT01576419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675592|NCT01576458|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
6675593|NCT01576458|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5805400|NCT02702960|Fludarabine|fludarabine|mesh-list
5805401|NCT02702960|Tacrolimus|tacrolimus|mesh-list
5805402|NCT02702960|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5805403|NCT02702960|Mesna|mesna|mesh-list
5805404|NCT02702960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5805405|NCT02702960|Immunologic Factors|immunologic factors|mesh-ancestor
5805406|NCT02702960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805407|NCT02702960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5805408|NCT02702960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5805409|NCT02702960|Alkylating Agents|alkylating agents|mesh-ancestor
5805410|NCT02702960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805411|NCT02702960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5805412|NCT02702960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5805413|NCT02702960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5805414|NCT02702960|Glucocorticoids|glucocorticoids|mesh-ancestor
5805415|NCT02702960|Hormones|hormones|mesh-ancestor
5805416|NCT02702960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5805417|NCT02702960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5805418|NCT02702960|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5805419|NCT02702960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5805420|NCT02702960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5805421|NCT02702960|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5805422|NCT02702960|Antitubercular Agents|antitubercular agents|mesh-ancestor
5805423|NCT02702960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5805424|NCT02702960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5805425|NCT02702960|Protective Agents|protective agents|mesh-ancestor
5805426|NCT02703051|Lenograstim|lenograstim|mesh-list
5805427|NCT02703051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5641718|NCT02292758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5641719|NCT02292758|Cetuximab|cetuximab|mesh-list
5641720|NCT02292758|Irinotecan|irinotecan|mesh-list
5641721|NCT02292758|Endothelial Growth Factors|endothelial growth factors|mesh-list
5641722|NCT02292758|Antibodies|antibodies|mesh-list
5641723|NCT02292758|Immunoglobulins|immunoglobulins|mesh-list
5641724|NCT02292758|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5641725|NCT02292758|Immunoglobulin G|immunoglobulin g|mesh-list
5641726|NCT02292758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5805428|NCT02703051|Immunologic Factors|immunologic factors|mesh-ancestor
5805429|NCT02703051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805430|NCT02703090|Remifentanil|remifentanil|mesh-list
5805431|NCT02703090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5805432|NCT02703090|Narcotics|narcotics|mesh-ancestor
5805433|NCT02703090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5805434|NCT02703090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805435|NCT02703090|Analgesics|analgesics|mesh-ancestor
5805436|NCT02703090|Sensory System Agents|sensory system agents|mesh-ancestor
5805437|NCT02703090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5805438|NCT02702843|Xenon|xenon|mesh-list
5805439|NCT02702843|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5805440|NCT02702843|Anesthetics, General|anesthetics, general|mesh-ancestor
5805441|NCT02702843|Anesthetics|anesthetics|mesh-ancestor
5805442|NCT02702843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5805443|NCT02702843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900372|NCT04846218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900373|NCT04846218|Luteolytic Agents|luteolytic agents|mesh-ancestor
5900374|NCT04846218|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5900375|NCT04846218|Contraceptive Agents|contraceptive agents|mesh-ancestor
5900376|NCT04846218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5900377|NCT04846218|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5900378|NCT04846218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5900379|NCT04846218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5900380|NCT04841499|Niacinamide|niacinamide|mesh-list
5900381|NCT04841499|Niacin|niacin|mesh-list
5900382|NCT04841499|Nicotinic Acids|nicotinic acids|mesh-list
5900383|NCT04841499|Vitamin B Complex|vitamin b complex|mesh-ancestor
5900384|NCT04841499|Vitamins|vitamins|mesh-ancestor
5900385|NCT04841499|Micronutrients|micronutrients|mesh-ancestor
5900386|NCT04841499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900387|NCT04841499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5900388|NCT04841499|Antimetabolites|antimetabolites|mesh-ancestor
5900389|NCT04841499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900390|NCT04841499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5900391|NCT04841499|Vasodilator Agents|vasodilator agents|mesh-ancestor
5900392|NCT04838041|Imatinib Mesylate|imatinib mesylate|mesh-list
5900393|NCT04838041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5900394|NCT04838041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5900395|NCT04838041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5900396|NCT04838041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900397|NCT04833582|Gemcitabine|gemcitabine|mesh-list
5900398|NCT04833582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5900399|NCT04833582|Antimetabolites|antimetabolites|mesh-ancestor
5900400|NCT04833582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900401|NCT04833582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5900402|NCT04833582|Antiviral Agents|antiviral agents|mesh-ancestor
5900403|NCT04833582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5900404|NCT04833582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5900405|NCT04833582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5900406|NCT04833582|Immunologic Factors|immunologic factors|mesh-ancestor
5900407|NCT04833582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900408|NCT04825678|Erenumab|erenumab|mesh-list
5900409|NCT04825678|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
5900410|NCT04825678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900411|NCT04825678|Analgesics|analgesics|mesh-ancestor
5900412|NCT04825678|Sensory System Agents|sensory system agents|mesh-ancestor
5805444|NCT02702817|Naproxen|naproxen|mesh-list
5805445|NCT02702817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5805446|NCT02702817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5805447|NCT02702817|Analgesics|analgesics|mesh-ancestor
5805448|NCT02702817|Sensory System Agents|sensory system agents|mesh-ancestor
5805449|NCT02702817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5805450|NCT02702817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805451|NCT02702817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5805452|NCT02702817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5805453|NCT02702817|Gout Suppressants|gout suppressants|mesh-ancestor
5805454|NCT02702817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5805455|NCT02702817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5805456|NCT02702817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805457|NCT02702700|Verteporfin|verteporfin|mesh-list
5805458|NCT02702700|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5805459|NCT02702700|Dermatologic Agents|dermatologic agents|mesh-ancestor
5805460|NCT02702674|Propranolol|propranolol|mesh-list
5805461|NCT02702674|Oxytocin|oxytocin|mesh-list
5805462|NCT02702674|Oxytocics|oxytocics|mesh-ancestor
5805463|NCT02702674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5805464|NCT02702674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805465|NCT02702674|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5805466|NCT02702674|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5805467|NCT02702674|Adrenergic Agents|adrenergic agents|mesh-ancestor
5805468|NCT02702674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5805469|NCT02702674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805470|NCT02702674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5805471|NCT02702674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5805472|NCT02702674|Vasodilator Agents|vasodilator agents|mesh-ancestor
5805473|NCT02702739|Ribavirin|ribavirin|mesh-list
5805474|NCT02702739|Sofosbuvir|sofosbuvir|mesh-list
5805475|NCT02702739|Simeprevir|simeprevir|mesh-list
5805476|NCT02702739|Antimetabolites|antimetabolites|mesh-ancestor
5805477|NCT02702739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805478|NCT02702739|Antiviral Agents|antiviral agents|mesh-ancestor
5805479|NCT02702739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5805480|NCT02702739|Protease Inhibitors|protease inhibitors|mesh-ancestor
5805481|NCT02702739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5805482|NCT02702622|Provitamins|provitamins|mesh-list
5805483|NCT02702622|Beta Carotene|beta carotene|mesh-list
5805484|NCT02702622|Vitamins|vitamins|mesh-ancestor
5805485|NCT02702622|Micronutrients|micronutrients|mesh-ancestor
5805486|NCT02702622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805487|NCT02702661|Anesthetics|anesthetics|mesh-list
5805488|NCT02702661|Levobupivacaine|levobupivacaine|mesh-list
5805489|NCT02702661|Anesthetics, Local|anesthetics, local|mesh-list
5805490|NCT02702661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5805491|NCT02702661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805492|NCT02702661|Sensory System Agents|sensory system agents|mesh-ancestor
5805493|NCT02702661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5805494|NCT02702778|Prednisone|prednisone|mesh-list
5805495|NCT02702778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5805496|NCT02702778|Glucocorticoids|glucocorticoids|mesh-ancestor
5805497|NCT02702778|Hormones|hormones|mesh-ancestor
5805498|NCT02702778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5805499|NCT02702778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805500|NCT02702778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5805501|NCT02702778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5805502|NCT02702492|Niacin|niacin|mesh-list
5805503|NCT02702492|Nivolumab|nivolumab|mesh-list
5805504|NCT02702492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5805505|NCT02702492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5805506|NCT02702492|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5805507|NCT02702492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805508|NCT02702492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5805509|NCT02702492|Antimetabolites|antimetabolites|mesh-ancestor
5805510|NCT02702492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5805511|NCT02702492|Vasodilator Agents|vasodilator agents|mesh-ancestor
5805512|NCT02702492|Vitamin B Complex|vitamin b complex|mesh-ancestor
5805513|NCT02702492|Vitamins|vitamins|mesh-ancestor
5805514|NCT02702492|Micronutrients|micronutrients|mesh-ancestor
5805515|NCT02702492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805516|NCT02702206|Triamcinolone|triamcinolone|mesh-list
5805517|NCT02702206|Hyaluronic Acid|hyaluronic acid|mesh-list
5805518|NCT02702206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5805519|NCT02702206|Glucocorticoids|glucocorticoids|mesh-ancestor
5805520|NCT02702206|Hormones|hormones|mesh-ancestor
5805521|NCT02702206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5805522|NCT02702206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805523|NCT02702206|Immunologic Factors|immunologic factors|mesh-ancestor
5805524|NCT02702206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5805525|NCT02702206|Viscosupplements|viscosupplements|mesh-ancestor
5805526|NCT02702206|Protective Agents|protective agents|mesh-ancestor
5805527|NCT02702323|Apatinib|apatinib|mesh-list
5805528|NCT02702323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5805529|NCT02702323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5805530|NCT02702323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5805531|NCT02702323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805532|NCT02702414|Pembrolizumab|pembrolizumab|mesh-list
5805533|NCT02702414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5805534|NCT02702414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5805535|NCT02702349|Penicillins|penicillins|mesh-list
5805536|NCT02702349|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5805537|NCT02702349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5805538|NCT02702076|Apomorphine|apomorphine|mesh-list
5805539|NCT02702076|Emetics|emetics|mesh-ancestor
5805540|NCT02702076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805541|NCT02702076|Autonomic Agents|autonomic agents|mesh-ancestor
5805542|NCT02702076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5805543|NCT02702076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5805544|NCT02702076|Dopamine Agonists|dopamine agonists|mesh-ancestor
5805545|NCT02702076|Dopamine Agents|dopamine agents|mesh-ancestor
5805546|NCT02702076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5805547|NCT02702076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805548|NCT02702128|Tranexamic Acid|tranexamic acid|mesh-list
5805549|NCT02702128|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5805550|NCT02702128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5805551|NCT02702128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805552|NCT02702128|Hemostatics|hemostatics|mesh-ancestor
5805553|NCT02702128|Coagulants|coagulants|mesh-ancestor
5805554|NCT02701933|Ketamine|ketamine|mesh-list
5805555|NCT02701933|Analgesics|analgesics|mesh-ancestor
5805556|NCT02701933|Sensory System Agents|sensory system agents|mesh-ancestor
5805557|NCT02701933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5805558|NCT02701933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805559|NCT02701933|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5805560|NCT02701933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5805561|NCT02701933|Anesthetics, General|anesthetics, general|mesh-ancestor
5805562|NCT02701933|Anesthetics|anesthetics|mesh-ancestor
5805563|NCT02701933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5805564|NCT02701933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5805565|NCT02701933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5805566|NCT02701933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5805567|NCT02701933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805568|NCT02701673|Pyridoxine|pyridoxine|mesh-list
5805569|NCT02701673|Gemcitabine|gemcitabine|mesh-list
5805570|NCT02701673|Azacitidine|azacitidine|mesh-list
5805571|NCT02701673|Melphalan|melphalan|mesh-list
5805572|NCT02701673|Busulfan|busulfan|mesh-list
5805573|NCT02701673|Belinostat|belinostat|mesh-list
5805574|NCT02701673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5805575|NCT02701673|Antimetabolites|antimetabolites|mesh-ancestor
5805576|NCT02701673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805577|NCT02701673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5805578|NCT02701673|Antiviral Agents|antiviral agents|mesh-ancestor
5805579|NCT02701673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5805580|NCT02701673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5805581|NCT02701673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5805582|NCT02701673|Immunologic Factors|immunologic factors|mesh-ancestor
5805583|NCT02701673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805584|NCT02701673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5805585|NCT02701673|Alkylating Agents|alkylating agents|mesh-ancestor
5805586|NCT02701673|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5805587|NCT02701673|Vitamin B Complex|vitamin b complex|mesh-ancestor
5805588|NCT02701673|Vitamins|vitamins|mesh-ancestor
5805589|NCT02701673|Micronutrients|micronutrients|mesh-ancestor
5805590|NCT02701673|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6674233|NCT01568125|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6674234|NCT01568125|Incretins|incretins|mesh-list
6674235|NCT01568125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674236|NCT01568125|Hormones|hormones|mesh-ancestor
6674237|NCT01568125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6674238|NCT01568177|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
6674239|NCT01568177|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6674240|NCT01568177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805591|NCT02701699|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
5805592|NCT02701699|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5805593|NCT02701699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805594|NCT02701595|Amoxicillin|amoxicillin|mesh-list
5805595|NCT02701595|Vancomycin|vancomycin|mesh-list
5805596|NCT02701595|Gentamicins|gentamicins|mesh-list
5805597|NCT02701595|Ceftriaxone|ceftriaxone|mesh-list
5805598|NCT02701595|Penicillins|penicillins|mesh-list
5805599|NCT02701595|Penicillin G|penicillin g|mesh-list
5805600|NCT02701595|Penicillin G Benzathine|penicillin g benzathine|mesh-list
5805601|NCT02701595|Penicillin G Procaine|penicillin g procaine|mesh-list
5805602|NCT02701595|Netilmicin|netilmicin|mesh-list
5805603|NCT02701595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5805604|NCT02701595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5805605|NCT02701595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5805606|NCT02701595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5805607|NCT02701595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805608|NCT02701608|Levofloxacin|levofloxacin|mesh-list
5805609|NCT02701608|Ofloxacin|ofloxacin|mesh-list
5805610|NCT02701608|Rifampin|rifampin|mesh-list
5805611|NCT02701608|Fluoroquinolones|fluoroquinolones|mesh-list
5805612|NCT02701608|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5805613|NCT02701608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5805614|NCT02701608|Renal Agents|renal agents|mesh-ancestor
5805615|NCT02701608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5805616|NCT02701608|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5805617|NCT02701608|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5805618|NCT02701608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5805619|NCT02701608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805620|NCT02701608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5805621|NCT02701608|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5805622|NCT02701608|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5805623|NCT02701608|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5805624|NCT02701608|Antitubercular Agents|antitubercular agents|mesh-ancestor
5805625|NCT02701608|Leprostatic Agents|leprostatic agents|mesh-ancestor
5805626|NCT02701608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5805627|NCT02701608|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5805628|NCT02701608|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5805629|NCT02701608|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5805630|NCT02701608|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5805631|NCT02701608|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5805632|NCT02701608|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5805633|NCT02701348|Letrozole|letrozole|mesh-list
5805634|NCT02701348|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5805635|NCT02701348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5805636|NCT02701348|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5805637|NCT02701348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5805638|NCT02701348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805639|NCT02701348|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5805640|NCT02701348|Hormone Antagonists|hormone antagonists|mesh-ancestor
5805641|NCT02701348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5805642|NCT02701348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805643|NCT02701478|Nitrous Oxide|nitrous oxide|mesh-list
5805644|NCT02701478|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5805645|NCT02701478|Anesthetics, General|anesthetics, general|mesh-ancestor
5805646|NCT02701478|Anesthetics|anesthetics|mesh-ancestor
5805647|NCT02701478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5805648|NCT02701478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805649|NCT02701478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5805650|NCT02701478|Analgesics|analgesics|mesh-ancestor
5805651|NCT02701478|Sensory System Agents|sensory system agents|mesh-ancestor
5805652|NCT02701478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5805653|NCT02701517|Cyclosporine|cyclosporine|mesh-list
5805654|NCT02701517|Methotrexate|methotrexate|mesh-list
5805655|NCT02701517|Alemtuzumab|alemtuzumab|mesh-list
5805656|NCT02701517|Cyclosporins|cyclosporins|mesh-list
5805657|NCT02701517|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5805658|NCT02701517|Abortifacient Agents|abortifacient agents|mesh-ancestor
5805659|NCT02701517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5805660|NCT02701517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805661|NCT02701517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5805662|NCT02701517|Antimetabolites|antimetabolites|mesh-ancestor
5805663|NCT02701517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805664|NCT02701517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5805665|NCT02701517|Dermatologic Agents|dermatologic agents|mesh-ancestor
5805666|NCT02701517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5805667|NCT02701517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5805668|NCT02701517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5805669|NCT02701517|Immunologic Factors|immunologic factors|mesh-ancestor
5805670|NCT02701517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5805671|NCT02701517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5805672|NCT02701517|Antifungal Agents|antifungal agents|mesh-ancestor
5805673|NCT02701517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5805674|NCT02701517|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5805675|NCT02701517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5805676|NCT02701309|Iron|iron|mesh-list
5805677|NCT02701309|Protoporphyrin IX|protoporphyrin ix|mesh-list
5805678|NCT02701309|Zinc protoporphyrin|zinc protoporphyrin|mesh-list
5805679|NCT02701309|Trace Elements|trace elements|mesh-ancestor
5805680|NCT02701309|Micronutrients|micronutrients|mesh-ancestor
5805681|NCT02701309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805682|NCT02701309|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5805683|NCT02701309|Dermatologic Agents|dermatologic agents|mesh-ancestor
5805684|NCT02701309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5805685|NCT02701309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805686|NCT02701179|Lidocaine|lidocaine|mesh-list
5805687|NCT02701179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5805688|NCT02701179|Anesthetics, Local|anesthetics, local|mesh-ancestor
5805689|NCT02701179|Anesthetics|anesthetics|mesh-ancestor
5805690|NCT02701179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5805691|NCT02701179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805692|NCT02701179|Sensory System Agents|sensory system agents|mesh-ancestor
5805693|NCT02701179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5805694|NCT02701179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5805695|NCT02701179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5805696|NCT02701179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5805697|NCT02701179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5805698|NCT02701179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900413|NCT04825678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5900414|NCT04825678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900415|NCT04822337|Dexamethasone|dexamethasone|mesh-list
5900416|NCT04822337|Lenalidomide|lenalidomide|mesh-list
5900417|NCT04822337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5900418|NCT04822337|Antiemetics|antiemetics|mesh-ancestor
5900419|NCT04822337|Autonomic Agents|autonomic agents|mesh-ancestor
5900420|NCT04822337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5900421|NCT04822337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900422|NCT04822337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5900423|NCT04822337|Glucocorticoids|glucocorticoids|mesh-ancestor
5900424|NCT04822337|Hormones|hormones|mesh-ancestor
5900425|NCT04822337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5900426|NCT04822337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5900427|NCT04822337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5900428|NCT04822337|Immunologic Factors|immunologic factors|mesh-ancestor
5900429|NCT04822337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5900430|NCT04822337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5900431|NCT04822337|Growth Substances|growth substances|mesh-ancestor
5900432|NCT04822337|Growth Inhibitors|growth inhibitors|mesh-ancestor
5900433|NCT04798027|Vaccines|vaccines|mesh-list
5900434|NCT04798027|Immunologic Factors|immunologic factors|mesh-ancestor
5900435|NCT04798027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900436|NCT04795661|Pembrolizumab|pembrolizumab|mesh-list
5900437|NCT04795661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5900438|NCT04795661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5900439|NCT04773405|Lidocaine|lidocaine|mesh-list
5900440|NCT04773405|Epinephrine|epinephrine|mesh-list
5900441|NCT04773405|Levobupivacaine|levobupivacaine|mesh-list
5900442|NCT04773405|Anesthetics, Local|anesthetics, local|mesh-ancestor
5900443|NCT04773405|Anesthetics|anesthetics|mesh-ancestor
6211144|NCT02168816|Antimalarials|antimalarials|mesh-ancestor
5805699|NCT02701127|Niacinamide|niacinamide|mesh-list
5805700|NCT02701127|Niacin|niacin|mesh-list
5805701|NCT02701127|Nicotinic Acids|nicotinic acids|mesh-list
5805702|NCT02701127|Vitamin B Complex|vitamin b complex|mesh-ancestor
5805703|NCT02701127|Vitamins|vitamins|mesh-ancestor
5805704|NCT02701127|Micronutrients|micronutrients|mesh-ancestor
5805705|NCT02701127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805706|NCT02701127|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5805707|NCT02701127|Antimetabolites|antimetabolites|mesh-ancestor
5805708|NCT02701127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805709|NCT02701127|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5805710|NCT02701127|Vasodilator Agents|vasodilator agents|mesh-ancestor
5805711|NCT02701166|Bezafibrate|bezafibrate|mesh-list
5805712|NCT02701166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5805713|NCT02701166|Antimetabolites|antimetabolites|mesh-ancestor
5805714|NCT02701166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805715|NCT02701166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5805716|NCT02700893|Atropine|atropine|mesh-list
5805717|NCT02700893|Sufentanil|sufentanil|mesh-list
5805718|NCT02700893|Propofol|propofol|mesh-list
5805719|NCT02700893|Atracurium|atracurium|mesh-list
5805720|NCT02700893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5805721|NCT02700893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5805722|NCT02700893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805723|NCT02700893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5805724|NCT02700893|Anesthetics, General|anesthetics, general|mesh-ancestor
5805725|NCT02700893|Anesthetics|anesthetics|mesh-ancestor
5805726|NCT02700893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5805727|NCT02700893|Narcotics|narcotics|mesh-ancestor
5805728|NCT02700893|Analgesics|analgesics|mesh-ancestor
5805729|NCT02700893|Sensory System Agents|sensory system agents|mesh-ancestor
5805730|NCT02700893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5805731|NCT02700893|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5805732|NCT02700893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5805733|NCT02700893|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5805734|NCT02700893|Autonomic Agents|autonomic agents|mesh-ancestor
6211145|NCT02168816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6211146|NCT02168816|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6211147|NCT02168816|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6211148|NCT02168842|Isradipine|isradipine|mesh-list
6211149|NCT02168842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6211150|NCT02168842|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6211151|NCT02168842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6211152|NCT02168842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211153|NCT02168842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6211154|NCT02168842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211155|NCT02168842|Vasodilator Agents|vasodilator agents|mesh-ancestor
6211156|NCT02168855|Nicotine|nicotine|mesh-list
6211157|NCT02168855|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5805735|NCT02700893|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5805736|NCT02700893|Respiratory System Agents|respiratory system agents|mesh-ancestor
5805737|NCT02700893|Mydriatics|mydriatics|mesh-ancestor
5805738|NCT02700893|Parasympatholytics|parasympatholytics|mesh-ancestor
5805739|NCT02700893|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5805740|NCT02700893|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5805741|NCT02700893|Cholinergic Agents|cholinergic agents|mesh-ancestor
5805742|NCT02700893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5805743|NCT02700893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805744|NCT02700893|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5805745|NCT02700893|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5805746|NCT02700893|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5805747|NCT02700893|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
5805748|NCT02700906|Lidocaine|lidocaine|mesh-list
5805749|NCT02700906|Anesthetics, Local|anesthetics, local|mesh-ancestor
5805750|NCT02700906|Anesthetics|anesthetics|mesh-ancestor
5805751|NCT02700906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5805752|NCT02700906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805753|NCT02700906|Sensory System Agents|sensory system agents|mesh-ancestor
5805754|NCT02700906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5805755|NCT02700906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5805756|NCT02700906|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5805757|NCT02700906|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5805758|NCT02700906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5805759|NCT02700906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805760|NCT02700828|Hydrocortisone|hydrocortisone|mesh-list
5805761|NCT02700828|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
5805762|NCT02700828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5805763|NCT02700568|Axitinib|axitinib|mesh-list
5805764|NCT02700568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5805765|NCT02700568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5805766|NCT02700568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5805767|NCT02700568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805768|NCT02700711|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5805769|NCT02700711|Methylphenidate|methylphenidate|mesh-list
5805770|NCT02700711|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5805771|NCT02700711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805772|NCT02700711|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5805773|NCT02700711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5805774|NCT02700711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5805775|NCT02700711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805776|NCT02700711|Dopamine Agents|dopamine agents|mesh-ancestor
5805777|NCT02700711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5805778|NCT02700711|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5805779|NCT02700711|Analgesics|analgesics|mesh-ancestor
5805780|NCT02700711|Sensory System Agents|sensory system agents|mesh-ancestor
5805781|NCT02700711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5805782|NCT02700711|Antidepressive Agents|antidepressive agents|mesh-ancestor
5805783|NCT02700711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5805784|NCT02700685|Methylphenidate|methylphenidate|mesh-list
5805785|NCT02700685|Pycnogenols|pycnogenols|mesh-list
5805786|NCT02700685|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5805787|NCT02700685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805788|NCT02700685|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5805789|NCT02700685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5805790|NCT02700685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5805791|NCT02700685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805792|NCT02700685|Dopamine Agents|dopamine agents|mesh-ancestor
5805793|NCT02700685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5805794|NCT02700685|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5805795|NCT02700685|Immunologic Factors|immunologic factors|mesh-ancestor
5805796|NCT02700685|Antioxidants|antioxidants|mesh-ancestor
5805797|NCT02700685|Protective Agents|protective agents|mesh-ancestor
5805798|NCT02700685|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5805799|NCT02700763|Dabrafenib|dabrafenib|mesh-list
5805800|NCT02700763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5805801|NCT02700763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5805802|NCT02700763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5805803|NCT02700763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805804|NCT02700347|Pyrazinamide|pyrazinamide|mesh-list
5805805|NCT02700347|Allopurinol|allopurinol|mesh-list
5805806|NCT02700347|Antimetabolites|antimetabolites|mesh-ancestor
5805807|NCT02700347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805808|NCT02700347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5805809|NCT02700347|Gout Suppressants|gout suppressants|mesh-ancestor
5805810|NCT02700347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5805811|NCT02700347|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5805812|NCT02700347|Antioxidants|antioxidants|mesh-ancestor
5805813|NCT02700347|Protective Agents|protective agents|mesh-ancestor
5805814|NCT02700347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805815|NCT02700347|Antitubercular Agents|antitubercular agents|mesh-ancestor
5805816|NCT02700347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5805817|NCT02700347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5805818|NCT02700451|Acetaminophen|acetaminophen|mesh-list
5805819|NCT02700451|Ketorolac|ketorolac|mesh-list
5805820|NCT02700451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5805821|NCT02700451|Analgesics|analgesics|mesh-ancestor
5805822|NCT02700451|Sensory System Agents|sensory system agents|mesh-ancestor
5805823|NCT02700451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5805824|NCT02700451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805825|NCT02700451|Antipyretics|antipyretics|mesh-ancestor
5805826|NCT02700451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5805827|NCT02700451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5805828|NCT02700451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5805829|NCT02700451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5805830|NCT02700451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5805831|NCT02700451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805832|NCT02700438|Nitroglycerin|nitroglycerin|mesh-list
5805833|NCT02700438|Vasodilator Agents|vasodilator agents|mesh-ancestor
5805834|NCT02700217|Remifentanil|remifentanil|mesh-list
5805835|NCT02700217|Heroin|heroin|mesh-list
5805836|NCT02700217|Bupivacaine|bupivacaine|mesh-list
5805837|NCT02700217|Propofol|propofol|mesh-list
5805838|NCT02700217|Anesthetics, Local|anesthetics, local|mesh-ancestor
5805839|NCT02700217|Anesthetics|anesthetics|mesh-ancestor
5805840|NCT02700217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5805841|NCT02700217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805842|NCT02700217|Sensory System Agents|sensory system agents|mesh-ancestor
5805843|NCT02700217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5805844|NCT02700217|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5805845|NCT02700217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5805846|NCT02700217|Anesthetics, General|anesthetics, general|mesh-ancestor
5805847|NCT02700217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5805848|NCT02700217|Narcotics|narcotics|mesh-ancestor
5805849|NCT02700217|Analgesics|analgesics|mesh-ancestor
5805850|NCT02701205|Etanercept|etanercept|mesh-list
5805851|NCT02701205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5805852|NCT02701205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5805853|NCT02701205|Analgesics|analgesics|mesh-ancestor
5805854|NCT02701205|Sensory System Agents|sensory system agents|mesh-ancestor
5805855|NCT02701205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5805856|NCT02701205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805857|NCT02701205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5805858|NCT02701205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5805859|NCT02701205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5805860|NCT02701205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5805861|NCT02701205|Immunologic Factors|immunologic factors|mesh-ancestor
5805862|NCT02700087|Famotidine|famotidine|mesh-list
5805863|NCT02700087|Ranitidine|ranitidine|mesh-list
5805864|NCT02700087|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
5805865|NCT02700087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5805866|NCT02700087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5805867|NCT02700087|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5805868|NCT02700087|Histamine Antagonists|histamine antagonists|mesh-ancestor
5805869|NCT02700087|Histamine Agents|histamine agents|mesh-ancestor
5805870|NCT02700087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5805871|NCT02700087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805872|NCT02700087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805873|NCT02700048|Naloxone|naloxone|mesh-list
5805874|NCT02700048|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5805875|NCT02700048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805876|NCT02700048|Sensory System Agents|sensory system agents|mesh-ancestor
5805877|NCT02700048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5805878|NCT02699879|Pirfenidone|pirfenidone|mesh-list
5805879|NCT02699879|Analgesics|analgesics|mesh-ancestor
5805880|NCT02699879|Sensory System Agents|sensory system agents|mesh-ancestor
5805881|NCT02699879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5805882|NCT02699879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805883|NCT02699879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5805884|NCT02699879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5805885|NCT02699879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5805886|NCT02699879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5805887|NCT02699879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5805888|NCT02699827|Magnesium Sulfate|magnesium sulfate|mesh-list
5805889|NCT02699827|Levobupivacaine|levobupivacaine|mesh-list
5805890|NCT02699827|Analgesics|analgesics|mesh-ancestor
5805891|NCT02699827|Sensory System Agents|sensory system agents|mesh-ancestor
5805892|NCT02699827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5805893|NCT02699827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805894|NCT02699827|Anesthetics|anesthetics|mesh-ancestor
5805895|NCT02699827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5805896|NCT02699827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5805897|NCT02699827|Anticonvulsants|anticonvulsants|mesh-ancestor
5805898|NCT02699827|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5805899|NCT02699827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5805900|NCT02699827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805901|NCT02699827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5805902|NCT02699827|Tocolytic Agents|tocolytic agents|mesh-ancestor
5805903|NCT02699827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5641727|NCT02292758|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5641728|NCT02292758|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5641729|NCT02292758|Growth Substances|growth substances|mesh-ancestor
5641730|NCT02292758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641731|NCT02292758|Growth Inhibitors|growth inhibitors|mesh-ancestor
6492047|NCT00606450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6492048|NCT00606450|Analgesics|analgesics|mesh-ancestor
6492049|NCT00606450|Sensory System Agents|sensory system agents|mesh-ancestor
6492050|NCT00606450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6492051|NCT00606450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492052|NCT00606450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6492053|NCT00606450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6492054|NCT00606450|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5641732|NCT02292758|Immunologic Factors|immunologic factors|mesh-ancestor
5805904|NCT02699827|Anesthetics, Local|anesthetics, local|mesh-ancestor
5805905|NCT02699723|Itraconazole|itraconazole|mesh-list
5805906|NCT02699723|Arsenic Trioxide|arsenic trioxide|mesh-list
5805907|NCT02699723|Antifungal Agents|antifungal agents|mesh-ancestor
5805908|NCT02699723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5805909|NCT02699723|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5805910|NCT02699723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5805911|NCT02699723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5805912|NCT02699723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805913|NCT02699723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5805914|NCT02699723|Hormone Antagonists|hormone antagonists|mesh-ancestor
5805915|NCT02699723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5805916|NCT02699723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805917|NCT02699723|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5805918|NCT02699723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5805919|NCT02699645|Amlodipine|amlodipine|mesh-list
5805920|NCT02699645|Telmisartan|telmisartan|mesh-list
5805921|NCT02699645|Indapamide|indapamide|mesh-list
5805922|NCT02699645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5805923|NCT02699645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5805924|NCT02699645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5805925|NCT02699645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805926|NCT02699645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5805927|NCT02699645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805928|NCT02699645|Vasodilator Agents|vasodilator agents|mesh-ancestor
5805929|NCT02699645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5641733|NCT02292758|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5641734|NCT02292758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5641735|NCT02292758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5641736|NCT02292758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641737|NCT02288247|Prednisolone|prednisolone|mesh-list
5641738|NCT02288247|Docetaxel|docetaxel|mesh-list
5641739|NCT02288247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5641740|NCT02288247|Tubulin Modulators|tubulin modulators|mesh-ancestor
5641741|NCT02288247|Antimitotic Agents|antimitotic agents|mesh-ancestor
5641742|NCT02288247|Mitosis Modulators|mitosis modulators|mesh-ancestor
5641743|NCT02288247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641744|NCT02288247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5641745|NCT02288247|Glucocorticoids|glucocorticoids|mesh-ancestor
5641746|NCT02288247|Hormones|hormones|mesh-ancestor
5641747|NCT02288247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5641748|NCT02288247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641749|NCT02288247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6492055|NCT00606450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6492056|NCT00606450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6492057|NCT00606450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492058|NCT00606450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6492059|NCT00606450|Immunologic Factors|immunologic factors|mesh-ancestor
6492060|NCT00606450|Leprostatic Agents|leprostatic agents|mesh-ancestor
6492061|NCT00606450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6492062|NCT00606450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6492063|NCT00606450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6492064|NCT00606450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6492065|NCT00606450|Growth Substances|growth substances|mesh-ancestor
6492066|NCT00606450|Growth Inhibitors|growth inhibitors|mesh-ancestor
6492067|NCT00606450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5805930|NCT02699645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5805931|NCT02699645|Diuretics|diuretics|mesh-ancestor
5805932|NCT02699645|Natriuretic Agents|natriuretic agents|mesh-ancestor
5805933|NCT02699645|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5805934|NCT02700022|Prednisone|prednisone|mesh-list
5805935|NCT02700022|Cyclophosphamide|cyclophosphamide|mesh-list
5805936|NCT02700022|Doxorubicin|doxorubicin|mesh-list
5805937|NCT02700022|Etoposide|etoposide|mesh-list
5805938|NCT02700022|Vincristine|vincristine|mesh-list
5805939|NCT02700022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5805940|NCT02700022|Immunologic Factors|immunologic factors|mesh-ancestor
5805941|NCT02700022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805942|NCT02700022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5805943|NCT02700022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5805944|NCT02700022|Alkylating Agents|alkylating agents|mesh-ancestor
5805945|NCT02700022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805946|NCT02700022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5805947|NCT02700022|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5805948|NCT02700022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5805949|NCT02700022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5805950|NCT02700022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5805951|NCT02700022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5805952|NCT02700022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5805953|NCT02700022|Glucocorticoids|glucocorticoids|mesh-ancestor
5805954|NCT02700022|Hormones|hormones|mesh-ancestor
5805955|NCT02700022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5805956|NCT02700022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5805957|NCT02700022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5805958|NCT02700022|Tubulin Modulators|tubulin modulators|mesh-ancestor
5805959|NCT02700022|Antimitotic Agents|antimitotic agents|mesh-ancestor
5805960|NCT02700022|Mitosis Modulators|mitosis modulators|mesh-ancestor
5805961|NCT02699658|Levofloxacin|levofloxacin|mesh-list
5805962|NCT02699658|Ofloxacin|ofloxacin|mesh-list
5805963|NCT02699658|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5805964|NCT02699658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5805965|NCT02699658|Renal Agents|renal agents|mesh-ancestor
5805966|NCT02699658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5805967|NCT02699658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5805968|NCT02699658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5805969|NCT02699658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5805970|NCT02699658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805971|NCT02699658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5805972|NCT02699658|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5805973|NCT02699658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5805974|NCT02699801|Dexmedetomidine|dexmedetomidine|mesh-list
5805975|NCT02699801|Propofol|propofol|mesh-list
5805976|NCT02699801|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5805977|NCT02699801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5805978|NCT02699801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805979|NCT02699801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5805980|NCT02699801|Anesthetics, General|anesthetics, general|mesh-ancestor
5805981|NCT02699801|Anesthetics|anesthetics|mesh-ancestor
5805982|NCT02699801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5805983|NCT02699801|Analgesics|analgesics|mesh-ancestor
5805984|NCT02699801|Sensory System Agents|sensory system agents|mesh-ancestor
5805985|NCT02699801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5805986|NCT02699801|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5805987|NCT02699801|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5805988|NCT02699801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5805989|NCT02699801|Adrenergic Agents|adrenergic agents|mesh-ancestor
5805990|NCT02699801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5805991|NCT02699801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5805992|NCT02699710|Folic Acid|folic acid|mesh-list
5805993|NCT02699710|Methotrexate|methotrexate|mesh-list
5805994|NCT02699710|Rabeprazole|rabeprazole|mesh-list
5805995|NCT02699710|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5805996|NCT02699710|Abortifacient Agents|abortifacient agents|mesh-ancestor
5805997|NCT02699710|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5805998|NCT02699710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5805999|NCT02699710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5806000|NCT02699710|Antimetabolites|antimetabolites|mesh-ancestor
5806001|NCT02699710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5806002|NCT02699710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6492068|NCT00606515|Paclitaxel|paclitaxel|mesh-list
6492069|NCT00606515|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6492070|NCT00606515|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6492071|NCT00606515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6492072|NCT00606515|Tubulin Modulators|tubulin modulators|mesh-ancestor
5806003|NCT02699710|Dermatologic Agents|dermatologic agents|mesh-ancestor
5806004|NCT02699710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5806005|NCT02699710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5806006|NCT02699710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5806007|NCT02699710|Immunologic Factors|immunologic factors|mesh-ancestor
5806008|NCT02699710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5806009|NCT02699710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5806010|NCT02699710|Hematinics|hematinics|mesh-ancestor
5806011|NCT02699710|Vitamin B Complex|vitamin b complex|mesh-ancestor
5806012|NCT02699710|Vitamins|vitamins|mesh-ancestor
5806013|NCT02699710|Micronutrients|micronutrients|mesh-ancestor
5806014|NCT02699710|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5806015|NCT02699710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5806016|NCT02699710|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5806017|NCT02699840|Vaccines|vaccines|mesh-list
5806018|NCT02699840|Immunologic Factors|immunologic factors|mesh-ancestor
5806019|NCT02699840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900444|NCT04773405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5900445|NCT04773405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900446|NCT04773405|Sensory System Agents|sensory system agents|mesh-ancestor
5900447|NCT04773405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5900448|NCT04773405|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5900449|NCT04773405|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5900450|NCT04773405|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5806020|NCT02699437|Antibodies|antibodies|mesh-list
5806021|NCT02699437|Antibodies, Antiphospholipid|antibodies, antiphospholipid|mesh-list
5806022|NCT02699437|Immunologic Factors|immunologic factors|mesh-ancestor
5806023|NCT02699437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806024|NCT02699281|Palmidrol|palmidrol|mesh-list
5806025|NCT02699281|Analgesics|analgesics|mesh-ancestor
5806026|NCT02699281|Sensory System Agents|sensory system agents|mesh-ancestor
5806027|NCT02699281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5806028|NCT02699281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806029|NCT02699281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5806030|NCT02699281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5806031|NCT02699281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5806032|NCT02699281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5806033|NCT02699281|Antiviral Agents|antiviral agents|mesh-ancestor
5806034|NCT02699281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5806035|NCT02699281|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5806036|NCT02699281|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5806037|NCT02699281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5806038|NCT02699281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492073|NCT00606515|Antimitotic Agents|antimitotic agents|mesh-ancestor
5806039|NCT02699281|Hormones|hormones|mesh-ancestor
5806040|NCT02699281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5806041|NCT02699385|Domperidone|domperidone|mesh-list
6492074|NCT00606515|Mitosis Modulators|mitosis modulators|mesh-ancestor
5806042|NCT02699385|Antiemetics|antiemetics|mesh-ancestor
5806043|NCT02699385|Autonomic Agents|autonomic agents|mesh-ancestor
5806044|NCT02699385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5806045|NCT02699385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806046|NCT02699385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5806047|NCT02699385|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5806048|NCT02699385|Dopamine Agents|dopamine agents|mesh-ancestor
5806049|NCT02699385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5806050|NCT02699385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5806051|NCT02699528|Methylphenidate|methylphenidate|mesh-list
5806052|NCT02699528|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5806053|NCT02699528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806054|NCT02699528|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5806055|NCT02699528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5806056|NCT02699528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5806057|NCT02699528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492075|NCT00606515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492076|NCT00606541|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6492077|NCT00606541|Antidepressive Agents|antidepressive agents|mesh-ancestor
6492078|NCT00606541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6492079|NCT00606541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5806058|NCT02699528|Dopamine Agents|dopamine agents|mesh-ancestor
5806059|NCT02699528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5806060|NCT02699008|Clopidogrel|clopidogrel|mesh-list
5806061|NCT02699008|Ticagrelor|ticagrelor|mesh-list
5806062|NCT02699008|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5806063|NCT02699008|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5806064|NCT02699008|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5806065|NCT02699008|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5806066|NCT02699008|Purinergic Agents|purinergic agents|mesh-ancestor
5806067|NCT02699008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5806068|NCT02699008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5806069|NCT02699008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806070|NCT02699138|Trazodone|trazodone|mesh-list
5806071|NCT02699138|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6492080|NCT00606541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6492081|NCT00606541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6492082|NCT00606541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492083|NCT00606775|Carvedilol|carvedilol|mesh-list
6492084|NCT00606775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6492085|NCT00606775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6492086|NCT00606775|Adrenergic Agents|adrenergic agents|mesh-ancestor
5806072|NCT02699138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6492087|NCT00606775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5806073|NCT02699138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5806074|NCT02699138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806075|NCT02699138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5806076|NCT02699138|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5806077|NCT02699138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5806078|NCT02699138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5806079|NCT02699138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5806080|NCT02699138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6674241|NCT01568268|Palonosetron|palonosetron|mesh-list
6674242|NCT01568268|Antiemetics|antiemetics|mesh-ancestor
6674243|NCT01568268|Autonomic Agents|autonomic agents|mesh-ancestor
6674244|NCT01568268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6674245|NCT01568268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674246|NCT01568268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6674247|NCT01568268|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6674248|NCT01568268|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6674249|NCT01568268|Serotonin Agents|serotonin agents|mesh-ancestor
6674250|NCT01568268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6674251|NCT01568268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674252|NCT01568281|Anastrozole|anastrozole|mesh-list
6674253|NCT01568281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5806081|NCT02699138|Serotonin Agents|serotonin agents|mesh-ancestor
5806082|NCT02699138|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5806083|NCT02699138|Antidepressive Agents|antidepressive agents|mesh-ancestor
5806084|NCT02698891|Paclitaxel|paclitaxel|mesh-list
5806085|NCT02698891|Cyclophosphamide|cyclophosphamide|mesh-list
5806086|NCT02698891|Doxorubicin|doxorubicin|mesh-list
5806087|NCT02698891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5806088|NCT02698891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5806089|NCT02698891|Tubulin Modulators|tubulin modulators|mesh-ancestor
5806090|NCT02698891|Antimitotic Agents|antimitotic agents|mesh-ancestor
5806091|NCT02698891|Mitosis Modulators|mitosis modulators|mesh-ancestor
5806092|NCT02698891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5806093|NCT02698891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5806094|NCT02698891|Immunologic Factors|immunologic factors|mesh-ancestor
5806095|NCT02698891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806096|NCT02698891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5806097|NCT02698891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5806098|NCT02698891|Alkylating Agents|alkylating agents|mesh-ancestor
5806099|NCT02698891|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5806100|NCT02698891|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5806101|NCT02698891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5806102|NCT02698891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5806103|NCT02698891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5806104|NCT02698982|Anesthetics|anesthetics|mesh-list
5806105|NCT02698982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5806106|NCT02698982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806107|NCT02698969|Atropine|atropine|mesh-list
5806108|NCT02698969|Fentanyl|fentanyl|mesh-list
5806109|NCT02698969|Propofol|propofol|mesh-list
5806110|NCT02698969|Sevoflurane|sevoflurane|mesh-list
5806111|NCT02698969|Rocuronium|rocuronium|mesh-list
5806112|NCT02698969|Neostigmine|neostigmine|mesh-list
5806113|NCT02698969|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5806114|NCT02698969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5806115|NCT02698969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806116|NCT02698969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5806117|NCT02698969|Anesthetics, General|anesthetics, general|mesh-ancestor
5806118|NCT02698969|Anesthetics|anesthetics|mesh-ancestor
5806119|NCT02698969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5806120|NCT02698969|Narcotics|narcotics|mesh-ancestor
5806121|NCT02698969|Analgesics|analgesics|mesh-ancestor
5806122|NCT02698969|Sensory System Agents|sensory system agents|mesh-ancestor
5806123|NCT02698969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5806124|NCT02698969|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5806125|NCT02698969|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5806126|NCT02698969|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5806127|NCT02698969|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5806128|NCT02698969|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5806129|NCT02698969|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5806130|NCT02698969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5806131|NCT02698969|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5806132|NCT02698969|Autonomic Agents|autonomic agents|mesh-ancestor
6211158|NCT02168855|Autonomic Agents|autonomic agents|mesh-ancestor
6211159|NCT02168855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6211160|NCT02168855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211161|NCT02168855|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6211162|NCT02168855|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6211163|NCT02168855|Cholinergic Agents|cholinergic agents|mesh-ancestor
6211164|NCT02168855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6211165|NCT02168855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211166|NCT02168946|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6211167|NCT02168946|Meropenem|meropenem|mesh-list
5806133|NCT02698969|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6211168|NCT02168946|Vaborbactam|vaborbactam|mesh-list
6211169|NCT02168946|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6211170|NCT02168946|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
6211171|NCT02168946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5806134|NCT02698969|Respiratory System Agents|respiratory system agents|mesh-ancestor
5806135|NCT02698969|Mydriatics|mydriatics|mesh-ancestor
5806136|NCT02698969|Parasympatholytics|parasympatholytics|mesh-ancestor
5806137|NCT02698969|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5806138|NCT02698969|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5806139|NCT02698969|Cholinergic Agents|cholinergic agents|mesh-ancestor
5806140|NCT02698969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5806141|NCT02698969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5806142|NCT02698969|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5806143|NCT02698969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5806144|NCT02698969|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5806145|NCT02698930|Dexmedetomidine|dexmedetomidine|mesh-list
5806146|NCT02698930|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5806147|NCT02698930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5806148|NCT02698930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806149|NCT02698930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5806150|NCT02698930|Analgesics|analgesics|mesh-ancestor
5806151|NCT02698930|Sensory System Agents|sensory system agents|mesh-ancestor
6211172|NCT02168946|Antitubercular Agents|antitubercular agents|mesh-ancestor
6211173|NCT02168946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6211174|NCT02168946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211175|NCT02169115|Omalizumab|omalizumab|mesh-list
6211176|NCT02169115|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6211177|NCT02169115|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5806152|NCT02698930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5806153|NCT02698930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5806154|NCT02698930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5806155|NCT02698930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5806156|NCT02698930|Adrenergic Agents|adrenergic agents|mesh-ancestor
5806157|NCT02698930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5806158|NCT02698930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5806159|NCT02698995|Acetaminophen|acetaminophen|mesh-list
5806160|NCT02698995|Dexamethasone|dexamethasone|mesh-list
5806161|NCT02698995|Lidocaine|lidocaine|mesh-list
5806162|NCT02698995|Morphine|morphine|mesh-list
5806163|NCT02698995|Ropivacaine|ropivacaine|mesh-list
5806164|NCT02698995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5806165|NCT02698995|Antiemetics|antiemetics|mesh-ancestor
5806166|NCT02698995|Autonomic Agents|autonomic agents|mesh-ancestor
5806167|NCT02698995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5806168|NCT02698995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806169|NCT02698995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5806170|NCT02698995|Glucocorticoids|glucocorticoids|mesh-ancestor
5806171|NCT02698995|Hormones|hormones|mesh-ancestor
5806172|NCT02698995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5806173|NCT02698995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5806174|NCT02698995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5806175|NCT02698995|Anesthetics, Local|anesthetics, local|mesh-ancestor
5806176|NCT02698995|Anesthetics|anesthetics|mesh-ancestor
5806177|NCT02698995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5806178|NCT02698995|Sensory System Agents|sensory system agents|mesh-ancestor
5806179|NCT02698995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5806180|NCT02698995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5806181|NCT02698995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5806182|NCT02698995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5806183|NCT02698995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5806184|NCT02698995|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5806185|NCT02698995|Narcotics|narcotics|mesh-ancestor
5806186|NCT02698995|Analgesics|analgesics|mesh-ancestor
5806187|NCT02698995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5806188|NCT02698995|Antipyretics|antipyretics|mesh-ancestor
5806189|NCT02698813|Hyaluronic Acid|hyaluronic acid|mesh-list
5806190|NCT02698813|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5806191|NCT02698813|Immunologic Factors|immunologic factors|mesh-ancestor
5806192|NCT02698813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806193|NCT02698813|Viscosupplements|viscosupplements|mesh-ancestor
5806194|NCT02698813|Protective Agents|protective agents|mesh-ancestor
5806195|NCT02698553|Bupropion|bupropion|mesh-list
5806196|NCT02698553|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5806197|NCT02698553|Antidepressive Agents|antidepressive agents|mesh-ancestor
5806198|NCT02698553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5806199|NCT02698553|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5806200|NCT02698553|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5806201|NCT02698553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5806202|NCT02698553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5806203|NCT02698553|Dopamine Agents|dopamine agents|mesh-ancestor
5806204|NCT02698553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5806205|NCT02698553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806206|NCT02698553|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5806207|NCT02698553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5806208|NCT02698553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5806209|NCT02698514|Sevoflurane|sevoflurane|mesh-list
5806210|NCT02698514|Desflurane|desflurane|mesh-list
5806211|NCT02698514|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5806212|NCT02698514|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5806213|NCT02698514|Anesthetics, General|anesthetics, general|mesh-ancestor
5806214|NCT02698514|Anesthetics|anesthetics|mesh-ancestor
5806215|NCT02698514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5806216|NCT02698514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806217|NCT02698527|Lidocaine|lidocaine|mesh-list
5806218|NCT02698527|Anesthetics, Local|anesthetics, local|mesh-ancestor
5806219|NCT02698527|Anesthetics|anesthetics|mesh-ancestor
5806220|NCT02698527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5806221|NCT02698527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806222|NCT02698527|Sensory System Agents|sensory system agents|mesh-ancestor
5806223|NCT02698527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5806224|NCT02698527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5806225|NCT02698527|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5806226|NCT02698527|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5806227|NCT02698527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5806228|NCT02698527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5806229|NCT02698748|Chloroquine|chloroquine|mesh-list
5806230|NCT02698748|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
5806231|NCT02698748|Amebicides|amebicides|mesh-ancestor
5806232|NCT02698748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5806233|NCT02698748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5806234|NCT02698748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5806235|NCT02698748|Antimalarials|antimalarials|mesh-ancestor
5806236|NCT02698748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5806237|NCT02698748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5806238|NCT02698748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5806239|NCT02698748|Analgesics|analgesics|mesh-ancestor
5806240|NCT02698748|Sensory System Agents|sensory system agents|mesh-ancestor
5806241|NCT02698748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5806242|NCT02698748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806243|NCT02698748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5806244|NCT02698748|Filaricides|filaricides|mesh-ancestor
5806245|NCT02698748|Antinematodal Agents|antinematodal agents|mesh-ancestor
5806246|NCT02698748|Anthelmintics|anthelmintics|mesh-ancestor
5806247|NCT02698267|Itraconazole|itraconazole|mesh-list
5806248|NCT02698267|Antifungal Agents|antifungal agents|mesh-ancestor
5806249|NCT02698267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5806250|NCT02698267|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5806251|NCT02698267|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5806252|NCT02698267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5806253|NCT02698267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5806254|NCT02698267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5806255|NCT02698267|Hormone Antagonists|hormone antagonists|mesh-ancestor
5806256|NCT02698267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5806257|NCT02698267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806258|NCT02698267|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5806259|NCT02698254|Bevacizumab|bevacizumab|mesh-list
5806260|NCT02698254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5806261|NCT02698254|Endothelial Growth Factors|endothelial growth factors|mesh-list
5806262|NCT02698254|Antibodies|antibodies|mesh-list
5806263|NCT02698254|Immunoglobulins|immunoglobulins|mesh-list
5806264|NCT02698254|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5806265|NCT02698254|Immunoglobulin G|immunoglobulin g|mesh-list
5806266|NCT02698254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5806267|NCT02698254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5806268|NCT02698254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5806269|NCT02698254|Growth Substances|growth substances|mesh-ancestor
5806270|NCT02698254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806271|NCT02698254|Growth Inhibitors|growth inhibitors|mesh-ancestor
5806272|NCT02698254|Immunologic Factors|immunologic factors|mesh-ancestor
5806273|NCT02698280|Bevacizumab|bevacizumab|mesh-list
5806274|NCT02698280|Nimustine|nimustine|mesh-list
5806275|NCT02698280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5806276|NCT02698280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5806277|NCT02698280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5806278|NCT02698280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5806279|NCT02698280|Growth Substances|growth substances|mesh-ancestor
5806280|NCT02698280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806281|NCT02698280|Growth Inhibitors|growth inhibitors|mesh-ancestor
5806282|NCT02698124|Decitabine|decitabine|mesh-list
5806283|NCT02698124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5806284|NCT02698124|Antimetabolites|antimetabolites|mesh-ancestor
5806285|NCT02698124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5806286|NCT02698124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5806287|NCT02698124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5806288|NCT02698306|Dexamethasone|dexamethasone|mesh-list
5806289|NCT02698306|Diclofenac|diclofenac|mesh-list
5806290|NCT02698306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5806291|NCT02698306|Antiemetics|antiemetics|mesh-ancestor
5806292|NCT02698306|Autonomic Agents|autonomic agents|mesh-ancestor
5806293|NCT02698306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5806294|NCT02698306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806295|NCT02698306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5806296|NCT02698306|Glucocorticoids|glucocorticoids|mesh-ancestor
5806297|NCT02698306|Hormones|hormones|mesh-ancestor
5806298|NCT02698306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5806299|NCT02698306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5806300|NCT02698306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5806301|NCT02698306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5806302|NCT02698306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5806303|NCT02698306|Analgesics|analgesics|mesh-ancestor
5806304|NCT02698306|Sensory System Agents|sensory system agents|mesh-ancestor
5806305|NCT02698306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5806306|NCT02698306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5806307|NCT02698306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5806308|NCT02698306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5806309|NCT02698098|Methadone|methadone|mesh-list
5806310|NCT02698098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5806311|NCT02698098|Narcotics|narcotics|mesh-ancestor
5806312|NCT02698098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5806313|NCT02698098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806314|NCT02698098|Analgesics|analgesics|mesh-ancestor
5806315|NCT02698098|Sensory System Agents|sensory system agents|mesh-ancestor
5806316|NCT02698098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5806317|NCT02698098|Antitussive Agents|antitussive agents|mesh-ancestor
5806318|NCT02698098|Respiratory System Agents|respiratory system agents|mesh-ancestor
5806319|NCT02698228|Morphine|morphine|mesh-list
5806320|NCT02698228|Bupivacaine|bupivacaine|mesh-list
5806321|NCT02698228|Anesthetics, Local|anesthetics, local|mesh-ancestor
5806322|NCT02698228|Anesthetics|anesthetics|mesh-ancestor
5806323|NCT02698228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5806324|NCT02698228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806325|NCT02698228|Sensory System Agents|sensory system agents|mesh-ancestor
5806326|NCT02698228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5806327|NCT02698228|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5806328|NCT02698228|Narcotics|narcotics|mesh-ancestor
5806329|NCT02698228|Analgesics|analgesics|mesh-ancestor
5806330|NCT02697955|Epinephrine|epinephrine|mesh-list
5806331|NCT02697955|Bupivacaine|bupivacaine|mesh-list
5806332|NCT02697955|Anesthetics, Local|anesthetics, local|mesh-ancestor
5806333|NCT02697955|Anesthetics|anesthetics|mesh-ancestor
5806334|NCT02697955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5806335|NCT02697955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806336|NCT02697955|Sensory System Agents|sensory system agents|mesh-ancestor
5806337|NCT02697955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5806338|NCT02697955|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5806339|NCT02697955|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5806340|NCT02697955|Adrenergic Agents|adrenergic agents|mesh-ancestor
5806341|NCT02697955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5806342|NCT02697955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5806343|NCT02697955|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5806344|NCT02697955|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5806345|NCT02697955|Autonomic Agents|autonomic agents|mesh-ancestor
5806346|NCT02697955|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5806347|NCT02697955|Respiratory System Agents|respiratory system agents|mesh-ancestor
5806348|NCT02697955|Mydriatics|mydriatics|mesh-ancestor
5806349|NCT02697955|Sympathomimetics|sympathomimetics|mesh-ancestor
5806350|NCT02697955|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5806351|NCT02697851|Atazanavir Sulfate|atazanavir sulfate|mesh-list
5806352|NCT02697851|Cobicistat|cobicistat|mesh-list
5806353|NCT02697851|Levonorgestrel|levonorgestrel|mesh-list
5806354|NCT02697851|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5806355|NCT02697851|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
5806356|NCT02697851|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
5806357|NCT02697851|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5806358|NCT02697851|Contraceptive Agents|contraceptive agents|mesh-ancestor
5806359|NCT02697851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5806360|NCT02697851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806361|NCT02697851|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5806362|NCT02697851|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5806363|NCT02697851|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5806364|NCT02697851|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5806365|NCT02697851|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5806366|NCT02697851|Protease Inhibitors|protease inhibitors|mesh-ancestor
5806367|NCT02697851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5806368|NCT02697851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5806369|NCT02697851|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5806370|NCT02697851|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5806371|NCT02697851|Antiviral Agents|antiviral agents|mesh-ancestor
6492088|NCT00606775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492089|NCT00606775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806372|NCT02697851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5806373|NCT02697851|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5806374|NCT02697851|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5806375|NCT02697851|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5806376|NCT02697851|Estrogens|estrogens|mesh-ancestor
5806377|NCT02697851|Hormones|hormones|mesh-ancestor
5806378|NCT02697851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5806379|NCT02697851|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5806380|NCT02697851|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
5806381|NCT02697851|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5806382|NCT02697851|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5806383|NCT02697877|Regadenoson|regadenoson|mesh-list
5806384|NCT02697877|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
5806385|NCT02697877|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5806386|NCT02697877|Purinergic Agonists|purinergic agonists|mesh-ancestor
5806387|NCT02697877|Purinergic Agents|purinergic agents|mesh-ancestor
5806388|NCT02697877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5806389|NCT02697877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5806390|NCT02697877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806391|NCT02697929|Neostigmine|neostigmine|mesh-list
5806392|NCT02697929|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5806393|NCT02697929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5806394|NCT02697929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5806395|NCT02697929|Cholinergic Agents|cholinergic agents|mesh-ancestor
5806396|NCT02697929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5806397|NCT02697929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806398|NCT02697929|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5806399|NCT02697929|Autonomic Agents|autonomic agents|mesh-ancestor
5806400|NCT02697929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5806401|NCT02697838|Paclitaxel|paclitaxel|mesh-list
5806402|NCT02697838|Apatinib|apatinib|mesh-list
5806403|NCT02697838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5806404|NCT02697838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5806405|NCT02697838|Tubulin Modulators|tubulin modulators|mesh-ancestor
5806406|NCT02697838|Antimitotic Agents|antimitotic agents|mesh-ancestor
5806407|NCT02697838|Mitosis Modulators|mitosis modulators|mesh-ancestor
5806408|NCT02697838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5806409|NCT02697838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5806410|NCT02697838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5900451|NCT04773405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5900452|NCT04773405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900453|NCT04773405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5900454|NCT04773405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5900455|NCT04773405|Adrenergic Agents|adrenergic agents|mesh-ancestor
5900456|NCT04773405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5900457|NCT04773405|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5900458|NCT04773405|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5900459|NCT04773405|Autonomic Agents|autonomic agents|mesh-ancestor
5900460|NCT04773405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5900461|NCT04773405|Respiratory System Agents|respiratory system agents|mesh-ancestor
5900462|NCT04773405|Mydriatics|mydriatics|mesh-ancestor
5900463|NCT04773405|Sympathomimetics|sympathomimetics|mesh-ancestor
5900464|NCT04773405|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5900465|NCT04766996|Aspirin|aspirin|mesh-list
5900466|NCT04766996|Acetaminophen|acetaminophen|mesh-list
5900467|NCT04766996|Prednisone|prednisone|mesh-list
5900468|NCT04766996|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
5900469|NCT04766996|Meloxicam|meloxicam|mesh-list
5900470|NCT04766996|Diclofenac|diclofenac|mesh-list
5900471|NCT04766996|Lidocaine|lidocaine|mesh-list
5900472|NCT04766996|Pregabalin|pregabalin|mesh-list
5900473|NCT04766996|Tramadol|tramadol|mesh-list
5900474|NCT04766996|Bupivacaine|bupivacaine|mesh-list
5900475|NCT04766996|Propofol|propofol|mesh-list
5900476|NCT04766996|Omeprazole|omeprazole|mesh-list
5900477|NCT04766996|Tranexamic Acid|tranexamic acid|mesh-list
5900478|NCT04766996|Anesthetics, Local|anesthetics, local|mesh-ancestor
5900479|NCT04766996|Anesthetics|anesthetics|mesh-ancestor
5900480|NCT04766996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5806411|NCT02697474|Vaccines|vaccines|mesh-list
5806412|NCT02697474|Immunologic Factors|immunologic factors|mesh-ancestor
5806413|NCT02697474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806414|NCT02697669|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5806415|NCT02697669|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5806416|NCT02697669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5806417|NCT02697448|Propofol|propofol|mesh-list
5806418|NCT02697448|Sevoflurane|sevoflurane|mesh-list
5806419|NCT02697448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5806420|NCT02697448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5806421|NCT02697448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806422|NCT02697448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5806423|NCT02697448|Anesthetics, General|anesthetics, general|mesh-ancestor
5806424|NCT02697448|Anesthetics|anesthetics|mesh-ancestor
5806425|NCT02697448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5806426|NCT02697448|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5806427|NCT02697630|Pembrolizumab|pembrolizumab|mesh-list
5806428|NCT02697630|Entinostat|entinostat|mesh-list
5806429|NCT02697630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5806430|NCT02697630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5806431|NCT02697630|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5806432|NCT02697630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5806433|NCT02697630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5806434|NCT02697253|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5806435|NCT02697253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5806436|NCT02697253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806437|NCT02697253|Incretins|incretins|mesh-ancestor
5806438|NCT02697253|Hormones|hormones|mesh-ancestor
5806439|NCT02697253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5806440|NCT02697253|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5806441|NCT02697253|Protease Inhibitors|protease inhibitors|mesh-ancestor
5806442|NCT02697253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5806443|NCT02697253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5806444|NCT02697162|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
5806445|NCT02697162|Octenidine|octenidine|mesh-list
5806446|NCT02697162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5806447|NCT02697201|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
5806448|NCT02697201|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
5806449|NCT02697201|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5806450|NCT02697201|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5806451|NCT02697331|Progesterone|progesterone|mesh-list
5806452|NCT02697331|Progestins|progestins|mesh-ancestor
5806453|NCT02697331|Hormones|hormones|mesh-ancestor
5806454|NCT02697331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5806455|NCT02697331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806456|NCT02697370|Factor VIII|factor viii|mesh-list
5806457|NCT02697370|Coagulants|coagulants|mesh-ancestor
5806458|NCT02697045|Aripiprazole|aripiprazole|mesh-list
5806459|NCT02697045|Antidepressive Agents|antidepressive agents|mesh-ancestor
5806460|NCT02697045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5806461|NCT02697045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5806462|NCT02697045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5806463|NCT02697045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5806464|NCT02697045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806465|NCT02697045|Dopamine Agonists|dopamine agonists|mesh-ancestor
5806466|NCT02697045|Dopamine Agents|dopamine agents|mesh-ancestor
5806467|NCT02697045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5806468|NCT02697045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5806469|NCT02697045|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5806470|NCT02697045|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5806471|NCT02697045|Serotonin Agents|serotonin agents|mesh-ancestor
5806472|NCT02697045|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5806473|NCT02697045|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5806474|NCT02697045|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5806475|NCT02697045|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5806476|NCT02697058|Calcium, Dietary|calcium, dietary|mesh-list
5806477|NCT02697058|Leucovorin|leucovorin|mesh-list
5806478|NCT02697058|Fluorouracil|fluorouracil|mesh-list
5806479|NCT02697058|Calcium|calcium|mesh-list
5806480|NCT02697058|Levoleucovorin|levoleucovorin|mesh-list
5806481|NCT02697058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5806482|NCT02697058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806483|NCT02697058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5806484|NCT02697058|Antimetabolites|antimetabolites|mesh-ancestor
5806485|NCT02697058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5806486|NCT02697058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5806487|NCT02697058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5806488|NCT02697058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5806489|NCT02697058|Immunologic Factors|immunologic factors|mesh-ancestor
5806490|NCT02697058|Antidotes|antidotes|mesh-ancestor
5806491|NCT02697058|Protective Agents|protective agents|mesh-ancestor
5806492|NCT02697058|Vitamin B Complex|vitamin b complex|mesh-ancestor
5806493|NCT02697058|Vitamins|vitamins|mesh-ancestor
5806494|NCT02697058|Micronutrients|micronutrients|mesh-ancestor
5806495|NCT02697318|Timolol|timolol|mesh-list
5806496|NCT02697318|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5806497|NCT02697318|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5806498|NCT02697318|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5806499|NCT02697318|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5806500|NCT02697318|Adrenergic Agents|adrenergic agents|mesh-ancestor
5806501|NCT02697318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5806502|NCT02697318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5806503|NCT02697318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806504|NCT02697318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5806505|NCT02697318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5806506|NCT02697344|Acetic Acid|acetic acid|mesh-list
5806507|NCT02697344|Dexamethasone|dexamethasone|mesh-list
5806508|NCT02697344|Dexamethasone acetate|dexamethasone acetate|mesh-list
5806509|NCT02697344|Lenalidomide|lenalidomide|mesh-list
5806510|NCT02697344|Retinol acetate|retinol acetate|mesh-list
5806511|NCT02697344|Gossypol acetic acid|gossypol acetic acid|mesh-list
5806512|NCT02697344|Gossypol|gossypol|mesh-list
5806513|NCT02697344|BB 1101|bb 1101|mesh-list
5806514|NCT02697344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5806515|NCT02697344|Antiemetics|antiemetics|mesh-ancestor
5806516|NCT02697344|Autonomic Agents|autonomic agents|mesh-ancestor
5806517|NCT02697344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5806518|NCT02697344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806519|NCT02697344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5806520|NCT02697344|Glucocorticoids|glucocorticoids|mesh-ancestor
5806521|NCT02697344|Hormones|hormones|mesh-ancestor
5806522|NCT02697344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5806523|NCT02697344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5806524|NCT02697344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5806525|NCT02697344|Immunologic Factors|immunologic factors|mesh-ancestor
5806526|NCT02697344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5806527|NCT02697344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5806528|NCT02697344|Growth Substances|growth substances|mesh-ancestor
5806529|NCT02697344|Growth Inhibitors|growth inhibitors|mesh-ancestor
5806530|NCT02697344|Protease Inhibitors|protease inhibitors|mesh-ancestor
5806531|NCT02697344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5806532|NCT02697344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5806533|NCT02697344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5806534|NCT02697344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5806535|NCT02697344|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5806536|NCT02697344|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5806537|NCT02697344|Protective Agents|protective agents|mesh-ancestor
5806538|NCT02697344|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5806539|NCT02697344|Contraceptive Agents|contraceptive agents|mesh-ancestor
5806540|NCT02697344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5806541|NCT02697344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5806542|NCT02697344|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5806543|NCT02697344|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
5806544|NCT02697344|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
5806545|NCT02697032|Bicalutamide|bicalutamide|mesh-list
5806546|NCT02697032|Androgen Antagonists|androgen antagonists|mesh-ancestor
5806547|NCT02697032|Hormone Antagonists|hormone antagonists|mesh-ancestor
5806548|NCT02697032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5806549|NCT02697032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806550|NCT02697032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5806551|NCT02696837|Rocuronium|rocuronium|mesh-list
5806552|NCT02696837|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5806553|NCT02696837|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5806554|NCT02696837|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5806555|NCT02696837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5806556|NCT02696837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806557|NCT02696928|Lumefantrine|lumefantrine|mesh-list
5806558|NCT02696928|Primaquine|primaquine|mesh-list
5806559|NCT02696928|Antimalarials|antimalarials|mesh-ancestor
5806560|NCT02696928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5806561|NCT02696928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5806562|NCT02696928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5806563|NCT02696720|Lidocaine|lidocaine|mesh-list
5806564|NCT02696720|Anesthetics, Local|anesthetics, local|mesh-ancestor
5806565|NCT02696720|Anesthetics|anesthetics|mesh-ancestor
5806566|NCT02696720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5806567|NCT02696720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806568|NCT02696720|Sensory System Agents|sensory system agents|mesh-ancestor
5806569|NCT02696720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5806570|NCT02696720|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6211178|NCT02169115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5806571|NCT02696720|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5806572|NCT02696720|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5806573|NCT02696720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5806574|NCT02696720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5806575|NCT02696694|Progesterone|progesterone|mesh-list
5806576|NCT02696694|Progestins|progestins|mesh-ancestor
5806577|NCT02696694|Hormones|hormones|mesh-ancestor
5806578|NCT02696694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5806579|NCT02696694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806580|NCT02696993|Nivolumab|nivolumab|mesh-list
5806581|NCT02696993|Ipilimumab|ipilimumab|mesh-list
5806582|NCT02696993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5806583|NCT02696993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5806584|NCT02696993|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5806585|NCT02696993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5806586|NCT02696941|Metformin|metformin|mesh-list
5806587|NCT02696941|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
5806588|NCT02696941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5806589|NCT02696941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806590|NCT02696941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5806591|NCT02696954|Lumefantrine|lumefantrine|mesh-list
5806592|NCT02696954|Artemether|artemether|mesh-list
5806593|NCT02696954|Primaquine|primaquine|mesh-list
5806594|NCT02696954|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
5806595|NCT02696954|Amodiaquine|amodiaquine|mesh-list
5806596|NCT02696954|Antimalarials|antimalarials|mesh-ancestor
5806597|NCT02696954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5806598|NCT02696954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5806599|NCT02696954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5806600|NCT02696733|Cephalosporins|cephalosporins|mesh-list
5806601|NCT02696733|Lidocaine|lidocaine|mesh-list
5806602|NCT02696733|Anesthetics, Local|anesthetics, local|mesh-ancestor
5806603|NCT02696733|Anesthetics|anesthetics|mesh-ancestor
5806604|NCT02696733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5806605|NCT02696733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806606|NCT02696733|Sensory System Agents|sensory system agents|mesh-ancestor
5806607|NCT02696733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5806608|NCT02696733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5806609|NCT02696733|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5806610|NCT02696733|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5806611|NCT02696733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5806612|NCT02696733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5806613|NCT02696733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5806614|NCT02696733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5806615|NCT02696915|Fentanyl|fentanyl|mesh-list
5806616|NCT02696915|Bupivacaine|bupivacaine|mesh-list
5806617|NCT02696915|Anesthetics, Local|anesthetics, local|mesh-ancestor
5806618|NCT02696915|Anesthetics|anesthetics|mesh-ancestor
5806619|NCT02696915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5806620|NCT02696915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806621|NCT02696915|Sensory System Agents|sensory system agents|mesh-ancestor
5806622|NCT02696915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5806623|NCT02696915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5806624|NCT02696915|Narcotics|narcotics|mesh-ancestor
5806625|NCT02696915|Analgesics|analgesics|mesh-ancestor
5806626|NCT02696915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5806627|NCT02696915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5806628|NCT02696915|Anesthetics, General|anesthetics, general|mesh-ancestor
5806629|NCT02696564|Losartan|losartan|mesh-list
5806630|NCT02696564|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5806631|NCT02696564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5806632|NCT02696564|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5806633|NCT02696564|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5806634|NCT02696564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5806635|NCT02696590|Vitamin D|vitamin d|mesh-list
5806636|NCT02696590|Cholecalciferol|cholecalciferol|mesh-list
5806637|NCT02696590|Vitamins|vitamins|mesh-ancestor
5806638|NCT02696590|Micronutrients|micronutrients|mesh-ancestor
5806639|NCT02696590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806640|NCT02696590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5806641|NCT02696590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5806642|NCT02696512|Thioctic Acid|thioctic acid|mesh-list
5806643|NCT02696512|Minocycline|minocycline|mesh-list
5806644|NCT02696512|Lamotrigine|lamotrigine|mesh-list
5806645|NCT02696512|Flumazenil|flumazenil|mesh-list
5806646|NCT02696512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5806647|NCT02696512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5806648|NCT02696512|Anticonvulsants|anticonvulsants|mesh-ancestor
5806649|NCT02696512|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5806650|NCT02696512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5806651|NCT02696512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5806652|NCT02696512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5806653|NCT02696512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806654|NCT02696512|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5806655|NCT02696512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5806656|NCT02696512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5806657|NCT02696512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5806658|NCT02696512|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5806659|NCT02696512|Antioxidants|antioxidants|mesh-ancestor
5806660|NCT02696512|Protective Agents|protective agents|mesh-ancestor
5806661|NCT02696512|Vitamin B Complex|vitamin b complex|mesh-ancestor
5806662|NCT02696512|Vitamins|vitamins|mesh-ancestor
5806663|NCT02696512|Micronutrients|micronutrients|mesh-ancestor
5806664|NCT02696512|Antidotes|antidotes|mesh-ancestor
5806665|NCT02696512|GABA Modulators|gaba modulators|mesh-ancestor
5806666|NCT02696512|GABA Agents|gaba agents|mesh-ancestor
5806667|NCT02696512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5806668|NCT02696577|Aspirin|aspirin|mesh-list
5806669|NCT02696577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5806670|NCT02696577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5806671|NCT02696577|Analgesics|analgesics|mesh-ancestor
5806672|NCT02696577|Sensory System Agents|sensory system agents|mesh-ancestor
5806673|NCT02696577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5806674|NCT02696577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806675|NCT02696577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5806676|NCT02696577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5806677|NCT02696577|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5806678|NCT02696577|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5806679|NCT02696577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5806680|NCT02696577|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5806681|NCT02696577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5806682|NCT02696577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5806683|NCT02696577|Antipyretics|antipyretics|mesh-ancestor
5806684|NCT02696642|Maytansine|maytansine|mesh-list
5806685|NCT02696642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5806686|NCT02696642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5806687|NCT02696642|Tubulin Modulators|tubulin modulators|mesh-ancestor
5806688|NCT02696642|Antimitotic Agents|antimitotic agents|mesh-ancestor
5806689|NCT02696642|Mitosis Modulators|mitosis modulators|mesh-ancestor
5806690|NCT02696642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5806691|NCT02696460|Lidocaine|lidocaine|mesh-list
5806692|NCT02696460|Prilocaine|prilocaine|mesh-list
5806693|NCT02696460|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
5806694|NCT02696460|Anesthetics, Local|anesthetics, local|mesh-ancestor
6492090|NCT00606775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5806695|NCT02696460|Anesthetics|anesthetics|mesh-ancestor
6492091|NCT00606775|Antioxidants|antioxidants|mesh-ancestor
5806696|NCT02696460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5806697|NCT02696460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806698|NCT02696460|Sensory System Agents|sensory system agents|mesh-ancestor
5806699|NCT02696460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5806700|NCT02696460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5806701|NCT02696460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5806702|NCT02696460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5806703|NCT02696460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5806704|NCT02696460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5806705|NCT02696460|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
5806706|NCT02696330|Enoxaparin|enoxaparin|mesh-list
5806707|NCT02696330|Clopidogrel|clopidogrel|mesh-list
5806708|NCT02696330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5806709|NCT02696330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5806710|NCT02696330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5806711|NCT02696330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5806712|NCT02696330|Purinergic Agents|purinergic agents|mesh-ancestor
5806713|NCT02696330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5806714|NCT02696330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5806715|NCT02696330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806716|NCT02696330|Anticoagulants|anticoagulants|mesh-ancestor
5806717|NCT02696330|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5806718|NCT02696330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5806719|NCT02696369|Lidocaine|lidocaine|mesh-list
5806720|NCT02696369|Epinephrine|epinephrine|mesh-list
5806721|NCT02696369|Racepinephrine|racepinephrine|mesh-list
5806722|NCT02696369|Epinephryl borate|epinephryl borate|mesh-list
5806723|NCT02696369|Anesthetics, Local|anesthetics, local|mesh-ancestor
5806724|NCT02696369|Anesthetics|anesthetics|mesh-ancestor
5641750|NCT02250326|Paclitaxel|paclitaxel|mesh-list
5641751|NCT02250326|Azacitidine|azacitidine|mesh-list
5641752|NCT02250326|Cc-486|cc-486|mesh-list
5641753|NCT02250326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5641754|NCT02250326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5641755|NCT02250326|Tubulin Modulators|tubulin modulators|mesh-ancestor
5806725|NCT02696369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5806726|NCT02696369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806727|NCT02696369|Sensory System Agents|sensory system agents|mesh-ancestor
5806728|NCT02696369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5806729|NCT02696369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5806730|NCT02696369|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5806731|NCT02696369|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5806732|NCT02696369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5806733|NCT02696369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5806734|NCT02696369|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5806735|NCT02696369|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5806736|NCT02696369|Adrenergic Agents|adrenergic agents|mesh-ancestor
5806737|NCT02696369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5806738|NCT02696369|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5806739|NCT02696369|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5806740|NCT02696369|Autonomic Agents|autonomic agents|mesh-ancestor
5806741|NCT02696369|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5806742|NCT02696369|Respiratory System Agents|respiratory system agents|mesh-ancestor
5806743|NCT02696369|Mydriatics|mydriatics|mesh-ancestor
5806744|NCT02696369|Sympathomimetics|sympathomimetics|mesh-ancestor
5806745|NCT02696369|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5900481|NCT04766996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900482|NCT04766996|Sensory System Agents|sensory system agents|mesh-ancestor
5900483|NCT04766996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5900484|NCT04766996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5900485|NCT04766996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5900486|NCT04766996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5900487|NCT04766996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5900488|NCT04766996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900489|NCT04766996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5900490|NCT04766996|Glucocorticoids|glucocorticoids|mesh-ancestor
5900491|NCT04766996|Hormones|hormones|mesh-ancestor
5900492|NCT04766996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5900493|NCT04766996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5900494|NCT04766996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5900495|NCT04766996|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5900496|NCT04766996|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5900497|NCT04766996|Anesthetics, General|anesthetics, general|mesh-ancestor
5900498|NCT04766996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5900499|NCT04766996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5806746|NCT02696096|Buprenorphine|buprenorphine|mesh-list
5806747|NCT02696096|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
5806748|NCT02696096|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5641756|NCT02250326|Antimitotic Agents|antimitotic agents|mesh-ancestor
5641757|NCT02250326|Mitosis Modulators|mitosis modulators|mesh-ancestor
5641758|NCT02250326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641759|NCT02250326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5641760|NCT02250326|Antimetabolites|antimetabolites|mesh-ancestor
5806749|NCT02696096|Narcotics|narcotics|mesh-ancestor
5806750|NCT02696096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5806751|NCT02696096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806752|NCT02696096|Analgesics|analgesics|mesh-ancestor
5806753|NCT02696096|Sensory System Agents|sensory system agents|mesh-ancestor
5806754|NCT02696096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6492092|NCT00606775|Protective Agents|protective agents|mesh-ancestor
6492093|NCT00606775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6492094|NCT00606775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6492095|NCT00606775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6492096|NCT00606775|Vasodilator Agents|vasodilator agents|mesh-ancestor
6492097|NCT00606775|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6492098|NCT00606775|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5806755|NCT02696096|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5806756|NCT02696122|Anesthetics|anesthetics|mesh-list
5806757|NCT02696122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5806758|NCT02696122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806759|NCT02696148|Liraglutide|liraglutide|mesh-list
5806760|NCT02696148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5806761|NCT02696148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806762|NCT02696148|Incretins|incretins|mesh-ancestor
5806763|NCT02696148|Hormones|hormones|mesh-ancestor
5806764|NCT02696148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5806765|NCT02695901|Chlorhexidine|chlorhexidine|mesh-list
5806766|NCT02695901|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5806767|NCT02695901|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5806768|NCT02695901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5806769|NCT02695901|Disinfectants|disinfectants|mesh-ancestor
5806770|NCT02695901|Dermatologic Agents|dermatologic agents|mesh-ancestor
5806771|NCT02695810|Metformin|metformin|mesh-list
5806772|NCT02695810|Dapagliflozin|dapagliflozin|mesh-list
5806773|NCT02695810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5806774|NCT02695810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806775|NCT02695810|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5806776|NCT02695810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5806777|NCT02695797|Prednisolone|prednisolone|mesh-list
5806778|NCT02695797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5806779|NCT02695797|Glucocorticoids|glucocorticoids|mesh-ancestor
5806780|NCT02695797|Hormones|hormones|mesh-ancestor
6492099|NCT00606814|Docetaxel|docetaxel|mesh-list
5641761|NCT02250326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5641762|NCT02152995|Iodine|iodine|mesh-list
5641763|NCT02152995|Cadexomer iodine|cadexomer iodine|mesh-list
5806781|NCT02695797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5806782|NCT02695797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806783|NCT02695797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5806784|NCT02695797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5806785|NCT02695654|Clonidine|clonidine|mesh-list
5806786|NCT02695654|Levobupivacaine|levobupivacaine|mesh-list
5806787|NCT02695654|Anesthetics, Local|anesthetics, local|mesh-ancestor
5806788|NCT02695654|Anesthetics|anesthetics|mesh-ancestor
5806789|NCT02695654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5806790|NCT02695654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806791|NCT02695654|Sensory System Agents|sensory system agents|mesh-ancestor
5806792|NCT02695654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5806793|NCT02695654|Analgesics|analgesics|mesh-ancestor
5806794|NCT02695654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5806795|NCT02695654|Sympatholytics|sympatholytics|mesh-ancestor
5806796|NCT02695654|Autonomic Agents|autonomic agents|mesh-ancestor
5806797|NCT02695654|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5806798|NCT02695654|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5806799|NCT02695654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5806800|NCT02695654|Adrenergic Agents|adrenergic agents|mesh-ancestor
5806801|NCT02695654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5806802|NCT02695654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5806803|NCT02695771|Gemcitabine|gemcitabine|mesh-list
5806804|NCT02695771|Mitomycins|mitomycins|mesh-list
5806805|NCT02695771|Mitomycin|mitomycin|mesh-list
5806806|NCT02695771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5806807|NCT02695771|Antimetabolites|antimetabolites|mesh-ancestor
5806808|NCT02695771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492100|NCT00606814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6492101|NCT00606814|Tubulin Modulators|tubulin modulators|mesh-ancestor
6492102|NCT00606814|Antimitotic Agents|antimitotic agents|mesh-ancestor
6492103|NCT00606814|Mitosis Modulators|mitosis modulators|mesh-ancestor
6492104|NCT00606814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492105|NCT00606866|Sorafenib|sorafenib|mesh-list
5806809|NCT02695771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5806810|NCT02695771|Antiviral Agents|antiviral agents|mesh-ancestor
5806811|NCT02695771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5806812|NCT02695771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5806813|NCT02695771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5806814|NCT02695771|Immunologic Factors|immunologic factors|mesh-ancestor
5806815|NCT02695771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492106|NCT00606866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5806816|NCT02695771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5806817|NCT02695771|Alkylating Agents|alkylating agents|mesh-ancestor
5806818|NCT02695771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5806819|NCT02695862|Terlipressin|terlipressin|mesh-list
5806820|NCT02695862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5806821|NCT02695862|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5806822|NCT02695758|Bupivacaine|bupivacaine|mesh-list
5806823|NCT02695758|Anesthetics, Local|anesthetics, local|mesh-ancestor
5806824|NCT02695758|Anesthetics|anesthetics|mesh-ancestor
5806825|NCT02695758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5806826|NCT02695758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806827|NCT02695758|Sensory System Agents|sensory system agents|mesh-ancestor
5806828|NCT02695758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5806829|NCT02695563|Lactoferrin|lactoferrin|mesh-list
5806830|NCT02695563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5806831|NCT02695459|Everolimus|everolimus|mesh-list
5806832|NCT02695459|Cisplatin|cisplatin|mesh-list
5806833|NCT02695459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5806834|NCT02695459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5806835|NCT02695459|Immunologic Factors|immunologic factors|mesh-ancestor
5806836|NCT02695459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806837|NCT02695641|Bevacizumab|bevacizumab|mesh-list
5806838|NCT02695641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5806839|NCT02695641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5806840|NCT02695641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5806841|NCT02695641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5806842|NCT02695641|Growth Substances|growth substances|mesh-ancestor
5806843|NCT02695641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806844|NCT02695641|Growth Inhibitors|growth inhibitors|mesh-ancestor
5806845|NCT02695745|Celecoxib|celecoxib|mesh-list
5806846|NCT02695745|Capsaicin|capsaicin|mesh-list
5806847|NCT02695745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5806848|NCT02695745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5806849|NCT02695745|Analgesics|analgesics|mesh-ancestor
5806850|NCT02695745|Sensory System Agents|sensory system agents|mesh-ancestor
5806851|NCT02695745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5806852|NCT02695745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806853|NCT02695745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5806854|NCT02695745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5806855|NCT02695745|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5806856|NCT02695745|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5806857|NCT02695745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5806858|NCT02695745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5806859|NCT02695745|Antipruritics|antipruritics|mesh-ancestor
5806860|NCT02695745|Dermatologic Agents|dermatologic agents|mesh-ancestor
5806861|NCT02695732|Carvedilol|carvedilol|mesh-list
5806862|NCT02695732|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5806863|NCT02695732|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5806864|NCT02695732|Adrenergic Agents|adrenergic agents|mesh-ancestor
5806865|NCT02695732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5806866|NCT02695732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5806867|NCT02695732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806868|NCT02695732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5806869|NCT02695732|Antioxidants|antioxidants|mesh-ancestor
5806870|NCT02695732|Protective Agents|protective agents|mesh-ancestor
5806871|NCT02695732|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5806872|NCT02695732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5806873|NCT02695732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5806874|NCT02695732|Vasodilator Agents|vasodilator agents|mesh-ancestor
5806875|NCT02695732|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5806876|NCT02695732|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5806877|NCT02695381|Etodolac|etodolac|mesh-list
5806878|NCT02695381|Lidocaine|lidocaine|mesh-list
5806879|NCT02695381|Anesthetics, Local|anesthetics, local|mesh-ancestor
5806880|NCT02695381|Anesthetics|anesthetics|mesh-ancestor
5806881|NCT02695381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5806882|NCT02695381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806883|NCT02695381|Sensory System Agents|sensory system agents|mesh-ancestor
5806884|NCT02695381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5806885|NCT02695381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5806886|NCT02695381|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6492107|NCT00606866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6492108|NCT00606866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6492109|NCT00606866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492110|NCT00606957|Vitamin D|vitamin d|mesh-list
5641764|NCT02152995|Trametinib|trametinib|mesh-list
5641765|NCT02152995|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5641766|NCT02152995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5641767|NCT02152995|Trace Elements|trace elements|mesh-ancestor
5641768|NCT02152995|Micronutrients|micronutrients|mesh-ancestor
5641769|NCT02152995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641770|NCT02152995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5641771|NCT02152995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5641772|NCT02152995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5641773|NCT02152995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641774|NCT02102113|Dronabinol|dronabinol|mesh-list
5641775|NCT02102113|Hallucinogens|hallucinogens|mesh-ancestor
5806887|NCT02695381|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5806888|NCT02695381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5806889|NCT02695381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5806890|NCT02695381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5806891|NCT02695381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6492111|NCT00606957|Cholecalciferol|cholecalciferol|mesh-list
6492112|NCT00606957|Vitamins|vitamins|mesh-ancestor
6492113|NCT00606957|Micronutrients|micronutrients|mesh-ancestor
5806892|NCT02695381|Analgesics|analgesics|mesh-ancestor
5806893|NCT02695381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5806894|NCT02695381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5806895|NCT02695381|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5806896|NCT02695381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5806897|NCT02695381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5806898|NCT02695355|Methylphenidate|methylphenidate|mesh-list
5806899|NCT02695355|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6492114|NCT00606957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492115|NCT00606957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5806900|NCT02695355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806901|NCT02695355|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5806902|NCT02695355|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5806903|NCT02695355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5806904|NCT02695355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5806905|NCT02695355|Dopamine Agents|dopamine agents|mesh-ancestor
5806906|NCT02695355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5806907|NCT02695212|Apremilast|apremilast|mesh-list
5806908|NCT02695212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5806909|NCT02695212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6492116|NCT00606957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6492117|NCT00606983|Tamsulosin|tamsulosin|mesh-list
6492118|NCT00606983|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6492119|NCT00606983|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5806910|NCT02695212|Analgesics|analgesics|mesh-ancestor
5806911|NCT02695212|Sensory System Agents|sensory system agents|mesh-ancestor
5806912|NCT02695212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5806913|NCT02695212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806914|NCT02695212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5806915|NCT02695212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5806916|NCT02695212|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5806917|NCT02695212|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5806918|NCT02695212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5806919|NCT02695212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5806920|NCT02695004|Donepezil|donepezil|mesh-list
5806921|NCT02695004|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5806922|NCT02695004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5806923|NCT02695004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5806924|NCT02695004|Cholinergic Agents|cholinergic agents|mesh-ancestor
5806925|NCT02695004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6492120|NCT00606983|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6492121|NCT00606983|Adrenergic Agents|adrenergic agents|mesh-ancestor
5806926|NCT02695004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806927|NCT02695004|Nootropic Agents|nootropic agents|mesh-ancestor
5806928|NCT02694874|Rosiglitazone|rosiglitazone|mesh-list
5806929|NCT02694874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5806930|NCT02694874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806931|NCT02694809|Bazedoxifene|bazedoxifene|mesh-list
5806932|NCT02694809|Estrogens|estrogens|mesh-list
5806933|NCT02694809|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
5806934|NCT02694809|Hormones|hormones|mesh-ancestor
5806935|NCT02694809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5806936|NCT02694809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806937|NCT02694809|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5806938|NCT02694809|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5806939|NCT02694809|Hormone Antagonists|hormone antagonists|mesh-ancestor
5806940|NCT02694809|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5806941|NCT02694692|Vaccines|vaccines|mesh-list
5806942|NCT02694692|Immunologic Factors|immunologic factors|mesh-ancestor
5806943|NCT02694692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806944|NCT02694848|Aspirin|aspirin|mesh-list
5806945|NCT02694848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5806946|NCT02694848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5806947|NCT02694848|Analgesics|analgesics|mesh-ancestor
5806948|NCT02694848|Sensory System Agents|sensory system agents|mesh-ancestor
5806949|NCT02694848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5806950|NCT02694848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806951|NCT02694848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5806952|NCT02694848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5806953|NCT02694848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5806954|NCT02694848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5806955|NCT02694848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5806956|NCT02694848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5806957|NCT02694848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5806958|NCT02694848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5806959|NCT02694848|Antipyretics|antipyretics|mesh-ancestor
5806960|NCT02694588|Infliximab|infliximab|mesh-list
5806961|NCT02694588|Vedolizumab|vedolizumab|mesh-list
5806962|NCT02694588|Dermatologic Agents|dermatologic agents|mesh-ancestor
5806963|NCT02694588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5806964|NCT02694588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5806965|NCT02694653|Acetaminophen|acetaminophen|mesh-list
5806966|NCT02694653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5806967|NCT02694653|Analgesics|analgesics|mesh-ancestor
5806968|NCT02694653|Sensory System Agents|sensory system agents|mesh-ancestor
5806969|NCT02694653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5806970|NCT02694653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806971|NCT02694653|Antipyretics|antipyretics|mesh-ancestor
5900500|NCT04766996|Analgesics|analgesics|mesh-ancestor
5900501|NCT04766996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5900502|NCT04766996|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5900503|NCT04766996|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5900504|NCT04766996|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5900505|NCT04766996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5900506|NCT04766996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5900507|NCT04766996|Antipyretics|antipyretics|mesh-ancestor
5900508|NCT04766996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5900509|NCT04766996|Anticonvulsants|anticonvulsants|mesh-ancestor
5900510|NCT04766996|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5900511|NCT04766996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5900512|NCT04766996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5900513|NCT04766996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5900514|NCT04766996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5900515|NCT04766996|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6211179|NCT02169115|Respiratory System Agents|respiratory system agents|mesh-ancestor
6211180|NCT02169115|Immunologic Factors|immunologic factors|mesh-ancestor
6211181|NCT02169115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211182|NCT02169219|Prednisone|prednisone|mesh-list
5900516|NCT04766996|Hemostatics|hemostatics|mesh-ancestor
5900517|NCT04766996|Coagulants|coagulants|mesh-ancestor
5900518|NCT04766996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5900519|NCT04766996|Narcotics|narcotics|mesh-ancestor
5900520|NCT04766996|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5900521|NCT04766996|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5900522|NCT04766996|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5900523|NCT04754061|Psilocybin|psilocybin|mesh-list
5900524|NCT04754061|Hallucinogens|hallucinogens|mesh-ancestor
5900525|NCT04754061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900526|NCT04754061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5900527|NCT04752475|Furosemide|furosemide|mesh-list
5900528|NCT04752475|Diuretics|diuretics|mesh-ancestor
5900529|NCT04752475|Natriuretic Agents|natriuretic agents|mesh-ancestor
5900530|NCT04752475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900531|NCT04752475|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5900532|NCT04752475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5900533|NCT04752475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900534|NCT04732260|Letermovir|letermovir|mesh-list
5900535|NCT04732260|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5900536|NCT04732260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5900537|NCT04732260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900538|NCT04732260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5900539|NCT04732260|Antiviral Agents|antiviral agents|mesh-ancestor
5900540|NCT04732260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5900541|NCT04722601|Azacitidine|azacitidine|mesh-list
5900542|NCT04722601|Venetoclax|venetoclax|mesh-list
5900543|NCT04722601|Obinutuzumab|obinutuzumab|mesh-list
5900544|NCT04722601|Cc-486|cc-486|mesh-list
5900545|NCT04722601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5900546|NCT04722601|Antimetabolites|antimetabolites|mesh-ancestor
5900547|NCT04722601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900548|NCT04722601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5900549|NCT04722601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6211183|NCT02169219|Rituximab|rituximab|mesh-list
5900550|NCT04722601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6211184|NCT02169219|Glucocorticoids|glucocorticoids|mesh-list
6211185|NCT02169219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6211186|NCT02169219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6211187|NCT02169219|Immunologic Factors|immunologic factors|mesh-ancestor
6211188|NCT02169219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211189|NCT02169219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6211190|NCT02169219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6211191|NCT02169219|Hormones|hormones|mesh-ancestor
6211192|NCT02169219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6211193|NCT02169219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5806972|NCT02694458|Vancomycin|vancomycin|mesh-list
5806973|NCT02694458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5806974|NCT02694458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5806975|NCT02694289|Metformin|metformin|mesh-list
6492122|NCT00606983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6492123|NCT00606983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492124|NCT00606983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492125|NCT00606983|Urological Agents|urological agents|mesh-ancestor
6492126|NCT00607035|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6492127|NCT00607035|Olmesartan|olmesartan|mesh-list
6492128|NCT00607035|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6492129|NCT00607035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6492130|NCT00607035|Diuretics|diuretics|mesh-ancestor
5806976|NCT02694289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5806977|NCT02694289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806978|NCT02694263|Pioglitazone|pioglitazone|mesh-list
5806979|NCT02694263|Glimepiride|glimepiride|mesh-list
5806980|NCT02694263|Canagliflozin|canagliflozin|mesh-list
5806981|NCT02694263|Repaglinide|repaglinide|mesh-list
5806982|NCT02694263|Gliclazide|gliclazide|mesh-list
5806983|NCT02694263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6211194|NCT02169271|Aspirin|aspirin|mesh-list
6211195|NCT02169271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5806984|NCT02694263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806985|NCT02694263|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6211196|NCT02169271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6211197|NCT02169271|Analgesics|analgesics|mesh-ancestor
6211198|NCT02169271|Sensory System Agents|sensory system agents|mesh-ancestor
6492131|NCT00607035|Natriuretic Agents|natriuretic agents|mesh-ancestor
6492132|NCT00607035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492133|NCT00607035|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6492134|NCT00607035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6492135|NCT00607035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492136|NCT00607035|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6492137|NCT00607035|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6492138|NCT00607074|Albendazole|albendazole|mesh-list
5806986|NCT02694263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5806987|NCT02694263|Immunologic Factors|immunologic factors|mesh-ancestor
5806988|NCT02694263|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5806989|NCT02694263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5806990|NCT02694146|Hylan|hylan|mesh-list
5806991|NCT02694146|Viscosupplements|viscosupplements|mesh-ancestor
5806992|NCT02694146|Protective Agents|protective agents|mesh-ancestor
5806993|NCT02694146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5806994|NCT02693769|Fluticasone|fluticasone|mesh-list
5806995|NCT02693769|Xhance|xhance|mesh-list
5806996|NCT02693769|Glycopyrrolate|glycopyrrolate|mesh-list
5806997|NCT02693769|Bromides|bromides|mesh-list
5806998|NCT02693769|Formoterol Fumarate|formoterol fumarate|mesh-list
5806999|NCT02693769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5807000|NCT02693769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5807001|NCT02693769|Autonomic Agents|autonomic agents|mesh-ancestor
5807002|NCT02693769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5807003|NCT02693769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807004|NCT02693769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5807005|NCT02693769|Respiratory System Agents|respiratory system agents|mesh-ancestor
5807006|NCT02693769|Dermatologic Agents|dermatologic agents|mesh-ancestor
5807007|NCT02693769|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5807008|NCT02693769|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5807009|NCT02693769|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5807010|NCT02693769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5807011|NCT02693769|Adrenergic Agents|adrenergic agents|mesh-ancestor
5807012|NCT02693769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5807013|NCT02693769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5807014|NCT02693769|Anticonvulsants|anticonvulsants|mesh-ancestor
5807015|NCT02693769|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5807016|NCT02693769|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5807017|NCT02693769|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5807018|NCT02693769|Cholinergic Agents|cholinergic agents|mesh-ancestor
5807019|NCT02694224|Paclitaxel|paclitaxel|mesh-list
5807020|NCT02694224|Cyclophosphamide|cyclophosphamide|mesh-list
5807021|NCT02694224|Epirubicin|epirubicin|mesh-list
5807022|NCT02694224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5807023|NCT02694224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5807024|NCT02694224|Tubulin Modulators|tubulin modulators|mesh-ancestor
5807025|NCT02694224|Antimitotic Agents|antimitotic agents|mesh-ancestor
5807026|NCT02694224|Mitosis Modulators|mitosis modulators|mesh-ancestor
5807027|NCT02694224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5807028|NCT02694224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5807029|NCT02694224|Immunologic Factors|immunologic factors|mesh-ancestor
5807030|NCT02694224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807031|NCT02694224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5807032|NCT02694224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5807033|NCT02694224|Alkylating Agents|alkylating agents|mesh-ancestor
5807034|NCT02694224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5807035|NCT02694224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5807036|NCT02694224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5807037|NCT02694224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5807038|NCT02694224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5807039|NCT02693951|Cefotiam|cefotiam|mesh-list
5807040|NCT02693951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5807041|NCT02693951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5807042|NCT02693860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6492139|NCT00607074|Anthelmintics|anthelmintics|mesh-list
5807043|NCT02693860|Immunologic Factors|immunologic factors|mesh-ancestor
5807044|NCT02693860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807045|NCT02693808|Hyaluronic Acid|hyaluronic acid|mesh-list
5807046|NCT02693808|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5807047|NCT02693808|Immunologic Factors|immunologic factors|mesh-ancestor
5807048|NCT02693808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807049|NCT02693808|Viscosupplements|viscosupplements|mesh-ancestor
5807050|NCT02693808|Protective Agents|protective agents|mesh-ancestor
5807051|NCT02693574|Amoxicillin|amoxicillin|mesh-list
5807052|NCT02693574|Clarithromycin|clarithromycin|mesh-list
5807053|NCT02693574|Levofloxacin|levofloxacin|mesh-list
5807054|NCT02693574|Ofloxacin|ofloxacin|mesh-list
5807055|NCT02693574|Esomeprazole|esomeprazole|mesh-list
5807056|NCT02693574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5807057|NCT02693574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5807058|NCT02693574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5807059|NCT02693574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5807060|NCT02693574|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5807061|NCT02693574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5807062|NCT02693574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5807063|NCT02693574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5807064|NCT02693574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5807065|NCT02693574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5807066|NCT02693574|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5807067|NCT02693574|Renal Agents|renal agents|mesh-ancestor
5807068|NCT02693574|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5807069|NCT02693574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5807070|NCT02693574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5807071|NCT02693574|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5807072|NCT02693470|Ustekinumab|ustekinumab|mesh-list
5807073|NCT02693470|Dermatologic Agents|dermatologic agents|mesh-ancestor
5807074|NCT02693444|Lidocaine|lidocaine|mesh-list
5807075|NCT02693444|Anesthetics, Local|anesthetics, local|mesh-ancestor
5807076|NCT02693444|Anesthetics|anesthetics|mesh-ancestor
5807077|NCT02693444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5807078|NCT02693444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807079|NCT02693444|Sensory System Agents|sensory system agents|mesh-ancestor
5807080|NCT02693444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5807081|NCT02693444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5807082|NCT02693444|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5807083|NCT02693444|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5807084|NCT02693444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5807085|NCT02693444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5807086|NCT02693184|Vitamin D|vitamin d|mesh-list
5807087|NCT02693184|Calcium|calcium|mesh-list
5807088|NCT02693184|Vitamins|vitamins|mesh-ancestor
5807089|NCT02693184|Micronutrients|micronutrients|mesh-ancestor
5807090|NCT02693184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807091|NCT02693184|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5807092|NCT02693184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5807093|NCT02693288|Anesthetics|anesthetics|mesh-list
5807094|NCT02693288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5807095|NCT02693288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807096|NCT02693392|Metformin|metformin|mesh-list
5807097|NCT02693392|Hypoglycemic Agents|hypoglycemic agents|mesh-list
5807098|NCT02693392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807099|NCT02693483|Povidone-Iodine|povidone-iodine|mesh-list
5807100|NCT02693483|Povidone|povidone|mesh-list
5807101|NCT02693483|Plasma Substitutes|plasma substitutes|mesh-ancestor
6211199|NCT02169271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5807102|NCT02693483|Blood Substitutes|blood substitutes|mesh-ancestor
5807103|NCT02693483|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5807104|NCT02693483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5807105|NCT02693145|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
5807106|NCT02693145|Antiviral Agents|antiviral agents|mesh-ancestor
5807107|NCT02693145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5807108|NCT02693210|Cyclophosphamide|cyclophosphamide|mesh-list
5807109|NCT02693210|Rituximab|rituximab|mesh-list
5807110|NCT02693210|Methotrexate|methotrexate|mesh-list
5807111|NCT02693210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5807112|NCT02693210|Immunologic Factors|immunologic factors|mesh-ancestor
5807113|NCT02693210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807114|NCT02693210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5807115|NCT02693210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5807116|NCT02693210|Alkylating Agents|alkylating agents|mesh-ancestor
5807117|NCT02693210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5807118|NCT02693210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5807119|NCT02693210|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5807120|NCT02693210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5807121|NCT02693210|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6211200|NCT02169271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211201|NCT02169271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5807122|NCT02693210|Abortifacient Agents|abortifacient agents|mesh-ancestor
5807123|NCT02693210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5807124|NCT02693210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6211202|NCT02169271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6211203|NCT02169271|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6211204|NCT02169271|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6211205|NCT02169271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5807125|NCT02693210|Antimetabolites|antimetabolites|mesh-ancestor
5807126|NCT02693210|Dermatologic Agents|dermatologic agents|mesh-ancestor
5807127|NCT02693210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5807128|NCT02693210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5807129|NCT02693210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5807130|NCT02692989|Anesthetics|anesthetics|mesh-list
5807131|NCT02692989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5807132|NCT02692989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807133|NCT02692963|Vaccines|vaccines|mesh-list
5807134|NCT02692963|Immunologic Factors|immunologic factors|mesh-ancestor
5807135|NCT02692963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807136|NCT02692976|Vaccines|vaccines|mesh-list
5807137|NCT02692976|Immunologic Factors|immunologic factors|mesh-ancestor
5807138|NCT02692976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900551|NCT04700514|Dexmedetomidine|dexmedetomidine|mesh-list
5900552|NCT04700514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5900553|NCT04700514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5900554|NCT04700514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900555|NCT04700514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5900556|NCT04700514|Analgesics|analgesics|mesh-ancestor
5900557|NCT04700514|Sensory System Agents|sensory system agents|mesh-ancestor
5900558|NCT04700514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5900559|NCT04700514|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5900560|NCT04700514|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5900561|NCT04700514|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5900562|NCT04700514|Adrenergic Agents|adrenergic agents|mesh-ancestor
5900563|NCT04700514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5900564|NCT04700514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900565|NCT04693468|Palbociclib|palbociclib|mesh-list
5900566|NCT04693468|Axitinib|axitinib|mesh-list
5900567|NCT04693468|Crizotinib|crizotinib|mesh-list
5900568|NCT04693468|Talazoparib|talazoparib|mesh-list
5900569|NCT04693468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5900570|NCT04693468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5900571|NCT04693468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5900572|NCT04693468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900573|NCT04693468|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5900574|NCT04684420|Metformin|metformin|mesh-list
5900575|NCT04684420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5900576|NCT04684420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900577|NCT04654312|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6211206|NCT02169271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6211207|NCT02169271|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6211208|NCT02169271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6211209|NCT02169271|Antipyretics|antipyretics|mesh-ancestor
6211210|NCT02169284|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6211211|NCT02169284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6211212|NCT02169284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6211213|NCT02169284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6211214|NCT02169284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211215|NCT02169336|Dexmedetomidine|dexmedetomidine|mesh-list
6211216|NCT02169336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5807139|NCT02692651|Vancomycin|vancomycin|mesh-list
5807140|NCT02692651|Fidaxomicin|fidaxomicin|mesh-list
5807141|NCT02692651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5807142|NCT02692651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5807143|NCT02692599|Vaccines|vaccines|mesh-list
5807144|NCT02692599|Immunologic Factors|immunologic factors|mesh-ancestor
5807145|NCT02692599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807146|NCT02692534|Cocaine|cocaine|mesh-list
5807147|NCT02692534|Anesthetics, Local|anesthetics, local|mesh-ancestor
5807148|NCT02692534|Anesthetics|anesthetics|mesh-ancestor
5807149|NCT02692534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5807150|NCT02692534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807151|NCT02692534|Sensory System Agents|sensory system agents|mesh-ancestor
5807152|NCT02692534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5807153|NCT02692534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5807154|NCT02692534|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5807155|NCT02692534|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5807156|NCT02692534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5807157|NCT02692534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5807158|NCT02692534|Dopamine Agents|dopamine agents|mesh-ancestor
5807159|NCT02692534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5807160|NCT02692339|Dexamethasone|dexamethasone|mesh-list
5807161|NCT02692339|Lenalidomide|lenalidomide|mesh-list
5807162|NCT02692339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5807163|NCT02692339|Antiemetics|antiemetics|mesh-ancestor
5807164|NCT02692339|Autonomic Agents|autonomic agents|mesh-ancestor
6492140|NCT00607074|Secnidazole|secnidazole|mesh-list
5807165|NCT02692339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5807166|NCT02692339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807167|NCT02692339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5807168|NCT02692339|Glucocorticoids|glucocorticoids|mesh-ancestor
5807169|NCT02692339|Hormones|hormones|mesh-ancestor
5807170|NCT02692339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5807171|NCT02692339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5807172|NCT02692339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5807173|NCT02692339|Immunologic Factors|immunologic factors|mesh-ancestor
5807174|NCT02692339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5807175|NCT02692339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5807176|NCT02692339|Growth Substances|growth substances|mesh-ancestor
5807177|NCT02692339|Growth Inhibitors|growth inhibitors|mesh-ancestor
5807178|NCT02692248|Gemcitabine|gemcitabine|mesh-list
5807179|NCT02692248|Dexamethasone|dexamethasone|mesh-list
5807180|NCT02692248|Rituximab|rituximab|mesh-list
5807181|NCT02692248|Oxaliplatin|oxaliplatin|mesh-list
5807182|NCT02692248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5807183|NCT02692248|Antiemetics|antiemetics|mesh-ancestor
5807184|NCT02692248|Autonomic Agents|autonomic agents|mesh-ancestor
5807185|NCT02692248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5807186|NCT02692248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807187|NCT02692248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5807188|NCT02692248|Glucocorticoids|glucocorticoids|mesh-ancestor
5807189|NCT02692248|Hormones|hormones|mesh-ancestor
5807190|NCT02692248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5807191|NCT02692248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5807192|NCT02692248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5807193|NCT02692248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5807194|NCT02692248|Immunologic Factors|immunologic factors|mesh-ancestor
5807195|NCT02692248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6211217|NCT02169336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5807196|NCT02692248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5807197|NCT02692248|Antimetabolites|antimetabolites|mesh-ancestor
5807198|NCT02692248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5807199|NCT02692248|Antiviral Agents|antiviral agents|mesh-ancestor
5807200|NCT02692248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5807201|NCT02692248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5807202|NCT02692248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5807203|NCT02692313|Epinephrine|epinephrine|mesh-list
5807204|NCT02692313|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5807205|NCT02692313|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5807206|NCT02692313|Adrenergic Agents|adrenergic agents|mesh-ancestor
5807207|NCT02692313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5807208|NCT02692313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5807209|NCT02692313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807210|NCT02692313|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5807211|NCT02692313|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5807212|NCT02692313|Autonomic Agents|autonomic agents|mesh-ancestor
5807213|NCT02692313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5807214|NCT02692313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5807215|NCT02692313|Respiratory System Agents|respiratory system agents|mesh-ancestor
5807216|NCT02692313|Mydriatics|mydriatics|mesh-ancestor
5807217|NCT02692313|Sympathomimetics|sympathomimetics|mesh-ancestor
5807218|NCT02692313|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5807219|NCT02692365|Manganese|manganese|mesh-list
5807220|NCT02692365|Trace Elements|trace elements|mesh-ancestor
5807221|NCT02692365|Micronutrients|micronutrients|mesh-ancestor
5807222|NCT02692365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807223|NCT02691949|Mycophenolic Acid|mycophenolic acid|mesh-list
5807224|NCT02691949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5807225|NCT02691949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5807226|NCT02691949|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5807227|NCT02691949|Antitubercular Agents|antitubercular agents|mesh-ancestor
5807228|NCT02691949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5807229|NCT02691949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5807230|NCT02691949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5807231|NCT02691949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5807232|NCT02691910|Chloroquine|chloroquine|mesh-list
5807233|NCT02691910|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
5807234|NCT02691910|Primaquine|primaquine|mesh-list
5807235|NCT02691910|Amebicides|amebicides|mesh-ancestor
5807236|NCT02691910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5807237|NCT02691910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5807238|NCT02691910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5807239|NCT02691910|Antimalarials|antimalarials|mesh-ancestor
5807240|NCT02691910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5807241|NCT02691910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5807242|NCT02691910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5807243|NCT02691910|Analgesics|analgesics|mesh-ancestor
5807244|NCT02691910|Sensory System Agents|sensory system agents|mesh-ancestor
5807245|NCT02691910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5807246|NCT02691910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807247|NCT02691910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5807248|NCT02691910|Filaricides|filaricides|mesh-ancestor
5807249|NCT02691910|Antinematodal Agents|antinematodal agents|mesh-ancestor
5807250|NCT02691910|Anthelmintics|anthelmintics|mesh-ancestor
5807251|NCT02691858|Hydrocortisone|hydrocortisone|mesh-list
5807252|NCT02691858|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
5807253|NCT02691858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5807254|NCT02691871|Docetaxel|docetaxel|mesh-list
5807255|NCT02691871|Apatinib|apatinib|mesh-list
5807256|NCT02691871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5807257|NCT02691871|Tubulin Modulators|tubulin modulators|mesh-ancestor
5807258|NCT02691871|Antimitotic Agents|antimitotic agents|mesh-ancestor
5807259|NCT02691871|Mitosis Modulators|mitosis modulators|mesh-ancestor
5807260|NCT02691871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5807261|NCT02691871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5807262|NCT02691871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5807263|NCT02691754|Acetaminophen|acetaminophen|mesh-list
5807264|NCT02691754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5807265|NCT02691754|Analgesics|analgesics|mesh-ancestor
5807266|NCT02691754|Sensory System Agents|sensory system agents|mesh-ancestor
5807267|NCT02691754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5807268|NCT02691754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807269|NCT02691754|Antipyretics|antipyretics|mesh-ancestor
5807270|NCT02691897|Melatonin|melatonin|mesh-list
5807271|NCT02691897|Antioxidants|antioxidants|mesh-ancestor
5807272|NCT02691897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5807273|NCT02691897|Protective Agents|protective agents|mesh-ancestor
5807274|NCT02691897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807275|NCT02691897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5807276|NCT02691676|Plasma-lyte 148|plasma-lyte 148|mesh-list
5807277|NCT02691676|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5807278|NCT02691676|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5807279|NCT02691780|Sorafenib|sorafenib|mesh-list
5807280|NCT02691780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5807281|NCT02691780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5807282|NCT02691780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5807283|NCT02691780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5807284|NCT02691923|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5807285|NCT02691923|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5807286|NCT02691923|Dermatologic Agents|dermatologic agents|mesh-ancestor
5807287|NCT02691793|Sunitinib|sunitinib|mesh-list
5807288|NCT02691793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5807289|NCT02691793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5807290|NCT02691793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5807291|NCT02691793|Growth Substances|growth substances|mesh-ancestor
5807292|NCT02691793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807293|NCT02691793|Growth Inhibitors|growth inhibitors|mesh-ancestor
5807294|NCT02691793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5807295|NCT02691793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5807296|NCT02691793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5807297|NCT02691533|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
5807298|NCT02691533|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
5807299|NCT02691533|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5807300|NCT02691533|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5807301|NCT02691325|Charcoal|charcoal|mesh-list
5807302|NCT02691325|Nemiralisib|nemiralisib|mesh-list
5807303|NCT02691325|Antidotes|antidotes|mesh-ancestor
5807304|NCT02691325|Protective Agents|protective agents|mesh-ancestor
5807305|NCT02691325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807306|NCT02691325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5807307|NCT02691325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5807308|NCT02691325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5807309|NCT02691403|Bupivacaine|bupivacaine|mesh-list
5807310|NCT02691403|Levobupivacaine|levobupivacaine|mesh-list
5807311|NCT02691403|Anesthetics, Local|anesthetics, local|mesh-ancestor
5807312|NCT02691403|Anesthetics|anesthetics|mesh-ancestor
5807313|NCT02691403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5807314|NCT02691403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807315|NCT02691403|Sensory System Agents|sensory system agents|mesh-ancestor
5807316|NCT02691403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5807317|NCT02691442|Epinephrine|epinephrine|mesh-list
5807318|NCT02691442|Ropivacaine|ropivacaine|mesh-list
5807319|NCT02691442|Levobupivacaine|levobupivacaine|mesh-list
5807320|NCT02691442|Anesthetics, Local|anesthetics, local|mesh-ancestor
5807321|NCT02691442|Anesthetics|anesthetics|mesh-ancestor
5807322|NCT02691442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5807323|NCT02691442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807324|NCT02691442|Sensory System Agents|sensory system agents|mesh-ancestor
5807325|NCT02691442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5807326|NCT02691442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5807327|NCT02691442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5807328|NCT02691442|Adrenergic Agents|adrenergic agents|mesh-ancestor
5807329|NCT02691442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5807330|NCT02691442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5807331|NCT02691442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5807332|NCT02691442|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5807333|NCT02691442|Autonomic Agents|autonomic agents|mesh-ancestor
5807334|NCT02691442|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5807335|NCT02691442|Respiratory System Agents|respiratory system agents|mesh-ancestor
5807336|NCT02691442|Mydriatics|mydriatics|mesh-ancestor
5807337|NCT02691442|Sympathomimetics|sympathomimetics|mesh-ancestor
5807338|NCT02691442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5807339|NCT02691156|Carbon Monoxide|carbon monoxide|mesh-list
5807340|NCT02691156|Bilirubin|bilirubin|mesh-list
5807341|NCT02691156|Antimetabolites|antimetabolites|mesh-ancestor
5807342|NCT02691156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5807343|NCT02691156|Gasotransmitters|gasotransmitters|mesh-ancestor
5807344|NCT02691156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5807345|NCT02691156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807346|NCT02691156|Antioxidants|antioxidants|mesh-ancestor
5807347|NCT02691156|Protective Agents|protective agents|mesh-ancestor
5807348|NCT02691026|Pembrolizumab|pembrolizumab|mesh-list
5807349|NCT02691026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5807350|NCT02691026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5807351|NCT02691195|Ropivacaine|ropivacaine|mesh-list
5807352|NCT02691195|Anesthetics, Local|anesthetics, local|mesh-list
5807353|NCT02691195|Anesthetics|anesthetics|mesh-list
5807354|NCT02691195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5807355|NCT02691195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807356|NCT02691195|Sensory System Agents|sensory system agents|mesh-ancestor
5807357|NCT02691195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5900578|NCT04654312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5900579|NCT04654312|Diuretics|diuretics|mesh-ancestor
5900580|NCT04654312|Natriuretic Agents|natriuretic agents|mesh-ancestor
6211218|NCT02169336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900581|NCT04654312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807358|NCT02691078|Octreotide|octreotide|mesh-list
5807359|NCT02691078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5807360|NCT02691078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5807361|NCT02691078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5807362|NCT02691065|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
5807363|NCT02691065|Integrase Inhibitors|integrase inhibitors|mesh-list
5807364|NCT02691065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5807365|NCT02691065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5807366|NCT02691065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5807367|NCT02691065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5807368|NCT02691065|Antiviral Agents|antiviral agents|mesh-ancestor
5807369|NCT02691065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5807370|NCT02690987|Exenatide|exenatide|mesh-list
5807371|NCT02690987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5807372|NCT02690987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807373|NCT02690987|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5807374|NCT02690987|Incretins|incretins|mesh-ancestor
5807375|NCT02690987|Hormones|hormones|mesh-ancestor
5807376|NCT02690987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5807377|NCT02690922|Dexamethasone|dexamethasone|mesh-list
5807378|NCT02690922|Prednisone|prednisone|mesh-list
5807379|NCT02690922|Methotrexate|methotrexate|mesh-list
5807380|NCT02690922|Dasatinib|dasatinib|mesh-list
5807381|NCT02690922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5807382|NCT02690922|Antiemetics|antiemetics|mesh-ancestor
5807383|NCT02690922|Autonomic Agents|autonomic agents|mesh-ancestor
5807384|NCT02690922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5807385|NCT02690922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807386|NCT02690922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5807387|NCT02690922|Glucocorticoids|glucocorticoids|mesh-ancestor
5807388|NCT02690922|Hormones|hormones|mesh-ancestor
5807389|NCT02690922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5807390|NCT02690922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5807391|NCT02690922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5807392|NCT02690922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5807393|NCT02690922|Abortifacient Agents|abortifacient agents|mesh-ancestor
5807394|NCT02690922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5807395|NCT02690922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5807396|NCT02690922|Antimetabolites|antimetabolites|mesh-ancestor
5807397|NCT02690922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5807398|NCT02690922|Dermatologic Agents|dermatologic agents|mesh-ancestor
5807399|NCT02690922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5807400|NCT02690922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5807401|NCT02690922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5807402|NCT02690922|Immunologic Factors|immunologic factors|mesh-ancestor
5807403|NCT02690922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5807404|NCT02690922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5807405|NCT02690922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5807406|NCT02690883|Exenatide|exenatide|mesh-list
5807407|NCT02690883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5807408|NCT02690883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807409|NCT02690883|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5807410|NCT02690883|Incretins|incretins|mesh-ancestor
5807411|NCT02690883|Hormones|hormones|mesh-ancestor
5807412|NCT02690883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5807413|NCT02690844|Clonazepam|clonazepam|mesh-list
5807414|NCT02690844|Anticonvulsants|anticonvulsants|mesh-ancestor
5807415|NCT02690844|GABA Modulators|gaba modulators|mesh-ancestor
5807416|NCT02690844|GABA Agents|gaba agents|mesh-ancestor
5807417|NCT02690844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5807418|NCT02690844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5807419|NCT02690844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807420|NCT02690870|Tamoxifen|tamoxifen|mesh-list
5807421|NCT02690870|Clomiphene|clomiphene|mesh-list
5807422|NCT02690870|Enclomiphene|enclomiphene|mesh-list
5807423|NCT02690870|Zuclomiphene|zuclomiphene|mesh-list
5807424|NCT02690870|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5807425|NCT02690870|Hormone Antagonists|hormone antagonists|mesh-ancestor
5807426|NCT02690870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5807427|NCT02690870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807428|NCT02690870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5807429|NCT02690870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5807430|NCT02690870|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5807431|NCT02690870|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5807432|NCT02690870|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5807433|NCT02690870|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5807434|NCT02690870|Fertility Agents|fertility agents|mesh-ancestor
5807435|NCT02690870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5807436|NCT02690792|Vitamin E|vitamin e|mesh-list
5807437|NCT02690792|Vitamins|vitamins|mesh-ancestor
5807438|NCT02690792|Micronutrients|micronutrients|mesh-ancestor
5807439|NCT02690792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807440|NCT02690792|Antioxidants|antioxidants|mesh-ancestor
5807441|NCT02690792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5807442|NCT02690792|Protective Agents|protective agents|mesh-ancestor
5807443|NCT02690506|Pregabalin|pregabalin|mesh-list
5807444|NCT02690506|Analgesics|analgesics|mesh-ancestor
5807445|NCT02690506|Sensory System Agents|sensory system agents|mesh-ancestor
5807446|NCT02690506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5807447|NCT02690506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807448|NCT02690506|Anticonvulsants|anticonvulsants|mesh-ancestor
5807449|NCT02690506|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5807450|NCT02690506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5807451|NCT02690506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5807452|NCT02690506|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5807453|NCT02690506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5807454|NCT02690506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5807455|NCT02690506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5807456|NCT02690506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5807457|NCT02690389|Flumazenil|flumazenil|mesh-list
5807458|NCT02690389|Antidotes|antidotes|mesh-ancestor
5807459|NCT02690389|Protective Agents|protective agents|mesh-ancestor
5807460|NCT02690389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807461|NCT02690389|GABA Modulators|gaba modulators|mesh-ancestor
5807462|NCT02690389|GABA Agents|gaba agents|mesh-ancestor
5807463|NCT02690389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5807464|NCT02690389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5807465|NCT02690415|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5807466|NCT02690415|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5807467|NCT02690415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5807468|NCT02690415|Antitubercular Agents|antitubercular agents|mesh-ancestor
5807469|NCT02690480|Fulvestrant|fulvestrant|mesh-list
5807470|NCT02690480|Palbociclib|palbociclib|mesh-list
5807471|NCT02690480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5807472|NCT02690480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5807473|NCT02690480|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5807474|NCT02690480|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5807475|NCT02690480|Hormone Antagonists|hormone antagonists|mesh-ancestor
5807476|NCT02690480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5807477|NCT02690480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807478|NCT02690480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5807479|NCT02690480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5807480|NCT02690480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5807481|NCT02689999|Rabeprazole|rabeprazole|mesh-list
6492141|NCT00607074|Metronidazole|metronidazole|mesh-list
6492142|NCT00607074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6492143|NCT00607074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6492144|NCT00607074|Anticestodal Agents|anticestodal agents|mesh-ancestor
6492145|NCT00607074|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6492146|NCT00607074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6492147|NCT00607074|Tubulin Modulators|tubulin modulators|mesh-ancestor
6492148|NCT00607074|Antimitotic Agents|antimitotic agents|mesh-ancestor
6492149|NCT00607074|Mitosis Modulators|mitosis modulators|mesh-ancestor
6492150|NCT00607074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492151|NCT00607074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6492152|NCT00607074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6492153|NCT00607152|Allopurinol|allopurinol|mesh-list
6492154|NCT00607152|Rasburicase|rasburicase|mesh-list
6492155|NCT00607152|Antimetabolites|antimetabolites|mesh-ancestor
6492156|NCT00607152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492157|NCT00607152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6492158|NCT00607152|Gout Suppressants|gout suppressants|mesh-ancestor
6492159|NCT00607152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5807482|NCT02689999|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5807483|NCT02689999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5807484|NCT02689999|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5807485|NCT02689999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5807486|NCT02689999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5807487|NCT02690064|Vitamins|vitamins|mesh-list
5807488|NCT02690064|Ascorbic Acid|ascorbic acid|mesh-list
5807489|NCT02690064|Vitamin E|vitamin e|mesh-list
5807490|NCT02690064|Tocopherols|tocopherols|mesh-list
6492160|NCT00607152|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6492161|NCT00607152|Antioxidants|antioxidants|mesh-ancestor
6492162|NCT00607152|Protective Agents|protective agents|mesh-ancestor
6492163|NCT00607152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492164|NCT00607178|Vaccines|vaccines|mesh-list
6492165|NCT00607178|Immunologic Factors|immunologic factors|mesh-ancestor
6492166|NCT00607178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492167|NCT00607217|Vaccines|vaccines|mesh-list
6492168|NCT00607217|Immunologic Factors|immunologic factors|mesh-ancestor
6492169|NCT00607217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492170|NCT00607282|Udenafil|udenafil|mesh-list
6492171|NCT00607282|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6492172|NCT00607282|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6492173|NCT00607282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6492174|NCT00607282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492175|NCT00607438|Paclitaxel|paclitaxel|mesh-list
6492176|NCT00607438|Sorafenib|sorafenib|mesh-list
6492177|NCT00607438|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6492178|NCT00607438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6492179|NCT00607438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6492180|NCT00607438|Tubulin Modulators|tubulin modulators|mesh-ancestor
6492181|NCT00607438|Antimitotic Agents|antimitotic agents|mesh-ancestor
6492182|NCT00607438|Mitosis Modulators|mitosis modulators|mesh-ancestor
6492183|NCT00607438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492184|NCT00607438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6492185|NCT00607438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6492186|NCT00607503|Terbutaline|terbutaline|mesh-list
6492187|NCT00607503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6492188|NCT00607503|Autonomic Agents|autonomic agents|mesh-ancestor
6492189|NCT00607503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6492190|NCT00607503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492191|NCT00607503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6492192|NCT00607503|Respiratory System Agents|respiratory system agents|mesh-ancestor
6492193|NCT00607503|Sympathomimetics|sympathomimetics|mesh-ancestor
6492194|NCT00607503|Tocolytic Agents|tocolytic agents|mesh-ancestor
6492195|NCT00607503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5807491|NCT02690064|Tocotrienols|tocotrienols|mesh-list
5807492|NCT02690064|alpha-Tocopherol|alpha-tocopherol|mesh-list
6492196|NCT00607503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6492197|NCT00607503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6492198|NCT00607503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6492199|NCT00607503|Adrenergic Agents|adrenergic agents|mesh-ancestor
6492200|NCT00607503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6492201|NCT00607503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492202|NCT00607542|Baclofen|baclofen|mesh-list
6492203|NCT00607542|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6492204|NCT00607542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807493|NCT02690064|Thioctic Acid|thioctic acid|mesh-list
5807494|NCT02690064|Ubiquinone|ubiquinone|mesh-list
5807495|NCT02690064|Resveratrol|resveratrol|mesh-list
5807496|NCT02690064|Antioxidants|antioxidants|mesh-list
5807497|NCT02690064|Micronutrients|micronutrients|mesh-ancestor
5807498|NCT02690064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807499|NCT02690064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5807500|NCT02690064|Protective Agents|protective agents|mesh-ancestor
5807501|NCT02690064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5807502|NCT02690064|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5807503|NCT02690064|Vitamin B Complex|vitamin b complex|mesh-ancestor
5807504|NCT02690038|Immunoglobulins|immunoglobulins|mesh-list
5807505|NCT02690038|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5807506|NCT02690038|Antibodies|antibodies|mesh-list
5807507|NCT02690038|gamma-Globulins|gamma-globulins|mesh-list
5807508|NCT02690038|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5807509|NCT02690038|Immunologic Factors|immunologic factors|mesh-ancestor
5807510|NCT02690038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807511|NCT02690103|Ribavirin|ribavirin|mesh-list
5807512|NCT02690103|Antimetabolites|antimetabolites|mesh-ancestor
5807513|NCT02690103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5807514|NCT02690103|Antiviral Agents|antiviral agents|mesh-ancestor
5807515|NCT02690103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5807516|NCT02690155|Vitamin K|vitamin k|mesh-list
5807517|NCT02690155|Rivaroxaban|rivaroxaban|mesh-list
5807518|NCT02690155|Vitamins|vitamins|mesh-ancestor
5807519|NCT02690155|Micronutrients|micronutrients|mesh-ancestor
5807520|NCT02690155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807521|NCT02690155|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5807522|NCT02690155|Antithrombins|antithrombins|mesh-ancestor
5807523|NCT02690155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5807524|NCT02690155|Protease Inhibitors|protease inhibitors|mesh-ancestor
5807525|NCT02690155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5807526|NCT02690155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5807527|NCT02690155|Anticoagulants|anticoagulants|mesh-ancestor
5807528|NCT02690155|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5807529|NCT02690155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5807530|NCT02690155|Hemostatics|hemostatics|mesh-ancestor
5807531|NCT02690155|Coagulants|coagulants|mesh-ancestor
5807532|NCT02690129|Progesterone|progesterone|mesh-list
5807533|NCT02690129|Progestins|progestins|mesh-ancestor
5807534|NCT02690129|Hormones|hormones|mesh-ancestor
5807535|NCT02690129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5807536|NCT02690129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807537|NCT02689960|Prednisone|prednisone|mesh-list
5807538|NCT02689960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5807539|NCT02689960|Glucocorticoids|glucocorticoids|mesh-ancestor
5807540|NCT02689960|Hormones|hormones|mesh-ancestor
5807541|NCT02689960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5807542|NCT02689960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807543|NCT02689960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5807544|NCT02689960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5807545|NCT02689882|Niacinamide|niacinamide|mesh-list
5807546|NCT02689882|Niacin|niacin|mesh-list
5807547|NCT02689882|Nicotinic Acids|nicotinic acids|mesh-list
5807548|NCT02689882|Vitamin B Complex|vitamin b complex|mesh-ancestor
5807549|NCT02689882|Vitamins|vitamins|mesh-ancestor
5807550|NCT02689882|Micronutrients|micronutrients|mesh-ancestor
5807551|NCT02689882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807552|NCT02689882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5807553|NCT02689882|Antimetabolites|antimetabolites|mesh-ancestor
5807554|NCT02689882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5807555|NCT02689882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5807556|NCT02689882|Vasodilator Agents|vasodilator agents|mesh-ancestor
5807557|NCT02690012|Magnesium citrate|magnesium citrate|mesh-list
5807558|NCT02690012|Magnesium Oxide|magnesium oxide|mesh-list
5807559|NCT02690012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5807560|NCT02690012|Cathartics|cathartics|mesh-ancestor
5807561|NCT02690012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5807562|NCT02690012|Antacids|antacids|mesh-ancestor
5807563|NCT02689986|Rituximab|rituximab|mesh-list
5807564|NCT02689986|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5807565|NCT02689986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5807566|NCT02689986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5807567|NCT02689986|Immunologic Factors|immunologic factors|mesh-ancestor
5807568|NCT02689986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807569|NCT02689986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5807570|NCT02689986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5807571|NCT02689986|Alkylating Agents|alkylating agents|mesh-ancestor
5807572|NCT02689986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5807573|NCT02689921|Trastuzumab|trastuzumab|mesh-list
5807574|NCT02689921|Pertuzumab|pertuzumab|mesh-list
5807575|NCT02689921|Letrozole|letrozole|mesh-list
5807576|NCT02689921|Anastrozole|anastrozole|mesh-list
5807577|NCT02689921|Leuprolide|leuprolide|mesh-list
5807578|NCT02689921|Exemestane|exemestane|mesh-list
5807579|NCT02689921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5807580|NCT02689921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5807581|NCT02689921|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5807582|NCT02689921|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5807583|NCT02689921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5807584|NCT02689921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5807585|NCT02689921|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5807586|NCT02689921|Hormone Antagonists|hormone antagonists|mesh-ancestor
5807587|NCT02689921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5807588|NCT02689921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807589|NCT02689921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5807590|NCT02689921|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5807591|NCT02689921|Fertility Agents|fertility agents|mesh-ancestor
5807592|NCT02689921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5807593|NCT02689895|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
5807594|NCT02689895|Antiviral Agents|antiviral agents|mesh-ancestor
5807595|NCT02689895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5807596|NCT02689856|Hydrocortisone|hydrocortisone|mesh-list
5807597|NCT02689856|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
5807598|NCT02689856|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
5807599|NCT02689856|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
5807600|NCT02689856|Lidocaine|lidocaine|mesh-list
5807601|NCT02689856|Anesthetics, Local|anesthetics, local|mesh-ancestor
5807602|NCT02689856|Anesthetics|anesthetics|mesh-ancestor
5807603|NCT02689856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5807604|NCT02689856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807605|NCT02689856|Sensory System Agents|sensory system agents|mesh-ancestor
5807606|NCT02689856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5807607|NCT02689856|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5807608|NCT02689856|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5807609|NCT02689856|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5807610|NCT02689856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5807611|NCT02689856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5807612|NCT02689856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5807613|NCT02689869|Obinutuzumab|obinutuzumab|mesh-list
5807614|NCT02689869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5807615|NCT02689869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5807616|NCT02689843|Metformin|metformin|mesh-list
5807617|NCT02689843|Pioglitazone|pioglitazone|mesh-list
5807618|NCT02689843|Cyproterone Acetate|cyproterone acetate|mesh-list
5807619|NCT02689843|Spironolactone|spironolactone|mesh-list
5807620|NCT02689843|Cyproterone|cyproterone|mesh-list
5807621|NCT02689843|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5807622|NCT02689843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807623|NCT02689843|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5807624|NCT02689843|Hormone Antagonists|hormone antagonists|mesh-ancestor
5807625|NCT02689843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5807626|NCT02689843|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5807627|NCT02689843|Diuretics|diuretics|mesh-ancestor
5807628|NCT02689843|Natriuretic Agents|natriuretic agents|mesh-ancestor
5807629|NCT02689843|Androgen Antagonists|androgen antagonists|mesh-ancestor
5807630|NCT02689843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5807631|NCT02689843|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5807632|NCT02689843|Contraceptive Agents|contraceptive agents|mesh-ancestor
5807633|NCT02689843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5807634|NCT02689726|Imiquimod|imiquimod|mesh-list
5807635|NCT02689726|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5807636|NCT02689726|Immunologic Factors|immunologic factors|mesh-ancestor
5807637|NCT02689726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807638|NCT02689726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5807639|NCT02689726|Interferon Inducers|interferon inducers|mesh-ancestor
5807640|NCT02689388|Anesthetics|anesthetics|mesh-list
5807641|NCT02689388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5807642|NCT02689388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807643|NCT02689713|Voriconazole|voriconazole|mesh-list
5807644|NCT02689713|Antifungal Agents|antifungal agents|mesh-ancestor
5807645|NCT02689713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5807646|NCT02689713|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5807647|NCT02689713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5807648|NCT02689713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5807649|NCT02689713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5807650|NCT02689713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5807651|NCT02689713|Hormone Antagonists|hormone antagonists|mesh-ancestor
5807652|NCT02689713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5807653|NCT02689713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807654|NCT02689713|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5807655|NCT02689778|Pirfenidone|pirfenidone|mesh-list
5807656|NCT02689778|Analgesics|analgesics|mesh-ancestor
5807657|NCT02689778|Sensory System Agents|sensory system agents|mesh-ancestor
5807658|NCT02689778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5807659|NCT02689778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807660|NCT02689778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5807661|NCT02689778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5807662|NCT02689778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5807663|NCT02689778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5807664|NCT02689778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5807665|NCT02689362|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5807666|NCT02689362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5807667|NCT02689362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807668|NCT02689362|Incretins|incretins|mesh-ancestor
5807669|NCT02689362|Hormones|hormones|mesh-ancestor
5807670|NCT02689362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5807671|NCT02689362|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5807672|NCT02689362|Protease Inhibitors|protease inhibitors|mesh-ancestor
5807673|NCT02689362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5807674|NCT02689362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5807675|NCT02689596|Oxytocin|oxytocin|mesh-list
5807676|NCT02689596|Oxytocics|oxytocics|mesh-ancestor
5807677|NCT02689596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5807678|NCT02689596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900582|NCT04654312|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5900583|NCT04654312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5900584|NCT04654312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900585|NCT04635644|Morphine|morphine|mesh-list
5900586|NCT04635644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5900587|NCT04635644|Narcotics|narcotics|mesh-ancestor
5900588|NCT04635644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5900589|NCT04635644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900590|NCT04635644|Analgesics|analgesics|mesh-ancestor
5900591|NCT04635644|Sensory System Agents|sensory system agents|mesh-ancestor
5900592|NCT04635644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5900593|NCT04633226|Vaccines|vaccines|mesh-list
5900594|NCT04633226|Immunologic Factors|immunologic factors|mesh-ancestor
5900595|NCT04633226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900596|NCT04623931|Temozolomide|temozolomide|mesh-list
5900597|NCT04623931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5900598|NCT04623931|Alkylating Agents|alkylating agents|mesh-ancestor
5900599|NCT04623931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900600|NCT04623931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5900601|NCT04617067|Gemcitabine|gemcitabine|mesh-list
5900602|NCT04617067|Paclitaxel|paclitaxel|mesh-list
5900603|NCT04617067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5900604|NCT04617067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5900605|NCT04617067|Tubulin Modulators|tubulin modulators|mesh-ancestor
5900606|NCT04617067|Antimitotic Agents|antimitotic agents|mesh-ancestor
5900607|NCT04617067|Mitosis Modulators|mitosis modulators|mesh-ancestor
5900608|NCT04617067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900609|NCT04617067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5900610|NCT04617067|Antimetabolites|antimetabolites|mesh-ancestor
5900611|NCT04617067|Antiviral Agents|antiviral agents|mesh-ancestor
5900612|NCT04617067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5900613|NCT04617067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5900614|NCT04617067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5900615|NCT04617067|Immunologic Factors|immunologic factors|mesh-ancestor
5900616|NCT04617067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900617|NCT04611139|Pembrolizumab|pembrolizumab|mesh-list
5900618|NCT04611139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5900619|NCT04611139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5807679|NCT02689583|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5807680|NCT02689583|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5807681|NCT02689583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5807682|NCT02689583|Antitubercular Agents|antitubercular agents|mesh-ancestor
5807683|NCT02689453|Alemtuzumab|alemtuzumab|mesh-list
5807684|NCT02689453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5807685|NCT02689453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5807686|NCT02689427|Paclitaxel|paclitaxel|mesh-list
5807687|NCT02689427|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5807688|NCT02689427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5807689|NCT02689427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5807690|NCT02689427|Tubulin Modulators|tubulin modulators|mesh-ancestor
5807691|NCT02689427|Antimitotic Agents|antimitotic agents|mesh-ancestor
5807692|NCT02689427|Mitosis Modulators|mitosis modulators|mesh-ancestor
5807693|NCT02689427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5807694|NCT02689401|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
5807695|NCT02689401|Hematinics|hematinics|mesh-ancestor
5807696|NCT02689401|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5807697|NCT02689401|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5807698|NCT02689141|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5807699|NCT02689141|Ofatumumab|ofatumumab|mesh-list
5807700|NCT02689141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5807701|NCT02689141|Alkylating Agents|alkylating agents|mesh-ancestor
5807702|NCT02689141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5807703|NCT02689141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5807704|NCT02689297|Chlorine dioxide|chlorine dioxide|mesh-list
5807705|NCT02689297|Dental Disinfectants|dental disinfectants|mesh-ancestor
5807706|NCT02689297|Disinfectants|disinfectants|mesh-ancestor
5807707|NCT02689297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5807708|NCT02689180|Furosemide|furosemide|mesh-list
5807709|NCT02689180|Diuretics|diuretics|mesh-ancestor
5807710|NCT02689180|Natriuretic Agents|natriuretic agents|mesh-ancestor
5807711|NCT02689180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807712|NCT02689180|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5807713|NCT02689180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5807714|NCT02689180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5807715|NCT02689245|Tenofovir|tenofovir|mesh-list
5807716|NCT02689245|Antiviral Agents|antiviral agents|mesh-ancestor
5807717|NCT02689245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5807718|NCT02689245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5807719|NCT02689245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5807720|NCT02689245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5807721|NCT02689245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5807722|NCT02689245|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5807723|NCT02689245|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5807724|NCT02689336|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5807725|NCT02689336|Temozolomide|temozolomide|mesh-list
5807726|NCT02689336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5807727|NCT02689336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5807728|NCT02689336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5807729|NCT02689336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5807730|NCT02689336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5807731|NCT02689336|Alkylating Agents|alkylating agents|mesh-ancestor
5807732|NCT02689284|Pembrolizumab|pembrolizumab|mesh-list
5807733|NCT02689284|Margetuximab|margetuximab|mesh-list
5807734|NCT02689284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5807735|NCT02689284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5807736|NCT02689089|Rifapentine|rifapentine|mesh-list
5807737|NCT02689089|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5807738|NCT02689089|Antitubercular Agents|antitubercular agents|mesh-ancestor
5807739|NCT02689089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5807740|NCT02689089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5807741|NCT02689089|Leprostatic Agents|leprostatic agents|mesh-ancestor
5807742|NCT02689024|Acetaminophen|acetaminophen|mesh-list
5807743|NCT02689024|Dipyrone|dipyrone|mesh-list
5807744|NCT02689024|Ibuprofen|ibuprofen|mesh-list
5807745|NCT02689024|Diclofenac|diclofenac|mesh-list
5807746|NCT02689024|Naproxen|naproxen|mesh-list
5807747|NCT02689024|Fentanyl|fentanyl|mesh-list
5807748|NCT02689024|Morphine|morphine|mesh-list
5807749|NCT02689024|Bupivacaine|bupivacaine|mesh-list
5807750|NCT02689024|Ropivacaine|ropivacaine|mesh-list
5807751|NCT02689024|Levobupivacaine|levobupivacaine|mesh-list
5807752|NCT02689024|Anesthetics, Local|anesthetics, local|mesh-ancestor
5807753|NCT02689024|Anesthetics|anesthetics|mesh-ancestor
5807754|NCT02689024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5807755|NCT02689024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807756|NCT02689024|Sensory System Agents|sensory system agents|mesh-ancestor
5807757|NCT02689024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5807758|NCT02689024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5807759|NCT02689024|Narcotics|narcotics|mesh-ancestor
5807760|NCT02689024|Analgesics|analgesics|mesh-ancestor
5807761|NCT02689024|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5807762|NCT02689024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5807763|NCT02689024|Anesthetics, General|anesthetics, general|mesh-ancestor
5807764|NCT02689024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5807765|NCT02689024|Antipyretics|antipyretics|mesh-ancestor
5807766|NCT02689024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5807767|NCT02689024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5807768|NCT02689024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5807769|NCT02689024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5807770|NCT02689024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5807771|NCT02689024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5807772|NCT02689024|Gout Suppressants|gout suppressants|mesh-ancestor
5807773|NCT02689037|Aspirin|aspirin|mesh-list
5807774|NCT02689037|Clopidogrel|clopidogrel|mesh-list
5807775|NCT02689037|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5807776|NCT02689037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5807777|NCT02689037|Analgesics|analgesics|mesh-ancestor
5807778|NCT02689037|Sensory System Agents|sensory system agents|mesh-ancestor
5807779|NCT02689037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5807780|NCT02689037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807781|NCT02689037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5807782|NCT02689037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6211219|NCT02169336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6211220|NCT02169336|Analgesics|analgesics|mesh-ancestor
6211221|NCT02169336|Sensory System Agents|sensory system agents|mesh-ancestor
6211222|NCT02169336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6211223|NCT02169336|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6211224|NCT02169336|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5807783|NCT02689037|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5807784|NCT02689037|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5807785|NCT02689037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5807786|NCT02689037|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5807787|NCT02689037|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5807788|NCT02689037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5807789|NCT02689037|Antipyretics|antipyretics|mesh-ancestor
5807790|NCT02689037|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5807791|NCT02689037|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5807792|NCT02689037|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5807793|NCT02689037|Purinergic Agents|purinergic agents|mesh-ancestor
6211225|NCT02169336|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6211226|NCT02169336|Adrenergic Agents|adrenergic agents|mesh-ancestor
5807794|NCT02689037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5807795|NCT02688803|Paclitaxel|paclitaxel|mesh-list
5807796|NCT02688803|Docetaxel|docetaxel|mesh-list
5807797|NCT02688803|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5807798|NCT02688803|Cyclophosphamide|cyclophosphamide|mesh-list
5807799|NCT02688803|Doxorubicin|doxorubicin|mesh-list
5807800|NCT02688803|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5807801|NCT02688803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5807802|NCT02688803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5807803|NCT02688803|Tubulin Modulators|tubulin modulators|mesh-ancestor
5807804|NCT02688803|Antimitotic Agents|antimitotic agents|mesh-ancestor
5807805|NCT02688803|Mitosis Modulators|mitosis modulators|mesh-ancestor
5807806|NCT02688803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5807807|NCT02688803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5807808|NCT02688803|Immunologic Factors|immunologic factors|mesh-ancestor
5807809|NCT02688803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807810|NCT02688803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5807811|NCT02688803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5807812|NCT02688803|Alkylating Agents|alkylating agents|mesh-ancestor
6211227|NCT02169336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5807813|NCT02688803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5807814|NCT02688803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5807815|NCT02688803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5807816|NCT02688803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5807817|NCT02688803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5807818|NCT02688738|Doxycycline|doxycycline|mesh-list
5807819|NCT02688738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5807820|NCT02688738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5807821|NCT02688738|Antimalarials|antimalarials|mesh-ancestor
5807822|NCT02688738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5807823|NCT02688738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5807824|NCT02688790|Dalbavancin|dalbavancin|mesh-list
5807825|NCT02688790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5807826|NCT02688790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5807827|NCT02688881|Sirolimus|sirolimus|mesh-list
5807828|NCT02688881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5807829|NCT02688881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5807830|NCT02688881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5807831|NCT02688881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5807832|NCT02688881|Antifungal Agents|antifungal agents|mesh-ancestor
5807833|NCT02688881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5807834|NCT02688881|Immunologic Factors|immunologic factors|mesh-ancestor
5807835|NCT02688881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807836|NCT02688712|Fluorouracil|fluorouracil|mesh-list
5807837|NCT02688712|Capecitabine|capecitabine|mesh-list
5807838|NCT02688712|Antimetabolites|antimetabolites|mesh-ancestor
5807839|NCT02688712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5807840|NCT02688712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5807841|NCT02688712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5807842|NCT02688712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5807843|NCT02688712|Immunologic Factors|immunologic factors|mesh-ancestor
5807844|NCT02688712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807845|NCT02688465|Apomorphine|apomorphine|mesh-list
5807846|NCT02688465|Emetics|emetics|mesh-ancestor
5807847|NCT02688465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807848|NCT02688465|Autonomic Agents|autonomic agents|mesh-ancestor
5807849|NCT02688465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5807850|NCT02688465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5807851|NCT02688465|Dopamine Agonists|dopamine agonists|mesh-ancestor
5807852|NCT02688465|Dopamine Agents|dopamine agents|mesh-ancestor
5807853|NCT02688465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5807854|NCT02688465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5807855|NCT02688907|Adavosertib|adavosertib|mesh-list
5807856|NCT02688907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5807857|NCT02688907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5807858|NCT02688530|Dexamethasone|dexamethasone|mesh-list
5807859|NCT02688530|Dexamethasone acetate|dexamethasone acetate|mesh-list
5807860|NCT02688530|BB 1101|bb 1101|mesh-list
5807861|NCT02688530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5807862|NCT02688530|Antiemetics|antiemetics|mesh-ancestor
5807863|NCT02688530|Autonomic Agents|autonomic agents|mesh-ancestor
5807864|NCT02688530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5807865|NCT02688530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807866|NCT02688530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5807867|NCT02688530|Glucocorticoids|glucocorticoids|mesh-ancestor
5807868|NCT02688530|Hormones|hormones|mesh-ancestor
5807869|NCT02688530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5807870|NCT02688530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5807871|NCT02688530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5807872|NCT02688530|Protease Inhibitors|protease inhibitors|mesh-ancestor
5807873|NCT02688530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5807874|NCT02688530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5807875|NCT02688634|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5807876|NCT02688634|Amoxicillin|amoxicillin|mesh-list
5807877|NCT02688634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5807878|NCT02688491|Sunitinib|sunitinib|mesh-list
5807879|NCT02688491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5807880|NCT02688491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5807881|NCT02688491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5807882|NCT02688491|Growth Substances|growth substances|mesh-ancestor
5807883|NCT02688491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807884|NCT02688491|Growth Inhibitors|growth inhibitors|mesh-ancestor
5807885|NCT02688491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5807886|NCT02688491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5807887|NCT02688491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5807888|NCT02688595|Anesthetics|anesthetics|mesh-list
5807889|NCT02688595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5807890|NCT02688595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807891|NCT02688400|Celecoxib|celecoxib|mesh-list
5807892|NCT02688400|Diacetylrhein|diacetylrhein|mesh-list
5807893|NCT02688400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5807894|NCT02688400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5807895|NCT02688400|Analgesics|analgesics|mesh-ancestor
5807896|NCT02688400|Sensory System Agents|sensory system agents|mesh-ancestor
5807897|NCT02688400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5807898|NCT02688400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807899|NCT02688400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5807900|NCT02688400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5807901|NCT02688400|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5807902|NCT02688400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5807903|NCT02688400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5807904|NCT02688400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5807905|NCT02688361|Acetylcysteine|acetylcysteine|mesh-list
5807906|NCT02688361|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5807907|NCT02688361|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5807908|NCT02688361|Antiviral Agents|antiviral agents|mesh-ancestor
5807909|NCT02688361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5807910|NCT02688361|Expectorants|expectorants|mesh-ancestor
5807911|NCT02688361|Respiratory System Agents|respiratory system agents|mesh-ancestor
5807912|NCT02688361|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5807913|NCT02688361|Antioxidants|antioxidants|mesh-ancestor
5807914|NCT02688361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5807915|NCT02688361|Protective Agents|protective agents|mesh-ancestor
5807916|NCT02688361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807917|NCT02688361|Antidotes|antidotes|mesh-ancestor
5807918|NCT02688127|Tranexamic Acid|tranexamic acid|mesh-list
5807919|NCT02688127|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5807920|NCT02688127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5807921|NCT02688127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5807922|NCT02688127|Hemostatics|hemostatics|mesh-ancestor
5807923|NCT02688127|Coagulants|coagulants|mesh-ancestor
5807924|NCT02688270|Nitroglycerin|nitroglycerin|mesh-list
5807925|NCT02688270|Vasodilator Agents|vasodilator agents|mesh-ancestor
5807926|NCT02688140|Cytarabine|cytarabine|mesh-list
5807927|NCT02688140|Methotrexate|methotrexate|mesh-list
5807928|NCT02688140|Mercaptopurine|mercaptopurine|mesh-list
5807929|NCT02688140|Mitoxantrone|mitoxantrone|mesh-list
5807930|NCT02688140|Idarubicin|idarubicin|mesh-list
5807931|NCT02688140|Tretinoin|tretinoin|mesh-list
5807932|NCT02688140|Arsenic Trioxide|arsenic trioxide|mesh-list
5807933|NCT02688140|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5807934|NCT02688140|Abortifacient Agents|abortifacient agents|mesh-ancestor
5807935|NCT02688140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5807936|NCT02688140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807937|NCT02688140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5807938|NCT02688140|Antimetabolites|antimetabolites|mesh-ancestor
5807939|NCT02688140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5807940|NCT02688140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5807941|NCT02688140|Dermatologic Agents|dermatologic agents|mesh-ancestor
5807942|NCT02688140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5807943|NCT02688140|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5807944|NCT02688140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5807945|NCT02688140|Immunologic Factors|immunologic factors|mesh-ancestor
5807946|NCT02688140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5807947|NCT02688140|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5807948|NCT02688140|Antiviral Agents|antiviral agents|mesh-ancestor
5807949|NCT02688140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5807950|NCT02688140|Analgesics|analgesics|mesh-ancestor
5807951|NCT02688140|Sensory System Agents|sensory system agents|mesh-ancestor
5807952|NCT02688140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5807953|NCT02688140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5807954|NCT02688140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5807955|NCT02688140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5807956|NCT02688140|Keratolytic Agents|keratolytic agents|mesh-ancestor
5807957|NCT02688374|Nicotine|nicotine|mesh-list
5807958|NCT02688374|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5807959|NCT02688374|Autonomic Agents|autonomic agents|mesh-ancestor
5807960|NCT02688374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5807961|NCT02688374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807962|NCT02688374|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5807963|NCT02688374|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5807964|NCT02688374|Cholinergic Agents|cholinergic agents|mesh-ancestor
5807965|NCT02688374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5807966|NCT02688374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5807967|NCT02688088|Midazolam|midazolam|mesh-list
5807968|NCT02688088|Dextromethorphan|dextromethorphan|mesh-list
5807969|NCT02688088|Caffeine|caffeine|mesh-list
5807970|NCT02688088|Warfarin|warfarin|mesh-list
5807971|NCT02688088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5807972|NCT02688088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5807973|NCT02688088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5807974|NCT02688088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5807975|NCT02688088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5807976|NCT02688088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5807977|NCT02688088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5807978|NCT02688088|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5807979|NCT02688088|Anesthetics, General|anesthetics, general|mesh-ancestor
5807980|NCT02688088|Anesthetics|anesthetics|mesh-ancestor
5807981|NCT02688088|GABA Modulators|gaba modulators|mesh-ancestor
5807982|NCT02688088|GABA Agents|gaba agents|mesh-ancestor
5807983|NCT02688088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5807984|NCT02688088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5807985|NCT02688088|Anticoagulants|anticoagulants|mesh-ancestor
5807986|NCT02688088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5807987|NCT02688088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5807988|NCT02688088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5807989|NCT02688088|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5807990|NCT02688088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5807991|NCT02688088|Purinergic Agents|purinergic agents|mesh-ancestor
5807992|NCT02688088|Antitussive Agents|antitussive agents|mesh-ancestor
5807993|NCT02688088|Respiratory System Agents|respiratory system agents|mesh-ancestor
5807994|NCT02688088|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5807995|NCT02688088|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5807996|NCT02688322|Sulbactam|sulbactam|mesh-list
5807997|NCT02688322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5807998|NCT02688322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5807999|NCT02688322|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5808000|NCT02688322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5808001|NCT02688322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808002|NCT02687984|Risperidone|risperidone|mesh-list
5808003|NCT02687984|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5808004|NCT02687984|Serotonin Agents|serotonin agents|mesh-ancestor
5808005|NCT02687984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5808006|NCT02687984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808007|NCT02687984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808008|NCT02687984|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5808009|NCT02687984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5808010|NCT02687984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5808011|NCT02687984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5808012|NCT02687984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5808013|NCT02687984|Dopamine Agents|dopamine agents|mesh-ancestor
5808014|NCT02687971|Miltefosine|miltefosine|mesh-list
5808015|NCT02687971|Antifungal Agents|antifungal agents|mesh-ancestor
5808016|NCT02687971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5808017|NCT02687971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5808018|NCT02687971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5808019|NCT02687971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5900620|NCT04610684|Carboplatin|carboplatin|mesh-list
5900621|NCT04610684|Etoposide|etoposide|mesh-list
5900622|NCT04610684|Atezolizumab|atezolizumab|mesh-list
5900623|NCT04610684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5900624|NCT04610684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5900625|NCT04610684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5900626|NCT04610684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5900627|NCT04610684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5900628|NCT04610684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900629|NCT04584567|Doxycycline|doxycycline|mesh-list
5900630|NCT04584567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5900631|NCT04584567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5900632|NCT04584567|Antimalarials|antimalarials|mesh-ancestor
5900633|NCT04584567|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5900634|NCT04584567|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5900635|NCT04578886|Guanfacine|guanfacine|mesh-list
5900636|NCT04578886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5900637|NCT04578886|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5900638|NCT04578886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5900639|NCT04578886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5900640|NCT04578886|Adrenergic Agents|adrenergic agents|mesh-ancestor
5900641|NCT04578886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5900642|NCT04578886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900643|NCT04578886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900644|NCT04576325|Voriconazole|voriconazole|mesh-list
5808020|NCT02688023|Leucovorin|leucovorin|mesh-list
5808021|NCT02688023|Fluorouracil|fluorouracil|mesh-list
5808022|NCT02688023|Capecitabine|capecitabine|mesh-list
5808023|NCT02688023|Oxaliplatin|oxaliplatin|mesh-list
5808024|NCT02688023|Irinotecan|irinotecan|mesh-list
5808025|NCT02688023|Antimetabolites|antimetabolites|mesh-ancestor
5808026|NCT02688023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808027|NCT02688023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5808028|NCT02688023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5808029|NCT02688023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5808030|NCT02688023|Immunologic Factors|immunologic factors|mesh-ancestor
5808031|NCT02688023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808032|NCT02688023|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5808033|NCT02688023|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5808034|NCT02688023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5808035|NCT02688023|Antidotes|antidotes|mesh-ancestor
5808036|NCT02688023|Protective Agents|protective agents|mesh-ancestor
5808037|NCT02688023|Vitamin B Complex|vitamin b complex|mesh-ancestor
5808038|NCT02688023|Vitamins|vitamins|mesh-ancestor
5808039|NCT02688023|Micronutrients|micronutrients|mesh-ancestor
5808040|NCT02687724|Golimumab|golimumab|mesh-list
5808041|NCT02687724|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
5808042|NCT02687724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5808043|NCT02687724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5808044|NCT02687724|Immunologic Factors|immunologic factors|mesh-ancestor
5808045|NCT02687724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808046|NCT02687958|Everolimus|everolimus|mesh-list
5808047|NCT02687958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5808048|NCT02687958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5808049|NCT02687958|Immunologic Factors|immunologic factors|mesh-ancestor
5808050|NCT02687958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808051|NCT02687841|Pentoxifylline|pentoxifylline|mesh-list
5808052|NCT02687841|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5808053|NCT02687841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5808054|NCT02687841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808055|NCT02687841|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5808056|NCT02687841|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5808057|NCT02687841|Protective Agents|protective agents|mesh-ancestor
5808058|NCT02687841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808059|NCT02687841|Vasodilator Agents|vasodilator agents|mesh-ancestor
5808060|NCT02687841|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5808061|NCT02687841|Antioxidants|antioxidants|mesh-ancestor
5808062|NCT02687906|Meropenem|meropenem|mesh-list
5808063|NCT02687906|Vaborbactam|vaborbactam|mesh-list
5808064|NCT02687906|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
5808065|NCT02687906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5808066|NCT02687906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5808067|NCT02687906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5808068|NCT02687906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808069|NCT02687932|Valsartan|valsartan|mesh-list
5808070|NCT02687932|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5808071|NCT02687932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5808072|NCT02687932|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5808073|NCT02687932|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5808074|NCT02687932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808075|NCT02687867|Vitamin K|vitamin k|mesh-list
5808076|NCT02687867|Dabigatran|dabigatran|mesh-list
5808077|NCT02687867|Vitamins|vitamins|mesh-ancestor
5808078|NCT02687867|Micronutrients|micronutrients|mesh-ancestor
5808079|NCT02687867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808080|NCT02687867|Antithrombins|antithrombins|mesh-ancestor
5808081|NCT02687867|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5808082|NCT02687867|Protease Inhibitors|protease inhibitors|mesh-ancestor
5808083|NCT02687867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5808084|NCT02687867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808085|NCT02687867|Anticoagulants|anticoagulants|mesh-ancestor
5808086|NCT02687867|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5808087|NCT02687867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5808088|NCT02687867|Hemostatics|hemostatics|mesh-ancestor
5808089|NCT02687867|Coagulants|coagulants|mesh-ancestor
5808090|NCT02687854|Vitamin K|vitamin k|mesh-list
5808091|NCT02687854|Apixaban|apixaban|mesh-list
5808092|NCT02687854|Vitamins|vitamins|mesh-ancestor
5808093|NCT02687854|Micronutrients|micronutrients|mesh-ancestor
5808094|NCT02687854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808095|NCT02687854|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5808096|NCT02687854|Antithrombins|antithrombins|mesh-ancestor
5808097|NCT02687854|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5808098|NCT02687854|Protease Inhibitors|protease inhibitors|mesh-ancestor
5808099|NCT02687854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5808100|NCT02687854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808101|NCT02687854|Anticoagulants|anticoagulants|mesh-ancestor
5808102|NCT02687854|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5808103|NCT02687854|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5808104|NCT02687854|Hemostatics|hemostatics|mesh-ancestor
5808105|NCT02687854|Coagulants|coagulants|mesh-ancestor
5808106|NCT02687490|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5808107|NCT02687490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5808108|NCT02687347|Morphine|morphine|mesh-list
5808109|NCT02687347|Methadone|methadone|mesh-list
5808110|NCT02687347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5808111|NCT02687347|Narcotics|narcotics|mesh-ancestor
5808112|NCT02687347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5808113|NCT02687347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808114|NCT02687347|Analgesics|analgesics|mesh-ancestor
5808115|NCT02687347|Sensory System Agents|sensory system agents|mesh-ancestor
5808116|NCT02687347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5808117|NCT02687347|Antitussive Agents|antitussive agents|mesh-ancestor
5808118|NCT02687347|Respiratory System Agents|respiratory system agents|mesh-ancestor
5808119|NCT02687425|Pioglitazone|pioglitazone|mesh-list
5808120|NCT02687425|Imatinib Mesylate|imatinib mesylate|mesh-list
5808121|NCT02687425|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5808122|NCT02687425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808123|NCT02687425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5808124|NCT02687425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5808125|NCT02687425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5808126|NCT02687425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808127|NCT02687438|Mometasone Furoate|mometasone furoate|mesh-list
5808128|NCT02687438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5808129|NCT02687438|Dermatologic Agents|dermatologic agents|mesh-ancestor
5808130|NCT02687438|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5808131|NCT02687256|Heparin|heparin|mesh-list
5808132|NCT02687256|Anticoagulants|anticoagulants|mesh-ancestor
5808133|NCT02687256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5808134|NCT02687256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5808135|NCT02687256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808136|NCT02687269|Ranolazine|ranolazine|mesh-list
5808137|NCT02687269|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5808138|NCT02687269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5808139|NCT02687269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808140|NCT02687204|Enoxaparin|enoxaparin|mesh-list
5808141|NCT02687204|Enoxaparin sodium|enoxaparin sodium|mesh-list
5808142|NCT02687204|Anticoagulants|anticoagulants|mesh-ancestor
5808143|NCT02687204|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5808144|NCT02687204|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5808145|NCT02687204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808146|NCT02686983|Betamethasone|betamethasone|mesh-list
5808147|NCT02686983|Anesthetics|anesthetics|mesh-list
5808148|NCT02686983|Anesthetics, Local|anesthetics, local|mesh-list
5808149|NCT02686983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5808150|NCT02686983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808151|NCT02686983|Sensory System Agents|sensory system agents|mesh-ancestor
5808152|NCT02686983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5808153|NCT02686983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5808154|NCT02686983|Glucocorticoids|glucocorticoids|mesh-ancestor
5808155|NCT02686983|Hormones|hormones|mesh-ancestor
5808156|NCT02686983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5808157|NCT02686983|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5808158|NCT02686983|Respiratory System Agents|respiratory system agents|mesh-ancestor
5808159|NCT02687178|Canrenone|canrenone|mesh-list
5808160|NCT02687178|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5808161|NCT02687178|Hormone Antagonists|hormone antagonists|mesh-ancestor
5808162|NCT02687178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5808163|NCT02687178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808164|NCT02687178|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5808165|NCT02687178|Diuretics|diuretics|mesh-ancestor
5808166|NCT02687178|Natriuretic Agents|natriuretic agents|mesh-ancestor
5808167|NCT02687009|Niclosamide|niclosamide|mesh-list
5808168|NCT02687009|Anticestodal Agents|anticestodal agents|mesh-ancestor
5808169|NCT02687009|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5808170|NCT02687009|Anthelmintics|anthelmintics|mesh-ancestor
5808171|NCT02687009|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5808172|NCT02687009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5808173|NCT02687009|Antinematodal Agents|antinematodal agents|mesh-ancestor
5808174|NCT02687100|Beclomethasone|beclomethasone|mesh-list
5808175|NCT02687100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5808176|NCT02687100|Glucocorticoids|glucocorticoids|mesh-ancestor
5808177|NCT02687100|Hormones|hormones|mesh-ancestor
5808178|NCT02687100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5808179|NCT02687100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808180|NCT02687100|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5808181|NCT02687100|Respiratory System Agents|respiratory system agents|mesh-ancestor
5808182|NCT02686905|Calcium, Dietary|calcium, dietary|mesh-list
5808183|NCT02686905|Vitamin D|vitamin d|mesh-list
5808184|NCT02686905|Vitamins|vitamins|mesh-list
5808185|NCT02686905|Hydroxocobalamin|hydroxocobalamin|mesh-list
5808186|NCT02686905|Vitamin B 12|vitamin b 12|mesh-list
5808187|NCT02686905|Calcium|calcium|mesh-list
5808188|NCT02686905|Micronutrients|micronutrients|mesh-ancestor
5808189|NCT02686905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808190|NCT02686905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5808191|NCT02686905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5808192|NCT02686905|Hematinics|hematinics|mesh-ancestor
5808193|NCT02686905|Vitamin B Complex|vitamin b complex|mesh-ancestor
5808194|NCT02686593|Mitoxantrone|mitoxantrone|mesh-list
5808195|NCT02686593|Clofarabine|clofarabine|mesh-list
5808196|NCT02686593|Analgesics|analgesics|mesh-ancestor
5808197|NCT02686593|Sensory System Agents|sensory system agents|mesh-ancestor
5808198|NCT02686593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5808199|NCT02686593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808200|NCT02686593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5808201|NCT02686593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5808202|NCT02686593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5808203|NCT02686593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5808204|NCT02686593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808205|NCT02686593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5808206|NCT02686593|Antimetabolites|antimetabolites|mesh-ancestor
5808207|NCT02686619|Cyclosporine|cyclosporine|mesh-list
5808208|NCT02686619|Sirolimus|sirolimus|mesh-list
5808209|NCT02686619|Prednisolone|prednisolone|mesh-list
5808210|NCT02686619|Cyclosporins|cyclosporins|mesh-list
5808211|NCT02686619|Daclizumab|daclizumab|mesh-list
5808212|NCT02686619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5808213|NCT02686619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808214|NCT02686619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5808215|NCT02686619|Immunologic Factors|immunologic factors|mesh-ancestor
5808216|NCT02686619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808217|NCT02686619|Antifungal Agents|antifungal agents|mesh-ancestor
5808218|NCT02686619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5808219|NCT02686619|Dermatologic Agents|dermatologic agents|mesh-ancestor
5808220|NCT02686619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5808221|NCT02686619|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5808222|NCT02686619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5808223|NCT02686619|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5808224|NCT02686619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5808225|NCT02686619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5808226|NCT02686619|Glucocorticoids|glucocorticoids|mesh-ancestor
5808227|NCT02686619|Hormones|hormones|mesh-ancestor
5808228|NCT02686619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5808229|NCT02686619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5808230|NCT02686710|Propofol|propofol|mesh-list
5808231|NCT02686710|Sevoflurane|sevoflurane|mesh-list
5808232|NCT02686710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5808233|NCT02686710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5808234|NCT02686710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808235|NCT02686710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5808236|NCT02686710|Anesthetics, General|anesthetics, general|mesh-ancestor
5808237|NCT02686710|Anesthetics|anesthetics|mesh-ancestor
5808238|NCT02686710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5808239|NCT02686710|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5808240|NCT02686684|Dimethyl Fumarate|dimethyl fumarate|mesh-list
5808241|NCT02686684|Dermatologic Agents|dermatologic agents|mesh-ancestor
5808242|NCT02686684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5808243|NCT02686684|Immunologic Factors|immunologic factors|mesh-ancestor
5808244|NCT02686684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808245|NCT02686645|Metronidazole|metronidazole|mesh-list
5808246|NCT02686645|Vancomycin|vancomycin|mesh-list
5808247|NCT02686645|Loperamide|loperamide|mesh-list
5808248|NCT02686645|Antidiarrheals|antidiarrheals|mesh-list
5808249|NCT02686645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5808250|NCT02686645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5808251|NCT02686645|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5808252|NCT02686645|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5808253|NCT02686645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5808254|NCT02686853|Amphotericin B|amphotericin b|mesh-list
5808255|NCT02686853|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
5808256|NCT02686853|Amebicides|amebicides|mesh-ancestor
5808257|NCT02686853|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5808258|NCT02686853|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5808259|NCT02686853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5808260|NCT02686853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5808261|NCT02686853|Antifungal Agents|antifungal agents|mesh-ancestor
5808262|NCT02686749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
5808263|NCT02686840|Misoprostol|misoprostol|mesh-list
5808264|NCT02686840|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5808265|NCT02686840|Abortifacient Agents|abortifacient agents|mesh-ancestor
5808266|NCT02686840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5808267|NCT02686840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808268|NCT02686840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5808269|NCT02686840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5808270|NCT02686840|Oxytocics|oxytocics|mesh-ancestor
5808271|NCT02686827|Vitamin D|vitamin d|mesh-list
5808272|NCT02686827|Ergocalciferols|ergocalciferols|mesh-list
5808273|NCT02686827|Vitamins|vitamins|mesh-ancestor
5808274|NCT02686827|Micronutrients|micronutrients|mesh-ancestor
5808275|NCT02686827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808276|NCT02686827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5808277|NCT02686827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5808278|NCT02686476|Empagliflozin|empagliflozin|mesh-list
5808279|NCT02686476|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5808280|NCT02686476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808281|NCT02686476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5808282|NCT02686476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808283|NCT02686385|Acetylcysteine|acetylcysteine|mesh-list
5808284|NCT02686385|Prednisolone|prednisolone|mesh-list
5808285|NCT02686385|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5808286|NCT02686385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5808287|NCT02686385|Glucocorticoids|glucocorticoids|mesh-ancestor
5808288|NCT02686385|Hormones|hormones|mesh-ancestor
5808289|NCT02686385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5808290|NCT02686385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808291|NCT02686385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5808292|NCT02686385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5808293|NCT02686385|Protective Agents|protective agents|mesh-ancestor
5808294|NCT02686385|Antiviral Agents|antiviral agents|mesh-ancestor
5808295|NCT02686385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5808296|NCT02686385|Expectorants|expectorants|mesh-ancestor
5808297|NCT02686385|Respiratory System Agents|respiratory system agents|mesh-ancestor
5808298|NCT02686385|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5808299|NCT02686385|Antioxidants|antioxidants|mesh-ancestor
5808300|NCT02686385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808301|NCT02686385|Antidotes|antidotes|mesh-ancestor
5808302|NCT02686151|Dexamethasone|dexamethasone|mesh-list
5808303|NCT02686151|Letrozole|letrozole|mesh-list
5808304|NCT02686151|Polygeline|polygeline|mesh-list
5808305|NCT02686151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5808306|NCT02686151|Antiemetics|antiemetics|mesh-ancestor
5808307|NCT02686151|Autonomic Agents|autonomic agents|mesh-ancestor
5808308|NCT02686151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5808309|NCT02686151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492205|NCT00607542|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6492206|NCT00607542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6492207|NCT00607542|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
5808310|NCT02686151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5808311|NCT02686151|Glucocorticoids|glucocorticoids|mesh-ancestor
5808312|NCT02686151|Hormones|hormones|mesh-ancestor
5808313|NCT02686151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5808314|NCT02686151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5808315|NCT02686151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5808316|NCT02686151|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5808317|NCT02686151|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5808318|NCT02686151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5808319|NCT02686151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808320|NCT02686151|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5808321|NCT02686151|Hormone Antagonists|hormone antagonists|mesh-ancestor
5808322|NCT02686151|Plasma Substitutes|plasma substitutes|mesh-ancestor
5808323|NCT02686151|Blood Substitutes|blood substitutes|mesh-ancestor
5900645|NCT04576325|Antifungal Agents|antifungal agents|mesh-ancestor
5900646|NCT04576325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5900647|NCT04576325|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5900648|NCT04576325|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5900649|NCT04576325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5900650|NCT04576325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900651|NCT04576325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5900652|NCT04576325|Hormone Antagonists|hormone antagonists|mesh-ancestor
5900653|NCT04576325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5900654|NCT04576325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900655|NCT04576325|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5900656|NCT04572828|Naproxen|naproxen|mesh-list
5900657|NCT04572828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5900658|NCT04572828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5900659|NCT04572828|Analgesics|analgesics|mesh-ancestor
5900660|NCT04572828|Sensory System Agents|sensory system agents|mesh-ancestor
5900661|NCT04572828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5900662|NCT04572828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900663|NCT04572828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5808324|NCT02686242|Anesthetics|anesthetics|mesh-list
5808325|NCT02686242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5808326|NCT02686242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808327|NCT02686086|Albuterol|albuterol|mesh-list
5808328|NCT02686086|Ipratropium|ipratropium|mesh-list
5808329|NCT02686086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5808330|NCT02686086|Autonomic Agents|autonomic agents|mesh-ancestor
5808331|NCT02686086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5808332|NCT02686086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808333|NCT02686086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5808334|NCT02686086|Respiratory System Agents|respiratory system agents|mesh-ancestor
5808335|NCT02686086|Tocolytic Agents|tocolytic agents|mesh-ancestor
5808336|NCT02686086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5808337|NCT02686086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5808338|NCT02686086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5808339|NCT02686086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5808340|NCT02686086|Adrenergic Agents|adrenergic agents|mesh-ancestor
5808341|NCT02686086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5808342|NCT02686086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808343|NCT02686086|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5808344|NCT02686086|Cholinergic Agents|cholinergic agents|mesh-ancestor
5808345|NCT02686177|Metformin|metformin|mesh-list
5808346|NCT02686177|Liraglutide|liraglutide|mesh-list
5808347|NCT02686177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5808348|NCT02686177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808349|NCT02686177|Incretins|incretins|mesh-ancestor
5808350|NCT02686177|Hormones|hormones|mesh-ancestor
5808351|NCT02686177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5808352|NCT02686047|Hyaluronic Acid|hyaluronic acid|mesh-list
5808353|NCT02686047|Hylan|hylan|mesh-list
5808354|NCT02686047|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5808355|NCT02686047|Immunologic Factors|immunologic factors|mesh-ancestor
5808356|NCT02686047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808357|NCT02686047|Viscosupplements|viscosupplements|mesh-ancestor
5808358|NCT02686047|Protective Agents|protective agents|mesh-ancestor
5808359|NCT02685852|Exenatide|exenatide|mesh-list
5808360|NCT02685852|Acarbose|acarbose|mesh-list
5808361|NCT02685852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5808362|NCT02685852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808363|NCT02685852|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5808364|NCT02685852|Incretins|incretins|mesh-ancestor
5808365|NCT02685852|Hormones|hormones|mesh-ancestor
5808366|NCT02685852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5808367|NCT02685852|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
5808368|NCT02685852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5808369|NCT02685852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808370|NCT02686021|Dipyrone|dipyrone|mesh-list
5808371|NCT02686021|Ibuprofen|ibuprofen|mesh-list
5808372|NCT02686021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5808373|NCT02686021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5808374|NCT02686021|Analgesics|analgesics|mesh-ancestor
5808375|NCT02686021|Sensory System Agents|sensory system agents|mesh-ancestor
5808376|NCT02686021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5808377|NCT02686021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808378|NCT02686021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5808379|NCT02686021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5808380|NCT02686021|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5808381|NCT02686021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5808382|NCT02686021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808383|NCT02686021|Antipyretics|antipyretics|mesh-ancestor
5808384|NCT02685748|Aspirin|aspirin|mesh-list
5808385|NCT02685748|Pantoprazole|pantoprazole|mesh-list
5808386|NCT02685748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5808387|NCT02685748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5808388|NCT02685748|Analgesics|analgesics|mesh-ancestor
5808389|NCT02685748|Sensory System Agents|sensory system agents|mesh-ancestor
5808390|NCT02685748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5808391|NCT02685748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808392|NCT02685748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5808393|NCT02685748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5808394|NCT02685748|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5808395|NCT02685748|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5808396|NCT02685748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808397|NCT02685748|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5808398|NCT02685748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5808399|NCT02685748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5808400|NCT02685748|Antipyretics|antipyretics|mesh-ancestor
5808401|NCT02685748|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5808402|NCT02685748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5808403|NCT02685748|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5808404|NCT02685930|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5808405|NCT02685930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5808406|NCT02685930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5808407|NCT02685930|Antitubercular Agents|antitubercular agents|mesh-ancestor
5808408|NCT02685969|Flutemetamol|flutemetamol|mesh-list
5808409|NCT02685969|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6492208|NCT00607542|GABA Agonists|gaba agonists|mesh-ancestor
6492209|NCT00607542|GABA Agents|gaba agents|mesh-ancestor
6492210|NCT00607542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6492211|NCT00607542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492212|NCT00607568|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6492213|NCT00607568|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6492214|NCT00607568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6211228|NCT02169336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808410|NCT02685969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808411|NCT02685657|Cyclophosphamide|cyclophosphamide|mesh-list
5808412|NCT02685657|Docetaxel|docetaxel|mesh-list
5808413|NCT02685657|Doxorubicin|doxorubicin|mesh-list
5808414|NCT02685657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5808415|NCT02685657|Immunologic Factors|immunologic factors|mesh-ancestor
5808416|NCT02685657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808417|NCT02685657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5808418|NCT02685657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5808419|NCT02685657|Alkylating Agents|alkylating agents|mesh-ancestor
5808420|NCT02685657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808421|NCT02685657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5808422|NCT02685657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5808423|NCT02685657|Tubulin Modulators|tubulin modulators|mesh-ancestor
5808424|NCT02685657|Antimitotic Agents|antimitotic agents|mesh-ancestor
5808425|NCT02685657|Mitosis Modulators|mitosis modulators|mesh-ancestor
5808426|NCT02685657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5808427|NCT02685657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5808428|NCT02685657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5808429|NCT02685657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5808430|NCT02685774|Metformin|metformin|mesh-list
5808431|NCT02685774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5808432|NCT02685774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808433|NCT02685670|Cyclophosphamide|cyclophosphamide|mesh-list
5808434|NCT02685670|Fludarabine|fludarabine|mesh-list
5808435|NCT02685670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5808436|NCT02685670|Immunologic Factors|immunologic factors|mesh-ancestor
5808437|NCT02685670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808438|NCT02685670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5808439|NCT02685670|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5808440|NCT02685670|Alkylating Agents|alkylating agents|mesh-ancestor
5808441|NCT02685670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808442|NCT02685670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5808443|NCT02685670|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5808444|NCT02685709|Octreotide|octreotide|mesh-list
5808445|NCT02685709|Lanreotide|lanreotide|mesh-list
5808446|NCT02685709|Cabergoline|cabergoline|mesh-list
5808447|NCT02685709|Somatostatin|somatostatin|mesh-list
5808448|NCT02685709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5808449|NCT02685709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5808450|NCT02685709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5808451|NCT02685709|Hormones|hormones|mesh-ancestor
5808452|NCT02685709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5808453|NCT02685709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808454|NCT02685709|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5808455|NCT02685709|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5808456|NCT02685709|Dopamine Agonists|dopamine agonists|mesh-ancestor
5808457|NCT02685709|Dopamine Agents|dopamine agents|mesh-ancestor
5808458|NCT02685709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5808459|NCT02685709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808460|NCT02686008|Olaparib|olaparib|mesh-list
5808461|NCT02686008|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5808462|NCT02686008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5808463|NCT02686008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808464|NCT02686008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5808465|NCT02685618|Iloprost|iloprost|mesh-list
5808466|NCT02685618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5808467|NCT02685618|Vasodilator Agents|vasodilator agents|mesh-ancestor
5808468|NCT02685397|Leuprolide|leuprolide|mesh-list
5808469|NCT02685397|Goserelin|goserelin|mesh-list
5808470|NCT02685397|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5808471|NCT02685397|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5808472|NCT02685397|Fertility Agents|fertility agents|mesh-ancestor
5808473|NCT02685397|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5808474|NCT02685397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808475|NCT02685397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5808476|NCT02685397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5808477|NCT02685397|Luteolytic Agents|luteolytic agents|mesh-ancestor
5808478|NCT02685397|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5808479|NCT02685397|Contraceptive Agents|contraceptive agents|mesh-ancestor
5808480|NCT02685397|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5808481|NCT02685345|Firuglipel|firuglipel|mesh-list
5808482|NCT02685345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5808483|NCT02685345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808484|NCT02685462|Digoxin|digoxin|mesh-list
5808485|NCT02685462|Caffeine|caffeine|mesh-list
5808486|NCT02685462|Atorvastatin|atorvastatin|mesh-list
5808487|NCT02685462|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5808488|NCT02685462|Simvastatin|simvastatin|mesh-list
5808489|NCT02685462|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5808490|NCT02685462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5808491|NCT02685462|Antimetabolites|antimetabolites|mesh-ancestor
5900664|NCT04572828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5808492|NCT02685462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808493|NCT02685462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5808494|NCT02685462|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5808495|NCT02685462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5808496|NCT02685462|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5808497|NCT02685462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808498|NCT02685462|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5808499|NCT02685462|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5808500|NCT02685462|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5808501|NCT02685462|Purinergic Agents|purinergic agents|mesh-ancestor
5808502|NCT02685462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5808503|NCT02685462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5808504|NCT02685462|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5808505|NCT02685462|Protective Agents|protective agents|mesh-ancestor
5808506|NCT02685306|Paclitaxel|paclitaxel|mesh-list
5808507|NCT02685306|Taxane|taxane|mesh-list
5808508|NCT02685306|Bavituximab|bavituximab|mesh-list
5808509|NCT02685306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5808510|NCT02685306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5808511|NCT02685306|Tubulin Modulators|tubulin modulators|mesh-ancestor
5808512|NCT02685306|Antimitotic Agents|antimitotic agents|mesh-ancestor
5808513|NCT02685306|Mitosis Modulators|mitosis modulators|mesh-ancestor
5808514|NCT02685306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808515|NCT02685306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5808516|NCT02685449|Insulin|insulin|mesh-list
5808517|NCT02685449|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5808518|NCT02685449|Insulin Aspart|insulin aspart|mesh-list
5808519|NCT02685449|Insulin Lispro|insulin lispro|mesh-list
5808520|NCT02685449|Insulin glulisine|insulin glulisine|mesh-list
5808521|NCT02685449|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5808522|NCT02685449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808523|NCT02685592|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5808524|NCT02685592|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5808525|NCT02685592|Dermatologic Agents|dermatologic agents|mesh-ancestor
5808526|NCT02685605|Temozolomide|temozolomide|mesh-list
5808527|NCT02685605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5808528|NCT02685605|Alkylating Agents|alkylating agents|mesh-ancestor
5808529|NCT02685605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808530|NCT02685605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5808531|NCT02685228|Gemcitabine|gemcitabine|mesh-list
5808532|NCT02685228|Decitabine|decitabine|mesh-list
5808533|NCT02685228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5808534|NCT02685228|Antimetabolites|antimetabolites|mesh-ancestor
5808535|NCT02685228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808536|NCT02685228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5808537|NCT02685228|Antiviral Agents|antiviral agents|mesh-ancestor
5808538|NCT02685228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5808539|NCT02685228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5808540|NCT02685228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5808541|NCT02685228|Immunologic Factors|immunologic factors|mesh-ancestor
5808542|NCT02685228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808543|NCT02685163|Antioxidants|antioxidants|mesh-list
5808544|NCT02685163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808545|NCT02685163|Protective Agents|protective agents|mesh-ancestor
5808546|NCT02685163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808547|NCT02685137|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
5808548|NCT02685137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5808549|NCT02685137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808550|NCT02685111|Lenograstim|lenograstim|mesh-list
5808551|NCT02685111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5808552|NCT02685111|Immunologic Factors|immunologic factors|mesh-ancestor
5808553|NCT02685111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211229|NCT02169414|Levodopa|levodopa|mesh-list
6211230|NCT02169414|Carbidopa|carbidopa|mesh-list
6211231|NCT02169414|Opicapone|opicapone|mesh-list
6211232|NCT02169414|Benserazide|benserazide|mesh-list
6211233|NCT02169414|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6492215|NCT00607568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6492216|NCT00607568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492217|NCT00607568|Adrenergic Agents|adrenergic agents|mesh-ancestor
6492218|NCT00607568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5808554|NCT02685150|Omeprazole|omeprazole|mesh-list
5808555|NCT02685150|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
5808556|NCT02685150|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5808557|NCT02685150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6211234|NCT02169414|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5808558|NCT02685150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5808559|NCT02685150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808560|NCT02684812|Tranexamic Acid|tranexamic acid|mesh-list
5808561|NCT02684812|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5808562|NCT02684812|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5808563|NCT02684812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808564|NCT02684812|Hemostatics|hemostatics|mesh-ancestor
5808565|NCT02684812|Coagulants|coagulants|mesh-ancestor
5808566|NCT02684786|Lidocaine|lidocaine|mesh-list
5808567|NCT02684786|Reserpine|reserpine|mesh-list
5808568|NCT02684786|Anesthetics, Local|anesthetics, local|mesh-ancestor
5808569|NCT02684786|Anesthetics|anesthetics|mesh-ancestor
5808570|NCT02684786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5808571|NCT02684786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808572|NCT02684786|Sensory System Agents|sensory system agents|mesh-ancestor
5808573|NCT02684786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5808574|NCT02684786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5808575|NCT02684786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5808576|NCT02684786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5808577|NCT02684786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5808578|NCT02684786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808579|NCT02684786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5808580|NCT02684786|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5808581|NCT02684786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5808582|NCT02684786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5808583|NCT02684786|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5808584|NCT02684786|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5808585|NCT02684786|Adrenergic Agents|adrenergic agents|mesh-ancestor
5808586|NCT02684786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5808587|NCT02684799|Cenicriviroc|cenicriviroc|mesh-list
5808588|NCT02684799|Omeprazole|omeprazole|mesh-list
5808589|NCT02684799|Famotidine|famotidine|mesh-list
5808590|NCT02684799|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5808591|NCT02684799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5808592|NCT02684799|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5808593|NCT02684799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5808594|NCT02684799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808595|NCT02684799|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5808596|NCT02684799|Histamine Antagonists|histamine antagonists|mesh-ancestor
5808597|NCT02684799|Histamine Agents|histamine agents|mesh-ancestor
5808598|NCT02684799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5808599|NCT02684799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808600|NCT02684799|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
5808601|NCT02684799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5808602|NCT02684799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5808603|NCT02684799|Antiviral Agents|antiviral agents|mesh-ancestor
5808604|NCT02684799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5808605|NCT02685176|Charcoal|charcoal|mesh-list
5808606|NCT02685176|Antidotes|antidotes|mesh-ancestor
5808607|NCT02685176|Protective Agents|protective agents|mesh-ancestor
5808608|NCT02685176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808609|NCT02685085|Misoprostol|misoprostol|mesh-list
5808610|NCT02685085|Dinoprostone|dinoprostone|mesh-list
5808611|NCT02685085|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5808612|NCT02685085|Abortifacient Agents|abortifacient agents|mesh-ancestor
5808613|NCT02685085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5808614|NCT02685085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808615|NCT02685085|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5808616|NCT02685085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5808617|NCT02685085|Oxytocics|oxytocics|mesh-ancestor
5808618|NCT02685059|Paclitaxel|paclitaxel|mesh-list
5808619|NCT02685059|Cyclophosphamide|cyclophosphamide|mesh-list
5808620|NCT02685059|Durvalumab|durvalumab|mesh-list
6492219|NCT00607568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808621|NCT02685059|Epirubicin|epirubicin|mesh-list
6492220|NCT00607581|Dexamethasone|dexamethasone|mesh-list
5808622|NCT02685059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5808623|NCT02685059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5808624|NCT02685059|Tubulin Modulators|tubulin modulators|mesh-ancestor
5808625|NCT02685059|Antimitotic Agents|antimitotic agents|mesh-ancestor
5808626|NCT02685059|Mitosis Modulators|mitosis modulators|mesh-ancestor
5808627|NCT02685059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808628|NCT02685059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5808629|NCT02685059|Immunologic Factors|immunologic factors|mesh-ancestor
5808630|NCT02685059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808631|NCT02685059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5808632|NCT02685059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5808633|NCT02685059|Alkylating Agents|alkylating agents|mesh-ancestor
5808634|NCT02685059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5808635|NCT02685059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5808636|NCT02685059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5808637|NCT02685059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5808638|NCT02685059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5808639|NCT02685059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5808640|NCT02685189|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
5808641|NCT02685189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5808642|NCT02685189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808643|NCT02685046|Imatinib Mesylate|imatinib mesylate|mesh-list
5808644|NCT02685046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5808645|NCT02685046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5808646|NCT02685046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5808647|NCT02685046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808648|NCT02684708|Prednisone|prednisone|mesh-list
5808649|NCT02684708|Cyclophosphamide|cyclophosphamide|mesh-list
5808650|NCT02684708|Dacarbazine|dacarbazine|mesh-list
5808651|NCT02684708|Vincristine|vincristine|mesh-list
5808652|NCT02684708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5808653|NCT02684708|Immunologic Factors|immunologic factors|mesh-ancestor
5808654|NCT02684708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808655|NCT02684708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5808656|NCT02684708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5808657|NCT02684708|Alkylating Agents|alkylating agents|mesh-ancestor
5808658|NCT02684708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808659|NCT02684708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5808660|NCT02684708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5808661|NCT02684708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5808662|NCT02684708|Glucocorticoids|glucocorticoids|mesh-ancestor
5808663|NCT02684708|Hormones|hormones|mesh-ancestor
5808664|NCT02684708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5808665|NCT02684708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5808666|NCT02684708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5808667|NCT02684708|Tubulin Modulators|tubulin modulators|mesh-ancestor
5808668|NCT02684708|Antimitotic Agents|antimitotic agents|mesh-ancestor
5808669|NCT02684708|Mitosis Modulators|mitosis modulators|mesh-ancestor
5808670|NCT02684487|Vitamin D|vitamin d|mesh-list
5808671|NCT02684487|Cholecalciferol|cholecalciferol|mesh-list
5808672|NCT02684487|Vitamins|vitamins|mesh-ancestor
5808673|NCT02684487|Micronutrients|micronutrients|mesh-ancestor
5808674|NCT02684487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808675|NCT02684487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5808676|NCT02684487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5900665|NCT04572828|Gout Suppressants|gout suppressants|mesh-ancestor
5808677|NCT02684409|Sumatriptan|sumatriptan|mesh-list
5808678|NCT02684409|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5808679|NCT02684409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5808680|NCT02684409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5808681|NCT02684409|Serotonin Agents|serotonin agents|mesh-ancestor
5808682|NCT02684409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5808683|NCT02684409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808684|NCT02684409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808685|NCT02684474|HBOC 201|hboc 201|mesh-list
5808686|NCT02684474|Blood Substitutes|blood substitutes|mesh-ancestor
5808687|NCT02684292|Pembrolizumab|pembrolizumab|mesh-list
5808688|NCT02684292|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5808689|NCT02684292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5808690|NCT02684292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5808691|NCT02684669|Naloxone|naloxone|mesh-list
5808692|NCT02684669|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5808693|NCT02684669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808694|NCT02684669|Sensory System Agents|sensory system agents|mesh-ancestor
5808695|NCT02684669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5808696|NCT02684019|Magnesium Sulfate|magnesium sulfate|mesh-list
5808697|NCT02684019|Dexmedetomidine|dexmedetomidine|mesh-list
5808698|NCT02684019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5808699|NCT02684019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5808700|NCT02684019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808701|NCT02684019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5808702|NCT02684019|Analgesics|analgesics|mesh-ancestor
5808703|NCT02684019|Sensory System Agents|sensory system agents|mesh-ancestor
5808704|NCT02684019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5808705|NCT02684019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5808706|NCT02684019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5808707|NCT02684019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6492221|NCT00607581|Cyclophosphamide|cyclophosphamide|mesh-list
6492222|NCT00607581|Lenalidomide|lenalidomide|mesh-list
6492223|NCT00607581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6492224|NCT00607581|Immunologic Factors|immunologic factors|mesh-ancestor
6492225|NCT00607581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492226|NCT00607581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6492227|NCT00607581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6492228|NCT00607581|Alkylating Agents|alkylating agents|mesh-ancestor
6492229|NCT00607581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492230|NCT00607581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6492231|NCT00607581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5808708|NCT02684019|Adrenergic Agents|adrenergic agents|mesh-ancestor
5808709|NCT02684019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5808710|NCT02684019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808711|NCT02684019|Anesthetics|anesthetics|mesh-ancestor
5808712|NCT02684019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5808713|NCT02684019|Anticonvulsants|anticonvulsants|mesh-ancestor
5808714|NCT02684019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5808715|NCT02684019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5808716|NCT02684019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5808717|NCT02684019|Tocolytic Agents|tocolytic agents|mesh-ancestor
5808718|NCT02684019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5808719|NCT02684162|Guadecitabine|guadecitabine|mesh-list
5808720|NCT02684162|Azacitidine|azacitidine|mesh-list
5808721|NCT02684162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5808722|NCT02684162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5808723|NCT02684162|Antimetabolites|antimetabolites|mesh-ancestor
5808724|NCT02684162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808725|NCT02684162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5808726|NCT02684071|Cyclophosphamide|cyclophosphamide|mesh-list
5808727|NCT02684071|Methotrexate|methotrexate|mesh-list
5808728|NCT02684071|Topotecan|topotecan|mesh-list
5808729|NCT02684071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5808730|NCT02684071|Immunologic Factors|immunologic factors|mesh-ancestor
5808731|NCT02684071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808732|NCT02684071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5808733|NCT02684071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5808734|NCT02684071|Alkylating Agents|alkylating agents|mesh-ancestor
5808735|NCT02684071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808736|NCT02684071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5808737|NCT02684071|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5808738|NCT02684071|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5808739|NCT02684071|Abortifacient Agents|abortifacient agents|mesh-ancestor
5808740|NCT02684071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5808741|NCT02684071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5808742|NCT02684071|Antimetabolites|antimetabolites|mesh-ancestor
5808743|NCT02684071|Dermatologic Agents|dermatologic agents|mesh-ancestor
5808744|NCT02684071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5808745|NCT02684071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5808746|NCT02684071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5808747|NCT02684071|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5808748|NCT02684071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5808749|NCT02684240|Nitazoxanide|nitazoxanide|mesh-list
5808750|NCT02684240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5808751|NCT02684240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5808752|NCT02684084|Dexamethasone|dexamethasone|mesh-list
5808753|NCT02684084|Ranibizumab|ranibizumab|mesh-list
5808754|NCT02684084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5808755|NCT02684084|Antiemetics|antiemetics|mesh-ancestor
5808756|NCT02684084|Autonomic Agents|autonomic agents|mesh-ancestor
5808757|NCT02684084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5808758|NCT02684084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808759|NCT02684084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5808760|NCT02684084|Glucocorticoids|glucocorticoids|mesh-ancestor
5808761|NCT02684084|Hormones|hormones|mesh-ancestor
5808762|NCT02684084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5808763|NCT02684084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5808764|NCT02684084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5808765|NCT02684084|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5808766|NCT02684084|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5808767|NCT02684084|Growth Substances|growth substances|mesh-ancestor
5808768|NCT02684084|Growth Inhibitors|growth inhibitors|mesh-ancestor
5808769|NCT02684305|Oxytocin|oxytocin|mesh-list
5808770|NCT02684305|Oxytocics|oxytocics|mesh-ancestor
5808771|NCT02684305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5808772|NCT02684305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808773|NCT02684318|Olaparib|olaparib|mesh-list
5808774|NCT02684318|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5808775|NCT02684318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5808776|NCT02684318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808777|NCT02684318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5808778|NCT02684253|Nivolumab|nivolumab|mesh-list
5808779|NCT02684253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5808780|NCT02684253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5808781|NCT02684253|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5808782|NCT02684253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808783|NCT02684123|Apremilast|apremilast|mesh-list
5808784|NCT02684123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5808785|NCT02684123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5808786|NCT02684123|Analgesics|analgesics|mesh-ancestor
5808787|NCT02684123|Sensory System Agents|sensory system agents|mesh-ancestor
5808788|NCT02684123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5808789|NCT02684123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808790|NCT02684123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5808791|NCT02684123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6211235|NCT02169414|Dopamine Agents|dopamine agents|mesh-ancestor
6211236|NCT02169414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6211237|NCT02169414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211238|NCT02169414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211239|NCT02169414|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6211240|NCT02169414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6211241|NCT02169414|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6211242|NCT02169427|Opicapone|opicapone|mesh-list
6211243|NCT02169427|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6211244|NCT02169427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6211245|NCT02169427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211246|NCT02169427|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6211247|NCT02169427|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6211248|NCT02169440|Opicapone|opicapone|mesh-list
6211249|NCT02169440|Warfarin|warfarin|mesh-list
6211250|NCT02169440|Anticoagulants|anticoagulants|mesh-ancestor
6211251|NCT02169440|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6211252|NCT02169440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5808792|NCT02684123|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5808793|NCT02684123|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5808794|NCT02684123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5808795|NCT02684123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808796|NCT02683837|Remifentanil|remifentanil|mesh-list
5808797|NCT02683837|Sevoflurane|sevoflurane|mesh-list
5808798|NCT02683837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5808799|NCT02683837|Narcotics|narcotics|mesh-ancestor
5808800|NCT02683837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5808801|NCT02683837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808802|NCT02683837|Analgesics|analgesics|mesh-ancestor
5808803|NCT02683837|Sensory System Agents|sensory system agents|mesh-ancestor
5808804|NCT02683837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5808805|NCT02683837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5808806|NCT02683837|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5808807|NCT02683837|Anesthetics, General|anesthetics, general|mesh-ancestor
5808808|NCT02683837|Anesthetics|anesthetics|mesh-ancestor
5808809|NCT02683759|Curcumin|curcumin|mesh-list
5808810|NCT02683759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5808811|NCT02683759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5808812|NCT02683759|Analgesics|analgesics|mesh-ancestor
5808813|NCT02683759|Sensory System Agents|sensory system agents|mesh-ancestor
5808814|NCT02683759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5808815|NCT02683759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808816|NCT02683759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5808817|NCT02683759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5808818|NCT02683759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5808819|NCT02683759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5808820|NCT02683759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808821|NCT02683863|Dimethyl Fumarate|dimethyl fumarate|mesh-list
5808822|NCT02683863|Dermatologic Agents|dermatologic agents|mesh-ancestor
5808823|NCT02683863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5808824|NCT02683863|Immunologic Factors|immunologic factors|mesh-ancestor
5808825|NCT02683863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808826|NCT02683733|Aminosalicylic Acid|aminosalicylic acid|mesh-list
5808827|NCT02683733|Curcumin|curcumin|mesh-list
5808828|NCT02683733|Mesalamine|mesalamine|mesh-list
5808829|NCT02683733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5808830|NCT02683733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5808831|NCT02683733|Analgesics|analgesics|mesh-ancestor
5808832|NCT02683733|Sensory System Agents|sensory system agents|mesh-ancestor
5808833|NCT02683733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5808834|NCT02683733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808835|NCT02683733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5808836|NCT02683733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5808837|NCT02683733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5808838|NCT02683733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5808839|NCT02683733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808840|NCT02683733|Antitubercular Agents|antitubercular agents|mesh-ancestor
5808841|NCT02683733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5808842|NCT02683733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5808843|NCT02683655|Apatinib|apatinib|mesh-list
5808844|NCT02683655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5808845|NCT02683655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5808846|NCT02683655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5808847|NCT02683655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808848|NCT02683564|Infliximab|infliximab|mesh-list
5808849|NCT02683564|Dermatologic Agents|dermatologic agents|mesh-ancestor
5808850|NCT02683564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5808851|NCT02683564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5808852|NCT02683603|Imipenem|imipenem|mesh-list
5808853|NCT02683603|Colistin|colistin|mesh-list
5808854|NCT02683603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5808855|NCT02683603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5808856|NCT02683369|Iron|iron|mesh-list
5808857|NCT02683369|Trace Elements|trace elements|mesh-ancestor
5808858|NCT02683369|Micronutrients|micronutrients|mesh-ancestor
5808859|NCT02683369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808860|NCT02682953|Plerixafor|plerixafor|mesh-list
5808861|NCT02682953|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5808862|NCT02682953|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5808863|NCT02682953|Antiviral Agents|antiviral agents|mesh-ancestor
5808864|NCT02682953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5808865|NCT02683031|Ionophores|ionophores|mesh-list
5808866|NCT02683031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5808867|NCT02683031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808868|NCT02683213|Fluoxetine|fluoxetine|mesh-list
5808869|NCT02683213|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5808870|NCT02683213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5808871|NCT02683213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5808872|NCT02683213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808873|NCT02683213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5808874|NCT02683213|Serotonin Agents|serotonin agents|mesh-ancestor
5808875|NCT02683213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808876|NCT02683213|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5808877|NCT02683213|Antidepressive Agents|antidepressive agents|mesh-ancestor
5808878|NCT02683213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5808879|NCT02683213|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5808880|NCT02683213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5808881|NCT02683213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5808882|NCT02683005|Sofosbuvir|sofosbuvir|mesh-list
5808883|NCT02683005|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
5808884|NCT02683005|Ledipasvir|ledipasvir|mesh-list
5808885|NCT02683005|Antiviral Agents|antiviral agents|mesh-ancestor
5808886|NCT02683005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5808887|NCT02683148|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
5808888|NCT02683148|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5808889|NCT02683148|Immunologic Factors|immunologic factors|mesh-ancestor
5808890|NCT02683148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808891|NCT02683070|Tramadol|tramadol|mesh-list
5808892|NCT02683070|Ropivacaine|ropivacaine|mesh-list
5808893|NCT02683070|Anesthetics, Local|anesthetics, local|mesh-ancestor
5808894|NCT02683070|Anesthetics|anesthetics|mesh-ancestor
5808895|NCT02683070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5808896|NCT02683070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808897|NCT02683070|Sensory System Agents|sensory system agents|mesh-ancestor
5808898|NCT02683070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5808899|NCT02683070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5808900|NCT02683070|Narcotics|narcotics|mesh-ancestor
5808901|NCT02683070|Analgesics|analgesics|mesh-ancestor
5808902|NCT02682927|Fenfluramine|fenfluramine|mesh-list
5808903|NCT02682927|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5808904|NCT02682927|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5808905|NCT02682927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5808906|NCT02682927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808907|NCT02682927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5808908|NCT02682927|Serotonin Agents|serotonin agents|mesh-ancestor
5808909|NCT02682927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808910|NCT02683291|Mycophenolic Acid|mycophenolic acid|mesh-list
5808911|NCT02683291|Sirolimus|sirolimus|mesh-list
5808912|NCT02683291|Prednisone|prednisone|mesh-list
5808913|NCT02683291|Tacrolimus|tacrolimus|mesh-list
5808914|NCT02683291|Thymoglobulin|thymoglobulin|mesh-list
5808915|NCT02683291|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5808916|NCT02683291|Basiliximab|basiliximab|mesh-list
5808917|NCT02683291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5808918|NCT02683291|Glucocorticoids|glucocorticoids|mesh-ancestor
5808919|NCT02683291|Hormones|hormones|mesh-ancestor
5808920|NCT02683291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5808921|NCT02683291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808922|NCT02683291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5808923|NCT02683291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5808924|NCT02683291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5808925|NCT02683291|Immunologic Factors|immunologic factors|mesh-ancestor
5808926|NCT02683291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5808927|NCT02683291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5808928|NCT02683291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808929|NCT02683291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5808930|NCT02683291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5808931|NCT02683291|Antitubercular Agents|antitubercular agents|mesh-ancestor
5808932|NCT02683291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5808933|NCT02683291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5808934|NCT02683291|Antifungal Agents|antifungal agents|mesh-ancestor
5808935|NCT02682862|Bromides|bromides|mesh-list
5808936|NCT02682862|Tiotropium Bromide|tiotropium bromide|mesh-list
5808937|NCT02682862|Olodaterol|olodaterol|mesh-list
5808938|NCT02682862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5808939|NCT02682862|Autonomic Agents|autonomic agents|mesh-ancestor
5808940|NCT02682862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5808941|NCT02682862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808942|NCT02682862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5808943|NCT02682862|Respiratory System Agents|respiratory system agents|mesh-ancestor
6492232|NCT00607581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6492233|NCT00607581|Antiemetics|antiemetics|mesh-ancestor
6492234|NCT00607581|Autonomic Agents|autonomic agents|mesh-ancestor
5808944|NCT02682862|Parasympatholytics|parasympatholytics|mesh-ancestor
6492235|NCT00607581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5808945|NCT02682862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5808946|NCT02682862|Cholinergic Agents|cholinergic agents|mesh-ancestor
5808947|NCT02682862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5808948|NCT02682862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808949|NCT02682862|Anticonvulsants|anticonvulsants|mesh-ancestor
5808950|NCT02682693|Denosumab|denosumab|mesh-list
5808951|NCT02682693|Paclitaxel|paclitaxel|mesh-list
5808952|NCT02682693|Cyclophosphamide|cyclophosphamide|mesh-list
5808953|NCT02682693|Carboplatin|carboplatin|mesh-list
5808954|NCT02682693|Trastuzumab|trastuzumab|mesh-list
5808955|NCT02682693|Epirubicin|epirubicin|mesh-list
5808956|NCT02682693|Pertuzumab|pertuzumab|mesh-list
5808957|NCT02682693|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5808958|NCT02682693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5808959|NCT02682693|Tubulin Modulators|tubulin modulators|mesh-ancestor
5808960|NCT02682693|Antimitotic Agents|antimitotic agents|mesh-ancestor
5808961|NCT02682693|Mitosis Modulators|mitosis modulators|mesh-ancestor
5808962|NCT02682693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808963|NCT02682693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5808964|NCT02682693|Immunologic Factors|immunologic factors|mesh-ancestor
5808965|NCT02682693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808966|NCT02682693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5808967|NCT02682693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5808968|NCT02682693|Alkylating Agents|alkylating agents|mesh-ancestor
5808969|NCT02682693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5808970|NCT02682693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5808971|NCT02682693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5808972|NCT02682693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5808973|NCT02682693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5808974|NCT02682693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5808975|NCT02682693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5900666|NCT04572828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5900667|NCT04572828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5900668|NCT04572828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900669|NCT04564625|Vitamin D|vitamin d|mesh-list
5900670|NCT04564625|Vitamins|vitamins|mesh-ancestor
5900671|NCT04564625|Micronutrients|micronutrients|mesh-ancestor
5900672|NCT04564625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900673|NCT04564625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5900674|NCT04558112|Levodopa|levodopa|mesh-list
5900675|NCT04558112|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5900676|NCT04558112|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5900677|NCT04558112|Dopamine Agents|dopamine agents|mesh-ancestor
5900678|NCT04558112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5900679|NCT04558112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900680|NCT04558112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900681|NCT04557189|Ondansetron|ondansetron|mesh-list
5900682|NCT04557189|Antiemetics|antiemetics|mesh-ancestor
5900683|NCT04557189|Autonomic Agents|autonomic agents|mesh-ancestor
5900684|NCT04557189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5900685|NCT04557189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900686|NCT04557189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5900687|NCT04557189|Antipruritics|antipruritics|mesh-ancestor
5900688|NCT04557189|Dermatologic Agents|dermatologic agents|mesh-ancestor
5900689|NCT04557189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5900690|NCT04557189|Serotonin Agents|serotonin agents|mesh-ancestor
5900691|NCT04557189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5900692|NCT04557189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808976|NCT02682680|Ezetimibe|ezetimibe|mesh-list
5808977|NCT02682680|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
5808978|NCT02682680|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5808979|NCT02682680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5808980|NCT02682680|Antimetabolites|antimetabolites|mesh-ancestor
5808981|NCT02682680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5808982|NCT02682680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5808983|NCT02682758|Xenon|xenon|mesh-list
5808984|NCT02682758|Anesthetics|anesthetics|mesh-ancestor
5808985|NCT02682758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5808986|NCT02682758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808987|NCT02682758|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5808988|NCT02682758|Anesthetics, General|anesthetics, general|mesh-ancestor
5808989|NCT02682524|Aceclofenac|aceclofenac|mesh-list
5808990|NCT02682524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5808991|NCT02682524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5808992|NCT02682524|Analgesics|analgesics|mesh-ancestor
5808993|NCT02682524|Sensory System Agents|sensory system agents|mesh-ancestor
5808994|NCT02682524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5808995|NCT02682524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5808996|NCT02682524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5808997|NCT02682524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5808998|NCT02682511|Ifetroban|ifetroban|mesh-list
5808999|NCT02682511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5809000|NCT02682485|Metronidazole|metronidazole|mesh-list
5809001|NCT02682485|Ciprofloxacin|ciprofloxacin|mesh-list
5809002|NCT02682485|Neomycin|neomycin|mesh-list
5809003|NCT02682485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5809004|NCT02682485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5809005|NCT02682485|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5809006|NCT02682485|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5809007|NCT02682485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5809008|NCT02682485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5809009|NCT02682485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5809010|NCT02682485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5809011|NCT02682485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5809012|NCT02682485|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5809013|NCT02682485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5809014|NCT02682485|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5809015|NCT02682186|Ropivacaine|ropivacaine|mesh-list
5809016|NCT02682186|Anesthetics, Local|anesthetics, local|mesh-ancestor
5809017|NCT02682186|Anesthetics|anesthetics|mesh-ancestor
5809018|NCT02682186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5809019|NCT02682186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809020|NCT02682186|Sensory System Agents|sensory system agents|mesh-ancestor
5809021|NCT02682186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5809022|NCT02682147|Sildenafil Citrate|sildenafil citrate|mesh-list
5809023|NCT02682147|Vasodilator Agents|vasodilator agents|mesh-ancestor
5809024|NCT02682147|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5809025|NCT02682147|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5809026|NCT02682147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5809027|NCT02682147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5809028|NCT02682147|Urological Agents|urological agents|mesh-ancestor
5809029|NCT02682134|Dexamethasone|dexamethasone|mesh-list
5809030|NCT02682134|Dexamethasone acetate|dexamethasone acetate|mesh-list
5809031|NCT02682134|Lidocaine|lidocaine|mesh-list
5809032|NCT02682134|BB 1101|bb 1101|mesh-list
5809033|NCT02682134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5809034|NCT02682134|Antiemetics|antiemetics|mesh-ancestor
5809035|NCT02682134|Autonomic Agents|autonomic agents|mesh-ancestor
5809036|NCT02682134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5809037|NCT02682134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809038|NCT02682134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5809039|NCT02682134|Glucocorticoids|glucocorticoids|mesh-ancestor
5809040|NCT02682134|Hormones|hormones|mesh-ancestor
5809041|NCT02682134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5809042|NCT02682134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5809043|NCT02682134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5809044|NCT02682134|Protease Inhibitors|protease inhibitors|mesh-ancestor
5809045|NCT02682134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5809046|NCT02682134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5809047|NCT02682134|Anesthetics, Local|anesthetics, local|mesh-ancestor
5809048|NCT02682134|Anesthetics|anesthetics|mesh-ancestor
5809049|NCT02682134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5809050|NCT02682134|Sensory System Agents|sensory system agents|mesh-ancestor
5809051|NCT02682134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5809052|NCT02682134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5809053|NCT02682134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5809054|NCT02682134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5809055|NCT02682329|Hydrogen Peroxide|hydrogen peroxide|mesh-list
5809056|NCT02682329|Carbamide Peroxide|carbamide peroxide|mesh-list
5809057|NCT02682329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5809058|NCT02682329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5809059|NCT02682459|Lisinopril|lisinopril|mesh-list
5809060|NCT02682459|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5809061|NCT02682459|Protease Inhibitors|protease inhibitors|mesh-ancestor
5809062|NCT02682459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5809063|NCT02682459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5809064|NCT02682459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5809065|NCT02682459|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5809066|NCT02682459|Protective Agents|protective agents|mesh-ancestor
5809067|NCT02682459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809068|NCT02682225|Ketamine|ketamine|mesh-list
5809069|NCT02682225|Esketamine|esketamine|mesh-list
5809070|NCT02682225|Analgesics|analgesics|mesh-ancestor
5809071|NCT02682225|Sensory System Agents|sensory system agents|mesh-ancestor
5809072|NCT02682225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5809073|NCT02682225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809074|NCT02682225|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5809075|NCT02682225|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5809076|NCT02682225|Anesthetics, General|anesthetics, general|mesh-ancestor
5809077|NCT02682225|Anesthetics|anesthetics|mesh-ancestor
5809078|NCT02682225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5809079|NCT02682225|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5809080|NCT02682225|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5809081|NCT02682225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5809082|NCT02682225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5809083|NCT02682225|Antidepressive Agents|antidepressive agents|mesh-ancestor
5809084|NCT02682225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5809085|NCT02682121|Metformin|metformin|mesh-list
5809086|NCT02682121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5809087|NCT02682121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809088|NCT02682004|Serotonin|serotonin|mesh-list
5809089|NCT02682004|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5809090|NCT02682004|Serotonin Agents|serotonin agents|mesh-ancestor
5809091|NCT02682004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5809092|NCT02682004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5809093|NCT02682004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809094|NCT02682017|Fucoidan|fucoidan|mesh-list
5809095|NCT02682017|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5809096|NCT02682017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5809097|NCT02682017|Anticoagulants|anticoagulants|mesh-ancestor
5809098|NCT02682017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5809099|NCT02682082|Bupivacaine|bupivacaine|mesh-list
5809100|NCT02682082|Anesthetics, Local|anesthetics, local|mesh-ancestor
5809101|NCT02682082|Anesthetics|anesthetics|mesh-ancestor
5809102|NCT02682082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5809103|NCT02682082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809104|NCT02682082|Sensory System Agents|sensory system agents|mesh-ancestor
5809105|NCT02682082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5809106|NCT02681848|Nicotine|nicotine|mesh-list
5809107|NCT02681848|Varenicline|varenicline|mesh-list
5809108|NCT02681848|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5809109|NCT02681848|Autonomic Agents|autonomic agents|mesh-ancestor
5809110|NCT02681848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5809111|NCT02681848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809112|NCT02681848|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5809113|NCT02681848|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5809114|NCT02681848|Cholinergic Agents|cholinergic agents|mesh-ancestor
5809115|NCT02681848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5809116|NCT02681848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5809117|NCT02681887|Melatonin|melatonin|mesh-list
5809118|NCT02681887|Antioxidants|antioxidants|mesh-ancestor
5809119|NCT02681887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5809120|NCT02681887|Protective Agents|protective agents|mesh-ancestor
5809121|NCT02681887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809122|NCT02681887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5809123|NCT02681913|Adenosine|adenosine|mesh-list
5809124|NCT02681913|Analgesics|analgesics|mesh-ancestor
5809125|NCT02681913|Sensory System Agents|sensory system agents|mesh-ancestor
5809126|NCT02681913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5809127|NCT02681913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809128|NCT02681913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5809129|NCT02681913|Vasodilator Agents|vasodilator agents|mesh-ancestor
5809130|NCT02681913|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5809131|NCT02681913|Purinergic Agonists|purinergic agonists|mesh-ancestor
5809132|NCT02681913|Purinergic Agents|purinergic agents|mesh-ancestor
5809133|NCT02681913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5809134|NCT02681913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5809135|NCT02681783|Aflibercept|aflibercept|mesh-list
5809136|NCT02681783|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5809137|NCT02681783|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5809138|NCT02681783|Growth Substances|growth substances|mesh-ancestor
5809139|NCT02681783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809140|NCT02681783|Growth Inhibitors|growth inhibitors|mesh-ancestor
5809141|NCT02681783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5809142|NCT02681679|Bromfenac|bromfenac|mesh-list
5809143|NCT02681679|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5809144|NCT02681679|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5809145|NCT02681679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5809146|NCT02681679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5809147|NCT02681679|Analgesics|analgesics|mesh-ancestor
5809148|NCT02681679|Sensory System Agents|sensory system agents|mesh-ancestor
5809149|NCT02681679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5809150|NCT02681679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809151|NCT02681679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5809152|NCT02681679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5809153|NCT02681562|Olaparib|olaparib|mesh-list
5809154|NCT02681562|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5809155|NCT02681562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5809156|NCT02681562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5809157|NCT02681562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5809158|NCT02681705|Temozolomide|temozolomide|mesh-list
5809159|NCT02681705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5809160|NCT02681705|Alkylating Agents|alkylating agents|mesh-ancestor
5809161|NCT02681705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5809162|NCT02681705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5809163|NCT02681653|Atorvastatin|atorvastatin|mesh-list
5809164|NCT02681653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5809165|NCT02681653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5809166|NCT02681653|Antimetabolites|antimetabolites|mesh-ancestor
5809167|NCT02681653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5809168|NCT02681653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5809169|NCT02681653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5809170|NCT02681653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5809171|NCT02681471|Mannitol|mannitol|mesh-list
5809172|NCT02681471|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5809173|NCT02681471|Diuretics|diuretics|mesh-ancestor
5809174|NCT02681471|Natriuretic Agents|natriuretic agents|mesh-ancestor
5809175|NCT02681471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809176|NCT02681536|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5809177|NCT02681536|Contraceptive Agents|contraceptive agents|mesh-list
5809178|NCT02681536|Contraceptives, Oral|contraceptives, oral|mesh-list
5809179|NCT02681536|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
5809180|NCT02681536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5809181|NCT02681536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809182|NCT02681536|Luteolytic Agents|luteolytic agents|mesh-ancestor
5809183|NCT02681536|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5809184|NCT02681536|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5809185|NCT02681536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5809186|NCT02681536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5809187|NCT02681796|Bupivacaine|bupivacaine|mesh-list
5809188|NCT02681796|Anesthetics, Local|anesthetics, local|mesh-ancestor
5809189|NCT02681796|Anesthetics|anesthetics|mesh-ancestor
5809190|NCT02681796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5809191|NCT02681796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809192|NCT02681796|Sensory System Agents|sensory system agents|mesh-ancestor
5809193|NCT02681796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5809194|NCT02681198|Lofexidine|lofexidine|mesh-list
5809195|NCT02681198|Paroxetine|paroxetine|mesh-list
5809196|NCT02681198|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5809197|NCT02681198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5809198|NCT02681198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5809199|NCT02681198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5809200|NCT02681198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5809201|NCT02681198|Serotonin Agents|serotonin agents|mesh-ancestor
5809202|NCT02681198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809203|NCT02681198|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5809204|NCT02681198|Antidepressive Agents|antidepressive agents|mesh-ancestor
5809205|NCT02681198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5809206|NCT02681198|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5809207|NCT02681198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5809208|NCT02681198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5809209|NCT02681198|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5809210|NCT02681198|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5809211|NCT02681198|Sensory System Agents|sensory system agents|mesh-ancestor
5809212|NCT02681198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6492236|NCT00607581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6492237|NCT00607581|Glucocorticoids|glucocorticoids|mesh-ancestor
6492238|NCT00607581|Hormones|hormones|mesh-ancestor
6496435|NCT00627991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5809213|NCT02681198|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5809214|NCT02681198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5809215|NCT02681198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6492239|NCT00607581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6492240|NCT00607581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6492241|NCT00607581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6492242|NCT00607581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5809216|NCT02681198|Adrenergic Agents|adrenergic agents|mesh-ancestor
5809217|NCT02681263|Temocillin|temocillin|mesh-list
5809218|NCT02681263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5809219|NCT02681263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5900693|NCT04557189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5900694|NCT04557189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5900695|NCT04557189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5900696|NCT04557189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5900697|NCT04557189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5908223|NCT04799015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5908224|NCT04799015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5908225|NCT04799015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5908226|NCT04799015|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5908227|NCT04799015|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5908228|NCT04799015|Dopamine Agents|dopamine agents|mesh-ancestor
5908229|NCT04799015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5908230|NCT04799015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908231|NCT04796584|Antibodies|antibodies|mesh-list
5908232|NCT04796584|Immunologic Factors|immunologic factors|mesh-ancestor
5908233|NCT04796584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5908234|NCT04791553|Cenobamate|cenobamate|mesh-list
5908235|NCT04791553|Anticonvulsants|anticonvulsants|mesh-ancestor
5908236|NCT04768296|Topotecan|topotecan|mesh-list
5908237|NCT04768296|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5908238|NCT04768296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5908239|NCT04768296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5908240|NCT04768296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908241|NCT04768296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5908242|NCT04765202|Carisoprodol|carisoprodol|mesh-list
5908243|NCT04765202|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5809220|NCT02681211|Diphenhydramine|diphenhydramine|mesh-list
5809221|NCT02681211|Promethazine|promethazine|mesh-list
5809222|NCT02681211|Ketorolac|ketorolac|mesh-list
5809223|NCT02681211|Metoclopramide|metoclopramide|mesh-list
5809224|NCT02681211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5809225|NCT02681211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5809226|NCT02681211|Analgesics|analgesics|mesh-ancestor
5809227|NCT02681211|Sensory System Agents|sensory system agents|mesh-ancestor
5809228|NCT02681211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5809229|NCT02681211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809230|NCT02681211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5809231|NCT02681211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5809232|NCT02681211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5809233|NCT02681211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5809234|NCT02681211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5809235|NCT02681211|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5809236|NCT02681211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5809237|NCT02681211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5809238|NCT02681211|Anesthetics, Local|anesthetics, local|mesh-ancestor
5809239|NCT02681211|Anesthetics|anesthetics|mesh-ancestor
5809240|NCT02681211|Antiemetics|antiemetics|mesh-ancestor
5809241|NCT02681211|Autonomic Agents|autonomic agents|mesh-ancestor
5809242|NCT02681211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5809243|NCT02681211|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5809244|NCT02681211|Histamine Antagonists|histamine antagonists|mesh-ancestor
5809245|NCT02681211|Histamine Agents|histamine agents|mesh-ancestor
5809246|NCT02681211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5809247|NCT02681211|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5809248|NCT02681211|Antipruritics|antipruritics|mesh-ancestor
5809249|NCT02681211|Dermatologic Agents|dermatologic agents|mesh-ancestor
5809250|NCT02681211|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5809251|NCT02681211|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5809252|NCT02681211|Dopamine Agents|dopamine agents|mesh-ancestor
5809253|NCT02680977|Levodopa|levodopa|mesh-list
5809254|NCT02680977|Benserazide|benserazide|mesh-list
5809255|NCT02680977|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5809256|NCT02680977|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5809257|NCT02680977|Dopamine Agents|dopamine agents|mesh-ancestor
5809258|NCT02680977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5809259|NCT02680977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5809260|NCT02680977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809261|NCT02680977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5809262|NCT02680938|Oxytocin|oxytocin|mesh-list
5809263|NCT02680938|Oxytocics|oxytocics|mesh-ancestor
5809264|NCT02680938|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5809265|NCT02680938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809266|NCT02680951|Cytarabine|cytarabine|mesh-list
5809267|NCT02680951|Fludarabine|fludarabine|mesh-list
5809268|NCT02680951|Dasatinib|dasatinib|mesh-list
5809269|NCT02680951|Idarubicin|idarubicin|mesh-list
5809270|NCT02680951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5809271|NCT02680951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5809272|NCT02680951|Antimetabolites|antimetabolites|mesh-ancestor
5809273|NCT02680951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5809274|NCT02680951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5809275|NCT02680951|Immunologic Factors|immunologic factors|mesh-ancestor
5809276|NCT02680951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809277|NCT02680951|Antiviral Agents|antiviral agents|mesh-ancestor
5809278|NCT02680951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5809279|NCT02680951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5809280|NCT02680951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5809281|NCT02680951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5809282|NCT02680951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5809283|NCT02680951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5809284|NCT02680717|Clobetasol|clobetasol|mesh-list
5809285|NCT02680717|Calcipotriene|calcipotriene|mesh-list
5809286|NCT02680717|Tacrolimus|tacrolimus|mesh-list
5809287|NCT02680717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5809288|NCT02680717|Immunologic Factors|immunologic factors|mesh-ancestor
5809289|NCT02680717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809290|NCT02680717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5809291|NCT02680717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5809292|NCT02680717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5809293|NCT02680717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5809294|NCT02680717|Glucocorticoids|glucocorticoids|mesh-ancestor
5809295|NCT02680717|Hormones|hormones|mesh-ancestor
5809296|NCT02680717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5809297|NCT02680717|Dermatologic Agents|dermatologic agents|mesh-ancestor
5809298|NCT02680795|Belinostat|belinostat|mesh-list
5809299|NCT02680795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5809300|NCT02680795|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5809301|NCT02680795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5809302|NCT02680795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5809303|NCT02680600|Cefepime|cefepime|mesh-list
5809304|NCT02680600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5809305|NCT02680600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5809306|NCT02680678|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5809307|NCT02680548|Methylprednisolone|methylprednisolone|mesh-list
5809308|NCT02680548|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5809309|NCT02680548|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5809310|NCT02680548|Prednisolone|prednisolone|mesh-list
5809311|NCT02680548|Prednisolone acetate|prednisolone acetate|mesh-list
5809312|NCT02680548|Bupivacaine|bupivacaine|mesh-list
5809313|NCT02680548|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5809314|NCT02680548|Prednisolone phosphate|prednisolone phosphate|mesh-list
5809315|NCT02680548|Anesthetics, Local|anesthetics, local|mesh-ancestor
5809316|NCT02680548|Anesthetics|anesthetics|mesh-ancestor
5809317|NCT02680548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5809318|NCT02680548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809319|NCT02680548|Sensory System Agents|sensory system agents|mesh-ancestor
5809320|NCT02680548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5809321|NCT02680548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5809322|NCT02680548|Antiemetics|antiemetics|mesh-ancestor
5809323|NCT02680548|Autonomic Agents|autonomic agents|mesh-ancestor
5809324|NCT02680548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5809325|NCT02680548|Glucocorticoids|glucocorticoids|mesh-ancestor
5809326|NCT02680548|Hormones|hormones|mesh-ancestor
5809327|NCT02680548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5809328|NCT02680548|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5809329|NCT02680548|Protective Agents|protective agents|mesh-ancestor
5809330|NCT02680548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5809331|NCT02680548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5809332|NCT02680626|Magnesium Sulfate|magnesium sulfate|mesh-list
5809333|NCT02680626|Ropivacaine|ropivacaine|mesh-list
5809334|NCT02680626|Anesthetics, Local|anesthetics, local|mesh-ancestor
5809335|NCT02680626|Anesthetics|anesthetics|mesh-ancestor
5809336|NCT02680626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5809337|NCT02680626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809338|NCT02680626|Sensory System Agents|sensory system agents|mesh-ancestor
5809339|NCT02680626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5809340|NCT02680626|Analgesics|analgesics|mesh-ancestor
5809341|NCT02680626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5809342|NCT02680626|Anticonvulsants|anticonvulsants|mesh-ancestor
5809343|NCT02680626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5809344|NCT02680626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5809345|NCT02680626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5809346|NCT02680626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5809347|NCT02680626|Tocolytic Agents|tocolytic agents|mesh-ancestor
5809348|NCT02680626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5809349|NCT02680808|Olorofim|olorofim|mesh-list
5809350|NCT02680808|Midazolam|midazolam|mesh-list
5809351|NCT02680808|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5809352|NCT02680808|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5809353|NCT02680808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5809354|NCT02680808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809355|NCT02680808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5809356|NCT02680808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5809357|NCT02680808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5809358|NCT02680808|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5809359|NCT02680808|Anesthetics, General|anesthetics, general|mesh-ancestor
5809360|NCT02680808|Anesthetics|anesthetics|mesh-ancestor
5809361|NCT02680808|GABA Modulators|gaba modulators|mesh-ancestor
5809362|NCT02680808|GABA Agents|gaba agents|mesh-ancestor
6211253|NCT02169440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5809363|NCT02680808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5809364|NCT02680808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5809365|NCT02680808|Antifungal Agents|antifungal agents|mesh-ancestor
5809366|NCT02680808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5809367|NCT02680379|Minocycline|minocycline|mesh-list
5809368|NCT02680379|Lovastatin|lovastatin|mesh-list
5809369|NCT02680379|L 647318|l 647318|mesh-list
5809370|NCT02680379|Dihydromevinolin|dihydromevinolin|mesh-list
6211254|NCT02169440|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6211255|NCT02169440|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6211256|NCT02169453|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
6211257|NCT02169453|Opicapone|opicapone|mesh-list
6211258|NCT02169453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6211259|NCT02169453|Immunologic Factors|immunologic factors|mesh-ancestor
6211260|NCT02169453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211261|NCT02169453|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6211262|NCT02169453|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6211263|NCT02169453|Dopamine Agonists|dopamine agonists|mesh-ancestor
6211264|NCT02169453|Dopamine Agents|dopamine agents|mesh-ancestor
6211265|NCT02169453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6211266|NCT02169453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211267|NCT02169453|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6211268|NCT02169453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6211269|NCT02169466|Opicapone|opicapone|mesh-list
6211270|NCT02169466|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
5809371|NCT02680379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5809372|NCT02680379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5809373|NCT02680379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5809374|NCT02680379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5809375|NCT02680379|Antimetabolites|antimetabolites|mesh-ancestor
5809376|NCT02680379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5809377|NCT02680379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5809378|NCT02680379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5809379|NCT02680379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5809380|NCT02680184|Pembrolizumab|pembrolizumab|mesh-list
5809381|NCT02680184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5809382|NCT02680184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6211271|NCT02169466|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
5809383|NCT02680119|Esomeprazole|esomeprazole|mesh-list
5809384|NCT02680119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5809385|NCT02680119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5809386|NCT02680119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5809387|NCT02680119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5809388|NCT02680119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5809389|NCT02680080|Moxifloxacin|moxifloxacin|mesh-list
5809390|NCT02680080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5809391|NCT02680080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5809392|NCT02680080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5809393|NCT02680080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5809394|NCT02680080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5809395|NCT02680080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5809396|NCT02680080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5809397|NCT02680132|Esomeprazole|esomeprazole|mesh-list
5809398|NCT02680132|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5809399|NCT02680132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5809400|NCT02680132|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5809401|NCT02680132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5809402|NCT02680132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5809403|NCT02679963|Olaparib|olaparib|mesh-list
5809404|NCT02679963|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5809405|NCT02679963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5809406|NCT02679963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5809407|NCT02679963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5809408|NCT02679924|Hyaluronic Acid|hyaluronic acid|mesh-list
5809409|NCT02679924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5809410|NCT02679924|Immunologic Factors|immunologic factors|mesh-ancestor
5809411|NCT02679924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809412|NCT02679924|Viscosupplements|viscosupplements|mesh-ancestor
5809413|NCT02679924|Protective Agents|protective agents|mesh-ancestor
5809414|NCT02679664|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5809415|NCT02679664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5809416|NCT02679664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5809417|NCT02679664|Antimetabolites|antimetabolites|mesh-ancestor
5809418|NCT02679664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5809419|NCT02679664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5809420|NCT02679664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5809421|NCT02679664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5809422|NCT02679833|Vitamin B 12|vitamin b 12|mesh-list
5809423|NCT02679833|Hydroxocobalamin|hydroxocobalamin|mesh-list
5809424|NCT02679833|Vitamin B Complex|vitamin b complex|mesh-ancestor
5809425|NCT02679833|Vitamins|vitamins|mesh-ancestor
5809426|NCT02679833|Micronutrients|micronutrients|mesh-ancestor
5809427|NCT02679833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809428|NCT02679833|Hematinics|hematinics|mesh-ancestor
5809429|NCT02679820|Copper|copper|mesh-list
5809430|NCT02679820|Trace Elements|trace elements|mesh-ancestor
5809431|NCT02679820|Micronutrients|micronutrients|mesh-ancestor
5809432|NCT02679820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809433|NCT02679339|Lidocaine|lidocaine|mesh-list
5809434|NCT02679339|Anesthetics, Local|anesthetics, local|mesh-ancestor
5809435|NCT02679339|Anesthetics|anesthetics|mesh-ancestor
5809436|NCT02679339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5809437|NCT02679339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809438|NCT02679339|Sensory System Agents|sensory system agents|mesh-ancestor
5809439|NCT02679339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5809440|NCT02679339|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5809441|NCT02679339|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5809442|NCT02679339|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5809443|NCT02679339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5809444|NCT02679339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900698|NCT04549311|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5900699|NCT04549311|Amoxicillin|amoxicillin|mesh-list
5900700|NCT04549311|Metronidazole|metronidazole|mesh-list
5900701|NCT04549311|Ciprofloxacin|ciprofloxacin|mesh-list
5900702|NCT04549311|Clavulanic Acids|clavulanic acids|mesh-list
5900703|NCT04549311|Clavulanic Acid|clavulanic acid|mesh-list
5900704|NCT04549311|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5900705|NCT04549311|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5900706|NCT04549311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5900707|NCT04549311|Antitubercular Agents|antitubercular agents|mesh-ancestor
5900708|NCT04549311|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5900709|NCT04549311|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5900710|NCT04549311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5900711|NCT04549311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5900712|NCT04549311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5900713|NCT04549311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900714|NCT04549311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5900715|NCT04549311|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5900716|NCT04549311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5900717|NCT04549311|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5900718|NCT04500665|Colchicine|colchicine|mesh-list
5900719|NCT04500665|Gout Suppressants|gout suppressants|mesh-ancestor
5900720|NCT04500665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5900721|NCT04500665|Tubulin Modulators|tubulin modulators|mesh-ancestor
5900722|NCT04500665|Antimitotic Agents|antimitotic agents|mesh-ancestor
5900723|NCT04500665|Mitosis Modulators|mitosis modulators|mesh-ancestor
5900724|NCT04500665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900725|NCT04500665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5900726|NCT04493138|Azacitidine|azacitidine|mesh-list
5900727|NCT04493138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5900728|NCT04493138|Antimetabolites|antimetabolites|mesh-ancestor
5908244|NCT04765202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809445|NCT02679456|Fluconazole|fluconazole|mesh-list
5809446|NCT02679456|Ibrexafungerp|ibrexafungerp|mesh-list
5809447|NCT02679456|Antifungal Agents|antifungal agents|mesh-ancestor
5809448|NCT02679456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5809449|NCT02679456|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5809450|NCT02679456|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5809451|NCT02679456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5809452|NCT02679456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5809453|NCT02679456|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5809454|NCT02679456|Hormone Antagonists|hormone antagonists|mesh-ancestor
5809455|NCT02679456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5809456|NCT02679456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809457|NCT02679456|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5809458|NCT02679456|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5809459|NCT02679261|Atorvastatin|atorvastatin|mesh-list
5809460|NCT02679261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5809461|NCT02679261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5809462|NCT02679261|Antimetabolites|antimetabolites|mesh-ancestor
5809463|NCT02679261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5809464|NCT02679261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5809465|NCT02679261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5809466|NCT02679261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5809467|NCT02678975|Copper|copper|mesh-list
5809468|NCT02678975|Temozolomide|temozolomide|mesh-list
5809469|NCT02678975|Lomustine|lomustine|mesh-list
5809470|NCT02678975|Disulfiram|disulfiram|mesh-list
5809471|NCT02678975|Alkylating Agents|alkylating agents|mesh-list
5809472|NCT02678975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5809473|NCT02678975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5809474|NCT02678975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5809475|NCT02678975|Trace Elements|trace elements|mesh-ancestor
5809476|NCT02678975|Micronutrients|micronutrients|mesh-ancestor
5809477|NCT02678975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809478|NCT02678975|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5809479|NCT02678975|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
5809480|NCT02678975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5809481|NCT02679001|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
5809482|NCT02679001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5809483|NCT02679131|Belinostat|belinostat|mesh-list
5809484|NCT02679131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5809485|NCT02679131|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5809486|NCT02679131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5809487|NCT02679131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5809488|NCT02679092|Misoprostol|misoprostol|mesh-list
5809489|NCT02679092|Mifepristone|mifepristone|mesh-list
5809490|NCT02679092|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5809491|NCT02679092|Abortifacient Agents|abortifacient agents|mesh-ancestor
5809492|NCT02679092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5809493|NCT02679092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809494|NCT02679092|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5809495|NCT02679092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5809496|NCT02679092|Oxytocics|oxytocics|mesh-ancestor
5809497|NCT02679092|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5809498|NCT02679092|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5809499|NCT02679092|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5809500|NCT02679092|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5809501|NCT02679092|Contraceptive Agents|contraceptive agents|mesh-ancestor
5809502|NCT02679092|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5809503|NCT02679092|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5809504|NCT02679092|Hormone Antagonists|hormone antagonists|mesh-ancestor
5809505|NCT02679092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5809506|NCT02679092|Luteolytic Agents|luteolytic agents|mesh-ancestor
5809507|NCT02679092|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5809508|NCT02679092|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5809509|NCT02679040|Trastuzumab|trastuzumab|mesh-list
5809510|NCT02679040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5809511|NCT02679040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5809512|NCT02678949|Fluticasone|fluticasone|mesh-list
5809513|NCT02678949|Xhance|xhance|mesh-list
5809514|NCT02678949|Albuterol|albuterol|mesh-list
5809515|NCT02678949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5809516|NCT02678949|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5809517|NCT02678949|Autonomic Agents|autonomic agents|mesh-ancestor
5809518|NCT02678949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5809519|NCT02678949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5908245|NCT04765202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6492243|NCT00607581|Growth Substances|growth substances|mesh-ancestor
6492244|NCT00607581|Growth Inhibitors|growth inhibitors|mesh-ancestor
6492245|NCT00607646|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
6492246|NCT00607646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6492247|NCT00607646|Immunologic Factors|immunologic factors|mesh-ancestor
6492248|NCT00607646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492249|NCT00607685|Fluorouracil|fluorouracil|mesh-list
6492250|NCT00607685|Hyaluronic Acid|hyaluronic acid|mesh-list
5809520|NCT02678949|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5809521|NCT02678949|Respiratory System Agents|respiratory system agents|mesh-ancestor
5809522|NCT02678949|Dermatologic Agents|dermatologic agents|mesh-ancestor
5809523|NCT02678949|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5809524|NCT02678949|Tocolytic Agents|tocolytic agents|mesh-ancestor
5809525|NCT02678949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5809526|NCT02678949|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5809527|NCT02678949|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5809528|NCT02678949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5809529|NCT02678949|Adrenergic Agents|adrenergic agents|mesh-ancestor
5809530|NCT02678949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5809531|NCT02678949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5809532|NCT02679144|Eflornithine|eflornithine|mesh-list
5809533|NCT02679144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5809534|NCT02679144|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5809535|NCT02679144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5809536|NCT02679144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5809537|NCT02679144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5809538|NCT02679144|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
5809539|NCT02679144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5809540|NCT02679144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5809541|NCT02678884|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5809542|NCT02678884|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5809543|NCT02678884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5809544|NCT02678728|Dexmedetomidine|dexmedetomidine|mesh-list
5809545|NCT02678728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5809546|NCT02678728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5809547|NCT02678728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809548|NCT02678728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5809549|NCT02678728|Analgesics|analgesics|mesh-ancestor
5809550|NCT02678728|Sensory System Agents|sensory system agents|mesh-ancestor
5809551|NCT02678728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5809552|NCT02678728|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5809553|NCT02678728|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5809554|NCT02678728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5809555|NCT02678728|Adrenergic Agents|adrenergic agents|mesh-ancestor
5809556|NCT02678728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5809557|NCT02678728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492251|NCT00607685|Antimetabolites|antimetabolites|mesh-ancestor
5809558|NCT02678780|Lenvatinib|lenvatinib|mesh-list
5809559|NCT02678780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5809560|NCT02678780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5809561|NCT02678780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5809562|NCT02678780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5809563|NCT02678767|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
5809564|NCT02678767|Hematinics|hematinics|mesh-ancestor
5809565|NCT02678767|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5809566|NCT02678767|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5809567|NCT02678520|Goserelin|goserelin|mesh-list
5809568|NCT02678520|Bicalutamide|bicalutamide|mesh-list
5809569|NCT02678520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5809570|NCT02678520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809571|NCT02678520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5809572|NCT02678520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5809573|NCT02678520|Androgen Antagonists|androgen antagonists|mesh-ancestor
5809574|NCT02678520|Hormone Antagonists|hormone antagonists|mesh-ancestor
5809575|NCT02678377|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5809576|NCT02678377|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5809577|NCT02678377|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5809578|NCT02678377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5809579|NCT02678377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809580|NCT02678377|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5809581|NCT02678377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5809582|NCT02678377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5809583|NCT02678377|Cholinergic Agents|cholinergic agents|mesh-ancestor
5809584|NCT02678377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5809585|NCT02678650|Anesthetics|anesthetics|mesh-list
5809586|NCT02678650|Propofol|propofol|mesh-list
5809587|NCT02678650|Isoflurane|isoflurane|mesh-list
5809588|NCT02678650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5809589|NCT02678650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809590|NCT02678650|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5809591|NCT02678650|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5809592|NCT02678650|Anesthetics, General|anesthetics, general|mesh-ancestor
5809593|NCT02678650|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5809594|NCT02678572|Melphalan|melphalan|mesh-list
5809595|NCT02678572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5809596|NCT02678572|Alkylating Agents|alkylating agents|mesh-ancestor
5809597|NCT02678572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5809598|NCT02678572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5809599|NCT02678572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6211272|NCT02169466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6211273|NCT02169466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211274|NCT02169466|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6211275|NCT02169466|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5809600|NCT02678572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5809601|NCT02678572|Immunologic Factors|immunologic factors|mesh-ancestor
5809602|NCT02678572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809603|NCT02678338|Magrolimab|magrolimab|mesh-list
5809604|NCT02678338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5809605|NCT02678338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5809606|NCT02678507|Analgesics, Opioid|analgesics, opioid|mesh-list
5809607|NCT02678507|Narcotics|narcotics|mesh-ancestor
5809608|NCT02678507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5809609|NCT02678507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809610|NCT02678507|Analgesics|analgesics|mesh-ancestor
5809611|NCT02678507|Sensory System Agents|sensory system agents|mesh-ancestor
5809612|NCT02678507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5809613|NCT02678598|Micafungin|micafungin|mesh-list
5809614|NCT02678598|Antifungal Agents|antifungal agents|mesh-ancestor
5809615|NCT02678598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5809616|NCT02678364|Vitamin D|vitamin d|mesh-list
5809617|NCT02678364|Cholecalciferol|cholecalciferol|mesh-list
5809618|NCT02678364|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
5809619|NCT02678364|Calcifediol|calcifediol|mesh-list
5809620|NCT02678364|Vitamins|vitamins|mesh-ancestor
5809621|NCT02678364|Micronutrients|micronutrients|mesh-ancestor
5809622|NCT02678364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492252|NCT00607685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492253|NCT00607685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6492254|NCT00607685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6492255|NCT00607685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6492256|NCT00607685|Immunologic Factors|immunologic factors|mesh-ancestor
6492257|NCT00607685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492258|NCT00607685|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6492259|NCT00607685|Viscosupplements|viscosupplements|mesh-ancestor
6492260|NCT00607685|Protective Agents|protective agents|mesh-ancestor
6492261|NCT00607711|Isophosphamide mustard|isophosphamide mustard|mesh-list
6492262|NCT00607711|Ifosfamide|ifosfamide|mesh-list
6492263|NCT00607711|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6492264|NCT00607711|Alkylating Agents|alkylating agents|mesh-ancestor
6211276|NCT02169466|Dopamine Agents|dopamine agents|mesh-ancestor
6211277|NCT02169466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6211278|NCT02169466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211279|NCT02169479|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
6496500|NCT00628238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5809623|NCT02678364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5809624|NCT02678364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5809625|NCT02678585|Lidocaine|lidocaine|mesh-list
5809626|NCT02678585|Nalbuphine|nalbuphine|mesh-list
6211280|NCT02169479|Opicapone|opicapone|mesh-list
6211281|NCT02169479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6211282|NCT02169479|Immunologic Factors|immunologic factors|mesh-ancestor
6211283|NCT02169479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211284|NCT02169479|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6211285|NCT02169479|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6211286|NCT02169479|Dopamine Agonists|dopamine agonists|mesh-ancestor
6211287|NCT02169479|Dopamine Agents|dopamine agents|mesh-ancestor
6211288|NCT02169479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6211289|NCT02169479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211290|NCT02169479|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6211291|NCT02169479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5809627|NCT02678585|Anesthetics, Local|anesthetics, local|mesh-ancestor
5809628|NCT02678585|Anesthetics|anesthetics|mesh-ancestor
5809629|NCT02678585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5809630|NCT02678585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809631|NCT02678585|Sensory System Agents|sensory system agents|mesh-ancestor
5809632|NCT02678585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5809633|NCT02678585|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5809634|NCT02678585|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5809635|NCT02678585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5809636|NCT02678585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5809637|NCT02678585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5809638|NCT02678585|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5809639|NCT02678585|Narcotics|narcotics|mesh-ancestor
5809640|NCT02678585|Analgesics|analgesics|mesh-ancestor
5809641|NCT02678208|Tranexamic Acid|tranexamic acid|mesh-list
5809642|NCT02678208|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5809643|NCT02678208|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5809644|NCT02678208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5809645|NCT02678208|Hemostatics|hemostatics|mesh-ancestor
5809646|NCT02678208|Coagulants|coagulants|mesh-ancestor
5809647|NCT02678260|Spartalizumab|spartalizumab|mesh-list
5809648|NCT02678260|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5809649|NCT02678260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5809650|NCT02678260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5809651|NCT02678195|Amoxicillin|amoxicillin|mesh-list
5809652|NCT02678195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5809653|NCT02678195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5809654|NCT02678104|Chlorhexidine|chlorhexidine|mesh-list
5809655|NCT02678104|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5809656|NCT02678104|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5809657|NCT02678104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5809658|NCT02678104|Disinfectants|disinfectants|mesh-ancestor
5809659|NCT02678104|Dermatologic Agents|dermatologic agents|mesh-ancestor
5809660|NCT02678221|Aspirin|aspirin|mesh-list
5809661|NCT02678221|Sildenafil Citrate|sildenafil citrate|mesh-list
5809662|NCT02678221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5809663|NCT02678221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5809664|NCT02678221|Analgesics|analgesics|mesh-ancestor
5809665|NCT02678221|Sensory System Agents|sensory system agents|mesh-ancestor
5809666|NCT02678221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5809667|NCT02678221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809668|NCT02678221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5809669|NCT02678221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6211292|NCT02169505|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5809670|NCT02678221|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5809671|NCT02678221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5809672|NCT02678221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5809673|NCT02678221|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5809674|NCT02678221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5809675|NCT02678221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5809676|NCT02678221|Antipyretics|antipyretics|mesh-ancestor
5809677|NCT02678221|Vasodilator Agents|vasodilator agents|mesh-ancestor
5809678|NCT02678221|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5809679|NCT02678221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5809680|NCT02678221|Urological Agents|urological agents|mesh-ancestor
5809681|NCT02678234|Acetaminophen|acetaminophen|mesh-list
5809682|NCT02678234|Ascorbic Acid|ascorbic acid|mesh-list
5809683|NCT02678234|Phenylephrine|phenylephrine|mesh-list
5809684|NCT02678234|Oxymetazoline|oxymetazoline|mesh-list
5809685|NCT02678234|Vitamins|vitamins|mesh-ancestor
5809686|NCT02678234|Micronutrients|micronutrients|mesh-ancestor
5809687|NCT02678234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809688|NCT02678234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5809689|NCT02678234|Analgesics|analgesics|mesh-ancestor
5809690|NCT02678234|Sensory System Agents|sensory system agents|mesh-ancestor
5809691|NCT02678234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5809692|NCT02678234|Antipyretics|antipyretics|mesh-ancestor
5809693|NCT02678234|Antioxidants|antioxidants|mesh-ancestor
5809694|NCT02678234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5809695|NCT02678234|Protective Agents|protective agents|mesh-ancestor
5809696|NCT02678234|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5809697|NCT02678234|Mydriatics|mydriatics|mesh-ancestor
5809698|NCT02678234|Autonomic Agents|autonomic agents|mesh-ancestor
5809699|NCT02678234|Sympathomimetics|sympathomimetics|mesh-ancestor
5809700|NCT02678234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5809701|NCT02678234|Nasal Decongestants|nasal decongestants|mesh-ancestor
5809702|NCT02678234|Respiratory System Agents|respiratory system agents|mesh-ancestor
5809703|NCT02678234|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5809704|NCT02678234|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5809705|NCT02678234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5809706|NCT02678234|Adrenergic Agents|adrenergic agents|mesh-ancestor
5809707|NCT02678234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5809708|NCT02678117|Magnesium Sulfate|magnesium sulfate|mesh-list
5809709|NCT02678117|Pregabalin|pregabalin|mesh-list
5809710|NCT02678117|Analgesics|analgesics|mesh-ancestor
5809711|NCT02678117|Sensory System Agents|sensory system agents|mesh-ancestor
5809712|NCT02678117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5809713|NCT02678117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809714|NCT02678117|Anticonvulsants|anticonvulsants|mesh-ancestor
5809715|NCT02678117|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5809716|NCT02678117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6211293|NCT02169505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5809717|NCT02678117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5809718|NCT02678117|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5809719|NCT02678117|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5809720|NCT02678117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5809721|NCT02678117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5809722|NCT02678117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5809723|NCT02678117|Anesthetics|anesthetics|mesh-ancestor
5809724|NCT02678117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5809725|NCT02678117|Tocolytic Agents|tocolytic agents|mesh-ancestor
5809726|NCT02678117|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5809727|NCT02678182|Capecitabine|capecitabine|mesh-list
5809728|NCT02678182|Trastuzumab|trastuzumab|mesh-list
5809729|NCT02678182|Durvalumab|durvalumab|mesh-list
5809730|NCT02678182|Ramucirumab|ramucirumab|mesh-list
5809731|NCT02678182|Rucaparib|rucaparib|mesh-list
5809732|NCT02678182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5809733|NCT02678182|Antimetabolites|antimetabolites|mesh-ancestor
5809734|NCT02678182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5809735|NCT02678182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5809736|NCT02678182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5809737|NCT02678182|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5809738|NCT02678182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5809739|NCT02678052|Vedolizumab|vedolizumab|mesh-list
5809740|NCT02678052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5809741|NCT02677597|Paclitaxel|paclitaxel|mesh-list
5809742|NCT02677597|Cisplatin|cisplatin|mesh-list
5809743|NCT02677597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5809744|NCT02677597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5809745|NCT02677597|Tubulin Modulators|tubulin modulators|mesh-ancestor
5809746|NCT02677597|Antimitotic Agents|antimitotic agents|mesh-ancestor
5809747|NCT02677597|Mitosis Modulators|mitosis modulators|mesh-ancestor
5809748|NCT02677597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5809749|NCT02677584|Caffeine|caffeine|mesh-list
5809750|NCT02677584|Caffeine citrate|caffeine citrate|mesh-list
5809751|NCT02677584|Citric Acid|citric acid|mesh-list
5809752|NCT02677584|Sodium Citrate|sodium citrate|mesh-list
5809753|NCT02677584|Anticoagulants|anticoagulants|mesh-ancestor
5809754|NCT02677584|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5809755|NCT02677584|Chelating Agents|chelating agents|mesh-ancestor
5809756|NCT02677584|Sequestering Agents|sequestering agents|mesh-ancestor
5809757|NCT02677584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5809758|NCT02677584|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5809759|NCT02677584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809760|NCT02677584|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5809761|NCT02677584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5809762|NCT02677584|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5809763|NCT02677584|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5809764|NCT02677584|Purinergic Agents|purinergic agents|mesh-ancestor
5809765|NCT02677584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5809766|NCT02677571|Morphine|morphine|mesh-list
5809767|NCT02677571|Levobupivacaine|levobupivacaine|mesh-list
5809768|NCT02677571|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5809769|NCT02677571|Narcotics|narcotics|mesh-ancestor
5809770|NCT02677571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5809771|NCT02677571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809772|NCT02677571|Analgesics|analgesics|mesh-ancestor
5809773|NCT02677571|Sensory System Agents|sensory system agents|mesh-ancestor
5809774|NCT02677571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5809775|NCT02677571|Anesthetics, Local|anesthetics, local|mesh-ancestor
5809776|NCT02677571|Anesthetics|anesthetics|mesh-ancestor
5809777|NCT02677532|Acetaminophen|acetaminophen|mesh-list
5809778|NCT02677532|Sufentanil|sufentanil|mesh-list
5809779|NCT02677532|Morphine|morphine|mesh-list
5809780|NCT02677532|Dsuvia|dsuvia|mesh-list
5809781|NCT02677532|Levobupivacaine|levobupivacaine|mesh-list
5809782|NCT02677532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5809783|NCT02677532|Narcotics|narcotics|mesh-ancestor
5809784|NCT02677532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5809785|NCT02677532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809786|NCT02677532|Analgesics|analgesics|mesh-ancestor
5809787|NCT02677532|Sensory System Agents|sensory system agents|mesh-ancestor
5809788|NCT02677532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5809789|NCT02677532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5809790|NCT02677532|Antipyretics|antipyretics|mesh-ancestor
5809791|NCT02677532|Anesthetics, Local|anesthetics, local|mesh-ancestor
5809792|NCT02677532|Anesthetics|anesthetics|mesh-ancestor
5809793|NCT02677532|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5809794|NCT02677532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5809795|NCT02677532|Anesthetics, General|anesthetics, general|mesh-ancestor
5809796|NCT02677519|Methylphenidate|methylphenidate|mesh-list
5809797|NCT02677519|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5809798|NCT02677519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809799|NCT02677519|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5809800|NCT02677519|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5809801|NCT02677519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5809802|NCT02677519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5809803|NCT02677519|Dopamine Agents|dopamine agents|mesh-ancestor
5809804|NCT02677519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5900729|NCT04493138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900730|NCT04493138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5900731|NCT04493138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5900732|NCT04479436|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
5900733|NCT04479436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5900734|NCT04479436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5900735|NCT04473716|Paclitaxel|paclitaxel|mesh-list
5900736|NCT04473716|Cisplatin|cisplatin|mesh-list
5900737|NCT04473716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5900738|NCT04473716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5900739|NCT04473716|Tubulin Modulators|tubulin modulators|mesh-ancestor
5900740|NCT04473716|Antimitotic Agents|antimitotic agents|mesh-ancestor
5900741|NCT04473716|Mitosis Modulators|mitosis modulators|mesh-ancestor
5900742|NCT04473716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900743|NCT04471233|Pregabalin|pregabalin|mesh-list
5900744|NCT04471233|Analgesics|analgesics|mesh-ancestor
5900745|NCT04471233|Sensory System Agents|sensory system agents|mesh-ancestor
5900746|NCT04471233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5900747|NCT04471233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900748|NCT04471233|Anticonvulsants|anticonvulsants|mesh-ancestor
5900749|NCT04471233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5900750|NCT04471233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5900751|NCT04471233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900752|NCT04471233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5900753|NCT04471233|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5900754|NCT04471233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5900755|NCT04471233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5900756|NCT04471233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5900757|NCT04435691|Azacitidine|azacitidine|mesh-list
5809805|NCT02677545|Aspirin|aspirin|mesh-list
5809806|NCT02677545|Clopidogrel|clopidogrel|mesh-list
5809807|NCT02677545|Ticagrelor|ticagrelor|mesh-list
5809808|NCT02677545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5809809|NCT02677545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5809810|NCT02677545|Analgesics|analgesics|mesh-ancestor
5809811|NCT02677545|Sensory System Agents|sensory system agents|mesh-ancestor
5809812|NCT02677545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5809813|NCT02677545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809814|NCT02677545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5809815|NCT02677545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5809816|NCT02677545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5809817|NCT02677545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5809818|NCT02677545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5809819|NCT02677545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5809820|NCT02677545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5809821|NCT02677545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5809822|NCT02677545|Antipyretics|antipyretics|mesh-ancestor
5809823|NCT02677545|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5809824|NCT02677545|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5809825|NCT02677545|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5809826|NCT02677545|Purinergic Agents|purinergic agents|mesh-ancestor
5809827|NCT02677545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5809828|NCT02677415|Anesthetics|anesthetics|mesh-list
5809829|NCT02677415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
5809830|NCT02677415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5809831|NCT02677415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809832|NCT02677415|Anesthetics, General|anesthetics, general|mesh-ancestor
5809833|NCT02677376|Listerine|listerine|mesh-list
6674254|NCT01568281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6674255|NCT01568281|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6674256|NCT01568281|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6674257|NCT01568281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6674258|NCT01568281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674259|NCT01568281|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6674260|NCT01568281|Hormone Antagonists|hormone antagonists|mesh-ancestor
6675594|NCT01576458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5809834|NCT02677376|Fluorides|fluorides|mesh-list
5809835|NCT02677376|Sodium Fluoride|sodium fluoride|mesh-list
5809836|NCT02677376|Cariostatic Agents|cariostatic agents|mesh-ancestor
5809837|NCT02677376|Protective Agents|protective agents|mesh-ancestor
5809838|NCT02677376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809839|NCT02677376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5809840|NCT02677376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5809841|NCT02677155|Rituximab|rituximab|mesh-list
5809842|NCT02677155|Pembrolizumab|pembrolizumab|mesh-list
5809843|NCT02677155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5809844|NCT02677155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5809845|NCT02677155|Immunologic Factors|immunologic factors|mesh-ancestor
5809846|NCT02677155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809847|NCT02677155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5809848|NCT02677051|Sulforaphane|sulforaphane|mesh-list
5809849|NCT02677051|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5809850|NCT02677051|Protective Agents|protective agents|mesh-ancestor
5809851|NCT02677051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809852|NCT02677051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5809853|NCT02677181|Mycophenolic Acid|mycophenolic acid|mesh-list
5809854|NCT02677181|Methotrexate|methotrexate|mesh-list
5809855|NCT02677181|Thymoglobulin|thymoglobulin|mesh-list
5809856|NCT02677181|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5809857|NCT02677181|Abortifacient Agents|abortifacient agents|mesh-ancestor
5809858|NCT02677181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5809859|NCT02677181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809860|NCT02677181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5809861|NCT02677181|Antimetabolites|antimetabolites|mesh-ancestor
5809862|NCT02677181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5809863|NCT02677181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5809864|NCT02677181|Dermatologic Agents|dermatologic agents|mesh-ancestor
5809865|NCT02677181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5809866|NCT02677181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5809867|NCT02677181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5809868|NCT02677181|Immunologic Factors|immunologic factors|mesh-ancestor
5809869|NCT02677181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5809870|NCT02677181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5809871|NCT02677181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5809872|NCT02677181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5809873|NCT02677181|Antitubercular Agents|antitubercular agents|mesh-ancestor
5809874|NCT02677181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5809875|NCT02677181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5809876|NCT02677259|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5809877|NCT02677259|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5809878|NCT02677259|Estradiol|estradiol|mesh-list
5809879|NCT02677259|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5809880|NCT02677259|Progesterone|progesterone|mesh-list
5809881|NCT02677259|Estrogens|estrogens|mesh-ancestor
5809882|NCT02677259|Hormones|hormones|mesh-ancestor
5809883|NCT02677259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5809884|NCT02677259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809885|NCT02677259|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5809886|NCT02677259|Contraceptive Agents|contraceptive agents|mesh-ancestor
5809887|NCT02677259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5809888|NCT02677259|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5809889|NCT02677259|Progestins|progestins|mesh-ancestor
5809890|NCT02677246|Denosumab|denosumab|mesh-list
5809891|NCT02677246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5809892|NCT02677246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809893|NCT02677077|Natalizumab|natalizumab|mesh-list
5809894|NCT02677077|Immunologic Factors|immunologic factors|mesh-ancestor
5809895|NCT02677077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809896|NCT02676986|Exemestane|exemestane|mesh-list
5809897|NCT02676986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5809898|NCT02676986|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5809899|NCT02676986|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5809900|NCT02676986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5809901|NCT02676986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5809902|NCT02676986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5809903|NCT02676986|Hormone Antagonists|hormone antagonists|mesh-ancestor
5809904|NCT02676986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5809905|NCT02676986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809906|NCT02676934|Anesthetics|anesthetics|mesh-list
5809907|NCT02676934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5809908|NCT02676934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809909|NCT02676622|Aldesleukin|aldesleukin|mesh-list
5809910|NCT02676622|Cyclophosphamide|cyclophosphamide|mesh-list
5809911|NCT02676622|Thymoglobulin|thymoglobulin|mesh-list
5809912|NCT02676622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5809913|NCT02676622|Immunologic Factors|immunologic factors|mesh-ancestor
5809914|NCT02676622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809915|NCT02676622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5809916|NCT02676622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5809917|NCT02676622|Alkylating Agents|alkylating agents|mesh-ancestor
5809918|NCT02676622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5809919|NCT02676622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5809920|NCT02676622|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5809921|NCT02676622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5809922|NCT02676622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5809923|NCT02676622|Antiviral Agents|antiviral agents|mesh-ancestor
5809924|NCT02676622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5809925|NCT02676674|Vitamin D|vitamin d|mesh-list
5809926|NCT02676674|Cholecalciferol|cholecalciferol|mesh-list
5809927|NCT02676674|Vitamins|vitamins|mesh-ancestor
5809928|NCT02676674|Micronutrients|micronutrients|mesh-ancestor
5809929|NCT02676674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809930|NCT02676674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5809931|NCT02676674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5809932|NCT02676609|Insulin|insulin|mesh-list
5809933|NCT02676609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5809934|NCT02676609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809935|NCT02676739|Adderall|adderall|mesh-list
5809936|NCT02676739|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5809937|NCT02676739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809938|NCT02676869|Pembrolizumab|pembrolizumab|mesh-list
5809939|NCT02676869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5809940|NCT02676869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5809941|NCT02676297|Tiotropium Bromide|tiotropium bromide|mesh-list
5809942|NCT02676297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5809943|NCT02676297|Autonomic Agents|autonomic agents|mesh-ancestor
5809944|NCT02676297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5809945|NCT02676297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809946|NCT02676297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6675595|NCT01576627|Zinc|zinc|mesh-list
5809947|NCT02676297|Respiratory System Agents|respiratory system agents|mesh-ancestor
5809948|NCT02676297|Parasympatholytics|parasympatholytics|mesh-ancestor
5809949|NCT02676297|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5809950|NCT02676297|Cholinergic Agents|cholinergic agents|mesh-ancestor
5809951|NCT02676297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5809952|NCT02676297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5809953|NCT02676154|Fesoterodine|fesoterodine|mesh-list
5809954|NCT02676154|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5809955|NCT02676154|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5809956|NCT02676154|Cholinergic Agents|cholinergic agents|mesh-ancestor
5809957|NCT02676154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5809958|NCT02676154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5809959|NCT02676154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809960|NCT02676154|Urological Agents|urological agents|mesh-ancestor
5809961|NCT02676310|Bimatoprost|bimatoprost|mesh-list
5809962|NCT02676310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5809963|NCT02676323|Leucovorin|leucovorin|mesh-list
5809964|NCT02676323|Cytarabine|cytarabine|mesh-list
5809965|NCT02676323|Hydrocortisone|hydrocortisone|mesh-list
5809966|NCT02676323|Methotrexate|methotrexate|mesh-list
5809967|NCT02676323|Fludarabine phosphate|fludarabine phosphate|mesh-list
5809968|NCT02676323|Fludarabine|fludarabine|mesh-list
5809969|NCT02676323|Panobinostat|panobinostat|mesh-list
5809970|NCT02676323|Levoleucovorin|levoleucovorin|mesh-list
5809971|NCT02676323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5809972|NCT02676323|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5809973|NCT02676323|Abortifacient Agents|abortifacient agents|mesh-ancestor
5809974|NCT02676323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5809975|NCT02676323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5809976|NCT02676323|Antimetabolites|antimetabolites|mesh-ancestor
5809977|NCT02676323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5809978|NCT02676323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5809979|NCT02676323|Dermatologic Agents|dermatologic agents|mesh-ancestor
5809980|NCT02676323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5809981|NCT02676323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6496501|NCT00628238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5809982|NCT02676323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5809983|NCT02676323|Immunologic Factors|immunologic factors|mesh-ancestor
5809984|NCT02676323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5809985|NCT02676323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5809986|NCT02676323|Antiviral Agents|antiviral agents|mesh-ancestor
5809987|NCT02676323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5809988|NCT02676323|Antidotes|antidotes|mesh-ancestor
5809989|NCT02676323|Protective Agents|protective agents|mesh-ancestor
5809990|NCT02676323|Vitamin B Complex|vitamin b complex|mesh-ancestor
5809991|NCT02676323|Vitamins|vitamins|mesh-ancestor
5809992|NCT02676323|Micronutrients|micronutrients|mesh-ancestor
5809993|NCT02676323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5809994|NCT02676323|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5809995|NCT02676336|Iodine|iodine|mesh-list
5809996|NCT02676336|Cadexomer iodine|cadexomer iodine|mesh-list
5809997|NCT02676336|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5809998|NCT02676336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5809999|NCT02676336|Trace Elements|trace elements|mesh-ancestor
5810000|NCT02676336|Micronutrients|micronutrients|mesh-ancestor
5810001|NCT02676336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810002|NCT02675868|Phenylephrine|phenylephrine|mesh-list
5810003|NCT02675868|Vasopressins|vasopressins|mesh-list
5810004|NCT02675868|Arginine Vasopressin|arginine vasopressin|mesh-list
5810005|NCT02675868|Oxymetazoline|oxymetazoline|mesh-list
5810006|NCT02675868|Norepinephrine|norepinephrine|mesh-list
6492265|NCT00607711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492266|NCT00607711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6492267|NCT00607737|Insulin Detemir|insulin detemir|mesh-list
6492268|NCT00607737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6492269|NCT00607737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492270|NCT00607750|Mecamylamine|mecamylamine|mesh-list
6492271|NCT00607750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6492272|NCT00607750|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
6492273|NCT00607750|Autonomic Agents|autonomic agents|mesh-ancestor
6492274|NCT00607750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6492275|NCT00607750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492276|NCT00607750|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
5810007|NCT02675868|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5810008|NCT02675868|Mydriatics|mydriatics|mesh-ancestor
5810009|NCT02675868|Autonomic Agents|autonomic agents|mesh-ancestor
5810010|NCT02675868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5810011|NCT02675868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810012|NCT02675868|Sympathomimetics|sympathomimetics|mesh-ancestor
5810013|NCT02675868|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5810014|NCT02675868|Nasal Decongestants|nasal decongestants|mesh-ancestor
5810015|NCT02675868|Respiratory System Agents|respiratory system agents|mesh-ancestor
5810016|NCT02675868|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5810017|NCT02675868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5810018|NCT02675868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5810019|NCT02675868|Adrenergic Agents|adrenergic agents|mesh-ancestor
5810020|NCT02675868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5810021|NCT02675868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496502|NCT00628238|Growth Substances|growth substances|mesh-ancestor
5810022|NCT02675868|Protective Agents|protective agents|mesh-ancestor
5810023|NCT02675868|Hemostatics|hemostatics|mesh-ancestor
5810024|NCT02675868|Coagulants|coagulants|mesh-ancestor
5810025|NCT02675868|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5810026|NCT02675868|Natriuretic Agents|natriuretic agents|mesh-ancestor
5810027|NCT02676011|Atropine|atropine|mesh-list
5810028|NCT02676011|Succinylcholine|succinylcholine|mesh-list
5810029|NCT02676011|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5810030|NCT02676011|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5810031|NCT02676011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5810032|NCT02676011|Autonomic Agents|autonomic agents|mesh-ancestor
5810033|NCT02676011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5810034|NCT02676011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810035|NCT02676011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5810036|NCT02676011|Respiratory System Agents|respiratory system agents|mesh-ancestor
5810037|NCT02676011|Mydriatics|mydriatics|mesh-ancestor
5810038|NCT02676011|Parasympatholytics|parasympatholytics|mesh-ancestor
5810039|NCT02676011|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5810040|NCT02676011|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5810041|NCT02676011|Cholinergic Agents|cholinergic agents|mesh-ancestor
5810042|NCT02676011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5810043|NCT02676011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810044|NCT02676011|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
5810045|NCT02676011|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5810046|NCT02676011|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5900758|NCT04435691|Venetoclax|venetoclax|mesh-list
5900759|NCT04435691|Magrolimab|magrolimab|mesh-list
5900760|NCT04435691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6492277|NCT00607750|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6492278|NCT00607750|Cholinergic Agents|cholinergic agents|mesh-ancestor
6492279|NCT00607750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6492280|NCT00607750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492281|NCT00607763|Micafungin|micafungin|mesh-list
5900761|NCT04435691|Antimetabolites|antimetabolites|mesh-ancestor
5900762|NCT04435691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900763|NCT04435691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5900764|NCT04435691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5900765|NCT04435691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5900766|NCT04422743|Tramiprosate|tramiprosate|mesh-list
5900767|NCT04422743|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
5900768|NCT04422743|Nootropic Agents|nootropic agents|mesh-ancestor
5900769|NCT04422743|Anticonvulsants|anticonvulsants|mesh-ancestor
5900770|NCT04422743|GABA Agonists|gaba agonists|mesh-ancestor
5900771|NCT04422743|GABA Agents|gaba agents|mesh-ancestor
5900772|NCT04422743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5900773|NCT04422743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900774|NCT04422743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900775|NCT04421378|Bevacizumab|bevacizumab|mesh-list
5900776|NCT04421378|Temozolomide|temozolomide|mesh-list
5900777|NCT04421378|Carmustine|carmustine|mesh-list
5900778|NCT04421378|Lomustine|lomustine|mesh-list
5900779|NCT04421378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5900780|NCT04421378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5900781|NCT04421378|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5900782|NCT04421378|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5900783|NCT04421378|Growth Substances|growth substances|mesh-ancestor
5900784|NCT04421378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900785|NCT04421378|Growth Inhibitors|growth inhibitors|mesh-ancestor
5900786|NCT04421378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5900787|NCT04421378|Alkylating Agents|alkylating agents|mesh-ancestor
5900788|NCT04421378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900789|NCT04413526|Chlorotrianisene|chlorotrianisene|mesh-list
5900790|NCT04413526|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
5900791|NCT04413526|Estrogens|estrogens|mesh-ancestor
5900792|NCT04413526|Hormones|hormones|mesh-ancestor
5908246|NCT04765202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5810047|NCT02675829|Trastuzumab|trastuzumab|mesh-list
5810048|NCT02675829|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
5810049|NCT02675829|Maytansine|maytansine|mesh-list
5810050|NCT02675829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5810051|NCT02675829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5810052|NCT02675829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5810053|NCT02675829|Tubulin Modulators|tubulin modulators|mesh-ancestor
5810054|NCT02675829|Antimitotic Agents|antimitotic agents|mesh-ancestor
5810055|NCT02675829|Mitosis Modulators|mitosis modulators|mesh-ancestor
5810056|NCT02675829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810057|NCT02676089|Tiotropium Bromide|tiotropium bromide|mesh-list
5810058|NCT02676089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5810059|NCT02676089|Autonomic Agents|autonomic agents|mesh-ancestor
5810060|NCT02676089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5810061|NCT02676089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810062|NCT02676089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5810063|NCT02676089|Respiratory System Agents|respiratory system agents|mesh-ancestor
5810064|NCT02676089|Parasympatholytics|parasympatholytics|mesh-ancestor
5810065|NCT02676089|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5810066|NCT02676089|Cholinergic Agents|cholinergic agents|mesh-ancestor
5810067|NCT02676089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5810068|NCT02676089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810069|NCT02675647|Heparin|heparin|mesh-list
5810070|NCT02675647|Protamines|protamines|mesh-list
5810071|NCT02675647|Anticoagulants|anticoagulants|mesh-ancestor
5810072|NCT02675647|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5810073|NCT02675647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5810074|NCT02675647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810075|NCT02675647|Heparin Antagonists|heparin antagonists|mesh-ancestor
5810076|NCT02675647|Coagulants|coagulants|mesh-ancestor
5810077|NCT02675413|Dimethyl Fumarate|dimethyl fumarate|mesh-list
5810078|NCT02675413|Dermatologic Agents|dermatologic agents|mesh-ancestor
5810079|NCT02675413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5810080|NCT02675413|Immunologic Factors|immunologic factors|mesh-ancestor
5810081|NCT02675413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810082|NCT02675530|Ketamine|ketamine|mesh-list
5810083|NCT02675530|Analgesics|analgesics|mesh-ancestor
5810084|NCT02675530|Sensory System Agents|sensory system agents|mesh-ancestor
5810085|NCT02675530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5810086|NCT02675530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810087|NCT02675530|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5810088|NCT02675530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5810089|NCT02675530|Anesthetics, General|anesthetics, general|mesh-ancestor
5810090|NCT02675530|Anesthetics|anesthetics|mesh-ancestor
5810091|NCT02675530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5810092|NCT02675530|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5810093|NCT02675530|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5810094|NCT02675530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5810095|NCT02675530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810096|NCT02675400|Methylphenidate|methylphenidate|mesh-list
5810097|NCT02675400|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
5810098|NCT02675400|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5810099|NCT02675400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810100|NCT02675400|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5810101|NCT02675400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5810102|NCT02675400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5810103|NCT02675400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810104|NCT02675400|Dopamine Agents|dopamine agents|mesh-ancestor
5810105|NCT02675400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5810106|NCT02675309|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5810107|NCT02675309|Simvastatin|simvastatin|mesh-list
5810108|NCT02675309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5810109|NCT02675309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5810110|NCT02675309|Antimetabolites|antimetabolites|mesh-ancestor
5810111|NCT02675309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810112|NCT02675309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5810113|NCT02675309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5810114|NCT02675309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5810115|NCT02675374|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
5810116|NCT02675374|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5810117|NCT02675374|Histamine Antagonists|histamine antagonists|mesh-ancestor
5810118|NCT02675374|Histamine Agents|histamine agents|mesh-ancestor
5810119|NCT02675374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5810120|NCT02675374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810121|NCT02675374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810122|NCT02675387|Lidocaine|lidocaine|mesh-list
5810123|NCT02675387|Anesthetics, Local|anesthetics, local|mesh-ancestor
5810124|NCT02675387|Anesthetics|anesthetics|mesh-ancestor
5810125|NCT02675387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5810126|NCT02675387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810127|NCT02675387|Sensory System Agents|sensory system agents|mesh-ancestor
5810128|NCT02675387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5810129|NCT02675387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5810130|NCT02675387|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5810131|NCT02675387|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5810132|NCT02675387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5810133|NCT02675387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810134|NCT02675335|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5810135|NCT02675335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5810136|NCT02675335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810137|NCT02675335|Incretins|incretins|mesh-ancestor
5810138|NCT02675335|Hormones|hormones|mesh-ancestor
5810139|NCT02675335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5810140|NCT02675335|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5810141|NCT02675335|Protease Inhibitors|protease inhibitors|mesh-ancestor
5810142|NCT02675335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5810143|NCT02675335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810144|NCT02675205|Aspirin|aspirin|mesh-list
5810145|NCT02675205|Clopidogrel|clopidogrel|mesh-list
5810146|NCT02675205|Ticagrelor|ticagrelor|mesh-list
5810147|NCT02675205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5810148|NCT02675205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5810149|NCT02675205|Analgesics|analgesics|mesh-ancestor
5810150|NCT02675205|Sensory System Agents|sensory system agents|mesh-ancestor
5810151|NCT02675205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5810152|NCT02675205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810153|NCT02675205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5810154|NCT02675205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5810155|NCT02675205|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5810156|NCT02675205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5810157|NCT02675205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810158|NCT02675205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5810159|NCT02675205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5810160|NCT02675205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5810161|NCT02675205|Antipyretics|antipyretics|mesh-ancestor
5810162|NCT02675205|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5810163|NCT02675205|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5810164|NCT02675205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5810165|NCT02675205|Purinergic Agents|purinergic agents|mesh-ancestor
5810166|NCT02675205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5810167|NCT02675101|Sucrose polyester|sucrose polyester|mesh-list
5810168|NCT02675101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5810169|NCT02675101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5810170|NCT02675101|Antimetabolites|antimetabolites|mesh-ancestor
5810171|NCT02675101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810172|NCT02675101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5810173|NCT02675153|Sirolimus|sirolimus|mesh-list
5810174|NCT02675153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5810175|NCT02675153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5810176|NCT02675153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5810177|NCT02675153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5810178|NCT02675153|Antifungal Agents|antifungal agents|mesh-ancestor
5810179|NCT02675153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5810180|NCT02675153|Immunologic Factors|immunologic factors|mesh-ancestor
5810181|NCT02675153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810182|NCT02675049|Dexmedetomidine|dexmedetomidine|mesh-list
5810183|NCT02675049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5810184|NCT02675049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5810185|NCT02675049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810186|NCT02675049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5810187|NCT02675049|Analgesics|analgesics|mesh-ancestor
5810188|NCT02675049|Sensory System Agents|sensory system agents|mesh-ancestor
5810189|NCT02675049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5810190|NCT02675049|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5810191|NCT02675049|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5810192|NCT02675049|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5810193|NCT02675049|Adrenergic Agents|adrenergic agents|mesh-ancestor
5810194|NCT02675049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5810195|NCT02675049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810196|NCT02675140|Vitamins|vitamins|mesh-list
5810197|NCT02675140|Vitamin A|vitamin a|mesh-list
5810198|NCT02675140|Albendazole|albendazole|mesh-list
5810199|NCT02675140|Retinol palmitate|retinol palmitate|mesh-list
5810200|NCT02675140|Micronutrients|micronutrients|mesh-ancestor
5810201|NCT02675140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810202|NCT02675140|Antioxidants|antioxidants|mesh-ancestor
5810203|NCT02675140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810204|NCT02675140|Protective Agents|protective agents|mesh-ancestor
5810205|NCT02675140|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5810206|NCT02675140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5810207|NCT02675140|Anthelmintics|anthelmintics|mesh-ancestor
5810208|NCT02675140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5810209|NCT02675140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5810210|NCT02675140|Anticestodal Agents|anticestodal agents|mesh-ancestor
5810211|NCT02675140|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5810212|NCT02675140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5810213|NCT02675140|Tubulin Modulators|tubulin modulators|mesh-ancestor
5810214|NCT02675140|Antimitotic Agents|antimitotic agents|mesh-ancestor
5810215|NCT02675140|Mitosis Modulators|mitosis modulators|mesh-ancestor
5810216|NCT02675023|Adalimumab|adalimumab|mesh-list
5810217|NCT02675023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5810218|NCT02675023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5810219|NCT02674906|Heparin|heparin|mesh-list
5810220|NCT02674906|Calcium heparin|calcium heparin|mesh-list
5810221|NCT02674906|Anticoagulants|anticoagulants|mesh-list
5810222|NCT02674906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810223|NCT02674906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5810224|NCT02674906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5810225|NCT02674997|Factor VIII|factor viii|mesh-list
5810226|NCT02674997|Coagulants|coagulants|mesh-ancestor
5810227|NCT02674737|Flurbiprofen|flurbiprofen|mesh-list
5810228|NCT02674737|Dexmedetomidine|dexmedetomidine|mesh-list
5810229|NCT02674737|Tramadol|tramadol|mesh-list
5810230|NCT02674737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5810231|NCT02674737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5810232|NCT02674737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810233|NCT02674737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5810234|NCT02674737|Analgesics|analgesics|mesh-ancestor
5810235|NCT02674737|Sensory System Agents|sensory system agents|mesh-ancestor
6492282|NCT00607763|Antifungal Agents|antifungal agents|mesh-ancestor
6492283|NCT00607763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6492284|NCT00607932|Indole-3-carbinol|indole-3-carbinol|mesh-list
6492285|NCT00607932|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5810236|NCT02674737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5810237|NCT02674737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5810238|NCT02674737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5810239|NCT02674737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5810240|NCT02674737|Adrenergic Agents|adrenergic agents|mesh-ancestor
5810241|NCT02674737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5810242|NCT02674737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810243|NCT02674737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5810244|NCT02674737|Narcotics|narcotics|mesh-ancestor
5810245|NCT02674737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5810246|NCT02674737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5810247|NCT02674737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5810248|NCT02674737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5810249|NCT02674737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5810250|NCT02674893|Liraglutide|liraglutide|mesh-list
5810251|NCT02674893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5810252|NCT02674893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810253|NCT02674893|Incretins|incretins|mesh-ancestor
5810254|NCT02674893|Hormones|hormones|mesh-ancestor
5810255|NCT02674893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5810256|NCT02674958|Aspirin|aspirin|mesh-list
5810257|NCT02674958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5810258|NCT02674958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5810259|NCT02674958|Analgesics|analgesics|mesh-ancestor
5810260|NCT02674958|Sensory System Agents|sensory system agents|mesh-ancestor
5810261|NCT02674958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5810262|NCT02674958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810263|NCT02674958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5810264|NCT02674958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5810265|NCT02674958|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5810266|NCT02674958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5810267|NCT02674958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810268|NCT02674958|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5810269|NCT02674958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5810270|NCT02674958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5810271|NCT02674958|Antipyretics|antipyretics|mesh-ancestor
5810272|NCT02674529|Citalopram|citalopram|mesh-list
5810273|NCT02674529|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5810274|NCT02674529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5810275|NCT02674529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5810276|NCT02674529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810277|NCT02674529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5810278|NCT02674529|Serotonin Agents|serotonin agents|mesh-ancestor
5810279|NCT02674529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810280|NCT02674529|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5810281|NCT02674529|Antidepressive Agents|antidepressive agents|mesh-ancestor
5810282|NCT02674529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5810283|NCT02674581|Fostemsavir|fostemsavir|mesh-list
5810284|NCT02674581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5810285|NCT02674581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5810286|NCT02674581|Antiviral Agents|antiviral agents|mesh-ancestor
5810287|NCT02674581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5810288|NCT02674581|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6492286|NCT00607932|Protective Agents|protective agents|mesh-ancestor
5810289|NCT02674581|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5810290|NCT02674581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810291|NCT02674295|Esketamine|esketamine|mesh-list
5810292|NCT02674295|Antidepressive Agents|antidepressive agents|mesh-ancestor
5810293|NCT02674295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5810294|NCT02674308|Vedolizumab|vedolizumab|mesh-list
5810295|NCT02674308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5810296|NCT02674555|Naquotinib|naquotinib|mesh-list
5810297|NCT02674555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5810298|NCT02674555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5810299|NCT02674555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6492287|NCT00607932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492288|NCT00607932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6492289|NCT00607945|Rosiglitazone|rosiglitazone|mesh-list
6492290|NCT00607945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6492291|NCT00607945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492292|NCT00607958|Ritonavir|ritonavir|mesh-list
6492293|NCT00607958|Tipranavir|tipranavir|mesh-list
6492294|NCT00607958|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6492295|NCT00607958|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6492296|NCT00607958|Protease Inhibitors|protease inhibitors|mesh-ancestor
6492297|NCT00607958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5810300|NCT02674555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900793|NCT04413526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5900794|NCT04413526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900795|NCT04413526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5900796|NCT04413526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5900797|NCT04375813|Sirolimus|sirolimus|mesh-list
5900798|NCT04375813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5900799|NCT04375813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5900800|NCT04375813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5900801|NCT04375813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5900802|NCT04375813|Antifungal Agents|antifungal agents|mesh-ancestor
5900803|NCT04375813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5900804|NCT04375813|Immunologic Factors|immunologic factors|mesh-ancestor
5900805|NCT04375813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900806|NCT04373733|Favipiravir|favipiravir|mesh-list
6496503|NCT00628238|Growth Inhibitors|growth inhibitors|mesh-ancestor
5810301|NCT02674243|Povidone-Iodine|povidone-iodine|mesh-list
5810302|NCT02674243|Povidone|povidone|mesh-list
5810303|NCT02674243|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5810304|NCT02674243|Plasma Substitutes|plasma substitutes|mesh-ancestor
5810305|NCT02674243|Blood Substitutes|blood substitutes|mesh-ancestor
5810306|NCT02674243|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5810307|NCT02674243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5810308|NCT02674139|Copper|copper|mesh-list
5810309|NCT02674139|Trace Elements|trace elements|mesh-ancestor
5810310|NCT02674139|Micronutrients|micronutrients|mesh-ancestor
5810311|NCT02674139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810312|NCT02673931|Exenatide|exenatide|mesh-list
5810313|NCT02673931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5810314|NCT02673931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810315|NCT02673931|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5810316|NCT02673931|Incretins|incretins|mesh-ancestor
5810317|NCT02673931|Hormones|hormones|mesh-ancestor
5810318|NCT02673931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5810319|NCT02674113|Bupivacaine|bupivacaine|mesh-list
5810320|NCT02674113|Anesthetics|anesthetics|mesh-list
5810321|NCT02674113|Anesthetics, Local|anesthetics, local|mesh-ancestor
5810322|NCT02674113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5810323|NCT02674113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810324|NCT02674113|Sensory System Agents|sensory system agents|mesh-ancestor
5810325|NCT02674113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5810326|NCT02674048|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
5810327|NCT02674048|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5810328|NCT02674048|Dermatologic Agents|dermatologic agents|mesh-ancestor
5810329|NCT02674191|Clindamycin|clindamycin|mesh-list
5810330|NCT02674191|Clindamycin palmitate|clindamycin palmitate|mesh-list
5810331|NCT02674191|Clindamycin phosphate|clindamycin phosphate|mesh-list
5810332|NCT02674191|Povidone-Iodine|povidone-iodine|mesh-list
5810333|NCT02674191|Mepivacaine|mepivacaine|mesh-list
5810334|NCT02674191|Benzocaine|benzocaine|mesh-list
6492298|NCT00607958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492299|NCT00607958|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5810335|NCT02674191|Povidone|povidone|mesh-list
5810336|NCT02674191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5810337|NCT02674191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5810338|NCT02674191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5810339|NCT02674191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5810340|NCT02674191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810341|NCT02674191|Plasma Substitutes|plasma substitutes|mesh-ancestor
5810342|NCT02674191|Blood Substitutes|blood substitutes|mesh-ancestor
5810343|NCT02674191|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5810344|NCT02674191|Anesthetics, Local|anesthetics, local|mesh-ancestor
5810345|NCT02674191|Anesthetics|anesthetics|mesh-ancestor
5810346|NCT02674191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5810347|NCT02674191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810348|NCT02674191|Sensory System Agents|sensory system agents|mesh-ancestor
5810349|NCT02674191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5810350|NCT02673879|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5810351|NCT02673879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5810352|NCT02673879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5900807|NCT04373733|Antiviral Agents|antiviral agents|mesh-ancestor
5810353|NCT02673879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810354|NCT02673866|Pregabalin|pregabalin|mesh-list
5810355|NCT02673866|Analgesics|analgesics|mesh-ancestor
5810356|NCT02673866|Sensory System Agents|sensory system agents|mesh-ancestor
5810357|NCT02673866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5810358|NCT02673866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810359|NCT02673866|Anticonvulsants|anticonvulsants|mesh-ancestor
5810360|NCT02673866|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5810361|NCT02673866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5810362|NCT02673866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810363|NCT02673866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5810364|NCT02673866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5810365|NCT02673866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5810366|NCT02673866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5810367|NCT02673866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5810368|NCT02673840|Ketotifen|ketotifen|mesh-list
5810369|NCT02673840|Antipruritics|antipruritics|mesh-ancestor
5810370|NCT02673840|Dermatologic Agents|dermatologic agents|mesh-ancestor
5810371|NCT02673840|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5810372|NCT02673840|Histamine Antagonists|histamine antagonists|mesh-ancestor
5810373|NCT02673840|Histamine Agents|histamine agents|mesh-ancestor
5810374|NCT02673840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5810375|NCT02673840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810376|NCT02673840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810377|NCT02673840|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5810378|NCT02673814|Durvalumab|durvalumab|mesh-list
5810379|NCT02673814|Bavituximab|bavituximab|mesh-list
5810380|NCT02673814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5810381|NCT02673814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5810382|NCT02673606|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5810383|NCT02673606|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5810384|NCT02673606|Estradiol|estradiol|mesh-list
5810385|NCT02673606|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5810386|NCT02673606|Estrogens|estrogens|mesh-ancestor
5810387|NCT02673606|Hormones|hormones|mesh-ancestor
5810388|NCT02673606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5810389|NCT02673606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810390|NCT02673606|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5810391|NCT02673606|Contraceptive Agents|contraceptive agents|mesh-ancestor
5810392|NCT02673606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5810393|NCT02673606|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5810394|NCT02673632|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5810395|NCT02673632|Luteolytic Agents|luteolytic agents|mesh-ancestor
5810396|NCT02673632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5810397|NCT02673632|Contraceptive Agents|contraceptive agents|mesh-ancestor
5810398|NCT02673632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5810399|NCT02673632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5908247|NCT04744831|Camptothecin|camptothecin|mesh-list
5810400|NCT02673632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5810401|NCT02673632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5810402|NCT02673632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5810403|NCT02673463|Spironolactone|spironolactone|mesh-list
5810404|NCT02673463|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5810405|NCT02673463|Hormone Antagonists|hormone antagonists|mesh-ancestor
5810406|NCT02673463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5810407|NCT02673463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810408|NCT02673463|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5810409|NCT02673463|Diuretics|diuretics|mesh-ancestor
5810410|NCT02673463|Natriuretic Agents|natriuretic agents|mesh-ancestor
5810411|NCT02673359|Progesterone|progesterone|mesh-list
5810412|NCT02673359|Progestins|progestins|mesh-ancestor
5810413|NCT02673359|Hormones|hormones|mesh-ancestor
5810414|NCT02673359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5810415|NCT02673359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810416|NCT02673229|Bacitracin|bacitracin|mesh-list
5810417|NCT02673229|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5810418|NCT02673229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5810419|NCT02673229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5810420|NCT02673047|Botulinum Toxins|botulinum toxins|mesh-list
5810421|NCT02673047|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5810422|NCT02673047|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5810423|NCT02673047|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5810424|NCT02673047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5810425|NCT02673047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810426|NCT02673047|Cholinergic Agents|cholinergic agents|mesh-ancestor
5810427|NCT02673047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5810428|NCT02673047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810429|NCT02673047|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5810430|NCT02673047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5810431|NCT02672839|Betadex|betadex|mesh-list
5810432|NCT02672839|Sequestering Agents|sequestering agents|mesh-ancestor
5810433|NCT02672839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810434|NCT02672917|Folfirinox|folfirinox|mesh-list
5810435|NCT02672917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5810436|NCT02672995|Bevacizumab|bevacizumab|mesh-list
5810437|NCT02672995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5810438|NCT02672995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5810439|NCT02672995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5810440|NCT02672995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5810441|NCT02672995|Growth Substances|growth substances|mesh-ancestor
5810442|NCT02672995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810443|NCT02672995|Growth Inhibitors|growth inhibitors|mesh-ancestor
5810444|NCT02672709|Apixaban|apixaban|mesh-list
5810445|NCT02672709|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5810446|NCT02672709|Antithrombins|antithrombins|mesh-ancestor
5810447|NCT02672709|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5810448|NCT02672709|Protease Inhibitors|protease inhibitors|mesh-ancestor
5810449|NCT02672709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5810450|NCT02672709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810451|NCT02672709|Anticoagulants|anticoagulants|mesh-ancestor
5810452|NCT02672592|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5810453|NCT02672592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5900808|NCT04373733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5900809|NCT04355130|Vitamin B 12|vitamin b 12|mesh-list
5900810|NCT04355130|Hydroxocobalamin|hydroxocobalamin|mesh-list
5900811|NCT04355130|Vitamins|vitamins|mesh-ancestor
5900812|NCT04355130|Micronutrients|micronutrients|mesh-ancestor
5810454|NCT02672527|Dexamethasone|dexamethasone|mesh-list
5810455|NCT02672527|Trabectedin|trabectedin|mesh-list
5810456|NCT02672527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5810457|NCT02672527|Antiemetics|antiemetics|mesh-ancestor
5810458|NCT02672527|Autonomic Agents|autonomic agents|mesh-ancestor
5810459|NCT02672527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5810460|NCT02672527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810461|NCT02672527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5810462|NCT02672527|Glucocorticoids|glucocorticoids|mesh-ancestor
5810463|NCT02672527|Hormones|hormones|mesh-ancestor
5810464|NCT02672527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5810465|NCT02672527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5810466|NCT02672527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5810467|NCT02672527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5810468|NCT02672527|Alkylating Agents|alkylating agents|mesh-ancestor
5810469|NCT02672527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810470|NCT02672566|Enoxaparin|enoxaparin|mesh-list
5810471|NCT02672566|Anticoagulants|anticoagulants|mesh-ancestor
5810472|NCT02672566|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5810473|NCT02672566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5810474|NCT02672566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810475|NCT02672488|Metformin|metformin|mesh-list
5810476|NCT02672488|Sorafenib|sorafenib|mesh-list
5810477|NCT02672488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5810478|NCT02672488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810479|NCT02672488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5810480|NCT02672488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5810481|NCT02672488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5810482|NCT02672488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810483|NCT02672475|Paclitaxel|paclitaxel|mesh-list
5810484|NCT02672475|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5810485|NCT02672475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5810486|NCT02672475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5810487|NCT02672475|Tubulin Modulators|tubulin modulators|mesh-ancestor
5810488|NCT02672475|Antimitotic Agents|antimitotic agents|mesh-ancestor
5810489|NCT02672475|Mitosis Modulators|mitosis modulators|mesh-ancestor
5810490|NCT02672475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810491|NCT02672345|Sevoflurane|sevoflurane|mesh-list
5810492|NCT02672345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5810493|NCT02672345|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5810494|NCT02672345|Anesthetics, General|anesthetics, general|mesh-ancestor
5810495|NCT02672345|Anesthetics|anesthetics|mesh-ancestor
5810496|NCT02672345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5810497|NCT02672345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810498|NCT02672358|Trametinib|trametinib|mesh-list
5810499|NCT02672358|Dabrafenib|dabrafenib|mesh-list
5810500|NCT02672358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5810501|NCT02672358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5810502|NCT02672358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5810503|NCT02672358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810504|NCT02672202|Pregabalin|pregabalin|mesh-list
5810505|NCT02672202|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5810506|NCT02672202|Analgesics|analgesics|mesh-ancestor
5810507|NCT02672202|Sensory System Agents|sensory system agents|mesh-ancestor
5810508|NCT02672202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5810509|NCT02672202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810510|NCT02672202|Anticonvulsants|anticonvulsants|mesh-ancestor
5810511|NCT02672202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5810512|NCT02672202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5810513|NCT02672202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810514|NCT02672202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5810515|NCT02672202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5810516|NCT02672202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5810517|NCT02672202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5810518|NCT02672202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5810519|NCT02672202|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5810520|NCT02672202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5810521|NCT02672202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5810522|NCT02672202|Antidepressive Agents|antidepressive agents|mesh-ancestor
5810523|NCT02672202|Dopamine Agents|dopamine agents|mesh-ancestor
5810524|NCT02672241|Temozolomide|temozolomide|mesh-list
5810525|NCT02672241|Nimotuzumab|nimotuzumab|mesh-list
5810526|NCT02672241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5810527|NCT02672241|Alkylating Agents|alkylating agents|mesh-ancestor
5810528|NCT02672241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810529|NCT02672241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5810530|NCT02672241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5810531|NCT02672098|Carboplatin|carboplatin|mesh-list
5810532|NCT02672098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5810533|NCT02671864|Hypoglycemic Agents|hypoglycemic agents|mesh-list
5810534|NCT02671864|Incretins|incretins|mesh-list
5810535|NCT02671864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810536|NCT02671864|Hormones|hormones|mesh-ancestor
5810537|NCT02671864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5810538|NCT02671851|Acetaminophen|acetaminophen|mesh-list
5810539|NCT02671851|Dipyrone|dipyrone|mesh-list
5810540|NCT02671851|Fentanyl|fentanyl|mesh-list
5810541|NCT02671851|Tramadol|tramadol|mesh-list
5810542|NCT02671851|Bupivacaine|bupivacaine|mesh-list
5810543|NCT02671851|Anesthetics, Local|anesthetics, local|mesh-ancestor
5810544|NCT02671851|Anesthetics|anesthetics|mesh-ancestor
5810545|NCT02671851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5810546|NCT02671851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810547|NCT02671851|Sensory System Agents|sensory system agents|mesh-ancestor
5810548|NCT02671851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5810549|NCT02671851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5810550|NCT02671851|Narcotics|narcotics|mesh-ancestor
5810551|NCT02671851|Analgesics|analgesics|mesh-ancestor
5810552|NCT02671851|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5810553|NCT02671851|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5810554|NCT02671851|Anesthetics, General|anesthetics, general|mesh-ancestor
5810555|NCT02671851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5810556|NCT02671851|Antipyretics|antipyretics|mesh-ancestor
5810557|NCT02671851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5810558|NCT02671851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5810559|NCT02671851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5810560|NCT02671578|Nitrous Oxide|nitrous oxide|mesh-list
5810561|NCT02671578|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5810562|NCT02671578|Anesthetics, General|anesthetics, general|mesh-ancestor
5810563|NCT02671578|Anesthetics|anesthetics|mesh-ancestor
5810564|NCT02671578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5810565|NCT02671578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810566|NCT02671578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5810567|NCT02671578|Analgesics|analgesics|mesh-ancestor
5810568|NCT02671578|Sensory System Agents|sensory system agents|mesh-ancestor
5810569|NCT02671578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5810570|NCT02671695|Amlodipine|amlodipine|mesh-list
5810571|NCT02671695|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5810572|NCT02671695|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5810573|NCT02671695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5810574|NCT02671695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810575|NCT02671695|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5810576|NCT02671695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810577|NCT02671695|Vasodilator Agents|vasodilator agents|mesh-ancestor
5810578|NCT02671708|Cyclophosphamide|cyclophosphamide|mesh-list
5810579|NCT02671708|Busulfan|busulfan|mesh-list
5810580|NCT02671708|Idarubicin|idarubicin|mesh-list
5810581|NCT02671708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5810582|NCT02671708|Immunologic Factors|immunologic factors|mesh-ancestor
5810583|NCT02671708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810584|NCT02671708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6492300|NCT00607958|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6492301|NCT00607958|Antiviral Agents|antiviral agents|mesh-ancestor
6492302|NCT00607958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5810585|NCT02671708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5810586|NCT02671708|Alkylating Agents|alkylating agents|mesh-ancestor
5810587|NCT02671708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810588|NCT02671708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5810589|NCT02671708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5810590|NCT02671708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5810591|NCT02671708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5810592|NCT02671708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5810593|NCT02671708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5810594|NCT02671565|Hyaluronic Acid|hyaluronic acid|mesh-list
5810595|NCT02671565|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5810596|NCT02671565|Immunologic Factors|immunologic factors|mesh-ancestor
6492303|NCT00607958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6492304|NCT00607958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6492305|NCT00607971|Renzapride|renzapride|mesh-list
5810597|NCT02671565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810598|NCT02671565|Viscosupplements|viscosupplements|mesh-ancestor
5810599|NCT02671565|Protective Agents|protective agents|mesh-ancestor
5810600|NCT02671383|Lopinavir|lopinavir|mesh-list
5810601|NCT02671383|Darunavir|darunavir|mesh-list
5810602|NCT02671383|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5810603|NCT02671383|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5810604|NCT02671383|Protease Inhibitors|protease inhibitors|mesh-ancestor
5810605|NCT02671383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5810606|NCT02671383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810607|NCT02671383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5810608|NCT02671383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5810609|NCT02671383|Antiviral Agents|antiviral agents|mesh-ancestor
5810610|NCT02671383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5810611|NCT02671383|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5810612|NCT02671383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5810613|NCT02671318|Sirolimus|sirolimus|mesh-list
5810614|NCT02671318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5810615|NCT02671318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5810616|NCT02671318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5810617|NCT02671318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5810618|NCT02671318|Antifungal Agents|antifungal agents|mesh-ancestor
5810619|NCT02671318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5810620|NCT02671318|Immunologic Factors|immunologic factors|mesh-ancestor
5810621|NCT02671318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810622|NCT02671227|Bupivacaine|bupivacaine|mesh-list
5810623|NCT02671227|Anesthetics, Local|anesthetics, local|mesh-ancestor
5810624|NCT02671227|Anesthetics|anesthetics|mesh-ancestor
5810625|NCT02671227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5810626|NCT02671227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810627|NCT02671227|Sensory System Agents|sensory system agents|mesh-ancestor
5810628|NCT02671227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5810629|NCT02671058|Hydrocortisone|hydrocortisone|mesh-list
5810630|NCT02671058|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
5810631|NCT02671058|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
5810632|NCT02671058|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6492306|NCT00607971|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6492307|NCT00607971|Serotonin Agents|serotonin agents|mesh-ancestor
6492308|NCT00607971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6492309|NCT00607971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492310|NCT00607971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810633|NCT02671058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5900813|NCT04355130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900814|NCT04355130|Vitamin B Complex|vitamin b complex|mesh-ancestor
5900815|NCT04355130|Hematinics|hematinics|mesh-ancestor
5900816|NCT04334070|Clofazimine|clofazimine|mesh-list
5900817|NCT04334070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5900818|NCT04334070|Leprostatic Agents|leprostatic agents|mesh-ancestor
5900819|NCT04334070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5900820|NCT04334070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5900821|NCT04317807|Levetiracetam|levetiracetam|mesh-list
5900822|NCT04317807|Anticonvulsants|anticonvulsants|mesh-ancestor
5900823|NCT04317807|Nootropic Agents|nootropic agents|mesh-ancestor
5900824|NCT04302324|Clarithromycin|clarithromycin|mesh-list
5900825|NCT04302324|Dexamethasone|dexamethasone|mesh-list
5900826|NCT04302324|Daratumumab|daratumumab|mesh-list
5900827|NCT04302324|Pomalidomide|pomalidomide|mesh-list
5900828|NCT04302324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5900829|NCT04302324|Antiemetics|antiemetics|mesh-ancestor
5900830|NCT04302324|Autonomic Agents|autonomic agents|mesh-ancestor
5900831|NCT04302324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5900832|NCT04302324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900833|NCT04302324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5900834|NCT04302324|Glucocorticoids|glucocorticoids|mesh-ancestor
5900835|NCT04302324|Hormones|hormones|mesh-ancestor
5900836|NCT04302324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5900837|NCT04302324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5900838|NCT04302324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5900839|NCT04302324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5900840|NCT04302324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5810634|NCT02671084|Sevoflurane|sevoflurane|mesh-list
5810635|NCT02671084|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5810636|NCT02671084|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5810637|NCT02671084|Anesthetics, General|anesthetics, general|mesh-ancestor
5810638|NCT02671084|Anesthetics|anesthetics|mesh-ancestor
5810639|NCT02671084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5810640|NCT02671084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810641|NCT02671175|Piperaquine|piperaquine|mesh-list
5810642|NCT02671175|Artenimol|artenimol|mesh-list
5810643|NCT02671175|Artemisinins|artemisinins|mesh-list
5810644|NCT02671175|Antimalarials|antimalarials|mesh-ancestor
5810645|NCT02671175|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5810646|NCT02671175|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5810647|NCT02671175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5810648|NCT02671097|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5810649|NCT02671097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5810650|NCT02671097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5810651|NCT02671097|Antimetabolites|antimetabolites|mesh-ancestor
5810652|NCT02671097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810653|NCT02671097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5810654|NCT02671097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5810655|NCT02671097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5810656|NCT02670954|Flurbiprofen|flurbiprofen|mesh-list
5810657|NCT02670954|Dexmedetomidine|dexmedetomidine|mesh-list
5810658|NCT02670954|Tramadol|tramadol|mesh-list
5810659|NCT02670954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5810660|NCT02670954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5810661|NCT02670954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810662|NCT02670954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5810663|NCT02670954|Analgesics|analgesics|mesh-ancestor
5810664|NCT02670954|Sensory System Agents|sensory system agents|mesh-ancestor
5908248|NCT04744831|Immunoconjugates|immunoconjugates|mesh-list
5810665|NCT02670954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5810666|NCT02670954|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5810667|NCT02670954|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5810668|NCT02670954|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5810669|NCT02670954|Adrenergic Agents|adrenergic agents|mesh-ancestor
5810670|NCT02670954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5810671|NCT02670954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810672|NCT02670954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5810673|NCT02670954|Narcotics|narcotics|mesh-ancestor
5810674|NCT02670954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5810675|NCT02670954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5810676|NCT02670954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5810677|NCT02670954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5810678|NCT02670954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5810679|NCT02670707|Cytarabine|cytarabine|mesh-list
5810680|NCT02670707|Prednisone|prednisone|mesh-list
5810681|NCT02670707|Vinblastine|vinblastine|mesh-list
5810682|NCT02670707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5810683|NCT02670707|Glucocorticoids|glucocorticoids|mesh-ancestor
5810684|NCT02670707|Hormones|hormones|mesh-ancestor
5810685|NCT02670707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5810686|NCT02670707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810687|NCT02670707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5810688|NCT02670707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5810689|NCT02670707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5810690|NCT02670707|Antimetabolites|antimetabolites|mesh-ancestor
5810691|NCT02670707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810692|NCT02670707|Antiviral Agents|antiviral agents|mesh-ancestor
5810693|NCT02670707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5810694|NCT02670707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5810695|NCT02670707|Immunologic Factors|immunologic factors|mesh-ancestor
5810696|NCT02670707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5810697|NCT02670707|Tubulin Modulators|tubulin modulators|mesh-ancestor
5810698|NCT02670707|Antimitotic Agents|antimitotic agents|mesh-ancestor
5810699|NCT02670707|Mitosis Modulators|mitosis modulators|mesh-ancestor
5810700|NCT02670564|Busulfan|busulfan|mesh-list
5810701|NCT02670564|Alkylating Agents|alkylating agents|mesh-ancestor
5810702|NCT02670564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810703|NCT02670564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5810704|NCT02670564|Immunologic Factors|immunologic factors|mesh-ancestor
5810705|NCT02670564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810706|NCT02670564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6211294|NCT02169505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6211295|NCT02169791|Ixazomib|ixazomib|mesh-list
5810707|NCT02670564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5810708|NCT02670564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5810709|NCT02670655|Lidocaine|lidocaine|mesh-list
5810710|NCT02670655|Prilocaine|prilocaine|mesh-list
5810711|NCT02670655|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
5810712|NCT02670655|Anesthetics, Local|anesthetics, local|mesh-ancestor
5810713|NCT02670655|Anesthetics|anesthetics|mesh-ancestor
5810714|NCT02670655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5810715|NCT02670655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211296|NCT02169791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5810716|NCT02670655|Sensory System Agents|sensory system agents|mesh-ancestor
5810717|NCT02670655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5810718|NCT02670655|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5810719|NCT02670655|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5810720|NCT02670655|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5810721|NCT02670655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5810722|NCT02670655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810723|NCT02670655|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
5810724|NCT02670759|Bupivacaine|bupivacaine|mesh-list
5810725|NCT02670759|Anesthetics, Local|anesthetics, local|mesh-ancestor
5810726|NCT02670759|Anesthetics|anesthetics|mesh-ancestor
5810727|NCT02670759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5810728|NCT02670759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810729|NCT02670759|Sensory System Agents|sensory system agents|mesh-ancestor
5810730|NCT02670759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5810731|NCT02670785|Estradiol|estradiol|mesh-list
5810732|NCT02670785|Estrogens|estrogens|mesh-ancestor
5810733|NCT02670785|Hormones|hormones|mesh-ancestor
5810734|NCT02670785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5810735|NCT02670785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810736|NCT02670616|Prednisolone|prednisolone|mesh-list
5810737|NCT02670616|Cyclophosphamide|cyclophosphamide|mesh-list
5810738|NCT02670616|Rituximab|rituximab|mesh-list
5810739|NCT02670616|Doxorubicin|doxorubicin|mesh-list
5810740|NCT02670616|Vincristine|vincristine|mesh-list
5810741|NCT02670616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5810742|NCT02670616|Immunologic Factors|immunologic factors|mesh-ancestor
5810743|NCT02670616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810744|NCT02670616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5810745|NCT02670616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5810746|NCT02670616|Alkylating Agents|alkylating agents|mesh-ancestor
5810747|NCT02670616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810748|NCT02670616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5810749|NCT02670616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5810750|NCT02670616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5810751|NCT02670616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5810752|NCT02670616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5810753|NCT02670616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5810754|NCT02670616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5810755|NCT02670616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5810756|NCT02670616|Tubulin Modulators|tubulin modulators|mesh-ancestor
5810757|NCT02670616|Antimitotic Agents|antimitotic agents|mesh-ancestor
5810758|NCT02670616|Mitosis Modulators|mitosis modulators|mesh-ancestor
5810759|NCT02670616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5810760|NCT02670616|Glucocorticoids|glucocorticoids|mesh-ancestor
5810761|NCT02670616|Hormones|hormones|mesh-ancestor
5810762|NCT02670616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5810763|NCT02670616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5810764|NCT02670603|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5810765|NCT02670772|Tenofovir|tenofovir|mesh-list
5810766|NCT02670772|Stavudine|stavudine|mesh-list
5810767|NCT02670772|Antiviral Agents|antiviral agents|mesh-ancestor
5810768|NCT02670772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5810769|NCT02670772|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5810770|NCT02670772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5810771|NCT02670772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5810772|NCT02670772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810773|NCT02670772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5810774|NCT02670772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5810775|NCT02670772|Antimetabolites|antimetabolites|mesh-ancestor
5810776|NCT02670642|Esomeprazole|esomeprazole|mesh-list
5810777|NCT02670642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5810778|NCT02670642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5810779|NCT02670642|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5810780|NCT02670642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5810781|NCT02670642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810782|NCT02670317|Prednisone|prednisone|mesh-list
5810783|NCT02670317|Cyclophosphamide|cyclophosphamide|mesh-list
5810784|NCT02670317|Doxorubicin|doxorubicin|mesh-list
5810785|NCT02670317|Vincristine|vincristine|mesh-list
5810786|NCT02670317|Obinutuzumab|obinutuzumab|mesh-list
5810787|NCT02670317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5810788|NCT02670317|Immunologic Factors|immunologic factors|mesh-ancestor
5810789|NCT02670317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810790|NCT02670317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5810791|NCT02670317|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5810792|NCT02670317|Alkylating Agents|alkylating agents|mesh-ancestor
5810793|NCT02670317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810794|NCT02670317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5810795|NCT02670317|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5810796|NCT02670317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5810797|NCT02670317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5810798|NCT02670317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5810799|NCT02670317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5810800|NCT02670317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5810801|NCT02670317|Glucocorticoids|glucocorticoids|mesh-ancestor
5810802|NCT02670317|Hormones|hormones|mesh-ancestor
5810803|NCT02670317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5810804|NCT02670317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5810805|NCT02670317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5810806|NCT02670317|Tubulin Modulators|tubulin modulators|mesh-ancestor
5810807|NCT02670317|Antimitotic Agents|antimitotic agents|mesh-ancestor
5810808|NCT02670317|Mitosis Modulators|mitosis modulators|mesh-ancestor
5810809|NCT02670317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5810810|NCT02670434|Pitavastatin|pitavastatin|mesh-list
5810811|NCT02670434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5810812|NCT02670434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5810813|NCT02670434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5810814|NCT02670434|Antimetabolites|antimetabolites|mesh-ancestor
5810815|NCT02670434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810816|NCT02670434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5810817|NCT02670434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5810818|NCT02670304|Aspirin|aspirin|mesh-list
5810819|NCT02670304|Letrozole|letrozole|mesh-list
5810820|NCT02670304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5810821|NCT02670304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5810822|NCT02670304|Analgesics|analgesics|mesh-ancestor
5810823|NCT02670304|Sensory System Agents|sensory system agents|mesh-ancestor
5810824|NCT02670304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5810825|NCT02670304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810826|NCT02670304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5810827|NCT02670304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5810828|NCT02670304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5810829|NCT02670304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5810830|NCT02670304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810831|NCT02670304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5810832|NCT02670304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5810833|NCT02670304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5810834|NCT02670304|Antipyretics|antipyretics|mesh-ancestor
5810835|NCT02670304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5810836|NCT02670304|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5810837|NCT02670304|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5810838|NCT02670304|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5810839|NCT02670304|Hormone Antagonists|hormone antagonists|mesh-ancestor
5810840|NCT02670304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5810841|NCT02670018|Metformin|metformin|mesh-list
5810842|NCT02670018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5810843|NCT02670018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810844|NCT02670070|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5810845|NCT02670070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5810846|NCT02670070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5810847|NCT02670070|Antimetabolites|antimetabolites|mesh-ancestor
5810848|NCT02670070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810849|NCT02670070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5810850|NCT02670070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5810851|NCT02670070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5810852|NCT02670096|Acetazolamide|acetazolamide|mesh-list
5810853|NCT02670096|Anticonvulsants|anticonvulsants|mesh-ancestor
5810854|NCT02670096|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5810855|NCT02670096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5810856|NCT02670096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810857|NCT02670096|Diuretics|diuretics|mesh-ancestor
5810858|NCT02670096|Natriuretic Agents|natriuretic agents|mesh-ancestor
5810859|NCT02670096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810860|NCT02670135|Triclosan|triclosan|mesh-list
5810861|NCT02670135|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5810862|NCT02670135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5810863|NCT02670135|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5810864|NCT02670135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5810865|NCT02670135|Antimetabolites|antimetabolites|mesh-ancestor
5810866|NCT02670135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810867|NCT02670135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5810868|NCT02670109|Cyclophosphamide|cyclophosphamide|mesh-list
5810869|NCT02670109|Busulfan|busulfan|mesh-list
5810870|NCT02670109|Carmustine|carmustine|mesh-list
5810871|NCT02670109|Carboplatin|carboplatin|mesh-list
5810872|NCT02670109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5810873|NCT02670109|Immunologic Factors|immunologic factors|mesh-ancestor
5810874|NCT02670109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810875|NCT02670109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5810876|NCT02670109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5810877|NCT02670109|Alkylating Agents|alkylating agents|mesh-ancestor
5810878|NCT02670109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810879|NCT02670109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5810880|NCT02670109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5810881|NCT02670252|Cyclophosphamide|cyclophosphamide|mesh-list
5810882|NCT02670252|Busulfan|busulfan|mesh-list
5810883|NCT02670252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5810884|NCT02670252|Immunologic Factors|immunologic factors|mesh-ancestor
5810885|NCT02670252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810886|NCT02670252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5810887|NCT02670252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5810888|NCT02670252|Alkylating Agents|alkylating agents|mesh-ancestor
5810889|NCT02670252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810890|NCT02670252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5810891|NCT02670252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5810892|NCT02669953|Aflibercept|aflibercept|mesh-list
5810893|NCT02669953|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5810894|NCT02669953|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5810895|NCT02669953|Growth Substances|growth substances|mesh-ancestor
5810896|NCT02669953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810897|NCT02669953|Growth Inhibitors|growth inhibitors|mesh-ancestor
5810898|NCT02669953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5810899|NCT02669901|Naloxone|naloxone|mesh-list
5810900|NCT02669901|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5810901|NCT02669901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810902|NCT02669901|Sensory System Agents|sensory system agents|mesh-ancestor
5810903|NCT02669901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5810904|NCT02669719|Carboplatin|carboplatin|mesh-list
5810905|NCT02669719|Pemetrexed|pemetrexed|mesh-list
5810906|NCT02669719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5810907|NCT02669719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6211297|NCT02169791|Protease Inhibitors|protease inhibitors|mesh-ancestor
5810908|NCT02669719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810909|NCT02669719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5810910|NCT02669719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5810911|NCT02669732|Firuglipel|firuglipel|mesh-list
5810912|NCT02669732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5810913|NCT02669732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810914|NCT02669706|Pentamidine|pentamidine|mesh-list
5810915|NCT02669706|Antifungal Agents|antifungal agents|mesh-ancestor
5810916|NCT02669706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5810917|NCT02669706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5810918|NCT02669706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5810919|NCT02669706|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5810920|NCT02669641|Choline|choline|mesh-list
5810921|NCT02669641|Lipotropic Agents|lipotropic agents|mesh-ancestor
5810922|NCT02669641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5810923|NCT02669641|Antimetabolites|antimetabolites|mesh-ancestor
5810924|NCT02669641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810925|NCT02669641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5810926|NCT02669641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5810927|NCT02669641|Nootropic Agents|nootropic agents|mesh-ancestor
5810928|NCT02669589|Heparin|heparin|mesh-list
5810929|NCT02669589|Anticoagulants|anticoagulants|mesh-ancestor
5810930|NCT02669589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810931|NCT02669589|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5810932|NCT02669589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5810933|NCT02669680|Lenograstim|lenograstim|mesh-list
5810934|NCT02669680|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5810935|NCT02669680|Immunologic Factors|immunologic factors|mesh-ancestor
5810936|NCT02669680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810937|NCT02669459|Imiquimod|imiquimod|mesh-list
5810938|NCT02669459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5641776|NCT02102113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641777|NCT02102113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5641778|NCT02102113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5641779|NCT02102113|Analgesics|analgesics|mesh-ancestor
5641780|NCT02102113|Sensory System Agents|sensory system agents|mesh-ancestor
5641781|NCT02102113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5641782|NCT02102113|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5641783|NCT02102113|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5641784|NCT02102113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5641785|NCT02102113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641786|NCT02102113|Hormones|hormones|mesh-ancestor
5641787|NCT02102113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5641788|NCT01951469|Pemetrexed|pemetrexed|mesh-list
5810939|NCT02669459|Immunologic Factors|immunologic factors|mesh-ancestor
5810940|NCT02669459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810941|NCT02669459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5810942|NCT02669459|Interferon Inducers|interferon inducers|mesh-ancestor
5900841|NCT04302324|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5900842|NCT04302324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5900843|NCT04302324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900844|NCT04302324|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5900845|NCT04302324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5900846|NCT04302324|Immunologic Factors|immunologic factors|mesh-ancestor
5900847|NCT04302324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5900848|NCT04302324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5900849|NCT04302324|Growth Substances|growth substances|mesh-ancestor
5900850|NCT04302324|Growth Inhibitors|growth inhibitors|mesh-ancestor
5900851|NCT04266912|Avelumab|avelumab|mesh-list
5900852|NCT04266912|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5900853|NCT04266912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5900854|NCT04266912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5900855|NCT04266912|Immunologic Factors|immunologic factors|mesh-ancestor
5900856|NCT04266912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900857|NCT04264663|Tinidazole|tinidazole|mesh-list
5900858|NCT04264663|Furazolidone|furazolidone|mesh-list
5900859|NCT04264663|Alkylating Agents|alkylating agents|mesh-ancestor
5900860|NCT04264663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900861|NCT04264663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5900862|NCT04264663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5900863|NCT04264663|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
5900864|NCT04264663|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5900865|NCT04264663|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5900866|NCT04264663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5900867|NCT04264663|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5900868|NCT04264663|Renal Agents|renal agents|mesh-ancestor
5810943|NCT02669303|Methylprednisolone|methylprednisolone|mesh-list
5810944|NCT02669303|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5810945|NCT02669303|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5810946|NCT02669303|Prednisolone|prednisolone|mesh-list
5810947|NCT02669303|Prednisolone acetate|prednisolone acetate|mesh-list
5810948|NCT02669303|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5810949|NCT02669303|Prednisolone phosphate|prednisolone phosphate|mesh-list
5810950|NCT02669303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5810951|NCT02669303|Antiemetics|antiemetics|mesh-ancestor
5810952|NCT02669303|Autonomic Agents|autonomic agents|mesh-ancestor
5810953|NCT02669303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5810954|NCT02669303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810955|NCT02669303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5810956|NCT02669303|Glucocorticoids|glucocorticoids|mesh-ancestor
5810957|NCT02669303|Hormones|hormones|mesh-ancestor
5810958|NCT02669303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5810959|NCT02669303|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5810960|NCT02669303|Protective Agents|protective agents|mesh-ancestor
5810961|NCT02669303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5810962|NCT02669303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5641789|NCT01951469|Gefitinib|gefitinib|mesh-list
5641790|NCT01951469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5641791|NCT01951469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5641792|NCT01951469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641793|NCT01951469|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5641794|NCT01951469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5641795|NCT01951469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5641796|NCT01922076|Adavosertib|adavosertib|mesh-list
5641797|NCT01922076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5641798|NCT01922076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641799|NCT01864018|Dexamethasone|dexamethasone|mesh-list
5641800|NCT01864018|Dexamethasone acetate|dexamethasone acetate|mesh-list
5641801|NCT01864018|Cyclophosphamide|cyclophosphamide|mesh-list
5641802|NCT01864018|Ixazomib|ixazomib|mesh-list
5641803|NCT01864018|Ichthammol|ichthammol|mesh-list
5641804|NCT01864018|BB 1101|bb 1101|mesh-list
5641805|NCT01864018|Glycine|glycine|mesh-list
5810963|NCT02669238|Etonogestrel|etonogestrel|mesh-list
5810964|NCT02669238|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5810965|NCT02669238|Contraceptive Agents|contraceptive agents|mesh-ancestor
5810966|NCT02669238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5810967|NCT02669238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810968|NCT02669238|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5810969|NCT02669277|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5810970|NCT02669277|gamma-Globulins|gamma-globulins|mesh-list
5810971|NCT02669277|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5810972|NCT02669277|Immunologic Factors|immunologic factors|mesh-ancestor
5810973|NCT02669277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810974|NCT02669368|Magnesium Sulfate|magnesium sulfate|mesh-list
5810975|NCT02669368|Rocuronium|rocuronium|mesh-list
5810976|NCT02669368|Analgesics|analgesics|mesh-ancestor
5810977|NCT02669368|Sensory System Agents|sensory system agents|mesh-ancestor
5810978|NCT02669368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5810979|NCT02669368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810980|NCT02669368|Anesthetics|anesthetics|mesh-ancestor
5810981|NCT02669368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5810982|NCT02669368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5810983|NCT02669368|Anticonvulsants|anticonvulsants|mesh-ancestor
5810984|NCT02669368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5810985|NCT02669368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5810986|NCT02669368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5810987|NCT02669368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5810988|NCT02669368|Tocolytic Agents|tocolytic agents|mesh-ancestor
5810989|NCT02669368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5810990|NCT02669368|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5810991|NCT02669368|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5810992|NCT02669368|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5810993|NCT02669030|Suvorexant|suvorexant|mesh-list
5810994|NCT02669030|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5810995|NCT02669030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5810996|NCT02669030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5810997|NCT02669030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5810998|NCT02669030|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
5810999|NCT02669030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5811000|NCT02669030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811001|NCT02669004|Morphine|morphine|mesh-list
5811002|NCT02669004|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5811003|NCT02669004|Narcotics|narcotics|mesh-ancestor
5811004|NCT02669004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5811005|NCT02669004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811006|NCT02669004|Analgesics|analgesics|mesh-ancestor
5811007|NCT02669004|Sensory System Agents|sensory system agents|mesh-ancestor
5811008|NCT02669004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5811009|NCT02668666|Tamoxifen|tamoxifen|mesh-list
5811010|NCT02668666|Palbociclib|palbociclib|mesh-list
5811011|NCT02668666|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5811012|NCT02668666|Hormone Antagonists|hormone antagonists|mesh-ancestor
5811013|NCT02668666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5811014|NCT02668666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811015|NCT02668666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5811016|NCT02668666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5811017|NCT02668666|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5811018|NCT02668666|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5811019|NCT02668666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5811020|NCT02668666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5811021|NCT02668666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5811022|NCT02668666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811023|NCT02668796|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5811024|NCT02668796|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5811025|NCT02668796|Estradiol|estradiol|mesh-list
5811026|NCT02668796|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6211298|NCT02169791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6211299|NCT02169791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211300|NCT02169869|Levonorgestrel|levonorgestrel|mesh-list
6211301|NCT02169869|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6211302|NCT02169869|Contraceptive Agents|contraceptive agents|mesh-ancestor
6211303|NCT02169869|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6211304|NCT02169869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211305|NCT02169869|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6211306|NCT02169869|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6211307|NCT02169869|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6211308|NCT02169895|Opicapone|opicapone|mesh-list
6211309|NCT02169895|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
6211310|NCT02169895|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
5811027|NCT02668796|Estrogens|estrogens|mesh-ancestor
5811028|NCT02668796|Hormones|hormones|mesh-ancestor
5811029|NCT02668796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5811030|NCT02668796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811031|NCT02668796|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5811032|NCT02668796|Contraceptive Agents|contraceptive agents|mesh-ancestor
5811033|NCT02668796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5811034|NCT02668796|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5811035|NCT02668861|Vitamin D|vitamin d|mesh-list
5811036|NCT02668861|Budesonide|budesonide|mesh-list
5811037|NCT02668861|Vitamins|vitamins|mesh-ancestor
5811038|NCT02668861|Micronutrients|micronutrients|mesh-ancestor
5811039|NCT02668861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811040|NCT02668861|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5811041|NCT02668861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5811042|NCT02668861|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5811043|NCT02668861|Autonomic Agents|autonomic agents|mesh-ancestor
5811044|NCT02668861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5811045|NCT02668861|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5811046|NCT02668861|Respiratory System Agents|respiratory system agents|mesh-ancestor
5811047|NCT02668861|Glucocorticoids|glucocorticoids|mesh-ancestor
5811048|NCT02668861|Hormones|hormones|mesh-ancestor
5811049|NCT02668861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5811050|NCT02668926|Amphetamine|amphetamine|mesh-list
5811051|NCT02668926|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
5811052|NCT02668926|Dextroamphetamine|dextroamphetamine|mesh-list
5811053|NCT02668926|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5811054|NCT02668926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811055|NCT02668926|Sympathomimetics|sympathomimetics|mesh-ancestor
5811056|NCT02668926|Autonomic Agents|autonomic agents|mesh-ancestor
5811057|NCT02668926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5811058|NCT02668926|Dopamine Agents|dopamine agents|mesh-ancestor
5811059|NCT02668926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5811060|NCT02668926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811061|NCT02668926|Adrenergic Agents|adrenergic agents|mesh-ancestor
5811062|NCT02668926|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5811063|NCT02668926|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5811064|NCT02668926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5811065|NCT02668926|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5811066|NCT02668679|Hormones|hormones|mesh-list
5811067|NCT02668679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5811068|NCT02668679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811069|NCT02668653|Cytarabine|cytarabine|mesh-list
5811070|NCT02668653|Daunorubicin|daunorubicin|mesh-list
5811071|NCT02668653|Idarubicin|idarubicin|mesh-list
5811072|NCT02668653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5811073|NCT02668653|Antimetabolites|antimetabolites|mesh-ancestor
5811074|NCT02668653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811075|NCT02668653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5811076|NCT02668653|Antiviral Agents|antiviral agents|mesh-ancestor
5811077|NCT02668653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5811078|NCT02668653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5811079|NCT02668653|Immunologic Factors|immunologic factors|mesh-ancestor
5811080|NCT02668653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641806|NCT01864018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5641807|NCT01864018|Immunologic Factors|immunologic factors|mesh-ancestor
5641808|NCT01864018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641809|NCT01864018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5641810|NCT01864018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5641811|NCT01864018|Alkylating Agents|alkylating agents|mesh-ancestor
5641812|NCT01864018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641813|NCT01864018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5641814|NCT01864018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5641815|NCT01864018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5641816|NCT01864018|Antiemetics|antiemetics|mesh-ancestor
5641817|NCT01864018|Autonomic Agents|autonomic agents|mesh-ancestor
5641818|NCT01864018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5641819|NCT01864018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5641820|NCT01864018|Glucocorticoids|glucocorticoids|mesh-ancestor
5641821|NCT01864018|Hormones|hormones|mesh-ancestor
5811081|NCT02668653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5811082|NCT02668653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5811083|NCT02668653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5811084|NCT02668653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5811085|NCT02668965|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5811086|NCT02668965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5811087|NCT02668965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811088|NCT02668536|Sunscreening Agents|sunscreening agents|mesh-list
5811089|NCT02668536|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5811090|NCT02668536|Protective Agents|protective agents|mesh-ancestor
5811091|NCT02668536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811092|NCT02668536|Dermatologic Agents|dermatologic agents|mesh-ancestor
5811093|NCT02668289|Anesthetics|anesthetics|mesh-list
5811094|NCT02668289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5811095|NCT02668289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811096|NCT02668497|Botulinum Toxins|botulinum toxins|mesh-list
5811097|NCT02668497|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5811098|NCT02668497|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5811099|NCT02668497|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
5811100|NCT02668497|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5811101|NCT02668497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5811102|NCT02668497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811103|NCT02668497|Cholinergic Agents|cholinergic agents|mesh-ancestor
5811104|NCT02668497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5811105|NCT02668497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811106|NCT02668497|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5811107|NCT02668497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5811108|NCT02668588|Octreotide|octreotide|mesh-list
5811109|NCT02668588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5811110|NCT02668588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5811111|NCT02668588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5811112|NCT02667886|Axitinib|axitinib|mesh-list
5811113|NCT02667886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5811114|NCT02667886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5811115|NCT02667886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5811116|NCT02667886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811117|NCT02668016|Atorvastatin|atorvastatin|mesh-list
5811118|NCT02668016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
5811119|NCT02668016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5811120|NCT02668016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5811121|NCT02668016|Antimetabolites|antimetabolites|mesh-ancestor
5811122|NCT02668016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811123|NCT02668016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5811124|NCT02668016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5811125|NCT02668159|Vitamin D|vitamin d|mesh-list
5811126|NCT02668159|Ergocalciferols|ergocalciferols|mesh-list
5811127|NCT02668159|Cholecalciferol|cholecalciferol|mesh-list
5811128|NCT02668159|Vitamins|vitamins|mesh-list
5811129|NCT02668159|Micronutrients|micronutrients|mesh-ancestor
5811130|NCT02668159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811131|NCT02668159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5811132|NCT02668159|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5811133|NCT02668172|Pasireotide|pasireotide|mesh-list
5811134|NCT02668172|Hormones|hormones|mesh-ancestor
5811135|NCT02668172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5811136|NCT02668172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211311|NCT02169895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6492311|NCT00607984|Melphalan|melphalan|mesh-list
5641822|NCT01864018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5641823|NCT01864018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5641824|NCT01864018|Protease Inhibitors|protease inhibitors|mesh-ancestor
5641825|NCT01864018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5641826|NCT01864018|Dermatologic Agents|dermatologic agents|mesh-ancestor
5641827|NCT01864018|Glycine Agents|glycine agents|mesh-ancestor
5641828|NCT01864018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5641829|NCT01856270|Amitriptyline|amitriptyline|mesh-list
5641830|NCT01856270|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
5641831|NCT01856270|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5641832|NCT01856270|Antidepressive Agents|antidepressive agents|mesh-ancestor
5641833|NCT01856270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5641834|NCT01856270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5641835|NCT01856270|Analgesics|analgesics|mesh-ancestor
5641836|NCT01856270|Sensory System Agents|sensory system agents|mesh-ancestor
5641837|NCT01856270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5641838|NCT01856270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641839|NCT01856270|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5641840|NCT01856270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5641841|NCT01856270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5641842|NCT01856270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641843|NCT01856270|Adrenergic Agents|adrenergic agents|mesh-ancestor
5641844|NCT01856270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5641845|NCT01856270|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5641846|NCT01856270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5641847|NCT01856270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5641848|NCT01741103|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5641849|NCT01741103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5641850|NCT01741103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641851|NCT01741103|Incretins|incretins|mesh-ancestor
5641852|NCT01741103|Hormones|hormones|mesh-ancestor
5641853|NCT01741103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5641854|NCT01741103|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5811137|NCT02667925|Cisplatin|cisplatin|mesh-list
5811138|NCT02667925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5811139|NCT02668094|Lidocaine|lidocaine|mesh-list
5811140|NCT02668094|Pregabalin|pregabalin|mesh-list
5811141|NCT02668094|Propofol|propofol|mesh-list
5811142|NCT02668094|Anesthetics, Local|anesthetics, local|mesh-ancestor
5811143|NCT02668094|Anesthetics|anesthetics|mesh-ancestor
5811144|NCT02668094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5811145|NCT02668094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811146|NCT02668094|Sensory System Agents|sensory system agents|mesh-ancestor
5811147|NCT02668094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5811148|NCT02668094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5811149|NCT02668094|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5811150|NCT02668094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5811151|NCT02668094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5811152|NCT02668094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811153|NCT02668094|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5811154|NCT02668094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5811155|NCT02668094|Anesthetics, General|anesthetics, general|mesh-ancestor
5811156|NCT02668094|Analgesics|analgesics|mesh-ancestor
5811157|NCT02668094|Anticonvulsants|anticonvulsants|mesh-ancestor
5811158|NCT02668094|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5811159|NCT02668094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5811160|NCT02668094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5811161|NCT02668094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5641855|NCT01741103|Protease Inhibitors|protease inhibitors|mesh-ancestor
5641856|NCT01741103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5641857|NCT01741103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641858|NCT01503632|Mercaptopurine|mercaptopurine|mesh-list
5811162|NCT02668094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5811163|NCT02667730|Acetaminophen|acetaminophen|mesh-list
5811164|NCT02667730|Celecoxib|celecoxib|mesh-list
5811165|NCT02667730|Naproxen|naproxen|mesh-list
5811166|NCT02667730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5811167|NCT02667730|Analgesics|analgesics|mesh-ancestor
5811168|NCT02667730|Sensory System Agents|sensory system agents|mesh-ancestor
5811169|NCT02667730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5811170|NCT02667730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811171|NCT02667730|Antipyretics|antipyretics|mesh-ancestor
5811172|NCT02667730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5811173|NCT02667730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5811174|NCT02667730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5811175|NCT02667730|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5811176|NCT02667730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5811177|NCT02667730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5811178|NCT02667730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811179|NCT02667730|Gout Suppressants|gout suppressants|mesh-ancestor
5900869|NCT04264663|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
5900870|NCT04264663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5900871|NCT04256434|Nalbuphine|nalbuphine|mesh-list
5900872|NCT04256434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5900873|NCT04256434|Narcotics|narcotics|mesh-ancestor
5900874|NCT04256434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5900875|NCT04256434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900876|NCT04256434|Analgesics|analgesics|mesh-ancestor
5900877|NCT04256434|Sensory System Agents|sensory system agents|mesh-ancestor
5900878|NCT04256434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5900879|NCT04253262|Rucaparib|rucaparib|mesh-list
5900880|NCT04253262|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5900881|NCT04253262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5900882|NCT04253262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900883|NCT04253262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5900884|NCT04227366|Methotrexate|methotrexate|mesh-list
5900885|NCT04227366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5900886|NCT04227366|Abortifacient Agents|abortifacient agents|mesh-ancestor
5900887|NCT04227366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5900888|NCT04227366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900889|NCT04227366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5900890|NCT04227366|Antimetabolites|antimetabolites|mesh-ancestor
5900891|NCT04227366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900892|NCT04227366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5900893|NCT04227366|Dermatologic Agents|dermatologic agents|mesh-ancestor
5900894|NCT04227366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5900895|NCT04227366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5900896|NCT04227366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5900897|NCT04227366|Immunologic Factors|immunologic factors|mesh-ancestor
5900898|NCT04227366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5900899|NCT04227366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5900900|NCT04219774|Aspirin|aspirin|mesh-list
5900901|NCT04219774|Clopidogrel|clopidogrel|mesh-list
5900902|NCT04219774|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5900903|NCT04219774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5900904|NCT04219774|Analgesics|analgesics|mesh-ancestor
5900905|NCT04219774|Sensory System Agents|sensory system agents|mesh-ancestor
5900906|NCT04219774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5900907|NCT04219774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811180|NCT02667743|Paclitaxel|paclitaxel|mesh-list
5811181|NCT02667743|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5811182|NCT02667743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5811183|NCT02667743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5811184|NCT02667743|Tubulin Modulators|tubulin modulators|mesh-ancestor
5811185|NCT02667743|Antimitotic Agents|antimitotic agents|mesh-ancestor
5811186|NCT02667743|Mitosis Modulators|mitosis modulators|mesh-ancestor
5811187|NCT02667743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811188|NCT02667561|Methyltestosterone|methyltestosterone|mesh-list
5811189|NCT02667561|Testosterone|testosterone|mesh-list
5811190|NCT02667561|Testosterone undecanoate|testosterone undecanoate|mesh-list
5811191|NCT02667561|Testosterone enanthate|testosterone enanthate|mesh-list
6492312|NCT00607984|Thiotepa|thiotepa|mesh-list
5811192|NCT02667561|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6492313|NCT00607984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6492314|NCT00607984|Alkylating Agents|alkylating agents|mesh-ancestor
6492315|NCT00607984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492316|NCT00607984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6492317|NCT00607984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6492318|NCT00607984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6492319|NCT00607984|Immunologic Factors|immunologic factors|mesh-ancestor
6492320|NCT00607984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492321|NCT00608075|Lithium Carbonate|lithium carbonate|mesh-list
6492322|NCT00608075|Antidepressive Agents|antidepressive agents|mesh-ancestor
6492323|NCT00608075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5811193|NCT02667561|Androgens|androgens|mesh-ancestor
5811194|NCT02667561|Hormones|hormones|mesh-ancestor
5811195|NCT02667561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5811196|NCT02667561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811197|NCT02667561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5811198|NCT02667561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5811199|NCT02667561|Anabolic Agents|anabolic agents|mesh-ancestor
5811200|NCT02667535|Isosorbide|isosorbide|mesh-list
5811201|NCT02667535|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
5811202|NCT02667535|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
5811203|NCT02667535|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5811204|NCT02667535|Diuretics|diuretics|mesh-ancestor
5811205|NCT02667535|Natriuretic Agents|natriuretic agents|mesh-ancestor
5811206|NCT02667535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811207|NCT02667535|Vasodilator Agents|vasodilator agents|mesh-ancestor
5811208|NCT02667535|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5811209|NCT02667535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811210|NCT02667470|Solifenacin Succinate|solifenacin succinate|mesh-list
6674261|NCT01568281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6674262|NCT01568281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674263|NCT01568294|Pomalidomide|pomalidomide|mesh-list
6674264|NCT01568294|Immunologic Factors|immunologic factors|mesh-ancestor
6674265|NCT01568294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674266|NCT01568294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6674267|NCT01568294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6674268|NCT01568294|Growth Substances|growth substances|mesh-ancestor
6674269|NCT01568294|Growth Inhibitors|growth inhibitors|mesh-ancestor
6674270|NCT01568294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6674271|NCT01568307|Antidepressive Agents|antidepressive agents|mesh-list
6674272|NCT01568307|Serotonin|serotonin|mesh-list
6674273|NCT01568307|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
6674274|NCT01568307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6674275|NCT01568307|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6674276|NCT01568307|Serotonin Agents|serotonin agents|mesh-ancestor
5811211|NCT02667470|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5811212|NCT02667470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5811213|NCT02667470|Cholinergic Agents|cholinergic agents|mesh-ancestor
5811214|NCT02667470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5811215|NCT02667470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811216|NCT02667470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811217|NCT02667470|Urological Agents|urological agents|mesh-ancestor
5811218|NCT02667197|Analgesics, Opioid|analgesics, opioid|mesh-list
5811219|NCT02667197|Narcotics|narcotics|mesh-ancestor
5811220|NCT02667197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5811221|NCT02667197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811222|NCT02667197|Analgesics|analgesics|mesh-ancestor
5811223|NCT02667197|Sensory System Agents|sensory system agents|mesh-ancestor
5811224|NCT02667197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5811225|NCT02667262|Analgesics, Opioid|analgesics, opioid|mesh-list
5811226|NCT02667262|Narcotics|narcotics|mesh-ancestor
5811227|NCT02667262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5811228|NCT02667262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811229|NCT02667262|Analgesics|analgesics|mesh-ancestor
5811230|NCT02667262|Sensory System Agents|sensory system agents|mesh-ancestor
5811231|NCT02667262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5811232|NCT02667223|Bococizumab|bococizumab|mesh-list
5811233|NCT02667223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5811234|NCT02667223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5811235|NCT02667223|Antimetabolites|antimetabolites|mesh-ancestor
5811236|NCT02667223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811237|NCT02667223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5811238|NCT02667353|Anesthetics|anesthetics|mesh-list
5811239|NCT02667353|Etomidate|etomidate|mesh-list
5811240|NCT02667353|Succinylcholine|succinylcholine|mesh-list
5811241|NCT02667353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5811242|NCT02667353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811243|NCT02667353|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5811244|NCT02667353|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5811245|NCT02667353|Anesthetics, General|anesthetics, general|mesh-ancestor
5811246|NCT02667353|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
5811247|NCT02667353|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5811248|NCT02667353|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5811249|NCT02667353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5811250|NCT02667496|Sargramostim|sargramostim|mesh-list
5811251|NCT02667496|Immunologic Factors|immunologic factors|mesh-ancestor
5811252|NCT02667496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811253|NCT02666898|Cyclophosphamide|cyclophosphamide|mesh-list
5811254|NCT02666898|Fludarabine|fludarabine|mesh-list
5811255|NCT02666898|Obinutuzumab|obinutuzumab|mesh-list
5811256|NCT02666898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5811257|NCT02666898|Immunologic Factors|immunologic factors|mesh-ancestor
5811258|NCT02666898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811259|NCT02666898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5811260|NCT02666898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5811261|NCT02666898|Alkylating Agents|alkylating agents|mesh-ancestor
5811262|NCT02666898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811263|NCT02666898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5811264|NCT02666898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5811265|NCT02666898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5811266|NCT02666703|Methylprednisolone|methylprednisolone|mesh-list
5811267|NCT02666703|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5811268|NCT02666703|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5811269|NCT02666703|Prednisolone|prednisolone|mesh-list
5811270|NCT02666703|Prednisolone acetate|prednisolone acetate|mesh-list
5811271|NCT02666703|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5811272|NCT02666703|Prednisolone phosphate|prednisolone phosphate|mesh-list
5811273|NCT02666703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5811274|NCT02666703|Antiemetics|antiemetics|mesh-ancestor
5811275|NCT02666703|Autonomic Agents|autonomic agents|mesh-ancestor
5811276|NCT02666703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5811277|NCT02666703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811278|NCT02666703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5811279|NCT02666703|Glucocorticoids|glucocorticoids|mesh-ancestor
5811280|NCT02666703|Hormones|hormones|mesh-ancestor
5811281|NCT02666703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5811282|NCT02666703|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5811283|NCT02666703|Protective Agents|protective agents|mesh-ancestor
5811284|NCT02666703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5811285|NCT02666703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5811286|NCT02667054|Anesthetics|anesthetics|mesh-list
5811287|NCT02667054|Anesthetics, Local|anesthetics, local|mesh-list
5811288|NCT02667054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5811289|NCT02667054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811290|NCT02667054|Sensory System Agents|sensory system agents|mesh-ancestor
5811291|NCT02667054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5811292|NCT02666599|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5811293|NCT02666599|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5811294|NCT02666599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811295|NCT02666716|Fluconazole|fluconazole|mesh-list
5811296|NCT02666716|Antifungal Agents|antifungal agents|mesh-ancestor
5811297|NCT02666716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5811298|NCT02666716|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5811299|NCT02666716|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5811300|NCT02666716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5811301|NCT02666716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811302|NCT02666716|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5641859|NCT01503632|Antimetabolites|antimetabolites|mesh-ancestor
5641860|NCT01503632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641861|NCT01503632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5641862|NCT01503632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5641863|NCT01503632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5641864|NCT01503632|Immunologic Factors|immunologic factors|mesh-ancestor
5641865|NCT01503632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641866|NCT01503632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5641867|NCT01503632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5641868|NCT01503515|Fluconazole|fluconazole|mesh-list
5641869|NCT01503515|Voriconazole|voriconazole|mesh-list
5641870|NCT01503515|Caspofungin|caspofungin|mesh-list
5641871|NCT01503515|Antifungal Agents|antifungal agents|mesh-ancestor
5641872|NCT01503515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5641873|NCT01503515|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5811303|NCT02666716|Hormone Antagonists|hormone antagonists|mesh-ancestor
5811304|NCT02666716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5811305|NCT02666716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811306|NCT02666716|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5811307|NCT02666716|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5811308|NCT02666547|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5811309|NCT02666547|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5811310|NCT02666547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811311|NCT02666794|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
5811312|NCT02666794|Sufentanil|sufentanil|mesh-list
5811313|NCT02666794|Morphine|morphine|mesh-list
5811314|NCT02666794|Dsuvia|dsuvia|mesh-list
5811315|NCT02666794|Bupivacaine|bupivacaine|mesh-list
5811316|NCT02666794|Anesthetics, Local|anesthetics, local|mesh-ancestor
5811317|NCT02666794|Anesthetics|anesthetics|mesh-ancestor
5811318|NCT02666794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5811319|NCT02666794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811320|NCT02666794|Sensory System Agents|sensory system agents|mesh-ancestor
5811321|NCT02666794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5811322|NCT02666794|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5811323|NCT02666794|Narcotics|narcotics|mesh-ancestor
5811324|NCT02666794|Analgesics|analgesics|mesh-ancestor
5811325|NCT02666794|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5811326|NCT02666794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5811327|NCT02666794|Anesthetics, General|anesthetics, general|mesh-ancestor
5811328|NCT02666768|Interferons|interferons|mesh-list
5811329|NCT02666768|Interferon-gamma|interferon-gamma|mesh-list
5811330|NCT02666768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5811331|NCT02666768|Antiviral Agents|antiviral agents|mesh-ancestor
5811332|NCT02666768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6492324|NCT00608075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6492325|NCT00608075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492326|NCT00608075|Antimanic Agents|antimanic agents|mesh-ancestor
6492327|NCT00608075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6492328|NCT00608075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5811333|NCT02666651|Tolvaptan|tolvaptan|mesh-list
5811334|NCT02666651|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
5811335|NCT02666651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811336|NCT02666651|Natriuretic Agents|natriuretic agents|mesh-ancestor
5811337|NCT02666651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811338|NCT02666534|Lidocaine|lidocaine|mesh-list
5811339|NCT02666534|Prilocaine|prilocaine|mesh-list
5811340|NCT02666534|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
5811341|NCT02666534|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5811342|NCT02666534|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
5811343|NCT02666534|Anesthetics, Local|anesthetics, local|mesh-ancestor
5811344|NCT02666534|Anesthetics|anesthetics|mesh-ancestor
5811345|NCT02666534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5811346|NCT02666534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811347|NCT02666534|Sensory System Agents|sensory system agents|mesh-ancestor
5811348|NCT02666534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5811349|NCT02666534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5811350|NCT02666534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5811351|NCT02666534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5811352|NCT02666534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5811353|NCT02666534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811354|NCT02666534|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5811355|NCT02666534|Dermatologic Agents|dermatologic agents|mesh-ancestor
5811356|NCT02666534|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
5811357|NCT02666170|Thioctic Acid|thioctic acid|mesh-list
5811358|NCT02666170|Antioxidants|antioxidants|mesh-ancestor
5811359|NCT02666170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811360|NCT02666170|Protective Agents|protective agents|mesh-ancestor
5811361|NCT02666170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811362|NCT02666170|Vitamin B Complex|vitamin b complex|mesh-ancestor
5811363|NCT02666170|Vitamins|vitamins|mesh-ancestor
5811364|NCT02666170|Micronutrients|micronutrients|mesh-ancestor
5811365|NCT02666209|Dexamethasone|dexamethasone|mesh-list
5811366|NCT02666209|Lenalidomide|lenalidomide|mesh-list
5811367|NCT02666209|Bortezomib|bortezomib|mesh-list
5811368|NCT02666209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5811369|NCT02666209|Antiemetics|antiemetics|mesh-ancestor
5811370|NCT02666209|Autonomic Agents|autonomic agents|mesh-ancestor
5811371|NCT02666209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5811372|NCT02666209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811373|NCT02666209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5811374|NCT02666209|Glucocorticoids|glucocorticoids|mesh-ancestor
6492329|NCT00608075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492330|NCT00608101|Dexamethasone|dexamethasone|mesh-list
5811375|NCT02666209|Hormones|hormones|mesh-ancestor
5811376|NCT02666209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5811377|NCT02666209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5811378|NCT02666209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5811379|NCT02666209|Immunologic Factors|immunologic factors|mesh-ancestor
5811380|NCT02666209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6492331|NCT00608101|Fludrocortisone|fludrocortisone|mesh-list
5811381|NCT02666209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5811382|NCT02666209|Growth Substances|growth substances|mesh-ancestor
5811383|NCT02666209|Growth Inhibitors|growth inhibitors|mesh-ancestor
5811384|NCT02666365|Cefazolin|cefazolin|mesh-list
5811385|NCT02666365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5811386|NCT02666365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5811387|NCT02666443|Dexamethasone|dexamethasone|mesh-list
5811388|NCT02666443|Dexamethasone acetate|dexamethasone acetate|mesh-list
5811389|NCT02666443|BB 1101|bb 1101|mesh-list
5811390|NCT02666443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5811391|NCT02666443|Antiemetics|antiemetics|mesh-ancestor
5811392|NCT02666443|Autonomic Agents|autonomic agents|mesh-ancestor
5811393|NCT02666443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5811394|NCT02666443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811395|NCT02666443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5811396|NCT02666443|Glucocorticoids|glucocorticoids|mesh-ancestor
5811397|NCT02666443|Hormones|hormones|mesh-ancestor
5811398|NCT02666443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5811399|NCT02666443|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5811400|NCT02666443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5811401|NCT02666443|Protease Inhibitors|protease inhibitors|mesh-ancestor
5811402|NCT02666443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5811403|NCT02666443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811404|NCT02666417|Iron|iron|mesh-list
5811405|NCT02666417|Trace Elements|trace elements|mesh-ancestor
5811406|NCT02666417|Micronutrients|micronutrients|mesh-ancestor
5811407|NCT02666417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811408|NCT02666092|Antibodies|antibodies|mesh-list
5811409|NCT02666092|Immunologic Factors|immunologic factors|mesh-ancestor
5811410|NCT02666092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811411|NCT02666157|Rivaroxaban|rivaroxaban|mesh-list
5811412|NCT02666157|Apixaban|apixaban|mesh-list
5811413|NCT02666157|Dabigatran|dabigatran|mesh-list
5811414|NCT02666157|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5811415|NCT02666157|Antithrombins|antithrombins|mesh-ancestor
5811416|NCT02666157|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5811417|NCT02666157|Protease Inhibitors|protease inhibitors|mesh-ancestor
5811418|NCT02666157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5811419|NCT02666157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811420|NCT02666157|Anticoagulants|anticoagulants|mesh-ancestor
5811421|NCT02666053|Fostemsavir|fostemsavir|mesh-list
5811422|NCT02666053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5811423|NCT02666053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5811424|NCT02666053|Antiviral Agents|antiviral agents|mesh-ancestor
6492332|NCT00608101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6492333|NCT00608101|Antiemetics|antiemetics|mesh-ancestor
6492334|NCT00608101|Autonomic Agents|autonomic agents|mesh-ancestor
6492335|NCT00608101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6492336|NCT00608101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492337|NCT00608101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6492338|NCT00608101|Glucocorticoids|glucocorticoids|mesh-ancestor
6492339|NCT00608101|Hormones|hormones|mesh-ancestor
6492340|NCT00608101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6492341|NCT00608101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5811425|NCT02666053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6492342|NCT00608101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5811426|NCT02666053|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5811427|NCT02666053|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5811428|NCT02666053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811429|NCT02666105|Exemestane|exemestane|mesh-list
5811430|NCT02666105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5811431|NCT02666105|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5811432|NCT02666105|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5811433|NCT02666105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5811434|NCT02666105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811435|NCT02666105|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6492343|NCT00608179|Glimepiride|glimepiride|mesh-list
6492344|NCT00608179|Glyburide|glyburide|mesh-list
6492345|NCT00608179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6492346|NCT00608179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6492347|NCT00608179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492348|NCT00608179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5811436|NCT02666105|Hormone Antagonists|hormone antagonists|mesh-ancestor
5811437|NCT02666105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5811438|NCT02666105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900908|NCT04219774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5900909|NCT04219774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5900910|NCT04219774|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5900911|NCT04219774|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5900912|NCT04219774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900913|NCT04219774|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5900914|NCT04219774|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5900915|NCT04219774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5900916|NCT04219774|Antipyretics|antipyretics|mesh-ancestor
5900917|NCT04219774|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5900918|NCT04219774|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5900919|NCT04219774|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5900920|NCT04219774|Purinergic Agents|purinergic agents|mesh-ancestor
6492349|NCT00608179|Immunologic Factors|immunologic factors|mesh-ancestor
6492350|NCT00608218|Ciclesonide|ciclesonide|mesh-list
6492351|NCT00608218|Glucocorticoids|glucocorticoids|mesh-ancestor
6492352|NCT00608218|Hormones|hormones|mesh-ancestor
6492353|NCT00608218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6492354|NCT00608218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492355|NCT00608218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6492356|NCT00608231|Dexmedetomidine|dexmedetomidine|mesh-list
6492357|NCT00608231|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5811439|NCT02666040|Anesthetics|anesthetics|mesh-list
5811440|NCT02666040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5811441|NCT02666040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811442|NCT02665806|Fluticasone|fluticasone|mesh-list
5811443|NCT02665806|Ciclesonide|ciclesonide|mesh-list
5811444|NCT02665806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5811445|NCT02665806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5811446|NCT02665806|Autonomic Agents|autonomic agents|mesh-ancestor
5811447|NCT02665806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5811448|NCT02665806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811449|NCT02665806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5811450|NCT02665806|Respiratory System Agents|respiratory system agents|mesh-ancestor
5811451|NCT02665806|Dermatologic Agents|dermatologic agents|mesh-ancestor
5811452|NCT02665806|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5811453|NCT02665806|Glucocorticoids|glucocorticoids|mesh-ancestor
5811454|NCT02665806|Hormones|hormones|mesh-ancestor
5811455|NCT02665806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5811456|NCT02666001|Fostemsavir|fostemsavir|mesh-list
5811457|NCT02666001|Buprenorphine|buprenorphine|mesh-list
5811458|NCT02666001|Methadone|methadone|mesh-list
5811459|NCT02666001|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6496504|NCT00628290|Cannabidiol|cannabidiol|mesh-list
5811460|NCT02666001|Narcotics|narcotics|mesh-ancestor
5811461|NCT02666001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5811462|NCT02666001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811463|NCT02666001|Analgesics|analgesics|mesh-ancestor
5811464|NCT02666001|Sensory System Agents|sensory system agents|mesh-ancestor
5811465|NCT02666001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5811466|NCT02666001|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5811467|NCT02666001|Antitussive Agents|antitussive agents|mesh-ancestor
5811468|NCT02666001|Respiratory System Agents|respiratory system agents|mesh-ancestor
5811469|NCT02666001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5811470|NCT02666001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5811471|NCT02666001|Antiviral Agents|antiviral agents|mesh-ancestor
5811472|NCT02666001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5811473|NCT02666001|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5811474|NCT02666001|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5811475|NCT02666001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811476|NCT02665936|Dexamethasone|dexamethasone|mesh-list
5811477|NCT02665936|Dexamethasone acetate|dexamethasone acetate|mesh-list
5811478|NCT02665936|Levobupivacaine|levobupivacaine|mesh-list
5811479|NCT02665936|BB 1101|bb 1101|mesh-list
5811480|NCT02665936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5811481|NCT02665936|Antiemetics|antiemetics|mesh-ancestor
5811482|NCT02665936|Autonomic Agents|autonomic agents|mesh-ancestor
5811483|NCT02665936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5811484|NCT02665936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811485|NCT02665936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5811486|NCT02665936|Glucocorticoids|glucocorticoids|mesh-ancestor
5811487|NCT02665936|Hormones|hormones|mesh-ancestor
5811488|NCT02665936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5811489|NCT02665936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5811490|NCT02665936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5811491|NCT02665936|Protease Inhibitors|protease inhibitors|mesh-ancestor
5811492|NCT02665936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5811493|NCT02665936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811494|NCT02665936|Anesthetics, Local|anesthetics, local|mesh-ancestor
5811495|NCT02665936|Anesthetics|anesthetics|mesh-ancestor
5811496|NCT02665936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5811497|NCT02665936|Sensory System Agents|sensory system agents|mesh-ancestor
5811498|NCT02665871|Vaccines|vaccines|mesh-list
5811499|NCT02665871|Immunologic Factors|immunologic factors|mesh-ancestor
6674277|NCT01568307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6674278|NCT01568307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811500|NCT02665871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811501|NCT02665845|Mesalamine|mesalamine|mesh-list
5811502|NCT02665845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5811503|NCT02665845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5811504|NCT02665845|Analgesics|analgesics|mesh-ancestor
5811505|NCT02665845|Sensory System Agents|sensory system agents|mesh-ancestor
5811506|NCT02665845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5811507|NCT02665845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811508|NCT02665845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5811509|NCT02665845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5811510|NCT02665780|Cetylpyridinium|cetylpyridinium|mesh-list
5811511|NCT02665780|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5811512|NCT02665780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5811513|NCT02665832|Amlodipine|amlodipine|mesh-list
5811514|NCT02665832|Olmesartan|olmesartan|mesh-list
5811515|NCT02665832|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5811516|NCT02665832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5811517|NCT02665832|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5811518|NCT02665832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5811519|NCT02665832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811520|NCT02665832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5811521|NCT02665832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811522|NCT02665832|Vasodilator Agents|vasodilator agents|mesh-ancestor
5811523|NCT02665832|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5811524|NCT02665832|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5811525|NCT02665832|Antimetabolites|antimetabolites|mesh-ancestor
5811526|NCT02665832|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5811527|NCT02665832|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5811528|NCT02665832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5811529|NCT02665832|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5811530|NCT02665832|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5811531|NCT02666014|Neostigmine|neostigmine|mesh-list
5811532|NCT02666014|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5811533|NCT02666014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5811534|NCT02666014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811535|NCT02666014|Cholinergic Agents|cholinergic agents|mesh-ancestor
5811536|NCT02666014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5811537|NCT02666014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811538|NCT02666014|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5811539|NCT02666014|Autonomic Agents|autonomic agents|mesh-ancestor
5811540|NCT02666014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5811541|NCT02665702|Cisplatin|cisplatin|mesh-list
5811542|NCT02665702|Vinorelbine|vinorelbine|mesh-list
5811543|NCT02665702|Endostar protein|endostar protein|mesh-list
5811544|NCT02665702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5811545|NCT02665702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5811546|NCT02665702|Tubulin Modulators|tubulin modulators|mesh-ancestor
5811547|NCT02665702|Antimitotic Agents|antimitotic agents|mesh-ancestor
5811548|NCT02665702|Mitosis Modulators|mitosis modulators|mesh-ancestor
5811549|NCT02665702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811550|NCT02665702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5811551|NCT02665702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5811552|NCT02665702|Growth Substances|growth substances|mesh-ancestor
5811553|NCT02665702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811554|NCT02665702|Growth Inhibitors|growth inhibitors|mesh-ancestor
5811555|NCT02665650|Pembrolizumab|pembrolizumab|mesh-list
5811556|NCT02665650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5811557|NCT02665650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5811558|NCT02665637|Trastuzumab|trastuzumab|mesh-list
5811559|NCT02665637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5811560|NCT02665637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5811561|NCT02665533|Dexamethasone|dexamethasone|mesh-list
5811562|NCT02665533|Dexamethasone acetate|dexamethasone acetate|mesh-list
5811563|NCT02665533|Diclofenac|diclofenac|mesh-list
5811564|NCT02665533|Codeine|codeine|mesh-list
5811565|NCT02665533|BB 1101|bb 1101|mesh-list
5811566|NCT02665533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5811567|NCT02665533|Antiemetics|antiemetics|mesh-ancestor
5811568|NCT02665533|Autonomic Agents|autonomic agents|mesh-ancestor
5811569|NCT02665533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5811570|NCT02665533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811571|NCT02665533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5811572|NCT02665533|Glucocorticoids|glucocorticoids|mesh-ancestor
5811573|NCT02665533|Hormones|hormones|mesh-ancestor
5811574|NCT02665533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5811575|NCT02665533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5811576|NCT02665533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5811577|NCT02665533|Protease Inhibitors|protease inhibitors|mesh-ancestor
5811578|NCT02665533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5811579|NCT02665533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811580|NCT02665533|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5811581|NCT02665533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5811582|NCT02665533|Analgesics|analgesics|mesh-ancestor
5811583|NCT02665533|Sensory System Agents|sensory system agents|mesh-ancestor
5811584|NCT02665533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5811585|NCT02665533|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5811586|NCT02665533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5811587|NCT02665533|Narcotics|narcotics|mesh-ancestor
5811588|NCT02665533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5811589|NCT02665533|Antitussive Agents|antitussive agents|mesh-ancestor
5811590|NCT02665533|Respiratory System Agents|respiratory system agents|mesh-ancestor
5811591|NCT02665624|Calcium, Dietary|calcium, dietary|mesh-list
5811592|NCT02665624|Sennosides|sennosides|mesh-list
5811593|NCT02665624|Senna Extract|senna extract|mesh-list
5811594|NCT02665624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5811595|NCT02665624|Calcium|calcium|mesh-list
5811596|NCT02665624|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5811597|NCT02665624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811598|NCT02665624|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5811599|NCT02665624|Laxatives|laxatives|mesh-ancestor
5811600|NCT02665624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5811601|NCT02665624|Cathartics|cathartics|mesh-ancestor
5811602|NCT02665351|Peramivir|peramivir|mesh-list
5811603|NCT02665351|Antiviral Agents|antiviral agents|mesh-ancestor
5811604|NCT02665351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5811605|NCT02665351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5811606|NCT02665351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811607|NCT02665416|Bevacizumab|bevacizumab|mesh-list
5811608|NCT02665416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5811609|NCT02665416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5811610|NCT02665416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5811611|NCT02665416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5811612|NCT02665416|Growth Substances|growth substances|mesh-ancestor
5811613|NCT02665416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811614|NCT02665416|Growth Inhibitors|growth inhibitors|mesh-ancestor
5811615|NCT02665208|Nicotine|nicotine|mesh-list
5811616|NCT02665208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5811617|NCT02665208|Autonomic Agents|autonomic agents|mesh-ancestor
5811618|NCT02665208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5811619|NCT02665208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641874|NCT01503515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5641875|NCT01503515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5641876|NCT01503515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641877|NCT01503515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5641878|NCT01503515|Hormone Antagonists|hormone antagonists|mesh-ancestor
5641879|NCT01503515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5641880|NCT01503515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811620|NCT02665208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5811621|NCT02665208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5811622|NCT02665208|Cholinergic Agents|cholinergic agents|mesh-ancestor
5811623|NCT02665208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5811624|NCT02665208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811625|NCT02665143|Nintedanib|nintedanib|mesh-list
5811626|NCT02665143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5811627|NCT02665143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5811628|NCT02665143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5811629|NCT02665143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811630|NCT02665039|Gemcitabine|gemcitabine|mesh-list
5811631|NCT02665039|Carboplatin|carboplatin|mesh-list
5811632|NCT02665039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5811633|NCT02665039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5811634|NCT02665039|Antimetabolites|antimetabolites|mesh-ancestor
5811635|NCT02665039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811636|NCT02665039|Antiviral Agents|antiviral agents|mesh-ancestor
5811637|NCT02665039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5811638|NCT02665039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5811639|NCT02665039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5811640|NCT02665039|Immunologic Factors|immunologic factors|mesh-ancestor
5811641|NCT02665039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811642|NCT02664857|Vitamin D|vitamin d|mesh-list
5811643|NCT02664857|Ergocalciferols|ergocalciferols|mesh-list
5811644|NCT02664857|Vitamins|vitamins|mesh-list
5811645|NCT02664857|Micronutrients|micronutrients|mesh-ancestor
5811646|NCT02664857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811647|NCT02664857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5811648|NCT02664857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5811649|NCT02664649|Apixaban|apixaban|mesh-list
5811650|NCT02664649|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
5811651|NCT02664649|Anticoagulants|anticoagulants|mesh-list
5811652|NCT02664649|Antithrombins|antithrombins|mesh-ancestor
5811653|NCT02664649|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5811654|NCT02664649|Protease Inhibitors|protease inhibitors|mesh-ancestor
5811655|NCT02664649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5811656|NCT02664649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811657|NCT02664493|Methylprednisolone|methylprednisolone|mesh-list
5811658|NCT02664493|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5811659|NCT02664493|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5811660|NCT02664493|Prednisolone|prednisolone|mesh-list
5811661|NCT02664493|Prednisolone acetate|prednisolone acetate|mesh-list
5811662|NCT02664493|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5811663|NCT02664493|Prednisolone phosphate|prednisolone phosphate|mesh-list
5811664|NCT02664493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5811665|NCT02664493|Antiemetics|antiemetics|mesh-ancestor
5811666|NCT02664493|Autonomic Agents|autonomic agents|mesh-ancestor
5811667|NCT02664493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5811668|NCT02664493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811669|NCT02664493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5811670|NCT02664493|Glucocorticoids|glucocorticoids|mesh-ancestor
5811671|NCT02664493|Hormones|hormones|mesh-ancestor
5811672|NCT02664493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5811673|NCT02664493|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5811674|NCT02664493|Protective Agents|protective agents|mesh-ancestor
5811675|NCT02664493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5811676|NCT02664493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5811677|NCT02664116|Diclofenac|diclofenac|mesh-list
5811678|NCT02664116|Ketorolac|ketorolac|mesh-list
5811679|NCT02664116|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5811680|NCT02664116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5811681|NCT02664116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5811682|NCT02664116|Analgesics|analgesics|mesh-ancestor
5811683|NCT02664116|Sensory System Agents|sensory system agents|mesh-ancestor
5811684|NCT02664116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5811685|NCT02664116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811686|NCT02664116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5811687|NCT02664116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5811688|NCT02664116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5811689|NCT02664116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5811690|NCT02664116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811691|NCT02664051|Cromolyn Sodium|cromolyn sodium|mesh-list
5811692|NCT02664051|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
5811693|NCT02664051|Immunologic Factors|immunologic factors|mesh-ancestor
5811694|NCT02664051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811695|NCT02664051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5811696|NCT02664051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5811697|NCT02664051|Respiratory System Agents|respiratory system agents|mesh-ancestor
5811698|NCT02664441|Exenatide|exenatide|mesh-list
5811699|NCT02664441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5811700|NCT02664441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811701|NCT02664441|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5811702|NCT02664441|Incretins|incretins|mesh-ancestor
5811703|NCT02664441|Hormones|hormones|mesh-ancestor
5811704|NCT02664441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5900921|NCT04219774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5900922|NCT04185012|Benralizumab|benralizumab|mesh-list
5900923|NCT04185012|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5900924|NCT04185012|Respiratory System Agents|respiratory system agents|mesh-ancestor
5908249|NCT04744831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5908250|NCT04744831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5908251|NCT04744831|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5908252|NCT04744831|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5908253|NCT04744831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5908254|NCT04744831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908255|NCT04744831|Immunologic Factors|immunologic factors|mesh-ancestor
5908256|NCT04744831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5908257|NCT04732065|Dopamine|dopamine|mesh-list
5908258|NCT04732065|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5908259|NCT04732065|Sympathomimetics|sympathomimetics|mesh-ancestor
5908260|NCT04732065|Autonomic Agents|autonomic agents|mesh-ancestor
5908261|NCT04732065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5908262|NCT04732065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5908263|NCT04732065|Dopamine Agents|dopamine agents|mesh-ancestor
5908264|NCT04732065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5908265|NCT04732065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908266|NCT04732065|Protective Agents|protective agents|mesh-ancestor
5908267|NCT04716387|Milbemycin oxime|milbemycin oxime|mesh-list
5908268|NCT04716387|Anthelmintics|anthelmintics|mesh-ancestor
5908269|NCT04716387|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5908270|NCT04716387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5908271|NCT04713657|Propranolol|propranolol|mesh-list
5908272|NCT04713657|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5908273|NCT04713657|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5908274|NCT04713657|Adrenergic Agents|adrenergic agents|mesh-ancestor
5908275|NCT04713657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5908276|NCT04713657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908277|NCT04713657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5908278|NCT04713657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5908279|NCT04713657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5908280|NCT04713657|Vasodilator Agents|vasodilator agents|mesh-ancestor
5908281|NCT04702880|Carboplatin|carboplatin|mesh-list
5908282|NCT04702880|Nivolumab|nivolumab|mesh-list
5908283|NCT04702880|Etoposide|etoposide|mesh-list
5811705|NCT02664142|Anesthetics|anesthetics|mesh-list
5811706|NCT02664142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5811707|NCT02664142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811708|NCT02664168|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
5811709|NCT02664168|Laxatives|laxatives|mesh-ancestor
5811710|NCT02664168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5811711|NCT02663960|Citric Acid|citric acid|mesh-list
5811712|NCT02663960|Sodium Citrate|sodium citrate|mesh-list
5811713|NCT02663960|Anticoagulants|anticoagulants|mesh-ancestor
5811714|NCT02663960|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5811715|NCT02663960|Chelating Agents|chelating agents|mesh-ancestor
5811716|NCT02663960|Sequestering Agents|sequestering agents|mesh-ancestor
5811717|NCT02663960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811718|NCT02664103|Cyclophosphamide|cyclophosphamide|mesh-list
5811719|NCT02664103|Capecitabine|capecitabine|mesh-list
5811720|NCT02664103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5811721|NCT02664103|Immunologic Factors|immunologic factors|mesh-ancestor
5811722|NCT02664103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811723|NCT02664103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5811724|NCT02664103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5811725|NCT02664103|Alkylating Agents|alkylating agents|mesh-ancestor
5811726|NCT02664103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811727|NCT02664103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5811728|NCT02664103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5811729|NCT02664103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5811730|NCT02664103|Antimetabolites|antimetabolites|mesh-ancestor
5811731|NCT02663999|Diazepam|diazepam|mesh-list
5811732|NCT02663999|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5811733|NCT02663999|Anticonvulsants|anticonvulsants|mesh-ancestor
5811734|NCT02663999|Antiemetics|antiemetics|mesh-ancestor
5811735|NCT02663999|Autonomic Agents|autonomic agents|mesh-ancestor
5811736|NCT02663999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5811737|NCT02663999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811738|NCT02663999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5811739|NCT02663999|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5811740|NCT02663999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5811741|NCT02663999|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5811742|NCT02663999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5811743|NCT02663999|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5811744|NCT02663999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5811745|NCT02663999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5811746|NCT02663999|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5811747|NCT02663999|Anesthetics, General|anesthetics, general|mesh-ancestor
5811748|NCT02663999|Anesthetics|anesthetics|mesh-ancestor
5811749|NCT02663999|GABA Modulators|gaba modulators|mesh-ancestor
5811750|NCT02663999|GABA Agents|gaba agents|mesh-ancestor
5811751|NCT02663999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5811752|NCT02663999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811753|NCT02664012|Menthol|menthol|mesh-list
5811754|NCT02664012|Nicotine|nicotine|mesh-list
5811755|NCT02664012|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5811756|NCT02664012|Autonomic Agents|autonomic agents|mesh-ancestor
5811757|NCT02664012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5811758|NCT02664012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811759|NCT02664012|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5811760|NCT02664012|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5811761|NCT02664012|Cholinergic Agents|cholinergic agents|mesh-ancestor
5811762|NCT02664012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5811763|NCT02664012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811764|NCT02664012|Antipruritics|antipruritics|mesh-ancestor
5811765|NCT02664012|Dermatologic Agents|dermatologic agents|mesh-ancestor
5811766|NCT02663713|Clopidogrel|clopidogrel|mesh-list
5811767|NCT02663713|Ticagrelor|ticagrelor|mesh-list
5811768|NCT02663713|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5811769|NCT02663713|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5811770|NCT02663713|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5811771|NCT02663713|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5811772|NCT02663713|Purinergic Agents|purinergic agents|mesh-ancestor
5811773|NCT02663713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5811774|NCT02663713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811775|NCT02663713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811776|NCT02663830|Sildenafil Citrate|sildenafil citrate|mesh-list
5811777|NCT02663830|Clomiphene|clomiphene|mesh-list
5811778|NCT02663830|Enclomiphene|enclomiphene|mesh-list
5811779|NCT02663830|Zuclomiphene|zuclomiphene|mesh-list
5811780|NCT02663830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811781|NCT02663830|Vasodilator Agents|vasodilator agents|mesh-ancestor
5811782|NCT02663830|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5811783|NCT02663830|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5811784|NCT02663830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5811785|NCT02663830|Urological Agents|urological agents|mesh-ancestor
5811786|NCT02663830|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5811787|NCT02663830|Hormone Antagonists|hormone antagonists|mesh-ancestor
5811788|NCT02663830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5811789|NCT02663830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811790|NCT02663830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5811791|NCT02663830|Fertility Agents|fertility agents|mesh-ancestor
5811792|NCT02663830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5811793|NCT02663830|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5811794|NCT02663830|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5811795|NCT02663700|Artesunate|artesunate|mesh-list
5811796|NCT02663700|Antimalarials|antimalarials|mesh-ancestor
5811797|NCT02663700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5811798|NCT02663700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5811799|NCT02663700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5811800|NCT02663700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5811801|NCT02663700|Antiviral Agents|antiviral agents|mesh-ancestor
5811802|NCT02663700|Schistosomicides|schistosomicides|mesh-ancestor
5811803|NCT02663700|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5811804|NCT02663700|Anthelmintics|anthelmintics|mesh-ancestor
5811805|NCT02663596|Vancomycin|vancomycin|mesh-list
5811806|NCT02663596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5811807|NCT02663596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5811808|NCT02663570|Melatonin|melatonin|mesh-list
5811809|NCT02663570|Antioxidants|antioxidants|mesh-ancestor
5811810|NCT02663570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811811|NCT02663570|Protective Agents|protective agents|mesh-ancestor
5811812|NCT02663570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811813|NCT02663570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5811814|NCT02663440|Temozolomide|temozolomide|mesh-list
5811815|NCT02663440|Molgramostim|molgramostim|mesh-list
5811816|NCT02663440|Sargramostim|sargramostim|mesh-list
5811817|NCT02663440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5811818|NCT02663440|Alkylating Agents|alkylating agents|mesh-ancestor
5811819|NCT02663440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811820|NCT02663440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5811821|NCT02663440|Immunologic Factors|immunologic factors|mesh-ancestor
5811822|NCT02663440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811823|NCT02663323|Sirolimus|sirolimus|mesh-list
5811824|NCT02663323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5811825|NCT02663323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5811826|NCT02663323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5811827|NCT02663323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5811828|NCT02663323|Antifungal Agents|antifungal agents|mesh-ancestor
5811829|NCT02663323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5811830|NCT02663323|Immunologic Factors|immunologic factors|mesh-ancestor
5811831|NCT02663323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811832|NCT02663206|Botulinum Toxins|botulinum toxins|mesh-list
5811833|NCT02663206|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5811834|NCT02663206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5811835|NCT02663206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811836|NCT02663206|Cholinergic Agents|cholinergic agents|mesh-ancestor
5811837|NCT02663206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5811838|NCT02663206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811839|NCT02663258|Pembrolizumab|pembrolizumab|mesh-list
5811840|NCT02663258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5811841|NCT02663258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5811842|NCT02663284|Ropivacaine|ropivacaine|mesh-list
5811843|NCT02663284|Anesthetics, Local|anesthetics, local|mesh-ancestor
5811844|NCT02663284|Anesthetics|anesthetics|mesh-ancestor
5811845|NCT02663284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5811846|NCT02663284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811847|NCT02663284|Sensory System Agents|sensory system agents|mesh-ancestor
5811848|NCT02663284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5811849|NCT02663141|Bevacizumab|bevacizumab|mesh-list
5811850|NCT02663141|Losartan|losartan|mesh-list
5811851|NCT02663141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5811852|NCT02663141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5811853|NCT02663141|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5811854|NCT02663141|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5811855|NCT02663141|Growth Substances|growth substances|mesh-ancestor
5811856|NCT02663141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811857|NCT02663141|Growth Inhibitors|growth inhibitors|mesh-ancestor
5811858|NCT02663141|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5811859|NCT02663141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5811860|NCT02663141|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5811861|NCT02663141|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5811862|NCT02663141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811863|NCT02663089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5811864|NCT02663050|Diclofenac|diclofenac|mesh-list
5811865|NCT02663050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5811866|NCT02663050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5811867|NCT02663050|Analgesics|analgesics|mesh-ancestor
5811868|NCT02663050|Sensory System Agents|sensory system agents|mesh-ancestor
5811869|NCT02663050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5811870|NCT02663050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811871|NCT02663050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5811872|NCT02663050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5811873|NCT02663050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5811874|NCT02663050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5811875|NCT02663050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811876|NCT02662972|Botulinum Toxins|botulinum toxins|mesh-list
5811877|NCT02662972|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5811878|NCT02662972|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5811879|NCT02662972|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5811880|NCT02662972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5811881|NCT02662972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811882|NCT02662972|Cholinergic Agents|cholinergic agents|mesh-ancestor
5811883|NCT02662972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5811884|NCT02662972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811885|NCT02662972|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5811886|NCT02662972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5811887|NCT02662959|Irinotecan|irinotecan|mesh-list
5811888|NCT02662959|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5811889|NCT02662959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5811890|NCT02662959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5811891|NCT02662959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811892|NCT02662959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5811893|NCT02662894|Valsartan|valsartan|mesh-list
5811894|NCT02662894|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5811895|NCT02662894|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5811896|NCT02662894|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5811897|NCT02662894|Antimetabolites|antimetabolites|mesh-ancestor
5811898|NCT02662894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811899|NCT02662894|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5811900|NCT02662894|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5811901|NCT02662894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5811902|NCT02662894|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5811903|NCT02662894|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5811904|NCT02662894|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5811905|NCT02662855|Favipiravir|favipiravir|mesh-list
5811906|NCT02662855|Antiviral Agents|antiviral agents|mesh-ancestor
5811907|NCT02662855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5811908|NCT02662647|Cytarabine|cytarabine|mesh-list
5811909|NCT02662647|Decitabine|decitabine|mesh-list
5811910|NCT02662647|Aclacinomycins|aclacinomycins|mesh-list
5811911|NCT02662647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5811912|NCT02662647|Antimetabolites|antimetabolites|mesh-ancestor
5811913|NCT02662647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811914|NCT02662647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5811915|NCT02662647|Antiviral Agents|antiviral agents|mesh-ancestor
5811916|NCT02662647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5811917|NCT02662647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5811918|NCT02662647|Immunologic Factors|immunologic factors|mesh-ancestor
6492358|NCT00608231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6492359|NCT00608231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492360|NCT00608231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6492361|NCT00608231|Analgesics|analgesics|mesh-ancestor
5811919|NCT02662647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811920|NCT02662647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5811921|NCT02662647|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5811922|NCT02662647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5811923|NCT02662660|Acetaminophen|acetaminophen|mesh-list
5811924|NCT02662660|Dipyrone|dipyrone|mesh-list
5811925|NCT02662660|Bupivacaine|bupivacaine|mesh-list
5811926|NCT02662660|Levobupivacaine|levobupivacaine|mesh-list
5811927|NCT02662660|Anesthetics, Local|anesthetics, local|mesh-ancestor
5811928|NCT02662660|Anesthetics|anesthetics|mesh-ancestor
5811929|NCT02662660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5811930|NCT02662660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492362|NCT00608231|Sensory System Agents|sensory system agents|mesh-ancestor
5641881|NCT01503515|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5641882|NCT01503515|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5641883|NCT01503515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5641884|NCT01491893|Vaccines|vaccines|mesh-list
5641885|NCT01491893|Immunologic Factors|immunologic factors|mesh-ancestor
5641886|NCT01491893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641887|NCT01180374|Dronabinol|dronabinol|mesh-list
5641888|NCT01180374|Cannabidiol|cannabidiol|mesh-list
5641889|NCT01180374|Anticonvulsants|anticonvulsants|mesh-ancestor
5641890|NCT01180374|Hallucinogens|hallucinogens|mesh-ancestor
5641891|NCT01180374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811931|NCT02662660|Sensory System Agents|sensory system agents|mesh-ancestor
5811932|NCT02662660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5811933|NCT02662660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5811934|NCT02662660|Analgesics|analgesics|mesh-ancestor
5811935|NCT02662660|Antipyretics|antipyretics|mesh-ancestor
5811936|NCT02662660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5811937|NCT02662660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5811938|NCT02662660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5811939|NCT02662725|Ipilimumab|ipilimumab|mesh-list
5811940|NCT02662725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5811941|NCT02662725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5811942|NCT02662725|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5811943|NCT02662725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811944|NCT02662530|Botulinum Toxins|botulinum toxins|mesh-list
5811945|NCT02662530|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5811946|NCT02662530|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5811947|NCT02662530|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5811948|NCT02662530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5811949|NCT02662530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811950|NCT02662530|Cholinergic Agents|cholinergic agents|mesh-ancestor
5811951|NCT02662530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5811952|NCT02662530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492363|NCT00608231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6492364|NCT00608231|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6492365|NCT00608231|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6492366|NCT00608231|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5811953|NCT02662530|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5811954|NCT02662530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5900925|NCT04139655|Colchicine|colchicine|mesh-list
5900926|NCT04139655|Gout Suppressants|gout suppressants|mesh-ancestor
5900927|NCT04139655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5900928|NCT04139655|Tubulin Modulators|tubulin modulators|mesh-ancestor
5900929|NCT04139655|Antimitotic Agents|antimitotic agents|mesh-ancestor
5900930|NCT04139655|Mitosis Modulators|mitosis modulators|mesh-ancestor
5900931|NCT04139655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900932|NCT04139655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5900933|NCT04122287|Levofloxacin|levofloxacin|mesh-list
5900934|NCT04122287|Ofloxacin|ofloxacin|mesh-list
5900935|NCT04122287|Tinidazole|tinidazole|mesh-list
5900936|NCT04122287|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5900937|NCT04122287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5900938|NCT04122287|Renal Agents|renal agents|mesh-ancestor
5900939|NCT04122287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5900940|NCT04122287|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5900941|NCT04122287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5900942|NCT04122287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5900943|NCT04122287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900944|NCT04122287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5811955|NCT02662504|Cisplatin|cisplatin|mesh-list
5811956|NCT02662504|Pemetrexed|pemetrexed|mesh-list
5811957|NCT02662504|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
5811958|NCT02662504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5811959|NCT02662504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5811960|NCT02662504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811961|NCT02662504|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5811962|NCT02662504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5811963|NCT02662504|Dermatologic Agents|dermatologic agents|mesh-ancestor
5811964|NCT02662504|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5811965|NCT02662491|Calcium, Dietary|calcium, dietary|mesh-list
5811966|NCT02662491|Vitamin D|vitamin d|mesh-list
5811967|NCT02662491|Ergocalciferols|ergocalciferols|mesh-list
5811968|NCT02662491|Vitamins|vitamins|mesh-list
5811969|NCT02662491|Calcium|calcium|mesh-list
5811970|NCT02662491|Micronutrients|micronutrients|mesh-ancestor
5811971|NCT02662491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5811972|NCT02662491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5811973|NCT02662491|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5811974|NCT02662634|Paclitaxel|paclitaxel|mesh-list
5811975|NCT02662634|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5811976|NCT02662634|Cisplatin|cisplatin|mesh-list
5811977|NCT02662634|Carboplatin|carboplatin|mesh-list
5811978|NCT02662634|Pemetrexed|pemetrexed|mesh-list
5811979|NCT02662634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5811980|NCT02662634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5811981|NCT02662634|Tubulin Modulators|tubulin modulators|mesh-ancestor
5811982|NCT02662634|Antimitotic Agents|antimitotic agents|mesh-ancestor
5811983|NCT02662634|Mitosis Modulators|mitosis modulators|mesh-ancestor
5811984|NCT02662634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492367|NCT00608231|Adrenergic Agents|adrenergic agents|mesh-ancestor
6492368|NCT00608231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6492369|NCT00608231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5811985|NCT02662634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5811986|NCT02662634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5811987|NCT02662634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5811988|NCT02662426|Oseltamivir|oseltamivir|mesh-list
5811989|NCT02662426|Antiviral Agents|antiviral agents|mesh-ancestor
5811990|NCT02662426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5811991|NCT02662426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5811992|NCT02662426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492370|NCT00608335|Micafungin|micafungin|mesh-list
5811993|NCT02662348|Aldesleukin|aldesleukin|mesh-list
5811994|NCT02662348|Interleukin-2|interleukin-2|mesh-list
5811995|NCT02662348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5811996|NCT02662348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5811997|NCT02662348|Analgesics|analgesics|mesh-ancestor
5811998|NCT02662348|Sensory System Agents|sensory system agents|mesh-ancestor
5811999|NCT02662348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5812000|NCT02662348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812001|NCT02662348|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5812002|NCT02662348|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5812003|NCT02662348|Antiviral Agents|antiviral agents|mesh-ancestor
5812004|NCT02662348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5812005|NCT02662322|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
5812006|NCT02662322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5812007|NCT02662322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812008|NCT02662283|Acteoside|acteoside|mesh-list
5812009|NCT02662283|Prednisolone|prednisolone|mesh-list
5812010|NCT02662283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5812011|NCT02662283|Glucocorticoids|glucocorticoids|mesh-ancestor
5812012|NCT02662283|Hormones|hormones|mesh-ancestor
5812013|NCT02662283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5812014|NCT02662283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812015|NCT02662283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5812016|NCT02662283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5812017|NCT02662283|Protective Agents|protective agents|mesh-ancestor
5812018|NCT02662283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5812019|NCT02662283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5812020|NCT02662283|Antioxidants|antioxidants|mesh-ancestor
5812021|NCT02662283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5812022|NCT02662283|Chelating Agents|chelating agents|mesh-ancestor
5812023|NCT02662283|Sequestering Agents|sequestering agents|mesh-ancestor
5812024|NCT02662283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5812025|NCT02662283|Immunologic Factors|immunologic factors|mesh-ancestor
5812026|NCT02662296|Idelalisib|idelalisib|mesh-list
5812027|NCT02662296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5812028|NCT02662296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5812029|NCT02662296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5812030|NCT02662309|Atezolizumab|atezolizumab|mesh-list
5812031|NCT02662309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5812032|NCT02662062|Pembrolizumab|pembrolizumab|mesh-list
5812033|NCT02662062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5812034|NCT02662062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5812035|NCT02662374|Nystatin|nystatin|mesh-list
5812036|NCT02662374|Calcium|calcium|mesh-list
5812037|NCT02662374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5812038|NCT02662374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812039|NCT02662374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5812040|NCT02662374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5812041|NCT02662374|Antifungal Agents|antifungal agents|mesh-ancestor
5812042|NCT02662374|Ionophores|ionophores|mesh-ancestor
5812043|NCT02662374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5812044|NCT02662374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5812045|NCT02661932|Letrozole|letrozole|mesh-list
5812046|NCT02661932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5812047|NCT02661932|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5812048|NCT02661932|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5812049|NCT02661932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5812050|NCT02661932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5812051|NCT02661932|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5812052|NCT02661932|Hormone Antagonists|hormone antagonists|mesh-ancestor
5812053|NCT02661932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5812054|NCT02661932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812055|NCT02661893|Rifampin|rifampin|mesh-list
5812056|NCT02661893|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5812057|NCT02661893|Antitubercular Agents|antitubercular agents|mesh-ancestor
5812058|NCT02661893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5812059|NCT02661893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5812060|NCT02661893|Leprostatic Agents|leprostatic agents|mesh-ancestor
5812061|NCT02661893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5812062|NCT02661893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5812063|NCT02661893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5812064|NCT02661893|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5812065|NCT02661893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5812066|NCT02661893|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5812067|NCT02661893|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5812068|NCT02661893|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5812069|NCT02661893|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5812070|NCT02661711|Aflibercept|aflibercept|mesh-list
5812071|NCT02661711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5812072|NCT02661711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5812073|NCT02661711|Growth Substances|growth substances|mesh-ancestor
5812074|NCT02661711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812075|NCT02661711|Growth Inhibitors|growth inhibitors|mesh-ancestor
5812076|NCT02661711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5812077|NCT02661789|Goserelin|goserelin|mesh-list
5812078|NCT02661789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5812079|NCT02661789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5812080|NCT02661425|Immunoglobulins|immunoglobulins|mesh-list
5812081|NCT02661425|Immunologic Factors|immunologic factors|mesh-ancestor
5812082|NCT02661425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812083|NCT02661373|Cobicistat|cobicistat|mesh-list
5812084|NCT02661373|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5812085|NCT02661373|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5812086|NCT02661373|Antiviral Agents|antiviral agents|mesh-ancestor
5812087|NCT02661373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5812088|NCT02661373|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5812089|NCT02661373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5812090|NCT02661373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5812091|NCT02661373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5812092|NCT02661503|Dexamethasone|dexamethasone|mesh-list
5812093|NCT02661503|Prednisone|prednisone|mesh-list
5812094|NCT02661503|Cyclophosphamide|cyclophosphamide|mesh-list
5812095|NCT02661503|Dacarbazine|dacarbazine|mesh-list
5812096|NCT02661503|Doxorubicin|doxorubicin|mesh-list
5812097|NCT02661503|Etoposide|etoposide|mesh-list
5812098|NCT02661503|Vincristine|vincristine|mesh-list
5812099|NCT02661503|Bleomycin|bleomycin|mesh-list
5812100|NCT02661503|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5812101|NCT02661503|Procarbazine|procarbazine|mesh-list
5812102|NCT02661503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5812103|NCT02661503|Immunologic Factors|immunologic factors|mesh-ancestor
5812104|NCT02661503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812105|NCT02661503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5812106|NCT02661503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5812107|NCT02661503|Alkylating Agents|alkylating agents|mesh-ancestor
5812108|NCT02661503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5812109|NCT02661503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5812110|NCT02661503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5812111|NCT02661503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5812112|NCT02661503|Antiemetics|antiemetics|mesh-ancestor
5812113|NCT02661503|Autonomic Agents|autonomic agents|mesh-ancestor
5812114|NCT02661503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5812115|NCT02661503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5812116|NCT02661503|Glucocorticoids|glucocorticoids|mesh-ancestor
5812117|NCT02661503|Hormones|hormones|mesh-ancestor
5812118|NCT02661503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5812119|NCT02661503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5812120|NCT02661503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5812121|NCT02661503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5812122|NCT02661503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5812123|NCT02661503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5812124|NCT02661503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5812125|NCT02661503|Tubulin Modulators|tubulin modulators|mesh-ancestor
5812126|NCT02661503|Antimitotic Agents|antimitotic agents|mesh-ancestor
5812127|NCT02661503|Mitosis Modulators|mitosis modulators|mesh-ancestor
5812128|NCT02661503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5812129|NCT02661438|Ciprofloxacin|ciprofloxacin|mesh-list
5812130|NCT02661438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5812131|NCT02661438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5812132|NCT02661438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5812133|NCT02661438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5812134|NCT02661438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5812135|NCT02661438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5812136|NCT02661438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5812137|NCT02661438|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5812138|NCT02661438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5812139|NCT02661347|Risperidone|risperidone|mesh-list
5812140|NCT02661347|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5812141|NCT02661347|Serotonin Agents|serotonin agents|mesh-ancestor
5812142|NCT02661347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5812143|NCT02661347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5812144|NCT02661347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812145|NCT02661347|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5812146|NCT02661347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5812147|NCT02661347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5812148|NCT02661347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5812149|NCT02661347|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5812150|NCT02661347|Dopamine Agents|dopamine agents|mesh-ancestor
5812151|NCT02661477|Interferons|interferons|mesh-list
5812152|NCT02661477|Interferon-alpha|interferon-alpha|mesh-list
5812153|NCT02661477|Interferon alpha-2|interferon alpha-2|mesh-list
5812154|NCT02661477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5812155|NCT02661477|Antiviral Agents|antiviral agents|mesh-ancestor
5812156|NCT02661477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5812157|NCT02661477|Immunologic Factors|immunologic factors|mesh-ancestor
5812158|NCT02661477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812159|NCT02661152|Nimorazole|nimorazole|mesh-list
5812160|NCT02661152|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
5812161|NCT02661152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5812162|NCT02661152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5812163|NCT02661152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5812164|NCT02661191|Cholecalciferol|cholecalciferol|mesh-list
5812165|NCT02661191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5812166|NCT02661191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812167|NCT02661191|Vitamins|vitamins|mesh-ancestor
5812168|NCT02661191|Micronutrients|micronutrients|mesh-ancestor
5812169|NCT02661191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5812170|NCT02661100|Pembrolizumab|pembrolizumab|mesh-list
5812171|NCT02661100|Poly ICLC|poly iclc|mesh-list
5812172|NCT02661100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5812173|NCT02661100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5812174|NCT02661100|Interferon Inducers|interferon inducers|mesh-ancestor
5812175|NCT02661100|Immunologic Factors|immunologic factors|mesh-ancestor
6492371|NCT00608335|Antifungal Agents|antifungal agents|mesh-ancestor
6492372|NCT00608335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6492373|NCT00608361|Dasatinib|dasatinib|mesh-list
6492374|NCT00608361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6492375|NCT00608361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6492376|NCT00608361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6492377|NCT00608361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492378|NCT00608374|Fludarabine|fludarabine|mesh-list
6492379|NCT00608374|Fludarabine phosphate|fludarabine phosphate|mesh-list
5812176|NCT02661100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812177|NCT02661035|Mycophenolic Acid|mycophenolic acid|mesh-list
5812178|NCT02661035|Cyclophosphamide|cyclophosphamide|mesh-list
5812179|NCT02661035|Fludarabine|fludarabine|mesh-list
5812180|NCT02661035|Allopurinol|allopurinol|mesh-list
5812181|NCT02661035|Tacrolimus|tacrolimus|mesh-list
5812182|NCT02661035|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5812183|NCT02661035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5812184|NCT02661035|Immunologic Factors|immunologic factors|mesh-ancestor
5812185|NCT02661035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812186|NCT02661035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5812187|NCT02661035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5812188|NCT02661035|Alkylating Agents|alkylating agents|mesh-ancestor
5812189|NCT02661035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5812190|NCT02661035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5812191|NCT02661035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5812192|NCT02661035|Antimetabolites|antimetabolites|mesh-ancestor
5812193|NCT02661035|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5812194|NCT02661035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5812195|NCT02661035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5812196|NCT02661035|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5812197|NCT02661035|Antitubercular Agents|antitubercular agents|mesh-ancestor
5812198|NCT02661035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5812199|NCT02661035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5812200|NCT02661035|Gout Suppressants|gout suppressants|mesh-ancestor
5812201|NCT02661035|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5812202|NCT02661035|Antioxidants|antioxidants|mesh-ancestor
5812203|NCT02661035|Protective Agents|protective agents|mesh-ancestor
5812204|NCT02660840|Flupenthixol|flupenthixol|mesh-list
6492380|NCT00608374|Chlorambucil|chlorambucil|mesh-list
6492381|NCT00608374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5812205|NCT02660840|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
5812206|NCT02660840|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5812207|NCT02660840|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5812208|NCT02660840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5812209|NCT02660840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812210|NCT02660840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5812211|NCT02660840|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5812212|NCT02660840|Dopamine Agents|dopamine agents|mesh-ancestor
5812213|NCT02660840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5812214|NCT02660840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900945|NCT04122287|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5900946|NCT04122287|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5900947|NCT04122287|Alkylating Agents|alkylating agents|mesh-ancestor
5900948|NCT04122287|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
5900949|NCT04122287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5900950|NCT04122287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5900951|NCT04117945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5900952|NCT04117945|Cetuximab|cetuximab|mesh-list
5900953|NCT04117945|Panitumumab|panitumumab|mesh-list
5900954|NCT04117945|Irinotecan|irinotecan|mesh-list
5900955|NCT04117945|Antibodies|antibodies|mesh-list
5900956|NCT04117945|Immunoglobulins|immunoglobulins|mesh-list
5900957|NCT04117945|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5900958|NCT04117945|Immunologic Factors|immunologic factors|mesh-ancestor
5900959|NCT04117945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900960|NCT04117945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5900961|NCT04117945|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5900962|NCT04117945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5900963|NCT04117945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5900964|NCT04117945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900965|NCT04095858|Methotrexate|methotrexate|mesh-list
5900966|NCT04095858|Tacrolimus|tacrolimus|mesh-list
5900967|NCT04095858|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5812215|NCT02660905|Tenofovir|tenofovir|mesh-list
5812216|NCT02660905|Emtricitabine|emtricitabine|mesh-list
5812217|NCT02660905|Sofosbuvir|sofosbuvir|mesh-list
5812218|NCT02660905|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
5812219|NCT02660905|Rilpivirine|rilpivirine|mesh-list
5812220|NCT02660905|Ledipasvir|ledipasvir|mesh-list
5812221|NCT02660905|Antiviral Agents|antiviral agents|mesh-ancestor
5812222|NCT02660905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5812223|NCT02660905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5812224|NCT02660905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5812225|NCT02660905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5812226|NCT02660905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5812227|NCT02660905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5812228|NCT02660905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5812229|NCT02660736|rGLP-1 protein|rglp-1 protein|mesh-list
5812230|NCT02660736|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5812231|NCT02660736|Incretins|incretins|mesh-ancestor
5812232|NCT02660736|Hormones|hormones|mesh-ancestor
5812233|NCT02660736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5812234|NCT02660736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812235|NCT02660866|Vorapaxar|vorapaxar|mesh-list
5812236|NCT02660866|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5812237|NCT02660762|Cytarabine|cytarabine|mesh-list
5812238|NCT02660762|Dexamethasone|dexamethasone|mesh-list
5812239|NCT02660762|Dexamethasone acetate|dexamethasone acetate|mesh-list
5812240|NCT02660762|Prednisone|prednisone|mesh-list
5812241|NCT02660762|Cyclophosphamide|cyclophosphamide|mesh-list
5812242|NCT02660762|Methotrexate|methotrexate|mesh-list
5812243|NCT02660762|Etoposide|etoposide|mesh-list
5812244|NCT02660762|Vincristine|vincristine|mesh-list
5812245|NCT02660762|Daunorubicin|daunorubicin|mesh-list
5812246|NCT02660762|Mercaptopurine|mercaptopurine|mesh-list
5812247|NCT02660762|Pegaspargase|pegaspargase|mesh-list
5812248|NCT02660762|Thioguanine|thioguanine|mesh-list
5812249|NCT02660762|BB 1101|bb 1101|mesh-list
5812250|NCT02660762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5812251|NCT02660762|Immunologic Factors|immunologic factors|mesh-ancestor
5812252|NCT02660762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812253|NCT02660762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5812254|NCT02660762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5812255|NCT02660762|Alkylating Agents|alkylating agents|mesh-ancestor
5812256|NCT02660762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5812257|NCT02660762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5812258|NCT02660762|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5812259|NCT02660762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5812260|NCT02660762|Antiemetics|antiemetics|mesh-ancestor
5812261|NCT02660762|Autonomic Agents|autonomic agents|mesh-ancestor
5812262|NCT02660762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5812263|NCT02660762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5812264|NCT02660762|Glucocorticoids|glucocorticoids|mesh-ancestor
5812265|NCT02660762|Hormones|hormones|mesh-ancestor
5812266|NCT02660762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5812267|NCT02660762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5812268|NCT02660762|Protease Inhibitors|protease inhibitors|mesh-ancestor
5812269|NCT02660762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5812270|NCT02660762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5812271|NCT02660762|Abortifacient Agents|abortifacient agents|mesh-ancestor
5812272|NCT02660762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5812273|NCT02660762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5812274|NCT02660762|Antimetabolites|antimetabolites|mesh-ancestor
5812275|NCT02660762|Dermatologic Agents|dermatologic agents|mesh-ancestor
5812276|NCT02660762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5812277|NCT02660762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5812278|NCT02660762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5812279|NCT02660762|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5812280|NCT02660762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5812281|NCT02660762|Antiviral Agents|antiviral agents|mesh-ancestor
5812282|NCT02660762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5812283|NCT02660762|Tubulin Modulators|tubulin modulators|mesh-ancestor
5812284|NCT02660762|Antimitotic Agents|antimitotic agents|mesh-ancestor
5812285|NCT02660762|Mitosis Modulators|mitosis modulators|mesh-ancestor
5812286|NCT02660762|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5812287|NCT02660684|Cyclosporine|cyclosporine|mesh-list
5812288|NCT02660684|Methotrexate|methotrexate|mesh-list
5812289|NCT02660684|Tacrolimus|tacrolimus|mesh-list
5812290|NCT02660684|Cyclosporins|cyclosporins|mesh-list
5812291|NCT02660684|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5812292|NCT02660684|Abortifacient Agents|abortifacient agents|mesh-ancestor
5812293|NCT02660684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5812294|NCT02660684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812295|NCT02660684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5812296|NCT02660684|Antimetabolites|antimetabolites|mesh-ancestor
5812297|NCT02660684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5812298|NCT02660684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5812299|NCT02660684|Dermatologic Agents|dermatologic agents|mesh-ancestor
5812300|NCT02660684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5812301|NCT02660684|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5812302|NCT02660684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5812303|NCT02660684|Immunologic Factors|immunologic factors|mesh-ancestor
5812304|NCT02660684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5812305|NCT02660684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5812306|NCT02660684|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5812307|NCT02660684|Antifungal Agents|antifungal agents|mesh-ancestor
5812308|NCT02660684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5812309|NCT02660658|Dexmedetomidine|dexmedetomidine|mesh-list
5812310|NCT02660658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5812311|NCT02660658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5812312|NCT02660658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812313|NCT02660658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5812314|NCT02660658|Analgesics|analgesics|mesh-ancestor
5812315|NCT02660658|Sensory System Agents|sensory system agents|mesh-ancestor
5812316|NCT02660658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5812317|NCT02660658|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5812318|NCT02660658|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5812319|NCT02660658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5812320|NCT02660658|Adrenergic Agents|adrenergic agents|mesh-ancestor
5812321|NCT02660658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5812322|NCT02660658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5812323|NCT02660502|Insulin|insulin|mesh-list
5812324|NCT02660502|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5812325|NCT02660502|Insulin Lispro|insulin lispro|mesh-list
5812326|NCT02660502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5812327|NCT02660502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812328|NCT02660606|Analgesics, Opioid|analgesics, opioid|mesh-list
5812329|NCT02660606|Narcotics|narcotics|mesh-ancestor
5812330|NCT02660606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5812331|NCT02660606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812332|NCT02660606|Analgesics|analgesics|mesh-ancestor
5812333|NCT02660606|Sensory System Agents|sensory system agents|mesh-ancestor
5812334|NCT02660606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5812335|NCT02660346|Vancomycin|vancomycin|mesh-list
5812336|NCT02660346|Daptomycin|daptomycin|mesh-list
5812337|NCT02660346|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
5812338|NCT02660346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5812339|NCT02660346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5812340|NCT02660255|Cannabidiol|cannabidiol|mesh-list
5812341|NCT02660255|Anticonvulsants|anticonvulsants|mesh-ancestor
5812342|NCT02660177|Dipyrone|dipyrone|mesh-list
5812343|NCT02660177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5812344|NCT02660177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5812345|NCT02660177|Analgesics|analgesics|mesh-ancestor
5812346|NCT02660177|Sensory System Agents|sensory system agents|mesh-ancestor
5812347|NCT02660177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5812348|NCT02660177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812349|NCT02660177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5812350|NCT02660177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5812351|NCT02660177|Antipyretics|antipyretics|mesh-ancestor
5812352|NCT02660008|Glucagon|glucagon|mesh-list
5812353|NCT02660008|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5812354|NCT02660008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5812355|NCT02660008|Hormones|hormones|mesh-ancestor
5812356|NCT02660008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5812357|NCT02660008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812358|NCT02660008|Incretins|incretins|mesh-ancestor
5812359|NCT02660060|Pramipexole|pramipexole|mesh-list
5812360|NCT02660060|Antioxidants|antioxidants|mesh-ancestor
5812361|NCT02660060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5812362|NCT02660060|Protective Agents|protective agents|mesh-ancestor
5812363|NCT02660060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812364|NCT02660060|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5812365|NCT02660060|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5812366|NCT02660060|Dopamine Agonists|dopamine agonists|mesh-ancestor
5812367|NCT02660060|Dopamine Agents|dopamine agents|mesh-ancestor
5812368|NCT02660060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5812369|NCT02660047|Liraglutide|liraglutide|mesh-list
5812370|NCT02660047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5812371|NCT02660047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812372|NCT02660047|Incretins|incretins|mesh-ancestor
5812373|NCT02660047|Hormones|hormones|mesh-ancestor
5812374|NCT02660047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5812375|NCT02659683|Esomeprazole|esomeprazole|mesh-list
5812376|NCT02659683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5812377|NCT02659683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5812378|NCT02659683|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5812379|NCT02659683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5812380|NCT02659683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5812381|NCT02659761|Lamivudine|lamivudine|mesh-list
5812382|NCT02659761|Abacavir|abacavir|mesh-list
5812383|NCT02659761|Dolutegravir|dolutegravir|mesh-list
5812384|NCT02659761|Triumeq|triumeq|mesh-list
5812385|NCT02659761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5900968|NCT04095858|Abortifacient Agents|abortifacient agents|mesh-ancestor
6496505|NCT00628290|Amisulpride|amisulpride|mesh-list
5812386|NCT02659761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5812387|NCT02659761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5812388|NCT02659761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5812389|NCT02659761|Antiviral Agents|antiviral agents|mesh-ancestor
5812390|NCT02659761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5812391|NCT02659761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5812392|NCT02659761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5812393|NCT02659761|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5812394|NCT02659761|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5812395|NCT02659917|Methamphetamine|methamphetamine|mesh-list
5812396|NCT02659917|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5812397|NCT02659917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812398|NCT02659917|Sympathomimetics|sympathomimetics|mesh-ancestor
5812399|NCT02659917|Autonomic Agents|autonomic agents|mesh-ancestor
5812400|NCT02659917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5812401|NCT02659917|Dopamine Agents|dopamine agents|mesh-ancestor
5812402|NCT02659917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5812403|NCT02659917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5812404|NCT02659917|Adrenergic Agents|adrenergic agents|mesh-ancestor
5812405|NCT02659917|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5812406|NCT02659917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5812407|NCT02659917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5812408|NCT02659917|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5812409|NCT02659657|Interleukin-2|interleukin-2|mesh-list
6211312|NCT02169895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211313|NCT02169895|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6211314|NCT02169895|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6211315|NCT02169895|Dopamine Agents|dopamine agents|mesh-ancestor
5812410|NCT02659657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5812411|NCT02659657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5812412|NCT02659657|Analgesics|analgesics|mesh-ancestor
5812413|NCT02659657|Sensory System Agents|sensory system agents|mesh-ancestor
5812414|NCT02659657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5812415|NCT02659657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812416|NCT02659891|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5812417|NCT02659891|Immunologic Factors|immunologic factors|mesh-ancestor
5812418|NCT02659891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812419|NCT02659488|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
5812420|NCT02659488|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5812421|NCT02659488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812422|NCT02659488|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5812423|NCT02659488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5812424|NCT02659488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5812425|NCT02659488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5812426|NCT02659488|Dopamine Agents|dopamine agents|mesh-ancestor
5812427|NCT02659488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5812428|NCT02659384|Aspirin|aspirin|mesh-list
5812429|NCT02659384|Bevacizumab|bevacizumab|mesh-list
5812430|NCT02659384|Atezolizumab|atezolizumab|mesh-list
5812431|NCT02659384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5812432|NCT02659384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5812433|NCT02659384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5812434|NCT02659384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5812435|NCT02659384|Growth Substances|growth substances|mesh-ancestor
5812436|NCT02659384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812437|NCT02659384|Growth Inhibitors|growth inhibitors|mesh-ancestor
5812438|NCT02659384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5812439|NCT02659384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5812440|NCT02659384|Analgesics|analgesics|mesh-ancestor
5812441|NCT02659384|Sensory System Agents|sensory system agents|mesh-ancestor
5812442|NCT02659384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5812443|NCT02659384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5812444|NCT02659384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5812445|NCT02659384|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5812446|NCT02659384|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5812447|NCT02659384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211316|NCT02169895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6211317|NCT02169895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812448|NCT02659384|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5812449|NCT02659384|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5812450|NCT02659384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5812451|NCT02659384|Antipyretics|antipyretics|mesh-ancestor
5812452|NCT02659306|Metformin|metformin|mesh-list
5812453|NCT02659306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5812454|NCT02659306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812455|NCT02659254|Sirolimus|sirolimus|mesh-list
5812456|NCT02659254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5812457|NCT02659254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5812458|NCT02659254|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5812459|NCT02659254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5812460|NCT02659254|Antifungal Agents|antifungal agents|mesh-ancestor
5812461|NCT02659254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5812462|NCT02659254|Immunologic Factors|immunologic factors|mesh-ancestor
5812463|NCT02659254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812464|NCT02659228|Anesthetics|anesthetics|mesh-list
5812465|NCT02659228|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
5812466|NCT02659228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5812467|NCT02659228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812468|NCT02659228|Anesthetics, General|anesthetics, general|mesh-ancestor
5812469|NCT02659527|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5812470|NCT02659527|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5812471|NCT02659527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5812472|NCT02659293|Dexamethasone|dexamethasone|mesh-list
5812473|NCT02659293|Lenalidomide|lenalidomide|mesh-list
5812474|NCT02659293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5812475|NCT02659293|Antiemetics|antiemetics|mesh-ancestor
5812476|NCT02659293|Autonomic Agents|autonomic agents|mesh-ancestor
5812477|NCT02659293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5812478|NCT02659293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812479|NCT02659293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5812480|NCT02659293|Glucocorticoids|glucocorticoids|mesh-ancestor
5812481|NCT02659293|Hormones|hormones|mesh-ancestor
5812482|NCT02659293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5812483|NCT02659293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5812484|NCT02659293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5812485|NCT02659293|Immunologic Factors|immunologic factors|mesh-ancestor
5812486|NCT02659293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5812487|NCT02659293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5812488|NCT02659293|Growth Substances|growth substances|mesh-ancestor
5812489|NCT02659293|Growth Inhibitors|growth inhibitors|mesh-ancestor
5900969|NCT04095858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5900970|NCT04095858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900971|NCT04095858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5900972|NCT04095858|Antimetabolites|antimetabolites|mesh-ancestor
5900973|NCT04095858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900974|NCT04095858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5900975|NCT04095858|Dermatologic Agents|dermatologic agents|mesh-ancestor
5900976|NCT04095858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5900977|NCT04095858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5900978|NCT04095858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5900979|NCT04095858|Immunologic Factors|immunologic factors|mesh-ancestor
5900980|NCT04095858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5900981|NCT04095858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5900982|NCT04095858|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5900983|NCT04061330|Morphine|morphine|mesh-list
5812490|NCT02659085|Ketamine|ketamine|mesh-list
5812491|NCT02659085|Analgesics|analgesics|mesh-ancestor
5812492|NCT02659085|Sensory System Agents|sensory system agents|mesh-ancestor
5812493|NCT02659085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5812494|NCT02659085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812495|NCT02659085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5812496|NCT02659085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5812497|NCT02659085|Anesthetics, General|anesthetics, general|mesh-ancestor
5812498|NCT02659085|Anesthetics|anesthetics|mesh-ancestor
5812499|NCT02659085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5812500|NCT02659085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5812501|NCT02659085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5812502|NCT02659085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5812503|NCT02659085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5812504|NCT02659033|Ceftriaxone|ceftriaxone|mesh-list
5812505|NCT02659033|Cefotaxime|cefotaxime|mesh-list
5812506|NCT02659033|Cefoxitin|cefoxitin|mesh-list
5812507|NCT02659033|Cephalosporins|cephalosporins|mesh-list
5812508|NCT02659033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5812509|NCT02659033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5812510|NCT02658864|Lafutidine|lafutidine|mesh-list
5812511|NCT02658864|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5812512|NCT02658864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5812513|NCT02658864|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5812514|NCT02658864|Histamine Antagonists|histamine antagonists|mesh-ancestor
5812515|NCT02658864|Histamine Agents|histamine agents|mesh-ancestor
5812516|NCT02658864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5812517|NCT02658864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5900984|NCT04061330|Ketamine|ketamine|mesh-list
5812518|NCT02658864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812519|NCT02658825|Moxifloxacin|moxifloxacin|mesh-list
5812520|NCT02658825|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6211318|NCT02170025|Riociguat|riociguat|mesh-list
6211319|NCT02170025|Enzyme Activators|enzyme activators|mesh-ancestor
5641892|NCT01180374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5641893|NCT01180374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5641894|NCT01180374|Analgesics|analgesics|mesh-ancestor
5641895|NCT01180374|Sensory System Agents|sensory system agents|mesh-ancestor
5641896|NCT01180374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5641897|NCT01180374|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5641898|NCT01180374|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5641899|NCT01180374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5641900|NCT01180374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641901|NCT01180374|Hormones|hormones|mesh-ancestor
5641902|NCT01180374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5641903|NCT01101438|Metformin|metformin|mesh-list
5641904|NCT01101438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5641905|NCT01101438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641906|NCT00700596|Salvinorin A|salvinorin a|mesh-list
5641907|NCT00700596|Hallucinogens|hallucinogens|mesh-ancestor
5641908|NCT00700596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641909|NCT00700596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5641910|NCT00687882|Anticoagulants|anticoagulants|mesh-list
5641911|NCT00565851|Gemcitabine|gemcitabine|mesh-list
5641912|NCT00565851|Paclitaxel|paclitaxel|mesh-list
5641913|NCT00565851|Docetaxel|docetaxel|mesh-list
5641914|NCT00565851|Bevacizumab|bevacizumab|mesh-list
5812521|NCT02658825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5812522|NCT02658825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5812523|NCT02658825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5812524|NCT02658825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5812525|NCT02658825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5812526|NCT02658825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5812527|NCT02658825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5812528|NCT02658825|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5812529|NCT02658825|Contraceptive Agents|contraceptive agents|mesh-ancestor
5812530|NCT02658825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5812531|NCT02658825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812532|NCT02658825|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5812533|NCT02658825|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5812534|NCT02658825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5812535|NCT02658838|Heparin|heparin|mesh-list
5812536|NCT02658838|Calcium heparin|calcium heparin|mesh-list
5812537|NCT02658838|Enoxaparin|enoxaparin|mesh-list
5812538|NCT02658838|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5812539|NCT02658838|Tinzaparin|tinzaparin|mesh-list
5812540|NCT02658838|Dalteparin|dalteparin|mesh-list
5812541|NCT02658838|Enoxaparin sodium|enoxaparin sodium|mesh-list
5812542|NCT02658838|Ticagrelor|ticagrelor|mesh-list
5812543|NCT02658838|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
5812544|NCT02658838|Anticoagulants|anticoagulants|mesh-ancestor
5812545|NCT02658838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5812546|NCT02658838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5812547|NCT02658838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5812548|NCT02658838|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5812549|NCT02658838|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5812550|NCT02658838|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5812551|NCT02658838|Purinergic Agents|purinergic agents|mesh-ancestor
5812552|NCT02658838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5812553|NCT02658838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812554|NCT02658799|Diclofenac|diclofenac|mesh-list
5812555|NCT02658799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5812556|NCT02658799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5812557|NCT02658799|Analgesics|analgesics|mesh-ancestor
5812558|NCT02658799|Sensory System Agents|sensory system agents|mesh-ancestor
5812559|NCT02658799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5812560|NCT02658799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812561|NCT02658799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5812562|NCT02658799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5812563|NCT02658799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5812564|NCT02658799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5812565|NCT02658799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5812566|NCT02658773|Lidocaine|lidocaine|mesh-list
5812567|NCT02658773|Prilocaine|prilocaine|mesh-list
5641915|NCT00565851|Carboplatin|carboplatin|mesh-list
5641916|NCT00565851|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5641917|NCT00565851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5641918|NCT00565851|Endothelial Growth Factors|endothelial growth factors|mesh-list
5641919|NCT00565851|Antibodies|antibodies|mesh-list
5641920|NCT00565851|Immunoglobulins|immunoglobulins|mesh-list
5641921|NCT00565851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5641922|NCT00565851|Immunoglobulin G|immunoglobulin g|mesh-list
5812568|NCT02658773|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
5812569|NCT02658773|Anesthetics, Local|anesthetics, local|mesh-ancestor
5812570|NCT02658773|Anesthetics|anesthetics|mesh-ancestor
5812571|NCT02658773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5812572|NCT02658773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812573|NCT02658773|Sensory System Agents|sensory system agents|mesh-ancestor
5812574|NCT02658773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5812575|NCT02658773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5812576|NCT02658773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5812577|NCT02658773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5812578|NCT02658773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5812579|NCT02658773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5812580|NCT02658773|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
5812581|NCT02658760|Dexmedetomidine|dexmedetomidine|mesh-list
5812582|NCT02658760|Bupivacaine|bupivacaine|mesh-list
5812583|NCT02658760|Anesthetics, Local|anesthetics, local|mesh-ancestor
5812584|NCT02658760|Anesthetics|anesthetics|mesh-ancestor
5812585|NCT02658760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5812586|NCT02658760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812587|NCT02658760|Sensory System Agents|sensory system agents|mesh-ancestor
5812588|NCT02658760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5812589|NCT02658760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5812590|NCT02658760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5812591|NCT02658760|Analgesics|analgesics|mesh-ancestor
5812592|NCT02658760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5812593|NCT02658760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5812594|NCT02658760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5812595|NCT02658760|Adrenergic Agents|adrenergic agents|mesh-ancestor
5812596|NCT02658760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5812597|NCT02658760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5812598|NCT02658721|Diclofenac|diclofenac|mesh-list
5812599|NCT02658721|Lidocaine|lidocaine|mesh-list
5812600|NCT02658721|Atropine|atropine|mesh-list
5812601|NCT02658721|Ephedrine|ephedrine|mesh-list
5812602|NCT02658721|Fentanyl|fentanyl|mesh-list
5812603|NCT02658721|Midazolam|midazolam|mesh-list
5812604|NCT02658721|Tramadol|tramadol|mesh-list
5812605|NCT02658721|Ondansetron|ondansetron|mesh-list
5812606|NCT02658721|Anesthetics, Local|anesthetics, local|mesh-ancestor
5812607|NCT02658721|Anesthetics|anesthetics|mesh-ancestor
5812608|NCT02658721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5812609|NCT02658721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812610|NCT02658721|Sensory System Agents|sensory system agents|mesh-ancestor
5812611|NCT02658721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5812612|NCT02658721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5812613|NCT02658721|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5812614|NCT02658721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5812615|NCT02658721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5812616|NCT02658721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5812617|NCT02658721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5812618|NCT02658721|Narcotics|narcotics|mesh-ancestor
5812619|NCT02658721|Analgesics|analgesics|mesh-ancestor
5812620|NCT02658721|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5812621|NCT02658721|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5812622|NCT02658721|Anesthetics, General|anesthetics, general|mesh-ancestor
5812623|NCT02658721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5812624|NCT02658721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5812625|NCT02658721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5812626|NCT02658721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5812627|NCT02658721|GABA Modulators|gaba modulators|mesh-ancestor
5812628|NCT02658721|GABA Agents|gaba agents|mesh-ancestor
5812629|NCT02658721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5812630|NCT02658721|Antiemetics|antiemetics|mesh-ancestor
5812631|NCT02658721|Autonomic Agents|autonomic agents|mesh-ancestor
5812632|NCT02658721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5812633|NCT02658721|Antipruritics|antipruritics|mesh-ancestor
5812634|NCT02658721|Dermatologic Agents|dermatologic agents|mesh-ancestor
5812635|NCT02658721|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5812636|NCT02658721|Serotonin Agents|serotonin agents|mesh-ancestor
5812637|NCT02658721|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5812638|NCT02658721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5812639|NCT02658721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5812640|NCT02658721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5812641|NCT02658721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5812642|NCT02658721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5812643|NCT02658721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5812644|NCT02658721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5812645|NCT02658721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5812646|NCT02658721|Respiratory System Agents|respiratory system agents|mesh-ancestor
5812647|NCT02658721|Mydriatics|mydriatics|mesh-ancestor
5812648|NCT02658721|Parasympatholytics|parasympatholytics|mesh-ancestor
5812649|NCT02658721|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5812650|NCT02658721|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5812651|NCT02658721|Cholinergic Agents|cholinergic agents|mesh-ancestor
5812652|NCT02658721|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5812653|NCT02658721|Sympathomimetics|sympathomimetics|mesh-ancestor
5812654|NCT02658721|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5812655|NCT02658721|Adrenergic Agents|adrenergic agents|mesh-ancestor
5812656|NCT02658422|Montelukast|montelukast|mesh-list
6211320|NCT02170025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211321|NCT02170064|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
6211322|NCT02170064|Anticonvulsants|anticonvulsants|mesh-ancestor
6211323|NCT02170064|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6211324|NCT02170064|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5812657|NCT02658422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5812658|NCT02658422|Respiratory System Agents|respiratory system agents|mesh-ancestor
5812659|NCT02658422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5812660|NCT02658422|Hormone Antagonists|hormone antagonists|mesh-ancestor
5812661|NCT02658422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5812662|NCT02658422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812663|NCT02658422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5812664|NCT02658422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5812665|NCT02658422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5812666|NCT02658526|Anesthetics|anesthetics|mesh-list
5812667|NCT02658526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5812668|NCT02658526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812669|NCT02658435|Tafenoquine|tafenoquine|mesh-list
5812670|NCT02658435|Antimalarials|antimalarials|mesh-ancestor
5812671|NCT02658435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5812672|NCT02658435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5812673|NCT02658435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5812674|NCT02658409|Vaccines|vaccines|mesh-list
5812675|NCT02658409|Immunologic Factors|immunologic factors|mesh-ancestor
5812676|NCT02658409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812677|NCT02658188|Gabapentin|gabapentin|mesh-list
5812678|NCT02658188|Analgesics|analgesics|mesh-ancestor
5812679|NCT02658188|Sensory System Agents|sensory system agents|mesh-ancestor
5812680|NCT02658188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5812681|NCT02658188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812682|NCT02658188|Anticonvulsants|anticonvulsants|mesh-ancestor
5812683|NCT02658188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5812684|NCT02658188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5812685|NCT02658188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5812686|NCT02658188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5812687|NCT02658188|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5812688|NCT02658188|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5812689|NCT02658188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5812690|NCT02658188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5812691|NCT02658188|Antimanic Agents|antimanic agents|mesh-ancestor
5812692|NCT02658396|Bortezomib|bortezomib|mesh-list
5812693|NCT02658396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5812694|NCT02658279|Pembrolizumab|pembrolizumab|mesh-list
5812695|NCT02658279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5812696|NCT02658279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5812697|NCT02658214|Leucovorin|leucovorin|mesh-list
5641923|NCT00565851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5641924|NCT00565851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5641925|NCT00565851|Tubulin Modulators|tubulin modulators|mesh-ancestor
5641926|NCT00565851|Antimitotic Agents|antimitotic agents|mesh-ancestor
5641927|NCT00565851|Mitosis Modulators|mitosis modulators|mesh-ancestor
5641928|NCT00565851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641929|NCT00565851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5641930|NCT00565851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5641931|NCT00565851|Growth Substances|growth substances|mesh-ancestor
5812698|NCT02658214|Folic Acid|folic acid|mesh-list
5812699|NCT02658214|Gemcitabine|gemcitabine|mesh-list
5812700|NCT02658214|Paclitaxel|paclitaxel|mesh-list
5812701|NCT02658214|Etoposide|etoposide|mesh-list
5812702|NCT02658214|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5812703|NCT02658214|Carboplatin|carboplatin|mesh-list
5812704|NCT02658214|Fluorouracil|fluorouracil|mesh-list
5812705|NCT02658214|Oxaliplatin|oxaliplatin|mesh-list
5812706|NCT02658214|Durvalumab|durvalumab|mesh-list
5812707|NCT02658214|Tremelimumab|tremelimumab|mesh-list
5812708|NCT02658214|Levoleucovorin|levoleucovorin|mesh-list
5812709|NCT02658214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5812710|NCT02658214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5812711|NCT02658214|Tubulin Modulators|tubulin modulators|mesh-ancestor
5812712|NCT02658214|Antimitotic Agents|antimitotic agents|mesh-ancestor
5812713|NCT02658214|Mitosis Modulators|mitosis modulators|mesh-ancestor
5812714|NCT02658214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5812715|NCT02658214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5812716|NCT02658214|Antimetabolites|antimetabolites|mesh-ancestor
5812717|NCT02658214|Antiviral Agents|antiviral agents|mesh-ancestor
5812718|NCT02658214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5812719|NCT02658214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5812720|NCT02658214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5812721|NCT02658214|Immunologic Factors|immunologic factors|mesh-ancestor
5812722|NCT02658214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812723|NCT02658214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5812724|NCT02658214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5812725|NCT02658214|Antidotes|antidotes|mesh-ancestor
5812726|NCT02658214|Protective Agents|protective agents|mesh-ancestor
5812727|NCT02658214|Vitamin B Complex|vitamin b complex|mesh-ancestor
5812728|NCT02658214|Vitamins|vitamins|mesh-ancestor
5812729|NCT02658214|Micronutrients|micronutrients|mesh-ancestor
5812730|NCT02658214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5812731|NCT02658214|Hematinics|hematinics|mesh-ancestor
5812732|NCT02658253|Aluminum Hydroxide|aluminum hydroxide|mesh-list
5812733|NCT02658253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5812734|NCT02658253|Immunologic Factors|immunologic factors|mesh-ancestor
5812735|NCT02658253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812736|NCT02658253|Antacids|antacids|mesh-ancestor
5812737|NCT02658253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5812738|NCT02658253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5812739|NCT02658097|Pembrolizumab|pembrolizumab|mesh-list
5812740|NCT02658097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5812741|NCT02658097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5812742|NCT02658292|Naftifine|naftifine|mesh-list
5812743|NCT02658292|Antifungal Agents|antifungal agents|mesh-ancestor
5812744|NCT02658292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5812745|NCT02657603|Lidocaine|lidocaine|mesh-list
5812746|NCT02657603|Anesthetics, Local|anesthetics, local|mesh-ancestor
5812747|NCT02657603|Anesthetics|anesthetics|mesh-ancestor
5812748|NCT02657603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5812749|NCT02657603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812750|NCT02657603|Sensory System Agents|sensory system agents|mesh-ancestor
5812751|NCT02657603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5812752|NCT02657603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5812753|NCT02657603|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5812754|NCT02657603|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5812755|NCT02657603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5812756|NCT02657603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5812757|NCT02657616|Vitamin K|vitamin k|mesh-list
5812758|NCT02657616|Anticoagulants|anticoagulants|mesh-list
5812759|NCT02657616|Vitamins|vitamins|mesh-ancestor
5812760|NCT02657616|Micronutrients|micronutrients|mesh-ancestor
6211325|NCT02170064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5812761|NCT02657616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812762|NCT02657616|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5812763|NCT02657616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5812764|NCT02657616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5812765|NCT02657616|Hemostatics|hemostatics|mesh-ancestor
5812766|NCT02657616|Coagulants|coagulants|mesh-ancestor
5812767|NCT02657694|Sofosbuvir|sofosbuvir|mesh-list
5812768|NCT02657694|Ledipasvir|ledipasvir|mesh-list
5812769|NCT02657694|Velpatasvir|velpatasvir|mesh-list
5812770|NCT02657694|Antiviral Agents|antiviral agents|mesh-ancestor
6492382|NCT00608374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6492383|NCT00608374|Antimetabolites|antimetabolites|mesh-ancestor
6492384|NCT00608374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492385|NCT00608374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6492386|NCT00608374|Immunologic Factors|immunologic factors|mesh-ancestor
6492387|NCT00608374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492388|NCT00608374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5812771|NCT02657694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5812772|NCT02657460|Cisplatin|cisplatin|mesh-list
5812773|NCT02657460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5812774|NCT02657447|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
5812775|NCT02657447|Chelating Agents|chelating agents|mesh-ancestor
5812776|NCT02657447|Sequestering Agents|sequestering agents|mesh-ancestor
5812777|NCT02657447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5812778|NCT02657512|Rivaroxaban|rivaroxaban|mesh-list
5812779|NCT02657512|Charcoal|charcoal|mesh-list
5812780|NCT02657512|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5812781|NCT02657512|Antithrombins|antithrombins|mesh-ancestor
5812782|NCT02657512|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5812783|NCT02657512|Protease Inhibitors|protease inhibitors|mesh-ancestor
5812784|NCT02657512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5812785|NCT02657512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5812786|NCT02657512|Anticoagulants|anticoagulants|mesh-ancestor
5812787|NCT02657512|Antidotes|antidotes|mesh-ancestor
5812788|NCT02657512|Protective Agents|protective agents|mesh-ancestor
5812789|NCT02657512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812790|NCT02657486|Infigratinib|infigratinib|mesh-list
5812791|NCT02657486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5812792|NCT02657343|Trastuzumab|trastuzumab|mesh-list
5812793|NCT02657343|Fulvestrant|fulvestrant|mesh-list
5812794|NCT02657343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5812795|NCT02657343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5812796|NCT02657343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5812797|NCT02657343|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5812798|NCT02657343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5812799|NCT02657343|Hormone Antagonists|hormone antagonists|mesh-ancestor
5812800|NCT02657343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5812801|NCT02657343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812802|NCT02657291|Ropivacaine|ropivacaine|mesh-list
5812803|NCT02657291|Anesthetics, Local|anesthetics, local|mesh-ancestor
5641932|NCT00565851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641933|NCT00565851|Growth Inhibitors|growth inhibitors|mesh-ancestor
5641934|NCT00565851|Immunologic Factors|immunologic factors|mesh-ancestor
5641935|NCT00565851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5641936|NCT00565851|Antimetabolites|antimetabolites|mesh-ancestor
5641937|NCT00565851|Antiviral Agents|antiviral agents|mesh-ancestor
5641938|NCT00565851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5641939|NCT00565851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5641940|NCT00565851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5641941|NCT00357565|Cyclosporine|cyclosporine|mesh-list
5812804|NCT02657291|Anesthetics|anesthetics|mesh-ancestor
5812805|NCT02657291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5812806|NCT02657291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812807|NCT02657291|Sensory System Agents|sensory system agents|mesh-ancestor
5812808|NCT02657291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5900985|NCT04061330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5900986|NCT04061330|Narcotics|narcotics|mesh-ancestor
5900987|NCT04061330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5900988|NCT04061330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5900989|NCT04061330|Analgesics|analgesics|mesh-ancestor
5900990|NCT04061330|Sensory System Agents|sensory system agents|mesh-ancestor
5900991|NCT04061330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5900992|NCT04061330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5900993|NCT04061330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5900994|NCT04061330|Anesthetics, General|anesthetics, general|mesh-ancestor
5900995|NCT04061330|Anesthetics|anesthetics|mesh-ancestor
5900996|NCT04061330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5900997|NCT04061330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5900998|NCT04061330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5900999|NCT04061330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901000|NCT04060394|Prednisone|prednisone|mesh-list
5901001|NCT04060394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5901002|NCT04060394|Glucocorticoids|glucocorticoids|mesh-ancestor
5901003|NCT04060394|Hormones|hormones|mesh-ancestor
5901004|NCT04060394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5901005|NCT04060394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901006|NCT04060394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5901007|NCT04060394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901008|NCT04051944|Rozanolixizumab|rozanolixizumab|mesh-list
5901009|NCT04051944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5901010|NCT04051944|Immunologic Factors|immunologic factors|mesh-ancestor
5901011|NCT04051944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901012|NCT04040621|Ceftazidime|ceftazidime|mesh-list
5901013|NCT04040621|Avibactam|avibactam|mesh-list
5901014|NCT04040621|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
5901015|NCT04040621|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5901016|NCT04040621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5812809|NCT02657473|Tobramycin|tobramycin|mesh-list
5812810|NCT02657473|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5812811|NCT02657473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5812812|NCT02657473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5812813|NCT02657187|Rocuronium|rocuronium|mesh-list
5812814|NCT02657187|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5812815|NCT02657187|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5812816|NCT02657187|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5812817|NCT02657187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5812818|NCT02657187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812819|NCT02657213|Insulin|insulin|mesh-list
5812820|NCT02657213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5812821|NCT02657213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5812822|NCT02657213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812823|NCT02657161|Vaccines|vaccines|mesh-list
5812824|NCT02657161|Immunologic Factors|immunologic factors|mesh-ancestor
5812825|NCT02657161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812826|NCT02657148|Contraceptive Agents|contraceptive agents|mesh-list
5812827|NCT02657148|Etonogestrel|etonogestrel|mesh-list
5812828|NCT02657148|Desogestrel|desogestrel|mesh-list
5812829|NCT02657148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5812830|NCT02657148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812831|NCT02657148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5812832|NCT02657148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5812833|NCT02657148|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5812834|NCT02657148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5812835|NCT02657148|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5812836|NCT02657148|Progestins|progestins|mesh-ancestor
5812837|NCT02657148|Hormones|hormones|mesh-ancestor
5812838|NCT02657148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5812839|NCT02657096|Hybenx|hybenx|mesh-list
5812840|NCT02657096|Dental Disinfectants|dental disinfectants|mesh-ancestor
5812841|NCT02657096|Disinfectants|disinfectants|mesh-ancestor
5812842|NCT02657096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5812843|NCT02656901|Anesthetics|anesthetics|mesh-list
5812844|NCT02656901|Sevoflurane|sevoflurane|mesh-list
5812845|NCT02656901|Desflurane|desflurane|mesh-list
5812846|NCT02656901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5812847|NCT02656901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812848|NCT02656901|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5812849|NCT02656901|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5812850|NCT02656901|Anesthetics, General|anesthetics, general|mesh-ancestor
5812851|NCT02656979|Latanoprost|latanoprost|mesh-list
5812852|NCT02656979|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5812853|NCT02656979|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5812854|NCT02656810|Teriparatide|teriparatide|mesh-list
5812855|NCT02656810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5812856|NCT02656810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812857|NCT02656810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5812858|NCT02656771|Metronidazole|metronidazole|mesh-list
5812859|NCT02656771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5812860|NCT02656771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5812861|NCT02656771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5812862|NCT02656771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5812863|NCT02656563|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
5812864|NCT02656563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5812865|NCT02656797|Amphotericin B|amphotericin b|mesh-list
5812866|NCT02656797|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
5812867|NCT02656797|Amebicides|amebicides|mesh-ancestor
5812868|NCT02656797|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5812869|NCT02656797|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5812870|NCT02656797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5812871|NCT02656797|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5812872|NCT02656797|Antifungal Agents|antifungal agents|mesh-ancestor
5812873|NCT02656511|Tenofovir|tenofovir|mesh-list
5812874|NCT02656511|Emtricitabine|emtricitabine|mesh-list
5812875|NCT02656511|Dolutegravir|dolutegravir|mesh-list
5812876|NCT02656511|Antiviral Agents|antiviral agents|mesh-ancestor
5812877|NCT02656511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5812878|NCT02656511|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5812879|NCT02656511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5812880|NCT02656511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6492389|NCT00608374|Alkylating Agents|alkylating agents|mesh-ancestor
6492390|NCT00608595|Celecoxib|celecoxib|mesh-list
6492391|NCT00608595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6492392|NCT00608595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6492393|NCT00608595|Analgesics|analgesics|mesh-ancestor
6492394|NCT00608595|Sensory System Agents|sensory system agents|mesh-ancestor
6492395|NCT00608595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6492396|NCT00608595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492397|NCT00608595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6492398|NCT00608595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6492399|NCT00608595|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6492400|NCT00608595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6492401|NCT00608595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5812881|NCT02656511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5812882|NCT02656511|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5812883|NCT02656511|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5812884|NCT02656511|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5812885|NCT02656511|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5812886|NCT02656550|Thymoglobulin|thymoglobulin|mesh-list
5812887|NCT02656550|Immunologic Factors|immunologic factors|mesh-ancestor
5812888|NCT02656550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812889|NCT02656550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5812890|NCT02656706|Nivolumab|nivolumab|mesh-list
5812891|NCT02656706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5812892|NCT02656706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5812893|NCT02656706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6492402|NCT00608595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492403|NCT00608673|Betamethasone|betamethasone|mesh-list
6492404|NCT00608673|Betamethasone Valerate|betamethasone valerate|mesh-list
6492405|NCT00608673|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
6492406|NCT00608673|Betamethasone benzoate|betamethasone benzoate|mesh-list
6492407|NCT00608673|Pimecrolimus|pimecrolimus|mesh-list
6492408|NCT00608673|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
6492409|NCT00608673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6492410|NCT00608673|Glucocorticoids|glucocorticoids|mesh-ancestor
6492411|NCT00608673|Hormones|hormones|mesh-ancestor
6492412|NCT00608673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6492413|NCT00608673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492414|NCT00608673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6492415|NCT00608673|Respiratory System Agents|respiratory system agents|mesh-ancestor
6492416|NCT00608673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6492417|NCT00608673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6492418|NCT00608673|Analgesics|analgesics|mesh-ancestor
6492419|NCT00608673|Sensory System Agents|sensory system agents|mesh-ancestor
6492420|NCT00608673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6492421|NCT00608673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6492422|NCT00608673|Dermatologic Agents|dermatologic agents|mesh-ancestor
6492423|NCT00608673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6492424|NCT00608673|Immunologic Factors|immunologic factors|mesh-ancestor
6492425|NCT00608673|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6492426|NCT00608673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6492427|NCT00608673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492428|NCT00608699|Niacin|niacin|mesh-list
6492429|NCT00608699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6492430|NCT00608699|Antimetabolites|antimetabolites|mesh-ancestor
6492431|NCT00608699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492432|NCT00608699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6492433|NCT00608699|Vasodilator Agents|vasodilator agents|mesh-ancestor
5812894|NCT02656706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5812895|NCT02656589|Capecitabine|capecitabine|mesh-list
5812896|NCT02656589|Trastuzumab|trastuzumab|mesh-list
5812897|NCT02656589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5812898|NCT02656589|Antimetabolites|antimetabolites|mesh-ancestor
5812899|NCT02656589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5812900|NCT02656589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5812901|NCT02656589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5812902|NCT02656472|Tranexamic Acid|tranexamic acid|mesh-list
6492434|NCT00608699|Vitamin B Complex|vitamin b complex|mesh-ancestor
6492435|NCT00608699|Vitamins|vitamins|mesh-ancestor
5812903|NCT02656472|Aminocaproic Acid|aminocaproic acid|mesh-list
5812904|NCT02656472|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5812905|NCT02656472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5812906|NCT02656472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5812907|NCT02656472|Hemostatics|hemostatics|mesh-ancestor
5812908|NCT02656472|Coagulants|coagulants|mesh-ancestor
5812909|NCT02656615|Abiraterone Acetate|abiraterone acetate|mesh-list
5812910|NCT02656615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5812911|NCT02656615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5812912|NCT02656615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5812913|NCT02656615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5812914|NCT02656615|Hormone Antagonists|hormone antagonists|mesh-ancestor
5812915|NCT02656615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5812916|NCT02656615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812917|NCT02656615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5812918|NCT02656251|Ethanol|ethanol|mesh-list
5812919|NCT02656251|Chlorhexidine|chlorhexidine|mesh-list
5812920|NCT02656251|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5812921|NCT02656251|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5812922|NCT02656251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5812923|NCT02656251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5812924|NCT02656251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812925|NCT02656251|Disinfectants|disinfectants|mesh-ancestor
5812926|NCT02656251|Dermatologic Agents|dermatologic agents|mesh-ancestor
5812927|NCT02656121|Vitamin D|vitamin d|mesh-list
5812928|NCT02656121|Clomiphene|clomiphene|mesh-list
5812929|NCT02656121|Vitamins|vitamins|mesh-ancestor
5812930|NCT02656121|Micronutrients|micronutrients|mesh-ancestor
5812931|NCT02656121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812932|NCT02656121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5812933|NCT02656121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5812934|NCT02656121|Hormone Antagonists|hormone antagonists|mesh-ancestor
5812935|NCT02656121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5812936|NCT02656121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5812937|NCT02656121|Fertility Agents|fertility agents|mesh-ancestor
5812938|NCT02656121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5812939|NCT02656121|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5812940|NCT02656121|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5812941|NCT02656342|Cycloserine|cycloserine|mesh-list
5812942|NCT02656342|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5812943|NCT02656342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5812944|NCT02656342|Renal Agents|renal agents|mesh-ancestor
5812945|NCT02656342|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6492436|NCT00608699|Micronutrients|micronutrients|mesh-ancestor
5812946|NCT02656342|Antitubercular Agents|antitubercular agents|mesh-ancestor
5812947|NCT02656342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5812948|NCT02656342|Antimetabolites|antimetabolites|mesh-ancestor
5812949|NCT02656342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5812950|NCT02656095|Heparin|heparin|mesh-list
5812951|NCT02656095|Anticoagulants|anticoagulants|mesh-ancestor
5812952|NCT02656095|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5812953|NCT02656095|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5812954|NCT02656095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5812955|NCT02656082|Etanercept|etanercept|mesh-list
5812956|NCT02656082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5812957|NCT02656082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5812958|NCT02656082|Analgesics|analgesics|mesh-ancestor
5812959|NCT02656082|Sensory System Agents|sensory system agents|mesh-ancestor
5812960|NCT02656082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5812961|NCT02656082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812962|NCT02656082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5812963|NCT02656082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5812964|NCT02656082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5812965|NCT02656082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5812966|NCT02656082|Immunologic Factors|immunologic factors|mesh-ancestor
5812967|NCT02656017|Metformin|metformin|mesh-list
5812968|NCT02656017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5812969|NCT02656017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812970|NCT02655692|Ketamine|ketamine|mesh-list
5812971|NCT02655692|Analgesics|analgesics|mesh-ancestor
5812972|NCT02655692|Sensory System Agents|sensory system agents|mesh-ancestor
5812973|NCT02655692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5812974|NCT02655692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492437|NCT00608699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492438|NCT00608712|Esomeprazole|esomeprazole|mesh-list
5812975|NCT02655692|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5812976|NCT02655692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5812977|NCT02655692|Anesthetics, General|anesthetics, general|mesh-ancestor
5812978|NCT02655692|Anesthetics|anesthetics|mesh-ancestor
5812979|NCT02655692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5812980|NCT02655692|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5812981|NCT02655692|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5812982|NCT02655692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5812983|NCT02655692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5812984|NCT02655757|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5812985|NCT02655757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5812986|NCT02655757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812987|NCT02655757|Incretins|incretins|mesh-ancestor
5812988|NCT02655757|Hormones|hormones|mesh-ancestor
5812989|NCT02655757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5812990|NCT02655757|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5812991|NCT02655757|Protease Inhibitors|protease inhibitors|mesh-ancestor
5812992|NCT02655757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5812993|NCT02655757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5812994|NCT02655770|Liraglutide|liraglutide|mesh-list
5812995|NCT02655770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5812996|NCT02655770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5812997|NCT02655770|Incretins|incretins|mesh-ancestor
5812998|NCT02655770|Hormones|hormones|mesh-ancestor
5812999|NCT02655770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5813000|NCT02655874|Vaccines|vaccines|mesh-list
5813001|NCT02655874|Immunologic Factors|immunologic factors|mesh-ancestor
6492439|NCT00608712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6492440|NCT00608712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6492441|NCT00608712|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6492442|NCT00608712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5813002|NCT02655874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813003|NCT02655913|Ascorbic Acid|ascorbic acid|mesh-list
5813004|NCT02655913|Vitamins|vitamins|mesh-ancestor
5813005|NCT02655913|Micronutrients|micronutrients|mesh-ancestor
5813006|NCT02655913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813007|NCT02655913|Antioxidants|antioxidants|mesh-ancestor
5813008|NCT02655913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813009|NCT02655913|Protective Agents|protective agents|mesh-ancestor
5813010|NCT02655822|Atezolizumab|atezolizumab|mesh-list
5813011|NCT02655822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5813012|NCT02655965|Clonidine|clonidine|mesh-list
5813013|NCT02655965|Ropivacaine|ropivacaine|mesh-list
5813014|NCT02655965|Anesthetics, Local|anesthetics, local|mesh-ancestor
5813015|NCT02655965|Anesthetics|anesthetics|mesh-ancestor
5813016|NCT02655965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5813017|NCT02655965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813018|NCT02655965|Sensory System Agents|sensory system agents|mesh-ancestor
5813019|NCT02655965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5813020|NCT02655965|Analgesics|analgesics|mesh-ancestor
5813021|NCT02655965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5813022|NCT02655965|Sympatholytics|sympatholytics|mesh-ancestor
5813023|NCT02655965|Autonomic Agents|autonomic agents|mesh-ancestor
5813024|NCT02655965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5813025|NCT02655965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5813026|NCT02655965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5813027|NCT02655965|Adrenergic Agents|adrenergic agents|mesh-ancestor
5813028|NCT02655965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5813029|NCT02655965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901017|NCT04040621|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5901018|NCT04040621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5901019|NCT04040621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901020|NCT04030000|Paclitaxel|paclitaxel|mesh-list
5901021|NCT04030000|Carboplatin|carboplatin|mesh-list
5901022|NCT04030000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5901023|NCT04030000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901024|NCT04030000|Tubulin Modulators|tubulin modulators|mesh-ancestor
5901025|NCT04030000|Antimitotic Agents|antimitotic agents|mesh-ancestor
5901026|NCT04030000|Mitosis Modulators|mitosis modulators|mesh-ancestor
5901027|NCT04030000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901028|NCT04028401|Benzoyl Peroxide|benzoyl peroxide|mesh-list
5901029|NCT04028401|Dermatologic Agents|dermatologic agents|mesh-ancestor
5901030|NCT04028115|Ixazomib|ixazomib|mesh-list
5901031|NCT04028115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901032|NCT04028115|Protease Inhibitors|protease inhibitors|mesh-ancestor
5901033|NCT04028115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5901034|NCT04028115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901035|NCT04006925|Sodium Oxybate|sodium oxybate|mesh-list
5901036|NCT04006925|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5901037|NCT04006925|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5901038|NCT04006925|Anesthetics, General|anesthetics, general|mesh-ancestor
5901039|NCT04006925|Anesthetics|anesthetics|mesh-ancestor
5901040|NCT04006925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5901041|NCT04006925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901042|NCT03965234|Cisplatin|cisplatin|mesh-list
5901043|NCT03965234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901044|NCT03959423|Insulin|insulin|mesh-list
5901045|NCT03959423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5901046|NCT03959423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901047|NCT03952091|Dexamethasone|dexamethasone|mesh-list
5901048|NCT03952091|Dexamethasone acetate|dexamethasone acetate|mesh-list
5901049|NCT03952091|Lenalidomide|lenalidomide|mesh-list
5901050|NCT03952091|BB 1101|bb 1101|mesh-list
5901051|NCT03952091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5901052|NCT03952091|Antiemetics|antiemetics|mesh-ancestor
5901053|NCT03952091|Autonomic Agents|autonomic agents|mesh-ancestor
5901054|NCT03952091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5901055|NCT03952091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901056|NCT03952091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5901057|NCT03952091|Glucocorticoids|glucocorticoids|mesh-ancestor
5901058|NCT03952091|Hormones|hormones|mesh-ancestor
5901059|NCT03952091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5901060|NCT03952091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5901061|NCT03952091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901062|NCT03952091|Protease Inhibitors|protease inhibitors|mesh-ancestor
5901063|NCT03952091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5901064|NCT03952091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901065|NCT03952091|Immunologic Factors|immunologic factors|mesh-ancestor
5901066|NCT03952091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5901067|NCT03952091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5901068|NCT03952091|Growth Substances|growth substances|mesh-ancestor
5901069|NCT03952091|Growth Inhibitors|growth inhibitors|mesh-ancestor
5901070|NCT03946527|Lanreotide|lanreotide|mesh-list
5901071|NCT03946527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901072|NCT03943173|Olaparib|olaparib|mesh-list
5901073|NCT03943173|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
5813030|NCT02655705|Cyclosporine|cyclosporine|mesh-list
5813031|NCT02655705|Methotrexate|methotrexate|mesh-list
5813032|NCT02655705|Cyclosporins|cyclosporins|mesh-list
5813033|NCT02655705|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5813034|NCT02655705|Abortifacient Agents|abortifacient agents|mesh-ancestor
6674279|NCT01568307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674280|NCT01568307|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6674281|NCT01568307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6674282|NCT01568333|Decitabine|decitabine|mesh-list
5813035|NCT02655705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5813036|NCT02655705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813037|NCT02655705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5813038|NCT02655705|Antimetabolites|antimetabolites|mesh-ancestor
5813039|NCT02655705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813040|NCT02655705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5813041|NCT02655705|Dermatologic Agents|dermatologic agents|mesh-ancestor
5813042|NCT02655705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5813043|NCT02655705|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5813044|NCT02655705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5813045|NCT02655705|Immunologic Factors|immunologic factors|mesh-ancestor
5813046|NCT02655705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5813047|NCT02655705|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5813048|NCT02655705|Antifungal Agents|antifungal agents|mesh-ancestor
5813049|NCT02655705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5813050|NCT02655705|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5813051|NCT02655614|Midazolam|midazolam|mesh-list
5813052|NCT02655614|Caffeine|caffeine|mesh-list
5813053|NCT02655614|Rabeprazole|rabeprazole|mesh-list
5813054|NCT02655614|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5813055|NCT02655614|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5813056|NCT02655614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5813057|NCT02655614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813058|NCT02655614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5813059|NCT02655614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5813060|NCT02655614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5813061|NCT02655614|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5813062|NCT02655614|Anesthetics, General|anesthetics, general|mesh-ancestor
5813063|NCT02655614|Anesthetics|anesthetics|mesh-ancestor
5813064|NCT02655614|GABA Modulators|gaba modulators|mesh-ancestor
5813065|NCT02655614|GABA Agents|gaba agents|mesh-ancestor
5813066|NCT02655614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5813067|NCT02655614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813068|NCT02655614|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5813069|NCT02655614|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5813070|NCT02655614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5813071|NCT02655614|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5813072|NCT02655614|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5813073|NCT02655614|Purinergic Agents|purinergic agents|mesh-ancestor
5813074|NCT02655614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5813075|NCT02655614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5813076|NCT02655614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6674283|NCT01568333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6674284|NCT01568333|Antimetabolites|antimetabolites|mesh-ancestor
6674285|NCT01568333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674286|NCT01568333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6674287|NCT01568333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5813077|NCT02655601|Manganese|manganese|mesh-list
5813078|NCT02655601|Temozolomide|temozolomide|mesh-list
5901074|NCT03943173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5813079|NCT02655601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5813080|NCT02655601|Alkylating Agents|alkylating agents|mesh-ancestor
5813081|NCT02655601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813082|NCT02655601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5813083|NCT02655601|Trace Elements|trace elements|mesh-ancestor
5813084|NCT02655601|Micronutrients|micronutrients|mesh-ancestor
5813085|NCT02655601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813086|NCT02655523|Dexamethasone|dexamethasone|mesh-list
5813087|NCT02655523|Triamcinolone|triamcinolone|mesh-list
5813088|NCT02655523|Bupivacaine|bupivacaine|mesh-list
5813089|NCT02655523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5813090|NCT02655523|Antiemetics|antiemetics|mesh-ancestor
5813091|NCT02655523|Autonomic Agents|autonomic agents|mesh-ancestor
5813092|NCT02655523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5813093|NCT02655523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813094|NCT02655523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5813095|NCT02655523|Glucocorticoids|glucocorticoids|mesh-ancestor
5813096|NCT02655523|Hormones|hormones|mesh-ancestor
5813097|NCT02655523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5813098|NCT02655523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5813099|NCT02655523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5813100|NCT02655523|Anesthetics, Local|anesthetics, local|mesh-ancestor
5813101|NCT02655523|Anesthetics|anesthetics|mesh-ancestor
5813102|NCT02655523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5813103|NCT02655523|Sensory System Agents|sensory system agents|mesh-ancestor
5813104|NCT02655562|Montelukast|montelukast|mesh-list
5813105|NCT02655562|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5813106|NCT02655562|Respiratory System Agents|respiratory system agents|mesh-ancestor
5813107|NCT02655562|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5813108|NCT02655562|Hormone Antagonists|hormone antagonists|mesh-ancestor
5813109|NCT02655562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5813110|NCT02655562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813111|NCT02655562|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5813112|NCT02655562|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5813113|NCT02655562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813114|NCT02655536|Bevacizumab|bevacizumab|mesh-list
5813115|NCT02655536|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5813116|NCT02655536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5813117|NCT02655536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5813118|NCT02655536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5813119|NCT02655536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5813120|NCT02655536|Growth Substances|growth substances|mesh-ancestor
5813121|NCT02655536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813122|NCT02655536|Growth Inhibitors|growth inhibitors|mesh-ancestor
5813123|NCT02655536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5813124|NCT02655536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5813125|NCT02655536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813126|NCT02655380|Ketamine|ketamine|mesh-list
5813127|NCT02655380|Remifentanil|remifentanil|mesh-list
5813128|NCT02655380|Analgesics|analgesics|mesh-ancestor
5813129|NCT02655380|Sensory System Agents|sensory system agents|mesh-ancestor
5813130|NCT02655380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5813131|NCT02655380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813132|NCT02655380|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5813133|NCT02655380|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5813134|NCT02655380|Anesthetics, General|anesthetics, general|mesh-ancestor
5813135|NCT02655380|Anesthetics|anesthetics|mesh-ancestor
5813136|NCT02655380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5813137|NCT02655380|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5813138|NCT02655380|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5813139|NCT02655380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5813140|NCT02655380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813141|NCT02655380|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5813142|NCT02655380|Narcotics|narcotics|mesh-ancestor
5813143|NCT02655458|Lenalidomide|lenalidomide|mesh-list
5813144|NCT02655458|Elotuzumab|elotuzumab|mesh-list
5813145|NCT02655458|Immunologic Factors|immunologic factors|mesh-ancestor
5813146|NCT02655458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813147|NCT02655458|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5813148|NCT02655458|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5813149|NCT02655458|Growth Substances|growth substances|mesh-ancestor
5813150|NCT02655458|Growth Inhibitors|growth inhibitors|mesh-ancestor
5813151|NCT02655458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5813152|NCT02655471|Zidovudine|zidovudine|mesh-list
5813153|NCT02655471|Raltegravir Potassium|raltegravir potassium|mesh-list
5813154|NCT02655471|Antimetabolites|antimetabolites|mesh-ancestor
5813155|NCT02655471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813156|NCT02655471|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5813157|NCT02655471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5813158|NCT02655471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5813159|NCT02655471|Antiviral Agents|antiviral agents|mesh-ancestor
5813160|NCT02655471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5813161|NCT02655471|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5813162|NCT02655471|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5813163|NCT02655471|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5813164|NCT02655471|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5813165|NCT02655315|Deferiprone|deferiprone|mesh-list
5813166|NCT02655315|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5813167|NCT02655315|Chelating Agents|chelating agents|mesh-ancestor
5813168|NCT02655315|Sequestering Agents|sequestering agents|mesh-ancestor
5813169|NCT02655315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813170|NCT02655276|Glycine|glycine|mesh-list
5813171|NCT02655276|Glycine Agents|glycine agents|mesh-ancestor
5813172|NCT02655276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5813173|NCT02655276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813174|NCT02655276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813175|NCT02655198|Fenfluramine|fenfluramine|mesh-list
5813176|NCT02655198|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5813177|NCT02655198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5813178|NCT02655198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5813179|NCT02655198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813180|NCT02655198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5813181|NCT02655198|Serotonin Agents|serotonin agents|mesh-ancestor
5813182|NCT02655198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813183|NCT02655146|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5813184|NCT02655146|Progesterone|progesterone|mesh-list
5813185|NCT02655146|Estradiol|estradiol|mesh-list
6496506|NCT00628290|Anticonvulsants|anticonvulsants|mesh-ancestor
5813186|NCT02655146|Progestins|progestins|mesh-ancestor
5813187|NCT02655146|Hormones|hormones|mesh-ancestor
5908284|NCT04702880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6492443|NCT00608712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813188|NCT02655146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5813189|NCT02655146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813190|NCT02655146|Luteolytic Agents|luteolytic agents|mesh-ancestor
5813191|NCT02655146|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5813192|NCT02655146|Contraceptive Agents|contraceptive agents|mesh-ancestor
5813193|NCT02655146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5813194|NCT02655146|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5813195|NCT02655146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5813196|NCT02655146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5813197|NCT02655146|Estrogens|estrogens|mesh-ancestor
5813198|NCT02654847|Norepinephrine|norepinephrine|mesh-list
5813199|NCT02654847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5813200|NCT02654847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5813201|NCT02654847|Adrenergic Agents|adrenergic agents|mesh-ancestor
5813202|NCT02654847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5813203|NCT02654847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813204|NCT02654847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813205|NCT02654847|Sympathomimetics|sympathomimetics|mesh-ancestor
5813206|NCT02654847|Autonomic Agents|autonomic agents|mesh-ancestor
5813207|NCT02654847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5813208|NCT02654847|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5813209|NCT02655029|Amlodipine|amlodipine|mesh-list
5813210|NCT02655029|Perindopril|perindopril|mesh-list
5813211|NCT02655029|Indapamide|indapamide|mesh-list
5813212|NCT02655029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5813213|NCT02655029|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5813214|NCT02655029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5813215|NCT02655029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813216|NCT02655029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5813217|NCT02655029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813218|NCT02655029|Vasodilator Agents|vasodilator agents|mesh-ancestor
5813219|NCT02655029|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5813220|NCT02655029|Protease Inhibitors|protease inhibitors|mesh-ancestor
5813221|NCT02655029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5813222|NCT02655029|Diuretics|diuretics|mesh-ancestor
5813223|NCT02655029|Natriuretic Agents|natriuretic agents|mesh-ancestor
5813224|NCT02655029|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5813225|NCT02654834|Nitrous Oxide|nitrous oxide|mesh-list
5813226|NCT02654834|Anesthetics|anesthetics|mesh-list
5813227|NCT02654834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5813228|NCT02654834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813229|NCT02654834|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5813230|NCT02654834|Anesthetics, General|anesthetics, general|mesh-ancestor
5813231|NCT02654834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5813232|NCT02654834|Analgesics|analgesics|mesh-ancestor
5813233|NCT02654834|Sensory System Agents|sensory system agents|mesh-ancestor
5813234|NCT02654834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5813235|NCT02654743|Sulforaphane|sulforaphane|mesh-list
5813236|NCT02654743|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5813237|NCT02654743|Protective Agents|protective agents|mesh-ancestor
5813238|NCT02654743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813239|NCT02654743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5813240|NCT02654561|Heparin|heparin|mesh-list
5813241|NCT02654561|Calcium heparin|calcium heparin|mesh-list
5813242|NCT02654561|Anticoagulants|anticoagulants|mesh-ancestor
5813243|NCT02654561|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5813244|NCT02654561|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5813245|NCT02654561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813246|NCT02654665|Liraglutide|liraglutide|mesh-list
5813247|NCT02654665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5813248|NCT02654665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813249|NCT02654665|Incretins|incretins|mesh-ancestor
5813250|NCT02654665|Hormones|hormones|mesh-ancestor
5813251|NCT02654665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5813252|NCT02654730|Piperaquine|piperaquine|mesh-list
5813253|NCT02654730|Primaquine|primaquine|mesh-list
5813254|NCT02654730|Artenimol|artenimol|mesh-list
5813255|NCT02654730|Artemisinins|artemisinins|mesh-list
5813256|NCT02654730|Antimalarials|antimalarials|mesh-ancestor
5813257|NCT02654730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5813258|NCT02654730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5813259|NCT02654730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5813260|NCT02654678|Enalapril|enalapril|mesh-list
5813261|NCT02654678|Enalaprilat|enalaprilat|mesh-list
5813262|NCT02654678|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5813263|NCT02654678|Protease Inhibitors|protease inhibitors|mesh-ancestor
5813264|NCT02654678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5813265|NCT02654678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813266|NCT02654678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5813267|NCT02654704|Vaccines|vaccines|mesh-list
5813268|NCT02654704|Immunologic Factors|immunologic factors|mesh-ancestor
5813269|NCT02654704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813270|NCT02654587|Docetaxel|docetaxel|mesh-list
5813271|NCT02654587|Pemetrexed|pemetrexed|mesh-list
5813272|NCT02654587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5813273|NCT02654587|Tubulin Modulators|tubulin modulators|mesh-ancestor
5813274|NCT02654587|Antimitotic Agents|antimitotic agents|mesh-ancestor
5813275|NCT02654587|Mitosis Modulators|mitosis modulators|mesh-ancestor
5813276|NCT02654587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813277|NCT02654587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5813278|NCT02654587|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5813279|NCT02654587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5813280|NCT02654405|Butyric Acid|butyric acid|mesh-list
5813281|NCT02654405|Histamine Antagonists|histamine antagonists|mesh-ancestor
5813282|NCT02654405|Histamine Agents|histamine agents|mesh-ancestor
5813283|NCT02654405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5813284|NCT02654405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813285|NCT02654405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813286|NCT02654379|Rituximab|rituximab|mesh-list
5813287|NCT02654379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5813288|NCT02654379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5813289|NCT02654379|Immunologic Factors|immunologic factors|mesh-ancestor
5813290|NCT02654379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641942|NCT00357565|Mycophenolic Acid|mycophenolic acid|mesh-list
5641943|NCT00357565|Fludarabine|fludarabine|mesh-list
5813291|NCT02654379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5813292|NCT02654093|Cholecalciferol|cholecalciferol|mesh-list
5813293|NCT02654093|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
5813294|NCT02654093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5813295|NCT02654093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813296|NCT02654093|Vitamins|vitamins|mesh-ancestor
5813297|NCT02654093|Micronutrients|micronutrients|mesh-ancestor
5813298|NCT02654093|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5813299|NCT02654093|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5813300|NCT02654093|Hormone Antagonists|hormone antagonists|mesh-ancestor
5813301|NCT02654093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5813302|NCT02654093|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5813303|NCT02654093|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5813304|NCT02654106|Temozolomide|temozolomide|mesh-list
5641944|NCT00357565|Fludarabine phosphate|fludarabine phosphate|mesh-list
5641945|NCT00357565|Melphalan|melphalan|mesh-list
5641946|NCT00357565|Busulfan|busulfan|mesh-list
5641947|NCT00357565|Cyclosporins|cyclosporins|mesh-list
5641948|NCT00357565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5641949|NCT00357565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5641950|NCT00357565|Antimetabolites|antimetabolites|mesh-ancestor
5641951|NCT00357565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813305|NCT02654106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5813306|NCT02654106|Alkylating Agents|alkylating agents|mesh-ancestor
5813307|NCT02654106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813308|NCT02654106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5813309|NCT02654119|Paclitaxel|paclitaxel|mesh-list
5813310|NCT02654119|Cyclophosphamide|cyclophosphamide|mesh-list
5813311|NCT02654119|Trastuzumab|trastuzumab|mesh-list
5813312|NCT02654119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5813313|NCT02654119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5813314|NCT02654119|Antibodies|antibodies|mesh-list
5813315|NCT02654119|Immunoglobulins|immunoglobulins|mesh-list
5813316|NCT02654119|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5813317|NCT02654119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5813318|NCT02654119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5813319|NCT02654119|Tubulin Modulators|tubulin modulators|mesh-ancestor
5813320|NCT02654119|Antimitotic Agents|antimitotic agents|mesh-ancestor
5813321|NCT02654119|Mitosis Modulators|mitosis modulators|mesh-ancestor
5813322|NCT02654119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813323|NCT02654119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5813324|NCT02654119|Immunologic Factors|immunologic factors|mesh-ancestor
5813325|NCT02654119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813326|NCT02654119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5813327|NCT02654119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5813328|NCT02654119|Alkylating Agents|alkylating agents|mesh-ancestor
5813329|NCT02654119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5813330|NCT02654171|Ziresovir|ziresovir|mesh-list
5813331|NCT02654171|Antiviral Agents|antiviral agents|mesh-ancestor
5813332|NCT02654171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5901075|NCT03943173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901076|NCT03943173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901077|NCT03933904|Sirolimus|sirolimus|mesh-list
5901078|NCT03933904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5901079|NCT03933904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5901080|NCT03933904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5901081|NCT03933904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901082|NCT03933904|Antifungal Agents|antifungal agents|mesh-ancestor
5901083|NCT03933904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5901084|NCT03933904|Immunologic Factors|immunologic factors|mesh-ancestor
5901085|NCT03933904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901086|NCT03933163|Resveratrol|resveratrol|mesh-list
5901087|NCT03933163|Antioxidants|antioxidants|mesh-ancestor
5901088|NCT03933163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901089|NCT03933163|Protective Agents|protective agents|mesh-ancestor
5901090|NCT03933163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901091|NCT03933163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5901092|NCT03933163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5901093|NCT03927443|Bimatoprost|bimatoprost|mesh-list
5901094|NCT03927443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5901095|NCT03913247|Metronidazole|metronidazole|mesh-list
5901096|NCT03913247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5901097|NCT03913247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5901098|NCT03913247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5901099|NCT03913247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5901100|NCT03912337|Erenumab|erenumab|mesh-list
5901101|NCT03912337|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
5901102|NCT03912337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813333|NCT02654288|Gemcitabine|gemcitabine|mesh-list
5813334|NCT02654288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5813335|NCT02654288|Antimetabolites|antimetabolites|mesh-ancestor
5813336|NCT02654288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813337|NCT02654288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5813338|NCT02654288|Antiviral Agents|antiviral agents|mesh-ancestor
5813339|NCT02654288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5813340|NCT02654288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5813341|NCT02654288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5813342|NCT02654288|Immunologic Factors|immunologic factors|mesh-ancestor
5813343|NCT02654288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813344|NCT02654041|Methimazole|methimazole|mesh-list
5813345|NCT02654041|Antithyroid Agents|antithyroid agents|mesh-ancestor
5813346|NCT02654041|Hormone Antagonists|hormone antagonists|mesh-ancestor
5813347|NCT02654041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5813348|NCT02654041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813349|NCT02653898|Artesunate|artesunate|mesh-list
5813350|NCT02653898|Piperaquine|piperaquine|mesh-list
5813351|NCT02653898|Primaquine|primaquine|mesh-list
5813352|NCT02653898|Artenimol|artenimol|mesh-list
5813353|NCT02653898|Mefloquine|mefloquine|mesh-list
5813354|NCT02653898|Permethrin|permethrin|mesh-list
5813355|NCT02653898|Antimalarials|antimalarials|mesh-ancestor
5813356|NCT02653898|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5813357|NCT02653898|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5813358|NCT02653898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5813359|NCT02653898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5813360|NCT02653898|Antiviral Agents|antiviral agents|mesh-ancestor
5813361|NCT02653898|Schistosomicides|schistosomicides|mesh-ancestor
5813362|NCT02653898|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5813363|NCT02653898|Anthelmintics|anthelmintics|mesh-ancestor
5813364|NCT02653898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5813365|NCT02653898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813366|NCT02653833|Tadalafil|tadalafil|mesh-list
5813367|NCT02653833|Vasodilator Agents|vasodilator agents|mesh-ancestor
6674288|NCT01568411|Itraconazole|itraconazole|mesh-list
6674289|NCT01568411|Antifungal Agents|antifungal agents|mesh-ancestor
6674290|NCT01568411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6674291|NCT01568411|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6674292|NCT01568411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6674293|NCT01568411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5813368|NCT02653833|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5813369|NCT02653833|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5813370|NCT02653833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5813371|NCT02653833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813372|NCT02653833|Urological Agents|urological agents|mesh-ancestor
5813373|NCT02653703|Ethanol|ethanol|mesh-list
5813374|NCT02653703|Menthol|menthol|mesh-list
5813375|NCT02653703|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5813376|NCT02653703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5813377|NCT02653703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5813378|NCT02653703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813379|NCT02653703|Antipruritics|antipruritics|mesh-ancestor
5813380|NCT02653703|Dermatologic Agents|dermatologic agents|mesh-ancestor
5813381|NCT02653742|Ketorolac|ketorolac|mesh-list
5813382|NCT02653742|Fentanyl|fentanyl|mesh-list
5813383|NCT02653742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5813384|NCT02653742|Narcotics|narcotics|mesh-ancestor
5813385|NCT02653742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5813386|NCT02653742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813387|NCT02653742|Analgesics|analgesics|mesh-ancestor
5813388|NCT02653742|Sensory System Agents|sensory system agents|mesh-ancestor
5813389|NCT02653742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5813390|NCT02653742|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5813391|NCT02653742|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5813392|NCT02653742|Anesthetics, General|anesthetics, general|mesh-ancestor
5813393|NCT02653742|Anesthetics|anesthetics|mesh-ancestor
5813394|NCT02653742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6675596|NCT01576627|Zinc Oxide|zinc oxide|mesh-list
5813395|NCT02653742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5813396|NCT02653742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5813397|NCT02653742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5813398|NCT02653742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5813399|NCT02653742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5813400|NCT02653742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813401|NCT02653963|Triamcinolone|triamcinolone|mesh-list
5813402|NCT02653963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5813403|NCT02653963|Glucocorticoids|glucocorticoids|mesh-ancestor
5813404|NCT02653963|Hormones|hormones|mesh-ancestor
5813405|NCT02653963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5813406|NCT02653963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813407|NCT02653651|Lidocaine|lidocaine|mesh-list
5813408|NCT02653651|Ketamine|ketamine|mesh-list
5813409|NCT02653651|Anesthetics, Local|anesthetics, local|mesh-ancestor
5813410|NCT02653651|Anesthetics|anesthetics|mesh-ancestor
5813411|NCT02653651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5813412|NCT02653651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813413|NCT02653651|Sensory System Agents|sensory system agents|mesh-ancestor
5813414|NCT02653651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6674294|NCT01568411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674295|NCT01568411|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6674296|NCT01568411|Hormone Antagonists|hormone antagonists|mesh-ancestor
6674297|NCT01568411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6674298|NCT01568411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674299|NCT01568411|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6674300|NCT01568450|Oxycodone|oxycodone|mesh-list
6674301|NCT01568450|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5813415|NCT02653651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5813416|NCT02653651|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5813417|NCT02653651|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5813418|NCT02653651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5813419|NCT02653651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813420|NCT02653651|Analgesics|analgesics|mesh-ancestor
5813421|NCT02653651|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5813422|NCT02653651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5813423|NCT02653651|Anesthetics, General|anesthetics, general|mesh-ancestor
5813424|NCT02653651|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5813425|NCT02653651|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5813426|NCT02653651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5813427|NCT02653638|Indomethacin|indomethacin|mesh-list
5813428|NCT02653638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5813429|NCT02653638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5813430|NCT02653638|Analgesics|analgesics|mesh-ancestor
5813431|NCT02653638|Sensory System Agents|sensory system agents|mesh-ancestor
5813432|NCT02653638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5813433|NCT02653638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813434|NCT02653638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6674302|NCT01568450|Narcotics|narcotics|mesh-ancestor
6674303|NCT01568450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6674304|NCT01568450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674305|NCT01568450|Analgesics|analgesics|mesh-ancestor
6674306|NCT01568450|Sensory System Agents|sensory system agents|mesh-ancestor
5813435|NCT02653638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5813436|NCT02653638|Gout Suppressants|gout suppressants|mesh-ancestor
5813437|NCT02653638|Tocolytic Agents|tocolytic agents|mesh-ancestor
5813438|NCT02653638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5813439|NCT02653638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5813440|NCT02653638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5813441|NCT02653638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813442|NCT02653235|Vaccines|vaccines|mesh-list
5813443|NCT02653235|Immunologic Factors|immunologic factors|mesh-ancestor
5813444|NCT02653235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813445|NCT02653261|Tranexamic Acid|tranexamic acid|mesh-list
5813446|NCT02653261|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5813447|NCT02653261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5813448|NCT02653261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813449|NCT02653261|Hemostatics|hemostatics|mesh-ancestor
5813450|NCT02653261|Coagulants|coagulants|mesh-ancestor
5813451|NCT02653196|Cyclosporine|cyclosporine|mesh-list
5813452|NCT02653196|Mycophenolic Acid|mycophenolic acid|mesh-list
5813453|NCT02653196|Fludarabine|fludarabine|mesh-list
5813454|NCT02653196|Etoposide|etoposide|mesh-list
5813455|NCT02653196|Melphalan|melphalan|mesh-list
5813456|NCT02653196|Alemtuzumab|alemtuzumab|mesh-list
5813457|NCT02653196|Thiotepa|thiotepa|mesh-list
5813458|NCT02653196|Tacrolimus|tacrolimus|mesh-list
5813459|NCT02653196|Cyclosporins|cyclosporins|mesh-list
5813460|NCT02653196|Mitogens|mitogens|mesh-list
5813461|NCT02653196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5813462|NCT02653196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813463|NCT02653196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5813464|NCT02653196|Immunologic Factors|immunologic factors|mesh-ancestor
5813465|NCT02653196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813466|NCT02653196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5813467|NCT02653196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5813468|NCT02653196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5813469|NCT02653196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5813470|NCT02653196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5813471|NCT02653196|Antifungal Agents|antifungal agents|mesh-ancestor
5813472|NCT02653196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5813473|NCT02653196|Dermatologic Agents|dermatologic agents|mesh-ancestor
5813474|NCT02653196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5813475|NCT02653196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5813476|NCT02653196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5813477|NCT02653196|Antitubercular Agents|antitubercular agents|mesh-ancestor
5813478|NCT02653196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5813479|NCT02653196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5813480|NCT02653196|Alkylating Agents|alkylating agents|mesh-ancestor
5813481|NCT02653196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5813482|NCT02653196|Mitosis Modulators|mitosis modulators|mesh-ancestor
5813483|NCT02653196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5813484|NCT02653209|Pioglitazone|pioglitazone|mesh-list
5813485|NCT02653209|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5813486|NCT02653209|Canagliflozin|canagliflozin|mesh-list
5813487|NCT02653209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5813488|NCT02653209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813489|NCT02653209|Incretins|incretins|mesh-ancestor
5813490|NCT02653209|Hormones|hormones|mesh-ancestor
5813491|NCT02653209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5813492|NCT02653209|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5813493|NCT02653209|Protease Inhibitors|protease inhibitors|mesh-ancestor
5813494|NCT02653209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5813495|NCT02653209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813496|NCT02653209|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5813497|NCT02653339|Loratadine|loratadine|mesh-list
5813498|NCT02653339|Antipruritics|antipruritics|mesh-ancestor
5813499|NCT02653339|Dermatologic Agents|dermatologic agents|mesh-ancestor
5813500|NCT02653339|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5813501|NCT02653339|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5813502|NCT02653339|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5813503|NCT02653339|Histamine Antagonists|histamine antagonists|mesh-ancestor
5813504|NCT02653339|Histamine Agents|histamine agents|mesh-ancestor
5813505|NCT02653339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5813506|NCT02653339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813507|NCT02653339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813508|NCT02653131|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5813509|NCT02653131|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
5813510|NCT02653131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5813511|NCT02653131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813512|NCT02653131|Incretins|incretins|mesh-ancestor
5813513|NCT02653131|Hormones|hormones|mesh-ancestor
5813514|NCT02653131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5813515|NCT02653131|Protease Inhibitors|protease inhibitors|mesh-ancestor
5813516|NCT02653131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5813517|NCT02653131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813518|NCT02653027|Ivacaftor|ivacaftor|mesh-list
5813519|NCT02653027|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
5813520|NCT02653027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5813521|NCT02653027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813522|NCT02653014|Mineralocorticoids|mineralocorticoids|mesh-list
5813523|NCT02653014|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
5813524|NCT02653014|Hormones|hormones|mesh-ancestor
5813525|NCT02653014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5813526|NCT02653014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813527|NCT02653014|Hormone Antagonists|hormone antagonists|mesh-ancestor
5813528|NCT02653014|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5813529|NCT02653014|Diuretics|diuretics|mesh-ancestor
5813530|NCT02653014|Natriuretic Agents|natriuretic agents|mesh-ancestor
6492444|NCT00608725|Propranolol|propranolol|mesh-list
6492445|NCT00608725|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5813531|NCT02652793|Lamivudine|lamivudine|mesh-list
5813532|NCT02652793|Atazanavir Sulfate|atazanavir sulfate|mesh-list
5813533|NCT02652793|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5813534|NCT02652793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5813535|NCT02652793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5901103|NCT03912337|Analgesics|analgesics|mesh-ancestor
6492446|NCT00608725|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6492447|NCT00608725|Adrenergic Agents|adrenergic agents|mesh-ancestor
6492448|NCT00608725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6492449|NCT00608725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492450|NCT00608725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492451|NCT00608725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6492452|NCT00608725|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6492453|NCT00608725|Vasodilator Agents|vasodilator agents|mesh-ancestor
6492454|NCT00608790|Albuterol|albuterol|mesh-list
6492455|NCT00608790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6492456|NCT00608790|Autonomic Agents|autonomic agents|mesh-ancestor
6492457|NCT00608790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6492458|NCT00608790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492459|NCT00608790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6492460|NCT00608790|Respiratory System Agents|respiratory system agents|mesh-ancestor
6492461|NCT00608790|Tocolytic Agents|tocolytic agents|mesh-ancestor
6492462|NCT00608790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6492463|NCT00608790|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6492464|NCT00608790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5813536|NCT02652793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813537|NCT02652793|Antiviral Agents|antiviral agents|mesh-ancestor
5813538|NCT02652793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5813539|NCT02652793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5813540|NCT02652793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5813541|NCT02652793|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5813542|NCT02652793|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5813543|NCT02652793|Protease Inhibitors|protease inhibitors|mesh-ancestor
5813544|NCT02652884|Betamethasone|betamethasone|mesh-list
5813545|NCT02652884|Betamethasone acetate|betamethasone acetate|mesh-list
5813546|NCT02652884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5813547|NCT02652884|Glucocorticoids|glucocorticoids|mesh-ancestor
5813548|NCT02652884|Hormones|hormones|mesh-ancestor
5813549|NCT02652884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5813550|NCT02652884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813551|NCT02652884|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5813552|NCT02652884|Respiratory System Agents|respiratory system agents|mesh-ancestor
5813553|NCT02652871|Cytarabine|cytarabine|mesh-list
5813554|NCT02652871|Idarubicin|idarubicin|mesh-list
5813555|NCT02652871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5813556|NCT02652871|Antimetabolites|antimetabolites|mesh-ancestor
5813557|NCT02652871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813558|NCT02652871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5813559|NCT02652871|Antiviral Agents|antiviral agents|mesh-ancestor
5813560|NCT02652871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5813561|NCT02652871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5813562|NCT02652871|Immunologic Factors|immunologic factors|mesh-ancestor
5813563|NCT02652871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813564|NCT02652871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5813565|NCT02652871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5813566|NCT02652871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5813567|NCT02652871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5813568|NCT02652650|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5813569|NCT02652650|Norethindrone|norethindrone|mesh-list
5813570|NCT02652650|Norethindrone Acetate|norethindrone acetate|mesh-list
5813571|NCT02652650|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5813572|NCT02652650|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5813573|NCT02652650|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5813574|NCT02652650|Contraceptive Agents|contraceptive agents|mesh-ancestor
5813575|NCT02652650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5813576|NCT02652650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813577|NCT02652650|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5813578|NCT02652650|Estrogens|estrogens|mesh-ancestor
5813579|NCT02652650|Hormones|hormones|mesh-ancestor
5813580|NCT02652650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5813581|NCT02652650|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5813582|NCT02652806|Epoetin Alfa|epoetin alfa|mesh-list
5813583|NCT02652806|Hematinics|hematinics|mesh-ancestor
5813584|NCT02652585|Naltrexone|naltrexone|mesh-list
5813585|NCT02652585|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5813586|NCT02652585|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5813587|NCT02652585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813588|NCT02652585|Sensory System Agents|sensory system agents|mesh-ancestor
5813589|NCT02652585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5813590|NCT02652637|Metronidazole|metronidazole|mesh-list
5813591|NCT02652637|Neomycin|neomycin|mesh-list
5813592|NCT02652637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5813593|NCT02652637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5813594|NCT02652637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5813595|NCT02652637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5813596|NCT02652637|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5813597|NCT02652637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5813598|NCT02652637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813599|NCT02652728|Enalapril|enalapril|mesh-list
5813600|NCT02652728|Enalaprilat|enalaprilat|mesh-list
5813601|NCT02652728|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5813602|NCT02652728|Protease Inhibitors|protease inhibitors|mesh-ancestor
5813603|NCT02652728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5813604|NCT02652728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813605|NCT02652728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5813606|NCT02652598|Tolcapone|tolcapone|mesh-list
5813607|NCT02652598|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5813608|NCT02652598|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5813609|NCT02652598|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
5813610|NCT02652598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5813611|NCT02652598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813612|NCT02652741|Enalapril|enalapril|mesh-list
5813613|NCT02652741|Enalaprilat|enalaprilat|mesh-list
5813614|NCT02652741|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5813615|NCT02652741|Protease Inhibitors|protease inhibitors|mesh-ancestor
5813616|NCT02652741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5813617|NCT02652741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813618|NCT02652741|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5813619|NCT02652507|Dexmedetomidine|dexmedetomidine|mesh-list
5813620|NCT02652507|Ketamine|ketamine|mesh-list
5813621|NCT02652507|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5813622|NCT02652507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5813623|NCT02652507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813624|NCT02652507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5813625|NCT02652507|Analgesics|analgesics|mesh-ancestor
5813626|NCT02652507|Sensory System Agents|sensory system agents|mesh-ancestor
5813627|NCT02652507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5813628|NCT02652507|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5813629|NCT02652507|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5813630|NCT02652507|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5813631|NCT02652507|Adrenergic Agents|adrenergic agents|mesh-ancestor
5813632|NCT02652507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5813633|NCT02652507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813634|NCT02652507|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5813635|NCT02652507|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5813636|NCT02652507|Anesthetics, General|anesthetics, general|mesh-ancestor
5813637|NCT02652507|Anesthetics|anesthetics|mesh-ancestor
5813638|NCT02652507|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5813639|NCT02652507|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5813640|NCT02652273|Abatacept|abatacept|mesh-list
5813641|NCT02652273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5813642|NCT02652273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813643|NCT02652273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5813644|NCT02652273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5813645|NCT02652273|Immunologic Factors|immunologic factors|mesh-ancestor
5813646|NCT02652273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813647|NCT02652273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5813648|NCT02652312|Diclofenac|diclofenac|mesh-list
5813649|NCT02652312|Fentanyl|fentanyl|mesh-list
5813650|NCT02652312|Dexmedetomidine|dexmedetomidine|mesh-list
5813651|NCT02652312|Ondansetron|ondansetron|mesh-list
5813652|NCT02652312|Propofol|propofol|mesh-list
5813653|NCT02652312|Desflurane|desflurane|mesh-list
5813654|NCT02652312|Atracurium|atracurium|mesh-list
5813655|NCT02652312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5813656|NCT02652312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5813657|NCT02652312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813658|NCT02652312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5813659|NCT02652312|Anesthetics, General|anesthetics, general|mesh-ancestor
5813660|NCT02652312|Anesthetics|anesthetics|mesh-ancestor
5813661|NCT02652312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5813662|NCT02652312|Analgesics|analgesics|mesh-ancestor
5813663|NCT02652312|Sensory System Agents|sensory system agents|mesh-ancestor
5813664|NCT02652312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5813665|NCT02652312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5813666|NCT02652312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5813667|NCT02652312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5813668|NCT02652312|Adrenergic Agents|adrenergic agents|mesh-ancestor
5813669|NCT02652312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5813670|NCT02652312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813671|NCT02652312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5813672|NCT02652312|Narcotics|narcotics|mesh-ancestor
5813673|NCT02652312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5813674|NCT02652312|Antiemetics|antiemetics|mesh-ancestor
5813675|NCT02652312|Autonomic Agents|autonomic agents|mesh-ancestor
5813676|NCT02652312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5813677|NCT02652312|Antipruritics|antipruritics|mesh-ancestor
5813678|NCT02652312|Dermatologic Agents|dermatologic agents|mesh-ancestor
5813679|NCT02652312|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5813680|NCT02652312|Serotonin Agents|serotonin agents|mesh-ancestor
5813681|NCT02652312|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5813682|NCT02652312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5813683|NCT02652312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5813684|NCT02652312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5813685|NCT02652312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5813686|NCT02652312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5813687|NCT02652312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5813688|NCT02652312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5813689|NCT02652312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5813690|NCT02652312|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5813691|NCT02652312|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5813692|NCT02652312|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5813693|NCT02652312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5813694|NCT02652312|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
5813695|NCT02652312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5813696|NCT02652312|Cholinergic Agents|cholinergic agents|mesh-ancestor
5813697|NCT02652325|Iodine|iodine|mesh-list
5813698|NCT02652325|Cadexomer iodine|cadexomer iodine|mesh-list
5813699|NCT02652325|Povidone-Iodine|povidone-iodine|mesh-list
5813700|NCT02652325|Povidone|povidone|mesh-list
5813701|NCT02652325|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5813702|NCT02652325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5813703|NCT02652325|Trace Elements|trace elements|mesh-ancestor
5813704|NCT02652325|Micronutrients|micronutrients|mesh-ancestor
5813705|NCT02652325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813706|NCT02652325|Plasma Substitutes|plasma substitutes|mesh-ancestor
5813707|NCT02652325|Blood Substitutes|blood substitutes|mesh-ancestor
5901104|NCT03912337|Sensory System Agents|sensory system agents|mesh-ancestor
5901105|NCT03912337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5901106|NCT03912337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901107|NCT03895099|Desogestrel|desogestrel|mesh-list
5901108|NCT03895099|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5901109|NCT03895099|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5901110|NCT03895099|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5901111|NCT03895099|Contraceptive Agents|contraceptive agents|mesh-ancestor
5901112|NCT03895099|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5901113|NCT03895099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901114|NCT03895099|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5901115|NCT03895099|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5813708|NCT02652234|Endostar protein|endostar protein|mesh-list
5813709|NCT02652234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5813710|NCT02652234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5813711|NCT02652234|Growth Substances|growth substances|mesh-ancestor
5813712|NCT02652234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813713|NCT02652234|Growth Inhibitors|growth inhibitors|mesh-ancestor
5813714|NCT02652234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5813715|NCT02652169|Amikacin|amikacin|mesh-list
5813716|NCT02652169|Teicoplanin|teicoplanin|mesh-list
5813717|NCT02652169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5813718|NCT02652169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5813719|NCT02652065|Acetylcholine|acetylcholine|mesh-list
5813720|NCT02652065|Vasodilator Agents|vasodilator agents|mesh-ancestor
5813721|NCT02652065|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5813722|NCT02652065|Cholinergic Agents|cholinergic agents|mesh-ancestor
5813723|NCT02652065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5813724|NCT02652065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813725|NCT02652065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813726|NCT02652091|Interferons|interferons|mesh-list
5813727|NCT02652091|Interferon-beta|interferon-beta|mesh-list
5813728|NCT02652091|Interferon beta-1b|interferon beta-1b|mesh-list
5813729|NCT02652091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5813730|NCT02652091|Antiviral Agents|antiviral agents|mesh-ancestor
5813731|NCT02652091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5813732|NCT02652091|Immunologic Factors|immunologic factors|mesh-ancestor
5813733|NCT02652091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813734|NCT02652091|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5813735|NCT02652130|Remestemcel-l|remestemcel-l|mesh-list
5813736|NCT02652130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5813737|NCT02652130|Antiviral Agents|antiviral agents|mesh-ancestor
5813738|NCT02652130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5813739|NCT02651870|Amlodipine|amlodipine|mesh-list
5813740|NCT02651870|Candesartan|candesartan|mesh-list
5813741|NCT02651870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5813742|NCT02651870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5813743|NCT02651870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5813744|NCT02651870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813745|NCT02651870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5813746|NCT02651870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813747|NCT02651870|Vasodilator Agents|vasodilator agents|mesh-ancestor
5813748|NCT02651870|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5813749|NCT02651870|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5813750|NCT02651792|Meperidine|meperidine|mesh-list
5813751|NCT02651792|Ketamine|ketamine|mesh-list
5813752|NCT02651792|Propofol|propofol|mesh-list
5813753|NCT02651792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5813754|NCT02651792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5813755|NCT02651792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813756|NCT02651792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5813757|NCT02651792|Anesthetics, General|anesthetics, general|mesh-ancestor
6211326|NCT02170064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211327|NCT02170077|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
6211328|NCT02170077|Anticonvulsants|anticonvulsants|mesh-ancestor
6211329|NCT02170077|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6211330|NCT02170077|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6211331|NCT02170077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5813758|NCT02651792|Anesthetics|anesthetics|mesh-ancestor
5813759|NCT02651792|Analgesics|analgesics|mesh-ancestor
5813760|NCT02651792|Sensory System Agents|sensory system agents|mesh-ancestor
5813761|NCT02651792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5813762|NCT02651792|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5813763|NCT02651792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5813764|NCT02651792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5813765|NCT02651792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5813766|NCT02651792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813767|NCT02651792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5813768|NCT02651792|Narcotics|narcotics|mesh-ancestor
5813769|NCT02651792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5813770|NCT02651753|Calcium, Dietary|calcium, dietary|mesh-list
5813771|NCT02651753|Atorvastatin|atorvastatin|mesh-list
5813772|NCT02651753|Fenofibrate|fenofibrate|mesh-list
5813773|NCT02651753|Calcium|calcium|mesh-list
5813774|NCT02651753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5813775|NCT02651753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813776|NCT02651753|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5813777|NCT02651753|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5813778|NCT02651753|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5813779|NCT02651753|Antimetabolites|antimetabolites|mesh-ancestor
5813780|NCT02651753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813781|NCT02651753|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5813782|NCT02651753|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5813783|NCT02651753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5813784|NCT02651610|Paclitaxel|paclitaxel|mesh-list
5813785|NCT02651610|Docetaxel|docetaxel|mesh-list
5813786|NCT02651610|Taxane|taxane|mesh-list
5813787|NCT02651610|Bavituximab|bavituximab|mesh-list
5813788|NCT02651610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5813789|NCT02651610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5813790|NCT02651610|Tubulin Modulators|tubulin modulators|mesh-ancestor
5813791|NCT02651610|Antimitotic Agents|antimitotic agents|mesh-ancestor
5813792|NCT02651610|Mitosis Modulators|mitosis modulators|mesh-ancestor
5813793|NCT02651610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813794|NCT02651610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5813795|NCT02651623|Moxifloxacin|moxifloxacin|mesh-list
5813796|NCT02651623|Sertraline|sertraline|mesh-list
5813797|NCT02651623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5813798|NCT02651623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5813799|NCT02651623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5813800|NCT02651623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5813801|NCT02651623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5813802|NCT02651623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813803|NCT02651623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5813804|NCT02651623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813805|NCT02651623|Antidepressive Agents|antidepressive agents|mesh-ancestor
5813806|NCT02651623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6211332|NCT02170077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813807|NCT02651623|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5813808|NCT02651623|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5813809|NCT02651623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5813810|NCT02651623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5813811|NCT02651623|Serotonin Agents|serotonin agents|mesh-ancestor
5813812|NCT02651727|Gemcitabine|gemcitabine|mesh-list
5813813|NCT02651727|Paclitaxel|paclitaxel|mesh-list
5813814|NCT02651727|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5813815|NCT02651727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5813816|NCT02651727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5813817|NCT02651727|Tubulin Modulators|tubulin modulators|mesh-ancestor
5813818|NCT02651727|Antimitotic Agents|antimitotic agents|mesh-ancestor
5813819|NCT02651727|Mitosis Modulators|mitosis modulators|mesh-ancestor
5813820|NCT02651727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813821|NCT02651727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5813822|NCT02651727|Antimetabolites|antimetabolites|mesh-ancestor
5813823|NCT02651727|Antiviral Agents|antiviral agents|mesh-ancestor
5813824|NCT02651727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5813825|NCT02651727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5813826|NCT02651727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5813827|NCT02651727|Immunologic Factors|immunologic factors|mesh-ancestor
5813828|NCT02651727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813829|NCT02651519|Ropivacaine|ropivacaine|mesh-list
5813830|NCT02651519|Anesthetics, Local|anesthetics, local|mesh-ancestor
5813831|NCT02651519|Anesthetics|anesthetics|mesh-ancestor
5813832|NCT02651519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5813833|NCT02651519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813834|NCT02651519|Sensory System Agents|sensory system agents|mesh-ancestor
5813835|NCT02651519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5813836|NCT02651662|Cemiplimab|cemiplimab|mesh-list
5813837|NCT02651662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5813838|NCT02651662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5813839|NCT02651844|Mifepristone|mifepristone|mesh-list
5813840|NCT02651844|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5813841|NCT02651844|Abortifacient Agents|abortifacient agents|mesh-ancestor
5813842|NCT02651844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5813843|NCT02651844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813844|NCT02651844|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5813845|NCT02651844|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5813846|NCT02651844|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5813847|NCT02651844|Contraceptive Agents|contraceptive agents|mesh-ancestor
5813848|NCT02651844|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5813849|NCT02651844|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5813850|NCT02651844|Hormone Antagonists|hormone antagonists|mesh-ancestor
5813851|NCT02651844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5813852|NCT02651844|Luteolytic Agents|luteolytic agents|mesh-ancestor
5813853|NCT02651844|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5813854|NCT02651844|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5813855|NCT02651636|Folic Acid|folic acid|mesh-list
5813856|NCT02651636|Thioctic Acid|thioctic acid|mesh-list
5813857|NCT02651636|Inositol|inositol|mesh-list
5813858|NCT02651636|Hematinics|hematinics|mesh-ancestor
5813859|NCT02651636|Vitamin B Complex|vitamin b complex|mesh-ancestor
5813860|NCT02651636|Vitamins|vitamins|mesh-ancestor
5813861|NCT02651636|Micronutrients|micronutrients|mesh-ancestor
5813862|NCT02651636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813863|NCT02651636|Antioxidants|antioxidants|mesh-ancestor
5813864|NCT02651636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813865|NCT02651636|Protective Agents|protective agents|mesh-ancestor
5813866|NCT02651441|Gemcitabine|gemcitabine|mesh-list
5813867|NCT02651441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5813868|NCT02651441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5813869|NCT02651441|Antimetabolites|antimetabolites|mesh-ancestor
5813870|NCT02651441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813871|NCT02651441|Antiviral Agents|antiviral agents|mesh-ancestor
5813872|NCT02651441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5813873|NCT02651441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5813874|NCT02651441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5813875|NCT02651441|Immunologic Factors|immunologic factors|mesh-ancestor
5813876|NCT02651441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813877|NCT02651350|Methylprednisolone|methylprednisolone|mesh-list
5813878|NCT02651350|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5813879|NCT02651350|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5813880|NCT02651350|Prednisolone|prednisolone|mesh-list
5813881|NCT02651350|Prednisolone acetate|prednisolone acetate|mesh-list
5813882|NCT02651350|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5813883|NCT02651350|Prednisolone phosphate|prednisolone phosphate|mesh-list
5813884|NCT02651350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5813885|NCT02651350|Antiemetics|antiemetics|mesh-ancestor
5813886|NCT02651350|Autonomic Agents|autonomic agents|mesh-ancestor
5813887|NCT02651350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5813888|NCT02651350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813889|NCT02651350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5813890|NCT02651350|Glucocorticoids|glucocorticoids|mesh-ancestor
5813891|NCT02651350|Hormones|hormones|mesh-ancestor
5813892|NCT02651350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5813893|NCT02651350|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5813894|NCT02651350|Protective Agents|protective agents|mesh-ancestor
5813895|NCT02651350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5813896|NCT02651350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5813897|NCT02651324|Ketamine|ketamine|mesh-list
5813898|NCT02651324|Analgesics|analgesics|mesh-ancestor
5813899|NCT02651324|Sensory System Agents|sensory system agents|mesh-ancestor
6211333|NCT02170207|Lansoprazole|lansoprazole|mesh-list
6211334|NCT02170207|Dexlansoprazole|dexlansoprazole|mesh-list
5813900|NCT02651324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5813901|NCT02651324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813902|NCT02651324|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5813903|NCT02651324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5813904|NCT02651324|Anesthetics, General|anesthetics, general|mesh-ancestor
5813905|NCT02651324|Anesthetics|anesthetics|mesh-ancestor
5813906|NCT02651324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5813907|NCT02651324|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5813908|NCT02651324|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5813909|NCT02651324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5813910|NCT02651324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813911|NCT02651311|Ibuprofen|ibuprofen|mesh-list
5813912|NCT02651311|Fentanyl|fentanyl|mesh-list
5813913|NCT02651311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5813914|NCT02651311|Narcotics|narcotics|mesh-ancestor
5813915|NCT02651311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5813916|NCT02651311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813917|NCT02651311|Analgesics|analgesics|mesh-ancestor
5813918|NCT02651311|Sensory System Agents|sensory system agents|mesh-ancestor
5813919|NCT02651311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5813920|NCT02651311|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5813921|NCT02651311|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5813922|NCT02651311|Anesthetics, General|anesthetics, general|mesh-ancestor
5813923|NCT02651311|Anesthetics|anesthetics|mesh-ancestor
5813924|NCT02651311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5813925|NCT02651311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5813926|NCT02651311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5813927|NCT02651311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5813928|NCT02651311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5813929|NCT02651311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5813930|NCT02651311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813931|NCT02651168|Aflibercept|aflibercept|mesh-list
5813932|NCT02651168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5813933|NCT02651168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5813934|NCT02651168|Growth Substances|growth substances|mesh-ancestor
5813935|NCT02651168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813936|NCT02651168|Growth Inhibitors|growth inhibitors|mesh-ancestor
6492465|NCT00608790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5813937|NCT02651168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5813938|NCT02651207|Lidocaine|lidocaine|mesh-list
5813939|NCT02651207|Ethyl Chloride|ethyl chloride|mesh-list
5813940|NCT02651207|Contraceptive Agents|contraceptive agents|mesh-list
5813941|NCT02651207|Anesthetics, Local|anesthetics, local|mesh-ancestor
5813942|NCT02651207|Anesthetics|anesthetics|mesh-ancestor
5813943|NCT02651207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5813944|NCT02651207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813945|NCT02651207|Sensory System Agents|sensory system agents|mesh-ancestor
5813946|NCT02651207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5813947|NCT02651207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5813948|NCT02651207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5813949|NCT02651207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5813950|NCT02651207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5813951|NCT02651207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813952|NCT02651207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5813953|NCT02651038|Micafungin|micafungin|mesh-list
5813954|NCT02651038|Antifungal Agents|antifungal agents|mesh-ancestor
5813955|NCT02651038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5813956|NCT02650752|Capecitabine|capecitabine|mesh-list
5813957|NCT02650752|Lapatinib|lapatinib|mesh-list
5813958|NCT02650752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5813959|NCT02650752|Antimetabolites|antimetabolites|mesh-ancestor
5813960|NCT02650752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813961|NCT02650752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5813962|NCT02650752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5813963|NCT02650752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5813964|NCT02650791|Tranexamic Acid|tranexamic acid|mesh-list
5813965|NCT02650791|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5813966|NCT02650791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5813967|NCT02650791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5813968|NCT02650791|Hemostatics|hemostatics|mesh-ancestor
5813969|NCT02650791|Coagulants|coagulants|mesh-ancestor
5813970|NCT02650713|Atezolizumab|atezolizumab|mesh-list
5813971|NCT02650713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5813972|NCT02650609|Methylprednisolone|methylprednisolone|mesh-list
5813973|NCT02650609|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5813974|NCT02650609|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5813975|NCT02650609|Prednisolone|prednisolone|mesh-list
5813976|NCT02650609|Prednisolone acetate|prednisolone acetate|mesh-list
5813977|NCT02650609|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5813978|NCT02650609|Prednisolone phosphate|prednisolone phosphate|mesh-list
5813979|NCT02650609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5813980|NCT02650609|Antiemetics|antiemetics|mesh-ancestor
5813981|NCT02650609|Autonomic Agents|autonomic agents|mesh-ancestor
5813982|NCT02650609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5813983|NCT02650609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813984|NCT02650609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5813985|NCT02650609|Glucocorticoids|glucocorticoids|mesh-ancestor
5813986|NCT02650609|Hormones|hormones|mesh-ancestor
5813987|NCT02650609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5813988|NCT02650609|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5813989|NCT02650609|Protective Agents|protective agents|mesh-ancestor
5813990|NCT02650609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5813991|NCT02650609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5813992|NCT02650635|Cyclophosphamide|cyclophosphamide|mesh-list
5813993|NCT02650635|Lenograstim|lenograstim|mesh-list
5813994|NCT02650635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5813995|NCT02650635|Immunologic Factors|immunologic factors|mesh-ancestor
5813996|NCT02650635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5813997|NCT02650635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5813998|NCT02650635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6211335|NCT02170207|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6211336|NCT02170207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6211337|NCT02170207|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5813999|NCT02650635|Alkylating Agents|alkylating agents|mesh-ancestor
6211338|NCT02170207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5814000|NCT02650635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814001|NCT02650635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5814002|NCT02650635|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5814003|NCT02650635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6211339|NCT02170207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814004|NCT02650596|Liraglutide|liraglutide|mesh-list
5814005|NCT02650596|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5814006|NCT02650596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814007|NCT02650596|Incretins|incretins|mesh-ancestor
5814008|NCT02650596|Hormones|hormones|mesh-ancestor
5814009|NCT02650596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5814010|NCT02650518|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5814011|NCT02650518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5901116|NCT03895099|Progestins|progestins|mesh-ancestor
5901117|NCT03895099|Hormones|hormones|mesh-ancestor
5901118|NCT03895099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5901119|NCT03864042|Losartan|losartan|mesh-list
6492466|NCT00608790|Adrenergic Agents|adrenergic agents|mesh-ancestor
6492467|NCT00608790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6492468|NCT00608790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492469|NCT00608803|Doxorubicin|doxorubicin|mesh-list
6492470|NCT00608803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6492471|NCT00608803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6492472|NCT00608803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6492473|NCT00608803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6492474|NCT00608803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6492475|NCT00608803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492476|NCT00608816|Epinephrine|epinephrine|mesh-list
6492477|NCT00608816|Racepinephrine|racepinephrine|mesh-list
6492478|NCT00608816|Epinephryl borate|epinephryl borate|mesh-list
6492479|NCT00608816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6492480|NCT00608816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5901120|NCT03864042|Midazolam|midazolam|mesh-list
5814012|NCT02650427|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5814013|NCT02650427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5814014|NCT02650427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814015|NCT02650427|Incretins|incretins|mesh-ancestor
5814016|NCT02650427|Hormones|hormones|mesh-ancestor
5814017|NCT02650427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5814018|NCT02650427|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5814019|NCT02650427|Protease Inhibitors|protease inhibitors|mesh-ancestor
5814020|NCT02650427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5814021|NCT02650427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814022|NCT02650479|Exenatide|exenatide|mesh-list
5814023|NCT02650479|Moxifloxacin|moxifloxacin|mesh-list
5814024|NCT02650479|Palonosetron|palonosetron|mesh-list
5814025|NCT02650479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5814026|NCT02650479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5814027|NCT02650479|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5814028|NCT02650479|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5814029|NCT02650479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5814030|NCT02650479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814031|NCT02650479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5814032|NCT02650479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814033|NCT02650479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5814034|NCT02650479|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5814035|NCT02650479|Incretins|incretins|mesh-ancestor
5814036|NCT02650479|Hormones|hormones|mesh-ancestor
5814037|NCT02650479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5814038|NCT02650479|Antiemetics|antiemetics|mesh-ancestor
5814039|NCT02650479|Autonomic Agents|autonomic agents|mesh-ancestor
5814040|NCT02650479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5814041|NCT02650479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5814042|NCT02650479|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5814043|NCT02650479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5814044|NCT02650479|Serotonin Agents|serotonin agents|mesh-ancestor
5814045|NCT02650479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5814046|NCT02650544|Mirtazapine|mirtazapine|mesh-list
5814047|NCT02650544|Antidepressive Agents|antidepressive agents|mesh-ancestor
5814048|NCT02650544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5814049|NCT02650544|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5814050|NCT02650544|Histamine Antagonists|histamine antagonists|mesh-ancestor
5814051|NCT02650544|Histamine Agents|histamine agents|mesh-ancestor
5814052|NCT02650544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5814053|NCT02650544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814054|NCT02650544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814055|NCT02650544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5814056|NCT02650544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5814057|NCT02650544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5814058|NCT02650544|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5814059|NCT02650544|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6211340|NCT02170220|Vortioxetine|vortioxetine|mesh-list
5814060|NCT02650544|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5814061|NCT02650544|Adrenergic Agents|adrenergic agents|mesh-ancestor
5814062|NCT02650544|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5814063|NCT02650544|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5814064|NCT02650544|Serotonin Agents|serotonin agents|mesh-ancestor
5814065|NCT02650544|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5814066|NCT02650245|Lactulose|lactulose|mesh-list
5814067|NCT02650245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5814068|NCT02650206|Liraglutide|liraglutide|mesh-list
5814069|NCT02650206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5814070|NCT02650206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814071|NCT02650206|Incretins|incretins|mesh-ancestor
5814072|NCT02650206|Hormones|hormones|mesh-ancestor
5814073|NCT02650206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5814074|NCT02650102|Olanzapine|olanzapine|mesh-list
5814075|NCT02650102|Risperidone|risperidone|mesh-list
5814076|NCT02650102|Quetiapine Fumarate|quetiapine fumarate|mesh-list
5814077|NCT02650102|Aripiprazole|aripiprazole|mesh-list
5814078|NCT02650102|Ziprasidone|ziprasidone|mesh-list
5814079|NCT02650102|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5814080|NCT02650102|Serotonin Agents|serotonin agents|mesh-ancestor
5814081|NCT02650102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5814082|NCT02650102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814083|NCT02650102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814084|NCT02650102|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5814085|NCT02650102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5814086|NCT02650102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5814087|NCT02650102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5814088|NCT02650102|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5814089|NCT02650102|Dopamine Agents|dopamine agents|mesh-ancestor
5814090|NCT02650102|Antiemetics|antiemetics|mesh-ancestor
5814091|NCT02650102|Autonomic Agents|autonomic agents|mesh-ancestor
5814092|NCT02650102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5814093|NCT02650102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5814094|NCT02650102|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5814095|NCT02650102|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5814096|NCT02650102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5814097|NCT02650102|Antidepressive Agents|antidepressive agents|mesh-ancestor
5814098|NCT02650102|Dopamine Agonists|dopamine agonists|mesh-ancestor
5814099|NCT02650102|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5814100|NCT02650102|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5814101|NCT02650102|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5814102|NCT02650102|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5814103|NCT02649920|Dinoprostone|dinoprostone|mesh-list
5814104|NCT02649920|Oxytocics|oxytocics|mesh-ancestor
5814105|NCT02649920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5814106|NCT02649920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814107|NCT02649998|Furosemide|furosemide|mesh-list
5814108|NCT02649998|Isosorbide|isosorbide|mesh-list
5814109|NCT02649998|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
5814110|NCT02649998|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
5814111|NCT02649998|Diuretics|diuretics|mesh-ancestor
5814112|NCT02649998|Natriuretic Agents|natriuretic agents|mesh-ancestor
5814113|NCT02649998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814114|NCT02649998|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5814115|NCT02649998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5814116|NCT02649998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814117|NCT02649998|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5814118|NCT02649998|Vasodilator Agents|vasodilator agents|mesh-ancestor
5814119|NCT02649998|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5814120|NCT02649751|Roscovitine|roscovitine|mesh-list
5814121|NCT02649751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5814122|NCT02649751|Antiviral Agents|antiviral agents|mesh-ancestor
5814123|NCT02649751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5814124|NCT02649751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5814125|NCT02649751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5814126|NCT02649751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814127|NCT02649686|Trastuzumab|trastuzumab|mesh-list
5814128|NCT02649686|Durvalumab|durvalumab|mesh-list
5814129|NCT02649686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5814130|NCT02649686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5814131|NCT02649829|Vaccines|vaccines|mesh-list
5814132|NCT02649829|Immunologic Factors|immunologic factors|mesh-ancestor
5814133|NCT02649829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814134|NCT02649673|Topotecan|topotecan|mesh-list
5814135|NCT02649673|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5814136|NCT02649673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5814137|NCT02649673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5814138|NCT02649673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814139|NCT02649673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5814140|NCT02649582|Temozolomide|temozolomide|mesh-list
5814141|NCT02649582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5814142|NCT02649582|Alkylating Agents|alkylating agents|mesh-ancestor
5814143|NCT02649582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814144|NCT02649582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5814145|NCT02649530|LGK974|lgk974|mesh-list
5814146|NCT02649530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5814147|NCT02649530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814148|NCT02649621|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5814149|NCT02649621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5814150|NCT02649504|Mycophenolic Acid|mycophenolic acid|mesh-list
5814151|NCT02649504|Dexamethasone|dexamethasone|mesh-list
5814152|NCT02649504|Rituximab|rituximab|mesh-list
5814153|NCT02649504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5814154|NCT02649504|Antiemetics|antiemetics|mesh-ancestor
5814155|NCT02649504|Autonomic Agents|autonomic agents|mesh-ancestor
5814156|NCT02649504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5814157|NCT02649504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814158|NCT02649504|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5814159|NCT02649504|Glucocorticoids|glucocorticoids|mesh-ancestor
5814160|NCT02649504|Hormones|hormones|mesh-ancestor
5814161|NCT02649504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5814162|NCT02649504|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5814163|NCT02649504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5814164|NCT02649504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5814165|NCT02649504|Immunologic Factors|immunologic factors|mesh-ancestor
5814166|NCT02649504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5814167|NCT02649504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5814168|NCT02649504|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5814169|NCT02649504|Antitubercular Agents|antitubercular agents|mesh-ancestor
5814170|NCT02649504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5814171|NCT02649504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5814172|NCT02649504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5814173|NCT02649504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814174|NCT02649478|Fluticasone|fluticasone|mesh-list
5814175|NCT02649478|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5814176|NCT02649478|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
5814177|NCT02649478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5814178|NCT02649478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5814179|NCT02649478|Autonomic Agents|autonomic agents|mesh-ancestor
5814180|NCT02649478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5814181|NCT02649478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814182|NCT02649478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5814183|NCT02649478|Respiratory System Agents|respiratory system agents|mesh-ancestor
5814184|NCT02649478|Dermatologic Agents|dermatologic agents|mesh-ancestor
5814185|NCT02649478|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5814186|NCT02649478|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5814187|NCT02649478|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5814188|NCT02649478|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5814189|NCT02649478|Adrenergic Agents|adrenergic agents|mesh-ancestor
5814190|NCT02649478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5814191|NCT02649478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814192|NCT02649478|Glucocorticoids|glucocorticoids|mesh-ancestor
5814193|NCT02649478|Hormones|hormones|mesh-ancestor
5814194|NCT02649478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6674307|NCT01568450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6674308|NCT01568632|Imetelstat|imetelstat|mesh-list
6674309|NCT01568632|Motesanib diphosphate|motesanib diphosphate|mesh-list
6674310|NCT01568632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6674311|NCT01568632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674312|NCT01568632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6674313|NCT01568645|Imatinib Mesylate|imatinib mesylate|mesh-list
6674314|NCT01568645|Carvedilol|carvedilol|mesh-list
6674315|NCT01568645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6674316|NCT01568645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6674317|NCT01568645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6674318|NCT01568645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674319|NCT01568645|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6674320|NCT01568645|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5814195|NCT02649478|Sympathomimetics|sympathomimetics|mesh-ancestor
5814196|NCT02649465|Glimepiride|glimepiride|mesh-list
5814197|NCT02649465|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
5814198|NCT02649465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5814199|NCT02649465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5814200|NCT02649465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814201|NCT02649465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5814202|NCT02649465|Immunologic Factors|immunologic factors|mesh-ancestor
5814203|NCT02649465|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5814204|NCT02649465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814205|NCT02649179|Ropivacaine|ropivacaine|mesh-list
5814206|NCT02649179|Anesthetics, Local|anesthetics, local|mesh-ancestor
5814207|NCT02649179|Anesthetics|anesthetics|mesh-ancestor
5814208|NCT02649179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5814209|NCT02649179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814210|NCT02649179|Sensory System Agents|sensory system agents|mesh-ancestor
5814211|NCT02649179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5814212|NCT02649335|Propranolol|propranolol|mesh-list
5814213|NCT02649335|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5814214|NCT02649335|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5814215|NCT02649335|Adrenergic Agents|adrenergic agents|mesh-ancestor
5814216|NCT02649335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5814217|NCT02649335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814218|NCT02649335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814219|NCT02649335|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5814220|NCT02649335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5814221|NCT02649335|Vasodilator Agents|vasodilator agents|mesh-ancestor
5814222|NCT02649413|Prednisone|prednisone|mesh-list
5814223|NCT02649413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5814224|NCT02649413|Glucocorticoids|glucocorticoids|mesh-ancestor
5814225|NCT02649413|Hormones|hormones|mesh-ancestor
5814226|NCT02649413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5814227|NCT02649413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814228|NCT02649413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5814229|NCT02649413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5814230|NCT02649140|Acetic Acid|acetic acid|mesh-list
5814231|NCT02649140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5814232|NCT02649140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5814233|NCT02648958|Dexmedetomidine|dexmedetomidine|mesh-list
5814234|NCT02648958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5814235|NCT02648958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5814236|NCT02648958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814237|NCT02648958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5814238|NCT02648958|Analgesics|analgesics|mesh-ancestor
5814239|NCT02648958|Sensory System Agents|sensory system agents|mesh-ancestor
5814240|NCT02648958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5814241|NCT02648958|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5814242|NCT02648958|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5814243|NCT02648958|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5814244|NCT02648958|Adrenergic Agents|adrenergic agents|mesh-ancestor
5814245|NCT02648958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5814246|NCT02648958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814247|NCT02648854|Metformin|metformin|mesh-list
5814248|NCT02648854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5814249|NCT02648854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814250|NCT02649075|Immunoglobulins|immunoglobulins|mesh-list
5814251|NCT02649075|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5814252|NCT02649075|Antibodies|antibodies|mesh-list
5814253|NCT02649075|Immunologic Factors|immunologic factors|mesh-ancestor
5814254|NCT02649075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814255|NCT02648906|Choline|choline|mesh-list
6492481|NCT00608816|Adrenergic Agents|adrenergic agents|mesh-ancestor
6492482|NCT00608816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6492483|NCT00608816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492484|NCT00608816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492485|NCT00608816|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6492486|NCT00608816|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6492487|NCT00608816|Autonomic Agents|autonomic agents|mesh-ancestor
6492488|NCT00608816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6492489|NCT00608816|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6492490|NCT00608816|Respiratory System Agents|respiratory system agents|mesh-ancestor
6492491|NCT00608816|Mydriatics|mydriatics|mesh-ancestor
6492492|NCT00608816|Sympathomimetics|sympathomimetics|mesh-ancestor
6492493|NCT00608816|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6492494|NCT00608946|Copper|copper|mesh-list
6492495|NCT00608946|Trace Elements|trace elements|mesh-ancestor
5814256|NCT02648906|Lipotropic Agents|lipotropic agents|mesh-ancestor
5814257|NCT02648906|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5814258|NCT02648906|Antimetabolites|antimetabolites|mesh-ancestor
5814259|NCT02648906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814260|NCT02648906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5814261|NCT02648906|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5814262|NCT02648906|Nootropic Agents|nootropic agents|mesh-ancestor
5814263|NCT02649101|Thalidomide|thalidomide|mesh-list
6492496|NCT00608946|Micronutrients|micronutrients|mesh-ancestor
6492497|NCT00608946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492498|NCT00608972|Bevacizumab|bevacizumab|mesh-list
6492499|NCT00608972|Carboplatin|carboplatin|mesh-list
6492500|NCT00608972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6492501|NCT00608972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6492502|NCT00608972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6492503|NCT00608972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6492504|NCT00608972|Growth Substances|growth substances|mesh-ancestor
6492505|NCT00608972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492506|NCT00608972|Growth Inhibitors|growth inhibitors|mesh-ancestor
6492507|NCT00609011|Temozolomide|temozolomide|mesh-list
5814264|NCT02649101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5814265|NCT02649101|Immunologic Factors|immunologic factors|mesh-ancestor
5814266|NCT02649101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814267|NCT02649101|Leprostatic Agents|leprostatic agents|mesh-ancestor
5814268|NCT02649101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5814269|NCT02649101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5814270|NCT02649101|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5814271|NCT02649101|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5814272|NCT02649101|Growth Substances|growth substances|mesh-ancestor
5814273|NCT02649101|Growth Inhibitors|growth inhibitors|mesh-ancestor
5814274|NCT02649101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901121|NCT03864042|Dextromethorphan|dextromethorphan|mesh-list
5901122|NCT03864042|Caffeine|caffeine|mesh-list
5901123|NCT03864042|Modafinil|modafinil|mesh-list
5901124|NCT03864042|Bupropion|bupropion|mesh-list
5901125|NCT03864042|Omeprazole|omeprazole|mesh-list
5901126|NCT03864042|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5901127|NCT03864042|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5901128|NCT03864042|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5901129|NCT03864042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5901130|NCT03864042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901131|NCT03864042|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5901132|NCT03864042|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5901133|NCT03864042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5901134|NCT03864042|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5901135|NCT03864042|Anesthetics, General|anesthetics, general|mesh-ancestor
5901136|NCT03864042|Anesthetics|anesthetics|mesh-ancestor
5901137|NCT03864042|GABA Modulators|gaba modulators|mesh-ancestor
5901138|NCT03864042|GABA Agents|gaba agents|mesh-ancestor
5901139|NCT03864042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5901140|NCT03864042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492508|NCT00609011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6492509|NCT00609011|Alkylating Agents|alkylating agents|mesh-ancestor
6492510|NCT00609011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492511|NCT00609011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901141|NCT03864042|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5901142|NCT03864042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5814275|NCT02648776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
5814276|NCT02648776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5814277|NCT02648776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814278|NCT02648425|Leucovorin|leucovorin|mesh-list
5814279|NCT02648425|Cisplatin|cisplatin|mesh-list
5814280|NCT02648425|Fluorouracil|fluorouracil|mesh-list
5814281|NCT02648425|Capecitabine|capecitabine|mesh-list
5814282|NCT02648425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5814283|NCT02648425|Antimetabolites|antimetabolites|mesh-ancestor
5814284|NCT02648425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814285|NCT02648425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5814286|NCT02648425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5814287|NCT02648425|Immunologic Factors|immunologic factors|mesh-ancestor
5814288|NCT02648425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814289|NCT02648425|Antidotes|antidotes|mesh-ancestor
5814290|NCT02648425|Protective Agents|protective agents|mesh-ancestor
5814291|NCT02648425|Vitamin B Complex|vitamin b complex|mesh-ancestor
5814292|NCT02648425|Vitamins|vitamins|mesh-ancestor
5814293|NCT02648425|Micronutrients|micronutrients|mesh-ancestor
5814294|NCT02648711|Leucovorin|leucovorin|mesh-list
5814295|NCT02648711|Bevacizumab|bevacizumab|mesh-list
5814296|NCT02648711|Oxaliplatin|oxaliplatin|mesh-list
5814297|NCT02648711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5814298|NCT02648711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5814299|NCT02648711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5814300|NCT02648711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5814301|NCT02648711|Growth Substances|growth substances|mesh-ancestor
5814302|NCT02648711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814303|NCT02648711|Growth Inhibitors|growth inhibitors|mesh-ancestor
5814304|NCT02648711|Antidotes|antidotes|mesh-ancestor
5814305|NCT02648711|Protective Agents|protective agents|mesh-ancestor
5814306|NCT02648711|Vitamin B Complex|vitamin b complex|mesh-ancestor
5814307|NCT02648711|Vitamins|vitamins|mesh-ancestor
5814308|NCT02648711|Micronutrients|micronutrients|mesh-ancestor
5814309|NCT02648464|Hydroxychloroquine|hydroxychloroquine|mesh-list
5814310|NCT02648464|Antimalarials|antimalarials|mesh-ancestor
5814311|NCT02648464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5814312|NCT02648464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5814313|NCT02648464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5814314|NCT02648464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6674321|NCT01568645|Adrenergic Agents|adrenergic agents|mesh-ancestor
6674322|NCT01568645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6674323|NCT01568645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674324|NCT01568645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6674325|NCT01568645|Antioxidants|antioxidants|mesh-ancestor
6674326|NCT01568645|Protective Agents|protective agents|mesh-ancestor
6674327|NCT01568645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6674328|NCT01568645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5814315|NCT02648464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814316|NCT02648464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6674329|NCT01568645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5814317|NCT02648503|Atropine|atropine|mesh-list
5814318|NCT02648503|Rocuronium|rocuronium|mesh-list
5814319|NCT02648503|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5814320|NCT02648503|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5814321|NCT02648503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5814322|NCT02648503|Autonomic Agents|autonomic agents|mesh-ancestor
5814323|NCT02648503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5814324|NCT02648503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814325|NCT02648503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5814326|NCT02648503|Respiratory System Agents|respiratory system agents|mesh-ancestor
5814327|NCT02648503|Mydriatics|mydriatics|mesh-ancestor
5814328|NCT02648503|Parasympatholytics|parasympatholytics|mesh-ancestor
5814329|NCT02648503|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5814330|NCT02648503|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5814331|NCT02648503|Cholinergic Agents|cholinergic agents|mesh-ancestor
5814332|NCT02648503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5814333|NCT02648503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814334|NCT02648503|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5814335|NCT02648503|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5814336|NCT02648503|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5814337|NCT02648490|Acetaminophen|acetaminophen|mesh-list
5814338|NCT02648490|Diphenhydramine|diphenhydramine|mesh-list
5814339|NCT02648490|Promethazine|promethazine|mesh-list
6492512|NCT00609063|Atorvastatin|atorvastatin|mesh-list
6492513|NCT00609063|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6492514|NCT00609063|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6492515|NCT00609063|Antimetabolites|antimetabolites|mesh-ancestor
6492516|NCT00609063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814340|NCT02648490|Dexamethasone|dexamethasone|mesh-list
5814341|NCT02648490|Cetuximab|cetuximab|mesh-list
6492517|NCT00609063|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6492518|NCT00609063|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6492519|NCT00609063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6492520|NCT00609115|Methylamphotericin B|methylamphotericin b|mesh-list
6492521|NCT00609115|Antifungal Agents|antifungal agents|mesh-ancestor
5814342|NCT02648490|Ondansetron|ondansetron|mesh-list
5814343|NCT02648490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5814344|NCT02648490|Antiemetics|antiemetics|mesh-ancestor
5814345|NCT02648490|Autonomic Agents|autonomic agents|mesh-ancestor
5814346|NCT02648490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5814347|NCT02648490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814348|NCT02648490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5814349|NCT02648490|Glucocorticoids|glucocorticoids|mesh-ancestor
5814350|NCT02648490|Hormones|hormones|mesh-ancestor
5814351|NCT02648490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5814352|NCT02648490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5814353|NCT02648490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6211341|NCT02170220|Antidepressive Agents|antidepressive agents|mesh-ancestor
6211342|NCT02170220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6211343|NCT02170220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6211344|NCT02170220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6211345|NCT02170220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6211346|NCT02170220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211347|NCT02170220|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6211348|NCT02170220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6211349|NCT02170220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6211350|NCT02170220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814354|NCT02648490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6211351|NCT02170220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5814355|NCT02648490|Analgesics|analgesics|mesh-ancestor
5814356|NCT02648490|Sensory System Agents|sensory system agents|mesh-ancestor
5814357|NCT02648490|Antipyretics|antipyretics|mesh-ancestor
5814358|NCT02648490|Antipruritics|antipruritics|mesh-ancestor
5814359|NCT02648490|Dermatologic Agents|dermatologic agents|mesh-ancestor
5814360|NCT02648490|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5814361|NCT02648490|Serotonin Agents|serotonin agents|mesh-ancestor
5814362|NCT02648490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5814363|NCT02648490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814364|NCT02648490|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5814365|NCT02648490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5814366|NCT02648490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5814367|NCT02648490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5814368|NCT02648490|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5814369|NCT02648490|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5814370|NCT02648490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5814371|NCT02648490|Anesthetics, Local|anesthetics, local|mesh-ancestor
5814372|NCT02648490|Anesthetics|anesthetics|mesh-ancestor
5814373|NCT02648490|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5814374|NCT02648490|Histamine Antagonists|histamine antagonists|mesh-ancestor
5814375|NCT02648490|Histamine Agents|histamine agents|mesh-ancestor
5814376|NCT02648490|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5814377|NCT02648490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5814378|NCT02648633|Nivolumab|nivolumab|mesh-list
5814379|NCT02648633|Valproic Acid|valproic acid|mesh-list
5814380|NCT02648633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5814381|NCT02648633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5814382|NCT02648633|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5814383|NCT02648633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814384|NCT02648633|Anticonvulsants|anticonvulsants|mesh-ancestor
5814385|NCT02648633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5814386|NCT02648633|GABA Agents|gaba agents|mesh-ancestor
5814387|NCT02648633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5901143|NCT03864042|Antimetabolites|antimetabolites|mesh-ancestor
5814388|NCT02648633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814389|NCT02648633|Antimanic Agents|antimanic agents|mesh-ancestor
5814390|NCT02648633|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5814391|NCT02648633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5814392|NCT02648633|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5814393|NCT02648659|Amoxicillin|amoxicillin|mesh-list
5814394|NCT02648659|Metronidazole|metronidazole|mesh-list
5814395|NCT02648659|Clarithromycin|clarithromycin|mesh-list
5814396|NCT02648659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5814397|NCT02648659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5814398|NCT02648659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5814399|NCT02648659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5814400|NCT02648659|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5814401|NCT02648659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5814402|NCT02648659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814403|NCT02648659|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5814404|NCT02648659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5814405|NCT02648412|Ketamine|ketamine|mesh-list
5814406|NCT02648412|Analgesics|analgesics|mesh-ancestor
5814407|NCT02648412|Sensory System Agents|sensory system agents|mesh-ancestor
5814408|NCT02648412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5814409|NCT02648412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814410|NCT02648412|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5814411|NCT02648412|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5814412|NCT02648412|Anesthetics, General|anesthetics, general|mesh-ancestor
5814413|NCT02648412|Anesthetics|anesthetics|mesh-ancestor
5814414|NCT02648412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5814415|NCT02648412|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5814416|NCT02648412|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5814417|NCT02648412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5814418|NCT02648412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814419|NCT02648282|Cyclophosphamide|cyclophosphamide|mesh-list
5814420|NCT02648282|Pembrolizumab|pembrolizumab|mesh-list
5814421|NCT02648282|Immunologic Factors|immunologic factors|mesh-ancestor
5814422|NCT02648282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814423|NCT02648282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5814424|NCT02648282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5814425|NCT02648282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5814426|NCT02648282|Alkylating Agents|alkylating agents|mesh-ancestor
5814427|NCT02648282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814428|NCT02648282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6211352|NCT02170220|Serotonin Agents|serotonin agents|mesh-ancestor
6211353|NCT02170220|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6211354|NCT02170220|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6211355|NCT02170220|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6211356|NCT02170220|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6211357|NCT02170376|Levodopa|levodopa|mesh-list
6211358|NCT02170376|Carbidopa|carbidopa|mesh-list
6211359|NCT02170376|Opicapone|opicapone|mesh-list
6211360|NCT02170376|Entacapone|entacapone|mesh-list
6211361|NCT02170376|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6211362|NCT02170376|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6211363|NCT02170376|Dopamine Agents|dopamine agents|mesh-ancestor
6492522|NCT00609115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6492523|NCT00609141|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6492524|NCT00609141|Immunologic Factors|immunologic factors|mesh-ancestor
6492525|NCT00609141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492526|NCT00609154|Glucagon|glucagon|mesh-list
6492527|NCT00609154|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6492528|NCT00609154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6492529|NCT00609154|Hormones|hormones|mesh-ancestor
6492530|NCT00609154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6492531|NCT00609154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492532|NCT00609154|Incretins|incretins|mesh-ancestor
6492533|NCT00609180|Antioxidants|antioxidants|mesh-list
6492534|NCT00609180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492535|NCT00609180|Protective Agents|protective agents|mesh-ancestor
6492536|NCT00609180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492537|NCT00609193|Quetiapine Fumarate|quetiapine fumarate|mesh-list
5814429|NCT02648282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5814430|NCT02648282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5814431|NCT02648048|Pirfenidone|pirfenidone|mesh-list
5814432|NCT02648048|Analgesics|analgesics|mesh-ancestor
5814433|NCT02648048|Sensory System Agents|sensory system agents|mesh-ancestor
5814434|NCT02648048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5814435|NCT02648048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814436|NCT02648048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5814437|NCT02648048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5814438|NCT02648048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5814439|NCT02648048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5814440|NCT02648048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5814441|NCT02647892|Lidocaine|lidocaine|mesh-list
5814442|NCT02647892|Anesthetics, Local|anesthetics, local|mesh-ancestor
5814443|NCT02647892|Anesthetics|anesthetics|mesh-ancestor
5814444|NCT02647892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5814445|NCT02647892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814446|NCT02647892|Sensory System Agents|sensory system agents|mesh-ancestor
5814447|NCT02647892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5814448|NCT02647892|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5814449|NCT02647892|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5814450|NCT02647892|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5814451|NCT02647892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5814452|NCT02647892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814453|NCT02647827|Metformin|metformin|mesh-list
5814454|NCT02647827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5814455|NCT02647827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814456|NCT02647918|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
5814457|NCT02647918|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5814458|NCT02647918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814459|NCT02647918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6492538|NCT00609193|Antidepressive Agents|antidepressive agents|mesh-ancestor
6492539|NCT00609193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6492540|NCT00609193|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6492541|NCT00609193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6492542|NCT00609193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6492543|NCT00609193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492544|NCT00609284|Carboplatin|carboplatin|mesh-list
6492545|NCT00609284|Cetuximab|cetuximab|mesh-list
6492546|NCT00609284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5814460|NCT02647918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814461|NCT02647671|Calcium Carbonate|calcium carbonate|mesh-list
5814462|NCT02647671|Calcium|calcium|mesh-list
5814463|NCT02647671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5814464|NCT02647671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814465|NCT02647671|Antacids|antacids|mesh-ancestor
5814466|NCT02647671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814467|NCT02647671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5814468|NCT02647567|Caffeine|caffeine|mesh-list
5814469|NCT02647567|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5814470|NCT02647567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814471|NCT02647567|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5814472|NCT02647567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5814473|NCT02647567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814474|NCT02647567|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5814475|NCT02647567|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5814476|NCT02647567|Purinergic Agents|purinergic agents|mesh-ancestor
5814477|NCT02647567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5814478|NCT02647385|Lidocaine|lidocaine|mesh-list
5814479|NCT02647385|Anesthetics, Local|anesthetics, local|mesh-ancestor
6492547|NCT00609284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6492548|NCT00609375|Cefepime|cefepime|mesh-list
6492549|NCT00609375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6492550|NCT00609375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6492551|NCT00609388|Tacrolimus|tacrolimus|mesh-list
6492552|NCT00609388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5814480|NCT02647385|Anesthetics|anesthetics|mesh-ancestor
5814481|NCT02647385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5814482|NCT02647385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814483|NCT02647385|Sensory System Agents|sensory system agents|mesh-ancestor
5814484|NCT02647385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5814485|NCT02647385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5814486|NCT02647385|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5814487|NCT02647385|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5814488|NCT02647385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5814489|NCT02647385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814490|NCT02647515|Ranibizumab|ranibizumab|mesh-list
6492553|NCT00609388|Immunologic Factors|immunologic factors|mesh-ancestor
5814491|NCT02647515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5814492|NCT02647515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5814493|NCT02647515|Growth Substances|growth substances|mesh-ancestor
5814494|NCT02647515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814495|NCT02647515|Growth Inhibitors|growth inhibitors|mesh-ancestor
5814496|NCT02647515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5814497|NCT02647437|Levetiracetam|levetiracetam|mesh-list
5814498|NCT02647437|Anticonvulsants|anticonvulsants|mesh-ancestor
5814499|NCT02647437|Nootropic Agents|nootropic agents|mesh-ancestor
5814500|NCT02647424|Letrozole|letrozole|mesh-list
5814501|NCT02647424|Clomiphene|clomiphene|mesh-list
5814502|NCT02647424|Enclomiphene|enclomiphene|mesh-list
5814503|NCT02647424|Zuclomiphene|zuclomiphene|mesh-list
5814504|NCT02647424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5814505|NCT02647424|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5814506|NCT02647424|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5814507|NCT02647424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5814508|NCT02647424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814509|NCT02647424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5814510|NCT02647424|Hormone Antagonists|hormone antagonists|mesh-ancestor
5814511|NCT02647424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5814512|NCT02647424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814513|NCT02647424|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5814514|NCT02647424|Fertility Agents|fertility agents|mesh-ancestor
5814515|NCT02647424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5814516|NCT02647424|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5814517|NCT02647424|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5814518|NCT02647632|Ribavirin|ribavirin|mesh-list
5814519|NCT02647632|Sofosbuvir|sofosbuvir|mesh-list
5814520|NCT02647632|Grazoprevir|grazoprevir|mesh-list
5814521|NCT02647632|Antimetabolites|antimetabolites|mesh-ancestor
5814522|NCT02647632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814523|NCT02647632|Antiviral Agents|antiviral agents|mesh-ancestor
5814524|NCT02647632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5814525|NCT02647489|Aluminum Hydroxide|aluminum hydroxide|mesh-list
5814526|NCT02647489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5814527|NCT02647489|Immunologic Factors|immunologic factors|mesh-ancestor
5814528|NCT02647489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814529|NCT02647489|Antacids|antacids|mesh-ancestor
5814530|NCT02647489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814531|NCT02647489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5814532|NCT02647554|Urinastatin|urinastatin|mesh-list
5814533|NCT02647554|Trypsin Inhibitors|trypsin inhibitors|mesh-list
5814534|NCT02647554|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5814535|NCT02647554|Protease Inhibitors|protease inhibitors|mesh-ancestor
5814536|NCT02647554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5814537|NCT02647554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814538|NCT02647190|Asparaginase|asparaginase|mesh-list
5814539|NCT02647190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5814540|NCT02647255|Methylprednisolone|methylprednisolone|mesh-list
5814541|NCT02647255|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5814542|NCT02647255|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5814543|NCT02647255|Prednisolone|prednisolone|mesh-list
5814544|NCT02647255|Prednisolone acetate|prednisolone acetate|mesh-list
5814545|NCT02647255|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5814546|NCT02647255|Prednisolone phosphate|prednisolone phosphate|mesh-list
5814547|NCT02647255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5814548|NCT02647255|Antiemetics|antiemetics|mesh-ancestor
5814549|NCT02647255|Autonomic Agents|autonomic agents|mesh-ancestor
5814550|NCT02647255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5814551|NCT02647255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814552|NCT02647255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5814553|NCT02647255|Glucocorticoids|glucocorticoids|mesh-ancestor
5814554|NCT02647255|Hormones|hormones|mesh-ancestor
5814555|NCT02647255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5814556|NCT02647255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5814557|NCT02647255|Protective Agents|protective agents|mesh-ancestor
5814558|NCT02647255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5814559|NCT02647255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5814560|NCT02647268|Magnesium Sulfate|magnesium sulfate|mesh-list
5814561|NCT02647268|Oxytocin|oxytocin|mesh-list
5814562|NCT02647268|Oxytocics|oxytocics|mesh-ancestor
5814563|NCT02647268|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5814564|NCT02647268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814565|NCT02647268|Analgesics|analgesics|mesh-ancestor
5814566|NCT02647268|Sensory System Agents|sensory system agents|mesh-ancestor
5814567|NCT02647268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5814568|NCT02647268|Anesthetics|anesthetics|mesh-ancestor
5814569|NCT02647268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5814570|NCT02647268|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5814571|NCT02647268|Anticonvulsants|anticonvulsants|mesh-ancestor
5814572|NCT02647268|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5814573|NCT02647268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5814574|NCT02647268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814575|NCT02647268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5814576|NCT02647268|Tocolytic Agents|tocolytic agents|mesh-ancestor
5901144|NCT03864042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5901145|NCT03864042|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5901146|NCT03864042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5901147|NCT03864042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5901148|NCT03864042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6492554|NCT00609388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814577|NCT02647151|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5814578|NCT02647151|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
5814579|NCT02647151|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5814580|NCT02647151|Dermatologic Agents|dermatologic agents|mesh-ancestor
5814581|NCT02647047|Acetaminophen|acetaminophen|mesh-list
5814582|NCT02647047|Ketorolac|ketorolac|mesh-list
5814583|NCT02647047|Sufentanil|sufentanil|mesh-list
5814584|NCT02647047|Ropivacaine|ropivacaine|mesh-list
5814585|NCT02647047|Anesthetics, Local|anesthetics, local|mesh-ancestor
5814586|NCT02647047|Anesthetics|anesthetics|mesh-ancestor
5814587|NCT02647047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5814588|NCT02647047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814589|NCT02647047|Sensory System Agents|sensory system agents|mesh-ancestor
5814590|NCT02647047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5814591|NCT02647047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5814592|NCT02647047|Analgesics|analgesics|mesh-ancestor
5814593|NCT02647047|Antipyretics|antipyretics|mesh-ancestor
5814594|NCT02647047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5814595|NCT02647047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5814596|NCT02647047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5814597|NCT02647047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5814598|NCT02647047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5814599|NCT02647047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814600|NCT02647047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5814601|NCT02647047|Narcotics|narcotics|mesh-ancestor
5814602|NCT02647047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5814603|NCT02647047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5814604|NCT02647047|Anesthetics, General|anesthetics, general|mesh-ancestor
5814605|NCT02646800|Micafungin|micafungin|mesh-list
5814606|NCT02646800|Antifungal Agents|antifungal agents|mesh-ancestor
5814607|NCT02646800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5814608|NCT02646774|Micafungin|micafungin|mesh-list
5814609|NCT02646774|Antifungal Agents|antifungal agents|mesh-ancestor
5814610|NCT02646774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5814611|NCT02647086|Metoprolol|metoprolol|mesh-list
5814612|NCT02647086|Midazolam|midazolam|mesh-list
5814613|NCT02647086|Caffeine|caffeine|mesh-list
5814614|NCT02647086|Omeprazole|omeprazole|mesh-list
5814615|NCT02647086|Warfarin|warfarin|mesh-list
5814616|NCT02647086|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5814617|NCT02647086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5814618|NCT02647086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5814619|NCT02647086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814620|NCT02647086|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5814621|NCT02647086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5814622|NCT02647086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5814623|NCT02647086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5814624|NCT02647086|Anesthetics, General|anesthetics, general|mesh-ancestor
5814625|NCT02647086|Anesthetics|anesthetics|mesh-ancestor
5814626|NCT02647086|GABA Modulators|gaba modulators|mesh-ancestor
5814627|NCT02647086|GABA Agents|gaba agents|mesh-ancestor
5814628|NCT02647086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5814629|NCT02647086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814630|NCT02647086|Anticoagulants|anticoagulants|mesh-ancestor
5814631|NCT02647086|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5814632|NCT02647086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5814633|NCT02647086|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5814634|NCT02647086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5814635|NCT02647086|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5814636|NCT02647086|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5814637|NCT02647086|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5814638|NCT02647086|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5814639|NCT02647086|Purinergic Agents|purinergic agents|mesh-ancestor
5814640|NCT02647086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5814641|NCT02647086|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5814642|NCT02647086|Sympatholytics|sympatholytics|mesh-ancestor
5814643|NCT02647086|Autonomic Agents|autonomic agents|mesh-ancestor
5814644|NCT02647086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5814645|NCT02647086|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5814646|NCT02647086|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5814647|NCT02647086|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5814648|NCT02647086|Adrenergic Agents|adrenergic agents|mesh-ancestor
5814649|NCT02646904|Beclomethasone|beclomethasone|mesh-list
5814650|NCT02646904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5814651|NCT02646904|Glucocorticoids|glucocorticoids|mesh-ancestor
5814652|NCT02646904|Hormones|hormones|mesh-ancestor
5814653|NCT02646904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6211364|NCT02170376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6211365|NCT02170376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211366|NCT02170376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211367|NCT02170376|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6211368|NCT02170376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6211369|NCT02170376|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6212597|NCT02191033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212598|NCT02191137|Riociguat|riociguat|mesh-list
6212599|NCT02191137|Enzyme Activators|enzyme activators|mesh-ancestor
6212600|NCT02191137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814654|NCT02646904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814655|NCT02646904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5814656|NCT02646904|Respiratory System Agents|respiratory system agents|mesh-ancestor
5814657|NCT02647099|Aspirin|aspirin|mesh-list
5814658|NCT02647099|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5814659|NCT02647099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5814660|NCT02647099|Analgesics|analgesics|mesh-ancestor
5814661|NCT02647099|Sensory System Agents|sensory system agents|mesh-ancestor
5814662|NCT02647099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5814663|NCT02647099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814664|NCT02647099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5814665|NCT02647099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5814666|NCT02647099|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5814667|NCT02647099|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5814668|NCT02647099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814669|NCT02647099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5814670|NCT02647099|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5814671|NCT02647099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5814672|NCT02647099|Antipyretics|antipyretics|mesh-ancestor
5814673|NCT02646748|Pembrolizumab|pembrolizumab|mesh-list
5814674|NCT02646748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5814675|NCT02646748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5814676|NCT02646709|Ketamine|ketamine|mesh-list
5814677|NCT02646709|Rocuronium|rocuronium|mesh-list
5814678|NCT02646709|Analgesics|analgesics|mesh-ancestor
5814679|NCT02646709|Sensory System Agents|sensory system agents|mesh-ancestor
5814680|NCT02646709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5814681|NCT02646709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814682|NCT02646709|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5814683|NCT02646709|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5814684|NCT02646709|Anesthetics, General|anesthetics, general|mesh-ancestor
5814685|NCT02646709|Anesthetics|anesthetics|mesh-ancestor
5814686|NCT02646709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5814687|NCT02646709|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5814688|NCT02646709|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5814689|NCT02646709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5814690|NCT02646709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814691|NCT02646709|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5814692|NCT02646709|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5814693|NCT02646709|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5814694|NCT02646735|Fulvestrant|fulvestrant|mesh-list
5814695|NCT02646735|Exemestane|exemestane|mesh-list
5814696|NCT02646735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5814697|NCT02646735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5814698|NCT02646735|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5814699|NCT02646735|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5814700|NCT02646735|Hormone Antagonists|hormone antagonists|mesh-ancestor
5814701|NCT02646735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5814702|NCT02646735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814703|NCT02646735|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5814704|NCT02646735|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5814705|NCT02646735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5814706|NCT02646735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814707|NCT02646683|Vedolizumab|vedolizumab|mesh-list
5814708|NCT02646683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6492555|NCT00609388|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5814709|NCT02646501|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
5814710|NCT02646397|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5814711|NCT02646397|Fosinopril|fosinopril|mesh-list
5814712|NCT02646397|Benidipine|benidipine|mesh-list
5814713|NCT02646397|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5814714|NCT02646397|Diuretics|diuretics|mesh-ancestor
5814715|NCT02646397|Natriuretic Agents|natriuretic agents|mesh-ancestor
5814716|NCT02646397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814717|NCT02646397|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5814718|NCT02646397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5814719|NCT02646397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814720|NCT02646397|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5814721|NCT02646397|Protease Inhibitors|protease inhibitors|mesh-ancestor
5814722|NCT02646397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5814723|NCT02646397|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6211370|NCT02170519|Iloprost|iloprost|mesh-list
5814724|NCT02646397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5814725|NCT02646397|Vasodilator Agents|vasodilator agents|mesh-ancestor
5814726|NCT02646592|Alfentanil|alfentanil|mesh-list
5814727|NCT02646592|Propofol|propofol|mesh-list
5814728|NCT02646592|Sevoflurane|sevoflurane|mesh-list
5814729|NCT02646592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5814730|NCT02646592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5814731|NCT02646592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814732|NCT02646592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5814733|NCT02646592|Anesthetics, General|anesthetics, general|mesh-ancestor
5814734|NCT02646592|Anesthetics|anesthetics|mesh-ancestor
5814735|NCT02646592|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5814736|NCT02646592|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5814737|NCT02646592|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5814738|NCT02646592|Narcotics|narcotics|mesh-ancestor
5814739|NCT02646592|Analgesics|analgesics|mesh-ancestor
5814740|NCT02646592|Sensory System Agents|sensory system agents|mesh-ancestor
5814741|NCT02646592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5814742|NCT02646670|Ranibizumab|ranibizumab|mesh-list
5814743|NCT02646670|Aflibercept|aflibercept|mesh-list
5814744|NCT02646670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5814745|NCT02646670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5814746|NCT02646670|Growth Substances|growth substances|mesh-ancestor
5814747|NCT02646670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814748|NCT02646670|Growth Inhibitors|growth inhibitors|mesh-ancestor
5814749|NCT02646670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5814750|NCT02646657|Vedolizumab|vedolizumab|mesh-list
5814751|NCT02646657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5814752|NCT02646540|Metolazone|metolazone|mesh-list
5814753|NCT02646540|Furosemide|furosemide|mesh-list
5814754|NCT02646540|Tolvaptan|tolvaptan|mesh-list
5814755|NCT02646540|Diuretics|diuretics|mesh-list
5814756|NCT02646540|Natriuretic Agents|natriuretic agents|mesh-ancestor
5814757|NCT02646540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814758|NCT02646540|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5814759|NCT02646540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5814760|NCT02646540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814761|NCT02646540|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
5814762|NCT02646540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5814763|NCT02646540|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5814764|NCT02646111|Ribavirin|ribavirin|mesh-list
5814765|NCT02646111|Antimetabolites|antimetabolites|mesh-ancestor
5814766|NCT02646111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814767|NCT02646111|Antiviral Agents|antiviral agents|mesh-ancestor
5814768|NCT02646111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5814769|NCT02646085|Carbon-11 methionine|carbon-11 methionine|mesh-list
5814770|NCT02646085|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5814771|NCT02646085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814772|NCT02646137|Chlorotrianisene|chlorotrianisene|mesh-list
5814773|NCT02646137|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
5814774|NCT02646137|Estrogens|estrogens|mesh-ancestor
5814775|NCT02646137|Hormones|hormones|mesh-ancestor
5814776|NCT02646137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5814777|NCT02646137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814778|NCT02646137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5814779|NCT02646137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5814780|NCT02646319|Sirolimus|sirolimus|mesh-list
6492556|NCT00609388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6492557|NCT00609388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492558|NCT00609401|Sorafenib|sorafenib|mesh-list
5814781|NCT02646319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5814782|NCT02646319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5814783|NCT02646319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5814784|NCT02646319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5814785|NCT02646319|Antifungal Agents|antifungal agents|mesh-ancestor
5814786|NCT02646319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5814787|NCT02646319|Immunologic Factors|immunologic factors|mesh-ancestor
5814788|NCT02646319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814789|NCT02646267|Warfarin|warfarin|mesh-list
5814790|NCT02646267|Dabigatran|dabigatran|mesh-list
5814791|NCT02646267|Anticoagulants|anticoagulants|mesh-ancestor
5814792|NCT02646267|Antithrombins|antithrombins|mesh-ancestor
5814793|NCT02646267|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5814794|NCT02646267|Protease Inhibitors|protease inhibitors|mesh-ancestor
5814795|NCT02646267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5814796|NCT02646267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814797|NCT02646189|Interferons|interferons|mesh-list
5814798|NCT02646189|Interferon-alpha|interferon-alpha|mesh-list
5814799|NCT02646189|Interferon alpha-2|interferon alpha-2|mesh-list
5814800|NCT02646189|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5814801|NCT02646189|REP 2139|rep 2139|mesh-list
5814802|NCT02646189|Thymalfasin|thymalfasin|mesh-list
5814803|NCT02646189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5814804|NCT02646189|Antiviral Agents|antiviral agents|mesh-ancestor
5814805|NCT02646189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5814806|NCT02646189|Immunologic Factors|immunologic factors|mesh-ancestor
5814807|NCT02646189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814808|NCT02646189|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5814809|NCT02646072|Ketorolac|ketorolac|mesh-list
5814810|NCT02646072|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
5814811|NCT02646072|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5814812|NCT02646072|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5814813|NCT02646072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6496507|NCT00628290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5814814|NCT02646072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5814815|NCT02646072|Analgesics|analgesics|mesh-ancestor
5814816|NCT02646072|Sensory System Agents|sensory system agents|mesh-ancestor
5814817|NCT02646072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5814818|NCT02646072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814819|NCT02646072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5814820|NCT02646072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5814821|NCT02646072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5814822|NCT02646072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5814823|NCT02646072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814824|NCT02645747|Aflibercept|aflibercept|mesh-list
5814825|NCT02645747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5814826|NCT02645747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5814827|NCT02645747|Growth Substances|growth substances|mesh-ancestor
5814828|NCT02645747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814829|NCT02645747|Growth Inhibitors|growth inhibitors|mesh-ancestor
5814830|NCT02645747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5814831|NCT02645864|Irinotecan|irinotecan|mesh-list
5814832|NCT02645864|Apatinib|apatinib|mesh-list
5814833|NCT02645864|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6492559|NCT00609401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5814834|NCT02645864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5814835|NCT02645864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5814836|NCT02645864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814837|NCT02645864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5814838|NCT02645864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5814839|NCT02645994|Anesthetics|anesthetics|mesh-list
5814840|NCT02645994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5814841|NCT02645994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814842|NCT02645734|Bevacizumab|bevacizumab|mesh-list
5814843|NCT02645734|Aflibercept|aflibercept|mesh-list
5814844|NCT02645734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5814845|NCT02645734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5814846|NCT02645734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5814847|NCT02645734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5814848|NCT02645734|Growth Substances|growth substances|mesh-ancestor
5814849|NCT02645734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492560|NCT00609401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6492561|NCT00609401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6492562|NCT00609401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492563|NCT00609531|Citalopram|citalopram|mesh-list
6492564|NCT00609531|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6492565|NCT00609531|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6492566|NCT00609531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6492567|NCT00609531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492568|NCT00609531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6492569|NCT00609531|Serotonin Agents|serotonin agents|mesh-ancestor
6492570|NCT00609531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814850|NCT02645734|Growth Inhibitors|growth inhibitors|mesh-ancestor
5814851|NCT02645565|Methylprednisolone|methylprednisolone|mesh-list
5814852|NCT02645565|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5814853|NCT02645565|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5814854|NCT02645565|Prednisolone|prednisolone|mesh-list
5814855|NCT02645565|Prednisolone acetate|prednisolone acetate|mesh-list
5814856|NCT02645565|Cyclophosphamide|cyclophosphamide|mesh-list
5814857|NCT02645565|Azathioprine|azathioprine|mesh-list
5814858|NCT02645565|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5814859|NCT02645565|Prednisolone phosphate|prednisolone phosphate|mesh-list
5814860|NCT02645565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5814861|NCT02645565|Immunologic Factors|immunologic factors|mesh-ancestor
5814862|NCT02645565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814863|NCT02645565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5814864|NCT02645565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5814865|NCT02645565|Alkylating Agents|alkylating agents|mesh-ancestor
5814866|NCT02645565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814867|NCT02645565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5814868|NCT02645565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6492571|NCT00609531|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6492572|NCT00609531|Antidepressive Agents|antidepressive agents|mesh-ancestor
6492573|NCT00609531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6492574|NCT00609544|Rilonacept|rilonacept|mesh-list
5814869|NCT02645565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5814870|NCT02645565|Antiemetics|antiemetics|mesh-ancestor
5814871|NCT02645565|Autonomic Agents|autonomic agents|mesh-ancestor
5814872|NCT02645565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6492575|NCT00609544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6492576|NCT00609557|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5814873|NCT02645565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5814874|NCT02645565|Glucocorticoids|glucocorticoids|mesh-ancestor
5814875|NCT02645565|Hormones|hormones|mesh-ancestor
5814876|NCT02645565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5814877|NCT02645565|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5814878|NCT02645565|Protective Agents|protective agents|mesh-ancestor
5814879|NCT02645565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5814880|NCT02645565|Antimetabolites|antimetabolites|mesh-ancestor
5814881|NCT02645565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5814882|NCT02645903|Morphine|morphine|mesh-list
5814883|NCT02645903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5814884|NCT02645903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814885|NCT02645903|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5814886|NCT02645903|Narcotics|narcotics|mesh-ancestor
5814887|NCT02645903|Analgesics|analgesics|mesh-ancestor
5814888|NCT02645903|Sensory System Agents|sensory system agents|mesh-ancestor
5814889|NCT02645903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5814890|NCT02645981|Sorafenib|sorafenib|mesh-list
5814891|NCT02645981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5814892|NCT02645981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5814893|NCT02645981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5814894|NCT02645981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814895|NCT02646020|Loratadine|loratadine|mesh-list
6492577|NCT00609557|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5814896|NCT02646020|Aprepitant|aprepitant|mesh-list
5814897|NCT02646020|Fosaprepitant|fosaprepitant|mesh-list
5814898|NCT02646020|Desloratadine|desloratadine|mesh-list
5814899|NCT02646020|Antiemetics|antiemetics|mesh-ancestor
5814900|NCT02646020|Autonomic Agents|autonomic agents|mesh-ancestor
5814901|NCT02646020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5814902|NCT02646020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814903|NCT02646020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5814904|NCT02646020|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5814905|NCT02646020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5814906|NCT02646020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814907|NCT02646020|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5814908|NCT02646020|Cholinergic Agents|cholinergic agents|mesh-ancestor
5814909|NCT02646020|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5814910|NCT02646020|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5814911|NCT02646020|Histamine Antagonists|histamine antagonists|mesh-ancestor
5814912|NCT02646020|Histamine Agents|histamine agents|mesh-ancestor
5814913|NCT02646020|Antipruritics|antipruritics|mesh-ancestor
5814914|NCT02646020|Dermatologic Agents|dermatologic agents|mesh-ancestor
5814915|NCT02646020|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5901149|NCT03864042|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5901150|NCT03864042|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5901151|NCT03864042|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5901152|NCT03864042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5901153|NCT03864042|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5901154|NCT03864042|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5901155|NCT03864042|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5901156|NCT03864042|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5901157|NCT03864042|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5901158|NCT03864042|Purinergic Agents|purinergic agents|mesh-ancestor
5901159|NCT03864042|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5901160|NCT03864042|Antidepressive Agents|antidepressive agents|mesh-ancestor
5901161|NCT03864042|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5901162|NCT03864042|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5901163|NCT03864042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5901164|NCT03864042|Dopamine Agents|dopamine agents|mesh-ancestor
5901165|NCT03864042|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5901166|NCT03864042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5901167|NCT03864042|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6674330|NCT01568645|Vasodilator Agents|vasodilator agents|mesh-ancestor
6674331|NCT01568645|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6674332|NCT01568645|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6674333|NCT01568684|Citalopram|citalopram|mesh-list
6674334|NCT01568684|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6674335|NCT01568684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6674336|NCT01568684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6674337|NCT01568684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674338|NCT01568684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6674339|NCT01568684|Serotonin Agents|serotonin agents|mesh-ancestor
5901168|NCT03864042|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5901169|NCT03864042|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5901170|NCT03864042|Antitussive Agents|antitussive agents|mesh-ancestor
5901171|NCT03864042|Respiratory System Agents|respiratory system agents|mesh-ancestor
5814916|NCT02645656|Curcumin|curcumin|mesh-list
5814917|NCT02645656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5814918|NCT02645656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5814919|NCT02645656|Analgesics|analgesics|mesh-ancestor
5814920|NCT02645656|Sensory System Agents|sensory system agents|mesh-ancestor
5814921|NCT02645656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5814922|NCT02645656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814923|NCT02645656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5814924|NCT02645656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5814925|NCT02645656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5814926|NCT02645656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5814927|NCT02645656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814928|NCT02645552|Tranexamic Acid|tranexamic acid|mesh-list
5814929|NCT02645552|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5814930|NCT02645552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5814931|NCT02645552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814932|NCT02645552|Hemostatics|hemostatics|mesh-ancestor
5814933|NCT02645552|Coagulants|coagulants|mesh-ancestor
5814934|NCT02645370|Topiramate|topiramate|mesh-list
5814935|NCT02645370|Anticonvulsants|anticonvulsants|mesh-ancestor
5814936|NCT02645370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5814937|NCT02645370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814938|NCT02645461|Palmidrol|palmidrol|mesh-list
5814939|NCT02645461|Riluzole|riluzole|mesh-list
5814940|NCT02645461|Anticonvulsants|anticonvulsants|mesh-ancestor
5814941|NCT02645461|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5814942|NCT02645461|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5814943|NCT02645461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5814944|NCT02645461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814945|NCT02645461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814946|NCT02645461|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5814947|NCT02645461|Protective Agents|protective agents|mesh-ancestor
5814948|NCT02645461|Analgesics|analgesics|mesh-ancestor
5814949|NCT02645461|Sensory System Agents|sensory system agents|mesh-ancestor
5814950|NCT02645461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6212601|NCT02191397|Dexetimide|dexetimide|mesh-list
5814951|NCT02645461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5814952|NCT02645461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5814953|NCT02645461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5814954|NCT02645461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5814955|NCT02645461|Antiviral Agents|antiviral agents|mesh-ancestor
5814956|NCT02645461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5814957|NCT02645461|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5814958|NCT02645461|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5814959|NCT02645461|Hormones|hormones|mesh-ancestor
5814960|NCT02645461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5814961|NCT02645227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5814962|NCT02645227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5814963|NCT02645227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5814964|NCT02645227|Antimetabolites|antimetabolites|mesh-ancestor
5814965|NCT02645227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814966|NCT02645227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5814967|NCT02645227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5814968|NCT02645227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5814969|NCT02645240|Heparin|heparin|mesh-list
5814970|NCT02645240|Calcium heparin|calcium heparin|mesh-list
5814971|NCT02645240|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5814972|NCT02645240|Tinzaparin|tinzaparin|mesh-list
5814973|NCT02645240|Dalteparin|dalteparin|mesh-list
5814974|NCT02645240|Anticoagulants|anticoagulants|mesh-ancestor
5814975|NCT02645240|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5814976|NCT02645240|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5814977|NCT02645240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5814978|NCT02645214|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
5814979|NCT02645214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5814980|NCT02645266|Aflibercept|aflibercept|mesh-list
5814981|NCT02645266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5814982|NCT02645266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5814983|NCT02645266|Growth Substances|growth substances|mesh-ancestor
5814984|NCT02645266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814985|NCT02645266|Growth Inhibitors|growth inhibitors|mesh-ancestor
5814986|NCT02645266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5814987|NCT02645279|Midazolam|midazolam|mesh-list
5814988|NCT02645279|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5814989|NCT02645279|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5814990|NCT02645279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5814991|NCT02645279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5814992|NCT02645279|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5814993|NCT02645279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5641952|NCT00357565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5641953|NCT00357565|Immunologic Factors|immunologic factors|mesh-ancestor
5641954|NCT00357565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641955|NCT00357565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5641956|NCT00357565|Antifungal Agents|antifungal agents|mesh-ancestor
5641957|NCT00357565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5641958|NCT00357565|Dermatologic Agents|dermatologic agents|mesh-ancestor
5641959|NCT00357565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5641960|NCT00357565|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5641961|NCT00357565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5641962|NCT00357565|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5641963|NCT00357565|Antitubercular Agents|antitubercular agents|mesh-ancestor
5641964|NCT00357565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5641965|NCT00357565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5641966|NCT00357565|Alkylating Agents|alkylating agents|mesh-ancestor
5641967|NCT00357565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5641968|NCT00284986|Remestemcel-l|remestemcel-l|mesh-list
5641969|NCT00284986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5641970|NCT00284986|Antiviral Agents|antiviral agents|mesh-ancestor
5641971|NCT00284986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5641972|NCT00245960|Etanercept|etanercept|mesh-list
5641973|NCT00245960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5641974|NCT00245960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5641975|NCT00245960|Analgesics|analgesics|mesh-ancestor
5641976|NCT00245960|Sensory System Agents|sensory system agents|mesh-ancestor
5641977|NCT00245960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5641978|NCT00245960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641979|NCT00245960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5641980|NCT00245960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5641981|NCT00245960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5641982|NCT00245960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5814994|NCT02645279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5814995|NCT02645279|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5814996|NCT02645279|Anesthetics, General|anesthetics, general|mesh-ancestor
5814997|NCT02645279|Anesthetics|anesthetics|mesh-ancestor
5814998|NCT02645279|GABA Modulators|gaba modulators|mesh-ancestor
5814999|NCT02645279|GABA Agents|gaba agents|mesh-ancestor
5815000|NCT02645279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5815001|NCT02645279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5815002|NCT02645058|Analgesics|analgesics|mesh-list
5815003|NCT02645058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815004|NCT02645058|Sensory System Agents|sensory system agents|mesh-ancestor
5815005|NCT02645058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5815006|NCT02645032|Vaccines|vaccines|mesh-list
5815007|NCT02645032|Immunologic Factors|immunologic factors|mesh-ancestor
5815008|NCT02645032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815009|NCT02644967|Pembrolizumab|pembrolizumab|mesh-list
5815010|NCT02644967|Ipilimumab|ipilimumab|mesh-list
5815011|NCT02644967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5815012|NCT02644967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5815013|NCT02644967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5641983|NCT00245960|Immunologic Factors|immunologic factors|mesh-ancestor
5641984|NCT00136903|Cyclosporine|cyclosporine|mesh-list
5641985|NCT00136903|Mycophenolic Acid|mycophenolic acid|mesh-list
5641986|NCT00136903|Remestemcel-l|remestemcel-l|mesh-list
5641987|NCT00136903|Prednisone|prednisone|mesh-list
5641988|NCT00136903|Methylprednisolone|methylprednisolone|mesh-list
5641989|NCT00136903|Tacrolimus|tacrolimus|mesh-list
5641990|NCT00136903|Cyclosporins|cyclosporins|mesh-list
5641991|NCT00136903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5641992|NCT00136903|Glucocorticoids|glucocorticoids|mesh-ancestor
5641993|NCT00136903|Hormones|hormones|mesh-ancestor
5641994|NCT00136903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5641995|NCT00136903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5641996|NCT00136903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5641997|NCT00136903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5815014|NCT02644967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5641998|NCT00136903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5815015|NCT02644980|Anesthetics|anesthetics|mesh-list
5815016|NCT02644980|Propofol|propofol|mesh-list
5815017|NCT02644980|Etomidate|etomidate|mesh-list
5815018|NCT02644980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5815019|NCT02644980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815020|NCT02644980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5815021|NCT02644980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5815022|NCT02644980|Anesthetics, General|anesthetics, general|mesh-ancestor
5815023|NCT02644954|Metformin|metformin|mesh-list
5815024|NCT02644954|Calcipotriene|calcipotriene|mesh-list
5815025|NCT02644954|Coal Tar|coal tar|mesh-list
5815026|NCT02644954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5815027|NCT02644954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815028|NCT02644954|Dermatologic Agents|dermatologic agents|mesh-ancestor
5815029|NCT02644954|Keratolytic Agents|keratolytic agents|mesh-ancestor
5815030|NCT02644785|Protamines|protamines|mesh-list
5815031|NCT02644785|Heparin Antagonists|heparin antagonists|mesh-ancestor
5815032|NCT02644785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5815033|NCT02644785|Coagulants|coagulants|mesh-ancestor
5815034|NCT02644694|Dexamethasone|dexamethasone|mesh-list
5815035|NCT02644694|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5815036|NCT02644694|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
5815037|NCT02644694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5815038|NCT02644694|Antiemetics|antiemetics|mesh-ancestor
5815039|NCT02644694|Autonomic Agents|autonomic agents|mesh-ancestor
5815040|NCT02644694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5815041|NCT02644694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815042|NCT02644694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5815043|NCT02644694|Glucocorticoids|glucocorticoids|mesh-ancestor
5815044|NCT02644694|Hormones|hormones|mesh-ancestor
5815045|NCT02644694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5815046|NCT02644694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5815047|NCT02644694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5815048|NCT02644694|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5815049|NCT02644707|Selenium|selenium|mesh-list
5815050|NCT02644707|Antioxidants|antioxidants|mesh-ancestor
5815051|NCT02644707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5815052|NCT02644707|Protective Agents|protective agents|mesh-ancestor
5815053|NCT02644707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815054|NCT02644707|Trace Elements|trace elements|mesh-ancestor
5815055|NCT02644707|Micronutrients|micronutrients|mesh-ancestor
5815056|NCT02644720|Dexamethasone|dexamethasone|mesh-list
5815057|NCT02644720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5815058|NCT02644720|Antiemetics|antiemetics|mesh-ancestor
5815059|NCT02644720|Autonomic Agents|autonomic agents|mesh-ancestor
5815060|NCT02644720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5815061|NCT02644720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815062|NCT02644720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5815063|NCT02644720|Glucocorticoids|glucocorticoids|mesh-ancestor
5815064|NCT02644720|Hormones|hormones|mesh-ancestor
5815065|NCT02644720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5815066|NCT02644720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5815067|NCT02644720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5815068|NCT02644863|Paclitaxel|paclitaxel|mesh-list
5815069|NCT02644863|Cisplatin|cisplatin|mesh-list
6211371|NCT02170519|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6211372|NCT02170519|Vasodilator Agents|vasodilator agents|mesh-ancestor
6211373|NCT02170532|Albuterol|albuterol|mesh-list
5815070|NCT02644863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5815071|NCT02644863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5815072|NCT02644863|Tubulin Modulators|tubulin modulators|mesh-ancestor
6211374|NCT02170532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6211375|NCT02170532|Autonomic Agents|autonomic agents|mesh-ancestor
6211376|NCT02170532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6211377|NCT02170532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211378|NCT02170532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6211379|NCT02170532|Respiratory System Agents|respiratory system agents|mesh-ancestor
6211380|NCT02170532|Tocolytic Agents|tocolytic agents|mesh-ancestor
5815073|NCT02644863|Antimitotic Agents|antimitotic agents|mesh-ancestor
5815074|NCT02644863|Mitosis Modulators|mitosis modulators|mesh-ancestor
5815075|NCT02644863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5815076|NCT02644629|Ketamine|ketamine|mesh-list
5815077|NCT02644629|Analgesics|analgesics|mesh-ancestor
5815078|NCT02644629|Sensory System Agents|sensory system agents|mesh-ancestor
5815079|NCT02644629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5815080|NCT02644629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815081|NCT02644629|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5815082|NCT02644629|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5815083|NCT02644629|Anesthetics, General|anesthetics, general|mesh-ancestor
5815084|NCT02644629|Anesthetics|anesthetics|mesh-ancestor
5815085|NCT02644629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5815086|NCT02644629|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5815087|NCT02644629|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5815088|NCT02644629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5815089|NCT02644629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5815090|NCT02644915|Edaravone|edaravone|mesh-list
5815091|NCT02644915|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5815092|NCT02644915|Antioxidants|antioxidants|mesh-ancestor
5815093|NCT02644915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5815094|NCT02644915|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5815095|NCT02644915|Protective Agents|protective agents|mesh-ancestor
5815096|NCT02644915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815097|NCT02644811|Anesthetics|anesthetics|mesh-list
5815098|NCT02644811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5815099|NCT02644811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815100|NCT02644616|Torsemide|torsemide|mesh-list
5815101|NCT02644616|Tolvaptan|tolvaptan|mesh-list
5815102|NCT02644616|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
5815103|NCT02644616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211381|NCT02170532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5641999|NCT00136903|Immunologic Factors|immunologic factors|mesh-ancestor
5642000|NCT00136903|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5642001|NCT00136903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5642002|NCT00136903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642003|NCT00136903|Antifungal Agents|antifungal agents|mesh-ancestor
5642004|NCT00136903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5642005|NCT00136903|Dermatologic Agents|dermatologic agents|mesh-ancestor
5642006|NCT00136903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5642007|NCT00136903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5642008|NCT00136903|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5642009|NCT00136903|Antitubercular Agents|antitubercular agents|mesh-ancestor
5642010|NCT00136903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5642011|NCT00136903|Antiemetics|antiemetics|mesh-ancestor
5642012|NCT00136903|Autonomic Agents|autonomic agents|mesh-ancestor
5642013|NCT00136903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5642014|NCT00136903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5642015|NCT00136903|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5642016|NCT00136903|Protective Agents|protective agents|mesh-ancestor
5642017|NCT00136903|Antiviral Agents|antiviral agents|mesh-ancestor
5642018|NCT00107289|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
5815104|NCT02644616|Natriuretic Agents|natriuretic agents|mesh-ancestor
5815105|NCT02644616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815106|NCT02644616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5642019|NCT00107289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5642020|NCT00107289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5642021|NCT00107289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642022|NCT00107289|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5693968|NCT03398785|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5693969|NCT03398759|Butorphanol|butorphanol|mesh-list
5693970|NCT03398759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5693971|NCT03398759|Narcotics|narcotics|mesh-ancestor
5693972|NCT03398759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5693973|NCT03398759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693974|NCT03398759|Analgesics|analgesics|mesh-ancestor
5693975|NCT03398759|Sensory System Agents|sensory system agents|mesh-ancestor
5693976|NCT03398759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5693977|NCT03398759|Antitussive Agents|antitussive agents|mesh-ancestor
5693978|NCT03398759|Respiratory System Agents|respiratory system agents|mesh-ancestor
5693979|NCT03398759|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5697881|NCT03372967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697882|NCT03372850|Esomeprazole|esomeprazole|mesh-list
5697883|NCT03372850|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5697884|NCT03372850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5697885|NCT03372850|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5697886|NCT03372850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5697887|NCT03372850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697888|NCT03372837|Rituximab|rituximab|mesh-list
5697889|NCT03372837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5697890|NCT03372837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5697891|NCT03372837|Immunologic Factors|immunologic factors|mesh-ancestor
5697892|NCT03372837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697893|NCT03372837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5697894|NCT03372785|Aspirin|aspirin|mesh-list
5697895|NCT03372785|Metoprolol|metoprolol|mesh-list
5697896|NCT03372785|Clopidogrel|clopidogrel|mesh-list
5697897|NCT03372785|Ticagrelor|ticagrelor|mesh-list
5697898|NCT03372785|Atorvastatin|atorvastatin|mesh-list
5697899|NCT03372785|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5697900|NCT03372785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5697901|NCT03372785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5697902|NCT03372785|Analgesics|analgesics|mesh-ancestor
5697903|NCT03372785|Sensory System Agents|sensory system agents|mesh-ancestor
5697904|NCT03372785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5697905|NCT03372785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697906|NCT03372785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5697907|NCT03372785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5697908|NCT03372785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5697909|NCT03372785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5697910|NCT03372785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5815107|NCT02644616|Diuretics|diuretics|mesh-ancestor
5815108|NCT02644616|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5815109|NCT02644616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5815110|NCT02644499|Folic Acid|folic acid|mesh-list
5815111|NCT02644499|Hydroxychloroquine|hydroxychloroquine|mesh-list
5815112|NCT02644499|Prednisolone|prednisolone|mesh-list
5697911|NCT03372785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5697912|NCT03372785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5697913|NCT03372785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5697914|NCT03372785|Antipyretics|antipyretics|mesh-ancestor
5697915|NCT03372785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5815113|NCT02644499|Methotrexate|methotrexate|mesh-list
5815114|NCT02644499|Leflunomide|leflunomide|mesh-list
5697916|NCT03372785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5697917|NCT03372785|Antimetabolites|antimetabolites|mesh-ancestor
5697918|NCT03372785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5642023|NCT05219110|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5642024|NCT05218915|Dulaglutide|dulaglutide|mesh-list
5642025|NCT05218915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5642026|NCT05218915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642027|NCT05218889|Gemcitabine|gemcitabine|mesh-list
5642028|NCT05218889|Paclitaxel|paclitaxel|mesh-list
5642029|NCT05218889|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5642030|NCT05218889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5642031|NCT05218889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6492578|NCT00609557|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6492579|NCT00609557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6492580|NCT00609557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492581|NCT00609557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6492582|NCT00609557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492583|NCT00609557|Analgesics|analgesics|mesh-ancestor
6492584|NCT00609557|Sensory System Agents|sensory system agents|mesh-ancestor
6492585|NCT00609557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6492586|NCT00609557|Antidepressive Agents|antidepressive agents|mesh-ancestor
6492587|NCT00609557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6492588|NCT00609557|Dopamine Agents|dopamine agents|mesh-ancestor
6492589|NCT00609570|Calcium|calcium|mesh-list
6492590|NCT00609570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6492591|NCT00609570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492592|NCT00609596|Dutasteride|dutasteride|mesh-list
6492593|NCT00609596|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
5642032|NCT05218889|Tubulin Modulators|tubulin modulators|mesh-ancestor
5642033|NCT05218889|Antimitotic Agents|antimitotic agents|mesh-ancestor
5642034|NCT05218889|Mitosis Modulators|mitosis modulators|mesh-ancestor
5642035|NCT05218889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642036|NCT05218889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5642037|NCT05218889|Antimetabolites|antimetabolites|mesh-ancestor
5642038|NCT05218889|Antiviral Agents|antiviral agents|mesh-ancestor
5642039|NCT05218889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5642040|NCT05218889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5642041|NCT05218889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5642042|NCT05218889|Immunologic Factors|immunologic factors|mesh-ancestor
5642043|NCT05218889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642044|NCT05218733|Fentanyl|fentanyl|mesh-list
5642045|NCT05218733|Morphine|morphine|mesh-list
5642046|NCT05218733|Anesthetics|anesthetics|mesh-ancestor
5642047|NCT05218733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5642048|NCT05218733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642049|NCT05218733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5642050|NCT05218733|Narcotics|narcotics|mesh-ancestor
5642051|NCT05218733|Analgesics|analgesics|mesh-ancestor
5642052|NCT05218733|Sensory System Agents|sensory system agents|mesh-ancestor
5642053|NCT05218733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5642054|NCT05218733|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5642055|NCT05218733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5642056|NCT05218733|Anesthetics, General|anesthetics, general|mesh-ancestor
5642066|NCT05218629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5642067|NCT05218629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642068|NCT05218629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5642069|NCT05218616|Sunitinib|sunitinib|mesh-list
5642070|NCT05218616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5642071|NCT05218616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5642072|NCT05218616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5642073|NCT05218616|Growth Substances|growth substances|mesh-ancestor
5642074|NCT05218616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642075|NCT05218616|Growth Inhibitors|growth inhibitors|mesh-ancestor
5642076|NCT05218616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5642077|NCT05218616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5815115|NCT02644499|Glucocorticoids|glucocorticoids|mesh-list
5815116|NCT02644499|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5815117|NCT02644499|Abortifacient Agents|abortifacient agents|mesh-ancestor
6496508|NCT00628290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5815118|NCT02644499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5642078|NCT05218616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642079|NCT05218603|Bortezomib|bortezomib|mesh-list
5642080|NCT05218603|Daratumumab|daratumumab|mesh-list
5642081|NCT05218603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5642082|NCT05218577|Selenium|selenium|mesh-list
5642083|NCT05218577|Antioxidants|antioxidants|mesh-ancestor
5642084|NCT05218577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642085|NCT05218577|Protective Agents|protective agents|mesh-ancestor
5642086|NCT05218577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642087|NCT05218577|Trace Elements|trace elements|mesh-ancestor
5642088|NCT05218577|Micronutrients|micronutrients|mesh-ancestor
5642089|NCT05218486|Isotretinoin|isotretinoin|mesh-list
5642090|NCT05218486|Dermatologic Agents|dermatologic agents|mesh-ancestor
5642091|NCT05218161|Dexmedetomidine|dexmedetomidine|mesh-list
5642092|NCT05218161|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5642093|NCT05218161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5642094|NCT05218161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642095|NCT05218161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5642096|NCT05218161|Analgesics|analgesics|mesh-ancestor
5642097|NCT05218161|Sensory System Agents|sensory system agents|mesh-ancestor
5642098|NCT05218161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5642099|NCT05218161|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5642100|NCT05218161|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5642101|NCT05218161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5642102|NCT05218161|Adrenergic Agents|adrenergic agents|mesh-ancestor
5642103|NCT05218161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5642104|NCT05218161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642105|NCT05218148|Oxaliplatin|oxaliplatin|mesh-list
5642106|NCT05218148|Trastuzumab|trastuzumab|mesh-list
5642107|NCT05218148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5642108|NCT05218148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5642109|NCT05217836|Hepcidins|hepcidins|mesh-list
5642110|NCT05217836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5815119|NCT02644499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815120|NCT02644499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5815121|NCT02644499|Antimetabolites|antimetabolites|mesh-ancestor
5642111|NCT05217706|Ketamine|ketamine|mesh-list
5642112|NCT05217706|Analgesics|analgesics|mesh-ancestor
5815122|NCT02644499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5815123|NCT02644499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5815124|NCT02644499|Dermatologic Agents|dermatologic agents|mesh-ancestor
5815125|NCT02644499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5815126|NCT02644499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5642113|NCT05217706|Sensory System Agents|sensory system agents|mesh-ancestor
5642114|NCT05217706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5642115|NCT05217706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642116|NCT05217706|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5642117|NCT05217706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5642118|NCT05217706|Anesthetics, General|anesthetics, general|mesh-ancestor
5642119|NCT05217706|Anesthetics|anesthetics|mesh-ancestor
5642120|NCT05217706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5642121|NCT05217706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5642122|NCT05217706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5642123|NCT05217706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5642124|NCT05217706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693980|NCT03398577|Dapagliflozin|dapagliflozin|mesh-list
5693981|NCT03398577|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5693982|NCT03398577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693983|NCT03398577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5815127|NCT02644499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5815128|NCT02644499|Immunologic Factors|immunologic factors|mesh-ancestor
5693984|NCT03398577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693985|NCT03398473|Epoetin Alfa|epoetin alfa|mesh-list
5815129|NCT02644499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5815130|NCT02644499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5815131|NCT02644499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5693986|NCT03398473|Hematinics|hematinics|mesh-ancestor
5693987|NCT03398434|Apixaban|apixaban|mesh-list
5693988|NCT03398434|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5693989|NCT03398434|Antithrombins|antithrombins|mesh-ancestor
5693990|NCT03398434|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5693991|NCT03398434|Protease Inhibitors|protease inhibitors|mesh-ancestor
5693992|NCT03398434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5815132|NCT02644499|Hormones|hormones|mesh-ancestor
5815133|NCT02644499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5815134|NCT02644499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5815135|NCT02644499|Antimalarials|antimalarials|mesh-ancestor
5815136|NCT02644499|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5815137|NCT02644499|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5815138|NCT02644499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5815139|NCT02644499|Hematinics|hematinics|mesh-ancestor
5815140|NCT02644499|Vitamin B Complex|vitamin b complex|mesh-ancestor
5815141|NCT02644499|Vitamins|vitamins|mesh-ancestor
5815142|NCT02644499|Micronutrients|micronutrients|mesh-ancestor
5815143|NCT02644590|Melatonin|melatonin|mesh-list
5815144|NCT02644590|Antioxidants|antioxidants|mesh-ancestor
5815145|NCT02644590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5815146|NCT02644590|Protective Agents|protective agents|mesh-ancestor
5815147|NCT02644590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815148|NCT02644590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5815149|NCT02644538|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5815150|NCT02644538|Antiviral Agents|antiviral agents|mesh-ancestor
5815151|NCT02644538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5815152|NCT02644551|Ciclopirox|ciclopirox|mesh-list
5815153|NCT02644551|Antifungal Agents|antifungal agents|mesh-ancestor
5815154|NCT02644551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5815155|NCT02644395|Amlodipine|amlodipine|mesh-list
5815156|NCT02644395|Chlorthalidone|chlorthalidone|mesh-list
5815157|NCT02644395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5815158|NCT02644395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5815159|NCT02644395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5815160|NCT02644395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5815161|NCT02644395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5815162|NCT02644395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815163|NCT02644395|Vasodilator Agents|vasodilator agents|mesh-ancestor
5642125|NCT05217680|Bevacizumab|bevacizumab|mesh-list
5642126|NCT05217680|Ranibizumab|ranibizumab|mesh-list
5642127|NCT05217680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5642128|NCT05217680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5642129|NCT05217680|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5642130|NCT05217680|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5642131|NCT05217680|Growth Substances|growth substances|mesh-ancestor
5642132|NCT05217680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642133|NCT05217680|Growth Inhibitors|growth inhibitors|mesh-ancestor
5642134|NCT05217589|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
5642135|NCT05217589|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
5642136|NCT05217589|beta-Endorphin|beta-endorphin|mesh-list
5642137|NCT05217589|Hormones|hormones|mesh-ancestor
5642138|NCT05217589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5642139|NCT05217589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642140|NCT05217589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5815164|NCT02644395|Diuretics|diuretics|mesh-ancestor
5815165|NCT02644395|Natriuretic Agents|natriuretic agents|mesh-ancestor
5815166|NCT02644395|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5815167|NCT02644304|Cabergoline|cabergoline|mesh-list
5815168|NCT02644304|Clomiphene|clomiphene|mesh-list
5815169|NCT02644304|Enclomiphene|enclomiphene|mesh-list
5815170|NCT02644304|Zuclomiphene|zuclomiphene|mesh-list
5815171|NCT02644304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5815172|NCT02644304|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5815173|NCT02644304|Hormone Antagonists|hormone antagonists|mesh-ancestor
5815174|NCT02644304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5815175|NCT02644304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815176|NCT02644304|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5815177|NCT02644304|Fertility Agents|fertility agents|mesh-ancestor
5815178|NCT02644304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5815179|NCT02644304|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5815180|NCT02644304|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5642141|NCT05217589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642142|NCT05217498|Istradefylline|istradefylline|mesh-list
5642143|NCT05217498|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
5642144|NCT05217498|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5642145|NCT05217498|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5642146|NCT05217498|Purinergic Agents|purinergic agents|mesh-ancestor
5642147|NCT05217498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5642148|NCT05217498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5815181|NCT02644304|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5815182|NCT02644304|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5642149|NCT05217498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642150|NCT05217446|Pembrolizumab|pembrolizumab|mesh-list
5642151|NCT05217446|Cetuximab|cetuximab|mesh-list
5642152|NCT05217446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5642153|NCT05217446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5642154|NCT05217355|Botulinum Toxins|botulinum toxins|mesh-list
5642155|NCT05217355|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5642156|NCT05217355|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5642157|NCT05217355|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5642158|NCT05217355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5642159|NCT05217355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642160|NCT05217355|Cholinergic Agents|cholinergic agents|mesh-ancestor
5642161|NCT05217355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5642162|NCT05217355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642163|NCT05217355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5642164|NCT05217355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5642165|NCT05217342|Diuretics|diuretics|mesh-list
5642166|NCT05217342|Natriuretic Agents|natriuretic agents|mesh-ancestor
5815183|NCT02644304|Dopamine Agonists|dopamine agonists|mesh-ancestor
5815184|NCT02644304|Dopamine Agents|dopamine agents|mesh-ancestor
5815185|NCT02644304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5815186|NCT02644408|Megestrol|megestrol|mesh-list
5815187|NCT02644408|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5815188|NCT02644408|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5815189|NCT02644408|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5815190|NCT02644408|Contraceptive Agents|contraceptive agents|mesh-ancestor
5815191|NCT02644408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5815192|NCT02644408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815193|NCT02644408|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5815194|NCT02644408|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5815195|NCT02644408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5815196|NCT02644408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5815197|NCT02644486|Irbesartan|irbesartan|mesh-list
5815198|NCT02644486|Sevelamer|sevelamer|mesh-list
5815199|NCT02644486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5815200|NCT02644486|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5815201|NCT02644486|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5815202|NCT02644486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642167|NCT05217342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642168|NCT05217238|Remifentanil|remifentanil|mesh-list
5642169|NCT05217238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5642170|NCT05217238|Narcotics|narcotics|mesh-ancestor
5642171|NCT05217238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5642172|NCT05217238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642173|NCT05217238|Analgesics|analgesics|mesh-ancestor
5642174|NCT05217238|Sensory System Agents|sensory system agents|mesh-ancestor
5642175|NCT05217238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5642176|NCT05217160|Morphine|morphine|mesh-list
5815203|NCT02644486|Chelating Agents|chelating agents|mesh-ancestor
5815204|NCT02644486|Sequestering Agents|sequestering agents|mesh-ancestor
5815205|NCT02644473|Tranexamic Acid|tranexamic acid|mesh-list
5815206|NCT02644473|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5815207|NCT02644473|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5815208|NCT02644473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5815209|NCT02644473|Hemostatics|hemostatics|mesh-ancestor
5815210|NCT02644473|Coagulants|coagulants|mesh-ancestor
5815211|NCT02644577|Metformin|metformin|mesh-list
5815212|NCT02644577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5815213|NCT02644577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815214|NCT02644083|Dimethyl Fumarate|dimethyl fumarate|mesh-list
5815215|NCT02644083|Dermatologic Agents|dermatologic agents|mesh-ancestor
5815216|NCT02644083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5642177|NCT05217160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5642178|NCT05217160|Narcotics|narcotics|mesh-ancestor
5642179|NCT05217160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5642180|NCT05217160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642181|NCT05217160|Analgesics|analgesics|mesh-ancestor
5642182|NCT05217160|Sensory System Agents|sensory system agents|mesh-ancestor
5642183|NCT05217160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5642184|NCT05217069|Leucovorin|leucovorin|mesh-list
5642185|NCT05217069|Folic Acid|folic acid|mesh-list
5642186|NCT05217069|Irinotecan|irinotecan|mesh-list
5642187|NCT05217069|Cetuximab|cetuximab|mesh-list
5642188|NCT05217069|Avelumab|avelumab|mesh-list
5642189|NCT05217069|Levoleucovorin|levoleucovorin|mesh-list
5642190|NCT05217069|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5815217|NCT02644083|Immunologic Factors|immunologic factors|mesh-ancestor
6212602|NCT02191397|Citalopram|citalopram|mesh-list
5642191|NCT05217069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5642192|NCT05217069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5642193|NCT05217069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642194|NCT05217069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5642195|NCT05217069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5642196|NCT05217069|Antidotes|antidotes|mesh-ancestor
5642197|NCT05217069|Protective Agents|protective agents|mesh-ancestor
5642198|NCT05217069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642199|NCT05217069|Vitamin B Complex|vitamin b complex|mesh-ancestor
5642200|NCT05217069|Vitamins|vitamins|mesh-ancestor
5642201|NCT05217069|Micronutrients|micronutrients|mesh-ancestor
5642202|NCT05217069|Hematinics|hematinics|mesh-ancestor
5642203|NCT05216952|Misoprostol|misoprostol|mesh-list
5642204|NCT05216952|Ulipristal acetate|ulipristal acetate|mesh-list
5642205|NCT05216952|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5642206|NCT05216952|Abortifacient Agents|abortifacient agents|mesh-ancestor
5642207|NCT05216952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5642208|NCT05216952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642209|NCT05216952|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5815218|NCT02644083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815219|NCT02644421|Lidocaine|lidocaine|mesh-list
5815220|NCT02644421|Anesthetics, Local|anesthetics, local|mesh-ancestor
5815221|NCT02644421|Anesthetics|anesthetics|mesh-ancestor
5815222|NCT02644421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5815223|NCT02644421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815224|NCT02644421|Sensory System Agents|sensory system agents|mesh-ancestor
5815225|NCT02644421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5815226|NCT02644421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5815227|NCT02644421|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5815228|NCT02644421|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5815229|NCT02644421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5815230|NCT02644421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5815231|NCT02644369|Pembrolizumab|pembrolizumab|mesh-list
5642210|NCT05216952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5642211|NCT05216952|Oxytocics|oxytocics|mesh-ancestor
5642212|NCT05216952|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5642213|NCT05216952|Contraceptive Agents|contraceptive agents|mesh-ancestor
5642214|NCT05216952|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5642215|NCT05216822|Racecadotril|racecadotril|mesh-list
5642216|NCT05216822|Antidiarrheals|antidiarrheals|mesh-ancestor
5642217|NCT05216822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5642218|NCT05216822|Protease Inhibitors|protease inhibitors|mesh-ancestor
5642219|NCT05216822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5642220|NCT05216822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642221|NCT05216770|Bupivacaine|bupivacaine|mesh-list
5642222|NCT05216770|Anesthetics, Local|anesthetics, local|mesh-ancestor
5642223|NCT05216770|Anesthetics|anesthetics|mesh-ancestor
5642224|NCT05216770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5642225|NCT05216770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642226|NCT05216770|Sensory System Agents|sensory system agents|mesh-ancestor
5642227|NCT05216770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5642228|NCT05215470|Nivolumab|nivolumab|mesh-list
5642229|NCT05215470|Ipilimumab|ipilimumab|mesh-list
5642230|NCT05215470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5642231|NCT05215470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5642232|NCT05215470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5642233|NCT05215470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642234|NCT05195242|Dexamethasone|dexamethasone|mesh-list
5642235|NCT05195242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5642236|NCT05195242|Antiemetics|antiemetics|mesh-ancestor
5642237|NCT05195242|Autonomic Agents|autonomic agents|mesh-ancestor
5642238|NCT05195242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5642239|NCT05195242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642240|NCT05195242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5642241|NCT05195242|Glucocorticoids|glucocorticoids|mesh-ancestor
5642242|NCT05195242|Hormones|hormones|mesh-ancestor
5642243|NCT05195242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5642244|NCT05195242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5642245|NCT05195242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5642246|NCT05193565|Mycophenolic Acid|mycophenolic acid|mesh-list
5642247|NCT05193565|Sirolimus|sirolimus|mesh-list
5642248|NCT05193565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5642249|NCT05193565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5642250|NCT05193565|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5642251|NCT05193565|Antitubercular Agents|antitubercular agents|mesh-ancestor
5815232|NCT02644369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5815233|NCT02644369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5815234|NCT02644252|Tocotrienols|tocotrienols|mesh-list
5815235|NCT02644252|Vitamin E|vitamin e|mesh-list
5815236|NCT02644252|Tocopherols|tocopherols|mesh-list
5815237|NCT02644252|Carboplatin|carboplatin|mesh-list
5815238|NCT02644252|Vinorelbine|vinorelbine|mesh-list
5815239|NCT02644252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5815240|NCT02644252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5815241|NCT02644252|Tubulin Modulators|tubulin modulators|mesh-ancestor
5642252|NCT05193565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5642253|NCT05193565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5642254|NCT05193565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5642255|NCT05193565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642256|NCT05193565|Antifungal Agents|antifungal agents|mesh-ancestor
5642257|NCT05193565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5642258|NCT05193565|Immunologic Factors|immunologic factors|mesh-ancestor
5642259|NCT05193565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642260|NCT05192460|Vaccines|vaccines|mesh-list
5642261|NCT05192460|Immunologic Factors|immunologic factors|mesh-ancestor
5642262|NCT05192460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642263|NCT05186779|Progestins|progestins|mesh-list
5815242|NCT02644252|Antimitotic Agents|antimitotic agents|mesh-ancestor
5815243|NCT02644252|Mitosis Modulators|mitosis modulators|mesh-ancestor
5815244|NCT02644252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642264|NCT05186779|Hormones|hormones|mesh-ancestor
5642265|NCT05186779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5642266|NCT05186779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642267|NCT05185973|Micronutrients|micronutrients|mesh-list
5642268|NCT05185973|Trace Elements|trace elements|mesh-list
5642269|NCT05185973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642270|NCT05178550|Heparin|heparin|mesh-list
5642271|NCT05178550|Anticoagulants|anticoagulants|mesh-ancestor
5642272|NCT05178550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5642273|NCT05178550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5642274|NCT05178550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642275|NCT05177133|Capecitabine|capecitabine|mesh-list
5815245|NCT02644252|Antioxidants|antioxidants|mesh-ancestor
5815246|NCT02644252|Protective Agents|protective agents|mesh-ancestor
5815247|NCT02644252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815248|NCT02644252|Vitamins|vitamins|mesh-ancestor
5815249|NCT02644252|Micronutrients|micronutrients|mesh-ancestor
5815250|NCT02644018|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
5815251|NCT02644018|Antiviral Agents|antiviral agents|mesh-ancestor
5815252|NCT02644018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5815253|NCT02644226|Sevoflurane|sevoflurane|mesh-list
5815254|NCT02644226|Desflurane|desflurane|mesh-list
5815255|NCT02644226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5642276|NCT05177133|Oxaliplatin|oxaliplatin|mesh-list
5642277|NCT05177133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5642278|NCT05177133|Antimetabolites|antimetabolites|mesh-ancestor
5642279|NCT05177133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642280|NCT05177133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5642281|NCT05176964|Capecitabine|capecitabine|mesh-list
5642282|NCT05176964|Oxaliplatin|oxaliplatin|mesh-list
5642283|NCT05176964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5642284|NCT05176964|Antimetabolites|antimetabolites|mesh-ancestor
5642285|NCT05176964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642286|NCT05176964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5642287|NCT05176314|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5642288|NCT05176314|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5642289|NCT05176314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5642290|NCT05176314|Antimetabolites|antimetabolites|mesh-ancestor
5642291|NCT05176314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642292|NCT05176314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5642293|NCT05176314|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5815256|NCT02644226|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5815257|NCT02644226|Anesthetics, General|anesthetics, general|mesh-ancestor
5815258|NCT02644226|Anesthetics|anesthetics|mesh-ancestor
5815259|NCT02644226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5815260|NCT02644226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815261|NCT02644187|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5815262|NCT02644187|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5815263|NCT02644187|Dermatologic Agents|dermatologic agents|mesh-ancestor
5815264|NCT02644044|Methotrexate|methotrexate|mesh-list
5815265|NCT02644044|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6492594|NCT00609596|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6492595|NCT00609596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6492596|NCT00609596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492597|NCT00609596|Hormone Antagonists|hormone antagonists|mesh-ancestor
6492598|NCT00609596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6492599|NCT00609596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642294|NCT05176314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5815266|NCT02644044|Abortifacient Agents|abortifacient agents|mesh-ancestor
5815267|NCT02644044|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5815268|NCT02644044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815269|NCT02644044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5815270|NCT02644044|Antimetabolites|antimetabolites|mesh-ancestor
5815271|NCT02644044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5815272|NCT02644044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5815273|NCT02644044|Dermatologic Agents|dermatologic agents|mesh-ancestor
5815274|NCT02644044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5815275|NCT02644044|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5815276|NCT02644044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5815277|NCT02644044|Immunologic Factors|immunologic factors|mesh-ancestor
5815278|NCT02644044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5815279|NCT02644044|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5901172|NCT03864042|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5901173|NCT03864042|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5901174|NCT03835949|Atezolizumab|atezolizumab|mesh-list
5901175|NCT03835949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901176|NCT03828045|Apremilast|apremilast|mesh-list
5642295|NCT05175781|Dexmedetomidine|dexmedetomidine|mesh-list
5642296|NCT05175781|Ketamine|ketamine|mesh-list
5642297|NCT05175781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5642298|NCT05175781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5642299|NCT05175781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642300|NCT05175781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5642301|NCT05175781|Analgesics|analgesics|mesh-ancestor
5642302|NCT05175781|Sensory System Agents|sensory system agents|mesh-ancestor
5642303|NCT05175781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5642304|NCT05175781|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5642305|NCT05175781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5642306|NCT05175781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5642307|NCT05175781|Adrenergic Agents|adrenergic agents|mesh-ancestor
5642308|NCT05175781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5642309|NCT05175781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642310|NCT05175781|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5642311|NCT05175781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5642312|NCT05175781|Anesthetics, General|anesthetics, general|mesh-ancestor
5642313|NCT05175781|Anesthetics|anesthetics|mesh-ancestor
5642314|NCT05175781|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5642315|NCT05175781|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5901177|NCT03828045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5901178|NCT03828045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5901179|NCT03828045|Analgesics|analgesics|mesh-ancestor
5901180|NCT03828045|Sensory System Agents|sensory system agents|mesh-ancestor
5901181|NCT03828045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5901182|NCT03828045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901183|NCT03828045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5901184|NCT03828045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5901185|NCT03828045|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5693993|NCT03398434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5693994|NCT03398434|Anticoagulants|anticoagulants|mesh-ancestor
5693995|NCT03398252|Doxazosin|doxazosin|mesh-list
5693996|NCT03398252|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5901186|NCT03828045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5901187|NCT03828045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5901188|NCT03828045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901189|NCT03825874|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5901190|NCT03825874|Amikacin|amikacin|mesh-list
5901191|NCT03825874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5901192|NCT03822351|Durvalumab|durvalumab|mesh-list
5901193|NCT03822351|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5901194|NCT03822351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5901195|NCT03822351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901196|NCT03822351|Immunologic Factors|immunologic factors|mesh-ancestor
5901197|NCT03822351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901198|NCT03805841|Bromides|bromides|mesh-list
5642339|NCT05161754|Hemostatics|hemostatics|mesh-list
5815280|NCT02644161|Antidepressive Agents|antidepressive agents|mesh-list
5815281|NCT02644161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5815282|NCT02644525|Imatinib Mesylate|imatinib mesylate|mesh-list
5815283|NCT02644525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5815284|NCT02644525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5815285|NCT02644525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5815286|NCT02644525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5815287|NCT02644291|Mebendazole|mebendazole|mesh-list
5815288|NCT02644291|Piperazine|piperazine|mesh-list
5815289|NCT02644291|Piperazine citrate|piperazine citrate|mesh-list
5815290|NCT02644291|DMP 777|dmp 777|mesh-list
5815291|NCT02644291|Antinematodal Agents|antinematodal agents|mesh-ancestor
5815292|NCT02644291|Anthelmintics|anthelmintics|mesh-ancestor
5815293|NCT02644291|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5815294|NCT02644291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5815295|NCT02644291|Tubulin Modulators|tubulin modulators|mesh-ancestor
5815296|NCT02644291|Antimitotic Agents|antimitotic agents|mesh-ancestor
5815297|NCT02644291|Mitosis Modulators|mitosis modulators|mesh-ancestor
5815298|NCT02644291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5815299|NCT02644291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5815300|NCT02644291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5815301|NCT02644057|Dobutamine|dobutamine|mesh-list
5815302|NCT02644057|Milrinone|milrinone|mesh-list
5815303|NCT02644057|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5815304|NCT02644057|Sympathomimetics|sympathomimetics|mesh-ancestor
5815305|NCT02644057|Autonomic Agents|autonomic agents|mesh-ancestor
5815306|NCT02644057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5815307|NCT02644057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815308|NCT02644057|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5815309|NCT02644057|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6492600|NCT00609752|Prednisolone|prednisolone|mesh-list
6492601|NCT00609752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5642340|NCT05161754|Coagulants|coagulants|mesh-ancestor
5642341|NCT05160428|Vaccines|vaccines|mesh-list
5642342|NCT05160428|Immunologic Factors|immunologic factors|mesh-ancestor
5642343|NCT05160428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642344|NCT05155709|Azacitidine|azacitidine|mesh-list
5642345|NCT05155709|Venetoclax|venetoclax|mesh-list
5642346|NCT05155709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5642347|NCT05155709|Antimetabolites|antimetabolites|mesh-ancestor
5642348|NCT05155709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642349|NCT05155709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5642350|NCT05155709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5642351|NCT05146232|Anesthetics|anesthetics|mesh-list
5642352|NCT05146232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5642353|NCT05146232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815310|NCT02644057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6492602|NCT00609752|Glucocorticoids|glucocorticoids|mesh-ancestor
6492603|NCT00609752|Hormones|hormones|mesh-ancestor
6492604|NCT00609752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6492605|NCT00609752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815311|NCT02644057|Adrenergic Agents|adrenergic agents|mesh-ancestor
6492606|NCT00609752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6675597|NCT01576627|Trace Elements|trace elements|mesh-ancestor
5642354|NCT05141305|Aspirin|aspirin|mesh-list
5642355|NCT05141305|Clopidogrel|clopidogrel|mesh-list
5642356|NCT05141305|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5642357|NCT05141305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5642358|NCT05141305|Analgesics|analgesics|mesh-ancestor
5642359|NCT05141305|Sensory System Agents|sensory system agents|mesh-ancestor
5642360|NCT05141305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5642361|NCT05141305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642362|NCT05141305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5642363|NCT05141305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5642364|NCT05141305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5642365|NCT05141305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5642366|NCT05141305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642367|NCT05141305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5642368|NCT05141305|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5642369|NCT05141305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5642370|NCT05141305|Antipyretics|antipyretics|mesh-ancestor
5642371|NCT05141305|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5642372|NCT05141305|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5642373|NCT05141305|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5642374|NCT05141305|Purinergic Agents|purinergic agents|mesh-ancestor
5642375|NCT05141305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5642376|NCT05125016|Cemiplimab|cemiplimab|mesh-list
5642377|NCT05125016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5642378|NCT05125016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5642379|NCT05114486|Pilocarpine|pilocarpine|mesh-list
5642380|NCT05114486|Miotics|miotics|mesh-ancestor
5642381|NCT05114486|Autonomic Agents|autonomic agents|mesh-ancestor
5642382|NCT05114486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5642383|NCT05114486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642384|NCT05114486|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
5642385|NCT05114486|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5815312|NCT02644057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5815313|NCT02644057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5815314|NCT02644057|Protective Agents|protective agents|mesh-ancestor
5815315|NCT02644057|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5815316|NCT02644057|Vasodilator Agents|vasodilator agents|mesh-ancestor
5815317|NCT02644057|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5815318|NCT02644057|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5815319|NCT02644057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5815320|NCT02643914|Nicotine|nicotine|mesh-list
5815321|NCT02643914|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5815322|NCT02643914|Autonomic Agents|autonomic agents|mesh-ancestor
5815323|NCT02643914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5815324|NCT02643914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815325|NCT02643914|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5815326|NCT02643914|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5815327|NCT02643914|Cholinergic Agents|cholinergic agents|mesh-ancestor
5815328|NCT02643914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5815329|NCT02643914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211382|NCT02170532|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6211383|NCT02170532|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6211384|NCT02170532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6211385|NCT02170532|Adrenergic Agents|adrenergic agents|mesh-ancestor
6211386|NCT02170532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6211387|NCT02170532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211388|NCT02170649|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
6211389|NCT02170649|Anticonvulsants|anticonvulsants|mesh-ancestor
6212603|NCT02191397|Bupropion|bupropion|mesh-list
5815330|NCT02643563|Epinephrine|epinephrine|mesh-list
5815331|NCT02643563|Bupivacaine|bupivacaine|mesh-list
5815332|NCT02643563|Ropivacaine|ropivacaine|mesh-list
5815333|NCT02643563|Anesthetics, Local|anesthetics, local|mesh-ancestor
5815334|NCT02643563|Anesthetics|anesthetics|mesh-ancestor
5815335|NCT02643563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5815336|NCT02643563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815337|NCT02643563|Sensory System Agents|sensory system agents|mesh-ancestor
5815338|NCT02643563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5815339|NCT02643563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5815340|NCT02643563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5815341|NCT02643563|Adrenergic Agents|adrenergic agents|mesh-ancestor
5815342|NCT02643563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5815343|NCT02643563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642386|NCT05114486|Cholinergic Agents|cholinergic agents|mesh-ancestor
5815344|NCT02643563|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5815345|NCT02643563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5815346|NCT02643563|Autonomic Agents|autonomic agents|mesh-ancestor
5815347|NCT02643563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5815348|NCT02643563|Respiratory System Agents|respiratory system agents|mesh-ancestor
5815349|NCT02643563|Mydriatics|mydriatics|mesh-ancestor
5815350|NCT02643563|Sympathomimetics|sympathomimetics|mesh-ancestor
5815351|NCT02643563|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5815352|NCT02643784|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5815353|NCT02643784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5815354|NCT02643784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5815355|NCT02643784|Antimetabolites|antimetabolites|mesh-ancestor
5815356|NCT02643784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5815357|NCT02643784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5815358|NCT02643784|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5815359|NCT02643784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5815360|NCT02643680|Chlorhexidine|chlorhexidine|mesh-list
5815361|NCT02643680|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5815362|NCT02643680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5815363|NCT02643680|Disinfectants|disinfectants|mesh-ancestor
5815364|NCT02643823|Methotrexate|methotrexate|mesh-list
5815365|NCT02643823|Antirheumatic Agents|antirheumatic agents|mesh-list
5642387|NCT05114486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5642388|NCT05114486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642389|NCT05113251|Paclitaxel|paclitaxel|mesh-list
5642390|NCT05113251|Cyclophosphamide|cyclophosphamide|mesh-list
5642391|NCT05113251|Doxorubicin|doxorubicin|mesh-list
5642392|NCT05113251|Trastuzumab|trastuzumab|mesh-list
5642393|NCT05113251|Pertuzumab|pertuzumab|mesh-list
5815366|NCT02643823|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5815367|NCT02643823|Abortifacient Agents|abortifacient agents|mesh-ancestor
5815368|NCT02643823|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5815369|NCT02643823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815370|NCT02643823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5642394|NCT05113251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5642395|NCT05113251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5642396|NCT05113251|Tubulin Modulators|tubulin modulators|mesh-ancestor
5642397|NCT05113251|Antimitotic Agents|antimitotic agents|mesh-ancestor
5642398|NCT05113251|Mitosis Modulators|mitosis modulators|mesh-ancestor
5642399|NCT05113251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642400|NCT05113251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5642401|NCT05113251|Immunologic Factors|immunologic factors|mesh-ancestor
5642402|NCT05113251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642403|NCT05113251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5642404|NCT05113251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5815371|NCT02643823|Antimetabolites|antimetabolites|mesh-ancestor
5815372|NCT02643823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5815373|NCT02643823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5815374|NCT02643823|Dermatologic Agents|dermatologic agents|mesh-ancestor
5815375|NCT02643823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5815376|NCT02643823|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5815377|NCT02643823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5815378|NCT02643823|Immunologic Factors|immunologic factors|mesh-ancestor
5815379|NCT02643823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5815380|NCT02643719|Topiramate|topiramate|mesh-list
5815381|NCT02643719|Naproxen|naproxen|mesh-list
5815382|NCT02643719|Sumatriptan|sumatriptan|mesh-list
5642405|NCT05113251|Alkylating Agents|alkylating agents|mesh-ancestor
5642406|NCT05113251|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5642407|NCT05113251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5642408|NCT05113251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5642409|NCT05113251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5642410|NCT05113251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5642411|NCT05113251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5642412|NCT05103605|Osimertinib|osimertinib|mesh-list
5642413|NCT05103605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5642414|NCT05103605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5642415|NCT05103605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5642416|NCT05103605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642417|NCT05096169|Citric Acid|citric acid|mesh-list
5815383|NCT02643719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5815384|NCT02643719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5642418|NCT05096169|Sodium Citrate|sodium citrate|mesh-list
5642419|NCT05096169|Clomiphene|clomiphene|mesh-list
5642420|NCT05096169|Enclomiphene|enclomiphene|mesh-list
5815385|NCT02643719|Analgesics|analgesics|mesh-ancestor
5642421|NCT05096169|Zuclomiphene|zuclomiphene|mesh-list
5642422|NCT05096169|Anticoagulants|anticoagulants|mesh-ancestor
5642423|NCT05096169|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5642424|NCT05096169|Chelating Agents|chelating agents|mesh-ancestor
5642425|NCT05096169|Sequestering Agents|sequestering agents|mesh-ancestor
5642426|NCT05096169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642427|NCT05096169|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5642428|NCT05096169|Hormone Antagonists|hormone antagonists|mesh-ancestor
5642429|NCT05096169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5642430|NCT05096169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642431|NCT05096169|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5642432|NCT05096169|Fertility Agents|fertility agents|mesh-ancestor
5642433|NCT05096169|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5642434|NCT05096169|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5642435|NCT05096169|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5642436|NCT05089708|Trifarotene|trifarotene|mesh-list
5642437|NCT05089708|Dermatologic Agents|dermatologic agents|mesh-ancestor
5642438|NCT05078879|Empagliflozin|empagliflozin|mesh-list
5642439|NCT05078879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5642440|NCT05078879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642441|NCT05078879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5642442|NCT05078879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642443|NCT05072184|Anesthetics|anesthetics|mesh-list
5642444|NCT05072184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5642445|NCT05072184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815386|NCT02643719|Sensory System Agents|sensory system agents|mesh-ancestor
5815387|NCT02643719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5815388|NCT02643719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815389|NCT02643719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5815390|NCT02643719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5815391|NCT02643719|Gout Suppressants|gout suppressants|mesh-ancestor
5815392|NCT02643719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5815393|NCT02643719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5815394|NCT02643719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5815395|NCT02643719|Anticonvulsants|anticonvulsants|mesh-ancestor
5815396|NCT02643719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5815397|NCT02643719|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5815398|NCT02643719|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5815399|NCT02643719|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5815400|NCT02643719|Serotonin Agents|serotonin agents|mesh-ancestor
5642446|NCT05065294|Psilocybin|psilocybin|mesh-list
5642447|NCT05065294|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
5642448|NCT05065294|Hallucinogens|hallucinogens|mesh-ancestor
5642449|NCT05065294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642450|NCT05065294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5642451|NCT05065294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5642452|NCT05065294|Serotonin Agents|serotonin agents|mesh-ancestor
5642453|NCT05065294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5642454|NCT05065294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642455|NCT05065294|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5642456|NCT05062330|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5642457|NCT05062330|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5642458|NCT05053867|Tranexamic Acid|tranexamic acid|mesh-list
5642459|NCT05053867|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5642460|NCT05053867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5642461|NCT05053867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642462|NCT05053867|Hemostatics|hemostatics|mesh-ancestor
5642463|NCT05053867|Coagulants|coagulants|mesh-ancestor
5642464|NCT05052970|Dexamethasone|dexamethasone|mesh-list
5642465|NCT05052970|Dexamethasone acetate|dexamethasone acetate|mesh-list
5642466|NCT05052970|Bortezomib|bortezomib|mesh-list
5642467|NCT05052970|Mitoxantrone|mitoxantrone|mesh-list
5642468|NCT05052970|BB 1101|bb 1101|mesh-list
5642469|NCT05052970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5642470|NCT05052970|Antiemetics|antiemetics|mesh-ancestor
5642471|NCT05052970|Autonomic Agents|autonomic agents|mesh-ancestor
5642472|NCT05052970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5815401|NCT02643719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5815402|NCT02643732|Methylphenidate|methylphenidate|mesh-list
5815403|NCT02643732|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5815404|NCT02643732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815405|NCT02643732|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5815406|NCT02643732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5642473|NCT05052970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642474|NCT05052970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5642475|NCT05052970|Glucocorticoids|glucocorticoids|mesh-ancestor
5642476|NCT05052970|Hormones|hormones|mesh-ancestor
5642477|NCT05052970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5642478|NCT05052970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5642479|NCT05052970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5642480|NCT05052970|Protease Inhibitors|protease inhibitors|mesh-ancestor
5642481|NCT05052970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5642482|NCT05052970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642483|NCT05052970|Analgesics|analgesics|mesh-ancestor
5642484|NCT05052970|Sensory System Agents|sensory system agents|mesh-ancestor
5642485|NCT05052970|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5642486|NCT05052970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5642487|NCT05039177|Cetuximab|cetuximab|mesh-list
5642488|NCT05039177|Palbociclib|palbociclib|mesh-list
5642489|NCT05039177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5642490|NCT05039177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5642491|NCT05039177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5642492|NCT05039177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5642493|NCT05039177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642494|NCT05034367|Mannitol|mannitol|mesh-list
5642495|NCT05034367|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5642496|NCT05034367|Diuretics|diuretics|mesh-ancestor
5642497|NCT05034367|Natriuretic Agents|natriuretic agents|mesh-ancestor
5642498|NCT05034367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642499|NCT05029973|Bevacizumab|bevacizumab|mesh-list
5642500|NCT05029973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5642501|NCT05029973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5642502|NCT05029973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5642503|NCT05029973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5642504|NCT05029973|Growth Substances|growth substances|mesh-ancestor
5642505|NCT05029973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642506|NCT05029973|Growth Inhibitors|growth inhibitors|mesh-ancestor
5642507|NCT05025085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5642508|NCT05025085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642509|NCT05025085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5642510|NCT05019027|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
5642511|NCT05019027|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5642512|NCT05019027|Adrenergic Agents|adrenergic agents|mesh-ancestor
5815407|NCT02643732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5815408|NCT02643732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5815409|NCT02643732|Dopamine Agents|dopamine agents|mesh-ancestor
5815410|NCT02643732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5815411|NCT02643550|Cetuximab|cetuximab|mesh-list
5815412|NCT02643550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5815413|NCT02643550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5815414|NCT02643602|Theophylline|theophylline|mesh-list
5815415|NCT02643602|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5815416|NCT02643602|Autonomic Agents|autonomic agents|mesh-ancestor
5815417|NCT02643602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5815418|NCT02643602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815419|NCT02643602|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5815420|NCT02643602|Respiratory System Agents|respiratory system agents|mesh-ancestor
5642513|NCT05019027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5642514|NCT05019027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642515|NCT05019027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642516|NCT05008783|Capecitabine|capecitabine|mesh-list
5642517|NCT05008783|Oxaliplatin|oxaliplatin|mesh-list
5642518|NCT05008783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5642519|NCT05008783|Antimetabolites|antimetabolites|mesh-ancestor
5642520|NCT05008783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642521|NCT05008783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5642522|NCT05005728|Carboplatin|carboplatin|mesh-list
5642523|NCT05005728|Olaparib|olaparib|mesh-list
5642524|NCT05005728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5642525|NCT05005728|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5642526|NCT05005728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5642527|NCT05005728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5815421|NCT02643602|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5815422|NCT02643602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5815423|NCT02643602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5815424|NCT02643602|Vasodilator Agents|vasodilator agents|mesh-ancestor
5815425|NCT02643602|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5642528|NCT04994977|Carboplatin|carboplatin|mesh-list
5642529|NCT04994977|Melphalan|melphalan|mesh-list
5642530|NCT04994977|Topotecan|topotecan|mesh-list
5642531|NCT04994977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5642532|NCT04994977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5642533|NCT04994977|Alkylating Agents|alkylating agents|mesh-ancestor
5642534|NCT04994977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642535|NCT04994977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5642536|NCT04994977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5642537|NCT04994977|Immunologic Factors|immunologic factors|mesh-ancestor
5642538|NCT04994977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642539|NCT04994977|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5642540|NCT04994977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5642541|NCT04994977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5642542|NCT04986579|Trastuzumab|trastuzumab|mesh-list
5642543|NCT04986579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5642544|NCT04986579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5642545|NCT04984044|Vitamin D|vitamin d|mesh-list
5642546|NCT04984044|Cholecalciferol|cholecalciferol|mesh-list
5642547|NCT04984044|Vitamins|vitamins|mesh-ancestor
5815426|NCT02643602|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5815427|NCT02643602|Purinergic Agents|purinergic agents|mesh-ancestor
5815428|NCT02643602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5815429|NCT02643433|Vaccines|vaccines|mesh-list
5815430|NCT02643433|Immunologic Factors|immunologic factors|mesh-ancestor
5815431|NCT02643433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815432|NCT02643407|Docetaxel|docetaxel|mesh-list
5815433|NCT02643407|Nedaplatin|nedaplatin|mesh-list
5815434|NCT02643407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5815435|NCT02643407|Tubulin Modulators|tubulin modulators|mesh-ancestor
5815436|NCT02643407|Antimitotic Agents|antimitotic agents|mesh-ancestor
5815437|NCT02643407|Mitosis Modulators|mitosis modulators|mesh-ancestor
5815438|NCT02643407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5815439|NCT02643329|Gliclazide|gliclazide|mesh-list
5815440|NCT02643329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5815441|NCT02643329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815442|NCT02643017|Dexmedetomidine|dexmedetomidine|mesh-list
5815443|NCT02643017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5815444|NCT02643017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5815445|NCT02643017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815446|NCT02643017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5815447|NCT02643017|Analgesics|analgesics|mesh-ancestor
5815448|NCT02643017|Sensory System Agents|sensory system agents|mesh-ancestor
5815449|NCT02643017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5815450|NCT02643017|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5815451|NCT02643017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5815452|NCT02643017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5815453|NCT02643017|Adrenergic Agents|adrenergic agents|mesh-ancestor
5642548|NCT04984044|Micronutrients|micronutrients|mesh-ancestor
5642549|NCT04984044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642550|NCT04984044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5642551|NCT04984044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5642552|NCT04969250|Vaccines|vaccines|mesh-list
5642553|NCT04969250|Immunologic Factors|immunologic factors|mesh-ancestor
5815454|NCT02643017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5815455|NCT02643017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5815456|NCT02643173|Anesthetics|anesthetics|mesh-list
5815457|NCT02643173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
5815458|NCT02643173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5815459|NCT02643173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815460|NCT02643173|Anesthetics, General|anesthetics, general|mesh-ancestor
5815461|NCT02643147|Furosemide|furosemide|mesh-list
5815462|NCT02643147|Diuretics|diuretics|mesh-list
5815463|NCT02643147|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
5815464|NCT02643147|Natriuretic Agents|natriuretic agents|mesh-ancestor
5815465|NCT02643147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815466|NCT02643147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5815467|NCT02643147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5815468|NCT02643186|Misoprostol|misoprostol|mesh-list
5815469|NCT02643186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5815470|NCT02643186|Abortifacient Agents|abortifacient agents|mesh-ancestor
5815471|NCT02643186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5815472|NCT02643186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642554|NCT04969250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642555|NCT04967664|Capsaicin|capsaicin|mesh-list
5815473|NCT02643186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5642556|NCT04967664|Antipruritics|antipruritics|mesh-ancestor
5642557|NCT04967664|Dermatologic Agents|dermatologic agents|mesh-ancestor
5642558|NCT04967664|Sensory System Agents|sensory system agents|mesh-ancestor
5642559|NCT04967664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5642560|NCT04967664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642561|NCT04959981|Osimertinib|osimertinib|mesh-list
5642562|NCT04959981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5642563|NCT04959981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5642564|NCT04959981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5642565|NCT04959981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642566|NCT04951492|Olaparib|olaparib|mesh-list
5642567|NCT04951492|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
5642568|NCT04951492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5642569|NCT04951492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642570|NCT04951492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5642571|NCT04930315|Apatinib|apatinib|mesh-list
5642572|NCT04930315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5642573|NCT04930315|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5642574|NCT04930315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5642575|NCT04930315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642576|NCT04921007|Bupivacaine|bupivacaine|mesh-list
5642577|NCT04921007|Anesthetics, Local|anesthetics, local|mesh-ancestor
5642578|NCT04921007|Anesthetics|anesthetics|mesh-ancestor
5642579|NCT04921007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5642580|NCT04921007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815474|NCT02643186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5815475|NCT02643186|Oxytocics|oxytocics|mesh-ancestor
5815476|NCT02643212|Rivaroxaban|rivaroxaban|mesh-list
5815477|NCT02643212|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5815478|NCT02643212|Antithrombins|antithrombins|mesh-ancestor
5815479|NCT02643212|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5815480|NCT02643212|Protease Inhibitors|protease inhibitors|mesh-ancestor
5815481|NCT02643212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5815482|NCT02643212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5815483|NCT02643212|Anticoagulants|anticoagulants|mesh-ancestor
5815484|NCT02642900|Nystatin|nystatin|mesh-list
5815485|NCT02642900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5815486|NCT02642900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5815487|NCT02642900|Antifungal Agents|antifungal agents|mesh-ancestor
5642581|NCT04921007|Sensory System Agents|sensory system agents|mesh-ancestor
5642582|NCT04921007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5642583|NCT04920994|Bupivacaine|bupivacaine|mesh-list
5642584|NCT04920994|Anesthetics, Local|anesthetics, local|mesh-ancestor
5642585|NCT04920994|Anesthetics|anesthetics|mesh-ancestor
5642586|NCT04920994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5642587|NCT04920994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642588|NCT04920994|Sensory System Agents|sensory system agents|mesh-ancestor
5642589|NCT04920994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5642590|NCT04909515|Isotretinoin|isotretinoin|mesh-list
5642591|NCT04909515|Dermatologic Agents|dermatologic agents|mesh-ancestor
5642592|NCT04908605|Melatonin|melatonin|mesh-list
5642593|NCT04908605|Mirtazapine|mirtazapine|mesh-list
5642594|NCT04908605|Antioxidants|antioxidants|mesh-ancestor
5815488|NCT02642900|Ionophores|ionophores|mesh-ancestor
5815489|NCT02642900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5815490|NCT02642900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5815491|NCT02642861|Cyclobenzaprine|cyclobenzaprine|mesh-list
5815492|NCT02642861|Calcium Carbonate|calcium carbonate|mesh-list
5815493|NCT02642861|Calcium|calcium|mesh-list
5815494|NCT02642861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5815495|NCT02642861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815496|NCT02642861|Antacids|antacids|mesh-ancestor
5815497|NCT02642861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5815498|NCT02642861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5815499|NCT02642861|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5815500|NCT02642861|Antidepressive Agents|antidepressive agents|mesh-ancestor
5815501|NCT02642861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5815502|NCT02642861|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5815503|NCT02642861|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5815504|NCT02642861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5642595|NCT04908605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642596|NCT04908605|Protective Agents|protective agents|mesh-ancestor
5642597|NCT04908605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642598|NCT04908605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5815505|NCT02642861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5642599|NCT04908605|Antidepressive Agents|antidepressive agents|mesh-ancestor
5642600|NCT04908605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5642601|NCT04908605|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5815506|NCT02642861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5815507|NCT02642913|Sorafenib|sorafenib|mesh-list
5815508|NCT02642913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5815509|NCT02642913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5815510|NCT02642913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5815511|NCT02642913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5815512|NCT02642874|Methocarbamol|methocarbamol|mesh-list
5815513|NCT02642874|Calcium Carbonate|calcium carbonate|mesh-list
5815514|NCT02642874|Calcium|calcium|mesh-list
5815515|NCT02642874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5815516|NCT02642874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642602|NCT04908605|Histamine Antagonists|histamine antagonists|mesh-ancestor
5642603|NCT04908605|Histamine Agents|histamine agents|mesh-ancestor
5642604|NCT04908605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5642605|NCT04908605|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5642606|NCT04908605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5642607|NCT04908605|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5642608|NCT04908605|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5642609|NCT04908605|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5642610|NCT04908605|Adrenergic Agents|adrenergic agents|mesh-ancestor
5642611|NCT04908605|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5642612|NCT04908605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5642613|NCT04908605|Serotonin Agents|serotonin agents|mesh-ancestor
6492607|NCT00609752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6492608|NCT00609791|Paclitaxel|paclitaxel|mesh-list
6492609|NCT00609791|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6492610|NCT00609791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6492611|NCT00609791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6492612|NCT00609791|Tubulin Modulators|tubulin modulators|mesh-ancestor
6492613|NCT00609791|Antimitotic Agents|antimitotic agents|mesh-ancestor
6492614|NCT00609791|Mitosis Modulators|mitosis modulators|mesh-ancestor
6492615|NCT00609791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492616|NCT00609817|Dexamethasone|dexamethasone|mesh-list
6492617|NCT00609817|Bortezomib|bortezomib|mesh-list
6492618|NCT00609817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5642614|NCT04908605|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5642615|NCT04908579|Ketamine|ketamine|mesh-list
5642616|NCT04908579|Bupivacaine|bupivacaine|mesh-list
5642617|NCT04908579|Anesthetics, Local|anesthetics, local|mesh-ancestor
5642618|NCT04908579|Anesthetics|anesthetics|mesh-ancestor
5642619|NCT04908579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5642620|NCT04908579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642621|NCT04908579|Sensory System Agents|sensory system agents|mesh-ancestor
5642622|NCT04908579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5642623|NCT04908579|Analgesics|analgesics|mesh-ancestor
5642624|NCT04908579|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5815517|NCT02642874|Antacids|antacids|mesh-ancestor
5815518|NCT02642874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5815519|NCT02642874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5815520|NCT02642874|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5815521|NCT02642874|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5815522|NCT02642874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5815523|NCT02642939|Mifepristone|mifepristone|mesh-list
5815524|NCT02642939|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5642625|NCT04908579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5642626|NCT04908579|Anesthetics, General|anesthetics, general|mesh-ancestor
5642627|NCT04908579|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5642628|NCT04908579|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5642629|NCT04908579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5642630|NCT04908579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642631|NCT04903210|Niacinamide|niacinamide|mesh-list
5642632|NCT04903210|Niacin|niacin|mesh-list
5642633|NCT04903210|Nicotinic Acids|nicotinic acids|mesh-list
5642634|NCT04903210|Vitamin B Complex|vitamin b complex|mesh-ancestor
5642635|NCT04903210|Vitamins|vitamins|mesh-ancestor
5642636|NCT04903210|Micronutrients|micronutrients|mesh-ancestor
5642637|NCT04903210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642638|NCT04903210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5642639|NCT04903210|Antimetabolites|antimetabolites|mesh-ancestor
5642640|NCT04903210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642641|NCT04903210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6492619|NCT00609817|Antiemetics|antiemetics|mesh-ancestor
5815525|NCT02642939|Abortifacient Agents|abortifacient agents|mesh-ancestor
5642642|NCT04903210|Vasodilator Agents|vasodilator agents|mesh-ancestor
5642643|NCT04896658|Dexamethasone|dexamethasone|mesh-list
5642644|NCT04896658|Cyclophosphamide|cyclophosphamide|mesh-list
5642645|NCT04896658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5642646|NCT04896658|Immunologic Factors|immunologic factors|mesh-ancestor
5642647|NCT04896658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642648|NCT04896658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6211390|NCT02170649|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6211391|NCT02170649|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6211392|NCT02170649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6211393|NCT02170649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211394|NCT02170662|Bimatoprost|bimatoprost|mesh-list
6211395|NCT02170662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6211396|NCT02171130|Glucagon|glucagon|mesh-list
5642649|NCT04896658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5642650|NCT04896658|Alkylating Agents|alkylating agents|mesh-ancestor
5642651|NCT04896658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5815526|NCT02642939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5815527|NCT02642939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815528|NCT02642939|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5815529|NCT02642939|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5815530|NCT02642939|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5815531|NCT02642939|Contraceptive Agents|contraceptive agents|mesh-ancestor
5815532|NCT02642939|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5815533|NCT02642939|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5815534|NCT02642939|Hormone Antagonists|hormone antagonists|mesh-ancestor
5815535|NCT02642939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5815536|NCT02642939|Luteolytic Agents|luteolytic agents|mesh-ancestor
5815537|NCT02642939|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5815538|NCT02642939|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5815539|NCT02642718|Ketorolac|ketorolac|mesh-list
5815540|NCT02642718|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
5815541|NCT02642718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5815542|NCT02642718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5815543|NCT02642718|Analgesics|analgesics|mesh-ancestor
5815544|NCT02642718|Sensory System Agents|sensory system agents|mesh-ancestor
5815545|NCT02642718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5815546|NCT02642718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815547|NCT02642718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5815548|NCT02642718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5815549|NCT02642718|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5815550|NCT02642718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5815551|NCT02642718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5815552|NCT02642640|Melatonin|melatonin|mesh-list
5815553|NCT02642640|Antioxidants|antioxidants|mesh-ancestor
5815554|NCT02642640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5815555|NCT02642640|Protective Agents|protective agents|mesh-ancestor
5815556|NCT02642640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815557|NCT02642640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5815558|NCT02642523|Insulin|insulin|mesh-list
5815559|NCT02642523|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5815560|NCT02642523|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
5815561|NCT02642523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5815562|NCT02642523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815563|NCT02642523|Natriuretic Agents|natriuretic agents|mesh-ancestor
5815564|NCT02642497|Ketamine|ketamine|mesh-list
5815565|NCT02642497|Analgesics|analgesics|mesh-ancestor
5815566|NCT02642497|Sensory System Agents|sensory system agents|mesh-ancestor
5815567|NCT02642497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5815568|NCT02642497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815569|NCT02642497|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5815570|NCT02642497|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5815571|NCT02642497|Anesthetics, General|anesthetics, general|mesh-ancestor
5815572|NCT02642497|Anesthetics|anesthetics|mesh-ancestor
5815573|NCT02642497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5815574|NCT02642497|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5815575|NCT02642497|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5815576|NCT02642497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5815577|NCT02642497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5815578|NCT02642484|Gabapentin|gabapentin|mesh-list
5815579|NCT02642484|Calcium Carbonate|calcium carbonate|mesh-list
5815580|NCT02642484|Calcium|calcium|mesh-list
5901199|NCT03805841|Anticonvulsants|anticonvulsants|mesh-ancestor
5815581|NCT02642484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5815582|NCT02642484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815583|NCT02642484|Analgesics|analgesics|mesh-ancestor
5815584|NCT02642484|Sensory System Agents|sensory system agents|mesh-ancestor
5815585|NCT02642484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5815586|NCT02642484|Anticonvulsants|anticonvulsants|mesh-ancestor
5815587|NCT02642484|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5815588|NCT02642484|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5815589|NCT02642484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5815590|NCT02642484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5642652|NCT04896658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5642653|NCT04896658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5642654|NCT04896658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5642655|NCT04896658|Antiemetics|antiemetics|mesh-ancestor
5642656|NCT04896658|Autonomic Agents|autonomic agents|mesh-ancestor
5642657|NCT04896658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5642658|NCT04896658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5642659|NCT04896658|Glucocorticoids|glucocorticoids|mesh-ancestor
5815591|NCT02642484|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5815592|NCT02642484|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5815593|NCT02642484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5815594|NCT02642484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5815595|NCT02642484|Antimanic Agents|antimanic agents|mesh-ancestor
5815596|NCT02642484|Antacids|antacids|mesh-ancestor
5815597|NCT02642484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5815598|NCT02642419|Aspirin|aspirin|mesh-list
5815599|NCT02642419|Rivaroxaban|rivaroxaban|mesh-list
5815600|NCT02642419|Clopidogrel|clopidogrel|mesh-list
5815601|NCT02642419|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
5815602|NCT02642419|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
5815603|NCT02642419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5642660|NCT04896658|Hormones|hormones|mesh-ancestor
5642661|NCT04896658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5642662|NCT04896658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6211397|NCT02171130|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6211398|NCT02171130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6211399|NCT02171130|Hormones|hormones|mesh-ancestor
6211400|NCT02171130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6211401|NCT02171130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642668|NCT04887506|Prednisone|prednisone|mesh-list
5642669|NCT04887506|Abiraterone Acetate|abiraterone acetate|mesh-list
5642670|NCT04887506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5642671|NCT04887506|Glucocorticoids|glucocorticoids|mesh-ancestor
5642672|NCT04887506|Hormones|hormones|mesh-ancestor
5642673|NCT04887506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5642674|NCT04887506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642675|NCT04887506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5642676|NCT04887506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5642677|NCT04887506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5642678|NCT04887506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5642679|NCT04887506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642680|NCT04887506|Hormone Antagonists|hormone antagonists|mesh-ancestor
5642681|NCT04887506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5642682|NCT04882085|Ceftazidime|ceftazidime|mesh-list
5642683|NCT04882085|Avibactam|avibactam|mesh-list
5815604|NCT02642419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5815605|NCT02642419|Analgesics|analgesics|mesh-ancestor
5815606|NCT02642419|Sensory System Agents|sensory system agents|mesh-ancestor
5815607|NCT02642419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5815608|NCT02642419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815609|NCT02642419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5815610|NCT02642419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5815611|NCT02642419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5815612|NCT02642419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5815613|NCT02642419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5815614|NCT02642419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5815615|NCT02642419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5815616|NCT02642419|Antipyretics|antipyretics|mesh-ancestor
5815617|NCT02642419|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5815618|NCT02642419|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5815619|NCT02642419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5815620|NCT02642419|Purinergic Agents|purinergic agents|mesh-ancestor
6211402|NCT02171130|Incretins|incretins|mesh-ancestor
5642684|NCT04882085|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
5642685|NCT04882085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5642686|NCT04882085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5642687|NCT04882085|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5642688|NCT04882085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5815621|NCT02642419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5815622|NCT02642419|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5815623|NCT02642419|Antithrombins|antithrombins|mesh-ancestor
5815624|NCT02642419|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5815625|NCT02642419|Protease Inhibitors|protease inhibitors|mesh-ancestor
5815626|NCT02642419|Anticoagulants|anticoagulants|mesh-ancestor
5815627|NCT02642380|Dexamethasone|dexamethasone|mesh-list
5815628|NCT02642380|Dexamethasone acetate|dexamethasone acetate|mesh-list
5815629|NCT02642380|BB 1101|bb 1101|mesh-list
5815630|NCT02642380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5815631|NCT02642380|Antiemetics|antiemetics|mesh-ancestor
5815632|NCT02642380|Autonomic Agents|autonomic agents|mesh-ancestor
5815633|NCT02642380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5815634|NCT02642380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815635|NCT02642380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5642689|NCT04882085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642690|NCT04856319|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5642691|NCT04856319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5642692|NCT04818632|Everolimus|everolimus|mesh-list
5642693|NCT04818632|Palbociclib|palbociclib|mesh-list
5642694|NCT04818632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5642695|NCT04818632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5642696|NCT04818632|Immunologic Factors|immunologic factors|mesh-ancestor
5642697|NCT04818632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642698|NCT04818632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5642699|NCT04818632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5642700|NCT04818632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642701|NCT04813926|Riociguat|riociguat|mesh-list
5642702|NCT04813926|Enzyme Activators|enzyme activators|mesh-ancestor
5642703|NCT04813926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642704|NCT04802837|Vancomycin|vancomycin|mesh-list
5642705|NCT04802837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5642706|NCT04802837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5642707|NCT04779138|Vaccines|vaccines|mesh-list
5642708|NCT04779138|Immunologic Factors|immunologic factors|mesh-ancestor
5642709|NCT04779138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5693997|NCT03398252|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5693998|NCT03398252|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5693999|NCT03398252|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5694000|NCT03398252|Adrenergic Agents|adrenergic agents|mesh-ancestor
5694001|NCT03398252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5815636|NCT02642380|Glucocorticoids|glucocorticoids|mesh-ancestor
5815637|NCT02642380|Hormones|hormones|mesh-ancestor
5815638|NCT02642380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5815639|NCT02642380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5694002|NCT03398252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694003|NCT03398252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694004|NCT03398135|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5694005|NCT03398135|Immunologic Factors|immunologic factors|mesh-ancestor
5694006|NCT03398135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694007|NCT03398122|Apatinib|apatinib|mesh-list
5694008|NCT03398122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5694009|NCT03398122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5694010|NCT03398122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5694011|NCT03398122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694012|NCT03398083|Alprazolam|alprazolam|mesh-list
5694013|NCT03398083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5694014|NCT03398083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5694015|NCT03398083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815640|NCT02642380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5815641|NCT02642380|Protease Inhibitors|protease inhibitors|mesh-ancestor
5815642|NCT02642380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5815643|NCT02642380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5815644|NCT02642601|Indomethacin|indomethacin|mesh-list
5815645|NCT02642601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5815646|NCT02642601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5815647|NCT02642601|Analgesics|analgesics|mesh-ancestor
5815648|NCT02642601|Sensory System Agents|sensory system agents|mesh-ancestor
5815649|NCT02642601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5815650|NCT02642601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815651|NCT02642601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5815652|NCT02642601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5815653|NCT02642601|Gout Suppressants|gout suppressants|mesh-ancestor
5815654|NCT02642601|Tocolytic Agents|tocolytic agents|mesh-ancestor
5815655|NCT02642601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5815656|NCT02642601|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5815657|NCT02642601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5815658|NCT02642601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5815659|NCT02642367|Rocuronium|rocuronium|mesh-list
5815660|NCT02642367|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5815661|NCT02642367|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5815662|NCT02642367|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5815663|NCT02642367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5815664|NCT02642367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815665|NCT02642146|Calcium Channel Blockers|calcium channel blockers|mesh-list
5815666|NCT02642146|Vasodilator Agents|vasodilator agents|mesh-list
5815667|NCT02642146|Calcium|calcium|mesh-list
5815668|NCT02642146|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
5815669|NCT02642146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5815670|NCT02642146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815671|NCT02642146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5815672|NCT02642146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642710|NCT04769401|Progesterone|progesterone|mesh-list
5642711|NCT04769401|Progestins|progestins|mesh-ancestor
5642712|NCT04769401|Hormones|hormones|mesh-ancestor
5642713|NCT04769401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5642714|NCT04769401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642715|NCT04762680|Vaccines|vaccines|mesh-list
5642716|NCT04762680|Immunologic Factors|immunologic factors|mesh-ancestor
5642717|NCT04762680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642718|NCT04750226|Levodopa|levodopa|mesh-list
5642719|NCT04750226|Carbidopa|carbidopa|mesh-list
5642720|NCT04750226|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5642721|NCT04750226|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5642722|NCT04750226|Dopamine Agents|dopamine agents|mesh-ancestor
5642723|NCT04750226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5642724|NCT04750226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642725|NCT04750226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642726|NCT04750226|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5642727|NCT04750226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5642728|NCT04742023|Insulin|insulin|mesh-list
5815673|NCT02642146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5901200|NCT03801434|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
5901201|NCT03801434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5901202|NCT03801434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5901203|NCT03801434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901204|NCT03772925|Belinostat|belinostat|mesh-list
5901205|NCT03772925|Enzyme Inhibitors|enzyme inhibitors|mesh-list
5642729|NCT04742023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5642730|NCT04742023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642731|NCT04733157|Tranexamic Acid|tranexamic acid|mesh-list
5642732|NCT04733157|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5642733|NCT04733157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5642734|NCT04733157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642735|NCT04733157|Hemostatics|hemostatics|mesh-ancestor
5642736|NCT04733157|Coagulants|coagulants|mesh-ancestor
5642737|NCT04727424|Budesonide|budesonide|mesh-list
5642738|NCT04727424|Fluvoxamine|fluvoxamine|mesh-list
5642739|NCT04727424|Maleic acid|maleic acid|mesh-list
5642740|NCT04727424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5642741|NCT04727424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5642742|NCT04727424|Autonomic Agents|autonomic agents|mesh-ancestor
5642743|NCT04727424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5642744|NCT04727424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642745|NCT04727424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5642746|NCT04727424|Respiratory System Agents|respiratory system agents|mesh-ancestor
5642747|NCT04727424|Glucocorticoids|glucocorticoids|mesh-ancestor
5642748|NCT04727424|Hormones|hormones|mesh-ancestor
5642749|NCT04727424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5642750|NCT04727424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5642751|NCT04727424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642752|NCT04727424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5642753|NCT04727424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5642754|NCT04727424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5901206|NCT03772925|Pevonedistat|pevonedistat|mesh-list
5642755|NCT04727424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5642756|NCT04727424|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5642757|NCT04727424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5642758|NCT04727424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5642759|NCT04727424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5642760|NCT04727424|Serotonin Agents|serotonin agents|mesh-ancestor
5642761|NCT04727424|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5642762|NCT04727424|Antidepressive Agents|antidepressive agents|mesh-ancestor
5642763|NCT04727424|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5642764|NCT04727424|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5642765|NCT04727424|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5642766|NCT04724252|Gabapentin|gabapentin|mesh-list
5815674|NCT02642250|Metronidazole|metronidazole|mesh-list
5815675|NCT02642250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5815676|NCT02642250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5815677|NCT02642250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5815678|NCT02642250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5815679|NCT02642263|Carbetocin|carbetocin|mesh-list
5815680|NCT02642263|Oxytocics|oxytocics|mesh-ancestor
5815681|NCT02642263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5815682|NCT02642263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815683|NCT02641990|Exenatide|exenatide|mesh-list
5815684|NCT02641990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5815685|NCT02641990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815686|NCT02641990|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5815687|NCT02641990|Incretins|incretins|mesh-ancestor
5815688|NCT02641990|Hormones|hormones|mesh-ancestor
5815689|NCT02641990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5815690|NCT02642094|Sirolimus|sirolimus|mesh-list
5642767|NCT04724252|Analgesics|analgesics|mesh-ancestor
5642768|NCT04724252|Sensory System Agents|sensory system agents|mesh-ancestor
5642769|NCT04724252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5642770|NCT04724252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642771|NCT04724252|Anticonvulsants|anticonvulsants|mesh-ancestor
5642772|NCT04724252|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5642773|NCT04724252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5642774|NCT04724252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5642775|NCT04724252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5642776|NCT04724252|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5642777|NCT04724252|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5642778|NCT04724252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5642779|NCT04724252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642780|NCT04724252|Antimanic Agents|antimanic agents|mesh-ancestor
5642781|NCT04720781|Esomeprazole|esomeprazole|mesh-list
5642782|NCT04720781|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5642783|NCT04720781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5642784|NCT04720781|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5642785|NCT04720781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5642786|NCT04720781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642787|NCT04719208|Chlorhexidine|chlorhexidine|mesh-list
5642788|NCT04719208|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5642789|NCT04719208|Hydrogen Peroxide|hydrogen peroxide|mesh-list
5642790|NCT04719208|Povidone-Iodine|povidone-iodine|mesh-list
5642791|NCT04719208|Listerine|listerine|mesh-list
5642792|NCT04719208|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5642793|NCT04719208|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5642794|NCT04719208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5642795|NCT04719208|Disinfectants|disinfectants|mesh-ancestor
5642796|NCT04719208|Dermatologic Agents|dermatologic agents|mesh-ancestor
5642797|NCT04718116|Tramadol|tramadol|mesh-list
5642798|NCT04718116|Tapentadol|tapentadol|mesh-list
5642799|NCT04718116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5642800|NCT04718116|Narcotics|narcotics|mesh-ancestor
5815691|NCT02642094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5815692|NCT02642094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5815693|NCT02642094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5815694|NCT02642094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5815695|NCT02642094|Antifungal Agents|antifungal agents|mesh-ancestor
5815696|NCT02642094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5815697|NCT02642094|Immunologic Factors|immunologic factors|mesh-ancestor
5815698|NCT02642094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815699|NCT02642003|Sargramostim|sargramostim|mesh-list
5815700|NCT02642003|Lenograstim|lenograstim|mesh-list
5815701|NCT02642003|Immunologic Factors|immunologic factors|mesh-ancestor
5815702|NCT02642003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642801|NCT04718116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5815703|NCT02642003|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5815704|NCT02641873|Leucovorin|leucovorin|mesh-list
5815705|NCT02641873|Bevacizumab|bevacizumab|mesh-list
5815706|NCT02641873|Irinotecan|irinotecan|mesh-list
5815707|NCT02641873|Levoleucovorin|levoleucovorin|mesh-list
5815708|NCT02641873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5815709|NCT02641873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5815710|NCT02641873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5815711|NCT02641873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5815712|NCT02641873|Growth Substances|growth substances|mesh-ancestor
5815713|NCT02641873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815714|NCT02641873|Growth Inhibitors|growth inhibitors|mesh-ancestor
5815715|NCT02641873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5815716|NCT02641873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5642802|NCT04718116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642803|NCT04718116|Analgesics|analgesics|mesh-ancestor
5642804|NCT04718116|Sensory System Agents|sensory system agents|mesh-ancestor
5642805|NCT04718116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5642806|NCT04718116|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5642807|NCT04718116|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5642808|NCT04718116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5642809|NCT04718116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642810|NCT04718116|Adrenergic Agents|adrenergic agents|mesh-ancestor
5642811|NCT04718116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5642812|NCT04717375|Pembrolizumab|pembrolizumab|mesh-list
5642813|NCT04717375|Cetuximab|cetuximab|mesh-list
5642814|NCT04717375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5642815|NCT04717375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5642816|NCT04707872|Antibodies|antibodies|mesh-list
5642817|NCT04707872|Immunologic Factors|immunologic factors|mesh-ancestor
5642818|NCT04707872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642819|NCT04706715|Cemiplimab|cemiplimab|mesh-list
5642820|NCT04706715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5642821|NCT04706715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5642822|NCT04701190|Norepinephrine|norepinephrine|mesh-list
5642823|NCT04701190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642824|NCT04701190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5642825|NCT04701190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5642826|NCT04701190|Adrenergic Agents|adrenergic agents|mesh-ancestor
5642827|NCT04701190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5642828|NCT04701190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642829|NCT04701190|Sympathomimetics|sympathomimetics|mesh-ancestor
5642830|NCT04701190|Autonomic Agents|autonomic agents|mesh-ancestor
5642831|NCT04701190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5642832|NCT04701190|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5642833|NCT04700423|Ivermectin|ivermectin|mesh-list
5642834|NCT04700423|Albendazole|albendazole|mesh-list
5642835|NCT04700423|Moxidectin|moxidectin|mesh-list
5642836|NCT04700423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5642837|NCT04700423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5642838|NCT04700423|Anthelmintics|anthelmintics|mesh-ancestor
5642839|NCT04700423|Anticestodal Agents|anticestodal agents|mesh-ancestor
5642840|NCT04700423|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5642841|NCT04700423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5642842|NCT04700423|Tubulin Modulators|tubulin modulators|mesh-ancestor
5642843|NCT04700423|Antimitotic Agents|antimitotic agents|mesh-ancestor
5642844|NCT04700423|Mitosis Modulators|mitosis modulators|mesh-ancestor
5642845|NCT04700423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642846|NCT04700423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5642847|NCT04700423|Antinematodal Agents|antinematodal agents|mesh-ancestor
5642848|NCT04699604|Levocetirizine|levocetirizine|mesh-list
5642849|NCT04699604|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5642850|NCT04699604|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5642851|NCT04699604|Histamine Antagonists|histamine antagonists|mesh-ancestor
5642852|NCT04699604|Histamine Agents|histamine agents|mesh-ancestor
5642853|NCT04699604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5642854|NCT04699604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642855|NCT04699604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642856|NCT04666454|Adenosine|adenosine|mesh-list
5642857|NCT04666454|Dipyridamole|dipyridamole|mesh-list
5642858|NCT04666454|Apixaban|apixaban|mesh-list
5642859|NCT04666454|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5815717|NCT02641873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5815718|NCT02641873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5815719|NCT02641873|Antidotes|antidotes|mesh-ancestor
5815720|NCT02641873|Protective Agents|protective agents|mesh-ancestor
5642860|NCT04666454|Antithrombins|antithrombins|mesh-ancestor
5694016|NCT03398083|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5642861|NCT04666454|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5642862|NCT04666454|Protease Inhibitors|protease inhibitors|mesh-ancestor
5642863|NCT04666454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5642864|NCT04666454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642865|NCT04666454|Anticoagulants|anticoagulants|mesh-ancestor
5642866|NCT04666454|Analgesics|analgesics|mesh-ancestor
5642867|NCT04666454|Sensory System Agents|sensory system agents|mesh-ancestor
5642868|NCT04666454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5642869|NCT04666454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642870|NCT04666454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5815721|NCT02641873|Vitamin B Complex|vitamin b complex|mesh-ancestor
5815722|NCT02641873|Vitamins|vitamins|mesh-ancestor
5815723|NCT02641873|Micronutrients|micronutrients|mesh-ancestor
5815724|NCT02641938|Dexmedetomidine|dexmedetomidine|mesh-list
5815725|NCT02641938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5815726|NCT02641938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5815727|NCT02641938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815728|NCT02641938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5815729|NCT02641938|Analgesics|analgesics|mesh-ancestor
5815730|NCT02641938|Sensory System Agents|sensory system agents|mesh-ancestor
5815731|NCT02641938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5815732|NCT02641938|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5815733|NCT02641938|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5642871|NCT04666454|Vasodilator Agents|vasodilator agents|mesh-ancestor
5642872|NCT04666454|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5642873|NCT04666454|Purinergic Agonists|purinergic agonists|mesh-ancestor
5642874|NCT04666454|Purinergic Agents|purinergic agents|mesh-ancestor
5642875|NCT04666454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5642876|NCT04666454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5642877|NCT04666454|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5642878|NCT04639219|Trastuzumab|trastuzumab|mesh-list
5642879|NCT04639219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5642880|NCT04639219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5642881|NCT04606316|Nivolumab|nivolumab|mesh-list
5642882|NCT04606316|Ipilimumab|ipilimumab|mesh-list
5642883|NCT04606316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5815734|NCT02641938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5815735|NCT02641938|Adrenergic Agents|adrenergic agents|mesh-ancestor
5815736|NCT02641938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5815737|NCT02641938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5815738|NCT02641847|Gemcitabine|gemcitabine|mesh-list
5815739|NCT02641847|Cyclophosphamide|cyclophosphamide|mesh-list
5815740|NCT02641847|Docetaxel|docetaxel|mesh-list
5815741|NCT02641847|Doxorubicin|doxorubicin|mesh-list
5815742|NCT02641847|Epirubicin|epirubicin|mesh-list
5815743|NCT02641847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5815744|NCT02641847|Immunologic Factors|immunologic factors|mesh-ancestor
5815745|NCT02641847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815746|NCT02641847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5815747|NCT02641847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5815748|NCT02641847|Alkylating Agents|alkylating agents|mesh-ancestor
5815749|NCT02641847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5815750|NCT02641847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5815751|NCT02641847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5815752|NCT02641847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5815753|NCT02641847|Antimetabolites|antimetabolites|mesh-ancestor
5815754|NCT02641847|Antiviral Agents|antiviral agents|mesh-ancestor
5815755|NCT02641847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5815756|NCT02641847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5815757|NCT02641847|Tubulin Modulators|tubulin modulators|mesh-ancestor
5815758|NCT02641847|Antimitotic Agents|antimitotic agents|mesh-ancestor
5815759|NCT02641847|Mitosis Modulators|mitosis modulators|mesh-ancestor
5815760|NCT02641847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5815761|NCT02641847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5815762|NCT02641847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5815763|NCT02641899|Acetaminophen|acetaminophen|mesh-list
5815764|NCT02641899|Exenatide|exenatide|mesh-list
5815765|NCT02641899|Digoxin|digoxin|mesh-list
5815766|NCT02641899|Lisinopril|lisinopril|mesh-list
5815767|NCT02641899|Warfarin|warfarin|mesh-list
5815768|NCT02641899|Atorvastatin|atorvastatin|mesh-list
5815769|NCT02641899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5815770|NCT02641899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5642884|NCT04606316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5694017|NCT03398083|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5815771|NCT02641899|Antimetabolites|antimetabolites|mesh-ancestor
5815772|NCT02641899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5815773|NCT02641899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5815774|NCT02641899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5815775|NCT02641899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5815776|NCT02641899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5815777|NCT02641899|Analgesics|analgesics|mesh-ancestor
5815778|NCT02641899|Sensory System Agents|sensory system agents|mesh-ancestor
5815779|NCT02641899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5642885|NCT04606316|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5642886|NCT04606316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642887|NCT04601883|Colchicine|colchicine|mesh-list
5642888|NCT04601883|Gout Suppressants|gout suppressants|mesh-ancestor
5642889|NCT04601883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5642890|NCT04601883|Tubulin Modulators|tubulin modulators|mesh-ancestor
5642891|NCT04601883|Antimitotic Agents|antimitotic agents|mesh-ancestor
5642892|NCT04601883|Mitosis Modulators|mitosis modulators|mesh-ancestor
5642893|NCT04601883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642894|NCT04601883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5642895|NCT04600921|Ertugliflozin|ertugliflozin|mesh-list
5642896|NCT04600921|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5642897|NCT04600921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642898|NCT04600921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5642899|NCT04600921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642900|NCT04579640|Vitamin D|vitamin d|mesh-list
5642901|NCT04579640|Vitamins|vitamins|mesh-ancestor
5642902|NCT04579640|Micronutrients|micronutrients|mesh-ancestor
5642903|NCT04579640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642904|NCT04579640|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5642905|NCT04573777|Evolocumab|evolocumab|mesh-list
5642906|NCT04573777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5642907|NCT04573777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5642908|NCT04573777|Antimetabolites|antimetabolites|mesh-ancestor
5642909|NCT04573777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642910|NCT04573777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5815780|NCT02641899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815781|NCT02641899|Antipyretics|antipyretics|mesh-ancestor
5815782|NCT02641899|Anticoagulants|anticoagulants|mesh-ancestor
5815783|NCT02641899|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5815784|NCT02641899|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6492620|NCT00609817|Autonomic Agents|autonomic agents|mesh-ancestor
6492621|NCT00609817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6492622|NCT00609817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492623|NCT00609817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6492624|NCT00609817|Glucocorticoids|glucocorticoids|mesh-ancestor
6492625|NCT00609817|Hormones|hormones|mesh-ancestor
6492626|NCT00609817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6492627|NCT00609817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6492628|NCT00609817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6492629|NCT00609843|Ethiodized Oil|ethiodized oil|mesh-list
6492630|NCT00609843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5642911|NCT04563325|Ceftriaxone|ceftriaxone|mesh-list
5694018|NCT03398083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6492631|NCT00609856|Insulin Glargine|insulin glargine|mesh-list
6492632|NCT00609856|Pioglitazone|pioglitazone|mesh-list
5815785|NCT02641899|Protective Agents|protective agents|mesh-ancestor
5815786|NCT02641899|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5815787|NCT02641899|Protease Inhibitors|protease inhibitors|mesh-ancestor
5815788|NCT02641899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5815789|NCT02641899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5815790|NCT02641899|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5815791|NCT02641899|Incretins|incretins|mesh-ancestor
5815792|NCT02641899|Hormones|hormones|mesh-ancestor
5815793|NCT02641899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5815794|NCT02641821|Nifedipine|nifedipine|mesh-list
5815795|NCT02641821|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5815796|NCT02641821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5815797|NCT02641821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5815798|NCT02641821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5815799|NCT02641821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815800|NCT02641821|Vasodilator Agents|vasodilator agents|mesh-ancestor
5815801|NCT02641821|Tocolytic Agents|tocolytic agents|mesh-ancestor
5815802|NCT02641821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5815803|NCT02641782|Aldesleukin|aldesleukin|mesh-list
5815804|NCT02641782|Interleukin-2|interleukin-2|mesh-list
5815805|NCT02641782|Tretinoin|tretinoin|mesh-list
6492633|NCT00609856|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5642912|NCT04563325|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5642913|NCT04563325|Dicloxacillin|dicloxacillin|mesh-list
5642914|NCT04563325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5642915|NCT04563325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5642916|NCT04563325|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5642917|NCT04563325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5642918|NCT04563325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642919|NCT04560166|Irinotecan|irinotecan|mesh-list
5642920|NCT04560166|Temozolomide|temozolomide|mesh-list
5642921|NCT04560166|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5642922|NCT04560166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5642923|NCT04560166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5642924|NCT04560166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642925|NCT04560166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5815806|NCT02641782|Dinutuximab|dinutuximab|mesh-list
5815807|NCT02641782|Isotretinoin|isotretinoin|mesh-list
5815808|NCT02641782|Antibodies|antibodies|mesh-list
5815809|NCT02641782|Sargramostim|sargramostim|mesh-list
5815810|NCT02641782|Immunologic Factors|immunologic factors|mesh-ancestor
5815811|NCT02641782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815812|NCT02641782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5815813|NCT02641782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5815814|NCT02641782|Analgesics|analgesics|mesh-ancestor
5815815|NCT02641782|Sensory System Agents|sensory system agents|mesh-ancestor
5815816|NCT02641782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5815817|NCT02641782|Keratolytic Agents|keratolytic agents|mesh-ancestor
5815818|NCT02641782|Dermatologic Agents|dermatologic agents|mesh-ancestor
5815819|NCT02641782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5642926|NCT04560166|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5642927|NCT04560166|Alkylating Agents|alkylating agents|mesh-ancestor
5642928|NCT04559646|Hemostatics|hemostatics|mesh-list
5642929|NCT04559646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5642930|NCT04559646|Coagulants|coagulants|mesh-ancestor
5815820|NCT02641782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5815821|NCT02641782|Antiviral Agents|antiviral agents|mesh-ancestor
5815822|NCT02641782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5815823|NCT02641652|Sertraline|sertraline|mesh-list
5815824|NCT02641652|Antidepressive Agents|antidepressive agents|mesh-ancestor
5815825|NCT02641652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5815826|NCT02641652|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5815827|NCT02641652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5815828|NCT02641652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5815829|NCT02641652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5815830|NCT02641652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5815831|NCT02641652|Serotonin Agents|serotonin agents|mesh-ancestor
5815832|NCT02641652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815833|NCT02641639|Fosbretabulin|fosbretabulin|mesh-list
5815834|NCT02641639|Combretastatin|combretastatin|mesh-list
5815835|NCT02641639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5815836|NCT02641639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5815837|NCT02641639|Tubulin Modulators|tubulin modulators|mesh-ancestor
5815838|NCT02641639|Antimitotic Agents|antimitotic agents|mesh-ancestor
5815839|NCT02641639|Mitosis Modulators|mitosis modulators|mesh-ancestor
5815840|NCT02641639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5815841|NCT02641457|Ranibizumab|ranibizumab|mesh-list
5815842|NCT02641457|Aflibercept|aflibercept|mesh-list
5642931|NCT04546126|Dexamethasone|dexamethasone|mesh-list
5642932|NCT04546126|Cosyntropin|cosyntropin|mesh-list
5642933|NCT04546126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5642934|NCT04546126|Antiemetics|antiemetics|mesh-ancestor
5642935|NCT04546126|Autonomic Agents|autonomic agents|mesh-ancestor
5642936|NCT04546126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5642937|NCT04546126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642938|NCT04546126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5642939|NCT04546126|Glucocorticoids|glucocorticoids|mesh-ancestor
5642940|NCT04546126|Hormones|hormones|mesh-ancestor
5642941|NCT04546126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5642942|NCT04546126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5642943|NCT04546126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5642944|NCT04538352|Insulin|insulin|mesh-list
5642945|NCT04538352|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5642946|NCT04538352|Insulin Aspart|insulin aspart|mesh-list
5815843|NCT02641457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5642947|NCT04538352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5815844|NCT02641457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5815845|NCT02641457|Growth Substances|growth substances|mesh-ancestor
5815846|NCT02641457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815847|NCT02641457|Growth Inhibitors|growth inhibitors|mesh-ancestor
5815848|NCT02641457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5815849|NCT02641210|Albendazole|albendazole|mesh-list
5815850|NCT02641210|Anthelmintics|anthelmintics|mesh-ancestor
5815851|NCT02641210|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5815852|NCT02641210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5815853|NCT02641210|Anticestodal Agents|anticestodal agents|mesh-ancestor
5815854|NCT02641210|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5815855|NCT02641210|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5815856|NCT02641210|Tubulin Modulators|tubulin modulators|mesh-ancestor
5815857|NCT02641210|Antimitotic Agents|antimitotic agents|mesh-ancestor
5815858|NCT02641210|Mitosis Modulators|mitosis modulators|mesh-ancestor
5815859|NCT02641210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5815860|NCT02641210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5815861|NCT02641431|Ajmaline|ajmaline|mesh-list
5815862|NCT02641431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5815863|NCT02641431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5815864|NCT02641431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5815865|NCT02641431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5815866|NCT02641431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5815867|NCT02641301|Morphine|morphine|mesh-list
5815868|NCT02641301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5815869|NCT02641301|Narcotics|narcotics|mesh-ancestor
5815870|NCT02641301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5815871|NCT02641301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815872|NCT02641301|Analgesics|analgesics|mesh-ancestor
5815873|NCT02641301|Sensory System Agents|sensory system agents|mesh-ancestor
5642948|NCT04538352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642949|NCT04531176|Liraglutide|liraglutide|mesh-list
5642950|NCT04531176|Topiramate|topiramate|mesh-list
5642951|NCT04531176|Orlistat|orlistat|mesh-list
5642952|NCT04531176|Phentermine|phentermine|mesh-list
5642953|NCT04531176|Naltrexone|naltrexone|mesh-list
5642954|NCT04531176|Bupropion|bupropion|mesh-list
5642955|NCT04531176|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5642956|NCT04531176|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5642957|NCT04531176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642958|NCT04531176|Sensory System Agents|sensory system agents|mesh-ancestor
5642959|NCT04531176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5642960|NCT04531176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5642961|NCT04531176|Incretins|incretins|mesh-ancestor
5642962|NCT04531176|Hormones|hormones|mesh-ancestor
5642963|NCT04531176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5642964|NCT04531176|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5642965|NCT04531176|Antidepressive Agents|antidepressive agents|mesh-ancestor
5642966|NCT04531176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5642967|NCT04531176|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5642968|NCT04531176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5642969|NCT04531176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5642970|NCT04531176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5642971|NCT04531176|Dopamine Agents|dopamine agents|mesh-ancestor
5642972|NCT04531176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5642973|NCT04531176|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5642974|NCT04531176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5642975|NCT04531176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5642976|NCT04531176|Anticonvulsants|anticonvulsants|mesh-ancestor
5642977|NCT04531176|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5642978|NCT04531176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5642979|NCT04531176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5642980|NCT04531176|Appetite Depressants|appetite depressants|mesh-ancestor
5642981|NCT04531176|Sympathomimetics|sympathomimetics|mesh-ancestor
5642982|NCT04531176|Autonomic Agents|autonomic agents|mesh-ancestor
5642983|NCT04531176|Adrenergic Agents|adrenergic agents|mesh-ancestor
5642984|NCT04519619|Aflibercept|aflibercept|mesh-list
5642985|NCT04519619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5642986|NCT04519619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5642987|NCT04519619|Growth Substances|growth substances|mesh-ancestor
5642988|NCT04519619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5642989|NCT04519619|Growth Inhibitors|growth inhibitors|mesh-ancestor
5642990|NCT04519619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5642991|NCT04496362|Heparin|heparin|mesh-list
5642992|NCT04496362|Anticoagulants|anticoagulants|mesh-ancestor
5642993|NCT04496362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5642994|NCT04496362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5815874|NCT02641301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6492634|NCT00609856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815875|NCT02641314|Celecoxib|celecoxib|mesh-list
5815876|NCT02641314|Propranolol|propranolol|mesh-list
5815877|NCT02641314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815878|NCT02641314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5815879|NCT02641314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5815880|NCT02641314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5815881|NCT02641314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5815882|NCT02641314|Analgesics|analgesics|mesh-ancestor
5815883|NCT02641314|Sensory System Agents|sensory system agents|mesh-ancestor
5815884|NCT02641314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5815885|NCT02641314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5642995|NCT04496362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694019|NCT03398083|GABA Modulators|gaba modulators|mesh-ancestor
5694020|NCT03398083|GABA Agents|gaba agents|mesh-ancestor
5694021|NCT03398083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5694022|NCT03398083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694023|NCT03398044|Dexamethasone|dexamethasone|mesh-list
5694024|NCT03398044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5694025|NCT03398044|Antiemetics|antiemetics|mesh-ancestor
5694026|NCT03398044|Autonomic Agents|autonomic agents|mesh-ancestor
5694027|NCT03398044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5694028|NCT03398044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694029|NCT03398044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5694030|NCT03398044|Glucocorticoids|glucocorticoids|mesh-ancestor
5694031|NCT03398044|Hormones|hormones|mesh-ancestor
5694032|NCT03398044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5694033|NCT03398044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5694034|NCT03398044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5694035|NCT03398031|Magnesium Oxide|magnesium oxide|mesh-list
5694036|NCT03398031|Antacids|antacids|mesh-ancestor
5694037|NCT03398031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694038|NCT03398031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5694039|NCT03398018|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
5694040|NCT03398018|Hormones|hormones|mesh-ancestor
5694041|NCT03398018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5694042|NCT03398018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694043|NCT03397992|Dialysis Solutions|dialysis solutions|mesh-list
5694044|NCT03397992|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5694045|NCT03397966|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
5694046|NCT03397966|Natriuretic Agents|natriuretic agents|mesh-ancestor
5694047|NCT03397966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694048|NCT03397953|Vinorelbine|vinorelbine|mesh-list
5694049|NCT03397953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5694050|NCT03397953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5694051|NCT03397953|Tubulin Modulators|tubulin modulators|mesh-ancestor
5694052|NCT03397953|Antimitotic Agents|antimitotic agents|mesh-ancestor
5694053|NCT03397953|Mitosis Modulators|mitosis modulators|mesh-ancestor
5694054|NCT03397953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694055|NCT03397914|Colistin|colistin|mesh-list
5694056|NCT03397914|Polymyxins|polymyxins|mesh-list
5694057|NCT03397914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5694058|NCT03397914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5694059|NCT03397888|Betrixaban|betrixaban|mesh-list
5694060|NCT03397888|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5694061|NCT03397888|Antithrombins|antithrombins|mesh-ancestor
5694062|NCT03397888|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5694063|NCT03397888|Protease Inhibitors|protease inhibitors|mesh-ancestor
5694064|NCT03397888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5694065|NCT03397888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694066|NCT03397888|Anticoagulants|anticoagulants|mesh-ancestor
5694067|NCT03397875|Zinc Oxide|zinc oxide|mesh-list
5694068|NCT03397875|Dermatologic Agents|dermatologic agents|mesh-ancestor
5694069|NCT03397875|Sunscreening Agents|sunscreening agents|mesh-ancestor
5694070|NCT03397875|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5694071|NCT03397875|Protective Agents|protective agents|mesh-ancestor
5694072|NCT03397875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694073|NCT03397862|Donepezil|donepezil|mesh-list
5694074|NCT03397862|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5694075|NCT03397862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5694076|NCT03397862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694077|NCT03397862|Cholinergic Agents|cholinergic agents|mesh-ancestor
5694078|NCT03397862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5694079|NCT03397862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694080|NCT03397862|Nootropic Agents|nootropic agents|mesh-ancestor
5694081|NCT03397797|Rocuronium|rocuronium|mesh-list
5642996|NCT04487925|Hormones|hormones|mesh-list
5642997|NCT04487925|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5642998|NCT04487925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5642999|NCT04487925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643000|NCT04465266|Tolperisone|tolperisone|mesh-list
5643001|NCT04465266|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5643002|NCT04465266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643003|NCT04465266|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5643004|NCT04465266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5643005|NCT04448886|Pembrolizumab|pembrolizumab|mesh-list
5643006|NCT04448886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5643007|NCT04448886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5643008|NCT04437108|Solifenacin Succinate|solifenacin succinate|mesh-list
5643009|NCT04437108|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5643010|NCT04437108|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5643011|NCT04437108|Cholinergic Agents|cholinergic agents|mesh-ancestor
5643012|NCT04437108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5643013|NCT04437108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643014|NCT04437108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815886|NCT02641314|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5815887|NCT02641314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5815888|NCT02641314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5815889|NCT02641314|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5815890|NCT02641314|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5815891|NCT02641314|Adrenergic Agents|adrenergic agents|mesh-ancestor
5815892|NCT02641314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5815893|NCT02641314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5815894|NCT02641314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5815895|NCT02641314|Vasodilator Agents|vasodilator agents|mesh-ancestor
5815896|NCT02641288|Ropivacaine|ropivacaine|mesh-list
5815897|NCT02641288|Anesthetics, Local|anesthetics, local|mesh-ancestor
5815898|NCT02641288|Anesthetics|anesthetics|mesh-ancestor
5815899|NCT02641288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5815900|NCT02641288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815901|NCT02641288|Sensory System Agents|sensory system agents|mesh-ancestor
5815902|NCT02641288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5815903|NCT02641340|Fentanyl|fentanyl|mesh-list
5815904|NCT02641340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5815905|NCT02641340|Narcotics|narcotics|mesh-ancestor
5815906|NCT02641340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5815907|NCT02641340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815908|NCT02641340|Analgesics|analgesics|mesh-ancestor
5815909|NCT02641340|Sensory System Agents|sensory system agents|mesh-ancestor
5815910|NCT02641340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5815911|NCT02641340|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5815912|NCT02641340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5815913|NCT02641340|Anesthetics, General|anesthetics, general|mesh-ancestor
5643015|NCT04437108|Urological Agents|urological agents|mesh-ancestor
5643016|NCT04434300|Daptomycin|daptomycin|mesh-list
5643017|NCT04434300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5643018|NCT04434300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5643019|NCT04433767|Nicotine|nicotine|mesh-list
5643020|NCT04433767|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5643021|NCT04433767|Autonomic Agents|autonomic agents|mesh-ancestor
5643022|NCT04433767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5643023|NCT04433767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643024|NCT04433767|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5643025|NCT04433767|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5643026|NCT04433767|Cholinergic Agents|cholinergic agents|mesh-ancestor
5643027|NCT04433767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5643028|NCT04433767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643029|NCT04423588|Dexlansoprazole|dexlansoprazole|mesh-list
5643030|NCT04423588|Lansoprazole|lansoprazole|mesh-list
5643031|NCT04423588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5643032|NCT04423588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5643033|NCT04423588|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5643034|NCT04423588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5643035|NCT04423588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643036|NCT04407377|Cyclobenzaprine|cyclobenzaprine|mesh-list
5643037|NCT04407377|Tolperisone|tolperisone|mesh-list
5643038|NCT04407377|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5643039|NCT04407377|Antidepressive Agents|antidepressive agents|mesh-ancestor
5815914|NCT02641340|Anesthetics|anesthetics|mesh-ancestor
5815915|NCT02641132|Mitomycins|mitomycins|mesh-list
5643040|NCT04407377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5815916|NCT02641132|Mitomycin|mitomycin|mesh-list
5815917|NCT02641132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5815918|NCT02641132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5815919|NCT02641132|Alkylating Agents|alkylating agents|mesh-ancestor
5815920|NCT02641132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5815921|NCT02641132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5815922|NCT02641132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5815923|NCT02641093|Pembrolizumab|pembrolizumab|mesh-list
5815924|NCT02641093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5815925|NCT02641093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5815926|NCT02640989|Vaccines|vaccines|mesh-list
5815927|NCT02640989|Immunologic Factors|immunologic factors|mesh-ancestor
5815928|NCT02640989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815929|NCT02640976|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5815930|NCT02640976|Cetrorelix|cetrorelix|mesh-list
5815931|NCT02640976|Menotropins|menotropins|mesh-list
5643041|NCT04407377|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5643042|NCT04407377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643043|NCT04407377|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5643044|NCT04407377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5643045|NCT04407377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5643046|NCT04407377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5643047|NCT04394117|Losartan|losartan|mesh-list
5643048|NCT04394117|Valsartan|valsartan|mesh-list
5643049|NCT04394117|Telmisartan|telmisartan|mesh-list
5643050|NCT04394117|Candesartan|candesartan|mesh-list
5643051|NCT04394117|Olmesartan|olmesartan|mesh-list
5643052|NCT04394117|Irbesartan|irbesartan|mesh-list
5643053|NCT04394117|Eprosartan|eprosartan|mesh-list
5643054|NCT04394117|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
5643055|NCT04394117|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5643056|NCT04394117|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5643057|NCT04394117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643058|NCT04394117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5643059|NCT04394117|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
5815932|NCT02640976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5815933|NCT02640976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815934|NCT02640976|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5815935|NCT02640976|Fertility Agents|fertility agents|mesh-ancestor
5815936|NCT02640976|Hormone Antagonists|hormone antagonists|mesh-ancestor
5815937|NCT02640976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5815938|NCT02640846|Simendan|simendan|mesh-list
5815939|NCT02640846|Milrinone|milrinone|mesh-list
5815940|NCT02640846|Norepinephrine|norepinephrine|mesh-list
5815941|NCT02640846|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5643060|NCT04379596|Fluorouracil|fluorouracil|mesh-list
5643061|NCT04379596|Pembrolizumab|pembrolizumab|mesh-list
5643062|NCT04379596|Capecitabine|capecitabine|mesh-list
5643063|NCT04379596|Oxaliplatin|oxaliplatin|mesh-list
5643064|NCT04379596|Trastuzumab|trastuzumab|mesh-list
5643065|NCT04379596|Durvalumab|durvalumab|mesh-list
5643066|NCT04379596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5643067|NCT04379596|Antimetabolites|antimetabolites|mesh-ancestor
5815942|NCT02640846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6211403|NCT02171195|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
6211404|NCT02171195|Anticonvulsants|anticonvulsants|mesh-ancestor
6211405|NCT02171195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6211406|NCT02171195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6211407|NCT02171195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5815943|NCT02640846|Adrenergic Agents|adrenergic agents|mesh-ancestor
5815944|NCT02640846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5815945|NCT02640846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5815946|NCT02640846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815947|NCT02640846|Sympathomimetics|sympathomimetics|mesh-ancestor
5815948|NCT02640846|Autonomic Agents|autonomic agents|mesh-ancestor
5815949|NCT02640846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5815950|NCT02640846|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5815951|NCT02640846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5815952|NCT02640846|Vasodilator Agents|vasodilator agents|mesh-ancestor
5815953|NCT02640846|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5815954|NCT02640846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5815955|NCT02640846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5815956|NCT02640846|Protective Agents|protective agents|mesh-ancestor
5815957|NCT02640846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5815958|NCT02640898|Docetaxel|docetaxel|mesh-list
5643068|NCT04379596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643069|NCT04379596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5815959|NCT02640898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5815960|NCT02640898|Tubulin Modulators|tubulin modulators|mesh-ancestor
5815961|NCT02640898|Antimitotic Agents|antimitotic agents|mesh-ancestor
5643070|NCT04379596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5643071|NCT04379596|Immunologic Factors|immunologic factors|mesh-ancestor
5643072|NCT04379596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643073|NCT04379596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5643074|NCT04354012|Gentian Violet|gentian violet|mesh-list
5643075|NCT04354012|Methylene Blue|methylene blue|mesh-list
5643076|NCT04354012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5643077|NCT04354012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643078|NCT04354012|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5643079|NCT04354012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5643080|NCT04344795|Pembrolizumab|pembrolizumab|mesh-list
5643081|NCT04344795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5815962|NCT02640898|Mitosis Modulators|mitosis modulators|mesh-ancestor
5815963|NCT02640898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5815964|NCT02641054|Levodopa|levodopa|mesh-list
5815965|NCT02641054|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5815966|NCT02641054|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5815967|NCT02641054|Dopamine Agents|dopamine agents|mesh-ancestor
5815968|NCT02641054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5815969|NCT02641054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5815970|NCT02641054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815971|NCT02640833|Venetoclax|venetoclax|mesh-list
5643082|NCT04344795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5643083|NCT04318015|Hydroxychloroquine|hydroxychloroquine|mesh-list
5643084|NCT04318015|Antimalarials|antimalarials|mesh-ancestor
5643085|NCT04318015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5643086|NCT04318015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5643087|NCT04318015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5643088|NCT04318015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5643089|NCT04318015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643090|NCT04318015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5643091|NCT04315948|Interferons|interferons|mesh-list
5643092|NCT04315948|Ritonavir|ritonavir|mesh-list
5643093|NCT04315948|Lopinavir|lopinavir|mesh-list
5643094|NCT04315948|Interferon-beta|interferon-beta|mesh-list
5643095|NCT04315948|Interferon beta-1a|interferon beta-1a|mesh-list
5643096|NCT04315948|Remdesivir|remdesivir|mesh-list
5643097|NCT04315948|Hydroxychloroquine|hydroxychloroquine|mesh-list
5643098|NCT04315948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5643099|NCT04315948|Antiviral Agents|antiviral agents|mesh-ancestor
5815972|NCT02640833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5815973|NCT02640703|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5643100|NCT04315948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5643101|NCT04315948|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5643102|NCT04315948|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5643103|NCT04315948|Protease Inhibitors|protease inhibitors|mesh-ancestor
5643104|NCT04315948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5643105|NCT04315948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643106|NCT04315948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5643107|NCT04315948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5643108|NCT04315948|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5643109|NCT04315948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5643110|NCT04315948|Antimalarials|antimalarials|mesh-ancestor
5643111|NCT04315948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5643112|NCT04315948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5643113|NCT04315948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5643114|NCT04315948|Immunologic Factors|immunologic factors|mesh-ancestor
5643115|NCT04315948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643116|NCT04315948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5643117|NCT04315948|Antimetabolites|antimetabolites|mesh-ancestor
5643118|NCT04315896|Hydroxychloroquine|hydroxychloroquine|mesh-list
5643119|NCT04315896|Antimalarials|antimalarials|mesh-ancestor
5643120|NCT04315896|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5643121|NCT04315896|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5643122|NCT04315896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5643123|NCT04315896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5815974|NCT02640703|Immunologic Factors|immunologic factors|mesh-ancestor
5815975|NCT02640703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492635|NCT00609895|Insulin Glargine|insulin glargine|mesh-list
5643124|NCT04315896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643125|NCT04315896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5643126|NCT04307797|Exenatide|exenatide|mesh-list
5643127|NCT04307797|Glucagon|glucagon|mesh-list
5815976|NCT02640794|Aspirin|aspirin|mesh-list
5643128|NCT04307797|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5643129|NCT04307797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5643130|NCT04307797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643131|NCT04307797|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5643132|NCT04307797|Incretins|incretins|mesh-ancestor
5643133|NCT04307797|Hormones|hormones|mesh-ancestor
5643134|NCT04307797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5643135|NCT04307797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5643136|NCT04297150|Rivaroxaban|rivaroxaban|mesh-list
5643137|NCT04297150|Apixaban|apixaban|mesh-list
5643138|NCT04297150|Edoxaban|edoxaban|mesh-list
5643139|NCT04297150|Dabigatran|dabigatran|mesh-list
5643140|NCT04297150|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5643141|NCT04297150|Antithrombins|antithrombins|mesh-ancestor
5643142|NCT04297150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5643143|NCT04297150|Protease Inhibitors|protease inhibitors|mesh-ancestor
5643144|NCT04297150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5643145|NCT04297150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643146|NCT04297150|Anticoagulants|anticoagulants|mesh-ancestor
5643147|NCT04276259|Naltrexone|naltrexone|mesh-list
5643148|NCT04276259|Buprenorphine|buprenorphine|mesh-list
5643149|NCT04276259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5643150|NCT04276259|Narcotics|narcotics|mesh-ancestor
5643151|NCT04276259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5643152|NCT04276259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643153|NCT04276259|Analgesics|analgesics|mesh-ancestor
5643154|NCT04276259|Sensory System Agents|sensory system agents|mesh-ancestor
5643155|NCT04276259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5643156|NCT04276259|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5643157|NCT04276259|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5643158|NCT04267939|Niraparib|niraparib|mesh-list
5643159|NCT04267939|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5643160|NCT04267939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5643161|NCT04267939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643162|NCT04267939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5643163|NCT04266301|Azacitidine|azacitidine|mesh-list
5643164|NCT04266301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5643165|NCT04266301|Antimetabolites|antimetabolites|mesh-ancestor
5643166|NCT04266301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643167|NCT04266301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5643168|NCT04266301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5643169|NCT04249362|Durvalumab|durvalumab|mesh-list
5643170|NCT04249362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5643171|NCT04249362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5643172|NCT04249323|Prednisone|prednisone|mesh-list
5643173|NCT04249323|Cortisone|cortisone|mesh-list
5643174|NCT04249323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5643175|NCT04249323|Glucocorticoids|glucocorticoids|mesh-ancestor
5643176|NCT04249323|Hormones|hormones|mesh-ancestor
5643177|NCT04249323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5643178|NCT04249323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643179|NCT04249323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5643180|NCT04249323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5643181|NCT04246047|Dexamethasone|dexamethasone|mesh-list
5643182|NCT04246047|Bortezomib|bortezomib|mesh-list
5643183|NCT04246047|Daratumumab|daratumumab|mesh-list
5643184|NCT04246047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5643185|NCT04246047|Antiemetics|antiemetics|mesh-ancestor
5643186|NCT04246047|Autonomic Agents|autonomic agents|mesh-ancestor
5643187|NCT04246047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5643188|NCT04246047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643189|NCT04246047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5643190|NCT04246047|Glucocorticoids|glucocorticoids|mesh-ancestor
5643191|NCT04246047|Hormones|hormones|mesh-ancestor
5643192|NCT04246047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5643193|NCT04246047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5643194|NCT04246047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5643195|NCT04227821|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
5643196|NCT04227327|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5643197|NCT04227327|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5643198|NCT04227327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5815977|NCT02640794|Clopidogrel|clopidogrel|mesh-list
5815978|NCT02640794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5643199|NCT04227327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643200|NCT04227327|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5643201|NCT04227327|Hormone Antagonists|hormone antagonists|mesh-ancestor
5815979|NCT02640794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5815980|NCT02640794|Analgesics|analgesics|mesh-ancestor
5815981|NCT02640794|Sensory System Agents|sensory system agents|mesh-ancestor
5815982|NCT02640794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5815983|NCT02640794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5815984|NCT02640794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5815985|NCT02640794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5815986|NCT02640794|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5815987|NCT02640794|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5815988|NCT02640794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5815989|NCT02640794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5815990|NCT02640794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5643202|NCT04227327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5643203|NCT04227327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643204|NCT04218357|Probenecid|probenecid|mesh-list
5643205|NCT04218357|Uricosuric Agents|uricosuric agents|mesh-ancestor
5815991|NCT02640794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5815992|NCT02640794|Antipyretics|antipyretics|mesh-ancestor
5815993|NCT02640794|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5815994|NCT02640794|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5815995|NCT02640794|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5815996|NCT02640794|Purinergic Agents|purinergic agents|mesh-ancestor
5815997|NCT02640794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5815998|NCT02640417|Vitamin B Complex|vitamin b complex|mesh-list
5815999|NCT02640417|Vitamins|vitamins|mesh-ancestor
5816000|NCT02640417|Micronutrients|micronutrients|mesh-ancestor
5816001|NCT02640417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901207|NCT03772925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901208|NCT03772925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901209|NCT03772925|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5901210|NCT03745729|Allopurinol|allopurinol|mesh-list
5643206|NCT04218357|Gout Suppressants|gout suppressants|mesh-ancestor
5643207|NCT04218357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5643208|NCT04218357|Renal Agents|renal agents|mesh-ancestor
5901211|NCT03745729|Antimetabolites|antimetabolites|mesh-ancestor
5901212|NCT03745729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901213|NCT03745729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5901214|NCT03745729|Gout Suppressants|gout suppressants|mesh-ancestor
5901215|NCT03745729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5901216|NCT03745729|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5901217|NCT03745729|Antioxidants|antioxidants|mesh-ancestor
5901218|NCT03745729|Protective Agents|protective agents|mesh-ancestor
5901219|NCT03745729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901220|NCT03744793|Pemetrexed|pemetrexed|mesh-list
5901221|NCT03744793|Avelumab|avelumab|mesh-list
5901222|NCT03744793|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5901223|NCT03744793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901224|NCT03744793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5901225|NCT03744793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901226|NCT03744793|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5901227|NCT03744793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5901228|NCT03744793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5901229|NCT03744793|Immunologic Factors|immunologic factors|mesh-ancestor
5901230|NCT03744793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901231|NCT03725384|Ascorbic Acid|ascorbic acid|mesh-list
5901232|NCT03725384|Iron|iron|mesh-list
5901233|NCT03725384|Vitamins|vitamins|mesh-ancestor
5901234|NCT03725384|Micronutrients|micronutrients|mesh-ancestor
5901235|NCT03725384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901236|NCT03725384|Trace Elements|trace elements|mesh-ancestor
5901237|NCT03725384|Antioxidants|antioxidants|mesh-ancestor
5643209|NCT04190056|Tamoxifen|tamoxifen|mesh-list
5643210|NCT04190056|Pembrolizumab|pembrolizumab|mesh-list
5643211|NCT04190056|Vorinostat|vorinostat|mesh-list
5643212|NCT04190056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5643213|NCT04190056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5643214|NCT04190056|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5643215|NCT04190056|Hormone Antagonists|hormone antagonists|mesh-ancestor
5643216|NCT04190056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5643217|NCT04190056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643218|NCT04190056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5643219|NCT04190056|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5643220|NCT04190056|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5901238|NCT03725384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901239|NCT03725384|Protective Agents|protective agents|mesh-ancestor
5901240|NCT03719430|Doxorubicin|doxorubicin|mesh-list
5643221|NCT04190056|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5643222|NCT04190056|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5643223|NCT04190056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5643224|NCT04190056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643225|NCT04186988|9-arabinofuranosylguanine|9-arabinofuranosylguanine|mesh-list
5643226|NCT04186988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5643227|NCT04150029|Azacitidine|azacitidine|mesh-list
5643228|NCT04150029|Venetoclax|venetoclax|mesh-list
5643229|NCT04150029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5643230|NCT04150029|Antimetabolites|antimetabolites|mesh-ancestor
5643231|NCT04150029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643232|NCT04150029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5643233|NCT04150029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5643234|NCT04149574|Nivolumab|nivolumab|mesh-list
5643235|NCT04149574|BCG Vaccine|bcg vaccine|mesh-list
5816002|NCT02640469|Chlorhexidine|chlorhexidine|mesh-list
5816003|NCT02640469|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5816004|NCT02640469|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5643236|NCT04149574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5643237|NCT04149574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5643238|NCT04149574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5643239|NCT04149574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643240|NCT04149574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5643241|NCT04149574|Immunologic Factors|immunologic factors|mesh-ancestor
5643242|NCT04149574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643243|NCT04143659|Levonorgestrel|levonorgestrel|mesh-list
5643244|NCT04143659|Levonorgestrel butanoate|levonorgestrel butanoate|mesh-list
5643245|NCT04143659|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5643246|NCT04143659|Contraceptive Agents|contraceptive agents|mesh-ancestor
5643247|NCT04143659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5816005|NCT02640469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5816006|NCT02640469|Disinfectants|disinfectants|mesh-ancestor
5816007|NCT02640469|Dermatologic Agents|dermatologic agents|mesh-ancestor
5816008|NCT02640495|Artesunate|artesunate|mesh-list
5816009|NCT02640495|Antimalarials|antimalarials|mesh-ancestor
5816010|NCT02640495|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5816011|NCT02640495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5816012|NCT02640495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5816013|NCT02640495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5816014|NCT02640495|Antiviral Agents|antiviral agents|mesh-ancestor
5816015|NCT02640495|Schistosomicides|schistosomicides|mesh-ancestor
5816016|NCT02640495|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5816017|NCT02640495|Anthelmintics|anthelmintics|mesh-ancestor
5816018|NCT02640508|Lenvatinib|lenvatinib|mesh-list
5643248|NCT04143659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643249|NCT04143659|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5643250|NCT04143659|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5643251|NCT04143659|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5643252|NCT04143659|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5643253|NCT04140266|Tenofovir|tenofovir|mesh-list
5643254|NCT04140266|Emtricitabine|emtricitabine|mesh-list
5643255|NCT04140266|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5643256|NCT04140266|Dapivirine|dapivirine|mesh-list
5643257|NCT04140266|Antiviral Agents|antiviral agents|mesh-ancestor
5643258|NCT04140266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5643259|NCT04140266|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5816019|NCT02640508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5816020|NCT02640508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6211408|NCT02171195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211409|NCT02171234|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
6211410|NCT02171234|Anticonvulsants|anticonvulsants|mesh-ancestor
6211411|NCT02171234|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5816021|NCT02640508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5816022|NCT02640508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5816023|NCT02640443|Sulfamethoxazole|sulfamethoxazole|mesh-list
5816024|NCT02640443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5816025|NCT02640534|Metformin|metformin|mesh-list
5816026|NCT02640534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5816027|NCT02640534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816028|NCT02640365|Leucovorin|leucovorin|mesh-list
5816029|NCT02640365|Bevacizumab|bevacizumab|mesh-list
5816030|NCT02640365|Irinotecan|irinotecan|mesh-list
5816031|NCT02640365|Camptothecin|camptothecin|mesh-list
6211412|NCT02171234|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6211413|NCT02171234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6212604|NCT02191397|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5816032|NCT02640365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5816033|NCT02640365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5816034|NCT02640365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5816035|NCT02640365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5816036|NCT02640365|Growth Substances|growth substances|mesh-ancestor
5816037|NCT02640365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816038|NCT02640365|Growth Inhibitors|growth inhibitors|mesh-ancestor
5816039|NCT02640365|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5816040|NCT02640365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5816041|NCT02640365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5816042|NCT02640365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5816043|NCT02640365|Antidotes|antidotes|mesh-ancestor
5816044|NCT02640365|Protective Agents|protective agents|mesh-ancestor
5816045|NCT02640365|Vitamin B Complex|vitamin b complex|mesh-ancestor
5816046|NCT02640365|Vitamins|vitamins|mesh-ancestor
5816047|NCT02640365|Micronutrients|micronutrients|mesh-ancestor
5816048|NCT02640365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5816049|NCT02640222|Vitamin K|vitamin k|mesh-list
5816050|NCT02640222|Rivaroxaban|rivaroxaban|mesh-list
5816051|NCT02640222|Apixaban|apixaban|mesh-list
5816052|NCT02640222|Dabigatran|dabigatran|mesh-list
5816053|NCT02640222|Vitamins|vitamins|mesh-ancestor
5816054|NCT02640222|Micronutrients|micronutrients|mesh-ancestor
5816055|NCT02640222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816056|NCT02640222|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5816057|NCT02640222|Antithrombins|antithrombins|mesh-ancestor
5816058|NCT02640222|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5816059|NCT02640222|Protease Inhibitors|protease inhibitors|mesh-ancestor
5816060|NCT02640222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5816061|NCT02640222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5816062|NCT02640222|Anticoagulants|anticoagulants|mesh-ancestor
5816063|NCT02640222|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5816064|NCT02640222|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5816065|NCT02640222|Hemostatics|hemostatics|mesh-ancestor
5816066|NCT02640222|Coagulants|coagulants|mesh-ancestor
5816067|NCT02640313|Choline|choline|mesh-list
5816068|NCT02640313|Lipotropic Agents|lipotropic agents|mesh-ancestor
5816069|NCT02640313|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5816070|NCT02640313|Antimetabolites|antimetabolites|mesh-ancestor
5816071|NCT02640313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5816072|NCT02640313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5816073|NCT02640313|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5816074|NCT02640313|Nootropic Agents|nootropic agents|mesh-ancestor
5816075|NCT02640300|Clozapine|clozapine|mesh-list
5816076|NCT02640300|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5816077|NCT02640300|Serotonin Agents|serotonin agents|mesh-ancestor
5816078|NCT02640300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5816079|NCT02640300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5816080|NCT02640300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816081|NCT02640300|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5816082|NCT02640300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5816083|NCT02640300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6211414|NCT02171234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643260|NCT04140266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5643261|NCT04140266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5643262|NCT04140266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643263|NCT04140266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5643264|NCT04140266|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5643265|NCT04136366|Methotrexate|methotrexate|mesh-list
5643266|NCT04136366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5643267|NCT04136366|Abortifacient Agents|abortifacient agents|mesh-ancestor
5643268|NCT04136366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5643269|NCT04136366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643270|NCT04136366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5643271|NCT04136366|Antimetabolites|antimetabolites|mesh-ancestor
5643272|NCT04136366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5816084|NCT02640300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5816085|NCT02640300|GABA Antagonists|gaba antagonists|mesh-ancestor
5816086|NCT02640300|GABA Agents|gaba agents|mesh-ancestor
5643273|NCT04136366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5643274|NCT04136366|Dermatologic Agents|dermatologic agents|mesh-ancestor
5816087|NCT02640144|Hyaluronic Acid|hyaluronic acid|mesh-list
5816088|NCT02640144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5816089|NCT02640144|Immunologic Factors|immunologic factors|mesh-ancestor
5816090|NCT02640144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816091|NCT02640144|Viscosupplements|viscosupplements|mesh-ancestor
5816092|NCT02640144|Protective Agents|protective agents|mesh-ancestor
5816093|NCT02640118|Lixisenatide|lixisenatide|mesh-list
5816094|NCT02640118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5816095|NCT02640118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816096|NCT02639858|Docetaxel|docetaxel|mesh-list
5816097|NCT02639858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5816098|NCT02639858|Tubulin Modulators|tubulin modulators|mesh-ancestor
5816099|NCT02639858|Antimitotic Agents|antimitotic agents|mesh-ancestor
5816100|NCT02639858|Mitosis Modulators|mitosis modulators|mesh-ancestor
5816101|NCT02639858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5816102|NCT02639767|Pemetrexed|pemetrexed|mesh-list
5816103|NCT02639767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5816104|NCT02639767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5816105|NCT02639767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5816106|NCT02639767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5816107|NCT02639767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5816108|NCT02639702|Clozapine|clozapine|mesh-list
5643275|NCT04136366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5816109|NCT02639702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5816110|NCT02639702|Serotonin Agents|serotonin agents|mesh-ancestor
5816111|NCT02639702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5816112|NCT02639702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5816113|NCT02639702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816114|NCT02639702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5643276|NCT04136366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5643277|NCT04136366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5643278|NCT04136366|Immunologic Factors|immunologic factors|mesh-ancestor
5643279|NCT04136366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5643280|NCT04136366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5643281|NCT04132388|Adalimumab|adalimumab|mesh-list
5643282|NCT04132388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5643283|NCT04132388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5643284|NCT04129502|Carboplatin|carboplatin|mesh-list
5643285|NCT04129502|Pemetrexed|pemetrexed|mesh-list
5643286|NCT04129502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5643287|NCT04129502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5643288|NCT04129502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643289|NCT04129502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5643290|NCT04129502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5643291|NCT04112641|Niacinamide|niacinamide|mesh-list
5643292|NCT04112641|Niacin|niacin|mesh-list
5816115|NCT02639702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5816116|NCT02639702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5816117|NCT02639702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5816118|NCT02639702|GABA Antagonists|gaba antagonists|mesh-ancestor
5643293|NCT04112641|Nicotinic Acids|nicotinic acids|mesh-list
5643294|NCT04112641|Vitamin B Complex|vitamin b complex|mesh-ancestor
5643295|NCT04112641|Vitamins|vitamins|mesh-ancestor
5643296|NCT04112641|Micronutrients|micronutrients|mesh-ancestor
5643297|NCT04112641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643298|NCT04112641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5643299|NCT04112641|Antimetabolites|antimetabolites|mesh-ancestor
5643300|NCT04112641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5816119|NCT02639702|GABA Agents|gaba agents|mesh-ancestor
5816120|NCT02639819|Aminocaproic Acid|aminocaproic acid|mesh-list
5816121|NCT02639819|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5816122|NCT02639819|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5816123|NCT02639819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5816124|NCT02639819|Hemostatics|hemostatics|mesh-ancestor
5816125|NCT02639819|Coagulants|coagulants|mesh-ancestor
5816126|NCT02639806|Lidocaine|lidocaine|mesh-list
5816127|NCT02639806|Sevoflurane|sevoflurane|mesh-list
5816128|NCT02639806|Anesthetics, Local|anesthetics, local|mesh-ancestor
5816129|NCT02639806|Anesthetics|anesthetics|mesh-ancestor
5816130|NCT02639806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5816131|NCT02639806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816132|NCT02639806|Sensory System Agents|sensory system agents|mesh-ancestor
5816133|NCT02639806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5643301|NCT04112641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5643302|NCT04112641|Vasodilator Agents|vasodilator agents|mesh-ancestor
5643303|NCT04108962|Benralizumab|benralizumab|mesh-list
5643304|NCT04108962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5643305|NCT04108962|Respiratory System Agents|respiratory system agents|mesh-ancestor
5694082|NCT03397797|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5694083|NCT03397797|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5816134|NCT02639806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5694084|NCT03397797|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5643306|NCT04091126|Dexamethasone|dexamethasone|mesh-list
5643307|NCT04091126|Lenalidomide|lenalidomide|mesh-list
5816135|NCT02639806|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5816136|NCT02639806|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5816137|NCT02639806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5816138|NCT02639806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5816139|NCT02639806|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5816140|NCT02639806|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5816141|NCT02639806|Anesthetics, General|anesthetics, general|mesh-ancestor
5816142|NCT02639741|Vitamins|vitamins|mesh-list
5816143|NCT02639741|Ascorbic Acid|ascorbic acid|mesh-list
5816144|NCT02639741|Melatonin|melatonin|mesh-list
5816145|NCT02639741|Micronutrients|micronutrients|mesh-ancestor
5816146|NCT02639741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816147|NCT02639741|Antioxidants|antioxidants|mesh-ancestor
5816148|NCT02639741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5816149|NCT02639741|Protective Agents|protective agents|mesh-ancestor
5816150|NCT02639741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5643308|NCT04091126|Bortezomib|bortezomib|mesh-list
5643309|NCT04091126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5643310|NCT04091126|Antiemetics|antiemetics|mesh-ancestor
5643311|NCT04091126|Autonomic Agents|autonomic agents|mesh-ancestor
5643312|NCT04091126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5643313|NCT04091126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643314|NCT04091126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5643315|NCT04091126|Glucocorticoids|glucocorticoids|mesh-ancestor
5643316|NCT04091126|Hormones|hormones|mesh-ancestor
5643317|NCT04091126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5643318|NCT04091126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5643319|NCT04091126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5643320|NCT04091126|Immunologic Factors|immunologic factors|mesh-ancestor
5643321|NCT04091126|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5643322|NCT04091126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5816151|NCT02639650|Dactinomycin|dactinomycin|mesh-list
5816152|NCT02639650|Paclitaxel|paclitaxel|mesh-list
5816153|NCT02639650|Etoposide|etoposide|mesh-list
5816154|NCT02639650|Vincristine|vincristine|mesh-list
5816155|NCT02639650|Cyclophosphamide|cyclophosphamide|mesh-list
5816156|NCT02639650|Carboplatin|carboplatin|mesh-list
5816157|NCT02639650|Methotrexate|methotrexate|mesh-list
5816158|NCT02639650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5816159|NCT02639650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5816160|NCT02639650|Tubulin Modulators|tubulin modulators|mesh-ancestor
5816161|NCT02639650|Antimitotic Agents|antimitotic agents|mesh-ancestor
5816162|NCT02639650|Mitosis Modulators|mitosis modulators|mesh-ancestor
5816163|NCT02639650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643323|NCT04091126|Growth Substances|growth substances|mesh-ancestor
5643324|NCT04091126|Growth Inhibitors|growth inhibitors|mesh-ancestor
5643325|NCT04090684|Ciprofloxacin|ciprofloxacin|mesh-list
5643326|NCT04090684|Celecoxib|celecoxib|mesh-list
5643327|NCT04090684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5643328|NCT04090684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5643329|NCT04090684|Analgesics|analgesics|mesh-ancestor
5643330|NCT04090684|Sensory System Agents|sensory system agents|mesh-ancestor
5643331|NCT04090684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5643332|NCT04090684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643333|NCT04090684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5643334|NCT04090684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5643335|NCT04090684|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5643336|NCT04090684|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5643337|NCT04090684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5643338|NCT04090684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643339|NCT04090684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5643340|NCT04090684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5643341|NCT04090684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5643342|NCT04090684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5643343|NCT04090684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5643344|NCT04090684|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5643345|NCT04090684|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5643346|NCT04085458|Factor VIII|factor viii|mesh-list
5643347|NCT04085458|Coagulants|coagulants|mesh-ancestor
5643348|NCT04051619|Oxytocin|oxytocin|mesh-list
5643349|NCT04051619|Oxytocics|oxytocics|mesh-ancestor
5816164|NCT02639650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5816165|NCT02639650|Immunologic Factors|immunologic factors|mesh-ancestor
5816166|NCT02639650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816167|NCT02639650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5816168|NCT02639650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5816169|NCT02639650|Alkylating Agents|alkylating agents|mesh-ancestor
5816170|NCT02639650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5816171|NCT02639650|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5816172|NCT02639650|Abortifacient Agents|abortifacient agents|mesh-ancestor
5643350|NCT04051619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5643351|NCT04051619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643352|NCT04045301|Omalizumab|omalizumab|mesh-list
5643353|NCT04045301|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5643354|NCT04045301|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5643355|NCT04045301|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5643356|NCT04045301|Respiratory System Agents|respiratory system agents|mesh-ancestor
5643357|NCT04045301|Immunologic Factors|immunologic factors|mesh-ancestor
5643358|NCT04045301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816173|NCT02639650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5816174|NCT02639650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5816175|NCT02639650|Antimetabolites|antimetabolites|mesh-ancestor
5816176|NCT02639650|Dermatologic Agents|dermatologic agents|mesh-ancestor
5816177|NCT02639650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5816178|NCT02639650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5816179|NCT02639650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5816180|NCT02639650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5816181|NCT02639650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5816182|NCT02639650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5643359|NCT04033107|Ascorbic Acid|ascorbic acid|mesh-list
5643360|NCT04033107|Metformin|metformin|mesh-list
5643361|NCT04033107|Vitamins|vitamins|mesh-ancestor
5643362|NCT04033107|Micronutrients|micronutrients|mesh-ancestor
5643363|NCT04033107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643364|NCT04033107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5643365|NCT04033107|Antioxidants|antioxidants|mesh-ancestor
5643366|NCT04033107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643367|NCT04033107|Protective Agents|protective agents|mesh-ancestor
5816183|NCT02639650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5643368|NCT04024761|Cyclophosphamide|cyclophosphamide|mesh-list
5643369|NCT04024761|Fludarabine|fludarabine|mesh-list
5643370|NCT04024761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5643371|NCT04024761|Immunologic Factors|immunologic factors|mesh-ancestor
5643372|NCT04024761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643373|NCT04024761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5643374|NCT04024761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5643375|NCT04024761|Alkylating Agents|alkylating agents|mesh-ancestor
5643376|NCT04024761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643377|NCT04024761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5643378|NCT04024761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5643379|NCT04006457|Vaccines|vaccines|mesh-list
5643380|NCT04006457|Immunologic Factors|immunologic factors|mesh-ancestor
5643381|NCT04006457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643382|NCT03986034|Venetoclax|venetoclax|mesh-list
5643383|NCT03986034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5643384|NCT03950245|Glucagon|glucagon|mesh-list
5643385|NCT03950245|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5643386|NCT03950245|Incretins|incretins|mesh-ancestor
5643387|NCT03950245|Hormones|hormones|mesh-ancestor
5643388|NCT03950245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5643389|NCT03950245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643390|NCT03950245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5643391|NCT03939104|Artesunate|artesunate|mesh-list
5816184|NCT02639650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5816185|NCT02639650|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5816186|NCT02639624|Dialysis Solutions|dialysis solutions|mesh-list
5816187|NCT02639624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5816188|NCT02639533|Pregabalin|pregabalin|mesh-list
5816189|NCT02639533|Analgesics|analgesics|mesh-ancestor
5816190|NCT02639533|Sensory System Agents|sensory system agents|mesh-ancestor
5816191|NCT02639533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5816192|NCT02639533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816193|NCT02639533|Anticonvulsants|anticonvulsants|mesh-ancestor
5816194|NCT02639533|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5816195|NCT02639533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5816196|NCT02639533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5816197|NCT02639533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5816198|NCT02639533|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5816199|NCT02639533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5643392|NCT03939104|Lumefantrine|lumefantrine|mesh-list
5643393|NCT03939104|Artemether|artemether|mesh-list
5816200|NCT02639533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5816201|NCT02639533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5816202|NCT02639377|Chlorhexidine|chlorhexidine|mesh-list
5816203|NCT02639377|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5816204|NCT02639377|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5816205|NCT02639377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5816206|NCT02639377|Disinfectants|disinfectants|mesh-ancestor
5816207|NCT02639377|Dermatologic Agents|dermatologic agents|mesh-ancestor
5816208|NCT02639598|Topiramate|topiramate|mesh-list
5816209|NCT02639598|Flunarizine|flunarizine|mesh-list
5816210|NCT02639598|Anticonvulsants|anticonvulsants|mesh-ancestor
5816211|NCT02639598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5816212|NCT02639598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816213|NCT02639598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5816214|NCT02639598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5816215|NCT02639598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5816216|NCT02639598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5816217|NCT02639598|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5816218|NCT02639598|Histamine Antagonists|histamine antagonists|mesh-ancestor
5816219|NCT02639598|Histamine Agents|histamine agents|mesh-ancestor
5816220|NCT02639598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5816221|NCT02639598|Vasodilator Agents|vasodilator agents|mesh-ancestor
5816222|NCT02639520|Fosfomycin|fosfomycin|mesh-list
5816223|NCT02639520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5816224|NCT02639520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5816225|NCT02639143|Clopidogrel|clopidogrel|mesh-list
5816226|NCT02639143|Ticagrelor|ticagrelor|mesh-list
5816227|NCT02639143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5816228|NCT02639143|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5816229|NCT02639143|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5816230|NCT02639143|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5816231|NCT02639143|Purinergic Agents|purinergic agents|mesh-ancestor
5816232|NCT02639143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5816233|NCT02639143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5816234|NCT02639143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816235|NCT02639065|Durvalumab|durvalumab|mesh-list
5816236|NCT02639065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5816237|NCT02639065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5816238|NCT02639234|Nivolumab|nivolumab|mesh-list
5816239|NCT02639234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5816240|NCT02639234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5816241|NCT02639234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5816242|NCT02639234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5816243|NCT02639039|Cortisone|cortisone|mesh-list
5816244|NCT02639039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5816245|NCT02639091|Pemetrexed|pemetrexed|mesh-list
5816246|NCT02639091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5816247|NCT02639091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5816248|NCT02639091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5816249|NCT02639091|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5816250|NCT02639091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5816251|NCT02638922|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5816252|NCT02638922|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5816253|NCT02638922|Trisequens|trisequens|mesh-list
5816254|NCT02638922|Norethindrone|norethindrone|mesh-list
5816255|NCT02638922|Estradiol|estradiol|mesh-list
5816256|NCT02638922|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5816257|NCT02638922|Estrogens|estrogens|mesh-ancestor
5816258|NCT02638922|Hormones|hormones|mesh-ancestor
5816259|NCT02638922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5643394|NCT03939104|Piperaquine|piperaquine|mesh-list
5643395|NCT03939104|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
5643396|NCT03939104|Amodiaquine|amodiaquine|mesh-list
5643397|NCT03939104|Mefloquine|mefloquine|mesh-list
5643398|NCT03939104|Antimalarials|antimalarials|mesh-ancestor
5643399|NCT03939104|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5643400|NCT03939104|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5643401|NCT03939104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5643402|NCT03939104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5643403|NCT03939104|Antiviral Agents|antiviral agents|mesh-ancestor
5643404|NCT03939104|Schistosomicides|schistosomicides|mesh-ancestor
5643405|NCT03939104|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5643406|NCT03939104|Anthelmintics|anthelmintics|mesh-ancestor
5643407|NCT03924804|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5643408|NCT03922945|Topiramate|topiramate|mesh-list
5643409|NCT03922945|Phentermine|phentermine|mesh-list
5643410|NCT03922945|Anticonvulsants|anticonvulsants|mesh-ancestor
5643411|NCT03922945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5816260|NCT02638922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816261|NCT02638922|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5816262|NCT02638922|Contraceptive Agents|contraceptive agents|mesh-ancestor
5816263|NCT02638922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5816264|NCT02638922|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5816265|NCT02638922|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5643412|NCT03922945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643413|NCT03922945|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5643414|NCT03922945|Appetite Depressants|appetite depressants|mesh-ancestor
5643415|NCT03922945|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5643416|NCT03922945|Sympathomimetics|sympathomimetics|mesh-ancestor
5643417|NCT03922945|Autonomic Agents|autonomic agents|mesh-ancestor
5643418|NCT03922945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5643419|NCT03922945|Adrenergic Agents|adrenergic agents|mesh-ancestor
5643420|NCT03922945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5643421|NCT03922945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643422|NCT03913091|Bupivacaine|bupivacaine|mesh-list
5643423|NCT03913091|Anesthetics, Local|anesthetics, local|mesh-ancestor
5643424|NCT03913091|Anesthetics|anesthetics|mesh-ancestor
5643425|NCT03913091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5643426|NCT03913091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643427|NCT03913091|Sensory System Agents|sensory system agents|mesh-ancestor
5643428|NCT03913091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5643429|NCT03906136|Adalimumab|adalimumab|mesh-list
5643430|NCT03906136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5643431|NCT03906136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5643432|NCT03893955|Paclitaxel|paclitaxel|mesh-list
5643433|NCT03893955|Carboplatin|carboplatin|mesh-list
5643434|NCT03893955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5643435|NCT03893955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5643436|NCT03893955|Tubulin Modulators|tubulin modulators|mesh-ancestor
5643437|NCT03893955|Antimitotic Agents|antimitotic agents|mesh-ancestor
5643438|NCT03893955|Mitosis Modulators|mitosis modulators|mesh-ancestor
5643439|NCT03893955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643440|NCT03889249|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5643441|NCT03889249|Tenecteplase|tenecteplase|mesh-list
5643442|NCT03889249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5643443|NCT03889249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5643444|NCT03889249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643445|NCT03858322|Paclitaxel|paclitaxel|mesh-list
5643446|NCT03858322|Cyclophosphamide|cyclophosphamide|mesh-list
5643447|NCT03858322|Carboplatin|carboplatin|mesh-list
5643448|NCT03858322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5643449|NCT03858322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5643450|NCT03858322|Tubulin Modulators|tubulin modulators|mesh-ancestor
5643451|NCT03858322|Antimitotic Agents|antimitotic agents|mesh-ancestor
5643452|NCT03858322|Mitosis Modulators|mitosis modulators|mesh-ancestor
5643453|NCT03858322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643454|NCT03858322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5643455|NCT03858322|Immunologic Factors|immunologic factors|mesh-ancestor
5643456|NCT03858322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643457|NCT03858322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5643458|NCT03858322|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5643459|NCT03858322|Alkylating Agents|alkylating agents|mesh-ancestor
5643460|NCT03858322|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5643461|NCT03845166|Atezolizumab|atezolizumab|mesh-list
5643462|NCT03845166|Avelumab|avelumab|mesh-list
5816266|NCT02638922|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5816267|NCT02638922|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5816268|NCT02638909|Ceritinib|ceritinib|mesh-list
5816269|NCT02638909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5816270|NCT02638909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5816271|NCT02638909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5816272|NCT02638909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5816273|NCT02638896|Sulfasalazine|sulfasalazine|mesh-list
5816274|NCT02638896|Celecoxib|celecoxib|mesh-list
5816275|NCT02638896|Etanercept|etanercept|mesh-list
5816276|NCT02638896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5816277|NCT02638896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5816278|NCT02638896|Analgesics|analgesics|mesh-ancestor
5816279|NCT02638896|Sensory System Agents|sensory system agents|mesh-ancestor
5643463|NCT03845166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5643464|NCT03845166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5643465|NCT03822637|Acetylcysteine|acetylcysteine|mesh-list
5643466|NCT03822637|Albuterol|albuterol|mesh-list
5643467|NCT03822637|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5643468|NCT03822637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5643469|NCT03822637|Autonomic Agents|autonomic agents|mesh-ancestor
5643470|NCT03822637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5643471|NCT03822637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643472|NCT03822637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5643473|NCT03822637|Respiratory System Agents|respiratory system agents|mesh-ancestor
5643474|NCT03822637|Tocolytic Agents|tocolytic agents|mesh-ancestor
5643475|NCT03822637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5643476|NCT03822637|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5643477|NCT03822637|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5643478|NCT03822637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5816280|NCT02638896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5816281|NCT02638896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816282|NCT02638896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5816283|NCT02638896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5816284|NCT02638896|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5816285|NCT02638896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5816286|NCT02638896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5816287|NCT02638896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5816288|NCT02638896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5643479|NCT03822637|Adrenergic Agents|adrenergic agents|mesh-ancestor
5643480|NCT03822637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5643481|NCT03822637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643482|NCT03822637|Antiviral Agents|antiviral agents|mesh-ancestor
5643483|NCT03822637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5643484|NCT03822637|Expectorants|expectorants|mesh-ancestor
5643485|NCT03822637|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5643486|NCT03822637|Antioxidants|antioxidants|mesh-ancestor
5643487|NCT03822637|Protective Agents|protective agents|mesh-ancestor
5643488|NCT03822637|Antidotes|antidotes|mesh-ancestor
5643489|NCT03802591|Capecitabine|capecitabine|mesh-list
5643490|NCT03802591|Oxaliplatin|oxaliplatin|mesh-list
5643491|NCT03802591|Antibodies|antibodies|mesh-list
5643492|NCT03802591|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5643493|NCT03802591|Immunologic Factors|immunologic factors|mesh-ancestor
5643494|NCT03802591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643495|NCT03802591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5643496|NCT03802591|Antimetabolites|antimetabolites|mesh-ancestor
5643497|NCT03802591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643498|NCT03802591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5643499|NCT03802565|Tolperisone|tolperisone|mesh-list
5643500|NCT03802565|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5643501|NCT03802565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643502|NCT03802565|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5643503|NCT03802565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5643504|NCT03763422|Temozolomide|temozolomide|mesh-list
5643505|NCT03763422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5816289|NCT02638896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5816290|NCT02638896|Immunologic Factors|immunologic factors|mesh-ancestor
5816291|NCT02638896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5816292|NCT02638870|Amitriptyline|amitriptyline|mesh-list
5816293|NCT02638870|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
5816294|NCT02638870|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5816295|NCT02638870|Antidepressive Agents|antidepressive agents|mesh-ancestor
5816296|NCT02638870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5816297|NCT02638870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5816298|NCT02638870|Analgesics|analgesics|mesh-ancestor
5816299|NCT02638870|Sensory System Agents|sensory system agents|mesh-ancestor
5816300|NCT02638870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5816301|NCT02638870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816302|NCT02638870|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5816303|NCT02638870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5816304|NCT02638870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5816305|NCT02638870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5816306|NCT02638870|Adrenergic Agents|adrenergic agents|mesh-ancestor
5816307|NCT02638870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5816308|NCT02638870|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6211415|NCT02171429|Adalimumab|adalimumab|mesh-list
5643506|NCT03763422|Alkylating Agents|alkylating agents|mesh-ancestor
5643507|NCT03763422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643508|NCT03763422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5643509|NCT03752307|Prednisone|prednisone|mesh-list
6211416|NCT02171429|Etrolizumab|etrolizumab|mesh-list
5643510|NCT03752307|Methylprednisolone|methylprednisolone|mesh-list
5643511|NCT03752307|Isoxsuprine|isoxsuprine|mesh-list
5643512|NCT03752307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5643513|NCT03752307|Glucocorticoids|glucocorticoids|mesh-ancestor
5643514|NCT03752307|Hormones|hormones|mesh-ancestor
5643515|NCT03752307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5643516|NCT03752307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643517|NCT03752307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5643518|NCT03752307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5643519|NCT03752307|Antiemetics|antiemetics|mesh-ancestor
5643520|NCT03752307|Autonomic Agents|autonomic agents|mesh-ancestor
5643521|NCT03752307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5643522|NCT03752307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5643523|NCT03752307|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5643524|NCT03752307|Protective Agents|protective agents|mesh-ancestor
5643525|NCT03752307|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5643526|NCT03752307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5643527|NCT03752307|Adrenergic Agents|adrenergic agents|mesh-ancestor
5643528|NCT03752307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5643529|NCT03752307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643530|NCT03752307|Sympathomimetics|sympathomimetics|mesh-ancestor
5643531|NCT03752307|Vasodilator Agents|vasodilator agents|mesh-ancestor
5643532|NCT03752307|Tocolytic Agents|tocolytic agents|mesh-ancestor
5643533|NCT03752307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5643534|NCT03740334|Dexamethasone|dexamethasone|mesh-list
5643535|NCT03740334|Everolimus|everolimus|mesh-list
5643536|NCT03740334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5643537|NCT03740334|Antiemetics|antiemetics|mesh-ancestor
5643538|NCT03740334|Autonomic Agents|autonomic agents|mesh-ancestor
5643539|NCT03740334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5643540|NCT03740334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643541|NCT03740334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5816309|NCT02638870|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5816310|NCT02638870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5901241|NCT03719430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5901242|NCT03719430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901243|NCT03719430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5901244|NCT03719430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5901245|NCT03719430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5901246|NCT03719430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901247|NCT03693807|Gemcitabine|gemcitabine|mesh-list
5643542|NCT03740334|Glucocorticoids|glucocorticoids|mesh-ancestor
5643543|NCT03740334|Hormones|hormones|mesh-ancestor
5643544|NCT03740334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5643545|NCT03740334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5643546|NCT03740334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5643547|NCT03740334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5643548|NCT03740334|Immunologic Factors|immunologic factors|mesh-ancestor
5901248|NCT03693807|Fluorouracil|fluorouracil|mesh-list
5901249|NCT03693807|Floxuridine|floxuridine|mesh-list
5901250|NCT03693807|Oxaliplatin|oxaliplatin|mesh-list
5901251|NCT03693807|Irinotecan|irinotecan|mesh-list
5643549|NCT03734653|Testosterone|testosterone|mesh-list
5643550|NCT03734653|Androgens|androgens|mesh-ancestor
5643551|NCT03734653|Hormones|hormones|mesh-ancestor
5643552|NCT03734653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5643553|NCT03734653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211417|NCT02171429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6211418|NCT02171429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6211419|NCT02171429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6211420|NCT02171429|Immunologic Factors|immunologic factors|mesh-ancestor
6211421|NCT02171429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211422|NCT02171611|Dabigatran|dabigatran|mesh-list
5901252|NCT03693807|Cetuximab|cetuximab|mesh-list
6492636|NCT00609895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6492637|NCT00609895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492638|NCT00609934|Sorafenib|sorafenib|mesh-list
6492639|NCT00609934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5643560|NCT03701308|Cytarabine|cytarabine|mesh-list
5901253|NCT03693807|Panitumumab|panitumumab|mesh-list
5901254|NCT03693807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5901255|NCT03693807|Antimetabolites|antimetabolites|mesh-ancestor
5901256|NCT03693807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901257|NCT03693807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6492640|NCT00609934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5901258|NCT03693807|Antiviral Agents|antiviral agents|mesh-ancestor
6492641|NCT00609934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5816311|NCT02638857|Epirubicin|epirubicin|mesh-list
5816312|NCT02638857|Mitomycins|mitomycins|mesh-list
5816313|NCT02638857|Mitomycin|mitomycin|mesh-list
5816314|NCT02638857|Ethiodized Oil|ethiodized oil|mesh-list
5816315|NCT02638857|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5816316|NCT02638857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5816317|NCT02638857|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5816318|NCT02638857|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5816319|NCT02638857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5816320|NCT02638857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5816321|NCT02638857|Alkylating Agents|alkylating agents|mesh-ancestor
5816322|NCT02638857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5816323|NCT02638545|Dexmedetomidine|dexmedetomidine|mesh-list
5816324|NCT02638545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5816325|NCT02638545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5816326|NCT02638545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816327|NCT02638545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5816328|NCT02638545|Analgesics|analgesics|mesh-ancestor
5816329|NCT02638545|Sensory System Agents|sensory system agents|mesh-ancestor
5816330|NCT02638545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5816331|NCT02638545|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5816332|NCT02638545|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5816333|NCT02638545|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5816334|NCT02638545|Adrenergic Agents|adrenergic agents|mesh-ancestor
5816335|NCT02638545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5816336|NCT02638545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5816337|NCT02638701|Infliximab|infliximab|mesh-list
5816338|NCT02638701|Dermatologic Agents|dermatologic agents|mesh-ancestor
5816339|NCT02638701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5816340|NCT02638701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5816341|NCT02638831|Ketorolac|ketorolac|mesh-list
5816342|NCT02638831|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
5816343|NCT02638831|Ketoprofen|ketoprofen|mesh-list
5816344|NCT02638831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5816345|NCT02638831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5816346|NCT02638831|Analgesics|analgesics|mesh-ancestor
5816347|NCT02638831|Sensory System Agents|sensory system agents|mesh-ancestor
5816348|NCT02638831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5816349|NCT02638831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816350|NCT02638831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5816351|NCT02638831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5816352|NCT02638831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5816353|NCT02638831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5816354|NCT02638831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5816355|NCT02638740|Mechlorethamine|mechlorethamine|mesh-list
5816356|NCT02638740|Alkylating Agents|alkylating agents|mesh-ancestor
5816357|NCT02638740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5816358|NCT02638740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5816359|NCT02638740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5816360|NCT02638519|Xenon|xenon|mesh-list
5816361|NCT02638519|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5816362|NCT02638519|Anesthetics, General|anesthetics, general|mesh-ancestor
5816363|NCT02638519|Anesthetics|anesthetics|mesh-ancestor
5816364|NCT02638519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5816365|NCT02638519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816366|NCT02638506|Fentanyl|fentanyl|mesh-list
5643561|NCT03701308|Daunorubicin|daunorubicin|mesh-list
5643562|NCT03701308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5643563|NCT03701308|Antimetabolites|antimetabolites|mesh-ancestor
5816367|NCT02638506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5816368|NCT02638506|Narcotics|narcotics|mesh-ancestor
5816369|NCT02638506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5816370|NCT02638506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816371|NCT02638506|Analgesics|analgesics|mesh-ancestor
5816372|NCT02638506|Sensory System Agents|sensory system agents|mesh-ancestor
5643564|NCT03701308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643565|NCT03701308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5643566|NCT03701308|Antiviral Agents|antiviral agents|mesh-ancestor
5643567|NCT03701308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5643568|NCT03701308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5643569|NCT03701308|Immunologic Factors|immunologic factors|mesh-ancestor
5643570|NCT03701308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643571|NCT03701308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5643572|NCT03701308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5643573|NCT03701308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5643574|NCT03701308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5643575|NCT03692325|Nivolumab|nivolumab|mesh-list
5643576|NCT03692325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5643577|NCT03692325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5643578|NCT03692325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5643579|NCT03692325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643580|NCT03637556|Deferasirox|deferasirox|mesh-list
5643581|NCT03637556|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5643582|NCT03637556|Chelating Agents|chelating agents|mesh-ancestor
5643583|NCT03637556|Sequestering Agents|sequestering agents|mesh-ancestor
5643584|NCT03637556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643585|NCT03627897|Bupivacaine|bupivacaine|mesh-list
5643586|NCT03627897|Anesthetics, Local|anesthetics, local|mesh-ancestor
5643587|NCT03627897|Anesthetics|anesthetics|mesh-ancestor
5643588|NCT03627897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5816373|NCT02638506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5816374|NCT02638506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5816375|NCT02638506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5816376|NCT02638506|Anesthetics, General|anesthetics, general|mesh-ancestor
5816377|NCT02638506|Anesthetics|anesthetics|mesh-ancestor
5816378|NCT02638389|Sirolimus|sirolimus|mesh-list
5816379|NCT02638389|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5816380|NCT02638389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5816381|NCT02638389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5816382|NCT02638389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5816383|NCT02638389|Antifungal Agents|antifungal agents|mesh-ancestor
5816384|NCT02638389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5643589|NCT03627897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643590|NCT03627897|Sensory System Agents|sensory system agents|mesh-ancestor
5643591|NCT03627897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5643592|NCT03603184|Paclitaxel|paclitaxel|mesh-list
5643593|NCT03603184|Carboplatin|carboplatin|mesh-list
5816385|NCT02638389|Immunologic Factors|immunologic factors|mesh-ancestor
5816386|NCT02638389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816387|NCT02638428|Cytarabine|cytarabine|mesh-list
5816388|NCT02638428|Carboplatin|carboplatin|mesh-list
5816389|NCT02638428|Fludarabine|fludarabine|mesh-list
5816390|NCT02638428|Trastuzumab|trastuzumab|mesh-list
5816391|NCT02638428|Etoposide|etoposide|mesh-list
5816392|NCT02638428|Everolimus|everolimus|mesh-list
5816393|NCT02638428|Sorafenib|sorafenib|mesh-list
5816394|NCT02638428|Ifosfamide|ifosfamide|mesh-list
5816395|NCT02638428|Dasatinib|dasatinib|mesh-list
5816396|NCT02638428|Axitinib|axitinib|mesh-list
5816397|NCT02638428|Vemurafenib|vemurafenib|mesh-list
5816398|NCT02638428|Crizotinib|crizotinib|mesh-list
5816399|NCT02638428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5816400|NCT02638428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5816401|NCT02638428|Antimetabolites|antimetabolites|mesh-ancestor
5816402|NCT02638428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5816403|NCT02638428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5816404|NCT02638428|Immunologic Factors|immunologic factors|mesh-ancestor
5816405|NCT02638428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816406|NCT02638428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5816407|NCT02638428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5816408|NCT02638428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5816409|NCT02638428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5816410|NCT02638428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5816411|NCT02638428|Antiviral Agents|antiviral agents|mesh-ancestor
5643594|NCT03603184|Atezolizumab|atezolizumab|mesh-list
5643595|NCT03603184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5643596|NCT03603184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5643597|NCT03603184|Tubulin Modulators|tubulin modulators|mesh-ancestor
5643598|NCT03603184|Antimitotic Agents|antimitotic agents|mesh-ancestor
5816412|NCT02638428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5816413|NCT02638428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5816414|NCT02638428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5816415|NCT02638428|Alkylating Agents|alkylating agents|mesh-ancestor
5816416|NCT02638233|Sofosbuvir|sofosbuvir|mesh-list
5816417|NCT02638233|Ledipasvir|ledipasvir|mesh-list
5816418|NCT02638233|Antiviral Agents|antiviral agents|mesh-ancestor
5816419|NCT02638233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5643599|NCT03603184|Mitosis Modulators|mitosis modulators|mesh-ancestor
5816420|NCT02638376|Riboflavin|riboflavin|mesh-list
5816421|NCT02638376|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5816422|NCT02638376|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5816423|NCT02638376|Vitamin B Complex|vitamin b complex|mesh-ancestor
5816424|NCT02638376|Vitamins|vitamins|mesh-ancestor
5816425|NCT02638376|Micronutrients|micronutrients|mesh-ancestor
5816426|NCT02638376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643600|NCT03603184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643601|NCT03594123|Brexpiprazole|brexpiprazole|mesh-list
5643602|NCT03594123|Serotonin Agents|serotonin agents|mesh-ancestor
5816427|NCT02638376|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5816428|NCT02638376|Dermatologic Agents|dermatologic agents|mesh-ancestor
5816429|NCT02638584|Rabeprazole|rabeprazole|mesh-list
5816430|NCT02638584|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5816431|NCT02638584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5816432|NCT02638584|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5816433|NCT02638584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5816434|NCT02638584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5816435|NCT02638415|Carvedilol|carvedilol|mesh-list
5816436|NCT02638415|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5816437|NCT02638415|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5816438|NCT02638415|Adrenergic Agents|adrenergic agents|mesh-ancestor
5816439|NCT02638415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5816440|NCT02638415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5816441|NCT02638415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816442|NCT02638415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5816443|NCT02638415|Antioxidants|antioxidants|mesh-ancestor
5816444|NCT02638415|Protective Agents|protective agents|mesh-ancestor
5816445|NCT02638415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5816446|NCT02638415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5816447|NCT02638415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5816448|NCT02638415|Vasodilator Agents|vasodilator agents|mesh-ancestor
5816449|NCT02638415|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5816450|NCT02638415|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5816451|NCT02638285|Clomiphene|clomiphene|mesh-list
5816452|NCT02638285|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5816453|NCT02638285|Hormone Antagonists|hormone antagonists|mesh-ancestor
5816454|NCT02638285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5816455|NCT02638285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816456|NCT02638285|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5643603|NCT03594123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5643604|NCT03594123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643605|NCT03594123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643606|NCT03594123|Dopamine Agonists|dopamine agonists|mesh-ancestor
5643607|NCT03594123|Dopamine Agents|dopamine agents|mesh-ancestor
5694085|NCT03397797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5694086|NCT03397797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694087|NCT03397706|Valganciclovir|valganciclovir|mesh-list
5694088|NCT03397706|Antiviral Agents|antiviral agents|mesh-ancestor
5694089|NCT03397706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5694090|NCT03397654|Pembrolizumab|pembrolizumab|mesh-list
5694091|NCT03397654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5694092|NCT03397654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5694093|NCT03397615|Povidone-Iodine|povidone-iodine|mesh-list
5694094|NCT03397615|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5694095|NCT03397615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5694096|NCT03397537|Letrozole|letrozole|mesh-list
5694097|NCT03397537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5816457|NCT02638285|Fertility Agents|fertility agents|mesh-ancestor
5816458|NCT02638285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5816459|NCT02638285|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5816460|NCT02638285|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5816461|NCT02638064|Surgiflo|surgiflo|mesh-list
5816462|NCT02638064|Hemostatics|hemostatics|mesh-ancestor
5694098|NCT03397537|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5694099|NCT03397537|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5694100|NCT03397537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5694101|NCT03397537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694102|NCT03397537|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5694103|NCT03397537|Hormone Antagonists|hormone antagonists|mesh-ancestor
5694104|NCT03397537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5694105|NCT03397537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694106|NCT03397446|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
5694107|NCT03397446|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5816463|NCT02638064|Coagulants|coagulants|mesh-ancestor
5816464|NCT02638142|Furosemide|furosemide|mesh-list
5816465|NCT02638142|Diuretics|diuretics|mesh-ancestor
5816466|NCT02638142|Natriuretic Agents|natriuretic agents|mesh-ancestor
5816467|NCT02638142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816468|NCT02638142|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5643608|NCT03548584|Brexpiprazole|brexpiprazole|mesh-list
5643609|NCT03548584|Serotonin Agents|serotonin agents|mesh-ancestor
5643610|NCT03548584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5643611|NCT03548584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643612|NCT03548584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643613|NCT03548584|Dopamine Agonists|dopamine agonists|mesh-ancestor
5643614|NCT03548584|Dopamine Agents|dopamine agents|mesh-ancestor
5643615|NCT03502031|Losartan|losartan|mesh-list
5816469|NCT02638142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5816470|NCT02638142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5816471|NCT02638116|Omeprazole|omeprazole|mesh-list
5816472|NCT02638116|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5816473|NCT02638116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5816474|NCT02638116|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5816475|NCT02638116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5816476|NCT02638116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5816477|NCT02637973|Empagliflozin|empagliflozin|mesh-list
5816478|NCT02637973|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5816479|NCT02637973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5816480|NCT02637973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5816481|NCT02637973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816482|NCT02637830|Fluorides|fluorides|mesh-list
5816483|NCT02637830|Fluorides, Topical|fluorides, topical|mesh-list
5816484|NCT02637830|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
5816485|NCT02637830|Cariostatic Agents|cariostatic agents|mesh-ancestor
5643616|NCT03502031|Valsartan|valsartan|mesh-list
5643617|NCT03502031|Enalapril|enalapril|mesh-list
5643618|NCT03502031|Enalaprilat|enalaprilat|mesh-list
5643619|NCT03502031|Lisinopril|lisinopril|mesh-list
5643620|NCT03502031|Perindopril|perindopril|mesh-list
5643621|NCT03502031|Spironolactone|spironolactone|mesh-list
5643622|NCT03502031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5816486|NCT02637830|Protective Agents|protective agents|mesh-ancestor
5816487|NCT02637830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816488|NCT02637648|Sodium Oxybate|sodium oxybate|mesh-list
5816489|NCT02637648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5816490|NCT02637648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5816491|NCT02637648|Anesthetics, General|anesthetics, general|mesh-ancestor
5816492|NCT02637648|Anesthetics|anesthetics|mesh-ancestor
5816493|NCT02637648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5816494|NCT02637648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816495|NCT02637726|Remifentanil|remifentanil|mesh-list
5816496|NCT02637726|Propofol|propofol|mesh-list
5816497|NCT02637726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5816498|NCT02637726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5816499|NCT02637726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816500|NCT02637726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5816501|NCT02637726|Anesthetics, General|anesthetics, general|mesh-ancestor
5816502|NCT02637726|Anesthetics|anesthetics|mesh-ancestor
5816503|NCT02637726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5816504|NCT02637726|Narcotics|narcotics|mesh-ancestor
5816505|NCT02637726|Analgesics|analgesics|mesh-ancestor
5816506|NCT02637726|Sensory System Agents|sensory system agents|mesh-ancestor
5816507|NCT02637726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5816508|NCT02637700|Immunoglobulins|immunoglobulins|mesh-list
5816509|NCT02637700|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5816510|NCT02637700|Antibodies|antibodies|mesh-list
5816511|NCT02637700|gamma-Globulins|gamma-globulins|mesh-list
5816512|NCT02637700|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5816513|NCT02637700|Immunologic Factors|immunologic factors|mesh-ancestor
5816514|NCT02637700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675598|NCT01576627|Micronutrients|micronutrients|mesh-ancestor
5816515|NCT02637531|Nivolumab|nivolumab|mesh-list
5816516|NCT02637531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5816517|NCT02637531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5816518|NCT02637531|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5816519|NCT02637531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5816520|NCT02637583|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5816521|NCT02637583|Immunologic Factors|immunologic factors|mesh-ancestor
5816522|NCT02637583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816523|NCT02637466|Vortioxetine|vortioxetine|mesh-list
5816524|NCT02637466|Antidepressive Agents|antidepressive agents|mesh-ancestor
5816525|NCT02637466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5816526|NCT02637466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5816527|NCT02637466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5816528|NCT02637466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5643623|NCT03502031|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6492642|NCT00609934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492643|NCT00609960|Midazolam|midazolam|mesh-list
6492644|NCT00609960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5816529|NCT02637466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816530|NCT02637466|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5643624|NCT03502031|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5643625|NCT03502031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643626|NCT03502031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5643627|NCT03502031|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5643628|NCT03502031|Hormone Antagonists|hormone antagonists|mesh-ancestor
5643629|NCT03502031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5643630|NCT03502031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643631|NCT03502031|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5643632|NCT03502031|Diuretics|diuretics|mesh-ancestor
5643633|NCT03502031|Natriuretic Agents|natriuretic agents|mesh-ancestor
5643634|NCT03502031|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5643635|NCT03502031|Protease Inhibitors|protease inhibitors|mesh-ancestor
5643636|NCT03502031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5643637|NCT03502031|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5643638|NCT03502031|Protective Agents|protective agents|mesh-ancestor
5643639|NCT03452111|ST 1435|st 1435|mesh-list
5643640|NCT03452111|Testosterone|testosterone|mesh-list
5643641|NCT03452111|Androgens|androgens|mesh-ancestor
5643642|NCT03452111|Hormones|hormones|mesh-ancestor
5643643|NCT03452111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5643644|NCT03452111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643645|NCT03452111|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5643646|NCT03452111|Contraceptive Agents|contraceptive agents|mesh-ancestor
5816531|NCT02637466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5816532|NCT02637466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5816533|NCT02637466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5816534|NCT02637466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5816535|NCT02637466|Serotonin Agents|serotonin agents|mesh-ancestor
5816536|NCT02637466|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5816537|NCT02637466|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5816538|NCT02637466|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5816539|NCT02637466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5816540|NCT02637479|Deoxyglucose|deoxyglucose|mesh-list
5816541|NCT02637479|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5816542|NCT02637479|Antimetabolites|antimetabolites|mesh-ancestor
5816543|NCT02637479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5816544|NCT02637479|Antiviral Agents|antiviral agents|mesh-ancestor
5816545|NCT02637479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6492645|NCT00609960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5643647|NCT03452111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5643648|NCT03452111|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5643649|NCT03441555|Venetoclax|venetoclax|mesh-list
5643650|NCT03441555|Alvocidib|alvocidib|mesh-list
5643651|NCT03441555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5643652|NCT03441555|Growth Inhibitors|growth inhibitors|mesh-ancestor
5643653|NCT03441555|Growth Substances|growth substances|mesh-ancestor
5643654|NCT03441555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643655|NCT03441555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5643656|NCT03441555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5643657|NCT03441555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643658|NCT03439293|Dexamethasone|dexamethasone|mesh-list
5643659|NCT03439293|Daratumumab|daratumumab|mesh-list
5643660|NCT03439293|Ixazomib|ixazomib|mesh-list
5643661|NCT03439293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5643662|NCT03439293|Antiemetics|antiemetics|mesh-ancestor
5643663|NCT03439293|Autonomic Agents|autonomic agents|mesh-ancestor
5643664|NCT03439293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5643665|NCT03439293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643666|NCT03439293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5643667|NCT03439293|Glucocorticoids|glucocorticoids|mesh-ancestor
5643668|NCT03439293|Hormones|hormones|mesh-ancestor
5643669|NCT03439293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5643670|NCT03439293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5643671|NCT03439293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5643672|NCT03439293|Protease Inhibitors|protease inhibitors|mesh-ancestor
5643673|NCT03439293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5643674|NCT03439293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643675|NCT03438526|Melatonin|melatonin|mesh-list
5816546|NCT02637479|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5816547|NCT02637284|BPC 157|bpc 157|mesh-list
5816548|NCT02637284|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5816549|NCT02637284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5816550|NCT02637375|Paclitaxel|paclitaxel|mesh-list
5816551|NCT02637375|Cyclophosphamide|cyclophosphamide|mesh-list
5816552|NCT02637375|Doxorubicin|doxorubicin|mesh-list
5643676|NCT03438526|Antioxidants|antioxidants|mesh-ancestor
5643677|NCT03438526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643678|NCT03438526|Protective Agents|protective agents|mesh-ancestor
5816553|NCT02637375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5816554|NCT02637375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5816555|NCT02637375|Tubulin Modulators|tubulin modulators|mesh-ancestor
5816556|NCT02637375|Antimitotic Agents|antimitotic agents|mesh-ancestor
5816557|NCT02637375|Mitosis Modulators|mitosis modulators|mesh-ancestor
5816558|NCT02637375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5816559|NCT02637375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5816560|NCT02637375|Immunologic Factors|immunologic factors|mesh-ancestor
5816561|NCT02637375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816562|NCT02637375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5816563|NCT02637375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5816564|NCT02637375|Alkylating Agents|alkylating agents|mesh-ancestor
5816565|NCT02637375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5816566|NCT02637375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5816567|NCT02637375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5816568|NCT02637375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5816569|NCT02637375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5816570|NCT02637167|Rifaximin|rifaximin|mesh-list
5816571|NCT02637167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5816572|NCT02637167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5816573|NCT02637167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5643679|NCT03438526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643680|NCT03438526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5643681|NCT03416179|Cytarabine|cytarabine|mesh-list
5643682|NCT03416179|Azacitidine|azacitidine|mesh-list
5643683|NCT03416179|Daunorubicin|daunorubicin|mesh-list
5643684|NCT03416179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5643685|NCT03416179|Antimetabolites|antimetabolites|mesh-ancestor
5643686|NCT03416179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643687|NCT03416179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5643688|NCT03416179|Antiviral Agents|antiviral agents|mesh-ancestor
5643689|NCT03416179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5643690|NCT03416179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5643691|NCT03416179|Immunologic Factors|immunologic factors|mesh-ancestor
5643692|NCT03416179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643693|NCT03416179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5643694|NCT03416179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5816574|NCT02637193|Moxifloxacin|moxifloxacin|mesh-list
5816575|NCT02637193|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
5816576|NCT02637193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5816577|NCT02637193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5816578|NCT02637193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5816579|NCT02637193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5816580|NCT02637193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5816581|NCT02637193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5816582|NCT02637193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5816583|NCT02637193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816584|NCT02637193|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5816585|NCT02637193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5816586|NCT02637193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5816587|NCT02637193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5816588|NCT02637193|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5816589|NCT02637193|Antidepressive Agents|antidepressive agents|mesh-ancestor
5816590|NCT02637193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5816591|NCT02637128|Artesunate|artesunate|mesh-list
5816592|NCT02637128|Lumefantrine|lumefantrine|mesh-list
5816593|NCT02637128|Artemether|artemether|mesh-list
5816594|NCT02637128|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
5816595|NCT02637128|Amodiaquine|amodiaquine|mesh-list
5816596|NCT02637128|Antimalarials|antimalarials|mesh-ancestor
5816597|NCT02637128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5816598|NCT02637128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5816599|NCT02637128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5816600|NCT02637128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5816601|NCT02637128|Antiviral Agents|antiviral agents|mesh-ancestor
5816602|NCT02637128|Schistosomicides|schistosomicides|mesh-ancestor
5643695|NCT03416179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5643696|NCT03416179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5643697|NCT03409198|Cyclophosphamide|cyclophosphamide|mesh-list
5643698|NCT03409198|Doxorubicin|doxorubicin|mesh-list
5816603|NCT02637128|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5816604|NCT02637128|Anthelmintics|anthelmintics|mesh-ancestor
5901259|NCT03693807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5901260|NCT03693807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5901261|NCT03693807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5901262|NCT03693807|Immunologic Factors|immunologic factors|mesh-ancestor
5901263|NCT03693807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901264|NCT03693807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5901265|NCT03693807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5901266|NCT03693807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5643699|NCT03409198|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5643700|NCT03409198|Nivolumab|nivolumab|mesh-list
5643701|NCT03409198|Ipilimumab|ipilimumab|mesh-list
5643702|NCT03409198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5643703|NCT03409198|Immunologic Factors|immunologic factors|mesh-ancestor
5643704|NCT03409198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643705|NCT03409198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5643706|NCT03409198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5643707|NCT03409198|Alkylating Agents|alkylating agents|mesh-ancestor
5643708|NCT03409198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643709|NCT03409198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901267|NCT03693014|Pembrolizumab|pembrolizumab|mesh-list
5901268|NCT03693014|Nivolumab|nivolumab|mesh-list
5901269|NCT03693014|Ipilimumab|ipilimumab|mesh-list
5901270|NCT03693014|Atezolizumab|atezolizumab|mesh-list
5901271|NCT03693014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5901272|NCT03693014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901273|NCT03693014|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5901274|NCT03693014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901275|NCT03692403|Quinagolide|quinagolide|mesh-list
5901276|NCT03692403|Dopamine Agonists|dopamine agonists|mesh-ancestor
5901277|NCT03692403|Dopamine Agents|dopamine agents|mesh-ancestor
5901278|NCT03692403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5901279|NCT03692403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901280|NCT03692403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901281|NCT03678350|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
5901282|NCT03678350|Trioxsalen|trioxsalen|mesh-list
5643710|NCT03409198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5643711|NCT03409198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5643712|NCT03409198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5643713|NCT03409198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5643714|NCT03409198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5643715|NCT03409198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5643716|NCT03409198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5643717|NCT03395197|Talazoparib|talazoparib|mesh-list
5643718|NCT03395197|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5643719|NCT03395197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5643720|NCT03395197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643721|NCT03395197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901283|NCT03678350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901284|NCT03678350|Dermatologic Agents|dermatologic agents|mesh-ancestor
5901285|NCT03678350|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5901286|NCT03649438|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
5901287|NCT03649438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901288|NCT03649438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5901289|NCT03649438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901290|NCT03649438|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5901291|NCT03635632|Cyclophosphamide|cyclophosphamide|mesh-list
5901292|NCT03635632|Fludarabine|fludarabine|mesh-list
5901293|NCT03635632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5901294|NCT03635632|Immunologic Factors|immunologic factors|mesh-ancestor
5901295|NCT03635632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901296|NCT03635632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5901297|NCT03635632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5643722|NCT03395184|PF-06700841|pf-06700841|mesh-list
5901298|NCT03635632|Alkylating Agents|alkylating agents|mesh-ancestor
5901299|NCT03635632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901300|NCT03635632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901301|NCT03635632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5901302|NCT03631043|Lenalidomide|lenalidomide|mesh-list
5901303|NCT03631043|Vaccines|vaccines|mesh-list
5816605|NCT02636816|Carbetocin|carbetocin|mesh-list
5816606|NCT02636816|Oxytocics|oxytocics|mesh-ancestor
5816607|NCT02636816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5816608|NCT02636816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816609|NCT02636803|Albendazole|albendazole|mesh-list
5816610|NCT02636803|Oxfendazole|oxfendazole|mesh-list
5816611|NCT02636803|Anthelmintics|anthelmintics|mesh-ancestor
5816612|NCT02636803|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6211423|NCT02171611|Antithrombins|antithrombins|mesh-ancestor
6211424|NCT02171611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6211425|NCT02171611|Protease Inhibitors|protease inhibitors|mesh-ancestor
6211426|NCT02171611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6211427|NCT02171611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211428|NCT02171611|Anticoagulants|anticoagulants|mesh-ancestor
5816613|NCT02636803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5816614|NCT02636803|Anticestodal Agents|anticestodal agents|mesh-ancestor
5816615|NCT02636803|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5816616|NCT02636803|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5816617|NCT02636803|Tubulin Modulators|tubulin modulators|mesh-ancestor
5816618|NCT02636803|Antimitotic Agents|antimitotic agents|mesh-ancestor
5816619|NCT02636803|Mitosis Modulators|mitosis modulators|mesh-ancestor
5816620|NCT02636803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5816621|NCT02636803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6211429|NCT02172040|Celecoxib|celecoxib|mesh-list
6211430|NCT02172040|Amlodipine|amlodipine|mesh-list
6211431|NCT02172040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6211432|NCT02172040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6211433|NCT02172040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6492646|NCT00609960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5643723|NCT03395184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5643724|NCT03395184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5643725|NCT03395184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643726|NCT03377179|Hydroxychloroquine|hydroxychloroquine|mesh-list
5643727|NCT03377179|Antimalarials|antimalarials|mesh-ancestor
5643728|NCT03377179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5643729|NCT03377179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5643730|NCT03377179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5643731|NCT03377179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5643732|NCT03377179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643733|NCT03377179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5643734|NCT03353922|Cyclobenzaprine|cyclobenzaprine|mesh-list
5643735|NCT03353922|Tolperisone|tolperisone|mesh-list
5643736|NCT03353922|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5643737|NCT03353922|Antidepressive Agents|antidepressive agents|mesh-ancestor
5643738|NCT03353922|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5643739|NCT03353922|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5643740|NCT03353922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643741|NCT03353922|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5643742|NCT03353922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5643743|NCT03353922|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5643744|NCT03353922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5643745|NCT03346239|Citalopram|citalopram|mesh-list
5643746|NCT03346239|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5643747|NCT03346239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5643748|NCT03346239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5643749|NCT03346239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643750|NCT03346239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5643751|NCT03346239|Serotonin Agents|serotonin agents|mesh-ancestor
5643752|NCT03346239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816622|NCT02636803|Antinematodal Agents|antinematodal agents|mesh-ancestor
5816623|NCT02636829|Calcium|calcium|mesh-list
5816624|NCT02636829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5816625|NCT02636829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816626|NCT02636842|Aripiprazole|aripiprazole|mesh-list
5816627|NCT02636842|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
5816628|NCT02636842|Antidepressive Agents|antidepressive agents|mesh-ancestor
5816629|NCT02636842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5816630|NCT02636842|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5816631|NCT02636842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5816632|NCT02636842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5816633|NCT02636842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816634|NCT02636842|Dopamine Agonists|dopamine agonists|mesh-ancestor
5816635|NCT02636842|Dopamine Agents|dopamine agents|mesh-ancestor
5816636|NCT02636842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5901304|NCT03631043|Immunologic Factors|immunologic factors|mesh-ancestor
5816637|NCT02636842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5816638|NCT02636842|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5816639|NCT02636842|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5816640|NCT02636842|Serotonin Agents|serotonin agents|mesh-ancestor
5816641|NCT02636842|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5816642|NCT02636842|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5816643|NCT02636842|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5816644|NCT02636842|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5816645|NCT02636569|Diclofenac|diclofenac|mesh-list
5816646|NCT02636569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5816647|NCT02636569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5816648|NCT02636569|Analgesics|analgesics|mesh-ancestor
5816649|NCT02636569|Sensory System Agents|sensory system agents|mesh-ancestor
5816650|NCT02636569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5816651|NCT02636569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816652|NCT02636569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5816653|NCT02636569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5816654|NCT02636569|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5816655|NCT02636569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5816656|NCT02636569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5816657|NCT02636426|Sorafenib|sorafenib|mesh-list
5816658|NCT02636426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5816659|NCT02636426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5816660|NCT02636426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5816661|NCT02636426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5816662|NCT02636491|Insulin|insulin|mesh-list
5816663|NCT02636491|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5816664|NCT02636491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5816665|NCT02636491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816666|NCT02636270|Mecasermin|mecasermin|mesh-list
5816667|NCT02636270|Growth Substances|growth substances|mesh-ancestor
5816668|NCT02636270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816669|NCT02636231|Endostatins|endostatins|mesh-list
5816670|NCT02636231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5816671|NCT02636231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5816672|NCT02636231|Growth Substances|growth substances|mesh-ancestor
5816673|NCT02636231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816674|NCT02636231|Growth Inhibitors|growth inhibitors|mesh-ancestor
5816675|NCT02636231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5816676|NCT02636218|Ketamine|ketamine|mesh-list
5816677|NCT02636218|Analgesics|analgesics|mesh-ancestor
5816678|NCT02636218|Sensory System Agents|sensory system agents|mesh-ancestor
5816679|NCT02636218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5816680|NCT02636218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816681|NCT02636218|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5816682|NCT02636218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5816683|NCT02636218|Anesthetics, General|anesthetics, general|mesh-ancestor
5816684|NCT02636218|Anesthetics|anesthetics|mesh-ancestor
5643753|NCT03346239|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5643754|NCT03346239|Antidepressive Agents|antidepressive agents|mesh-ancestor
5643755|NCT03346239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5643756|NCT03314181|Dexamethasone|dexamethasone|mesh-list
5643757|NCT03314181|Bortezomib|bortezomib|mesh-list
5643758|NCT03314181|Venetoclax|venetoclax|mesh-list
5643759|NCT03314181|Daratumumab|daratumumab|mesh-list
5643760|NCT03314181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5643761|NCT03314181|Antiemetics|antiemetics|mesh-ancestor
5643762|NCT03314181|Autonomic Agents|autonomic agents|mesh-ancestor
5643763|NCT03314181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5643764|NCT03314181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643765|NCT03314181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5643766|NCT03314181|Glucocorticoids|glucocorticoids|mesh-ancestor
5643767|NCT03314181|Hormones|hormones|mesh-ancestor
5643768|NCT03314181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5643769|NCT03314181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5643770|NCT03314181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5643771|NCT03290794|Aflibercept|aflibercept|mesh-list
5643772|NCT03290794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5816685|NCT02636218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5816686|NCT02636218|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5816687|NCT02636218|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5816688|NCT02636218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5901305|NCT03631043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643773|NCT03290794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5643774|NCT03290794|Growth Substances|growth substances|mesh-ancestor
5816689|NCT02636218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5816690|NCT02636348|Vitamin D|vitamin d|mesh-list
5816691|NCT02636348|Calcium|calcium|mesh-list
5816692|NCT02636348|Vitamins|vitamins|mesh-ancestor
5816693|NCT02636348|Micronutrients|micronutrients|mesh-ancestor
5816694|NCT02636348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816695|NCT02636348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5816696|NCT02636348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5816697|NCT02636322|Prednisone|prednisone|mesh-list
5816698|NCT02636322|Cortisone|cortisone|mesh-list
5816699|NCT02636322|Cyclophosphamide|cyclophosphamide|mesh-list
5816700|NCT02636322|Rituximab|rituximab|mesh-list
5816701|NCT02636322|Doxorubicin|doxorubicin|mesh-list
5816702|NCT02636322|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5816703|NCT02636322|Etoposide|etoposide|mesh-list
5816704|NCT02636322|Vincristine|vincristine|mesh-list
5816705|NCT02636322|Lenalidomide|lenalidomide|mesh-list
5816706|NCT02636322|Etoposide phosphate|etoposide phosphate|mesh-list
5816707|NCT02636322|Podophyllotoxin|podophyllotoxin|mesh-list
5816708|NCT02636322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5816709|NCT02636322|Antibodies|antibodies|mesh-list
5816710|NCT02636322|Immunoglobulins|immunoglobulins|mesh-list
5816711|NCT02636322|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5816712|NCT02636322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5816713|NCT02636322|Immunologic Factors|immunologic factors|mesh-ancestor
5816714|NCT02636322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816715|NCT02636322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5816716|NCT02636322|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5816717|NCT02636322|Alkylating Agents|alkylating agents|mesh-ancestor
5816718|NCT02636322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5816719|NCT02636322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5816720|NCT02636322|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5816721|NCT02636322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5816722|NCT02636322|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5816723|NCT02636322|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5816724|NCT02636322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5816725|NCT02636322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5816726|NCT02636322|Glucocorticoids|glucocorticoids|mesh-ancestor
5816727|NCT02636322|Hormones|hormones|mesh-ancestor
5816728|NCT02636322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5816729|NCT02636322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5816730|NCT02636322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5816731|NCT02636322|Tubulin Modulators|tubulin modulators|mesh-ancestor
5816732|NCT02636322|Antimitotic Agents|antimitotic agents|mesh-ancestor
5816733|NCT02636322|Mitosis Modulators|mitosis modulators|mesh-ancestor
5816734|NCT02636322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5816735|NCT02636322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5816736|NCT02636322|Growth Substances|growth substances|mesh-ancestor
5816737|NCT02636322|Growth Inhibitors|growth inhibitors|mesh-ancestor
5816738|NCT02636322|Keratolytic Agents|keratolytic agents|mesh-ancestor
5816739|NCT02636322|Dermatologic Agents|dermatologic agents|mesh-ancestor
5816740|NCT02636387|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
5816741|NCT02636387|Hemostatics|hemostatics|mesh-ancestor
5816742|NCT02636387|Coagulants|coagulants|mesh-ancestor
5816743|NCT02636387|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5643775|NCT03290794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643776|NCT03290794|Growth Inhibitors|growth inhibitors|mesh-ancestor
5643777|NCT03290794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5643778|NCT03260491|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
5643779|NCT03260491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5816744|NCT02636387|Natriuretic Agents|natriuretic agents|mesh-ancestor
5816745|NCT02636387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816746|NCT02636101|Betamethasone|betamethasone|mesh-list
5816747|NCT02636101|Betamethasone Valerate|betamethasone valerate|mesh-list
5816748|NCT02636101|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5816749|NCT02636101|Betamethasone benzoate|betamethasone benzoate|mesh-list
5643780|NCT03260491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5643781|NCT03259074|Adalimumab|adalimumab|mesh-list
5643782|NCT03259074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5643783|NCT03259074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5643784|NCT03249792|Pembrolizumab|pembrolizumab|mesh-list
5643785|NCT03249792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5643786|NCT03249792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5643787|NCT03236857|Venetoclax|venetoclax|mesh-list
5816750|NCT02636101|Calcipotriene|calcipotriene|mesh-list
5816751|NCT02636101|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
5643788|NCT03236857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5816752|NCT02636101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5643789|NCT03198650|Obinutuzumab|obinutuzumab|mesh-list
5643790|NCT03198650|Acalabrutinib|acalabrutinib|mesh-list
5643791|NCT03198650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5643792|NCT03198650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5643793|NCT03188705|Aspirin|aspirin|mesh-list
5643794|NCT03188705|Clopidogrel|clopidogrel|mesh-list
5643795|NCT03188705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5643796|NCT03188705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5643797|NCT03188705|Analgesics|analgesics|mesh-ancestor
5643798|NCT03188705|Sensory System Agents|sensory system agents|mesh-ancestor
5643799|NCT03188705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5816753|NCT02636101|Glucocorticoids|glucocorticoids|mesh-ancestor
5816754|NCT02636101|Hormones|hormones|mesh-ancestor
5816755|NCT02636101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5816756|NCT02636101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816757|NCT02636101|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5816758|NCT02636101|Respiratory System Agents|respiratory system agents|mesh-ancestor
5816759|NCT02636101|Dermatologic Agents|dermatologic agents|mesh-ancestor
5816760|NCT02636088|Cetuximab|cetuximab|mesh-list
5816761|NCT02636088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5816762|NCT02636088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5816763|NCT02635841|Deferiprone|deferiprone|mesh-list
5816764|NCT02635841|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5816765|NCT02635841|Chelating Agents|chelating agents|mesh-ancestor
5816766|NCT02635841|Sequestering Agents|sequestering agents|mesh-ancestor
5816767|NCT02635841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5816768|NCT02635802|Lidocaine|lidocaine|mesh-list
5816769|NCT02635802|Midazolam|midazolam|mesh-list
5816770|NCT02635802|Remifentanil|remifentanil|mesh-list
5816771|NCT02635802|Anesthetics, Local|anesthetics, local|mesh-ancestor
5816772|NCT02635802|Anesthetics|anesthetics|mesh-ancestor
5816773|NCT02635802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5816774|NCT02635802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816775|NCT02635802|Sensory System Agents|sensory system agents|mesh-ancestor
5816776|NCT02635802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5816777|NCT02635802|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5816778|NCT02635802|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5643800|NCT03188705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643801|NCT03188705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5643802|NCT03188705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5643803|NCT03188705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5643804|NCT03188705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5643805|NCT03188705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643806|NCT03188705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5643807|NCT03188705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5643808|NCT03188705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5816779|NCT02635802|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5816780|NCT02635802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5816781|NCT02635802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5816782|NCT02635802|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5816783|NCT02635802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5816784|NCT02635802|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5816785|NCT02635802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5816786|NCT02635802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5816787|NCT02635802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5816788|NCT02635802|Anesthetics, General|anesthetics, general|mesh-ancestor
5816789|NCT02635802|GABA Modulators|gaba modulators|mesh-ancestor
5816790|NCT02635802|GABA Agents|gaba agents|mesh-ancestor
5816791|NCT02635802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5816792|NCT02635802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5816793|NCT02635802|Narcotics|narcotics|mesh-ancestor
5816794|NCT02635802|Analgesics|analgesics|mesh-ancestor
5816795|NCT02635971|Gemcitabine|gemcitabine|mesh-list
5816796|NCT02635971|Oxaliplatin|oxaliplatin|mesh-list
5816797|NCT02635971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5816798|NCT02635971|Antimetabolites|antimetabolites|mesh-ancestor
5816799|NCT02635971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5816800|NCT02635971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5816801|NCT02635971|Antiviral Agents|antiviral agents|mesh-ancestor
5816802|NCT02635971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5816803|NCT02635971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5816804|NCT02635971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5816805|NCT02635971|Immunologic Factors|immunologic factors|mesh-ancestor
5816806|NCT02635971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816807|NCT02635607|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5643809|NCT03188705|Antipyretics|antipyretics|mesh-ancestor
5816808|NCT02635607|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5816809|NCT02635607|Ganirelix|ganirelix|mesh-list
5816810|NCT02635607|Luteolytic Agents|luteolytic agents|mesh-ancestor
5816811|NCT02635607|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5816812|NCT02635607|Contraceptive Agents|contraceptive agents|mesh-ancestor
5816813|NCT02635607|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5816814|NCT02635607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816815|NCT02635607|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5816816|NCT02635607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5816817|NCT02635607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5816818|NCT02635607|Hormones|hormones|mesh-ancestor
5816819|NCT02635607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5816820|NCT02635607|Hormone Antagonists|hormone antagonists|mesh-ancestor
5816821|NCT02636010|Pembrolizumab|pembrolizumab|mesh-list
5816822|NCT02636010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5816823|NCT02636010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5816824|NCT02635750|Donepezil|donepezil|mesh-list
5816825|NCT02635750|BI 409306|bi 409306|mesh-list
5816826|NCT02635750|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5816827|NCT02635750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5816828|NCT02635750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5816829|NCT02635750|Cholinergic Agents|cholinergic agents|mesh-ancestor
5816830|NCT02635750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5816831|NCT02635750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816832|NCT02635750|Nootropic Agents|nootropic agents|mesh-ancestor
5816833|NCT02635750|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5816834|NCT02635867|Calcium, Dietary|calcium, dietary|mesh-list
5816835|NCT02635867|Calcium|calcium|mesh-list
5816836|NCT02635867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5816837|NCT02635867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816838|NCT02635867|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5816839|NCT02635893|Cycloserine|cycloserine|mesh-list
5816840|NCT02635893|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5816841|NCT02635893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5816842|NCT02635893|Renal Agents|renal agents|mesh-ancestor
5816843|NCT02635893|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5816844|NCT02635893|Antitubercular Agents|antitubercular agents|mesh-ancestor
5816845|NCT02635893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5816846|NCT02635893|Antimetabolites|antimetabolites|mesh-ancestor
5816847|NCT02635893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5816848|NCT02635555|Phenylephrine|phenylephrine|mesh-list
5816849|NCT02635555|Oxymetazoline|oxymetazoline|mesh-list
5816850|NCT02635555|Ephedrine|ephedrine|mesh-list
5816851|NCT02635555|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5816852|NCT02635555|Mydriatics|mydriatics|mesh-ancestor
5816853|NCT02635555|Autonomic Agents|autonomic agents|mesh-ancestor
5816854|NCT02635555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5816855|NCT02635555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816856|NCT02635555|Sympathomimetics|sympathomimetics|mesh-ancestor
5816857|NCT02635555|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5816858|NCT02635555|Nasal Decongestants|nasal decongestants|mesh-ancestor
5816859|NCT02635555|Respiratory System Agents|respiratory system agents|mesh-ancestor
5643810|NCT03188705|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5643811|NCT03188705|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6492647|NCT00609960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492648|NCT00609960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6492649|NCT00609960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6492650|NCT00609960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6492651|NCT00609960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6492652|NCT00609960|Anesthetics, General|anesthetics, general|mesh-ancestor
5643812|NCT03188705|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5643813|NCT03188705|Purinergic Agents|purinergic agents|mesh-ancestor
5643814|NCT03188705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5643815|NCT03179436|Pembrolizumab|pembrolizumab|mesh-list
5643816|NCT03179436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5643817|NCT03179436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5816860|NCT02635555|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5816861|NCT02635555|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5816862|NCT02635555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5816863|NCT02635555|Adrenergic Agents|adrenergic agents|mesh-ancestor
5816864|NCT02635555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5816865|NCT02635555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5816866|NCT02635555|Protective Agents|protective agents|mesh-ancestor
5816867|NCT02635555|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6492653|NCT00609960|Anesthetics|anesthetics|mesh-ancestor
5643818|NCT03173456|Acetaminophen|acetaminophen|mesh-list
5643819|NCT03173456|Ibuprofen|ibuprofen|mesh-list
5643820|NCT03173456|Oxycodone|oxycodone|mesh-list
5643821|NCT03173456|Hydrocodone|hydrocodone|mesh-list
5643822|NCT03173456|Codeine|codeine|mesh-list
5643823|NCT03173456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5643824|NCT03173456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5816868|NCT02635243|Glucagon|glucagon|mesh-list
5816869|NCT02635243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816870|NCT02635243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5816871|NCT02635243|Hormones|hormones|mesh-ancestor
5816872|NCT02635243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5816873|NCT02635334|Montelukast|montelukast|mesh-list
5816874|NCT02635334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5816875|NCT02635334|Respiratory System Agents|respiratory system agents|mesh-ancestor
5816876|NCT02635334|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5816877|NCT02635334|Hormone Antagonists|hormone antagonists|mesh-ancestor
5816878|NCT02635334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5816879|NCT02635334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816880|NCT02635334|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5816881|NCT02635334|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5816882|NCT02635334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901306|NCT03631043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5901307|NCT03631043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5901308|NCT03631043|Growth Substances|growth substances|mesh-ancestor
5901309|NCT03631043|Growth Inhibitors|growth inhibitors|mesh-ancestor
5901310|NCT03631043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5908285|NCT04702880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5908286|NCT04702880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5908287|NCT04702880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908288|NCT04702880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5643825|NCT03173456|Analgesics|analgesics|mesh-ancestor
5643826|NCT03173456|Sensory System Agents|sensory system agents|mesh-ancestor
5643827|NCT03173456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5643828|NCT03173456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643829|NCT03173456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5643830|NCT03173456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5643831|NCT03173456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5643832|NCT03173456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5643833|NCT03173456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643834|NCT03173456|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5643835|NCT03173456|Narcotics|narcotics|mesh-ancestor
5643836|NCT03173456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5643837|NCT03173456|Antipyretics|antipyretics|mesh-ancestor
5643838|NCT03173456|Antitussive Agents|antitussive agents|mesh-ancestor
5643839|NCT03173456|Respiratory System Agents|respiratory system agents|mesh-ancestor
5643840|NCT03167437|Vorinostat|vorinostat|mesh-list
5643841|NCT03167437|Ustekinumab|ustekinumab|mesh-list
5643842|NCT03167437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5643843|NCT03167437|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5643844|NCT03167437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5643845|NCT03167437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643846|NCT03167437|Dermatologic Agents|dermatologic agents|mesh-ancestor
5643847|NCT03161678|Clopidogrel|clopidogrel|mesh-list
5643848|NCT03161678|Ticagrelor|ticagrelor|mesh-list
5643849|NCT03161678|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5643850|NCT03161678|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5908289|NCT04702880|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5908290|NCT04702880|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5908291|NCT04702880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5908292|NCT04701593|Triamcinolone|triamcinolone|mesh-list
5908293|NCT04701593|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5908294|NCT04701593|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5908295|NCT04701593|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5908296|NCT04701593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5908297|NCT04701593|Glucocorticoids|glucocorticoids|mesh-ancestor
5908298|NCT04701593|Hormones|hormones|mesh-ancestor
5908299|NCT04701593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5908300|NCT04701593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5908301|NCT04701593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5908302|NCT04701593|Immunologic Factors|immunologic factors|mesh-ancestor
5643851|NCT03161678|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5643852|NCT03161678|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5643853|NCT03161678|Purinergic Agents|purinergic agents|mesh-ancestor
5816883|NCT02635230|Aspirin|aspirin|mesh-list
5816884|NCT02635230|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5816885|NCT02635230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5816886|NCT02635230|Analgesics|analgesics|mesh-ancestor
5816887|NCT02635230|Sensory System Agents|sensory system agents|mesh-ancestor
5816888|NCT02635230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5816889|NCT02635230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643854|NCT03161678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5643855|NCT03161678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643856|NCT03161678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643857|NCT03149003|Bevacizumab|bevacizumab|mesh-list
5643858|NCT03149003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5643859|NCT03149003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5643860|NCT03149003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5643861|NCT03149003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5643862|NCT03149003|Growth Substances|growth substances|mesh-ancestor
5643863|NCT03149003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816890|NCT02635230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5816891|NCT02635230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5816892|NCT02635230|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5816893|NCT02635230|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5816894|NCT02635230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5816895|NCT02635230|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5816896|NCT02635230|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5816897|NCT02635230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5816898|NCT02635230|Antipyretics|antipyretics|mesh-ancestor
5816899|NCT02635360|Pembrolizumab|pembrolizumab|mesh-list
5816900|NCT02635360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5816901|NCT02635360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5816902|NCT02635282|Fentanyl|fentanyl|mesh-list
5816903|NCT02635282|Midazolam|midazolam|mesh-list
5816904|NCT02635282|Ketamine|ketamine|mesh-list
5816905|NCT02635282|Analgesics|analgesics|mesh-ancestor
5816906|NCT02635282|Sensory System Agents|sensory system agents|mesh-ancestor
5816907|NCT02635282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5816908|NCT02635282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816909|NCT02635282|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5816910|NCT02635282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5816911|NCT02635282|Anesthetics, General|anesthetics, general|mesh-ancestor
5816912|NCT02635282|Anesthetics|anesthetics|mesh-ancestor
5816913|NCT02635282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5816914|NCT02635282|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5816915|NCT02635282|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5816916|NCT02635282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5816917|NCT02635282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5816918|NCT02635282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5816919|NCT02635282|Narcotics|narcotics|mesh-ancestor
5816920|NCT02635282|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5643864|NCT03149003|Growth Inhibitors|growth inhibitors|mesh-ancestor
5643865|NCT03136055|Paclitaxel|paclitaxel|mesh-list
5643866|NCT03136055|Pembrolizumab|pembrolizumab|mesh-list
5643867|NCT03136055|Irinotecan|irinotecan|mesh-list
5643868|NCT03136055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5643869|NCT03136055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5643870|NCT03136055|Tubulin Modulators|tubulin modulators|mesh-ancestor
5643871|NCT03136055|Antimitotic Agents|antimitotic agents|mesh-ancestor
5643872|NCT03136055|Mitosis Modulators|mitosis modulators|mesh-ancestor
5643873|NCT03136055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643874|NCT03136055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5643875|NCT03136055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5643876|NCT03136055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5643877|NCT03136055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5643878|NCT03101566|Gemcitabine|gemcitabine|mesh-list
5643879|NCT03101566|Nivolumab|nivolumab|mesh-list
5643880|NCT03101566|Ipilimumab|ipilimumab|mesh-list
5643881|NCT03101566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5643882|NCT03101566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5643883|NCT03101566|Antimetabolites|antimetabolites|mesh-ancestor
5643884|NCT03101566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643885|NCT03101566|Antiviral Agents|antiviral agents|mesh-ancestor
5643886|NCT03101566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5643887|NCT03101566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5643888|NCT03101566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5816921|NCT02635282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5643889|NCT03101566|Immunologic Factors|immunologic factors|mesh-ancestor
5816922|NCT02635282|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5816923|NCT02635282|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5816924|NCT02635282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5816925|NCT02635282|GABA Modulators|gaba modulators|mesh-ancestor
5816926|NCT02635282|GABA Agents|gaba agents|mesh-ancestor
5643890|NCT03101566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643891|NCT03101566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5643892|NCT03101566|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5643893|NCT03020199|Betamethasone|betamethasone|mesh-list
5643894|NCT03020199|Calcipotriene|calcipotriene|mesh-list
5643895|NCT03020199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5643896|NCT03020199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5643897|NCT03020199|Glucocorticoids|glucocorticoids|mesh-ancestor
5643898|NCT03020199|Hormones|hormones|mesh-ancestor
5643899|NCT03020199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5643900|NCT03020199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643901|NCT03020199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5643902|NCT03020199|Respiratory System Agents|respiratory system agents|mesh-ancestor
5643903|NCT03020199|Immunologic Factors|immunologic factors|mesh-ancestor
5643904|NCT03020199|Dermatologic Agents|dermatologic agents|mesh-ancestor
5816927|NCT02635074|Cytarabine|cytarabine|mesh-list
5816928|NCT02635074|Idarubicin|idarubicin|mesh-list
5816929|NCT02635074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5816930|NCT02635074|Antimetabolites|antimetabolites|mesh-ancestor
5816931|NCT02635074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5816932|NCT02635074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5816933|NCT02635074|Antiviral Agents|antiviral agents|mesh-ancestor
5816934|NCT02635074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5816935|NCT02635074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5816936|NCT02635074|Immunologic Factors|immunologic factors|mesh-ancestor
5643905|NCT03006068|Upadacitinib|upadacitinib|mesh-list
5643906|NCT03006068|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
5643907|NCT03006068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5643908|NCT03006068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5643909|NCT03006068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643910|NCT03006068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5643911|NCT03003520|Prednisone|prednisone|mesh-list
5643912|NCT03003520|Prednisolone|prednisolone|mesh-list
5643913|NCT03003520|Cyclophosphamide|cyclophosphamide|mesh-list
5643914|NCT03003520|Rituximab|rituximab|mesh-list
5643915|NCT03003520|Doxorubicin|doxorubicin|mesh-list
5643916|NCT03003520|Vincristine|vincristine|mesh-list
5643917|NCT03003520|Lenalidomide|lenalidomide|mesh-list
5643918|NCT03003520|Durvalumab|durvalumab|mesh-list
6492654|NCT00609960|GABA Modulators|gaba modulators|mesh-ancestor
6492655|NCT00609960|GABA Agents|gaba agents|mesh-ancestor
6492656|NCT00609960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6492657|NCT00609960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492658|NCT00609999|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6492659|NCT00609999|Dasatinib|dasatinib|mesh-list
6492660|NCT00609999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6492661|NCT00609999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6492662|NCT00609999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6492663|NCT00609999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492664|NCT00610038|Glyburide|glyburide|mesh-list
6492665|NCT00610038|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6492666|NCT00610038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492667|NCT00610051|Alprostadil|alprostadil|mesh-list
6492668|NCT00610051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6492669|NCT00610051|Vasodilator Agents|vasodilator agents|mesh-ancestor
6492670|NCT00610051|Urological Agents|urological agents|mesh-ancestor
6492671|NCT00610077|Letrozole|letrozole|mesh-list
6492672|NCT00610077|Clomiphene|clomiphene|mesh-list
6492673|NCT00610077|Enclomiphene|enclomiphene|mesh-list
6492674|NCT00610077|Zuclomiphene|zuclomiphene|mesh-list
5643919|NCT03003520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5643920|NCT03003520|Immunologic Factors|immunologic factors|mesh-ancestor
5643921|NCT03003520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643922|NCT03003520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5643923|NCT03003520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5643924|NCT03003520|Alkylating Agents|alkylating agents|mesh-ancestor
5643925|NCT03003520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643926|NCT03003520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5816937|NCT02635074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643927|NCT03003520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5816938|NCT02635074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5816939|NCT02635074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6492675|NCT00610077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643928|NCT03003520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5643929|NCT03003520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5643930|NCT03003520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5643931|NCT03003520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5643932|NCT03003520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5643933|NCT03003520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5643934|NCT03003520|Glucocorticoids|glucocorticoids|mesh-ancestor
5643935|NCT03003520|Hormones|hormones|mesh-ancestor
5643936|NCT03003520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5643937|NCT03003520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5643938|NCT03003520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5643939|NCT03003520|Tubulin Modulators|tubulin modulators|mesh-ancestor
5643940|NCT03003520|Antimitotic Agents|antimitotic agents|mesh-ancestor
5643941|NCT03003520|Mitosis Modulators|mitosis modulators|mesh-ancestor
5643942|NCT03003520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5643943|NCT03003520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5643944|NCT03003520|Growth Substances|growth substances|mesh-ancestor
5643945|NCT03003520|Growth Inhibitors|growth inhibitors|mesh-ancestor
5643946|NCT02992015|Gemcitabine|gemcitabine|mesh-list
5643947|NCT02992015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5643948|NCT02992015|Antimetabolites|antimetabolites|mesh-ancestor
5643949|NCT02992015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643950|NCT02992015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5643951|NCT02992015|Antiviral Agents|antiviral agents|mesh-ancestor
5643952|NCT02992015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5643953|NCT02992015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5643954|NCT02992015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5643955|NCT02992015|Immunologic Factors|immunologic factors|mesh-ancestor
5643956|NCT02992015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643957|NCT02991495|Vaccines|vaccines|mesh-list
5643958|NCT02991495|Immunologic Factors|immunologic factors|mesh-ancestor
5643959|NCT02991495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643960|NCT02966756|Venetoclax|venetoclax|mesh-list
5643961|NCT02966756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5643962|NCT02928406|Atezolizumab|atezolizumab|mesh-list
5643963|NCT02928406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5643964|NCT02918370|Aripiprazole|aripiprazole|mesh-list
5643965|NCT02918370|Antidepressive Agents|antidepressive agents|mesh-ancestor
5643966|NCT02918370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5643967|NCT02918370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5643968|NCT02918370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5643969|NCT02918370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5643970|NCT02918370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643971|NCT02918370|Dopamine Agonists|dopamine agonists|mesh-ancestor
5643972|NCT02918370|Dopamine Agents|dopamine agents|mesh-ancestor
5643973|NCT02918370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5643974|NCT02918370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5643975|NCT02918370|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5816940|NCT02635074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5816941|NCT02635074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5816942|NCT02635191|Amoxicillin|amoxicillin|mesh-list
5816943|NCT02635191|Metronidazole|metronidazole|mesh-list
5816944|NCT02635191|Clarithromycin|clarithromycin|mesh-list
5816945|NCT02635191|Esomeprazole|esomeprazole|mesh-list
5816946|NCT02635191|Omeprazole|omeprazole|mesh-list
5816947|NCT02635191|Rabeprazole|rabeprazole|mesh-list
5816948|NCT02635191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5816949|NCT02635191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5816950|NCT02635191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5816951|NCT02635191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5816952|NCT02635191|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5816953|NCT02635191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5816954|NCT02635191|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5816955|NCT02635191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5816956|NCT02635191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5816957|NCT02635191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5816958|NCT02635191|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5816959|NCT02635191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5816960|NCT02635061|Nivolumab|nivolumab|mesh-list
5816961|NCT02635061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5816962|NCT02635061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5816963|NCT02635061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5816964|NCT02635061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5816965|NCT02634970|Ranibizumab|ranibizumab|mesh-list
5816966|NCT02634970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5643976|NCT02918370|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5643977|NCT02918370|Serotonin Agents|serotonin agents|mesh-ancestor
5643978|NCT02918370|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5643979|NCT02918370|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5643980|NCT02918370|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5643981|NCT02918370|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5643982|NCT02891824|Bevacizumab|bevacizumab|mesh-list
5643983|NCT02891824|Atezolizumab|atezolizumab|mesh-list
5643984|NCT02891824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5643985|NCT02891824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5643986|NCT02891824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5643987|NCT02891824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5643988|NCT02891824|Growth Substances|growth substances|mesh-ancestor
5643989|NCT02891824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5643990|NCT02891824|Growth Inhibitors|growth inhibitors|mesh-ancestor
5643991|NCT02862457|Paclitaxel|paclitaxel|mesh-list
5643992|NCT02862457|Cisplatin|cisplatin|mesh-list
5643993|NCT02862457|Carboplatin|carboplatin|mesh-list
5643994|NCT02862457|Pembrolizumab|pembrolizumab|mesh-list
5643995|NCT02862457|Pemetrexed|pemetrexed|mesh-list
5643996|NCT02862457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5643997|NCT02862457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5643998|NCT02862457|Tubulin Modulators|tubulin modulators|mesh-ancestor
5643999|NCT02862457|Antimitotic Agents|antimitotic agents|mesh-ancestor
5644000|NCT02862457|Mitosis Modulators|mitosis modulators|mesh-ancestor
5644001|NCT02862457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644002|NCT02862457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5644003|NCT02862457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5644004|NCT02862457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5644005|NCT02862457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5644006|NCT02845323|Nivolumab|nivolumab|mesh-list
5644007|NCT02845323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5644008|NCT02845323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5644009|NCT02845323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5644010|NCT02845323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644011|NCT02790515|Sirolimus|sirolimus|mesh-list
5644012|NCT02790515|Cyclophosphamide|cyclophosphamide|mesh-list
5644013|NCT02790515|Melphalan|melphalan|mesh-list
5644014|NCT02790515|Mechlorethamine|mechlorethamine|mesh-list
5644015|NCT02790515|Thiotepa|thiotepa|mesh-list
5644016|NCT02790515|Rituximab|rituximab|mesh-list
5644017|NCT02790515|Fludarabine|fludarabine|mesh-list
5644018|NCT02790515|Blinatumomab|blinatumomab|mesh-list
5644019|NCT02790515|Tacrolimus|tacrolimus|mesh-list
5644020|NCT02790515|Thymoglobulin|thymoglobulin|mesh-list
5644021|NCT02790515|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5644022|NCT02790515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5644023|NCT02790515|Immunologic Factors|immunologic factors|mesh-ancestor
5644024|NCT02790515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644025|NCT02790515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5644026|NCT02790515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5644027|NCT02790515|Alkylating Agents|alkylating agents|mesh-ancestor
5644028|NCT02790515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644029|NCT02790515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5644030|NCT02790515|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5816967|NCT02634970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5816968|NCT02634970|Growth Substances|growth substances|mesh-ancestor
5644031|NCT02790515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5644032|NCT02790515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5644033|NCT02790515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5644034|NCT02790515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5644035|NCT02790515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5644036|NCT02790515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5644037|NCT02790515|Antifungal Agents|antifungal agents|mesh-ancestor
5644038|NCT02733042|Rituximab|rituximab|mesh-list
5644039|NCT02733042|Durvalumab|durvalumab|mesh-list
5644040|NCT02733042|Lenalidomide|lenalidomide|mesh-list
5644041|NCT02733042|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5644042|NCT02733042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5644043|NCT02733042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5644044|NCT02733042|Immunologic Factors|immunologic factors|mesh-ancestor
5644045|NCT02733042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644046|NCT02733042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5644047|NCT02733042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5644048|NCT02733042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5644049|NCT02733042|Growth Substances|growth substances|mesh-ancestor
5644050|NCT02733042|Growth Inhibitors|growth inhibitors|mesh-ancestor
5816969|NCT02634970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816970|NCT02634970|Growth Inhibitors|growth inhibitors|mesh-ancestor
5816971|NCT02634970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5816972|NCT02634723|Factor VIII|factor viii|mesh-list
5816973|NCT02634723|Coagulants|coagulants|mesh-ancestor
5816974|NCT02634541|Adalimumab|adalimumab|mesh-list
5816975|NCT02634541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5644051|NCT02733042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5644052|NCT02733042|Alkylating Agents|alkylating agents|mesh-ancestor
5816976|NCT02634541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5816977|NCT02634489|Tamsulosin|tamsulosin|mesh-list
5816978|NCT02634489|Solifenacin Succinate|solifenacin succinate|mesh-list
5816979|NCT02634489|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5816980|NCT02634489|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5816981|NCT02634489|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5816982|NCT02634489|Adrenergic Agents|adrenergic agents|mesh-ancestor
5816983|NCT02634489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5816984|NCT02634489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5816985|NCT02634489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816986|NCT02634489|Urological Agents|urological agents|mesh-ancestor
5816987|NCT02634489|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5816988|NCT02634489|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5816989|NCT02634489|Cholinergic Agents|cholinergic agents|mesh-ancestor
5816990|NCT02634476|Ethanol|ethanol|mesh-list
5816991|NCT02634476|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5816992|NCT02634476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5816993|NCT02634476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5816994|NCT02634476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5816995|NCT02634528|Insulin|insulin|mesh-list
5816996|NCT02634528|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5816997|NCT02634528|Insulin, Isophane|insulin, isophane|mesh-list
5816998|NCT02634528|Isophane Insulin, Human|isophane insulin, human|mesh-list
5816999|NCT02634528|Isophane insulin, beef|isophane insulin, beef|mesh-list
5817000|NCT02634528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5817001|NCT02634528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817002|NCT02634463|Olanzapine|olanzapine|mesh-list
5817003|NCT02634463|Risperidone|risperidone|mesh-list
5817004|NCT02634463|Aripiprazole|aripiprazole|mesh-list
5817005|NCT02634463|Paliperidone Palmitate|paliperidone palmitate|mesh-list
5817006|NCT02634463|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5817007|NCT02634463|Serotonin Agents|serotonin agents|mesh-ancestor
5817008|NCT02634463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5817009|NCT02634463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817010|NCT02634463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817011|NCT02634463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5817012|NCT02634463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5817013|NCT02634463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5817014|NCT02634463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5817015|NCT02634463|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5817016|NCT02634463|Dopamine Agents|dopamine agents|mesh-ancestor
5817017|NCT02634463|Antiemetics|antiemetics|mesh-ancestor
5817018|NCT02634463|Autonomic Agents|autonomic agents|mesh-ancestor
5817019|NCT02634463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5817020|NCT02634463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5817021|NCT02634463|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5817022|NCT02634463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5817023|NCT02634463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5817024|NCT02634463|Antidepressive Agents|antidepressive agents|mesh-ancestor
5817025|NCT02634463|Dopamine Agonists|dopamine agonists|mesh-ancestor
5817026|NCT02634463|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5817027|NCT02634463|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5817028|NCT02634463|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5644053|NCT02733042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644054|NCT02688985|Ocrelizumab|ocrelizumab|mesh-list
5644055|NCT02688985|Histamine Antagonists|histamine antagonists|mesh-list
5644056|NCT02688985|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
5644057|NCT02688985|Immunologic Factors|immunologic factors|mesh-ancestor
5644058|NCT02688985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644059|NCT02688985|Histamine Agents|histamine agents|mesh-ancestor
5644060|NCT02688985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5644061|NCT02688985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694108|NCT03397446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694109|NCT03397446|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5817029|NCT02634463|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5817030|NCT02634437|Ulipristal acetate|ulipristal acetate|mesh-list
5644062|NCT02663518|Rituximab|rituximab|mesh-list
5644063|NCT02663518|Nivolumab|nivolumab|mesh-list
5644064|NCT02663518|Immunoglobulin G|immunoglobulin g|mesh-list
5644065|NCT02663518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5644066|NCT02663518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5644067|NCT02663518|Immunologic Factors|immunologic factors|mesh-ancestor
5644068|NCT02663518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644069|NCT02663518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5644070|NCT02663518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5817031|NCT02634437|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5817032|NCT02634437|Contraceptive Agents|contraceptive agents|mesh-ancestor
5817033|NCT02634437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5817034|NCT02634437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817035|NCT02634437|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5817036|NCT02634294|Interferons|interferons|mesh-list
5817037|NCT02634294|Interferon-alpha|interferon-alpha|mesh-list
5817038|NCT02634294|Interferon alpha-2|interferon alpha-2|mesh-list
5817039|NCT02634294|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
5817040|NCT02634294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5817041|NCT02634294|Antiviral Agents|antiviral agents|mesh-ancestor
5817042|NCT02634294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5817043|NCT02634294|Immunologic Factors|immunologic factors|mesh-ancestor
5817044|NCT02634294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817045|NCT02634515|Insulin|insulin|mesh-list
5817046|NCT02634515|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5817047|NCT02634515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5817048|NCT02634515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817049|NCT02634281|Varenicline|varenicline|mesh-list
5817050|NCT02634281|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5817051|NCT02634281|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5817052|NCT02634281|Cholinergic Agents|cholinergic agents|mesh-ancestor
5817053|NCT02634281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5817054|NCT02634281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817055|NCT02634281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817056|NCT02634255|Fentanyl|fentanyl|mesh-list
5817057|NCT02634255|Propofol|propofol|mesh-list
5817058|NCT02634255|Rocuronium|rocuronium|mesh-list
5817059|NCT02634255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5817060|NCT02634255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5817061|NCT02634255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817062|NCT02634255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5817063|NCT02634255|Anesthetics, General|anesthetics, general|mesh-ancestor
5644071|NCT02663518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644072|NCT02663271|Bevacizumab|bevacizumab|mesh-list
5644073|NCT02663271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5644074|NCT02663271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5817064|NCT02634255|Anesthetics|anesthetics|mesh-ancestor
5817065|NCT02634255|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5817066|NCT02634255|Narcotics|narcotics|mesh-ancestor
5817067|NCT02634255|Analgesics|analgesics|mesh-ancestor
5817068|NCT02634255|Sensory System Agents|sensory system agents|mesh-ancestor
5817069|NCT02634255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5817070|NCT02634255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5817071|NCT02634255|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5817072|NCT02634255|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5817073|NCT02634255|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5817074|NCT02634034|Pitavastatin|pitavastatin|mesh-list
5817075|NCT02634034|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5817076|NCT02634034|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5817077|NCT02634034|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5817078|NCT02634034|Antimetabolites|antimetabolites|mesh-ancestor
5817079|NCT02634034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817080|NCT02634034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5817081|NCT02634034|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5817082|NCT02634203|Riociguat|riociguat|mesh-list
5817083|NCT02634203|Enzyme Activators|enzyme activators|mesh-ancestor
5817084|NCT02634203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817085|NCT02634021|Midazolam|midazolam|mesh-list
5817086|NCT02634021|Dexmedetomidine|dexmedetomidine|mesh-list
5817087|NCT02634021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5644075|NCT02663271|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5817088|NCT02634021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6211434|NCT02172040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211435|NCT02172040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6211436|NCT02172040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644076|NCT02663271|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5644077|NCT02663271|Growth Substances|growth substances|mesh-ancestor
5644078|NCT02663271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644079|NCT02663271|Growth Inhibitors|growth inhibitors|mesh-ancestor
5644080|NCT02661971|Leucovorin|leucovorin|mesh-list
5644081|NCT02661971|Docetaxel|docetaxel|mesh-list
5644082|NCT02661971|Fluorouracil|fluorouracil|mesh-list
5644083|NCT02661971|Oxaliplatin|oxaliplatin|mesh-list
5644084|NCT02661971|Ramucirumab|ramucirumab|mesh-list
5644085|NCT02661971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5644086|NCT02661971|Tubulin Modulators|tubulin modulators|mesh-ancestor
5644087|NCT02661971|Antimitotic Agents|antimitotic agents|mesh-ancestor
5644088|NCT02661971|Mitosis Modulators|mitosis modulators|mesh-ancestor
5644089|NCT02661971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644090|NCT02661971|Antimetabolites|antimetabolites|mesh-ancestor
5644091|NCT02661971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5644092|NCT02661971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5644093|NCT02661971|Immunologic Factors|immunologic factors|mesh-ancestor
5644094|NCT02661971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644095|NCT02661971|Antidotes|antidotes|mesh-ancestor
5644096|NCT02661971|Protective Agents|protective agents|mesh-ancestor
5644097|NCT02661971|Vitamin B Complex|vitamin b complex|mesh-ancestor
5644098|NCT02661971|Vitamins|vitamins|mesh-ancestor
5644099|NCT02661971|Micronutrients|micronutrients|mesh-ancestor
5644100|NCT02609737|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
5644101|NCT02609737|Chelating Agents|chelating agents|mesh-ancestor
5644102|NCT02609737|Sequestering Agents|sequestering agents|mesh-ancestor
5644103|NCT02609737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644104|NCT02588105|Leucovorin|leucovorin|mesh-list
5644105|NCT02588105|Folic Acid|folic acid|mesh-list
5644106|NCT02588105|Fluorouracil|fluorouracil|mesh-list
5644107|NCT02588105|Irinotecan|irinotecan|mesh-list
5644108|NCT02588105|Olaparib|olaparib|mesh-list
5644109|NCT02588105|AZD0156|azd0156|mesh-list
5644110|NCT02588105|Levoleucovorin|levoleucovorin|mesh-list
5644111|NCT02588105|Antimetabolites|antimetabolites|mesh-ancestor
5644112|NCT02588105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644113|NCT02588105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5644114|NCT02588105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5644115|NCT02588105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5644116|NCT02588105|Immunologic Factors|immunologic factors|mesh-ancestor
5644117|NCT02588105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644118|NCT02588105|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5644119|NCT02588105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5644120|NCT02588105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5644121|NCT02588105|Antidotes|antidotes|mesh-ancestor
5644122|NCT02588105|Protective Agents|protective agents|mesh-ancestor
5644123|NCT02588105|Vitamin B Complex|vitamin b complex|mesh-ancestor
5644124|NCT02588105|Vitamins|vitamins|mesh-ancestor
5644125|NCT02588105|Micronutrients|micronutrients|mesh-ancestor
5644126|NCT02588105|Hematinics|hematinics|mesh-ancestor
5644127|NCT02588105|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5644128|NCT02588105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5644129|NCT02575144|Clarithromycin|clarithromycin|mesh-list
5644130|NCT02575144|Dexamethasone|dexamethasone|mesh-list
5644131|NCT02575144|Lenalidomide|lenalidomide|mesh-list
5644132|NCT02575144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5644133|NCT02575144|Antiemetics|antiemetics|mesh-ancestor
5644134|NCT02575144|Autonomic Agents|autonomic agents|mesh-ancestor
5644135|NCT02575144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5644136|NCT02575144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644137|NCT02575144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5644138|NCT02575144|Glucocorticoids|glucocorticoids|mesh-ancestor
5644139|NCT02575144|Hormones|hormones|mesh-ancestor
5644140|NCT02575144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5644141|NCT02575144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5644142|NCT02575144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5644143|NCT02575144|Immunologic Factors|immunologic factors|mesh-ancestor
5644144|NCT02575144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5644145|NCT02575144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5644146|NCT02575144|Growth Substances|growth substances|mesh-ancestor
5644147|NCT02575144|Growth Inhibitors|growth inhibitors|mesh-ancestor
5817089|NCT02634021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644148|NCT02575144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5644149|NCT02575144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5644150|NCT02575144|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5644151|NCT02575144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5644152|NCT02575144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644153|NCT02575144|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5644154|NCT02575144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5644155|NCT02574286|Vitamin D|vitamin d|mesh-list
5644156|NCT02574286|Vitamins|vitamins|mesh-ancestor
5644157|NCT02574286|Micronutrients|micronutrients|mesh-ancestor
5644158|NCT02574286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644159|NCT02574286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5644160|NCT02542956|Bupivacaine|bupivacaine|mesh-list
5644161|NCT02542956|Anesthetics, Local|anesthetics, local|mesh-ancestor
5644162|NCT02542956|Anesthetics|anesthetics|mesh-ancestor
5644163|NCT02542956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5644164|NCT02542956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644165|NCT02542956|Sensory System Agents|sensory system agents|mesh-ancestor
5644166|NCT02542956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5644167|NCT02471144|Etanercept|etanercept|mesh-list
5644168|NCT02471144|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5644169|NCT02471144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5644170|NCT02471144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5644171|NCT02471144|Analgesics|analgesics|mesh-ancestor
5644172|NCT02471144|Sensory System Agents|sensory system agents|mesh-ancestor
5644173|NCT02471144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5644174|NCT02471144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644175|NCT02471144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5644176|NCT02471144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5644177|NCT02471144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5644178|NCT02471144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5644179|NCT02471144|Immunologic Factors|immunologic factors|mesh-ancestor
5644180|NCT02440464|Fludarabine|fludarabine|mesh-list
5644181|NCT02440464|Bortezomib|bortezomib|mesh-list
5644182|NCT02440464|Melphalan|melphalan|mesh-list
5644183|NCT02440464|Ixazomib|ixazomib|mesh-list
5644184|NCT02440464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5817090|NCT02634021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5817091|NCT02634021|Analgesics|analgesics|mesh-ancestor
5817092|NCT02634021|Sensory System Agents|sensory system agents|mesh-ancestor
5817093|NCT02634021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5817094|NCT02634021|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5817095|NCT02634021|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5817096|NCT02634021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5817097|NCT02634021|Adrenergic Agents|adrenergic agents|mesh-ancestor
5644185|NCT02440464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644186|NCT02440464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5644187|NCT02440464|Immunologic Factors|immunologic factors|mesh-ancestor
5644188|NCT02440464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644189|NCT02440464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5644190|NCT02440464|Alkylating Agents|alkylating agents|mesh-ancestor
5644191|NCT02440464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5644192|NCT02440464|Protease Inhibitors|protease inhibitors|mesh-ancestor
5644193|NCT02440464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5644194|NCT02428985|Riociguat|riociguat|mesh-list
5644195|NCT02428985|Enzyme Activators|enzyme activators|mesh-ancestor
6492676|NCT00610077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6492677|NCT00610077|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6492678|NCT00610077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6492679|NCT00610077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6492680|NCT00610077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6492681|NCT00610077|Hormone Antagonists|hormone antagonists|mesh-ancestor
6492682|NCT00610077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6492683|NCT00610077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492684|NCT00610077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5644196|NCT02428985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644197|NCT02366728|Temozolomide|temozolomide|mesh-list
5644198|NCT02366728|Basiliximab|basiliximab|mesh-list
5644199|NCT02366728|Immunologic Factors|immunologic factors|mesh-ancestor
5817098|NCT02634021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5817099|NCT02634021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817100|NCT02634021|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5817101|NCT02634021|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5817102|NCT02634021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5817103|NCT02634021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5817104|NCT02634021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5817105|NCT02634021|Anesthetics, General|anesthetics, general|mesh-ancestor
5817106|NCT02634021|Anesthetics|anesthetics|mesh-ancestor
5817107|NCT02634021|GABA Modulators|gaba modulators|mesh-ancestor
5817108|NCT02634021|GABA Agents|gaba agents|mesh-ancestor
5644200|NCT02366728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817109|NCT02633969|Indomethacin|indomethacin|mesh-list
5817110|NCT02633969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5817111|NCT02633969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5817112|NCT02633969|Analgesics|analgesics|mesh-ancestor
5817113|NCT02633969|Sensory System Agents|sensory system agents|mesh-ancestor
5817114|NCT02633969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5817115|NCT02633969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817116|NCT02633969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5817117|NCT02633969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5817118|NCT02633969|Gout Suppressants|gout suppressants|mesh-ancestor
5817119|NCT02633969|Tocolytic Agents|tocolytic agents|mesh-ancestor
5817120|NCT02633969|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5817121|NCT02633969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5817122|NCT02633969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5817123|NCT02633969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817124|NCT02634008|Ritonavir|ritonavir|mesh-list
5817125|NCT02634008|Ribavirin|ribavirin|mesh-list
5817126|NCT02634008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5817127|NCT02634008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5817128|NCT02634008|Protease Inhibitors|protease inhibitors|mesh-ancestor
5817129|NCT02634008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5817130|NCT02634008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817131|NCT02634008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5817132|NCT02634008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5817133|NCT02634008|Antiviral Agents|antiviral agents|mesh-ancestor
5817134|NCT02634008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5644201|NCT02366728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5644202|NCT02366728|Alkylating Agents|alkylating agents|mesh-ancestor
5644203|NCT02366728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644204|NCT02366728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5644205|NCT02366728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5644206|NCT02344355|Ascorbic Acid|ascorbic acid|mesh-list
5644207|NCT02344355|Temozolomide|temozolomide|mesh-list
5644208|NCT02344355|Vitamins|vitamins|mesh-ancestor
5817135|NCT02634008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5817136|NCT02634008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6492685|NCT00610077|Fertility Agents|fertility agents|mesh-ancestor
5817137|NCT02634008|Antimetabolites|antimetabolites|mesh-ancestor
5817138|NCT02633930|Amoxicillin|amoxicillin|mesh-list
5817139|NCT02633930|Clarithromycin|clarithromycin|mesh-list
5817140|NCT02633930|Lansoprazole|lansoprazole|mesh-list
5817141|NCT02633930|Dexlansoprazole|dexlansoprazole|mesh-list
5817142|NCT02633930|Bismuth|bismuth|mesh-list
5817143|NCT02633930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5817144|NCT02633930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5817145|NCT02633930|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5817146|NCT02633930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5817147|NCT02633930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817148|NCT02633930|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5817149|NCT02633930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5817150|NCT02633930|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5817151|NCT02633930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5817152|NCT02633930|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5817153|NCT02633930|Antacids|antacids|mesh-ancestor
5817154|NCT02633995|Anesthetics|anesthetics|mesh-list
5817155|NCT02633995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5817156|NCT02633995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817157|NCT02633878|Progesterone|progesterone|mesh-list
5817158|NCT02633878|Progestins|progestins|mesh-ancestor
5817159|NCT02633878|Hormones|hormones|mesh-ancestor
5817160|NCT02633878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5817161|NCT02633878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817162|NCT02633696|Silybin|silybin|mesh-list
5817163|NCT02633696|Silymarin|silymarin|mesh-list
5817164|NCT02633696|Antioxidants|antioxidants|mesh-ancestor
5817165|NCT02633696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817166|NCT02633696|Protective Agents|protective agents|mesh-ancestor
5817167|NCT02633696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817168|NCT02633696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5817169|NCT02633696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5644209|NCT02344355|Micronutrients|micronutrients|mesh-ancestor
5644210|NCT02344355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644211|NCT02344355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5644212|NCT02344355|Alkylating Agents|alkylating agents|mesh-ancestor
5644213|NCT02344355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644214|NCT02344355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5644215|NCT02344355|Antioxidants|antioxidants|mesh-ancestor
5644216|NCT02344355|Protective Agents|protective agents|mesh-ancestor
5644217|NCT02332850|Dexamethasone|dexamethasone|mesh-list
5644218|NCT02332850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5644219|NCT02332850|Antiemetics|antiemetics|mesh-ancestor
5644220|NCT02332850|Autonomic Agents|autonomic agents|mesh-ancestor
5644221|NCT02332850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5644222|NCT02332850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644223|NCT02332850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5644224|NCT02332850|Glucocorticoids|glucocorticoids|mesh-ancestor
5644225|NCT02332850|Hormones|hormones|mesh-ancestor
5644226|NCT02332850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5644227|NCT02332850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5644228|NCT02332850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5644229|NCT02313870|Clobetasol|clobetasol|mesh-list
5644230|NCT02313870|Methotrexate|methotrexate|mesh-list
5644231|NCT02313870|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5644232|NCT02313870|Abortifacient Agents|abortifacient agents|mesh-ancestor
5644233|NCT02313870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5644234|NCT02313870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644235|NCT02313870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5644236|NCT02313870|Antimetabolites|antimetabolites|mesh-ancestor
5644237|NCT02313870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644238|NCT02313870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5644239|NCT02313870|Dermatologic Agents|dermatologic agents|mesh-ancestor
5644240|NCT02313870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5644241|NCT02313870|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5644242|NCT02313870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5644243|NCT02313870|Immunologic Factors|immunologic factors|mesh-ancestor
5644244|NCT02313870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5644245|NCT02313870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5644246|NCT02313870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5644247|NCT02313870|Glucocorticoids|glucocorticoids|mesh-ancestor
5644248|NCT02313870|Hormones|hormones|mesh-ancestor
5644249|NCT02313870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5644250|NCT02310321|Cytarabine|cytarabine|mesh-list
5644251|NCT02310321|Idarubicin|idarubicin|mesh-list
5644252|NCT02310321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5644253|NCT02310321|Antimetabolites|antimetabolites|mesh-ancestor
5644254|NCT02310321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644255|NCT02310321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5644256|NCT02310321|Antiviral Agents|antiviral agents|mesh-ancestor
5644257|NCT02310321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5644258|NCT02310321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5644259|NCT02310321|Immunologic Factors|immunologic factors|mesh-ancestor
5644260|NCT02310321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644261|NCT02310321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5644262|NCT02310321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5644263|NCT02310321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5644264|NCT02310321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5644265|NCT02271932|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5644266|NCT02271932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5644267|NCT02243709|Mifepristone|mifepristone|mesh-list
5644268|NCT02243709|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5644269|NCT02243709|Abortifacient Agents|abortifacient agents|mesh-ancestor
5644270|NCT02243709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5644271|NCT02243709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644272|NCT02243709|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5644273|NCT02243709|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5644274|NCT02243709|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5644275|NCT02243709|Contraceptive Agents|contraceptive agents|mesh-ancestor
5644276|NCT02243709|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5644277|NCT02243709|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5644278|NCT02243709|Hormone Antagonists|hormone antagonists|mesh-ancestor
5644279|NCT02243709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5644280|NCT02243709|Luteolytic Agents|luteolytic agents|mesh-ancestor
5817170|NCT02633683|Gabapentin|gabapentin|mesh-list
5817171|NCT02633683|Analgesics|analgesics|mesh-ancestor
5817172|NCT02633683|Sensory System Agents|sensory system agents|mesh-ancestor
5817173|NCT02633683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5817174|NCT02633683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817175|NCT02633683|Anticonvulsants|anticonvulsants|mesh-ancestor
5817176|NCT02633683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5817177|NCT02633683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5644281|NCT02243709|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5644282|NCT02243709|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5644283|NCT02236806|Ramipril|ramipril|mesh-list
5644284|NCT02236806|Bisoprolol|bisoprolol|mesh-list
5644285|NCT02236806|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5644286|NCT02236806|Protease Inhibitors|protease inhibitors|mesh-ancestor
5644287|NCT02236806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5644288|NCT02236806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644289|NCT02236806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5644290|NCT02236806|Sympatholytics|sympatholytics|mesh-ancestor
5644291|NCT02236806|Autonomic Agents|autonomic agents|mesh-ancestor
5644292|NCT02236806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5644293|NCT02236806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644294|NCT02236806|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5644295|NCT02236806|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5644296|NCT02236806|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5644297|NCT02236806|Adrenergic Agents|adrenergic agents|mesh-ancestor
5644298|NCT02236806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5644299|NCT02236572|Everolimus|everolimus|mesh-list
5644300|NCT02236572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5644301|NCT02236572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5644302|NCT02236572|Immunologic Factors|immunologic factors|mesh-ancestor
5644303|NCT02236572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644304|NCT02220452|Anesthetics|anesthetics|mesh-list
5644305|NCT02220452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5644306|NCT02220452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644307|NCT02117817|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5644308|NCT02117817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5644309|NCT02099058|Nivolumab|nivolumab|mesh-list
5644310|NCT02099058|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5644311|NCT02099058|Osimertinib|osimertinib|mesh-list
5644312|NCT02099058|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5644313|NCT02099058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5644314|NCT02099058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5644315|NCT02099058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5644316|NCT02099058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644317|NCT02099058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5644318|NCT02099058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5644319|NCT02099058|Immunologic Factors|immunologic factors|mesh-ancestor
5644320|NCT02099058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644321|NCT02083354|Trametinib|trametinib|mesh-list
5644322|NCT02083354|Dabrafenib|dabrafenib|mesh-list
5644323|NCT02083354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5644324|NCT02083354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5644325|NCT02083354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5817178|NCT02633683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5817179|NCT02633683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5817180|NCT02633683|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5817181|NCT02633683|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5817182|NCT02633683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5817183|NCT02633683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817184|NCT02633683|Antimanic Agents|antimanic agents|mesh-ancestor
5644326|NCT02083354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644327|NCT02067819|Salicylic Acid|salicylic acid|mesh-list
5644328|NCT02067819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5644329|NCT02067819|Antifungal Agents|antifungal agents|mesh-ancestor
5817185|NCT02633813|Naftifine|naftifine|mesh-list
5817186|NCT02633813|Antifungal Agents|antifungal agents|mesh-ancestor
5817187|NCT02633813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5901311|NCT03608657|Apremilast|apremilast|mesh-list
5901312|NCT03608657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5901313|NCT03608657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5901314|NCT03608657|Analgesics|analgesics|mesh-ancestor
5901315|NCT03608657|Sensory System Agents|sensory system agents|mesh-ancestor
5901316|NCT03608657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5901317|NCT03608657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901318|NCT03608657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5901319|NCT03608657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5901320|NCT03608657|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5644330|NCT02067819|Keratolytic Agents|keratolytic agents|mesh-ancestor
5644331|NCT02067819|Dermatologic Agents|dermatologic agents|mesh-ancestor
5644332|NCT02065635|Propofol|propofol|mesh-list
5644333|NCT02065635|Sevoflurane|sevoflurane|mesh-list
5644334|NCT02065635|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6211437|NCT02172040|Vasodilator Agents|vasodilator agents|mesh-ancestor
5817188|NCT02633852|Aflibercept|aflibercept|mesh-list
5817189|NCT02633852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5817190|NCT02633852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5817191|NCT02633852|Growth Substances|growth substances|mesh-ancestor
5817192|NCT02633852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817193|NCT02633852|Growth Inhibitors|growth inhibitors|mesh-ancestor
5817194|NCT02633852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5817195|NCT02633774|Propafenone|propafenone|mesh-list
5817196|NCT02633774|Apixaban|apixaban|mesh-list
5817197|NCT02633774|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5817198|NCT02633774|Antithrombins|antithrombins|mesh-ancestor
5817199|NCT02633774|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5817200|NCT02633774|Protease Inhibitors|protease inhibitors|mesh-ancestor
5817201|NCT02633774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5817202|NCT02633774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817203|NCT02633774|Anticoagulants|anticoagulants|mesh-ancestor
5817204|NCT02633774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5817205|NCT02633774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5817206|NCT02633774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5817207|NCT02633774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5817208|NCT02633709|Itraconazole|itraconazole|mesh-list
5817209|NCT02633709|Risdiplam|risdiplam|mesh-list
5817210|NCT02633709|Antifungal Agents|antifungal agents|mesh-ancestor
5817211|NCT02633709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5817212|NCT02633709|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5817213|NCT02633709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5817214|NCT02633709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5817215|NCT02633709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817216|NCT02633709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5817217|NCT02633709|Hormone Antagonists|hormone antagonists|mesh-ancestor
5817218|NCT02633709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5817219|NCT02633709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817220|NCT02633709|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5817221|NCT02633709|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5817222|NCT02633709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5817223|NCT02633657|Gabapentin|gabapentin|mesh-list
5817224|NCT02633657|Analgesics|analgesics|mesh-ancestor
5817225|NCT02633657|Sensory System Agents|sensory system agents|mesh-ancestor
5817226|NCT02633657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5817227|NCT02633657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817228|NCT02633657|Anticonvulsants|anticonvulsants|mesh-ancestor
5817229|NCT02633657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5817230|NCT02633657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5817231|NCT02633657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5817232|NCT02633657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5817233|NCT02633657|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5817234|NCT02633657|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5817235|NCT02633657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5817236|NCT02633657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817237|NCT02633657|Antimanic Agents|antimanic agents|mesh-ancestor
5817238|NCT02633761|Misoprostol|misoprostol|mesh-list
5817239|NCT02633761|Mifepristone|mifepristone|mesh-list
5817240|NCT02633761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5817241|NCT02633761|Abortifacient Agents|abortifacient agents|mesh-ancestor
5817242|NCT02633761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5817243|NCT02633761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644335|NCT02065635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5644336|NCT02065635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644337|NCT02065635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5644338|NCT02065635|Anesthetics, General|anesthetics, general|mesh-ancestor
5644339|NCT02065635|Anesthetics|anesthetics|mesh-ancestor
5644340|NCT02065635|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5644341|NCT02065635|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5644342|NCT02061514|Propofol|propofol|mesh-list
5644343|NCT02061514|Desflurane|desflurane|mesh-list
5644344|NCT02061514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5644345|NCT02061514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5644346|NCT02061514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644347|NCT02061514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5644348|NCT02061514|Anesthetics, General|anesthetics, general|mesh-ancestor
5644349|NCT02061514|Anesthetics|anesthetics|mesh-ancestor
5644350|NCT02061514|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5644351|NCT01937468|Interleukin-2|interleukin-2|mesh-list
5644352|NCT01937468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5817244|NCT02633761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5817245|NCT02633761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5817246|NCT02633761|Oxytocics|oxytocics|mesh-ancestor
5817247|NCT02633761|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5817248|NCT02633761|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5817249|NCT02633761|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5817250|NCT02633761|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5817251|NCT02633761|Contraceptive Agents|contraceptive agents|mesh-ancestor
5817252|NCT02633761|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5817253|NCT02633761|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5817254|NCT02633761|Hormone Antagonists|hormone antagonists|mesh-ancestor
5817255|NCT02633761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5817256|NCT02633761|Luteolytic Agents|luteolytic agents|mesh-ancestor
5817257|NCT02633761|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5817258|NCT02633761|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5817259|NCT02633839|Carbidopa|carbidopa|mesh-list
5817260|NCT02633839|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5817261|NCT02633839|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5817262|NCT02633839|Dopamine Agents|dopamine agents|mesh-ancestor
5817263|NCT02633839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5817264|NCT02633839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817265|NCT02633839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817266|NCT02633839|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5817267|NCT02633839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5817268|NCT02633579|Erythromycin|erythromycin|mesh-list
5817269|NCT02633579|Erythromycin Estolate|erythromycin estolate|mesh-list
5817270|NCT02633579|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
5817271|NCT02633579|Erythromycin stearate|erythromycin stearate|mesh-list
5817272|NCT02633579|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
5817273|NCT02633579|Atropine|atropine|mesh-list
5817274|NCT02633579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5817275|NCT02633579|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5817276|NCT02633579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5817277|NCT02633579|Autonomic Agents|autonomic agents|mesh-ancestor
5817278|NCT02633579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5817279|NCT02633579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817280|NCT02633579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5817281|NCT02633579|Respiratory System Agents|respiratory system agents|mesh-ancestor
5817282|NCT02633579|Mydriatics|mydriatics|mesh-ancestor
5817283|NCT02633579|Parasympatholytics|parasympatholytics|mesh-ancestor
5817284|NCT02633579|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5817285|NCT02633579|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5817286|NCT02633579|Cholinergic Agents|cholinergic agents|mesh-ancestor
5817287|NCT02633579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5817288|NCT02633579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817289|NCT02633579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5817290|NCT02633579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5817291|NCT02633579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5817292|NCT02633579|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5817293|NCT02633579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5817294|NCT02633618|Neurotropin|neurotropin|mesh-list
5817295|NCT02633618|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5817296|NCT02633618|Immunologic Factors|immunologic factors|mesh-ancestor
5817297|NCT02633618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817298|NCT02633618|Analgesics|analgesics|mesh-ancestor
5817299|NCT02633618|Sensory System Agents|sensory system agents|mesh-ancestor
5817300|NCT02633618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5817301|NCT02633618|Anticonvulsants|anticonvulsants|mesh-ancestor
5817302|NCT02633384|Sorbitol|sorbitol|mesh-list
5817303|NCT02633384|SMOFlipid|smoflipid|mesh-list
5817304|NCT02633384|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
5817305|NCT02633384|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5817306|NCT02633384|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5817307|NCT02633384|Cathartics|cathartics|mesh-ancestor
5817308|NCT02633384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5817309|NCT02633462|Inositol|inositol|mesh-list
5817310|NCT02633462|Vitamin B Complex|vitamin b complex|mesh-ancestor
5817311|NCT02633462|Vitamins|vitamins|mesh-ancestor
5817312|NCT02633462|Micronutrients|micronutrients|mesh-ancestor
5817313|NCT02633462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817314|NCT02633202|Cisplatin|cisplatin|mesh-list
5817315|NCT02633202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5817316|NCT02633176|Docetaxel|docetaxel|mesh-list
5817317|NCT02633176|Capecitabine|capecitabine|mesh-list
5817318|NCT02633176|Cetuximab|cetuximab|mesh-list
5817319|NCT02633176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5817320|NCT02633176|Tubulin Modulators|tubulin modulators|mesh-ancestor
5817321|NCT02633176|Antimitotic Agents|antimitotic agents|mesh-ancestor
5817322|NCT02633176|Mitosis Modulators|mitosis modulators|mesh-ancestor
5817323|NCT02633176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817324|NCT02633176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5817325|NCT02633176|Antimetabolites|antimetabolites|mesh-ancestor
5817326|NCT02633176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5817327|NCT02633189|Bevacizumab|bevacizumab|mesh-list
5817328|NCT02633189|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5817329|NCT02633189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5817330|NCT02633189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5817331|NCT02633189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5817332|NCT02633189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5817333|NCT02633189|Growth Substances|growth substances|mesh-ancestor
5817334|NCT02633189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817335|NCT02633189|Growth Inhibitors|growth inhibitors|mesh-ancestor
5817336|NCT02633189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5817337|NCT02633189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5817338|NCT02633189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817339|NCT02632916|Zoledronic Acid|zoledronic acid|mesh-list
5644353|NCT01937468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5644354|NCT01937468|Analgesics|analgesics|mesh-ancestor
6492686|NCT00610077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6492687|NCT00610077|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5644355|NCT01937468|Sensory System Agents|sensory system agents|mesh-ancestor
5644356|NCT01937468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5644357|NCT01937468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644358|NCT01775813|Metformin|metformin|mesh-list
5644359|NCT01775813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5644360|NCT01775813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644361|NCT01694069|Tazobactam|tazobactam|mesh-list
5644362|NCT01694069|Piperacillin|piperacillin|mesh-list
5644363|NCT01694069|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
5644364|NCT01694069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5644365|NCT01694069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5644366|NCT01694069|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5644367|NCT01694069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5644368|NCT01694069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644369|NCT01446016|Paclitaxel|paclitaxel|mesh-list
5644370|NCT01446016|Docetaxel|docetaxel|mesh-list
5644371|NCT01446016|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5644372|NCT01446016|Taxane|taxane|mesh-list
5644373|NCT01446016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5644374|NCT01446016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5644375|NCT01446016|Tubulin Modulators|tubulin modulators|mesh-ancestor
5644376|NCT01446016|Antimitotic Agents|antimitotic agents|mesh-ancestor
5644377|NCT01446016|Mitosis Modulators|mitosis modulators|mesh-ancestor
5644378|NCT01446016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817340|NCT02632916|Denosumab|denosumab|mesh-list
5817341|NCT02632916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5817342|NCT02632916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817343|NCT02633514|Etoposide|etoposide|mesh-list
5817344|NCT02633514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5817345|NCT02633514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5817346|NCT02633514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5817347|NCT02633514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5817348|NCT02633514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5817349|NCT02633514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817350|NCT02633137|Cytarabine|cytarabine|mesh-list
5817351|NCT02633137|Lenalidomide|lenalidomide|mesh-list
5817352|NCT02633137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5817353|NCT02633137|Antimetabolites|antimetabolites|mesh-ancestor
5644379|NCT01434602|Everolimus|everolimus|mesh-list
5644380|NCT01434602|Sorafenib|sorafenib|mesh-list
5644381|NCT01434602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5644382|NCT01434602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5817354|NCT02633137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817355|NCT02633137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5817356|NCT02633137|Antiviral Agents|antiviral agents|mesh-ancestor
5817357|NCT02633137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5817358|NCT02633137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5817359|NCT02633137|Immunologic Factors|immunologic factors|mesh-ancestor
5817360|NCT02633137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644383|NCT01434602|Immunologic Factors|immunologic factors|mesh-ancestor
5644384|NCT01434602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492688|NCT00610077|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6492689|NCT00610103|Apomorphine|apomorphine|mesh-list
6492690|NCT00610103|Emetics|emetics|mesh-ancestor
6492691|NCT00610103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492692|NCT00610103|Autonomic Agents|autonomic agents|mesh-ancestor
6492693|NCT00610103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5644385|NCT01434602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5644386|NCT01434602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5644387|NCT01434602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644388|NCT01399918|Bevacizumab|bevacizumab|mesh-list
5644389|NCT01399918|Everolimus|everolimus|mesh-list
5644390|NCT01399918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5644391|NCT01399918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5644392|NCT01399918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5644393|NCT01399918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5644394|NCT01399918|Growth Substances|growth substances|mesh-ancestor
5644395|NCT01399918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644396|NCT01399918|Growth Inhibitors|growth inhibitors|mesh-ancestor
5644397|NCT01399918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5644398|NCT01399918|Immunologic Factors|immunologic factors|mesh-ancestor
5644399|NCT01078454|Dexamethasone|dexamethasone|mesh-list
5644400|NCT01078454|Bortezomib|bortezomib|mesh-list
5644401|NCT01078454|Melphalan|melphalan|mesh-list
5644402|NCT01078454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5644403|NCT01078454|Antiemetics|antiemetics|mesh-ancestor
5644404|NCT01078454|Autonomic Agents|autonomic agents|mesh-ancestor
5644405|NCT01078454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5644406|NCT01078454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644407|NCT01078454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5644408|NCT01078454|Glucocorticoids|glucocorticoids|mesh-ancestor
5644409|NCT01078454|Hormones|hormones|mesh-ancestor
5644410|NCT01078454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5644411|NCT01078454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5644412|NCT01078454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5644413|NCT01078454|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5644414|NCT01078454|Alkylating Agents|alkylating agents|mesh-ancestor
5644415|NCT01078454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644416|NCT01078454|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5644417|NCT01078454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5644418|NCT01078454|Immunologic Factors|immunologic factors|mesh-ancestor
5644419|NCT00472654|Vitamin D|vitamin d|mesh-list
5644420|NCT00472654|Vitamins|vitamins|mesh-ancestor
5644421|NCT00472654|Micronutrients|micronutrients|mesh-ancestor
5644422|NCT00472654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644423|NCT00472654|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5644424|NCT00458536|Molgramostim|molgramostim|mesh-list
5644425|NCT00458536|Sargramostim|sargramostim|mesh-list
5644426|NCT00458536|Immunologic Factors|immunologic factors|mesh-ancestor
5644427|NCT00458536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644428|NCT00458536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5644429|NCT00112840|Bevacizumab|bevacizumab|mesh-list
5644430|NCT00112840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5644431|NCT00112840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5644432|NCT00112840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5644433|NCT00112840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5644434|NCT00112840|Growth Substances|growth substances|mesh-ancestor
6492694|NCT00610103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6492695|NCT00610103|Dopamine Agonists|dopamine agonists|mesh-ancestor
6492696|NCT00610103|Dopamine Agents|dopamine agents|mesh-ancestor
6492697|NCT00610103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6492698|NCT00610103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492699|NCT00610142|Hydrocortisone|hydrocortisone|mesh-list
6492700|NCT00610142|Pimecrolimus|pimecrolimus|mesh-list
6492701|NCT00610142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6492702|NCT00610142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5644435|NCT00112840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644436|NCT00112840|Growth Inhibitors|growth inhibitors|mesh-ancestor
5644437|NCT05223335|Clopidogrel|clopidogrel|mesh-list
5644438|NCT05223335|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
5644439|NCT05223335|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5644440|NCT05223335|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5644441|NCT05223335|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5644442|NCT05223335|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5644443|NCT05223335|Purinergic Agents|purinergic agents|mesh-ancestor
6492703|NCT00610142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5644444|NCT05223335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5644445|NCT05223335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644446|NCT05223335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492704|NCT00610142|Analgesics|analgesics|mesh-ancestor
6492705|NCT00610142|Sensory System Agents|sensory system agents|mesh-ancestor
6492706|NCT00610142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6492707|NCT00610142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817361|NCT02633137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5817362|NCT02633137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5817363|NCT02633137|Growth Substances|growth substances|mesh-ancestor
5644447|NCT05223244|Triamcinolone|triamcinolone|mesh-list
5644448|NCT05223244|Heparin|heparin|mesh-list
5644449|NCT05223244|Bupivacaine|bupivacaine|mesh-list
5644450|NCT05223244|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
5644451|NCT05223244|Anesthetics, Local|anesthetics, local|mesh-ancestor
5644452|NCT05223244|Anesthetics|anesthetics|mesh-ancestor
5644453|NCT05223244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5644454|NCT05223244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644455|NCT05223244|Sensory System Agents|sensory system agents|mesh-ancestor
5644456|NCT05223244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5644457|NCT05223244|Anticoagulants|anticoagulants|mesh-ancestor
5644458|NCT05223244|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5644459|NCT05223244|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5817364|NCT02633137|Growth Inhibitors|growth inhibitors|mesh-ancestor
5817365|NCT02633059|Dexamethasone|dexamethasone|mesh-list
5817366|NCT02633059|Dexamethasone acetate|dexamethasone acetate|mesh-list
5817367|NCT02633059|Ixazomib|ixazomib|mesh-list
5817368|NCT02633059|Ichthammol|ichthammol|mesh-list
5817369|NCT02633059|BB 1101|bb 1101|mesh-list
5817370|NCT02633059|Glycine|glycine|mesh-list
5644460|NCT05223244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644461|NCT05223244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5817371|NCT02633059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5817372|NCT02633059|Antiemetics|antiemetics|mesh-ancestor
5817373|NCT02633059|Autonomic Agents|autonomic agents|mesh-ancestor
5817374|NCT02633059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5817375|NCT02633059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817376|NCT02633059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5817377|NCT02633059|Glucocorticoids|glucocorticoids|mesh-ancestor
5817378|NCT02633059|Hormones|hormones|mesh-ancestor
5817379|NCT02633059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5817380|NCT02633059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5817381|NCT02633059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5817382|NCT02633059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817383|NCT02633059|Protease Inhibitors|protease inhibitors|mesh-ancestor
5817384|NCT02633059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5817385|NCT02633059|Dermatologic Agents|dermatologic agents|mesh-ancestor
5817386|NCT02633059|Glycine Agents|glycine agents|mesh-ancestor
5817387|NCT02633059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5817388|NCT02633007|Levodopa|levodopa|mesh-list
5817389|NCT02633007|Carbidopa|carbidopa|mesh-list
5817390|NCT02633007|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5817391|NCT02633007|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5817392|NCT02633007|Dopamine Agents|dopamine agents|mesh-ancestor
5817393|NCT02633007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5817394|NCT02633007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817395|NCT02633007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817396|NCT02633007|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5817397|NCT02633007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5817398|NCT02632903|Zoledronic Acid|zoledronic acid|mesh-list
5817399|NCT02632903|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6492708|NCT00610142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5644462|NCT05223244|Glucocorticoids|glucocorticoids|mesh-ancestor
5644463|NCT05223244|Hormones|hormones|mesh-ancestor
5644464|NCT05223244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5644465|NCT05223244|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
5644466|NCT05223244|Protective Agents|protective agents|mesh-ancestor
5644467|NCT05223244|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5644468|NCT05223244|Antioxidants|antioxidants|mesh-ancestor
5644469|NCT05223231|Antibodies|antibodies|mesh-list
5644470|NCT05223231|Immunoglobulins|immunoglobulins|mesh-list
5644471|NCT05223231|Immunologic Factors|immunologic factors|mesh-ancestor
5644472|NCT05223231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644473|NCT05223101|Telmisartan|telmisartan|mesh-list
5644474|NCT05223101|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5644475|NCT05223101|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5817400|NCT02632903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817401|NCT02632877|Pirfenidone|pirfenidone|mesh-list
5817402|NCT02632877|Ketanserin|ketanserin|mesh-list
5817403|NCT02632877|Analgesics|analgesics|mesh-ancestor
5644476|NCT05223101|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6211438|NCT02172040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6211439|NCT02172040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6211440|NCT02172040|Analgesics|analgesics|mesh-ancestor
6211441|NCT02172040|Sensory System Agents|sensory system agents|mesh-ancestor
6211442|NCT02172040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6211443|NCT02172040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6211444|NCT02172040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6211445|NCT02172040|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6211446|NCT02172040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6211447|NCT02172040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6211448|NCT02172742|Digoxin|digoxin|mesh-list
5817404|NCT02632877|Sensory System Agents|sensory system agents|mesh-ancestor
5817405|NCT02632877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5817406|NCT02632877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817407|NCT02632877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5817408|NCT02632877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5817409|NCT02632877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5817410|NCT02632877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5817411|NCT02632877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5817412|NCT02632877|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5817413|NCT02632877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5817414|NCT02632877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5817415|NCT02632877|Serotonin Agents|serotonin agents|mesh-ancestor
5817416|NCT02632877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5817417|NCT02632877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817418|NCT02632708|Cytarabine|cytarabine|mesh-list
5817419|NCT02632708|Etoposide|etoposide|mesh-list
5817420|NCT02632708|Daunorubicin|daunorubicin|mesh-list
5817421|NCT02632708|Mitoxantrone|mitoxantrone|mesh-list
5817422|NCT02632708|Idarubicin|idarubicin|mesh-list
5817423|NCT02632708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5817424|NCT02632708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6211449|NCT02172742|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
6211450|NCT02172742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6211451|NCT02172742|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6211452|NCT02172742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5817425|NCT02632708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5817426|NCT02632708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5817427|NCT02632708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5817428|NCT02632708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817429|NCT02632708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5817430|NCT02632708|Antimetabolites|antimetabolites|mesh-ancestor
5817431|NCT02632708|Antiviral Agents|antiviral agents|mesh-ancestor
5817432|NCT02632708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5817433|NCT02632708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5817434|NCT02632708|Immunologic Factors|immunologic factors|mesh-ancestor
6211453|NCT02172742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211454|NCT02172742|Protective Agents|protective agents|mesh-ancestor
6211455|NCT02172742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211456|NCT02172742|Anticonvulsants|anticonvulsants|mesh-ancestor
6211457|NCT02172742|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6211458|NCT02172742|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5644477|NCT05223101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644478|NCT05223088|Oxaliplatin|oxaliplatin|mesh-list
5644479|NCT05223088|Apatinib|apatinib|mesh-list
5644480|NCT05223088|Tegafur|tegafur|mesh-list
5644481|NCT05223088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5644482|NCT05223088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5644483|NCT05223088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5644484|NCT05223088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644485|NCT05223088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5644486|NCT05223088|Antimetabolites|antimetabolites|mesh-ancestor
5694110|NCT03397446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5694111|NCT03397446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5694112|NCT03397446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694113|NCT03397446|Dopamine Agents|dopamine agents|mesh-ancestor
5694114|NCT03397446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5694115|NCT03397264|Aflibercept|aflibercept|mesh-list
5694116|NCT03397264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5694117|NCT03397264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5694118|NCT03397264|Growth Substances|growth substances|mesh-ancestor
5817435|NCT02632708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817436|NCT02632708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5817437|NCT02632708|Analgesics|analgesics|mesh-ancestor
5817438|NCT02632708|Sensory System Agents|sensory system agents|mesh-ancestor
5817439|NCT02632708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5817440|NCT02632760|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
5817441|NCT02632760|Hematinics|hematinics|mesh-ancestor
5644487|NCT05223075|Lidocaine|lidocaine|mesh-list
5644488|NCT05223075|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
5644489|NCT05223075|Carticaine|carticaine|mesh-list
5644490|NCT05223075|Anesthetics, Local|anesthetics, local|mesh-ancestor
5644491|NCT05223075|Anesthetics|anesthetics|mesh-ancestor
5644492|NCT05223075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5644493|NCT05223075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644494|NCT05223075|Sensory System Agents|sensory system agents|mesh-ancestor
5644495|NCT05223075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5644496|NCT05223075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5644497|NCT05223075|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5644498|NCT05223075|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5644499|NCT05223075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5644500|NCT05223075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644501|NCT05223010|Sevoflurane|sevoflurane|mesh-list
5817442|NCT02632565|Lidocaine|lidocaine|mesh-list
5817443|NCT02632565|Anesthetics, Local|anesthetics, local|mesh-ancestor
5817444|NCT02632565|Anesthetics|anesthetics|mesh-ancestor
5817445|NCT02632565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5817446|NCT02632565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817447|NCT02632565|Sensory System Agents|sensory system agents|mesh-ancestor
5817448|NCT02632565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5817449|NCT02632565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5817450|NCT02632565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5817451|NCT02632565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5817452|NCT02632565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5817453|NCT02632565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817454|NCT02632578|Vaccines|vaccines|mesh-list
5817455|NCT02632578|Immunologic Factors|immunologic factors|mesh-ancestor
5817456|NCT02632578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817457|NCT02632474|Tenofovir|tenofovir|mesh-list
5817458|NCT02632474|Lamivudine|lamivudine|mesh-list
5817459|NCT02632474|Efavirenz|efavirenz|mesh-list
5817460|NCT02632474|Antiviral Agents|antiviral agents|mesh-ancestor
5817461|NCT02632474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5817462|NCT02632474|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5817463|NCT02632474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5817464|NCT02632474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5817465|NCT02632474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817466|NCT02632474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5817467|NCT02632474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5817468|NCT02632474|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5644502|NCT05223010|Melatonin|melatonin|mesh-list
5644503|NCT05223010|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5644504|NCT05223010|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5644505|NCT05223010|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5644506|NCT05223010|Anesthetics, General|anesthetics, general|mesh-ancestor
5644507|NCT05223010|Anesthetics|anesthetics|mesh-ancestor
5644508|NCT05223010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5644509|NCT05223010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644510|NCT05223010|Antioxidants|antioxidants|mesh-ancestor
5644511|NCT05223010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644512|NCT05223010|Protective Agents|protective agents|mesh-ancestor
6492709|NCT00610142|Dermatologic Agents|dermatologic agents|mesh-ancestor
5817469|NCT02632474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5817470|NCT02632474|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5817471|NCT02632474|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5817472|NCT02632474|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5817473|NCT02632474|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5817474|NCT02632448|Gemcitabine|gemcitabine|mesh-list
5817475|NCT02632448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5817476|NCT02632448|Antimetabolites|antimetabolites|mesh-ancestor
5817477|NCT02632448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817478|NCT02632448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5817479|NCT02632448|Antiviral Agents|antiviral agents|mesh-ancestor
5817480|NCT02632448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5817481|NCT02632448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6211459|NCT02172742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6211460|NCT02172755|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
6211461|NCT02172755|Anticonvulsants|anticonvulsants|mesh-ancestor
6211462|NCT02172755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5817482|NCT02632448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5817483|NCT02632448|Immunologic Factors|immunologic factors|mesh-ancestor
5817484|NCT02632448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817485|NCT02632331|Gabapentin|gabapentin|mesh-list
5817486|NCT02632331|Analgesics|analgesics|mesh-ancestor
5817487|NCT02632331|Sensory System Agents|sensory system agents|mesh-ancestor
5817488|NCT02632331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5817489|NCT02632331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211463|NCT02172755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6211464|NCT02172755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5817490|NCT02632331|Anticonvulsants|anticonvulsants|mesh-ancestor
5817491|NCT02632331|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5817492|NCT02632331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5817493|NCT02632331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5817494|NCT02632331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5817495|NCT02632331|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5817496|NCT02632331|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5817497|NCT02632331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5817498|NCT02632331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817499|NCT02632331|Antimanic Agents|antimanic agents|mesh-ancestor
5817500|NCT02632019|Gemcitabine|gemcitabine|mesh-list
5817501|NCT02632019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5817502|NCT02632019|Antimetabolites|antimetabolites|mesh-ancestor
5817503|NCT02632019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817504|NCT02632019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5644521|NCT05222971|Durvalumab|durvalumab|mesh-list
5644522|NCT05222971|Olaparib|olaparib|mesh-list
5644523|NCT05222971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5644524|NCT05222971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5644525|NCT05222971|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5644526|NCT05222971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5644527|NCT05222971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644528|NCT05222932|Avelumab|avelumab|mesh-list
5644529|NCT05222932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5644530|NCT05222932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5644531|NCT05222828|Mepivacaine|mepivacaine|mesh-list
5644532|NCT05222828|Anesthetics, Local|anesthetics, local|mesh-ancestor
5817505|NCT02632019|Antiviral Agents|antiviral agents|mesh-ancestor
5817506|NCT02632019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5817507|NCT02632019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5817508|NCT02632019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5817509|NCT02632019|Immunologic Factors|immunologic factors|mesh-ancestor
5817510|NCT02632019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817511|NCT02632279|Tryptophan|tryptophan|mesh-list
5817512|NCT02632279|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5817513|NCT02632279|Antidepressive Agents|antidepressive agents|mesh-ancestor
5817514|NCT02632279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5817515|NCT02632305|Gemcitabine|gemcitabine|mesh-list
5817516|NCT02632305|Paclitaxel|paclitaxel|mesh-list
5817517|NCT02632305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5817518|NCT02632305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5817519|NCT02632305|Tubulin Modulators|tubulin modulators|mesh-ancestor
5817520|NCT02632305|Antimitotic Agents|antimitotic agents|mesh-ancestor
5817521|NCT02632305|Mitosis Modulators|mitosis modulators|mesh-ancestor
5817522|NCT02632305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817523|NCT02632305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5817524|NCT02632305|Antimetabolites|antimetabolites|mesh-ancestor
5817525|NCT02632305|Antiviral Agents|antiviral agents|mesh-ancestor
5817526|NCT02632305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5817527|NCT02632305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5817528|NCT02632305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5817529|NCT02632305|Immunologic Factors|immunologic factors|mesh-ancestor
5817530|NCT02632305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817531|NCT02632032|Insulin|insulin|mesh-list
5644533|NCT05222828|Anesthetics|anesthetics|mesh-ancestor
5644534|NCT05222828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5644535|NCT05222828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644536|NCT05222828|Sensory System Agents|sensory system agents|mesh-ancestor
5817532|NCT02632032|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5817533|NCT02632032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5908303|NCT04701593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5817534|NCT02632032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817535|NCT02631993|Furocoumarins|furocoumarins|mesh-list
5817536|NCT02631993|Dermatologic Agents|dermatologic agents|mesh-ancestor
5817537|NCT02631993|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5817538|NCT02632136|Bupivacaine|bupivacaine|mesh-list
5817539|NCT02632136|Anesthetics, Local|anesthetics, local|mesh-ancestor
5817540|NCT02632136|Anesthetics|anesthetics|mesh-ancestor
5817541|NCT02632136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5817542|NCT02632136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817543|NCT02632136|Sensory System Agents|sensory system agents|mesh-ancestor
5817544|NCT02632136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5901321|NCT03608657|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5901322|NCT03608657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5901323|NCT03608657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901324|NCT03595592|Paclitaxel|paclitaxel|mesh-list
5901325|NCT03595592|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5901326|NCT03595592|Cyclophosphamide|cyclophosphamide|mesh-list
5901327|NCT03595592|Carboplatin|carboplatin|mesh-list
5901328|NCT03595592|Doxorubicin|doxorubicin|mesh-list
5901329|NCT03595592|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5901330|NCT03595592|Trastuzumab|trastuzumab|mesh-list
5901331|NCT03595592|Atezolizumab|atezolizumab|mesh-list
5901332|NCT03595592|Pertuzumab|pertuzumab|mesh-list
5644537|NCT05222828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5644538|NCT05222750|Vaccines|vaccines|mesh-list
5644539|NCT05222750|Immunologic Factors|immunologic factors|mesh-ancestor
5644540|NCT05222750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644541|NCT05222724|Ibuprofen|ibuprofen|mesh-list
5644542|NCT05222724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5644543|NCT05222724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5644544|NCT05222724|Analgesics|analgesics|mesh-ancestor
5644545|NCT05222724|Sensory System Agents|sensory system agents|mesh-ancestor
5644546|NCT05222724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5644547|NCT05222724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644548|NCT05222724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5644549|NCT05222724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5644550|NCT05222724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5644551|NCT05222724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5644552|NCT05222724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644553|NCT05222646|Metoclopramide|metoclopramide|mesh-list
5644554|NCT05222646|Antiemetics|antiemetics|mesh-ancestor
5644555|NCT05222646|Autonomic Agents|autonomic agents|mesh-ancestor
5644556|NCT05222646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5644557|NCT05222646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644558|NCT05222646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5901333|NCT03595592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5901334|NCT03595592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901335|NCT03595592|Tubulin Modulators|tubulin modulators|mesh-ancestor
5901336|NCT03595592|Antimitotic Agents|antimitotic agents|mesh-ancestor
5901337|NCT03595592|Mitosis Modulators|mitosis modulators|mesh-ancestor
5901338|NCT03595592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901339|NCT03595592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5901340|NCT03595592|Immunologic Factors|immunologic factors|mesh-ancestor
5901341|NCT03595592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901342|NCT03595592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5901343|NCT03595592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5901344|NCT03595592|Alkylating Agents|alkylating agents|mesh-ancestor
5901345|NCT03595592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5901346|NCT03595592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5901347|NCT03595592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5901348|NCT03595592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5901349|NCT03595592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5901350|NCT03595592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5901351|NCT03577431|Cyclophosphamide|cyclophosphamide|mesh-list
5901352|NCT03577431|Everolimus|everolimus|mesh-list
5901353|NCT03577431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5901354|NCT03577431|Immunologic Factors|immunologic factors|mesh-ancestor
5644559|NCT05222646|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5644560|NCT05222646|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5644561|NCT05222646|Dopamine Agents|dopamine agents|mesh-ancestor
5644562|NCT05222646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5644563|NCT05222646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644564|NCT05222633|Ranibizumab|ranibizumab|mesh-list
5901355|NCT03577431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901356|NCT03577431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5644565|NCT05222633|Aflibercept|aflibercept|mesh-list
5817545|NCT02632071|Paclitaxel|paclitaxel|mesh-list
5817546|NCT02632071|Ricolinostat|ricolinostat|mesh-list
5817547|NCT02632071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5817548|NCT02632071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5817549|NCT02632071|Tubulin Modulators|tubulin modulators|mesh-ancestor
5644566|NCT05222633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5644567|NCT05222633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5644568|NCT05222633|Growth Substances|growth substances|mesh-ancestor
5644569|NCT05222633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644570|NCT05222633|Growth Inhibitors|growth inhibitors|mesh-ancestor
5644571|NCT05222633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5644572|NCT05222607|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
5644573|NCT05222607|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5644574|NCT05222607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5644575|NCT05222607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644576|NCT05222607|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5644577|NCT05222607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5644578|NCT05222607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644579|NCT05222607|Cholinergic Agents|cholinergic agents|mesh-ancestor
5817550|NCT02632071|Antimitotic Agents|antimitotic agents|mesh-ancestor
5817551|NCT02632071|Mitosis Modulators|mitosis modulators|mesh-ancestor
5817552|NCT02632071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817553|NCT02632071|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5817554|NCT02632071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5817555|NCT02631928|Insulin|insulin|mesh-list
5817556|NCT02631928|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5817557|NCT02631928|Biphasic Insulins|biphasic insulins|mesh-list
5817558|NCT02631928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5817559|NCT02631928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644580|NCT05222607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5644581|NCT05222438|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
5644582|NCT05222438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5644583|NCT05222438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5644584|NCT05222334|Bupivacaine|bupivacaine|mesh-list
5644585|NCT05222334|Anesthetics, Local|anesthetics, local|mesh-ancestor
5644586|NCT05222334|Anesthetics|anesthetics|mesh-ancestor
5817560|NCT02631759|Levetiracetam|levetiracetam|mesh-list
5817561|NCT02631759|Anticonvulsants|anticonvulsants|mesh-ancestor
5817562|NCT02631759|Nootropic Agents|nootropic agents|mesh-ancestor
6211465|NCT02172755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211466|NCT02173054|Adapalene|adapalene|mesh-list
6211467|NCT02173054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6211468|NCT02173054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6211469|NCT02173054|Analgesics|analgesics|mesh-ancestor
6211470|NCT02173054|Sensory System Agents|sensory system agents|mesh-ancestor
6211471|NCT02173054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6211472|NCT02173054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211473|NCT02173054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6211474|NCT02173054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5817563|NCT02631694|Propranolol|propranolol|mesh-list
5817564|NCT02631694|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5817565|NCT02631694|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5817566|NCT02631694|Adrenergic Agents|adrenergic agents|mesh-ancestor
5817567|NCT02631694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5817568|NCT02631694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817569|NCT02631694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817570|NCT02631694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5817571|NCT02631694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5817572|NCT02631694|Vasodilator Agents|vasodilator agents|mesh-ancestor
5817573|NCT02631616|Somatostatin|somatostatin|mesh-list
5817574|NCT02631616|Hormones|hormones|mesh-ancestor
5817575|NCT02631616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5817576|NCT02631616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817577|NCT02631668|Ascorbic Acid|ascorbic acid|mesh-list
5817578|NCT02631668|Ferrous succinate|ferrous succinate|mesh-list
5817579|NCT02631668|Vitamins|vitamins|mesh-ancestor
5817580|NCT02631668|Micronutrients|micronutrients|mesh-ancestor
5817581|NCT02631668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817582|NCT02631668|Antioxidants|antioxidants|mesh-ancestor
5817583|NCT02631668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817584|NCT02631668|Protective Agents|protective agents|mesh-ancestor
5817585|NCT02631668|Hematinics|hematinics|mesh-ancestor
6211475|NCT02173054|Dermatologic Agents|dermatologic agents|mesh-ancestor
6211476|NCT02173392|Brodalumab|brodalumab|mesh-list
6492710|NCT00610142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5817586|NCT02631603|Prednisolone|prednisolone|mesh-list
5817587|NCT02631603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5817588|NCT02631603|Glucocorticoids|glucocorticoids|mesh-ancestor
5817589|NCT02631603|Hormones|hormones|mesh-ancestor
5817590|NCT02631603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5817591|NCT02631603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817592|NCT02631603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5817593|NCT02631603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5817594|NCT02631499|Epirubicin|epirubicin|mesh-list
5817595|NCT02631499|Ethiodized Oil|ethiodized oil|mesh-list
5817596|NCT02631499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5817597|NCT02631499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5817598|NCT02631499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5817599|NCT02631499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5817600|NCT02631499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5817601|NCT02631499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817602|NCT02631473|Ritonavir|ritonavir|mesh-list
5817603|NCT02631473|Lopinavir|lopinavir|mesh-list
5817604|NCT02631473|Efavirenz|efavirenz|mesh-list
5817605|NCT02631473|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5817606|NCT02631473|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5817607|NCT02631473|Protease Inhibitors|protease inhibitors|mesh-ancestor
5817608|NCT02631473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5817609|NCT02631473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817610|NCT02631473|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5817611|NCT02631473|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5817612|NCT02631473|Antiviral Agents|antiviral agents|mesh-ancestor
5817613|NCT02631473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5817614|NCT02631473|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5817615|NCT02631473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5817616|NCT02631473|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5817617|NCT02631473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5817618|NCT02631473|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5817619|NCT02631473|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5817620|NCT02631473|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5817621|NCT02631473|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5817622|NCT02631473|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5817623|NCT02631252|Hydroxychloroquine|hydroxychloroquine|mesh-list
5817624|NCT02631252|Etoposide|etoposide|mesh-list
5817625|NCT02631252|Mitoxantrone|mitoxantrone|mesh-list
5817626|NCT02631252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5817627|NCT02631252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5817628|NCT02631252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5817629|NCT02631252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5817630|NCT02631252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5817631|NCT02631252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817632|NCT02631252|Antimalarials|antimalarials|mesh-ancestor
5817633|NCT02631252|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5817634|NCT02631252|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5817635|NCT02631252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6211477|NCT02173392|Dermatologic Agents|dermatologic agents|mesh-ancestor
6211478|NCT02173548|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6211479|NCT02173548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6211480|NCT02173769|Tiotropium Bromide|tiotropium bromide|mesh-list
6211481|NCT02173769|Olodaterol|olodaterol|mesh-list
6211482|NCT02173769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6211483|NCT02173769|Autonomic Agents|autonomic agents|mesh-ancestor
6211484|NCT02173769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6211485|NCT02173769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644587|NCT05222334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5644588|NCT05222334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644589|NCT05222334|Sensory System Agents|sensory system agents|mesh-ancestor
5644590|NCT05222334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5644591|NCT05222243|Calcium|calcium|mesh-list
5644592|NCT05222243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5644593|NCT05222243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644594|NCT05222204|Gemcitabine|gemcitabine|mesh-list
5644595|NCT05222204|Paclitaxel|paclitaxel|mesh-list
5644596|NCT05222204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5817636|NCT02631252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5817637|NCT02631252|Analgesics|analgesics|mesh-ancestor
5817638|NCT02631252|Sensory System Agents|sensory system agents|mesh-ancestor
5817639|NCT02631252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5817640|NCT02631252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817641|NCT02631460|Carboplatin|carboplatin|mesh-list
5817642|NCT02631460|Pemetrexed|pemetrexed|mesh-list
5817643|NCT02631460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5817644|NCT02631460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5817645|NCT02631460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817646|NCT02631460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5817647|NCT02631460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5817648|NCT02631408|Vancomycin|vancomycin|mesh-list
5817649|NCT02631408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5817650|NCT02631408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5817651|NCT02631239|Dexamethasone|dexamethasone|mesh-list
5817652|NCT02631239|Methotrexate|methotrexate|mesh-list
5817653|NCT02631239|Etoposide|etoposide|mesh-list
5817654|NCT02631239|Pegaspargase|pegaspargase|mesh-list
5817655|NCT02631239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5817656|NCT02631239|Antiemetics|antiemetics|mesh-ancestor
5817657|NCT02631239|Autonomic Agents|autonomic agents|mesh-ancestor
5817658|NCT02631239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5644597|NCT05222204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5644598|NCT05222204|Tubulin Modulators|tubulin modulators|mesh-ancestor
5644599|NCT05222204|Antimitotic Agents|antimitotic agents|mesh-ancestor
5644600|NCT05222204|Mitosis Modulators|mitosis modulators|mesh-ancestor
5644601|NCT05222204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644602|NCT05222204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5644603|NCT05222204|Antimetabolites|antimetabolites|mesh-ancestor
5644604|NCT05222204|Antiviral Agents|antiviral agents|mesh-ancestor
5644605|NCT05222204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5644606|NCT05222204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5817659|NCT02631239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817660|NCT02631239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5817661|NCT02631239|Glucocorticoids|glucocorticoids|mesh-ancestor
5817662|NCT02631239|Hormones|hormones|mesh-ancestor
5817663|NCT02631239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5817664|NCT02631239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5817665|NCT02631239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5817666|NCT02631239|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5817667|NCT02631239|Abortifacient Agents|abortifacient agents|mesh-ancestor
5817668|NCT02631239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5817669|NCT02631239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5817670|NCT02631239|Antimetabolites|antimetabolites|mesh-ancestor
5817671|NCT02631239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817672|NCT02631239|Dermatologic Agents|dermatologic agents|mesh-ancestor
5817673|NCT02631239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5817674|NCT02631239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5817675|NCT02631239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5817676|NCT02631239|Immunologic Factors|immunologic factors|mesh-ancestor
5817677|NCT02631239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5817678|NCT02631239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5817679|NCT02631239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5817680|NCT02631239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5817681|NCT02631239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5817682|NCT02631135|Dexmedetomidine|dexmedetomidine|mesh-list
5817683|NCT02631135|Remifentanil|remifentanil|mesh-list
5817684|NCT02631135|Propofol|propofol|mesh-list
5817685|NCT02631135|Rocuronium|rocuronium|mesh-list
5817686|NCT02631135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5817687|NCT02631135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5817688|NCT02631135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817689|NCT02631135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5817690|NCT02631135|Anesthetics, General|anesthetics, general|mesh-ancestor
5817691|NCT02631135|Anesthetics|anesthetics|mesh-ancestor
5817692|NCT02631135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5817693|NCT02631135|Analgesics|analgesics|mesh-ancestor
5817694|NCT02631135|Sensory System Agents|sensory system agents|mesh-ancestor
5817695|NCT02631135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5817696|NCT02631135|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5817697|NCT02631135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5817698|NCT02631135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5817699|NCT02631135|Adrenergic Agents|adrenergic agents|mesh-ancestor
5817700|NCT02631135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5817701|NCT02631135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817702|NCT02631135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5817703|NCT02631135|Narcotics|narcotics|mesh-ancestor
5817704|NCT02631135|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5817705|NCT02631135|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5644607|NCT05222204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5644608|NCT05222204|Immunologic Factors|immunologic factors|mesh-ancestor
5817706|NCT02631135|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5817707|NCT02631031|Valsartan|valsartan|mesh-list
5817708|NCT02631031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5817709|NCT02631031|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5817710|NCT02631031|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5817711|NCT02631031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817712|NCT02630862|Aspirin|aspirin|mesh-list
5817713|NCT02630862|Dipyridamole|dipyridamole|mesh-list
5817714|NCT02630862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5817715|NCT02630862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5644609|NCT05222204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644610|NCT05222191|Chlorthalidone|chlorthalidone|mesh-list
5644611|NCT05222191|Spironolactone|spironolactone|mesh-list
5644612|NCT05222191|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5644613|NCT05222191|Hormone Antagonists|hormone antagonists|mesh-ancestor
5644614|NCT05222191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5644615|NCT05222191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644616|NCT05222191|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5644617|NCT05222191|Diuretics|diuretics|mesh-ancestor
5644618|NCT05222191|Natriuretic Agents|natriuretic agents|mesh-ancestor
5644619|NCT05222191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5644620|NCT05222191|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5644621|NCT05222191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5817716|NCT02630862|Analgesics|analgesics|mesh-ancestor
5817717|NCT02630862|Sensory System Agents|sensory system agents|mesh-ancestor
5817718|NCT02630862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5817719|NCT02630862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817720|NCT02630862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5817721|NCT02630862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5644622|NCT05222191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644623|NCT05222165|Infigratinib|infigratinib|mesh-list
5644624|NCT05222165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5644625|NCT05222152|Hydrocortisone|hydrocortisone|mesh-list
5644626|NCT05222152|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
5644627|NCT05222152|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
5644628|NCT05222152|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
5644629|NCT05222152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5644633|NCT05222113|Remdesivir|remdesivir|mesh-list
5644634|NCT05222113|Favipiravir|favipiravir|mesh-list
5644635|NCT05222113|Antimetabolites|antimetabolites|mesh-ancestor
5644636|NCT05222113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644637|NCT05222113|Antiviral Agents|antiviral agents|mesh-ancestor
5644638|NCT05222113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5644639|NCT05221892|Thiamine|thiamine|mesh-list
5644640|NCT05221892|Pyridoxine|pyridoxine|mesh-list
5644641|NCT05221892|Vitamin B 12|vitamin b 12|mesh-list
5644642|NCT05221892|Hydroxocobalamin|hydroxocobalamin|mesh-list
5644643|NCT05221892|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
5644644|NCT05221892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817722|NCT02630862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5817723|NCT02630862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5817724|NCT02630862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817725|NCT02630862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5817726|NCT02630862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5817727|NCT02630862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5817728|NCT02630862|Antipyretics|antipyretics|mesh-ancestor
5817729|NCT02630862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5817730|NCT02630862|Vasodilator Agents|vasodilator agents|mesh-ancestor
5817731|NCT02631174|Antithrombins|antithrombins|mesh-list
5817732|NCT02631174|Antithrombin III|antithrombin iii|mesh-list
5817733|NCT02631174|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5817734|NCT02631174|Protease Inhibitors|protease inhibitors|mesh-ancestor
5817735|NCT02631174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5817736|NCT02631174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817737|NCT02631174|Anticoagulants|anticoagulants|mesh-ancestor
5817738|NCT02630888|Memantine|memantine|mesh-list
5817739|NCT02630888|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5817740|NCT02630888|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5817741|NCT02630888|Dopamine Agents|dopamine agents|mesh-ancestor
5817742|NCT02630888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6492711|NCT00610142|Immunologic Factors|immunologic factors|mesh-ancestor
5644645|NCT05221892|Vitamin B Complex|vitamin b complex|mesh-ancestor
5644646|NCT05221892|Vitamins|vitamins|mesh-ancestor
5644647|NCT05221892|Micronutrients|micronutrients|mesh-ancestor
5817743|NCT02630888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817744|NCT02630888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817745|NCT02630888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5817746|NCT02630888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5817747|NCT02631109|Methylprednisolone|methylprednisolone|mesh-list
5817748|NCT02631109|Doxorubicin|doxorubicin|mesh-list
5817749|NCT02631109|Etoposide|etoposide|mesh-list
5817750|NCT02631109|Pegaspargase|pegaspargase|mesh-list
5817751|NCT02631109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5817752|NCT02631109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5817753|NCT02631109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5817754|NCT02631109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5817755|NCT02631109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5817756|NCT02631109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817757|NCT02631109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5817758|NCT02631109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6674340|NCT01568684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674341|NCT01568684|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6674342|NCT01568684|Antidepressive Agents|antidepressive agents|mesh-ancestor
6674343|NCT01568684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6674344|NCT01568749|Acetaminophen|acetaminophen|mesh-list
6674345|NCT01568749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6674346|NCT01568749|Analgesics|analgesics|mesh-ancestor
6674347|NCT01568749|Sensory System Agents|sensory system agents|mesh-ancestor
6674348|NCT01568749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6674349|NCT01568749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674350|NCT01568749|Antipyretics|antipyretics|mesh-ancestor
6674351|NCT01568788|Vaccines|vaccines|mesh-list
6674352|NCT01568788|Immunologic Factors|immunologic factors|mesh-ancestor
6674353|NCT01568788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674354|NCT01568853|Norepinephrine|norepinephrine|mesh-list
5644648|NCT05221892|Hematinics|hematinics|mesh-ancestor
5644649|NCT05221892|GABA Agents|gaba agents|mesh-ancestor
5644650|NCT05221892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5644651|NCT05221892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644652|NCT05221879|Enoxaparin|enoxaparin|mesh-list
5644653|NCT05221879|Anticoagulants|anticoagulants|mesh-ancestor
6674355|NCT01568853|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6674356|NCT01568853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6674357|NCT01568853|Adrenergic Agents|adrenergic agents|mesh-ancestor
6674358|NCT01568853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6674359|NCT01568853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674360|NCT01568853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674361|NCT01568853|Sympathomimetics|sympathomimetics|mesh-ancestor
5644654|NCT05221879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5644655|NCT05221879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5817759|NCT02631109|Antiemetics|antiemetics|mesh-ancestor
5817760|NCT02631109|Autonomic Agents|autonomic agents|mesh-ancestor
5817761|NCT02631109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5817762|NCT02631109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817763|NCT02631109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5817764|NCT02631109|Glucocorticoids|glucocorticoids|mesh-ancestor
5817765|NCT02631109|Hormones|hormones|mesh-ancestor
5817766|NCT02631109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5817767|NCT02631109|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5817768|NCT02631109|Protective Agents|protective agents|mesh-ancestor
5817769|NCT02630823|Paclitaxel|paclitaxel|mesh-list
5817770|NCT02630823|Carboplatin|carboplatin|mesh-list
6211486|NCT02173769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6211487|NCT02173769|Respiratory System Agents|respiratory system agents|mesh-ancestor
6211488|NCT02173769|Parasympatholytics|parasympatholytics|mesh-ancestor
6211489|NCT02173769|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6211490|NCT02173769|Cholinergic Agents|cholinergic agents|mesh-ancestor
6674362|NCT01568853|Autonomic Agents|autonomic agents|mesh-ancestor
5817771|NCT02630823|Pembrolizumab|pembrolizumab|mesh-list
5817772|NCT02630823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5817773|NCT02630823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5817774|NCT02630823|Tubulin Modulators|tubulin modulators|mesh-ancestor
5817775|NCT02630823|Antimitotic Agents|antimitotic agents|mesh-ancestor
5817776|NCT02630823|Mitosis Modulators|mitosis modulators|mesh-ancestor
5644656|NCT05221879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644657|NCT05221840|Durvalumab|durvalumab|mesh-list
5644658|NCT05221840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5817777|NCT02630823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817778|NCT02630823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5817779|NCT02630511|Mannitol|mannitol|mesh-list
5817780|NCT02630511|Methacholine Chloride|methacholine chloride|mesh-list
5817781|NCT02630511|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5817782|NCT02630511|Diuretics|diuretics|mesh-ancestor
5817783|NCT02630511|Natriuretic Agents|natriuretic agents|mesh-ancestor
5817784|NCT02630511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817785|NCT02630511|Miotics|miotics|mesh-ancestor
5817786|NCT02630511|Autonomic Agents|autonomic agents|mesh-ancestor
5817787|NCT02630511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5817788|NCT02630511|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5817789|NCT02630511|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
5817790|NCT02630511|Respiratory System Agents|respiratory system agents|mesh-ancestor
5817791|NCT02630511|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
5817792|NCT02630511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5817793|NCT02630511|Cholinergic Agents|cholinergic agents|mesh-ancestor
5817794|NCT02630511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5817795|NCT02630511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817796|NCT02630485|Inositol|inositol|mesh-list
5817797|NCT02630485|Letrozole|letrozole|mesh-list
5817798|NCT02630485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5817799|NCT02630485|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5817800|NCT02630485|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5817801|NCT02630485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5817802|NCT02630485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817803|NCT02630485|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5817804|NCT02630485|Hormone Antagonists|hormone antagonists|mesh-ancestor
5817805|NCT02630485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5817806|NCT02630485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817807|NCT02630485|Vitamin B Complex|vitamin b complex|mesh-ancestor
5817808|NCT02630485|Vitamins|vitamins|mesh-ancestor
5817809|NCT02630485|Micronutrients|micronutrients|mesh-ancestor
5817810|NCT02630628|Mycophenolic Acid|mycophenolic acid|mesh-list
5817811|NCT02630628|Tacrolimus|tacrolimus|mesh-list
5817812|NCT02630628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5817813|NCT02630628|Immunologic Factors|immunologic factors|mesh-ancestor
5817814|NCT02630628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817815|NCT02630628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5817816|NCT02630628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5817817|NCT02630628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817818|NCT02630628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5817819|NCT02630628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5817820|NCT02630628|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5817821|NCT02630628|Antitubercular Agents|antitubercular agents|mesh-ancestor
5817822|NCT02630628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5817823|NCT02630628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5817824|NCT02630420|Cetuximab|cetuximab|mesh-list
5817825|NCT02630420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5817826|NCT02630420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5817827|NCT02630394|Azithromycin|azithromycin|mesh-list
5817828|NCT02630394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5817829|NCT02630394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5901357|NCT03577431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5901358|NCT03577431|Alkylating Agents|alkylating agents|mesh-ancestor
5901359|NCT03577431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901360|NCT03577431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901361|NCT03577431|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5901362|NCT03568929|Idelalisib|idelalisib|mesh-list
5644659|NCT05221840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5644660|NCT05221775|Lenvatinib|lenvatinib|mesh-list
5644661|NCT05221775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5644662|NCT05221775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5644663|NCT05221775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5644664|NCT05221775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644665|NCT05221749|Fluorides|fluorides|mesh-list
5817830|NCT02630069|Choline|choline|mesh-list
5817831|NCT02630069|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
5817832|NCT02630069|Lipotropic Agents|lipotropic agents|mesh-ancestor
5817833|NCT02630069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5817834|NCT02630069|Antimetabolites|antimetabolites|mesh-ancestor
5817835|NCT02630069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817836|NCT02630069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5817837|NCT02630069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5817838|NCT02630069|Nootropic Agents|nootropic agents|mesh-ancestor
5817839|NCT02630043|Oxaliplatin|oxaliplatin|mesh-list
5817840|NCT02630043|Tolcapone|tolcapone|mesh-list
5817841|NCT02630043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5817842|NCT02630043|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5817843|NCT02630043|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5817844|NCT02630043|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
5817845|NCT02630043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5817846|NCT02630043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817847|NCT02630303|Coal Tar|coal tar|mesh-list
5817848|NCT02630303|Keratolytic Agents|keratolytic agents|mesh-ancestor
5817849|NCT02630303|Dermatologic Agents|dermatologic agents|mesh-ancestor
5817850|NCT02630264|Paclitaxel|paclitaxel|mesh-list
5817851|NCT02630264|Endostatins|endostatins|mesh-list
5644666|NCT05221749|Cariostatic Agents|cariostatic agents|mesh-ancestor
5644667|NCT05221749|Protective Agents|protective agents|mesh-ancestor
5644668|NCT05221749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817852|NCT02630264|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5817853|NCT02630264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5817854|NCT02630264|Tubulin Modulators|tubulin modulators|mesh-ancestor
5817855|NCT02630264|Antimitotic Agents|antimitotic agents|mesh-ancestor
5817856|NCT02630264|Mitosis Modulators|mitosis modulators|mesh-ancestor
5817857|NCT02630264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817858|NCT02630264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5817859|NCT02630264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5817860|NCT02630264|Growth Substances|growth substances|mesh-ancestor
5817861|NCT02630264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817862|NCT02630264|Growth Inhibitors|growth inhibitors|mesh-ancestor
5817863|NCT02630290|Dexmedetomidine|dexmedetomidine|mesh-list
5817864|NCT02630290|Ropivacaine|ropivacaine|mesh-list
5817865|NCT02630290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5817866|NCT02630290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5817867|NCT02630290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817868|NCT02630290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5817869|NCT02630290|Analgesics|analgesics|mesh-ancestor
5817870|NCT02630290|Sensory System Agents|sensory system agents|mesh-ancestor
5817871|NCT02630290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5817872|NCT02630290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5817873|NCT02630290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5817874|NCT02630290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5817875|NCT02630290|Adrenergic Agents|adrenergic agents|mesh-ancestor
5817876|NCT02630290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5817877|NCT02630290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817878|NCT02630290|Anesthetics, Local|anesthetics, local|mesh-ancestor
5817879|NCT02630290|Anesthetics|anesthetics|mesh-ancestor
5817880|NCT02630160|Epinephrine|epinephrine|mesh-list
5817881|NCT02630160|Bupivacaine|bupivacaine|mesh-list
6492712|NCT00610142|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6492713|NCT00610142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6492714|NCT00610142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496436|NCT00627991|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6496437|NCT00627991|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6496509|NCT00628290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5817882|NCT02630160|Anesthetics, Local|anesthetics, local|mesh-ancestor
5817883|NCT02630160|Anesthetics|anesthetics|mesh-ancestor
5817884|NCT02630160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5817885|NCT02630160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817886|NCT02630160|Sensory System Agents|sensory system agents|mesh-ancestor
5817887|NCT02630160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5644669|NCT05221736|Ethanol|ethanol|mesh-list
5644670|NCT05221736|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5644671|NCT05221736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5644672|NCT05221736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5644673|NCT05221736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817888|NCT02630160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5644674|NCT05221645|Rituximab|rituximab|mesh-list
5817889|NCT02630160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5817890|NCT02630160|Adrenergic Agents|adrenergic agents|mesh-ancestor
5817891|NCT02630160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5817892|NCT02630160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817893|NCT02630160|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5817894|NCT02630160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5817895|NCT02630160|Autonomic Agents|autonomic agents|mesh-ancestor
5817896|NCT02630160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5817897|NCT02630160|Respiratory System Agents|respiratory system agents|mesh-ancestor
5817898|NCT02630160|Mydriatics|mydriatics|mesh-ancestor
5817899|NCT02630160|Sympathomimetics|sympathomimetics|mesh-ancestor
5817900|NCT02630160|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5817901|NCT02630277|Aflibercept|aflibercept|mesh-list
5817902|NCT02630277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5817903|NCT02630277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5817904|NCT02630277|Growth Substances|growth substances|mesh-ancestor
5817905|NCT02630277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817906|NCT02630277|Growth Inhibitors|growth inhibitors|mesh-ancestor
5817907|NCT02630277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5817908|NCT02630199|Paclitaxel|paclitaxel|mesh-list
5817909|NCT02630199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5817910|NCT02630199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5817911|NCT02630199|Tubulin Modulators|tubulin modulators|mesh-ancestor
5817912|NCT02630199|Antimitotic Agents|antimitotic agents|mesh-ancestor
5817913|NCT02630199|Mitosis Modulators|mitosis modulators|mesh-ancestor
5817914|NCT02630199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817915|NCT02630108|Epirubicin|epirubicin|mesh-list
5817916|NCT02630108|Ethiodized Oil|ethiodized oil|mesh-list
5817917|NCT02630108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5817918|NCT02630108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5817919|NCT02630108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5817920|NCT02630108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5817921|NCT02630108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5817922|NCT02630108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817923|NCT02630121|Phenylephrine|phenylephrine|mesh-list
5817924|NCT02630121|Oxymetazoline|oxymetazoline|mesh-list
5817925|NCT02630121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5817926|NCT02630121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5817927|NCT02630121|Adrenergic Agents|adrenergic agents|mesh-ancestor
5817928|NCT02630121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5817929|NCT02630121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817930|NCT02630121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817931|NCT02630121|Sympathomimetics|sympathomimetics|mesh-ancestor
5817932|NCT02630121|Autonomic Agents|autonomic agents|mesh-ancestor
5817933|NCT02630121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5817934|NCT02630121|Nasal Decongestants|nasal decongestants|mesh-ancestor
5817935|NCT02630121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5817936|NCT02630121|Respiratory System Agents|respiratory system agents|mesh-ancestor
5817937|NCT02630121|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5817938|NCT02630121|Mydriatics|mydriatics|mesh-ancestor
5817939|NCT02630121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5817940|NCT02630121|Protective Agents|protective agents|mesh-ancestor
5817941|NCT02630095|Nadroparin|nadroparin|mesh-list
5817942|NCT02630095|Warfarin|warfarin|mesh-list
5817943|NCT02630095|Calcium|calcium|mesh-list
5817944|NCT02630095|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5644675|NCT05221645|Pembrolizumab|pembrolizumab|mesh-list
5644676|NCT05221645|Carboplatin|carboplatin|mesh-list
5644677|NCT05221645|Etoposide|etoposide|mesh-list
5644678|NCT05221645|Ifosfamide|ifosfamide|mesh-list
5644679|NCT05221645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5644680|NCT05221645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5644681|NCT05221645|Immunologic Factors|immunologic factors|mesh-ancestor
5644682|NCT05221645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644683|NCT05221645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5644684|NCT05221645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5644685|NCT05221645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5644686|NCT05221645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5644687|NCT05221645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5644688|NCT05221645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644689|NCT05221645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5644690|NCT05221645|Alkylating Agents|alkylating agents|mesh-ancestor
5644691|NCT05221593|Lithium Carbonate|lithium carbonate|mesh-list
5644692|NCT05221593|Antidepressive Agents|antidepressive agents|mesh-ancestor
5644693|NCT05221593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5817945|NCT02630095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817946|NCT02630095|Anticoagulants|anticoagulants|mesh-ancestor
5644694|NCT05221593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5644695|NCT05221593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644696|NCT05221593|Antimanic Agents|antimanic agents|mesh-ancestor
5644697|NCT05221593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5644698|NCT05221593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6674363|NCT01568853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6674364|NCT01568853|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6674365|NCT01568931|Coal Tar|coal tar|mesh-list
6674366|NCT01568931|Keratolytic Agents|keratolytic agents|mesh-ancestor
5644699|NCT05221593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644700|NCT05221580|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
5644701|NCT05221580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5644702|NCT05221580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644703|NCT05221554|Tacrine|tacrine|mesh-list
5644704|NCT05221554|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5644705|NCT05221554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5644706|NCT05221554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644707|NCT05221554|Cholinergic Agents|cholinergic agents|mesh-ancestor
5644708|NCT05221554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5644709|NCT05221554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644710|NCT05221554|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5644711|NCT05221554|Autonomic Agents|autonomic agents|mesh-ancestor
5644712|NCT05221554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5644713|NCT05221554|Nootropic Agents|nootropic agents|mesh-ancestor
5644714|NCT05221502|Bedaquiline|bedaquiline|mesh-list
5644715|NCT05221502|Diarylquinolines|diarylquinolines|mesh-list
5644716|NCT05221502|Antitubercular Agents|antitubercular agents|mesh-ancestor
5644717|NCT05221502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5817947|NCT02630095|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5817948|NCT02630095|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5817949|NCT02630095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817950|NCT02630004|Melatonin|melatonin|mesh-list
5817951|NCT02630004|Antioxidants|antioxidants|mesh-ancestor
5817952|NCT02630004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817953|NCT02630004|Protective Agents|protective agents|mesh-ancestor
5644718|NCT05221502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5694119|NCT03397264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694120|NCT03397264|Growth Inhibitors|growth inhibitors|mesh-ancestor
5694121|NCT03397264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5697919|NCT03372785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5817954|NCT02630004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817955|NCT02630004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5817956|NCT02629848|Paclitaxel|paclitaxel|mesh-list
5817957|NCT02629848|Carboplatin|carboplatin|mesh-list
5817958|NCT02629848|Motesanib diphosphate|motesanib diphosphate|mesh-list
5817959|NCT02629848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5817960|NCT02629848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5817961|NCT02629848|Tubulin Modulators|tubulin modulators|mesh-ancestor
5817962|NCT02629848|Antimitotic Agents|antimitotic agents|mesh-ancestor
5817963|NCT02629848|Mitosis Modulators|mitosis modulators|mesh-ancestor
5817964|NCT02629848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817965|NCT02629848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5817966|NCT02629848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5817967|NCT02629835|Dexamethasone|dexamethasone|mesh-list
5817968|NCT02629835|Dexamethasone acetate|dexamethasone acetate|mesh-list
5817969|NCT02629835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5817970|NCT02629835|BB 1101|bb 1101|mesh-list
5817971|NCT02629835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5817972|NCT02629835|Antiemetics|antiemetics|mesh-ancestor
5697920|NCT03372785|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5697921|NCT03372785|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5697922|NCT03372785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5697923|NCT03372785|Purinergic Agents|purinergic agents|mesh-ancestor
5697924|NCT03372785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5697925|NCT03372785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5697926|NCT03372785|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5697927|NCT03372785|Sympatholytics|sympatholytics|mesh-ancestor
5697928|NCT03372785|Autonomic Agents|autonomic agents|mesh-ancestor
5697929|NCT03372785|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5697930|NCT03372785|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5697931|NCT03372785|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5697932|NCT03372785|Adrenergic Agents|adrenergic agents|mesh-ancestor
5697933|NCT03372681|Antidiarrheals|antidiarrheals|mesh-list
5817973|NCT02629835|Autonomic Agents|autonomic agents|mesh-ancestor
5817974|NCT02629835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5817975|NCT02629835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817976|NCT02629835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5817977|NCT02629835|Glucocorticoids|glucocorticoids|mesh-ancestor
5817978|NCT02629835|Hormones|hormones|mesh-ancestor
5817979|NCT02629835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5817980|NCT02629835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5817981|NCT02629835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5817982|NCT02629835|Protease Inhibitors|protease inhibitors|mesh-ancestor
5817983|NCT02629835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5817984|NCT02629835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644719|NCT05221437|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5644720|NCT05221437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5644721|NCT05221411|Mycophenolic Acid|mycophenolic acid|mesh-list
5644722|NCT05221411|Tacrolimus|tacrolimus|mesh-list
5644723|NCT05221411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5644724|NCT05221411|Immunologic Factors|immunologic factors|mesh-ancestor
5644725|NCT05221411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644726|NCT05221411|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5817985|NCT02629770|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5817986|NCT02629770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5817987|NCT02629744|Etrolizumab|etrolizumab|mesh-list
5817988|NCT02629744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5817989|NCT02629744|Immunologic Factors|immunologic factors|mesh-ancestor
5644727|NCT05221411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5644728|NCT05221411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644729|NCT05221411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5644730|NCT05221411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5644731|NCT05221411|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5644732|NCT05221411|Antitubercular Agents|antitubercular agents|mesh-ancestor
5644733|NCT05221411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5644734|NCT05221411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5644735|NCT05221359|Insulin Aspart|insulin aspart|mesh-list
5644736|NCT05221359|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5644737|NCT05221359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644738|NCT05221229|Liraglutide|liraglutide|mesh-list
5644739|NCT05221229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5644740|NCT05221229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644741|NCT05221229|Incretins|incretins|mesh-ancestor
5644742|NCT05221229|Hormones|hormones|mesh-ancestor
5644743|NCT05221229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5644744|NCT05221190|Lidocaine|lidocaine|mesh-list
5644745|NCT05221190|Anesthetics, Local|anesthetics, local|mesh-ancestor
5644746|NCT05221190|Anesthetics|anesthetics|mesh-ancestor
5644747|NCT05221190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5644748|NCT05221190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817990|NCT02629744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5817991|NCT02629718|Paclitaxel|paclitaxel|mesh-list
5817992|NCT02629718|Carboplatin|carboplatin|mesh-list
5817993|NCT02629718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5817994|NCT02629718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5817995|NCT02629718|Tubulin Modulators|tubulin modulators|mesh-ancestor
5817996|NCT02629718|Antimitotic Agents|antimitotic agents|mesh-ancestor
5817997|NCT02629718|Mitosis Modulators|mitosis modulators|mesh-ancestor
5817998|NCT02629718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5817999|NCT02629536|Acetylcysteine|acetylcysteine|mesh-list
5818000|NCT02629536|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5818001|NCT02629536|Antiviral Agents|antiviral agents|mesh-ancestor
5644749|NCT05221190|Sensory System Agents|sensory system agents|mesh-ancestor
5644750|NCT05221190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5644751|NCT05221190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5644752|NCT05221190|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5644753|NCT05221190|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5644754|NCT05221190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5644755|NCT05221190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644756|NCT05221164|Aspirin|aspirin|mesh-list
5644757|NCT05221164|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5644758|NCT05221164|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5644759|NCT05221164|Analgesics|analgesics|mesh-ancestor
5644760|NCT05221164|Sensory System Agents|sensory system agents|mesh-ancestor
5644761|NCT05221164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5644762|NCT05221164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644763|NCT05221164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5644764|NCT05221164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5644765|NCT05221164|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5644766|NCT05221164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5644767|NCT05221164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644768|NCT05221164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5818002|NCT02629536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5818003|NCT02629536|Expectorants|expectorants|mesh-ancestor
5818004|NCT02629536|Respiratory System Agents|respiratory system agents|mesh-ancestor
5818005|NCT02629536|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5818006|NCT02629536|Antioxidants|antioxidants|mesh-ancestor
5644769|NCT05221164|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5644770|NCT05221164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5644771|NCT05221164|Antipyretics|antipyretics|mesh-ancestor
5644772|NCT05221151|Pregabalin|pregabalin|mesh-list
5644773|NCT05221151|Ondansetron|ondansetron|mesh-list
5644774|NCT05221151|Melatonin|melatonin|mesh-list
5644775|NCT05221151|Analgesics|analgesics|mesh-ancestor
5644776|NCT05221151|Sensory System Agents|sensory system agents|mesh-ancestor
5644777|NCT05221151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5644778|NCT05221151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644779|NCT05221151|Anticonvulsants|anticonvulsants|mesh-ancestor
5644780|NCT05221151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5644781|NCT05221151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5644782|NCT05221151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644783|NCT05221151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5644784|NCT05221151|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5644785|NCT05221151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5644786|NCT05221151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5644787|NCT05221151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5818007|NCT02629536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818008|NCT02629536|Protective Agents|protective agents|mesh-ancestor
5818009|NCT02629536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818010|NCT02629536|Antidotes|antidotes|mesh-ancestor
5818011|NCT02629523|Afatinib|afatinib|mesh-list
5818012|NCT02629523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5818013|NCT02629523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5818014|NCT02629523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5818015|NCT02629523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818016|NCT02629627|Metformin|metformin|mesh-list
5818017|NCT02629627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5818018|NCT02629627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818019|NCT02629575|Sirolimus|sirolimus|mesh-list
5818020|NCT02629575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5818021|NCT02629575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5818022|NCT02629575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5818023|NCT02629575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5818024|NCT02629575|Antifungal Agents|antifungal agents|mesh-ancestor
5818025|NCT02629575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5818026|NCT02629575|Immunologic Factors|immunologic factors|mesh-ancestor
5818027|NCT02629575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818028|NCT02629224|Gabapentin|gabapentin|mesh-list
5818029|NCT02629224|Analgesics|analgesics|mesh-ancestor
5818030|NCT02629224|Sensory System Agents|sensory system agents|mesh-ancestor
5818031|NCT02629224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5818032|NCT02629224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818033|NCT02629224|Anticonvulsants|anticonvulsants|mesh-ancestor
5818034|NCT02629224|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5818035|NCT02629224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5818036|NCT02629224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5818037|NCT02629224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5818038|NCT02629224|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5818039|NCT02629224|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5818040|NCT02629224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5818041|NCT02629224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644788|NCT05221151|Antioxidants|antioxidants|mesh-ancestor
5644789|NCT05221151|Protective Agents|protective agents|mesh-ancestor
5644790|NCT05221151|Antiemetics|antiemetics|mesh-ancestor
5644791|NCT05221151|Autonomic Agents|autonomic agents|mesh-ancestor
5644792|NCT05221151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5644793|NCT05221151|Antipruritics|antipruritics|mesh-ancestor
5644794|NCT05221151|Dermatologic Agents|dermatologic agents|mesh-ancestor
5818042|NCT02629224|Antimanic Agents|antimanic agents|mesh-ancestor
5818043|NCT02629289|Lenograstim|lenograstim|mesh-list
5818044|NCT02629289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5818045|NCT02629289|Immunologic Factors|immunologic factors|mesh-ancestor
5818046|NCT02629289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644795|NCT05221151|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5818047|NCT02629315|Formaldehyde|formaldehyde|mesh-list
5818048|NCT02629315|Disinfectants|disinfectants|mesh-ancestor
5818049|NCT02629315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5818050|NCT02629042|Prednisolone|prednisolone|mesh-list
5818051|NCT02629042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818052|NCT02629042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5818053|NCT02629042|Glucocorticoids|glucocorticoids|mesh-ancestor
5818054|NCT02629042|Hormones|hormones|mesh-ancestor
5818055|NCT02629042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5818056|NCT02629042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5818057|NCT02629042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5818058|NCT02629146|Fentanyl|fentanyl|mesh-list
5818059|NCT02629146|Midazolam|midazolam|mesh-list
5818060|NCT02629146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5818061|NCT02629146|Narcotics|narcotics|mesh-ancestor
5818062|NCT02629146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5818063|NCT02629146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818064|NCT02629146|Analgesics|analgesics|mesh-ancestor
5818065|NCT02629146|Sensory System Agents|sensory system agents|mesh-ancestor
5818066|NCT02629146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5818067|NCT02629146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5818068|NCT02629146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5818069|NCT02629146|Anesthetics, General|anesthetics, general|mesh-ancestor
5818070|NCT02629146|Anesthetics|anesthetics|mesh-ancestor
5818071|NCT02629146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5818072|NCT02629146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5818073|NCT02629146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5818074|NCT02629146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5818075|NCT02629146|GABA Modulators|gaba modulators|mesh-ancestor
5818076|NCT02629146|GABA Agents|gaba agents|mesh-ancestor
5818077|NCT02629146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5818078|NCT02629146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818079|NCT02629380|Hyaluronic Acid|hyaluronic acid|mesh-list
5818080|NCT02629380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5818081|NCT02629380|Immunologic Factors|immunologic factors|mesh-ancestor
5818082|NCT02629380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818083|NCT02629380|Viscosupplements|viscosupplements|mesh-ancestor
5818084|NCT02629380|Protective Agents|protective agents|mesh-ancestor
5818085|NCT02628704|Dexamethasone|dexamethasone|mesh-list
5818086|NCT02628704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5818087|NCT02628704|Antiemetics|antiemetics|mesh-ancestor
5818088|NCT02628704|Autonomic Agents|autonomic agents|mesh-ancestor
5818089|NCT02628704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5818090|NCT02628704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818091|NCT02628704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5818092|NCT02628704|Glucocorticoids|glucocorticoids|mesh-ancestor
5818093|NCT02628704|Hormones|hormones|mesh-ancestor
5818094|NCT02628704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5818095|NCT02628704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5818096|NCT02628704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5818097|NCT02628847|Sildenafil Citrate|sildenafil citrate|mesh-list
5818098|NCT02628847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818099|NCT02628847|Vasodilator Agents|vasodilator agents|mesh-ancestor
5818100|NCT02628847|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5818101|NCT02628847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5818102|NCT02628847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5818103|NCT02628847|Urological Agents|urological agents|mesh-ancestor
5818104|NCT02628951|Paclitaxel|paclitaxel|mesh-list
5818105|NCT02628951|Ramucirumab|ramucirumab|mesh-list
5818106|NCT02628951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5818107|NCT02628951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5818108|NCT02628951|Tubulin Modulators|tubulin modulators|mesh-ancestor
5818109|NCT02628951|Antimitotic Agents|antimitotic agents|mesh-ancestor
5818110|NCT02628951|Mitosis Modulators|mitosis modulators|mesh-ancestor
5818111|NCT02628951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818112|NCT02628886|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5818113|NCT02628886|Immunologic Factors|immunologic factors|mesh-ancestor
5818114|NCT02628886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901363|NCT03568929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901364|NCT03568929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5901365|NCT03568929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901366|NCT03537690|Paclitaxel|paclitaxel|mesh-list
5901367|NCT03537690|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5901368|NCT03537690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5901369|NCT03537690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901370|NCT03537690|Tubulin Modulators|tubulin modulators|mesh-ancestor
5818115|NCT02628860|Ferric Compounds|ferric compounds|mesh-list
5818116|NCT02628860|Hematinics|hematinics|mesh-ancestor
5818117|NCT02628665|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
5818118|NCT02628665|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
5644796|NCT05221151|Serotonin Agents|serotonin agents|mesh-ancestor
5644797|NCT05221151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5644798|NCT05221151|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5644799|NCT05221021|Mirabegron|mirabegron|mesh-list
5644800|NCT05221021|Estradiol|estradiol|mesh-list
5644801|NCT05221021|Estrogens|estrogens|mesh-list
5644802|NCT05221021|Hormones|hormones|mesh-ancestor
5644803|NCT05221021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5644804|NCT05221021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644805|NCT05221021|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
5644806|NCT05221021|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5644807|NCT05221021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5644808|NCT05221021|Adrenergic Agents|adrenergic agents|mesh-ancestor
5644809|NCT05221021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5644810|NCT05221021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644811|NCT05221021|Urological Agents|urological agents|mesh-ancestor
5644812|NCT05220748|Pembrolizumab|pembrolizumab|mesh-list
5644813|NCT05220748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5644814|NCT05220748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5644815|NCT05220722|Pembrolizumab|pembrolizumab|mesh-list
5644816|NCT05220722|Nivolumab|nivolumab|mesh-list
5644817|NCT05220722|Ipilimumab|ipilimumab|mesh-list
5644818|NCT05220722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5644819|NCT05220722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5644820|NCT05220722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5644821|NCT05220722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644822|NCT05220527|Triamcinolone|triamcinolone|mesh-list
5818119|NCT02628665|Trioxsalen|trioxsalen|mesh-list
5818120|NCT02628665|Photosensitizing Agents|photosensitizing agents|mesh-list
5818121|NCT02628665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5818122|NCT02628665|Dermatologic Agents|dermatologic agents|mesh-ancestor
5818123|NCT02628613|Paclitaxel|paclitaxel|mesh-list
5818124|NCT02628613|Vinorelbine|vinorelbine|mesh-list
5818125|NCT02628613|Epirubicin|epirubicin|mesh-list
5818126|NCT02628613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5818127|NCT02628613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5818128|NCT02628613|Tubulin Modulators|tubulin modulators|mesh-ancestor
5818129|NCT02628613|Antimitotic Agents|antimitotic agents|mesh-ancestor
5818130|NCT02628613|Mitosis Modulators|mitosis modulators|mesh-ancestor
5818131|NCT02628613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818132|NCT02628613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5818133|NCT02628613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5818134|NCT02628613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5818135|NCT02628613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5818136|NCT02628587|Clopidogrel|clopidogrel|mesh-list
5818137|NCT02628587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5818138|NCT02628587|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5818139|NCT02628587|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5818140|NCT02628587|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5818141|NCT02628587|Purinergic Agents|purinergic agents|mesh-ancestor
5818142|NCT02628587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5644823|NCT05220527|Hyaluronic Acid|hyaluronic acid|mesh-list
5644824|NCT05220527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5644825|NCT05220527|Glucocorticoids|glucocorticoids|mesh-ancestor
5644826|NCT05220527|Hormones|hormones|mesh-ancestor
5644827|NCT05220527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5644828|NCT05220527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644829|NCT05220527|Immunologic Factors|immunologic factors|mesh-ancestor
5644830|NCT05220527|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5644831|NCT05220527|Viscosupplements|viscosupplements|mesh-ancestor
5644832|NCT05220527|Protective Agents|protective agents|mesh-ancestor
5644833|NCT05220462|Midazolam|midazolam|mesh-list
5644834|NCT05220462|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5644835|NCT05220462|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5644836|NCT05220462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5644837|NCT05220462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644838|NCT05220462|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5644839|NCT05220462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5644840|NCT05220462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5818143|NCT02628587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644841|NCT05220462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5644842|NCT05220462|Anesthetics, General|anesthetics, general|mesh-ancestor
5818144|NCT02628587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818145|NCT02628574|Gemcitabine|gemcitabine|mesh-list
5818146|NCT02628574|Pembrolizumab|pembrolizumab|mesh-list
5818147|NCT02628574|Nivolumab|nivolumab|mesh-list
5818148|NCT02628574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5818149|NCT02628574|Antimetabolites|antimetabolites|mesh-ancestor
5644843|NCT05220462|Anesthetics|anesthetics|mesh-ancestor
5644844|NCT05220462|GABA Modulators|gaba modulators|mesh-ancestor
5644845|NCT05220462|GABA Agents|gaba agents|mesh-ancestor
5644846|NCT05220462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5644847|NCT05220462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644848|NCT05220358|Fostemsavir|fostemsavir|mesh-list
5644849|NCT05220358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5644850|NCT05220358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5644851|NCT05220358|Antiviral Agents|antiviral agents|mesh-ancestor
5644852|NCT05220358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5818150|NCT02628574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818151|NCT02628574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5818152|NCT02628574|Antiviral Agents|antiviral agents|mesh-ancestor
5818153|NCT02628574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5818154|NCT02628574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5818155|NCT02628574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5818156|NCT02628574|Immunologic Factors|immunologic factors|mesh-ancestor
5818157|NCT02628574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818158|NCT02628574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5818159|NCT02628574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5644853|NCT05220358|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5644854|NCT05220358|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5644855|NCT05220358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644856|NCT05220293|Betamethasone|betamethasone|mesh-list
5644857|NCT05220293|Betamethasone Valerate|betamethasone valerate|mesh-list
5644858|NCT05220293|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5644859|NCT05220293|Betamethasone benzoate|betamethasone benzoate|mesh-list
5644860|NCT05220293|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
5644861|NCT05220293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5818160|NCT02628366|Dialysis Solutions|dialysis solutions|mesh-list
5818161|NCT02628366|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5818162|NCT02628392|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5818163|NCT02628392|Firuglipel|firuglipel|mesh-list
5818164|NCT02628392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5818165|NCT02628392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818166|NCT02628392|Incretins|incretins|mesh-ancestor
5818167|NCT02628392|Hormones|hormones|mesh-ancestor
5818168|NCT02628392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5818169|NCT02628392|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5818170|NCT02628392|Protease Inhibitors|protease inhibitors|mesh-ancestor
5818171|NCT02628392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5818172|NCT02628392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818173|NCT02628522|Lidocaine|lidocaine|mesh-list
5818174|NCT02628522|Epinephrine|epinephrine|mesh-list
5818175|NCT02628522|Anesthetics, Local|anesthetics, local|mesh-ancestor
5818176|NCT02628522|Anesthetics|anesthetics|mesh-ancestor
5818177|NCT02628522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5818178|NCT02628522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818179|NCT02628522|Sensory System Agents|sensory system agents|mesh-ancestor
5818180|NCT02628522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5818181|NCT02628522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5818182|NCT02628522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5818183|NCT02628522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5818184|NCT02628522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5818185|NCT02628522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818186|NCT02628522|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5818187|NCT02628522|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5818188|NCT02628522|Adrenergic Agents|adrenergic agents|mesh-ancestor
5818189|NCT02628522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5818190|NCT02628522|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5644862|NCT05220293|Glucocorticoids|glucocorticoids|mesh-ancestor
5644863|NCT05220293|Hormones|hormones|mesh-ancestor
5644864|NCT05220293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5818191|NCT02628522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5818192|NCT02628522|Autonomic Agents|autonomic agents|mesh-ancestor
5818193|NCT02628522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5818194|NCT02628522|Respiratory System Agents|respiratory system agents|mesh-ancestor
5818195|NCT02628522|Mydriatics|mydriatics|mesh-ancestor
5818196|NCT02628522|Sympathomimetics|sympathomimetics|mesh-ancestor
5818197|NCT02628522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5818198|NCT02628197|Vitamin D|vitamin d|mesh-list
5818199|NCT02628197|Calcium|calcium|mesh-list
5818200|NCT02628197|Vitamins|vitamins|mesh-ancestor
5818201|NCT02628197|Micronutrients|micronutrients|mesh-ancestor
5818202|NCT02628197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818203|NCT02628197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5818204|NCT02628197|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5818205|NCT02628002|Regadenoson|regadenoson|mesh-list
5818206|NCT02628002|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
5818207|NCT02628002|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5818208|NCT02628002|Purinergic Agonists|purinergic agonists|mesh-ancestor
5818209|NCT02628002|Purinergic Agents|purinergic agents|mesh-ancestor
5818210|NCT02628002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5818211|NCT02628002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818212|NCT02628002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818213|NCT02627846|Lidocaine|lidocaine|mesh-list
5818214|NCT02627846|Epinephrine|epinephrine|mesh-list
5818215|NCT02627846|Racepinephrine|racepinephrine|mesh-list
5818216|NCT02627846|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5818217|NCT02627846|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
5818218|NCT02627846|Epinephryl borate|epinephryl borate|mesh-list
5818219|NCT02627846|Anesthetics, Local|anesthetics, local|mesh-ancestor
5818220|NCT02627846|Anesthetics|anesthetics|mesh-ancestor
5818221|NCT02627846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5818222|NCT02627846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818223|NCT02627846|Sensory System Agents|sensory system agents|mesh-ancestor
5818224|NCT02627846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5818225|NCT02627846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5818226|NCT02627846|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5818227|NCT02627846|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5818228|NCT02627846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5818229|NCT02627846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818230|NCT02627846|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5818231|NCT02627846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5818232|NCT02627846|Adrenergic Agents|adrenergic agents|mesh-ancestor
5818233|NCT02627846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5818234|NCT02627846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5818235|NCT02627846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5644865|NCT05220293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644866|NCT05220293|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5644867|NCT05220293|Respiratory System Agents|respiratory system agents|mesh-ancestor
5644868|NCT05220280|Imatinib Mesylate|imatinib mesylate|mesh-list
5644869|NCT05220280|Infliximab|infliximab|mesh-list
5644870|NCT05220280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5644871|NCT05220280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5644872|NCT05220280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5818236|NCT02627846|Autonomic Agents|autonomic agents|mesh-ancestor
5818237|NCT02627846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5818238|NCT02627846|Respiratory System Agents|respiratory system agents|mesh-ancestor
5818239|NCT02627846|Mydriatics|mydriatics|mesh-ancestor
5818240|NCT02627846|Sympathomimetics|sympathomimetics|mesh-ancestor
5818241|NCT02627846|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5818242|NCT02627846|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
5818243|NCT02628132|Paclitaxel|paclitaxel|mesh-list
5818244|NCT02628132|Durvalumab|durvalumab|mesh-list
5818245|NCT02628132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5818246|NCT02628132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5818247|NCT02628132|Tubulin Modulators|tubulin modulators|mesh-ancestor
5818248|NCT02628132|Antimitotic Agents|antimitotic agents|mesh-ancestor
5818249|NCT02628132|Mitosis Modulators|mitosis modulators|mesh-ancestor
5644873|NCT05220280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644874|NCT05220280|Dermatologic Agents|dermatologic agents|mesh-ancestor
5644875|NCT05220280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5644876|NCT05220280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5644877|NCT05220228|Prucalopride|prucalopride|mesh-list
5644878|NCT05220228|Laxatives|laxatives|mesh-ancestor
5818250|NCT02628132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818251|NCT02628132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5818252|NCT02628080|Atovaquone|atovaquone|mesh-list
5818253|NCT02628080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5818254|NCT02628080|Antimalarials|antimalarials|mesh-ancestor
5818255|NCT02628080|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5818256|NCT02628080|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5818257|NCT02628080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5818258|NCT02628080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818259|NCT02627989|Diflucortolone|diflucortolone|mesh-list
5818260|NCT02627989|Diflucortolone valerate|diflucortolone valerate|mesh-list
5818261|NCT02627989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5818262|NCT02627989|Glucocorticoids|glucocorticoids|mesh-ancestor
5818263|NCT02627989|Hormones|hormones|mesh-ancestor
5818264|NCT02627989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5818265|NCT02627989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818266|NCT02627950|Metoclopramide|metoclopramide|mesh-list
5818267|NCT02627950|Ticagrelor|ticagrelor|mesh-list
5818268|NCT02627950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5818269|NCT02627950|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5818270|NCT02627950|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5818271|NCT02627950|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5818272|NCT02627950|Purinergic Agents|purinergic agents|mesh-ancestor
5818273|NCT02627950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5818274|NCT02627950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818275|NCT02627950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818276|NCT02627950|Antiemetics|antiemetics|mesh-ancestor
5818277|NCT02627950|Autonomic Agents|autonomic agents|mesh-ancestor
5818278|NCT02627950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5818279|NCT02627950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5818280|NCT02627950|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5818281|NCT02627950|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5818282|NCT02627950|Dopamine Agents|dopamine agents|mesh-ancestor
5818283|NCT02627807|Gemcitabine|gemcitabine|mesh-list
5818284|NCT02627807|Cisplatin|cisplatin|mesh-list
5818285|NCT02627807|Docetaxel|docetaxel|mesh-list
5818286|NCT02627807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5818287|NCT02627807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5818288|NCT02627807|Antimetabolites|antimetabolites|mesh-ancestor
5818289|NCT02627807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644879|NCT05220228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5644880|NCT05220228|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
5644881|NCT05220228|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5644882|NCT05220228|Serotonin Agents|serotonin agents|mesh-ancestor
5644883|NCT05220228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5644884|NCT05220228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644885|NCT05220228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644886|NCT05220020|Lenvatinib|lenvatinib|mesh-list
5644887|NCT05220020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5644888|NCT05220020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5644889|NCT05220020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5644890|NCT05220020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694122|NCT03397199|Apatinib|apatinib|mesh-list
5818290|NCT02627807|Antiviral Agents|antiviral agents|mesh-ancestor
5818291|NCT02627807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5818292|NCT02627807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5818293|NCT02627807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5818294|NCT02627807|Immunologic Factors|immunologic factors|mesh-ancestor
5818295|NCT02627807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818296|NCT02627807|Tubulin Modulators|tubulin modulators|mesh-ancestor
5818297|NCT02627807|Antimitotic Agents|antimitotic agents|mesh-ancestor
5818298|NCT02627807|Mitosis Modulators|mitosis modulators|mesh-ancestor
5818299|NCT02627625|Tiotropium Bromide|tiotropium bromide|mesh-list
5818300|NCT02627625|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5818301|NCT02627625|Autonomic Agents|autonomic agents|mesh-ancestor
5818302|NCT02627625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5818303|NCT02627625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818304|NCT02627625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5818305|NCT02627625|Respiratory System Agents|respiratory system agents|mesh-ancestor
5818306|NCT02627625|Parasympatholytics|parasympatholytics|mesh-ancestor
5818307|NCT02627625|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5818308|NCT02627625|Cholinergic Agents|cholinergic agents|mesh-ancestor
5818309|NCT02627625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5818310|NCT02627625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818311|NCT02627573|Mycophenolic Acid|mycophenolic acid|mesh-list
5818312|NCT02627573|Cyclophosphamide|cyclophosphamide|mesh-list
5818313|NCT02627573|Busulfan|busulfan|mesh-list
5818314|NCT02627573|Fludarabine|fludarabine|mesh-list
5818315|NCT02627573|Fludarabine phosphate|fludarabine phosphate|mesh-list
5818316|NCT02627573|Tacrolimus|tacrolimus|mesh-list
5818317|NCT02627573|Thymoglobulin|thymoglobulin|mesh-list
5694123|NCT03397199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5818318|NCT02627573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5818319|NCT02627573|Immunologic Factors|immunologic factors|mesh-ancestor
5818320|NCT02627573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644891|NCT05219942|Insulin Glargine|insulin glargine|mesh-list
5644892|NCT05219942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5644893|NCT05219942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644894|NCT05219929|Tetracycline|tetracycline|mesh-list
5644895|NCT05219929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5644896|NCT05219929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5644897|NCT05219929|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5644898|NCT05219929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5644899|NCT05219929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818321|NCT02627573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5818322|NCT02627573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5818323|NCT02627573|Alkylating Agents|alkylating agents|mesh-ancestor
5818324|NCT02627573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818325|NCT02627573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5818326|NCT02627573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5818327|NCT02627573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5818328|NCT02627573|Antimetabolites|antimetabolites|mesh-ancestor
5818329|NCT02627573|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5818330|NCT02627573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5818331|NCT02627573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5818332|NCT02627573|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5818333|NCT02627573|Antitubercular Agents|antitubercular agents|mesh-ancestor
5818334|NCT02627573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5818335|NCT02627573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5644900|NCT05219825|Psychotropic Drugs|psychotropic drugs|mesh-list
5644901|NCT05219669|Nalmefene|nalmefene|mesh-list
5644902|NCT05219669|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5644903|NCT05219669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644904|NCT05219669|Sensory System Agents|sensory system agents|mesh-ancestor
5644905|NCT05219669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5644906|NCT05219656|Cyclosporine|cyclosporine|mesh-list
5644907|NCT05219656|Cyclosporins|cyclosporins|mesh-list
5818336|NCT02627560|Tranexamic Acid|tranexamic acid|mesh-list
5818337|NCT02627560|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5818338|NCT02627560|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5818339|NCT02627560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818340|NCT02627560|Hemostatics|hemostatics|mesh-ancestor
5818341|NCT02627560|Coagulants|coagulants|mesh-ancestor
5818342|NCT02627521|Ticagrelor|ticagrelor|mesh-list
5818343|NCT02627521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5818344|NCT02627521|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5818345|NCT02627521|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5818346|NCT02627521|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5818347|NCT02627521|Purinergic Agents|purinergic agents|mesh-ancestor
5818348|NCT02627521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5818349|NCT02627521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818350|NCT02627521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818351|NCT02627534|Anti-Infective Agents|anti-infective agents|mesh-list
5818352|NCT02627534|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5818353|NCT02627456|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
5818354|NCT02627456|Antimalarials|antimalarials|mesh-ancestor
5818355|NCT02627456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5818356|NCT02627456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5818357|NCT02627456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5818358|NCT02627469|Listerine|listerine|mesh-list
5818359|NCT02627469|Fluorides|fluorides|mesh-list
5818360|NCT02627469|Sodium Fluoride|sodium fluoride|mesh-list
5818361|NCT02627469|Cariostatic Agents|cariostatic agents|mesh-ancestor
5818362|NCT02627469|Protective Agents|protective agents|mesh-ancestor
5818363|NCT02627469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818364|NCT02627469|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5818365|NCT02627469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5818366|NCT02627417|Dapsone|dapsone|mesh-list
5818367|NCT02627417|Prednisone|prednisone|mesh-list
5818368|NCT02627417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6674367|NCT01568931|Dermatologic Agents|dermatologic agents|mesh-ancestor
6674368|NCT01568996|Sulforaphane|sulforaphane|mesh-list
6674369|NCT01568996|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5818369|NCT02627417|Glucocorticoids|glucocorticoids|mesh-ancestor
5818370|NCT02627417|Hormones|hormones|mesh-ancestor
5818371|NCT02627417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5818372|NCT02627417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818373|NCT02627417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5818374|NCT02627417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5644908|NCT05219656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6674370|NCT01568996|Protective Agents|protective agents|mesh-ancestor
5644909|NCT05219656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644910|NCT05219656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5818375|NCT02627417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5818376|NCT02627417|Antimalarials|antimalarials|mesh-ancestor
5818377|NCT02627417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5818378|NCT02627417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5818379|NCT02627417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5818380|NCT02627417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5818381|NCT02627417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818382|NCT02627417|Leprostatic Agents|leprostatic agents|mesh-ancestor
5818383|NCT02627417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5818384|NCT02627430|Talazoparib|talazoparib|mesh-list
5818385|NCT02627430|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5818386|NCT02627430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5818387|NCT02627430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818388|NCT02627430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5818389|NCT02627053|Rivaroxaban|rivaroxaban|mesh-list
5818390|NCT02627053|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5818391|NCT02627053|Antithrombins|antithrombins|mesh-ancestor
5818392|NCT02627053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5644911|NCT05219656|Immunologic Factors|immunologic factors|mesh-ancestor
5644912|NCT05219656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644913|NCT05219656|Antifungal Agents|antifungal agents|mesh-ancestor
5644914|NCT05219656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5644915|NCT05219656|Dermatologic Agents|dermatologic agents|mesh-ancestor
5644916|NCT05219656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5644917|NCT05219656|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5644918|NCT05219513|Obinutuzumab|obinutuzumab|mesh-list
5644919|NCT05219513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5644920|NCT05219513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5644921|NCT05219487|Risdiplam|risdiplam|mesh-list
5644922|NCT05219487|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5644923|NCT05219487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5644924|NCT05219487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644925|NCT05219435|Nivolumab|nivolumab|mesh-list
5644926|NCT05219435|Ipilimumab|ipilimumab|mesh-list
5644927|NCT05219435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5818393|NCT02627053|Protease Inhibitors|protease inhibitors|mesh-ancestor
5818394|NCT02627053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5818395|NCT02627053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818396|NCT02627053|Anticoagulants|anticoagulants|mesh-ancestor
5818397|NCT02627222|Vitamin A|vitamin a|mesh-list
5818398|NCT02627222|Provitamins|provitamins|mesh-list
5818399|NCT02627222|Vitamins|vitamins|mesh-ancestor
5818400|NCT02627222|Micronutrients|micronutrients|mesh-ancestor
5818401|NCT02627222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818402|NCT02627027|Metformin|metformin|mesh-list
5818403|NCT02627027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5818404|NCT02627027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818405|NCT02627248|Cyclophosphamide|cyclophosphamide|mesh-list
5818406|NCT02627248|Docetaxel|docetaxel|mesh-list
6492715|NCT00610246|Sorafenib|sorafenib|mesh-list
5644928|NCT05219435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5644929|NCT05219435|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5644930|NCT05219435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644931|NCT05219409|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5644932|NCT05219409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5644933|NCT05219409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644934|NCT05219409|Incretins|incretins|mesh-ancestor
5644935|NCT05219409|Hormones|hormones|mesh-ancestor
6492716|NCT00610246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6492717|NCT00610246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6492718|NCT00610246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6492719|NCT00610246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492720|NCT00610324|Chlorhexidine|chlorhexidine|mesh-list
5644936|NCT05219409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5644937|NCT05219409|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5644938|NCT05219409|Protease Inhibitors|protease inhibitors|mesh-ancestor
5644939|NCT05219409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5644940|NCT05219409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644941|NCT05219266|Midostaurin|midostaurin|mesh-list
5644942|NCT05219266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5818407|NCT02627248|Epirubicin|epirubicin|mesh-list
5818408|NCT02627248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5818409|NCT02627248|Immunologic Factors|immunologic factors|mesh-ancestor
5901371|NCT03537690|Antimitotic Agents|antimitotic agents|mesh-ancestor
5818410|NCT02627248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818411|NCT02627248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5818412|NCT02627248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5818413|NCT02627248|Alkylating Agents|alkylating agents|mesh-ancestor
5818414|NCT02627248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818415|NCT02627248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5818416|NCT02627248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5818417|NCT02627248|Tubulin Modulators|tubulin modulators|mesh-ancestor
5818418|NCT02627248|Antimitotic Agents|antimitotic agents|mesh-ancestor
5818419|NCT02627248|Mitosis Modulators|mitosis modulators|mesh-ancestor
5818420|NCT02627248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5818421|NCT02627248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5818422|NCT02627248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5818423|NCT02627248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5901372|NCT03537690|Mitosis Modulators|mitosis modulators|mesh-ancestor
5901373|NCT03537690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901374|NCT03536728|Eflornithine|eflornithine|mesh-list
5901375|NCT03536728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901376|NCT03536728|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5901377|NCT03536728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5901378|NCT03536728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5901379|NCT03536728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5901380|NCT03536728|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
5901381|NCT03536728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5901382|NCT03536728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901383|NCT03510390|Metformin|metformin|mesh-list
5901384|NCT03510390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5901385|NCT03510390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901386|NCT03449108|Aldesleukin|aldesleukin|mesh-list
5901387|NCT03449108|Cyclophosphamide|cyclophosphamide|mesh-list
5901388|NCT03449108|Nivolumab|nivolumab|mesh-list
5901389|NCT03449108|Fludarabine|fludarabine|mesh-list
5901390|NCT03449108|Ipilimumab|ipilimumab|mesh-list
5901391|NCT03449108|Interleukin-2|interleukin-2|mesh-list
5901392|NCT03449108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5901393|NCT03449108|Immunologic Factors|immunologic factors|mesh-ancestor
5901394|NCT03449108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901395|NCT03449108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5901396|NCT03449108|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5901397|NCT03449108|Alkylating Agents|alkylating agents|mesh-ancestor
5901398|NCT03449108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901399|NCT03449108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901400|NCT03449108|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5901401|NCT03449108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5901402|NCT03449108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5901403|NCT03449108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5901404|NCT03449108|Analgesics|analgesics|mesh-ancestor
5901405|NCT03449108|Sensory System Agents|sensory system agents|mesh-ancestor
5901406|NCT03449108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5901407|NCT03449108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5901408|NCT03449108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5901409|NCT03449108|Antiviral Agents|antiviral agents|mesh-ancestor
5901410|NCT03449108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5901411|NCT03442088|Apremilast|apremilast|mesh-list
5901412|NCT03442088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5901413|NCT03442088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5901414|NCT03442088|Analgesics|analgesics|mesh-ancestor
5901415|NCT03442088|Sensory System Agents|sensory system agents|mesh-ancestor
5901416|NCT03442088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5901417|NCT03442088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644943|NCT05219266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5644944|NCT05219266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5644945|NCT05219266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644946|NCT05201300|Propofol|propofol|mesh-list
5644947|NCT05201300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5644948|NCT05201300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5644949|NCT05201300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644950|NCT05201300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5644951|NCT05201300|Anesthetics, General|anesthetics, general|mesh-ancestor
5901418|NCT03442088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5901419|NCT03442088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5901420|NCT03442088|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5901421|NCT03442088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5901422|NCT03442088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5644952|NCT05201300|Anesthetics|anesthetics|mesh-ancestor
5644953|NCT05198453|Vaccines|vaccines|mesh-list
5644954|NCT05198453|Immunologic Factors|immunologic factors|mesh-ancestor
5818424|NCT02627092|Copper|copper|mesh-list
5818425|NCT02627092|Trace Elements|trace elements|mesh-ancestor
5644955|NCT05198453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644956|NCT05197374|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5644957|NCT05197374|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5644958|NCT05197374|Estradiol|estradiol|mesh-list
5644959|NCT05197374|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5644960|NCT05197374|Estrogens|estrogens|mesh-ancestor
5644961|NCT05197374|Hormones|hormones|mesh-ancestor
5644962|NCT05197374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5644963|NCT05197374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644964|NCT05197374|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5644965|NCT05197374|Contraceptive Agents|contraceptive agents|mesh-ancestor
5818426|NCT02627092|Micronutrients|micronutrients|mesh-ancestor
5818427|NCT02627092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818428|NCT02626936|Insulin|insulin|mesh-list
5818429|NCT02626936|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5818430|NCT02626936|Glucagon|glucagon|mesh-list
5818431|NCT02626936|Hormones|hormones|mesh-list
5818432|NCT02626936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5644966|NCT05197374|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5644967|NCT05197374|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5644968|NCT05192200|Interferons|interferons|mesh-list
5644969|NCT05192200|Interferon-beta|interferon-beta|mesh-list
5644970|NCT05192200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5644971|NCT05192200|Antiviral Agents|antiviral agents|mesh-ancestor
5644972|NCT05192200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5644973|NCT05192200|Immunologic Factors|immunologic factors|mesh-ancestor
5644974|NCT05192200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5644975|NCT05191290|Heparin|heparin|mesh-list
5644976|NCT05191290|Calcium heparin|calcium heparin|mesh-list
5644977|NCT05191290|Citric Acid|citric acid|mesh-list
5644978|NCT05191290|Sodium Citrate|sodium citrate|mesh-list
5644979|NCT05191290|Anticoagulants|anticoagulants|mesh-ancestor
5644980|NCT05191290|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5644981|NCT05191290|Chelating Agents|chelating agents|mesh-ancestor
5644982|NCT05191290|Sequestering Agents|sequestering agents|mesh-ancestor
5644983|NCT05191290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5644984|NCT05191290|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5818433|NCT02626936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818434|NCT02626936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5818435|NCT02626936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5818436|NCT02626962|Nivolumab|nivolumab|mesh-list
5818437|NCT02626962|Ipilimumab|ipilimumab|mesh-list
5818438|NCT02626962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5818439|NCT02626962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5818440|NCT02626962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5818441|NCT02626962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818442|NCT02626754|Sunitinib|sunitinib|mesh-list
5818443|NCT02626754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5818444|NCT02626754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5818445|NCT02626754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5644985|NCT05191290|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5644986|NCT05189444|Amoxicillin|amoxicillin|mesh-list
5644987|NCT05189444|Clarithromycin|clarithromycin|mesh-list
5818446|NCT02626754|Growth Substances|growth substances|mesh-ancestor
5818447|NCT02626754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818448|NCT02626754|Growth Inhibitors|growth inhibitors|mesh-ancestor
5818449|NCT02626754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5818450|NCT02626754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5818451|NCT02626754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818452|NCT02626845|Rituximab|rituximab|mesh-list
5818453|NCT02626845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5818454|NCT02626845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5818455|NCT02626845|Immunologic Factors|immunologic factors|mesh-ancestor
5818456|NCT02626845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818457|NCT02626845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5818458|NCT02626364|Crenolanib|crenolanib|mesh-list
5818459|NCT02626364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5818460|NCT02626559|Bupivacaine|bupivacaine|mesh-list
5644988|NCT05189444|Potassium Citrate|potassium citrate|mesh-list
5818461|NCT02626559|Anesthetics, Local|anesthetics, local|mesh-ancestor
5644989|NCT05189444|Esomeprazole|esomeprazole|mesh-list
5644990|NCT05189444|Bismuth|bismuth|mesh-list
5818462|NCT02626559|Anesthetics|anesthetics|mesh-ancestor
5818463|NCT02626559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5644991|NCT05189444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818464|NCT02626559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818465|NCT02626559|Sensory System Agents|sensory system agents|mesh-ancestor
5818466|NCT02626559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5818467|NCT02626247|Vitamin A|vitamin a|mesh-list
5818468|NCT02626247|Vitamins|vitamins|mesh-ancestor
5818469|NCT02626247|Micronutrients|micronutrients|mesh-ancestor
5644992|NCT05189444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5644993|NCT05189444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5644994|NCT05189444|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5644995|NCT05189444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5644996|NCT05189444|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5644997|NCT05189444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5644998|NCT05189444|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5644999|NCT05189444|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5645000|NCT05189444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5645001|NCT05189444|Antacids|antacids|mesh-ancestor
5645002|NCT05189444|Diuretics|diuretics|mesh-ancestor
5645003|NCT05189444|Natriuretic Agents|natriuretic agents|mesh-ancestor
5645004|NCT05189444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645005|NCT05189444|Expectorants|expectorants|mesh-ancestor
5645006|NCT05189444|Respiratory System Agents|respiratory system agents|mesh-ancestor
5645007|NCT05189028|Gemcitabine|gemcitabine|mesh-list
5645008|NCT05189028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5818470|NCT02626247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818471|NCT02626169|Clopidogrel|clopidogrel|mesh-list
5818472|NCT02626169|Ticagrelor|ticagrelor|mesh-list
5818473|NCT02626169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5818474|NCT02626169|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5818475|NCT02626169|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5818476|NCT02626169|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5818477|NCT02626169|Purinergic Agents|purinergic agents|mesh-ancestor
5645009|NCT05189028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5645010|NCT05189028|Antimetabolites|antimetabolites|mesh-ancestor
5645011|NCT05189028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818478|NCT02626169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5818479|NCT02626169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818480|NCT02626169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818481|NCT02626208|ST 1435|st 1435|mesh-list
5818482|NCT02626208|Contraceptive Agents|contraceptive agents|mesh-list
5818483|NCT02626208|Estradiol|estradiol|mesh-list
5818484|NCT02626208|Estrogens|estrogens|mesh-ancestor
5818485|NCT02626208|Hormones|hormones|mesh-ancestor
5818486|NCT02626208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5818487|NCT02626208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818488|NCT02626208|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5818489|NCT02626208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5818490|NCT02626208|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5818491|NCT02626234|Digoxin|digoxin|mesh-list
5818492|NCT02626234|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5818493|NCT02626234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5818494|NCT02626234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5818495|NCT02626234|Antimetabolites|antimetabolites|mesh-ancestor
5818496|NCT02626234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818497|NCT02626234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5818498|NCT02626234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5818499|NCT02626234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5818500|NCT02626234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5818501|NCT02626234|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5818502|NCT02626234|Protective Agents|protective agents|mesh-ancestor
5818503|NCT02626234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818504|NCT02626481|Dexamethasone|dexamethasone|mesh-list
5818505|NCT02626481|Daratumumab|daratumumab|mesh-list
5818506|NCT02626481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5818507|NCT02626481|Antiemetics|antiemetics|mesh-ancestor
5818508|NCT02626481|Autonomic Agents|autonomic agents|mesh-ancestor
5645012|NCT05189028|Antiviral Agents|antiviral agents|mesh-ancestor
5645013|NCT05189028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5645014|NCT05189028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5645015|NCT05189028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5645016|NCT05189028|Immunologic Factors|immunologic factors|mesh-ancestor
5645017|NCT05189028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645018|NCT05187377|Hormones|hormones|mesh-list
5645019|NCT05187377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5645020|NCT05187377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818509|NCT02626481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5645021|NCT05184868|Insulin Aspart|insulin aspart|mesh-list
5645022|NCT05184868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5645023|NCT05184868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694124|NCT03397199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5694125|NCT03397199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5694126|NCT03397199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694127|NCT03397186|Trabectedin|trabectedin|mesh-list
5694128|NCT03397186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5694129|NCT03397186|Alkylating Agents|alkylating agents|mesh-ancestor
5694130|NCT03397186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694131|NCT03397186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5694132|NCT03397173|Ascorbic Acid|ascorbic acid|mesh-list
5694133|NCT03397173|Azacitidine|azacitidine|mesh-list
5694134|NCT03397173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5694135|NCT03397173|Antimetabolites|antimetabolites|mesh-ancestor
5694136|NCT03397173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694137|NCT03397173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5694138|NCT03397173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5694139|NCT03397173|Antioxidants|antioxidants|mesh-ancestor
5694140|NCT03397173|Protective Agents|protective agents|mesh-ancestor
5694141|NCT03397173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694142|NCT03397173|Vitamins|vitamins|mesh-ancestor
5694143|NCT03397173|Micronutrients|micronutrients|mesh-ancestor
5694144|NCT03397082|Lidocaine|lidocaine|mesh-list
5694145|NCT03397082|Anesthetics, Local|anesthetics, local|mesh-ancestor
5694146|NCT03397082|Anesthetics|anesthetics|mesh-ancestor
5694147|NCT03397082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5694148|NCT03397082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694149|NCT03397082|Sensory System Agents|sensory system agents|mesh-ancestor
5694150|NCT03397082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5694151|NCT03397082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5694152|NCT03397082|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5694153|NCT03397082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5694154|NCT03397082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5694155|NCT03397082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694156|NCT03397069|Midazolam|midazolam|mesh-list
5694157|NCT03397069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5694158|NCT03397069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5694159|NCT03397069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5694160|NCT03397069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694161|NCT03397069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5694162|NCT03397069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5694163|NCT03397069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5694164|NCT03397069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5694165|NCT03397069|Anesthetics, General|anesthetics, general|mesh-ancestor
5694166|NCT03397069|Anesthetics|anesthetics|mesh-ancestor
5694167|NCT03397069|GABA Modulators|gaba modulators|mesh-ancestor
5694168|NCT03397069|GABA Agents|gaba agents|mesh-ancestor
5694169|NCT03397069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5694170|NCT03397069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694171|NCT03396926|Bevacizumab|bevacizumab|mesh-list
5694172|NCT03396926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5694173|NCT03396926|Pembrolizumab|pembrolizumab|mesh-list
5694174|NCT03396926|Capecitabine|capecitabine|mesh-list
5694175|NCT03396926|Endothelial Growth Factors|endothelial growth factors|mesh-list
5818510|NCT02626481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818511|NCT02626481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5818512|NCT02626481|Glucocorticoids|glucocorticoids|mesh-ancestor
5818513|NCT02626481|Hormones|hormones|mesh-ancestor
5818514|NCT02626481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5818515|NCT02626481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5818516|NCT02626481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5818517|NCT02626065|Nivolumab|nivolumab|mesh-list
5818518|NCT02626065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5818519|NCT02626065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5818520|NCT02626065|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5818521|NCT02626065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818522|NCT02625961|Pembrolizumab|pembrolizumab|mesh-list
5818523|NCT02625961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5818524|NCT02625961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5818525|NCT02626104|Lactoferrin|lactoferrin|mesh-list
5818526|NCT02626104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5818527|NCT02626130|Tremelimumab|tremelimumab|mesh-list
5694176|NCT03396926|Antibodies|antibodies|mesh-list
5818528|NCT02626130|Ipilimumab|ipilimumab|mesh-list
5818529|NCT02626130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5818530|NCT02626130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5818531|NCT02626130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5818532|NCT02626130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818533|NCT02625948|Tranexamic Acid|tranexamic acid|mesh-list
5818534|NCT02625948|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5818535|NCT02625948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5818536|NCT02625948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818537|NCT02625948|Hemostatics|hemostatics|mesh-ancestor
5818538|NCT02625948|Coagulants|coagulants|mesh-ancestor
5818539|NCT02625753|Acetaminophen|acetaminophen|mesh-list
5818540|NCT02625753|Codeine|codeine|mesh-list
5818541|NCT02625753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5818542|NCT02625753|Analgesics|analgesics|mesh-ancestor
5818543|NCT02625753|Sensory System Agents|sensory system agents|mesh-ancestor
5818544|NCT02625753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5818545|NCT02625753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645024|NCT05181124|Naproxen|naproxen|mesh-list
5645025|NCT05181124|Meloxicam|meloxicam|mesh-list
5645026|NCT05181124|Aceclofenac|aceclofenac|mesh-list
5645027|NCT05181124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5645028|NCT05181124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5645029|NCT05181124|Analgesics|analgesics|mesh-ancestor
5645030|NCT05181124|Sensory System Agents|sensory system agents|mesh-ancestor
5645031|NCT05181124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5645032|NCT05181124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645033|NCT05181124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5645034|NCT05181124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5645035|NCT05181124|Gout Suppressants|gout suppressants|mesh-ancestor
5645036|NCT05181124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5645037|NCT05181124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5645038|NCT05181124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5645039|NCT05181124|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5645040|NCT05180591|BCG Vaccine|bcg vaccine|mesh-list
5645041|NCT05180591|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5645042|NCT05180591|Immunologic Factors|immunologic factors|mesh-ancestor
5645043|NCT05180591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645044|NCT05179876|Selexipag|selexipag|mesh-list
5645045|NCT05179876|Tadalafil|tadalafil|mesh-list
5645046|NCT05179876|Macitentan|macitentan|mesh-list
5645047|NCT05179876|Vasodilator Agents|vasodilator agents|mesh-ancestor
5645048|NCT05179876|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5645049|NCT05179876|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5645050|NCT05179876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5645051|NCT05179876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5645052|NCT05179876|Urological Agents|urological agents|mesh-ancestor
5645053|NCT05179876|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
5645054|NCT05179876|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5645055|NCT05179876|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
5645056|NCT05179876|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5645057|NCT05179499|Norepinephrine|norepinephrine|mesh-list
5645058|NCT05179499|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5818546|NCT02625753|Antipyretics|antipyretics|mesh-ancestor
5818547|NCT02625753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5818548|NCT02625753|Narcotics|narcotics|mesh-ancestor
5818549|NCT02625753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5818550|NCT02625753|Antitussive Agents|antitussive agents|mesh-ancestor
5818551|NCT02625753|Respiratory System Agents|respiratory system agents|mesh-ancestor
5818552|NCT02625779|Valproic Acid|valproic acid|mesh-list
5818553|NCT02625779|Anticonvulsants|anticonvulsants|mesh-ancestor
5818554|NCT02625779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5818555|NCT02625779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818556|NCT02625779|GABA Agents|gaba agents|mesh-ancestor
5818557|NCT02625779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5818558|NCT02625779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818559|NCT02625779|Antimanic Agents|antimanic agents|mesh-ancestor
5818560|NCT02625779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5818561|NCT02625779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5818562|NCT02625779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5818563|NCT02625805|Methylphenidate|methylphenidate|mesh-list
5818564|NCT02625805|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5645059|NCT05179499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5645060|NCT05179499|Adrenergic Agents|adrenergic agents|mesh-ancestor
5818565|NCT02625805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818566|NCT02625805|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5818567|NCT02625805|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5818568|NCT02625805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5818569|NCT02625805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818570|NCT02625805|Dopamine Agents|dopamine agents|mesh-ancestor
5818571|NCT02625805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5818572|NCT02625740|Paclitaxel|paclitaxel|mesh-list
5818573|NCT02625740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5818574|NCT02625740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5818575|NCT02625740|Tubulin Modulators|tubulin modulators|mesh-ancestor
5818576|NCT02625740|Antimitotic Agents|antimitotic agents|mesh-ancestor
5818577|NCT02625740|Mitosis Modulators|mitosis modulators|mesh-ancestor
5818578|NCT02625740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5645061|NCT05179499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5645062|NCT05179499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5645063|NCT05179499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645064|NCT05179499|Sympathomimetics|sympathomimetics|mesh-ancestor
5645065|NCT05179499|Autonomic Agents|autonomic agents|mesh-ancestor
5645066|NCT05179499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5645067|NCT05179499|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5818579|NCT02625519|Hormones|hormones|mesh-list
5818580|NCT02625519|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5818581|NCT02625519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5818582|NCT02625519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818583|NCT02625636|Glucagon|glucagon|mesh-list
5818584|NCT02625636|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5818585|NCT02625636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5818586|NCT02625636|Hormones|hormones|mesh-ancestor
5818587|NCT02625636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5818588|NCT02625636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818589|NCT02625636|Incretins|incretins|mesh-ancestor
5818590|NCT02625727|Hyaluronic Acid|hyaluronic acid|mesh-list
5818591|NCT02625727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5818592|NCT02625727|Immunologic Factors|immunologic factors|mesh-ancestor
5818593|NCT02625727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645068|NCT05179421|Oxytocin|oxytocin|mesh-list
5645069|NCT05179421|Oxytocics|oxytocics|mesh-ancestor
5645070|NCT05179421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5645071|NCT05179421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645072|NCT05174507|Empagliflozin|empagliflozin|mesh-list
5645073|NCT05174507|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5645074|NCT05174507|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5645075|NCT05174507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5645076|NCT05174507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5645077|NCT05174507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645078|NCT05174507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5818594|NCT02625727|Viscosupplements|viscosupplements|mesh-ancestor
5818595|NCT02625727|Protective Agents|protective agents|mesh-ancestor
5645079|NCT05172245|Cisplatin|cisplatin|mesh-list
5645080|NCT05172245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5645081|NCT05171387|Androgens|androgens|mesh-list
5645082|NCT05171387|Hormones|hormones|mesh-ancestor
5645083|NCT05171387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5645084|NCT05171387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645085|NCT05169437|Niraparib|niraparib|mesh-list
5645086|NCT05169437|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5645087|NCT05169437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5645088|NCT05169437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5645089|NCT05169437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5645090|NCT05168644|Niclosamide|niclosamide|mesh-list
5645091|NCT05168644|Anticestodal Agents|anticestodal agents|mesh-ancestor
5645092|NCT05168644|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5645093|NCT05168644|Anthelmintics|anthelmintics|mesh-ancestor
5645094|NCT05168644|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5645095|NCT05168644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5645096|NCT05168644|Antinematodal Agents|antinematodal agents|mesh-ancestor
5645097|NCT05167825|Macitentan|macitentan|mesh-list
5645098|NCT05167825|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
5645099|NCT05167825|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5645100|NCT05167825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818596|NCT02625506|Tramadol|tramadol|mesh-list
5818597|NCT02625506|Levobupivacaine|levobupivacaine|mesh-list
5818598|NCT02625506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5818599|NCT02625506|Narcotics|narcotics|mesh-ancestor
5818600|NCT02625506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5818601|NCT02625506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818602|NCT02625506|Analgesics|analgesics|mesh-ancestor
5818603|NCT02625506|Sensory System Agents|sensory system agents|mesh-ancestor
5818604|NCT02625506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5818605|NCT02625506|Anesthetics, Local|anesthetics, local|mesh-ancestor
5818606|NCT02625506|Anesthetics|anesthetics|mesh-ancestor
5818607|NCT02625558|Riociguat|riociguat|mesh-list
5818608|NCT02625558|Enzyme Activators|enzyme activators|mesh-ancestor
5818609|NCT02625558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901423|NCT03442088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901424|NCT03291990|Temozolomide|temozolomide|mesh-list
5901425|NCT03291990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5901426|NCT03291990|Alkylating Agents|alkylating agents|mesh-ancestor
5901427|NCT03291990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901428|NCT03291990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901429|NCT03277924|Doxorubicin|doxorubicin|mesh-list
5901430|NCT03277924|Methotrexate|methotrexate|mesh-list
5901431|NCT03277924|Nivolumab|nivolumab|mesh-list
5901432|NCT03277924|Sunitinib|sunitinib|mesh-list
5901433|NCT03277924|Epirubicin|epirubicin|mesh-list
6492721|NCT00610324|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6492722|NCT00610324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6492723|NCT00610324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6492724|NCT00610324|Disinfectants|disinfectants|mesh-ancestor
6492725|NCT00610324|Dermatologic Agents|dermatologic agents|mesh-ancestor
6492726|NCT00610350|Simendan|simendan|mesh-list
6492727|NCT00610350|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6492728|NCT00610350|Vasodilator Agents|vasodilator agents|mesh-ancestor
6492729|NCT00610350|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6492730|NCT00610350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6492731|NCT00610350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6492732|NCT00610350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492733|NCT00610350|Protective Agents|protective agents|mesh-ancestor
6492734|NCT00610350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492735|NCT00610454|Levetiracetam|levetiracetam|mesh-list
6492736|NCT00610454|Anticonvulsants|anticonvulsants|mesh-ancestor
6492737|NCT00610454|Nootropic Agents|nootropic agents|mesh-ancestor
6492738|NCT00610493|Sirolimus|sirolimus|mesh-list
6492739|NCT00610493|Bevacizumab|bevacizumab|mesh-list
6492740|NCT00610493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6492741|NCT00610493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6492742|NCT00610493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6492743|NCT00610493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6492744|NCT00610493|Growth Substances|growth substances|mesh-ancestor
5901434|NCT03277924|Ifosfamide|ifosfamide|mesh-list
5901435|NCT03277924|Dacarbazine|dacarbazine|mesh-list
5645101|NCT05167825|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
5645102|NCT05166876|Brequinar|brequinar|mesh-list
5645103|NCT05166876|Dipyridamole|dipyridamole|mesh-list
6492745|NCT00610493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492746|NCT00610493|Growth Inhibitors|growth inhibitors|mesh-ancestor
6492747|NCT00610493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5645104|NCT05166876|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5645105|NCT05166876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5645106|NCT05166876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5645107|NCT05166876|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5645108|NCT05166876|Vasodilator Agents|vasodilator agents|mesh-ancestor
5645109|NCT05166876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5645110|NCT05166876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5645111|NCT05166876|Immunologic Factors|immunologic factors|mesh-ancestor
5645112|NCT05166876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645113|NCT05165836|Dexmedetomidine|dexmedetomidine|mesh-list
5645114|NCT05165836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5645115|NCT05165836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5901436|NCT03277924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901437|NCT03277924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5901438|NCT03277924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5901439|NCT03277924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5901440|NCT03277924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5901441|NCT03277924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901442|NCT03277924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5901443|NCT03277924|Abortifacient Agents|abortifacient agents|mesh-ancestor
5901444|NCT03277924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6492748|NCT00610493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5645116|NCT05165836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645117|NCT05165836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5645118|NCT05165836|Analgesics|analgesics|mesh-ancestor
5645119|NCT05165836|Sensory System Agents|sensory system agents|mesh-ancestor
5645120|NCT05165836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5645121|NCT05165836|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5645122|NCT05165836|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5645123|NCT05165836|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5645124|NCT05165836|Adrenergic Agents|adrenergic agents|mesh-ancestor
5645125|NCT05165836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5645126|NCT05165836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5645127|NCT05159778|Pembrolizumab|pembrolizumab|mesh-list
5645128|NCT05159778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5645129|NCT05159778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5645130|NCT05152147|Fluorouracil|fluorouracil|mesh-list
5645131|NCT05152147|Capecitabine|capecitabine|mesh-list
5645132|NCT05152147|Oxaliplatin|oxaliplatin|mesh-list
5645133|NCT05152147|Trastuzumab|trastuzumab|mesh-list
5645134|NCT05152147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5645135|NCT05152147|Antimetabolites|antimetabolites|mesh-ancestor
5645136|NCT05152147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5645137|NCT05152147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5645138|NCT05152147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5645139|NCT05152147|Immunologic Factors|immunologic factors|mesh-ancestor
5645140|NCT05152147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645141|NCT05152147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5645142|NCT05149131|Leuprolide|leuprolide|mesh-list
5645143|NCT05149131|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5645144|NCT05149131|Fertility Agents|fertility agents|mesh-ancestor
5645145|NCT05149131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5645146|NCT05149131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645147|NCT05149131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5645148|NCT05149131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5645149|NCT05145907|Pembrolizumab|pembrolizumab|mesh-list
5645150|NCT05145907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5645151|NCT05145907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5645152|NCT05141357|Pembrolizumab|pembrolizumab|mesh-list
5645153|NCT05141357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5645154|NCT05141357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5645155|NCT05139225|Daratumumab|daratumumab|mesh-list
5645156|NCT05139225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5818610|NCT02625415|Vitamins|vitamins|mesh-list
5818611|NCT02625415|Vitamin B 6|vitamin b 6|mesh-list
5818612|NCT02625415|Pyridoxal|pyridoxal|mesh-list
5818613|NCT02625415|Pyridoxine|pyridoxine|mesh-list
5818614|NCT02625415|Vitamin B Complex|vitamin b complex|mesh-list
5818615|NCT02625415|Micronutrients|micronutrients|mesh-ancestor
5818616|NCT02625415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818617|NCT02625389|Ethiodized Oil|ethiodized oil|mesh-list
5818618|NCT02625389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5818619|NCT02625454|Acetaminophen|acetaminophen|mesh-list
5818620|NCT02625454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5818621|NCT02625454|Analgesics|analgesics|mesh-ancestor
5645157|NCT05126264|Ibuprofen|ibuprofen|mesh-list
5645158|NCT05126264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5645159|NCT05126264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5645160|NCT05126264|Analgesics|analgesics|mesh-ancestor
5645161|NCT05126264|Sensory System Agents|sensory system agents|mesh-ancestor
5645162|NCT05126264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5645163|NCT05126264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645164|NCT05126264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5645165|NCT05126264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5645166|NCT05126264|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5645167|NCT05126264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5818622|NCT02625454|Sensory System Agents|sensory system agents|mesh-ancestor
5818623|NCT02625454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5818624|NCT02625454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818625|NCT02625454|Antipyretics|antipyretics|mesh-ancestor
5818626|NCT02625103|Clozapine|clozapine|mesh-list
5818627|NCT02625103|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5818628|NCT02625103|Serotonin Agents|serotonin agents|mesh-ancestor
5818629|NCT02625103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5818630|NCT02625103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818631|NCT02625103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818632|NCT02625103|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5818633|NCT02625103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5645168|NCT05126264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818634|NCT02625103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5818635|NCT02625103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5818636|NCT02625103|GABA Antagonists|gaba antagonists|mesh-ancestor
5818637|NCT02625103|GABA Agents|gaba agents|mesh-ancestor
5818638|NCT02625376|Resveratrol|resveratrol|mesh-list
5818639|NCT02625376|Antioxidants|antioxidants|mesh-ancestor
5818640|NCT02625376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818641|NCT02625376|Protective Agents|protective agents|mesh-ancestor
5818642|NCT02625376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818643|NCT02625376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5818644|NCT02625376|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5818645|NCT02625168|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5818646|NCT02625168|Afatinib|afatinib|mesh-list
5818647|NCT02625168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5818648|NCT02625168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5818649|NCT02625168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5818650|NCT02625168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818651|NCT02625337|Pembrolizumab|pembrolizumab|mesh-list
5818652|NCT02625337|Trametinib|trametinib|mesh-list
5818653|NCT02625337|Dabrafenib|dabrafenib|mesh-list
5818654|NCT02625337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5818655|NCT02625337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5818656|NCT02625337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5818657|NCT02625337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5818658|NCT02625337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818659|NCT02624999|Cisplatin|cisplatin|mesh-list
5818660|NCT02624999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5818661|NCT02624856|Dexamethasone|dexamethasone|mesh-list
5818662|NCT02624856|Bupivacaine|bupivacaine|mesh-list
5818663|NCT02624856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5818664|NCT02624856|Antiemetics|antiemetics|mesh-ancestor
5818665|NCT02624856|Autonomic Agents|autonomic agents|mesh-ancestor
5818666|NCT02624856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5818667|NCT02624856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818668|NCT02624856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5818669|NCT02624856|Glucocorticoids|glucocorticoids|mesh-ancestor
5818670|NCT02624856|Hormones|hormones|mesh-ancestor
5818671|NCT02624856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5818672|NCT02624856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5818673|NCT02624856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5818674|NCT02624856|Anesthetics, Local|anesthetics, local|mesh-ancestor
5818675|NCT02624856|Anesthetics|anesthetics|mesh-ancestor
5818676|NCT02624856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5818677|NCT02624856|Sensory System Agents|sensory system agents|mesh-ancestor
5818678|NCT02624973|Tamoxifen|tamoxifen|mesh-list
5818679|NCT02624973|Cyclophosphamide|cyclophosphamide|mesh-list
5818680|NCT02624973|Docetaxel|docetaxel|mesh-list
5818681|NCT02624973|Trastuzumab|trastuzumab|mesh-list
5818682|NCT02624973|Letrozole|letrozole|mesh-list
5818683|NCT02624973|Epirubicin|epirubicin|mesh-list
5818684|NCT02624973|Olaparib|olaparib|mesh-list
5818685|NCT02624973|Palbociclib|palbociclib|mesh-list
5818686|NCT02624973|Goserelin|goserelin|mesh-list
5818687|NCT02624973|Pertuzumab|pertuzumab|mesh-list
5818688|NCT02624973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5818689|NCT02624973|Immunologic Factors|immunologic factors|mesh-ancestor
5818690|NCT02624973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818691|NCT02624973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5818692|NCT02624973|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5818693|NCT02624973|Alkylating Agents|alkylating agents|mesh-ancestor
5818694|NCT02624973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818695|NCT02624973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5818696|NCT02624973|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5818697|NCT02624973|Tubulin Modulators|tubulin modulators|mesh-ancestor
5818698|NCT02624973|Antimitotic Agents|antimitotic agents|mesh-ancestor
6492749|NCT00610493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5645169|NCT05113537|177Lu-PSMA-617|177lu-psma-617|mesh-list
5645170|NCT05113537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5645171|NCT05113537|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5645172|NCT05107427|Avelumab|avelumab|mesh-list
5645173|NCT05107427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5645174|NCT05107427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5645175|NCT05106153|Zolpidem|zolpidem|mesh-list
5818699|NCT02624973|Mitosis Modulators|mitosis modulators|mesh-ancestor
5818700|NCT02624973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5818701|NCT02624973|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6492750|NCT00610493|Antifungal Agents|antifungal agents|mesh-ancestor
5818702|NCT02624973|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5818703|NCT02624973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5818704|NCT02624973|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5818705|NCT02624973|Hormone Antagonists|hormone antagonists|mesh-ancestor
5818706|NCT02624973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5818707|NCT02624973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5818708|NCT02624973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5818709|NCT02624973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5818710|NCT02624973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5818711|NCT02624973|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5818712|NCT02624973|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5818713|NCT02624973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5818714|NCT02624973|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5818715|NCT02624973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5818716|NCT02624817|Glyburide|glyburide|mesh-list
5818717|NCT02624817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5645176|NCT05106153|Suvorexant|suvorexant|mesh-list
5645177|NCT05106153|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5645178|NCT05106153|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5645179|NCT05106153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5645180|NCT05106153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645181|NCT05106153|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
5645182|NCT05106153|GABA Agonists|gaba agonists|mesh-ancestor
5645183|NCT05106153|GABA Agents|gaba agents|mesh-ancestor
5645184|NCT05106153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5645185|NCT05106153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5645186|NCT05106153|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
5645187|NCT05104866|Gemcitabine|gemcitabine|mesh-list
5645188|NCT05104866|Capecitabine|capecitabine|mesh-list
5645189|NCT05104866|Vinorelbine|vinorelbine|mesh-list
5645190|NCT05104866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5645191|NCT05104866|Antimetabolites|antimetabolites|mesh-ancestor
5645192|NCT05104866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5645193|NCT05104866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5645194|NCT05104866|Antiviral Agents|antiviral agents|mesh-ancestor
5645195|NCT05104866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5645196|NCT05104866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5645197|NCT05104866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5818718|NCT02624817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492751|NCT00610493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6492752|NCT00610493|Immunologic Factors|immunologic factors|mesh-ancestor
6492753|NCT00610506|Dexetimide|dexetimide|mesh-list
6492754|NCT00610506|Citalopram|citalopram|mesh-list
6492755|NCT00610506|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6492756|NCT00610506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6492757|NCT00610506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6492758|NCT00610506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492759|NCT00610506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6492760|NCT00610506|Serotonin Agents|serotonin agents|mesh-ancestor
6492761|NCT00610506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492762|NCT00610506|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6492763|NCT00610506|Antidepressive Agents|antidepressive agents|mesh-ancestor
6492764|NCT00610506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6492765|NCT00610506|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6492766|NCT00610506|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6492767|NCT00610506|Parasympatholytics|parasympatholytics|mesh-ancestor
6492768|NCT00610506|Autonomic Agents|autonomic agents|mesh-ancestor
6492769|NCT00610506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5645198|NCT05104866|Immunologic Factors|immunologic factors|mesh-ancestor
5818719|NCT02624908|Canagliflozin|canagliflozin|mesh-list
5818720|NCT02624908|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5818721|NCT02624908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818722|NCT02624908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5818723|NCT02624908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818724|NCT02624726|Leucovorin|leucovorin|mesh-list
5818725|NCT02624726|Fluorouracil|fluorouracil|mesh-list
5818726|NCT02624726|Irinotecan|irinotecan|mesh-list
5818727|NCT02624726|Aflibercept|aflibercept|mesh-list
5818728|NCT02624726|Levoleucovorin|levoleucovorin|mesh-list
5818729|NCT02624726|Antimetabolites|antimetabolites|mesh-ancestor
5818730|NCT02624726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818731|NCT02624726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6492770|NCT00610506|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5818732|NCT02624726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5818733|NCT02624726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5818734|NCT02624726|Immunologic Factors|immunologic factors|mesh-ancestor
5818735|NCT02624726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818736|NCT02624726|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5818737|NCT02624726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5818738|NCT02624726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5818739|NCT02624726|Antidotes|antidotes|mesh-ancestor
5818740|NCT02624726|Protective Agents|protective agents|mesh-ancestor
5818741|NCT02624726|Vitamin B Complex|vitamin b complex|mesh-ancestor
5818742|NCT02624726|Vitamins|vitamins|mesh-ancestor
5818743|NCT02624726|Micronutrients|micronutrients|mesh-ancestor
5818744|NCT02624726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5818745|NCT02624726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5818746|NCT02624726|Growth Substances|growth substances|mesh-ancestor
5818747|NCT02624726|Growth Inhibitors|growth inhibitors|mesh-ancestor
5818748|NCT02624830|Glyburide|glyburide|mesh-list
5818749|NCT02624830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5818750|NCT02624830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818751|NCT02624661|Glycerol|glycerol|mesh-list
5818752|NCT02624661|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
5645199|NCT05104866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645200|NCT05104866|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5645201|NCT05104866|Tubulin Modulators|tubulin modulators|mesh-ancestor
5645202|NCT05104866|Antimitotic Agents|antimitotic agents|mesh-ancestor
5645203|NCT05104866|Mitosis Modulators|mitosis modulators|mesh-ancestor
5645204|NCT05095311|Cetirizine|cetirizine|mesh-list
5645205|NCT05095311|Nedocromil|nedocromil|mesh-list
5645206|NCT05095311|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5645207|NCT05095311|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5645208|NCT05095311|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5645209|NCT05095311|Histamine Antagonists|histamine antagonists|mesh-ancestor
5645210|NCT05095311|Histamine Agents|histamine agents|mesh-ancestor
5645211|NCT05095311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5645212|NCT05095311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5645213|NCT05095311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645214|NCT05095311|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
5645215|NCT05095311|Immunologic Factors|immunologic factors|mesh-ancestor
5645216|NCT05095311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5645217|NCT05095311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5645218|NCT05095311|Respiratory System Agents|respiratory system agents|mesh-ancestor
5645219|NCT05092269|Ustekinumab|ustekinumab|mesh-list
5645220|NCT05092269|Dermatologic Agents|dermatologic agents|mesh-ancestor
5645221|NCT05091528|Capecitabine|capecitabine|mesh-list
5645222|NCT05091528|Trastuzumab|trastuzumab|mesh-list
5645223|NCT05091528|Tucatinib|tucatinib|mesh-list
5645224|NCT05091528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5645225|NCT05091528|Antimetabolites|antimetabolites|mesh-ancestor
5645226|NCT05091528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5645227|NCT05091528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5818753|NCT02624661|Protective Agents|protective agents|mesh-ancestor
5818754|NCT02624661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818755|NCT02624622|Chlorhexidine|chlorhexidine|mesh-list
5818756|NCT02624622|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5818757|NCT02624622|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5818758|NCT02624622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5818759|NCT02624622|Disinfectants|disinfectants|mesh-ancestor
5818760|NCT02624622|Dermatologic Agents|dermatologic agents|mesh-ancestor
5818761|NCT02624505|Albuterol|albuterol|mesh-list
5818762|NCT02624505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5818763|NCT02624505|Autonomic Agents|autonomic agents|mesh-ancestor
5818764|NCT02624505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5818765|NCT02624505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818766|NCT02624505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5818767|NCT02624505|Respiratory System Agents|respiratory system agents|mesh-ancestor
5818768|NCT02624505|Tocolytic Agents|tocolytic agents|mesh-ancestor
5818769|NCT02624505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5818770|NCT02624505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5818771|NCT02624505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5818772|NCT02624505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5818773|NCT02624505|Adrenergic Agents|adrenergic agents|mesh-ancestor
5818774|NCT02624505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5818775|NCT02624505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818776|NCT02624479|Sodium thiosulfate|sodium thiosulfate|mesh-list
5818777|NCT02624479|Antidotes|antidotes|mesh-ancestor
5818778|NCT02624479|Protective Agents|protective agents|mesh-ancestor
5818779|NCT02624479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818780|NCT02624479|Antioxidants|antioxidants|mesh-ancestor
5818781|NCT02624479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818782|NCT02624479|Antitubercular Agents|antitubercular agents|mesh-ancestor
5818783|NCT02624479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5818784|NCT02624479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5818785|NCT02624479|Chelating Agents|chelating agents|mesh-ancestor
5818786|NCT02624479|Sequestering Agents|sequestering agents|mesh-ancestor
5818787|NCT02624518|Bombesin|bombesin|mesh-list
5818788|NCT02624518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5818789|NCT02624518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818790|NCT02624518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818791|NCT02624544|Desonide|desonide|mesh-list
5645228|NCT05091528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5645229|NCT05091528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5645230|NCT05091528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5645231|NCT05089370|Nivolumab|nivolumab|mesh-list
5645232|NCT05089370|Decitabine|decitabine|mesh-list
5645233|NCT05089370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5645234|NCT05089370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5645235|NCT05089370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5645236|NCT05089370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5645237|NCT05089370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5645238|NCT05089370|Antimetabolites|antimetabolites|mesh-ancestor
5645239|NCT05089370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5694177|NCT03396926|Immunoglobulins|immunoglobulins|mesh-list
5694178|NCT03396926|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5694179|NCT03396926|Immunoglobulin G|immunoglobulin g|mesh-list
5694180|NCT03396926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5694181|NCT03396926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5694182|NCT03396926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5818792|NCT02624544|Esomeprazole|esomeprazole|mesh-list
5818793|NCT02624544|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5818794|NCT02624544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5818795|NCT02624544|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5694183|NCT03396926|Growth Substances|growth substances|mesh-ancestor
5694184|NCT03396926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694185|NCT03396926|Growth Inhibitors|growth inhibitors|mesh-ancestor
5694186|NCT03396926|Immunologic Factors|immunologic factors|mesh-ancestor
5694187|NCT03396926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5694188|NCT03396926|Antimetabolites|antimetabolites|mesh-ancestor
5694189|NCT03396926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694190|NCT03396874|Edetic Acid|edetic acid|mesh-list
5694191|NCT03396874|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5694192|NCT03396874|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5694193|NCT03396874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694194|NCT03396874|Anticoagulants|anticoagulants|mesh-ancestor
5694195|NCT03396874|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5694196|NCT03396874|Chelating Agents|chelating agents|mesh-ancestor
5694197|NCT03396874|Sequestering Agents|sequestering agents|mesh-ancestor
5694198|NCT03396861|Aflibercept|aflibercept|mesh-list
5694199|NCT03396861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5694200|NCT03396861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5694201|NCT03396861|Growth Substances|growth substances|mesh-ancestor
5694202|NCT03396861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694203|NCT03396861|Growth Inhibitors|growth inhibitors|mesh-ancestor
5694204|NCT03396861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5694205|NCT03396601|Ketamine|ketamine|mesh-list
5694206|NCT03396601|Analgesics|analgesics|mesh-ancestor
5818796|NCT02624544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5818797|NCT02624544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818798|NCT02624544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5818799|NCT02624570|Midostaurin|midostaurin|mesh-list
5818800|NCT02624570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5694207|NCT03396601|Sensory System Agents|sensory system agents|mesh-ancestor
5694208|NCT03396601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5818801|NCT02624570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5818802|NCT02624570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5818803|NCT02624570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818804|NCT02624453|Fluconazole|fluconazole|mesh-list
5818805|NCT02624453|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
5818806|NCT02624453|Antifungal Agents|antifungal agents|mesh-ancestor
5818807|NCT02624453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5818808|NCT02624453|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5818809|NCT02624453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5818810|NCT02624453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5818811|NCT02624453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818812|NCT02624453|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5818813|NCT02624453|Hormone Antagonists|hormone antagonists|mesh-ancestor
5818814|NCT02624453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5818815|NCT02624453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818816|NCT02624453|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5818817|NCT02624453|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5818818|NCT02624453|Antiviral Agents|antiviral agents|mesh-ancestor
5818819|NCT02624388|Genistein|genistein|mesh-list
5818820|NCT02624388|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5818821|NCT02624388|Protective Agents|protective agents|mesh-ancestor
5818822|NCT02624388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818823|NCT02624388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5818824|NCT02624388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5818825|NCT02624388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5818826|NCT02624388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818827|NCT02624388|Phytoestrogens|phytoestrogens|mesh-ancestor
5818828|NCT02624388|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
5818829|NCT02624388|Estrogens|estrogens|mesh-ancestor
5818830|NCT02624388|Hormones|hormones|mesh-ancestor
5818831|NCT02624388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5818832|NCT02624531|Cisplatin|cisplatin|mesh-list
5818833|NCT02624531|Taxane|taxane|mesh-list
5818834|NCT02624531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5818835|NCT02624401|Dexmedetomidine|dexmedetomidine|mesh-list
5818836|NCT02624401|Ketamine|ketamine|mesh-list
5818837|NCT02624401|Propofol|propofol|mesh-list
5818838|NCT02624401|Sevoflurane|sevoflurane|mesh-list
5818839|NCT02624401|Esketamine|esketamine|mesh-list
5818840|NCT02624401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5818841|NCT02624401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5818842|NCT02624401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818843|NCT02624401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5818844|NCT02624401|Anesthetics, General|anesthetics, general|mesh-ancestor
5818845|NCT02624401|Anesthetics|anesthetics|mesh-ancestor
5818846|NCT02624401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5818847|NCT02624401|Analgesics|analgesics|mesh-ancestor
5818848|NCT02624401|Sensory System Agents|sensory system agents|mesh-ancestor
5818849|NCT02624401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5818850|NCT02624401|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5645240|NCT05085873|Midazolam|midazolam|mesh-list
5645241|NCT05085873|Sodium Oxybate|sodium oxybate|mesh-list
5645242|NCT05085873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5645243|NCT05085873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5645244|NCT05085873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5645245|NCT05085873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645246|NCT05085873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5645247|NCT05085873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5818851|NCT02624401|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5818852|NCT02624401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5818853|NCT02624401|Adrenergic Agents|adrenergic agents|mesh-ancestor
5818854|NCT02624401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5818855|NCT02624401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818856|NCT02624401|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5818857|NCT02624401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5818858|NCT02624401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5818859|NCT02624401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5645248|NCT05085873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5645249|NCT05085873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5645250|NCT05085873|Anesthetics, General|anesthetics, general|mesh-ancestor
5645251|NCT05085873|Anesthetics|anesthetics|mesh-ancestor
5645252|NCT05085873|GABA Modulators|gaba modulators|mesh-ancestor
5645253|NCT05085873|GABA Agents|gaba agents|mesh-ancestor
5645254|NCT05085873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5645255|NCT05085873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818860|NCT02624401|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5818861|NCT02624401|Antidepressive Agents|antidepressive agents|mesh-ancestor
5818862|NCT02624401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5818863|NCT02624362|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
5818864|NCT02624362|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5818865|NCT02624362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5818866|NCT02624362|Disinfectants|disinfectants|mesh-ancestor
5818867|NCT02624310|Droxidopa|droxidopa|mesh-list
5818868|NCT02624310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5818869|NCT02624310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5818870|NCT02624440|Clarithromycin|clarithromycin|mesh-list
5645256|NCT05083182|Ustekinumab|ustekinumab|mesh-list
5645257|NCT05083182|Dermatologic Agents|dermatologic agents|mesh-ancestor
5645258|NCT05081375|Enoxaparin|enoxaparin|mesh-list
5645259|NCT05081375|Anticoagulants|anticoagulants|mesh-ancestor
5645260|NCT05081375|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5645261|NCT05081375|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5645262|NCT05081375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5645263|NCT05067439|Efavirenz|efavirenz|mesh-list
5645264|NCT05067439|Caffeine|caffeine|mesh-list
5645265|NCT05067439|Omeprazole|omeprazole|mesh-list
5645266|NCT05067439|Abrocitinib|abrocitinib|mesh-list
5645267|NCT05067439|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5645268|NCT05067439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5645269|NCT05067439|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5645270|NCT05067439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5645271|NCT05067439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5645272|NCT05067439|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5645273|NCT05067439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645274|NCT05067439|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5645275|NCT05067439|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5645276|NCT05067439|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5645277|NCT05067439|Purinergic Agents|purinergic agents|mesh-ancestor
5645278|NCT05067439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5645279|NCT05067439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5645280|NCT05067439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5645281|NCT05067439|Antiviral Agents|antiviral agents|mesh-ancestor
5645282|NCT05067439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5645283|NCT05067439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5645284|NCT05067439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5645285|NCT05067439|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5645286|NCT05067439|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5645287|NCT05067439|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5645288|NCT05067439|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5645289|NCT05067439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5645290|NCT05063552|Bevacizumab|bevacizumab|mesh-list
5645291|NCT05063552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5645292|NCT05063552|Cetuximab|cetuximab|mesh-list
5645293|NCT05063552|Cisplatin|cisplatin|mesh-list
5645294|NCT05063552|Carboplatin|carboplatin|mesh-list
5645295|NCT05063552|Docetaxel|docetaxel|mesh-list
5645296|NCT05063552|Atezolizumab|atezolizumab|mesh-list
5645297|NCT05063552|Endothelial Growth Factors|endothelial growth factors|mesh-list
5818871|NCT02624440|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
5818872|NCT02624440|Trimethoprim|trimethoprim|mesh-list
5818873|NCT02624440|Sulfamethoxazole|sulfamethoxazole|mesh-list
5818874|NCT02624440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5818875|NCT02624440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5818876|NCT02624440|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5818877|NCT02624440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5818878|NCT02624440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818879|NCT02624440|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5818880|NCT02624440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5818881|NCT02624440|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5818882|NCT02624440|Renal Agents|renal agents|mesh-ancestor
5818883|NCT02624440|Antimalarials|antimalarials|mesh-ancestor
5818884|NCT02624440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5818885|NCT02624440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5818886|NCT02624440|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5818887|NCT02624440|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5818888|NCT02624440|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
5818889|NCT02624063|Sofosbuvir|sofosbuvir|mesh-list
5818890|NCT02624063|Simeprevir|simeprevir|mesh-list
5818891|NCT02624063|Antiviral Agents|antiviral agents|mesh-ancestor
5818892|NCT02624063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5818893|NCT02624063|Protease Inhibitors|protease inhibitors|mesh-ancestor
5818894|NCT02624063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5818895|NCT02624063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5645298|NCT05063552|Antibodies|antibodies|mesh-list
5645299|NCT05063552|Immunoglobulins|immunoglobulins|mesh-list
5645300|NCT05063552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5645301|NCT05063552|Immunoglobulin G|immunoglobulin g|mesh-list
5645302|NCT05063552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5645303|NCT05063552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5818896|NCT02624102|Antidepressive Agents|antidepressive agents|mesh-list
5645304|NCT05063552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5645305|NCT05063552|Growth Substances|growth substances|mesh-ancestor
5818897|NCT02624102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5818898|NCT02624141|Epoetin Alfa|epoetin alfa|mesh-list
5818899|NCT02624141|Hematinics|hematinics|mesh-ancestor
5818900|NCT02623881|Progesterone|progesterone|mesh-list
5818901|NCT02623881|Progestins|progestins|mesh-ancestor
5818902|NCT02623881|Hormones|hormones|mesh-ancestor
5818903|NCT02623881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5818904|NCT02623881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818905|NCT02624089|Ropivacaine|ropivacaine|mesh-list
5818906|NCT02624089|Anesthetics, Local|anesthetics, local|mesh-ancestor
5818907|NCT02624089|Anesthetics|anesthetics|mesh-ancestor
5818908|NCT02624089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5818909|NCT02624089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818910|NCT02624089|Sensory System Agents|sensory system agents|mesh-ancestor
5818911|NCT02624089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5818912|NCT02623998|Metformin|metformin|mesh-list
5818913|NCT02623998|Insulin Glargine|insulin glargine|mesh-list
5818914|NCT02623998|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5818915|NCT02623998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5818916|NCT02623998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818917|NCT02623998|Incretins|incretins|mesh-ancestor
5818918|NCT02623998|Hormones|hormones|mesh-ancestor
5818919|NCT02623998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5818920|NCT02623998|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5818921|NCT02623998|Protease Inhibitors|protease inhibitors|mesh-ancestor
5818922|NCT02623998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5818923|NCT02623998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818924|NCT02623816|Omeprazole|omeprazole|mesh-list
5818925|NCT02623816|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5818926|NCT02623816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5818927|NCT02623816|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5818928|NCT02623816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5818929|NCT02623816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818930|NCT02623920|Rituximab|rituximab|mesh-list
5818931|NCT02623920|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5818932|NCT02623920|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5818933|NCT02623920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5818934|NCT02623920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5818935|NCT02623920|Immunologic Factors|immunologic factors|mesh-ancestor
5818936|NCT02623920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818937|NCT02623920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5818938|NCT02623920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5818939|NCT02623920|Alkylating Agents|alkylating agents|mesh-ancestor
5818940|NCT02623920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818941|NCT02623751|Exemestane|exemestane|mesh-list
5818942|NCT02623751|Entinostat|entinostat|mesh-list
5818943|NCT02623751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5818944|NCT02623751|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5818945|NCT02623751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5818946|NCT02623751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5818947|NCT02623751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5818948|NCT02623751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5818949|NCT02623751|Hormone Antagonists|hormone antagonists|mesh-ancestor
5818950|NCT02623751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5818951|NCT02623751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818952|NCT02623751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5818953|NCT02623621|Bevacizumab|bevacizumab|mesh-list
5818954|NCT02623621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5818955|NCT02623621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5818956|NCT02623621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5818957|NCT02623621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5818958|NCT02623621|Growth Substances|growth substances|mesh-ancestor
5818959|NCT02623621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818960|NCT02623621|Growth Inhibitors|growth inhibitors|mesh-ancestor
5901445|NCT03277924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901446|NCT03277924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5901447|NCT03277924|Antimetabolites|antimetabolites|mesh-ancestor
5901448|NCT03277924|Dermatologic Agents|dermatologic agents|mesh-ancestor
5901449|NCT03277924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5901450|NCT03277924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5901451|NCT03277924|Immunologic Factors|immunologic factors|mesh-ancestor
5901452|NCT03277924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5901453|NCT03277924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5901454|NCT03277924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5645306|NCT05063552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645307|NCT05063552|Growth Inhibitors|growth inhibitors|mesh-ancestor
5645308|NCT05063552|Immunologic Factors|immunologic factors|mesh-ancestor
5645309|NCT05063552|Tubulin Modulators|tubulin modulators|mesh-ancestor
5645310|NCT05063552|Antimitotic Agents|antimitotic agents|mesh-ancestor
5645311|NCT05063552|Mitosis Modulators|mitosis modulators|mesh-ancestor
5645312|NCT05063552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5645313|NCT05062174|Mifepristone|mifepristone|mesh-list
5645314|NCT05062174|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5645315|NCT05062174|Abortifacient Agents|abortifacient agents|mesh-ancestor
5645316|NCT05062174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5645317|NCT05062174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645318|NCT05062174|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5645319|NCT05062174|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5645320|NCT05062174|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5645321|NCT05062174|Contraceptive Agents|contraceptive agents|mesh-ancestor
5645322|NCT05062174|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5645323|NCT05062174|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5645324|NCT05062174|Hormone Antagonists|hormone antagonists|mesh-ancestor
5645325|NCT05062174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5818961|NCT02623738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5818962|NCT02623738|Latanoprost|latanoprost|mesh-list
5818963|NCT02623738|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5818964|NCT02623582|Cyclophosphamide|cyclophosphamide|mesh-list
5818965|NCT02623582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5818966|NCT02623582|Immunologic Factors|immunologic factors|mesh-ancestor
5818967|NCT02623582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818968|NCT02623582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5818969|NCT02623582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5818970|NCT02623582|Alkylating Agents|alkylating agents|mesh-ancestor
5818971|NCT02623582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5645326|NCT05062174|Luteolytic Agents|luteolytic agents|mesh-ancestor
5645327|NCT05062174|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5645328|NCT05062174|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5645329|NCT05053152|Relugolix|relugolix|mesh-list
5645330|NCT05053152|Androgen Antagonists|androgen antagonists|mesh-ancestor
5645331|NCT05053152|Hormone Antagonists|hormone antagonists|mesh-ancestor
5645332|NCT05053152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5645333|NCT05053152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645334|NCT05052827|Caseins|caseins|mesh-list
5645335|NCT05052827|Chelating Agents|chelating agents|mesh-ancestor
5645336|NCT05052827|Sequestering Agents|sequestering agents|mesh-ancestor
5645337|NCT05052827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5645338|NCT05049278|Phenylephrine|phenylephrine|mesh-list
5645339|NCT05049278|Oxymetazoline|oxymetazoline|mesh-list
5645340|NCT05049278|Norepinephrine|norepinephrine|mesh-list
5645341|NCT05049278|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5645342|NCT05049278|Mydriatics|mydriatics|mesh-ancestor
5645343|NCT05049278|Autonomic Agents|autonomic agents|mesh-ancestor
5645344|NCT05049278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5645345|NCT05049278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645346|NCT05049278|Sympathomimetics|sympathomimetics|mesh-ancestor
5645347|NCT05049278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5645348|NCT05049278|Nasal Decongestants|nasal decongestants|mesh-ancestor
5645349|NCT05049278|Respiratory System Agents|respiratory system agents|mesh-ancestor
5645350|NCT05049278|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5645351|NCT05049278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5645352|NCT05049278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5645353|NCT05049278|Adrenergic Agents|adrenergic agents|mesh-ancestor
5645354|NCT05049278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5694209|NCT03396601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818972|NCT02623582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5818973|NCT02623582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5818974|NCT02623673|Dexamethasone|dexamethasone|mesh-list
5818975|NCT02623673|Bevacizumab|bevacizumab|mesh-list
5818976|NCT02623673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5818977|NCT02623673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5818978|NCT02623673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5818979|NCT02623673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5818980|NCT02623673|Growth Substances|growth substances|mesh-ancestor
5818981|NCT02623673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818982|NCT02623673|Growth Inhibitors|growth inhibitors|mesh-ancestor
5818983|NCT02623673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5818984|NCT02623673|Antiemetics|antiemetics|mesh-ancestor
5818985|NCT02623673|Autonomic Agents|autonomic agents|mesh-ancestor
5818986|NCT02623673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5818987|NCT02623673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5818988|NCT02623673|Glucocorticoids|glucocorticoids|mesh-ancestor
5818989|NCT02623673|Hormones|hormones|mesh-ancestor
5818990|NCT02623673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5818991|NCT02623673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5818992|NCT02623569|Atenolol|atenolol|mesh-list
5818993|NCT02623569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5818994|NCT02623569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5818995|NCT02623569|Sympatholytics|sympatholytics|mesh-ancestor
5645355|NCT05049278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5645356|NCT05049278|Protective Agents|protective agents|mesh-ancestor
5645357|NCT05041335|Heparin|heparin|mesh-list
5645358|NCT05041335|Anticoagulants|anticoagulants|mesh-ancestor
5645359|NCT05041335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5645360|NCT05041335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5645361|NCT05041335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5645362|NCT05039632|Nivolumab|nivolumab|mesh-list
5645363|NCT05039632|Ipilimumab|ipilimumab|mesh-list
5645364|NCT05039632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5645365|NCT05039632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5645366|NCT05039632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5818996|NCT02623569|Autonomic Agents|autonomic agents|mesh-ancestor
5818997|NCT02623569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5818998|NCT02623569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5818999|NCT02623569|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5819000|NCT02623569|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5819001|NCT02623569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5645367|NCT05039632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5645368|NCT05039281|Atezolizumab|atezolizumab|mesh-list
5645369|NCT05039281|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5645370|NCT05039281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5645371|NCT05039281|Immunologic Factors|immunologic factors|mesh-ancestor
5645372|NCT05039281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645373|NCT05029921|Ustekinumab|ustekinumab|mesh-list
5645374|NCT05029921|Dermatologic Agents|dermatologic agents|mesh-ancestor
5645375|NCT05011357|Phenylephrine|phenylephrine|mesh-list
5819002|NCT02623569|Adrenergic Agents|adrenergic agents|mesh-ancestor
5819003|NCT02623569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6492771|NCT00610506|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5645376|NCT05011357|Oxymetazoline|oxymetazoline|mesh-list
5645377|NCT05011357|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5645378|NCT05011357|Mydriatics|mydriatics|mesh-ancestor
5645379|NCT05011357|Autonomic Agents|autonomic agents|mesh-ancestor
5645380|NCT05011357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5645381|NCT05011357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645382|NCT05011357|Sympathomimetics|sympathomimetics|mesh-ancestor
5645383|NCT05011357|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5645384|NCT05011357|Nasal Decongestants|nasal decongestants|mesh-ancestor
5645385|NCT05011357|Respiratory System Agents|respiratory system agents|mesh-ancestor
5645386|NCT05011357|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5645387|NCT05011357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5645388|NCT05011357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5645389|NCT05011357|Adrenergic Agents|adrenergic agents|mesh-ancestor
5645390|NCT05011357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5645391|NCT05011357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5645392|NCT05011357|Protective Agents|protective agents|mesh-ancestor
5645393|NCT05011188|Antibodies|antibodies|mesh-list
5645394|NCT05011188|Immunoglobulins|immunoglobulins|mesh-list
5645395|NCT05011188|Immunoconjugates|immunoconjugates|mesh-list
5645396|NCT05011188|Immunologic Factors|immunologic factors|mesh-ancestor
5645397|NCT05011188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645398|NCT05008809|Leucovorin|leucovorin|mesh-list
6492772|NCT00610506|Cholinergic Agents|cholinergic agents|mesh-ancestor
5645399|NCT05008809|Fluorouracil|fluorouracil|mesh-list
5645400|NCT05008809|Oxaliplatin|oxaliplatin|mesh-list
5645401|NCT05008809|Irinotecan|irinotecan|mesh-list
6492773|NCT00610545|Atorvastatin|atorvastatin|mesh-list
5645402|NCT05008809|Levoleucovorin|levoleucovorin|mesh-list
5645403|NCT05008809|Antimetabolites|antimetabolites|mesh-ancestor
5645404|NCT05008809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5645405|NCT05008809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6492774|NCT00610545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6492775|NCT00610545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6492776|NCT00610545|Antimetabolites|antimetabolites|mesh-ancestor
5819004|NCT02623569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819005|NCT02623426|Dexamethasone|dexamethasone|mesh-list
6211491|NCT02173769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6211492|NCT02173769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211493|NCT02174276|Tenofovir|tenofovir|mesh-list
5645406|NCT05008809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5645407|NCT05008809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5645408|NCT05008809|Immunologic Factors|immunologic factors|mesh-ancestor
6211494|NCT02174276|Antiviral Agents|antiviral agents|mesh-ancestor
6211495|NCT02174276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6211496|NCT02174276|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6211497|NCT02174276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6211498|NCT02174276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6211499|NCT02174276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211500|NCT02174276|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6211501|NCT02174276|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6211502|NCT02174419|Nalbuphine|nalbuphine|mesh-list
6211503|NCT02174419|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5645409|NCT05008809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645410|NCT05008809|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5645411|NCT05008809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5645412|NCT05008809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5645413|NCT05008809|Antidotes|antidotes|mesh-ancestor
5645414|NCT05008809|Protective Agents|protective agents|mesh-ancestor
5645415|NCT05008809|Vitamin B Complex|vitamin b complex|mesh-ancestor
5645416|NCT05008809|Vitamins|vitamins|mesh-ancestor
5645417|NCT05008809|Micronutrients|micronutrients|mesh-ancestor
5645418|NCT05007782|Pembrolizumab|pembrolizumab|mesh-list
5645419|NCT05007782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5645420|NCT05007782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5645421|NCT05007392|Febuxostat|febuxostat|mesh-list
6211504|NCT02174419|Narcotics|narcotics|mesh-ancestor
5819006|NCT02623426|Methotrexate|methotrexate|mesh-list
5819007|NCT02623426|Ranibizumab|ranibizumab|mesh-list
5819008|NCT02623426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5819009|NCT02623426|Antiemetics|antiemetics|mesh-ancestor
5819010|NCT02623426|Autonomic Agents|autonomic agents|mesh-ancestor
5819011|NCT02623426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5819012|NCT02623426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819013|NCT02623426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5819014|NCT02623426|Glucocorticoids|glucocorticoids|mesh-ancestor
5819015|NCT02623426|Hormones|hormones|mesh-ancestor
5819016|NCT02623426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5819017|NCT02623426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5819018|NCT02623426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5819019|NCT02623426|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5819020|NCT02623426|Abortifacient Agents|abortifacient agents|mesh-ancestor
5819021|NCT02623426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5819022|NCT02623426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5819023|NCT02623426|Antimetabolites|antimetabolites|mesh-ancestor
5819024|NCT02623426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819025|NCT02623426|Dermatologic Agents|dermatologic agents|mesh-ancestor
5819026|NCT02623426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5819027|NCT02623426|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6492777|NCT00610545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492778|NCT00610545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6492779|NCT00610545|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6492780|NCT00610545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6492781|NCT00610571|Temozolomide|temozolomide|mesh-list
6492782|NCT00610571|Topotecan|topotecan|mesh-list
6492783|NCT00610571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6492784|NCT00610571|Alkylating Agents|alkylating agents|mesh-ancestor
6492785|NCT00610571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492786|NCT00610571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6492787|NCT00610571|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6492788|NCT00610571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6492789|NCT00610571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6492790|NCT00610584|Cetirizine|cetirizine|mesh-list
6492791|NCT00610584|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6492792|NCT00610584|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6492793|NCT00610584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6492794|NCT00610584|Histamine Antagonists|histamine antagonists|mesh-ancestor
6492795|NCT00610584|Histamine Agents|histamine agents|mesh-ancestor
6492796|NCT00610584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5819028|NCT02623426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5819029|NCT02623426|Immunologic Factors|immunologic factors|mesh-ancestor
5819030|NCT02623426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5819031|NCT02623426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5819032|NCT02623426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5819033|NCT02623426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5819034|NCT02623426|Growth Substances|growth substances|mesh-ancestor
5819035|NCT02623426|Growth Inhibitors|growth inhibitors|mesh-ancestor
5819036|NCT02623595|Molgramostim|molgramostim|mesh-list
5819037|NCT02623595|Sargramostim|sargramostim|mesh-list
5819038|NCT02623595|Immunologic Factors|immunologic factors|mesh-ancestor
5819039|NCT02623595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819040|NCT02623595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5819041|NCT02623465|Insulin Lispro|insulin lispro|mesh-list
5819042|NCT02623465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5819043|NCT02623465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819044|NCT02623452|Insulin Lispro|insulin lispro|mesh-list
5819045|NCT02623452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5819046|NCT02623452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819047|NCT02623504|Carbamazepine|carbamazepine|mesh-list
5819048|NCT02623504|Anticonvulsants|anticonvulsants|mesh-ancestor
5819049|NCT02623504|Antimanic Agents|antimanic agents|mesh-ancestor
5819050|NCT02623504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5819051|NCT02623504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5819052|NCT02623504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819053|NCT02623504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5819054|NCT02623504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5819055|NCT02623504|Analgesics|analgesics|mesh-ancestor
5819056|NCT02623504|Sensory System Agents|sensory system agents|mesh-ancestor
5819057|NCT02623504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5819058|NCT02623504|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5819059|NCT02623504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5819060|NCT02623504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819061|NCT02623504|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5819062|NCT02623504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5819063|NCT02623478|Insulin Lispro|insulin lispro|mesh-list
5819064|NCT02623478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5819065|NCT02623478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819066|NCT02623439|Cyclophosphamide|cyclophosphamide|mesh-list
5819067|NCT02623439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5819068|NCT02623439|Immunologic Factors|immunologic factors|mesh-ancestor
5819069|NCT02623439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819070|NCT02623439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5819071|NCT02623439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5819072|NCT02623439|Alkylating Agents|alkylating agents|mesh-ancestor
5819073|NCT02623439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819074|NCT02623439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5819075|NCT02623439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5819076|NCT02623205|Citalopram|citalopram|mesh-list
5819077|NCT02623205|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5819078|NCT02623205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5819079|NCT02623205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5819080|NCT02623205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819081|NCT02623205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5819082|NCT02623205|Serotonin Agents|serotonin agents|mesh-ancestor
5819083|NCT02623205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819084|NCT02623205|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5819085|NCT02623205|Antidepressive Agents|antidepressive agents|mesh-ancestor
5819086|NCT02623205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5819087|NCT02623062|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
5819088|NCT02623062|Antacids|antacids|mesh-ancestor
5819089|NCT02623062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819090|NCT02623062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5819091|NCT02623127|Sunitinib|sunitinib|mesh-list
5819092|NCT02623127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5819093|NCT02623127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5819094|NCT02623127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5819095|NCT02623127|Growth Substances|growth substances|mesh-ancestor
5819096|NCT02623127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819097|NCT02623127|Growth Inhibitors|growth inhibitors|mesh-ancestor
5819098|NCT02623127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5819099|NCT02623127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5901455|NCT03277924|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5645422|NCT05007392|Dotinurad|dotinurad|mesh-list
5645423|NCT05007392|Gout Suppressants|gout suppressants|mesh-ancestor
5645424|NCT05007392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5645425|NCT05007392|Uricosuric Agents|uricosuric agents|mesh-ancestor
5645426|NCT05007392|Renal Agents|renal agents|mesh-ancestor
5645427|NCT05006794|Gemcitabine|gemcitabine|mesh-list
5645428|NCT05006794|Docetaxel|docetaxel|mesh-list
5645429|NCT05006794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5645430|NCT05006794|Antimetabolites|antimetabolites|mesh-ancestor
5645431|NCT05006794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5645432|NCT05006794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5645433|NCT05006794|Antiviral Agents|antiviral agents|mesh-ancestor
5645434|NCT05006794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5645435|NCT05006794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5645436|NCT05006794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5645437|NCT05006794|Immunologic Factors|immunologic factors|mesh-ancestor
5645438|NCT05006794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645439|NCT05006794|Tubulin Modulators|tubulin modulators|mesh-ancestor
5645440|NCT05006794|Antimitotic Agents|antimitotic agents|mesh-ancestor
5645441|NCT05006794|Mitosis Modulators|mitosis modulators|mesh-ancestor
5819100|NCT02623127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819101|NCT02623036|Enalapril|enalapril|mesh-list
5819102|NCT02623036|Lisinopril|lisinopril|mesh-list
5819103|NCT02623036|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5819104|NCT02623036|Protease Inhibitors|protease inhibitors|mesh-ancestor
5819105|NCT02623036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5819106|NCT02623036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819107|NCT02623036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5819108|NCT02623036|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5819109|NCT02623036|Protective Agents|protective agents|mesh-ancestor
5819110|NCT02623036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819111|NCT02623049|Anticoagulants|anticoagulants|mesh-list
5819112|NCT02623231|Citalopram|citalopram|mesh-list
5819113|NCT02623231|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5819114|NCT02623231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5819115|NCT02623231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5819116|NCT02623231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819117|NCT02623231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5819118|NCT02623231|Serotonin Agents|serotonin agents|mesh-ancestor
5819119|NCT02623231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819120|NCT02623231|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5819121|NCT02623231|Antidepressive Agents|antidepressive agents|mesh-ancestor
5819122|NCT02623231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5819123|NCT02623153|Docetaxel|docetaxel|mesh-list
5819124|NCT02623153|Capecitabine|capecitabine|mesh-list
5819125|NCT02623153|Oxaliplatin|oxaliplatin|mesh-list
5819126|NCT02623153|Tegafur|tegafur|mesh-list
5819127|NCT02623153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5819128|NCT02623153|Tubulin Modulators|tubulin modulators|mesh-ancestor
5819129|NCT02623153|Antimitotic Agents|antimitotic agents|mesh-ancestor
5819130|NCT02623153|Mitosis Modulators|mitosis modulators|mesh-ancestor
5819131|NCT02623153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819132|NCT02623153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5819133|NCT02623153|Antimetabolites|antimetabolites|mesh-ancestor
6492797|NCT00610584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492798|NCT00610584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492799|NCT00610610|Paroxetine|paroxetine|mesh-list
6492800|NCT00610610|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6492801|NCT00610610|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6492802|NCT00610610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6492803|NCT00610610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819134|NCT02623114|Methylphenidate|methylphenidate|mesh-list
5819135|NCT02623114|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
5819136|NCT02623114|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5819137|NCT02623114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819138|NCT02623114|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5819139|NCT02623114|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5819140|NCT02623114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5819141|NCT02623114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819142|NCT02623114|Dopamine Agents|dopamine agents|mesh-ancestor
5819143|NCT02623114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6211505|NCT02174419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5645442|NCT05004688|BCG Vaccine|bcg vaccine|mesh-list
5645443|NCT05004688|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5819144|NCT02623114|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5819145|NCT02623114|Adrenergic Agents|adrenergic agents|mesh-ancestor
5819146|NCT02623023|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
5645444|NCT05004688|Immunologic Factors|immunologic factors|mesh-ancestor
5645445|NCT05004688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645446|NCT05004350|Fluorouracil|fluorouracil|mesh-list
5645447|NCT05004350|Irinotecan|irinotecan|mesh-list
5645448|NCT05004350|Cetuximab|cetuximab|mesh-list
5645449|NCT05004350|Antimetabolites|antimetabolites|mesh-ancestor
5645450|NCT05004350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5645451|NCT05004350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5645452|NCT05004350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5645453|NCT05004350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5645454|NCT05004350|Immunologic Factors|immunologic factors|mesh-ancestor
5645455|NCT05004350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645456|NCT05004350|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5645457|NCT05004350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5645458|NCT05004350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5645459|NCT05004350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5645460|NCT04990388|Acetaminophen|acetaminophen|mesh-list
5645461|NCT04990388|Antipyretics|antipyretics|mesh-list
5645462|NCT04990388|Cetirizine|cetirizine|mesh-list
5645463|NCT04990388|Ibuprofen|ibuprofen|mesh-list
5645464|NCT04990388|Famotidine|famotidine|mesh-list
5645465|NCT04990388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5645466|NCT04990388|Analgesics|analgesics|mesh-ancestor
5645467|NCT04990388|Sensory System Agents|sensory system agents|mesh-ancestor
5645468|NCT04990388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5819147|NCT02623023|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5819148|NCT02623023|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5819149|NCT02623023|Adrenergic Agents|adrenergic agents|mesh-ancestor
5819150|NCT02623023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5819151|NCT02623023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819152|NCT02623023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819153|NCT02623023|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5819154|NCT02623023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5819155|NCT02623023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5819156|NCT02622906|Pasireotide|pasireotide|mesh-list
5819157|NCT02622906|Hormones|hormones|mesh-ancestor
5819158|NCT02622906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5819159|NCT02622906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819160|NCT02622854|Insulin|insulin|mesh-list
5819161|NCT02622854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5819162|NCT02622854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819163|NCT02622503|Rituximab|rituximab|mesh-list
5819164|NCT02622503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5819165|NCT02622503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5819166|NCT02622503|Immunologic Factors|immunologic factors|mesh-ancestor
5819167|NCT02622503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819168|NCT02622503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5819169|NCT02622594|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5819170|NCT02622594|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5819171|NCT02622594|Dermatologic Agents|dermatologic agents|mesh-ancestor
5819172|NCT02622555|Mirabegron|mirabegron|mesh-list
5819173|NCT02622555|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
5819174|NCT02622555|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5645469|NCT04990388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645470|NCT04990388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5645471|NCT04990388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5645472|NCT04990388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5645473|NCT04990388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5819175|NCT02622555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5819176|NCT02622555|Adrenergic Agents|adrenergic agents|mesh-ancestor
5819177|NCT02622555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5819178|NCT02622555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819179|NCT02622555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819180|NCT02622555|Urological Agents|urological agents|mesh-ancestor
5819181|NCT02622672|Coenzyme Q10|coenzyme q10|mesh-list
5819182|NCT02622672|Micronutrients|micronutrients|mesh-ancestor
5819183|NCT02622672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645474|NCT04990388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5645475|NCT04990388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5645476|NCT04990388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5819184|NCT02622672|Vitamins|vitamins|mesh-ancestor
5645477|NCT04990388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5645478|NCT04990388|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5645479|NCT04990388|Histamine Antagonists|histamine antagonists|mesh-ancestor
5819185|NCT02622802|Acetaminophen|acetaminophen|mesh-list
5819186|NCT02622802|Azithromycin|azithromycin|mesh-list
5819187|NCT02622802|Erythromycin|erythromycin|mesh-list
5819188|NCT02622802|Erythromycin Estolate|erythromycin estolate|mesh-list
5819189|NCT02622802|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
5819190|NCT02622802|Erythromycin stearate|erythromycin stearate|mesh-list
5645480|NCT04990388|Histamine Agents|histamine agents|mesh-ancestor
5645481|NCT04990388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5645482|NCT04990388|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5645483|NCT04990388|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5819191|NCT02622802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5819192|NCT02622802|Analgesics|analgesics|mesh-ancestor
5819193|NCT02622802|Sensory System Agents|sensory system agents|mesh-ancestor
5819194|NCT02622802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5819195|NCT02622802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819196|NCT02622802|Antipyretics|antipyretics|mesh-ancestor
5819197|NCT02622802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5819198|NCT02622802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5819199|NCT02622802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5819200|NCT02622802|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5819201|NCT02622802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5819202|NCT02622802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819203|NCT02622477|Pirfenidone|pirfenidone|mesh-list
5819204|NCT02622477|Analgesics|analgesics|mesh-ancestor
5819205|NCT02622477|Sensory System Agents|sensory system agents|mesh-ancestor
5819206|NCT02622477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5819207|NCT02622477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645484|NCT04990388|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5645485|NCT04983238|Sodium thiosulfate|sodium thiosulfate|mesh-list
5645486|NCT04983238|Trastuzumab|trastuzumab|mesh-list
5645487|NCT04983238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5645488|NCT04983238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5645489|NCT04983238|Antidotes|antidotes|mesh-ancestor
5645490|NCT04983238|Protective Agents|protective agents|mesh-ancestor
5645491|NCT04983238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645492|NCT04983238|Antioxidants|antioxidants|mesh-ancestor
5645493|NCT04983238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5645494|NCT04983238|Antitubercular Agents|antitubercular agents|mesh-ancestor
5645495|NCT04983238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5645496|NCT04983238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5645497|NCT04983238|Chelating Agents|chelating agents|mesh-ancestor
5645498|NCT04983238|Sequestering Agents|sequestering agents|mesh-ancestor
5645499|NCT04970407|Botulinum Toxins|botulinum toxins|mesh-list
5645500|NCT04970407|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5645501|NCT04970407|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5645502|NCT04970407|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
5819208|NCT02622477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5819209|NCT02622477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5819210|NCT02622477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5819211|NCT02622477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5819212|NCT02622477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5819213|NCT02622685|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
5819214|NCT02622685|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5819215|NCT02622685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5819216|NCT02622607|Zoledronic Acid|zoledronic acid|mesh-list
5819217|NCT02622607|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5819218|NCT02622607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819219|NCT02622334|Latanoprost|latanoprost|mesh-list
5819220|NCT02622334|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5819221|NCT02622334|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5819222|NCT02622386|Riboflavin|riboflavin|mesh-list
5819223|NCT02622386|Vitamins|vitamins|mesh-ancestor
5819224|NCT02622386|Micronutrients|micronutrients|mesh-ancestor
5819225|NCT02622386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819226|NCT02622386|Vitamin B Complex|vitamin b complex|mesh-ancestor
5819227|NCT02622386|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5819228|NCT02622386|Dermatologic Agents|dermatologic agents|mesh-ancestor
5819229|NCT02622126|Atropine|atropine|mesh-list
5819230|NCT02622126|Ephedrine|ephedrine|mesh-list
5819231|NCT02622126|Morphine|morphine|mesh-list
5819232|NCT02622126|Bupivacaine|bupivacaine|mesh-list
5819233|NCT02622126|Anesthetics, Local|anesthetics, local|mesh-ancestor
5645503|NCT04970407|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5819234|NCT02622126|Anesthetics|anesthetics|mesh-ancestor
5819235|NCT02622126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5819236|NCT02622126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645504|NCT04970407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5645505|NCT04970407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5645506|NCT04970407|Cholinergic Agents|cholinergic agents|mesh-ancestor
5645507|NCT04970407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5645508|NCT04970407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645509|NCT04970407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5819237|NCT02622126|Sensory System Agents|sensory system agents|mesh-ancestor
5819238|NCT02622126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5819239|NCT02622126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5819240|NCT02622126|Narcotics|narcotics|mesh-ancestor
5819241|NCT02622126|Analgesics|analgesics|mesh-ancestor
5819242|NCT02622126|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5819243|NCT02622126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5819244|NCT02622126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5819245|NCT02622126|Autonomic Agents|autonomic agents|mesh-ancestor
5819246|NCT02622126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5819247|NCT02622126|Respiratory System Agents|respiratory system agents|mesh-ancestor
5819248|NCT02622126|Mydriatics|mydriatics|mesh-ancestor
5819249|NCT02622126|Parasympatholytics|parasympatholytics|mesh-ancestor
5819250|NCT02622126|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5819251|NCT02622126|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5819252|NCT02622126|Cholinergic Agents|cholinergic agents|mesh-ancestor
5819253|NCT02622126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5819254|NCT02622126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819255|NCT02622126|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5819256|NCT02622126|Sympathomimetics|sympathomimetics|mesh-ancestor
5819257|NCT02622126|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5819258|NCT02622126|Adrenergic Agents|adrenergic agents|mesh-ancestor
5819259|NCT02622243|Glycopyrrolate|glycopyrrolate|mesh-list
5819260|NCT02622243|Tiotropium Bromide|tiotropium bromide|mesh-list
5819261|NCT02622243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5819262|NCT02622243|Autonomic Agents|autonomic agents|mesh-ancestor
5819263|NCT02622243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5819264|NCT02622243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819265|NCT02622243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5819266|NCT02622243|Respiratory System Agents|respiratory system agents|mesh-ancestor
5819267|NCT02622243|Parasympatholytics|parasympatholytics|mesh-ancestor
5819268|NCT02622243|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5819269|NCT02622243|Cholinergic Agents|cholinergic agents|mesh-ancestor
5819270|NCT02622243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5819271|NCT02622243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819272|NCT02622243|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5819273|NCT02622243|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5901456|NCT03277924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5901457|NCT03277924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5901458|NCT03277924|Growth Substances|growth substances|mesh-ancestor
5901459|NCT03277924|Growth Inhibitors|growth inhibitors|mesh-ancestor
5901460|NCT03277924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5901461|NCT03277924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5901462|NCT03277924|Alkylating Agents|alkylating agents|mesh-ancestor
5901463|NCT03258853|Pancrelipase|pancrelipase|mesh-list
5901464|NCT03258853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5901465|NCT03257267|Cemiplimab|cemiplimab|mesh-list
5901466|NCT03257267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5901467|NCT03257267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901468|NCT03247088|Mycophenolic Acid|mycophenolic acid|mesh-list
5901469|NCT03247088|Cyclophosphamide|cyclophosphamide|mesh-list
5901470|NCT03247088|Busulfan|busulfan|mesh-list
5901471|NCT03247088|Fludarabine|fludarabine|mesh-list
5901472|NCT03247088|Sorafenib|sorafenib|mesh-list
5901473|NCT03247088|Tacrolimus|tacrolimus|mesh-list
5901474|NCT03247088|Lenograstim|lenograstim|mesh-list
5645510|NCT04970407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5645511|NCT04969861|Pembrolizumab|pembrolizumab|mesh-list
5645512|NCT04969861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5645513|NCT04969861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5645514|NCT04963816|Dexamethasone|dexamethasone|mesh-list
5645515|NCT04963816|Dexamethasone acetate|dexamethasone acetate|mesh-list
5645516|NCT04963816|Bupivacaine|bupivacaine|mesh-list
5645517|NCT04963816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5901475|NCT03247088|Sargramostim|sargramostim|mesh-list
5901476|NCT03247088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5901477|NCT03247088|Immunologic Factors|immunologic factors|mesh-ancestor
5901478|NCT03247088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901479|NCT03247088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5901480|NCT03247088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5901481|NCT03247088|Alkylating Agents|alkylating agents|mesh-ancestor
5819274|NCT02622022|Morphine|morphine|mesh-list
5819275|NCT02622022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5819276|NCT02622022|Narcotics|narcotics|mesh-ancestor
5819277|NCT02622022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5819278|NCT02622022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819279|NCT02622022|Analgesics|analgesics|mesh-ancestor
5819280|NCT02622022|Sensory System Agents|sensory system agents|mesh-ancestor
5819281|NCT02622022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5819282|NCT02621957|Pravastatin|pravastatin|mesh-list
5819283|NCT02621957|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5819284|NCT02621957|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5819285|NCT02621957|Antimetabolites|antimetabolites|mesh-ancestor
5819286|NCT02621957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819287|NCT02621957|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5819288|NCT02621957|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5819289|NCT02621957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5819290|NCT02621970|Cisplatin|cisplatin|mesh-list
5819291|NCT02621970|Docetaxel|docetaxel|mesh-list
5819292|NCT02621970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5819293|NCT02621970|Tubulin Modulators|tubulin modulators|mesh-ancestor
5819294|NCT02621970|Antimitotic Agents|antimitotic agents|mesh-ancestor
5819295|NCT02621970|Mitosis Modulators|mitosis modulators|mesh-ancestor
5819296|NCT02621970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819297|NCT02621944|Melatonin|melatonin|mesh-list
5819298|NCT02621944|Antioxidants|antioxidants|mesh-ancestor
5819299|NCT02621944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819300|NCT02621944|Protective Agents|protective agents|mesh-ancestor
5819301|NCT02621944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819302|NCT02621944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5819303|NCT02621905|Itraconazole|itraconazole|mesh-list
5819304|NCT02621905|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
5819305|NCT02621905|Antifungal Agents|antifungal agents|mesh-ancestor
5819306|NCT02621905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5819307|NCT02621905|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5819308|NCT02621905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5819309|NCT02621905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5819310|NCT02621905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819311|NCT02621905|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5819312|NCT02621905|Hormone Antagonists|hormone antagonists|mesh-ancestor
5819313|NCT02621905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5819314|NCT02621905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819315|NCT02621905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5819316|NCT02621827|Calcifediol|calcifediol|mesh-list
5819317|NCT02621827|Vitamins|vitamins|mesh-ancestor
5819318|NCT02621827|Micronutrients|micronutrients|mesh-ancestor
5819319|NCT02621827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819320|NCT02621827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5819321|NCT02621554|Resveratrol|resveratrol|mesh-list
5819322|NCT02621554|Antioxidants|antioxidants|mesh-ancestor
5819323|NCT02621554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819324|NCT02621554|Protective Agents|protective agents|mesh-ancestor
5819325|NCT02621554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819326|NCT02621554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5819327|NCT02621554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5645518|NCT04963816|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
5645519|NCT04963816|BB 1101|bb 1101|mesh-list
5645520|NCT04963816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5645521|NCT04963816|Antiemetics|antiemetics|mesh-ancestor
5645522|NCT04963816|Autonomic Agents|autonomic agents|mesh-ancestor
5645523|NCT04963816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5645524|NCT04963816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645525|NCT04963816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5645526|NCT04963816|Glucocorticoids|glucocorticoids|mesh-ancestor
5645527|NCT04963816|Hormones|hormones|mesh-ancestor
5645528|NCT04963816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5645529|NCT04963816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5645530|NCT04963816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5645531|NCT04963816|Protease Inhibitors|protease inhibitors|mesh-ancestor
5645532|NCT04963816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5645533|NCT04963816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5645534|NCT04963816|Anesthetics, Local|anesthetics, local|mesh-ancestor
5819328|NCT02621515|Nivolumab|nivolumab|mesh-list
5645535|NCT04963816|Anesthetics|anesthetics|mesh-ancestor
5819329|NCT02621515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5819330|NCT02621515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5819331|NCT02621515|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5819332|NCT02621515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819333|NCT02621385|Midazolam|midazolam|mesh-list
5819334|NCT02621385|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5819335|NCT02621385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5819336|NCT02621385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5819337|NCT02621385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819338|NCT02621385|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5819339|NCT02621385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5819340|NCT02621385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5819341|NCT02621385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5819342|NCT02621385|Anesthetics, General|anesthetics, general|mesh-ancestor
5819343|NCT02621385|Anesthetics|anesthetics|mesh-ancestor
5819344|NCT02621385|GABA Modulators|gaba modulators|mesh-ancestor
5819345|NCT02621385|GABA Agents|gaba agents|mesh-ancestor
5819346|NCT02621385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5819347|NCT02621385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5645536|NCT04963816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5645537|NCT04963816|Sensory System Agents|sensory system agents|mesh-ancestor
5645538|NCT04963725|Ustekinumab|ustekinumab|mesh-list
5645539|NCT04963725|Dermatologic Agents|dermatologic agents|mesh-ancestor
5819348|NCT02621489|Metformin|metformin|mesh-list
5819349|NCT02621489|Insulin Aspart|insulin aspart|mesh-list
5819350|NCT02621489|Exenatide|exenatide|mesh-list
5819351|NCT02621489|Biguanides|biguanides|mesh-list
5819352|NCT02621489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5819353|NCT02621489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819354|NCT02621489|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5819355|NCT02621489|Incretins|incretins|mesh-ancestor
5819356|NCT02621489|Hormones|hormones|mesh-ancestor
5819357|NCT02621489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5819358|NCT02621398|Paclitaxel|paclitaxel|mesh-list
5819359|NCT02621398|Carboplatin|carboplatin|mesh-list
5819360|NCT02621398|Pembrolizumab|pembrolizumab|mesh-list
5819361|NCT02621398|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5819362|NCT02621398|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5819363|NCT02621398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5819364|NCT02621398|Tubulin Modulators|tubulin modulators|mesh-ancestor
5819365|NCT02621398|Antimitotic Agents|antimitotic agents|mesh-ancestor
5819366|NCT02621398|Mitosis Modulators|mitosis modulators|mesh-ancestor
5819367|NCT02621398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819368|NCT02621398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5819369|NCT02621359|Doxycycline|doxycycline|mesh-list
5819370|NCT02621359|Levofloxacin|levofloxacin|mesh-list
5694210|NCT03396601|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5694211|NCT03396601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5694212|NCT03396601|Anesthetics, General|anesthetics, general|mesh-ancestor
5694213|NCT03396601|Anesthetics|anesthetics|mesh-ancestor
5694214|NCT03396601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5694215|NCT03396601|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5694216|NCT03396601|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5694217|NCT03396601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5694218|NCT03396601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694219|NCT03396588|Clonidine|clonidine|mesh-list
5694220|NCT03396588|Morphine|morphine|mesh-list
5694221|NCT03396588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5694222|NCT03396588|Narcotics|narcotics|mesh-ancestor
5694223|NCT03396588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5694224|NCT03396588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694225|NCT03396588|Analgesics|analgesics|mesh-ancestor
5694226|NCT03396588|Sensory System Agents|sensory system agents|mesh-ancestor
5694227|NCT03396588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5694228|NCT03396588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5694229|NCT03396588|Sympatholytics|sympatholytics|mesh-ancestor
5694230|NCT03396588|Autonomic Agents|autonomic agents|mesh-ancestor
5819371|NCT02621359|Ofloxacin|ofloxacin|mesh-list
5819372|NCT02621359|Nitazoxanide|nitazoxanide|mesh-list
5819373|NCT02621359|Omeprazole|omeprazole|mesh-list
5819374|NCT02621359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5819375|NCT02621359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5819376|NCT02621359|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5819377|NCT02621359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5819378|NCT02621359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819379|NCT02621359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5819380|NCT02621359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5819381|NCT02621359|Antimalarials|antimalarials|mesh-ancestor
5819382|NCT02621359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5819383|NCT02621359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5819384|NCT02621359|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5819385|NCT02621359|Renal Agents|renal agents|mesh-ancestor
5819386|NCT02621359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5819387|NCT02621359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5819388|NCT02621359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5819389|NCT02621359|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5819390|NCT02621359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5819391|NCT02621242|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5819392|NCT02621242|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5819393|NCT02621242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5819394|NCT02621242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5819395|NCT02621242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819396|NCT02621242|Antiviral Agents|antiviral agents|mesh-ancestor
5819397|NCT02621242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5819398|NCT02621242|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5819399|NCT02621242|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5819400|NCT02621320|Vitamin D|vitamin d|mesh-list
5819401|NCT02621320|Vitamins|vitamins|mesh-ancestor
5819402|NCT02621320|Micronutrients|micronutrients|mesh-ancestor
5819403|NCT02621320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819404|NCT02621320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5819405|NCT02621255|Bupivacaine|bupivacaine|mesh-list
5819406|NCT02621255|Anesthetics|anesthetics|mesh-list
5819407|NCT02621255|Sevoflurane|sevoflurane|mesh-list
5819408|NCT02621255|Anesthetics, Local|anesthetics, local|mesh-ancestor
5819409|NCT02621255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5819410|NCT02621255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819411|NCT02621255|Sensory System Agents|sensory system agents|mesh-ancestor
5819412|NCT02621255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5819413|NCT02621255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5819414|NCT02621255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5819415|NCT02621255|Anesthetics, General|anesthetics, general|mesh-ancestor
5819416|NCT02621112|Imiquimod|imiquimod|mesh-list
5819417|NCT02621112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5694231|NCT03396588|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5694232|NCT03396588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5694233|NCT03396588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5819418|NCT02621112|Immunologic Factors|immunologic factors|mesh-ancestor
5819419|NCT02621112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819420|NCT02621112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5645575|NCT04946435|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5645576|NCT04946435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5645577|NCT04940039|Risperidone|risperidone|mesh-list
5645578|NCT04940039|Paliperidone Palmitate|paliperidone palmitate|mesh-list
5645579|NCT04940039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5645580|NCT04940039|Serotonin Agents|serotonin agents|mesh-ancestor
5645581|NCT04940039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5819421|NCT02621112|Interferon Inducers|interferon inducers|mesh-ancestor
5819422|NCT02620995|Sildenafil Citrate|sildenafil citrate|mesh-list
5819423|NCT02620995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819424|NCT02620995|Vasodilator Agents|vasodilator agents|mesh-ancestor
5819425|NCT02620995|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5819426|NCT02620995|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5819427|NCT02620995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5645582|NCT04940039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5645583|NCT04940039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645584|NCT04940039|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5645585|NCT04940039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5645586|NCT04940039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5645587|NCT04940039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5645588|NCT04940039|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5645589|NCT04940039|Dopamine Agents|dopamine agents|mesh-ancestor
5645590|NCT04940039|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5645591|NCT04940039|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5645592|NCT04933552|Siponimod|siponimod|mesh-list
5645593|NCT04933552|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5645594|NCT04933552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5645595|NCT04933552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5645596|NCT04933552|Immunologic Factors|immunologic factors|mesh-ancestor
5645597|NCT04933552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645598|NCT04933240|Tamoxifen|tamoxifen|mesh-list
5645599|NCT04933240|Estradiol|estradiol|mesh-list
5819428|NCT02620995|Urological Agents|urological agents|mesh-ancestor
5819429|NCT02620969|Dialysis Solutions|dialysis solutions|mesh-list
5819430|NCT02620969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5819431|NCT02620800|Leucovorin|leucovorin|mesh-list
5819432|NCT02620800|Paclitaxel|paclitaxel|mesh-list
5819433|NCT02620800|Bevacizumab|bevacizumab|mesh-list
5819434|NCT02620800|Oxaliplatin|oxaliplatin|mesh-list
5819435|NCT02620800|Calcium|calcium|mesh-list
5819436|NCT02620800|Levoleucovorin|levoleucovorin|mesh-list
5819437|NCT02620800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5819438|NCT02620800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5819439|NCT02620800|Tubulin Modulators|tubulin modulators|mesh-ancestor
5819440|NCT02620800|Antimitotic Agents|antimitotic agents|mesh-ancestor
5819441|NCT02620800|Mitosis Modulators|mitosis modulators|mesh-ancestor
5819442|NCT02620800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819443|NCT02620800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5819444|NCT02620800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5819445|NCT02620800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5819446|NCT02620800|Growth Substances|growth substances|mesh-ancestor
5819447|NCT02620800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819448|NCT02620800|Growth Inhibitors|growth inhibitors|mesh-ancestor
5819449|NCT02620800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5819450|NCT02620800|Antidotes|antidotes|mesh-ancestor
5819451|NCT02620800|Protective Agents|protective agents|mesh-ancestor
5819452|NCT02620800|Vitamin B Complex|vitamin b complex|mesh-ancestor
5819453|NCT02620800|Vitamins|vitamins|mesh-ancestor
5819454|NCT02620800|Micronutrients|micronutrients|mesh-ancestor
5819455|NCT02620813|Tretinoin|tretinoin|mesh-list
5819456|NCT02620813|Isotretinoin|isotretinoin|mesh-list
5819457|NCT02620813|Dermatologic Agents|dermatologic agents|mesh-ancestor
5819458|NCT02620813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5819459|NCT02620813|Keratolytic Agents|keratolytic agents|mesh-ancestor
5819460|NCT02620865|Calcium, Dietary|calcium, dietary|mesh-list
5645600|NCT04933240|Estrogens|estrogens|mesh-ancestor
5645601|NCT04933240|Hormones|hormones|mesh-ancestor
5645602|NCT04933240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5645603|NCT04933240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645604|NCT04933240|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5645605|NCT04933240|Hormone Antagonists|hormone antagonists|mesh-ancestor
5645606|NCT04933240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5819461|NCT02620865|Leucovorin|leucovorin|mesh-list
5819462|NCT02620865|Folic Acid|folic acid|mesh-list
5819463|NCT02620865|Gemcitabine|gemcitabine|mesh-list
5819464|NCT02620865|Aldesleukin|aldesleukin|mesh-list
5645607|NCT04933240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5645608|NCT04933240|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5645609|NCT04933240|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5645610|NCT04933240|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5645611|NCT04927884|Cyclophosphamide|cyclophosphamide|mesh-list
5645612|NCT04927884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5645613|NCT04927884|Immunologic Factors|immunologic factors|mesh-ancestor
5645614|NCT04927884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645615|NCT04927884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5645616|NCT04927884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5645617|NCT04927884|Alkylating Agents|alkylating agents|mesh-ancestor
5645618|NCT04927884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5645619|NCT04927884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5645620|NCT04927884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5645621|NCT04924322|Enoxaparin|enoxaparin|mesh-list
5819465|NCT02620865|Paclitaxel|paclitaxel|mesh-list
5819466|NCT02620865|Camptothecin|camptothecin|mesh-list
5819467|NCT02620865|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5819468|NCT02620865|Fluorouracil|fluorouracil|mesh-list
5819469|NCT02620865|Oxaliplatin|oxaliplatin|mesh-list
5819470|NCT02620865|Irinotecan|irinotecan|mesh-list
5819471|NCT02620865|Interleukin-2|interleukin-2|mesh-list
5819472|NCT02620865|Antibodies|antibodies|mesh-list
5819473|NCT02620865|Immunoglobulins|immunoglobulins|mesh-list
5819474|NCT02620865|Sargramostim|sargramostim|mesh-list
5819475|NCT02620865|Calcium|calcium|mesh-list
5819476|NCT02620865|Levoleucovorin|levoleucovorin|mesh-list
5819477|NCT02620865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5819478|NCT02620865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5819479|NCT02620865|Tubulin Modulators|tubulin modulators|mesh-ancestor
5819480|NCT02620865|Antimitotic Agents|antimitotic agents|mesh-ancestor
5819481|NCT02620865|Mitosis Modulators|mitosis modulators|mesh-ancestor
5819482|NCT02620865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819483|NCT02620865|Immunologic Factors|immunologic factors|mesh-ancestor
5819484|NCT02620865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819485|NCT02620865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5819486|NCT02620865|Antimetabolites|antimetabolites|mesh-ancestor
5819487|NCT02620865|Antiviral Agents|antiviral agents|mesh-ancestor
5819488|NCT02620865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5819489|NCT02620865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5819490|NCT02620865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5819491|NCT02620865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5819492|NCT02620865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5819493|NCT02620865|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5819494|NCT02620865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5819495|NCT02620865|Antidotes|antidotes|mesh-ancestor
5819496|NCT02620865|Protective Agents|protective agents|mesh-ancestor
5819497|NCT02620865|Vitamin B Complex|vitamin b complex|mesh-ancestor
5819498|NCT02620865|Vitamins|vitamins|mesh-ancestor
5819499|NCT02620865|Micronutrients|micronutrients|mesh-ancestor
5819500|NCT02620865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5819501|NCT02620865|Analgesics|analgesics|mesh-ancestor
5819502|NCT02620865|Sensory System Agents|sensory system agents|mesh-ancestor
5819503|NCT02620865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5819504|NCT02620865|Hematinics|hematinics|mesh-ancestor
5819505|NCT02620865|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5819506|NCT02620865|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5819507|NCT02620748|Tranexamic Acid|tranexamic acid|mesh-list
5819508|NCT02620748|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5819509|NCT02620748|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5645622|NCT04924322|Anticoagulants|anticoagulants|mesh-ancestor
5645623|NCT04924322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5645624|NCT04924322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5645625|NCT04924322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5645626|NCT04917861|Vaccines|vaccines|mesh-list
5645627|NCT04917861|Immunologic Factors|immunologic factors|mesh-ancestor
5645628|NCT04917861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645629|NCT04915768|Aluminum Hydroxide|aluminum hydroxide|mesh-list
5645630|NCT04915768|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5645631|NCT04915768|Immunologic Factors|immunologic factors|mesh-ancestor
5645632|NCT04915768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645633|NCT04915768|Antacids|antacids|mesh-ancestor
5645634|NCT04915768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819510|NCT02620748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211506|NCT02174419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211507|NCT02174419|Analgesics|analgesics|mesh-ancestor
5819511|NCT02620748|Hemostatics|hemostatics|mesh-ancestor
5819512|NCT02620748|Coagulants|coagulants|mesh-ancestor
5819513|NCT02620839|Cisplatin|cisplatin|mesh-list
5819514|NCT02620839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5819515|NCT02620761|Fenoldopam|fenoldopam|mesh-list
5819516|NCT02620761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5819517|NCT02620761|Vasodilator Agents|vasodilator agents|mesh-ancestor
5819518|NCT02620761|Dopamine Agonists|dopamine agonists|mesh-ancestor
5819519|NCT02620761|Dopamine Agents|dopamine agents|mesh-ancestor
5819520|NCT02620761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5819521|NCT02620761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819522|NCT02620761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819523|NCT02620605|Cabergoline|cabergoline|mesh-list
5819524|NCT02620605|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5819525|NCT02620605|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5819526|NCT02620605|Dopamine Agonists|dopamine agonists|mesh-ancestor
5819527|NCT02620605|Dopamine Agents|dopamine agents|mesh-ancestor
5819528|NCT02620605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5819529|NCT02620605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819530|NCT02620605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819531|NCT02620618|Infliximab|infliximab|mesh-list
5819532|NCT02620618|Dermatologic Agents|dermatologic agents|mesh-ancestor
5819533|NCT02620618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5819534|NCT02620618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5819535|NCT02620566|Bupivacaine|bupivacaine|mesh-list
5645635|NCT04915768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5645636|NCT04905810|Azacitidine|azacitidine|mesh-list
5645637|NCT04905810|Decitabine|decitabine|mesh-list
5645638|NCT04905810|Venetoclax|venetoclax|mesh-list
5645639|NCT04905810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5645640|NCT04905810|Antimetabolites|antimetabolites|mesh-ancestor
5645641|NCT04905810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5645642|NCT04905810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5645643|NCT04905810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5645644|NCT04897217|Megestrol|megestrol|mesh-list
5645645|NCT04897217|Megestrol Acetate|megestrol acetate|mesh-list
5645646|NCT04897217|Levonorgestrel|levonorgestrel|mesh-list
5645647|NCT04897217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5645648|NCT04897217|Contraceptive Agents|contraceptive agents|mesh-ancestor
5645649|NCT04897217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5645650|NCT04897217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645651|NCT04897217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5645652|NCT04897217|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5645653|NCT04897217|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5645654|NCT04897217|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5645655|NCT04897217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5645656|NCT04897217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5645657|NCT04897217|Appetite Stimulants|appetite stimulants|mesh-ancestor
5645658|NCT04897217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5819536|NCT02620566|Anesthetics, Local|anesthetics, local|mesh-ancestor
5819537|NCT02620566|Anesthetics|anesthetics|mesh-ancestor
5819538|NCT02620566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5819539|NCT02620566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819540|NCT02620566|Sensory System Agents|sensory system agents|mesh-ancestor
5819541|NCT02620566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5901482|NCT03247088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901483|NCT03247088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901484|NCT03247088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5901485|NCT03247088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5901486|NCT03247088|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5901487|NCT03247088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5901488|NCT03247088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5901489|NCT03247088|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5901490|NCT03247088|Antitubercular Agents|antitubercular agents|mesh-ancestor
5901491|NCT03247088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5901492|NCT03247088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5901493|NCT03247088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5901494|NCT03217747|Avelumab|avelumab|mesh-list
5901495|NCT03217747|Antibodies|antibodies|mesh-list
5901496|NCT03217747|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5901497|NCT03217747|Immunoglobulin G|immunoglobulin g|mesh-list
5901498|NCT03217747|Immunologic Factors|immunologic factors|mesh-ancestor
5645659|NCT04892706|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
5645660|NCT04892706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5645661|NCT04892706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5645662|NCT04892706|Analgesics|analgesics|mesh-ancestor
5645663|NCT04892706|Sensory System Agents|sensory system agents|mesh-ancestor
5901499|NCT03217747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819542|NCT02620501|Lidocaine|lidocaine|mesh-list
5819543|NCT02620501|Anesthetics, Local|anesthetics, local|mesh-ancestor
5819544|NCT02620501|Anesthetics|anesthetics|mesh-ancestor
5819545|NCT02620501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5819546|NCT02620501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819547|NCT02620501|Sensory System Agents|sensory system agents|mesh-ancestor
5819548|NCT02620501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5819549|NCT02620501|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5819550|NCT02620501|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5819551|NCT02620501|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5819552|NCT02620501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5819553|NCT02620501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819554|NCT02620631|Morphine|morphine|mesh-list
5819555|NCT02620631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5819556|NCT02620631|Narcotics|narcotics|mesh-ancestor
5819557|NCT02620631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5819558|NCT02620631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819559|NCT02620631|Analgesics|analgesics|mesh-ancestor
5819560|NCT02620631|Sensory System Agents|sensory system agents|mesh-ancestor
5819561|NCT02620631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5819562|NCT02620423|Leucovorin|leucovorin|mesh-list
5819563|NCT02620423|Gemcitabine|gemcitabine|mesh-list
5819564|NCT02620423|Fluorouracil|fluorouracil|mesh-list
5819565|NCT02620423|Pembrolizumab|pembrolizumab|mesh-list
5819566|NCT02620423|Irinotecan|irinotecan|mesh-list
5819567|NCT02620423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5645664|NCT04892706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5645665|NCT04892706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645666|NCT04892706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5645667|NCT04892706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5645668|NCT04892706|Dermatologic Agents|dermatologic agents|mesh-ancestor
6211508|NCT02174419|Sensory System Agents|sensory system agents|mesh-ancestor
6211509|NCT02174419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6211510|NCT02174432|Nalbuphine|nalbuphine|mesh-list
5645672|NCT04891289|Gemcitabine|gemcitabine|mesh-list
5645673|NCT04891289|Dexamethasone|dexamethasone|mesh-list
5645674|NCT04891289|Oxaliplatin|oxaliplatin|mesh-list
5645675|NCT04891289|Floxuridine|floxuridine|mesh-list
5645676|NCT04891289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5645677|NCT04891289|Antiemetics|antiemetics|mesh-ancestor
5645678|NCT04891289|Autonomic Agents|autonomic agents|mesh-ancestor
5645679|NCT04891289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5645680|NCT04891289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645681|NCT04891289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5645682|NCT04891289|Glucocorticoids|glucocorticoids|mesh-ancestor
5645683|NCT04891289|Hormones|hormones|mesh-ancestor
5645684|NCT04891289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5645685|NCT04891289|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5645686|NCT04891289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5645687|NCT04891289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5645688|NCT04891289|Antimetabolites|antimetabolites|mesh-ancestor
5645689|NCT04891289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5645690|NCT04891289|Antiviral Agents|antiviral agents|mesh-ancestor
5645691|NCT04891289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5645692|NCT04891289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5645693|NCT04891289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5819568|NCT02620423|Antimetabolites|antimetabolites|mesh-ancestor
5819569|NCT02620423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819570|NCT02620423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5819571|NCT02620423|Antiviral Agents|antiviral agents|mesh-ancestor
5819572|NCT02620423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5819573|NCT02620423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5819574|NCT02620423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5819575|NCT02620423|Immunologic Factors|immunologic factors|mesh-ancestor
5645694|NCT04891289|Immunologic Factors|immunologic factors|mesh-ancestor
5645695|NCT04891250|Ivermectin|ivermectin|mesh-list
5645696|NCT04891250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5645697|NCT04891250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5645698|NCT04889703|Salicylic Acid|salicylic acid|mesh-list
5645699|NCT04889703|Salicylates|salicylates|mesh-list
5645700|NCT04889703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5645701|NCT04889703|Antifungal Agents|antifungal agents|mesh-ancestor
5645702|NCT04889703|Keratolytic Agents|keratolytic agents|mesh-ancestor
5645703|NCT04889703|Dermatologic Agents|dermatologic agents|mesh-ancestor
5645704|NCT04889703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5819576|NCT02620423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645705|NCT04889703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5819577|NCT02620423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5819578|NCT02620423|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5819579|NCT02620423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5819580|NCT02620423|Antidotes|antidotes|mesh-ancestor
5819581|NCT02620423|Protective Agents|protective agents|mesh-ancestor
5819582|NCT02620423|Vitamin B Complex|vitamin b complex|mesh-ancestor
5819583|NCT02620423|Vitamins|vitamins|mesh-ancestor
5819584|NCT02620423|Micronutrients|micronutrients|mesh-ancestor
5645706|NCT04889703|Analgesics|analgesics|mesh-ancestor
5645707|NCT04889703|Sensory System Agents|sensory system agents|mesh-ancestor
5645708|NCT04889703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5645709|NCT04889703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645710|NCT04889703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5645711|NCT04889703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5645712|NCT04889703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5645713|NCT04889703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5645714|NCT04889703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5645715|NCT04887831|Gemcitabine|gemcitabine|mesh-list
5645716|NCT04887831|Carboplatin|carboplatin|mesh-list
6211511|NCT02174432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6211512|NCT02174432|Narcotics|narcotics|mesh-ancestor
6211513|NCT02174432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5645717|NCT04887831|Avelumab|avelumab|mesh-list
5645718|NCT04887831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5645719|NCT04887831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5645720|NCT04887831|Antimetabolites|antimetabolites|mesh-ancestor
5645721|NCT04887831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5645722|NCT04887831|Antiviral Agents|antiviral agents|mesh-ancestor
5645723|NCT04887831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5645724|NCT04887831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5645725|NCT04887831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5645726|NCT04887831|Immunologic Factors|immunologic factors|mesh-ancestor
5645727|NCT04887831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645728|NCT04887831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5645729|NCT04887792|Acetazolamide|acetazolamide|mesh-list
5645730|NCT04887792|Anticonvulsants|anticonvulsants|mesh-ancestor
5645731|NCT04887792|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5645732|NCT04887792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5645733|NCT04887792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819585|NCT02620150|Citalopram|citalopram|mesh-list
5819586|NCT02620150|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5819587|NCT02620150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5819588|NCT02620150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5819589|NCT02620150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819590|NCT02620150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5819591|NCT02620150|Serotonin Agents|serotonin agents|mesh-ancestor
5819592|NCT02620150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819593|NCT02620150|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5819594|NCT02620150|Antidepressive Agents|antidepressive agents|mesh-ancestor
5819595|NCT02620150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5819596|NCT02620163|Amlodipine|amlodipine|mesh-list
5819597|NCT02620163|Telmisartan|telmisartan|mesh-list
5819598|NCT02620163|Chlorthalidone|chlorthalidone|mesh-list
5819599|NCT02620163|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
5819600|NCT02620163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5819601|NCT02620163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5819602|NCT02620163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5819603|NCT02620163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819604|NCT02620163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5819605|NCT02620163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819606|NCT02620163|Vasodilator Agents|vasodilator agents|mesh-ancestor
5819607|NCT02620163|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5819608|NCT02620163|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5819609|NCT02620163|Diuretics|diuretics|mesh-ancestor
5819610|NCT02620163|Natriuretic Agents|natriuretic agents|mesh-ancestor
5819611|NCT02620163|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5819612|NCT02620189|Adalimumab|adalimumab|mesh-list
5819613|NCT02620189|Etanercept|etanercept|mesh-list
5819614|NCT02620189|Certolizumab Pegol|certolizumab pegol|mesh-list
5819615|NCT02620189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6211514|NCT02174432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645734|NCT04887792|Diuretics|diuretics|mesh-ancestor
5645735|NCT04887792|Natriuretic Agents|natriuretic agents|mesh-ancestor
5694234|NCT03396588|Adrenergic Agents|adrenergic agents|mesh-ancestor
5819616|NCT02620189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5819617|NCT02620189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5819618|NCT02620189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5819619|NCT02620189|Analgesics|analgesics|mesh-ancestor
5819620|NCT02620189|Sensory System Agents|sensory system agents|mesh-ancestor
5819621|NCT02620189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5819622|NCT02620189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819623|NCT02620189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5819624|NCT02620189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5819625|NCT02620189|Immunologic Factors|immunologic factors|mesh-ancestor
5819626|NCT02620124|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5819627|NCT02620124|Hormones|hormones|mesh-list
5819628|NCT02620124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5819629|NCT02620124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819630|NCT02620124|Luteolytic Agents|luteolytic agents|mesh-ancestor
5645736|NCT04887792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645737|NCT04882072|Ustekinumab|ustekinumab|mesh-list
5645738|NCT04882072|Dermatologic Agents|dermatologic agents|mesh-ancestor
5645739|NCT04880850|Insulin|insulin|mesh-list
5645740|NCT04880850|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5645741|NCT04880850|Insulin Glargine|insulin glargine|mesh-list
5645742|NCT04880850|Insulin Aspart|insulin aspart|mesh-list
5645743|NCT04880850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5645744|NCT04880850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645745|NCT04875715|Hydroquinone|hydroquinone|mesh-list
5645746|NCT04875715|Antioxidants|antioxidants|mesh-ancestor
5645747|NCT04875715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5645748|NCT04875715|Protective Agents|protective agents|mesh-ancestor
5645749|NCT04875715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645750|NCT04875715|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5645751|NCT04873375|Cemiplimab|cemiplimab|mesh-list
5645752|NCT04873375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5645753|NCT04873375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5645754|NCT04857931|Colchicine|colchicine|mesh-list
5645755|NCT04857931|Gout Suppressants|gout suppressants|mesh-ancestor
5645756|NCT04857931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5645757|NCT04857931|Tubulin Modulators|tubulin modulators|mesh-ancestor
5645758|NCT04857931|Antimitotic Agents|antimitotic agents|mesh-ancestor
5645759|NCT04857931|Mitosis Modulators|mitosis modulators|mesh-ancestor
5645760|NCT04857931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5645761|NCT04857931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5645762|NCT04848220|APD791|apd791|mesh-list
5645763|NCT04848220|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5645764|NCT04848220|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5645765|NCT04848220|Serotonin Agents|serotonin agents|mesh-ancestor
5645766|NCT04848220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5645767|NCT04848220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5645768|NCT04848220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694235|NCT03396588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5694236|NCT03396588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694237|NCT03396523|Losartan|losartan|mesh-list
5819631|NCT02620124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5819632|NCT02620124|Contraceptive Agents|contraceptive agents|mesh-ancestor
5819633|NCT02620124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5819634|NCT02620124|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5819635|NCT02620124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5819636|NCT02620124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5819637|NCT02620215|Dinoprostone|dinoprostone|mesh-list
5819638|NCT02620215|Oxytocics|oxytocics|mesh-ancestor
5819639|NCT02620215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5819640|NCT02620215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819641|NCT02620345|Dydrogesterone|dydrogesterone|mesh-list
5819642|NCT02620345|Progestins|progestins|mesh-ancestor
5819643|NCT02620345|Hormones|hormones|mesh-ancestor
5819644|NCT02620345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5819645|NCT02620345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819646|NCT02620293|Emollients|emollients|mesh-list
5819647|NCT02620293|Dermatologic Agents|dermatologic agents|mesh-ancestor
5819648|NCT02619981|Lidocaine|lidocaine|mesh-list
5819649|NCT02619981|Anesthetics, Local|anesthetics, local|mesh-ancestor
5819650|NCT02619981|Anesthetics|anesthetics|mesh-ancestor
5819651|NCT02619981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5819652|NCT02619981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211515|NCT02174432|Analgesics|analgesics|mesh-ancestor
5694238|NCT03396523|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5694239|NCT03396523|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5819653|NCT02619981|Sensory System Agents|sensory system agents|mesh-ancestor
5819654|NCT02619981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5819655|NCT02619981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5645769|NCT04838743|Xultophy|xultophy|mesh-list
5645770|NCT04838743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5645771|NCT04838743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645772|NCT04838743|Incretins|incretins|mesh-ancestor
5645773|NCT04838743|Hormones|hormones|mesh-ancestor
5645774|NCT04838743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5645775|NCT04829318|Esketamine|esketamine|mesh-list
5645776|NCT04829318|Antidepressive Agents|antidepressive agents|mesh-ancestor
5819656|NCT02619981|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5819657|NCT02619981|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5819658|NCT02619981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5819659|NCT02619981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819660|NCT02620280|Paclitaxel|paclitaxel|mesh-list
5819661|NCT02620280|Carboplatin|carboplatin|mesh-list
5819662|NCT02620280|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5819663|NCT02620280|Atezolizumab|atezolizumab|mesh-list
5819664|NCT02620280|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5819665|NCT02620280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5819666|NCT02620280|Tubulin Modulators|tubulin modulators|mesh-ancestor
5645777|NCT04829318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5645778|NCT04814433|Lidocaine|lidocaine|mesh-list
5645779|NCT04814433|Epinephrine|epinephrine|mesh-list
5645780|NCT04814433|Racepinephrine|racepinephrine|mesh-list
5645781|NCT04814433|Bupivacaine|bupivacaine|mesh-list
5645782|NCT04814433|Tranexamic Acid|tranexamic acid|mesh-list
5645783|NCT04814433|Aminocaproic Acid|aminocaproic acid|mesh-list
5645784|NCT04814433|Thrombin|thrombin|mesh-list
5645785|NCT04814433|Epinephryl borate|epinephryl borate|mesh-list
5645786|NCT04814433|Anesthetics, Local|anesthetics, local|mesh-ancestor
5645787|NCT04814433|Anesthetics|anesthetics|mesh-ancestor
5645788|NCT04814433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5645789|NCT04814433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645790|NCT04814433|Sensory System Agents|sensory system agents|mesh-ancestor
5645791|NCT04814433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5645792|NCT04814433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5645793|NCT04814433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5819667|NCT02620280|Antimitotic Agents|antimitotic agents|mesh-ancestor
5819668|NCT02620280|Mitosis Modulators|mitosis modulators|mesh-ancestor
5819669|NCT02620280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819670|NCT02620046|Vedolizumab|vedolizumab|mesh-list
5819671|NCT02620046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5819672|NCT02619929|Vinorelbine|vinorelbine|mesh-list
5819673|NCT02619929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5819674|NCT02619929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5819675|NCT02619929|Tubulin Modulators|tubulin modulators|mesh-ancestor
5819676|NCT02619929|Antimitotic Agents|antimitotic agents|mesh-ancestor
5819677|NCT02619929|Mitosis Modulators|mitosis modulators|mesh-ancestor
5819678|NCT02619929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819679|NCT02619994|Levofloxacin|levofloxacin|mesh-list
5819680|NCT02619994|Ofloxacin|ofloxacin|mesh-list
5819681|NCT02619994|Linezolid|linezolid|mesh-list
5819682|NCT02619994|Pyrazinamide|pyrazinamide|mesh-list
5819683|NCT02619994|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5819684|NCT02619994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5819685|NCT02619994|Renal Agents|renal agents|mesh-ancestor
5819686|NCT02619994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5819687|NCT02619994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5819688|NCT02619994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5819689|NCT02619994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5819690|NCT02619994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819691|NCT02619994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5819692|NCT02619994|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5819693|NCT02619994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5819694|NCT02619994|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5819695|NCT02619994|Antitubercular Agents|antitubercular agents|mesh-ancestor
5819696|NCT02620306|Losartan|losartan|mesh-list
5819697|NCT02620306|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5819698|NCT02620306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5819699|NCT02620306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5819700|NCT02620306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6492804|NCT00610610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5645794|NCT04814433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5645795|NCT04814433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5645796|NCT04814433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5645797|NCT04814433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5645798|NCT04814433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5645799|NCT04814433|Adrenergic Agents|adrenergic agents|mesh-ancestor
5645800|NCT04814433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5645801|NCT04814433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5645802|NCT04814433|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5645803|NCT04814433|Autonomic Agents|autonomic agents|mesh-ancestor
5645804|NCT04814433|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5645805|NCT04814433|Respiratory System Agents|respiratory system agents|mesh-ancestor
5645806|NCT04814433|Mydriatics|mydriatics|mesh-ancestor
5819701|NCT02620306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819702|NCT02620072|Insulin|insulin|mesh-list
5819703|NCT02620072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5819704|NCT02620072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819705|NCT02620007|Ciprofloxacin|ciprofloxacin|mesh-list
5819706|NCT02620007|Rifaximin|rifaximin|mesh-list
5819707|NCT02620007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5819708|NCT02620007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5819709|NCT02620007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5819710|NCT02620007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5819711|NCT02620007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5819712|NCT02620007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819713|NCT02620007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5819714|NCT02620007|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5819715|NCT02620007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5819716|NCT02620007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5819717|NCT02619773|Mupirocin|mupirocin|mesh-list
5819718|NCT02619773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5819719|NCT02619773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5819720|NCT02619773|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5819721|NCT02619773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5819722|NCT02619773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819723|NCT02619786|Colistin|colistin|mesh-list
5819724|NCT02619786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5819725|NCT02619786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5819726|NCT02619669|Letrozole|letrozole|mesh-list
5819727|NCT02619669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5819728|NCT02619669|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5645807|NCT04814433|Sympathomimetics|sympathomimetics|mesh-ancestor
5819729|NCT02619669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5819730|NCT02619669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5819731|NCT02619669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819732|NCT02619669|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5819733|NCT02619669|Hormone Antagonists|hormone antagonists|mesh-ancestor
5819734|NCT02619669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5819735|NCT02619669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819736|NCT02619513|Dexmedetomidine|dexmedetomidine|mesh-list
5819737|NCT02619513|Ropivacaine|ropivacaine|mesh-list
5819738|NCT02619513|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5819739|NCT02619513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5819740|NCT02619513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819741|NCT02619513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5819742|NCT02619513|Analgesics|analgesics|mesh-ancestor
5819743|NCT02619513|Sensory System Agents|sensory system agents|mesh-ancestor
6211516|NCT02174432|Sensory System Agents|sensory system agents|mesh-ancestor
6211517|NCT02174432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6211518|NCT02174510|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
6211519|NCT02174510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6211520|NCT02174510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6211521|NCT02174510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6211522|NCT02174510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211523|NCT02174510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6211524|NCT02174510|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6211525|NCT02174510|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6211526|NCT02174510|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6211527|NCT02174510|Adrenergic Agents|adrenergic agents|mesh-ancestor
6211528|NCT02174510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6211529|NCT02174510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211530|NCT02174510|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6211531|NCT02174510|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6211532|NCT02174510|Serotonin Agents|serotonin agents|mesh-ancestor
5645808|NCT04814433|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5645809|NCT04814433|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5645810|NCT04814433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5645811|NCT04814433|Hemostatics|hemostatics|mesh-ancestor
5645812|NCT04814433|Coagulants|coagulants|mesh-ancestor
5645813|NCT04805125|Vaccines|vaccines|mesh-list
5645814|NCT04805125|Immunologic Factors|immunologic factors|mesh-ancestor
5645815|NCT04805125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645816|NCT04789499|Theophylline|theophylline|mesh-list
5819744|NCT02619513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5819745|NCT02619513|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5819746|NCT02619513|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5819747|NCT02619513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5819748|NCT02619513|Adrenergic Agents|adrenergic agents|mesh-ancestor
5819749|NCT02619513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5819750|NCT02619513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819751|NCT02619513|Anesthetics, Local|anesthetics, local|mesh-ancestor
5819752|NCT02619513|Anesthetics|anesthetics|mesh-ancestor
5819753|NCT02619747|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
5819754|NCT02619747|Antacids|antacids|mesh-ancestor
5819755|NCT02619747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819756|NCT02619747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5819757|NCT02619448|Paclitaxel|paclitaxel|mesh-list
5819758|NCT02619448|Carboplatin|carboplatin|mesh-list
5819759|NCT02619448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5819760|NCT02619448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5819761|NCT02619448|Tubulin Modulators|tubulin modulators|mesh-ancestor
5819762|NCT02619448|Antimitotic Agents|antimitotic agents|mesh-ancestor
5819763|NCT02619448|Mitosis Modulators|mitosis modulators|mesh-ancestor
5819764|NCT02619448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819765|NCT02619578|Remifentanil|remifentanil|mesh-list
5819766|NCT02619578|Propofol|propofol|mesh-list
5819767|NCT02619578|Vecuronium Bromide|vecuronium bromide|mesh-list
5819768|NCT02619578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5819769|NCT02619578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5819770|NCT02619578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819771|NCT02619578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5819772|NCT02619578|Anesthetics, General|anesthetics, general|mesh-ancestor
5819773|NCT02619578|Anesthetics|anesthetics|mesh-ancestor
5819774|NCT02619578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5819775|NCT02619578|Narcotics|narcotics|mesh-ancestor
5819776|NCT02619578|Analgesics|analgesics|mesh-ancestor
5645817|NCT04789499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5645818|NCT04789499|Autonomic Agents|autonomic agents|mesh-ancestor
5645819|NCT04789499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5645820|NCT04789499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645821|NCT04789499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5819777|NCT02619578|Sensory System Agents|sensory system agents|mesh-ancestor
5819778|NCT02619578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5819779|NCT02619578|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5819780|NCT02619578|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5819781|NCT02619578|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5819782|NCT02619578|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
5819783|NCT02619578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5819784|NCT02619578|Cholinergic Agents|cholinergic agents|mesh-ancestor
5819785|NCT02619578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5819786|NCT02619578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819787|NCT02619552|Prednisone|prednisone|mesh-list
5819788|NCT02619552|Budesonide|budesonide|mesh-list
5819789|NCT02619552|Adalimumab|adalimumab|mesh-list
5819790|NCT02619552|Infliximab|infliximab|mesh-list
5819791|NCT02619552|Certolizumab Pegol|certolizumab pegol|mesh-list
5819792|NCT02619552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5819793|NCT02619552|Glucocorticoids|glucocorticoids|mesh-ancestor
5819794|NCT02619552|Hormones|hormones|mesh-ancestor
5819795|NCT02619552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5819796|NCT02619552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819797|NCT02619552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5819798|NCT02619552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5819799|NCT02619552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5819800|NCT02619552|Autonomic Agents|autonomic agents|mesh-ancestor
5819801|NCT02619552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5819802|NCT02619552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5645822|NCT04789499|Respiratory System Agents|respiratory system agents|mesh-ancestor
5645823|NCT04789499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5819803|NCT02619552|Respiratory System Agents|respiratory system agents|mesh-ancestor
5819804|NCT02619552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5819805|NCT02619552|Dermatologic Agents|dermatologic agents|mesh-ancestor
5819806|NCT02619552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5819807|NCT02619552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5819808|NCT02619552|Immunologic Factors|immunologic factors|mesh-ancestor
5819809|NCT02619526|Carvedilol|carvedilol|mesh-list
5819810|NCT02619526|Nebivolol|nebivolol|mesh-list
5819811|NCT02619526|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5819812|NCT02619526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5819813|NCT02619526|Adrenergic Agents|adrenergic agents|mesh-ancestor
5819814|NCT02619526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5645824|NCT04789499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5645825|NCT04789499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5645826|NCT04789499|Vasodilator Agents|vasodilator agents|mesh-ancestor
5645827|NCT04789499|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5645828|NCT04789499|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5645829|NCT04789499|Purinergic Agents|purinergic agents|mesh-ancestor
5645830|NCT04789499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5645831|NCT04776993|Methimazole|methimazole|mesh-list
5645832|NCT04776993|Antithyroid Agents|antithyroid agents|mesh-ancestor
5645833|NCT04776993|Hormone Antagonists|hormone antagonists|mesh-ancestor
5819815|NCT02619526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819816|NCT02619526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819817|NCT02619526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5819818|NCT02619526|Antioxidants|antioxidants|mesh-ancestor
5819819|NCT02619526|Protective Agents|protective agents|mesh-ancestor
5819820|NCT02619526|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5645834|NCT04776993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5645835|NCT04776993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645836|NCT04770532|Insulin|insulin|mesh-list
5645837|NCT04770532|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5645838|NCT04770532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5645839|NCT04770532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645840|NCT04765644|Celecoxib|celecoxib|mesh-list
5645841|NCT04765644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5645842|NCT04765644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5645843|NCT04765644|Analgesics|analgesics|mesh-ancestor
5645844|NCT04765644|Sensory System Agents|sensory system agents|mesh-ancestor
5645845|NCT04765644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5819821|NCT02619526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5819822|NCT02619526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5819823|NCT02619526|Vasodilator Agents|vasodilator agents|mesh-ancestor
5819824|NCT02619526|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5819825|NCT02619526|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5819826|NCT02619526|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5819827|NCT02619526|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5819828|NCT02619526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5819829|NCT02619201|Ondansetron|ondansetron|mesh-list
5819830|NCT02619201|Metoclopramide|metoclopramide|mesh-list
5819831|NCT02619201|Antiemetics|antiemetics|mesh-ancestor
5819832|NCT02619201|Autonomic Agents|autonomic agents|mesh-ancestor
5819833|NCT02619201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5819834|NCT02619201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819835|NCT02619201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5819836|NCT02619201|Antipruritics|antipruritics|mesh-ancestor
5819837|NCT02619201|Dermatologic Agents|dermatologic agents|mesh-ancestor
5819838|NCT02619201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5819839|NCT02619201|Serotonin Agents|serotonin agents|mesh-ancestor
5819840|NCT02619201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5819841|NCT02619201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819842|NCT02619201|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5819843|NCT02619201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5819844|NCT02619201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5819845|NCT02619201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5819846|NCT02619201|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5819847|NCT02619201|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5645846|NCT04765644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645847|NCT04765644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5645848|NCT04765644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5645849|NCT04765644|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5645850|NCT04765644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5645851|NCT04765644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5819848|NCT02619201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5819849|NCT02619201|Dopamine Agents|dopamine agents|mesh-ancestor
5819850|NCT02619162|Letrozole|letrozole|mesh-list
5819851|NCT02619162|Nintedanib|nintedanib|mesh-list
5819852|NCT02619162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5819853|NCT02619162|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5819854|NCT02619162|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5819855|NCT02619162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5819856|NCT02619162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819857|NCT02619162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5819858|NCT02619162|Hormone Antagonists|hormone antagonists|mesh-ancestor
5819859|NCT02619162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5819860|NCT02619162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819861|NCT02619162|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5819862|NCT02619266|Megestrol|megestrol|mesh-list
5819863|NCT02619266|Megestrol Acetate|megestrol acetate|mesh-list
5819864|NCT02619266|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5819865|NCT02619266|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5819866|NCT02619266|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5819867|NCT02619266|Contraceptive Agents|contraceptive agents|mesh-ancestor
5819868|NCT02619266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5819869|NCT02619266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819870|NCT02619266|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5645852|NCT04765644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5645853|NCT04757636|Aflibercept|aflibercept|mesh-list
5645854|NCT04757636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5645855|NCT04757636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5645856|NCT04757636|Growth Substances|growth substances|mesh-ancestor
5645857|NCT04757636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645858|NCT04757636|Growth Inhibitors|growth inhibitors|mesh-ancestor
5645859|NCT04757636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5645860|NCT04757610|Ranibizumab|ranibizumab|mesh-list
5645861|NCT04757610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5819871|NCT02619266|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5819872|NCT02619266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5819873|NCT02619266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5819874|NCT02619266|Appetite Stimulants|appetite stimulants|mesh-ancestor
5819875|NCT02619266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5819876|NCT02619149|Tazobactam|tazobactam|mesh-list
5819877|NCT02619149|Piperacillin|piperacillin|mesh-list
5819878|NCT02619149|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
5819879|NCT02619149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5819880|NCT02619149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5819881|NCT02619149|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5819882|NCT02619149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5819883|NCT02619149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819884|NCT02619019|Dexamethasone|dexamethasone|mesh-list
5819885|NCT02619019|Meperidine|meperidine|mesh-list
5645862|NCT04757610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5645863|NCT04757610|Growth Substances|growth substances|mesh-ancestor
5645864|NCT04757610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645865|NCT04757610|Growth Inhibitors|growth inhibitors|mesh-ancestor
5645866|NCT04757610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5645867|NCT04756427|Citric Acid|citric acid|mesh-list
5645868|NCT04756427|Sodium Citrate|sodium citrate|mesh-list
5645869|NCT04756427|Anticoagulants|anticoagulants|mesh-list
5645870|NCT04756427|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5645871|NCT04756427|Chelating Agents|chelating agents|mesh-ancestor
5645872|NCT04756427|Sequestering Agents|sequestering agents|mesh-ancestor
5645873|NCT04756427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5645874|NCT04751383|Dinutuximab|dinutuximab|mesh-list
5645875|NCT04751383|Magrolimab|magrolimab|mesh-list
5645876|NCT04751383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5645877|NCT04751383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5645878|NCT04747314|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5645879|NCT04747314|Aripiprazole|aripiprazole|mesh-list
5819886|NCT02619019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5819887|NCT02619019|Antiemetics|antiemetics|mesh-ancestor
5819888|NCT02619019|Autonomic Agents|autonomic agents|mesh-ancestor
5819889|NCT02619019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5819890|NCT02619019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819891|NCT02619019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5819892|NCT02619019|Glucocorticoids|glucocorticoids|mesh-ancestor
5819893|NCT02619019|Hormones|hormones|mesh-ancestor
5645880|NCT04747314|Mirtazapine|mirtazapine|mesh-list
5645881|NCT04747314|Citalopram|citalopram|mesh-list
5645882|NCT04747314|Bupropion|bupropion|mesh-list
5645883|NCT04747314|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6492805|NCT00610610|Serotonin Agents|serotonin agents|mesh-ancestor
5645884|NCT04747314|Sertraline|sertraline|mesh-list
5645885|NCT04747314|Antidepressive Agents|antidepressive agents|mesh-list
5645886|NCT04747314|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5645887|NCT04747314|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5645888|NCT04747314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5819894|NCT02619019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5819895|NCT02619019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5819896|NCT02619019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5819897|NCT02619019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5819898|NCT02619019|Narcotics|narcotics|mesh-ancestor
5819899|NCT02619019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5819900|NCT02619019|Analgesics|analgesics|mesh-ancestor
5819901|NCT02619019|Sensory System Agents|sensory system agents|mesh-ancestor
5819902|NCT02619019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5901500|NCT03217747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5901501|NCT03217747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901502|NCT03206151|Leucovorin|leucovorin|mesh-list
5901503|NCT03206151|Folic Acid|folic acid|mesh-list
5901504|NCT03206151|Fluorouracil|fluorouracil|mesh-list
5901505|NCT03206151|Irinotecan|irinotecan|mesh-list
5901506|NCT03206151|Levoleucovorin|levoleucovorin|mesh-list
5901507|NCT03206151|Antimetabolites|antimetabolites|mesh-ancestor
5901508|NCT03206151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901509|NCT03206151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5901510|NCT03206151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901511|NCT03206151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5901512|NCT03206151|Immunologic Factors|immunologic factors|mesh-ancestor
5901513|NCT03206151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901514|NCT03206151|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5901515|NCT03206151|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5901516|NCT03206151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5901517|NCT03206151|Antidotes|antidotes|mesh-ancestor
5901518|NCT03206151|Protective Agents|protective agents|mesh-ancestor
5901519|NCT03206151|Vitamin B Complex|vitamin b complex|mesh-ancestor
5901520|NCT03206151|Vitamins|vitamins|mesh-ancestor
5901521|NCT03206151|Micronutrients|micronutrients|mesh-ancestor
5901522|NCT03206151|Hematinics|hematinics|mesh-ancestor
5645889|NCT04747314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5645890|NCT04747314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5645891|NCT04747314|Serotonin Agents|serotonin agents|mesh-ancestor
5645892|NCT04747314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645893|NCT04747314|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5645894|NCT04747314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5645895|NCT04747314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5645896|NCT04747314|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5645897|NCT04747314|Dopamine Agents|dopamine agents|mesh-ancestor
5901523|NCT03165136|Hydroxychloroquine|hydroxychloroquine|mesh-list
5901524|NCT03165136|Antimalarials|antimalarials|mesh-ancestor
5901525|NCT03165136|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5901526|NCT03165136|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5901527|NCT03165136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5901528|NCT03165136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5901529|NCT03165136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901530|NCT03165136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5901531|NCT03131726|Simvastatin|simvastatin|mesh-list
5901532|NCT03131726|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5901533|NCT03131726|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5901534|NCT03131726|Antimetabolites|antimetabolites|mesh-ancestor
5901535|NCT03131726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901536|NCT03131726|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5901537|NCT03131726|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5901538|NCT03131726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5901539|NCT03110978|Nivolumab|nivolumab|mesh-list
5901540|NCT03110978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5901541|NCT03110978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901542|NCT03110978|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5901543|NCT03110978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901544|NCT03085719|Pembrolizumab|pembrolizumab|mesh-list
5901545|NCT03085719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5901546|NCT03085719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901547|NCT03083808|Pembrolizumab|pembrolizumab|mesh-list
5901548|NCT03083808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5901549|NCT03083808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901550|NCT03070327|Cyclophosphamide|cyclophosphamide|mesh-list
5901551|NCT03070327|Lenalidomide|lenalidomide|mesh-list
5819903|NCT02619032|Fentanyl|fentanyl|mesh-list
5819904|NCT02619032|Remifentanil|remifentanil|mesh-list
5819905|NCT02619032|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5819906|NCT02619032|Narcotics|narcotics|mesh-ancestor
5819907|NCT02619032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5819908|NCT02619032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819909|NCT02619032|Analgesics|analgesics|mesh-ancestor
5819910|NCT02619032|Sensory System Agents|sensory system agents|mesh-ancestor
5819911|NCT02619032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5819912|NCT02619032|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5819913|NCT02619032|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5819914|NCT02619032|Anesthetics, General|anesthetics, general|mesh-ancestor
5819915|NCT02619032|Anesthetics|anesthetics|mesh-ancestor
5819916|NCT02618876|Nalbuphine|nalbuphine|mesh-list
5819917|NCT02618876|Bupivacaine|bupivacaine|mesh-list
5819918|NCT02618876|Anesthetics, Local|anesthetics, local|mesh-ancestor
5645898|NCT04747314|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5645899|NCT04747314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5645900|NCT04747314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5645901|NCT04747314|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5645902|NCT04747314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5645903|NCT04747314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5645904|NCT04747314|Dopamine Agonists|dopamine agonists|mesh-ancestor
5645905|NCT04747314|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5645906|NCT04747314|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5819919|NCT02618876|Anesthetics|anesthetics|mesh-ancestor
5819920|NCT02618876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5819921|NCT02618876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819922|NCT02618876|Sensory System Agents|sensory system agents|mesh-ancestor
5819923|NCT02618876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5819924|NCT02618876|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5819925|NCT02618876|Narcotics|narcotics|mesh-ancestor
5819926|NCT02618876|Analgesics|analgesics|mesh-ancestor
5819927|NCT02618824|Tryptophan|tryptophan|mesh-list
5819928|NCT02618824|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5819929|NCT02618824|Antidepressive Agents|antidepressive agents|mesh-ancestor
5819930|NCT02618824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5819931|NCT02618668|Ketamine|ketamine|mesh-list
5819932|NCT02618668|Propofol|propofol|mesh-list
5819933|NCT02618668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5819934|NCT02618668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5819935|NCT02618668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819936|NCT02618668|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5819937|NCT02618668|Anesthetics, General|anesthetics, general|mesh-ancestor
5819938|NCT02618668|Anesthetics|anesthetics|mesh-ancestor
5819939|NCT02618668|Analgesics|analgesics|mesh-ancestor
5819940|NCT02618668|Sensory System Agents|sensory system agents|mesh-ancestor
5819941|NCT02618668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5819942|NCT02618668|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5645907|NCT04747314|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5645908|NCT04747314|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5645909|NCT04747314|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5645910|NCT04747314|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5645911|NCT04747314|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5645912|NCT04747314|Analgesics|analgesics|mesh-ancestor
5645913|NCT04747314|Sensory System Agents|sensory system agents|mesh-ancestor
5645914|NCT04747314|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5645915|NCT04747314|Histamine Antagonists|histamine antagonists|mesh-ancestor
5645916|NCT04747314|Histamine Agents|histamine agents|mesh-ancestor
5645917|NCT04747314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5645918|NCT04747314|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5645919|NCT04747314|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5645920|NCT04747314|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5645921|NCT04747314|Adrenergic Agents|adrenergic agents|mesh-ancestor
5645922|NCT04747314|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5645928|NCT04740645|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
5645929|NCT04740645|Hemostatics|hemostatics|mesh-ancestor
5645930|NCT04740645|Coagulants|coagulants|mesh-ancestor
5645931|NCT04740645|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5645932|NCT04740645|Natriuretic Agents|natriuretic agents|mesh-ancestor
5819943|NCT02618668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5645933|NCT04740645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645934|NCT04730193|Caffeine|caffeine|mesh-list
5645935|NCT04730193|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5645936|NCT04730193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645937|NCT04730193|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5645938|NCT04730193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5645939|NCT04730193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5645940|NCT04730193|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5645941|NCT04730193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5645942|NCT04730193|Purinergic Agents|purinergic agents|mesh-ancestor
5645943|NCT04730193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5645944|NCT04717765|Vitamin E|vitamin e|mesh-list
5645945|NCT04717765|alpha-Tocopherol|alpha-tocopherol|mesh-list
5645946|NCT04717765|Tocopherols|tocopherols|mesh-list
5645947|NCT04717765|Antioxidants|antioxidants|mesh-ancestor
5645948|NCT04717765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5645949|NCT04717765|Protective Agents|protective agents|mesh-ancestor
5645950|NCT04717765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645951|NCT04717765|Vitamins|vitamins|mesh-ancestor
5645952|NCT04717765|Micronutrients|micronutrients|mesh-ancestor
5645953|NCT04705818|Durvalumab|durvalumab|mesh-list
5645954|NCT04705818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5645955|NCT04705818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5645956|NCT04704219|Pembrolizumab|pembrolizumab|mesh-list
5645957|NCT04704219|Lenvatinib|lenvatinib|mesh-list
5645958|NCT04704219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5645959|NCT04704219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5819944|NCT02618668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5819945|NCT02618668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5819946|NCT02618668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819947|NCT02618577|Edoxaban|edoxaban|mesh-list
5819948|NCT02618577|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5819949|NCT02618577|Antithrombins|antithrombins|mesh-ancestor
5819950|NCT02618577|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5819951|NCT02618577|Protease Inhibitors|protease inhibitors|mesh-ancestor
5819952|NCT02618577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5819953|NCT02618577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819954|NCT02618577|Anticoagulants|anticoagulants|mesh-ancestor
5819955|NCT02618395|Hydrocodone|hydrocodone|mesh-list
5819956|NCT02618395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5819957|NCT02618395|Narcotics|narcotics|mesh-ancestor
5819958|NCT02618395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5819959|NCT02618395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819960|NCT02618395|Analgesics|analgesics|mesh-ancestor
5819961|NCT02618395|Sensory System Agents|sensory system agents|mesh-ancestor
5819962|NCT02618395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5819963|NCT02618395|Antitussive Agents|antitussive agents|mesh-ancestor
5819964|NCT02618395|Respiratory System Agents|respiratory system agents|mesh-ancestor
5819965|NCT02618564|Sennosides|sennosides|mesh-list
5819966|NCT02618564|Laxatives|laxatives|mesh-ancestor
5819967|NCT02618564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5819968|NCT02618720|Ornidazole|ornidazole|mesh-list
5819969|NCT02618720|Amebicides|amebicides|mesh-ancestor
5819970|NCT02618720|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5819971|NCT02618720|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5819972|NCT02618720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5819973|NCT02618720|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
5819974|NCT02618603|Triamcinolone|triamcinolone|mesh-list
5819975|NCT02618603|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5819976|NCT02618603|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5819977|NCT02618603|Botulinum Toxins|botulinum toxins|mesh-list
5819978|NCT02618603|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5819979|NCT02618603|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5819980|NCT02618603|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5819981|NCT02618603|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5819982|NCT02618603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5819983|NCT02618603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5819984|NCT02618603|Cholinergic Agents|cholinergic agents|mesh-ancestor
5819985|NCT02618603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5819986|NCT02618603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5819987|NCT02618603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5819988|NCT02618603|Glucocorticoids|glucocorticoids|mesh-ancestor
5819989|NCT02618603|Hormones|hormones|mesh-ancestor
5819990|NCT02618603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5819991|NCT02618603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5819992|NCT02618603|Immunologic Factors|immunologic factors|mesh-ancestor
5819993|NCT02618603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5819994|NCT02618603|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5819995|NCT02618603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5819996|NCT02618356|Raltitrexed|raltitrexed|mesh-list
5819997|NCT02618356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5819998|NCT02618356|Antimetabolites|antimetabolites|mesh-ancestor
5819999|NCT02618356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820000|NCT02618356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5820001|NCT02618356|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5820002|NCT02618356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5820003|NCT02618499|Oxytocin|oxytocin|mesh-list
5820004|NCT02618499|Oxytocics|oxytocics|mesh-ancestor
5820005|NCT02618499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5820006|NCT02618499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820007|NCT02618317|Minocycline|minocycline|mesh-list
5820008|NCT02618317|Heparin|heparin|mesh-list
5820009|NCT02618317|Anticoagulants|anticoagulants|mesh-ancestor
5820010|NCT02618317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820011|NCT02618317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5820012|NCT02618317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5820013|NCT02618317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5820014|NCT02618317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5820015|NCT02618096|Oxytocin|oxytocin|mesh-list
5820016|NCT02618096|Dinoprostone|dinoprostone|mesh-list
5820017|NCT02618096|Oxytocics|oxytocics|mesh-ancestor
5820018|NCT02618096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5820019|NCT02618096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820020|NCT02618733|Clopidogrel|clopidogrel|mesh-list
5820021|NCT02618733|Ticagrelor|ticagrelor|mesh-list
5820022|NCT02618733|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5820023|NCT02618733|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5820024|NCT02618733|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5820025|NCT02618733|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5645960|NCT04704219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5645961|NCT04704219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5645962|NCT04704219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5645963|NCT04702893|Nintedanib|nintedanib|mesh-list
5645964|NCT04702893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5645965|NCT04702893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5645966|NCT04702893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5645967|NCT04702893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820026|NCT02618733|Purinergic Agents|purinergic agents|mesh-ancestor
5820027|NCT02618733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5820028|NCT02618733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820029|NCT02618733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820030|NCT02618057|Levofloxacin|levofloxacin|mesh-list
5820031|NCT02618057|Ofloxacin|ofloxacin|mesh-list
5820032|NCT02618057|Prednisolone|prednisolone|mesh-list
5820033|NCT02618057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5820034|NCT02618057|Glucocorticoids|glucocorticoids|mesh-ancestor
5820035|NCT02618057|Hormones|hormones|mesh-ancestor
5820036|NCT02618057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5820037|NCT02618057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820038|NCT02618057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5820039|NCT02618057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5820040|NCT02618057|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5820041|NCT02618057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5820042|NCT02618057|Renal Agents|renal agents|mesh-ancestor
5820043|NCT02618057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5820044|NCT02618057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5645968|NCT04685811|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5820045|NCT02618057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5820046|NCT02618057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5820047|NCT02618057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820048|NCT02618057|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5820049|NCT02618057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5820050|NCT02617862|Anesthetics|anesthetics|mesh-list
5820051|NCT02617862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5820052|NCT02617862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820053|NCT02617849|Paclitaxel|paclitaxel|mesh-list
5820054|NCT02617849|Carboplatin|carboplatin|mesh-list
5820055|NCT02617849|Pembrolizumab|pembrolizumab|mesh-list
5820056|NCT02617849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5820057|NCT02617849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5645969|NCT04685811|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5820058|NCT02617849|Tubulin Modulators|tubulin modulators|mesh-ancestor
5820059|NCT02617849|Antimitotic Agents|antimitotic agents|mesh-ancestor
5820060|NCT02617849|Mitosis Modulators|mitosis modulators|mesh-ancestor
5820061|NCT02617849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820062|NCT02617849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5820063|NCT02617680|Nitric Oxide|nitric oxide|mesh-list
5820064|NCT02617680|Desflurane|desflurane|mesh-list
5820065|NCT02617680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5820066|NCT02617680|Autonomic Agents|autonomic agents|mesh-ancestor
5820067|NCT02617680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5645970|NCT04685811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5645971|NCT04681339|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5645972|NCT04681339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5645973|NCT04681339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5645974|NCT04681339|Antitubercular Agents|antitubercular agents|mesh-ancestor
5694240|NCT03396523|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5694241|NCT03396523|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5694242|NCT03396523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694243|NCT03396497|Pembrolizumab|pembrolizumab|mesh-list
5694244|NCT03396497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5694245|NCT03396497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5694246|NCT03396484|Methyldopa|methyldopa|mesh-list
5694247|NCT03396484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5694248|NCT03396484|Sympatholytics|sympatholytics|mesh-ancestor
5820068|NCT02617680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820069|NCT02617680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5820070|NCT02617680|Respiratory System Agents|respiratory system agents|mesh-ancestor
5820071|NCT02617680|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5820072|NCT02617680|Antioxidants|antioxidants|mesh-ancestor
5820073|NCT02617680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820074|NCT02617680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5820075|NCT02617680|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5820076|NCT02617680|Vasodilator Agents|vasodilator agents|mesh-ancestor
5820077|NCT02617680|Gasotransmitters|gasotransmitters|mesh-ancestor
5820078|NCT02617680|Protective Agents|protective agents|mesh-ancestor
5820079|NCT02617680|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5820080|NCT02617680|Anesthetics, General|anesthetics, general|mesh-ancestor
5820081|NCT02617680|Anesthetics|anesthetics|mesh-ancestor
5694249|NCT03396484|Autonomic Agents|autonomic agents|mesh-ancestor
5694250|NCT03396484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5694251|NCT03396484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694252|NCT03396484|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5694253|NCT03396484|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5694254|NCT03396484|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5694255|NCT03396484|Adrenergic Agents|adrenergic agents|mesh-ancestor
5694256|NCT03396484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5694257|NCT03396484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694258|NCT03396393|Artenimol|artenimol|mesh-list
5694259|NCT03396393|Antimalarials|antimalarials|mesh-ancestor
5694260|NCT03396393|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5694261|NCT03396393|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5694262|NCT03396393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5694263|NCT03396380|Calcium, Dietary|calcium, dietary|mesh-list
5694264|NCT03396380|Vitamin D|vitamin d|mesh-list
5694265|NCT03396380|Citric Acid|citric acid|mesh-list
5694266|NCT03396380|Sodium Citrate|sodium citrate|mesh-list
5694267|NCT03396380|Clomiphene|clomiphene|mesh-list
5694268|NCT03396380|Enclomiphene|enclomiphene|mesh-list
5694269|NCT03396380|Zuclomiphene|zuclomiphene|mesh-list
5694270|NCT03396380|Calcium|calcium|mesh-list
5694271|NCT03396380|Vitamins|vitamins|mesh-ancestor
5694272|NCT03396380|Micronutrients|micronutrients|mesh-ancestor
5694273|NCT03396380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694274|NCT03396380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5694275|NCT03396380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5694276|NCT03396380|Anticoagulants|anticoagulants|mesh-ancestor
6492806|NCT00610610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492807|NCT00610610|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6492808|NCT00610610|Antidepressive Agents|antidepressive agents|mesh-ancestor
6492809|NCT00610610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5820082|NCT02617680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5820083|NCT02617810|Midazolam|midazolam|mesh-list
6492810|NCT00610610|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5694277|NCT03396380|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5820084|NCT02617810|Warfarin|warfarin|mesh-list
5820085|NCT02617810|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6492811|NCT00610610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6492812|NCT00610610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6492813|NCT00610623|Azithromycin|azithromycin|mesh-list
5645975|NCT04674683|Nivolumab|nivolumab|mesh-list
5645976|NCT04674683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5645977|NCT04674683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5645978|NCT04674683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5645979|NCT04674683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5645980|NCT04673357|Ustekinumab|ustekinumab|mesh-list
5645981|NCT04673357|Dermatologic Agents|dermatologic agents|mesh-ancestor
5645982|NCT04671355|Fluticasone|fluticasone|mesh-list
5645983|NCT04671355|Xhance|xhance|mesh-list
5645984|NCT04671355|Beclomethasone|beclomethasone|mesh-list
5645985|NCT04671355|Glycopyrrolate|glycopyrrolate|mesh-list
5645986|NCT04671355|Formoterol Fumarate|formoterol fumarate|mesh-list
5645987|NCT04671355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5645988|NCT04671355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5645989|NCT04671355|Autonomic Agents|autonomic agents|mesh-ancestor
5645990|NCT04671355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5645991|NCT04671355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5645992|NCT04671355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5645993|NCT04671355|Respiratory System Agents|respiratory system agents|mesh-ancestor
5645994|NCT04671355|Dermatologic Agents|dermatologic agents|mesh-ancestor
5645995|NCT04671355|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5645996|NCT04671355|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5645997|NCT04671355|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5645998|NCT04671355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5645999|NCT04671355|Adrenergic Agents|adrenergic agents|mesh-ancestor
5646000|NCT04671355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5646001|NCT04671355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646002|NCT04671355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5646003|NCT04671355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5646004|NCT04671355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5646005|NCT04671355|Cholinergic Agents|cholinergic agents|mesh-ancestor
5646006|NCT04671355|Glucocorticoids|glucocorticoids|mesh-ancestor
5646007|NCT04671355|Hormones|hormones|mesh-ancestor
5646008|NCT04671355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5646009|NCT04651400|Antithrombins|antithrombins|mesh-list
5646010|NCT04651400|Antithrombin III|antithrombin iii|mesh-list
5646011|NCT04651400|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5646012|NCT04651400|Protease Inhibitors|protease inhibitors|mesh-ancestor
5820086|NCT02617810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5820087|NCT02617810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5820088|NCT02617810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820089|NCT02617810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5820090|NCT02617810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5820091|NCT02617810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5820092|NCT02617810|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5820093|NCT02617810|Anesthetics, General|anesthetics, general|mesh-ancestor
5820094|NCT02617810|Anesthetics|anesthetics|mesh-ancestor
5820095|NCT02617810|GABA Modulators|gaba modulators|mesh-ancestor
5820096|NCT02617810|GABA Agents|gaba agents|mesh-ancestor
5820097|NCT02617810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5820098|NCT02617810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820099|NCT02617810|Anticoagulants|anticoagulants|mesh-ancestor
5820100|NCT02617771|Vitamin D|vitamin d|mesh-list
5820101|NCT02617771|Cholecalciferol|cholecalciferol|mesh-list
5820102|NCT02617771|Vitamins|vitamins|mesh-ancestor
5820103|NCT02617771|Micronutrients|micronutrients|mesh-ancestor
5820104|NCT02617771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820105|NCT02617771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5820106|NCT02617771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5820107|NCT02617459|Betaxolol|betaxolol|mesh-list
5820108|NCT02617459|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5820109|NCT02617459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5820110|NCT02617459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5820111|NCT02617459|Sympatholytics|sympatholytics|mesh-ancestor
5820112|NCT02617459|Autonomic Agents|autonomic agents|mesh-ancestor
5820113|NCT02617459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5820114|NCT02617459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820115|NCT02617459|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5820116|NCT02617459|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5820117|NCT02617459|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5820118|NCT02617459|Adrenergic Agents|adrenergic agents|mesh-ancestor
6492814|NCT00610623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5646013|NCT04651400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6492815|NCT00610623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5646014|NCT04651400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820119|NCT02617459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5820120|NCT02617459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820121|NCT02617758|Fentanyl|fentanyl|mesh-list
5820122|NCT02617758|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5820123|NCT02617758|Narcotics|narcotics|mesh-ancestor
5820124|NCT02617758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5820125|NCT02617758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820126|NCT02617758|Analgesics|analgesics|mesh-ancestor
5820127|NCT02617758|Sensory System Agents|sensory system agents|mesh-ancestor
5820128|NCT02617758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5820129|NCT02617758|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5820130|NCT02617758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5820131|NCT02617758|Anesthetics, General|anesthetics, general|mesh-ancestor
5820132|NCT02617758|Anesthetics|anesthetics|mesh-ancestor
5646015|NCT04651400|Anticoagulants|anticoagulants|mesh-ancestor
5646016|NCT04644237|Trastuzumab|trastuzumab|mesh-list
5646017|NCT04644237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5646018|NCT04644237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5646019|NCT04642365|Atezolizumab|atezolizumab|mesh-list
5646020|NCT04642365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5646021|NCT04630028|Ustekinumab|ustekinumab|mesh-list
5646022|NCT04630028|Dermatologic Agents|dermatologic agents|mesh-ancestor
5646023|NCT04627246|Vaccines|vaccines|mesh-list
5646024|NCT04627246|Immunologic Factors|immunologic factors|mesh-ancestor
5646025|NCT04627246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646026|NCT04626128|Aflibercept|aflibercept|mesh-list
5646027|NCT04626128|Axitinib|axitinib|mesh-list
5820133|NCT02617654|Liraglutide|liraglutide|mesh-list
5820134|NCT02617654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5820135|NCT02617654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820136|NCT02617654|Incretins|incretins|mesh-ancestor
5820137|NCT02617654|Hormones|hormones|mesh-ancestor
5820138|NCT02617654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5901552|NCT03070327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5901553|NCT03070327|Immunologic Factors|immunologic factors|mesh-ancestor
5901554|NCT03070327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901555|NCT03070327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5901556|NCT03070327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5901557|NCT03070327|Alkylating Agents|alkylating agents|mesh-ancestor
5901558|NCT03070327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901559|NCT03070327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901560|NCT03070327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5901561|NCT03070327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5901562|NCT03070327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5901563|NCT03070327|Growth Substances|growth substances|mesh-ancestor
5901564|NCT03070327|Growth Inhibitors|growth inhibitors|mesh-ancestor
5901565|NCT03049618|Pembrolizumab|pembrolizumab|mesh-list
5901566|NCT03049618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5901567|NCT03049618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901568|NCT03031821|Metformin|metformin|mesh-list
5901569|NCT03031821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5901570|NCT03031821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901571|NCT03023631|Vaccines|vaccines|mesh-list
5901572|NCT03023631|Immunologic Factors|immunologic factors|mesh-ancestor
5901573|NCT03023631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901574|NCT03023462|Droperidol|droperidol|mesh-list
5901575|NCT03023462|Oxycodone|oxycodone|mesh-list
5901576|NCT03023462|Ondansetron|ondansetron|mesh-list
5901577|NCT03023462|Ropivacaine|ropivacaine|mesh-list
5901578|NCT03023462|Anesthetics, Local|anesthetics, local|mesh-ancestor
5901579|NCT03023462|Anesthetics|anesthetics|mesh-ancestor
5901580|NCT03023462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5901581|NCT03023462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901582|NCT03023462|Sensory System Agents|sensory system agents|mesh-ancestor
5901583|NCT03023462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5901584|NCT03023462|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5901585|NCT03023462|Narcotics|narcotics|mesh-ancestor
5901586|NCT03023462|Analgesics|analgesics|mesh-ancestor
5901587|NCT03023462|Antiemetics|antiemetics|mesh-ancestor
5901588|NCT03023462|Autonomic Agents|autonomic agents|mesh-ancestor
5901589|NCT03023462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5901590|NCT03023462|Antipruritics|antipruritics|mesh-ancestor
5901591|NCT03023462|Dermatologic Agents|dermatologic agents|mesh-ancestor
5901592|NCT03023462|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5646028|NCT04626128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901593|NCT03023462|Serotonin Agents|serotonin agents|mesh-ancestor
5901594|NCT03023462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5646029|NCT04626128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5646030|NCT04626128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5646031|NCT04626128|Growth Substances|growth substances|mesh-ancestor
5646032|NCT04626128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646033|NCT04626128|Growth Inhibitors|growth inhibitors|mesh-ancestor
5646034|NCT04626128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5646035|NCT04626128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5646036|NCT04626128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646037|NCT04625088|Atropine|atropine|mesh-list
5646038|NCT04625088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5646039|NCT04625088|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5646040|NCT04625088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5646041|NCT04625088|Autonomic Agents|autonomic agents|mesh-ancestor
5646042|NCT04625088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5646043|NCT04625088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646044|NCT04625088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5646045|NCT04625088|Respiratory System Agents|respiratory system agents|mesh-ancestor
5646046|NCT04625088|Mydriatics|mydriatics|mesh-ancestor
5820139|NCT02617485|Prednisone|prednisone|mesh-list
5820140|NCT02617485|Cyclophosphamide|cyclophosphamide|mesh-list
5820141|NCT02617485|Rituximab|rituximab|mesh-list
5820142|NCT02617485|Doxorubicin|doxorubicin|mesh-list
5820143|NCT02617485|Vincristine|vincristine|mesh-list
5820144|NCT02617485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5820145|NCT02617485|Immunologic Factors|immunologic factors|mesh-ancestor
5820146|NCT02617485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820147|NCT02617485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5820148|NCT02617485|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5820149|NCT02617485|Alkylating Agents|alkylating agents|mesh-ancestor
5820150|NCT02617485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820151|NCT02617485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5820152|NCT02617485|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5820153|NCT02617485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5820154|NCT02617485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5820155|NCT02617485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5820156|NCT02617485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5820157|NCT02617485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5820158|NCT02617485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5820159|NCT02617485|Glucocorticoids|glucocorticoids|mesh-ancestor
5820160|NCT02617485|Hormones|hormones|mesh-ancestor
5646047|NCT04625088|Parasympatholytics|parasympatholytics|mesh-ancestor
5646048|NCT04625088|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5646049|NCT04625088|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5646050|NCT04625088|Cholinergic Agents|cholinergic agents|mesh-ancestor
5646051|NCT04625088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5646052|NCT04625088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646053|NCT04614545|Phentermine|phentermine|mesh-list
5646054|NCT04614545|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6492816|NCT00610792|Doxorubicin|doxorubicin|mesh-list
6492817|NCT00610792|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6492818|NCT00610792|Bortezomib|bortezomib|mesh-list
6492819|NCT00610792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6492820|NCT00610792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6492821|NCT00610792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5820161|NCT02617485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5820162|NCT02617485|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5820163|NCT02617485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5820164|NCT02617485|Tubulin Modulators|tubulin modulators|mesh-ancestor
5820165|NCT02617485|Antimitotic Agents|antimitotic agents|mesh-ancestor
5820166|NCT02617485|Mitosis Modulators|mitosis modulators|mesh-ancestor
5820167|NCT02617121|Gabapentin|gabapentin|mesh-list
5820168|NCT02617121|Ramosetron|ramosetron|mesh-list
5820169|NCT02617121|Analgesics|analgesics|mesh-ancestor
5820170|NCT02617121|Sensory System Agents|sensory system agents|mesh-ancestor
5820171|NCT02617121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5820172|NCT02617121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820173|NCT02617121|Anticonvulsants|anticonvulsants|mesh-ancestor
5820174|NCT02617121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5820175|NCT02617121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5820176|NCT02617121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5820177|NCT02617121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5820178|NCT02617121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5820179|NCT02617121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6492822|NCT00610792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6492823|NCT00610792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6492824|NCT00610792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646055|NCT04614545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646056|NCT04614545|Appetite Depressants|appetite depressants|mesh-ancestor
5646057|NCT04614545|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5646058|NCT04614545|Sympathomimetics|sympathomimetics|mesh-ancestor
5646059|NCT04614545|Autonomic Agents|autonomic agents|mesh-ancestor
5646060|NCT04614545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5646061|NCT04614545|Adrenergic Agents|adrenergic agents|mesh-ancestor
5646062|NCT04614545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5646063|NCT04614545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646064|NCT04610671|Nivolumab|nivolumab|mesh-list
5646065|NCT04610671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5646066|NCT04610671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5646067|NCT04610671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5646068|NCT04610671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646069|NCT04599855|Esketamine|esketamine|mesh-list
5646070|NCT04599855|Antidepressive Agents|antidepressive agents|mesh-ancestor
5646071|NCT04599855|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5646072|NCT04597671|Durvalumab|durvalumab|mesh-list
5646073|NCT04597671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5646074|NCT04597671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5646075|NCT04588727|Aspirin|aspirin|mesh-list
5646076|NCT04588727|Ticagrelor|ticagrelor|mesh-list
5646077|NCT04588727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5646078|NCT04588727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5820180|NCT02617121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5820181|NCT02617121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820182|NCT02617121|Antimanic Agents|antimanic agents|mesh-ancestor
5820183|NCT02617121|Antiemetics|antiemetics|mesh-ancestor
5820184|NCT02617121|Autonomic Agents|autonomic agents|mesh-ancestor
5820185|NCT02617121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5820186|NCT02617121|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5820187|NCT02617121|Serotonin Agents|serotonin agents|mesh-ancestor
5646079|NCT04588727|Analgesics|analgesics|mesh-ancestor
5646080|NCT04588727|Sensory System Agents|sensory system agents|mesh-ancestor
5646081|NCT04588727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5646082|NCT04588727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646083|NCT04588727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5646084|NCT04588727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5646085|NCT04588727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5646086|NCT04588727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5646087|NCT04588727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646088|NCT04588727|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5646089|NCT04588727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5646090|NCT04588727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5646091|NCT04588727|Antipyretics|antipyretics|mesh-ancestor
5646092|NCT04588727|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5646093|NCT04588727|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5646094|NCT04588727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5646095|NCT04588727|Purinergic Agents|purinergic agents|mesh-ancestor
5646096|NCT04588727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5646097|NCT04573946|Vitamin D|vitamin d|mesh-list
5646098|NCT04573946|Ergocalciferols|ergocalciferols|mesh-list
5646099|NCT04573946|Cholecalciferol|cholecalciferol|mesh-list
5646100|NCT04573946|Vitamins|vitamins|mesh-list
5646101|NCT04573946|Micronutrients|micronutrients|mesh-ancestor
5820188|NCT02617407|Listerine|listerine|mesh-list
5820189|NCT02617407|Sodium Fluoride|sodium fluoride|mesh-list
5820190|NCT02617407|Cariostatic Agents|cariostatic agents|mesh-ancestor
5820191|NCT02617407|Protective Agents|protective agents|mesh-ancestor
5820192|NCT02617407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820193|NCT02617407|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5820194|NCT02617407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5820195|NCT02617199|Fentanyl|fentanyl|mesh-list
5820196|NCT02617199|Analgesics|analgesics|mesh-list
5820197|NCT02617199|Ropivacaine|ropivacaine|mesh-list
5820198|NCT02617199|Anesthetics|anesthetics|mesh-ancestor
5820199|NCT02617199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5820200|NCT02617199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820201|NCT02617199|Anesthetics, Local|anesthetics, local|mesh-ancestor
5820202|NCT02617199|Sensory System Agents|sensory system agents|mesh-ancestor
5820203|NCT02617199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5646102|NCT04573946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820204|NCT02617199|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5820205|NCT02617199|Narcotics|narcotics|mesh-ancestor
6492825|NCT00610818|Mitogens|mitogens|mesh-list
5820206|NCT02617199|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5820207|NCT02617199|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5820208|NCT02617199|Anesthetics, General|anesthetics, general|mesh-ancestor
5820209|NCT02617290|Clopidogrel|clopidogrel|mesh-list
5820210|NCT02617290|Ticagrelor|ticagrelor|mesh-list
5820211|NCT02617290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5820212|NCT02617290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5820213|NCT02617290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5820214|NCT02617290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5820215|NCT02617290|Purinergic Agents|purinergic agents|mesh-ancestor
5820216|NCT02617290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5820217|NCT02617290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820218|NCT02617290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820219|NCT02617069|Botulinum Toxins|botulinum toxins|mesh-list
5820220|NCT02617069|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5820221|NCT02617069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6674371|NCT01568996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674372|NCT01568996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6674373|NCT01569035|Warfarin|warfarin|mesh-list
5820222|NCT02617069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820223|NCT02617069|Cholinergic Agents|cholinergic agents|mesh-ancestor
5820224|NCT02617069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5820225|NCT02617069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820226|NCT02617017|Buspirone|buspirone|mesh-list
5820227|NCT02617017|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5820228|NCT02617017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5820229|NCT02617017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5820230|NCT02617017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820231|NCT02617017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5820232|NCT02617017|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5820233|NCT02617017|Serotonin Agents|serotonin agents|mesh-ancestor
5820234|NCT02617017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5820235|NCT02617017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820236|NCT02616913|Moxifloxacin|moxifloxacin|mesh-list
5820237|NCT02616913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5820238|NCT02616913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5820239|NCT02616913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5820240|NCT02616913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5820241|NCT02616913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5820242|NCT02616913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820243|NCT02616913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5820244|NCT02616770|Perflubron|perflubron|mesh-list
5820245|NCT02616770|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5820246|NCT02616692|Sorafenib|sorafenib|mesh-list
5820247|NCT02616692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5820248|NCT02616692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5820249|NCT02616692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5820250|NCT02616692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820251|NCT02616666|Dapagliflozin|dapagliflozin|mesh-list
5820252|NCT02616666|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5820253|NCT02616666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820254|NCT02616666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5820255|NCT02616666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820256|NCT02616744|Ibandronic Acid|ibandronic acid|mesh-list
5820257|NCT02616744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5820258|NCT02616744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820259|NCT02616822|Resveratrol|resveratrol|mesh-list
5820260|NCT02616822|Antioxidants|antioxidants|mesh-ancestor
5820261|NCT02616822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820262|NCT02616822|Protective Agents|protective agents|mesh-ancestor
5820263|NCT02616822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820264|NCT02616822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5820265|NCT02616822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5820266|NCT02616731|Tranexamic Acid|tranexamic acid|mesh-list
5646103|NCT04573946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5646104|NCT04573946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5646105|NCT04565990|Selexipag|selexipag|mesh-list
5646106|NCT04565990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5646107|NCT04564898|Trifluridine|trifluridine|mesh-list
5646108|NCT04564898|Bevacizumab|bevacizumab|mesh-list
5646109|NCT04564898|Capecitabine|capecitabine|mesh-list
5646110|NCT04564898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5646111|NCT04564898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5646112|NCT04564898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5820267|NCT02616731|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5820268|NCT02616731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5820269|NCT02616731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820270|NCT02616731|Hemostatics|hemostatics|mesh-ancestor
5820271|NCT02616731|Coagulants|coagulants|mesh-ancestor
5820272|NCT02616874|Romidepsin|romidepsin|mesh-list
5820273|NCT02616874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5820274|NCT02616874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5820275|NCT02616861|Praliciguat|praliciguat|mesh-list
5820276|NCT02616861|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
5820277|NCT02616861|Enzyme Activators|enzyme activators|mesh-ancestor
5820278|NCT02616861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820279|NCT02616861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5820280|NCT02616848|Everolimus|everolimus|mesh-list
5820281|NCT02616848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5820282|NCT02616848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5820283|NCT02616848|Immunologic Factors|immunologic factors|mesh-ancestor
5820284|NCT02616848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820285|NCT02616640|Dexamethasone|dexamethasone|mesh-list
5820286|NCT02616640|Durvalumab|durvalumab|mesh-list
5820287|NCT02616640|Pomalidomide|pomalidomide|mesh-list
5820288|NCT02616640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5820289|NCT02616640|Antiemetics|antiemetics|mesh-ancestor
5820290|NCT02616640|Autonomic Agents|autonomic agents|mesh-ancestor
5820291|NCT02616640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5820292|NCT02616640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820293|NCT02616640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5820294|NCT02616640|Glucocorticoids|glucocorticoids|mesh-ancestor
5820295|NCT02616640|Hormones|hormones|mesh-ancestor
5820296|NCT02616640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5820297|NCT02616640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5820298|NCT02616640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5820299|NCT02616640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5820300|NCT02616640|Immunologic Factors|immunologic factors|mesh-ancestor
5820301|NCT02616640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5820302|NCT02616640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5820303|NCT02616640|Growth Substances|growth substances|mesh-ancestor
5820304|NCT02616640|Growth Inhibitors|growth inhibitors|mesh-ancestor
5820305|NCT02616354|Imipenem|imipenem|mesh-list
5820306|NCT02616354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5820307|NCT02616354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5820308|NCT02616367|Bupivacaine|bupivacaine|mesh-list
5820309|NCT02616367|Ropivacaine|ropivacaine|mesh-list
5820310|NCT02616367|Anesthetics, Local|anesthetics, local|mesh-ancestor
5820311|NCT02616367|Anesthetics|anesthetics|mesh-ancestor
5820312|NCT02616367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5820313|NCT02616367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820314|NCT02616367|Sensory System Agents|sensory system agents|mesh-ancestor
5820315|NCT02616367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5820316|NCT02616289|Emollients|emollients|mesh-list
5820317|NCT02616289|Dermatologic Agents|dermatologic agents|mesh-ancestor
5820318|NCT02616497|Aspirin|aspirin|mesh-list
5820319|NCT02616497|Triflusal|triflusal|mesh-list
5820320|NCT02616497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5820321|NCT02616497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5820322|NCT02616497|Analgesics|analgesics|mesh-ancestor
5820323|NCT02616497|Sensory System Agents|sensory system agents|mesh-ancestor
5820324|NCT02616497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5820325|NCT02616497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820326|NCT02616497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5820327|NCT02616497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5820328|NCT02616497|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5820329|NCT02616497|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5820330|NCT02616497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820331|NCT02616497|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5820332|NCT02616497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5820333|NCT02616497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5820334|NCT02616497|Antipyretics|antipyretics|mesh-ancestor
6674374|NCT01569035|Anticoagulants|anticoagulants|mesh-ancestor
6674375|NCT01569048|Dexmedetomidine|dexmedetomidine|mesh-list
6674376|NCT01569048|Remifentanil|remifentanil|mesh-list
6674377|NCT01569048|Propofol|propofol|mesh-list
6674378|NCT01569048|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6674379|NCT01569048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6674380|NCT01569048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820335|NCT02616419|Lidocaine|lidocaine|mesh-list
6674381|NCT01569048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5820336|NCT02616419|Anesthetics, Local|anesthetics, local|mesh-ancestor
5820337|NCT02616419|Anesthetics|anesthetics|mesh-ancestor
5820338|NCT02616419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5820339|NCT02616419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820340|NCT02616419|Sensory System Agents|sensory system agents|mesh-ancestor
5820341|NCT02616419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5820342|NCT02616419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5820343|NCT02616419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5820344|NCT02616419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5820345|NCT02616419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5820346|NCT02616419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820347|NCT02616315|Naltrexone|naltrexone|mesh-list
5820348|NCT02616315|Bupropion|bupropion|mesh-list
5820349|NCT02616315|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5820350|NCT02616315|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5820351|NCT02616315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820352|NCT02616315|Sensory System Agents|sensory system agents|mesh-ancestor
5820353|NCT02616315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5820354|NCT02616315|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5820355|NCT02616315|Antidepressive Agents|antidepressive agents|mesh-ancestor
5820356|NCT02616315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5820357|NCT02616315|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5820358|NCT02616315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5820359|NCT02616315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5820360|NCT02616315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820361|NCT02616315|Dopamine Agents|dopamine agents|mesh-ancestor
5820362|NCT02616315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5820363|NCT02616315|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5820364|NCT02616315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5820365|NCT02616315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5820366|NCT02616003|Liraglutide|liraglutide|mesh-list
5820367|NCT02616003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5820368|NCT02616003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820369|NCT02616003|Incretins|incretins|mesh-ancestor
5820370|NCT02616003|Hormones|hormones|mesh-ancestor
5820371|NCT02616003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5820372|NCT02615938|Hydroxychloroquine|hydroxychloroquine|mesh-list
5646113|NCT04564898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5646114|NCT04564898|Growth Substances|growth substances|mesh-ancestor
5646115|NCT04564898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646116|NCT04564898|Growth Inhibitors|growth inhibitors|mesh-ancestor
5646117|NCT04564898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5646118|NCT04564898|Antimetabolites|antimetabolites|mesh-ancestor
5646119|NCT04564898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646120|NCT04564898|Antiviral Agents|antiviral agents|mesh-ancestor
5646121|NCT04564898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5646122|NCT04562779|Naltrexone|naltrexone|mesh-list
5646123|NCT04562779|Ketamine|ketamine|mesh-list
5646124|NCT04562779|Analgesics|analgesics|mesh-ancestor
5646125|NCT04562779|Sensory System Agents|sensory system agents|mesh-ancestor
5646126|NCT04562779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5646127|NCT04562779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646128|NCT04562779|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5646129|NCT04562779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5646130|NCT04562779|Anesthetics, General|anesthetics, general|mesh-ancestor
5646131|NCT04562779|Anesthetics|anesthetics|mesh-ancestor
5646132|NCT04562779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5646133|NCT04562779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5646134|NCT04562779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5646135|NCT04562779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5646136|NCT04562779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646137|NCT04562779|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5646138|NCT04562779|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5646139|NCT04556838|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5646140|NCT04556838|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5646141|NCT04547790|Psyllium|psyllium|mesh-list
5646142|NCT04547790|Cathartics|cathartics|mesh-ancestor
5646143|NCT04547790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5646144|NCT04546009|Letrozole|letrozole|mesh-list
5646145|NCT04546009|Palbociclib|palbociclib|mesh-list
5646146|NCT04546009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5646147|NCT04546009|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5646148|NCT04546009|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5820373|NCT02615938|Antimalarials|antimalarials|mesh-ancestor
5646149|NCT04546009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5646150|NCT04546009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646151|NCT04546009|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5646152|NCT04546009|Hormone Antagonists|hormone antagonists|mesh-ancestor
5646153|NCT04546009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5646154|NCT04546009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646155|NCT04546009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5646156|NCT04542148|Insulin|insulin|mesh-list
5646157|NCT04542148|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5646158|NCT04542148|Insulin Aspart|insulin aspart|mesh-list
5646159|NCT04542148|Insulin Lispro|insulin lispro|mesh-list
5646160|NCT04542148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5646161|NCT04542148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646162|NCT04540211|Paclitaxel|paclitaxel|mesh-list
5646163|NCT04540211|Atezolizumab|atezolizumab|mesh-list
5646164|NCT04540211|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5646165|NCT04540211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5646166|NCT04540211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5646167|NCT04540211|Tubulin Modulators|tubulin modulators|mesh-ancestor
5646168|NCT04540211|Antimitotic Agents|antimitotic agents|mesh-ancestor
5646169|NCT04540211|Mitosis Modulators|mitosis modulators|mesh-ancestor
5646170|NCT04540211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646171|NCT04540211|Immunologic Factors|immunologic factors|mesh-ancestor
5646172|NCT04540211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646173|NCT04539938|Trastuzumab|trastuzumab|mesh-list
5646174|NCT04539938|Tucatinib|tucatinib|mesh-list
5646175|NCT04539938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5646176|NCT04539938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5646177|NCT04539938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5646178|NCT04539938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5646179|NCT04539938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646180|NCT04523363|Metformin|metformin|mesh-list
5646181|NCT04523363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5646182|NCT04523363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646183|NCT04518410|Gabexate|gabexate|mesh-list
5646184|NCT04518410|Immunoglobulins|immunoglobulins|mesh-list
5820374|NCT02615938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5820375|NCT02615938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5820376|NCT02615938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5646185|NCT04518410|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5646186|NCT04518410|Antibodies|antibodies|mesh-list
5646187|NCT04518410|Camostat|camostat|mesh-list
5646188|NCT04518410|Immunologic Factors|immunologic factors|mesh-ancestor
5646189|NCT04518410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646190|NCT04518410|Protease Inhibitors|protease inhibitors|mesh-ancestor
5646191|NCT04518410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5646192|NCT04518410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646193|NCT04518410|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5646194|NCT04518410|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5646195|NCT04518410|Anticoagulants|anticoagulants|mesh-ancestor
5646196|NCT04517435|Prednisone|prednisone|mesh-list
5646197|NCT04517435|Cyclophosphamide|cyclophosphamide|mesh-list
5646198|NCT04517435|Rituximab|rituximab|mesh-list
5646199|NCT04517435|Doxorubicin|doxorubicin|mesh-list
5646200|NCT04517435|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5646201|NCT04517435|Vincristine|vincristine|mesh-list
5646202|NCT04517435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5646203|NCT04517435|Immunologic Factors|immunologic factors|mesh-ancestor
5646204|NCT04517435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646205|NCT04517435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5646206|NCT04517435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5646207|NCT04517435|Alkylating Agents|alkylating agents|mesh-ancestor
5646208|NCT04517435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646209|NCT04517435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5646210|NCT04517435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5646211|NCT04517435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5646212|NCT04517435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5646213|NCT04517435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5646214|NCT04517435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5646215|NCT04517435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5646216|NCT04517435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5646217|NCT04517435|Glucocorticoids|glucocorticoids|mesh-ancestor
5646218|NCT04517435|Hormones|hormones|mesh-ancestor
5646219|NCT04517435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5646220|NCT04517435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5646221|NCT04517435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5820377|NCT02615938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5820378|NCT02615938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820379|NCT02615938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5820380|NCT02615977|Ethanol|ethanol|mesh-list
5820381|NCT02615977|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5820382|NCT02615977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5646222|NCT04517435|Tubulin Modulators|tubulin modulators|mesh-ancestor
5646223|NCT04517435|Antimitotic Agents|antimitotic agents|mesh-ancestor
6211533|NCT02174510|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5820383|NCT02615977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5820384|NCT02615977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820385|NCT02616068|Loxoprofen|loxoprofen|mesh-list
5820386|NCT02616068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5820387|NCT02616068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5820388|NCT02616068|Analgesics|analgesics|mesh-ancestor
5820389|NCT02616068|Sensory System Agents|sensory system agents|mesh-ancestor
5820390|NCT02616068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5820391|NCT02616068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820392|NCT02616068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5820393|NCT02616068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5820394|NCT02615873|Levodopa|levodopa|mesh-list
5820395|NCT02615873|Carbidopa|carbidopa|mesh-list
5820396|NCT02615873|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
5820397|NCT02615873|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5820398|NCT02615873|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5820399|NCT02615873|Dopamine Agents|dopamine agents|mesh-ancestor
5820400|NCT02615873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5820401|NCT02615873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820402|NCT02615873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820403|NCT02615873|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5820404|NCT02615873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6211534|NCT02174510|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6211535|NCT02174510|Dopamine Agents|dopamine agents|mesh-ancestor
6211536|NCT02174523|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
6211537|NCT02174523|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6211538|NCT02174523|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6211539|NCT02174523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6211540|NCT02174523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211541|NCT02174523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6211542|NCT02174523|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6211543|NCT02174523|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5646224|NCT04517435|Mitosis Modulators|mitosis modulators|mesh-ancestor
5646225|NCT04513912|Quetiapine Fumarate|quetiapine fumarate|mesh-list
5646226|NCT04513912|Antidepressive Agents|antidepressive agents|mesh-ancestor
5646227|NCT04513912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5646228|NCT04513912|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5646229|NCT04513912|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5646230|NCT04513912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5646231|NCT04513912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646232|NCT04513717|Leuprolide|leuprolide|mesh-list
5646233|NCT04513717|Goserelin|goserelin|mesh-list
5646234|NCT04513717|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5646235|NCT04513717|Flutamide|flutamide|mesh-list
5646236|NCT04513717|Bicalutamide|bicalutamide|mesh-list
5646237|NCT04513717|Tryptophan|tryptophan|mesh-list
5646238|NCT04513717|Buserelin|buserelin|mesh-list
5646239|NCT04513717|Hormones|hormones|mesh-list
5646240|NCT04513717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5646241|NCT04513717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646242|NCT04513717|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5646243|NCT04513717|Fertility Agents|fertility agents|mesh-ancestor
5646244|NCT04513717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5646245|NCT04513717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5646246|NCT04513717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5646247|NCT04513717|Androgen Antagonists|androgen antagonists|mesh-ancestor
5646248|NCT04513717|Hormone Antagonists|hormone antagonists|mesh-ancestor
5820405|NCT02615873|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5820406|NCT02615873|Immunologic Factors|immunologic factors|mesh-ancestor
5820407|NCT02615873|Dopamine Agonists|dopamine agonists|mesh-ancestor
5820408|NCT02615847|Memantine|memantine|mesh-list
5820409|NCT02615847|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6211544|NCT02174523|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6211545|NCT02174523|Adrenergic Agents|adrenergic agents|mesh-ancestor
5646249|NCT04513717|Luteolytic Agents|luteolytic agents|mesh-ancestor
5646250|NCT04513717|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5646251|NCT04513717|Contraceptive Agents|contraceptive agents|mesh-ancestor
5820410|NCT02615847|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5820411|NCT02615847|Dopamine Agents|dopamine agents|mesh-ancestor
5820412|NCT02615847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5820413|NCT02615847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820414|NCT02615847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820415|NCT02615847|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5820416|NCT02615847|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5901595|NCT03023462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901596|NCT03023462|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5901597|NCT03023462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5901598|NCT03023462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5901599|NCT03023462|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5901600|NCT03023462|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5901601|NCT03023462|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5901602|NCT03023462|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5901603|NCT03023462|Dopamine Agents|dopamine agents|mesh-ancestor
5901604|NCT03023449|Nitric Oxide|nitric oxide|mesh-list
5901605|NCT03023449|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6492826|NCT00610818|Mitosis Modulators|mitosis modulators|mesh-ancestor
5646252|NCT04513717|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5646253|NCT04513717|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5646254|NCT04513717|Antidepressive Agents|antidepressive agents|mesh-ancestor
5646255|NCT04513717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5694278|NCT03396380|Chelating Agents|chelating agents|mesh-ancestor
5694279|NCT03396380|Sequestering Agents|sequestering agents|mesh-ancestor
5694280|NCT03396380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694281|NCT03396380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5694282|NCT03396380|Hormone Antagonists|hormone antagonists|mesh-ancestor
5694283|NCT03396380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5694284|NCT03396380|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5694285|NCT03396380|Fertility Agents|fertility agents|mesh-ancestor
5694286|NCT03396380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5694287|NCT03396380|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5694288|NCT03396380|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5694289|NCT03396315|Zoledronic Acid|zoledronic acid|mesh-list
5901606|NCT03023449|Autonomic Agents|autonomic agents|mesh-ancestor
5901607|NCT03023449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5901608|NCT03023449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901609|NCT03023449|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5901610|NCT03023449|Respiratory System Agents|respiratory system agents|mesh-ancestor
5901611|NCT03023449|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5901612|NCT03023449|Antioxidants|antioxidants|mesh-ancestor
5901613|NCT03023449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901614|NCT03023449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5901615|NCT03023449|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5901616|NCT03023449|Vasodilator Agents|vasodilator agents|mesh-ancestor
5901617|NCT03023449|Gasotransmitters|gasotransmitters|mesh-ancestor
5901618|NCT03023449|Protective Agents|protective agents|mesh-ancestor
5901619|NCT02994069|Cisplatin|cisplatin|mesh-list
5901620|NCT02994069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901621|NCT02987686|Infliximab|infliximab|mesh-list
5901622|NCT02987686|Dermatologic Agents|dermatologic agents|mesh-ancestor
5901623|NCT02987686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5901624|NCT02987686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5901625|NCT02970318|Rituximab|rituximab|mesh-list
5901626|NCT02970318|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5901627|NCT02970318|Acalabrutinib|acalabrutinib|mesh-list
5901628|NCT02970318|Idelalisib|idelalisib|mesh-list
5901629|NCT02970318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5694290|NCT03396315|Alendronate|alendronate|mesh-list
5694291|NCT03396315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5694292|NCT03396315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694293|NCT03396276|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
5694294|NCT03396276|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5694295|NCT03396276|Narcotics|narcotics|mesh-ancestor
5901630|NCT02970318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901631|NCT02970318|Immunologic Factors|immunologic factors|mesh-ancestor
5901632|NCT02970318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901633|NCT02970318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5901634|NCT02970318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5901635|NCT02970318|Alkylating Agents|alkylating agents|mesh-ancestor
5901636|NCT02970318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901637|NCT02970318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5901638|NCT02963064|Antibodies|antibodies|mesh-list
5820417|NCT02615912|Castor Oil|castor oil|mesh-list
5820418|NCT02615912|Cathartics|cathartics|mesh-ancestor
5820419|NCT02615912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5820420|NCT02615639|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5820421|NCT02615639|Interferon-alpha|interferon-alpha|mesh-list
5820422|NCT02615639|Entecavir|entecavir|mesh-list
5820423|NCT02615639|Telbivudine|telbivudine|mesh-list
5820424|NCT02615639|Interferon alpha-2|interferon alpha-2|mesh-list
5820425|NCT02615639|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
5820426|NCT02615639|Vaccines|vaccines|mesh-list
5820427|NCT02615639|Immunologic Factors|immunologic factors|mesh-ancestor
5646256|NCT04511702|Methotrexate|methotrexate|mesh-list
5646257|NCT04511702|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5646258|NCT04511702|Abortifacient Agents|abortifacient agents|mesh-ancestor
5646259|NCT04511702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5646260|NCT04511702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646261|NCT04511702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5646262|NCT04511702|Antimetabolites|antimetabolites|mesh-ancestor
5646263|NCT04511702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646264|NCT04511702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5646265|NCT04511702|Dermatologic Agents|dermatologic agents|mesh-ancestor
5646266|NCT04511702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5646267|NCT04511702|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5646268|NCT04511702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5646269|NCT04511702|Immunologic Factors|immunologic factors|mesh-ancestor
5646270|NCT04511702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5646271|NCT04511702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5646272|NCT04509050|Ivacaftor|ivacaftor|mesh-list
5646273|NCT04509050|Elexacaftor|elexacaftor|mesh-list
5646274|NCT04509050|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
5646275|NCT04509050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5646276|NCT04509050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646277|NCT04508023|Rivaroxaban|rivaroxaban|mesh-list
5646278|NCT04508023|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5820428|NCT02615639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820429|NCT02615639|Antiviral Agents|antiviral agents|mesh-ancestor
5820430|NCT02615639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5820431|NCT02615639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5820432|NCT02615639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5820433|NCT02615639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820434|NCT02615639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5820435|NCT02615730|Paclitaxel|paclitaxel|mesh-list
5820436|NCT02615730|GSK2636771|gsk2636771|mesh-list
6492827|NCT00610818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492828|NCT00610870|Atorvastatin|atorvastatin|mesh-list
6492829|NCT00610870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6492830|NCT00610870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6492831|NCT00610870|Antimetabolites|antimetabolites|mesh-ancestor
6492832|NCT00610870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492833|NCT00610870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6492834|NCT00610870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6492835|NCT00610870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5820437|NCT02615730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5820438|NCT02615730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5820439|NCT02615730|Tubulin Modulators|tubulin modulators|mesh-ancestor
5820440|NCT02615730|Antimitotic Agents|antimitotic agents|mesh-ancestor
5820441|NCT02615730|Mitosis Modulators|mitosis modulators|mesh-ancestor
5820442|NCT02615730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820443|NCT02615730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5820444|NCT02615730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5820445|NCT02615782|Tadalafil|tadalafil|mesh-list
5820446|NCT02615782|Tamsulosin|tamsulosin|mesh-list
5820447|NCT02615782|Vasodilator Agents|vasodilator agents|mesh-ancestor
5820448|NCT02615782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5820449|NCT02615782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5820450|NCT02615782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6492836|NCT00610909|Paroxetine|paroxetine|mesh-list
5646279|NCT04508023|Antithrombins|antithrombins|mesh-ancestor
6492837|NCT00610909|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6492838|NCT00610909|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6492839|NCT00610909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5646280|NCT04508023|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5820451|NCT02615782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646281|NCT04508023|Protease Inhibitors|protease inhibitors|mesh-ancestor
5820452|NCT02615782|Urological Agents|urological agents|mesh-ancestor
5901639|NCT02963064|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5820453|NCT02615782|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5820454|NCT02615782|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5820455|NCT02615782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5820456|NCT02615782|Adrenergic Agents|adrenergic agents|mesh-ancestor
5820457|NCT02615782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5820458|NCT02615782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820459|NCT02615496|Aflibercept|aflibercept|mesh-list
5820460|NCT02615496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5820461|NCT02615496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5820462|NCT02615496|Growth Substances|growth substances|mesh-ancestor
5820463|NCT02615496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820464|NCT02615496|Growth Inhibitors|growth inhibitors|mesh-ancestor
5820465|NCT02615496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5820466|NCT02615561|Pantothenic Acid|pantothenic acid|mesh-list
5820467|NCT02615561|Vitamin B Complex|vitamin b complex|mesh-ancestor
5820468|NCT02615561|Vitamins|vitamins|mesh-ancestor
5820469|NCT02615561|Micronutrients|micronutrients|mesh-ancestor
5820470|NCT02615561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820471|NCT02615691|Factor VIII|factor viii|mesh-list
5820472|NCT02615691|BAX 855|bax 855|mesh-list
5820473|NCT02615691|Coagulants|coagulants|mesh-ancestor
5820474|NCT02615574|Interferons|interferons|mesh-list
5820475|NCT02615574|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
5820476|NCT02615574|Celecoxib|celecoxib|mesh-list
5820477|NCT02615574|Vaccines|vaccines|mesh-list
5820478|NCT02615574|Immunologic Factors|immunologic factors|mesh-ancestor
5820479|NCT02615574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820480|NCT02615574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5820481|NCT02615574|Antiviral Agents|antiviral agents|mesh-ancestor
5820482|NCT02615574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5820483|NCT02615574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5820484|NCT02615574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5820485|NCT02615574|Analgesics|analgesics|mesh-ancestor
5820486|NCT02615574|Sensory System Agents|sensory system agents|mesh-ancestor
5820487|NCT02615574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5820488|NCT02615574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5820489|NCT02615574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5820490|NCT02615574|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5820491|NCT02615574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5820492|NCT02615574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5820493|NCT02615574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820494|NCT02615366|Tranexamic Acid|tranexamic acid|mesh-list
5820495|NCT02615366|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5820496|NCT02615366|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5820497|NCT02615366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820498|NCT02615366|Hemostatics|hemostatics|mesh-ancestor
5820499|NCT02615366|Coagulants|coagulants|mesh-ancestor
5820500|NCT02615223|Bicalutamide|bicalutamide|mesh-list
6674382|NCT01569048|Anesthetics, General|anesthetics, general|mesh-ancestor
6674383|NCT01569048|Anesthetics|anesthetics|mesh-ancestor
6674384|NCT01569048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6674385|NCT01569048|Analgesics|analgesics|mesh-ancestor
5646282|NCT04508023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5646283|NCT04508023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646284|NCT04508023|Anticoagulants|anticoagulants|mesh-ancestor
5646285|NCT04503993|Antibodies|antibodies|mesh-list
5646286|NCT04503993|Immunoglobulins|immunoglobulins|mesh-list
5646287|NCT04503993|Immunologic Factors|immunologic factors|mesh-ancestor
5646288|NCT04503993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646289|NCT04502433|Poractant alfa|poractant alfa|mesh-list
5646290|NCT04502433|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
5646291|NCT04502433|Respiratory System Agents|respiratory system agents|mesh-ancestor
5646292|NCT04496960|Tofacitinib|tofacitinib|mesh-list
5646293|NCT04496960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5646294|NCT04496960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5646295|NCT04496960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646296|NCT04491877|Vaccines|vaccines|mesh-list
5646297|NCT04491877|Immunologic Factors|immunologic factors|mesh-ancestor
5646298|NCT04491877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646299|NCT04484922|Dexmedetomidine|dexmedetomidine|mesh-list
5646300|NCT04484922|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5646301|NCT04484922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5646302|NCT04484922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646303|NCT04484922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5646304|NCT04484922|Analgesics|analgesics|mesh-ancestor
6674386|NCT01569048|Sensory System Agents|sensory system agents|mesh-ancestor
6674387|NCT01569048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5820501|NCT02615223|Hormones|hormones|mesh-list
5820502|NCT02615223|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
5820503|NCT02615223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5820504|NCT02615223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820505|NCT02615223|Androgen Antagonists|androgen antagonists|mesh-ancestor
5820506|NCT02615223|Hormone Antagonists|hormone antagonists|mesh-ancestor
5820507|NCT02615223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5820508|NCT02615288|Vitamin D|vitamin d|mesh-list
5646305|NCT04484922|Sensory System Agents|sensory system agents|mesh-ancestor
5646306|NCT04484922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5646307|NCT04484922|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5646308|NCT04484922|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5646309|NCT04484922|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5646310|NCT04484922|Adrenergic Agents|adrenergic agents|mesh-ancestor
5646311|NCT04484922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5646312|NCT04484922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646313|NCT04476446|Esketamine|esketamine|mesh-list
5646314|NCT04476446|Antidepressive Agents|antidepressive agents|mesh-ancestor
5646315|NCT04476446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5646316|NCT04466475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5646317|NCT04466475|Melphalan|melphalan|mesh-list
5646318|NCT04466475|Mechlorethamine|mechlorethamine|mesh-list
5646319|NCT04466475|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
5646320|NCT04466475|Daratumumab|daratumumab|mesh-list
5646321|NCT04466475|Antibodies|antibodies|mesh-list
5646322|NCT04466475|Immunoglobulins|immunoglobulins|mesh-list
5646323|NCT04466475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5646324|NCT04466475|Immunologic Factors|immunologic factors|mesh-ancestor
5646325|NCT04466475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646326|NCT04466475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5646327|NCT04466475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5646328|NCT04466475|Alkylating Agents|alkylating agents|mesh-ancestor
5646329|NCT04466475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646330|NCT04466475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5646331|NCT04466475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5646332|NCT04460456|Pembrolizumab|pembrolizumab|mesh-list
5646333|NCT04460456|Cemiplimab|cemiplimab|mesh-list
5646334|NCT04460456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5646335|NCT04460456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5646336|NCT04451187|Zopiclone|zopiclone|mesh-list
5646337|NCT04451187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5646338|NCT04451187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5646339|NCT04451187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646340|NCT04446962|Lenalidomide|lenalidomide|mesh-list
5646341|NCT04446962|Immunologic Factors|immunologic factors|mesh-ancestor
5646342|NCT04446962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646343|NCT04446962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5646344|NCT04446962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5646345|NCT04446962|Growth Substances|growth substances|mesh-ancestor
5646346|NCT04446962|Growth Inhibitors|growth inhibitors|mesh-ancestor
5646347|NCT04446962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5646348|NCT04446390|Listerine|listerine|mesh-list
5646349|NCT04446390|Sodium Fluoride|sodium fluoride|mesh-list
5646350|NCT04446390|Cariostatic Agents|cariostatic agents|mesh-ancestor
5646351|NCT04446390|Protective Agents|protective agents|mesh-ancestor
5646352|NCT04446390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646353|NCT04446390|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5646354|NCT04446390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5646355|NCT04436913|Fluorides|fluorides|mesh-list
5646356|NCT04436913|Fluorides, Topical|fluorides, topical|mesh-list
5646357|NCT04436913|Cariostatic Agents|cariostatic agents|mesh-ancestor
5646358|NCT04436913|Protective Agents|protective agents|mesh-ancestor
5646359|NCT04436913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646360|NCT04435782|Selexipag|selexipag|mesh-list
5646361|NCT04435782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5646362|NCT04431453|Remdesivir|remdesivir|mesh-list
5646363|NCT04431453|Antimetabolites|antimetabolites|mesh-ancestor
5646364|NCT04431453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646365|NCT04431453|Antiviral Agents|antiviral agents|mesh-ancestor
5646366|NCT04431453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5646367|NCT04429880|Oxytocin|oxytocin|mesh-list
5646368|NCT04429880|Oxytocics|oxytocics|mesh-ancestor
5646369|NCT04429880|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5646370|NCT04429880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646371|NCT04421196|Analgesics, Opioid|analgesics, opioid|mesh-list
5820509|NCT02615288|Cholecalciferol|cholecalciferol|mesh-list
5646372|NCT04421196|Analgesics|analgesics|mesh-list
5646373|NCT04421196|Narcotics|narcotics|mesh-ancestor
5646374|NCT04421196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5646375|NCT04421196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646376|NCT04421196|Sensory System Agents|sensory system agents|mesh-ancestor
5646377|NCT04421196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5646378|NCT04418466|Risperidone|risperidone|mesh-list
5646379|NCT04418466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5646380|NCT04418466|Serotonin Agents|serotonin agents|mesh-ancestor
5646381|NCT04418466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5646382|NCT04418466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492840|NCT00610909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492841|NCT00610909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6492842|NCT00610909|Serotonin Agents|serotonin agents|mesh-ancestor
6492843|NCT00610909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492844|NCT00610909|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5646383|NCT04418466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646384|NCT04418466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5646385|NCT04418466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5646386|NCT04418466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5646387|NCT04418466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5646388|NCT04418466|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5820510|NCT02615288|Vitamins|vitamins|mesh-ancestor
5820511|NCT02615288|Micronutrients|micronutrients|mesh-ancestor
5820512|NCT02615288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820513|NCT02615288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5820514|NCT02615288|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5820515|NCT02615041|Meropenem|meropenem|mesh-list
5820516|NCT02615041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5820517|NCT02615041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5646389|NCT04418466|Dopamine Agents|dopamine agents|mesh-ancestor
5646390|NCT04412707|Dexamethasone|dexamethasone|mesh-list
5646391|NCT04412707|Melphalan|melphalan|mesh-list
5646392|NCT04412707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5646393|NCT04412707|Antiemetics|antiemetics|mesh-ancestor
5646394|NCT04412707|Autonomic Agents|autonomic agents|mesh-ancestor
5646395|NCT04412707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5646396|NCT04412707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646397|NCT04412707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5646398|NCT04412707|Glucocorticoids|glucocorticoids|mesh-ancestor
5646399|NCT04412707|Hormones|hormones|mesh-ancestor
5646400|NCT04412707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5820518|NCT02615340|Melatonin|melatonin|mesh-list
5820519|NCT02615340|Antioxidants|antioxidants|mesh-ancestor
5820520|NCT02615340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820521|NCT02615340|Protective Agents|protective agents|mesh-ancestor
5820522|NCT02615340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820523|NCT02615340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5820524|NCT02615301|Vitamin D|vitamin d|mesh-list
5820525|NCT02615301|Ergocalciferols|ergocalciferols|mesh-list
5820526|NCT02615301|Cholecalciferol|cholecalciferol|mesh-list
5646401|NCT04412707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5646402|NCT04412707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5646403|NCT04412707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5646404|NCT04412707|Alkylating Agents|alkylating agents|mesh-ancestor
5646405|NCT04412707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646406|NCT04412707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5646407|NCT04412707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5646408|NCT04412707|Immunologic Factors|immunologic factors|mesh-ancestor
5646409|NCT04410445|Nivolumab|nivolumab|mesh-list
5646410|NCT04410445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5646411|NCT04410445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5820527|NCT02615301|Vitamins|vitamins|mesh-list
5820528|NCT02615301|Micronutrients|micronutrients|mesh-ancestor
5820529|NCT02615301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820530|NCT02615301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5820531|NCT02615301|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5820532|NCT02615080|Pemirolast|pemirolast|mesh-list
5820533|NCT02615080|Histamine Antagonists|histamine antagonists|mesh-ancestor
5820534|NCT02615080|Histamine Agents|histamine agents|mesh-ancestor
5820535|NCT02615080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5820536|NCT02615080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820537|NCT02615080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646412|NCT04410445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5694296|NCT03396276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5820538|NCT02615106|Endostar protein|endostar protein|mesh-list
5646413|NCT04410445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646414|NCT04400058|gamma-Globulins|gamma-globulins|mesh-list
5646415|NCT04400058|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5646416|NCT04400058|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5646417|NCT04400058|Immunologic Factors|immunologic factors|mesh-ancestor
5646418|NCT04400058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646419|NCT04390945|Capecitabine|capecitabine|mesh-list
5646420|NCT04390945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5646421|NCT04390945|Antimetabolites|antimetabolites|mesh-ancestor
5646422|NCT04390945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820539|NCT02615106|Endostatins|endostatins|mesh-list
5820540|NCT02615106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5820541|NCT02615106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5820542|NCT02615106|Growth Substances|growth substances|mesh-ancestor
5820543|NCT02615106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820544|NCT02615106|Growth Inhibitors|growth inhibitors|mesh-ancestor
5820545|NCT02615106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5820546|NCT02615262|Dexamethasone|dexamethasone|mesh-list
5820547|NCT02615262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5820548|NCT02615262|Antiemetics|antiemetics|mesh-ancestor
5820549|NCT02615262|Autonomic Agents|autonomic agents|mesh-ancestor
5820550|NCT02615262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5820551|NCT02615262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820552|NCT02615262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5820553|NCT02615262|Glucocorticoids|glucocorticoids|mesh-ancestor
5820554|NCT02615262|Hormones|hormones|mesh-ancestor
5646423|NCT04390945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5646424|NCT04385368|Durvalumab|durvalumab|mesh-list
5646425|NCT04385368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5646426|NCT04385368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5646427|NCT04381364|Ciclesonide|ciclesonide|mesh-list
5646428|NCT04381364|Glucocorticoids|glucocorticoids|mesh-ancestor
5646429|NCT04381364|Hormones|hormones|mesh-ancestor
5646430|NCT04381364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5646431|NCT04381364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646432|NCT04381364|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5646433|NCT04375384|Cetuximab|cetuximab|mesh-list
5646434|NCT04375384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5646435|NCT04375384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5646436|NCT04373031|Pembrolizumab|pembrolizumab|mesh-list
5646437|NCT04373031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5646438|NCT04373031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5820555|NCT02615262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5820556|NCT02615262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5820557|NCT02615262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5820558|NCT02614937|Squalamine|squalamine|mesh-list
5820559|NCT02614937|Ranibizumab|ranibizumab|mesh-list
5820560|NCT02614937|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5820561|NCT02614937|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5820562|NCT02614937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5820563|NCT02614937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5820564|NCT02614937|Growth Substances|growth substances|mesh-ancestor
5820565|NCT02614937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820566|NCT02614937|Growth Inhibitors|growth inhibitors|mesh-ancestor
5820567|NCT02614937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5646439|NCT04363164|Methyltestosterone|methyltestosterone|mesh-list
5646440|NCT04363164|Testosterone|testosterone|mesh-list
5646441|NCT04363164|Testosterone undecanoate|testosterone undecanoate|mesh-list
5646442|NCT04363164|Testosterone enanthate|testosterone enanthate|mesh-list
5646443|NCT04363164|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5646444|NCT04363164|Androgens|androgens|mesh-ancestor
5646445|NCT04363164|Hormones|hormones|mesh-ancestor
5646446|NCT04363164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5646447|NCT04363164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646448|NCT04363164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5646449|NCT04363164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5646450|NCT04363164|Anabolic Agents|anabolic agents|mesh-ancestor
5820568|NCT02614937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5820569|NCT02614937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5820570|NCT02614937|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5820571|NCT02614937|Protective Agents|protective agents|mesh-ancestor
5820572|NCT02614872|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
5820573|NCT02614872|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5646451|NCT04337827|Rituximab|rituximab|mesh-list
5646452|NCT04337827|Acalabrutinib|acalabrutinib|mesh-list
5820574|NCT02614872|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5646453|NCT04337827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5646454|NCT04337827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5646455|NCT04337827|Immunologic Factors|immunologic factors|mesh-ancestor
5646456|NCT04337827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646457|NCT04337827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5646458|NCT04332068|Ivermectin|ivermectin|mesh-list
5646459|NCT04332068|Permethrin|permethrin|mesh-list
5646460|NCT04332068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5646461|NCT04332068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5646462|NCT04332068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5646463|NCT04332068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646464|NCT04327024|Allopurinol|allopurinol|mesh-list
5646465|NCT04327024|Verinurad|verinurad|mesh-list
5646466|NCT04327024|Antimetabolites|antimetabolites|mesh-ancestor
5646467|NCT04327024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646468|NCT04327024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5646469|NCT04327024|Gout Suppressants|gout suppressants|mesh-ancestor
5646470|NCT04327024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5820575|NCT02614872|Protease Inhibitors|protease inhibitors|mesh-ancestor
5820576|NCT02614872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5820577|NCT02614872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820578|NCT02614859|Metformin|metformin|mesh-list
5820579|NCT02614859|Bicalutamide|bicalutamide|mesh-list
5820580|NCT02614859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5820581|NCT02614859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820582|NCT02614859|Androgen Antagonists|androgen antagonists|mesh-ancestor
5820583|NCT02614859|Hormone Antagonists|hormone antagonists|mesh-ancestor
5820584|NCT02614859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5820585|NCT02614859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5820586|NCT02614612|Prednisone|prednisone|mesh-list
5820587|NCT02614612|Methylprednisolone|methylprednisolone|mesh-list
5820588|NCT02614612|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5820589|NCT02614612|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5820590|NCT02614612|Prednisolone|prednisolone|mesh-list
5820591|NCT02614612|Prednisolone acetate|prednisolone acetate|mesh-list
5820592|NCT02614612|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5820593|NCT02614612|Prednisolone phosphate|prednisolone phosphate|mesh-list
5820594|NCT02614612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5820595|NCT02614612|Glucocorticoids|glucocorticoids|mesh-ancestor
5820596|NCT02614612|Hormones|hormones|mesh-ancestor
5820597|NCT02614612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5820598|NCT02614612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820599|NCT02614612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5820600|NCT02614612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5820601|NCT02614612|Antiemetics|antiemetics|mesh-ancestor
5820602|NCT02614612|Autonomic Agents|autonomic agents|mesh-ancestor
5820603|NCT02614612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5820604|NCT02614612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5820605|NCT02614612|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5820606|NCT02614612|Protective Agents|protective agents|mesh-ancestor
5820607|NCT02614833|Paclitaxel|paclitaxel|mesh-list
5820608|NCT02614833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5820609|NCT02614833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5820610|NCT02614833|Tubulin Modulators|tubulin modulators|mesh-ancestor
5646471|NCT04327024|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5646472|NCT04327024|Antioxidants|antioxidants|mesh-ancestor
5646473|NCT04327024|Protective Agents|protective agents|mesh-ancestor
5646474|NCT04327024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646475|NCT04324840|Temozolomide|temozolomide|mesh-list
5646476|NCT04324840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5646477|NCT04324840|Alkylating Agents|alkylating agents|mesh-ancestor
5646478|NCT04324840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646479|NCT04324840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5646480|NCT04322669|Pidotimod|pidotimod|mesh-list
5646481|NCT04322669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5646482|NCT04322669|Immunologic Factors|immunologic factors|mesh-ancestor
5820611|NCT02614833|Antimitotic Agents|antimitotic agents|mesh-ancestor
5820612|NCT02614833|Mitosis Modulators|mitosis modulators|mesh-ancestor
5820613|NCT02614833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646483|NCT04322669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646484|NCT04312659|Infliximab|infliximab|mesh-list
5646485|NCT04312659|Dermatologic Agents|dermatologic agents|mesh-ancestor
5646486|NCT04312659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5820614|NCT02614482|Fesoterodine|fesoterodine|mesh-list
5820615|NCT02614482|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5820616|NCT02614482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5820617|NCT02614482|Cholinergic Agents|cholinergic agents|mesh-ancestor
5820618|NCT02614482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5820619|NCT02614482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820620|NCT02614482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820621|NCT02614482|Urological Agents|urological agents|mesh-ancestor
5820622|NCT02614456|Interferons|interferons|mesh-list
5820623|NCT02614456|Interferon-gamma|interferon-gamma|mesh-list
5820624|NCT02614456|Nivolumab|nivolumab|mesh-list
5820625|NCT02614456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5820626|NCT02614456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5820627|NCT02614456|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5820628|NCT02614456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820629|NCT02614456|Antiviral Agents|antiviral agents|mesh-ancestor
5820630|NCT02614456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5820631|NCT02614352|Candesartan|candesartan|mesh-list
5820632|NCT02614352|Atorvastatin|atorvastatin|mesh-list
5820633|NCT02614352|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5820634|NCT02614352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5820635|NCT02614352|Antimetabolites|antimetabolites|mesh-ancestor
5820636|NCT02614352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820637|NCT02614352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5820638|NCT02614352|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5820639|NCT02614352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5820640|NCT02614352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5820641|NCT02614352|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5820642|NCT02614352|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5820643|NCT02614339|Metformin|metformin|mesh-list
5820644|NCT02614339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5820645|NCT02614339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820646|NCT02614534|Mitomycins|mitomycins|mesh-list
5820647|NCT02614534|Mitomycin|mitomycin|mesh-list
5646487|NCT04312659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5646488|NCT04305470|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5646489|NCT04305470|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5646490|NCT04305470|Dermatologic Agents|dermatologic agents|mesh-ancestor
5646491|NCT04296396|Oxycodone|oxycodone|mesh-list
5646492|NCT04296396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5646493|NCT04296396|Narcotics|narcotics|mesh-ancestor
5646494|NCT04296396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5646495|NCT04296396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646496|NCT04296396|Analgesics|analgesics|mesh-ancestor
5646497|NCT04296396|Sensory System Agents|sensory system agents|mesh-ancestor
5646498|NCT04296396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5820648|NCT02614534|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5820649|NCT02614534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5820650|NCT02614534|Alkylating Agents|alkylating agents|mesh-ancestor
5820651|NCT02614534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820652|NCT02614534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5820653|NCT02614534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5820654|NCT02614404|Piperaquine|piperaquine|mesh-list
5820655|NCT02614404|Artenimol|artenimol|mesh-list
5820656|NCT02614404|Imatinib Mesylate|imatinib mesylate|mesh-list
5820657|NCT02614404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5820658|NCT02614404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5820659|NCT02614404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5820660|NCT02614404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820661|NCT02614404|Antimalarials|antimalarials|mesh-ancestor
5820662|NCT02614404|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5820663|NCT02614404|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5820664|NCT02614404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5820665|NCT02614118|Acetaminophen|acetaminophen|mesh-list
5646499|NCT04291521|Ketamine|ketamine|mesh-list
5646500|NCT04291521|Propofol|propofol|mesh-list
5646501|NCT04291521|Etomidate|etomidate|mesh-list
5820666|NCT02614118|Ketorolac|ketorolac|mesh-list
5820667|NCT02614118|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
5820668|NCT02614118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5820669|NCT02614118|Analgesics|analgesics|mesh-ancestor
5820670|NCT02614118|Sensory System Agents|sensory system agents|mesh-ancestor
5820671|NCT02614118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5820672|NCT02614118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820673|NCT02614118|Antipyretics|antipyretics|mesh-ancestor
5820674|NCT02614118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5820675|NCT02614118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5646502|NCT04291521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5646503|NCT04291521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5820676|NCT02614118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5820677|NCT02614118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5820678|NCT02614118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5820679|NCT02614118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901640|NCT02963064|Immunologic Factors|immunologic factors|mesh-ancestor
5901641|NCT02963064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901642|NCT02960230|Nivolumab|nivolumab|mesh-list
5901643|NCT02960230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5901644|NCT02960230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901645|NCT02960230|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5901646|NCT02960230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901647|NCT02909686|Curcumin|curcumin|mesh-list
5901648|NCT02909686|Resveratrol|resveratrol|mesh-list
5901649|NCT02909686|Pycnogenols|pycnogenols|mesh-list
5901650|NCT02909686|Turmeric extract|turmeric extract|mesh-list
5901651|NCT02909686|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5901652|NCT02909686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5901653|NCT02909686|Analgesics|analgesics|mesh-ancestor
5901654|NCT02909686|Sensory System Agents|sensory system agents|mesh-ancestor
5901655|NCT02909686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5901656|NCT02909686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901657|NCT02909686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5901658|NCT02909686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5901659|NCT02909686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901660|NCT02909686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5901661|NCT02909686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901662|NCT02909686|Antioxidants|antioxidants|mesh-ancestor
5901663|NCT02909686|Protective Agents|protective agents|mesh-ancestor
5901664|NCT02909686|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5901665|NCT02909686|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5901666|NCT02909686|Immunologic Factors|immunologic factors|mesh-ancestor
5901667|NCT02865928|Bupivacaine|bupivacaine|mesh-list
5901668|NCT02865928|Anesthetics, Local|anesthetics, local|mesh-ancestor
5901669|NCT02865928|Anesthetics|anesthetics|mesh-ancestor
5901670|NCT02865928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5901671|NCT02865928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901672|NCT02865928|Sensory System Agents|sensory system agents|mesh-ancestor
5901673|NCT02865928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5901674|NCT02860091|Ropivacaine|ropivacaine|mesh-list
5901675|NCT02860091|Anesthetics, Local|anesthetics, local|mesh-ancestor
5901676|NCT02860091|Anesthetics|anesthetics|mesh-ancestor
5901677|NCT02860091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5901678|NCT02860091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901679|NCT02860091|Sensory System Agents|sensory system agents|mesh-ancestor
5901680|NCT02860091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5901681|NCT02825641|Oxytocin|oxytocin|mesh-list
5901682|NCT02825641|Dinoprostone|dinoprostone|mesh-list
5901683|NCT02825641|Oxytocics|oxytocics|mesh-ancestor
5901684|NCT02825641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5901685|NCT02825641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901686|NCT02824952|Osimertinib|osimertinib|mesh-list
5901687|NCT02824952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901688|NCT02824952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5901689|NCT02824952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5901690|NCT02824952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901691|NCT02812420|Durvalumab|durvalumab|mesh-list
5901692|NCT02812420|Ipilimumab|ipilimumab|mesh-list
5901693|NCT02812420|Tremelimumab|tremelimumab|mesh-list
5901694|NCT02812420|Immunoglobulins|immunoglobulins|mesh-list
5901695|NCT02812420|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5901696|NCT02812420|Immunoglobulin G|immunoglobulin g|mesh-list
5901697|NCT02812420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5901698|NCT02812420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901699|NCT02812420|Immunologic Factors|immunologic factors|mesh-ancestor
5901700|NCT02812420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901701|NCT02812420|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5901702|NCT02812420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901703|NCT02780609|Dexamethasone|dexamethasone|mesh-list
5901704|NCT02780609|Melphalan|melphalan|mesh-list
5901705|NCT02780609|Fosaprepitant|fosaprepitant|mesh-list
5901706|NCT02780609|Aprepitant|aprepitant|mesh-list
5901707|NCT02780609|Antiemetics|antiemetics|mesh-list
5901708|NCT02780609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5901709|NCT02780609|Autonomic Agents|autonomic agents|mesh-ancestor
5901710|NCT02780609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5901711|NCT02780609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901712|NCT02780609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5820680|NCT02614248|Protective Agents|protective agents|mesh-list
5820681|NCT02614248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820682|NCT02614508|Ofatumumab|ofatumumab|mesh-list
5820683|NCT02614508|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5820684|NCT02614508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5820685|NCT02614508|Immunologic Factors|immunologic factors|mesh-ancestor
5820686|NCT02614508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820687|NCT02614040|Plasma-lyte 148|plasma-lyte 148|mesh-list
5820688|NCT02614040|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5820689|NCT02614040|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5820690|NCT02613715|Ethanol|ethanol|mesh-list
5820691|NCT02613715|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5820692|NCT02613715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5820693|NCT02613715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5820694|NCT02613715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820695|NCT02613585|Permethrin|permethrin|mesh-list
5820696|NCT02613585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5820697|NCT02613585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820698|NCT02613676|Bilirubin|bilirubin|mesh-list
5820699|NCT02613676|Antioxidants|antioxidants|mesh-ancestor
5820700|NCT02613676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820701|NCT02613676|Protective Agents|protective agents|mesh-ancestor
5820702|NCT02613676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820703|NCT02613494|Glycopyrrolate|glycopyrrolate|mesh-list
5820704|NCT02613494|Scopolamine|scopolamine|mesh-list
5820705|NCT02613494|Bromides|bromides|mesh-list
5820706|NCT02613494|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
5820707|NCT02613494|Anticonvulsants|anticonvulsants|mesh-ancestor
5820708|NCT02613494|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5820709|NCT02613494|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5820710|NCT02613494|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5820711|NCT02613494|Cholinergic Agents|cholinergic agents|mesh-ancestor
5820712|NCT02613494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5820713|NCT02613494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820714|NCT02613494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820715|NCT02613494|Antiemetics|antiemetics|mesh-ancestor
5820716|NCT02613494|Autonomic Agents|autonomic agents|mesh-ancestor
5820717|NCT02613494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5820718|NCT02613494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5820719|NCT02613494|Mydriatics|mydriatics|mesh-ancestor
5820720|NCT02613494|Parasympatholytics|parasympatholytics|mesh-ancestor
5820721|NCT02613455|Triamcinolone|triamcinolone|mesh-list
5820722|NCT02613455|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5820723|NCT02613455|Lidocaine|lidocaine|mesh-list
5820724|NCT02613455|Anesthetics, Local|anesthetics, local|mesh-ancestor
5820725|NCT02613455|Anesthetics|anesthetics|mesh-ancestor
5820726|NCT02613455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5820727|NCT02613455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820728|NCT02613455|Sensory System Agents|sensory system agents|mesh-ancestor
5820729|NCT02613455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5820730|NCT02613455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5820731|NCT02613455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5820732|NCT02613455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5820733|NCT02613455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5820734|NCT02613455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820735|NCT02613455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5820736|NCT02613455|Glucocorticoids|glucocorticoids|mesh-ancestor
5820737|NCT02613455|Hormones|hormones|mesh-ancestor
5820738|NCT02613455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5820739|NCT02613455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5820740|NCT02613455|Immunologic Factors|immunologic factors|mesh-ancestor
5820741|NCT02613195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5820742|NCT02613247|Hylan|hylan|mesh-list
5820743|NCT02613247|Viscosupplements|viscosupplements|mesh-ancestor
5820744|NCT02613247|Protective Agents|protective agents|mesh-ancestor
5820745|NCT02613247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820746|NCT02613130|Fluorides|fluorides|mesh-list
5820747|NCT02613130|Tin Fluorides|tin fluorides|mesh-list
5820748|NCT02613130|Cariostatic Agents|cariostatic agents|mesh-ancestor
5820749|NCT02613130|Protective Agents|protective agents|mesh-ancestor
5820750|NCT02613130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820751|NCT02613091|Clemastine|clemastine|mesh-list
5820752|NCT02613091|Antipruritics|antipruritics|mesh-ancestor
5820753|NCT02613091|Dermatologic Agents|dermatologic agents|mesh-ancestor
5820754|NCT02613091|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5820755|NCT02613091|Histamine Antagonists|histamine antagonists|mesh-ancestor
5820756|NCT02613091|Histamine Agents|histamine agents|mesh-ancestor
5820757|NCT02613091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5820758|NCT02613091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820759|NCT02613091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820760|NCT02613091|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5820761|NCT02612948|Quetiapine Fumarate|quetiapine fumarate|mesh-list
5820762|NCT02612948|Antidepressive Agents|antidepressive agents|mesh-ancestor
5820763|NCT02612948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5820764|NCT02612948|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5646504|NCT04291521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646505|NCT04291521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5646506|NCT04291521|Anesthetics, General|anesthetics, general|mesh-ancestor
5820765|NCT02612948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5820766|NCT02612948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5820767|NCT02612948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820768|NCT02612844|Insulin Aspart|insulin aspart|mesh-list
5820769|NCT02612844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5820770|NCT02612844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820771|NCT02613052|Propofol|propofol|mesh-list
5820772|NCT02613052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5820773|NCT02613052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5820774|NCT02613052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820775|NCT02613052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5820776|NCT02613052|Anesthetics, General|anesthetics, general|mesh-ancestor
5820777|NCT02613052|Anesthetics|anesthetics|mesh-ancestor
5820778|NCT02613013|Proxymetacaine|proxymetacaine|mesh-list
5820779|NCT02613013|Pilocarpine|pilocarpine|mesh-list
5820780|NCT02613013|Miotics|miotics|mesh-ancestor
5646507|NCT04291521|Anesthetics|anesthetics|mesh-ancestor
5646508|NCT04291521|Analgesics|analgesics|mesh-ancestor
5646509|NCT04291521|Sensory System Agents|sensory system agents|mesh-ancestor
5646510|NCT04291521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5646511|NCT04291521|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5646512|NCT04291521|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5646513|NCT04291521|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5646514|NCT04291521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5646515|NCT04291521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646516|NCT04288778|Metformin|metformin|mesh-list
5646517|NCT04288778|Canagliflozin|canagliflozin|mesh-list
5820781|NCT02613013|Autonomic Agents|autonomic agents|mesh-ancestor
5820782|NCT02613013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5820783|NCT02613013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820784|NCT02613013|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
5820785|NCT02613013|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5820786|NCT02613013|Cholinergic Agents|cholinergic agents|mesh-ancestor
5820787|NCT02613013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5820788|NCT02613013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820789|NCT02613013|Anesthetics, Local|anesthetics, local|mesh-ancestor
5820790|NCT02613013|Anesthetics|anesthetics|mesh-ancestor
5820791|NCT02613013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5820792|NCT02613013|Sensory System Agents|sensory system agents|mesh-ancestor
5820793|NCT02613039|Contraceptive Agents|contraceptive agents|mesh-list
5820794|NCT02613039|Contraceptives, Oral|contraceptives, oral|mesh-list
5820795|NCT02613039|Estrogens|estrogens|mesh-list
6492845|NCT00610909|Antidepressive Agents|antidepressive agents|mesh-ancestor
6492846|NCT00610909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5646518|NCT04288778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5646519|NCT04288778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646520|NCT04288778|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5646521|NCT04288778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694297|NCT03396276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694298|NCT03396276|Analgesics|analgesics|mesh-ancestor
5694299|NCT03396276|Sensory System Agents|sensory system agents|mesh-ancestor
5694300|NCT03396276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6492847|NCT00610909|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6492848|NCT00610909|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6492849|NCT00610909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6492850|NCT00610948|Leucovorin|leucovorin|mesh-list
6492851|NCT00610948|Fluorouracil|fluorouracil|mesh-list
6492852|NCT00610948|Oxaliplatin|oxaliplatin|mesh-list
5694301|NCT03396276|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5694302|NCT03396250|Diphenhydramine|diphenhydramine|mesh-list
5694303|NCT03396250|Promethazine|promethazine|mesh-list
5694304|NCT03396250|Naproxen|naproxen|mesh-list
5820796|NCT02613039|Progestins|progestins|mesh-list
5820797|NCT02613039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5901713|NCT02780609|Glucocorticoids|glucocorticoids|mesh-ancestor
6492853|NCT00610948|Everolimus|everolimus|mesh-list
5646522|NCT04286295|Nicotine|nicotine|mesh-list
5646523|NCT04286295|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5646524|NCT04286295|Autonomic Agents|autonomic agents|mesh-ancestor
5646525|NCT04286295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5646526|NCT04286295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646527|NCT04286295|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5646528|NCT04286295|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5646529|NCT04286295|Cholinergic Agents|cholinergic agents|mesh-ancestor
5646530|NCT04286295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5646531|NCT04286295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646532|NCT04273945|Macitentan|macitentan|mesh-list
5646533|NCT04273945|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
5646534|NCT04273945|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5646535|NCT04273945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646536|NCT04273945|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
5646537|NCT04271475|Macitentan|macitentan|mesh-list
5646538|NCT04271475|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
5646539|NCT04271475|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5646540|NCT04271475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646541|NCT04271475|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
5646542|NCT04268277|Rituximab|rituximab|mesh-list
5820798|NCT02613039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820799|NCT02613039|Hormones|hormones|mesh-ancestor
5820800|NCT02613039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5820801|NCT02613039|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5820802|NCT02613026|Cyclophosphamide|cyclophosphamide|mesh-list
5820803|NCT02613026|Docetaxel|docetaxel|mesh-list
5820804|NCT02613026|Pirarubicin|pirarubicin|mesh-list
5820805|NCT02613026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5820806|NCT02613026|Immunologic Factors|immunologic factors|mesh-ancestor
5820807|NCT02613026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646543|NCT04268277|Pembrolizumab|pembrolizumab|mesh-list
5646544|NCT04268277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5646545|NCT04268277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5646546|NCT04268277|Immunologic Factors|immunologic factors|mesh-ancestor
5646547|NCT04268277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646548|NCT04268277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5646549|NCT04265950|Vaccines|vaccines|mesh-list
5646550|NCT04265950|Immunologic Factors|immunologic factors|mesh-ancestor
5646551|NCT04265950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646552|NCT04261439|Spartalizumab|spartalizumab|mesh-list
5646553|NCT04261439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5820808|NCT02613026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5820809|NCT02613026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5820810|NCT02613026|Alkylating Agents|alkylating agents|mesh-ancestor
5820811|NCT02613026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820812|NCT02613026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5820813|NCT02613026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5820814|NCT02613026|Tubulin Modulators|tubulin modulators|mesh-ancestor
5820815|NCT02613026|Antimitotic Agents|antimitotic agents|mesh-ancestor
5820816|NCT02613026|Mitosis Modulators|mitosis modulators|mesh-ancestor
5820817|NCT02612896|Praziquantel|praziquantel|mesh-list
5820818|NCT02612896|Anthelmintics|anthelmintics|mesh-ancestor
5820819|NCT02612896|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5820820|NCT02612896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5820821|NCT02612792|Atorvastatin|atorvastatin|mesh-list
5820822|NCT02612792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5820823|NCT02612792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5820824|NCT02612792|Antimetabolites|antimetabolites|mesh-ancestor
5820825|NCT02612792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820826|NCT02612792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5820827|NCT02612792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5646554|NCT04261439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646555|NCT04261439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5646556|NCT04240171|Dapagliflozin|dapagliflozin|mesh-list
5646557|NCT04240171|Glimepiride|glimepiride|mesh-list
5646558|NCT04240171|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5646559|NCT04240171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820828|NCT02612792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5820829|NCT02612545|Piperaquine|piperaquine|mesh-list
5820830|NCT02612545|Artenimol|artenimol|mesh-list
5820831|NCT02612545|Mefloquine|mefloquine|mesh-list
5820832|NCT02612545|Antimalarials|antimalarials|mesh-ancestor
5820833|NCT02612545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5820834|NCT02612545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5820835|NCT02612545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5820836|NCT02612480|Aspirin|aspirin|mesh-list
5820837|NCT02612480|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
5820838|NCT02612480|Clopidogrel|clopidogrel|mesh-list
5820839|NCT02612480|Ticagrelor|ticagrelor|mesh-list
5820840|NCT02612480|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5820841|NCT02612480|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5820842|NCT02612480|Analgesics|analgesics|mesh-ancestor
5820843|NCT02612480|Sensory System Agents|sensory system agents|mesh-ancestor
5820844|NCT02612480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5820845|NCT02612480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820846|NCT02612480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5820847|NCT02612480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5820848|NCT02612480|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5820849|NCT02612480|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5820850|NCT02612480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820851|NCT02612480|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5820852|NCT02612480|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5820853|NCT02612480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5820854|NCT02612480|Antipyretics|antipyretics|mesh-ancestor
5820855|NCT02612480|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5820856|NCT02612480|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5820857|NCT02612480|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5820858|NCT02612480|Purinergic Agents|purinergic agents|mesh-ancestor
5820859|NCT02612480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5820860|NCT02612701|Nicotine|nicotine|mesh-list
5820861|NCT02612701|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5820862|NCT02612701|Autonomic Agents|autonomic agents|mesh-ancestor
5820863|NCT02612701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5820864|NCT02612701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646560|NCT04240171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5646561|NCT04240171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646562|NCT04240171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5646563|NCT04240171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5646564|NCT04240171|Immunologic Factors|immunologic factors|mesh-ancestor
5646565|NCT04239092|Cyclophosphamide|cyclophosphamide|mesh-list
5646566|NCT04239092|Temozolomide|temozolomide|mesh-list
5646567|NCT04239092|Irinotecan|irinotecan|mesh-list
5646568|NCT04239092|Topotecan|topotecan|mesh-list
5646569|NCT04239092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5646570|NCT04239092|Immunologic Factors|immunologic factors|mesh-ancestor
5646571|NCT04239092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646572|NCT04239092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5646573|NCT04239092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5646574|NCT04239092|Alkylating Agents|alkylating agents|mesh-ancestor
5646575|NCT04239092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820865|NCT02612701|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5820866|NCT02612701|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5820867|NCT02612701|Cholinergic Agents|cholinergic agents|mesh-ancestor
5820868|NCT02612701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5820869|NCT02612701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820870|NCT02612649|Ramosetron|ramosetron|mesh-list
5820871|NCT02612649|Antiemetics|antiemetics|mesh-ancestor
5820872|NCT02612649|Autonomic Agents|autonomic agents|mesh-ancestor
5820873|NCT02612649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5820874|NCT02612649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820875|NCT02612649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5820876|NCT02612649|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5820877|NCT02612649|Serotonin Agents|serotonin agents|mesh-ancestor
5820878|NCT02612649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5820879|NCT02612649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820880|NCT02612714|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5820881|NCT02612714|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5820882|NCT02612714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5820883|NCT02612714|Antimetabolites|antimetabolites|mesh-ancestor
5820884|NCT02612714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820885|NCT02612714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5820886|NCT02612714|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5820887|NCT02612714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5901714|NCT02780609|Hormones|hormones|mesh-ancestor
5901715|NCT02780609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6492854|NCT00610948|Panitumumab|panitumumab|mesh-list
5646576|NCT04239092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5646577|NCT04239092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5646578|NCT04239092|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5646579|NCT04239092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5646580|NCT04239092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5646581|NCT04235101|Trastuzumab|trastuzumab|mesh-list
5646582|NCT04235101|Niraparib|niraparib|mesh-list
5646583|NCT04235101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5646584|NCT04235101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5646585|NCT04235101|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5646586|NCT04235101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5646587|NCT04235101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646588|NCT04230954|Pembrolizumab|pembrolizumab|mesh-list
5820888|NCT02612363|Dexmedetomidine|dexmedetomidine|mesh-list
5820889|NCT02612363|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5820890|NCT02612363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5820891|NCT02612363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820892|NCT02612363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5820893|NCT02612363|Analgesics|analgesics|mesh-ancestor
5820894|NCT02612363|Sensory System Agents|sensory system agents|mesh-ancestor
5820895|NCT02612363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5820896|NCT02612363|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5820897|NCT02612363|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5820898|NCT02612363|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5820899|NCT02612363|Adrenergic Agents|adrenergic agents|mesh-ancestor
5646589|NCT04230954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5646590|NCT04230954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5646591|NCT04230161|Milbemycin oxime|milbemycin oxime|mesh-list
5646592|NCT04230161|Anthelmintics|anthelmintics|mesh-ancestor
5646593|NCT04230161|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5646594|NCT04230161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5646595|NCT04214691|Acetaminophen|acetaminophen|mesh-list
5646596|NCT04214691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5646597|NCT04214691|Analgesics|analgesics|mesh-ancestor
5646598|NCT04214691|Sensory System Agents|sensory system agents|mesh-ancestor
5646599|NCT04214691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5646600|NCT04214691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646601|NCT04214691|Antipyretics|antipyretics|mesh-ancestor
5646602|NCT04205630|Trastuzumab|trastuzumab|mesh-list
5646603|NCT04205630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5646604|NCT04205630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5646605|NCT04204941|Doxorubicin|doxorubicin|mesh-list
5820900|NCT02612363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5820901|NCT02612363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820902|NCT02612272|Ketorolac|ketorolac|mesh-list
5820903|NCT02612272|Betamethasone|betamethasone|mesh-list
5820904|NCT02612272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5820905|NCT02612272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5820906|NCT02612272|Analgesics|analgesics|mesh-ancestor
5820907|NCT02612272|Sensory System Agents|sensory system agents|mesh-ancestor
5820908|NCT02612272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5820909|NCT02612272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820910|NCT02612272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5820911|NCT02612272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5820912|NCT02612272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5820913|NCT02612272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5646606|NCT04204941|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5646607|NCT04204941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5646608|NCT04204941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5646609|NCT04204941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5646610|NCT04204941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5646611|NCT04204941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5646612|NCT04204941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646613|NCT04198766|Pembrolizumab|pembrolizumab|mesh-list
5646614|NCT04198766|Antibodies|antibodies|mesh-list
5646615|NCT04198766|Immunologic Factors|immunologic factors|mesh-ancestor
5646616|NCT04198766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646617|NCT04198766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5646618|NCT04198766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5646619|NCT04198116|Guanfacine|guanfacine|mesh-list
5646620|NCT04198116|Varenicline|varenicline|mesh-list
5646621|NCT04198116|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5646622|NCT04198116|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5646623|NCT04198116|Cholinergic Agents|cholinergic agents|mesh-ancestor
5646624|NCT04198116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5646625|NCT04198116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646626|NCT04198116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820914|NCT02612272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820915|NCT02612272|Glucocorticoids|glucocorticoids|mesh-ancestor
5820916|NCT02612272|Hormones|hormones|mesh-ancestor
5820917|NCT02612272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5820918|NCT02612272|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5820919|NCT02612272|Respiratory System Agents|respiratory system agents|mesh-ancestor
5820920|NCT02612298|Metoprolol|metoprolol|mesh-list
5820921|NCT02612298|Arotinolol|arotinolol|mesh-list
5820922|NCT02612298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5820923|NCT02612298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5820924|NCT02612298|Sympatholytics|sympatholytics|mesh-ancestor
5820925|NCT02612298|Autonomic Agents|autonomic agents|mesh-ancestor
5820926|NCT02612298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5820927|NCT02612298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820928|NCT02612298|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5820929|NCT02612298|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5820930|NCT02612298|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5820931|NCT02612298|Adrenergic Agents|adrenergic agents|mesh-ancestor
6674388|NCT01569048|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5646627|NCT04198116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5646628|NCT04198116|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5646629|NCT04198116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5646630|NCT04198116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5646631|NCT04198116|Adrenergic Agents|adrenergic agents|mesh-ancestor
5646632|NCT04196868|Metformin|metformin|mesh-list
5646633|NCT04196868|Methotrexate|methotrexate|mesh-list
5646634|NCT04196868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5646635|NCT04196868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646636|NCT04196868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5646637|NCT04196868|Abortifacient Agents|abortifacient agents|mesh-ancestor
5646638|NCT04196868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5646639|NCT04196868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5646640|NCT04196868|Antimetabolites|antimetabolites|mesh-ancestor
5646641|NCT04196868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646642|NCT04196868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5646643|NCT04196868|Dermatologic Agents|dermatologic agents|mesh-ancestor
5646644|NCT04196868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5646645|NCT04196868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5646646|NCT04196868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5646647|NCT04196868|Immunologic Factors|immunologic factors|mesh-ancestor
5646648|NCT04196868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5646649|NCT04196868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6211546|NCT02174523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6211547|NCT02174523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211548|NCT02174523|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6211549|NCT02174523|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6211550|NCT02174523|Serotonin Agents|serotonin agents|mesh-ancestor
6211551|NCT02174523|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6211552|NCT02174523|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5646657|NCT04183452|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
5646658|NCT04183452|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
5646659|NCT04183452|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5646660|NCT04183452|Hormone Antagonists|hormone antagonists|mesh-ancestor
5646661|NCT04183452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5646662|NCT04183452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646663|NCT04183452|Progestins|progestins|mesh-ancestor
5646664|NCT04183452|Hormones|hormones|mesh-ancestor
5646665|NCT04175600|Selexipag|selexipag|mesh-list
5646666|NCT04175600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5646667|NCT04165135|Factor VIII|factor viii|mesh-list
5646668|NCT04165135|Coagulants|coagulants|mesh-ancestor
5646669|NCT04157894|Milbemycin oxime|milbemycin oxime|mesh-list
5646670|NCT04157894|Anthelmintics|anthelmintics|mesh-ancestor
5646671|NCT04157894|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5646672|NCT04157894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5646673|NCT04155710|Interleukin-2|interleukin-2|mesh-list
5646674|NCT04155710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5646675|NCT04155710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5646676|NCT04155710|Analgesics|analgesics|mesh-ancestor
6674389|NCT01569048|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6674390|NCT01569048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5820932|NCT02612298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5820933|NCT02612298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646677|NCT04155710|Sensory System Agents|sensory system agents|mesh-ancestor
5646678|NCT04155710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5646679|NCT04155710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646680|NCT04154943|Cemiplimab|cemiplimab|mesh-list
5646681|NCT04154943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5646682|NCT04154943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5646683|NCT04142086|Vaccines|vaccines|mesh-list
5646684|NCT04142086|Immunologic Factors|immunologic factors|mesh-ancestor
5646685|NCT04142086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646686|NCT04136756|Rituximab|rituximab|mesh-list
5820934|NCT02612298|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5820935|NCT02612181|Dexmedetomidine|dexmedetomidine|mesh-list
5820936|NCT02612181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5820937|NCT02612181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5820938|NCT02612181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820939|NCT02612181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5820940|NCT02612181|Analgesics|analgesics|mesh-ancestor
5820941|NCT02612181|Sensory System Agents|sensory system agents|mesh-ancestor
5820942|NCT02612181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5820943|NCT02612181|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5820944|NCT02612181|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5820945|NCT02612181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5646687|NCT04136756|Daratumumab|daratumumab|mesh-list
5646688|NCT04136756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5646689|NCT04136756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5646690|NCT04136756|Immunologic Factors|immunologic factors|mesh-ancestor
5646691|NCT04136756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646692|NCT04136756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5646693|NCT04134260|Hormones|hormones|mesh-list
5646694|NCT04134260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5646695|NCT04134260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646696|NCT04126096|Lactams|lactams|mesh-list
5646697|NCT04126096|beta-Lactams|beta-lactams|mesh-list
5646698|NCT04126096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5646699|NCT04126096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5646700|NCT04113187|Propranolol|propranolol|mesh-list
5646701|NCT04113187|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5646702|NCT04113187|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5646703|NCT04113187|Adrenergic Agents|adrenergic agents|mesh-ancestor
5646704|NCT04113187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5646705|NCT04113187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646706|NCT04113187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646707|NCT04113187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5646708|NCT04113187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5646709|NCT04113187|Vasodilator Agents|vasodilator agents|mesh-ancestor
5646710|NCT04098666|Metformin|metformin|mesh-list
5646711|NCT04098666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5646712|NCT04098666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646713|NCT04095208|Nivolumab|nivolumab|mesh-list
5646714|NCT04095208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5646715|NCT04095208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5646716|NCT04095208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5646717|NCT04095208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646718|NCT04088591|Ascorbic Acid|ascorbic acid|mesh-list
5646719|NCT04088591|Antioxidants|antioxidants|mesh-ancestor
5646720|NCT04088591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646721|NCT04088591|Protective Agents|protective agents|mesh-ancestor
5646722|NCT04088591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646723|NCT04088591|Vitamins|vitamins|mesh-ancestor
5646724|NCT04088591|Micronutrients|micronutrients|mesh-ancestor
5820946|NCT02612181|Adrenergic Agents|adrenergic agents|mesh-ancestor
5820947|NCT02612181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5820948|NCT02612181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646725|NCT04068194|Avelumab|avelumab|mesh-list
5646726|NCT04068194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5646727|NCT04068194|Peposertib|peposertib|mesh-list
5646728|NCT04068194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5646729|NCT04068194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5646730|NCT04068194|Immunologic Factors|immunologic factors|mesh-ancestor
5646731|NCT04068194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646732|NCT04068194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5646733|NCT04068194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5646734|NCT04068194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820949|NCT02612259|Tryptophan|tryptophan|mesh-list
5820950|NCT02612259|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5646735|NCT04067609|Dexamethasone|dexamethasone|mesh-list
5646736|NCT04067609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5646737|NCT04067609|Antiemetics|antiemetics|mesh-ancestor
5646738|NCT04067609|Autonomic Agents|autonomic agents|mesh-ancestor
5646739|NCT04067609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5646740|NCT04067609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646741|NCT04067609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5646742|NCT04067609|Glucocorticoids|glucocorticoids|mesh-ancestor
5646743|NCT04067609|Hormones|hormones|mesh-ancestor
5646744|NCT04067609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5646745|NCT04067609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5646746|NCT04067609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5646747|NCT04065841|Licogliflozin|licogliflozin|mesh-list
5646748|NCT04065841|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5646749|NCT04065841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646750|NCT04065841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5646751|NCT04065841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694305|NCT03396250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5694306|NCT03396250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5694307|NCT03396250|Analgesics|analgesics|mesh-ancestor
5694308|NCT03396250|Sensory System Agents|sensory system agents|mesh-ancestor
5694309|NCT03396250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5694310|NCT03396250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694311|NCT03396250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5694312|NCT03396250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5694313|NCT03396250|Gout Suppressants|gout suppressants|mesh-ancestor
5694314|NCT03396250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5694315|NCT03396250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5694316|NCT03396250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694317|NCT03396250|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5694318|NCT03396250|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5694319|NCT03396250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5694320|NCT03396250|Anesthetics, Local|anesthetics, local|mesh-ancestor
5694321|NCT03396250|Anesthetics|anesthetics|mesh-ancestor
5694322|NCT03396250|Antiemetics|antiemetics|mesh-ancestor
5694323|NCT03396250|Autonomic Agents|autonomic agents|mesh-ancestor
5694324|NCT03396250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5694325|NCT03396250|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5694326|NCT03396250|Histamine Antagonists|histamine antagonists|mesh-ancestor
5694327|NCT03396250|Histamine Agents|histamine agents|mesh-ancestor
5694328|NCT03396250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5694329|NCT03396250|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5694330|NCT03396250|Antipruritics|antipruritics|mesh-ancestor
5694331|NCT03396250|Dermatologic Agents|dermatologic agents|mesh-ancestor
5820951|NCT02612259|Antidepressive Agents|antidepressive agents|mesh-ancestor
5820952|NCT02612259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5820953|NCT02612233|Pregabalin|pregabalin|mesh-list
5820954|NCT02612233|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5820955|NCT02612233|Analgesics|analgesics|mesh-ancestor
5820956|NCT02612233|Sensory System Agents|sensory system agents|mesh-ancestor
5820957|NCT02612233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5820958|NCT02612233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820959|NCT02612233|Anticonvulsants|anticonvulsants|mesh-ancestor
5820960|NCT02612233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5820961|NCT02612233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5820962|NCT02612233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820963|NCT02612233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5820964|NCT02612233|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5820965|NCT02612233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5820966|NCT02612233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5820967|NCT02612233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5820968|NCT02612233|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5820969|NCT02612233|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5820970|NCT02612233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5694332|NCT03396107|Dexamethasone|dexamethasone|mesh-list
5694333|NCT03396107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5694334|NCT03396107|Antiemetics|antiemetics|mesh-ancestor
5694335|NCT03396107|Autonomic Agents|autonomic agents|mesh-ancestor
5694336|NCT03396107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5694337|NCT03396107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694338|NCT03396107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5694339|NCT03396107|Glucocorticoids|glucocorticoids|mesh-ancestor
5694340|NCT03396107|Hormones|hormones|mesh-ancestor
6211553|NCT02174523|Dopamine Agents|dopamine agents|mesh-ancestor
6211554|NCT02174731|Epoetin Alfa|epoetin alfa|mesh-list
5820971|NCT02612233|Antidepressive Agents|antidepressive agents|mesh-ancestor
5820972|NCT02612233|Dopamine Agents|dopamine agents|mesh-ancestor
5820973|NCT02612207|Bilirubin|bilirubin|mesh-list
5820974|NCT02612207|Antioxidants|antioxidants|mesh-ancestor
5820975|NCT02612207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820976|NCT02612207|Protective Agents|protective agents|mesh-ancestor
5820977|NCT02612207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820978|NCT02612116|Ticagrelor|ticagrelor|mesh-list
5820979|NCT02612116|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5820980|NCT02612116|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5820981|NCT02612116|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5820982|NCT02612116|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5820983|NCT02612116|Purinergic Agents|purinergic agents|mesh-ancestor
5820984|NCT02612116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5820985|NCT02612116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5820986|NCT02612116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820987|NCT02611973|Aspirin|aspirin|mesh-list
5820988|NCT02611973|Hydroxyurea|hydroxyurea|mesh-list
5820989|NCT02611973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5820990|NCT02611973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5820991|NCT02611973|Analgesics|analgesics|mesh-ancestor
5820992|NCT02611973|Sensory System Agents|sensory system agents|mesh-ancestor
5820993|NCT02611973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5820994|NCT02611973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5820995|NCT02611973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5820996|NCT02611973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5820997|NCT02611973|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5820998|NCT02611973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5820999|NCT02611973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821000|NCT02611973|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5821001|NCT02611973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5821002|NCT02611973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5821003|NCT02611973|Antipyretics|antipyretics|mesh-ancestor
5821004|NCT02611973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5646752|NCT04061980|Nivolumab|nivolumab|mesh-list
5646753|NCT04061980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5646754|NCT04061980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5646755|NCT04061980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5646756|NCT04061980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646757|NCT04045665|Anticoagulants|anticoagulants|mesh-list
5646758|NCT04042077|Vancomycin|vancomycin|mesh-list
5646759|NCT04042077|Tazobactam|tazobactam|mesh-list
5646760|NCT04042077|Linezolid|linezolid|mesh-list
5646761|NCT04042077|Piperacillin|piperacillin|mesh-list
5646762|NCT04042077|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
5646763|NCT04042077|Tigecycline|tigecycline|mesh-list
5646764|NCT04042077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5646765|NCT04042077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5646766|NCT04042077|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5646767|NCT04042077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5646768|NCT04042077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646769|NCT04042077|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5646770|NCT04022239|Mycophenolic Acid|mycophenolic acid|mesh-list
5646771|NCT04022239|Cyclophosphamide|cyclophosphamide|mesh-list
5646772|NCT04022239|Melphalan|melphalan|mesh-list
5646773|NCT04022239|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5646774|NCT04022239|Mechlorethamine|mechlorethamine|mesh-list
5646775|NCT04022239|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
5646776|NCT04022239|Rituximab|rituximab|mesh-list
5646777|NCT04022239|Fludarabine|fludarabine|mesh-list
5646778|NCT04022239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5646779|NCT04022239|Tacrolimus|tacrolimus|mesh-list
5646780|NCT04022239|Antibodies|antibodies|mesh-list
5646781|NCT04022239|Immunoglobulins|immunoglobulins|mesh-list
5646782|NCT04022239|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5646783|NCT04022239|Lenograstim|lenograstim|mesh-list
5646784|NCT04022239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5646785|NCT04022239|Immunologic Factors|immunologic factors|mesh-ancestor
5646786|NCT04022239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646787|NCT04022239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5646788|NCT04022239|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5646789|NCT04022239|Alkylating Agents|alkylating agents|mesh-ancestor
5646790|NCT04022239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646791|NCT04022239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5646792|NCT04022239|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5646793|NCT04022239|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5821005|NCT02611973|Antisickling Agents|antisickling agents|mesh-ancestor
5821006|NCT02611973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5821007|NCT02612220|Hemostatics|hemostatics|mesh-list
5821008|NCT02612220|Coagulants|coagulants|mesh-ancestor
5821009|NCT02612051|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5821010|NCT02611908|Obinutuzumab|obinutuzumab|mesh-list
5821011|NCT02611908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5821012|NCT02611908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5821013|NCT02611921|Ketamine|ketamine|mesh-list
5821014|NCT02611921|Analgesics|analgesics|mesh-ancestor
5646794|NCT04022239|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5646795|NCT04022239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5646796|NCT04022239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5646797|NCT04022239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5646798|NCT04022239|Antitubercular Agents|antitubercular agents|mesh-ancestor
5646799|NCT04022239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5646800|NCT04022239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5646801|NCT04012996|Meloxicam|meloxicam|mesh-list
5646802|NCT04012996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5646803|NCT04012996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5646804|NCT04012996|Analgesics|analgesics|mesh-ancestor
5646805|NCT04012996|Sensory System Agents|sensory system agents|mesh-ancestor
5646806|NCT04012996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5646807|NCT04012996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646808|NCT04012996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5646809|NCT04012996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5646810|NCT04012996|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5646811|NCT04012996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5646812|NCT04012996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5646813|NCT04012996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646814|NCT04010539|Azithromycin|azithromycin|mesh-list
5646815|NCT04010539|Ceftriaxone|ceftriaxone|mesh-list
5646816|NCT04010539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5646817|NCT04010539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5646818|NCT04009668|Adalimumab|adalimumab|mesh-list
5646819|NCT04009668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5646820|NCT04009668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5821015|NCT02611921|Sensory System Agents|sensory system agents|mesh-ancestor
5821016|NCT02611921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5821017|NCT02611921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821018|NCT02611921|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5821019|NCT02611921|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5821020|NCT02611921|Anesthetics, General|anesthetics, general|mesh-ancestor
5821021|NCT02611921|Anesthetics|anesthetics|mesh-ancestor
5821022|NCT02611921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5821023|NCT02611921|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5821024|NCT02611921|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5821025|NCT02611921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5821026|NCT02611921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821027|NCT02611700|Paclitaxel|paclitaxel|mesh-list
5821028|NCT02611700|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5821029|NCT02611700|Cisplatin|cisplatin|mesh-list
5821030|NCT02611700|Nimotuzumab|nimotuzumab|mesh-list
5821031|NCT02611700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5821032|NCT02611700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5821033|NCT02611700|Tubulin Modulators|tubulin modulators|mesh-ancestor
5821034|NCT02611700|Antimitotic Agents|antimitotic agents|mesh-ancestor
5821035|NCT02611700|Mitosis Modulators|mitosis modulators|mesh-ancestor
5646821|NCT04008238|Trabectedin|trabectedin|mesh-list
5646822|NCT04008238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5646823|NCT04008238|Alkylating Agents|alkylating agents|mesh-ancestor
5646824|NCT04008238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646825|NCT04008238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5646826|NCT03995017|Nivolumab|nivolumab|mesh-list
5646827|NCT03995017|Ramucirumab|ramucirumab|mesh-list
5646828|NCT03995017|Rucaparib|rucaparib|mesh-list
5646829|NCT03995017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5646830|NCT03995017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5646831|NCT03995017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5646832|NCT03995017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646833|NCT03995017|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5646834|NCT03995017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5646835|NCT03981744|Ustekinumab|ustekinumab|mesh-list
5646836|NCT03981744|Dermatologic Agents|dermatologic agents|mesh-ancestor
5821036|NCT02611700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646837|NCT03980314|Nivolumab|nivolumab|mesh-list
5646838|NCT03980314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5646839|NCT03980314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5646840|NCT03980314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5646841|NCT03980314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646842|NCT03977467|Atezolizumab|atezolizumab|mesh-list
5646843|NCT03977467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5646844|NCT03972527|Analgesics|analgesics|mesh-list
5821037|NCT02611700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5821038|NCT02611596|Ranolazine|ranolazine|mesh-list
5646845|NCT03972527|Sensory System Agents|sensory system agents|mesh-ancestor
5646846|NCT03972527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5646847|NCT03972527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646857|NCT03942211|Selexipag|selexipag|mesh-list
5646858|NCT03942211|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5646859|NCT03942120|Ustekinumab|ustekinumab|mesh-list
5646860|NCT03942120|Dermatologic Agents|dermatologic agents|mesh-ancestor
5646861|NCT03927690|Ranibizumab|ranibizumab|mesh-list
5646862|NCT03927690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5821039|NCT02611596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5821040|NCT02611596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5821041|NCT02611596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821042|NCT02611635|Warfarin|warfarin|mesh-list
5821043|NCT02611635|Rivaroxaban|rivaroxaban|mesh-list
5821044|NCT02611635|Dabigatran|dabigatran|mesh-list
5821045|NCT02611635|Apixaban|apixaban|mesh-list
5821046|NCT02611635|Edoxaban|edoxaban|mesh-list
5821047|NCT02611635|Anticoagulants|anticoagulants|mesh-ancestor
5821048|NCT02611635|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5821049|NCT02611635|Antithrombins|antithrombins|mesh-ancestor
5821050|NCT02611635|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5821051|NCT02611635|Protease Inhibitors|protease inhibitors|mesh-ancestor
5821052|NCT02611635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5821053|NCT02611635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821054|NCT02611804|Diclofenac|diclofenac|mesh-list
5821055|NCT02611804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5821056|NCT02611804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5821057|NCT02611804|Analgesics|analgesics|mesh-ancestor
5821058|NCT02611804|Sensory System Agents|sensory system agents|mesh-ancestor
5821059|NCT02611804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5821060|NCT02611804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821061|NCT02611804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5821062|NCT02611804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5821063|NCT02611804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5821064|NCT02611804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5821065|NCT02611804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646863|NCT03927690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5646864|NCT03927690|Growth Substances|growth substances|mesh-ancestor
5646865|NCT03927690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646866|NCT03927690|Growth Inhibitors|growth inhibitors|mesh-ancestor
5646867|NCT03927690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5646868|NCT03926299|Clobetasol|clobetasol|mesh-list
5646869|NCT03926299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5646870|NCT03926299|Glucocorticoids|glucocorticoids|mesh-ancestor
5646871|NCT03926299|Hormones|hormones|mesh-ancestor
5646872|NCT03926299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5646873|NCT03926299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646874|NCT03923374|Buprenorphine|buprenorphine|mesh-list
5646875|NCT03923374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5646876|NCT03923374|Narcotics|narcotics|mesh-ancestor
5646877|NCT03923374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5646878|NCT03923374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821066|NCT02611492|Cytarabine|cytarabine|mesh-list
5821067|NCT02611492|Dexamethasone|dexamethasone|mesh-list
5646879|NCT03923374|Analgesics|analgesics|mesh-ancestor
5646880|NCT03923374|Sensory System Agents|sensory system agents|mesh-ancestor
5646881|NCT03923374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5821068|NCT02611492|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5821069|NCT02611492|Methotrexate|methotrexate|mesh-list
5821070|NCT02611492|Vincristine|vincristine|mesh-list
5821071|NCT02611492|Mercaptopurine|mercaptopurine|mesh-list
5821072|NCT02611492|Sargramostim|sargramostim|mesh-list
5821073|NCT02611492|Lenograstim|lenograstim|mesh-list
5821074|NCT02611492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5821075|NCT02611492|Antiemetics|antiemetics|mesh-ancestor
5821076|NCT02611492|Autonomic Agents|autonomic agents|mesh-ancestor
5821077|NCT02611492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5821078|NCT02611492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821079|NCT02611492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5821080|NCT02611492|Glucocorticoids|glucocorticoids|mesh-ancestor
5821081|NCT02611492|Hormones|hormones|mesh-ancestor
5821082|NCT02611492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5821083|NCT02611492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5821084|NCT02611492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5821085|NCT02611492|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5821086|NCT02611492|Abortifacient Agents|abortifacient agents|mesh-ancestor
5821087|NCT02611492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5821088|NCT02611492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5821089|NCT02611492|Antimetabolites|antimetabolites|mesh-ancestor
5821090|NCT02611492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821091|NCT02611492|Dermatologic Agents|dermatologic agents|mesh-ancestor
5821092|NCT02611492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5821093|NCT02611492|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5821094|NCT02611492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5821095|NCT02611492|Immunologic Factors|immunologic factors|mesh-ancestor
5821096|NCT02611492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5821097|NCT02611492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5821098|NCT02611492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5821099|NCT02611492|Tubulin Modulators|tubulin modulators|mesh-ancestor
5821100|NCT02611492|Antimitotic Agents|antimitotic agents|mesh-ancestor
5821101|NCT02611492|Mitosis Modulators|mitosis modulators|mesh-ancestor
5821102|NCT02611492|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5821103|NCT02611492|Antiviral Agents|antiviral agents|mesh-ancestor
5821104|NCT02611492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5821105|NCT02611518|Metformin|metformin|mesh-list
5821106|NCT02611518|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5821107|NCT02611518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5821108|NCT02611518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821109|NCT02611518|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5821110|NCT02611518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5821111|NCT02611518|Antimetabolites|antimetabolites|mesh-ancestor
5821112|NCT02611518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821113|NCT02611518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5821114|NCT02611518|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5821115|NCT02611518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5821116|NCT02611505|Esketamine|esketamine|mesh-list
5821117|NCT02611505|Antidepressive Agents|antidepressive agents|mesh-ancestor
5821118|NCT02611505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5821119|NCT02611336|Tadalafil|tadalafil|mesh-list
5646882|NCT03923374|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5646883|NCT03918798|Chloroprocaine|chloroprocaine|mesh-list
5646884|NCT03918798|Procaine|procaine|mesh-list
5646885|NCT03918798|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5646886|NCT03918798|Anesthetics, Local|anesthetics, local|mesh-ancestor
5646887|NCT03918798|Anesthetics|anesthetics|mesh-ancestor
5646888|NCT03918798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5646889|NCT03918798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646890|NCT03918798|Sensory System Agents|sensory system agents|mesh-ancestor
5646891|NCT03918798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5646892|NCT03915678|Atezolizumab|atezolizumab|mesh-list
5646893|NCT03915678|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5646894|NCT03915678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5821120|NCT02611336|Vasodilator Agents|vasodilator agents|mesh-ancestor
5821121|NCT02611336|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5821122|NCT02611336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5821123|NCT02611336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5821124|NCT02611336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821125|NCT02611336|Urological Agents|urological agents|mesh-ancestor
5821126|NCT02611271|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5821127|NCT02611271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5821128|NCT02611258|Tadalafil|tadalafil|mesh-list
5821129|NCT02611258|Vasodilator Agents|vasodilator agents|mesh-ancestor
5821130|NCT02611258|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5821131|NCT02611258|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5646895|NCT03915678|Immunologic Factors|immunologic factors|mesh-ancestor
5646896|NCT03915678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646897|NCT03913104|Mifepristone|mifepristone|mesh-list
5646898|NCT03913104|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5646899|NCT03913104|Abortifacient Agents|abortifacient agents|mesh-ancestor
5646900|NCT03913104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5646901|NCT03913104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646902|NCT03913104|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5821132|NCT02611258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5821133|NCT02611258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821134|NCT02611258|Urological Agents|urological agents|mesh-ancestor
5821135|NCT02611466|Naproxen|naproxen|mesh-list
5821136|NCT02611466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5821137|NCT02611466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5821138|NCT02611466|Analgesics|analgesics|mesh-ancestor
5821139|NCT02611466|Sensory System Agents|sensory system agents|mesh-ancestor
5821140|NCT02611466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5821141|NCT02611466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821142|NCT02611466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5821143|NCT02611466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5821144|NCT02611466|Gout Suppressants|gout suppressants|mesh-ancestor
5821145|NCT02611466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5821146|NCT02611466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5821147|NCT02611466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821148|NCT02610920|Iron|iron|mesh-list
5821149|NCT02610920|Trace Elements|trace elements|mesh-ancestor
5646903|NCT03913104|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5646904|NCT03913104|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5646905|NCT03913104|Contraceptive Agents|contraceptive agents|mesh-ancestor
5646906|NCT03913104|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5646907|NCT03913104|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5646908|NCT03913104|Hormone Antagonists|hormone antagonists|mesh-ancestor
5646909|NCT03913104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5821150|NCT02610920|Micronutrients|micronutrients|mesh-ancestor
5821151|NCT02610920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821152|NCT02610933|Vitamin K|vitamin k|mesh-list
5821153|NCT02610933|Vitamin K 2|vitamin k 2|mesh-list
5821154|NCT02610933|Rivaroxaban|rivaroxaban|mesh-list
5821155|NCT02610933|Vitamins|vitamins|mesh-ancestor
5821156|NCT02610933|Micronutrients|micronutrients|mesh-ancestor
5821157|NCT02610933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821158|NCT02610933|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5821159|NCT02610933|Antithrombins|antithrombins|mesh-ancestor
5821160|NCT02610933|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5821161|NCT02610933|Protease Inhibitors|protease inhibitors|mesh-ancestor
5821162|NCT02610933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5646910|NCT03913104|Luteolytic Agents|luteolytic agents|mesh-ancestor
5646911|NCT03913104|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5646912|NCT03913104|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5646913|NCT03910660|Pembrolizumab|pembrolizumab|mesh-list
5646914|NCT03910660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5646915|NCT03910660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5646916|NCT03910621|Miglustat|miglustat|mesh-list
5646917|NCT03910621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5646918|NCT03910621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821163|NCT02610933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821164|NCT02610933|Anticoagulants|anticoagulants|mesh-ancestor
5821165|NCT02610933|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5646919|NCT03910621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5646920|NCT03910621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5646921|NCT03910621|Antiviral Agents|antiviral agents|mesh-ancestor
5821166|NCT02610933|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5821167|NCT02610933|Hemostatics|hemostatics|mesh-ancestor
5821168|NCT02610933|Coagulants|coagulants|mesh-ancestor
5821169|NCT02610881|Iron|iron|mesh-list
5821170|NCT02610881|Trace Elements|trace elements|mesh-list
5821171|NCT02610881|Folic Acid|folic acid|mesh-list
5821172|NCT02610881|Micronutrients|micronutrients|mesh-list
5821173|NCT02610881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821174|NCT02610881|Hematinics|hematinics|mesh-ancestor
5821175|NCT02610881|Vitamin B Complex|vitamin b complex|mesh-ancestor
5821176|NCT02610881|Vitamins|vitamins|mesh-ancestor
5821177|NCT02610712|Ketamine|ketamine|mesh-list
5821178|NCT02610712|Analgesics|analgesics|mesh-ancestor
5821179|NCT02610712|Sensory System Agents|sensory system agents|mesh-ancestor
5821180|NCT02610712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5821181|NCT02610712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821182|NCT02610712|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5821183|NCT02610712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5821184|NCT02610712|Anesthetics, General|anesthetics, general|mesh-ancestor
5821185|NCT02610712|Anesthetics|anesthetics|mesh-ancestor
5821186|NCT02610712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5821187|NCT02610712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5821188|NCT02610712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5821189|NCT02610712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5821190|NCT02610712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821191|NCT02610829|Vitamin E|vitamin e|mesh-list
5821192|NCT02610829|Tocopherols|tocopherols|mesh-list
5821193|NCT02610829|Tocotrienols|tocotrienols|mesh-list
5821194|NCT02610829|alpha-Tocopherol|alpha-tocopherol|mesh-list
5821195|NCT02610829|gamma-Tocopherol|gamma-tocopherol|mesh-list
5821196|NCT02610829|Vitamins|vitamins|mesh-ancestor
5821197|NCT02610829|Micronutrients|micronutrients|mesh-ancestor
5821198|NCT02610829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821199|NCT02610829|Antioxidants|antioxidants|mesh-ancestor
5821200|NCT02610829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821201|NCT02610829|Protective Agents|protective agents|mesh-ancestor
5821202|NCT02610686|Chloroquine|chloroquine|mesh-list
5646922|NCT03910621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5646923|NCT03910621|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
5821203|NCT02610686|Amebicides|amebicides|mesh-ancestor
5821204|NCT02610686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5821205|NCT02610686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5821206|NCT02610686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5821207|NCT02610686|Antimalarials|antimalarials|mesh-ancestor
5821208|NCT02610686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5901716|NCT02780609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5901717|NCT02780609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901718|NCT02780609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5901719|NCT02780609|Alkylating Agents|alkylating agents|mesh-ancestor
5901720|NCT02780609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901721|NCT02780609|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5901722|NCT02780609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5901723|NCT02780609|Immunologic Factors|immunologic factors|mesh-ancestor
5901724|NCT02780609|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5901725|NCT02780609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5908304|NCT04701593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908305|NCT04689828|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5908306|NCT04689828|177Lu-PSMA-617|177lu-psma-617|mesh-list
5908307|NCT04689828|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5908308|NCT04689828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908309|NCT04685135|Docetaxel|docetaxel|mesh-list
5908310|NCT04685135|Adagrasib|adagrasib|mesh-list
5646924|NCT03910621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5646925|NCT03910621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646926|NCT03905265|Moxidectin|moxidectin|mesh-list
5646927|NCT03905265|Anthelmintics|anthelmintics|mesh-ancestor
5646928|NCT03905265|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5646929|NCT03905265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5646930|NCT03905265|Antinematodal Agents|antinematodal agents|mesh-ancestor
5908311|NCT04685135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5908312|NCT04685135|Tubulin Modulators|tubulin modulators|mesh-ancestor
5908313|NCT04685135|Antimitotic Agents|antimitotic agents|mesh-ancestor
5908314|NCT04685135|Mitosis Modulators|mitosis modulators|mesh-ancestor
5908315|NCT04685135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908316|NCT04681729|Histamine Antagonists|histamine antagonists|mesh-list
5908317|NCT04681729|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
5908318|NCT04681729|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-list
5908319|NCT04681729|Histamine Agents|histamine agents|mesh-ancestor
5908320|NCT04681729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5908321|NCT04681729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908322|NCT04681729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5908323|NCT04667104|Tenofovir|tenofovir|mesh-list
5908324|NCT04667104|Entecavir|entecavir|mesh-list
5908325|NCT04667104|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5908326|NCT04667104|Antiviral Agents|antiviral agents|mesh-ancestor
5908327|NCT04667104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5908328|NCT04667104|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5908329|NCT04667104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5908330|NCT04667104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5908331|NCT04667104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646931|NCT03905135|Avelumab|avelumab|mesh-list
5908332|NCT04667104|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5908333|NCT04667104|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5646932|NCT03905135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5646933|NCT03905135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5646934|NCT03904693|Tadalafil|tadalafil|mesh-list
5646935|NCT03904693|Macitentan|macitentan|mesh-list
5646936|NCT03904693|Vasodilator Agents|vasodilator agents|mesh-ancestor
5646937|NCT03904693|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5646938|NCT03904693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5646939|NCT03904693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5646940|NCT03904693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646941|NCT03904693|Urological Agents|urological agents|mesh-ancestor
5821209|NCT02610647|Anesthetics|anesthetics|mesh-list
5821210|NCT02610647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5821211|NCT02610647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821212|NCT02610530|Hypoglycemic Agents|hypoglycemic agents|mesh-list
5821213|NCT02610530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821214|NCT02610556|Cisplatin|cisplatin|mesh-list
5821215|NCT02610556|Docetaxel|docetaxel|mesh-list
5821216|NCT02610556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5821217|NCT02610556|Tubulin Modulators|tubulin modulators|mesh-ancestor
5821218|NCT02610556|Antimitotic Agents|antimitotic agents|mesh-ancestor
5821219|NCT02610556|Mitosis Modulators|mitosis modulators|mesh-ancestor
5821220|NCT02610556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821221|NCT02610504|Hyaluronic Acid|hyaluronic acid|mesh-list
5821222|NCT02610504|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5821223|NCT02610504|Immunologic Factors|immunologic factors|mesh-ancestor
5821224|NCT02610504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821225|NCT02610504|Viscosupplements|viscosupplements|mesh-ancestor
5646942|NCT03904693|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
5646943|NCT03904693|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5646944|NCT03904693|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
5646945|NCT03897491|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5821226|NCT02610504|Protective Agents|protective agents|mesh-ancestor
5821227|NCT02610348|Vaccines|vaccines|mesh-list
5821228|NCT02610348|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5821229|NCT02610348|Immunologic Factors|immunologic factors|mesh-ancestor
5821230|NCT02610348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821231|NCT02610153|Vitamin K|vitamin k|mesh-list
5821232|NCT02610153|Vitamins|vitamins|mesh-ancestor
5821233|NCT02610153|Micronutrients|micronutrients|mesh-ancestor
5821234|NCT02610153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821235|NCT02610153|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5821236|NCT02610153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5821237|NCT02610153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821238|NCT02610153|Hemostatics|hemostatics|mesh-ancestor
5821239|NCT02610153|Coagulants|coagulants|mesh-ancestor
5821240|NCT02610010|Cisplatin|cisplatin|mesh-list
5646946|NCT03897491|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5646947|NCT03897491|Dermatologic Agents|dermatologic agents|mesh-ancestor
5646948|NCT03893903|Avelumab|avelumab|mesh-list
5646949|NCT03893903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5646950|NCT03893903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5646951|NCT03884556|Gemcitabine|gemcitabine|mesh-list
5646952|NCT03884556|Paclitaxel|paclitaxel|mesh-list
5646953|NCT03884556|Pembrolizumab|pembrolizumab|mesh-list
5646954|NCT03884556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5646955|NCT03884556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5646956|NCT03884556|Tubulin Modulators|tubulin modulators|mesh-ancestor
5646957|NCT03884556|Antimitotic Agents|antimitotic agents|mesh-ancestor
5646958|NCT03884556|Mitosis Modulators|mitosis modulators|mesh-ancestor
5646959|NCT03884556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646960|NCT03884556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5646961|NCT03884556|Antimetabolites|antimetabolites|mesh-ancestor
5821241|NCT02610010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5821242|NCT02610088|Dapagliflozin|dapagliflozin|mesh-list
5821243|NCT02610088|Gliclazide|gliclazide|mesh-list
5821244|NCT02610088|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5821245|NCT02610088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821246|NCT02610088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5821247|NCT02610088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821248|NCT02610127|Factor VIII|factor viii|mesh-list
5821249|NCT02610127|Coagulants|coagulants|mesh-ancestor
5821250|NCT02610075|Adavosertib|adavosertib|mesh-list
5821251|NCT02610075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5821252|NCT02610075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821253|NCT02609932|Interferons|interferons|mesh-list
5821254|NCT02609932|Interferon-gamma|interferon-gamma|mesh-list
5821255|NCT02609932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5821256|NCT02609932|Antiviral Agents|antiviral agents|mesh-ancestor
5821257|NCT02609932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5821258|NCT02609945|Oxazolidinones|oxazolidinones|mesh-list
5821259|NCT02609945|Zolmitriptan|zolmitriptan|mesh-list
5646962|NCT03884556|Antiviral Agents|antiviral agents|mesh-ancestor
5646963|NCT03884556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5646964|NCT03884556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5646965|NCT03884556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5646966|NCT03884556|Immunologic Factors|immunologic factors|mesh-ancestor
5646967|NCT03884556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646968|NCT03884556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5646969|NCT03875092|Paclitaxel|paclitaxel|mesh-list
5646970|NCT03875092|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5646971|NCT03875092|Carboplatin|carboplatin|mesh-list
5646972|NCT03875092|Pembrolizumab|pembrolizumab|mesh-list
5646973|NCT03875092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5646974|NCT03875092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5646975|NCT03875092|Tubulin Modulators|tubulin modulators|mesh-ancestor
5646976|NCT03875092|Antimitotic Agents|antimitotic agents|mesh-ancestor
5646977|NCT03875092|Mitosis Modulators|mitosis modulators|mesh-ancestor
5646978|NCT03875092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646979|NCT03875092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5646980|NCT03868956|Fibrin fragment D|fibrin fragment d|mesh-list
5646981|NCT03868956|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5646982|NCT03868956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5646983|NCT03868956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646984|NCT03868956|Hemostatics|hemostatics|mesh-ancestor
5646985|NCT03868956|Coagulants|coagulants|mesh-ancestor
5646986|NCT03864926|Tacrolimus|tacrolimus|mesh-list
5646987|NCT03864926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5646988|NCT03864926|Immunologic Factors|immunologic factors|mesh-ancestor
5646989|NCT03864926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5646990|NCT03864926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5646991|NCT03864926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5646992|NCT03864926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5646993|NCT03861793|Pembrolizumab|pembrolizumab|mesh-list
5646994|NCT03861793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5646995|NCT03861793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5646996|NCT03841097|Tacrolimus|tacrolimus|mesh-list
5646997|NCT03841097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5646998|NCT03841097|Immunologic Factors|immunologic factors|mesh-ancestor
5821260|NCT02609945|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5821261|NCT02609945|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5821262|NCT02609945|Serotonin Agents|serotonin agents|mesh-ancestor
5821263|NCT02609945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5646999|NCT03841097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647000|NCT03841097|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5647001|NCT03841097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5647002|NCT03841097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647003|NCT03815058|Pembrolizumab|pembrolizumab|mesh-list
5647004|NCT03815058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5647005|NCT03815058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647006|NCT03814356|Methylphenidate|methylphenidate|mesh-list
5647007|NCT03814356|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5647008|NCT03814356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647009|NCT03814356|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5647010|NCT03814356|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5821264|NCT02609945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821265|NCT02609945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821266|NCT02609945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5821267|NCT02609945|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5821268|NCT02609945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5821269|NCT02609997|Dexamethasone|dexamethasone|mesh-list
5821270|NCT02609997|Proxymetacaine|proxymetacaine|mesh-list
5821271|NCT02609997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5821272|NCT02609997|Antiemetics|antiemetics|mesh-ancestor
5821273|NCT02609997|Autonomic Agents|autonomic agents|mesh-ancestor
5821274|NCT02609997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5821275|NCT02609997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821276|NCT02609997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5821277|NCT02609997|Glucocorticoids|glucocorticoids|mesh-ancestor
5821278|NCT02609997|Hormones|hormones|mesh-ancestor
5821279|NCT02609997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5821280|NCT02609997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5901726|NCT02730325|Immunoglobulins|immunoglobulins|mesh-list
5821281|NCT02609997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5821282|NCT02609997|Anesthetics, Local|anesthetics, local|mesh-ancestor
5821283|NCT02609997|Anesthetics|anesthetics|mesh-ancestor
5821284|NCT02609997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5821285|NCT02609997|Sensory System Agents|sensory system agents|mesh-ancestor
5821286|NCT02609919|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
5821287|NCT02609919|Chelating Agents|chelating agents|mesh-ancestor
5821288|NCT02609919|Sequestering Agents|sequestering agents|mesh-ancestor
5821289|NCT02609919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821290|NCT02609802|Sevoflurane|sevoflurane|mesh-list
5821291|NCT02609802|Desflurane|desflurane|mesh-list
5821292|NCT02609802|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5821293|NCT02609802|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5821294|NCT02609802|Anesthetics, General|anesthetics, general|mesh-ancestor
5821295|NCT02609802|Anesthetics|anesthetics|mesh-ancestor
5821296|NCT02609802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5821297|NCT02609802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821298|NCT02609646|Vancomycin|vancomycin|mesh-list
5821299|NCT02609646|Meropenem|meropenem|mesh-list
5821300|NCT02609646|Tazobactam|tazobactam|mesh-list
5647011|NCT03814356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5647012|NCT03814356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647013|NCT03814356|Dopamine Agents|dopamine agents|mesh-ancestor
5647014|NCT03814356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5647015|NCT03814200|Rifampin|rifampin|mesh-list
5647016|NCT03814200|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5647017|NCT03814200|Antitubercular Agents|antitubercular agents|mesh-ancestor
5647018|NCT03814200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5647019|NCT03814200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5647020|NCT03814200|Leprostatic Agents|leprostatic agents|mesh-ancestor
5647021|NCT03814200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5647022|NCT03814200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5647023|NCT03814200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647024|NCT03814200|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5647025|NCT03814200|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5821301|NCT02609646|Linezolid|linezolid|mesh-list
5821302|NCT02609646|Piperacillin|piperacillin|mesh-list
5821303|NCT02609646|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
5821304|NCT02609646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5821305|NCT02609646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5821306|NCT02609646|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5821307|NCT02609646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5821308|NCT02609646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821309|NCT02609646|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5821310|NCT02609581|Immunologic Factors|immunologic factors|mesh-list
5821311|NCT02609581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821312|NCT02609490|Olmesartan|olmesartan|mesh-list
5821313|NCT02609490|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
5821314|NCT02609490|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
5821315|NCT02609490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5821316|NCT02609490|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5821317|NCT02609490|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5821318|NCT02609490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821319|NCT02609711|Candesartan|candesartan|mesh-list
5821320|NCT02609711|Candesartan cilexetil|candesartan cilexetil|mesh-list
5821321|NCT02609711|Atorvastatin|atorvastatin|mesh-list
5821322|NCT02609711|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5821323|NCT02609711|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5821324|NCT02609711|Antimetabolites|antimetabolites|mesh-ancestor
5821325|NCT02609711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821326|NCT02609711|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5821327|NCT02609711|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5821328|NCT02609711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5821329|NCT02609711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5821330|NCT02609711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6674391|NCT01569048|Adrenergic Agents|adrenergic agents|mesh-ancestor
6674392|NCT01569048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6674393|NCT01569048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647026|NCT03814200|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5647027|NCT03814200|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5647028|NCT03814200|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5821331|NCT02609711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5821332|NCT02609698|Aspirin|aspirin|mesh-list
5821333|NCT02609698|Clopidogrel|clopidogrel|mesh-list
5821334|NCT02609698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5821335|NCT02609698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5821336|NCT02609698|Analgesics|analgesics|mesh-ancestor
5821337|NCT02609698|Sensory System Agents|sensory system agents|mesh-ancestor
5821338|NCT02609698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5821339|NCT02609698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821340|NCT02609698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5821341|NCT02609698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5821342|NCT02609698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5821343|NCT02609698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5821344|NCT02609698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821345|NCT02609698|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5821346|NCT02609698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5821347|NCT02609698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5647029|NCT03814200|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5647030|NCT03811847|Methylphenidate|methylphenidate|mesh-list
5647031|NCT03811847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5647032|NCT03811847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647033|NCT03811847|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5647034|NCT03811847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5647035|NCT03811847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5647036|NCT03811847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647037|NCT03811847|Dopamine Agents|dopamine agents|mesh-ancestor
5647038|NCT03811847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5647039|NCT03809624|Pembrolizumab|pembrolizumab|mesh-list
5647040|NCT03809624|Antibodies|antibodies|mesh-list
5647041|NCT03809624|Immunologic Factors|immunologic factors|mesh-ancestor
5647042|NCT03809624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647043|NCT03809624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5647044|NCT03809624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647045|NCT03805022|Doxorubicin|doxorubicin|mesh-list
5647046|NCT03805022|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5647047|NCT03805022|Ifosfamide|ifosfamide|mesh-list
5647048|NCT03805022|Isophosphamide mustard|isophosphamide mustard|mesh-list
5647049|NCT03805022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5647050|NCT03805022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647051|NCT03805022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5647052|NCT03805022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5647053|NCT03805022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5647054|NCT03805022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647055|NCT03805022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5647056|NCT03805022|Alkylating Agents|alkylating agents|mesh-ancestor
5647057|NCT03802240|Pemetrexed|pemetrexed|mesh-list
5647058|NCT03802240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647059|NCT03802240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5647060|NCT03802240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647061|NCT03802240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5647062|NCT03802240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5647063|NCT03798678|Dexamethasone|dexamethasone|mesh-list
5647064|NCT03798678|Dexamethasone acetate|dexamethasone acetate|mesh-list
5647065|NCT03798678|Ichthammol|ichthammol|mesh-list
5647066|NCT03798678|BB 1101|bb 1101|mesh-list
5821348|NCT02609698|Antipyretics|antipyretics|mesh-ancestor
5821349|NCT02609698|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5821350|NCT02609698|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5821351|NCT02609698|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5821352|NCT02609698|Purinergic Agents|purinergic agents|mesh-ancestor
5821353|NCT02609698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5821354|NCT02609477|Phentermine|phentermine|mesh-list
5647067|NCT03798678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5647068|NCT03798678|Antiemetics|antiemetics|mesh-ancestor
5647069|NCT03798678|Autonomic Agents|autonomic agents|mesh-ancestor
5647070|NCT03798678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5647071|NCT03798678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647072|NCT03798678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5647073|NCT03798678|Glucocorticoids|glucocorticoids|mesh-ancestor
5821355|NCT02609477|Istradefylline|istradefylline|mesh-list
5821356|NCT02609477|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5821357|NCT02609477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821358|NCT02609477|Appetite Depressants|appetite depressants|mesh-ancestor
5821359|NCT02609477|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5821360|NCT02609477|Sympathomimetics|sympathomimetics|mesh-ancestor
5647074|NCT03798678|Hormones|hormones|mesh-ancestor
5821361|NCT02609477|Autonomic Agents|autonomic agents|mesh-ancestor
5821362|NCT02609477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5821363|NCT02609477|Adrenergic Agents|adrenergic agents|mesh-ancestor
5821364|NCT02609477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5821365|NCT02609477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821366|NCT02609477|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
5821367|NCT02609477|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5821368|NCT02609477|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5821369|NCT02609477|Purinergic Agents|purinergic agents|mesh-ancestor
5821370|NCT02609386|Zinc|zinc|mesh-list
5821371|NCT02609386|Indomethacin|indomethacin|mesh-list
5821372|NCT02609386|Cyclophosphamide|cyclophosphamide|mesh-list
5821373|NCT02609386|Omeprazole|omeprazole|mesh-list
5821374|NCT02609386|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
5821375|NCT02609386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5821376|NCT02609386|Immunologic Factors|immunologic factors|mesh-ancestor
5821377|NCT02609386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821378|NCT02609386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5821379|NCT02609386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5821380|NCT02609386|Alkylating Agents|alkylating agents|mesh-ancestor
5821381|NCT02609386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821382|NCT02609386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5821383|NCT02609386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5821384|NCT02609386|Micronutrients|micronutrients|mesh-ancestor
5821385|NCT02609386|Trace Elements|trace elements|mesh-ancestor
5821386|NCT02609386|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5821387|NCT02609386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5821388|NCT02609386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5821389|NCT02609386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5821390|NCT02609386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5821391|NCT02609386|Analgesics|analgesics|mesh-ancestor
5821392|NCT02609386|Sensory System Agents|sensory system agents|mesh-ancestor
5821393|NCT02609386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5647075|NCT03798678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5647076|NCT03798678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5647077|NCT03798678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647078|NCT03798678|Protease Inhibitors|protease inhibitors|mesh-ancestor
5647079|NCT03798678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5647080|NCT03798678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647081|NCT03798678|Dermatologic Agents|dermatologic agents|mesh-ancestor
5694341|NCT03396107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5694342|NCT03396107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5694343|NCT03396107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5694344|NCT03396068|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
5694345|NCT03396068|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5694346|NCT03396068|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5694347|NCT03396068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5694348|NCT03396068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694349|NCT03396068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5694350|NCT03396068|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5694351|NCT03396068|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5694352|NCT03396068|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5694353|NCT03396068|Adrenergic Agents|adrenergic agents|mesh-ancestor
5694354|NCT03396068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5694355|NCT03396068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694356|NCT03396068|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5821394|NCT02609386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5821395|NCT02609386|Gout Suppressants|gout suppressants|mesh-ancestor
5821396|NCT02609386|Tocolytic Agents|tocolytic agents|mesh-ancestor
5821397|NCT02609386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5821398|NCT02609386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5821399|NCT02609230|TIC10 compound|tic10 compound|mesh-list
5821400|NCT02609230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5821401|NCT02609087|Propofol|propofol|mesh-list
5821402|NCT02609087|Sevoflurane|sevoflurane|mesh-list
5821403|NCT02609087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5821404|NCT02609087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5821405|NCT02609087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821406|NCT02609087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5821407|NCT02609087|Anesthetics, General|anesthetics, general|mesh-ancestor
5821408|NCT02609087|Anesthetics|anesthetics|mesh-ancestor
5821409|NCT02609087|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5821410|NCT02609087|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5647082|NCT03785925|Nivolumab|nivolumab|mesh-list
5647083|NCT03785925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5647084|NCT03785925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647085|NCT03785925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5647086|NCT03785925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647087|NCT03784066|Durvalumab|durvalumab|mesh-list
5647088|NCT03784066|Tremelimumab|tremelimumab|mesh-list
5647089|NCT03784066|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5647090|NCT03784066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5647091|NCT03784066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647092|NCT03784066|Immunologic Factors|immunologic factors|mesh-ancestor
5647093|NCT03784066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647094|NCT03782376|Ustekinumab|ustekinumab|mesh-list
5647095|NCT03782376|Dermatologic Agents|dermatologic agents|mesh-ancestor
5647096|NCT03764098|Guanfacine|guanfacine|mesh-list
5647097|NCT03764098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5647098|NCT03764098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5647099|NCT03764098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5647100|NCT03764098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5647101|NCT03764098|Adrenergic Agents|adrenergic agents|mesh-ancestor
5647102|NCT03764098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5647103|NCT03764098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647104|NCT03764098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647105|NCT03746951|Ropivacaine|ropivacaine|mesh-list
5647106|NCT03746951|Anesthetics, Local|anesthetics, local|mesh-ancestor
5647107|NCT03746951|Anesthetics|anesthetics|mesh-ancestor
5647108|NCT03746951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5647109|NCT03746951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647110|NCT03746951|Sensory System Agents|sensory system agents|mesh-ancestor
5647111|NCT03746951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5647112|NCT03740009|Bazedoxifene|bazedoxifene|mesh-list
5647113|NCT03740009|Estrogens|estrogens|mesh-list
5647114|NCT03740009|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
5821411|NCT02608944|Adenosine|adenosine|mesh-list
5821412|NCT02608944|Regadenoson|regadenoson|mesh-list
5821413|NCT02608944|Analgesics|analgesics|mesh-ancestor
5647115|NCT03740009|Hormones|hormones|mesh-ancestor
5647116|NCT03740009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5647117|NCT03740009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647118|NCT03740009|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5647119|NCT03740009|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5647120|NCT03740009|Hormone Antagonists|hormone antagonists|mesh-ancestor
5647121|NCT03740009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5647122|NCT03738852|Insulin|insulin|mesh-list
5647123|NCT03738852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5647124|NCT03738852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647125|NCT03738397|Upadacitinib|upadacitinib|mesh-list
5647126|NCT03738397|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5647127|NCT03738397|Immunologic Factors|immunologic factors|mesh-ancestor
5647128|NCT03738397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647129|NCT03738397|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
5647130|NCT03738397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5647131|NCT03738397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5647132|NCT03738397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647133|NCT03738397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5647134|NCT03729245|Nivolumab|nivolumab|mesh-list
5647135|NCT03729245|Sunitinib|sunitinib|mesh-list
5647136|NCT03729245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5647137|NCT03729245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647138|NCT03729245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5647139|NCT03729245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647140|NCT03729245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5647141|NCT03729245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5647142|NCT03729245|Growth Substances|growth substances|mesh-ancestor
5647143|NCT03729245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647144|NCT03729245|Growth Inhibitors|growth inhibitors|mesh-ancestor
5647145|NCT03729245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5647146|NCT03729245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5647147|NCT03727061|Carboplatin|carboplatin|mesh-list
5647148|NCT03727061|Fluorouracil|fluorouracil|mesh-list
5647149|NCT03727061|Pembrolizumab|pembrolizumab|mesh-list
5647150|NCT03727061|Nivolumab|nivolumab|mesh-list
5647151|NCT03727061|Cetuximab|cetuximab|mesh-list
5647152|NCT03727061|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
5821414|NCT02608944|Sensory System Agents|sensory system agents|mesh-ancestor
5647153|NCT03727061|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
5821415|NCT02608944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5821416|NCT02608944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821417|NCT02608944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5821418|NCT02608944|Vasodilator Agents|vasodilator agents|mesh-ancestor
5821419|NCT02608944|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5821420|NCT02608944|Purinergic Agonists|purinergic agonists|mesh-ancestor
5821421|NCT02608944|Purinergic Agents|purinergic agents|mesh-ancestor
5821422|NCT02608944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5821423|NCT02608944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821424|NCT02608944|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
5821425|NCT02609152|Esmolol|esmolol|mesh-list
5821426|NCT02609152|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5821427|NCT02609152|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5821428|NCT02609152|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5821429|NCT02609152|Adrenergic Agents|adrenergic agents|mesh-ancestor
5821430|NCT02609152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5821431|NCT02609152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821432|NCT02609152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821433|NCT02608918|BMS-955176|bms-955176|mesh-list
5821434|NCT02608918|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5821435|NCT02608918|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5821436|NCT02608918|Antiviral Agents|antiviral agents|mesh-ancestor
5821437|NCT02608918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5821438|NCT02609061|Alendronate|alendronate|mesh-list
5821439|NCT02609061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5821440|NCT02609061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901727|NCT02730325|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5901728|NCT02730325|Antibodies|antibodies|mesh-list
5901729|NCT02730325|Immunologic Factors|immunologic factors|mesh-ancestor
5901730|NCT02730325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901731|NCT02717156|Pembrolizumab|pembrolizumab|mesh-list
5901732|NCT02717156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5901733|NCT02717156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647154|NCT03727061|Trioxsalen|trioxsalen|mesh-list
5647155|NCT03727061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647156|NCT03727061|Antimetabolites|antimetabolites|mesh-ancestor
5647157|NCT03727061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647158|NCT03727061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5647159|NCT03727061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5647160|NCT03727061|Immunologic Factors|immunologic factors|mesh-ancestor
5647161|NCT03727061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901734|NCT02514382|Dexamethasone|dexamethasone|mesh-list
5901735|NCT02514382|Dexamethasone acetate|dexamethasone acetate|mesh-list
5901736|NCT02514382|Bortezomib|bortezomib|mesh-list
5901737|NCT02514382|Ichthammol|ichthammol|mesh-list
5901738|NCT02514382|BB 1101|bb 1101|mesh-list
5901739|NCT02514382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5901740|NCT02514382|Antiemetics|antiemetics|mesh-ancestor
5901741|NCT02514382|Autonomic Agents|autonomic agents|mesh-ancestor
5901742|NCT02514382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5901743|NCT02514382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901744|NCT02514382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5901745|NCT02514382|Glucocorticoids|glucocorticoids|mesh-ancestor
5901746|NCT02514382|Hormones|hormones|mesh-ancestor
5901747|NCT02514382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5901748|NCT02514382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5901749|NCT02514382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901750|NCT02514382|Protease Inhibitors|protease inhibitors|mesh-ancestor
5901751|NCT02514382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5901752|NCT02514382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901753|NCT02514382|Dermatologic Agents|dermatologic agents|mesh-ancestor
5901754|NCT02512692|Gemcitabine|gemcitabine|mesh-list
5901755|NCT02512692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901756|NCT02512692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5901757|NCT02512692|Antimetabolites|antimetabolites|mesh-ancestor
5901758|NCT02512692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901759|NCT02512692|Antiviral Agents|antiviral agents|mesh-ancestor
5901760|NCT02512692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5901761|NCT02512692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5901762|NCT02512692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5901763|NCT02512692|Immunologic Factors|immunologic factors|mesh-ancestor
5901764|NCT02512692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901765|NCT02460445|Cyproterone Acetate|cyproterone acetate|mesh-list
5901766|NCT02460445|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5901767|NCT02460445|Cyproterone|cyproterone|mesh-list
5647162|NCT03727061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5647163|NCT03727061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5647164|NCT03727061|Dermatologic Agents|dermatologic agents|mesh-ancestor
5647165|NCT03727061|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5647166|NCT03712228|Antibodies|antibodies|mesh-list
5647167|NCT03712228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5647168|NCT03712228|Immunologic Factors|immunologic factors|mesh-ancestor
5647169|NCT03712228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647170|NCT03710642|Prazosin|prazosin|mesh-list
5647171|NCT03710642|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5647172|NCT03710642|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5647173|NCT03710642|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5647174|NCT03710642|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5647175|NCT03710642|Adrenergic Agents|adrenergic agents|mesh-ancestor
5647176|NCT03710642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5647177|NCT03710642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647178|NCT03710642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647179|NCT03705845|Tocotrienols|tocotrienols|mesh-list
5647180|NCT03705845|Vitamin E|vitamin e|mesh-list
5647181|NCT03705845|Tocopherols|tocopherols|mesh-list
5647182|NCT03705845|Antioxidants|antioxidants|mesh-ancestor
5647183|NCT03705845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647184|NCT03705845|Protective Agents|protective agents|mesh-ancestor
5647185|NCT03705845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647186|NCT03705845|Vitamins|vitamins|mesh-ancestor
5647187|NCT03705845|Micronutrients|micronutrients|mesh-ancestor
5647188|NCT03693300|Durvalumab|durvalumab|mesh-list
5647189|NCT03693300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5647190|NCT03693300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647191|NCT03689244|Selexipag|selexipag|mesh-list
5647192|NCT03689244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5647193|NCT03674320|Methyltestosterone|methyltestosterone|mesh-list
5647194|NCT03674320|Testosterone|testosterone|mesh-list
5647195|NCT03674320|Testosterone undecanoate|testosterone undecanoate|mesh-list
5647196|NCT03674320|Testosterone enanthate|testosterone enanthate|mesh-list
5647197|NCT03674320|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5647198|NCT03674320|Androgens|androgens|mesh-ancestor
5647199|NCT03674320|Hormones|hormones|mesh-ancestor
5647200|NCT03674320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5647201|NCT03674320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821441|NCT02608996|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
5821442|NCT02608996|Natriuretic Agents|natriuretic agents|mesh-ancestor
5821443|NCT02608996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821444|NCT02609334|Pemirolast|pemirolast|mesh-list
5821445|NCT02609334|Histamine Antagonists|histamine antagonists|mesh-ancestor
5821446|NCT02609334|Histamine Agents|histamine agents|mesh-ancestor
5821447|NCT02609334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5821448|NCT02609334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821449|NCT02609334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821450|NCT02608931|Dronabinol|dronabinol|mesh-list
5821451|NCT02608931|Hallucinogens|hallucinogens|mesh-ancestor
5821452|NCT02608931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821453|NCT02608931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5821454|NCT02608931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5821455|NCT02608931|Analgesics|analgesics|mesh-ancestor
5821456|NCT02608931|Sensory System Agents|sensory system agents|mesh-ancestor
5821457|NCT02608931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5821458|NCT02608931|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5821459|NCT02608931|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5821460|NCT02608931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5821461|NCT02608931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821462|NCT02608931|Hormones|hormones|mesh-ancestor
5821463|NCT02608931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5821464|NCT02609165|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5821465|NCT02609165|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5821466|NCT02608710|Verinurad|verinurad|mesh-list
5821467|NCT02608710|Gout Suppressants|gout suppressants|mesh-ancestor
5821468|NCT02608710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5821469|NCT02608736|Valproic Acid|valproic acid|mesh-list
5821470|NCT02608736|Anticonvulsants|anticonvulsants|mesh-ancestor
5821471|NCT02608736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5821472|NCT02608736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821473|NCT02608736|GABA Agents|gaba agents|mesh-ancestor
5647202|NCT03674320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5647203|NCT03674320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647204|NCT03674320|Anabolic Agents|anabolic agents|mesh-ancestor
5821474|NCT02608736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5821475|NCT02608736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821476|NCT02608736|Antimanic Agents|antimanic agents|mesh-ancestor
5821477|NCT02608736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5821478|NCT02608736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5821479|NCT02608736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5821480|NCT02608788|Ketorolac|ketorolac|mesh-list
5821481|NCT02608788|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5821482|NCT02608788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5821483|NCT02608788|Analgesics|analgesics|mesh-ancestor
5821484|NCT02608788|Sensory System Agents|sensory system agents|mesh-ancestor
5821485|NCT02608788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5821486|NCT02608788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821487|NCT02608788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5821488|NCT02608788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5821489|NCT02608788|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5821490|NCT02608788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5821491|NCT02608788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821492|NCT02608619|Choline|choline|mesh-list
5821493|NCT02608619|Lipotropic Agents|lipotropic agents|mesh-ancestor
5821494|NCT02608619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5647205|NCT03673007|Contraceptive Agents|contraceptive agents|mesh-list
5647206|NCT03673007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5647207|NCT03673007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647208|NCT03664232|JNJ-42165279|jnj-42165279|mesh-list
5647209|NCT03664232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5647210|NCT03664232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647211|NCT03650894|Nivolumab|nivolumab|mesh-list
5647212|NCT03650894|Ipilimumab|ipilimumab|mesh-list
5647213|NCT03650894|Bicalutamide|bicalutamide|mesh-list
5647214|NCT03650894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5647215|NCT03650894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647216|NCT03650894|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5647217|NCT03650894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647218|NCT03650894|Androgen Antagonists|androgen antagonists|mesh-ancestor
5647219|NCT03650894|Hormone Antagonists|hormone antagonists|mesh-ancestor
5647220|NCT03650894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5647221|NCT03650894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647222|NCT03639610|Dexamethasone|dexamethasone|mesh-list
5647223|NCT03639610|Melphalan|melphalan|mesh-list
5647224|NCT03639610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5647225|NCT03639610|Antiemetics|antiemetics|mesh-ancestor
5647226|NCT03639610|Autonomic Agents|autonomic agents|mesh-ancestor
5647227|NCT03639610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5647228|NCT03639610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647229|NCT03639610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5647230|NCT03639610|Glucocorticoids|glucocorticoids|mesh-ancestor
5647231|NCT03639610|Hormones|hormones|mesh-ancestor
5647232|NCT03639610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5647233|NCT03639610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5647234|NCT03639610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647235|NCT03639610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5647236|NCT03639610|Alkylating Agents|alkylating agents|mesh-ancestor
5647237|NCT03639610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821495|NCT02608619|Antimetabolites|antimetabolites|mesh-ancestor
5821496|NCT02608619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821497|NCT02608619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5821498|NCT02608619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5821499|NCT02608619|Nootropic Agents|nootropic agents|mesh-ancestor
5821500|NCT02608658|Immunoglobulins|immunoglobulins|mesh-list
5647238|NCT03639610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5647239|NCT03639610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5647240|NCT03639610|Immunologic Factors|immunologic factors|mesh-ancestor
5647241|NCT03635892|Nivolumab|nivolumab|mesh-list
5647242|NCT03635892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5647243|NCT03635892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647244|NCT03635892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5647245|NCT03635892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647246|NCT03631706|Pembrolizumab|pembrolizumab|mesh-list
5647247|NCT03631706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5647248|NCT03631706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647249|NCT03629951|Antipsychotic Agents|antipsychotic agents|mesh-list
5647250|NCT03629951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5821501|NCT02608658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5647251|NCT03629951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5647252|NCT03629951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647253|NCT03629951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5647254|NCT03617445|Vancomycin|vancomycin|mesh-list
5647255|NCT03617445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5647256|NCT03617445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5647257|NCT03606499|Ustekinumab|ustekinumab|mesh-list
6492855|NCT00610948|Calcium|calcium|mesh-list
6492856|NCT00610948|Levoleucovorin|levoleucovorin|mesh-list
5821502|NCT02608658|Antibodies|antibodies|mesh-list
5821503|NCT02608658|Immunologic Factors|immunologic factors|mesh-ancestor
5821504|NCT02608658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821505|NCT02608606|Tacrolimus|tacrolimus|mesh-list
5821506|NCT02608606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5821507|NCT02608606|Immunologic Factors|immunologic factors|mesh-ancestor
5821508|NCT02608606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821509|NCT02608606|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5821510|NCT02608606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5821511|NCT02608606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821512|NCT02608437|Ipilimumab|ipilimumab|mesh-list
6492857|NCT00610948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6492858|NCT00610948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492859|NCT00610948|Antimetabolites|antimetabolites|mesh-ancestor
5647258|NCT03606499|Dermatologic Agents|dermatologic agents|mesh-ancestor
5647259|NCT03596645|Golimumab|golimumab|mesh-list
5647260|NCT03596645|Infliximab|infliximab|mesh-list
5647261|NCT03596645|Dermatologic Agents|dermatologic agents|mesh-ancestor
5647262|NCT03596645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5647263|NCT03596645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5647264|NCT03596645|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
5821513|NCT02608437|Guadecitabine|guadecitabine|mesh-list
5821514|NCT02608437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5821515|NCT02608437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5821516|NCT02608437|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5647265|NCT03596645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5647266|NCT03596645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5647267|NCT03596645|Immunologic Factors|immunologic factors|mesh-ancestor
5647268|NCT03596645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647269|NCT03589729|Cytarabine|cytarabine|mesh-list
5647270|NCT03589729|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
5647271|NCT03589729|Idarubicin|idarubicin|mesh-list
5647272|NCT03589729|Cladribine|cladribine|mesh-list
5647273|NCT03589729|Gemtuzumab|gemtuzumab|mesh-list
5647274|NCT03589729|Dexrazoxane|dexrazoxane|mesh-list
5647275|NCT03589729|Razoxane|razoxane|mesh-list
5647276|NCT03589729|Calicheamicins|calicheamicins|mesh-list
5647277|NCT03589729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5647278|NCT03589729|Antimetabolites|antimetabolites|mesh-ancestor
5647279|NCT03589729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647280|NCT03589729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647281|NCT03589729|Antiviral Agents|antiviral agents|mesh-ancestor
5647282|NCT03589729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5821517|NCT02608437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821518|NCT02608242|Amlodipine|amlodipine|mesh-list
5821519|NCT02608242|Telmisartan|telmisartan|mesh-list
5821520|NCT02608242|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
5821521|NCT02608242|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5821522|NCT02608242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5821523|NCT02608242|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5821524|NCT02608242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5821525|NCT02608242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821526|NCT02608242|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5821527|NCT02608242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821528|NCT02608242|Vasodilator Agents|vasodilator agents|mesh-ancestor
5821529|NCT02608242|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5821530|NCT02608242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5821531|NCT02608242|Antimetabolites|antimetabolites|mesh-ancestor
5821532|NCT02608242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5647283|NCT03589729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5647284|NCT03589729|Immunologic Factors|immunologic factors|mesh-ancestor
5647285|NCT03589729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647286|NCT03589729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5647287|NCT03589729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5647288|NCT03589729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5647289|NCT03589729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5647290|NCT03589729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5821533|NCT02608242|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5647291|NCT03589729|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5647292|NCT03589729|Protective Agents|protective agents|mesh-ancestor
5647293|NCT03589729|Antimitotic Agents|antimitotic agents|mesh-ancestor
5647294|NCT03589729|Mitosis Modulators|mitosis modulators|mesh-ancestor
5647295|NCT03588754|Propranolol|propranolol|mesh-list
5647296|NCT03588754|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5647297|NCT03588754|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5647298|NCT03588754|Adrenergic Agents|adrenergic agents|mesh-ancestor
5647299|NCT03588754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5647300|NCT03588754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647301|NCT03588754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647302|NCT03588754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5647303|NCT03588754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5647304|NCT03588754|Vasodilator Agents|vasodilator agents|mesh-ancestor
5647305|NCT03569293|Upadacitinib|upadacitinib|mesh-list
5647306|NCT03569293|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
5647307|NCT03569293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5647308|NCT03569293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5647309|NCT03569293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647310|NCT03569293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5647311|NCT03564678|Folic Acid|folic acid|mesh-list
5647312|NCT03564678|Vitamin B Complex|vitamin b complex|mesh-list
5647313|NCT03564678|Vitamins|vitamins|mesh-ancestor
5647314|NCT03564678|Micronutrients|micronutrients|mesh-ancestor
5647315|NCT03564678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647316|NCT03564678|Hematinics|hematinics|mesh-ancestor
5647317|NCT03520491|Nivolumab|nivolumab|mesh-list
5647318|NCT03520491|Ipilimumab|ipilimumab|mesh-list
5647319|NCT03520491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5647320|NCT03520491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647321|NCT03520491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5647322|NCT03520491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647323|NCT03495388|Oxycodone|oxycodone|mesh-list
5647324|NCT03495388|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5647325|NCT03495388|Narcotics|narcotics|mesh-ancestor
5647326|NCT03495388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5647327|NCT03495388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647328|NCT03495388|Analgesics|analgesics|mesh-ancestor
5647329|NCT03495388|Sensory System Agents|sensory system agents|mesh-ancestor
5821534|NCT02608242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5821535|NCT02608242|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5647330|NCT03495388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5647331|NCT03492177|Selexipag|selexipag|mesh-list
5647332|NCT03492177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5647333|NCT03488420|Edoxaban|edoxaban|mesh-list
5647334|NCT03488420|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5647335|NCT03488420|Antithrombins|antithrombins|mesh-ancestor
5647336|NCT03488420|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5647337|NCT03488420|Protease Inhibitors|protease inhibitors|mesh-ancestor
5647338|NCT03488420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5647339|NCT03488420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647340|NCT03488420|Anticoagulants|anticoagulants|mesh-ancestor
5694357|NCT03396068|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5694358|NCT03396068|Serotonin Agents|serotonin agents|mesh-ancestor
5694359|NCT03396068|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5694360|NCT03396068|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5694361|NCT03396068|Dopamine Agents|dopamine agents|mesh-ancestor
5694362|NCT03395977|Febuxostat|febuxostat|mesh-list
5694363|NCT03395977|Rasburicase|rasburicase|mesh-list
5694364|NCT03395977|Gout Suppressants|gout suppressants|mesh-ancestor
5694365|NCT03395977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5694366|NCT03395951|Diuretics|diuretics|mesh-list
5694367|NCT03395951|Natriuretic Agents|natriuretic agents|mesh-ancestor
5821536|NCT02608242|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5821537|NCT02608320|Fentanyl|fentanyl|mesh-list
5821538|NCT02608320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5821539|NCT02608320|Narcotics|narcotics|mesh-ancestor
5821540|NCT02608320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5821541|NCT02608320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821542|NCT02608320|Analgesics|analgesics|mesh-ancestor
5821543|NCT02608320|Sensory System Agents|sensory system agents|mesh-ancestor
5821544|NCT02608320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5821545|NCT02608320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5694368|NCT03395951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694369|NCT03395912|Anesthetics|anesthetics|mesh-list
5694370|NCT03395912|Anesthetics, Local|anesthetics, local|mesh-list
5694371|NCT03395912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5694372|NCT03395912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821546|NCT02608320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5821547|NCT02608320|Anesthetics, General|anesthetics, general|mesh-ancestor
5821548|NCT02608320|Anesthetics|anesthetics|mesh-ancestor
5821549|NCT02608216|Paclitaxel|paclitaxel|mesh-list
5821550|NCT02608216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5821551|NCT02608216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5821552|NCT02608216|Tubulin Modulators|tubulin modulators|mesh-ancestor
5821553|NCT02608216|Antimitotic Agents|antimitotic agents|mesh-ancestor
5821554|NCT02608216|Mitosis Modulators|mitosis modulators|mesh-ancestor
5647341|NCT03476330|Quercetin|quercetin|mesh-list
5647342|NCT03476330|Antioxidants|antioxidants|mesh-ancestor
5647343|NCT03476330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647344|NCT03476330|Protective Agents|protective agents|mesh-ancestor
5647345|NCT03476330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647346|NCT03473977|Benralizumab|benralizumab|mesh-list
5821555|NCT02608216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821556|NCT02608164|Vitamin D|vitamin d|mesh-list
5821557|NCT02608164|Cholecalciferol|cholecalciferol|mesh-list
5821558|NCT02608164|Vitamins|vitamins|mesh-ancestor
5821559|NCT02608164|Micronutrients|micronutrients|mesh-ancestor
5821560|NCT02608164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821561|NCT02608164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5821562|NCT02608164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5821563|NCT02608112|Methotrexate|methotrexate|mesh-list
5647347|NCT03473977|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5647348|NCT03473977|Respiratory System Agents|respiratory system agents|mesh-ancestor
5821564|NCT02608112|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5821565|NCT02608112|Abortifacient Agents|abortifacient agents|mesh-ancestor
5821566|NCT02608112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5821567|NCT02608112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821568|NCT02608112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5821569|NCT02608112|Antimetabolites|antimetabolites|mesh-ancestor
5821570|NCT02608112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821571|NCT02608112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5821572|NCT02608112|Dermatologic Agents|dermatologic agents|mesh-ancestor
5821573|NCT02608112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5821574|NCT02608112|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5647349|NCT03466411|Ustekinumab|ustekinumab|mesh-list
5647350|NCT03466411|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5647351|NCT03466411|Dermatologic Agents|dermatologic agents|mesh-ancestor
5821575|NCT02608112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5821576|NCT02608112|Immunologic Factors|immunologic factors|mesh-ancestor
5821577|NCT02608112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5821578|NCT02608112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5821579|NCT02607904|Cannabidiol|cannabidiol|mesh-list
5821580|NCT02607904|Anticonvulsants|anticonvulsants|mesh-ancestor
5821581|NCT02607943|Insulin|insulin|mesh-list
5821582|NCT02607943|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5821583|NCT02607943|Insulin Glargine|insulin glargine|mesh-list
5821584|NCT02607943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5821585|NCT02607943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821586|NCT02607891|Cannabidiol|cannabidiol|mesh-list
5821587|NCT02607891|Anticonvulsants|anticonvulsants|mesh-ancestor
5821588|NCT02607982|Paclitaxel|paclitaxel|mesh-list
5821589|NCT02607982|Oxaliplatin|oxaliplatin|mesh-list
5821590|NCT02607982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5821591|NCT02607982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5821592|NCT02607982|Tubulin Modulators|tubulin modulators|mesh-ancestor
5821593|NCT02607982|Antimitotic Agents|antimitotic agents|mesh-ancestor
5821594|NCT02607982|Mitosis Modulators|mitosis modulators|mesh-ancestor
5821595|NCT02607982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821596|NCT02608034|Itraconazole|itraconazole|mesh-list
5821597|NCT02608034|Rifampin|rifampin|mesh-list
5821598|NCT02608034|Vemurafenib|vemurafenib|mesh-list
5821599|NCT02608034|Antifungal Agents|antifungal agents|mesh-ancestor
5821600|NCT02608034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5821601|NCT02608034|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5647352|NCT03466411|Immunologic Factors|immunologic factors|mesh-ancestor
5647353|NCT03466411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647354|NCT03461445|Tacrolimus|tacrolimus|mesh-list
5647355|NCT03461445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5647356|NCT03461445|Immunologic Factors|immunologic factors|mesh-ancestor
5647357|NCT03461445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647358|NCT03461445|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5821602|NCT02608034|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5821603|NCT02608034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5821604|NCT02608034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821605|NCT02608034|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5821606|NCT02608034|Hormone Antagonists|hormone antagonists|mesh-ancestor
5821607|NCT02608034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5821608|NCT02608034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821609|NCT02608034|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5821610|NCT02608034|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5821611|NCT02608034|Antitubercular Agents|antitubercular agents|mesh-ancestor
5821612|NCT02608034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5821613|NCT02608034|Leprostatic Agents|leprostatic agents|mesh-ancestor
5821614|NCT02608034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5821615|NCT02608034|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5821616|NCT02608034|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5821617|NCT02608034|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5821618|NCT02608034|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5821619|NCT02608034|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5821620|NCT02608034|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5821621|NCT02608034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647359|NCT03461445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5647360|NCT03461445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647361|NCT03451006|Metformin|metformin|mesh-list
5647362|NCT03451006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5647363|NCT03451006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647364|NCT03437421|Vitamin D|vitamin d|mesh-list
5647365|NCT03437421|Cholecalciferol|cholecalciferol|mesh-list
5647366|NCT03437421|Vitamins|vitamins|mesh-ancestor
5647367|NCT03437421|Micronutrients|micronutrients|mesh-ancestor
5647368|NCT03437421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647369|NCT03437421|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5647370|NCT03437421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5647371|NCT03435640|Nivolumab|nivolumab|mesh-list
5647372|NCT03435640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5647373|NCT03435640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647374|NCT03435640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5647375|NCT03435640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647376|NCT03422328|Macitentan|macitentan|mesh-list
5647377|NCT03422328|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
5647378|NCT03422328|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5821622|NCT02608034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5821623|NCT02608073|Capecitabine|capecitabine|mesh-list
5821624|NCT02608073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5821625|NCT02608073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5821626|NCT02608073|Antimetabolites|antimetabolites|mesh-ancestor
5821627|NCT02608073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821628|NCT02608060|Epoetin Alfa|epoetin alfa|mesh-list
5821629|NCT02608060|Hematinics|hematinics|mesh-ancestor
5821630|NCT02607631|Pembrolizumab|pembrolizumab|mesh-list
5821631|NCT02607631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5821632|NCT02607631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5821633|NCT02607657|Eplerenone|eplerenone|mesh-list
5821634|NCT02607657|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5821635|NCT02607657|Hormone Antagonists|hormone antagonists|mesh-ancestor
5821636|NCT02607657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5821637|NCT02607657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821638|NCT02607657|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5821639|NCT02607657|Diuretics|diuretics|mesh-ancestor
5821640|NCT02607657|Natriuretic Agents|natriuretic agents|mesh-ancestor
5821641|NCT02607657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5821642|NCT02607748|Listerine|listerine|mesh-list
5821643|NCT02607748|Fluorides|fluorides|mesh-list
5821644|NCT02607748|Sodium Fluoride|sodium fluoride|mesh-list
5821645|NCT02607748|Cariostatic Agents|cariostatic agents|mesh-ancestor
5821646|NCT02607748|Protective Agents|protective agents|mesh-ancestor
5821647|NCT02607748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821648|NCT02607748|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5821649|NCT02607748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5821650|NCT02607696|Zolpidem|zolpidem|mesh-list
5821651|NCT02607696|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5821652|NCT02607696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5821653|NCT02607696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5821654|NCT02607696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821655|NCT02607696|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
5821656|NCT02607696|GABA Agonists|gaba agonists|mesh-ancestor
5821657|NCT02607696|GABA Agents|gaba agents|mesh-ancestor
5821658|NCT02607696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5821659|NCT02607696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821660|NCT02607774|Midazolam|midazolam|mesh-list
5821661|NCT02607774|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5821662|NCT02607774|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5821663|NCT02607774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5821664|NCT02607774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821665|NCT02607774|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5821666|NCT02607774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5821667|NCT02607774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5647379|NCT03422328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647380|NCT03422328|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
5647381|NCT03420950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
5647382|NCT03420950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5647383|NCT03420950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647384|NCT03414229|Pembrolizumab|pembrolizumab|mesh-list
5647385|NCT03414229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5647386|NCT03414229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647387|NCT03396211|Nivolumab|nivolumab|mesh-list
5647388|NCT03396211|Apatinib|apatinib|mesh-list
5647389|NCT03396211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5647390|NCT03396211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647391|NCT03396211|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5647392|NCT03396211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647393|NCT03396211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5647394|NCT03396211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5647395|NCT03392441|Insulin|insulin|mesh-list
5647396|NCT03392441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5647397|NCT03392441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647398|NCT03389243|Acetaminophen|acetaminophen|mesh-list
5647399|NCT03389243|Dipyrone|dipyrone|mesh-list
5647400|NCT03389243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5647401|NCT03389243|Analgesics|analgesics|mesh-ancestor
5647402|NCT03389243|Sensory System Agents|sensory system agents|mesh-ancestor
5647403|NCT03389243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5647404|NCT03389243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647405|NCT03389243|Antipyretics|antipyretics|mesh-ancestor
5647406|NCT03389243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5647407|NCT03389243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5647408|NCT03389243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5647409|NCT03370133|Ustekinumab|ustekinumab|mesh-list
5647410|NCT03370133|Dermatologic Agents|dermatologic agents|mesh-ancestor
5647411|NCT03364491|Tranexamic Acid|tranexamic acid|mesh-list
5647412|NCT03364491|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5647413|NCT03364491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5647414|NCT03364491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647415|NCT03364491|Hemostatics|hemostatics|mesh-ancestor
5647416|NCT03364491|Coagulants|coagulants|mesh-ancestor
5647417|NCT03338920|Sumatriptan|sumatriptan|mesh-list
5647418|NCT03338920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5647419|NCT03338920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5821668|NCT02607774|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5821669|NCT02607774|Anesthetics, General|anesthetics, general|mesh-ancestor
5821670|NCT02607774|Anesthetics|anesthetics|mesh-ancestor
5821671|NCT02607774|GABA Modulators|gaba modulators|mesh-ancestor
5821672|NCT02607774|GABA Agents|gaba agents|mesh-ancestor
5821673|NCT02607774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5821674|NCT02607774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647420|NCT03338920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5647421|NCT03338920|Serotonin Agents|serotonin agents|mesh-ancestor
5647422|NCT03338920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5647423|NCT03338920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647424|NCT03338920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647425|NCT03335488|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
5647426|NCT03335488|Glycerol|glycerol|mesh-list
5821675|NCT02607579|Ropivacaine|ropivacaine|mesh-list
5647427|NCT03335488|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
5647428|NCT03335488|Protective Agents|protective agents|mesh-ancestor
5647429|NCT03335488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647430|NCT03335488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647431|NCT03301038|Rifampin|rifampin|mesh-list
5821676|NCT02607579|Anesthetics, Local|anesthetics, local|mesh-ancestor
5821677|NCT02607579|Anesthetics|anesthetics|mesh-ancestor
5821678|NCT02607579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5647432|NCT03301038|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5647433|NCT03301038|Antitubercular Agents|antitubercular agents|mesh-ancestor
5647434|NCT03301038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5647435|NCT03301038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5647436|NCT03301038|Leprostatic Agents|leprostatic agents|mesh-ancestor
5647437|NCT03301038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5647438|NCT03301038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5647439|NCT03301038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647440|NCT03301038|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5647441|NCT03301038|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5647442|NCT03301038|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5647443|NCT03301038|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5647444|NCT03301038|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5647445|NCT03301038|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5647446|NCT03262935|Capecitabine|capecitabine|mesh-list
5647447|NCT03262935|Trastuzumab|trastuzumab|mesh-list
5647448|NCT03262935|Vinorelbine|vinorelbine|mesh-list
5647449|NCT03262935|Lapatinib|lapatinib|mesh-list
5647450|NCT03262935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5647451|NCT03262935|Antimetabolites|antimetabolites|mesh-ancestor
5647452|NCT03262935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647453|NCT03262935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647454|NCT03262935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5647455|NCT03262935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5647456|NCT03262935|Tubulin Modulators|tubulin modulators|mesh-ancestor
5647457|NCT03262935|Antimitotic Agents|antimitotic agents|mesh-ancestor
5647458|NCT03262935|Mitosis Modulators|mitosis modulators|mesh-ancestor
5647459|NCT03262935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5647460|NCT03262935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5647461|NCT03243838|Apatinib|apatinib|mesh-list
5821679|NCT02607579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821680|NCT02607579|Sensory System Agents|sensory system agents|mesh-ancestor
5821681|NCT02607579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5821682|NCT02607540|Cisplatin|cisplatin|mesh-list
5821683|NCT02607540|Fluorouracil|fluorouracil|mesh-list
5821684|NCT02607540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5821685|NCT02607540|Antimetabolites|antimetabolites|mesh-ancestor
5821686|NCT02607540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821687|NCT02607540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5821688|NCT02607540|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5821689|NCT02607540|Immunologic Factors|immunologic factors|mesh-ancestor
5647462|NCT03243838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647463|NCT03243838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5647464|NCT03243838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6492860|NCT00610948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492861|NCT00610948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5647465|NCT03243838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647466|NCT03237780|Atezolizumab|atezolizumab|mesh-list
5647467|NCT03237780|Halichondrin B|halichondrin b|mesh-list
5647468|NCT03237780|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5647469|NCT03237780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647470|NCT03237780|Immunologic Factors|immunologic factors|mesh-ancestor
5647471|NCT03237780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647472|NCT03237780|Tubulin Modulators|tubulin modulators|mesh-ancestor
5647473|NCT03237780|Antimitotic Agents|antimitotic agents|mesh-ancestor
5647474|NCT03237780|Mitosis Modulators|mitosis modulators|mesh-ancestor
5647475|NCT03237780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647476|NCT03232073|Ponesimod|ponesimod|mesh-list
5647477|NCT03232073|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5647478|NCT03232073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647479|NCT03232073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5647480|NCT03232073|Immunologic Factors|immunologic factors|mesh-ancestor
5821690|NCT02607540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821691|NCT02607410|Insulin|insulin|mesh-list
5821692|NCT02607410|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5821693|NCT02607410|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5821694|NCT02607410|Insulin, Isophane|insulin, isophane|mesh-list
5821695|NCT02607410|Isophane Insulin, Human|isophane insulin, human|mesh-list
5821696|NCT02607410|Isophane insulin, beef|isophane insulin, beef|mesh-list
5647481|NCT03232073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647482|NCT03221309|Analgesics, Opioid|analgesics, opioid|mesh-list
5647483|NCT03221309|Narcotics|narcotics|mesh-ancestor
5647484|NCT03221309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5821697|NCT02607410|Insulin, Long-Acting|insulin, long-acting|mesh-list
5647485|NCT03221309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647486|NCT03221309|Analgesics|analgesics|mesh-ancestor
5647487|NCT03221309|Sensory System Agents|sensory system agents|mesh-ancestor
5647488|NCT03221309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5647489|NCT03218488|Ustekinumab|ustekinumab|mesh-list
5647490|NCT03218488|Dermatologic Agents|dermatologic agents|mesh-ancestor
5647491|NCT03205761|Olaparib|olaparib|mesh-list
5647492|NCT03205761|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5647493|NCT03205761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5647494|NCT03205761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647495|NCT03205761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647496|NCT03191149|Osimertinib|osimertinib|mesh-list
5821698|NCT02607410|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
5821699|NCT02607410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5821700|NCT02607410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821701|NCT02607410|Incretins|incretins|mesh-ancestor
5821702|NCT02607410|Hormones|hormones|mesh-ancestor
5821703|NCT02607410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5821704|NCT02607410|Protease Inhibitors|protease inhibitors|mesh-ancestor
5821705|NCT02607410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5821706|NCT02607410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821707|NCT02607436|Aspirin|aspirin|mesh-list
5821708|NCT02607436|Sarpogrelate|sarpogrelate|mesh-list
5821709|NCT02607436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5821710|NCT02607436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5647497|NCT03191149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647498|NCT03191149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5647499|NCT03191149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5821711|NCT02607436|Analgesics|analgesics|mesh-ancestor
5821712|NCT02607436|Sensory System Agents|sensory system agents|mesh-ancestor
5821713|NCT02607436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5821714|NCT02607436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821715|NCT02607436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5821716|NCT02607436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5821717|NCT02607436|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5821718|NCT02607436|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5821719|NCT02607436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821720|NCT02607436|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5821721|NCT02607436|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5821722|NCT02607436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5821723|NCT02607436|Antipyretics|antipyretics|mesh-ancestor
6674394|NCT01569048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5647500|NCT03191149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821724|NCT02607436|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5821725|NCT02607436|Serotonin Agents|serotonin agents|mesh-ancestor
5821726|NCT02607436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5821727|NCT02607592|Pemetrexed|pemetrexed|mesh-list
5821728|NCT02607592|Nedaplatin|nedaplatin|mesh-list
5821729|NCT02607592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5821730|NCT02607592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5821731|NCT02607592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821732|NCT02607592|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5821733|NCT02607592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5821734|NCT02607488|Lidocaine|lidocaine|mesh-list
5647501|NCT03185819|Midazolam|midazolam|mesh-list
5647502|NCT03185819|Esketamine|esketamine|mesh-list
5647503|NCT03185819|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5647504|NCT03185819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5647505|NCT03185819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5647506|NCT03185819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647507|NCT03185819|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5647508|NCT03185819|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5647509|NCT03185819|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5647510|NCT03185819|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5647511|NCT03185819|Anesthetics, General|anesthetics, general|mesh-ancestor
5647512|NCT03185819|Anesthetics|anesthetics|mesh-ancestor
5647513|NCT03185819|GABA Modulators|gaba modulators|mesh-ancestor
5647514|NCT03185819|GABA Agents|gaba agents|mesh-ancestor
5647515|NCT03185819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5647516|NCT03185819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647517|NCT03185819|Antidepressive Agents|antidepressive agents|mesh-ancestor
5647518|NCT03170518|Canagliflozin|canagliflozin|mesh-list
5821735|NCT02607488|Anesthetics, Local|anesthetics, local|mesh-ancestor
5821736|NCT02607488|Anesthetics|anesthetics|mesh-ancestor
5821737|NCT02607488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6674395|NCT01569048|Narcotics|narcotics|mesh-ancestor
5821738|NCT02607488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821739|NCT02607488|Sensory System Agents|sensory system agents|mesh-ancestor
5821740|NCT02607488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5821741|NCT02607488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5821742|NCT02607488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5821743|NCT02607488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5821744|NCT02607488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5821745|NCT02607488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821746|NCT02607215|Vinorelbine|vinorelbine|mesh-list
5821747|NCT02607215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5821748|NCT02607215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5821749|NCT02607215|Tubulin Modulators|tubulin modulators|mesh-ancestor
5821750|NCT02607215|Antimitotic Agents|antimitotic agents|mesh-ancestor
5821751|NCT02607215|Mitosis Modulators|mitosis modulators|mesh-ancestor
5821752|NCT02607215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821753|NCT02607423|Gemcitabine|gemcitabine|mesh-list
5821754|NCT02607423|Deoxyglucose|deoxyglucose|mesh-list
5821755|NCT02607423|Cisplatin|cisplatin|mesh-list
5821756|NCT02607423|Docetaxel|docetaxel|mesh-list
5821757|NCT02607423|Pemetrexed|pemetrexed|mesh-list
5821758|NCT02607423|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5821759|NCT02607423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5821760|NCT02607423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5821761|NCT02607423|Antimetabolites|antimetabolites|mesh-ancestor
5647519|NCT03170518|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5647520|NCT03170518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647521|NCT03170518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5647522|NCT03170518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821762|NCT02607423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821763|NCT02607423|Antiviral Agents|antiviral agents|mesh-ancestor
5821764|NCT02607423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5821765|NCT02607423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5821766|NCT02607423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5821767|NCT02607423|Immunologic Factors|immunologic factors|mesh-ancestor
5821768|NCT02607423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821769|NCT02607423|Tubulin Modulators|tubulin modulators|mesh-ancestor
5647523|NCT03151811|Dexamethasone|dexamethasone|mesh-list
5647524|NCT03151811|Dexamethasone acetate|dexamethasone acetate|mesh-list
5647525|NCT03151811|Melphalan|melphalan|mesh-list
5647526|NCT03151811|Pomalidomide|pomalidomide|mesh-list
5647527|NCT03151811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5647528|NCT03151811|Antiemetics|antiemetics|mesh-ancestor
5647529|NCT03151811|Autonomic Agents|autonomic agents|mesh-ancestor
5647530|NCT03151811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5647531|NCT03151811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647532|NCT03151811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5647533|NCT03151811|Glucocorticoids|glucocorticoids|mesh-ancestor
5647534|NCT03151811|Hormones|hormones|mesh-ancestor
5821770|NCT02607423|Antimitotic Agents|antimitotic agents|mesh-ancestor
5821771|NCT02607423|Mitosis Modulators|mitosis modulators|mesh-ancestor
5821772|NCT02607423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5821773|NCT02607423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5821774|NCT02607423|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5821775|NCT02607293|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
5821776|NCT02607293|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5647535|NCT03151811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5647536|NCT03151811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5647537|NCT03151811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647538|NCT03151811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5647539|NCT03151811|Alkylating Agents|alkylating agents|mesh-ancestor
5647540|NCT03151811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821777|NCT02607293|Hormones|hormones|mesh-ancestor
5821778|NCT02607293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5821779|NCT02607293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821780|NCT02607371|Rivaroxaban|rivaroxaban|mesh-list
5821781|NCT02607371|Apixaban|apixaban|mesh-list
5821782|NCT02607371|Edoxaban|edoxaban|mesh-list
5821783|NCT02607371|Dabigatran|dabigatran|mesh-list
5821784|NCT02607371|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5821785|NCT02607371|Antithrombins|antithrombins|mesh-ancestor
5821786|NCT02607371|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5821787|NCT02607371|Protease Inhibitors|protease inhibitors|mesh-ancestor
5821788|NCT02607371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5821789|NCT02607371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647541|NCT03151811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5647542|NCT03151811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5647543|NCT03151811|Immunologic Factors|immunologic factors|mesh-ancestor
5647544|NCT03151811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5647545|NCT03151811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5647546|NCT03151811|Growth Substances|growth substances|mesh-ancestor
5821790|NCT02607371|Anticoagulants|anticoagulants|mesh-ancestor
5901768|NCT02460445|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5901769|NCT02460445|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5901770|NCT02460445|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5901771|NCT02460445|Contraceptive Agents|contraceptive agents|mesh-ancestor
5901772|NCT02460445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5901773|NCT02460445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901774|NCT02460445|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5901775|NCT02460445|Estrogens|estrogens|mesh-ancestor
5901776|NCT02460445|Hormones|hormones|mesh-ancestor
5901777|NCT02460445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5901778|NCT02460445|Androgen Antagonists|androgen antagonists|mesh-ancestor
5901779|NCT02460445|Hormone Antagonists|hormone antagonists|mesh-ancestor
5901780|NCT02460445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901781|NCT02460445|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5901782|NCT02432404|NuvaRing|nuvaring|mesh-list
5901783|NCT02432404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5901784|NCT02432404|Contraceptive Agents|contraceptive agents|mesh-ancestor
5901785|NCT02432404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5901786|NCT02432404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901787|NCT02429557|Midodrine|midodrine|mesh-list
5647547|NCT03151811|Growth Inhibitors|growth inhibitors|mesh-ancestor
5647548|NCT03138889|Paclitaxel|paclitaxel|mesh-list
5647549|NCT03138889|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5647550|NCT03138889|Carboplatin|carboplatin|mesh-list
5647551|NCT03138889|Pembrolizumab|pembrolizumab|mesh-list
5647552|NCT03138889|Pemetrexed|pemetrexed|mesh-list
5647553|NCT03138889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5647554|NCT03138889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647555|NCT03138889|Tubulin Modulators|tubulin modulators|mesh-ancestor
5647556|NCT03138889|Antimitotic Agents|antimitotic agents|mesh-ancestor
5647557|NCT03138889|Mitosis Modulators|mitosis modulators|mesh-ancestor
5647558|NCT03138889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647559|NCT03138889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5647560|NCT03138889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5647561|NCT03138889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5647562|NCT03138889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5647563|NCT03138512|Nivolumab|nivolumab|mesh-list
5647564|NCT03138512|Ipilimumab|ipilimumab|mesh-list
5647565|NCT03138512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5647566|NCT03138512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647567|NCT03138512|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5647568|NCT03138512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647569|NCT03126968|Epinephrine|epinephrine|mesh-list
5647570|NCT03126968|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5647571|NCT03126968|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5647572|NCT03126968|Adrenergic Agents|adrenergic agents|mesh-ancestor
5647573|NCT03126968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5647574|NCT03126968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647575|NCT03126968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647576|NCT03126968|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5647577|NCT03126968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5901788|NCT02429557|Sympathomimetics|sympathomimetics|mesh-ancestor
5901789|NCT02429557|Autonomic Agents|autonomic agents|mesh-ancestor
5901790|NCT02429557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5901791|NCT02429557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901792|NCT02429557|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5901793|NCT02429557|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5901794|NCT02429557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5901795|NCT02429557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5901796|NCT02429557|Adrenergic Agents|adrenergic agents|mesh-ancestor
5901797|NCT02429557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5901798|NCT02429557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901799|NCT02419495|Calcium, Dietary|calcium, dietary|mesh-list
5901800|NCT02419495|Leucovorin|leucovorin|mesh-list
5647578|NCT03126968|Autonomic Agents|autonomic agents|mesh-ancestor
5647579|NCT03126968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5647580|NCT03126968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5647581|NCT03126968|Respiratory System Agents|respiratory system agents|mesh-ancestor
5821791|NCT02607332|Paclitaxel|paclitaxel|mesh-list
5821792|NCT02607332|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5647582|NCT03126968|Mydriatics|mydriatics|mesh-ancestor
5647583|NCT03126968|Sympathomimetics|sympathomimetics|mesh-ancestor
5647584|NCT03126968|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5647585|NCT03117751|Cytarabine|cytarabine|mesh-list
5647586|NCT03117751|Dexamethasone|dexamethasone|mesh-list
5647587|NCT03117751|Prednisone|prednisone|mesh-list
5647588|NCT03117751|Prednisolone|prednisolone|mesh-list
5647589|NCT03117751|Cyclophosphamide|cyclophosphamide|mesh-list
5647590|NCT03117751|Doxorubicin|doxorubicin|mesh-list
5647591|NCT03117751|Methotrexate|methotrexate|mesh-list
5647592|NCT03117751|Etoposide|etoposide|mesh-list
5647593|NCT03117751|Etoposide phosphate|etoposide phosphate|mesh-list
5647594|NCT03117751|Vincristine|vincristine|mesh-list
5647595|NCT03117751|Bortezomib|bortezomib|mesh-list
5647596|NCT03117751|Daunorubicin|daunorubicin|mesh-list
5647597|NCT03117751|Asparaginase|asparaginase|mesh-list
5647598|NCT03117751|Dasatinib|dasatinib|mesh-list
5647599|NCT03117751|Mercaptopurine|mercaptopurine|mesh-list
5647600|NCT03117751|Vorinostat|vorinostat|mesh-list
5647601|NCT03117751|Idarubicin|idarubicin|mesh-list
5647602|NCT03117751|Clofarabine|clofarabine|mesh-list
5647603|NCT03117751|Pegaspargase|pegaspargase|mesh-list
5647604|NCT03117751|Thioguanine|thioguanine|mesh-list
5821793|NCT02607332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5821794|NCT02607332|Tubulin Modulators|tubulin modulators|mesh-ancestor
5821795|NCT02607332|Antimitotic Agents|antimitotic agents|mesh-ancestor
5821796|NCT02607332|Mitosis Modulators|mitosis modulators|mesh-ancestor
5821797|NCT02607332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821798|NCT02607072|Aspirin|aspirin|mesh-list
5821799|NCT02607072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5821800|NCT02607072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5821801|NCT02607072|Analgesics|analgesics|mesh-ancestor
5821802|NCT02607072|Sensory System Agents|sensory system agents|mesh-ancestor
5647605|NCT03117751|Blinatumomab|blinatumomab|mesh-list
5647606|NCT03117751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5647607|NCT03117751|Immunologic Factors|immunologic factors|mesh-ancestor
5647608|NCT03117751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647609|NCT03117751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5647610|NCT03117751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5647611|NCT03117751|Alkylating Agents|alkylating agents|mesh-ancestor
5647612|NCT03117751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821803|NCT02607072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5821804|NCT02607072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821805|NCT02607072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5821806|NCT02607072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5821807|NCT02607072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5821808|NCT02607072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5821809|NCT02607072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821810|NCT02607072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5821811|NCT02607072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5821812|NCT02607072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5821813|NCT02607072|Antipyretics|antipyretics|mesh-ancestor
5821814|NCT02607202|Gemcitabine|gemcitabine|mesh-list
5821815|NCT02607202|Paclitaxel|paclitaxel|mesh-list
5821816|NCT02607202|Carboplatin|carboplatin|mesh-list
5821817|NCT02607202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5821818|NCT02607202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5821819|NCT02607202|Tubulin Modulators|tubulin modulators|mesh-ancestor
5821820|NCT02607202|Antimitotic Agents|antimitotic agents|mesh-ancestor
5821821|NCT02607202|Mitosis Modulators|mitosis modulators|mesh-ancestor
5821822|NCT02607202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821823|NCT02607202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5821824|NCT02607202|Antimetabolites|antimetabolites|mesh-ancestor
5821825|NCT02607202|Antiviral Agents|antiviral agents|mesh-ancestor
5821826|NCT02607202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5821827|NCT02607202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5821828|NCT02607202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5821829|NCT02607202|Immunologic Factors|immunologic factors|mesh-ancestor
5821830|NCT02607202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821831|NCT02607111|Dalteparin|dalteparin|mesh-list
5821832|NCT02607111|Tinzaparin|tinzaparin|mesh-list
5647613|NCT03117751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647614|NCT03117751|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5647615|NCT03117751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5647616|NCT03117751|Antiemetics|antiemetics|mesh-ancestor
5647617|NCT03117751|Autonomic Agents|autonomic agents|mesh-ancestor
5647618|NCT03117751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5647619|NCT03117751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5821833|NCT02607111|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5647620|NCT03117751|Glucocorticoids|glucocorticoids|mesh-ancestor
5647621|NCT03117751|Hormones|hormones|mesh-ancestor
5647622|NCT03117751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5647623|NCT03117751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5647624|NCT03117751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5647625|NCT03117751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5647626|NCT03117751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5647627|NCT03117751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5647628|NCT03117751|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5647629|NCT03117751|Abortifacient Agents|abortifacient agents|mesh-ancestor
5647630|NCT03117751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5647631|NCT03117751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5647632|NCT03117751|Antimetabolites|antimetabolites|mesh-ancestor
5647633|NCT03117751|Dermatologic Agents|dermatologic agents|mesh-ancestor
5647634|NCT03117751|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5647635|NCT03117751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5647636|NCT03117751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5647637|NCT03117751|Antiviral Agents|antiviral agents|mesh-ancestor
5647638|NCT03117751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5647639|NCT03117751|Tubulin Modulators|tubulin modulators|mesh-ancestor
5647640|NCT03117751|Antimitotic Agents|antimitotic agents|mesh-ancestor
5647641|NCT03117751|Mitosis Modulators|mitosis modulators|mesh-ancestor
5647642|NCT03117751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5647643|NCT03117751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5647644|NCT03099564|Pembrolizumab|pembrolizumab|mesh-list
5647645|NCT03099564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5647646|NCT03099564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647647|NCT03086096|Irinotecan|irinotecan|mesh-list
5647648|NCT03086096|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5647649|NCT03086096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5647650|NCT03086096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5647651|NCT03086096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647652|NCT03086096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647653|NCT03085680|Curcumin|curcumin|mesh-list
5647654|NCT03085680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5647655|NCT03085680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5647656|NCT03085680|Analgesics|analgesics|mesh-ancestor
5647657|NCT03085680|Sensory System Agents|sensory system agents|mesh-ancestor
5647658|NCT03085680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5647659|NCT03085680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647660|NCT03085680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5647661|NCT03085680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5647662|NCT03085680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647663|NCT03085680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5647664|NCT03085680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647665|NCT03084471|Durvalumab|durvalumab|mesh-list
5647666|NCT03084471|Tremelimumab|tremelimumab|mesh-list
5647667|NCT03084471|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5647668|NCT03084471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5647669|NCT03084471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647670|NCT03084471|Immunologic Factors|immunologic factors|mesh-ancestor
5821834|NCT02607111|Anticoagulants|anticoagulants|mesh-ancestor
5821835|NCT02607111|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5821836|NCT02607111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5821837|NCT02607111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821838|NCT02607163|Dexmedetomidine|dexmedetomidine|mesh-list
5821839|NCT02607163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5821840|NCT02607163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5821841|NCT02607163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821842|NCT02607163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5821843|NCT02607163|Analgesics|analgesics|mesh-ancestor
5821844|NCT02607163|Sensory System Agents|sensory system agents|mesh-ancestor
5821845|NCT02607163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5821846|NCT02607163|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5821847|NCT02607163|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5821848|NCT02607163|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5821849|NCT02607163|Adrenergic Agents|adrenergic agents|mesh-ancestor
5647671|NCT03084471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647672|NCT03080883|Apixaban|apixaban|mesh-list
5647673|NCT03080883|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5647674|NCT03080883|Antithrombins|antithrombins|mesh-ancestor
5647675|NCT03080883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5821850|NCT02607163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5821851|NCT02607163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821852|NCT02606773|Ascorbic Acid|ascorbic acid|mesh-list
5821853|NCT02606773|Antioxidants|antioxidants|mesh-ancestor
5821854|NCT02606773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821855|NCT02606773|Protective Agents|protective agents|mesh-ancestor
5821856|NCT02606773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821857|NCT02606773|Vitamins|vitamins|mesh-ancestor
5821858|NCT02606773|Micronutrients|micronutrients|mesh-ancestor
5821859|NCT02606864|Nifurtimox|nifurtimox|mesh-list
5821860|NCT02606864|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5821861|NCT02606864|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5821862|NCT02606864|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5821863|NCT02606864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5821864|NCT02606994|Diphenhydramine|diphenhydramine|mesh-list
5821865|NCT02606994|Lidocaine|lidocaine|mesh-list
5821866|NCT02606994|Anesthetics, Local|anesthetics, local|mesh-ancestor
5821867|NCT02606994|Anesthetics|anesthetics|mesh-ancestor
5647676|NCT03080883|Protease Inhibitors|protease inhibitors|mesh-ancestor
5647677|NCT03080883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5647678|NCT03080883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647679|NCT03080883|Anticoagulants|anticoagulants|mesh-ancestor
5647680|NCT03059446|Cenicriviroc|cenicriviroc|mesh-list
5647681|NCT03059446|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
5647682|NCT03059446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647683|NCT03059446|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5647684|NCT03059446|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5647685|NCT03059446|Antiviral Agents|antiviral agents|mesh-ancestor
5647686|NCT03059446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5647687|NCT03051282|Enalapril|enalapril|mesh-list
5821868|NCT02606994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5821869|NCT02606994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821870|NCT02606994|Sensory System Agents|sensory system agents|mesh-ancestor
5821871|NCT02606994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5821872|NCT02606994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5821873|NCT02606994|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5821874|NCT02606994|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5821875|NCT02606994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5821876|NCT02606994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821877|NCT02606994|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5821878|NCT02606994|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5821879|NCT02606994|Antiemetics|antiemetics|mesh-ancestor
5821880|NCT02606994|Autonomic Agents|autonomic agents|mesh-ancestor
5821881|NCT02606994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5821882|NCT02606994|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5821883|NCT02606994|Histamine Antagonists|histamine antagonists|mesh-ancestor
5647688|NCT03051282|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5647689|NCT03051282|Protease Inhibitors|protease inhibitors|mesh-ancestor
5647690|NCT03051282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5647691|NCT03051282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647692|NCT03051282|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5647693|NCT03041701|Dasatinib|dasatinib|mesh-list
5647694|NCT03041701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647695|NCT03041701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5821884|NCT02606994|Histamine Agents|histamine agents|mesh-ancestor
5821885|NCT02606994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5821886|NCT02606994|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5821887|NCT02606981|Vitamins|vitamins|mesh-list
5821888|NCT02606981|Ascorbic Acid|ascorbic acid|mesh-list
5821889|NCT02606981|Micronutrients|micronutrients|mesh-ancestor
5821890|NCT02606981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821891|NCT02606981|Antioxidants|antioxidants|mesh-ancestor
5821892|NCT02606981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821893|NCT02606981|Protective Agents|protective agents|mesh-ancestor
5821894|NCT02606617|Mosapride|mosapride|mesh-list
5821895|NCT02606617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5647696|NCT03041701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5647697|NCT03041701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647698|NCT03039673|Interleukin-2|interleukin-2|mesh-list
5647699|NCT03039673|Riluzole|riluzole|mesh-list
5647700|NCT03039673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647701|NCT03039673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5647702|NCT03039673|Analgesics|analgesics|mesh-ancestor
5647703|NCT03039673|Sensory System Agents|sensory system agents|mesh-ancestor
5821896|NCT02606617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5647704|NCT03039673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5821897|NCT02606617|Serotonin Agents|serotonin agents|mesh-ancestor
5821898|NCT02606617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5901801|NCT02419495|Folic Acid|folic acid|mesh-list
5647705|NCT03039673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647706|NCT03039673|Anticonvulsants|anticonvulsants|mesh-ancestor
5647707|NCT03039673|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5647708|NCT03039673|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5647709|NCT03039673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5647710|NCT03039673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647711|NCT03039673|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5647712|NCT03039673|Protective Agents|protective agents|mesh-ancestor
5694373|NCT03395912|Sensory System Agents|sensory system agents|mesh-ancestor
5694374|NCT03395912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5694375|NCT03395899|Bevacizumab|bevacizumab|mesh-list
5694376|NCT03395899|Atezolizumab|atezolizumab|mesh-list
5694377|NCT03395899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5694378|NCT03395899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5694379|NCT03395899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5694380|NCT03395899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5694381|NCT03395899|Growth Substances|growth substances|mesh-ancestor
5694382|NCT03395899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694383|NCT03395899|Growth Inhibitors|growth inhibitors|mesh-ancestor
5694384|NCT03395873|Decitabine|decitabine|mesh-list
5694385|NCT03395873|Avelumab|avelumab|mesh-list
5694386|NCT03395873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5694387|NCT03395873|Antimetabolites|antimetabolites|mesh-ancestor
5694388|NCT03395873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694389|NCT03395873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5694390|NCT03395873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5694391|NCT03395873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5694392|NCT03395847|Pembrolizumab|pembrolizumab|mesh-list
5694393|NCT03395847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5694394|NCT03395847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5694395|NCT03395756|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
5821899|NCT02606617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821900|NCT02606617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821901|NCT02606565|Chlorhexidine|chlorhexidine|mesh-list
5821902|NCT02606565|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5694396|NCT03395756|Medroxyprogesterone|medroxyprogesterone|mesh-list
5694397|NCT03395756|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5694398|NCT03395756|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5694399|NCT03395756|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5694400|NCT03395756|Contraceptive Agents|contraceptive agents|mesh-ancestor
5694401|NCT03395756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5694402|NCT03395756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694403|NCT03395756|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5694404|NCT03395756|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5694405|NCT03395756|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5694406|NCT03395756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5694407|NCT03395756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5694408|NCT03395730|Oxytocin|oxytocin|mesh-list
5694409|NCT03395730|Oxytocics|oxytocics|mesh-ancestor
5694410|NCT03395730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5694411|NCT03395730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694412|NCT03395704|Hepcidins|hepcidins|mesh-list
5694413|NCT03395704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5694414|NCT03395665|Estradiol|estradiol|mesh-list
5694415|NCT03395665|Progesterone|progesterone|mesh-list
5694416|NCT03395665|Estrogens|estrogens|mesh-ancestor
5694417|NCT03395665|Hormones|hormones|mesh-ancestor
5694418|NCT03395665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5694419|NCT03395665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694420|NCT03395665|Progestins|progestins|mesh-ancestor
5697934|NCT03372681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5697935|NCT03372486|Bupivacaine|bupivacaine|mesh-list
5697936|NCT03372486|Naloxone|naloxone|mesh-list
5697937|NCT03372486|Anesthetics, Local|anesthetics, local|mesh-ancestor
5697938|NCT03372486|Anesthetics|anesthetics|mesh-ancestor
5697939|NCT03372486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5697940|NCT03372486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697941|NCT03372486|Sensory System Agents|sensory system agents|mesh-ancestor
5697942|NCT03372486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5697943|NCT03372486|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5697944|NCT03372473|Loratadine|loratadine|mesh-list
5697945|NCT03372473|Montelukast|montelukast|mesh-list
5697946|NCT03372473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5697947|NCT03372473|Respiratory System Agents|respiratory system agents|mesh-ancestor
5697948|NCT03372473|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5821903|NCT02606565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5821904|NCT02606565|Disinfectants|disinfectants|mesh-ancestor
5821905|NCT02606409|Dexmedetomidine|dexmedetomidine|mesh-list
5821906|NCT02606409|Propofol|propofol|mesh-list
5821907|NCT02606409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5821908|NCT02606409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5821909|NCT02606409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821910|NCT02606409|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5821911|NCT02606409|Anesthetics, General|anesthetics, general|mesh-ancestor
5821912|NCT02606409|Anesthetics|anesthetics|mesh-ancestor
5821913|NCT02606409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5821914|NCT02606409|Analgesics|analgesics|mesh-ancestor
5821915|NCT02606409|Sensory System Agents|sensory system agents|mesh-ancestor
5821916|NCT02606409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5821917|NCT02606409|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5821918|NCT02606409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5821919|NCT02606409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5821920|NCT02606409|Adrenergic Agents|adrenergic agents|mesh-ancestor
5821921|NCT02606409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5821922|NCT02606409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821923|NCT02606448|Bupivacaine|bupivacaine|mesh-list
5821924|NCT02606448|Anesthetics, Local|anesthetics, local|mesh-ancestor
5821925|NCT02606448|Anesthetics|anesthetics|mesh-ancestor
5821926|NCT02606448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5821927|NCT02606448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821928|NCT02606448|Sensory System Agents|sensory system agents|mesh-ancestor
5821929|NCT02606448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5821930|NCT02606552|Aspirin|aspirin|mesh-list
5821931|NCT02606552|Clopidogrel|clopidogrel|mesh-list
5821932|NCT02606552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5821933|NCT02606552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5821934|NCT02606552|Analgesics|analgesics|mesh-ancestor
5821935|NCT02606552|Sensory System Agents|sensory system agents|mesh-ancestor
5821936|NCT02606552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5821937|NCT02606552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821938|NCT02606552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5647713|NCT03033225|Verteporfin|verteporfin|mesh-list
5647714|NCT03033225|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5647715|NCT03033225|Dermatologic Agents|dermatologic agents|mesh-ancestor
5647716|NCT03011034|Daratumumab|daratumumab|mesh-list
5647717|NCT03011034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647718|NCT03006172|Metformin|metformin|mesh-list
5647719|NCT03006172|Trastuzumab|trastuzumab|mesh-list
5647720|NCT03006172|Pertuzumab|pertuzumab|mesh-list
5647721|NCT03006172|Letrozole|letrozole|mesh-list
5647722|NCT03006172|Fulvestrant|fulvestrant|mesh-list
5647723|NCT03006172|Palbociclib|palbociclib|mesh-list
5647724|NCT03006172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5647725|NCT03006172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647726|NCT03006172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5647727|NCT03006172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647728|NCT03006172|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5647729|NCT03006172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5647730|NCT03006172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5647731|NCT03006172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647732|NCT03006172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5647733|NCT03006172|Hormone Antagonists|hormone antagonists|mesh-ancestor
5647734|NCT03006172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5647735|NCT03006172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5647736|NCT03006172|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5647737|NCT03006172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5647738|NCT03000439|Tofacitinib|tofacitinib|mesh-list
5647739|NCT03000439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5647740|NCT03000439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5647741|NCT03000439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647742|NCT02999477|Paclitaxel|paclitaxel|mesh-list
5647743|NCT02999477|Pembrolizumab|pembrolizumab|mesh-list
5647744|NCT02999477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5647745|NCT02999477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647746|NCT02999477|Tubulin Modulators|tubulin modulators|mesh-ancestor
5647747|NCT02999477|Antimitotic Agents|antimitotic agents|mesh-ancestor
5647748|NCT02999477|Mitosis Modulators|mitosis modulators|mesh-ancestor
5647749|NCT02999477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821939|NCT02606552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5821940|NCT02606552|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5821941|NCT02606552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5821942|NCT02606552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821943|NCT02606552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5821944|NCT02606552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5821945|NCT02606552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5821946|NCT02606552|Antipyretics|antipyretics|mesh-ancestor
5821947|NCT02606552|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5821948|NCT02606552|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5821949|NCT02606552|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5821950|NCT02606552|Purinergic Agents|purinergic agents|mesh-ancestor
5821951|NCT02606552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5821952|NCT02606539|Leucovorin|leucovorin|mesh-list
5821953|NCT02606539|Folic Acid|folic acid|mesh-list
5821954|NCT02606539|Methotrexate|methotrexate|mesh-list
5821955|NCT02606539|Levoleucovorin|levoleucovorin|mesh-list
5821956|NCT02606539|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5821957|NCT02606539|Abortifacient Agents|abortifacient agents|mesh-ancestor
5821958|NCT02606539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5821959|NCT02606539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821960|NCT02606539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5821961|NCT02606539|Antimetabolites|antimetabolites|mesh-ancestor
5821962|NCT02606539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821963|NCT02606539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5821964|NCT02606539|Dermatologic Agents|dermatologic agents|mesh-ancestor
5821965|NCT02606539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5821966|NCT02606539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5821967|NCT02606539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5821968|NCT02606539|Immunologic Factors|immunologic factors|mesh-ancestor
5821969|NCT02606539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5821970|NCT02606539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5821971|NCT02606539|Antidotes|antidotes|mesh-ancestor
5821972|NCT02606539|Protective Agents|protective agents|mesh-ancestor
5821973|NCT02606539|Vitamin B Complex|vitamin b complex|mesh-ancestor
5821974|NCT02606539|Vitamins|vitamins|mesh-ancestor
5821975|NCT02606539|Micronutrients|micronutrients|mesh-ancestor
5821976|NCT02606539|Hematinics|hematinics|mesh-ancestor
5821977|NCT02606383|Ketoconazole|ketoconazole|mesh-list
5821978|NCT02606383|Antifungal Agents|antifungal agents|mesh-ancestor
5821979|NCT02606383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5821980|NCT02606383|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5821981|NCT02606383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5821982|NCT02606383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5821983|NCT02606383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5821984|NCT02606383|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5821985|NCT02606383|Hormone Antagonists|hormone antagonists|mesh-ancestor
5821986|NCT02606383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5821987|NCT02606383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5821988|NCT02606383|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5821989|NCT02606357|Insulin Glargine|insulin glargine|mesh-list
5821990|NCT02606357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5821991|NCT02606357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647750|NCT02999477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5647751|NCT02992743|Cyclophosphamide|cyclophosphamide|mesh-list
5647752|NCT02992743|Fludarabine|fludarabine|mesh-list
5647753|NCT02992743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5647754|NCT02992743|Immunologic Factors|immunologic factors|mesh-ancestor
5647755|NCT02992743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647756|NCT02992743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5647757|NCT02992743|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5647758|NCT02992743|Alkylating Agents|alkylating agents|mesh-ancestor
5647759|NCT02992743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647760|NCT02992743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647761|NCT02992743|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5647762|NCT02980666|Teduglutide|teduglutide|mesh-list
5647763|NCT02980666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5647764|NCT02980666|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5647765|NCT02980666|Protective Agents|protective agents|mesh-ancestor
5647766|NCT02980666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647767|NCT02971748|Pembrolizumab|pembrolizumab|mesh-list
5647768|NCT02971748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5647769|NCT02971748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647770|NCT02968108|Ustekinumab|ustekinumab|mesh-list
5647771|NCT02968108|Dermatologic Agents|dermatologic agents|mesh-ancestor
5821992|NCT02606266|Valganciclovir|valganciclovir|mesh-list
5821993|NCT02606266|Antiviral Agents|antiviral agents|mesh-ancestor
5647772|NCT02962102|Calcitriol|calcitriol|mesh-list
5821994|NCT02606266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5821995|NCT02606084|Esketamine|esketamine|mesh-list
5821996|NCT02606084|Antidepressive Agents|antidepressive agents|mesh-ancestor
5821997|NCT02606084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5821998|NCT02605915|Cyclophosphamide|cyclophosphamide|mesh-list
5821999|NCT02605915|Carboplatin|carboplatin|mesh-list
5822000|NCT02605915|Docetaxel|docetaxel|mesh-list
5822001|NCT02605915|Doxorubicin|doxorubicin|mesh-list
5822002|NCT02605915|Trastuzumab|trastuzumab|mesh-list
5822003|NCT02605915|Atezolizumab|atezolizumab|mesh-list
5822004|NCT02605915|Pertuzumab|pertuzumab|mesh-list
5822005|NCT02605915|Maytansine|maytansine|mesh-list
5822006|NCT02605915|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
5647773|NCT02962102|Calcifediol|calcifediol|mesh-list
5647774|NCT02962102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5647775|NCT02962102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647776|NCT02962102|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
5647777|NCT02962102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5647778|NCT02962102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647779|NCT02962102|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5647780|NCT02962102|Vitamins|vitamins|mesh-ancestor
5647781|NCT02962102|Micronutrients|micronutrients|mesh-ancestor
5647782|NCT02962102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5647783|NCT02950259|Indomethacin|indomethacin|mesh-list
5647784|NCT02950259|Cyclophosphamide|cyclophosphamide|mesh-list
5647785|NCT02950259|Omeprazole|omeprazole|mesh-list
5647786|NCT02950259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5647787|NCT02950259|Immunologic Factors|immunologic factors|mesh-ancestor
5647788|NCT02950259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647789|NCT02950259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5647790|NCT02950259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5647791|NCT02950259|Alkylating Agents|alkylating agents|mesh-ancestor
5647792|NCT02950259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647793|NCT02950259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647794|NCT02950259|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5647795|NCT02950259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5647796|NCT02950259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5822007|NCT02605915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5822008|NCT02605915|Immunologic Factors|immunologic factors|mesh-ancestor
5822009|NCT02605915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822010|NCT02605915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5822011|NCT02605915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5822012|NCT02605915|Alkylating Agents|alkylating agents|mesh-ancestor
5822013|NCT02605915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822014|NCT02605915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5822015|NCT02605915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5822016|NCT02605915|Tubulin Modulators|tubulin modulators|mesh-ancestor
5822017|NCT02605915|Antimitotic Agents|antimitotic agents|mesh-ancestor
5647797|NCT02950259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5647798|NCT02950259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5647799|NCT02950259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5647800|NCT02950259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5647801|NCT02950259|Analgesics|analgesics|mesh-ancestor
5647802|NCT02950259|Sensory System Agents|sensory system agents|mesh-ancestor
5647803|NCT02950259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5647804|NCT02950259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5647805|NCT02950259|Gout Suppressants|gout suppressants|mesh-ancestor
5647806|NCT02950259|Tocolytic Agents|tocolytic agents|mesh-ancestor
5647807|NCT02950259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5647808|NCT02950259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5647809|NCT02947750|Folic Acid|folic acid|mesh-list
5647810|NCT02947750|Hematinics|hematinics|mesh-ancestor
5822018|NCT02605915|Mitosis Modulators|mitosis modulators|mesh-ancestor
5822019|NCT02605915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5822020|NCT02605915|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5822021|NCT02605915|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5822022|NCT02605915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5822023|NCT02605915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5822024|NCT02605915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5822025|NCT02606032|Metronidazole|metronidazole|mesh-list
5822026|NCT02606032|Doxycycline|doxycycline|mesh-list
5822027|NCT02606032|Terbinafine|terbinafine|mesh-list
5822028|NCT02606032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5822029|NCT02606032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5647811|NCT02947750|Vitamin B Complex|vitamin b complex|mesh-ancestor
5822030|NCT02606032|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5822031|NCT02606032|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5822032|NCT02606032|Antimalarials|antimalarials|mesh-ancestor
5822033|NCT02606032|Antifungal Agents|antifungal agents|mesh-ancestor
5822034|NCT02606032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5822035|NCT02606032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822036|NCT02605798|Sofosbuvir|sofosbuvir|mesh-list
5822037|NCT02605798|Antiviral Agents|antiviral agents|mesh-ancestor
5822038|NCT02605798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5822039|NCT02606045|Tranexamic Acid|tranexamic acid|mesh-list
5822040|NCT02606045|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5822041|NCT02606045|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5822042|NCT02606045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822043|NCT02606045|Hemostatics|hemostatics|mesh-ancestor
5822044|NCT02606045|Coagulants|coagulants|mesh-ancestor
5822045|NCT02605746|Ceritinib|ceritinib|mesh-list
5822046|NCT02605746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5822047|NCT02605746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5822048|NCT02605746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5822049|NCT02605746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822050|NCT02605772|Metformin|metformin|mesh-list
5822051|NCT02605772|Saxagliptin|saxagliptin|mesh-list
5822052|NCT02605772|Acarbose|acarbose|mesh-list
5822053|NCT02605772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5822054|NCT02605772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822055|NCT02605772|Incretins|incretins|mesh-ancestor
5822056|NCT02605772|Hormones|hormones|mesh-ancestor
5822057|NCT02605772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5822058|NCT02605772|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5822059|NCT02605772|Protease Inhibitors|protease inhibitors|mesh-ancestor
5822060|NCT02605772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5822061|NCT02605772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822062|NCT02605772|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
5822063|NCT02605811|Temozolomide|temozolomide|mesh-list
5822064|NCT02605811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5822065|NCT02605811|Alkylating Agents|alkylating agents|mesh-ancestor
5822066|NCT02605811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822067|NCT02605811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5822068|NCT02605460|Plerixafor|plerixafor|mesh-list
5822069|NCT02605460|Cyclophosphamide|cyclophosphamide|mesh-list
5822070|NCT02605460|Busulfan|busulfan|mesh-list
5822071|NCT02605460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5822072|NCT02605460|Immunologic Factors|immunologic factors|mesh-ancestor
5822073|NCT02605460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822074|NCT02605460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5822075|NCT02605460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5822076|NCT02605460|Alkylating Agents|alkylating agents|mesh-ancestor
5822077|NCT02605460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822078|NCT02605460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5822079|NCT02605460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5822080|NCT02605460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5822081|NCT02605460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5822082|NCT02605460|Antiviral Agents|antiviral agents|mesh-ancestor
5822083|NCT02605460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5822084|NCT02605720|Piperaquine|piperaquine|mesh-list
5822085|NCT02605720|Artenimol|artenimol|mesh-list
5822086|NCT02605720|Antimalarials|antimalarials|mesh-ancestor
5822087|NCT02605720|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5822088|NCT02605720|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5822089|NCT02605720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5822090|NCT02605421|Cyclophosphamide|cyclophosphamide|mesh-list
5822091|NCT02605421|Melphalan|melphalan|mesh-list
5822092|NCT02605421|Thiotepa|thiotepa|mesh-list
5822093|NCT02605421|Carboplatin|carboplatin|mesh-list
5822094|NCT02605421|Etoposide|etoposide|mesh-list
5822095|NCT02605421|Sargramostim|sargramostim|mesh-list
5822096|NCT02605421|Lenograstim|lenograstim|mesh-list
5822097|NCT02605421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5822098|NCT02605421|Immunologic Factors|immunologic factors|mesh-ancestor
5822099|NCT02605421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822100|NCT02605421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5822101|NCT02605421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5822102|NCT02605421|Alkylating Agents|alkylating agents|mesh-ancestor
5822103|NCT02605421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822104|NCT02605421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5822105|NCT02605421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5822106|NCT02605421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5822107|NCT02605421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5822108|NCT02605421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5822109|NCT02605421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5822110|NCT02605421|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5822111|NCT02605538|Vaccines|vaccines|mesh-list
5822112|NCT02605538|Immunologic Factors|immunologic factors|mesh-ancestor
5822113|NCT02605538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901802|NCT02419495|Paclitaxel|paclitaxel|mesh-list
5901803|NCT02419495|Camptothecin|camptothecin|mesh-list
5901804|NCT02419495|Cyclophosphamide|cyclophosphamide|mesh-list
5901805|NCT02419495|Carboplatin|carboplatin|mesh-list
5647812|NCT02947750|Vitamins|vitamins|mesh-ancestor
5647813|NCT02947750|Micronutrients|micronutrients|mesh-ancestor
5647814|NCT02947750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647815|NCT02935634|Nivolumab|nivolumab|mesh-list
5647816|NCT02935634|Ipilimumab|ipilimumab|mesh-list
5647817|NCT02935634|Rucaparib|rucaparib|mesh-list
5647818|NCT02935634|Linrodostat|linrodostat|mesh-list
5647819|NCT02935634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5647820|NCT02935634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647821|NCT02935634|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5647822|NCT02935634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647823|NCT02935634|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5647824|NCT02935634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5647825|NCT02932410|Macitentan|macitentan|mesh-list
5647826|NCT02932410|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
5647827|NCT02932410|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5647828|NCT02932410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647829|NCT02932410|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
5647830|NCT02921893|Dexamethasone|dexamethasone|mesh-list
5647831|NCT02921893|Dexamethasone acetate|dexamethasone acetate|mesh-list
5647832|NCT02921893|Lenalidomide|lenalidomide|mesh-list
5647833|NCT02921893|Ixazomib|ixazomib|mesh-list
5647834|NCT02921893|Ichthammol|ichthammol|mesh-list
5647835|NCT02921893|BB 1101|bb 1101|mesh-list
5647836|NCT02921893|Glycine|glycine|mesh-list
5647837|NCT02921893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5647838|NCT02921893|Antiemetics|antiemetics|mesh-ancestor
5647839|NCT02921893|Autonomic Agents|autonomic agents|mesh-ancestor
5647840|NCT02921893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5647841|NCT02921893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647842|NCT02921893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5647843|NCT02921893|Glucocorticoids|glucocorticoids|mesh-ancestor
5647844|NCT02921893|Hormones|hormones|mesh-ancestor
5647845|NCT02921893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5647846|NCT02921893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5647847|NCT02921893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647848|NCT02921893|Protease Inhibitors|protease inhibitors|mesh-ancestor
5901806|NCT02419495|Doxorubicin|doxorubicin|mesh-list
5901807|NCT02419495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5901808|NCT02419495|Fluorouracil|fluorouracil|mesh-list
5901809|NCT02419495|Pembrolizumab|pembrolizumab|mesh-list
5901810|NCT02419495|Capecitabine|capecitabine|mesh-list
5901811|NCT02419495|Oxaliplatin|oxaliplatin|mesh-list
5901812|NCT02419495|Nivolumab|nivolumab|mesh-list
5901813|NCT02419495|Irinotecan|irinotecan|mesh-list
5901814|NCT02419495|Pemetrexed|pemetrexed|mesh-list
5901815|NCT02419495|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5901816|NCT02419495|Ipilimumab|ipilimumab|mesh-list
5901817|NCT02419495|Topotecan|topotecan|mesh-list
5901818|NCT02419495|Daunorubicin|daunorubicin|mesh-list
5901819|NCT02419495|Olaparib|olaparib|mesh-list
5901820|NCT02419495|Calcium|calcium|mesh-list
5901821|NCT02419495|Levoleucovorin|levoleucovorin|mesh-list
5901822|NCT02419495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5901823|NCT02419495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647849|NCT02921893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5647850|NCT02921893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647851|NCT02921893|Immunologic Factors|immunologic factors|mesh-ancestor
5647852|NCT02921893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5647853|NCT02921893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5647854|NCT02921893|Growth Substances|growth substances|mesh-ancestor
5647855|NCT02921893|Growth Inhibitors|growth inhibitors|mesh-ancestor
5647856|NCT02921893|Dermatologic Agents|dermatologic agents|mesh-ancestor
5647857|NCT02921893|Glycine Agents|glycine agents|mesh-ancestor
5647858|NCT02921893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5647859|NCT02880020|Nivolumab|nivolumab|mesh-list
5647860|NCT02880020|Ipilimumab|ipilimumab|mesh-list
5901824|NCT02419495|Tubulin Modulators|tubulin modulators|mesh-ancestor
5647861|NCT02880020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5901825|NCT02419495|Antimitotic Agents|antimitotic agents|mesh-ancestor
5901826|NCT02419495|Mitosis Modulators|mitosis modulators|mesh-ancestor
5901827|NCT02419495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901828|NCT02419495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5822114|NCT02605694|Prednisone|prednisone|mesh-list
5822115|NCT02605694|Rituximab|rituximab|mesh-list
5647862|NCT02880020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647863|NCT02880020|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5647864|NCT02880020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647865|NCT02867813|Evolocumab|evolocumab|mesh-list
5647866|NCT02867813|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5647867|NCT02867813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5647868|NCT02867813|Antimetabolites|antimetabolites|mesh-ancestor
5647869|NCT02867813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647870|NCT02867813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5647871|NCT02862275|Atezolizumab|atezolizumab|mesh-list
5647872|NCT02862275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5647873|NCT02862275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647874|NCT02862275|Immunologic Factors|immunologic factors|mesh-ancestor
5647875|NCT02862275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647876|NCT02853331|Pembrolizumab|pembrolizumab|mesh-list
5647877|NCT02853331|Sunitinib|sunitinib|mesh-list
5647878|NCT02853331|Axitinib|axitinib|mesh-list
5647879|NCT02853331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5647880|NCT02853331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647881|NCT02853331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5647882|NCT02853331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5647883|NCT02853331|Growth Substances|growth substances|mesh-ancestor
5647884|NCT02853331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647885|NCT02853331|Growth Inhibitors|growth inhibitors|mesh-ancestor
5647886|NCT02853331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5647887|NCT02853331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5647888|NCT02853331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647889|NCT02818517|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
5822116|NCT02605694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5822117|NCT02605694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5822118|NCT02605694|Immunologic Factors|immunologic factors|mesh-ancestor
5822119|NCT02605694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822120|NCT02605694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5822121|NCT02605694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5822122|NCT02605694|Glucocorticoids|glucocorticoids|mesh-ancestor
5822123|NCT02605694|Hormones|hormones|mesh-ancestor
5822124|NCT02605694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5822125|NCT02605694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5822126|NCT02605434|Levodopa|levodopa|mesh-list
5822127|NCT02605434|Carbidopa|carbidopa|mesh-list
5822128|NCT02605434|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
5822129|NCT02605434|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5822130|NCT02605434|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5822131|NCT02605434|Dopamine Agents|dopamine agents|mesh-ancestor
5822132|NCT02605434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5822133|NCT02605434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822134|NCT02605434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822135|NCT02605434|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5822136|NCT02605434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5822137|NCT02605434|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5822138|NCT02605434|Immunologic Factors|immunologic factors|mesh-ancestor
5822139|NCT02605434|Dopamine Agonists|dopamine agonists|mesh-ancestor
5822140|NCT02605382|Chlorhexidine|chlorhexidine|mesh-list
5822141|NCT02605382|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5822142|NCT02605382|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5822143|NCT02605382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5822144|NCT02605382|Disinfectants|disinfectants|mesh-ancestor
5822145|NCT02605382|Dermatologic Agents|dermatologic agents|mesh-ancestor
5822146|NCT02605356|Dexamethasone|dexamethasone|mesh-list
5822147|NCT02605356|Bortezomib|bortezomib|mesh-list
5822148|NCT02605356|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
5822149|NCT02605356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5822150|NCT02605356|Antiemetics|antiemetics|mesh-ancestor
5822151|NCT02605356|Autonomic Agents|autonomic agents|mesh-ancestor
5822152|NCT02605356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5822153|NCT02605356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822154|NCT02605356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5822155|NCT02605356|Glucocorticoids|glucocorticoids|mesh-ancestor
5822156|NCT02605356|Hormones|hormones|mesh-ancestor
5822157|NCT02605356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5822158|NCT02605356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5822159|NCT02605356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5822160|NCT02605213|Vancomycin|vancomycin|mesh-list
5822161|NCT02605213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5822162|NCT02605213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5822163|NCT02605226|Bicalutamide|bicalutamide|mesh-list
5822164|NCT02605226|Hormones|hormones|mesh-list
5822165|NCT02605226|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
5822166|NCT02605226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5822167|NCT02605226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822168|NCT02605226|Androgen Antagonists|androgen antagonists|mesh-ancestor
5822169|NCT02605226|Hormone Antagonists|hormone antagonists|mesh-ancestor
5822170|NCT02605226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5822171|NCT02604992|Dronabinol|dronabinol|mesh-list
5822172|NCT02604992|Hallucinogens|hallucinogens|mesh-ancestor
5822173|NCT02604992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822174|NCT02604992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5822175|NCT02604992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5822176|NCT02604992|Analgesics|analgesics|mesh-ancestor
5822177|NCT02604992|Sensory System Agents|sensory system agents|mesh-ancestor
5822178|NCT02604992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5822179|NCT02604992|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5822180|NCT02604992|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5822181|NCT02604992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5822182|NCT02604992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822183|NCT02604992|Hormones|hormones|mesh-ancestor
5822184|NCT02604992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5822185|NCT02605252|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
5822186|NCT02605252|Antiviral Agents|antiviral agents|mesh-ancestor
5822187|NCT02605252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5822188|NCT02604966|Artesunate|artesunate|mesh-list
5822189|NCT02604966|Antimalarials|antimalarials|mesh-ancestor
5822190|NCT02604966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5822191|NCT02604966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5822192|NCT02604966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5822193|NCT02604966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5822194|NCT02604966|Antiviral Agents|antiviral agents|mesh-ancestor
5822195|NCT02604966|Schistosomicides|schistosomicides|mesh-ancestor
5822196|NCT02604966|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5822197|NCT02604966|Anthelmintics|anthelmintics|mesh-ancestor
5647890|NCT02818517|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6211555|NCT02174731|Hematinics|hematinics|mesh-ancestor
6211556|NCT02174848|Deferiprone|deferiprone|mesh-list
6211557|NCT02174848|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6211558|NCT02174848|Chelating Agents|chelating agents|mesh-ancestor
6211559|NCT02174848|Sequestering Agents|sequestering agents|mesh-ancestor
6211560|NCT02174848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211561|NCT02174861|Erenumab|erenumab|mesh-list
6211562|NCT02174861|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
5647891|NCT02818517|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5647892|NCT02818517|Adrenergic Agents|adrenergic agents|mesh-ancestor
5647893|NCT02818517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5647894|NCT02818517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647895|NCT02818517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647896|NCT02818517|Protease Inhibitors|protease inhibitors|mesh-ancestor
5647897|NCT02818517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5647898|NCT02812524|Ipilimumab|ipilimumab|mesh-list
5647899|NCT02812524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5647900|NCT02812524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647901|NCT02812524|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5647902|NCT02812524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647903|NCT02811133|Inositol|inositol|mesh-list
5822198|NCT02605265|Capecitabine|capecitabine|mesh-list
5822199|NCT02605265|Oxaliplatin|oxaliplatin|mesh-list
5822200|NCT02605265|Irinotecan|irinotecan|mesh-list
5822201|NCT02605265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5822202|NCT02605265|Antimetabolites|antimetabolites|mesh-ancestor
5822203|NCT02605265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822204|NCT02605265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5822205|NCT02605265|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5822206|NCT02605265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5822207|NCT02605265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5822208|NCT02604914|Levodopa|levodopa|mesh-list
5822209|NCT02604914|Carbidopa|carbidopa|mesh-list
5822210|NCT02604914|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
5822211|NCT02604914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5822212|NCT02604914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5822213|NCT02604914|Dopamine Agents|dopamine agents|mesh-ancestor
5647904|NCT02811133|Vitamin B Complex|vitamin b complex|mesh-ancestor
6674396|NCT01569113|Levonorgestrel|levonorgestrel|mesh-list
5822214|NCT02604914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5822215|NCT02604914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822216|NCT02604914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822217|NCT02604914|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5822218|NCT02604914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5822219|NCT02604914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5822220|NCT02604914|Immunologic Factors|immunologic factors|mesh-ancestor
5822221|NCT02604914|Dopamine Agonists|dopamine agonists|mesh-ancestor
5822222|NCT02604849|Gentamicins|gentamicins|mesh-list
5822223|NCT02604849|Neomycin|neomycin|mesh-list
5822224|NCT02604849|Streptomycin|streptomycin|mesh-list
5822225|NCT02604849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5822226|NCT02604849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5822227|NCT02604849|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5822228|NCT02604849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5822229|NCT02604849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822230|NCT02604940|Dexmedetomidine|dexmedetomidine|mesh-list
5822231|NCT02604940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5822232|NCT02604940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5822233|NCT02604940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822234|NCT02604940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5822235|NCT02604940|Analgesics|analgesics|mesh-ancestor
5822236|NCT02604940|Sensory System Agents|sensory system agents|mesh-ancestor
5822237|NCT02604940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5822238|NCT02604940|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5822239|NCT02604940|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5822240|NCT02604940|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5822241|NCT02604940|Adrenergic Agents|adrenergic agents|mesh-ancestor
5822242|NCT02604940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5822243|NCT02604940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822244|NCT02604628|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5822245|NCT02604628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5822246|NCT02604719|Tranexamic Acid|tranexamic acid|mesh-list
5822247|NCT02604719|Ethamsylate|ethamsylate|mesh-list
5822248|NCT02604719|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5822249|NCT02604719|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5822250|NCT02604719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822251|NCT02604719|Hemostatics|hemostatics|mesh-ancestor
5822252|NCT02604719|Coagulants|coagulants|mesh-ancestor
5822253|NCT02604797|Flurbiprofen|flurbiprofen|mesh-list
5822254|NCT02604797|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
5822255|NCT02604797|Sufentanil|sufentanil|mesh-list
5822256|NCT02604797|Dsuvia|dsuvia|mesh-list
5822257|NCT02604797|Nalbuphine|nalbuphine|mesh-list
5822258|NCT02604797|Ramosetron|ramosetron|mesh-list
5822259|NCT02604797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5822260|NCT02604797|Narcotics|narcotics|mesh-ancestor
5822261|NCT02604797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5822262|NCT02604797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822263|NCT02604797|Analgesics|analgesics|mesh-ancestor
5822264|NCT02604797|Sensory System Agents|sensory system agents|mesh-ancestor
5822265|NCT02604797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5822266|NCT02604797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5822267|NCT02604797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5822268|NCT02604797|Anesthetics, General|anesthetics, general|mesh-ancestor
5822269|NCT02604797|Anesthetics|anesthetics|mesh-ancestor
5822270|NCT02604797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5822271|NCT02604797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5822272|NCT02604797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5822273|NCT02604797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5822274|NCT02604797|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5822275|NCT02604797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5822276|NCT02604797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822277|NCT02604797|Antiemetics|antiemetics|mesh-ancestor
5822278|NCT02604797|Autonomic Agents|autonomic agents|mesh-ancestor
5822279|NCT02604797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5822280|NCT02604797|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5822281|NCT02604797|Serotonin Agents|serotonin agents|mesh-ancestor
5822282|NCT02604797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5822283|NCT02604784|Cisplatin|cisplatin|mesh-list
5822284|NCT02604784|Doxorubicin|doxorubicin|mesh-list
5822285|NCT02604784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5822286|NCT02604784|Oxaliplatin|oxaliplatin|mesh-list
5822287|NCT02604784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5822288|NCT02604784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6674397|NCT01569113|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5822289|NCT02604784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5647905|NCT02811133|Vitamins|vitamins|mesh-ancestor
5647906|NCT02811133|Micronutrients|micronutrients|mesh-ancestor
5647907|NCT02811133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647908|NCT02782104|Esketamine|esketamine|mesh-list
5647909|NCT02782104|Antidepressive Agents|antidepressive agents|mesh-ancestor
5647910|NCT02782104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5647911|NCT02781584|Firsocostat|firsocostat|mesh-list
5647912|NCT02781584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5647913|NCT02781584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647914|NCT02777424|Thrombin|thrombin|mesh-list
5647915|NCT02777424|Hemostatics|hemostatics|mesh-ancestor
5647916|NCT02777424|Coagulants|coagulants|mesh-ancestor
5647917|NCT02748369|Glucagon|glucagon|mesh-list
5647918|NCT02748369|Hormones|hormones|mesh-list
5647919|NCT02748369|Somatostatin|somatostatin|mesh-list
5647920|NCT02748369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5647921|NCT02748369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647922|NCT02748369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5822290|NCT02604784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5822291|NCT02604784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5822292|NCT02604784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822293|NCT02604823|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5822294|NCT02604823|Antiviral Agents|antiviral agents|mesh-ancestor
5822295|NCT02604823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5822296|NCT02604836|Ibandronic Acid|ibandronic acid|mesh-list
5822297|NCT02604836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5822298|NCT02604836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822299|NCT02604615|Capecitabine|capecitabine|mesh-list
5822300|NCT02604615|Oxaliplatin|oxaliplatin|mesh-list
5822301|NCT02604615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5822302|NCT02604615|Antimetabolites|antimetabolites|mesh-ancestor
5822303|NCT02604615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822304|NCT02604615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5822305|NCT02604576|Bromopride|bromopride|mesh-list
5822306|NCT02604576|Metoclopramide|metoclopramide|mesh-list
5822307|NCT02604576|Simethicone|simethicone|mesh-list
5822308|NCT02604576|Antifoaming Agents|antifoaming agents|mesh-ancestor
5822309|NCT02604576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822310|NCT02604576|Emollients|emollients|mesh-ancestor
5822311|NCT02604576|Dermatologic Agents|dermatologic agents|mesh-ancestor
5822312|NCT02604576|Antiemetics|antiemetics|mesh-ancestor
5822313|NCT02604576|Autonomic Agents|autonomic agents|mesh-ancestor
5822314|NCT02604576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5822315|NCT02604576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822316|NCT02604576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5822317|NCT02604576|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5822318|NCT02604576|Dopamine Agents|dopamine agents|mesh-ancestor
5822319|NCT02604576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5822320|NCT02604576|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5822321|NCT02604537|Ketorolac|ketorolac|mesh-list
5822322|NCT02604537|Betamethasone|betamethasone|mesh-list
5822323|NCT02604537|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5822324|NCT02604537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5822325|NCT02604537|Analgesics|analgesics|mesh-ancestor
5822326|NCT02604537|Sensory System Agents|sensory system agents|mesh-ancestor
5822327|NCT02604537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5647923|NCT02734290|Paclitaxel|paclitaxel|mesh-list
5647924|NCT02734290|Pembrolizumab|pembrolizumab|mesh-list
5647925|NCT02734290|Capecitabine|capecitabine|mesh-list
5647926|NCT02734290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5647927|NCT02734290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647928|NCT02734290|Tubulin Modulators|tubulin modulators|mesh-ancestor
5647929|NCT02734290|Antimitotic Agents|antimitotic agents|mesh-ancestor
5647930|NCT02734290|Mitosis Modulators|mitosis modulators|mesh-ancestor
5647931|NCT02734290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647932|NCT02734290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5647933|NCT02734290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5647934|NCT02734290|Antimetabolites|antimetabolites|mesh-ancestor
5647935|NCT02667587|Nivolumab|nivolumab|mesh-list
5647936|NCT02667587|Temozolomide|temozolomide|mesh-list
5647937|NCT02667587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5647938|NCT02667587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647939|NCT02667587|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5822328|NCT02604537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822329|NCT02604537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5647940|NCT02667587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694421|NCT03395587|Temozolomide|temozolomide|mesh-list
5647941|NCT02667587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5647942|NCT02667587|Alkylating Agents|alkylating agents|mesh-ancestor
5647943|NCT02630368|Cyclophosphamide|cyclophosphamide|mesh-list
5822330|NCT02604537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5822331|NCT02604537|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5822332|NCT02604537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5822333|NCT02604537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822334|NCT02604537|Glucocorticoids|glucocorticoids|mesh-ancestor
5822335|NCT02604537|Hormones|hormones|mesh-ancestor
5822336|NCT02604537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5822337|NCT02604537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5822338|NCT02604537|Respiratory System Agents|respiratory system agents|mesh-ancestor
5822339|NCT02604420|Eculizumab|eculizumab|mesh-list
5822340|NCT02604420|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5822341|NCT02604420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5822342|NCT02604420|Immunologic Factors|immunologic factors|mesh-ancestor
5822343|NCT02604420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822344|NCT02604459|Fentanyl|fentanyl|mesh-list
5822345|NCT02604459|Anesthetics|anesthetics|mesh-list
5647944|NCT02630368|Avelumab|avelumab|mesh-list
5647945|NCT02630368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5647946|NCT02630368|Immunologic Factors|immunologic factors|mesh-ancestor
5647947|NCT02630368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647948|NCT02630368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5647949|NCT02630368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5647950|NCT02630368|Alkylating Agents|alkylating agents|mesh-ancestor
5647951|NCT02630368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647952|NCT02630368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647953|NCT02630368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5647954|NCT02630368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5647955|NCT02619682|Lenalidomide|lenalidomide|mesh-list
5647956|NCT02619682|Ixazomib|ixazomib|mesh-list
5822346|NCT02604459|Propofol|propofol|mesh-list
6492862|NCT00610948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5822347|NCT02604459|Sevoflurane|sevoflurane|mesh-list
5822348|NCT02604459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5822349|NCT02604459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822350|NCT02604459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5822351|NCT02604459|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5822352|NCT02604459|Anesthetics, General|anesthetics, general|mesh-ancestor
5822353|NCT02604459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5822354|NCT02604459|Narcotics|narcotics|mesh-ancestor
5822355|NCT02604459|Analgesics|analgesics|mesh-ancestor
5822356|NCT02604459|Sensory System Agents|sensory system agents|mesh-ancestor
5822357|NCT02604459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5822358|NCT02604459|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5822359|NCT02604459|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5822360|NCT02604459|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5822361|NCT02604225|Methoxyflurane|methoxyflurane|mesh-list
5822362|NCT02604225|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5822363|NCT02604225|Anesthetics, General|anesthetics, general|mesh-ancestor
5822364|NCT02604225|Anesthetics|anesthetics|mesh-ancestor
5822365|NCT02604225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5822366|NCT02604225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822367|NCT02604238|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5822368|NCT02604238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5822369|NCT02604238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5822370|NCT02604238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822371|NCT02604186|Botulinum Toxins|botulinum toxins|mesh-list
5822372|NCT02604186|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5822373|NCT02604186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5822374|NCT02604186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822375|NCT02604186|Cholinergic Agents|cholinergic agents|mesh-ancestor
5822376|NCT02604186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5822377|NCT02604186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822378|NCT02604134|Silver Nitrate|silver nitrate|mesh-list
5822379|NCT02604134|Fluorides|fluorides|mesh-list
5822380|NCT02604134|Fluorides, Topical|fluorides, topical|mesh-list
5822381|NCT02604134|Cariostatic Agents|cariostatic agents|mesh-ancestor
5822382|NCT02604134|Protective Agents|protective agents|mesh-ancestor
5822383|NCT02604134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822384|NCT02604134|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5822385|NCT02604134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5822386|NCT02604095|Melatonin|melatonin|mesh-list
6492863|NCT00610948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5647957|NCT02619682|Glycine|glycine|mesh-list
5822387|NCT02604095|Antioxidants|antioxidants|mesh-ancestor
5822388|NCT02604095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822389|NCT02604095|Protective Agents|protective agents|mesh-ancestor
5822390|NCT02604095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822391|NCT02604095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5822392|NCT02604004|Lamivudine|lamivudine|mesh-list
5822393|NCT02604004|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5822394|NCT02604004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6492864|NCT00610948|Immunologic Factors|immunologic factors|mesh-ancestor
6492865|NCT00610948|Antidotes|antidotes|mesh-ancestor
6492866|NCT00610948|Protective Agents|protective agents|mesh-ancestor
6492867|NCT00610948|Vitamin B Complex|vitamin b complex|mesh-ancestor
6492868|NCT00610948|Vitamins|vitamins|mesh-ancestor
6492869|NCT00610948|Micronutrients|micronutrients|mesh-ancestor
5822395|NCT02604004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5822396|NCT02604004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822397|NCT02604004|Antiviral Agents|antiviral agents|mesh-ancestor
5822398|NCT02604004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5822399|NCT02604004|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5822400|NCT02604004|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5822401|NCT02603848|Ibuprofen|ibuprofen|mesh-list
5822402|NCT02603848|Morphine|morphine|mesh-list
5822403|NCT02603848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5822404|NCT02603848|Narcotics|narcotics|mesh-ancestor
5822405|NCT02603848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5822406|NCT02603848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822407|NCT02603848|Analgesics|analgesics|mesh-ancestor
5822408|NCT02603848|Sensory System Agents|sensory system agents|mesh-ancestor
6492870|NCT00610948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6492871|NCT00611000|Folic Acid|folic acid|mesh-list
5822409|NCT02603848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5822410|NCT02603848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5822411|NCT02603848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5822412|NCT02603848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5822413|NCT02603848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5822414|NCT02603848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5822415|NCT02603848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5822416|NCT02603848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822417|NCT02603965|Copper|copper|mesh-list
5822418|NCT02603965|Trace Elements|trace elements|mesh-ancestor
5822419|NCT02603965|Micronutrients|micronutrients|mesh-ancestor
5822420|NCT02603965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822421|NCT02603757|Vitamin D|vitamin d|mesh-list
5822422|NCT02603757|Cholecalciferol|cholecalciferol|mesh-list
5822423|NCT02603757|Vitamins|vitamins|mesh-ancestor
5822424|NCT02603757|Micronutrients|micronutrients|mesh-ancestor
5822425|NCT02603757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822426|NCT02603757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5822427|NCT02603757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5822428|NCT02603822|Indomethacin|indomethacin|mesh-list
5822429|NCT02603822|Mannitol|mannitol|mesh-list
5822430|NCT02603822|Lactulose|lactulose|mesh-list
5822431|NCT02603822|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5822432|NCT02603822|Diuretics|diuretics|mesh-ancestor
5822433|NCT02603822|Natriuretic Agents|natriuretic agents|mesh-ancestor
5822434|NCT02603822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822435|NCT02603822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5822436|NCT02603822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5822437|NCT02603822|Analgesics|analgesics|mesh-ancestor
5822438|NCT02603822|Sensory System Agents|sensory system agents|mesh-ancestor
5822439|NCT02603822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5822440|NCT02603822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5822441|NCT02603822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5822442|NCT02603822|Gout Suppressants|gout suppressants|mesh-ancestor
5822443|NCT02603822|Tocolytic Agents|tocolytic agents|mesh-ancestor
5822444|NCT02603822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5822445|NCT02603822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5822446|NCT02603822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5822447|NCT02603822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822448|NCT02603822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5822449|NCT02603861|Modafinil|modafinil|mesh-list
5822450|NCT02603861|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5822451|NCT02603861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822452|NCT02603861|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
5822453|NCT02603861|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6492872|NCT00611000|Hematinics|hematinics|mesh-ancestor
5822454|NCT02603861|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5822455|NCT02603861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822456|NCT02603783|Capsaicin|capsaicin|mesh-list
5822457|NCT02603783|Antipruritics|antipruritics|mesh-ancestor
5822458|NCT02603783|Dermatologic Agents|dermatologic agents|mesh-ancestor
5822459|NCT02603783|Sensory System Agents|sensory system agents|mesh-ancestor
5822460|NCT02603783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5822461|NCT02603783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901829|NCT02419495|Immunologic Factors|immunologic factors|mesh-ancestor
5901830|NCT02419495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901831|NCT02419495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5901832|NCT02419495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5901833|NCT02419495|Alkylating Agents|alkylating agents|mesh-ancestor
5901834|NCT02419495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5901835|NCT02419495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5901836|NCT02419495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5901837|NCT02419495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5901838|NCT02419495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5901839|NCT02419495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5901840|NCT02419495|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6492873|NCT00611000|Vitamin B Complex|vitamin b complex|mesh-ancestor
5647958|NCT02619682|Immunologic Factors|immunologic factors|mesh-ancestor
5647959|NCT02619682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647960|NCT02619682|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5647961|NCT02619682|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5647962|NCT02619682|Growth Substances|growth substances|mesh-ancestor
5647963|NCT02619682|Growth Inhibitors|growth inhibitors|mesh-ancestor
5647964|NCT02619682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647965|NCT02619682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647966|NCT02619682|Protease Inhibitors|protease inhibitors|mesh-ancestor
5647967|NCT02619682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5647968|NCT02619682|Glycine Agents|glycine agents|mesh-ancestor
5647969|NCT02619682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5647970|NCT02616965|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5647971|NCT02616965|Romidepsin|romidepsin|mesh-list
5901841|NCT02419495|Antimetabolites|antimetabolites|mesh-ancestor
5901842|NCT02419495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5901843|NCT02419495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5901844|NCT02419495|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5901845|NCT02419495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5901846|NCT02419495|Antidotes|antidotes|mesh-ancestor
5901847|NCT02419495|Protective Agents|protective agents|mesh-ancestor
5901848|NCT02419495|Vitamin B Complex|vitamin b complex|mesh-ancestor
5901849|NCT02419495|Vitamins|vitamins|mesh-ancestor
5901850|NCT02419495|Micronutrients|micronutrients|mesh-ancestor
5901851|NCT02419495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5901852|NCT02419495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5901853|NCT02419495|Hematinics|hematinics|mesh-ancestor
5901854|NCT02419495|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5647972|NCT02616965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5647973|NCT02616965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647974|NCT02616965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5647975|NCT02613416|Denosumab|denosumab|mesh-list
5647976|NCT02613416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6492874|NCT00611000|Vitamins|vitamins|mesh-ancestor
5647977|NCT02613416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647978|NCT02601014|Nivolumab|nivolumab|mesh-list
5647979|NCT02601014|Ipilimumab|ipilimumab|mesh-list
5647980|NCT02601014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5647981|NCT02601014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647982|NCT02601014|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5647983|NCT02601014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5647984|NCT02598999|Lactoferrin|lactoferrin|mesh-list
5647985|NCT02598999|Hypothiocyanite ion|hypothiocyanite ion|mesh-list
5647986|NCT02598999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5647987|NCT02588651|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5647988|NCT02588651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5647989|NCT02588651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647990|NCT02581787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5647991|NCT02581787|Antibodies|antibodies|mesh-list
6492875|NCT00611000|Micronutrients|micronutrients|mesh-ancestor
6492876|NCT00611000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492877|NCT00611039|Ritonavir|ritonavir|mesh-list
6492878|NCT00611039|Darunavir|darunavir|mesh-list
6492879|NCT00611039|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6674398|NCT01569113|Ulipristal acetate|ulipristal acetate|mesh-list
6674399|NCT01569113|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
6674400|NCT01569113|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
5822462|NCT02603770|Lovastatin|lovastatin|mesh-list
5822463|NCT02603770|L 647318|l 647318|mesh-list
5822464|NCT02603770|Dihydromevinolin|dihydromevinolin|mesh-list
5822465|NCT02603770|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5822466|NCT02603770|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5822467|NCT02603770|Antimetabolites|antimetabolites|mesh-ancestor
5822468|NCT02603770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822469|NCT02603770|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5822470|NCT02603770|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5822471|NCT02603770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6211563|NCT02174861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211564|NCT02174861|Analgesics|analgesics|mesh-ancestor
6211565|NCT02174861|Sensory System Agents|sensory system agents|mesh-ancestor
6211566|NCT02174861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6211567|NCT02174861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211568|NCT02174913|Fentanyl|fentanyl|mesh-list
6211569|NCT02174913|Propofol|propofol|mesh-list
6211570|NCT02174913|Atracurium|atracurium|mesh-list
6211571|NCT02174913|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6211572|NCT02174913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6211573|NCT02174913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211574|NCT02174913|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6211575|NCT02174913|Anesthetics, General|anesthetics, general|mesh-ancestor
6211576|NCT02174913|Anesthetics|anesthetics|mesh-ancestor
6211577|NCT02174913|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6211578|NCT02174913|Narcotics|narcotics|mesh-ancestor
6211579|NCT02174913|Analgesics|analgesics|mesh-ancestor
6211580|NCT02174913|Sensory System Agents|sensory system agents|mesh-ancestor
6211581|NCT02174913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6211582|NCT02174913|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6211583|NCT02174913|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6211584|NCT02174913|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6211585|NCT02174913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6211586|NCT02174913|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
6211587|NCT02174913|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6211588|NCT02174913|Cholinergic Agents|cholinergic agents|mesh-ancestor
6211589|NCT02174913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6211590|NCT02174913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211591|NCT02175212|Ascorbic Acid|ascorbic acid|mesh-list
5822472|NCT02603991|Levetiracetam|levetiracetam|mesh-list
5822473|NCT02603991|Anticonvulsants|anticonvulsants|mesh-ancestor
5822474|NCT02603991|Nootropic Agents|nootropic agents|mesh-ancestor
5822475|NCT02603705|Oxycodone|oxycodone|mesh-list
5822476|NCT02603705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5822477|NCT02603705|Narcotics|narcotics|mesh-ancestor
5822478|NCT02603705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5822479|NCT02603705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822480|NCT02603705|Analgesics|analgesics|mesh-ancestor
5822481|NCT02603705|Sensory System Agents|sensory system agents|mesh-ancestor
5822482|NCT02603705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5822483|NCT02603406|Epoetin Alfa|epoetin alfa|mesh-list
5822484|NCT02603406|Hematinics|hematinics|mesh-ancestor
5822485|NCT02603510|Insulin Lispro|insulin lispro|mesh-list
5822486|NCT02603510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5822487|NCT02603510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822488|NCT02603575|Caspofungin|caspofungin|mesh-list
5822489|NCT02603575|Sulfanilamide|sulfanilamide|mesh-list
5822490|NCT02603575|Sulfanilamides|sulfanilamides|mesh-list
5822491|NCT02603575|Methylprednisolone|methylprednisolone|mesh-list
5822492|NCT02603575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5822493|NCT02603575|Antiemetics|antiemetics|mesh-ancestor
5822494|NCT02603575|Autonomic Agents|autonomic agents|mesh-ancestor
5822495|NCT02603575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5822496|NCT02603575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822497|NCT02603575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5822498|NCT02603575|Glucocorticoids|glucocorticoids|mesh-ancestor
5822499|NCT02603575|Hormones|hormones|mesh-ancestor
5822500|NCT02603575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5822501|NCT02603575|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5822502|NCT02603575|Protective Agents|protective agents|mesh-ancestor
5822503|NCT02603575|Antifungal Agents|antifungal agents|mesh-ancestor
5822504|NCT02603575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5822505|NCT02603575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6211592|NCT02175212|Methyltestosterone|methyltestosterone|mesh-list
6211593|NCT02175212|Androgens|androgens|mesh-list
5822506|NCT02603575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822507|NCT02603575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5822508|NCT02603445|Idelalisib|idelalisib|mesh-list
5822509|NCT02603445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5822510|NCT02603445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5822511|NCT02603445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822512|NCT02603679|Tamoxifen|tamoxifen|mesh-list
5822513|NCT02603679|Paclitaxel|paclitaxel|mesh-list
5822514|NCT02603679|Letrozole|letrozole|mesh-list
5822515|NCT02603679|Palbociclib|palbociclib|mesh-list
5822516|NCT02603679|Anastrozole|anastrozole|mesh-list
5822517|NCT02603679|Exemestane|exemestane|mesh-list
5822518|NCT02603679|Goserelin|goserelin|mesh-list
5822519|NCT02603679|Aromatase Inhibitors|aromatase inhibitors|mesh-list
6674401|NCT01569113|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6674402|NCT01569113|Contraceptive Agents|contraceptive agents|mesh-ancestor
6674403|NCT01569113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6674404|NCT01569113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674405|NCT01569113|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5822520|NCT02603679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5822521|NCT02603679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5822522|NCT02603679|Tubulin Modulators|tubulin modulators|mesh-ancestor
5822523|NCT02603679|Antimitotic Agents|antimitotic agents|mesh-ancestor
5822524|NCT02603679|Mitosis Modulators|mitosis modulators|mesh-ancestor
5822525|NCT02603679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822526|NCT02603679|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5822527|NCT02603679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5822528|NCT02603679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5822529|NCT02603679|Hormone Antagonists|hormone antagonists|mesh-ancestor
5822530|NCT02603679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5822531|NCT02603679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822532|NCT02603679|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5822533|NCT02603679|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5822534|NCT02603679|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5822535|NCT02603679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5822536|NCT02603679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5822537|NCT02603497|Peficitinib|peficitinib|mesh-list
5822538|NCT02603497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5822539|NCT02603497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822540|NCT02603497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5822541|NCT02603497|Immunologic Factors|immunologic factors|mesh-ancestor
5647992|NCT02581787|Immunoglobulins|immunoglobulins|mesh-list
5647993|NCT02581787|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5822542|NCT02603497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822543|NCT02603315|Mitogens|mitogens|mesh-list
5822544|NCT02603315|Endothelial Growth Factors|endothelial growth factors|mesh-list
5647994|NCT02581787|Immunoglobulin G|immunoglobulin g|mesh-list
5647995|NCT02581787|Immunologic Factors|immunologic factors|mesh-ancestor
5647996|NCT02581787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5647997|NCT02581787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5647998|NCT02581085|Tocotrienols|tocotrienols|mesh-list
5647999|NCT02581085|Vitamin E|vitamin e|mesh-list
5648000|NCT02581085|Tocopherols|tocopherols|mesh-list
5648001|NCT02581085|Antioxidants|antioxidants|mesh-ancestor
5648002|NCT02581085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648003|NCT02581085|Protective Agents|protective agents|mesh-ancestor
5648004|NCT02581085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648005|NCT02581085|Vitamins|vitamins|mesh-ancestor
5648006|NCT02581085|Micronutrients|micronutrients|mesh-ancestor
5648007|NCT02579096|Allopurinol|allopurinol|mesh-list
5648008|NCT02579096|Febuxostat|febuxostat|mesh-list
5648009|NCT02579096|Antimetabolites|antimetabolites|mesh-ancestor
5648010|NCT02579096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648011|NCT02579096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5822545|NCT02603315|Mitosis Modulators|mitosis modulators|mesh-ancestor
5822546|NCT02603315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822547|NCT02603315|Growth Substances|growth substances|mesh-ancestor
5822548|NCT02603315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822549|NCT02603068|Treprostinil|treprostinil|mesh-list
5822550|NCT02603068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5822551|NCT02603159|Capecitabine|capecitabine|mesh-list
5822552|NCT02603159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5822553|NCT02603159|Antimetabolites|antimetabolites|mesh-ancestor
5648012|NCT02579096|Gout Suppressants|gout suppressants|mesh-ancestor
5648013|NCT02579096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5822554|NCT02603159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822555|NCT02603159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5822556|NCT02603003|Pemetrexed|pemetrexed|mesh-list
5822557|NCT02603003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5822558|NCT02603003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5822559|NCT02603003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822560|NCT02603003|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5648014|NCT02579096|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5648015|NCT02579096|Antioxidants|antioxidants|mesh-ancestor
5648016|NCT02579096|Protective Agents|protective agents|mesh-ancestor
5648017|NCT02579096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648018|NCT02577406|Cytarabine|cytarabine|mesh-list
5648019|NCT02577406|Azacitidine|azacitidine|mesh-list
5648020|NCT02577406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5648021|NCT02577406|Antimetabolites|antimetabolites|mesh-ancestor
5648022|NCT02577406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648023|NCT02577406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5648024|NCT02577406|Antiviral Agents|antiviral agents|mesh-ancestor
5648025|NCT02577406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5648026|NCT02577406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5648027|NCT02577406|Immunologic Factors|immunologic factors|mesh-ancestor
5648028|NCT02577406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648029|NCT02577406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5648030|NCT02568553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5648031|NCT02568553|Lenalidomide|lenalidomide|mesh-list
5648032|NCT02568553|Blinatumomab|blinatumomab|mesh-list
5648033|NCT02568553|Antibodies|antibodies|mesh-list
5648034|NCT02568553|Immunoglobulins|immunoglobulins|mesh-list
5822561|NCT02603003|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5822562|NCT02603081|Ebselen|ebselen|mesh-list
5822563|NCT02603081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5822564|NCT02603081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5822565|NCT02603081|Analgesics|analgesics|mesh-ancestor
5822566|NCT02603081|Sensory System Agents|sensory system agents|mesh-ancestor
5822567|NCT02603081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5822568|NCT02603081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822569|NCT02603081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5822570|NCT02603081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5822571|NCT02603081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5822572|NCT02603081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5822573|NCT02603081|Antioxidants|antioxidants|mesh-ancestor
5822574|NCT02603081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822575|NCT02603081|Protective Agents|protective agents|mesh-ancestor
5822576|NCT02603081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5822577|NCT02603081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5822578|NCT02603081|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5822579|NCT02603276|Red yeast rice|red yeast rice|mesh-list
5822580|NCT02603276|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5822581|NCT02603276|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5648035|NCT02568553|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5648036|NCT02568553|Muromonab-CD3|muromonab-cd3|mesh-list
5822582|NCT02603276|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5822583|NCT02603276|Antimetabolites|antimetabolites|mesh-ancestor
5822584|NCT02603276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822585|NCT02603276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5822586|NCT02603276|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5822587|NCT02602938|Aspirin|aspirin|mesh-list
5822588|NCT02602938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5822589|NCT02602938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5822590|NCT02602938|Analgesics|analgesics|mesh-ancestor
5822591|NCT02602938|Sensory System Agents|sensory system agents|mesh-ancestor
5822592|NCT02602938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5648037|NCT02568553|Antibodies, Bispecific|antibodies, bispecific|mesh-list
5648038|NCT02568553|Immunologic Factors|immunologic factors|mesh-ancestor
5648039|NCT02568553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648040|NCT02568553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5648041|NCT02568553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5648042|NCT02568553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5648043|NCT02568553|Growth Substances|growth substances|mesh-ancestor
5648044|NCT02568553|Growth Inhibitors|growth inhibitors|mesh-ancestor
5648045|NCT02568553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5648046|NCT02545868|Vaccines|vaccines|mesh-list
5822593|NCT02602938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648047|NCT02545868|Immunologic Factors|immunologic factors|mesh-ancestor
5648048|NCT02545868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648049|NCT02538666|Nivolumab|nivolumab|mesh-list
5822594|NCT02602938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5822595|NCT02602938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5822596|NCT02602938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5822597|NCT02602938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5822598|NCT02602938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822599|NCT02602938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5822600|NCT02602938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5822601|NCT02602938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5822602|NCT02602938|Antipyretics|antipyretics|mesh-ancestor
5822603|NCT02603198|Epinephrine|epinephrine|mesh-list
5822604|NCT02603198|Nordefrin|nordefrin|mesh-list
5822605|NCT02603198|Anesthetics|anesthetics|mesh-list
5822606|NCT02603198|Mepivacaine|mepivacaine|mesh-list
5822607|NCT02603198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5822608|NCT02603198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822609|NCT02603198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5822610|NCT02603198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5822611|NCT02603198|Adrenergic Agents|adrenergic agents|mesh-ancestor
5822612|NCT02603198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5822613|NCT02603198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822614|NCT02603198|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5822615|NCT02603198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5822616|NCT02603198|Autonomic Agents|autonomic agents|mesh-ancestor
5822617|NCT02603198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5822618|NCT02603198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5648050|NCT02538666|Ipilimumab|ipilimumab|mesh-list
5648051|NCT02538666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5648052|NCT02538666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5822619|NCT02603198|Respiratory System Agents|respiratory system agents|mesh-ancestor
5822620|NCT02603198|Mydriatics|mydriatics|mesh-ancestor
5822621|NCT02603198|Sympathomimetics|sympathomimetics|mesh-ancestor
5822622|NCT02603198|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5822623|NCT02603198|Anesthetics, Local|anesthetics, local|mesh-ancestor
5822624|NCT02603198|Sensory System Agents|sensory system agents|mesh-ancestor
5822625|NCT02603055|Vaccines|vaccines|mesh-list
5822626|NCT02603055|Immunologic Factors|immunologic factors|mesh-ancestor
5822627|NCT02603055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822628|NCT02602860|Levetiracetam|levetiracetam|mesh-list
5822629|NCT02602860|Brivaracetam|brivaracetam|mesh-list
5822630|NCT02602860|Anticonvulsants|anticonvulsants|mesh-ancestor
5822631|NCT02602860|Nootropic Agents|nootropic agents|mesh-ancestor
5822632|NCT02602743|Ketamine|ketamine|mesh-list
5822633|NCT02602743|Remifentanil|remifentanil|mesh-list
5822634|NCT02602743|Propofol|propofol|mesh-list
5822635|NCT02602743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5822636|NCT02602743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5648053|NCT02538666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5648054|NCT02538666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648055|NCT02527200|Liraglutide|liraglutide|mesh-list
5648056|NCT02527200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5648057|NCT02527200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648058|NCT02527200|Incretins|incretins|mesh-ancestor
5648059|NCT02527200|Hormones|hormones|mesh-ancestor
5648060|NCT02527200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5648061|NCT02516696|Clarithromycin|clarithromycin|mesh-list
5648062|NCT02516696|Dexamethasone|dexamethasone|mesh-list
5648063|NCT02516696|Lenalidomide|lenalidomide|mesh-list
5648064|NCT02516696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5648065|NCT02516696|Antiemetics|antiemetics|mesh-ancestor
5648066|NCT02516696|Autonomic Agents|autonomic agents|mesh-ancestor
5648067|NCT02516696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5648068|NCT02516696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648069|NCT02516696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5648070|NCT02516696|Glucocorticoids|glucocorticoids|mesh-ancestor
5648071|NCT02516696|Hormones|hormones|mesh-ancestor
5648072|NCT02516696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5822637|NCT02602743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822638|NCT02602743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5822639|NCT02602743|Anesthetics, General|anesthetics, general|mesh-ancestor
5822640|NCT02602743|Anesthetics|anesthetics|mesh-ancestor
5822641|NCT02602743|Analgesics|analgesics|mesh-ancestor
5822642|NCT02602743|Sensory System Agents|sensory system agents|mesh-ancestor
5822643|NCT02602743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5822644|NCT02602743|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5822645|NCT02602743|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5822646|NCT02602743|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5822647|NCT02602743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5648073|NCT02516696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5648074|NCT02516696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5648075|NCT02516696|Immunologic Factors|immunologic factors|mesh-ancestor
5648076|NCT02516696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5648077|NCT02516696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6492880|NCT00611039|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5822648|NCT02602743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822649|NCT02602743|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5822650|NCT02602743|Narcotics|narcotics|mesh-ancestor
5822651|NCT02602652|Vaccines|vaccines|mesh-list
5822652|NCT02602652|Immunologic Factors|immunologic factors|mesh-ancestor
5648078|NCT02516696|Growth Substances|growth substances|mesh-ancestor
5648079|NCT02516696|Growth Inhibitors|growth inhibitors|mesh-ancestor
5648080|NCT02516696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5648081|NCT02516696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6492881|NCT00611039|Protease Inhibitors|protease inhibitors|mesh-ancestor
5648082|NCT02516696|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5648083|NCT02516696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5648084|NCT02516696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648085|NCT02516696|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5648086|NCT02516696|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5648087|NCT02511106|Osimertinib|osimertinib|mesh-list
5648088|NCT02511106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5648089|NCT02511106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5648090|NCT02511106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5648091|NCT02511106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648092|NCT02491099|Afatinib|afatinib|mesh-list
5648093|NCT02491099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648094|NCT02491099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5648095|NCT02491099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5648096|NCT02491099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5648097|NCT02476058|Diphenhydramine|diphenhydramine|mesh-list
5648098|NCT02476058|Promethazine|promethazine|mesh-list
5648099|NCT02476058|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5648100|NCT02476058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5648101|NCT02476058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5648102|NCT02476058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648103|NCT02476058|Anesthetics, Local|anesthetics, local|mesh-ancestor
5648104|NCT02476058|Anesthetics|anesthetics|mesh-ancestor
5648105|NCT02476058|Sensory System Agents|sensory system agents|mesh-ancestor
5648106|NCT02476058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5648107|NCT02476058|Antiemetics|antiemetics|mesh-ancestor
5822653|NCT02602652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822654|NCT02602704|Bazedoxifene|bazedoxifene|mesh-list
5822655|NCT02602704|Calcium|calcium|mesh-list
5822656|NCT02602704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5822657|NCT02602704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822658|NCT02602704|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5822659|NCT02602704|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5822660|NCT02602704|Hormone Antagonists|hormone antagonists|mesh-ancestor
5822661|NCT02602704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5822662|NCT02602704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5822663|NCT02602600|Liraglutide|liraglutide|mesh-list
5822664|NCT02602600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5822665|NCT02602600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822666|NCT02602600|Incretins|incretins|mesh-ancestor
5822667|NCT02602600|Hormones|hormones|mesh-ancestor
5822668|NCT02602600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5648108|NCT02476058|Autonomic Agents|autonomic agents|mesh-ancestor
5648109|NCT02476058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5648110|NCT02476058|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5648111|NCT02476058|Histamine Antagonists|histamine antagonists|mesh-ancestor
5648112|NCT02476058|Histamine Agents|histamine agents|mesh-ancestor
5648113|NCT02476058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5822669|NCT02602444|Ticagrelor|ticagrelor|mesh-list
5822670|NCT02602444|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5822671|NCT02602444|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5822672|NCT02602444|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5822673|NCT02602444|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5822674|NCT02602444|Purinergic Agents|purinergic agents|mesh-ancestor
6492882|NCT00611039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6492883|NCT00611039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492884|NCT00611039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5822675|NCT02602444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5822676|NCT02602444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822677|NCT02602444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822678|NCT02602509|Rifampin|rifampin|mesh-list
5822679|NCT02602509|Pyrazinamide|pyrazinamide|mesh-list
5822680|NCT02602509|Celecoxib|celecoxib|mesh-list
5822681|NCT02602509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5822682|NCT02602509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5822683|NCT02602509|Analgesics|analgesics|mesh-ancestor
5822684|NCT02602509|Sensory System Agents|sensory system agents|mesh-ancestor
5822685|NCT02602509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5822686|NCT02602509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822687|NCT02602509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5648114|NCT02476058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648115|NCT02476058|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5648116|NCT02476058|Antipruritics|antipruritics|mesh-ancestor
5648117|NCT02476058|Dermatologic Agents|dermatologic agents|mesh-ancestor
5648118|NCT02451553|Capecitabine|capecitabine|mesh-list
5648119|NCT02451553|Afatinib|afatinib|mesh-list
5648120|NCT02451553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5648121|NCT02451553|Antimetabolites|antimetabolites|mesh-ancestor
5648122|NCT02451553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648123|NCT02451553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5648124|NCT02451553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5648125|NCT02451553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5648126|NCT02432209|Orlistat|orlistat|mesh-list
5648127|NCT02432209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5648128|NCT02432209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648129|NCT02432209|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5648130|NCT02432209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5694422|NCT03395587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5694423|NCT03395587|Alkylating Agents|alkylating agents|mesh-ancestor
5694424|NCT03395587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694425|NCT03395587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5694426|NCT03395574|Terlipressin|terlipressin|mesh-list
5694427|NCT03395574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5694428|NCT03395574|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5694429|NCT03395470|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5694430|NCT03395470|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5694431|NCT03395470|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5694432|NCT03395470|Antimetabolites|antimetabolites|mesh-ancestor
5694433|NCT03395470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694434|NCT03395470|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5694435|NCT03395470|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5694436|NCT03395470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5694437|NCT03395405|Nitazoxanide|nitazoxanide|mesh-list
5694438|NCT03395405|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5694439|NCT03395405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5694440|NCT03395392|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
5694441|NCT03395392|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5694442|NCT03395392|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5694443|NCT03395392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5694444|NCT03395392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694445|NCT03395392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5694446|NCT03395392|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5694447|NCT03395392|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5694448|NCT03395392|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5694449|NCT03395392|Adrenergic Agents|adrenergic agents|mesh-ancestor
5694450|NCT03395392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5694451|NCT03395392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694452|NCT03395392|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5694453|NCT03395392|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5694454|NCT03395392|Serotonin Agents|serotonin agents|mesh-ancestor
5694455|NCT03395392|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5694456|NCT03395392|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5694457|NCT03395392|Dopamine Agents|dopamine agents|mesh-ancestor
5694458|NCT03395262|Caffeine|caffeine|mesh-list
5694459|NCT03395262|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5822688|NCT02602509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5822689|NCT02602509|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5822690|NCT02602509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5822691|NCT02602509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5822692|NCT02602509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822693|NCT02602509|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5822694|NCT02602509|Antitubercular Agents|antitubercular agents|mesh-ancestor
5822695|NCT02602509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5822696|NCT02602509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5822697|NCT02602509|Leprostatic Agents|leprostatic agents|mesh-ancestor
5822698|NCT02602509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5822699|NCT02602509|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5822700|NCT02602509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5822701|NCT02602509|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5822702|NCT02602509|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5822703|NCT02602509|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5822704|NCT02602509|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5822705|NCT02602470|Metronidazole|metronidazole|mesh-list
5822706|NCT02602470|Azelaic acid|azelaic acid|mesh-list
5822707|NCT02602470|Brimonidine Tartrate|brimonidine tartrate|mesh-list
5822708|NCT02602470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5822709|NCT02602470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5822710|NCT02602470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5822711|NCT02602470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5822712|NCT02602470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5822713|NCT02602470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5822714|NCT02602470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5822715|NCT02602470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5822716|NCT02602470|Adrenergic Agents|adrenergic agents|mesh-ancestor
6674406|NCT01569113|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6674407|NCT01569113|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6674408|NCT01569113|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6674409|NCT01569113|Estrogens|estrogens|mesh-ancestor
6674410|NCT01569113|Hormones|hormones|mesh-ancestor
5822717|NCT02602470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5822718|NCT02602470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822719|NCT02602470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648131|NCT02422381|Gemcitabine|gemcitabine|mesh-list
5648132|NCT02422381|Pembrolizumab|pembrolizumab|mesh-list
5648133|NCT02422381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5648134|NCT02422381|Antimetabolites|antimetabolites|mesh-ancestor
5648135|NCT02422381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648136|NCT02422381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5648137|NCT02422381|Antiviral Agents|antiviral agents|mesh-ancestor
5648138|NCT02422381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5648139|NCT02422381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5648140|NCT02422381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6211594|NCT02175212|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6211595|NCT02175212|Hormones|hormones|mesh-ancestor
6211596|NCT02175212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5648141|NCT02422381|Immunologic Factors|immunologic factors|mesh-ancestor
5648142|NCT02422381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648143|NCT02422381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5648144|NCT02418195|Ketamine|ketamine|mesh-list
5648145|NCT02418195|Analgesics|analgesics|mesh-ancestor
5648146|NCT02418195|Sensory System Agents|sensory system agents|mesh-ancestor
5648147|NCT02418195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5648148|NCT02418195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648149|NCT02418195|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5648150|NCT02418195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5648151|NCT02418195|Anesthetics, General|anesthetics, general|mesh-ancestor
5648152|NCT02418195|Anesthetics|anesthetics|mesh-ancestor
5822720|NCT02602470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5822721|NCT02602470|Dermatologic Agents|dermatologic agents|mesh-ancestor
5822722|NCT02602483|Ascorbic Acid|ascorbic acid|mesh-list
5822723|NCT02602483|Ibuprofen|ibuprofen|mesh-list
5822724|NCT02602483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5822725|NCT02602483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5822726|NCT02602483|Analgesics|analgesics|mesh-ancestor
5822727|NCT02602483|Sensory System Agents|sensory system agents|mesh-ancestor
5822728|NCT02602483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5822729|NCT02602483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822730|NCT02602483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5822731|NCT02602483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6675599|NCT01576627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648153|NCT02418195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5648154|NCT02418195|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5648155|NCT02418195|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5648156|NCT02418195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5822732|NCT02602483|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5822733|NCT02602483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5822734|NCT02602483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822735|NCT02602483|Antioxidants|antioxidants|mesh-ancestor
5822736|NCT02602483|Protective Agents|protective agents|mesh-ancestor
5822737|NCT02602483|Vitamins|vitamins|mesh-ancestor
5822738|NCT02602483|Micronutrients|micronutrients|mesh-ancestor
5648157|NCT02418195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648158|NCT02392637|Gemcitabine|gemcitabine|mesh-list
5648159|NCT02392637|Paclitaxel|paclitaxel|mesh-list
5648160|NCT02392637|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5648161|NCT02392637|Cisplatin|cisplatin|mesh-list
5648162|NCT02392637|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5648163|NCT02392637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5648164|NCT02392637|Tubulin Modulators|tubulin modulators|mesh-ancestor
5648165|NCT02392637|Antimitotic Agents|antimitotic agents|mesh-ancestor
5648166|NCT02392637|Mitosis Modulators|mitosis modulators|mesh-ancestor
5648167|NCT02392637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648168|NCT02392637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5648169|NCT02392637|Antimetabolites|antimetabolites|mesh-ancestor
5648170|NCT02392637|Antiviral Agents|antiviral agents|mesh-ancestor
5697949|NCT03372473|Hormone Antagonists|hormone antagonists|mesh-ancestor
5822739|NCT02602197|Acetaminophen|acetaminophen|mesh-list
5822740|NCT02602197|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
5822741|NCT02602197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5822742|NCT02602197|Analgesics|analgesics|mesh-ancestor
5822743|NCT02602197|Sensory System Agents|sensory system agents|mesh-ancestor
5822744|NCT02602197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5822745|NCT02602197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822746|NCT02602197|Antipyretics|antipyretics|mesh-ancestor
5822747|NCT02602197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5822748|NCT02602197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5822749|NCT02602197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5822750|NCT02602210|Hydrocortisone|hydrocortisone|mesh-list
5822751|NCT02602210|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
5822752|NCT02602210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6492885|NCT00611039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6492886|NCT00611039|Antiviral Agents|antiviral agents|mesh-ancestor
6492887|NCT00611039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6492888|NCT00611039|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5822753|NCT02602002|Remifentanil|remifentanil|mesh-list
5822754|NCT02602002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5822755|NCT02602002|Narcotics|narcotics|mesh-ancestor
5822756|NCT02602002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5822757|NCT02602002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822758|NCT02602002|Analgesics|analgesics|mesh-ancestor
5822759|NCT02602002|Sensory System Agents|sensory system agents|mesh-ancestor
5822760|NCT02602002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5901855|NCT02312557|Pembrolizumab|pembrolizumab|mesh-list
5901856|NCT02312557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5901857|NCT02312557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901858|NCT02247349|Nivolumab|nivolumab|mesh-list
5901859|NCT02247349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5822761|NCT02602301|Oxytocin|oxytocin|mesh-list
5822762|NCT02602301|Oxytocics|oxytocics|mesh-ancestor
5822763|NCT02602301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5822764|NCT02602301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822765|NCT02601989|Tadalafil|tadalafil|mesh-list
5822766|NCT02601989|Vasodilator Agents|vasodilator agents|mesh-ancestor
5822767|NCT02601989|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5822768|NCT02601989|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5822769|NCT02601989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5822770|NCT02601989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822771|NCT02601989|Urological Agents|urological agents|mesh-ancestor
5822772|NCT02602028|Colchicine|colchicine|mesh-list
5822773|NCT02602028|Gout Suppressants|gout suppressants|mesh-ancestor
5822774|NCT02602028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5822775|NCT02602028|Tubulin Modulators|tubulin modulators|mesh-ancestor
5822776|NCT02602028|Antimitotic Agents|antimitotic agents|mesh-ancestor
5648171|NCT02392637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5648172|NCT02392637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5648173|NCT02392637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5648174|NCT02392637|Immunologic Factors|immunologic factors|mesh-ancestor
5648175|NCT02392637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648176|NCT02376699|Gemcitabine|gemcitabine|mesh-list
5648177|NCT02376699|Paclitaxel|paclitaxel|mesh-list
5648178|NCT02376699|Pembrolizumab|pembrolizumab|mesh-list
5648179|NCT02376699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5648180|NCT02376699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5648181|NCT02376699|Tubulin Modulators|tubulin modulators|mesh-ancestor
5648182|NCT02376699|Antimitotic Agents|antimitotic agents|mesh-ancestor
5648183|NCT02376699|Mitosis Modulators|mitosis modulators|mesh-ancestor
5648184|NCT02376699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648185|NCT02376699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5648186|NCT02376699|Antimetabolites|antimetabolites|mesh-ancestor
5648187|NCT02376699|Antiviral Agents|antiviral agents|mesh-ancestor
5648188|NCT02376699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5648189|NCT02376699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5648190|NCT02376699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5648191|NCT02376699|Immunologic Factors|immunologic factors|mesh-ancestor
5648192|NCT02376699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648193|NCT02376699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5648194|NCT02372630|Linagliptin|linagliptin|mesh-list
5822777|NCT02602028|Mitosis Modulators|mitosis modulators|mesh-ancestor
5822778|NCT02602028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822779|NCT02602028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5822780|NCT02602288|Nicotine|nicotine|mesh-list
5822781|NCT02602288|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5822782|NCT02602288|Autonomic Agents|autonomic agents|mesh-ancestor
5822783|NCT02602288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5822784|NCT02602288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822785|NCT02602288|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5822786|NCT02602288|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5822787|NCT02602288|Cholinergic Agents|cholinergic agents|mesh-ancestor
5822788|NCT02602288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5822789|NCT02602288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822790|NCT02601859|Lithium Carbonate|lithium carbonate|mesh-list
5822791|NCT02601859|Antidepressive Agents|antidepressive agents|mesh-ancestor
5822792|NCT02601859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5822793|NCT02601859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5822794|NCT02601859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822795|NCT02601859|Antimanic Agents|antimanic agents|mesh-ancestor
5822796|NCT02601859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5822797|NCT02601859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5822798|NCT02601859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822799|NCT02601911|Acetaminophen|acetaminophen|mesh-list
5822800|NCT02601911|Ketorolac|ketorolac|mesh-list
5822801|NCT02601911|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
5822802|NCT02601911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5822803|NCT02601911|Analgesics|analgesics|mesh-ancestor
5822804|NCT02601911|Sensory System Agents|sensory system agents|mesh-ancestor
5822805|NCT02601911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5822806|NCT02601911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822807|NCT02601911|Antipyretics|antipyretics|mesh-ancestor
5822808|NCT02601911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5822809|NCT02601911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5822810|NCT02601911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5648195|NCT02372630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5822811|NCT02601911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5648196|NCT02372630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648197|NCT02372630|Incretins|incretins|mesh-ancestor
5648198|NCT02372630|Hormones|hormones|mesh-ancestor
5648199|NCT02372630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5648200|NCT02372630|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5648201|NCT02372630|Protease Inhibitors|protease inhibitors|mesh-ancestor
5648202|NCT02372630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5648203|NCT02372630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648204|NCT02341014|Lenalidomide|lenalidomide|mesh-list
5648205|NCT02341014|Romidepsin|romidepsin|mesh-list
5648206|NCT02341014|Immunologic Factors|immunologic factors|mesh-ancestor
5648207|NCT02341014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648208|NCT02341014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5648209|NCT02341014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5648210|NCT02341014|Growth Substances|growth substances|mesh-ancestor
5648211|NCT02341014|Growth Inhibitors|growth inhibitors|mesh-ancestor
5648212|NCT02341014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5648213|NCT02341014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5648214|NCT02292706|Sofosbuvir|sofosbuvir|mesh-list
5648215|NCT02292706|Antiviral Agents|antiviral agents|mesh-ancestor
5648216|NCT02292706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5648217|NCT02270814|Paclitaxel|paclitaxel|mesh-list
5822812|NCT02601911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5822813|NCT02601911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822814|NCT02601963|Minocycline|minocycline|mesh-list
5822815|NCT02601963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5822816|NCT02601963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5822817|NCT02601924|Anesthetics|anesthetics|mesh-list
5822818|NCT02601924|Anesthetics, Local|anesthetics, local|mesh-list
5822819|NCT02601924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5822820|NCT02601924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822821|NCT02601924|Sensory System Agents|sensory system agents|mesh-ancestor
5822822|NCT02601924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5822823|NCT02601898|Thioctic Acid|thioctic acid|mesh-list
5822824|NCT02601898|Progesterone|progesterone|mesh-list
5822825|NCT02601898|Progestins|progestins|mesh-ancestor
5822826|NCT02601898|Hormones|hormones|mesh-ancestor
5822827|NCT02601898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5822828|NCT02601898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822829|NCT02601898|Antioxidants|antioxidants|mesh-ancestor
5822830|NCT02601898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822831|NCT02601898|Protective Agents|protective agents|mesh-ancestor
5822832|NCT02601898|Vitamin B Complex|vitamin b complex|mesh-ancestor
5822833|NCT02601898|Vitamins|vitamins|mesh-ancestor
5648218|NCT02270814|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5648219|NCT02270814|Cisplatin|cisplatin|mesh-list
5648220|NCT02270814|Carboplatin|carboplatin|mesh-list
5648221|NCT02270814|Cetuximab|cetuximab|mesh-list
5648222|NCT02270814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5648223|NCT02270814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5648224|NCT02270814|Tubulin Modulators|tubulin modulators|mesh-ancestor
5648225|NCT02270814|Antimitotic Agents|antimitotic agents|mesh-ancestor
5648226|NCT02270814|Mitosis Modulators|mitosis modulators|mesh-ancestor
5648227|NCT02270814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648228|NCT02270814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5648229|NCT02253316|Dexamethasone|dexamethasone|mesh-list
5648230|NCT02253316|Dexamethasone acetate|dexamethasone acetate|mesh-list
5648231|NCT02253316|Lenalidomide|lenalidomide|mesh-list
5648232|NCT02253316|Ixazomib|ixazomib|mesh-list
5648233|NCT02253316|BB 1101|bb 1101|mesh-list
5648234|NCT02253316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5648235|NCT02253316|Antiemetics|antiemetics|mesh-ancestor
5648236|NCT02253316|Autonomic Agents|autonomic agents|mesh-ancestor
5648237|NCT02253316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5648238|NCT02253316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648239|NCT02253316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5822834|NCT02601898|Micronutrients|micronutrients|mesh-ancestor
5822835|NCT02601677|Fluoxetine|fluoxetine|mesh-list
5822836|NCT02601677|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5822837|NCT02601677|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5822838|NCT02601677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5822839|NCT02601677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822840|NCT02601677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5648240|NCT02253316|Glucocorticoids|glucocorticoids|mesh-ancestor
5648241|NCT02253316|Hormones|hormones|mesh-ancestor
5694460|NCT03395262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822841|NCT02601677|Serotonin Agents|serotonin agents|mesh-ancestor
5822842|NCT02601677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822843|NCT02601677|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5822844|NCT02601677|Antidepressive Agents|antidepressive agents|mesh-ancestor
5822845|NCT02601677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5822846|NCT02601677|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5822847|NCT02601677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5822848|NCT02601677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5822849|NCT02601703|Tacrolimus|tacrolimus|mesh-list
5822850|NCT02601703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5822851|NCT02601703|Immunologic Factors|immunologic factors|mesh-ancestor
5648242|NCT02253316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5648243|NCT02253316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5648244|NCT02253316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5648245|NCT02253316|Protease Inhibitors|protease inhibitors|mesh-ancestor
5648246|NCT02253316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5648247|NCT02253316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648248|NCT02253316|Immunologic Factors|immunologic factors|mesh-ancestor
5648249|NCT02253316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5648250|NCT02253316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5822852|NCT02601703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822853|NCT02601703|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5822854|NCT02601703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5822855|NCT02601703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822856|NCT02601651|Lidocaine|lidocaine|mesh-list
5822857|NCT02601651|Anesthetics, Local|anesthetics, local|mesh-ancestor
5822858|NCT02601651|Anesthetics|anesthetics|mesh-ancestor
5822859|NCT02601651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5822860|NCT02601651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822861|NCT02601651|Sensory System Agents|sensory system agents|mesh-ancestor
5822862|NCT02601651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5822863|NCT02601651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5822864|NCT02601651|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5822865|NCT02601651|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5822866|NCT02601651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5822867|NCT02601651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822868|NCT02601586|Oxycodone|oxycodone|mesh-list
5822869|NCT02601586|Levodopa|levodopa|mesh-list
5822870|NCT02601586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5822871|NCT02601586|Narcotics|narcotics|mesh-ancestor
5822872|NCT02601586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5822873|NCT02601586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822874|NCT02601586|Analgesics|analgesics|mesh-ancestor
5822875|NCT02601586|Sensory System Agents|sensory system agents|mesh-ancestor
5822876|NCT02601586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5822877|NCT02601586|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5648251|NCT02253316|Growth Substances|growth substances|mesh-ancestor
5648252|NCT02253316|Growth Inhibitors|growth inhibitors|mesh-ancestor
5648253|NCT02245230|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
5648254|NCT02245230|Trimethaphan|trimethaphan|mesh-list
5648255|NCT02245230|Phenylephrine|phenylephrine|mesh-list
5648256|NCT02245230|Oxymetazoline|oxymetazoline|mesh-list
5822878|NCT02601586|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5822879|NCT02601586|Dopamine Agents|dopamine agents|mesh-ancestor
5822880|NCT02601586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5822881|NCT02601586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822882|NCT02601508|Rocuronium|rocuronium|mesh-list
5822883|NCT02601508|Atracurium|atracurium|mesh-list
5822884|NCT02601508|Cisatracurium|cisatracurium|mesh-list
5822885|NCT02601508|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5822886|NCT02601508|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5822887|NCT02601508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5822888|NCT02601508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5822889|NCT02601508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822890|NCT02601508|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
5822891|NCT02601508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5822892|NCT02601508|Cholinergic Agents|cholinergic agents|mesh-ancestor
5822893|NCT02601508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5648257|NCT02245230|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
5648258|NCT02245230|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5648259|NCT02245230|Mydriatics|mydriatics|mesh-ancestor
5648260|NCT02245230|Autonomic Agents|autonomic agents|mesh-ancestor
5648261|NCT02245230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5648262|NCT02245230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648263|NCT02245230|Sympathomimetics|sympathomimetics|mesh-ancestor
5648264|NCT02245230|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5648265|NCT02245230|Nasal Decongestants|nasal decongestants|mesh-ancestor
5648266|NCT02245230|Respiratory System Agents|respiratory system agents|mesh-ancestor
5822894|NCT02601508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822895|NCT02601365|Molgramostim|molgramostim|mesh-list
5822896|NCT02601365|Sargramostim|sargramostim|mesh-list
5822897|NCT02601365|Immunologic Factors|immunologic factors|mesh-ancestor
5822898|NCT02601365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822899|NCT02601365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5822900|NCT02601287|Botulinum Toxins|botulinum toxins|mesh-list
5822901|NCT02601287|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5822902|NCT02601287|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5822903|NCT02601287|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5822904|NCT02601287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5822905|NCT02601287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822906|NCT02601287|Cholinergic Agents|cholinergic agents|mesh-ancestor
5822907|NCT02601287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5822908|NCT02601287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648267|NCT02245230|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5648268|NCT02245230|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5648269|NCT02245230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5648270|NCT02245230|Adrenergic Agents|adrenergic agents|mesh-ancestor
5648271|NCT02245230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5648272|NCT02245230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648273|NCT02245230|Protective Agents|protective agents|mesh-ancestor
5648274|NCT02245230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5648275|NCT02245230|Vasodilator Agents|vasodilator agents|mesh-ancestor
5648276|NCT02245230|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5648277|NCT02245230|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
5648278|NCT02245230|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
5648279|NCT02245230|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5648280|NCT02245230|Cholinergic Agents|cholinergic agents|mesh-ancestor
5648281|NCT02224573|Cannabidiol|cannabidiol|mesh-list
5648282|NCT02224573|Anticonvulsants|anticonvulsants|mesh-ancestor
5648283|NCT02164643|Flutemetamol|flutemetamol|mesh-list
5648284|NCT02164643|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5648285|NCT02164643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648286|NCT02155920|Everolimus|everolimus|mesh-list
5648287|NCT02155920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5648288|NCT02155920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5648289|NCT02155920|Immunologic Factors|immunologic factors|mesh-ancestor
5648290|NCT02155920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648291|NCT02130492|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5648292|NCT02130492|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5648293|NCT02130492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648294|NCT02123823|Everolimus|everolimus|mesh-list
5648295|NCT02123823|Exemestane|exemestane|mesh-list
5648296|NCT02123823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5648297|NCT02123823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5648298|NCT02123823|Immunologic Factors|immunologic factors|mesh-ancestor
5648299|NCT02123823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648300|NCT02123823|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5648301|NCT02123823|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5648302|NCT02123823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5648303|NCT02123823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648304|NCT02123823|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5648305|NCT02123823|Hormone Antagonists|hormone antagonists|mesh-ancestor
5822909|NCT02601287|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5822910|NCT02601287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5822911|NCT02601157|Aspirin|aspirin|mesh-list
5822912|NCT02601157|Sirolimus|sirolimus|mesh-list
5822913|NCT02601157|Clopidogrel|clopidogrel|mesh-list
5822914|NCT02601157|Ticagrelor|ticagrelor|mesh-list
5822915|NCT02601157|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
5822916|NCT02601157|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5648306|NCT02123823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5648307|NCT02085148|Irinotecan|irinotecan|mesh-list
5648308|NCT02085148|Vincristine|vincristine|mesh-list
5648309|NCT02085148|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5648310|NCT02085148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5648311|NCT02085148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5648312|NCT02085148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648313|NCT02085148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5648314|NCT02085148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5822917|NCT02601157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5822918|NCT02601157|Analgesics|analgesics|mesh-ancestor
5822919|NCT02601157|Sensory System Agents|sensory system agents|mesh-ancestor
5822920|NCT02601157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5822921|NCT02601157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822922|NCT02601157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5648315|NCT02085148|Tubulin Modulators|tubulin modulators|mesh-ancestor
5648316|NCT02085148|Antimitotic Agents|antimitotic agents|mesh-ancestor
5648317|NCT02085148|Mitosis Modulators|mitosis modulators|mesh-ancestor
5648318|NCT02060721|Macitentan|macitentan|mesh-list
5648319|NCT02060721|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
5648320|NCT02060721|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5648321|NCT02060721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648322|NCT02060721|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
6211597|NCT02175212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822923|NCT02601157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5822924|NCT02601157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5822925|NCT02601157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5822926|NCT02601157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822927|NCT02601157|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5822928|NCT02601157|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5822929|NCT02601157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5822930|NCT02601157|Antipyretics|antipyretics|mesh-ancestor
5822931|NCT02601157|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5822932|NCT02601157|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5822933|NCT02601157|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5822934|NCT02601157|Purinergic Agents|purinergic agents|mesh-ancestor
5822935|NCT02601157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5822936|NCT02601157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5822937|NCT02601157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5822938|NCT02601157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5822939|NCT02601157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5822940|NCT02601157|Antifungal Agents|antifungal agents|mesh-ancestor
5822941|NCT02601157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5822942|NCT02601157|Immunologic Factors|immunologic factors|mesh-ancestor
5822943|NCT02601040|Vaccines|vaccines|mesh-list
6211598|NCT02175212|Antioxidants|antioxidants|mesh-ancestor
6211599|NCT02175212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211600|NCT02175212|Protective Agents|protective agents|mesh-ancestor
6211601|NCT02175212|Vitamins|vitamins|mesh-ancestor
6211602|NCT02175212|Micronutrients|micronutrients|mesh-ancestor
6211603|NCT02175212|Estrogens|estrogens|mesh-ancestor
6211604|NCT02175212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6211605|NCT02175212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6211606|NCT02175212|Anabolic Agents|anabolic agents|mesh-ancestor
6211607|NCT02175225|Deferoxamine|deferoxamine|mesh-list
6211608|NCT02175225|Siderophores|siderophores|mesh-ancestor
6211609|NCT02175225|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6211610|NCT02175225|Chelating Agents|chelating agents|mesh-ancestor
6211611|NCT02175225|Sequestering Agents|sequestering agents|mesh-ancestor
6211612|NCT02175225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211613|NCT02175277|Darbepoetin alfa|darbepoetin alfa|mesh-list
6211614|NCT02175277|Hematinics|hematinics|mesh-ancestor
6211615|NCT02175745|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
6211616|NCT02175745|Dopamine Agents|dopamine agents|mesh-ancestor
6211617|NCT02175745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5822944|NCT02601040|Immunologic Factors|immunologic factors|mesh-ancestor
5822945|NCT02601040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822946|NCT02601235|Pyrilamine|pyrilamine|mesh-list
5822947|NCT02601235|Phenylephrine|phenylephrine|mesh-list
5822948|NCT02601235|Oxymetazoline|oxymetazoline|mesh-list
5822949|NCT02601235|Naphazoline|naphazoline|mesh-list
5822950|NCT02601235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822951|NCT02601235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5822952|NCT02601235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5822953|NCT02601235|Adrenergic Agents|adrenergic agents|mesh-ancestor
5822954|NCT02601235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5822955|NCT02601235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822956|NCT02601235|Sympathomimetics|sympathomimetics|mesh-ancestor
5822957|NCT02601235|Autonomic Agents|autonomic agents|mesh-ancestor
5822958|NCT02601235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5822959|NCT02601235|Nasal Decongestants|nasal decongestants|mesh-ancestor
5822960|NCT02601235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5822961|NCT02601235|Respiratory System Agents|respiratory system agents|mesh-ancestor
5822962|NCT02601235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6211618|NCT02175745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5822963|NCT02601235|Mydriatics|mydriatics|mesh-ancestor
5822964|NCT02601235|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5822965|NCT02601235|Protective Agents|protective agents|mesh-ancestor
5822966|NCT02601235|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5822967|NCT02601235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5822968|NCT02601235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5822969|NCT02601235|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5822970|NCT02601235|Histamine Antagonists|histamine antagonists|mesh-ancestor
5822971|NCT02601235|Histamine Agents|histamine agents|mesh-ancestor
5822972|NCT02601235|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5822973|NCT02601196|Ulipristal acetate|ulipristal acetate|mesh-list
5822974|NCT02601196|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6211619|NCT02175745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211620|NCT02175758|Ribavirin|ribavirin|mesh-list
6211621|NCT02175758|Sofosbuvir|sofosbuvir|mesh-list
6211622|NCT02175758|Antimetabolites|antimetabolites|mesh-ancestor
6211623|NCT02175758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211624|NCT02175758|Antiviral Agents|antiviral agents|mesh-ancestor
6211625|NCT02175758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6211626|NCT02175771|Fluticasone|fluticasone|mesh-list
6211627|NCT02175771|Xhance|xhance|mesh-list
5822975|NCT02601196|Contraceptive Agents|contraceptive agents|mesh-ancestor
5822976|NCT02601196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5822977|NCT02601196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822978|NCT02601196|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5822979|NCT02600988|Vitamin D|vitamin d|mesh-list
5822980|NCT02600988|Ergocalciferols|ergocalciferols|mesh-list
6211628|NCT02175771|Albuterol|albuterol|mesh-list
6211629|NCT02175771|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6211630|NCT02175771|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6211631|NCT02175771|Adrenergic Agonists|adrenergic agonists|mesh-list
6211632|NCT02175771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6211633|NCT02175771|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6211634|NCT02175771|Autonomic Agents|autonomic agents|mesh-ancestor
6211635|NCT02175771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6211636|NCT02175771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822981|NCT02600988|Vitamins|vitamins|mesh-list
5822982|NCT02600988|Micronutrients|micronutrients|mesh-ancestor
5822983|NCT02600988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5822984|NCT02600988|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5822985|NCT02600988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5822986|NCT02600793|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
5822987|NCT02600793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5822988|NCT02600793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5822989|NCT02600806|Azithromycin|azithromycin|mesh-list
5822990|NCT02600806|Levofloxacin|levofloxacin|mesh-list
5822991|NCT02600806|Ofloxacin|ofloxacin|mesh-list
5822992|NCT02600806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5822993|NCT02600806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5822994|NCT02600806|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5822995|NCT02600806|Renal Agents|renal agents|mesh-ancestor
6211637|NCT02175771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6211638|NCT02175771|Respiratory System Agents|respiratory system agents|mesh-ancestor
6211639|NCT02175771|Dermatologic Agents|dermatologic agents|mesh-ancestor
6211640|NCT02175771|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6211641|NCT02175771|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6211642|NCT02175771|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6211643|NCT02175771|Adrenergic Agents|adrenergic agents|mesh-ancestor
6211644|NCT02175771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5822996|NCT02600806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5822997|NCT02600806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5822998|NCT02600806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5822999|NCT02600806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823000|NCT02600806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5823001|NCT02600806|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5823002|NCT02600806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5823003|NCT02600780|Allopurinol|allopurinol|mesh-list
5823004|NCT02600780|Febuxostat|febuxostat|mesh-list
5823005|NCT02600780|Antimetabolites|antimetabolites|mesh-ancestor
5823006|NCT02600780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823007|NCT02600780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5823008|NCT02600780|Gout Suppressants|gout suppressants|mesh-ancestor
6211645|NCT02175771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211646|NCT02175771|Tocolytic Agents|tocolytic agents|mesh-ancestor
5823009|NCT02600780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6211647|NCT02175771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5823010|NCT02600780|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5823011|NCT02600780|Antioxidants|antioxidants|mesh-ancestor
5823012|NCT02600780|Protective Agents|protective agents|mesh-ancestor
5823013|NCT02600780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823014|NCT02600741|Droperidol|droperidol|mesh-list
5823015|NCT02600741|Haloperidol|haloperidol|mesh-list
5823016|NCT02600741|Pimozide|pimozide|mesh-list
5823017|NCT02600741|Olanzapine|olanzapine|mesh-list
5823018|NCT02600741|Prochlorperazine|prochlorperazine|mesh-list
5823019|NCT02600741|Chlorpromazine|chlorpromazine|mesh-list
5823020|NCT02600741|Trifluoperazine|trifluoperazine|mesh-list
5823021|NCT02600741|Risperidone|risperidone|mesh-list
5823022|NCT02600741|Quetiapine Fumarate|quetiapine fumarate|mesh-list
5823023|NCT02600741|Aripiprazole|aripiprazole|mesh-list
5823024|NCT02600741|Paliperidone Palmitate|paliperidone palmitate|mesh-list
5823025|NCT02600741|Ziprasidone|ziprasidone|mesh-list
5823026|NCT02600741|Clozapine|clozapine|mesh-list
5823027|NCT02600741|Asenapine|asenapine|mesh-list
5823028|NCT02600741|Loxapine|loxapine|mesh-list
5823029|NCT02600741|Iloperidone|iloperidone|mesh-list
5823030|NCT02600741|Perphenazine|perphenazine|mesh-list
5823031|NCT02600741|Fluphenazine|fluphenazine|mesh-list
5823032|NCT02600741|Fluphenazine depot|fluphenazine depot|mesh-list
5823033|NCT02600741|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
5823034|NCT02600741|Thioridazine|thioridazine|mesh-list
5823035|NCT02600741|Thiothixene|thiothixene|mesh-list
5823036|NCT02600741|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5823037|NCT02600741|Serotonin Agents|serotonin agents|mesh-ancestor
5823038|NCT02600741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5823039|NCT02600741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823040|NCT02600741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823041|NCT02600741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5823042|NCT02600741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5823043|NCT02600741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5823044|NCT02600741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5823045|NCT02600741|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5823046|NCT02600741|Dopamine Agents|dopamine agents|mesh-ancestor
5823047|NCT02600741|Antiemetics|antiemetics|mesh-ancestor
5823048|NCT02600741|Autonomic Agents|autonomic agents|mesh-ancestor
5823049|NCT02600741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5823050|NCT02600741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5823051|NCT02600741|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5823052|NCT02600741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5823053|NCT02600741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5823054|NCT02600741|Antidepressive Agents|antidepressive agents|mesh-ancestor
5823055|NCT02600741|Dopamine Agonists|dopamine agonists|mesh-ancestor
5823056|NCT02600741|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5823057|NCT02600741|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5823058|NCT02600741|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5823059|NCT02600741|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5823060|NCT02600741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5823061|NCT02600741|GABA Antagonists|gaba antagonists|mesh-ancestor
5823062|NCT02600741|GABA Agents|gaba agents|mesh-ancestor
5823063|NCT02600741|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5823064|NCT02600650|Testosterone|testosterone|mesh-list
5823065|NCT02600650|Androgens|androgens|mesh-ancestor
5823066|NCT02600650|Hormones|hormones|mesh-ancestor
5823067|NCT02600650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5823068|NCT02600650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823069|NCT02600585|Vaccines|vaccines|mesh-list
5823070|NCT02600585|Immunologic Factors|immunologic factors|mesh-ancestor
5823071|NCT02600585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901860|NCT02247349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901861|NCT02247349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5901862|NCT02247349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901863|NCT02214407|Decitabine|decitabine|mesh-list
6211648|NCT02175771|Glucocorticoids|glucocorticoids|mesh-ancestor
6211649|NCT02175771|Hormones|hormones|mesh-ancestor
6211650|NCT02175771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6211651|NCT02175771|Sympathomimetics|sympathomimetics|mesh-ancestor
6211652|NCT02175966|Ribavirin|ribavirin|mesh-list
6211653|NCT02175966|Sofosbuvir|sofosbuvir|mesh-list
5648381|NCT01966471|Maytansine|maytansine|mesh-list
5648382|NCT01966471|Docetaxel|docetaxel|mesh-list
5648383|NCT01966471|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
5648384|NCT01966471|Cyclophosphamide|cyclophosphamide|mesh-list
5901864|NCT02214407|Hydroxyurea|hydroxyurea|mesh-list
5901865|NCT02214407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5901866|NCT02214407|Antimetabolites|antimetabolites|mesh-ancestor
5901867|NCT02214407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211654|NCT02175966|Antimetabolites|antimetabolites|mesh-ancestor
5823072|NCT02600455|Abatacept|abatacept|mesh-list
5823073|NCT02600455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5823074|NCT02600455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823075|NCT02600455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5823076|NCT02600455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5823077|NCT02600455|Immunologic Factors|immunologic factors|mesh-ancestor
5823078|NCT02600455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823079|NCT02600455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5648385|NCT01966471|Doxorubicin|doxorubicin|mesh-list
5648386|NCT01966471|Fluorouracil|fluorouracil|mesh-list
5648387|NCT01966471|Trastuzumab|trastuzumab|mesh-list
5648388|NCT01966471|Epirubicin|epirubicin|mesh-list
5648389|NCT01966471|Pertuzumab|pertuzumab|mesh-list
5648390|NCT01966471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5648391|NCT01966471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5648392|NCT01966471|Tubulin Modulators|tubulin modulators|mesh-ancestor
5648393|NCT01966471|Antimitotic Agents|antimitotic agents|mesh-ancestor
5648394|NCT01966471|Mitosis Modulators|mitosis modulators|mesh-ancestor
5648395|NCT01966471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648396|NCT01966471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5648397|NCT01966471|Immunologic Factors|immunologic factors|mesh-ancestor
5648398|NCT01966471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648399|NCT01966471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5648400|NCT01966471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5648401|NCT01966471|Alkylating Agents|alkylating agents|mesh-ancestor
5648402|NCT01966471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5648403|NCT01966471|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5648404|NCT01966471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5648405|NCT01966471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5823080|NCT02600468|Abatacept|abatacept|mesh-list
5823081|NCT02600468|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5823082|NCT02600468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823083|NCT02600468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5823084|NCT02600468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5823085|NCT02600468|Immunologic Factors|immunologic factors|mesh-ancestor
5823086|NCT02600468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492889|NCT00611039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6492890|NCT00611143|Atorvastatin|atorvastatin|mesh-list
6492891|NCT00611143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6492892|NCT00611143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6492893|NCT00611143|Antimetabolites|antimetabolites|mesh-ancestor
6492894|NCT00611143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492895|NCT00611143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6492896|NCT00611143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6492897|NCT00611143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6492898|NCT00611169|Tirofiban|tirofiban|mesh-list
6492899|NCT00611169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5823087|NCT02600468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5823088|NCT02600273|Nicotine|nicotine|mesh-list
5823089|NCT02600273|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5823090|NCT02600273|Autonomic Agents|autonomic agents|mesh-ancestor
5823091|NCT02600273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5823092|NCT02600273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823093|NCT02600273|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5823094|NCT02600273|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5823095|NCT02600273|Cholinergic Agents|cholinergic agents|mesh-ancestor
5823096|NCT02600273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5823097|NCT02600273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823098|NCT02600247|Acetaminophen|acetaminophen|mesh-list
5823099|NCT02600247|Celecoxib|celecoxib|mesh-list
5823100|NCT02600247|Pregabalin|pregabalin|mesh-list
5823101|NCT02600247|Oxycodone|oxycodone|mesh-list
5823102|NCT02600247|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5823103|NCT02600247|Tramadol|tramadol|mesh-list
5823104|NCT02600247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5823105|NCT02600247|Analgesics|analgesics|mesh-ancestor
5823106|NCT02600247|Sensory System Agents|sensory system agents|mesh-ancestor
5823107|NCT02600247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5823108|NCT02600247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823109|NCT02600247|Antipyretics|antipyretics|mesh-ancestor
5823110|NCT02600247|Anticonvulsants|anticonvulsants|mesh-ancestor
5823111|NCT02600247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5823112|NCT02600247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5823113|NCT02600247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823114|NCT02600247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5648406|NCT01966471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5823115|NCT02600247|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5823116|NCT02600247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5823117|NCT02600247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5823118|NCT02600247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5823119|NCT02600247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5648407|NCT01966471|Antimetabolites|antimetabolites|mesh-ancestor
5648408|NCT01966471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5648409|NCT01966471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5648410|NCT01953926|Trastuzumab|trastuzumab|mesh-list
5648411|NCT01953926|Fulvestrant|fulvestrant|mesh-list
5648412|NCT01953926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5648413|NCT01953926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5648414|NCT01953926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5648415|NCT01953926|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5648416|NCT01953926|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5648417|NCT01953926|Hormone Antagonists|hormone antagonists|mesh-ancestor
5648418|NCT01953926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5648419|NCT01953926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648420|NCT01927744|Docetaxel|docetaxel|mesh-list
5648421|NCT01927744|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5648422|NCT01927744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5648423|NCT01927744|Tubulin Modulators|tubulin modulators|mesh-ancestor
5648424|NCT01927744|Antimitotic Agents|antimitotic agents|mesh-ancestor
5648425|NCT01927744|Mitosis Modulators|mitosis modulators|mesh-ancestor
5648426|NCT01927744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823120|NCT02600247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5823121|NCT02600247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5823122|NCT02600247|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5823123|NCT02600247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5823124|NCT02600247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5823125|NCT02600247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5823126|NCT02600247|Narcotics|narcotics|mesh-ancestor
5823127|NCT02600247|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5823128|NCT02600247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5823129|NCT02600247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5823130|NCT02600247|Antidepressive Agents|antidepressive agents|mesh-ancestor
5823131|NCT02600247|Dopamine Agents|dopamine agents|mesh-ancestor
5823132|NCT02600260|Enoxaparin|enoxaparin|mesh-list
5823133|NCT02600260|Enoxaparin sodium|enoxaparin sodium|mesh-list
5823134|NCT02600260|Anticoagulants|anticoagulants|mesh-ancestor
5823135|NCT02600260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5823136|NCT02600260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5823137|NCT02600260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823138|NCT02600117|Tenofovir|tenofovir|mesh-list
5823139|NCT02600117|Antiviral Agents|antiviral agents|mesh-ancestor
5823140|NCT02600117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5823141|NCT02600117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5823142|NCT02600117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5823143|NCT02600117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5823144|NCT02600117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648427|NCT01927744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5648428|NCT01927744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5648429|NCT01774721|Gefitinib|gefitinib|mesh-list
5648430|NCT01774721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5648431|NCT01774721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5648432|NCT01774721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5648433|NCT01774721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648434|NCT01747447|Vitamin D|vitamin d|mesh-list
5648435|NCT01747447|Ergocalciferols|ergocalciferols|mesh-list
5648436|NCT01747447|Cholecalciferol|cholecalciferol|mesh-list
5648437|NCT01747447|Vitamins|vitamins|mesh-list
5648438|NCT01747447|Micronutrients|micronutrients|mesh-ancestor
5648439|NCT01747447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648440|NCT01747447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5648441|NCT01747447|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5648442|NCT01746836|Ponatinib|ponatinib|mesh-list
5648443|NCT01746836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5648444|NCT01746836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5648445|NCT01746836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5648446|NCT01746836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648447|NCT01704859|Vitamin D|vitamin d|mesh-list
5648448|NCT01704859|Ergocalciferols|ergocalciferols|mesh-list
5648449|NCT01704859|Cholecalciferol|cholecalciferol|mesh-list
5648450|NCT01704859|Vitamins|vitamins|mesh-list
5648451|NCT01704859|Micronutrients|micronutrients|mesh-ancestor
5823145|NCT02600117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5823146|NCT02600117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5823147|NCT02599701|Gabapentin|gabapentin|mesh-list
5823148|NCT02599701|Analgesics|analgesics|mesh-ancestor
5823149|NCT02599701|Sensory System Agents|sensory system agents|mesh-ancestor
5823150|NCT02599701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5823151|NCT02599701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823152|NCT02599701|Anticonvulsants|anticonvulsants|mesh-ancestor
5823153|NCT02599701|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5823154|NCT02599701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5823155|NCT02599701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5823156|NCT02599701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5823157|NCT02599701|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5823158|NCT02599701|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5823159|NCT02599701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5823160|NCT02599701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823161|NCT02599701|Antimanic Agents|antimanic agents|mesh-ancestor
5823162|NCT02599675|Vitamin D|vitamin d|mesh-list
5823163|NCT02599675|Cholecalciferol|cholecalciferol|mesh-list
5823164|NCT02599675|Vitamins|vitamins|mesh-ancestor
5823165|NCT02599675|Micronutrients|micronutrients|mesh-ancestor
5823166|NCT02599675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823167|NCT02599675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5823168|NCT02599675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5823169|NCT02599779|Pembrolizumab|pembrolizumab|mesh-list
5823170|NCT02599779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5823171|NCT02599779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5648452|NCT01704859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648453|NCT01704859|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5648454|NCT01704859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5648455|NCT01689740|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
5648456|NCT01689740|Hallucinogens|hallucinogens|mesh-ancestor
5648457|NCT01689740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648458|NCT01689740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5648459|NCT01689740|Serotonin Agents|serotonin agents|mesh-ancestor
5648460|NCT01689740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5648461|NCT01689740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648462|NCT01689740|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5823172|NCT02599857|Bisoprolol|bisoprolol|mesh-list
5823173|NCT02599857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5823174|NCT02599857|Sympatholytics|sympatholytics|mesh-ancestor
5823175|NCT02599857|Autonomic Agents|autonomic agents|mesh-ancestor
5823176|NCT02599857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5823177|NCT02599857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823178|NCT02599857|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5823179|NCT02599857|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5823180|NCT02599857|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5823181|NCT02599857|Adrenergic Agents|adrenergic agents|mesh-ancestor
5823182|NCT02599857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5823183|NCT02599857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823184|NCT02599792|Ivacaftor|ivacaftor|mesh-list
5823185|NCT02599792|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
5823186|NCT02599792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5823187|NCT02599792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823188|NCT02599532|Apixaban|apixaban|mesh-list
5823189|NCT02599532|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5823190|NCT02599532|Antithrombins|antithrombins|mesh-ancestor
5823191|NCT02599532|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5823192|NCT02599532|Protease Inhibitors|protease inhibitors|mesh-ancestor
5823193|NCT02599532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5823194|NCT02599532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823195|NCT02599532|Anticoagulants|anticoagulants|mesh-ancestor
5823196|NCT02599571|Nicotine|nicotine|mesh-list
5648463|NCT01689740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5648464|NCT01689740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5648465|NCT01689740|Adrenergic Agents|adrenergic agents|mesh-ancestor
5648466|NCT01659151|Aldesleukin|aldesleukin|mesh-list
5648467|NCT01659151|Cyclophosphamide|cyclophosphamide|mesh-list
5648468|NCT01659151|Fludarabine|fludarabine|mesh-list
5648469|NCT01659151|Interleukin-2|interleukin-2|mesh-list
5648470|NCT01659151|Vemurafenib|vemurafenib|mesh-list
5648471|NCT01659151|Enzyme Inhibitors|enzyme inhibitors|mesh-list
5648472|NCT01659151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5648473|NCT01659151|Immunologic Factors|immunologic factors|mesh-ancestor
5823197|NCT02599571|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5648474|NCT01659151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648475|NCT01659151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5823198|NCT02599571|Autonomic Agents|autonomic agents|mesh-ancestor
5823199|NCT02599571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5823200|NCT02599571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823201|NCT02599571|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5823202|NCT02599571|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5823203|NCT02599571|Cholinergic Agents|cholinergic agents|mesh-ancestor
5823204|NCT02599571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5823205|NCT02599571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823206|NCT02599623|Anesthetics|anesthetics|mesh-list
5823207|NCT02599623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5823208|NCT02599623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823209|NCT02599493|Rifampin|rifampin|mesh-list
5823210|NCT02599493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5823211|NCT02599493|Antitubercular Agents|antitubercular agents|mesh-ancestor
5823212|NCT02599493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5823213|NCT02599493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5823214|NCT02599493|Leprostatic Agents|leprostatic agents|mesh-ancestor
5823215|NCT02599493|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5823216|NCT02599493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5823217|NCT02599493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823218|NCT02599493|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5823219|NCT02599493|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5823220|NCT02599493|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5823221|NCT02599493|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5823222|NCT02599493|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5823223|NCT02599493|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5823224|NCT02599311|Tolterodine Tartrate|tolterodine tartrate|mesh-list
5823225|NCT02599311|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5823226|NCT02599311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5823227|NCT02599311|Cholinergic Agents|cholinergic agents|mesh-ancestor
5823228|NCT02599311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5823229|NCT02599311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823230|NCT02599311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823231|NCT02599311|Urological Agents|urological agents|mesh-ancestor
5823232|NCT02599480|Mirabegron|mirabegron|mesh-list
5823233|NCT02599480|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
5823234|NCT02599480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5823235|NCT02599480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5823236|NCT02599480|Adrenergic Agents|adrenergic agents|mesh-ancestor
5823237|NCT02599480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5823238|NCT02599480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823239|NCT02599480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823240|NCT02599480|Urological Agents|urological agents|mesh-ancestor
5823241|NCT02599337|Sorafenib|sorafenib|mesh-list
5823242|NCT02599337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5823243|NCT02599337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5823244|NCT02599337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5908334|NCT04660344|Atezolizumab|atezolizumab|mesh-list
5648476|NCT01659151|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5648477|NCT01659151|Alkylating Agents|alkylating agents|mesh-ancestor
5648478|NCT01659151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648479|NCT01659151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5648480|NCT01659151|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5648481|NCT01659151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5648482|NCT01659151|Analgesics|analgesics|mesh-ancestor
5648483|NCT01659151|Sensory System Agents|sensory system agents|mesh-ancestor
5648484|NCT01659151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5648485|NCT01659151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5648486|NCT01659151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5648487|NCT01659151|Antiviral Agents|antiviral agents|mesh-ancestor
5648488|NCT01659151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5648489|NCT01659151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5648490|NCT01656434|Ferrous fumarate|ferrous fumarate|mesh-list
5648491|NCT01656434|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5648492|NCT01656434|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5648493|NCT01656434|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5648494|NCT01656434|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5648495|NCT01656434|Contraceptive Agents|contraceptive agents|mesh-ancestor
5648496|NCT01656434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5648497|NCT01656434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823245|NCT02599337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823246|NCT02599324|Paclitaxel|paclitaxel|mesh-list
5823247|NCT02599324|Docetaxel|docetaxel|mesh-list
5823248|NCT02599324|Pembrolizumab|pembrolizumab|mesh-list
5823249|NCT02599324|Cetuximab|cetuximab|mesh-list
5823250|NCT02599324|Everolimus|everolimus|mesh-list
5823251|NCT02599324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5823252|NCT02599324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5823253|NCT02599324|Tubulin Modulators|tubulin modulators|mesh-ancestor
5823254|NCT02599324|Antimitotic Agents|antimitotic agents|mesh-ancestor
5823255|NCT02599324|Mitosis Modulators|mitosis modulators|mesh-ancestor
5823256|NCT02599324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823257|NCT02599324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5823258|NCT02599324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5823259|NCT02599324|Immunologic Factors|immunologic factors|mesh-ancestor
5823260|NCT02599324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823261|NCT02599168|Dexmedetomidine|dexmedetomidine|mesh-list
5823262|NCT02599168|Propofol|propofol|mesh-list
5823263|NCT02599168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5823264|NCT02599168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5823265|NCT02599168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823266|NCT02599168|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5823267|NCT02599168|Anesthetics, General|anesthetics, general|mesh-ancestor
5823268|NCT02599168|Anesthetics|anesthetics|mesh-ancestor
5823269|NCT02599168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5823270|NCT02599168|Analgesics|analgesics|mesh-ancestor
5823271|NCT02599168|Sensory System Agents|sensory system agents|mesh-ancestor
5823272|NCT02599168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5648498|NCT01656434|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5648499|NCT01656434|Estrogens|estrogens|mesh-ancestor
5648500|NCT01656434|Hormones|hormones|mesh-ancestor
5648501|NCT01656434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5648502|NCT01656434|Trace Elements|trace elements|mesh-ancestor
5648503|NCT01656434|Micronutrients|micronutrients|mesh-ancestor
5648504|NCT01601522|Ranitidine|ranitidine|mesh-list
5648505|NCT01601522|Desloratadine|desloratadine|mesh-list
5648506|NCT01601522|Histamine Antagonists|histamine antagonists|mesh-list
5648507|NCT01601522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
5648508|NCT01601522|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5648509|NCT01601522|Cholinergic Agents|cholinergic agents|mesh-ancestor
5648510|NCT01601522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5648511|NCT01601522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648512|NCT01601522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648513|NCT01601522|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5648514|NCT01601522|Histamine Agents|histamine agents|mesh-ancestor
5648515|NCT01601522|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5823273|NCT02599168|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5823274|NCT02599168|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5823275|NCT02599168|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5823276|NCT02599168|Adrenergic Agents|adrenergic agents|mesh-ancestor
5823277|NCT02599168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5823278|NCT02599168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823279|NCT02599077|Dienogest|dienogest|mesh-list
5823280|NCT02599077|Levonorgestrel|levonorgestrel|mesh-list
5823281|NCT02599077|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5823282|NCT02599077|Contraceptive Agents|contraceptive agents|mesh-ancestor
5823283|NCT02599077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5823284|NCT02599077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823285|NCT02599077|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5823286|NCT02599077|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5823287|NCT02599077|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5823288|NCT02599077|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5823289|NCT02599077|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5823290|NCT02599077|Hormone Antagonists|hormone antagonists|mesh-ancestor
5823291|NCT02599077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5823292|NCT02599077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5823293|NCT02599077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5823294|NCT02598830|Vitamin D|vitamin d|mesh-list
5823295|NCT02598830|Cholecalciferol|cholecalciferol|mesh-list
5823296|NCT02598830|Vitamins|vitamins|mesh-ancestor
5823297|NCT02598830|Micronutrients|micronutrients|mesh-ancestor
5823298|NCT02598830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823299|NCT02598830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5823300|NCT02598830|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5823301|NCT02599090|Temozolomide|temozolomide|mesh-list
5648516|NCT01601522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5648517|NCT01601522|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5648518|NCT01599494|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5648519|NCT01599494|Progesterone|progesterone|mesh-list
5648520|NCT01599494|Ganirelix|ganirelix|mesh-list
5648521|NCT01599494|Progestins|progestins|mesh-ancestor
5823302|NCT02599090|Sorafenib|sorafenib|mesh-list
5823303|NCT02599090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5823304|NCT02599090|Alkylating Agents|alkylating agents|mesh-ancestor
5823305|NCT02599090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823306|NCT02599090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5823307|NCT02599090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5823308|NCT02599090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5823309|NCT02598778|Chlorhexidine|chlorhexidine|mesh-list
5823310|NCT02598778|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5823311|NCT02598778|Listerine|listerine|mesh-list
5823312|NCT02598778|Fluorides|fluorides|mesh-list
5823313|NCT02598778|Sodium Fluoride|sodium fluoride|mesh-list
5823314|NCT02598778|Cariostatic Agents|cariostatic agents|mesh-ancestor
5648522|NCT01599494|Hormones|hormones|mesh-ancestor
5648523|NCT01599494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5648524|NCT01599494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648525|NCT01599494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5648526|NCT01599494|Hormone Antagonists|hormone antagonists|mesh-ancestor
5648527|NCT01518517|Asparaginase|asparaginase|mesh-list
5648528|NCT01518517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5648529|NCT01496118|Panobinostat|panobinostat|mesh-list
5648530|NCT01496118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5648531|NCT01496118|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5648532|NCT01496118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5648533|NCT01496118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648534|NCT01415674|Afatinib|afatinib|mesh-list
5648535|NCT01415674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5648536|NCT01415674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5648537|NCT01415674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5648538|NCT01415674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648539|NCT01371630|Cytarabine|cytarabine|mesh-list
5648540|NCT01371630|Prednisone|prednisone|mesh-list
5648541|NCT01371630|Cortisone|cortisone|mesh-list
5648542|NCT01371630|Cyclophosphamide|cyclophosphamide|mesh-list
5648543|NCT01371630|Rituximab|rituximab|mesh-list
5648544|NCT01371630|Methotrexate|methotrexate|mesh-list
5648545|NCT01371630|Vincristine|vincristine|mesh-list
5823315|NCT02598778|Protective Agents|protective agents|mesh-ancestor
5823316|NCT02598778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823317|NCT02598778|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5823318|NCT02598778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5823319|NCT02598778|Disinfectants|disinfectants|mesh-ancestor
5823320|NCT02598778|Dermatologic Agents|dermatologic agents|mesh-ancestor
5901868|NCT02214407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901869|NCT02214407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5901870|NCT02214407|Antisickling Agents|antisickling agents|mesh-ancestor
5901871|NCT02214407|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5901872|NCT02142803|Bevacizumab|bevacizumab|mesh-list
5901873|NCT02142803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5901874|NCT02142803|Endothelial Growth Factors|endothelial growth factors|mesh-list
5901875|NCT02142803|Antibodies|antibodies|mesh-list
5901876|NCT02142803|Immunoglobulins|immunoglobulins|mesh-list
5901877|NCT02142803|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5901878|NCT02142803|Immunoglobulin G|immunoglobulin g|mesh-list
5901879|NCT02142803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901880|NCT02142803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5901881|NCT02142803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5901882|NCT02142803|Growth Substances|growth substances|mesh-ancestor
5901883|NCT02142803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901884|NCT02142803|Growth Inhibitors|growth inhibitors|mesh-ancestor
5901885|NCT02142803|Immunologic Factors|immunologic factors|mesh-ancestor
5901886|NCT01982630|Liraglutide|liraglutide|mesh-list
5901887|NCT01982630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5901888|NCT01982630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901889|NCT01982630|Incretins|incretins|mesh-ancestor
5901890|NCT01982630|Hormones|hormones|mesh-ancestor
5901891|NCT01982630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6675600|NCT01576627|Dermatologic Agents|dermatologic agents|mesh-ancestor
5648546|NCT01371630|Mercaptopurine|mercaptopurine|mesh-list
5648547|NCT01371630|Blinatumomab|blinatumomab|mesh-list
5648548|NCT01371630|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
5648549|NCT01371630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5901892|NCT01899989|Carboplatin|carboplatin|mesh-list
5648550|NCT01371630|Muromonab-CD3|muromonab-cd3|mesh-list
5823321|NCT02598856|Naloxone|naloxone|mesh-list
5823322|NCT02598856|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5823323|NCT02598856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823324|NCT02598856|Sensory System Agents|sensory system agents|mesh-ancestor
5823325|NCT02598856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5823326|NCT02598869|Triamcinolone|triamcinolone|mesh-list
5823327|NCT02598869|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5823328|NCT02598869|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5823329|NCT02598869|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5823330|NCT02598869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5823331|NCT02598869|Glucocorticoids|glucocorticoids|mesh-ancestor
5823332|NCT02598869|Hormones|hormones|mesh-ancestor
5823333|NCT02598869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5823334|NCT02598869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648551|NCT01371630|Antibodies|antibodies|mesh-list
5648552|NCT01371630|Immunoglobulins|immunoglobulins|mesh-list
5648553|NCT01371630|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5648554|NCT01371630|Antibodies, Bispecific|antibodies, bispecific|mesh-list
5648555|NCT01371630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5648556|NCT01371630|Immunologic Factors|immunologic factors|mesh-ancestor
5648557|NCT01371630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648558|NCT01371630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5648559|NCT01371630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5648560|NCT01371630|Alkylating Agents|alkylating agents|mesh-ancestor
5648561|NCT01371630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648562|NCT01371630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5648563|NCT01371630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5648564|NCT01371630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5648565|NCT01371630|Glucocorticoids|glucocorticoids|mesh-ancestor
5823335|NCT02598869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5823336|NCT02598869|Immunologic Factors|immunologic factors|mesh-ancestor
5823337|NCT02598869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5823338|NCT02598869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823339|NCT02598726|Curcumin|curcumin|mesh-list
5823340|NCT02598726|Piperine|piperine|mesh-list
5823341|NCT02598726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5823342|NCT02598726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5823343|NCT02598726|Analgesics|analgesics|mesh-ancestor
5823344|NCT02598726|Sensory System Agents|sensory system agents|mesh-ancestor
5823345|NCT02598726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5823346|NCT02598726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823347|NCT02598726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5823348|NCT02598726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5823349|NCT02598726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5823350|NCT02598726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5823351|NCT02598726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823352|NCT02598726|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5823353|NCT02598596|Azathioprine|azathioprine|mesh-list
5823354|NCT02598596|Antimetabolites|antimetabolites|mesh-ancestor
5823355|NCT02598596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823356|NCT02598596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5823357|NCT02598596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5823358|NCT02598596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5823359|NCT02598596|Immunologic Factors|immunologic factors|mesh-ancestor
5823360|NCT02598596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823361|NCT02598596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5648566|NCT01371630|Hormones|hormones|mesh-ancestor
5648567|NCT01371630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5648568|NCT01371630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5648569|NCT01371630|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5823362|NCT02598791|Glucagon|glucagon|mesh-list
5823363|NCT02598791|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5823364|NCT02598791|Incretins|incretins|mesh-ancestor
6674411|NCT01569113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6674412|NCT01569113|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6674413|NCT01569113|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
6674414|NCT01569113|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6674415|NCT01569113|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6674416|NCT01569165|Fluorides|fluorides|mesh-list
6674417|NCT01569165|Fluorides, Topical|fluorides, topical|mesh-list
6674418|NCT01569165|Cariostatic Agents|cariostatic agents|mesh-ancestor
6674419|NCT01569165|Protective Agents|protective agents|mesh-ancestor
6675601|NCT01576627|Sunscreening Agents|sunscreening agents|mesh-ancestor
5648570|NCT01371630|Abortifacient Agents|abortifacient agents|mesh-ancestor
5648571|NCT01371630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5648572|NCT01371630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5648573|NCT01371630|Antimetabolites|antimetabolites|mesh-ancestor
5648574|NCT01371630|Dermatologic Agents|dermatologic agents|mesh-ancestor
5648575|NCT01371630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5648576|NCT01371630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5648577|NCT01371630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5648578|NCT01371630|Antiviral Agents|antiviral agents|mesh-ancestor
5648579|NCT01371630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5648580|NCT01371630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5648581|NCT01371630|Tubulin Modulators|tubulin modulators|mesh-ancestor
5648582|NCT01371630|Antimitotic Agents|antimitotic agents|mesh-ancestor
5648583|NCT01371630|Mitosis Modulators|mitosis modulators|mesh-ancestor
5648584|NCT01371630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5648585|NCT01358669|Denosumab|denosumab|mesh-list
5648586|NCT01358669|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5648587|NCT01358669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648588|NCT01350934|Vitamin D|vitamin d|mesh-list
6492900|NCT00611169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6492901|NCT00611169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492902|NCT00611169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6492903|NCT00611195|Remifentanil|remifentanil|mesh-list
6492904|NCT00611195|Propofol|propofol|mesh-list
5648589|NCT01350934|Cholecalciferol|cholecalciferol|mesh-list
5823365|NCT02598791|Hormones|hormones|mesh-ancestor
5823366|NCT02598791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5823367|NCT02598791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823368|NCT02598791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5823369|NCT02598635|Cholecalciferol|cholecalciferol|mesh-list
5823370|NCT02598635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5823371|NCT02598635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823372|NCT02598635|Vitamins|vitamins|mesh-ancestor
5823373|NCT02598635|Micronutrients|micronutrients|mesh-ancestor
5823374|NCT02598635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5823375|NCT02598687|Paclitaxel|paclitaxel|mesh-list
5823376|NCT02598687|Carboplatin|carboplatin|mesh-list
5823377|NCT02598687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5823378|NCT02598687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5823379|NCT02598687|Tubulin Modulators|tubulin modulators|mesh-ancestor
5823380|NCT02598687|Antimitotic Agents|antimitotic agents|mesh-ancestor
5823381|NCT02598687|Mitosis Modulators|mitosis modulators|mesh-ancestor
5823382|NCT02598687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823383|NCT02598453|Ibandronic Acid|ibandronic acid|mesh-list
5823384|NCT02598453|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5823385|NCT02598453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823386|NCT02598466|Abatacept|abatacept|mesh-list
5823387|NCT02598466|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5823388|NCT02598466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823389|NCT02598466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5823390|NCT02598466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5823391|NCT02598466|Immunologic Factors|immunologic factors|mesh-ancestor
5823392|NCT02598466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823393|NCT02598466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5823394|NCT02598427|Trastuzumab|trastuzumab|mesh-list
5823395|NCT02598427|Pertuzumab|pertuzumab|mesh-list
5823396|NCT02598427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5823397|NCT02598427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5823398|NCT02598414|Fluorophosphate|fluorophosphate|mesh-list
5823399|NCT02598414|Cariostatic Agents|cariostatic agents|mesh-ancestor
5823400|NCT02598414|Protective Agents|protective agents|mesh-ancestor
5823401|NCT02598414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823402|NCT02598440|Alendronate|alendronate|mesh-list
5823403|NCT02598440|Ibandronic Acid|ibandronic acid|mesh-list
5823404|NCT02598440|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5823405|NCT02598440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823406|NCT02598310|Paclitaxel|paclitaxel|mesh-list
5823407|NCT02598310|Trastuzumab|trastuzumab|mesh-list
5823408|NCT02598310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5823409|NCT02598310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5823410|NCT02598310|Tubulin Modulators|tubulin modulators|mesh-ancestor
5648590|NCT01350934|Alendronate|alendronate|mesh-list
5648591|NCT01350934|Calcitriol|calcitriol|mesh-list
5823411|NCT02598310|Antimitotic Agents|antimitotic agents|mesh-ancestor
5823412|NCT02598310|Mitosis Modulators|mitosis modulators|mesh-ancestor
5823413|NCT02598310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823414|NCT02598310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5823415|NCT02598362|Ciprofloxacin|ciprofloxacin|mesh-list
5823416|NCT02598362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5823417|NCT02598362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5823418|NCT02598362|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5823419|NCT02598362|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5823420|NCT02598362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5823421|NCT02598362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823422|NCT02598362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5823423|NCT02598362|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5823424|NCT02598362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5823425|NCT02598102|Diclofenac|diclofenac|mesh-list
6674420|NCT01569165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674421|NCT01569204|Dexamethasone|dexamethasone|mesh-list
6674422|NCT01569204|Prednisone|prednisone|mesh-list
5823426|NCT02598102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5823427|NCT02598102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5823428|NCT02598102|Analgesics|analgesics|mesh-ancestor
5823429|NCT02598102|Sensory System Agents|sensory system agents|mesh-ancestor
5823430|NCT02598102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5823431|NCT02598102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823432|NCT02598102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5823433|NCT02598102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5823434|NCT02598102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5823435|NCT02598102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5823436|NCT02598102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823437|NCT02597998|BI 409306|bi 409306|mesh-list
5823438|NCT02597998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5823439|NCT02597998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5823440|NCT02597998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823441|NCT02598063|Lamivudine|lamivudine|mesh-list
5823442|NCT02598063|Adefovir|adefovir|mesh-list
5823443|NCT02598063|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
5823444|NCT02598063|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5823445|NCT02598063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5823446|NCT02598063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5823447|NCT02598063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5823448|NCT02598063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823449|NCT02598063|Antiviral Agents|antiviral agents|mesh-ancestor
5823450|NCT02598063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5823451|NCT02598063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5823452|NCT02598063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5823453|NCT02598011|Flucytosine|flucytosine|mesh-list
5823454|NCT02598011|Antifungal Agents|antifungal agents|mesh-ancestor
5823455|NCT02598011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5823456|NCT02598011|Antimetabolites|antimetabolites|mesh-ancestor
6492905|NCT00611195|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6492906|NCT00611195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6492907|NCT00611195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492908|NCT00611195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6492909|NCT00611195|Anesthetics, General|anesthetics, general|mesh-ancestor
6492910|NCT00611195|Anesthetics|anesthetics|mesh-ancestor
6492911|NCT00611195|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6492912|NCT00611195|Narcotics|narcotics|mesh-ancestor
6492913|NCT00611195|Analgesics|analgesics|mesh-ancestor
6492914|NCT00611195|Sensory System Agents|sensory system agents|mesh-ancestor
6492915|NCT00611195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5823457|NCT02598011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823458|NCT02597868|Capecitabine|capecitabine|mesh-list
5823459|NCT02597868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5823460|NCT02597868|Antimetabolites|antimetabolites|mesh-ancestor
5823461|NCT02597868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823462|NCT02597868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5823463|NCT02597829|Certolizumab Pegol|certolizumab pegol|mesh-list
5823464|NCT02597829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5823465|NCT02597829|Immunologic Factors|immunologic factors|mesh-ancestor
5823466|NCT02597829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823467|NCT02597829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5823468|NCT02597699|Lidocaine|lidocaine|mesh-list
5823469|NCT02597699|Sufentanil|sufentanil|mesh-list
6492916|NCT00611286|Sirolimus|sirolimus|mesh-list
5823470|NCT02597699|Remifentanil|remifentanil|mesh-list
5823471|NCT02597699|Dsuvia|dsuvia|mesh-list
6492917|NCT00611286|Paclitaxel|paclitaxel|mesh-list
6492918|NCT00611286|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6674423|NCT01569204|Cyclophosphamide|cyclophosphamide|mesh-list
6674424|NCT01569204|Dacarbazine|dacarbazine|mesh-list
5823472|NCT02597699|Anesthetics, Local|anesthetics, local|mesh-ancestor
5823473|NCT02597699|Anesthetics|anesthetics|mesh-ancestor
5823474|NCT02597699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5823475|NCT02597699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648592|NCT01350934|Calcium|calcium|mesh-list
5648593|NCT01350934|Vitamins|vitamins|mesh-ancestor
5648594|NCT01350934|Micronutrients|micronutrients|mesh-ancestor
5648595|NCT01350934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648596|NCT01350934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5648597|NCT01350934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5648598|NCT01350934|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
5648599|NCT01350934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5648600|NCT01350934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823476|NCT02597699|Sensory System Agents|sensory system agents|mesh-ancestor
5823477|NCT02597699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5823478|NCT02597699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5823479|NCT02597699|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5823480|NCT02597699|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5823481|NCT02597699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5823482|NCT02597699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823483|NCT02597699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5823484|NCT02597699|Narcotics|narcotics|mesh-ancestor
5648601|NCT01350934|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5648602|NCT01304511|Ganirelix|ganirelix|mesh-list
5648603|NCT01304511|Hormone Antagonists|hormone antagonists|mesh-ancestor
5648604|NCT01304511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5648605|NCT01304511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648606|NCT01286207|Rizatriptan|rizatriptan|mesh-list
5648607|NCT01286207|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5648608|NCT01286207|Serotonin Agents|serotonin agents|mesh-ancestor
5648609|NCT01286207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5648610|NCT01286207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648611|NCT01286207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648612|NCT01263769|Axitinib|axitinib|mesh-list
5648613|NCT01263769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5648614|NCT01263769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5648615|NCT01263769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5648616|NCT01263769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648617|NCT01227187|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
5648618|NCT01227187|Protein C|protein c|mesh-list
5648619|NCT01227187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5648620|NCT01227187|Anticoagulants|anticoagulants|mesh-ancestor
5648621|NCT01227187|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5648622|NCT01227187|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5648623|NCT01227187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648624|NCT01222247|Betamethasone|betamethasone|mesh-list
5648625|NCT01222247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5648626|NCT01222247|Glucocorticoids|glucocorticoids|mesh-ancestor
5648627|NCT01222247|Hormones|hormones|mesh-ancestor
5648628|NCT01222247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5648629|NCT01222247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648630|NCT01222247|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5648631|NCT01222247|Respiratory System Agents|respiratory system agents|mesh-ancestor
5648632|NCT01211405|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
5648633|NCT01211405|Hallucinogens|hallucinogens|mesh-ancestor
5823485|NCT02597699|Analgesics|analgesics|mesh-ancestor
5823486|NCT02597699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5823487|NCT02597699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5823488|NCT02597699|Anesthetics, General|anesthetics, general|mesh-ancestor
5823489|NCT02597660|Hormones|hormones|mesh-list
5823490|NCT02597660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5823491|NCT02597660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823492|NCT02597556|Albendazole|albendazole|mesh-list
5823493|NCT02597556|Anthelmintics|anthelmintics|mesh-ancestor
5823494|NCT02597556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5823495|NCT02597556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5823496|NCT02597556|Anticestodal Agents|anticestodal agents|mesh-ancestor
5823497|NCT02597556|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5823498|NCT02597556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5648634|NCT01211405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648635|NCT01211405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5648636|NCT01211405|Serotonin Agents|serotonin agents|mesh-ancestor
5823499|NCT02597556|Tubulin Modulators|tubulin modulators|mesh-ancestor
5648637|NCT01211405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5648638|NCT01211405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648639|NCT01211405|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5648640|NCT01211405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5648641|NCT01211405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5648642|NCT01211405|Adrenergic Agents|adrenergic agents|mesh-ancestor
5648643|NCT01146418|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5823500|NCT02597556|Antimitotic Agents|antimitotic agents|mesh-ancestor
5823501|NCT02597556|Mitosis Modulators|mitosis modulators|mesh-ancestor
5823502|NCT02597556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823503|NCT02597556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5823504|NCT02597387|Mitoxantrone|mitoxantrone|mesh-list
5823505|NCT02597387|Analgesics|analgesics|mesh-ancestor
5823506|NCT02597387|Sensory System Agents|sensory system agents|mesh-ancestor
5823507|NCT02597387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5823508|NCT02597387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823509|NCT02597387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5823510|NCT02597387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5648644|NCT01146418|Hormones|hormones|mesh-ancestor
5648645|NCT01146418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5648646|NCT01146418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648647|NCT01144416|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5648648|NCT01144416|Hormones|hormones|mesh-ancestor
5648649|NCT01144416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5648650|NCT01144416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648651|NCT01093326|Ponesimod|ponesimod|mesh-list
5648652|NCT01093326|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5648653|NCT01093326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648654|NCT01093326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5648655|NCT01093326|Immunologic Factors|immunologic factors|mesh-ancestor
5648656|NCT01093326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648657|NCT01077817|Alendronate|alendronate|mesh-list
5648658|NCT01077817|Risedronic Acid|risedronic acid|mesh-list
5648659|NCT01077817|Ibandronic Acid|ibandronic acid|mesh-list
5648660|NCT01077817|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
5648661|NCT01077817|Etidronic Acid|etidronic acid|mesh-list
5648662|NCT01077817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5648663|NCT01077817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823511|NCT02597387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5823512|NCT02597387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5823513|NCT02597387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823514|NCT02597400|Metformin|metformin|mesh-list
5823515|NCT02597400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5823516|NCT02597400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823517|NCT02597361|Irbesartan|irbesartan|mesh-list
5823518|NCT02597361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5823519|NCT02597361|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5823520|NCT02597361|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5823521|NCT02597361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823522|NCT02597283|Sirolimus|sirolimus|mesh-list
5648664|NCT01077817|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5648665|NCT01077817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5648666|NCT01077817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648667|NCT01077817|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5823523|NCT02597283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5823524|NCT02597283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5823525|NCT02597283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5823526|NCT02597283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5648668|NCT01077817|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5648669|NCT01077817|Hormone Antagonists|hormone antagonists|mesh-ancestor
5648670|NCT01077817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5648671|NCT01077817|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5648672|NCT01077817|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6492919|NCT00611286|Everolimus|everolimus|mesh-list
6492920|NCT00611286|Clopidogrel|clopidogrel|mesh-list
6492921|NCT00611286|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
6492922|NCT00611286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6492923|NCT00611286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6492924|NCT00611286|Tubulin Modulators|tubulin modulators|mesh-ancestor
6492925|NCT00611286|Antimitotic Agents|antimitotic agents|mesh-ancestor
6492926|NCT00611286|Mitosis Modulators|mitosis modulators|mesh-ancestor
5823527|NCT02597283|Antifungal Agents|antifungal agents|mesh-ancestor
5823528|NCT02597283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5823529|NCT02597283|Immunologic Factors|immunologic factors|mesh-ancestor
5823530|NCT02597283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823531|NCT02597231|Melatonin|melatonin|mesh-list
5823532|NCT02597231|Antioxidants|antioxidants|mesh-ancestor
5823533|NCT02597231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823534|NCT02597231|Protective Agents|protective agents|mesh-ancestor
5823535|NCT02597231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823536|NCT02597231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5823537|NCT02597309|Canagliflozin|canagliflozin|mesh-list
5823538|NCT02597309|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5823539|NCT02597309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823540|NCT02597309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5823541|NCT02597309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823542|NCT02597114|Insulin|insulin|mesh-list
5823543|NCT02597114|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5823544|NCT02597114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5823545|NCT02597114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823546|NCT02597257|Lidocaine|lidocaine|mesh-list
5823547|NCT02597257|Anesthetics, Local|anesthetics, local|mesh-ancestor
5823548|NCT02597257|Anesthetics|anesthetics|mesh-ancestor
5823549|NCT02597257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5823550|NCT02597257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823551|NCT02597257|Sensory System Agents|sensory system agents|mesh-ancestor
5823552|NCT02597257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5823553|NCT02597257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5823554|NCT02597257|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5823555|NCT02597257|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5823556|NCT02597257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5823557|NCT02597257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823558|NCT02597140|Lidocaine|lidocaine|mesh-list
5823559|NCT02597140|Propofol|propofol|mesh-list
5823560|NCT02597140|Anesthetics, Local|anesthetics, local|mesh-ancestor
5823561|NCT02597140|Anesthetics|anesthetics|mesh-ancestor
5823562|NCT02597140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5823563|NCT02597140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823564|NCT02597140|Sensory System Agents|sensory system agents|mesh-ancestor
5823565|NCT02597140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5823566|NCT02597140|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5823567|NCT02597140|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5823568|NCT02597140|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5823569|NCT02597140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5823570|NCT02597140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823571|NCT02597140|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5823572|NCT02597140|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5823573|NCT02597140|Anesthetics, General|anesthetics, general|mesh-ancestor
5901893|NCT01899989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5648673|NCT01065779|Alendronate|alendronate|mesh-list
5648674|NCT01065779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5648675|NCT01065779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648676|NCT01056159|Albuterol|albuterol|mesh-list
5648677|NCT01056159|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5648678|NCT01056159|Autonomic Agents|autonomic agents|mesh-ancestor
5648679|NCT01056159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5648680|NCT01056159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648681|NCT01056159|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5648682|NCT01056159|Respiratory System Agents|respiratory system agents|mesh-ancestor
5901894|NCT01869114|Sirolimus|sirolimus|mesh-list
5901895|NCT01869114|Azacitidine|azacitidine|mesh-list
5901896|NCT01869114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6492927|NCT00611286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492928|NCT00611286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6492929|NCT00611286|Immunologic Factors|immunologic factors|mesh-ancestor
5901897|NCT01869114|Antimetabolites|antimetabolites|mesh-ancestor
5901898|NCT01869114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901899|NCT01869114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901900|NCT01869114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5901901|NCT01869114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5901902|NCT01869114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5901903|NCT01869114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6492930|NCT00611286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492931|NCT00611286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5823574|NCT02597166|Sofosbuvir|sofosbuvir|mesh-list
5823575|NCT02597166|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
5823576|NCT02597166|Ledipasvir|ledipasvir|mesh-list
5823577|NCT02597166|Antiviral Agents|antiviral agents|mesh-ancestor
5823578|NCT02597166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5823579|NCT02597153|Mitoxantrone|mitoxantrone|mesh-list
5823580|NCT02597153|Analgesics|analgesics|mesh-ancestor
5823581|NCT02597153|Sensory System Agents|sensory system agents|mesh-ancestor
5823582|NCT02597153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5823583|NCT02597153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823584|NCT02597153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5823585|NCT02597153|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5823586|NCT02597153|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5823587|NCT02597153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5823588|NCT02597153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823589|NCT02596997|Brincidofovir|brincidofovir|mesh-list
5823590|NCT02596997|Antiviral Agents|antiviral agents|mesh-ancestor
5823591|NCT02596997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5823592|NCT02596984|Caspofungin|caspofungin|mesh-list
5823593|NCT02596984|Antifungal Agents|antifungal agents|mesh-ancestor
5823594|NCT02596984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5823595|NCT02596984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5823596|NCT02596984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823597|NCT02597322|Axitinib|axitinib|mesh-list
5823598|NCT02597322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5823599|NCT02597322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5823600|NCT02597322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5823601|NCT02597322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823602|NCT02597036|Paclitaxel|paclitaxel|mesh-list
5823603|NCT02597036|Ramucirumab|ramucirumab|mesh-list
5823604|NCT02597036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5823605|NCT02597036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5823606|NCT02597036|Tubulin Modulators|tubulin modulators|mesh-ancestor
5823607|NCT02597036|Antimitotic Agents|antimitotic agents|mesh-ancestor
5823608|NCT02597036|Mitosis Modulators|mitosis modulators|mesh-ancestor
5823609|NCT02597036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823610|NCT02596880|Ribavirin|ribavirin|mesh-list
5823611|NCT02596880|Sofosbuvir|sofosbuvir|mesh-list
5823612|NCT02596880|Antimetabolites|antimetabolites|mesh-ancestor
5823613|NCT02596880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823614|NCT02596880|Antiviral Agents|antiviral agents|mesh-ancestor
5823615|NCT02596880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5823616|NCT02596828|Sirolimus|sirolimus|mesh-list
5823617|NCT02596828|Irinotecan|irinotecan|mesh-list
5823618|NCT02596828|Temozolomide|temozolomide|mesh-list
5823619|NCT02596828|Dasatinib|dasatinib|mesh-list
5823620|NCT02596828|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5823621|NCT02596828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5823622|NCT02596828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5823623|NCT02596828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823624|NCT02596828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5823625|NCT02596828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5823626|NCT02596828|Alkylating Agents|alkylating agents|mesh-ancestor
5823627|NCT02596828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5823628|NCT02596828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5823629|NCT02596828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5648683|NCT01056159|Tocolytic Agents|tocolytic agents|mesh-ancestor
5648684|NCT01056159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5648685|NCT01056159|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5648686|NCT01056159|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5648687|NCT01056159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5648688|NCT01056159|Adrenergic Agents|adrenergic agents|mesh-ancestor
5648689|NCT01056159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5648690|NCT01056159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694461|NCT03395262|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5694462|NCT03395262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5694463|NCT03395262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694464|NCT03395262|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5694465|NCT03395262|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5694466|NCT03395262|Purinergic Agents|purinergic agents|mesh-ancestor
5694467|NCT03395262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5694468|NCT03395223|Methylene Blue|methylene blue|mesh-list
5694469|NCT03395223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5823630|NCT02596828|Antifungal Agents|antifungal agents|mesh-ancestor
5823631|NCT02596828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5823632|NCT02596828|Immunologic Factors|immunologic factors|mesh-ancestor
5823633|NCT02596828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823634|NCT02596828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5823635|NCT02596776|Deuterium Oxide|deuterium oxide|mesh-list
5823636|NCT02596776|Propranolol|propranolol|mesh-list
5823637|NCT02596776|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5823638|NCT02596776|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5823639|NCT02596776|Adrenergic Agents|adrenergic agents|mesh-ancestor
5823640|NCT02596776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5823641|NCT02596776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823642|NCT02596776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823643|NCT02596776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5823644|NCT02596776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5823645|NCT02596776|Vasodilator Agents|vasodilator agents|mesh-ancestor
5823646|NCT02596776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5823647|NCT02596776|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5823648|NCT02596776|Protective Agents|protective agents|mesh-ancestor
5823649|NCT02596763|Baclofen|baclofen|mesh-list
5823650|NCT02596763|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5823651|NCT02596763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823652|NCT02596763|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5648691|NCT00988260|Ganirelix|ganirelix|mesh-list
5648692|NCT00988260|Hormone Antagonists|hormone antagonists|mesh-ancestor
5648693|NCT00988260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5648694|NCT00988260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648695|NCT00974571|Cetirizine|cetirizine|mesh-list
5648696|NCT00974571|Montelukast|montelukast|mesh-list
5648697|NCT00974571|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5648698|NCT00974571|Respiratory System Agents|respiratory system agents|mesh-ancestor
5648699|NCT00974571|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5648700|NCT00974571|Hormone Antagonists|hormone antagonists|mesh-ancestor
5648701|NCT00974571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5648702|NCT00974571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648703|NCT00974571|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5648704|NCT00974571|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5648705|NCT00974571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648706|NCT00974571|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5648707|NCT00974571|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5648708|NCT00974571|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5648709|NCT00974571|Histamine Antagonists|histamine antagonists|mesh-ancestor
5648710|NCT00974571|Histamine Agents|histamine agents|mesh-ancestor
5648711|NCT00974571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5648712|NCT00972738|Loratadine|loratadine|mesh-list
5648713|NCT00972738|Montelukast|montelukast|mesh-list
5648714|NCT00972738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5648715|NCT00972738|Respiratory System Agents|respiratory system agents|mesh-ancestor
5648716|NCT00972738|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5648717|NCT00972738|Hormone Antagonists|hormone antagonists|mesh-ancestor
5823653|NCT02596763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5823654|NCT02596763|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
5823655|NCT02596763|GABA Agonists|gaba agonists|mesh-ancestor
5823656|NCT02596763|GABA Agents|gaba agents|mesh-ancestor
5823657|NCT02596763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5823658|NCT02596763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823659|NCT02596685|Nicotine|nicotine|mesh-list
5823660|NCT02596685|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5823661|NCT02596685|Autonomic Agents|autonomic agents|mesh-ancestor
5823662|NCT02596685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5823663|NCT02596685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823664|NCT02596685|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5823665|NCT02596685|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5823666|NCT02596685|Cholinergic Agents|cholinergic agents|mesh-ancestor
5823667|NCT02596685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5648718|NCT00972738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5648719|NCT00972738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648720|NCT00972738|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5648721|NCT00972738|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5648722|NCT00972738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648723|NCT00972738|Antipruritics|antipruritics|mesh-ancestor
5648724|NCT00972738|Dermatologic Agents|dermatologic agents|mesh-ancestor
5648725|NCT00972738|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5823668|NCT02596685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823669|NCT02596555|Dabigatran|dabigatran|mesh-list
5823670|NCT02596555|Antithrombins|antithrombins|mesh-ancestor
5823671|NCT02596555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5823672|NCT02596555|Protease Inhibitors|protease inhibitors|mesh-ancestor
5823673|NCT02596555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5823674|NCT02596555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823675|NCT02596555|Anticoagulants|anticoagulants|mesh-ancestor
5823676|NCT02596373|Mitoxantrone|mitoxantrone|mesh-list
5823677|NCT02596373|Analgesics|analgesics|mesh-ancestor
5823678|NCT02596373|Sensory System Agents|sensory system agents|mesh-ancestor
5823679|NCT02596373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5823680|NCT02596373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823681|NCT02596373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5823682|NCT02596373|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5823683|NCT02596373|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5823684|NCT02596373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5823685|NCT02596373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823686|NCT02596282|Anesthetics|anesthetics|mesh-list
5823687|NCT02596282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5648726|NCT00972738|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5648727|NCT00972738|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5648728|NCT00972738|Histamine Antagonists|histamine antagonists|mesh-ancestor
5648729|NCT00972738|Histamine Agents|histamine agents|mesh-ancestor
5648730|NCT00972738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5648731|NCT00968201|Montelukast|montelukast|mesh-list
5648732|NCT00968201|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5648733|NCT00968201|Respiratory System Agents|respiratory system agents|mesh-ancestor
5648734|NCT00968201|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5648735|NCT00968201|Hormone Antagonists|hormone antagonists|mesh-ancestor
5648736|NCT00968201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5648737|NCT00968201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648738|NCT00968201|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5648739|NCT00968201|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5648740|NCT00968201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648741|NCT00968149|Montelukast|montelukast|mesh-list
5648742|NCT00968149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5823688|NCT02596282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823689|NCT02596334|Lamivudine|lamivudine|mesh-list
5823690|NCT02596334|Abacavir|abacavir|mesh-list
5823691|NCT02596334|Dolutegravir|dolutegravir|mesh-list
5823692|NCT02596334|Triumeq|triumeq|mesh-list
5823693|NCT02596334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5823694|NCT02596334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5823695|NCT02596334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5823696|NCT02596334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823697|NCT02596334|Antiviral Agents|antiviral agents|mesh-ancestor
5823698|NCT02596334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5823699|NCT02596334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5823700|NCT02596334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5823701|NCT02596334|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5823702|NCT02596334|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5823703|NCT02596100|Betrixaban|betrixaban|mesh-list
5823704|NCT02596100|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5823705|NCT02596100|Antithrombins|antithrombins|mesh-ancestor
5823706|NCT02596100|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5823707|NCT02596100|Protease Inhibitors|protease inhibitors|mesh-ancestor
5823708|NCT02596100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5823709|NCT02596100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648743|NCT00968149|Respiratory System Agents|respiratory system agents|mesh-ancestor
5648744|NCT00968149|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5648745|NCT00968149|Hormone Antagonists|hormone antagonists|mesh-ancestor
5648746|NCT00968149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5648747|NCT00968149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648748|NCT00968149|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5648749|NCT00968149|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5823710|NCT02596100|Anticoagulants|anticoagulants|mesh-ancestor
5823711|NCT02596217|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5823712|NCT02596217|Immunologic Factors|immunologic factors|mesh-ancestor
5823713|NCT02596217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648750|NCT00968149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648751|NCT00967785|Plerixafor|plerixafor|mesh-list
5648752|NCT00967785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5648753|NCT00967785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5823714|NCT02596243|Vaccines|vaccines|mesh-list
5823715|NCT02596243|Immunologic Factors|immunologic factors|mesh-ancestor
5901904|NCT01869114|Antifungal Agents|antifungal agents|mesh-ancestor
5823716|NCT02596243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823717|NCT02596126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
5823718|NCT02596269|Nefopam|nefopam|mesh-list
5823719|NCT02596269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5823720|NCT02596269|Analgesics|analgesics|mesh-ancestor
5823721|NCT02596269|Sensory System Agents|sensory system agents|mesh-ancestor
5823722|NCT02596269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5823723|NCT02596269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648754|NCT00967785|Antiviral Agents|antiviral agents|mesh-ancestor
5648755|NCT00967785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5648756|NCT00963469|Loratadine|loratadine|mesh-list
5648757|NCT00963469|Montelukast|montelukast|mesh-list
5648758|NCT00963469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5648759|NCT00963469|Respiratory System Agents|respiratory system agents|mesh-ancestor
5648760|NCT00963469|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5648761|NCT00963469|Hormone Antagonists|hormone antagonists|mesh-ancestor
5648762|NCT00963469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5648763|NCT00963469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648764|NCT00963469|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5648765|NCT00963469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5648766|NCT00963469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648767|NCT00963469|Antipruritics|antipruritics|mesh-ancestor
5648768|NCT00963469|Dermatologic Agents|dermatologic agents|mesh-ancestor
5648769|NCT00963469|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5648770|NCT00963469|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5648771|NCT00963469|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5648772|NCT00963469|Histamine Antagonists|histamine antagonists|mesh-ancestor
5648773|NCT00963469|Histamine Agents|histamine agents|mesh-ancestor
5648774|NCT00963469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5648775|NCT00960141|Loratadine|loratadine|mesh-list
5648776|NCT00960141|Montelukast|montelukast|mesh-list
5823724|NCT02596256|Docetaxel|docetaxel|mesh-list
5823725|NCT02596256|Apatinib|apatinib|mesh-list
5823726|NCT02596256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5823727|NCT02596256|Tubulin Modulators|tubulin modulators|mesh-ancestor
5823728|NCT02596256|Antimitotic Agents|antimitotic agents|mesh-ancestor
5823729|NCT02596256|Mitosis Modulators|mitosis modulators|mesh-ancestor
5823730|NCT02596256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823731|NCT02596256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5823732|NCT02596256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5823733|NCT02595801|Anesthetics|anesthetics|mesh-list
5823734|NCT02595801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5823735|NCT02595801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823736|NCT02595658|Insulin, Short-Acting|insulin, short-acting|mesh-list
5823737|NCT02595658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5823738|NCT02595658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648777|NCT00960141|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5648778|NCT00960141|Respiratory System Agents|respiratory system agents|mesh-ancestor
5648779|NCT00960141|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5823739|NCT02595918|Nivolumab|nivolumab|mesh-list
5823740|NCT02595918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5823741|NCT02595918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5823742|NCT02595918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5823743|NCT02595918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823744|NCT02595840|Pemetrexed|pemetrexed|mesh-list
5823745|NCT02595840|Afatinib|afatinib|mesh-list
5823746|NCT02595840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5823747|NCT02595840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5823748|NCT02595840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823749|NCT02595840|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5823750|NCT02595840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5823751|NCT02595840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5823752|NCT02595606|Hyaluronic Acid|hyaluronic acid|mesh-list
5823753|NCT02595606|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5823754|NCT02595606|Immunologic Factors|immunologic factors|mesh-ancestor
5823755|NCT02595606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648780|NCT00960141|Hormone Antagonists|hormone antagonists|mesh-ancestor
5648781|NCT00960141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5648782|NCT00960141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648783|NCT00960141|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5648784|NCT00960141|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5823756|NCT02595606|Viscosupplements|viscosupplements|mesh-ancestor
5823757|NCT02595606|Protective Agents|protective agents|mesh-ancestor
5823758|NCT02595554|Paclitaxel|paclitaxel|mesh-list
5823759|NCT02595554|Cisplatin|cisplatin|mesh-list
5823760|NCT02595554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5823761|NCT02595554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5823762|NCT02595554|Tubulin Modulators|tubulin modulators|mesh-ancestor
5823763|NCT02595554|Antimitotic Agents|antimitotic agents|mesh-ancestor
5823764|NCT02595554|Mitosis Modulators|mitosis modulators|mesh-ancestor
5823765|NCT02595554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823766|NCT02595346|Hydroxychloroquine|hydroxychloroquine|mesh-list
5823767|NCT02595346|Antimalarials|antimalarials|mesh-ancestor
5823768|NCT02595346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5823769|NCT02595346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5823770|NCT02595346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5648785|NCT00960141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648786|NCT00960141|Antipruritics|antipruritics|mesh-ancestor
5648787|NCT00960141|Dermatologic Agents|dermatologic agents|mesh-ancestor
5648788|NCT00960141|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5648789|NCT00960141|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5648790|NCT00960141|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5648791|NCT00960141|Histamine Antagonists|histamine antagonists|mesh-ancestor
5648792|NCT00960141|Histamine Agents|histamine agents|mesh-ancestor
5648793|NCT00960141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5648794|NCT00943683|Montelukast|montelukast|mesh-list
5648795|NCT00943683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5648796|NCT00943683|Respiratory System Agents|respiratory system agents|mesh-ancestor
5648797|NCT00943683|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5648798|NCT00943683|Hormone Antagonists|hormone antagonists|mesh-ancestor
5648799|NCT00943683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5648800|NCT00943683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648801|NCT00943683|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5648802|NCT00943683|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5648803|NCT00943683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648804|NCT00943397|Montelukast|montelukast|mesh-list
5648805|NCT00943397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5648806|NCT00943397|Respiratory System Agents|respiratory system agents|mesh-ancestor
5648807|NCT00943397|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5648808|NCT00943397|Hormone Antagonists|hormone antagonists|mesh-ancestor
5648809|NCT00943397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5648810|NCT00943397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648811|NCT00943397|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5648812|NCT00943397|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5648813|NCT00943397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648814|NCT00911547|Beclomethasone|beclomethasone|mesh-list
5648815|NCT00911547|Montelukast|montelukast|mesh-list
5648816|NCT00911547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5648817|NCT00911547|Respiratory System Agents|respiratory system agents|mesh-ancestor
5648818|NCT00911547|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5648819|NCT00911547|Hormone Antagonists|hormone antagonists|mesh-ancestor
5648820|NCT00911547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5648821|NCT00911547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648822|NCT00911547|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5648823|NCT00911547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5648824|NCT00911547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648825|NCT00911547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5648826|NCT00911547|Glucocorticoids|glucocorticoids|mesh-ancestor
5648827|NCT00911547|Hormones|hormones|mesh-ancestor
5648828|NCT00899379|Rizatriptan|rizatriptan|mesh-list
5648829|NCT00899379|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5648830|NCT00899379|Serotonin Agents|serotonin agents|mesh-ancestor
5648831|NCT00899379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5648832|NCT00899379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648833|NCT00899379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648834|NCT00898677|Sumatriptan|sumatriptan|mesh-list
5648835|NCT00898677|Rizatriptan|rizatriptan|mesh-list
5648836|NCT00898677|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5648837|NCT00898677|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5648838|NCT00898677|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5648839|NCT00898677|Serotonin Agents|serotonin agents|mesh-ancestor
5648840|NCT00898677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5648841|NCT00898677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648842|NCT00898677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823771|NCT02595346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5648843|NCT00897949|Rizatriptan|rizatriptan|mesh-list
5648844|NCT00897949|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5823772|NCT02595346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823773|NCT02595346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5823774|NCT02595359|Moxifloxacin|moxifloxacin|mesh-list
5823775|NCT02595359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5823776|NCT02595359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5823777|NCT02595359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5823778|NCT02595359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5823779|NCT02595359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5823780|NCT02595359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823781|NCT02595359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5823782|NCT02595463|Lidocaine|lidocaine|mesh-list
5823783|NCT02595463|Anesthetics, Local|anesthetics, local|mesh-ancestor
5823784|NCT02595463|Anesthetics|anesthetics|mesh-ancestor
5823785|NCT02595463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5823786|NCT02595463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823787|NCT02595463|Sensory System Agents|sensory system agents|mesh-ancestor
5823788|NCT02595463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5823789|NCT02595463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5823790|NCT02595463|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5823791|NCT02595463|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5823792|NCT02595463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5823793|NCT02595463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823794|NCT02595476|Remifentanil|remifentanil|mesh-list
5823795|NCT02595476|Propofol|propofol|mesh-list
5823796|NCT02595476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5823797|NCT02595476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5823798|NCT02595476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823799|NCT02595476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5823800|NCT02595476|Anesthetics, General|anesthetics, general|mesh-ancestor
5823801|NCT02595476|Anesthetics|anesthetics|mesh-ancestor
5823802|NCT02595476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5823803|NCT02595476|Narcotics|narcotics|mesh-ancestor
5823804|NCT02595476|Analgesics|analgesics|mesh-ancestor
5823805|NCT02595476|Sensory System Agents|sensory system agents|mesh-ancestor
5823806|NCT02595476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5823807|NCT02595541|Milrinone|milrinone|mesh-list
5823808|NCT02595541|Sildenafil Citrate|sildenafil citrate|mesh-list
5823809|NCT02595541|Vasodilator Agents|vasodilator agents|mesh-ancestor
5823810|NCT02595541|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5823811|NCT02595541|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5823812|NCT02595541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5823813|NCT02595541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823814|NCT02595541|Urological Agents|urological agents|mesh-ancestor
5823815|NCT02595541|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5823816|NCT02595541|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5823817|NCT02595541|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5823818|NCT02595541|Protective Agents|protective agents|mesh-ancestor
5823819|NCT02595541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823820|NCT02595489|Vitamin D|vitamin d|mesh-list
5823821|NCT02595489|Ergocalciferols|ergocalciferols|mesh-list
5823822|NCT02595489|Cholecalciferol|cholecalciferol|mesh-list
5823823|NCT02595489|Vitamins|vitamins|mesh-list
5823824|NCT02595489|Micronutrients|micronutrients|mesh-ancestor
5823825|NCT02595489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823826|NCT02595489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5823827|NCT02595489|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6492932|NCT00611286|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5648845|NCT00897949|Serotonin Agents|serotonin agents|mesh-ancestor
5648846|NCT00897949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5648847|NCT00897949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648848|NCT00897949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648849|NCT00897104|Sumatriptan|sumatriptan|mesh-list
5648850|NCT00897104|Rizatriptan|rizatriptan|mesh-list
5648851|NCT00897104|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5648852|NCT00897104|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5648853|NCT00897104|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5648854|NCT00897104|Serotonin Agents|serotonin agents|mesh-ancestor
5648855|NCT00897104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5648856|NCT00897104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648857|NCT00897104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648858|NCT00817817|Mometasone Furoate|mometasone furoate|mesh-list
5648859|NCT00817817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5823828|NCT02595268|Pitavastatin|pitavastatin|mesh-list
5823829|NCT02595268|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5823830|NCT02595268|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5823831|NCT02595268|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5823832|NCT02595268|Antimetabolites|antimetabolites|mesh-ancestor
5823833|NCT02595268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823834|NCT02595268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5823835|NCT02595268|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5901905|NCT01869114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5901906|NCT01869114|Immunologic Factors|immunologic factors|mesh-ancestor
5901907|NCT01869114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901908|NCT01786265|Prednisone|prednisone|mesh-list
5901909|NCT01786265|Cortisone|cortisone|mesh-list
5901910|NCT01786265|Leuprolide|leuprolide|mesh-list
5901911|NCT01786265|Goserelin|goserelin|mesh-list
5901912|NCT01786265|Flutamide|flutamide|mesh-list
5901913|NCT01786265|Abiraterone Acetate|abiraterone acetate|mesh-list
5901914|NCT01786265|Bicalutamide|bicalutamide|mesh-list
5901915|NCT01786265|Nilutamide|nilutamide|mesh-list
5901916|NCT01786265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5901917|NCT01786265|Glucocorticoids|glucocorticoids|mesh-ancestor
5901918|NCT01786265|Hormones|hormones|mesh-ancestor
5901919|NCT01786265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5901920|NCT01786265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901921|NCT01786265|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5901922|NCT01786265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901923|NCT01786265|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5901924|NCT01786265|Fertility Agents|fertility agents|mesh-ancestor
5901925|NCT01786265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5901926|NCT01786265|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5901927|NCT01786265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5901928|NCT01786265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901929|NCT01786265|Hormone Antagonists|hormone antagonists|mesh-ancestor
5648860|NCT00817817|Dermatologic Agents|dermatologic agents|mesh-ancestor
5648861|NCT00817817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5648862|NCT00803790|Vitamin D|vitamin d|mesh-list
5648863|NCT00803790|Ergocalciferols|ergocalciferols|mesh-list
5648864|NCT00803790|Alendronate|alendronate|mesh-list
5648865|NCT00803790|Vitamins|vitamins|mesh-list
5648866|NCT00803790|Micronutrients|micronutrients|mesh-ancestor
5648867|NCT00803790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648868|NCT00803790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5648869|NCT00803790|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5648870|NCT00792506|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
5648871|NCT00792506|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
5648872|NCT00792506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5648873|NCT00792506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648874|NCT00773357|Carvedilol|carvedilol|mesh-list
5648875|NCT00773357|Guanfacine|guanfacine|mesh-list
5901930|NCT01786265|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5901931|NCT01786265|Androgen Antagonists|androgen antagonists|mesh-ancestor
5901932|NCT01737619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5901933|NCT01594398|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5901934|NCT01594398|Exemestane|exemestane|mesh-list
5901935|NCT01594398|Entinostat|entinostat|mesh-list
5901936|NCT01594398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901937|NCT01594398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5901938|NCT01594398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5901939|NCT01594398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901940|NCT01594398|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5901941|NCT01594398|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5901942|NCT01594398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5901943|NCT01594398|Hormone Antagonists|hormone antagonists|mesh-ancestor
5901944|NCT01594398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5901945|NCT01594398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901946|NCT01594398|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5901947|NCT01573429|Bisphenol A|bisphenol a|mesh-list
5901948|NCT01573429|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
5901949|NCT01573429|Estrogens|estrogens|mesh-ancestor
5901950|NCT01573429|Hormones|hormones|mesh-ancestor
5901951|NCT01573429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5901952|NCT01573429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648876|NCT00773357|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5648877|NCT00773357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5901953|NCT01573429|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5823836|NCT02595203|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5823837|NCT02595190|Gabapentin|gabapentin|mesh-list
5823838|NCT02595190|Tramadol|tramadol|mesh-list
5823839|NCT02595190|Analgesics|analgesics|mesh-ancestor
5823840|NCT02595190|Sensory System Agents|sensory system agents|mesh-ancestor
5823841|NCT02595190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5823842|NCT02595190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823843|NCT02595190|Anticonvulsants|anticonvulsants|mesh-ancestor
5823844|NCT02595190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5823845|NCT02595190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5823846|NCT02595190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5823847|NCT02595190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5823848|NCT02595190|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5823849|NCT02595190|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5823850|NCT02595190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5823851|NCT02595190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823852|NCT02595190|Antimanic Agents|antimanic agents|mesh-ancestor
5823853|NCT02595190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5823854|NCT02595190|Narcotics|narcotics|mesh-ancestor
5823855|NCT02595138|Zoledronic Acid|zoledronic acid|mesh-list
5823856|NCT02595138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5823857|NCT02595138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823858|NCT02595242|Prednisone|prednisone|mesh-list
5823859|NCT02595242|Cyclophosphamide|cyclophosphamide|mesh-list
5823860|NCT02595242|Vincristine|vincristine|mesh-list
5823861|NCT02595242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5823862|NCT02595242|Immunologic Factors|immunologic factors|mesh-ancestor
5823863|NCT02595242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823864|NCT02595242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5823865|NCT02595242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5823866|NCT02595242|Alkylating Agents|alkylating agents|mesh-ancestor
5823867|NCT02595242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823868|NCT02595242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5648878|NCT00773357|Adrenergic Agents|adrenergic agents|mesh-ancestor
5648879|NCT00773357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5648880|NCT00773357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648881|NCT00773357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648882|NCT00773357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5648883|NCT00773357|Antioxidants|antioxidants|mesh-ancestor
5648884|NCT00773357|Protective Agents|protective agents|mesh-ancestor
5648885|NCT00773357|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5648886|NCT00773357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5648887|NCT00773357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5648888|NCT00773357|Vasodilator Agents|vasodilator agents|mesh-ancestor
5648889|NCT00773357|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5823869|NCT02595242|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5823870|NCT02595242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5823871|NCT02595242|Glucocorticoids|glucocorticoids|mesh-ancestor
5823872|NCT02595242|Hormones|hormones|mesh-ancestor
5823873|NCT02595242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5823874|NCT02595242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5823875|NCT02595242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5823876|NCT02595242|Tubulin Modulators|tubulin modulators|mesh-ancestor
5823877|NCT02595242|Antimitotic Agents|antimitotic agents|mesh-ancestor
5823878|NCT02595242|Mitosis Modulators|mitosis modulators|mesh-ancestor
5823879|NCT02595034|Clindamycin|clindamycin|mesh-list
5823880|NCT02595034|Clindamycin palmitate|clindamycin palmitate|mesh-list
5823881|NCT02595034|Clindamycin phosphate|clindamycin phosphate|mesh-list
5823882|NCT02595034|Benzoyl Peroxide|benzoyl peroxide|mesh-list
5823883|NCT02595034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5823884|NCT02595034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5823885|NCT02595034|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5823886|NCT02595034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5823887|NCT02595034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823888|NCT02595034|Dermatologic Agents|dermatologic agents|mesh-ancestor
5823889|NCT02594579|Vitamin D|vitamin d|mesh-list
5823890|NCT02594579|Cholecalciferol|cholecalciferol|mesh-list
5648890|NCT00773357|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5648891|NCT00773357|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5648892|NCT00773357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5648893|NCT00773357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5648894|NCT00745108|Tibolone|tibolone|mesh-list
5823891|NCT02594579|Vitamins|vitamins|mesh-ancestor
5823892|NCT02594579|Micronutrients|micronutrients|mesh-ancestor
5823893|NCT02594579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823894|NCT02594579|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5823895|NCT02594579|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5823896|NCT02594761|Trastuzumab|trastuzumab|mesh-list
5823897|NCT02594761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5823898|NCT02594761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5823899|NCT02594800|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5823900|NCT02594800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5823901|NCT02594800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5823902|NCT02594800|Antimetabolites|antimetabolites|mesh-ancestor
5823903|NCT02594800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823904|NCT02594800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5823905|NCT02594800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5823906|NCT02594800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5823907|NCT02594735|Abatacept|abatacept|mesh-list
5823908|NCT02594735|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5823909|NCT02594735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823910|NCT02594735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5823911|NCT02594735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5823912|NCT02594735|Immunologic Factors|immunologic factors|mesh-ancestor
5823913|NCT02594735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823914|NCT02594735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5823915|NCT02594358|Caffeine|caffeine|mesh-list
5823916|NCT02594358|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5823917|NCT02594358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823918|NCT02594358|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5823919|NCT02594358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5823920|NCT02594358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823921|NCT02594358|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5823922|NCT02594358|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5823923|NCT02594358|Purinergic Agents|purinergic agents|mesh-ancestor
5823924|NCT02594358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5823925|NCT02594423|Bevacizumab|bevacizumab|mesh-list
5823926|NCT02594423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5823927|NCT02594423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5823928|NCT02594423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5823929|NCT02594423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5823930|NCT02594423|Growth Substances|growth substances|mesh-ancestor
5823931|NCT02594423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823932|NCT02594423|Growth Inhibitors|growth inhibitors|mesh-ancestor
5823933|NCT02594293|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5823934|NCT02594293|Antiviral Agents|antiviral agents|mesh-ancestor
5823935|NCT02594293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5823936|NCT02594410|Lercanidipine|lercanidipine|mesh-list
5823937|NCT02594410|Clopidogrel|clopidogrel|mesh-list
5823938|NCT02594410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5823939|NCT02594410|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5823940|NCT02594410|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5823941|NCT02594410|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5823942|NCT02594410|Purinergic Agents|purinergic agents|mesh-ancestor
5823943|NCT02594410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5823944|NCT02594410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5823945|NCT02594410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823946|NCT02594410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5823947|NCT02594410|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5823948|NCT02594410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5823949|NCT02594410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5823950|NCT02594462|Contraceptive Agents|contraceptive agents|mesh-list
6492933|NCT00611286|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6492934|NCT00611286|Purinergic Agents|purinergic agents|mesh-ancestor
6492935|NCT00611286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6492936|NCT00611286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6492937|NCT00611286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6492938|NCT00611286|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6492939|NCT00611286|Antifungal Agents|antifungal agents|mesh-ancestor
6492940|NCT00611416|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
6492941|NCT00611416|Caffeine|caffeine|mesh-list
5823951|NCT02594462|Etonogestrel|etonogestrel|mesh-list
5823952|NCT02594462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5823953|NCT02594462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823954|NCT02594462|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5823955|NCT02594462|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5823956|NCT02594241|Prednisolone|prednisolone|mesh-list
6674425|NCT01569204|Doxorubicin|doxorubicin|mesh-list
5823957|NCT02594241|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5823958|NCT02594241|Methylprednisolone|methylprednisolone|mesh-list
5823959|NCT02594241|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5823960|NCT02594241|Prednisolone acetate|prednisolone acetate|mesh-list
5823961|NCT02594241|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5823962|NCT02594241|Prednisolone phosphate|prednisolone phosphate|mesh-list
5823963|NCT02594241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5823964|NCT02594241|Glucocorticoids|glucocorticoids|mesh-ancestor
5823965|NCT02594241|Hormones|hormones|mesh-ancestor
5823966|NCT02594241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5823967|NCT02594241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823968|NCT02594241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5648895|NCT00745108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648896|NCT00745108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5648897|NCT00745108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5648898|NCT00745108|Hormones|hormones|mesh-ancestor
5648899|NCT00745108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5823969|NCT02594241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5823970|NCT02594241|Antiemetics|antiemetics|mesh-ancestor
5823971|NCT02594241|Autonomic Agents|autonomic agents|mesh-ancestor
5823972|NCT02594241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5823973|NCT02594241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5823974|NCT02594241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5823975|NCT02594241|Protective Agents|protective agents|mesh-ancestor
5823976|NCT02594449|Benzalkonium Compounds|benzalkonium compounds|mesh-list
5823977|NCT02594449|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5823978|NCT02594449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5823979|NCT02594033|Insulin Aspart|insulin aspart|mesh-list
5823980|NCT02594033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5823981|NCT02594033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823982|NCT02593942|Remifentanil|remifentanil|mesh-list
5648900|NCT00745108|Androgen Antagonists|androgen antagonists|mesh-ancestor
5648901|NCT00745108|Hormone Antagonists|hormone antagonists|mesh-ancestor
5648902|NCT00745108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5648903|NCT00745108|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5648904|NCT00745108|Anabolic Agents|anabolic agents|mesh-ancestor
5648905|NCT00725491|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5648906|NCT00725491|Ganirelix|ganirelix|mesh-list
5648907|NCT00725491|Luteolytic Agents|luteolytic agents|mesh-ancestor
5648908|NCT00725491|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5648909|NCT00725491|Contraceptive Agents|contraceptive agents|mesh-ancestor
5648910|NCT00725491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5648911|NCT00725491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648912|NCT00725491|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5648913|NCT00725491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5648914|NCT00725491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5648915|NCT00725491|Hormone Antagonists|hormone antagonists|mesh-ancestor
5648916|NCT00725491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5648917|NCT00725374|Tibolone|tibolone|mesh-list
5648918|NCT00725374|Androgen Antagonists|androgen antagonists|mesh-ancestor
5648919|NCT00725374|Hormone Antagonists|hormone antagonists|mesh-ancestor
5648920|NCT00725374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5648921|NCT00725374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823983|NCT02593942|Propofol|propofol|mesh-list
6492942|NCT00611416|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6492943|NCT00611416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492944|NCT00611416|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6492945|NCT00611416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6674426|NCT01569204|Etoposide|etoposide|mesh-list
5823984|NCT02593942|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5823985|NCT02593942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5823986|NCT02593942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5823987|NCT02593942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5823988|NCT02593942|Anesthetics, General|anesthetics, general|mesh-ancestor
5823989|NCT02593942|Anesthetics|anesthetics|mesh-ancestor
5823990|NCT02593942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5823991|NCT02593942|Narcotics|narcotics|mesh-ancestor
5823992|NCT02593942|Analgesics|analgesics|mesh-ancestor
5823993|NCT02593942|Sensory System Agents|sensory system agents|mesh-ancestor
5823994|NCT02593942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5648922|NCT00725374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5648923|NCT00725374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5648924|NCT00725374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5648925|NCT00725374|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5823995|NCT02593786|Nivolumab|nivolumab|mesh-list
5823996|NCT02593786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5823997|NCT02593786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5823998|NCT02593786|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5823999|NCT02593786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492946|NCT00611416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5648926|NCT00725374|Anabolic Agents|anabolic agents|mesh-ancestor
5648927|NCT00725374|Hormones|hormones|mesh-ancestor
5648928|NCT00724789|Ganirelix|ganirelix|mesh-list
5648929|NCT00724789|Hormone Antagonists|hormone antagonists|mesh-ancestor
5648930|NCT00724789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5648931|NCT00724789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648932|NCT00711607|Estradiol|estradiol|mesh-list
5648933|NCT00711607|Estrogens|estrogens|mesh-ancestor
5648934|NCT00711607|Hormones|hormones|mesh-ancestor
6492947|NCT00611416|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6492948|NCT00611416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6492949|NCT00611416|Purinergic Agents|purinergic agents|mesh-ancestor
6492950|NCT00611416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6492951|NCT00611416|Antioxidants|antioxidants|mesh-ancestor
6492952|NCT00611416|Protective Agents|protective agents|mesh-ancestor
5824000|NCT02594072|Goserelin|goserelin|mesh-list
5824001|NCT02594072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5824002|NCT02594072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5824003|NCT02593968|Interferons|interferons|mesh-list
5824004|NCT02593968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5824005|NCT02593968|Antiviral Agents|antiviral agents|mesh-ancestor
5824006|NCT02593968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5824007|NCT02593747|Loratadine|loratadine|mesh-list
5824008|NCT02593747|Antipruritics|antipruritics|mesh-ancestor
5824009|NCT02593747|Dermatologic Agents|dermatologic agents|mesh-ancestor
5824010|NCT02593747|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6492953|NCT00611416|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
6492954|NCT00611416|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6492955|NCT00611416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6492956|NCT00611416|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6492957|NCT00611494|Mycophenolic Acid|mycophenolic acid|mesh-list
6492958|NCT00611494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6492959|NCT00611494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6492960|NCT00611494|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5824011|NCT02593747|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5824012|NCT02593747|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5824013|NCT02593747|Histamine Antagonists|histamine antagonists|mesh-ancestor
5824014|NCT02593747|Histamine Agents|histamine agents|mesh-ancestor
5824015|NCT02593747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5824016|NCT02593747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824017|NCT02593747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824018|NCT02593734|Olanzapine|olanzapine|mesh-list
5824019|NCT02593734|Risperidone|risperidone|mesh-list
5824020|NCT02593734|Fluoxetine|fluoxetine|mesh-list
5824021|NCT02593734|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5824022|NCT02593734|Serotonin Agents|serotonin agents|mesh-ancestor
5824023|NCT02593734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5824024|NCT02593734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824025|NCT02593734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648935|NCT00711607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5824026|NCT02593734|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5824027|NCT02593734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5824028|NCT02593734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5824029|NCT02593734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5824030|NCT02593734|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5824031|NCT02593734|Dopamine Agents|dopamine agents|mesh-ancestor
5824032|NCT02593734|Antiemetics|antiemetics|mesh-ancestor
5824033|NCT02593734|Autonomic Agents|autonomic agents|mesh-ancestor
5824034|NCT02593734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5824035|NCT02593734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5824036|NCT02593734|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5824037|NCT02593734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5824038|NCT02593734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5824039|NCT02593734|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5824040|NCT02593734|Antidepressive Agents|antidepressive agents|mesh-ancestor
5824041|NCT02593734|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5824042|NCT02593734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5824043|NCT02593734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5901954|NCT01573429|Antioxidants|antioxidants|mesh-ancestor
6492961|NCT00611494|Antitubercular Agents|antitubercular agents|mesh-ancestor
5824044|NCT02593708|Paclitaxel|paclitaxel|mesh-list
5824045|NCT02593708|Trastuzumab|trastuzumab|mesh-list
5824046|NCT02593708|Pertuzumab|pertuzumab|mesh-list
5824047|NCT02593708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5824048|NCT02593708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5824049|NCT02593708|Tubulin Modulators|tubulin modulators|mesh-ancestor
5824050|NCT02593708|Antimitotic Agents|antimitotic agents|mesh-ancestor
5824051|NCT02593708|Mitosis Modulators|mitosis modulators|mesh-ancestor
5824052|NCT02593708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824053|NCT02593708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5824054|NCT02593695|Fluoxetine|fluoxetine|mesh-list
5824055|NCT02593695|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5824056|NCT02593695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5824057|NCT02593695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5824058|NCT02593695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824059|NCT02593695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5824060|NCT02593695|Serotonin Agents|serotonin agents|mesh-ancestor
5824061|NCT02593695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824062|NCT02593695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5824063|NCT02593695|Antidepressive Agents|antidepressive agents|mesh-ancestor
5824064|NCT02593695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5824065|NCT02593695|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5824066|NCT02593695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5824067|NCT02593695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5824068|NCT02593721|Ibuprofen|ibuprofen|mesh-list
5824069|NCT02593721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5824070|NCT02593721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5824071|NCT02593721|Analgesics|analgesics|mesh-ancestor
5824072|NCT02593721|Sensory System Agents|sensory system agents|mesh-ancestor
5824073|NCT02593721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5824074|NCT02593721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824075|NCT02593721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5824076|NCT02593721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5824077|NCT02593721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5824078|NCT02593721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5824079|NCT02593721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824080|NCT02593526|Bumetanide|bumetanide|mesh-list
5824081|NCT02593526|Dialysis Solutions|dialysis solutions|mesh-list
5824082|NCT02593526|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5824083|NCT02593526|Diuretics|diuretics|mesh-ancestor
5824084|NCT02593526|Natriuretic Agents|natriuretic agents|mesh-ancestor
5648936|NCT00711607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648937|NCT00703014|Progesterone|progesterone|mesh-list
5648938|NCT00703014|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5648939|NCT00703014|Ganirelix|ganirelix|mesh-list
5648940|NCT00703014|Progestins|progestins|mesh-ancestor
5648941|NCT00703014|Hormones|hormones|mesh-ancestor
5648942|NCT00703014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5648943|NCT00703014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648944|NCT00703014|Hormone Antagonists|hormone antagonists|mesh-ancestor
5648945|NCT00702988|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5648946|NCT00702988|Hormones|hormones|mesh-ancestor
5648947|NCT00702988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5648948|NCT00702988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648949|NCT00702845|Hormones|hormones|mesh-list
5648950|NCT00702845|Progesterone|progesterone|mesh-list
5648951|NCT00702845|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5648952|NCT00702845|Ganirelix|ganirelix|mesh-list
5648953|NCT00702845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5824085|NCT02593526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824086|NCT02593526|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5824087|NCT02593526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5824088|NCT02593526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824089|NCT02593643|Midazolam|midazolam|mesh-list
5824090|NCT02593643|Ketamine|ketamine|mesh-list
5824091|NCT02593643|Analgesics|analgesics|mesh-ancestor
5824092|NCT02593643|Sensory System Agents|sensory system agents|mesh-ancestor
5824093|NCT02593643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5824094|NCT02593643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824095|NCT02593643|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5824096|NCT02593643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5824097|NCT02593643|Anesthetics, General|anesthetics, general|mesh-ancestor
5648954|NCT00702845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824098|NCT02593643|Anesthetics|anesthetics|mesh-ancestor
5824099|NCT02593643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5824100|NCT02593643|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5824101|NCT02593643|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5824102|NCT02593643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5824103|NCT02593643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824104|NCT02593643|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5824105|NCT02593643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5824106|NCT02593643|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5824107|NCT02593643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5824108|NCT02593643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5824109|NCT02593643|GABA Modulators|gaba modulators|mesh-ancestor
5824110|NCT02593643|GABA Agents|gaba agents|mesh-ancestor
5824111|NCT02593669|Dexamethasone|dexamethasone|mesh-list
5824112|NCT02593669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5824113|NCT02593669|Antiemetics|antiemetics|mesh-ancestor
5648955|NCT00702845|Progestins|progestins|mesh-ancestor
5648956|NCT00702845|Hormone Antagonists|hormone antagonists|mesh-ancestor
5648957|NCT00702806|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5648958|NCT00702806|Ganirelix|ganirelix|mesh-list
5648959|NCT00702806|Hormone Antagonists|hormone antagonists|mesh-ancestor
5648960|NCT00702806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5648961|NCT00702806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648962|NCT00702806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5648963|NCT00702624|Hormones|hormones|mesh-list
5648964|NCT00702624|Progesterone|progesterone|mesh-list
5648965|NCT00702624|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5648966|NCT00702624|Ganirelix|ganirelix|mesh-list
5648967|NCT00702624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5648968|NCT00702624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648969|NCT00702624|Progestins|progestins|mesh-ancestor
5648970|NCT00702624|Hormone Antagonists|hormone antagonists|mesh-ancestor
5648971|NCT00702546|Hormones|hormones|mesh-list
5648972|NCT00702546|Progesterone|progesterone|mesh-list
5648973|NCT00702546|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5648974|NCT00702546|Ganirelix|ganirelix|mesh-list
5648975|NCT00702546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5648976|NCT00702546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648977|NCT00702546|Progestins|progestins|mesh-ancestor
5648978|NCT00702546|Hormone Antagonists|hormone antagonists|mesh-ancestor
5648979|NCT00702520|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5648980|NCT00702520|Hormones|hormones|mesh-list
5648981|NCT00702520|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5648982|NCT00702520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5648983|NCT00702520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648984|NCT00702520|Luteolytic Agents|luteolytic agents|mesh-ancestor
5648985|NCT00702520|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5648986|NCT00702520|Contraceptive Agents|contraceptive agents|mesh-ancestor
5824114|NCT02593669|Autonomic Agents|autonomic agents|mesh-ancestor
5824115|NCT02593669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5824116|NCT02593669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824117|NCT02593669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5824118|NCT02593669|Glucocorticoids|glucocorticoids|mesh-ancestor
5824119|NCT02593669|Hormones|hormones|mesh-ancestor
5824120|NCT02593669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5824121|NCT02593669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5824122|NCT02593669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5824123|NCT02593500|Budesonide|budesonide|mesh-list
5824124|NCT02593500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5824125|NCT02593500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5824126|NCT02593500|Autonomic Agents|autonomic agents|mesh-ancestor
5824127|NCT02593500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5824128|NCT02593500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824129|NCT02593500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5824130|NCT02593500|Respiratory System Agents|respiratory system agents|mesh-ancestor
5824131|NCT02593500|Glucocorticoids|glucocorticoids|mesh-ancestor
5824132|NCT02593500|Hormones|hormones|mesh-ancestor
5824133|NCT02593500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5824134|NCT02593383|Clindamycin|clindamycin|mesh-list
5824135|NCT02593383|Clindamycin palmitate|clindamycin palmitate|mesh-list
5824136|NCT02593383|Clindamycin phosphate|clindamycin phosphate|mesh-list
5824137|NCT02593383|Adapalene|adapalene|mesh-list
5824138|NCT02593383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5824139|NCT02593383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5824140|NCT02593383|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5824141|NCT02593383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5648987|NCT00702520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5648988|NCT00702520|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5648989|NCT00702520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5648990|NCT00702520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5648991|NCT00702338|Hormones|hormones|mesh-list
5648992|NCT00702338|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5648993|NCT00702338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5648994|NCT00702338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5648995|NCT00702273|Progesterone|progesterone|mesh-list
5648996|NCT00702273|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5648997|NCT00702273|Ganirelix|ganirelix|mesh-list
5648998|NCT00702273|Progestins|progestins|mesh-ancestor
5648999|NCT00702273|Hormones|hormones|mesh-ancestor
5649000|NCT00702273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5649001|NCT00702273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649002|NCT00702273|Hormone Antagonists|hormone antagonists|mesh-ancestor
5649003|NCT00702234|Progesterone|progesterone|mesh-list
5649004|NCT00702234|Progestins|progestins|mesh-ancestor
5649005|NCT00702234|Hormones|hormones|mesh-ancestor
5649006|NCT00702234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5649007|NCT00702234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649008|NCT00702195|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5649009|NCT00702195|Hormones|hormones|mesh-ancestor
5649010|NCT00702195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5649011|NCT00702195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649012|NCT00697255|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5649013|NCT00697255|Hormones|hormones|mesh-list
5649014|NCT00697255|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5649015|NCT00697255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5649016|NCT00697255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649017|NCT00697255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5649018|NCT00696878|Progesterone|progesterone|mesh-list
5649019|NCT00696878|Progestins|progestins|mesh-ancestor
5649020|NCT00696878|Hormones|hormones|mesh-ancestor
5649021|NCT00696878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5824142|NCT02593383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824143|NCT02593383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5824144|NCT02593383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5824145|NCT02593383|Analgesics|analgesics|mesh-ancestor
5824146|NCT02593383|Sensory System Agents|sensory system agents|mesh-ancestor
5824147|NCT02593383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5824148|NCT02593383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824149|NCT02593383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5824150|NCT02593383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5824151|NCT02593383|Dermatologic Agents|dermatologic agents|mesh-ancestor
5824152|NCT02593409|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5824153|NCT02593409|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5824154|NCT02593409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5824155|NCT02593409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5824156|NCT02593409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824157|NCT02593409|Antiviral Agents|antiviral agents|mesh-ancestor
5824158|NCT02593409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5824159|NCT02593409|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5824160|NCT02593409|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5824161|NCT02593474|Naltrexone|naltrexone|mesh-list
5824162|NCT02593474|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5824163|NCT02593474|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5824164|NCT02593474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824165|NCT02593474|Sensory System Agents|sensory system agents|mesh-ancestor
5824166|NCT02593474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5824167|NCT02593448|Anesthetics|anesthetics|mesh-list
5824168|NCT02593448|Propofol|propofol|mesh-list
6492962|NCT00611494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6492963|NCT00611494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6492964|NCT00611494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6492965|NCT00611494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824169|NCT02593448|Sevoflurane|sevoflurane|mesh-list
5824170|NCT02593448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5824171|NCT02593448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824172|NCT02593448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5824173|NCT02593448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5824174|NCT02593448|Anesthetics, General|anesthetics, general|mesh-ancestor
5824175|NCT02593448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5824176|NCT02593448|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5824177|NCT02593487|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5824178|NCT02593487|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5824179|NCT02593487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5824180|NCT02593487|Antimetabolites|antimetabolites|mesh-ancestor
5824181|NCT02593487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824182|NCT02593487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5824183|NCT02593487|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5824184|NCT02593487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5824185|NCT02593370|Lidocaine|lidocaine|mesh-list
5824186|NCT02593370|Epinephrine|epinephrine|mesh-list
5824187|NCT02593370|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
5824188|NCT02593370|Anesthetics, Local|anesthetics, local|mesh-ancestor
5824189|NCT02593370|Anesthetics|anesthetics|mesh-ancestor
5824190|NCT02593370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5824191|NCT02593370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824192|NCT02593370|Sensory System Agents|sensory system agents|mesh-ancestor
5824193|NCT02593370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5649022|NCT00696878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649023|NCT00696800|Progesterone|progesterone|mesh-list
5649024|NCT00696800|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5649025|NCT00696800|Ganirelix|ganirelix|mesh-list
5649026|NCT00696800|Progestins|progestins|mesh-ancestor
5649027|NCT00696800|Hormones|hormones|mesh-ancestor
5649028|NCT00696800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5649029|NCT00696800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649030|NCT00696800|Hormone Antagonists|hormone antagonists|mesh-ancestor
5649031|NCT00647933|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5649032|NCT00647933|Lynestrenol|lynestrenol|mesh-list
5649033|NCT00647933|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5649034|NCT00647933|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5649035|NCT00647933|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5649036|NCT00647933|Contraceptive Agents|contraceptive agents|mesh-ancestor
5649037|NCT00647933|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5649038|NCT00647933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649039|NCT00647933|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5649040|NCT00647933|Estrogens|estrogens|mesh-ancestor
5649041|NCT00647933|Hormones|hormones|mesh-ancestor
5649042|NCT00647933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5649043|NCT00647933|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5649044|NCT00641771|Cholecalciferol|cholecalciferol|mesh-list
5649045|NCT00641771|Alendronate|alendronate|mesh-list
5649046|NCT00641771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5649047|NCT00641771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649048|NCT00641771|Vitamins|vitamins|mesh-ancestor
5649049|NCT00641771|Micronutrients|micronutrients|mesh-ancestor
5649050|NCT00641771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5649051|NCT00616967|Paclitaxel|paclitaxel|mesh-list
5649052|NCT00616967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5824194|NCT02593370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5824195|NCT02593370|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5824196|NCT02593370|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5824197|NCT02593370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5824198|NCT02593370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824199|NCT02593370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5824200|NCT02593370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5824201|NCT02593370|Adrenergic Agents|adrenergic agents|mesh-ancestor
5824202|NCT02593370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5824203|NCT02593370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5824204|NCT02593370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5649053|NCT00616967|Carboplatin|carboplatin|mesh-list
5649054|NCT00616967|Vorinostat|vorinostat|mesh-list
5649055|NCT00616967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5649056|NCT00616967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5649057|NCT00616967|Tubulin Modulators|tubulin modulators|mesh-ancestor
5649058|NCT00616967|Antimitotic Agents|antimitotic agents|mesh-ancestor
5649059|NCT00616967|Mitosis Modulators|mitosis modulators|mesh-ancestor
5649060|NCT00616967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649061|NCT00616967|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5649062|NCT00616967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5649063|NCT00606346|Infliximab|infliximab|mesh-list
5649064|NCT00606346|Dermatologic Agents|dermatologic agents|mesh-ancestor
5649065|NCT00606346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5824205|NCT02593370|Autonomic Agents|autonomic agents|mesh-ancestor
5824206|NCT02593370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5824207|NCT02593370|Respiratory System Agents|respiratory system agents|mesh-ancestor
5824208|NCT02593370|Mydriatics|mydriatics|mesh-ancestor
5824209|NCT02593370|Sympathomimetics|sympathomimetics|mesh-ancestor
5824210|NCT02593370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5824211|NCT02593370|Chelating Agents|chelating agents|mesh-ancestor
5824212|NCT02593370|Sequestering Agents|sequestering agents|mesh-ancestor
5824213|NCT02593019|Adavosertib|adavosertib|mesh-list
5824214|NCT02593019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5824215|NCT02593019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824216|NCT02593162|Ribavirin|ribavirin|mesh-list
5824217|NCT02593162|Antimetabolites|antimetabolites|mesh-ancestor
5824218|NCT02593162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824219|NCT02593162|Antiviral Agents|antiviral agents|mesh-ancestor
5824220|NCT02593162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5824221|NCT02592980|Warfarin|warfarin|mesh-list
5824222|NCT02592980|Anticoagulants|anticoagulants|mesh-ancestor
5824223|NCT02593201|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5824224|NCT02593201|Cefazolin|cefazolin|mesh-list
5824225|NCT02593201|Ceftazidime|ceftazidime|mesh-list
5824226|NCT02593201|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5824227|NCT02593201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5824228|NCT02593201|Antitubercular Agents|antitubercular agents|mesh-ancestor
5824229|NCT02592941|Deflazacort|deflazacort|mesh-list
5824230|NCT02592941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5824231|NCT02592941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5824232|NCT02592941|Immunologic Factors|immunologic factors|mesh-ancestor
5649066|NCT00606346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5649067|NCT00598208|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5649068|NCT00598208|Hormones|hormones|mesh-ancestor
5649069|NCT00598208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5649070|NCT00598208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649071|NCT00519857|Tibolone|tibolone|mesh-list
5649072|NCT00519857|Androgen Antagonists|androgen antagonists|mesh-ancestor
5649073|NCT00519857|Hormone Antagonists|hormone antagonists|mesh-ancestor
5649074|NCT00519857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5649075|NCT00519857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649076|NCT00519857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5649077|NCT00519857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5649078|NCT00519857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5649079|NCT00519857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5649080|NCT00519857|Anabolic Agents|anabolic agents|mesh-ancestor
5649081|NCT00519857|Hormones|hormones|mesh-ancestor
5649082|NCT00480662|Alendronate|alendronate|mesh-list
5649083|NCT00480662|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5649084|NCT00480662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649085|NCT00461032|Montelukast|montelukast|mesh-list
5649086|NCT00461032|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5649087|NCT00461032|Respiratory System Agents|respiratory system agents|mesh-ancestor
5649088|NCT00461032|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5649089|NCT00461032|Hormone Antagonists|hormone antagonists|mesh-ancestor
5649090|NCT00461032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5649091|NCT00461032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649092|NCT00461032|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5649093|NCT00461032|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5649094|NCT00461032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649095|NCT00446056|Ketotifen|ketotifen|mesh-list
5649096|NCT00446056|Montelukast|montelukast|mesh-list
5824233|NCT02592941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824234|NCT02593227|Cyclophosphamide|cyclophosphamide|mesh-list
5824235|NCT02593227|Vaccines|vaccines|mesh-list
5824236|NCT02593227|Immunologic Factors|immunologic factors|mesh-ancestor
6211655|NCT02175966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211656|NCT02175966|Antiviral Agents|antiviral agents|mesh-ancestor
5649097|NCT00446056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5649098|NCT00446056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649099|NCT00446056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649100|NCT00446056|Respiratory System Agents|respiratory system agents|mesh-ancestor
5649101|NCT00446056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5649102|NCT00446056|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5649103|NCT00446056|Hormone Antagonists|hormone antagonists|mesh-ancestor
5824237|NCT02593227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824238|NCT02593227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5824239|NCT02593227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5824240|NCT02593227|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5824241|NCT02593227|Alkylating Agents|alkylating agents|mesh-ancestor
5824242|NCT02593227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824243|NCT02593227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5824244|NCT02593227|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5824245|NCT02593110|Telmisartan|telmisartan|mesh-list
5824246|NCT02593110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5824247|NCT02593110|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5824248|NCT02593110|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5824249|NCT02593110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824250|NCT02592863|Pentoxifylline|pentoxifylline|mesh-list
5824251|NCT02592863|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5824252|NCT02592863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5824253|NCT02592863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824254|NCT02592863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5824255|NCT02592863|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5824256|NCT02592863|Protective Agents|protective agents|mesh-ancestor
5824257|NCT02592863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824258|NCT02592863|Vasodilator Agents|vasodilator agents|mesh-ancestor
5824259|NCT02592863|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5824260|NCT02592863|Antioxidants|antioxidants|mesh-ancestor
5824261|NCT02592772|Menthol|menthol|mesh-list
5824262|NCT02592772|Nicotine|nicotine|mesh-list
5824263|NCT02592772|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5824264|NCT02592772|Autonomic Agents|autonomic agents|mesh-ancestor
5824265|NCT02592772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5824266|NCT02592772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824267|NCT02592772|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5824268|NCT02592772|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5824269|NCT02592772|Cholinergic Agents|cholinergic agents|mesh-ancestor
5824270|NCT02592772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5824271|NCT02592772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824272|NCT02592772|Antipruritics|antipruritics|mesh-ancestor
5824273|NCT02592772|Dermatologic Agents|dermatologic agents|mesh-ancestor
5824274|NCT02592915|Clonidine|clonidine|mesh-list
5824275|NCT02592915|Anesthetics|anesthetics|mesh-list
5824276|NCT02592915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5824277|NCT02592915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824278|NCT02592915|Analgesics|analgesics|mesh-ancestor
5824279|NCT02592915|Sensory System Agents|sensory system agents|mesh-ancestor
5824280|NCT02592915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5824281|NCT02592915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5824282|NCT02592915|Sympatholytics|sympatholytics|mesh-ancestor
5824283|NCT02592915|Autonomic Agents|autonomic agents|mesh-ancestor
5824284|NCT02592915|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5824285|NCT02592915|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5824286|NCT02592915|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5824287|NCT02592915|Adrenergic Agents|adrenergic agents|mesh-ancestor
5824288|NCT02592915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5824289|NCT02592915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824290|NCT02592720|Tenecteplase|tenecteplase|mesh-list
5824291|NCT02592720|Tirofiban|tirofiban|mesh-list
5824292|NCT02592720|Bivalirudin|bivalirudin|mesh-list
5824293|NCT02592720|Antithrombins|antithrombins|mesh-ancestor
5824294|NCT02592720|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5824295|NCT02592720|Protease Inhibitors|protease inhibitors|mesh-ancestor
5824296|NCT02592720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5824297|NCT02592720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824298|NCT02592720|Anticoagulants|anticoagulants|mesh-ancestor
5824299|NCT02592720|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5824300|NCT02592720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5824301|NCT02592720|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5824302|NCT02592746|Capecitabine|capecitabine|mesh-list
5824303|NCT02592746|Palbociclib|palbociclib|mesh-list
5824304|NCT02592746|Leuprolide|leuprolide|mesh-list
5824305|NCT02592746|Exemestane|exemestane|mesh-list
5824306|NCT02592746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5824307|NCT02592746|Antimetabolites|antimetabolites|mesh-ancestor
5824308|NCT02592746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824309|NCT02592746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5824310|NCT02592746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5824311|NCT02592746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5824312|NCT02592746|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5824313|NCT02592746|Fertility Agents|fertility agents|mesh-ancestor
5824314|NCT02592746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5824315|NCT02592746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824316|NCT02592746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5824317|NCT02592746|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5824318|NCT02592746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5824319|NCT02592746|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5824320|NCT02592746|Hormone Antagonists|hormone antagonists|mesh-ancestor
5824321|NCT02592746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5824322|NCT02592694|Tenecteplase|tenecteplase|mesh-list
5824323|NCT02592694|Tirofiban|tirofiban|mesh-list
5824324|NCT02592694|Bivalirudin|bivalirudin|mesh-list
5824325|NCT02592694|Antithrombins|antithrombins|mesh-ancestor
5824326|NCT02592694|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5824327|NCT02592694|Protease Inhibitors|protease inhibitors|mesh-ancestor
5824328|NCT02592694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5824329|NCT02592694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824330|NCT02592694|Anticoagulants|anticoagulants|mesh-ancestor
5824331|NCT02592694|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5824332|NCT02592694|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5824333|NCT02592694|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5824334|NCT02592226|Anesthetics|anesthetics|mesh-list
5824335|NCT02592226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5824336|NCT02592226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824337|NCT02592395|Folfirinox|folfirinox|mesh-list
5824338|NCT02592395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5824339|NCT02592278|Listerine|listerine|mesh-list
5824340|NCT02592278|Fluorides|fluorides|mesh-list
5824341|NCT02592278|Fluorides, Topical|fluorides, topical|mesh-list
5824342|NCT02592278|Sodium Fluoride|sodium fluoride|mesh-list
5824343|NCT02592278|Cariostatic Agents|cariostatic agents|mesh-ancestor
5824344|NCT02592278|Protective Agents|protective agents|mesh-ancestor
5824345|NCT02592278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824346|NCT02592278|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5824347|NCT02592278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5824348|NCT02592083|Tamoxifen|tamoxifen|mesh-list
5824349|NCT02592083|Goserelin|goserelin|mesh-list
5824350|NCT02592083|Palbociclib|palbociclib|mesh-list
5824351|NCT02592083|Exemestane|exemestane|mesh-list
5824352|NCT02592083|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5824353|NCT02592083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5824354|NCT02592083|Hormone Antagonists|hormone antagonists|mesh-ancestor
5824355|NCT02592083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5824356|NCT02592083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824357|NCT02592083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5824358|NCT02592083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5824359|NCT02592083|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5824360|NCT02592083|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5824361|NCT02592083|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5824362|NCT02592083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5824363|NCT02592083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5824364|NCT02592083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824365|NCT02592083|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5824366|NCT02592122|Bromides|bromides|mesh-list
5824367|NCT02592122|Albuterol|albuterol|mesh-list
6492966|NCT00611507|Fluorouracil|fluorouracil|mesh-list
6492967|NCT00611507|Oxaliplatin|oxaliplatin|mesh-list
6492968|NCT00611507|Antimetabolites|antimetabolites|mesh-ancestor
5824368|NCT02592122|Anticonvulsants|anticonvulsants|mesh-ancestor
5824369|NCT02592122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5824370|NCT02592122|Autonomic Agents|autonomic agents|mesh-ancestor
5824371|NCT02592122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5824372|NCT02592122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824373|NCT02592122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5824374|NCT02592122|Respiratory System Agents|respiratory system agents|mesh-ancestor
5824375|NCT02592122|Tocolytic Agents|tocolytic agents|mesh-ancestor
5824376|NCT02592122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5824377|NCT02592122|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5824378|NCT02592122|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5824379|NCT02592122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5824380|NCT02592122|Adrenergic Agents|adrenergic agents|mesh-ancestor
5824381|NCT02592122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5824382|NCT02592122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901955|NCT01573429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901956|NCT01573429|Protective Agents|protective agents|mesh-ancestor
5901957|NCT01478542|Rituximab|rituximab|mesh-list
5901958|NCT01478542|Vincristine|vincristine|mesh-list
6492969|NCT00611507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824383|NCT02591953|Methylprednisolone|methylprednisolone|mesh-list
5824384|NCT02591953|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5824385|NCT02591953|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5824386|NCT02591953|Prednisolone|prednisolone|mesh-list
5824387|NCT02591953|Prednisolone acetate|prednisolone acetate|mesh-list
5824388|NCT02591953|Lidocaine|lidocaine|mesh-list
5824389|NCT02591953|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5824390|NCT02591953|Prednisolone phosphate|prednisolone phosphate|mesh-list
5649104|NCT00446056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5649105|NCT00446056|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5649106|NCT00446056|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5649107|NCT00446056|Antipruritics|antipruritics|mesh-ancestor
5649108|NCT00446056|Dermatologic Agents|dermatologic agents|mesh-ancestor
5649109|NCT00446056|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5649110|NCT00446056|Histamine Antagonists|histamine antagonists|mesh-ancestor
5649111|NCT00446056|Histamine Agents|histamine agents|mesh-ancestor
5824391|NCT02591953|Anesthetics, Local|anesthetics, local|mesh-ancestor
5824392|NCT02591953|Anesthetics|anesthetics|mesh-ancestor
5824393|NCT02591953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5824394|NCT02591953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824395|NCT02591953|Sensory System Agents|sensory system agents|mesh-ancestor
5824396|NCT02591953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5824397|NCT02591953|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5824398|NCT02591953|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5649112|NCT00446056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5649113|NCT00442338|Aminophylline|aminophylline|mesh-list
5649114|NCT00442338|Theophylline|theophylline|mesh-list
5649115|NCT00442338|Montelukast|montelukast|mesh-list
5649116|NCT00442338|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5649117|NCT00442338|Respiratory System Agents|respiratory system agents|mesh-ancestor
5649118|NCT00442338|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5649119|NCT00442338|Hormone Antagonists|hormone antagonists|mesh-ancestor
5649120|NCT00442338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5649121|NCT00442338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649122|NCT00442338|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5649123|NCT00442338|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5649124|NCT00442338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649125|NCT00442338|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5649126|NCT00442338|Autonomic Agents|autonomic agents|mesh-ancestor
5649127|NCT00442338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5649128|NCT00442338|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5649129|NCT00442338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5649130|NCT00442338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5649131|NCT00442338|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5649132|NCT00442338|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5649133|NCT00442338|Purinergic Agents|purinergic agents|mesh-ancestor
5649134|NCT00442338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5649135|NCT00442338|Protective Agents|protective agents|mesh-ancestor
5649136|NCT00442338|Vasodilator Agents|vasodilator agents|mesh-ancestor
5649137|NCT00431093|Tibolone|tibolone|mesh-list
5649138|NCT00431093|Estradiol|estradiol|mesh-list
5649139|NCT00431093|Estrogens|estrogens|mesh-ancestor
5649140|NCT00431093|Hormones|hormones|mesh-ancestor
5649141|NCT00431093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5649142|NCT00431093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649143|NCT00431093|Androgen Antagonists|androgen antagonists|mesh-ancestor
5649144|NCT00431093|Hormone Antagonists|hormone antagonists|mesh-ancestor
5649145|NCT00431093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5649146|NCT00431093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5649147|NCT00431093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5649148|NCT00431093|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5649149|NCT00431093|Anabolic Agents|anabolic agents|mesh-ancestor
5649150|NCT00398931|Alendronate|alendronate|mesh-list
5649151|NCT00398931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649152|NCT00398931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5649153|NCT00398606|Alendronate|alendronate|mesh-list
5824399|NCT02591953|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5824400|NCT02591953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5824401|NCT02591953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824402|NCT02591953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5824403|NCT02591953|Antiemetics|antiemetics|mesh-ancestor
5824404|NCT02591953|Autonomic Agents|autonomic agents|mesh-ancestor
5824405|NCT02591953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5824406|NCT02591953|Glucocorticoids|glucocorticoids|mesh-ancestor
5824407|NCT02591953|Hormones|hormones|mesh-ancestor
5649154|NCT00398606|Calcium Carbonate|calcium carbonate|mesh-list
5649155|NCT00398606|Calcium|calcium|mesh-list
5649156|NCT00398606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5649157|NCT00398606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649158|NCT00398606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649159|NCT00398606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5649160|NCT00398606|Antacids|antacids|mesh-ancestor
5649161|NCT00398606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5824408|NCT02591953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5824409|NCT02591953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5824410|NCT02591953|Protective Agents|protective agents|mesh-ancestor
5824411|NCT02591953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5649162|NCT00395408|Beclomethasone|beclomethasone|mesh-list
5649163|NCT00395408|Montelukast|montelukast|mesh-list
5649164|NCT00395408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649165|NCT00395408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649166|NCT00395408|Respiratory System Agents|respiratory system agents|mesh-ancestor
5649167|NCT00395408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5649168|NCT00395408|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5649169|NCT00395408|Hormone Antagonists|hormone antagonists|mesh-ancestor
5649170|NCT00395408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5649171|NCT00395408|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5649172|NCT00395408|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5649173|NCT00395408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5649174|NCT00395408|Glucocorticoids|glucocorticoids|mesh-ancestor
5649175|NCT00395408|Hormones|hormones|mesh-ancestor
5649176|NCT00394069|Montelukast|montelukast|mesh-list
5649177|NCT00394069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5649178|NCT00394069|Respiratory System Agents|respiratory system agents|mesh-ancestor
5649179|NCT00394069|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5649180|NCT00394069|Hormone Antagonists|hormone antagonists|mesh-ancestor
5649181|NCT00394069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5649182|NCT00394069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649183|NCT00394069|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5649184|NCT00394069|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5649185|NCT00394069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824412|NCT02591953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5824413|NCT02592096|Carbamide Peroxide|carbamide peroxide|mesh-list
5824414|NCT02592096|Pazufloxacin|pazufloxacin|mesh-list
5824415|NCT02592096|Fluoroquinolones|fluoroquinolones|mesh-list
5824416|NCT02592096|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5824417|NCT02592096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5649186|NCT00389740|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
5649187|NCT00389740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649188|NCT00389740|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5649189|NCT00389740|Hormone Antagonists|hormone antagonists|mesh-ancestor
5649190|NCT00389740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5649191|NCT00389740|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5649192|NCT00389740|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5824418|NCT02592096|Antitubercular Agents|antitubercular agents|mesh-ancestor
5824419|NCT02592096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5824420|NCT02592096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5824421|NCT02592096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5824422|NCT02592096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5824423|NCT02592096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824424|NCT02592096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5824425|NCT02592096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5824426|NCT02592057|Sofosbuvir|sofosbuvir|mesh-list
5824427|NCT02592057|Antiviral Agents|antiviral agents|mesh-ancestor
5824428|NCT02592057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5824429|NCT02591914|Bevacizumab|bevacizumab|mesh-list
5824430|NCT02591914|Ranibizumab|ranibizumab|mesh-list
5824431|NCT02591914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5824432|NCT02591914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5824433|NCT02591914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5824434|NCT02591914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5824435|NCT02591914|Growth Substances|growth substances|mesh-ancestor
5824436|NCT02591914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824437|NCT02591914|Growth Inhibitors|growth inhibitors|mesh-ancestor
5824438|NCT02591927|Insulin|insulin|mesh-list
5824439|NCT02591927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5824440|NCT02591927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824441|NCT02591615|Paclitaxel|paclitaxel|mesh-list
5824442|NCT02591615|Carboplatin|carboplatin|mesh-list
5824443|NCT02591615|Pembrolizumab|pembrolizumab|mesh-list
5824444|NCT02591615|Pemetrexed|pemetrexed|mesh-list
5824445|NCT02591615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5824446|NCT02591615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5824447|NCT02591615|Tubulin Modulators|tubulin modulators|mesh-ancestor
5824448|NCT02591615|Antimitotic Agents|antimitotic agents|mesh-ancestor
5824449|NCT02591615|Mitosis Modulators|mitosis modulators|mesh-ancestor
5824450|NCT02591615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824451|NCT02591615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5824452|NCT02591615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5649193|NCT00389740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5649194|NCT00353938|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
5649195|NCT00353938|Hallucinogens|hallucinogens|mesh-ancestor
5649196|NCT00353938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649197|NCT00353938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5649198|NCT00353938|Serotonin Agents|serotonin agents|mesh-ancestor
5649199|NCT00353938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5649200|NCT00353938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649201|NCT00353938|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5649202|NCT00353938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5649203|NCT00353938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5649204|NCT00353938|Adrenergic Agents|adrenergic agents|mesh-ancestor
5649205|NCT00335777|Dihydroergotamine|dihydroergotamine|mesh-list
5649206|NCT00335777|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5649207|NCT00335777|Dopamine Agonists|dopamine agonists|mesh-ancestor
5649208|NCT00335777|Dopamine Agents|dopamine agents|mesh-ancestor
5649209|NCT00335777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5649210|NCT00335777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824453|NCT02591615|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5824454|NCT02591615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5824455|NCT02591888|Bupivacaine|bupivacaine|mesh-list
5649211|NCT00335777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649212|NCT00335777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5649213|NCT00335777|Analgesics|analgesics|mesh-ancestor
5649214|NCT00335777|Sensory System Agents|sensory system agents|mesh-ancestor
5649215|NCT00335777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5649216|NCT00289874|Montelukast|montelukast|mesh-list
5649217|NCT00289874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5649218|NCT00289874|Respiratory System Agents|respiratory system agents|mesh-ancestor
5649219|NCT00289874|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5649220|NCT00289874|Hormone Antagonists|hormone antagonists|mesh-ancestor
5649221|NCT00289874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5649222|NCT00289874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649223|NCT00289874|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5649224|NCT00289874|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5649225|NCT00289874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649226|NCT00250458|Rizatriptan|rizatriptan|mesh-list
5649227|NCT00250458|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5649228|NCT00250458|Serotonin Agents|serotonin agents|mesh-ancestor
5649229|NCT00250458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5649230|NCT00250458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649231|NCT00250458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649232|NCT00245570|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5649233|NCT00245570|Montelukast|montelukast|mesh-list
5649234|NCT00245570|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5649235|NCT00245570|Autonomic Agents|autonomic agents|mesh-ancestor
5649236|NCT00245570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5649237|NCT00245570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649238|NCT00245570|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5649239|NCT00245570|Respiratory System Agents|respiratory system agents|mesh-ancestor
5824456|NCT02591888|Anesthetics, Local|anesthetics, local|mesh-ancestor
5824457|NCT02591888|Anesthetics|anesthetics|mesh-ancestor
5824458|NCT02591888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5824459|NCT02591888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824460|NCT02591888|Sensory System Agents|sensory system agents|mesh-ancestor
5824461|NCT02591888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5824462|NCT02591771|Epinephrine|epinephrine|mesh-list
5824463|NCT02591771|Racepinephrine|racepinephrine|mesh-list
6492970|NCT00611507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6492971|NCT00611507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5824464|NCT02591771|Epinephryl borate|epinephryl borate|mesh-list
5824465|NCT02591771|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5824466|NCT02591771|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5824467|NCT02591771|Adrenergic Agents|adrenergic agents|mesh-ancestor
5824468|NCT02591771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5824469|NCT02591771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492972|NCT00611507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6492973|NCT00611507|Immunologic Factors|immunologic factors|mesh-ancestor
6492974|NCT00611507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492975|NCT00611572|Flumazenil|flumazenil|mesh-list
6492976|NCT00611572|Antidotes|antidotes|mesh-ancestor
6492977|NCT00611572|Protective Agents|protective agents|mesh-ancestor
6492978|NCT00611572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492979|NCT00611572|GABA Modulators|gaba modulators|mesh-ancestor
6492980|NCT00611572|GABA Agents|gaba agents|mesh-ancestor
6492981|NCT00611572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6492982|NCT00611572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492983|NCT00611611|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5649240|NCT00245570|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5824470|NCT02591771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824471|NCT02591771|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5824472|NCT02591771|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5824473|NCT02591771|Autonomic Agents|autonomic agents|mesh-ancestor
5824474|NCT02591771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5824475|NCT02591771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5824476|NCT02591771|Respiratory System Agents|respiratory system agents|mesh-ancestor
5824477|NCT02591771|Mydriatics|mydriatics|mesh-ancestor
5824478|NCT02591771|Sympathomimetics|sympathomimetics|mesh-ancestor
5824479|NCT02591771|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5824480|NCT02591836|Atorvastatin|atorvastatin|mesh-list
5824481|NCT02591836|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5824482|NCT02591836|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5824483|NCT02591836|Antimetabolites|antimetabolites|mesh-ancestor
5824484|NCT02591836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824485|NCT02591836|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5824486|NCT02591836|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5824487|NCT02591836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5824488|NCT02591849|Glucagon|glucagon|mesh-list
5824489|NCT02591849|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5824490|NCT02591849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5824491|NCT02591849|Hormones|hormones|mesh-ancestor
5824492|NCT02591849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5824493|NCT02591849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824494|NCT02591849|Incretins|incretins|mesh-ancestor
5649241|NCT00245570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5649242|NCT00245570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5649243|NCT00245570|Adrenergic Agents|adrenergic agents|mesh-ancestor
5649244|NCT00245570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5649245|NCT00245570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649246|NCT00245570|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5649247|NCT00245570|Hormone Antagonists|hormone antagonists|mesh-ancestor
5649248|NCT00245570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5649249|NCT00245570|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5649250|NCT00245570|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5649251|NCT00229970|Montelukast|montelukast|mesh-list
5649252|NCT00229970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5649253|NCT00229970|Respiratory System Agents|respiratory system agents|mesh-ancestor
5649254|NCT00229970|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5649255|NCT00229970|Hormone Antagonists|hormone antagonists|mesh-ancestor
5698107|NCT03371342|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5824495|NCT02591784|Nimotuzumab|nimotuzumab|mesh-list
5824496|NCT02591784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5824497|NCT02591784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5824498|NCT02591667|Bevacizumab|bevacizumab|mesh-list
5824499|NCT02591667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5824500|NCT02591667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5824501|NCT02591667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5824502|NCT02591667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5824503|NCT02591667|Growth Substances|growth substances|mesh-ancestor
5824504|NCT02591667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492984|NCT00611611|Immunologic Factors|immunologic factors|mesh-ancestor
5824505|NCT02591667|Growth Inhibitors|growth inhibitors|mesh-ancestor
5824506|NCT02591654|Pembrolizumab|pembrolizumab|mesh-list
6674427|NCT01569204|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5824507|NCT02591654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5824508|NCT02591654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5824509|NCT02591628|Chlorthalidone|chlorthalidone|mesh-list
5824510|NCT02591628|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5824511|NCT02591628|Diuretics|diuretics|mesh-ancestor
5824512|NCT02591628|Natriuretic Agents|natriuretic agents|mesh-ancestor
5824513|NCT02591628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824514|NCT02591628|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5824515|NCT02591628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5824516|NCT02591628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824517|NCT02591277|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
5824518|NCT02591277|Antiviral Agents|antiviral agents|mesh-ancestor
5824519|NCT02591277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5824520|NCT02591225|Phenprocoumon|phenprocoumon|mesh-list
5824521|NCT02591225|Anticoagulants|anticoagulants|mesh-ancestor
5824522|NCT02591251|Povidone-Iodine|povidone-iodine|mesh-list
5824523|NCT02591251|Povidone|povidone|mesh-list
5824524|NCT02591251|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5824525|NCT02591251|Plasma Substitutes|plasma substitutes|mesh-ancestor
5824526|NCT02591251|Blood Substitutes|blood substitutes|mesh-ancestor
5824527|NCT02591251|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5824528|NCT02591251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5824529|NCT02590900|Acetaminophen|acetaminophen|mesh-list
5824530|NCT02590900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5824531|NCT02590900|Analgesics|analgesics|mesh-ancestor
5824532|NCT02590900|Sensory System Agents|sensory system agents|mesh-ancestor
5824533|NCT02590900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5824534|NCT02590900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824535|NCT02590900|Antipyretics|antipyretics|mesh-ancestor
5824536|NCT02591173|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
5824537|NCT02591173|Angiotensin II|angiotensin ii|mesh-list
5824538|NCT02591173|Angiotensinogen|angiotensinogen|mesh-list
5824539|NCT02591173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5649256|NCT00229970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5649257|NCT00229970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649258|NCT00229970|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5649259|NCT00229970|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5649260|NCT00229970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649261|NCT00140946|Montelukast|montelukast|mesh-list
5649262|NCT00140946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649263|NCT00140946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649264|NCT00140946|Respiratory System Agents|respiratory system agents|mesh-ancestor
5649265|NCT00140946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5649266|NCT00140946|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5824540|NCT02591173|Vasodilator Agents|vasodilator agents|mesh-ancestor
5824541|NCT02591173|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5824542|NCT02591173|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5824543|NCT02591173|Protease Inhibitors|protease inhibitors|mesh-ancestor
5824544|NCT02591173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5824545|NCT02591173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824546|NCT02590874|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5824547|NCT02590874|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5824548|NCT02590874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5824549|NCT02590874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5824550|NCT02590874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824551|NCT02590874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5824552|NCT02590874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824553|NCT02590874|Analgesics|analgesics|mesh-ancestor
5824554|NCT02590874|Sensory System Agents|sensory system agents|mesh-ancestor
5824555|NCT02590874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5824556|NCT02590874|Antidepressive Agents|antidepressive agents|mesh-ancestor
5824557|NCT02590874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5824558|NCT02590874|Dopamine Agents|dopamine agents|mesh-ancestor
5824559|NCT02591017|Morphine|morphine|mesh-list
5824560|NCT02591017|Ketamine|ketamine|mesh-list
5649267|NCT00140946|Hormone Antagonists|hormone antagonists|mesh-ancestor
5649268|NCT00140946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5824561|NCT02591017|Chitosan|chitosan|mesh-list
5824562|NCT02591017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5824563|NCT02591017|Narcotics|narcotics|mesh-ancestor
5824564|NCT02591017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5824565|NCT02591017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824566|NCT02591017|Analgesics|analgesics|mesh-ancestor
5824567|NCT02591017|Sensory System Agents|sensory system agents|mesh-ancestor
5824568|NCT02591017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5649269|NCT00140946|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5649270|NCT00140946|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5649271|NCT00140881|Montelukast|montelukast|mesh-list
5649272|NCT00140881|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5649273|NCT00140881|Respiratory System Agents|respiratory system agents|mesh-ancestor
5649274|NCT00140881|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5649275|NCT00140881|Hormone Antagonists|hormone antagonists|mesh-ancestor
5649276|NCT00140881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5649277|NCT00140881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649278|NCT00140881|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5649279|NCT00140881|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5649280|NCT00140881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824569|NCT02591017|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5824570|NCT02591017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5824571|NCT02591017|Anesthetics, General|anesthetics, general|mesh-ancestor
5824572|NCT02591017|Anesthetics|anesthetics|mesh-ancestor
5824573|NCT02591017|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5824574|NCT02591017|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5824575|NCT02591017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5824576|NCT02591017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824577|NCT02591017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5824578|NCT02591017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5824579|NCT02591017|Antimetabolites|antimetabolites|mesh-ancestor
5824580|NCT02591017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5824581|NCT02591017|Chelating Agents|chelating agents|mesh-ancestor
5824582|NCT02591017|Sequestering Agents|sequestering agents|mesh-ancestor
5824583|NCT02591017|Hemostatics|hemostatics|mesh-ancestor
5824584|NCT02591017|Coagulants|coagulants|mesh-ancestor
5824585|NCT02591095|Navitoclax|navitoclax|mesh-list
5824586|NCT02591095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5824587|NCT02591004|Nifedipine|nifedipine|mesh-list
5824588|NCT02591004|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5824589|NCT02591004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5824590|NCT02591004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824591|NCT02591004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5824592|NCT02591004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824593|NCT02591004|Vasodilator Agents|vasodilator agents|mesh-ancestor
5824594|NCT02591004|Tocolytic Agents|tocolytic agents|mesh-ancestor
5824595|NCT02591004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5824596|NCT02590653|Atorvastatin|atorvastatin|mesh-list
5824597|NCT02590653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5824598|NCT02590653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5824599|NCT02590653|Antimetabolites|antimetabolites|mesh-ancestor
5824600|NCT02590653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824601|NCT02590653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5824602|NCT02590653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5824603|NCT02590653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5824604|NCT02590536|Sildenafil Citrate|sildenafil citrate|mesh-list
5824605|NCT02590536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824606|NCT02590536|Vasodilator Agents|vasodilator agents|mesh-ancestor
5824607|NCT02590536|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5824608|NCT02590536|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5824609|NCT02590536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5824610|NCT02590536|Urological Agents|urological agents|mesh-ancestor
5824611|NCT02590705|Lidocaine|lidocaine|mesh-list
5824612|NCT02590705|Anesthetics, Local|anesthetics, local|mesh-ancestor
5824613|NCT02590705|Anesthetics|anesthetics|mesh-ancestor
5824614|NCT02590705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5824615|NCT02590705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824616|NCT02590705|Sensory System Agents|sensory system agents|mesh-ancestor
5824617|NCT02590705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5649281|NCT00111722|Rizatriptan|rizatriptan|mesh-list
5649282|NCT00111722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5649283|NCT00111722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649284|NCT00111722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649285|NCT00111722|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5824618|NCT02590705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5824619|NCT02590705|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5824620|NCT02590705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5824621|NCT02590705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5649286|NCT00111722|Serotonin Agents|serotonin agents|mesh-ancestor
5649287|NCT00111709|Rizatriptan|rizatriptan|mesh-list
5649288|NCT00111709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5649289|NCT00111709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649290|NCT00111709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649291|NCT00111709|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5649292|NCT00111709|Serotonin Agents|serotonin agents|mesh-ancestor
5649293|NCT00095004|Rizatriptan|rizatriptan|mesh-list
5649294|NCT00095004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5649295|NCT00095004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649296|NCT00095004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649297|NCT00095004|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5649298|NCT00095004|Serotonin Agents|serotonin agents|mesh-ancestor
5649299|NCT00092963|Rizatriptan|rizatriptan|mesh-list
5649300|NCT00092963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5649301|NCT00092963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649302|NCT00092963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649303|NCT00092963|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5649304|NCT00092963|Serotonin Agents|serotonin agents|mesh-ancestor
5649305|NCT00092885|Montelukast|montelukast|mesh-list
5649306|NCT00092885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5649307|NCT00092885|Respiratory System Agents|respiratory system agents|mesh-ancestor
5649308|NCT00092885|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5649309|NCT00092885|Hormone Antagonists|hormone antagonists|mesh-ancestor
5649310|NCT00092885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5649311|NCT00092885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649312|NCT00092885|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5649313|NCT00092885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5649314|NCT00092885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649315|NCT00092131|Montelukast|montelukast|mesh-list
5649316|NCT00092131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5649317|NCT00092131|Respiratory System Agents|respiratory system agents|mesh-ancestor
5649318|NCT00092131|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5649319|NCT00092131|Hormone Antagonists|hormone antagonists|mesh-ancestor
5649320|NCT00092131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5649321|NCT00092131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649322|NCT00092131|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5649323|NCT00092131|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5649324|NCT00092131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649325|NCT00092118|Montelukast|montelukast|mesh-list
5649326|NCT00092118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5649327|NCT00092118|Respiratory System Agents|respiratory system agents|mesh-ancestor
5649328|NCT00092118|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5649329|NCT00092118|Hormone Antagonists|hormone antagonists|mesh-ancestor
5824622|NCT02590705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824623|NCT02590523|Moxifloxacin|moxifloxacin|mesh-list
5824624|NCT02590523|Vancomycin|vancomycin|mesh-list
5824625|NCT02590523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5824626|NCT02590523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5824627|NCT02590523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5824628|NCT02590523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5824629|NCT02590523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5824630|NCT02590523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824631|NCT02590523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5824632|NCT02590601|Bromocriptine|bromocriptine|mesh-list
5824633|NCT02590601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5824634|NCT02590601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5824635|NCT02590601|Hormone Antagonists|hormone antagonists|mesh-ancestor
5824636|NCT02590601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5824637|NCT02590601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824638|NCT02590601|Dopamine Agonists|dopamine agonists|mesh-ancestor
5824639|NCT02590601|Dopamine Agents|dopamine agents|mesh-ancestor
5824640|NCT02590601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5824641|NCT02590601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824642|NCT02590627|Lumefantrine|lumefantrine|mesh-list
5824643|NCT02590627|Artemether|artemether|mesh-list
5824644|NCT02590627|Piperaquine|piperaquine|mesh-list
5824645|NCT02590627|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
5824646|NCT02590627|Artenimol|artenimol|mesh-list
5824647|NCT02590627|Antimalarials|antimalarials|mesh-ancestor
5824648|NCT02590627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6492985|NCT00611611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824649|NCT02590627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5824650|NCT02590627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5824651|NCT02590614|Vitamin D|vitamin d|mesh-list
5824652|NCT02590614|Vitamins|vitamins|mesh-ancestor
5824653|NCT02590614|Micronutrients|micronutrients|mesh-ancestor
5824654|NCT02590614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824655|NCT02590614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5649330|NCT00092118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5649331|NCT00092118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649332|NCT00092118|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5649333|NCT00092118|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5649334|NCT00092118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649335|NCT00092105|Montelukast|montelukast|mesh-list
5649336|NCT00092105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5901959|NCT01478542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5901960|NCT01478542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901961|NCT01478542|Immunologic Factors|immunologic factors|mesh-ancestor
5901962|NCT01478542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901963|NCT01478542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5901964|NCT01478542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5901965|NCT01478542|Tubulin Modulators|tubulin modulators|mesh-ancestor
5901966|NCT01478542|Antimitotic Agents|antimitotic agents|mesh-ancestor
5901967|NCT01478542|Mitosis Modulators|mitosis modulators|mesh-ancestor
5901968|NCT01478542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901969|NCT00819221|Doxorubicin|doxorubicin|mesh-list
5901970|NCT00819221|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5901971|NCT00819221|Olaparib|olaparib|mesh-list
5901972|NCT00819221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5901973|NCT00819221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901974|NCT00819221|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5901975|NCT00819221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5901976|NCT00819221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5901977|NCT00819221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901978|NCT00819221|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5901979|NCT00807651|Insulin|insulin|mesh-list
5901980|NCT00807651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5901981|NCT00807651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5901982|NCT00807651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901983|NCT00700791|Vitamins|vitamins|mesh-list
5901984|NCT00700791|Vitamin E|vitamin e|mesh-list
5901985|NCT00700791|Tocopherols|tocopherols|mesh-list
5901986|NCT00700791|Tocotrienols|tocotrienols|mesh-list
5901987|NCT00700791|alpha-Tocopherol|alpha-tocopherol|mesh-list
5901988|NCT00700791|Micronutrients|micronutrients|mesh-ancestor
5901989|NCT00700791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5901990|NCT00700791|Antioxidants|antioxidants|mesh-ancestor
5901991|NCT00700791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5901992|NCT00700791|Protective Agents|protective agents|mesh-ancestor
5901993|NCT00452023|Interferons|interferons|mesh-list
5901994|NCT00452023|Interferon-alpha|interferon-alpha|mesh-list
5901995|NCT00452023|Interferon alpha-2|interferon alpha-2|mesh-list
5901996|NCT00452023|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5901997|NCT00452023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5901998|NCT00452023|Antiviral Agents|antiviral agents|mesh-ancestor
5901999|NCT00452023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5902000|NCT00452023|Immunologic Factors|immunologic factors|mesh-ancestor
5902001|NCT00452023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902002|NCT05129748|Sodium thiosulfate|sodium thiosulfate|mesh-list
5902003|NCT05129748|Mannitol|mannitol|mesh-list
5902004|NCT05129748|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5649337|NCT00092105|Respiratory System Agents|respiratory system agents|mesh-ancestor
5649338|NCT00092105|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5649339|NCT00092105|Hormone Antagonists|hormone antagonists|mesh-ancestor
5649340|NCT00092105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5649341|NCT00092105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649342|NCT00092105|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5649343|NCT00092105|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5649344|NCT00092105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649345|NCT00092092|Budesonide|budesonide|mesh-list
5649346|NCT00092092|Montelukast|montelukast|mesh-list
5649347|NCT00092092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5649348|NCT00092092|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5902005|NCT05129748|Diuretics|diuretics|mesh-ancestor
5902006|NCT05129748|Natriuretic Agents|natriuretic agents|mesh-ancestor
5902007|NCT05129748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649349|NCT00092092|Autonomic Agents|autonomic agents|mesh-ancestor
5649350|NCT00092092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5649351|NCT00092092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824656|NCT02590510|Methotrexate|methotrexate|mesh-list
5824657|NCT02590510|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5824658|NCT02590510|Abortifacient Agents|abortifacient agents|mesh-ancestor
5824659|NCT02590510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5824660|NCT02590510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824661|NCT02590510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5824662|NCT02590510|Antimetabolites|antimetabolites|mesh-ancestor
5824663|NCT02590510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824664|NCT02590510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5824665|NCT02590510|Dermatologic Agents|dermatologic agents|mesh-ancestor
5824666|NCT02590510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5824667|NCT02590510|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5824668|NCT02590510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5824669|NCT02590510|Immunologic Factors|immunologic factors|mesh-ancestor
5824670|NCT02590510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5824671|NCT02590510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5824672|NCT02590263|Temozolomide|temozolomide|mesh-list
5824673|NCT02590263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5824674|NCT02590263|Alkylating Agents|alkylating agents|mesh-ancestor
5824675|NCT02590263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824676|NCT02590263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5824677|NCT02590224|Glycine|glycine|mesh-list
5824678|NCT02590224|Glycine Agents|glycine agents|mesh-ancestor
5824679|NCT02590224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5824680|NCT02590224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824681|NCT02590224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824682|NCT02590133|Fluorouracil|fluorouracil|mesh-list
5824683|NCT02590133|Endostar protein|endostar protein|mesh-list
5824684|NCT02590133|Endostatins|endostatins|mesh-list
5824685|NCT02590133|Nedaplatin|nedaplatin|mesh-list
5824686|NCT02590133|Antimetabolites|antimetabolites|mesh-ancestor
5824687|NCT02590133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824688|NCT02590133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5824689|NCT02590133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5824690|NCT02590133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5824691|NCT02590133|Immunologic Factors|immunologic factors|mesh-ancestor
5824692|NCT02590133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824693|NCT02590133|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5824694|NCT02590133|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5824695|NCT02590133|Growth Substances|growth substances|mesh-ancestor
5824696|NCT02590133|Growth Inhibitors|growth inhibitors|mesh-ancestor
5824697|NCT02590250|Botulinum Toxins|botulinum toxins|mesh-list
5824698|NCT02590250|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5824699|NCT02590250|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5824700|NCT02590250|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5824701|NCT02590250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5824702|NCT02590250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824703|NCT02590250|Cholinergic Agents|cholinergic agents|mesh-ancestor
5824704|NCT02590250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5824705|NCT02590250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824706|NCT02590250|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5824707|NCT02590250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5824708|NCT02590055|Gemcitabine|gemcitabine|mesh-list
5824709|NCT02590055|Docetaxel|docetaxel|mesh-list
5824710|NCT02590055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5824711|NCT02590055|Antimetabolites|antimetabolites|mesh-ancestor
5824712|NCT02590055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649352|NCT00092092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5649353|NCT00092092|Respiratory System Agents|respiratory system agents|mesh-ancestor
5649354|NCT00092092|Glucocorticoids|glucocorticoids|mesh-ancestor
5649355|NCT00092092|Hormones|hormones|mesh-ancestor
5649356|NCT00092092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5649357|NCT00092092|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5649358|NCT00092092|Hormone Antagonists|hormone antagonists|mesh-ancestor
5649359|NCT00092092|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5649360|NCT00092092|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5649361|NCT00092092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649362|NCT00092066|Cholecalciferol|cholecalciferol|mesh-list
5649363|NCT00092066|Alendronate|alendronate|mesh-list
5824713|NCT02590055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5649364|NCT00092066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5649365|NCT00092066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649366|NCT00092066|Vitamins|vitamins|mesh-ancestor
5649367|NCT00092066|Micronutrients|micronutrients|mesh-ancestor
5649368|NCT00092066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5649369|NCT00092053|Ibandronic Acid|ibandronic acid|mesh-list
5649370|NCT00092053|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5649371|NCT00092053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649372|NCT00092040|Alendronate|alendronate|mesh-list
5649373|NCT00092040|Risedronic Acid|risedronic acid|mesh-list
5649374|NCT00092040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649375|NCT00092040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649376|NCT00092040|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5649377|NCT00092040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5649378|NCT00092040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5649379|NCT00092040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5649380|NCT00092027|Alendronate|alendronate|mesh-list
5649381|NCT00092027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649382|NCT00092027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5649383|NCT00092014|Vitamin D|vitamin d|mesh-list
5649384|NCT00092014|Alendronate|alendronate|mesh-list
5649385|NCT00092014|Risedronic Acid|risedronic acid|mesh-list
5824714|NCT02590055|Antiviral Agents|antiviral agents|mesh-ancestor
5824715|NCT02590055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5824716|NCT02590055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5824717|NCT02590055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5824718|NCT02590055|Immunologic Factors|immunologic factors|mesh-ancestor
5824719|NCT02590055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824720|NCT02590055|Tubulin Modulators|tubulin modulators|mesh-ancestor
5824721|NCT02590055|Antimitotic Agents|antimitotic agents|mesh-ancestor
5824722|NCT02590055|Mitosis Modulators|mitosis modulators|mesh-ancestor
5824723|NCT02590016|Insulin|insulin|mesh-list
5824724|NCT02590016|Insulin Aspart|insulin aspart|mesh-list
5824725|NCT02590016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5824726|NCT02590016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824727|NCT02589782|Moxifloxacin|moxifloxacin|mesh-list
5824728|NCT02589782|Linezolid|linezolid|mesh-list
5824729|NCT02589782|Bedaquiline|bedaquiline|mesh-list
5824730|NCT02589782|Clofazimine|clofazimine|mesh-list
5824731|NCT02589782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5824732|NCT02589782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5824733|NCT02589782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5824734|NCT02589782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5824735|NCT02589782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5649386|NCT00092014|Calcium|calcium|mesh-list
5649387|NCT00092014|Vitamins|vitamins|mesh-ancestor
5649388|NCT00092014|Micronutrients|micronutrients|mesh-ancestor
5649389|NCT00092014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649390|NCT00092014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5649391|NCT00092014|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5649392|NCT00092014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5649393|NCT00092014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5649394|NCT00092014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649395|NCT00090142|Montelukast|montelukast|mesh-list
5649396|NCT00090142|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5649397|NCT00090142|Respiratory System Agents|respiratory system agents|mesh-ancestor
5649398|NCT00090142|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5649399|NCT00090142|Hormone Antagonists|hormone antagonists|mesh-ancestor
5649400|NCT00090142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5649401|NCT00090142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649402|NCT00090142|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5649403|NCT00090142|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5649404|NCT00090142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649405|NCT00076973|Montelukast|montelukast|mesh-list
5649406|NCT00076973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5649407|NCT00076973|Respiratory System Agents|respiratory system agents|mesh-ancestor
5824736|NCT02589782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824737|NCT02589782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5824738|NCT02589782|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5824739|NCT02589782|Antitubercular Agents|antitubercular agents|mesh-ancestor
5824740|NCT02589782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5824741|NCT02589782|Leprostatic Agents|leprostatic agents|mesh-ancestor
5824742|NCT02589717|Atezolizumab|atezolizumab|mesh-list
5824743|NCT02589717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5824744|NCT02589457|Tenofovir|tenofovir|mesh-list
5824745|NCT02589457|Antiviral Agents|antiviral agents|mesh-ancestor
5824746|NCT02589457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5824747|NCT02589457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5824748|NCT02589457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5824749|NCT02589457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5824750|NCT02589457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824751|NCT02589457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5824752|NCT02589457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5824753|NCT02589496|Pembrolizumab|pembrolizumab|mesh-list
5824754|NCT02589496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5824755|NCT02589496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5824756|NCT02589444|Vitamin D|vitamin d|mesh-list
5824757|NCT02589444|Cholecalciferol|cholecalciferol|mesh-list
5824758|NCT02589444|Vitamins|vitamins|mesh-ancestor
5824759|NCT02589444|Micronutrients|micronutrients|mesh-ancestor
5649408|NCT00076973|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5649409|NCT00076973|Hormone Antagonists|hormone antagonists|mesh-ancestor
5649410|NCT00076973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5649411|NCT00076973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649412|NCT00076973|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5649413|NCT00076973|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5649414|NCT00076973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649415|NCT00043108|Paclitaxel|paclitaxel|mesh-list
5649416|NCT00043108|Carboplatin|carboplatin|mesh-list
5649417|NCT00043108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5649418|NCT00043108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5649419|NCT00043108|Tubulin Modulators|tubulin modulators|mesh-ancestor
5649420|NCT00043108|Antimitotic Agents|antimitotic agents|mesh-ancestor
5649421|NCT00043108|Mitosis Modulators|mitosis modulators|mesh-ancestor
5649422|NCT00043108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694470|NCT03395223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694471|NCT03395171|Vitamin D|vitamin d|mesh-list
5824760|NCT02589444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824761|NCT02589444|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5824762|NCT02589444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5824763|NCT02589353|Acarbose|acarbose|mesh-list
5824764|NCT02589353|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
5824765|NCT02589353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5824766|NCT02589353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824767|NCT02589353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5824768|NCT02589353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824769|NCT02589678|Vaccines|vaccines|mesh-list
5824770|NCT02589678|Immunologic Factors|immunologic factors|mesh-ancestor
5824771|NCT02589678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824772|NCT02589652|Interferons|interferons|mesh-list
5824773|NCT02589652|Interferon-alpha|interferon-alpha|mesh-list
5824774|NCT02589652|Interferon alpha-2|interferon alpha-2|mesh-list
5824775|NCT02589652|Entecavir|entecavir|mesh-list
5824776|NCT02589652|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5824777|NCT02589652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5824778|NCT02589652|Antiviral Agents|antiviral agents|mesh-ancestor
5824779|NCT02589652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5824780|NCT02589652|Immunologic Factors|immunologic factors|mesh-ancestor
5824781|NCT02589652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824782|NCT02589340|Buspirone|buspirone|mesh-list
5824783|NCT02589340|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5824784|NCT02589340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5824785|NCT02589340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5824786|NCT02589340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492986|NCT00611650|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
6492987|NCT00611650|Antioxidants|antioxidants|mesh-ancestor
6492988|NCT00611650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6492989|NCT00611650|Protective Agents|protective agents|mesh-ancestor
6492990|NCT00611650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492991|NCT00611650|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
6492992|NCT00611650|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6492993|NCT00611650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6492994|NCT00611650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6492995|NCT00611663|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6492996|NCT00611663|Immunologic Factors|immunologic factors|mesh-ancestor
6492997|NCT00611663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6492998|NCT00611676|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6492999|NCT00611676|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5824787|NCT02589340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5824788|NCT02589340|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5824789|NCT02589340|Serotonin Agents|serotonin agents|mesh-ancestor
5824790|NCT02589340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5824791|NCT02589340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824792|NCT02589288|Ropivacaine|ropivacaine|mesh-list
5824793|NCT02589288|Anesthetics, Local|anesthetics, local|mesh-ancestor
5824794|NCT02589288|Anesthetics|anesthetics|mesh-ancestor
5824795|NCT02589288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5824796|NCT02589288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824797|NCT02589288|Sensory System Agents|sensory system agents|mesh-ancestor
5824798|NCT02589288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5824799|NCT02589041|Ropivacaine|ropivacaine|mesh-list
5824800|NCT02589041|Anesthetics, Local|anesthetics, local|mesh-ancestor
5824801|NCT02589041|Anesthetics|anesthetics|mesh-ancestor
5824802|NCT02589041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5824803|NCT02589041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824804|NCT02589041|Sensory System Agents|sensory system agents|mesh-ancestor
5824805|NCT02589041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5824806|NCT02588820|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
5824807|NCT02588820|Antiviral Agents|antiviral agents|mesh-ancestor
5824808|NCT02588820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5824809|NCT02589158|Atazanavir Sulfate|atazanavir sulfate|mesh-list
5649423|NCT05225610|Dexmedetomidine|dexmedetomidine|mesh-list
5649424|NCT05225610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5649425|NCT05225610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5649426|NCT05225610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649427|NCT05225610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5649428|NCT05225610|Analgesics|analgesics|mesh-ancestor
5649429|NCT05225610|Sensory System Agents|sensory system agents|mesh-ancestor
5824810|NCT02589158|Darunavir|darunavir|mesh-list
6674428|NCT01569204|Procarbazine|procarbazine|mesh-list
6674429|NCT01569204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6674430|NCT01569204|Immunologic Factors|immunologic factors|mesh-ancestor
6674431|NCT01569204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674432|NCT01569204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6674433|NCT01569204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6674434|NCT01569204|Alkylating Agents|alkylating agents|mesh-ancestor
6674435|NCT01569204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674436|NCT01569204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6674437|NCT01569204|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6674438|NCT01569204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6674439|NCT01569204|Antiemetics|antiemetics|mesh-ancestor
6674440|NCT01569204|Autonomic Agents|autonomic agents|mesh-ancestor
6674441|NCT01569204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6674442|NCT01569204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6674443|NCT01569204|Glucocorticoids|glucocorticoids|mesh-ancestor
6674444|NCT01569204|Hormones|hormones|mesh-ancestor
6674445|NCT01569204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6674446|NCT01569204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6674447|NCT01569204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6674448|NCT01569204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6674449|NCT01569204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6674450|NCT01569204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6674451|NCT01569204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6674452|NCT01569204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6674453|NCT01569256|Cabergoline|cabergoline|mesh-list
6674454|NCT01569256|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5649430|NCT05225610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5824811|NCT02589158|Cobicistat|cobicistat|mesh-list
5824812|NCT02589158|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5824813|NCT02589158|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5824814|NCT02589158|Protease Inhibitors|protease inhibitors|mesh-ancestor
5824815|NCT02589158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5824816|NCT02589158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824817|NCT02589158|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5824818|NCT02589158|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5824819|NCT02589158|Antiviral Agents|antiviral agents|mesh-ancestor
5824820|NCT02589158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5824821|NCT02589158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5824822|NCT02589158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5824823|NCT02588755|Chlorotrianisene|chlorotrianisene|mesh-list
5649431|NCT05225610|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5649432|NCT05225610|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5824824|NCT02588755|Tegafur|tegafur|mesh-list
5824825|NCT02588755|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
5824826|NCT02588755|Estrogens|estrogens|mesh-ancestor
5824827|NCT02588755|Hormones|hormones|mesh-ancestor
5824828|NCT02588755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5824829|NCT02588755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824830|NCT02588755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5824831|NCT02588755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5824832|NCT02588755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5824833|NCT02588755|Antimetabolites|antimetabolites|mesh-ancestor
5824834|NCT02588755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824835|NCT02588781|Pemetrexed|pemetrexed|mesh-list
5824836|NCT02588781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5824837|NCT02588781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5824838|NCT02588781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824839|NCT02588781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5824840|NCT02588781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5902008|NCT05129748|Antidotes|antidotes|mesh-ancestor
5902009|NCT05129748|Protective Agents|protective agents|mesh-ancestor
5902010|NCT05129748|Antioxidants|antioxidants|mesh-ancestor
5902011|NCT05129748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902012|NCT05129748|Antitubercular Agents|antitubercular agents|mesh-ancestor
5902013|NCT05129748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5902014|NCT05129748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5902015|NCT05129748|Chelating Agents|chelating agents|mesh-ancestor
5902016|NCT05129748|Sequestering Agents|sequestering agents|mesh-ancestor
5902017|NCT05129722|Empagliflozin|empagliflozin|mesh-list
5902018|NCT05129722|Eplerenone|eplerenone|mesh-list
5902019|NCT05129722|Bumetanide|bumetanide|mesh-list
5902020|NCT05129722|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5902021|NCT05129722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902022|NCT05129722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5902023|NCT05129722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902024|NCT05129722|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5902025|NCT05129722|Hormone Antagonists|hormone antagonists|mesh-ancestor
5902026|NCT05129722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5902027|NCT05129722|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5902028|NCT05129722|Diuretics|diuretics|mesh-ancestor
5902029|NCT05129722|Natriuretic Agents|natriuretic agents|mesh-ancestor
5902030|NCT05129722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5902031|NCT05129722|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5902032|NCT05129722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5902033|NCT05129670|Calcium Carbonate|calcium carbonate|mesh-list
5902034|NCT05129670|Antacids|antacids|mesh-ancestor
5649433|NCT05225610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5649434|NCT05225610|Adrenergic Agents|adrenergic agents|mesh-ancestor
5649435|NCT05225610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5902035|NCT05129670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902036|NCT05129670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5902037|NCT05129410|Mycophenolic Acid|mycophenolic acid|mesh-list
5902038|NCT05129410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5902039|NCT05129410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5902040|NCT05129410|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5902041|NCT05129410|Antitubercular Agents|antitubercular agents|mesh-ancestor
5902042|NCT05129410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5902043|NCT05129410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5902044|NCT05129410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5902045|NCT05129410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902046|NCT05129332|Vitamin E|vitamin e|mesh-list
5902047|NCT05129332|Vitamins|vitamins|mesh-ancestor
5902048|NCT05129332|Micronutrients|micronutrients|mesh-ancestor
5902049|NCT05129332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902050|NCT05129332|Antioxidants|antioxidants|mesh-ancestor
5902051|NCT05129332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902052|NCT05129332|Protective Agents|protective agents|mesh-ancestor
5902053|NCT05129137|Acetaminophen|acetaminophen|mesh-list
5902054|NCT05129137|Nefopam|nefopam|mesh-list
5902055|NCT05129137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5649436|NCT05225610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649437|NCT05225597|Carbachol|carbachol|mesh-list
5649438|NCT05225597|Epinephrine|epinephrine|mesh-list
5649439|NCT05225597|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5649440|NCT05225597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5649441|NCT05225597|Adrenergic Agents|adrenergic agents|mesh-ancestor
5824841|NCT02588937|Entecavir|entecavir|mesh-list
5824842|NCT02588937|Antiviral Agents|antiviral agents|mesh-ancestor
5649442|NCT05225597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5649443|NCT05225597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649444|NCT05225597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649445|NCT05225597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6493000|NCT00611676|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6493001|NCT00611676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6493002|NCT00611676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493003|NCT00611676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6493004|NCT00611676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493005|NCT00611676|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6493006|NCT00611676|Antidepressive Agents|antidepressive agents|mesh-ancestor
6493007|NCT00611676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6493008|NCT00611689|Imatinib Mesylate|imatinib mesylate|mesh-list
6493009|NCT00611689|Vatalanib|vatalanib|mesh-list
6493010|NCT00611689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6493011|NCT00611689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5649446|NCT05225597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5649447|NCT05225597|Autonomic Agents|autonomic agents|mesh-ancestor
5649448|NCT05225597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5649449|NCT05225597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5649450|NCT05225597|Respiratory System Agents|respiratory system agents|mesh-ancestor
5649451|NCT05225597|Mydriatics|mydriatics|mesh-ancestor
5649452|NCT05225597|Sympathomimetics|sympathomimetics|mesh-ancestor
5649453|NCT05225597|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5649454|NCT05225597|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5649455|NCT05225597|Miotics|miotics|mesh-ancestor
5649456|NCT05225597|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5649457|NCT05225597|Cholinergic Agents|cholinergic agents|mesh-ancestor
5649458|NCT05225597|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5649459|NCT05225597|Analgesics|analgesics|mesh-ancestor
5649460|NCT05225597|Sensory System Agents|sensory system agents|mesh-ancestor
5649461|NCT05225597|Protective Agents|protective agents|mesh-ancestor
5649462|NCT05225558|Vancomycin|vancomycin|mesh-list
5649463|NCT05225558|Delpazolid|delpazolid|mesh-list
5649464|NCT05225558|Oxazolidinones|oxazolidinones|mesh-list
5649465|NCT05225558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5649466|NCT05225558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5649467|NCT05225558|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5824843|NCT02588937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5824844|NCT02588534|Etanercept|etanercept|mesh-list
5824845|NCT02588534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5824846|NCT02588534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5824847|NCT02588534|Analgesics|analgesics|mesh-ancestor
5824848|NCT02588534|Sensory System Agents|sensory system agents|mesh-ancestor
5824849|NCT02588534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5824850|NCT02588534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824851|NCT02588534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5824852|NCT02588534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5824853|NCT02588534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5824854|NCT02588534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5824855|NCT02588534|Immunologic Factors|immunologic factors|mesh-ancestor
5824856|NCT02588547|Granisetron|granisetron|mesh-list
5824857|NCT02588547|Antiemetics|antiemetics|mesh-ancestor
5824858|NCT02588547|Autonomic Agents|autonomic agents|mesh-ancestor
5824859|NCT02588547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5824860|NCT02588547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824861|NCT02588547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5824862|NCT02588547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5824863|NCT02588547|Serotonin Agents|serotonin agents|mesh-ancestor
5824864|NCT02588547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5824865|NCT02588547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824866|NCT02588443|Gemcitabine|gemcitabine|mesh-list
5824867|NCT02588443|Paclitaxel|paclitaxel|mesh-list
5824868|NCT02588443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5824869|NCT02588443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5824870|NCT02588443|Tubulin Modulators|tubulin modulators|mesh-ancestor
5824871|NCT02588443|Antimitotic Agents|antimitotic agents|mesh-ancestor
5824872|NCT02588443|Mitosis Modulators|mitosis modulators|mesh-ancestor
5649468|NCT05225558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5649469|NCT05225558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649470|NCT05225545|Iron|iron|mesh-list
5824873|NCT02588443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649471|NCT05225545|Trace Elements|trace elements|mesh-ancestor
5649472|NCT05225545|Micronutrients|micronutrients|mesh-ancestor
5902056|NCT05129137|Analgesics|analgesics|mesh-ancestor
5824874|NCT02588443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5824875|NCT02588443|Antimetabolites|antimetabolites|mesh-ancestor
5649473|NCT05225545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649474|NCT05225402|Norepinephrine|norepinephrine|mesh-list
5649475|NCT05225402|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5649476|NCT05225402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5649477|NCT05225402|Adrenergic Agents|adrenergic agents|mesh-ancestor
5649478|NCT05225402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5649479|NCT05225402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649480|NCT05225402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649481|NCT05225402|Sympathomimetics|sympathomimetics|mesh-ancestor
5649482|NCT05225402|Autonomic Agents|autonomic agents|mesh-ancestor
5649483|NCT05225402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5649484|NCT05225402|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5649485|NCT05225155|Enoxaparin|enoxaparin|mesh-list
5649486|NCT05225155|Anticoagulants|anticoagulants|mesh-ancestor
5649487|NCT05225155|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5649488|NCT05225155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5649489|NCT05225155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649490|NCT05225116|Lenvatinib|lenvatinib|mesh-list
5649491|NCT05225116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5649492|NCT05225116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5649493|NCT05225116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5649494|NCT05225116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649495|NCT05225077|Dapagliflozin|dapagliflozin|mesh-list
5649496|NCT05225077|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5824876|NCT02588443|Antiviral Agents|antiviral agents|mesh-ancestor
5824877|NCT02588443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5649497|NCT05225077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649498|NCT05225077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5649499|NCT05225077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649500|NCT05225064|Vaccines|vaccines|mesh-list
5649501|NCT05225064|Immunologic Factors|immunologic factors|mesh-ancestor
5649502|NCT05225064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649503|NCT05224999|Nivolumab|nivolumab|mesh-list
5649504|NCT05224999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5649505|NCT05224999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5649506|NCT05224999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5649507|NCT05224999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649508|NCT05224687|Daptomycin|daptomycin|mesh-list
5649509|NCT05224687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5649510|NCT05224687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5824878|NCT02588443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5824879|NCT02588443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5824880|NCT02588443|Immunologic Factors|immunologic factors|mesh-ancestor
5824881|NCT02588443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824882|NCT02588742|Melatonin|melatonin|mesh-list
5824883|NCT02588742|Antioxidants|antioxidants|mesh-ancestor
5824884|NCT02588742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824885|NCT02588742|Protective Agents|protective agents|mesh-ancestor
5824886|NCT02588742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824887|NCT02588742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5824888|NCT02588716|Terlipressin|terlipressin|mesh-list
5824889|NCT02588716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5824890|NCT02588716|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5824891|NCT02588417|Dexamethasone|dexamethasone|mesh-list
5649511|NCT05224401|Amoxicillin|amoxicillin|mesh-list
5649512|NCT05224401|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5649513|NCT05224401|Clavulanic Acids|clavulanic acids|mesh-list
5649514|NCT05224401|Clavulanic Acid|clavulanic acid|mesh-list
5649515|NCT05224401|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
5649516|NCT05224401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5649517|NCT05224401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5649518|NCT05224401|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5824892|NCT02588417|Levobupivacaine|levobupivacaine|mesh-list
5824893|NCT02588417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5824894|NCT02588417|Antiemetics|antiemetics|mesh-ancestor
5824895|NCT02588417|Autonomic Agents|autonomic agents|mesh-ancestor
5824896|NCT02588417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5824897|NCT02588417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824898|NCT02588417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5824899|NCT02588417|Glucocorticoids|glucocorticoids|mesh-ancestor
5824900|NCT02588417|Hormones|hormones|mesh-ancestor
5649519|NCT05224401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5824901|NCT02588417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5824902|NCT02588417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5649520|NCT05224401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649521|NCT05224401|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5649522|NCT05224401|Renal Agents|renal agents|mesh-ancestor
5649523|NCT05224388|Heparin|heparin|mesh-list
5649524|NCT05224388|Enoxaparin|enoxaparin|mesh-list
5649525|NCT05224388|Anticoagulants|anticoagulants|mesh-ancestor
5649526|NCT05224388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5649527|NCT05224388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5649528|NCT05224388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649529|NCT05224336|Niacin|niacin|mesh-list
5649530|NCT05224336|Psilocybin|psilocybin|mesh-list
5649531|NCT05224336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5649532|NCT05224336|Antimetabolites|antimetabolites|mesh-ancestor
5649533|NCT05224336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649534|NCT05224336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5649535|NCT05224336|Vasodilator Agents|vasodilator agents|mesh-ancestor
5649536|NCT05224336|Vitamin B Complex|vitamin b complex|mesh-ancestor
5649537|NCT05224336|Vitamins|vitamins|mesh-ancestor
5649538|NCT05224336|Micronutrients|micronutrients|mesh-ancestor
5649539|NCT05224336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649540|NCT05224336|Hallucinogens|hallucinogens|mesh-ancestor
5649541|NCT05224336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5649542|NCT05224167|Melatonin|melatonin|mesh-list
5649543|NCT05224167|Hydroxyzine|hydroxyzine|mesh-list
5649544|NCT05224167|Antioxidants|antioxidants|mesh-ancestor
5649545|NCT05224167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649546|NCT05224167|Protective Agents|protective agents|mesh-ancestor
5649547|NCT05224167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649548|NCT05224167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5649549|NCT05224167|Antipruritics|antipruritics|mesh-ancestor
5649550|NCT05224167|Dermatologic Agents|dermatologic agents|mesh-ancestor
5649551|NCT05224167|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5649552|NCT05224167|Histamine Antagonists|histamine antagonists|mesh-ancestor
5649553|NCT05224167|Histamine Agents|histamine agents|mesh-ancestor
5824903|NCT02588417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5824904|NCT02588417|Anesthetics, Local|anesthetics, local|mesh-ancestor
5824905|NCT02588417|Anesthetics|anesthetics|mesh-ancestor
5824906|NCT02588417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5824907|NCT02588417|Sensory System Agents|sensory system agents|mesh-ancestor
5824908|NCT02588404|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5824909|NCT02588404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5824910|NCT02588404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5824911|NCT02588404|Luteolytic Agents|luteolytic agents|mesh-ancestor
5824912|NCT02588404|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5824913|NCT02588404|Contraceptive Agents|contraceptive agents|mesh-ancestor
5824914|NCT02588404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5824915|NCT02588404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824916|NCT02588404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5824917|NCT02588287|Tenofovir|tenofovir|mesh-list
5824918|NCT02588287|Antiviral Agents|antiviral agents|mesh-ancestor
5824919|NCT02588287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5824920|NCT02588287|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5824921|NCT02588287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5824922|NCT02588287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5824923|NCT02588287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824924|NCT02588287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5824925|NCT02588287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5824926|NCT02588235|Atorvastatin|atorvastatin|mesh-list
5824927|NCT02588235|Ezetimibe|ezetimibe|mesh-list
5824928|NCT02588235|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5824929|NCT02588235|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5824930|NCT02588235|Antimetabolites|antimetabolites|mesh-ancestor
5824931|NCT02588235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824932|NCT02588235|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5824933|NCT02588235|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5824934|NCT02588235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5824935|NCT02588196|Dexamethasone|dexamethasone|mesh-list
5824936|NCT02588196|Dexamethasone acetate|dexamethasone acetate|mesh-list
5824937|NCT02588196|BB 1101|bb 1101|mesh-list
5824938|NCT02588196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5824939|NCT02588196|Antiemetics|antiemetics|mesh-ancestor
6493012|NCT00611689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5649554|NCT05224167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5694472|NCT03395171|Cholecalciferol|cholecalciferol|mesh-list
5694473|NCT03395171|Vitamins|vitamins|mesh-ancestor
5694474|NCT03395171|Micronutrients|micronutrients|mesh-ancestor
5824940|NCT02588196|Autonomic Agents|autonomic agents|mesh-ancestor
5824941|NCT02588196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5824942|NCT02588196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824943|NCT02588196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5824944|NCT02588196|Glucocorticoids|glucocorticoids|mesh-ancestor
5824945|NCT02588196|Hormones|hormones|mesh-ancestor
5824946|NCT02588196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5824947|NCT02588196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5824948|NCT02588196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5649555|NCT05224141|Carboplatin|carboplatin|mesh-list
5649556|NCT05224141|Pembrolizumab|pembrolizumab|mesh-list
5649557|NCT05224141|Etoposide|etoposide|mesh-list
5649558|NCT05224141|Atezolizumab|atezolizumab|mesh-list
5649559|NCT05224141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5649560|NCT05224141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5649561|NCT05224141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5649562|NCT05224141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5649563|NCT05224141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5649564|NCT05224141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5649565|NCT05224141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649566|NCT05224128|Imatinib Mesylate|imatinib mesylate|mesh-list
5649567|NCT05224128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5649568|NCT05224128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5649569|NCT05224128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5649570|NCT05224128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649571|NCT05224089|Dexamethasone|dexamethasone|mesh-list
5649572|NCT05224089|Epinephrine|epinephrine|mesh-list
5649573|NCT05224089|Bupivacaine|bupivacaine|mesh-list
5824949|NCT02588196|Protease Inhibitors|protease inhibitors|mesh-ancestor
5824950|NCT02588196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5824951|NCT02588196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824952|NCT02588131|Durvalumab|durvalumab|mesh-list
5824953|NCT02588131|Tremelimumab|tremelimumab|mesh-list
5824954|NCT02588131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5824955|NCT02588131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5824956|NCT02588248|Peppermint oil|peppermint oil|mesh-list
5824957|NCT02588248|Menthol|menthol|mesh-list
5649574|NCT05224089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5649575|NCT05224089|Antiemetics|antiemetics|mesh-ancestor
5649576|NCT05224089|Autonomic Agents|autonomic agents|mesh-ancestor
5649577|NCT05224089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5649578|NCT05224089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649579|NCT05224089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5649580|NCT05224089|Glucocorticoids|glucocorticoids|mesh-ancestor
5649581|NCT05224089|Hormones|hormones|mesh-ancestor
5649582|NCT05224089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5649583|NCT05224089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5649584|NCT05224089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5649585|NCT05224089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649586|NCT05224089|Anesthetics, Local|anesthetics, local|mesh-ancestor
5649587|NCT05224089|Anesthetics|anesthetics|mesh-ancestor
5649588|NCT05224089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5649589|NCT05224089|Sensory System Agents|sensory system agents|mesh-ancestor
5649590|NCT05224089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5649591|NCT05224089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5649592|NCT05224089|Adrenergic Agents|adrenergic agents|mesh-ancestor
5649593|NCT05224089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5824958|NCT02588248|Antipruritics|antipruritics|mesh-ancestor
5824959|NCT02588248|Dermatologic Agents|dermatologic agents|mesh-ancestor
5824960|NCT02588248|Antiemetics|antiemetics|mesh-ancestor
5824961|NCT02588248|Autonomic Agents|autonomic agents|mesh-ancestor
5824962|NCT02588248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5824963|NCT02588248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824964|NCT02588248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5824965|NCT02588248|Parasympatholytics|parasympatholytics|mesh-ancestor
5824966|NCT02588118|Propofol|propofol|mesh-list
5824967|NCT02588118|Cisatracurium|cisatracurium|mesh-list
5824968|NCT02588118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5824969|NCT02588118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5824970|NCT02588118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824971|NCT02588118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5824972|NCT02588118|Anesthetics, General|anesthetics, general|mesh-ancestor
5824973|NCT02588118|Anesthetics|anesthetics|mesh-ancestor
5649594|NCT05224089|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5824974|NCT02588118|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5824975|NCT02588118|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6493013|NCT00611689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493014|NCT00611728|Irinotecan|irinotecan|mesh-list
6493015|NCT00611728|Sunitinib|sunitinib|mesh-list
5649595|NCT05224089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5649596|NCT05224089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5824976|NCT02588118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5824977|NCT02588027|Ibuprofen|ibuprofen|mesh-list
5824978|NCT02588027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5824979|NCT02588027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5824980|NCT02588027|Analgesics|analgesics|mesh-ancestor
5824981|NCT02588027|Sensory System Agents|sensory system agents|mesh-ancestor
5824982|NCT02588027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5824983|NCT02588027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824984|NCT02588027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5824985|NCT02588027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5824986|NCT02588027|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5824987|NCT02588027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5824988|NCT02588027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824989|NCT02587845|Tranexamic Acid|tranexamic acid|mesh-list
5824990|NCT02587845|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5824991|NCT02587845|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5824992|NCT02587845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5824993|NCT02587845|Hemostatics|hemostatics|mesh-ancestor
5824994|NCT02587845|Coagulants|coagulants|mesh-ancestor
5824995|NCT02587871|Cytarabine|cytarabine|mesh-list
5824996|NCT02587871|Immunologic Factors|immunologic factors|mesh-ancestor
5824997|NCT02587871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5824998|NCT02587871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5824999|NCT02587871|Antimetabolites|antimetabolites|mesh-ancestor
5825000|NCT02587871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5825001|NCT02587871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5825002|NCT02587871|Antiviral Agents|antiviral agents|mesh-ancestor
5825003|NCT02587871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5825004|NCT02587871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5825005|NCT02587455|Pembrolizumab|pembrolizumab|mesh-list
5825006|NCT02587455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5825007|NCT02587455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5825008|NCT02587533|Dopamine|dopamine|mesh-list
5825009|NCT02587533|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5825010|NCT02587533|Sympathomimetics|sympathomimetics|mesh-ancestor
5825011|NCT02587533|Autonomic Agents|autonomic agents|mesh-ancestor
5825012|NCT02587533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5825013|NCT02587533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825014|NCT02587533|Dopamine Agents|dopamine agents|mesh-ancestor
5825015|NCT02587533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5825016|NCT02587533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5825017|NCT02587533|Protective Agents|protective agents|mesh-ancestor
5825018|NCT02587312|Nicotine|nicotine|mesh-list
5825019|NCT02587312|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5825020|NCT02587312|Autonomic Agents|autonomic agents|mesh-ancestor
5825021|NCT02587312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5825022|NCT02587312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825023|NCT02587312|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5825024|NCT02587312|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5825025|NCT02587312|Cholinergic Agents|cholinergic agents|mesh-ancestor
5825026|NCT02587312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5825027|NCT02587312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5825028|NCT02587416|Atorvastatin|atorvastatin|mesh-list
5825029|NCT02587416|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5825030|NCT02587416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5825031|NCT02587416|Antimetabolites|antimetabolites|mesh-ancestor
5825032|NCT02587416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493016|NCT00611728|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5649597|NCT05224089|Respiratory System Agents|respiratory system agents|mesh-ancestor
5649598|NCT05224089|Mydriatics|mydriatics|mesh-ancestor
5649599|NCT05224089|Sympathomimetics|sympathomimetics|mesh-ancestor
5649600|NCT05224089|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5649601|NCT05224050|Nicotine|nicotine|mesh-list
5649602|NCT05224050|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5649603|NCT05224050|Autonomic Agents|autonomic agents|mesh-ancestor
5649604|NCT05224050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5649605|NCT05224050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649606|NCT05224050|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5649607|NCT05224050|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5649608|NCT05224050|Cholinergic Agents|cholinergic agents|mesh-ancestor
5649609|NCT05224050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5649610|NCT05224050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649611|NCT05223907|Propofol|propofol|mesh-list
5649612|NCT05223907|Etomidate|etomidate|mesh-list
5649613|NCT05223907|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5649614|NCT05223907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5649615|NCT05223907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649616|NCT05223907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5649617|NCT05223907|Anesthetics, General|anesthetics, general|mesh-ancestor
5649618|NCT05223907|Anesthetics|anesthetics|mesh-ancestor
5649619|NCT05223829|Brexanolone|brexanolone|mesh-list
5649620|NCT05223829|Neurosteroids|neurosteroids|mesh-ancestor
5649621|NCT05223829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5649622|NCT05223829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649623|NCT05223829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649624|NCT05223829|GABA Modulators|gaba modulators|mesh-ancestor
5649625|NCT05223829|GABA Agents|gaba agents|mesh-ancestor
5649626|NCT05223673|Trifluridine|trifluridine|mesh-list
5649627|NCT05223673|Antimetabolites|antimetabolites|mesh-ancestor
5649628|NCT05223673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649629|NCT05223673|Antiviral Agents|antiviral agents|mesh-ancestor
5649630|NCT05223673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5649631|NCT05223647|Carboplatin|carboplatin|mesh-list
5649632|NCT05223647|Etoposide|etoposide|mesh-list
5649633|NCT05223647|Durvalumab|durvalumab|mesh-list
5649634|NCT05223647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5649635|NCT05223647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5649636|NCT05223647|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5649637|NCT05223647|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5649638|NCT05223647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5649639|NCT05223647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649640|NCT05223647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5649641|NCT05223582|Prednisone|prednisone|mesh-list
5649642|NCT05223582|Abiraterone Acetate|abiraterone acetate|mesh-list
5825033|NCT02587416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5825034|NCT02587416|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5825035|NCT02587416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5825036|NCT02587390|Simvastatin|simvastatin|mesh-list
5825037|NCT02587390|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5825038|NCT02587390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5825039|NCT02587390|Antimetabolites|antimetabolites|mesh-ancestor
5825040|NCT02587390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5825041|NCT02587390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5825042|NCT02587390|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5825043|NCT02587390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5825044|NCT02587325|Sirolimus|sirolimus|mesh-list
5825045|NCT02587325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5825046|NCT02587325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5825047|NCT02587325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5825048|NCT02587325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5825049|NCT02587325|Antifungal Agents|antifungal agents|mesh-ancestor
5825050|NCT02587325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5825051|NCT02587325|Immunologic Factors|immunologic factors|mesh-ancestor
5825052|NCT02587325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825053|NCT02587273|Fentanyl|fentanyl|mesh-list
5825054|NCT02587273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5825055|NCT02587273|Narcotics|narcotics|mesh-ancestor
5825056|NCT02587273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5825057|NCT02587273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825058|NCT02587273|Analgesics|analgesics|mesh-ancestor
5825059|NCT02587273|Sensory System Agents|sensory system agents|mesh-ancestor
5825060|NCT02587273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5825061|NCT02587273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5825062|NCT02587273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5825063|NCT02587273|Anesthetics, General|anesthetics, general|mesh-ancestor
5825064|NCT02587273|Anesthetics|anesthetics|mesh-ancestor
5825065|NCT02587260|Clopidogrel|clopidogrel|mesh-list
5825066|NCT02587260|Ticagrelor|ticagrelor|mesh-list
5825067|NCT02587260|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
5825068|NCT02587260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5825069|NCT02587260|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5825070|NCT02587260|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5649643|NCT05223582|Androgens|androgens|mesh-list
5649644|NCT05223582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5649645|NCT05223582|Glucocorticoids|glucocorticoids|mesh-ancestor
5649646|NCT05223582|Hormones|hormones|mesh-ancestor
5825071|NCT02587260|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5649647|NCT05223582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5649648|NCT05223582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649649|NCT05223582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5649650|NCT05223582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5649651|NCT05223582|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5649652|NCT05223582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5649653|NCT05223582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649654|NCT05223582|Hormone Antagonists|hormone antagonists|mesh-ancestor
5649655|NCT05223582|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5649656|NCT05223400|Clindamycin|clindamycin|mesh-list
5649657|NCT05223400|Clindamycin palmitate|clindamycin palmitate|mesh-list
5649658|NCT05223400|Clindamycin phosphate|clindamycin phosphate|mesh-list
5649659|NCT05223400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5649660|NCT05223400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5649661|NCT05223400|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5825072|NCT02587260|Purinergic Agents|purinergic agents|mesh-ancestor
5825073|NCT02587260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5825074|NCT02587260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5825075|NCT02587260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825076|NCT02587247|Antibodies|antibodies|mesh-list
5825077|NCT02587247|Immunologic Factors|immunologic factors|mesh-ancestor
5825078|NCT02587247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902057|NCT05129137|Sensory System Agents|sensory system agents|mesh-ancestor
5902058|NCT05129137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5902059|NCT05129137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902060|NCT05129137|Antipyretics|antipyretics|mesh-ancestor
5902061|NCT05129085|Dexamethasone|dexamethasone|mesh-list
5902062|NCT05129085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5902063|NCT05129085|Antiemetics|antiemetics|mesh-ancestor
5902064|NCT05129085|Autonomic Agents|autonomic agents|mesh-ancestor
5902065|NCT05129085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5902066|NCT05129085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902067|NCT05129085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5902068|NCT05129085|Glucocorticoids|glucocorticoids|mesh-ancestor
5902069|NCT05129085|Hormones|hormones|mesh-ancestor
5902070|NCT05129085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5902071|NCT05129085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5902072|NCT05129085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5908335|NCT04660344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5908791|NCT04115319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5908792|NCT04099888|Gemcitabine|gemcitabine|mesh-list
5908793|NCT04099888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5908794|NCT04099888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5908795|NCT04099888|Antimetabolites|antimetabolites|mesh-ancestor
5908796|NCT04099888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908797|NCT04099888|Antiviral Agents|antiviral agents|mesh-ancestor
5908798|NCT04099888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5908799|NCT04099888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5908800|NCT04099888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5908801|NCT04099888|Immunologic Factors|immunologic factors|mesh-ancestor
5908802|NCT04099888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5908803|NCT04094688|Vitamin D|vitamin d|mesh-list
5908804|NCT04094688|Cholecalciferol|cholecalciferol|mesh-list
5908805|NCT04094688|Leucovorin|leucovorin|mesh-list
5908806|NCT04094688|Bevacizumab|bevacizumab|mesh-list
5908807|NCT04094688|Fluorouracil|fluorouracil|mesh-list
5908808|NCT04094688|Oxaliplatin|oxaliplatin|mesh-list
5908809|NCT04094688|Irinotecan|irinotecan|mesh-list
5908810|NCT04094688|Levoleucovorin|levoleucovorin|mesh-list
5908811|NCT04094688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5908812|NCT04094688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5908813|NCT04094688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5908814|NCT04094688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5908815|NCT04094688|Growth Substances|growth substances|mesh-ancestor
5908816|NCT04094688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5908817|NCT04094688|Growth Inhibitors|growth inhibitors|mesh-ancestor
5908818|NCT04094688|Vitamins|vitamins|mesh-ancestor
5908819|NCT04094688|Micronutrients|micronutrients|mesh-ancestor
5908820|NCT04094688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5908821|NCT04094688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5908822|NCT04094688|Antimetabolites|antimetabolites|mesh-ancestor
5908823|NCT04094688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908824|NCT04094688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5649662|NCT05223400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5649663|NCT05223400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649664|NCT05222529|Glycopyrrolate|glycopyrrolate|mesh-list
5649665|NCT05222529|Bromides|bromides|mesh-list
5649666|NCT05222529|Anticonvulsants|anticonvulsants|mesh-ancestor
5649667|NCT05222529|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5649668|NCT05222529|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5649669|NCT05222529|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5649670|NCT05222529|Cholinergic Agents|cholinergic agents|mesh-ancestor
5649671|NCT05222529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5649672|NCT05222529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649673|NCT05222529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649674|NCT05202002|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
5649675|NCT05202002|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
5649676|NCT05202002|beta-Endorphin|beta-endorphin|mesh-list
5649677|NCT05202002|Hormones|hormones|mesh-ancestor
5649678|NCT05202002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5825079|NCT02587741|Metformin|metformin|mesh-list
5825080|NCT02587741|Acarbose|acarbose|mesh-list
5825081|NCT02587741|Gliclazide|gliclazide|mesh-list
5825082|NCT02587741|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
5825083|NCT02587741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5825084|NCT02587741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825085|NCT02587741|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
5825086|NCT02587741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5825087|NCT02587741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5825088|NCT02587052|Tacrolimus|tacrolimus|mesh-list
5825089|NCT02587052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5825090|NCT02587052|Immunologic Factors|immunologic factors|mesh-ancestor
5825091|NCT02587052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825092|NCT02587052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5825093|NCT02587052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5825094|NCT02587052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5825095|NCT02587130|Ketamine|ketamine|mesh-list
5825096|NCT02587130|Analgesics|analgesics|mesh-ancestor
5825097|NCT02587130|Sensory System Agents|sensory system agents|mesh-ancestor
5825098|NCT02587130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5825099|NCT02587130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825100|NCT02587130|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5825101|NCT02587130|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5825102|NCT02587130|Anesthetics, General|anesthetics, general|mesh-ancestor
5649679|NCT05202002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649680|NCT05202002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5649681|NCT05202002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649682|NCT05198544|Hyaluronic Acid|hyaluronic acid|mesh-list
5649683|NCT05198544|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5649684|NCT05198544|Immunologic Factors|immunologic factors|mesh-ancestor
5649685|NCT05198544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649686|NCT05198544|Viscosupplements|viscosupplements|mesh-ancestor
5649687|NCT05198544|Protective Agents|protective agents|mesh-ancestor
5649688|NCT05197322|Pembrolizumab|pembrolizumab|mesh-list
5649689|NCT05197322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5649690|NCT05197322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5649691|NCT05196932|Antibodies|antibodies|mesh-list
5649692|NCT05196932|Immunologic Factors|immunologic factors|mesh-ancestor
5649693|NCT05196932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649694|NCT05194189|Ascorbic Acid|ascorbic acid|mesh-list
5649695|NCT05194189|Vitamins|vitamins|mesh-ancestor
5649696|NCT05194189|Micronutrients|micronutrients|mesh-ancestor
5649697|NCT05194189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649698|NCT05194189|Antioxidants|antioxidants|mesh-ancestor
5649699|NCT05194189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649700|NCT05194189|Protective Agents|protective agents|mesh-ancestor
5649701|NCT05194124|alpha-MSH|alpha-msh|mesh-list
5649702|NCT05194124|Hormones|hormones|mesh-ancestor
5649703|NCT05194124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5649704|NCT05194124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649705|NCT05194111|Valsartan|valsartan|mesh-list
5649706|NCT05194111|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5649707|NCT05194111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5825103|NCT02587130|Anesthetics|anesthetics|mesh-ancestor
5825104|NCT02587130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5649708|NCT05194111|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5902073|NCT05129033|Omalizumab|omalizumab|mesh-list
5649709|NCT05194111|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5649710|NCT05194111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649711|NCT05193968|Nitroprusside|nitroprusside|mesh-list
6493017|NCT00611728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6493018|NCT00611728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6493019|NCT00611728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493020|NCT00611728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6493021|NCT00611728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6493022|NCT00611728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6493023|NCT00611728|Growth Substances|growth substances|mesh-ancestor
6493024|NCT00611728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493025|NCT00611728|Growth Inhibitors|growth inhibitors|mesh-ancestor
6493026|NCT00611728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6493027|NCT00611741|Furosemide|furosemide|mesh-list
6493028|NCT00611741|Diuretics|diuretics|mesh-ancestor
6493029|NCT00611741|Natriuretic Agents|natriuretic agents|mesh-ancestor
5649712|NCT05193968|Norepinephrine|norepinephrine|mesh-list
5649713|NCT05193968|Acetylcholine|acetylcholine|mesh-list
5649714|NCT05193968|Terbutaline|terbutaline|mesh-list
5649715|NCT05193968|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5649716|NCT05193968|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5649717|NCT05193968|Adrenergic Agents|adrenergic agents|mesh-ancestor
5649718|NCT05193968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5649719|NCT05193968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649720|NCT05193968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649721|NCT05193968|Sympathomimetics|sympathomimetics|mesh-ancestor
5649722|NCT05193968|Autonomic Agents|autonomic agents|mesh-ancestor
5649723|NCT05193968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5649724|NCT05193968|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5649725|NCT05193968|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5649726|NCT05193968|Vasodilator Agents|vasodilator agents|mesh-ancestor
5649727|NCT05193968|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5649728|NCT05193968|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5649729|NCT05193968|Cholinergic Agents|cholinergic agents|mesh-ancestor
5649730|NCT05193968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5649731|NCT05193968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5649732|NCT05193968|Respiratory System Agents|respiratory system agents|mesh-ancestor
5649733|NCT05193968|Tocolytic Agents|tocolytic agents|mesh-ancestor
5649734|NCT05193968|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5825105|NCT02587130|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5825106|NCT02587130|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5825107|NCT02587130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5825108|NCT02587130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5825109|NCT02587195|Teriflunomide|teriflunomide|mesh-list
5825110|NCT02587195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5825111|NCT02587195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5649735|NCT05193968|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5649736|NCT05193968|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5649737|NCT05183308|Clodronic Acid|clodronic acid|mesh-list
5649738|NCT05183308|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5649739|NCT05183308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649740|NCT05175274|Colchicine|colchicine|mesh-list
5649741|NCT05175274|Gout Suppressants|gout suppressants|mesh-ancestor
5649742|NCT05175274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5649743|NCT05175274|Tubulin Modulators|tubulin modulators|mesh-ancestor
5649744|NCT05175274|Antimitotic Agents|antimitotic agents|mesh-ancestor
5649745|NCT05175274|Mitosis Modulators|mitosis modulators|mesh-ancestor
5649746|NCT05175274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649747|NCT05175274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5694475|NCT03395171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694476|NCT03395171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5694477|NCT03395171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5694478|NCT03395132|Fusidic Acid|fusidic acid|mesh-list
5694479|NCT03395132|Betamethasone|betamethasone|mesh-list
5694480|NCT03395132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5694481|NCT03395132|Glucocorticoids|glucocorticoids|mesh-ancestor
5694482|NCT03395132|Hormones|hormones|mesh-ancestor
5694483|NCT03395132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5694484|NCT03395132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694485|NCT03395132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5694486|NCT03395132|Respiratory System Agents|respiratory system agents|mesh-ancestor
5694487|NCT03395132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5825112|NCT02587195|Analgesics|analgesics|mesh-ancestor
5825113|NCT02587195|Sensory System Agents|sensory system agents|mesh-ancestor
5825114|NCT02587195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5825115|NCT02587195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825116|NCT02587195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5825117|NCT02587195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5825118|NCT02587195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5825119|NCT02587195|Immunologic Factors|immunologic factors|mesh-ancestor
5825120|NCT02587000|Ulipristal acetate|ulipristal acetate|mesh-list
5825121|NCT02587000|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5825122|NCT02587000|Contraceptive Agents|contraceptive agents|mesh-ancestor
5825123|NCT02587000|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5825124|NCT02587000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825125|NCT02587000|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5825126|NCT02587169|Doxorubicin|doxorubicin|mesh-list
5825127|NCT02587169|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5825128|NCT02587169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5649748|NCT05169905|Vaccines|vaccines|mesh-list
5649749|NCT05169905|Immunologic Factors|immunologic factors|mesh-ancestor
5649750|NCT05169905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649751|NCT05169866|Amiodarone|amiodarone|mesh-list
5649752|NCT05169866|Nifekalant|nifekalant|mesh-list
5649753|NCT05169866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5649754|NCT05169866|Vasodilator Agents|vasodilator agents|mesh-ancestor
5649755|NCT05169866|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5649756|NCT05169866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5649757|NCT05169866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649758|NCT05169866|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5649759|NCT05169866|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5649760|NCT05169866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5649761|NCT05169866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5825129|NCT02587169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5825130|NCT02587169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5825131|NCT02587169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5825132|NCT02587169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5825133|NCT02587169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5825134|NCT02586987|Durvalumab|durvalumab|mesh-list
5825135|NCT02586987|Tremelimumab|tremelimumab|mesh-list
5825136|NCT02586987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5825137|NCT02586987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5825138|NCT02586961|Betamethasone|betamethasone|mesh-list
5825139|NCT02586961|Betamethasone Valerate|betamethasone valerate|mesh-list
5825140|NCT02586961|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5825141|NCT02586961|Betamethasone benzoate|betamethasone benzoate|mesh-list
5825142|NCT02586961|Epinephrine|epinephrine|mesh-list
5825143|NCT02586961|Racepinephrine|racepinephrine|mesh-list
5825144|NCT02586961|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
5825145|NCT02586961|Epinephryl borate|epinephryl borate|mesh-list
5825146|NCT02586961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5825147|NCT02586961|Glucocorticoids|glucocorticoids|mesh-ancestor
5825148|NCT02586961|Hormones|hormones|mesh-ancestor
5825149|NCT02586961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5825150|NCT02586961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825151|NCT02586961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5825152|NCT02586961|Respiratory System Agents|respiratory system agents|mesh-ancestor
5825153|NCT02586961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5649762|NCT05169866|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5649763|NCT05169866|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5649764|NCT05169866|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5649765|NCT05160987|Midazolam|midazolam|mesh-list
5649766|NCT05160987|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5649767|NCT05160987|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5649768|NCT05160987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5649769|NCT05160987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825154|NCT02586961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5825155|NCT02586961|Adrenergic Agents|adrenergic agents|mesh-ancestor
5825156|NCT02586961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5825157|NCT02586961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5825158|NCT02586961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5825159|NCT02586961|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5825160|NCT02586961|Autonomic Agents|autonomic agents|mesh-ancestor
5825161|NCT02586961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5825162|NCT02586961|Mydriatics|mydriatics|mesh-ancestor
5825163|NCT02586961|Sympathomimetics|sympathomimetics|mesh-ancestor
5825164|NCT02586961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5649770|NCT05160987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5825165|NCT02586753|Paclitaxel|paclitaxel|mesh-list
5649771|NCT05160987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5649772|NCT05160987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5649773|NCT05160987|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5649774|NCT05160987|Anesthetics, General|anesthetics, general|mesh-ancestor
5649775|NCT05160987|Anesthetics|anesthetics|mesh-ancestor
5649776|NCT05160987|GABA Modulators|gaba modulators|mesh-ancestor
5649777|NCT05160987|GABA Agents|gaba agents|mesh-ancestor
5649778|NCT05160987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5649779|NCT05160987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649780|NCT05153395|Insulin|insulin|mesh-list
5649781|NCT05153395|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5649782|NCT05153395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5649783|NCT05153395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649784|NCT05147220|Teriflunomide|teriflunomide|mesh-list
5649785|NCT05147220|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5649786|NCT05147220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5649787|NCT05147220|Analgesics|analgesics|mesh-ancestor
5649788|NCT05147220|Sensory System Agents|sensory system agents|mesh-ancestor
5649789|NCT05147220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5649790|NCT05147220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825166|NCT02586753|Cisplatin|cisplatin|mesh-list
5825167|NCT02586753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5825168|NCT02586753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5649791|NCT05147220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5649792|NCT05147220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5649793|NCT05147220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5825169|NCT02586753|Tubulin Modulators|tubulin modulators|mesh-ancestor
5825170|NCT02586753|Antimitotic Agents|antimitotic agents|mesh-ancestor
5825171|NCT02586753|Mitosis Modulators|mitosis modulators|mesh-ancestor
5825172|NCT02586753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5825173|NCT02586649|Bromides|bromides|mesh-list
5825174|NCT02586649|Tiotropium Bromide|tiotropium bromide|mesh-list
5825175|NCT02586649|Cholinergic Antagonists|cholinergic antagonists|mesh-list
5825176|NCT02586649|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5825177|NCT02586649|Autonomic Agents|autonomic agents|mesh-ancestor
5649794|NCT05147220|Immunologic Factors|immunologic factors|mesh-ancestor
5649795|NCT05138614|Analgesics, Opioid|analgesics, opioid|mesh-list
5649796|NCT05138614|Narcotics|narcotics|mesh-ancestor
5649797|NCT05138614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5825178|NCT02586649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5825179|NCT02586649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825180|NCT02586649|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5825181|NCT02586649|Respiratory System Agents|respiratory system agents|mesh-ancestor
5825182|NCT02586649|Parasympatholytics|parasympatholytics|mesh-ancestor
5825183|NCT02586649|Cholinergic Agents|cholinergic agents|mesh-ancestor
5825184|NCT02586649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5825185|NCT02586649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649798|NCT05138614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649799|NCT05138614|Analgesics|analgesics|mesh-ancestor
5649800|NCT05138614|Sensory System Agents|sensory system agents|mesh-ancestor
5649801|NCT05138614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5649802|NCT05137600|Clarithromycin|clarithromycin|mesh-list
5649803|NCT05137600|Midazolam|midazolam|mesh-list
5649804|NCT05137600|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5649805|NCT05137600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5649806|NCT05137600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5649807|NCT05137600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649808|NCT05137600|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5649809|NCT05137600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5649810|NCT05137600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5649811|NCT05137600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5649812|NCT05137600|Anesthetics, General|anesthetics, general|mesh-ancestor
5649813|NCT05137600|Anesthetics|anesthetics|mesh-ancestor
5649814|NCT05137600|GABA Modulators|gaba modulators|mesh-ancestor
5649815|NCT05137600|GABA Agents|gaba agents|mesh-ancestor
5649816|NCT05137600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5649817|NCT05137600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649818|NCT05137600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5649819|NCT05137600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5649820|NCT05137600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5649821|NCT05137600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5649822|NCT05137600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5649823|NCT05137600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5649824|NCT05137548|Tenofovir|tenofovir|mesh-list
5649825|NCT05137548|Antiviral Agents|antiviral agents|mesh-ancestor
5649826|NCT05137548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5825186|NCT02586649|Anticonvulsants|anticonvulsants|mesh-ancestor
5825187|NCT02586610|Pembrolizumab|pembrolizumab|mesh-list
5825188|NCT02586610|Capecitabine|capecitabine|mesh-list
5825189|NCT02586610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5825190|NCT02586610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5825191|NCT02586610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5825192|NCT02586610|Antimetabolites|antimetabolites|mesh-ancestor
5825193|NCT02586610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5825194|NCT02586636|Metformin|metformin|mesh-list
5825195|NCT02586636|Omeprazole|omeprazole|mesh-list
5825196|NCT02586636|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5825197|NCT02586636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825198|NCT02586636|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5825199|NCT02586636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5649827|NCT05137548|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5649828|NCT05137548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5649829|NCT05137548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5649830|NCT05137548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649831|NCT05137548|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5649832|NCT05137548|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5649833|NCT05130086|Islatravir|islatravir|mesh-list
5649834|NCT05130086|Antiviral Agents|antiviral agents|mesh-ancestor
5649835|NCT05130086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5649836|NCT05130086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5649837|NCT05130086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649838|NCT05130086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5825200|NCT02586636|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5825201|NCT02586636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5825202|NCT02586636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5825203|NCT02586311|Amlodipine|amlodipine|mesh-list
5825204|NCT02586311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5825205|NCT02586311|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5825206|NCT02586311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5825207|NCT02586311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5825208|NCT02586311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5825209|NCT02586311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825210|NCT02586311|Vasodilator Agents|vasodilator agents|mesh-ancestor
5825211|NCT02586402|Epoetin Alfa|epoetin alfa|mesh-list
5825212|NCT02586402|Hematinics|hematinics|mesh-ancestor
5825213|NCT02586259|Budesonide|budesonide|mesh-list
5825214|NCT02586259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5825215|NCT02586259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5825216|NCT02586259|Autonomic Agents|autonomic agents|mesh-ancestor
5825217|NCT02586259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5825218|NCT02586259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825219|NCT02586259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5825220|NCT02586259|Respiratory System Agents|respiratory system agents|mesh-ancestor
5825221|NCT02586259|Glucocorticoids|glucocorticoids|mesh-ancestor
5825222|NCT02586259|Hormones|hormones|mesh-ancestor
5825223|NCT02586259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5825224|NCT02586441|Bromides|bromides|mesh-list
5825225|NCT02586441|Propofol|propofol|mesh-list
5825226|NCT02586441|Rocuronium|rocuronium|mesh-list
5825227|NCT02586441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5825228|NCT02586441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5825229|NCT02586441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825230|NCT02586441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5825231|NCT02586441|Anesthetics, General|anesthetics, general|mesh-ancestor
5825232|NCT02586441|Anesthetics|anesthetics|mesh-ancestor
5825233|NCT02586441|Anticonvulsants|anticonvulsants|mesh-ancestor
5825234|NCT02586441|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5825235|NCT02586441|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5825236|NCT02586441|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5825237|NCT02586441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5825238|NCT02586454|Morphine|morphine|mesh-list
5825239|NCT02586454|Ropivacaine|ropivacaine|mesh-list
5825240|NCT02586454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5825241|NCT02586454|Narcotics|narcotics|mesh-ancestor
5825242|NCT02586454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5825243|NCT02586454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649839|NCT05130086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5649840|NCT05130086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5649841|NCT05094128|Upadacitinib|upadacitinib|mesh-list
5825244|NCT02586454|Analgesics|analgesics|mesh-ancestor
5825245|NCT02586454|Sensory System Agents|sensory system agents|mesh-ancestor
5902074|NCT05129033|Itraconazole|itraconazole|mesh-list
5825246|NCT02586454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5825247|NCT02586454|Anesthetics, Local|anesthetics, local|mesh-ancestor
5825248|NCT02586454|Anesthetics|anesthetics|mesh-ancestor
5825249|NCT02586363|Entecavir|entecavir|mesh-list
5825250|NCT02586363|Antiviral Agents|antiviral agents|mesh-ancestor
5825251|NCT02586363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5825252|NCT02586246|Certolizumab Pegol|certolizumab pegol|mesh-list
5825253|NCT02586246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5825254|NCT02586246|Immunologic Factors|immunologic factors|mesh-ancestor
5825255|NCT02586246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825256|NCT02586246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5825257|NCT02586194|Peficitinib|peficitinib|mesh-list
5825258|NCT02586194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5825259|NCT02586194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5825260|NCT02586194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5825261|NCT02586194|Immunologic Factors|immunologic factors|mesh-ancestor
5825262|NCT02586194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825263|NCT02586038|Thalidomide|thalidomide|mesh-list
5825264|NCT02586038|Dexamethasone|dexamethasone|mesh-list
5825265|NCT02586038|Cyclophosphamide|cyclophosphamide|mesh-list
5649842|NCT05094128|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
5649843|NCT05094128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5649844|NCT05094128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5649845|NCT05094128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649846|NCT05094128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5649847|NCT05091294|Anesthetics|anesthetics|mesh-list
5649848|NCT05091294|Anesthetics, Local|anesthetics, local|mesh-list
5649849|NCT05091294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5649850|NCT05091294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649851|NCT05091294|Sensory System Agents|sensory system agents|mesh-ancestor
5825266|NCT02586038|Ixazomib|ixazomib|mesh-list
5825267|NCT02586038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5825268|NCT02586038|Immunologic Factors|immunologic factors|mesh-ancestor
5825269|NCT02586038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825270|NCT02586038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5825271|NCT02586038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5825272|NCT02586038|Alkylating Agents|alkylating agents|mesh-ancestor
5825273|NCT02586038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5825274|NCT02586038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5825275|NCT02586038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5825276|NCT02586038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5825277|NCT02586038|Antiemetics|antiemetics|mesh-ancestor
5825278|NCT02586038|Autonomic Agents|autonomic agents|mesh-ancestor
5825279|NCT02586038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5825280|NCT02586038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5825281|NCT02586038|Glucocorticoids|glucocorticoids|mesh-ancestor
5825282|NCT02586038|Hormones|hormones|mesh-ancestor
5825283|NCT02586038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5825284|NCT02586038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5825285|NCT02586038|Leprostatic Agents|leprostatic agents|mesh-ancestor
5825286|NCT02586038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5825287|NCT02586038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5825288|NCT02586038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5825289|NCT02586038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5649852|NCT05091294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5649853|NCT05082285|Vaccines|vaccines|mesh-list
5649854|NCT05082285|Immunologic Factors|immunologic factors|mesh-ancestor
5649855|NCT05082285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649856|NCT05078060|Vaccines|vaccines|mesh-list
5649857|NCT05078060|Immunologic Factors|immunologic factors|mesh-ancestor
5649858|NCT05078060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649859|NCT05072704|Sufentanil|sufentanil|mesh-list
5649860|NCT05072704|Dexmedetomidine|dexmedetomidine|mesh-list
5649861|NCT05072704|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5649862|NCT05072704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5649863|NCT05072704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649864|NCT05072704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5649865|NCT05072704|Analgesics|analgesics|mesh-ancestor
5649866|NCT05072704|Sensory System Agents|sensory system agents|mesh-ancestor
5825290|NCT02586038|Growth Substances|growth substances|mesh-ancestor
5825291|NCT02586038|Growth Inhibitors|growth inhibitors|mesh-ancestor
5825292|NCT02586038|Protease Inhibitors|protease inhibitors|mesh-ancestor
5825293|NCT02586038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5649867|NCT05072704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5825294|NCT02586181|Calcium, Dietary|calcium, dietary|mesh-list
5825295|NCT02586181|Vitamin D|vitamin d|mesh-list
5825296|NCT02586181|Ergocalciferols|ergocalciferols|mesh-list
5649868|NCT05072704|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5649869|NCT05072704|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5649870|NCT05072704|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5649871|NCT05072704|Adrenergic Agents|adrenergic agents|mesh-ancestor
5649872|NCT05072704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5649873|NCT05072704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649874|NCT05072704|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5649875|NCT05072704|Narcotics|narcotics|mesh-ancestor
5649876|NCT05072704|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5649877|NCT05072704|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5649878|NCT05072704|Anesthetics, General|anesthetics, general|mesh-ancestor
5649879|NCT05072704|Anesthetics|anesthetics|mesh-ancestor
5825297|NCT02586181|Vitamins|vitamins|mesh-list
5825298|NCT02586181|Folic Acid|folic acid|mesh-list
5825299|NCT02586181|Calcium|calcium|mesh-list
5825300|NCT02586181|Micronutrients|micronutrients|mesh-ancestor
5825301|NCT02586181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825302|NCT02586181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5825303|NCT02586181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5825304|NCT02586181|Vitamin B Complex|vitamin b complex|mesh-ancestor
5825305|NCT02586181|Hematinics|hematinics|mesh-ancestor
5825306|NCT02586129|Metformin|metformin|mesh-list
5825307|NCT02586129|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5825308|NCT02586129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5825309|NCT02586129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825310|NCT02586129|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5825311|NCT02586129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5825312|NCT02586129|Antimetabolites|antimetabolites|mesh-ancestor
5825313|NCT02586129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5825314|NCT02586129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5825315|NCT02586129|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5825316|NCT02586129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5825317|NCT02586051|Obinutuzumab|obinutuzumab|mesh-list
5825318|NCT02586051|Immunoglobulins|immunoglobulins|mesh-list
5825319|NCT02586051|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5825320|NCT02586051|Antibodies|antibodies|mesh-list
5825321|NCT02586051|gamma-Globulins|gamma-globulins|mesh-list
5825322|NCT02586051|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5825323|NCT02586051|Immunologic Factors|immunologic factors|mesh-ancestor
5825324|NCT02586051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825325|NCT02586051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5825326|NCT02586051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5825327|NCT02586142|Botulinum Toxins|botulinum toxins|mesh-list
5825328|NCT02586142|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5825329|NCT02586142|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5825330|NCT02586142|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5825331|NCT02586142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5825332|NCT02586142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5825333|NCT02586142|Cholinergic Agents|cholinergic agents|mesh-ancestor
5825334|NCT02586142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5825335|NCT02586142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825336|NCT02586142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5825337|NCT02586142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5825338|NCT02585973|Cisplatin|cisplatin|mesh-list
5649880|NCT05041426|Valganciclovir|valganciclovir|mesh-list
5649881|NCT05041426|Letermovir|letermovir|mesh-list
5649882|NCT05041426|Antiviral Agents|antiviral agents|mesh-ancestor
5649883|NCT05041426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5649884|NCT05041426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5649885|NCT05041426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5649886|NCT05041426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649887|NCT05041426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5649888|NCT05029050|Clonidine|clonidine|mesh-list
5649889|NCT05029050|Dexmedetomidine|dexmedetomidine|mesh-list
5649890|NCT05029050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5825339|NCT02585973|Adavosertib|adavosertib|mesh-list
5825340|NCT02585973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5825341|NCT02585973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5825342|NCT02585973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5825343|NCT02585947|Tenofovir|tenofovir|mesh-list
5825344|NCT02585947|Antiviral Agents|antiviral agents|mesh-ancestor
5825345|NCT02585947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5825346|NCT02585947|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5825347|NCT02585947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5825348|NCT02585947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5649891|NCT05029050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5649892|NCT05029050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649893|NCT05029050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5649894|NCT05029050|Analgesics|analgesics|mesh-ancestor
5649895|NCT05029050|Sensory System Agents|sensory system agents|mesh-ancestor
5649896|NCT05029050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5649897|NCT05029050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5649898|NCT05029050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5825349|NCT02585947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5825350|NCT02585947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5825351|NCT02585947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5825352|NCT02585882|Fluorides|fluorides|mesh-list
5825353|NCT02585882|Cariostatic Agents|cariostatic agents|mesh-ancestor
5825354|NCT02585882|Protective Agents|protective agents|mesh-ancestor
5825355|NCT02585882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825356|NCT02585648|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5825357|NCT02585648|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5649899|NCT05029050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5649900|NCT05029050|Adrenergic Agents|adrenergic agents|mesh-ancestor
5649901|NCT05029050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5649902|NCT05029050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649903|NCT05029050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5649904|NCT05029050|Sympatholytics|sympatholytics|mesh-ancestor
5649905|NCT05029050|Autonomic Agents|autonomic agents|mesh-ancestor
5649906|NCT05005403|Pembrolizumab|pembrolizumab|mesh-list
5825358|NCT02585674|Insulin Glargine|insulin glargine|mesh-list
5825359|NCT02585674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5825360|NCT02585674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825361|NCT02585804|Dapagliflozin|dapagliflozin|mesh-list
5825362|NCT02585804|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5825363|NCT02585804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5825364|NCT02585804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5825365|NCT02585804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825366|NCT02585791|Glycerol|glycerol|mesh-list
5825367|NCT02585791|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
5825368|NCT02585791|Protective Agents|protective agents|mesh-ancestor
5825369|NCT02585791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825370|NCT02585765|Pioglitazone|pioglitazone|mesh-list
5825371|NCT02585765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5825372|NCT02585765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825373|NCT02585531|Dexamethasone|dexamethasone|mesh-list
5825374|NCT02585531|Epinephrine|epinephrine|mesh-list
5825375|NCT02585531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5825376|NCT02585531|Antiemetics|antiemetics|mesh-ancestor
5825377|NCT02585531|Autonomic Agents|autonomic agents|mesh-ancestor
5825378|NCT02585531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5825379|NCT02585531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825380|NCT02585531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5825381|NCT02585531|Glucocorticoids|glucocorticoids|mesh-ancestor
5825382|NCT02585531|Hormones|hormones|mesh-ancestor
5825383|NCT02585531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5825384|NCT02585531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5825385|NCT02585531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5825386|NCT02585531|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5825387|NCT02585531|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5825388|NCT02585531|Adrenergic Agents|adrenergic agents|mesh-ancestor
5825389|NCT02585531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5825390|NCT02585531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649907|NCT05005403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5649908|NCT05005403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5649909|NCT05002829|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5649910|NCT05002829|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5649911|NCT05002829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5649912|NCT05002829|Antitubercular Agents|antitubercular agents|mesh-ancestor
5649913|NCT04987372|Lidocaine|lidocaine|mesh-list
5649914|NCT04987372|Magnesium Sulfate|magnesium sulfate|mesh-list
5649915|NCT04987372|Pregabalin|pregabalin|mesh-list
5649916|NCT04987372|Dexmedetomidine|dexmedetomidine|mesh-list
5649917|NCT04987372|Ketamine|ketamine|mesh-list
5649918|NCT04987372|Anesthetics, Local|anesthetics, local|mesh-ancestor
5649919|NCT04987372|Anesthetics|anesthetics|mesh-ancestor
5649920|NCT04987372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5649921|NCT04987372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649922|NCT04987372|Sensory System Agents|sensory system agents|mesh-ancestor
5902075|NCT05129033|Prednisone|prednisone|mesh-list
5649923|NCT04987372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5649924|NCT04987372|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5825391|NCT02585531|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5825392|NCT02585531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5825393|NCT02585531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5825394|NCT02585531|Respiratory System Agents|respiratory system agents|mesh-ancestor
5825395|NCT02585531|Mydriatics|mydriatics|mesh-ancestor
5825396|NCT02585531|Sympathomimetics|sympathomimetics|mesh-ancestor
5825397|NCT02585531|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5825398|NCT02585570|Phenylephrine|phenylephrine|mesh-list
5825399|NCT02585570|Oxymetazoline|oxymetazoline|mesh-list
5825400|NCT02585570|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5825401|NCT02585570|Mydriatics|mydriatics|mesh-ancestor
5825402|NCT02585570|Autonomic Agents|autonomic agents|mesh-ancestor
5825403|NCT02585570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5825404|NCT02585570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825405|NCT02585570|Sympathomimetics|sympathomimetics|mesh-ancestor
5825406|NCT02585570|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5825407|NCT02585570|Nasal Decongestants|nasal decongestants|mesh-ancestor
5825408|NCT02585570|Respiratory System Agents|respiratory system agents|mesh-ancestor
5825409|NCT02585570|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5825410|NCT02585570|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5825411|NCT02585570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5825412|NCT02585570|Adrenergic Agents|adrenergic agents|mesh-ancestor
5825413|NCT02585570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5825414|NCT02585570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5825415|NCT02585570|Protective Agents|protective agents|mesh-ancestor
5825416|NCT02585479|Oxaliplatin|oxaliplatin|mesh-list
5825417|NCT02585479|Ethiodized Oil|ethiodized oil|mesh-list
5825418|NCT02585479|Pirarubicin|pirarubicin|mesh-list
5825419|NCT02585479|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
5825420|NCT02585479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5825421|NCT02585479|Hemostatics|hemostatics|mesh-ancestor
5825422|NCT02585479|Coagulants|coagulants|mesh-ancestor
5902076|NCT05129033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5902077|NCT05129033|Glucocorticoids|glucocorticoids|mesh-ancestor
5902078|NCT05129033|Hormones|hormones|mesh-ancestor
5902079|NCT05129033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5902080|NCT05129033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902081|NCT05129033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5902082|NCT05129033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5902083|NCT05129033|Antifungal Agents|antifungal agents|mesh-ancestor
5902084|NCT05129033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5902085|NCT05129033|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5902086|NCT05129033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5649925|NCT04987372|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5649926|NCT04987372|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5649927|NCT04987372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5649928|NCT04987372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649929|NCT04987372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5649930|NCT04987372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5649931|NCT04987372|Analgesics|analgesics|mesh-ancestor
5649932|NCT04987372|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5649933|NCT04987372|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5649934|NCT04987372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5649935|NCT04987372|Adrenergic Agents|adrenergic agents|mesh-ancestor
5649936|NCT04987372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5649937|NCT04987372|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5649938|NCT04987372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5649939|NCT04987372|Anesthetics, General|anesthetics, general|mesh-ancestor
5902087|NCT05129033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5902088|NCT05129033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902089|NCT05129033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5902090|NCT05129033|Hormone Antagonists|hormone antagonists|mesh-ancestor
5902091|NCT05129033|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5902092|NCT05129033|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5902093|NCT05129033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5902094|NCT05129033|Respiratory System Agents|respiratory system agents|mesh-ancestor
5902095|NCT05128916|Terbinafine|terbinafine|mesh-list
5649940|NCT04987372|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5649941|NCT04987372|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5649942|NCT04987372|Anticonvulsants|anticonvulsants|mesh-ancestor
5649943|NCT04987372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5649944|NCT04987372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5902096|NCT05128916|Antifungal Agents|antifungal agents|mesh-ancestor
5902097|NCT05128916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5825423|NCT02585440|Hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|mesh-list
5825424|NCT02585440|Antiviral Agents|antiviral agents|mesh-ancestor
5825425|NCT02585440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5825426|NCT02585440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5825427|NCT02585440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5825428|NCT02585180|Silver Sulfadiazine|silver sulfadiazine|mesh-list
5825429|NCT02585180|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5825430|NCT02585180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5825431|NCT02585258|Prednisolone|prednisolone|mesh-list
5825432|NCT02585258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5825433|NCT02585258|Glucocorticoids|glucocorticoids|mesh-ancestor
5825434|NCT02585258|Hormones|hormones|mesh-ancestor
5825435|NCT02585258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5825436|NCT02585258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825437|NCT02585258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5825438|NCT02585258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5825439|NCT02585401|Aflibercept|aflibercept|mesh-list
5825440|NCT02585401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5825441|NCT02585401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5825442|NCT02585401|Growth Substances|growth substances|mesh-ancestor
5825443|NCT02585401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825444|NCT02585401|Growth Inhibitors|growth inhibitors|mesh-ancestor
5825445|NCT02585401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5825446|NCT02585388|Letrozole|letrozole|mesh-list
5825447|NCT02585388|Vinorelbine|vinorelbine|mesh-list
5825448|NCT02585388|Anastrozole|anastrozole|mesh-list
5825449|NCT02585388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5825450|NCT02585388|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5825451|NCT02585388|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5825452|NCT02585388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5825453|NCT02585388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5825454|NCT02585388|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5825455|NCT02585388|Hormone Antagonists|hormone antagonists|mesh-ancestor
5825456|NCT02585388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5825457|NCT02585388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825458|NCT02585388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5825459|NCT02585388|Tubulin Modulators|tubulin modulators|mesh-ancestor
5825460|NCT02585388|Antimitotic Agents|antimitotic agents|mesh-ancestor
5825461|NCT02585388|Mitosis Modulators|mitosis modulators|mesh-ancestor
5825462|NCT02585388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5825463|NCT02585375|Latanoprost|latanoprost|mesh-list
5825464|NCT02585375|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5825465|NCT02585375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5825466|NCT02585141|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5649945|NCT04987372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5649946|NCT04987372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5649947|NCT04987372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5649948|NCT04987372|Tocolytic Agents|tocolytic agents|mesh-ancestor
5649949|NCT04987372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5649950|NCT04981067|Ropivacaine|ropivacaine|mesh-list
5649951|NCT04981067|Anesthetics, Local|anesthetics, local|mesh-ancestor
5649952|NCT04981067|Anesthetics|anesthetics|mesh-ancestor
5649953|NCT04981067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5649954|NCT04981067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649955|NCT04981067|Sensory System Agents|sensory system agents|mesh-ancestor
5649956|NCT04981067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5649958|NCT04964050|Captopril, hydrochlorothiazide drug combination|captopril, hydrochlorothiazide drug combination|mesh-list
5649959|NCT04964050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5649960|NCT04964050|Protease Inhibitors|protease inhibitors|mesh-ancestor
5649961|NCT04964050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5825467|NCT02585141|Clindamycin|clindamycin|mesh-list
5825468|NCT02585141|Clindamycin palmitate|clindamycin palmitate|mesh-list
5825469|NCT02585141|Clindamycin phosphate|clindamycin phosphate|mesh-list
5825470|NCT02585141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5825471|NCT02585141|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5825472|NCT02585141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5825473|NCT02585141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5825474|NCT02585011|Epinephrine|epinephrine|mesh-list
5825475|NCT02585011|Ropivacaine|ropivacaine|mesh-list
5825476|NCT02585011|Anesthetics, Local|anesthetics, local|mesh-ancestor
5825477|NCT02585011|Anesthetics|anesthetics|mesh-ancestor
5825478|NCT02585011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5825479|NCT02585011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825480|NCT02585011|Sensory System Agents|sensory system agents|mesh-ancestor
5649962|NCT04964050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649963|NCT04964050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5649964|NCT04964050|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5649965|NCT04964050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5649966|NCT04964050|Diuretics|diuretics|mesh-ancestor
5649967|NCT04964050|Natriuretic Agents|natriuretic agents|mesh-ancestor
5649968|NCT04964050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649969|NCT04905862|Antipyretics|antipyretics|mesh-list
5649970|NCT04905862|Analgesics|analgesics|mesh-list
5649971|NCT04905862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649972|NCT04905862|Sensory System Agents|sensory system agents|mesh-ancestor
5649973|NCT04905862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5649974|NCT04898309|Complement C1s|complement c1s|mesh-list
5649975|NCT04898309|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
5649976|NCT04898309|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
5649977|NCT04898309|Immunologic Factors|immunologic factors|mesh-ancestor
5649978|NCT04898309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649979|NCT04898309|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5649980|NCT04898309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5649981|NCT04895202|Siponimod|siponimod|mesh-list
5649982|NCT04895202|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5649983|NCT04895202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649984|NCT04895202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5649985|NCT04895202|Immunologic Factors|immunologic factors|mesh-ancestor
5649986|NCT04895202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5649987|NCT04891770|Tenofovir|tenofovir|mesh-list
5649988|NCT04891770|Nivolumab|nivolumab|mesh-list
5649989|NCT04891770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5649990|NCT04891770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5649991|NCT04891770|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5649992|NCT04891770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5649993|NCT04891770|Antiviral Agents|antiviral agents|mesh-ancestor
5649994|NCT04891770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5649995|NCT04891770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5649996|NCT04891770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5649997|NCT04891770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5649998|NCT04891770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5649999|NCT04891770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5650000|NCT04886154|Vaccines|vaccines|mesh-list
5650001|NCT04886154|Immunologic Factors|immunologic factors|mesh-ancestor
5650002|NCT04886154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650003|NCT04840264|Docetaxel|docetaxel|mesh-list
5825481|NCT02585011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5825482|NCT02585011|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5825483|NCT02585011|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5825484|NCT02585011|Adrenergic Agents|adrenergic agents|mesh-ancestor
5825485|NCT02585011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5825486|NCT02585011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5825487|NCT02585011|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5825488|NCT02585011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5825489|NCT02585011|Autonomic Agents|autonomic agents|mesh-ancestor
5825490|NCT02585011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5825491|NCT02585011|Respiratory System Agents|respiratory system agents|mesh-ancestor
5825492|NCT02585011|Mydriatics|mydriatics|mesh-ancestor
5825493|NCT02585011|Sympathomimetics|sympathomimetics|mesh-ancestor
5825494|NCT02585011|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5825495|NCT02584920|Rituximab|rituximab|mesh-list
5825496|NCT02584920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5825497|NCT02584920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5825498|NCT02584920|Immunologic Factors|immunologic factors|mesh-ancestor
5825499|NCT02584920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825500|NCT02584920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5825501|NCT02584881|Analgesics, Opioid|analgesics, opioid|mesh-list
5825502|NCT02584881|Narcotics|narcotics|mesh-ancestor
5825503|NCT02584881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5825504|NCT02584881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825505|NCT02584881|Analgesics|analgesics|mesh-ancestor
5825506|NCT02584881|Sensory System Agents|sensory system agents|mesh-ancestor
5825507|NCT02584881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5825508|NCT02584829|Interferons|interferons|mesh-list
5825509|NCT02584829|Interferon-beta|interferon-beta|mesh-list
5825510|NCT02584829|Avelumab|avelumab|mesh-list
5650004|NCT04840264|Fluorouracil|fluorouracil|mesh-list
5650005|NCT04840264|Oxaliplatin|oxaliplatin|mesh-list
5825511|NCT02584829|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5650006|NCT04840264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5650007|NCT04840264|Tubulin Modulators|tubulin modulators|mesh-ancestor
5650008|NCT04840264|Antimitotic Agents|antimitotic agents|mesh-ancestor
5650009|NCT04840264|Mitosis Modulators|mitosis modulators|mesh-ancestor
5650010|NCT04840264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650011|NCT04840264|Antimetabolites|antimetabolites|mesh-ancestor
5650012|NCT04840264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5650013|NCT04840264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5650014|NCT04840264|Immunologic Factors|immunologic factors|mesh-ancestor
5650015|NCT04840264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650016|NCT04839042|Cloricromen|cloricromen|mesh-list
5650017|NCT04839042|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5650018|NCT04827576|Docetaxel|docetaxel|mesh-list
5825512|NCT02584829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5825513|NCT02584829|Antiviral Agents|antiviral agents|mesh-ancestor
5825514|NCT02584829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5650019|NCT04827576|Magrolimab|magrolimab|mesh-list
5650020|NCT04827576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5650021|NCT04827576|Tubulin Modulators|tubulin modulators|mesh-ancestor
5650022|NCT04827576|Antimitotic Agents|antimitotic agents|mesh-ancestor
5650023|NCT04827576|Mitosis Modulators|mitosis modulators|mesh-ancestor
5650024|NCT04827576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650025|NCT04827576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5694488|NCT03395132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5694489|NCT03395132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5694490|NCT03395132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5694491|NCT03395132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694492|NCT03395093|Fentanyl|fentanyl|mesh-list
5694493|NCT03395093|Midazolam|midazolam|mesh-list
5694494|NCT03395093|Propofol|propofol|mesh-list
5694495|NCT03395093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5694496|NCT03395093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5825515|NCT02584829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5825516|NCT02584829|Immunologic Factors|immunologic factors|mesh-ancestor
5825517|NCT02584829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825518|NCT02584816|Vaccines|vaccines|mesh-list
5825519|NCT02584816|Immunologic Factors|immunologic factors|mesh-ancestor
5825520|NCT02584816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825521|NCT02584751|Nitric Oxide|nitric oxide|mesh-list
5825522|NCT02584751|Omeprazole|omeprazole|mesh-list
5694497|NCT03395093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694498|NCT03395093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5694499|NCT03395093|Anesthetics, General|anesthetics, general|mesh-ancestor
5694500|NCT03395093|Anesthetics|anesthetics|mesh-ancestor
5694501|NCT03395093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5694502|NCT03395093|Narcotics|narcotics|mesh-ancestor
5694503|NCT03395093|Analgesics|analgesics|mesh-ancestor
5694504|NCT03395093|Sensory System Agents|sensory system agents|mesh-ancestor
5694505|NCT03395093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5694506|NCT03395093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5694507|NCT03395093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5825523|NCT02584751|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5825524|NCT02584751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5825525|NCT02584751|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5825526|NCT02584751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5825527|NCT02584751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5825528|NCT02584751|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5694508|NCT03395093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5694509|NCT03395093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5694510|NCT03395093|GABA Modulators|gaba modulators|mesh-ancestor
5694511|NCT03395093|GABA Agents|gaba agents|mesh-ancestor
5694512|NCT03395093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5694513|NCT03395093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694514|NCT03395080|Paclitaxel|paclitaxel|mesh-list
5694515|NCT03395080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5694516|NCT03395080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5694517|NCT03395080|Tubulin Modulators|tubulin modulators|mesh-ancestor
5694518|NCT03395080|Antimitotic Agents|antimitotic agents|mesh-ancestor
5694519|NCT03395080|Mitosis Modulators|mitosis modulators|mesh-ancestor
5694520|NCT03395080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694521|NCT03395028|Lenograstim|lenograstim|mesh-list
5694522|NCT03395028|Sargramostim|sargramostim|mesh-list
5694523|NCT03395028|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5825529|NCT02584751|Autonomic Agents|autonomic agents|mesh-ancestor
5694524|NCT03395028|Immunologic Factors|immunologic factors|mesh-ancestor
5694525|NCT03395028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694526|NCT03395002|Fluticasone|fluticasone|mesh-list
5825530|NCT02584751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5825531|NCT02584751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825532|NCT02584751|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5825533|NCT02584751|Respiratory System Agents|respiratory system agents|mesh-ancestor
5825534|NCT02584751|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5825535|NCT02584751|Antioxidants|antioxidants|mesh-ancestor
5825536|NCT02584751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5825537|NCT02584751|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5825538|NCT02584751|Vasodilator Agents|vasodilator agents|mesh-ancestor
5825539|NCT02584751|Gasotransmitters|gasotransmitters|mesh-ancestor
5825540|NCT02584751|Protective Agents|protective agents|mesh-ancestor
5825541|NCT02584738|Methylprednisolone|methylprednisolone|mesh-list
5825542|NCT02584738|Prednisolone|prednisolone|mesh-list
5825543|NCT02584738|Magnesium Sulfate|magnesium sulfate|mesh-list
5825544|NCT02584738|Bromides|bromides|mesh-list
5825545|NCT02584738|Albuterol|albuterol|mesh-list
5650026|NCT04822467|Ethanol|ethanol|mesh-list
5650027|NCT04822467|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5650028|NCT04822467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5650029|NCT04822467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5650030|NCT04822467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650031|NCT04821310|Pantoprazole|pantoprazole|mesh-list
5650032|NCT04821310|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5825546|NCT02584738|Ipratropium|ipratropium|mesh-list
5825547|NCT02584738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5825548|NCT02584738|Antiemetics|antiemetics|mesh-ancestor
5825549|NCT02584738|Autonomic Agents|autonomic agents|mesh-ancestor
5825550|NCT02584738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5825551|NCT02584738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825552|NCT02584738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5825553|NCT02584738|Glucocorticoids|glucocorticoids|mesh-ancestor
5825554|NCT02584738|Hormones|hormones|mesh-ancestor
5825555|NCT02584738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5825556|NCT02584738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5825557|NCT02584738|Protective Agents|protective agents|mesh-ancestor
5825558|NCT02584738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5825559|NCT02584738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5825560|NCT02584738|Anticonvulsants|anticonvulsants|mesh-ancestor
5825561|NCT02584738|Analgesics|analgesics|mesh-ancestor
5825562|NCT02584738|Sensory System Agents|sensory system agents|mesh-ancestor
5825563|NCT02584738|Anesthetics|anesthetics|mesh-ancestor
5825564|NCT02584738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5825565|NCT02584738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5825566|NCT02584738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5825567|NCT02584738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5825568|NCT02584738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5825569|NCT02584738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5825570|NCT02584738|Tocolytic Agents|tocolytic agents|mesh-ancestor
5825571|NCT02584738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5825572|NCT02584738|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5825573|NCT02584738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5825574|NCT02584738|Respiratory System Agents|respiratory system agents|mesh-ancestor
5825575|NCT02584738|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5825576|NCT02584738|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5825577|NCT02584738|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5825578|NCT02584738|Adrenergic Agents|adrenergic agents|mesh-ancestor
5825579|NCT02584738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5825580|NCT02584738|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5825581|NCT02584738|Cholinergic Agents|cholinergic agents|mesh-ancestor
5825582|NCT02584647|Sirolimus|sirolimus|mesh-list
5825583|NCT02584647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5825584|NCT02584647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5825585|NCT02584647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5825586|NCT02584647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5825587|NCT02584647|Antifungal Agents|antifungal agents|mesh-ancestor
5825588|NCT02584647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5825589|NCT02584647|Immunologic Factors|immunologic factors|mesh-ancestor
5825590|NCT02584647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825591|NCT02584582|Liraglutide|liraglutide|mesh-list
5825592|NCT02584582|Exenatide|exenatide|mesh-list
5650033|NCT04821310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5650034|NCT04821310|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5650035|NCT04821310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5825593|NCT02584582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5825594|NCT02584582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825595|NCT02584582|Incretins|incretins|mesh-ancestor
5825596|NCT02584582|Hormones|hormones|mesh-ancestor
5825597|NCT02584582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5825598|NCT02584582|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5825599|NCT02584543|Vaccines|vaccines|mesh-list
5825600|NCT02584543|Immunologic Factors|immunologic factors|mesh-ancestor
5825601|NCT02584543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825602|NCT02584465|Tamoxifen|tamoxifen|mesh-list
5825603|NCT02584465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5650036|NCT04821310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650037|NCT04809220|Dulaglutide|dulaglutide|mesh-list
5650038|NCT04809220|Biguanides|biguanides|mesh-list
5650039|NCT04809220|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
5650040|NCT04809220|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
5825604|NCT02584465|Hormone Antagonists|hormone antagonists|mesh-ancestor
5825605|NCT02584465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5825606|NCT02584465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825607|NCT02584465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5825608|NCT02584465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5825609|NCT02584465|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5825610|NCT02584465|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5825611|NCT02584465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5825612|NCT02584426|Cefazolin|cefazolin|mesh-list
5825613|NCT02584426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5825614|NCT02584426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5825615|NCT02584400|Imidazole|imidazole|mesh-list
5825616|NCT02584400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5825617|NCT02584400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5825618|NCT02584335|Lidocaine|lidocaine|mesh-list
5825619|NCT02584335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5825620|NCT02584335|Anesthetics, Local|anesthetics, local|mesh-ancestor
5825621|NCT02584335|Anesthetics|anesthetics|mesh-ancestor
5825622|NCT02584335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5825623|NCT02584335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825624|NCT02584335|Sensory System Agents|sensory system agents|mesh-ancestor
6493030|NCT00611741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493031|NCT00611741|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6493032|NCT00611741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5650041|NCT04809220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5650042|NCT04809220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650043|NCT04809220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5650044|NCT04809220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650045|NCT04808973|Lamivudine|lamivudine|mesh-list
5650046|NCT04808973|Dolutegravir|dolutegravir|mesh-list
5650047|NCT04808973|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5650048|NCT04808973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5650049|NCT04808973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5650050|NCT04808973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650051|NCT04808973|Antiviral Agents|antiviral agents|mesh-ancestor
5650052|NCT04808973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5650053|NCT04808973|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5650054|NCT04808973|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5650055|NCT04808973|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5650056|NCT04808973|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5650057|NCT04804007|Etoposide|etoposide|mesh-list
5650058|NCT04804007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5650059|NCT04804007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5650060|NCT04804007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5650061|NCT04804007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5650062|NCT04804007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5650063|NCT04804007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650064|NCT04787692|Analgesics, Opioid|analgesics, opioid|mesh-list
5650065|NCT04787692|Narcotics|narcotics|mesh-ancestor
5650066|NCT04787692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5650067|NCT04787692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650068|NCT04787692|Analgesics|analgesics|mesh-ancestor
5650069|NCT04787692|Sensory System Agents|sensory system agents|mesh-ancestor
5650070|NCT04787692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5650071|NCT04759833|Prucalopride|prucalopride|mesh-list
5650072|NCT04759833|Laxatives|laxatives|mesh-ancestor
5650073|NCT04759833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5650074|NCT04759833|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
5650075|NCT04759833|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5650076|NCT04759833|Serotonin Agents|serotonin agents|mesh-ancestor
5694527|NCT03395002|Xhance|xhance|mesh-list
6493033|NCT00611741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493034|NCT00611754|Fluorouracil|fluorouracil|mesh-list
6493035|NCT00611754|Oxaliplatin|oxaliplatin|mesh-list
6493036|NCT00611754|Antimetabolites|antimetabolites|mesh-ancestor
6493037|NCT00611754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493038|NCT00611754|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5650077|NCT04759833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5825625|NCT02584335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5825626|NCT02584335|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5825627|NCT02584335|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5825628|NCT02584335|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5825629|NCT02584335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5825630|NCT02584335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5825631|NCT02584075|Metformin|metformin|mesh-list
5825632|NCT02584075|Exenatide|exenatide|mesh-list
5825633|NCT02584075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5825634|NCT02584075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825635|NCT02584075|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5825636|NCT02584075|Incretins|incretins|mesh-ancestor
5825637|NCT02584075|Hormones|hormones|mesh-ancestor
5825638|NCT02584075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5825639|NCT02584231|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
5825640|NCT02584231|Hemostatics|hemostatics|mesh-ancestor
5825641|NCT02584231|Coagulants|coagulants|mesh-ancestor
5825642|NCT02584231|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5825643|NCT02584231|Natriuretic Agents|natriuretic agents|mesh-ancestor
5825644|NCT02584231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825645|NCT02584036|Vaccines|vaccines|mesh-list
5825646|NCT02584036|Immunologic Factors|immunologic factors|mesh-ancestor
5825647|NCT02584036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825648|NCT02584153|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
5825649|NCT02584153|Hemostatics|hemostatics|mesh-ancestor
5825650|NCT02584153|Coagulants|coagulants|mesh-ancestor
5825651|NCT02584309|Doxorubicin|doxorubicin|mesh-list
5825652|NCT02584309|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5825653|NCT02584309|Dexrazoxane|dexrazoxane|mesh-list
5825654|NCT02584309|Razoxane|razoxane|mesh-list
5825655|NCT02584309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5825656|NCT02584309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5825657|NCT02584309|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5825658|NCT02584309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5825659|NCT02584309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5650078|NCT04759833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650079|NCT04759833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650080|NCT04755244|Azacitidine|azacitidine|mesh-list
5650081|NCT04755244|Venetoclax|venetoclax|mesh-list
5650082|NCT04755244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5650083|NCT04755244|Antimetabolites|antimetabolites|mesh-ancestor
5650084|NCT04755244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650085|NCT04755244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5650086|NCT04755244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5650087|NCT04741945|Metformin|metformin|mesh-list
5650088|NCT04741945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5650089|NCT04741945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650090|NCT04741074|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5650091|NCT04733742|Tenecteplase|tenecteplase|mesh-list
5650092|NCT04733742|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5650093|NCT04733742|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5650094|NCT04733742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650095|NCT04720612|Omalizumab|omalizumab|mesh-list
5650096|NCT04720612|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5650097|NCT04720612|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5650098|NCT04720612|Respiratory System Agents|respiratory system agents|mesh-ancestor
5650099|NCT04695847|Antibodies|antibodies|mesh-list
5650100|NCT04695847|Immunoglobulins|immunoglobulins|mesh-list
5650101|NCT04695847|Immunoconjugates|immunoconjugates|mesh-list
5650102|NCT04695847|Antibodies, Bispecific|antibodies, bispecific|mesh-list
5650103|NCT04695847|Immunologic Factors|immunologic factors|mesh-ancestor
5650104|NCT04695847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650105|NCT04688320|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5650106|NCT04688320|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5650107|NCT04688320|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5650108|NCT04688320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5825660|NCT02584309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5825661|NCT02584309|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5825662|NCT02584309|Protective Agents|protective agents|mesh-ancestor
5650109|NCT04667949|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
5825663|NCT02584309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825664|NCT02584309|Antimitotic Agents|antimitotic agents|mesh-ancestor
5825665|NCT02584309|Mitosis Modulators|mitosis modulators|mesh-ancestor
5825666|NCT02584010|Silicon|silicon|mesh-list
5825667|NCT02584010|Trace Elements|trace elements|mesh-ancestor
5825668|NCT02584010|Micronutrients|micronutrients|mesh-ancestor
5825669|NCT02584010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825670|NCT02583958|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
5825671|NCT02583958|Laxatives|laxatives|mesh-ancestor
5825672|NCT02583958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5902098|NCT05128916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5902099|NCT05128916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650110|NCT04667949|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5650111|NCT04667949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650112|NCT04667949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5650113|NCT04667949|Immunologic Factors|immunologic factors|mesh-ancestor
5650114|NCT04667949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650115|NCT04661137|Dexamethasone|dexamethasone|mesh-list
5650116|NCT04661137|Daratumumab|daratumumab|mesh-list
5650117|NCT04661137|Pomalidomide|pomalidomide|mesh-list
5650118|NCT04661137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5650119|NCT04661137|Antiemetics|antiemetics|mesh-ancestor
5650120|NCT04661137|Autonomic Agents|autonomic agents|mesh-ancestor
5650121|NCT04661137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5650122|NCT04661137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650123|NCT04661137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5650124|NCT04661137|Glucocorticoids|glucocorticoids|mesh-ancestor
5650125|NCT04661137|Hormones|hormones|mesh-ancestor
5650126|NCT04661137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5650127|NCT04661137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5650128|NCT04661137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5650129|NCT04661137|Immunologic Factors|immunologic factors|mesh-ancestor
5650130|NCT04661137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5650131|NCT04661137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5650132|NCT04661137|Growth Substances|growth substances|mesh-ancestor
5650133|NCT04661137|Growth Inhibitors|growth inhibitors|mesh-ancestor
5650134|NCT04660760|Trifluridine|trifluridine|mesh-list
5650135|NCT04660760|Paclitaxel|paclitaxel|mesh-list
5650136|NCT04660760|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5650137|NCT04660760|Ramucirumab|ramucirumab|mesh-list
5902100|NCT05128734|Temozolomide|temozolomide|mesh-list
5902101|NCT05128734|Olaparib|olaparib|mesh-list
5902102|NCT05128734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5902103|NCT05128734|Alkylating Agents|alkylating agents|mesh-ancestor
5902104|NCT05128734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902105|NCT05128734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5902106|NCT05128734|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5902107|NCT05128734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5902108|NCT05128721|Vaccines|vaccines|mesh-list
5902109|NCT05128721|Immunologic Factors|immunologic factors|mesh-ancestor
5902110|NCT05128721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902111|NCT05128630|Durvalumab|durvalumab|mesh-list
5902112|NCT05128630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5902113|NCT05128630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5902114|NCT05126511|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
5902115|NCT05126511|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
5902116|NCT05126511|beta-Endorphin|beta-endorphin|mesh-list
5902117|NCT05126511|Hormones|hormones|mesh-ancestor
5902118|NCT05126511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5902119|NCT05126511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902120|NCT05126511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5902121|NCT05126511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902122|NCT05117736|Valsartan|valsartan|mesh-list
5902123|NCT05117736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5902124|NCT05117736|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5650138|NCT04660760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5650139|NCT04660760|Antibodies|antibodies|mesh-list
5650140|NCT04660760|Immunoglobulins|immunoglobulins|mesh-list
5650141|NCT04660760|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5650142|NCT04660760|Lexatumumab|lexatumumab|mesh-list
5650143|NCT04660760|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5902125|NCT05117736|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5650144|NCT04660760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5650145|NCT04660760|Tubulin Modulators|tubulin modulators|mesh-ancestor
5825673|NCT02583854|Hemostatics|hemostatics|mesh-list
5825674|NCT02583854|Coagulants|coagulants|mesh-ancestor
5825675|NCT02583828|Cyclophosphamide|cyclophosphamide|mesh-list
5825676|NCT02583828|Letrozole|letrozole|mesh-list
5825677|NCT02583828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5825678|NCT02583828|Immunologic Factors|immunologic factors|mesh-ancestor
5825679|NCT02583828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825680|NCT02583828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5825681|NCT02583828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5825682|NCT02583828|Alkylating Agents|alkylating agents|mesh-ancestor
5825683|NCT02583828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5825684|NCT02583828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5825685|NCT02583828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5825686|NCT02583828|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5825687|NCT02583828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5825688|NCT02583828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5825689|NCT02583828|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5825690|NCT02583828|Hormone Antagonists|hormone antagonists|mesh-ancestor
5825691|NCT02583828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5825692|NCT02583893|Cytarabine|cytarabine|mesh-list
5825693|NCT02583893|Sirolimus|sirolimus|mesh-list
5825694|NCT02583893|Etoposide|etoposide|mesh-list
5825695|NCT02583893|Mitoxantrone|mitoxantrone|mesh-list
5825696|NCT02583893|Etoposide phosphate|etoposide phosphate|mesh-list
5825697|NCT02583893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5825698|NCT02583893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5825699|NCT02583893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5825700|NCT02583893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5825701|NCT02583893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5825702|NCT02583893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5825703|NCT02583893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5825704|NCT02583893|Antimetabolites|antimetabolites|mesh-ancestor
5825705|NCT02583893|Antiviral Agents|antiviral agents|mesh-ancestor
5825706|NCT02583893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5825707|NCT02583893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5825708|NCT02583893|Immunologic Factors|immunologic factors|mesh-ancestor
5825709|NCT02583893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825710|NCT02583893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5825711|NCT02583893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5825712|NCT02583893|Antifungal Agents|antifungal agents|mesh-ancestor
5825713|NCT02583893|Analgesics|analgesics|mesh-ancestor
5825714|NCT02583893|Sensory System Agents|sensory system agents|mesh-ancestor
5825715|NCT02583893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5825716|NCT02583698|Carvedilol|carvedilol|mesh-list
5825717|NCT02583698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5825718|NCT02583698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5825719|NCT02583698|Adrenergic Agents|adrenergic agents|mesh-ancestor
5825720|NCT02583698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5825721|NCT02583698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5825722|NCT02583698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650146|NCT04660760|Antimitotic Agents|antimitotic agents|mesh-ancestor
5650147|NCT04660760|Mitosis Modulators|mitosis modulators|mesh-ancestor
5650148|NCT04660760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650149|NCT04660760|Immunologic Factors|immunologic factors|mesh-ancestor
5650150|NCT04660760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650151|NCT04660760|Antimetabolites|antimetabolites|mesh-ancestor
5650152|NCT04660760|Antiviral Agents|antiviral agents|mesh-ancestor
5650153|NCT04660760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5650154|NCT04657666|Nabiximols|nabiximols|mesh-list
5650155|NCT04657666|Analgesics|analgesics|mesh-ancestor
5650156|NCT04657666|Sensory System Agents|sensory system agents|mesh-ancestor
5650157|NCT04657666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5650158|NCT04657666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650159|NCT04643574|Cyclophosphamide|cyclophosphamide|mesh-list
5650160|NCT04643574|Fludarabine|fludarabine|mesh-list
5650161|NCT04643574|Interleukin-2|interleukin-2|mesh-list
5650162|NCT04643574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5650163|NCT04643574|Immunologic Factors|immunologic factors|mesh-ancestor
5650164|NCT04643574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650165|NCT04643574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5650166|NCT04643574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5650167|NCT04643574|Alkylating Agents|alkylating agents|mesh-ancestor
5650168|NCT04643574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650169|NCT04643574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5650170|NCT04643574|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5650171|NCT04643574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5825723|NCT02583698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5825724|NCT02583698|Antioxidants|antioxidants|mesh-ancestor
5825725|NCT02583698|Protective Agents|protective agents|mesh-ancestor
5825726|NCT02583698|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5825727|NCT02583698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5825728|NCT02583698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5825729|NCT02583698|Vasodilator Agents|vasodilator agents|mesh-ancestor
5825730|NCT02583698|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5825731|NCT02583698|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5825732|NCT02583672|Acetylcysteine|acetylcysteine|mesh-list
5825733|NCT02583672|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5825734|NCT02583672|Antiviral Agents|antiviral agents|mesh-ancestor
5825735|NCT02583672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5825736|NCT02583672|Expectorants|expectorants|mesh-ancestor
5825737|NCT02583672|Respiratory System Agents|respiratory system agents|mesh-ancestor
5825738|NCT02583672|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5825739|NCT02583672|Antioxidants|antioxidants|mesh-ancestor
5825740|NCT02583672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5825741|NCT02583672|Protective Agents|protective agents|mesh-ancestor
5825742|NCT02583672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650172|NCT04643574|Analgesics|analgesics|mesh-ancestor
5650173|NCT04643574|Sensory System Agents|sensory system agents|mesh-ancestor
5650174|NCT04643574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5650175|NCT04633889|Deferoxamine|deferoxamine|mesh-list
5650176|NCT04633889|Siderophores|siderophores|mesh-ancestor
5650177|NCT04633889|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5650178|NCT04633889|Chelating Agents|chelating agents|mesh-ancestor
5650179|NCT04633889|Sequestering Agents|sequestering agents|mesh-ancestor
5650180|NCT04633889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650181|NCT04626596|Etonogestrel|etonogestrel|mesh-list
5650182|NCT04626596|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5650183|NCT04626596|Contraceptive Agents|contraceptive agents|mesh-ancestor
5650184|NCT04626596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5650185|NCT04626596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650186|NCT04626596|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5825743|NCT02583672|Antidotes|antidotes|mesh-ancestor
5825744|NCT02583594|Loratadine|loratadine|mesh-list
5825745|NCT02583594|Acyclovir|acyclovir|mesh-list
5825746|NCT02583594|Methylprednisolone|methylprednisolone|mesh-list
5825747|NCT02583594|Alemtuzumab|alemtuzumab|mesh-list
5650187|NCT04624204|Pembrolizumab|pembrolizumab|mesh-list
5650188|NCT04624204|Etoposide|etoposide|mesh-list
5650189|NCT04624204|Olaparib|olaparib|mesh-list
5825748|NCT02583594|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
5825749|NCT02583594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5825750|NCT02583594|Antiemetics|antiemetics|mesh-ancestor
5825751|NCT02583594|Autonomic Agents|autonomic agents|mesh-ancestor
5825752|NCT02583594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5825753|NCT02583594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825754|NCT02583594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5825755|NCT02583594|Glucocorticoids|glucocorticoids|mesh-ancestor
5825756|NCT02583594|Hormones|hormones|mesh-ancestor
6493039|NCT00611754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6493040|NCT00611754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6493041|NCT00611754|Immunologic Factors|immunologic factors|mesh-ancestor
6493042|NCT00611754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493043|NCT00611793|Bevacizumab|bevacizumab|mesh-list
6493044|NCT00611793|Vatalanib|vatalanib|mesh-list
6493045|NCT00611793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5650190|NCT04624204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5825757|NCT02583594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5825758|NCT02583594|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5825759|NCT02583594|Protective Agents|protective agents|mesh-ancestor
5825760|NCT02583594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5825761|NCT02583594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5825762|NCT02583594|Antiviral Agents|antiviral agents|mesh-ancestor
5825763|NCT02583594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5825764|NCT02583594|Antipruritics|antipruritics|mesh-ancestor
5825765|NCT02583594|Dermatologic Agents|dermatologic agents|mesh-ancestor
5825766|NCT02583594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5825767|NCT02583594|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5825768|NCT02583594|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5825769|NCT02583594|Histamine Antagonists|histamine antagonists|mesh-ancestor
5825770|NCT02583594|Histamine Agents|histamine agents|mesh-ancestor
5825771|NCT02583594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5825772|NCT02583594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493046|NCT00611793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5825773|NCT02583633|Nifedipine|nifedipine|mesh-list
5825774|NCT02583633|Nitroglycerin|nitroglycerin|mesh-list
5825775|NCT02583633|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5825776|NCT02583633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5825777|NCT02583633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5825778|NCT02583633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5825779|NCT02583633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825780|NCT02583633|Vasodilator Agents|vasodilator agents|mesh-ancestor
5825781|NCT02583633|Tocolytic Agents|tocolytic agents|mesh-ancestor
5825782|NCT02583633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5825783|NCT02583568|Bevacizumab|bevacizumab|mesh-list
5825784|NCT02583568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5825785|NCT02583568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5825786|NCT02583568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5825787|NCT02583568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5825788|NCT02583568|Growth Substances|growth substances|mesh-ancestor
5825789|NCT02583568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825790|NCT02583568|Growth Inhibitors|growth inhibitors|mesh-ancestor
5825791|NCT02583451|Lemborexant|lemborexant|mesh-list
5825792|NCT02583451|Zopiclone|zopiclone|mesh-list
5825793|NCT02583451|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
5825794|NCT02583451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5825795|NCT02583451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5825796|NCT02583451|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5825797|NCT02583451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5825798|NCT02583451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5825799|NCT02583451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825800|NCT02583464|Tenofovir|tenofovir|mesh-list
5825801|NCT02583464|Emtricitabine|emtricitabine|mesh-list
5825802|NCT02583464|Antiviral Agents|antiviral agents|mesh-ancestor
5825803|NCT02583464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5825804|NCT02583464|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5825805|NCT02583464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5825806|NCT02583464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5825807|NCT02583464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5825808|NCT02583464|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5650191|NCT04624204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5650192|NCT04624204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5650193|NCT04624204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5650194|NCT04624204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5650195|NCT04624204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5650196|NCT04624204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650197|NCT04624204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5650198|NCT04620252|Calcium, Dietary|calcium, dietary|mesh-list
6493047|NCT00611793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6493048|NCT00611793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5650199|NCT04620252|Calcium Carbonate|calcium carbonate|mesh-list
5650200|NCT04620252|Calcium|calcium|mesh-list
5650201|NCT04620252|Fluorides|fluorides|mesh-list
5650202|NCT04620252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5650203|NCT04620252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825809|NCT02583464|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5825810|NCT02583438|Saxagliptin|saxagliptin|mesh-list
5825811|NCT02583438|Incretins|incretins|mesh-ancestor
5825812|NCT02583438|Hormones|hormones|mesh-ancestor
5825813|NCT02583438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5825814|NCT02583438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825815|NCT02583438|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5825816|NCT02583438|Protease Inhibitors|protease inhibitors|mesh-ancestor
5825817|NCT02583438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5825818|NCT02583438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5825819|NCT02583438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5825820|NCT02583685|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5825821|NCT02583685|Interferon-alpha|interferon-alpha|mesh-list
5825822|NCT02583685|Ribavirin|ribavirin|mesh-list
5908336|NCT04657302|Obinutuzumab|obinutuzumab|mesh-list
5825823|NCT02583685|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
5825824|NCT02583685|Simeprevir|simeprevir|mesh-list
5825825|NCT02583685|Antiviral Agents|antiviral agents|mesh-ancestor
5825826|NCT02583685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5825827|NCT02583685|Immunologic Factors|immunologic factors|mesh-ancestor
5825828|NCT02583685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825829|NCT02583685|Antimetabolites|antimetabolites|mesh-ancestor
5825830|NCT02583685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5825831|NCT02583685|Protease Inhibitors|protease inhibitors|mesh-ancestor
5825832|NCT02583685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5825833|NCT02583516|Vemurafenib|vemurafenib|mesh-list
5825834|NCT02583516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5825835|NCT02583516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5825836|NCT02583516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5825837|NCT02583516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5825838|NCT02583321|Silver Sulfadiazine|silver sulfadiazine|mesh-list
5825839|NCT02583321|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5825840|NCT02583321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5825841|NCT02582996|Acetaminophen|acetaminophen|mesh-list
5825842|NCT02582996|Dihydroergotamine|dihydroergotamine|mesh-list
5825843|NCT02582996|Metoclopramide|metoclopramide|mesh-list
5825844|NCT02582996|Caffeine|caffeine|mesh-list
5825845|NCT02582996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5825846|NCT02582996|Analgesics|analgesics|mesh-ancestor
5825847|NCT02582996|Sensory System Agents|sensory system agents|mesh-ancestor
5825848|NCT02582996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5825849|NCT02582996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825850|NCT02582996|Antipyretics|antipyretics|mesh-ancestor
5825851|NCT02582996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5825852|NCT02582996|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5825853|NCT02582996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5825854|NCT02582996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5825855|NCT02582996|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5825856|NCT02582996|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5825857|NCT02582996|Purinergic Agents|purinergic agents|mesh-ancestor
5825858|NCT02582996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5825859|NCT02582996|Antiemetics|antiemetics|mesh-ancestor
5825860|NCT02582996|Autonomic Agents|autonomic agents|mesh-ancestor
5825861|NCT02582996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5825862|NCT02582996|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5825863|NCT02582996|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5825864|NCT02582996|Dopamine Agents|dopamine agents|mesh-ancestor
5825865|NCT02582996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5825866|NCT02582996|Dopamine Agonists|dopamine agonists|mesh-ancestor
5825867|NCT02583217|Ketamine|ketamine|mesh-list
5825868|NCT02583217|Remifentanil|remifentanil|mesh-list
6211657|NCT02175966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6211658|NCT02176005|Moxifloxacin|moxifloxacin|mesh-list
6211659|NCT02176005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6211660|NCT02176005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6211661|NCT02176005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5825869|NCT02583217|Propofol|propofol|mesh-list
5825870|NCT02583217|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5825871|NCT02583217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5825872|NCT02583217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825873|NCT02583217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5825874|NCT02583217|Anesthetics, General|anesthetics, general|mesh-ancestor
5825875|NCT02583217|Anesthetics|anesthetics|mesh-ancestor
5825876|NCT02583217|Analgesics|analgesics|mesh-ancestor
5825877|NCT02583217|Sensory System Agents|sensory system agents|mesh-ancestor
5825878|NCT02583217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5825879|NCT02583217|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5825880|NCT02583217|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5825881|NCT02583217|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5825882|NCT02583217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6211662|NCT02176005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6211663|NCT02176005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6211664|NCT02176005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650204|NCT04620252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5825883|NCT02583217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5825884|NCT02583217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5825885|NCT02583217|Narcotics|narcotics|mesh-ancestor
5825886|NCT02583243|Buprenorphine|buprenorphine|mesh-list
5825887|NCT02583243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5825888|NCT02583243|Narcotics|narcotics|mesh-ancestor
5825889|NCT02583243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5825890|NCT02583243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825891|NCT02583243|Analgesics|analgesics|mesh-ancestor
5825892|NCT02583243|Sensory System Agents|sensory system agents|mesh-ancestor
5825893|NCT02583243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5825894|NCT02583243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5825895|NCT02583191|Rivaroxaban|rivaroxaban|mesh-list
5825896|NCT02583191|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6674455|NCT01569256|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6674456|NCT01569256|Dopamine Agonists|dopamine agonists|mesh-ancestor
6674457|NCT01569256|Dopamine Agents|dopamine agents|mesh-ancestor
5650205|NCT04620252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650206|NCT04620252|Cariostatic Agents|cariostatic agents|mesh-ancestor
5650207|NCT04620252|Protective Agents|protective agents|mesh-ancestor
5650208|NCT04620252|Antacids|antacids|mesh-ancestor
5650209|NCT04620252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5650210|NCT04544280|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
5650211|NCT04544280|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5650212|NCT04544280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5650213|NCT04544280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650214|NCT04544280|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5650215|NCT04544280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5650216|NCT04544280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650217|NCT04544280|Cholinergic Agents|cholinergic agents|mesh-ancestor
5650218|NCT04544280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5650219|NCT04544007|Poly ICLC|poly iclc|mesh-list
5650220|NCT04544007|Interferon Inducers|interferon inducers|mesh-ancestor
5650221|NCT04544007|Immunologic Factors|immunologic factors|mesh-ancestor
5650222|NCT04544007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650223|NCT04510207|Vaccines|vaccines|mesh-list
5650224|NCT04510207|Immunologic Factors|immunologic factors|mesh-ancestor
5650225|NCT04510207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650226|NCT04509115|Analgesics, Opioid|analgesics, opioid|mesh-list
5650227|NCT04509115|Narcotics|narcotics|mesh-ancestor
5650228|NCT04509115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5650229|NCT04509115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650230|NCT04509115|Analgesics|analgesics|mesh-ancestor
5825897|NCT02583191|Antithrombins|antithrombins|mesh-ancestor
5825898|NCT02583191|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5825899|NCT02583191|Protease Inhibitors|protease inhibitors|mesh-ancestor
6674458|NCT01569256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6674459|NCT01569256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674460|NCT01569256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674461|NCT01569633|Erythromycin|erythromycin|mesh-list
6674462|NCT01569633|Erythromycin Estolate|erythromycin estolate|mesh-list
6674463|NCT01569633|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
5825900|NCT02583191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5825901|NCT02583191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5825902|NCT02583191|Anticoagulants|anticoagulants|mesh-ancestor
5825903|NCT02583308|Silver Sulfadiazine|silver sulfadiazine|mesh-list
5825904|NCT02583308|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5825905|NCT02583308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5825906|NCT02583282|Doxycycline|doxycycline|mesh-list
5825907|NCT02583282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5825908|NCT02583282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5825909|NCT02583282|Antimalarials|antimalarials|mesh-ancestor
5650231|NCT04509115|Sensory System Agents|sensory system agents|mesh-ancestor
5650232|NCT04509115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5650233|NCT04499495|Aminosalicylic Acid|aminosalicylic acid|mesh-list
5650234|NCT04499495|Mesalamine|mesalamine|mesh-list
5650235|NCT04499495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5650236|NCT04499495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5650237|NCT04499495|Analgesics|analgesics|mesh-ancestor
5650238|NCT04499495|Sensory System Agents|sensory system agents|mesh-ancestor
5650239|NCT04499495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5650240|NCT04499495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650241|NCT04499495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5650242|NCT04499495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5650243|NCT04499495|Antitubercular Agents|antitubercular agents|mesh-ancestor
5650244|NCT04499495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5650245|NCT04499495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5650246|NCT04484701|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5650247|NCT04484701|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5650248|NCT04484701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650249|NCT04479566|Lithium Carbonate|lithium carbonate|mesh-list
5650250|NCT04479566|Calcium Carbonate|calcium carbonate|mesh-list
5650251|NCT04479566|Calcium|calcium|mesh-list
5650252|NCT04479566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5825910|NCT02583282|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5825911|NCT02583282|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5825912|NCT02583022|Pimecrolimus|pimecrolimus|mesh-list
5825913|NCT02583022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5825914|NCT02583022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5825915|NCT02583022|Analgesics|analgesics|mesh-ancestor
5825916|NCT02583022|Sensory System Agents|sensory system agents|mesh-ancestor
5825917|NCT02583022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5650253|NCT04479566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650254|NCT04479566|Antidepressive Agents|antidepressive agents|mesh-ancestor
5650255|NCT04479566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5650256|NCT04479566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5650257|NCT04479566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650258|NCT04479566|Antimanic Agents|antimanic agents|mesh-ancestor
5650259|NCT04479566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5650260|NCT04479566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5650261|NCT04479566|Antacids|antacids|mesh-ancestor
5650262|NCT04479566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5650263|NCT04458922|Atezolizumab|atezolizumab|mesh-list
5650264|NCT04458922|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5650265|NCT04458922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5650266|NCT04458922|Immunologic Factors|immunologic factors|mesh-ancestor
5650267|NCT04458922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650268|NCT04428307|Artemisinins|artemisinins|mesh-list
5650269|NCT04428307|Artemisinin|artemisinin|mesh-list
5650270|NCT04428307|Antimalarials|antimalarials|mesh-ancestor
6493049|NCT00611793|Growth Substances|growth substances|mesh-ancestor
5825918|NCT02583022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825919|NCT02583022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5825920|NCT02583022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5825921|NCT02583022|Dermatologic Agents|dermatologic agents|mesh-ancestor
5825922|NCT02583022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5825923|NCT02583022|Immunologic Factors|immunologic factors|mesh-ancestor
5825924|NCT02583022|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5825925|NCT02583022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5825926|NCT02583022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5825927|NCT02582892|Vitamin D|vitamin d|mesh-list
5825928|NCT02582892|Vitamins|vitamins|mesh-ancestor
5825929|NCT02582892|Micronutrients|micronutrients|mesh-ancestor
5825930|NCT02582892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825931|NCT02582892|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5825932|NCT02582736|Methotrimeprazine|methotrimeprazine|mesh-list
5825933|NCT02582736|Haloperidol|haloperidol|mesh-list
5825934|NCT02582736|Pimozide|pimozide|mesh-list
5825935|NCT02582736|Olanzapine|olanzapine|mesh-list
5825936|NCT02582736|Chlorpromazine|chlorpromazine|mesh-list
5825937|NCT02582736|Trifluoperazine|trifluoperazine|mesh-list
5825938|NCT02582736|Risperidone|risperidone|mesh-list
5825939|NCT02582736|Quetiapine Fumarate|quetiapine fumarate|mesh-list
5825940|NCT02582736|Aripiprazole|aripiprazole|mesh-list
5825941|NCT02582736|Paliperidone Palmitate|paliperidone palmitate|mesh-list
5650271|NCT04428307|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5825942|NCT02582736|Ziprasidone|ziprasidone|mesh-list
5825943|NCT02582736|Antipsychotic Agents|antipsychotic agents|mesh-list
5825944|NCT02582736|Clozapine|clozapine|mesh-list
5825945|NCT02582736|Loxapine|loxapine|mesh-list
6493050|NCT00611793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493051|NCT00611793|Growth Inhibitors|growth inhibitors|mesh-ancestor
5650272|NCT04428307|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5650273|NCT04428307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5650274|NCT04374877|Pembrolizumab|pembrolizumab|mesh-list
5650275|NCT04374877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5650276|NCT04374877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5650277|NCT04356495|Ciclesonide|ciclesonide|mesh-list
5650278|NCT04356495|Interferons|interferons|mesh-list
5825946|NCT02582736|Perphenazine|perphenazine|mesh-list
5825947|NCT02582736|Fluphenazine|fluphenazine|mesh-list
5825948|NCT02582736|Thioridazine|thioridazine|mesh-list
5825949|NCT02582736|Flupenthixol|flupenthixol|mesh-list
5825950|NCT02582736|Clopenthixol|clopenthixol|mesh-list
5825951|NCT02582736|Chlorprothixene|chlorprothixene|mesh-list
5825952|NCT02582736|Fluspirilene|fluspirilene|mesh-list
5825953|NCT02582736|Thiothixene|thiothixene|mesh-list
5825954|NCT02582736|Mesoridazine|mesoridazine|mesh-list
5825955|NCT02582736|Chlormezanone|chlormezanone|mesh-list
5825956|NCT02582736|Tetrabenazine|tetrabenazine|mesh-list
5825957|NCT02582736|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5825958|NCT02582736|Serotonin Agents|serotonin agents|mesh-ancestor
5825959|NCT02582736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5825960|NCT02582736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5825961|NCT02582736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5825962|NCT02582736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5825963|NCT02582736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5825964|NCT02582736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5825965|NCT02582736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5825966|NCT02582736|Dopamine Agents|dopamine agents|mesh-ancestor
5825967|NCT02582736|Antiemetics|antiemetics|mesh-ancestor
5825968|NCT02582736|Autonomic Agents|autonomic agents|mesh-ancestor
5825969|NCT02582736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5825970|NCT02582736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5825971|NCT02582736|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5825972|NCT02582736|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5825973|NCT02582736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5825974|NCT02582736|Antidepressive Agents|antidepressive agents|mesh-ancestor
5825975|NCT02582736|Dopamine Agonists|dopamine agonists|mesh-ancestor
5825976|NCT02582736|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5825977|NCT02582736|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5825978|NCT02582736|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5825979|NCT02582736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5825980|NCT02582736|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5825981|NCT02582736|GABA Antagonists|gaba antagonists|mesh-ancestor
5825982|NCT02582736|GABA Agents|gaba agents|mesh-ancestor
5650279|NCT04356495|Interferon-beta|interferon-beta|mesh-list
5650280|NCT04356495|Telmisartan|telmisartan|mesh-list
5825983|NCT02582736|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5825984|NCT02582736|Adrenergic Agents|adrenergic agents|mesh-ancestor
5825985|NCT02582736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5825986|NCT02582736|Analgesics|analgesics|mesh-ancestor
5825987|NCT02582736|Sensory System Agents|sensory system agents|mesh-ancestor
5825988|NCT02582736|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5825989|NCT02582736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5825990|NCT02582736|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5825991|NCT02582359|Cytarabine|cytarabine|mesh-list
5825992|NCT02582359|Daunorubicin|daunorubicin|mesh-list
5825993|NCT02582359|Ixazomib|ixazomib|mesh-list
5825994|NCT02582359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5825995|NCT02582359|Antimetabolites|antimetabolites|mesh-ancestor
5825996|NCT02582359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5825997|NCT02582359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5825998|NCT02582359|Antiviral Agents|antiviral agents|mesh-ancestor
5825999|NCT02582359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5826000|NCT02582359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5826001|NCT02582359|Immunologic Factors|immunologic factors|mesh-ancestor
5826002|NCT02582359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826003|NCT02582359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5826004|NCT02582359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5826005|NCT02582359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5650281|NCT04356495|Interferon beta-1b|interferon beta-1b|mesh-list
5650282|NCT04356495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826006|NCT02582359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5826007|NCT02582359|Protease Inhibitors|protease inhibitors|mesh-ancestor
5826008|NCT02582372|Fentanyl|fentanyl|mesh-list
5650283|NCT04356495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5826009|NCT02582372|Dexmedetomidine|dexmedetomidine|mesh-list
5826010|NCT02582372|Bupivacaine|bupivacaine|mesh-list
5826011|NCT02582372|Anesthetics, Local|anesthetics, local|mesh-ancestor
5826012|NCT02582372|Anesthetics|anesthetics|mesh-ancestor
5826013|NCT02582372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5826014|NCT02582372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826015|NCT02582372|Sensory System Agents|sensory system agents|mesh-ancestor
5826016|NCT02582372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5826017|NCT02582372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5826018|NCT02582372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5826019|NCT02582372|Analgesics|analgesics|mesh-ancestor
5826020|NCT02582372|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5826021|NCT02582372|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5650284|NCT04356495|Antiviral Agents|antiviral agents|mesh-ancestor
5650285|NCT04356495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5650286|NCT04356495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5650287|NCT04356495|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5650288|NCT04356495|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5650289|NCT04356495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650290|NCT04356495|Glucocorticoids|glucocorticoids|mesh-ancestor
5650291|NCT04356495|Hormones|hormones|mesh-ancestor
5650292|NCT04356495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5650293|NCT04356495|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5650294|NCT04356495|Immunologic Factors|immunologic factors|mesh-ancestor
5650295|NCT04356495|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5650296|NCT04355572|Vitamin D|vitamin d|mesh-list
5826022|NCT02582372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5826023|NCT02582372|Adrenergic Agents|adrenergic agents|mesh-ancestor
5826024|NCT02582372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5826025|NCT02582372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826026|NCT02582372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5826027|NCT02582372|Narcotics|narcotics|mesh-ancestor
5826028|NCT02582372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5826029|NCT02582372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5826030|NCT02582372|Anesthetics, General|anesthetics, general|mesh-ancestor
5826031|NCT02582437|Analgesics, Opioid|analgesics, opioid|mesh-list
5826032|NCT02582437|Narcotics|narcotics|mesh-ancestor
5826033|NCT02582437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5826034|NCT02582437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826035|NCT02582437|Analgesics|analgesics|mesh-ancestor
5826036|NCT02582437|Sensory System Agents|sensory system agents|mesh-ancestor
5826037|NCT02582437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5650297|NCT04355572|Vitamins|vitamins|mesh-ancestor
5650298|NCT04355572|Micronutrients|micronutrients|mesh-ancestor
5650299|NCT04355572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650300|NCT04355572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5694528|NCT03395002|Tiotropium Bromide|tiotropium bromide|mesh-list
5694529|NCT03395002|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5694530|NCT03395002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5694531|NCT03395002|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5694532|NCT03395002|Autonomic Agents|autonomic agents|mesh-ancestor
5694533|NCT03395002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5694534|NCT03395002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694535|NCT03395002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5694536|NCT03395002|Respiratory System Agents|respiratory system agents|mesh-ancestor
5694537|NCT03395002|Dermatologic Agents|dermatologic agents|mesh-ancestor
5694538|NCT03395002|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5694539|NCT03395002|Parasympatholytics|parasympatholytics|mesh-ancestor
5694540|NCT03395002|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5694541|NCT03395002|Cholinergic Agents|cholinergic agents|mesh-ancestor
5694542|NCT03395002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5694543|NCT03395002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826038|NCT02582307|Acetaminophen|acetaminophen|mesh-list
5826039|NCT02582307|Scopolamine|scopolamine|mesh-list
5826040|NCT02582307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
5826041|NCT02582307|Analgesics|analgesics|mesh-list
5826042|NCT02582307|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
5826043|NCT02582307|Sensory System Agents|sensory system agents|mesh-ancestor
5826044|NCT02582307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5826045|NCT02582307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826046|NCT02582307|Antipyretics|antipyretics|mesh-ancestor
5826047|NCT02582307|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5826048|NCT02582307|Antiemetics|antiemetics|mesh-ancestor
5826049|NCT02582307|Autonomic Agents|autonomic agents|mesh-ancestor
5826050|NCT02582307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5826051|NCT02582307|Mydriatics|mydriatics|mesh-ancestor
5826052|NCT02582307|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5826053|NCT02582307|Cholinergic Agents|cholinergic agents|mesh-ancestor
5826054|NCT02582307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5826055|NCT02582307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826056|NCT02582307|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5826057|NCT02582307|Parasympatholytics|parasympatholytics|mesh-ancestor
5826058|NCT02582476|Bumetanide|bumetanide|mesh-list
5826059|NCT02582476|Diuretics|diuretics|mesh-ancestor
5650301|NCT04353492|Ofatumumab|ofatumumab|mesh-list
5650302|NCT04353492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6211665|NCT02176005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6211666|NCT02176018|Quinidine|quinidine|mesh-list
6211667|NCT02176018|Dextromethorphan|dextromethorphan|mesh-list
6211668|NCT02176018|Antitussive Agents|antitussive agents|mesh-ancestor
6211669|NCT02176018|Respiratory System Agents|respiratory system agents|mesh-ancestor
6211670|NCT02176018|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6211671|NCT02176018|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6211672|NCT02176018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6211673|NCT02176018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211674|NCT02176018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211675|NCT02176018|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6211676|NCT02176018|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6211677|NCT02176018|Adrenergic Agents|adrenergic agents|mesh-ancestor
6211678|NCT02176018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6211679|NCT02176018|Antimalarials|antimalarials|mesh-ancestor
6211680|NCT02176018|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5650319|NCT04318548|Vaccines|vaccines|mesh-list
5650320|NCT04318548|Immunologic Factors|immunologic factors|mesh-ancestor
5650321|NCT04318548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650322|NCT04303507|Hydroxychloroquine|hydroxychloroquine|mesh-list
5650323|NCT04303507|Chloroquine|chloroquine|mesh-list
5826060|NCT02582476|Natriuretic Agents|natriuretic agents|mesh-ancestor
5826061|NCT02582476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826062|NCT02582476|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5826063|NCT02582476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5826064|NCT02582476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826065|NCT02582190|Colchicine|colchicine|mesh-list
5826066|NCT02582190|Gout Suppressants|gout suppressants|mesh-ancestor
5826067|NCT02582190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5826068|NCT02582190|Tubulin Modulators|tubulin modulators|mesh-ancestor
5650324|NCT04303507|Antimalarials|antimalarials|mesh-ancestor
5650325|NCT04303507|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5650326|NCT04303507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5650327|NCT04303507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5650328|NCT04303507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5650329|NCT04303507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650330|NCT04303507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5650331|NCT04303507|Amebicides|amebicides|mesh-ancestor
5650332|NCT04303195|Metopimazine|metopimazine|mesh-list
5650333|NCT04303195|Antiemetics|antiemetics|mesh-ancestor
5650334|NCT04303195|Autonomic Agents|autonomic agents|mesh-ancestor
5650335|NCT04303195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5650336|NCT04303195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650337|NCT04303195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5650338|NCT04238819|Irinotecan|irinotecan|mesh-list
5826069|NCT02582190|Antimitotic Agents|antimitotic agents|mesh-ancestor
5826070|NCT02582190|Mitosis Modulators|mitosis modulators|mesh-ancestor
5650339|NCT04238819|Temozolomide|temozolomide|mesh-list
5650340|NCT04238819|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5650341|NCT04238819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5650342|NCT04238819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5650343|NCT04238819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650344|NCT04238819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5650345|NCT04238819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5650346|NCT04238819|Alkylating Agents|alkylating agents|mesh-ancestor
5650347|NCT04218825|Mechlorethamine|mechlorethamine|mesh-list
5650348|NCT04218825|Alkylating Agents|alkylating agents|mesh-ancestor
5650349|NCT04218825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650350|NCT04218825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5650351|NCT04218825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6211681|NCT02176018|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6211682|NCT02176018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6211683|NCT02176018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6211684|NCT02176018|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6211685|NCT02176018|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6211686|NCT02176018|Cholinergic Agents|cholinergic agents|mesh-ancestor
6211687|NCT02176018|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5826071|NCT02582190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826072|NCT02582190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5826073|NCT02582177|Ketoconazole|ketoconazole|mesh-list
5826074|NCT02582177|Clotrimazole|clotrimazole|mesh-list
5826075|NCT02582177|Miconazole|miconazole|mesh-list
5826076|NCT02582177|Dexamethasone|dexamethasone|mesh-list
5826077|NCT02582177|Dexamethasone acetate|dexamethasone acetate|mesh-list
5826078|NCT02582177|Betamethasone|betamethasone|mesh-list
5826079|NCT02582177|Betamethasone Valerate|betamethasone valerate|mesh-list
5826080|NCT02582177|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5826081|NCT02582177|Betamethasone benzoate|betamethasone benzoate|mesh-list
5826082|NCT02582177|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
5826083|NCT02582177|BB 1101|bb 1101|mesh-list
5826084|NCT02582177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5826085|NCT02582177|Antiemetics|antiemetics|mesh-ancestor
5826086|NCT02582177|Autonomic Agents|autonomic agents|mesh-ancestor
5826087|NCT02582177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5826088|NCT02582177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826089|NCT02582177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5826090|NCT02582177|Glucocorticoids|glucocorticoids|mesh-ancestor
5826091|NCT02582177|Hormones|hormones|mesh-ancestor
5826092|NCT02582177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5826093|NCT02582177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5826094|NCT02582177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5826095|NCT02582177|Protease Inhibitors|protease inhibitors|mesh-ancestor
5826096|NCT02582177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5826097|NCT02582177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826098|NCT02582177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5826099|NCT02582177|Respiratory System Agents|respiratory system agents|mesh-ancestor
5826100|NCT02582177|Antifungal Agents|antifungal agents|mesh-ancestor
5826101|NCT02582177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5826102|NCT02582177|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5826103|NCT02582177|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5826104|NCT02582177|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5650360|NCT04200963|Nivolumab|nivolumab|mesh-list
5650361|NCT04200963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5650362|NCT04200963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5650363|NCT04200963|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5650364|NCT04200963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650365|NCT04200911|Sirolimus|sirolimus|mesh-list
5650366|NCT04200911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5650367|NCT04200911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5650368|NCT04200911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5650369|NCT04200911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5650370|NCT04200911|Antifungal Agents|antifungal agents|mesh-ancestor
5650371|NCT04200911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5650372|NCT04200911|Immunologic Factors|immunologic factors|mesh-ancestor
5826105|NCT02582177|Hormone Antagonists|hormone antagonists|mesh-ancestor
5826106|NCT02582177|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5826107|NCT02582177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5826108|NCT02582177|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5902126|NCT05117736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902127|NCT05097794|Indapamide|indapamide|mesh-list
5902128|NCT05097794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5902129|NCT05097794|Diuretics|diuretics|mesh-ancestor
5902130|NCT05097794|Natriuretic Agents|natriuretic agents|mesh-ancestor
5902131|NCT05097794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902132|NCT05097794|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5902133|NCT05097794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5902134|NCT05097794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650373|NCT04200911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650374|NCT04140162|Dexamethasone|dexamethasone|mesh-list
5650375|NCT04140162|Lenalidomide|lenalidomide|mesh-list
5650376|NCT04140162|Bortezomib|bortezomib|mesh-list
5650377|NCT04140162|Daratumumab|daratumumab|mesh-list
5650378|NCT04140162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5650379|NCT04140162|Antiemetics|antiemetics|mesh-ancestor
5650380|NCT04140162|Autonomic Agents|autonomic agents|mesh-ancestor
5902135|NCT05073562|Folic Acid|folic acid|mesh-list
5902136|NCT05073562|Mebendazole|mebendazole|mesh-list
5902137|NCT05073562|Piperazine|piperazine|mesh-list
5902138|NCT05073562|Piperazine citrate|piperazine citrate|mesh-list
5650381|NCT04140162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5902139|NCT05073562|DMP 777|dmp 777|mesh-list
5650382|NCT04140162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902140|NCT05073562|Hematinics|hematinics|mesh-ancestor
5826109|NCT02582203|Vancomycin|vancomycin|mesh-list
5826110|NCT02582203|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
5826111|NCT02582203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5826112|NCT02582203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5826113|NCT02582047|Vaccines|vaccines|mesh-list
5826114|NCT02582047|Immunologic Factors|immunologic factors|mesh-ancestor
5826115|NCT02582047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826116|NCT02582099|Gentamicins|gentamicins|mesh-list
5826117|NCT02582099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5826118|NCT02582099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5826119|NCT02582099|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5826120|NCT02582099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5826121|NCT02582099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826122|NCT02582008|Bupropion|bupropion|mesh-list
5826123|NCT02582008|Nicotine|nicotine|mesh-list
5826124|NCT02582008|Varenicline|varenicline|mesh-list
5826125|NCT02582008|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5826126|NCT02582008|Autonomic Agents|autonomic agents|mesh-ancestor
5826127|NCT02582008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5826128|NCT02582008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826129|NCT02582008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5826130|NCT02582008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5826131|NCT02582008|Cholinergic Agents|cholinergic agents|mesh-ancestor
5826132|NCT02582008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5826133|NCT02582008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826134|NCT02582008|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5826135|NCT02582008|Antidepressive Agents|antidepressive agents|mesh-ancestor
5826136|NCT02582008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5826137|NCT02582008|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5826138|NCT02582008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5826139|NCT02582008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5826140|NCT02582008|Dopamine Agents|dopamine agents|mesh-ancestor
5650383|NCT04140162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5650384|NCT04140162|Glucocorticoids|glucocorticoids|mesh-ancestor
5650385|NCT04140162|Hormones|hormones|mesh-ancestor
5650386|NCT04140162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5650387|NCT04140162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5650388|NCT04140162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5650389|NCT04140162|Immunologic Factors|immunologic factors|mesh-ancestor
5650390|NCT04140162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5650391|NCT04140162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5650392|NCT04140162|Growth Substances|growth substances|mesh-ancestor
5650393|NCT04140162|Growth Inhibitors|growth inhibitors|mesh-ancestor
5650394|NCT04104178|Clindamycin|clindamycin|mesh-list
5650395|NCT04104178|Clindamycin palmitate|clindamycin palmitate|mesh-list
5650396|NCT04104178|Clindamycin phosphate|clindamycin phosphate|mesh-list
5650397|NCT04104178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5650398|NCT04104178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5650399|NCT04104178|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5650400|NCT04104178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5650401|NCT04104178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650402|NCT04095364|Paclitaxel|paclitaxel|mesh-list
5650403|NCT04095364|Carboplatin|carboplatin|mesh-list
5650404|NCT04095364|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5650405|NCT04095364|Letrozole|letrozole|mesh-list
5650406|NCT04095364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5650407|NCT04095364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5650408|NCT04095364|Tubulin Modulators|tubulin modulators|mesh-ancestor
5650409|NCT04095364|Antimitotic Agents|antimitotic agents|mesh-ancestor
5650410|NCT04095364|Mitosis Modulators|mitosis modulators|mesh-ancestor
5826141|NCT02582008|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5826142|NCT02582008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5826143|NCT02582008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5826144|NCT02581969|Factor VIII|factor viii|mesh-list
5826145|NCT02581969|Coagulants|coagulants|mesh-ancestor
5826146|NCT02581982|Paclitaxel|paclitaxel|mesh-list
5826147|NCT02581982|Pembrolizumab|pembrolizumab|mesh-list
5826148|NCT02581982|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5826149|NCT02581982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5826150|NCT02581982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5826151|NCT02581982|Tubulin Modulators|tubulin modulators|mesh-ancestor
5826152|NCT02581982|Antimitotic Agents|antimitotic agents|mesh-ancestor
5826153|NCT02581982|Mitosis Modulators|mitosis modulators|mesh-ancestor
5826154|NCT02581982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650411|NCT04095364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493052|NCT00611793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6493053|NCT00611793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6493054|NCT00611793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493055|NCT00611819|Interferons|interferons|mesh-list
6493056|NCT00611819|Ribavirin|ribavirin|mesh-list
6493057|NCT00611819|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6493058|NCT00611819|Interferon-alpha|interferon-alpha|mesh-list
5826155|NCT02581982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5826156|NCT02581943|Paclitaxel|paclitaxel|mesh-list
5826157|NCT02581943|Carboplatin|carboplatin|mesh-list
5826158|NCT02581943|Pembrolizumab|pembrolizumab|mesh-list
5826159|NCT02581943|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5826160|NCT02581943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5826161|NCT02581943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5826162|NCT02581943|Tubulin Modulators|tubulin modulators|mesh-ancestor
5826163|NCT02581943|Antimitotic Agents|antimitotic agents|mesh-ancestor
5826164|NCT02581943|Mitosis Modulators|mitosis modulators|mesh-ancestor
5826165|NCT02581943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826166|NCT02581943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5826167|NCT02581826|Silodosin|silodosin|mesh-list
5826168|NCT02581826|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5826169|NCT02581826|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5826170|NCT02581826|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5826171|NCT02581826|Adrenergic Agents|adrenergic agents|mesh-ancestor
5826172|NCT02581826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6493059|NCT00611819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6493060|NCT00611819|Antiviral Agents|antiviral agents|mesh-ancestor
6493061|NCT00611819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6493062|NCT00611819|Antimetabolites|antimetabolites|mesh-ancestor
5650412|NCT04095364|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5650413|NCT04095364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5650414|NCT04095364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5650415|NCT04095364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5650416|NCT04095364|Hormone Antagonists|hormone antagonists|mesh-ancestor
5650417|NCT04095364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5650418|NCT04095364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650419|NCT04092452|PF-06700841|pf-06700841|mesh-list
5650420|NCT04092452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5650421|NCT04092452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5650422|NCT04092452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650423|NCT04039204|Contraceptive Agents|contraceptive agents|mesh-list
5650424|NCT04039204|Contraceptives, Oral|contraceptives, oral|mesh-list
5650425|NCT04039204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5650426|NCT04039204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650427|NCT04039204|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5650428|NCT03999268|Insulin|insulin|mesh-list
5650429|NCT03999268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5650430|NCT03999268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650431|NCT03997370|Carboplatin|carboplatin|mesh-list
5650432|NCT03997370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5650433|NCT03974828|Anesthetics|anesthetics|mesh-list
5650434|NCT03974828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5826173|NCT02581826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826174|NCT02581826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826175|NCT02581826|Urological Agents|urological agents|mesh-ancestor
5826176|NCT02581761|Misoprostol|misoprostol|mesh-list
5826177|NCT02581761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5826178|NCT02581761|Abortifacient Agents|abortifacient agents|mesh-ancestor
5826179|NCT02581761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5826180|NCT02581761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826181|NCT02581761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5650435|NCT03974828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650436|NCT03971643|Vilobelimab|vilobelimab|mesh-list
5650437|NCT03971643|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5650438|NCT03971643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5650439|NCT03971643|Immunologic Factors|immunologic factors|mesh-ancestor
5650440|NCT03971643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650441|NCT03971253|Peficitinib|peficitinib|mesh-list
5650442|NCT03971253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5650443|NCT03971253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650444|NCT03971253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5826182|NCT02581761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5826183|NCT02581761|Oxytocics|oxytocics|mesh-ancestor
6674464|NCT01569633|Erythromycin stearate|erythromycin stearate|mesh-list
5826184|NCT02581696|Irsogladine|irsogladine|mesh-list
5650445|NCT03971253|Immunologic Factors|immunologic factors|mesh-ancestor
5650446|NCT03971253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650447|NCT03946202|Hydrogen Peroxide|hydrogen peroxide|mesh-list
5650448|NCT03946202|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5650449|NCT03946202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5650450|NCT03929718|Spironolactone|spironolactone|mesh-list
5650451|NCT03929718|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5650452|NCT03929718|Hormone Antagonists|hormone antagonists|mesh-ancestor
5650453|NCT03929718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5650454|NCT03929718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493063|NCT00611819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493064|NCT00611819|Immunologic Factors|immunologic factors|mesh-ancestor
6493065|NCT00611819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493066|NCT00611845|Aprotinin|aprotinin|mesh-list
6493067|NCT00611845|Hemostatics|hemostatics|mesh-ancestor
5826185|NCT02581696|Lafutidine|lafutidine|mesh-list
5826186|NCT02581696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826187|NCT02581696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5826188|NCT02581696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5826189|NCT02581696|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5826190|NCT02581696|Histamine Antagonists|histamine antagonists|mesh-ancestor
5826191|NCT02581696|Histamine Agents|histamine agents|mesh-ancestor
5826192|NCT02581696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5826193|NCT02581696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650455|NCT03929718|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5650456|NCT03929718|Diuretics|diuretics|mesh-ancestor
5650457|NCT03929718|Natriuretic Agents|natriuretic agents|mesh-ancestor
5650458|NCT03918915|Atropine|atropine|mesh-list
5650459|NCT03918915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5650460|NCT03918915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5650461|NCT03918915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5650462|NCT03918915|Autonomic Agents|autonomic agents|mesh-ancestor
5650463|NCT03918915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5650464|NCT03918915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650465|NCT03918915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5650466|NCT03918915|Respiratory System Agents|respiratory system agents|mesh-ancestor
5650467|NCT03918915|Mydriatics|mydriatics|mesh-ancestor
5650468|NCT03918915|Parasympatholytics|parasympatholytics|mesh-ancestor
5650469|NCT03918915|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5650470|NCT03918915|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5650471|NCT03918915|Cholinergic Agents|cholinergic agents|mesh-ancestor
5650472|NCT03918915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5650473|NCT03918915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650474|NCT03882918|Gaboxadol|gaboxadol|mesh-list
5650475|NCT03882918|Analgesics|analgesics|mesh-ancestor
5650476|NCT03882918|Sensory System Agents|sensory system agents|mesh-ancestor
5650477|NCT03882918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5650478|NCT03882918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650479|NCT03882918|Anticonvulsants|anticonvulsants|mesh-ancestor
5650480|NCT03882918|GABA Agonists|gaba agonists|mesh-ancestor
5650481|NCT03882918|GABA Agents|gaba agents|mesh-ancestor
5650482|NCT03882918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5650483|NCT03882918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650484|NCT03878459|Pioglitazone|pioglitazone|mesh-list
5650485|NCT03878459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5650486|NCT03878459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650487|NCT03876717|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
5650488|NCT03876717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5650489|NCT03876717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5650490|NCT03876717|Antimetabolites|antimetabolites|mesh-ancestor
5826194|NCT02581696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5826195|NCT02581696|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5826196|NCT02581696|Protective Agents|protective agents|mesh-ancestor
5826197|NCT02581696|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5826198|NCT02581683|Magnesium Sulfate|magnesium sulfate|mesh-list
6493068|NCT00611845|Coagulants|coagulants|mesh-ancestor
5650491|NCT03876717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650492|NCT03876717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5650493|NCT03850067|Carboplatin|carboplatin|mesh-list
5650494|NCT03850067|Nivolumab|nivolumab|mesh-list
5650495|NCT03850067|Etoposide|etoposide|mesh-list
5650496|NCT03850067|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
5650497|NCT03850067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5650498|NCT03850067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5826199|NCT02581683|Ropivacaine|ropivacaine|mesh-list
5826200|NCT02581683|Anesthetics, Local|anesthetics, local|mesh-ancestor
5650499|NCT03850067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5650500|NCT03850067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650501|NCT03850067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5650502|NCT03850067|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5650503|NCT03850067|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5650504|NCT03850067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5650505|NCT03843008|Melatonin|melatonin|mesh-list
5650506|NCT03843008|Antioxidants|antioxidants|mesh-ancestor
5650507|NCT03843008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650508|NCT03843008|Protective Agents|protective agents|mesh-ancestor
5650509|NCT03843008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650510|NCT03843008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5650511|NCT03840616|Fluconazole|fluconazole|mesh-list
5650512|NCT03840616|Antifungal Agents|antifungal agents|mesh-ancestor
5650513|NCT03840616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5650514|NCT03840616|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5650515|NCT03840616|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5650516|NCT03840616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5650517|NCT03840616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650518|NCT03840616|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5650519|NCT03840616|Hormone Antagonists|hormone antagonists|mesh-ancestor
5650520|NCT03840616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5650521|NCT03840616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650522|NCT03840616|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5650523|NCT03840616|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5650524|NCT03837977|Leucovorin|leucovorin|mesh-list
5650525|NCT03837977|Folic Acid|folic acid|mesh-list
5650526|NCT03837977|Docetaxel|docetaxel|mesh-list
5650527|NCT03837977|Fluorouracil|fluorouracil|mesh-list
5650528|NCT03837977|Irinotecan|irinotecan|mesh-list
5650529|NCT03837977|Levoleucovorin|levoleucovorin|mesh-list
5650530|NCT03837977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5650531|NCT03837977|Tubulin Modulators|tubulin modulators|mesh-ancestor
5650532|NCT03837977|Antimitotic Agents|antimitotic agents|mesh-ancestor
5650533|NCT03837977|Mitosis Modulators|mitosis modulators|mesh-ancestor
5650534|NCT03837977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650535|NCT03837977|Antimetabolites|antimetabolites|mesh-ancestor
5650536|NCT03837977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5650537|NCT03837977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5650538|NCT03837977|Immunologic Factors|immunologic factors|mesh-ancestor
5650539|NCT03837977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650540|NCT03837977|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5650541|NCT03837977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5650542|NCT03837977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5650543|NCT03837977|Antidotes|antidotes|mesh-ancestor
5650544|NCT03837977|Protective Agents|protective agents|mesh-ancestor
5650545|NCT03837977|Vitamin B Complex|vitamin b complex|mesh-ancestor
5650546|NCT03837977|Vitamins|vitamins|mesh-ancestor
5650547|NCT03837977|Micronutrients|micronutrients|mesh-ancestor
5650548|NCT03837977|Hematinics|hematinics|mesh-ancestor
5650549|NCT03787654|Solifenacin Succinate|solifenacin succinate|mesh-list
5650550|NCT03787654|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5650551|NCT03787654|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5650552|NCT03787654|Cholinergic Agents|cholinergic agents|mesh-ancestor
5650553|NCT03787654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5650554|NCT03787654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650555|NCT03787654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650556|NCT03787654|Urological Agents|urological agents|mesh-ancestor
5650557|NCT03772353|Letrozole|letrozole|mesh-list
5650558|NCT03772353|Fulvestrant|fulvestrant|mesh-list
5650559|NCT03772353|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5650560|NCT03772353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5650561|NCT03772353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5650562|NCT03772353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5826201|NCT02581683|Anesthetics|anesthetics|mesh-ancestor
5826202|NCT02581683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5826203|NCT02581683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826204|NCT02581683|Sensory System Agents|sensory system agents|mesh-ancestor
5826205|NCT02581683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5826206|NCT02581683|Analgesics|analgesics|mesh-ancestor
5826207|NCT02581683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5826208|NCT02581683|Anticonvulsants|anticonvulsants|mesh-ancestor
5826209|NCT02581683|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5826210|NCT02581683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5826211|NCT02581683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826212|NCT02581683|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5826213|NCT02581683|Tocolytic Agents|tocolytic agents|mesh-ancestor
5826214|NCT02581683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5826215|NCT02581748|Trastuzumab|trastuzumab|mesh-list
5826216|NCT02581748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5826217|NCT02581748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5826218|NCT02581553|Allopurinol|allopurinol|mesh-list
5826219|NCT02581553|Lesinurad|lesinurad|mesh-list
5826220|NCT02581553|Antimetabolites|antimetabolites|mesh-ancestor
5826221|NCT02581553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826222|NCT02581553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5826223|NCT02581553|Gout Suppressants|gout suppressants|mesh-ancestor
5826224|NCT02581553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5826225|NCT02581553|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5826226|NCT02581553|Antioxidants|antioxidants|mesh-ancestor
5826227|NCT02581553|Protective Agents|protective agents|mesh-ancestor
5826228|NCT02581553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826229|NCT02581553|Uricosuric Agents|uricosuric agents|mesh-ancestor
5826230|NCT02581553|Renal Agents|renal agents|mesh-ancestor
5826231|NCT02581566|Dexmedetomidine|dexmedetomidine|mesh-list
5826232|NCT02581566|Bupivacaine|bupivacaine|mesh-list
5826233|NCT02581566|Anesthetics, Local|anesthetics, local|mesh-ancestor
5826234|NCT02581566|Anesthetics|anesthetics|mesh-ancestor
5826235|NCT02581566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5826236|NCT02581566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826237|NCT02581566|Sensory System Agents|sensory system agents|mesh-ancestor
5826238|NCT02581566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5826239|NCT02581566|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5826240|NCT02581566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5826241|NCT02581566|Analgesics|analgesics|mesh-ancestor
5826242|NCT02581566|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5826243|NCT02581566|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5826244|NCT02581566|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5826245|NCT02581566|Adrenergic Agents|adrenergic agents|mesh-ancestor
5650563|NCT03772353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650564|NCT03772353|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5650565|NCT03772353|Hormone Antagonists|hormone antagonists|mesh-ancestor
5650566|NCT03772353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5650567|NCT03772353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650568|NCT03772353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5650569|NCT03772353|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5650570|NCT03721341|Hormones|hormones|mesh-list
5650571|NCT03721341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5650572|NCT03721341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650573|NCT03697720|Naproxen|naproxen|mesh-list
5650574|NCT03697720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5650575|NCT03697720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5650576|NCT03697720|Analgesics|analgesics|mesh-ancestor
5650577|NCT03697720|Sensory System Agents|sensory system agents|mesh-ancestor
5650578|NCT03697720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5650579|NCT03697720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650580|NCT03697720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5650581|NCT03697720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5650582|NCT03697720|Gout Suppressants|gout suppressants|mesh-ancestor
5650583|NCT03697720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5650584|NCT03697720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5650585|NCT03697720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694544|NCT03395002|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5694545|NCT03395002|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5694546|NCT03395002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5694547|NCT03395002|Adrenergic Agents|adrenergic agents|mesh-ancestor
5694548|NCT03394989|Fluticasone|fluticasone|mesh-list
5694549|NCT03394989|Xhance|xhance|mesh-list
5694550|NCT03394989|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5694551|NCT03394989|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
5694552|NCT03394989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5694553|NCT03394989|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5694554|NCT03394989|Autonomic Agents|autonomic agents|mesh-ancestor
5694555|NCT03394989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5826246|NCT02581566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5826247|NCT02581566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826248|NCT02581527|Rifampin|rifampin|mesh-list
5826249|NCT02581527|Isoniazid|isoniazid|mesh-list
5826250|NCT02581527|Pyrazinamide|pyrazinamide|mesh-list
5826251|NCT02581527|Ethambutol|ethambutol|mesh-list
5650586|NCT03680274|Ascorbic Acid|ascorbic acid|mesh-list
5650587|NCT03680274|Vitamins|vitamins|mesh-ancestor
5650588|NCT03680274|Micronutrients|micronutrients|mesh-ancestor
5650589|NCT03680274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650590|NCT03680274|Antioxidants|antioxidants|mesh-ancestor
5650591|NCT03680274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650592|NCT03680274|Protective Agents|protective agents|mesh-ancestor
5826252|NCT02581527|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5826253|NCT02581527|Antitubercular Agents|antitubercular agents|mesh-ancestor
5826254|NCT02581527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5826255|NCT02581527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5826256|NCT02581527|Leprostatic Agents|leprostatic agents|mesh-ancestor
5826257|NCT02581527|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5826258|NCT02581527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5826259|NCT02581527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826260|NCT02581527|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5826261|NCT02581527|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5826262|NCT02581527|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5826263|NCT02581527|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5826264|NCT02581527|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5650593|NCT03649633|Vitamins|vitamins|mesh-list
5650594|NCT03649633|Ascorbic Acid|ascorbic acid|mesh-list
5650595|NCT03649633|Hydrocortisone|hydrocortisone|mesh-list
5650596|NCT03649633|Micronutrients|micronutrients|mesh-ancestor
5650597|NCT03649633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650598|NCT03649633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6493069|NCT00611845|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6493070|NCT00611845|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6493071|NCT00611845|Protease Inhibitors|protease inhibitors|mesh-ancestor
6493072|NCT00611845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6493073|NCT00611845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493074|NCT00611871|Propranolol|propranolol|mesh-list
6493075|NCT00611871|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6493076|NCT00611871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6493077|NCT00611871|Adrenergic Agents|adrenergic agents|mesh-ancestor
6493078|NCT00611871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6493079|NCT00611871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826265|NCT02581527|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5826266|NCT02581527|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5826267|NCT02581527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5826268|NCT02581527|Antimetabolites|antimetabolites|mesh-ancestor
5826269|NCT02581527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6493080|NCT00611871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493081|NCT00611871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6493082|NCT00611871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6493083|NCT00611871|Vasodilator Agents|vasodilator agents|mesh-ancestor
6493084|NCT00611910|Sirolimus|sirolimus|mesh-list
6493085|NCT00611910|Paclitaxel|paclitaxel|mesh-list
6493086|NCT00611910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6493087|NCT00611910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6493088|NCT00611910|Tubulin Modulators|tubulin modulators|mesh-ancestor
6493089|NCT00611910|Antimitotic Agents|antimitotic agents|mesh-ancestor
6493090|NCT00611910|Mitosis Modulators|mitosis modulators|mesh-ancestor
5826270|NCT02581371|Cerebrolysin|cerebrolysin|mesh-list
5826271|NCT02581371|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5826272|NCT02581371|Protective Agents|protective agents|mesh-ancestor
5826273|NCT02581371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826274|NCT02581371|Nootropic Agents|nootropic agents|mesh-ancestor
5826275|NCT02581501|Gemcitabine|gemcitabine|mesh-list
5826276|NCT02581501|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5826277|NCT02581501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5826278|NCT02581501|Antimetabolites|antimetabolites|mesh-ancestor
5826279|NCT02581501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826280|NCT02581501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5826281|NCT02581501|Antiviral Agents|antiviral agents|mesh-ancestor
5826282|NCT02581501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5826283|NCT02581501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5826284|NCT02581501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5826285|NCT02581501|Immunologic Factors|immunologic factors|mesh-ancestor
5826286|NCT02581501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826287|NCT02581462|Trastuzumab|trastuzumab|mesh-list
5826288|NCT02581462|Pertuzumab|pertuzumab|mesh-list
6493091|NCT00611910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493092|NCT00611910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5650599|NCT03649633|Antioxidants|antioxidants|mesh-ancestor
6493093|NCT00611910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5650600|NCT03649633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650601|NCT03649633|Protective Agents|protective agents|mesh-ancestor
5650602|NCT03623373|Cytarabine|cytarabine|mesh-list
5650603|NCT03623373|Rituximab|rituximab|mesh-list
5650604|NCT03623373|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5650605|NCT03623373|Acalabrutinib|acalabrutinib|mesh-list
5650606|NCT03623373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5650607|NCT03623373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5650608|NCT03623373|Immunologic Factors|immunologic factors|mesh-ancestor
5650609|NCT03623373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650610|NCT03623373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5650611|NCT03623373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5650612|NCT03623373|Antimetabolites|antimetabolites|mesh-ancestor
5650613|NCT03623373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650614|NCT03623373|Antiviral Agents|antiviral agents|mesh-ancestor
5650615|NCT03623373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5650616|NCT03623373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5650617|NCT03623373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5826289|NCT02581462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5826290|NCT02581462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5826291|NCT02581631|Nivolumab|nivolumab|mesh-list
5826292|NCT02581631|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5826293|NCT02581631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5826294|NCT02581631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5826295|NCT02581631|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5826296|NCT02581631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826297|NCT02581423|Capecitabine|capecitabine|mesh-list
5826298|NCT02581423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5826299|NCT02581423|Antimetabolites|antimetabolites|mesh-ancestor
5826300|NCT02581423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826301|NCT02581423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5826302|NCT02581124|Lapatinib|lapatinib|mesh-list
5826303|NCT02581124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5826304|NCT02581124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5826305|NCT02581124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5826306|NCT02581124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826307|NCT02581176|Apixaban|apixaban|mesh-list
5826308|NCT02581176|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5826309|NCT02581176|Antithrombins|antithrombins|mesh-ancestor
5826310|NCT02581176|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5826311|NCT02581176|Protease Inhibitors|protease inhibitors|mesh-ancestor
5826312|NCT02581176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5826313|NCT02581176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826314|NCT02581176|Anticoagulants|anticoagulants|mesh-ancestor
5826315|NCT02580838|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5826316|NCT02580838|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5650618|NCT03623373|Alkylating Agents|alkylating agents|mesh-ancestor
5650619|NCT03607890|Nivolumab|nivolumab|mesh-list
5650620|NCT03607890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5650621|NCT03607890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5650622|NCT03607890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5650623|NCT03607890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650624|NCT03603964|Guadecitabine|guadecitabine|mesh-list
5650625|NCT03603964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5650626|NCT03583528|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5650627|NCT03583528|Edotreotide|edotreotide|mesh-list
5826317|NCT02580838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5826318|NCT02580838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5826319|NCT02580838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826320|NCT02580838|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5826321|NCT02580838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5826322|NCT02580838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826323|NCT02580838|Cholinergic Agents|cholinergic agents|mesh-ancestor
5826324|NCT02580838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5826325|NCT02580968|Flunarizine|flunarizine|mesh-list
5826326|NCT02580968|Anticonvulsants|anticonvulsants|mesh-ancestor
5826327|NCT02580968|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5826328|NCT02580968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5826329|NCT02580968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826330|NCT02580968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6493094|NCT00611910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5650628|NCT03583528|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5650629|NCT03583528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650630|NCT03582774|Edetic Acid|edetic acid|mesh-list
5650631|NCT03582774|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5826331|NCT02580968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826332|NCT02580968|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5826333|NCT02580968|Histamine Antagonists|histamine antagonists|mesh-ancestor
5826334|NCT02580968|Histamine Agents|histamine agents|mesh-ancestor
5826335|NCT02580968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5826336|NCT02580968|Vasodilator Agents|vasodilator agents|mesh-ancestor
5826337|NCT02580994|Carboplatin|carboplatin|mesh-list
5826338|NCT02580994|Pembrolizumab|pembrolizumab|mesh-list
5826339|NCT02580994|Etoposide|etoposide|mesh-list
5826340|NCT02580994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5826341|NCT02580994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5826342|NCT02580994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5826343|NCT02580994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5826344|NCT02580994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5826345|NCT02580994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5826346|NCT02580994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826347|NCT02581046|Dexamethasone|dexamethasone|mesh-list
5826348|NCT02581046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5826349|NCT02581046|Antiemetics|antiemetics|mesh-ancestor
5826350|NCT02581046|Autonomic Agents|autonomic agents|mesh-ancestor
5826351|NCT02581046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5826352|NCT02581046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826353|NCT02581046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5650632|NCT03582774|Chelating Agents|chelating agents|mesh-ancestor
5650633|NCT03582774|Sequestering Agents|sequestering agents|mesh-ancestor
5650634|NCT03582774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650635|NCT03582774|Anticoagulants|anticoagulants|mesh-ancestor
5650636|NCT03582774|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5650637|NCT03582774|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5650638|NCT03568058|Pembrolizumab|pembrolizumab|mesh-list
5650639|NCT03568058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5650640|NCT03568058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5650641|NCT03512210|Sofosbuvir|sofosbuvir|mesh-list
5650642|NCT03512210|Velpatasvir|velpatasvir|mesh-list
5650643|NCT03512210|Antiviral Agents|antiviral agents|mesh-ancestor
5650644|NCT03512210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5650645|NCT03506412|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5650646|NCT03506412|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5650647|NCT03506412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650648|NCT03505320|Leucovorin|leucovorin|mesh-list
5650649|NCT03505320|Folic Acid|folic acid|mesh-list
5650650|NCT03505320|Fluorouracil|fluorouracil|mesh-list
5650651|NCT03505320|Pembrolizumab|pembrolizumab|mesh-list
5650652|NCT03505320|Oxaliplatin|oxaliplatin|mesh-list
5826354|NCT02581046|Glucocorticoids|glucocorticoids|mesh-ancestor
5826355|NCT02581046|Hormones|hormones|mesh-ancestor
5826356|NCT02581046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5826357|NCT02581046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5826358|NCT02581046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5826359|NCT02581007|Cyclophosphamide|cyclophosphamide|mesh-list
5826360|NCT02581007|Melphalan|melphalan|mesh-list
5826361|NCT02581007|Fludarabine|fludarabine|mesh-list
5826362|NCT02581007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5826363|NCT02581007|Immunologic Factors|immunologic factors|mesh-ancestor
5826364|NCT02581007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826365|NCT02581007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5826366|NCT02581007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5826367|NCT02581007|Alkylating Agents|alkylating agents|mesh-ancestor
5826368|NCT02581007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826369|NCT02581007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5826370|NCT02581007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5826371|NCT02580773|Tinzaparin|tinzaparin|mesh-list
5826372|NCT02580773|Anticoagulants|anticoagulants|mesh-ancestor
5826373|NCT02580773|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5826374|NCT02580773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5826375|NCT02580773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826376|NCT02580604|Calcium|calcium|mesh-list
5826377|NCT02580604|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5826378|NCT02580604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826379|NCT02580734|Melatonin|melatonin|mesh-list
5826380|NCT02580734|Antioxidants|antioxidants|mesh-ancestor
5826381|NCT02580734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650653|NCT03505320|Nivolumab|nivolumab|mesh-list
5826382|NCT02580734|Protective Agents|protective agents|mesh-ancestor
5826383|NCT02580734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826384|NCT02580734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5826385|NCT02580344|Ibuprofen|ibuprofen|mesh-list
5826386|NCT02580344|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5650654|NCT03505320|Levoleucovorin|levoleucovorin|mesh-list
5650655|NCT03505320|Antimetabolites|antimetabolites|mesh-ancestor
5650656|NCT03505320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650657|NCT03505320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5650658|NCT03505320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5650659|NCT03505320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5650660|NCT03505320|Immunologic Factors|immunologic factors|mesh-ancestor
5650661|NCT03505320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826387|NCT02580344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5826388|NCT02580344|Analgesics|analgesics|mesh-ancestor
5826389|NCT02580344|Sensory System Agents|sensory system agents|mesh-ancestor
5826390|NCT02580344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5826391|NCT02580344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826392|NCT02580344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5650662|NCT03505320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5650663|NCT03505320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5650664|NCT03505320|Antidotes|antidotes|mesh-ancestor
5826393|NCT02580344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5826394|NCT02580344|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5826395|NCT02580344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5826396|NCT02580344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826397|NCT02580448|Seviteronel|seviteronel|mesh-list
5826398|NCT02580448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5826399|NCT02580448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5826400|NCT02580448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5826401|NCT02580448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826402|NCT02580331|Metformin|metformin|mesh-list
5826403|NCT02580331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5826404|NCT02580331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902141|NCT05073562|Vitamin B Complex|vitamin b complex|mesh-ancestor
5902142|NCT05073562|Vitamins|vitamins|mesh-ancestor
5902143|NCT05073562|Micronutrients|micronutrients|mesh-ancestor
5902144|NCT05073562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902145|NCT05073562|Antinematodal Agents|antinematodal agents|mesh-ancestor
5902146|NCT05073562|Anthelmintics|anthelmintics|mesh-ancestor
5902147|NCT05073562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5902148|NCT05073562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5902149|NCT05073562|Tubulin Modulators|tubulin modulators|mesh-ancestor
5902150|NCT05073562|Antimitotic Agents|antimitotic agents|mesh-ancestor
5902151|NCT05073562|Mitosis Modulators|mitosis modulators|mesh-ancestor
5902152|NCT05073562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902153|NCT05073562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5902154|NCT05073562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5902155|NCT05032807|Cannabidiol|cannabidiol|mesh-list
5902156|NCT05032807|Anticonvulsants|anticonvulsants|mesh-ancestor
5902157|NCT04975997|Dexamethasone|dexamethasone|mesh-list
5902158|NCT04975997|Dexamethasone acetate|dexamethasone acetate|mesh-list
5902159|NCT04975997|Bortezomib|bortezomib|mesh-list
5902160|NCT04975997|Daratumumab|daratumumab|mesh-list
5902161|NCT04975997|BB 1101|bb 1101|mesh-list
5902162|NCT04975997|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5902163|NCT04975997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5902164|NCT04975997|Antiemetics|antiemetics|mesh-ancestor
5902165|NCT04975997|Autonomic Agents|autonomic agents|mesh-ancestor
5902166|NCT04975997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5902167|NCT04975997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902168|NCT04975997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5902169|NCT04975997|Glucocorticoids|glucocorticoids|mesh-ancestor
5902170|NCT04975997|Hormones|hormones|mesh-ancestor
5902171|NCT04975997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5902172|NCT04975997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5902173|NCT04975997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5902174|NCT04975997|Protease Inhibitors|protease inhibitors|mesh-ancestor
5902175|NCT04975997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5902176|NCT04975997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902177|NCT04975997|Immunologic Factors|immunologic factors|mesh-ancestor
5902178|NCT04969731|Gemcitabine|gemcitabine|mesh-list
5902179|NCT04969731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5902180|NCT04969731|Antimetabolites|antimetabolites|mesh-ancestor
5902181|NCT04969731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650665|NCT03505320|Protective Agents|protective agents|mesh-ancestor
5650666|NCT03505320|Vitamin B Complex|vitamin b complex|mesh-ancestor
5650667|NCT03505320|Vitamins|vitamins|mesh-ancestor
5650668|NCT03505320|Micronutrients|micronutrients|mesh-ancestor
5650669|NCT03505320|Hematinics|hematinics|mesh-ancestor
5650670|NCT03504397|Leucovorin|leucovorin|mesh-list
5650671|NCT03504397|Folic Acid|folic acid|mesh-list
5650672|NCT03504397|Fluorouracil|fluorouracil|mesh-list
5650673|NCT03504397|Oxaliplatin|oxaliplatin|mesh-list
5650674|NCT03504397|Levoleucovorin|levoleucovorin|mesh-list
5650675|NCT03504397|Antimetabolites|antimetabolites|mesh-ancestor
5650676|NCT03504397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650677|NCT03504397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5650678|NCT03504397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5826405|NCT02580474|Asunaprevir|asunaprevir|mesh-list
5826406|NCT02580474|Protease Inhibitors|protease inhibitors|mesh-ancestor
5826407|NCT02580474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5826408|NCT02580474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826409|NCT02580695|Hyaluronic Acid|hyaluronic acid|mesh-list
5826410|NCT02580695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5826411|NCT02580695|Immunologic Factors|immunologic factors|mesh-ancestor
5826412|NCT02580695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826413|NCT02580695|Viscosupplements|viscosupplements|mesh-ancestor
5826414|NCT02580695|Protective Agents|protective agents|mesh-ancestor
5826415|NCT02580227|Tranexamic Acid|tranexamic acid|mesh-list
5826416|NCT02580227|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5650679|NCT03504397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5650680|NCT03504397|Immunologic Factors|immunologic factors|mesh-ancestor
5650681|NCT03504397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650682|NCT03504397|Antidotes|antidotes|mesh-ancestor
5650683|NCT03504397|Protective Agents|protective agents|mesh-ancestor
5650684|NCT03504397|Vitamin B Complex|vitamin b complex|mesh-ancestor
5650685|NCT03504397|Vitamins|vitamins|mesh-ancestor
5650686|NCT03504397|Micronutrients|micronutrients|mesh-ancestor
5650687|NCT03504397|Hematinics|hematinics|mesh-ancestor
5650688|NCT03502577|Cyclophosphamide|cyclophosphamide|mesh-list
5650689|NCT03502577|Fludarabine|fludarabine|mesh-list
5650690|NCT03502577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5826417|NCT02580227|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5826418|NCT02580227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826419|NCT02580227|Hemostatics|hemostatics|mesh-ancestor
5826420|NCT02580227|Coagulants|coagulants|mesh-ancestor
5826421|NCT02580006|Epoetin Alfa|epoetin alfa|mesh-list
5826422|NCT02580006|Hematinics|hematinics|mesh-ancestor
5826423|NCT02580149|Clopidogrel|clopidogrel|mesh-list
5650691|NCT03502577|Immunologic Factors|immunologic factors|mesh-ancestor
5650692|NCT03502577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650693|NCT03502577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5650694|NCT03502577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5650695|NCT03502577|Alkylating Agents|alkylating agents|mesh-ancestor
5650696|NCT03502577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650697|NCT03502577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5650698|NCT03502577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5650699|NCT03493854|Paclitaxel|paclitaxel|mesh-list
5650700|NCT03493854|Docetaxel|docetaxel|mesh-list
5650701|NCT03493854|Cyclophosphamide|cyclophosphamide|mesh-list
5650702|NCT03493854|Doxorubicin|doxorubicin|mesh-list
5650703|NCT03493854|Trastuzumab|trastuzumab|mesh-list
5826424|NCT02580149|Ticagrelor|ticagrelor|mesh-list
5826425|NCT02580149|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5826426|NCT02580149|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5826427|NCT02580149|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5826428|NCT02580149|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5826429|NCT02580149|Purinergic Agents|purinergic agents|mesh-ancestor
5826430|NCT02580149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5826431|NCT02580149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826432|NCT02580149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826433|NCT02579642|Ketamine|ketamine|mesh-list
5826434|NCT02579642|Analgesics|analgesics|mesh-ancestor
5826435|NCT02579642|Sensory System Agents|sensory system agents|mesh-ancestor
6493095|NCT00611910|Antifungal Agents|antifungal agents|mesh-ancestor
6493096|NCT00611910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5650704|NCT03493854|Pertuzumab|pertuzumab|mesh-list
5826436|NCT02579642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5826437|NCT02579642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650705|NCT03493854|Hormones|hormones|mesh-list
5650706|NCT03493854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5650707|NCT03493854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5650708|NCT03493854|Tubulin Modulators|tubulin modulators|mesh-ancestor
5650709|NCT03493854|Antimitotic Agents|antimitotic agents|mesh-ancestor
5650710|NCT03493854|Mitosis Modulators|mitosis modulators|mesh-ancestor
5650711|NCT03493854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650712|NCT03493854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5650713|NCT03493854|Immunologic Factors|immunologic factors|mesh-ancestor
5650714|NCT03493854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650715|NCT03493854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5650716|NCT03493854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5650717|NCT03493854|Alkylating Agents|alkylating agents|mesh-ancestor
5650718|NCT03493854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5650719|NCT03493854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5650720|NCT03493854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5650721|NCT03493854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5650722|NCT03493854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5650723|NCT03493854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5650724|NCT03493854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5650725|NCT03383770|Anesthetics|anesthetics|mesh-list
5650726|NCT03383770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5650727|NCT03383770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650728|NCT03381274|Osimertinib|osimertinib|mesh-list
5650729|NCT03381274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5650730|NCT03381274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5650731|NCT03381274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5650732|NCT03381274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650733|NCT03278665|Pembrolizumab|pembrolizumab|mesh-list
5650734|NCT03278665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5650735|NCT03278665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6211688|NCT02176018|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6211689|NCT02176018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5826438|NCT02579642|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5826439|NCT02579642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5826440|NCT02579642|Anesthetics, General|anesthetics, general|mesh-ancestor
5826441|NCT02579642|Anesthetics|anesthetics|mesh-ancestor
5826442|NCT02579642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5826443|NCT02579642|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5826444|NCT02579642|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5826445|NCT02579642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5826446|NCT02579642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826447|NCT02579902|Vitamin D|vitamin d|mesh-list
5826448|NCT02579902|Cholecalciferol|cholecalciferol|mesh-list
5826449|NCT02579902|Vitamins|vitamins|mesh-ancestor
6211690|NCT02176018|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6211691|NCT02176018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6211692|NCT02176031|Methylprednisolone|methylprednisolone|mesh-list
6211693|NCT02176031|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6211694|NCT02176031|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6211695|NCT02176031|Prednisolone|prednisolone|mesh-list
6211696|NCT02176031|Prednisolone acetate|prednisolone acetate|mesh-list
6211697|NCT02176031|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5650746|NCT03198689|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5650747|NCT03198689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5650748|NCT03198689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5650749|NCT03073967|Foscarnet|foscarnet|mesh-list
5650750|NCT03073967|Pritelivir|pritelivir|mesh-list
5650751|NCT03073967|Antiviral Agents|antiviral agents|mesh-ancestor
5650752|NCT03073967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5650753|NCT03073967|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5650754|NCT03073967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5650755|NCT03073967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5650756|NCT03073967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650757|NCT03073941|Cimetidine|cimetidine|mesh-list
5650758|NCT03073941|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5650759|NCT03073941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5650760|NCT03073941|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5650761|NCT03073941|Histamine Antagonists|histamine antagonists|mesh-ancestor
5826450|NCT02579902|Micronutrients|micronutrients|mesh-ancestor
5826451|NCT02579902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826452|NCT02579902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5826453|NCT02579902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5826454|NCT02579590|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
5826455|NCT02579590|Medroxyprogesterone|medroxyprogesterone|mesh-list
5826456|NCT02579590|Desogestrel|desogestrel|mesh-list
5650762|NCT03073941|Histamine Agents|histamine agents|mesh-ancestor
5650763|NCT03073941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5650764|NCT03073941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650765|NCT03073941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650766|NCT03073941|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5650767|NCT03073941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5650768|NCT03073941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5826457|NCT02579590|Etonogestrel|etonogestrel|mesh-list
5826458|NCT02579590|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5826459|NCT02579590|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5826460|NCT02579590|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5826461|NCT02579590|Contraceptive Agents|contraceptive agents|mesh-ancestor
5826462|NCT02579590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5826463|NCT02579590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826464|NCT02579590|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5826465|NCT02579590|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5826466|NCT02579590|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5826467|NCT02579590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5826468|NCT02579590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5826469|NCT02579590|Progestins|progestins|mesh-ancestor
5826470|NCT02579590|Hormones|hormones|mesh-ancestor
5826471|NCT02579590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5650769|NCT02902757|Deoxyglucose|deoxyglucose|mesh-list
5650770|NCT02902757|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5650771|NCT02902757|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5650772|NCT02902757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650773|NCT02902757|Antimetabolites|antimetabolites|mesh-ancestor
5650774|NCT02902757|Antiviral Agents|antiviral agents|mesh-ancestor
5650775|NCT02902757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5650776|NCT02831673|Tenofovir|tenofovir|mesh-list
5650777|NCT02831673|Lamivudine|lamivudine|mesh-list
5650778|NCT02831673|Emtricitabine|emtricitabine|mesh-list
5650779|NCT02831673|Dolutegravir|dolutegravir|mesh-list
5650780|NCT02831673|Antiviral Agents|antiviral agents|mesh-ancestor
5650781|NCT02831673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5650782|NCT02831673|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5650783|NCT02831673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5650784|NCT02831673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5650785|NCT02831673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650786|NCT02831673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5650787|NCT02831673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5650788|NCT02831673|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5650789|NCT02831673|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5650790|NCT02668822|Ibuprofen|ibuprofen|mesh-list
5650791|NCT02668822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5650792|NCT02668822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5650793|NCT02668822|Analgesics|analgesics|mesh-ancestor
5650794|NCT02668822|Sensory System Agents|sensory system agents|mesh-ancestor
5650795|NCT02668822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5650796|NCT02668822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650797|NCT02668822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5650798|NCT02668822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5650799|NCT02668822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5650800|NCT02668822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5650801|NCT02668822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650802|NCT02668783|Ibuprofen|ibuprofen|mesh-list
5650803|NCT02668783|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5650804|NCT02668783|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5650805|NCT02668783|Etonogestrel|etonogestrel|mesh-list
5650806|NCT02668783|Estradiol|estradiol|mesh-list
5650807|NCT02668783|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5650808|NCT02668783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5650809|NCT02668783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5650810|NCT02668783|Analgesics|analgesics|mesh-ancestor
5650811|NCT02668783|Sensory System Agents|sensory system agents|mesh-ancestor
5650812|NCT02668783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5650813|NCT02668783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650814|NCT02668783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5650815|NCT02668783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5650816|NCT02668783|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5650817|NCT02668783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5650818|NCT02668783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650819|NCT02668783|Estrogens|estrogens|mesh-ancestor
5650820|NCT02668783|Hormones|hormones|mesh-ancestor
5826472|NCT02579564|Gemcitabine|gemcitabine|mesh-list
5826473|NCT02579564|Paclitaxel|paclitaxel|mesh-list
5826474|NCT02579564|Vinorelbine|vinorelbine|mesh-list
5826475|NCT02579564|Pemetrexed|pemetrexed|mesh-list
5826476|NCT02579564|Endostar protein|endostar protein|mesh-list
5826477|NCT02579564|Endostatins|endostatins|mesh-list
5826478|NCT02579564|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5826479|NCT02579564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5826480|NCT02579564|Tubulin Modulators|tubulin modulators|mesh-ancestor
5826481|NCT02579564|Antimitotic Agents|antimitotic agents|mesh-ancestor
5826482|NCT02579564|Mitosis Modulators|mitosis modulators|mesh-ancestor
5826483|NCT02579564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826484|NCT02579564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5826485|NCT02579564|Antimetabolites|antimetabolites|mesh-ancestor
5826486|NCT02579564|Antiviral Agents|antiviral agents|mesh-ancestor
5826487|NCT02579564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5826488|NCT02579564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5826489|NCT02579564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5826490|NCT02579564|Immunologic Factors|immunologic factors|mesh-ancestor
5826491|NCT02579564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826492|NCT02579564|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5826493|NCT02579564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5826494|NCT02579564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5826495|NCT02579564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5826496|NCT02579564|Growth Substances|growth substances|mesh-ancestor
5826497|NCT02579564|Growth Inhibitors|growth inhibitors|mesh-ancestor
5826498|NCT02579707|Ivosidenib|ivosidenib|mesh-list
5826499|NCT02579707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5826500|NCT02579707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5826501|NCT02579707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650821|NCT02668783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5650822|NCT02668783|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5650823|NCT02668783|Contraceptive Agents|contraceptive agents|mesh-ancestor
5826502|NCT02579681|Dimethyl Fumarate|dimethyl fumarate|mesh-list
5826503|NCT02579681|Dermatologic Agents|dermatologic agents|mesh-ancestor
5826504|NCT02579681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5826505|NCT02579681|Immunologic Factors|immunologic factors|mesh-ancestor
5826506|NCT02579681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493097|NCT00611910|Immunologic Factors|immunologic factors|mesh-ancestor
6493098|NCT00611910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493099|NCT00611936|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6493100|NCT00611936|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6493101|NCT00611936|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6493102|NCT00611936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6493103|NCT00611936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493104|NCT00611936|Adrenergic Agents|adrenergic agents|mesh-ancestor
6493105|NCT00611936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5826507|NCT02579733|Azathioprine|azathioprine|mesh-list
5826508|NCT02579733|Antimetabolites|antimetabolites|mesh-ancestor
5826509|NCT02579733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826510|NCT02579733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5826511|NCT02579733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5826512|NCT02579733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5650824|NCT02668783|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5650825|NCT02668783|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5650826|NCT02616146|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5650827|NCT02616146|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5650828|NCT02616146|Levonorgestrel|levonorgestrel|mesh-list
5650829|NCT02616146|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5650830|NCT02616146|Etonogestrel|etonogestrel|mesh-list
5650831|NCT02616146|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
5650832|NCT02616146|Estradiol|estradiol|mesh-list
5650833|NCT02616146|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5650834|NCT02616146|Estrogens|estrogens|mesh-ancestor
5650835|NCT02616146|Hormones|hormones|mesh-ancestor
5650836|NCT02616146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5650837|NCT02616146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650838|NCT02616146|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5650839|NCT02616146|Contraceptive Agents|contraceptive agents|mesh-ancestor
5650840|NCT02616146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5650841|NCT02616146|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5650842|NCT02616146|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5650843|NCT02616146|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5650844|NCT02616146|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5826513|NCT02579733|Immunologic Factors|immunologic factors|mesh-ancestor
5826514|NCT02579733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650845|NCT02616146|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5650846|NCT02567422|Cisplatin|cisplatin|mesh-list
5826515|NCT02579733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5826516|NCT02579499|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
5650847|NCT02567422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5650848|NCT02538510|Pembrolizumab|pembrolizumab|mesh-list
5650849|NCT02538510|Vorinostat|vorinostat|mesh-list
5650850|NCT02538510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5650851|NCT02538510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5650852|NCT02538510|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5650853|NCT02538510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5650854|NCT02538510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650855|NCT02489942|Empagliflozin|empagliflozin|mesh-list
5650856|NCT02489942|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5650857|NCT02489942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650858|NCT02489942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5650859|NCT02489942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650860|NCT02477644|Olaparib|olaparib|mesh-list
5650861|NCT02477644|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5650862|NCT02477644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5650863|NCT02477644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650864|NCT02477644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5650865|NCT02420860|Lenalidomide|lenalidomide|mesh-list
5650866|NCT02420860|Elotuzumab|elotuzumab|mesh-list
5826517|NCT02579499|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5826518|NCT02579499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5826519|NCT02579499|Antimetabolites|antimetabolites|mesh-ancestor
5826520|NCT02579499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826521|NCT02579499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5826522|NCT02579499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5826523|NCT02579473|Rotigotine|rotigotine|mesh-list
5826524|NCT02579473|Dopamine Agonists|dopamine agonists|mesh-ancestor
5826525|NCT02579473|Dopamine Agents|dopamine agents|mesh-ancestor
5826526|NCT02579473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5826527|NCT02579473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826528|NCT02579473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650867|NCT02420860|Immunologic Factors|immunologic factors|mesh-ancestor
5650868|NCT02420860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650869|NCT02420860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5650870|NCT02420860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5650871|NCT02420860|Growth Substances|growth substances|mesh-ancestor
5650872|NCT02420860|Growth Inhibitors|growth inhibitors|mesh-ancestor
5650873|NCT02420860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5650874|NCT02420613|Sirolimus|sirolimus|mesh-list
5650875|NCT02420613|Vorinostat|vorinostat|mesh-list
5650876|NCT02420613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5650877|NCT02420613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5650878|NCT02420613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5650879|NCT02420613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5650880|NCT02420613|Antifungal Agents|antifungal agents|mesh-ancestor
5650881|NCT02420613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5650882|NCT02420613|Immunologic Factors|immunologic factors|mesh-ancestor
5826529|NCT02579434|Midazolam|midazolam|mesh-list
5826530|NCT02579434|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5826531|NCT02579434|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5826532|NCT02579434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5826533|NCT02579434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826534|NCT02579434|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5826535|NCT02579434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5826536|NCT02579434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5826537|NCT02579434|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5826538|NCT02579434|Anesthetics, General|anesthetics, general|mesh-ancestor
5826539|NCT02579434|Anesthetics|anesthetics|mesh-ancestor
5826540|NCT02579434|GABA Modulators|gaba modulators|mesh-ancestor
5826541|NCT02579434|GABA Agents|gaba agents|mesh-ancestor
5826542|NCT02579434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5826543|NCT02579434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826544|NCT02579356|Telmisartan|telmisartan|mesh-list
5826545|NCT02579356|Atorvastatin|atorvastatin|mesh-list
5826546|NCT02579356|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5826547|NCT02579356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5826548|NCT02579356|Antimetabolites|antimetabolites|mesh-ancestor
5826549|NCT02579356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826550|NCT02579356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5826551|NCT02579356|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5826552|NCT02579356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5826553|NCT02579356|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5826554|NCT02579356|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5826555|NCT02579356|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5826556|NCT02579187|Anesthetics|anesthetics|mesh-list
5826557|NCT02579187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5826558|NCT02579187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826559|NCT02579161|Metronidazole|metronidazole|mesh-list
5826560|NCT02579161|Clindamycin|clindamycin|mesh-list
5826561|NCT02579161|Clindamycin palmitate|clindamycin palmitate|mesh-list
5826562|NCT02579161|Clindamycin phosphate|clindamycin phosphate|mesh-list
5826563|NCT02579161|Sulbactam|sulbactam|mesh-list
5826564|NCT02579161|Cephalosporins|cephalosporins|mesh-list
5826565|NCT02579161|Fluoroquinolones|fluoroquinolones|mesh-list
5826566|NCT02579161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5826567|NCT02579161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5826568|NCT02579161|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5826569|NCT02579161|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5826570|NCT02579161|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5826571|NCT02579161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5826572|NCT02579161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826573|NCT02579161|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5826574|NCT02579161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5826575|NCT02578914|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5826576|NCT02578914|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5826577|NCT02579044|Everolimus|everolimus|mesh-list
5826578|NCT02579044|Lonafarnib|lonafarnib|mesh-list
5826579|NCT02579044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5826580|NCT02579044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5826581|NCT02579044|Immunologic Factors|immunologic factors|mesh-ancestor
5826582|NCT02579044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826583|NCT02579044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5826584|NCT02579044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826585|NCT02578953|Dutasteride|dutasteride|mesh-list
5826586|NCT02578953|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
5826587|NCT02578953|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5826588|NCT02578953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5826589|NCT02578953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826590|NCT02578953|Hormone Antagonists|hormone antagonists|mesh-ancestor
5826591|NCT02578953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5826592|NCT02578953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826593|NCT02578849|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
5826594|NCT02578849|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5826595|NCT02578849|Immunologic Factors|immunologic factors|mesh-ancestor
5826596|NCT02578849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826597|NCT02578849|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5826598|NCT02578849|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5826599|NCT02578849|Dopamine Agonists|dopamine agonists|mesh-ancestor
5826600|NCT02578849|Dopamine Agents|dopamine agents|mesh-ancestor
5826601|NCT02578849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5826602|NCT02578849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826603|NCT02578823|Antipyretics|antipyretics|mesh-list
5826604|NCT02578823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826605|NCT02578719|Bupivacaine|bupivacaine|mesh-list
5826606|NCT02578719|Anesthetics, Local|anesthetics, local|mesh-ancestor
5826607|NCT02578719|Anesthetics|anesthetics|mesh-ancestor
5826608|NCT02578719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5826609|NCT02578719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826610|NCT02578719|Sensory System Agents|sensory system agents|mesh-ancestor
5650883|NCT02420613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650884|NCT02420613|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5650885|NCT02420613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5650886|NCT02420613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650887|NCT02409342|Gemcitabine|gemcitabine|mesh-list
5650888|NCT02409342|Carboplatin|carboplatin|mesh-list
5650889|NCT02409342|Pemetrexed|pemetrexed|mesh-list
5650890|NCT02409342|Atezolizumab|atezolizumab|mesh-list
5650891|NCT02409342|Antibodies|antibodies|mesh-list
5650892|NCT02409342|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5826611|NCT02578719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5826612|NCT02578641|Gemcitabine|gemcitabine|mesh-list
5826613|NCT02578641|Carboplatin|carboplatin|mesh-list
5826614|NCT02578641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5826615|NCT02578641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5650893|NCT02409342|Immunologic Factors|immunologic factors|mesh-ancestor
5650894|NCT02409342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826616|NCT02578641|Antimetabolites|antimetabolites|mesh-ancestor
5826617|NCT02578641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826618|NCT02578641|Antiviral Agents|antiviral agents|mesh-ancestor
5826619|NCT02578641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5826620|NCT02578641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5826621|NCT02578641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5826622|NCT02578641|Immunologic Factors|immunologic factors|mesh-ancestor
5826623|NCT02578641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902182|NCT04969731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5902183|NCT04969731|Antiviral Agents|antiviral agents|mesh-ancestor
5902184|NCT04969731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5902185|NCT04969731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5902186|NCT04969731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5902187|NCT04969731|Immunologic Factors|immunologic factors|mesh-ancestor
5902188|NCT04969731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902189|NCT04965155|Dexamethasone|dexamethasone|mesh-list
5902190|NCT04965155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5902191|NCT04965155|Antiemetics|antiemetics|mesh-ancestor
5902192|NCT04965155|Autonomic Agents|autonomic agents|mesh-ancestor
5902193|NCT04965155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5650895|NCT02409342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5650896|NCT02409342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5650897|NCT02409342|Antimetabolites|antimetabolites|mesh-ancestor
5650898|NCT02409342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650899|NCT02409342|Antiviral Agents|antiviral agents|mesh-ancestor
5650900|NCT02409342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5650901|NCT02409342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5650902|NCT02409342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5650903|NCT02409342|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5650904|NCT02409342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5650905|NCT02394535|Paclitaxel|paclitaxel|mesh-list
5650906|NCT02394535|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5650907|NCT02394535|Capecitabine|capecitabine|mesh-list
5650908|NCT02394535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5650909|NCT02394535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5650910|NCT02394535|Tubulin Modulators|tubulin modulators|mesh-ancestor
5650911|NCT02394535|Antimitotic Agents|antimitotic agents|mesh-ancestor
5650912|NCT02394535|Mitosis Modulators|mitosis modulators|mesh-ancestor
5650913|NCT02394535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650914|NCT02394535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5650915|NCT02394535|Antimetabolites|antimetabolites|mesh-ancestor
5650916|NCT02385110|Dexamethasone|dexamethasone|mesh-list
5650917|NCT02385110|Methotrexate|methotrexate|mesh-list
5650918|NCT02385110|Etoposide|etoposide|mesh-list
5650919|NCT02385110|Alemtuzumab|alemtuzumab|mesh-list
5902194|NCT04965155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902195|NCT04965155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5902196|NCT04965155|Glucocorticoids|glucocorticoids|mesh-ancestor
5902197|NCT04965155|Hormones|hormones|mesh-ancestor
5902198|NCT04965155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5902199|NCT04965155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5902200|NCT04965155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5902201|NCT04955938|Ivosidenib|ivosidenib|mesh-list
5902202|NCT04955938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5902203|NCT04955938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5902204|NCT04955938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902205|NCT04930991|Omeprazole|omeprazole|mesh-list
5902206|NCT04930991|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5902207|NCT04930991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5902208|NCT04930991|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5902209|NCT04930991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5902210|NCT04930991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650920|NCT02385110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5650921|NCT02385110|Antiemetics|antiemetics|mesh-ancestor
5650922|NCT02385110|Autonomic Agents|autonomic agents|mesh-ancestor
5650923|NCT02385110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5650924|NCT02385110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650925|NCT02385110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5650926|NCT02385110|Glucocorticoids|glucocorticoids|mesh-ancestor
5650927|NCT02385110|Hormones|hormones|mesh-ancestor
5902211|NCT04928222|Doxorubicin|doxorubicin|mesh-list
5902212|NCT04928222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5902213|NCT04928222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5902214|NCT04928222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5694556|NCT03394989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826624|NCT02578602|Edetic Acid|edetic acid|mesh-list
5650928|NCT02385110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5650929|NCT02385110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5650930|NCT02385110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5650931|NCT02385110|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5650932|NCT02385110|Abortifacient Agents|abortifacient agents|mesh-ancestor
5650933|NCT02385110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5650934|NCT02385110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5650935|NCT02385110|Antimetabolites|antimetabolites|mesh-ancestor
5826625|NCT02578602|Pentetic Acid|pentetic acid|mesh-list
5826626|NCT02578602|Antidotes|antidotes|mesh-ancestor
5826627|NCT02578602|Protective Agents|protective agents|mesh-ancestor
5826628|NCT02578602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826629|NCT02578602|Chelating Agents|chelating agents|mesh-ancestor
5826630|NCT02578602|Sequestering Agents|sequestering agents|mesh-ancestor
5826631|NCT02578602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826632|NCT02578602|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5826633|NCT02578602|Anticoagulants|anticoagulants|mesh-ancestor
5650936|NCT02385110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650937|NCT02385110|Dermatologic Agents|dermatologic agents|mesh-ancestor
5650938|NCT02385110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5650939|NCT02385110|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5650940|NCT02385110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5650941|NCT02385110|Immunologic Factors|immunologic factors|mesh-ancestor
5650942|NCT02385110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5650943|NCT02385110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5650944|NCT02385110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5650945|NCT02385110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5650946|NCT02385110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5650947|NCT02385110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6493106|NCT00611936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493107|NCT00611962|Paclitaxel|paclitaxel|mesh-list
6493108|NCT00611962|Oxaliplatin|oxaliplatin|mesh-list
5650948|NCT02349217|Hydrocortisone|hydrocortisone|mesh-list
5650949|NCT02349217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5650950|NCT02337686|Pembrolizumab|pembrolizumab|mesh-list
5650951|NCT02337686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5826634|NCT02578602|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5826635|NCT02578550|Tenofovir|tenofovir|mesh-list
5826636|NCT02578550|Emtricitabine|emtricitabine|mesh-list
5826637|NCT02578550|Darunavir|darunavir|mesh-list
5826638|NCT02578550|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5826639|NCT02578550|Cobicistat|cobicistat|mesh-list
5826640|NCT02578550|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
5826641|NCT02578550|Antiviral Agents|antiviral agents|mesh-ancestor
5826642|NCT02578550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5826643|NCT02578550|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5826644|NCT02578550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5826645|NCT02578550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5826646|NCT02578550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826647|NCT02578550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5826648|NCT02578550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5826649|NCT02578550|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5826650|NCT02578550|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5826651|NCT02578550|Protease Inhibitors|protease inhibitors|mesh-ancestor
5826652|NCT02578550|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5826653|NCT02578550|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5826654|NCT02578251|Acetaminophen|acetaminophen|mesh-list
5826655|NCT02578251|Meperidine|meperidine|mesh-list
5826656|NCT02578251|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5826657|NCT02578251|Analgesics|analgesics|mesh-ancestor
5826658|NCT02578251|Sensory System Agents|sensory system agents|mesh-ancestor
5826659|NCT02578251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5826660|NCT02578251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826661|NCT02578251|Antipyretics|antipyretics|mesh-ancestor
5826662|NCT02578251|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5826663|NCT02578251|Narcotics|narcotics|mesh-ancestor
5826664|NCT02578251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5826665|NCT02578251|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5826666|NCT02578277|BMS-955176|bms-955176|mesh-list
5826667|NCT02578277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5826668|NCT02578277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5826669|NCT02578277|Antiviral Agents|antiviral agents|mesh-ancestor
5826670|NCT02578277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6493109|NCT00611962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5650952|NCT02337686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5650953|NCT02316834|Talazoparib|talazoparib|mesh-list
5650954|NCT02316834|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5826671|NCT02578537|Clopidogrel|clopidogrel|mesh-list
5826672|NCT02578537|Ticagrelor|ticagrelor|mesh-list
5826673|NCT02578537|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5826674|NCT02578537|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5826675|NCT02578537|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5826676|NCT02578537|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5650955|NCT02316834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5650956|NCT02316834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650957|NCT02316834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5650958|NCT02293655|Methylphenidate|methylphenidate|mesh-list
5650959|NCT02293655|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5650960|NCT02293655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650961|NCT02293655|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5650962|NCT02293655|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5650963|NCT02293655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5650964|NCT02293655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650965|NCT02293655|Dopamine Agents|dopamine agents|mesh-ancestor
5650966|NCT02293655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5694557|NCT03394989|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5694558|NCT03394989|Respiratory System Agents|respiratory system agents|mesh-ancestor
5694559|NCT03394989|Dermatologic Agents|dermatologic agents|mesh-ancestor
5694560|NCT03394989|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5694561|NCT03394989|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5694562|NCT03394989|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5694563|NCT03394989|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5694564|NCT03394989|Adrenergic Agents|adrenergic agents|mesh-ancestor
5694565|NCT03394989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5694566|NCT03394989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694567|NCT03394989|Glucocorticoids|glucocorticoids|mesh-ancestor
5694568|NCT03394989|Hormones|hormones|mesh-ancestor
5694569|NCT03394989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5694570|NCT03394989|Sympathomimetics|sympathomimetics|mesh-ancestor
5694571|NCT03394950|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5694572|NCT03394950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5694573|NCT03394950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5694574|NCT03394950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694575|NCT03394833|Polygeline|polygeline|mesh-list
5694576|NCT03394833|Plasma Substitutes|plasma substitutes|mesh-ancestor
5694577|NCT03394833|Blood Substitutes|blood substitutes|mesh-ancestor
5694578|NCT03394820|Dexamethasone|dexamethasone|mesh-list
5694579|NCT03394820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5694580|NCT03394820|Antiemetics|antiemetics|mesh-ancestor
5694581|NCT03394820|Autonomic Agents|autonomic agents|mesh-ancestor
5694582|NCT03394820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5694583|NCT03394820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694584|NCT03394820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5826677|NCT02578537|Purinergic Agents|purinergic agents|mesh-ancestor
5826678|NCT02578537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5826679|NCT02578537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826680|NCT02578537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826681|NCT02578472|Zolpidem|zolpidem|mesh-list
5826682|NCT02578472|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5826683|NCT02578472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5826684|NCT02578472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5826685|NCT02578472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826686|NCT02578472|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
5826687|NCT02578472|GABA Agonists|gaba agonists|mesh-ancestor
5826688|NCT02578472|GABA Agents|gaba agents|mesh-ancestor
5826689|NCT02578472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5826690|NCT02578472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826691|NCT02578511|Ixazomib|ixazomib|mesh-list
5826692|NCT02578511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5826693|NCT02578511|Protease Inhibitors|protease inhibitors|mesh-ancestor
5826694|NCT02578511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5694585|NCT03394820|Glucocorticoids|glucocorticoids|mesh-ancestor
5694586|NCT03394820|Hormones|hormones|mesh-ancestor
5694587|NCT03394820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5694588|NCT03394820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5826695|NCT02578511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650967|NCT02275546|NuvaRing|nuvaring|mesh-list
5826696|NCT02578368|Leucovorin|leucovorin|mesh-list
5826697|NCT02578368|Docetaxel|docetaxel|mesh-list
5650968|NCT02275546|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5650969|NCT02275546|Desogestrel|desogestrel|mesh-list
5650970|NCT02275546|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5650971|NCT02275546|Contraceptive Agents|contraceptive agents|mesh-ancestor
5650972|NCT02275546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5650973|NCT02275546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5650974|NCT02275546|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5650975|NCT02275546|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5650976|NCT02275546|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5650977|NCT02275546|Estrogens|estrogens|mesh-ancestor
5650978|NCT02275546|Hormones|hormones|mesh-ancestor
5650979|NCT02275546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5650980|NCT02275546|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5650981|NCT02275546|Progestins|progestins|mesh-ancestor
5650982|NCT02264678|Carboplatin|carboplatin|mesh-list
5650983|NCT02264678|Durvalumab|durvalumab|mesh-list
5650984|NCT02264678|Olaparib|olaparib|mesh-list
5650985|NCT02264678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5650986|NCT02264678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5650987|NCT02264678|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6674465|NCT01569633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6674466|NCT01569633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6674467|NCT01569633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6674468|NCT01569633|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5650988|NCT02264678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6211698|NCT02176031|Prednisolone phosphate|prednisolone phosphate|mesh-list
6211699|NCT02176031|Natalizumab|natalizumab|mesh-list
6211700|NCT02176031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6211701|NCT02176031|Antiemetics|antiemetics|mesh-ancestor
6211702|NCT02176031|Autonomic Agents|autonomic agents|mesh-ancestor
6211703|NCT02176031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6211704|NCT02176031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211705|NCT02176031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6211706|NCT02176031|Glucocorticoids|glucocorticoids|mesh-ancestor
6211707|NCT02176031|Hormones|hormones|mesh-ancestor
6211708|NCT02176031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6211709|NCT02176031|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6211710|NCT02176031|Protective Agents|protective agents|mesh-ancestor
6211711|NCT02176031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6211712|NCT02176031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6211713|NCT02176031|Immunologic Factors|immunologic factors|mesh-ancestor
6211714|NCT02176291|Buprenorphine|buprenorphine|mesh-list
6211715|NCT02176291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5650989|NCT02264678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826698|NCT02578368|Fluorouracil|fluorouracil|mesh-list
5650990|NCT02131597|Guadecitabine|guadecitabine|mesh-list
5826699|NCT02578368|Oxaliplatin|oxaliplatin|mesh-list
5826700|NCT02578368|Trastuzumab|trastuzumab|mesh-list
5826701|NCT02578368|Levoleucovorin|levoleucovorin|mesh-list
5826702|NCT02578368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5826703|NCT02578368|Tubulin Modulators|tubulin modulators|mesh-ancestor
5826704|NCT02578368|Antimitotic Agents|antimitotic agents|mesh-ancestor
5826705|NCT02578368|Mitosis Modulators|mitosis modulators|mesh-ancestor
5826706|NCT02578368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826707|NCT02578368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826708|NCT02578368|Antimetabolites|antimetabolites|mesh-ancestor
5826709|NCT02578368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5826710|NCT02578368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5826711|NCT02578368|Immunologic Factors|immunologic factors|mesh-ancestor
5826712|NCT02578368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5826713|NCT02578368|Antidotes|antidotes|mesh-ancestor
5826714|NCT02578368|Protective Agents|protective agents|mesh-ancestor
5650991|NCT02131597|Azacitidine|azacitidine|mesh-list
5650992|NCT02131597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5650993|NCT02131597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5650994|NCT02131597|Antimetabolites|antimetabolites|mesh-ancestor
5650995|NCT02131597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5650996|NCT02131597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5650997|NCT02077166|Rituximab|rituximab|mesh-list
5650998|NCT02077166|Lenalidomide|lenalidomide|mesh-list
5650999|NCT02077166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5826715|NCT02578368|Vitamin B Complex|vitamin b complex|mesh-ancestor
5826716|NCT02578368|Vitamins|vitamins|mesh-ancestor
5826717|NCT02578368|Micronutrients|micronutrients|mesh-ancestor
5826718|NCT02578043|Clindamycin|clindamycin|mesh-list
5826719|NCT02578043|Clindamycin palmitate|clindamycin palmitate|mesh-list
5826720|NCT02578043|Clindamycin phosphate|clindamycin phosphate|mesh-list
5826721|NCT02578043|Benzoyl Peroxide|benzoyl peroxide|mesh-list
5826722|NCT02578043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5826723|NCT02578043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5826724|NCT02578043|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5826725|NCT02578043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5826726|NCT02578043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826727|NCT02578043|Dermatologic Agents|dermatologic agents|mesh-ancestor
5826728|NCT02578108|Lidocaine|lidocaine|mesh-list
5826729|NCT02578108|Anesthetics, Local|anesthetics, local|mesh-list
5826730|NCT02578108|Anesthetics|anesthetics|mesh-list
5826731|NCT02578108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5826732|NCT02578108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826733|NCT02578108|Sensory System Agents|sensory system agents|mesh-ancestor
5826734|NCT02578108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5826735|NCT02578108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5826736|NCT02578108|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5826737|NCT02578108|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5826738|NCT02578108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5826739|NCT02578108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826740|NCT02577965|Everolimus|everolimus|mesh-list
5826741|NCT02577965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5826742|NCT02577965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5826743|NCT02577965|Immunologic Factors|immunologic factors|mesh-ancestor
5826744|NCT02577965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826745|NCT02578121|Dexamethasone|dexamethasone|mesh-list
5826746|NCT02578121|Pomalidomide|pomalidomide|mesh-list
5826747|NCT02578121|Ixazomib|ixazomib|mesh-list
5826748|NCT02578121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5826749|NCT02578121|Antiemetics|antiemetics|mesh-ancestor
5826750|NCT02578121|Autonomic Agents|autonomic agents|mesh-ancestor
5826751|NCT02578121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5826752|NCT02578121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826753|NCT02578121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5826754|NCT02578121|Glucocorticoids|glucocorticoids|mesh-ancestor
5826755|NCT02578121|Hormones|hormones|mesh-ancestor
5826756|NCT02578121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5826757|NCT02578121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5826758|NCT02578121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5826759|NCT02578121|Immunologic Factors|immunologic factors|mesh-ancestor
5826760|NCT02578121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5826761|NCT02578121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5826762|NCT02578121|Growth Substances|growth substances|mesh-ancestor
5826763|NCT02578121|Growth Inhibitors|growth inhibitors|mesh-ancestor
5826764|NCT02578121|Protease Inhibitors|protease inhibitors|mesh-ancestor
5826765|NCT02578121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5826766|NCT02578121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826767|NCT02577848|Liraglutide|liraglutide|mesh-list
5826768|NCT02577848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5826769|NCT02577848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826770|NCT02577848|Incretins|incretins|mesh-ancestor
5826771|NCT02577848|Hormones|hormones|mesh-ancestor
5826772|NCT02577848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5826773|NCT02577809|Indomethacin|indomethacin|mesh-list
5651000|NCT02077166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5651001|NCT02077166|Immunologic Factors|immunologic factors|mesh-ancestor
5651002|NCT02077166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651003|NCT02077166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5651004|NCT02077166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5826774|NCT02577809|Fentanyl|fentanyl|mesh-list
5826775|NCT02577809|Morphine|morphine|mesh-list
5826776|NCT02577809|Bupivacaine|bupivacaine|mesh-list
5826777|NCT02577809|Anesthetics, Local|anesthetics, local|mesh-ancestor
5651005|NCT02077166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5651006|NCT02077166|Growth Substances|growth substances|mesh-ancestor
5651007|NCT02077166|Growth Inhibitors|growth inhibitors|mesh-ancestor
5651008|NCT02027935|Aldesleukin|aldesleukin|mesh-list
5651009|NCT02027935|Cyclophosphamide|cyclophosphamide|mesh-list
5651010|NCT02027935|Ipilimumab|ipilimumab|mesh-list
5651011|NCT02027935|Interleukin-2|interleukin-2|mesh-list
5651012|NCT02027935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5651013|NCT02027935|Immunologic Factors|immunologic factors|mesh-ancestor
5651014|NCT02027935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651015|NCT02027935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5826778|NCT02577809|Anesthetics|anesthetics|mesh-ancestor
5826779|NCT02577809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5651016|NCT02027935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5651017|NCT02027935|Alkylating Agents|alkylating agents|mesh-ancestor
5651018|NCT02027935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5651019|NCT02027935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5826780|NCT02577809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826781|NCT02577809|Sensory System Agents|sensory system agents|mesh-ancestor
5826782|NCT02577809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5826783|NCT02577809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5826784|NCT02577809|Narcotics|narcotics|mesh-ancestor
5826785|NCT02577809|Analgesics|analgesics|mesh-ancestor
5826786|NCT02577809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5826787|NCT02577809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5826788|NCT02577809|Anesthetics, General|anesthetics, general|mesh-ancestor
5826789|NCT02577809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5826790|NCT02577809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5826791|NCT02577809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5826792|NCT02577809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5826793|NCT02577809|Gout Suppressants|gout suppressants|mesh-ancestor
5826794|NCT02577809|Tocolytic Agents|tocolytic agents|mesh-ancestor
5826795|NCT02577809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5826796|NCT02577809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5826797|NCT02577809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5826798|NCT02577809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826799|NCT02577783|Dexamethasone|dexamethasone|mesh-list
5826800|NCT02577783|Dexamethasone acetate|dexamethasone acetate|mesh-list
5826801|NCT02577783|Doxorubicin|doxorubicin|mesh-list
5826802|NCT02577783|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5826803|NCT02577783|BB 1101|bb 1101|mesh-list
5826804|NCT02577783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5826805|NCT02577783|Antiemetics|antiemetics|mesh-ancestor
5826806|NCT02577783|Autonomic Agents|autonomic agents|mesh-ancestor
5826807|NCT02577783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5826808|NCT02577783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826809|NCT02577783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5826810|NCT02577783|Glucocorticoids|glucocorticoids|mesh-ancestor
5826811|NCT02577783|Hormones|hormones|mesh-ancestor
5826812|NCT02577783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5826813|NCT02577783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5826814|NCT02577783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5826815|NCT02577783|Protease Inhibitors|protease inhibitors|mesh-ancestor
5651020|NCT02027935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5651021|NCT02027935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5651022|NCT02027935|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5651023|NCT02027935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5651024|NCT02027935|Analgesics|analgesics|mesh-ancestor
5651025|NCT02027935|Sensory System Agents|sensory system agents|mesh-ancestor
5651026|NCT02027935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5651027|NCT02027935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5651028|NCT02027935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5651029|NCT02027935|Antiviral Agents|antiviral agents|mesh-ancestor
5651030|NCT02027935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5651031|NCT01965132|Adalimumab|adalimumab|mesh-list
5651032|NCT01965132|Etanercept|etanercept|mesh-list
5651033|NCT01965132|Golimumab|golimumab|mesh-list
5651034|NCT01965132|Abatacept|abatacept|mesh-list
5651035|NCT01965132|Infliximab|infliximab|mesh-list
5651036|NCT01965132|Upadacitinib|upadacitinib|mesh-list
5651037|NCT01965132|Ustekinumab|ustekinumab|mesh-list
5651038|NCT01965132|Ixekizumab|ixekizumab|mesh-list
5651039|NCT01965132|Tofacitinib|tofacitinib|mesh-list
5651040|NCT01965132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5651041|NCT01965132|Immunologic Factors|immunologic factors|mesh-ancestor
5826816|NCT02577783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5826817|NCT02577783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826818|NCT02577783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5651042|NCT01965132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651043|NCT01965132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5651044|NCT01965132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5651045|NCT01965132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5651046|NCT01965132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5651047|NCT01965132|Analgesics|analgesics|mesh-ancestor
5651048|NCT01965132|Sensory System Agents|sensory system agents|mesh-ancestor
5651049|NCT01965132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5651050|NCT01965132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5651051|NCT01965132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5826819|NCT02577783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5651052|NCT01965132|Dermatologic Agents|dermatologic agents|mesh-ancestor
5826820|NCT02577783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5826821|NCT02577523|Levodopa|levodopa|mesh-list
5826822|NCT02577523|Carbidopa|carbidopa|mesh-list
5826823|NCT02577523|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5826824|NCT02577523|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5826825|NCT02577523|Dopamine Agents|dopamine agents|mesh-ancestor
5826826|NCT02577523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5826827|NCT02577523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826828|NCT02577523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826829|NCT02577523|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5651053|NCT01965132|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5651054|NCT01965132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5651055|NCT01965132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5651056|NCT01965132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5651057|NCT01965132|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
5651058|NCT01965132|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
5651059|NCT01891344|Rucaparib|rucaparib|mesh-list
5651060|NCT01891344|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5651061|NCT01891344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5651062|NCT01891344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5651063|NCT01891344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5651064|NCT01847274|Niraparib|niraparib|mesh-list
5651065|NCT01847274|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5651066|NCT01847274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5651067|NCT01847274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5651068|NCT01847274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5651069|NCT01764191|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5651070|NCT01764191|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5826830|NCT02577523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5826831|NCT02577575|Oxytocin|oxytocin|mesh-list
5826832|NCT02577575|Oxytocics|oxytocics|mesh-ancestor
5826833|NCT02577575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5826834|NCT02577575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651071|NCT01764191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5651072|NCT01670656|Ibuprofen|ibuprofen|mesh-list
5651073|NCT01670656|Contraceptive Agents|contraceptive agents|mesh-list
5651074|NCT01670656|Etonogestrel|etonogestrel|mesh-list
5826835|NCT02577614|Coagulants|coagulants|mesh-list
5826836|NCT02577614|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
5826837|NCT02577458|Everolimus|everolimus|mesh-list
5826838|NCT02577458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5826839|NCT02577458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5826840|NCT02577458|Immunologic Factors|immunologic factors|mesh-ancestor
5826841|NCT02577458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826842|NCT02577341|Docetaxel|docetaxel|mesh-list
5826843|NCT02577341|Nimotuzumab|nimotuzumab|mesh-list
5826844|NCT02577341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5826845|NCT02577341|Tubulin Modulators|tubulin modulators|mesh-ancestor
5826846|NCT02577341|Antimitotic Agents|antimitotic agents|mesh-ancestor
5826847|NCT02577341|Mitosis Modulators|mitosis modulators|mesh-ancestor
5826848|NCT02577341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826849|NCT02577341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5826850|NCT02577497|Fluticasone|fluticasone|mesh-list
5826851|NCT02577497|Beclomethasone|beclomethasone|mesh-list
5826852|NCT02577497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5826853|NCT02577497|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5826854|NCT02577497|Autonomic Agents|autonomic agents|mesh-ancestor
5826855|NCT02577497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5826856|NCT02577497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826857|NCT02577497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5826858|NCT02577497|Respiratory System Agents|respiratory system agents|mesh-ancestor
5826859|NCT02577497|Dermatologic Agents|dermatologic agents|mesh-ancestor
5826860|NCT02577497|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5826861|NCT02577497|Glucocorticoids|glucocorticoids|mesh-ancestor
5826862|NCT02577497|Hormones|hormones|mesh-ancestor
5826863|NCT02577497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5826864|NCT02577393|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
5826865|NCT02577393|Antioxidants|antioxidants|mesh-ancestor
5826866|NCT02577393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826867|NCT02577393|Protective Agents|protective agents|mesh-ancestor
5826868|NCT02577393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826869|NCT02577393|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
5826870|NCT02577393|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5826871|NCT02577393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5826872|NCT02577393|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5826873|NCT02577770|Caffeine|caffeine|mesh-list
5826874|NCT02577770|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5826875|NCT02577770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826876|NCT02577770|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5826877|NCT02577770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5651075|NCT01670656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5651076|NCT01670656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5651077|NCT01670656|Analgesics|analgesics|mesh-ancestor
5651078|NCT01670656|Sensory System Agents|sensory system agents|mesh-ancestor
5651079|NCT01670656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5651080|NCT01670656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651081|NCT01670656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5651082|NCT01670656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5651083|NCT01670656|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5651084|NCT01670656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5651085|NCT01670656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5651086|NCT01670656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5651087|NCT01670656|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5826878|NCT02577770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826879|NCT02577770|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5826880|NCT02577770|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5826881|NCT02577770|Purinergic Agents|purinergic agents|mesh-ancestor
5826882|NCT02577770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5826883|NCT02577432|Fentanyl|fentanyl|mesh-list
5826884|NCT02577432|Bupivacaine|bupivacaine|mesh-list
5826885|NCT02577432|Anesthetics, Local|anesthetics, local|mesh-ancestor
5826886|NCT02577432|Anesthetics|anesthetics|mesh-ancestor
5826887|NCT02577432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5826888|NCT02577432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826889|NCT02577432|Sensory System Agents|sensory system agents|mesh-ancestor
5826890|NCT02577432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5826891|NCT02577432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5826892|NCT02577432|Narcotics|narcotics|mesh-ancestor
5651088|NCT01670656|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5651089|NCT01648751|Estrogens|estrogens|mesh-list
5651090|NCT01648751|Hormones|hormones|mesh-ancestor
5651091|NCT01648751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5651092|NCT01648751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211716|NCT02176291|Narcotics|narcotics|mesh-ancestor
6211717|NCT02176291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5651095|NCT01498770|Olanzapine|olanzapine|mesh-list
5651096|NCT01498770|Risperidone|risperidone|mesh-list
5651097|NCT01498770|Quetiapine Fumarate|quetiapine fumarate|mesh-list
5651098|NCT01498770|Aripiprazole|aripiprazole|mesh-list
5651099|NCT01498770|Paliperidone Palmitate|paliperidone palmitate|mesh-list
5651100|NCT01498770|Ziprasidone|ziprasidone|mesh-list
5826893|NCT02577432|Analgesics|analgesics|mesh-ancestor
5826894|NCT02577432|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5826895|NCT02577432|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5826896|NCT02577432|Anesthetics, General|anesthetics, general|mesh-ancestor
5826897|NCT02577250|Ketamine|ketamine|mesh-list
5826898|NCT02577250|Analgesics|analgesics|mesh-ancestor
5826899|NCT02577250|Sensory System Agents|sensory system agents|mesh-ancestor
5826900|NCT02577250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5826901|NCT02577250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826902|NCT02577250|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5826903|NCT02577250|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5826904|NCT02577250|Anesthetics, General|anesthetics, general|mesh-ancestor
5826905|NCT02577250|Anesthetics|anesthetics|mesh-ancestor
5826906|NCT02577250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5826907|NCT02577250|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5826908|NCT02577250|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5826909|NCT02577250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5826910|NCT02577250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826911|NCT02577120|Decanoic acid|decanoic acid|mesh-list
5826912|NCT02577120|Petrolatum|petrolatum|mesh-list
5826913|NCT02577120|Emollients|emollients|mesh-ancestor
5826914|NCT02577120|Dermatologic Agents|dermatologic agents|mesh-ancestor
5826915|NCT02577120|Antifungal Agents|antifungal agents|mesh-ancestor
5826916|NCT02577120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5826917|NCT02577185|Botulinum Toxins|botulinum toxins|mesh-list
5826918|NCT02577185|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5826919|NCT02577185|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5826920|NCT02577185|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5826921|NCT02577185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6674469|NCT01569633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5826922|NCT02577185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826923|NCT02577185|Cholinergic Agents|cholinergic agents|mesh-ancestor
5826924|NCT02577185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5826925|NCT02577185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826926|NCT02577185|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5826927|NCT02577185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5826928|NCT02576964|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5826929|NCT02576964|Capecitabine|capecitabine|mesh-list
5826930|NCT02576964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5826931|NCT02576964|Antimetabolites|antimetabolites|mesh-ancestor
5826932|NCT02576964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826933|NCT02576964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5826934|NCT02576964|Antiviral Agents|antiviral agents|mesh-ancestor
5826935|NCT02576964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5826936|NCT02576782|Dexamethasone|dexamethasone|mesh-list
5826937|NCT02576782|Dexamethasone acetate|dexamethasone acetate|mesh-list
5826938|NCT02576782|Bupivacaine|bupivacaine|mesh-list
5826939|NCT02576782|BB 1101|bb 1101|mesh-list
5826940|NCT02576782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5826941|NCT02576782|Antiemetics|antiemetics|mesh-ancestor
5826942|NCT02576782|Autonomic Agents|autonomic agents|mesh-ancestor
5826943|NCT02576782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5826944|NCT02576782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826945|NCT02576782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5826946|NCT02576782|Glucocorticoids|glucocorticoids|mesh-ancestor
5826947|NCT02576782|Hormones|hormones|mesh-ancestor
5826948|NCT02576782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5826949|NCT02576782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5826950|NCT02576782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5826951|NCT02576782|Protease Inhibitors|protease inhibitors|mesh-ancestor
5826952|NCT02576782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5826953|NCT02576782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826954|NCT02576782|Anesthetics, Local|anesthetics, local|mesh-ancestor
5826955|NCT02576782|Anesthetics|anesthetics|mesh-ancestor
5826956|NCT02576782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5826957|NCT02576782|Sensory System Agents|sensory system agents|mesh-ancestor
5826958|NCT02577094|Fludarabine|fludarabine|mesh-list
5826959|NCT02577094|Busulfan|busulfan|mesh-list
5826960|NCT02577094|Epratuzumab|epratuzumab|mesh-list
5826961|NCT02577094|Thymoglobulin|thymoglobulin|mesh-list
5826962|NCT02577094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5826963|NCT02577094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826964|NCT02577094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5826965|NCT02577094|Immunologic Factors|immunologic factors|mesh-ancestor
5826966|NCT02577094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826967|NCT02577094|Alkylating Agents|alkylating agents|mesh-ancestor
5826968|NCT02577094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5826969|NCT02577094|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5826970|NCT02577094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5826971|NCT02577068|Propacetamol|propacetamol|mesh-list
5826972|NCT02577068|Nefopam|nefopam|mesh-list
5826973|NCT02577068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5826974|NCT02577068|Analgesics|analgesics|mesh-ancestor
5826975|NCT02577068|Sensory System Agents|sensory system agents|mesh-ancestor
5826976|NCT02577068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5826977|NCT02577068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826978|NCT02577068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5826979|NCT02577068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5826980|NCT02577068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5826981|NCT02577159|Dapagliflozin|dapagliflozin|mesh-list
5826982|NCT02577159|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5826983|NCT02577159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826984|NCT02577159|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5826985|NCT02577159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902215|NCT04928222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5902216|NCT04928222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5902217|NCT04928222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902218|NCT04898894|Vidarabine|vidarabine|mesh-list
5902219|NCT04898894|Cytarabine|cytarabine|mesh-list
5902220|NCT04898894|Hydrocortisone|hydrocortisone|mesh-list
5902221|NCT04898894|Methotrexate|methotrexate|mesh-list
5902222|NCT04898894|Fludarabine phosphate|fludarabine phosphate|mesh-list
5902223|NCT04898894|Fludarabine|fludarabine|mesh-list
5902224|NCT04898894|Venetoclax|venetoclax|mesh-list
5902225|NCT04898894|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5902226|NCT04898894|Abortifacient Agents|abortifacient agents|mesh-ancestor
5651101|NCT01498770|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
5826986|NCT02576912|Dronabinol|dronabinol|mesh-list
5826987|NCT02576912|Hallucinogens|hallucinogens|mesh-ancestor
5826988|NCT02576912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5826989|NCT02576912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5826990|NCT02576912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5826991|NCT02576912|Analgesics|analgesics|mesh-ancestor
5651102|NCT01498770|Clozapine|clozapine|mesh-list
5651103|NCT01498770|Asenapine|asenapine|mesh-list
5651104|NCT01498770|Amisulpride|amisulpride|mesh-list
5826992|NCT02576912|Sensory System Agents|sensory system agents|mesh-ancestor
5826993|NCT02576912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5826994|NCT02576912|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5651105|NCT01498770|Iloperidone|iloperidone|mesh-list
5651106|NCT01498770|Sertindole|sertindole|mesh-list
5651107|NCT01498770|Zotepine|zotepine|mesh-list
5826995|NCT02576912|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5826996|NCT02576912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5826997|NCT02576912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5826998|NCT02576912|Hormones|hormones|mesh-ancestor
5826999|NCT02576912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5651108|NCT01498770|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5651109|NCT01498770|Serotonin Agents|serotonin agents|mesh-ancestor
5651110|NCT01498770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5651111|NCT01498770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5651112|NCT01498770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651113|NCT01498770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5651114|NCT01498770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5651115|NCT01498770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5651116|NCT01498770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5827000|NCT02576808|Loratadine|loratadine|mesh-list
5827001|NCT02576808|Antipruritics|antipruritics|mesh-ancestor
5827002|NCT02576808|Dermatologic Agents|dermatologic agents|mesh-ancestor
5827003|NCT02576808|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5827004|NCT02576808|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5827005|NCT02576808|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5827006|NCT02576808|Histamine Antagonists|histamine antagonists|mesh-ancestor
5827007|NCT02576808|Histamine Agents|histamine agents|mesh-ancestor
5827008|NCT02576808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5827009|NCT02576808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5827010|NCT02576808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827011|NCT02576717|Ozanimod|ozanimod|mesh-list
5827012|NCT02576717|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5827013|NCT02576717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5827014|NCT02576717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5827015|NCT02576717|Immunologic Factors|immunologic factors|mesh-ancestor
5827016|NCT02576717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651117|NCT01498770|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5651118|NCT01498770|Dopamine Agents|dopamine agents|mesh-ancestor
5651119|NCT01498770|Antiemetics|antiemetics|mesh-ancestor
5651120|NCT01498770|Autonomic Agents|autonomic agents|mesh-ancestor
5651121|NCT01498770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5651122|NCT01498770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5651123|NCT01498770|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5651124|NCT01498770|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5651125|NCT01498770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5651126|NCT01498770|Antidepressive Agents|antidepressive agents|mesh-ancestor
5827017|NCT02576626|Glycopyrrolate|glycopyrrolate|mesh-list
5827018|NCT02576626|Albuterol|albuterol|mesh-list
5827019|NCT02576626|Ipratropium|ipratropium|mesh-list
5827020|NCT02576626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5827021|NCT02576626|Autonomic Agents|autonomic agents|mesh-ancestor
5827022|NCT02576626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5827023|NCT02576626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827024|NCT02576626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5827025|NCT02576626|Respiratory System Agents|respiratory system agents|mesh-ancestor
5827026|NCT02576626|Tocolytic Agents|tocolytic agents|mesh-ancestor
5827027|NCT02576626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5827028|NCT02576626|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5827029|NCT02576626|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5827030|NCT02576626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5827031|NCT02576626|Adrenergic Agents|adrenergic agents|mesh-ancestor
5827032|NCT02576626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5827033|NCT02576626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5651127|NCT01498770|Dopamine Agonists|dopamine agonists|mesh-ancestor
5827034|NCT02576626|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5827035|NCT02576626|Cholinergic Agents|cholinergic agents|mesh-ancestor
5827036|NCT02576626|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5827037|NCT02576626|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6493110|NCT00611962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6493111|NCT00611962|Tubulin Modulators|tubulin modulators|mesh-ancestor
6493112|NCT00611962|Antimitotic Agents|antimitotic agents|mesh-ancestor
5651128|NCT01498770|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5651129|NCT01498770|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5651130|NCT01498770|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5651131|NCT01498770|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5651132|NCT01498770|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5651133|NCT01498770|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5651134|NCT01498770|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5651135|NCT01498770|Adrenergic Agents|adrenergic agents|mesh-ancestor
6493113|NCT00611962|Mitosis Modulators|mitosis modulators|mesh-ancestor
6493114|NCT00611962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496438|NCT00627991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496439|NCT00628043|Epoetin Alfa|epoetin alfa|mesh-list
5827038|NCT02576665|Flucytosine|flucytosine|mesh-list
5827039|NCT02576665|Antifungal Agents|antifungal agents|mesh-ancestor
5827040|NCT02576665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5827041|NCT02576665|Antimetabolites|antimetabolites|mesh-ancestor
5827042|NCT02576665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5827043|NCT02576600|Remifentanil|remifentanil|mesh-list
5827044|NCT02576600|Propofol|propofol|mesh-list
5827045|NCT02576600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5827046|NCT02576600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5827047|NCT02576600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827048|NCT02576600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5827049|NCT02576600|Anesthetics, General|anesthetics, general|mesh-ancestor
5827050|NCT02576600|Anesthetics|anesthetics|mesh-ancestor
5827051|NCT02576600|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5827052|NCT02576600|Narcotics|narcotics|mesh-ancestor
5827053|NCT02576600|Analgesics|analgesics|mesh-ancestor
5827054|NCT02576600|Sensory System Agents|sensory system agents|mesh-ancestor
5827055|NCT02576600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5827056|NCT02576457|BMS-936559|bms-936559|mesh-list
5827057|NCT02576457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5827058|NCT02576457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5827059|NCT02576444|Olaparib|olaparib|mesh-list
5827060|NCT02576444|Adavosertib|adavosertib|mesh-list
5827061|NCT02576444|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5827062|NCT02576444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5827063|NCT02576444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5827064|NCT02576444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5827065|NCT02576353|Fentanyl|fentanyl|mesh-list
5827066|NCT02576353|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5651136|NCT01498770|GABA Antagonists|gaba antagonists|mesh-ancestor
5827067|NCT02576353|Narcotics|narcotics|mesh-ancestor
5827068|NCT02576353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5827069|NCT02576353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827070|NCT02576353|Analgesics|analgesics|mesh-ancestor
5827071|NCT02576353|Sensory System Agents|sensory system agents|mesh-ancestor
5651137|NCT01498770|GABA Agents|gaba agents|mesh-ancestor
5651138|NCT01498770|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5651139|NCT01335399|Dexamethasone|dexamethasone|mesh-list
5651140|NCT01335399|Dexamethasone acetate|dexamethasone acetate|mesh-list
5651141|NCT01335399|Lenalidomide|lenalidomide|mesh-list
5651142|NCT01335399|Elotuzumab|elotuzumab|mesh-list
5827072|NCT02576353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5827073|NCT02576353|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5827074|NCT02576353|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5827075|NCT02576353|Anesthetics, General|anesthetics, general|mesh-ancestor
5827076|NCT02576353|Anesthetics|anesthetics|mesh-ancestor
5827077|NCT02576340|Octylonium|octylonium|mesh-list
5827078|NCT02576340|Bromides|bromides|mesh-list
5827079|NCT02576340|Anticonvulsants|anticonvulsants|mesh-ancestor
5827080|NCT02576340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5827081|NCT02576340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5827082|NCT02576340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5827083|NCT02576340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5827084|NCT02576340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827085|NCT02576340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5827086|NCT02576340|Parasympatholytics|parasympatholytics|mesh-ancestor
6496440|NCT00628043|Hematinics|hematinics|mesh-ancestor
6674470|NCT01569633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674471|NCT01569659|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
6674472|NCT01569659|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6674473|NCT01569659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6674474|NCT01569659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6674475|NCT01569659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674476|NCT01569659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5827087|NCT02576340|Autonomic Agents|autonomic agents|mesh-ancestor
5827088|NCT02576340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5827089|NCT02576340|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5827090|NCT02576340|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5827091|NCT02576340|Cholinergic Agents|cholinergic agents|mesh-ancestor
5827092|NCT02576340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5827093|NCT02576314|Sofosbuvir|sofosbuvir|mesh-list
5827094|NCT02576314|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
5827095|NCT02576314|Ledipasvir|ledipasvir|mesh-list
5827096|NCT02576314|Antiviral Agents|antiviral agents|mesh-ancestor
5827097|NCT02576314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5827098|NCT02576301|Cytarabine|cytarabine|mesh-list
5827099|NCT02576301|Combretastatin|combretastatin|mesh-list
5827100|NCT02576301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5827101|NCT02576301|Antimetabolites|antimetabolites|mesh-ancestor
5827102|NCT02576301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5827103|NCT02576301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5651143|NCT01335399|BB 1101|bb 1101|mesh-list
5651144|NCT01335399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5651145|NCT01335399|Antiemetics|antiemetics|mesh-ancestor
5651146|NCT01335399|Autonomic Agents|autonomic agents|mesh-ancestor
5651147|NCT01335399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5651148|NCT01335399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651149|NCT01335399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5651150|NCT01335399|Glucocorticoids|glucocorticoids|mesh-ancestor
5651151|NCT01335399|Hormones|hormones|mesh-ancestor
5651152|NCT01335399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5651153|NCT01335399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5651154|NCT01335399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5651155|NCT01335399|Protease Inhibitors|protease inhibitors|mesh-ancestor
5651156|NCT01335399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5651157|NCT01335399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5651158|NCT01335399|Immunologic Factors|immunologic factors|mesh-ancestor
5651159|NCT01335399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5651160|NCT01335399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5651161|NCT01335399|Growth Substances|growth substances|mesh-ancestor
5651162|NCT01335399|Growth Inhibitors|growth inhibitors|mesh-ancestor
5827104|NCT02576301|Antiviral Agents|antiviral agents|mesh-ancestor
5827105|NCT02576301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5827106|NCT02576301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5827107|NCT02576301|Immunologic Factors|immunologic factors|mesh-ancestor
5827108|NCT02576301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827109|NCT02576301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5827110|NCT02576301|Tubulin Modulators|tubulin modulators|mesh-ancestor
5827111|NCT02576301|Antimitotic Agents|antimitotic agents|mesh-ancestor
5827112|NCT02576301|Mitosis Modulators|mitosis modulators|mesh-ancestor
5827113|NCT02576288|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5827114|NCT02576288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5827115|NCT02576288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827116|NCT02576288|Incretins|incretins|mesh-ancestor
5827117|NCT02576288|Hormones|hormones|mesh-ancestor
5827118|NCT02576288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5827119|NCT02576288|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5827120|NCT02576288|Protease Inhibitors|protease inhibitors|mesh-ancestor
5827121|NCT02576288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5827122|NCT02576288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5827123|NCT02576275|Rituximab|rituximab|mesh-list
5827124|NCT02576275|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5827125|NCT02576275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5827126|NCT02576275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5827127|NCT02576275|Immunologic Factors|immunologic factors|mesh-ancestor
5827128|NCT02576275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827129|NCT02576275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5827130|NCT02576275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5827131|NCT02576275|Alkylating Agents|alkylating agents|mesh-ancestor
5827132|NCT02576275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5827133|NCT02576223|Ropivacaine|ropivacaine|mesh-list
5827134|NCT02576223|Anesthetics, Local|anesthetics, local|mesh-ancestor
5827135|NCT02576223|Anesthetics|anesthetics|mesh-ancestor
5827136|NCT02576223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5827137|NCT02576223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827138|NCT02576223|Sensory System Agents|sensory system agents|mesh-ancestor
5827139|NCT02576223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5827140|NCT02576366|Rifampin|rifampin|mesh-list
5827141|NCT02576366|Voriconazole|voriconazole|mesh-list
5827142|NCT02576366|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5827143|NCT02576366|Antitubercular Agents|antitubercular agents|mesh-ancestor
5827144|NCT02576366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5827145|NCT02576366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5827146|NCT02576366|Leprostatic Agents|leprostatic agents|mesh-ancestor
5827147|NCT02576366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5827148|NCT02576366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5827149|NCT02576366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5827150|NCT02576366|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5827151|NCT02576366|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5827152|NCT02576366|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5651163|NCT01277211|NuvaRing|nuvaring|mesh-list
5651164|NCT01277211|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5651165|NCT01277211|Contraceptive Agents|contraceptive agents|mesh-ancestor
5651166|NCT01277211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5651167|NCT01277211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651168|NCT01272037|Tamoxifen|tamoxifen|mesh-list
5651169|NCT01272037|Letrozole|letrozole|mesh-list
5651170|NCT01272037|Anastrozole|anastrozole|mesh-list
5651171|NCT01272037|Exemestane|exemestane|mesh-list
5651172|NCT01272037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5827153|NCT02576366|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5827154|NCT02576366|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5827155|NCT02576366|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5827156|NCT02576366|Antifungal Agents|antifungal agents|mesh-ancestor
5827157|NCT02576366|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5827158|NCT02576366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5827159|NCT02576366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5827160|NCT02576366|Hormone Antagonists|hormone antagonists|mesh-ancestor
5827161|NCT02576366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5827162|NCT02576366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827163|NCT02576366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5827164|NCT02576327|Dexamethasone|dexamethasone|mesh-list
5827165|NCT02576327|Dexamethasone acetate|dexamethasone acetate|mesh-list
5827166|NCT02576327|Aprepitant|aprepitant|mesh-list
5827167|NCT02576327|Tropisetron|tropisetron|mesh-list
5827168|NCT02576327|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
5827169|NCT02576327|BB 1101|bb 1101|mesh-list
5827170|NCT02576327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5827171|NCT02576327|Antiemetics|antiemetics|mesh-ancestor
5827172|NCT02576327|Autonomic Agents|autonomic agents|mesh-ancestor
6493115|NCT00612079|Sertindole|sertindole|mesh-list
6493116|NCT00612079|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6493117|NCT00612079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6493118|NCT00612079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6493119|NCT00612079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493120|NCT00612079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6493121|NCT00612144|Metformin|metformin|mesh-list
6493122|NCT00612144|Glimepiride|glimepiride|mesh-list
5827173|NCT02576327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5827174|NCT02576327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827175|NCT02576327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5827176|NCT02576327|Glucocorticoids|glucocorticoids|mesh-ancestor
5827177|NCT02576327|Hormones|hormones|mesh-ancestor
5827178|NCT02576327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5827179|NCT02576327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5827180|NCT02576327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5827181|NCT02576327|Protease Inhibitors|protease inhibitors|mesh-ancestor
5827182|NCT02576327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5827183|NCT02576327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493123|NCT00612144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6493124|NCT00612144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493125|NCT00612144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6493126|NCT00612144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6493127|NCT00612144|Immunologic Factors|immunologic factors|mesh-ancestor
6493128|NCT00612157|Eszopiclone|eszopiclone|mesh-list
5651173|NCT01272037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6493129|NCT00612157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6493130|NCT00612157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6493131|NCT00612157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493132|NCT00612183|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6493133|NCT00612183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6493134|NCT00612183|Alkylating Agents|alkylating agents|mesh-ancestor
5651174|NCT01272037|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5651175|NCT01272037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5651176|NCT01272037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5651177|NCT01272037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5651178|NCT01272037|Hormone Antagonists|hormone antagonists|mesh-ancestor
5651179|NCT01272037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5651180|NCT01272037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651181|NCT01272037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5651182|NCT01272037|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5651183|NCT01272037|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5651184|NCT01272037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5651185|NCT01267812|Rituximab|rituximab|mesh-list
6493135|NCT00612183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493136|NCT00612183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6493137|NCT00612261|Triamcinolone|triamcinolone|mesh-list
6493138|NCT00612261|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6493139|NCT00612261|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6493140|NCT00612261|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5827184|NCT02576327|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5827185|NCT02576327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5827186|NCT02576327|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5827187|NCT02576327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5827188|NCT02576327|Serotonin Agents|serotonin agents|mesh-ancestor
5827189|NCT02576015|Lidocaine|lidocaine|mesh-list
5827190|NCT02576015|Ropivacaine|ropivacaine|mesh-list
5827191|NCT02576015|Anesthetics, Local|anesthetics, local|mesh-ancestor
5827192|NCT02576015|Anesthetics|anesthetics|mesh-ancestor
5827193|NCT02576015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5827194|NCT02576015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827195|NCT02576015|Sensory System Agents|sensory system agents|mesh-ancestor
5827196|NCT02576015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5827197|NCT02576015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5827198|NCT02576015|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5827199|NCT02576015|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5827200|NCT02576015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5827201|NCT02576015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5827202|NCT02576080|Imatinib Mesylate|imatinib mesylate|mesh-list
5827203|NCT02576080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5827204|NCT02576080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5827205|NCT02576080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5827206|NCT02576080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5827207|NCT02576119|Moxifloxacin|moxifloxacin|mesh-list
5827208|NCT02576119|BMS-955176|bms-955176|mesh-list
5827209|NCT02576119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5827210|NCT02576119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5827211|NCT02576119|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5827212|NCT02576119|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5827213|NCT02576119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5827214|NCT02576119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5827215|NCT02576119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5827216|NCT02576119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5827217|NCT02576119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5827218|NCT02576119|Antiviral Agents|antiviral agents|mesh-ancestor
5827219|NCT02575963|Cytarabine|cytarabine|mesh-list
5827220|NCT02575963|Lintuzumab|lintuzumab|mesh-list
5827221|NCT02575963|Furosemide|furosemide|mesh-list
5827222|NCT02575963|Spironolactone|spironolactone|mesh-list
5827223|NCT02575963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5827224|NCT02575963|Antimetabolites|antimetabolites|mesh-ancestor
5827225|NCT02575963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5651186|NCT01267812|Bortezomib|bortezomib|mesh-list
5651187|NCT01267812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5651188|NCT01267812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5651189|NCT01267812|Immunologic Factors|immunologic factors|mesh-ancestor
5651190|NCT01267812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651191|NCT01267812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5827226|NCT02575963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5651192|NCT01244828|Asenapine|asenapine|mesh-list
5651193|NCT01244828|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5651194|NCT01244828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5651195|NCT01244828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5651196|NCT01244828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651197|NCT01244828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5651198|NCT01047540|Pritelivir|pritelivir|mesh-list
5827227|NCT02575963|Antiviral Agents|antiviral agents|mesh-ancestor
5827228|NCT02575963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5827229|NCT02575963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5651199|NCT01047540|Antiviral Agents|antiviral agents|mesh-ancestor
5651200|NCT01047540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5651201|NCT01047540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5651202|NCT01047540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5827230|NCT02575963|Immunologic Factors|immunologic factors|mesh-ancestor
5827231|NCT02575963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827232|NCT02575963|Diuretics|diuretics|mesh-ancestor
5827233|NCT02575963|Natriuretic Agents|natriuretic agents|mesh-ancestor
5827234|NCT02575963|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5827235|NCT02575963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5827236|NCT02575963|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5827237|NCT02575963|Hormone Antagonists|hormone antagonists|mesh-ancestor
5827238|NCT02575963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5827239|NCT02575963|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5827240|NCT02575963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5827241|NCT02575924|Imidacloprid|imidacloprid|mesh-list
5827242|NCT02575924|Cholinergic Agents|cholinergic agents|mesh-ancestor
5827243|NCT02575924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5827244|NCT02575924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5827245|NCT02575924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827246|NCT02575859|Cisplatin|cisplatin|mesh-list
5827247|NCT02575859|Mitomycins|mitomycins|mesh-list
5827248|NCT02575859|Mitomycin|mitomycin|mesh-list
5827249|NCT02575859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5827250|NCT02575859|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5827251|NCT02575859|Alkylating Agents|alkylating agents|mesh-ancestor
5827252|NCT02575859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5827253|NCT02575859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5827254|NCT02575859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5827255|NCT02575885|Nicotine|nicotine|mesh-list
5827256|NCT02575885|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5827257|NCT02575885|Autonomic Agents|autonomic agents|mesh-ancestor
5827258|NCT02575885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5827259|NCT02575885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827260|NCT02575885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5827261|NCT02575885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5827262|NCT02575885|Cholinergic Agents|cholinergic agents|mesh-ancestor
5827263|NCT02575885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5651203|NCT01044056|Contraceptive Agents|contraceptive agents|mesh-list
5651204|NCT01044056|Levonorgestrel|levonorgestrel|mesh-list
5651205|NCT01044056|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5651206|NCT01044056|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
5651207|NCT01044056|NuvaRing|nuvaring|mesh-list
5651208|NCT01044056|Contraceptives, Oral|contraceptives, oral|mesh-list
5827264|NCT02575885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5827265|NCT02575768|Adenosine|adenosine|mesh-list
5827266|NCT02575768|Analgesics|analgesics|mesh-ancestor
5827267|NCT02575768|Sensory System Agents|sensory system agents|mesh-ancestor
5827268|NCT02575768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5827269|NCT02575768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827270|NCT02575768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5827271|NCT02575768|Vasodilator Agents|vasodilator agents|mesh-ancestor
5827272|NCT02575768|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5827273|NCT02575768|Purinergic Agonists|purinergic agonists|mesh-ancestor
5827274|NCT02575768|Purinergic Agents|purinergic agents|mesh-ancestor
5827275|NCT02575768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5827276|NCT02575768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5827277|NCT02575755|Azithromycin|azithromycin|mesh-list
5827278|NCT02575755|Pyrimethamine|pyrimethamine|mesh-list
5827279|NCT02575755|Piperaquine|piperaquine|mesh-list
5827280|NCT02575755|Sulfadoxine|sulfadoxine|mesh-list
5827281|NCT02575755|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
5827282|NCT02575755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5827283|NCT02575755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5651209|NCT01044056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5827284|NCT02575755|Antimalarials|antimalarials|mesh-ancestor
5827285|NCT02575755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5827286|NCT02575755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5827287|NCT02575755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5827288|NCT02575755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5827289|NCT02575755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5827290|NCT02575755|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5827291|NCT02575755|Renal Agents|renal agents|mesh-ancestor
5827292|NCT02575729|Betamethasone|betamethasone|mesh-list
5827293|NCT02575729|Glucocorticoids|glucocorticoids|mesh-list
5827294|NCT02575729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5827295|NCT02575729|Hormones|hormones|mesh-ancestor
5827296|NCT02575729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5827297|NCT02575729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827298|NCT02575729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5827299|NCT02575729|Respiratory System Agents|respiratory system agents|mesh-ancestor
5827300|NCT02575677|Oxycodone|oxycodone|mesh-list
5827301|NCT02575677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5827302|NCT02575677|Narcotics|narcotics|mesh-ancestor
5827303|NCT02575677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5827304|NCT02575677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651210|NCT01044056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651211|NCT01044056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5651212|NCT01044056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5651213|NCT01044056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5651214|NCT01044056|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5651215|NCT01044056|Estrogens|estrogens|mesh-ancestor
5651216|NCT01044056|Hormones|hormones|mesh-ancestor
5827305|NCT02575677|Analgesics|analgesics|mesh-ancestor
5827306|NCT02575677|Sensory System Agents|sensory system agents|mesh-ancestor
5827307|NCT02575677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5827308|NCT02575443|Rocuronium|rocuronium|mesh-list
5827309|NCT02575443|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5827310|NCT02575443|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5827311|NCT02575443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5827312|NCT02575443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5827313|NCT02575443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827314|NCT02575534|Procainamide|procainamide|mesh-list
5827315|NCT02575534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5827316|NCT02575534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5827317|NCT02575534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5827318|NCT02575534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5827319|NCT02575534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5827320|NCT02575521|Dexmedetomidine|dexmedetomidine|mesh-list
5827321|NCT02575521|Propofol|propofol|mesh-list
5827322|NCT02575521|Sevoflurane|sevoflurane|mesh-list
5827323|NCT02575521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5827324|NCT02575521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5827325|NCT02575521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827326|NCT02575521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5827327|NCT02575521|Anesthetics, General|anesthetics, general|mesh-ancestor
5827328|NCT02575521|Anesthetics|anesthetics|mesh-ancestor
5827329|NCT02575521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5827330|NCT02575521|Analgesics|analgesics|mesh-ancestor
5827331|NCT02575521|Sensory System Agents|sensory system agents|mesh-ancestor
5827332|NCT02575521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5827333|NCT02575521|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5827334|NCT02575521|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5827335|NCT02575521|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5827336|NCT02575521|Adrenergic Agents|adrenergic agents|mesh-ancestor
5827337|NCT02575521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5827338|NCT02575521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5827339|NCT02575521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5827340|NCT02575521|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5827341|NCT02575638|Camptothecin|camptothecin|mesh-list
5827342|NCT02575638|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5827343|NCT02575638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6211718|NCT02176291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651217|NCT01044056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5651218|NCT01044056|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5651219|NCT01005056|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5651220|NCT01005056|Desogestrel|desogestrel|mesh-list
5651221|NCT01005056|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5827344|NCT02575638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5827345|NCT02575638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5827346|NCT02575638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5827347|NCT02575638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5827348|NCT02575547|Docetaxel|docetaxel|mesh-list
5827349|NCT02575547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5827350|NCT02575547|Tubulin Modulators|tubulin modulators|mesh-ancestor
5827351|NCT02575547|Antimitotic Agents|antimitotic agents|mesh-ancestor
5827352|NCT02575547|Mitosis Modulators|mitosis modulators|mesh-ancestor
5827353|NCT02575547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5827354|NCT02575664|Buprenorphine|buprenorphine|mesh-list
5827355|NCT02575664|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5827356|NCT02575664|Narcotics|narcotics|mesh-ancestor
5827357|NCT02575664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5827358|NCT02575664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827359|NCT02575664|Analgesics|analgesics|mesh-ancestor
5827360|NCT02575664|Sensory System Agents|sensory system agents|mesh-ancestor
5827361|NCT02575664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5827362|NCT02575664|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5651222|NCT01005056|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5651223|NCT01005056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5651224|NCT01005056|Contraceptive Agents|contraceptive agents|mesh-ancestor
5651225|NCT01005056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5651226|NCT01005056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651227|NCT01005056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5651228|NCT01005056|Estrogens|estrogens|mesh-ancestor
5651229|NCT01005056|Hormones|hormones|mesh-ancestor
5651230|NCT01005056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5651231|NCT01005056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5651232|NCT01005056|Progestins|progestins|mesh-ancestor
5651233|NCT00967746|Etonogestrel|etonogestrel|mesh-list
5651234|NCT00967746|Desogestrel|desogestrel|mesh-list
5651235|NCT00967746|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5827363|NCT02575339|Sorafenib|sorafenib|mesh-list
5827364|NCT02575339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5827365|NCT02575339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5827366|NCT02575339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5827367|NCT02575339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5827368|NCT02575495|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5827369|NCT02575495|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5827370|NCT02575495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5827371|NCT02575495|Antitubercular Agents|antitubercular agents|mesh-ancestor
5827372|NCT02575508|Fluorouracil|fluorouracil|mesh-list
5827373|NCT02575508|Oxaliplatin|oxaliplatin|mesh-list
5827374|NCT02575508|Irinotecan|irinotecan|mesh-list
5827375|NCT02575508|Camptothecin|camptothecin|mesh-list
5827376|NCT02575508|Infigratinib|infigratinib|mesh-list
5827377|NCT02575508|Antimetabolites|antimetabolites|mesh-ancestor
5827378|NCT02575508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5827379|NCT02575508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5827380|NCT02575508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5827381|NCT02575508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5827382|NCT02575508|Immunologic Factors|immunologic factors|mesh-ancestor
5827383|NCT02575508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827384|NCT02575508|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5827385|NCT02575508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5827386|NCT02575508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5827387|NCT02575508|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5827388|NCT02575248|Dienogest|dienogest|mesh-list
5827389|NCT02575248|Clomiphene|clomiphene|mesh-list
5827390|NCT02575248|Enclomiphene|enclomiphene|mesh-list
5827391|NCT02575248|Zuclomiphene|zuclomiphene|mesh-list
5827392|NCT02575248|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5827393|NCT02575248|Hormone Antagonists|hormone antagonists|mesh-ancestor
5827394|NCT02575248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5827395|NCT02575248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827396|NCT02575248|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5827397|NCT02575248|Fertility Agents|fertility agents|mesh-ancestor
5827398|NCT02575248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5827399|NCT02575248|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5827400|NCT02575248|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5827401|NCT02575248|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5827402|NCT02575248|Contraceptive Agents|contraceptive agents|mesh-ancestor
5651236|NCT00967746|Contraceptive Agents|contraceptive agents|mesh-ancestor
5651237|NCT00967746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6211719|NCT02176291|Analgesics|analgesics|mesh-ancestor
5827403|NCT02575248|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5827404|NCT02575248|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5827405|NCT02575248|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5827406|NCT02575248|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5827407|NCT02575248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5827408|NCT02575248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5827409|NCT02575183|Varenicline|varenicline|mesh-list
5827410|NCT02575183|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5827411|NCT02575183|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5827412|NCT02575183|Cholinergic Agents|cholinergic agents|mesh-ancestor
5827413|NCT02575183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5827414|NCT02575183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5827415|NCT02575183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827416|NCT02575170|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5902227|NCT04898894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5902228|NCT04898894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902229|NCT04898894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5651238|NCT00967746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651239|NCT00967746|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5651240|NCT00967746|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5651241|NCT00967746|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5651242|NCT00967746|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5651243|NCT00967746|Progestins|progestins|mesh-ancestor
5651244|NCT00967746|Hormones|hormones|mesh-ancestor
5651245|NCT00967746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5651246|NCT00944216|Emollients|emollients|mesh-list
5651247|NCT00944216|Dermatologic Agents|dermatologic agents|mesh-ancestor
5651248|NCT00920634|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5651249|NCT00920634|Hormones|hormones|mesh-ancestor
5651250|NCT00920634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5651251|NCT00920634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651252|NCT00920361|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5651253|NCT00920361|Hormones|hormones|mesh-ancestor
5651254|NCT00920361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5651255|NCT00920361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902230|NCT04898894|Antimetabolites|antimetabolites|mesh-ancestor
5902231|NCT04898894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902232|NCT04898894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5902233|NCT04898894|Dermatologic Agents|dermatologic agents|mesh-ancestor
5902234|NCT04898894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5902235|NCT04898894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5902236|NCT04898894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5902237|NCT04898894|Immunologic Factors|immunologic factors|mesh-ancestor
5902238|NCT04898894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5902239|NCT04898894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5902240|NCT04898894|Antiviral Agents|antiviral agents|mesh-ancestor
5902241|NCT04898894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5902242|NCT04898894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5902243|NCT04892043|Nivolumab|nivolumab|mesh-list
5902244|NCT04892043|Ipilimumab|ipilimumab|mesh-list
5902245|NCT04892043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5902246|NCT04892043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5902247|NCT04892043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5902248|NCT04892043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908337|NCT04657302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5908338|NCT04657302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5908339|NCT04642469|Durvalumab|durvalumab|mesh-list
5908340|NCT04642469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5908341|NCT04642469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5908342|NCT04637594|Pembrolizumab|pembrolizumab|mesh-list
5908343|NCT04637594|Nivolumab|nivolumab|mesh-list
5908344|NCT04637594|Durvalumab|durvalumab|mesh-list
5908345|NCT04637594|Avelumab|avelumab|mesh-list
5908346|NCT04637594|Atezolizumab|atezolizumab|mesh-list
5908347|NCT04637594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5908348|NCT04637594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5908349|NCT04637594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5908350|NCT04637594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493141|NCT00612261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5651256|NCT00886691|Bevacizumab|bevacizumab|mesh-list
6493142|NCT00612261|Glucocorticoids|glucocorticoids|mesh-ancestor
6493143|NCT00612261|Hormones|hormones|mesh-ancestor
5827417|NCT02575235|Cetylpyridinium|cetylpyridinium|mesh-list
5827418|NCT02575235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5827419|NCT02575235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5827420|NCT02575222|Nivolumab|nivolumab|mesh-list
5827421|NCT02575222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5827422|NCT02575222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5827423|NCT02575222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5827424|NCT02575222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5827425|NCT02574962|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
5827426|NCT02574962|Hormones|hormones|mesh-ancestor
5827427|NCT02574962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5827428|NCT02574962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827429|NCT02575092|Folic Acid|folic acid|mesh-list
5827430|NCT02575092|Enalapril|enalapril|mesh-list
5827431|NCT02575092|Enalaprilat|enalaprilat|mesh-list
5827432|NCT02575092|Maleic acid|maleic acid|mesh-list
5827433|NCT02575092|Hematinics|hematinics|mesh-ancestor
5827434|NCT02575092|Vitamin B Complex|vitamin b complex|mesh-ancestor
5827435|NCT02575092|Vitamins|vitamins|mesh-ancestor
5827436|NCT02575092|Micronutrients|micronutrients|mesh-ancestor
5827437|NCT02575092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827438|NCT02575092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5827439|NCT02575092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493144|NCT00612261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6493145|NCT00612261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493146|NCT00612261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6493147|NCT00612261|Immunologic Factors|immunologic factors|mesh-ancestor
6493148|NCT00612261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5651257|NCT00886691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5651258|NCT00886691|Everolimus|everolimus|mesh-list
5651259|NCT00886691|Endothelial Growth Factors|endothelial growth factors|mesh-list
5651260|NCT00886691|Antibodies|antibodies|mesh-list
5651261|NCT00886691|Immunoglobulins|immunoglobulins|mesh-list
5651262|NCT00886691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5651263|NCT00886691|Immunoglobulin G|immunoglobulin g|mesh-list
5827440|NCT02575092|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5827441|NCT02575092|Protease Inhibitors|protease inhibitors|mesh-ancestor
5827442|NCT02575092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5827443|NCT02575001|Hydrocortisone|hydrocortisone|mesh-list
5827444|NCT02575001|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
5827445|NCT02575001|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
5827446|NCT02575001|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
5827447|NCT02575001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5827448|NCT02574819|Methylnaltrexone|methylnaltrexone|mesh-list
5827449|NCT02574819|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5651264|NCT00886691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5651265|NCT00886691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5651266|NCT00886691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5651267|NCT00886691|Growth Substances|growth substances|mesh-ancestor
5651268|NCT00886691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651269|NCT00886691|Growth Inhibitors|growth inhibitors|mesh-ancestor
5651270|NCT00886691|Immunologic Factors|immunologic factors|mesh-ancestor
5651271|NCT00886691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5651272|NCT00878462|Asenapine|asenapine|mesh-list
5651273|NCT00878462|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5651274|NCT00878462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5651275|NCT00878462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5827450|NCT02574819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827451|NCT02574819|Sensory System Agents|sensory system agents|mesh-ancestor
5827452|NCT02574819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5827453|NCT02574975|Budesonide|budesonide|mesh-list
5827454|NCT02574975|Adenosine|adenosine|mesh-list
5827455|NCT02574975|Formoterol Fumarate|formoterol fumarate|mesh-list
5827456|NCT02574975|Methacholine Chloride|methacholine chloride|mesh-list
5827457|NCT02574975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5827458|NCT02574975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5827459|NCT02574975|Autonomic Agents|autonomic agents|mesh-ancestor
5827460|NCT02574975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5827461|NCT02574975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827462|NCT02574975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5827463|NCT02574975|Respiratory System Agents|respiratory system agents|mesh-ancestor
5827464|NCT02574975|Glucocorticoids|glucocorticoids|mesh-ancestor
5827465|NCT02574975|Hormones|hormones|mesh-ancestor
5827466|NCT02574975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5651276|NCT00878462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827467|NCT02574975|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5827468|NCT02574975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5827469|NCT02574975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5827470|NCT02574975|Adrenergic Agents|adrenergic agents|mesh-ancestor
5827471|NCT02574975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5827472|NCT02574975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5827473|NCT02574975|Analgesics|analgesics|mesh-ancestor
5827474|NCT02574975|Sensory System Agents|sensory system agents|mesh-ancestor
5827475|NCT02574975|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5827476|NCT02574975|Vasodilator Agents|vasodilator agents|mesh-ancestor
5827477|NCT02574975|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5827478|NCT02574975|Purinergic Agonists|purinergic agonists|mesh-ancestor
5827479|NCT02574975|Purinergic Agents|purinergic agents|mesh-ancestor
5827480|NCT02574975|Miotics|miotics|mesh-ancestor
5827481|NCT02574975|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5827482|NCT02574975|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
5827483|NCT02574975|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
5827484|NCT02574975|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5827485|NCT02574975|Cholinergic Agents|cholinergic agents|mesh-ancestor
5827486|NCT02574533|Pembrolizumab|pembrolizumab|mesh-list
5827487|NCT02574533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5827488|NCT02574533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5827489|NCT02574533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5827490|NCT02574533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5827491|NCT02574741|Aripiprazole|aripiprazole|mesh-list
5827492|NCT02574741|Antidepressive Agents|antidepressive agents|mesh-ancestor
5827493|NCT02574741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5827494|NCT02574741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5827495|NCT02574741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5827496|NCT02574741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5827497|NCT02574741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827498|NCT02574741|Dopamine Agonists|dopamine agonists|mesh-ancestor
5827499|NCT02574741|Dopamine Agents|dopamine agents|mesh-ancestor
5827500|NCT02574741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5827501|NCT02574741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5827502|NCT02574741|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5827503|NCT02574741|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5827504|NCT02574741|Serotonin Agents|serotonin agents|mesh-ancestor
5827505|NCT02574741|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5827506|NCT02574741|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5827507|NCT02574741|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5827508|NCT02574741|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5827509|NCT02574663|Leucovorin|leucovorin|mesh-list
5827510|NCT02574663|Folic Acid|folic acid|mesh-list
5827511|NCT02574663|Gemcitabine|gemcitabine|mesh-list
5827512|NCT02574663|Paclitaxel|paclitaxel|mesh-list
5827513|NCT02574663|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5827514|NCT02574663|Bevacizumab|bevacizumab|mesh-list
5827515|NCT02574663|Fluorouracil|fluorouracil|mesh-list
5651277|NCT00878462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5651278|NCT00778999|Desogestrel|desogestrel|mesh-list
5651279|NCT00778999|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5651280|NCT00778999|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5651281|NCT00778999|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5651282|NCT00778999|Contraceptive Agents|contraceptive agents|mesh-ancestor
5651283|NCT00778999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5651284|NCT00778999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651285|NCT00778999|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5651286|NCT00778999|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5651287|NCT00778999|Progestins|progestins|mesh-ancestor
5827516|NCT02574663|Oxaliplatin|oxaliplatin|mesh-list
5827517|NCT02574663|Levoleucovorin|levoleucovorin|mesh-list
5651288|NCT00778999|Hormones|hormones|mesh-ancestor
5827518|NCT02574663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5827519|NCT02574663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5827520|NCT02574663|Tubulin Modulators|tubulin modulators|mesh-ancestor
5827521|NCT02574663|Antimitotic Agents|antimitotic agents|mesh-ancestor
5827522|NCT02574663|Mitosis Modulators|mitosis modulators|mesh-ancestor
5827523|NCT02574663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5827524|NCT02574663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5827525|NCT02574663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5827526|NCT02574663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5827527|NCT02574663|Growth Substances|growth substances|mesh-ancestor
5694589|NCT03394820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5827528|NCT02574663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827529|NCT02574663|Growth Inhibitors|growth inhibitors|mesh-ancestor
5827530|NCT02574663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5827531|NCT02574663|Antimetabolites|antimetabolites|mesh-ancestor
5827532|NCT02574663|Antiviral Agents|antiviral agents|mesh-ancestor
5827533|NCT02574663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5827534|NCT02574663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5827535|NCT02574663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5827536|NCT02574663|Immunologic Factors|immunologic factors|mesh-ancestor
5827537|NCT02574663|Antidotes|antidotes|mesh-ancestor
5651289|NCT00778999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5651290|NCT00725413|Etonogestrel|etonogestrel|mesh-list
5651291|NCT00725413|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5651292|NCT00725413|Contraceptive Agents|contraceptive agents|mesh-ancestor
5651293|NCT00725413|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5651294|NCT00725413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651295|NCT00725413|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5651296|NCT00651807|Etonogestrel|etonogestrel|mesh-list
5651297|NCT00651807|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5651298|NCT00651807|Contraceptive Agents|contraceptive agents|mesh-ancestor
5651299|NCT00651807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5651300|NCT00651807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651301|NCT00651807|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5651302|NCT00620464|Etonogestrel|etonogestrel|mesh-list
5651303|NCT00620464|Desogestrel|desogestrel|mesh-list
5651304|NCT00620464|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5651305|NCT00620464|Contraceptive Agents|contraceptive agents|mesh-ancestor
6493149|NCT00612261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493150|NCT00612274|Sirolimus|sirolimus|mesh-list
6493151|NCT00612274|Methotrexate|methotrexate|mesh-list
6493152|NCT00612274|Tacrolimus|tacrolimus|mesh-list
6493153|NCT00612274|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5651306|NCT00620464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5651307|NCT00620464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651308|NCT00620464|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5651309|NCT00620464|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5651310|NCT00620464|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5651311|NCT00620464|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5651312|NCT00620464|Progestins|progestins|mesh-ancestor
5651313|NCT00620464|Hormones|hormones|mesh-ancestor
5827538|NCT02574663|Protective Agents|protective agents|mesh-ancestor
5827539|NCT02574663|Vitamin B Complex|vitamin b complex|mesh-ancestor
5827540|NCT02574663|Vitamins|vitamins|mesh-ancestor
5827541|NCT02574663|Micronutrients|micronutrients|mesh-ancestor
5827542|NCT02574663|Hematinics|hematinics|mesh-ancestor
5827543|NCT02574468|Dexamethasone|dexamethasone|mesh-list
5827544|NCT02574468|Dexamethasone acetate|dexamethasone acetate|mesh-list
5827545|NCT02574468|BB 1101|bb 1101|mesh-list
5827546|NCT02574468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5827547|NCT02574468|Antiemetics|antiemetics|mesh-ancestor
5827548|NCT02574468|Autonomic Agents|autonomic agents|mesh-ancestor
5827549|NCT02574468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6493154|NCT00612274|Abortifacient Agents|abortifacient agents|mesh-ancestor
5651314|NCT00620464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5651315|NCT00620035|Etonogestrel|etonogestrel|mesh-list
5651316|NCT00620035|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5651317|NCT00620035|Contraceptive Agents|contraceptive agents|mesh-ancestor
5651318|NCT00620035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5651319|NCT00620035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651320|NCT00620035|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5651321|NCT00541684|Atenolol|atenolol|mesh-list
5651322|NCT00541684|Adrenergic Agents|adrenergic agents|mesh-ancestor
5651323|NCT00541684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5651324|NCT00541684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5651325|NCT00541684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651326|NCT00541684|Autonomic Agents|autonomic agents|mesh-ancestor
5651327|NCT00541684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5651328|NCT00541684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5651329|NCT00541684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5651330|NCT00541684|Sympatholytics|sympatholytics|mesh-ancestor
5651331|NCT00541684|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5651332|NCT00541684|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5694590|NCT03394807|Levobupivacaine|levobupivacaine|mesh-list
5827550|NCT02574468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493155|NCT00612274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5827551|NCT02574468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5827552|NCT02574468|Glucocorticoids|glucocorticoids|mesh-ancestor
5827553|NCT02574468|Hormones|hormones|mesh-ancestor
5827554|NCT02574468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5827555|NCT02574468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5827556|NCT02574468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5827557|NCT02574468|Protease Inhibitors|protease inhibitors|mesh-ancestor
5827558|NCT02574468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5827559|NCT02574468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5827560|NCT02574611|Glycopyrrolate|glycopyrrolate|mesh-list
5827561|NCT02574611|Neostigmine|neostigmine|mesh-list
5827562|NCT02574611|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5827563|NCT02574611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5827564|NCT02574611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5827565|NCT02574611|Cholinergic Agents|cholinergic agents|mesh-ancestor
5827566|NCT02574611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5827567|NCT02574611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827568|NCT02574611|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5651333|NCT00541684|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5651334|NCT00431431|Tibolone|tibolone|mesh-list
5651335|NCT00431431|Androgen Antagonists|androgen antagonists|mesh-ancestor
5651336|NCT00431431|Hormone Antagonists|hormone antagonists|mesh-ancestor
5651337|NCT00431431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5651338|NCT00431431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651339|NCT00431431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5651340|NCT00431431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5651341|NCT00431431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5651342|NCT00431431|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5651343|NCT00431431|Anabolic Agents|anabolic agents|mesh-ancestor
5651344|NCT00431431|Hormones|hormones|mesh-ancestor
5651345|NCT00413764|Tibolone|tibolone|mesh-list
5651346|NCT00413764|Norethindrone|norethindrone|mesh-list
5651347|NCT00413764|Norethindrone Acetate|norethindrone acetate|mesh-list
5651348|NCT00413764|Estradiol|estradiol|mesh-list
5651349|NCT00413764|Estrogens|estrogens|mesh-ancestor
5651350|NCT00413764|Hormones|hormones|mesh-ancestor
5651351|NCT00413764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5651352|NCT00413764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651353|NCT00413764|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5827569|NCT02574611|Autonomic Agents|autonomic agents|mesh-ancestor
5827570|NCT02574611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5827571|NCT02574611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5827572|NCT02574611|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5827573|NCT02574611|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5827574|NCT02574754|Warfarin|warfarin|mesh-list
5827575|NCT02574754|Anticoagulants|anticoagulants|mesh-ancestor
5827576|NCT02574715|Levonorgestrel|levonorgestrel|mesh-list
5827577|NCT02574715|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5827578|NCT02574715|Contraceptive Agents|contraceptive agents|mesh-ancestor
5827579|NCT02574715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5827580|NCT02574715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827581|NCT02574715|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5827582|NCT02574715|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5827583|NCT02574715|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5827584|NCT02574403|Eculizumab|eculizumab|mesh-list
5827585|NCT02574403|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5827586|NCT02574403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5827587|NCT02574403|Immunologic Factors|immunologic factors|mesh-ancestor
5827588|NCT02574403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827589|NCT02574377|Vaccines|vaccines|mesh-list
5827590|NCT02574377|Immunologic Factors|immunologic factors|mesh-ancestor
5827591|NCT02574377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827592|NCT02574221|Fluorides|fluorides|mesh-list
5827593|NCT02574221|Tin Fluorides|tin fluorides|mesh-list
5827594|NCT02574221|Cariostatic Agents|cariostatic agents|mesh-ancestor
5827595|NCT02574221|Protective Agents|protective agents|mesh-ancestor
5827596|NCT02574221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827597|NCT02574338|Alprostadil|alprostadil|mesh-list
5827598|NCT02574338|Misoprostol|misoprostol|mesh-list
5827599|NCT02574338|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5827600|NCT02574338|Abortifacient Agents|abortifacient agents|mesh-ancestor
5827601|NCT02574338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5827602|NCT02574338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827603|NCT02574338|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5827604|NCT02574338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5651354|NCT00413764|Contraceptive Agents|contraceptive agents|mesh-ancestor
5827605|NCT02574338|Oxytocics|oxytocics|mesh-ancestor
5827606|NCT02574338|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5827607|NCT02574338|Vasodilator Agents|vasodilator agents|mesh-ancestor
5827608|NCT02574338|Urological Agents|urological agents|mesh-ancestor
5827609|NCT02574156|Insulin|insulin|mesh-list
5827610|NCT02574156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5827611|NCT02574156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827612|NCT02574130|Amikacin|amikacin|mesh-list
5827613|NCT02574130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5827614|NCT02574130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5827615|NCT02573935|Clarithromycin|clarithromycin|mesh-list
5827616|NCT02573935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5827617|NCT02573935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5827618|NCT02573935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5827619|NCT02573935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5827620|NCT02573935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5827621|NCT02573935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5827622|NCT02573935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5827623|NCT02573909|Oxycodone|oxycodone|mesh-list
5827624|NCT02573909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5827625|NCT02573909|Narcotics|narcotics|mesh-ancestor
5827626|NCT02573909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5827627|NCT02573909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827628|NCT02573909|Analgesics|analgesics|mesh-ancestor
5827629|NCT02573909|Sensory System Agents|sensory system agents|mesh-ancestor
5827630|NCT02573909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5827631|NCT02573922|Oxycodone|oxycodone|mesh-list
5827632|NCT02573922|Naloxone|naloxone|mesh-list
5827633|NCT02573922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5827634|NCT02573922|Narcotics|narcotics|mesh-ancestor
5827635|NCT02573922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5827636|NCT02573922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651355|NCT00413764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5651356|NCT00413764|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5651357|NCT00413764|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5651358|NCT00413764|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5651359|NCT00413764|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5651360|NCT00413764|Androgen Antagonists|androgen antagonists|mesh-ancestor
5651361|NCT00413764|Hormone Antagonists|hormone antagonists|mesh-ancestor
5651362|NCT00413764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5827637|NCT02573922|Analgesics|analgesics|mesh-ancestor
5827638|NCT02573922|Sensory System Agents|sensory system agents|mesh-ancestor
5827639|NCT02573922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5827640|NCT02573922|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5827641|NCT02573896|Lenalidomide|lenalidomide|mesh-list
5827642|NCT02573896|Dinutuximab|dinutuximab|mesh-list
5827643|NCT02573896|Immunologic Factors|immunologic factors|mesh-ancestor
5827644|NCT02573896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827645|NCT02573896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5827646|NCT02573896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5827647|NCT02573896|Growth Substances|growth substances|mesh-ancestor
5827648|NCT02573896|Growth Inhibitors|growth inhibitors|mesh-ancestor
5827649|NCT02573896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5827650|NCT02573987|Lidocaine|lidocaine|mesh-list
5827651|NCT02573987|Nitrous Oxide|nitrous oxide|mesh-list
5827652|NCT02573987|Anesthetics, Local|anesthetics, local|mesh-ancestor
5827653|NCT02573987|Anesthetics|anesthetics|mesh-ancestor
5827654|NCT02573987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5827655|NCT02573987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827656|NCT02573987|Sensory System Agents|sensory system agents|mesh-ancestor
5827657|NCT02573987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5827658|NCT02573987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5827659|NCT02573987|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5827660|NCT02573987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5827661|NCT02573987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5827662|NCT02573987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5827663|NCT02573987|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5827664|NCT02573987|Anesthetics, General|anesthetics, general|mesh-ancestor
5827665|NCT02573987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5827666|NCT02573987|Analgesics|analgesics|mesh-ancestor
5827667|NCT02573714|Ketamine|ketamine|mesh-list
5827668|NCT02573714|Analgesics|analgesics|mesh-ancestor
5827669|NCT02573714|Sensory System Agents|sensory system agents|mesh-ancestor
5827670|NCT02573714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5827671|NCT02573714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827672|NCT02573714|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5827673|NCT02573714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5827674|NCT02573714|Anesthetics, General|anesthetics, general|mesh-ancestor
5827675|NCT02573714|Anesthetics|anesthetics|mesh-ancestor
5827676|NCT02573714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5827677|NCT02573714|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5827678|NCT02573714|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5827679|NCT02573714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5827680|NCT02573714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5827681|NCT02573701|Risperidone|risperidone|mesh-list
5827682|NCT02573701|Antipsychotic Agents|antipsychotic agents|mesh-list
5827683|NCT02573701|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5827684|NCT02573701|Serotonin Agents|serotonin agents|mesh-ancestor
5827685|NCT02573701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5827686|NCT02573701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5827687|NCT02573701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827688|NCT02573701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5827689|NCT02573701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5827690|NCT02573701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5827691|NCT02573701|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5827692|NCT02573701|Dopamine Agents|dopamine agents|mesh-ancestor
5827693|NCT02573831|Oxycodone|oxycodone|mesh-list
5651363|NCT00413764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5651364|NCT00413764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5651365|NCT00413764|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5651366|NCT00413764|Anabolic Agents|anabolic agents|mesh-ancestor
5651367|NCT00408863|Tibolone|tibolone|mesh-list
5827694|NCT02573831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5827695|NCT02573831|Narcotics|narcotics|mesh-ancestor
5827696|NCT02573831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5827697|NCT02573831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827698|NCT02573831|Analgesics|analgesics|mesh-ancestor
5827699|NCT02573831|Sensory System Agents|sensory system agents|mesh-ancestor
5827700|NCT02573831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5827701|NCT02573610|Levofloxacin|levofloxacin|mesh-list
5827702|NCT02573610|Ofloxacin|ofloxacin|mesh-list
5827703|NCT02573610|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5827704|NCT02573610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5827705|NCT02573610|Renal Agents|renal agents|mesh-ancestor
5651368|NCT00408863|Androgen Antagonists|androgen antagonists|mesh-ancestor
5651369|NCT00408863|Hormone Antagonists|hormone antagonists|mesh-ancestor
5651370|NCT00408863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5651371|NCT00408863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651372|NCT00408863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5651373|NCT00408863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5651374|NCT00408863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5651375|NCT00408863|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5651376|NCT00408863|Anabolic Agents|anabolic agents|mesh-ancestor
5651377|NCT00408863|Hormones|hormones|mesh-ancestor
5651378|NCT00403793|Methyltestosterone|methyltestosterone|mesh-list
5651379|NCT00403793|Etonogestrel|etonogestrel|mesh-list
5651380|NCT00403793|Testosterone|testosterone|mesh-list
5651381|NCT00403793|Testosterone undecanoate|testosterone undecanoate|mesh-list
5651382|NCT00403793|Testosterone enanthate|testosterone enanthate|mesh-list
5651383|NCT00403793|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5651384|NCT00403793|Androgens|androgens|mesh-ancestor
5651385|NCT00403793|Hormones|hormones|mesh-ancestor
5651386|NCT00403793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5651387|NCT00403793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651388|NCT00403793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5651389|NCT00403793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5651390|NCT00403793|Anabolic Agents|anabolic agents|mesh-ancestor
5651391|NCT00403793|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5651392|NCT00403793|Contraceptive Agents|contraceptive agents|mesh-ancestor
5651393|NCT00403793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5651394|NCT00403793|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5651395|NCT00159796|Olanzapine|olanzapine|mesh-list
5651396|NCT00159796|Asenapine|asenapine|mesh-list
5827706|NCT02573610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5827707|NCT02573610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5827708|NCT02573610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5827709|NCT02573610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5827710|NCT02573610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5827711|NCT02573610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5827712|NCT02573610|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5651397|NCT00159796|Antiemetics|antiemetics|mesh-ancestor
5651398|NCT00159796|Autonomic Agents|autonomic agents|mesh-ancestor
5651399|NCT00159796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5651400|NCT00159796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651401|NCT00159796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5651402|NCT00159796|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5651403|NCT00159796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5651404|NCT00159796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5651405|NCT00159796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5827713|NCT02573610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5651406|NCT00159796|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5651407|NCT00159796|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5651408|NCT00159796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5651409|NCT00159796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5651410|NCT00159796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5651411|NCT00159796|Serotonin Agents|serotonin agents|mesh-ancestor
5651412|NCT00159744|Olanzapine|olanzapine|mesh-list
5651413|NCT00159744|Asenapine|asenapine|mesh-list
5651414|NCT00159744|Antiemetics|antiemetics|mesh-ancestor
5651415|NCT00159744|Autonomic Agents|autonomic agents|mesh-ancestor
5651416|NCT00159744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5651417|NCT00159744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651418|NCT00159744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5651419|NCT00159744|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5651420|NCT00159744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5651421|NCT00159744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5651422|NCT00159744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5651423|NCT00159744|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5651424|NCT00159744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5902288|NCT04789434|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5902289|NCT04789434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902290|NCT04789434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5902291|NCT04779216|Alendronate|alendronate|mesh-list
5651425|NCT00159744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5651426|NCT00159744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5651427|NCT00159744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5651428|NCT00159744|Serotonin Agents|serotonin agents|mesh-ancestor
5651429|NCT00143182|Olanzapine|olanzapine|mesh-list
5902292|NCT04779216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5827714|NCT02573597|Sufentanil|sufentanil|mesh-list
5651430|NCT00143182|Asenapine|asenapine|mesh-list
5651431|NCT00143182|Antiemetics|antiemetics|mesh-ancestor
5651432|NCT00143182|Autonomic Agents|autonomic agents|mesh-ancestor
5651433|NCT00143182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5651434|NCT00143182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651435|NCT00143182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5651436|NCT00143182|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5651437|NCT00143182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5651438|NCT00143182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5651439|NCT00143182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5651440|NCT00143182|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5651441|NCT00143182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5651442|NCT00143182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5651443|NCT00143182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5651444|NCT00143182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5827715|NCT02573597|Bupivacaine|bupivacaine|mesh-list
5827716|NCT02573597|Anesthetics, Local|anesthetics, local|mesh-ancestor
5827717|NCT02573597|Anesthetics|anesthetics|mesh-ancestor
5827718|NCT02573597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5827719|NCT02573597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827720|NCT02573597|Sensory System Agents|sensory system agents|mesh-ancestor
5827721|NCT02573597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5827722|NCT02573597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5827723|NCT02573597|Narcotics|narcotics|mesh-ancestor
5827724|NCT02573597|Analgesics|analgesics|mesh-ancestor
5827725|NCT02573597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5827726|NCT02573597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5827727|NCT02573597|Anesthetics, General|anesthetics, general|mesh-ancestor
5827728|NCT02573519|Acetylcholine|acetylcholine|mesh-list
5827729|NCT02573519|Donepezil|donepezil|mesh-list
5827730|NCT02573519|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
5827731|NCT02573519|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5827732|NCT02573519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5827733|NCT02573519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5827734|NCT02573519|Cholinergic Agents|cholinergic agents|mesh-ancestor
5827735|NCT02573519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5827736|NCT02573519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827737|NCT02573519|Nootropic Agents|nootropic agents|mesh-ancestor
5827738|NCT02573519|Vasodilator Agents|vasodilator agents|mesh-ancestor
5827739|NCT02573519|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5827740|NCT02573727|Terlipressin|terlipressin|mesh-list
5827741|NCT02573727|Epinephrine|epinephrine|mesh-list
5827742|NCT02573727|Racepinephrine|racepinephrine|mesh-list
5827743|NCT02573727|Norepinephrine|norepinephrine|mesh-list
5827744|NCT02573727|Epinephryl borate|epinephryl borate|mesh-list
5827745|NCT02573727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5827746|NCT02573727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5827747|NCT02573727|Adrenergic Agents|adrenergic agents|mesh-ancestor
5827748|NCT02573727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5827749|NCT02573727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5827750|NCT02573727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827751|NCT02573727|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5827752|NCT02573727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5827753|NCT02573727|Autonomic Agents|autonomic agents|mesh-ancestor
5827754|NCT02573727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5827755|NCT02573727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5827756|NCT02573727|Respiratory System Agents|respiratory system agents|mesh-ancestor
5827757|NCT02573727|Mydriatics|mydriatics|mesh-ancestor
5827758|NCT02573727|Sympathomimetics|sympathomimetics|mesh-ancestor
5827759|NCT02573727|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5651445|NCT00143182|Serotonin Agents|serotonin agents|mesh-ancestor
5651446|NCT03705442|Loperamide|loperamide|mesh-list
5651447|NCT03705442|Antidiarrheals|antidiarrheals|mesh-list
5651448|NCT03705442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5651449|NCT03705429|Paclitaxel|paclitaxel|mesh-list
5651450|NCT03705429|Docetaxel|docetaxel|mesh-list
5651451|NCT03705429|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5651452|NCT03705429|Cyclophosphamide|cyclophosphamide|mesh-list
5651453|NCT03705429|Trastuzumab|trastuzumab|mesh-list
5651454|NCT03705429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5651455|NCT03705429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5651456|NCT03705429|Tubulin Modulators|tubulin modulators|mesh-ancestor
5651457|NCT03705429|Antimitotic Agents|antimitotic agents|mesh-ancestor
5651458|NCT03705429|Mitosis Modulators|mitosis modulators|mesh-ancestor
5694591|NCT03394807|Anesthetics, Local|anesthetics, local|mesh-ancestor
5827760|NCT02573727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5827761|NCT02573558|Dexmedetomidine|dexmedetomidine|mesh-list
5827762|NCT02573558|Propofol|propofol|mesh-list
5651459|NCT03705429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5651460|NCT03705429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5827763|NCT02573558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5827764|NCT02573558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5827765|NCT02573558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827766|NCT02573558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5827767|NCT02573558|Anesthetics, General|anesthetics, general|mesh-ancestor
5827768|NCT02573558|Anesthetics|anesthetics|mesh-ancestor
5827769|NCT02573558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5827770|NCT02573558|Analgesics|analgesics|mesh-ancestor
5827771|NCT02573558|Sensory System Agents|sensory system agents|mesh-ancestor
5827772|NCT02573558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5827773|NCT02573558|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5827774|NCT02573558|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5827775|NCT02573558|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5827776|NCT02573558|Adrenergic Agents|adrenergic agents|mesh-ancestor
5827777|NCT02573558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5827778|NCT02573558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5827779|NCT02573363|Cytarabine|cytarabine|mesh-list
5827780|NCT02573363|Mitoxantrone|mitoxantrone|mesh-list
5827781|NCT02573363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5827782|NCT02573363|Antimetabolites|antimetabolites|mesh-ancestor
5827783|NCT02573363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5827784|NCT02573363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5827785|NCT02573363|Antiviral Agents|antiviral agents|mesh-ancestor
5827786|NCT02573363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5827787|NCT02573363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5827788|NCT02573363|Immunologic Factors|immunologic factors|mesh-ancestor
5827789|NCT02573363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827790|NCT02573363|Analgesics|analgesics|mesh-ancestor
5827791|NCT02573363|Sensory System Agents|sensory system agents|mesh-ancestor
5827792|NCT02573363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5827793|NCT02573363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5827794|NCT02573363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5827795|NCT02573363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5827796|NCT02573337|Lidocaine|lidocaine|mesh-list
5827797|NCT02573337|Anesthetics, Local|anesthetics, local|mesh-ancestor
5827798|NCT02573337|Anesthetics|anesthetics|mesh-ancestor
5827799|NCT02573337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5827800|NCT02573337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827801|NCT02573337|Sensory System Agents|sensory system agents|mesh-ancestor
5827802|NCT02573337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5827803|NCT02573337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5827804|NCT02573337|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5827805|NCT02573337|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5827806|NCT02573337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5827807|NCT02573337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5827808|NCT02573168|Psychotropic Drugs|psychotropic drugs|mesh-list
5827809|NCT02573064|Vancomycin|vancomycin|mesh-list
5827810|NCT02573064|Colistin|colistin|mesh-list
5827811|NCT02573064|Tigecycline|tigecycline|mesh-list
5827812|NCT02573064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5827813|NCT02573064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5827814|NCT02573064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5827815|NCT02573064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5827816|NCT02573064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5827817|NCT02573220|Leucovorin|leucovorin|mesh-list
5827818|NCT02573220|Fluorouracil|fluorouracil|mesh-list
5827819|NCT02573220|Irinotecan|irinotecan|mesh-list
5827820|NCT02573220|Cetuximab|cetuximab|mesh-list
5827821|NCT02573220|Camptothecin|camptothecin|mesh-list
5827822|NCT02573220|Calcium|calcium|mesh-list
5827823|NCT02573220|Levoleucovorin|levoleucovorin|mesh-list
6493156|NCT00612274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493157|NCT00612274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6493158|NCT00612274|Antimetabolites|antimetabolites|mesh-ancestor
6493159|NCT00612274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493160|NCT00612274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5651461|NCT03705429|Immunologic Factors|immunologic factors|mesh-ancestor
5651462|NCT03705429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651463|NCT03705429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5651464|NCT03705429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5651465|NCT03705429|Alkylating Agents|alkylating agents|mesh-ancestor
5651466|NCT03705429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5694592|NCT03394807|Anesthetics|anesthetics|mesh-ancestor
5651467|NCT03705429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5651468|NCT03705351|Temozolomide|temozolomide|mesh-list
5651469|NCT03705351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5651470|NCT03705351|Alkylating Agents|alkylating agents|mesh-ancestor
5651471|NCT03705351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5651472|NCT03705351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5651473|NCT03705338|Propofol|propofol|mesh-list
5651474|NCT03705338|Anesthetics|anesthetics|mesh-list
5651475|NCT03705338|Anesthetics, General|anesthetics, general|mesh-list
5651476|NCT03705338|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5651477|NCT03705338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5651478|NCT03705338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651479|NCT03705338|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5651480|NCT03705195|Gliclazide|gliclazide|mesh-list
5651481|NCT03705195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5651482|NCT03705195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651483|NCT03705065|Bupivacaine|bupivacaine|mesh-list
5651484|NCT03705065|Anesthetics, Local|anesthetics, local|mesh-ancestor
5651485|NCT03705065|Anesthetics|anesthetics|mesh-ancestor
5651486|NCT03705065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5651487|NCT03705065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827824|NCT02573220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5827825|NCT02573220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827826|NCT02573220|Antimetabolites|antimetabolites|mesh-ancestor
5651488|NCT03705065|Sensory System Agents|sensory system agents|mesh-ancestor
5651489|NCT03705065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5694593|NCT03394807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5694594|NCT03394807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694595|NCT03394807|Sensory System Agents|sensory system agents|mesh-ancestor
5694596|NCT03394807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5827827|NCT02573220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5827828|NCT02573220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5827829|NCT02573220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5827830|NCT02573220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5827831|NCT02573220|Immunologic Factors|immunologic factors|mesh-ancestor
5827832|NCT02573220|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5827833|NCT02573220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5827834|NCT02573220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5827835|NCT02573220|Antidotes|antidotes|mesh-ancestor
5827836|NCT02573220|Protective Agents|protective agents|mesh-ancestor
5827837|NCT02573220|Vitamin B Complex|vitamin b complex|mesh-ancestor
5827838|NCT02573220|Vitamins|vitamins|mesh-ancestor
5827839|NCT02573220|Micronutrients|micronutrients|mesh-ancestor
5827840|NCT02573220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5827841|NCT02573220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5827842|NCT02573038|Aflibercept|aflibercept|mesh-list
5694597|NCT03394729|Propolis|propolis|mesh-list
5694598|NCT03394729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5694599|NCT03394586|Golimumab|golimumab|mesh-list
5694600|NCT03394586|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
5694601|NCT03394586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5694602|NCT03394586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5694603|NCT03394586|Immunologic Factors|immunologic factors|mesh-ancestor
5694604|NCT03394586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694605|NCT03394573|Aflibercept|aflibercept|mesh-list
5694606|NCT03394573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5694607|NCT03394573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5694608|NCT03394573|Growth Substances|growth substances|mesh-ancestor
5694609|NCT03394573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827843|NCT02573038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5827844|NCT02573038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5827845|NCT02573038|Growth Substances|growth substances|mesh-ancestor
5827846|NCT02573038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827847|NCT02573038|Growth Inhibitors|growth inhibitors|mesh-ancestor
5827848|NCT02573038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5827849|NCT02573051|Isosorbide|isosorbide|mesh-list
5827850|NCT02573051|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
5694610|NCT03394573|Growth Inhibitors|growth inhibitors|mesh-ancestor
5827851|NCT02573051|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
5827852|NCT02573051|Misoprostol|misoprostol|mesh-list
5827853|NCT02573051|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5827854|NCT02573051|Abortifacient Agents|abortifacient agents|mesh-ancestor
6211720|NCT02176291|Sensory System Agents|sensory system agents|mesh-ancestor
5694611|NCT03394573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5694612|NCT03394430|Midazolam|midazolam|mesh-list
5651490|NCT03704909|Epinephrine|epinephrine|mesh-list
5651491|NCT03704909|Racepinephrine|racepinephrine|mesh-list
5651492|NCT03704909|Ephedrine|ephedrine|mesh-list
5651493|NCT03704909|Epinephryl borate|epinephryl borate|mesh-list
5651494|NCT03704909|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5651495|NCT03704909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5651496|NCT03704909|Adrenergic Agents|adrenergic agents|mesh-ancestor
5651497|NCT03704909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5827855|NCT02573051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5827856|NCT02573051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827857|NCT02573051|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5827858|NCT02573051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5827859|NCT02573051|Oxytocics|oxytocics|mesh-ancestor
5827860|NCT02573051|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5827861|NCT02573051|Diuretics|diuretics|mesh-ancestor
5827862|NCT02573051|Natriuretic Agents|natriuretic agents|mesh-ancestor
5827863|NCT02573051|Vasodilator Agents|vasodilator agents|mesh-ancestor
5827864|NCT02573051|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5827865|NCT02573051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5827866|NCT02573025|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5827867|NCT02573025|Interferon-alpha|interferon-alpha|mesh-list
5827868|NCT02573025|Interferon alpha-2|interferon alpha-2|mesh-list
5827869|NCT02573025|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
5827870|NCT02573025|Antiviral Agents|antiviral agents|mesh-ancestor
5827871|NCT02573025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5827872|NCT02573025|Immunologic Factors|immunologic factors|mesh-ancestor
5827873|NCT02573025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827874|NCT02573025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5827875|NCT02572986|Permethrin|permethrin|mesh-list
5827876|NCT02572986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5827877|NCT02572986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5827878|NCT02572960|Vitamin D|vitamin d|mesh-list
5827879|NCT02572960|Cholecalciferol|cholecalciferol|mesh-list
5827880|NCT02572960|Valsartan|valsartan|mesh-list
5827881|NCT02572960|Vitamins|vitamins|mesh-ancestor
5827882|NCT02572960|Micronutrients|micronutrients|mesh-ancestor
5827883|NCT02572960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827884|NCT02572960|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5827885|NCT02572960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5827886|NCT02572960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5827887|NCT02572960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5651498|NCT03704909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5651499|NCT03704909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651500|NCT03704909|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5651501|NCT03704909|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5651502|NCT03704909|Autonomic Agents|autonomic agents|mesh-ancestor
5651503|NCT03704909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5651504|NCT03704909|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5651505|NCT03704909|Respiratory System Agents|respiratory system agents|mesh-ancestor
5651506|NCT03704909|Mydriatics|mydriatics|mesh-ancestor
5651507|NCT03704909|Sympathomimetics|sympathomimetics|mesh-ancestor
5651508|NCT03704909|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5651509|NCT03704909|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5651510|NCT03704831|Anesthetics|anesthetics|mesh-list
5651511|NCT03704831|Anesthetics, Local|anesthetics, local|mesh-list
5651512|NCT03704831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5651513|NCT03704831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651514|NCT03704831|Sensory System Agents|sensory system agents|mesh-ancestor
5651515|NCT03704831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5651516|NCT03704818|Dapagliflozin|dapagliflozin|mesh-list
5651517|NCT03704818|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5827888|NCT02572960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5827889|NCT02572960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5827890|NCT02572947|Dolutegravir|dolutegravir|mesh-list
5827891|NCT02572947|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5827892|NCT02572947|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5827893|NCT02572947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5651518|NCT03704818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5651519|NCT03704818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5651520|NCT03704818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651521|NCT03704766|Defensins|defensins|mesh-list
5651522|NCT03704766|alpha-Defensins|alpha-defensins|mesh-list
5651523|NCT03704766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5651524|NCT03704753|Ropivacaine|ropivacaine|mesh-list
5651525|NCT03704753|Anesthetics, Local|anesthetics, local|mesh-ancestor
5827894|NCT02572947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5651526|NCT03704753|Anesthetics|anesthetics|mesh-ancestor
5651527|NCT03704753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5651528|NCT03704753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651529|NCT03704753|Sensory System Agents|sensory system agents|mesh-ancestor
5651530|NCT03704753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5651531|NCT03704714|Prednisone|prednisone|mesh-list
5651532|NCT03704714|Cortisone|cortisone|mesh-list
5651533|NCT03704714|Cyclophosphamide|cyclophosphamide|mesh-list
5651534|NCT03704714|Rituximab|rituximab|mesh-list
5827895|NCT02572947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5827896|NCT02572947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5827897|NCT02572947|Antiviral Agents|antiviral agents|mesh-ancestor
5827898|NCT02572947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5827899|NCT02572505|Tenofovir|tenofovir|mesh-list
5827900|NCT02572505|Emtricitabine|emtricitabine|mesh-list
5827901|NCT02572505|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5827902|NCT02572505|Antiviral Agents|antiviral agents|mesh-ancestor
5827903|NCT02572505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5827904|NCT02572505|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5827905|NCT02572505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5827906|NCT02572505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5827907|NCT02572505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5827908|NCT02572505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5827909|NCT02572505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5827910|NCT02572583|Oseltamivir|oseltamivir|mesh-list
5827911|NCT02572583|Antiviral Agents|antiviral agents|mesh-ancestor
5827912|NCT02572583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5827913|NCT02572583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5827914|NCT02572583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5827915|NCT02572687|Durvalumab|durvalumab|mesh-list
5827916|NCT02572687|Ramucirumab|ramucirumab|mesh-list
5827917|NCT02572687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5827918|NCT02572687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5827919|NCT02572596|Cyclophosphamide|cyclophosphamide|mesh-list
5827920|NCT02572596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5827921|NCT02572596|Immunologic Factors|immunologic factors|mesh-ancestor
5827922|NCT02572596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827923|NCT02572596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5827924|NCT02572596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5827925|NCT02572596|Alkylating Agents|alkylating agents|mesh-ancestor
5827926|NCT02572596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5827927|NCT02572596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5827928|NCT02572596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5827929|NCT02572492|Dexamethasone|dexamethasone|mesh-list
5827930|NCT02572492|Dexamethasone acetate|dexamethasone acetate|mesh-list
5827931|NCT02572492|Melphalan|melphalan|mesh-list
5827932|NCT02572492|BB 1101|bb 1101|mesh-list
5827933|NCT02572492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5827934|NCT02572492|Antiemetics|antiemetics|mesh-ancestor
5827935|NCT02572492|Autonomic Agents|autonomic agents|mesh-ancestor
5827936|NCT02572492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5827937|NCT02572492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827938|NCT02572492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5827939|NCT02572492|Glucocorticoids|glucocorticoids|mesh-ancestor
5827940|NCT02572492|Hormones|hormones|mesh-ancestor
5827941|NCT02572492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5827942|NCT02572492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5827943|NCT02572492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5827944|NCT02572492|Protease Inhibitors|protease inhibitors|mesh-ancestor
5827945|NCT02572492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5827946|NCT02572492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5827947|NCT02572492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5827948|NCT02572492|Alkylating Agents|alkylating agents|mesh-ancestor
5827949|NCT02572492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5827950|NCT02572492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5827951|NCT02572492|Immunologic Factors|immunologic factors|mesh-ancestor
5827952|NCT02572323|Tesamorelin|tesamorelin|mesh-list
5827953|NCT02572323|Growth Substances|growth substances|mesh-ancestor
5827954|NCT02572323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827955|NCT02572336|Plasminogen|plasminogen|mesh-list
5827956|NCT02572336|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5827957|NCT02572336|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5827958|NCT02572336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5827959|NCT02572336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5651535|NCT03704714|Doxorubicin|doxorubicin|mesh-list
5651536|NCT03704714|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5651537|NCT03704714|Nivolumab|nivolumab|mesh-list
5651538|NCT03704714|Vincristine|vincristine|mesh-list
5651539|NCT03704714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5651540|NCT03704714|Antibodies|antibodies|mesh-list
5651541|NCT03704714|Immunoglobulins|immunoglobulins|mesh-list
5651542|NCT03704714|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5651543|NCT03704714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5651544|NCT03704714|Immunologic Factors|immunologic factors|mesh-ancestor
5651545|NCT03704714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651546|NCT03704714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5651547|NCT03704714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5651548|NCT03704714|Alkylating Agents|alkylating agents|mesh-ancestor
5651549|NCT03704714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5651550|NCT03704714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5651551|NCT03704714|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5651552|NCT03704714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5651553|NCT03704714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5651554|NCT03704714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5651555|NCT03704714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5651556|NCT03704714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5651557|NCT03704714|Glucocorticoids|glucocorticoids|mesh-ancestor
5651558|NCT03704714|Hormones|hormones|mesh-ancestor
5651559|NCT03704714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5651560|NCT03704714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5651561|NCT03704714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5651562|NCT03704714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5651563|NCT03704714|Tubulin Modulators|tubulin modulators|mesh-ancestor
5651564|NCT03704714|Antimitotic Agents|antimitotic agents|mesh-ancestor
5651565|NCT03704714|Mitosis Modulators|mitosis modulators|mesh-ancestor
5651566|NCT03704623|Acetaminophen|acetaminophen|mesh-list
5651567|NCT03704623|Parecoxib|parecoxib|mesh-list
5651568|NCT03704623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5651569|NCT03704623|Analgesics|analgesics|mesh-ancestor
5651570|NCT03704623|Sensory System Agents|sensory system agents|mesh-ancestor
5651571|NCT03704623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5651572|NCT03704623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827960|NCT02572375|Phenylpropanolamine|phenylpropanolamine|mesh-list
5827961|NCT02572375|Codeine|codeine|mesh-list
5827962|NCT02572375|Guaifenesin|guaifenesin|mesh-list
5827963|NCT02572375|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
5827964|NCT02572375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5827965|NCT02572375|Narcotics|narcotics|mesh-ancestor
5827966|NCT02572375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5827967|NCT02572375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827968|NCT02572375|Analgesics|analgesics|mesh-ancestor
5827969|NCT02572375|Sensory System Agents|sensory system agents|mesh-ancestor
5827970|NCT02572375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5827971|NCT02572375|Antitussive Agents|antitussive agents|mesh-ancestor
5827972|NCT02572375|Respiratory System Agents|respiratory system agents|mesh-ancestor
5827973|NCT02572375|Expectorants|expectorants|mesh-ancestor
5827974|NCT02572375|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5651573|NCT03704623|Antipyretics|antipyretics|mesh-ancestor
5651574|NCT03704623|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5651575|NCT03704623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5651576|NCT03704623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5651577|NCT03704623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5651578|NCT03704623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5651579|NCT03704623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5651580|NCT03704623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5651581|NCT03704506|Amoxicillin|amoxicillin|mesh-list
5651582|NCT03704506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5651583|NCT03704506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5651584|NCT03704480|Durvalumab|durvalumab|mesh-list
5651585|NCT03704480|Tremelimumab|tremelimumab|mesh-list
5827975|NCT02572375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5827976|NCT02572375|Adrenergic Agents|adrenergic agents|mesh-ancestor
5827977|NCT02572375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5827978|NCT02572375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5827979|NCT02572375|Appetite Depressants|appetite depressants|mesh-ancestor
5827980|NCT02572375|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5827981|NCT02572375|Sympathomimetics|sympathomimetics|mesh-ancestor
5827982|NCT02572375|Autonomic Agents|autonomic agents|mesh-ancestor
5651586|NCT03704480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5651587|NCT03704480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5827983|NCT02572375|Nasal Decongestants|nasal decongestants|mesh-ancestor
5651588|NCT03704441|Bupivacaine|bupivacaine|mesh-list
5827984|NCT02572375|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5827985|NCT02572089|Naloxone|naloxone|mesh-list
5827986|NCT02572089|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5827987|NCT02572089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5827988|NCT02572089|Sensory System Agents|sensory system agents|mesh-ancestor
5827989|NCT02572089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5827990|NCT02572141|Leucovorin|leucovorin|mesh-list
5827991|NCT02572141|Fluorouracil|fluorouracil|mesh-list
5827992|NCT02572141|Capecitabine|capecitabine|mesh-list
5827993|NCT02572141|Oxaliplatin|oxaliplatin|mesh-list
5827994|NCT02572141|Levoleucovorin|levoleucovorin|mesh-list
5827995|NCT02572141|Antimetabolites|antimetabolites|mesh-ancestor
5827996|NCT02572141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5827997|NCT02572141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5827998|NCT02572141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5827999|NCT02572141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5828000|NCT02572141|Immunologic Factors|immunologic factors|mesh-ancestor
5828001|NCT02572141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211721|NCT02176291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6211722|NCT02176291|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6211723|NCT02176356|Bimatoprost|bimatoprost|mesh-list
6211724|NCT02176356|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6211725|NCT02176356|Botulinum Toxins|botulinum toxins|mesh-list
6211726|NCT02176356|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6211727|NCT02176356|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6211728|NCT02176356|Hyaluronic Acid|hyaluronic acid|mesh-list
5828002|NCT02572141|Antidotes|antidotes|mesh-ancestor
5828003|NCT02572141|Protective Agents|protective agents|mesh-ancestor
5828004|NCT02572141|Vitamin B Complex|vitamin b complex|mesh-ancestor
5828005|NCT02572141|Vitamins|vitamins|mesh-ancestor
5828006|NCT02572141|Micronutrients|micronutrients|mesh-ancestor
5902293|NCT04779216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902294|NCT04773184|Capsaicin|capsaicin|mesh-list
5902295|NCT04773184|Antipruritics|antipruritics|mesh-ancestor
5902296|NCT04773184|Dermatologic Agents|dermatologic agents|mesh-ancestor
5902297|NCT04773184|Sensory System Agents|sensory system agents|mesh-ancestor
5902298|NCT04773184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5902299|NCT04773184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902300|NCT04765371|Dexamethasone|dexamethasone|mesh-list
5902301|NCT04765371|Dexamethasone acetate|dexamethasone acetate|mesh-list
5902302|NCT04765371|Prednisolone|prednisolone|mesh-list
5902303|NCT04765371|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5902304|NCT04765371|Methylprednisolone|methylprednisolone|mesh-list
5902305|NCT04765371|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5902306|NCT04765371|Prednisolone acetate|prednisolone acetate|mesh-list
5902307|NCT04765371|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5902308|NCT04765371|Prednisolone phosphate|prednisolone phosphate|mesh-list
5902309|NCT04765371|BB 1101|bb 1101|mesh-list
5902310|NCT04765371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5902311|NCT04765371|Antiemetics|antiemetics|mesh-ancestor
5902312|NCT04765371|Autonomic Agents|autonomic agents|mesh-ancestor
5902313|NCT04765371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5902314|NCT04765371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902315|NCT04765371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5902316|NCT04765371|Glucocorticoids|glucocorticoids|mesh-ancestor
5902317|NCT04765371|Hormones|hormones|mesh-ancestor
5902318|NCT04765371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5902319|NCT04765371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5902320|NCT04765371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5902321|NCT04765371|Protease Inhibitors|protease inhibitors|mesh-ancestor
5902322|NCT04765371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5902323|NCT04765371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902324|NCT04765371|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5902325|NCT04765371|Protective Agents|protective agents|mesh-ancestor
5902326|NCT04739995|Naltrexone|naltrexone|mesh-list
5902327|NCT04739995|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5902328|NCT04739995|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5902329|NCT04739995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902330|NCT04739995|Sensory System Agents|sensory system agents|mesh-ancestor
5902331|NCT04739995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5902332|NCT04710641|Sorafenib|sorafenib|mesh-list
5902333|NCT04710641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5902334|NCT04710641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5902335|NCT04710641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5902336|NCT04710641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902337|NCT04562129|Aldesleukin|aldesleukin|mesh-list
5902338|NCT04562129|Nivolumab|nivolumab|mesh-list
5902339|NCT04562129|Ipilimumab|ipilimumab|mesh-list
6211729|NCT02176356|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5828007|NCT02571842|Prednisolone|prednisolone|mesh-list
5828008|NCT02571842|Rituximab|rituximab|mesh-list
5828009|NCT02571842|Enalapril|enalapril|mesh-list
5828010|NCT02571842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5828011|NCT02571842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5828012|NCT02571842|Immunologic Factors|immunologic factors|mesh-ancestor
5828013|NCT02571842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828014|NCT02571842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5828015|NCT02571842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5828016|NCT02571842|Glucocorticoids|glucocorticoids|mesh-ancestor
5828017|NCT02571842|Hormones|hormones|mesh-ancestor
5828018|NCT02571842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5828019|NCT02571842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5828020|NCT02571842|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5828021|NCT02571842|Protease Inhibitors|protease inhibitors|mesh-ancestor
5828022|NCT02571842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5828023|NCT02571842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5828024|NCT02571842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5651589|NCT03704441|Anesthetics, Local|anesthetics, local|mesh-ancestor
5651590|NCT03704441|Anesthetics|anesthetics|mesh-ancestor
5651591|NCT03704441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5651592|NCT03704441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651593|NCT03704441|Sensory System Agents|sensory system agents|mesh-ancestor
5651594|NCT03704441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5651595|NCT03704363|Infliximab|infliximab|mesh-list
5651596|NCT03704363|Dermatologic Agents|dermatologic agents|mesh-ancestor
5651597|NCT03704363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5651598|NCT03704363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5651599|NCT03704285|Propofol|propofol|mesh-list
5651600|NCT03704285|Anesthetics|anesthetics|mesh-list
5651601|NCT03704285|Anesthetics, General|anesthetics, general|mesh-list
5651602|NCT03704285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5651603|NCT03704285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5651604|NCT03704285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651605|NCT03704285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5651606|NCT03704246|Antibodies|antibodies|mesh-list
5651607|NCT03704246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5651608|NCT03704246|Immunologic Factors|immunologic factors|mesh-ancestor
5651609|NCT03704246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651610|NCT03704220|Warfarin|warfarin|mesh-list
5651611|NCT03704220|Anticoagulants|anticoagulants|mesh-ancestor
5651612|NCT03704181|Colchicine|colchicine|mesh-list
5651613|NCT03704181|Gout Suppressants|gout suppressants|mesh-ancestor
5651614|NCT03704181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5651615|NCT03704181|Tubulin Modulators|tubulin modulators|mesh-ancestor
5651616|NCT03704181|Antimitotic Agents|antimitotic agents|mesh-ancestor
5651617|NCT03704181|Mitosis Modulators|mitosis modulators|mesh-ancestor
5651618|NCT03704181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5651619|NCT03704181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5651620|NCT03704155|Botulinum Toxins|botulinum toxins|mesh-list
5828025|NCT02571959|Amoxicillin|amoxicillin|mesh-list
5828026|NCT02571959|Clavulanic Acids|clavulanic acids|mesh-list
5828027|NCT02571959|Clavulanic Acid|clavulanic acid|mesh-list
5828028|NCT02571959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5828029|NCT02571959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5828030|NCT02571959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5828031|NCT02571959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5828032|NCT02571959|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5828033|NCT02571712|Timolol|timolol|mesh-list
5828034|NCT02571712|Bimatoprost|bimatoprost|mesh-list
5828035|NCT02571712|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5828036|NCT02571712|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5828037|NCT02571712|Adrenergic Agents|adrenergic agents|mesh-ancestor
5828038|NCT02571712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5828039|NCT02571712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5828040|NCT02571712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828041|NCT02571712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5828042|NCT02571712|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5828043|NCT02571881|Oxycodone|oxycodone|mesh-list
5828044|NCT02571881|Naloxone|naloxone|mesh-list
5828045|NCT02571881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5828046|NCT02571881|Narcotics|narcotics|mesh-ancestor
5828047|NCT02571881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5828048|NCT02571881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651621|NCT03704155|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5651622|NCT03704155|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5651623|NCT03704155|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5651624|NCT03704155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5651625|NCT03704155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5828049|NCT02571881|Analgesics|analgesics|mesh-ancestor
5828050|NCT02571881|Sensory System Agents|sensory system agents|mesh-ancestor
5828051|NCT02571881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5828052|NCT02571881|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5828053|NCT02571725|Olaparib|olaparib|mesh-list
5828054|NCT02571725|Tremelimumab|tremelimumab|mesh-list
5828055|NCT02571725|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5828056|NCT02571725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5651626|NCT03704155|Cholinergic Agents|cholinergic agents|mesh-ancestor
5651627|NCT03704155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5651628|NCT03704155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651629|NCT03704155|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5651630|NCT03704155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5651631|NCT03704077|Paclitaxel|paclitaxel|mesh-list
5651632|NCT03704077|Nivolumab|nivolumab|mesh-list
5651633|NCT03704077|Ramucirumab|ramucirumab|mesh-list
5651634|NCT03704077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5651635|NCT03704077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5651636|NCT03704077|Tubulin Modulators|tubulin modulators|mesh-ancestor
5651637|NCT03704077|Antimitotic Agents|antimitotic agents|mesh-ancestor
5651638|NCT03704077|Mitosis Modulators|mitosis modulators|mesh-ancestor
5828057|NCT02571725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5828058|NCT02571725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5828059|NCT02571608|Metformin|metformin|mesh-list
5828060|NCT02571608|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5828061|NCT02571608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828062|NCT02571283|Epinephrine|epinephrine|mesh-list
5828063|NCT02571283|Bupivacaine|bupivacaine|mesh-list
5828064|NCT02571283|Anesthetics, Local|anesthetics, local|mesh-ancestor
5828065|NCT02571283|Anesthetics|anesthetics|mesh-ancestor
5828066|NCT02571283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5828067|NCT02571283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828068|NCT02571283|Sensory System Agents|sensory system agents|mesh-ancestor
5828069|NCT02571283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5828070|NCT02571283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5828071|NCT02571283|Autonomic Agents|autonomic agents|mesh-ancestor
5828072|NCT02571283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5828073|NCT02571283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5828074|NCT02571283|Adrenergic Agents|adrenergic agents|mesh-ancestor
5828075|NCT02571283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5828076|NCT02571283|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5828077|NCT02571283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5828078|NCT02571283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5828079|NCT02571283|Respiratory System Agents|respiratory system agents|mesh-ancestor
5828080|NCT02571283|Mydriatics|mydriatics|mesh-ancestor
5828081|NCT02571283|Sympathomimetics|sympathomimetics|mesh-ancestor
5828082|NCT02571283|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5828083|NCT02571517|Methylprednisolone|methylprednisolone|mesh-list
5828084|NCT02571517|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5828085|NCT02571517|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5828086|NCT02571517|Prednisolone|prednisolone|mesh-list
5651639|NCT03704077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5651640|NCT03704077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5651641|NCT03704077|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5651642|NCT03703960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
5651643|NCT03703960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5828087|NCT02571517|Prednisolone acetate|prednisolone acetate|mesh-list
5828088|NCT02571517|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5828089|NCT02571517|Prednisolone phosphate|prednisolone phosphate|mesh-list
5828090|NCT02571517|Glucocorticoids|glucocorticoids|mesh-list
5828091|NCT02571517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5828092|NCT02571517|Antiemetics|antiemetics|mesh-ancestor
5828093|NCT02571517|Autonomic Agents|autonomic agents|mesh-ancestor
5828094|NCT02571517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5828095|NCT02571517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828096|NCT02571517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5828097|NCT02571517|Hormones|hormones|mesh-ancestor
5828098|NCT02571517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5828099|NCT02571517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5828100|NCT02571517|Protective Agents|protective agents|mesh-ancestor
5828101|NCT02571517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5828102|NCT02571517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5828103|NCT02571556|Dexamethasone|dexamethasone|mesh-list
5828104|NCT02571556|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5651644|NCT03703960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651645|NCT03703869|Insulin Glargine|insulin glargine|mesh-list
5651646|NCT03703869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5651647|NCT03703869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651648|NCT03703856|Memantine|memantine|mesh-list
5651649|NCT03703856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5651650|NCT03703856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5651651|NCT03703856|Dopamine Agents|dopamine agents|mesh-ancestor
5651652|NCT03703856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5651653|NCT03703856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5651654|NCT03703856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651655|NCT03703856|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5651656|NCT03703856|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5651657|NCT03703596|Docetaxel|docetaxel|mesh-list
5651658|NCT03703596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5651659|NCT03703596|Tubulin Modulators|tubulin modulators|mesh-ancestor
5828105|NCT02571556|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
5828106|NCT02571556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5828107|NCT02571556|Antiemetics|antiemetics|mesh-ancestor
5828108|NCT02571556|Autonomic Agents|autonomic agents|mesh-ancestor
5828109|NCT02571556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5828110|NCT02571556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828111|NCT02571556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5651660|NCT03703596|Antimitotic Agents|antimitotic agents|mesh-ancestor
5651661|NCT03703596|Mitosis Modulators|mitosis modulators|mesh-ancestor
5651662|NCT03703596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5651663|NCT03703427|Capecitabine|capecitabine|mesh-list
5651664|NCT03703427|Vinorelbine|vinorelbine|mesh-list
5651665|NCT03703427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5651666|NCT03703427|Antimetabolites|antimetabolites|mesh-ancestor
5651667|NCT03703427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5651668|NCT03703427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5828112|NCT02571556|Glucocorticoids|glucocorticoids|mesh-ancestor
5828113|NCT02571556|Hormones|hormones|mesh-ancestor
5828114|NCT02571556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5828115|NCT02571556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5828116|NCT02571556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5828117|NCT02571556|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5828118|NCT02571426|Propofol|propofol|mesh-list
5828119|NCT02571426|Sevoflurane|sevoflurane|mesh-list
5828120|NCT02571426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5828121|NCT02571426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5828122|NCT02571426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828123|NCT02571426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5828124|NCT02571426|Anesthetics, General|anesthetics, general|mesh-ancestor
5828125|NCT02571426|Anesthetics|anesthetics|mesh-ancestor
5828126|NCT02571426|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5828127|NCT02571426|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5828128|NCT02571361|Acetaminophen|acetaminophen|mesh-list
5828129|NCT02571361|Ibuprofen|ibuprofen|mesh-list
5828130|NCT02571361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5651669|NCT03703427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5651670|NCT03703427|Tubulin Modulators|tubulin modulators|mesh-ancestor
5651671|NCT03703427|Antimitotic Agents|antimitotic agents|mesh-ancestor
5651672|NCT03703427|Mitosis Modulators|mitosis modulators|mesh-ancestor
5694613|NCT03394430|Dexmedetomidine|dexmedetomidine|mesh-list
5694614|NCT03394430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5694615|NCT03394430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5694616|NCT03394430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694617|NCT03394430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5694618|NCT03394430|Analgesics|analgesics|mesh-ancestor
5694619|NCT03394430|Sensory System Agents|sensory system agents|mesh-ancestor
5694620|NCT03394430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5694621|NCT03394430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5694622|NCT03394430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5694623|NCT03394430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5694624|NCT03394430|Adrenergic Agents|adrenergic agents|mesh-ancestor
5694625|NCT03394430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5694626|NCT03394430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5828131|NCT02571361|Analgesics|analgesics|mesh-ancestor
5828132|NCT02571361|Sensory System Agents|sensory system agents|mesh-ancestor
5828133|NCT02571361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5828134|NCT02571361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828135|NCT02571361|Antipyretics|antipyretics|mesh-ancestor
5828136|NCT02571361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5828137|NCT02571361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5651673|NCT03703349|Magnesium Sulfate|magnesium sulfate|mesh-list
5651674|NCT03703349|Analgesics|analgesics|mesh-ancestor
5651675|NCT03703349|Sensory System Agents|sensory system agents|mesh-ancestor
5651676|NCT03703349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5651677|NCT03703349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651678|NCT03703349|Anesthetics|anesthetics|mesh-ancestor
5651679|NCT03703349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5651680|NCT03703349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5651681|NCT03703349|Anticonvulsants|anticonvulsants|mesh-ancestor
5828138|NCT02571361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5828139|NCT02571361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5828140|NCT02571361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5828141|NCT02571361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5651682|NCT03703349|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5651683|NCT03703349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5651684|NCT03703349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5651685|NCT03703349|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5651686|NCT03703349|Tocolytic Agents|tocolytic agents|mesh-ancestor
5651687|NCT03703349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5651688|NCT03703310|Veratrum Alkaloids|veratrum alkaloids|mesh-list
5651689|NCT03703310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5651690|NCT03703271|Methotrexate|methotrexate|mesh-list
5651691|NCT03703271|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5651692|NCT03703271|Abortifacient Agents|abortifacient agents|mesh-ancestor
5651693|NCT03703271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5651694|NCT03703271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651695|NCT03703271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5651696|NCT03703271|Antimetabolites|antimetabolites|mesh-ancestor
5651697|NCT03703271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5651698|NCT03703271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5651699|NCT03703271|Dermatologic Agents|dermatologic agents|mesh-ancestor
5651700|NCT03703271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5651701|NCT03703271|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5651702|NCT03703271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5651703|NCT03703271|Immunologic Factors|immunologic factors|mesh-ancestor
5651704|NCT03703271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5651705|NCT03703271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5651706|NCT03703206|Anesthetics|anesthetics|mesh-list
5651707|NCT03703206|Anesthetics, Local|anesthetics, local|mesh-list
5651708|NCT03703206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5651709|NCT03703206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651710|NCT03703206|Sensory System Agents|sensory system agents|mesh-ancestor
5651711|NCT03703206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5651712|NCT03703167|Rituximab|rituximab|mesh-list
5651713|NCT03703167|Lenalidomide|lenalidomide|mesh-list
5651714|NCT03703167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5651715|NCT03703167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5651716|NCT03703167|Immunologic Factors|immunologic factors|mesh-ancestor
5651717|NCT03703167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651718|NCT03703167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5651719|NCT03703167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5651720|NCT03703167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5651721|NCT03703167|Growth Substances|growth substances|mesh-ancestor
5651722|NCT03703167|Growth Inhibitors|growth inhibitors|mesh-ancestor
5651723|NCT03703154|Tacrolimus|tacrolimus|mesh-list
5651724|NCT03703154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5651725|NCT03703154|Immunologic Factors|immunologic factors|mesh-ancestor
5651726|NCT03703154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651727|NCT03703154|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5651728|NCT03703154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5651729|NCT03703154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5651730|NCT03703089|Gemcitabine|gemcitabine|mesh-list
5651731|NCT03703089|Paclitaxel|paclitaxel|mesh-list
5651732|NCT03703089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5651733|NCT03703089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5651734|NCT03703089|Tubulin Modulators|tubulin modulators|mesh-ancestor
5651735|NCT03703089|Antimitotic Agents|antimitotic agents|mesh-ancestor
5651736|NCT03703089|Mitosis Modulators|mitosis modulators|mesh-ancestor
5651737|NCT03703089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5651738|NCT03703089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5651739|NCT03703089|Antimetabolites|antimetabolites|mesh-ancestor
5651740|NCT03703089|Antiviral Agents|antiviral agents|mesh-ancestor
5828142|NCT02571543|Ibuprofen|ibuprofen|mesh-list
5651741|NCT03703089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5651742|NCT03703089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5651743|NCT03703089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5651744|NCT03703089|Immunologic Factors|immunologic factors|mesh-ancestor
5651745|NCT03703089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651746|NCT03703063|Leucovorin|leucovorin|mesh-list
5828143|NCT02571543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5828144|NCT02571543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5828145|NCT02571543|Analgesics|analgesics|mesh-ancestor
5828146|NCT02571543|Sensory System Agents|sensory system agents|mesh-ancestor
5828147|NCT02571543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5828148|NCT02571543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828149|NCT02571543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5828150|NCT02571543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5828151|NCT02571543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5828152|NCT02571543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5828153|NCT02571543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5651747|NCT03703063|Gemcitabine|gemcitabine|mesh-list
5651748|NCT03703063|Paclitaxel|paclitaxel|mesh-list
5651749|NCT03703063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5651750|NCT03703063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5651751|NCT03703063|Tubulin Modulators|tubulin modulators|mesh-ancestor
5651752|NCT03703063|Antimitotic Agents|antimitotic agents|mesh-ancestor
5651753|NCT03703063|Mitosis Modulators|mitosis modulators|mesh-ancestor
5828154|NCT02571205|Testosterone|testosterone|mesh-list
5828155|NCT02571205|Androgens|androgens|mesh-ancestor
5828156|NCT02571205|Hormones|hormones|mesh-ancestor
5828157|NCT02571205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5828158|NCT02571205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828159|NCT02571296|Progesterone|progesterone|mesh-list
5828160|NCT02571296|Progestins|progestins|mesh-ancestor
5828161|NCT02571296|Hormones|hormones|mesh-ancestor
5828162|NCT02571296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5828163|NCT02571296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828164|NCT02571192|Volixibat|volixibat|mesh-list
5828165|NCT02571192|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5828166|NCT02571400|Analgesics, Opioid|analgesics, opioid|mesh-list
5828167|NCT02571400|Analgesics|analgesics|mesh-list
5828168|NCT02571400|Narcotics|narcotics|mesh-ancestor
5828169|NCT02571400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5828170|NCT02571400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828171|NCT02571400|Sensory System Agents|sensory system agents|mesh-ancestor
5828172|NCT02571400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5828173|NCT02571491|Morphine|morphine|mesh-list
5828174|NCT02571491|Remifentanil|remifentanil|mesh-list
6493161|NCT00612274|Dermatologic Agents|dermatologic agents|mesh-ancestor
6493162|NCT00612274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6493163|NCT00612274|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5651754|NCT03703063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5651755|NCT03703063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5651756|NCT03703063|Antimetabolites|antimetabolites|mesh-ancestor
5651757|NCT03703063|Antiviral Agents|antiviral agents|mesh-ancestor
5651758|NCT03703063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5651759|NCT03703063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5651760|NCT03703063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5651761|NCT03703063|Immunologic Factors|immunologic factors|mesh-ancestor
5651762|NCT03703063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651763|NCT03703063|Antidotes|antidotes|mesh-ancestor
5651764|NCT03703063|Protective Agents|protective agents|mesh-ancestor
5651765|NCT03703063|Vitamin B Complex|vitamin b complex|mesh-ancestor
5828175|NCT02571491|Ketamine|ketamine|mesh-list
5828176|NCT02571491|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5828177|NCT02571491|Narcotics|narcotics|mesh-ancestor
5828178|NCT02571491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5651766|NCT03703063|Vitamins|vitamins|mesh-ancestor
5651767|NCT03703063|Micronutrients|micronutrients|mesh-ancestor
5651768|NCT03703050|Nivolumab|nivolumab|mesh-list
5651769|NCT03703050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5651770|NCT03703050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5651771|NCT03703050|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5651772|NCT03703050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5651773|NCT03702985|Capecitabine|capecitabine|mesh-list
5651774|NCT03702985|Irinotecan|irinotecan|mesh-list
5651775|NCT03702985|Amifostine|amifostine|mesh-list
5828179|NCT02571491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828180|NCT02571491|Analgesics|analgesics|mesh-ancestor
6493164|NCT00612274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5828181|NCT02571491|Sensory System Agents|sensory system agents|mesh-ancestor
5828182|NCT02571491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5828183|NCT02571491|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5828184|NCT02571491|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5828185|NCT02571491|Anesthetics, General|anesthetics, general|mesh-ancestor
5828186|NCT02571491|Anesthetics|anesthetics|mesh-ancestor
5828187|NCT02571491|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5828188|NCT02571491|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5828189|NCT02571491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5828190|NCT02571491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5651776|NCT03702985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5651777|NCT03702985|Antimetabolites|antimetabolites|mesh-ancestor
5651778|NCT03702985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5651779|NCT03702985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5828191|NCT02571166|Valacyclovir|valacyclovir|mesh-list
5828192|NCT02571166|Antiviral Agents|antiviral agents|mesh-ancestor
5828193|NCT02571166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5828194|NCT02571179|Fentanyl|fentanyl|mesh-list
5828195|NCT02571179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5828196|NCT02571179|Narcotics|narcotics|mesh-ancestor
5828197|NCT02571179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5828198|NCT02571179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651780|NCT03702985|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5651781|NCT03702985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5651782|NCT03702985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5828199|NCT02571179|Analgesics|analgesics|mesh-ancestor
5828200|NCT02571179|Sensory System Agents|sensory system agents|mesh-ancestor
5828201|NCT02571179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5828202|NCT02571179|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5828203|NCT02571179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5828204|NCT02571179|Anesthetics, General|anesthetics, general|mesh-ancestor
5828205|NCT02571179|Anesthetics|anesthetics|mesh-ancestor
5828206|NCT02570893|Paclitaxel|paclitaxel|mesh-list
5828207|NCT02570893|Carboplatin|carboplatin|mesh-list
5828208|NCT02570893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5828209|NCT02570893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5828210|NCT02570893|Tubulin Modulators|tubulin modulators|mesh-ancestor
5828211|NCT02570893|Antimitotic Agents|antimitotic agents|mesh-ancestor
5828212|NCT02570893|Mitosis Modulators|mitosis modulators|mesh-ancestor
5828213|NCT02570893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5828214|NCT02570971|Mannitol|mannitol|mesh-list
5828215|NCT02570971|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5828216|NCT02570971|Diuretics|diuretics|mesh-ancestor
5828217|NCT02570971|Natriuretic Agents|natriuretic agents|mesh-ancestor
5828218|NCT02570971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828219|NCT02571140|Teriparatide|teriparatide|mesh-list
5828220|NCT02571140|Parathyroid Hormone|parathyroid hormone|mesh-list
5828221|NCT02571140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5828222|NCT02571140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828223|NCT02571140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5828224|NCT02570841|Capsaicin|capsaicin|mesh-list
5828225|NCT02570841|Antipruritics|antipruritics|mesh-ancestor
5828226|NCT02570841|Dermatologic Agents|dermatologic agents|mesh-ancestor
5828227|NCT02570841|Sensory System Agents|sensory system agents|mesh-ancestor
5828228|NCT02570841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5828229|NCT02570841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828230|NCT02570789|Sunitinib|sunitinib|mesh-list
5828231|NCT02570789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5828232|NCT02570789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5828233|NCT02570789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5828234|NCT02570789|Growth Substances|growth substances|mesh-ancestor
5651783|NCT03702985|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5651784|NCT03702985|Protective Agents|protective agents|mesh-ancestor
5651785|NCT03702985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651786|NCT03702959|Betamethasone|betamethasone|mesh-list
5651787|NCT03702959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5651788|NCT03702959|Glucocorticoids|glucocorticoids|mesh-ancestor
5651789|NCT03702959|Hormones|hormones|mesh-ancestor
5828235|NCT02570789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828236|NCT02570789|Growth Inhibitors|growth inhibitors|mesh-ancestor
5828237|NCT02570789|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5828238|NCT02570789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5828239|NCT02570789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5828240|NCT02570477|Vancomycin|vancomycin|mesh-list
5828241|NCT02570477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5828242|NCT02570477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5828243|NCT02570581|Acetaminophen|acetaminophen|mesh-list
5828244|NCT02570581|Ramipril|ramipril|mesh-list
5828245|NCT02570581|Furosemide|furosemide|mesh-list
5828246|NCT02570581|Memantine|memantine|mesh-list
5828247|NCT02570581|Alprazolam|alprazolam|mesh-list
5828248|NCT02570581|Zopiclone|zopiclone|mesh-list
5828249|NCT02570581|Oxazepam|oxazepam|mesh-list
5828250|NCT02570581|Donepezil|donepezil|mesh-list
5828251|NCT02570581|Clopidogrel|clopidogrel|mesh-list
5828252|NCT02570581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5828253|NCT02570581|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5828254|NCT02570581|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5828255|NCT02570581|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5828256|NCT02570581|Purinergic Agents|purinergic agents|mesh-ancestor
5828257|NCT02570581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5828258|NCT02570581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5828259|NCT02570581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828260|NCT02570581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5828261|NCT02570581|Analgesics|analgesics|mesh-ancestor
5828262|NCT02570581|Sensory System Agents|sensory system agents|mesh-ancestor
5828263|NCT02570581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5828264|NCT02570581|Antipyretics|antipyretics|mesh-ancestor
5828265|NCT02570581|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5828266|NCT02570581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5828267|NCT02570581|Cholinergic Agents|cholinergic agents|mesh-ancestor
5828268|NCT02570581|Nootropic Agents|nootropic agents|mesh-ancestor
5828269|NCT02570581|Diuretics|diuretics|mesh-ancestor
5828270|NCT02570581|Natriuretic Agents|natriuretic agents|mesh-ancestor
5828271|NCT02570581|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5828272|NCT02570581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6493165|NCT00612274|Immunologic Factors|immunologic factors|mesh-ancestor
6493166|NCT00612274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6493167|NCT00612274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6493168|NCT00612274|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6493169|NCT00612274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6493170|NCT00612274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6493171|NCT00612274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6493172|NCT00612274|Antifungal Agents|antifungal agents|mesh-ancestor
6493173|NCT00612287|Buprenorphine|buprenorphine|mesh-list
6493174|NCT00612287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6493175|NCT00612287|Narcotics|narcotics|mesh-ancestor
6493176|NCT00612287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6493177|NCT00612287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493178|NCT00612287|Analgesics|analgesics|mesh-ancestor
5651790|NCT03702959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5828273|NCT02570581|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5828274|NCT02570581|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5828275|NCT02570581|Dopamine Agents|dopamine agents|mesh-ancestor
5828276|NCT02570581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5828277|NCT02570581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5828278|NCT02570581|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5828279|NCT02570581|Protease Inhibitors|protease inhibitors|mesh-ancestor
5828280|NCT02570581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5828281|NCT02570581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5828282|NCT02570581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5828283|NCT02570581|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5828284|NCT02570581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5828285|NCT02570581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5828286|NCT02570581|GABA Modulators|gaba modulators|mesh-ancestor
5828287|NCT02570581|GABA Agents|gaba agents|mesh-ancestor
5902340|NCT04562129|Interleukin-2|interleukin-2|mesh-list
5902341|NCT04562129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5902342|NCT04562129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5902343|NCT04562129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5902344|NCT04562129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902345|NCT04562129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5902346|NCT04562129|Analgesics|analgesics|mesh-ancestor
5902347|NCT04562129|Sensory System Agents|sensory system agents|mesh-ancestor
5651791|NCT03702959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651792|NCT03702959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5651793|NCT03702959|Respiratory System Agents|respiratory system agents|mesh-ancestor
5651794|NCT03702946|Oxytocin|oxytocin|mesh-list
5651795|NCT03702946|Oxytocics|oxytocics|mesh-ancestor
5651796|NCT03702946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6493179|NCT00612287|Sensory System Agents|sensory system agents|mesh-ancestor
5651797|NCT03702946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651798|NCT03702894|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5651799|NCT03702894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5651800|NCT03702894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5651801|NCT03702894|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6674477|NCT01569659|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6674478|NCT01569659|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6674479|NCT01569659|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6674480|NCT01569659|Adrenergic Agents|adrenergic agents|mesh-ancestor
6674481|NCT01569659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5828288|NCT02570191|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5828289|NCT02570191|Antiviral Agents|antiviral agents|mesh-ancestor
5828290|NCT02570191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5828291|NCT02570230|Ketamine|ketamine|mesh-list
5828292|NCT02570230|Analgesics|analgesics|mesh-ancestor
5828293|NCT02570230|Sensory System Agents|sensory system agents|mesh-ancestor
5828294|NCT02570230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5828295|NCT02570230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828296|NCT02570230|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5828297|NCT02570230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5828298|NCT02570230|Anesthetics, General|anesthetics, general|mesh-ancestor
5828299|NCT02570230|Anesthetics|anesthetics|mesh-ancestor
5828300|NCT02570230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5651802|NCT03702894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5651803|NCT03702894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5651804|NCT03702855|Tetrabenazine|tetrabenazine|mesh-list
5651805|NCT03702855|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5651806|NCT03702855|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5651807|NCT03702855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5651808|NCT03702855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5651809|NCT03702855|Adrenergic Agents|adrenergic agents|mesh-ancestor
5651810|NCT03702855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5651811|NCT03702855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651812|NCT03702803|Alprazolam|alprazolam|mesh-list
5651813|NCT03702803|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5651814|NCT03702803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5651815|NCT03702803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651816|NCT03702803|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5651817|NCT03702803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5651818|NCT03702803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5651819|NCT03702803|GABA Modulators|gaba modulators|mesh-ancestor
5651820|NCT03702803|GABA Agents|gaba agents|mesh-ancestor
5651821|NCT03702803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5694627|NCT03394430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5828301|NCT02570230|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5828302|NCT02570230|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5828303|NCT02570230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5828304|NCT02570230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5828305|NCT02570334|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
5828306|NCT02570334|Antiviral Agents|antiviral agents|mesh-ancestor
5828307|NCT02570334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5828308|NCT02570243|Heparin|heparin|mesh-list
5828309|NCT02570243|Calcium heparin|calcium heparin|mesh-list
5828310|NCT02570243|Anticoagulants|anticoagulants|mesh-ancestor
5828311|NCT02570243|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5828312|NCT02570243|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5828313|NCT02570243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5828314|NCT02570347|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5828315|NCT02570347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5828316|NCT02570347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5828317|NCT02570347|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5828318|NCT02570347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5828319|NCT02570347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5828320|NCT02569866|Cephalexin|cephalexin|mesh-list
5828321|NCT02569866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5828322|NCT02569866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5828323|NCT02569879|Vaccines|vaccines|mesh-list
5828324|NCT02569879|Immunologic Factors|immunologic factors|mesh-ancestor
5828325|NCT02569879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828326|NCT02570035|Mirabegron|mirabegron|mesh-list
5828327|NCT02570035|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
5828328|NCT02570035|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5828329|NCT02570035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5828330|NCT02570035|Adrenergic Agents|adrenergic agents|mesh-ancestor
5828331|NCT02570035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5828332|NCT02570035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5828333|NCT02570035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828334|NCT02570035|Urological Agents|urological agents|mesh-ancestor
5828335|NCT02569970|Fluoxetine|fluoxetine|mesh-list
5828336|NCT02569970|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5828337|NCT02569970|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5828338|NCT02569970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5828339|NCT02569970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5828340|NCT02569970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5828341|NCT02569970|Serotonin Agents|serotonin agents|mesh-ancestor
5828342|NCT02569970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828343|NCT02569970|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5828344|NCT02569970|Antidepressive Agents|antidepressive agents|mesh-ancestor
5651822|NCT03702803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5651823|NCT03702738|Acetylcysteine|acetylcysteine|mesh-list
5651824|NCT03702738|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5651825|NCT03702738|Antiviral Agents|antiviral agents|mesh-ancestor
5651826|NCT03702738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5651827|NCT03702738|Expectorants|expectorants|mesh-ancestor
5828345|NCT02569970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5828346|NCT02569970|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5828347|NCT02569970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5828348|NCT02569970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5828349|NCT02569905|Flurbiprofen|flurbiprofen|mesh-list
5828350|NCT02569905|Parecoxib|parecoxib|mesh-list
5828351|NCT02569905|Analgesics|analgesics|mesh-ancestor
5828352|NCT02569905|Sensory System Agents|sensory system agents|mesh-ancestor
5828353|NCT02569905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5828354|NCT02569905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828355|NCT02569905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5651828|NCT03702738|Respiratory System Agents|respiratory system agents|mesh-ancestor
5651829|NCT03702738|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5651830|NCT03702738|Antioxidants|antioxidants|mesh-ancestor
5651831|NCT03702738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5651832|NCT03702738|Protective Agents|protective agents|mesh-ancestor
5651833|NCT03702738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651834|NCT03702738|Antidotes|antidotes|mesh-ancestor
5828356|NCT02569905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5828357|NCT02569905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5828358|NCT02569905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5828359|NCT02569905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5828360|NCT02569905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5828361|NCT02569905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5828362|NCT02569905|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5828363|NCT02569814|Amlodipine|amlodipine|mesh-list
5828364|NCT02569814|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5828365|NCT02569814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5828366|NCT02569814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5828367|NCT02569814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5828368|NCT02569814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5828369|NCT02569814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5828370|NCT02569814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828371|NCT02569814|Vasodilator Agents|vasodilator agents|mesh-ancestor
5828372|NCT02569814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5828373|NCT02569814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5828374|NCT02569814|Antimetabolites|antimetabolites|mesh-ancestor
5828375|NCT02569814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5828376|NCT02569814|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5828377|NCT02569814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5828378|NCT02569489|Paclitaxel|paclitaxel|mesh-list
5828379|NCT02569489|Trastuzumab|trastuzumab|mesh-list
5828380|NCT02569489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5828381|NCT02569489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5828382|NCT02569489|Tubulin Modulators|tubulin modulators|mesh-ancestor
5651835|NCT03702725|Dexamethasone|dexamethasone|mesh-list
5651836|NCT03702725|Lenalidomide|lenalidomide|mesh-list
5651837|NCT03702725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5651838|NCT03702725|Antiemetics|antiemetics|mesh-ancestor
5651839|NCT03702725|Autonomic Agents|autonomic agents|mesh-ancestor
5651840|NCT03702725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5651841|NCT03702725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651842|NCT03702725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5651843|NCT03702725|Glucocorticoids|glucocorticoids|mesh-ancestor
5651844|NCT03702725|Hormones|hormones|mesh-ancestor
5828383|NCT02569489|Antimitotic Agents|antimitotic agents|mesh-ancestor
5828384|NCT02569489|Mitosis Modulators|mitosis modulators|mesh-ancestor
5828385|NCT02569489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5828386|NCT02569489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5828387|NCT02569515|Epoetin Alfa|epoetin alfa|mesh-list
5828388|NCT02569515|Hematinics|hematinics|mesh-ancestor
5828389|NCT02569463|Aldesleukin|aldesleukin|mesh-list
5828390|NCT02569463|Interleukin-2|interleukin-2|mesh-list
5828391|NCT02569463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5828392|NCT02569463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5828393|NCT02569463|Analgesics|analgesics|mesh-ancestor
5828394|NCT02569463|Sensory System Agents|sensory system agents|mesh-ancestor
5828395|NCT02569463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5828396|NCT02569463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828397|NCT02569463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5828398|NCT02569463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5828399|NCT02569463|Antiviral Agents|antiviral agents|mesh-ancestor
5828400|NCT02569463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5828401|NCT02569645|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5828402|NCT02569645|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5828403|NCT02569645|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5828404|NCT02569645|Antimetabolites|antimetabolites|mesh-ancestor
5828405|NCT02569645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5828406|NCT02569645|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5828407|NCT02569645|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5828408|NCT02569645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5828409|NCT02569502|Enfuvirtide|enfuvirtide|mesh-list
5828410|NCT02569502|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5828411|NCT02569502|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5828412|NCT02569502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5828413|NCT02569502|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5828414|NCT02569502|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5828415|NCT02569502|Antiviral Agents|antiviral agents|mesh-ancestor
5651845|NCT03702725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5651846|NCT03702725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5651847|NCT03702725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5651848|NCT03702725|Immunologic Factors|immunologic factors|mesh-ancestor
5651849|NCT03702725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5651850|NCT03702725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5651851|NCT03702725|Growth Substances|growth substances|mesh-ancestor
5651852|NCT03702725|Growth Inhibitors|growth inhibitors|mesh-ancestor
5651853|NCT03702647|Ropivacaine|ropivacaine|mesh-list
5651854|NCT03702647|Anesthetics, Local|anesthetics, local|mesh-ancestor
5651855|NCT03702647|Anesthetics|anesthetics|mesh-ancestor
5651856|NCT03702647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5651857|NCT03702647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651858|NCT03702647|Sensory System Agents|sensory system agents|mesh-ancestor
5651859|NCT03702647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5651860|NCT03702621|Bupivacaine|bupivacaine|mesh-list
5651861|NCT03702621|Anesthetics, Local|anesthetics, local|mesh-ancestor
5651862|NCT03702621|Anesthetics|anesthetics|mesh-ancestor
5651863|NCT03702621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5651864|NCT03702621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828416|NCT02569502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5828417|NCT02569554|Rabeprazole|rabeprazole|mesh-list
5828418|NCT02569554|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5828419|NCT02569554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5828420|NCT02569554|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5828421|NCT02569554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5828422|NCT02569554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5828423|NCT02569346|Triumeq|triumeq|mesh-list
5828424|NCT02569346|Lamivudine|lamivudine|mesh-list
5828425|NCT02569346|Abacavir|abacavir|mesh-list
5828426|NCT02569346|Dolutegravir|dolutegravir|mesh-list
5828427|NCT02569346|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5828428|NCT02569346|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5828429|NCT02569346|Antiviral Agents|antiviral agents|mesh-ancestor
5828430|NCT02569346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5828431|NCT02569346|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5828432|NCT02569346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5828433|NCT02569346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5828434|NCT02569346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5828435|NCT02569346|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5828436|NCT02569346|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5828437|NCT02569307|Minocycline|minocycline|mesh-list
6496441|NCT00628056|Perhexiline|perhexiline|mesh-list
5651865|NCT03702621|Sensory System Agents|sensory system agents|mesh-ancestor
5651866|NCT03702621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5651867|NCT03702582|Warfarin|warfarin|mesh-list
5651868|NCT03702582|Rivaroxaban|rivaroxaban|mesh-list
5651869|NCT03702582|Anticoagulants|anticoagulants|mesh-ancestor
5651870|NCT03702582|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5651871|NCT03702582|Antithrombins|antithrombins|mesh-ancestor
5651872|NCT03702582|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5651873|NCT03702582|Protease Inhibitors|protease inhibitors|mesh-ancestor
5651874|NCT03702582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5651875|NCT03702582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5651876|NCT03702530|Albendazole|albendazole|mesh-list
5651877|NCT03702530|Vaccines|vaccines|mesh-list
5651878|NCT03702530|Anthelmintics|anthelmintics|mesh-ancestor
5651879|NCT03702530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5651880|NCT03702530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5651881|NCT03702530|Anticestodal Agents|anticestodal agents|mesh-ancestor
5651882|NCT03702530|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5651883|NCT03702530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5651884|NCT03702530|Tubulin Modulators|tubulin modulators|mesh-ancestor
5651885|NCT03702530|Antimitotic Agents|antimitotic agents|mesh-ancestor
5828438|NCT02569307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5828439|NCT02569307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5828440|NCT02569073|Dronabinol|dronabinol|mesh-list
5828441|NCT02569073|Hallucinogens|hallucinogens|mesh-ancestor
5828442|NCT02569073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828443|NCT02569073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5828444|NCT02569073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5828445|NCT02569073|Analgesics|analgesics|mesh-ancestor
5651886|NCT03702530|Mitosis Modulators|mitosis modulators|mesh-ancestor
5651887|NCT03702530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5651888|NCT03702530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5651889|NCT03702530|Immunologic Factors|immunologic factors|mesh-ancestor
5651890|NCT03702530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651891|NCT03702491|Oxaliplatin|oxaliplatin|mesh-list
5651892|NCT03702491|Apatinib|apatinib|mesh-list
5651893|NCT03702491|Tegafur|tegafur|mesh-list
5828446|NCT02569073|Sensory System Agents|sensory system agents|mesh-ancestor
5828447|NCT02569073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5828448|NCT02569073|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5828449|NCT02569073|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5828450|NCT02569073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5828451|NCT02569073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5828452|NCT02569073|Hormones|hormones|mesh-ancestor
5828453|NCT02569073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5828454|NCT02569320|Dexamethasone|dexamethasone|mesh-list
5828455|NCT02569320|Dexamethasone acetate|dexamethasone acetate|mesh-list
5828456|NCT02569320|Pomalidomide|pomalidomide|mesh-list
5828457|NCT02569320|Ichthammol|ichthammol|mesh-list
5828458|NCT02569320|BB 1101|bb 1101|mesh-list
5828459|NCT02569320|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
5828460|NCT02569320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5828461|NCT02569320|Antiemetics|antiemetics|mesh-ancestor
5828462|NCT02569320|Autonomic Agents|autonomic agents|mesh-ancestor
5651894|NCT03702491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5651895|NCT03702491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5651896|NCT03702491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5828463|NCT02569320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5828464|NCT02569320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828465|NCT02569320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5828466|NCT02569320|Glucocorticoids|glucocorticoids|mesh-ancestor
5828467|NCT02569320|Hormones|hormones|mesh-ancestor
5828468|NCT02569320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5828469|NCT02569320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5828470|NCT02569320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5828471|NCT02569320|Protease Inhibitors|protease inhibitors|mesh-ancestor
5828472|NCT02569320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5828473|NCT02569320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5828474|NCT02569320|Immunologic Factors|immunologic factors|mesh-ancestor
5828475|NCT02569320|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5828476|NCT02569320|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5828477|NCT02569320|Growth Substances|growth substances|mesh-ancestor
5828478|NCT02569320|Growth Inhibitors|growth inhibitors|mesh-ancestor
5651897|NCT03702491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5651898|NCT03702491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5651899|NCT03702491|Antimetabolites|antimetabolites|mesh-ancestor
5651900|NCT03702426|Norfloxacin|norfloxacin|mesh-list
5651901|NCT03702426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5651902|NCT03702426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5651903|NCT03702426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5651904|NCT03702426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5651905|NCT03702426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5651906|NCT03702426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5651907|NCT03702426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5651908|NCT03702426|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5828479|NCT02569320|Dermatologic Agents|dermatologic agents|mesh-ancestor
5828480|NCT02569125|Everolimus|everolimus|mesh-list
5828481|NCT02569125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5828482|NCT02569125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5828483|NCT02569125|Immunologic Factors|immunologic factors|mesh-ancestor
5828484|NCT02569125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828485|NCT02568995|Ketorolac|ketorolac|mesh-list
5828486|NCT02568995|Epinephrine|epinephrine|mesh-list
5828487|NCT02568995|Racepinephrine|racepinephrine|mesh-list
5828488|NCT02568995|Ropivacaine|ropivacaine|mesh-list
5828489|NCT02568995|Epinephryl borate|epinephryl borate|mesh-list
5828490|NCT02568995|Anesthetics, Local|anesthetics, local|mesh-ancestor
5828491|NCT02568995|Anesthetics|anesthetics|mesh-ancestor
5828492|NCT02568995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5828493|NCT02568995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828494|NCT02568995|Sensory System Agents|sensory system agents|mesh-ancestor
5828495|NCT02568995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5828496|NCT02568995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5828497|NCT02568995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5828498|NCT02568995|Analgesics|analgesics|mesh-ancestor
5828499|NCT02568995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5828500|NCT02568995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5828501|NCT02568995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5828502|NCT02568995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5828503|NCT02568995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5828504|NCT02568995|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5828505|NCT02568995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5828506|NCT02568995|Adrenergic Agents|adrenergic agents|mesh-ancestor
5828507|NCT02568995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5828508|NCT02568995|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5828509|NCT02568995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5828510|NCT02568995|Autonomic Agents|autonomic agents|mesh-ancestor
5828511|NCT02568995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5828512|NCT02568995|Respiratory System Agents|respiratory system agents|mesh-ancestor
5828513|NCT02568995|Mydriatics|mydriatics|mesh-ancestor
5828514|NCT02568995|Sympathomimetics|sympathomimetics|mesh-ancestor
5828515|NCT02568995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5828516|NCT02568943|Panobinostat|panobinostat|mesh-list
5828517|NCT02568943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5828518|NCT02568943|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5828519|NCT02568943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5828520|NCT02568943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5828521|NCT02568839|Docetaxel|docetaxel|mesh-list
5828522|NCT02568839|Trastuzumab|trastuzumab|mesh-list
5651909|NCT03702426|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5651910|NCT03702400|Phenylephrine|phenylephrine|mesh-list
5651911|NCT03702400|Oxymetazoline|oxymetazoline|mesh-list
5651912|NCT03702400|Norepinephrine|norepinephrine|mesh-list
5651913|NCT03702400|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5651914|NCT03702400|Mydriatics|mydriatics|mesh-ancestor
5651915|NCT03702400|Autonomic Agents|autonomic agents|mesh-ancestor
5651916|NCT03702400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5651917|NCT03702400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651918|NCT03702400|Sympathomimetics|sympathomimetics|mesh-ancestor
5651919|NCT03702400|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5651920|NCT03702400|Nasal Decongestants|nasal decongestants|mesh-ancestor
5651921|NCT03702400|Respiratory System Agents|respiratory system agents|mesh-ancestor
5651922|NCT03702400|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5651923|NCT03702400|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5651924|NCT03702400|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5651925|NCT03702400|Adrenergic Agents|adrenergic agents|mesh-ancestor
5828523|NCT02568839|Pertuzumab|pertuzumab|mesh-list
5828524|NCT02568839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5828525|NCT02568839|Tubulin Modulators|tubulin modulators|mesh-ancestor
5828526|NCT02568839|Antimitotic Agents|antimitotic agents|mesh-ancestor
5651926|NCT03702400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5828527|NCT02568839|Mitosis Modulators|mitosis modulators|mesh-ancestor
5828528|NCT02568839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5828529|NCT02568839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5828530|NCT02568800|Cefepime|cefepime|mesh-list
5828531|NCT02568800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5828532|NCT02568800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5828533|NCT02568709|Oxytocin|oxytocin|mesh-list
5828534|NCT02568709|Oxytocics|oxytocics|mesh-ancestor
5828535|NCT02568709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5828536|NCT02568709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828537|NCT02568735|Etoricoxib|etoricoxib|mesh-list
5828538|NCT02568735|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
5828539|NCT02568735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5828540|NCT02568735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5828541|NCT02568735|Analgesics|analgesics|mesh-ancestor
5828542|NCT02568735|Sensory System Agents|sensory system agents|mesh-ancestor
5828543|NCT02568735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5828544|NCT02568735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828545|NCT02568735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5828546|NCT02568735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5828547|NCT02568735|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5828548|NCT02568735|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5828549|NCT02568735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5828550|NCT02568735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902348|NCT04562129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5902349|NCT04562129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902350|NCT04562129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5651927|NCT03702400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5651928|NCT03702400|Protective Agents|protective agents|mesh-ancestor
5651929|NCT03702387|Anesthetics|anesthetics|mesh-list
5651930|NCT03702387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5651931|NCT03702387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902351|NCT04562129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5902352|NCT04562129|Antiviral Agents|antiviral agents|mesh-ancestor
5902353|NCT04562129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5902354|NCT04477759|Atezolizumab|atezolizumab|mesh-list
5902355|NCT04477759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5902356|NCT04437888|Ketamine|ketamine|mesh-list
5902357|NCT04437888|Analgesics|analgesics|mesh-ancestor
5902358|NCT04437888|Sensory System Agents|sensory system agents|mesh-ancestor
5902359|NCT04437888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5902360|NCT04437888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902361|NCT04437888|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5902362|NCT04437888|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5902363|NCT04437888|Anesthetics, General|anesthetics, general|mesh-ancestor
5902364|NCT04437888|Anesthetics|anesthetics|mesh-ancestor
5902365|NCT04437888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5902366|NCT04437888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5902367|NCT04437888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5902368|NCT04437888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5902369|NCT04437888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902370|NCT04430569|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5902371|NCT04430569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5902372|NCT04430569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5902373|NCT04430569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902374|NCT04405674|Paclitaxel|paclitaxel|mesh-list
5902375|NCT04405674|Bevacizumab|bevacizumab|mesh-list
5902376|NCT04405674|Carboplatin|carboplatin|mesh-list
5902377|NCT04405674|Pemetrexed|pemetrexed|mesh-list
5902378|NCT04405674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5902379|NCT04405674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5902380|NCT04405674|Tubulin Modulators|tubulin modulators|mesh-ancestor
5902381|NCT04405674|Antimitotic Agents|antimitotic agents|mesh-ancestor
5902382|NCT04405674|Mitosis Modulators|mitosis modulators|mesh-ancestor
5902383|NCT04405674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902384|NCT04405674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5902385|NCT04405674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5902386|NCT04405674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5902387|NCT04405674|Growth Substances|growth substances|mesh-ancestor
5902388|NCT04405674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651932|NCT03702374|Antioxidants|antioxidants|mesh-list
5651933|NCT03702374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5651934|NCT03702374|Protective Agents|protective agents|mesh-ancestor
5651935|NCT03702374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651936|NCT03702218|Antiviral Agents|antiviral agents|mesh-list
5902389|NCT04405674|Growth Inhibitors|growth inhibitors|mesh-ancestor
5651937|NCT03702218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5651938|NCT03702205|Betaine|betaine|mesh-list
5651939|NCT03702205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5651940|NCT03702205|Lipotropic Agents|lipotropic agents|mesh-ancestor
5651941|NCT03702205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5651942|NCT03702205|Antimetabolites|antimetabolites|mesh-ancestor
5651943|NCT03702205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5651944|NCT03702205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5651945|NCT03702179|Durvalumab|durvalumab|mesh-list
5651946|NCT03702179|Tremelimumab|tremelimumab|mesh-list
5651947|NCT03702179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5651948|NCT03702179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5651949|NCT03702140|Teriparatide|teriparatide|mesh-list
5651950|NCT03702140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5651951|NCT03702140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651952|NCT03702140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5651953|NCT03702023|Acetaminophen|acetaminophen|mesh-list
5651954|NCT03702023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5651955|NCT03702023|Analgesics|analgesics|mesh-ancestor
5651956|NCT03702023|Sensory System Agents|sensory system agents|mesh-ancestor
5651957|NCT03702023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5651958|NCT03702023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651959|NCT03702023|Antipyretics|antipyretics|mesh-ancestor
5651960|NCT03701984|Lidocaine|lidocaine|mesh-list
5651961|NCT03701984|Tramadol|tramadol|mesh-list
5651962|NCT03701984|Anesthetics, Local|anesthetics, local|mesh-ancestor
5651963|NCT03701984|Anesthetics|anesthetics|mesh-ancestor
5651964|NCT03701984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5651965|NCT03701984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651966|NCT03701984|Sensory System Agents|sensory system agents|mesh-ancestor
5651967|NCT03701984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5651968|NCT03701984|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5651969|NCT03701984|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5651970|NCT03701984|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5828551|NCT02568618|Analgesics|analgesics|mesh-list
5828552|NCT02568618|Sensory System Agents|sensory system agents|mesh-ancestor
5828553|NCT02568618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5828554|NCT02568618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828555|NCT02568488|Metformin|metformin|mesh-list
5828556|NCT02568488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5828557|NCT02568488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828558|NCT02568241|Interferons|interferons|mesh-list
5828559|NCT02568241|Interferon-alpha|interferon-alpha|mesh-list
5828560|NCT02568241|Interferon alpha-2|interferon alpha-2|mesh-list
5828561|NCT02568241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5828562|NCT02568241|Antiviral Agents|antiviral agents|mesh-ancestor
5828563|NCT02568241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5828564|NCT02568241|Immunologic Factors|immunologic factors|mesh-ancestor
5828565|NCT02568241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828566|NCT02568280|Insulin|insulin|mesh-list
5828567|NCT02568280|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5828568|NCT02568280|Insulin Aspart|insulin aspart|mesh-list
5828569|NCT02568280|Insulin, Long-Acting|insulin, long-acting|mesh-list
5828570|NCT02568280|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
5828571|NCT02568280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5828572|NCT02568280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828573|NCT02568176|Midazolam|midazolam|mesh-list
5828574|NCT02568176|Bupropion|bupropion|mesh-list
5828575|NCT02568176|Esketamine|esketamine|mesh-list
5828576|NCT02568176|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5828577|NCT02568176|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5828578|NCT02568176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5828579|NCT02568176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828580|NCT02568176|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5828581|NCT02568176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5828582|NCT02568176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5828583|NCT02568176|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5828584|NCT02568176|Anesthetics, General|anesthetics, general|mesh-ancestor
5828585|NCT02568176|Anesthetics|anesthetics|mesh-ancestor
5828586|NCT02568176|GABA Modulators|gaba modulators|mesh-ancestor
5828587|NCT02568176|GABA Agents|gaba agents|mesh-ancestor
5828588|NCT02568176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5828589|NCT02568176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5828590|NCT02568176|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5828591|NCT02568176|Antidepressive Agents|antidepressive agents|mesh-ancestor
5828592|NCT02568176|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5651971|NCT03701984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5651972|NCT03701984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5651973|NCT03701984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5651974|NCT03701984|Narcotics|narcotics|mesh-ancestor
5651975|NCT03701984|Analgesics|analgesics|mesh-ancestor
5651976|NCT03701919|Botulinum Toxins|botulinum toxins|mesh-list
5651977|NCT03701919|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5651978|NCT03701919|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5651979|NCT03701919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5651980|NCT03701919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5651981|NCT03701919|Cholinergic Agents|cholinergic agents|mesh-ancestor
5651982|NCT03701919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5651983|NCT03701919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828593|NCT02568176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5828594|NCT02568176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5828595|NCT02568176|Dopamine Agents|dopamine agents|mesh-ancestor
5828596|NCT02568176|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5828597|NCT02568176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5828598|NCT02568176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5828599|NCT02568319|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5828600|NCT02568319|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5828601|NCT02568319|Autonomic Agents|autonomic agents|mesh-ancestor
5828602|NCT02568319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5828603|NCT02568319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828604|NCT02568319|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5828605|NCT02568319|Respiratory System Agents|respiratory system agents|mesh-ancestor
5828606|NCT02568319|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5828607|NCT02568319|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5828608|NCT02568319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5828609|NCT02568319|Adrenergic Agents|adrenergic agents|mesh-ancestor
5828610|NCT02568319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5828611|NCT02568319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5828612|NCT02567955|Vaccines|vaccines|mesh-list
5828613|NCT02567955|Immunologic Factors|immunologic factors|mesh-ancestor
5828614|NCT02567955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651984|NCT03701919|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5651985|NCT03701919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5651986|NCT03701880|Bisoprolol|bisoprolol|mesh-list
5651987|NCT03701880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5651988|NCT03701880|Sympatholytics|sympatholytics|mesh-ancestor
5828615|NCT02567942|Propofol|propofol|mesh-list
5828616|NCT02567942|Sevoflurane|sevoflurane|mesh-list
5828617|NCT02567942|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5651989|NCT03701880|Autonomic Agents|autonomic agents|mesh-ancestor
5651990|NCT03701880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5828618|NCT02567942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5828619|NCT02567942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828620|NCT02567942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5828621|NCT02567942|Anesthetics, General|anesthetics, general|mesh-ancestor
5651991|NCT03701880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5651992|NCT03701880|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5651993|NCT03701880|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5651994|NCT03701880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5651995|NCT03701880|Adrenergic Agents|adrenergic agents|mesh-ancestor
5651996|NCT03701880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5651997|NCT03701880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694628|NCT03394430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5694629|NCT03394430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5694630|NCT03394430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5694631|NCT03394430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5694632|NCT03394430|Anesthetics, General|anesthetics, general|mesh-ancestor
5694633|NCT03394430|Anesthetics|anesthetics|mesh-ancestor
5694634|NCT03394430|GABA Modulators|gaba modulators|mesh-ancestor
5828622|NCT02567942|Anesthetics|anesthetics|mesh-ancestor
5828623|NCT02567942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5828624|NCT02567942|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5828625|NCT02568423|Mirikizumab|mirikizumab|mesh-list
5828626|NCT02568423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5828627|NCT02568423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5828628|NCT02568423|Analgesics|analgesics|mesh-ancestor
5828629|NCT02568423|Sensory System Agents|sensory system agents|mesh-ancestor
5828630|NCT02568423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5828631|NCT02568423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828632|NCT02568423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5694635|NCT03394430|GABA Agents|gaba agents|mesh-ancestor
5651998|NCT03701750|Heparin|heparin|mesh-list
5651999|NCT03701750|Enoxaparin|enoxaparin|mesh-list
5652000|NCT03701750|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5652001|NCT03701750|Tinzaparin|tinzaparin|mesh-list
5652002|NCT03701750|Dalteparin|dalteparin|mesh-list
5828633|NCT02568423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5828634|NCT02568423|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5828635|NCT02568423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5828636|NCT02568111|Interferons|interferons|mesh-list
5828637|NCT02568111|Interferon-beta|interferon-beta|mesh-list
5828638|NCT02568111|Interferon beta-1a|interferon beta-1a|mesh-list
5828639|NCT02568111|Brimonidine Tartrate|brimonidine tartrate|mesh-list
5828640|NCT02568111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5828641|NCT02568111|Antiviral Agents|antiviral agents|mesh-ancestor
5828642|NCT02568111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5828643|NCT02568111|Immunologic Factors|immunologic factors|mesh-ancestor
5828644|NCT02568111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828645|NCT02568111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5828646|NCT02568111|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5828647|NCT02568111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5828648|NCT02568111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5828649|NCT02568111|Adrenergic Agents|adrenergic agents|mesh-ancestor
5828650|NCT02568111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5828651|NCT02568111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5828652|NCT02568111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5828653|NCT02567981|Vitamin A|vitamin a|mesh-list
5828654|NCT02567981|Micronutrients|micronutrients|mesh-list
5828655|NCT02567981|Trace Elements|trace elements|mesh-list
5828656|NCT02567981|Vitamins|vitamins|mesh-ancestor
5828657|NCT02567981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828658|NCT02568033|Paclitaxel|paclitaxel|mesh-list
5828659|NCT02568033|Docetaxel|docetaxel|mesh-list
5828660|NCT02568033|Carboplatin|carboplatin|mesh-list
5828661|NCT02568033|Pemetrexed|pemetrexed|mesh-list
5828662|NCT02568033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5828663|NCT02568033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5828664|NCT02568033|Tubulin Modulators|tubulin modulators|mesh-ancestor
5828665|NCT02568033|Antimitotic Agents|antimitotic agents|mesh-ancestor
5828666|NCT02568033|Mitosis Modulators|mitosis modulators|mesh-ancestor
5828667|NCT02568033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5828668|NCT02568033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5828669|NCT02568033|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5828670|NCT02568033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5828671|NCT02567916|Propofol|propofol|mesh-list
5652003|NCT03701750|Enoxaparin sodium|enoxaparin sodium|mesh-list
5652004|NCT03701750|Anticoagulants|anticoagulants|mesh-ancestor
5652005|NCT03701750|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5652006|NCT03701750|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5652007|NCT03701750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652008|NCT03701698|Methylprednisolone|methylprednisolone|mesh-list
5652009|NCT03701698|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5828672|NCT02567916|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5828673|NCT02567916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5828674|NCT02567916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828675|NCT02567916|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5828676|NCT02567916|Anesthetics, General|anesthetics, general|mesh-ancestor
5828677|NCT02567916|Anesthetics|anesthetics|mesh-ancestor
5828678|NCT02567929|Propofol|propofol|mesh-list
5828679|NCT02567929|Sevoflurane|sevoflurane|mesh-list
5828680|NCT02567929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5828681|NCT02567929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5828682|NCT02567929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828683|NCT02567929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5652010|NCT03701698|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5652011|NCT03701698|Prednisolone|prednisolone|mesh-list
5652012|NCT03701698|Prednisolone acetate|prednisolone acetate|mesh-list
5652013|NCT03701698|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5652014|NCT03701698|Prednisolone phosphate|prednisolone phosphate|mesh-list
5652015|NCT03701698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5652016|NCT03701698|Antiemetics|antiemetics|mesh-ancestor
5828684|NCT02567929|Anesthetics, General|anesthetics, general|mesh-ancestor
5828685|NCT02567929|Anesthetics|anesthetics|mesh-ancestor
5828686|NCT02567929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5828687|NCT02567929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5828688|NCT02567851|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5652017|NCT03701698|Autonomic Agents|autonomic agents|mesh-ancestor
5652018|NCT03701698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5828689|NCT02567851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5828690|NCT02567851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5828691|NCT02567838|Lidocaine|lidocaine|mesh-list
5828692|NCT02567838|Anesthetics, Local|anesthetics, local|mesh-ancestor
5828693|NCT02567838|Anesthetics|anesthetics|mesh-ancestor
5828694|NCT02567838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5828695|NCT02567838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652019|NCT03701698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652020|NCT03701698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5652021|NCT03701698|Glucocorticoids|glucocorticoids|mesh-ancestor
5652022|NCT03701698|Hormones|hormones|mesh-ancestor
5652023|NCT03701698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5652024|NCT03701698|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5652025|NCT03701698|Protective Agents|protective agents|mesh-ancestor
5652026|NCT03701698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5652027|NCT03701698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5652028|NCT03701672|Analgesics, Opioid|analgesics, opioid|mesh-list
5652029|NCT03701672|Analgesics|analgesics|mesh-list
5652030|NCT03701672|Narcotics|narcotics|mesh-ancestor
5652031|NCT03701672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5652032|NCT03701672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652033|NCT03701672|Sensory System Agents|sensory system agents|mesh-ancestor
5652034|NCT03701672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5828696|NCT02567838|Sensory System Agents|sensory system agents|mesh-ancestor
5828697|NCT02567838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5828698|NCT02567838|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5828699|NCT02567838|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5828700|NCT02567838|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5828701|NCT02567838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5828702|NCT02567838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5828703|NCT02567773|Itraconazole|itraconazole|mesh-list
5828704|NCT02567773|GSK2881078|gsk2881078|mesh-list
5828705|NCT02567773|Antifungal Agents|antifungal agents|mesh-ancestor
5828706|NCT02567773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5828707|NCT02567773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5828708|NCT02567773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5828709|NCT02567773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5828710|NCT02567773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5828711|NCT02567773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5828712|NCT02567773|Hormone Antagonists|hormone antagonists|mesh-ancestor
5828713|NCT02567773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5828714|NCT02567773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828715|NCT02567773|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5828716|NCT02567773|Anabolic Agents|anabolic agents|mesh-ancestor
5828717|NCT02567773|Hormones|hormones|mesh-ancestor
5828718|NCT02567487|Levobupivacaine|levobupivacaine|mesh-list
5828719|NCT02567487|Anesthetics, Local|anesthetics, local|mesh-ancestor
5828720|NCT02567487|Anesthetics|anesthetics|mesh-ancestor
5652035|NCT03701581|4-Aminopyridine|4-aminopyridine|mesh-list
5652036|NCT03701581|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5652037|NCT03701581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5652038|NCT03701581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652039|NCT03701529|Anesthetics|anesthetics|mesh-list
5652040|NCT03701529|Propofol|propofol|mesh-list
5652041|NCT03701529|Sevoflurane|sevoflurane|mesh-list
5652042|NCT03701529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5652043|NCT03701529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652044|NCT03701529|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5828721|NCT02567487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5828722|NCT02567487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828723|NCT02567487|Sensory System Agents|sensory system agents|mesh-ancestor
5828724|NCT02567487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5828725|NCT02567383|Docetaxel|docetaxel|mesh-list
5828726|NCT02567383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5828727|NCT02567383|Tubulin Modulators|tubulin modulators|mesh-ancestor
5652045|NCT03701529|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5652046|NCT03701529|Anesthetics, General|anesthetics, general|mesh-ancestor
5652047|NCT03701529|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5652048|NCT03701529|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5652049|NCT03701503|Hormones|hormones|mesh-list
5652050|NCT03701503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5652051|NCT03701503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652052|NCT03701490|Progesterone|progesterone|mesh-list
5652053|NCT03701490|Progestins|progestins|mesh-ancestor
5652054|NCT03701490|Hormones|hormones|mesh-ancestor
5694636|NCT03394287|Apatinib|apatinib|mesh-list
5828728|NCT02567383|Antimitotic Agents|antimitotic agents|mesh-ancestor
5828729|NCT02567383|Mitosis Modulators|mitosis modulators|mesh-ancestor
5828730|NCT02567383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5828731|NCT02567786|Plasma-lyte 148|plasma-lyte 148|mesh-list
5828732|NCT02567786|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5828733|NCT02567786|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5828734|NCT02567461|Aspirin|aspirin|mesh-list
5828735|NCT02567461|Edoxaban|edoxaban|mesh-list
5828736|NCT02567461|Clopidogrel|clopidogrel|mesh-list
5828737|NCT02567461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5828738|NCT02567461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5828739|NCT02567461|Analgesics|analgesics|mesh-ancestor
5828740|NCT02567461|Sensory System Agents|sensory system agents|mesh-ancestor
5828741|NCT02567461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5828742|NCT02567461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828743|NCT02567461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5828744|NCT02567461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5828745|NCT02567461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5828746|NCT02567461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5828747|NCT02567461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5828748|NCT02567461|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5828749|NCT02567461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5828750|NCT02567461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5828751|NCT02567461|Antipyretics|antipyretics|mesh-ancestor
5828752|NCT02567461|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5828753|NCT02567461|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5828754|NCT02567461|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5828755|NCT02567461|Purinergic Agents|purinergic agents|mesh-ancestor
5828756|NCT02567461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5652055|NCT03701490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5652056|NCT03701490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652057|NCT03701451|Decitabine|decitabine|mesh-list
5652058|NCT03701451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5652059|NCT03701451|Antimetabolites|antimetabolites|mesh-ancestor
5652060|NCT03701451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652061|NCT03701451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5652062|NCT03701451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5828757|NCT02567461|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5828758|NCT02567461|Antithrombins|antithrombins|mesh-ancestor
5828759|NCT02567461|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5828760|NCT02567461|Protease Inhibitors|protease inhibitors|mesh-ancestor
5828761|NCT02567461|Anticoagulants|anticoagulants|mesh-ancestor
5828762|NCT02567396|Talazoparib|talazoparib|mesh-list
5828763|NCT02567396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5828764|NCT02567396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5828765|NCT02567396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5828766|NCT02567396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5828767|NCT02567799|Paclitaxel|paclitaxel|mesh-list
5828768|NCT02567799|Carboplatin|carboplatin|mesh-list
5828769|NCT02567799|Genistein|genistein|mesh-list
5828770|NCT02567799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5828771|NCT02567799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5828772|NCT02567799|Tubulin Modulators|tubulin modulators|mesh-ancestor
5828773|NCT02567799|Antimitotic Agents|antimitotic agents|mesh-ancestor
5828774|NCT02567799|Mitosis Modulators|mitosis modulators|mesh-ancestor
5828775|NCT02567799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5828776|NCT02567799|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5828777|NCT02567799|Protective Agents|protective agents|mesh-ancestor
5828778|NCT02567799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828779|NCT02567799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5828780|NCT02567799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5828781|NCT02567799|Phytoestrogens|phytoestrogens|mesh-ancestor
5828782|NCT02567799|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
5828783|NCT02567799|Estrogens|estrogens|mesh-ancestor
5828784|NCT02567799|Hormones|hormones|mesh-ancestor
5828785|NCT02567799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5652063|NCT03701321|Dexamethasone|dexamethasone|mesh-list
5652064|NCT03701321|Dexamethasone acetate|dexamethasone acetate|mesh-list
5652065|NCT03701321|Bortezomib|bortezomib|mesh-list
5652066|NCT03701321|Venetoclax|venetoclax|mesh-list
5652067|NCT03701321|Daratumumab|daratumumab|mesh-list
5652068|NCT03701321|Ichthammol|ichthammol|mesh-list
5652069|NCT03701321|BB 1101|bb 1101|mesh-list
5828786|NCT02567409|Gemcitabine|gemcitabine|mesh-list
5828787|NCT02567409|Cisplatin|cisplatin|mesh-list
5828788|NCT02567409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5902390|NCT04405674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5828789|NCT02567409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5828790|NCT02567409|Antimetabolites|antimetabolites|mesh-ancestor
5828791|NCT02567409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5828792|NCT02567409|Antiviral Agents|antiviral agents|mesh-ancestor
5828793|NCT02567409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5828794|NCT02567409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5828795|NCT02567409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5828796|NCT02567409|Immunologic Factors|immunologic factors|mesh-ancestor
5828797|NCT02567409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828798|NCT02567331|Capecitabine|capecitabine|mesh-list
5828799|NCT02567331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5828800|NCT02567331|Antimetabolites|antimetabolites|mesh-ancestor
5828801|NCT02567331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5828802|NCT02567331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5828803|NCT02567032|Oxytocin|oxytocin|mesh-list
5828804|NCT02567032|Oxytocics|oxytocics|mesh-ancestor
5828805|NCT02567032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5828806|NCT02567032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828807|NCT02567149|Cidofovir|cidofovir|mesh-list
5828808|NCT02567149|Antiviral Agents|antiviral agents|mesh-ancestor
5828809|NCT02567149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5828810|NCT02567149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5828811|NCT02567149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652070|NCT03701321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5652071|NCT03701321|Antiemetics|antiemetics|mesh-ancestor
5652072|NCT03701321|Autonomic Agents|autonomic agents|mesh-ancestor
5652073|NCT03701321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5652074|NCT03701321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828812|NCT02567253|Cisplatin|cisplatin|mesh-list
5828813|NCT02567253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5828814|NCT02567279|Denosumab|denosumab|mesh-list
5828815|NCT02567279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5828816|NCT02567279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828817|NCT02567175|Domperidone|domperidone|mesh-list
5828818|NCT02567175|Antiemetics|antiemetics|mesh-ancestor
5828819|NCT02567175|Autonomic Agents|autonomic agents|mesh-ancestor
5828820|NCT02567175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5828821|NCT02567175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828822|NCT02567175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5828823|NCT02567175|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5828824|NCT02567175|Dopamine Agents|dopamine agents|mesh-ancestor
5828825|NCT02567175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5828826|NCT02567175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902391|NCT04405674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5902392|NCT04405674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5902393|NCT04370509|Pembrolizumab|pembrolizumab|mesh-list
5902394|NCT04370509|Axitinib|axitinib|mesh-list
5652075|NCT03701321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5652076|NCT03701321|Glucocorticoids|glucocorticoids|mesh-ancestor
5652077|NCT03701321|Hormones|hormones|mesh-ancestor
5652078|NCT03701321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5652079|NCT03701321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5902395|NCT04370509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5902396|NCT04370509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5902397|NCT04370509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5902398|NCT04370509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5902399|NCT04370509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902400|NCT04366518|Scopolamine|scopolamine|mesh-list
5902401|NCT04366518|Rivastigmine|rivastigmine|mesh-list
5902402|NCT04366518|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
5902403|NCT04366518|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5902404|NCT04366518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5902405|NCT04366518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902406|NCT04366518|Cholinergic Agents|cholinergic agents|mesh-ancestor
5902407|NCT04366518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5902408|NCT04366518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902409|NCT04366518|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5902410|NCT04366518|Protective Agents|protective agents|mesh-ancestor
5902411|NCT04366518|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5652080|NCT03701321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5652081|NCT03701321|Protease Inhibitors|protease inhibitors|mesh-ancestor
5652082|NCT03701321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5652083|NCT03701321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652084|NCT03701321|Dermatologic Agents|dermatologic agents|mesh-ancestor
5902412|NCT04366518|Antiemetics|antiemetics|mesh-ancestor
5828827|NCT02567240|Carbon Monoxide|carbon monoxide|mesh-list
5828828|NCT02567240|Antimetabolites|antimetabolites|mesh-ancestor
5828829|NCT02567240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5828830|NCT02567240|Gasotransmitters|gasotransmitters|mesh-ancestor
5828831|NCT02567240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5828832|NCT02567240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828833|NCT02566967|Tofacitinib|tofacitinib|mesh-list
5652085|NCT03701256|Atracurium|atracurium|mesh-list
5652086|NCT03701256|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5652087|NCT03701256|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5652088|NCT03701256|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5652089|NCT03701256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5652090|NCT03701256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652091|NCT03701256|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
5652092|NCT03701256|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5652093|NCT03701256|Cholinergic Agents|cholinergic agents|mesh-ancestor
5652094|NCT03701256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5828834|NCT02566967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5828835|NCT02566967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5828836|NCT02566967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5828837|NCT02567214|Glycopyrrolate|glycopyrrolate|mesh-list
5828838|NCT02567214|Tiotropium Bromide|tiotropium bromide|mesh-list
5828839|NCT02567214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5828840|NCT02567214|Autonomic Agents|autonomic agents|mesh-ancestor
5828841|NCT02567214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5828842|NCT02567214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828843|NCT02567214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5828844|NCT02567214|Respiratory System Agents|respiratory system agents|mesh-ancestor
5828845|NCT02567214|Parasympatholytics|parasympatholytics|mesh-ancestor
5828846|NCT02567214|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5828847|NCT02567214|Cholinergic Agents|cholinergic agents|mesh-ancestor
5828848|NCT02567214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5828849|NCT02567214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5828850|NCT02567214|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5828851|NCT02567214|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5828852|NCT02566824|Methylphenidate|methylphenidate|mesh-list
5828853|NCT02566824|Amphetamine|amphetamine|mesh-list
5828854|NCT02566824|Adderall|adderall|mesh-list
5828855|NCT02566824|Dextroamphetamine|dextroamphetamine|mesh-list
5828856|NCT02566824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5828857|NCT02566824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828858|NCT02566824|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5828859|NCT02566824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5828860|NCT02566824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5828861|NCT02566824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5828862|NCT02566824|Dopamine Agents|dopamine agents|mesh-ancestor
5828863|NCT02566824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5828864|NCT02566824|Sympathomimetics|sympathomimetics|mesh-ancestor
5828865|NCT02566824|Autonomic Agents|autonomic agents|mesh-ancestor
5828866|NCT02566824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5828867|NCT02566824|Adrenergic Agents|adrenergic agents|mesh-ancestor
5652095|NCT03701256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652096|NCT03701126|Bupivacaine|bupivacaine|mesh-list
5652097|NCT03701126|Anesthetics, Local|anesthetics, local|mesh-ancestor
5828868|NCT02566824|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5828869|NCT02566928|Chlorhexidine|chlorhexidine|mesh-list
5828870|NCT02566928|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5828871|NCT02566928|Bacitracin|bacitracin|mesh-list
5828872|NCT02566928|Mupirocin|mupirocin|mesh-list
5828873|NCT02566928|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5828874|NCT02566928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5828875|NCT02566928|Disinfectants|disinfectants|mesh-ancestor
5828876|NCT02566928|Dermatologic Agents|dermatologic agents|mesh-ancestor
5828877|NCT02566928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5828878|NCT02566928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5828879|NCT02566928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5828880|NCT02566928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5828881|NCT02566707|Lamivudine|lamivudine|mesh-list
5828882|NCT02566707|Atazanavir Sulfate|atazanavir sulfate|mesh-list
5828883|NCT02566707|Dolutegravir|dolutegravir|mesh-list
5828884|NCT02566707|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5828885|NCT02566707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5828886|NCT02566707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5828887|NCT02566707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5828888|NCT02566707|Antiviral Agents|antiviral agents|mesh-ancestor
5828889|NCT02566707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5828890|NCT02566707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5828891|NCT02566707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5828892|NCT02566707|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5828893|NCT02566707|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5828894|NCT02566707|Protease Inhibitors|protease inhibitors|mesh-ancestor
5828895|NCT02566707|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5828896|NCT02566707|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5828897|NCT02566720|Amantadine|amantadine|mesh-list
5652098|NCT03701126|Anesthetics|anesthetics|mesh-ancestor
5652099|NCT03701126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5652100|NCT03701126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652101|NCT03701126|Sensory System Agents|sensory system agents|mesh-ancestor
5652102|NCT03701126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5652103|NCT03701087|Vitamin D|vitamin d|mesh-list
5652104|NCT03701087|Vitamins|vitamins|mesh-ancestor
5652105|NCT03701087|Micronutrients|micronutrients|mesh-ancestor
5652106|NCT03701087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652107|NCT03701087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5652108|NCT03701022|Apatinib|apatinib|mesh-list
5652109|NCT03701022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5652110|NCT03701022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5652111|NCT03701022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5652112|NCT03701022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652113|NCT03700905|Nivolumab|nivolumab|mesh-list
5652114|NCT03700905|Ipilimumab|ipilimumab|mesh-list
5652115|NCT03700905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5652116|NCT03700905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5652117|NCT03700905|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5652118|NCT03700905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652119|NCT03700814|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5652120|NCT03700814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5652121|NCT03700814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5652122|NCT03700814|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5652123|NCT03700814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5652124|NCT03700814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652125|NCT03700801|Insulin|insulin|mesh-list
5652126|NCT03700801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5652127|NCT03700801|Metformin|metformin|mesh-list
5652128|NCT03700801|Insulin Aspart|insulin aspart|mesh-list
5652129|NCT03700801|Dapagliflozin|dapagliflozin|mesh-list
5652130|NCT03700801|Saxagliptin|saxagliptin|mesh-list
5652131|NCT03700801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5652132|NCT03700801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652133|NCT03700801|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5652134|NCT03700801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652135|NCT03700801|Incretins|incretins|mesh-ancestor
5652136|NCT03700801|Hormones|hormones|mesh-ancestor
5652137|NCT03700801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5652138|NCT03700801|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5652139|NCT03700801|Protease Inhibitors|protease inhibitors|mesh-ancestor
5652140|NCT03700801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5652141|NCT03700788|Chlorhexidine|chlorhexidine|mesh-list
5652142|NCT03700788|Calcium|calcium|mesh-list
5652143|NCT03700788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5652144|NCT03700788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652145|NCT03700788|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5652146|NCT03700788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5652147|NCT03700788|Disinfectants|disinfectants|mesh-ancestor
5652148|NCT03700749|Iodine|iodine|mesh-list
5652149|NCT03700749|Chlorhexidine|chlorhexidine|mesh-list
5652150|NCT03700749|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5828898|NCT02566720|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5828899|NCT02566720|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5828900|NCT02566720|Antiviral Agents|antiviral agents|mesh-ancestor
5828901|NCT02566720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5828902|NCT02566720|Dopamine Agents|dopamine agents|mesh-ancestor
5828903|NCT02566720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5828904|NCT02566720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5828905|NCT02566720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828906|NCT02566720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5828907|NCT02566720|Analgesics|analgesics|mesh-ancestor
5828908|NCT02566720|Sensory System Agents|sensory system agents|mesh-ancestor
5652151|NCT03700749|Cadexomer iodine|cadexomer iodine|mesh-list
5652152|NCT03700749|Povidone-Iodine|povidone-iodine|mesh-list
5652153|NCT03700749|Povidone|povidone|mesh-list
5828909|NCT02566720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5828910|NCT02566733|Remifentanil|remifentanil|mesh-list
5828911|NCT02566733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5828912|NCT02566733|Narcotics|narcotics|mesh-ancestor
5828913|NCT02566733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5828914|NCT02566733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652154|NCT03700749|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5652155|NCT03700749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5652156|NCT03700749|Disinfectants|disinfectants|mesh-ancestor
5652157|NCT03700749|Dermatologic Agents|dermatologic agents|mesh-ancestor
5652158|NCT03700749|Trace Elements|trace elements|mesh-ancestor
5652159|NCT03700749|Micronutrients|micronutrients|mesh-ancestor
5652160|NCT03700749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828915|NCT02566733|Analgesics|analgesics|mesh-ancestor
5828916|NCT02566733|Sensory System Agents|sensory system agents|mesh-ancestor
5828917|NCT02566733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5828918|NCT02566304|Vidarabine|vidarabine|mesh-list
5828919|NCT02566304|Mycophenolic Acid|mycophenolic acid|mesh-list
5828920|NCT02566304|Cyclophosphamide|cyclophosphamide|mesh-list
5828921|NCT02566304|Fludarabine|fludarabine|mesh-list
5828922|NCT02566304|Fludarabine phosphate|fludarabine phosphate|mesh-list
5828923|NCT02566304|Tacrolimus|tacrolimus|mesh-list
5828924|NCT02566304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5828925|NCT02566304|Immunologic Factors|immunologic factors|mesh-ancestor
5828926|NCT02566304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828927|NCT02566304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5828928|NCT02566304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5828929|NCT02566304|Alkylating Agents|alkylating agents|mesh-ancestor
5828930|NCT02566304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5828931|NCT02566304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5828932|NCT02566304|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5828933|NCT02566304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5828934|NCT02566304|Antimetabolites|antimetabolites|mesh-ancestor
5828935|NCT02566304|Antiviral Agents|antiviral agents|mesh-ancestor
5828936|NCT02566304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5828937|NCT02566304|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5652161|NCT03700749|Plasma Substitutes|plasma substitutes|mesh-ancestor
5652162|NCT03700749|Blood Substitutes|blood substitutes|mesh-ancestor
5652163|NCT03700645|Allopurinol|allopurinol|mesh-list
5828938|NCT02566304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5828939|NCT02566304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5828940|NCT02566304|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5828941|NCT02566304|Antitubercular Agents|antitubercular agents|mesh-ancestor
5828942|NCT02566304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5828943|NCT02566395|Cyclophosphamide|cyclophosphamide|mesh-list
5828944|NCT02566395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5828945|NCT02566395|Immunologic Factors|immunologic factors|mesh-ancestor
5828946|NCT02566395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828947|NCT02566395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5828948|NCT02566395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5828949|NCT02566395|Alkylating Agents|alkylating agents|mesh-ancestor
5828950|NCT02566395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5828951|NCT02566395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5828952|NCT02566395|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5828953|NCT02566356|Oxytocin|oxytocin|mesh-list
5828954|NCT02566356|Oxytocics|oxytocics|mesh-ancestor
5828955|NCT02566356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5828956|NCT02566356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828957|NCT02566252|Cromolyn Sodium|cromolyn sodium|mesh-list
5828958|NCT02566252|Albuterol|albuterol|mesh-list
5828959|NCT02566252|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
5828960|NCT02566252|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5828961|NCT02566252|Autonomic Agents|autonomic agents|mesh-ancestor
5828962|NCT02566252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5652164|NCT03700645|Antimetabolites|antimetabolites|mesh-ancestor
5652165|NCT03700645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652166|NCT03700645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5828963|NCT02566252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828964|NCT02566252|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5828965|NCT02566252|Respiratory System Agents|respiratory system agents|mesh-ancestor
5828966|NCT02566252|Tocolytic Agents|tocolytic agents|mesh-ancestor
5828967|NCT02566252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5828968|NCT02566252|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5652167|NCT03700645|Gout Suppressants|gout suppressants|mesh-ancestor
5828969|NCT02566252|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5828970|NCT02566252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5828971|NCT02566252|Adrenergic Agents|adrenergic agents|mesh-ancestor
5828972|NCT02566252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5828973|NCT02566252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5828974|NCT02566252|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
5828975|NCT02566252|Immunologic Factors|immunologic factors|mesh-ancestor
5828976|NCT02566252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5828977|NCT02565979|Resveratrol|resveratrol|mesh-list
5828978|NCT02565979|Antioxidants|antioxidants|mesh-ancestor
5828979|NCT02565979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5828980|NCT02565979|Protective Agents|protective agents|mesh-ancestor
5828981|NCT02565979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5828982|NCT02565979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5828983|NCT02565979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5828984|NCT02565953|Paclitaxel|paclitaxel|mesh-list
5828985|NCT02565953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5828986|NCT02565953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5828987|NCT02565953|Tubulin Modulators|tubulin modulators|mesh-ancestor
5828988|NCT02565953|Antimitotic Agents|antimitotic agents|mesh-ancestor
5828989|NCT02565953|Mitosis Modulators|mitosis modulators|mesh-ancestor
5828990|NCT02565953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5828991|NCT02566187|Atorvastatin|atorvastatin|mesh-list
5828992|NCT02566187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5828993|NCT02566187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5828994|NCT02566187|Antimetabolites|antimetabolites|mesh-ancestor
5828995|NCT02566187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5828996|NCT02566187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5828997|NCT02566187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5828998|NCT02566187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5828999|NCT02565992|Pembrolizumab|pembrolizumab|mesh-list
5829000|NCT02565992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5829001|NCT02565992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5829002|NCT02566096|Morphine|morphine|mesh-list
5652168|NCT03700645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5652169|NCT03700645|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5652170|NCT03700645|Antioxidants|antioxidants|mesh-ancestor
5652171|NCT03700645|Protective Agents|protective agents|mesh-ancestor
5652172|NCT03700645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652173|NCT03700515|Epoetin Alfa|epoetin alfa|mesh-list
5829003|NCT02566096|Bupivacaine|bupivacaine|mesh-list
5829004|NCT02566096|Anesthetics, Local|anesthetics, local|mesh-list
5829005|NCT02566096|Anesthetics|anesthetics|mesh-list
5829006|NCT02566096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5829007|NCT02566096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829008|NCT02566096|Sensory System Agents|sensory system agents|mesh-ancestor
5829009|NCT02566096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5829010|NCT02566096|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5829011|NCT02566096|Narcotics|narcotics|mesh-ancestor
5829012|NCT02566096|Analgesics|analgesics|mesh-ancestor
5829013|NCT02566226|Morphine|morphine|mesh-list
5829014|NCT02566226|Bupivacaine|bupivacaine|mesh-list
5829015|NCT02566226|Anesthetics, Local|anesthetics, local|mesh-ancestor
5829016|NCT02566226|Anesthetics|anesthetics|mesh-ancestor
5829017|NCT02566226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5829018|NCT02566226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829019|NCT02566226|Sensory System Agents|sensory system agents|mesh-ancestor
5829020|NCT02566226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5829021|NCT02566226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5829022|NCT02566226|Narcotics|narcotics|mesh-ancestor
5829023|NCT02566226|Analgesics|analgesics|mesh-ancestor
5829024|NCT02565888|Ritonavir|ritonavir|mesh-list
5829025|NCT02565888|Atazanavir Sulfate|atazanavir sulfate|mesh-list
5829026|NCT02565888|Cobicistat|cobicistat|mesh-list
5652174|NCT03700515|Hematinics|hematinics|mesh-ancestor
5652175|NCT03700489|Titanium dioxide|titanium dioxide|mesh-list
5652176|NCT03700489|Sunscreening Agents|sunscreening agents|mesh-ancestor
5652177|NCT03700489|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5652178|NCT03700489|Protective Agents|protective agents|mesh-ancestor
5652179|NCT03700489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652180|NCT03700489|Dermatologic Agents|dermatologic agents|mesh-ancestor
5652181|NCT03700489|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5652182|NCT03700476|Gemcitabine|gemcitabine|mesh-list
5829027|NCT02565888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5829028|NCT02565888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5829029|NCT02565888|Protease Inhibitors|protease inhibitors|mesh-ancestor
5829030|NCT02565888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5829031|NCT02565888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652183|NCT03700476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5652184|NCT03700476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5652185|NCT03700476|Antimetabolites|antimetabolites|mesh-ancestor
5652186|NCT03700476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652187|NCT03700476|Antiviral Agents|antiviral agents|mesh-ancestor
5652188|NCT03700476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5652189|NCT03700476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5652190|NCT03700476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5652191|NCT03700476|Immunologic Factors|immunologic factors|mesh-ancestor
5652192|NCT03700476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652193|NCT03700450|Cyclophosphamide|cyclophosphamide|mesh-list
5652194|NCT03700450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5652195|NCT03700450|Immunologic Factors|immunologic factors|mesh-ancestor
5652196|NCT03700450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652197|NCT03700450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5652198|NCT03700450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5652199|NCT03700450|Alkylating Agents|alkylating agents|mesh-ancestor
5652200|NCT03700450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652201|NCT03700450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5652202|NCT03700450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5652203|NCT03700359|Etoposide|etoposide|mesh-list
5829032|NCT02565888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5829033|NCT02565888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5829034|NCT02565888|Antiviral Agents|antiviral agents|mesh-ancestor
5829035|NCT02565888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5829036|NCT02565888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5829037|NCT02565888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5829038|NCT02565719|Interferons|interferons|mesh-list
5829039|NCT02565719|Tenofovir|tenofovir|mesh-list
5829040|NCT02565719|Interferon-alpha|interferon-alpha|mesh-list
5829041|NCT02565719|Interferon alpha-2|interferon alpha-2|mesh-list
5829042|NCT02565719|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5829043|NCT02565719|REP 2139|rep 2139|mesh-list
5829044|NCT02565719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5829045|NCT02565719|Antiviral Agents|antiviral agents|mesh-ancestor
5829046|NCT02565719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5829047|NCT02565719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5829048|NCT02565719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5829049|NCT02565719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5829050|NCT02565719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5829051|NCT02565719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5829052|NCT02565719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5829053|NCT02565719|Immunologic Factors|immunologic factors|mesh-ancestor
5829054|NCT02565719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829055|NCT02565680|Prednisone|prednisone|mesh-list
5829056|NCT02565680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5829057|NCT02565680|Glucocorticoids|glucocorticoids|mesh-ancestor
5829058|NCT02565680|Hormones|hormones|mesh-ancestor
5829059|NCT02565680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5829060|NCT02565680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829061|NCT02565680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5652204|NCT03700359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5652205|NCT03700359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5652206|NCT03700359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5652207|NCT03700359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5652208|NCT03700359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5652209|NCT03700359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652210|NCT03700333|Pemetrexed|pemetrexed|mesh-list
5652211|NCT03700333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5652212|NCT03700333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5829062|NCT02565680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5829063|NCT02565862|Metformin|metformin|mesh-list
5829064|NCT02565862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5829065|NCT02565862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829066|NCT02565836|Thrombin|thrombin|mesh-list
5829067|NCT02565836|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
5829068|NCT02565836|Hemostatics|hemostatics|mesh-ancestor
5829069|NCT02565836|Coagulants|coagulants|mesh-ancestor
5829070|NCT02565641|Gemcitabine|gemcitabine|mesh-list
5829071|NCT02565641|Capecitabine|capecitabine|mesh-list
5829072|NCT02565641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5829073|NCT02565641|Antimetabolites|antimetabolites|mesh-ancestor
5829074|NCT02565641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652213|NCT03700333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5829075|NCT02565641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5829076|NCT02565641|Antiviral Agents|antiviral agents|mesh-ancestor
5829077|NCT02565641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5829078|NCT02565641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5829079|NCT02565641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5829080|NCT02565641|Immunologic Factors|immunologic factors|mesh-ancestor
5829081|NCT02565641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652214|NCT03700333|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5652215|NCT03700333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5652216|NCT03700229|Rituximab|rituximab|mesh-list
5652217|NCT03700229|Bortezomib|bortezomib|mesh-list
5652218|NCT03700229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5652219|NCT03700229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5652220|NCT03700229|Immunologic Factors|immunologic factors|mesh-ancestor
5652221|NCT03700229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652222|NCT03700229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5829082|NCT02565693|Aspirin|aspirin|mesh-list
5829083|NCT02565693|Carbaspirin calcium|carbaspirin calcium|mesh-list
5829084|NCT02565693|Dipyridamole|dipyridamole|mesh-list
5829085|NCT02565693|Apixaban|apixaban|mesh-list
5829086|NCT02565693|Clopidogrel|clopidogrel|mesh-list
5829087|NCT02565693|Calcium|calcium|mesh-list
5829088|NCT02565693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5829089|NCT02565693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829090|NCT02565693|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5829091|NCT02565693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5652223|NCT03700177|Dexamethasone|dexamethasone|mesh-list
5652224|NCT03700177|Ropivacaine|ropivacaine|mesh-list
5652225|NCT03700177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5652226|NCT03700177|Antiemetics|antiemetics|mesh-ancestor
5652227|NCT03700177|Autonomic Agents|autonomic agents|mesh-ancestor
5652228|NCT03700177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5652229|NCT03700177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652230|NCT03700177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5652231|NCT03700177|Glucocorticoids|glucocorticoids|mesh-ancestor
5652232|NCT03700177|Hormones|hormones|mesh-ancestor
5652233|NCT03700177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5652234|NCT03700177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5652235|NCT03700177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5652236|NCT03700177|Anesthetics, Local|anesthetics, local|mesh-ancestor
5652237|NCT03700177|Anesthetics|anesthetics|mesh-ancestor
5652238|NCT03700177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5652239|NCT03700177|Sensory System Agents|sensory system agents|mesh-ancestor
5652240|NCT03700138|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5652241|NCT03700138|Immunologic Factors|immunologic factors|mesh-ancestor
5652242|NCT03700138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694637|NCT03394287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5694638|NCT03394287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5694639|NCT03394287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5694640|NCT03394287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694641|NCT03394222|Budesonide|budesonide|mesh-list
5694642|NCT03394222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5694643|NCT03394222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5694644|NCT03394222|Autonomic Agents|autonomic agents|mesh-ancestor
5694645|NCT03394222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5694646|NCT03394222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694647|NCT03394222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5694648|NCT03394222|Respiratory System Agents|respiratory system agents|mesh-ancestor
5694649|NCT03394222|Glucocorticoids|glucocorticoids|mesh-ancestor
5694650|NCT03394222|Hormones|hormones|mesh-ancestor
5694651|NCT03394222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5694652|NCT03394209|Oseltamivir|oseltamivir|mesh-list
5694653|NCT03394209|Favipiravir|favipiravir|mesh-list
5694654|NCT03394209|Antiviral Agents|antiviral agents|mesh-ancestor
5694655|NCT03394209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5694656|NCT03394209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5694657|NCT03394209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694658|NCT03394196|Ritonavir|ritonavir|mesh-list
5694659|NCT03394196|Lopinavir|lopinavir|mesh-list
5694660|NCT03394196|Darunavir|darunavir|mesh-list
5694661|NCT03394196|Tenofovir|tenofovir|mesh-list
5694662|NCT03394196|Lamivudine|lamivudine|mesh-list
5694663|NCT03394196|Zidovudine|zidovudine|mesh-list
5694664|NCT03394196|Emtricitabine|emtricitabine|mesh-list
5694665|NCT03394196|Raltegravir Potassium|raltegravir potassium|mesh-list
5694666|NCT03394196|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5694667|NCT03394196|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5694668|NCT03394196|Protease Inhibitors|protease inhibitors|mesh-ancestor
5694669|NCT03394196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5829092|NCT02565693|Analgesics|analgesics|mesh-ancestor
5829093|NCT02565693|Sensory System Agents|sensory system agents|mesh-ancestor
5829094|NCT02565693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5829095|NCT02565693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5829096|NCT02565693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5829097|NCT02565693|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5829098|NCT02565693|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5829099|NCT02565693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5829100|NCT02565693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5829101|NCT02565693|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5829102|NCT02565693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5829103|NCT02565693|Antipyretics|antipyretics|mesh-ancestor
5829104|NCT02565693|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5652243|NCT03700099|Docetaxel|docetaxel|mesh-list
5652244|NCT03700099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5652245|NCT03700099|Tubulin Modulators|tubulin modulators|mesh-ancestor
5652246|NCT03700099|Antimitotic Agents|antimitotic agents|mesh-ancestor
5652247|NCT03700099|Mitosis Modulators|mitosis modulators|mesh-ancestor
5652248|NCT03700099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652249|NCT03699995|Lidocaine|lidocaine|mesh-list
5652250|NCT03699995|Anesthetics, Local|anesthetics, local|mesh-ancestor
5652251|NCT03699995|Anesthetics|anesthetics|mesh-ancestor
5652252|NCT03699995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5652253|NCT03699995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652254|NCT03699995|Sensory System Agents|sensory system agents|mesh-ancestor
5652255|NCT03699995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5652256|NCT03699995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5652257|NCT03699995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5652258|NCT03699995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5652259|NCT03699995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5652260|NCT03699995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652261|NCT03699956|Carboplatin|carboplatin|mesh-list
5652262|NCT03699956|Etoposide|etoposide|mesh-list
5652263|NCT03699956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5829105|NCT02565693|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6493180|NCT00612287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6493181|NCT00612287|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6493182|NCT00612469|Chlorhexidine|chlorhexidine|mesh-list
6493183|NCT00612469|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5652264|NCT03699956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5652265|NCT03699956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5652266|NCT03699956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5652267|NCT03699956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5652268|NCT03699956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652269|NCT03699904|Valacyclovir|valacyclovir|mesh-list
5652270|NCT03699904|Antiviral Agents|antiviral agents|mesh-ancestor
5652271|NCT03699904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5652272|NCT03699839|Vaccines|vaccines|mesh-list
5652273|NCT03699839|Immunologic Factors|immunologic factors|mesh-ancestor
5652274|NCT03699839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652275|NCT03699774|Firuglipel|firuglipel|mesh-list
5652276|NCT03699774|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5652277|NCT03699774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5652278|NCT03699774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5652279|NCT03699774|Antimetabolites|antimetabolites|mesh-ancestor
5652280|NCT03699774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652281|NCT03699774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5652282|NCT03699774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6493184|NCT00612469|Listerine|listerine|mesh-list
6493185|NCT00612469|Vancomycin|vancomycin|mesh-list
5829106|NCT02565693|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5829107|NCT02565693|Purinergic Agents|purinergic agents|mesh-ancestor
5829108|NCT02565693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5829109|NCT02565693|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5829110|NCT02565693|Antithrombins|antithrombins|mesh-ancestor
5829111|NCT02565693|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5829112|NCT02565693|Protease Inhibitors|protease inhibitors|mesh-ancestor
5829113|NCT02565693|Anticoagulants|anticoagulants|mesh-ancestor
5829114|NCT02565693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5829115|NCT02565693|Vasodilator Agents|vasodilator agents|mesh-ancestor
5829116|NCT02565602|Vitamin D|vitamin d|mesh-list
5829117|NCT02565602|Cholecalciferol|cholecalciferol|mesh-list
5829118|NCT02565602|Vitamins|vitamins|mesh-ancestor
5829119|NCT02565602|Micronutrients|micronutrients|mesh-ancestor
5829120|NCT02565602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829121|NCT02565602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6493186|NCT00612469|Fluorides|fluorides|mesh-list
5652283|NCT03699774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5652284|NCT03699774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5652285|NCT03699774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652286|NCT03699696|Propofol|propofol|mesh-list
5652287|NCT03699696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5652288|NCT03699696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5652289|NCT03699696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652290|NCT03699696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5652291|NCT03699696|Anesthetics, General|anesthetics, general|mesh-ancestor
5652292|NCT03699696|Anesthetics|anesthetics|mesh-ancestor
5652293|NCT03699631|Methotrexate|methotrexate|mesh-list
5652294|NCT03699631|Tacrolimus|tacrolimus|mesh-list
5652295|NCT03699631|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5652296|NCT03699631|Abortifacient Agents|abortifacient agents|mesh-ancestor
5652297|NCT03699631|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5652298|NCT03699631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652299|NCT03699631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5829122|NCT02565602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5829123|NCT02565368|Metformin|metformin|mesh-list
5829124|NCT02565368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5829125|NCT02565368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829126|NCT02565212|Montelukast|montelukast|mesh-list
5829127|NCT02565212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5829128|NCT02565212|Respiratory System Agents|respiratory system agents|mesh-ancestor
5652300|NCT03699631|Antimetabolites|antimetabolites|mesh-ancestor
5652301|NCT03699631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652302|NCT03699631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5652303|NCT03699631|Dermatologic Agents|dermatologic agents|mesh-ancestor
5652304|NCT03699631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5652305|NCT03699631|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5652306|NCT03699631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5652307|NCT03699631|Immunologic Factors|immunologic factors|mesh-ancestor
5652308|NCT03699631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5652309|NCT03699631|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5652310|NCT03699631|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5652311|NCT03699618|Bevacizumab|bevacizumab|mesh-list
5652312|NCT03699618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5652313|NCT03699618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5652314|NCT03699618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5652315|NCT03699618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5652316|NCT03699618|Growth Substances|growth substances|mesh-ancestor
5652317|NCT03699618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652318|NCT03699618|Growth Inhibitors|growth inhibitors|mesh-ancestor
5652319|NCT03699449|Paclitaxel|paclitaxel|mesh-list
5652320|NCT03699449|Durvalumab|durvalumab|mesh-list
5652321|NCT03699449|Olaparib|olaparib|mesh-list
5652322|NCT03699449|Tremelimumab|tremelimumab|mesh-list
5652323|NCT03699449|Cediranib|cediranib|mesh-list
5652324|NCT03699449|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5652325|NCT03699449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5829129|NCT02565212|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5829130|NCT02565212|Hormone Antagonists|hormone antagonists|mesh-ancestor
5829131|NCT02565212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5829132|NCT02565212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829133|NCT02565212|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5829134|NCT02565212|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5829135|NCT02565212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902413|NCT04366518|Autonomic Agents|autonomic agents|mesh-ancestor
5902414|NCT04366518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5652326|NCT03699449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5652327|NCT03699449|Tubulin Modulators|tubulin modulators|mesh-ancestor
5652328|NCT03699449|Antimitotic Agents|antimitotic agents|mesh-ancestor
5652329|NCT03699449|Mitosis Modulators|mitosis modulators|mesh-ancestor
5902415|NCT04366518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5902416|NCT04366518|Mydriatics|mydriatics|mesh-ancestor
5902417|NCT04366518|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5902418|NCT04366518|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6211730|NCT02176356|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5652330|NCT03699449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652331|NCT03699449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5652332|NCT03699449|Immunologic Factors|immunologic factors|mesh-ancestor
5652333|NCT03699449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652334|NCT03699449|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5652335|NCT03699449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5829136|NCT02565303|Ropivacaine|ropivacaine|mesh-list
5829137|NCT02565303|Anesthetics, Local|anesthetics, local|mesh-ancestor
5829138|NCT02565303|Anesthetics|anesthetics|mesh-ancestor
5829139|NCT02565303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5829140|NCT02565303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829141|NCT02565303|Sensory System Agents|sensory system agents|mesh-ancestor
5829142|NCT02565303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5829143|NCT02565316|Sertraline|sertraline|mesh-list
5829144|NCT02565316|Antidepressive Agents|antidepressive agents|mesh-ancestor
5829145|NCT02565316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5829146|NCT02565316|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5829147|NCT02565316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5829148|NCT02565316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5829149|NCT02565316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652336|NCT03699449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5652337|NCT03699423|Atropine|atropine|mesh-list
5652338|NCT03699423|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5652339|NCT03699423|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5652340|NCT03699423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5652341|NCT03699423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5652342|NCT03699423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5652343|NCT03699423|Autonomic Agents|autonomic agents|mesh-ancestor
5829150|NCT02565316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5829151|NCT02565316|Serotonin Agents|serotonin agents|mesh-ancestor
5829152|NCT02565316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829153|NCT02565173|Timolol|timolol|mesh-list
5829154|NCT02565173|Adenosine|adenosine|mesh-list
5829155|NCT02565173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5829156|NCT02565173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5829157|NCT02565173|Adrenergic Agents|adrenergic agents|mesh-ancestor
5829158|NCT02565173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5829159|NCT02565173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5829160|NCT02565173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829161|NCT02565173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5829162|NCT02565173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5829163|NCT02565173|Analgesics|analgesics|mesh-ancestor
5829164|NCT02565173|Sensory System Agents|sensory system agents|mesh-ancestor
5829165|NCT02565173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5829166|NCT02565173|Vasodilator Agents|vasodilator agents|mesh-ancestor
5829167|NCT02565173|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6493187|NCT00612469|Sodium Fluoride|sodium fluoride|mesh-list
6493188|NCT00612469|Cariostatic Agents|cariostatic agents|mesh-ancestor
6493189|NCT00612469|Protective Agents|protective agents|mesh-ancestor
6493190|NCT00612469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829168|NCT02565173|Purinergic Agonists|purinergic agonists|mesh-ancestor
5829169|NCT02565173|Purinergic Agents|purinergic agents|mesh-ancestor
5829170|NCT02564536|Decitabine|decitabine|mesh-list
5829171|NCT02564536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5829172|NCT02564536|Antimetabolites|antimetabolites|mesh-ancestor
5829173|NCT02564536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493191|NCT00612469|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5652344|NCT03699423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5652345|NCT03699423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652346|NCT03699423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5652347|NCT03699423|Respiratory System Agents|respiratory system agents|mesh-ancestor
5652348|NCT03699423|Mydriatics|mydriatics|mesh-ancestor
5652349|NCT03699423|Parasympatholytics|parasympatholytics|mesh-ancestor
5652350|NCT03699423|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5652351|NCT03699423|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5652352|NCT03699423|Cholinergic Agents|cholinergic agents|mesh-ancestor
5652353|NCT03699423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5829174|NCT02564536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5829175|NCT02564536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5829176|NCT02564315|Nicotine|nicotine|mesh-list
5829177|NCT02564315|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5829178|NCT02564315|Autonomic Agents|autonomic agents|mesh-ancestor
5829179|NCT02564315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5829180|NCT02564315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829181|NCT02564315|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5829182|NCT02564315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5829183|NCT02564315|Cholinergic Agents|cholinergic agents|mesh-ancestor
5829184|NCT02564315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5829185|NCT02564315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5829186|NCT02564237|Vaccines|vaccines|mesh-list
5829187|NCT02564237|Immunologic Factors|immunologic factors|mesh-ancestor
6493192|NCT00612469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6493193|NCT00612469|Disinfectants|disinfectants|mesh-ancestor
6493194|NCT00612469|Dermatologic Agents|dermatologic agents|mesh-ancestor
5652354|NCT03699423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652355|NCT03699384|Azacitidine|azacitidine|mesh-list
5652356|NCT03699384|Avelumab|avelumab|mesh-list
5652357|NCT03699384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5652358|NCT03699384|Antimetabolites|antimetabolites|mesh-ancestor
5652359|NCT03699384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652360|NCT03699384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5652361|NCT03699384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5652362|NCT03699384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5652363|NCT03699332|Labetuzumab|labetuzumab|mesh-list
5652364|NCT03699332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5652365|NCT03699332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5652366|NCT03699319|Leucovorin|leucovorin|mesh-list
5652367|NCT03699319|Folic Acid|folic acid|mesh-list
6493195|NCT00612469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6493196|NCT00612495|Fluorouracil|fluorouracil|mesh-list
6493197|NCT00612495|Oxaliplatin|oxaliplatin|mesh-list
5652368|NCT03699319|Oxaliplatin|oxaliplatin|mesh-list
5652369|NCT03699319|Irinotecan|irinotecan|mesh-list
5652370|NCT03699319|Levoleucovorin|levoleucovorin|mesh-list
5652371|NCT03699319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652372|NCT03699319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5652373|NCT03699319|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5652374|NCT03699319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5652375|NCT03699319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5652376|NCT03699319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652377|NCT03699319|Antidotes|antidotes|mesh-ancestor
5652378|NCT03699319|Protective Agents|protective agents|mesh-ancestor
5652379|NCT03699319|Vitamin B Complex|vitamin b complex|mesh-ancestor
5652380|NCT03699319|Vitamins|vitamins|mesh-ancestor
5652381|NCT03699319|Micronutrients|micronutrients|mesh-ancestor
5652382|NCT03699319|Hematinics|hematinics|mesh-ancestor
5652383|NCT03699293|Aspirin|aspirin|mesh-list
5652384|NCT03699293|Celecoxib|celecoxib|mesh-list
5652385|NCT03699293|Naproxen|naproxen|mesh-list
5652386|NCT03699293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5652387|NCT03699293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5652388|NCT03699293|Analgesics|analgesics|mesh-ancestor
5652389|NCT03699293|Sensory System Agents|sensory system agents|mesh-ancestor
5652390|NCT03699293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5652391|NCT03699293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652392|NCT03699293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5652393|NCT03699293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5652394|NCT03699293|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6493198|NCT00612495|Antimetabolites|antimetabolites|mesh-ancestor
6493199|NCT00612495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493200|NCT00612495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6493201|NCT00612495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6493202|NCT00612495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6493203|NCT00612495|Immunologic Factors|immunologic factors|mesh-ancestor
6493204|NCT00612495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493205|NCT00612521|Adenosine|adenosine|mesh-list
6493206|NCT00612521|Analgesics|analgesics|mesh-ancestor
6493207|NCT00612521|Sensory System Agents|sensory system agents|mesh-ancestor
5652395|NCT03699293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5652396|NCT03699293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652397|NCT03699293|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5652398|NCT03699293|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5652399|NCT03699293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5652400|NCT03699293|Antipyretics|antipyretics|mesh-ancestor
5652401|NCT03699293|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5652402|NCT03699293|Gout Suppressants|gout suppressants|mesh-ancestor
5652403|NCT03699254|Valganciclovir|valganciclovir|mesh-list
5652404|NCT03699254|Ganciclovir|ganciclovir|mesh-list
5652405|NCT03699254|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
5652406|NCT03699254|Antiviral Agents|antiviral agents|mesh-ancestor
5652407|NCT03699254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5652408|NCT03699254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6493208|NCT00612521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5829188|NCT02564237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829189|NCT02564094|Epoetin Alfa|epoetin alfa|mesh-list
5652409|NCT03699254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5652410|NCT03699254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652411|NCT03699215|Simendan|simendan|mesh-list
5829190|NCT02564094|Hematinics|hematinics|mesh-ancestor
5829191|NCT02564107|Ibandronic Acid|ibandronic acid|mesh-list
5829192|NCT02564107|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5829193|NCT02564107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829194|NCT02564146|Gemcitabine|gemcitabine|mesh-list
5829195|NCT02564146|Paclitaxel|paclitaxel|mesh-list
5829196|NCT02564146|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5829197|NCT02564146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5829198|NCT02564146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5652412|NCT03699215|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5652413|NCT03699215|Vasodilator Agents|vasodilator agents|mesh-ancestor
5652414|NCT03699215|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5652415|NCT03699215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5652416|NCT03699215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5652417|NCT03699215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652418|NCT03699215|Protective Agents|protective agents|mesh-ancestor
5652419|NCT03699215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652420|NCT03699202|Ziresovir|ziresovir|mesh-list
5652421|NCT03699202|Antiviral Agents|antiviral agents|mesh-ancestor
5652422|NCT03699202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5652423|NCT03699033|Paclitaxel|paclitaxel|mesh-list
5652424|NCT03699033|Carboplatin|carboplatin|mesh-list
5652425|NCT03699033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5652426|NCT03699033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5652427|NCT03699033|Tubulin Modulators|tubulin modulators|mesh-ancestor
5652428|NCT03699033|Antimitotic Agents|antimitotic agents|mesh-ancestor
5652429|NCT03699033|Mitosis Modulators|mitosis modulators|mesh-ancestor
5652430|NCT03699033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652431|NCT03698916|Celecoxib|celecoxib|mesh-list
5652432|NCT03698916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5652433|NCT03698916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5652434|NCT03698916|Analgesics|analgesics|mesh-ancestor
5652435|NCT03698916|Sensory System Agents|sensory system agents|mesh-ancestor
5652436|NCT03698916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5652437|NCT03698916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652438|NCT03698916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5652439|NCT03698916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5829199|NCT02564146|Tubulin Modulators|tubulin modulators|mesh-ancestor
5829200|NCT02564146|Antimitotic Agents|antimitotic agents|mesh-ancestor
5829201|NCT02564146|Mitosis Modulators|mitosis modulators|mesh-ancestor
5829202|NCT02564146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5829203|NCT02564146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5829204|NCT02564146|Antimetabolites|antimetabolites|mesh-ancestor
5829205|NCT02564146|Antiviral Agents|antiviral agents|mesh-ancestor
5829206|NCT02564146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5829207|NCT02564146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5829208|NCT02564146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5829209|NCT02564146|Immunologic Factors|immunologic factors|mesh-ancestor
5829210|NCT02564146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829211|NCT02564003|Oxycodone|oxycodone|mesh-list
5652440|NCT03698916|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5652441|NCT03698916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5829212|NCT02564003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5829213|NCT02564003|Narcotics|narcotics|mesh-ancestor
5829214|NCT02564003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5829215|NCT02564003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829216|NCT02564003|Analgesics|analgesics|mesh-ancestor
5829217|NCT02564003|Sensory System Agents|sensory system agents|mesh-ancestor
5829218|NCT02564003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5829219|NCT02563951|Granisetron|granisetron|mesh-list
5829220|NCT02563951|Antiemetics|antiemetics|mesh-ancestor
5829221|NCT02563951|Autonomic Agents|autonomic agents|mesh-ancestor
5829222|NCT02563951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5829223|NCT02563951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829224|NCT02563951|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5829225|NCT02563951|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5829226|NCT02563951|Serotonin Agents|serotonin agents|mesh-ancestor
5829227|NCT02563951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5829228|NCT02563951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5829229|NCT02563925|Durvalumab|durvalumab|mesh-list
5829230|NCT02563925|Tremelimumab|tremelimumab|mesh-list
5829231|NCT02563925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5829232|NCT02563925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5829233|NCT02563782|Mycophenolic Acid|mycophenolic acid|mesh-list
5829234|NCT02563782|Tacrolimus|tacrolimus|mesh-list
5829235|NCT02563782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5652442|NCT03698916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5652443|NCT03698916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652444|NCT03698851|Methamphetamine|methamphetamine|mesh-list
5652445|NCT03698851|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5652446|NCT03698851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652447|NCT03698851|Sympathomimetics|sympathomimetics|mesh-ancestor
5652448|NCT03698851|Autonomic Agents|autonomic agents|mesh-ancestor
5652449|NCT03698851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5652450|NCT03698851|Dopamine Agents|dopamine agents|mesh-ancestor
5652451|NCT03698851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5829236|NCT02563782|Immunologic Factors|immunologic factors|mesh-ancestor
5829237|NCT02563782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829238|NCT02563782|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5829239|NCT02563782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5829240|NCT02563782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5829241|NCT02563782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5829242|NCT02563782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5829243|NCT02563782|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5829244|NCT02563782|Antitubercular Agents|antitubercular agents|mesh-ancestor
5829245|NCT02563782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5829246|NCT02563782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5829247|NCT02563795|Fentanyl|fentanyl|mesh-list
5829248|NCT02563795|Bupivacaine|bupivacaine|mesh-list
5829249|NCT02563795|Anesthetics, Local|anesthetics, local|mesh-ancestor
5829250|NCT02563795|Anesthetics|anesthetics|mesh-ancestor
5829251|NCT02563795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5829252|NCT02563795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829253|NCT02563795|Sensory System Agents|sensory system agents|mesh-ancestor
5829254|NCT02563795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5829255|NCT02563795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5829256|NCT02563795|Narcotics|narcotics|mesh-ancestor
5829257|NCT02563795|Analgesics|analgesics|mesh-ancestor
5829258|NCT02563795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5829259|NCT02563795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5829260|NCT02563795|Anesthetics, General|anesthetics, general|mesh-ancestor
5829261|NCT02563847|Erythritol|erythritol|mesh-list
5829262|NCT02563847|Tryptophan|tryptophan|mesh-list
5829263|NCT02563847|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5829264|NCT02563847|Antidepressive Agents|antidepressive agents|mesh-ancestor
5829265|NCT02563847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5829266|NCT02563847|Vasodilator Agents|vasodilator agents|mesh-ancestor
5829267|NCT02563769|Clavulanic Acids|clavulanic acids|mesh-list
5829268|NCT02563769|Clavulanic Acid|clavulanic acid|mesh-list
5829269|NCT02563769|Cocaine|cocaine|mesh-list
5829270|NCT02563769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5829271|NCT02563769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5829272|NCT02563769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5829273|NCT02563769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5829274|NCT02563769|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5829275|NCT02563769|Anesthetics, Local|anesthetics, local|mesh-ancestor
5829276|NCT02563769|Anesthetics|anesthetics|mesh-ancestor
5829277|NCT02563769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5829278|NCT02563769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829279|NCT02563769|Sensory System Agents|sensory system agents|mesh-ancestor
5829280|NCT02563769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5829281|NCT02563769|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5829282|NCT02563769|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5829283|NCT02563769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5829284|NCT02563769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5829285|NCT02563769|Dopamine Agents|dopamine agents|mesh-ancestor
5829286|NCT02563769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5829287|NCT02563704|Artesunate|artesunate|mesh-list
5829288|NCT02563704|Quinine|quinine|mesh-list
5829289|NCT02563704|Antimalarials|antimalarials|mesh-ancestor
5829290|NCT02563704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5829291|NCT02563704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5829292|NCT02563704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5829293|NCT02563704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5829294|NCT02563704|Antiviral Agents|antiviral agents|mesh-ancestor
5829295|NCT02563704|Schistosomicides|schistosomicides|mesh-ancestor
5829296|NCT02563704|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5829297|NCT02563704|Anthelmintics|anthelmintics|mesh-ancestor
5829298|NCT02563704|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5829299|NCT02563704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829300|NCT02563704|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5829301|NCT02563704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5829302|NCT02563704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5829303|NCT02563704|Analgesics|analgesics|mesh-ancestor
5829304|NCT02563704|Sensory System Agents|sensory system agents|mesh-ancestor
5829305|NCT02563821|Clonidine|clonidine|mesh-list
5829306|NCT02563821|Sufentanil|sufentanil|mesh-list
5829307|NCT02563821|Levobupivacaine|levobupivacaine|mesh-list
5829308|NCT02563821|Anesthetics, Local|anesthetics, local|mesh-ancestor
5829309|NCT02563821|Anesthetics|anesthetics|mesh-ancestor
5829310|NCT02563821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5829311|NCT02563821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829312|NCT02563821|Sensory System Agents|sensory system agents|mesh-ancestor
5829313|NCT02563821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5829314|NCT02563821|Analgesics|analgesics|mesh-ancestor
5829315|NCT02563821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5829316|NCT02563821|Sympatholytics|sympatholytics|mesh-ancestor
5652452|NCT03698851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652453|NCT03698851|Adrenergic Agents|adrenergic agents|mesh-ancestor
5652454|NCT03698851|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5652455|NCT03698851|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5652456|NCT03698851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5652457|NCT03698851|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5652458|NCT03698734|Evening primrose oil|evening primrose oil|mesh-list
5652459|NCT03698734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5829317|NCT02563821|Autonomic Agents|autonomic agents|mesh-ancestor
5829318|NCT02563821|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5829319|NCT02563821|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5829320|NCT02563821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5829321|NCT02563821|Adrenergic Agents|adrenergic agents|mesh-ancestor
5829322|NCT02563821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5652460|NCT03698734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5652461|NCT03698734|Analgesics|analgesics|mesh-ancestor
5652462|NCT03698734|Sensory System Agents|sensory system agents|mesh-ancestor
5652463|NCT03698734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5652464|NCT03698734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652465|NCT03698734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5652466|NCT03698734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5652467|NCT03698734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5652468|NCT03698734|Antimetabolites|antimetabolites|mesh-ancestor
5652469|NCT03698734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652470|NCT03698734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5652471|NCT03698734|Dermatologic Agents|dermatologic agents|mesh-ancestor
5652472|NCT03698695|Mefloquine|mefloquine|mesh-list
5652473|NCT03698695|Donepezil|donepezil|mesh-list
5652474|NCT03698695|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5652475|NCT03698695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5652476|NCT03698695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652477|NCT03698695|Cholinergic Agents|cholinergic agents|mesh-ancestor
5652478|NCT03698695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5652479|NCT03698695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652480|NCT03698695|Nootropic Agents|nootropic agents|mesh-ancestor
5652481|NCT03698695|Antimalarials|antimalarials|mesh-ancestor
5652482|NCT03698695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5652483|NCT03698695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5652484|NCT03698695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5652485|NCT03698682|Levofloxacin|levofloxacin|mesh-list
5652486|NCT03698682|Ofloxacin|ofloxacin|mesh-list
5652487|NCT03698682|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5652488|NCT03698682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5652489|NCT03698682|Renal Agents|renal agents|mesh-ancestor
5652490|NCT03698682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5652491|NCT03698682|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5652492|NCT03698682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5652493|NCT03698682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5652494|NCT03698682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652495|NCT03698682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5652496|NCT03698682|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5652497|NCT03698682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5652498|NCT03698669|Analgesics, Opioid|analgesics, opioid|mesh-list
5652499|NCT03698669|Narcotics|narcotics|mesh-ancestor
5652500|NCT03698669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5652501|NCT03698669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652502|NCT03698669|Analgesics|analgesics|mesh-ancestor
5829323|NCT02563821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652503|NCT03698669|Sensory System Agents|sensory system agents|mesh-ancestor
5829324|NCT02563821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5829325|NCT02563821|Narcotics|narcotics|mesh-ancestor
5829326|NCT02563821|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5829327|NCT02563821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5829328|NCT02563821|Anesthetics, General|anesthetics, general|mesh-ancestor
5902419|NCT04366518|Parasympatholytics|parasympatholytics|mesh-ancestor
5902420|NCT04360629|Tranexamic Acid|tranexamic acid|mesh-list
5652504|NCT03698669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5694670|NCT03394196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694671|NCT03394196|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5694672|NCT03394196|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5694673|NCT03394196|Antiviral Agents|antiviral agents|mesh-ancestor
5694674|NCT03394196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5694675|NCT03394196|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5694676|NCT03394196|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5694677|NCT03394196|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5694678|NCT03394196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5902421|NCT04360629|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5902422|NCT04360629|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5902423|NCT04360629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902424|NCT04360629|Hemostatics|hemostatics|mesh-ancestor
5902425|NCT04360629|Coagulants|coagulants|mesh-ancestor
5902426|NCT04330664|Adagrasib|adagrasib|mesh-list
5902427|NCT04330664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5902428|NCT04237649|Spartalizumab|spartalizumab|mesh-list
5902429|NCT04237649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5902430|NCT04237649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902431|NCT04237649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5902432|NCT04230148|Triclabendazole|triclabendazole|mesh-list
5902433|NCT04230148|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5694679|NCT03394196|Antimetabolites|antimetabolites|mesh-ancestor
5694680|NCT03394196|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5694681|NCT03394196|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5694682|NCT03394144|Durvalumab|durvalumab|mesh-list
5694683|NCT03394144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5694684|NCT03394144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5694685|NCT03394131|Insulin|insulin|mesh-list
5694686|NCT03394131|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5694687|NCT03394131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5694688|NCT03394131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694689|NCT03394118|Osimertinib|osimertinib|mesh-list
5694690|NCT03394118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5694691|NCT03394118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5694692|NCT03394118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5694693|NCT03394118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694694|NCT03394105|Docetaxel|docetaxel|mesh-list
5694695|NCT03394105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5694696|NCT03394105|Tubulin Modulators|tubulin modulators|mesh-ancestor
5694697|NCT03394105|Antimitotic Agents|antimitotic agents|mesh-ancestor
5694698|NCT03394105|Mitosis Modulators|mitosis modulators|mesh-ancestor
5694699|NCT03394105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697950|NCT03372473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5697951|NCT03372473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697952|NCT03372473|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5697953|NCT03372473|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5697954|NCT03372473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697955|NCT03372473|Antipruritics|antipruritics|mesh-ancestor
5697956|NCT03372473|Dermatologic Agents|dermatologic agents|mesh-ancestor
5697957|NCT03372473|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5697958|NCT03372473|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5697959|NCT03372473|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5697960|NCT03372473|Histamine Antagonists|histamine antagonists|mesh-ancestor
5697961|NCT03372473|Histamine Agents|histamine agents|mesh-ancestor
5697962|NCT03372473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5697963|NCT03372447|Thiamine|thiamine|mesh-list
5697964|NCT03372447|Pyridoxine|pyridoxine|mesh-list
5697965|NCT03372447|Hydroxocobalamin|hydroxocobalamin|mesh-list
5697966|NCT03372447|Vitamin B 12|vitamin b 12|mesh-list
5697967|NCT03372447|Vitamin B Complex|vitamin b complex|mesh-ancestor
5697968|NCT03372447|Vitamins|vitamins|mesh-ancestor
5697969|NCT03372447|Micronutrients|micronutrients|mesh-ancestor
5697970|NCT03372447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697971|NCT03372447|Hematinics|hematinics|mesh-ancestor
5697972|NCT03372304|Ropivacaine|ropivacaine|mesh-list
5697973|NCT03372304|Anesthetics, Local|anesthetics, local|mesh-ancestor
5902434|NCT04230148|Anthelmintics|anthelmintics|mesh-ancestor
5902435|NCT04230148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5829329|NCT02563405|Doxazosin|doxazosin|mesh-list
5829330|NCT02563405|Nifedipine|nifedipine|mesh-list
5829331|NCT02563405|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5829332|NCT02563405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5829333|NCT02563405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5829334|NCT02563405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5829335|NCT02563405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829336|NCT02563405|Vasodilator Agents|vasodilator agents|mesh-ancestor
5829337|NCT02563405|Tocolytic Agents|tocolytic agents|mesh-ancestor
5829338|NCT02563405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5829339|NCT02563405|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5829340|NCT02563405|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5829341|NCT02563405|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5829342|NCT02563405|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5829343|NCT02563405|Adrenergic Agents|adrenergic agents|mesh-ancestor
5829344|NCT02563405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5829345|NCT02563340|Rituximab|rituximab|mesh-list
5829346|NCT02563340|Bortezomib|bortezomib|mesh-list
5829347|NCT02563340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5829348|NCT02563340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5829349|NCT02563340|Immunologic Factors|immunologic factors|mesh-ancestor
5829350|NCT02563340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829351|NCT02563340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5829352|NCT02563353|Teriparatide|teriparatide|mesh-list
5829353|NCT02563353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5829354|NCT02563353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829355|NCT02563353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5829356|NCT02563288|Dexmedetomidine|dexmedetomidine|mesh-list
5829357|NCT02563288|Esmolol|esmolol|mesh-list
5829358|NCT02563288|Adrenergic Agents|adrenergic agents|mesh-list
5829359|NCT02563288|Adrenergic Agonists|adrenergic agonists|mesh-list
5829360|NCT02563288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-list
5829361|NCT02563288|Adrenergic Antagonists|adrenergic antagonists|mesh-list
5829362|NCT02563288|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5829363|NCT02563288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5829364|NCT02563288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829365|NCT02563288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5829366|NCT02563288|Analgesics|analgesics|mesh-ancestor
5829367|NCT02563288|Sensory System Agents|sensory system agents|mesh-ancestor
5829368|NCT02563288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5829369|NCT02563288|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5829370|NCT02563288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5829371|NCT02563288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5829372|NCT02563288|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5829373|NCT02563288|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5829374|NCT02563327|Pyridoxine|pyridoxine|mesh-list
5829375|NCT02563327|Vitamin B 6|vitamin b 6|mesh-list
5829376|NCT02563327|Moxifloxacin|moxifloxacin|mesh-list
5829377|NCT02563327|Rifampin|rifampin|mesh-list
5829378|NCT02563327|Isoniazid|isoniazid|mesh-list
5829379|NCT02563327|Pyrazinamide|pyrazinamide|mesh-list
5829380|NCT02563327|Ethambutol|ethambutol|mesh-list
5829381|NCT02563327|Rifapentine|rifapentine|mesh-list
5829382|NCT02563327|Vitamins|vitamins|mesh-ancestor
5829383|NCT02563327|Micronutrients|micronutrients|mesh-ancestor
5829384|NCT02563327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829385|NCT02563327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5652505|NCT03698630|Dexamethasone|dexamethasone|mesh-list
5652506|NCT03698630|Prednisolone|prednisolone|mesh-list
5652507|NCT03698630|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5652508|NCT03698630|Methylprednisolone|methylprednisolone|mesh-list
5652509|NCT03698630|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6493209|NCT00612521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493210|NCT00612521|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6493211|NCT00612521|Vasodilator Agents|vasodilator agents|mesh-ancestor
6493212|NCT00612521|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6493213|NCT00612521|Purinergic Agonists|purinergic agonists|mesh-ancestor
5829386|NCT02563327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6493214|NCT00612521|Purinergic Agents|purinergic agents|mesh-ancestor
5652510|NCT03698630|Prednisolone acetate|prednisolone acetate|mesh-list
5652511|NCT03698630|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5652512|NCT03698630|Prednisolone phosphate|prednisolone phosphate|mesh-list
5652513|NCT03698630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5652514|NCT03698630|Antiemetics|antiemetics|mesh-ancestor
5652515|NCT03698630|Autonomic Agents|autonomic agents|mesh-ancestor
5652516|NCT03698630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5652517|NCT03698630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652518|NCT03698630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5652519|NCT03698630|Glucocorticoids|glucocorticoids|mesh-ancestor
5652520|NCT03698630|Hormones|hormones|mesh-ancestor
5652521|NCT03698630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5652522|NCT03698630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5652523|NCT03698630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5652524|NCT03698630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5652525|NCT03698630|Protective Agents|protective agents|mesh-ancestor
5652526|NCT03698617|Propofol|propofol|mesh-list
5652527|NCT03698617|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5652528|NCT03698617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5652529|NCT03698617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652530|NCT03698617|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5652531|NCT03698617|Anesthetics, General|anesthetics, general|mesh-ancestor
5652532|NCT03698617|Anesthetics|anesthetics|mesh-ancestor
5652533|NCT03698513|Aspirin|aspirin|mesh-list
5652534|NCT03698513|Clopidogrel|clopidogrel|mesh-list
5652535|NCT03698513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5652536|NCT03698513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5652537|NCT03698513|Analgesics|analgesics|mesh-ancestor
5652538|NCT03698513|Sensory System Agents|sensory system agents|mesh-ancestor
5652539|NCT03698513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5652540|NCT03698513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652541|NCT03698513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5652542|NCT03698513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5652543|NCT03698513|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5652544|NCT03698513|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5652545|NCT03698513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652546|NCT03698513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5694700|NCT03394001|Ketorolac|ketorolac|mesh-list
5829387|NCT02563327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5829388|NCT02563327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5829389|NCT02563327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5829390|NCT02563327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5829391|NCT02563327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5829392|NCT02563327|Vitamin B Complex|vitamin b complex|mesh-ancestor
5829393|NCT02563327|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5829394|NCT02563327|Antitubercular Agents|antitubercular agents|mesh-ancestor
5829395|NCT02563327|Leprostatic Agents|leprostatic agents|mesh-ancestor
5829396|NCT02563327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5829397|NCT02563327|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5829398|NCT02563327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5829399|NCT02563327|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5829400|NCT02563327|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5829401|NCT02563327|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5829402|NCT02563327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5829403|NCT02563327|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5829404|NCT02563327|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5829405|NCT02563327|Antimetabolites|antimetabolites|mesh-ancestor
5829406|NCT02563327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5829407|NCT02563054|Fluorouracil|fluorouracil|mesh-list
5829408|NCT02563054|Capecitabine|capecitabine|mesh-list
5829409|NCT02563054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5829410|NCT02563054|Antimetabolites|antimetabolites|mesh-ancestor
5829411|NCT02563054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5829412|NCT02563054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5829413|NCT02563054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5829414|NCT02563054|Immunologic Factors|immunologic factors|mesh-ancestor
5829415|NCT02563054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829416|NCT02563002|Bevacizumab|bevacizumab|mesh-list
5829417|NCT02563002|Pembrolizumab|pembrolizumab|mesh-list
5829418|NCT02563002|Cetuximab|cetuximab|mesh-list
5829419|NCT02563002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5829420|NCT02563002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5829421|NCT02563002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5829422|NCT02563002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5829423|NCT02563002|Growth Substances|growth substances|mesh-ancestor
5829424|NCT02563002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829425|NCT02563002|Growth Inhibitors|growth inhibitors|mesh-ancestor
5829426|NCT02563041|Heparin|heparin|mesh-list
5829427|NCT02563041|Calcium heparin|calcium heparin|mesh-list
5829428|NCT02563041|Anticoagulants|anticoagulants|mesh-ancestor
5829429|NCT02563041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5829430|NCT02563041|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5829431|NCT02563041|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5829432|NCT02562950|Midazolam|midazolam|mesh-list
5829433|NCT02562950|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5829434|NCT02562950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5829435|NCT02562950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5829436|NCT02562950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829437|NCT02562950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5829438|NCT02562950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5829439|NCT02562950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5652547|NCT03698513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5652548|NCT03698513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5652549|NCT03698513|Antipyretics|antipyretics|mesh-ancestor
5829440|NCT02562950|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5829441|NCT02562950|Anesthetics, General|anesthetics, general|mesh-ancestor
5829442|NCT02562950|Anesthetics|anesthetics|mesh-ancestor
5829443|NCT02562950|GABA Modulators|gaba modulators|mesh-ancestor
5829444|NCT02562950|GABA Agents|gaba agents|mesh-ancestor
5829445|NCT02562950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5829446|NCT02562950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5829447|NCT02562742|Ribavirin|ribavirin|mesh-list
5829448|NCT02562742|Antimetabolites|antimetabolites|mesh-ancestor
5829449|NCT02562742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5829450|NCT02562742|Antiviral Agents|antiviral agents|mesh-ancestor
5829451|NCT02562742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5829452|NCT02562690|Thrombin|thrombin|mesh-list
5829453|NCT02562690|Hemostatics|hemostatics|mesh-ancestor
5829454|NCT02562690|Coagulants|coagulants|mesh-ancestor
5829455|NCT02562417|Dexamethasone|dexamethasone|mesh-list
5829456|NCT02562417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5829457|NCT02562417|Antiemetics|antiemetics|mesh-ancestor
5829458|NCT02562417|Autonomic Agents|autonomic agents|mesh-ancestor
5829459|NCT02562417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5829460|NCT02562417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829461|NCT02562417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5829462|NCT02562417|Glucocorticoids|glucocorticoids|mesh-ancestor
5829463|NCT02562417|Hormones|hormones|mesh-ancestor
5829464|NCT02562417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5829465|NCT02562417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5829466|NCT02562417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5829467|NCT02562651|Doxycycline|doxycycline|mesh-list
5829468|NCT02562651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5829469|NCT02562651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5829470|NCT02562651|Antimalarials|antimalarials|mesh-ancestor
5829471|NCT02562651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5829472|NCT02562651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5829473|NCT02562625|Pembrolizumab|pembrolizumab|mesh-list
5829474|NCT02562625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5829475|NCT02562625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5829476|NCT02562664|Metformin|metformin|mesh-list
5829477|NCT02562664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5829478|NCT02562664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829479|NCT02562365|Cyclophosphamide|cyclophosphamide|mesh-list
5829480|NCT02562365|Carboplatin|carboplatin|mesh-list
5829481|NCT02562365|Etoposide|etoposide|mesh-list
5829482|NCT02562365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5829483|NCT02562365|Immunologic Factors|immunologic factors|mesh-ancestor
5829484|NCT02562365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829485|NCT02562365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5829486|NCT02562365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5829487|NCT02562365|Alkylating Agents|alkylating agents|mesh-ancestor
5829488|NCT02562365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5829489|NCT02562365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5829490|NCT02562365|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5829491|NCT02562365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5829492|NCT02562365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5829493|NCT02562365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5829494|NCT02562365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5652550|NCT03698513|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5652551|NCT03698513|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5652552|NCT03698513|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5652553|NCT03698513|Purinergic Agents|purinergic agents|mesh-ancestor
5652554|NCT03698513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5652555|NCT03698474|Ascorbic Acid|ascorbic acid|mesh-list
5652556|NCT03698474|Magnesium Sulfate|magnesium sulfate|mesh-list
5652557|NCT03698474|Picosulfate sodium|picosulfate sodium|mesh-list
5829495|NCT02562443|ON 01910|on 01910|mesh-list
5829496|NCT02562443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5829497|NCT02562443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5829498|NCT02562443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5829499|NCT02562443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5829500|NCT02562508|Vaccines|vaccines|mesh-list
5829501|NCT02562508|Immunologic Factors|immunologic factors|mesh-ancestor
5829502|NCT02562508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829503|NCT02562326|Insulin Lispro|insulin lispro|mesh-list
5829504|NCT02562326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5829505|NCT02562326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652558|NCT03698474|Magnesium citrate|magnesium citrate|mesh-list
5652559|NCT03698474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652560|NCT03698474|Analgesics|analgesics|mesh-ancestor
5652561|NCT03698474|Sensory System Agents|sensory system agents|mesh-ancestor
5652562|NCT03698474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5652563|NCT03698474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652564|NCT03698474|Anesthetics|anesthetics|mesh-ancestor
5652565|NCT03698474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5652566|NCT03698474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5829506|NCT02562144|Lidocaine|lidocaine|mesh-list
5829507|NCT02562144|Anesthetics, Local|anesthetics, local|mesh-ancestor
5829508|NCT02562144|Anesthetics|anesthetics|mesh-ancestor
5829509|NCT02562144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5829510|NCT02562144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829511|NCT02562144|Sensory System Agents|sensory system agents|mesh-ancestor
5829512|NCT02562144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5829513|NCT02562144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5829514|NCT02562144|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5829515|NCT02562144|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5829516|NCT02562144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5829517|NCT02562144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5829518|NCT02562300|Misoprostol|misoprostol|mesh-list
5829519|NCT02562300|Oxytocin|oxytocin|mesh-list
5829520|NCT02562300|Oxytocics|oxytocics|mesh-ancestor
5829521|NCT02562300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5652567|NCT03698474|Anticonvulsants|anticonvulsants|mesh-ancestor
5652568|NCT03698474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5652569|NCT03698474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5652570|NCT03698474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5652571|NCT03698474|Tocolytic Agents|tocolytic agents|mesh-ancestor
5652572|NCT03698474|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5652573|NCT03698474|Antioxidants|antioxidants|mesh-ancestor
5652574|NCT03698474|Protective Agents|protective agents|mesh-ancestor
5652575|NCT03698474|Vitamins|vitamins|mesh-ancestor
5652576|NCT03698474|Micronutrients|micronutrients|mesh-ancestor
5652577|NCT03698474|Cathartics|cathartics|mesh-ancestor
5652578|NCT03698474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5652579|NCT03698461|Leucovorin|leucovorin|mesh-list
5652580|NCT03698461|Bevacizumab|bevacizumab|mesh-list
5652581|NCT03698461|Fluorouracil|fluorouracil|mesh-list
5652582|NCT03698461|Oxaliplatin|oxaliplatin|mesh-list
5652583|NCT03698461|Atezolizumab|atezolizumab|mesh-list
5652584|NCT03698461|Levoleucovorin|levoleucovorin|mesh-list
5652585|NCT03698461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5652586|NCT03698461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5652587|NCT03698461|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5829522|NCT02562300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829523|NCT02562300|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5829524|NCT02562300|Abortifacient Agents|abortifacient agents|mesh-ancestor
5829525|NCT02562300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5829526|NCT02562300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6675602|NCT01576627|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5652588|NCT03698461|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5652589|NCT03698461|Growth Substances|growth substances|mesh-ancestor
5652590|NCT03698461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652591|NCT03698461|Growth Inhibitors|growth inhibitors|mesh-ancestor
5652592|NCT03698461|Antimetabolites|antimetabolites|mesh-ancestor
5652593|NCT03698461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652594|NCT03698461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5652595|NCT03698461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5652596|NCT03698461|Immunologic Factors|immunologic factors|mesh-ancestor
5652597|NCT03698461|Antidotes|antidotes|mesh-ancestor
5652598|NCT03698461|Protective Agents|protective agents|mesh-ancestor
5652599|NCT03698461|Vitamin B Complex|vitamin b complex|mesh-ancestor
5652600|NCT03698461|Vitamins|vitamins|mesh-ancestor
5652601|NCT03698461|Micronutrients|micronutrients|mesh-ancestor
5652602|NCT03698435|Valganciclovir|valganciclovir|mesh-list
5652603|NCT03698435|Ganciclovir|ganciclovir|mesh-list
5652604|NCT03698435|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
5829527|NCT02562118|Letrozole|letrozole|mesh-list
5829528|NCT02562118|Lenvatinib|lenvatinib|mesh-list
5829529|NCT02562118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5829530|NCT02562118|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5829531|NCT02562118|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5829532|NCT02562118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5829533|NCT02562118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5829534|NCT02562118|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5829535|NCT02562118|Hormone Antagonists|hormone antagonists|mesh-ancestor
5829536|NCT02562118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5829537|NCT02562118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829538|NCT02562118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5829539|NCT02562183|Kallikreins|kallikreins|mesh-list
5829540|NCT02562183|Coagulants|coagulants|mesh-ancestor
5829541|NCT02562183|Fertility Agents, Male|fertility agents, male|mesh-ancestor
5829542|NCT02562183|Fertility Agents|fertility agents|mesh-ancestor
5829543|NCT02562183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5652605|NCT03698435|Antiviral Agents|antiviral agents|mesh-ancestor
5652606|NCT03698435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5652607|NCT03698435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5652608|NCT03698435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5652609|NCT03698435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652610|NCT03698383|Trastuzumab|trastuzumab|mesh-list
5652611|NCT03698383|Gedatolisib|gedatolisib|mesh-list
5652612|NCT03698383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5652613|NCT03698383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5652614|NCT03698383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5652615|NCT03698383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5652616|NCT03698383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652617|NCT03698292|Metoclopramide|metoclopramide|mesh-list
5652618|NCT03698292|Antiemetics|antiemetics|mesh-ancestor
5652619|NCT03698292|Autonomic Agents|autonomic agents|mesh-ancestor
5652620|NCT03698292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5652621|NCT03698292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652622|NCT03698292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5652623|NCT03698292|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5829544|NCT02562183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829545|NCT02562287|Olanzapine|olanzapine|mesh-list
5829546|NCT02562287|Risperidone|risperidone|mesh-list
5829547|NCT02562287|Quetiapine Fumarate|quetiapine fumarate|mesh-list
5829548|NCT02562287|Clozapine|clozapine|mesh-list
5829549|NCT02562287|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5829550|NCT02562287|Serotonin Agents|serotonin agents|mesh-ancestor
5829551|NCT02562287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5829552|NCT02562287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5829553|NCT02562287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829554|NCT02562287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5829555|NCT02562287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5829556|NCT02562287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5829557|NCT02562287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5829558|NCT02562287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5829559|NCT02562287|Dopamine Agents|dopamine agents|mesh-ancestor
5829560|NCT02562287|Antiemetics|antiemetics|mesh-ancestor
5829561|NCT02562287|Autonomic Agents|autonomic agents|mesh-ancestor
5829562|NCT02562287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5829563|NCT02562287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5829564|NCT02562287|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5829565|NCT02562287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5829566|NCT02562287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5829567|NCT02562287|Antidepressive Agents|antidepressive agents|mesh-ancestor
5829568|NCT02562287|GABA Antagonists|gaba antagonists|mesh-ancestor
5829569|NCT02562287|GABA Agents|gaba agents|mesh-ancestor
5829570|NCT02562053|Fluoxetine|fluoxetine|mesh-list
5829571|NCT02562053|Contraceptive Agents|contraceptive agents|mesh-list
5829572|NCT02562053|Contraceptives, Oral|contraceptives, oral|mesh-list
5829573|NCT02562053|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
5829574|NCT02562053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5829575|NCT02562053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829576|NCT02562053|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5829577|NCT02562053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5829578|NCT02562053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5829579|NCT02562053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5829580|NCT02562053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5829581|NCT02562053|Serotonin Agents|serotonin agents|mesh-ancestor
6675603|NCT01576627|Protective Agents|protective agents|mesh-ancestor
5652624|NCT03698292|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5652625|NCT03698292|Dopamine Agents|dopamine agents|mesh-ancestor
5652626|NCT03698292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5652627|NCT03698292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493215|NCT00612521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6493216|NCT00612521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493217|NCT00612547|Artesunate|artesunate|mesh-list
6493218|NCT00612547|Amodiaquine|amodiaquine|mesh-list
6493219|NCT00612547|Antimalarials|antimalarials|mesh-ancestor
6493220|NCT00612547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6493221|NCT00612547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6493222|NCT00612547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6493223|NCT00612547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6493224|NCT00612547|Antiviral Agents|antiviral agents|mesh-ancestor
6493225|NCT00612547|Schistosomicides|schistosomicides|mesh-ancestor
6493226|NCT00612547|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6493227|NCT00612547|Anthelmintics|anthelmintics|mesh-ancestor
6493228|NCT00612599|Insulin Aspart|insulin aspart|mesh-list
6493229|NCT00612599|Biphasic Insulins|biphasic insulins|mesh-list
6493230|NCT00612599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6493231|NCT00612599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652628|NCT03698227|Doxorubicin|doxorubicin|mesh-list
5652629|NCT03698227|Dexrazoxane|dexrazoxane|mesh-list
5652630|NCT03698227|Razoxane|razoxane|mesh-list
5652631|NCT03698227|Olaratumab|olaratumab|mesh-list
5652632|NCT03698227|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5829582|NCT02562053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5829583|NCT02562053|Antidepressive Agents|antidepressive agents|mesh-ancestor
5829584|NCT02562053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5829585|NCT02562053|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5829586|NCT02562053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5829587|NCT02562053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5829588|NCT02562053|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5829589|NCT02562313|Insulin Lispro|insulin lispro|mesh-list
5829590|NCT02562313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5829591|NCT02562313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829592|NCT02561936|Rilpivirine|rilpivirine|mesh-list
5829593|NCT02561936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5829594|NCT02561936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5829595|NCT02561936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5829596|NCT02561936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5829597|NCT02561936|Antiviral Agents|antiviral agents|mesh-ancestor
5829598|NCT02561936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5829599|NCT02561936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5829600|NCT02561936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5829601|NCT02561923|Rivaroxaban|rivaroxaban|mesh-list
5829602|NCT02561923|Tranexamic Acid|tranexamic acid|mesh-list
5829603|NCT02561923|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6493232|NCT00612612|Rituximab|rituximab|mesh-list
6493233|NCT00612612|Fludarabine|fludarabine|mesh-list
6493234|NCT00612612|Fludarabine phosphate|fludarabine phosphate|mesh-list
6493235|NCT00612612|Obatoclax|obatoclax|mesh-list
6493236|NCT00612612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6493237|NCT00612612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6493238|NCT00612612|Immunologic Factors|immunologic factors|mesh-ancestor
6493239|NCT00612612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493240|NCT00612612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6493241|NCT00612612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6493242|NCT00612612|Antimetabolites|antimetabolites|mesh-ancestor
6493243|NCT00612612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493244|NCT00612612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6493245|NCT00612612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5829604|NCT02561923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5829605|NCT02561923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5829606|NCT02561923|Hemostatics|hemostatics|mesh-ancestor
5829607|NCT02561923|Coagulants|coagulants|mesh-ancestor
5829608|NCT02561923|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5829609|NCT02561923|Antithrombins|antithrombins|mesh-ancestor
5829610|NCT02561923|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5829611|NCT02561923|Protease Inhibitors|protease inhibitors|mesh-ancestor
5829612|NCT02561923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5829613|NCT02561923|Anticoagulants|anticoagulants|mesh-ancestor
5829614|NCT02561884|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
5829615|NCT02561884|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6493246|NCT00612625|Glucagon|glucagon|mesh-list
5652633|NCT03698227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5694701|NCT03394001|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6493247|NCT00612625|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5652634|NCT03698227|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5652635|NCT03698227|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5652636|NCT03698227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5652637|NCT03698227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652638|NCT03698227|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5652639|NCT03698227|Protective Agents|protective agents|mesh-ancestor
5652640|NCT03698227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652641|NCT03698227|Antimitotic Agents|antimitotic agents|mesh-ancestor
5652642|NCT03698227|Mitosis Modulators|mitosis modulators|mesh-ancestor
5652643|NCT03698045|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5652644|NCT03698045|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5652645|NCT03698006|Ropivacaine|ropivacaine|mesh-list
5652646|NCT03698006|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5652647|NCT03698006|Anesthetics, Local|anesthetics, local|mesh-ancestor
5652648|NCT03698006|Anesthetics|anesthetics|mesh-ancestor
5652649|NCT03698006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5652650|NCT03698006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652651|NCT03698006|Sensory System Agents|sensory system agents|mesh-ancestor
5652652|NCT03698006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5652653|NCT03697889|Naproxen|naproxen|mesh-list
5652654|NCT03697889|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5652655|NCT03697889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5652656|NCT03697889|Analgesics|analgesics|mesh-ancestor
5652657|NCT03697889|Sensory System Agents|sensory system agents|mesh-ancestor
5652658|NCT03697889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5652659|NCT03697889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652660|NCT03697889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5652661|NCT03697889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5652662|NCT03697889|Gout Suppressants|gout suppressants|mesh-ancestor
5652663|NCT03697889|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5829616|NCT02561884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5829617|NCT02561884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5829618|NCT02561884|Antimetabolites|antimetabolites|mesh-ancestor
5829619|NCT02561884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5829620|NCT02561884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5829621|NCT02561884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5829622|NCT02561884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5829623|NCT02561884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5829624|NCT02561884|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5829625|NCT02561884|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5902436|NCT04230148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5902437|NCT04227314|Apremilast|apremilast|mesh-list
5902438|NCT04227314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5902439|NCT04227314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5902440|NCT04227314|Analgesics|analgesics|mesh-ancestor
5902441|NCT04227314|Sensory System Agents|sensory system agents|mesh-ancestor
5902442|NCT04227314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5902443|NCT04227314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902444|NCT04227314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5902445|NCT04227314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5902446|NCT04227314|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5902447|NCT04227314|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5902448|NCT04227314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5902449|NCT04227314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902450|NCT04223648|Nivolumab|nivolumab|mesh-list
5902451|NCT04223648|Ipilimumab|ipilimumab|mesh-list
5902452|NCT04223648|Durvalumab|durvalumab|mesh-list
5902453|NCT04223648|Tremelimumab|tremelimumab|mesh-list
5902454|NCT04223648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5902455|NCT04223648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5902456|NCT04223648|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5902457|NCT04223648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902458|NCT04220775|Atezolizumab|atezolizumab|mesh-list
5902459|NCT04220775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5902460|NCT04218708|Nicotine|nicotine|mesh-list
5902461|NCT04218708|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5652664|NCT03697889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5652665|NCT03697889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652666|NCT03697850|Atezolizumab|atezolizumab|mesh-list
5652667|NCT03697850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5652668|NCT03697824|Cyclophosphamide|cyclophosphamide|mesh-list
5652669|NCT03697824|Pembrolizumab|pembrolizumab|mesh-list
5652670|NCT03697824|Fludarabine|fludarabine|mesh-list
5652671|NCT03697824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5652672|NCT03697824|Immunologic Factors|immunologic factors|mesh-ancestor
5829626|NCT02561845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5829627|NCT02561845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5829628|NCT02561845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5829629|NCT02561845|Antimetabolites|antimetabolites|mesh-ancestor
5829630|NCT02561845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493248|NCT00612625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6493249|NCT00612625|Hormones|hormones|mesh-ancestor
6493250|NCT00612625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6493251|NCT00612625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493252|NCT00612625|Incretins|incretins|mesh-ancestor
6493253|NCT00612638|Irinotecan|irinotecan|mesh-list
6493254|NCT00612638|Temozolomide|temozolomide|mesh-list
6493255|NCT00612638|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
6493256|NCT00612638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6493257|NCT00612638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6493258|NCT00612638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6493259|NCT00612638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493260|NCT00612638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6493261|NCT00612638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6493262|NCT00612638|Alkylating Agents|alkylating agents|mesh-ancestor
6493263|NCT00612651|Temozolomide|temozolomide|mesh-list
6493264|NCT00612651|Lonafarnib|lonafarnib|mesh-list
6493265|NCT00612651|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6493266|NCT00612651|Alkylating Agents|alkylating agents|mesh-ancestor
6493267|NCT00612651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493268|NCT00612651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6493269|NCT00612651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6493270|NCT00612755|Ribavirin|ribavirin|mesh-list
6493271|NCT00612755|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6493272|NCT00612755|Antimetabolites|antimetabolites|mesh-ancestor
5652673|NCT03697824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652674|NCT03697824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5652675|NCT03697824|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5829631|NCT02561845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5829632|NCT02561845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5829633|NCT02561845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5829634|NCT02561767|Mycophenolic Acid|mycophenolic acid|mesh-list
5829635|NCT02561767|Tacrolimus|tacrolimus|mesh-list
5829636|NCT02561767|Basiliximab|basiliximab|mesh-list
5829637|NCT02561767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5829638|NCT02561767|Immunologic Factors|immunologic factors|mesh-ancestor
5652676|NCT03697824|Alkylating Agents|alkylating agents|mesh-ancestor
5652677|NCT03697824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652678|NCT03697824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5652679|NCT03697824|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5652680|NCT03697824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5652681|NCT03697811|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5652682|NCT03697811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5652683|NCT03697746|Acetaminophen|acetaminophen|mesh-list
5652684|NCT03697746|Ibuprofen|ibuprofen|mesh-list
5652685|NCT03697746|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
5652686|NCT03697746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5652687|NCT03697746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5652688|NCT03697746|Analgesics|analgesics|mesh-ancestor
5652689|NCT03697746|Sensory System Agents|sensory system agents|mesh-ancestor
5652690|NCT03697746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5652691|NCT03697746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652692|NCT03697746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5652693|NCT03697746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5652694|NCT03697746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5829639|NCT02561767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829640|NCT02561767|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5829641|NCT02561767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5829642|NCT02561767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5829643|NCT02561767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5829644|NCT02561767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5829645|NCT02561767|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5829646|NCT02561767|Antitubercular Agents|antitubercular agents|mesh-ancestor
5652695|NCT03697746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5652696|NCT03697746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652697|NCT03697746|Antipyretics|antipyretics|mesh-ancestor
5829647|NCT02561767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5829648|NCT02561767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5829649|NCT02561494|Nefopam|nefopam|mesh-list
5829650|NCT02561494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5829651|NCT02561494|Analgesics|analgesics|mesh-ancestor
5829652|NCT02561494|Sensory System Agents|sensory system agents|mesh-ancestor
5829653|NCT02561494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5829654|NCT02561494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829655|NCT02561520|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5829656|NCT02561520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5829657|NCT02561468|Nefopam|nefopam|mesh-list
5829658|NCT02561468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5829659|NCT02561468|Analgesics|analgesics|mesh-ancestor
5829660|NCT02561468|Sensory System Agents|sensory system agents|mesh-ancestor
5829661|NCT02561468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5829662|NCT02561468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829663|NCT02561117|Metronidazole|metronidazole|mesh-list
5829664|NCT02561117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5829665|NCT02561117|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5829666|NCT02561117|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5829667|NCT02561117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5652698|NCT03697681|Tranexamic Acid|tranexamic acid|mesh-list
5652699|NCT03697681|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5652700|NCT03697681|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5652701|NCT03697681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5829668|NCT02561169|Oseltamivir|oseltamivir|mesh-list
5829669|NCT02561169|Calcium Carbonate|calcium carbonate|mesh-list
5829670|NCT02561169|Antiviral Agents|antiviral agents|mesh-ancestor
5829671|NCT02561169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5829672|NCT02561169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5829673|NCT02561169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5829674|NCT02561169|Antacids|antacids|mesh-ancestor
5829675|NCT02561169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5829676|NCT02561039|Ibandronic Acid|ibandronic acid|mesh-list
5652702|NCT03697681|Hemostatics|hemostatics|mesh-ancestor
5652703|NCT03697681|Coagulants|coagulants|mesh-ancestor
5652704|NCT03697668|Piperaquine|piperaquine|mesh-list
5652705|NCT03697668|Artenimol|artenimol|mesh-list
5652706|NCT03697668|Imatinib Mesylate|imatinib mesylate|mesh-list
5829677|NCT02561039|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5829678|NCT02561039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829679|NCT02561013|Monensin|monensin|mesh-list
5829680|NCT02561013|Antifungal Agents|antifungal agents|mesh-ancestor
5829681|NCT02561013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5829682|NCT02561013|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5829683|NCT02561013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5829684|NCT02561013|Coccidiostats|coccidiostats|mesh-ancestor
5829685|NCT02561013|Proton Ionophores|proton ionophores|mesh-ancestor
5829686|NCT02561013|Uncoupling Agents|uncoupling agents|mesh-ancestor
5829687|NCT02561013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5829688|NCT02561013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5829689|NCT02561013|Ionophores|ionophores|mesh-ancestor
5829690|NCT02561013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5829691|NCT02561013|Sodium Ionophores|sodium ionophores|mesh-ancestor
5829692|NCT02560974|Capecitabine|capecitabine|mesh-list
5829693|NCT02560974|Oxaliplatin|oxaliplatin|mesh-list
5829694|NCT02560974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5829695|NCT02560974|Antimetabolites|antimetabolites|mesh-ancestor
5829696|NCT02560974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5829697|NCT02560974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5829698|NCT02560935|Hydroxyurea|hydroxyurea|mesh-list
5829699|NCT02560935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5829700|NCT02560935|Antisickling Agents|antisickling agents|mesh-ancestor
5829701|NCT02560935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5829702|NCT02560935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5829703|NCT02560935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5652707|NCT03697668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5652708|NCT03697668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5652709|NCT03697668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5652710|NCT03697668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652711|NCT03697668|Antimalarials|antimalarials|mesh-ancestor
5829704|NCT02560909|Vaccines|vaccines|mesh-list
5829705|NCT02560909|Immunologic Factors|immunologic factors|mesh-ancestor
5829706|NCT02560909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829707|NCT02560870|Chlorhexidine|chlorhexidine|mesh-list
5829708|NCT02560870|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5829709|NCT02560870|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5829710|NCT02560870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5652712|NCT03697668|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5829711|NCT02560870|Disinfectants|disinfectants|mesh-ancestor
5829712|NCT02560870|Dermatologic Agents|dermatologic agents|mesh-ancestor
5829713|NCT02560766|Gabapentin|gabapentin|mesh-list
5829714|NCT02560766|Analgesics|analgesics|mesh-ancestor
5829715|NCT02560766|Sensory System Agents|sensory system agents|mesh-ancestor
5829716|NCT02560766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5829717|NCT02560766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829718|NCT02560766|Anticonvulsants|anticonvulsants|mesh-ancestor
5652713|NCT03697668|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5652714|NCT03697668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5652715|NCT03697655|Daratumumab|daratumumab|mesh-list
5652716|NCT03697655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5652717|NCT03697603|Brexpiprazole|brexpiprazole|mesh-list
5652718|NCT03697603|Serotonin Agents|serotonin agents|mesh-ancestor
5829719|NCT02560766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5829720|NCT02560766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5829721|NCT02560766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5829722|NCT02560766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5829723|NCT02560766|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5829724|NCT02560766|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5829725|NCT02560766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5829726|NCT02560766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5829727|NCT02560766|Antimanic Agents|antimanic agents|mesh-ancestor
5829728|NCT02560688|Clopidogrel|clopidogrel|mesh-list
5829729|NCT02560688|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5829730|NCT02560688|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5829731|NCT02560688|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5829732|NCT02560688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5829733|NCT02560688|Purinergic Agents|purinergic agents|mesh-ancestor
5829734|NCT02560688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5829735|NCT02560688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5829736|NCT02560688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829737|NCT02560649|Tenofovir|tenofovir|mesh-list
5829738|NCT02560649|Lamivudine|lamivudine|mesh-list
5829739|NCT02560649|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5829740|NCT02560649|Interferon-alpha|interferon-alpha|mesh-list
5829741|NCT02560649|Entecavir|entecavir|mesh-list
5829742|NCT02560649|Adefovir|adefovir|mesh-list
5829743|NCT02560649|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
5829744|NCT02560649|Antiviral Agents|antiviral agents|mesh-ancestor
5829745|NCT02560649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5829746|NCT02560649|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5829747|NCT02560649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5829748|NCT02560649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5829749|NCT02560649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5829750|NCT02560649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5829751|NCT02560649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5829752|NCT02560649|Immunologic Factors|immunologic factors|mesh-ancestor
5829753|NCT02560649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652719|NCT03697603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5652720|NCT03697603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652721|NCT03697603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652722|NCT03697603|Dopamine Agonists|dopamine agonists|mesh-ancestor
5652723|NCT03697603|Dopamine Agents|dopamine agents|mesh-ancestor
5652724|NCT03697564|Gemcitabine|gemcitabine|mesh-list
5652725|NCT03697564|Nivolumab|nivolumab|mesh-list
5652726|NCT03697564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5652727|NCT03697564|Antimetabolites|antimetabolites|mesh-ancestor
5652728|NCT03697564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652729|NCT03697564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5652730|NCT03697564|Antiviral Agents|antiviral agents|mesh-ancestor
5652731|NCT03697564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5652732|NCT03697564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5652733|NCT03697564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5829754|NCT02560636|Pembrolizumab|pembrolizumab|mesh-list
5829755|NCT02560636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5829756|NCT02560636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5829757|NCT02560519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5829758|NCT02560376|Exenatide|exenatide|mesh-list
5829759|NCT02560376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5829760|NCT02560376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829761|NCT02560376|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5829762|NCT02560376|Incretins|incretins|mesh-ancestor
5829763|NCT02560376|Hormones|hormones|mesh-ancestor
5829764|NCT02560376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5829765|NCT02560220|Mitomycins|mitomycins|mesh-list
5829766|NCT02560220|Mitomycin|mitomycin|mesh-list
5829767|NCT02560220|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5829768|NCT02560220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5829769|NCT02560220|Alkylating Agents|alkylating agents|mesh-ancestor
5829770|NCT02560220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5829771|NCT02560220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5829772|NCT02560220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5829773|NCT02560207|Cefotaxime|cefotaxime|mesh-list
5829774|NCT02560207|Cefoxitin|cefoxitin|mesh-list
5829775|NCT02560207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5829776|NCT02560207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5902462|NCT04218708|Autonomic Agents|autonomic agents|mesh-ancestor
5902463|NCT04218708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5902464|NCT04218708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902465|NCT04218708|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5902466|NCT04218708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5902467|NCT04218708|Cholinergic Agents|cholinergic agents|mesh-ancestor
5902468|NCT04218708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5902469|NCT04218708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902470|NCT04215146|Paclitaxel|paclitaxel|mesh-list
5902471|NCT04215146|Avelumab|avelumab|mesh-list
5902472|NCT04215146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5902473|NCT04215146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5902474|NCT04215146|Tubulin Modulators|tubulin modulators|mesh-ancestor
5902475|NCT04215146|Antimitotic Agents|antimitotic agents|mesh-ancestor
5902476|NCT04215146|Mitosis Modulators|mitosis modulators|mesh-ancestor
5902477|NCT04215146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902478|NCT04215146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5902479|NCT04212013|Rituximab|rituximab|mesh-list
5902480|NCT04212013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5902481|NCT04212013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5902482|NCT04212013|Immunologic Factors|immunologic factors|mesh-ancestor
5902483|NCT04212013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902484|NCT04212013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5908365|NCT04611529|Ibuprofen|ibuprofen|mesh-list
5908366|NCT04611529|Diclofenac|diclofenac|mesh-list
5908367|NCT04611529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5908368|NCT04611529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5908369|NCT04611529|Analgesics|analgesics|mesh-ancestor
5908370|NCT04611529|Sensory System Agents|sensory system agents|mesh-ancestor
5908371|NCT04611529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5908372|NCT04611529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5908373|NCT04611529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5908374|NCT04611529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5908375|NCT04611529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5908376|NCT04611529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5908377|NCT04611529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908378|NCT04600336|Oxybutynin|oxybutynin|mesh-list
5908379|NCT04600336|Parasympatholytics|parasympatholytics|mesh-ancestor
5652734|NCT03697564|Immunologic Factors|immunologic factors|mesh-ancestor
5652735|NCT03697564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652736|NCT03697564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5652737|NCT03697564|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5652738|NCT03697408|Everolimus|everolimus|mesh-list
5652739|NCT03697408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5652740|NCT03697408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5652741|NCT03697408|Immunologic Factors|immunologic factors|mesh-ancestor
5652742|NCT03697408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652743|NCT03697356|Dexamethasone|dexamethasone|mesh-list
5652744|NCT03697356|Rituximab|rituximab|mesh-list
5652745|NCT03697356|Lenalidomide|lenalidomide|mesh-list
5652746|NCT03697356|Bortezomib|bortezomib|mesh-list
5652747|NCT03697356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5652748|NCT03697356|Antiemetics|antiemetics|mesh-ancestor
5652749|NCT03697356|Autonomic Agents|autonomic agents|mesh-ancestor
5829777|NCT02560155|Chlorhexidine|chlorhexidine|mesh-list
5829778|NCT02560155|Mupirocin|mupirocin|mesh-list
5829779|NCT02560155|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5829780|NCT02560155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5829781|NCT02560155|Disinfectants|disinfectants|mesh-ancestor
5829782|NCT02560155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5829783|NCT02560155|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5829784|NCT02560155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5829785|NCT02560155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5829786|NCT02559973|Buprenorphine|buprenorphine|mesh-list
5829787|NCT02559973|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
5829788|NCT02559973|Naloxone|naloxone|mesh-list
5829789|NCT02559973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5829790|NCT02559973|Narcotics|narcotics|mesh-ancestor
5829791|NCT02559973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5829792|NCT02559973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829793|NCT02559973|Analgesics|analgesics|mesh-ancestor
5829794|NCT02559973|Sensory System Agents|sensory system agents|mesh-ancestor
5829795|NCT02559973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5829796|NCT02559973|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5829797|NCT02559921|Vaccines|vaccines|mesh-list
5829798|NCT02559921|Immunologic Factors|immunologic factors|mesh-ancestor
5829799|NCT02559921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829800|NCT02559908|Hyaluronic Acid|hyaluronic acid|mesh-list
5829801|NCT02559908|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5829802|NCT02559908|Immunologic Factors|immunologic factors|mesh-ancestor
5829803|NCT02559908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829804|NCT02559908|Viscosupplements|viscosupplements|mesh-ancestor
5829805|NCT02559908|Protective Agents|protective agents|mesh-ancestor
5829806|NCT02559791|Reslizumab|reslizumab|mesh-list
5829807|NCT02559791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5829808|NCT02559791|Respiratory System Agents|respiratory system agents|mesh-ancestor
5829809|NCT02559778|Eflornithine|eflornithine|mesh-list
5829810|NCT02559778|Sorafenib|sorafenib|mesh-list
5829811|NCT02559778|Dasatinib|dasatinib|mesh-list
5829812|NCT02559778|Vorinostat|vorinostat|mesh-list
5829813|NCT02559778|Ceritinib|ceritinib|mesh-list
5829814|NCT02559778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5829815|NCT02559778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5829816|NCT02559778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5829817|NCT02559778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5829818|NCT02559778|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5829819|NCT02559778|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5829820|NCT02559778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5829821|NCT02559778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5829822|NCT02559778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5829823|NCT02559778|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
5829824|NCT02559674|Gemcitabine|gemcitabine|mesh-list
5829825|NCT02559674|Paclitaxel|paclitaxel|mesh-list
5829826|NCT02559674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5829827|NCT02559674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5829828|NCT02559674|Tubulin Modulators|tubulin modulators|mesh-ancestor
5829829|NCT02559674|Antimitotic Agents|antimitotic agents|mesh-ancestor
5652750|NCT03697356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5652751|NCT03697356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652752|NCT03697356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5652753|NCT03697356|Glucocorticoids|glucocorticoids|mesh-ancestor
5652754|NCT03697356|Hormones|hormones|mesh-ancestor
5652755|NCT03697356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5652756|NCT03697356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5652757|NCT03697356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5652758|NCT03697356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5652759|NCT03697356|Immunologic Factors|immunologic factors|mesh-ancestor
5652760|NCT03697356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5652761|NCT03697356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5652762|NCT03697356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5652763|NCT03697356|Growth Substances|growth substances|mesh-ancestor
5652764|NCT03697356|Growth Inhibitors|growth inhibitors|mesh-ancestor
5652765|NCT03697265|Pregnanolone|pregnanolone|mesh-list
5652766|NCT03697265|Anesthetics|anesthetics|mesh-ancestor
5652767|NCT03697265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5652768|NCT03697265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652769|NCT03697239|Ascorbic Acid|ascorbic acid|mesh-list
5829830|NCT02559674|Mitosis Modulators|mitosis modulators|mesh-ancestor
5829831|NCT02559674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5829832|NCT02559674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5829833|NCT02559674|Antimetabolites|antimetabolites|mesh-ancestor
5829834|NCT02559674|Antiviral Agents|antiviral agents|mesh-ancestor
5829835|NCT02559674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5829836|NCT02559674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5829837|NCT02559674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5829838|NCT02559674|Immunologic Factors|immunologic factors|mesh-ancestor
5829839|NCT02559674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829840|NCT02559648|Denosumab|denosumab|mesh-list
5829841|NCT02559648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5829842|NCT02559648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829843|NCT02559440|Mometasone Furoate|mometasone furoate|mesh-list
5829844|NCT02559440|Phenylephrine|phenylephrine|mesh-list
5829845|NCT02559440|Oxymetazoline|oxymetazoline|mesh-list
5829846|NCT02559440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5829847|NCT02559440|Dermatologic Agents|dermatologic agents|mesh-ancestor
5829848|NCT02559440|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5829849|NCT02559440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5829850|NCT02559440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5829851|NCT02559440|Adrenergic Agents|adrenergic agents|mesh-ancestor
5829852|NCT02559440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5829853|NCT02559440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5829854|NCT02559440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829855|NCT02559440|Sympathomimetics|sympathomimetics|mesh-ancestor
5829856|NCT02559440|Autonomic Agents|autonomic agents|mesh-ancestor
5829857|NCT02559440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5829858|NCT02559440|Nasal Decongestants|nasal decongestants|mesh-ancestor
5829859|NCT02559440|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5829860|NCT02559440|Respiratory System Agents|respiratory system agents|mesh-ancestor
5829861|NCT02559440|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5829862|NCT02559440|Mydriatics|mydriatics|mesh-ancestor
5829863|NCT02559440|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5829864|NCT02559440|Protective Agents|protective agents|mesh-ancestor
5829865|NCT02559388|Montelukast|montelukast|mesh-list
5829866|NCT02559388|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5829867|NCT02559388|Respiratory System Agents|respiratory system agents|mesh-ancestor
5829868|NCT02559388|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5829869|NCT02559388|Hormone Antagonists|hormone antagonists|mesh-ancestor
5829870|NCT02559388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5829871|NCT02559388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829872|NCT02559388|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5829873|NCT02559388|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5829874|NCT02559388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5829875|NCT02559297|Sevoflurane|sevoflurane|mesh-list
5829876|NCT02559297|Desflurane|desflurane|mesh-list
5829877|NCT02559297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5829878|NCT02559297|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5829879|NCT02559297|Anesthetics, General|anesthetics, general|mesh-ancestor
5829880|NCT02559297|Anesthetics|anesthetics|mesh-ancestor
5829881|NCT02559297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5652770|NCT03697239|Gemcitabine|gemcitabine|mesh-list
5652771|NCT03697239|Paclitaxel|paclitaxel|mesh-list
5652772|NCT03697239|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5652773|NCT03697239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5652774|NCT03697239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5652775|NCT03697239|Tubulin Modulators|tubulin modulators|mesh-ancestor
5829882|NCT02559297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829883|NCT02559232|Anticoagulants|anticoagulants|mesh-list
5829884|NCT02559154|Thalidomide|thalidomide|mesh-list
5829885|NCT02559154|Dexamethasone|dexamethasone|mesh-list
5829886|NCT02559154|Cyclophosphamide|cyclophosphamide|mesh-list
5829887|NCT02559154|Doxorubicin|doxorubicin|mesh-list
5829888|NCT02559154|Bortezomib|bortezomib|mesh-list
5829889|NCT02559154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5829890|NCT02559154|Immunologic Factors|immunologic factors|mesh-ancestor
5829891|NCT02559154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829892|NCT02559154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5652776|NCT03697239|Antimitotic Agents|antimitotic agents|mesh-ancestor
5652777|NCT03697239|Mitosis Modulators|mitosis modulators|mesh-ancestor
5652778|NCT03697239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652779|NCT03697239|Vitamins|vitamins|mesh-ancestor
5652780|NCT03697239|Micronutrients|micronutrients|mesh-ancestor
5652781|NCT03697239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694702|NCT03394001|Lidocaine|lidocaine|mesh-list
5829893|NCT02559154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5829894|NCT02559154|Alkylating Agents|alkylating agents|mesh-ancestor
5902485|NCT04113720|Dexmedetomidine|dexmedetomidine|mesh-list
5829895|NCT02559154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5829896|NCT02559154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5829897|NCT02559154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5829898|NCT02559154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5829899|NCT02559154|Antiemetics|antiemetics|mesh-ancestor
5829900|NCT02559154|Autonomic Agents|autonomic agents|mesh-ancestor
5652782|NCT03697239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5652783|NCT03697239|Antimetabolites|antimetabolites|mesh-ancestor
5652784|NCT03697239|Antiviral Agents|antiviral agents|mesh-ancestor
5652785|NCT03697239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5652786|NCT03697239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5652787|NCT03697239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5652788|NCT03697239|Immunologic Factors|immunologic factors|mesh-ancestor
5652789|NCT03697239|Antioxidants|antioxidants|mesh-ancestor
5652790|NCT03697239|Protective Agents|protective agents|mesh-ancestor
5652791|NCT03697161|Gaboxadol|gaboxadol|mesh-list
5652792|NCT03697161|Analgesics|analgesics|mesh-ancestor
5652793|NCT03697161|Sensory System Agents|sensory system agents|mesh-ancestor
5652794|NCT03697161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5652795|NCT03697161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652796|NCT03697161|Anticonvulsants|anticonvulsants|mesh-ancestor
5652797|NCT03697161|GABA Agonists|gaba agonists|mesh-ancestor
5652798|NCT03697161|GABA Agents|gaba agents|mesh-ancestor
5652799|NCT03697161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5652800|NCT03697161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5829901|NCT02559154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5829902|NCT02559154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5829903|NCT02559154|Glucocorticoids|glucocorticoids|mesh-ancestor
5652801|NCT03697057|Anesthetics|anesthetics|mesh-list
5652802|NCT03697057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5652803|NCT03697057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652804|NCT03697044|Irinotecan|irinotecan|mesh-list
5652805|NCT03697044|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5652806|NCT03697044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5652807|NCT03697044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5652808|NCT03697044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652809|NCT03697044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5652810|NCT03697018|Lithium Carbonate|lithium carbonate|mesh-list
5829904|NCT02559154|Hormones|hormones|mesh-ancestor
5829905|NCT02559154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5829906|NCT02559154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5829907|NCT02559154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5829908|NCT02559154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5829909|NCT02559154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5829910|NCT02559154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5829911|NCT02559154|Leprostatic Agents|leprostatic agents|mesh-ancestor
5829912|NCT02559154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5829913|NCT02559154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5829914|NCT02559154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5829915|NCT02559154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5829916|NCT02559154|Growth Substances|growth substances|mesh-ancestor
5829917|NCT02559154|Growth Inhibitors|growth inhibitors|mesh-ancestor
5829918|NCT02559167|Cannabidiol|cannabidiol|mesh-list
5829919|NCT02559167|Anticonvulsants|anticonvulsants|mesh-ancestor
5829920|NCT02559180|Aflibercept|aflibercept|mesh-list
5829921|NCT02559180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5829922|NCT02559180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5652811|NCT03697018|Antidepressive Agents|antidepressive agents|mesh-ancestor
5652812|NCT03697018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5652813|NCT03697018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5652814|NCT03697018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652815|NCT03697018|Antimanic Agents|antimanic agents|mesh-ancestor
5652816|NCT03697018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5652817|NCT03697018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5652818|NCT03697018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694703|NCT03394001|Anesthetics, Local|anesthetics, local|mesh-ancestor
5694704|NCT03394001|Anesthetics|anesthetics|mesh-ancestor
5694705|NCT03394001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5694706|NCT03394001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694707|NCT03394001|Sensory System Agents|sensory system agents|mesh-ancestor
5694708|NCT03394001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5694709|NCT03394001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5694710|NCT03394001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5829923|NCT02559180|Growth Substances|growth substances|mesh-ancestor
5694711|NCT03394001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5652819|NCT03696940|Atorvastatin|atorvastatin|mesh-list
5652820|NCT03696940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5652821|NCT03696940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5652822|NCT03696940|Antimetabolites|antimetabolites|mesh-ancestor
5652823|NCT03696940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652824|NCT03696940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5652825|NCT03696940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5652826|NCT03696940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5652827|NCT03696901|Dalbavancin|dalbavancin|mesh-list
5652828|NCT03696901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5652829|NCT03696901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5829924|NCT02559180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829925|NCT02559180|Growth Inhibitors|growth inhibitors|mesh-ancestor
5829926|NCT02559180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5829927|NCT02559141|Dobutamine|dobutamine|mesh-list
5829928|NCT02559141|Norepinephrine|norepinephrine|mesh-list
5829929|NCT02559141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5829930|NCT02559141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5652830|NCT03696641|Lithium Carbonate|lithium carbonate|mesh-list
5652831|NCT03696641|Antidepressive Agents|antidepressive agents|mesh-ancestor
5652832|NCT03696641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5652833|NCT03696641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5652834|NCT03696641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652835|NCT03696641|Antimanic Agents|antimanic agents|mesh-ancestor
5652836|NCT03696641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5652837|NCT03696641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5652838|NCT03696641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652839|NCT03696537|Fludarabine|fludarabine|mesh-list
5652840|NCT03696537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5652841|NCT03696459|Moxifloxacin|moxifloxacin|mesh-list
5652842|NCT03696459|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
5652843|NCT03696459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5652844|NCT03696459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5652845|NCT03696459|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5829931|NCT02559141|Adrenergic Agents|adrenergic agents|mesh-ancestor
5829932|NCT02559141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5829933|NCT02559141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5829934|NCT02559141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829935|NCT02559141|Sympathomimetics|sympathomimetics|mesh-ancestor
5829936|NCT02559141|Autonomic Agents|autonomic agents|mesh-ancestor
5829937|NCT02559141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5829938|NCT02559141|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5829939|NCT02559141|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5829940|NCT02559141|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5829941|NCT02559141|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5829942|NCT02559141|Protective Agents|protective agents|mesh-ancestor
5829943|NCT02559102|Dexmedetomidine|dexmedetomidine|mesh-list
5829944|NCT02559102|Anesthetics|anesthetics|mesh-list
5829945|NCT02559102|Sevoflurane|sevoflurane|mesh-list
5829946|NCT02559102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5829947|NCT02559102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829948|NCT02559102|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5829949|NCT02559102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5829950|NCT02559102|Analgesics|analgesics|mesh-ancestor
5829951|NCT02559102|Sensory System Agents|sensory system agents|mesh-ancestor
5829952|NCT02559102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5829953|NCT02559102|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5829954|NCT02559102|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5829955|NCT02559102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5829956|NCT02559102|Adrenergic Agents|adrenergic agents|mesh-ancestor
5829957|NCT02559102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5829958|NCT02559102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5829959|NCT02559102|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5829960|NCT02559102|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5829961|NCT02559102|Anesthetics, General|anesthetics, general|mesh-ancestor
5829962|NCT02558972|Droxidopa|droxidopa|mesh-list
5829963|NCT02558972|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5829964|NCT02558972|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5829965|NCT02558933|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
5829966|NCT02558933|Antioxidants|antioxidants|mesh-ancestor
5829967|NCT02558933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5829968|NCT02558933|Protective Agents|protective agents|mesh-ancestor
5829969|NCT02558933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652846|NCT03696459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5652847|NCT03696459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5652848|NCT03696459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652849|NCT03696459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5652850|NCT03696459|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5652851|NCT03696459|Contraceptive Agents|contraceptive agents|mesh-ancestor
5829970|NCT02558933|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
5829971|NCT02558933|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5829972|NCT02558933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5829973|NCT02558933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5829974|NCT02558959|Capecitabine|capecitabine|mesh-list
5829975|NCT02558959|Irinotecan|irinotecan|mesh-list
5829976|NCT02558959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5829977|NCT02558959|Antimetabolites|antimetabolites|mesh-ancestor
5829978|NCT02558959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5829979|NCT02558959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5829980|NCT02558959|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5829981|NCT02558959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5829982|NCT02558959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5829983|NCT02558868|Oxaliplatin|oxaliplatin|mesh-list
5829984|NCT02558868|Irinotecan|irinotecan|mesh-list
5829985|NCT02558868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5829986|NCT02558868|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5829987|NCT02558868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5829988|NCT02558868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5829989|NCT02558868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5829990|NCT02558816|Obinutuzumab|obinutuzumab|mesh-list
5829991|NCT02558816|Venetoclax|venetoclax|mesh-list
5829992|NCT02558816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5829993|NCT02558816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5829994|NCT02558751|Vaccines|vaccines|mesh-list
5829995|NCT02558751|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5829996|NCT02558751|Immunologic Factors|immunologic factors|mesh-ancestor
5829997|NCT02558751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5829998|NCT02558595|Niacinamide|niacinamide|mesh-list
5652852|NCT03696459|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5652853|NCT03696459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652854|NCT03696459|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5652855|NCT03696459|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5829999|NCT02558595|Niacin|niacin|mesh-list
5830000|NCT02558595|Nicotinic Acids|nicotinic acids|mesh-list
5830001|NCT02558595|Vitamins|vitamins|mesh-ancestor
5830002|NCT02558595|Micronutrients|micronutrients|mesh-ancestor
5830003|NCT02558595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830004|NCT02558595|Vitamin B Complex|vitamin b complex|mesh-ancestor
5830005|NCT02558595|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5830006|NCT02558595|Antimetabolites|antimetabolites|mesh-ancestor
5830007|NCT02558595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830008|NCT02558595|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5830009|NCT02558595|Vasodilator Agents|vasodilator agents|mesh-ancestor
5830010|NCT02558569|Levobupivacaine|levobupivacaine|mesh-list
5830011|NCT02558569|Anesthetics, Local|anesthetics, local|mesh-ancestor
5830012|NCT02558569|Anesthetics|anesthetics|mesh-ancestor
5830013|NCT02558569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5830014|NCT02558569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830015|NCT02558569|Sensory System Agents|sensory system agents|mesh-ancestor
5830016|NCT02558569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5830017|NCT02558465|Rivaroxaban|rivaroxaban|mesh-list
5830018|NCT02558465|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5830019|NCT02558465|Antithrombins|antithrombins|mesh-ancestor
5830020|NCT02558465|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5830021|NCT02558465|Protease Inhibitors|protease inhibitors|mesh-ancestor
5830022|NCT02558465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5830023|NCT02558465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830024|NCT02558465|Anticoagulants|anticoagulants|mesh-ancestor
5902486|NCT04113720|Levobupivacaine|levobupivacaine|mesh-list
5902487|NCT04113720|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5652856|NCT03696459|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5652857|NCT03696355|GDC-0084|gdc-0084|mesh-list
5652858|NCT03696355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5652859|NCT03696355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652860|NCT03696329|Tetrabenazine|tetrabenazine|mesh-list
5652861|NCT03696329|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5652862|NCT03696329|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5652863|NCT03696329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5902488|NCT04113720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5652864|NCT03696329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652865|NCT03696329|Adrenergic Agents|adrenergic agents|mesh-ancestor
5652866|NCT03696329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5652867|NCT03696329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652868|NCT03696290|Aztreonam|aztreonam|mesh-list
5652869|NCT03696290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5652870|NCT03696290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5652871|NCT03696212|Pembrolizumab|pembrolizumab|mesh-list
5652872|NCT03696212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5652873|NCT03696212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5652874|NCT03696199|Anesthetics|anesthetics|mesh-list
5652875|NCT03696199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5652876|NCT03696199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652877|NCT03696186|Phenobarbital|phenobarbital|mesh-list
5830025|NCT02558517|Prednisone|prednisone|mesh-list
5830026|NCT02558517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5830027|NCT02558517|Glucocorticoids|glucocorticoids|mesh-ancestor
5830028|NCT02558517|Hormones|hormones|mesh-ancestor
5830029|NCT02558517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5830030|NCT02558517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830031|NCT02558517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5830032|NCT02558517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5830033|NCT02558452|Tacrolimus|tacrolimus|mesh-list
5830034|NCT02558452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5830035|NCT02558452|Immunologic Factors|immunologic factors|mesh-ancestor
5830036|NCT02558452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830037|NCT02558452|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5830038|NCT02558452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5830039|NCT02558452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830040|NCT02558387|Nintedanib|nintedanib|mesh-list
5830041|NCT02558387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5830042|NCT02558387|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5830043|NCT02558387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5830044|NCT02558387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830045|NCT02558205|Liver Extracts|liver extracts|mesh-list
5830046|NCT02558205|Hematinics|hematinics|mesh-ancestor
5830047|NCT02558283|Lidocaine|lidocaine|mesh-list
5830048|NCT02558283|Anesthetics, Local|anesthetics, local|mesh-ancestor
5830049|NCT02558283|Anesthetics|anesthetics|mesh-ancestor
5830050|NCT02558283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5830051|NCT02558283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830052|NCT02558283|Sensory System Agents|sensory system agents|mesh-ancestor
5830053|NCT02558283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5830054|NCT02558283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5830055|NCT02558283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5652878|NCT03696186|Anticonvulsants|anticonvulsants|mesh-ancestor
5652879|NCT03696186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5652880|NCT03696186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5652881|NCT03696186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652882|NCT03696186|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5652883|NCT03696186|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5652884|NCT03696186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5652885|NCT03696186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652886|NCT03696186|GABA Modulators|gaba modulators|mesh-ancestor
5652887|NCT03696186|GABA Agents|gaba agents|mesh-ancestor
5652888|NCT03696186|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5652889|NCT03696186|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5652890|NCT03696186|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5652891|NCT03696121|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
5652892|NCT03696121|Hemostatics|hemostatics|mesh-ancestor
5652893|NCT03696121|Coagulants|coagulants|mesh-ancestor
5652894|NCT03696121|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5830056|NCT02558283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5830057|NCT02558283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5830058|NCT02558283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830059|NCT02558270|Dapagliflozin|dapagliflozin|mesh-list
5830060|NCT02558270|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5830061|NCT02558270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830062|NCT02558270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5830063|NCT02558270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830064|NCT02558218|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
5652895|NCT03696121|Natriuretic Agents|natriuretic agents|mesh-ancestor
5697974|NCT03372304|Anesthetics|anesthetics|mesh-ancestor
5830065|NCT02558218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5830066|NCT02558218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5652896|NCT03696121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652897|NCT03696095|Ropivacaine|ropivacaine|mesh-list
5652898|NCT03696095|Anesthetics, Local|anesthetics, local|mesh-ancestor
5652899|NCT03696095|Anesthetics|anesthetics|mesh-ancestor
5652900|NCT03696095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5830067|NCT02558218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5830068|NCT02558218|Glucocorticoids|glucocorticoids|mesh-ancestor
5830069|NCT02558218|Hormones|hormones|mesh-ancestor
5830070|NCT02558218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5830071|NCT02558218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830072|NCT02558218|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5830073|NCT02558218|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5830074|NCT02558361|Apremilast|apremilast|mesh-list
5830075|NCT02558361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5830076|NCT02558361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5830077|NCT02558361|Analgesics|analgesics|mesh-ancestor
5830078|NCT02558361|Sensory System Agents|sensory system agents|mesh-ancestor
5830079|NCT02558361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5830080|NCT02558361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652901|NCT03696095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652902|NCT03696095|Sensory System Agents|sensory system agents|mesh-ancestor
5652903|NCT03696095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5652904|NCT03695952|Pembrolizumab|pembrolizumab|mesh-list
5652905|NCT03695952|Nivolumab|nivolumab|mesh-list
5652906|NCT03695952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5652907|NCT03695952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5652908|NCT03695952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5652909|NCT03695952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652910|NCT03695887|Nitrous Oxide|nitrous oxide|mesh-list
5830081|NCT02558361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5830082|NCT02558361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5830083|NCT02558361|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5830084|NCT02558361|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5830085|NCT02558361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5830086|NCT02558361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830087|NCT02558153|Paclitaxel|paclitaxel|mesh-list
5830088|NCT02558153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5830089|NCT02558153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5830090|NCT02558153|Tubulin Modulators|tubulin modulators|mesh-ancestor
5830091|NCT02558153|Antimitotic Agents|antimitotic agents|mesh-ancestor
5830092|NCT02558153|Mitosis Modulators|mitosis modulators|mesh-ancestor
5830093|NCT02558153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830094|NCT02558088|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5830095|NCT02558088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5830096|NCT02558088|Autonomic Agents|autonomic agents|mesh-ancestor
5652911|NCT03695887|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5652912|NCT03695887|Anesthetics, General|anesthetics, general|mesh-ancestor
5652913|NCT03695887|Anesthetics|anesthetics|mesh-ancestor
5652914|NCT03695887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5652915|NCT03695887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652916|NCT03695887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5652917|NCT03695887|Analgesics|analgesics|mesh-ancestor
5652918|NCT03695887|Sensory System Agents|sensory system agents|mesh-ancestor
5652919|NCT03695887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5830097|NCT02558088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5830098|NCT02558088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830099|NCT02558088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5652920|NCT03695861|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5652921|NCT03695861|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5652922|NCT03695861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652923|NCT03695835|Sargramostim|sargramostim|mesh-list
5652924|NCT03695835|Immunologic Factors|immunologic factors|mesh-ancestor
5652925|NCT03695835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652926|NCT03695822|Mirabegron|mirabegron|mesh-list
5652927|NCT03695822|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
5652928|NCT03695822|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5652929|NCT03695822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5652930|NCT03695822|Adrenergic Agents|adrenergic agents|mesh-ancestor
5652931|NCT03695822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5652932|NCT03695822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652933|NCT03695822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652934|NCT03695822|Urological Agents|urological agents|mesh-ancestor
5652935|NCT03695744|Dexamethasone|dexamethasone|mesh-list
5652936|NCT03695744|Bortezomib|bortezomib|mesh-list
5652937|NCT03695744|Daratumumab|daratumumab|mesh-list
5652938|NCT03695744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5830100|NCT02558088|Respiratory System Agents|respiratory system agents|mesh-ancestor
5830101|NCT02558088|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5830102|NCT02558088|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5830103|NCT02558088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5830104|NCT02558088|Adrenergic Agents|adrenergic agents|mesh-ancestor
5830105|NCT02558088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5830106|NCT02558088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652939|NCT03695744|Antiemetics|antiemetics|mesh-ancestor
5652940|NCT03695744|Autonomic Agents|autonomic agents|mesh-ancestor
5652941|NCT03695744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5652942|NCT03695744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652943|NCT03695744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5652944|NCT03695744|Glucocorticoids|glucocorticoids|mesh-ancestor
5652945|NCT03695744|Hormones|hormones|mesh-ancestor
5652946|NCT03695744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5830107|NCT02558114|Ribavirin|ribavirin|mesh-list
5830108|NCT02558114|Antimetabolites|antimetabolites|mesh-ancestor
5830109|NCT02558114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830110|NCT02558114|Antiviral Agents|antiviral agents|mesh-ancestor
5830111|NCT02558114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5830112|NCT02558036|Pyrithione zinc|pyrithione zinc|mesh-list
5830113|NCT02558036|Keratolytic Agents|keratolytic agents|mesh-ancestor
5830114|NCT02558036|Dermatologic Agents|dermatologic agents|mesh-ancestor
5830115|NCT02558023|Nicardipine|nicardipine|mesh-list
5830116|NCT02558023|Urapidil|urapidil|mesh-list
5830117|NCT02558023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5830118|NCT02558023|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5830119|NCT02558023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5830120|NCT02558023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830121|NCT02558023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5830122|NCT02558023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830123|NCT02558023|Vasodilator Agents|vasodilator agents|mesh-ancestor
5830124|NCT02558023|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5830125|NCT02558023|Serotonin Agents|serotonin agents|mesh-ancestor
5830126|NCT02558023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5830127|NCT02558023|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5830128|NCT02558023|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5830129|NCT02558023|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5830130|NCT02558023|Adrenergic Agents|adrenergic agents|mesh-ancestor
5830131|NCT02557932|Bismuth|bismuth|mesh-list
5830132|NCT02557932|Antacids|antacids|mesh-ancestor
5830133|NCT02557932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830134|NCT02557932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5830135|NCT02557984|Naltrexone|naltrexone|mesh-list
5830136|NCT02557984|Amisulpride|amisulpride|mesh-list
5830137|NCT02557984|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5830138|NCT02557984|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5830139|NCT02557984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830140|NCT02557984|Sensory System Agents|sensory system agents|mesh-ancestor
5830141|NCT02557984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5830142|NCT02557984|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5830143|NCT02557984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5830144|NCT02557984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5830145|NCT02557984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5652947|NCT03695744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5652948|NCT03695744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5652949|NCT03695705|Rifaximin|rifaximin|mesh-list
5652950|NCT03695705|Norfloxacin|norfloxacin|mesh-list
5652951|NCT03695705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5652952|NCT03695705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5652953|NCT03695705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5652954|NCT03695705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5652955|NCT03695705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5652956|NCT03695705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5652957|NCT03695705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652958|NCT03695705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5652959|NCT03695705|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5652960|NCT03695705|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5652961|NCT03695640|Magnesium Sulfate|magnesium sulfate|mesh-list
5652962|NCT03695640|Analgesics|analgesics|mesh-ancestor
5830146|NCT02557984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5830147|NCT02557984|Dopamine Agents|dopamine agents|mesh-ancestor
5830148|NCT02557984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5830149|NCT02557984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830150|NCT02557984|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5830151|NCT02557984|Antidepressive Agents|antidepressive agents|mesh-ancestor
5830152|NCT02557971|Botulinum Toxins|botulinum toxins|mesh-list
5652963|NCT03695640|Sensory System Agents|sensory system agents|mesh-ancestor
5652964|NCT03695640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5652965|NCT03695640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652966|NCT03695640|Anesthetics|anesthetics|mesh-ancestor
5652967|NCT03695640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5652968|NCT03695640|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5652969|NCT03695640|Anticonvulsants|anticonvulsants|mesh-ancestor
5652970|NCT03695640|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5652971|NCT03695640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5652972|NCT03695640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652973|NCT03695640|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5652974|NCT03695640|Tocolytic Agents|tocolytic agents|mesh-ancestor
5652975|NCT03695640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5652976|NCT03695510|Pembrolizumab|pembrolizumab|mesh-list
5652977|NCT03695510|Afatinib|afatinib|mesh-list
5652978|NCT03695510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5652979|NCT03695510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5652980|NCT03695510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5652981|NCT03695510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5652982|NCT03695510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652983|NCT03695471|Pembrolizumab|pembrolizumab|mesh-list
5652984|NCT03695471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5652985|NCT03695471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5652986|NCT03695445|Norepinephrine|norepinephrine|mesh-list
5652987|NCT03695445|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5830153|NCT02557971|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5830154|NCT02557971|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5830155|NCT02557971|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5830156|NCT02557971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5830157|NCT02557971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830158|NCT02557971|Cholinergic Agents|cholinergic agents|mesh-ancestor
5830159|NCT02557971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5830160|NCT02557971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830161|NCT02557971|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5830162|NCT02557971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5830163|NCT02557945|Gabapentin|gabapentin|mesh-list
5830164|NCT02557945|Analgesics|analgesics|mesh-ancestor
5830165|NCT02557945|Sensory System Agents|sensory system agents|mesh-ancestor
5830166|NCT02557945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5830167|NCT02557945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830168|NCT02557945|Anticonvulsants|anticonvulsants|mesh-ancestor
5830169|NCT02557945|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5830170|NCT02557945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5830171|NCT02557945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5830172|NCT02557945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5830173|NCT02557945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5830174|NCT02557945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5830175|NCT02557945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5830176|NCT02557945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830177|NCT02557945|Antimanic Agents|antimanic agents|mesh-ancestor
5830178|NCT02557867|Dexmedetomidine|dexmedetomidine|mesh-list
5830179|NCT02557867|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5830180|NCT02557867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5830181|NCT02557867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830182|NCT02557867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5652988|NCT03695445|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5652989|NCT03695445|Adrenergic Agents|adrenergic agents|mesh-ancestor
5652990|NCT03695445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5652991|NCT03695445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652992|NCT03695445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5652993|NCT03695445|Sympathomimetics|sympathomimetics|mesh-ancestor
5652994|NCT03695445|Autonomic Agents|autonomic agents|mesh-ancestor
5652995|NCT03695445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5652996|NCT03695445|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5694712|NCT03394001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5830183|NCT02557867|Analgesics|analgesics|mesh-ancestor
5830184|NCT02557867|Sensory System Agents|sensory system agents|mesh-ancestor
5830185|NCT02557867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5830186|NCT02557867|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5830187|NCT02557867|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5830188|NCT02557867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5830189|NCT02557867|Adrenergic Agents|adrenergic agents|mesh-ancestor
5830190|NCT02557867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5830191|NCT02557867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830192|NCT02557737|Botulinum Toxins|botulinum toxins|mesh-list
5830193|NCT02557737|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5830194|NCT02557737|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5830195|NCT02557737|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6211731|NCT02176356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6211732|NCT02176356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5652997|NCT03695107|Nifedipine|nifedipine|mesh-list
5652998|NCT03695107|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5652999|NCT03695107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5653000|NCT03695107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653001|NCT03695107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5653002|NCT03695107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653003|NCT03695107|Vasodilator Agents|vasodilator agents|mesh-ancestor
5653004|NCT03695107|Tocolytic Agents|tocolytic agents|mesh-ancestor
5653005|NCT03695107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5653006|NCT03695029|Tenofovir|tenofovir|mesh-list
5653007|NCT03695029|Antiviral Agents|antiviral agents|mesh-ancestor
5653008|NCT03695029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5653009|NCT03695029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5653010|NCT03695029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5653011|NCT03695029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5653012|NCT03695029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653013|NCT03695029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5653014|NCT03695029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5653015|NCT03694977|Spartalizumab|spartalizumab|mesh-list
5653016|NCT03694977|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5653017|NCT03694977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653018|NCT03694977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5653019|NCT03694886|Caffeine|caffeine|mesh-list
5653020|NCT03694886|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5653021|NCT03694886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653022|NCT03694886|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5653023|NCT03694886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5653024|NCT03694886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211733|NCT02176356|Cholinergic Agents|cholinergic agents|mesh-ancestor
6211734|NCT02176356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6211735|NCT02176356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211736|NCT02176356|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6211737|NCT02176356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6211738|NCT02176356|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6211739|NCT02176356|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6211740|NCT02176356|Immunologic Factors|immunologic factors|mesh-ancestor
6211741|NCT02176356|Viscosupplements|viscosupplements|mesh-ancestor
6211742|NCT02176356|Protective Agents|protective agents|mesh-ancestor
6211743|NCT02176382|Zoledronic Acid|zoledronic acid|mesh-list
6211744|NCT02176382|Denosumab|denosumab|mesh-list
6211745|NCT02176382|Teriparatide|teriparatide|mesh-list
6493273|NCT00612755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493274|NCT00612755|Antiviral Agents|antiviral agents|mesh-ancestor
6493275|NCT00612755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6493276|NCT00612794|Exenatide|exenatide|mesh-list
6493277|NCT00612794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6493278|NCT00612794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493279|NCT00612794|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6493280|NCT00612794|Incretins|incretins|mesh-ancestor
5653025|NCT03694886|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5653026|NCT03694886|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5653027|NCT03694886|Purinergic Agents|purinergic agents|mesh-ancestor
5653028|NCT03694886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5653029|NCT03694873|Celecoxib|celecoxib|mesh-list
5653030|NCT03694873|Tramadol|tramadol|mesh-list
5653031|NCT03694873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5653032|NCT03694873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5653033|NCT03694873|Analgesics|analgesics|mesh-ancestor
5653034|NCT03694873|Sensory System Agents|sensory system agents|mesh-ancestor
5830196|NCT02557737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5830197|NCT02557737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830198|NCT02557737|Cholinergic Agents|cholinergic agents|mesh-ancestor
5830199|NCT02557737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5830200|NCT02557737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830201|NCT02557737|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5653035|NCT03694873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5653036|NCT03694873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653037|NCT03694873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5653038|NCT03694873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5653039|NCT03694873|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5653040|NCT03694873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5653041|NCT03694873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5653042|NCT03694873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653043|NCT03694873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5653044|NCT03694873|Narcotics|narcotics|mesh-ancestor
5653045|NCT03694873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5653046|NCT03694808|Vaccines|vaccines|mesh-list
5653047|NCT03694808|Immunologic Factors|immunologic factors|mesh-ancestor
5653048|NCT03694808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653049|NCT03694587|Ibuprofen|ibuprofen|mesh-list
5653050|NCT03694587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5830202|NCT02557737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5830203|NCT02557789|Lefamulin|lefamulin|mesh-list
5830204|NCT02557789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5830205|NCT02557789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5830206|NCT02557581|Terbutaline|terbutaline|mesh-list
5830207|NCT02557581|Clenbuterol|clenbuterol|mesh-list
5830208|NCT02557581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5830209|NCT02557581|Autonomic Agents|autonomic agents|mesh-ancestor
5830210|NCT02557581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5830211|NCT02557581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830212|NCT02557581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5830213|NCT02557581|Respiratory System Agents|respiratory system agents|mesh-ancestor
5830214|NCT02557581|Sympathomimetics|sympathomimetics|mesh-ancestor
5830215|NCT02557581|Tocolytic Agents|tocolytic agents|mesh-ancestor
5830216|NCT02557581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5830217|NCT02557581|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5830218|NCT02557581|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5830219|NCT02557581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5830220|NCT02557581|Adrenergic Agents|adrenergic agents|mesh-ancestor
5830221|NCT02557581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5830222|NCT02557581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830223|NCT02557958|Azithromycin|azithromycin|mesh-list
5830224|NCT02557958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5830225|NCT02557958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5830226|NCT02557854|Doxorubicin|doxorubicin|mesh-list
5830227|NCT02557854|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5830228|NCT02557854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5830229|NCT02557854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5830230|NCT02557854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5830231|NCT02557854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5830232|NCT02557854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5830233|NCT02557854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830234|NCT02557451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
5830235|NCT02557451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5830236|NCT02557451|Growth Substances|growth substances|mesh-ancestor
5830237|NCT02557451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830238|NCT02557451|Growth Inhibitors|growth inhibitors|mesh-ancestor
5830239|NCT02557451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5830240|NCT02557594|Tenofovir|tenofovir|mesh-list
5653051|NCT03694587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5653052|NCT03694587|Analgesics|analgesics|mesh-ancestor
5653053|NCT03694587|Sensory System Agents|sensory system agents|mesh-ancestor
5653054|NCT03694587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5653055|NCT03694587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653056|NCT03694587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5653057|NCT03694587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5653058|NCT03694587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5653059|NCT03694587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5653060|NCT03694587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653061|NCT03694535|Mitomycins|mitomycins|mesh-list
5653062|NCT03694535|Mitomycin|mitomycin|mesh-list
5653063|NCT03694535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5653064|NCT03694535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5653065|NCT03694535|Alkylating Agents|alkylating agents|mesh-ancestor
5653066|NCT03694535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653067|NCT03694535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5653068|NCT03694535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5653069|NCT03694522|Bemarituzumab|bemarituzumab|mesh-list
5653070|NCT03694522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5653071|NCT03694522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5653072|NCT03694262|Bevacizumab|bevacizumab|mesh-list
5653073|NCT03694262|Atezolizumab|atezolizumab|mesh-list
5653074|NCT03694262|Rucaparib|rucaparib|mesh-list
5653075|NCT03694262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5653076|NCT03694262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5653077|NCT03694262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5653078|NCT03694262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5653079|NCT03694262|Growth Substances|growth substances|mesh-ancestor
5653080|NCT03694262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653081|NCT03694262|Growth Inhibitors|growth inhibitors|mesh-ancestor
5653082|NCT03694262|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5653083|NCT03694262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5653084|NCT03694262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653085|NCT03694249|Ifetroban|ifetroban|mesh-list
5653086|NCT03694249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5653087|NCT03694236|Durvalumab|durvalumab|mesh-list
5653088|NCT03694236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5653089|NCT03694236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5653090|NCT03694119|Phenelzine|phenelzine|mesh-list
5830241|NCT02557594|Antiviral Agents|antiviral agents|mesh-ancestor
5830242|NCT02557594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5830243|NCT02557594|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5830244|NCT02557594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5830245|NCT02557594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5830246|NCT02557594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830247|NCT02557594|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5830248|NCT02557594|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5830249|NCT02557542|Polidocanol|polidocanol|mesh-list
5830250|NCT02557542|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
5830251|NCT02557542|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
5830252|NCT02557542|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5830253|NCT02557490|Oxaliplatin|oxaliplatin|mesh-list
5830254|NCT02557490|Raltitrexed|raltitrexed|mesh-list
5830255|NCT02557490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5830256|NCT02557490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5830257|NCT02557490|Antimetabolites|antimetabolites|mesh-ancestor
5830258|NCT02557490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653091|NCT03694119|Ozanimod|ozanimod|mesh-list
5653092|NCT03694119|Tyramine|tyramine|mesh-list
5653093|NCT03694119|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5653094|NCT03694119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653095|NCT03694119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5653096|NCT03694119|Immunologic Factors|immunologic factors|mesh-ancestor
5653097|NCT03694119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653098|NCT03694119|Antidepressive Agents|antidepressive agents|mesh-ancestor
5653099|NCT03694119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5653100|NCT03694119|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
5653101|NCT03694119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5653102|NCT03694119|Sympathomimetics|sympathomimetics|mesh-ancestor
5653103|NCT03694119|Autonomic Agents|autonomic agents|mesh-ancestor
5653104|NCT03694119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5653105|NCT03694119|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5653106|NCT03694119|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5830259|NCT02557490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5830260|NCT02557490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5830261|NCT02557503|Fluorouracil|fluorouracil|mesh-list
5830262|NCT02557503|Oxaliplatin|oxaliplatin|mesh-list
5830263|NCT02557503|Antimetabolites|antimetabolites|mesh-ancestor
5830264|NCT02557503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830265|NCT02557503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5830266|NCT02557503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5830267|NCT02557503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5830268|NCT02557503|Immunologic Factors|immunologic factors|mesh-ancestor
5830269|NCT02557503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830270|NCT02557386|Levobupivacaine|levobupivacaine|mesh-list
5830271|NCT02557386|Anesthetics, Local|anesthetics, local|mesh-ancestor
5830272|NCT02557386|Anesthetics|anesthetics|mesh-ancestor
5653107|NCT03694119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5653108|NCT03694119|Adrenergic Agents|adrenergic agents|mesh-ancestor
5653109|NCT03694119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5830273|NCT02557386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5830274|NCT02557386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830275|NCT02557386|Sensory System Agents|sensory system agents|mesh-ancestor
5830276|NCT02557386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5830277|NCT02557373|Vitamins|vitamins|mesh-list
5830278|NCT02557373|Vitamin A|vitamin a|mesh-list
5830279|NCT02557373|Retinol palmitate|retinol palmitate|mesh-list
5830280|NCT02557373|Micronutrients|micronutrients|mesh-ancestor
5830281|NCT02557373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653110|NCT03694080|Calcium|calcium|mesh-list
5653111|NCT03694080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5653112|NCT03694080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653113|NCT03693976|Xylometazoline|xylometazoline|mesh-list
5653114|NCT03693976|Nasal Decongestants|nasal decongestants|mesh-ancestor
5653115|NCT03693976|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5653116|NCT03693976|Respiratory System Agents|respiratory system agents|mesh-ancestor
5653117|NCT03693885|Oxytocin|oxytocin|mesh-list
5653118|NCT03693885|Oxytocics|oxytocics|mesh-ancestor
5653119|NCT03693885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5653120|NCT03693885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653121|NCT03693872|Dopamine|dopamine|mesh-list
5653122|NCT03693872|Apomorphine|apomorphine|mesh-list
5653123|NCT03693872|Dopamine Agonists|dopamine agonists|mesh-list
5653124|NCT03693872|Emetics|emetics|mesh-ancestor
5653125|NCT03693872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653126|NCT03693872|Autonomic Agents|autonomic agents|mesh-ancestor
5653127|NCT03693872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5653128|NCT03693872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5653129|NCT03693872|Dopamine Agents|dopamine agents|mesh-ancestor
5653130|NCT03693872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5653131|NCT03693872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653132|NCT03693872|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5830282|NCT02557373|Antioxidants|antioxidants|mesh-ancestor
5830283|NCT02557373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830284|NCT02557373|Protective Agents|protective agents|mesh-ancestor
5830285|NCT02557373|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5830286|NCT02557373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5830287|NCT02557269|Mometasone Furoate|mometasone furoate|mesh-list
5830288|NCT02557269|Azelastine|azelastine|mesh-list
5830289|NCT02557269|Prednisolone|prednisolone|mesh-list
5830290|NCT02557269|Xylometazoline|xylometazoline|mesh-list
5830291|NCT02557269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5830292|NCT02557269|Glucocorticoids|glucocorticoids|mesh-ancestor
5830293|NCT02557269|Hormones|hormones|mesh-ancestor
5830294|NCT02557269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5830295|NCT02557269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830296|NCT02557269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5830297|NCT02557269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5830298|NCT02557269|Autonomic Agents|autonomic agents|mesh-ancestor
5830299|NCT02557269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5830300|NCT02557269|Dermatologic Agents|dermatologic agents|mesh-ancestor
5830301|NCT02557269|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5830302|NCT02557269|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5830303|NCT02557269|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5830304|NCT02557269|Respiratory System Agents|respiratory system agents|mesh-ancestor
5830305|NCT02557269|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
5830306|NCT02557269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5830307|NCT02557269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830308|NCT02557269|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5653133|NCT03693872|Sympathomimetics|sympathomimetics|mesh-ancestor
5653134|NCT03693872|Protective Agents|protective agents|mesh-ancestor
5653135|NCT03693833|Cannabidiol|cannabidiol|mesh-list
5653136|NCT03693833|Anticonvulsants|anticonvulsants|mesh-ancestor
5653137|NCT03693781|Colchicine|colchicine|mesh-list
5653138|NCT03693781|Gout Suppressants|gout suppressants|mesh-ancestor
5830309|NCT02557269|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5830310|NCT02557269|Histamine Antagonists|histamine antagonists|mesh-ancestor
5653139|NCT03693781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5653140|NCT03693781|Tubulin Modulators|tubulin modulators|mesh-ancestor
5653141|NCT03693781|Antimitotic Agents|antimitotic agents|mesh-ancestor
5653142|NCT03693781|Mitosis Modulators|mitosis modulators|mesh-ancestor
5653143|NCT03693781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830311|NCT02557269|Histamine Agents|histamine agents|mesh-ancestor
5830312|NCT02557269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5653144|NCT03693781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5653145|NCT03693677|Gemcitabine|gemcitabine|mesh-list
5653146|NCT03693677|Paclitaxel|paclitaxel|mesh-list
5653147|NCT03693677|Irinotecan|irinotecan|mesh-list
5653148|NCT03693677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5653149|NCT03693677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5653150|NCT03693677|Tubulin Modulators|tubulin modulators|mesh-ancestor
5653151|NCT03693677|Antimitotic Agents|antimitotic agents|mesh-ancestor
5653152|NCT03693677|Mitosis Modulators|mitosis modulators|mesh-ancestor
5653153|NCT03693677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653154|NCT03693677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5653155|NCT03693677|Antimetabolites|antimetabolites|mesh-ancestor
5653156|NCT03693677|Antiviral Agents|antiviral agents|mesh-ancestor
5653157|NCT03693677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5653158|NCT03693677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5653159|NCT03693677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5653160|NCT03693677|Immunologic Factors|immunologic factors|mesh-ancestor
5653161|NCT03693677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653162|NCT03693677|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5653163|NCT03693677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5653164|NCT03693638|Fentanyl|fentanyl|mesh-list
5653165|NCT03693638|Bupivacaine|bupivacaine|mesh-list
5653166|NCT03693638|Anesthetics, Local|anesthetics, local|mesh-ancestor
5653167|NCT03693638|Anesthetics|anesthetics|mesh-ancestor
5653168|NCT03693638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5653169|NCT03693638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653170|NCT03693638|Sensory System Agents|sensory system agents|mesh-ancestor
5653171|NCT03693638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5653172|NCT03693638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5653173|NCT03693638|Narcotics|narcotics|mesh-ancestor
5653174|NCT03693638|Analgesics|analgesics|mesh-ancestor
5653175|NCT03693638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5653176|NCT03693638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5653177|NCT03693638|Anesthetics, General|anesthetics, general|mesh-ancestor
5653178|NCT03693612|Paclitaxel|paclitaxel|mesh-list
5653179|NCT03693612|Docetaxel|docetaxel|mesh-list
5653180|NCT03693612|Cetuximab|cetuximab|mesh-list
5653181|NCT03693612|Tremelimumab|tremelimumab|mesh-list
5653182|NCT03693612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5653183|NCT03693612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5653184|NCT03693612|Tubulin Modulators|tubulin modulators|mesh-ancestor
5653185|NCT03693612|Antimitotic Agents|antimitotic agents|mesh-ancestor
5653186|NCT03693612|Mitosis Modulators|mitosis modulators|mesh-ancestor
5653187|NCT03693612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653188|NCT03693612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5653189|NCT03693599|Carbetocin|carbetocin|mesh-list
5653190|NCT03693599|Syntometrine|syntometrine|mesh-list
5653191|NCT03693599|Oxytocics|oxytocics|mesh-ancestor
5653192|NCT03693599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5653193|NCT03693599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653194|NCT03693573|Bevacizumab|bevacizumab|mesh-list
5653195|NCT03693573|Atezolizumab|atezolizumab|mesh-list
5653196|NCT03693573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5653197|NCT03693573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5653198|NCT03693573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5653199|NCT03693573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5653200|NCT03693573|Growth Substances|growth substances|mesh-ancestor
5653201|NCT03693573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653202|NCT03693573|Growth Inhibitors|growth inhibitors|mesh-ancestor
5694713|NCT03394001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694714|NCT03394001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5830313|NCT02557269|Nasal Decongestants|nasal decongestants|mesh-ancestor
5830314|NCT02557269|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5830315|NCT02557321|Pembrolizumab|pembrolizumab|mesh-list
5830316|NCT02557321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5830317|NCT02557321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5830318|NCT02557087|Scopolamine|scopolamine|mesh-list
5830319|NCT02557087|Meperidine|meperidine|mesh-list
5830320|NCT02557087|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5830321|NCT02557087|Antiemetics|antiemetics|mesh-ancestor
5830322|NCT02557087|Autonomic Agents|autonomic agents|mesh-ancestor
5830323|NCT02557087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5830324|NCT02557087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830325|NCT02557087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5830326|NCT02557087|Mydriatics|mydriatics|mesh-ancestor
5830327|NCT02557087|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5694715|NCT03394001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5694716|NCT03394001|Analgesics|analgesics|mesh-ancestor
5830328|NCT02557087|Cholinergic Agents|cholinergic agents|mesh-ancestor
5830329|NCT02557087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5830330|NCT02557087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830331|NCT02557087|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5830332|NCT02557087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5830333|NCT02557087|Narcotics|narcotics|mesh-ancestor
5830334|NCT02557087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5830335|NCT02557087|Analgesics|analgesics|mesh-ancestor
5830336|NCT02557087|Sensory System Agents|sensory system agents|mesh-ancestor
5830337|NCT02556931|Mycophenolic Acid|mycophenolic acid|mesh-list
5830338|NCT02556931|Cyclophosphamide|cyclophosphamide|mesh-list
5830339|NCT02556931|Fludarabine|fludarabine|mesh-list
5830340|NCT02556931|Tacrolimus|tacrolimus|mesh-list
5830341|NCT02556931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5830342|NCT02556931|Immunologic Factors|immunologic factors|mesh-ancestor
5830343|NCT02556931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830344|NCT02556931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5830345|NCT02556931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5830346|NCT02556931|Alkylating Agents|alkylating agents|mesh-ancestor
5830347|NCT02556931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830348|NCT02556931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5830349|NCT02556931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5830350|NCT02556931|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5830351|NCT02556931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5830352|NCT02556931|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5830353|NCT02556931|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5830354|NCT02556931|Antitubercular Agents|antitubercular agents|mesh-ancestor
5830355|NCT02556931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5830356|NCT02556931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5902489|NCT04113720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902490|NCT04113720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5902491|NCT04113720|Analgesics|analgesics|mesh-ancestor
5902492|NCT04113720|Sensory System Agents|sensory system agents|mesh-ancestor
5902493|NCT04113720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5902494|NCT04113720|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5902495|NCT04113720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5902496|NCT04113720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5902497|NCT04113720|Adrenergic Agents|adrenergic agents|mesh-ancestor
5902498|NCT04113720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5902499|NCT04113720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493281|NCT00612794|Hormones|hormones|mesh-ancestor
6493282|NCT00612794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6493283|NCT00612859|Levetiracetam|levetiracetam|mesh-list
6493284|NCT00612859|Anticonvulsants|anticonvulsants|mesh-ancestor
6493285|NCT00612859|Nootropic Agents|nootropic agents|mesh-ancestor
6493286|NCT00612898|Lamivudine|lamivudine|mesh-list
6493287|NCT00612898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5653203|NCT03693560|Metformin|metformin|mesh-list
5653204|NCT03693560|Glimepiride|glimepiride|mesh-list
5653205|NCT03693560|Vildagliptin|vildagliptin|mesh-list
5653206|NCT03693560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5653207|NCT03693560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493288|NCT00612898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6493289|NCT00612898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6493290|NCT00612898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493291|NCT00612898|Antiviral Agents|antiviral agents|mesh-ancestor
6493292|NCT00612898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6493293|NCT00612898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6493294|NCT00612898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6493295|NCT00612950|Glucagon|glucagon|mesh-list
6493296|NCT00612950|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
6493297|NCT00612950|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6493298|NCT00612950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6493299|NCT00612950|Hormones|hormones|mesh-ancestor
6493300|NCT00612950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6493301|NCT00612950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493302|NCT00612950|Incretins|incretins|mesh-ancestor
6493303|NCT00612989|Temozolomide|temozolomide|mesh-list
6493304|NCT00612989|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
6493305|NCT00612989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5653208|NCT03693560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5653209|NCT03693560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5653210|NCT03693560|Immunologic Factors|immunologic factors|mesh-ancestor
5653211|NCT03693560|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5653212|NCT03693560|Protease Inhibitors|protease inhibitors|mesh-ancestor
5830357|NCT02556905|Dexamethasone|dexamethasone|mesh-list
5830358|NCT02556905|Lenalidomide|lenalidomide|mesh-list
5830359|NCT02556905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5830360|NCT02556905|Antiemetics|antiemetics|mesh-ancestor
5830361|NCT02556905|Autonomic Agents|autonomic agents|mesh-ancestor
5830362|NCT02556905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5830363|NCT02556905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830364|NCT02556905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5830365|NCT02556905|Glucocorticoids|glucocorticoids|mesh-ancestor
5830366|NCT02556905|Hormones|hormones|mesh-ancestor
5830367|NCT02556905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5830368|NCT02556905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5830369|NCT02556905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5830370|NCT02556905|Immunologic Factors|immunologic factors|mesh-ancestor
5830371|NCT02556905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5830372|NCT02556905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5830373|NCT02556905|Growth Substances|growth substances|mesh-ancestor
5830374|NCT02556905|Growth Inhibitors|growth inhibitors|mesh-ancestor
5830375|NCT02556970|Acetaminophen|acetaminophen|mesh-list
5830376|NCT02556970|Diclofenac|diclofenac|mesh-list
5830377|NCT02556970|Levobupivacaine|levobupivacaine|mesh-list
5830378|NCT02556970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5830379|NCT02556970|Analgesics|analgesics|mesh-ancestor
5830380|NCT02556970|Sensory System Agents|sensory system agents|mesh-ancestor
5830381|NCT02556970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5830382|NCT02556970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830383|NCT02556970|Antipyretics|antipyretics|mesh-ancestor
5830384|NCT02556970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5830385|NCT02556970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5830386|NCT02556970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5830387|NCT02556970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5653213|NCT03693560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5653214|NCT03693560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653215|NCT03693508|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5653216|NCT03693508|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5653217|NCT03693508|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5653218|NCT03693508|Antiviral Agents|antiviral agents|mesh-ancestor
5653219|NCT03693508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5653220|NCT03693404|Ketorolac|ketorolac|mesh-list
5830388|NCT02556970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6493306|NCT00612989|Alkylating Agents|alkylating agents|mesh-ancestor
6493307|NCT00612989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493308|NCT00612989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6493309|NCT00612989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5830389|NCT02556970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830390|NCT02556970|Anesthetics, Local|anesthetics, local|mesh-ancestor
5830391|NCT02556970|Anesthetics|anesthetics|mesh-ancestor
5830392|NCT02556970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5830393|NCT02556879|Liver Extracts|liver extracts|mesh-list
5830394|NCT02556879|Antibodies|antibodies|mesh-list
5830395|NCT02556879|Immunologic Factors|immunologic factors|mesh-ancestor
5830396|NCT02556879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830397|NCT02556879|Hematinics|hematinics|mesh-ancestor
5830398|NCT02556866|Prednisone|prednisone|mesh-list
5830399|NCT02556866|Rituximab|rituximab|mesh-list
5830400|NCT02556866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5830401|NCT02556866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5830402|NCT02556866|Immunologic Factors|immunologic factors|mesh-ancestor
5830403|NCT02556866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830404|NCT02556866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5830405|NCT02556866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6493310|NCT00613054|Imatinib Mesylate|imatinib mesylate|mesh-list
6493311|NCT00613054|Hydroxyurea|hydroxyurea|mesh-list
6493312|NCT00613054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6493313|NCT00613054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6493314|NCT00613054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6493315|NCT00613054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493316|NCT00613054|Antisickling Agents|antisickling agents|mesh-ancestor
6493317|NCT00613054|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6493318|NCT00613067|Citalopram|citalopram|mesh-list
5830406|NCT02556866|Glucocorticoids|glucocorticoids|mesh-ancestor
5830407|NCT02556866|Hormones|hormones|mesh-ancestor
5653221|NCT03693404|Morphine|morphine|mesh-list
5653222|NCT03693404|Bupivacaine|bupivacaine|mesh-list
5830408|NCT02556866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5830409|NCT02556866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5653223|NCT03693404|Anesthetics|anesthetics|mesh-list
5653224|NCT03693404|Anesthetics, General|anesthetics, general|mesh-list
5653225|NCT03693404|Anesthetics, Local|anesthetics, local|mesh-ancestor
5653226|NCT03693404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5653227|NCT03693404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653228|NCT03693404|Sensory System Agents|sensory system agents|mesh-ancestor
5653229|NCT03693404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5653230|NCT03693404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5653231|NCT03693404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5830410|NCT02556723|Aflibercept|aflibercept|mesh-list
5830411|NCT02556723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5830412|NCT02556723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5830413|NCT02556723|Growth Substances|growth substances|mesh-ancestor
5830414|NCT02556723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830415|NCT02556723|Growth Inhibitors|growth inhibitors|mesh-ancestor
5830416|NCT02556723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5830417|NCT02556658|Anesthetics|anesthetics|mesh-list
5830418|NCT02556658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5830419|NCT02556658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830420|NCT02556814|Dexamethasone|dexamethasone|mesh-list
5830421|NCT02556814|Caffeic acid|caffeic acid|mesh-list
5830422|NCT02556814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5830423|NCT02556814|Antiemetics|antiemetics|mesh-ancestor
5653232|NCT03693404|Analgesics|analgesics|mesh-ancestor
5653233|NCT03693404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5653234|NCT03693404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5653235|NCT03693404|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5653236|NCT03693404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5653237|NCT03693404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653238|NCT03693404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5653239|NCT03693404|Narcotics|narcotics|mesh-ancestor
5653240|NCT03693391|Fluorides|fluorides|mesh-list
5653241|NCT03693391|Cariostatic Agents|cariostatic agents|mesh-ancestor
5653242|NCT03693391|Protective Agents|protective agents|mesh-ancestor
5653243|NCT03693391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653244|NCT03693326|Spartalizumab|spartalizumab|mesh-list
5653245|NCT03693326|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5653246|NCT03693326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653247|NCT03693326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5653248|NCT03693248|Paclitaxel|paclitaxel|mesh-list
5653249|NCT03693248|Carboplatin|carboplatin|mesh-list
5653250|NCT03693248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5653251|NCT03693248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5653252|NCT03693248|Tubulin Modulators|tubulin modulators|mesh-ancestor
5653253|NCT03693248|Antimitotic Agents|antimitotic agents|mesh-ancestor
5653254|NCT03693248|Mitosis Modulators|mitosis modulators|mesh-ancestor
5653255|NCT03693248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653256|NCT03693222|Morphine|morphine|mesh-list
5653257|NCT03693222|Tramadol|tramadol|mesh-list
5653258|NCT03693222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5653259|NCT03693222|Narcotics|narcotics|mesh-ancestor
5653260|NCT03693222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5830424|NCT02556814|Autonomic Agents|autonomic agents|mesh-ancestor
5830425|NCT02556814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5830426|NCT02556814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830427|NCT02556814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5830428|NCT02556814|Glucocorticoids|glucocorticoids|mesh-ancestor
5830429|NCT02556814|Hormones|hormones|mesh-ancestor
5830430|NCT02556814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5830431|NCT02556814|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5830432|NCT02556814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5830433|NCT02556814|Antioxidants|antioxidants|mesh-ancestor
5830434|NCT02556814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830435|NCT02556814|Protective Agents|protective agents|mesh-ancestor
5830436|NCT02556840|Insulin|insulin|mesh-list
5830437|NCT02556840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5830438|NCT02556840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830439|NCT02556593|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5830440|NCT02556593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5830441|NCT02556593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5830442|NCT02556593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5830443|NCT02556593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830444|NCT02556411|Levonorgestrel|levonorgestrel|mesh-list
5830445|NCT02556411|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5830446|NCT02556411|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5653261|NCT03693222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653262|NCT03693222|Analgesics|analgesics|mesh-ancestor
5653263|NCT03693222|Sensory System Agents|sensory system agents|mesh-ancestor
5653264|NCT03693222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5653265|NCT03693183|Ketorolac|ketorolac|mesh-list
5653266|NCT03693183|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
5653267|NCT03693183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5653268|NCT03693183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5653269|NCT03693183|Analgesics|analgesics|mesh-ancestor
5653270|NCT03693183|Sensory System Agents|sensory system agents|mesh-ancestor
5653271|NCT03693183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5653272|NCT03693183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653273|NCT03693183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5653274|NCT03693183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5653275|NCT03693183|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5653276|NCT03693183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5653277|NCT03693183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653278|NCT03693170|Cetuximab|cetuximab|mesh-list
5653279|NCT03693170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5653280|NCT03693170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5653281|NCT03693131|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
5653282|NCT03693131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5653283|NCT03693131|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5653284|NCT03693066|Chlorhexidine|chlorhexidine|mesh-list
5653285|NCT03693066|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5830447|NCT02556411|Contraceptive Agents|contraceptive agents|mesh-ancestor
5830448|NCT02556411|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5830449|NCT02556411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830450|NCT02556411|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5830451|NCT02556411|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5830452|NCT02556411|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5830453|NCT02556411|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5830454|NCT02556411|Estrogens|estrogens|mesh-ancestor
5830455|NCT02556411|Hormones|hormones|mesh-ancestor
5830456|NCT02556411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5830457|NCT02556463|Durvalumab|durvalumab|mesh-list
5830458|NCT02556463|MEDI9197|medi9197|mesh-list
5830459|NCT02556463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5830460|NCT02556463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5830461|NCT02556463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5830462|NCT02556463|Immunologic Factors|immunologic factors|mesh-ancestor
5830463|NCT02556463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830464|NCT02556437|Immunoglobulins|immunoglobulins|mesh-list
5830465|NCT02556437|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5830466|NCT02556437|Antibodies|antibodies|mesh-list
5830467|NCT02556437|Immunologic Factors|immunologic factors|mesh-ancestor
5830468|NCT02556437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830469|NCT02556320|Anticonvulsants|anticonvulsants|mesh-list
5830470|NCT02556424|Dexamethasone|dexamethasone|mesh-list
5830471|NCT02556424|Triamcinolone|triamcinolone|mesh-list
5830472|NCT02556424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5830473|NCT02556424|Antiemetics|antiemetics|mesh-ancestor
5653286|NCT03693066|Disinfectants|disinfectants|mesh-list
5653287|NCT03693066|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5653288|NCT03693066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5653289|NCT03693066|Dermatologic Agents|dermatologic agents|mesh-ancestor
5653290|NCT03692871|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5830474|NCT02556424|Autonomic Agents|autonomic agents|mesh-ancestor
5830475|NCT02556424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5830476|NCT02556424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830477|NCT02556424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5830478|NCT02556424|Glucocorticoids|glucocorticoids|mesh-ancestor
5830479|NCT02556424|Hormones|hormones|mesh-ancestor
5830480|NCT02556424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5830481|NCT02556424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5830482|NCT02556424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5830483|NCT02556268|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
5830484|NCT02556268|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5830485|NCT02556268|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5830486|NCT02556268|Triumeq|triumeq|mesh-list
5830487|NCT02556268|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
5830488|NCT02556268|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
5830489|NCT02556268|Riociguat|riociguat|mesh-list
5653291|NCT03692871|Immunologic Factors|immunologic factors|mesh-ancestor
5653292|NCT03692871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653293|NCT03692819|Amoxicillin|amoxicillin|mesh-list
5653294|NCT03692819|Metronidazole|metronidazole|mesh-list
5653295|NCT03692819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5653296|NCT03692819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5653297|NCT03692819|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5830490|NCT02556268|Protease Inhibitors|protease inhibitors|mesh-list
5830491|NCT02556268|Antiviral Agents|antiviral agents|mesh-ancestor
5830492|NCT02556268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5830493|NCT02556268|Enzyme Activators|enzyme activators|mesh-ancestor
5830494|NCT02556268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830495|NCT02556268|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5830496|NCT02556268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5830497|NCT02556268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5830498|NCT02556268|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5830499|NCT02556268|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5830500|NCT02556229|Aflibercept|aflibercept|mesh-list
5830501|NCT02556229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5830502|NCT02556229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6493319|NCT00613067|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6493320|NCT00613067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6493321|NCT00613067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6493322|NCT00613067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830503|NCT02556229|Growth Substances|growth substances|mesh-ancestor
5830504|NCT02556229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830505|NCT02556229|Growth Inhibitors|growth inhibitors|mesh-ancestor
5830506|NCT02556229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5830507|NCT02556099|Hydroxyurea|hydroxyurea|mesh-list
5830508|NCT02556099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5830509|NCT02556099|Antisickling Agents|antisickling agents|mesh-ancestor
5830510|NCT02556099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5830511|NCT02556099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830512|NCT02556099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5830513|NCT02556008|Cannabidiol|cannabidiol|mesh-list
5830514|NCT02556008|Anticonvulsants|anticonvulsants|mesh-ancestor
5830515|NCT02556060|Lamotrigine|lamotrigine|mesh-list
5830516|NCT02556060|Anticonvulsants|anticonvulsants|mesh-ancestor
5830517|NCT02556060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5830518|NCT02556060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5830519|NCT02556060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830520|NCT02556060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5830521|NCT02556060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830522|NCT02556060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5830523|NCT02556060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5830524|NCT02556060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5830525|NCT02556060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5830526|NCT02556060|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5830527|NCT02556086|Sofosbuvir|sofosbuvir|mesh-list
5830528|NCT02556086|Antiviral Agents|antiviral agents|mesh-ancestor
5830529|NCT02556086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5830530|NCT02555943|Ritonavir|ritonavir|mesh-list
5830531|NCT02555943|Tenofovir|tenofovir|mesh-list
5830532|NCT02555943|Sofosbuvir|sofosbuvir|mesh-list
5830533|NCT02555943|Entecavir|entecavir|mesh-list
5830534|NCT02555943|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
5830535|NCT02555943|Ledipasvir|ledipasvir|mesh-list
5830536|NCT02555943|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5830537|NCT02555943|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5830538|NCT02555943|Protease Inhibitors|protease inhibitors|mesh-ancestor
5830539|NCT02555943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5830540|NCT02555943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830541|NCT02555943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5830542|NCT02555943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5830543|NCT02555943|Antiviral Agents|antiviral agents|mesh-ancestor
5830544|NCT02555943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5830545|NCT02555943|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5830546|NCT02555943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5830547|NCT02555943|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5830548|NCT02555943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5830549|NCT02555813|Gemcitabine|gemcitabine|mesh-list
5653298|NCT03692819|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5653299|NCT03692754|Calcium, Dietary|calcium, dietary|mesh-list
5653300|NCT03692754|Dexamethasone|dexamethasone|mesh-list
5653301|NCT03692754|Atorvastatin|atorvastatin|mesh-list
5653302|NCT03692754|Calcium|calcium|mesh-list
5653303|NCT03692754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5653304|NCT03692754|Antiemetics|antiemetics|mesh-ancestor
5653305|NCT03692754|Autonomic Agents|autonomic agents|mesh-ancestor
5653306|NCT03692754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5653307|NCT03692754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653308|NCT03692754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5653309|NCT03692754|Glucocorticoids|glucocorticoids|mesh-ancestor
5653310|NCT03692754|Hormones|hormones|mesh-ancestor
5653311|NCT03692754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5653312|NCT03692754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5653313|NCT03692754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5653314|NCT03692754|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5653315|NCT03692754|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5653316|NCT03692754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5653317|NCT03692754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5653318|NCT03692754|Antimetabolites|antimetabolites|mesh-ancestor
5653319|NCT03692754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653320|NCT03692754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5653321|NCT03692754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5653322|NCT03692754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5653323|NCT03692546|Bupivacaine|bupivacaine|mesh-list
5653324|NCT03692546|Anesthetics, Local|anesthetics, local|mesh-ancestor
5830550|NCT02555813|Paclitaxel|paclitaxel|mesh-list
5830551|NCT02555813|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5830552|NCT02555813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5830553|NCT02555813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5830554|NCT02555813|Tubulin Modulators|tubulin modulators|mesh-ancestor
5830555|NCT02555813|Antimitotic Agents|antimitotic agents|mesh-ancestor
5830556|NCT02555813|Mitosis Modulators|mitosis modulators|mesh-ancestor
5830557|NCT02555813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830558|NCT02555813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5830559|NCT02555813|Antimetabolites|antimetabolites|mesh-ancestor
5830560|NCT02555813|Antiviral Agents|antiviral agents|mesh-ancestor
5830561|NCT02555813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5830562|NCT02555813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5830563|NCT02555813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5830564|NCT02555813|Immunologic Factors|immunologic factors|mesh-ancestor
5830565|NCT02555813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830566|NCT02555800|Cidofovir|cidofovir|mesh-list
5830567|NCT02555800|Bevacizumab|bevacizumab|mesh-list
5830568|NCT02555800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5830569|NCT02555800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5830570|NCT02555800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5830571|NCT02555800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5830572|NCT02555800|Growth Substances|growth substances|mesh-ancestor
5830573|NCT02555800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830574|NCT02555800|Growth Inhibitors|growth inhibitors|mesh-ancestor
5830575|NCT02555800|Antiviral Agents|antiviral agents|mesh-ancestor
5830576|NCT02555800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5830577|NCT02555800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5830578|NCT02555800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830579|NCT02555839|Thalidomide|thalidomide|mesh-list
5830580|NCT02555839|Dexamethasone|dexamethasone|mesh-list
5830581|NCT02555839|Dexamethasone acetate|dexamethasone acetate|mesh-list
5830582|NCT02555839|Bortezomib|bortezomib|mesh-list
5653325|NCT03692546|Anesthetics|anesthetics|mesh-ancestor
5653326|NCT03692546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5653327|NCT03692546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653328|NCT03692546|Sensory System Agents|sensory system agents|mesh-ancestor
5653329|NCT03692546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5653330|NCT03692481|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5653331|NCT03692481|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5830583|NCT02555839|Pomalidomide|pomalidomide|mesh-list
5830584|NCT02555839|BB 1101|bb 1101|mesh-list
5830585|NCT02555839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5830586|NCT02555839|Antiemetics|antiemetics|mesh-ancestor
5830587|NCT02555839|Autonomic Agents|autonomic agents|mesh-ancestor
5830588|NCT02555839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5830589|NCT02555839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830590|NCT02555839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5830591|NCT02555839|Glucocorticoids|glucocorticoids|mesh-ancestor
5830592|NCT02555839|Hormones|hormones|mesh-ancestor
5830593|NCT02555839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5830594|NCT02555839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5830595|NCT02555839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5830596|NCT02555839|Protease Inhibitors|protease inhibitors|mesh-ancestor
5830597|NCT02555839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5830598|NCT02555839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830599|NCT02555839|Immunologic Factors|immunologic factors|mesh-ancestor
5830600|NCT02555839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5830601|NCT02555839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5830602|NCT02555839|Growth Substances|growth substances|mesh-ancestor
5830603|NCT02555839|Growth Inhibitors|growth inhibitors|mesh-ancestor
5830604|NCT02555839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5830605|NCT02555839|Leprostatic Agents|leprostatic agents|mesh-ancestor
5830606|NCT02555839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5830607|NCT02555839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5830608|NCT02555852|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
5830609|NCT02555852|Esomeprazole|esomeprazole|mesh-list
5830610|NCT02555852|Omeprazole|omeprazole|mesh-list
5830611|NCT02555852|Rabeprazole|rabeprazole|mesh-list
5830612|NCT02555852|Pantoprazole|pantoprazole|mesh-list
5830613|NCT02555852|Lansoprazole|lansoprazole|mesh-list
5830614|NCT02555852|Famotidine|famotidine|mesh-list
5653332|NCT03692481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653333|NCT03692416|Prednisone|prednisone|mesh-list
5653334|NCT03692416|Ibuprofen|ibuprofen|mesh-list
5653335|NCT03692416|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5830615|NCT02555852|Ranitidine|ranitidine|mesh-list
5830616|NCT02555852|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
5830617|NCT02555852|Cimetidine|cimetidine|mesh-list
5830618|NCT02555852|Nizatidine|nizatidine|mesh-list
5830619|NCT02555852|Lafutidine|lafutidine|mesh-list
5830620|NCT02555852|Roxatidine acetate|roxatidine acetate|mesh-list
5830621|NCT02555852|Bismuth|bismuth|mesh-list
5830622|NCT02555852|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
5653336|NCT03692416|Methotrexate|methotrexate|mesh-list
5653337|NCT03692416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5653338|NCT03692416|Glucocorticoids|glucocorticoids|mesh-ancestor
5653339|NCT03692416|Hormones|hormones|mesh-ancestor
5653340|NCT03692416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5653341|NCT03692416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830623|NCT02555852|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
5830624|NCT02555852|Histamine|histamine|mesh-list
5653342|NCT03692416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5653343|NCT03692416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5653344|NCT03692416|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5653345|NCT03692416|Abortifacient Agents|abortifacient agents|mesh-ancestor
5653346|NCT03692416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5653347|NCT03692416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5653348|NCT03692416|Antimetabolites|antimetabolites|mesh-ancestor
5653349|NCT03692416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653350|NCT03692416|Dermatologic Agents|dermatologic agents|mesh-ancestor
5653351|NCT03692416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5653352|NCT03692416|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5653353|NCT03692416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5653354|NCT03692416|Immunologic Factors|immunologic factors|mesh-ancestor
5653355|NCT03692416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5653356|NCT03692416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5653357|NCT03692416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5830625|NCT02555852|Histamine phosphate|histamine phosphate|mesh-list
5830626|NCT02555852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830627|NCT02555852|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5653358|NCT03692416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5653359|NCT03692416|Analgesics|analgesics|mesh-ancestor
5653360|NCT03692416|Sensory System Agents|sensory system agents|mesh-ancestor
5653361|NCT03692416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5653362|NCT03692416|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5653363|NCT03692416|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5653364|NCT03692416|Protective Agents|protective agents|mesh-ancestor
5653365|NCT03692299|Metronidazole|metronidazole|mesh-list
5653366|NCT03692299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5653367|NCT03692299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5653368|NCT03692299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5653369|NCT03692299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5653370|NCT03692286|Calcium, Dietary|calcium, dietary|mesh-list
5653371|NCT03692286|Calcium|calcium|mesh-list
5653372|NCT03692286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5653373|NCT03692286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653374|NCT03692286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5653375|NCT03692143|Alendronate|alendronate|mesh-list
5830628|NCT02555852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5830629|NCT02555852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5830630|NCT02555852|Antacids|antacids|mesh-ancestor
5830631|NCT02555852|Histamine Antagonists|histamine antagonists|mesh-ancestor
5830632|NCT02555852|Histamine Agents|histamine agents|mesh-ancestor
5830633|NCT02555852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5830634|NCT02555852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830635|NCT02555852|Histamine Agonists|histamine agonists|mesh-ancestor
5830636|NCT02555852|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5830637|NCT02555852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5830638|NCT02555852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5830639|NCT02555696|Paclitaxel|paclitaxel|mesh-list
5830640|NCT02555696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5830641|NCT02555696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5830642|NCT02555696|Tubulin Modulators|tubulin modulators|mesh-ancestor
5830643|NCT02555696|Antimitotic Agents|antimitotic agents|mesh-ancestor
5830644|NCT02555696|Mitosis Modulators|mitosis modulators|mesh-ancestor
5830645|NCT02555696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830646|NCT02555644|Cetuximab|cetuximab|mesh-list
5830647|NCT02555644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5830648|NCT02555644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5830649|NCT02555761|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5830650|NCT02555761|Alcaftadine|alcaftadine|mesh-list
5830651|NCT02555761|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5830652|NCT02555761|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5830653|NCT02555761|Histamine Antagonists|histamine antagonists|mesh-ancestor
5830654|NCT02555761|Histamine Agents|histamine agents|mesh-ancestor
5830655|NCT02555761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5830656|NCT02555761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830657|NCT02555761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830658|NCT02555748|Sunitinib|sunitinib|mesh-list
5830659|NCT02555748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5830660|NCT02555748|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5830661|NCT02555748|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5830662|NCT02555748|Growth Substances|growth substances|mesh-ancestor
5830663|NCT02555748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830664|NCT02555748|Growth Inhibitors|growth inhibitors|mesh-ancestor
5830665|NCT02555748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5830666|NCT02555748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5830667|NCT02555748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830668|NCT02555605|Dexmedetomidine|dexmedetomidine|mesh-list
5830669|NCT02555605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5830670|NCT02555605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5830671|NCT02555605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830672|NCT02555605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5830673|NCT02555605|Analgesics|analgesics|mesh-ancestor
5830674|NCT02555605|Sensory System Agents|sensory system agents|mesh-ancestor
5830675|NCT02555605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5830676|NCT02555605|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5830677|NCT02555605|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5830678|NCT02555605|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5830679|NCT02555605|Adrenergic Agents|adrenergic agents|mesh-ancestor
5830680|NCT02555605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5830681|NCT02555605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830682|NCT02555488|Methylene Blue|methylene blue|mesh-list
5830683|NCT02555488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5830684|NCT02555488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830685|NCT02555358|Docetaxel|docetaxel|mesh-list
5830686|NCT02555358|Capecitabine|capecitabine|mesh-list
5830687|NCT02555358|Oxaliplatin|oxaliplatin|mesh-list
5830688|NCT02555358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5830689|NCT02555358|Tubulin Modulators|tubulin modulators|mesh-ancestor
5653376|NCT03692143|Teriparatide|teriparatide|mesh-list
5653377|NCT03692143|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5653378|NCT03692143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653379|NCT03692143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5694717|NCT03394001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5694718|NCT03394001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5694719|NCT03394001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5694720|NCT03394001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5694721|NCT03393988|Fentanyl|fentanyl|mesh-list
5830690|NCT02555358|Antimitotic Agents|antimitotic agents|mesh-ancestor
5830691|NCT02555358|Mitosis Modulators|mitosis modulators|mesh-ancestor
5830692|NCT02555358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830693|NCT02555358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5830694|NCT02555358|Antimetabolites|antimetabolites|mesh-ancestor
5653380|NCT03692065|Apixaban|apixaban|mesh-list
5653381|NCT03692065|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6493323|NCT00613067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6493324|NCT00613067|Serotonin Agents|serotonin agents|mesh-ancestor
6493325|NCT00613067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493326|NCT00613067|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5653382|NCT03692065|Antithrombins|antithrombins|mesh-ancestor
5653383|NCT03692065|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5653384|NCT03692065|Protease Inhibitors|protease inhibitors|mesh-ancestor
5653385|NCT03692065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5653386|NCT03692065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653387|NCT03692065|Anticoagulants|anticoagulants|mesh-ancestor
5653388|NCT03692026|Melatonin|melatonin|mesh-list
5653389|NCT03692026|Hyaluronic Acid|hyaluronic acid|mesh-list
5653390|NCT03692026|Antioxidants|antioxidants|mesh-ancestor
5653391|NCT03692026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653392|NCT03692026|Protective Agents|protective agents|mesh-ancestor
5653393|NCT03692026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653394|NCT03692026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5653395|NCT03692026|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5653396|NCT03692026|Immunologic Factors|immunologic factors|mesh-ancestor
5653397|NCT03692026|Viscosupplements|viscosupplements|mesh-ancestor
5653398|NCT03692013|Losartan|losartan|mesh-list
5653399|NCT03692013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5653400|NCT03692013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5653401|NCT03692013|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5653402|NCT03692013|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5830695|NCT02555254|Methamphetamine|methamphetamine|mesh-list
6493327|NCT00613067|Antidepressive Agents|antidepressive agents|mesh-ancestor
6493328|NCT00613067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6493329|NCT00613093|Temozolomide|temozolomide|mesh-list
6493330|NCT00613093|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
6493331|NCT00613093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6493332|NCT00613093|Alkylating Agents|alkylating agents|mesh-ancestor
6493333|NCT00613093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493334|NCT00613093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6493335|NCT00613093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6493336|NCT00613132|Everolimus|everolimus|mesh-list
6493337|NCT00613132|Imatinib Mesylate|imatinib mesylate|mesh-list
6493338|NCT00613132|Hydroxyurea|hydroxyurea|mesh-list
6493339|NCT00613132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6493340|NCT00613132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6493341|NCT00613132|Immunologic Factors|immunologic factors|mesh-ancestor
6493342|NCT00613132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493343|NCT00613132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6493344|NCT00613132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6493345|NCT00613132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493346|NCT00613132|Antisickling Agents|antisickling agents|mesh-ancestor
6493347|NCT00613132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5830696|NCT02555254|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5830697|NCT02555254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830698|NCT02555254|Sympathomimetics|sympathomimetics|mesh-ancestor
5830699|NCT02555254|Autonomic Agents|autonomic agents|mesh-ancestor
5830700|NCT02555254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5830701|NCT02555254|Dopamine Agents|dopamine agents|mesh-ancestor
5830702|NCT02555254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5830703|NCT02555254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830704|NCT02555254|Adrenergic Agents|adrenergic agents|mesh-ancestor
5830705|NCT02555254|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5830706|NCT02555254|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5830707|NCT02555254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5830708|NCT02555254|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5902500|NCT04113720|Anesthetics, Local|anesthetics, local|mesh-ancestor
5902501|NCT04113720|Anesthetics|anesthetics|mesh-ancestor
5902502|NCT04094675|Sirolimus|sirolimus|mesh-list
5830709|NCT02555423|Anesthetics|anesthetics|mesh-list
5830710|NCT02555423|Levobupivacaine|levobupivacaine|mesh-list
5830711|NCT02555423|Anesthetics, Local|anesthetics, local|mesh-list
5830712|NCT02555423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5830713|NCT02555423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653403|NCT03692013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653404|NCT03691935|Ropivacaine|ropivacaine|mesh-list
5653405|NCT03691935|Anesthetics|anesthetics|mesh-list
5653406|NCT03691935|Anesthetics, Local|anesthetics, local|mesh-ancestor
5653407|NCT03691935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5830714|NCT02555423|Sensory System Agents|sensory system agents|mesh-ancestor
5830715|NCT02555423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5830716|NCT02555059|Ciprofloxacin|ciprofloxacin|mesh-list
5830717|NCT02555059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5830718|NCT02555059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5830719|NCT02555059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5830720|NCT02555059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5830721|NCT02555059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5830722|NCT02555059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830723|NCT02555059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5830724|NCT02555059|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5653408|NCT03691935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653409|NCT03691935|Sensory System Agents|sensory system agents|mesh-ancestor
5653410|NCT03691935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5653411|NCT03691922|Epinephrine|epinephrine|mesh-list
5653412|NCT03691922|Racepinephrine|racepinephrine|mesh-list
5653413|NCT03691922|Bupivacaine|bupivacaine|mesh-list
5653414|NCT03691922|Epinephryl borate|epinephryl borate|mesh-list
5653415|NCT03691922|Anesthetics, Local|anesthetics, local|mesh-ancestor
5653416|NCT03691922|Anesthetics|anesthetics|mesh-ancestor
5653417|NCT03691922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5653418|NCT03691922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653419|NCT03691922|Sensory System Agents|sensory system agents|mesh-ancestor
5653420|NCT03691922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5830725|NCT02555059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5830726|NCT02555111|Rivaroxaban|rivaroxaban|mesh-list
5830727|NCT02555111|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5830728|NCT02555111|Antithrombins|antithrombins|mesh-ancestor
5830729|NCT02555111|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5830730|NCT02555111|Protease Inhibitors|protease inhibitors|mesh-ancestor
5830731|NCT02555111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5653421|NCT03691922|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5653422|NCT03691922|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5653423|NCT03691922|Adrenergic Agents|adrenergic agents|mesh-ancestor
5830732|NCT02555111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830733|NCT02555111|Anticoagulants|anticoagulants|mesh-ancestor
5830734|NCT02555150|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
5830735|NCT02555150|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5830736|NCT02555150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830737|NCT02555150|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5830738|NCT02555150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5830739|NCT02555150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5830740|NCT02555150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830741|NCT02555150|Dopamine Agents|dopamine agents|mesh-ancestor
5830742|NCT02555150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5653424|NCT03691922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5653425|NCT03691922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653426|NCT03691922|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5653427|NCT03691922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5653428|NCT03691922|Autonomic Agents|autonomic agents|mesh-ancestor
5653429|NCT03691922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5653430|NCT03691922|Respiratory System Agents|respiratory system agents|mesh-ancestor
5653431|NCT03691922|Mydriatics|mydriatics|mesh-ancestor
5653432|NCT03691922|Sympathomimetics|sympathomimetics|mesh-ancestor
5653433|NCT03691922|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5830743|NCT02555046|Anesthetics|anesthetics|mesh-list
5830744|NCT02555046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5830745|NCT02555046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830746|NCT02554942|Epoetin Alfa|epoetin alfa|mesh-list
5830747|NCT02554942|Hematinics|hematinics|mesh-ancestor
5830748|NCT02555007|Vinorelbine|vinorelbine|mesh-list
5830749|NCT02555007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5830750|NCT02555007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5830751|NCT02555007|Tubulin Modulators|tubulin modulators|mesh-ancestor
5830752|NCT02555007|Antimitotic Agents|antimitotic agents|mesh-ancestor
5830753|NCT02555007|Mitosis Modulators|mitosis modulators|mesh-ancestor
5830754|NCT02555007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830755|NCT02554955|Mycophenolic Acid|mycophenolic acid|mesh-list
5830756|NCT02554955|Daclizumab|daclizumab|mesh-list
5830757|NCT02554955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5830758|NCT02554955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5830759|NCT02554955|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5830760|NCT02554955|Antitubercular Agents|antitubercular agents|mesh-ancestor
5830761|NCT02554955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5830762|NCT02554955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5830763|NCT02554955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5830764|NCT02554955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830765|NCT02554955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5830766|NCT02554955|Immunologic Factors|immunologic factors|mesh-ancestor
5830767|NCT02554955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830768|NCT02554864|Lidocaine|lidocaine|mesh-list
5830769|NCT02554864|Ropivacaine|ropivacaine|mesh-list
5830770|NCT02554864|Anesthetics, Local|anesthetics, local|mesh-ancestor
5830771|NCT02554864|Anesthetics|anesthetics|mesh-ancestor
5830772|NCT02554864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5830773|NCT02554864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830774|NCT02554864|Sensory System Agents|sensory system agents|mesh-ancestor
5830775|NCT02554864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5830776|NCT02554864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5830777|NCT02554864|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5830778|NCT02554864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5830779|NCT02554864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5830780|NCT02554864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653434|NCT03691896|Cholecalciferol|cholecalciferol|mesh-list
5653435|NCT03691896|Vitamin D|vitamin d|mesh-list
5653436|NCT03691896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5653437|NCT03691896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653438|NCT03691896|Vitamins|vitamins|mesh-ancestor
5653439|NCT03691896|Micronutrients|micronutrients|mesh-ancestor
5653440|NCT03691896|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5653441|NCT03691818|Ibuprofen|ibuprofen|mesh-list
5653442|NCT03691818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5653443|NCT03691818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5653444|NCT03691818|Analgesics|analgesics|mesh-ancestor
5653445|NCT03691818|Sensory System Agents|sensory system agents|mesh-ancestor
5653446|NCT03691818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5653447|NCT03691818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653448|NCT03691818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5653449|NCT03691818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5653450|NCT03691818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5653451|NCT03691818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5653452|NCT03691818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653453|NCT03691688|Aspirin|aspirin|mesh-list
5653454|NCT03691688|Clopidogrel|clopidogrel|mesh-list
5653455|NCT03691688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5653456|NCT03691688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5653457|NCT03691688|Analgesics|analgesics|mesh-ancestor
5653458|NCT03691688|Sensory System Agents|sensory system agents|mesh-ancestor
5653459|NCT03691688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5653460|NCT03691688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653461|NCT03691688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5653462|NCT03691688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5653463|NCT03691688|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5653464|NCT03691688|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5653465|NCT03691688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653466|NCT03691688|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5653467|NCT03691688|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5653468|NCT03691688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5653469|NCT03691688|Antipyretics|antipyretics|mesh-ancestor
5653470|NCT03691688|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5653471|NCT03691688|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5653472|NCT03691688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5653473|NCT03691688|Purinergic Agents|purinergic agents|mesh-ancestor
5653474|NCT03691688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5653475|NCT03691662|Timolol|timolol|mesh-list
5653476|NCT03691662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5653477|NCT03691662|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5653478|NCT03691662|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5653479|NCT03691662|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5653480|NCT03691662|Adrenergic Agents|adrenergic agents|mesh-ancestor
5653481|NCT03691662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5653482|NCT03691662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653483|NCT03691662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653484|NCT03691662|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5653485|NCT03691662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5653486|NCT03691649|Timolol|timolol|mesh-list
5653487|NCT03691649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5653488|NCT03691649|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5653489|NCT03691649|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5653490|NCT03691649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5653491|NCT03691649|Adrenergic Agents|adrenergic agents|mesh-ancestor
5653492|NCT03691649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5653493|NCT03691649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653494|NCT03691649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653495|NCT03691649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5653496|NCT03691649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5653497|NCT03691636|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5653498|NCT03691636|Lifitegrast|lifitegrast|mesh-list
5830781|NCT02554851|Mitogens|mitogens|mesh-list
5830782|NCT02554851|Mitosis Modulators|mitosis modulators|mesh-ancestor
5830783|NCT02554851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830784|NCT02554812|Avelumab|avelumab|mesh-list
5830785|NCT02554812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5830786|NCT02554812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5830787|NCT02554734|Levodopa|levodopa|mesh-list
5830788|NCT02554734|Carbidopa|carbidopa|mesh-list
5830789|NCT02554734|Entacapone|entacapone|mesh-list
5830790|NCT02554734|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5830791|NCT02554734|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5830792|NCT02554734|Dopamine Agents|dopamine agents|mesh-ancestor
5830793|NCT02554734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5830794|NCT02554734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830795|NCT02554734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830796|NCT02554734|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5830797|NCT02554734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5830798|NCT02554734|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
5830799|NCT02554695|Denosumab|denosumab|mesh-list
5830800|NCT02554695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5830801|NCT02554695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830802|NCT02554318|Rifampin|rifampin|mesh-list
5830803|NCT02554318|Isoniazid|isoniazid|mesh-list
5830804|NCT02554318|Pyrazinamide|pyrazinamide|mesh-list
5830805|NCT02554318|Ethambutol|ethambutol|mesh-list
5830806|NCT02554318|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5830807|NCT02554318|Antitubercular Agents|antitubercular agents|mesh-ancestor
5830808|NCT02554318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5830809|NCT02554318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5830810|NCT02554318|Leprostatic Agents|leprostatic agents|mesh-ancestor
5830811|NCT02554318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5830812|NCT02554318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5830813|NCT02554318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830814|NCT02554318|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5830815|NCT02554318|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5830816|NCT02554318|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5830817|NCT02554318|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5830818|NCT02554318|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5830819|NCT02554318|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5830820|NCT02554318|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5830821|NCT02554318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5830822|NCT02554318|Antimetabolites|antimetabolites|mesh-ancestor
6211746|NCT02176382|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5653499|NCT03691636|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5653500|NCT03691493|Tamoxifen|tamoxifen|mesh-list
5830823|NCT02554318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5830824|NCT02554357|Bupivacaine|bupivacaine|mesh-list
5830825|NCT02554357|Anesthetics, Local|anesthetics, local|mesh-ancestor
5830826|NCT02554357|Anesthetics|anesthetics|mesh-ancestor
5830827|NCT02554357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5830828|NCT02554357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830829|NCT02554357|Sensory System Agents|sensory system agents|mesh-ancestor
5830830|NCT02554357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5830831|NCT02554175|Propofol|propofol|mesh-list
5830832|NCT02554175|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5830833|NCT02554175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5830834|NCT02554175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830835|NCT02554175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5830836|NCT02554175|Anesthetics, General|anesthetics, general|mesh-ancestor
5830837|NCT02554175|Anesthetics|anesthetics|mesh-ancestor
5830838|NCT02554344|Curcumin|curcumin|mesh-list
5830839|NCT02554344|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5830840|NCT02554344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5830841|NCT02554344|Analgesics|analgesics|mesh-ancestor
5830842|NCT02554344|Sensory System Agents|sensory system agents|mesh-ancestor
5830843|NCT02554344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5830844|NCT02554344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830845|NCT02554344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5830846|NCT02554344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5830847|NCT02554344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5830848|NCT02554344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5653501|NCT03691493|Letrozole|letrozole|mesh-list
5653502|NCT03691493|Fulvestrant|fulvestrant|mesh-list
5653503|NCT03691493|Palbociclib|palbociclib|mesh-list
5830849|NCT02554344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830850|NCT02554123|Vitamin E|vitamin e|mesh-list
5830851|NCT02554123|Petrolatum|petrolatum|mesh-list
5830852|NCT02554123|Vitamins|vitamins|mesh-ancestor
5830853|NCT02554123|Micronutrients|micronutrients|mesh-ancestor
5653504|NCT03691493|Anastrozole|anastrozole|mesh-list
5653505|NCT03691493|Exemestane|exemestane|mesh-list
5653506|NCT03691493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5653507|NCT03691493|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5653508|NCT03691493|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5830854|NCT02554123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830855|NCT02554123|Antioxidants|antioxidants|mesh-ancestor
5830856|NCT02554123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830857|NCT02554123|Protective Agents|protective agents|mesh-ancestor
5830858|NCT02554123|Emollients|emollients|mesh-ancestor
5830859|NCT02554123|Dermatologic Agents|dermatologic agents|mesh-ancestor
5830860|NCT02554045|Tadalafil|tadalafil|mesh-list
5830861|NCT02554045|Vasodilator Agents|vasodilator agents|mesh-ancestor
5830862|NCT02554045|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5830863|NCT02554045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5830864|NCT02554045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5830865|NCT02554045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830866|NCT02554045|Urological Agents|urological agents|mesh-ancestor
5830867|NCT02553824|Topiramate|topiramate|mesh-list
5830868|NCT02553824|Phentermine|phentermine|mesh-list
5830869|NCT02553824|Anticonvulsants|anticonvulsants|mesh-ancestor
5830870|NCT02553824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5830871|NCT02553824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830872|NCT02553824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5830873|NCT02553824|Appetite Depressants|appetite depressants|mesh-ancestor
5830874|NCT02553824|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5830875|NCT02553824|Sympathomimetics|sympathomimetics|mesh-ancestor
5830876|NCT02553824|Autonomic Agents|autonomic agents|mesh-ancestor
5830877|NCT02553824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5830878|NCT02553824|Adrenergic Agents|adrenergic agents|mesh-ancestor
5830879|NCT02553824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5830880|NCT02553824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830881|NCT02553551|Vitamins|vitamins|mesh-list
5653509|NCT03691493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5653510|NCT03691493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653511|NCT03691493|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5653512|NCT03691493|Hormone Antagonists|hormone antagonists|mesh-ancestor
5830882|NCT02553551|Ascorbic Acid|ascorbic acid|mesh-list
5830883|NCT02553551|Micronutrients|micronutrients|mesh-ancestor
5830884|NCT02553551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653513|NCT03691493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5830885|NCT02553551|Antioxidants|antioxidants|mesh-ancestor
5830886|NCT02553551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830887|NCT02553551|Protective Agents|protective agents|mesh-ancestor
5830888|NCT02553642|Nivolumab|nivolumab|mesh-list
5830889|NCT02553642|Ipilimumab|ipilimumab|mesh-list
5830890|NCT02553642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5830891|NCT02553642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5830892|NCT02553642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5830893|NCT02553642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830894|NCT02553707|Ibandronic Acid|ibandronic acid|mesh-list
5830895|NCT02553707|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5830896|NCT02553707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830897|NCT02553603|Hormones|hormones|mesh-list
5830898|NCT02553603|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
5830899|NCT02553603|Tesamorelin|tesamorelin|mesh-list
5830900|NCT02553603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5830901|NCT02553603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830902|NCT02553603|Growth Substances|growth substances|mesh-ancestor
5902503|NCT04094675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5902504|NCT04094675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5902505|NCT04094675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5902506|NCT04094675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5902507|NCT04094675|Antifungal Agents|antifungal agents|mesh-ancestor
5902508|NCT04094675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5653514|NCT03691493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653515|NCT03691493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5653516|NCT03691493|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5653517|NCT03691493|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5653518|NCT03691493|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5653519|NCT03691493|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5653520|NCT03691493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5653521|NCT03691467|Hyaluronic Acid|hyaluronic acid|mesh-list
5653522|NCT03691467|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5653523|NCT03691467|Immunologic Factors|immunologic factors|mesh-ancestor
5653524|NCT03691467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653525|NCT03691467|Viscosupplements|viscosupplements|mesh-ancestor
5653526|NCT03691467|Protective Agents|protective agents|mesh-ancestor
5653527|NCT03691454|Docetaxel|docetaxel|mesh-list
5653528|NCT03691454|Oxaliplatin|oxaliplatin|mesh-list
5653529|NCT03691454|Trastuzumab|trastuzumab|mesh-list
5902509|NCT04094675|Immunologic Factors|immunologic factors|mesh-ancestor
5902510|NCT04094675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902511|NCT04092270|Doxorubicin|doxorubicin|mesh-list
5902512|NCT04092270|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5902513|NCT04092270|Peposertib|peposertib|mesh-list
5902514|NCT04092270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5902515|NCT04092270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5902516|NCT04092270|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5902517|NCT04092270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5902518|NCT04092270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5902519|NCT04092270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902520|NCT04092270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5653530|NCT03691454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5653531|NCT03691454|Tubulin Modulators|tubulin modulators|mesh-ancestor
5653532|NCT03691454|Antimitotic Agents|antimitotic agents|mesh-ancestor
5653533|NCT03691454|Mitosis Modulators|mitosis modulators|mesh-ancestor
5653534|NCT03691454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653535|NCT03691454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5653536|NCT03691415|Deoxycholic Acid|deoxycholic acid|mesh-list
5653537|NCT03691415|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5653538|NCT03691415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6493348|NCT00613145|Capecitabine|capecitabine|mesh-list
6493349|NCT00613145|Sorafenib|sorafenib|mesh-list
6493350|NCT00613145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6493351|NCT00613145|Antimetabolites|antimetabolites|mesh-ancestor
5653539|NCT03691376|Aldesleukin|aldesleukin|mesh-list
5653540|NCT03691376|Melphalan|melphalan|mesh-list
5653541|NCT03691376|Mechlorethamine|mechlorethamine|mesh-list
5902521|NCT04076748|Sufentanil|sufentanil|mesh-list
5902522|NCT04076748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5902523|NCT04076748|Narcotics|narcotics|mesh-ancestor
5902524|NCT04076748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5902525|NCT04076748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902526|NCT04076748|Analgesics|analgesics|mesh-ancestor
5902527|NCT04076748|Sensory System Agents|sensory system agents|mesh-ancestor
6496442|NCT00628056|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5653542|NCT03691376|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
5830903|NCT02553226|Oxytocin|oxytocin|mesh-list
5830904|NCT02553226|Oxytocics|oxytocics|mesh-ancestor
5653543|NCT03691376|Interleukin-2|interleukin-2|mesh-list
5653544|NCT03691376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5653545|NCT03691376|Alkylating Agents|alkylating agents|mesh-ancestor
5653546|NCT03691376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653547|NCT03691376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5653548|NCT03691376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5653549|NCT03691376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5653550|NCT03691376|Immunologic Factors|immunologic factors|mesh-ancestor
5653551|NCT03691376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653552|NCT03691376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5653553|NCT03691376|Analgesics|analgesics|mesh-ancestor
5653554|NCT03691376|Sensory System Agents|sensory system agents|mesh-ancestor
5653555|NCT03691376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5653556|NCT03691376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5653557|NCT03691376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5653558|NCT03691376|Antiviral Agents|antiviral agents|mesh-ancestor
5653559|NCT03691376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5653560|NCT03691350|Nicotine|nicotine|mesh-list
5653561|NCT03691350|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5653562|NCT03691350|Autonomic Agents|autonomic agents|mesh-ancestor
5653563|NCT03691350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5653564|NCT03691350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653565|NCT03691350|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5653566|NCT03691350|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5653567|NCT03691350|Cholinergic Agents|cholinergic agents|mesh-ancestor
5653568|NCT03691350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5653569|NCT03691350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653570|NCT03691337|Bupivacaine|bupivacaine|mesh-list
5653571|NCT03691337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5653572|NCT03691337|Anesthetics, Local|anesthetics, local|mesh-ancestor
5653573|NCT03691337|Anesthetics|anesthetics|mesh-ancestor
5653574|NCT03691337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5653575|NCT03691337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653576|NCT03691337|Sensory System Agents|sensory system agents|mesh-ancestor
5653577|NCT03691337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5653578|NCT03691090|Paclitaxel|paclitaxel|mesh-list
5653579|NCT03691090|Cisplatin|cisplatin|mesh-list
5653580|NCT03691090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5653581|NCT03691090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5653582|NCT03691090|Tubulin Modulators|tubulin modulators|mesh-ancestor
5653583|NCT03691090|Antimitotic Agents|antimitotic agents|mesh-ancestor
5653584|NCT03691090|Mitosis Modulators|mitosis modulators|mesh-ancestor
5653585|NCT03691090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653586|NCT03691077|Ocrelizumab|ocrelizumab|mesh-list
5653587|NCT03691077|Immunologic Factors|immunologic factors|mesh-ancestor
5653588|NCT03691077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653589|NCT03691064|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
5653590|NCT03691064|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5653591|NCT03691064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653592|NCT03691038|Pregabalin|pregabalin|mesh-list
5653593|NCT03691038|Analgesics|analgesics|mesh-ancestor
5653594|NCT03691038|Sensory System Agents|sensory system agents|mesh-ancestor
5653595|NCT03691038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5653596|NCT03691038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653597|NCT03691038|Anticonvulsants|anticonvulsants|mesh-ancestor
5653598|NCT03691038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5653599|NCT03691038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5653600|NCT03691038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653601|NCT03691038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5653602|NCT03691038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5653603|NCT03691038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5653604|NCT03691038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5653605|NCT03691038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5653606|NCT03690986|Nivolumab|nivolumab|mesh-list
5653607|NCT03690986|Ipilimumab|ipilimumab|mesh-list
5653608|NCT03690986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5653609|NCT03690986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5653610|NCT03690986|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5653611|NCT03690986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653612|NCT03690947|Ranibizumab|ranibizumab|mesh-list
5653613|NCT03690947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5653614|NCT03690947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5830905|NCT02553226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5830906|NCT02553226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830907|NCT02553473|Doxycycline|doxycycline|mesh-list
5830908|NCT02553473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5830909|NCT02553473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5830910|NCT02553473|Antimalarials|antimalarials|mesh-ancestor
5830911|NCT02553473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5830912|NCT02553473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5653615|NCT03690947|Growth Substances|growth substances|mesh-ancestor
5653616|NCT03690947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653617|NCT03690947|Growth Inhibitors|growth inhibitors|mesh-ancestor
5653618|NCT03690947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5653619|NCT03690921|Cisplatin|cisplatin|mesh-list
5653620|NCT03690921|Fluorouracil|fluorouracil|mesh-list
5653621|NCT03690921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5653622|NCT03690921|Antimetabolites|antimetabolites|mesh-ancestor
5653623|NCT03690921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653624|NCT03690921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5653625|NCT03690921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5653626|NCT03690921|Immunologic Factors|immunologic factors|mesh-ancestor
5653627|NCT03690921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653628|NCT03690778|Metformin|metformin|mesh-list
5653629|NCT03690778|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5653630|NCT03690778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5653631|NCT03690778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830924|NCT02553083|Amoxicillin|amoxicillin|mesh-list
5830925|NCT02553083|Doxycycline|doxycycline|mesh-list
5830926|NCT02553083|Esomeprazole|esomeprazole|mesh-list
5830927|NCT02553083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5830928|NCT02553083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5830929|NCT02553083|Antimalarials|antimalarials|mesh-ancestor
5830930|NCT02553083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5830931|NCT02553083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5830932|NCT02553083|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5830933|NCT02553083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5830934|NCT02553083|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5830935|NCT02553083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5830936|NCT02553083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830937|NCT02553018|Methotrexate|methotrexate|mesh-list
5830938|NCT02553018|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5830939|NCT02553018|Abortifacient Agents|abortifacient agents|mesh-ancestor
5830940|NCT02553018|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5830941|NCT02553018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830942|NCT02553018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5830943|NCT02553018|Antimetabolites|antimetabolites|mesh-ancestor
5830944|NCT02553018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830945|NCT02553018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5830946|NCT02553018|Dermatologic Agents|dermatologic agents|mesh-ancestor
5830947|NCT02553018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5830948|NCT02553018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5830949|NCT02553018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5830950|NCT02553018|Immunologic Factors|immunologic factors|mesh-ancestor
5830951|NCT02553018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5830952|NCT02553018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5830953|NCT02552745|Parecoxib|parecoxib|mesh-list
5830954|NCT02552745|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5830955|NCT02552745|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5830956|NCT02552745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5830957|NCT02552745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830958|NCT02552745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5830959|NCT02552745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5830960|NCT02552745|Analgesics|analgesics|mesh-ancestor
5830961|NCT02552745|Sensory System Agents|sensory system agents|mesh-ancestor
5830962|NCT02552745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5908380|NCT04600336|Autonomic Agents|autonomic agents|mesh-ancestor
5653632|NCT03690778|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5653633|NCT03690778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5653634|NCT03690778|Antimetabolites|antimetabolites|mesh-ancestor
5653635|NCT03690778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653636|NCT03690778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5653637|NCT03690778|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5653638|NCT03690778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5653639|NCT03690739|Gemcitabine|gemcitabine|mesh-list
5653640|NCT03690739|Paclitaxel|paclitaxel|mesh-list
5653641|NCT03690739|Bevacizumab|bevacizumab|mesh-list
5653642|NCT03690739|Carboplatin|carboplatin|mesh-list
5653643|NCT03690739|Trabectedin|trabectedin|mesh-list
5653644|NCT03690739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5653645|NCT03690739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5653646|NCT03690739|Tubulin Modulators|tubulin modulators|mesh-ancestor
5653647|NCT03690739|Antimitotic Agents|antimitotic agents|mesh-ancestor
5653648|NCT03690739|Mitosis Modulators|mitosis modulators|mesh-ancestor
5830963|NCT02552745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830964|NCT02552745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5830965|NCT02552745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5830966|NCT02553044|Vitamin D|vitamin d|mesh-list
5830967|NCT02553044|Cholecalciferol|cholecalciferol|mesh-list
5653649|NCT03690739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653650|NCT03690739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5653651|NCT03690739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5830968|NCT02553044|Vitamins|vitamins|mesh-ancestor
5830969|NCT02553044|Micronutrients|micronutrients|mesh-ancestor
5830970|NCT02553044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830971|NCT02553044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5830972|NCT02553044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5830973|NCT02552654|Hydrocortisone|hydrocortisone|mesh-list
5830974|NCT02552654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5830975|NCT02552641|Amoxicillin|amoxicillin|mesh-list
5830976|NCT02552641|Clarithromycin|clarithromycin|mesh-list
5830977|NCT02552641|Esomeprazole|esomeprazole|mesh-list
5830978|NCT02552641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5830979|NCT02552641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5830980|NCT02552641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5653652|NCT03690739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5653653|NCT03690739|Growth Substances|growth substances|mesh-ancestor
5653654|NCT03690739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653655|NCT03690739|Growth Inhibitors|growth inhibitors|mesh-ancestor
5653656|NCT03690739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5653657|NCT03690739|Antimetabolites|antimetabolites|mesh-ancestor
5653658|NCT03690739|Antiviral Agents|antiviral agents|mesh-ancestor
5653659|NCT03690739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5653660|NCT03690739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5653661|NCT03690739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5653662|NCT03690739|Immunologic Factors|immunologic factors|mesh-ancestor
5653663|NCT03690739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5653664|NCT03690739|Alkylating Agents|alkylating agents|mesh-ancestor
5653665|NCT03690622|Dexmedetomidine|dexmedetomidine|mesh-list
5653666|NCT03690622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5653667|NCT03690622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5653668|NCT03690622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653669|NCT03690622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5830981|NCT02552641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5830982|NCT02552641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5830983|NCT02552641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5830984|NCT02552641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5830985|NCT02552641|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5830986|NCT02552641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5830987|NCT02552641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5830988|NCT02552459|Sufentanil|sufentanil|mesh-list
5830989|NCT02552459|Dexmedetomidine|dexmedetomidine|mesh-list
5830990|NCT02552459|Dsuvia|dsuvia|mesh-list
5830991|NCT02552459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5830992|NCT02552459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5830993|NCT02552459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5830994|NCT02552459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5830995|NCT02552459|Analgesics|analgesics|mesh-ancestor
5653670|NCT03690622|Analgesics|analgesics|mesh-ancestor
5653671|NCT03690622|Sensory System Agents|sensory system agents|mesh-ancestor
5653672|NCT03690622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5830996|NCT02552459|Sensory System Agents|sensory system agents|mesh-ancestor
5830997|NCT02552459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5830998|NCT02552459|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5830999|NCT02552459|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5831000|NCT02552459|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5831001|NCT02552459|Adrenergic Agents|adrenergic agents|mesh-ancestor
5831002|NCT02552459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5831003|NCT02552459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831004|NCT02552459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5831005|NCT02552459|Narcotics|narcotics|mesh-ancestor
5831006|NCT02552459|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5831007|NCT02552459|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5831008|NCT02552459|Anesthetics, General|anesthetics, general|mesh-ancestor
5831009|NCT02552459|Anesthetics|anesthetics|mesh-ancestor
5831010|NCT02552342|Methylprednisolone|methylprednisolone|mesh-list
5831011|NCT02552342|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5831012|NCT02552342|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5831013|NCT02552342|Prednisolone|prednisolone|mesh-list
5831014|NCT02552342|Prednisolone acetate|prednisolone acetate|mesh-list
5831015|NCT02552342|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5831016|NCT02552342|Prednisolone phosphate|prednisolone phosphate|mesh-list
5831017|NCT02552342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5831018|NCT02552342|Antiemetics|antiemetics|mesh-ancestor
5831019|NCT02552342|Autonomic Agents|autonomic agents|mesh-ancestor
5831020|NCT02552342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5831021|NCT02552342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831022|NCT02552342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5831023|NCT02552342|Glucocorticoids|glucocorticoids|mesh-ancestor
5831024|NCT02552342|Hormones|hormones|mesh-ancestor
5831025|NCT02552342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5831026|NCT02552342|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5831027|NCT02552342|Protective Agents|protective agents|mesh-ancestor
5831028|NCT02552342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5831029|NCT02552342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5831030|NCT02552537|Mannitol|mannitol|mesh-list
5831031|NCT02552537|Omeprazole|omeprazole|mesh-list
5831032|NCT02552537|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5831033|NCT02552537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5831034|NCT02552537|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5831035|NCT02552537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5831036|NCT02552537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831037|NCT02552537|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5831038|NCT02552537|Diuretics|diuretics|mesh-ancestor
5831039|NCT02552537|Natriuretic Agents|natriuretic agents|mesh-ancestor
5831040|NCT02552537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831041|NCT02552589|Fluorides|fluorides|mesh-list
5831042|NCT02552589|Fluorophosphate|fluorophosphate|mesh-list
5831043|NCT02552589|Cariostatic Agents|cariostatic agents|mesh-ancestor
5831044|NCT02552589|Protective Agents|protective agents|mesh-ancestor
5831045|NCT02552589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831046|NCT02551861|Ribavirin|ribavirin|mesh-list
5831047|NCT02551861|Sofosbuvir|sofosbuvir|mesh-list
5831048|NCT02551861|Antimetabolites|antimetabolites|mesh-ancestor
5653673|NCT03690622|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5653674|NCT03690622|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5653675|NCT03690622|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5653676|NCT03690622|Adrenergic Agents|adrenergic agents|mesh-ancestor
5653677|NCT03690622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5653678|NCT03690622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653679|NCT03690583|Zinc|zinc|mesh-list
5653680|NCT03690583|Zinc Sulfate|zinc sulfate|mesh-list
5653681|NCT03690583|Trace Elements|trace elements|mesh-ancestor
5653682|NCT03690583|Micronutrients|micronutrients|mesh-ancestor
5653683|NCT03690583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653684|NCT03690583|Astringents|astringents|mesh-ancestor
5653685|NCT03690583|Dermatologic Agents|dermatologic agents|mesh-ancestor
5653686|NCT03690544|Apremilast|apremilast|mesh-list
5653687|NCT03690544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5653688|NCT03690544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5653689|NCT03690544|Analgesics|analgesics|mesh-ancestor
5653690|NCT03690544|Sensory System Agents|sensory system agents|mesh-ancestor
5653691|NCT03690544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5653692|NCT03690544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653693|NCT03690544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5653694|NCT03690544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5653695|NCT03690544|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5653696|NCT03690544|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5831049|NCT02551861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831050|NCT02551861|Antiviral Agents|antiviral agents|mesh-ancestor
5831051|NCT02551861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5831052|NCT02551848|Botulinum Toxins|botulinum toxins|mesh-list
5831053|NCT02551848|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5831054|NCT02551848|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5831055|NCT02551848|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
5831056|NCT02551848|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5653697|NCT03690544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5653698|NCT03690544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694722|NCT03393988|Dexmedetomidine|dexmedetomidine|mesh-list
5694723|NCT03393988|Sympathomimetics|sympathomimetics|mesh-list
5694724|NCT03393988|Anesthetics|anesthetics|mesh-ancestor
5694725|NCT03393988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5694726|NCT03393988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694727|NCT03393988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5694728|NCT03393988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5694729|NCT03393988|Analgesics|analgesics|mesh-ancestor
5694730|NCT03393988|Sensory System Agents|sensory system agents|mesh-ancestor
5694731|NCT03393988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5694732|NCT03393988|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5694733|NCT03393988|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5694734|NCT03393988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5694735|NCT03393988|Adrenergic Agents|adrenergic agents|mesh-ancestor
5694736|NCT03393988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5694737|NCT03393988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694738|NCT03393988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5694739|NCT03393988|Narcotics|narcotics|mesh-ancestor
5831057|NCT02551848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5831058|NCT02551848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831059|NCT02551848|Cholinergic Agents|cholinergic agents|mesh-ancestor
5831060|NCT02551848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5694740|NCT03393988|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5694741|NCT03393988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5694742|NCT03393988|Anesthetics, General|anesthetics, general|mesh-ancestor
5694743|NCT03393988|Autonomic Agents|autonomic agents|mesh-ancestor
5694744|NCT03393949|Methylprednisolone|methylprednisolone|mesh-list
5694745|NCT03393949|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5694746|NCT03393949|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5694747|NCT03393949|Prednisolone|prednisolone|mesh-list
5694748|NCT03393949|Prednisolone acetate|prednisolone acetate|mesh-list
5694749|NCT03393949|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5694750|NCT03393949|Prednisolone phosphate|prednisolone phosphate|mesh-list
5694751|NCT03393949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5694752|NCT03393949|Antiemetics|antiemetics|mesh-ancestor
5694753|NCT03393949|Autonomic Agents|autonomic agents|mesh-ancestor
5694754|NCT03393949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5694755|NCT03393949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694756|NCT03393949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5694757|NCT03393949|Glucocorticoids|glucocorticoids|mesh-ancestor
5694758|NCT03393949|Hormones|hormones|mesh-ancestor
5694759|NCT03393949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5694760|NCT03393949|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5694761|NCT03393949|Protective Agents|protective agents|mesh-ancestor
5694762|NCT03393949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5694763|NCT03393949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5694764|NCT03393884|Paclitaxel|paclitaxel|mesh-list
5694765|NCT03393884|Carboplatin|carboplatin|mesh-list
5694766|NCT03393884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5694767|NCT03393884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5694768|NCT03393884|Tubulin Modulators|tubulin modulators|mesh-ancestor
5694769|NCT03393884|Antimitotic Agents|antimitotic agents|mesh-ancestor
5694770|NCT03393884|Mitosis Modulators|mitosis modulators|mesh-ancestor
5694771|NCT03393884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694772|NCT03393858|Antibodies|antibodies|mesh-list
5694773|NCT03393858|Immunologic Factors|immunologic factors|mesh-ancestor
5694774|NCT03393858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694775|NCT03393819|Ethanol|ethanol|mesh-list
5694776|NCT03393819|Chlorhexidine|chlorhexidine|mesh-list
5694777|NCT03393819|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5694778|NCT03393819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5694779|NCT03393819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5694780|NCT03393819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694781|NCT03393819|Disinfectants|disinfectants|mesh-ancestor
5694782|NCT03393780|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5694783|NCT03393780|Hormones|hormones|mesh-ancestor
5694784|NCT03393780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5653699|NCT03690414|Atropine|atropine|mesh-list
5653700|NCT03690414|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5653701|NCT03690414|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5653702|NCT03690414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5653703|NCT03690414|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5653704|NCT03690414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5653705|NCT03690414|Autonomic Agents|autonomic agents|mesh-ancestor
5653706|NCT03690414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5653707|NCT03690414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653708|NCT03690414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5653709|NCT03690414|Respiratory System Agents|respiratory system agents|mesh-ancestor
5831061|NCT02551848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831062|NCT02551848|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5831063|NCT02551848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5902528|NCT04076748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5902529|NCT04076748|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5902530|NCT04076748|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5902531|NCT04076748|Anesthetics, General|anesthetics, general|mesh-ancestor
5902532|NCT04076748|Anesthetics|anesthetics|mesh-ancestor
5902533|NCT04075981|Botulinum Toxins|botulinum toxins|mesh-list
5902534|NCT04075981|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5902535|NCT04075981|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5902536|NCT04075981|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
5902537|NCT04075981|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5902538|NCT04075981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5902539|NCT04075981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902540|NCT04075981|Cholinergic Agents|cholinergic agents|mesh-ancestor
5902541|NCT04075981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5902542|NCT04075981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902543|NCT04075981|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5902544|NCT04075981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5902545|NCT04047862|Paclitaxel|paclitaxel|mesh-list
5902546|NCT04047862|Etoposide|etoposide|mesh-list
5902547|NCT04047862|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5902548|NCT04047862|Carboplatin|carboplatin|mesh-list
5902549|NCT04047862|Fluorouracil|fluorouracil|mesh-list
5902550|NCT04047862|Capecitabine|capecitabine|mesh-list
5902551|NCT04047862|Oxaliplatin|oxaliplatin|mesh-list
5902552|NCT04047862|Pemetrexed|pemetrexed|mesh-list
5902553|NCT04047862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5902554|NCT04047862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5902555|NCT04047862|Tubulin Modulators|tubulin modulators|mesh-ancestor
5902556|NCT04047862|Antimitotic Agents|antimitotic agents|mesh-ancestor
5902557|NCT04047862|Mitosis Modulators|mitosis modulators|mesh-ancestor
5902558|NCT04047862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902559|NCT04047862|Antimetabolites|antimetabolites|mesh-ancestor
5902560|NCT04047862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5902561|NCT04047862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5902562|NCT04047862|Immunologic Factors|immunologic factors|mesh-ancestor
5902563|NCT04047862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902564|NCT04047862|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5902565|NCT04047862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5902566|NCT04047862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5653710|NCT03690414|Mydriatics|mydriatics|mesh-ancestor
5653711|NCT03690414|Parasympatholytics|parasympatholytics|mesh-ancestor
5653712|NCT03690414|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5653713|NCT03690414|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5653714|NCT03690414|Cholinergic Agents|cholinergic agents|mesh-ancestor
5653715|NCT03690414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5653716|NCT03690414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653717|NCT03690323|Gemcitabine|gemcitabine|mesh-list
5653718|NCT03690323|Paclitaxel|paclitaxel|mesh-list
5653719|NCT03690323|Folfirinox|folfirinox|mesh-list
5653720|NCT03690323|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5653721|NCT03690323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5653722|NCT03690323|Tubulin Modulators|tubulin modulators|mesh-ancestor
5653723|NCT03690323|Antimitotic Agents|antimitotic agents|mesh-ancestor
5653724|NCT03690323|Mitosis Modulators|mitosis modulators|mesh-ancestor
5653725|NCT03690323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653726|NCT03690323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5653727|NCT03690323|Antimetabolites|antimetabolites|mesh-ancestor
5653728|NCT03690323|Antiviral Agents|antiviral agents|mesh-ancestor
5653729|NCT03690323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5653730|NCT03690323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5653731|NCT03690323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5902567|NCT04047862|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6675604|NCT01576640|Bupropion|bupropion|mesh-list
5653732|NCT03690323|Immunologic Factors|immunologic factors|mesh-ancestor
5653733|NCT03690323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653734|NCT03690167|Mitogens|mitogens|mesh-list
5653735|NCT03690167|Mitosis Modulators|mitosis modulators|mesh-ancestor
5653736|NCT03690167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653737|NCT03690115|Ponatinib|ponatinib|mesh-list
5653738|NCT03690115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5653739|NCT03690115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5653740|NCT03690115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5653741|NCT03690115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653742|NCT03690089|Atropine|atropine|mesh-list
5653743|NCT03690089|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5653744|NCT03690089|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5653745|NCT03690089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5653746|NCT03690089|Autonomic Agents|autonomic agents|mesh-ancestor
5653747|NCT03690089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5653748|NCT03690089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653749|NCT03690089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5653750|NCT03690089|Respiratory System Agents|respiratory system agents|mesh-ancestor
5653751|NCT03690089|Mydriatics|mydriatics|mesh-ancestor
5831064|NCT02551549|Rezafungin|rezafungin|mesh-list
5831065|NCT02551549|Antifungal Agents|antifungal agents|mesh-ancestor
5831066|NCT02551549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5831067|NCT02551523|Dolutegravir|dolutegravir|mesh-list
5831068|NCT02551523|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
5831069|NCT02551523|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5831070|NCT02551523|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5831071|NCT02551523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5831072|NCT02551523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831073|NCT02551523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5831074|NCT02551523|Antiviral Agents|antiviral agents|mesh-ancestor
5831075|NCT02551523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5831076|NCT02551536|Fexofenadine|fexofenadine|mesh-list
5831077|NCT02551536|Montelukast|montelukast|mesh-list
5831078|NCT02551536|Levocetirizine|levocetirizine|mesh-list
5831079|NCT02551536|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5831080|NCT02551536|Respiratory System Agents|respiratory system agents|mesh-ancestor
5831081|NCT02551536|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5831082|NCT02551536|Hormone Antagonists|hormone antagonists|mesh-ancestor
5831083|NCT02551536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5831084|NCT02551536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831085|NCT02551536|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5831086|NCT02551536|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5831087|NCT02551536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831088|NCT02551536|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5831089|NCT02551536|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5831090|NCT02551536|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5831091|NCT02551536|Histamine Antagonists|histamine antagonists|mesh-ancestor
5653752|NCT03690089|Parasympatholytics|parasympatholytics|mesh-ancestor
5653753|NCT03690089|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5653754|NCT03690089|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5653755|NCT03690089|Cholinergic Agents|cholinergic agents|mesh-ancestor
5653756|NCT03690089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5653757|NCT03690089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653758|NCT03690037|Tranexamic Acid|tranexamic acid|mesh-list
5831092|NCT02551536|Histamine Agents|histamine agents|mesh-ancestor
5831093|NCT02551536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5831094|NCT02551796|Levofloxacin|levofloxacin|mesh-list
5831095|NCT02551796|Ofloxacin|ofloxacin|mesh-list
5831096|NCT02551796|Tobramycin|tobramycin|mesh-list
5653759|NCT03690037|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5653760|NCT03690037|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5653761|NCT03690037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653762|NCT03690037|Hemostatics|hemostatics|mesh-ancestor
5653763|NCT03690037|Coagulants|coagulants|mesh-ancestor
5653764|NCT03689998|Melatonin|melatonin|mesh-list
5653765|NCT03689998|Antioxidants|antioxidants|mesh-ancestor
5831097|NCT02551796|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
5831098|NCT02551796|Dexamethasone|dexamethasone|mesh-list
5831099|NCT02551796|Dexamethasone acetate|dexamethasone acetate|mesh-list
5831100|NCT02551796|BB 1101|bb 1101|mesh-list
5831101|NCT02551796|Hyaluronic Acid|hyaluronic acid|mesh-list
5831102|NCT02551796|Dipivefrin|dipivefrin|mesh-list
5831103|NCT02551796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6211747|NCT02176382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831104|NCT02551796|Antiemetics|antiemetics|mesh-ancestor
5831105|NCT02551796|Autonomic Agents|autonomic agents|mesh-ancestor
5653766|NCT03689998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653767|NCT03689998|Protective Agents|protective agents|mesh-ancestor
5653768|NCT03689998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653769|NCT03689998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5653770|NCT03689972|Natalizumab|natalizumab|mesh-list
5653771|NCT03689972|Immunologic Factors|immunologic factors|mesh-ancestor
5653772|NCT03689972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653773|NCT03689946|Listerine|listerine|mesh-list
5653774|NCT03689946|Evolocumab|evolocumab|mesh-list
5653775|NCT03689946|Fluorides|fluorides|mesh-list
5653776|NCT03689946|Sodium Fluoride|sodium fluoride|mesh-list
5653777|NCT03689946|Cariostatic Agents|cariostatic agents|mesh-ancestor
5653778|NCT03689946|Protective Agents|protective agents|mesh-ancestor
5653779|NCT03689946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653780|NCT03689946|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5653781|NCT03689946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5653782|NCT03689946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5653783|NCT03689946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5653784|NCT03689946|Antimetabolites|antimetabolites|mesh-ancestor
5831106|NCT02551796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5831107|NCT02551796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831108|NCT02551796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5831109|NCT02551796|Glucocorticoids|glucocorticoids|mesh-ancestor
5831110|NCT02551796|Hormones|hormones|mesh-ancestor
5831111|NCT02551796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5831112|NCT02551796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5831113|NCT02551796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5831114|NCT02551796|Protease Inhibitors|protease inhibitors|mesh-ancestor
5831115|NCT02551796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5831116|NCT02551796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831117|NCT02551796|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5831118|NCT02551796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5831119|NCT02551796|Renal Agents|renal agents|mesh-ancestor
5831120|NCT02551796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5831121|NCT02551796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5831122|NCT02551796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5831123|NCT02551796|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5831124|NCT02551796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5831125|NCT02551796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5831126|NCT02551796|Immunologic Factors|immunologic factors|mesh-ancestor
5831127|NCT02551796|Viscosupplements|viscosupplements|mesh-ancestor
5831128|NCT02551796|Protective Agents|protective agents|mesh-ancestor
5831129|NCT02551796|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5831130|NCT02551796|Adrenergic Agents|adrenergic agents|mesh-ancestor
5831131|NCT02551796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5831132|NCT02551796|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5831133|NCT02551796|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5831134|NCT02551276|Albuterol|albuterol|mesh-list
5831135|NCT02551276|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5831136|NCT02551276|Autonomic Agents|autonomic agents|mesh-ancestor
5831137|NCT02551276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5831138|NCT02551276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831139|NCT02551276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5831140|NCT02551276|Respiratory System Agents|respiratory system agents|mesh-ancestor
5831141|NCT02551276|Tocolytic Agents|tocolytic agents|mesh-ancestor
5831142|NCT02551276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5831143|NCT02551276|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5831144|NCT02551276|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5653785|NCT03689946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653786|NCT03689946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5653787|NCT03689894|Rituximab|rituximab|mesh-list
5653788|NCT03689894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5653789|NCT03689894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5653790|NCT03689894|Immunologic Factors|immunologic factors|mesh-ancestor
5653791|NCT03689894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653792|NCT03689894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5653793|NCT03689699|Nivolumab|nivolumab|mesh-list
5653794|NCT03689699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5653795|NCT03689699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5653796|NCT03689699|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5653797|NCT03689699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653798|NCT03689465|Cyclosporine|cyclosporine|mesh-list
5653799|NCT03689465|Mycophenolic Acid|mycophenolic acid|mesh-list
5653800|NCT03689465|Methotrexate|methotrexate|mesh-list
5653801|NCT03689465|Cyclosporins|cyclosporins|mesh-list
5831145|NCT02551276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5831146|NCT02551276|Adrenergic Agents|adrenergic agents|mesh-ancestor
5831147|NCT02551276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5831148|NCT02551276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653802|NCT03689465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5653803|NCT03689465|Abortifacient Agents|abortifacient agents|mesh-ancestor
5653804|NCT03689465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5653805|NCT03689465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653806|NCT03689465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5653807|NCT03689465|Antimetabolites|antimetabolites|mesh-ancestor
5653808|NCT03689465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653809|NCT03689465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5831149|NCT02551237|Capecitabine|capecitabine|mesh-list
5831150|NCT02551237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5831151|NCT02551237|Antimetabolites|antimetabolites|mesh-ancestor
5831152|NCT02551237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831153|NCT02551237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5831154|NCT02551367|Letrozole|letrozole|mesh-list
5831155|NCT02551367|Clomiphene|clomiphene|mesh-list
5831156|NCT02551367|Enclomiphene|enclomiphene|mesh-list
5831157|NCT02551367|Zuclomiphene|zuclomiphene|mesh-list
5831158|NCT02551367|Hormones|hormones|mesh-list
5831159|NCT02551367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831160|NCT02551367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5831161|NCT02551367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831162|NCT02551367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5831163|NCT02551367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5831164|NCT02551367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5831165|NCT02551367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5831166|NCT02551367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5831167|NCT02551367|Hormone Antagonists|hormone antagonists|mesh-ancestor
5831168|NCT02551367|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5831169|NCT02551367|Fertility Agents|fertility agents|mesh-ancestor
5831170|NCT02551367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5653810|NCT03689465|Dermatologic Agents|dermatologic agents|mesh-ancestor
5653811|NCT03689465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5653812|NCT03689465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5653813|NCT03689465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5653814|NCT03689465|Immunologic Factors|immunologic factors|mesh-ancestor
5653815|NCT03689465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5653816|NCT03689465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5653817|NCT03689465|Antifungal Agents|antifungal agents|mesh-ancestor
5653818|NCT03689465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5653819|NCT03689465|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5831171|NCT02551367|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5831172|NCT02551367|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5831173|NCT02551042|Factor VIII|factor viii|mesh-list
5831174|NCT02551042|Coagulants|coagulants|mesh-ancestor
5831175|NCT02551029|Capsaicin|capsaicin|mesh-list
5831176|NCT02551029|Antipruritics|antipruritics|mesh-ancestor
5831177|NCT02551029|Dermatologic Agents|dermatologic agents|mesh-ancestor
5831178|NCT02551029|Sensory System Agents|sensory system agents|mesh-ancestor
5831179|NCT02551029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5831180|NCT02551029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831181|NCT02550977|Gestodene|gestodene|mesh-list
5831182|NCT02550977|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5831183|NCT02550977|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5831184|NCT02550977|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5831185|NCT02550977|Contraceptive Agents|contraceptive agents|mesh-ancestor
5831186|NCT02550977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5831187|NCT02550977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831188|NCT02550977|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5831189|NCT02550977|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5831190|NCT02550977|Progestins|progestins|mesh-ancestor
5831191|NCT02550977|Hormones|hormones|mesh-ancestor
5831192|NCT02550977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5831193|NCT02551107|Nitric Oxide|nitric oxide|mesh-list
5831194|NCT02551107|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5831195|NCT02551107|Autonomic Agents|autonomic agents|mesh-ancestor
5831196|NCT02551107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5831197|NCT02551107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831198|NCT02551107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5831199|NCT02551107|Respiratory System Agents|respiratory system agents|mesh-ancestor
5831200|NCT02551107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5653820|NCT03689465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5653821|NCT03689465|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5653822|NCT03689465|Antitubercular Agents|antitubercular agents|mesh-ancestor
5653823|NCT03689465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5653824|NCT03689114|Topiramate|topiramate|mesh-list
5653825|NCT03689114|Lamotrigine|lamotrigine|mesh-list
5653826|NCT03689114|Zonisamide|zonisamide|mesh-list
5653827|NCT03689114|Carbamazepine|carbamazepine|mesh-list
5653828|NCT03689114|Oxcarbazepine|oxcarbazepine|mesh-list
5653829|NCT03689114|Gabapentin|gabapentin|mesh-list
5653830|NCT03689114|Levetiracetam|levetiracetam|mesh-list
5831201|NCT02551107|Antioxidants|antioxidants|mesh-ancestor
5831202|NCT02551107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831203|NCT02551107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5831204|NCT02551107|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5831205|NCT02551107|Vasodilator Agents|vasodilator agents|mesh-ancestor
5831206|NCT02551107|Gasotransmitters|gasotransmitters|mesh-ancestor
5831207|NCT02551107|Protective Agents|protective agents|mesh-ancestor
5831208|NCT02551133|Dexamethasone|dexamethasone|mesh-list
5831209|NCT02551133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5831210|NCT02551133|Antiemetics|antiemetics|mesh-ancestor
5831211|NCT02551133|Autonomic Agents|autonomic agents|mesh-ancestor
5831212|NCT02551133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5831213|NCT02551133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831214|NCT02551133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5831215|NCT02551133|Glucocorticoids|glucocorticoids|mesh-ancestor
5831216|NCT02551133|Hormones|hormones|mesh-ancestor
5831217|NCT02551133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5831218|NCT02551133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5831219|NCT02551133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5831220|NCT02550912|Vitamin D|vitamin d|mesh-list
5831221|NCT02550912|Ergocalciferols|ergocalciferols|mesh-list
5831222|NCT02550912|Cholecalciferol|cholecalciferol|mesh-list
5831223|NCT02550912|Vitamins|vitamins|mesh-list
5831224|NCT02550912|Micronutrients|micronutrients|mesh-ancestor
5831225|NCT02550912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831226|NCT02550912|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5831227|NCT02550912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5831228|NCT02550782|Dexmedetomidine|dexmedetomidine|mesh-list
5831229|NCT02550782|Bupivacaine|bupivacaine|mesh-list
5831230|NCT02550782|Anesthetics, Local|anesthetics, local|mesh-ancestor
5831231|NCT02550782|Anesthetics|anesthetics|mesh-ancestor
5831232|NCT02550782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5831233|NCT02550782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831234|NCT02550782|Sensory System Agents|sensory system agents|mesh-ancestor
5831235|NCT02550782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5831236|NCT02550782|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5831237|NCT02550782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5653831|NCT03689114|Anticonvulsants|anticonvulsants|mesh-list
5653832|NCT03689114|Valproic Acid|valproic acid|mesh-list
5653833|NCT03689114|Analgesics|analgesics|mesh-ancestor
5653834|NCT03689114|Sensory System Agents|sensory system agents|mesh-ancestor
5653835|NCT03689114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5653836|NCT03689114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653837|NCT03689114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5653838|NCT03689114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5653839|NCT03689114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5653840|NCT03689114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5653841|NCT03689114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5653842|NCT03689114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5653843|NCT03689114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5653844|NCT03689114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653845|NCT03689114|Antimanic Agents|antimanic agents|mesh-ancestor
5653846|NCT03689114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5831238|NCT02550782|Analgesics|analgesics|mesh-ancestor
5831239|NCT02550782|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5831240|NCT02550782|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5831241|NCT02550782|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5831242|NCT02550782|Adrenergic Agents|adrenergic agents|mesh-ancestor
5831243|NCT02550782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5831244|NCT02550782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831245|NCT02550756|Capsaicin|capsaicin|mesh-list
5831246|NCT02550756|Antipruritics|antipruritics|mesh-ancestor
5831247|NCT02550756|Dermatologic Agents|dermatologic agents|mesh-ancestor
5831248|NCT02550756|Sensory System Agents|sensory system agents|mesh-ancestor
5831249|NCT02550756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5831250|NCT02550756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653847|NCT03689114|Nootropic Agents|nootropic agents|mesh-ancestor
5831251|NCT02550665|Donepezil|donepezil|mesh-list
5831252|NCT02550665|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5831253|NCT02550665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5831254|NCT02550665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831255|NCT02550665|Cholinergic Agents|cholinergic agents|mesh-ancestor
5831256|NCT02550665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5831257|NCT02550665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831258|NCT02550665|Nootropic Agents|nootropic agents|mesh-ancestor
5831259|NCT02550483|Beta Carotene|beta carotene|mesh-list
5831260|NCT02550483|Lycopene|lycopene|mesh-list
5831261|NCT02550483|Carotenoids|carotenoids|mesh-list
5831262|NCT02550483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5831263|NCT02550483|Antioxidants|antioxidants|mesh-ancestor
5831264|NCT02550483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831265|NCT02550483|Protective Agents|protective agents|mesh-ancestor
5831266|NCT02550483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831267|NCT02550483|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5831268|NCT02550483|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5831269|NCT02550483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5831270|NCT02550483|Provitamins|provitamins|mesh-ancestor
5831271|NCT02550483|Vitamins|vitamins|mesh-ancestor
5831272|NCT02550483|Micronutrients|micronutrients|mesh-ancestor
5831273|NCT02550470|Sevoflurane|sevoflurane|mesh-list
5831274|NCT02550470|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5831275|NCT02550470|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5831276|NCT02550470|Anesthetics, General|anesthetics, general|mesh-ancestor
5831277|NCT02550470|Anesthetics|anesthetics|mesh-ancestor
5831278|NCT02550470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5831279|NCT02550470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831280|NCT02550717|Aspirin|aspirin|mesh-list
5831281|NCT02550717|Anticoagulants|anticoagulants|mesh-list
5831282|NCT02550717|Clopidogrel|clopidogrel|mesh-list
5831283|NCT02550717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5831284|NCT02550717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5831285|NCT02550717|Analgesics|analgesics|mesh-ancestor
5831286|NCT02550717|Sensory System Agents|sensory system agents|mesh-ancestor
5831287|NCT02550717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5831288|NCT02550717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831289|NCT02550717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5831290|NCT02550717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5831291|NCT02550717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5831292|NCT02550717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5831293|NCT02550717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831294|NCT02550717|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5831295|NCT02550717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5831296|NCT02550717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5831297|NCT02550717|Antipyretics|antipyretics|mesh-ancestor
5831298|NCT02550717|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5831299|NCT02550717|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5831300|NCT02550717|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5831301|NCT02550717|Purinergic Agents|purinergic agents|mesh-ancestor
5653848|NCT03689114|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5653849|NCT03689114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5653850|NCT03689114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5653851|NCT03689114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5653852|NCT03689114|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5653853|NCT03689114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5653854|NCT03689114|GABA Agents|gaba agents|mesh-ancestor
5653855|NCT03689114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5653856|NCT03689114|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5653857|NCT03689114|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5653858|NCT03689114|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5653859|NCT03689075|Tacrolimus|tacrolimus|mesh-list
5653860|NCT03689075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5653861|NCT03689075|Immunologic Factors|immunologic factors|mesh-ancestor
5653862|NCT03689075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653863|NCT03689075|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5653864|NCT03689075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5653865|NCT03689075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653866|NCT03689010|Azelaic acid|azelaic acid|mesh-list
5653867|NCT03689010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5653868|NCT03689010|Dermatologic Agents|dermatologic agents|mesh-ancestor
5653869|NCT03688971|Ketoconazole|ketoconazole|mesh-list
5653870|NCT03688971|Antifungal Agents|antifungal agents|mesh-ancestor
5653871|NCT03688971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5653872|NCT03688971|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5653873|NCT03688971|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5653874|NCT03688971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5653875|NCT03688971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653876|NCT03688971|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5653877|NCT03688971|Hormone Antagonists|hormone antagonists|mesh-ancestor
5653878|NCT03688971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5653879|NCT03688971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653880|NCT03688971|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5653881|NCT03688958|Iodine|iodine|mesh-list
5653882|NCT03688958|Cadexomer iodine|cadexomer iodine|mesh-list
5653883|NCT03688958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5653884|NCT03688958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5653885|NCT03688958|Trace Elements|trace elements|mesh-ancestor
5653886|NCT03688958|Micronutrients|micronutrients|mesh-ancestor
5653887|NCT03688958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694785|NCT03393780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694786|NCT03393767|Ranibizumab|ranibizumab|mesh-list
5694787|NCT03393767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5694788|NCT03393767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5694789|NCT03393767|Growth Substances|growth substances|mesh-ancestor
5694790|NCT03393767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694791|NCT03393767|Growth Inhibitors|growth inhibitors|mesh-ancestor
5694792|NCT03393767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5694793|NCT03393728|Propranolol|propranolol|mesh-list
5694794|NCT03393728|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5694795|NCT03393728|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5694796|NCT03393728|Adrenergic Agents|adrenergic agents|mesh-ancestor
5694797|NCT03393728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5831302|NCT02550717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5831303|NCT02550444|Clonidine|clonidine|mesh-list
5831304|NCT02550444|Analgesics|analgesics|mesh-ancestor
5831305|NCT02550444|Sensory System Agents|sensory system agents|mesh-ancestor
5694798|NCT03393728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694799|NCT03393728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694800|NCT03393728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5694801|NCT03393728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5694802|NCT03393728|Vasodilator Agents|vasodilator agents|mesh-ancestor
5694803|NCT03393715|Perindopril|perindopril|mesh-list
5694804|NCT03393715|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5694805|NCT03393715|Protease Inhibitors|protease inhibitors|mesh-ancestor
5694806|NCT03393715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5694807|NCT03393715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694808|NCT03393715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5694809|NCT03393702|Gabapentin|gabapentin|mesh-list
5694810|NCT03393702|Analgesics|analgesics|mesh-ancestor
5694811|NCT03393702|Sensory System Agents|sensory system agents|mesh-ancestor
5694812|NCT03393702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5694813|NCT03393702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694814|NCT03393702|Anticonvulsants|anticonvulsants|mesh-ancestor
5694815|NCT03393702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5694816|NCT03393702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5694817|NCT03393702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5694818|NCT03393702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5831306|NCT02550444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5831307|NCT02550444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831308|NCT02550444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5831309|NCT02550444|Sympatholytics|sympatholytics|mesh-ancestor
5831310|NCT02550444|Autonomic Agents|autonomic agents|mesh-ancestor
5831311|NCT02550444|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5831312|NCT02550444|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5831313|NCT02550444|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5831314|NCT02550444|Adrenergic Agents|adrenergic agents|mesh-ancestor
5831315|NCT02550444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5831316|NCT02550444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831317|NCT02550314|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
5831318|NCT02550314|Hemostatics|hemostatics|mesh-ancestor
5831319|NCT02550314|Coagulants|coagulants|mesh-ancestor
5831320|NCT02550119|Dexamethasone|dexamethasone|mesh-list
5831321|NCT02550119|Dexamethasone acetate|dexamethasone acetate|mesh-list
5831322|NCT02550119|Aprepitant|aprepitant|mesh-list
5831323|NCT02550119|Dolasetron|dolasetron|mesh-list
5831324|NCT02550119|Ichthammol|ichthammol|mesh-list
5831325|NCT02550119|BB 1101|bb 1101|mesh-list
5831326|NCT02550119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5831327|NCT02550119|Antiemetics|antiemetics|mesh-ancestor
5831328|NCT02550119|Autonomic Agents|autonomic agents|mesh-ancestor
5831329|NCT02550119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5831330|NCT02550119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831331|NCT02550119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5653888|NCT03688789|Hydrocortisone|hydrocortisone|mesh-list
5653889|NCT03688789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5653890|NCT03688659|Vancomycin|vancomycin|mesh-list
5653891|NCT03688659|Gentamicins|gentamicins|mesh-list
5653892|NCT03688659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5653893|NCT03688659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5653894|NCT03688659|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5653895|NCT03688659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5653896|NCT03688659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653897|NCT03688568|Imatinib Mesylate|imatinib mesylate|mesh-list
5653898|NCT03688568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5653899|NCT03688568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5653900|NCT03688568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5653901|NCT03688568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831332|NCT02550119|Glucocorticoids|glucocorticoids|mesh-ancestor
5831333|NCT02550119|Hormones|hormones|mesh-ancestor
5831334|NCT02550119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5831335|NCT02550119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5831336|NCT02550119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5831337|NCT02550119|Protease Inhibitors|protease inhibitors|mesh-ancestor
5831338|NCT02550119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5831339|NCT02550119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831340|NCT02550119|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5831341|NCT02550119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5831342|NCT02550119|Dermatologic Agents|dermatologic agents|mesh-ancestor
5831343|NCT02550119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5831344|NCT02550119|Serotonin Agents|serotonin agents|mesh-ancestor
5831345|NCT02550093|Oxytocin|oxytocin|mesh-list
5831346|NCT02550093|Oxytocics|oxytocics|mesh-ancestor
5831347|NCT02550093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5831348|NCT02550093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831349|NCT02550067|Copper|copper|mesh-list
5831350|NCT02550067|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
5831351|NCT02550067|Levonorgestrel|levonorgestrel|mesh-list
5831352|NCT02550067|Medroxyprogesterone|medroxyprogesterone|mesh-list
5831353|NCT02550067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5831354|NCT02550067|Contraceptive Agents|contraceptive agents|mesh-ancestor
5831355|NCT02550067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5831356|NCT02550067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831357|NCT02550067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5831358|NCT02550067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5831359|NCT02550067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5831360|NCT02550067|Trace Elements|trace elements|mesh-ancestor
5831361|NCT02550067|Micronutrients|micronutrients|mesh-ancestor
5831362|NCT02550067|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5831363|NCT02550067|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5831364|NCT02550067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5831365|NCT02550067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5831366|NCT02550262|Fentanyl|fentanyl|mesh-list
5831367|NCT02550262|Bupivacaine|bupivacaine|mesh-list
5831368|NCT02550262|Anesthetics, Local|anesthetics, local|mesh-ancestor
5831369|NCT02550262|Anesthetics|anesthetics|mesh-ancestor
5831370|NCT02550262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5831371|NCT02550262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831372|NCT02550262|Sensory System Agents|sensory system agents|mesh-ancestor
5831373|NCT02550262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5831374|NCT02550262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5831375|NCT02550262|Narcotics|narcotics|mesh-ancestor
5831376|NCT02550262|Analgesics|analgesics|mesh-ancestor
5831377|NCT02550262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5831378|NCT02550262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5831379|NCT02550262|Anesthetics, General|anesthetics, general|mesh-ancestor
5831380|NCT02550418|Budesonide|budesonide|mesh-list
5831381|NCT02550418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5831382|NCT02550418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5831383|NCT02550418|Autonomic Agents|autonomic agents|mesh-ancestor
5831384|NCT02550418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5831385|NCT02550418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653902|NCT03688464|Diphenhydramine|diphenhydramine|mesh-list
5831386|NCT02550418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5831387|NCT02550418|Respiratory System Agents|respiratory system agents|mesh-ancestor
5831388|NCT02550418|Glucocorticoids|glucocorticoids|mesh-ancestor
5831389|NCT02550418|Hormones|hormones|mesh-ancestor
5831390|NCT02550418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5902568|NCT04047862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5902569|NCT04040790|Phenylephrine|phenylephrine|mesh-list
5902570|NCT04040790|Oxymetazoline|oxymetazoline|mesh-list
5902571|NCT04040790|Tropicamide|tropicamide|mesh-list
5902572|NCT04040790|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5902573|NCT04040790|Mydriatics|mydriatics|mesh-ancestor
5902574|NCT04040790|Autonomic Agents|autonomic agents|mesh-ancestor
5653903|NCT03688464|Promethazine|promethazine|mesh-list
5653904|NCT03688464|Melatonin|melatonin|mesh-list
5653905|NCT03688464|Antioxidants|antioxidants|mesh-ancestor
5653906|NCT03688464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653907|NCT03688464|Protective Agents|protective agents|mesh-ancestor
5653908|NCT03688464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653909|NCT03688464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5653910|NCT03688464|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5653911|NCT03688464|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5653912|NCT03688464|Anesthetics, Local|anesthetics, local|mesh-ancestor
5653913|NCT03688464|Anesthetics|anesthetics|mesh-ancestor
5653914|NCT03688464|Sensory System Agents|sensory system agents|mesh-ancestor
5653915|NCT03688464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5902575|NCT04040790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5902576|NCT04040790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902577|NCT04040790|Sympathomimetics|sympathomimetics|mesh-ancestor
5902578|NCT04040790|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5902579|NCT04040790|Nasal Decongestants|nasal decongestants|mesh-ancestor
5902580|NCT04040790|Respiratory System Agents|respiratory system agents|mesh-ancestor
5902581|NCT04040790|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5902582|NCT04040790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5902583|NCT04040790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5902584|NCT04040790|Adrenergic Agents|adrenergic agents|mesh-ancestor
5902585|NCT04040790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5902586|NCT04040790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902587|NCT04040790|Protective Agents|protective agents|mesh-ancestor
5902588|NCT04040790|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5902589|NCT04040790|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5902590|NCT04040790|Cholinergic Agents|cholinergic agents|mesh-ancestor
5902591|NCT04038489|Aspirin|aspirin|mesh-list
5902592|NCT04038489|Tamoxifen|tamoxifen|mesh-list
5902593|NCT04038489|Paclitaxel|paclitaxel|mesh-list
5902594|NCT04038489|Cyclophosphamide|cyclophosphamide|mesh-list
5902595|NCT04038489|Doxorubicin|doxorubicin|mesh-list
5902596|NCT04038489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5902597|NCT04038489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5653916|NCT03688464|Antiemetics|antiemetics|mesh-ancestor
5653917|NCT03688464|Autonomic Agents|autonomic agents|mesh-ancestor
5653918|NCT03688464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5653919|NCT03688464|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5653920|NCT03688464|Histamine Antagonists|histamine antagonists|mesh-ancestor
5653921|NCT03688464|Histamine Agents|histamine agents|mesh-ancestor
5653922|NCT03688464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5653923|NCT03688464|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5653924|NCT03688464|Antipruritics|antipruritics|mesh-ancestor
5653925|NCT03688464|Dermatologic Agents|dermatologic agents|mesh-ancestor
5653926|NCT03688451|Rituximab|rituximab|mesh-list
5653927|NCT03688451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5653928|NCT03688451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5653929|NCT03688451|Immunologic Factors|immunologic factors|mesh-ancestor
5653930|NCT03688451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653931|NCT03688451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5902598|NCT04038489|Tubulin Modulators|tubulin modulators|mesh-ancestor
5902599|NCT04038489|Antimitotic Agents|antimitotic agents|mesh-ancestor
5902600|NCT04038489|Mitosis Modulators|mitosis modulators|mesh-ancestor
5902601|NCT04038489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902602|NCT04038489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5902603|NCT04038489|Immunologic Factors|immunologic factors|mesh-ancestor
5902604|NCT04038489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902605|NCT04038489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5902606|NCT04038489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5902607|NCT04038489|Alkylating Agents|alkylating agents|mesh-ancestor
5902608|NCT04038489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5902609|NCT04038489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5653932|NCT03688295|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5653933|NCT03688295|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5653934|NCT03688295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5831391|NCT02550080|Dapsone|dapsone|mesh-list
5831392|NCT02550080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5831393|NCT02550080|Antimalarials|antimalarials|mesh-ancestor
5831394|NCT02550080|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5831395|NCT02550080|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5831396|NCT02550080|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5831397|NCT02550080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5831398|NCT02550080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831399|NCT02550080|Leprostatic Agents|leprostatic agents|mesh-ancestor
5831400|NCT02550080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5831401|NCT02550249|Nivolumab|nivolumab|mesh-list
5831402|NCT02550249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5831403|NCT02550249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5831404|NCT02550249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5831405|NCT02550249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831406|NCT02550028|Levetiracetam|levetiracetam|mesh-list
5831407|NCT02550028|Phenobarbital|phenobarbital|mesh-list
5831408|NCT02550028|Anticonvulsants|anticonvulsants|mesh-ancestor
5831409|NCT02550028|Nootropic Agents|nootropic agents|mesh-ancestor
5831410|NCT02550028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5831411|NCT02550028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5831412|NCT02550028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831413|NCT02550028|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5831414|NCT02550028|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5831415|NCT02550028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5831416|NCT02550028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831417|NCT02550028|GABA Modulators|gaba modulators|mesh-ancestor
5831418|NCT02550028|GABA Agents|gaba agents|mesh-ancestor
5831419|NCT02550028|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5831420|NCT02550028|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5831421|NCT02550028|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5831422|NCT02550327|Gemcitabine|gemcitabine|mesh-list
5831423|NCT02550327|Paclitaxel|paclitaxel|mesh-list
5831424|NCT02550327|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5831425|NCT02550327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5831426|NCT02550327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5831427|NCT02550327|Tubulin Modulators|tubulin modulators|mesh-ancestor
5831428|NCT02550327|Antimitotic Agents|antimitotic agents|mesh-ancestor
5831429|NCT02550327|Mitosis Modulators|mitosis modulators|mesh-ancestor
5831430|NCT02550327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831431|NCT02550327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5831432|NCT02550327|Antimetabolites|antimetabolites|mesh-ancestor
5831433|NCT02550327|Antiviral Agents|antiviral agents|mesh-ancestor
5831434|NCT02550327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5831435|NCT02550327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5831436|NCT02550327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5653935|NCT03688295|Antitubercular Agents|antitubercular agents|mesh-ancestor
5653936|NCT03688269|Dexamethasone|dexamethasone|mesh-list
5653937|NCT03688269|Ropivacaine|ropivacaine|mesh-list
5653938|NCT03688269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5653939|NCT03688269|Antiemetics|antiemetics|mesh-ancestor
5653940|NCT03688269|Autonomic Agents|autonomic agents|mesh-ancestor
5653941|NCT03688269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5653942|NCT03688269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653943|NCT03688269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5653944|NCT03688269|Glucocorticoids|glucocorticoids|mesh-ancestor
5653945|NCT03688269|Hormones|hormones|mesh-ancestor
5831437|NCT02550327|Immunologic Factors|immunologic factors|mesh-ancestor
5831438|NCT02550327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831439|NCT02550327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5831440|NCT02549846|Atorvastatin|atorvastatin|mesh-list
5831441|NCT02549846|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5831442|NCT02549846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5831443|NCT02549846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5831444|NCT02549846|Antimetabolites|antimetabolites|mesh-ancestor
5831445|NCT02549846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831446|NCT02549846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5831447|NCT02549846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5831448|NCT02549846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5831449|NCT02549924|Resveratrol|resveratrol|mesh-list
5831450|NCT02549924|Antioxidants|antioxidants|mesh-ancestor
5831451|NCT02549924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831452|NCT02549924|Protective Agents|protective agents|mesh-ancestor
5831453|NCT02549924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831454|NCT02549924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5831455|NCT02549924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5831456|NCT02549742|Bleomycin|bleomycin|mesh-list
5831457|NCT02549742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5831458|NCT02549742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5831459|NCT02549963|Rivaroxaban|rivaroxaban|mesh-list
5831460|NCT02549963|Anticoagulants|anticoagulants|mesh-list
5831461|NCT02549963|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5831462|NCT02549963|Antithrombins|antithrombins|mesh-ancestor
5831463|NCT02549963|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5831464|NCT02549963|Protease Inhibitors|protease inhibitors|mesh-ancestor
5831465|NCT02549963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5831466|NCT02549963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831467|NCT02550002|Aflibercept|aflibercept|mesh-list
5831468|NCT02550002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5831469|NCT02550002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5831470|NCT02550002|Growth Substances|growth substances|mesh-ancestor
5831471|NCT02550002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831472|NCT02550002|Growth Inhibitors|growth inhibitors|mesh-ancestor
5831473|NCT02550002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5831474|NCT02549898|Cilostazol|cilostazol|mesh-list
5831475|NCT02549898|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
5831476|NCT02549898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5831477|NCT02549898|Autonomic Agents|autonomic agents|mesh-ancestor
5831478|NCT02549898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5831479|NCT02549898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831480|NCT02549898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5831481|NCT02549898|Respiratory System Agents|respiratory system agents|mesh-ancestor
5831482|NCT02549898|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5831483|NCT02549898|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5831484|NCT02549898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831485|NCT02549898|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5831486|NCT02549898|Vasodilator Agents|vasodilator agents|mesh-ancestor
5831487|NCT02549898|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5831488|NCT02549898|Protective Agents|protective agents|mesh-ancestor
5831489|NCT02549898|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5831490|NCT02549898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5831491|NCT02549898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5831492|NCT02549898|Hematinics|hematinics|mesh-ancestor
5831493|NCT02549898|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5831494|NCT02549898|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5831495|NCT02549690|Testosterone|testosterone|mesh-list
5831496|NCT02549690|Androgens|androgens|mesh-ancestor
5831497|NCT02549690|Hormones|hormones|mesh-ancestor
5831498|NCT02549690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5831499|NCT02549690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831500|NCT02549768|Dexmedetomidine|dexmedetomidine|mesh-list
5831501|NCT02549768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5831502|NCT02549768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5831503|NCT02549768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831504|NCT02549768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5831505|NCT02549768|Analgesics|analgesics|mesh-ancestor
5831506|NCT02549768|Sensory System Agents|sensory system agents|mesh-ancestor
5831507|NCT02549768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5653946|NCT03688269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5653947|NCT03688269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5653948|NCT03688269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5653949|NCT03688269|Anesthetics, Local|anesthetics, local|mesh-ancestor
5653950|NCT03688269|Anesthetics|anesthetics|mesh-ancestor
5653951|NCT03688269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5653952|NCT03688269|Sensory System Agents|sensory system agents|mesh-ancestor
5653953|NCT03688230|Cetuximab|cetuximab|mesh-list
5653954|NCT03688230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5653955|NCT03688230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5653956|NCT03688191|Sirolimus|sirolimus|mesh-list
5653957|NCT03688191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5653958|NCT03688191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5653959|NCT03688191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5653960|NCT03688191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5653961|NCT03688191|Antifungal Agents|antifungal agents|mesh-ancestor
5653962|NCT03688191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5653963|NCT03688191|Immunologic Factors|immunologic factors|mesh-ancestor
5653964|NCT03688191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653965|NCT03688178|Temozolomide|temozolomide|mesh-list
5653966|NCT03688178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5831508|NCT02549768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5831509|NCT02549768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5653967|NCT03688178|Alkylating Agents|alkylating agents|mesh-ancestor
5653968|NCT03688178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653969|NCT03688178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5653970|NCT03687931|Dexamethasone|dexamethasone|mesh-list
5653971|NCT03687931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5653972|NCT03687931|Antiemetics|antiemetics|mesh-ancestor
5653973|NCT03687931|Autonomic Agents|autonomic agents|mesh-ancestor
5653974|NCT03687931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5831510|NCT02549768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5831511|NCT02549768|Adrenergic Agents|adrenergic agents|mesh-ancestor
5831512|NCT02549768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5831513|NCT02549768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831514|NCT02549677|Cyclophosphamide|cyclophosphamide|mesh-list
5831515|NCT02549677|Docetaxel|docetaxel|mesh-list
5831516|NCT02549677|Epirubicin|epirubicin|mesh-list
5831517|NCT02549677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5831518|NCT02549677|Immunologic Factors|immunologic factors|mesh-ancestor
5831519|NCT02549677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831520|NCT02549677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5831521|NCT02549677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5653975|NCT03687931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653976|NCT03687931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5653977|NCT03687931|Glucocorticoids|glucocorticoids|mesh-ancestor
5653978|NCT03687931|Hormones|hormones|mesh-ancestor
5653979|NCT03687931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5653980|NCT03687931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5653981|NCT03687931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5653982|NCT03687905|Hydroxychloroquine|hydroxychloroquine|mesh-list
5653983|NCT03687905|Chloroquine|chloroquine|mesh-list
5653984|NCT03687905|Antimalarials|antimalarials|mesh-ancestor
5653985|NCT03687905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5653986|NCT03687905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5653987|NCT03687905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5653988|NCT03687905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5653989|NCT03687905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5653990|NCT03687905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5653991|NCT03687905|Amebicides|amebicides|mesh-ancestor
5653992|NCT03687606|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5653993|NCT03687606|Menotropins|menotropins|mesh-list
5653994|NCT03687606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5653995|NCT03687606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5653996|NCT03687606|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5653997|NCT03687606|Fertility Agents|fertility agents|mesh-ancestor
5653998|NCT03687515|Prednisone|prednisone|mesh-list
5653999|NCT03687515|Budesonide|budesonide|mesh-list
5654000|NCT03687515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5654001|NCT03687515|Glucocorticoids|glucocorticoids|mesh-ancestor
5831522|NCT02549677|Alkylating Agents|alkylating agents|mesh-ancestor
5831523|NCT02549677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831524|NCT02549677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5831525|NCT02549677|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5831526|NCT02549677|Tubulin Modulators|tubulin modulators|mesh-ancestor
5831527|NCT02549677|Antimitotic Agents|antimitotic agents|mesh-ancestor
5831528|NCT02549677|Mitosis Modulators|mitosis modulators|mesh-ancestor
5831529|NCT02549677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5831530|NCT02549677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5831531|NCT02549677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5831532|NCT02549677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6493352|NCT00613145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5654002|NCT03687515|Hormones|hormones|mesh-ancestor
5654003|NCT03687515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5654004|NCT03687515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654005|NCT03687515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5654006|NCT03687515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5831533|NCT02549651|Durvalumab|durvalumab|mesh-list
6493353|NCT00613145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6493354|NCT00613145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6493355|NCT00613145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6493356|NCT00613223|Etoposide|etoposide|mesh-list
6493357|NCT00613223|Etoposide phosphate|etoposide phosphate|mesh-list
6493358|NCT00613223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6493359|NCT00613223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5654007|NCT03687515|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5831534|NCT02549651|Tremelimumab|tremelimumab|mesh-list
5831535|NCT02549651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5831536|NCT02549651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5831537|NCT02549261|Etoposide|etoposide|mesh-list
5831538|NCT02549261|Nimotuzumab|nimotuzumab|mesh-list
5831539|NCT02549261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5831540|NCT02549261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5831541|NCT02549261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5831542|NCT02549261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5831543|NCT02549261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5831544|NCT02549261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831545|NCT02549261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5831546|NCT02549326|Vitamin D|vitamin d|mesh-list
5831547|NCT02549326|Cholecalciferol|cholecalciferol|mesh-list
5831548|NCT02549326|Vitamins|vitamins|mesh-ancestor
5831549|NCT02549326|Micronutrients|micronutrients|mesh-ancestor
5831550|NCT02549326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831551|NCT02549326|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5654008|NCT03687515|Autonomic Agents|autonomic agents|mesh-ancestor
5654009|NCT03687515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5654010|NCT03687515|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5831552|NCT02549326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5831553|NCT02549469|Naproxen|naproxen|mesh-list
5831554|NCT02549469|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5831555|NCT02549469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5654011|NCT03687515|Respiratory System Agents|respiratory system agents|mesh-ancestor
5654012|NCT03687463|Decitabine|decitabine|mesh-list
5654013|NCT03687463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5654014|NCT03687463|Antimetabolites|antimetabolites|mesh-ancestor
5654015|NCT03687463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5654016|NCT03687463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5654017|NCT03687463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5654018|NCT03687268|Naloxone|naloxone|mesh-list
5654019|NCT03687268|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5654020|NCT03687268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654021|NCT03687268|Sensory System Agents|sensory system agents|mesh-ancestor
5654022|NCT03687268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5654023|NCT03687255|Tazobactam|tazobactam|mesh-list
5654024|NCT03687255|Piperacillin|piperacillin|mesh-list
5654025|NCT03687255|Cefepime|cefepime|mesh-list
5654026|NCT03687255|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
5654027|NCT03687255|Enmetazobactam|enmetazobactam|mesh-list
5654028|NCT03687255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5654029|NCT03687255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5654030|NCT03687255|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5654031|NCT03687255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5654032|NCT03687255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5654033|NCT03687229|Insulin|insulin|mesh-list
5654034|NCT03687229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5654035|NCT03687229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694819|NCT03393702|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5694820|NCT03393702|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5694821|NCT03393702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5831556|NCT02549469|Analgesics|analgesics|mesh-ancestor
5831557|NCT02549469|Sensory System Agents|sensory system agents|mesh-ancestor
5831558|NCT02549469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5831559|NCT02549469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831560|NCT02549469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5831561|NCT02549469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5831562|NCT02549469|Gout Suppressants|gout suppressants|mesh-ancestor
5831563|NCT02549469|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5831564|NCT02549469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5831565|NCT02549469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831566|NCT02549391|Cinacalcet|cinacalcet|mesh-list
5831567|NCT02549391|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5831568|NCT02549391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831569|NCT02549391|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
5831570|NCT02549391|Hormone Antagonists|hormone antagonists|mesh-ancestor
5831571|NCT02549391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5831572|NCT02549430|Letrozole|letrozole|mesh-list
5831573|NCT02549430|Fulvestrant|fulvestrant|mesh-list
5831574|NCT02549430|Palbociclib|palbociclib|mesh-list
5831575|NCT02549430|Anastrozole|anastrozole|mesh-list
5831576|NCT02549430|Exemestane|exemestane|mesh-list
5694822|NCT03393702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694823|NCT03393702|Antimanic Agents|antimanic agents|mesh-ancestor
5654036|NCT03687073|Silybin|silybin|mesh-list
5654037|NCT03687073|Indole-3-carbinol|indole-3-carbinol|mesh-list
5654038|NCT03687073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5831577|NCT02549430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5831578|NCT02549430|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5831579|NCT02549430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5831580|NCT02549430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5831581|NCT02549430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831582|NCT02549430|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5831583|NCT02549430|Hormone Antagonists|hormone antagonists|mesh-ancestor
5831584|NCT02549430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5831585|NCT02549430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831586|NCT02549430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5831587|NCT02549430|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5831588|NCT02549430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5831589|NCT02549105|Lidocaine|lidocaine|mesh-list
5831590|NCT02549105|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
5831591|NCT02549105|Anesthetics, Local|anesthetics, local|mesh-ancestor
5831592|NCT02549105|Anesthetics|anesthetics|mesh-ancestor
5831593|NCT02549105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5831594|NCT02549105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831595|NCT02549105|Sensory System Agents|sensory system agents|mesh-ancestor
5831596|NCT02549105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5831597|NCT02549105|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5831598|NCT02549105|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5831599|NCT02549105|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5831600|NCT02549105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5831601|NCT02549105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831602|NCT02549105|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
5831603|NCT02549001|Amorolfine|amorolfine|mesh-list
5831604|NCT02549001|Antifungal Agents|antifungal agents|mesh-ancestor
5831605|NCT02549001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5831606|NCT02548923|Dexmedetomidine|dexmedetomidine|mesh-list
5831607|NCT02548923|Propofol|propofol|mesh-list
5831608|NCT02548923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5831609|NCT02548923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5831610|NCT02548923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831611|NCT02548923|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5831612|NCT02548923|Anesthetics, General|anesthetics, general|mesh-ancestor
5831613|NCT02548923|Anesthetics|anesthetics|mesh-ancestor
5831614|NCT02548923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5831615|NCT02548923|Analgesics|analgesics|mesh-ancestor
5831616|NCT02548923|Sensory System Agents|sensory system agents|mesh-ancestor
5831617|NCT02548923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5831618|NCT02548923|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5831619|NCT02548923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5831620|NCT02548923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5831621|NCT02548923|Adrenergic Agents|adrenergic agents|mesh-ancestor
5831622|NCT02548923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5831623|NCT02548923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831624|NCT02549118|Tenoxicam|tenoxicam|mesh-list
5831625|NCT02549118|Meperidine|meperidine|mesh-list
5831626|NCT02549118|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5831627|NCT02549118|Narcotics|narcotics|mesh-ancestor
5831628|NCT02549118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5831629|NCT02549118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831630|NCT02549118|Analgesics|analgesics|mesh-ancestor
5831631|NCT02549118|Sensory System Agents|sensory system agents|mesh-ancestor
5831632|NCT02549118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5831633|NCT02549118|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5654039|NCT03687073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5654040|NCT03687073|Protective Agents|protective agents|mesh-ancestor
5654041|NCT03687073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654042|NCT03687073|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5654043|NCT03687034|Temozolomide|temozolomide|mesh-list
5654044|NCT03687034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5654045|NCT03687034|Alkylating Agents|alkylating agents|mesh-ancestor
5654046|NCT03687034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5654047|NCT03687034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5654048|NCT03687021|Progesterone|progesterone|mesh-list
5654049|NCT03687021|Progestins|progestins|mesh-ancestor
5654050|NCT03687021|Hormones|hormones|mesh-ancestor
5694824|NCT03393572|Magnesium Sulfate|magnesium sulfate|mesh-list
5654051|NCT03687021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5654052|NCT03687021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654053|NCT03686930|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5654054|NCT03686904|Benzalkonium Compounds|benzalkonium compounds|mesh-list
5654055|NCT03686904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5654056|NCT03686904|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5654057|NCT03686878|Lifitegrast|lifitegrast|mesh-list
5831634|NCT02549118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5831635|NCT02549118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5831636|NCT02549118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5831637|NCT02549118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5831638|NCT02549118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5831639|NCT02549118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5831640|NCT02549118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831641|NCT02548975|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
5831642|NCT02548975|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
5831643|NCT02548975|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5831644|NCT02548975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5654058|NCT03686878|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5654059|NCT03686878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5654060|NCT03686787|Tranexamic Acid|tranexamic acid|mesh-list
5654061|NCT03686787|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5831645|NCT02548975|Antimetabolites|antimetabolites|mesh-ancestor
5831646|NCT02548975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831647|NCT02548975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6493360|NCT00613223|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6493361|NCT00613223|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6493362|NCT00613223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6493363|NCT00613223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493364|NCT00613249|Dapivirine|dapivirine|mesh-list
6493365|NCT00613249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6493366|NCT00613249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6493367|NCT00613249|Antiviral Agents|antiviral agents|mesh-ancestor
6493368|NCT00613249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6493369|NCT00613288|Testosterone|testosterone|mesh-list
6493370|NCT00613288|Androgens|androgens|mesh-ancestor
5654062|NCT03686787|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5654063|NCT03686787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5654064|NCT03686787|Hemostatics|hemostatics|mesh-ancestor
5654065|NCT03686787|Coagulants|coagulants|mesh-ancestor
5654066|NCT03686774|Memantine|memantine|mesh-list
5654067|NCT03686774|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5831648|NCT02548975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5831649|NCT02548975|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5831650|NCT02548975|Adrenergic Agents|adrenergic agents|mesh-ancestor
5831651|NCT02548975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5831652|NCT02548975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831653|NCT02549066|Milrinone|milrinone|mesh-list
5831654|NCT02549066|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5831655|NCT02549066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5831656|NCT02549066|Vasodilator Agents|vasodilator agents|mesh-ancestor
5831657|NCT02549066|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5831658|NCT02549066|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5831659|NCT02549066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5831660|NCT02549066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831661|NCT02549066|Protective Agents|protective agents|mesh-ancestor
5831662|NCT02549066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831663|NCT02548936|Simvastatin|simvastatin|mesh-list
5831664|NCT02548936|Ezetimibe|ezetimibe|mesh-list
5831665|NCT02548936|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6493371|NCT00613288|Hormones|hormones|mesh-ancestor
5654068|NCT03686774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5654069|NCT03686774|Dopamine Agents|dopamine agents|mesh-ancestor
5654070|NCT03686774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5654071|NCT03686774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5654072|NCT03686774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654073|NCT03686774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5654074|NCT03686774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5654075|NCT03686722|Metformin|metformin|mesh-list
5654076|NCT03686722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5654077|NCT03686722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654078|NCT03686696|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
5654079|NCT03686696|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
5654080|NCT03686696|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
5654081|NCT03686696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5654082|NCT03686696|Adrenergic Agents|adrenergic agents|mesh-ancestor
5654083|NCT03686696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5654084|NCT03686696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5654085|NCT03686696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654086|NCT03686696|Protease Inhibitors|protease inhibitors|mesh-ancestor
5654087|NCT03686696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5654088|NCT03686657|Metformin|metformin|mesh-list
5654089|NCT03686657|Celecoxib|celecoxib|mesh-list
5654090|NCT03686657|Valsartan|valsartan|mesh-list
5654091|NCT03686657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5654092|NCT03686657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654093|NCT03686657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5654094|NCT03686657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5654095|NCT03686657|Analgesics|analgesics|mesh-ancestor
5831666|NCT02548936|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5831667|NCT02548936|Antimetabolites|antimetabolites|mesh-ancestor
5831668|NCT02548936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831669|NCT02548936|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5831670|NCT02548936|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5654096|NCT03686657|Sensory System Agents|sensory system agents|mesh-ancestor
5654097|NCT03686657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5654098|NCT03686657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5831671|NCT02548936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5831672|NCT02548832|Magnesium Oxide|magnesium oxide|mesh-list
5831673|NCT02548832|Bezafibrate|bezafibrate|mesh-list
5831674|NCT02548832|Antacids|antacids|mesh-ancestor
5831675|NCT02548832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831676|NCT02548832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5831677|NCT02548832|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5831678|NCT02548832|Antimetabolites|antimetabolites|mesh-ancestor
5831679|NCT02548832|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5831680|NCT02548806|Clonidine|clonidine|mesh-list
5831681|NCT02548806|Analgesics|analgesics|mesh-ancestor
5831682|NCT02548806|Sensory System Agents|sensory system agents|mesh-ancestor
5831683|NCT02548806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5831684|NCT02548806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831685|NCT02548806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5831686|NCT02548806|Sympatholytics|sympatholytics|mesh-ancestor
5831687|NCT02548806|Autonomic Agents|autonomic agents|mesh-ancestor
5831688|NCT02548806|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5831689|NCT02548806|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5831690|NCT02548806|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5654099|NCT03686657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5654100|NCT03686657|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5654101|NCT03686657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5654102|NCT03686657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5654103|NCT03686657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5654104|NCT03686657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5654105|NCT03686657|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5654106|NCT03686657|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6493372|NCT00613288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6493373|NCT00613288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493374|NCT00613392|Antioxidants|antioxidants|mesh-list
6493375|NCT00613392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493376|NCT00613392|Protective Agents|protective agents|mesh-ancestor
5654107|NCT03686618|Secretin|secretin|mesh-list
5654108|NCT03686618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6493377|NCT00613392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493378|NCT00613457|Cytarabine|cytarabine|mesh-list
6493379|NCT00613457|Dexamethasone|dexamethasone|mesh-list
6493380|NCT00613457|Prednisone|prednisone|mesh-list
5654109|NCT03686618|Hormones|hormones|mesh-ancestor
5654110|NCT03686618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5654111|NCT03686618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654112|NCT03686332|Atezolizumab|atezolizumab|mesh-list
5654113|NCT03686332|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5654114|NCT03686332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5654115|NCT03686332|Immunologic Factors|immunologic factors|mesh-ancestor
5654116|NCT03686332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654117|NCT03686267|Lithium Carbonate|lithium carbonate|mesh-list
5654118|NCT03686267|Antidepressive Agents|antidepressive agents|mesh-ancestor
5654119|NCT03686267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5654120|NCT03686267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5694825|NCT03393572|Nalbuphine|nalbuphine|mesh-list
5654121|NCT03686267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831691|NCT02548806|Adrenergic Agents|adrenergic agents|mesh-ancestor
5831692|NCT02548806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5831693|NCT02548806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831694|NCT02548741|Metformin|metformin|mesh-list
5831695|NCT02548741|Calcium Carbonate|calcium carbonate|mesh-list
5831696|NCT02548741|Calcium|calcium|mesh-list
5831697|NCT02548741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5831698|NCT02548741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831699|NCT02548741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5831700|NCT02548741|Antacids|antacids|mesh-ancestor
5831701|NCT02548741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5654122|NCT03686267|Antimanic Agents|antimanic agents|mesh-ancestor
5654123|NCT03686267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5654124|NCT03686267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5654125|NCT03686267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654126|NCT03686254|Bevacizumab|bevacizumab|mesh-list
5654127|NCT03686254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5831702|NCT02548741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5831703|NCT02548780|Doxorubicin|doxorubicin|mesh-list
5831704|NCT02548780|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5831705|NCT02548780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5831706|NCT02548780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5831707|NCT02548780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5831708|NCT02548780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5831709|NCT02548780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831710|NCT02548468|Vidarabine|vidarabine|mesh-list
5831711|NCT02548468|Mycophenolic Acid|mycophenolic acid|mesh-list
5831712|NCT02548468|Cyclophosphamide|cyclophosphamide|mesh-list
5831713|NCT02548468|Fludarabine|fludarabine|mesh-list
5831714|NCT02548468|Fludarabine phosphate|fludarabine phosphate|mesh-list
5831715|NCT02548468|Tacrolimus|tacrolimus|mesh-list
5831716|NCT02548468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5831717|NCT02548468|Immunologic Factors|immunologic factors|mesh-ancestor
5831718|NCT02548468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831719|NCT02548468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5831720|NCT02548468|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5831721|NCT02548468|Alkylating Agents|alkylating agents|mesh-ancestor
5831722|NCT02548468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831723|NCT02548468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5831724|NCT02548468|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5831725|NCT02548468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5654128|NCT03686254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5654129|NCT03686254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5654130|NCT03686254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5654131|NCT03686254|Growth Substances|growth substances|mesh-ancestor
5654132|NCT03686254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654133|NCT03686254|Growth Inhibitors|growth inhibitors|mesh-ancestor
5654134|NCT03686163|Mitogens|mitogens|mesh-list
5654135|NCT03686163|Mitosis Modulators|mitosis modulators|mesh-ancestor
5654136|NCT03686163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5654137|NCT03686150|Vitamin D|vitamin d|mesh-list
5654138|NCT03686150|Cholecalciferol|cholecalciferol|mesh-list
5654139|NCT03686150|Vitamins|vitamins|mesh-ancestor
5654140|NCT03686150|Micronutrients|micronutrients|mesh-ancestor
5654141|NCT03686150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654142|NCT03686150|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5831726|NCT02548468|Antimetabolites|antimetabolites|mesh-ancestor
6211748|NCT02176382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6211749|NCT02176421|Lidocaine|lidocaine|mesh-list
5654143|NCT03686150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5654144|NCT03686124|Atezolizumab|atezolizumab|mesh-list
5654145|NCT03686124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5654146|NCT03686085|Dinoprostone|dinoprostone|mesh-list
5654147|NCT03686085|Oxytocics|oxytocics|mesh-ancestor
5654148|NCT03686085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5654149|NCT03686085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654150|NCT03685890|Nivolumab|nivolumab|mesh-list
5654151|NCT03685890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5654152|NCT03685890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5654153|NCT03685890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6211750|NCT02176421|Anesthetics, Local|anesthetics, local|mesh-ancestor
5654154|NCT03685890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831727|NCT02548468|Antiviral Agents|antiviral agents|mesh-ancestor
5654155|NCT03685747|Vancomycin|vancomycin|mesh-list
6211751|NCT02176421|Anesthetics|anesthetics|mesh-ancestor
6211752|NCT02176421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6211753|NCT02176421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211754|NCT02176421|Sensory System Agents|sensory system agents|mesh-ancestor
6211755|NCT02176421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6211756|NCT02176421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6211757|NCT02176421|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6211758|NCT02176421|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6211759|NCT02176421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6211760|NCT02176421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211761|NCT02176486|Ixazomib|ixazomib|mesh-list
6211762|NCT02176486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6211763|NCT02176486|Protease Inhibitors|protease inhibitors|mesh-ancestor
6211764|NCT02176486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6211765|NCT02176486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211766|NCT02176642|Oxybutynin|oxybutynin|mesh-list
6211767|NCT02176642|Parasympatholytics|parasympatholytics|mesh-ancestor
6211768|NCT02176642|Autonomic Agents|autonomic agents|mesh-ancestor
6211769|NCT02176642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5831728|NCT02548468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5831729|NCT02548468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5831730|NCT02548468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5831731|NCT02548468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5831732|NCT02548468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5831733|NCT02548468|Antitubercular Agents|antitubercular agents|mesh-ancestor
5831734|NCT02548468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5831735|NCT02548611|Clopidogrel|clopidogrel|mesh-list
5831736|NCT02548611|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
5831737|NCT02548611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5831738|NCT02548611|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5831739|NCT02548611|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5654156|NCT03685747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5654157|NCT03685747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5654158|NCT03685630|Brivaracetam|brivaracetam|mesh-list
5654159|NCT03685630|Anticonvulsants|anticonvulsants|mesh-ancestor
5654160|NCT03685500|Emtricitabine|emtricitabine|mesh-list
5654161|NCT03685500|Darunavir|darunavir|mesh-list
5654162|NCT03685500|Cobicistat|cobicistat|mesh-list
5654163|NCT03685500|Antiviral Agents|antiviral agents|mesh-ancestor
5654164|NCT03685500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5654165|NCT03685500|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5654166|NCT03685500|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5654167|NCT03685500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5654168|NCT03685500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5654169|NCT03685500|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5654170|NCT03685500|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5654171|NCT03685500|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5654172|NCT03685500|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5654173|NCT03685500|Protease Inhibitors|protease inhibitors|mesh-ancestor
5654174|NCT03685500|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5654175|NCT03685500|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5694826|NCT03393572|Bupivacaine|bupivacaine|mesh-list
5694827|NCT03393572|Anesthetics, Local|anesthetics, local|mesh-ancestor
5694828|NCT03393572|Anesthetics|anesthetics|mesh-ancestor
5694829|NCT03393572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5694830|NCT03393572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694831|NCT03393572|Sensory System Agents|sensory system agents|mesh-ancestor
5694832|NCT03393572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5694833|NCT03393572|Analgesics|analgesics|mesh-ancestor
5694834|NCT03393572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5694835|NCT03393572|Anticonvulsants|anticonvulsants|mesh-ancestor
5694836|NCT03393572|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5694837|NCT03393572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5694838|NCT03393572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694839|NCT03393572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5694840|NCT03393572|Tocolytic Agents|tocolytic agents|mesh-ancestor
5694841|NCT03393572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5694842|NCT03393572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5694843|NCT03393572|Narcotics|narcotics|mesh-ancestor
5694844|NCT03393507|Apatinib|apatinib|mesh-list
5694845|NCT03393507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5694846|NCT03393507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5694847|NCT03393507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5654176|NCT03685409|Metformin|metformin|mesh-list
5654177|NCT03685409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5654178|NCT03685409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831740|NCT02548611|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5831741|NCT02548611|Purinergic Agents|purinergic agents|mesh-ancestor
5831742|NCT02548611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5831743|NCT02548611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831744|NCT02548611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831745|NCT02548533|Lidocaine|lidocaine|mesh-list
5831746|NCT02548533|Epinephrine|epinephrine|mesh-list
5831747|NCT02548533|Prilocaine|prilocaine|mesh-list
5831748|NCT02548533|Carticaine|carticaine|mesh-list
5831749|NCT02548533|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
5831750|NCT02548533|Anesthetics, Local|anesthetics, local|mesh-ancestor
5831751|NCT02548533|Anesthetics|anesthetics|mesh-ancestor
5831752|NCT02548533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5831753|NCT02548533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654179|NCT03685331|Olaparib|olaparib|mesh-list
5654180|NCT03685331|Fulvestrant|fulvestrant|mesh-list
5654181|NCT03685331|Palbociclib|palbociclib|mesh-list
5831754|NCT02548533|Sensory System Agents|sensory system agents|mesh-ancestor
5831755|NCT02548533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5831756|NCT02548533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5831757|NCT02548533|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5831758|NCT02548533|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5831759|NCT02548533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5831760|NCT02548533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831761|NCT02548533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5831762|NCT02548533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5831763|NCT02548533|Adrenergic Agents|adrenergic agents|mesh-ancestor
5831764|NCT02548533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5831765|NCT02548533|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5831766|NCT02548533|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5831767|NCT02548533|Autonomic Agents|autonomic agents|mesh-ancestor
5831768|NCT02548533|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5831769|NCT02548533|Respiratory System Agents|respiratory system agents|mesh-ancestor
5654182|NCT03685331|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5654183|NCT03685331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5654184|NCT03685331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831770|NCT02548533|Mydriatics|mydriatics|mesh-ancestor
5831771|NCT02548533|Sympathomimetics|sympathomimetics|mesh-ancestor
5831772|NCT02548533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5831773|NCT02548533|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
5831774|NCT02548559|Cannabidiol|cannabidiol|mesh-list
5831775|NCT02548559|Anticonvulsants|anticonvulsants|mesh-ancestor
5902610|NCT04038489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5902611|NCT04038489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5902612|NCT04038489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5902613|NCT04038489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5902614|NCT04038489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5902615|NCT04038489|Analgesics|analgesics|mesh-ancestor
5902616|NCT04038489|Sensory System Agents|sensory system agents|mesh-ancestor
5902617|NCT04038489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5902618|NCT04038489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5902619|NCT04038489|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5902620|NCT04038489|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5902621|NCT04038489|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5902622|NCT04038489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5902623|NCT04038489|Antipyretics|antipyretics|mesh-ancestor
5902624|NCT04038489|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6493381|NCT00613457|Cyclophosphamide|cyclophosphamide|mesh-list
6493382|NCT00613457|Ifosfamide|ifosfamide|mesh-list
6493383|NCT00613457|Doxorubicin|doxorubicin|mesh-list
6493384|NCT00613457|Methotrexate|methotrexate|mesh-list
6493385|NCT00613457|Etoposide|etoposide|mesh-list
6493386|NCT00613457|Vincristine|vincristine|mesh-list
6493387|NCT00613457|Daunorubicin|daunorubicin|mesh-list
6493388|NCT00613457|Asparaginase|asparaginase|mesh-list
6493389|NCT00613457|Mercaptopurine|mercaptopurine|mesh-list
6493390|NCT00613457|Thioguanine|thioguanine|mesh-list
5902625|NCT04038489|Hormone Antagonists|hormone antagonists|mesh-ancestor
5902626|NCT04038489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5902627|NCT04038489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5908381|NCT04600336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5654185|NCT03685331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6493391|NCT00613457|Vindesine|vindesine|mesh-list
6493392|NCT00613457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5831776|NCT02548494|Insulin|insulin|mesh-list
5831777|NCT02548494|Insulin Glargine|insulin glargine|mesh-list
5831778|NCT02548494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5831779|NCT02548494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831780|NCT02548403|Simethicone|simethicone|mesh-list
5831781|NCT02548403|Antifoaming Agents|antifoaming agents|mesh-ancestor
5831782|NCT02548403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831783|NCT02548403|Emollients|emollients|mesh-ancestor
5831784|NCT02548403|Dermatologic Agents|dermatologic agents|mesh-ancestor
5831785|NCT02548364|Vitamin D|vitamin d|mesh-list
5831786|NCT02548364|Calcifediol|calcifediol|mesh-list
5831787|NCT02548364|Vitamins|vitamins|mesh-ancestor
5831788|NCT02548364|Micronutrients|micronutrients|mesh-ancestor
5831789|NCT02548364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831790|NCT02548364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5831791|NCT02548117|Finasteride|finasteride|mesh-list
5831792|NCT02548117|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
5831793|NCT02548117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5831794|NCT02548117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5831795|NCT02548117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831796|NCT02548117|Hormone Antagonists|hormone antagonists|mesh-ancestor
5831797|NCT02548117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5831798|NCT02548117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831799|NCT02548117|Urological Agents|urological agents|mesh-ancestor
5831800|NCT02548195|Gemcitabine|gemcitabine|mesh-list
5831801|NCT02548195|Capecitabine|capecitabine|mesh-list
5831802|NCT02548195|Oxaliplatin|oxaliplatin|mesh-list
5831803|NCT02548195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5831804|NCT02548195|Antimetabolites|antimetabolites|mesh-ancestor
5831805|NCT02548195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831806|NCT02548195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5831807|NCT02548195|Antiviral Agents|antiviral agents|mesh-ancestor
5831808|NCT02548195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5831809|NCT02548195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5831810|NCT02548195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5831811|NCT02548195|Immunologic Factors|immunologic factors|mesh-ancestor
5831812|NCT02548195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831813|NCT02548286|Amlodipine|amlodipine|mesh-list
5831814|NCT02548286|Candesartan|candesartan|mesh-list
5831815|NCT02548286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5831816|NCT02548286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5831817|NCT02548286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5831818|NCT02548286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831819|NCT02548286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5831820|NCT02548286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831821|NCT02548286|Vasodilator Agents|vasodilator agents|mesh-ancestor
5831822|NCT02548286|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5831823|NCT02548286|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5831824|NCT02548052|Betamethasone|betamethasone|mesh-list
5831825|NCT02548052|Betamethasone Valerate|betamethasone valerate|mesh-list
5831826|NCT02548052|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5654186|NCT03685331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5654187|NCT03685331|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5654188|NCT03685331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5654189|NCT03685331|Hormone Antagonists|hormone antagonists|mesh-ancestor
5831827|NCT02548052|Betamethasone benzoate|betamethasone benzoate|mesh-list
5831828|NCT02548052|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
5831829|NCT02548052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5831830|NCT02548052|Glucocorticoids|glucocorticoids|mesh-ancestor
5654190|NCT03685331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5654191|NCT03685331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654192|NCT03685331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5654193|NCT03685253|Niacinamide|niacinamide|mesh-list
5654194|NCT03685253|Vitamin B Complex|vitamin b complex|mesh-ancestor
5654195|NCT03685253|Vitamins|vitamins|mesh-ancestor
5654196|NCT03685253|Micronutrients|micronutrients|mesh-ancestor
5654197|NCT03685253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654198|NCT03685149|Flecainide|flecainide|mesh-list
5654199|NCT03685149|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5654200|NCT03685149|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5654201|NCT03685149|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5831831|NCT02548052|Hormones|hormones|mesh-ancestor
5831832|NCT02548052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5831833|NCT02548052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831834|NCT02548052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5831835|NCT02548052|Respiratory System Agents|respiratory system agents|mesh-ancestor
5831836|NCT02547597|Atenolol|atenolol|mesh-list
5831837|NCT02547597|Carvedilol|carvedilol|mesh-list
5831838|NCT02547597|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5831839|NCT02547597|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5654202|NCT03685149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5654203|NCT03685149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5654204|NCT03685084|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5654205|NCT03685084|Piperacillin|piperacillin|mesh-list
5654206|NCT03685084|Cefepime|cefepime|mesh-list
5654207|NCT03685084|Lactams|lactams|mesh-list
5654208|NCT03685084|beta-Lactams|beta-lactams|mesh-list
5654209|NCT03685084|Enmetazobactam|enmetazobactam|mesh-list
5654210|NCT03685084|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5654211|NCT03685084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5654212|NCT03685084|Antitubercular Agents|antitubercular agents|mesh-ancestor
5654213|NCT03685084|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5654214|NCT03685084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5654215|NCT03685084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5654216|NCT03685032|Dexamethasone|dexamethasone|mesh-list
5654217|NCT03685032|Ondansetron|ondansetron|mesh-list
5654218|NCT03685032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5654219|NCT03685032|Antiemetics|antiemetics|mesh-ancestor
5654220|NCT03685032|Autonomic Agents|autonomic agents|mesh-ancestor
5831840|NCT02547597|Adrenergic Agents|adrenergic agents|mesh-ancestor
5831841|NCT02547597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5831842|NCT02547597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831843|NCT02547597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831844|NCT02547597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5831845|NCT02547597|Antioxidants|antioxidants|mesh-ancestor
5831846|NCT02547597|Protective Agents|protective agents|mesh-ancestor
5831847|NCT02547597|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5831848|NCT02547597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5831849|NCT02547597|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5831850|NCT02547597|Vasodilator Agents|vasodilator agents|mesh-ancestor
5831851|NCT02547597|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5831852|NCT02547597|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5831853|NCT02547597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5831854|NCT02547597|Sympatholytics|sympatholytics|mesh-ancestor
5831855|NCT02547597|Autonomic Agents|autonomic agents|mesh-ancestor
5831856|NCT02547597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5831857|NCT02547597|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5831858|NCT02547662|Dexamethasone|dexamethasone|mesh-list
5831859|NCT02547662|Dexamethasone acetate|dexamethasone acetate|mesh-list
5831860|NCT02547662|Pomalidomide|pomalidomide|mesh-list
5831861|NCT02547662|Ixazomib|ixazomib|mesh-list
5831862|NCT02547662|Ichthammol|ichthammol|mesh-list
5831863|NCT02547662|BB 1101|bb 1101|mesh-list
5831864|NCT02547662|Glycine|glycine|mesh-list
5831865|NCT02547662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5831866|NCT02547662|Antiemetics|antiemetics|mesh-ancestor
5831867|NCT02547662|Autonomic Agents|autonomic agents|mesh-ancestor
5831868|NCT02547662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5831869|NCT02547662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831870|NCT02547662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5831871|NCT02547662|Glucocorticoids|glucocorticoids|mesh-ancestor
5654221|NCT03685032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5654222|NCT03685032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654223|NCT03685032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5654224|NCT03685032|Glucocorticoids|glucocorticoids|mesh-ancestor
5654225|NCT03685032|Hormones|hormones|mesh-ancestor
5654226|NCT03685032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5654227|NCT03685032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5654228|NCT03685032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5654229|NCT03685032|Antipruritics|antipruritics|mesh-ancestor
5654230|NCT03685032|Dermatologic Agents|dermatologic agents|mesh-ancestor
5654231|NCT03685032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5654232|NCT03685032|Serotonin Agents|serotonin agents|mesh-ancestor
5654233|NCT03685032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5654234|NCT03685032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5654235|NCT03685032|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5654236|NCT03685032|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5654237|NCT03685032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5654238|NCT03685032|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5831872|NCT02547662|Hormones|hormones|mesh-ancestor
5902628|NCT04038489|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5654239|NCT03685032|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5654240|NCT03684993|Chlorhexidine|chlorhexidine|mesh-list
5654241|NCT03684993|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5654242|NCT03684993|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5831873|NCT02547662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5831874|NCT02547662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5831875|NCT02547662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5831876|NCT02547662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831877|NCT02547662|Protease Inhibitors|protease inhibitors|mesh-ancestor
5831878|NCT02547662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5831879|NCT02547662|Immunologic Factors|immunologic factors|mesh-ancestor
5831880|NCT02547662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5831881|NCT02547662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5831882|NCT02547662|Growth Substances|growth substances|mesh-ancestor
5831883|NCT02547662|Growth Inhibitors|growth inhibitors|mesh-ancestor
5831884|NCT02547662|Dermatologic Agents|dermatologic agents|mesh-ancestor
5831885|NCT02547662|Glycine Agents|glycine agents|mesh-ancestor
5831886|NCT02547662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5831887|NCT02547792|Vaccines|vaccines|mesh-list
5831888|NCT02547792|Immunologic Factors|immunologic factors|mesh-ancestor
5831889|NCT02547792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831890|NCT02547870|Rilpivirine|rilpivirine|mesh-list
5831891|NCT02547870|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5831892|NCT02547870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5831893|NCT02547870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5831894|NCT02547870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831895|NCT02547870|Antiviral Agents|antiviral agents|mesh-ancestor
5831896|NCT02547870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5831897|NCT02547870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5831898|NCT02547870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5831899|NCT02547896|Diclofenac|diclofenac|mesh-list
5831900|NCT02547896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
5831901|NCT02547896|Codeine|codeine|mesh-list
5831902|NCT02547896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5831903|NCT02547896|Analgesics|analgesics|mesh-ancestor
5831904|NCT02547896|Sensory System Agents|sensory system agents|mesh-ancestor
5831905|NCT02547896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5831906|NCT02547896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654243|NCT03684993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5654244|NCT03684993|Disinfectants|disinfectants|mesh-ancestor
5654245|NCT03684993|Dermatologic Agents|dermatologic agents|mesh-ancestor
5654246|NCT03684876|Diuretics|diuretics|mesh-list
5654247|NCT03684876|Natriuretic Agents|natriuretic agents|mesh-ancestor
5654248|NCT03684876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654249|NCT03684863|Capecitabine|capecitabine|mesh-list
5654250|NCT03684863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5654251|NCT03684863|Antimetabolites|antimetabolites|mesh-ancestor
5654252|NCT03684863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5654253|NCT03684863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5654254|NCT03684837|Vitamin D|vitamin d|mesh-list
5654255|NCT03684837|Vitamins|vitamins|mesh-ancestor
5654256|NCT03684837|Micronutrients|micronutrients|mesh-ancestor
5654257|NCT03684837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654258|NCT03684837|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5654259|NCT03684824|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5654260|NCT03684824|Luteolytic Agents|luteolytic agents|mesh-ancestor
5654261|NCT03684824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5654262|NCT03684824|Contraceptive Agents|contraceptive agents|mesh-ancestor
5654263|NCT03684824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5654264|NCT03684824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654265|NCT03684824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5654266|NCT03684824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5654267|NCT03684824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5654268|NCT03684811|Gemcitabine|gemcitabine|mesh-list
5654269|NCT03684811|Nivolumab|nivolumab|mesh-list
5654270|NCT03684811|Azacitidine|azacitidine|mesh-list
5654271|NCT03684811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5654272|NCT03684811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5654273|NCT03684811|Antimetabolites|antimetabolites|mesh-ancestor
5654274|NCT03684811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5654275|NCT03684811|Antiviral Agents|antiviral agents|mesh-ancestor
5654276|NCT03684811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5654277|NCT03684811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5654278|NCT03684811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5654279|NCT03684811|Immunologic Factors|immunologic factors|mesh-ancestor
5831907|NCT02547896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5831908|NCT02547896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5831909|NCT02547896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5831910|NCT02547896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5831911|NCT02547896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831912|NCT02547896|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5831913|NCT02547896|Narcotics|narcotics|mesh-ancestor
5831914|NCT02547896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5831915|NCT02547896|Antitussive Agents|antitussive agents|mesh-ancestor
5831916|NCT02547896|Respiratory System Agents|respiratory system agents|mesh-ancestor
5831917|NCT02547844|Tenofovir|tenofovir|mesh-list
5654280|NCT03684811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654281|NCT03684811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5654282|NCT03684811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5654283|NCT03684772|Digoxin|digoxin|mesh-list
5654284|NCT03684772|Furosemide|furosemide|mesh-list
5654285|NCT03684772|Diuretics|diuretics|mesh-ancestor
5654286|NCT03684772|Natriuretic Agents|natriuretic agents|mesh-ancestor
5654287|NCT03684772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654288|NCT03684772|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5831918|NCT02547844|Efavirenz|efavirenz|mesh-list
5831919|NCT02547844|Emtricitabine|emtricitabine|mesh-list
5831920|NCT02547844|Antiviral Agents|antiviral agents|mesh-ancestor
5831921|NCT02547844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5831922|NCT02547844|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5831923|NCT02547844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5831924|NCT02547844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5831925|NCT02547844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831926|NCT02547844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5831927|NCT02547844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5831928|NCT02547844|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5831929|NCT02547844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5831930|NCT02547844|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5831931|NCT02547844|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5831932|NCT02547844|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5831933|NCT02547844|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5831934|NCT02547519|Insulin|insulin|mesh-list
5831935|NCT02547519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5831936|NCT02547519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831937|NCT02547350|Pirarubicin|pirarubicin|mesh-list
5831938|NCT02547350|Epirubicin|epirubicin|mesh-list
5831939|NCT02547350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5831940|NCT02547350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5831941|NCT02547350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5831942|NCT02547350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5831943|NCT02547350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5831944|NCT02547350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831945|NCT02547402|CXA-10|cxa-10|mesh-list
5831946|NCT02547402|Simvastatin|simvastatin|mesh-list
5831947|NCT02547402|Ezetimibe|ezetimibe|mesh-list
5831948|NCT02547402|Pravastatin|pravastatin|mesh-list
5654289|NCT03684772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5654290|NCT03684772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5654291|NCT03684772|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5654292|NCT03684772|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5654293|NCT03684772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5654294|NCT03684772|Protective Agents|protective agents|mesh-ancestor
5654295|NCT03684707|Metformin|metformin|mesh-list
5654296|NCT03684707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5654297|NCT03684707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654298|NCT03684564|Warfarin|warfarin|mesh-list
5654299|NCT03684564|Rivaroxaban|rivaroxaban|mesh-list
5654300|NCT03684564|Anticoagulants|anticoagulants|mesh-ancestor
5654301|NCT03684564|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5654302|NCT03684564|Antithrombins|antithrombins|mesh-ancestor
5654303|NCT03684564|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5654304|NCT03684564|Protease Inhibitors|protease inhibitors|mesh-ancestor
5654305|NCT03684564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5654306|NCT03684564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5654307|NCT03684538|Zinc|zinc|mesh-list
5654308|NCT03684538|Trace Elements|trace elements|mesh-ancestor
5654309|NCT03684538|Micronutrients|micronutrients|mesh-ancestor
5654310|NCT03684538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654311|NCT03684447|Propofol|propofol|mesh-list
5654312|NCT03684447|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5831949|NCT02547402|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
5654313|NCT03684447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5654314|NCT03684447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654315|NCT03684447|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5654316|NCT03684447|Anesthetics, General|anesthetics, general|mesh-ancestor
5654317|NCT03684447|Anesthetics|anesthetics|mesh-ancestor
5654318|NCT03684395|Warfarin|warfarin|mesh-list
5654319|NCT03684395|Rivaroxaban|rivaroxaban|mesh-list
5831950|NCT02547402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5831951|NCT02547402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5831952|NCT02547402|Antimetabolites|antimetabolites|mesh-ancestor
5831953|NCT02547402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831954|NCT02547402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5831955|NCT02547402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5654320|NCT03684395|Dabigatran|dabigatran|mesh-list
5654321|NCT03684395|Apixaban|apixaban|mesh-list
5654322|NCT03684395|Anticoagulants|anticoagulants|mesh-ancestor
5654323|NCT03684395|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5654324|NCT03684395|Antithrombins|antithrombins|mesh-ancestor
5654325|NCT03684395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5654326|NCT03684395|Protease Inhibitors|protease inhibitors|mesh-ancestor
5654327|NCT03684395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5654328|NCT03684395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5654329|NCT03684330|Vitamin D|vitamin d|mesh-list
5654330|NCT03684330|Vitamins|vitamins|mesh-ancestor
5654331|NCT03684330|Micronutrients|micronutrients|mesh-ancestor
5654332|NCT03684330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654333|NCT03684330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5654334|NCT03684278|Infliximab|infliximab|mesh-list
5654335|NCT03684278|Dermatologic Agents|dermatologic agents|mesh-ancestor
5654336|NCT03684278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5654337|NCT03684278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5654338|NCT03684018|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5654339|NCT03684018|Immunologic Factors|immunologic factors|mesh-ancestor
5654340|NCT03684018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654341|NCT03683914|Dinoprostone|dinoprostone|mesh-list
5654342|NCT03683914|Oxytocics|oxytocics|mesh-ancestor
5654343|NCT03683914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5654344|NCT03683914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831956|NCT02547402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5831957|NCT02547402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5831958|NCT02547480|Irinotecan|irinotecan|mesh-list
5831959|NCT02547480|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5831960|NCT02547480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5831961|NCT02547480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5831962|NCT02547480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831963|NCT02547480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5831964|NCT02547025|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5831965|NCT02547025|Amoxicillin|amoxicillin|mesh-list
5831966|NCT02547025|Clarithromycin|clarithromycin|mesh-list
5831967|NCT02547025|Levofloxacin|levofloxacin|mesh-list
5831968|NCT02547025|Ofloxacin|ofloxacin|mesh-list
5831969|NCT02547025|Tetracycline|tetracycline|mesh-list
5831970|NCT02547025|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5831971|NCT02547025|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
5831972|NCT02547025|Rabeprazole|rabeprazole|mesh-list
5831973|NCT02547025|Bismuth|bismuth|mesh-list
5831974|NCT02547025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5831975|NCT02547025|Antitubercular Agents|antitubercular agents|mesh-ancestor
5831976|NCT02547025|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5831977|NCT02547025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5831978|NCT02547025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5831979|NCT02547025|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5831980|NCT02547025|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5831981|NCT02547025|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5831982|NCT02547025|Renal Agents|renal agents|mesh-ancestor
5831983|NCT02547025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5831984|NCT02547025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5831985|NCT02547025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5831986|NCT02547025|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5831987|NCT02547025|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5831988|NCT02547025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5831989|NCT02547025|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5831990|NCT02547025|Antacids|antacids|mesh-ancestor
5694848|NCT03393507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694849|NCT03393481|Enoxaparin|enoxaparin|mesh-list
5694850|NCT03393481|Anticoagulants|anticoagulants|mesh-ancestor
5831991|NCT02547155|Anesthetics|anesthetics|mesh-list
6493393|NCT00613457|Immunologic Factors|immunologic factors|mesh-ancestor
5831992|NCT02547155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5654345|NCT03683810|Lactoferrin|lactoferrin|mesh-list
5831993|NCT02547155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5831994|NCT02547103|Chlorhexidine|chlorhexidine|mesh-list
5831995|NCT02547103|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5831996|NCT02547103|Mupirocin|mupirocin|mesh-list
5831997|NCT02547103|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5831998|NCT02547103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5831999|NCT02547103|Disinfectants|disinfectants|mesh-ancestor
5832000|NCT02547103|Dermatologic Agents|dermatologic agents|mesh-ancestor
5832001|NCT02547103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5832002|NCT02547103|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5832003|NCT02547103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5832004|NCT02547103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832005|NCT02547116|Rifampin|rifampin|mesh-list
5832006|NCT02547116|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5832007|NCT02547116|Antitubercular Agents|antitubercular agents|mesh-ancestor
5832008|NCT02547116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5832009|NCT02547116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5832010|NCT02547116|Leprostatic Agents|leprostatic agents|mesh-ancestor
5832011|NCT02547116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5832012|NCT02547116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5832013|NCT02547116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832014|NCT02547116|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5832015|NCT02547116|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5832016|NCT02547116|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5832017|NCT02547116|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5832018|NCT02547116|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5832019|NCT02547116|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5832020|NCT02546843|Rocuronium|rocuronium|mesh-list
5832021|NCT02546843|Atracurium|atracurium|mesh-list
5832022|NCT02546843|Cisatracurium|cisatracurium|mesh-list
5832023|NCT02546843|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5832024|NCT02546843|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5832025|NCT02546843|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5832026|NCT02546843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5832027|NCT02546843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832028|NCT02546843|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
5832029|NCT02546843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5832030|NCT02546843|Cholinergic Agents|cholinergic agents|mesh-ancestor
5832031|NCT02546843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5832032|NCT02546843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832033|NCT02546791|Dasatinib|dasatinib|mesh-list
5832034|NCT02546791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5832035|NCT02546791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5832036|NCT02546791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5832037|NCT02546791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5654346|NCT03683810|Epoetin Alfa|epoetin alfa|mesh-list
5654347|NCT03683810|Hematinics|hematinics|mesh-ancestor
5654348|NCT03683810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5654349|NCT03683667|Azithromycin|azithromycin|mesh-list
5654350|NCT03683667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5654351|NCT03683667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5654352|NCT03683563|Citric Acid|citric acid|mesh-list
5654353|NCT03683563|Sodium Citrate|sodium citrate|mesh-list
5654354|NCT03683563|Anticoagulants|anticoagulants|mesh-ancestor
5654355|NCT03683563|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5654356|NCT03683563|Chelating Agents|chelating agents|mesh-ancestor
5654357|NCT03683563|Sequestering Agents|sequestering agents|mesh-ancestor
5654358|NCT03683563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5654359|NCT03683524|Darunavir|darunavir|mesh-list
5654360|NCT03683524|Dolutegravir|dolutegravir|mesh-list
5654361|NCT03683524|Cobicistat|cobicistat|mesh-list
5832038|NCT02546804|Chlorhexidine|chlorhexidine|mesh-list
5832039|NCT02546804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5832040|NCT02546804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5832041|NCT02546804|Disinfectants|disinfectants|mesh-ancestor
5832042|NCT02546934|Gemcitabine|gemcitabine|mesh-list
5832043|NCT02546934|Cisplatin|cisplatin|mesh-list
5832044|NCT02546934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5832045|NCT02546934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5832046|NCT02546934|Antimetabolites|antimetabolites|mesh-ancestor
5832047|NCT02546934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832048|NCT02546934|Antiviral Agents|antiviral agents|mesh-ancestor
5832049|NCT02546934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5832050|NCT02546934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5832051|NCT02546934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5832052|NCT02546934|Immunologic Factors|immunologic factors|mesh-ancestor
5832053|NCT02546934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832054|NCT02546648|Tranexamic Acid|tranexamic acid|mesh-list
5832055|NCT02546648|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5832056|NCT02546648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5832057|NCT02546648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5832058|NCT02546648|Antimetabolites|antimetabolites|mesh-ancestor
5832059|NCT02546648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832060|NCT02546648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5832061|NCT02546648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5832062|NCT02546648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5832063|NCT02546648|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5832064|NCT02546648|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5832065|NCT02546648|Hemostatics|hemostatics|mesh-ancestor
5832066|NCT02546648|Coagulants|coagulants|mesh-ancestor
5832067|NCT02546583|Chlorothiazide|chlorothiazide|mesh-list
5832068|NCT02546583|Furosemide|furosemide|mesh-list
5832069|NCT02546583|Bumetanide|bumetanide|mesh-list
5832070|NCT02546583|Diuretics|diuretics|mesh-list
5832071|NCT02546583|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
5832072|NCT02546583|Natriuretic Agents|natriuretic agents|mesh-ancestor
5654362|NCT03683524|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5654363|NCT03683524|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5654364|NCT03683524|Protease Inhibitors|protease inhibitors|mesh-ancestor
5654365|NCT03683524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5654366|NCT03683524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5654367|NCT03683524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6493394|NCT00613457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493395|NCT00613457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6493396|NCT00613457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6493397|NCT00613457|Alkylating Agents|alkylating agents|mesh-ancestor
6493398|NCT00613457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493399|NCT00613457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6493400|NCT00613457|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6493401|NCT00613457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6493402|NCT00613457|Antiemetics|antiemetics|mesh-ancestor
6493403|NCT00613457|Autonomic Agents|autonomic agents|mesh-ancestor
6493404|NCT00613457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5654368|NCT03683524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5654369|NCT03683524|Antiviral Agents|antiviral agents|mesh-ancestor
5654370|NCT03683524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5654371|NCT03683524|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5654372|NCT03683524|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5654373|NCT03683524|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5654374|NCT03683524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5654375|NCT03683433|Azacitidine|azacitidine|mesh-list
5654376|NCT03683433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5654377|NCT03683433|Antimetabolites|antimetabolites|mesh-ancestor
5654378|NCT03683433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832073|NCT02546583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832074|NCT02546583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5832075|NCT02546583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832076|NCT02546583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5832077|NCT02546583|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5902629|NCT04038489|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5902630|NCT04038489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5902631|NCT03956368|Atorvastatin|atorvastatin|mesh-list
5902632|NCT03956368|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5902633|NCT03956368|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5902634|NCT03956368|Antimetabolites|antimetabolites|mesh-ancestor
6493405|NCT00613457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5832078|NCT02546531|Gemcitabine|gemcitabine|mesh-list
5832079|NCT02546531|Pembrolizumab|pembrolizumab|mesh-list
5832080|NCT02546531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5832081|NCT02546531|Antimetabolites|antimetabolites|mesh-ancestor
5832082|NCT02546531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832083|NCT02546531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5832084|NCT02546531|Antiviral Agents|antiviral agents|mesh-ancestor
5832085|NCT02546531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5832086|NCT02546531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5832087|NCT02546531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5832088|NCT02546531|Immunologic Factors|immunologic factors|mesh-ancestor
5832089|NCT02546531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832090|NCT02546531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5832091|NCT02546440|Dimethyl Fumarate|dimethyl fumarate|mesh-list
5832092|NCT02546440|Dermatologic Agents|dermatologic agents|mesh-ancestor
5832093|NCT02546440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5832094|NCT02546440|Immunologic Factors|immunologic factors|mesh-ancestor
5832095|NCT02546440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832096|NCT02546401|Insulin Aspart|insulin aspart|mesh-list
5832097|NCT02546401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5832098|NCT02546401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832099|NCT02546141|Caseins|caseins|mesh-list
5832100|NCT02546141|Chelating Agents|chelating agents|mesh-ancestor
5832101|NCT02546141|Sequestering Agents|sequestering agents|mesh-ancestor
5832102|NCT02546141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832103|NCT02546349|Fluticasone|fluticasone|mesh-list
5832104|NCT02546349|Tiotropium Bromide|tiotropium bromide|mesh-list
5832105|NCT02546349|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5832106|NCT02546349|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
5832107|NCT02546349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5654379|NCT03683433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5654380|NCT03683433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5654381|NCT03683329|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5654382|NCT03683329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5654383|NCT03683277|Dexamethasone|dexamethasone|mesh-list
5654384|NCT03683277|Pomalidomide|pomalidomide|mesh-list
5654385|NCT03683277|Ixazomib|ixazomib|mesh-list
5654386|NCT03683277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5654387|NCT03683277|Antiemetics|antiemetics|mesh-ancestor
5832108|NCT02546349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5832109|NCT02546349|Autonomic Agents|autonomic agents|mesh-ancestor
5832110|NCT02546349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5832111|NCT02546349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832112|NCT02546349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5832113|NCT02546349|Respiratory System Agents|respiratory system agents|mesh-ancestor
5832114|NCT02546349|Dermatologic Agents|dermatologic agents|mesh-ancestor
5832115|NCT02546349|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5832116|NCT02546349|Parasympatholytics|parasympatholytics|mesh-ancestor
5832117|NCT02546349|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5832118|NCT02546349|Cholinergic Agents|cholinergic agents|mesh-ancestor
5832119|NCT02546349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5832120|NCT02546349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832121|NCT02546349|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5832122|NCT02546349|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5832123|NCT02546349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5832124|NCT02546349|Adrenergic Agents|adrenergic agents|mesh-ancestor
5832125|NCT02546349|Glucocorticoids|glucocorticoids|mesh-ancestor
5832126|NCT02546349|Hormones|hormones|mesh-ancestor
5832127|NCT02546349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5832128|NCT02546349|Sympathomimetics|sympathomimetics|mesh-ancestor
5832129|NCT02546154|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
5832130|NCT02546154|Hematinics|hematinics|mesh-ancestor
5832131|NCT02546232|Paclitaxel|paclitaxel|mesh-list
5832132|NCT02546232|Carboplatin|carboplatin|mesh-list
5832133|NCT02546232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5832134|NCT02546232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5654388|NCT03683277|Autonomic Agents|autonomic agents|mesh-ancestor
5654389|NCT03683277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5654390|NCT03683277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654391|NCT03683277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5654392|NCT03683277|Glucocorticoids|glucocorticoids|mesh-ancestor
5654393|NCT03683277|Hormones|hormones|mesh-ancestor
5654394|NCT03683277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5654395|NCT03683277|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5832135|NCT02546232|Tubulin Modulators|tubulin modulators|mesh-ancestor
5832136|NCT02546232|Antimitotic Agents|antimitotic agents|mesh-ancestor
5832137|NCT02546232|Mitosis Modulators|mitosis modulators|mesh-ancestor
5832138|NCT02546232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832139|NCT02546297|Budesonide|budesonide|mesh-list
5832140|NCT02546297|Bromides|bromides|mesh-list
5832141|NCT02546297|Formoterol Fumarate|formoterol fumarate|mesh-list
5832142|NCT02546297|Tiotropium Bromide|tiotropium bromide|mesh-list
5832143|NCT02546297|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
5832144|NCT02546297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5832145|NCT02546297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5832146|NCT02546297|Autonomic Agents|autonomic agents|mesh-ancestor
5832147|NCT02546297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5832148|NCT02546297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832149|NCT02546297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5832150|NCT02546297|Respiratory System Agents|respiratory system agents|mesh-ancestor
5832151|NCT02546297|Glucocorticoids|glucocorticoids|mesh-ancestor
5832152|NCT02546297|Hormones|hormones|mesh-ancestor
5832153|NCT02546297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5832154|NCT02546297|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5832155|NCT02546297|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5832156|NCT02546297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5832157|NCT02546297|Adrenergic Agents|adrenergic agents|mesh-ancestor
5832158|NCT02546297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5832159|NCT02546297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832160|NCT02546297|Parasympatholytics|parasympatholytics|mesh-ancestor
5832161|NCT02546297|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5832162|NCT02546297|Cholinergic Agents|cholinergic agents|mesh-ancestor
5654396|NCT03683277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5654397|NCT03683277|Immunologic Factors|immunologic factors|mesh-ancestor
5654398|NCT03683277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5654399|NCT03683277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5654400|NCT03683277|Growth Substances|growth substances|mesh-ancestor
5654401|NCT03683277|Growth Inhibitors|growth inhibitors|mesh-ancestor
5654402|NCT03683277|Protease Inhibitors|protease inhibitors|mesh-ancestor
5654403|NCT03683277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5654404|NCT03683277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5654405|NCT03683108|Resveratrol|resveratrol|mesh-list
5654406|NCT03683108|Antioxidants|antioxidants|mesh-ancestor
5654407|NCT03683108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5654408|NCT03683108|Protective Agents|protective agents|mesh-ancestor
5654409|NCT03683108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654410|NCT03683108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5654411|NCT03683108|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5832163|NCT02546297|Anticonvulsants|anticonvulsants|mesh-ancestor
5832164|NCT02546050|Metformin|metformin|mesh-list
5832165|NCT02546050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6493406|NCT00613457|Glucocorticoids|glucocorticoids|mesh-ancestor
6493407|NCT00613457|Hormones|hormones|mesh-ancestor
6493408|NCT00613457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6493409|NCT00613457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6493410|NCT00613457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5832166|NCT02546050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832167|NCT02546024|Antidepressive Agents|antidepressive agents|mesh-list
5654412|NCT03683043|Leuprolide|leuprolide|mesh-list
5654413|NCT03683043|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5654414|NCT03683043|Fertility Agents|fertility agents|mesh-ancestor
5654415|NCT03683043|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5654416|NCT03683043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654417|NCT03683043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5654418|NCT03683043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5654419|NCT03682978|Baclofen|baclofen|mesh-list
5654420|NCT03682978|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5654421|NCT03682978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654422|NCT03682978|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5654423|NCT03682978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5654424|NCT03682978|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
5654425|NCT03682978|GABA Agonists|gaba agonists|mesh-ancestor
5654426|NCT03682978|GABA Agents|gaba agents|mesh-ancestor
5654427|NCT03682978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5654428|NCT03682978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5654429|NCT03682952|Alprostadil|alprostadil|mesh-list
5654430|NCT03682952|Beraprost|beraprost|mesh-list
5654431|NCT03682952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5832168|NCT02546024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5832169|NCT02545751|Thymalfasin|thymalfasin|mesh-list
5832170|NCT02545751|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5832171|NCT02545751|Immunologic Factors|immunologic factors|mesh-ancestor
5654432|NCT03682952|Vasodilator Agents|vasodilator agents|mesh-ancestor
5654433|NCT03682952|Urological Agents|urological agents|mesh-ancestor
5654434|NCT03682939|Vaccines|vaccines|mesh-list
5654435|NCT03682939|Immunologic Factors|immunologic factors|mesh-ancestor
5654436|NCT03682939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654437|NCT03682718|Misoprostol|misoprostol|mesh-list
5654438|NCT03682718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5654439|NCT03682718|Abortifacient Agents|abortifacient agents|mesh-ancestor
5654440|NCT03682718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5654441|NCT03682718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654442|NCT03682718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5654443|NCT03682718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5654444|NCT03682718|Oxytocics|oxytocics|mesh-ancestor
5654445|NCT03682692|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
5654446|NCT03682692|Protease Inhibitors|protease inhibitors|mesh-ancestor
5654447|NCT03682692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5654448|NCT03682692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5654449|NCT03682653|Azithromycin|azithromycin|mesh-list
5654450|NCT03682653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5654451|NCT03682653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5654452|NCT03682640|Insulin|insulin|mesh-list
5654453|NCT03682640|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5654454|NCT03682640|Insulin Lispro|insulin lispro|mesh-list
5654455|NCT03682640|Azithromycin|azithromycin|mesh-list
5654456|NCT03682640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5654457|NCT03682640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654458|NCT03682640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5654459|NCT03682640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5654460|NCT03682497|Spironolactone|spironolactone|mesh-list
5654461|NCT03682497|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5654462|NCT03682497|Hormone Antagonists|hormone antagonists|mesh-ancestor
5654463|NCT03682497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5654464|NCT03682497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654465|NCT03682497|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5832172|NCT02545751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832173|NCT02545842|Insulin Glargine|insulin glargine|mesh-list
5832174|NCT02545842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5832175|NCT02545842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832176|NCT02545712|Ethanol|ethanol|mesh-list
5832177|NCT02545712|Benzyl Alcohol|benzyl alcohol|mesh-list
5832178|NCT02545712|Sorbitol|sorbitol|mesh-list
5832179|NCT02545712|Glycerol|glycerol|mesh-list
5832180|NCT02545712|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5832181|NCT02545712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5832182|NCT02545712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5832183|NCT02545712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832184|NCT02545712|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
5832185|NCT02545712|Protective Agents|protective agents|mesh-ancestor
5832186|NCT02545712|Cathartics|cathartics|mesh-ancestor
5832187|NCT02545712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5832188|NCT02545712|Anesthetics, Local|anesthetics, local|mesh-ancestor
5832189|NCT02545712|Anesthetics|anesthetics|mesh-ancestor
5832190|NCT02545712|Sensory System Agents|sensory system agents|mesh-ancestor
5832191|NCT02545712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5832192|NCT02545777|Diclofenac|diclofenac|mesh-list
5832193|NCT02545777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5832194|NCT02545777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5832195|NCT02545777|Analgesics|analgesics|mesh-ancestor
5654466|NCT03682497|Diuretics|diuretics|mesh-ancestor
5654467|NCT03682497|Natriuretic Agents|natriuretic agents|mesh-ancestor
5654468|NCT03682471|Deoxycholic Acid|deoxycholic acid|mesh-list
5654469|NCT03682471|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5654470|NCT03682471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5654471|NCT03682393|Hydrocortisone|hydrocortisone|mesh-list
5654472|NCT03682393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5694851|NCT03393481|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5694852|NCT03393481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5694853|NCT03393481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694854|NCT03393416|Antibodies|antibodies|mesh-list
5694855|NCT03393416|Immunologic Factors|immunologic factors|mesh-ancestor
5832196|NCT02545777|Sensory System Agents|sensory system agents|mesh-ancestor
5832197|NCT02545777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5694856|NCT03393416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694857|NCT03393403|Dexmedetomidine|dexmedetomidine|mesh-list
5832198|NCT02545777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832199|NCT02545777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5832200|NCT02545777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5832201|NCT02545777|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5832202|NCT02545777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5832203|NCT02545777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832204|NCT02545972|Tacrolimus|tacrolimus|mesh-list
5832205|NCT02545972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5832206|NCT02545972|Immunologic Factors|immunologic factors|mesh-ancestor
5654473|NCT03682289|Olaparib|olaparib|mesh-list
5654474|NCT03682289|Adenosine|adenosine|mesh-list
5654475|NCT03682289|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5654476|NCT03682289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5654477|NCT03682289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5654478|NCT03682289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5654479|NCT03682289|Analgesics|analgesics|mesh-ancestor
5654480|NCT03682289|Sensory System Agents|sensory system agents|mesh-ancestor
5654481|NCT03682289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5654482|NCT03682289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654483|NCT03682289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5654484|NCT03682289|Vasodilator Agents|vasodilator agents|mesh-ancestor
5832207|NCT02545972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832208|NCT02545972|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5832209|NCT02545972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5832210|NCT02545972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832211|NCT02545959|Methylprednisolone|methylprednisolone|mesh-list
5654485|NCT03682289|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5654486|NCT03682289|Purinergic Agonists|purinergic agonists|mesh-ancestor
5654487|NCT03682289|Purinergic Agents|purinergic agents|mesh-ancestor
5654488|NCT03682289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5654489|NCT03682276|Nivolumab|nivolumab|mesh-list
5654490|NCT03682276|Ipilimumab|ipilimumab|mesh-list
5654491|NCT03682276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5654492|NCT03682276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5832212|NCT02545959|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5832213|NCT02545959|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5832214|NCT02545959|Prednisolone|prednisolone|mesh-list
5832215|NCT02545959|Prednisolone acetate|prednisolone acetate|mesh-list
5832216|NCT02545959|Rituximab|rituximab|mesh-list
5832217|NCT02545959|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5832218|NCT02545959|Prednisolone phosphate|prednisolone phosphate|mesh-list
5832219|NCT02545959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5832220|NCT02545959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5832221|NCT02545959|Immunologic Factors|immunologic factors|mesh-ancestor
5832222|NCT02545959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832223|NCT02545959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5832224|NCT02545959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5832225|NCT02545959|Antiemetics|antiemetics|mesh-ancestor
5832226|NCT02545959|Autonomic Agents|autonomic agents|mesh-ancestor
5832227|NCT02545959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5832228|NCT02545959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5832229|NCT02545959|Glucocorticoids|glucocorticoids|mesh-ancestor
5832230|NCT02545959|Hormones|hormones|mesh-ancestor
5832231|NCT02545959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5832232|NCT02545959|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5832233|NCT02545959|Protective Agents|protective agents|mesh-ancestor
5832234|NCT02545959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5832235|NCT02545634|Sulfalene|sulfalene|mesh-list
5832236|NCT02545634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5832237|NCT02545634|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5832238|NCT02545634|Renal Agents|renal agents|mesh-ancestor
5832239|NCT02545634|Antimalarials|antimalarials|mesh-ancestor
5832240|NCT02545634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5832241|NCT02545634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5832242|NCT02545738|Liraglutide|liraglutide|mesh-list
5832243|NCT02545738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5832244|NCT02545738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654493|NCT03682276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5654494|NCT03682276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5654495|NCT03682211|Fentanyl|fentanyl|mesh-list
5654496|NCT03682211|Morphine|morphine|mesh-list
5654497|NCT03682211|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5654498|NCT03682211|Narcotics|narcotics|mesh-ancestor
5654499|NCT03682211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5832245|NCT02545738|Incretins|incretins|mesh-ancestor
5832246|NCT02545738|Hormones|hormones|mesh-ancestor
5832247|NCT02545738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5832248|NCT02545465|Riociguat|riociguat|mesh-list
5832249|NCT02545465|Enzyme Activators|enzyme activators|mesh-ancestor
5832250|NCT02545465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832251|NCT02545426|Dialysis Solutions|dialysis solutions|mesh-list
5832252|NCT02545426|Calcium|calcium|mesh-list
5832253|NCT02545426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5832254|NCT02545426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654500|NCT03682211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654501|NCT03682211|Analgesics|analgesics|mesh-ancestor
5654502|NCT03682211|Sensory System Agents|sensory system agents|mesh-ancestor
5654503|NCT03682211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5654504|NCT03682211|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5654505|NCT03682211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5654506|NCT03682211|Anesthetics, General|anesthetics, general|mesh-ancestor
5654507|NCT03682211|Anesthetics|anesthetics|mesh-ancestor
5832255|NCT02545426|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5832256|NCT02545530|Clonidine|clonidine|mesh-list
5832257|NCT02545530|Analgesics|analgesics|mesh-ancestor
5832258|NCT02545530|Sensory System Agents|sensory system agents|mesh-ancestor
5832259|NCT02545530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5832260|NCT02545530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832261|NCT02545530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5654508|NCT03682198|Phenylephrine|phenylephrine|mesh-list
5654509|NCT03682198|Oxymetazoline|oxymetazoline|mesh-list
5654510|NCT03682198|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5654511|NCT03682198|Mydriatics|mydriatics|mesh-ancestor
5654512|NCT03682198|Autonomic Agents|autonomic agents|mesh-ancestor
5654513|NCT03682198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5654514|NCT03682198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832262|NCT02545530|Sympatholytics|sympatholytics|mesh-ancestor
5832263|NCT02545530|Autonomic Agents|autonomic agents|mesh-ancestor
5832264|NCT02545530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5832265|NCT02545530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5832266|NCT02545530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5832267|NCT02545530|Adrenergic Agents|adrenergic agents|mesh-ancestor
5832268|NCT02545530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5832269|NCT02545530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832270|NCT02545452|Anastrozole|anastrozole|mesh-list
5832271|NCT02545452|Levonorgestrel|levonorgestrel|mesh-list
5832272|NCT02545452|Nonoxynol|nonoxynol|mesh-list
5832273|NCT02545452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5832274|NCT02545452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5654515|NCT03682198|Sympathomimetics|sympathomimetics|mesh-ancestor
5654516|NCT03682198|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5654517|NCT03682198|Nasal Decongestants|nasal decongestants|mesh-ancestor
5654518|NCT03682198|Respiratory System Agents|respiratory system agents|mesh-ancestor
5654519|NCT03682198|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5654520|NCT03682198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5654521|NCT03682198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5654522|NCT03682198|Adrenergic Agents|adrenergic agents|mesh-ancestor
5654523|NCT03682198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5654524|NCT03682198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5654525|NCT03682198|Protective Agents|protective agents|mesh-ancestor
5654526|NCT03682172|Glucagon|glucagon|mesh-list
5654527|NCT03682172|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5654528|NCT03682172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5654529|NCT03682172|Hormones|hormones|mesh-ancestor
5654530|NCT03682172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5654531|NCT03682172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654532|NCT03682172|Incretins|incretins|mesh-ancestor
5654533|NCT03682029|Ascorbic Acid|ascorbic acid|mesh-list
5654534|NCT03682029|Vitamins|vitamins|mesh-ancestor
5654535|NCT03682029|Micronutrients|micronutrients|mesh-ancestor
5654536|NCT03682029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654537|NCT03682029|Antioxidants|antioxidants|mesh-ancestor
5832275|NCT02545452|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5832276|NCT02545452|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5832277|NCT02545452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5832278|NCT02545452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832279|NCT02545452|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5832280|NCT02545452|Hormone Antagonists|hormone antagonists|mesh-ancestor
5832281|NCT02545452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6493411|NCT00613457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5654538|NCT03682029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5654539|NCT03682029|Protective Agents|protective agents|mesh-ancestor
5832282|NCT02545452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832283|NCT02545452|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5832284|NCT02545452|Contraceptive Agents|contraceptive agents|mesh-ancestor
5832285|NCT02545452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5832286|NCT02545452|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5832287|NCT02545452|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5832288|NCT02545452|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5832289|NCT02545452|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
5832290|NCT02545452|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
5832291|NCT02545452|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5654540|NCT03681691|Estradiol|estradiol|mesh-list
5654541|NCT03681691|Estrogens|estrogens|mesh-ancestor
5654542|NCT03681691|Hormones|hormones|mesh-ancestor
5654543|NCT03681691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5654544|NCT03681691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654545|NCT03681652|Azathioprine|azathioprine|mesh-list
5654546|NCT03681652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5654547|NCT03681652|Antimetabolites|antimetabolites|mesh-ancestor
5654548|NCT03681652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5654549|NCT03681652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5654550|NCT03681652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5654551|NCT03681652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5654552|NCT03681652|Immunologic Factors|immunologic factors|mesh-ancestor
5654553|NCT03681652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654554|NCT03681639|Cobalt|cobalt|mesh-list
5654555|NCT03681639|Chromium|chromium|mesh-list
5654556|NCT03681639|Trace Elements|trace elements|mesh-ancestor
5654557|NCT03681639|Micronutrients|micronutrients|mesh-ancestor
5654558|NCT03681639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654559|NCT03681613|Pyrantel|pyrantel|mesh-list
5654560|NCT03681613|Pyrantel Pamoate|pyrantel pamoate|mesh-list
5654561|NCT03681613|Antinematodal Agents|antinematodal agents|mesh-ancestor
5654562|NCT03681613|Anthelmintics|anthelmintics|mesh-ancestor
5654563|NCT03681613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5654564|NCT03681613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5654565|NCT03681613|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
5654566|NCT03681613|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5654567|NCT03681613|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5654568|NCT03681613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5654569|NCT03681613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654570|NCT03681574|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
5654571|NCT03681574|GABA Agents|gaba agents|mesh-ancestor
5654572|NCT03681574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5654573|NCT03681574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5654574|NCT03681574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654575|NCT03681548|Doxorubicin|doxorubicin|mesh-list
5654576|NCT03681548|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5654577|NCT03681548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5654578|NCT03681548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5832292|NCT02545231|Pitavastatin|pitavastatin|mesh-list
5654579|NCT03681548|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5654580|NCT03681548|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5654581|NCT03681548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5654582|NCT03681548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5654583|NCT03681509|Pramipexole|pramipexole|mesh-list
5654584|NCT03681509|Antioxidants|antioxidants|mesh-ancestor
5654585|NCT03681509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5654586|NCT03681509|Protective Agents|protective agents|mesh-ancestor
5654587|NCT03681509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654588|NCT03681509|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5654589|NCT03681509|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5654590|NCT03681509|Dopamine Agonists|dopamine agonists|mesh-ancestor
5654591|NCT03681509|Dopamine Agents|dopamine agents|mesh-ancestor
5654592|NCT03681509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5654593|NCT03681470|Dapsone|dapsone|mesh-list
5654594|NCT03681470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5654595|NCT03681470|Antimalarials|antimalarials|mesh-ancestor
5654596|NCT03681470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5654597|NCT03681470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5654598|NCT03681470|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5654599|NCT03681470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5654600|NCT03681470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5654601|NCT03681470|Leprostatic Agents|leprostatic agents|mesh-ancestor
5654602|NCT03681470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5654603|NCT03681431|Ceftriaxone|ceftriaxone|mesh-list
5654604|NCT03681431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5654605|NCT03681431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5654606|NCT03681275|Tofacitinib|tofacitinib|mesh-list
5654607|NCT03681275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5654608|NCT03681275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5654609|NCT03681275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5654610|NCT03681197|Metformin|metformin|mesh-list
5654611|NCT03681197|Clomiphene|clomiphene|mesh-list
5654612|NCT03681197|Enclomiphene|enclomiphene|mesh-list
5654613|NCT03681197|Zuclomiphene|zuclomiphene|mesh-list
5654614|NCT03681197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5654615|NCT03681197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654616|NCT03681197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5654617|NCT03681197|Hormone Antagonists|hormone antagonists|mesh-ancestor
5654618|NCT03681197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5654619|NCT03681197|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5654620|NCT03681197|Fertility Agents|fertility agents|mesh-ancestor
5654621|NCT03681197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5654622|NCT03681197|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5654623|NCT03681197|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5654624|NCT03681158|Valproic Acid|valproic acid|mesh-list
5654625|NCT03681158|Anticonvulsants|anticonvulsants|mesh-ancestor
5654626|NCT03681158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5654627|NCT03681158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5654628|NCT03681158|GABA Agents|gaba agents|mesh-ancestor
5654629|NCT03681158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5654630|NCT03681158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654631|NCT03681158|Antimanic Agents|antimanic agents|mesh-ancestor
5654632|NCT03681158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5654633|NCT03681158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5654634|NCT03681158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5654635|NCT03680976|CXA-10|cxa-10|mesh-list
5654636|NCT03680976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5654637|NCT03680885|Lidocaine|lidocaine|mesh-list
5654638|NCT03680885|Anesthetics, Local|anesthetics, local|mesh-ancestor
5654639|NCT03680885|Anesthetics|anesthetics|mesh-ancestor
5654640|NCT03680885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5654641|NCT03680885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654642|NCT03680885|Sensory System Agents|sensory system agents|mesh-ancestor
5654643|NCT03680885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5654644|NCT03680885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5654645|NCT03680885|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5654646|NCT03680885|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5654647|NCT03680885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5832293|NCT02545231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5832294|NCT02545231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5832295|NCT02545231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5832296|NCT02545231|Antimetabolites|antimetabolites|mesh-ancestor
5832297|NCT02545231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832298|NCT02545231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5832299|NCT02545231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5832300|NCT02545244|Chlorhexidine|chlorhexidine|mesh-list
5832301|NCT02545244|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5832302|NCT02545244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5832303|NCT02545244|Disinfectants|disinfectants|mesh-ancestor
5832304|NCT02545010|Paclitaxel|paclitaxel|mesh-list
5832305|NCT02545010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5832306|NCT02545010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5832307|NCT02545010|Tubulin Modulators|tubulin modulators|mesh-ancestor
5832308|NCT02545010|Antimitotic Agents|antimitotic agents|mesh-ancestor
5832309|NCT02545010|Mitosis Modulators|mitosis modulators|mesh-ancestor
5832310|NCT02545010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5654648|NCT03680885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5654649|NCT03680716|Ropivacaine|ropivacaine|mesh-list
5654650|NCT03680716|Anesthetics, Local|anesthetics, local|mesh-ancestor
5654651|NCT03680716|Anesthetics|anesthetics|mesh-ancestor
5654652|NCT03680716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5654653|NCT03680716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654654|NCT03680716|Sensory System Agents|sensory system agents|mesh-ancestor
5654655|NCT03680716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5832311|NCT02544919|SMOFlipid|smoflipid|mesh-list
5832312|NCT02544919|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
5832313|NCT02544919|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5654656|NCT03680638|Allopurinol|allopurinol|mesh-list
5654657|NCT03680638|Tempol|tempol|mesh-list
5832314|NCT02544919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5902635|NCT03956368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902636|NCT03956368|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5902637|NCT03956368|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5902638|NCT03956368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5902639|NCT03933007|Fexofenadine|fexofenadine|mesh-list
5902640|NCT03933007|Colchicine|colchicine|mesh-list
5902641|NCT03933007|Midazolam|midazolam|mesh-list
5902642|NCT03933007|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5902643|NCT03933007|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5902644|NCT03933007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5902645|NCT03933007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902646|NCT03933007|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5902647|NCT03933007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5902648|NCT03933007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5902649|NCT03933007|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5902650|NCT03933007|Anesthetics, General|anesthetics, general|mesh-ancestor
5902651|NCT03933007|Anesthetics|anesthetics|mesh-ancestor
5902652|NCT03933007|GABA Modulators|gaba modulators|mesh-ancestor
5902653|NCT03933007|GABA Agents|gaba agents|mesh-ancestor
5902654|NCT03933007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5902655|NCT03933007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902656|NCT03933007|Gout Suppressants|gout suppressants|mesh-ancestor
5902657|NCT03933007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5654658|NCT03680638|Antimetabolites|antimetabolites|mesh-ancestor
5654659|NCT03680638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5654660|NCT03680638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5654661|NCT03680638|Gout Suppressants|gout suppressants|mesh-ancestor
5654662|NCT03680638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5654663|NCT03680638|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5654664|NCT03680638|Antioxidants|antioxidants|mesh-ancestor
5654665|NCT03680638|Protective Agents|protective agents|mesh-ancestor
5654666|NCT03680638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654667|NCT03680638|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5654668|NCT03680638|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5654669|NCT03680638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5654670|NCT03680612|Cefepime|cefepime|mesh-list
5654671|NCT03680612|Enmetazobactam|enmetazobactam|mesh-list
5654672|NCT03680612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5654673|NCT03680612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5654674|NCT03680612|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5654675|NCT03680612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5654676|NCT03680612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5654677|NCT03680573|Allopurinol|allopurinol|mesh-list
5654678|NCT03680573|Nitroprusside|nitroprusside|mesh-list
5654679|NCT03680573|Nitroarginine|nitroarginine|mesh-list
5654680|NCT03680573|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
5654681|NCT03680573|Antimetabolites|antimetabolites|mesh-ancestor
5654682|NCT03680573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5654683|NCT03680573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5654684|NCT03680573|Gout Suppressants|gout suppressants|mesh-ancestor
5654685|NCT03680573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5654686|NCT03680573|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5654687|NCT03680573|Antioxidants|antioxidants|mesh-ancestor
5654688|NCT03680573|Protective Agents|protective agents|mesh-ancestor
5654689|NCT03680573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654690|NCT03680573|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5654691|NCT03680573|Vasodilator Agents|vasodilator agents|mesh-ancestor
5654692|NCT03680573|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5654693|NCT03680560|Trastuzumab|trastuzumab|mesh-list
5654694|NCT03680560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5654695|NCT03680560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5694858|NCT03393403|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5694859|NCT03393403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5694860|NCT03393403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694861|NCT03393403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5694862|NCT03393403|Analgesics|analgesics|mesh-ancestor
5694863|NCT03393403|Sensory System Agents|sensory system agents|mesh-ancestor
5694864|NCT03393403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5694865|NCT03393403|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5694866|NCT03393403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5694867|NCT03393403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5694868|NCT03393403|Adrenergic Agents|adrenergic agents|mesh-ancestor
5694869|NCT03393403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5697975|NCT03372304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5654696|NCT03680508|Antibodies|antibodies|mesh-list
5654697|NCT03680508|Immunoglobulins|immunoglobulins|mesh-list
5654698|NCT03680508|Immunologic Factors|immunologic factors|mesh-ancestor
5654699|NCT03680508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654700|NCT03680495|Methylprednisolone|methylprednisolone|mesh-list
5654701|NCT03680495|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5654702|NCT03680495|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5654703|NCT03680495|Prednisolone|prednisolone|mesh-list
5654704|NCT03680495|Prednisolone acetate|prednisolone acetate|mesh-list
5654705|NCT03680495|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5654706|NCT03680495|Prednisolone phosphate|prednisolone phosphate|mesh-list
5654707|NCT03680495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5654708|NCT03680495|Antiemetics|antiemetics|mesh-ancestor
5654709|NCT03680495|Autonomic Agents|autonomic agents|mesh-ancestor
5654710|NCT03680495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5654711|NCT03680495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654712|NCT03680495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5654713|NCT03680495|Glucocorticoids|glucocorticoids|mesh-ancestor
5654714|NCT03680495|Hormones|hormones|mesh-ancestor
5654715|NCT03680495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5654716|NCT03680495|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5654717|NCT03680495|Protective Agents|protective agents|mesh-ancestor
5654718|NCT03680495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5654719|NCT03680495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5654720|NCT03680404|Allopurinol|allopurinol|mesh-list
5654721|NCT03680404|Phenylephrine|phenylephrine|mesh-list
5654722|NCT03680404|Oxymetazoline|oxymetazoline|mesh-list
5654723|NCT03680404|Tempol|tempol|mesh-list
5654724|NCT03680404|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5654725|NCT03680404|Mydriatics|mydriatics|mesh-ancestor
5654726|NCT03680404|Autonomic Agents|autonomic agents|mesh-ancestor
5654727|NCT03680404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5654728|NCT03680404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654729|NCT03680404|Sympathomimetics|sympathomimetics|mesh-ancestor
5832315|NCT02544906|Propofol|propofol|mesh-list
5832316|NCT02544906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5832317|NCT02544906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5832318|NCT02544906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654730|NCT03680404|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5654731|NCT03680404|Nasal Decongestants|nasal decongestants|mesh-ancestor
5654732|NCT03680404|Respiratory System Agents|respiratory system agents|mesh-ancestor
5654733|NCT03680404|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5654734|NCT03680404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5654735|NCT03680404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5654736|NCT03680404|Adrenergic Agents|adrenergic agents|mesh-ancestor
5654737|NCT03680404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5654738|NCT03680404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5654739|NCT03680404|Protective Agents|protective agents|mesh-ancestor
5654740|NCT03680404|Antimetabolites|antimetabolites|mesh-ancestor
5654741|NCT03680404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5654742|NCT03680404|Gout Suppressants|gout suppressants|mesh-ancestor
5654743|NCT03680404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5654744|NCT03680404|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5654745|NCT03680404|Antioxidants|antioxidants|mesh-ancestor
5654746|NCT03680404|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5654747|NCT03680404|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5654748|NCT03680404|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5654749|NCT03680378|Cefepime|cefepime|mesh-list
5654750|NCT03680378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5832319|NCT02544906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5832320|NCT02544906|Anesthetics, General|anesthetics, general|mesh-ancestor
5832321|NCT02544906|Anesthetics|anesthetics|mesh-ancestor
5832322|NCT02544880|Tadalafil|tadalafil|mesh-list
5832323|NCT02544880|Vaccines|vaccines|mesh-list
5832324|NCT02544880|Immunologic Factors|immunologic factors|mesh-ancestor
5832325|NCT02544880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654751|NCT03680378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5654752|NCT03680352|Cefepime|cefepime|mesh-list
5654753|NCT03680352|Enmetazobactam|enmetazobactam|mesh-list
5654754|NCT03680352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5654755|NCT03680352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5832326|NCT02544880|Vasodilator Agents|vasodilator agents|mesh-ancestor
5832327|NCT02544880|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5654756|NCT03680352|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5654757|NCT03680352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5654758|NCT03680352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5654759|NCT03680339|Misoprostol|misoprostol|mesh-list
5654760|NCT03680339|Oxytocin|oxytocin|mesh-list
5902658|NCT03933007|Tubulin Modulators|tubulin modulators|mesh-ancestor
5654761|NCT03680339|Oxytocics|oxytocics|mesh-ancestor
5654762|NCT03680339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5654763|NCT03680339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654764|NCT03680339|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5832328|NCT02544880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5832329|NCT02544880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5832330|NCT02544880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832331|NCT02544880|Urological Agents|urological agents|mesh-ancestor
5832332|NCT02544893|Dexmedetomidine|dexmedetomidine|mesh-list
5654765|NCT03680339|Abortifacient Agents|abortifacient agents|mesh-ancestor
5654766|NCT03680339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5654767|NCT03680339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5654768|NCT03680183|Entecavir|entecavir|mesh-list
5654769|NCT03680183|Antiviral Agents|antiviral agents|mesh-ancestor
5654770|NCT03680183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5654771|NCT03680092|Cyclophosphamide|cyclophosphamide|mesh-list
5654772|NCT03680092|Methotrexate|methotrexate|mesh-list
5654773|NCT03680092|Abatacept|abatacept|mesh-list
5654774|NCT03680092|Tacrolimus|tacrolimus|mesh-list
5654775|NCT03680092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5654776|NCT03680092|Immunologic Factors|immunologic factors|mesh-ancestor
5654777|NCT03680092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654778|NCT03680092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5654779|NCT03680092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5654780|NCT03680092|Alkylating Agents|alkylating agents|mesh-ancestor
5832333|NCT02544893|Bupivacaine|bupivacaine|mesh-list
5832334|NCT02544893|Anesthetics, Local|anesthetics, local|mesh-ancestor
5832335|NCT02544893|Anesthetics|anesthetics|mesh-ancestor
5654781|NCT03680092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5654782|NCT03680092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5654783|NCT03680092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5654784|NCT03680092|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5654785|NCT03680092|Abortifacient Agents|abortifacient agents|mesh-ancestor
5654786|NCT03680092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5654787|NCT03680092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5654788|NCT03680092|Antimetabolites|antimetabolites|mesh-ancestor
5654789|NCT03680092|Dermatologic Agents|dermatologic agents|mesh-ancestor
5832336|NCT02544893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5832337|NCT02544893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832338|NCT02544893|Sensory System Agents|sensory system agents|mesh-ancestor
5832339|NCT02544893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5832340|NCT02544893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5832341|NCT02544893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5832342|NCT02544893|Analgesics|analgesics|mesh-ancestor
5832343|NCT02544893|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5832344|NCT02544893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5832345|NCT02544893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5832346|NCT02544893|Adrenergic Agents|adrenergic agents|mesh-ancestor
5832347|NCT02544893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5832348|NCT02544893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832349|NCT02545153|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
5832350|NCT02545153|Aprotinin|aprotinin|mesh-list
5832351|NCT02545153|Hemostatics|hemostatics|mesh-ancestor
5832352|NCT02545153|Coagulants|coagulants|mesh-ancestor
5832353|NCT02545153|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5832354|NCT02545153|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5832355|NCT02545153|Protease Inhibitors|protease inhibitors|mesh-ancestor
5832356|NCT02545153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5832357|NCT02545153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832358|NCT02544815|Digoxin|digoxin|mesh-list
5832359|NCT02544815|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5832360|NCT02544815|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5832361|NCT02544815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5832362|NCT02544815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832363|NCT02544815|Protective Agents|protective agents|mesh-ancestor
5832364|NCT02544815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654790|NCT03680092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5654791|NCT03680092|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5654792|NCT03680092|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5654793|NCT03680092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5654794|NCT03680092|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5654795|NCT03680053|Cetrorelix|cetrorelix|mesh-list
5654796|NCT03680053|Dydrogesterone|dydrogesterone|mesh-list
5832365|NCT02544932|Warfarin|warfarin|mesh-list
5832366|NCT02544932|Dabigatran|dabigatran|mesh-list
5832367|NCT02544932|Anticoagulants|anticoagulants|mesh-ancestor
5832368|NCT02544932|Antithrombins|antithrombins|mesh-ancestor
5654797|NCT03680053|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5654798|NCT03680053|Fertility Agents|fertility agents|mesh-ancestor
5654799|NCT03680053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5654800|NCT03680053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654801|NCT03680053|Hormone Antagonists|hormone antagonists|mesh-ancestor
5832369|NCT02544932|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5832370|NCT02544932|Protease Inhibitors|protease inhibitors|mesh-ancestor
5832371|NCT02544932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5832372|NCT02544932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832373|NCT02544828|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
5832374|NCT02544828|Hematinics|hematinics|mesh-ancestor
5832375|NCT02544854|Propofol|propofol|mesh-list
5832376|NCT02544854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5832377|NCT02544854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5832378|NCT02544854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832379|NCT02544854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5832380|NCT02544854|Anesthetics, General|anesthetics, general|mesh-ancestor
5832381|NCT02544854|Anesthetics|anesthetics|mesh-ancestor
5832382|NCT02545114|Tolvaptan|tolvaptan|mesh-list
5832383|NCT02545114|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
5832384|NCT02545114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832385|NCT02545114|Natriuretic Agents|natriuretic agents|mesh-ancestor
5832386|NCT02545114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654802|NCT03680053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5654803|NCT03680053|Progestins|progestins|mesh-ancestor
5654804|NCT03680053|Hormones|hormones|mesh-ancestor
5654805|NCT03679949|Oxycodone|oxycodone|mesh-list
5832387|NCT02544776|Amlodipine|amlodipine|mesh-list
5832388|NCT02544776|Clomiphene|clomiphene|mesh-list
5832389|NCT02544776|Enclomiphene|enclomiphene|mesh-list
5832390|NCT02544776|Zuclomiphene|zuclomiphene|mesh-list
5832391|NCT02544776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832392|NCT02544776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5832393|NCT02544776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5832394|NCT02544776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5832395|NCT02544776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5832396|NCT02544776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832397|NCT02544776|Vasodilator Agents|vasodilator agents|mesh-ancestor
5832398|NCT02544776|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5832399|NCT02544776|Hormone Antagonists|hormone antagonists|mesh-ancestor
5832400|NCT02544776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5832401|NCT02544776|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5832402|NCT02544776|Fertility Agents|fertility agents|mesh-ancestor
5832403|NCT02544776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5832404|NCT02544776|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5832405|NCT02544776|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5832406|NCT02544750|Cannabidiol|cannabidiol|mesh-list
5832407|NCT02544750|Anticonvulsants|anticonvulsants|mesh-ancestor
5832408|NCT02544659|Pamidronate|pamidronate|mesh-list
5832409|NCT02544659|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5832410|NCT02544659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832411|NCT02544698|Vaccines|vaccines|mesh-list
5832412|NCT02544698|Immunologic Factors|immunologic factors|mesh-ancestor
5832413|NCT02544698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832414|NCT02544789|Clofarabine|clofarabine|mesh-list
5832415|NCT02544789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5832416|NCT02544789|Antimetabolites|antimetabolites|mesh-ancestor
5832417|NCT02544789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832418|NCT02544789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5832419|NCT02544737|Apatinib|apatinib|mesh-list
5832420|NCT02544737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5832421|NCT02544737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5832422|NCT02544737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5832423|NCT02544737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832424|NCT02544724|Interleukin-12|interleukin-12|mesh-list
5654806|NCT03679949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5654807|NCT03679949|Narcotics|narcotics|mesh-ancestor
5654808|NCT03679949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5654809|NCT03679949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654810|NCT03679949|Analgesics|analgesics|mesh-ancestor
5654811|NCT03679949|Sensory System Agents|sensory system agents|mesh-ancestor
5654812|NCT03679949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5654813|NCT03679897|Ropivacaine|ropivacaine|mesh-list
5654814|NCT03679897|Levobupivacaine|levobupivacaine|mesh-list
5832425|NCT02544724|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5654815|NCT03679897|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5654816|NCT03679897|Anesthetics, Local|anesthetics, local|mesh-ancestor
5654817|NCT03679897|Anesthetics|anesthetics|mesh-ancestor
5654818|NCT03679897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5654819|NCT03679897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654820|NCT03679897|Sensory System Agents|sensory system agents|mesh-ancestor
5654821|NCT03679897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5654822|NCT03679676|Omalizumab|omalizumab|mesh-list
5654823|NCT03679676|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5654824|NCT03679676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6493412|NCT00613457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6493413|NCT00613457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6493414|NCT00613457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6493415|NCT00613457|Abortifacient Agents|abortifacient agents|mesh-ancestor
6493416|NCT00613457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6493417|NCT00613457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6493418|NCT00613457|Antimetabolites|antimetabolites|mesh-ancestor
6493419|NCT00613457|Dermatologic Agents|dermatologic agents|mesh-ancestor
6493420|NCT00613457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5832426|NCT02544724|Immunologic Factors|immunologic factors|mesh-ancestor
5832427|NCT02544724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832428|NCT02544724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5832429|NCT02544724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5832430|NCT02544724|Growth Substances|growth substances|mesh-ancestor
5832431|NCT02544724|Growth Inhibitors|growth inhibitors|mesh-ancestor
5832432|NCT02544724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5654825|NCT03679676|Respiratory System Agents|respiratory system agents|mesh-ancestor
5654826|NCT03679546|Infliximab|infliximab|mesh-list
5654827|NCT03679546|Vedolizumab|vedolizumab|mesh-list
5654828|NCT03679546|Dermatologic Agents|dermatologic agents|mesh-ancestor
5654829|NCT03679546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5654830|NCT03679546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5654831|NCT03679481|Tranexamic Acid|tranexamic acid|mesh-list
5654832|NCT03679481|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5832433|NCT02544529|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
5832434|NCT02544529|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5832435|NCT02544529|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5832436|NCT02544529|Echothiophate Iodide|echothiophate iodide|mesh-list
5832437|NCT02544529|Laxatives|laxatives|mesh-ancestor
5832438|NCT02544529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5832439|NCT02544529|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5832440|NCT02544529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5832441|NCT02544529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832442|NCT02544529|Cholinergic Agents|cholinergic agents|mesh-ancestor
5832443|NCT02544529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5832444|NCT02544529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654833|NCT03679481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5654834|NCT03679481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5654835|NCT03679481|Hemostatics|hemostatics|mesh-ancestor
5654836|NCT03679481|Coagulants|coagulants|mesh-ancestor
5654837|NCT03679455|Obinutuzumab|obinutuzumab|mesh-list
5654838|NCT03679455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5654839|NCT03679455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5654840|NCT03679442|Acetylcysteine|acetylcysteine|mesh-list
5832445|NCT02544529|Miotics|miotics|mesh-ancestor
5832446|NCT02544529|Autonomic Agents|autonomic agents|mesh-ancestor
5832447|NCT02544529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5832448|NCT02544529|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5832449|NCT02544425|Dexamethasone|dexamethasone|mesh-list
5832450|NCT02544425|Etoposide|etoposide|mesh-list
5832451|NCT02544425|Melphalan|melphalan|mesh-list
5832452|NCT02544425|Busulfan|busulfan|mesh-list
5832453|NCT02544425|Asparaginase|asparaginase|mesh-list
5832454|NCT02544425|Ifosfamide|ifosfamide|mesh-list
5832455|NCT02544425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5832456|NCT02544425|Antiemetics|antiemetics|mesh-ancestor
5832457|NCT02544425|Autonomic Agents|autonomic agents|mesh-ancestor
5832458|NCT02544425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5832459|NCT02544425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832460|NCT02544425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5832461|NCT02544425|Glucocorticoids|glucocorticoids|mesh-ancestor
5832462|NCT02544425|Hormones|hormones|mesh-ancestor
5654841|NCT03679442|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5654842|NCT03679442|Antidotes|antidotes|mesh-list
5832463|NCT02544425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5832464|NCT02544425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5832465|NCT02544425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5654843|NCT03679442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654844|NCT03679442|Antiviral Agents|antiviral agents|mesh-ancestor
5654845|NCT03679442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5654846|NCT03679442|Expectorants|expectorants|mesh-ancestor
5654847|NCT03679442|Respiratory System Agents|respiratory system agents|mesh-ancestor
5654848|NCT03679442|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5654849|NCT03679442|Antioxidants|antioxidants|mesh-ancestor
5654850|NCT03679442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5654851|NCT03679442|Protective Agents|protective agents|mesh-ancestor
5654852|NCT03679390|Ketamine|ketamine|mesh-list
5654853|NCT03679390|Analgesics|analgesics|mesh-ancestor
5654854|NCT03679390|Sensory System Agents|sensory system agents|mesh-ancestor
5654855|NCT03679390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5654856|NCT03679390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654857|NCT03679390|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5654858|NCT03679390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5654859|NCT03679390|Anesthetics, General|anesthetics, general|mesh-ancestor
5654860|NCT03679390|Anesthetics|anesthetics|mesh-ancestor
5654861|NCT03679390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5654862|NCT03679390|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5654863|NCT03679390|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5654864|NCT03679390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5654865|NCT03679390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832466|NCT02544425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5832467|NCT02544425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5832468|NCT02544425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5832469|NCT02544425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5832470|NCT02544425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832471|NCT02544425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5832472|NCT02544425|Alkylating Agents|alkylating agents|mesh-ancestor
5832473|NCT02544425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5832474|NCT02544425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5832475|NCT02544425|Immunologic Factors|immunologic factors|mesh-ancestor
5832476|NCT02544282|Acetaminophen|acetaminophen|mesh-list
5832477|NCT02544282|Sufentanil|sufentanil|mesh-list
5832478|NCT02544282|Tramadol|tramadol|mesh-list
5832479|NCT02544282|Pirinitramide|pirinitramide|mesh-list
5832480|NCT02544282|Propofol|propofol|mesh-list
5832481|NCT02544282|Sevoflurane|sevoflurane|mesh-list
5832482|NCT02544282|Levobupivacaine|levobupivacaine|mesh-list
5832483|NCT02544282|Atracurium|atracurium|mesh-list
5832484|NCT02544282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5832485|NCT02544282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5832486|NCT02544282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832487|NCT02544282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5832488|NCT02544282|Anesthetics, General|anesthetics, general|mesh-ancestor
5832489|NCT02544282|Anesthetics|anesthetics|mesh-ancestor
5832490|NCT02544282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5832491|NCT02544282|Analgesics|analgesics|mesh-ancestor
5832492|NCT02544282|Sensory System Agents|sensory system agents|mesh-ancestor
5832493|NCT02544282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5832494|NCT02544282|Antipyretics|antipyretics|mesh-ancestor
5832495|NCT02544282|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5832496|NCT02544282|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5832497|NCT02544282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5832498|NCT02544282|Narcotics|narcotics|mesh-ancestor
5832499|NCT02544282|Anesthetics, Local|anesthetics, local|mesh-ancestor
5832500|NCT02544282|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5832501|NCT02544282|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5832502|NCT02544282|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6493421|NCT00613457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6493422|NCT00613457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5654866|NCT03679325|Vitamin D|vitamin d|mesh-list
5654867|NCT03679325|Vitamins|vitamins|mesh-ancestor
5654868|NCT03679325|Micronutrients|micronutrients|mesh-ancestor
5654869|NCT03679325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654870|NCT03679325|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5654871|NCT03679312|Nitric Oxide|nitric oxide|mesh-list
5654872|NCT03679312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5654873|NCT03679312|Autonomic Agents|autonomic agents|mesh-ancestor
5654874|NCT03679312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5654875|NCT03679312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654876|NCT03679312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6493423|NCT00613457|Antiviral Agents|antiviral agents|mesh-ancestor
5832503|NCT02544282|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5832504|NCT02544282|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
5654877|NCT03679312|Respiratory System Agents|respiratory system agents|mesh-ancestor
5654878|NCT03679312|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5654879|NCT03679312|Antioxidants|antioxidants|mesh-ancestor
5654880|NCT03679312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832505|NCT02544282|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5832506|NCT02544282|Cholinergic Agents|cholinergic agents|mesh-ancestor
5832507|NCT02544282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5832508|NCT02544282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832509|NCT02544308|Dexamethasone|dexamethasone|mesh-list
5832510|NCT02544308|Lenalidomide|lenalidomide|mesh-list
6493424|NCT00613457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6493425|NCT00613457|Tubulin Modulators|tubulin modulators|mesh-ancestor
6493426|NCT00613457|Antimitotic Agents|antimitotic agents|mesh-ancestor
6493427|NCT00613457|Mitosis Modulators|mitosis modulators|mesh-ancestor
6493428|NCT00613470|Citalopram|citalopram|mesh-list
6493429|NCT00613470|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6493430|NCT00613470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6493431|NCT00613470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6493432|NCT00613470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493433|NCT00613470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6493434|NCT00613470|Serotonin Agents|serotonin agents|mesh-ancestor
6493435|NCT00613470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493436|NCT00613470|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6493437|NCT00613470|Antidepressive Agents|antidepressive agents|mesh-ancestor
6493438|NCT00613470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6493439|NCT00613496|Irbesartan|irbesartan|mesh-list
6493440|NCT00613496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6493441|NCT00613496|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6493442|NCT00613496|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6493443|NCT00613496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832511|NCT02544308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5832512|NCT02544308|Antiemetics|antiemetics|mesh-ancestor
5832513|NCT02544308|Autonomic Agents|autonomic agents|mesh-ancestor
5832514|NCT02544308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5832515|NCT02544308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832516|NCT02544308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5832517|NCT02544308|Glucocorticoids|glucocorticoids|mesh-ancestor
5832518|NCT02544308|Hormones|hormones|mesh-ancestor
5832519|NCT02544308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5832520|NCT02544308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5832521|NCT02544308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5832522|NCT02544308|Immunologic Factors|immunologic factors|mesh-ancestor
5832523|NCT02544308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5832524|NCT02544308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5832525|NCT02544308|Growth Substances|growth substances|mesh-ancestor
5832526|NCT02544308|Growth Inhibitors|growth inhibitors|mesh-ancestor
5832527|NCT02544191|Goserelin|goserelin|mesh-list
5832528|NCT02544191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5832529|NCT02544191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5832530|NCT02544165|Caffeine|caffeine|mesh-list
5832531|NCT02544165|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5832532|NCT02544165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832533|NCT02544165|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5654881|NCT03679312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5654882|NCT03679312|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5654883|NCT03679312|Vasodilator Agents|vasodilator agents|mesh-ancestor
5654884|NCT03679312|Gasotransmitters|gasotransmitters|mesh-ancestor
5654885|NCT03679312|Protective Agents|protective agents|mesh-ancestor
5654886|NCT03679182|Olanzapine|olanzapine|mesh-list
5654887|NCT03679182|Antiemetics|antiemetics|mesh-ancestor
5654888|NCT03679182|Autonomic Agents|autonomic agents|mesh-ancestor
5654889|NCT03679182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5832534|NCT02544165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5832535|NCT02544165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832536|NCT02544165|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5832537|NCT02544165|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5832538|NCT02544165|Purinergic Agents|purinergic agents|mesh-ancestor
5832539|NCT02544165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5832540|NCT02544243|Gemcitabine|gemcitabine|mesh-list
5832541|NCT02544243|Vinorelbine|vinorelbine|mesh-list
5832542|NCT02544243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5832543|NCT02544243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5832544|NCT02544243|Antimetabolites|antimetabolites|mesh-ancestor
5832545|NCT02544243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832546|NCT02544243|Antiviral Agents|antiviral agents|mesh-ancestor
5832547|NCT02544243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5832548|NCT02544243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5832549|NCT02544243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5832550|NCT02544243|Immunologic Factors|immunologic factors|mesh-ancestor
5832551|NCT02544243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832552|NCT02544243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5832553|NCT02544243|Tubulin Modulators|tubulin modulators|mesh-ancestor
5832554|NCT02544243|Antimitotic Agents|antimitotic agents|mesh-ancestor
5832555|NCT02544243|Mitosis Modulators|mitosis modulators|mesh-ancestor
5832556|NCT02544269|Bupivacaine|bupivacaine|mesh-list
5832557|NCT02544269|Ropivacaine|ropivacaine|mesh-list
5832558|NCT02544269|Anesthetics, Local|anesthetics, local|mesh-ancestor
5832559|NCT02544269|Anesthetics|anesthetics|mesh-ancestor
5832560|NCT02544269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5832561|NCT02544269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832562|NCT02544269|Sensory System Agents|sensory system agents|mesh-ancestor
5832563|NCT02544269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5832564|NCT02544061|Interleukin-12|interleukin-12|mesh-list
5832565|NCT02544061|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5832566|NCT02544061|Immunologic Factors|immunologic factors|mesh-ancestor
5832567|NCT02544061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832568|NCT02544061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5832569|NCT02544061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5832570|NCT02544061|Growth Substances|growth substances|mesh-ancestor
5832571|NCT02544061|Growth Inhibitors|growth inhibitors|mesh-ancestor
5832572|NCT02544061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5832573|NCT02543879|Azacitidine|azacitidine|mesh-list
5902659|NCT03933007|Antimitotic Agents|antimitotic agents|mesh-ancestor
5654890|NCT03679182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654891|NCT03679182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5654892|NCT03679182|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5654893|NCT03679182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5654894|NCT03679182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5654895|NCT03679182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5654896|NCT03679182|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5654897|NCT03679182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5654898|NCT03679182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5654899|NCT03679182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5654900|NCT03679182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5654901|NCT03679182|Serotonin Agents|serotonin agents|mesh-ancestor
5654902|NCT03679065|Acetaminophen|acetaminophen|mesh-list
5654903|NCT03679065|Dexamethasone|dexamethasone|mesh-list
5654904|NCT03679065|Dexamethasone acetate|dexamethasone acetate|mesh-list
5654905|NCT03679065|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
5654906|NCT03679065|BB 1101|bb 1101|mesh-list
5654907|NCT03679065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5654908|NCT03679065|Antiemetics|antiemetics|mesh-ancestor
5654909|NCT03679065|Autonomic Agents|autonomic agents|mesh-ancestor
5654910|NCT03679065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5654911|NCT03679065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654912|NCT03679065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5654913|NCT03679065|Glucocorticoids|glucocorticoids|mesh-ancestor
5654914|NCT03679065|Hormones|hormones|mesh-ancestor
5654915|NCT03679065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5654916|NCT03679065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5654917|NCT03679065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5654918|NCT03679065|Protease Inhibitors|protease inhibitors|mesh-ancestor
5654919|NCT03679065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5654920|NCT03679065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5654921|NCT03679065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5654922|NCT03679065|Analgesics|analgesics|mesh-ancestor
5654923|NCT03679065|Sensory System Agents|sensory system agents|mesh-ancestor
5654924|NCT03679065|Antipyretics|antipyretics|mesh-ancestor
5654925|NCT03679052|Clonidine|clonidine|mesh-list
5654926|NCT03679052|Mirtazapine|mirtazapine|mesh-list
5654927|NCT03679052|Analgesics|analgesics|mesh-ancestor
5654928|NCT03679052|Sensory System Agents|sensory system agents|mesh-ancestor
5654929|NCT03679052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5654930|NCT03679052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654931|NCT03679052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5654932|NCT03679052|Sympatholytics|sympatholytics|mesh-ancestor
5654933|NCT03679052|Autonomic Agents|autonomic agents|mesh-ancestor
5832574|NCT02543879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5832575|NCT02543879|Antimetabolites|antimetabolites|mesh-ancestor
5832576|NCT02543879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832577|NCT02543879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5832578|NCT02543879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5832579|NCT05227742|Psilocybin|psilocybin|mesh-list
5832580|NCT05227742|Hallucinogens|hallucinogens|mesh-ancestor
5832581|NCT05227742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832582|NCT05227742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5832583|NCT05227716|Magnesium Sulfate|magnesium sulfate|mesh-list
5832584|NCT05227716|Analgesics|analgesics|mesh-ancestor
5832585|NCT05227716|Sensory System Agents|sensory system agents|mesh-ancestor
5832586|NCT05227716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5832587|NCT05227716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654934|NCT03679052|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5654935|NCT03679052|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5654936|NCT03679052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5654937|NCT03679052|Adrenergic Agents|adrenergic agents|mesh-ancestor
5654938|NCT03679052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5654939|NCT03679052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5654940|NCT03679052|Antidepressive Agents|antidepressive agents|mesh-ancestor
5654941|NCT03679052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5654942|NCT03679052|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5654943|NCT03679052|Histamine Antagonists|histamine antagonists|mesh-ancestor
5654944|NCT03679052|Histamine Agents|histamine agents|mesh-ancestor
5654945|NCT03679052|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5654946|NCT03679052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5654947|NCT03679052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5654948|NCT03679052|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5654949|NCT03679052|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5654950|NCT03679052|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5654951|NCT03679052|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5654952|NCT03679052|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5654953|NCT03679052|Serotonin Agents|serotonin agents|mesh-ancestor
5654954|NCT03679052|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5694870|NCT03393403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694871|NCT03393377|Valsartan|valsartan|mesh-list
5832588|NCT05227716|Anesthetics|anesthetics|mesh-ancestor
6674482|NCT01569659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674483|NCT01569659|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6674484|NCT01569659|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6674485|NCT01569659|Serotonin Agents|serotonin agents|mesh-ancestor
6674486|NCT01569659|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6674487|NCT01569659|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6674488|NCT01569659|Dopamine Agents|dopamine agents|mesh-ancestor
6674489|NCT01569685|Sertraline|sertraline|mesh-list
6674490|NCT01569685|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6674491|NCT01569685|Antidepressive Agents|antidepressive agents|mesh-ancestor
6674492|NCT01569685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6211770|NCT02176642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211771|NCT02176642|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6211772|NCT02176642|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5832589|NCT05227716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5832590|NCT05227716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5832591|NCT05227716|Anticonvulsants|anticonvulsants|mesh-ancestor
5832592|NCT05227716|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5832593|NCT05227716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5832594|NCT05227716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832595|NCT05227716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5832596|NCT05227716|Tocolytic Agents|tocolytic agents|mesh-ancestor
5832597|NCT05227716|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5902660|NCT03933007|Mitosis Modulators|mitosis modulators|mesh-ancestor
5902661|NCT03933007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5832598|NCT05227391|Letrozole|letrozole|mesh-list
5832599|NCT05227391|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5832600|NCT05227391|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5832601|NCT05227391|Estradiol|estradiol|mesh-list
5832602|NCT05227391|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5832603|NCT05227391|Estrogens|estrogens|mesh-ancestor
5832604|NCT05227391|Hormones|hormones|mesh-ancestor
5832605|NCT05227391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5832606|NCT05227391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832607|NCT05227391|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5832608|NCT05227391|Contraceptive Agents|contraceptive agents|mesh-ancestor
5832609|NCT05227391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6211773|NCT02176642|Cholinergic Agents|cholinergic agents|mesh-ancestor
6211774|NCT02176642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6211775|NCT02176642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211776|NCT02176642|Urological Agents|urological agents|mesh-ancestor
6211777|NCT02176655|Aspirin|aspirin|mesh-list
6211778|NCT02176655|Sumatriptan|sumatriptan|mesh-list
6211779|NCT02176655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6211780|NCT02176655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6211781|NCT02176655|Analgesics|analgesics|mesh-ancestor
5654955|NCT03679013|Acetaminophen|acetaminophen|mesh-list
5654956|NCT03679013|Gabapentin|gabapentin|mesh-list
5654957|NCT03679013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5654958|NCT03679013|Analgesics|analgesics|mesh-ancestor
5654959|NCT03679013|Sensory System Agents|sensory system agents|mesh-ancestor
5654960|NCT03679013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5654961|NCT03679013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654962|NCT03679013|Antipyretics|antipyretics|mesh-ancestor
5654963|NCT03679013|Anticonvulsants|anticonvulsants|mesh-ancestor
5654964|NCT03679013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5654965|NCT03679013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5654966|NCT03679013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5654967|NCT03679013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5654968|NCT03679013|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5654969|NCT03679013|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5654970|NCT03679013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5832610|NCT05227391|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5832611|NCT05227391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5832612|NCT05227391|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5832613|NCT05227391|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5654971|NCT03679013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5654972|NCT03679013|Antimanic Agents|antimanic agents|mesh-ancestor
5654973|NCT03678987|Mycophenolic Acid|mycophenolic acid|mesh-list
5654974|NCT03678987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5654975|NCT03678987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5654976|NCT03678987|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5654977|NCT03678987|Antitubercular Agents|antitubercular agents|mesh-ancestor
5654978|NCT03678987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5654979|NCT03678987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5654980|NCT03678987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5654981|NCT03678987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5654982|NCT03678792|Morphine|morphine|mesh-list
5654983|NCT03678792|Buprenorphine|buprenorphine|mesh-list
5654984|NCT03678792|Tramadol|tramadol|mesh-list
5654985|NCT03678792|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
5654986|NCT03678792|Naloxone|naloxone|mesh-list
5654987|NCT03678792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5654988|NCT03678792|Narcotics|narcotics|mesh-ancestor
5654989|NCT03678792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5654990|NCT03678792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5654991|NCT03678792|Analgesics|analgesics|mesh-ancestor
5654992|NCT03678792|Sensory System Agents|sensory system agents|mesh-ancestor
5654993|NCT03678792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5654994|NCT03678792|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5654995|NCT03678688|Bedaquiline|bedaquiline|mesh-list
5654996|NCT03678688|Diarylquinolines|diarylquinolines|mesh-list
5654997|NCT03678688|Antitubercular Agents|antitubercular agents|mesh-ancestor
5654998|NCT03678688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5654999|NCT03678688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5832614|NCT05227391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5832615|NCT05227391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493444|NCT00613561|Fludarabine|fludarabine|mesh-list
6493445|NCT00613561|Busulfan|busulfan|mesh-list
5655000|NCT03678675|Ketorolac|ketorolac|mesh-list
5655001|NCT03678675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5655002|NCT03678675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5832616|NCT05227391|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5832617|NCT05227391|Hormone Antagonists|hormone antagonists|mesh-ancestor
5832618|NCT05227300|Lidocaine|lidocaine|mesh-list
5832619|NCT05227300|Epinephrine|epinephrine|mesh-list
5832620|NCT05227300|Anesthetics, Local|anesthetics, local|mesh-ancestor
5832621|NCT05227300|Anesthetics|anesthetics|mesh-ancestor
5832622|NCT05227300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5832623|NCT05227300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832624|NCT05227300|Sensory System Agents|sensory system agents|mesh-ancestor
5832625|NCT05227300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5832626|NCT05227300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5832627|NCT05227300|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5832628|NCT05227300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5832629|NCT05227300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5832630|NCT05227300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832631|NCT05227300|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5832632|NCT05227300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5832633|NCT05227300|Adrenergic Agents|adrenergic agents|mesh-ancestor
5832634|NCT05227300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5832635|NCT05227300|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5832636|NCT05227300|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5832637|NCT05227300|Autonomic Agents|autonomic agents|mesh-ancestor
5832638|NCT05227300|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5832639|NCT05227300|Respiratory System Agents|respiratory system agents|mesh-ancestor
5832640|NCT05227300|Mydriatics|mydriatics|mesh-ancestor
5832641|NCT05227300|Sympathomimetics|sympathomimetics|mesh-ancestor
5832642|NCT05227300|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5832643|NCT05226923|Meropenem|meropenem|mesh-list
5832644|NCT05226923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5832645|NCT05226923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5832646|NCT05226897|Metformin|metformin|mesh-list
5832647|NCT05226897|Dapagliflozin|dapagliflozin|mesh-list
5832648|NCT05226897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5832649|NCT05226897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832650|NCT05226897|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5832651|NCT05226897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832652|NCT05226871|Cetuximab|cetuximab|mesh-list
5832653|NCT05226871|Letrozole|letrozole|mesh-list
5832654|NCT05226871|Fulvestrant|fulvestrant|mesh-list
5832655|NCT05226871|Palbociclib|palbociclib|mesh-list
5832656|NCT05226871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5832657|NCT05226871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5832658|NCT05226871|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5832659|NCT05226871|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5832660|NCT05226871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5832661|NCT05226871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832662|NCT05226871|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5832663|NCT05226871|Hormone Antagonists|hormone antagonists|mesh-ancestor
5832664|NCT05226871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5832665|NCT05226871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832666|NCT05226871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5832667|NCT05226871|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5832668|NCT05226871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5832669|NCT05226832|Triamcinolone|triamcinolone|mesh-list
5832670|NCT05226832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5832671|NCT05226832|Glucocorticoids|glucocorticoids|mesh-ancestor
5832672|NCT05226832|Hormones|hormones|mesh-ancestor
5832673|NCT05226832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5655003|NCT03678675|Analgesics|analgesics|mesh-ancestor
5655004|NCT03678675|Sensory System Agents|sensory system agents|mesh-ancestor
5655005|NCT03678675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5655006|NCT03678675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655007|NCT03678675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5655008|NCT03678675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5655009|NCT03678675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5655010|NCT03678675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5655011|NCT03678675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655012|NCT03678649|Capecitabine|capecitabine|mesh-list
5655013|NCT03678649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5655014|NCT03678649|Antimetabolites|antimetabolites|mesh-ancestor
5832674|NCT05226832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832675|NCT05226754|Diacetylrhein|diacetylrhein|mesh-list
5832676|NCT05226754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5832677|NCT05226728|Pembrolizumab|pembrolizumab|mesh-list
5832678|NCT05226728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5832679|NCT05226728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5832680|NCT05226663|Fluorides|fluorides|mesh-list
5832681|NCT05226663|Cariostatic Agents|cariostatic agents|mesh-ancestor
5832682|NCT05226663|Protective Agents|protective agents|mesh-ancestor
5832683|NCT05226663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832684|NCT05226598|Paclitaxel|paclitaxel|mesh-list
5832685|NCT05226598|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5832686|NCT05226598|Carboplatin|carboplatin|mesh-list
5832687|NCT05226598|Pembrolizumab|pembrolizumab|mesh-list
5832688|NCT05226598|Pemetrexed|pemetrexed|mesh-list
5832689|NCT05226598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5832690|NCT05226598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5832691|NCT05226598|Tubulin Modulators|tubulin modulators|mesh-ancestor
5832692|NCT05226598|Antimitotic Agents|antimitotic agents|mesh-ancestor
5832693|NCT05226598|Mitosis Modulators|mitosis modulators|mesh-ancestor
5832694|NCT05226598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832695|NCT05226598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5832696|NCT05226598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5832697|NCT05226598|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5832698|NCT05226598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5832699|NCT05226455|Azacitidine|azacitidine|mesh-list
5832700|NCT05226455|Venetoclax|venetoclax|mesh-list
5832701|NCT05226455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5832702|NCT05226455|Antimetabolites|antimetabolites|mesh-ancestor
5832703|NCT05226455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832704|NCT05226455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5832705|NCT05226455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5832706|NCT05226429|Vaccines|vaccines|mesh-list
5832707|NCT05226429|Immunologic Factors|immunologic factors|mesh-ancestor
5832708|NCT05226429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832709|NCT05226351|Dronabinol|dronabinol|mesh-list
5832710|NCT05226351|Hallucinogens|hallucinogens|mesh-ancestor
5832711|NCT05226351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832712|NCT05226351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5832713|NCT05226351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5832714|NCT05226351|Analgesics|analgesics|mesh-ancestor
6211782|NCT02176655|Sensory System Agents|sensory system agents|mesh-ancestor
6211783|NCT02176655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6211784|NCT02176655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211785|NCT02176655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6211786|NCT02176655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6211787|NCT02176655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6211788|NCT02176655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6211789|NCT02176655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655015|NCT03678649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655016|NCT03678649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5655017|NCT03678636|Anti-Infective Agents|anti-infective agents|mesh-list
5655018|NCT03678636|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5655019|NCT03678610|Ionomycin|ionomycin|mesh-list
5655020|NCT03678610|Calcium Ionophores|calcium ionophores|mesh-ancestor
5655021|NCT03678610|Ionophores|ionophores|mesh-ancestor
5655022|NCT03678610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5655023|NCT03678610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655024|NCT03678532|Midazolam|midazolam|mesh-list
5655025|NCT03678532|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5655026|NCT03678532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5655027|NCT03678532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5655028|NCT03678532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655029|NCT03678532|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5655030|NCT03678532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5655031|NCT03678532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5655032|NCT03678532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5655033|NCT03678532|Anesthetics, General|anesthetics, general|mesh-ancestor
5655034|NCT03678532|Anesthetics|anesthetics|mesh-ancestor
5655035|NCT03678532|GABA Modulators|gaba modulators|mesh-ancestor
5655036|NCT03678532|GABA Agents|gaba agents|mesh-ancestor
5655037|NCT03678532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5655038|NCT03678532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655039|NCT03678506|Apixaban|apixaban|mesh-list
5655040|NCT03678506|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5655041|NCT03678506|Antithrombins|antithrombins|mesh-ancestor
5655042|NCT03678506|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5655043|NCT03678506|Protease Inhibitors|protease inhibitors|mesh-ancestor
5655044|NCT03678506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5655045|NCT03678506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655046|NCT03678506|Anticoagulants|anticoagulants|mesh-ancestor
6493446|NCT00613561|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6493447|NCT00613561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6493448|NCT00613561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832715|NCT05226351|Sensory System Agents|sensory system agents|mesh-ancestor
5832716|NCT05226351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5832717|NCT05226351|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5832718|NCT05226351|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5832719|NCT05226351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5832720|NCT05226351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832721|NCT05226351|Hormones|hormones|mesh-ancestor
5832722|NCT05226351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5832723|NCT05226325|Dexmedetomidine|dexmedetomidine|mesh-list
5832724|NCT05226325|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5832725|NCT05226325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5832726|NCT05226325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832727|NCT05226325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5832728|NCT05226325|Analgesics|analgesics|mesh-ancestor
5832729|NCT05226325|Sensory System Agents|sensory system agents|mesh-ancestor
5832730|NCT05226325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5832731|NCT05226325|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5832732|NCT05226325|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5832733|NCT05226325|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5832734|NCT05226325|Adrenergic Agents|adrenergic agents|mesh-ancestor
5832735|NCT05226325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5832736|NCT05226325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832737|NCT05226299|Capsaicin|capsaicin|mesh-list
5832738|NCT05226299|Antipruritics|antipruritics|mesh-ancestor
5832739|NCT05226299|Dermatologic Agents|dermatologic agents|mesh-ancestor
5832740|NCT05226299|Sensory System Agents|sensory system agents|mesh-ancestor
5832741|NCT05226299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5832742|NCT05226299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832743|NCT05226013|Rasburicase|rasburicase|mesh-list
6493449|NCT00613561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6493450|NCT00613561|Immunologic Factors|immunologic factors|mesh-ancestor
6493451|NCT00613561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493452|NCT00613561|Alkylating Agents|alkylating agents|mesh-ancestor
5655047|NCT03678480|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
5655048|NCT03678480|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5655049|NCT03678480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5655050|NCT03678428|Leucovorin|leucovorin|mesh-list
5655051|NCT03678428|Oxaliplatin|oxaliplatin|mesh-list
5655052|NCT03678428|Irinotecan|irinotecan|mesh-list
5655053|NCT03678428|Floxuridine|floxuridine|mesh-list
6493453|NCT00613561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6493454|NCT00613561|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6493455|NCT00613600|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
6493456|NCT00613600|Cathartics|cathartics|mesh-ancestor
6493457|NCT00613600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5655054|NCT03678428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5832744|NCT05226013|Gout Suppressants|gout suppressants|mesh-ancestor
5832745|NCT05226013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5832746|NCT05225974|Liraglutide|liraglutide|mesh-list
5832747|NCT05225974|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5832748|NCT05225974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832749|NCT05225974|Incretins|incretins|mesh-ancestor
5655055|NCT03678428|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5655056|NCT03678428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5655057|NCT03678428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5655058|NCT03678428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655059|NCT03678428|Antidotes|antidotes|mesh-ancestor
5655060|NCT03678428|Protective Agents|protective agents|mesh-ancestor
5655061|NCT03678428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655062|NCT03678428|Vitamin B Complex|vitamin b complex|mesh-ancestor
5655063|NCT03678428|Vitamins|vitamins|mesh-ancestor
5832750|NCT05225974|Hormones|hormones|mesh-ancestor
5832751|NCT05225974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5832752|NCT05225961|Aspirin|aspirin|mesh-list
5832753|NCT05225961|Tirofiban|tirofiban|mesh-list
5832754|NCT05225961|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5832755|NCT05225961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5832756|NCT05225961|Analgesics|analgesics|mesh-ancestor
5832757|NCT05225961|Sensory System Agents|sensory system agents|mesh-ancestor
5832758|NCT05225961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6493458|NCT00613613|Fenofibrate|fenofibrate|mesh-list
6493459|NCT00613613|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5832759|NCT05225961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832760|NCT05225961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5832761|NCT05225961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5832762|NCT05225961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5832763|NCT05225961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5832764|NCT05225961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832765|NCT05225961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5832766|NCT05225961|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5832767|NCT05225961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5832768|NCT05225961|Antipyretics|antipyretics|mesh-ancestor
5832769|NCT05225844|Apatinib|apatinib|mesh-list
5832770|NCT05225844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5832771|NCT05225844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5832772|NCT05225844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5832773|NCT05225844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832774|NCT05225831|Cyclophosphamide|cyclophosphamide|mesh-list
5832775|NCT05225831|Fludarabine|fludarabine|mesh-list
5832776|NCT05225831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5832777|NCT05225831|Immunologic Factors|immunologic factors|mesh-ancestor
5832778|NCT05225831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832779|NCT05225831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5832780|NCT05225831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5832781|NCT05225831|Alkylating Agents|alkylating agents|mesh-ancestor
5832782|NCT05225831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832783|NCT05225831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5832784|NCT05225831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5832785|NCT05225805|Lefamulin|lefamulin|mesh-list
5832786|NCT05225805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5832787|NCT05225805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5832788|NCT05225766|Bupivacaine|bupivacaine|mesh-list
5832789|NCT05225766|Anesthetics, Local|anesthetics, local|mesh-ancestor
5832790|NCT05225766|Anesthetics|anesthetics|mesh-ancestor
5832791|NCT05225766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5832792|NCT05225766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832793|NCT05225766|Sensory System Agents|sensory system agents|mesh-ancestor
5832794|NCT05225766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5902662|NCT03933007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5902663|NCT03933007|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5902664|NCT03933007|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5902665|NCT03933007|Histamine Antagonists|histamine antagonists|mesh-ancestor
5902666|NCT03933007|Histamine Agents|histamine agents|mesh-ancestor
5902667|NCT03923270|Durvalumab|durvalumab|mesh-list
5902668|NCT03923270|Olaparib|olaparib|mesh-list
5902669|NCT03923270|Tremelimumab|tremelimumab|mesh-list
5902670|NCT03923270|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5902671|NCT03923270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5902672|NCT03923270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5902673|NCT03923270|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5902674|NCT03923270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5902675|NCT03923270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902676|NCT03923270|Immunologic Factors|immunologic factors|mesh-ancestor
5902677|NCT03923270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902678|NCT03921060|Denosumab|denosumab|mesh-list
5902679|NCT03921060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5902680|NCT03921060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902681|NCT03875287|Decitabine|decitabine|mesh-list
5902682|NCT03875287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5902683|NCT03875287|Antimetabolites|antimetabolites|mesh-ancestor
5902684|NCT03875287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902685|NCT03875287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5655064|NCT03678428|Micronutrients|micronutrients|mesh-ancestor
5655065|NCT03678428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5655066|NCT03678428|Antimetabolites|antimetabolites|mesh-ancestor
5655067|NCT03678233|Testosterone|testosterone|mesh-list
5655068|NCT03678233|Androgens|androgens|mesh-ancestor
5655069|NCT03678233|Hormones|hormones|mesh-ancestor
5655070|NCT03678233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5655071|NCT03678233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655072|NCT03678142|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5655073|NCT03678142|Vancomycin|vancomycin|mesh-list
5655074|NCT03678142|Imipenem|imipenem|mesh-list
5655075|NCT03678142|Floxacillin|floxacillin|mesh-list
5655076|NCT03678142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5655077|NCT03678116|Caffeine|caffeine|mesh-list
5655078|NCT03678116|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5832795|NCT05225363|Cyclophosphamide|cyclophosphamide|mesh-list
5832796|NCT05225363|Fludarabine|fludarabine|mesh-list
5832797|NCT05225363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5832798|NCT05225363|Immunologic Factors|immunologic factors|mesh-ancestor
5832799|NCT05225363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832800|NCT05225363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5832801|NCT05225363|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5832802|NCT05225363|Alkylating Agents|alkylating agents|mesh-ancestor
5832803|NCT05225363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832804|NCT05225363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5832805|NCT05225363|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5832806|NCT05224492|Sulforaphane|sulforaphane|mesh-list
5832807|NCT05224492|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5832808|NCT05224492|Protective Agents|protective agents|mesh-ancestor
5832809|NCT05224492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655079|NCT03678116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655080|NCT03678116|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5655081|NCT03678116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5655082|NCT03678116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655083|NCT03678116|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5655084|NCT03678116|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5655085|NCT03678116|Purinergic Agents|purinergic agents|mesh-ancestor
5655086|NCT03678116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5655087|NCT03678090|Plasminogen|plasminogen|mesh-list
5655088|NCT03678090|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5655089|NCT03678090|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5655090|NCT03678090|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5655091|NCT03678090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655092|NCT03678038|Triamcinolone|triamcinolone|mesh-list
5655093|NCT03678038|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5832810|NCT05224492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5832811|NCT05202080|Analgesics, Opioid|analgesics, opioid|mesh-list
5832812|NCT05202080|Narcotics|narcotics|mesh-ancestor
5832813|NCT05202080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5832814|NCT05202080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832815|NCT05202080|Analgesics|analgesics|mesh-ancestor
5832816|NCT05202080|Sensory System Agents|sensory system agents|mesh-ancestor
5832817|NCT05202080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5832818|NCT05198362|Metoprolol|metoprolol|mesh-list
5832819|NCT05198362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5832820|NCT05198362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5832821|NCT05198362|Sympatholytics|sympatholytics|mesh-ancestor
5832822|NCT05198362|Autonomic Agents|autonomic agents|mesh-ancestor
5832823|NCT05198362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5832824|NCT05198362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832825|NCT05198362|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5655094|NCT03678038|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5655095|NCT03678038|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5655096|NCT03678038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5655097|NCT03678038|Glucocorticoids|glucocorticoids|mesh-ancestor
5655098|NCT03678038|Hormones|hormones|mesh-ancestor
5655099|NCT03678038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5832826|NCT05198362|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5832827|NCT05198362|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5832828|NCT05198362|Adrenergic Agents|adrenergic agents|mesh-ancestor
5832829|NCT05198362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5832830|NCT05198362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832831|NCT05177822|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5832832|NCT05177822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5832833|NCT05173987|Paclitaxel|paclitaxel|mesh-list
5832834|NCT05173987|Docetaxel|docetaxel|mesh-list
5832835|NCT05173987|Carboplatin|carboplatin|mesh-list
5832836|NCT05173987|Pembrolizumab|pembrolizumab|mesh-list
5832837|NCT05173987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5832838|NCT05173987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5832839|NCT05173987|Tubulin Modulators|tubulin modulators|mesh-ancestor
5832840|NCT05173987|Antimitotic Agents|antimitotic agents|mesh-ancestor
5832841|NCT05173987|Mitosis Modulators|mitosis modulators|mesh-ancestor
5832842|NCT05173987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832843|NCT05173987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5832844|NCT05171972|Ofatumumab|ofatumumab|mesh-list
5832845|NCT05171972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5832846|NCT05167864|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5832847|NCT05167864|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
5832848|NCT05167864|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5832849|NCT05167864|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5832850|NCT05167864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5832851|NCT05167864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832852|NCT05167864|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5832853|NCT05167864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5832854|NCT05167864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832855|NCT05167864|Cholinergic Agents|cholinergic agents|mesh-ancestor
5832856|NCT05167864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5832857|NCT05162131|Ticagrelor|ticagrelor|mesh-list
5832858|NCT05162131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5832859|NCT05162131|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5832860|NCT05162131|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5832861|NCT05162131|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5832862|NCT05162131|Purinergic Agents|purinergic agents|mesh-ancestor
5832863|NCT05162131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5832864|NCT05162131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832865|NCT05162131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832866|NCT05157412|Doxycycline|doxycycline|mesh-list
5832867|NCT05157412|Prednisolone|prednisolone|mesh-list
5832868|NCT05157412|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5832869|NCT05157412|Methylprednisolone|methylprednisolone|mesh-list
5832870|NCT05157412|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5832871|NCT05157412|Prednisolone acetate|prednisolone acetate|mesh-list
5832872|NCT05157412|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5832873|NCT05157412|Prednisolone phosphate|prednisolone phosphate|mesh-list
5832874|NCT05157412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5832875|NCT05157412|Glucocorticoids|glucocorticoids|mesh-ancestor
5832876|NCT05157412|Hormones|hormones|mesh-ancestor
5832877|NCT05157412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5832878|NCT05157412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832879|NCT05157412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5832880|NCT05157412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5655100|NCT03678038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655101|NCT03678038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5655102|NCT03678038|Immunologic Factors|immunologic factors|mesh-ancestor
5655103|NCT03678038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5655104|NCT03678038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655105|NCT03678012|Hydrogen Peroxide|hydrogen peroxide|mesh-list
5655106|NCT03678012|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
5655107|NCT03678012|Hematinics|hematinics|mesh-ancestor
5655108|NCT03678012|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5655109|NCT03678012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5655110|NCT03678012|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5655111|NCT03678012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5655112|NCT03677895|Hyaluronic Acid|hyaluronic acid|mesh-list
5655113|NCT03677895|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5655114|NCT03677895|Immunologic Factors|immunologic factors|mesh-ancestor
5655115|NCT03677895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655116|NCT03677895|Viscosupplements|viscosupplements|mesh-ancestor
5655117|NCT03677895|Protective Agents|protective agents|mesh-ancestor
5655118|NCT03677817|Lidocaine|lidocaine|mesh-list
5655119|NCT03677817|Anesthetics, Local|anesthetics, local|mesh-ancestor
5655120|NCT03677817|Anesthetics|anesthetics|mesh-ancestor
5655121|NCT03677817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5655122|NCT03677817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655123|NCT03677817|Sensory System Agents|sensory system agents|mesh-ancestor
5655124|NCT03677817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5655125|NCT03677817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5655126|NCT03677817|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5655127|NCT03677817|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5655128|NCT03677817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5655129|NCT03677817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655130|NCT03677492|Cytochalasin D|cytochalasin d|mesh-list
5655131|NCT03677492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5655132|NCT03677492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5655133|NCT03677492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655134|NCT03677466|Tenecteplase|tenecteplase|mesh-list
5655135|NCT03677466|Streptokinase|streptokinase|mesh-list
5655136|NCT03677466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5655137|NCT03677466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5655138|NCT03677466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832881|NCT05157412|Antiemetics|antiemetics|mesh-ancestor
5832882|NCT05157412|Autonomic Agents|autonomic agents|mesh-ancestor
5832883|NCT05157412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5832884|NCT05157412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5832885|NCT05157412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5832886|NCT05157412|Protective Agents|protective agents|mesh-ancestor
5832887|NCT05157412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5832888|NCT05157412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5832889|NCT05157412|Antimalarials|antimalarials|mesh-ancestor
5832890|NCT05157412|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5832891|NCT05157412|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5832892|NCT05155436|Amlodipine|amlodipine|mesh-list
5832893|NCT05155436|Telmisartan|telmisartan|mesh-list
5832894|NCT05155436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5832895|NCT05155436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5832896|NCT05155436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5832897|NCT05155436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832898|NCT05155436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5832899|NCT05155436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832900|NCT05155436|Vasodilator Agents|vasodilator agents|mesh-ancestor
5832901|NCT05155436|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5832902|NCT05155436|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5832903|NCT05151744|Ranibizumab|ranibizumab|mesh-list
5832904|NCT05151744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5832905|NCT05151744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5832906|NCT05151744|Growth Substances|growth substances|mesh-ancestor
5832907|NCT05151744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832908|NCT05151744|Growth Inhibitors|growth inhibitors|mesh-ancestor
5832909|NCT05151744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5832910|NCT05151731|Ranibizumab|ranibizumab|mesh-list
5832911|NCT05151731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5832912|NCT05151731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5655139|NCT03677336|Progesterone|progesterone|mesh-list
5655140|NCT03677336|Dydrogesterone|dydrogesterone|mesh-list
5655141|NCT03677336|Progestins|progestins|mesh-ancestor
5655142|NCT03677336|Hormones|hormones|mesh-ancestor
5655143|NCT03677336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5655144|NCT03677336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655145|NCT03677323|Sufentanil|sufentanil|mesh-list
5655146|NCT03677323|Droperidol|droperidol|mesh-list
5832913|NCT05151731|Growth Substances|growth substances|mesh-ancestor
5832914|NCT05151731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832915|NCT05151731|Growth Inhibitors|growth inhibitors|mesh-ancestor
5832916|NCT05151731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5832917|NCT05151263|Aspirin|aspirin|mesh-list
5832918|NCT05151263|Salicylates|salicylates|mesh-list
5832919|NCT05151263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5832920|NCT05151263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5832921|NCT05151263|Analgesics|analgesics|mesh-ancestor
5832922|NCT05151263|Sensory System Agents|sensory system agents|mesh-ancestor
5832923|NCT05151263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5832924|NCT05151263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832925|NCT05151263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5832926|NCT05151263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5832927|NCT05151263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5832928|NCT05151263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5832929|NCT05151263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832930|NCT05151263|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5655147|NCT03677323|Propofol|propofol|mesh-list
5655148|NCT03677323|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5655149|NCT03677323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5655150|NCT03677323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655151|NCT03677323|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5655152|NCT03677323|Anesthetics, General|anesthetics, general|mesh-ancestor
5655153|NCT03677323|Anesthetics|anesthetics|mesh-ancestor
5655154|NCT03677323|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5655155|NCT03677323|Narcotics|narcotics|mesh-ancestor
5832931|NCT05151263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5832932|NCT05151263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5832933|NCT05151263|Antipyretics|antipyretics|mesh-ancestor
6211790|NCT02176655|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6211791|NCT02176655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6211792|NCT02176655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6211793|NCT02176655|Antipyretics|antipyretics|mesh-ancestor
6493460|NCT00613613|Antimetabolites|antimetabolites|mesh-ancestor
5655156|NCT03677323|Analgesics|analgesics|mesh-ancestor
5655157|NCT03677323|Sensory System Agents|sensory system agents|mesh-ancestor
5655158|NCT03677323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5655159|NCT03677323|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5655160|NCT03677323|Antiemetics|antiemetics|mesh-ancestor
5655161|NCT03677323|Autonomic Agents|autonomic agents|mesh-ancestor
5655162|NCT03677323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5655163|NCT03677323|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5655164|NCT03677323|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6493461|NCT00613613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655165|NCT03677323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5655166|NCT03677323|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5655167|NCT03677323|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5655168|NCT03677323|Dopamine Agents|dopamine agents|mesh-ancestor
5655169|NCT03677323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5655170|NCT03677323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655171|NCT03677297|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5655172|NCT03677297|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5655173|NCT03677297|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5655174|NCT03677297|Antimetabolites|antimetabolites|mesh-ancestor
5655175|NCT03677297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655176|NCT03677297|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5655177|NCT03677297|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5655178|NCT03677297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5655179|NCT03677258|Hyaluronic Acid|hyaluronic acid|mesh-list
5655180|NCT03677258|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5655181|NCT03677258|Immunologic Factors|immunologic factors|mesh-ancestor
5832934|NCT05142696|Carboplatin|carboplatin|mesh-list
5832935|NCT05142696|Etoposide|etoposide|mesh-list
5832936|NCT05142696|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
5832937|NCT05142696|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
5832938|NCT05142696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5832939|NCT05142696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5832940|NCT05142696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5832941|NCT05142696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5832942|NCT05142696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5832943|NCT05142696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832944|NCT05142696|Chelating Agents|chelating agents|mesh-ancestor
5832945|NCT05142696|Sequestering Agents|sequestering agents|mesh-ancestor
5832946|NCT05142696|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5832947|NCT05139212|Dexmedetomidine|dexmedetomidine|mesh-list
5832948|NCT05139212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5832949|NCT05139212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5832950|NCT05139212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5832951|NCT05139212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5832952|NCT05139212|Analgesics|analgesics|mesh-ancestor
5832953|NCT05139212|Sensory System Agents|sensory system agents|mesh-ancestor
5832954|NCT05139212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5832955|NCT05139212|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5832956|NCT05139212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5832957|NCT05139212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5832958|NCT05139212|Adrenergic Agents|adrenergic agents|mesh-ancestor
5832959|NCT05139212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5832960|NCT05139212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832961|NCT05134974|Phentolamine|phentolamine|mesh-list
5832962|NCT05134974|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5832963|NCT05134974|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5832964|NCT05134974|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5832965|NCT05134974|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5832966|NCT05134974|Adrenergic Agents|adrenergic agents|mesh-ancestor
5902686|NCT03875287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6493462|NCT00613613|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6493463|NCT00613665|Vaccines|vaccines|mesh-list
6493464|NCT00613665|Immunologic Factors|immunologic factors|mesh-ancestor
6493465|NCT00613665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493466|NCT00613717|Vitamin D|vitamin d|mesh-list
6493467|NCT00613717|Vitamins|vitamins|mesh-list
6493468|NCT00613717|Folic Acid|folic acid|mesh-list
6493469|NCT00613717|Vitamin A|vitamin a|mesh-list
6493470|NCT00613717|Iron|iron|mesh-list
6493471|NCT00613717|Vitamin B Complex|vitamin b complex|mesh-list
6493472|NCT00613717|Retinol palmitate|retinol palmitate|mesh-list
6493473|NCT00613717|Micronutrients|micronutrients|mesh-ancestor
6493474|NCT00613717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493475|NCT00613717|Trace Elements|trace elements|mesh-ancestor
6493476|NCT00613717|Hematinics|hematinics|mesh-ancestor
6493477|NCT00613717|Antioxidants|antioxidants|mesh-ancestor
6496443|NCT00628056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5832967|NCT05134974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5832968|NCT05134974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832969|NCT05134974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211794|NCT02176655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6211795|NCT02176655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6211796|NCT02176655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6211797|NCT02176655|Serotonin Agents|serotonin agents|mesh-ancestor
6211798|NCT02176655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6211799|NCT02177032|Vaccines|vaccines|mesh-list
5655182|NCT03677258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655183|NCT03677258|Viscosupplements|viscosupplements|mesh-ancestor
5655184|NCT03677258|Protective Agents|protective agents|mesh-ancestor
5655185|NCT03676985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5655186|NCT03676985|Antibodies|antibodies|mesh-list
5655187|NCT03676985|Immunoglobulins|immunoglobulins|mesh-list
5655188|NCT03676985|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5655189|NCT03676985|Immunologic Factors|immunologic factors|mesh-ancestor
5655190|NCT03676985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655191|NCT03676985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5655192|NCT03676959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5655193|NCT03676959|Antibodies|antibodies|mesh-list
5655194|NCT03676959|Immunoglobulins|immunoglobulins|mesh-list
5655195|NCT03676959|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5655196|NCT03676959|Immunologic Factors|immunologic factors|mesh-ancestor
6211800|NCT02177032|Immunoglobulins|immunoglobulins|mesh-list
6211801|NCT02177032|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6211802|NCT02177032|Antibodies|antibodies|mesh-list
6211803|NCT02177032|Immunologic Factors|immunologic factors|mesh-ancestor
6211804|NCT02177032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211805|NCT02177786|Selonsertib|selonsertib|mesh-list
6211806|NCT02177786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6211807|NCT02177786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5832970|NCT05134974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5832971|NCT05127876|Ephedrine|ephedrine|mesh-list
5832972|NCT05127876|Pseudoephedrine|pseudoephedrine|mesh-list
5832973|NCT05127876|Ondansetron|ondansetron|mesh-list
5832974|NCT05127876|Antiemetics|antiemetics|mesh-ancestor
5832975|NCT05127876|Autonomic Agents|autonomic agents|mesh-ancestor
5832976|NCT05127876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5832977|NCT05127876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655197|NCT03676959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655198|NCT03676959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5655199|NCT03676946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5655200|NCT03676946|Antibodies|antibodies|mesh-list
5655201|NCT03676946|Immunoglobulins|immunoglobulins|mesh-list
5655202|NCT03676946|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5655203|NCT03676946|Immunologic Factors|immunologic factors|mesh-ancestor
5832978|NCT05127876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5832979|NCT05127876|Antipruritics|antipruritics|mesh-ancestor
5832980|NCT05127876|Dermatologic Agents|dermatologic agents|mesh-ancestor
5832981|NCT05127876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5832982|NCT05127876|Serotonin Agents|serotonin agents|mesh-ancestor
5832983|NCT05127876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5832984|NCT05127876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5832985|NCT05127876|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5832986|NCT05127876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5832987|NCT05127876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5832988|NCT05127876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5832989|NCT05127876|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5832990|NCT05127876|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5832991|NCT05127876|Sympathomimetics|sympathomimetics|mesh-ancestor
5832992|NCT05127876|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5832993|NCT05127876|Adrenergic Agents|adrenergic agents|mesh-ancestor
5832994|NCT05127876|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5832995|NCT05127876|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6211808|NCT02177786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655204|NCT03676946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655205|NCT03676946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5655206|NCT03676933|Hydrocortisone|hydrocortisone|mesh-list
5655207|NCT03676933|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
5655208|NCT03676933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5655209|NCT03676933|Dermatologic Agents|dermatologic agents|mesh-ancestor
5655210|NCT03676764|Azithromycin|azithromycin|mesh-list
5655211|NCT03676764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5655212|NCT03676764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5655213|NCT03676621|Misoprostol|misoprostol|mesh-list
5655214|NCT03676621|Oxytocin|oxytocin|mesh-list
5832996|NCT05127876|Respiratory System Agents|respiratory system agents|mesh-ancestor
5832997|NCT05127876|Nasal Decongestants|nasal decongestants|mesh-ancestor
5832998|NCT05124275|Pilocarpine|pilocarpine|mesh-list
5832999|NCT05124275|Miotics|miotics|mesh-ancestor
5833000|NCT05124275|Autonomic Agents|autonomic agents|mesh-ancestor
5833001|NCT05124275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5833002|NCT05124275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5833003|NCT05124275|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
5833004|NCT05124275|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5833005|NCT05124275|Cholinergic Agents|cholinergic agents|mesh-ancestor
5833006|NCT05124275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5833007|NCT05124275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833008|NCT05119920|Pilocarpine|pilocarpine|mesh-list
5833009|NCT05119920|Miotics|miotics|mesh-ancestor
5833010|NCT05119920|Autonomic Agents|autonomic agents|mesh-ancestor
5833011|NCT05119920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5833012|NCT05119920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5833013|NCT05119920|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
5833014|NCT05119920|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5833015|NCT05119920|Cholinergic Agents|cholinergic agents|mesh-ancestor
5833016|NCT05119920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5833017|NCT05119920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833018|NCT05118776|Bevacizumab|bevacizumab|mesh-list
5833019|NCT05118776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5833020|NCT05118776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833021|NCT05118776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5833022|NCT05118776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5833023|NCT05118776|Growth Substances|growth substances|mesh-ancestor
5833024|NCT05118776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5833025|NCT05118776|Growth Inhibitors|growth inhibitors|mesh-ancestor
5833026|NCT05100199|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5655215|NCT03676621|Oxytocics|oxytocics|mesh-ancestor
5655216|NCT03676621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5833027|NCT05100199|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5833028|NCT05100199|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5833029|NCT05100199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5833030|NCT05100199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5833031|NCT05100199|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5833032|NCT05100199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5833033|NCT05100199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833034|NCT05100199|Cholinergic Agents|cholinergic agents|mesh-ancestor
5833035|NCT05100199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5833036|NCT05097599|Talazoparib|talazoparib|mesh-list
5833037|NCT05097599|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5833038|NCT05097599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5833039|NCT05097599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833040|NCT05097599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5902687|NCT03805581|Defibrotide|defibrotide|mesh-list
5902688|NCT03805581|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5655217|NCT03676621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655218|NCT03676621|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5655219|NCT03676621|Abortifacient Agents|abortifacient agents|mesh-ancestor
5655220|NCT03676621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5655221|NCT03676621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5655222|NCT03676556|Lidocaine|lidocaine|mesh-list
5655223|NCT03676556|Anesthetics, Local|anesthetics, local|mesh-ancestor
5655224|NCT03676556|Anesthetics|anesthetics|mesh-ancestor
5902689|NCT03805581|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5902690|NCT03805581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655225|NCT03676556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5655226|NCT03676556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655227|NCT03676556|Sensory System Agents|sensory system agents|mesh-ancestor
5655228|NCT03676556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5655229|NCT03676556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5655230|NCT03676556|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5655231|NCT03676556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5655232|NCT03676556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5655233|NCT03676556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655234|NCT03676504|Cyclophosphamide|cyclophosphamide|mesh-list
5655235|NCT03676504|Fludarabine|fludarabine|mesh-list
5655236|NCT03676504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5655237|NCT03676504|Immunologic Factors|immunologic factors|mesh-ancestor
5655238|NCT03676504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655239|NCT03676504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5655240|NCT03676504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5655241|NCT03676504|Alkylating Agents|alkylating agents|mesh-ancestor
5655242|NCT03676504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655243|NCT03676504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833047|NCT05079230|Azacitidine|azacitidine|mesh-list
5833048|NCT05079230|Venetoclax|venetoclax|mesh-list
5833049|NCT05079230|Magrolimab|magrolimab|mesh-list
5833050|NCT05079230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5833051|NCT05079230|Antimetabolites|antimetabolites|mesh-ancestor
5833052|NCT05079230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833053|NCT05079230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5655244|NCT03676504|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5655245|NCT03676413|Fluticasone|fluticasone|mesh-list
5655246|NCT03676413|Xhance|xhance|mesh-list
5655247|NCT03676413|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5655248|NCT03676413|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
5655249|NCT03676413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5655250|NCT03676413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5655251|NCT03676413|Autonomic Agents|autonomic agents|mesh-ancestor
5655252|NCT03676413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5655253|NCT03676413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655254|NCT03676413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5655255|NCT03676413|Respiratory System Agents|respiratory system agents|mesh-ancestor
5655256|NCT03676413|Dermatologic Agents|dermatologic agents|mesh-ancestor
5655257|NCT03676413|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5655258|NCT03676413|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5655259|NCT03676413|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5655260|NCT03676413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5655261|NCT03676413|Adrenergic Agents|adrenergic agents|mesh-ancestor
5655262|NCT03676413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5655263|NCT03676413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655264|NCT03676413|Glucocorticoids|glucocorticoids|mesh-ancestor
5655265|NCT03676413|Hormones|hormones|mesh-ancestor
5655266|NCT03676413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5655267|NCT03676413|Sympathomimetics|sympathomimetics|mesh-ancestor
5655268|NCT03676374|Prucalopride|prucalopride|mesh-list
5655269|NCT03676374|Laxatives|laxatives|mesh-ancestor
5655270|NCT03676374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5655271|NCT03676374|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
5655272|NCT03676374|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5655273|NCT03676374|Serotonin Agents|serotonin agents|mesh-ancestor
5655274|NCT03676374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5655275|NCT03676374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655276|NCT03676374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655277|NCT03676361|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
5655278|NCT03676361|Hemostatics|hemostatics|mesh-ancestor
5655279|NCT03676361|Coagulants|coagulants|mesh-ancestor
5655280|NCT03676361|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5655281|NCT03676361|Natriuretic Agents|natriuretic agents|mesh-ancestor
5655282|NCT03676361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655283|NCT03676335|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5655284|NCT03676335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5655285|NCT03676296|Puerarin|puerarin|mesh-list
5655286|NCT03676296|Vasodilator Agents|vasodilator agents|mesh-ancestor
5655287|NCT03676192|Bevacizumab|bevacizumab|mesh-list
5655288|NCT03676192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5655289|NCT03676192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5655290|NCT03676192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5655291|NCT03676192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5655292|NCT03676192|Growth Substances|growth substances|mesh-ancestor
5655293|NCT03676192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655294|NCT03676192|Growth Inhibitors|growth inhibitors|mesh-ancestor
5655295|NCT03676140|Azithromycin|azithromycin|mesh-list
5655296|NCT03676140|Ivermectin|ivermectin|mesh-list
5655297|NCT03676140|Albendazole|albendazole|mesh-list
5655298|NCT03676140|Diethylcarbamazine|diethylcarbamazine|mesh-list
5655299|NCT03676140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5655300|NCT03676140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5833054|NCT05079230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5833055|NCT05079230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5833056|NCT05069896|Mirikizumab|mirikizumab|mesh-list
5833057|NCT05069896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5833058|NCT05069896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5833059|NCT05069896|Analgesics|analgesics|mesh-ancestor
5833060|NCT05069896|Sensory System Agents|sensory system agents|mesh-ancestor
5833061|NCT05069896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5833062|NCT05069896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5833063|NCT05069896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5833064|NCT05069896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5833065|NCT05069896|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5833066|NCT05069896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5833067|NCT05066698|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5833068|NCT05066698|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5833069|NCT05056233|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5833070|NCT05056233|Lubricant Eye Drops|lubricant eye drops|mesh-list
5833071|NCT05056233|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5833072|NCT05049525|Itraconazole|itraconazole|mesh-list
5833073|NCT05049525|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
5833074|NCT05049525|Terbinafine|terbinafine|mesh-list
5833075|NCT05049525|Antifungal Agents|antifungal agents|mesh-ancestor
5833076|NCT05049525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5833077|NCT05049525|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5833078|NCT05049525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5833079|NCT05049525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5655301|NCT03676140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5655302|NCT03676140|Anthelmintics|anthelmintics|mesh-ancestor
6493478|NCT00613717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655303|NCT03676140|Anticestodal Agents|anticestodal agents|mesh-ancestor
5655304|NCT03676140|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5655305|NCT03676140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5655306|NCT03676140|Tubulin Modulators|tubulin modulators|mesh-ancestor
5655307|NCT03676140|Antimitotic Agents|antimitotic agents|mesh-ancestor
5833080|NCT05049525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833081|NCT05049525|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5833082|NCT05049525|Hormone Antagonists|hormone antagonists|mesh-ancestor
5833083|NCT05049525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5833084|NCT05049525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5833085|NCT05049525|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5833086|NCT05041907|Ivermectin|ivermectin|mesh-list
5833087|NCT05041907|Remdesivir|remdesivir|mesh-list
5833088|NCT05041907|Favipiravir|favipiravir|mesh-list
5833089|NCT05041907|Antibodies|antibodies|mesh-list
5833090|NCT05041907|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5833091|NCT05041907|Immunologic Factors|immunologic factors|mesh-ancestor
5833092|NCT05041907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655308|NCT03676140|Mitosis Modulators|mitosis modulators|mesh-ancestor
5655309|NCT03676140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655310|NCT03676140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5655311|NCT03676140|Filaricides|filaricides|mesh-ancestor
5833093|NCT05041907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5833094|NCT05041907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5833095|NCT05041907|Antimetabolites|antimetabolites|mesh-ancestor
5655312|NCT03676140|Antinematodal Agents|antinematodal agents|mesh-ancestor
5655313|NCT03676140|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
5655314|NCT03676140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5655315|NCT03676114|Ketamine|ketamine|mesh-list
5655316|NCT03676114|Analgesics|analgesics|mesh-ancestor
5655317|NCT03676114|Sensory System Agents|sensory system agents|mesh-ancestor
5833096|NCT05041907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833097|NCT05041907|Antiviral Agents|antiviral agents|mesh-ancestor
5833098|NCT05030298|Temozolomide|temozolomide|mesh-list
5833099|NCT05030298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5833100|NCT05030298|Alkylating Agents|alkylating agents|mesh-ancestor
5833101|NCT05030298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833102|NCT05030298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833103|NCT05018091|Dexamethasone|dexamethasone|mesh-list
5833104|NCT05018091|Dexamethasone acetate|dexamethasone acetate|mesh-list
5833105|NCT05018091|BB 1101|bb 1101|mesh-list
5833106|NCT05018091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5833107|NCT05018091|Antiemetics|antiemetics|mesh-ancestor
5833108|NCT05018091|Autonomic Agents|autonomic agents|mesh-ancestor
5833109|NCT05018091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5833110|NCT05018091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5833111|NCT05018091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5833112|NCT05018091|Glucocorticoids|glucocorticoids|mesh-ancestor
5833113|NCT05018091|Hormones|hormones|mesh-ancestor
5833114|NCT05018091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5833115|NCT05018091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5833116|NCT05018091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833117|NCT05018091|Protease Inhibitors|protease inhibitors|mesh-ancestor
5833118|NCT05018091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5833119|NCT05018091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833120|NCT05014919|Vortioxetine|vortioxetine|mesh-list
5833121|NCT05014919|Antidepressive Agents|antidepressive agents|mesh-ancestor
5833122|NCT05014919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5833123|NCT05014919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5833124|NCT05014919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5833125|NCT05014919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5833126|NCT05014919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5833127|NCT05014919|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5833128|NCT05014919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5833129|NCT05014919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5833130|NCT05014919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833131|NCT05014919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5833132|NCT05014919|Serotonin Agents|serotonin agents|mesh-ancestor
5833133|NCT05014919|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5833134|NCT05014919|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5833135|NCT05014919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5833136|NCT05014919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5833137|NCT04999969|Gemcitabine|gemcitabine|mesh-list
5833138|NCT04999969|Paclitaxel|paclitaxel|mesh-list
5833139|NCT04999969|Durvalumab|durvalumab|mesh-list
5833140|NCT04999969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5833141|NCT04999969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833142|NCT04999969|Tubulin Modulators|tubulin modulators|mesh-ancestor
5833143|NCT04999969|Antimitotic Agents|antimitotic agents|mesh-ancestor
5833144|NCT04999969|Mitosis Modulators|mitosis modulators|mesh-ancestor
5833145|NCT04999969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833146|NCT04999969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5833147|NCT04999969|Antimetabolites|antimetabolites|mesh-ancestor
5833148|NCT04999969|Antiviral Agents|antiviral agents|mesh-ancestor
5833149|NCT04999969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5833150|NCT04999969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5833151|NCT04999969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5833152|NCT04999969|Immunologic Factors|immunologic factors|mesh-ancestor
5833153|NCT04999969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5833154|NCT04999969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5833155|NCT04989699|Aflibercept|aflibercept|mesh-list
6211809|NCT02177838|Cetuximab|cetuximab|mesh-list
5655318|NCT03676114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5655319|NCT03676114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655320|NCT03676114|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5655321|NCT03676114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5655322|NCT03676114|Anesthetics, General|anesthetics, general|mesh-ancestor
5655323|NCT03676114|Anesthetics|anesthetics|mesh-ancestor
5655324|NCT03676114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5655325|NCT03676114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5655326|NCT03676114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5655327|NCT03676114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5655328|NCT03676114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655329|NCT03676088|Mitogens|mitogens|mesh-list
5655330|NCT03676088|Mitosis Modulators|mitosis modulators|mesh-ancestor
5655331|NCT03676088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655332|NCT03676049|Cannabidiol|cannabidiol|mesh-list
5655333|NCT03676049|Anticonvulsants|anticonvulsants|mesh-ancestor
5655334|NCT03676036|Mometasone Furoate|mometasone furoate|mesh-list
5655335|NCT03676036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5655336|NCT03676036|Dermatologic Agents|dermatologic agents|mesh-ancestor
5655337|NCT03676036|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5655338|NCT03676023|Tranexamic Acid|tranexamic acid|mesh-list
5655339|NCT03676023|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5655340|NCT03676023|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5655341|NCT03676023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655342|NCT03676023|Hemostatics|hemostatics|mesh-ancestor
5655343|NCT03676023|Coagulants|coagulants|mesh-ancestor
5655344|NCT03675893|Letrozole|letrozole|mesh-list
5655345|NCT03675893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833156|NCT04989699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5833157|NCT04989699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5833158|NCT04989699|Growth Substances|growth substances|mesh-ancestor
5833159|NCT04989699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5833160|NCT04989699|Growth Inhibitors|growth inhibitors|mesh-ancestor
5833161|NCT04989699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833162|NCT04980482|Interferons|interferons|mesh-list
5833163|NCT04980482|Interferon-alpha|interferon-alpha|mesh-list
5833164|NCT04980482|Interferon alpha-2|interferon alpha-2|mesh-list
5833165|NCT04980482|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5833166|NCT04980482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833167|NCT04980482|Antiviral Agents|antiviral agents|mesh-ancestor
5833168|NCT04980482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5833169|NCT04980482|Immunologic Factors|immunologic factors|mesh-ancestor
5833170|NCT04980482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5833171|NCT04957914|Insulin Glargine|insulin glargine|mesh-list
5833172|NCT04957914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5833173|NCT04957914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5833174|NCT04947124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5833175|NCT04947124|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5833176|NCT04930536|Acalabrutinib|acalabrutinib|mesh-list
5833177|NCT04930536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833178|NCT04891484|Ondansetron|ondansetron|mesh-list
5833179|NCT04891484|Antiemetics|antiemetics|mesh-ancestor
5833180|NCT04891484|Autonomic Agents|autonomic agents|mesh-ancestor
5833181|NCT04891484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5833182|NCT04891484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5833183|NCT04891484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5833184|NCT04891484|Antipruritics|antipruritics|mesh-ancestor
5833185|NCT04891484|Dermatologic Agents|dermatologic agents|mesh-ancestor
5833186|NCT04891484|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5833187|NCT04891484|Serotonin Agents|serotonin agents|mesh-ancestor
5655346|NCT03675893|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5655347|NCT03675893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5655348|NCT03675893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5655349|NCT03675893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655350|NCT03675893|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5655351|NCT03675893|Hormone Antagonists|hormone antagonists|mesh-ancestor
5655352|NCT03675893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5655353|NCT03675893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655354|NCT03675854|Cefazolin|cefazolin|mesh-list
5655355|NCT03675854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5655356|NCT03675854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5655357|NCT03675841|Carbamide Peroxide|carbamide peroxide|mesh-list
5655358|NCT03675841|Pazufloxacin|pazufloxacin|mesh-list
5655359|NCT03675841|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5655360|NCT03675841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5655361|NCT03675841|Antitubercular Agents|antitubercular agents|mesh-ancestor
5655362|NCT03675841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5655363|NCT03675841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5655364|NCT03675841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5655365|NCT03675841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5655366|NCT03675841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655367|NCT03675841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5694872|NCT03393377|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5833188|NCT04891484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5833189|NCT04891484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833190|NCT04891484|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5833191|NCT04891484|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5833192|NCT04891484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5833193|NCT04891484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5833194|NCT04891484|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5833195|NCT04869943|Exemestane|exemestane|mesh-list
5833196|NCT04869943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833197|NCT04869943|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5833198|NCT04869943|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5833199|NCT04869943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5833200|NCT04869943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833201|NCT04869943|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5833202|NCT04869943|Hormone Antagonists|hormone antagonists|mesh-ancestor
5833203|NCT04869943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5833204|NCT04869943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5833205|NCT04861298|Quercetin|quercetin|mesh-list
5833206|NCT04861298|Antioxidants|antioxidants|mesh-ancestor
5902691|NCT03805581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5833207|NCT04861298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833208|NCT04861298|Protective Agents|protective agents|mesh-ancestor
5833209|NCT04861298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5833210|NCT04859946|Cyclophosphamide|cyclophosphamide|mesh-list
5833211|NCT04859946|Busulfan|busulfan|mesh-list
5833212|NCT04859946|Thiotepa|thiotepa|mesh-list
5833213|NCT04859946|Fludarabine|fludarabine|mesh-list
5833214|NCT04859946|Tacrolimus|tacrolimus|mesh-list
5833215|NCT04859946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5833216|NCT04859946|Immunologic Factors|immunologic factors|mesh-ancestor
5833217|NCT04859946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5833218|NCT04859946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5833219|NCT04859946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5833220|NCT04859946|Alkylating Agents|alkylating agents|mesh-ancestor
5833221|NCT04859946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833222|NCT04859946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833223|NCT04859946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5833224|NCT04859946|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5833225|NCT04859946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5833226|NCT04858425|Niclosamide|niclosamide|mesh-list
5833227|NCT04858425|Anticestodal Agents|anticestodal agents|mesh-ancestor
5833228|NCT04858425|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5833229|NCT04858425|Anthelmintics|anthelmintics|mesh-ancestor
5833230|NCT04858425|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5833231|NCT04858425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5833232|NCT04858425|Antinematodal Agents|antinematodal agents|mesh-ancestor
5833233|NCT04846231|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5833234|NCT04846231|Red yeast rice|red yeast rice|mesh-list
5833235|NCT04846231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5833236|NCT04846231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5833237|NCT04846231|Antimetabolites|antimetabolites|mesh-ancestor
5833238|NCT04846231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833239|NCT04846231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5833240|NCT04846231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5833241|NCT04846231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5833242|NCT04844918|Tirzepatide|tirzepatide|mesh-list
5833243|NCT04844918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5833244|NCT04844918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5833245|NCT04844918|Incretins|incretins|mesh-ancestor
5655368|NCT03675815|Ritonavir|ritonavir|mesh-list
5655369|NCT03675815|Darunavir|darunavir|mesh-list
5655370|NCT03675815|Tenofovir|tenofovir|mesh-list
5655371|NCT03675815|Lamivudine|lamivudine|mesh-list
5655372|NCT03675815|Emtricitabine|emtricitabine|mesh-list
5655373|NCT03675815|Dolutegravir|dolutegravir|mesh-list
5655374|NCT03675815|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
5655375|NCT03675815|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5655376|NCT03675815|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5655377|NCT03675815|Protease Inhibitors|protease inhibitors|mesh-ancestor
5655378|NCT03675815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5655379|NCT03675815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655380|NCT03675815|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5655381|NCT03675815|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5655382|NCT03675815|Antiviral Agents|antiviral agents|mesh-ancestor
5655383|NCT03675815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5655384|NCT03675815|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5655385|NCT03675815|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5655386|NCT03675815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5655387|NCT03675815|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5655388|NCT03675815|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5833246|NCT04844918|Hormones|hormones|mesh-ancestor
5833247|NCT04844918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5833248|NCT04842708|Vaccines|vaccines|mesh-list
5833249|NCT04842708|Immunologic Factors|immunologic factors|mesh-ancestor
5833250|NCT04842708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655389|NCT03675802|Misoprostol|misoprostol|mesh-list
5655390|NCT03675802|Dinoprostone|dinoprostone|mesh-list
5655391|NCT03675802|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5655392|NCT03675802|Abortifacient Agents|abortifacient agents|mesh-ancestor
5655393|NCT03675802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5655394|NCT03675802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655395|NCT03675802|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5655396|NCT03675802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5655397|NCT03675802|Oxytocics|oxytocics|mesh-ancestor
5655398|NCT03675646|Morphine|morphine|mesh-list
5655399|NCT03675646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5655400|NCT03675646|Narcotics|narcotics|mesh-ancestor
5833251|NCT04840628|Respiratory System Agents|respiratory system agents|mesh-list
5833252|NCT04826393|Cemiplimab|cemiplimab|mesh-list
5833253|NCT04826393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5833254|NCT04826393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833255|NCT04812366|Prednisone|prednisone|mesh-list
5833256|NCT04812366|Docetaxel|docetaxel|mesh-list
5833257|NCT04812366|Atezolizumab|atezolizumab|mesh-list
5833258|NCT04812366|Abiraterone Acetate|abiraterone acetate|mesh-list
5833259|NCT04812366|Niraparib|niraparib|mesh-list
5833260|NCT04812366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833261|NCT04812366|Tubulin Modulators|tubulin modulators|mesh-ancestor
5833262|NCT04812366|Antimitotic Agents|antimitotic agents|mesh-ancestor
5833263|NCT04812366|Mitosis Modulators|mitosis modulators|mesh-ancestor
5833264|NCT04812366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833265|NCT04812366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5833266|NCT04812366|Glucocorticoids|glucocorticoids|mesh-ancestor
5833267|NCT04812366|Hormones|hormones|mesh-ancestor
5833268|NCT04812366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5833269|NCT04812366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5833270|NCT04812366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5833271|NCT04812366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5833272|NCT04812366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5833273|NCT04812366|Hormone Antagonists|hormone antagonists|mesh-ancestor
5833274|NCT04812366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5833275|NCT04812366|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5833276|NCT04802759|Trastuzumab|trastuzumab|mesh-list
5833277|NCT04802759|Pertuzumab|pertuzumab|mesh-list
5833278|NCT04802759|Everolimus|everolimus|mesh-list
5833279|NCT04802759|Palbociclib|palbociclib|mesh-list
5833280|NCT04802759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5833281|NCT04802759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833282|NCT04802759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5833283|NCT04802759|Immunologic Factors|immunologic factors|mesh-ancestor
5833284|NCT04802759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5833285|NCT04802759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5833286|NCT04802759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5833287|NCT04802759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833288|NCT04778397|Cytarabine|cytarabine|mesh-list
5833289|NCT04778397|Azacitidine|azacitidine|mesh-list
5833290|NCT04778397|Daunorubicin|daunorubicin|mesh-list
5833291|NCT04778397|Venetoclax|venetoclax|mesh-list
5833292|NCT04778397|Idarubicin|idarubicin|mesh-list
5833293|NCT04778397|Magrolimab|magrolimab|mesh-list
5833294|NCT04778397|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5833295|NCT04778397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5833296|NCT04778397|Antimetabolites|antimetabolites|mesh-ancestor
5833297|NCT04778397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833298|NCT04778397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833299|NCT04778397|Antiviral Agents|antiviral agents|mesh-ancestor
5833300|NCT04778397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5833301|NCT04778397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5833302|NCT04778397|Immunologic Factors|immunologic factors|mesh-ancestor
5833303|NCT04778397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493479|NCT00613717|Protective Agents|protective agents|mesh-ancestor
6493480|NCT00613717|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6493481|NCT00613717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6493482|NCT00613717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6493483|NCT00613743|Morphine|morphine|mesh-list
6493484|NCT00613743|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5833304|NCT04778397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5833305|NCT04778397|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5833306|NCT04778397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5833307|NCT04778397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5833308|NCT04778397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6493485|NCT00613743|Narcotics|narcotics|mesh-ancestor
6493486|NCT00613743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5833309|NCT04778397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5833310|NCT04771130|Posaconazole|posaconazole|mesh-list
5833311|NCT04771130|Azacitidine|azacitidine|mesh-list
5833312|NCT04771130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5833313|NCT04771130|Antimetabolites|antimetabolites|mesh-ancestor
5833314|NCT04771130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833315|NCT04771130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833316|NCT04771130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5833317|NCT04771130|Antifungal Agents|antifungal agents|mesh-ancestor
5833318|NCT04771130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5833319|NCT04771130|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5833320|NCT04771130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5833321|NCT04771130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5833322|NCT04771130|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5833323|NCT04771130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5655401|NCT03675646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5655402|NCT03675646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655403|NCT03675646|Analgesics|analgesics|mesh-ancestor
5655404|NCT03675646|Sensory System Agents|sensory system agents|mesh-ancestor
5655405|NCT03675646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5655406|NCT03675594|Cobalt|cobalt|mesh-list
5655407|NCT03675594|Chromium|chromium|mesh-list
5655408|NCT03675594|Trace Elements|trace elements|mesh-ancestor
5655409|NCT03675594|Micronutrients|micronutrients|mesh-ancestor
5655410|NCT03675594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655411|NCT03675555|Dexamethasone|dexamethasone|mesh-list
5655412|NCT03675555|Mirtazapine|mirtazapine|mesh-list
5655413|NCT03675555|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
5655414|NCT03675555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5655415|NCT03675555|Antiemetics|antiemetics|mesh-ancestor
5655416|NCT03675555|Autonomic Agents|autonomic agents|mesh-ancestor
5655417|NCT03675555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5655418|NCT03675555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5833324|NCT04771130|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5833325|NCT04771130|Hormone Antagonists|hormone antagonists|mesh-ancestor
5833326|NCT04771130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5833327|NCT04771130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902692|NCT03791593|Evolocumab|evolocumab|mesh-list
5902693|NCT03791593|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5902694|NCT03791593|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5902695|NCT03791593|Antimetabolites|antimetabolites|mesh-ancestor
5902696|NCT03791593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902697|NCT03791593|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5902698|NCT03732950|Pembrolizumab|pembrolizumab|mesh-list
5902699|NCT03732950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5902700|NCT03732950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5902701|NCT03715465|Melatonin|melatonin|mesh-list
5902702|NCT03715465|Antioxidants|antioxidants|mesh-ancestor
5902703|NCT03715465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902704|NCT03715465|Protective Agents|protective agents|mesh-ancestor
5902705|NCT03715465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902706|NCT03715465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5902707|NCT03682536|Epoetin Alfa|epoetin alfa|mesh-list
5902708|NCT03682536|Luspatercept|luspatercept|mesh-list
5902709|NCT03682536|Hematinics|hematinics|mesh-ancestor
5902710|NCT03665506|Trifluridine|trifluridine|mesh-list
5902711|NCT03665506|Antimetabolites|antimetabolites|mesh-ancestor
5902712|NCT03665506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902713|NCT03665506|Antiviral Agents|antiviral agents|mesh-ancestor
5902714|NCT03665506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5902715|NCT03630809|Vaccines|vaccines|mesh-list
5902716|NCT03630809|Immunologic Factors|immunologic factors|mesh-ancestor
5902717|NCT03630809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902718|NCT03598309|Curcumin|curcumin|mesh-list
5902719|NCT03598309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5902720|NCT03598309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5902721|NCT03598309|Analgesics|analgesics|mesh-ancestor
5902722|NCT03598309|Sensory System Agents|sensory system agents|mesh-ancestor
5655419|NCT03675555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5655420|NCT03675555|Glucocorticoids|glucocorticoids|mesh-ancestor
5655421|NCT03675555|Hormones|hormones|mesh-ancestor
5655422|NCT03675555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5655423|NCT03675555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5655424|NCT03675555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5655425|NCT03675555|Antidepressive Agents|antidepressive agents|mesh-ancestor
5655426|NCT03675555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5655427|NCT03675555|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5655428|NCT03675555|Histamine Antagonists|histamine antagonists|mesh-ancestor
5655429|NCT03675555|Histamine Agents|histamine agents|mesh-ancestor
5655430|NCT03675555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5655431|NCT03675555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655432|NCT03675555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5655433|NCT03675555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5902723|NCT03598309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5902724|NCT03598309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655434|NCT03675555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5655435|NCT03675555|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5655436|NCT03675555|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5655437|NCT03675555|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5655438|NCT03675555|Adrenergic Agents|adrenergic agents|mesh-ancestor
5655439|NCT03675555|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5655440|NCT03675555|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5655441|NCT03675555|Serotonin Agents|serotonin agents|mesh-ancestor
5655442|NCT03675555|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5655443|NCT03675412|Caffeine|caffeine|mesh-list
5655444|NCT03675412|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5655445|NCT03675412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655446|NCT03675412|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5655447|NCT03675412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5655448|NCT03675412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655449|NCT03675412|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5655450|NCT03675412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5655451|NCT03675412|Purinergic Agents|purinergic agents|mesh-ancestor
5655452|NCT03675412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5655453|NCT03675191|Orlistat|orlistat|mesh-list
5833328|NCT04748848|Azacitidine|azacitidine|mesh-list
5833329|NCT04748848|Venetoclax|venetoclax|mesh-list
5833330|NCT04748848|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
5833331|NCT04748848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5833332|NCT04748848|Antimetabolites|antimetabolites|mesh-ancestor
5833333|NCT04748848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833334|NCT04748848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833335|NCT04748848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5833336|NCT04742777|Sirolimus|sirolimus|mesh-list
5833337|NCT04742777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5833338|NCT04742777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5655454|NCT03675191|Phentermine|phentermine|mesh-list
5655455|NCT03675191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5655456|NCT03675191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655457|NCT03675191|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5655458|NCT03675191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5655459|NCT03675191|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5655460|NCT03675191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655461|NCT03675191|Appetite Depressants|appetite depressants|mesh-ancestor
5655462|NCT03675191|Sympathomimetics|sympathomimetics|mesh-ancestor
5655463|NCT03675191|Autonomic Agents|autonomic agents|mesh-ancestor
5655464|NCT03675191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5655465|NCT03675191|Adrenergic Agents|adrenergic agents|mesh-ancestor
5833339|NCT04742777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5833340|NCT04742777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833341|NCT04742777|Antifungal Agents|antifungal agents|mesh-ancestor
5833342|NCT04742777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5655466|NCT03675191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5655467|NCT03675178|Ceftriaxone|ceftriaxone|mesh-list
5655468|NCT03675178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5655469|NCT03675178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5655470|NCT03675139|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
5655471|NCT03675139|Medroxyprogesterone|medroxyprogesterone|mesh-list
5655472|NCT03675139|Dydrogesterone|dydrogesterone|mesh-list
5655473|NCT03675139|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5655474|NCT03675139|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5655475|NCT03675139|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5655476|NCT03675139|Contraceptive Agents|contraceptive agents|mesh-ancestor
5655477|NCT03675139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5655478|NCT03675139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655479|NCT03675139|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5655480|NCT03675139|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5655481|NCT03675139|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5655482|NCT03675139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5655483|NCT03675139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5655484|NCT03675139|Progestins|progestins|mesh-ancestor
5655485|NCT03675139|Hormones|hormones|mesh-ancestor
5655486|NCT03675139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5655487|NCT03674866|Insulin|insulin|mesh-list
5655488|NCT03674866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5655489|NCT03674866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655490|NCT03674853|Gamma-oryzanol|gamma-oryzanol|mesh-list
5655491|NCT03674853|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5833343|NCT04742777|Immunologic Factors|immunologic factors|mesh-ancestor
5833344|NCT04742777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5833345|NCT04740996|Pembrolizumab|pembrolizumab|mesh-list
5833346|NCT04740996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5833347|NCT04740996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833348|NCT04732208|Mydriatics|mydriatics|mesh-list
5833349|NCT04732208|Autonomic Agents|autonomic agents|mesh-ancestor
5833350|NCT04732208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5833351|NCT04732208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5833352|NCT04731779|Cannabidiol|cannabidiol|mesh-list
5833353|NCT04731779|Anticonvulsants|anticonvulsants|mesh-ancestor
5833354|NCT04721626|Chlorhexidine|chlorhexidine|mesh-list
5833355|NCT04721626|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5833356|NCT04721626|Povidone-Iodine|povidone-iodine|mesh-list
5833357|NCT04721626|Tetracycline|tetracycline|mesh-list
5833358|NCT04721626|Doxycycline|doxycycline|mesh-list
5833359|NCT04721626|Povidone|povidone|mesh-list
5833360|NCT04721626|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5833361|NCT04721626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5833362|NCT04721626|Disinfectants|disinfectants|mesh-ancestor
5833363|NCT04721626|Dermatologic Agents|dermatologic agents|mesh-ancestor
5833364|NCT04721626|Plasma Substitutes|plasma substitutes|mesh-ancestor
5833365|NCT04721626|Blood Substitutes|blood substitutes|mesh-ancestor
5833366|NCT04721626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5833367|NCT04721626|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5833368|NCT04721626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5833369|NCT04721626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655492|NCT03674853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5655493|NCT03674853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5655494|NCT03674853|Antimetabolites|antimetabolites|mesh-ancestor
5655495|NCT03674853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655496|NCT03674853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5655497|NCT03674671|Ketamine|ketamine|mesh-list
5655498|NCT03674671|Analgesics|analgesics|mesh-ancestor
5655499|NCT03674671|Sensory System Agents|sensory system agents|mesh-ancestor
5655500|NCT03674671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5655501|NCT03674671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655502|NCT03674671|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5655503|NCT03674671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5655504|NCT03674671|Anesthetics, General|anesthetics, general|mesh-ancestor
5655505|NCT03674671|Anesthetics|anesthetics|mesh-ancestor
5655506|NCT03674671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5655507|NCT03674671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5655508|NCT03674671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5655509|NCT03674671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5655510|NCT03674671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655511|NCT03674658|Propafenone|propafenone|mesh-list
5655512|NCT03674658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5655513|NCT03674658|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5655514|NCT03674658|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5655515|NCT03674658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5655516|NCT03674658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655517|NCT03674606|Aspirin|aspirin|mesh-list
5655518|NCT03674606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5655519|NCT03674606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5655520|NCT03674606|Analgesics|analgesics|mesh-ancestor
5655521|NCT03674606|Sensory System Agents|sensory system agents|mesh-ancestor
5655522|NCT03674606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5655523|NCT03674606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655524|NCT03674606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5655525|NCT03674606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5833370|NCT04721626|Antimalarials|antimalarials|mesh-ancestor
5833371|NCT04721626|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5833372|NCT04721626|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5833373|NCT04712097|Rituximab|rituximab|mesh-list
5833374|NCT04712097|Lenalidomide|lenalidomide|mesh-list
5833375|NCT04712097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5833376|NCT04712097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833377|NCT04712097|Immunologic Factors|immunologic factors|mesh-ancestor
5833378|NCT04712097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5833379|NCT04712097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5833380|NCT04712097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5833381|NCT04712097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5833382|NCT04712097|Growth Substances|growth substances|mesh-ancestor
5833383|NCT04712097|Growth Inhibitors|growth inhibitors|mesh-ancestor
5833384|NCT04669288|Azithromycin|azithromycin|mesh-list
5833385|NCT04669288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5655526|NCT03674606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5655527|NCT03674606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5655528|NCT03674606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833386|NCT04669288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5833387|NCT04659161|Xanomeline|xanomeline|mesh-list
5833388|NCT04659161|Trospium chloride|trospium chloride|mesh-list
5833389|NCT04659161|Parasympatholytics|parasympatholytics|mesh-ancestor
5833390|NCT04659161|Autonomic Agents|autonomic agents|mesh-ancestor
5833391|NCT04659161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5833392|NCT04659161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5833393|NCT04659161|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5833394|NCT04659161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5833395|NCT04659161|Cholinergic Agents|cholinergic agents|mesh-ancestor
5833396|NCT04659161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5833397|NCT04659161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833398|NCT04659161|Urological Agents|urological agents|mesh-ancestor
5833399|NCT04659161|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6211810|NCT02177838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6211811|NCT02177838|Antibodies|antibodies|mesh-list
5655529|NCT03674606|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5833400|NCT04659161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5833401|NCT04659161|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
5833402|NCT04659161|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5833403|NCT04649203|Riboflavin|riboflavin|mesh-list
5833404|NCT04649203|Niacinamide|niacinamide|mesh-list
5833405|NCT04649203|Niacin|niacin|mesh-list
5833406|NCT04649203|Nicotinic Acids|nicotinic acids|mesh-list
5833407|NCT04649203|Vitamin B Complex|vitamin b complex|mesh-ancestor
5833408|NCT04649203|Vitamins|vitamins|mesh-ancestor
5833409|NCT04649203|Micronutrients|micronutrients|mesh-ancestor
5833410|NCT04649203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5833411|NCT04649203|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5833412|NCT04649203|Dermatologic Agents|dermatologic agents|mesh-ancestor
5833413|NCT04649203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5833414|NCT04649203|Antimetabolites|antimetabolites|mesh-ancestor
5833415|NCT04649203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833416|NCT04649203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5833417|NCT04649203|Vasodilator Agents|vasodilator agents|mesh-ancestor
5833418|NCT04638660|Phentolamine|phentolamine|mesh-list
5833419|NCT04638660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5833420|NCT04638660|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5655530|NCT03674606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5655531|NCT03674606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5655532|NCT03674606|Antipyretics|antipyretics|mesh-ancestor
5655533|NCT03674541|Bromides|bromides|mesh-list
5655534|NCT03674541|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
5655535|NCT03674541|Anticonvulsants|anticonvulsants|mesh-ancestor
5655536|NCT03674541|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5655537|NCT03674541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5655538|NCT03674541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655539|NCT03674541|Cholinergic Agents|cholinergic agents|mesh-ancestor
5655540|NCT03674541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5655541|NCT03674541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655542|NCT03674424|Avelumab|avelumab|mesh-list
5655543|NCT03674424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5833421|NCT04638660|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5833422|NCT04638660|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5833423|NCT04638660|Adrenergic Agents|adrenergic agents|mesh-ancestor
5833424|NCT04638660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5833425|NCT04638660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833426|NCT04638660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5833427|NCT04638660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5833428|NCT04638465|Cisplatin|cisplatin|mesh-list
5833429|NCT04638465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5655544|NCT03674424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5655545|NCT03674411|Mycophenolic Acid|mycophenolic acid|mesh-list
5655546|NCT03674411|Cyclophosphamide|cyclophosphamide|mesh-list
5655547|NCT03674411|Melphalan|melphalan|mesh-list
5655548|NCT03674411|Busulfan|busulfan|mesh-list
5655549|NCT03674411|Fludarabine|fludarabine|mesh-list
5655550|NCT03674411|Tacrolimus|tacrolimus|mesh-list
5655551|NCT03674411|Sargramostim|sargramostim|mesh-list
5655552|NCT03674411|Lenograstim|lenograstim|mesh-list
5655553|NCT03674411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5655554|NCT03674411|Immunologic Factors|immunologic factors|mesh-ancestor
5655555|NCT03674411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655556|NCT03674411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5833430|NCT04634162|Cangrelor|cangrelor|mesh-list
6211812|NCT02177838|Immunoglobulins|immunoglobulins|mesh-list
5655557|NCT03674411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5655558|NCT03674411|Alkylating Agents|alkylating agents|mesh-ancestor
5655559|NCT03674411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833431|NCT04634162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5833432|NCT04634162|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5833433|NCT04634162|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5833434|NCT04634162|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5833435|NCT04634162|Purinergic Agents|purinergic agents|mesh-ancestor
5833436|NCT04634162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5833437|NCT04634162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833438|NCT04634162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5833439|NCT04633148|Cyclophosphamide|cyclophosphamide|mesh-list
5833440|NCT04633148|Fludarabine|fludarabine|mesh-list
5833441|NCT04633148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5833442|NCT04633148|Immunologic Factors|immunologic factors|mesh-ancestor
5833443|NCT04633148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5833444|NCT04633148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5833445|NCT04633148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5833446|NCT04633148|Alkylating Agents|alkylating agents|mesh-ancestor
5833447|NCT04633148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833448|NCT04633148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833449|NCT04633148|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5833450|NCT04627753|Rituximab|rituximab|mesh-list
5833451|NCT04627753|Lenalidomide|lenalidomide|mesh-list
5833452|NCT04627753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5833453|NCT04627753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833454|NCT04627753|Immunologic Factors|immunologic factors|mesh-ancestor
5833455|NCT04627753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5833456|NCT04627753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5833457|NCT04627753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5833458|NCT04627753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5833459|NCT04627753|Growth Substances|growth substances|mesh-ancestor
5833460|NCT04627753|Growth Inhibitors|growth inhibitors|mesh-ancestor
5833461|NCT04612790|Benralizumab|benralizumab|mesh-list
5833462|NCT04612790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5833463|NCT04612790|Respiratory System Agents|respiratory system agents|mesh-ancestor
5833464|NCT04605094|Benralizumab|benralizumab|mesh-list
5833465|NCT04605094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5833466|NCT04605094|Respiratory System Agents|respiratory system agents|mesh-ancestor
5833467|NCT04599504|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
5833468|NCT04599504|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5833469|NCT04599504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5833470|NCT04599504|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5833471|NCT04599504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5833472|NCT04599504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5833473|NCT04599504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833474|NCT04599504|Dopamine Agents|dopamine agents|mesh-ancestor
5833475|NCT04599504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5833476|NCT04599465|Ivacaftor|ivacaftor|mesh-list
5833477|NCT04599465|Elexacaftor|elexacaftor|mesh-list
5833478|NCT04599465|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
5833479|NCT04599465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5833480|NCT04599465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833481|NCT04589676|Naloxone|naloxone|mesh-list
5833482|NCT04589676|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5833483|NCT04589676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5833484|NCT04589676|Sensory System Agents|sensory system agents|mesh-ancestor
5833485|NCT04589676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5833486|NCT04576156|Imetelstat|imetelstat|mesh-list
5833487|NCT04576156|Motesanib diphosphate|motesanib diphosphate|mesh-list
5833488|NCT04576156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5833489|NCT04576156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833490|NCT04576156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6211813|NCT02177838|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5655560|NCT03674411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5655561|NCT03674411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5655562|NCT03674411|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5655563|NCT03674411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5655564|NCT03674411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5655565|NCT03674411|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5655566|NCT03674411|Antitubercular Agents|antitubercular agents|mesh-ancestor
5655567|NCT03674411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5655568|NCT03674411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5655569|NCT03674411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5655570|NCT03674385|Vitamin E|vitamin e|mesh-list
5655571|NCT03674385|Metformin|metformin|mesh-list
5655572|NCT03674385|Clomiphene|clomiphene|mesh-list
5655573|NCT03674385|Enclomiphene|enclomiphene|mesh-list
5655574|NCT03674385|Zuclomiphene|zuclomiphene|mesh-list
5833491|NCT04565925|Sildenafil Citrate|sildenafil citrate|mesh-list
5833492|NCT04565925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833493|NCT04565925|Vasodilator Agents|vasodilator agents|mesh-ancestor
5833494|NCT04565925|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5833495|NCT04565925|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5833496|NCT04565925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5833497|NCT04565925|Urological Agents|urological agents|mesh-ancestor
5833498|NCT04551352|Adalimumab|adalimumab|mesh-list
5833499|NCT04551352|Obinutuzumab|obinutuzumab|mesh-list
5833500|NCT04551352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5833501|NCT04551352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5833502|NCT04551352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5833503|NCT04551352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833504|NCT04545515|Ivacaftor|ivacaftor|mesh-list
5833505|NCT04545515|Elexacaftor|elexacaftor|mesh-list
5833506|NCT04545515|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
5833507|NCT04545515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5833508|NCT04545515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833509|NCT04533750|Peposertib|peposertib|mesh-list
5833510|NCT04533750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5833511|NCT04533750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5833512|NCT04533750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833516|NCT04515615|Oxaliplatin|oxaliplatin|mesh-list
5833517|NCT04515615|Tegafur|tegafur|mesh-list
5833518|NCT04515615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833519|NCT04515615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5833520|NCT04515615|Antimetabolites|antimetabolites|mesh-ancestor
5833521|NCT04515615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833522|NCT04489628|Vitamin D|vitamin d|mesh-list
5833523|NCT04489628|Cholecalciferol|cholecalciferol|mesh-list
5655575|NCT03674385|Vitamins|vitamins|mesh-ancestor
5655576|NCT03674385|Micronutrients|micronutrients|mesh-ancestor
5655577|NCT03674385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655578|NCT03674385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5655579|NCT03674385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833524|NCT04489628|Vitamins|vitamins|mesh-ancestor
5833525|NCT04489628|Micronutrients|micronutrients|mesh-ancestor
5833526|NCT04489628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5833527|NCT04489628|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5833528|NCT04489628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5833529|NCT04485013|Pembrolizumab|pembrolizumab|mesh-list
5833530|NCT04485013|Cetuximab|cetuximab|mesh-list
5833531|NCT04485013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5833532|NCT04485013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833533|NCT04484337|Cabotegravir|cabotegravir|mesh-list
5833534|NCT04484337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
5833535|NCT04484337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
5833536|NCT04484337|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5833537|NCT04484337|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5833538|NCT04484337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5833539|NCT04484337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833540|NCT04484337|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5833541|NCT04484337|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5833542|NCT04484337|Antiviral Agents|antiviral agents|mesh-ancestor
5833543|NCT04484337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5833544|NCT04484337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5833545|NCT04484337|Analgesics|analgesics|mesh-ancestor
5833546|NCT04484337|Sensory System Agents|sensory system agents|mesh-ancestor
5833547|NCT04484337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5833548|NCT04484337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5833549|NCT04484337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5833550|NCT04483414|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5655580|NCT03674385|Antioxidants|antioxidants|mesh-ancestor
5655581|NCT03674385|Protective Agents|protective agents|mesh-ancestor
5655582|NCT03674385|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5833551|NCT04483414|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5833552|NCT04483414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655583|NCT03674385|Hormone Antagonists|hormone antagonists|mesh-ancestor
5655584|NCT03674385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5833553|NCT04439318|Trametinib|trametinib|mesh-list
5833554|NCT04439318|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
5833555|NCT04439318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833556|NCT04439318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5833557|NCT04439318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5833558|NCT04439318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833559|NCT04439318|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
5833560|NCT04439318|Protective Agents|protective agents|mesh-ancestor
5833561|NCT04439318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5833562|NCT04439318|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5833563|NCT04439318|Antioxidants|antioxidants|mesh-ancestor
5833564|NCT04439292|Trametinib|trametinib|mesh-list
5833565|NCT04439292|Dabrafenib|dabrafenib|mesh-list
5833566|NCT04439292|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
5833567|NCT04439292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833568|NCT04439292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5833569|NCT04439292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5833570|NCT04439292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833571|NCT04439292|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
5833572|NCT04439292|Protective Agents|protective agents|mesh-ancestor
5833573|NCT04439292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5833574|NCT04439292|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5833575|NCT04439292|Antioxidants|antioxidants|mesh-ancestor
5833576|NCT04439279|Trametinib|trametinib|mesh-list
5833577|NCT04439279|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
5833578|NCT04439279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5655585|NCT03674385|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5655586|NCT03674385|Fertility Agents|fertility agents|mesh-ancestor
5655587|NCT03674385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5655588|NCT03674385|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5655589|NCT03674385|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5655590|NCT03674333|Folic Acid|folic acid|mesh-list
5833579|NCT04439279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5833580|NCT04439279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5833581|NCT04439279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833582|NCT04439279|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
5833583|NCT04439279|Protective Agents|protective agents|mesh-ancestor
5833584|NCT04439279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5833585|NCT04439279|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5833586|NCT04439279|Antioxidants|antioxidants|mesh-ancestor
5833587|NCT04439266|Crizotinib|crizotinib|mesh-list
5833588|NCT04439266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833589|NCT04439266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5655591|NCT03674333|Hematinics|hematinics|mesh-ancestor
5655592|NCT03674333|Vitamin B Complex|vitamin b complex|mesh-ancestor
5655593|NCT03674333|Vitamins|vitamins|mesh-ancestor
5655594|NCT03674333|Micronutrients|micronutrients|mesh-ancestor
5655595|NCT03674333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655596|NCT03674294|Dexamethasone|dexamethasone|mesh-list
5655597|NCT03674294|Aprepitant|aprepitant|mesh-list
5655598|NCT03674294|Palonosetron|palonosetron|mesh-list
5655599|NCT03674294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5655600|NCT03674294|Antiemetics|antiemetics|mesh-ancestor
5655601|NCT03674294|Autonomic Agents|autonomic agents|mesh-ancestor
5655602|NCT03674294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5655603|NCT03674294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655604|NCT03674294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5655605|NCT03674294|Glucocorticoids|glucocorticoids|mesh-ancestor
5655606|NCT03674294|Hormones|hormones|mesh-ancestor
5655607|NCT03674294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5655608|NCT03674294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5833590|NCT04439266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5833591|NCT04439266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833592|NCT04439253|Crizotinib|crizotinib|mesh-list
5833593|NCT04439253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833594|NCT04439253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5833595|NCT04439253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5833596|NCT04439253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833597|NCT04439227|Adavosertib|adavosertib|mesh-list
5833598|NCT04439227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5833599|NCT04439227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655609|NCT03674294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833600|NCT04439201|Palbociclib|palbociclib|mesh-list
5833601|NCT04439201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5655610|NCT03674294|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5655611|NCT03674294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5655612|NCT03674294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655613|NCT03674294|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5655614|NCT03674294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5655615|NCT03674294|Serotonin Agents|serotonin agents|mesh-ancestor
5655616|NCT03674242|Gemcitabine|gemcitabine|mesh-list
5655617|NCT03674242|Carboplatin|carboplatin|mesh-list
5655618|NCT03674242|Asparaginase|asparaginase|mesh-list
5655619|NCT03674242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5655620|NCT03674242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5655621|NCT03674242|Antimetabolites|antimetabolites|mesh-ancestor
5655622|NCT03674242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655623|NCT03674242|Antiviral Agents|antiviral agents|mesh-ancestor
5655624|NCT03674242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5655625|NCT03674242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5655626|NCT03674242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5655627|NCT03674242|Immunologic Factors|immunologic factors|mesh-ancestor
5655628|NCT03674242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694873|NCT03393377|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5694874|NCT03393377|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5694875|NCT03393377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694876|NCT03393364|Ketorolac|ketorolac|mesh-list
5694877|NCT03393364|Oxycodone|oxycodone|mesh-list
5694878|NCT03393364|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5694879|NCT03393364|Narcotics|narcotics|mesh-ancestor
5694880|NCT03393364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5694881|NCT03393364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694882|NCT03393364|Analgesics|analgesics|mesh-ancestor
5694883|NCT03393364|Sensory System Agents|sensory system agents|mesh-ancestor
5694884|NCT03393364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5694885|NCT03393364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5694886|NCT03393364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5694887|NCT03393364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5694888|NCT03393364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5694889|NCT03393364|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5833602|NCT04439201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5833603|NCT04439201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5833604|NCT04439201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833605|NCT04439188|GSK2636771|gsk2636771|mesh-list
5833606|NCT04439188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833607|NCT04439188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5833608|NCT04439188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5833609|NCT04439188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833610|NCT04439149|GSK2636771|gsk2636771|mesh-list
5833611|NCT04439149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833612|NCT04439149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5833613|NCT04439149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5833614|NCT04439149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902725|NCT03598309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5902726|NCT03598309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5902727|NCT03598309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5902728|NCT03598309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5902729|NCT03598309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902730|NCT03559647|Atezolizumab|atezolizumab|mesh-list
5902731|NCT03559647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5902732|NCT03519971|Paclitaxel|paclitaxel|mesh-list
5902733|NCT03519971|Etoposide|etoposide|mesh-list
5902734|NCT03519971|Cisplatin|cisplatin|mesh-list
5902735|NCT03519971|Carboplatin|carboplatin|mesh-list
5902736|NCT03519971|Pemetrexed|pemetrexed|mesh-list
5902737|NCT03519971|Durvalumab|durvalumab|mesh-list
5902738|NCT03519971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5902739|NCT03519971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5902740|NCT03519971|Tubulin Modulators|tubulin modulators|mesh-ancestor
5902741|NCT03519971|Antimitotic Agents|antimitotic agents|mesh-ancestor
5902742|NCT03519971|Mitosis Modulators|mitosis modulators|mesh-ancestor
5902743|NCT03519971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902744|NCT03519971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5902745|NCT03519971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5902746|NCT03519971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6493487|NCT00613743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902747|NCT03519971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5902748|NCT03519971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6493488|NCT00613743|Analgesics|analgesics|mesh-ancestor
6493489|NCT00613743|Sensory System Agents|sensory system agents|mesh-ancestor
6493490|NCT00613743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6493491|NCT00613769|Metronidazole|metronidazole|mesh-list
6493492|NCT00613769|Trimethoprim|trimethoprim|mesh-list
5655629|NCT03674151|Povidone|povidone|mesh-list
5655630|NCT03674151|Plasma Substitutes|plasma substitutes|mesh-ancestor
5655631|NCT03674151|Blood Substitutes|blood substitutes|mesh-ancestor
5655632|NCT03674099|Methylprednisolone|methylprednisolone|mesh-list
5655633|NCT03674099|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5655634|NCT03674099|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5655635|NCT03674099|Prednisolone|prednisolone|mesh-list
5655636|NCT03674099|Prednisolone acetate|prednisolone acetate|mesh-list
5655637|NCT03674099|Imatinib Mesylate|imatinib mesylate|mesh-list
5655638|NCT03674099|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5655639|NCT03674099|Prednisolone phosphate|prednisolone phosphate|mesh-list
5655640|NCT03674099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5655641|NCT03674099|Antiemetics|antiemetics|mesh-ancestor
5655642|NCT03674099|Autonomic Agents|autonomic agents|mesh-ancestor
5655643|NCT03674099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5655644|NCT03674099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655645|NCT03674099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5655646|NCT03674099|Glucocorticoids|glucocorticoids|mesh-ancestor
5655647|NCT03674099|Hormones|hormones|mesh-ancestor
5655648|NCT03674099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5655649|NCT03674099|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5655650|NCT03674099|Protective Agents|protective agents|mesh-ancestor
5655651|NCT03674099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5655652|NCT03674099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5655653|NCT03674099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5655654|NCT03674099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5655655|NCT03674099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655656|NCT03674073|Vaccines|vaccines|mesh-list
5655657|NCT03674073|Immunologic Factors|immunologic factors|mesh-ancestor
5655658|NCT03674073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655659|NCT03674060|Sorafenib|sorafenib|mesh-list
5655660|NCT03674060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5655661|NCT03674060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5655662|NCT03674060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5655663|NCT03674060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655664|NCT03674008|Propofol|propofol|mesh-list
6493493|NCT00613769|Sulfamethoxazole|sulfamethoxazole|mesh-list
6493494|NCT00613769|Cefuroxime|cefuroxime|mesh-list
6493495|NCT00613769|Cefuroxime axetil|cefuroxime axetil|mesh-list
5833615|NCT04439136|Afatinib|afatinib|mesh-list
5833616|NCT04439136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833617|NCT04439136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5833618|NCT04439136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5833619|NCT04439136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833620|NCT04439110|Trastuzumab|trastuzumab|mesh-list
5833621|NCT04439110|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
5833622|NCT04439110|Maytansine|maytansine|mesh-list
5655665|NCT03674008|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5655666|NCT03674008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5655667|NCT03674008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655668|NCT03674008|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5655669|NCT03674008|Anesthetics, General|anesthetics, general|mesh-ancestor
5655670|NCT03674008|Anesthetics|anesthetics|mesh-ancestor
5655671|NCT03673995|Inositol|inositol|mesh-list
5655672|NCT03673995|Vitamin B Complex|vitamin b complex|mesh-ancestor
5655673|NCT03673995|Vitamins|vitamins|mesh-ancestor
5655674|NCT03673995|Micronutrients|micronutrients|mesh-ancestor
5655675|NCT03673995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655676|NCT03673956|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5655677|NCT03673956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5655678|NCT03673826|Dexamethasone|dexamethasone|mesh-list
5833623|NCT04439110|Immunoconjugates|immunoconjugates|mesh-list
5833624|NCT04439110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5833625|NCT04439110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833626|NCT04439110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5833627|NCT04439110|Tubulin Modulators|tubulin modulators|mesh-ancestor
5833628|NCT04439110|Antimitotic Agents|antimitotic agents|mesh-ancestor
5833629|NCT04439110|Mitosis Modulators|mitosis modulators|mesh-ancestor
5833630|NCT04439110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655679|NCT03673826|Lenalidomide|lenalidomide|mesh-list
5833631|NCT04439110|Immunologic Factors|immunologic factors|mesh-ancestor
5655680|NCT03673826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6493496|NCT00613769|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
5655681|NCT03673826|Antiemetics|antiemetics|mesh-ancestor
5833632|NCT04439110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5833633|NCT04434196|Obinutuzumab|obinutuzumab|mesh-list
5655682|NCT03673826|Autonomic Agents|autonomic agents|mesh-ancestor
5655683|NCT03673826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5655684|NCT03673826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655685|NCT03673826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5655686|NCT03673826|Glucocorticoids|glucocorticoids|mesh-ancestor
5655687|NCT03673826|Hormones|hormones|mesh-ancestor
5655688|NCT03673826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5655689|NCT03673826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5655690|NCT03673826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5655691|NCT03673826|Immunologic Factors|immunologic factors|mesh-ancestor
5655692|NCT03673826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5655693|NCT03673826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5655694|NCT03673826|Growth Substances|growth substances|mesh-ancestor
5655695|NCT03673826|Growth Inhibitors|growth inhibitors|mesh-ancestor
5655696|NCT03673787|Atezolizumab|atezolizumab|mesh-list
5655697|NCT03673787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5655698|NCT03673735|Durvalumab|durvalumab|mesh-list
5655699|NCT03673735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5655700|NCT03673735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5655701|NCT03673605|Warfarin|warfarin|mesh-list
5655702|NCT03673605|Rivaroxaban|rivaroxaban|mesh-list
5655703|NCT03673605|Anticoagulants|anticoagulants|mesh-ancestor
5655704|NCT03673605|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5655705|NCT03673605|Antithrombins|antithrombins|mesh-ancestor
5655706|NCT03673605|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5833634|NCT04434196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5833635|NCT04434196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833641|NCT04432584|Eculizumab|eculizumab|mesh-list
5833642|NCT04432584|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5833643|NCT04432584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5833644|NCT04432584|Immunologic Factors|immunologic factors|mesh-ancestor
5833645|NCT04432584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5833651|NCT04406857|Capecitabine|capecitabine|mesh-list
5833652|NCT04406857|Ropidoxuridine|ropidoxuridine|mesh-list
5833653|NCT04406857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5833654|NCT04406857|Antimetabolites|antimetabolites|mesh-ancestor
5833655|NCT04406857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833656|NCT04406857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833657|NCT04390581|Lidocaine|lidocaine|mesh-list
5833658|NCT04390581|Anesthetics, Local|anesthetics, local|mesh-ancestor
5833659|NCT04390581|Anesthetics|anesthetics|mesh-ancestor
5833660|NCT04390581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5833661|NCT04390581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5833662|NCT04390581|Sensory System Agents|sensory system agents|mesh-ancestor
5833663|NCT04390581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5833664|NCT04390581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5833665|NCT04390581|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5833666|NCT04390581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5833667|NCT04390581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5833668|NCT04390581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833669|NCT04379635|Paclitaxel|paclitaxel|mesh-list
5833670|NCT04379635|Carboplatin|carboplatin|mesh-list
5833671|NCT04379635|Pemetrexed|pemetrexed|mesh-list
5833672|NCT04379635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5833673|NCT04379635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833674|NCT04379635|Tubulin Modulators|tubulin modulators|mesh-ancestor
5833675|NCT04379635|Antimitotic Agents|antimitotic agents|mesh-ancestor
5833676|NCT04379635|Mitosis Modulators|mitosis modulators|mesh-ancestor
5833677|NCT04379635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833678|NCT04379635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5833679|NCT04379635|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5655707|NCT03673605|Protease Inhibitors|protease inhibitors|mesh-ancestor
5833680|NCT04379635|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5833681|NCT04366115|Dexamethasone|dexamethasone|mesh-list
5833682|NCT04366115|Dexamethasone acetate|dexamethasone acetate|mesh-list
5833683|NCT04366115|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
5833684|NCT04366115|BB 1101|bb 1101|mesh-list
5833685|NCT04366115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5833686|NCT04366115|Antiemetics|antiemetics|mesh-ancestor
5833687|NCT04366115|Autonomic Agents|autonomic agents|mesh-ancestor
5833688|NCT04366115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5833689|NCT04366115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5833690|NCT04366115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5833691|NCT04366115|Glucocorticoids|glucocorticoids|mesh-ancestor
5833692|NCT04366115|Hormones|hormones|mesh-ancestor
5833693|NCT04366115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5655708|NCT03673605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5655709|NCT03673605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655710|NCT03673527|Tacrolimus|tacrolimus|mesh-list
5655711|NCT03673527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5655712|NCT03673527|Immunologic Factors|immunologic factors|mesh-ancestor
5655713|NCT03673527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655714|NCT03673527|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5833694|NCT04366115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5833695|NCT04366115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833696|NCT04366115|Protease Inhibitors|protease inhibitors|mesh-ancestor
5833697|NCT04366115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5833698|NCT04366115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655715|NCT03673527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5655716|NCT03673527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655717|NCT03673501|Sunitinib|sunitinib|mesh-list
5655718|NCT03673501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5655719|NCT03673501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5655720|NCT03673501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5655721|NCT03673501|Growth Substances|growth substances|mesh-ancestor
5655722|NCT03673501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655723|NCT03673501|Growth Inhibitors|growth inhibitors|mesh-ancestor
5655724|NCT03673501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5655725|NCT03673501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5655726|NCT03673501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655727|NCT03673384|Fluticasone|fluticasone|mesh-list
5655728|NCT03673384|Xhance|xhance|mesh-list
5655729|NCT03673384|Histamine|histamine|mesh-list
5655730|NCT03673384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5655731|NCT03673384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5655732|NCT03673384|Autonomic Agents|autonomic agents|mesh-ancestor
5655733|NCT03673384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5655734|NCT03673384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655735|NCT03673384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5655736|NCT03673384|Respiratory System Agents|respiratory system agents|mesh-ancestor
5655737|NCT03673384|Dermatologic Agents|dermatologic agents|mesh-ancestor
5655738|NCT03673384|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5655739|NCT03673384|Histamine Agonists|histamine agonists|mesh-ancestor
5655740|NCT03673384|Histamine Agents|histamine agents|mesh-ancestor
5655741|NCT03673384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5655742|NCT03673384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833699|NCT04362761|Ivacaftor|ivacaftor|mesh-list
5833700|NCT04362761|Elexacaftor|elexacaftor|mesh-list
5833701|NCT04362761|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
5833702|NCT04362761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5833703|NCT04362761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833704|NCT04335201|Defibrotide|defibrotide|mesh-list
5833705|NCT04335201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5833706|NCT04335201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5833707|NCT04335201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833708|NCT04335201|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5833709|NCT04313881|Azacitidine|azacitidine|mesh-list
5833710|NCT04313881|Magrolimab|magrolimab|mesh-list
5655743|NCT03673332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5655744|NCT03673332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655745|NCT03673332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5655746|NCT03673280|Morphine|morphine|mesh-list
5655747|NCT03673280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5655748|NCT03673280|Narcotics|narcotics|mesh-ancestor
5655749|NCT03673280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5655750|NCT03673280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655751|NCT03673280|Analgesics|analgesics|mesh-ancestor
5833711|NCT04313881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5655752|NCT03673280|Sensory System Agents|sensory system agents|mesh-ancestor
5655753|NCT03673280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5655754|NCT03673163|Lidocaine|lidocaine|mesh-list
5833712|NCT04313881|Antimetabolites|antimetabolites|mesh-ancestor
5833713|NCT04313881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833714|NCT04313881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833715|NCT04313881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5833716|NCT04313881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5833717|NCT04313244|Vaccines|vaccines|mesh-list
5833718|NCT04313244|Immunologic Factors|immunologic factors|mesh-ancestor
5833719|NCT04313244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655755|NCT03673163|Anesthetics, Local|anesthetics, local|mesh-ancestor
5655756|NCT03673163|Anesthetics|anesthetics|mesh-ancestor
5655757|NCT03673163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5655758|NCT03673163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655759|NCT03673163|Sensory System Agents|sensory system agents|mesh-ancestor
5655760|NCT03673163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5655761|NCT03673163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5655762|NCT03673163|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5655763|NCT03673163|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5655764|NCT03673163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5655765|NCT03673163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833725|NCT04303858|Atezolizumab|atezolizumab|mesh-list
5833726|NCT04303858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833727|NCT04295772|Islatravir|islatravir|mesh-list
5833728|NCT04295772|Antiviral Agents|antiviral agents|mesh-ancestor
5833729|NCT04295772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5655766|NCT03673137|Gemcitabine|gemcitabine|mesh-list
5655767|NCT03673137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5655768|NCT03673137|Antimetabolites|antimetabolites|mesh-ancestor
5655769|NCT03673137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655770|NCT03673137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5655771|NCT03673137|Antiviral Agents|antiviral agents|mesh-ancestor
5655772|NCT03673137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5655773|NCT03673137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5655774|NCT03673137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5655775|NCT03673137|Immunologic Factors|immunologic factors|mesh-ancestor
5655776|NCT03673137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655777|NCT03673072|Gemcitabine|gemcitabine|mesh-list
5655778|NCT03673072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833730|NCT04295772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5833731|NCT04295772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833732|NCT04295772|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5833733|NCT04295772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5833734|NCT04295772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5833735|NCT04294225|Letrozole|letrozole|mesh-list
5833736|NCT04294225|Anastrozole|anastrozole|mesh-list
5833737|NCT04294225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833738|NCT04294225|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5833739|NCT04294225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5655779|NCT03673072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5655780|NCT03673072|Antimetabolites|antimetabolites|mesh-ancestor
5655781|NCT03673072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655782|NCT03673072|Antiviral Agents|antiviral agents|mesh-ancestor
5655783|NCT03673072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5655784|NCT03673072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5655785|NCT03673072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5655786|NCT03673072|Immunologic Factors|immunologic factors|mesh-ancestor
5655787|NCT03673072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655788|NCT03672812|Liraglutide|liraglutide|mesh-list
5655789|NCT03672812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5655790|NCT03672812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655791|NCT03672812|Incretins|incretins|mesh-ancestor
5655792|NCT03672812|Hormones|hormones|mesh-ancestor
5655793|NCT03672812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5655794|NCT03672695|Venetoclax|venetoclax|mesh-list
5655795|NCT03672695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5694890|NCT03393364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5697976|NCT03372304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5833740|NCT04294225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5833741|NCT04294225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833742|NCT04294225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5833743|NCT04294225|Hormone Antagonists|hormone antagonists|mesh-ancestor
5833744|NCT04294225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5833745|NCT04294225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5833746|NCT04294225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5833747|NCT04292470|Amitriptyline|amitriptyline|mesh-list
5833748|NCT04292470|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
5833749|NCT04292470|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5833750|NCT04292470|Antidepressive Agents|antidepressive agents|mesh-ancestor
5655796|NCT03672539|Cytarabine|cytarabine|mesh-list
5655797|NCT03672539|Daunorubicin|daunorubicin|mesh-list
5655798|NCT03672539|Gemtuzumab|gemtuzumab|mesh-list
5833751|NCT04292470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5833752|NCT04292470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5833753|NCT04292470|Analgesics|analgesics|mesh-ancestor
5833754|NCT04292470|Sensory System Agents|sensory system agents|mesh-ancestor
5833755|NCT04292470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5833756|NCT04292470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5833757|NCT04292470|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5833758|NCT04292470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5833759|NCT04292470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5833760|NCT04292470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833761|NCT04292470|Adrenergic Agents|adrenergic agents|mesh-ancestor
5833762|NCT04292470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5833763|NCT04292470|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5833764|NCT04292470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5833765|NCT04292470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5833766|NCT04277442|Nivolumab|nivolumab|mesh-list
5833767|NCT04277442|Decitabine|decitabine|mesh-list
5833768|NCT04277442|Venetoclax|venetoclax|mesh-list
5833769|NCT04277442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5833770|NCT04277442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833771|NCT04277442|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5833772|NCT04277442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833773|NCT04277442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5833774|NCT04277442|Antimetabolites|antimetabolites|mesh-ancestor
5833775|NCT04277442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5833776|NCT04256317|Azacitidine|azacitidine|mesh-list
5833777|NCT04256317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5833778|NCT04256317|Antimetabolites|antimetabolites|mesh-ancestor
5833779|NCT04256317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833780|NCT04256317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833781|NCT04256317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5833782|NCT04248829|Gefitinib|gefitinib|mesh-list
5655799|NCT03672539|Calicheamicins|calicheamicins|mesh-list
5655800|NCT03672539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5655801|NCT03672539|Antimetabolites|antimetabolites|mesh-ancestor
5655802|NCT03672539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655803|NCT03672539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5655804|NCT03672539|Antiviral Agents|antiviral agents|mesh-ancestor
5655805|NCT03672539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5655806|NCT03672539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5655807|NCT03672539|Immunologic Factors|immunologic factors|mesh-ancestor
5655808|NCT03672539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655809|NCT03672539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5655810|NCT03672539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5655811|NCT03672539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5655812|NCT03672539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5655813|NCT03672539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5655814|NCT03672500|Epinephrine|epinephrine|mesh-list
5655815|NCT03672500|Bupivacaine|bupivacaine|mesh-list
5655816|NCT03672500|Anesthetics, Local|anesthetics, local|mesh-ancestor
5655817|NCT03672500|Anesthetics|anesthetics|mesh-ancestor
5655818|NCT03672500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5655819|NCT03672500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655820|NCT03672500|Sensory System Agents|sensory system agents|mesh-ancestor
5655821|NCT03672500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5655822|NCT03672500|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5655823|NCT03672500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5655824|NCT03672500|Adrenergic Agents|adrenergic agents|mesh-ancestor
5833783|NCT04248829|Lazertinib|lazertinib|mesh-list
5655825|NCT03672500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5655826|NCT03672500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655827|NCT03672500|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5655828|NCT03672500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5655829|NCT03672500|Autonomic Agents|autonomic agents|mesh-ancestor
5833784|NCT04248829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833785|NCT04248829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5833786|NCT04248829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5833787|NCT04248829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833788|NCT04232761|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
5833789|NCT04232761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833790|NCT04209790|Temozolomide|temozolomide|mesh-list
5833791|NCT04209790|Benzolamide|benzolamide|mesh-list
5833792|NCT04209790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5833793|NCT04209790|Alkylating Agents|alkylating agents|mesh-ancestor
5833794|NCT04209790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833795|NCT04209790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833796|NCT04209790|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5833797|NCT04209790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5833798|NCT04196413|Cyclophosphamide|cyclophosphamide|mesh-list
5833799|NCT04196413|Fludarabine|fludarabine|mesh-list
5833800|NCT04196413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5833801|NCT04196413|Immunologic Factors|immunologic factors|mesh-ancestor
5833802|NCT04196413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5833803|NCT04196413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5833804|NCT04196413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5833805|NCT04196413|Alkylating Agents|alkylating agents|mesh-ancestor
5833806|NCT04196413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833807|NCT04196413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833808|NCT04196413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5833809|NCT04194203|Paclitaxel|paclitaxel|mesh-list
5833810|NCT04194203|Bevacizumab|bevacizumab|mesh-list
5833811|NCT04194203|Carboplatin|carboplatin|mesh-list
5833812|NCT04194203|Pemetrexed|pemetrexed|mesh-list
5833813|NCT04194203|Atezolizumab|atezolizumab|mesh-list
5833814|NCT04194203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5833815|NCT04194203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833816|NCT04194203|Tubulin Modulators|tubulin modulators|mesh-ancestor
5833817|NCT04194203|Antimitotic Agents|antimitotic agents|mesh-ancestor
5833818|NCT04194203|Mitosis Modulators|mitosis modulators|mesh-ancestor
5833819|NCT04194203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833820|NCT04194203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5833821|NCT04194203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5833822|NCT04194203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5833823|NCT04194203|Growth Substances|growth substances|mesh-ancestor
5833824|NCT04194203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655830|NCT03672500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5655831|NCT03672500|Respiratory System Agents|respiratory system agents|mesh-ancestor
5655832|NCT03672500|Mydriatics|mydriatics|mesh-ancestor
5655833|NCT03672500|Sympathomimetics|sympathomimetics|mesh-ancestor
5655834|NCT03672500|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5655835|NCT03672435|Proxymetacaine|proxymetacaine|mesh-list
5655836|NCT03672435|Anesthetics, Local|anesthetics, local|mesh-ancestor
5655837|NCT03672435|Anesthetics|anesthetics|mesh-ancestor
5655838|NCT03672435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5655839|NCT03672435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655840|NCT03672435|Sensory System Agents|sensory system agents|mesh-ancestor
5655841|NCT03672435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5655842|NCT03672357|Liver Extracts|liver extracts|mesh-list
5655843|NCT03672357|Hematinics|hematinics|mesh-ancestor
5833825|NCT04194203|Growth Inhibitors|growth inhibitors|mesh-ancestor
5833826|NCT04194203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5833827|NCT04194203|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5833828|NCT04194203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5833829|NCT04183790|Ivacaftor|ivacaftor|mesh-list
5833830|NCT04183790|Elexacaftor|elexacaftor|mesh-list
5833831|NCT04183790|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
5833832|NCT04183790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5833833|NCT04183790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833834|NCT04180371|Nivolumab|nivolumab|mesh-list
5833835|NCT04180371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5833836|NCT04180371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5655844|NCT03672292|Voriconazole|voriconazole|mesh-list
5655845|NCT03672292|Ibrexafungerp|ibrexafungerp|mesh-list
5655846|NCT03672292|Antifungal Agents|antifungal agents|mesh-ancestor
5655847|NCT03672292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5833837|NCT04180371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5833838|NCT04180371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833839|NCT04179396|Rucaparib|rucaparib|mesh-list
5833840|NCT04179396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5833841|NCT04179396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5833842|NCT04179396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833843|NCT04179396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833844|NCT04177108|Paclitaxel|paclitaxel|mesh-list
5833845|NCT04177108|Atezolizumab|atezolizumab|mesh-list
5833846|NCT04177108|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5833847|NCT04177108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5833848|NCT04177108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833849|NCT04177108|Tubulin Modulators|tubulin modulators|mesh-ancestor
5833850|NCT04177108|Antimitotic Agents|antimitotic agents|mesh-ancestor
5833851|NCT04177108|Mitosis Modulators|mitosis modulators|mesh-ancestor
5833852|NCT04177108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655848|NCT03672292|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5655849|NCT03672292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5655850|NCT03672292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5655851|NCT03672292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655852|NCT03672292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5655853|NCT03672292|Hormone Antagonists|hormone antagonists|mesh-ancestor
5655854|NCT03672292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5655855|NCT03672292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655856|NCT03672292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5655857|NCT03672149|Cefazolin|cefazolin|mesh-list
5655858|NCT03672149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5655859|NCT03672149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5655860|NCT03672071|Ephedrine|ephedrine|mesh-list
5655861|NCT03672071|Pseudoephedrine|pseudoephedrine|mesh-list
5655862|NCT03672071|Norepinephrine|norepinephrine|mesh-list
5655863|NCT03672071|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5655864|NCT03672071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655865|NCT03672071|Sympathomimetics|sympathomimetics|mesh-ancestor
5655866|NCT03672071|Autonomic Agents|autonomic agents|mesh-ancestor
5655867|NCT03672071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5655868|NCT03672071|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5655869|NCT03672071|Adrenergic Agents|adrenergic agents|mesh-ancestor
5655870|NCT03672071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5655871|NCT03672071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655872|NCT03672071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5655873|NCT03672071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5655874|NCT03672071|Respiratory System Agents|respiratory system agents|mesh-ancestor
5655875|NCT03672071|Nasal Decongestants|nasal decongestants|mesh-ancestor
5655876|NCT03672071|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5655877|NCT03672071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5655878|NCT03672045|Carbetocin|carbetocin|mesh-list
5655879|NCT03672045|Oxytocics|oxytocics|mesh-ancestor
5655880|NCT03672045|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5655881|NCT03672045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655882|NCT03671941|Ticagrelor|ticagrelor|mesh-list
5655883|NCT03671941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5655884|NCT03671941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5655885|NCT03671941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5655886|NCT03671941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5833853|NCT04177108|Immunologic Factors|immunologic factors|mesh-ancestor
5833854|NCT04177108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5833855|NCT04176705|Triamcinolone|triamcinolone|mesh-list
5833856|NCT04176705|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5833857|NCT04176705|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5833858|NCT04176705|Lidocaine|lidocaine|mesh-list
5833859|NCT04176705|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5655887|NCT03671941|Purinergic Agents|purinergic agents|mesh-ancestor
5655888|NCT03671941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5655889|NCT03671941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655890|NCT03671941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655891|NCT03671915|Insulin|insulin|mesh-list
5655892|NCT03671915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5833860|NCT04176705|Anesthetics, Local|anesthetics, local|mesh-ancestor
5833861|NCT04176705|Anesthetics|anesthetics|mesh-ancestor
5833862|NCT04176705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5833863|NCT04176705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655893|NCT03671915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5833864|NCT04176705|Sensory System Agents|sensory system agents|mesh-ancestor
5833865|NCT04176705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5833866|NCT04176705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5833867|NCT04176705|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5833868|NCT04176705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5833869|NCT04176705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5833870|NCT04176705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833871|NCT04176705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5833872|NCT04176705|Glucocorticoids|glucocorticoids|mesh-ancestor
5833873|NCT04176705|Hormones|hormones|mesh-ancestor
5833874|NCT04176705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5833875|NCT04176705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5655894|NCT03671811|Megestrol|megestrol|mesh-list
5655895|NCT03671811|Megestrol Acetate|megestrol acetate|mesh-list
5655896|NCT03671811|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5655897|NCT03671811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5655898|NCT03671811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5655899|NCT03671811|Contraceptive Agents|contraceptive agents|mesh-ancestor
5655900|NCT03671811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5655901|NCT03671811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655902|NCT03671811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5655903|NCT03671811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5655904|NCT03671811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5655905|NCT03671811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5655906|NCT03671811|Appetite Stimulants|appetite stimulants|mesh-ancestor
5655907|NCT03671811|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5655908|NCT03671759|Caffeine|caffeine|mesh-list
5655909|NCT03671759|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5655910|NCT03671759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655911|NCT03671759|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5655912|NCT03671759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5655913|NCT03671759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655914|NCT03671759|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5655915|NCT03671759|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5655916|NCT03671759|Purinergic Agents|purinergic agents|mesh-ancestor
5655917|NCT03671759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5655918|NCT03671746|Ketorolac|ketorolac|mesh-list
5655919|NCT03671746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5655920|NCT03671746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5655921|NCT03671746|Analgesics|analgesics|mesh-ancestor
5655922|NCT03671746|Sensory System Agents|sensory system agents|mesh-ancestor
5655923|NCT03671746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5655924|NCT03671746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655925|NCT03671746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5655926|NCT03671746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5655927|NCT03671746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5655928|NCT03671746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5655929|NCT03671746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655930|NCT03671733|Liraglutide|liraglutide|mesh-list
5655931|NCT03671733|Exenatide|exenatide|mesh-list
5655932|NCT03671733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5655933|NCT03671733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655934|NCT03671733|Incretins|incretins|mesh-ancestor
5655935|NCT03671733|Hormones|hormones|mesh-ancestor
5655936|NCT03671733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5655937|NCT03671733|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5655938|NCT03671707|Nicotine|nicotine|mesh-list
5655939|NCT03671707|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5655940|NCT03671707|Autonomic Agents|autonomic agents|mesh-ancestor
5655941|NCT03671707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5655942|NCT03671707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655943|NCT03671707|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5655944|NCT03671707|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5655945|NCT03671707|Cholinergic Agents|cholinergic agents|mesh-ancestor
5655946|NCT03671707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5655947|NCT03671707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655948|NCT03671655|Paclitaxel|paclitaxel|mesh-list
5655949|NCT03671655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5655950|NCT03671655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5655951|NCT03671655|Tubulin Modulators|tubulin modulators|mesh-ancestor
5655952|NCT03671655|Antimitotic Agents|antimitotic agents|mesh-ancestor
5655953|NCT03671655|Mitosis Modulators|mitosis modulators|mesh-ancestor
5833876|NCT04176705|Immunologic Factors|immunologic factors|mesh-ancestor
5655954|NCT03671655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655955|NCT03671538|Pemetrexed|pemetrexed|mesh-list
5655956|NCT03671538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5655957|NCT03671538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5655958|NCT03671538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655959|NCT03671538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5655960|NCT03671538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5655961|NCT03671369|Vaccines|vaccines|mesh-list
5655962|NCT03671369|Immunologic Factors|immunologic factors|mesh-ancestor
5655963|NCT03671369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655964|NCT03671265|Apatinib|apatinib|mesh-list
5655965|NCT03671265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833877|NCT04176705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5833878|NCT04165096|Acetaminophen|acetaminophen|mesh-list
5833879|NCT04165096|Diphenhydramine|diphenhydramine|mesh-list
5833880|NCT04165096|Promethazine|promethazine|mesh-list
5833881|NCT04165096|Pembrolizumab|pembrolizumab|mesh-list
5833882|NCT04165096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5833883|NCT04165096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833884|NCT04165096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5833885|NCT04165096|Analgesics|analgesics|mesh-ancestor
5833886|NCT04165096|Sensory System Agents|sensory system agents|mesh-ancestor
5833887|NCT04165096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5833888|NCT04165096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655966|NCT03671265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5655967|NCT03671265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5655968|NCT03671265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655969|NCT03671174|Aspirin|aspirin|mesh-list
5655970|NCT03671174|Hydroxychloroquine|hydroxychloroquine|mesh-list
5655971|NCT03671174|Prednisone|prednisone|mesh-list
5655972|NCT03671174|Heparin|heparin|mesh-list
5655973|NCT03671174|Enoxaparin|enoxaparin|mesh-list
5655974|NCT03671174|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5655975|NCT03671174|Tinzaparin|tinzaparin|mesh-list
5655976|NCT03671174|Dalteparin|dalteparin|mesh-list
5655977|NCT03671174|Nadroparin|nadroparin|mesh-list
5655978|NCT03671174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5833889|NCT04165096|Antipyretics|antipyretics|mesh-ancestor
5833890|NCT04165096|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5833891|NCT04165096|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5655979|NCT03671174|Glucocorticoids|glucocorticoids|mesh-ancestor
5655980|NCT03671174|Hormones|hormones|mesh-ancestor
5655981|NCT03671174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5655982|NCT03671174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5655983|NCT03671174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5655984|NCT03671174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5655985|NCT03671174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5655986|NCT03671174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5655987|NCT03671174|Analgesics|analgesics|mesh-ancestor
5833892|NCT04165096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5833893|NCT04165096|Anesthetics, Local|anesthetics, local|mesh-ancestor
5833894|NCT04165096|Anesthetics|anesthetics|mesh-ancestor
5833895|NCT04165096|Antiemetics|antiemetics|mesh-ancestor
5833896|NCT04165096|Autonomic Agents|autonomic agents|mesh-ancestor
5833897|NCT04165096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5833898|NCT04165096|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5833899|NCT04165096|Histamine Antagonists|histamine antagonists|mesh-ancestor
5833900|NCT04165096|Histamine Agents|histamine agents|mesh-ancestor
5833901|NCT04165096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5833902|NCT04165096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833903|NCT04165096|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5833904|NCT04165096|Antipruritics|antipruritics|mesh-ancestor
5833905|NCT04165096|Dermatologic Agents|dermatologic agents|mesh-ancestor
5833906|NCT04165083|Pembrolizumab|pembrolizumab|mesh-list
5833907|NCT04165083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5833908|NCT04165083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833909|NCT04165070|Paclitaxel|paclitaxel|mesh-list
5833910|NCT04165070|Carboplatin|carboplatin|mesh-list
6211814|NCT02177838|Immunologic Factors|immunologic factors|mesh-ancestor
6211815|NCT02177838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211816|NCT02177838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6211817|NCT02177942|Micronutrients|micronutrients|mesh-list
6211818|NCT02177942|Trace Elements|trace elements|mesh-list
6211819|NCT02177942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211820|NCT02178059|Terbutaline|terbutaline|mesh-list
6211821|NCT02178059|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5833911|NCT04165070|Pembrolizumab|pembrolizumab|mesh-list
6211822|NCT02178059|Autonomic Agents|autonomic agents|mesh-ancestor
6493497|NCT00613769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6493498|NCT00613769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6493499|NCT00613769|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5655988|NCT03671174|Sensory System Agents|sensory system agents|mesh-ancestor
5655989|NCT03671174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5655990|NCT03671174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5655991|NCT03671174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6493500|NCT00613769|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6493501|NCT00613769|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6493502|NCT00613769|Renal Agents|renal agents|mesh-ancestor
6493503|NCT00613769|Antimalarials|antimalarials|mesh-ancestor
6493504|NCT00613769|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6493505|NCT00613769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6493506|NCT00613769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493507|NCT00613769|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6493508|NCT00613769|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
5833912|NCT04165070|Pemetrexed|pemetrexed|mesh-list
5833913|NCT04165070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5833914|NCT04165070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833915|NCT04165070|Tubulin Modulators|tubulin modulators|mesh-ancestor
5833916|NCT04165070|Antimitotic Agents|antimitotic agents|mesh-ancestor
5833917|NCT04165070|Mitosis Modulators|mitosis modulators|mesh-ancestor
5833918|NCT04165070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833919|NCT04165070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5833920|NCT04165070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5833921|NCT04165070|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5833922|NCT04165070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5833923|NCT04152863|Pembrolizumab|pembrolizumab|mesh-list
5833924|NCT04152863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5833925|NCT04152863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833926|NCT04140214|Carbocysteine|carbocysteine|mesh-list
5833927|NCT04140214|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5833928|NCT04140214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5833929|NCT04140214|Expectorants|expectorants|mesh-ancestor
5833930|NCT04140214|Respiratory System Agents|respiratory system agents|mesh-ancestor
5833931|NCT04115774|Diphosphonates|diphosphonates|mesh-list
5833932|NCT04115774|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5833933|NCT04115774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5833934|NCT04102098|Bevacizumab|bevacizumab|mesh-list
5833935|NCT04102098|Atezolizumab|atezolizumab|mesh-list
5833936|NCT04102098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5833937|NCT04102098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833938|NCT04102098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5833939|NCT04102098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5833940|NCT04102098|Growth Substances|growth substances|mesh-ancestor
5833941|NCT04102098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5833942|NCT04102098|Growth Inhibitors|growth inhibitors|mesh-ancestor
5902749|NCT03519971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5902750|NCT03481556|Dexamethasone|dexamethasone|mesh-list
5902751|NCT03481556|Dexamethasone acetate|dexamethasone acetate|mesh-list
5902752|NCT03481556|Bortezomib|bortezomib|mesh-list
5902753|NCT03481556|Melphalan|melphalan|mesh-list
5902754|NCT03481556|Daratumumab|daratumumab|mesh-list
5902755|NCT03481556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5902756|NCT03481556|Antiemetics|antiemetics|mesh-ancestor
5902757|NCT03481556|Autonomic Agents|autonomic agents|mesh-ancestor
5655992|NCT03671174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5655993|NCT03671174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5655994|NCT03671174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5655995|NCT03671174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5655996|NCT03671174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5655997|NCT03671174|Antipyretics|antipyretics|mesh-ancestor
5655998|NCT03671174|Anticoagulants|anticoagulants|mesh-ancestor
5655999|NCT03671174|Antimalarials|antimalarials|mesh-ancestor
5656000|NCT03671174|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5656001|NCT03671174|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5656002|NCT03671174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5656003|NCT03671161|Insulin|insulin|mesh-list
5656004|NCT03671161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5656005|NCT03671161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656006|NCT03671109|Piperaquine|piperaquine|mesh-list
5656007|NCT03671109|Artenimol|artenimol|mesh-list
5656008|NCT03671109|Antimalarials|antimalarials|mesh-ancestor
5656009|NCT03671109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5656010|NCT03671109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5656011|NCT03671109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5902758|NCT03481556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5833943|NCT04082676|Bupivacaine|bupivacaine|mesh-list
5833944|NCT04082676|Anesthetics, Local|anesthetics, local|mesh-ancestor
5833945|NCT04082676|Anesthetics|anesthetics|mesh-ancestor
5833946|NCT04082676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5833947|NCT04082676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5833948|NCT04082676|Sensory System Agents|sensory system agents|mesh-ancestor
5833949|NCT04082676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5833950|NCT04082520|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
5833951|NCT04082520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833952|NCT04082520|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5833953|NCT04046328|Cholestyramine Resin|cholestyramine resin|mesh-list
5833954|NCT04046328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5833955|NCT04046328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5833956|NCT04046328|Antimetabolites|antimetabolites|mesh-ancestor
5656012|NCT03671070|Epinephrine|epinephrine|mesh-list
5656013|NCT03671070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5656014|NCT03671070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5656015|NCT03671070|Adrenergic Agents|adrenergic agents|mesh-ancestor
5656016|NCT03671070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5656017|NCT03671070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656018|NCT03671070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656019|NCT03671070|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5656020|NCT03671070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5656021|NCT03671070|Autonomic Agents|autonomic agents|mesh-ancestor
5656022|NCT03671070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5656023|NCT03671070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5656024|NCT03671070|Respiratory System Agents|respiratory system agents|mesh-ancestor
5656025|NCT03671070|Mydriatics|mydriatics|mesh-ancestor
5656026|NCT03671070|Sympathomimetics|sympathomimetics|mesh-ancestor
5656027|NCT03671070|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5656028|NCT03671057|Midazolam|midazolam|mesh-list
5656029|NCT03671057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5656030|NCT03671057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5656031|NCT03671057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5833957|NCT04046328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833958|NCT04046328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5833959|NCT04034004|Naloxone|naloxone|mesh-list
5833960|NCT04034004|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5833961|NCT04034004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5833962|NCT04034004|Sensory System Agents|sensory system agents|mesh-ancestor
5833963|NCT04034004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5833964|NCT04015622|Docetaxel|docetaxel|mesh-list
5833965|NCT04015622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5833966|NCT04015622|Tubulin Modulators|tubulin modulators|mesh-ancestor
5833967|NCT04015622|Antimitotic Agents|antimitotic agents|mesh-ancestor
5833968|NCT04015622|Mitosis Modulators|mitosis modulators|mesh-ancestor
5833969|NCT04015622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833970|NCT04015115|Analgesics, Opioid|analgesics, opioid|mesh-list
5656032|NCT03671057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656033|NCT03671057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5656034|NCT03671057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5656035|NCT03671057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5656036|NCT03671057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5656037|NCT03671057|Anesthetics, General|anesthetics, general|mesh-ancestor
5656038|NCT03671057|Anesthetics|anesthetics|mesh-ancestor
5833971|NCT04015115|Narcotics|narcotics|mesh-ancestor
5833972|NCT04015115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5833973|NCT04015115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5833974|NCT04015115|Analgesics|analgesics|mesh-ancestor
5833975|NCT04015115|Sensory System Agents|sensory system agents|mesh-ancestor
5833976|NCT04015115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5833977|NCT04012138|Insulin|insulin|mesh-list
5833978|NCT04012138|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5833979|NCT04012138|Insulin Aspart|insulin aspart|mesh-list
5833980|NCT04012138|Albuterol|albuterol|mesh-list
5833981|NCT04012138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5656039|NCT03671057|GABA Modulators|gaba modulators|mesh-ancestor
5656040|NCT03671057|GABA Agents|gaba agents|mesh-ancestor
5656041|NCT03671057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5656042|NCT03671057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656043|NCT03671044|Docetaxel|docetaxel|mesh-list
5656044|NCT03671044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5656045|NCT03671044|Tubulin Modulators|tubulin modulators|mesh-ancestor
5656046|NCT03671044|Antimitotic Agents|antimitotic agents|mesh-ancestor
5656047|NCT03671044|Mitosis Modulators|mitosis modulators|mesh-ancestor
5656048|NCT03671044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656049|NCT03670953|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
5656050|NCT03670953|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5656051|NCT03670953|Immunologic Factors|immunologic factors|mesh-ancestor
5656052|NCT03670953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656053|NCT03670953|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5833982|NCT04012138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5833983|NCT04012138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5833984|NCT04012138|Autonomic Agents|autonomic agents|mesh-ancestor
5833985|NCT04012138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5833986|NCT04012138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5833987|NCT04012138|Respiratory System Agents|respiratory system agents|mesh-ancestor
5833988|NCT04012138|Tocolytic Agents|tocolytic agents|mesh-ancestor
5833989|NCT04012138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5833990|NCT04012138|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5833991|NCT04012138|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5833992|NCT04012138|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5833993|NCT04012138|Adrenergic Agents|adrenergic agents|mesh-ancestor
5833994|NCT04012138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5656054|NCT03670953|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5656055|NCT03670953|Dopamine Agonists|dopamine agonists|mesh-ancestor
5656056|NCT03670953|Dopamine Agents|dopamine agents|mesh-ancestor
5656057|NCT03670953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5656058|NCT03670953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833995|NCT04012138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5833996|NCT03992456|Trifluridine|trifluridine|mesh-list
5833997|NCT03992456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5833998|NCT03992456|Panitumumab|panitumumab|mesh-list
5833999|NCT03992456|Antibodies|antibodies|mesh-list
5834000|NCT03992456|Immunoglobulins|immunoglobulins|mesh-list
5834001|NCT03992456|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5834002|NCT03992456|Immunologic Factors|immunologic factors|mesh-ancestor
5834003|NCT03992456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834004|NCT03992456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5834005|NCT03992456|Antimetabolites|antimetabolites|mesh-ancestor
5834006|NCT03992456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5834007|NCT03992456|Antiviral Agents|antiviral agents|mesh-ancestor
5834008|NCT03992456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5834009|NCT03972306|Ocrelizumab|ocrelizumab|mesh-list
5834010|NCT03972306|Immunologic Factors|immunologic factors|mesh-ancestor
5834011|NCT03972306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834012|NCT03969212|Baloxavir|baloxavir|mesh-list
5834013|NCT03969212|Antiviral Agents|antiviral agents|mesh-ancestor
5834014|NCT03969212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5834015|NCT03969212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5834016|NCT03969212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5834017|NCT03955861|Adalimumab|adalimumab|mesh-list
5834018|NCT03955861|Etanercept|etanercept|mesh-list
5834019|NCT03955861|Golimumab|golimumab|mesh-list
5834020|NCT03955861|Certolizumab Pegol|certolizumab pegol|mesh-list
5834021|NCT03955861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5834022|NCT03955861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5834023|NCT03955861|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5834024|NCT03955861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5656059|NCT03670901|Rituximab|rituximab|mesh-list
5656060|NCT03670901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5656061|NCT03670901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5656062|NCT03670901|Immunologic Factors|immunologic factors|mesh-ancestor
5656063|NCT03670901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656064|NCT03670901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5656065|NCT03670888|Rituximab|rituximab|mesh-list
5656066|NCT03670888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5656067|NCT03670888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5656068|NCT03670888|Immunologic Factors|immunologic factors|mesh-ancestor
5656069|NCT03670888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656070|NCT03670888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5656071|NCT03670875|Curcumin|curcumin|mesh-list
5656072|NCT03670875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5656073|NCT03670875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5656074|NCT03670875|Analgesics|analgesics|mesh-ancestor
5656075|NCT03670875|Sensory System Agents|sensory system agents|mesh-ancestor
5656076|NCT03670875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5656077|NCT03670875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656078|NCT03670875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5656079|NCT03670875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5834025|NCT03955861|Analgesics|analgesics|mesh-ancestor
5834026|NCT03955861|Sensory System Agents|sensory system agents|mesh-ancestor
5834027|NCT03955861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5834028|NCT03955861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834029|NCT03955861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5834030|NCT03955861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5834031|NCT03955861|Immunologic Factors|immunologic factors|mesh-ancestor
5834032|NCT03955861|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
5834033|NCT03912831|Cyclophosphamide|cyclophosphamide|mesh-list
5834034|NCT03912831|Fludarabine|fludarabine|mesh-list
5834035|NCT03912831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5834036|NCT03912831|Immunologic Factors|immunologic factors|mesh-ancestor
5834037|NCT03912831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834038|NCT03912831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5834039|NCT03912831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5834040|NCT03912831|Alkylating Agents|alkylating agents|mesh-ancestor
5834041|NCT03912831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5834042|NCT03912831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5834043|NCT03912831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5834044|NCT03912298|Analgesics, Opioid|analgesics, opioid|mesh-list
5834045|NCT03912298|Narcotics|narcotics|mesh-ancestor
5834046|NCT03912298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5834047|NCT03912298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834048|NCT03912298|Analgesics|analgesics|mesh-ancestor
5834049|NCT03912298|Sensory System Agents|sensory system agents|mesh-ancestor
5834050|NCT03912298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5834051|NCT02543697|Epinephrine|epinephrine|mesh-list
5834052|NCT02543697|Racepinephrine|racepinephrine|mesh-list
5834053|NCT02543697|Epinephryl borate|epinephryl borate|mesh-list
5834054|NCT02543697|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5834055|NCT02543697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5656080|NCT03670875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5656081|NCT03670875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5656082|NCT03670875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656083|NCT03670836|Misoprostol|misoprostol|mesh-list
5656084|NCT03670836|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5656085|NCT03670836|Abortifacient Agents|abortifacient agents|mesh-ancestor
5656086|NCT03670836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5656087|NCT03670836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656088|NCT03670836|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5656089|NCT03670836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5834056|NCT02543697|Adrenergic Agents|adrenergic agents|mesh-ancestor
5834057|NCT02543697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5834058|NCT02543697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5834059|NCT02543697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834060|NCT02543697|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5834061|NCT02543697|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5834062|NCT02543697|Autonomic Agents|autonomic agents|mesh-ancestor
5834063|NCT02543697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5834064|NCT02543697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5834065|NCT02543697|Respiratory System Agents|respiratory system agents|mesh-ancestor
5834066|NCT02543697|Mydriatics|mydriatics|mesh-ancestor
5834067|NCT02543697|Sympathomimetics|sympathomimetics|mesh-ancestor
5834068|NCT02543697|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5834069|NCT02543944|Clonidine|clonidine|mesh-list
6493509|NCT00613769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6493510|NCT00613782|Methyltestosterone|methyltestosterone|mesh-list
6493511|NCT00613782|Testosterone|testosterone|mesh-list
6493512|NCT00613782|Testosterone undecanoate|testosterone undecanoate|mesh-list
6493513|NCT00613782|Testosterone enanthate|testosterone enanthate|mesh-list
6493514|NCT00613782|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6493515|NCT00613782|Androgens|androgens|mesh-ancestor
6493516|NCT00613782|Hormones|hormones|mesh-ancestor
6493517|NCT00613782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5656090|NCT03670836|Oxytocics|oxytocics|mesh-ancestor
5834070|NCT02543944|Naltrexone|naltrexone|mesh-list
5834071|NCT02543944|Buprenorphine|buprenorphine|mesh-list
5834072|NCT02543944|Gabapentin|gabapentin|mesh-list
5834073|NCT02543944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5834074|NCT02543944|Narcotics|narcotics|mesh-ancestor
5834075|NCT02543944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5834076|NCT02543944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656091|NCT03670758|Protein S|protein s|mesh-list
5656092|NCT03670758|Anticoagulants|anticoagulants|mesh-ancestor
5656093|NCT03670706|Analgesics|analgesics|mesh-list
5656094|NCT03670706|Sensory System Agents|sensory system agents|mesh-ancestor
5834077|NCT02543944|Analgesics|analgesics|mesh-ancestor
5656095|NCT03670706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5834078|NCT02543944|Sensory System Agents|sensory system agents|mesh-ancestor
5834079|NCT02543944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5834080|NCT02543944|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5834081|NCT02543944|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5834082|NCT02543944|Anticonvulsants|anticonvulsants|mesh-ancestor
5834083|NCT02543944|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5834084|NCT02543944|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5834085|NCT02543944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5834086|NCT02543944|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5834087|NCT02543944|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5834088|NCT02543944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5834089|NCT02543944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5834090|NCT02543944|Antimanic Agents|antimanic agents|mesh-ancestor
5834091|NCT02543944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5834092|NCT02543944|Sympatholytics|sympatholytics|mesh-ancestor
5834093|NCT02543944|Autonomic Agents|autonomic agents|mesh-ancestor
5834094|NCT02543944|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5834095|NCT02543944|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5834096|NCT02543944|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5834097|NCT02543944|Adrenergic Agents|adrenergic agents|mesh-ancestor
5834098|NCT02543710|Taxane|taxane|mesh-list
5834099|NCT02543710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5834100|NCT02543671|Vitamin D|vitamin d|mesh-list
5834101|NCT02543671|Cholecalciferol|cholecalciferol|mesh-list
5834102|NCT02543671|Vitamins|vitamins|mesh-ancestor
5834103|NCT02543671|Micronutrients|micronutrients|mesh-ancestor
5834104|NCT02543671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834105|NCT02543671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5834106|NCT02543671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5834107|NCT02543645|Atezolizumab|atezolizumab|mesh-list
5834108|NCT02543645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5834109|NCT02543411|Lidocaine|lidocaine|mesh-list
5834110|NCT02543411|Anesthetics, Local|anesthetics, local|mesh-ancestor
5834111|NCT02543411|Anesthetics|anesthetics|mesh-ancestor
5834112|NCT02543411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5834113|NCT02543411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834114|NCT02543411|Sensory System Agents|sensory system agents|mesh-ancestor
5834115|NCT02543411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5834116|NCT02543411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5834117|NCT02543411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5834118|NCT02543411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5834119|NCT02543411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5834120|NCT02543411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5834121|NCT02543606|Esomeprazole|esomeprazole|mesh-list
5834122|NCT02543606|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5834123|NCT02543606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5834124|NCT02543606|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5834125|NCT02543606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5834126|NCT02543606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5834127|NCT02543385|Ketamine|ketamine|mesh-list
5834128|NCT02543385|Esketamine|esketamine|mesh-list
5834129|NCT02543385|Analgesics|analgesics|mesh-ancestor
5834130|NCT02543385|Sensory System Agents|sensory system agents|mesh-ancestor
5834131|NCT02543385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5834132|NCT02543385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834133|NCT02543385|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5834134|NCT02543385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5834135|NCT02543385|Anesthetics, General|anesthetics, general|mesh-ancestor
5834136|NCT02543385|Anesthetics|anesthetics|mesh-ancestor
5834137|NCT02543385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5834138|NCT02543385|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5834139|NCT02543385|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5834140|NCT02543385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5834141|NCT02543385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5834142|NCT02543385|Antidepressive Agents|antidepressive agents|mesh-ancestor
5834143|NCT02543385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5834144|NCT02543034|Petrolatum|petrolatum|mesh-list
5834145|NCT02543034|Emollients|emollients|mesh-ancestor
5834146|NCT02543034|Dermatologic Agents|dermatologic agents|mesh-ancestor
5834147|NCT02543099|Policosanol|policosanol|mesh-list
5834148|NCT02543099|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5834149|NCT02543099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5834150|NCT02543099|Antimetabolites|antimetabolites|mesh-ancestor
5834151|NCT02543099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5834152|NCT02543099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5656096|NCT03670706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656097|NCT03670212|Hydrocortisone|hydrocortisone|mesh-list
5656098|NCT03670212|Yohimbine|yohimbine|mesh-list
5656099|NCT03670212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5656100|NCT03670212|Mydriatics|mydriatics|mesh-ancestor
5656101|NCT03670212|Autonomic Agents|autonomic agents|mesh-ancestor
5656102|NCT03670212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5656103|NCT03670212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656104|NCT03670212|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5656105|NCT03670212|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5656106|NCT03670212|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5834153|NCT02543099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5834154|NCT02543086|Piperaquine|piperaquine|mesh-list
5834155|NCT02543086|Antimalarials|antimalarials|mesh-ancestor
5834156|NCT02543086|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5834157|NCT02543086|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5834158|NCT02543086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5834159|NCT02543229|Ranibizumab|ranibizumab|mesh-list
5834160|NCT02543229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5834161|NCT02543229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5834162|NCT02543229|Growth Substances|growth substances|mesh-ancestor
5834163|NCT02543229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834164|NCT02543229|Growth Inhibitors|growth inhibitors|mesh-ancestor
5834165|NCT02543229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5834166|NCT02543060|Fluorides|fluorides|mesh-list
5834167|NCT02543060|Tin Fluorides|tin fluorides|mesh-list
5834168|NCT02543060|Cariostatic Agents|cariostatic agents|mesh-ancestor
5834169|NCT02543060|Protective Agents|protective agents|mesh-ancestor
5834170|NCT02543060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834171|NCT02542969|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5834172|NCT02542969|Simvastatin|simvastatin|mesh-list
5834173|NCT02542969|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5834174|NCT02542969|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5834175|NCT02542969|Antimetabolites|antimetabolites|mesh-ancestor
5834176|NCT02542969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5834177|NCT02542969|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5834178|NCT02542969|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5834179|NCT02542969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5834180|NCT02543073|Glucocorticoids|glucocorticoids|mesh-list
5834181|NCT02543073|Hormones|hormones|mesh-ancestor
5834182|NCT02543073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5834183|NCT02543073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834184|NCT02542930|Thymalfasin|thymalfasin|mesh-list
5834185|NCT02542930|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5834186|NCT02542930|Immunologic Factors|immunologic factors|mesh-ancestor
5834187|NCT02542930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834188|NCT02542852|Ritonavir|ritonavir|mesh-list
5834189|NCT02542852|Atazanavir Sulfate|atazanavir sulfate|mesh-list
5834190|NCT02542852|Dolutegravir|dolutegravir|mesh-list
5834191|NCT02542852|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5834192|NCT02542852|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5834193|NCT02542852|Protease Inhibitors|protease inhibitors|mesh-ancestor
5834194|NCT02542852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5834195|NCT02542852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5834196|NCT02542852|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5834197|NCT02542852|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5834198|NCT02542852|Antiviral Agents|antiviral agents|mesh-ancestor
5834199|NCT02542852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5834200|NCT02542852|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5834201|NCT02542852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5834202|NCT02542852|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5834203|NCT02542852|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5902759|NCT03481556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902760|NCT03481556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5902761|NCT03481556|Glucocorticoids|glucocorticoids|mesh-ancestor
5902762|NCT03481556|Hormones|hormones|mesh-ancestor
5902763|NCT03481556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5902764|NCT03481556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5902765|NCT03481556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5902766|NCT03481556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5902767|NCT03481556|Alkylating Agents|alkylating agents|mesh-ancestor
5902768|NCT03481556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902769|NCT03481556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5656107|NCT03670212|Adrenergic Agents|adrenergic agents|mesh-ancestor
5902770|NCT03481556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5656108|NCT03670212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5656109|NCT03670212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656110|NCT03670212|Urological Agents|urological agents|mesh-ancestor
5656111|NCT03670095|Memantine|memantine|mesh-list
5656112|NCT03670095|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5656113|NCT03670095|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5656114|NCT03670095|Dopamine Agents|dopamine agents|mesh-ancestor
5656115|NCT03670095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5656116|NCT03670095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656117|NCT03670095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656118|NCT03670095|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5656119|NCT03670095|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5656120|NCT03670056|Nivolumab|nivolumab|mesh-list
5656121|NCT03670056|Ipilimumab|ipilimumab|mesh-list
5656122|NCT03670056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5656123|NCT03670056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5656124|NCT03670056|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5656125|NCT03670056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656126|NCT03670043|Metformin|metformin|mesh-list
5656127|NCT03670043|Psyllium|psyllium|mesh-list
5656128|NCT03670043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5656129|NCT03670043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656130|NCT03670043|Cathartics|cathartics|mesh-ancestor
5656131|NCT03670043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5656132|NCT03669783|Dactinomycin|dactinomycin|mesh-list
5656133|NCT03669783|Carboplatin|carboplatin|mesh-list
5656134|NCT03669783|Doxorubicin|doxorubicin|mesh-list
5656135|NCT03669783|Etoposide|etoposide|mesh-list
5656136|NCT03669783|Vincristine|vincristine|mesh-list
5656137|NCT03669783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5656138|NCT03669783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5656139|NCT03669783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5656140|NCT03669783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5656141|NCT03669783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5656142|NCT03669783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656143|NCT03669783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5656144|NCT03669783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5656145|NCT03669783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5656146|NCT03669783|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5656147|NCT03669783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5656148|NCT03669783|Tubulin Modulators|tubulin modulators|mesh-ancestor
5656149|NCT03669783|Antimitotic Agents|antimitotic agents|mesh-ancestor
5656150|NCT03669783|Mitosis Modulators|mitosis modulators|mesh-ancestor
5656151|NCT03669757|Betamethasone|betamethasone|mesh-list
5656152|NCT03669757|Betamethasone Valerate|betamethasone valerate|mesh-list
5656153|NCT03669757|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5656154|NCT03669757|Betamethasone benzoate|betamethasone benzoate|mesh-list
5656155|NCT03669757|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
5656156|NCT03669757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5656157|NCT03669757|Glucocorticoids|glucocorticoids|mesh-ancestor
5656158|NCT03669757|Hormones|hormones|mesh-ancestor
5656159|NCT03669757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5656160|NCT03669757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656161|NCT03669757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5656162|NCT03669757|Respiratory System Agents|respiratory system agents|mesh-ancestor
5656163|NCT03669614|Gallium citrate|gallium citrate|mesh-list
5834204|NCT02542748|Norepinephrine|norepinephrine|mesh-list
5834205|NCT02542748|Ephedrine|ephedrine|mesh-list
5834206|NCT02542748|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5834207|NCT02542748|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5834208|NCT02542748|Adrenergic Agents|adrenergic agents|mesh-ancestor
5834209|NCT02542748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5834210|NCT02542748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5834211|NCT02542748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834212|NCT02542748|Sympathomimetics|sympathomimetics|mesh-ancestor
5834213|NCT02542748|Autonomic Agents|autonomic agents|mesh-ancestor
5834214|NCT02542748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5834215|NCT02542748|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5834216|NCT02542748|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5834217|NCT02542839|Botulinum Toxins|botulinum toxins|mesh-list
5834218|NCT02542839|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5834219|NCT02542839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5834220|NCT02542839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656164|NCT03669614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5834221|NCT02542839|Cholinergic Agents|cholinergic agents|mesh-ancestor
5834222|NCT02542839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5834223|NCT02542839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834224|NCT02542592|Methylprednisolone|methylprednisolone|mesh-list
5834225|NCT02542592|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5834226|NCT02542592|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5834227|NCT02542592|Prednisolone|prednisolone|mesh-list
5834228|NCT02542592|Prednisolone acetate|prednisolone acetate|mesh-list
5834229|NCT02542592|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5834230|NCT02542592|Prednisolone phosphate|prednisolone phosphate|mesh-list
5834231|NCT02542592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5834232|NCT02542592|Antiemetics|antiemetics|mesh-ancestor
5834233|NCT02542592|Autonomic Agents|autonomic agents|mesh-ancestor
5834234|NCT02542592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5834235|NCT02542592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834236|NCT02542592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5834237|NCT02542592|Glucocorticoids|glucocorticoids|mesh-ancestor
5834238|NCT02542592|Hormones|hormones|mesh-ancestor
5834239|NCT02542592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5834240|NCT02542592|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5834241|NCT02542592|Protective Agents|protective agents|mesh-ancestor
5834242|NCT02542592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5834243|NCT02542592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5834244|NCT02542813|Oxytocin|oxytocin|mesh-list
5834245|NCT02542813|Oxytocics|oxytocics|mesh-ancestor
5834246|NCT02542813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5834247|NCT02542813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834248|NCT02542241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5834249|NCT02542254|Albuterol|albuterol|mesh-list
5834250|NCT02542254|Ipratropium|ipratropium|mesh-list
5834251|NCT02542254|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5834252|NCT02542254|Autonomic Agents|autonomic agents|mesh-ancestor
5834253|NCT02542254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5834254|NCT02542254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834255|NCT02542254|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5834256|NCT02542254|Respiratory System Agents|respiratory system agents|mesh-ancestor
5834257|NCT02542254|Tocolytic Agents|tocolytic agents|mesh-ancestor
5834258|NCT02542254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5834259|NCT02542254|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5834260|NCT02542254|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5834261|NCT02542254|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5834262|NCT02542254|Adrenergic Agents|adrenergic agents|mesh-ancestor
5834263|NCT02542254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5834264|NCT02542254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5834265|NCT02542254|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5834266|NCT02542254|Cholinergic Agents|cholinergic agents|mesh-ancestor
5834267|NCT02542293|Gemcitabine|gemcitabine|mesh-list
5834268|NCT02542293|Paclitaxel|paclitaxel|mesh-list
5834269|NCT02542293|Cisplatin|cisplatin|mesh-list
5834270|NCT02542293|Carboplatin|carboplatin|mesh-list
5834271|NCT02542293|Pemetrexed|pemetrexed|mesh-list
5834272|NCT02542293|Durvalumab|durvalumab|mesh-list
5834273|NCT02542293|Tremelimumab|tremelimumab|mesh-list
5834274|NCT02542293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5834275|NCT02542293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5834276|NCT02542293|Tubulin Modulators|tubulin modulators|mesh-ancestor
5834277|NCT02542293|Antimitotic Agents|antimitotic agents|mesh-ancestor
5656165|NCT03669614|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5656166|NCT03669601|Gemcitabine|gemcitabine|mesh-list
5656167|NCT03669601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5656168|NCT03669601|Antimetabolites|antimetabolites|mesh-ancestor
5656169|NCT03669601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656170|NCT03669601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5656171|NCT03669601|Antiviral Agents|antiviral agents|mesh-ancestor
5656172|NCT03669601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5656173|NCT03669601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5656174|NCT03669601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5656175|NCT03669601|Immunologic Factors|immunologic factors|mesh-ancestor
5656176|NCT03669601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656177|NCT03669562|Alprostadil|alprostadil|mesh-list
5656178|NCT03669562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5656179|NCT03669562|Vasodilator Agents|vasodilator agents|mesh-ancestor
5656180|NCT03669562|Urological Agents|urological agents|mesh-ancestor
5656181|NCT03669484|Fentanyl|fentanyl|mesh-list
5656182|NCT03669484|Bromides|bromides|mesh-list
5656183|NCT03669484|Propofol|propofol|mesh-list
5656184|NCT03669484|Rocuronium|rocuronium|mesh-list
5656185|NCT03669484|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5834278|NCT02542293|Mitosis Modulators|mitosis modulators|mesh-ancestor
5834279|NCT02542293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5834280|NCT02542293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5834281|NCT02542293|Antimetabolites|antimetabolites|mesh-ancestor
5834282|NCT02542293|Antiviral Agents|antiviral agents|mesh-ancestor
5656186|NCT03669484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5656187|NCT03669484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656188|NCT03669484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5656189|NCT03669484|Anesthetics, General|anesthetics, general|mesh-ancestor
5656190|NCT03669484|Anesthetics|anesthetics|mesh-ancestor
5834283|NCT02542293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5834284|NCT02542293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5834285|NCT02542293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5834286|NCT02542293|Immunologic Factors|immunologic factors|mesh-ancestor
5834287|NCT02542293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834288|NCT02542293|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5834289|NCT02542293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5834290|NCT02542293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5834291|NCT02542137|Thymalfasin|thymalfasin|mesh-list
5834292|NCT02542137|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5834293|NCT02542137|Immunologic Factors|immunologic factors|mesh-ancestor
5834294|NCT02542137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834295|NCT02542124|Interleukin-12|interleukin-12|mesh-list
5834296|NCT02542124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5834297|NCT02542124|Immunologic Factors|immunologic factors|mesh-ancestor
5834298|NCT02542124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834299|NCT02542124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5834300|NCT02542124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5834301|NCT02542124|Growth Substances|growth substances|mesh-ancestor
5834302|NCT02542124|Growth Inhibitors|growth inhibitors|mesh-ancestor
5834303|NCT02542124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5834304|NCT02542111|Gemcitabine|gemcitabine|mesh-list
5834305|NCT02542111|Dexamethasone|dexamethasone|mesh-list
5834306|NCT02542111|Bortezomib|bortezomib|mesh-list
5834307|NCT02542111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5834308|NCT02542111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5834309|NCT02542111|Antiemetics|antiemetics|mesh-ancestor
5834310|NCT02542111|Autonomic Agents|autonomic agents|mesh-ancestor
5834311|NCT02542111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5834312|NCT02542111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834313|NCT02542111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5834314|NCT02542111|Glucocorticoids|glucocorticoids|mesh-ancestor
5834315|NCT02542111|Hormones|hormones|mesh-ancestor
5834316|NCT02542111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5834317|NCT02542111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5834318|NCT02542111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5656191|NCT03669484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5656192|NCT03669484|Narcotics|narcotics|mesh-ancestor
5656193|NCT03669484|Analgesics|analgesics|mesh-ancestor
5656194|NCT03669484|Sensory System Agents|sensory system agents|mesh-ancestor
5834319|NCT02542111|Antimetabolites|antimetabolites|mesh-ancestor
5834320|NCT02542111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5834321|NCT02542111|Antiviral Agents|antiviral agents|mesh-ancestor
5834322|NCT02542111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5834323|NCT02542111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5834324|NCT02542111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5834325|NCT02542111|Immunologic Factors|immunologic factors|mesh-ancestor
5834326|NCT02542007|Sirolimus|sirolimus|mesh-list
5834327|NCT02542007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5834328|NCT02542007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5834329|NCT02542007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5834330|NCT02542007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5834331|NCT02542007|Antifungal Agents|antifungal agents|mesh-ancestor
5834332|NCT02542007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5834333|NCT02542007|Immunologic Factors|immunologic factors|mesh-ancestor
5656195|NCT03669484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5656196|NCT03669484|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5656197|NCT03669484|Anticonvulsants|anticonvulsants|mesh-ancestor
5656198|NCT03669484|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5656199|NCT03669484|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5656200|NCT03669484|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5656201|NCT03669445|Dexamethasone|dexamethasone|mesh-list
5656202|NCT03669445|Lenalidomide|lenalidomide|mesh-list
5834334|NCT02542007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834335|NCT02542098|Hydrocodone|hydrocodone|mesh-list
5834336|NCT02542098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5834337|NCT02542098|Narcotics|narcotics|mesh-ancestor
5834338|NCT02542098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5834339|NCT02542098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834340|NCT02542098|Analgesics|analgesics|mesh-ancestor
5834341|NCT02542098|Sensory System Agents|sensory system agents|mesh-ancestor
5834342|NCT02542098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5834343|NCT02542098|Antitussive Agents|antitussive agents|mesh-ancestor
5834344|NCT02542098|Respiratory System Agents|respiratory system agents|mesh-ancestor
5834345|NCT02541734|Exenatide|exenatide|mesh-list
5834346|NCT02541734|Polygeline|polygeline|mesh-list
5834347|NCT02541734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5834348|NCT02541734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834349|NCT02541734|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5834350|NCT02541734|Incretins|incretins|mesh-ancestor
5834351|NCT02541734|Hormones|hormones|mesh-ancestor
5834352|NCT02541734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5834353|NCT02541734|Plasma Substitutes|plasma substitutes|mesh-ancestor
5834354|NCT02541734|Blood Substitutes|blood substitutes|mesh-ancestor
5834355|NCT02541786|Rabeprazole|rabeprazole|mesh-list
5834356|NCT02541786|Dexlansoprazole|dexlansoprazole|mesh-list
5834357|NCT02541786|Lansoprazole|lansoprazole|mesh-list
5834358|NCT02541786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5834359|NCT02541786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5834360|NCT02541786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5834361|NCT02541786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5834362|NCT02541786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5834363|NCT02541760|Mometasone Furoate|mometasone furoate|mesh-list
5834364|NCT02541760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5834365|NCT02541760|Dermatologic Agents|dermatologic agents|mesh-ancestor
5834366|NCT02541760|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5834367|NCT02541643|Elotuzumab|elotuzumab|mesh-list
5656203|NCT03669445|Daratumumab|daratumumab|mesh-list
5656204|NCT03669445|Ixazomib|ixazomib|mesh-list
5656205|NCT03669445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5656206|NCT03669445|Antiemetics|antiemetics|mesh-ancestor
5656207|NCT03669445|Autonomic Agents|autonomic agents|mesh-ancestor
5656208|NCT03669445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5656209|NCT03669445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656210|NCT03669445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5656211|NCT03669445|Glucocorticoids|glucocorticoids|mesh-ancestor
5656212|NCT03669445|Hormones|hormones|mesh-ancestor
5656213|NCT03669445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5656214|NCT03669445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5656215|NCT03669445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5656216|NCT03669445|Immunologic Factors|immunologic factors|mesh-ancestor
5656217|NCT03669445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5656218|NCT03669445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5656219|NCT03669445|Growth Substances|growth substances|mesh-ancestor
5656220|NCT03669445|Growth Inhibitors|growth inhibitors|mesh-ancestor
5656221|NCT03669445|Protease Inhibitors|protease inhibitors|mesh-ancestor
5656222|NCT03669445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5656223|NCT03669445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694891|NCT03393364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694892|NCT03393325|Tadalafil|tadalafil|mesh-list
5694893|NCT03393325|Vasodilator Agents|vasodilator agents|mesh-ancestor
5694894|NCT03393325|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5694895|NCT03393325|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5694896|NCT03393325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5694897|NCT03393325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694898|NCT03393325|Urological Agents|urological agents|mesh-ancestor
5694899|NCT03393273|Elotuzumab|elotuzumab|mesh-list
5694900|NCT03393273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5694901|NCT03393247|Azathioprine|azathioprine|mesh-list
5694902|NCT03393247|Infliximab|infliximab|mesh-list
5694903|NCT03393247|Dermatologic Agents|dermatologic agents|mesh-ancestor
5694904|NCT03393247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5694905|NCT03393247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5694906|NCT03393247|Antimetabolites|antimetabolites|mesh-ancestor
5694907|NCT03393247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694908|NCT03393247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5694909|NCT03393247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5834368|NCT02541643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5834369|NCT02541708|Folic Acid|folic acid|mesh-list
5834370|NCT02541708|Hematinics|hematinics|mesh-ancestor
5834371|NCT02541708|Vitamin B Complex|vitamin b complex|mesh-ancestor
5834372|NCT02541708|Vitamins|vitamins|mesh-ancestor
5834373|NCT02541708|Micronutrients|micronutrients|mesh-ancestor
5834374|NCT02541708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834375|NCT02541526|Mirtazapine|mirtazapine|mesh-list
5834376|NCT02541526|Antidepressive Agents|antidepressive agents|mesh-ancestor
5834377|NCT02541526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5834378|NCT02541526|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5834379|NCT02541526|Histamine Antagonists|histamine antagonists|mesh-ancestor
5834380|NCT02541526|Histamine Agents|histamine agents|mesh-ancestor
5834381|NCT02541526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5834382|NCT02541526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5834383|NCT02541526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674493|NCT01569685|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6674494|NCT01569685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6674495|NCT01569685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6674496|NCT01569685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674497|NCT01569685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6674498|NCT01569685|Serotonin Agents|serotonin agents|mesh-ancestor
6674499|NCT01569685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674500|NCT01569685|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6674501|NCT01569685|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5656224|NCT03669367|Abatacept|abatacept|mesh-list
5656225|NCT03669367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5656226|NCT03669367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656227|NCT03669367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5656228|NCT03669367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5656229|NCT03669367|Immunologic Factors|immunologic factors|mesh-ancestor
5834384|NCT02541526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5834385|NCT02541526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5834386|NCT02541526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5834387|NCT02541526|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5834388|NCT02541526|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5834389|NCT02541526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5834390|NCT02541526|Adrenergic Agents|adrenergic agents|mesh-ancestor
5834391|NCT02541526|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5834392|NCT02541526|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5834393|NCT02541526|Serotonin Agents|serotonin agents|mesh-ancestor
5834394|NCT02541526|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5834395|NCT02541552|Ropivacaine|ropivacaine|mesh-list
5834396|NCT02541552|Anesthetics, Local|anesthetics, local|mesh-ancestor
5834397|NCT02541552|Anesthetics|anesthetics|mesh-ancestor
5834398|NCT02541552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5834399|NCT02541552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834400|NCT02541552|Sensory System Agents|sensory system agents|mesh-ancestor
5834401|NCT02541552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5834402|NCT02541500|Minocycline|minocycline|mesh-list
5834403|NCT02541500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5834404|NCT02541500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5834405|NCT02541396|Ketamine|ketamine|mesh-list
5834406|NCT02541396|Oxycodone|oxycodone|mesh-list
5834407|NCT02541396|Analgesics|analgesics|mesh-ancestor
5834408|NCT02541396|Sensory System Agents|sensory system agents|mesh-ancestor
5834409|NCT02541396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5834410|NCT02541396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834411|NCT02541396|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5834412|NCT02541396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5834413|NCT02541396|Anesthetics, General|anesthetics, general|mesh-ancestor
5834414|NCT02541396|Anesthetics|anesthetics|mesh-ancestor
5834415|NCT02541396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5834416|NCT02541396|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5834417|NCT02541396|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5656230|NCT03669367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656231|NCT03669367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5656232|NCT03669328|Anesthetics|anesthetics|mesh-list
5656233|NCT03669328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5656234|NCT03669328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656235|NCT03669263|Fentanyl|fentanyl|mesh-list
5656236|NCT03669263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5656237|NCT03669263|Narcotics|narcotics|mesh-ancestor
5656238|NCT03669263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5656239|NCT03669263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656240|NCT03669263|Analgesics|analgesics|mesh-ancestor
5656241|NCT03669263|Sensory System Agents|sensory system agents|mesh-ancestor
5656242|NCT03669263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5656243|NCT03669263|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5656244|NCT03669263|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5656245|NCT03669263|Anesthetics, General|anesthetics, general|mesh-ancestor
5656246|NCT03669263|Anesthetics|anesthetics|mesh-ancestor
5656247|NCT03669224|Chlorhexidine|chlorhexidine|mesh-list
5656248|NCT03669224|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5656249|NCT03669224|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5656250|NCT03669224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5656251|NCT03669224|Disinfectants|disinfectants|mesh-ancestor
5656252|NCT03669224|Dermatologic Agents|dermatologic agents|mesh-ancestor
5656253|NCT03669029|Golimumab|golimumab|mesh-list
5656254|NCT03669029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5656255|NCT03669029|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6211823|NCT02178059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6211824|NCT02178059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211825|NCT02178059|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6211826|NCT02178059|Respiratory System Agents|respiratory system agents|mesh-ancestor
6211827|NCT02178059|Sympathomimetics|sympathomimetics|mesh-ancestor
6211828|NCT02178059|Tocolytic Agents|tocolytic agents|mesh-ancestor
6211829|NCT02178059|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6211830|NCT02178059|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6211831|NCT02178059|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6211832|NCT02178059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6211833|NCT02178059|Adrenergic Agents|adrenergic agents|mesh-ancestor
6493518|NCT00613782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656256|NCT03669029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5656257|NCT03669029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5656258|NCT03669029|Immunologic Factors|immunologic factors|mesh-ancestor
5656259|NCT03669029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656260|NCT03669003|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
5656261|NCT03669003|Hemostatics|hemostatics|mesh-ancestor
5656262|NCT03669003|Coagulants|coagulants|mesh-ancestor
5656263|NCT03668964|Vitamin D|vitamin d|mesh-list
5656264|NCT03668964|Cholecalciferol|cholecalciferol|mesh-list
5656265|NCT03668964|Vitamins|vitamins|mesh-list
5656266|NCT03668964|Vitamin E|vitamin e|mesh-list
5656267|NCT03668964|Tocopherols|tocopherols|mesh-list
5656268|NCT03668964|alpha-Tocopherol|alpha-tocopherol|mesh-list
5656269|NCT03668964|Vitamin A|vitamin a|mesh-list
5656270|NCT03668964|Riboflavin|riboflavin|mesh-list
5656271|NCT03668964|Vitamin B Complex|vitamin b complex|mesh-list
5656272|NCT03668964|Micronutrients|micronutrients|mesh-ancestor
5656273|NCT03668964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656274|NCT03668964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5834418|NCT02541396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5834419|NCT02541396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5834420|NCT02541396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5834421|NCT02541396|Narcotics|narcotics|mesh-ancestor
5834422|NCT02541383|Thalidomide|thalidomide|mesh-list
5834423|NCT02541383|Dexamethasone|dexamethasone|mesh-list
5834424|NCT02541383|Dexamethasone acetate|dexamethasone acetate|mesh-list
5834425|NCT02541383|Bortezomib|bortezomib|mesh-list
5834426|NCT02541383|Daratumumab|daratumumab|mesh-list
5834427|NCT02541383|BB 1101|bb 1101|mesh-list
5834428|NCT02541383|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5834429|NCT02541383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5834430|NCT02541383|Antiemetics|antiemetics|mesh-ancestor
5834431|NCT02541383|Autonomic Agents|autonomic agents|mesh-ancestor
5834432|NCT02541383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5834433|NCT02541383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834434|NCT02541383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5834435|NCT02541383|Glucocorticoids|glucocorticoids|mesh-ancestor
5834436|NCT02541383|Hormones|hormones|mesh-ancestor
5656275|NCT03668964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5656276|NCT03668964|Antioxidants|antioxidants|mesh-ancestor
5656277|NCT03668964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656278|NCT03668964|Protective Agents|protective agents|mesh-ancestor
5834437|NCT02541383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6211834|NCT02178059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6493519|NCT00613782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6493520|NCT00613782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6493521|NCT00613782|Anabolic Agents|anabolic agents|mesh-ancestor
6493522|NCT00613808|Nitric Oxide|nitric oxide|mesh-list
6493523|NCT00613808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6493524|NCT00613808|Autonomic Agents|autonomic agents|mesh-ancestor
6493525|NCT00613808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6493526|NCT00613808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493527|NCT00613808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6493528|NCT00613808|Respiratory System Agents|respiratory system agents|mesh-ancestor
5834438|NCT02541383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5834439|NCT02541383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5834440|NCT02541383|Protease Inhibitors|protease inhibitors|mesh-ancestor
5834441|NCT02541383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5834442|NCT02541383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5834443|NCT02541383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5834444|NCT02541383|Immunologic Factors|immunologic factors|mesh-ancestor
5656279|NCT03668964|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5656280|NCT03668964|Dermatologic Agents|dermatologic agents|mesh-ancestor
5656281|NCT03668951|Dexmedetomidine|dexmedetomidine|mesh-list
5656282|NCT03668951|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5656283|NCT03668951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5656284|NCT03668951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834445|NCT02541383|Leprostatic Agents|leprostatic agents|mesh-ancestor
5834446|NCT02541383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5834447|NCT02541383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5834448|NCT02541383|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5834449|NCT02541383|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5834450|NCT02541383|Growth Substances|growth substances|mesh-ancestor
5834451|NCT02541383|Growth Inhibitors|growth inhibitors|mesh-ancestor
5834452|NCT02541331|Broncho-Vaxom|broncho-vaxom|mesh-list
5834453|NCT02541331|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5834454|NCT02541331|Immunologic Factors|immunologic factors|mesh-ancestor
5834455|NCT02541331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834456|NCT02541084|Aflibercept|aflibercept|mesh-list
5834457|NCT02541084|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5834458|NCT02541084|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5834459|NCT02541084|Growth Substances|growth substances|mesh-ancestor
5834460|NCT02541084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834461|NCT02541084|Growth Inhibitors|growth inhibitors|mesh-ancestor
5834462|NCT02541084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5834463|NCT02541071|Clonidine|clonidine|mesh-list
5834464|NCT02541071|Yohimbine|yohimbine|mesh-list
5834465|NCT02541071|Analgesics|analgesics|mesh-ancestor
5834466|NCT02541071|Sensory System Agents|sensory system agents|mesh-ancestor
5834467|NCT02541071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5834468|NCT02541071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834469|NCT02541071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5834470|NCT02541071|Sympatholytics|sympatholytics|mesh-ancestor
5834471|NCT02541071|Autonomic Agents|autonomic agents|mesh-ancestor
5834472|NCT02541071|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5834473|NCT02541071|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5834474|NCT02541071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5834475|NCT02541071|Adrenergic Agents|adrenergic agents|mesh-ancestor
5834476|NCT02541071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5834477|NCT02541071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5834478|NCT02541071|Mydriatics|mydriatics|mesh-ancestor
5834479|NCT02541071|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5834480|NCT02541071|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5834481|NCT02541071|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5834482|NCT02541071|Urological Agents|urological agents|mesh-ancestor
5834483|NCT02541045|Metadoxine|metadoxine|mesh-list
5834484|NCT02541045|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5834485|NCT02541227|Cerebrolysin|cerebrolysin|mesh-list
5834486|NCT02541227|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5834487|NCT02541227|Protective Agents|protective agents|mesh-ancestor
5834488|NCT02541227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834489|NCT02541227|Nootropic Agents|nootropic agents|mesh-ancestor
5834490|NCT02541032|Minocycline|minocycline|mesh-list
5834491|NCT02541032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5656285|NCT03668951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5656286|NCT03668951|Analgesics|analgesics|mesh-ancestor
5656287|NCT03668951|Sensory System Agents|sensory system agents|mesh-ancestor
5656288|NCT03668951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5656289|NCT03668951|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5834492|NCT02541032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5902771|NCT03481556|Immunologic Factors|immunologic factors|mesh-ancestor
5902772|NCT03452137|Atezolizumab|atezolizumab|mesh-list
5902773|NCT03452137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5902774|NCT03412643|Paclitaxel|paclitaxel|mesh-list
5902775|NCT03412643|Cyclophosphamide|cyclophosphamide|mesh-list
5902776|NCT03412643|Doxorubicin|doxorubicin|mesh-list
5902777|NCT03412643|Trastuzumab|trastuzumab|mesh-list
5902778|NCT03412643|Pertuzumab|pertuzumab|mesh-list
5902779|NCT03412643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5902780|NCT03412643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5902781|NCT03412643|Tubulin Modulators|tubulin modulators|mesh-ancestor
6211835|NCT02178059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211836|NCT02178241|Gemcitabine|gemcitabine|mesh-list
6211837|NCT02178241|Halichondrin B|halichondrin b|mesh-list
5834493|NCT02541019|Ondansetron|ondansetron|mesh-list
5834494|NCT02541019|Palonosetron|palonosetron|mesh-list
5834495|NCT02541019|Antiemetics|antiemetics|mesh-ancestor
5834496|NCT02541019|Autonomic Agents|autonomic agents|mesh-ancestor
5834497|NCT02541019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5834498|NCT02541019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834499|NCT02541019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5834500|NCT02541019|Antipruritics|antipruritics|mesh-ancestor
5834501|NCT02541019|Dermatologic Agents|dermatologic agents|mesh-ancestor
5834502|NCT02541019|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5834503|NCT02541019|Serotonin Agents|serotonin agents|mesh-ancestor
5834504|NCT02541019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5834505|NCT02541019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5834506|NCT02541019|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5834507|NCT02541019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5834508|NCT02541019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5834509|NCT02541019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5834510|NCT02541019|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5656290|NCT03668951|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5656291|NCT03668951|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5656292|NCT03668951|Adrenergic Agents|adrenergic agents|mesh-ancestor
5656293|NCT03668951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5656294|NCT03668951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656295|NCT03668860|Dexamethasone|dexamethasone|mesh-list
5656296|NCT03668860|Dexamethasone acetate|dexamethasone acetate|mesh-list
6493529|NCT00613808|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6493530|NCT00613808|Antioxidants|antioxidants|mesh-ancestor
5656297|NCT03668860|Betamethasone|betamethasone|mesh-list
5834511|NCT02541019|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5834512|NCT02540928|N-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine|n-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9h-purin-6-amine|mesh-list
5834513|NCT02540928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5834514|NCT02540928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5834515|NCT02541006|Tiotropium Bromide|tiotropium bromide|mesh-list
5834516|NCT02541006|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5834517|NCT02541006|Autonomic Agents|autonomic agents|mesh-ancestor
5834518|NCT02541006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5834519|NCT02541006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834520|NCT02541006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5834521|NCT02541006|Respiratory System Agents|respiratory system agents|mesh-ancestor
5834522|NCT02541006|Parasympatholytics|parasympatholytics|mesh-ancestor
5834523|NCT02541006|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5834524|NCT02541006|Cholinergic Agents|cholinergic agents|mesh-ancestor
5834525|NCT02541006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5834526|NCT02541006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5834527|NCT02540876|Ilorasertib|ilorasertib|mesh-list
5834528|NCT02540876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5834529|NCT02540876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5834530|NCT02540876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5834531|NCT02540876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5834532|NCT02540824|Apatinib|apatinib|mesh-list
5834533|NCT02540824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5834534|NCT02540824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5834535|NCT02540824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5834536|NCT02540824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5834537|NCT02540837|Bupivacaine|bupivacaine|mesh-list
5834538|NCT02540837|Anesthetics, Local|anesthetics, local|mesh-ancestor
5834539|NCT02540837|Anesthetics|anesthetics|mesh-ancestor
5834540|NCT02540837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5834541|NCT02540837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834542|NCT02540837|Sensory System Agents|sensory system agents|mesh-ancestor
5834543|NCT02540837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5834544|NCT02540785|Levofloxacin|levofloxacin|mesh-list
5834545|NCT02540785|Ofloxacin|ofloxacin|mesh-list
5834546|NCT02540785|Tobramycin|tobramycin|mesh-list
5656298|NCT03668860|Betamethasone Valerate|betamethasone valerate|mesh-list
5656299|NCT03668860|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5656300|NCT03668860|Betamethasone benzoate|betamethasone benzoate|mesh-list
5656301|NCT03668860|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
5656302|NCT03668860|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
5656303|NCT03668860|BB 1101|bb 1101|mesh-list
5656304|NCT03668860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5656305|NCT03668860|Antiemetics|antiemetics|mesh-ancestor
5834547|NCT02540785|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
5834548|NCT02540785|Dexamethasone|dexamethasone|mesh-list
5834549|NCT02540785|Dexamethasone acetate|dexamethasone acetate|mesh-list
5834550|NCT02540785|BB 1101|bb 1101|mesh-list
5834551|NCT02540785|Hyaluronic Acid|hyaluronic acid|mesh-list
5834552|NCT02540785|Dipivefrin|dipivefrin|mesh-list
5834553|NCT02540785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5834554|NCT02540785|Antiemetics|antiemetics|mesh-ancestor
5834555|NCT02540785|Autonomic Agents|autonomic agents|mesh-ancestor
5834556|NCT02540785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5834557|NCT02540785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834558|NCT02540785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5834559|NCT02540785|Glucocorticoids|glucocorticoids|mesh-ancestor
5834560|NCT02540785|Hormones|hormones|mesh-ancestor
5834561|NCT02540785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5834562|NCT02540785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5834563|NCT02540785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5834564|NCT02540785|Protease Inhibitors|protease inhibitors|mesh-ancestor
5834565|NCT02540785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5834566|NCT02540785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5834567|NCT02540785|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5834568|NCT02540785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5834569|NCT02540785|Renal Agents|renal agents|mesh-ancestor
6674502|NCT01569919|Folic Acid|folic acid|mesh-list
6674503|NCT01569919|Vitamin B 12|vitamin b 12|mesh-list
6674504|NCT01569919|Hydroxocobalamin|hydroxocobalamin|mesh-list
6674505|NCT01569919|Dexamethasone|dexamethasone|mesh-list
6674506|NCT01569919|Pemetrexed|pemetrexed|mesh-list
6674507|NCT01569919|Vitamins|vitamins|mesh-ancestor
6674508|NCT01569919|Micronutrients|micronutrients|mesh-ancestor
6674509|NCT01569919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674510|NCT01569919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6211838|NCT02178241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6211839|NCT02178241|Antimetabolites|antimetabolites|mesh-ancestor
6211840|NCT02178241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211841|NCT02178241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6493531|NCT00613808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493532|NCT00613808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6493533|NCT00613808|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6493534|NCT00613808|Vasodilator Agents|vasodilator agents|mesh-ancestor
6493535|NCT00613808|Gasotransmitters|gasotransmitters|mesh-ancestor
6493536|NCT00613808|Protective Agents|protective agents|mesh-ancestor
6493537|NCT00613847|Trastuzumab|trastuzumab|mesh-list
6493538|NCT00613847|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
6493539|NCT00613847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6493540|NCT00613847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6493541|NCT00613847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656306|NCT03668860|Autonomic Agents|autonomic agents|mesh-ancestor
6211842|NCT02178241|Antiviral Agents|antiviral agents|mesh-ancestor
6211843|NCT02178241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6211844|NCT02178241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6211845|NCT02178241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6211846|NCT02178241|Immunologic Factors|immunologic factors|mesh-ancestor
6674511|NCT01569919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5656307|NCT03668860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5656308|NCT03668860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674512|NCT01569919|Antiemetics|antiemetics|mesh-ancestor
5656309|NCT03668860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5656310|NCT03668860|Glucocorticoids|glucocorticoids|mesh-ancestor
5656311|NCT03668860|Hormones|hormones|mesh-ancestor
5656312|NCT03668860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5656313|NCT03668860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5656314|NCT03668860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5656315|NCT03668860|Protease Inhibitors|protease inhibitors|mesh-ancestor
5656316|NCT03668860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5656317|NCT03668860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656318|NCT03668860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5656319|NCT03668860|Respiratory System Agents|respiratory system agents|mesh-ancestor
5656320|NCT03668860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5656321|NCT03668808|Insulin|insulin|mesh-list
5656322|NCT03668808|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5656323|NCT03668808|Insulin Glargine|insulin glargine|mesh-list
5656324|NCT03668808|Insulin, Long-Acting|insulin, long-acting|mesh-list
5656325|NCT03668808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5656326|NCT03668808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834570|NCT02540785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5834571|NCT02540785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5834572|NCT02540785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5834573|NCT02540785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5834574|NCT02540785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5834575|NCT02540785|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5834576|NCT02540785|Immunologic Factors|immunologic factors|mesh-ancestor
5834577|NCT02540785|Viscosupplements|viscosupplements|mesh-ancestor
5834578|NCT02540785|Protective Agents|protective agents|mesh-ancestor
5834579|NCT02540785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5834580|NCT02540785|Adrenergic Agents|adrenergic agents|mesh-ancestor
5834581|NCT02540785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5834582|NCT02540785|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5834583|NCT02540785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5834584|NCT02540720|Dexamethasone|dexamethasone|mesh-list
5834585|NCT02540720|gamma-Globulins|gamma-globulins|mesh-list
5834586|NCT02540720|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5834587|NCT02540720|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6211847|NCT02178241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211848|NCT02178241|Tubulin Modulators|tubulin modulators|mesh-ancestor
6211849|NCT02178241|Antimitotic Agents|antimitotic agents|mesh-ancestor
5834588|NCT02540720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5834589|NCT02540720|Antiemetics|antiemetics|mesh-ancestor
5834590|NCT02540720|Autonomic Agents|autonomic agents|mesh-ancestor
5834591|NCT02540720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5834592|NCT02540720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834593|NCT02540720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5834594|NCT02540720|Glucocorticoids|glucocorticoids|mesh-ancestor
5834595|NCT02540720|Hormones|hormones|mesh-ancestor
5834596|NCT02540720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5834597|NCT02540720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5834598|NCT02540720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5834599|NCT02540720|Immunologic Factors|immunologic factors|mesh-ancestor
5834600|NCT02540642|Vitamin B 12|vitamin b 12|mesh-list
5834601|NCT02540642|Vitamins|vitamins|mesh-ancestor
5834602|NCT02540642|Micronutrients|micronutrients|mesh-ancestor
5834603|NCT02540642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674513|NCT01569919|Autonomic Agents|autonomic agents|mesh-ancestor
6674514|NCT01569919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6674515|NCT01569919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5834604|NCT02540642|Vitamin B Complex|vitamin b complex|mesh-ancestor
5834605|NCT02540486|Insulin Glargine|insulin glargine|mesh-list
5834606|NCT02540486|Insulin, Long-Acting|insulin, long-acting|mesh-list
5834607|NCT02540486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5834608|NCT02540486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834609|NCT02540707|Solifenacin Succinate|solifenacin succinate|mesh-list
5834610|NCT02540707|Mirabegron|mirabegron|mesh-list
5834611|NCT02540707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5834612|NCT02540707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5834613|NCT02540707|Cholinergic Agents|cholinergic agents|mesh-ancestor
5656327|NCT03668730|Paclitaxel|paclitaxel|mesh-list
5656328|NCT03668730|Fluorouracil|fluorouracil|mesh-list
5656329|NCT03668730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5656330|NCT03668730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5656331|NCT03668730|Tubulin Modulators|tubulin modulators|mesh-ancestor
5656332|NCT03668730|Antimitotic Agents|antimitotic agents|mesh-ancestor
5656333|NCT03668730|Mitosis Modulators|mitosis modulators|mesh-ancestor
5834614|NCT02540707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5834615|NCT02540707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5834616|NCT02540707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834617|NCT02540707|Urological Agents|urological agents|mesh-ancestor
5834618|NCT02540707|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
5834619|NCT02540707|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5834620|NCT02540707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5834621|NCT02540707|Adrenergic Agents|adrenergic agents|mesh-ancestor
5834622|NCT02540460|Delpazolid|delpazolid|mesh-list
5656334|NCT03668730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656335|NCT03668730|Antimetabolites|antimetabolites|mesh-ancestor
5656336|NCT03668730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5656337|NCT03668730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5656338|NCT03668730|Immunologic Factors|immunologic factors|mesh-ancestor
5834623|NCT02540460|Oxazolidinones|oxazolidinones|mesh-list
5834624|NCT02540460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5656339|NCT03668730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834625|NCT02540460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5834626|NCT02540460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5834627|NCT02540460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5834628|NCT02540460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5834629|NCT02540512|Acetaminophen|acetaminophen|mesh-list
5834630|NCT02540512|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
5834631|NCT02540512|Hydrocodone|hydrocodone|mesh-list
5834632|NCT02540512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5834633|NCT02540512|Analgesics|analgesics|mesh-ancestor
5834634|NCT02540512|Sensory System Agents|sensory system agents|mesh-ancestor
5834635|NCT02540512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5834636|NCT02540512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834637|NCT02540512|Antipyretics|antipyretics|mesh-ancestor
5834638|NCT02540512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5834639|NCT02540512|Narcotics|narcotics|mesh-ancestor
5656340|NCT03668665|Hyaluronic Acid|hyaluronic acid|mesh-list
5656341|NCT03668665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5656342|NCT03668665|Immunologic Factors|immunologic factors|mesh-ancestor
5656343|NCT03668665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656344|NCT03668665|Viscosupplements|viscosupplements|mesh-ancestor
5656345|NCT03668665|Protective Agents|protective agents|mesh-ancestor
6493542|NCT00613964|Diuretics|diuretics|mesh-list
6493543|NCT00613964|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
6493544|NCT00613964|Natriuretic Agents|natriuretic agents|mesh-ancestor
6493545|NCT00613964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493546|NCT00613964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6493547|NCT00613964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5834640|NCT02540512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5834641|NCT02540512|Antitussive Agents|antitussive agents|mesh-ancestor
5834642|NCT02540512|Respiratory System Agents|respiratory system agents|mesh-ancestor
5834643|NCT02540512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5834644|NCT02540512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5834645|NCT02540512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5834646|NCT02540239|Simethicone|simethicone|mesh-list
5834647|NCT02540239|Antifoaming Agents|antifoaming agents|mesh-ancestor
5834648|NCT02540239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5834649|NCT02540239|Emollients|emollients|mesh-ancestor
5834650|NCT02540239|Dermatologic Agents|dermatologic agents|mesh-ancestor
5834651|NCT02540395|Mycophenolic Acid|mycophenolic acid|mesh-list
5834652|NCT02540395|Prednisolone|prednisolone|mesh-list
5834653|NCT02540395|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5834654|NCT02540395|Methylprednisolone|methylprednisolone|mesh-list
5834655|NCT02540395|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5834656|NCT02540395|Prednisolone acetate|prednisolone acetate|mesh-list
5834657|NCT02540395|Tacrolimus|tacrolimus|mesh-list
5834658|NCT02540395|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5834659|NCT02540395|Prednisolone phosphate|prednisolone phosphate|mesh-list
5834660|NCT02540395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5834661|NCT02540395|Immunologic Factors|immunologic factors|mesh-ancestor
5834662|NCT02540395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834663|NCT02540395|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5834664|NCT02540395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5834665|NCT02540395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5834666|NCT02540395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5834667|NCT02540395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5834668|NCT02540395|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5834669|NCT02540395|Antitubercular Agents|antitubercular agents|mesh-ancestor
5834670|NCT02540395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5834671|NCT02540395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5656346|NCT03668470|Dulaglutide|dulaglutide|mesh-list
5656347|NCT03668470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5656348|NCT03668470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656349|NCT03668431|Trametinib|trametinib|mesh-list
5656350|NCT03668431|Dabrafenib|dabrafenib|mesh-list
5656351|NCT03668431|Spartalizumab|spartalizumab|mesh-list
5656352|NCT03668431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5656353|NCT03668431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5656354|NCT03668431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5656355|NCT03668431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656356|NCT03668431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5656357|NCT03668418|Gemcitabine|gemcitabine|mesh-list
5656358|NCT03668418|Camptothecin|camptothecin|mesh-list
5656359|NCT03668418|Docetaxel|docetaxel|mesh-list
5656360|NCT03668418|Fluorouracil|fluorouracil|mesh-list
5656361|NCT03668418|Oxaliplatin|oxaliplatin|mesh-list
5656362|NCT03668418|Irinotecan|irinotecan|mesh-list
5656363|NCT03668418|Epirubicin|epirubicin|mesh-list
5656364|NCT03668418|Taxane|taxane|mesh-list
5656365|NCT03668418|Antimetabolites|antimetabolites|mesh-list
5656366|NCT03668418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5656367|NCT03668418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5656368|NCT03668418|Tubulin Modulators|tubulin modulators|mesh-ancestor
5656369|NCT03668418|Antimitotic Agents|antimitotic agents|mesh-ancestor
5656370|NCT03668418|Mitosis Modulators|mitosis modulators|mesh-ancestor
5656371|NCT03668418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656372|NCT03668418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5656373|NCT03668418|Antiviral Agents|antiviral agents|mesh-ancestor
5656374|NCT03668418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5656375|NCT03668418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5656376|NCT03668418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5656377|NCT03668418|Immunologic Factors|immunologic factors|mesh-ancestor
5656378|NCT03668418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656379|NCT03668418|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5656380|NCT03668418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5656381|NCT03668418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5656382|NCT03668418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5656383|NCT03668340|Adavosertib|adavosertib|mesh-list
5656384|NCT03668340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5656385|NCT03668340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656386|NCT03668262|Atracurium|atracurium|mesh-list
5656387|NCT03668262|Cisatracurium|cisatracurium|mesh-list
5656388|NCT03668262|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5656389|NCT03668262|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5656390|NCT03668262|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5656391|NCT03668262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5834672|NCT02540395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5834673|NCT02540395|Glucocorticoids|glucocorticoids|mesh-ancestor
5834674|NCT02540395|Hormones|hormones|mesh-ancestor
5834675|NCT02540395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5834676|NCT02540395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5834677|NCT02540395|Antiemetics|antiemetics|mesh-ancestor
5834678|NCT02540395|Autonomic Agents|autonomic agents|mesh-ancestor
5834679|NCT02540395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5834680|NCT02540395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5834681|NCT02540395|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5834682|NCT02540395|Protective Agents|protective agents|mesh-ancestor
5834683|NCT02540330|Fulvestrant|fulvestrant|mesh-list
5834684|NCT02540330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5834685|NCT02540330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5834686|NCT02540330|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5656392|NCT03668262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656393|NCT03668262|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
5834687|NCT02540330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5834688|NCT02540330|Hormone Antagonists|hormone antagonists|mesh-ancestor
5834689|NCT02540330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5834690|NCT02540330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834691|NCT02540369|Aflibercept|aflibercept|mesh-list
5834692|NCT02540369|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5834693|NCT02540369|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5834694|NCT02540369|Growth Substances|growth substances|mesh-ancestor
5834695|NCT02540369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656394|NCT03668262|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5656395|NCT03668262|Cholinergic Agents|cholinergic agents|mesh-ancestor
5656396|NCT03668262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5656397|NCT03668262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656398|NCT03668054|Bevacizumab|bevacizumab|mesh-list
5656399|NCT03668054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5656400|NCT03668054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5656401|NCT03668054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5656402|NCT03668054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5656403|NCT03668054|Growth Substances|growth substances|mesh-ancestor
5656404|NCT03668054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656405|NCT03668054|Growth Inhibitors|growth inhibitors|mesh-ancestor
5656406|NCT03668041|Gabapentin|gabapentin|mesh-list
5656407|NCT03668041|Trazodone|trazodone|mesh-list
5834696|NCT02540369|Growth Inhibitors|growth inhibitors|mesh-ancestor
5834697|NCT02540369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5834698|NCT02540070|Ketorolac|ketorolac|mesh-list
5834699|NCT02540070|Epinephrine|epinephrine|mesh-list
5834700|NCT02540070|Dexmedetomidine|dexmedetomidine|mesh-list
5834701|NCT02540070|Morphine|morphine|mesh-list
5834702|NCT02540070|Ropivacaine|ropivacaine|mesh-list
5656408|NCT03668041|Eszopiclone|eszopiclone|mesh-list
5834703|NCT02540070|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5834704|NCT02540070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5834705|NCT02540070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834706|NCT02540070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5834707|NCT02540070|Analgesics|analgesics|mesh-ancestor
5834708|NCT02540070|Sensory System Agents|sensory system agents|mesh-ancestor
5834709|NCT02540070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5834710|NCT02540070|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5834711|NCT02540070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5834712|NCT02540070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5834713|NCT02540070|Adrenergic Agents|adrenergic agents|mesh-ancestor
5834714|NCT02540070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5656409|NCT03668041|Analgesics|analgesics|mesh-ancestor
5656410|NCT03668041|Sensory System Agents|sensory system agents|mesh-ancestor
5656411|NCT03668041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5656412|NCT03668041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656413|NCT03668041|Anticonvulsants|anticonvulsants|mesh-ancestor
5656414|NCT03668041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5656415|NCT03668041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5656416|NCT03668041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5656417|NCT03668041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5656418|NCT03668041|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5656419|NCT03668041|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5834715|NCT02540070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5834716|NCT02540070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5834717|NCT02540070|Narcotics|narcotics|mesh-ancestor
5834718|NCT02540070|Anesthetics, Local|anesthetics, local|mesh-ancestor
5834719|NCT02540070|Anesthetics|anesthetics|mesh-ancestor
5834720|NCT02540070|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5834721|NCT02540070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5834722|NCT02540070|Autonomic Agents|autonomic agents|mesh-ancestor
5834723|NCT02540070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5834724|NCT02540070|Respiratory System Agents|respiratory system agents|mesh-ancestor
5834725|NCT02540070|Mydriatics|mydriatics|mesh-ancestor
5834726|NCT02540070|Sympathomimetics|sympathomimetics|mesh-ancestor
5834727|NCT02540070|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5834728|NCT02540070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5834729|NCT02540070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5834730|NCT02540070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5834731|NCT02540070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5834732|NCT02540070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5834733|NCT02539979|Acetaminophen|acetaminophen|mesh-list
5834734|NCT02539979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5834735|NCT02539979|Analgesics|analgesics|mesh-ancestor
5656420|NCT03668041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5656421|NCT03668041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5834736|NCT02539979|Sensory System Agents|sensory system agents|mesh-ancestor
5834737|NCT02539979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5834738|NCT02539979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834739|NCT02539979|Antipyretics|antipyretics|mesh-ancestor
5834740|NCT02539966|Sirolimus|sirolimus|mesh-list
5834741|NCT02539966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5656422|NCT03668041|Antimanic Agents|antimanic agents|mesh-ancestor
5656423|NCT03668041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5656424|NCT03668041|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5656425|NCT03668041|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5656426|NCT03668041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5656427|NCT03668041|Serotonin Agents|serotonin agents|mesh-ancestor
5656428|NCT03668041|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5656429|NCT03668041|Antidepressive Agents|antidepressive agents|mesh-ancestor
5656430|NCT03668015|Sorbitol|sorbitol|mesh-list
5656431|NCT03668015|Cathartics|cathartics|mesh-ancestor
5656432|NCT03668015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5834742|NCT02539966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5834743|NCT02539966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5834744|NCT02539966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5834745|NCT02539966|Antifungal Agents|antifungal agents|mesh-ancestor
5834746|NCT02539966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5834747|NCT02539966|Immunologic Factors|immunologic factors|mesh-ancestor
5834748|NCT02539966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834749|NCT02540018|Paclitaxel|paclitaxel|mesh-list
5834750|NCT02540018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5834751|NCT02540018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6493548|NCT00614029|Sumatriptan|sumatriptan|mesh-list
6493549|NCT00614029|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5656433|NCT03667963|Lactulose|lactulose|mesh-list
5834752|NCT02540018|Tubulin Modulators|tubulin modulators|mesh-ancestor
6493550|NCT00614029|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6493551|NCT00614029|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6493552|NCT00614029|Serotonin Agents|serotonin agents|mesh-ancestor
6493553|NCT00614029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5834753|NCT02540018|Antimitotic Agents|antimitotic agents|mesh-ancestor
5834754|NCT02540018|Mitosis Modulators|mitosis modulators|mesh-ancestor
5834755|NCT02540018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5834756|NCT02539940|Paclitaxel|paclitaxel|mesh-list
5834757|NCT02539940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5834758|NCT02539940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5834759|NCT02539940|Tubulin Modulators|tubulin modulators|mesh-ancestor
5834760|NCT02539940|Antimitotic Agents|antimitotic agents|mesh-ancestor
5834761|NCT02539940|Mitosis Modulators|mitosis modulators|mesh-ancestor
6493554|NCT00614029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493555|NCT00614029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674516|NCT01569919|Glucocorticoids|glucocorticoids|mesh-ancestor
5656434|NCT03667963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5694910|NCT03393247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5694911|NCT03393247|Immunologic Factors|immunologic factors|mesh-ancestor
5694912|NCT03393247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694913|NCT03393117|Narcotics|narcotics|mesh-list
5694914|NCT03393117|Bupivacaine|bupivacaine|mesh-list
5694915|NCT03393117|Anesthetics, Local|anesthetics, local|mesh-ancestor
5694916|NCT03393117|Anesthetics|anesthetics|mesh-ancestor
5694917|NCT03393117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5694918|NCT03393117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694919|NCT03393117|Sensory System Agents|sensory system agents|mesh-ancestor
5694920|NCT03393117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5694921|NCT03393117|Analgesics|analgesics|mesh-ancestor
5694922|NCT03393026|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
5694923|NCT03393026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5694924|NCT03393026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5694925|NCT03393026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5694926|NCT03393026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834762|NCT02539940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5834763|NCT02539849|Adalimumab|adalimumab|mesh-list
5834764|NCT02539849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5834765|NCT02539849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5834766|NCT02539810|Antihypertensive Agents|antihypertensive agents|mesh-list
5834767|NCT02539706|Rocuronium|rocuronium|mesh-list
5834768|NCT02539706|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5694927|NCT03393026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5694928|NCT03393026|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5694929|NCT03393026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5694930|NCT03393026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5694931|NCT03393026|Adrenergic Agents|adrenergic agents|mesh-ancestor
5694932|NCT03393026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5694933|NCT03393026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694934|NCT03393026|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5694935|NCT03393026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5834769|NCT02539706|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5834770|NCT02539706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5834771|NCT02539706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5834772|NCT02539706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834773|NCT02539745|Vitamin D|vitamin d|mesh-list
5834774|NCT02539745|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
5834775|NCT02539745|Vitamins|vitamins|mesh-ancestor
5834776|NCT02539745|Micronutrients|micronutrients|mesh-ancestor
5834777|NCT02539745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834778|NCT02539745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5694936|NCT03393026|Serotonin Agents|serotonin agents|mesh-ancestor
5694937|NCT03393026|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5694938|NCT03393026|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5694939|NCT03393026|Dopamine Agents|dopamine agents|mesh-ancestor
5694940|NCT03392961|Insulin|insulin|mesh-list
5694941|NCT03392961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5694942|NCT03392961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694943|NCT03392909|Gentamicins|gentamicins|mesh-list
5694944|NCT03392909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5834779|NCT02539641|Hormones|hormones|mesh-list
5834780|NCT02539641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5834781|NCT02539641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834782|NCT02539628|Ropivacaine|ropivacaine|mesh-list
5834783|NCT02539628|Anesthetics, Local|anesthetics, local|mesh-ancestor
5834784|NCT02539628|Anesthetics|anesthetics|mesh-ancestor
5834785|NCT02539628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5834786|NCT02539628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834787|NCT02539628|Sensory System Agents|sensory system agents|mesh-ancestor
5834788|NCT02539628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5834789|NCT02539537|Leucovorin|leucovorin|mesh-list
5834790|NCT02539537|Folic Acid|folic acid|mesh-list
5834791|NCT02539537|Gemcitabine|gemcitabine|mesh-list
5834792|NCT02539537|Fluorouracil|fluorouracil|mesh-list
5834793|NCT02539537|Oxaliplatin|oxaliplatin|mesh-list
5834794|NCT02539537|Irinotecan|irinotecan|mesh-list
5834795|NCT02539537|Levoleucovorin|levoleucovorin|mesh-list
5834796|NCT02539537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5834797|NCT02539537|Antimetabolites|antimetabolites|mesh-ancestor
5834798|NCT02539537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5834799|NCT02539537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5834800|NCT02539537|Antiviral Agents|antiviral agents|mesh-ancestor
5834801|NCT02539537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5834802|NCT02539537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5834803|NCT02539537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5834804|NCT02539537|Immunologic Factors|immunologic factors|mesh-ancestor
5834805|NCT02539537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834806|NCT02539537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5834807|NCT02539537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5834808|NCT02539537|Antidotes|antidotes|mesh-ancestor
5834809|NCT02539537|Protective Agents|protective agents|mesh-ancestor
5834810|NCT02539537|Vitamin B Complex|vitamin b complex|mesh-ancestor
5834811|NCT02539537|Vitamins|vitamins|mesh-ancestor
5834812|NCT02539537|Micronutrients|micronutrients|mesh-ancestor
5834813|NCT02539537|Hematinics|hematinics|mesh-ancestor
5902782|NCT03412643|Antimitotic Agents|antimitotic agents|mesh-ancestor
5902783|NCT03412643|Mitosis Modulators|mitosis modulators|mesh-ancestor
6493556|NCT00614159|Ketamine|ketamine|mesh-list
6493557|NCT00614159|Propofol|propofol|mesh-list
6493558|NCT00614159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6493559|NCT00614159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6493560|NCT00614159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493561|NCT00614159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6493562|NCT00614159|Anesthetics, General|anesthetics, general|mesh-ancestor
5656435|NCT03667937|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
5656436|NCT03667937|Laxatives|laxatives|mesh-ancestor
5656437|NCT03667937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5656438|NCT03667820|Osimertinib|osimertinib|mesh-list
5656439|NCT03667820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5902784|NCT03412643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902785|NCT03412643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5902786|NCT03412643|Immunologic Factors|immunologic factors|mesh-ancestor
5902787|NCT03412643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902788|NCT03412643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5902789|NCT03412643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5902790|NCT03412643|Alkylating Agents|alkylating agents|mesh-ancestor
5902791|NCT03412643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5902792|NCT03412643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5902793|NCT03412643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5902794|NCT03412643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5902795|NCT03412643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5902796|NCT03412643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5902797|NCT03389022|Ketamine|ketamine|mesh-list
5902798|NCT03389022|Analgesics|analgesics|mesh-ancestor
5902799|NCT03389022|Sensory System Agents|sensory system agents|mesh-ancestor
5902800|NCT03389022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5902801|NCT03389022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902802|NCT03389022|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5902803|NCT03389022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5902804|NCT03389022|Anesthetics, General|anesthetics, general|mesh-ancestor
5902805|NCT03389022|Anesthetics|anesthetics|mesh-ancestor
5902806|NCT03389022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6493563|NCT00614159|Anesthetics|anesthetics|mesh-ancestor
5656440|NCT03667820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5656441|NCT03667820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5656442|NCT03667820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656443|NCT03667703|Famotidine|famotidine|mesh-list
5656444|NCT03667703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5656445|NCT03667703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5656446|NCT03667703|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5656447|NCT03667703|Histamine Antagonists|histamine antagonists|mesh-ancestor
5656448|NCT03667703|Histamine Agents|histamine agents|mesh-ancestor
5656449|NCT03667703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5656450|NCT03667703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656451|NCT03667703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656452|NCT03667677|Amlodipine|amlodipine|mesh-list
5656453|NCT03667677|Tandospirone|tandospirone|mesh-list
5656454|NCT03667677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5656455|NCT03667677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5656456|NCT03667677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5656457|NCT03667677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5834814|NCT02539316|SMOFlipid|smoflipid|mesh-list
5834815|NCT02539316|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
5834816|NCT02539316|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5834817|NCT02539316|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5834818|NCT02539199|Misoprostol|misoprostol|mesh-list
5656458|NCT03667677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5656459|NCT03667677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656460|NCT03667677|Vasodilator Agents|vasodilator agents|mesh-ancestor
5656461|NCT03667677|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5656462|NCT03667677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5656463|NCT03667677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5656464|NCT03667677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5656465|NCT03667677|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5656466|NCT03667677|Serotonin Agents|serotonin agents|mesh-ancestor
5656467|NCT03667677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5656468|NCT03667651|Decanoic acid|decanoic acid|mesh-list
5656469|NCT03667651|Antifungal Agents|antifungal agents|mesh-ancestor
5656470|NCT03667651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5656471|NCT03667443|Inositol|inositol|mesh-list
5656472|NCT03667443|Vitamin B Complex|vitamin b complex|mesh-ancestor
5656473|NCT03667443|Vitamins|vitamins|mesh-ancestor
5656474|NCT03667443|Micronutrients|micronutrients|mesh-ancestor
5656475|NCT03667443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656476|NCT03667352|Fentanyl|fentanyl|mesh-list
5656477|NCT03667352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5656478|NCT03667352|Narcotics|narcotics|mesh-ancestor
5656479|NCT03667352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5834819|NCT02539199|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5834820|NCT02539199|Abortifacient Agents|abortifacient agents|mesh-ancestor
5834821|NCT02539199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5834822|NCT02539199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834823|NCT02539199|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5834824|NCT02539199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5834825|NCT02539199|Oxytocics|oxytocics|mesh-ancestor
5834826|NCT02539394|Methylprednisolone|methylprednisolone|mesh-list
5834827|NCT02539394|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5834828|NCT02539394|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5834829|NCT02539394|Prednisolone|prednisolone|mesh-list
5834830|NCT02539394|Prednisolone acetate|prednisolone acetate|mesh-list
5834831|NCT02539394|Hemostatics|hemostatics|mesh-list
5834832|NCT02539394|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5834833|NCT02539394|Prednisolone phosphate|prednisolone phosphate|mesh-list
5834834|NCT02539394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5834835|NCT02539394|Antiemetics|antiemetics|mesh-ancestor
5834836|NCT02539394|Autonomic Agents|autonomic agents|mesh-ancestor
5834837|NCT02539394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5834838|NCT02539394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834839|NCT02539394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5834840|NCT02539394|Glucocorticoids|glucocorticoids|mesh-ancestor
5834841|NCT02539394|Hormones|hormones|mesh-ancestor
5834842|NCT02539394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5834843|NCT02539394|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5834844|NCT02539394|Protective Agents|protective agents|mesh-ancestor
5834845|NCT02539394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5834846|NCT02539394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5834847|NCT02539394|Coagulants|coagulants|mesh-ancestor
5834848|NCT02538926|Prednisone|prednisone|mesh-list
5834849|NCT02538926|Cortisone|cortisone|mesh-list
5656480|NCT03667352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656481|NCT03667352|Analgesics|analgesics|mesh-ancestor
5656482|NCT03667352|Sensory System Agents|sensory system agents|mesh-ancestor
5656483|NCT03667352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5656484|NCT03667352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5656485|NCT03667352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5656486|NCT03667352|Anesthetics, General|anesthetics, general|mesh-ancestor
5834850|NCT02538926|Cyclophosphamide|cyclophosphamide|mesh-list
5834851|NCT02538926|Rituximab|rituximab|mesh-list
5834852|NCT02538926|Doxorubicin|doxorubicin|mesh-list
5834853|NCT02538926|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5834854|NCT02538926|Etoposide|etoposide|mesh-list
5656487|NCT03667352|Anesthetics|anesthetics|mesh-ancestor
5656488|NCT03667326|Aspirin|aspirin|mesh-list
5656489|NCT03667326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5656490|NCT03667326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5656491|NCT03667326|Analgesics|analgesics|mesh-ancestor
5656492|NCT03667326|Sensory System Agents|sensory system agents|mesh-ancestor
5656493|NCT03667326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5656494|NCT03667326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656495|NCT03667326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5656496|NCT03667326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5656497|NCT03667326|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5656498|NCT03667326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5656499|NCT03667326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656500|NCT03667326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5656501|NCT03667326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5656502|NCT03667326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5656503|NCT03667326|Antipyretics|antipyretics|mesh-ancestor
5656504|NCT03667313|Sirolimus|sirolimus|mesh-list
5656505|NCT03667313|Paclitaxel|paclitaxel|mesh-list
5656506|NCT03667313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5656507|NCT03667313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5656508|NCT03667313|Tubulin Modulators|tubulin modulators|mesh-ancestor
5656509|NCT03667313|Antimitotic Agents|antimitotic agents|mesh-ancestor
5656510|NCT03667313|Mitosis Modulators|mitosis modulators|mesh-ancestor
5656511|NCT03667313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656512|NCT03667313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5656513|NCT03667313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5656514|NCT03667313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5656515|NCT03667313|Antifungal Agents|antifungal agents|mesh-ancestor
5834855|NCT02538926|Vincristine|vincristine|mesh-list
5834856|NCT02538926|Etoposide phosphate|etoposide phosphate|mesh-list
5834857|NCT02538926|Imatinib Mesylate|imatinib mesylate|mesh-list
5834858|NCT02538926|Asparaginase|asparaginase|mesh-list
5834859|NCT02538926|Podophyllotoxin|podophyllotoxin|mesh-list
5834860|NCT02538926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5834861|NCT02538926|Antibodies|antibodies|mesh-list
5834862|NCT02538926|Immunoglobulins|immunoglobulins|mesh-list
5834863|NCT02538926|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5834864|NCT02538926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5834865|NCT02538926|Immunologic Factors|immunologic factors|mesh-ancestor
5834866|NCT02538926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834867|NCT02538926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5834868|NCT02538926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5834869|NCT02538926|Alkylating Agents|alkylating agents|mesh-ancestor
5834870|NCT02538926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5834871|NCT02538926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5834872|NCT02538926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5834873|NCT02538926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5834874|NCT02538926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5834875|NCT02538926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5834876|NCT02538926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5834877|NCT02538926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5834878|NCT02538926|Glucocorticoids|glucocorticoids|mesh-ancestor
5834879|NCT02538926|Hormones|hormones|mesh-ancestor
5834880|NCT02538926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5834881|NCT02538926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5834882|NCT02538926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5834883|NCT02538926|Tubulin Modulators|tubulin modulators|mesh-ancestor
5834884|NCT02538926|Antimitotic Agents|antimitotic agents|mesh-ancestor
5834885|NCT02538926|Mitosis Modulators|mitosis modulators|mesh-ancestor
5834886|NCT02538926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5834887|NCT02538926|Keratolytic Agents|keratolytic agents|mesh-ancestor
5834888|NCT02538926|Dermatologic Agents|dermatologic agents|mesh-ancestor
5834889|NCT02538939|Sodium thiosulfate|sodium thiosulfate|mesh-list
5834890|NCT02538939|Antidotes|antidotes|mesh-ancestor
5834891|NCT02538939|Protective Agents|protective agents|mesh-ancestor
5834892|NCT02538939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834893|NCT02538939|Antioxidants|antioxidants|mesh-ancestor
5834894|NCT02538939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5834895|NCT02538939|Antitubercular Agents|antitubercular agents|mesh-ancestor
5834896|NCT02538939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5834897|NCT02538939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5834898|NCT02538939|Chelating Agents|chelating agents|mesh-ancestor
5834899|NCT02538939|Sequestering Agents|sequestering agents|mesh-ancestor
5834900|NCT02538744|Doxazosin|doxazosin|mesh-list
5656516|NCT03667313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5656517|NCT03667313|Immunologic Factors|immunologic factors|mesh-ancestor
5656518|NCT03667313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656519|NCT03667300|Linagliptin|linagliptin|mesh-list
5656520|NCT03667300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5656521|NCT03667300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656522|NCT03667300|Incretins|incretins|mesh-ancestor
5656523|NCT03667300|Hormones|hormones|mesh-ancestor
5656524|NCT03667300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5656525|NCT03667300|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5656526|NCT03667300|Protease Inhibitors|protease inhibitors|mesh-ancestor
5656527|NCT03667300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5656528|NCT03667300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656529|NCT03667235|Glutaral|glutaral|mesh-list
5656530|NCT03667235|Disinfectants|disinfectants|mesh-ancestor
5656531|NCT03667235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5656532|NCT03667222|Minocycline|minocycline|mesh-list
5656533|NCT03667222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5656534|NCT03667222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5656535|NCT03667131|Enalapril|enalapril|mesh-list
5656536|NCT03667131|Enalaprilat|enalaprilat|mesh-list
5656537|NCT03667131|Enzyme Inhibitors|enzyme inhibitors|mesh-list
5656538|NCT03667131|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
5656539|NCT03667131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656540|NCT03667131|Protease Inhibitors|protease inhibitors|mesh-ancestor
5656541|NCT03667131|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5656542|NCT03667079|Vaccines|vaccines|mesh-list
5656543|NCT03667079|Immunologic Factors|immunologic factors|mesh-ancestor
5656544|NCT03667079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656545|NCT03667066|Clopidogrel|clopidogrel|mesh-list
5656546|NCT03667066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5656547|NCT03667066|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5656548|NCT03667066|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5656549|NCT03667066|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5656550|NCT03667066|Purinergic Agents|purinergic agents|mesh-ancestor
5656551|NCT03667066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5656552|NCT03667066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656553|NCT03667066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656554|NCT03667001|Lidocaine|lidocaine|mesh-list
5656555|NCT03667001|Anesthetics, Local|anesthetics, local|mesh-ancestor
5656556|NCT03667001|Anesthetics|anesthetics|mesh-ancestor
5656557|NCT03667001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5656558|NCT03667001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656559|NCT03667001|Sensory System Agents|sensory system agents|mesh-ancestor
5656560|NCT03667001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5656561|NCT03667001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5656562|NCT03667001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5656563|NCT03667001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5656564|NCT03667001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5656565|NCT03667001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656566|NCT03666949|Anesthetics|anesthetics|mesh-list
5656567|NCT03666949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5656568|NCT03666949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656569|NCT03666884|Cyclosporine|cyclosporine|mesh-list
5656570|NCT03666884|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5656571|NCT03666884|Cyclosporins|cyclosporins|mesh-list
5656572|NCT03666884|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5656573|NCT03666884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5656574|NCT03666884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656575|NCT03666884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5656576|NCT03666884|Immunologic Factors|immunologic factors|mesh-ancestor
5656577|NCT03666884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656578|NCT03666884|Antifungal Agents|antifungal agents|mesh-ancestor
5656579|NCT03666884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5656580|NCT03666884|Dermatologic Agents|dermatologic agents|mesh-ancestor
5656581|NCT03666884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5656582|NCT03666884|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5656583|NCT03666715|Paliperidone Palmitate|paliperidone palmitate|mesh-list
5656584|NCT03666715|Antipsychotic Agents|antipsychotic agents|mesh-list
5656585|NCT03666715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5656586|NCT03666715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5834901|NCT02538744|Cocaine|cocaine|mesh-list
5834902|NCT02538744|Modafinil|modafinil|mesh-list
5834903|NCT02538744|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5834904|NCT02538744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834905|NCT02538744|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
5834906|NCT02538744|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5834907|NCT02538744|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5834908|NCT02538744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5834909|NCT02538744|Anesthetics, Local|anesthetics, local|mesh-ancestor
5834910|NCT02538744|Anesthetics|anesthetics|mesh-ancestor
5834911|NCT02538744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5834912|NCT02538744|Sensory System Agents|sensory system agents|mesh-ancestor
5834913|NCT02538744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5834914|NCT02538744|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5834915|NCT02538744|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5834916|NCT02538744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5834917|NCT02538744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5834918|NCT02538744|Dopamine Agents|dopamine agents|mesh-ancestor
5834919|NCT02538744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5834920|NCT02538744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5834921|NCT02538744|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5834922|NCT02538744|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5834923|NCT02538744|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5834924|NCT02538744|Adrenergic Agents|adrenergic agents|mesh-ancestor
5834925|NCT02538718|Ritodrine|ritodrine|mesh-list
5834926|NCT02538718|Sympathomimetics|sympathomimetics|mesh-ancestor
5834927|NCT02538718|Autonomic Agents|autonomic agents|mesh-ancestor
5834928|NCT02538718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5834929|NCT02538718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834930|NCT02538718|Tocolytic Agents|tocolytic agents|mesh-ancestor
5834931|NCT02538718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5834932|NCT02538718|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5834933|NCT02538718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5834934|NCT02538718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5834935|NCT02538718|Adrenergic Agents|adrenergic agents|mesh-ancestor
5834936|NCT02538718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5834937|NCT02538718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656587|NCT03666715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656588|NCT03666715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5656589|NCT03666715|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5656590|NCT03666715|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5656591|NCT03666715|Serotonin Agents|serotonin agents|mesh-ancestor
5656592|NCT03666715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5656593|NCT03666715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656594|NCT03666715|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5656595|NCT03666715|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5656596|NCT03666715|Dopamine Agents|dopamine agents|mesh-ancestor
5656597|NCT03666650|Edoxaban|edoxaban|mesh-list
5656598|NCT03666650|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5834938|NCT02538627|Trametinib|trametinib|mesh-list
5834939|NCT02538627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5834940|NCT02538627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5834941|NCT02538627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5834942|NCT02538627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5834943|NCT02538484|Letrozole|letrozole|mesh-list
5834944|NCT02538484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5834945|NCT02538484|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5834946|NCT02538484|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5834947|NCT02538484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5834948|NCT02538484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5834949|NCT02538484|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5834950|NCT02538484|Hormone Antagonists|hormone antagonists|mesh-ancestor
5834951|NCT02538484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5834952|NCT02538484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834953|NCT02538367|Prucalopride|prucalopride|mesh-list
5834954|NCT02538367|YH12852|yh12852|mesh-list
5834955|NCT02538367|Laxatives|laxatives|mesh-ancestor
5834956|NCT02538367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5834957|NCT02538367|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
5834958|NCT02538367|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5834959|NCT02538367|Serotonin Agents|serotonin agents|mesh-ancestor
5834960|NCT02538367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5834961|NCT02538367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5834962|NCT02538367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834963|NCT02538393|Sorafenib|sorafenib|mesh-list
5834964|NCT02538393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5834965|NCT02538393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5656599|NCT03666650|Antithrombins|antithrombins|mesh-ancestor
5656600|NCT03666650|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5656601|NCT03666650|Protease Inhibitors|protease inhibitors|mesh-ancestor
5656602|NCT03666650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5656603|NCT03666650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656604|NCT03666650|Anticoagulants|anticoagulants|mesh-ancestor
5656605|NCT03666559|Azacitidine|azacitidine|mesh-list
5834966|NCT02538393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5834967|NCT02538393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5834968|NCT02538224|Doxycycline|doxycycline|mesh-list
5834969|NCT02538224|Ketoprofen|ketoprofen|mesh-list
5834970|NCT02538224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5834971|NCT02538224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5834972|NCT02538224|Antimalarials|antimalarials|mesh-ancestor
5834973|NCT02538224|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5834974|NCT02538224|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5834975|NCT02538224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5834976|NCT02538224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5834977|NCT02538224|Analgesics|analgesics|mesh-ancestor
5834978|NCT02538224|Sensory System Agents|sensory system agents|mesh-ancestor
5834979|NCT02538224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5834980|NCT02538224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834981|NCT02538224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5834982|NCT02538224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5834983|NCT02538224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5834984|NCT02538224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5834985|NCT02538224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5834986|NCT02538211|Vaccines|vaccines|mesh-list
5834987|NCT02538211|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5834988|NCT02538211|Immunologic Factors|immunologic factors|mesh-ancestor
5834989|NCT02538211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5834990|NCT02538302|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
5834991|NCT02538302|Oxybutynin|oxybutynin|mesh-list
5834992|NCT02538302|Parasympatholytics|parasympatholytics|mesh-ancestor
5834993|NCT02538302|Autonomic Agents|autonomic agents|mesh-ancestor
5834994|NCT02538302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5834995|NCT02538302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656606|NCT03666559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5656607|NCT03666559|Antimetabolites|antimetabolites|mesh-ancestor
5656608|NCT03666559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5834996|NCT02538302|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5834997|NCT02538302|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5834998|NCT02538302|Cholinergic Agents|cholinergic agents|mesh-ancestor
5834999|NCT02538302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5835000|NCT02538302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835001|NCT02538302|Urological Agents|urological agents|mesh-ancestor
5835002|NCT02538302|Hemostatics|hemostatics|mesh-ancestor
5835003|NCT02538302|Coagulants|coagulants|mesh-ancestor
5835004|NCT02538302|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5835005|NCT02538302|Natriuretic Agents|natriuretic agents|mesh-ancestor
5835006|NCT02538432|Gemcitabine|gemcitabine|mesh-list
5835007|NCT02538432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5835008|NCT02538432|Antimetabolites|antimetabolites|mesh-ancestor
5835009|NCT02538432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835010|NCT02538432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5835011|NCT02538432|Antiviral Agents|antiviral agents|mesh-ancestor
5835012|NCT02538432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5835013|NCT02538432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5835014|NCT02538432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5835015|NCT02538432|Immunologic Factors|immunologic factors|mesh-ancestor
5835016|NCT02538432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835017|NCT02538237|Ibuprofen|ibuprofen|mesh-list
5835018|NCT02538237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5835019|NCT02538237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5835020|NCT02538237|Analgesics|analgesics|mesh-ancestor
5835021|NCT02538237|Sensory System Agents|sensory system agents|mesh-ancestor
5835022|NCT02538237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5835023|NCT02538237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835024|NCT02538237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5835025|NCT02538237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5835026|NCT02538237|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5835027|NCT02538237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5835028|NCT02538237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656609|NCT03666559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5835029|NCT02538198|Lenalidomide|lenalidomide|mesh-list
5835030|NCT02538198|Immunologic Factors|immunologic factors|mesh-ancestor
5835031|NCT02538198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835032|NCT02538198|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5835033|NCT02538198|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5835034|NCT02538198|Growth Substances|growth substances|mesh-ancestor
5835035|NCT02538198|Growth Inhibitors|growth inhibitors|mesh-ancestor
5835036|NCT02538198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5835037|NCT02538172|Valganciclovir|valganciclovir|mesh-list
5835038|NCT02538172|Antiviral Agents|antiviral agents|mesh-ancestor
5835039|NCT02538172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5835040|NCT02538003|Delpazolid|delpazolid|mesh-list
5835041|NCT02538003|Oxazolidinones|oxazolidinones|mesh-list
5835042|NCT02538003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5835043|NCT02538003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5835044|NCT02538003|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5835045|NCT02538003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5835046|NCT02538003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835047|NCT02538146|Acetylcarnitine|acetylcarnitine|mesh-list
5835048|NCT02538146|Vitamin B Complex|vitamin b complex|mesh-ancestor
5835049|NCT02538146|Vitamins|vitamins|mesh-ancestor
5835050|NCT02538146|Micronutrients|micronutrients|mesh-ancestor
5835051|NCT02538146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835052|NCT02538146|Nootropic Agents|nootropic agents|mesh-ancestor
5835053|NCT02537964|Chlorhexidine|chlorhexidine|mesh-list
5835054|NCT02537964|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5835055|NCT02537964|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5835056|NCT02537964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5835057|NCT02537964|Disinfectants|disinfectants|mesh-ancestor
5835058|NCT02537964|Dermatologic Agents|dermatologic agents|mesh-ancestor
5835059|NCT02538081|Risperidone|risperidone|mesh-list
5835060|NCT02538081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5835061|NCT02538081|Serotonin Agents|serotonin agents|mesh-ancestor
5835062|NCT02538081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5835063|NCT02538081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835064|NCT02538081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835065|NCT02538081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5835066|NCT02538081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5835067|NCT02538081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5835068|NCT02538081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5835069|NCT02538081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5835070|NCT02538081|Dopamine Agents|dopamine agents|mesh-ancestor
5835071|NCT02537860|Fentanyl|fentanyl|mesh-list
5835072|NCT02537860|Bupivacaine|bupivacaine|mesh-list
5835073|NCT02537860|Anesthetics, Local|anesthetics, local|mesh-ancestor
5835074|NCT02537860|Anesthetics|anesthetics|mesh-ancestor
5835075|NCT02537860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5835076|NCT02537860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835077|NCT02537860|Sensory System Agents|sensory system agents|mesh-ancestor
5835078|NCT02537860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5835079|NCT02537860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5835080|NCT02537860|Narcotics|narcotics|mesh-ancestor
5835081|NCT02537860|Analgesics|analgesics|mesh-ancestor
5835082|NCT02537860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5835083|NCT02537860|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5656610|NCT03666559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5656611|NCT03666546|Methamphetamine|methamphetamine|mesh-list
5656612|NCT03666546|Lactulose|lactulose|mesh-list
5656613|NCT03666546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5656614|NCT03666546|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5656615|NCT03666546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656616|NCT03666546|Sympathomimetics|sympathomimetics|mesh-ancestor
5656617|NCT03666546|Autonomic Agents|autonomic agents|mesh-ancestor
5656618|NCT03666546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5656619|NCT03666546|Dopamine Agents|dopamine agents|mesh-ancestor
5656620|NCT03666546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5656621|NCT03666546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656622|NCT03666546|Adrenergic Agents|adrenergic agents|mesh-ancestor
5656623|NCT03666546|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5656624|NCT03666546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5656625|NCT03666546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5656626|NCT03666546|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5835084|NCT02537860|Anesthetics, General|anesthetics, general|mesh-ancestor
5835085|NCT02537847|Ertapenem|ertapenem|mesh-list
5835086|NCT02537847|Fluoroquinolones|fluoroquinolones|mesh-list
5835087|NCT02537847|Sitafloxacin|sitafloxacin|mesh-list
5835088|NCT02537847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5835089|NCT02537847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6211850|NCT02178241|Mitosis Modulators|mitosis modulators|mesh-ancestor
5835090|NCT02537847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5835091|NCT02537847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5835092|NCT02537847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835093|NCT02537847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5835094|NCT02537847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5835095|NCT02537847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5835096|NCT02537925|Celecoxib|celecoxib|mesh-list
5835097|NCT02537925|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
5835098|NCT02537925|Nedaplatin|nedaplatin|mesh-list
5835099|NCT02537925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5835100|NCT02537925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5835101|NCT02537925|Analgesics|analgesics|mesh-ancestor
5835102|NCT02537925|Sensory System Agents|sensory system agents|mesh-ancestor
5835103|NCT02537925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5835104|NCT02537925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835105|NCT02537925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5835106|NCT02537925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5835107|NCT02537925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5835108|NCT02537925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5835109|NCT02537925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835110|NCT02537925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5835111|NCT02537834|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
5835112|NCT02537834|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5835113|NCT02537834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835114|NCT02537834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5835115|NCT02537834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902807|NCT03389022|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5902808|NCT03389022|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5902809|NCT03389022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5902810|NCT03389022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656627|NCT03666494|Fentanyl|fentanyl|mesh-list
5656628|NCT03666494|Ketamine|ketamine|mesh-list
5656629|NCT03666494|Propofol|propofol|mesh-list
5656630|NCT03666494|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5656631|NCT03666494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5656632|NCT03666494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656633|NCT03666494|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5656634|NCT03666494|Anesthetics, General|anesthetics, general|mesh-ancestor
5656635|NCT03666494|Anesthetics|anesthetics|mesh-ancestor
5656636|NCT03666494|Analgesics|analgesics|mesh-ancestor
5656637|NCT03666494|Sensory System Agents|sensory system agents|mesh-ancestor
5656638|NCT03666494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5656639|NCT03666494|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5656640|NCT03666494|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5902811|NCT03381183|Durvalumab|durvalumab|mesh-list
5902812|NCT03381183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5902813|NCT03381183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5902814|NCT03344159|Spironolactone|spironolactone|mesh-list
5902815|NCT03344159|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5902816|NCT03344159|Hormone Antagonists|hormone antagonists|mesh-ancestor
5902817|NCT03344159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5902818|NCT03344159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902819|NCT03344159|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5902820|NCT03344159|Diuretics|diuretics|mesh-ancestor
5902821|NCT03344159|Natriuretic Agents|natriuretic agents|mesh-ancestor
5902822|NCT03336333|Rituximab|rituximab|mesh-list
5902823|NCT03336333|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5902824|NCT03336333|Venetoclax|venetoclax|mesh-list
5902825|NCT03336333|Zanubrutinib|zanubrutinib|mesh-list
5902826|NCT03336333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5902827|NCT03336333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5902828|NCT03336333|Immunologic Factors|immunologic factors|mesh-ancestor
5902829|NCT03336333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902830|NCT03336333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5656641|NCT03666494|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5656642|NCT03666494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5656643|NCT03666494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656644|NCT03666494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5656645|NCT03666494|Narcotics|narcotics|mesh-ancestor
5656646|NCT03666494|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5694945|NCT03392909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5656647|NCT03666390|Midazolam|midazolam|mesh-list
5656648|NCT03666390|Ketamine|ketamine|mesh-list
5656649|NCT03666390|Analgesics|analgesics|mesh-ancestor
5656650|NCT03666390|Sensory System Agents|sensory system agents|mesh-ancestor
5656651|NCT03666390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5656652|NCT03666390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656653|NCT03666390|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5656654|NCT03666390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5656655|NCT03666390|Anesthetics, General|anesthetics, general|mesh-ancestor
5656656|NCT03666390|Anesthetics|anesthetics|mesh-ancestor
5656657|NCT03666390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5656658|NCT03666390|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5656659|NCT03666390|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5656660|NCT03666390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5656661|NCT03666390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656662|NCT03666390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5656663|NCT03666390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5656664|NCT03666390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5656665|NCT03666390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5656666|NCT03666390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5656667|NCT03666390|GABA Modulators|gaba modulators|mesh-ancestor
5656668|NCT03666390|GABA Agents|gaba agents|mesh-ancestor
5656669|NCT03666351|Losartan|losartan|mesh-list
5656670|NCT03666351|Amlodipine|amlodipine|mesh-list
5656671|NCT03666351|Chlorthalidone|chlorthalidone|mesh-list
5656672|NCT03666351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5835116|NCT02537509|Cholecalciferol|cholecalciferol|mesh-list
5835117|NCT02537509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5835118|NCT02537509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835119|NCT02537509|Vitamins|vitamins|mesh-ancestor
5835120|NCT02537509|Micronutrients|micronutrients|mesh-ancestor
5835121|NCT02537509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5656673|NCT03666351|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5656674|NCT03666351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5656675|NCT03666351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656676|NCT03666351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5656677|NCT03666351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835122|NCT02537691|Theophylline|theophylline|mesh-list
5835123|NCT02537691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5835124|NCT02537691|Autonomic Agents|autonomic agents|mesh-ancestor
5835125|NCT02537691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5835126|NCT02537691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835127|NCT02537691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5835128|NCT02537691|Respiratory System Agents|respiratory system agents|mesh-ancestor
5835129|NCT02537691|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5835130|NCT02537691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5835131|NCT02537691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835132|NCT02537691|Vasodilator Agents|vasodilator agents|mesh-ancestor
5835133|NCT02537691|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5835134|NCT02537691|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5835135|NCT02537691|Purinergic Agents|purinergic agents|mesh-ancestor
5835136|NCT02537691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5835137|NCT02537457|Rivaroxaban|rivaroxaban|mesh-list
5835138|NCT02537457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5835139|NCT02537457|Antithrombins|antithrombins|mesh-ancestor
5835140|NCT02537457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5835141|NCT02537457|Protease Inhibitors|protease inhibitors|mesh-ancestor
5835142|NCT02537457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5835143|NCT02537457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835144|NCT02537457|Anticoagulants|anticoagulants|mesh-ancestor
5835145|NCT02537353|Epinephrine|epinephrine|mesh-list
5835146|NCT02537353|Racepinephrine|racepinephrine|mesh-list
5835147|NCT02537353|Epinephryl borate|epinephryl borate|mesh-list
5835148|NCT02537353|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5835149|NCT02537353|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5835150|NCT02537353|Adrenergic Agents|adrenergic agents|mesh-ancestor
5835151|NCT02537353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5835152|NCT02537353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835153|NCT02537353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835154|NCT02537353|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5835155|NCT02537353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5835156|NCT02537353|Autonomic Agents|autonomic agents|mesh-ancestor
5656678|NCT03666351|Vasodilator Agents|vasodilator agents|mesh-ancestor
5835157|NCT02537353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5835158|NCT02537353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5835159|NCT02537353|Respiratory System Agents|respiratory system agents|mesh-ancestor
5835160|NCT02537353|Mydriatics|mydriatics|mesh-ancestor
5835161|NCT02537353|Sympathomimetics|sympathomimetics|mesh-ancestor
5835162|NCT02537353|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5835163|NCT02537470|Remogliflozin etabonate|remogliflozin etabonate|mesh-list
5835164|NCT02537470|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5835165|NCT02537470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835166|NCT02537470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5835167|NCT02537470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835168|NCT02537561|Gemcitabine|gemcitabine|mesh-list
5835169|NCT02537561|Cisplatin|cisplatin|mesh-list
5835170|NCT02537561|Talazoparib|talazoparib|mesh-list
5835171|NCT02537561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5835172|NCT02537561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5835173|NCT02537561|Antimetabolites|antimetabolites|mesh-ancestor
5835174|NCT02537561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835175|NCT02537561|Antiviral Agents|antiviral agents|mesh-ancestor
5835176|NCT02537561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5835177|NCT02537561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5835178|NCT02537561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5835179|NCT02537561|Immunologic Factors|immunologic factors|mesh-ancestor
5835180|NCT02537561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835181|NCT02537561|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5835182|NCT02537600|Vemurafenib|vemurafenib|mesh-list
5835183|NCT02537600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5835184|NCT02537600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5835185|NCT02537600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5835186|NCT02537600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835187|NCT02537379|Ribavirin|ribavirin|mesh-list
5835188|NCT02537379|Antimetabolites|antimetabolites|mesh-ancestor
5835189|NCT02537379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835190|NCT02537379|Antiviral Agents|antiviral agents|mesh-ancestor
5835191|NCT02537379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5835192|NCT02537366|Dexmedetomidine|dexmedetomidine|mesh-list
5835193|NCT02537366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5835194|NCT02537366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5835195|NCT02537366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835196|NCT02537366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5835197|NCT02537366|Analgesics|analgesics|mesh-ancestor
5835198|NCT02537366|Sensory System Agents|sensory system agents|mesh-ancestor
5835199|NCT02537366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5835200|NCT02537366|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5835201|NCT02537366|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5835202|NCT02537366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5835203|NCT02537366|Adrenergic Agents|adrenergic agents|mesh-ancestor
5835204|NCT02537366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5835205|NCT02537366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835206|NCT02537392|Folic Acid|folic acid|mesh-list
5835207|NCT02537392|Vitamin B Complex|vitamin b complex|mesh-list
5835208|NCT02537392|Vitamins|vitamins|mesh-ancestor
5656679|NCT03666351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5656680|NCT03666351|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5656681|NCT03666351|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5656682|NCT03666351|Diuretics|diuretics|mesh-ancestor
5656683|NCT03666351|Natriuretic Agents|natriuretic agents|mesh-ancestor
5656684|NCT03666351|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5656685|NCT03666325|Pembrolizumab|pembrolizumab|mesh-list
5656686|NCT03666325|Cetuximab|cetuximab|mesh-list
5656687|NCT03666325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5656688|NCT03666325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5656689|NCT03666299|Lidocaine|lidocaine|mesh-list
5656690|NCT03666299|Anesthetics, Local|anesthetics, local|mesh-ancestor
5656691|NCT03666299|Anesthetics|anesthetics|mesh-ancestor
5656692|NCT03666299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5656693|NCT03666299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656694|NCT03666299|Sensory System Agents|sensory system agents|mesh-ancestor
5656695|NCT03666299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5656696|NCT03666299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5656697|NCT03666299|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5656698|NCT03666299|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5656699|NCT03666299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5656700|NCT03666299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835209|NCT02537392|Micronutrients|micronutrients|mesh-ancestor
5835210|NCT02537392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835211|NCT02537392|Hematinics|hematinics|mesh-ancestor
5835212|NCT02537249|Dexmedetomidine|dexmedetomidine|mesh-list
5835213|NCT02537249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5835214|NCT02537249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5835215|NCT02537249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835216|NCT02537249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5835217|NCT02537249|Analgesics|analgesics|mesh-ancestor
5835218|NCT02537249|Sensory System Agents|sensory system agents|mesh-ancestor
5835219|NCT02537249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5835220|NCT02537249|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5835221|NCT02537249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5835222|NCT02537249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5835223|NCT02537249|Adrenergic Agents|adrenergic agents|mesh-ancestor
5835224|NCT02537249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5835225|NCT02537249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835226|NCT02537314|Benzocaine|benzocaine|mesh-list
5835227|NCT02537314|Anesthetics, Local|anesthetics, local|mesh-ancestor
5835228|NCT02537314|Anesthetics|anesthetics|mesh-ancestor
5835229|NCT02537314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5835230|NCT02537314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835231|NCT02537314|Sensory System Agents|sensory system agents|mesh-ancestor
5835232|NCT02537314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5835233|NCT02537210|Mesalamine|mesalamine|mesh-list
5835234|NCT02537210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5835235|NCT02537210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5835236|NCT02537210|Analgesics|analgesics|mesh-ancestor
5835237|NCT02537210|Sensory System Agents|sensory system agents|mesh-ancestor
5835238|NCT02537210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5835239|NCT02537210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835240|NCT02537210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5835241|NCT02537210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5835242|NCT02537158|Sorafenib|sorafenib|mesh-list
5835243|NCT02537158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5835244|NCT02537158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5835245|NCT02537158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5835246|NCT02537158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835247|NCT02537223|Cisplatin|cisplatin|mesh-list
5835248|NCT02537223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5835249|NCT02537197|Naltrexone|naltrexone|mesh-list
5835250|NCT02537197|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5835251|NCT02537197|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5835252|NCT02537197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493564|NCT00614159|Analgesics|analgesics|mesh-ancestor
6493565|NCT00614159|Sensory System Agents|sensory system agents|mesh-ancestor
6493566|NCT00614159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6493567|NCT00614159|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6493568|NCT00614159|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5835253|NCT02537197|Sensory System Agents|sensory system agents|mesh-ancestor
5835254|NCT02537197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5835255|NCT02537171|Apatinib|apatinib|mesh-list
5835256|NCT02537171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5835257|NCT02537171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5835258|NCT02537171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5835259|NCT02537171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835260|NCT02537288|Moxifloxacin|moxifloxacin|mesh-list
5835261|NCT02537288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5835262|NCT02537288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5835263|NCT02537288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5835264|NCT02537288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5835265|NCT02537288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6493569|NCT00614159|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5656701|NCT03666221|Nimotuzumab|nimotuzumab|mesh-list
5656702|NCT03666221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5656703|NCT03666221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5656704|NCT03666208|Sirolimus|sirolimus|mesh-list
5656705|NCT03666208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5656706|NCT03666208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5656707|NCT03666208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5656708|NCT03666208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5656709|NCT03666208|Antifungal Agents|antifungal agents|mesh-ancestor
5656710|NCT03666208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5656711|NCT03666208|Immunologic Factors|immunologic factors|mesh-ancestor
5656712|NCT03666208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656713|NCT03666195|Titanium dioxide|titanium dioxide|mesh-list
5656714|NCT03666195|Sunscreening Agents|sunscreening agents|mesh-ancestor
5835266|NCT02537288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835267|NCT02537288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5835268|NCT02537080|Nimodipine|nimodipine|mesh-list
5835269|NCT02537080|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5835270|NCT02537080|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5835271|NCT02537080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5835272|NCT02537080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835273|NCT02537080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5835274|NCT02537080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835275|NCT02537080|Vasodilator Agents|vasodilator agents|mesh-ancestor
5656715|NCT03666195|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5656716|NCT03666195|Protective Agents|protective agents|mesh-ancestor
5656717|NCT03666195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656718|NCT03666195|Dermatologic Agents|dermatologic agents|mesh-ancestor
5656719|NCT03666195|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5656720|NCT03666065|Insulin|insulin|mesh-list
5656721|NCT03666065|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5656722|NCT03666065|Insulin Aspart|insulin aspart|mesh-list
5656723|NCT03666065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5656724|NCT03666065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656725|NCT03666000|Cyclophosphamide|cyclophosphamide|mesh-list
5656726|NCT03666000|Fludarabine|fludarabine|mesh-list
5656727|NCT03666000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5656728|NCT03666000|Immunologic Factors|immunologic factors|mesh-ancestor
5656729|NCT03666000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656730|NCT03666000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5656731|NCT03666000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5835276|NCT02537405|Rivaroxaban|rivaroxaban|mesh-list
5835277|NCT02537405|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5835278|NCT02537405|Antithrombins|antithrombins|mesh-ancestor
5835279|NCT02537405|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5835280|NCT02537405|Protease Inhibitors|protease inhibitors|mesh-ancestor
5835281|NCT02537405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5835282|NCT02537405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835283|NCT02537405|Anticoagulants|anticoagulants|mesh-ancestor
5835284|NCT02537054|Aflibercept|aflibercept|mesh-list
5835285|NCT02537054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5835286|NCT02537054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5835287|NCT02537054|Growth Substances|growth substances|mesh-ancestor
5835288|NCT02537054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835289|NCT02537054|Growth Inhibitors|growth inhibitors|mesh-ancestor
5835290|NCT02537054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5835291|NCT02536989|Omeprazole|omeprazole|mesh-list
5835292|NCT02536989|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5835293|NCT02536989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5835294|NCT02536989|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5835295|NCT02536989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5835296|NCT02536989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835297|NCT02536859|Insulin|insulin|mesh-list
5835298|NCT02536859|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5835299|NCT02536859|Insulin Glargine|insulin glargine|mesh-list
5835300|NCT02536859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5835301|NCT02536859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835302|NCT02536937|Eliglustat|eliglustat|mesh-list
5835303|NCT02536937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5835304|NCT02536937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835305|NCT02536807|Hyaluronic Acid|hyaluronic acid|mesh-list
5835306|NCT02536807|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5835307|NCT02536807|Immunologic Factors|immunologic factors|mesh-ancestor
5835308|NCT02536807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835309|NCT02536807|Viscosupplements|viscosupplements|mesh-ancestor
5835310|NCT02536807|Protective Agents|protective agents|mesh-ancestor
5835311|NCT02536690|Midazolam|midazolam|mesh-list
5835312|NCT02536690|Remifentanil|remifentanil|mesh-list
5835313|NCT02536690|Propofol|propofol|mesh-list
5835314|NCT02536690|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5835315|NCT02536690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5835316|NCT02536690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835317|NCT02536690|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5656732|NCT03666000|Alkylating Agents|alkylating agents|mesh-ancestor
5656733|NCT03666000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656734|NCT03666000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5656735|NCT03666000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5656736|NCT03665779|Pyridoxine|pyridoxine|mesh-list
5656737|NCT03665779|Isosorbide|isosorbide|mesh-list
5656738|NCT03665779|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
5656739|NCT03665779|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
5656740|NCT03665779|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5656741|NCT03665779|Diuretics|diuretics|mesh-ancestor
5656742|NCT03665779|Natriuretic Agents|natriuretic agents|mesh-ancestor
5656743|NCT03665779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656744|NCT03665779|Vasodilator Agents|vasodilator agents|mesh-ancestor
5835318|NCT02536690|Anesthetics, General|anesthetics, general|mesh-ancestor
5835319|NCT02536690|Anesthetics|anesthetics|mesh-ancestor
5835320|NCT02536690|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5835321|NCT02536690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5835322|NCT02536690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5835323|NCT02536690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5835324|NCT02536690|GABA Modulators|gaba modulators|mesh-ancestor
5835325|NCT02536690|GABA Agents|gaba agents|mesh-ancestor
5835326|NCT02536690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5835327|NCT02536690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835328|NCT02536690|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5835329|NCT02536690|Narcotics|narcotics|mesh-ancestor
5835330|NCT02536690|Analgesics|analgesics|mesh-ancestor
5835331|NCT02536690|Sensory System Agents|sensory system agents|mesh-ancestor
5835332|NCT02536690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5835333|NCT02536911|Eliglustat|eliglustat|mesh-list
5835334|NCT02536911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5835335|NCT02536911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835336|NCT02536742|Fulvestrant|fulvestrant|mesh-list
5835337|NCT02536742|Palbociclib|palbociclib|mesh-list
5835338|NCT02536742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5835339|NCT02536742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5835340|NCT02536742|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5835341|NCT02536742|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5835342|NCT02536742|Hormone Antagonists|hormone antagonists|mesh-ancestor
5835343|NCT02536742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5835344|NCT02536742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835345|NCT02536742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5835346|NCT02536742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5835347|NCT02536742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835348|NCT02536755|Eliglustat|eliglustat|mesh-list
5835349|NCT02536755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5835350|NCT02536755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835351|NCT02536872|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5835352|NCT02536872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5835353|NCT02536495|Docetaxel|docetaxel|mesh-list
5835354|NCT02536495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5835355|NCT02536495|Tubulin Modulators|tubulin modulators|mesh-ancestor
5835356|NCT02536495|Antimitotic Agents|antimitotic agents|mesh-ancestor
5835357|NCT02536495|Mitosis Modulators|mitosis modulators|mesh-ancestor
5835358|NCT02536495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835359|NCT02536417|Melatonin|melatonin|mesh-list
5835360|NCT02536417|Antioxidants|antioxidants|mesh-ancestor
5835361|NCT02536417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835362|NCT02536417|Protective Agents|protective agents|mesh-ancestor
5835363|NCT02536417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835364|NCT02536417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5835365|NCT02536209|Oxycodone|oxycodone|mesh-list
5835366|NCT02536209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5835367|NCT02536209|Narcotics|narcotics|mesh-ancestor
5835368|NCT02536209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5835369|NCT02536209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835370|NCT02536209|Analgesics|analgesics|mesh-ancestor
5835371|NCT02536209|Sensory System Agents|sensory system agents|mesh-ancestor
5835372|NCT02536209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5835373|NCT02536430|Ketorolac|ketorolac|mesh-list
6211851|NCT02178540|Tobramycin|tobramycin|mesh-list
5656745|NCT03665779|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5656746|NCT03665779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656747|NCT03665779|Vitamin B Complex|vitamin b complex|mesh-ancestor
5656748|NCT03665779|Vitamins|vitamins|mesh-ancestor
5656749|NCT03665779|Micronutrients|micronutrients|mesh-ancestor
5656750|NCT03665766|Cycloserine|cycloserine|mesh-list
5656751|NCT03665766|Tacrolimus|tacrolimus|mesh-list
5656752|NCT03665766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5656753|NCT03665766|Immunologic Factors|immunologic factors|mesh-ancestor
5656754|NCT03665766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835374|NCT02536430|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
5835375|NCT02536430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5835376|NCT02536430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5835377|NCT02536430|Analgesics|analgesics|mesh-ancestor
5835378|NCT02536430|Sensory System Agents|sensory system agents|mesh-ancestor
5835379|NCT02536430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5835380|NCT02536430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835381|NCT02536430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5835382|NCT02536430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5835383|NCT02536430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5835384|NCT02536430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5835385|NCT02536430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835386|NCT02536352|Vitamins|vitamins|mesh-list
5835387|NCT02536352|Fluorides|fluorides|mesh-list
5835388|NCT02536352|Micronutrients|micronutrients|mesh-ancestor
5835389|NCT02536352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835390|NCT02536352|Cariostatic Agents|cariostatic agents|mesh-ancestor
5835391|NCT02536352|Protective Agents|protective agents|mesh-ancestor
5902831|NCT03336333|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5902832|NCT03336333|Alkylating Agents|alkylating agents|mesh-ancestor
5902833|NCT03336333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902834|NCT03336333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5902835|NCT03336333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5902836|NCT03319459|Trastuzumab|trastuzumab|mesh-list
5656755|NCT03665766|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5656756|NCT03665766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5656757|NCT03665766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656758|NCT03665766|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5656759|NCT03665766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5656760|NCT03665766|Renal Agents|renal agents|mesh-ancestor
5656761|NCT03665766|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5656762|NCT03665766|Antitubercular Agents|antitubercular agents|mesh-ancestor
5656763|NCT03665766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5656764|NCT03665766|Antimetabolites|antimetabolites|mesh-ancestor
5656765|NCT03665753|Ketorolac|ketorolac|mesh-list
5656766|NCT03665753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5656767|NCT03665753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5656768|NCT03665753|Analgesics|analgesics|mesh-ancestor
5656769|NCT03665753|Sensory System Agents|sensory system agents|mesh-ancestor
5902837|NCT03319459|Cetuximab|cetuximab|mesh-list
5902838|NCT03319459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5902839|NCT03319459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5902840|NCT03318874|Hyaluronic Acid|hyaluronic acid|mesh-list
5902841|NCT03318874|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5902842|NCT03318874|Immunologic Factors|immunologic factors|mesh-ancestor
5902843|NCT03318874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902844|NCT03318874|Viscosupplements|viscosupplements|mesh-ancestor
5902845|NCT03318874|Protective Agents|protective agents|mesh-ancestor
5902846|NCT03269136|Thalidomide|thalidomide|mesh-list
5902847|NCT03269136|Dexamethasone|dexamethasone|mesh-list
5902848|NCT03269136|Dexamethasone acetate|dexamethasone acetate|mesh-list
5902849|NCT03269136|Lenalidomide|lenalidomide|mesh-list
5902850|NCT03269136|Pomalidomide|pomalidomide|mesh-list
5902851|NCT03269136|Antibodies|antibodies|mesh-list
5902852|NCT03269136|Immunoglobulins|immunoglobulins|mesh-list
5902853|NCT03269136|Antibodies, Bispecific|antibodies, bispecific|mesh-list
5902854|NCT03269136|BB 1101|bb 1101|mesh-list
5902855|NCT03269136|Immunologic Factors|immunologic factors|mesh-ancestor
5902856|NCT03269136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902857|NCT03269136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5902858|NCT03269136|Antiemetics|antiemetics|mesh-ancestor
5902859|NCT03269136|Autonomic Agents|autonomic agents|mesh-ancestor
5902860|NCT03269136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5902861|NCT03269136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5902862|NCT03269136|Glucocorticoids|glucocorticoids|mesh-ancestor
5902863|NCT03269136|Hormones|hormones|mesh-ancestor
5902864|NCT03269136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5902865|NCT03269136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5902866|NCT03269136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5902867|NCT03269136|Protease Inhibitors|protease inhibitors|mesh-ancestor
5902868|NCT03269136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5902869|NCT03269136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902870|NCT03269136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5902871|NCT03269136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5902872|NCT03269136|Growth Substances|growth substances|mesh-ancestor
5902873|NCT03269136|Growth Inhibitors|growth inhibitors|mesh-ancestor
5656770|NCT03665753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5902874|NCT03269136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5902875|NCT03269136|Leprostatic Agents|leprostatic agents|mesh-ancestor
5902876|NCT03269136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5835392|NCT02535988|Thymalfasin|thymalfasin|mesh-list
5656771|NCT03665753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656772|NCT03665753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5656773|NCT03665753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5656774|NCT03665753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5656775|NCT03665753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5656776|NCT03665753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656777|NCT03665740|Resveratrol|resveratrol|mesh-list
5656778|NCT03665740|Antioxidants|antioxidants|mesh-ancestor
5656779|NCT03665740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656780|NCT03665740|Protective Agents|protective agents|mesh-ancestor
5656781|NCT03665740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656782|NCT03665740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5656783|NCT03665740|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5656784|NCT03665610|Ozanimod|ozanimod|mesh-list
5835393|NCT02535988|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5835394|NCT02535988|Immunologic Factors|immunologic factors|mesh-ancestor
5835395|NCT02535988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835396|NCT02535910|Vitamin D|vitamin d|mesh-list
5835397|NCT02535910|Cholecalciferol|cholecalciferol|mesh-list
5835398|NCT02535910|Calcifediol|calcifediol|mesh-list
5835399|NCT02535910|Vitamins|vitamins|mesh-ancestor
5835400|NCT02535910|Micronutrients|micronutrients|mesh-ancestor
5835401|NCT02535910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835402|NCT02535910|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5835403|NCT02535910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5835404|NCT02535975|Metformin|metformin|mesh-list
5835405|NCT02535975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5835406|NCT02535975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835407|NCT02536014|Dexmedetomidine|dexmedetomidine|mesh-list
5835408|NCT02536014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5835409|NCT02536014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5835410|NCT02536014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835411|NCT02536014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5835412|NCT02536014|Analgesics|analgesics|mesh-ancestor
5835413|NCT02536014|Sensory System Agents|sensory system agents|mesh-ancestor
5835414|NCT02536014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5835415|NCT02536014|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5835416|NCT02536014|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5835417|NCT02536014|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5835418|NCT02536014|Adrenergic Agents|adrenergic agents|mesh-ancestor
5835419|NCT02536014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5835420|NCT02536014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835421|NCT02535767|Primaquine|primaquine|mesh-list
5835422|NCT02535767|Antimalarials|antimalarials|mesh-ancestor
5835423|NCT02535767|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5835424|NCT02535767|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5835425|NCT02535767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5835426|NCT02535936|Anesthetics|anesthetics|mesh-list
5835427|NCT02535936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5835428|NCT02535936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835429|NCT02535832|Pioglitazone|pioglitazone|mesh-list
5835430|NCT02535832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5835431|NCT02535832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835432|NCT02535689|Tofacitinib|tofacitinib|mesh-list
5835433|NCT02535689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5835434|NCT02535689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5835435|NCT02535689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835436|NCT02535533|Selenium|selenium|mesh-list
5835437|NCT02535533|Axitinib|axitinib|mesh-list
5835438|NCT02535533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5835439|NCT02535533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5835440|NCT02535533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5835441|NCT02535533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835442|NCT02535533|Antioxidants|antioxidants|mesh-ancestor
5835443|NCT02535533|Protective Agents|protective agents|mesh-ancestor
5835444|NCT02535533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835445|NCT02535533|Trace Elements|trace elements|mesh-ancestor
5835446|NCT02535533|Micronutrients|micronutrients|mesh-ancestor
5835447|NCT02535650|Tipifarnib|tipifarnib|mesh-list
5835448|NCT02535650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5835449|NCT02535351|Sunitinib|sunitinib|mesh-list
5656785|NCT03665610|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5656786|NCT03665610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835450|NCT02535351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5835451|NCT02535351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5835452|NCT02535351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5835453|NCT02535351|Growth Substances|growth substances|mesh-ancestor
5835454|NCT02535351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835455|NCT02535351|Growth Inhibitors|growth inhibitors|mesh-ancestor
5835456|NCT02535351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5835457|NCT02535351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5835458|NCT02535351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835459|NCT02535299|Metformin|metformin|mesh-list
5835460|NCT02535299|Liraglutide|liraglutide|mesh-list
5835461|NCT02535299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5835462|NCT02535299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835463|NCT02535299|Incretins|incretins|mesh-ancestor
5835464|NCT02535299|Hormones|hormones|mesh-ancestor
5835465|NCT02535299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5835466|NCT02535273|Lidocaine|lidocaine|mesh-list
5835467|NCT02535273|Dexmedetomidine|dexmedetomidine|mesh-list
5835468|NCT02535273|Anesthetics, Local|anesthetics, local|mesh-ancestor
5835469|NCT02535273|Anesthetics|anesthetics|mesh-ancestor
5835470|NCT02535273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5835471|NCT02535273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835472|NCT02535273|Sensory System Agents|sensory system agents|mesh-ancestor
5835473|NCT02535273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5835474|NCT02535273|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5835475|NCT02535273|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5835476|NCT02535273|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5835477|NCT02535273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5835478|NCT02535273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835479|NCT02535273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5835480|NCT02535273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5835481|NCT02535273|Analgesics|analgesics|mesh-ancestor
5835482|NCT02535273|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5835483|NCT02535273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5656787|NCT03665610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5656788|NCT03665610|Immunologic Factors|immunologic factors|mesh-ancestor
5656789|NCT03665610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835484|NCT02535273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5835485|NCT02535273|Adrenergic Agents|adrenergic agents|mesh-ancestor
5835486|NCT02535273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5835487|NCT02535156|Risperidone|risperidone|mesh-list
5835488|NCT02535156|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5835489|NCT02535156|Serotonin Agents|serotonin agents|mesh-ancestor
5835490|NCT02535156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5835491|NCT02535156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835492|NCT02535156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835493|NCT02535156|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5835494|NCT02535156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5835495|NCT02535156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5835496|NCT02535156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5835497|NCT02535156|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5835498|NCT02535156|Dopamine Agents|dopamine agents|mesh-ancestor
5835499|NCT02535052|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5835500|NCT02535052|Immunologic Factors|immunologic factors|mesh-ancestor
5835501|NCT02535052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835502|NCT02535247|Pembrolizumab|pembrolizumab|mesh-list
5835503|NCT02535247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5835504|NCT02535247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5835505|NCT02535104|Ranpirnase|ranpirnase|mesh-list
5835506|NCT02535104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5835507|NCT02535104|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5835508|NCT02535104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5835509|NCT02535104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835510|NCT02535130|Amikacin|amikacin|mesh-list
5835511|NCT02535130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5835512|NCT02535130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5835513|NCT02534961|Cefazolin|cefazolin|mesh-list
5835514|NCT02534961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5835515|NCT02534961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6211852|NCT02178540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6211853|NCT02178540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6211854|NCT02178553|Bupivacaine|bupivacaine|mesh-list
5656793|NCT03665545|Poly I-C|poly i-c|mesh-list
5656794|NCT03665545|Pembrolizumab|pembrolizumab|mesh-list
5656795|NCT03665545|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
5656796|NCT03665545|Poly ICLC|poly iclc|mesh-list
5835516|NCT02535039|Methylprednisolone|methylprednisolone|mesh-list
5656797|NCT03665545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5656798|NCT03665545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5656799|NCT03665545|Interferon Inducers|interferon inducers|mesh-ancestor
5656800|NCT03665545|Immunologic Factors|immunologic factors|mesh-ancestor
5656801|NCT03665545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656802|NCT03665545|Laxatives|laxatives|mesh-ancestor
5656803|NCT03665545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5656804|NCT03665545|Antiviral Agents|antiviral agents|mesh-ancestor
5656805|NCT03665545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5656806|NCT03665519|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
5656807|NCT03665519|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5656808|NCT03665519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5656809|NCT03665454|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
5835517|NCT02535039|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5835518|NCT02535039|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5835519|NCT02535039|Prednisolone|prednisolone|mesh-list
5835520|NCT02535039|Prednisolone acetate|prednisolone acetate|mesh-list
5835521|NCT02535039|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5835522|NCT02535039|Prednisolone phosphate|prednisolone phosphate|mesh-list
5835523|NCT02535039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5835524|NCT02535039|Antiemetics|antiemetics|mesh-ancestor
5835525|NCT02535039|Autonomic Agents|autonomic agents|mesh-ancestor
5835526|NCT02535039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5835527|NCT02535039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835528|NCT02535039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5835529|NCT02535039|Glucocorticoids|glucocorticoids|mesh-ancestor
5835530|NCT02535039|Hormones|hormones|mesh-ancestor
5835531|NCT02535039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5835532|NCT02535039|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5835533|NCT02535039|Protective Agents|protective agents|mesh-ancestor
5835534|NCT02535039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5835535|NCT02535039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5835536|NCT02534870|Ritonavir|ritonavir|mesh-list
5835537|NCT02534870|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5835538|NCT02534870|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5835539|NCT02534870|Protease Inhibitors|protease inhibitors|mesh-ancestor
5835540|NCT02534870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5835541|NCT02534870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835542|NCT02534870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5835543|NCT02534870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5835544|NCT02534870|Antiviral Agents|antiviral agents|mesh-ancestor
5835545|NCT02534870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5835546|NCT02534870|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5835547|NCT02534870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5835548|NCT02534753|Ascorbic Acid|ascorbic acid|mesh-list
5835549|NCT02534753|Antioxidants|antioxidants|mesh-ancestor
5835550|NCT02534753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835551|NCT02534753|Protective Agents|protective agents|mesh-ancestor
5835552|NCT02534753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835553|NCT02534753|Vitamins|vitamins|mesh-ancestor
5835554|NCT02534753|Micronutrients|micronutrients|mesh-ancestor
5835555|NCT02534571|Epinephrine|epinephrine|mesh-list
5835556|NCT02534571|Hemostatics|hemostatics|mesh-list
5835557|NCT02534571|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5656810|NCT03665454|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5656811|NCT03665454|Immunologic Factors|immunologic factors|mesh-ancestor
5656812|NCT03665454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656813|NCT03665454|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5656814|NCT03665454|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5656815|NCT03665454|Dopamine Agonists|dopamine agonists|mesh-ancestor
5656816|NCT03665454|Dopamine Agents|dopamine agents|mesh-ancestor
5656817|NCT03665454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5656818|NCT03665454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656819|NCT03665441|Leucovorin|leucovorin|mesh-list
5656820|NCT03665441|Gemcitabine|gemcitabine|mesh-list
5656821|NCT03665441|Paclitaxel|paclitaxel|mesh-list
5656822|NCT03665441|Irinotecan|irinotecan|mesh-list
5656823|NCT03665441|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5656824|NCT03665441|Asparaginase|asparaginase|mesh-list
5656825|NCT03665441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5656826|NCT03665441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5656827|NCT03665441|Tubulin Modulators|tubulin modulators|mesh-ancestor
5656828|NCT03665441|Antimitotic Agents|antimitotic agents|mesh-ancestor
5656829|NCT03665441|Mitosis Modulators|mitosis modulators|mesh-ancestor
5835558|NCT02534571|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5835559|NCT02534571|Adrenergic Agents|adrenergic agents|mesh-ancestor
5656830|NCT03665441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656831|NCT03665441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5656832|NCT03665441|Antimetabolites|antimetabolites|mesh-ancestor
5656833|NCT03665441|Antiviral Agents|antiviral agents|mesh-ancestor
5656834|NCT03665441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5656835|NCT03665441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5656836|NCT03665441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5656837|NCT03665441|Immunologic Factors|immunologic factors|mesh-ancestor
5656838|NCT03665441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835560|NCT02534571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5835561|NCT02534571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835562|NCT02534571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835563|NCT02534571|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5835564|NCT02534571|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5835565|NCT02534571|Autonomic Agents|autonomic agents|mesh-ancestor
5835566|NCT02534571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5835567|NCT02534571|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5835568|NCT02534571|Respiratory System Agents|respiratory system agents|mesh-ancestor
5835569|NCT02534571|Mydriatics|mydriatics|mesh-ancestor
5835570|NCT02534571|Sympathomimetics|sympathomimetics|mesh-ancestor
5835571|NCT02534571|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5835572|NCT02534571|Coagulants|coagulants|mesh-ancestor
5835573|NCT02534506|Nivolumab|nivolumab|mesh-list
5835574|NCT02534506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5835575|NCT02534506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5835576|NCT02534506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5835577|NCT02534506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835578|NCT02534415|Hyaluronic Acid|hyaluronic acid|mesh-list
5835579|NCT02534415|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5835580|NCT02534415|Immunologic Factors|immunologic factors|mesh-ancestor
5835581|NCT02534415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835582|NCT02534415|Viscosupplements|viscosupplements|mesh-ancestor
5835583|NCT02534415|Protective Agents|protective agents|mesh-ancestor
5835584|NCT02534610|Etoricoxib|etoricoxib|mesh-list
5835585|NCT02534610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5835586|NCT02534610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5835587|NCT02534610|Analgesics|analgesics|mesh-ancestor
5835588|NCT02534610|Sensory System Agents|sensory system agents|mesh-ancestor
5835589|NCT02534610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5835590|NCT02534610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835591|NCT02534610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5835592|NCT02534610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5835593|NCT02534610|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5835594|NCT02534610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5835595|NCT02534610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5835596|NCT02534610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656839|NCT03665441|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5656840|NCT03665441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5656841|NCT03665441|Antidotes|antidotes|mesh-ancestor
5656842|NCT03665441|Protective Agents|protective agents|mesh-ancestor
5656843|NCT03665441|Vitamin B Complex|vitamin b complex|mesh-ancestor
5656844|NCT03665441|Vitamins|vitamins|mesh-ancestor
5656845|NCT03665441|Micronutrients|micronutrients|mesh-ancestor
5656846|NCT03665428|Bismuth|bismuth|mesh-list
5656847|NCT03665428|Antacids|antacids|mesh-ancestor
5656848|NCT03665428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656849|NCT03665428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5656850|NCT03665402|Isoniazid|isoniazid|mesh-list
5656851|NCT03665402|Antitubercular Agents|antitubercular agents|mesh-ancestor
5656852|NCT03665402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5656853|NCT03665402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5656854|NCT03665402|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5656855|NCT03665402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5656856|NCT03665402|Antimetabolites|antimetabolites|mesh-ancestor
5656857|NCT03665402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656858|NCT03665402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5656859|NCT03665350|Insulin|insulin|mesh-list
5656860|NCT03665350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5656861|NCT03665350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656862|NCT03665207|Insulin|insulin|mesh-list
5656863|NCT03665207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5656864|NCT03665207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656865|NCT03665181|Bismuth|bismuth|mesh-list
5656866|NCT03665181|Antacids|antacids|mesh-ancestor
5656867|NCT03665181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835597|NCT02534363|Quetiapine Fumarate|quetiapine fumarate|mesh-list
5835598|NCT02534363|Aripiprazole|aripiprazole|mesh-list
5835599|NCT02534363|Ziprasidone|ziprasidone|mesh-list
5835600|NCT02534363|Antidepressive Agents|antidepressive agents|mesh-ancestor
5835601|NCT02534363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5835602|NCT02534363|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5835603|NCT02534363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5835604|NCT02534363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5835605|NCT02534363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656868|NCT03665181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5656869|NCT03664986|Bupivacaine|bupivacaine|mesh-list
5656870|NCT03664986|Anesthetics, Local|anesthetics, local|mesh-ancestor
5656871|NCT03664986|Anesthetics|anesthetics|mesh-ancestor
5656872|NCT03664986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5656873|NCT03664986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656874|NCT03664986|Sensory System Agents|sensory system agents|mesh-ancestor
5656875|NCT03664986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5656876|NCT03664908|Antibodies|antibodies|mesh-list
5656877|NCT03664908|Immunologic Factors|immunologic factors|mesh-ancestor
5656878|NCT03664908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694946|NCT03392909|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5835606|NCT02534363|Dopamine Agonists|dopamine agonists|mesh-ancestor
5835607|NCT02534363|Dopamine Agents|dopamine agents|mesh-ancestor
5835608|NCT02534363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5835609|NCT02534363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835610|NCT02534363|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5835611|NCT02534363|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5835612|NCT02534363|Serotonin Agents|serotonin agents|mesh-ancestor
5835613|NCT02534363|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5835614|NCT02534363|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5835615|NCT02534363|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5835616|NCT02534363|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5835617|NCT02534376|Simvastatin|simvastatin|mesh-list
5835618|NCT02534376|Ezetimibe|ezetimibe|mesh-list
5835619|NCT02534376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5694947|NCT03392909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5694948|NCT03392909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694949|NCT03392792|Plasminogen|plasminogen|mesh-list
5694950|NCT03392792|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5694951|NCT03392792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5694952|NCT03392792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5694953|NCT03392792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694954|NCT03392740|Lisinopril|lisinopril|mesh-list
5694955|NCT03392740|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5694956|NCT03392740|Protease Inhibitors|protease inhibitors|mesh-ancestor
5694957|NCT03392740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5694958|NCT03392740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694959|NCT03392740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5694960|NCT03392740|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5835620|NCT02534376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5835621|NCT02534376|Antimetabolites|antimetabolites|mesh-ancestor
5835622|NCT02534376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835623|NCT02534376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5835624|NCT02534376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5835625|NCT02534376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5835626|NCT02534636|Interferons|interferons|mesh-list
5835627|NCT02534636|Interferon-alpha|interferon-alpha|mesh-list
5835628|NCT02534636|Interferon alpha-2|interferon alpha-2|mesh-list
5835629|NCT02534636|BMS-986165|bms-986165|mesh-list
5835630|NCT02534636|Famotidine|famotidine|mesh-list
5694961|NCT03392740|Protective Agents|protective agents|mesh-ancestor
5694962|NCT03392740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694963|NCT03392623|Niacinamide|niacinamide|mesh-list
5694964|NCT03392623|Niacin|niacin|mesh-list
5694965|NCT03392623|Nicotinic Acids|nicotinic acids|mesh-list
5694966|NCT03392623|Tretinoin|tretinoin|mesh-list
5694967|NCT03392623|Sunscreening Agents|sunscreening agents|mesh-list
5694968|NCT03392623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5694969|NCT03392623|Keratolytic Agents|keratolytic agents|mesh-ancestor
5694970|NCT03392623|Dermatologic Agents|dermatologic agents|mesh-ancestor
5694971|NCT03392623|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5694972|NCT03392623|Protective Agents|protective agents|mesh-ancestor
5694973|NCT03392623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694974|NCT03392623|Vitamin B Complex|vitamin b complex|mesh-ancestor
5694975|NCT03392623|Vitamins|vitamins|mesh-ancestor
5694976|NCT03392623|Micronutrients|micronutrients|mesh-ancestor
5835631|NCT02534636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5835632|NCT02534636|Antiviral Agents|antiviral agents|mesh-ancestor
5656879|NCT03664895|Goserelin|goserelin|mesh-list
5656880|NCT03664895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5656881|NCT03664895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5656882|NCT03664882|Fexofenadine|fexofenadine|mesh-list
5656883|NCT03664882|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5656884|NCT03664882|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5656885|NCT03664882|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5656886|NCT03664882|Histamine Antagonists|histamine antagonists|mesh-ancestor
5656887|NCT03664882|Histamine Agents|histamine agents|mesh-ancestor
5656888|NCT03664882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5656889|NCT03664882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656890|NCT03664882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835633|NCT02534636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5835634|NCT02534636|Immunologic Factors|immunologic factors|mesh-ancestor
5835635|NCT02534636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835636|NCT02534636|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5835637|NCT02534636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5835638|NCT02534636|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5835639|NCT02534636|Histamine Antagonists|histamine antagonists|mesh-ancestor
5835640|NCT02534636|Histamine Agents|histamine agents|mesh-ancestor
5835641|NCT02534636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5835642|NCT02534636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656891|NCT03664869|Mitomycins|mitomycins|mesh-list
5656892|NCT03664869|Mitomycin|mitomycin|mesh-list
5656893|NCT03664869|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5656894|NCT03664869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5656895|NCT03664869|Alkylating Agents|alkylating agents|mesh-ancestor
5656896|NCT03664869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835643|NCT02534636|Dermatologic Agents|dermatologic agents|mesh-ancestor
5835644|NCT02534636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5656897|NCT03664869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5656898|NCT03664869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5656899|NCT03664687|Zoledronic Acid|zoledronic acid|mesh-list
5656900|NCT03664687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5656901|NCT03664687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656902|NCT03664622|Morphine|morphine|mesh-list
5656903|NCT03664622|Ketamine|ketamine|mesh-list
5656904|NCT03664622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5656905|NCT03664622|Narcotics|narcotics|mesh-ancestor
5656906|NCT03664622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5656907|NCT03664622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656908|NCT03664622|Analgesics|analgesics|mesh-ancestor
5656909|NCT03664622|Sensory System Agents|sensory system agents|mesh-ancestor
5656910|NCT03664622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5656911|NCT03664622|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5656912|NCT03664622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5656913|NCT03664622|Anesthetics, General|anesthetics, general|mesh-ancestor
5656914|NCT03664622|Anesthetics|anesthetics|mesh-ancestor
5656915|NCT03664622|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5835645|NCT02534636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5835646|NCT02534467|Montelukast|montelukast|mesh-list
5835647|NCT02534467|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5835648|NCT02534467|Respiratory System Agents|respiratory system agents|mesh-ancestor
5835649|NCT02534467|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5835650|NCT02534467|Hormone Antagonists|hormone antagonists|mesh-ancestor
5835651|NCT02534467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5835652|NCT02534467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835653|NCT02534467|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5835654|NCT02534467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5835655|NCT02534467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902877|NCT03269136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5902878|NCT03259698|Tenofovir|tenofovir|mesh-list
5902879|NCT03259698|Emtricitabine|emtricitabine|mesh-list
5902880|NCT03259698|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
5902881|NCT03259698|Antiviral Agents|antiviral agents|mesh-ancestor
5902882|NCT03259698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5902883|NCT03259698|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5902884|NCT03259698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5902885|NCT03259698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5902886|NCT03259698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902887|NCT03259698|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5656916|NCT03664622|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5835656|NCT02534337|Leucovorin|leucovorin|mesh-list
5835657|NCT02534337|Gemcitabine|gemcitabine|mesh-list
5835658|NCT02534337|Fluorouracil|fluorouracil|mesh-list
5835659|NCT02534337|Oxaliplatin|oxaliplatin|mesh-list
5835660|NCT02534337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6493570|NCT00614159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6493571|NCT00614159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493572|NCT00614328|Naltrexone|naltrexone|mesh-list
5835661|NCT02534337|Antimetabolites|antimetabolites|mesh-ancestor
5835662|NCT02534337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835663|NCT02534337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5835664|NCT02534337|Antiviral Agents|antiviral agents|mesh-ancestor
5835665|NCT02534337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5835666|NCT02534337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5835667|NCT02534337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5835668|NCT02534337|Immunologic Factors|immunologic factors|mesh-ancestor
5835669|NCT02534337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835670|NCT02534337|Antidotes|antidotes|mesh-ancestor
5835671|NCT02534337|Protective Agents|protective agents|mesh-ancestor
5835672|NCT02534337|Vitamin B Complex|vitamin b complex|mesh-ancestor
5835673|NCT02534337|Vitamins|vitamins|mesh-ancestor
5835674|NCT02534337|Micronutrients|micronutrients|mesh-ancestor
5835675|NCT02534623|Fentanyl|fentanyl|mesh-list
5835676|NCT02534623|Bupivacaine|bupivacaine|mesh-list
5835677|NCT02534623|Anesthetics|anesthetics|mesh-list
5835678|NCT02534623|Propofol|propofol|mesh-list
5835679|NCT02534623|Sevoflurane|sevoflurane|mesh-list
5835680|NCT02534623|Anesthetics, Local|anesthetics, local|mesh-ancestor
5835681|NCT02534623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5835682|NCT02534623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835683|NCT02534623|Sensory System Agents|sensory system agents|mesh-ancestor
5835684|NCT02534623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5835685|NCT02534623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5835686|NCT02534623|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5835687|NCT02534623|Anesthetics, General|anesthetics, general|mesh-ancestor
5835688|NCT02534623|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5835689|NCT02534623|Narcotics|narcotics|mesh-ancestor
5835690|NCT02534623|Analgesics|analgesics|mesh-ancestor
5835691|NCT02534623|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5835692|NCT02534623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5835693|NCT02534623|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5835694|NCT02534454|Nicotine|nicotine|mesh-list
5835695|NCT02534454|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5835696|NCT02534454|Autonomic Agents|autonomic agents|mesh-ancestor
5835697|NCT02534454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5835698|NCT02534454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835699|NCT02534454|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5835700|NCT02534454|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5835701|NCT02534454|Cholinergic Agents|cholinergic agents|mesh-ancestor
5835702|NCT02534454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5835703|NCT02534454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656917|NCT03664622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5656918|NCT03664622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656919|NCT03664596|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
5656920|NCT03664596|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5656921|NCT03664596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5656922|NCT03664440|Nevirapine|nevirapine|mesh-list
5656923|NCT03664440|Rilpivirine|rilpivirine|mesh-list
5656924|NCT03664440|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5656925|NCT03664440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5656926|NCT03664440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5835704|NCT02534402|Prednisone|prednisone|mesh-list
5835705|NCT02534402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5835706|NCT02534402|Glucocorticoids|glucocorticoids|mesh-ancestor
5835707|NCT02534402|Hormones|hormones|mesh-ancestor
5835708|NCT02534402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5835709|NCT02534402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835710|NCT02534402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5835711|NCT02534402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5835712|NCT02533908|Fentanyl|fentanyl|mesh-list
5835713|NCT02533908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5835714|NCT02533908|Narcotics|narcotics|mesh-ancestor
5835715|NCT02533908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5835716|NCT02533908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835717|NCT02533908|Analgesics|analgesics|mesh-ancestor
5835718|NCT02533908|Sensory System Agents|sensory system agents|mesh-ancestor
5835719|NCT02533908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5835720|NCT02533908|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5835721|NCT02533908|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5656927|NCT03664440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656928|NCT03664440|Antiviral Agents|antiviral agents|mesh-ancestor
5656929|NCT03664440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5656930|NCT03664440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5656931|NCT03664440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5656932|NCT03664440|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5656933|NCT03664440|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5656934|NCT03664414|Pentoxifylline|pentoxifylline|mesh-list
5656935|NCT03664414|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5656936|NCT03664414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5656937|NCT03664414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656938|NCT03664414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5656939|NCT03664414|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5835722|NCT02533908|Anesthetics, General|anesthetics, general|mesh-ancestor
5835723|NCT02533908|Anesthetics|anesthetics|mesh-ancestor
5835724|NCT02533973|Calcipotriene|calcipotriene|mesh-list
5835725|NCT02533973|Dermatologic Agents|dermatologic agents|mesh-ancestor
5835726|NCT02533791|Vaccines|vaccines|mesh-list
5835727|NCT02533791|Immunologic Factors|immunologic factors|mesh-ancestor
5835728|NCT02533791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835729|NCT02533648|Allopurinol|allopurinol|mesh-list
5835730|NCT02533648|Antimetabolites|antimetabolites|mesh-ancestor
5835731|NCT02533648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835732|NCT02533648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5835733|NCT02533648|Gout Suppressants|gout suppressants|mesh-ancestor
5835734|NCT02533648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5835735|NCT02533648|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5835736|NCT02533648|Antioxidants|antioxidants|mesh-ancestor
5835737|NCT02533648|Protective Agents|protective agents|mesh-ancestor
5835738|NCT02533648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835739|NCT02533440|Anesthetics|anesthetics|mesh-list
5835740|NCT02533440|Anesthetics, Local|anesthetics, local|mesh-list
5835741|NCT02533440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5835742|NCT02533440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835743|NCT02533440|Sensory System Agents|sensory system agents|mesh-ancestor
5835744|NCT02533440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5835745|NCT02533765|Olaparib|olaparib|mesh-list
5835746|NCT02533765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5835747|NCT02533765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5835748|NCT02533765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835749|NCT02533765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5835750|NCT02533557|Lidocaine|lidocaine|mesh-list
5835751|NCT02533557|Epinephrine|epinephrine|mesh-list
5835752|NCT02533557|Racepinephrine|racepinephrine|mesh-list
5835753|NCT02533557|Epinephryl borate|epinephryl borate|mesh-list
5835754|NCT02533557|Anesthetics, Local|anesthetics, local|mesh-ancestor
5835755|NCT02533557|Anesthetics|anesthetics|mesh-ancestor
5835756|NCT02533557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5835757|NCT02533557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835758|NCT02533557|Sensory System Agents|sensory system agents|mesh-ancestor
5835759|NCT02533557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5835760|NCT02533557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5835761|NCT02533557|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5835762|NCT02533557|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5835763|NCT02533557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5835764|NCT02533557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835765|NCT02533557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5835766|NCT02533557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5656940|NCT03664414|Protective Agents|protective agents|mesh-ancestor
5656941|NCT03664414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656942|NCT03664414|Vasodilator Agents|vasodilator agents|mesh-ancestor
5656943|NCT03664414|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5656944|NCT03664414|Antioxidants|antioxidants|mesh-ancestor
5656945|NCT03664388|Clopidogrel|clopidogrel|mesh-list
5835767|NCT02533557|Adrenergic Agents|adrenergic agents|mesh-ancestor
5835768|NCT02533557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5835769|NCT02533557|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5835770|NCT02533557|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5835771|NCT02533557|Autonomic Agents|autonomic agents|mesh-ancestor
5835772|NCT02533557|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5835773|NCT02533557|Respiratory System Agents|respiratory system agents|mesh-ancestor
5835774|NCT02533557|Mydriatics|mydriatics|mesh-ancestor
5835775|NCT02533557|Sympathomimetics|sympathomimetics|mesh-ancestor
5656946|NCT03664388|Ticagrelor|ticagrelor|mesh-list
5835776|NCT02533557|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5656947|NCT03664388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5656948|NCT03664388|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5656949|NCT03664388|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5656950|NCT03664388|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5656951|NCT03664388|Purinergic Agents|purinergic agents|mesh-ancestor
5656952|NCT03664388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5656953|NCT03664388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835777|NCT02533544|Tenofovir|tenofovir|mesh-list
5835778|NCT02533544|Antiviral Agents|antiviral agents|mesh-ancestor
5835779|NCT02533544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5835780|NCT02533544|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5835781|NCT02533544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5835782|NCT02533544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5835783|NCT02533544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835784|NCT02533544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5656954|NCT03664388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656955|NCT03664375|Botulinum Toxins|botulinum toxins|mesh-list
5656956|NCT03664375|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5656957|NCT03664375|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5656958|NCT03664375|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5656959|NCT03664375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5656960|NCT03664375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656961|NCT03664375|Cholinergic Agents|cholinergic agents|mesh-ancestor
5656962|NCT03664375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5656963|NCT03664375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656964|NCT03664375|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5656965|NCT03664375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5656966|NCT03664180|Heparin|heparin|mesh-list
5656967|NCT03664180|Calcium heparin|calcium heparin|mesh-list
5656968|NCT03664180|Enoxaparin|enoxaparin|mesh-list
5656969|NCT03664180|Hirudins|hirudins|mesh-list
5656970|NCT03664180|Enoxaparin sodium|enoxaparin sodium|mesh-list
5656971|NCT03664180|Bivalirudin|bivalirudin|mesh-list
5656972|NCT03664180|Anticoagulants|anticoagulants|mesh-ancestor
5656973|NCT03664180|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5835785|NCT02533544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5835786|NCT02533492|Triclosan|triclosan|mesh-list
5835787|NCT02533492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5835788|NCT02533492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5835789|NCT02533492|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5835790|NCT02533492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5835791|NCT02533492|Antimetabolites|antimetabolites|mesh-ancestor
5835792|NCT02533492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835793|NCT02533492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5835794|NCT02533323|Gemcitabine|gemcitabine|mesh-list
5835795|NCT02533323|Oxaliplatin|oxaliplatin|mesh-list
5835796|NCT02533323|Pegaspargase|pegaspargase|mesh-list
5835797|NCT02533323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5835798|NCT02533323|Antimetabolites|antimetabolites|mesh-ancestor
5835799|NCT02533323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835800|NCT02533323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5835801|NCT02533323|Antiviral Agents|antiviral agents|mesh-ancestor
5835802|NCT02533323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5835803|NCT02533323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5835804|NCT02533323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5835805|NCT02533323|Immunologic Factors|immunologic factors|mesh-ancestor
5835806|NCT02533323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835807|NCT02533336|Abamectin|abamectin|mesh-list
5835808|NCT02533336|Anthelmintics|anthelmintics|mesh-ancestor
5835809|NCT02533336|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5835810|NCT02533336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5835811|NCT02533349|Pantoprazole|pantoprazole|mesh-list
5835812|NCT02533349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5656974|NCT03664180|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5656975|NCT03664180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656976|NCT03664180|Antithrombins|antithrombins|mesh-ancestor
5656977|NCT03664180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5656978|NCT03664180|Protease Inhibitors|protease inhibitors|mesh-ancestor
5656979|NCT03664180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5656980|NCT03664115|Itraconazole|itraconazole|mesh-list
5656981|NCT03664115|Antifungal Agents|antifungal agents|mesh-ancestor
5656982|NCT03664115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5656983|NCT03664115|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5656984|NCT03664115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5835813|NCT02533349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5835814|NCT02533349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5656985|NCT03664115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5835815|NCT02533349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5835816|NCT02533349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835817|NCT02533284|Magnesium Sulfate|magnesium sulfate|mesh-list
5835818|NCT02533284|Analgesics|analgesics|mesh-ancestor
5835819|NCT02533284|Sensory System Agents|sensory system agents|mesh-ancestor
5835820|NCT02533284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5835821|NCT02533284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493573|NCT00614328|Baclofen|baclofen|mesh-list
6493574|NCT00614328|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6493575|NCT00614328|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6493576|NCT00614328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493577|NCT00614328|Sensory System Agents|sensory system agents|mesh-ancestor
6493578|NCT00614328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6493579|NCT00614328|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6493580|NCT00614328|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6493581|NCT00614328|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6493582|NCT00614328|GABA Agonists|gaba agonists|mesh-ancestor
5835822|NCT02533284|Anesthetics|anesthetics|mesh-ancestor
5835823|NCT02533284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5835824|NCT02533284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5835825|NCT02533284|Anticonvulsants|anticonvulsants|mesh-ancestor
5835826|NCT02533284|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5835827|NCT02533284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5835828|NCT02533284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835829|NCT02533284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5835830|NCT02533284|Tocolytic Agents|tocolytic agents|mesh-ancestor
5835831|NCT02533284|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5835832|NCT02533141|Simvastatin|simvastatin|mesh-list
5835833|NCT02533141|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5835834|NCT02533141|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5835835|NCT02533141|Antimetabolites|antimetabolites|mesh-ancestor
5835836|NCT02533141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835837|NCT02533141|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5835838|NCT02533141|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5835839|NCT02533141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5835840|NCT02533232|Minocycline|minocycline|mesh-list
5835841|NCT02533232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5835842|NCT02533232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5835843|NCT02533011|Heparin|heparin|mesh-list
5835844|NCT02533011|Anticoagulants|anticoagulants|mesh-ancestor
5835845|NCT02533011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5835846|NCT02533011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5835847|NCT02533011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835848|NCT02533076|Capsaicin|capsaicin|mesh-list
5835849|NCT02533076|Antipruritics|antipruritics|mesh-ancestor
5835850|NCT02533076|Dermatologic Agents|dermatologic agents|mesh-ancestor
5835851|NCT02533076|Sensory System Agents|sensory system agents|mesh-ancestor
5835852|NCT02533076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5835853|NCT02533076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835854|NCT02533219|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
5835855|NCT02533219|Dopamine Agents|dopamine agents|mesh-ancestor
5835856|NCT02533219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5835857|NCT02533219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835858|NCT02533219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835859|NCT02532660|Dexetimide|dexetimide|mesh-list
5835860|NCT02532660|Citalopram|citalopram|mesh-list
5835861|NCT02532660|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5835862|NCT02532660|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5835863|NCT02532660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5835864|NCT02532660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835865|NCT02532660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5835866|NCT02532660|Serotonin Agents|serotonin agents|mesh-ancestor
5835867|NCT02532660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493583|NCT00614328|GABA Agents|gaba agents|mesh-ancestor
5656986|NCT03664115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5656987|NCT03664115|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5656988|NCT03664115|Hormone Antagonists|hormone antagonists|mesh-ancestor
5656989|NCT03664115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5656990|NCT03664115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5656991|NCT03664115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5656992|NCT03664063|Azithromycin|azithromycin|mesh-list
5656993|NCT03664063|Ivermectin|ivermectin|mesh-list
5835868|NCT02532660|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5835869|NCT02532660|Antidepressive Agents|antidepressive agents|mesh-ancestor
5835870|NCT02532660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5835871|NCT02532660|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5835872|NCT02532660|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5835873|NCT02532660|Parasympatholytics|parasympatholytics|mesh-ancestor
5835874|NCT02532660|Autonomic Agents|autonomic agents|mesh-ancestor
5835875|NCT02532660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5835876|NCT02532660|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5835877|NCT02532660|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5835878|NCT02532660|Cholinergic Agents|cholinergic agents|mesh-ancestor
5835879|NCT02532790|Prednisone|prednisone|mesh-list
5835880|NCT02532790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5835881|NCT02532790|Glucocorticoids|glucocorticoids|mesh-ancestor
5835882|NCT02532790|Hormones|hormones|mesh-ancestor
5835883|NCT02532790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5835884|NCT02532790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835885|NCT02532790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5835886|NCT02532790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5902888|NCT03259698|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5902889|NCT03222531|Sofosbuvir|sofosbuvir|mesh-list
5902890|NCT03222531|Velpatasvir|velpatasvir|mesh-list
5902891|NCT03222531|Antiviral Agents|antiviral agents|mesh-ancestor
5902892|NCT03222531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5902893|NCT03137771|Gemcitabine|gemcitabine|mesh-list
5902894|NCT03137771|Docetaxel|docetaxel|mesh-list
5902895|NCT03137771|Pembrolizumab|pembrolizumab|mesh-list
5902896|NCT03137771|Pemetrexed|pemetrexed|mesh-list
5902897|NCT03137771|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5902898|NCT03137771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5902899|NCT03137771|Antimetabolites|antimetabolites|mesh-ancestor
5902900|NCT03137771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902901|NCT03137771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5902902|NCT03137771|Antiviral Agents|antiviral agents|mesh-ancestor
5902903|NCT03137771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5902904|NCT03137771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5902905|NCT03137771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5902906|NCT03137771|Immunologic Factors|immunologic factors|mesh-ancestor
5902907|NCT03137771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902908|NCT03137771|Tubulin Modulators|tubulin modulators|mesh-ancestor
5902909|NCT03137771|Antimitotic Agents|antimitotic agents|mesh-ancestor
5902910|NCT03137771|Mitosis Modulators|mitosis modulators|mesh-ancestor
5902911|NCT03137771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5902912|NCT03137771|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5902913|NCT03137771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5902914|NCT03137771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5656994|NCT03664063|Albendazole|albendazole|mesh-list
5656995|NCT03664063|Diethylcarbamazine|diethylcarbamazine|mesh-list
5656996|NCT03664063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5656997|NCT03664063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5656998|NCT03664063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5656999|NCT03664063|Anthelmintics|anthelmintics|mesh-ancestor
5657000|NCT03664063|Anticestodal Agents|anticestodal agents|mesh-ancestor
5657001|NCT03664063|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5657002|NCT03664063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5657003|NCT03664063|Tubulin Modulators|tubulin modulators|mesh-ancestor
5657004|NCT03664063|Antimitotic Agents|antimitotic agents|mesh-ancestor
5657005|NCT03664063|Mitosis Modulators|mitosis modulators|mesh-ancestor
5657006|NCT03664063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657007|NCT03664063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5657008|NCT03664063|Filaricides|filaricides|mesh-ancestor
5657009|NCT03664063|Antinematodal Agents|antinematodal agents|mesh-ancestor
5657010|NCT03664063|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
5657011|NCT03664063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5657012|NCT03664050|Letrozole|letrozole|mesh-list
5657013|NCT03664050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5657014|NCT03664050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5908382|NCT04600336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5908383|NCT04600336|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5908384|NCT04600336|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5908385|NCT04600336|Cholinergic Agents|cholinergic agents|mesh-ancestor
5908386|NCT04600336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5657015|NCT03664050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5908387|NCT04600336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908388|NCT04600336|Urological Agents|urological agents|mesh-ancestor
5908389|NCT04598815|Sirolimus|sirolimus|mesh-list
5657016|NCT03664050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5835887|NCT02532777|Mycophenolic Acid|mycophenolic acid|mesh-list
5835888|NCT02532777|Prednisone|prednisone|mesh-list
5835889|NCT02532777|Methylprednisolone|methylprednisolone|mesh-list
5835890|NCT02532777|Cyclophosphamide|cyclophosphamide|mesh-list
5835891|NCT02532777|Leflunomide|leflunomide|mesh-list
5835892|NCT02532777|Enzyme Inhibitors|enzyme inhibitors|mesh-list
5835893|NCT02532777|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
5835894|NCT02532777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5835895|NCT02532777|Immunologic Factors|immunologic factors|mesh-ancestor
5835896|NCT02532777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835897|NCT02532777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5835898|NCT02532777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5835899|NCT02532777|Alkylating Agents|alkylating agents|mesh-ancestor
5835900|NCT02532777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835901|NCT02532777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5835902|NCT02532777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5835903|NCT02532777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5835904|NCT02532777|Glucocorticoids|glucocorticoids|mesh-ancestor
5835905|NCT02532777|Hormones|hormones|mesh-ancestor
5835906|NCT02532777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5835907|NCT02532777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5835908|NCT02532777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5835909|NCT02532777|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5835910|NCT02532777|Antitubercular Agents|antitubercular agents|mesh-ancestor
5835911|NCT02532777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5835912|NCT02532777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5835913|NCT02532777|Antiemetics|antiemetics|mesh-ancestor
5835914|NCT02532777|Autonomic Agents|autonomic agents|mesh-ancestor
5835915|NCT02532777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5835916|NCT02532777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5835917|NCT02532777|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5835918|NCT02532777|Protective Agents|protective agents|mesh-ancestor
5835919|NCT02532777|Protease Inhibitors|protease inhibitors|mesh-ancestor
5835920|NCT02532413|Entecavir|entecavir|mesh-list
5835921|NCT02532413|Poly I-C|poly i-c|mesh-list
5657017|NCT03664050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657018|NCT03664050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5657019|NCT03664050|Hormone Antagonists|hormone antagonists|mesh-ancestor
5657020|NCT03664050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5657021|NCT03664050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657022|NCT03664037|Dexamethasone|dexamethasone|mesh-list
5657023|NCT03664037|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
5657024|NCT03664037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5835922|NCT02532413|Antiviral Agents|antiviral agents|mesh-ancestor
5835923|NCT02532413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5835924|NCT02532413|Interferon Inducers|interferon inducers|mesh-ancestor
5835925|NCT02532413|Immunologic Factors|immunologic factors|mesh-ancestor
5835926|NCT02532413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835927|NCT02532634|Dexamethasone|dexamethasone|mesh-list
5835928|NCT02532634|Dexamethasone acetate|dexamethasone acetate|mesh-list
5835929|NCT02532634|Aprepitant|aprepitant|mesh-list
5835930|NCT02532634|Fosaprepitant|fosaprepitant|mesh-list
5835931|NCT02532634|Palonosetron|palonosetron|mesh-list
5835932|NCT02532634|Ramosetron|ramosetron|mesh-list
5835933|NCT02532634|BB 1101|bb 1101|mesh-list
5835934|NCT02532634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5835935|NCT02532634|Antiemetics|antiemetics|mesh-ancestor
5835936|NCT02532634|Autonomic Agents|autonomic agents|mesh-ancestor
5835937|NCT02532634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5835938|NCT02532634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835939|NCT02532634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5835940|NCT02532634|Glucocorticoids|glucocorticoids|mesh-ancestor
5835941|NCT02532634|Hormones|hormones|mesh-ancestor
5835942|NCT02532634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5835943|NCT02532634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5835944|NCT02532634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5835945|NCT02532634|Protease Inhibitors|protease inhibitors|mesh-ancestor
5835946|NCT02532634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5835947|NCT02532634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835948|NCT02532634|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5835949|NCT02532634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5835950|NCT02532634|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5835951|NCT02532634|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5835952|NCT02532634|Serotonin Agents|serotonin agents|mesh-ancestor
5835953|NCT02532400|Goserelin|goserelin|mesh-list
5835954|NCT02532400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5657025|NCT03664037|Antiemetics|antiemetics|mesh-ancestor
5657026|NCT03664037|Autonomic Agents|autonomic agents|mesh-ancestor
5657027|NCT03664037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5835955|NCT02532400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5835956|NCT02532491|Risperidone|risperidone|mesh-list
5835957|NCT02532491|Aripiprazole|aripiprazole|mesh-list
5835958|NCT02532491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5835959|NCT02532491|Serotonin Agents|serotonin agents|mesh-ancestor
5835960|NCT02532491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5835961|NCT02532491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835962|NCT02532491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835963|NCT02532491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5835964|NCT02532491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5835965|NCT02532491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5835966|NCT02532491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5835967|NCT02532491|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5835968|NCT02532491|Dopamine Agents|dopamine agents|mesh-ancestor
5657028|NCT03664037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657029|NCT03664037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5657030|NCT03664037|Glucocorticoids|glucocorticoids|mesh-ancestor
5657031|NCT03664037|Hormones|hormones|mesh-ancestor
5657032|NCT03664037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5657033|NCT03664037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5657034|NCT03664037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5657035|NCT03663751|Decitabine|decitabine|mesh-list
5657036|NCT03663751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5657037|NCT03663751|Antimetabolites|antimetabolites|mesh-ancestor
5657038|NCT03663751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835969|NCT02532491|Antidepressive Agents|antidepressive agents|mesh-ancestor
5835970|NCT02532491|Dopamine Agonists|dopamine agonists|mesh-ancestor
5835971|NCT02532491|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5835972|NCT02532491|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5835973|NCT02532491|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5835974|NCT02532491|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5835975|NCT02532569|Vaccines|vaccines|mesh-list
5835976|NCT02532569|Immunologic Factors|immunologic factors|mesh-ancestor
5835977|NCT02532569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5835978|NCT02532309|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5835979|NCT02532309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5835980|NCT02532309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5835981|NCT02532309|Antimetabolites|antimetabolites|mesh-ancestor
5835982|NCT02532309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5835983|NCT02532309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5835984|NCT02532309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5835985|NCT02532309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5835986|NCT02532335|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
5835987|NCT02532335|Cathartics|cathartics|mesh-ancestor
5835988|NCT02532335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5835989|NCT02532114|Niclosamide|niclosamide|mesh-list
5835990|NCT02532114|Anticestodal Agents|anticestodal agents|mesh-ancestor
5835991|NCT02532114|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5835992|NCT02532114|Anthelmintics|anthelmintics|mesh-ancestor
5835993|NCT02532114|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5835994|NCT02532114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5835995|NCT02532114|Antinematodal Agents|antinematodal agents|mesh-ancestor
5835996|NCT02532270|Phenylephrine|phenylephrine|mesh-list
5657039|NCT03663751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5657040|NCT03663751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5657041|NCT03663673|Decanoic acid|decanoic acid|mesh-list
5657042|NCT03663673|Antifungal Agents|antifungal agents|mesh-ancestor
5657043|NCT03663673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5657044|NCT03663543|Estrogens|estrogens|mesh-list
5657045|NCT03663543|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
5657046|NCT03663543|Hormones|hormones|mesh-ancestor
5657047|NCT03663543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5657048|NCT03663543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657049|NCT03663504|Metronidazole|metronidazole|mesh-list
5657050|NCT03663504|Neomycin|neomycin|mesh-list
5657051|NCT03663504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5657052|NCT03663504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5657053|NCT03663504|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5657054|NCT03663504|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5657055|NCT03663504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5835997|NCT02532270|Oxymetazoline|oxymetazoline|mesh-list
5835998|NCT02532270|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5657056|NCT03663504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5835999|NCT02532270|Mydriatics|mydriatics|mesh-ancestor
5836000|NCT02532270|Autonomic Agents|autonomic agents|mesh-ancestor
5836001|NCT02532270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5836002|NCT02532270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836003|NCT02532270|Sympathomimetics|sympathomimetics|mesh-ancestor
5836004|NCT02532270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5836005|NCT02532270|Nasal Decongestants|nasal decongestants|mesh-ancestor
5836006|NCT02532270|Respiratory System Agents|respiratory system agents|mesh-ancestor
5657057|NCT03663504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657058|NCT03663478|Ropivacaine|ropivacaine|mesh-list
5657059|NCT03663478|Anesthetics, Local|anesthetics, local|mesh-ancestor
5657060|NCT03663478|Anesthetics|anesthetics|mesh-ancestor
5657061|NCT03663478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5657062|NCT03663478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657063|NCT03663478|Sensory System Agents|sensory system agents|mesh-ancestor
5657064|NCT03663478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5657065|NCT03663465|Antipsychotic Agents|antipsychotic agents|mesh-list
5657066|NCT03663465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5657067|NCT03663465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5836007|NCT02532270|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5836008|NCT02532270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5836009|NCT02532270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5836010|NCT02532270|Adrenergic Agents|adrenergic agents|mesh-ancestor
5836011|NCT02532270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5836012|NCT02532270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836013|NCT02532270|Protective Agents|protective agents|mesh-ancestor
5836014|NCT02532062|Vitamin D|vitamin d|mesh-list
5836015|NCT02532062|Cholecalciferol|cholecalciferol|mesh-list
5836016|NCT02532062|Vitamins|vitamins|mesh-ancestor
5836017|NCT02532062|Micronutrients|micronutrients|mesh-ancestor
5836018|NCT02532062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836019|NCT02532062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5836020|NCT02532062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5836021|NCT02531984|Azithromycin|azithromycin|mesh-list
5836022|NCT02531984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5657068|NCT03663465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657069|NCT03663465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5694977|NCT03392623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5694978|NCT03392623|Antimetabolites|antimetabolites|mesh-ancestor
5694979|NCT03392623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694980|NCT03392623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5694981|NCT03392623|Vasodilator Agents|vasodilator agents|mesh-ancestor
5694982|NCT03392571|Gemcitabine|gemcitabine|mesh-list
5694983|NCT03392571|Paclitaxel|paclitaxel|mesh-list
5694984|NCT03392571|Cisplatin|cisplatin|mesh-list
5836023|NCT02531984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5836024|NCT02532140|Cefepime|cefepime|mesh-list
5836025|NCT02532140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5836026|NCT02532140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5836027|NCT02532192|Cytarabine|cytarabine|mesh-list
5694985|NCT03392571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5694986|NCT03392571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5694987|NCT03392571|Tubulin Modulators|tubulin modulators|mesh-ancestor
5694988|NCT03392571|Antimitotic Agents|antimitotic agents|mesh-ancestor
5694989|NCT03392571|Mitosis Modulators|mitosis modulators|mesh-ancestor
5694990|NCT03392571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5694991|NCT03392571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5694992|NCT03392571|Antimetabolites|antimetabolites|mesh-ancestor
5694993|NCT03392571|Antiviral Agents|antiviral agents|mesh-ancestor
5694994|NCT03392571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5694995|NCT03392571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5694996|NCT03392571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5694997|NCT03392571|Immunologic Factors|immunologic factors|mesh-ancestor
5694998|NCT03392571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5694999|NCT03392545|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
5695000|NCT03392545|Immunologic Factors|immunologic factors|mesh-ancestor
5695001|NCT03392545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697977|NCT03372304|Sensory System Agents|sensory system agents|mesh-ancestor
5697978|NCT03372304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5697979|NCT03372265|Ropivacaine|ropivacaine|mesh-list
5697980|NCT03372265|Anesthetics, Local|anesthetics, local|mesh-ancestor
5697981|NCT03372265|Anesthetics|anesthetics|mesh-ancestor
5697982|NCT03372265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5697983|NCT03372265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836028|NCT02532192|Ciprofloxacin|ciprofloxacin|mesh-list
5836029|NCT02532192|Fluconazole|fluconazole|mesh-list
5657070|NCT03663114|Lenvatinib|lenvatinib|mesh-list
5657071|NCT03663114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5657072|NCT03663114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5657073|NCT03663114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5657074|NCT03663114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657075|NCT03662984|Ciprofibrate|ciprofibrate|mesh-list
5657076|NCT03662984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5657077|NCT03662984|Antimetabolites|antimetabolites|mesh-ancestor
5657078|NCT03662984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657079|NCT03662984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5657080|NCT03662971|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5657081|NCT03662971|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5657082|NCT03662958|Leuprolide|leuprolide|mesh-list
5657083|NCT03662958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5657084|NCT03662958|Fertility Agents|fertility agents|mesh-ancestor
5657085|NCT03662958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5657086|NCT03662958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657087|NCT03662958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5657088|NCT03662958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5657089|NCT03662919|Adalimumab|adalimumab|mesh-list
5657090|NCT03662919|Infliximab|infliximab|mesh-list
5657091|NCT03662919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5657092|NCT03662919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5657093|NCT03662919|Dermatologic Agents|dermatologic agents|mesh-ancestor
5657094|NCT03662919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5657095|NCT03662893|Muscarinic Antagonists|muscarinic antagonists|mesh-list
5657096|NCT03662893|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5657097|NCT03662893|Cholinergic Agents|cholinergic agents|mesh-ancestor
5657098|NCT03662893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5657099|NCT03662893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657100|NCT03662893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657101|NCT03662763|Guanfacine|guanfacine|mesh-list
5657102|NCT03662763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5657103|NCT03662763|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5657104|NCT03662763|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5657105|NCT03662763|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5657106|NCT03662763|Adrenergic Agents|adrenergic agents|mesh-ancestor
5657107|NCT03662763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5657108|NCT03662763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657109|NCT03662763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657110|NCT03662724|Venetoclax|venetoclax|mesh-list
5657111|NCT03662724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5657112|NCT03662711|Bronchodilator Agents|bronchodilator agents|mesh-list
5657113|NCT03662711|Olodaterol|olodaterol|mesh-list
5657114|NCT03662711|Autonomic Agents|autonomic agents|mesh-ancestor
5657115|NCT03662711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5657116|NCT03662711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657117|NCT03662711|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5657118|NCT03662711|Respiratory System Agents|respiratory system agents|mesh-ancestor
5657119|NCT03662685|Coal Tar|coal tar|mesh-list
5657120|NCT03662685|Keratolytic Agents|keratolytic agents|mesh-ancestor
5657121|NCT03662685|Dermatologic Agents|dermatologic agents|mesh-ancestor
5657122|NCT03662620|Amlodipine|amlodipine|mesh-list
5657123|NCT03662620|Telmisartan|telmisartan|mesh-list
5657124|NCT03662620|Chlorthalidone|chlorthalidone|mesh-list
5657125|NCT03662620|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5657126|NCT03662620|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5657127|NCT03662620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5657128|NCT03662620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657129|NCT03662620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5657130|NCT03662620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657131|NCT03662620|Vasodilator Agents|vasodilator agents|mesh-ancestor
5657132|NCT03662620|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5657133|NCT03662620|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5657134|NCT03662620|Diuretics|diuretics|mesh-ancestor
5657135|NCT03662620|Natriuretic Agents|natriuretic agents|mesh-ancestor
5836030|NCT02532192|Dexamethasone|dexamethasone|mesh-list
5836031|NCT02532192|Cisplatin|cisplatin|mesh-list
5836032|NCT02532192|Rituximab|rituximab|mesh-list
5836033|NCT02532192|Belinostat|belinostat|mesh-list
5836034|NCT02532192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5836035|NCT02532192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5836036|NCT02532192|Antiemetics|antiemetics|mesh-ancestor
5836037|NCT02532192|Autonomic Agents|autonomic agents|mesh-ancestor
5836038|NCT02532192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5836039|NCT02532192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836040|NCT02532192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5836041|NCT02532192|Glucocorticoids|glucocorticoids|mesh-ancestor
5836042|NCT02532192|Hormones|hormones|mesh-ancestor
5836043|NCT02532192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5836044|NCT02532192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5836045|NCT02532192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5836046|NCT02532192|Immunologic Factors|immunologic factors|mesh-ancestor
5836047|NCT02532192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5836048|NCT02532192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5836049|NCT02532192|Antimetabolites|antimetabolites|mesh-ancestor
5836050|NCT02532192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836051|NCT02532192|Antiviral Agents|antiviral agents|mesh-ancestor
5836052|NCT02532192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5657136|NCT03662620|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5657137|NCT03662568|Ritonavir|ritonavir|mesh-list
5657138|NCT03662568|Tenofovir|tenofovir|mesh-list
5657139|NCT03662568|Entecavir|entecavir|mesh-list
5657140|NCT03662568|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5657141|NCT03662568|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5836053|NCT02532192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5836054|NCT02532192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5836055|NCT02532192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5836056|NCT02532192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5836057|NCT02532192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5836058|NCT02532192|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5836059|NCT02532192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5836060|NCT02532192|Antifungal Agents|antifungal agents|mesh-ancestor
5836061|NCT02532192|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5836062|NCT02532192|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5836063|NCT02532192|Hormone Antagonists|hormone antagonists|mesh-ancestor
5836064|NCT02532192|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5836065|NCT02532192|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5836066|NCT02532192|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5836067|NCT02532153|Ketamine|ketamine|mesh-list
5836068|NCT02532153|Analgesics|analgesics|mesh-ancestor
5836069|NCT02532153|Sensory System Agents|sensory system agents|mesh-ancestor
5836070|NCT02532153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5836071|NCT02532153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836072|NCT02532153|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5836073|NCT02532153|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5836074|NCT02532153|Anesthetics, General|anesthetics, general|mesh-ancestor
5657142|NCT03662568|Protease Inhibitors|protease inhibitors|mesh-ancestor
5657143|NCT03662568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5657144|NCT03662568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657145|NCT03662568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5657146|NCT03662568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5836075|NCT02532153|Anesthetics|anesthetics|mesh-ancestor
5836076|NCT02532153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5836077|NCT02532153|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5836078|NCT02532153|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5836079|NCT02532153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5836080|NCT02532153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836081|NCT02532322|Acetaminophen|acetaminophen|mesh-list
5836082|NCT02532322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5836083|NCT02532322|Analgesics|analgesics|mesh-ancestor
5836084|NCT02532322|Sensory System Agents|sensory system agents|mesh-ancestor
5836085|NCT02532322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5836086|NCT02532322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836087|NCT02532322|Antipyretics|antipyretics|mesh-ancestor
5836088|NCT02531997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
5836089|NCT02531997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5836090|NCT02531997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836091|NCT02532023|Curcumin|curcumin|mesh-list
5836092|NCT02532023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5836093|NCT02532023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5836094|NCT02532023|Analgesics|analgesics|mesh-ancestor
5836095|NCT02532023|Sensory System Agents|sensory system agents|mesh-ancestor
5836096|NCT02532023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5836097|NCT02532023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836098|NCT02532023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5657147|NCT03662568|Antiviral Agents|antiviral agents|mesh-ancestor
5657148|NCT03662568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5657149|NCT03662568|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5657150|NCT03662568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5836099|NCT02532023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5657151|NCT03662568|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5657152|NCT03662568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5657153|NCT03662516|Levonorgestrel|levonorgestrel|mesh-list
5657154|NCT03662516|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5657155|NCT03662516|Contraceptive Agents|contraceptive agents|mesh-list
5657156|NCT03662516|Contraceptives, Oral|contraceptives, oral|mesh-list
5657157|NCT03662516|Estradiol|estradiol|mesh-list
5657158|NCT03662516|Abrocitinib|abrocitinib|mesh-list
5657159|NCT03662516|Estrogens|estrogens|mesh-ancestor
5657160|NCT03662516|Hormones|hormones|mesh-ancestor
6211855|NCT02178553|Anesthetics, Local|anesthetics, local|mesh-ancestor
6211856|NCT02178553|Anesthetics|anesthetics|mesh-ancestor
6211857|NCT02178553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6211858|NCT02178553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211859|NCT02178553|Sensory System Agents|sensory system agents|mesh-ancestor
6211860|NCT02178553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6211861|NCT02178696|Citalopram|citalopram|mesh-list
6211862|NCT02178696|Antidepressive Agents|antidepressive agents|mesh-list
6211863|NCT02178696|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6211864|NCT02178696|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6211865|NCT02178696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5836100|NCT02532023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5836101|NCT02532023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5836102|NCT02532023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836103|NCT02531906|Oxycodone|oxycodone|mesh-list
5836104|NCT02531906|Methadone|methadone|mesh-list
5836105|NCT02531906|Gabapentin|gabapentin|mesh-list
5836106|NCT02531906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5836107|NCT02531906|Narcotics|narcotics|mesh-ancestor
6211866|NCT02178696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493584|NCT00614328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5657161|NCT03662516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5657162|NCT03662516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657163|NCT03662516|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5657164|NCT03662516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5657165|NCT03662516|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5836108|NCT02531906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5836109|NCT02531906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836110|NCT02531906|Analgesics|analgesics|mesh-ancestor
5836111|NCT02531906|Sensory System Agents|sensory system agents|mesh-ancestor
5836112|NCT02531906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5836113|NCT02531906|Anticonvulsants|anticonvulsants|mesh-ancestor
5836114|NCT02531906|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5836115|NCT02531906|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5836116|NCT02531906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5836117|NCT02531906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5836118|NCT02531906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5836119|NCT02531906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5836120|NCT02531906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836121|NCT02531906|Antimanic Agents|antimanic agents|mesh-ancestor
5836122|NCT02531906|Antitussive Agents|antitussive agents|mesh-ancestor
5836123|NCT02531906|Respiratory System Agents|respiratory system agents|mesh-ancestor
5836124|NCT02531854|Pemetrexed|pemetrexed|mesh-list
5836125|NCT02531854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5836126|NCT02531854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5836127|NCT02531854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836128|NCT02531854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5836129|NCT02531854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5836130|NCT02531490|Labetalol|labetalol|mesh-list
5836131|NCT02531490|Methyldopa|methyldopa|mesh-list
5836132|NCT02531490|Nifedipine|nifedipine|mesh-list
5836133|NCT02531490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5836134|NCT02531490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5836135|NCT02531490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836136|NCT02531490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5836137|NCT02531490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836138|NCT02531490|Vasodilator Agents|vasodilator agents|mesh-ancestor
5836139|NCT02531490|Tocolytic Agents|tocolytic agents|mesh-ancestor
5836140|NCT02531490|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5836141|NCT02531490|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5836142|NCT02531490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5836143|NCT02531490|Adrenergic Agents|adrenergic agents|mesh-ancestor
5836144|NCT02531490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6674517|NCT01569919|Hormones|hormones|mesh-ancestor
5657166|NCT03662516|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5657167|NCT03662516|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5657168|NCT03662516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5657169|NCT03662516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5657170|NCT03662516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657171|NCT03662425|Oxytocin|oxytocin|mesh-list
5657172|NCT03662425|Oxytocics|oxytocics|mesh-ancestor
5657173|NCT03662425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5657174|NCT03662425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657175|NCT03662412|Sirolimus|sirolimus|mesh-list
5657176|NCT03662412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5657177|NCT03662412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5657178|NCT03662412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5657179|NCT03662412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5657180|NCT03662412|Antifungal Agents|antifungal agents|mesh-ancestor
5657181|NCT03662412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5657182|NCT03662412|Immunologic Factors|immunologic factors|mesh-ancestor
5657183|NCT03662412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657184|NCT03662269|Indomethacin|indomethacin|mesh-list
5657185|NCT03662269|Omeprazole|omeprazole|mesh-list
5657186|NCT03662269|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5657187|NCT03662269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5657188|NCT03662269|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5657189|NCT03662269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5657190|NCT03662269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657191|NCT03662269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5657192|NCT03662269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5657193|NCT03662269|Analgesics|analgesics|mesh-ancestor
5657194|NCT03662269|Sensory System Agents|sensory system agents|mesh-ancestor
5657195|NCT03662269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5657196|NCT03662269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657197|NCT03662269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5657198|NCT03662269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5657199|NCT03662269|Gout Suppressants|gout suppressants|mesh-ancestor
5657200|NCT03662269|Tocolytic Agents|tocolytic agents|mesh-ancestor
5657201|NCT03662269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5657202|NCT03662269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5836145|NCT02531490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5836146|NCT02531490|Sympathomimetics|sympathomimetics|mesh-ancestor
5836147|NCT02531490|Autonomic Agents|autonomic agents|mesh-ancestor
5836148|NCT02531490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5836149|NCT02531490|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5836150|NCT02531490|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5836151|NCT02531490|Sympatholytics|sympatholytics|mesh-ancestor
5836152|NCT02531490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5836153|NCT02531490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5836154|NCT02531490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5836155|NCT02531581|Furosemide|furosemide|mesh-list
5836156|NCT02531581|Diuretics|diuretics|mesh-list
5836157|NCT02531581|Natriuretic Agents|natriuretic agents|mesh-ancestor
5836158|NCT02531581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836159|NCT02531581|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5836160|NCT02531581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5836161|NCT02531581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836162|NCT02531672|Choline|choline|mesh-list
5836163|NCT02531672|Lipotropic Agents|lipotropic agents|mesh-ancestor
5836164|NCT02531672|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5657203|NCT03662113|Domperidone|domperidone|mesh-list
5657204|NCT03662113|Simethicone|simethicone|mesh-list
5657205|NCT03662113|Antiemetics|antiemetics|mesh-ancestor
5657206|NCT03662113|Autonomic Agents|autonomic agents|mesh-ancestor
5657207|NCT03662113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5657208|NCT03662113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657209|NCT03662113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5657210|NCT03662113|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5657211|NCT03662113|Dopamine Agents|dopamine agents|mesh-ancestor
5657212|NCT03662113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5657213|NCT03662113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657214|NCT03662113|Antifoaming Agents|antifoaming agents|mesh-ancestor
5657215|NCT03662113|Emollients|emollients|mesh-ancestor
5836165|NCT02531672|Antimetabolites|antimetabolites|mesh-ancestor
5836166|NCT02531672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657216|NCT03662113|Dermatologic Agents|dermatologic agents|mesh-ancestor
5657217|NCT03662100|Mirikizumab|mirikizumab|mesh-list
5695002|NCT03392428|177Lu-PSMA-617|177lu-psma-617|mesh-list
5836167|NCT02531672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5836168|NCT02531672|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5836169|NCT02531672|Nootropic Agents|nootropic agents|mesh-ancestor
5836170|NCT02531568|Warfarin|warfarin|mesh-list
5836171|NCT02531568|Anticoagulants|anticoagulants|mesh-ancestor
5836172|NCT02531451|Aspirin|aspirin|mesh-list
5836173|NCT02531451|Ibuprofen|ibuprofen|mesh-list
5836174|NCT02531451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5836175|NCT02531451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5836176|NCT02531451|Analgesics|analgesics|mesh-ancestor
5836177|NCT02531451|Sensory System Agents|sensory system agents|mesh-ancestor
5836178|NCT02531451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5836179|NCT02531451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836180|NCT02531451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5836181|NCT02531451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5836182|NCT02531451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5836183|NCT02531451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5836184|NCT02531451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836185|NCT02531451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5836186|NCT02531451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5836187|NCT02531451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5836188|NCT02531451|Antipyretics|antipyretics|mesh-ancestor
5836189|NCT02531529|Fentanyl|fentanyl|mesh-list
5836190|NCT02531529|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5836191|NCT02531529|Narcotics|narcotics|mesh-ancestor
5836192|NCT02531529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5836193|NCT02531529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836194|NCT02531529|Analgesics|analgesics|mesh-ancestor
5836195|NCT02531529|Sensory System Agents|sensory system agents|mesh-ancestor
5836196|NCT02531529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5836197|NCT02531529|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5836198|NCT02531529|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5836199|NCT02531529|Anesthetics, General|anesthetics, general|mesh-ancestor
5836200|NCT02531529|Anesthetics|anesthetics|mesh-ancestor
5836201|NCT02531841|Dexamethasone acetate|dexamethasone acetate|mesh-list
5836202|NCT02531841|Dexamethasone|dexamethasone|mesh-list
5836203|NCT02531841|Etoposide phosphate|etoposide phosphate|mesh-list
5836204|NCT02531841|Etoposide|etoposide|mesh-list
5836205|NCT02531841|Ifosfamide|ifosfamide|mesh-list
5836206|NCT02531841|Isophosphamide mustard|isophosphamide mustard|mesh-list
5836207|NCT02531841|Thiotepa|thiotepa|mesh-list
5836208|NCT02531841|Carmustine|carmustine|mesh-list
5836209|NCT02531841|Busulfan|busulfan|mesh-list
5836210|NCT02531841|BB 1101|bb 1101|mesh-list
5836211|NCT02531841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5657218|NCT03662100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5657219|NCT03662100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5657220|NCT03662100|Analgesics|analgesics|mesh-ancestor
5657221|NCT03662100|Sensory System Agents|sensory system agents|mesh-ancestor
5657222|NCT03662100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5657223|NCT03662100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657224|NCT03662100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5657225|NCT03662100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5657226|NCT03662100|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5657227|NCT03662100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5657228|NCT03662035|Apatinib|apatinib|mesh-list
5657229|NCT03662035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5657230|NCT03662035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5657231|NCT03662035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5657232|NCT03662035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657233|NCT03661996|Lidocaine|lidocaine|mesh-list
5657234|NCT03661996|Epinephrine|epinephrine|mesh-list
5657235|NCT03661996|Capsaicin|capsaicin|mesh-list
5657236|NCT03661996|Anesthetics, Local|anesthetics, local|mesh-ancestor
5657237|NCT03661996|Anesthetics|anesthetics|mesh-ancestor
5657238|NCT03661996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5657239|NCT03661996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657240|NCT03661996|Sensory System Agents|sensory system agents|mesh-ancestor
5657241|NCT03661996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5657242|NCT03661996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5657243|NCT03661996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5657244|NCT03661996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5836212|NCT02531841|Antiemetics|antiemetics|mesh-ancestor
5836213|NCT02531841|Autonomic Agents|autonomic agents|mesh-ancestor
5836214|NCT02531841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5836215|NCT02531841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836216|NCT02531841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5836217|NCT02531841|Glucocorticoids|glucocorticoids|mesh-ancestor
5836218|NCT02531841|Hormones|hormones|mesh-ancestor
5657245|NCT03661996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5836219|NCT02531841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5836220|NCT02531841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5836221|NCT02531841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6674518|NCT01569919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6674519|NCT01569919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6674520|NCT01569919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6674521|NCT01569919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674522|NCT01569919|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6674523|NCT01569919|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6674524|NCT01569919|Hematinics|hematinics|mesh-ancestor
6674525|NCT01569919|Vitamin B Complex|vitamin b complex|mesh-ancestor
6674526|NCT01569945|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6674527|NCT01569945|Clomiphene|clomiphene|mesh-list
6674528|NCT01569945|Menotropins|menotropins|mesh-list
6674529|NCT01569945|Estradiol|estradiol|mesh-list
6674530|NCT01569945|Estrogens|estrogens|mesh-ancestor
5836222|NCT02531841|Protease Inhibitors|protease inhibitors|mesh-ancestor
5836223|NCT02531841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5657246|NCT03661996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657247|NCT03661996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5657248|NCT03661996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5657249|NCT03661996|Adrenergic Agents|adrenergic agents|mesh-ancestor
5657250|NCT03661996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5657251|NCT03661996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5657252|NCT03661996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5657253|NCT03661996|Autonomic Agents|autonomic agents|mesh-ancestor
5657254|NCT03661996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5657255|NCT03661996|Respiratory System Agents|respiratory system agents|mesh-ancestor
5657256|NCT03661996|Mydriatics|mydriatics|mesh-ancestor
5657257|NCT03661996|Sympathomimetics|sympathomimetics|mesh-ancestor
5657258|NCT03661996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5657259|NCT03661996|Antipruritics|antipruritics|mesh-ancestor
5657260|NCT03661996|Dermatologic Agents|dermatologic agents|mesh-ancestor
5657261|NCT03661892|Dronabinol|dronabinol|mesh-list
5657262|NCT03661892|Hallucinogens|hallucinogens|mesh-ancestor
5657263|NCT03661892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657264|NCT03661892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5657265|NCT03661892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5657266|NCT03661892|Analgesics|analgesics|mesh-ancestor
5657267|NCT03661892|Sensory System Agents|sensory system agents|mesh-ancestor
5657268|NCT03661892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5657269|NCT03661892|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5836224|NCT02531841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836225|NCT02531841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5836226|NCT02531841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5836227|NCT02531841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5836228|NCT02531841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5836229|NCT02531841|Alkylating Agents|alkylating agents|mesh-ancestor
5836230|NCT02531841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5836231|NCT02531841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5836232|NCT02531841|Immunologic Factors|immunologic factors|mesh-ancestor
5836233|NCT02531737|Docetaxel|docetaxel|mesh-list
5836234|NCT02531737|Nintedanib|nintedanib|mesh-list
5836235|NCT02531737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5836236|NCT02531737|Tubulin Modulators|tubulin modulators|mesh-ancestor
5836237|NCT02531737|Antimitotic Agents|antimitotic agents|mesh-ancestor
5836238|NCT02531737|Mitosis Modulators|mitosis modulators|mesh-ancestor
5836239|NCT02531737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836240|NCT02531737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5836241|NCT02531737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5836242|NCT02531412|Spironolactone|spironolactone|mesh-list
5836243|NCT02531412|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5836244|NCT02531412|Hormone Antagonists|hormone antagonists|mesh-ancestor
5836245|NCT02531412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5836246|NCT02531412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836247|NCT02531412|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5836248|NCT02531412|Diuretics|diuretics|mesh-ancestor
5836249|NCT02531412|Natriuretic Agents|natriuretic agents|mesh-ancestor
5836250|NCT02531477|Propofol|propofol|mesh-list
5836251|NCT02531477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5836252|NCT02531477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6674531|NCT01569945|Hormones|hormones|mesh-ancestor
5657270|NCT03661892|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5657271|NCT03661892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5836253|NCT02531477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836254|NCT02531477|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5836255|NCT02531477|Anesthetics, General|anesthetics, general|mesh-ancestor
5836256|NCT02531477|Anesthetics|anesthetics|mesh-ancestor
5836257|NCT02531724|Simendan|simendan|mesh-list
5836258|NCT02531724|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5836259|NCT02531724|Vasodilator Agents|vasodilator agents|mesh-ancestor
6211867|NCT02178696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6211868|NCT02178696|Serotonin Agents|serotonin agents|mesh-ancestor
6211869|NCT02178696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211870|NCT02178696|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6211871|NCT02178696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6211872|NCT02178800|Cabotegravir|cabotegravir|mesh-list
6496510|NCT00628290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836260|NCT02531724|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5836261|NCT02531724|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5836262|NCT02531724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5836263|NCT02531724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836264|NCT02531724|Protective Agents|protective agents|mesh-ancestor
5836265|NCT02531724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836266|NCT02531165|Aspirin|aspirin|mesh-list
5836267|NCT02531165|Heparin|heparin|mesh-list
5836268|NCT02531165|Fentanyl|fentanyl|mesh-list
5836269|NCT02531165|Morphine|morphine|mesh-list
5836270|NCT02531165|Ticagrelor|ticagrelor|mesh-list
5836271|NCT02531165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5836272|NCT02531165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5836273|NCT02531165|Analgesics|analgesics|mesh-ancestor
5836274|NCT02531165|Sensory System Agents|sensory system agents|mesh-ancestor
5836275|NCT02531165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5836276|NCT02531165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836277|NCT02531165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5836278|NCT02531165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5836279|NCT02531165|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5836280|NCT02531165|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5836281|NCT02531165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836282|NCT02531165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5836283|NCT02531165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5836284|NCT02531165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5836285|NCT02531165|Antipyretics|antipyretics|mesh-ancestor
5836286|NCT02531165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5836287|NCT02531165|Narcotics|narcotics|mesh-ancestor
5836288|NCT02531165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5836289|NCT02531165|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5657272|NCT03661892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657273|NCT03661892|Hormones|hormones|mesh-ancestor
5657274|NCT03661892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5657275|NCT03661788|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
5657276|NCT03661788|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5657277|NCT03661788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5836290|NCT02531165|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5836291|NCT02531165|Anesthetics, General|anesthetics, general|mesh-ancestor
5836292|NCT02531165|Anesthetics|anesthetics|mesh-ancestor
5836293|NCT02531165|Anticoagulants|anticoagulants|mesh-ancestor
5836294|NCT02531165|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5836295|NCT02531165|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5836296|NCT02531165|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5836297|NCT02531165|Purinergic Agents|purinergic agents|mesh-ancestor
5836298|NCT02531165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5836299|NCT02531191|Peficitinib|peficitinib|mesh-list
5836300|NCT02531191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5836301|NCT02531191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836302|NCT02531191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5836303|NCT02531191|Immunologic Factors|immunologic factors|mesh-ancestor
5836304|NCT02531191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836305|NCT02531152|Latanoprost|latanoprost|mesh-list
5836306|NCT02531152|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5836307|NCT02531152|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5902915|NCT03124355|Bromides|bromides|mesh-list
5902916|NCT03124355|Galantamine|galantamine|mesh-list
5902917|NCT03124355|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
5902918|NCT03124355|Anticonvulsants|anticonvulsants|mesh-ancestor
5902919|NCT03124355|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5902920|NCT03124355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6211873|NCT02178800|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5836308|NCT02530918|Ranibizumab|ranibizumab|mesh-list
5836309|NCT02530918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5836310|NCT02530918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5836311|NCT02530918|Growth Substances|growth substances|mesh-ancestor
5836312|NCT02530918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836313|NCT02530918|Growth Inhibitors|growth inhibitors|mesh-ancestor
5836314|NCT02530918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5836315|NCT02530788|Selenium|selenium|mesh-list
5836316|NCT02530788|Selenious Acid|selenious acid|mesh-list
5836317|NCT02530788|Sodium Selenite|sodium selenite|mesh-list
5836318|NCT02530788|Antioxidants|antioxidants|mesh-ancestor
5836319|NCT02530788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836320|NCT02530788|Protective Agents|protective agents|mesh-ancestor
5836321|NCT02530788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836322|NCT02530788|Trace Elements|trace elements|mesh-ancestor
5836323|NCT02530788|Micronutrients|micronutrients|mesh-ancestor
5836324|NCT02530801|Bevacizumab|bevacizumab|mesh-list
5836325|NCT02530801|Fluorouracil|fluorouracil|mesh-list
5836326|NCT02530801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5836327|NCT02530801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5836328|NCT02530801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5836329|NCT02530801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5836330|NCT02530801|Growth Substances|growth substances|mesh-ancestor
5836331|NCT02530801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836332|NCT02530801|Growth Inhibitors|growth inhibitors|mesh-ancestor
5836333|NCT02530801|Antimetabolites|antimetabolites|mesh-ancestor
5836334|NCT02530801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836335|NCT02530801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5836336|NCT02530801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5836337|NCT02530801|Immunologic Factors|immunologic factors|mesh-ancestor
5836338|NCT02530827|Hypolipidemic Agents|hypolipidemic agents|mesh-list
5836339|NCT02530827|Antimetabolites|antimetabolites|mesh-ancestor
5836340|NCT02530827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836341|NCT02530827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5836342|NCT02530879|Esomeprazole|esomeprazole|mesh-list
5836343|NCT02530879|Omeprazole|omeprazole|mesh-list
5836344|NCT02530879|Lansoprazole|lansoprazole|mesh-list
5836345|NCT02530879|Dexlansoprazole|dexlansoprazole|mesh-list
5836346|NCT02530879|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5836347|NCT02530879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5836348|NCT02530879|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5836349|NCT02530879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5836350|NCT02530879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836351|NCT02530697|Miltefosine|miltefosine|mesh-list
5836352|NCT02530697|Meglumine Antimoniate|meglumine antimoniate|mesh-list
5836353|NCT02530697|Pentoxifylline|pentoxifylline|mesh-list
5657278|NCT03661788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5657279|NCT03661788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657280|NCT03661788|Adrenergic Agents|adrenergic agents|mesh-ancestor
5657281|NCT03661788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5657282|NCT03661788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657283|NCT03661775|Magnesium Sulfate|magnesium sulfate|mesh-list
5657284|NCT03661775|Analgesics|analgesics|mesh-ancestor
5836354|NCT02530697|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5836355|NCT02530697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5836356|NCT02530697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836357|NCT02530697|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5836358|NCT02530697|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5836359|NCT02530697|Protective Agents|protective agents|mesh-ancestor
5836360|NCT02530697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836361|NCT02530697|Vasodilator Agents|vasodilator agents|mesh-ancestor
5836362|NCT02530697|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5836363|NCT02530697|Antioxidants|antioxidants|mesh-ancestor
5836364|NCT02530697|Antifungal Agents|antifungal agents|mesh-ancestor
5836365|NCT02530697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5836366|NCT02530697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5836367|NCT02530697|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5836368|NCT02530697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5836369|NCT02530632|Propofol|propofol|mesh-list
5836370|NCT02530632|Sevoflurane|sevoflurane|mesh-list
5836371|NCT02530632|Anesthetics|anesthetics|mesh-ancestor
5836372|NCT02530632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5836373|NCT02530632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836374|NCT02530632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5836375|NCT02530632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5836376|NCT02530632|Anesthetics, General|anesthetics, general|mesh-ancestor
5836377|NCT02530632|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5836378|NCT02530632|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5836379|NCT02530437|Paclitaxel|paclitaxel|mesh-list
5836380|NCT02530437|Carboplatin|carboplatin|mesh-list
5657285|NCT03661775|Sensory System Agents|sensory system agents|mesh-ancestor
5657286|NCT03661775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5657287|NCT03661775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657288|NCT03661775|Anesthetics|anesthetics|mesh-ancestor
5657289|NCT03661775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5657290|NCT03661775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5657291|NCT03661775|Anticonvulsants|anticonvulsants|mesh-ancestor
5657292|NCT03661775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5657293|NCT03661775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5657294|NCT03661775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657295|NCT03661775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5657296|NCT03661775|Tocolytic Agents|tocolytic agents|mesh-ancestor
5657297|NCT03661775|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5657298|NCT03661723|Bevacizumab|bevacizumab|mesh-list
6493585|NCT00614328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493586|NCT00614471|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6493587|NCT00614471|Interferon-alpha|interferon-alpha|mesh-list
6493588|NCT00614471|Entecavir|entecavir|mesh-list
5657299|NCT03661723|Pembrolizumab|pembrolizumab|mesh-list
5657300|NCT03661723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5657301|NCT03661723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5657302|NCT03661723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5657303|NCT03661723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5657304|NCT03661723|Growth Substances|growth substances|mesh-ancestor
5657305|NCT03661723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657306|NCT03661723|Growth Inhibitors|growth inhibitors|mesh-ancestor
5657307|NCT03661684|Prednisone|prednisone|mesh-list
5657308|NCT03661684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5657309|NCT03661684|Glucocorticoids|glucocorticoids|mesh-ancestor
5657310|NCT03661684|Hormones|hormones|mesh-ancestor
5657311|NCT03661684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5657312|NCT03661684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657313|NCT03661684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5657314|NCT03661684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5657315|NCT03661645|Dexamethasone|dexamethasone|mesh-list
5657316|NCT03661645|Dexamethasone acetate|dexamethasone acetate|mesh-list
5657317|NCT03661645|Methylprednisolone|methylprednisolone|mesh-list
5836381|NCT02530437|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5836382|NCT02530437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5836383|NCT02530437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5836384|NCT02530437|Tubulin Modulators|tubulin modulators|mesh-ancestor
5836385|NCT02530437|Antimitotic Agents|antimitotic agents|mesh-ancestor
5836386|NCT02530437|Mitosis Modulators|mitosis modulators|mesh-ancestor
5836387|NCT02530437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836388|NCT02530411|Fulvestrant|fulvestrant|mesh-list
5836389|NCT02530411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5836390|NCT02530411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5836391|NCT02530411|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5836392|NCT02530411|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5836393|NCT02530411|Hormone Antagonists|hormone antagonists|mesh-ancestor
5657318|NCT03661645|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5657319|NCT03661645|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5657320|NCT03661645|BB 1101|bb 1101|mesh-list
5657321|NCT03661645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5657322|NCT03661645|Antiemetics|antiemetics|mesh-ancestor
5657323|NCT03661645|Autonomic Agents|autonomic agents|mesh-ancestor
5657324|NCT03661645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5657325|NCT03661645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836394|NCT02530411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5836395|NCT02530411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836396|NCT02530424|Trastuzumab|trastuzumab|mesh-list
5836397|NCT02530424|Pertuzumab|pertuzumab|mesh-list
5836398|NCT02530424|Fulvestrant|fulvestrant|mesh-list
5836399|NCT02530424|Palbociclib|palbociclib|mesh-list
5657326|NCT03661645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5657327|NCT03661645|Glucocorticoids|glucocorticoids|mesh-ancestor
5657328|NCT03661645|Hormones|hormones|mesh-ancestor
5657329|NCT03661645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5657330|NCT03661645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5836400|NCT02530424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6493589|NCT00614471|Antiviral Agents|antiviral agents|mesh-ancestor
5836401|NCT02530424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5836402|NCT02530424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5836403|NCT02530424|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5836404|NCT02530424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5836405|NCT02530424|Hormone Antagonists|hormone antagonists|mesh-ancestor
5836406|NCT02530424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5836407|NCT02530424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836408|NCT02530424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5836409|NCT02530424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5836410|NCT02530424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836411|NCT02530463|Nivolumab|nivolumab|mesh-list
5836412|NCT02530463|Ipilimumab|ipilimumab|mesh-list
5836413|NCT02530463|Azacitidine|azacitidine|mesh-list
5836414|NCT02530463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5836415|NCT02530463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5836416|NCT02530463|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5836417|NCT02530463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836418|NCT02530463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5836419|NCT02530463|Antimetabolites|antimetabolites|mesh-ancestor
5836420|NCT02530463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5836421|NCT02530502|Pembrolizumab|pembrolizumab|mesh-list
5836422|NCT02530502|Temozolomide|temozolomide|mesh-list
5836423|NCT02530502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5836424|NCT02530502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5836425|NCT02530502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5836426|NCT02530502|Alkylating Agents|alkylating agents|mesh-ancestor
5836427|NCT02530502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836428|NCT02530489|Paclitaxel|paclitaxel|mesh-list
6674532|NCT01569945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6674533|NCT01569945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657331|NCT03661645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5657332|NCT03661645|Protease Inhibitors|protease inhibitors|mesh-ancestor
5657333|NCT03661645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5657334|NCT03661645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674534|NCT01569945|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6674535|NCT01569945|Contraceptive Agents|contraceptive agents|mesh-ancestor
6674536|NCT01569945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6674537|NCT01569945|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5836429|NCT02530489|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5836430|NCT02530489|Atezolizumab|atezolizumab|mesh-list
5836431|NCT02530489|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5836432|NCT02530489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5836433|NCT02530489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5836434|NCT02530489|Tubulin Modulators|tubulin modulators|mesh-ancestor
5836435|NCT02530489|Antimitotic Agents|antimitotic agents|mesh-ancestor
5836436|NCT02530489|Mitosis Modulators|mitosis modulators|mesh-ancestor
5836437|NCT02530489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836438|NCT02530489|Immunologic Factors|immunologic factors|mesh-ancestor
5836439|NCT02530489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836440|NCT02530359|Pirfenidone|pirfenidone|mesh-list
5836441|NCT02530359|Analgesics|analgesics|mesh-ancestor
5836442|NCT02530359|Sensory System Agents|sensory system agents|mesh-ancestor
5836443|NCT02530359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5836444|NCT02530359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836445|NCT02530359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5836446|NCT02530359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5836447|NCT02530359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5836448|NCT02530359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5836449|NCT02530359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5836450|NCT02530320|Palbociclib|palbociclib|mesh-list
5836451|NCT02530320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5836452|NCT02530320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5836453|NCT02530320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5657335|NCT03661645|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5657336|NCT03661645|Protective Agents|protective agents|mesh-ancestor
5695003|NCT03392428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5695004|NCT03392428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695005|NCT03392376|Haloperidol|haloperidol|mesh-list
5695006|NCT03392376|Haloperidol decanoate|haloperidol decanoate|mesh-list
5695007|NCT03392376|Antiemetics|antiemetics|mesh-ancestor
5695008|NCT03392376|Autonomic Agents|autonomic agents|mesh-ancestor
5695009|NCT03392376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5657337|NCT03661567|Methylprednisolone|methylprednisolone|mesh-list
5657338|NCT03661567|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5657339|NCT03661567|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5657340|NCT03661567|Prednisolone|prednisolone|mesh-list
5657341|NCT03661567|Prednisolone acetate|prednisolone acetate|mesh-list
5657342|NCT03661567|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5657343|NCT03661567|Prednisolone phosphate|prednisolone phosphate|mesh-list
5836454|NCT02530320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836455|NCT02529982|Curcumin|curcumin|mesh-list
5836456|NCT02529982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5836457|NCT02529982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5836458|NCT02529982|Analgesics|analgesics|mesh-ancestor
5836459|NCT02529982|Sensory System Agents|sensory system agents|mesh-ancestor
5836460|NCT02529982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5836461|NCT02529982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836462|NCT02529982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5836463|NCT02529982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5836464|NCT02529982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5836465|NCT02529982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5836466|NCT02529982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836467|NCT02530060|Tenofovir|tenofovir|mesh-list
5836468|NCT02530060|Emtricitabine|emtricitabine|mesh-list
5836469|NCT02530060|Rilpivirine|rilpivirine|mesh-list
5836470|NCT02530060|Antiviral Agents|antiviral agents|mesh-ancestor
5836471|NCT02530060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5836472|NCT02530060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5836473|NCT02530060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5836474|NCT02530060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5836475|NCT02530060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836476|NCT02530060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5836477|NCT02530060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5836478|NCT02530047|Interferons|interferons|mesh-list
5836479|NCT02530047|Interferon-beta|interferon-beta|mesh-list
5836480|NCT02530047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5836481|NCT02530047|Antiviral Agents|antiviral agents|mesh-ancestor
5836482|NCT02530047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5836483|NCT02530047|Immunologic Factors|immunologic factors|mesh-ancestor
5836484|NCT02530047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836485|NCT02529969|Curcumin|curcumin|mesh-list
5836486|NCT02529969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5836487|NCT02529969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5836488|NCT02529969|Analgesics|analgesics|mesh-ancestor
5836489|NCT02529969|Sensory System Agents|sensory system agents|mesh-ancestor
5836490|NCT02529969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5836491|NCT02529969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836492|NCT02529969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5836493|NCT02529969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5836494|NCT02529969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5836495|NCT02529969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5836496|NCT02529969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836497|NCT02529878|Paclitaxel|paclitaxel|mesh-list
5836498|NCT02529878|Apatinib|apatinib|mesh-list
5836499|NCT02529878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5836500|NCT02529878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5836501|NCT02529878|Tubulin Modulators|tubulin modulators|mesh-ancestor
5836502|NCT02529878|Antimitotic Agents|antimitotic agents|mesh-ancestor
5836503|NCT02529878|Mitosis Modulators|mitosis modulators|mesh-ancestor
5836504|NCT02529878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836505|NCT02529878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5836506|NCT02529878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5657344|NCT03661567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5657345|NCT03661567|Antiemetics|antiemetics|mesh-ancestor
5657346|NCT03661567|Autonomic Agents|autonomic agents|mesh-ancestor
5657347|NCT03661567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5657348|NCT03661567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657349|NCT03661567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5657350|NCT03661567|Glucocorticoids|glucocorticoids|mesh-ancestor
5657351|NCT03661567|Hormones|hormones|mesh-ancestor
5657352|NCT03661567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5657353|NCT03661567|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5657354|NCT03661567|Protective Agents|protective agents|mesh-ancestor
5657355|NCT03661567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5657356|NCT03661567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5836507|NCT02529852|Prednisone|prednisone|mesh-list
5836508|NCT02529852|Cyclophosphamide|cyclophosphamide|mesh-list
5836509|NCT02529852|Doxorubicin|doxorubicin|mesh-list
5836510|NCT02529852|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5836511|NCT02529852|Vincristine|vincristine|mesh-list
5836512|NCT02529852|Lenalidomide|lenalidomide|mesh-list
5836513|NCT02529852|Obinutuzumab|obinutuzumab|mesh-list
5836514|NCT02529852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5836515|NCT02529852|Immunologic Factors|immunologic factors|mesh-ancestor
5836516|NCT02529852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836517|NCT02529852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5836518|NCT02529852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5836519|NCT02529852|Alkylating Agents|alkylating agents|mesh-ancestor
5836520|NCT02529852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836521|NCT02529852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5836522|NCT02529852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5836523|NCT02529852|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5836524|NCT02529852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5836525|NCT02529852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5836526|NCT02529852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5836527|NCT02529852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5836528|NCT02529852|Glucocorticoids|glucocorticoids|mesh-ancestor
5836529|NCT02529852|Hormones|hormones|mesh-ancestor
5836530|NCT02529852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5836531|NCT02529852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5836532|NCT02529852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5836533|NCT02529852|Tubulin Modulators|tubulin modulators|mesh-ancestor
5836534|NCT02529852|Antimitotic Agents|antimitotic agents|mesh-ancestor
5836535|NCT02529852|Mitosis Modulators|mitosis modulators|mesh-ancestor
5836536|NCT02529852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5836537|NCT02529852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5836538|NCT02529852|Growth Substances|growth substances|mesh-ancestor
5836539|NCT02529852|Growth Inhibitors|growth inhibitors|mesh-ancestor
5836540|NCT02529852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5836541|NCT02529839|Cyclophosphamide|cyclophosphamide|mesh-list
5836542|NCT02529839|Fludarabine|fludarabine|mesh-list
5836543|NCT02529839|Alemtuzumab|alemtuzumab|mesh-list
5836544|NCT02529839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5836545|NCT02529839|Immunologic Factors|immunologic factors|mesh-ancestor
5836546|NCT02529839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836547|NCT02529839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5836548|NCT02529839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5836549|NCT02529839|Alkylating Agents|alkylating agents|mesh-ancestor
5836550|NCT02529839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836551|NCT02529839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5836552|NCT02529839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5836553|NCT02529839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5836554|NCT02529787|Dexlansoprazole|dexlansoprazole|mesh-list
5657357|NCT03661515|Cytarabine|cytarabine|mesh-list
5657358|NCT03661515|Fludarabine|fludarabine|mesh-list
5657359|NCT03661515|Idarubicin|idarubicin|mesh-list
5657360|NCT03661515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5657361|NCT03661515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5657362|NCT03661515|Antimetabolites|antimetabolites|mesh-ancestor
5657363|NCT03661515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657364|NCT03661515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5657365|NCT03661515|Immunologic Factors|immunologic factors|mesh-ancestor
5657366|NCT03661515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657367|NCT03661515|Antiviral Agents|antiviral agents|mesh-ancestor
5657368|NCT03661515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5657369|NCT03661515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5657370|NCT03661515|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5836555|NCT02529787|Lansoprazole|lansoprazole|mesh-list
5836556|NCT02529787|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5836557|NCT02529787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5836558|NCT02529787|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5836559|NCT02529787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5836560|NCT02529787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836561|NCT02529774|Leucovorin|leucovorin|mesh-list
5836562|NCT02529774|Dexamethasone|dexamethasone|mesh-list
5836563|NCT02529774|Capecitabine|capecitabine|mesh-list
5836564|NCT02529774|Oxaliplatin|oxaliplatin|mesh-list
5836565|NCT02529774|Fluorouracil|fluorouracil|mesh-list
5836566|NCT02529774|Floxuridine|floxuridine|mesh-list
5836567|NCT02529774|Heparin|heparin|mesh-list
5836568|NCT02529774|Levoleucovorin|levoleucovorin|mesh-list
6211874|NCT02178800|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5657371|NCT03661515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5836569|NCT02529774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5657372|NCT03661515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5657373|NCT03661489|Propofol|propofol|mesh-list
5657374|NCT03661489|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5657375|NCT03661489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5657376|NCT03661489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657377|NCT03661489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5657378|NCT03661489|Anesthetics, General|anesthetics, general|mesh-ancestor
5657379|NCT03661489|Anesthetics|anesthetics|mesh-ancestor
5657380|NCT03661463|Aspirin|aspirin|mesh-list
5657381|NCT03661463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5657382|NCT03661463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5657383|NCT03661463|Analgesics|analgesics|mesh-ancestor
5657384|NCT03661463|Sensory System Agents|sensory system agents|mesh-ancestor
5657385|NCT03661463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5657386|NCT03661463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657387|NCT03661463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5657388|NCT03661463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5657389|NCT03661463|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5657390|NCT03661463|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5657391|NCT03661463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657392|NCT03661463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5657393|NCT03661463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5657394|NCT03661463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5657395|NCT03661463|Antipyretics|antipyretics|mesh-ancestor
5657396|NCT03661411|Aspirin|aspirin|mesh-list
5657397|NCT03661411|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5657398|NCT03661411|Clopidogrel|clopidogrel|mesh-list
5657399|NCT03661411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5657400|NCT03661411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5657401|NCT03661411|Analgesics|analgesics|mesh-ancestor
5657402|NCT03661411|Sensory System Agents|sensory system agents|mesh-ancestor
5657403|NCT03661411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5657404|NCT03661411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657405|NCT03661411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5657406|NCT03661411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5657407|NCT03661411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5657408|NCT03661411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5657409|NCT03661411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657410|NCT03661411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5657411|NCT03661411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5657412|NCT03661411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5657413|NCT03661411|Antipyretics|antipyretics|mesh-ancestor
5657414|NCT03661411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5657415|NCT03661411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5657416|NCT03661411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5657417|NCT03661411|Purinergic Agents|purinergic agents|mesh-ancestor
5657418|NCT03661411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5657419|NCT03661385|Nitric Oxide|nitric oxide|mesh-list
5657420|NCT03661385|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5657421|NCT03661385|Autonomic Agents|autonomic agents|mesh-ancestor
5657422|NCT03661385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5836570|NCT02529774|Antiemetics|antiemetics|mesh-ancestor
5836571|NCT02529774|Autonomic Agents|autonomic agents|mesh-ancestor
5836572|NCT02529774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5836573|NCT02529774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836574|NCT02529774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5836575|NCT02529774|Glucocorticoids|glucocorticoids|mesh-ancestor
5836576|NCT02529774|Hormones|hormones|mesh-ancestor
5836577|NCT02529774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5836578|NCT02529774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5836579|NCT02529774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5836580|NCT02529774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5836581|NCT02529774|Antimetabolites|antimetabolites|mesh-ancestor
5836582|NCT02529774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836583|NCT02529774|Antidotes|antidotes|mesh-ancestor
5836584|NCT02529774|Protective Agents|protective agents|mesh-ancestor
5836585|NCT02529774|Vitamin B Complex|vitamin b complex|mesh-ancestor
5836586|NCT02529774|Vitamins|vitamins|mesh-ancestor
5836587|NCT02529774|Micronutrients|micronutrients|mesh-ancestor
5836588|NCT02529774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5836589|NCT02529774|Immunologic Factors|immunologic factors|mesh-ancestor
5836590|NCT02529774|Anticoagulants|anticoagulants|mesh-ancestor
5836591|NCT02529774|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5836592|NCT02529774|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5836593|NCT02529514|Baclofen|baclofen|mesh-list
6211875|NCT02178800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5836594|NCT02529514|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5836595|NCT02529514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836596|NCT02529514|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5836597|NCT02529514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5836598|NCT02529514|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
5836599|NCT02529514|GABA Agonists|gaba agonists|mesh-ancestor
5836600|NCT02529514|GABA Agents|gaba agents|mesh-ancestor
5836601|NCT02529514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5836602|NCT02529514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836603|NCT02529579|Gemcitabine|gemcitabine|mesh-list
5836604|NCT02529579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5657423|NCT03661385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657424|NCT03661385|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5657425|NCT03661385|Respiratory System Agents|respiratory system agents|mesh-ancestor
5657426|NCT03661385|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5657427|NCT03661385|Antioxidants|antioxidants|mesh-ancestor
5657428|NCT03661385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657429|NCT03661385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5657430|NCT03661385|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5836605|NCT02529579|Antimetabolites|antimetabolites|mesh-ancestor
5836606|NCT02529579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836607|NCT02529579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5836608|NCT02529579|Antiviral Agents|antiviral agents|mesh-ancestor
5836609|NCT02529579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5836610|NCT02529579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5836611|NCT02529579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5836612|NCT02529579|Immunologic Factors|immunologic factors|mesh-ancestor
5657431|NCT03661385|Vasodilator Agents|vasodilator agents|mesh-ancestor
5657432|NCT03661385|Gasotransmitters|gasotransmitters|mesh-ancestor
5657433|NCT03661385|Protective Agents|protective agents|mesh-ancestor
5657434|NCT03661307|Decitabine|decitabine|mesh-list
5657435|NCT03661307|Venetoclax|venetoclax|mesh-list
5657436|NCT03661307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5657437|NCT03661307|Antimetabolites|antimetabolites|mesh-ancestor
5657438|NCT03661307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657439|NCT03661307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5657440|NCT03661307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5657441|NCT03661125|Saracatinib|saracatinib|mesh-list
5657442|NCT03661125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5657443|NCT03661125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5657444|NCT03661125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657454|NCT03660917|Riluzole|riluzole|mesh-list
5657455|NCT03660917|Anticonvulsants|anticonvulsants|mesh-ancestor
5657456|NCT03660917|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5657457|NCT03660917|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5657458|NCT03660917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5657459|NCT03660917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657460|NCT03660917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657461|NCT03660917|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5657462|NCT03660917|Protective Agents|protective agents|mesh-ancestor
5657463|NCT03660813|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5657464|NCT03660813|Luteolytic Agents|luteolytic agents|mesh-ancestor
5657465|NCT03660813|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5657466|NCT03660813|Contraceptive Agents|contraceptive agents|mesh-ancestor
5657467|NCT03660813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5657468|NCT03660813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836613|NCT02529579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836614|NCT02529540|Methamphetamine|methamphetamine|mesh-list
5836615|NCT02529540|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5836616|NCT02529540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836617|NCT02529540|Sympathomimetics|sympathomimetics|mesh-ancestor
5836618|NCT02529540|Autonomic Agents|autonomic agents|mesh-ancestor
5836619|NCT02529540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5836620|NCT02529540|Dopamine Agents|dopamine agents|mesh-ancestor
5657469|NCT03660813|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5836621|NCT02529540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5836622|NCT02529540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836623|NCT02529540|Adrenergic Agents|adrenergic agents|mesh-ancestor
5836624|NCT02529540|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5836625|NCT02529540|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5836626|NCT02529540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5836627|NCT02529540|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5836628|NCT02529631|Orlistat|orlistat|mesh-list
5836629|NCT02529631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5836630|NCT02529631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657470|NCT03660813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5657471|NCT03660813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5657472|NCT03660761|Apatinib|apatinib|mesh-list
5657473|NCT03660761|Temozolomide|temozolomide|mesh-list
5657474|NCT03660761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5657475|NCT03660761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5657476|NCT03660761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5657477|NCT03660761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657478|NCT03660761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5836631|NCT02529631|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5836632|NCT02529631|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5836633|NCT02529670|Lidocaine|lidocaine|mesh-list
5836634|NCT02529670|Anesthetics, Local|anesthetics, local|mesh-ancestor
5836635|NCT02529670|Anesthetics|anesthetics|mesh-ancestor
5836636|NCT02529670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5836637|NCT02529670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836638|NCT02529670|Sensory System Agents|sensory system agents|mesh-ancestor
5836639|NCT02529670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5657479|NCT03660761|Alkylating Agents|alkylating agents|mesh-ancestor
5657480|NCT03660683|Dapagliflozin|dapagliflozin|mesh-list
5657481|NCT03660683|Saxagliptin|saxagliptin|mesh-list
5657482|NCT03660683|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5657483|NCT03660683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657484|NCT03660683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5657485|NCT03660683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657486|NCT03660683|Incretins|incretins|mesh-ancestor
5657487|NCT03660683|Hormones|hormones|mesh-ancestor
5657488|NCT03660683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5657489|NCT03660683|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5657490|NCT03660683|Protease Inhibitors|protease inhibitors|mesh-ancestor
5657491|NCT03660683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5657492|NCT03660488|Penicillins|penicillins|mesh-list
5657493|NCT03660488|Cefixime|cefixime|mesh-list
5657494|NCT03660488|Penicillin G|penicillin g|mesh-list
5657495|NCT03660488|Penicillin G Benzathine|penicillin g benzathine|mesh-list
5657496|NCT03660488|Penicillin G Procaine|penicillin g procaine|mesh-list
5657497|NCT03660488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5657498|NCT03660488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5657499|NCT03660475|Naltrexone|naltrexone|mesh-list
5657500|NCT03660475|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5657501|NCT03660475|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5657502|NCT03660475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657503|NCT03660475|Sensory System Agents|sensory system agents|mesh-ancestor
5836640|NCT02529670|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5836641|NCT02529670|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5836642|NCT02529670|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5836643|NCT02529670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5836644|NCT02529670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836645|NCT02529683|NuvaRing|nuvaring|mesh-list
5836646|NCT02529683|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5657504|NCT03660475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5657505|NCT03660436|Mycophenolic Acid|mycophenolic acid|mesh-list
5657506|NCT03660436|BMS-986165|bms-986165|mesh-list
5657507|NCT03660436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5657508|NCT03660436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5657509|NCT03660436|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5657510|NCT03660436|Antitubercular Agents|antitubercular agents|mesh-ancestor
5836647|NCT02529683|Contraceptive Agents|contraceptive agents|mesh-ancestor
5836648|NCT02529683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5836649|NCT02529683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836650|NCT02529761|Sorafenib|sorafenib|mesh-list
5836651|NCT02529761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6211876|NCT02178800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657511|NCT03660436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5657512|NCT03660436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5657513|NCT03660436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5657514|NCT03660436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657515|NCT03660436|Dermatologic Agents|dermatologic agents|mesh-ancestor
5657516|NCT03660436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5657517|NCT03660397|Antihypertensive Agents|antihypertensive agents|mesh-list
5657518|NCT03660306|Analgesics, Opioid|analgesics, opioid|mesh-list
5657519|NCT03660306|Anesthetics|anesthetics|mesh-list
5657520|NCT03660306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5657521|NCT03660306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836652|NCT02529761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5836653|NCT02529761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5836654|NCT02529761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836655|NCT02529449|Ipragliflozin|ipragliflozin|mesh-list
5836656|NCT02529449|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5836657|NCT02529449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836658|NCT02529449|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5836659|NCT02529449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836660|NCT02529124|Caseins|caseins|mesh-list
5836661|NCT02529124|Chelating Agents|chelating agents|mesh-ancestor
5836662|NCT02529124|Sequestering Agents|sequestering agents|mesh-ancestor
5836663|NCT02529124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902921|NCT03124355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902922|NCT03124355|Cholinergic Agents|cholinergic agents|mesh-ancestor
5902923|NCT03124355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5902924|NCT03124355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902925|NCT03124355|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5902926|NCT03124355|Autonomic Agents|autonomic agents|mesh-ancestor
5657522|NCT03660306|Narcotics|narcotics|mesh-ancestor
5657523|NCT03660306|Analgesics|analgesics|mesh-ancestor
5657524|NCT03660306|Sensory System Agents|sensory system agents|mesh-ancestor
5657525|NCT03660306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5657526|NCT03660293|Captopril|captopril|mesh-list
5657527|NCT03660293|Atorvastatin|atorvastatin|mesh-list
5657528|NCT03660293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5657529|NCT03660293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5657530|NCT03660293|Antimetabolites|antimetabolites|mesh-ancestor
5657531|NCT03660293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657532|NCT03660293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5902927|NCT03124355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5902928|NCT03124355|Nootropic Agents|nootropic agents|mesh-ancestor
5902929|NCT03056339|Vidarabine|vidarabine|mesh-list
5902930|NCT03056339|Cyclophosphamide|cyclophosphamide|mesh-list
5902931|NCT03056339|Fludarabine|fludarabine|mesh-list
5902932|NCT03056339|Fludarabine phosphate|fludarabine phosphate|mesh-list
5902933|NCT03056339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5902934|NCT03056339|Immunologic Factors|immunologic factors|mesh-ancestor
5902935|NCT03056339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902936|NCT03056339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5902937|NCT03056339|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5902938|NCT03056339|Alkylating Agents|alkylating agents|mesh-ancestor
5902939|NCT03056339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657533|NCT03660293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5657534|NCT03660293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5657535|NCT03660293|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5657536|NCT03660293|Protease Inhibitors|protease inhibitors|mesh-ancestor
5657537|NCT03660293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6674538|NCT01569945|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6674539|NCT01569945|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6674540|NCT01569945|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6674541|NCT01569945|Hormone Antagonists|hormone antagonists|mesh-ancestor
5902940|NCT03056339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5902941|NCT03056339|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5902942|NCT03056339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5902943|NCT03056339|Antimetabolites|antimetabolites|mesh-ancestor
5902944|NCT03056339|Antiviral Agents|antiviral agents|mesh-ancestor
5902945|NCT03056339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5902946|NCT02937571|Dexamethasone|dexamethasone|mesh-list
5902947|NCT02937571|Lenalidomide|lenalidomide|mesh-list
5902948|NCT02937571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5902949|NCT02937571|Antiemetics|antiemetics|mesh-ancestor
5902950|NCT02937571|Autonomic Agents|autonomic agents|mesh-ancestor
5902951|NCT02937571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6211877|NCT02178800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6674542|NCT01569945|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6674543|NCT01569945|Fertility Agents|fertility agents|mesh-ancestor
6674544|NCT01569945|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6674545|NCT01569945|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6674546|NCT01569984|Bevacizumab|bevacizumab|mesh-list
6674547|NCT01569984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6674548|NCT01569984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5657538|NCT03660267|Caffeine|caffeine|mesh-list
5657539|NCT03660267|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5657540|NCT03660267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657541|NCT03660267|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5657542|NCT03660267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5836664|NCT02529059|Tenofovir|tenofovir|mesh-list
5836665|NCT02529059|Emtricitabine|emtricitabine|mesh-list
5836666|NCT02529059|Rilpivirine|rilpivirine|mesh-list
5836667|NCT02529059|Antiviral Agents|antiviral agents|mesh-ancestor
5836668|NCT02529059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5836669|NCT02529059|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5836670|NCT02529059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5657543|NCT03660267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657544|NCT03660267|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5657545|NCT03660267|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5657546|NCT03660267|Purinergic Agents|purinergic agents|mesh-ancestor
5657547|NCT03660267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5657548|NCT03660046|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
5657549|NCT03660046|Levonorgestrel|levonorgestrel|mesh-list
5657550|NCT03660046|Medroxyprogesterone|medroxyprogesterone|mesh-list
5657551|NCT03660046|Etonogestrel|etonogestrel|mesh-list
5657552|NCT03660046|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5657553|NCT03660046|Contraceptive Agents|contraceptive agents|mesh-ancestor
5657554|NCT03660046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5657555|NCT03660046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657556|NCT03660046|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5657557|NCT03660046|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5657558|NCT03660046|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5657559|NCT03660046|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5657560|NCT03660046|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5657561|NCT03660046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5657562|NCT03660046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5657563|NCT03660020|Anesthetics|anesthetics|mesh-list
5657564|NCT03660020|Anesthetics, Local|anesthetics, local|mesh-list
5657565|NCT03660020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5657566|NCT03660020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657567|NCT03660020|Sensory System Agents|sensory system agents|mesh-ancestor
5657568|NCT03660020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5695010|NCT03392376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695011|NCT03392376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5695012|NCT03392376|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5836671|NCT02529059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5836672|NCT02529059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836673|NCT02529059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5836674|NCT02529059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5836675|NCT02529241|Delpazolid|delpazolid|mesh-list
5836676|NCT02529241|Oxazolidinones|oxazolidinones|mesh-list
5836677|NCT02529241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5836678|NCT02529241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5836679|NCT02529241|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5836680|NCT02529241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5836681|NCT02529241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695013|NCT03392376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5695014|NCT03392376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5695015|NCT03392376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5695016|NCT03392376|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5695017|NCT03392376|Dopamine Agents|dopamine agents|mesh-ancestor
5695018|NCT03392376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5695019|NCT03392376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695020|NCT03392376|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5695021|NCT03392311|Calcipotriene|calcipotriene|mesh-list
5695022|NCT03392311|Dermatologic Agents|dermatologic agents|mesh-ancestor
5695023|NCT03392272|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
5695024|NCT03392272|Hemostatics|hemostatics|mesh-ancestor
5836682|NCT02529202|Dexmedetomidine|dexmedetomidine|mesh-list
5836683|NCT02529202|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5836684|NCT02529202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5836685|NCT02529202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657569|NCT03659851|Simendan|simendan|mesh-list
5657570|NCT03659851|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5657571|NCT03659851|Vasodilator Agents|vasodilator agents|mesh-ancestor
5657572|NCT03659851|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5657573|NCT03659851|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5657574|NCT03659851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5657575|NCT03659851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657576|NCT03659851|Protective Agents|protective agents|mesh-ancestor
5836686|NCT02529202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5836687|NCT02529202|Analgesics|analgesics|mesh-ancestor
5836688|NCT02529202|Sensory System Agents|sensory system agents|mesh-ancestor
5836689|NCT02529202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5836690|NCT02529202|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5836691|NCT02529202|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5836692|NCT02529202|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5836693|NCT02529202|Adrenergic Agents|adrenergic agents|mesh-ancestor
5836694|NCT02529202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5836695|NCT02529202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836696|NCT02529293|Insulin Lispro|insulin lispro|mesh-list
5836697|NCT02529293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5657577|NCT03659851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674549|NCT01569984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6674550|NCT01569984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6674551|NCT01569984|Growth Substances|growth substances|mesh-ancestor
6674552|NCT01569984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674553|NCT01569984|Growth Inhibitors|growth inhibitors|mesh-ancestor
5836698|NCT02529293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836699|NCT02528695|Hypoglycemic Agents|hypoglycemic agents|mesh-list
5836700|NCT02528695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674554|NCT01570049|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6674555|NCT01570049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5836701|NCT02528877|Sirolimus|sirolimus|mesh-list
5836702|NCT02528877|Fludarabine|fludarabine|mesh-list
5836703|NCT02528877|Fludarabine phosphate|fludarabine phosphate|mesh-list
5836704|NCT02528877|Melphalan|melphalan|mesh-list
5836705|NCT02528877|Mechlorethamine|mechlorethamine|mesh-list
5836706|NCT02528877|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
6674556|NCT01570049|Alkylating Agents|alkylating agents|mesh-ancestor
6674557|NCT01570049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674558|NCT01570049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6674559|NCT01570088|Folic Acid|folic acid|mesh-list
6674560|NCT01570088|Hematinics|hematinics|mesh-ancestor
6674561|NCT01570088|Vitamin B Complex|vitamin b complex|mesh-ancestor
6674562|NCT01570088|Vitamins|vitamins|mesh-ancestor
6674563|NCT01570088|Micronutrients|micronutrients|mesh-ancestor
6674564|NCT01570088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674565|NCT01570296|Gefitinib|gefitinib|mesh-list
6674566|NCT01570296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5657578|NCT03659799|Insulin|insulin|mesh-list
5657579|NCT03659799|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5657580|NCT03659799|Insulin Aspart|insulin aspart|mesh-list
5657581|NCT03659799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5657582|NCT03659799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657583|NCT03659734|Analgesics, Opioid|analgesics, opioid|mesh-list
5657584|NCT03659734|Narcotics|narcotics|mesh-ancestor
5657585|NCT03659734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5657586|NCT03659734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657587|NCT03659734|Analgesics|analgesics|mesh-ancestor
5657588|NCT03659734|Sensory System Agents|sensory system agents|mesh-ancestor
5657589|NCT03659734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5657590|NCT03659461|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5657591|NCT03659461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5657592|NCT03659461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657593|NCT03659461|Incretins|incretins|mesh-ancestor
5657594|NCT03659461|Hormones|hormones|mesh-ancestor
5657595|NCT03659461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5657596|NCT03659461|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5657597|NCT03659461|Protease Inhibitors|protease inhibitors|mesh-ancestor
5657598|NCT03659461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5657599|NCT03659461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657600|NCT03659435|Rivastigmine|rivastigmine|mesh-list
5657601|NCT03659435|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5657602|NCT03659435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5657603|NCT03659435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836707|NCT02528877|Tacrolimus|tacrolimus|mesh-list
5657604|NCT03659435|Cholinergic Agents|cholinergic agents|mesh-ancestor
5657605|NCT03659435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5657606|NCT03659435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836708|NCT02528877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5836709|NCT02528877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5836710|NCT02528877|Antimetabolites|antimetabolites|mesh-ancestor
5836711|NCT02528877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836712|NCT02528877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5836713|NCT02528877|Immunologic Factors|immunologic factors|mesh-ancestor
5836714|NCT02528877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836715|NCT02528877|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5836716|NCT02528877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5836717|NCT02528877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5836718|NCT02528877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5836719|NCT02528877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5836720|NCT02528877|Antifungal Agents|antifungal agents|mesh-ancestor
5836721|NCT02528877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5836722|NCT02528877|Alkylating Agents|alkylating agents|mesh-ancestor
5836723|NCT02528877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5836724|NCT02528682|Vaccines|vaccines|mesh-list
5836725|NCT02528682|Immunologic Factors|immunologic factors|mesh-ancestor
5836726|NCT02528682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836727|NCT02528825|Remifentanil|remifentanil|mesh-list
5836728|NCT02528825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5836729|NCT02528825|Narcotics|narcotics|mesh-ancestor
5657607|NCT03659435|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5657608|NCT03659435|Protective Agents|protective agents|mesh-ancestor
5657609|NCT03659383|Hypoglycemic Agents|hypoglycemic agents|mesh-list
5657610|NCT03659383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657611|NCT03659305|Bevacizumab|bevacizumab|mesh-list
5657612|NCT03659305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5657613|NCT03659305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5657614|NCT03659305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5657615|NCT03659305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5657616|NCT03659305|Growth Substances|growth substances|mesh-ancestor
5657617|NCT03659305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657618|NCT03659305|Growth Inhibitors|growth inhibitors|mesh-ancestor
5657619|NCT03659292|Anesthetics|anesthetics|mesh-list
5657620|NCT03659292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5657621|NCT03659292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657622|NCT03659162|Antifungal Agents|antifungal agents|mesh-list
5657623|NCT03659162|Clotrimazole|clotrimazole|mesh-list
5657624|NCT03659162|Miconazole|miconazole|mesh-list
5657625|NCT03659162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5657626|NCT03659162|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5657627|NCT03659162|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5657628|NCT03659162|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5657629|NCT03659162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5657630|NCT03659162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836730|NCT02528825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5836731|NCT02528825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836732|NCT02528825|Analgesics|analgesics|mesh-ancestor
5836733|NCT02528825|Sensory System Agents|sensory system agents|mesh-ancestor
5836734|NCT02528825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5836735|NCT02528760|Erythromycin|erythromycin|mesh-list
5836736|NCT02528760|Erythromycin Estolate|erythromycin estolate|mesh-list
5836737|NCT02528760|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
5836738|NCT02528760|Erythromycin stearate|erythromycin stearate|mesh-list
5836739|NCT02528760|Metoclopramide|metoclopramide|mesh-list
5836740|NCT02528760|Antiemetics|antiemetics|mesh-ancestor
5836741|NCT02528760|Autonomic Agents|autonomic agents|mesh-ancestor
5836742|NCT02528760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5836743|NCT02528760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836744|NCT02528760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5836745|NCT02528760|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5836746|NCT02528760|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5836747|NCT02528760|Dopamine Agents|dopamine agents|mesh-ancestor
5836748|NCT02528760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5836749|NCT02528760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836750|NCT02528760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5836751|NCT02528760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5836752|NCT02528760|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5836753|NCT02528760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5836754|NCT02528526|Inositol|inositol|mesh-list
5836755|NCT02528526|Vitamin B Complex|vitamin b complex|mesh-ancestor
5836756|NCT02528526|Vitamins|vitamins|mesh-ancestor
5836757|NCT02528526|Micronutrients|micronutrients|mesh-ancestor
5836758|NCT02528526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836759|NCT02528461|Sofosbuvir|sofosbuvir|mesh-list
5836760|NCT02528461|Liver Extracts|liver extracts|mesh-list
5836761|NCT02528461|Hematinics|hematinics|mesh-ancestor
5836762|NCT02528461|Antiviral Agents|antiviral agents|mesh-ancestor
5836763|NCT02528461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5836764|NCT02528513|Fentanyl|fentanyl|mesh-list
5836765|NCT02528513|Midazolam|midazolam|mesh-list
5836766|NCT02528513|Dexmedetomidine|dexmedetomidine|mesh-list
5836767|NCT02528513|Propofol|propofol|mesh-list
5836768|NCT02528513|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5836769|NCT02528513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5836770|NCT02528513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836771|NCT02528513|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5836772|NCT02528513|Anesthetics, General|anesthetics, general|mesh-ancestor
5836773|NCT02528513|Anesthetics|anesthetics|mesh-ancestor
5836774|NCT02528513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5836775|NCT02528513|Analgesics|analgesics|mesh-ancestor
5836776|NCT02528513|Sensory System Agents|sensory system agents|mesh-ancestor
5836777|NCT02528513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5836778|NCT02528513|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5836779|NCT02528513|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5836780|NCT02528513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5836781|NCT02528513|Adrenergic Agents|adrenergic agents|mesh-ancestor
5836782|NCT02528513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5836783|NCT02528513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836784|NCT02528513|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5836785|NCT02528513|Narcotics|narcotics|mesh-ancestor
5836786|NCT02528513|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5836787|NCT02528513|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5836788|NCT02528513|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5836789|NCT02528513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5836790|NCT02528513|GABA Modulators|gaba modulators|mesh-ancestor
5836791|NCT02528513|GABA Agents|gaba agents|mesh-ancestor
5836792|NCT02528175|Capecitabine|capecitabine|mesh-list
5836793|NCT02528175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5836794|NCT02528175|Antimetabolites|antimetabolites|mesh-ancestor
5836795|NCT02528175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836796|NCT02528175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5836797|NCT02528396|Insulin Lispro|insulin lispro|mesh-list
5836798|NCT02528396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5836799|NCT02528396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657631|NCT03659162|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5657632|NCT03659162|Hormone Antagonists|hormone antagonists|mesh-ancestor
5657633|NCT03659162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5657634|NCT03659162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657635|NCT03659162|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5657636|NCT03659162|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5657637|NCT03659084|Deferasirox|deferasirox|mesh-list
5657638|NCT03659084|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5657639|NCT03659084|Chelating Agents|chelating agents|mesh-ancestor
5657640|NCT03659084|Sequestering Agents|sequestering agents|mesh-ancestor
5657641|NCT03659084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657642|NCT03659058|Colchicine|colchicine|mesh-list
5657643|NCT03659058|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
5657644|NCT03659058|Antioxidants|antioxidants|mesh-list
5657645|NCT03659058|Silymarin|silymarin|mesh-list
5657646|NCT03659058|Gout Suppressants|gout suppressants|mesh-ancestor
5657647|NCT03659058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5657648|NCT03659058|Tubulin Modulators|tubulin modulators|mesh-ancestor
5657649|NCT03659058|Antimitotic Agents|antimitotic agents|mesh-ancestor
5657650|NCT03659058|Mitosis Modulators|mitosis modulators|mesh-ancestor
5657651|NCT03659058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657652|NCT03659058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5657653|NCT03659058|Protective Agents|protective agents|mesh-ancestor
5657654|NCT03659058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657655|NCT03659058|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5657656|NCT03659058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5657657|NCT03658993|Rifaximin|rifaximin|mesh-list
5657658|NCT03658993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5657659|NCT03658993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5657660|NCT03658993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5657661|NCT03658850|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5657662|NCT03658850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5657663|NCT03658850|Diuretics|diuretics|mesh-ancestor
5836800|NCT02528201|Celecoxib|celecoxib|mesh-list
5836801|NCT02528201|Diclofenac|diclofenac|mesh-list
5836802|NCT02528201|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5836803|NCT02528201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5836804|NCT02528201|Analgesics|analgesics|mesh-ancestor
5836805|NCT02528201|Sensory System Agents|sensory system agents|mesh-ancestor
5836806|NCT02528201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5657664|NCT03658850|Natriuretic Agents|natriuretic agents|mesh-ancestor
5657665|NCT03658850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657666|NCT03658850|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5657667|NCT03658850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5657668|NCT03658850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657669|NCT03658785|Aldesleukin|aldesleukin|mesh-list
5657670|NCT03658785|Cyclophosphamide|cyclophosphamide|mesh-list
5657671|NCT03658785|Fludarabine|fludarabine|mesh-list
5657672|NCT03658785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5657673|NCT03658785|Immunologic Factors|immunologic factors|mesh-ancestor
5657674|NCT03658785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657675|NCT03658785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5657676|NCT03658785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5657677|NCT03658785|Alkylating Agents|alkylating agents|mesh-ancestor
5657678|NCT03658785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836807|NCT02528201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836808|NCT02528201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5836809|NCT02528201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5836810|NCT02528201|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5836811|NCT02528201|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5836812|NCT02528201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5836813|NCT02528201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836814|NCT02528383|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5836815|NCT02528383|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5836816|NCT02528383|Estradiol|estradiol|mesh-list
5836817|NCT02528383|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5836818|NCT02528383|Estrogens|estrogens|mesh-ancestor
5836819|NCT02528383|Hormones|hormones|mesh-ancestor
5657679|NCT03658785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5657680|NCT03658785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5657681|NCT03658785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5657682|NCT03658785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5657683|NCT03658785|Antiviral Agents|antiviral agents|mesh-ancestor
5657684|NCT03658785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5657685|NCT03658746|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5657686|NCT03658746|Amoxicillin|amoxicillin|mesh-list
5657687|NCT03658746|Metronidazole|metronidazole|mesh-list
5657688|NCT03658746|Clarithromycin|clarithromycin|mesh-list
5836820|NCT02528383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5836821|NCT02528383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836822|NCT02528383|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5836823|NCT02528383|Contraceptive Agents|contraceptive agents|mesh-ancestor
5836824|NCT02528383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5836825|NCT02528383|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5836826|NCT02528279|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
5836827|NCT02528279|Antimalarials|antimalarials|mesh-ancestor
5836828|NCT02528279|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5836829|NCT02528279|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5836830|NCT02528279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5836831|NCT02528448|Plasma-lyte 148|plasma-lyte 148|mesh-list
5836832|NCT02528448|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5836833|NCT02528448|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5836834|NCT02528136|Oxytocin|oxytocin|mesh-list
5836835|NCT02528136|Carbetocin|carbetocin|mesh-list
5836836|NCT02528136|Oxytocics|oxytocics|mesh-ancestor
5836837|NCT02528136|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5836838|NCT02528136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836839|NCT02528123|Tobramycin|tobramycin|mesh-list
5836840|NCT02528123|Ofloxacin|ofloxacin|mesh-list
5657689|NCT03658746|Levofloxacin|levofloxacin|mesh-list
5657690|NCT03658746|Ofloxacin|ofloxacin|mesh-list
5657691|NCT03658746|Tetracycline|tetracycline|mesh-list
5657692|NCT03658746|Tinidazole|tinidazole|mesh-list
5657693|NCT03658746|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5657694|NCT03658746|Furazolidone|furazolidone|mesh-list
5836841|NCT02528123|Dexamethasone|dexamethasone|mesh-list
5836842|NCT02528123|Benoxinate|benoxinate|mesh-list
5836843|NCT02528123|Proxymetacaine|proxymetacaine|mesh-list
5836844|NCT02528123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5657695|NCT03658746|Bismuth|bismuth|mesh-list
5657696|NCT03658746|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
5657697|NCT03658746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5657698|NCT03658746|Antitubercular Agents|antitubercular agents|mesh-ancestor
5657699|NCT03658746|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5657700|NCT03658746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5657701|NCT03658746|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5657702|NCT03658746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5657703|NCT03658746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657704|NCT03658746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5657705|NCT03658746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5657706|NCT03658746|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5657707|NCT03658746|Renal Agents|renal agents|mesh-ancestor
5657708|NCT03658746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5657709|NCT03658746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5657710|NCT03658746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5657711|NCT03658746|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5657712|NCT03658746|Antacids|antacids|mesh-ancestor
5657713|NCT03658746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5657714|NCT03658746|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5657715|NCT03658746|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
5836845|NCT02528123|Antiemetics|antiemetics|mesh-ancestor
5836846|NCT02528123|Autonomic Agents|autonomic agents|mesh-ancestor
5836847|NCT02528123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5836848|NCT02528123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836849|NCT02528123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5836850|NCT02528123|Glucocorticoids|glucocorticoids|mesh-ancestor
5836851|NCT02528123|Hormones|hormones|mesh-ancestor
5836852|NCT02528123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5657716|NCT03658746|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
5657717|NCT03658746|Alkylating Agents|alkylating agents|mesh-ancestor
5657718|NCT03658733|Amoxicillin|amoxicillin|mesh-list
5657719|NCT03658733|Tetracycline|tetracycline|mesh-list
5657720|NCT03658733|Furazolidone|furazolidone|mesh-list
5657721|NCT03658733|Esomeprazole|esomeprazole|mesh-list
5657722|NCT03658733|Rabeprazole|rabeprazole|mesh-list
5657723|NCT03658733|Bismuth|bismuth|mesh-list
5657724|NCT03658733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5657725|NCT03658733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5657726|NCT03658733|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5657727|NCT03658733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5657728|NCT03658733|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5657729|NCT03658733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5657730|NCT03658733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657731|NCT03658733|Antacids|antacids|mesh-ancestor
5657732|NCT03658733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5657733|NCT03658733|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5657734|NCT03658733|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5836853|NCT02528123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5836854|NCT02528123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5836855|NCT02528123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5836856|NCT02528123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5836857|NCT02528123|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5836858|NCT02528123|Renal Agents|renal agents|mesh-ancestor
5836859|NCT02528123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5836860|NCT02528123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5836861|NCT02528123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5836862|NCT02528123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836863|NCT02528123|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5836864|NCT02528123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5657735|NCT03658733|Renal Agents|renal agents|mesh-ancestor
5657736|NCT03658733|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
5657737|NCT03658733|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5657738|NCT03658733|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5657739|NCT03658733|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
5657740|NCT03658720|Ibuprofen|ibuprofen|mesh-list
5657741|NCT03658720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5657742|NCT03658720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5657743|NCT03658720|Analgesics|analgesics|mesh-ancestor
5836865|NCT02528123|Anesthetics, Local|anesthetics, local|mesh-ancestor
5836866|NCT02528123|Anesthetics|anesthetics|mesh-ancestor
5657744|NCT03658720|Sensory System Agents|sensory system agents|mesh-ancestor
5657745|NCT03658720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5657746|NCT03658720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657747|NCT03658720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5657748|NCT03658720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5657749|NCT03658720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5657750|NCT03658720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5657751|NCT03658720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657752|NCT03658590|Dexamethasone|dexamethasone|mesh-list
5657753|NCT03658590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5657754|NCT03658590|Antiemetics|antiemetics|mesh-ancestor
5657755|NCT03658590|Autonomic Agents|autonomic agents|mesh-ancestor
5657756|NCT03658590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5657757|NCT03658590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657758|NCT03658590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5657759|NCT03658590|Glucocorticoids|glucocorticoids|mesh-ancestor
5657760|NCT03658590|Hormones|hormones|mesh-ancestor
5657761|NCT03658590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5657762|NCT03658590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5657763|NCT03658590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5836867|NCT02528123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5836868|NCT02528123|Sensory System Agents|sensory system agents|mesh-ancestor
5836869|NCT02528019|Glimepiride|glimepiride|mesh-list
5836870|NCT02528019|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
5836871|NCT02528019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5836872|NCT02528019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5836873|NCT02528019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836874|NCT02528019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5836875|NCT02528019|Immunologic Factors|immunologic factors|mesh-ancestor
5836876|NCT02528019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657764|NCT03658473|Naproxen|naproxen|mesh-list
5657765|NCT03658473|Rabeprazole|rabeprazole|mesh-list
5657766|NCT03658473|Rebamipide|rebamipide|mesh-list
5657767|NCT03658473|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5657768|NCT03658473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5657769|NCT03658473|Analgesics|analgesics|mesh-ancestor
5657770|NCT03658473|Sensory System Agents|sensory system agents|mesh-ancestor
5657771|NCT03658473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5657772|NCT03658473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674567|NCT01570296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6674568|NCT01570296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6674569|NCT01570296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674570|NCT01570478|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6674571|NCT01570478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6674572|NCT01570478|Autonomic Agents|autonomic agents|mesh-ancestor
6674573|NCT01570478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6674574|NCT01570478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674575|NCT01570478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5657773|NCT03658473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5657774|NCT03658473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5657775|NCT03658473|Gout Suppressants|gout suppressants|mesh-ancestor
5657776|NCT03658473|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5657777|NCT03658473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5657778|NCT03658473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657779|NCT03658473|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5657780|NCT03658473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5657781|NCT03658473|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5657782|NCT03658473|Antioxidants|antioxidants|mesh-ancestor
5657783|NCT03658473|Protective Agents|protective agents|mesh-ancestor
5657784|NCT03658447|Pembrolizumab|pembrolizumab|mesh-list
5657785|NCT03658447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5657786|NCT03658447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5695025|NCT03392272|Coagulants|coagulants|mesh-ancestor
5695026|NCT03392103|Raltitrexed|raltitrexed|mesh-list
5695027|NCT03392103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5695028|NCT03392103|Antimetabolites|antimetabolites|mesh-ancestor
5695029|NCT03392103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695030|NCT03392103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5695031|NCT03392103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5695032|NCT03392103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5695033|NCT03392051|Clopidogrel|clopidogrel|mesh-list
5836877|NCT02527941|Metronidazole|metronidazole|mesh-list
5836878|NCT02527941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5836879|NCT02527941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5836880|NCT02527941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5836881|NCT02527941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5836882|NCT02527993|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5836883|NCT02527993|Liraglutide|liraglutide|mesh-list
5836884|NCT02527993|Acarbose|acarbose|mesh-list
5836885|NCT02527993|Verapamil|verapamil|mesh-list
5836886|NCT02527993|Pasireotide|pasireotide|mesh-list
5836887|NCT02527993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5836888|NCT02527993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836889|NCT02527993|Incretins|incretins|mesh-ancestor
5836890|NCT02527993|Hormones|hormones|mesh-ancestor
5836891|NCT02527993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5836892|NCT02527993|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5836893|NCT02527993|Protease Inhibitors|protease inhibitors|mesh-ancestor
5836894|NCT02527993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5836895|NCT02527993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836896|NCT02527993|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
5836897|NCT02527993|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5836898|NCT02527993|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5836899|NCT02527993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5836900|NCT02527993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5836901|NCT02527993|Vasodilator Agents|vasodilator agents|mesh-ancestor
5836902|NCT02527733|Ranibizumab|ranibizumab|mesh-list
5836903|NCT02527733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5836904|NCT02527733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5836905|NCT02527733|Growth Substances|growth substances|mesh-ancestor
5836906|NCT02527733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836907|NCT02527733|Growth Inhibitors|growth inhibitors|mesh-ancestor
5836908|NCT02527733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6493590|NCT00614471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6493591|NCT00614471|Immunologic Factors|immunologic factors|mesh-ancestor
6493592|NCT00614471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493593|NCT00614536|Rabeprazole|rabeprazole|mesh-list
5657787|NCT03658421|Dexmedetomidine|dexmedetomidine|mesh-list
5657788|NCT03658421|Morphine|morphine|mesh-list
5657789|NCT03658421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5657790|NCT03658421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5657791|NCT03658421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657792|NCT03658421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6493594|NCT00614536|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6493595|NCT00614536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6493596|NCT00614536|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6493597|NCT00614536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6493598|NCT00614536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493599|NCT00614588|Anesthetics|anesthetics|mesh-list
6493600|NCT00614588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6493601|NCT00614588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493602|NCT00614653|Bevacizumab|bevacizumab|mesh-list
6493603|NCT00614653|Capecitabine|capecitabine|mesh-list
6493604|NCT00614653|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6493605|NCT00614653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6493606|NCT00614653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6493607|NCT00614653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6493608|NCT00614653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6493609|NCT00614653|Growth Substances|growth substances|mesh-ancestor
6493610|NCT00614653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493611|NCT00614653|Growth Inhibitors|growth inhibitors|mesh-ancestor
6493612|NCT00614653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5836909|NCT02527746|Cyclophosphamide|cyclophosphamide|mesh-list
5836910|NCT02527746|Epirubicin|epirubicin|mesh-list
5836911|NCT02527746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5836912|NCT02527746|Immunologic Factors|immunologic factors|mesh-ancestor
5836913|NCT02527746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836914|NCT02527746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5836915|NCT02527746|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5836916|NCT02527746|Alkylating Agents|alkylating agents|mesh-ancestor
5836917|NCT02527746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836918|NCT02527746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5836919|NCT02527746|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5657793|NCT03658421|Analgesics|analgesics|mesh-ancestor
5657794|NCT03658421|Sensory System Agents|sensory system agents|mesh-ancestor
5657795|NCT03658421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5657796|NCT03658421|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5657797|NCT03658421|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5657798|NCT03658421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5657799|NCT03658421|Adrenergic Agents|adrenergic agents|mesh-ancestor
5657800|NCT03658421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5657801|NCT03658421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657802|NCT03658421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5657803|NCT03658421|Narcotics|narcotics|mesh-ancestor
5657804|NCT03658408|4-Aminopyridine|4-aminopyridine|mesh-list
5657805|NCT03658408|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5657806|NCT03658408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5657807|NCT03658408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657808|NCT03658330|Naltrexone|naltrexone|mesh-list
5657809|NCT03658330|Ketamine|ketamine|mesh-list
5657810|NCT03658330|Analgesics|analgesics|mesh-ancestor
6674576|NCT01570478|Respiratory System Agents|respiratory system agents|mesh-ancestor
6674577|NCT01570478|Glucocorticoids|glucocorticoids|mesh-ancestor
6674578|NCT01570478|Hormones|hormones|mesh-ancestor
6674579|NCT01570478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6674580|NCT01570478|Sympathomimetics|sympathomimetics|mesh-ancestor
6674581|NCT01570504|Ivermectin|ivermectin|mesh-list
6674582|NCT01570504|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6674583|NCT01570504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6674584|NCT01570556|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6674585|NCT01570556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6674586|NCT01570569|Losartan|losartan|mesh-list
6674587|NCT01570569|Midazolam|midazolam|mesh-list
6674588|NCT01570569|Dextromethorphan|dextromethorphan|mesh-list
5657811|NCT03658330|Sensory System Agents|sensory system agents|mesh-ancestor
5657812|NCT03658330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5657813|NCT03658330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657814|NCT03658330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5657815|NCT03658330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5657816|NCT03658330|Anesthetics, General|anesthetics, general|mesh-ancestor
5657817|NCT03658330|Anesthetics|anesthetics|mesh-ancestor
5657818|NCT03658330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5657819|NCT03658330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5657820|NCT03658330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5657821|NCT03658330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5657822|NCT03658330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657823|NCT03658330|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5657824|NCT03658330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5657825|NCT03658317|Uric Acid|uric acid|mesh-list
5657826|NCT03658317|Antioxidants|antioxidants|mesh-ancestor
5657827|NCT03658317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674589|NCT01570569|Caffeine|caffeine|mesh-list
6674590|NCT01570569|Omeprazole|omeprazole|mesh-list
6674591|NCT01570569|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5657828|NCT03658317|Protective Agents|protective agents|mesh-ancestor
5657829|NCT03658317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657830|NCT03658291|Levofloxacin|levofloxacin|mesh-list
5657831|NCT03658291|Ofloxacin|ofloxacin|mesh-list
5657832|NCT03658291|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5657833|NCT03658291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5657834|NCT03658291|Renal Agents|renal agents|mesh-ancestor
5657835|NCT03658291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5657836|NCT03658291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5657837|NCT03658291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5657838|NCT03658291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5836920|NCT02527746|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5836921|NCT02527746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5836922|NCT02527746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5836923|NCT02527746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5836924|NCT02527785|Oxaliplatin|oxaliplatin|mesh-list
5836925|NCT02527785|Irinotecan|irinotecan|mesh-list
5836926|NCT02527785|Tegafur|tegafur|mesh-list
5836927|NCT02527785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5836928|NCT02527785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5836929|NCT02527785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5836930|NCT02527785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5836931|NCT02527785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836932|NCT02527785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5836933|NCT02527785|Antimetabolites|antimetabolites|mesh-ancestor
5836934|NCT02527824|Oxaliplatin|oxaliplatin|mesh-list
5695034|NCT03392051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5836935|NCT02527824|Irinotecan|irinotecan|mesh-list
6674592|NCT01570569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5657839|NCT03658291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657840|NCT03658291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5657841|NCT03658291|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5657842|NCT03658291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5657843|NCT03658213|Goserelin|goserelin|mesh-list
5657844|NCT03658213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5657845|NCT03658213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5657846|NCT03658109|Lidocaine|lidocaine|mesh-list
5657847|NCT03658109|Anesthetics, Local|anesthetics, local|mesh-ancestor
5657848|NCT03658109|Anesthetics|anesthetics|mesh-ancestor
5657849|NCT03658109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5657850|NCT03658109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657851|NCT03658109|Sensory System Agents|sensory system agents|mesh-ancestor
5657852|NCT03658109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5657853|NCT03658109|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5657854|NCT03658109|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5657855|NCT03658109|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5657856|NCT03658109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5657857|NCT03658109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657858|NCT03658057|Rocuronium|rocuronium|mesh-list
5657859|NCT03658057|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5657860|NCT03658057|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5657861|NCT03658057|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5836936|NCT02527824|Tegafur|tegafur|mesh-list
5836937|NCT02527824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5836938|NCT02527824|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5836939|NCT02527824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5836940|NCT02527824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5836941|NCT02527824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836942|NCT02527824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5836943|NCT02527824|Antimetabolites|antimetabolites|mesh-ancestor
5836944|NCT02527811|Urinastatin|urinastatin|mesh-list
5836945|NCT02527811|Trypsin Inhibitors|trypsin inhibitors|mesh-list
5836946|NCT02527811|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5836947|NCT02527811|Protease Inhibitors|protease inhibitors|mesh-ancestor
5836948|NCT02527811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5836949|NCT02527811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836950|NCT02527863|Tolvaptan|tolvaptan|mesh-list
5836951|NCT02527863|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
5836952|NCT02527863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5836953|NCT02527863|Natriuretic Agents|natriuretic agents|mesh-ancestor
5836954|NCT02527863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836955|NCT02527772|Leucovorin|leucovorin|mesh-list
5836956|NCT02527772|Gemcitabine|gemcitabine|mesh-list
5836957|NCT02527772|Fluorouracil|fluorouracil|mesh-list
5836958|NCT02527772|Doxorubicin|doxorubicin|mesh-list
5836959|NCT02527772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5836960|NCT02527772|Oxaliplatin|oxaliplatin|mesh-list
5836961|NCT02527772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5836962|NCT02527772|Antimetabolites|antimetabolites|mesh-ancestor
5836963|NCT02527772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674593|NCT01570569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6674594|NCT01570569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674595|NCT01570569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6674596|NCT01570569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6674597|NCT01570569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6674598|NCT01570569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5657862|NCT03658057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5657863|NCT03658057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657864|NCT03658031|Dapagliflozin|dapagliflozin|mesh-list
5657865|NCT03658031|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5657866|NCT03658031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657867|NCT03658031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5657868|NCT03658031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657869|NCT03657979|Ropivacaine|ropivacaine|mesh-list
5657870|NCT03657979|Anesthetics, Local|anesthetics, local|mesh-ancestor
5657871|NCT03657979|Anesthetics|anesthetics|mesh-ancestor
5657872|NCT03657979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5657873|NCT03657979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657874|NCT03657979|Sensory System Agents|sensory system agents|mesh-ancestor
5657875|NCT03657979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5657876|NCT03657966|Gemcitabine|gemcitabine|mesh-list
5657877|NCT03657966|Paclitaxel|paclitaxel|mesh-list
5657878|NCT03657966|Carboplatin|carboplatin|mesh-list
5657879|NCT03657966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5657880|NCT03657966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5657881|NCT03657966|Tubulin Modulators|tubulin modulators|mesh-ancestor
5657882|NCT03657966|Antimitotic Agents|antimitotic agents|mesh-ancestor
5657883|NCT03657966|Mitosis Modulators|mitosis modulators|mesh-ancestor
5657884|NCT03657966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657885|NCT03657966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6674599|NCT01570569|Anesthetics, General|anesthetics, general|mesh-ancestor
6674600|NCT01570569|Anesthetics|anesthetics|mesh-ancestor
5836964|NCT02527772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5836965|NCT02527772|Antiviral Agents|antiviral agents|mesh-ancestor
5836966|NCT02527772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5836967|NCT02527772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5836968|NCT02527772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5836969|NCT02527772|Immunologic Factors|immunologic factors|mesh-ancestor
5836970|NCT02527772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836971|NCT02527772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5836972|NCT02527772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5836973|NCT02527772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5836974|NCT02527772|Antidotes|antidotes|mesh-ancestor
5836975|NCT02527772|Protective Agents|protective agents|mesh-ancestor
5836976|NCT02527772|Vitamin B Complex|vitamin b complex|mesh-ancestor
5836977|NCT02527772|Vitamins|vitamins|mesh-ancestor
5836978|NCT02527772|Micronutrients|micronutrients|mesh-ancestor
5902952|NCT02937571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902953|NCT02937571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5902954|NCT02937571|Glucocorticoids|glucocorticoids|mesh-ancestor
5902955|NCT02937571|Hormones|hormones|mesh-ancestor
5902956|NCT02937571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5902957|NCT02937571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5902958|NCT02937571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5902959|NCT02937571|Immunologic Factors|immunologic factors|mesh-ancestor
5902960|NCT02937571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5902961|NCT02937571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5902962|NCT02937571|Growth Substances|growth substances|mesh-ancestor
5657886|NCT03657966|Antimetabolites|antimetabolites|mesh-ancestor
5657887|NCT03657966|Antiviral Agents|antiviral agents|mesh-ancestor
5657888|NCT03657966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5657889|NCT03657966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5657890|NCT03657966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5657891|NCT03657966|Immunologic Factors|immunologic factors|mesh-ancestor
5657892|NCT03657966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657893|NCT03657862|Fluorides|fluorides|mesh-list
5657894|NCT03657862|Cariostatic Agents|cariostatic agents|mesh-ancestor
5657895|NCT03657862|Protective Agents|protective agents|mesh-ancestor
5657896|NCT03657862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657897|NCT03657836|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5657898|NCT03657836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5657899|NCT03657758|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5657900|NCT03657758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5657901|NCT03657758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5657902|NCT03657758|Antimetabolites|antimetabolites|mesh-ancestor
5657903|NCT03657758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657904|NCT03657758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5657905|NCT03657758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5902963|NCT02937571|Growth Inhibitors|growth inhibitors|mesh-ancestor
5902964|NCT02648581|Ustekinumab|ustekinumab|mesh-list
5902965|NCT02648581|Dermatologic Agents|dermatologic agents|mesh-ancestor
6674601|NCT01570569|GABA Modulators|gaba modulators|mesh-ancestor
5657906|NCT03657758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5657907|NCT03657641|Pembrolizumab|pembrolizumab|mesh-list
5657908|NCT03657641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5657909|NCT03657641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5657910|NCT03657602|Levonorgestrel|levonorgestrel|mesh-list
5657911|NCT03657602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5657912|NCT03657602|Contraceptive Agents|contraceptive agents|mesh-ancestor
5657913|NCT03657602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5657914|NCT03657602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657915|NCT03657602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5657916|NCT03657602|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5657917|NCT03657602|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5657918|NCT03657550|Niacin|niacin|mesh-list
5657919|NCT03657550|Amlodipine|amlodipine|mesh-list
5657920|NCT03657550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5657921|NCT03657550|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5657922|NCT03657550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5836979|NCT02527668|Vitamin D|vitamin d|mesh-list
5836980|NCT02527668|Cholecalciferol|cholecalciferol|mesh-list
5836981|NCT02527668|Calcifediol|calcifediol|mesh-list
5836982|NCT02527668|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
5836983|NCT02527668|Vitamins|vitamins|mesh-ancestor
5836984|NCT02527668|Micronutrients|micronutrients|mesh-ancestor
5836985|NCT02527668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836986|NCT02527668|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5836987|NCT02527668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5836988|NCT02527603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
5836989|NCT02527603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
5836990|NCT02527603|Analgesics|analgesics|mesh-ancestor
5836991|NCT02527603|Sensory System Agents|sensory system agents|mesh-ancestor
5836992|NCT02527603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5836993|NCT02527603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5836994|NCT02527603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5836995|NCT02527603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5836996|NCT02527564|Suvorexant|suvorexant|mesh-list
5836997|NCT02527564|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5836998|NCT02527564|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5836999|NCT02527564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5837000|NCT02527564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837001|NCT02527564|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
5837002|NCT02527564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5837003|NCT02527564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5837004|NCT02527460|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5837005|NCT02527460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5837006|NCT02527577|Ropivacaine|ropivacaine|mesh-list
5837007|NCT02527577|Anesthetics, Local|anesthetics, local|mesh-ancestor
5837008|NCT02527577|Anesthetics|anesthetics|mesh-ancestor
5837009|NCT02527577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5837010|NCT02527577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837011|NCT02527577|Sensory System Agents|sensory system agents|mesh-ancestor
5657923|NCT03657550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657924|NCT03657550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5657925|NCT03657550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657926|NCT03657550|Vasodilator Agents|vasodilator agents|mesh-ancestor
5837012|NCT02527577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5837013|NCT02527213|Sodium thiosulfate|sodium thiosulfate|mesh-list
5837014|NCT02527213|Antidotes|antidotes|mesh-ancestor
5837015|NCT02527213|Protective Agents|protective agents|mesh-ancestor
5837016|NCT02527213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837017|NCT02527213|Antioxidants|antioxidants|mesh-ancestor
5837018|NCT02527213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5837019|NCT02527213|Antitubercular Agents|antitubercular agents|mesh-ancestor
5837020|NCT02527213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5837021|NCT02527213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5837022|NCT02527213|Chelating Agents|chelating agents|mesh-ancestor
5837023|NCT02527213|Sequestering Agents|sequestering agents|mesh-ancestor
5837024|NCT02527174|Cytarabine|cytarabine|mesh-list
5837025|NCT02527174|Idarubicin|idarubicin|mesh-list
5837026|NCT02527174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5837027|NCT02527174|Antimetabolites|antimetabolites|mesh-ancestor
6211878|NCT02178800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6211879|NCT02178800|Antiviral Agents|antiviral agents|mesh-ancestor
6211880|NCT02178800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5837028|NCT02527174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211881|NCT02178956|Paclitaxel|paclitaxel|mesh-list
6211882|NCT02178956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6211883|NCT02178956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6211884|NCT02178956|Tubulin Modulators|tubulin modulators|mesh-ancestor
6211885|NCT02178956|Antimitotic Agents|antimitotic agents|mesh-ancestor
6211886|NCT02178956|Mitosis Modulators|mitosis modulators|mesh-ancestor
6211887|NCT02178956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657927|NCT03657550|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5657928|NCT03657550|Antimetabolites|antimetabolites|mesh-ancestor
5657929|NCT03657550|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5657930|NCT03657550|Vitamin B Complex|vitamin b complex|mesh-ancestor
5657931|NCT03657550|Vitamins|vitamins|mesh-ancestor
5657932|NCT03657550|Micronutrients|micronutrients|mesh-ancestor
6493613|NCT00614653|Antimetabolites|antimetabolites|mesh-ancestor
6211888|NCT02178995|Methylphenidate|methylphenidate|mesh-list
6211889|NCT02178995|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6211890|NCT02178995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496511|NCT00628290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5657933|NCT03657472|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
5657934|NCT03657472|Atorvastatin|atorvastatin|mesh-list
5657935|NCT03657472|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5657936|NCT03657472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5657937|NCT03657472|Antimetabolites|antimetabolites|mesh-ancestor
5657938|NCT03657472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657939|NCT03657472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5657940|NCT03657472|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5657941|NCT03657472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5657942|NCT03657472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5657943|NCT03657446|Moxifloxacin|moxifloxacin|mesh-list
5837029|NCT02527174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5837030|NCT02527174|Antiviral Agents|antiviral agents|mesh-ancestor
5837031|NCT02527174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5837032|NCT02527174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5837033|NCT02527174|Immunologic Factors|immunologic factors|mesh-ancestor
5837034|NCT02527174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837035|NCT02527174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5837036|NCT02527174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5837037|NCT02527174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5837038|NCT02527174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5837039|NCT02527109|Nifedipine|nifedipine|mesh-list
5837040|NCT02527109|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5837041|NCT02527109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5837042|NCT02527109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5837043|NCT02527109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5837044|NCT02527109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837045|NCT02527109|Vasodilator Agents|vasodilator agents|mesh-ancestor
5837046|NCT02527109|Tocolytic Agents|tocolytic agents|mesh-ancestor
5837047|NCT02527109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5837048|NCT02527096|Lamivudine|lamivudine|mesh-list
5837049|NCT02527096|Dolutegravir|dolutegravir|mesh-list
5837050|NCT02527096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5837051|NCT02527096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5837052|NCT02527096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5837053|NCT02527096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5837054|NCT02527096|Antiviral Agents|antiviral agents|mesh-ancestor
5837055|NCT02527096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5837056|NCT02527096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5837057|NCT02527096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5837058|NCT02527096|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5837059|NCT02527096|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5837060|NCT02527083|Ketamine|ketamine|mesh-list
5837061|NCT02527083|Remifentanil|remifentanil|mesh-list
5837062|NCT02527083|Propofol|propofol|mesh-list
5837063|NCT02527083|Sevoflurane|sevoflurane|mesh-list
5837064|NCT02527083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5837065|NCT02527083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5657944|NCT03657446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5657945|NCT03657446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5657946|NCT03657446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5657947|NCT03657446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5657948|NCT03657446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5657949|NCT03657446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657950|NCT03657446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5657951|NCT03657433|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
5657952|NCT03657433|Hematinics|hematinics|mesh-ancestor
5837066|NCT02527083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837067|NCT02527083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5837068|NCT02527083|Anesthetics, General|anesthetics, general|mesh-ancestor
5657953|NCT03657433|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5657954|NCT03657433|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5657955|NCT03657420|Dexamethasone|dexamethasone|mesh-list
5657956|NCT03657420|Pomalidomide|pomalidomide|mesh-list
5657957|NCT03657420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5657958|NCT03657420|Antiemetics|antiemetics|mesh-ancestor
5657959|NCT03657420|Autonomic Agents|autonomic agents|mesh-ancestor
5657960|NCT03657420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5657961|NCT03657420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657962|NCT03657420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5657963|NCT03657420|Glucocorticoids|glucocorticoids|mesh-ancestor
5657964|NCT03657420|Hormones|hormones|mesh-ancestor
5657965|NCT03657420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5837069|NCT02527083|Anesthetics|anesthetics|mesh-ancestor
5837070|NCT02527083|Analgesics|analgesics|mesh-ancestor
5837071|NCT02527083|Sensory System Agents|sensory system agents|mesh-ancestor
5837072|NCT02527083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5837073|NCT02527083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5837074|NCT02527083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5837075|NCT02527083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5837076|NCT02527083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5837077|NCT02527083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5837078|NCT02527083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5837079|NCT02527083|Narcotics|narcotics|mesh-ancestor
5837080|NCT02527083|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5837081|NCT02527083|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5657966|NCT03657420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5657967|NCT03657420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5657968|NCT03657420|Immunologic Factors|immunologic factors|mesh-ancestor
5657969|NCT03657420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5657970|NCT03657420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5657971|NCT03657420|Growth Substances|growth substances|mesh-ancestor
5657972|NCT03657420|Growth Inhibitors|growth inhibitors|mesh-ancestor
5657973|NCT03657381|Antibodies|antibodies|mesh-list
5657974|NCT03657381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5657975|NCT03657381|Immunologic Factors|immunologic factors|mesh-ancestor
5657976|NCT03657381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657977|NCT03657355|Zolpidem|zolpidem|mesh-list
5657978|NCT03657355|Suvorexant|suvorexant|mesh-list
5657979|NCT03657355|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5657980|NCT03657355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5657981|NCT03657355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5657982|NCT03657355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657983|NCT03657355|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
5657984|NCT03657355|GABA Agonists|gaba agonists|mesh-ancestor
5657985|NCT03657355|GABA Agents|gaba agents|mesh-ancestor
5657986|NCT03657355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5657987|NCT03657355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657988|NCT03657355|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
5657989|NCT03657342|Cyclosporine|cyclosporine|mesh-list
5837082|NCT02526888|Diltiazem|diltiazem|mesh-list
5837083|NCT02526888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5837084|NCT02526888|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5837085|NCT02526888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5657990|NCT03657342|Cyclosporins|cyclosporins|mesh-list
5657991|NCT03657342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5657992|NCT03657342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5657993|NCT03657342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5657994|NCT03657342|Immunologic Factors|immunologic factors|mesh-ancestor
5657995|NCT03657342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5657996|NCT03657342|Antifungal Agents|antifungal agents|mesh-ancestor
5657997|NCT03657342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5657998|NCT03657342|Dermatologic Agents|dermatologic agents|mesh-ancestor
5657999|NCT03657342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5658000|NCT03657342|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5658001|NCT03657212|Zolpidem|zolpidem|mesh-list
5658002|NCT03657212|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5658003|NCT03657212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5658004|NCT03657212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5658005|NCT03657212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658006|NCT03657212|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
5658007|NCT03657212|GABA Agonists|gaba agonists|mesh-ancestor
5658008|NCT03657212|GABA Agents|gaba agents|mesh-ancestor
5658009|NCT03657212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5837086|NCT02526888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5837087|NCT02526888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5837088|NCT02526888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837089|NCT02526888|Vasodilator Agents|vasodilator agents|mesh-ancestor
5837090|NCT02526914|Vasopressins|vasopressins|mesh-list
5837091|NCT02526914|Arginine Vasopressin|arginine vasopressin|mesh-list
5837092|NCT02526914|Oxytocin|oxytocin|mesh-list
5837093|NCT02526914|Oxytocics|oxytocics|mesh-ancestor
5837094|NCT02526914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5837095|NCT02526914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837096|NCT02526914|Hemostatics|hemostatics|mesh-ancestor
5837097|NCT02526914|Coagulants|coagulants|mesh-ancestor
5837098|NCT02526914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5837099|NCT02526914|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5658010|NCT03657212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658011|NCT03657160|Vedolizumab|vedolizumab|mesh-list
5658012|NCT03657160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5658013|NCT03656965|Acyclovir|acyclovir|mesh-list
5658014|NCT03656965|Antiviral Agents|antiviral agents|mesh-ancestor
5658015|NCT03656965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5658016|NCT03656952|Moxifloxacin|moxifloxacin|mesh-list
5658017|NCT03656952|PF-06700841|pf-06700841|mesh-list
5658018|NCT03656952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5658019|NCT03656952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5658020|NCT03656952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5658021|NCT03656952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5658022|NCT03656952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5658023|NCT03656952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658024|NCT03656952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5658025|NCT03656952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5658026|NCT03656926|Cyclosporine|cyclosporine|mesh-list
5658027|NCT03656926|Cyclosporins|cyclosporins|mesh-list
5658028|NCT03656926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5658029|NCT03656926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658030|NCT03656926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5658031|NCT03656926|Immunologic Factors|immunologic factors|mesh-ancestor
5658032|NCT03656926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658033|NCT03656926|Antifungal Agents|antifungal agents|mesh-ancestor
5658034|NCT03656926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5658035|NCT03656926|Dermatologic Agents|dermatologic agents|mesh-ancestor
5658036|NCT03656926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5658037|NCT03656926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5695035|NCT03392051|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5695036|NCT03392051|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5695037|NCT03392051|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5695038|NCT03392051|Purinergic Agents|purinergic agents|mesh-ancestor
5695039|NCT03392051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5695040|NCT03392051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695041|NCT03392051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695042|NCT03391934|Leucovorin|leucovorin|mesh-list
5695043|NCT03391934|Fluorouracil|fluorouracil|mesh-list
5837100|NCT02526914|Natriuretic Agents|natriuretic agents|mesh-ancestor
5837101|NCT02527005|Azithromycin|azithromycin|mesh-list
5837102|NCT02527005|Pyrimethamine|pyrimethamine|mesh-list
5837103|NCT02527005|Sulfadoxine|sulfadoxine|mesh-list
5837104|NCT02527005|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
5837105|NCT02527005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5837106|NCT02527005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5837107|NCT02527005|Antimalarials|antimalarials|mesh-ancestor
5837108|NCT02527005|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5837109|NCT02527005|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5837110|NCT02527005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5837111|NCT02527005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5837112|NCT02527005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5837113|NCT02527005|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5837114|NCT02527005|Renal Agents|renal agents|mesh-ancestor
5837115|NCT02526953|Paclitaxel|paclitaxel|mesh-list
5837116|NCT02526953|Capecitabine|capecitabine|mesh-list
5837117|NCT02526953|Mitomycins|mitomycins|mesh-list
5837118|NCT02526953|Mitomycin|mitomycin|mesh-list
5837119|NCT02526953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5837120|NCT02526953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5695044|NCT03391934|Irinotecan|irinotecan|mesh-list
5695045|NCT03391934|Cetuximab|cetuximab|mesh-list
5837121|NCT02526953|Tubulin Modulators|tubulin modulators|mesh-ancestor
5837122|NCT02526953|Antimitotic Agents|antimitotic agents|mesh-ancestor
5837123|NCT02526953|Mitosis Modulators|mitosis modulators|mesh-ancestor
5902966|NCT02609815|Metformin|metformin|mesh-list
5658038|NCT03656783|Tenofovir|tenofovir|mesh-list
5658039|NCT03656783|Emtricitabine|emtricitabine|mesh-list
5658040|NCT03656783|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
5658041|NCT03656783|Antiviral Agents|antiviral agents|mesh-ancestor
5658042|NCT03656783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5658043|NCT03656783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5658044|NCT03656783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5658045|NCT03656783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5658046|NCT03656783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658047|NCT03656783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5658048|NCT03656783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5658049|NCT03656679|Iodine|iodine|mesh-list
5658050|NCT03656679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5658051|NCT03656679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5837124|NCT02526953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5837125|NCT02526953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5837126|NCT02526953|Antimetabolites|antimetabolites|mesh-ancestor
5837127|NCT02526953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5837128|NCT02526953|Alkylating Agents|alkylating agents|mesh-ancestor
5837129|NCT02526953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5837130|NCT02526953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5837131|NCT02526979|Mirabegron|mirabegron|mesh-list
5837132|NCT02526979|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
5837133|NCT02526979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5837134|NCT02526979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5658052|NCT03656679|Trace Elements|trace elements|mesh-ancestor
5658053|NCT03656679|Micronutrients|micronutrients|mesh-ancestor
5658054|NCT03656679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658055|NCT03656666|Thalidomide|thalidomide|mesh-list
5658056|NCT03656666|Apremilast|apremilast|mesh-list
5658057|NCT03656666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5658058|NCT03656666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5658059|NCT03656666|Analgesics|analgesics|mesh-ancestor
5658060|NCT03656666|Sensory System Agents|sensory system agents|mesh-ancestor
5837135|NCT02526979|Adrenergic Agents|adrenergic agents|mesh-ancestor
5837136|NCT02526979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5837137|NCT02526979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5837138|NCT02526979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837139|NCT02526979|Urological Agents|urological agents|mesh-ancestor
5837140|NCT02526875|Amlodipine|amlodipine|mesh-list
5837141|NCT02526875|Telmisartan|telmisartan|mesh-list
5837142|NCT02526875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5837143|NCT02526875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5837144|NCT02526875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5837145|NCT02526875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5837146|NCT02526875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5837147|NCT02526875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837148|NCT02526875|Vasodilator Agents|vasodilator agents|mesh-ancestor
5837149|NCT02526875|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5837150|NCT02526875|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5837151|NCT02526810|Insulin|insulin|mesh-list
5837152|NCT02526810|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5837153|NCT02526810|Insulin Glargine|insulin glargine|mesh-list
5837154|NCT02526810|Insulin Lispro|insulin lispro|mesh-list
5837155|NCT02526810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5837156|NCT02526810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837157|NCT02526758|Budesonide|budesonide|mesh-list
5837158|NCT02526758|Beclomethasone|beclomethasone|mesh-list
5837159|NCT02526758|Formoterol Fumarate|formoterol fumarate|mesh-list
5837160|NCT02526758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5837161|NCT02526758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5837162|NCT02526758|Autonomic Agents|autonomic agents|mesh-ancestor
5837163|NCT02526758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5658061|NCT03656666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5658062|NCT03656666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658063|NCT03656666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5658064|NCT03656666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5658065|NCT03656666|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5658066|NCT03656666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5658067|NCT03656666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5658068|NCT03656666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658069|NCT03656666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5658070|NCT03656666|Immunologic Factors|immunologic factors|mesh-ancestor
5658071|NCT03656666|Leprostatic Agents|leprostatic agents|mesh-ancestor
5837164|NCT02526758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837165|NCT02526758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5837166|NCT02526758|Respiratory System Agents|respiratory system agents|mesh-ancestor
5658072|NCT03656666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5658073|NCT03656666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5658074|NCT03656666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5658075|NCT03656666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5658076|NCT03656666|Growth Substances|growth substances|mesh-ancestor
5658077|NCT03656666|Growth Inhibitors|growth inhibitors|mesh-ancestor
5658078|NCT03656666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5658079|NCT03656627|Nivolumab|nivolumab|mesh-list
5658080|NCT03656627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5658081|NCT03656627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5658082|NCT03656627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5658083|NCT03656627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658084|NCT03656614|Neostigmine|neostigmine|mesh-list
5658085|NCT03656614|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5658086|NCT03656614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5658087|NCT03656614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658088|NCT03656614|Cholinergic Agents|cholinergic agents|mesh-ancestor
5658089|NCT03656614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5658090|NCT03656614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658091|NCT03656614|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5658092|NCT03656614|Autonomic Agents|autonomic agents|mesh-ancestor
5658093|NCT03656614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5658094|NCT03656588|Iodine|iodine|mesh-list
5658095|NCT03656588|Chlorhexidine|chlorhexidine|mesh-list
5658096|NCT03656588|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5837167|NCT02526758|Glucocorticoids|glucocorticoids|mesh-ancestor
5837168|NCT02526758|Hormones|hormones|mesh-ancestor
5837169|NCT02526758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5837170|NCT02526758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5837171|NCT02526758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5837172|NCT02526758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5837173|NCT02526758|Adrenergic Agents|adrenergic agents|mesh-ancestor
5837174|NCT02526758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5837175|NCT02526758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5837176|NCT02526615|Metformin|metformin|mesh-list
5837177|NCT02526615|Rosiglitazone|rosiglitazone|mesh-list
5837178|NCT02526615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5837179|NCT02526615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837180|NCT02526745|Vaccines|vaccines|mesh-list
5837181|NCT02526745|Immunologic Factors|immunologic factors|mesh-ancestor
5837182|NCT02526745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837183|NCT02526368|Carbamide Peroxide|carbamide peroxide|mesh-list
5837184|NCT02526368|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5837185|NCT02526368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5837186|NCT02526316|Freund's Adjuvant|freund's adjuvant|mesh-list
5837187|NCT02526316|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5837188|NCT02526316|Immunologic Factors|immunologic factors|mesh-ancestor
5837189|NCT02526316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837190|NCT02526303|Nadroparin|nadroparin|mesh-list
5837191|NCT02526303|Warfarin|warfarin|mesh-list
5837192|NCT02526303|Calcium|calcium|mesh-list
5837193|NCT02526303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5837194|NCT02526303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837195|NCT02526303|Anticoagulants|anticoagulants|mesh-ancestor
5837196|NCT02526303|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5837197|NCT02526303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5837198|NCT02526303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5837199|NCT02526394|Vaccines|vaccines|mesh-list
5837200|NCT02526394|Immunologic Factors|immunologic factors|mesh-ancestor
5837201|NCT02526394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837202|NCT02526004|Tobramycin|tobramycin|mesh-list
5837203|NCT02526004|Ceftazidime|ceftazidime|mesh-list
5837204|NCT02526004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5837205|NCT02526004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5837206|NCT02525991|Loxapine|loxapine|mesh-list
5837207|NCT02525991|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6211891|NCT02178995|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6496512|NCT00628290|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5658097|NCT03656588|Cadexomer iodine|cadexomer iodine|mesh-list
5658098|NCT03656588|Hydrogen Peroxide|hydrogen peroxide|mesh-list
5658099|NCT03656588|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5658100|NCT03656588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5837208|NCT02525991|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5902967|NCT02609815|Glimepiride|glimepiride|mesh-list
6211892|NCT02178995|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5658101|NCT03656588|Disinfectants|disinfectants|mesh-ancestor
5658102|NCT03656588|Dermatologic Agents|dermatologic agents|mesh-ancestor
5658103|NCT03656588|Trace Elements|trace elements|mesh-ancestor
5658104|NCT03656588|Micronutrients|micronutrients|mesh-ancestor
5658105|NCT03656588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658106|NCT03656549|Pemetrexed|pemetrexed|mesh-list
5658107|NCT03656549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5658108|NCT03656549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5658109|NCT03656549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658110|NCT03656549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5658111|NCT03656549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5658112|NCT03656484|Metronidazole|metronidazole|mesh-list
5658113|NCT03656484|Tetracycline|tetracycline|mesh-list
5658114|NCT03656484|Melatonin|melatonin|mesh-list
6211893|NCT02178995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6211894|NCT02178995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211895|NCT02178995|Dopamine Agents|dopamine agents|mesh-ancestor
6211896|NCT02178995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6211897|NCT02179177|Apixaban|apixaban|mesh-list
6211898|NCT02179177|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6211899|NCT02179177|Antithrombins|antithrombins|mesh-ancestor
6211900|NCT02179177|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6493614|NCT00614653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493615|NCT00614653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6493616|NCT00614653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6493617|NCT00614666|Nikkomycin|nikkomycin|mesh-list
6211901|NCT02179177|Protease Inhibitors|protease inhibitors|mesh-ancestor
6211902|NCT02179177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6211903|NCT02179177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211904|NCT02179177|Anticoagulants|anticoagulants|mesh-ancestor
6212605|NCT02191397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6212606|NCT02191397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5837209|NCT02525991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5837210|NCT02525991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837211|NCT02525991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5837212|NCT02525991|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5837213|NCT02525991|Dopamine Agents|dopamine agents|mesh-ancestor
5837214|NCT02525991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5837215|NCT02525991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902968|NCT02609815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5902969|NCT02609815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902970|NCT02609815|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5902971|NCT02609815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5902972|NCT02609815|Immunologic Factors|immunologic factors|mesh-ancestor
5902973|NCT02506959|Gemcitabine|gemcitabine|mesh-list
5902974|NCT02506959|Melphalan|melphalan|mesh-list
5902975|NCT02506959|Busulfan|busulfan|mesh-list
5658115|NCT03656484|Hyaluronic Acid|hyaluronic acid|mesh-list
5658116|NCT03656484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5658117|NCT03656484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5658118|NCT03656484|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5658119|NCT03656484|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5658120|NCT03656484|Antioxidants|antioxidants|mesh-ancestor
5658121|NCT03656484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658122|NCT03656484|Protective Agents|protective agents|mesh-ancestor
5658123|NCT03656484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658124|NCT03656484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5658125|NCT03656484|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5658126|NCT03656484|Immunologic Factors|immunologic factors|mesh-ancestor
5658127|NCT03656484|Viscosupplements|viscosupplements|mesh-ancestor
5658128|NCT03656484|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5658129|NCT03656484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5658130|NCT03656445|Tranexamic Acid|tranexamic acid|mesh-list
5658131|NCT03656445|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5658132|NCT03656445|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5658133|NCT03656445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5902976|NCT02506959|Mechlorethamine|mechlorethamine|mesh-list
5902977|NCT02506959|Panobinostat|panobinostat|mesh-list
5902978|NCT02506959|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
5902979|NCT02506959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5902980|NCT02506959|Antimetabolites|antimetabolites|mesh-ancestor
5902981|NCT02506959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658134|NCT03656445|Hemostatics|hemostatics|mesh-ancestor
5658135|NCT03656445|Coagulants|coagulants|mesh-ancestor
5658136|NCT03656432|Fluorides|fluorides|mesh-list
5837216|NCT02526199|Dexamethasone|dexamethasone|mesh-list
5837217|NCT02526199|Epinephrine|epinephrine|mesh-list
5837218|NCT02526199|Bupivacaine|bupivacaine|mesh-list
5837219|NCT02526199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5837220|NCT02526199|Antiemetics|antiemetics|mesh-ancestor
5837221|NCT02526199|Autonomic Agents|autonomic agents|mesh-ancestor
5837222|NCT02526199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5837223|NCT02526199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837224|NCT02526199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5837225|NCT02526199|Glucocorticoids|glucocorticoids|mesh-ancestor
5837226|NCT02526199|Hormones|hormones|mesh-ancestor
5837227|NCT02526199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5837228|NCT02526199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5837229|NCT02526199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5837230|NCT02526199|Anesthetics, Local|anesthetics, local|mesh-ancestor
5837231|NCT02526199|Anesthetics|anesthetics|mesh-ancestor
5837232|NCT02526199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5837233|NCT02526199|Sensory System Agents|sensory system agents|mesh-ancestor
5837234|NCT02526199|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5837235|NCT02526199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5837236|NCT02526199|Adrenergic Agents|adrenergic agents|mesh-ancestor
5837237|NCT02526199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5658137|NCT03656432|Cariostatic Agents|cariostatic agents|mesh-ancestor
5658138|NCT03656432|Protective Agents|protective agents|mesh-ancestor
5658139|NCT03656432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658140|NCT03656393|Carboplatin|carboplatin|mesh-list
5658141|NCT03656393|Vinorelbine|vinorelbine|mesh-list
5658142|NCT03656393|Gefitinib|gefitinib|mesh-list
5658143|NCT03656393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5658144|NCT03656393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5658145|NCT03656393|Tubulin Modulators|tubulin modulators|mesh-ancestor
5658146|NCT03656393|Antimitotic Agents|antimitotic agents|mesh-ancestor
5658147|NCT03656393|Mitosis Modulators|mitosis modulators|mesh-ancestor
5658148|NCT03656393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658149|NCT03656393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5658150|NCT03656393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5658151|NCT03656289|Etonogestrel|etonogestrel|mesh-list
5658152|NCT03656289|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5658153|NCT03656289|Contraceptive Agents|contraceptive agents|mesh-ancestor
5658154|NCT03656289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5658155|NCT03656289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658156|NCT03656289|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5658157|NCT03656094|Docetaxel|docetaxel|mesh-list
5658158|NCT03656094|Pembrolizumab|pembrolizumab|mesh-list
5658159|NCT03656094|Pemetrexed|pemetrexed|mesh-list
5658160|NCT03656094|Vinorelbine|vinorelbine|mesh-list
5658161|NCT03656094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5837238|NCT02526199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5837239|NCT02526199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5837240|NCT02526199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5837241|NCT02526199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5837242|NCT02526199|Respiratory System Agents|respiratory system agents|mesh-ancestor
5837243|NCT02526199|Mydriatics|mydriatics|mesh-ancestor
5837244|NCT02526199|Sympathomimetics|sympathomimetics|mesh-ancestor
5658162|NCT03656094|Tubulin Modulators|tubulin modulators|mesh-ancestor
5658163|NCT03656094|Antimitotic Agents|antimitotic agents|mesh-ancestor
5658164|NCT03656094|Mitosis Modulators|mitosis modulators|mesh-ancestor
5658165|NCT03656094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658166|NCT03656094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5658167|NCT03656094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5658168|NCT03656094|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5837245|NCT02526199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5837246|NCT02526017|Nivolumab|nivolumab|mesh-list
5837247|NCT02526017|Sargramostim|sargramostim|mesh-list
5837248|NCT02526017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5837249|NCT02526017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5837250|NCT02526017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5837251|NCT02526017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5837252|NCT02526017|Immunologic Factors|immunologic factors|mesh-ancestor
5837253|NCT02526017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837254|NCT02526030|Quetiapine Fumarate|quetiapine fumarate|mesh-list
5837255|NCT02526030|Aripiprazole|aripiprazole|mesh-list
5837256|NCT02526030|Ziprasidone|ziprasidone|mesh-list
5658169|NCT03656094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5837257|NCT02526030|Antidepressive Agents|antidepressive agents|mesh-ancestor
5837258|NCT02526030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5837259|NCT02526030|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5837260|NCT02526030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5837261|NCT02526030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5837262|NCT02526030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837263|NCT02526030|Dopamine Agonists|dopamine agonists|mesh-ancestor
5837264|NCT02526030|Dopamine Agents|dopamine agents|mesh-ancestor
5837265|NCT02526030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5837266|NCT02526030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5837267|NCT02526030|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5837268|NCT02526030|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5837269|NCT02526030|Serotonin Agents|serotonin agents|mesh-ancestor
5837270|NCT02526030|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5837271|NCT02526030|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5837272|NCT02526030|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5837273|NCT02526030|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5837274|NCT02525939|Dalcetrapib|dalcetrapib|mesh-list
5837275|NCT02525939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5837276|NCT02525939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5837277|NCT02525939|Antimetabolites|antimetabolites|mesh-ancestor
5837278|NCT02525939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5837279|NCT02525939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5837280|NCT02525848|Dexamethasone|dexamethasone|mesh-list
5837281|NCT02525848|Gabapentin|gabapentin|mesh-list
5837282|NCT02525848|Aprepitant|aprepitant|mesh-list
5837283|NCT02525848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5837284|NCT02525848|Antiemetics|antiemetics|mesh-ancestor
6211905|NCT02179671|Docetaxel|docetaxel|mesh-list
6211906|NCT02179671|Gefitinib|gefitinib|mesh-list
6211907|NCT02179671|Tremelimumab|tremelimumab|mesh-list
5658170|NCT03656094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5658171|NCT03656042|Lenograstim|lenograstim|mesh-list
5658172|NCT03656042|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5658173|NCT03656042|Immunologic Factors|immunologic factors|mesh-ancestor
5658174|NCT03656042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658175|NCT03655964|Olmesartan|olmesartan|mesh-list
5658176|NCT03655964|Nebivolol|nebivolol|mesh-list
5658177|NCT03655964|Antihypertensive Agents|antihypertensive agents|mesh-list
5658178|NCT03655964|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5658179|NCT03655964|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5658180|NCT03655964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658181|NCT03655964|Vasodilator Agents|vasodilator agents|mesh-ancestor
5658182|NCT03655964|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5658183|NCT03655964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5658184|NCT03655964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6211908|NCT02179671|Osimertinib|osimertinib|mesh-list
6211909|NCT02179671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5658185|NCT03655964|Adrenergic Agents|adrenergic agents|mesh-ancestor
5658186|NCT03655964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5658187|NCT03655964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658188|NCT03655847|Dexmedetomidine|dexmedetomidine|mesh-list
5658189|NCT03655847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5658190|NCT03655847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5658191|NCT03655847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658192|NCT03655847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5658193|NCT03655847|Analgesics|analgesics|mesh-ancestor
5658194|NCT03655847|Sensory System Agents|sensory system agents|mesh-ancestor
5658195|NCT03655847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5658196|NCT03655847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5658197|NCT03655847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5658198|NCT03655847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5658199|NCT03655847|Adrenergic Agents|adrenergic agents|mesh-ancestor
6211910|NCT02179671|Tubulin Modulators|tubulin modulators|mesh-ancestor
6211911|NCT02179671|Antimitotic Agents|antimitotic agents|mesh-ancestor
6211912|NCT02179671|Mitosis Modulators|mitosis modulators|mesh-ancestor
6211913|NCT02179671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211914|NCT02179671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6211915|NCT02179671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6211916|NCT02179788|Metformin|metformin|mesh-list
6211917|NCT02179788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6211918|NCT02179788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211919|NCT02179892|Acetaminophen|acetaminophen|mesh-list
6211920|NCT02179892|Dexamethasone|dexamethasone|mesh-list
6211921|NCT02179892|Dexamethasone acetate|dexamethasone acetate|mesh-list
6211922|NCT02179892|Bupivacaine|bupivacaine|mesh-list
6211923|NCT02179892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6211924|NCT02179892|Antiemetics|antiemetics|mesh-ancestor
6211925|NCT02179892|Autonomic Agents|autonomic agents|mesh-ancestor
5658200|NCT03655847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5658201|NCT03655847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658202|NCT03655834|Pemetrexed|pemetrexed|mesh-list
5658203|NCT03655834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5658204|NCT03655834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5658205|NCT03655834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658206|NCT03655834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5837285|NCT02525848|Autonomic Agents|autonomic agents|mesh-ancestor
5837286|NCT02525848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5837287|NCT02525848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837288|NCT02525848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5837289|NCT02525848|Glucocorticoids|glucocorticoids|mesh-ancestor
5837290|NCT02525848|Hormones|hormones|mesh-ancestor
5837291|NCT02525848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5837292|NCT02525848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5837293|NCT02525848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5837294|NCT02525848|Analgesics|analgesics|mesh-ancestor
5658207|NCT03655834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5658208|NCT03655821|Pemetrexed|pemetrexed|mesh-list
5658209|NCT03655821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5658210|NCT03655821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5658211|NCT03655821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658212|NCT03655821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5658213|NCT03655821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5658214|NCT03655730|Psychotropic Drugs|psychotropic drugs|mesh-list
5658215|NCT03655717|Ethanol|ethanol|mesh-list
5658216|NCT03655717|Dronabinol|dronabinol|mesh-list
5658217|NCT03655717|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5658218|NCT03655717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5658219|NCT03655717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5658220|NCT03655717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658221|NCT03655717|Hallucinogens|hallucinogens|mesh-ancestor
5658222|NCT03655717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5658223|NCT03655717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5658224|NCT03655717|Analgesics|analgesics|mesh-ancestor
5658225|NCT03655717|Sensory System Agents|sensory system agents|mesh-ancestor
5658226|NCT03655717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5658227|NCT03655717|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5658228|NCT03655717|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5837295|NCT02525848|Sensory System Agents|sensory system agents|mesh-ancestor
5837296|NCT02525848|Anticonvulsants|anticonvulsants|mesh-ancestor
5837297|NCT02525848|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5658229|NCT03655717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5658230|NCT03655717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658231|NCT03655717|Hormones|hormones|mesh-ancestor
5658232|NCT03655717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5658233|NCT03655665|Ofloxacin|ofloxacin|mesh-list
5658234|NCT03655665|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5658235|NCT03655665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5658236|NCT03655665|Renal Agents|renal agents|mesh-ancestor
5658237|NCT03655665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5658238|NCT03655665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5658239|NCT03655665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5658240|NCT03655665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5658241|NCT03655665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658242|NCT03655665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5658243|NCT03655665|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5658244|NCT03655665|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5837298|NCT02525848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5837299|NCT02525848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5837300|NCT02525848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5837301|NCT02525848|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5837302|NCT02525848|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5837303|NCT02525848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6493618|NCT00614666|Antifungal Agents|antifungal agents|mesh-ancestor
5658245|NCT03655613|Nivolumab|nivolumab|mesh-list
5658246|NCT03655613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5658247|NCT03655613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5658248|NCT03655613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5658249|NCT03655613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658250|NCT03655535|PAZ320|paz320|mesh-list
5658251|NCT03655535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5658252|NCT03655535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658253|NCT03655457|Poractant alfa|poractant alfa|mesh-list
5658254|NCT03655457|Beractant|beractant|mesh-list
5658255|NCT03655457|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
5658256|NCT03655457|Respiratory System Agents|respiratory system agents|mesh-ancestor
5658257|NCT03655392|Nitric Oxide|nitric oxide|mesh-list
5837304|NCT02525848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5837305|NCT02525848|Antimanic Agents|antimanic agents|mesh-ancestor
5837306|NCT02525848|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5837307|NCT02525822|Tazarotene|tazarotene|mesh-list
5837308|NCT02525822|Dermatologic Agents|dermatologic agents|mesh-ancestor
5837309|NCT02525822|Keratolytic Agents|keratolytic agents|mesh-ancestor
5658258|NCT03655392|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5658259|NCT03655392|Autonomic Agents|autonomic agents|mesh-ancestor
5658260|NCT03655392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5658261|NCT03655392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658262|NCT03655392|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5658263|NCT03655392|Respiratory System Agents|respiratory system agents|mesh-ancestor
5658264|NCT03655392|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5658265|NCT03655392|Antioxidants|antioxidants|mesh-ancestor
5658266|NCT03655392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658267|NCT03655392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5837310|NCT02525484|Pirfenidone|pirfenidone|mesh-list
5837311|NCT02525484|Analgesics|analgesics|mesh-ancestor
5837312|NCT02525484|Sensory System Agents|sensory system agents|mesh-ancestor
5837313|NCT02525484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5837314|NCT02525484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837315|NCT02525484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5837316|NCT02525484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5658268|NCT03655392|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5658269|NCT03655392|Vasodilator Agents|vasodilator agents|mesh-ancestor
5658270|NCT03655392|Gasotransmitters|gasotransmitters|mesh-ancestor
5837317|NCT02525484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5837318|NCT02525484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5837319|NCT02525484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5837320|NCT02525146|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
5837321|NCT02525146|Antiviral Agents|antiviral agents|mesh-ancestor
5837322|NCT02525146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5837323|NCT02525211|Ropivacaine|ropivacaine|mesh-list
5837324|NCT02525211|Anesthetics, Local|anesthetics, local|mesh-ancestor
5837325|NCT02525211|Anesthetics|anesthetics|mesh-ancestor
5658271|NCT03655392|Protective Agents|protective agents|mesh-ancestor
5695046|NCT03391934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695047|NCT03391934|Antimetabolites|antimetabolites|mesh-ancestor
5695048|NCT03391934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695049|NCT03391934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5695050|NCT03391934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5695051|NCT03391934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5695052|NCT03391934|Immunologic Factors|immunologic factors|mesh-ancestor
5695053|NCT03391934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5695054|NCT03391934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5695055|NCT03391934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5695056|NCT03391934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5695057|NCT03391934|Antidotes|antidotes|mesh-ancestor
5695058|NCT03391934|Protective Agents|protective agents|mesh-ancestor
5695059|NCT03391934|Vitamin B Complex|vitamin b complex|mesh-ancestor
5695060|NCT03391934|Vitamins|vitamins|mesh-ancestor
5695061|NCT03391934|Micronutrients|micronutrients|mesh-ancestor
5695062|NCT03391856|Acetylcysteine|acetylcysteine|mesh-list
5695063|NCT03391856|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5695064|NCT03391856|Antiviral Agents|antiviral agents|mesh-ancestor
5695065|NCT03391856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5695066|NCT03391856|Expectorants|expectorants|mesh-ancestor
5695067|NCT03391856|Respiratory System Agents|respiratory system agents|mesh-ancestor
5695068|NCT03391856|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5695069|NCT03391856|Antioxidants|antioxidants|mesh-ancestor
5695070|NCT03391856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695071|NCT03391856|Protective Agents|protective agents|mesh-ancestor
5695072|NCT03391856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695073|NCT03391856|Antidotes|antidotes|mesh-ancestor
5695074|NCT03391843|Cetuximab|cetuximab|mesh-list
5695075|NCT03391843|Oxaliplatin|oxaliplatin|mesh-list
5695076|NCT03391843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5695077|NCT03391843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5695078|NCT03391830|Ascorbic Acid|ascorbic acid|mesh-list
5695079|NCT03391830|Atorvastatin|atorvastatin|mesh-list
5695080|NCT03391830|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5837326|NCT02525211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5837327|NCT02525211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837328|NCT02525211|Sensory System Agents|sensory system agents|mesh-ancestor
5837329|NCT02525211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5837330|NCT02525172|Rituximab|rituximab|mesh-list
5837331|NCT02525172|Methotrexate|methotrexate|mesh-list
5837332|NCT02525172|Bortezomib|bortezomib|mesh-list
5837333|NCT02525172|Immunoglobulins|immunoglobulins|mesh-list
5837334|NCT02525172|Antibodies|antibodies|mesh-list
5837335|NCT02525172|gamma-Globulins|gamma-globulins|mesh-list
5837336|NCT02525172|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5837337|NCT02525172|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5837338|NCT02525172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5837339|NCT02525172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5837340|NCT02525172|Immunologic Factors|immunologic factors|mesh-ancestor
5837341|NCT02525172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837342|NCT02525172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5837343|NCT02525172|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5837344|NCT02525172|Abortifacient Agents|abortifacient agents|mesh-ancestor
5837345|NCT02525172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5837346|NCT02525172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5837347|NCT02525172|Antimetabolites|antimetabolites|mesh-ancestor
5837348|NCT02525172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5837349|NCT02525172|Dermatologic Agents|dermatologic agents|mesh-ancestor
5837350|NCT02525172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5837351|NCT02525172|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5837352|NCT02525172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5837353|NCT02525172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5837354|NCT02525250|Lenalidomide|lenalidomide|mesh-list
5837355|NCT02525250|Immunologic Factors|immunologic factors|mesh-ancestor
5837356|NCT02525250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837357|NCT02525250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5837358|NCT02525250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5658278|NCT03655002|Cyclophosphamide|cyclophosphamide|mesh-list
5658279|NCT03655002|Nivolumab|nivolumab|mesh-list
5658280|NCT03655002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5658281|NCT03655002|Immunologic Factors|immunologic factors|mesh-ancestor
5658282|NCT03655002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658283|NCT03655002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5658284|NCT03655002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5658285|NCT03655002|Alkylating Agents|alkylating agents|mesh-ancestor
5658286|NCT03655002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658287|NCT03655002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5658288|NCT03655002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5658289|NCT03655002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5658290|NCT03655002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5658291|NCT03654989|Treprostinil|treprostinil|mesh-list
5658292|NCT03654989|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5658293|NCT03654937|Vaccines|vaccines|mesh-list
5658294|NCT03654937|Immunologic Factors|immunologic factors|mesh-ancestor
5658295|NCT03654937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658311|NCT03654820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5658312|NCT03654794|Tacrolimus|tacrolimus|mesh-list
5658313|NCT03654794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5658314|NCT03654794|Immunologic Factors|immunologic factors|mesh-ancestor
5658315|NCT03654794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837359|NCT02525250|Growth Substances|growth substances|mesh-ancestor
5837360|NCT02525250|Growth Inhibitors|growth inhibitors|mesh-ancestor
5837361|NCT02525250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5837362|NCT02525237|Apatinib|apatinib|mesh-list
5837363|NCT02525237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5837364|NCT02525237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5837365|NCT02525237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5837366|NCT02525237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5837367|NCT02525276|Hormones|hormones|mesh-list
5837368|NCT02525276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5837369|NCT02525276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837370|NCT02525302|Halofuginone|halofuginone|mesh-list
5837371|NCT02525302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5837372|NCT02525302|Coccidiostats|coccidiostats|mesh-ancestor
5837373|NCT02525302|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5837374|NCT02525302|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5837375|NCT02525302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5837376|NCT02525302|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5837377|NCT02525302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5837378|NCT02525302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5837379|NCT02525302|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5837380|NCT02525302|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5837381|NCT02525302|Growth Substances|growth substances|mesh-ancestor
5837382|NCT02525302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837383|NCT02525302|Growth Inhibitors|growth inhibitors|mesh-ancestor
5837384|NCT02525081|Ramipril|ramipril|mesh-list
5837385|NCT02525081|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
5837386|NCT02525081|Protease Inhibitors|protease inhibitors|mesh-ancestor
5837387|NCT02525081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5837388|NCT02525081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5837389|NCT02525081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5837390|NCT02525016|Lidocaine|lidocaine|mesh-list
5658316|NCT03654794|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5658317|NCT03654794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5658318|NCT03654794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658319|NCT03654768|Dasatinib|dasatinib|mesh-list
5658320|NCT03654768|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
5658321|NCT03654768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5658322|NCT03654768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5658323|NCT03654768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5658324|NCT03654768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658325|NCT03654716|Cytarabine|cytarabine|mesh-list
5658326|NCT03654716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5658327|NCT03654716|Antimetabolites|antimetabolites|mesh-ancestor
5658328|NCT03654716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658329|NCT03654716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5658330|NCT03654716|Antiviral Agents|antiviral agents|mesh-ancestor
5658331|NCT03654716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5658332|NCT03654716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5658333|NCT03654716|Immunologic Factors|immunologic factors|mesh-ancestor
5658334|NCT03654716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658335|NCT03654703|Cyclophosphamide|cyclophosphamide|mesh-list
5658336|NCT03654703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5658337|NCT03654703|Immunologic Factors|immunologic factors|mesh-ancestor
5658338|NCT03654703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658339|NCT03654703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5658340|NCT03654703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5658341|NCT03654703|Alkylating Agents|alkylating agents|mesh-ancestor
5658342|NCT03654703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658343|NCT03654703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5658344|NCT03654703|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5658345|NCT03654612|Apatinib|apatinib|mesh-list
5658346|NCT03654612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5658347|NCT03654612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5658348|NCT03654612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5658349|NCT03654612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658350|NCT03654365|Caffeine|caffeine|mesh-list
5658351|NCT03654365|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5658352|NCT03654365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658353|NCT03654365|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5658354|NCT03654365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5658355|NCT03654365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5837391|NCT02525016|Anesthetics, Local|anesthetics, local|mesh-ancestor
5658356|NCT03654365|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5658357|NCT03654365|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5658358|NCT03654365|Purinergic Agents|purinergic agents|mesh-ancestor
5658359|NCT03654365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5658360|NCT03654274|Norethindrone|norethindrone|mesh-list
5658361|NCT03654274|Norethindrone Acetate|norethindrone acetate|mesh-list
5658362|NCT03654274|Estradiol|estradiol|mesh-list
5658363|NCT03654274|Relugolix|relugolix|mesh-list
5658364|NCT03654274|Estrogens|estrogens|mesh-ancestor
5658365|NCT03654274|Hormones|hormones|mesh-ancestor
5658366|NCT03654274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5658367|NCT03654274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658368|NCT03654274|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5658369|NCT03654274|Contraceptive Agents|contraceptive agents|mesh-ancestor
5658370|NCT03654274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5658371|NCT03654274|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5658372|NCT03654274|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5658373|NCT03654274|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5658374|NCT03654274|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5658375|NCT03654274|Androgen Antagonists|androgen antagonists|mesh-ancestor
5658376|NCT03654274|Hormone Antagonists|hormone antagonists|mesh-ancestor
5658377|NCT03654170|BI 425809|bi 425809|mesh-list
6493619|NCT00614666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6493620|NCT00614666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6493621|NCT00614666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493622|NCT00614679|Tigecycline|tigecycline|mesh-list
6493623|NCT00614679|Heparin|heparin|mesh-list
6493624|NCT00614679|Anticoagulants|anticoagulants|mesh-ancestor
5837392|NCT02525016|Anesthetics|anesthetics|mesh-ancestor
5837393|NCT02525016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5837394|NCT02525016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837395|NCT02525016|Sensory System Agents|sensory system agents|mesh-ancestor
5837396|NCT02525016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5837397|NCT02525016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5837398|NCT02525016|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5837399|NCT02525016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5837400|NCT02525016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5837401|NCT02525016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5837402|NCT02525003|Vitamin D|vitamin d|mesh-list
5837403|NCT02525003|Ergocalciferols|ergocalciferols|mesh-list
5837404|NCT02525003|Cholecalciferol|cholecalciferol|mesh-list
5837405|NCT02525003|Vitamins|vitamins|mesh-list
5837406|NCT02525003|Micronutrients|micronutrients|mesh-ancestor
5837407|NCT02525003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837408|NCT02525003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5837409|NCT02525003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5837410|NCT02525458|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
5837411|NCT02525458|Vasodilator Agents|vasodilator agents|mesh-ancestor
5837412|NCT02525458|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
5837413|NCT02525458|Protective Agents|protective agents|mesh-ancestor
5837414|NCT02525458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837415|NCT02524899|Guanfacine|guanfacine|mesh-list
5837416|NCT02524899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5837417|NCT02524899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5837418|NCT02524899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5837419|NCT02524899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5837420|NCT02524899|Adrenergic Agents|adrenergic agents|mesh-ancestor
5837421|NCT02524899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5837422|NCT02524899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5837423|NCT02524899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837424|NCT02524964|Tanshinone|tanshinone|mesh-list
5837425|NCT02524964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5837426|NCT02524964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5837427|NCT02524964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5837428|NCT02524964|Analgesics|analgesics|mesh-ancestor
5837429|NCT02524964|Sensory System Agents|sensory system agents|mesh-ancestor
5837430|NCT02524964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5837431|NCT02524964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837432|NCT02524964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5837433|NCT02524964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6493625|NCT00614679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5658378|NCT03654170|Nootropic Agents|nootropic agents|mesh-ancestor
5658379|NCT03654144|Dienogest|dienogest|mesh-list
5658380|NCT03654144|Contraceptive Agents|contraceptive agents|mesh-list
5837434|NCT02524964|Anticoagulants|anticoagulants|mesh-ancestor
5837435|NCT02524964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5837436|NCT02524964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5837437|NCT02524964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5837438|NCT02524964|Immunologic Factors|immunologic factors|mesh-ancestor
5837439|NCT02524821|Metformin|metformin|mesh-list
5837440|NCT02524821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5837441|NCT02524821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837442|NCT02524743|Acetaminophen|acetaminophen|mesh-list
5837443|NCT02524743|Lidocaine|lidocaine|mesh-list
5837444|NCT02524743|Anesthetics, Local|anesthetics, local|mesh-ancestor
5837445|NCT02524743|Anesthetics|anesthetics|mesh-ancestor
5837446|NCT02524743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5837447|NCT02524743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837448|NCT02524743|Sensory System Agents|sensory system agents|mesh-ancestor
5837449|NCT02524743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5837450|NCT02524743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6496513|NCT00628290|Dopamine Agents|dopamine agents|mesh-ancestor
5658381|NCT03654144|Contraceptives, Oral|contraceptives, oral|mesh-list
5658382|NCT03654144|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
5837451|NCT02524743|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5837452|NCT02524743|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5837453|NCT02524743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5837454|NCT02524743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5837455|NCT02524743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5837456|NCT02524743|Analgesics|analgesics|mesh-ancestor
5837457|NCT02524743|Antipyretics|antipyretics|mesh-ancestor
5837458|NCT02524652|Ropivacaine|ropivacaine|mesh-list
5837459|NCT02524652|Anesthetics, Local|anesthetics, local|mesh-ancestor
5837460|NCT02524652|Anesthetics|anesthetics|mesh-ancestor
5837461|NCT02524652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5837462|NCT02524652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837463|NCT02524652|Sensory System Agents|sensory system agents|mesh-ancestor
5837464|NCT02524652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5837465|NCT02524639|Sirolimus|sirolimus|mesh-list
5837466|NCT02524639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5837467|NCT02524639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5837468|NCT02524639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5658383|NCT03654144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5658384|NCT03654144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658385|NCT03654144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5658386|NCT03654144|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5658387|NCT03654144|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5658388|NCT03654144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5658389|NCT03654144|Hormone Antagonists|hormone antagonists|mesh-ancestor
5837469|NCT02524639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5837470|NCT02524639|Antifungal Agents|antifungal agents|mesh-ancestor
5837471|NCT02524639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5837472|NCT02524639|Immunologic Factors|immunologic factors|mesh-ancestor
5837473|NCT02524639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837474|NCT02524444|Pyrimethamine|pyrimethamine|mesh-list
5658390|NCT03654144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5658391|NCT03654144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5658392|NCT03654144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5658393|NCT03654105|Aspirin|aspirin|mesh-list
5658394|NCT03654105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5658395|NCT03654105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5658396|NCT03654105|Analgesics|analgesics|mesh-ancestor
5658397|NCT03654105|Sensory System Agents|sensory system agents|mesh-ancestor
5658398|NCT03654105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5837475|NCT02524444|Sulfadoxine|sulfadoxine|mesh-list
5837476|NCT02524444|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
5837477|NCT02524444|Mefloquine|mefloquine|mesh-list
5837478|NCT02524444|Antimalarials|antimalarials|mesh-ancestor
5837479|NCT02524444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5837480|NCT02524444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5837481|NCT02524444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5837482|NCT02524444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5837483|NCT02524444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5837484|NCT02524444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5837485|NCT02524444|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5837486|NCT02524444|Renal Agents|renal agents|mesh-ancestor
5902982|NCT02506959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5902983|NCT02506959|Antiviral Agents|antiviral agents|mesh-ancestor
5902984|NCT02506959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5658399|NCT03654105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658400|NCT03654105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5658401|NCT03654105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5658402|NCT03654105|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5658403|NCT03654105|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5658404|NCT03654105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658405|NCT03654105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5658406|NCT03654105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5658407|NCT03654105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5658408|NCT03654105|Antipyretics|antipyretics|mesh-ancestor
5658409|NCT03654066|Botulinum Toxins|botulinum toxins|mesh-list
5658410|NCT03654066|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5658411|NCT03654066|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5658412|NCT03654066|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5658413|NCT03654066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5658414|NCT03654066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658415|NCT03654066|Cholinergic Agents|cholinergic agents|mesh-ancestor
5658416|NCT03654066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5658417|NCT03654066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658418|NCT03654066|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5658419|NCT03654066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5658420|NCT03654053|Simvastatin|simvastatin|mesh-list
5658421|NCT03654053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5658422|NCT03654053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5658423|NCT03654053|Antimetabolites|antimetabolites|mesh-ancestor
5658424|NCT03654053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658425|NCT03654053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5658426|NCT03654053|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5658427|NCT03654053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5658428|NCT03654040|Cyclophosphamide|cyclophosphamide|mesh-list
5658429|NCT03654040|Everolimus|everolimus|mesh-list
5658430|NCT03654040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5658431|NCT03654040|Immunologic Factors|immunologic factors|mesh-ancestor
5658432|NCT03654040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658433|NCT03654040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5658434|NCT03654040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5837487|NCT02524405|Corticosterone|corticosterone|mesh-list
5837488|NCT02524405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5837489|NCT02524379|Glyburide|glyburide|mesh-list
5837490|NCT02524379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5837491|NCT02524379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837492|NCT02524301|Diprenorphine|diprenorphine|mesh-list
5837493|NCT02524301|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5837494|NCT02524301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837495|NCT02524301|Sensory System Agents|sensory system agents|mesh-ancestor
5837496|NCT02524301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5837497|NCT02524249|Caffeine|caffeine|mesh-list
5837498|NCT02524249|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5837499|NCT02524249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837500|NCT02524249|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5837501|NCT02524249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5837502|NCT02524249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5837503|NCT02524249|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5837504|NCT02524249|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5837505|NCT02524249|Purinergic Agents|purinergic agents|mesh-ancestor
5837506|NCT02524249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5837507|NCT02524210|Omeprazole|omeprazole|mesh-list
5837508|NCT02524210|Rabeprazole|rabeprazole|mesh-list
5837509|NCT02524210|Dabigatran|dabigatran|mesh-list
5837510|NCT02524210|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5837511|NCT02524210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5837512|NCT02524210|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6493626|NCT00614679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6493627|NCT00614679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493628|NCT00614679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5837513|NCT02524210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5658435|NCT03654040|Alkylating Agents|alkylating agents|mesh-ancestor
5837514|NCT02524210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5837515|NCT02524210|Antithrombins|antithrombins|mesh-ancestor
5837516|NCT02524210|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5837517|NCT02524210|Protease Inhibitors|protease inhibitors|mesh-ancestor
5837518|NCT02524210|Anticoagulants|anticoagulants|mesh-ancestor
5837519|NCT02523820|Fluticasone|fluticasone|mesh-list
5837520|NCT02523820|Xhance|xhance|mesh-list
5837521|NCT02523820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5837522|NCT02523820|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5837523|NCT02523820|Autonomic Agents|autonomic agents|mesh-ancestor
5837524|NCT02523820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5837525|NCT02523820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837526|NCT02523820|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5837527|NCT02523820|Respiratory System Agents|respiratory system agents|mesh-ancestor
5837528|NCT02523820|Dermatologic Agents|dermatologic agents|mesh-ancestor
5837529|NCT02523820|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5837530|NCT02523911|Magnesium Sulfate|magnesium sulfate|mesh-list
5658436|NCT03654040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658437|NCT03654040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5658438|NCT03654040|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5658439|NCT03654027|Docetaxel|docetaxel|mesh-list
5658440|NCT03654027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5658441|NCT03654027|Tubulin Modulators|tubulin modulators|mesh-ancestor
5658442|NCT03654027|Antimitotic Agents|antimitotic agents|mesh-ancestor
5658443|NCT03654027|Mitosis Modulators|mitosis modulators|mesh-ancestor
5658444|NCT03654027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658445|NCT03653845|Epinephrine|epinephrine|mesh-list
5837531|NCT02523911|Simethicone|simethicone|mesh-list
5837532|NCT02523911|Sodium sulfate|sodium sulfate|mesh-list
5837533|NCT02523911|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5837534|NCT02523911|Analgesics|analgesics|mesh-ancestor
5837535|NCT02523911|Sensory System Agents|sensory system agents|mesh-ancestor
5837536|NCT02523911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5837537|NCT02523911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837538|NCT02523911|Anesthetics|anesthetics|mesh-ancestor
5837539|NCT02523911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5837540|NCT02523911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5837541|NCT02523911|Anticonvulsants|anticonvulsants|mesh-ancestor
5658446|NCT03653845|Racepinephrine|racepinephrine|mesh-list
5658447|NCT03653845|Epinephryl borate|epinephryl borate|mesh-list
5658448|NCT03653845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5658449|NCT03653845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5658450|NCT03653845|Adrenergic Agents|adrenergic agents|mesh-ancestor
5658451|NCT03653845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5658452|NCT03653845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658453|NCT03653845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658454|NCT03653845|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5658455|NCT03653845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5658456|NCT03653845|Autonomic Agents|autonomic agents|mesh-ancestor
5658457|NCT03653845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5658458|NCT03653845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5658459|NCT03653845|Respiratory System Agents|respiratory system agents|mesh-ancestor
5658460|NCT03653845|Mydriatics|mydriatics|mesh-ancestor
5658461|NCT03653845|Sympathomimetics|sympathomimetics|mesh-ancestor
5658462|NCT03653845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5658463|NCT03653832|Clonidine|clonidine|mesh-list
5658464|NCT03653832|Dexmedetomidine|dexmedetomidine|mesh-list
5658465|NCT03653832|Propofol|propofol|mesh-list
5658466|NCT03653832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5658467|NCT03653832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5658468|NCT03653832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837542|NCT02523911|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5837543|NCT02523911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5837544|NCT02523911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5837545|NCT02523911|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5837546|NCT02523911|Tocolytic Agents|tocolytic agents|mesh-ancestor
5837547|NCT02523911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5837548|NCT02523911|Antifoaming Agents|antifoaming agents|mesh-ancestor
5837549|NCT02523911|Emollients|emollients|mesh-ancestor
5837550|NCT02523911|Dermatologic Agents|dermatologic agents|mesh-ancestor
5837551|NCT02523911|Cathartics|cathartics|mesh-ancestor
5837552|NCT02523911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5837553|NCT02523898|Metformin|metformin|mesh-list
5837554|NCT02523898|Clomiphene|clomiphene|mesh-list
5837555|NCT02523898|Enclomiphene|enclomiphene|mesh-list
5837556|NCT02523898|Zuclomiphene|zuclomiphene|mesh-list
5837557|NCT02523898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5837558|NCT02523898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837559|NCT02523898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5837560|NCT02523898|Hormone Antagonists|hormone antagonists|mesh-ancestor
5837561|NCT02523898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5837562|NCT02523898|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5658469|NCT03653832|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5837563|NCT02523898|Fertility Agents|fertility agents|mesh-ancestor
5902985|NCT02506959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5658470|NCT03653832|Anesthetics, General|anesthetics, general|mesh-ancestor
5658471|NCT03653832|Anesthetics|anesthetics|mesh-ancestor
5658472|NCT03653832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5658473|NCT03653832|Analgesics|analgesics|mesh-ancestor
5658474|NCT03653832|Sensory System Agents|sensory system agents|mesh-ancestor
5658475|NCT03653832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5658476|NCT03653832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5658477|NCT03653832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5658478|NCT03653832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5658479|NCT03653832|Adrenergic Agents|adrenergic agents|mesh-ancestor
5658480|NCT03653832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5658481|NCT03653832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658482|NCT03653832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5837564|NCT02523898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5837565|NCT02523898|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5837566|NCT02523898|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5837567|NCT02523768|Basiliximab|basiliximab|mesh-list
5837568|NCT02523768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5837569|NCT02523768|Immunologic Factors|immunologic factors|mesh-ancestor
5837570|NCT02523768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837571|NCT02524184|Sildenafil Citrate|sildenafil citrate|mesh-list
5837572|NCT02524184|Vasodilator Agents|vasodilator agents|mesh-ancestor
5837573|NCT02524184|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5837574|NCT02524184|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5837575|NCT02524184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5837576|NCT02524184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5837577|NCT02524184|Urological Agents|urological agents|mesh-ancestor
5837578|NCT02523833|Albuterol|albuterol|mesh-list
5837579|NCT02523833|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5837580|NCT02523833|Autonomic Agents|autonomic agents|mesh-ancestor
5837581|NCT02523833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5658483|NCT03653832|Sympatholytics|sympatholytics|mesh-ancestor
5658484|NCT03653832|Autonomic Agents|autonomic agents|mesh-ancestor
5695081|NCT03391830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5695082|NCT03391830|Antimetabolites|antimetabolites|mesh-ancestor
5695083|NCT03391830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695084|NCT03391830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5695085|NCT03391830|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5695086|NCT03391830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5695087|NCT03391830|Antioxidants|antioxidants|mesh-ancestor
5695088|NCT03391830|Protective Agents|protective agents|mesh-ancestor
5837582|NCT02523833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837583|NCT02523833|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5837584|NCT02523833|Respiratory System Agents|respiratory system agents|mesh-ancestor
5837585|NCT02523833|Tocolytic Agents|tocolytic agents|mesh-ancestor
5837586|NCT02523833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5837587|NCT02523833|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5837588|NCT02523833|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5695089|NCT03391830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695090|NCT03391830|Vitamins|vitamins|mesh-ancestor
5695091|NCT03391830|Micronutrients|micronutrients|mesh-ancestor
5695092|NCT03391700|Rocuronium|rocuronium|mesh-list
5695093|NCT03391700|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5695094|NCT03391700|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5837589|NCT02523833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5837590|NCT02523833|Adrenergic Agents|adrenergic agents|mesh-ancestor
5837591|NCT02523833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5837592|NCT02523833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5837593|NCT02523859|Propofol|propofol|mesh-list
5837594|NCT02523859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5837595|NCT02523859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5837596|NCT02523859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837597|NCT02523859|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5837598|NCT02523859|Anesthetics, General|anesthetics, general|mesh-ancestor
5837599|NCT02523859|Anesthetics|anesthetics|mesh-ancestor
5837600|NCT02523846|Morphine|morphine|mesh-list
5837601|NCT02523846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5837602|NCT02523846|Narcotics|narcotics|mesh-ancestor
5837603|NCT02523846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5695095|NCT03391700|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5695096|NCT03391700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5695097|NCT03391700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695098|NCT03391609|Dexmedetomidine|dexmedetomidine|mesh-list
5695099|NCT03391609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6674602|NCT01570569|GABA Agents|gaba agents|mesh-ancestor
5837604|NCT02523846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837605|NCT02523846|Analgesics|analgesics|mesh-ancestor
5837606|NCT02523846|Sensory System Agents|sensory system agents|mesh-ancestor
5837607|NCT02523846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5837608|NCT02523976|Cytarabine|cytarabine|mesh-list
5837609|NCT02523976|Dexamethasone|dexamethasone|mesh-list
5837610|NCT02523976|Prednisone|prednisone|mesh-list
5837611|NCT02523976|Cyclophosphamide|cyclophosphamide|mesh-list
5837612|NCT02523976|Methotrexate|methotrexate|mesh-list
5837613|NCT02523976|Etoposide|etoposide|mesh-list
5837614|NCT02523976|Vincristine|vincristine|mesh-list
5837615|NCT02523976|Daunorubicin|daunorubicin|mesh-list
5837616|NCT02523976|Dasatinib|dasatinib|mesh-list
5837617|NCT02523976|Mercaptopurine|mercaptopurine|mesh-list
5837618|NCT02523976|Mitoxantrone|mitoxantrone|mesh-list
5837619|NCT02523976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5837620|NCT02523976|Immunologic Factors|immunologic factors|mesh-ancestor
5837621|NCT02523976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837622|NCT02523976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5837623|NCT02523976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5837624|NCT02523976|Alkylating Agents|alkylating agents|mesh-ancestor
5837625|NCT02523976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5837626|NCT02523976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5837627|NCT02523976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5658485|NCT03653663|Simvastatin|simvastatin|mesh-list
5658486|NCT03653663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5658487|NCT03653663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5658488|NCT03653663|Antimetabolites|antimetabolites|mesh-ancestor
5658489|NCT03653663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658490|NCT03653663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5658491|NCT03653663|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5837628|NCT02523976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5837629|NCT02523976|Antiemetics|antiemetics|mesh-ancestor
5837630|NCT02523976|Autonomic Agents|autonomic agents|mesh-ancestor
5837631|NCT02523976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5837632|NCT02523976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5837633|NCT02523976|Glucocorticoids|glucocorticoids|mesh-ancestor
5837634|NCT02523976|Hormones|hormones|mesh-ancestor
5837635|NCT02523976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5837636|NCT02523976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5837637|NCT02523976|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6493629|NCT00614679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6493630|NCT00614679|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6493631|NCT00614679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6493632|NCT00614757|Acetylcysteine|acetylcysteine|mesh-list
6493633|NCT00614757|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6493634|NCT00614757|Antiviral Agents|antiviral agents|mesh-ancestor
6493635|NCT00614757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6493636|NCT00614757|Expectorants|expectorants|mesh-ancestor
6493637|NCT00614757|Respiratory System Agents|respiratory system agents|mesh-ancestor
6493638|NCT00614757|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5837638|NCT02523976|Abortifacient Agents|abortifacient agents|mesh-ancestor
5837639|NCT02523976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5837640|NCT02523976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5837641|NCT02523976|Antimetabolites|antimetabolites|mesh-ancestor
5837642|NCT02523976|Dermatologic Agents|dermatologic agents|mesh-ancestor
5837643|NCT02523976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5837644|NCT02523976|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5837645|NCT02523976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5837646|NCT02523976|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5837647|NCT02523976|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5837648|NCT02523976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5837649|NCT02523976|Antiviral Agents|antiviral agents|mesh-ancestor
5837650|NCT02523976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5837651|NCT02523976|Tubulin Modulators|tubulin modulators|mesh-ancestor
5837652|NCT02523976|Antimitotic Agents|antimitotic agents|mesh-ancestor
5658492|NCT03653663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5658493|NCT03653546|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5658494|NCT03653546|Gefitinib|gefitinib|mesh-list
5837653|NCT02523976|Mitosis Modulators|mitosis modulators|mesh-ancestor
5837654|NCT02523976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5837655|NCT02523976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5837656|NCT02523976|Analgesics|analgesics|mesh-ancestor
5837657|NCT02523976|Sensory System Agents|sensory system agents|mesh-ancestor
6493639|NCT00614757|Antioxidants|antioxidants|mesh-ancestor
5837658|NCT02523755|Ropivacaine|ropivacaine|mesh-list
5837659|NCT02523755|Anesthetics, Local|anesthetics, local|mesh-ancestor
6493640|NCT00614757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5837660|NCT02523755|Anesthetics|anesthetics|mesh-ancestor
5658495|NCT03653546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5658496|NCT03653546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5658497|NCT03653546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5658498|NCT03653546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658499|NCT03653520|Diazepam|diazepam|mesh-list
5658500|NCT03653520|Tramadol|tramadol|mesh-list
5658501|NCT03653520|Ondansetron|ondansetron|mesh-list
5658502|NCT03653520|Antiemetics|antiemetics|mesh-ancestor
5837661|NCT02523755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5837662|NCT02523755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837663|NCT02523755|Sensory System Agents|sensory system agents|mesh-ancestor
5837664|NCT02523755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5837665|NCT02523547|Entecavir|entecavir|mesh-list
5837666|NCT02523547|Antiviral Agents|antiviral agents|mesh-ancestor
5658503|NCT03653520|Autonomic Agents|autonomic agents|mesh-ancestor
5658504|NCT03653520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5658505|NCT03653520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658506|NCT03653520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5658507|NCT03653520|Antipruritics|antipruritics|mesh-ancestor
5658508|NCT03653520|Dermatologic Agents|dermatologic agents|mesh-ancestor
5658509|NCT03653520|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5837667|NCT02523547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5837668|NCT02523703|N-Methylaspartate|n-methylaspartate|mesh-list
5837669|NCT02523703|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
5658510|NCT03653520|Serotonin Agents|serotonin agents|mesh-ancestor
5658511|NCT03653520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5658512|NCT03653520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658513|NCT03653520|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5658514|NCT03653520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5658515|NCT03653520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5658516|NCT03653520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5658517|NCT03653520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5658518|NCT03653520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5658519|NCT03653520|Narcotics|narcotics|mesh-ancestor
5837670|NCT02523703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5837671|NCT02523703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5837672|NCT02523703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5837673|NCT02523703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837674|NCT02523638|Interferons|interferons|mesh-list
5837675|NCT02523638|Interferon-alpha|interferon-alpha|mesh-list
5837676|NCT02523638|Interferon alpha-2|interferon alpha-2|mesh-list
5837677|NCT02523638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5837678|NCT02523638|Antiviral Agents|antiviral agents|mesh-ancestor
5837679|NCT02523638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5837680|NCT02523638|Immunologic Factors|immunologic factors|mesh-ancestor
5837681|NCT02523638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837682|NCT02523664|Hydrocortisone|hydrocortisone|mesh-list
5837683|NCT02523664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5837684|NCT02523300|Methylprednisolone|methylprednisolone|mesh-list
5837685|NCT02523300|Glucocorticoids|glucocorticoids|mesh-list
5658520|NCT03653520|Analgesics|analgesics|mesh-ancestor
5658521|NCT03653520|Sensory System Agents|sensory system agents|mesh-ancestor
5658522|NCT03653520|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5658523|NCT03653520|Anticonvulsants|anticonvulsants|mesh-ancestor
5658524|NCT03653520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5658525|NCT03653520|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5658526|NCT03653520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5658527|NCT03653520|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5658528|NCT03653520|Anesthetics, General|anesthetics, general|mesh-ancestor
5658529|NCT03653520|Anesthetics|anesthetics|mesh-ancestor
5658530|NCT03653520|GABA Modulators|gaba modulators|mesh-ancestor
5658531|NCT03653520|GABA Agents|gaba agents|mesh-ancestor
5837686|NCT02523300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5837687|NCT02523300|Antiemetics|antiemetics|mesh-ancestor
5837688|NCT02523300|Autonomic Agents|autonomic agents|mesh-ancestor
5837689|NCT02523300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5837690|NCT02523300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837691|NCT02523300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5837692|NCT02523300|Hormones|hormones|mesh-ancestor
5902986|NCT02506959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5658532|NCT03653338|Rituximab|rituximab|mesh-list
5658533|NCT03653338|Alemtuzumab|alemtuzumab|mesh-list
5658534|NCT03653338|Fludarabine|fludarabine|mesh-list
5658535|NCT03653338|Thiotepa|thiotepa|mesh-list
5658536|NCT03653338|Hydroxyurea|hydroxyurea|mesh-list
5658537|NCT03653338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5658538|NCT03653338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5658539|NCT03653338|Immunologic Factors|immunologic factors|mesh-ancestor
5658540|NCT03653338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658541|NCT03653338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5658542|NCT03653338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658543|NCT03653338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5658544|NCT03653338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5658545|NCT03653338|Alkylating Agents|alkylating agents|mesh-ancestor
5658546|NCT03653338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5658547|NCT03653338|Antisickling Agents|antisickling agents|mesh-ancestor
5658548|NCT03653338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5658549|NCT03653338|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5658550|NCT03653260|Lidocaine|lidocaine|mesh-list
5837693|NCT02523300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5837694|NCT02523300|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5837695|NCT02523300|Protective Agents|protective agents|mesh-ancestor
5837696|NCT02523131|Insulin|insulin|mesh-list
5837697|NCT02523131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5837698|NCT02523131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837699|NCT02523144|Dexmedetomidine|dexmedetomidine|mesh-list
5837700|NCT02523144|Chloral Hydrate|chloral hydrate|mesh-list
5837701|NCT02523144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5837702|NCT02523144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5837703|NCT02523144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837704|NCT02523144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5837705|NCT02523144|Analgesics|analgesics|mesh-ancestor
5837706|NCT02523144|Sensory System Agents|sensory system agents|mesh-ancestor
5837707|NCT02523144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5837708|NCT02523144|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5837709|NCT02523144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5837710|NCT02523144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5837711|NCT02523144|Adrenergic Agents|adrenergic agents|mesh-ancestor
5837712|NCT02523144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5837713|NCT02523144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5837714|NCT02523092|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
5837715|NCT02523092|Hormones|hormones|mesh-ancestor
5837716|NCT02523092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5837717|NCT02523092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837718|NCT02523053|Fluorouracil|fluorouracil|mesh-list
5837719|NCT02523053|Antimetabolites|antimetabolites|mesh-ancestor
5837720|NCT02523053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5837721|NCT02523053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5837722|NCT02523053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5837723|NCT02523053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5658551|NCT03653260|Anesthetics, Local|anesthetics, local|mesh-ancestor
5658552|NCT03653260|Anesthetics|anesthetics|mesh-ancestor
5658553|NCT03653260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5658554|NCT03653260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658555|NCT03653260|Sensory System Agents|sensory system agents|mesh-ancestor
5658556|NCT03653260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5658557|NCT03653260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5658558|NCT03653260|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5658559|NCT03653260|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5658560|NCT03653260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5658561|NCT03653260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658562|NCT03653052|Durvalumab|durvalumab|mesh-list
5658563|NCT03653052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5837724|NCT02523053|Immunologic Factors|immunologic factors|mesh-ancestor
5837725|NCT02523053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837726|NCT02522897|Ranibizumab|ranibizumab|mesh-list
5837727|NCT02522897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5902987|NCT02506959|Immunologic Factors|immunologic factors|mesh-ancestor
5658564|NCT03653052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5658565|NCT03653000|Anesthetics|anesthetics|mesh-list
5658566|NCT03653000|Anesthetics, Local|anesthetics, local|mesh-list
5658567|NCT03653000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5658568|NCT03653000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658569|NCT03653000|Sensory System Agents|sensory system agents|mesh-ancestor
5658570|NCT03653000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5658571|NCT03652974|Valproic Acid|valproic acid|mesh-list
5658572|NCT03652974|Clozapine|clozapine|mesh-list
5658573|NCT03652974|Amisulpride|amisulpride|mesh-list
5658574|NCT03652974|Anticonvulsants|anticonvulsants|mesh-ancestor
5658575|NCT03652974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5695100|NCT03391609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5837728|NCT02522897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5837729|NCT02522897|Growth Substances|growth substances|mesh-ancestor
5837730|NCT02522897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837731|NCT02522897|Growth Inhibitors|growth inhibitors|mesh-ancestor
5837732|NCT02522897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5837733|NCT02522975|Epoetin Alfa|epoetin alfa|mesh-list
5837734|NCT02522975|Hematinics|hematinics|mesh-ancestor
5837735|NCT02522910|Docetaxel|docetaxel|mesh-list
5837736|NCT02522910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5837737|NCT02522910|Tubulin Modulators|tubulin modulators|mesh-ancestor
5837738|NCT02522910|Antimitotic Agents|antimitotic agents|mesh-ancestor
5837739|NCT02522910|Mitosis Modulators|mitosis modulators|mesh-ancestor
5837740|NCT02522910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5837741|NCT02522858|Atropine|atropine|mesh-list
5837742|NCT02522858|Ephedrine|ephedrine|mesh-list
5837743|NCT02522858|Dexmedetomidine|dexmedetomidine|mesh-list
5837744|NCT02522858|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5837745|NCT02522858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5837746|NCT02522858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837747|NCT02522858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5837748|NCT02522858|Analgesics|analgesics|mesh-ancestor
5837749|NCT02522858|Sensory System Agents|sensory system agents|mesh-ancestor
5837750|NCT02522858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5837751|NCT02522858|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5837752|NCT02522858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5837753|NCT02522858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5837754|NCT02522858|Adrenergic Agents|adrenergic agents|mesh-ancestor
5837755|NCT02522858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5837756|NCT02522858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658576|NCT03652974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658577|NCT03652974|GABA Agents|gaba agents|mesh-ancestor
5658578|NCT03652974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5658579|NCT03652974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658580|NCT03652974|Antimanic Agents|antimanic agents|mesh-ancestor
5658581|NCT03652974|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5837757|NCT02522858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5837758|NCT02522858|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5837759|NCT02522858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5837760|NCT02522858|Autonomic Agents|autonomic agents|mesh-ancestor
5837761|NCT02522858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5837762|NCT02522858|Respiratory System Agents|respiratory system agents|mesh-ancestor
5837763|NCT02522858|Mydriatics|mydriatics|mesh-ancestor
5837764|NCT02522858|Parasympatholytics|parasympatholytics|mesh-ancestor
5658582|NCT03652974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5658583|NCT03652974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5658584|NCT03652974|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5658585|NCT03652974|Serotonin Agents|serotonin agents|mesh-ancestor
5658586|NCT03652974|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5658587|NCT03652974|GABA Antagonists|gaba antagonists|mesh-ancestor
5658588|NCT03652974|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5658589|NCT03652974|Dopamine Agents|dopamine agents|mesh-ancestor
5658590|NCT03652974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5658591|NCT03652974|Antidepressive Agents|antidepressive agents|mesh-ancestor
5658592|NCT03652961|Abatacept|abatacept|mesh-list
5658593|NCT03652961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5658594|NCT03652961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658595|NCT03652961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5658596|NCT03652961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5658597|NCT03652961|Immunologic Factors|immunologic factors|mesh-ancestor
5658598|NCT03652961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658599|NCT03652961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5658600|NCT03652896|Liver Extracts|liver extracts|mesh-list
5658601|NCT03652896|Hematinics|hematinics|mesh-ancestor
5658602|NCT03652870|Dexetimide|dexetimide|mesh-list
5658603|NCT03652870|Citalopram|citalopram|mesh-list
5658604|NCT03652870|Nortriptyline|nortriptyline|mesh-list
5658605|NCT03652870|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5658606|NCT03652870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5658607|NCT03652870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5658608|NCT03652870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658609|NCT03652870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5658610|NCT03652870|Serotonin Agents|serotonin agents|mesh-ancestor
5658611|NCT03652870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658612|NCT03652870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5658613|NCT03652870|Antidepressive Agents|antidepressive agents|mesh-ancestor
5658614|NCT03652870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5837765|NCT02522858|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5837766|NCT02522858|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5837767|NCT02522858|Cholinergic Agents|cholinergic agents|mesh-ancestor
5837768|NCT02522858|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5837769|NCT02522858|Sympathomimetics|sympathomimetics|mesh-ancestor
5837770|NCT02522858|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5902988|NCT02506959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902989|NCT02506959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5902990|NCT02506959|Alkylating Agents|alkylating agents|mesh-ancestor
5658615|NCT03652870|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5658616|NCT03652870|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5658617|NCT03652870|Parasympatholytics|parasympatholytics|mesh-ancestor
5658618|NCT03652870|Autonomic Agents|autonomic agents|mesh-ancestor
5658619|NCT03652870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5658620|NCT03652870|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5902991|NCT02506959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5902992|NCT02506959|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5902993|NCT02502786|Antibodies|antibodies|mesh-list
5902994|NCT02502786|Immunologic Factors|immunologic factors|mesh-ancestor
5902995|NCT02502786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5902996|NCT02464878|Etanercept|etanercept|mesh-list
5902997|NCT02464878|Thymoglobulin|thymoglobulin|mesh-list
5902998|NCT02464878|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5902999|NCT02464878|Basiliximab|basiliximab|mesh-list
5903000|NCT02464878|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
5903001|NCT02464878|Protein C Inhibitor|protein c inhibitor|mesh-list
5903002|NCT02464878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5903003|NCT02464878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5903004|NCT02464878|Analgesics|analgesics|mesh-ancestor
5903005|NCT02464878|Sensory System Agents|sensory system agents|mesh-ancestor
5903006|NCT02464878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5903007|NCT02464878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903008|NCT02464878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5903009|NCT02464878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5903010|NCT02464878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5903011|NCT02464878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5903012|NCT02464878|Immunologic Factors|immunologic factors|mesh-ancestor
5903013|NCT02464878|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5903014|NCT02464878|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5903015|NCT02464878|Protease Inhibitors|protease inhibitors|mesh-ancestor
5903016|NCT02464878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5903017|NCT02464878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903018|NCT02250937|Fludarabine|fludarabine|mesh-list
5903019|NCT02250937|Fludarabine phosphate|fludarabine phosphate|mesh-list
5903020|NCT02250937|Busulfan|busulfan|mesh-list
5903021|NCT02250937|Venetoclax|venetoclax|mesh-list
5903022|NCT02250937|Cladribine|cladribine|mesh-list
5903023|NCT02250937|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
5903024|NCT02250937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5903025|NCT02250937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5903026|NCT02250937|Antimetabolites|antimetabolites|mesh-ancestor
5903027|NCT02250937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903028|NCT02250937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5903029|NCT02250937|Immunologic Factors|immunologic factors|mesh-ancestor
5903030|NCT02250937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903031|NCT02250937|Alkylating Agents|alkylating agents|mesh-ancestor
5903032|NCT02250937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5903033|NCT02250937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5903034|NCT02010606|Bevacizumab|bevacizumab|mesh-list
5903035|NCT02010606|Temozolomide|temozolomide|mesh-list
5903036|NCT02010606|Vaccines|vaccines|mesh-list
5903037|NCT02010606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5903038|NCT02010606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5903039|NCT02010606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5903040|NCT02010606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5903041|NCT02010606|Growth Substances|growth substances|mesh-ancestor
5903042|NCT02010606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903043|NCT02010606|Growth Inhibitors|growth inhibitors|mesh-ancestor
6493641|NCT00614757|Protective Agents|protective agents|mesh-ancestor
5658621|NCT03652870|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5658622|NCT03652870|Cholinergic Agents|cholinergic agents|mesh-ancestor
5658623|NCT03652870|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5658624|NCT03652870|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5658625|NCT03652870|Adrenergic Agents|adrenergic agents|mesh-ancestor
5658626|NCT03652857|Apatinib|apatinib|mesh-list
5658627|NCT03652857|Vinorelbine|vinorelbine|mesh-list
5658628|NCT03652857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5658629|NCT03652857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5658630|NCT03652857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5658631|NCT03652857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658632|NCT03652857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5658633|NCT03652857|Tubulin Modulators|tubulin modulators|mesh-ancestor
5658634|NCT03652857|Antimitotic Agents|antimitotic agents|mesh-ancestor
5658635|NCT03652857|Mitosis Modulators|mitosis modulators|mesh-ancestor
5658636|NCT03652792|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
5658637|NCT03652792|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5658638|NCT03652792|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5658639|NCT03652792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5837771|NCT02522754|Vaccines|vaccines|mesh-list
5837772|NCT02522754|Immunologic Factors|immunologic factors|mesh-ancestor
5837773|NCT02522754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837774|NCT02522936|Muramidase|muramidase|mesh-list
5837775|NCT02522936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5837776|NCT02522650|Amiloride|amiloride|mesh-list
5837777|NCT02522650|Triamterene|triamterene|mesh-list
5837778|NCT02522650|Diuretics|diuretics|mesh-ancestor
5837779|NCT02522650|Natriuretic Agents|natriuretic agents|mesh-ancestor
5837780|NCT02522650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837781|NCT02522650|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
5837782|NCT02522650|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5837783|NCT02522650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5837784|NCT02522650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5837785|NCT02522650|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
5837786|NCT02522650|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5837787|NCT02522572|Plerixafor|plerixafor|mesh-list
5837788|NCT02522572|Bortezomib|bortezomib|mesh-list
5837789|NCT02522572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5837790|NCT02522572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5837791|NCT02522572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5837792|NCT02522572|Antiviral Agents|antiviral agents|mesh-ancestor
5837793|NCT02522572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5837794|NCT02522234|Lenograstim|lenograstim|mesh-list
5837795|NCT02522234|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5837796|NCT02522234|Immunologic Factors|immunologic factors|mesh-ancestor
5837797|NCT02522234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493642|NCT00614757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493643|NCT00614757|Antidotes|antidotes|mesh-ancestor
6493644|NCT00614809|Gefitinib|gefitinib|mesh-list
5658640|NCT03652753|Acetylcysteine|acetylcysteine|mesh-list
5658641|NCT03652753|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5658642|NCT03652753|Antiviral Agents|antiviral agents|mesh-ancestor
5658643|NCT03652753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5658644|NCT03652753|Expectorants|expectorants|mesh-ancestor
5658645|NCT03652753|Respiratory System Agents|respiratory system agents|mesh-ancestor
5658646|NCT03652753|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5658647|NCT03652753|Antioxidants|antioxidants|mesh-ancestor
5658648|NCT03652753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658649|NCT03652753|Protective Agents|protective agents|mesh-ancestor
6493645|NCT00614809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6493646|NCT00614809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6493647|NCT00614809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6493648|NCT00614809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493649|NCT00614835|Gemcitabine|gemcitabine|mesh-list
5837798|NCT02522221|Warfarin|warfarin|mesh-list
5837799|NCT02522221|Anticoagulants|anticoagulants|mesh-ancestor
5837800|NCT02522169|Infliximab|infliximab|mesh-list
5837801|NCT02522169|Dermatologic Agents|dermatologic agents|mesh-ancestor
5837802|NCT02522169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5837803|NCT02522169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5837804|NCT02522208|Hydralazine|hydralazine|mesh-list
5837805|NCT02522208|Isosorbide|isosorbide|mesh-list
5837806|NCT02522208|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
5837807|NCT02522208|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
5837808|NCT02522208|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5837809|NCT02522208|Diuretics|diuretics|mesh-ancestor
5837810|NCT02522208|Natriuretic Agents|natriuretic agents|mesh-ancestor
5837811|NCT02522208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837812|NCT02522208|Vasodilator Agents|vasodilator agents|mesh-ancestor
5837813|NCT02522208|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5837814|NCT02522208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5837815|NCT02522208|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5837816|NCT02522078|Misoprostol|misoprostol|mesh-list
5837817|NCT02522078|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5837818|NCT02522078|Abortifacient Agents|abortifacient agents|mesh-ancestor
5658650|NCT03652753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658651|NCT03652753|Antidotes|antidotes|mesh-ancestor
5658652|NCT03652714|Anesthetics|anesthetics|mesh-list
5837819|NCT02522078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5837820|NCT02522078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837821|NCT02522078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5837822|NCT02522078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5837823|NCT02522078|Oxytocics|oxytocics|mesh-ancestor
5837824|NCT02522117|Atorvastatin|atorvastatin|mesh-list
5837825|NCT02522117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5837826|NCT02522117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5837827|NCT02522117|Antimetabolites|antimetabolites|mesh-ancestor
5837828|NCT02522117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5837829|NCT02522117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5837830|NCT02522117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5837831|NCT02522117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5837832|NCT02522130|Naproxen|naproxen|mesh-list
5837833|NCT02522130|Lidocaine|lidocaine|mesh-list
5837834|NCT02522130|Misoprostol|misoprostol|mesh-list
5837835|NCT02522130|Anesthetics, Local|anesthetics, local|mesh-ancestor
5837836|NCT02522130|Anesthetics|anesthetics|mesh-ancestor
5837837|NCT02522130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5837838|NCT02522130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837839|NCT02522130|Sensory System Agents|sensory system agents|mesh-ancestor
5837840|NCT02522130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5837841|NCT02522130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5837842|NCT02522130|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5837843|NCT02522130|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5837844|NCT02522130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5837845|NCT02522130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5837846|NCT02522130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5837847|NCT02522130|Abortifacient Agents|abortifacient agents|mesh-ancestor
5837848|NCT02522130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5837849|NCT02522130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5837850|NCT02522130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5837851|NCT02522130|Oxytocics|oxytocics|mesh-ancestor
5837852|NCT02522130|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5837853|NCT02522130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5837854|NCT02522130|Analgesics|analgesics|mesh-ancestor
5837855|NCT02522130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5837856|NCT02522130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5837857|NCT02522130|Gout Suppressants|gout suppressants|mesh-ancestor
5837858|NCT02522130|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5837859|NCT02522130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5837860|NCT02522039|Timolol|timolol|mesh-list
5837861|NCT02522039|Dorzolamide|dorzolamide|mesh-list
5837862|NCT02522039|Latanoprost|latanoprost|mesh-list
5837863|NCT02522039|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5837864|NCT02522039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5837865|NCT02522039|Adrenergic Agents|adrenergic agents|mesh-ancestor
5837866|NCT02522039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5837867|NCT02522039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5837868|NCT02522039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837869|NCT02522039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5658653|NCT03652714|Anesthetics, Local|anesthetics, local|mesh-list
5658654|NCT03652714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5658655|NCT03652714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658656|NCT03652714|Sensory System Agents|sensory system agents|mesh-ancestor
5658657|NCT03652714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5658658|NCT03652571|Nortriptyline|nortriptyline|mesh-list
5658659|NCT03652571|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5658660|NCT03652571|Antidepressive Agents|antidepressive agents|mesh-ancestor
5658661|NCT03652571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5658662|NCT03652571|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5658663|NCT03652571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5658664|NCT03652571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5658665|NCT03652571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658666|NCT03652571|Adrenergic Agents|adrenergic agents|mesh-ancestor
5658667|NCT03652571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5658668|NCT03652571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658669|NCT03652493|Carboplatin|carboplatin|mesh-list
5658670|NCT03652493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5658671|NCT03652480|Methylprednisolone|methylprednisolone|mesh-list
5658672|NCT03652480|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5837870|NCT02522039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5837871|NCT02522039|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5837872|NCT02522039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5837873|NCT02522039|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5837874|NCT02522039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5837875|NCT02522013|Aminophylline|aminophylline|mesh-list
5837876|NCT02522013|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5837877|NCT02522013|Autonomic Agents|autonomic agents|mesh-ancestor
5837878|NCT02522013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5837879|NCT02522013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837880|NCT02522013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5837881|NCT02522013|Respiratory System Agents|respiratory system agents|mesh-ancestor
5837882|NCT02522013|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5837883|NCT02522013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5837884|NCT02522013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5837885|NCT02522013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5837886|NCT02522013|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5837887|NCT02522013|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5837888|NCT02522013|Purinergic Agents|purinergic agents|mesh-ancestor
5837889|NCT02522013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5837890|NCT02522013|Protective Agents|protective agents|mesh-ancestor
5837891|NCT02521831|Bupivacaine|bupivacaine|mesh-list
5837892|NCT02521831|Anesthetics|anesthetics|mesh-list
5837893|NCT02521831|Isoflurane|isoflurane|mesh-list
5837894|NCT02521831|Anesthetics, Local|anesthetics, local|mesh-ancestor
5837895|NCT02521831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5837896|NCT02521831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837897|NCT02521831|Sensory System Agents|sensory system agents|mesh-ancestor
5837898|NCT02521831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5837899|NCT02521831|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5837900|NCT02521831|Anesthetics, General|anesthetics, general|mesh-ancestor
5837901|NCT02521714|Lenalidomide|lenalidomide|mesh-list
5837902|NCT02521714|Immunologic Factors|immunologic factors|mesh-ancestor
5837903|NCT02521714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658673|NCT03652480|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5658674|NCT03652480|Prednisolone|prednisolone|mesh-list
5658675|NCT03652480|Prednisolone acetate|prednisolone acetate|mesh-list
5658676|NCT03652480|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5658677|NCT03652480|Prednisolone phosphate|prednisolone phosphate|mesh-list
5658678|NCT03652480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5658679|NCT03652480|Antiemetics|antiemetics|mesh-ancestor
5658680|NCT03652480|Autonomic Agents|autonomic agents|mesh-ancestor
5658681|NCT03652480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5658682|NCT03652480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658683|NCT03652480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5658684|NCT03652480|Glucocorticoids|glucocorticoids|mesh-ancestor
5658685|NCT03652480|Hormones|hormones|mesh-ancestor
5658686|NCT03652480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5658687|NCT03652480|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5658688|NCT03652480|Protective Agents|protective agents|mesh-ancestor
5658689|NCT03652480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5837904|NCT02521714|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5837905|NCT02521714|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5837906|NCT02521714|Growth Substances|growth substances|mesh-ancestor
5837907|NCT02521714|Growth Inhibitors|growth inhibitors|mesh-ancestor
5837908|NCT02521714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5837909|NCT02521753|Metformin|metformin|mesh-list
5837910|NCT02521753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5837911|NCT02521753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837912|NCT02521662|Nicotine|nicotine|mesh-list
5837913|NCT02521662|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5837914|NCT02521662|Autonomic Agents|autonomic agents|mesh-ancestor
5837915|NCT02521662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5837916|NCT02521662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837917|NCT02521662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5837918|NCT02521662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5837919|NCT02521662|Cholinergic Agents|cholinergic agents|mesh-ancestor
6211926|NCT02179892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5837920|NCT02521662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5837921|NCT02521662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5837922|NCT02521441|Lenograstim|lenograstim|mesh-list
5837923|NCT02521441|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5837924|NCT02521441|Immunologic Factors|immunologic factors|mesh-ancestor
5658690|NCT03652480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5837925|NCT02521441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837926|NCT02521415|Acetaminophen|acetaminophen|mesh-list
5837927|NCT02521415|Ibuprofen|ibuprofen|mesh-list
5837928|NCT02521415|Fentanyl|fentanyl|mesh-list
5837929|NCT02521415|Ketamine|ketamine|mesh-list
5837930|NCT02521415|Analgesics|analgesics|mesh-list
5837931|NCT02521415|Sensory System Agents|sensory system agents|mesh-ancestor
5837932|NCT02521415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5837933|NCT02521415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658691|NCT03652467|Chlorotrianisene|chlorotrianisene|mesh-list
5658692|NCT03652467|Deferoxamine|deferoxamine|mesh-list
5658693|NCT03652467|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
5658694|NCT03652467|Estrogens|estrogens|mesh-ancestor
5658695|NCT03652467|Hormones|hormones|mesh-ancestor
5658696|NCT03652467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5658697|NCT03652467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837934|NCT02521415|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5837935|NCT02521415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5837936|NCT02521415|Anesthetics, General|anesthetics, general|mesh-ancestor
5837937|NCT02521415|Anesthetics|anesthetics|mesh-ancestor
5837938|NCT02521415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5658698|NCT03652467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5658699|NCT03652467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5658700|NCT03652467|Siderophores|siderophores|mesh-ancestor
5658701|NCT03652467|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5658702|NCT03652467|Chelating Agents|chelating agents|mesh-ancestor
5658703|NCT03652467|Sequestering Agents|sequestering agents|mesh-ancestor
5658704|NCT03652467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658705|NCT03652441|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5658706|NCT03652441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5658707|NCT03652441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5658708|NCT03652428|Gemcitabine|gemcitabine|mesh-list
5658709|NCT03652428|Paclitaxel|paclitaxel|mesh-list
5658710|NCT03652428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5658711|NCT03652428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5658712|NCT03652428|Tubulin Modulators|tubulin modulators|mesh-ancestor
5658713|NCT03652428|Antimitotic Agents|antimitotic agents|mesh-ancestor
5658714|NCT03652428|Mitosis Modulators|mitosis modulators|mesh-ancestor
5658715|NCT03652428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658716|NCT03652428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5658717|NCT03652428|Antimetabolites|antimetabolites|mesh-ancestor
5658718|NCT03652428|Antiviral Agents|antiviral agents|mesh-ancestor
5658719|NCT03652428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5658720|NCT03652428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5658721|NCT03652428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5658722|NCT03652428|Immunologic Factors|immunologic factors|mesh-ancestor
5658723|NCT03652428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658724|NCT03652415|Lubricant Eye Drops|lubricant eye drops|mesh-list
5658725|NCT03652415|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5658726|NCT03652415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5658727|NCT03652376|Benralizumab|benralizumab|mesh-list
5658728|NCT03652376|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5658729|NCT03652376|Respiratory System Agents|respiratory system agents|mesh-ancestor
5658730|NCT03652233|Nivolumab|nivolumab|mesh-list
5837939|NCT02521415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5837940|NCT02521415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5837941|NCT02521415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5837942|NCT02521415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5837943|NCT02521415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5837944|NCT02521415|Narcotics|narcotics|mesh-ancestor
5837945|NCT02521415|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6211927|NCT02179892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658731|NCT03652233|Afatinib|afatinib|mesh-list
5658732|NCT03652233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5658733|NCT03652233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5658734|NCT03652233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5658735|NCT03652233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658736|NCT03652233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5658737|NCT03652233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5658738|NCT03652142|Nivolumab|nivolumab|mesh-list
5658739|NCT03652142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5658740|NCT03652142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5658741|NCT03652142|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5658742|NCT03652142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658743|NCT03652116|Meperidine|meperidine|mesh-list
5658744|NCT03652116|Bupivacaine|bupivacaine|mesh-list
5658745|NCT03652116|Anesthetics, Local|anesthetics, local|mesh-ancestor
5658746|NCT03652116|Anesthetics|anesthetics|mesh-ancestor
5658747|NCT03652116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5658748|NCT03652116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658749|NCT03652116|Sensory System Agents|sensory system agents|mesh-ancestor
5658750|NCT03652116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5658751|NCT03652116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5658752|NCT03652116|Narcotics|narcotics|mesh-ancestor
5837946|NCT02521415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5837947|NCT02521415|Antipyretics|antipyretics|mesh-ancestor
5837948|NCT02521415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5837949|NCT02521415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5837950|NCT02521415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5837951|NCT02521415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5837952|NCT02521415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5837953|NCT02521636|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5837954|NCT02521636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5837955|NCT02521363|Taxane|taxane|mesh-list
5837956|NCT02521363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5837957|NCT02521298|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5837958|NCT02521298|Methylprednisolone|methylprednisolone|mesh-list
5837959|NCT02521298|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5837960|NCT02521298|Prednisolone|prednisolone|mesh-list
5837961|NCT02521298|Prednisolone acetate|prednisolone acetate|mesh-list
5837962|NCT02521298|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5837963|NCT02521298|Prednisolone phosphate|prednisolone phosphate|mesh-list
5837964|NCT02521298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5837965|NCT02521298|Antiemetics|antiemetics|mesh-ancestor
5837966|NCT02521298|Autonomic Agents|autonomic agents|mesh-ancestor
5837967|NCT02521298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5837968|NCT02521298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5837969|NCT02521298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5837970|NCT02521298|Glucocorticoids|glucocorticoids|mesh-ancestor
5837971|NCT02521298|Hormones|hormones|mesh-ancestor
5837972|NCT02521298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5837973|NCT02521298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5837974|NCT02521298|Protective Agents|protective agents|mesh-ancestor
5837975|NCT02521298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5658753|NCT03652116|Analgesics|analgesics|mesh-ancestor
5658754|NCT03652116|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5658755|NCT03652103|Bupivacaine|bupivacaine|mesh-list
5658756|NCT03652103|Anesthetics, Local|anesthetics, local|mesh-ancestor
5658757|NCT03652103|Anesthetics|anesthetics|mesh-ancestor
5658758|NCT03652103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5658759|NCT03652103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658760|NCT03652103|Sensory System Agents|sensory system agents|mesh-ancestor
5658761|NCT03652103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5695101|NCT03391609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695102|NCT03391609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5695103|NCT03391609|Analgesics|analgesics|mesh-ancestor
5695104|NCT03391609|Sensory System Agents|sensory system agents|mesh-ancestor
5695105|NCT03391609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5695106|NCT03391609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5695107|NCT03391609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5695108|NCT03391609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5695109|NCT03391609|Adrenergic Agents|adrenergic agents|mesh-ancestor
5695110|NCT03391609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5695111|NCT03391609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695112|NCT03391570|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
5695113|NCT03391570|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5695114|NCT03391570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5837976|NCT02521298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5837977|NCT02521246|Losartan|losartan|mesh-list
5837978|NCT02521246|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5837979|NCT02521246|Candesartan|candesartan|mesh-list
5837980|NCT02521246|Candesartan cilexetil|candesartan cilexetil|mesh-list
5837981|NCT02521246|Chlorthalidone|chlorthalidone|mesh-list
5837982|NCT02521246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5837983|NCT02521246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5837984|NCT02521246|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5837985|NCT02521246|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5837986|NCT02521246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5837987|NCT02521246|Diuretics|diuretics|mesh-ancestor
5837988|NCT02521246|Natriuretic Agents|natriuretic agents|mesh-ancestor
5837989|NCT02521246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493650|NCT00614835|Docetaxel|docetaxel|mesh-list
5837990|NCT02521246|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5837991|NCT02521246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5837992|NCT02521233|Losartan|losartan|mesh-list
5837993|NCT02521233|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5837994|NCT02521233|Candesartan|candesartan|mesh-list
5837995|NCT02521233|Candesartan cilexetil|candesartan cilexetil|mesh-list
5837996|NCT02521233|Chlorthalidone|chlorthalidone|mesh-list
5837997|NCT02521233|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5837998|NCT02521233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5837999|NCT02521233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5838000|NCT02521233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5838001|NCT02521233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5838002|NCT02521233|Diuretics|diuretics|mesh-ancestor
5838003|NCT02521233|Natriuretic Agents|natriuretic agents|mesh-ancestor
5838004|NCT02521233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838005|NCT02521233|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5838006|NCT02521233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5903044|NCT02010606|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5903045|NCT02010606|Alkylating Agents|alkylating agents|mesh-ancestor
5903046|NCT02010606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903047|NCT02010606|Immunologic Factors|immunologic factors|mesh-ancestor
5903048|NCT02002130|Aluminum sulfate|aluminum sulfate|mesh-list
5903049|NCT02002130|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
5903050|NCT02002130|Butyric Acid|butyric acid|mesh-list
5903051|NCT02002130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5903052|NCT02002130|Immunologic Factors|immunologic factors|mesh-ancestor
5903053|NCT02002130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903054|NCT02002130|GABA Agents|gaba agents|mesh-ancestor
5903055|NCT02002130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5903056|NCT02002130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903057|NCT02002130|Histamine Antagonists|histamine antagonists|mesh-ancestor
5903058|NCT02002130|Histamine Agents|histamine agents|mesh-ancestor
5903059|NCT01794520|Dexamethasone|dexamethasone|mesh-list
5903060|NCT01794520|Venetoclax|venetoclax|mesh-list
5903061|NCT01794520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5903062|NCT01794520|Antiemetics|antiemetics|mesh-ancestor
5903063|NCT01794520|Autonomic Agents|autonomic agents|mesh-ancestor
5903064|NCT01794520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5903065|NCT01794520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903066|NCT01794520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5903067|NCT01794520|Glucocorticoids|glucocorticoids|mesh-ancestor
5903068|NCT01794520|Hormones|hormones|mesh-ancestor
5903069|NCT01794520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5903070|NCT01794520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5903071|NCT01794520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5903072|NCT01737502|Sirolimus|sirolimus|mesh-list
5903073|NCT01737502|Auranofin|auranofin|mesh-list
5903074|NCT01737502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5903075|NCT01737502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5903076|NCT01737502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5903077|NCT01737502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5903078|NCT01737502|Antifungal Agents|antifungal agents|mesh-ancestor
5903079|NCT01737502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5903080|NCT01737502|Immunologic Factors|immunologic factors|mesh-ancestor
5903081|NCT01737502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903082|NCT01737502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5903083|NCT01701986|Gemcitabine|gemcitabine|mesh-list
5658762|NCT03651947|Denosumab|denosumab|mesh-list
5658763|NCT03651947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5658764|NCT03651947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658765|NCT03651934|Iron|iron|mesh-list
5658766|NCT03651934|Selenium|selenium|mesh-list
5658767|NCT03651934|Trace Elements|trace elements|mesh-ancestor
5658768|NCT03651934|Micronutrients|micronutrients|mesh-ancestor
5658769|NCT03651934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658770|NCT03651934|Antioxidants|antioxidants|mesh-ancestor
5658771|NCT03651934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658772|NCT03651934|Protective Agents|protective agents|mesh-ancestor
5658773|NCT03651895|Metformin|metformin|mesh-list
5658774|NCT03651895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5658775|NCT03651895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903084|NCT01701986|Mycophenolic Acid|mycophenolic acid|mesh-list
5903085|NCT01701986|Rituximab|rituximab|mesh-list
5658776|NCT03651882|Oxytocin|oxytocin|mesh-list
5658777|NCT03651882|Carbetocin|carbetocin|mesh-list
5903086|NCT01701986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5903087|NCT01701986|Busulfan|busulfan|mesh-list
5658778|NCT03651882|Oxytocics|oxytocics|mesh-ancestor
5658779|NCT03651882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5658780|NCT03651882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658781|NCT03651726|Palmidrol|palmidrol|mesh-list
5658782|NCT03651726|Dronabinol|dronabinol|mesh-list
5658783|NCT03651726|Hallucinogens|hallucinogens|mesh-ancestor
5658784|NCT03651726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658785|NCT03651726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5658786|NCT03651726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5838007|NCT02521207|Ibuprofen|ibuprofen|mesh-list
5838008|NCT02521207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5838009|NCT02521207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5838010|NCT02521207|Analgesics|analgesics|mesh-ancestor
5838011|NCT02521207|Sensory System Agents|sensory system agents|mesh-ancestor
5838012|NCT02521207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5838013|NCT02521207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838014|NCT02521207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5838015|NCT02521207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5838016|NCT02521207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5838017|NCT02521207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5838018|NCT02521207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5838019|NCT02521051|Bevacizumab|bevacizumab|mesh-list
5658787|NCT03651726|Analgesics|analgesics|mesh-ancestor
5658788|NCT03651726|Sensory System Agents|sensory system agents|mesh-ancestor
5658789|NCT03651726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5658790|NCT03651726|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5658791|NCT03651726|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5658792|NCT03651726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5658793|NCT03651726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658794|NCT03651726|Hormones|hormones|mesh-ancestor
5658795|NCT03651726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5658796|NCT03651726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5658797|NCT03651726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5658798|NCT03651726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5658799|NCT03651726|Antiviral Agents|antiviral agents|mesh-ancestor
5658800|NCT03651726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5658801|NCT03651674|Olanzapine|olanzapine|mesh-list
5658802|NCT03651674|Clozapine|clozapine|mesh-list
5658803|NCT03651674|Antiemetics|antiemetics|mesh-ancestor
5658804|NCT03651674|Autonomic Agents|autonomic agents|mesh-ancestor
5658805|NCT03651674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5658806|NCT03651674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658807|NCT03651674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5658808|NCT03651674|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5658809|NCT03651674|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5658810|NCT03651674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5658811|NCT03651674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5658812|NCT03651674|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5658813|NCT03651674|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5658814|NCT03651674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5658815|NCT03651674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658816|NCT03651674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5658817|NCT03651674|Serotonin Agents|serotonin agents|mesh-ancestor
5838020|NCT02521051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5838021|NCT02521051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6493651|NCT00614835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6211928|NCT02179892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6493652|NCT00614835|Antimetabolites|antimetabolites|mesh-ancestor
6493653|NCT00614835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493654|NCT00614835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6493655|NCT00614835|Antiviral Agents|antiviral agents|mesh-ancestor
6493656|NCT00614835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6493657|NCT00614835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6493658|NCT00614835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6493659|NCT00614835|Immunologic Factors|immunologic factors|mesh-ancestor
6493660|NCT00614835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838022|NCT02521051|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5838023|NCT02521051|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6211929|NCT02179892|Glucocorticoids|glucocorticoids|mesh-ancestor
6493661|NCT00614835|Tubulin Modulators|tubulin modulators|mesh-ancestor
6493662|NCT00614835|Antimitotic Agents|antimitotic agents|mesh-ancestor
6493663|NCT00614835|Mitosis Modulators|mitosis modulators|mesh-ancestor
6493664|NCT00614965|Irinotecan|irinotecan|mesh-list
5658818|NCT03651674|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5658819|NCT03651674|GABA Antagonists|gaba antagonists|mesh-ancestor
5658820|NCT03651674|GABA Agents|gaba agents|mesh-ancestor
5838024|NCT02521051|Growth Substances|growth substances|mesh-ancestor
5838025|NCT02521051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838026|NCT02521051|Growth Inhibitors|growth inhibitors|mesh-ancestor
5838027|NCT02521155|Fenbendazole|fenbendazole|mesh-list
5838028|NCT02521155|Antinematodal Agents|antinematodal agents|mesh-ancestor
5838029|NCT02521155|Anthelmintics|anthelmintics|mesh-ancestor
5838030|NCT02521155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5838031|NCT02521155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5838032|NCT02521064|Prednisone|prednisone|mesh-list
5838033|NCT02521064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5838034|NCT02521064|Glucocorticoids|glucocorticoids|mesh-ancestor
5838035|NCT02521064|Hormones|hormones|mesh-ancestor
5838036|NCT02521064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5838037|NCT02521064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838038|NCT02521064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5838039|NCT02521064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5838040|NCT02521077|Ascorbic Acid|ascorbic acid|mesh-list
5838041|NCT02521077|Vitamins|vitamins|mesh-ancestor
5838042|NCT02521077|Micronutrients|micronutrients|mesh-ancestor
5838043|NCT02521077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838044|NCT02521077|Antioxidants|antioxidants|mesh-ancestor
5838045|NCT02521077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5838046|NCT02521077|Protective Agents|protective agents|mesh-ancestor
5838047|NCT02521038|Ticagrelor|ticagrelor|mesh-list
5838048|NCT02521038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5838049|NCT02521038|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5838050|NCT02521038|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5838051|NCT02521038|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5838052|NCT02521038|Purinergic Agents|purinergic agents|mesh-ancestor
5838053|NCT02521038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5838054|NCT02521038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5838055|NCT02521038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838056|NCT02520934|Miglustat|miglustat|mesh-list
5838057|NCT02520934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5838058|NCT02520934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5838059|NCT02520934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5838060|NCT02520934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5838061|NCT02520934|Antiviral Agents|antiviral agents|mesh-ancestor
6493665|NCT00614965|Pemetrexed|pemetrexed|mesh-list
6493666|NCT00614965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5658821|NCT03651661|Insulin|insulin|mesh-list
5658822|NCT03651661|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5658823|NCT03651661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5658824|NCT03651661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658825|NCT03651557|Salicylates|salicylates|mesh-list
5838062|NCT02520934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5838063|NCT02520934|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
5838064|NCT02520934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5838065|NCT02520934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838066|NCT02520921|Aspirin|aspirin|mesh-list
5838067|NCT02520921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5838068|NCT02520921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5838069|NCT02520921|Analgesics|analgesics|mesh-ancestor
5838070|NCT02520921|Sensory System Agents|sensory system agents|mesh-ancestor
5838071|NCT02520921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5838072|NCT02520921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838073|NCT02520921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5838074|NCT02520921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5838075|NCT02520921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5838076|NCT02520921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5838077|NCT02520921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5838078|NCT02520921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5658826|NCT03651557|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6493667|NCT00614965|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5658827|NCT03651557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5658828|NCT03651557|Analgesics|analgesics|mesh-ancestor
5658829|NCT03651557|Sensory System Agents|sensory system agents|mesh-ancestor
5658830|NCT03651557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5658831|NCT03651557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658832|NCT03651557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5658833|NCT03651557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5658834|NCT03651557|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5658835|NCT03651557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5838079|NCT02520921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5658836|NCT03651557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658837|NCT03651531|Metformin|metformin|mesh-list
5658838|NCT03651531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5658839|NCT03651531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658840|NCT03651427|Estradiol|estradiol|mesh-list
5658841|NCT03651427|Estrogens|estrogens|mesh-ancestor
5658842|NCT03651427|Hormones|hormones|mesh-ancestor
5658843|NCT03651427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5658844|NCT03651427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658845|NCT03651219|Irinotecan|irinotecan|mesh-list
5658846|NCT03651219|Apatinib|apatinib|mesh-list
5658847|NCT03651219|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5838080|NCT02520921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5838081|NCT02520921|Antipyretics|antipyretics|mesh-ancestor
5838082|NCT02521012|Vitamin D|vitamin d|mesh-list
5838083|NCT02521012|Ergocalciferols|ergocalciferols|mesh-list
5838084|NCT02521012|Vitamins|vitamins|mesh-list
5838085|NCT02521012|Micronutrients|micronutrients|mesh-ancestor
5838086|NCT02521012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838087|NCT02521012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5838088|NCT02521012|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5838089|NCT02520635|Temozolomide|temozolomide|mesh-list
5838090|NCT02520635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5838091|NCT02520635|Alkylating Agents|alkylating agents|mesh-ancestor
5838092|NCT02520635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5838093|NCT02520635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5838094|NCT02520752|Midazolam|midazolam|mesh-list
5838095|NCT02520752|Caffeine|caffeine|mesh-list
5838096|NCT02520752|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5838097|NCT02520752|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5838098|NCT02520752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5838099|NCT02520752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838100|NCT02520752|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5838101|NCT02520752|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5838102|NCT02520752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5838103|NCT02520752|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5838104|NCT02520752|Anesthetics, General|anesthetics, general|mesh-ancestor
5838105|NCT02520752|Anesthetics|anesthetics|mesh-ancestor
5838106|NCT02520752|GABA Modulators|gaba modulators|mesh-ancestor
5838107|NCT02520752|GABA Agents|gaba agents|mesh-ancestor
5838108|NCT02520752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5838109|NCT02520752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5838110|NCT02520752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5838111|NCT02520752|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5838112|NCT02520752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5838113|NCT02520752|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5658848|NCT03651219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5658849|NCT03651219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5658850|NCT03651219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658851|NCT03651219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5658852|NCT03651219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5658853|NCT03651102|Thalidomide|thalidomide|mesh-list
5658854|NCT03651102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5658855|NCT03651102|Immunologic Factors|immunologic factors|mesh-ancestor
5658856|NCT03651102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658857|NCT03651102|Leprostatic Agents|leprostatic agents|mesh-ancestor
5658858|NCT03651102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5658859|NCT03651102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5658860|NCT03651102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5658861|NCT03651102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5838114|NCT02520752|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5838115|NCT02520752|Purinergic Agents|purinergic agents|mesh-ancestor
5838116|NCT02520570|Urinastatin|urinastatin|mesh-list
5838117|NCT02520570|Trypsin Inhibitors|trypsin inhibitors|mesh-list
5658862|NCT03651102|Growth Substances|growth substances|mesh-ancestor
5658863|NCT03651102|Growth Inhibitors|growth inhibitors|mesh-ancestor
5658864|NCT03651102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5658865|NCT03651011|Aflibercept|aflibercept|mesh-list
5658866|NCT03651011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5658867|NCT03651011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5658868|NCT03651011|Growth Substances|growth substances|mesh-ancestor
5658869|NCT03651011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658870|NCT03651011|Growth Inhibitors|growth inhibitors|mesh-ancestor
5658871|NCT03651011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5838118|NCT02520570|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5838119|NCT02520570|Protease Inhibitors|protease inhibitors|mesh-ancestor
5658872|NCT03650998|Ropivacaine|ropivacaine|mesh-list
5658873|NCT03650998|Anesthetics, Local|anesthetics, local|mesh-ancestor
5658874|NCT03650998|Anesthetics|anesthetics|mesh-ancestor
5658875|NCT03650998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5658876|NCT03650998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658877|NCT03650998|Sensory System Agents|sensory system agents|mesh-ancestor
5658878|NCT03650998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5658879|NCT03650881|Adapalene|adapalene|mesh-list
5658880|NCT03650881|Benzoyl Peroxide|benzoyl peroxide|mesh-list
5658881|NCT03650881|Dermatologic Agents|dermatologic agents|mesh-ancestor
5658882|NCT03650881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5838120|NCT02520570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5838121|NCT02520570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5838122|NCT02520479|Pegaspargase|pegaspargase|mesh-list
5838123|NCT02520479|Asparaginase|asparaginase|mesh-list
5838124|NCT02520479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5838125|NCT02520947|Desflurane|desflurane|mesh-list
5838126|NCT02520947|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5838127|NCT02520947|Anesthetics, General|anesthetics, general|mesh-ancestor
5838128|NCT02520947|Anesthetics|anesthetics|mesh-ancestor
5838129|NCT02520947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5838130|NCT02520947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838131|NCT02520505|Citric Acid|citric acid|mesh-list
5838132|NCT02520505|Sodium Citrate|sodium citrate|mesh-list
5838133|NCT02520505|Clomiphene|clomiphene|mesh-list
5838134|NCT02520505|Enclomiphene|enclomiphene|mesh-list
5838135|NCT02520505|Zuclomiphene|zuclomiphene|mesh-list
5838136|NCT02520505|Anticoagulants|anticoagulants|mesh-ancestor
5838137|NCT02520505|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5838138|NCT02520505|Chelating Agents|chelating agents|mesh-ancestor
5838139|NCT02520505|Sequestering Agents|sequestering agents|mesh-ancestor
5838140|NCT02520505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5838141|NCT02520505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5838142|NCT02520505|Hormone Antagonists|hormone antagonists|mesh-ancestor
5838143|NCT02520505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5838144|NCT02520505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838145|NCT02520505|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5838146|NCT02520505|Fertility Agents|fertility agents|mesh-ancestor
5838147|NCT02520505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5838148|NCT02520505|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5838149|NCT02520505|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5838150|NCT02520362|Denosumab|denosumab|mesh-list
5838151|NCT02520362|Diphosphonates|diphosphonates|mesh-list
5838152|NCT02520362|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5838153|NCT02520362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838154|NCT02520453|Durvalumab|durvalumab|mesh-list
5838155|NCT02520453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5838156|NCT02520453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5838157|NCT02520817|Vitamins|vitamins|mesh-list
5838158|NCT02520817|Ascorbic Acid|ascorbic acid|mesh-list
5838159|NCT02520817|Vitamin E|vitamin e|mesh-list
5838160|NCT02520817|Vitamin A|vitamin a|mesh-list
5838161|NCT02520817|Lactulose|lactulose|mesh-list
6674603|NCT01570569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6674604|NCT01570569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674605|NCT01570569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6674606|NCT01570569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6674607|NCT01570569|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6674608|NCT01570569|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6674609|NCT01570569|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5658883|NCT03650881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5658884|NCT03650881|Analgesics|analgesics|mesh-ancestor
5658885|NCT03650881|Sensory System Agents|sensory system agents|mesh-ancestor
5658886|NCT03650881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5658887|NCT03650881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658888|NCT03650881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5658889|NCT03650881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5658890|NCT03650777|Warfarin|warfarin|mesh-list
5658891|NCT03650777|Anticoagulants|anticoagulants|mesh-ancestor
5658892|NCT03650738|Paclitaxel|paclitaxel|mesh-list
5658893|NCT03650738|Carboplatin|carboplatin|mesh-list
5658894|NCT03650738|Apatinib|apatinib|mesh-list
5658895|NCT03650738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5658896|NCT03650738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5658897|NCT03650738|Tubulin Modulators|tubulin modulators|mesh-ancestor
5658898|NCT03650738|Antimitotic Agents|antimitotic agents|mesh-ancestor
5658899|NCT03650738|Mitosis Modulators|mitosis modulators|mesh-ancestor
5838162|NCT02520817|Micronutrients|micronutrients|mesh-ancestor
5838163|NCT02520817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838164|NCT02520817|Antioxidants|antioxidants|mesh-ancestor
5838165|NCT02520817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5838166|NCT02520817|Protective Agents|protective agents|mesh-ancestor
5838167|NCT02520817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5838168|NCT02520219|Endostar protein|endostar protein|mesh-list
5838169|NCT02520219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5838170|NCT02520219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5838171|NCT02520219|Growth Substances|growth substances|mesh-ancestor
5838172|NCT02520219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838173|NCT02520219|Growth Inhibitors|growth inhibitors|mesh-ancestor
5838174|NCT02520219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5838175|NCT02520245|Cemiplimab|cemiplimab|mesh-list
5838176|NCT02520245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5838177|NCT02520245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5838178|NCT02520180|Everolimus|everolimus|mesh-list
5838179|NCT02520180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5838180|NCT02520180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5838181|NCT02520180|Immunologic Factors|immunologic factors|mesh-ancestor
5838182|NCT02520180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838183|NCT02520076|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
5838184|NCT02520076|Protein C Inhibitor|protein c inhibitor|mesh-list
5838185|NCT02520076|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5838186|NCT02520076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5838187|NCT02520076|Protease Inhibitors|protease inhibitors|mesh-ancestor
5838188|NCT02520076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5838189|NCT02520076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5838190|NCT02520115|Dexamethasone|dexamethasone|mesh-list
5838191|NCT02520115|Dexamethasone acetate|dexamethasone acetate|mesh-list
5838192|NCT02520115|Valproic Acid|valproic acid|mesh-list
5838193|NCT02520115|Ichthammol|ichthammol|mesh-list
5838194|NCT02520115|BB 1101|bb 1101|mesh-list
5838195|NCT02520115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5658900|NCT03650738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658901|NCT03650738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5658902|NCT03650738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5658903|NCT03650608|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5658904|NCT03650608|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5658905|NCT03650582|Glucagon|glucagon|mesh-list
5658906|NCT03650582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5658907|NCT03650582|Hormones|hormones|mesh-ancestor
5658908|NCT03650582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5658909|NCT03650582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658910|NCT03650543|Amoxicillin|amoxicillin|mesh-list
5658911|NCT03650543|Clarithromycin|clarithromycin|mesh-list
5658912|NCT03650543|Omeprazole|omeprazole|mesh-list
5658913|NCT03650543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5658914|NCT03650543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5658915|NCT03650543|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5658916|NCT03650543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5658917|NCT03650543|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5658918|NCT03650543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5658919|NCT03650543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658920|NCT03650543|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5658921|NCT03650543|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5658922|NCT03650543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5695115|NCT03391570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695116|NCT03391570|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5695117|NCT03391570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5695118|NCT03391570|Analgesics|analgesics|mesh-ancestor
5695119|NCT03391570|Sensory System Agents|sensory system agents|mesh-ancestor
5695120|NCT03391570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5838196|NCT02520115|Antiemetics|antiemetics|mesh-ancestor
5838197|NCT02520115|Autonomic Agents|autonomic agents|mesh-ancestor
5838198|NCT02520115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5838199|NCT02520115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838200|NCT02520115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5838201|NCT02520115|Glucocorticoids|glucocorticoids|mesh-ancestor
5838202|NCT02520115|Hormones|hormones|mesh-ancestor
5838203|NCT02520115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5838204|NCT02520115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5838205|NCT02520115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5838206|NCT02520115|Protease Inhibitors|protease inhibitors|mesh-ancestor
5838207|NCT02520115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5903088|NCT01701986|Clofarabine|clofarabine|mesh-list
5838208|NCT02520115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5838209|NCT02520115|Anticonvulsants|anticonvulsants|mesh-ancestor
5838210|NCT02520115|GABA Agents|gaba agents|mesh-ancestor
5838211|NCT02520115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5838212|NCT02520115|Antimanic Agents|antimanic agents|mesh-ancestor
5838213|NCT02520115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5838214|NCT02520115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5838215|NCT02520115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5658923|NCT03650361|Adapalene|adapalene|mesh-list
5658924|NCT03650361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5658925|NCT03650361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5658926|NCT03650361|Analgesics|analgesics|mesh-ancestor
5658927|NCT03650361|Sensory System Agents|sensory system agents|mesh-ancestor
5658928|NCT03650361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5658929|NCT03650361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658930|NCT03650361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5658931|NCT03650361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5658932|NCT03650361|Dermatologic Agents|dermatologic agents|mesh-ancestor
5658933|NCT03650348|Atezolizumab|atezolizumab|mesh-list
5838216|NCT02520115|Dermatologic Agents|dermatologic agents|mesh-ancestor
5838217|NCT02519816|Plasma-lyte 148|plasma-lyte 148|mesh-list
5838218|NCT02519816|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5838219|NCT02519816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5838220|NCT02520141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5838221|NCT02520141|Ramucirumab|ramucirumab|mesh-list
5838222|NCT02520141|Antibodies|antibodies|mesh-list
5838223|NCT02520141|Immunoglobulins|immunoglobulins|mesh-list
5838224|NCT02520141|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5838225|NCT02520141|Lexatumumab|lexatumumab|mesh-list
5838226|NCT02520141|Immunologic Factors|immunologic factors|mesh-ancestor
5838227|NCT02520141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838228|NCT02520141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5838229|NCT02520102|Sargramostim|sargramostim|mesh-list
5838230|NCT02520102|Immunologic Factors|immunologic factors|mesh-ancestor
5838231|NCT02520102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838232|NCT02519543|Metformin|metformin|mesh-list
5838233|NCT02519543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5838234|NCT02519543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838235|NCT02519582|Niclosamide|niclosamide|mesh-list
5838236|NCT02519582|Anticestodal Agents|anticestodal agents|mesh-ancestor
5838237|NCT02519582|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5838238|NCT02519582|Anthelmintics|anthelmintics|mesh-ancestor
5838239|NCT02519582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5838240|NCT02519582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5838241|NCT02519582|Antinematodal Agents|antinematodal agents|mesh-ancestor
5838242|NCT02519699|Norepinephrine|norepinephrine|mesh-list
5838243|NCT02519699|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5838244|NCT02519699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5838245|NCT02519699|Adrenergic Agents|adrenergic agents|mesh-ancestor
5838246|NCT02519699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5838247|NCT02519699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5838248|NCT02519699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838249|NCT02519699|Sympathomimetics|sympathomimetics|mesh-ancestor
5838250|NCT02519699|Autonomic Agents|autonomic agents|mesh-ancestor
5838251|NCT02519699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5838252|NCT02519699|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5838253|NCT02519608|Aspirin|aspirin|mesh-list
5838254|NCT02519608|Clopidogrel|clopidogrel|mesh-list
5838255|NCT02519608|Ticagrelor|ticagrelor|mesh-list
5838256|NCT02519608|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5838257|NCT02519608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5838258|NCT02519608|Analgesics|analgesics|mesh-ancestor
5838259|NCT02519608|Sensory System Agents|sensory system agents|mesh-ancestor
5658934|NCT03650348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5658935|NCT03650270|Phenytoin|phenytoin|mesh-list
5658936|NCT03650270|Midazolam|midazolam|mesh-list
5658937|NCT03650270|Phenobarbital|phenobarbital|mesh-list
5658938|NCT03650270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5658939|NCT03650270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5658940|NCT03650270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5658941|NCT03650270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658942|NCT03650270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5838260|NCT02519608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5838261|NCT02519608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658943|NCT03650270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5838262|NCT02519608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5838263|NCT02519608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5838264|NCT02519608|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5658944|NCT03650270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5658945|NCT03650270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5658946|NCT03650270|Anesthetics, General|anesthetics, general|mesh-ancestor
5658947|NCT03650270|Anesthetics|anesthetics|mesh-ancestor
5658948|NCT03650270|GABA Modulators|gaba modulators|mesh-ancestor
5658949|NCT03650270|GABA Agents|gaba agents|mesh-ancestor
5838265|NCT02519608|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5838266|NCT02519608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5838267|NCT02519608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5838268|NCT02519608|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5838269|NCT02519608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5838270|NCT02519608|Antipyretics|antipyretics|mesh-ancestor
5838271|NCT02519608|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5838272|NCT02519608|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5838273|NCT02519608|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5838274|NCT02519608|Purinergic Agents|purinergic agents|mesh-ancestor
5838275|NCT02519608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5658950|NCT03650270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5658951|NCT03650270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658952|NCT03650270|Anticonvulsants|anticonvulsants|mesh-ancestor
5658953|NCT03650270|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5658954|NCT03650270|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5658955|NCT03650270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5658956|NCT03650270|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5658957|NCT03650270|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5658958|NCT03650270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5658959|NCT03650270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5658960|NCT03650270|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5658961|NCT03650270|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5658962|NCT03650257|Temozolomide|temozolomide|mesh-list
5658963|NCT03650257|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5658964|NCT03650257|Alkylating Agents|alkylating agents|mesh-ancestor
5903089|NCT01701986|Antibodies|antibodies|mesh-list
5903090|NCT01701986|Immunoglobulins|immunoglobulins|mesh-list
5903091|NCT01701986|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5903092|NCT01701986|Tacrolimus|tacrolimus|mesh-list
5903093|NCT01701986|Thymoglobulin|thymoglobulin|mesh-list
5903094|NCT01701986|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5903095|NCT01701986|Immunologic Factors|immunologic factors|mesh-ancestor
5903096|NCT01701986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5658965|NCT03650257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658966|NCT03650257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5658967|NCT03650023|Chitosan|chitosan|mesh-list
5903097|NCT01701986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5903098|NCT01701986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5903099|NCT01701986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5903100|NCT01701986|Antimetabolites|antimetabolites|mesh-ancestor
5903101|NCT01701986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658968|NCT03650023|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5658969|NCT03650023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5658970|NCT03650023|Antimetabolites|antimetabolites|mesh-ancestor
5658971|NCT03650023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658972|NCT03650023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5658973|NCT03650023|Chelating Agents|chelating agents|mesh-ancestor
5658974|NCT03650023|Sequestering Agents|sequestering agents|mesh-ancestor
5658975|NCT03650023|Hemostatics|hemostatics|mesh-ancestor
5658976|NCT03650023|Coagulants|coagulants|mesh-ancestor
5658977|NCT03649945|Docetaxel|docetaxel|mesh-list
5658978|NCT03649945|Endostar protein|endostar protein|mesh-list
5658979|NCT03649945|Nedaplatin|nedaplatin|mesh-list
5658980|NCT03649945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5658981|NCT03649945|Tubulin Modulators|tubulin modulators|mesh-ancestor
5658982|NCT03649945|Antimitotic Agents|antimitotic agents|mesh-ancestor
5658983|NCT03649945|Mitosis Modulators|mitosis modulators|mesh-ancestor
5658984|NCT03649945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5658985|NCT03649945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5658986|NCT03649945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5658987|NCT03649945|Growth Substances|growth substances|mesh-ancestor
5903102|NCT01701986|Antiviral Agents|antiviral agents|mesh-ancestor
5903103|NCT01701986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5903104|NCT01701986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5903105|NCT01701986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5903106|NCT01701986|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5903107|NCT01701986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5658988|NCT03649945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838276|NCT02519660|Lidocaine|lidocaine|mesh-list
5838277|NCT02519660|Tetracaine|tetracaine|mesh-list
5838278|NCT02519660|Prilocaine|prilocaine|mesh-list
5838279|NCT02519660|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
5838280|NCT02519660|Anesthetics, Local|anesthetics, local|mesh-ancestor
5838281|NCT02519660|Anesthetics|anesthetics|mesh-ancestor
5838282|NCT02519660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5838283|NCT02519660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838284|NCT02519660|Sensory System Agents|sensory system agents|mesh-ancestor
5838285|NCT02519660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5838286|NCT02519660|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5838287|NCT02519660|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5838288|NCT02519660|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5838289|NCT02519660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5838290|NCT02519660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5838291|NCT02519660|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
5838292|NCT02519413|Dimethyl Fumarate|dimethyl fumarate|mesh-list
5838293|NCT02519413|Dermatologic Agents|dermatologic agents|mesh-ancestor
5838294|NCT02519413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5838295|NCT02519413|Immunologic Factors|immunologic factors|mesh-ancestor
5838296|NCT02519413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838297|NCT02519335|Dexrazoxane|dexrazoxane|mesh-list
5838298|NCT02519335|Razoxane|razoxane|mesh-list
5838299|NCT02519335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5838300|NCT02519335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5838301|NCT02519335|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5838302|NCT02519335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5838303|NCT02519335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5838304|NCT02519335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5838305|NCT02519335|Protective Agents|protective agents|mesh-ancestor
5658989|NCT03649945|Growth Inhibitors|growth inhibitors|mesh-ancestor
5658990|NCT03649841|Ascorbic Acid|ascorbic acid|mesh-list
5658991|NCT03649841|Prednisone|prednisone|mesh-list
5838306|NCT02519335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838307|NCT02519335|Antimitotic Agents|antimitotic agents|mesh-ancestor
5838308|NCT02519335|Mitosis Modulators|mitosis modulators|mesh-ancestor
5838309|NCT02519322|Nivolumab|nivolumab|mesh-list
5838310|NCT02519322|Ipilimumab|ipilimumab|mesh-list
5838311|NCT02519322|Immunoglobulins|immunoglobulins|mesh-list
5838312|NCT02519322|Immunoglobulin G|immunoglobulin g|mesh-list
5838313|NCT02519322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5838314|NCT02519322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5838315|NCT02519322|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5838316|NCT02519322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5838317|NCT02519322|Immunologic Factors|immunologic factors|mesh-ancestor
5838318|NCT02519322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838319|NCT02519400|Amitriptyline|amitriptyline|mesh-list
5838320|NCT02519400|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
5658992|NCT03649841|Cortisone|cortisone|mesh-list
5658993|NCT03649841|Methyltestosterone|methyltestosterone|mesh-list
5658994|NCT03649841|Abiraterone Acetate|abiraterone acetate|mesh-list
5658995|NCT03649841|Hormones|hormones|mesh-list
5658996|NCT03649841|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
5658997|NCT03649841|Androgens|androgens|mesh-list
5658998|NCT03649841|Androgen Antagonists|androgen antagonists|mesh-list
5658999|NCT03649841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5659000|NCT03649841|Glucocorticoids|glucocorticoids|mesh-ancestor
5659001|NCT03649841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5659002|NCT03649841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659003|NCT03649841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5659004|NCT03649841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5659005|NCT03649841|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5659006|NCT03649841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5659007|NCT03649841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659008|NCT03649841|Hormone Antagonists|hormone antagonists|mesh-ancestor
5659009|NCT03649841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5659010|NCT03649841|Antioxidants|antioxidants|mesh-ancestor
5659011|NCT03649841|Protective Agents|protective agents|mesh-ancestor
5659012|NCT03649841|Vitamins|vitamins|mesh-ancestor
5838321|NCT02519400|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5838322|NCT02519400|Antidepressive Agents|antidepressive agents|mesh-ancestor
5838323|NCT02519400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5838324|NCT02519400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5838325|NCT02519400|Analgesics|analgesics|mesh-ancestor
5659013|NCT03649841|Micronutrients|micronutrients|mesh-ancestor
5659014|NCT03649841|Estrogens|estrogens|mesh-ancestor
5659015|NCT03649841|Anabolic Agents|anabolic agents|mesh-ancestor
5659016|NCT03649802|Vitamin D|vitamin d|mesh-list
5659017|NCT03649802|Ergocalciferols|ergocalciferols|mesh-list
5659018|NCT03649802|Cholecalciferol|cholecalciferol|mesh-list
5659019|NCT03649802|Vitamins|vitamins|mesh-list
5659020|NCT03649802|Micronutrients|micronutrients|mesh-ancestor
5659021|NCT03649802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659022|NCT03649802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5659023|NCT03649802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5659024|NCT03649763|Lidocaine|lidocaine|mesh-list
5659025|NCT03649763|Bupivacaine|bupivacaine|mesh-list
5659026|NCT03649763|Anesthetics, Local|anesthetics, local|mesh-ancestor
5659027|NCT03649763|Anesthetics|anesthetics|mesh-ancestor
5838326|NCT02519400|Sensory System Agents|sensory system agents|mesh-ancestor
5838327|NCT02519400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5838328|NCT02519400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838329|NCT02519400|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5838330|NCT02519400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5838331|NCT02519400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5838332|NCT02519400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5838333|NCT02519400|Adrenergic Agents|adrenergic agents|mesh-ancestor
5838334|NCT02519400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5659028|NCT03649763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5659029|NCT03649763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659030|NCT03649763|Sensory System Agents|sensory system agents|mesh-ancestor
5659031|NCT03649763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5659032|NCT03649763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5659033|NCT03649763|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5659034|NCT03649763|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5659035|NCT03649763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5659036|NCT03649763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659037|NCT03649724|Leuprolide|leuprolide|mesh-list
5659038|NCT03649724|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5659039|NCT03649724|Fertility Agents|fertility agents|mesh-ancestor
5659040|NCT03649724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5659041|NCT03649724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659042|NCT03649724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5659043|NCT03649724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5659044|NCT03649711|Aspirin|aspirin|mesh-list
5659045|NCT03649711|Clopidogrel|clopidogrel|mesh-list
5659046|NCT03649711|Ticagrelor|ticagrelor|mesh-list
5659047|NCT03649711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5659048|NCT03649711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5659049|NCT03649711|Analgesics|analgesics|mesh-ancestor
5659050|NCT03649711|Sensory System Agents|sensory system agents|mesh-ancestor
5659051|NCT03649711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5659052|NCT03649711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659053|NCT03649711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5659054|NCT03649711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5659055|NCT03649711|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5659056|NCT03649711|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5659057|NCT03649711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659058|NCT03649711|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5659059|NCT03649711|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5659060|NCT03649711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5659061|NCT03649711|Antipyretics|antipyretics|mesh-ancestor
5659062|NCT03649711|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5659063|NCT03649711|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5659064|NCT03649711|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5659065|NCT03649711|Purinergic Agents|purinergic agents|mesh-ancestor
5659066|NCT03649711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5659067|NCT03649659|Fluorides|fluorides|mesh-list
5659068|NCT03649659|Cariostatic Agents|cariostatic agents|mesh-ancestor
5659069|NCT03649659|Protective Agents|protective agents|mesh-ancestor
5659070|NCT03649659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659071|NCT03649464|Antineoplastic Agents|antineoplastic agents|mesh-list
5659072|NCT03649334|Ketorolac|ketorolac|mesh-list
5659073|NCT03649334|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
5838335|NCT02519400|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5838336|NCT02519400|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5838337|NCT02519400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5838338|NCT02519153|Sildenafil Citrate|sildenafil citrate|mesh-list
5838339|NCT02519153|Vasodilator Agents|vasodilator agents|mesh-ancestor
5659074|NCT03649334|Fentanyl|fentanyl|mesh-list
5659075|NCT03649334|Ketamine|ketamine|mesh-list
5659076|NCT03649334|Analgesics|analgesics|mesh-ancestor
5838340|NCT02519153|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5838341|NCT02519153|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5838342|NCT02519153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5838343|NCT02519153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5838344|NCT02519153|Urological Agents|urological agents|mesh-ancestor
5838345|NCT02519010|Amlodipine|amlodipine|mesh-list
5838346|NCT02519010|Valsartan|valsartan|mesh-list
5838347|NCT02519010|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
5838348|NCT02519010|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5838349|NCT02519010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5838350|NCT02519010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5838351|NCT02519010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5838352|NCT02519010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5838353|NCT02519010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838354|NCT02519010|Vasodilator Agents|vasodilator agents|mesh-ancestor
5838355|NCT02519010|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5838356|NCT02519010|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5838357|NCT02518802|Pemetrexed|pemetrexed|mesh-list
5838358|NCT02518802|Gefitinib|gefitinib|mesh-list
5659077|NCT03649334|Sensory System Agents|sensory system agents|mesh-ancestor
5659078|NCT03649334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5659079|NCT03649334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659080|NCT03649334|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5838359|NCT02518802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5838360|NCT02518802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5838361|NCT02518802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5838362|NCT02518802|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5838363|NCT02518802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5838364|NCT02518802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5838365|NCT02518945|Liraglutide|liraglutide|mesh-list
5838366|NCT02518945|Dapagliflozin|dapagliflozin|mesh-list
5838367|NCT02518945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5838368|NCT02518945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838369|NCT02518945|Incretins|incretins|mesh-ancestor
5838370|NCT02518945|Hormones|hormones|mesh-ancestor
5838371|NCT02518945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5838372|NCT02518945|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5838373|NCT02518945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5838374|NCT02518763|Vitamin D|vitamin d|mesh-list
5838375|NCT02518763|Ergocalciferols|ergocalciferols|mesh-list
5838376|NCT02518763|Cholecalciferol|cholecalciferol|mesh-list
5838377|NCT02518763|Vitamins|vitamins|mesh-list
5838378|NCT02518763|Micronutrients|micronutrients|mesh-ancestor
5838379|NCT02518763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838380|NCT02518763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5838381|NCT02518763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5838382|NCT02518789|Fentanyl|fentanyl|mesh-list
5838383|NCT02518789|Midazolam|midazolam|mesh-list
6674610|NCT01570569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6674611|NCT01570569|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6674612|NCT01570569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6674613|NCT01570569|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6674614|NCT01570569|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6674615|NCT01570569|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5659081|NCT03649334|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5838384|NCT02518789|Dexmedetomidine|dexmedetomidine|mesh-list
5838385|NCT02518789|Remifentanil|remifentanil|mesh-list
5659082|NCT03649334|Anesthetics, General|anesthetics, general|mesh-ancestor
5659083|NCT03649334|Anesthetics|anesthetics|mesh-ancestor
5659084|NCT03649334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5659085|NCT03649334|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5659086|NCT03649334|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5659087|NCT03649334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5659088|NCT03649334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659089|NCT03649334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5659090|NCT03649334|Narcotics|narcotics|mesh-ancestor
5659091|NCT03649334|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5659092|NCT03649334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5659093|NCT03649334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5659094|NCT03649334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5659095|NCT03649334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5838386|NCT02518789|Propofol|propofol|mesh-list
5838387|NCT02518789|Etomidate|etomidate|mesh-list
5838388|NCT02518789|Atracurium|atracurium|mesh-list
5838389|NCT02518789|Rocuronium|rocuronium|mesh-list
5659096|NCT03649334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5659097|NCT03649334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5659098|NCT03649269|Bezafibrate|bezafibrate|mesh-list
5659099|NCT03649269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5659100|NCT03649269|Antimetabolites|antimetabolites|mesh-ancestor
5659101|NCT03649269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659102|NCT03649269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5659103|NCT03649243|Propolis|propolis|mesh-list
5659104|NCT03649243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5659105|NCT03649230|Palonosetron|palonosetron|mesh-list
5659106|NCT03649230|Antiemetics|antiemetics|mesh-ancestor
5659107|NCT03649230|Autonomic Agents|autonomic agents|mesh-ancestor
5659108|NCT03649230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5659109|NCT03649230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659110|NCT03649230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5659111|NCT03649230|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5659112|NCT03649230|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5659113|NCT03649230|Serotonin Agents|serotonin agents|mesh-ancestor
5659114|NCT03649230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5659115|NCT03649230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659116|NCT03649165|Acetaminophen|acetaminophen|mesh-list
5659117|NCT03649165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5659118|NCT03649165|Analgesics|analgesics|mesh-ancestor
5659119|NCT03649165|Sensory System Agents|sensory system agents|mesh-ancestor
5659120|NCT03649165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5659121|NCT03649165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659122|NCT03649165|Antipyretics|antipyretics|mesh-ancestor
5659123|NCT03649152|Proxigermanium|proxigermanium|mesh-list
5659124|NCT03649152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5659125|NCT03649152|Interferon Inducers|interferon inducers|mesh-ancestor
5659126|NCT03649152|Immunologic Factors|immunologic factors|mesh-ancestor
5659127|NCT03649152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659128|NCT03649061|Etanercept|etanercept|mesh-list
5659129|NCT03649061|Leflunomide|leflunomide|mesh-list
5659130|NCT03649061|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5659131|NCT03649061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5659132|NCT03649061|Analgesics|analgesics|mesh-ancestor
5659133|NCT03649061|Sensory System Agents|sensory system agents|mesh-ancestor
5659134|NCT03649061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5659135|NCT03649061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659136|NCT03649061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5659137|NCT03649061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5659138|NCT03649061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5838390|NCT02518789|Cisatracurium|cisatracurium|mesh-list
5838391|NCT02518789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5838392|NCT02518789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5838393|NCT02518789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838394|NCT02518789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5838395|NCT02518789|Anesthetics, General|anesthetics, general|mesh-ancestor
5659139|NCT03649061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5659140|NCT03649061|Immunologic Factors|immunologic factors|mesh-ancestor
5659141|NCT03649061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5659142|NCT03649061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659143|NCT03649048|Cisplatin|cisplatin|mesh-list
5659144|NCT03649048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5838396|NCT02518789|Anesthetics|anesthetics|mesh-ancestor
5838397|NCT02518789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5838398|NCT02518789|Analgesics|analgesics|mesh-ancestor
5838399|NCT02518789|Sensory System Agents|sensory system agents|mesh-ancestor
5838400|NCT02518789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5838401|NCT02518789|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5838402|NCT02518789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5838403|NCT02518789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5838404|NCT02518789|Adrenergic Agents|adrenergic agents|mesh-ancestor
5838405|NCT02518789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5838406|NCT02518789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5838407|NCT02518789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5838408|NCT02518789|Narcotics|narcotics|mesh-ancestor
5838409|NCT02518789|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5838410|NCT02518789|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6211930|NCT02179892|Hormones|hormones|mesh-ancestor
5838411|NCT02518789|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5838412|NCT02518789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5659145|NCT03649009|Thiamine|thiamine|mesh-list
5659146|NCT03649009|Hydrocortisone|hydrocortisone|mesh-list
5838413|NCT02518789|GABA Modulators|gaba modulators|mesh-ancestor
5838414|NCT02518789|GABA Agents|gaba agents|mesh-ancestor
5838415|NCT02518789|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5838416|NCT02518789|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5838417|NCT02518789|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5838418|NCT02518789|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
5838419|NCT02518789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5838420|NCT02518789|Cholinergic Agents|cholinergic agents|mesh-ancestor
5838421|NCT02518958|Nivolumab|nivolumab|mesh-list
5838422|NCT02518958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5838423|NCT02518958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5838424|NCT02518958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5838425|NCT02518958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5838426|NCT02518698|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
5659147|NCT03649009|Metoclopramide|metoclopramide|mesh-list
5659148|NCT03649009|Vitamins|vitamins|mesh-ancestor
5659149|NCT03649009|Micronutrients|micronutrients|mesh-ancestor
5659150|NCT03649009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659151|NCT03649009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5659152|NCT03649009|Vitamin B Complex|vitamin b complex|mesh-ancestor
5659153|NCT03649009|Antiemetics|antiemetics|mesh-ancestor
5659154|NCT03649009|Autonomic Agents|autonomic agents|mesh-ancestor
5659155|NCT03649009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5659156|NCT03649009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5659157|NCT03649009|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5659158|NCT03649009|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5659159|NCT03649009|Dopamine Agents|dopamine agents|mesh-ancestor
5659160|NCT03649009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5659161|NCT03649009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659162|NCT03648996|Allopurinol|allopurinol|mesh-list
5659163|NCT03648996|Antimetabolites|antimetabolites|mesh-ancestor
5659164|NCT03648996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659165|NCT03648996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5659166|NCT03648996|Gout Suppressants|gout suppressants|mesh-ancestor
5659167|NCT03648996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5659168|NCT03648996|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5659169|NCT03648996|Antioxidants|antioxidants|mesh-ancestor
5659170|NCT03648996|Protective Agents|protective agents|mesh-ancestor
5659171|NCT03648996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659172|NCT03648970|Pravastatin|pravastatin|mesh-list
5659173|NCT03648970|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5659174|NCT03648970|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5659175|NCT03648970|Antimetabolites|antimetabolites|mesh-ancestor
5659176|NCT03648970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659177|NCT03648970|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5659178|NCT03648970|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5659179|NCT03648970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5838427|NCT02518698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5838428|NCT02518503|Atorvastatin|atorvastatin|mesh-list
5838429|NCT02518503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5838430|NCT02518503|Simvastatin|simvastatin|mesh-list
5838431|NCT02518503|Pravastatin|pravastatin|mesh-list
5838432|NCT02518503|Lovastatin|lovastatin|mesh-list
5838433|NCT02518503|L 647318|l 647318|mesh-list
5838434|NCT02518503|Dihydromevinolin|dihydromevinolin|mesh-list
5838435|NCT02518503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5838436|NCT02518503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5838437|NCT02518503|Antimetabolites|antimetabolites|mesh-ancestor
5838438|NCT02518503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5838439|NCT02518503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5838440|NCT02518503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5838441|NCT02518503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5695121|NCT03391570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695122|NCT03391570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5695123|NCT03391570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5695124|NCT03391427|Lidocaine|lidocaine|mesh-list
5695125|NCT03391427|Ketamine|ketamine|mesh-list
5695126|NCT03391427|Anesthetics, Local|anesthetics, local|mesh-ancestor
5695127|NCT03391427|Anesthetics|anesthetics|mesh-ancestor
5695128|NCT03391427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5695129|NCT03391427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695130|NCT03391427|Sensory System Agents|sensory system agents|mesh-ancestor
5695131|NCT03391427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5695132|NCT03391427|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5659180|NCT03648697|Cyclophosphamide|cyclophosphamide|mesh-list
5659181|NCT03648697|Fludarabine|fludarabine|mesh-list
5659182|NCT03648697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5838445|NCT02518594|Progesterone|progesterone|mesh-list
5838446|NCT02518594|Progestins|progestins|mesh-ancestor
5838447|NCT02518594|Hormones|hormones|mesh-ancestor
5838448|NCT02518594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5838449|NCT02518594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838450|NCT02518451|Valsartan|valsartan|mesh-list
5838451|NCT02518451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5838452|NCT02518451|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5838453|NCT02518451|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5838454|NCT02518451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5838455|NCT02518373|Omeprazole|omeprazole|mesh-list
6493668|NCT00614965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6493669|NCT00614965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6493670|NCT00614965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493671|NCT00614965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6493672|NCT00614965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6493673|NCT00614978|Temozolomide|temozolomide|mesh-list
6493674|NCT00614978|Lapatinib|lapatinib|mesh-list
5838456|NCT02518373|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5838457|NCT02518373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5659183|NCT03648697|Immunologic Factors|immunologic factors|mesh-ancestor
5659184|NCT03648697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659185|NCT03648697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5659186|NCT03648697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5659187|NCT03648697|Alkylating Agents|alkylating agents|mesh-ancestor
5659188|NCT03648697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659189|NCT03648697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5659190|NCT03648697|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5659191|NCT03648684|Caffeine|caffeine|mesh-list
5659192|NCT03648684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5659193|NCT03648684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659194|NCT03648684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5659195|NCT03648684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5659196|NCT03648684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659197|NCT03648684|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5659198|NCT03648684|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5659199|NCT03648684|Purinergic Agents|purinergic agents|mesh-ancestor
5659200|NCT03648684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5659201|NCT03648671|Rasagiline|rasagiline|mesh-list
5659202|NCT03648671|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
5659203|NCT03648671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5659204|NCT03648671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659205|NCT03648671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5659206|NCT03648671|Protective Agents|protective agents|mesh-ancestor
5838458|NCT02518373|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5838459|NCT02518373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5838460|NCT02518373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5838461|NCT02518516|Atorvastatin|atorvastatin|mesh-list
5838462|NCT02518516|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5838463|NCT02518516|Simvastatin|simvastatin|mesh-list
5838464|NCT02518516|Pravastatin|pravastatin|mesh-list
5838465|NCT02518516|Lovastatin|lovastatin|mesh-list
5838466|NCT02518516|L 647318|l 647318|mesh-list
5838467|NCT02518516|Dihydromevinolin|dihydromevinolin|mesh-list
5838468|NCT02518516|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5838469|NCT02518516|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5838470|NCT02518516|Antimetabolites|antimetabolites|mesh-ancestor
6211931|NCT02179892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6211932|NCT02179892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6211933|NCT02179892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6211934|NCT02179892|Anesthetics, Local|anesthetics, local|mesh-ancestor
6211935|NCT02179892|Anesthetics|anesthetics|mesh-ancestor
6211936|NCT02179892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6211937|NCT02179892|Sensory System Agents|sensory system agents|mesh-ancestor
6211938|NCT02179892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6211939|NCT02179892|Analgesics|analgesics|mesh-ancestor
6211940|NCT02179892|Antipyretics|antipyretics|mesh-ancestor
6211941|NCT02179918|Pembrolizumab|pembrolizumab|mesh-list
6211942|NCT02179918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6211943|NCT02179918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6211944|NCT02180061|Pembrolizumab|pembrolizumab|mesh-list
5838471|NCT02518516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211945|NCT02180061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6211946|NCT02180061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6211947|NCT02180100|Fluconazole|fluconazole|mesh-list
6211948|NCT02180100|Terconazole|terconazole|mesh-list
6211949|NCT02180100|Antifungal Agents|antifungal agents|mesh-ancestor
6211950|NCT02180100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6211951|NCT02180100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6211952|NCT02180100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6211953|NCT02180100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5659207|NCT03648671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659208|NCT03648658|Acetaminophen|acetaminophen|mesh-list
5838472|NCT02518516|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5838473|NCT02518516|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5838474|NCT02518516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5838475|NCT02518438|Tramadol|tramadol|mesh-list
5838476|NCT02518438|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5838477|NCT02518438|Narcotics|narcotics|mesh-ancestor
5838478|NCT02518438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5838479|NCT02518438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659209|NCT03648658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5659210|NCT03648658|Analgesics|analgesics|mesh-ancestor
5659211|NCT03648658|Sensory System Agents|sensory system agents|mesh-ancestor
5659212|NCT03648658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5659213|NCT03648658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659214|NCT03648658|Antipyretics|antipyretics|mesh-ancestor
5659215|NCT03648554|Dulaglutide|dulaglutide|mesh-list
5659216|NCT03648554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5659217|NCT03648554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659218|NCT03648528|Cholecalciferol|cholecalciferol|mesh-list
5659219|NCT03648528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5659220|NCT03648528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659221|NCT03648528|Vitamins|vitamins|mesh-ancestor
5659222|NCT03648528|Micronutrients|micronutrients|mesh-ancestor
5659223|NCT03648528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5659224|NCT03648489|Paclitaxel|paclitaxel|mesh-list
5659225|NCT03648489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5659226|NCT03648489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5659227|NCT03648489|Tubulin Modulators|tubulin modulators|mesh-ancestor
5659228|NCT03648489|Antimitotic Agents|antimitotic agents|mesh-ancestor
5659229|NCT03648489|Mitosis Modulators|mitosis modulators|mesh-ancestor
5659230|NCT03648489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659231|NCT03648437|Acetaminophen|acetaminophen|mesh-list
5659232|NCT03648437|Ibuprofen|ibuprofen|mesh-list
5659233|NCT03648437|Indomethacin|indomethacin|mesh-list
5659234|NCT03648437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5659235|NCT03648437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5659236|NCT03648437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5838480|NCT02518438|Analgesics|analgesics|mesh-ancestor
5838481|NCT02518438|Sensory System Agents|sensory system agents|mesh-ancestor
5838482|NCT02518438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5838483|NCT02518295|Sulfalene|sulfalene|mesh-list
5838484|NCT02518295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5838485|NCT02518295|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5838486|NCT02518295|Renal Agents|renal agents|mesh-ancestor
5838487|NCT02518295|Antimalarials|antimalarials|mesh-ancestor
5838488|NCT02518295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5838489|NCT02518295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5838490|NCT02518152|Alendronate|alendronate|mesh-list
5838491|NCT02518152|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5838492|NCT02518152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838493|NCT02518022|Insulin|insulin|mesh-list
5838494|NCT02518022|Insulin Lispro|insulin lispro|mesh-list
5838495|NCT02518022|Insulin Aspart|insulin aspart|mesh-list
5838496|NCT02518022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5838497|NCT02518022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838498|NCT02518009|Estrogens|estrogens|mesh-list
5838499|NCT02518009|Androgens|androgens|mesh-list
5838500|NCT02518009|Hormones|hormones|mesh-ancestor
5838501|NCT02518009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5838502|NCT02518009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838503|NCT02517814|Vitamin D|vitamin d|mesh-list
5838504|NCT02517814|Vitamins|vitamins|mesh-ancestor
5838505|NCT02517814|Micronutrients|micronutrients|mesh-ancestor
5838506|NCT02517814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838507|NCT02517814|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5903108|NCT01701986|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6211954|NCT02180100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5838508|NCT02517827|Paclitaxel|paclitaxel|mesh-list
5838509|NCT02517827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5838510|NCT02517827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5838511|NCT02517827|Tubulin Modulators|tubulin modulators|mesh-ancestor
5838512|NCT02517827|Antimitotic Agents|antimitotic agents|mesh-ancestor
5838513|NCT02517827|Mitosis Modulators|mitosis modulators|mesh-ancestor
5838514|NCT02517827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5838515|NCT02517788|Interferons|interferons|mesh-list
5838516|NCT02517788|Interferon-beta|interferon-beta|mesh-list
5838517|NCT02517788|Interferon beta-1a|interferon beta-1a|mesh-list
5838518|NCT02517788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5838519|NCT02517788|Antiviral Agents|antiviral agents|mesh-ancestor
5838520|NCT02517788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5838521|NCT02517788|Immunologic Factors|immunologic factors|mesh-ancestor
5838522|NCT02517788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838523|NCT02517788|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5838524|NCT02517957|Loperamide|loperamide|mesh-list
5838525|NCT02517957|Antidiarrheals|antidiarrheals|mesh-list
5838526|NCT02517957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5659237|NCT03648437|Analgesics|analgesics|mesh-ancestor
5659238|NCT03648437|Sensory System Agents|sensory system agents|mesh-ancestor
5659239|NCT03648437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5659240|NCT03648437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659241|NCT03648437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5659242|NCT03648437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5659243|NCT03648437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5838527|NCT02517918|Zoledronic Acid|zoledronic acid|mesh-list
5838528|NCT02517918|Sirolimus|sirolimus|mesh-list
5838529|NCT02517918|Methotrexate|methotrexate|mesh-list
5838530|NCT02517918|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5838531|NCT02517918|Abortifacient Agents|abortifacient agents|mesh-ancestor
5659244|NCT03648437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5659245|NCT03648437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659246|NCT03648437|Antipyretics|antipyretics|mesh-ancestor
5659247|NCT03648437|Gout Suppressants|gout suppressants|mesh-ancestor
5659248|NCT03648437|Tocolytic Agents|tocolytic agents|mesh-ancestor
5659249|NCT03648437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5659250|NCT03648346|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5659251|NCT03648333|Niacin|niacin|mesh-list
5838532|NCT02517918|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5838533|NCT02517918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838534|NCT02517918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5838535|NCT02517918|Antimetabolites|antimetabolites|mesh-ancestor
5838536|NCT02517918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5838537|NCT02517918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5838538|NCT02517918|Dermatologic Agents|dermatologic agents|mesh-ancestor
5838539|NCT02517918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5838540|NCT02517918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5838541|NCT02517918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5838542|NCT02517918|Immunologic Factors|immunologic factors|mesh-ancestor
5838543|NCT02517918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5838544|NCT02517918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5838545|NCT02517918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5838546|NCT02517918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5838547|NCT02517918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5838548|NCT02517918|Antifungal Agents|antifungal agents|mesh-ancestor
5838549|NCT02517918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5838550|NCT02517736|Sorafenib|sorafenib|mesh-list
5838551|NCT02517736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5838552|NCT02517736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5838553|NCT02517736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5838554|NCT02517736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5838555|NCT02517684|Prednisolone|prednisolone|mesh-list
5838556|NCT02517684|Azathioprine|azathioprine|mesh-list
5838557|NCT02517684|Infliximab|infliximab|mesh-list
5838558|NCT02517684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5838559|NCT02517684|Glucocorticoids|glucocorticoids|mesh-ancestor
5838560|NCT02517684|Hormones|hormones|mesh-ancestor
5838561|NCT02517684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5838562|NCT02517684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838563|NCT02517684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5838564|NCT02517684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5838565|NCT02517684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5838566|NCT02517684|Dermatologic Agents|dermatologic agents|mesh-ancestor
5659252|NCT03648333|Amlodipine|amlodipine|mesh-list
5838567|NCT02517684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5659253|NCT03648333|Valsartan|valsartan|mesh-list
5838568|NCT02517684|Antimetabolites|antimetabolites|mesh-ancestor
5838569|NCT02517684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5838570|NCT02517684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5838571|NCT02517684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5838572|NCT02517684|Immunologic Factors|immunologic factors|mesh-ancestor
5838573|NCT02517619|Dexamethasone|dexamethasone|mesh-list
5838574|NCT02517619|Prednisolone|prednisolone|mesh-list
5838575|NCT02517619|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5838576|NCT02517619|Methylprednisolone|methylprednisolone|mesh-list
5659254|NCT03648333|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
5659255|NCT03648333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5659256|NCT03648333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5659257|NCT03648333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5659258|NCT03648333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659259|NCT03648333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5659260|NCT03648333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659261|NCT03648333|Vasodilator Agents|vasodilator agents|mesh-ancestor
5659262|NCT03648333|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5659263|NCT03648333|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5838577|NCT02517619|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5838578|NCT02517619|Prednisolone acetate|prednisolone acetate|mesh-list
5838579|NCT02517619|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5838580|NCT02517619|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5838581|NCT02517619|Prednisolone phosphate|prednisolone phosphate|mesh-list
5838582|NCT02517619|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
5838583|NCT02517619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5838584|NCT02517619|Antiemetics|antiemetics|mesh-ancestor
5838585|NCT02517619|Autonomic Agents|autonomic agents|mesh-ancestor
5838586|NCT02517619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5659264|NCT03648333|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5659265|NCT03648333|Antimetabolites|antimetabolites|mesh-ancestor
5659266|NCT03648333|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5659267|NCT03648333|Vitamin B Complex|vitamin b complex|mesh-ancestor
5659268|NCT03648333|Vitamins|vitamins|mesh-ancestor
5659269|NCT03648333|Micronutrients|micronutrients|mesh-ancestor
5659270|NCT03648229|Timolol|timolol|mesh-list
5659271|NCT03648229|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5659272|NCT03648229|Latanoprost|latanoprost|mesh-list
5659273|NCT03648229|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5659274|NCT03648229|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5659275|NCT03648229|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5659276|NCT03648229|Adrenergic Agents|adrenergic agents|mesh-ancestor
5659277|NCT03648229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5659278|NCT03648229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659279|NCT03648229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659280|NCT03648229|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5659281|NCT03648229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5838587|NCT02517619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838588|NCT02517619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5838589|NCT02517619|Glucocorticoids|glucocorticoids|mesh-ancestor
5838590|NCT02517619|Hormones|hormones|mesh-ancestor
5838591|NCT02517619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5838592|NCT02517619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5838593|NCT02517619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5838594|NCT02517619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5838595|NCT02517619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5838596|NCT02517619|Protective Agents|protective agents|mesh-ancestor
5838597|NCT02517372|Pemirolast|pemirolast|mesh-list
5838598|NCT02517372|Histamine Antagonists|histamine antagonists|mesh-ancestor
5838599|NCT02517372|Histamine Agents|histamine agents|mesh-ancestor
5838600|NCT02517372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5838601|NCT02517372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5838602|NCT02517372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838603|NCT02517489|Hydrocortisone|hydrocortisone|mesh-list
5838604|NCT02517489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5838605|NCT02517424|Dronabinol|dronabinol|mesh-list
5838606|NCT02517424|Hallucinogens|hallucinogens|mesh-ancestor
5838607|NCT02517424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838608|NCT02517424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5838609|NCT02517424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5838610|NCT02517424|Analgesics|analgesics|mesh-ancestor
5838611|NCT02517424|Sensory System Agents|sensory system agents|mesh-ancestor
5838612|NCT02517424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5838613|NCT02517424|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5838614|NCT02517424|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5838615|NCT02517424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5838616|NCT02517424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5838617|NCT02517424|Hormones|hormones|mesh-ancestor
5838618|NCT02517424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5838619|NCT02517307|Heparin|heparin|mesh-list
5838620|NCT02517307|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
5838621|NCT02517307|Glycerol|glycerol|mesh-list
5838622|NCT02517307|Anticoagulants|anticoagulants|mesh-ancestor
5838623|NCT02517307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5838624|NCT02517307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5838625|NCT02517307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5838626|NCT02517307|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
5838627|NCT02517307|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5838628|NCT02517307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5838629|NCT02517307|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
5838630|NCT02517307|Protective Agents|protective agents|mesh-ancestor
5838631|NCT02517307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838632|NCT02517164|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
5838633|NCT02517164|Calcifediol|calcifediol|mesh-list
5838634|NCT02517164|Vitamins|vitamins|mesh-ancestor
5838635|NCT02517164|Micronutrients|micronutrients|mesh-ancestor
5838636|NCT02517164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838637|NCT02517164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5838638|NCT02516826|Olmesartan|olmesartan|mesh-list
5838639|NCT02516826|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
5838640|NCT02516826|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5838641|NCT02516826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5838642|NCT02516826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5838643|NCT02516826|Antimetabolites|antimetabolites|mesh-ancestor
5838644|NCT02516826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659282|NCT03648125|Salicylic Acid|salicylic acid|mesh-list
5659283|NCT03648125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5659284|NCT03648125|Antifungal Agents|antifungal agents|mesh-ancestor
5659285|NCT03648125|Keratolytic Agents|keratolytic agents|mesh-ancestor
5659286|NCT03648125|Dermatologic Agents|dermatologic agents|mesh-ancestor
5659287|NCT03648034|Ropivacaine|ropivacaine|mesh-list
5659288|NCT03648034|Anesthetics, Local|anesthetics, local|mesh-ancestor
5659289|NCT03648034|Anesthetics|anesthetics|mesh-ancestor
5659290|NCT03648034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5659291|NCT03648034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659292|NCT03648034|Sensory System Agents|sensory system agents|mesh-ancestor
5659293|NCT03648034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5659294|NCT03648008|Morphine|morphine|mesh-list
5659295|NCT03648008|Hydromorphone|hydromorphone|mesh-list
5659296|NCT03648008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5659297|NCT03648008|Narcotics|narcotics|mesh-ancestor
5659298|NCT03648008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5659299|NCT03648008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659300|NCT03648008|Analgesics|analgesics|mesh-ancestor
5659301|NCT03648008|Sensory System Agents|sensory system agents|mesh-ancestor
5659302|NCT03648008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5659303|NCT03647982|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5659304|NCT03647982|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5659305|NCT03647982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5659306|NCT03647982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659307|NCT03647982|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5659308|NCT03647982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5659309|NCT03647982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659310|NCT03647982|Cholinergic Agents|cholinergic agents|mesh-ancestor
5659311|NCT03647982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5659312|NCT03647969|Nivolumab|nivolumab|mesh-list
5659313|NCT03647969|Ipilimumab|ipilimumab|mesh-list
5659314|NCT03647969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5659315|NCT03647969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5659316|NCT03647969|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5659317|NCT03647969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659318|NCT03647956|Bevacizumab|bevacizumab|mesh-list
5659319|NCT03647956|Carboplatin|carboplatin|mesh-list
5659320|NCT03647956|Pemetrexed|pemetrexed|mesh-list
5659321|NCT03647956|Atezolizumab|atezolizumab|mesh-list
5659322|NCT03647956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5659323|NCT03647956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5659324|NCT03647956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5659325|NCT03647956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5659326|NCT03647956|Growth Substances|growth substances|mesh-ancestor
5659327|NCT03647956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659328|NCT03647956|Growth Inhibitors|growth inhibitors|mesh-ancestor
5659329|NCT03647956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5659330|NCT03647956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659331|NCT03647956|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5659332|NCT03647956|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5659333|NCT03647839|Nivolumab|nivolumab|mesh-list
5659334|NCT03647839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5659335|NCT03647839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5659336|NCT03647839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5659337|NCT03647839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659338|NCT03647774|Naltrexone|naltrexone|mesh-list
5838645|NCT02516826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5838646|NCT02516826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5838647|NCT02516826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5838648|NCT02516826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5838649|NCT02516826|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5838650|NCT02516826|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5838651|NCT02517099|Azithromycin|azithromycin|mesh-list
5838652|NCT02517099|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5838653|NCT02517099|Beclomethasone|beclomethasone|mesh-list
5838654|NCT02517099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5838655|NCT02517099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5838656|NCT02517099|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5838657|NCT02517099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5838658|NCT02517099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5838659|NCT02517099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5838660|NCT02517099|Glucocorticoids|glucocorticoids|mesh-ancestor
5838661|NCT02517099|Hormones|hormones|mesh-ancestor
5838662|NCT02517099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5838663|NCT02517099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838664|NCT02517099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5838665|NCT02517099|Respiratory System Agents|respiratory system agents|mesh-ancestor
5838666|NCT02516774|Adalimumab|adalimumab|mesh-list
5838667|NCT02516774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5838668|NCT02516774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5838669|NCT02516618|Fasinumab|fasinumab|mesh-list
5838670|NCT02516618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5838671|NCT02516618|Analgesics|analgesics|mesh-ancestor
5659339|NCT03647774|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5659340|NCT03647774|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5838672|NCT02516618|Sensory System Agents|sensory system agents|mesh-ancestor
5838673|NCT02516618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5838674|NCT02516618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838675|NCT02516813|Peposertib|peposertib|mesh-list
5838676|NCT02516813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5838677|NCT02516813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5838678|NCT02516813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5838679|NCT02516670|Vitamins|vitamins|mesh-list
5838680|NCT02516670|Ascorbic Acid|ascorbic acid|mesh-list
5838681|NCT02516670|Docetaxel|docetaxel|mesh-list
5838682|NCT02516670|Micronutrients|micronutrients|mesh-ancestor
5838683|NCT02516670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838684|NCT02516670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5838685|NCT02516670|Tubulin Modulators|tubulin modulators|mesh-ancestor
5838686|NCT02516670|Antimitotic Agents|antimitotic agents|mesh-ancestor
5838687|NCT02516670|Mitosis Modulators|mitosis modulators|mesh-ancestor
5838688|NCT02516670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5838689|NCT02516670|Antioxidants|antioxidants|mesh-ancestor
5838690|NCT02516670|Protective Agents|protective agents|mesh-ancestor
5838691|NCT02516904|Rezafungin|rezafungin|mesh-list
5838692|NCT02516904|Antifungal Agents|antifungal agents|mesh-ancestor
5838693|NCT02516904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5838694|NCT02516631|Misoprostol|misoprostol|mesh-list
5838695|NCT02516631|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5659341|NCT03647774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659342|NCT03647774|Sensory System Agents|sensory system agents|mesh-ancestor
5659343|NCT03647774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5659344|NCT03647670|Midazolam|midazolam|mesh-list
5659345|NCT03647670|Abrocitinib|abrocitinib|mesh-list
5659346|NCT03647670|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5659347|NCT03647670|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5838696|NCT02516631|Abortifacient Agents|abortifacient agents|mesh-ancestor
5838697|NCT02516631|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5838698|NCT02516631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838699|NCT02516631|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5838700|NCT02516631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5838701|NCT02516631|Oxytocics|oxytocics|mesh-ancestor
5838702|NCT02516527|Ipilimumab|ipilimumab|mesh-list
5838703|NCT02516527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5838704|NCT02516527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5838705|NCT02516527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5838706|NCT02516527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5838707|NCT02516475|Zinc Sulfate|zinc sulfate|mesh-list
5838708|NCT02516475|Astringents|astringents|mesh-ancestor
5838709|NCT02516475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838710|NCT02516475|Dermatologic Agents|dermatologic agents|mesh-ancestor
5838711|NCT02516423|Zoledronic Acid|zoledronic acid|mesh-list
5838712|NCT02516423|Dexamethasone|dexamethasone|mesh-list
5838713|NCT02516423|Lenalidomide|lenalidomide|mesh-list
5838714|NCT02516423|Ixazomib|ixazomib|mesh-list
5838715|NCT02516423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5838716|NCT02516423|Antiemetics|antiemetics|mesh-ancestor
5659348|NCT03647670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5659349|NCT03647670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659350|NCT03647670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5838717|NCT02516423|Autonomic Agents|autonomic agents|mesh-ancestor
5838718|NCT02516423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5838719|NCT02516423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838720|NCT02516423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5838721|NCT02516423|Glucocorticoids|glucocorticoids|mesh-ancestor
5659351|NCT03647670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5659352|NCT03647670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5659353|NCT03647670|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5659354|NCT03647670|Anesthetics, General|anesthetics, general|mesh-ancestor
5659355|NCT03647670|Anesthetics|anesthetics|mesh-ancestor
5659356|NCT03647670|GABA Modulators|gaba modulators|mesh-ancestor
5659357|NCT03647670|GABA Agents|gaba agents|mesh-ancestor
5659358|NCT03647670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5659359|NCT03647670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5838722|NCT02516423|Hormones|hormones|mesh-ancestor
5838723|NCT02516423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5838724|NCT02516423|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5838725|NCT02516423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5838726|NCT02516423|Immunologic Factors|immunologic factors|mesh-ancestor
5838727|NCT02516423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5838728|NCT02516423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5838729|NCT02516423|Growth Substances|growth substances|mesh-ancestor
5838730|NCT02516423|Growth Inhibitors|growth inhibitors|mesh-ancestor
5838731|NCT02516423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5838732|NCT02516423|Protease Inhibitors|protease inhibitors|mesh-ancestor
5838733|NCT02516423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5838734|NCT02516423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5838735|NCT02516657|Liraglutide|liraglutide|mesh-list
5838736|NCT02516657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5838737|NCT02516657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838738|NCT02516657|Incretins|incretins|mesh-ancestor
5838739|NCT02516657|Hormones|hormones|mesh-ancestor
5838740|NCT02516657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5838741|NCT02516436|Buprenorphine|buprenorphine|mesh-list
5838742|NCT02516436|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5659360|NCT03647670|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5659361|NCT03647670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5659362|NCT03647592|Bevacizumab|bevacizumab|mesh-list
5659363|NCT03647592|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5659364|NCT03647592|Gefitinib|gefitinib|mesh-list
5659365|NCT03647592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5659366|NCT03647592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5659367|NCT03647592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5659368|NCT03647592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5659369|NCT03647592|Growth Substances|growth substances|mesh-ancestor
5659370|NCT03647592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659371|NCT03647592|Growth Inhibitors|growth inhibitors|mesh-ancestor
5659372|NCT03647592|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5659373|NCT03647592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5659374|NCT03647592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659375|NCT03647579|Midazolam|midazolam|mesh-list
5659376|NCT03647579|Dexmedetomidine|dexmedetomidine|mesh-list
5659377|NCT03647579|Ketamine|ketamine|mesh-list
5838743|NCT02516436|Narcotics|narcotics|mesh-ancestor
5838744|NCT02516436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5838745|NCT02516436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838746|NCT02516436|Analgesics|analgesics|mesh-ancestor
5838747|NCT02516436|Sensory System Agents|sensory system agents|mesh-ancestor
5838748|NCT02516436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5838749|NCT02516436|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5838750|NCT02516462|Hormones|hormones|mesh-list
5838751|NCT02516462|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5838752|NCT02516462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5838753|NCT02516462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903109|NCT01701986|Antitubercular Agents|antitubercular agents|mesh-ancestor
5903110|NCT01701986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5903111|NCT01701986|Alkylating Agents|alkylating agents|mesh-ancestor
5903112|NCT01701986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5903113|NCT01701986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5903114|NCT00754949|Azithromycin|azithromycin|mesh-list
5903115|NCT00754949|Dexamethasone|dexamethasone|mesh-list
5903116|NCT00754949|Dexamethasone acetate|dexamethasone acetate|mesh-list
5903117|NCT00754949|BB 1101|bb 1101|mesh-list
5903118|NCT00754949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5903119|NCT00754949|Antiemetics|antiemetics|mesh-ancestor
5903120|NCT00754949|Autonomic Agents|autonomic agents|mesh-ancestor
5903121|NCT00754949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5903122|NCT00754949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903123|NCT00754949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5903124|NCT00754949|Glucocorticoids|glucocorticoids|mesh-ancestor
5903125|NCT00754949|Hormones|hormones|mesh-ancestor
5903126|NCT00754949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5903127|NCT00754949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5903128|NCT00754949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5903129|NCT00754949|Protease Inhibitors|protease inhibitors|mesh-ancestor
5903130|NCT00754949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5903131|NCT00754949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903132|NCT00754949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5903133|NCT00754949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5903134|NCT00466531|Cyclophosphamide|cyclophosphamide|mesh-list
5903135|NCT00466531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5903136|NCT00466531|Immunologic Factors|immunologic factors|mesh-ancestor
5903137|NCT00466531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903138|NCT00466531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5903139|NCT00466531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5903140|NCT00466531|Alkylating Agents|alkylating agents|mesh-ancestor
5903141|NCT00466531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903142|NCT00466531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5903143|NCT00466531|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5903144|NCT05132023|Metformin|metformin|mesh-list
5903145|NCT05132023|Empagliflozin|empagliflozin|mesh-list
5903146|NCT05132023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5903147|NCT05132023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903148|NCT05132023|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5903149|NCT05132023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903150|NCT05131984|Ocrelizumab|ocrelizumab|mesh-list
5903151|NCT05131984|Immunologic Factors|immunologic factors|mesh-ancestor
5903152|NCT05131984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903153|NCT05131919|Pembrolizumab|pembrolizumab|mesh-list
5903154|NCT05131919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5903155|NCT05131919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5903156|NCT05131893|Tamoxifen|tamoxifen|mesh-list
5659378|NCT03647579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5659379|NCT03647579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5659380|NCT03647579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659381|NCT03647579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5659382|NCT03647579|Analgesics|analgesics|mesh-ancestor
5659383|NCT03647579|Sensory System Agents|sensory system agents|mesh-ancestor
5659384|NCT03647579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5659385|NCT03647579|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5659386|NCT03647579|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5659387|NCT03647579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5659388|NCT03647579|Adrenergic Agents|adrenergic agents|mesh-ancestor
5659389|NCT03647579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5659390|NCT03647579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659391|NCT03647579|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5838754|NCT02516085|Metformin|metformin|mesh-list
5838755|NCT02516085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5659392|NCT03647579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5659393|NCT03647579|Anesthetics, General|anesthetics, general|mesh-ancestor
5659394|NCT03647579|Anesthetics|anesthetics|mesh-ancestor
5659395|NCT03647579|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5659396|NCT03647579|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5659397|NCT03647579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5659398|NCT03647579|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5659399|NCT03647579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5659400|NCT03647579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5659401|NCT03647579|GABA Modulators|gaba modulators|mesh-ancestor
5659402|NCT03647579|GABA Agents|gaba agents|mesh-ancestor
5659403|NCT03647566|Listerine|listerine|mesh-list
5659404|NCT03647566|Fluorides|fluorides|mesh-list
5659405|NCT03647566|Sodium Fluoride|sodium fluoride|mesh-list
5659406|NCT03647566|Cariostatic Agents|cariostatic agents|mesh-ancestor
5659407|NCT03647566|Protective Agents|protective agents|mesh-ancestor
5659408|NCT03647566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659409|NCT03647566|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5838756|NCT02516085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838757|NCT02516059|Oxycodone|oxycodone|mesh-list
5838758|NCT02516059|Naloxone|naloxone|mesh-list
5838759|NCT02516059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5838760|NCT02516059|Narcotics|narcotics|mesh-ancestor
5838761|NCT02516059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5838762|NCT02516059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838763|NCT02516059|Analgesics|analgesics|mesh-ancestor
5838764|NCT02516059|Sensory System Agents|sensory system agents|mesh-ancestor
5838765|NCT02516059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5838766|NCT02516059|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5838767|NCT02515968|Propofol|propofol|mesh-list
5838768|NCT02515968|Desflurane|desflurane|mesh-list
5838769|NCT02515968|Anesthetics|anesthetics|mesh-ancestor
5838770|NCT02515968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5838771|NCT02515968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838772|NCT02515968|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5838773|NCT02515968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5838774|NCT02515968|Anesthetics, General|anesthetics, general|mesh-ancestor
5838775|NCT02515968|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5838776|NCT02515955|Minocycline|minocycline|mesh-list
5838777|NCT02515955|Amphetamine|amphetamine|mesh-list
5838778|NCT02515955|Dextroamphetamine|dextroamphetamine|mesh-list
5838779|NCT02515955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5838780|NCT02515955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5838781|NCT02515955|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5838782|NCT02515955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838783|NCT02515955|Sympathomimetics|sympathomimetics|mesh-ancestor
5838784|NCT02515955|Autonomic Agents|autonomic agents|mesh-ancestor
5838785|NCT02515955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5838786|NCT02515955|Dopamine Agents|dopamine agents|mesh-ancestor
5838787|NCT02515955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5838788|NCT02515955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5838789|NCT02515955|Adrenergic Agents|adrenergic agents|mesh-ancestor
5838790|NCT02515955|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5838791|NCT02515955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5838792|NCT02515955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5838793|NCT02515955|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5659410|NCT03647566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5659411|NCT03647514|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5838794|NCT02515929|Proanthocyanidin|proanthocyanidin|mesh-list
5838795|NCT02515929|Procyanidin|procyanidin|mesh-list
5838796|NCT02515929|Antioxidants|antioxidants|mesh-ancestor
5838797|NCT02515929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5838798|NCT02515929|Protective Agents|protective agents|mesh-ancestor
5838799|NCT02515929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838800|NCT02515929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5838801|NCT02515929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5838802|NCT02515929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5838803|NCT02515877|Carboplatin|carboplatin|mesh-list
5838804|NCT02515877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5838805|NCT02515864|Moxifloxacin|moxifloxacin|mesh-list
5838806|NCT02515864|Dotinurad|dotinurad|mesh-list
5838807|NCT02515864|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
5838808|NCT02515864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5838809|NCT02515864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5659412|NCT03647514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5659413|NCT03647423|Cyclophosphamide|cyclophosphamide|mesh-list
5838810|NCT02515864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5838811|NCT02515864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5659414|NCT03647423|Cetuximab|cetuximab|mesh-list
5659415|NCT03647423|Avelumab|avelumab|mesh-list
5659416|NCT03647423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5659417|NCT03647423|Immunologic Factors|immunologic factors|mesh-ancestor
5659418|NCT03647423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659419|NCT03647423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5659420|NCT03647423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5659421|NCT03647423|Alkylating Agents|alkylating agents|mesh-ancestor
5659422|NCT03647423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659423|NCT03647423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5659424|NCT03647423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5659425|NCT03647423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5659426|NCT03647280|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5659427|NCT03647280|Epirubicin|epirubicin|mesh-list
5659428|NCT03647280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5659429|NCT03647280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659430|NCT03647280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5659431|NCT03647280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5659432|NCT03647280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5659433|NCT03647280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5695133|NCT03391427|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5695134|NCT03391427|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5695135|NCT03391427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5695136|NCT03391427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695137|NCT03391427|Analgesics|analgesics|mesh-ancestor
5695138|NCT03391427|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5695139|NCT03391427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5695140|NCT03391427|Anesthetics, General|anesthetics, general|mesh-ancestor
5695141|NCT03391427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5695142|NCT03391427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5695143|NCT03391427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5695144|NCT03391284|Acetaminophen|acetaminophen|mesh-list
5838812|NCT02515864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5838813|NCT02515864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5838814|NCT02515864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5838815|NCT02515864|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5838816|NCT02515864|Contraceptive Agents|contraceptive agents|mesh-ancestor
5838817|NCT02515864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5695145|NCT03391284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5695146|NCT03391284|Analgesics|analgesics|mesh-ancestor
5695147|NCT03391284|Sensory System Agents|sensory system agents|mesh-ancestor
5695148|NCT03391284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5695149|NCT03391284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695150|NCT03391284|Antipyretics|antipyretics|mesh-ancestor
5695151|NCT03391245|Vitamin D|vitamin d|mesh-list
5695152|NCT03391245|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
5695153|NCT03391245|Calcifediol|calcifediol|mesh-list
5695154|NCT03391245|Vitamins|vitamins|mesh-ancestor
5695155|NCT03391245|Micronutrients|micronutrients|mesh-ancestor
5695156|NCT03391245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695157|NCT03391245|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5695158|NCT03391219|Bevacizumab|bevacizumab|mesh-list
5695159|NCT03391219|Fasudil|fasudil|mesh-list
5695160|NCT03391219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5695161|NCT03391219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5838818|NCT02515864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838819|NCT02515864|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5838820|NCT02515864|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5695162|NCT03391219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5695163|NCT03391219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5695164|NCT03391219|Growth Substances|growth substances|mesh-ancestor
5695165|NCT03391219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695166|NCT03391219|Growth Inhibitors|growth inhibitors|mesh-ancestor
5695167|NCT03391219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5695168|NCT03391219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5695169|NCT03391219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695170|NCT03391219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5695171|NCT03391219|Vasodilator Agents|vasodilator agents|mesh-ancestor
5838821|NCT02515864|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5695172|NCT03391219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5695173|NCT03391219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5838822|NCT02515864|Uricosuric Agents|uricosuric agents|mesh-ancestor
5838823|NCT02515864|Gout Suppressants|gout suppressants|mesh-ancestor
5838824|NCT02515864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5838825|NCT02515864|Renal Agents|renal agents|mesh-ancestor
5838829|NCT02515682|Equol|equol|mesh-list
5659434|NCT03647150|Amoxicillin|amoxicillin|mesh-list
5659435|NCT03647150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5659436|NCT03647150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5659437|NCT03647124|Lenalidomide|lenalidomide|mesh-list
5659438|NCT03647124|Immunologic Factors|immunologic factors|mesh-ancestor
5659439|NCT03647124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659440|NCT03647124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5659441|NCT03647124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5659442|NCT03647124|Growth Substances|growth substances|mesh-ancestor
5659443|NCT03647124|Growth Inhibitors|growth inhibitors|mesh-ancestor
5659444|NCT03647124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5659445|NCT03647111|Crizotinib|crizotinib|mesh-list
5659446|NCT03647111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5838830|NCT02515682|Phytoestrogens|phytoestrogens|mesh-ancestor
5838831|NCT02515682|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
5838832|NCT02515682|Estrogens|estrogens|mesh-ancestor
5838833|NCT02515682|Hormones|hormones|mesh-ancestor
5838834|NCT02515682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5838835|NCT02515682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838836|NCT02515695|Interferons|interferons|mesh-list
5838837|NCT02515695|Interferon-beta|interferon-beta|mesh-list
5838838|NCT02515695|Interferon beta-1a|interferon beta-1a|mesh-list
5838839|NCT02515695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5838840|NCT02515695|Antiviral Agents|antiviral agents|mesh-ancestor
5838841|NCT02515695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5838842|NCT02515695|Immunologic Factors|immunologic factors|mesh-ancestor
5838843|NCT02515695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838844|NCT02515695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5838845|NCT02515734|Leucovorin|leucovorin|mesh-list
5838846|NCT02515734|Bevacizumab|bevacizumab|mesh-list
5838847|NCT02515734|Cetuximab|cetuximab|mesh-list
5838848|NCT02515734|Fluorouracil|fluorouracil|mesh-list
5838849|NCT02515734|Oxaliplatin|oxaliplatin|mesh-list
5838850|NCT02515734|Irinotecan|irinotecan|mesh-list
5838851|NCT02515734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5838852|NCT02515734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5838853|NCT02515734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5838854|NCT02515734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5838855|NCT02515734|Growth Substances|growth substances|mesh-ancestor
5838856|NCT02515734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838857|NCT02515734|Growth Inhibitors|growth inhibitors|mesh-ancestor
5838858|NCT02515734|Antimetabolites|antimetabolites|mesh-ancestor
5838859|NCT02515734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5838860|NCT02515734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5838861|NCT02515734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5838862|NCT02515734|Immunologic Factors|immunologic factors|mesh-ancestor
5838863|NCT02515734|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5838864|NCT02515734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5659447|NCT03647111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5838865|NCT02515734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5838866|NCT02515734|Antidotes|antidotes|mesh-ancestor
5838867|NCT02515734|Protective Agents|protective agents|mesh-ancestor
5838868|NCT02515734|Vitamin B Complex|vitamin b complex|mesh-ancestor
5838869|NCT02515734|Vitamins|vitamins|mesh-ancestor
5838870|NCT02515734|Micronutrients|micronutrients|mesh-ancestor
5838871|NCT02515604|Misoprostol|misoprostol|mesh-list
5838872|NCT02515604|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5838873|NCT02515604|Abortifacient Agents|abortifacient agents|mesh-ancestor
5838874|NCT02515604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5838875|NCT02515604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838876|NCT02515604|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5838877|NCT02515604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5838878|NCT02515604|Oxytocics|oxytocics|mesh-ancestor
5838879|NCT02515617|Silver Sulfadiazine|silver sulfadiazine|mesh-list
5838880|NCT02515617|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5838881|NCT02515617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5838882|NCT02515526|Tolbutamide|tolbutamide|mesh-list
5838883|NCT02515526|Ethanol|ethanol|mesh-list
5838884|NCT02515526|Digoxin|digoxin|mesh-list
5838885|NCT02515526|Midazolam|midazolam|mesh-list
5838886|NCT02515526|Dextromethorphan|dextromethorphan|mesh-list
5838887|NCT02515526|Caffeine|caffeine|mesh-list
5838888|NCT02515526|Omeprazole|omeprazole|mesh-list
5659448|NCT03647111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5659449|NCT03647111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659450|NCT03647072|Famotidine|famotidine|mesh-list
5659451|NCT03647072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5659452|NCT03647072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5659453|NCT03647072|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5659454|NCT03647072|Histamine Antagonists|histamine antagonists|mesh-ancestor
5659455|NCT03647072|Histamine Agents|histamine agents|mesh-ancestor
5659456|NCT03647072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5659457|NCT03647072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659458|NCT03647072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659459|NCT03646994|Crizotinib|crizotinib|mesh-list
5659460|NCT03646994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5659461|NCT03646994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5659462|NCT03646994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5659463|NCT03646994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5838889|NCT02515526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5838890|NCT02515526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5838891|NCT02515526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5838892|NCT02515526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838893|NCT02515526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5838894|NCT02515526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5838895|NCT02515526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5838896|NCT02515526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5838897|NCT02515526|Anesthetics, General|anesthetics, general|mesh-ancestor
5838898|NCT02515526|Anesthetics|anesthetics|mesh-ancestor
5838899|NCT02515526|GABA Modulators|gaba modulators|mesh-ancestor
5838900|NCT02515526|GABA Agents|gaba agents|mesh-ancestor
5838901|NCT02515526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5838902|NCT02515526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5838903|NCT02515526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5838904|NCT02515526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5838905|NCT02515526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5838906|NCT02515526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5838907|NCT02515526|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5838908|NCT02515526|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5659464|NCT03646968|Docetaxel|docetaxel|mesh-list
5659465|NCT03646968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5659466|NCT03646968|Tubulin Modulators|tubulin modulators|mesh-ancestor
5838909|NCT02515526|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5838910|NCT02515526|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5838911|NCT02515526|Purinergic Agents|purinergic agents|mesh-ancestor
5838912|NCT02515526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5838913|NCT02515526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5838914|NCT02515526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5838915|NCT02515526|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5838916|NCT02515526|Protective Agents|protective agents|mesh-ancestor
5838917|NCT02515526|Antitussive Agents|antitussive agents|mesh-ancestor
5838918|NCT02515526|Respiratory System Agents|respiratory system agents|mesh-ancestor
5838919|NCT02515526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5659467|NCT03646968|Antimitotic Agents|antimitotic agents|mesh-ancestor
5659468|NCT03646968|Mitosis Modulators|mitosis modulators|mesh-ancestor
5659469|NCT03646968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659470|NCT03646916|Dexamethasone|dexamethasone|mesh-list
5659471|NCT03646916|Dexamethasone acetate|dexamethasone acetate|mesh-list
5659472|NCT03646916|BB 1101|bb 1101|mesh-list
5659473|NCT03646916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5659474|NCT03646916|Antiemetics|antiemetics|mesh-ancestor
5659475|NCT03646916|Autonomic Agents|autonomic agents|mesh-ancestor
5659476|NCT03646916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5659477|NCT03646916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659478|NCT03646916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5659479|NCT03646916|Glucocorticoids|glucocorticoids|mesh-ancestor
5659480|NCT03646916|Hormones|hormones|mesh-ancestor
5659481|NCT03646916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5659482|NCT03646916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5659483|NCT03646916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5659484|NCT03646916|Protease Inhibitors|protease inhibitors|mesh-ancestor
5659485|NCT03646916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5659486|NCT03646916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659487|NCT03646825|Antioxidants|antioxidants|mesh-list
5659488|NCT03646825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659489|NCT03646825|Protective Agents|protective agents|mesh-ancestor
5659490|NCT03646825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838920|NCT02515526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5838921|NCT02515526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5838922|NCT02515448|Gentamicins|gentamicins|mesh-list
5838923|NCT02515448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5838924|NCT02515448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5838925|NCT02515448|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5838926|NCT02515448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5838927|NCT02515448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5838928|NCT02515435|Apatinib|apatinib|mesh-list
5838929|NCT02515435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5838930|NCT02515435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5838931|NCT02515435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5838932|NCT02515435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5838933|NCT02515565|Erythromycin|erythromycin|mesh-list
5838934|NCT02515565|Erythromycin Estolate|erythromycin estolate|mesh-list
5838935|NCT02515565|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
5838936|NCT02515565|Erythromycin stearate|erythromycin stearate|mesh-list
5838937|NCT02515565|Cephalosporins|cephalosporins|mesh-list
5838938|NCT02515565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5838939|NCT02515565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5838940|NCT02515565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5838941|NCT02515565|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5838942|NCT02515565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5838943|NCT02515565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5838944|NCT02515201|Taurolidine|taurolidine|mesh-list
5838945|NCT02515201|Heparin|heparin|mesh-list
5838946|NCT02515201|Calcium heparin|calcium heparin|mesh-list
5838947|NCT02515201|Anticoagulants|anticoagulants|mesh-ancestor
5838948|NCT02515201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5838949|NCT02515201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5838950|NCT02515201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5838951|NCT02515201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5838952|NCT02515201|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5838953|NCT02515201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5838954|NCT02515240|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5838955|NCT02515240|Immunologic Factors|immunologic factors|mesh-ancestor
5838956|NCT02515240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838957|NCT02515227|Pembrolizumab|pembrolizumab|mesh-list
5838958|NCT02515227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5838959|NCT02515227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5838960|NCT02515422|Ketamine|ketamine|mesh-list
5838961|NCT02515422|Bupivacaine|bupivacaine|mesh-list
5838962|NCT02515422|Anesthetics, Local|anesthetics, local|mesh-ancestor
5838963|NCT02515422|Anesthetics|anesthetics|mesh-ancestor
5838964|NCT02515422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5838965|NCT02515422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838966|NCT02515422|Sensory System Agents|sensory system agents|mesh-ancestor
5838967|NCT02515422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5838968|NCT02515422|Analgesics|analgesics|mesh-ancestor
5838969|NCT02515422|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5838970|NCT02515422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5838971|NCT02515422|Anesthetics, General|anesthetics, general|mesh-ancestor
5838972|NCT02515422|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5838973|NCT02515422|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5838974|NCT02515422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5838975|NCT02515422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5838976|NCT02515188|Acetaminophen|acetaminophen|mesh-list
5838977|NCT02515188|Propacetamol|propacetamol|mesh-list
5659491|NCT03646721|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5659492|NCT03646721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5659493|NCT03646721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659494|NCT03646721|Incretins|incretins|mesh-ancestor
5659495|NCT03646721|Hormones|hormones|mesh-ancestor
5838978|NCT02515188|Analgesics|analgesics|mesh-ancestor
5838979|NCT02515188|Sensory System Agents|sensory system agents|mesh-ancestor
5838980|NCT02515188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5659496|NCT03646721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5659497|NCT03646721|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5659498|NCT03646721|Protease Inhibitors|protease inhibitors|mesh-ancestor
5659499|NCT03646721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5659500|NCT03646721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659501|NCT03646617|Nivolumab|nivolumab|mesh-list
5659502|NCT03646617|Ipilimumab|ipilimumab|mesh-list
5659503|NCT03646617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5659504|NCT03646617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5838981|NCT02515188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838982|NCT02515188|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5659505|NCT03646617|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5659506|NCT03646617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659507|NCT03646526|Amitriptyline|amitriptyline|mesh-list
5659508|NCT03646526|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
5659509|NCT03646526|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5659510|NCT03646526|Antidepressive Agents|antidepressive agents|mesh-ancestor
5659511|NCT03646526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5659512|NCT03646526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5659513|NCT03646526|Analgesics|analgesics|mesh-ancestor
5659514|NCT03646526|Sensory System Agents|sensory system agents|mesh-ancestor
5659515|NCT03646526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5659516|NCT03646526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659517|NCT03646526|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5659518|NCT03646526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5659519|NCT03646526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5659520|NCT03646526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659521|NCT03646526|Adrenergic Agents|adrenergic agents|mesh-ancestor
5659522|NCT03646526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5659523|NCT03646526|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5659524|NCT03646526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5659525|NCT03646526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5659526|NCT03646500|Remifentanil|remifentanil|mesh-list
5659527|NCT03646500|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5659528|NCT03646500|Narcotics|narcotics|mesh-ancestor
5659529|NCT03646500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5659530|NCT03646500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659531|NCT03646500|Analgesics|analgesics|mesh-ancestor
5659532|NCT03646500|Sensory System Agents|sensory system agents|mesh-ancestor
5659533|NCT03646500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5659534|NCT03646474|Tranexamic Acid|tranexamic acid|mesh-list
5659535|NCT03646474|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5838983|NCT02515188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5838984|NCT02515188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5838985|NCT02515188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5838986|NCT02515188|Antipyretics|antipyretics|mesh-ancestor
5838987|NCT02514941|Acetaminophen|acetaminophen|mesh-list
5838988|NCT02514941|Amoxicillin|amoxicillin|mesh-list
5838989|NCT02514941|Talinolol|talinolol|mesh-list
5838990|NCT02514941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5838991|NCT02514941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5838992|NCT02514941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5838993|NCT02514941|Analgesics|analgesics|mesh-ancestor
5838994|NCT02514941|Sensory System Agents|sensory system agents|mesh-ancestor
5838995|NCT02514941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5838996|NCT02514941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5838997|NCT02514941|Antipyretics|antipyretics|mesh-ancestor
5838998|NCT02514941|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5838999|NCT02514941|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5839000|NCT02514941|Adrenergic Agents|adrenergic agents|mesh-ancestor
5839001|NCT02514941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5839002|NCT02514941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839003|NCT02514941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5839004|NCT02514941|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5839005|NCT02514980|Ketamine|ketamine|mesh-list
5839006|NCT02514980|Bupivacaine|bupivacaine|mesh-list
5839007|NCT02514980|Anesthetics, Local|anesthetics, local|mesh-ancestor
5839008|NCT02514980|Anesthetics|anesthetics|mesh-ancestor
5839009|NCT02514980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5839010|NCT02514980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839011|NCT02514980|Sensory System Agents|sensory system agents|mesh-ancestor
5839012|NCT02514980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5839013|NCT02514980|Analgesics|analgesics|mesh-ancestor
5659536|NCT03646474|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5659537|NCT03646474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659538|NCT03646474|Hemostatics|hemostatics|mesh-ancestor
5659539|NCT03646474|Coagulants|coagulants|mesh-ancestor
5839014|NCT02514980|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5839015|NCT02514980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5839016|NCT02514980|Anesthetics, General|anesthetics, general|mesh-ancestor
5839017|NCT02514980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5839018|NCT02514980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5839019|NCT02514980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5659540|NCT03646396|Sofosbuvir|sofosbuvir|mesh-list
5839020|NCT02514980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839021|NCT02514954|Insulin Lispro|insulin lispro|mesh-list
5839022|NCT02514954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5839023|NCT02514954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839024|NCT02514850|Insulin Lispro|insulin lispro|mesh-list
5839025|NCT02514850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5839026|NCT02514850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839027|NCT02514681|Gemcitabine|gemcitabine|mesh-list
5839028|NCT02514681|Paclitaxel|paclitaxel|mesh-list
5839029|NCT02514681|Vinorelbine|vinorelbine|mesh-list
5839030|NCT02514681|Docetaxel|docetaxel|mesh-list
5659541|NCT03646396|Antiviral Agents|antiviral agents|mesh-ancestor
5659542|NCT03646396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5659543|NCT03646370|Tenofovir|tenofovir|mesh-list
5659544|NCT03646370|Antiviral Agents|antiviral agents|mesh-ancestor
5659545|NCT03646370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5659546|NCT03646370|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5659547|NCT03646370|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5659548|NCT03646370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5659549|NCT03646370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659550|NCT03646370|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5659551|NCT03646370|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5659552|NCT03646357|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
5659553|NCT03646357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5659554|NCT03646357|Adrenergic Agents|adrenergic agents|mesh-ancestor
5659555|NCT03646357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5659556|NCT03646357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659557|NCT03646357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659558|NCT03646318|Ketanserin|ketanserin|mesh-list
5659559|NCT03646318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5659560|NCT03646318|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5659561|NCT03646318|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5659562|NCT03646318|Serotonin Agents|serotonin agents|mesh-ancestor
5659563|NCT03646318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5659564|NCT03646318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659565|NCT03646318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659566|NCT03646292|Pioglitazone|pioglitazone|mesh-list
5659567|NCT03646292|Empagliflozin|empagliflozin|mesh-list
5659568|NCT03646292|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5659569|NCT03646292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659570|NCT03646292|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5659571|NCT03646292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659572|NCT03646266|Bromides|bromides|mesh-list
5659573|NCT03646266|Rocuronium|rocuronium|mesh-list
5659574|NCT03646266|Anticonvulsants|anticonvulsants|mesh-ancestor
5659575|NCT03646266|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5659576|NCT03646266|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5659577|NCT03646266|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5659578|NCT03646266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5659579|NCT03646266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659580|NCT03646188|Doxorubicin|doxorubicin|mesh-list
5659581|NCT03646188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5659582|NCT03646188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5659583|NCT03646188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5659584|NCT03646188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5659585|NCT03646188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5659586|NCT03646188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5659587|NCT03646188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659588|NCT03646175|Choline|choline|mesh-list
5839031|NCT02514681|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5839032|NCT02514681|Capecitabine|capecitabine|mesh-list
5839033|NCT02514681|Trastuzumab|trastuzumab|mesh-list
5839034|NCT02514681|Pertuzumab|pertuzumab|mesh-list
5839035|NCT02514681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5839036|NCT02514681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5839037|NCT02514681|Tubulin Modulators|tubulin modulators|mesh-ancestor
5839038|NCT02514681|Antimitotic Agents|antimitotic agents|mesh-ancestor
5839039|NCT02514681|Mitosis Modulators|mitosis modulators|mesh-ancestor
5659589|NCT03646175|Lipotropic Agents|lipotropic agents|mesh-ancestor
5659590|NCT03646175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5659591|NCT03646175|Antimetabolites|antimetabolites|mesh-ancestor
5659592|NCT03646175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659593|NCT03646175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5839040|NCT02514681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839041|NCT02514681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5839042|NCT02514681|Antimetabolites|antimetabolites|mesh-ancestor
5839043|NCT02514681|Antiviral Agents|antiviral agents|mesh-ancestor
5839044|NCT02514681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5839045|NCT02514681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5839046|NCT02514681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5839047|NCT02514681|Immunologic Factors|immunologic factors|mesh-ancestor
5839048|NCT02514681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659594|NCT03646175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5659595|NCT03646175|Nootropic Agents|nootropic agents|mesh-ancestor
5659596|NCT03646058|Buprenorphine|buprenorphine|mesh-list
5659597|NCT03646058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5659598|NCT03646058|Narcotics|narcotics|mesh-ancestor
5659599|NCT03646058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5659600|NCT03646058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659601|NCT03646058|Analgesics|analgesics|mesh-ancestor
5839049|NCT02514681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5839050|NCT02514642|Clopidogrel|clopidogrel|mesh-list
5839051|NCT02514642|Ticagrelor|ticagrelor|mesh-list
5839052|NCT02514642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5839053|NCT02514642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5839054|NCT02514642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5839055|NCT02514642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5839056|NCT02514642|Purinergic Agents|purinergic agents|mesh-ancestor
5839057|NCT02514642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5839058|NCT02514642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839059|NCT02514642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839060|NCT02514655|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5839061|NCT02514655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5839062|NCT02514629|Metformin|metformin|mesh-list
5839063|NCT02514629|Methyltestosterone|methyltestosterone|mesh-list
5839064|NCT02514629|Testosterone|testosterone|mesh-list
5839065|NCT02514629|Testosterone undecanoate|testosterone undecanoate|mesh-list
5839066|NCT02514629|Testosterone enanthate|testosterone enanthate|mesh-list
5839067|NCT02514629|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5839068|NCT02514629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5839069|NCT02514629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839070|NCT02514629|Androgens|androgens|mesh-ancestor
5839071|NCT02514629|Hormones|hormones|mesh-ancestor
5839072|NCT02514629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5839073|NCT02514629|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5839074|NCT02514629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5839075|NCT02514629|Anabolic Agents|anabolic agents|mesh-ancestor
5659602|NCT03646058|Sensory System Agents|sensory system agents|mesh-ancestor
5659603|NCT03646058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5659604|NCT03646058|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5659605|NCT03646006|Bupivacaine|bupivacaine|mesh-list
5659606|NCT03646006|Anesthetics, Local|anesthetics, local|mesh-ancestor
5659607|NCT03646006|Anesthetics|anesthetics|mesh-ancestor
5659608|NCT03646006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5659609|NCT03646006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659610|NCT03646006|Sensory System Agents|sensory system agents|mesh-ancestor
5659611|NCT03646006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5839076|NCT02514538|Acetaminophen|acetaminophen|mesh-list
5839077|NCT02514538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5839078|NCT02514538|Analgesics|analgesics|mesh-ancestor
5839079|NCT02514538|Sensory System Agents|sensory system agents|mesh-ancestor
5839080|NCT02514538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5839081|NCT02514538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839082|NCT02514538|Antipyretics|antipyretics|mesh-ancestor
5839083|NCT02514278|Capecitabine|capecitabine|mesh-list
5839084|NCT02514278|Folfirinox|folfirinox|mesh-list
5839085|NCT02514278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5839086|NCT02514278|Antimetabolites|antimetabolites|mesh-ancestor
5839087|NCT02514278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839088|NCT02514278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5903157|NCT05131893|Docetaxel|docetaxel|mesh-list
5903158|NCT05131893|Cyclophosphamide|cyclophosphamide|mesh-list
6493675|NCT00614978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5659612|NCT03645980|Sorafenib|sorafenib|mesh-list
5659613|NCT03645980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5659614|NCT03645980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5659615|NCT03645980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5659616|NCT03645980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659617|NCT03645876|Capecitabine|capecitabine|mesh-list
5903159|NCT05131893|Capecitabine|capecitabine|mesh-list
5903160|NCT05131893|Trastuzumab|trastuzumab|mesh-list
5839089|NCT02514343|Magnesium Sulfate|magnesium sulfate|mesh-list
5839090|NCT02514343|Bupivacaine|bupivacaine|mesh-list
5839091|NCT02514343|Anesthetics, Local|anesthetics, local|mesh-ancestor
5839092|NCT02514343|Anesthetics|anesthetics|mesh-ancestor
5659618|NCT03645876|Oxaliplatin|oxaliplatin|mesh-list
5659619|NCT03645876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5659620|NCT03645876|Antimetabolites|antimetabolites|mesh-ancestor
5659621|NCT03645876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659622|NCT03645876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5659623|NCT03645850|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5659624|NCT03645850|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5659625|NCT03645668|Meropenem|meropenem|mesh-list
5659626|NCT03645668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5659627|NCT03645668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5659628|NCT03645642|Midodrine|midodrine|mesh-list
5659629|NCT03645642|Diuretics|diuretics|mesh-list
5659630|NCT03645642|Natriuretic Agents|natriuretic agents|mesh-ancestor
5659631|NCT03645642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659632|NCT03645642|Sympathomimetics|sympathomimetics|mesh-ancestor
5659633|NCT03645642|Autonomic Agents|autonomic agents|mesh-ancestor
5659634|NCT03645642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5659635|NCT03645642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5659636|NCT03645642|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5659637|NCT03645642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5839093|NCT02514343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5839094|NCT02514343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839095|NCT02514343|Sensory System Agents|sensory system agents|mesh-ancestor
5839096|NCT02514343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5839097|NCT02514343|Analgesics|analgesics|mesh-ancestor
5839098|NCT02514343|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5839099|NCT02514343|Anticonvulsants|anticonvulsants|mesh-ancestor
5839100|NCT02514343|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5839101|NCT02514343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5839102|NCT02514343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839103|NCT02514343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5839104|NCT02514343|Tocolytic Agents|tocolytic agents|mesh-ancestor
5839105|NCT02514343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5839106|NCT02514330|Dihydrotachysterol|dihydrotachysterol|mesh-list
5839107|NCT02514330|Vitamins|vitamins|mesh-ancestor
5839108|NCT02514330|Micronutrients|micronutrients|mesh-ancestor
5839109|NCT02514330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839110|NCT02514330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5659638|NCT03645642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5659639|NCT03645642|Adrenergic Agents|adrenergic agents|mesh-ancestor
5659640|NCT03645642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5659641|NCT03645642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695174|NCT03391193|Vaccines|vaccines|mesh-list
5695175|NCT03391193|Immunologic Factors|immunologic factors|mesh-ancestor
5695176|NCT03391193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695177|NCT03391050|Dabrafenib|dabrafenib|mesh-list
5695178|NCT03391050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5695179|NCT03391050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5839111|NCT02514421|Gemcitabine|gemcitabine|mesh-list
5839112|NCT02514421|Paclitaxel|paclitaxel|mesh-list
5839113|NCT02514421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5839114|NCT02514421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5839115|NCT02514421|Tubulin Modulators|tubulin modulators|mesh-ancestor
5839116|NCT02514421|Antimitotic Agents|antimitotic agents|mesh-ancestor
5839117|NCT02514421|Mitosis Modulators|mitosis modulators|mesh-ancestor
5839118|NCT02514421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839119|NCT02514421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5839120|NCT02514421|Antimetabolites|antimetabolites|mesh-ancestor
5839121|NCT02514421|Antiviral Agents|antiviral agents|mesh-ancestor
5839122|NCT02514421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5839123|NCT02514421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5839124|NCT02514421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5839125|NCT02514421|Immunologic Factors|immunologic factors|mesh-ancestor
5839126|NCT02514421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839127|NCT02514200|Riboflavin|riboflavin|mesh-list
5839128|NCT02514200|Vitamin B Complex|vitamin b complex|mesh-ancestor
5839129|NCT02514200|Vitamins|vitamins|mesh-ancestor
5839130|NCT02514200|Micronutrients|micronutrients|mesh-ancestor
5839131|NCT02514200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695180|NCT03391050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5697984|NCT03372265|Sensory System Agents|sensory system agents|mesh-ancestor
5839132|NCT02514200|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5839133|NCT02514200|Dermatologic Agents|dermatologic agents|mesh-ancestor
5839134|NCT02514018|Vaccines|vaccines|mesh-list
5839135|NCT02514018|Immunologic Factors|immunologic factors|mesh-ancestor
5659642|NCT03645304|Ropivacaine|ropivacaine|mesh-list
5659643|NCT03645304|Anesthetics, Local|anesthetics, local|mesh-ancestor
5659644|NCT03645304|Anesthetics|anesthetics|mesh-ancestor
5659645|NCT03645304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5659646|NCT03645304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659647|NCT03645304|Sensory System Agents|sensory system agents|mesh-ancestor
5659648|NCT03645304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5659649|NCT03645200|Apatinib|apatinib|mesh-list
5659650|NCT03645200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5659651|NCT03645200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5659652|NCT03645200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5659653|NCT03645200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659654|NCT03645187|Celecoxib|celecoxib|mesh-list
5659655|NCT03645187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5659656|NCT03645187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5659657|NCT03645187|Analgesics|analgesics|mesh-ancestor
5659658|NCT03645187|Sensory System Agents|sensory system agents|mesh-ancestor
5659659|NCT03645187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5839136|NCT02514018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839137|NCT02513875|Vitamin D|vitamin d|mesh-list
5839138|NCT02513875|Vitamins|vitamins|mesh-ancestor
5839139|NCT02513875|Micronutrients|micronutrients|mesh-ancestor
5839140|NCT02513875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839141|NCT02513875|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5839142|NCT02513849|Tamoxifen|tamoxifen|mesh-list
5839143|NCT02513849|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5839144|NCT02513849|Hormone Antagonists|hormone antagonists|mesh-ancestor
5659660|NCT03645187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659661|NCT03645187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5659662|NCT03645187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5659663|NCT03645187|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5659664|NCT03645187|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5659665|NCT03645187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5659666|NCT03645187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659667|NCT03645109|Vitamin D|vitamin d|mesh-list
5839145|NCT02513849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5839146|NCT02513849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839147|NCT02513849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5839148|NCT02513849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5839149|NCT02513849|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5839150|NCT02513849|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5839151|NCT02513849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5839152|NCT02513862|Heparin|heparin|mesh-list
5839153|NCT02513862|Protamines|protamines|mesh-list
5839154|NCT02513862|Anticoagulants|anticoagulants|mesh-ancestor
5839155|NCT02513862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5839156|NCT02513862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5839157|NCT02513862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839158|NCT02513862|Heparin Antagonists|heparin antagonists|mesh-ancestor
5839159|NCT02513862|Coagulants|coagulants|mesh-ancestor
5839160|NCT02513927|Metoprolol|metoprolol|mesh-list
5839161|NCT02513927|Nifedipine|nifedipine|mesh-list
5839162|NCT02513927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5839163|NCT02513927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5839164|NCT02513927|Sympatholytics|sympatholytics|mesh-ancestor
5839165|NCT02513927|Autonomic Agents|autonomic agents|mesh-ancestor
5839166|NCT02513927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5839167|NCT02513927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839168|NCT02513927|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5839169|NCT02513927|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5839170|NCT02513927|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5839171|NCT02513927|Adrenergic Agents|adrenergic agents|mesh-ancestor
5839172|NCT02513927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5839173|NCT02513927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839174|NCT02513927|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5839175|NCT02513927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5839176|NCT02513927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5659668|NCT03645109|Cholecalciferol|cholecalciferol|mesh-list
5659669|NCT03645109|Vitamins|vitamins|mesh-ancestor
5659670|NCT03645109|Micronutrients|micronutrients|mesh-ancestor
5659671|NCT03645109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839177|NCT02513927|Vasodilator Agents|vasodilator agents|mesh-ancestor
5659672|NCT03645109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5659673|NCT03645109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5659674|NCT03645057|Tacrolimus|tacrolimus|mesh-list
5659675|NCT03645057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5659676|NCT03645057|Immunologic Factors|immunologic factors|mesh-ancestor
5659677|NCT03645057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659678|NCT03645057|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5659679|NCT03645057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5659680|NCT03645057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659681|NCT03644966|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5659682|NCT03644966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5659683|NCT03644823|Atezolizumab|atezolizumab|mesh-list
5659684|NCT03644823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5659685|NCT03644706|Potassium Citrate|potassium citrate|mesh-list
5659686|NCT03644706|Diuretics|diuretics|mesh-ancestor
5659687|NCT03644706|Natriuretic Agents|natriuretic agents|mesh-ancestor
5839178|NCT02513927|Tocolytic Agents|tocolytic agents|mesh-ancestor
5839179|NCT02513927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5839180|NCT02513654|Lamotrigine|lamotrigine|mesh-list
5839181|NCT02513654|Anticonvulsants|anticonvulsants|mesh-ancestor
5839182|NCT02513654|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5839183|NCT02513654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5839184|NCT02513654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839185|NCT02513654|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5839186|NCT02513654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839187|NCT02513654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5839188|NCT02513654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5839189|NCT02513654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5839190|NCT02513654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5839191|NCT02513654|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5839192|NCT02513888|Vitamin D|vitamin d|mesh-list
5839193|NCT02513888|Vitamins|vitamins|mesh-ancestor
5839194|NCT02513888|Micronutrients|micronutrients|mesh-ancestor
5839195|NCT02513888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659688|NCT03644706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659689|NCT03644706|Expectorants|expectorants|mesh-ancestor
5659690|NCT03644706|Respiratory System Agents|respiratory system agents|mesh-ancestor
5659691|NCT03644667|Mycophenolic Acid|mycophenolic acid|mesh-list
5659692|NCT03644667|Prednisone|prednisone|mesh-list
5659693|NCT03644667|Methylprednisolone|methylprednisolone|mesh-list
5659694|NCT03644667|Tacrolimus|tacrolimus|mesh-list
5659695|NCT03644667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
5659696|NCT03644667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5659697|NCT03644667|Glucocorticoids|glucocorticoids|mesh-ancestor
5659698|NCT03644667|Hormones|hormones|mesh-ancestor
5659699|NCT03644667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5659700|NCT03644667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659701|NCT03644667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5659702|NCT03644667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5659703|NCT03644667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5659704|NCT03644667|Immunologic Factors|immunologic factors|mesh-ancestor
5659705|NCT03644667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5659706|NCT03644667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659707|NCT03644667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5839196|NCT02513888|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5839197|NCT02513693|Rocuronium|rocuronium|mesh-list
5839198|NCT02513693|Neostigmine|neostigmine|mesh-list
5839199|NCT02513693|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5839200|NCT02513693|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5839201|NCT02513693|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5839202|NCT02513693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5839203|NCT02513693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839204|NCT02513693|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5839205|NCT02513693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5839206|NCT02513693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839207|NCT02513693|Cholinergic Agents|cholinergic agents|mesh-ancestor
5839208|NCT02513693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5839209|NCT02513693|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5839210|NCT02513693|Autonomic Agents|autonomic agents|mesh-ancestor
5839211|NCT02513433|Bupivacaine|bupivacaine|mesh-list
5839212|NCT02513433|Ropivacaine|ropivacaine|mesh-list
5839213|NCT02513433|Levobupivacaine|levobupivacaine|mesh-list
5839214|NCT02513433|Anesthetics, Local|anesthetics, local|mesh-ancestor
5839215|NCT02513433|Anesthetics|anesthetics|mesh-ancestor
5839216|NCT02513433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5659708|NCT03644667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5839217|NCT02513433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839218|NCT02513433|Sensory System Agents|sensory system agents|mesh-ancestor
5839219|NCT02513433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5839220|NCT02513381|Vitamin D|vitamin d|mesh-list
5839221|NCT02513381|Cholecalciferol|cholecalciferol|mesh-list
5839222|NCT02513381|Vitamins|vitamins|mesh-ancestor
5839223|NCT02513381|Micronutrients|micronutrients|mesh-ancestor
5839224|NCT02513381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839225|NCT02513381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5839226|NCT02513381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5839227|NCT02513394|Palbociclib|palbociclib|mesh-list
5839228|NCT02513394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5839229|NCT02513394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5839230|NCT02513394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5839231|NCT02513394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659709|NCT03644667|Antitubercular Agents|antitubercular agents|mesh-ancestor
5659710|NCT03644667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5659711|NCT03644667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5659712|NCT03644667|Antiemetics|antiemetics|mesh-ancestor
5659713|NCT03644667|Autonomic Agents|autonomic agents|mesh-ancestor
5659714|NCT03644667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5659715|NCT03644667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5659716|NCT03644667|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5659717|NCT03644667|Protective Agents|protective agents|mesh-ancestor
5659718|NCT03644641|Propofol|propofol|mesh-list
5659719|NCT03644641|Desflurane|desflurane|mesh-list
5659720|NCT03644641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5659721|NCT03644641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5659722|NCT03644641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659723|NCT03644641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5659724|NCT03644641|Anesthetics, General|anesthetics, general|mesh-ancestor
5659725|NCT03644641|Anesthetics|anesthetics|mesh-ancestor
5839232|NCT02513355|Cisplatin|cisplatin|mesh-list
5839233|NCT02513355|Endostar protein|endostar protein|mesh-list
5839234|NCT02513355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5839235|NCT02513355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5839236|NCT02513355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5659726|NCT03644641|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5659727|NCT03644589|Pembrolizumab|pembrolizumab|mesh-list
5659728|NCT03644589|Immunoglobulins|immunoglobulins|mesh-list
5659729|NCT03644589|Immunoglobulin G|immunoglobulin g|mesh-list
5659730|NCT03644589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5659731|NCT03644589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5659732|NCT03644589|Immunologic Factors|immunologic factors|mesh-ancestor
5659733|NCT03644589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659734|NCT03644576|Pseudoephedrine|pseudoephedrine|mesh-list
5659735|NCT03644576|Ephedrine|ephedrine|mesh-list
5659736|NCT03644576|Ozanimod|ozanimod|mesh-list
5659737|NCT03644576|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5659738|NCT03644576|Autonomic Agents|autonomic agents|mesh-ancestor
5839237|NCT02513355|Growth Substances|growth substances|mesh-ancestor
5839238|NCT02513355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839239|NCT02513355|Growth Inhibitors|growth inhibitors|mesh-ancestor
5839240|NCT02513290|Loratadine|loratadine|mesh-list
5839241|NCT02513290|Antipruritics|antipruritics|mesh-ancestor
5839242|NCT02513290|Dermatologic Agents|dermatologic agents|mesh-ancestor
5839243|NCT02513290|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5839244|NCT02513290|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5839245|NCT02513290|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5839246|NCT02513290|Histamine Antagonists|histamine antagonists|mesh-ancestor
5839247|NCT02513290|Histamine Agents|histamine agents|mesh-ancestor
5839248|NCT02513290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5839249|NCT02513290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839250|NCT02513290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839251|NCT02513342|Docetaxel|docetaxel|mesh-list
5839252|NCT02513342|Endostar protein|endostar protein|mesh-list
5839253|NCT02513342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5839254|NCT02513342|Tubulin Modulators|tubulin modulators|mesh-ancestor
5839255|NCT02513342|Antimitotic Agents|antimitotic agents|mesh-ancestor
5839256|NCT02513342|Mitosis Modulators|mitosis modulators|mesh-ancestor
5839257|NCT02513342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839258|NCT02513342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5839259|NCT02513342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5659739|NCT03644576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5659740|NCT03644576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659741|NCT03644576|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5659742|NCT03644576|Respiratory System Agents|respiratory system agents|mesh-ancestor
5839260|NCT02513342|Growth Substances|growth substances|mesh-ancestor
5839261|NCT02513342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839262|NCT02513342|Growth Inhibitors|growth inhibitors|mesh-ancestor
5839263|NCT02513004|Clopidogrel|clopidogrel|mesh-list
5839264|NCT02513004|Ticagrelor|ticagrelor|mesh-list
5839265|NCT02513004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5839266|NCT02513004|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5839267|NCT02513004|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5839268|NCT02513004|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5839269|NCT02513004|Purinergic Agents|purinergic agents|mesh-ancestor
5839270|NCT02513004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5839271|NCT02513004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839272|NCT02513004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839273|NCT02512926|Cyclophosphamide|cyclophosphamide|mesh-list
5839274|NCT02512926|Etoposide|etoposide|mesh-list
5839275|NCT02512926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5839276|NCT02512926|Immunologic Factors|immunologic factors|mesh-ancestor
5659743|NCT03644576|Nasal Decongestants|nasal decongestants|mesh-ancestor
5659744|NCT03644576|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5839277|NCT02512926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839278|NCT02512926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5839279|NCT02512926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5839280|NCT02512926|Alkylating Agents|alkylating agents|mesh-ancestor
5839281|NCT02512926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659745|NCT03644576|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5659746|NCT03644576|Sympathomimetics|sympathomimetics|mesh-ancestor
5659747|NCT03644576|Adrenergic Agents|adrenergic agents|mesh-ancestor
5659748|NCT03644576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5659749|NCT03644576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659750|NCT03644576|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5659751|NCT03644576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5659752|NCT03644576|Immunologic Factors|immunologic factors|mesh-ancestor
5659753|NCT03644511|Sorafenib|sorafenib|mesh-list
5659754|NCT03644511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5659755|NCT03644511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5659756|NCT03644511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5659757|NCT03644511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659758|NCT03644446|Bisoprolol|bisoprolol|mesh-list
5839282|NCT02512926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5839283|NCT02512926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5839284|NCT02512926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5839285|NCT02512926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5839286|NCT02512926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5659759|NCT03644446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5659760|NCT03644446|Sympatholytics|sympatholytics|mesh-ancestor
5659761|NCT03644446|Autonomic Agents|autonomic agents|mesh-ancestor
5659762|NCT03644446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5659763|NCT03644446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659764|NCT03644446|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5659765|NCT03644446|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5659766|NCT03644446|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5659767|NCT03644446|Adrenergic Agents|adrenergic agents|mesh-ancestor
5659768|NCT03644446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5659769|NCT03644446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659770|NCT03644264|Sevelamer|sevelamer|mesh-list
5659771|NCT03644264|Chelating Agents|chelating agents|mesh-ancestor
5659772|NCT03644264|Sequestering Agents|sequestering agents|mesh-ancestor
5659773|NCT03644264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659774|NCT03644147|Acetaminophen|acetaminophen|mesh-list
5659775|NCT03644147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5659776|NCT03644147|Analgesics|analgesics|mesh-ancestor
5659777|NCT03644147|Sensory System Agents|sensory system agents|mesh-ancestor
5659778|NCT03644147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5659779|NCT03644147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659780|NCT03644147|Antipyretics|antipyretics|mesh-ancestor
5695181|NCT03391050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695182|NCT03390972|Dexmedetomidine|dexmedetomidine|mesh-list
5695183|NCT03390972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5695184|NCT03390972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5695185|NCT03390972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695186|NCT03390972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5695187|NCT03390972|Analgesics|analgesics|mesh-ancestor
5695188|NCT03390972|Sensory System Agents|sensory system agents|mesh-ancestor
5659781|NCT03643913|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
5659782|NCT03643913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5659783|NCT03643913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5659784|NCT03643913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659785|NCT03643900|Indomethacin|indomethacin|mesh-list
5659786|NCT03643900|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5659787|NCT03643900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5659788|NCT03643900|Analgesics|analgesics|mesh-ancestor
5839287|NCT02512926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5839288|NCT02513147|Lopinavir|lopinavir|mesh-list
5839289|NCT02513147|Atazanavir Sulfate|atazanavir sulfate|mesh-list
5839290|NCT02513147|Darunavir|darunavir|mesh-list
5839291|NCT02513147|Fosamprenavir|fosamprenavir|mesh-list
5839292|NCT02513147|Dolutegravir|dolutegravir|mesh-list
5839293|NCT02513147|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5839294|NCT02513147|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5839295|NCT02513147|Protease Inhibitors|protease inhibitors|mesh-ancestor
5839296|NCT02513147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5839297|NCT02513147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839298|NCT02513147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5839299|NCT02513147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5839300|NCT02513147|Antiviral Agents|antiviral agents|mesh-ancestor
5839301|NCT02513147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5839302|NCT02513147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5839303|NCT02513147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5839304|NCT02513147|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5839305|NCT02513147|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5659789|NCT03643900|Sensory System Agents|sensory system agents|mesh-ancestor
5659790|NCT03643900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5659791|NCT03643900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659792|NCT03643900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5659793|NCT03643900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5659794|NCT03643900|Gout Suppressants|gout suppressants|mesh-ancestor
5659795|NCT03643900|Tocolytic Agents|tocolytic agents|mesh-ancestor
5659796|NCT03643900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5659797|NCT03643900|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5659798|NCT03643900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5659799|NCT03643900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659800|NCT03643874|Albuterol|albuterol|mesh-list
5659801|NCT03643874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5659802|NCT03643874|Autonomic Agents|autonomic agents|mesh-ancestor
5659803|NCT03643874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5659804|NCT03643874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659805|NCT03643874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5659806|NCT03643874|Respiratory System Agents|respiratory system agents|mesh-ancestor
5659807|NCT03643874|Tocolytic Agents|tocolytic agents|mesh-ancestor
5659808|NCT03643874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5659809|NCT03643874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5659810|NCT03643874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5659811|NCT03643874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5659812|NCT03643874|Adrenergic Agents|adrenergic agents|mesh-ancestor
5659813|NCT03643874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5659814|NCT03643874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659815|NCT03643757|Bupivacaine|bupivacaine|mesh-list
5659816|NCT03643757|Anesthetics, Local|anesthetics, local|mesh-ancestor
5659817|NCT03643757|Anesthetics|anesthetics|mesh-ancestor
5659818|NCT03643757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5659819|NCT03643757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659820|NCT03643757|Sensory System Agents|sensory system agents|mesh-ancestor
5659821|NCT03643757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5659822|NCT03643666|Dexamethasone|dexamethasone|mesh-list
5659823|NCT03643666|Magnesium Sulfate|magnesium sulfate|mesh-list
5659824|NCT03643666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5659825|NCT03643666|Antiemetics|antiemetics|mesh-ancestor
5659826|NCT03643666|Autonomic Agents|autonomic agents|mesh-ancestor
5839306|NCT02513069|Nicotine|nicotine|mesh-list
5839307|NCT02513069|Carbon Monoxide|carbon monoxide|mesh-list
5839308|NCT02513069|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5839309|NCT02513069|Autonomic Agents|autonomic agents|mesh-ancestor
5839310|NCT02513069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5659827|NCT03643666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5659828|NCT03643666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839311|NCT02513069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839312|NCT02513069|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5839313|NCT02513069|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5839314|NCT02513069|Cholinergic Agents|cholinergic agents|mesh-ancestor
5839315|NCT02513069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5839316|NCT02513069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839317|NCT02513069|Antimetabolites|antimetabolites|mesh-ancestor
5839318|NCT02513069|Gasotransmitters|gasotransmitters|mesh-ancestor
5839319|NCT02512887|Anesthetics|anesthetics|mesh-list
5839320|NCT02512887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5839321|NCT02512887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839322|NCT02512562|Simeprevir|simeprevir|mesh-list
5839323|NCT02512562|Odalasvir|odalasvir|mesh-list
5839324|NCT02512562|Antiviral Agents|antiviral agents|mesh-ancestor
5839325|NCT02512562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5839326|NCT02512562|Protease Inhibitors|protease inhibitors|mesh-ancestor
5839327|NCT02512562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5839328|NCT02512562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839329|NCT02512536|Botulinum Toxins|botulinum toxins|mesh-list
5839330|NCT02512536|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5659829|NCT03643666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5659830|NCT03643666|Glucocorticoids|glucocorticoids|mesh-ancestor
5659831|NCT03643666|Hormones|hormones|mesh-ancestor
5659832|NCT03643666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5659833|NCT03643666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5659834|NCT03643666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5659835|NCT03643666|Analgesics|analgesics|mesh-ancestor
5659836|NCT03643666|Sensory System Agents|sensory system agents|mesh-ancestor
5659837|NCT03643666|Anesthetics|anesthetics|mesh-ancestor
5659838|NCT03643666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5659839|NCT03643666|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5659840|NCT03643666|Anticonvulsants|anticonvulsants|mesh-ancestor
5659841|NCT03643666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5659842|NCT03643666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5659843|NCT03643666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659844|NCT03643666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5659845|NCT03643666|Tocolytic Agents|tocolytic agents|mesh-ancestor
5659846|NCT03643666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5659847|NCT03643588|Hyaluronic Acid|hyaluronic acid|mesh-list
5659848|NCT03643588|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5659849|NCT03643588|Immunologic Factors|immunologic factors|mesh-ancestor
5659850|NCT03643588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659851|NCT03643588|Viscosupplements|viscosupplements|mesh-ancestor
5659852|NCT03643588|Protective Agents|protective agents|mesh-ancestor
5659853|NCT03643549|Temozolomide|temozolomide|mesh-list
5659854|NCT03643549|Bortezomib|bortezomib|mesh-list
5659855|NCT03643549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5659856|NCT03643549|Alkylating Agents|alkylating agents|mesh-ancestor
5659857|NCT03643549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659858|NCT03643549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5659859|NCT03643510|Fulvestrant|fulvestrant|mesh-list
5659860|NCT03643510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5659861|NCT03643510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5659862|NCT03643510|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5659863|NCT03643510|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5659864|NCT03643510|Hormone Antagonists|hormone antagonists|mesh-ancestor
5659865|NCT03643510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5659866|NCT03643510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659867|NCT03643497|Meropenem|meropenem|mesh-list
5659868|NCT03643497|Linezolid|linezolid|mesh-list
5659869|NCT03643497|Anti-Infective Agents|anti-infective agents|mesh-list
5659870|NCT03643497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5659871|NCT03643497|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5659872|NCT03643497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5659873|NCT03643497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659874|NCT03643367|Propofol|propofol|mesh-list
5659875|NCT03643367|Sevoflurane|sevoflurane|mesh-list
5659876|NCT03643367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5659877|NCT03643367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5659878|NCT03643367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659879|NCT03643367|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5659880|NCT03643367|Anesthetics, General|anesthetics, general|mesh-ancestor
5659881|NCT03643367|Anesthetics|anesthetics|mesh-ancestor
5659882|NCT03643367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5659883|NCT03643367|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5659884|NCT03643276|Cytarabine|cytarabine|mesh-list
5659885|NCT03643276|Dexamethasone|dexamethasone|mesh-list
5659886|NCT03643276|Prednisone|prednisone|mesh-list
5659887|NCT03643276|Prednisolone|prednisolone|mesh-list
5659888|NCT03643276|Cyclophosphamide|cyclophosphamide|mesh-list
5839331|NCT02512536|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5839332|NCT02512536|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5839333|NCT02512536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5839334|NCT02512536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839335|NCT02512536|Cholinergic Agents|cholinergic agents|mesh-ancestor
5839336|NCT02512536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5839337|NCT02512536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839338|NCT02512536|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5839339|NCT02512536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5839340|NCT02512718|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
5839341|NCT02512718|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
5839342|NCT02512718|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5839343|NCT02512718|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5839344|NCT02512497|Vidarabine|vidarabine|mesh-list
5839345|NCT02512497|Fludarabine|fludarabine|mesh-list
5839346|NCT02512497|Fludarabine phosphate|fludarabine phosphate|mesh-list
5839347|NCT02512497|Busulfan|busulfan|mesh-list
5839348|NCT02512497|Romidepsin|romidepsin|mesh-list
5839349|NCT02512497|Thymoglobulin|thymoglobulin|mesh-list
5839350|NCT02512497|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5839351|NCT02512497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5839352|NCT02512497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5839353|NCT02512497|Antimetabolites|antimetabolites|mesh-ancestor
5839354|NCT02512497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839355|NCT02512497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5839356|NCT02512497|Immunologic Factors|immunologic factors|mesh-ancestor
5839357|NCT02512497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839358|NCT02512497|Antiviral Agents|antiviral agents|mesh-ancestor
5839359|NCT02512497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5839360|NCT02512497|Alkylating Agents|alkylating agents|mesh-ancestor
5839361|NCT02512497|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5839362|NCT02512497|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5839363|NCT02512497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5903161|NCT05131893|Letrozole|letrozole|mesh-list
5903162|NCT05131893|Epirubicin|epirubicin|mesh-list
5903163|NCT05131893|Goserelin|goserelin|mesh-list
5903164|NCT05131893|Pertuzumab|pertuzumab|mesh-list
5903165|NCT05131893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5903166|NCT05131893|Tubulin Modulators|tubulin modulators|mesh-ancestor
5903167|NCT05131893|Antimitotic Agents|antimitotic agents|mesh-ancestor
5903168|NCT05131893|Mitosis Modulators|mitosis modulators|mesh-ancestor
5903169|NCT05131893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659889|NCT03643276|Ifosfamide|ifosfamide|mesh-list
5659890|NCT03643276|Doxorubicin|doxorubicin|mesh-list
5659891|NCT03643276|Methotrexate|methotrexate|mesh-list
5659892|NCT03643276|Fludarabine|fludarabine|mesh-list
5659893|NCT03643276|Fludarabine phosphate|fludarabine phosphate|mesh-list
5659894|NCT03643276|Etoposide|etoposide|mesh-list
5659895|NCT03643276|Vincristine|vincristine|mesh-list
5659896|NCT03643276|Bortezomib|bortezomib|mesh-list
5659897|NCT03643276|Daunorubicin|daunorubicin|mesh-list
5659898|NCT03643276|Mercaptopurine|mercaptopurine|mesh-list
5659899|NCT03643276|Pegaspargase|pegaspargase|mesh-list
5659900|NCT03643276|Blinatumomab|blinatumomab|mesh-list
5659901|NCT03643276|Vindesine|vindesine|mesh-list
5659902|NCT03643276|Asparaginase|asparaginase|mesh-list
5659903|NCT03643276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5659904|NCT03643276|Immunologic Factors|immunologic factors|mesh-ancestor
5659905|NCT03643276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659906|NCT03643276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5659907|NCT03643276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5659908|NCT03643276|Alkylating Agents|alkylating agents|mesh-ancestor
5659909|NCT03643276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659910|NCT03643276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5659911|NCT03643276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5659912|NCT03643276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5659913|NCT03643276|Antiemetics|antiemetics|mesh-ancestor
5659914|NCT03643276|Autonomic Agents|autonomic agents|mesh-ancestor
5659915|NCT03643276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5659916|NCT03643276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5659917|NCT03643276|Glucocorticoids|glucocorticoids|mesh-ancestor
5659918|NCT03643276|Hormones|hormones|mesh-ancestor
5659919|NCT03643276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5659920|NCT03643276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5659921|NCT03643276|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5659922|NCT03643276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5659923|NCT03643276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5659924|NCT03643276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5659925|NCT03643276|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5659926|NCT03643276|Abortifacient Agents|abortifacient agents|mesh-ancestor
5659927|NCT03643276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5659928|NCT03643276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5659929|NCT03643276|Antimetabolites|antimetabolites|mesh-ancestor
5659930|NCT03643276|Dermatologic Agents|dermatologic agents|mesh-ancestor
5659931|NCT03643276|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5659932|NCT03643276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5659933|NCT03643276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5659934|NCT03643276|Antiviral Agents|antiviral agents|mesh-ancestor
5659935|NCT03643276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5659936|NCT03643276|Tubulin Modulators|tubulin modulators|mesh-ancestor
5659937|NCT03643276|Antimitotic Agents|antimitotic agents|mesh-ancestor
5839364|NCT02512601|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
5839365|NCT02512601|Anticoagulants|anticoagulants|mesh-ancestor
5839366|NCT02512601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5839367|NCT02512601|Antimetabolites|antimetabolites|mesh-ancestor
5839368|NCT02512601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839369|NCT02512601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5839370|NCT02512601|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5839371|NCT02512601|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5839372|NCT02512601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5839373|NCT02512601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839374|NCT02512614|Anti-Infective Agents|anti-infective agents|mesh-list
5839375|NCT02512614|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5839376|NCT02512471|Ropivacaine|ropivacaine|mesh-list
5839377|NCT02512471|Anesthetics, Local|anesthetics, local|mesh-ancestor
5839378|NCT02512471|Anesthetics|anesthetics|mesh-ancestor
5839379|NCT02512471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5839380|NCT02512471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839381|NCT02512471|Sensory System Agents|sensory system agents|mesh-ancestor
5839382|NCT02512471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5839383|NCT02512523|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5839384|NCT02512523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5839385|NCT02512523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839386|NCT02512523|Incretins|incretins|mesh-ancestor
5839387|NCT02512523|Hormones|hormones|mesh-ancestor
6674616|NCT01570569|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6674617|NCT01570569|Purinergic Agents|purinergic agents|mesh-ancestor
5839388|NCT02512523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5839389|NCT02512523|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5839390|NCT02512523|Protease Inhibitors|protease inhibitors|mesh-ancestor
5659938|NCT03643276|Mitosis Modulators|mitosis modulators|mesh-ancestor
5659939|NCT03643198|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5659940|NCT03643198|Metronidazole|metronidazole|mesh-list
5659941|NCT03643198|Ciprofloxacin|ciprofloxacin|mesh-list
5659942|NCT03643198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5659943|NCT03643198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5659944|NCT03643198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5659945|NCT03643198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5659946|NCT03643198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5659947|NCT03643198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5659948|NCT03643198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659949|NCT03643198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5659950|NCT03643198|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5659951|NCT03643198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5659952|NCT03643133|Mifamurtide|mifamurtide|mesh-list
5659953|NCT03643133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5659954|NCT03643133|Immunologic Factors|immunologic factors|mesh-ancestor
5659955|NCT03643133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659956|NCT03643107|Prednisolone|prednisolone|mesh-list
5659957|NCT03643107|Irofulven|irofulven|mesh-list
5659958|NCT03643107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5659959|NCT03643107|Glucocorticoids|glucocorticoids|mesh-ancestor
5659960|NCT03643107|Hormones|hormones|mesh-ancestor
5659961|NCT03643107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5839391|NCT02512523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5839392|NCT02512523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839393|NCT02512380|Docetaxel|docetaxel|mesh-list
5839394|NCT02512380|Oxaliplatin|oxaliplatin|mesh-list
5839395|NCT02512380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5839396|NCT02512380|Tubulin Modulators|tubulin modulators|mesh-ancestor
5839397|NCT02512380|Antimitotic Agents|antimitotic agents|mesh-ancestor
5839398|NCT02512380|Mitosis Modulators|mitosis modulators|mesh-ancestor
5839399|NCT02512380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839400|NCT02512315|Cisplatin|cisplatin|mesh-list
5839401|NCT02512315|Docetaxel|docetaxel|mesh-list
5839402|NCT02512315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5839403|NCT02512315|Tubulin Modulators|tubulin modulators|mesh-ancestor
5659962|NCT03643107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659963|NCT03643107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5659964|NCT03643107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5659965|NCT03643107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5659966|NCT03643107|Alkylating Agents|alkylating agents|mesh-ancestor
5659967|NCT03643107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659968|NCT03642990|Niacinamide|niacinamide|mesh-list
5659969|NCT03642990|Niacin|niacin|mesh-list
5659970|NCT03642990|Nicotinic Acids|nicotinic acids|mesh-list
5659971|NCT03642990|Vitamin B Complex|vitamin b complex|mesh-ancestor
5659972|NCT03642990|Vitamins|vitamins|mesh-ancestor
5659973|NCT03642990|Micronutrients|micronutrients|mesh-ancestor
5659974|NCT03642990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659975|NCT03642990|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5659976|NCT03642990|Antimetabolites|antimetabolites|mesh-ancestor
5659977|NCT03642990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659978|NCT03642990|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5659979|NCT03642990|Vasodilator Agents|vasodilator agents|mesh-ancestor
5659980|NCT03642847|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5659981|NCT03642847|Immunologic Factors|immunologic factors|mesh-ancestor
5839404|NCT02512315|Antimitotic Agents|antimitotic agents|mesh-ancestor
5839405|NCT02512315|Mitosis Modulators|mitosis modulators|mesh-ancestor
5839406|NCT02512315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839407|NCT02512055|Atropine|atropine|mesh-list
5839408|NCT02512055|Ketamine|ketamine|mesh-list
5839409|NCT02512055|Analgesics|analgesics|mesh-ancestor
5659982|NCT03642847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659983|NCT03642665|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5659984|NCT03642665|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5659985|NCT03642665|Estradiol|estradiol|mesh-list
5659986|NCT03642665|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5659987|NCT03642665|Progesterone|progesterone|mesh-list
5659988|NCT03642665|Estrogens|estrogens|mesh-ancestor
5659989|NCT03642665|Hormones|hormones|mesh-ancestor
5659990|NCT03642665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5659991|NCT03642665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659992|NCT03642665|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5659993|NCT03642665|Contraceptive Agents|contraceptive agents|mesh-ancestor
5659994|NCT03642665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5659995|NCT03642665|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5659996|NCT03642665|Progestins|progestins|mesh-ancestor
5839410|NCT02512055|Sensory System Agents|sensory system agents|mesh-ancestor
5839411|NCT02512055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5839412|NCT02512055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839413|NCT02512055|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5839414|NCT02512055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5839415|NCT02512055|Anesthetics, General|anesthetics, general|mesh-ancestor
5839416|NCT02512055|Anesthetics|anesthetics|mesh-ancestor
5839417|NCT02512055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5839418|NCT02512055|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5839419|NCT02512055|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5839420|NCT02512055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5839421|NCT02512055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839422|NCT02512055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5839423|NCT02512055|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5839424|NCT02512055|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5839425|NCT02512055|Autonomic Agents|autonomic agents|mesh-ancestor
5839426|NCT02512055|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5839427|NCT02512055|Respiratory System Agents|respiratory system agents|mesh-ancestor
5839428|NCT02512055|Mydriatics|mydriatics|mesh-ancestor
5839429|NCT02512055|Parasympatholytics|parasympatholytics|mesh-ancestor
5839430|NCT02512055|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5839431|NCT02512055|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5839432|NCT02512055|Cholinergic Agents|cholinergic agents|mesh-ancestor
5839433|NCT02511873|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-list
5839434|NCT02511873|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5839435|NCT02511873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5839436|NCT02511873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5659997|NCT03642626|Vidarabine|vidarabine|mesh-list
5659998|NCT03642626|Cyclophosphamide|cyclophosphamide|mesh-list
5839437|NCT02511873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5659999|NCT03642626|Fludarabine|fludarabine|mesh-list
5839438|NCT02511795|Olaparib|olaparib|mesh-list
5839439|NCT02511795|Adavosertib|adavosertib|mesh-list
5660000|NCT03642626|Fludarabine phosphate|fludarabine phosphate|mesh-list
5660001|NCT03642626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5660002|NCT03642626|Immunologic Factors|immunologic factors|mesh-ancestor
5660003|NCT03642626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660004|NCT03642626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5839440|NCT02511795|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5839441|NCT02511795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5839442|NCT02511795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839443|NCT02511795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5839444|NCT02511613|Squalamine|squalamine|mesh-list
5839445|NCT02511613|Ranibizumab|ranibizumab|mesh-list
5839446|NCT02511613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5839447|NCT02511613|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5839448|NCT02511613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5839449|NCT02511613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5839450|NCT02511613|Growth Substances|growth substances|mesh-ancestor
5839451|NCT02511613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839452|NCT02511613|Growth Inhibitors|growth inhibitors|mesh-ancestor
5839453|NCT02511613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5839454|NCT02511613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5839455|NCT02511613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5660005|NCT03642626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5660006|NCT03642626|Alkylating Agents|alkylating agents|mesh-ancestor
5660007|NCT03642626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660008|NCT03642626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5660009|NCT03642626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5660010|NCT03642626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5660011|NCT03642626|Antimetabolites|antimetabolites|mesh-ancestor
5660012|NCT03642626|Antiviral Agents|antiviral agents|mesh-ancestor
5839456|NCT02511613|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5839457|NCT02511613|Protective Agents|protective agents|mesh-ancestor
5839458|NCT02511665|Metformin|metformin|mesh-list
5839459|NCT02511665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5839460|NCT02511665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839461|NCT02511847|Afatinib|afatinib|mesh-list
5839462|NCT02511847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5839463|NCT02511847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5839464|NCT02511847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5660013|NCT03642626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5660014|NCT03642600|Folic Acid|folic acid|mesh-list
5660015|NCT03642600|Inositol|inositol|mesh-list
5660016|NCT03642600|Liraglutide|liraglutide|mesh-list
5660017|NCT03642600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5660018|NCT03642600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660019|NCT03642600|Incretins|incretins|mesh-ancestor
5660020|NCT03642600|Hormones|hormones|mesh-ancestor
5660021|NCT03642600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5660022|NCT03642600|Hematinics|hematinics|mesh-ancestor
5839465|NCT02511847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839466|NCT02511639|Everolimus|everolimus|mesh-list
5839467|NCT02511639|Letrozole|letrozole|mesh-list
5839468|NCT02511639|Anastrozole|anastrozole|mesh-list
5839469|NCT02511639|Exemestane|exemestane|mesh-list
5839470|NCT02511639|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5839471|NCT02511639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5839472|NCT02511639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5839473|NCT02511639|Immunologic Factors|immunologic factors|mesh-ancestor
5839474|NCT02511639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839475|NCT02511639|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5839476|NCT02511639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5660023|NCT03642600|Vitamin B Complex|vitamin b complex|mesh-ancestor
5660024|NCT03642600|Vitamins|vitamins|mesh-ancestor
5660025|NCT03642600|Micronutrients|micronutrients|mesh-ancestor
5660026|NCT03642535|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5660027|NCT03642535|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5660028|NCT03642535|Dermatologic Agents|dermatologic agents|mesh-ancestor
5660029|NCT03642509|Rivaroxaban|rivaroxaban|mesh-list
5660030|NCT03642509|Apixaban|apixaban|mesh-list
5660031|NCT03642509|Edoxaban|edoxaban|mesh-list
5660032|NCT03642509|Dabigatran|dabigatran|mesh-list
5660033|NCT03642509|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5660034|NCT03642509|Antithrombins|antithrombins|mesh-ancestor
5660035|NCT03642509|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5660036|NCT03642509|Protease Inhibitors|protease inhibitors|mesh-ancestor
5660037|NCT03642509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5839477|NCT02511639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839478|NCT02511639|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5839479|NCT02511639|Hormone Antagonists|hormone antagonists|mesh-ancestor
5839480|NCT02511639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5660038|NCT03642509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660039|NCT03642509|Anticoagulants|anticoagulants|mesh-ancestor
5695189|NCT03390972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5695190|NCT03390972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5695191|NCT03390972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5839481|NCT02511639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5839482|NCT02511483|Propranolol|propranolol|mesh-list
5839483|NCT02511483|Morphine|morphine|mesh-list
5695192|NCT03390972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5695193|NCT03390972|Adrenergic Agents|adrenergic agents|mesh-ancestor
5695194|NCT03390972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5695195|NCT03390972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697985|NCT03372265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5697986|NCT03372239|Tryptophan|tryptophan|mesh-list
5697987|NCT03372239|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5697988|NCT03372239|Antidepressive Agents|antidepressive agents|mesh-ancestor
5697989|NCT03372239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5839484|NCT02511483|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5839485|NCT02511483|Narcotics|narcotics|mesh-ancestor
5839486|NCT02511483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5839487|NCT02511483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839488|NCT02511483|Analgesics|analgesics|mesh-ancestor
5697990|NCT03372200|Febuxostat|febuxostat|mesh-list
5697991|NCT03372200|Dotinurad|dotinurad|mesh-list
5697992|NCT03372200|Gout Suppressants|gout suppressants|mesh-ancestor
5697993|NCT03372200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5697994|NCT03372200|Uricosuric Agents|uricosuric agents|mesh-ancestor
5697995|NCT03372200|Renal Agents|renal agents|mesh-ancestor
5697996|NCT03372122|Chlorhexidine|chlorhexidine|mesh-list
5697997|NCT03372122|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5697998|NCT03372122|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5697999|NCT03372122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5698000|NCT03372122|Disinfectants|disinfectants|mesh-ancestor
5698001|NCT03372122|Dermatologic Agents|dermatologic agents|mesh-ancestor
5698002|NCT03372109|Calcium|calcium|mesh-list
5698003|NCT03372109|Turmeric extract|turmeric extract|mesh-list
5698004|NCT03372109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5698005|NCT03372109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839489|NCT02511483|Sensory System Agents|sensory system agents|mesh-ancestor
5839490|NCT02511483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5839491|NCT02511483|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5839492|NCT02511483|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5839493|NCT02511483|Adrenergic Agents|adrenergic agents|mesh-ancestor
5839494|NCT02511483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5839495|NCT02511483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839496|NCT02511483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5839497|NCT02511483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5839498|NCT02511483|Vasodilator Agents|vasodilator agents|mesh-ancestor
5839499|NCT02511704|Nicotine|nicotine|mesh-list
5839500|NCT02511704|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5839501|NCT02511704|Autonomic Agents|autonomic agents|mesh-ancestor
5839502|NCT02511704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5839503|NCT02511704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839504|NCT02511704|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5839505|NCT02511704|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5839506|NCT02511704|Cholinergic Agents|cholinergic agents|mesh-ancestor
5839507|NCT02511704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5839508|NCT02511704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839509|NCT02511574|Progesterone|progesterone|mesh-list
5839510|NCT02511574|Progestins|progestins|mesh-ancestor
5839511|NCT02511574|Hormones|hormones|mesh-ancestor
5839512|NCT02511574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5839513|NCT02511574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839514|NCT02511405|Bevacizumab|bevacizumab|mesh-list
5839515|NCT02511405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5839516|NCT02511405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5839517|NCT02511405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5698006|NCT03372109|Antioxidants|antioxidants|mesh-ancestor
5698007|NCT03372109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5698008|NCT03372109|Protective Agents|protective agents|mesh-ancestor
5698009|NCT03371992|Pembrolizumab|pembrolizumab|mesh-list
5839518|NCT02511405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5839519|NCT02511405|Growth Substances|growth substances|mesh-ancestor
5839520|NCT02511405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839521|NCT02511405|Growth Inhibitors|growth inhibitors|mesh-ancestor
5839522|NCT02511353|Ivermectin|ivermectin|mesh-list
5839523|NCT02511353|Piperaquine|piperaquine|mesh-list
5839524|NCT02511353|Artenimol|artenimol|mesh-list
5839525|NCT02511353|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5839526|NCT02511353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5839527|NCT02511353|Antimalarials|antimalarials|mesh-ancestor
5839528|NCT02511353|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5839529|NCT02511418|Simvastatin|simvastatin|mesh-list
5839530|NCT02511418|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5839531|NCT02511418|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5839532|NCT02511418|Antimetabolites|antimetabolites|mesh-ancestor
5839533|NCT02511418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839534|NCT02511418|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5839535|NCT02511418|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5839536|NCT02511418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5839537|NCT02511366|Caseins|caseins|mesh-list
5839538|NCT02511366|Chelating Agents|chelating agents|mesh-ancestor
5839539|NCT02511366|Sequestering Agents|sequestering agents|mesh-ancestor
5839540|NCT02511366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839541|NCT02511340|HH-GV-678|hh-gv-678|mesh-list
5839542|NCT02511340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5839543|NCT02511340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5839544|NCT02511340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839545|NCT02511327|Vaccines|vaccines|mesh-list
5839546|NCT02511327|Immunologic Factors|immunologic factors|mesh-ancestor
5839547|NCT02511327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839548|NCT02511223|Olaparib|olaparib|mesh-list
5839549|NCT02511223|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5839550|NCT02511223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5839551|NCT02511223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839552|NCT02511223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5839553|NCT02511145|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
5839554|NCT02511145|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5839555|NCT02511145|Dermatologic Agents|dermatologic agents|mesh-ancestor
5839556|NCT02511210|Anesthetics|anesthetics|mesh-list
5839557|NCT02511210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5839558|NCT02511210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839559|NCT02511054|Chloroquine|chloroquine|mesh-list
5839560|NCT02511054|Pyrimethamine|pyrimethamine|mesh-list
5839561|NCT02511054|Amebicides|amebicides|mesh-ancestor
5839562|NCT02511054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5839563|NCT02511054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5839564|NCT02511054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5839565|NCT02511054|Antimalarials|antimalarials|mesh-ancestor
5839566|NCT02511054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5839567|NCT02511054|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5839568|NCT02511054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5839569|NCT02511054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839570|NCT02511067|Ranibizumab|ranibizumab|mesh-list
5839571|NCT02511067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5839572|NCT02511067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5839573|NCT02511067|Growth Substances|growth substances|mesh-ancestor
5839574|NCT02511067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839575|NCT02511067|Growth Inhibitors|growth inhibitors|mesh-ancestor
5839576|NCT02511067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5839577|NCT02511132|Irinotecan|irinotecan|mesh-list
5660040|NCT03642366|Tadalafil|tadalafil|mesh-list
5660041|NCT03642366|Vasodilator Agents|vasodilator agents|mesh-ancestor
5660042|NCT03642366|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5660043|NCT03642366|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5660044|NCT03642366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5660045|NCT03642366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660046|NCT03642366|Urological Agents|urological agents|mesh-ancestor
5660047|NCT03642353|Listerine|listerine|mesh-list
5660048|NCT03642353|Triclosan|triclosan|mesh-list
5660049|NCT03642353|Sodium Fluoride|sodium fluoride|mesh-list
5660050|NCT03642353|Cariostatic Agents|cariostatic agents|mesh-ancestor
5660051|NCT03642353|Protective Agents|protective agents|mesh-ancestor
5660052|NCT03642353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660053|NCT03642353|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5660054|NCT03642353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5660055|NCT03642353|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5839578|NCT02511132|Temozolomide|temozolomide|mesh-list
5839579|NCT02511132|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5839580|NCT02511132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5839581|NCT02511132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5839582|NCT02511132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839583|NCT02511132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5839584|NCT02511132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5839585|NCT02511132|Alkylating Agents|alkylating agents|mesh-ancestor
5839586|NCT02510976|Prucalopride|prucalopride|mesh-list
5839587|NCT02510976|Laxatives|laxatives|mesh-ancestor
5839588|NCT02510976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5839589|NCT02510976|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
5839590|NCT02510976|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5839591|NCT02510976|Serotonin Agents|serotonin agents|mesh-ancestor
5839592|NCT02510976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5839593|NCT02510976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839594|NCT02510976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903170|NCT05131893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5903171|NCT05131893|Immunologic Factors|immunologic factors|mesh-ancestor
5903172|NCT05131893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903173|NCT05131893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5903174|NCT05131893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5903175|NCT05131893|Alkylating Agents|alkylating agents|mesh-ancestor
5903176|NCT05131893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5903177|NCT05131893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5903178|NCT05131893|Antimetabolites|antimetabolites|mesh-ancestor
5903179|NCT05131893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5903180|NCT05131893|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5903181|NCT05131893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5903182|NCT05131893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5903183|NCT05131893|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5903184|NCT05131893|Hormone Antagonists|hormone antagonists|mesh-ancestor
5903185|NCT05131893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5903186|NCT05131893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5903187|NCT05131893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5903188|NCT05131893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5903189|NCT05131893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5903190|NCT05131893|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5903191|NCT05131893|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5903192|NCT05131893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5903193|NCT05131867|Nimodipine|nimodipine|mesh-list
5903194|NCT05131867|Milrinone|milrinone|mesh-list
5903195|NCT05131867|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5903196|NCT05131867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5903197|NCT05131867|Vasodilator Agents|vasodilator agents|mesh-ancestor
5660056|NCT03642353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5660057|NCT03642353|Antimetabolites|antimetabolites|mesh-ancestor
5660058|NCT03642353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660059|NCT03642353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5660060|NCT03642184|Empagliflozin|empagliflozin|mesh-list
5660061|NCT03642184|Linagliptin|linagliptin|mesh-list
5903198|NCT05131867|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5903199|NCT05131867|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5903200|NCT05131867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5903201|NCT05131867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903202|NCT05131867|Protective Agents|protective agents|mesh-ancestor
5903203|NCT05131867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903204|NCT05131867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5903205|NCT05131867|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5903206|NCT05131867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5903207|NCT05131867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5903208|NCT05131841|Vinorelbine|vinorelbine|mesh-list
5903209|NCT05131841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5660062|NCT03642184|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5660063|NCT03642184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660064|NCT03642184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5660065|NCT03642184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660066|NCT03642184|Incretins|incretins|mesh-ancestor
5660067|NCT03642184|Hormones|hormones|mesh-ancestor
5660068|NCT03642184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5660069|NCT03642184|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5660070|NCT03642184|Protease Inhibitors|protease inhibitors|mesh-ancestor
5660071|NCT03642184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5660072|NCT03642145|Deflazacort|deflazacort|mesh-list
5660073|NCT03642145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5660074|NCT03642145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5660075|NCT03642145|Immunologic Factors|immunologic factors|mesh-ancestor
5660076|NCT03642145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660077|NCT03641950|Botulinum Toxins|botulinum toxins|mesh-list
5660078|NCT03641950|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5660079|NCT03641950|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5660080|NCT03641950|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5660081|NCT03641950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5660082|NCT03641950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660083|NCT03641950|Cholinergic Agents|cholinergic agents|mesh-ancestor
5660084|NCT03641950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5660085|NCT03641950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660086|NCT03641950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5660087|NCT03641950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5660088|NCT03641846|Tadalafil|tadalafil|mesh-list
5660089|NCT03641846|Vasodilator Agents|vasodilator agents|mesh-ancestor
5660090|NCT03641846|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5660091|NCT03641846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5660092|NCT03641846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5660093|NCT03641846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660094|NCT03641846|Urological Agents|urological agents|mesh-ancestor
5660095|NCT03641690|Anti-Infective Agents|anti-infective agents|mesh-list
5660096|NCT03641690|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5660097|NCT03641651|Frovatriptan|frovatriptan|mesh-list
5660098|NCT03641651|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5660099|NCT03641651|Serotonin Agents|serotonin agents|mesh-ancestor
5660100|NCT03641651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5660101|NCT03641651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660102|NCT03641651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660103|NCT03641547|Capecitabine|capecitabine|mesh-list
5660104|NCT03641547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5660105|NCT03641547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5660106|NCT03641547|Antimetabolites|antimetabolites|mesh-ancestor
5660107|NCT03641547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839595|NCT02510781|Carboplatin|carboplatin|mesh-list
5839596|NCT02510781|Docetaxel|docetaxel|mesh-list
5839597|NCT02510781|Trastuzumab|trastuzumab|mesh-list
5839598|NCT02510781|Epirubicin|epirubicin|mesh-list
5839599|NCT02510781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5839600|NCT02510781|Tubulin Modulators|tubulin modulators|mesh-ancestor
5839601|NCT02510781|Antimitotic Agents|antimitotic agents|mesh-ancestor
5839602|NCT02510781|Mitosis Modulators|mitosis modulators|mesh-ancestor
5839603|NCT02510781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839604|NCT02510781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5839605|NCT02510781|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5839606|NCT02510781|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5839607|NCT02510781|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5839608|NCT02510781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5839609|NCT02510911|Caffeine|caffeine|mesh-list
5839610|NCT02510911|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5839611|NCT02510911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839612|NCT02510911|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5839613|NCT02510911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5839614|NCT02510911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839615|NCT02510911|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5839616|NCT02510911|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5839617|NCT02510911|Purinergic Agents|purinergic agents|mesh-ancestor
5839618|NCT02510911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5839619|NCT02510872|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5839620|NCT02510872|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5839621|NCT02510872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660108|NCT03641456|Dexamethasone|dexamethasone|mesh-list
5660109|NCT03641456|Dexamethasone acetate|dexamethasone acetate|mesh-list
5660110|NCT03641456|Lenalidomide|lenalidomide|mesh-list
5839622|NCT02510950|Temozolomide|temozolomide|mesh-list
5839623|NCT02510950|Poly ICLC|poly iclc|mesh-list
5839624|NCT02510950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5839625|NCT02510950|Alkylating Agents|alkylating agents|mesh-ancestor
5839626|NCT02510950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839627|NCT02510950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5839628|NCT02510950|Interferon Inducers|interferon inducers|mesh-ancestor
5839629|NCT02510950|Immunologic Factors|immunologic factors|mesh-ancestor
5839630|NCT02510950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660111|NCT03641456|Bortezomib|bortezomib|mesh-list
5839631|NCT02510586|Sevoflurane|sevoflurane|mesh-list
5839632|NCT02510586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5839633|NCT02510586|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5839634|NCT02510586|Anesthetics, General|anesthetics, general|mesh-ancestor
5839635|NCT02510586|Anesthetics|anesthetics|mesh-ancestor
5839636|NCT02510586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5839637|NCT02510586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839638|NCT02510534|Menotropins|menotropins|mesh-list
5839639|NCT02510534|Progesterone|progesterone|mesh-list
5839640|NCT02510534|Progestins|progestins|mesh-ancestor
5839641|NCT02510534|Hormones|hormones|mesh-ancestor
5839642|NCT02510534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5839643|NCT02510534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839644|NCT02510534|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5660112|NCT03641456|BB 1101|bb 1101|mesh-list
5660113|NCT03641456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5660114|NCT03641456|Antiemetics|antiemetics|mesh-ancestor
5660115|NCT03641456|Autonomic Agents|autonomic agents|mesh-ancestor
5660116|NCT03641456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5660117|NCT03641456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660118|NCT03641456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5660119|NCT03641456|Glucocorticoids|glucocorticoids|mesh-ancestor
5660120|NCT03641456|Hormones|hormones|mesh-ancestor
5660121|NCT03641456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5660122|NCT03641456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5660123|NCT03641456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5660124|NCT03641456|Protease Inhibitors|protease inhibitors|mesh-ancestor
5660125|NCT03641456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5839645|NCT02510534|Fertility Agents|fertility agents|mesh-ancestor
5839646|NCT02510534|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5839647|NCT02510612|Dexmedetomidine|dexmedetomidine|mesh-list
5839648|NCT02510612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5839649|NCT02510612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5839650|NCT02510612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839651|NCT02510612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5839652|NCT02510612|Analgesics|analgesics|mesh-ancestor
5839653|NCT02510612|Sensory System Agents|sensory system agents|mesh-ancestor
5839654|NCT02510612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5839655|NCT02510612|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5839656|NCT02510612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5839657|NCT02510612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5839658|NCT02510612|Adrenergic Agents|adrenergic agents|mesh-ancestor
5839659|NCT02510612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5839660|NCT02510612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839661|NCT02510963|Tenofovir|tenofovir|mesh-list
5839662|NCT02510963|Antiviral Agents|antiviral agents|mesh-ancestor
5839663|NCT02510963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5839664|NCT02510963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5839665|NCT02510963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5839666|NCT02510963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5839667|NCT02510963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839668|NCT02510963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5839669|NCT02510963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5839670|NCT02510287|Lidocaine|lidocaine|mesh-list
5839671|NCT02510287|Fentanyl|fentanyl|mesh-list
5839672|NCT02510287|Bupivacaine|bupivacaine|mesh-list
5839673|NCT02510287|Anesthetics, Local|anesthetics, local|mesh-ancestor
5839674|NCT02510287|Anesthetics|anesthetics|mesh-ancestor
5839675|NCT02510287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5839676|NCT02510287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839677|NCT02510287|Sensory System Agents|sensory system agents|mesh-ancestor
5839678|NCT02510287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5839679|NCT02510287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5839680|NCT02510287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5839681|NCT02510287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5839682|NCT02510287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5839683|NCT02510287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839684|NCT02510287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5839685|NCT02510287|Narcotics|narcotics|mesh-ancestor
5839686|NCT02510287|Analgesics|analgesics|mesh-ancestor
5839687|NCT02510287|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5839688|NCT02510287|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5839689|NCT02510287|Anesthetics, General|anesthetics, general|mesh-ancestor
5903210|NCT05131841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5695196|NCT03390933|Fluoxetine|fluoxetine|mesh-list
5660126|NCT03641456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839690|NCT02510248|1-2-isopropoxy-2-oxidodihydro-4H,6H-spiro(furo(3,2-d)(1,3,2)dioxaphosphinine-7,2'-oxetan)-6-yl)pyrimidine-2,4(1H,3H)-dione|1-2-isopropoxy-2-oxidodihydro-4h,6h-spiro(furo(3,2-d)(1,3,2)dioxaphosphinine-7,2'-oxetan)-6-yl)pyrimidine-2,4(1h,3h)-dione|mesh-list
5839691|NCT02510248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5839692|NCT02510248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839693|NCT02510469|Apatinib|apatinib|mesh-list
5839694|NCT02510469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5839695|NCT02510469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5839696|NCT02510469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5839697|NCT02510469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493676|NCT00614978|Alkylating Agents|alkylating agents|mesh-ancestor
6493677|NCT00614978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493678|NCT00614978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6493679|NCT00614978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6493680|NCT00614978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5839698|NCT02510222|Magnesium Sulfate|magnesium sulfate|mesh-list
5839699|NCT02510222|Analgesics|analgesics|mesh-ancestor
5839700|NCT02510222|Sensory System Agents|sensory system agents|mesh-ancestor
5839701|NCT02510222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5839702|NCT02510222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839703|NCT02510222|Anesthetics|anesthetics|mesh-ancestor
5839704|NCT02510222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5839705|NCT02510222|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5839706|NCT02510222|Anticonvulsants|anticonvulsants|mesh-ancestor
5839707|NCT02510222|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5839708|NCT02510222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5839709|NCT02510222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839710|NCT02510222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5839711|NCT02510222|Tocolytic Agents|tocolytic agents|mesh-ancestor
5839712|NCT02510222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5839713|NCT02510235|Hyaluronic Acid|hyaluronic acid|mesh-list
5839714|NCT02510235|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5839715|NCT02510235|Immunologic Factors|immunologic factors|mesh-ancestor
5839716|NCT02510235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839717|NCT02510235|Viscosupplements|viscosupplements|mesh-ancestor
5839718|NCT02510235|Protective Agents|protective agents|mesh-ancestor
5839719|NCT02510157|Dexamethasone|dexamethasone|mesh-list
5839720|NCT02510157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5839721|NCT02510157|Antiemetics|antiemetics|mesh-ancestor
5839722|NCT02510157|Autonomic Agents|autonomic agents|mesh-ancestor
5839723|NCT02510157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5839724|NCT02510157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839725|NCT02510157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5839726|NCT02510157|Glucocorticoids|glucocorticoids|mesh-ancestor
5839727|NCT02510157|Hormones|hormones|mesh-ancestor
5839728|NCT02510157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5839729|NCT02510157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5839730|NCT02510157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5839731|NCT02510053|Caspofungin|caspofungin|mesh-list
5839732|NCT02510053|Antifungal Agents|antifungal agents|mesh-ancestor
5839733|NCT02510053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5839734|NCT02510053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5660127|NCT03641456|Immunologic Factors|immunologic factors|mesh-ancestor
5660128|NCT03641456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5660129|NCT03641456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5660130|NCT03641456|Growth Substances|growth substances|mesh-ancestor
5839735|NCT02510053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839736|NCT02509949|Dexmedetomidine|dexmedetomidine|mesh-list
5839737|NCT02509949|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5839738|NCT02509949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5839739|NCT02509949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839740|NCT02509949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5839741|NCT02509949|Analgesics|analgesics|mesh-ancestor
5839742|NCT02509949|Sensory System Agents|sensory system agents|mesh-ancestor
5839743|NCT02509949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6493681|NCT00615134|Enfuvirtide|enfuvirtide|mesh-list
5660131|NCT03641456|Growth Inhibitors|growth inhibitors|mesh-ancestor
5660132|NCT03641404|Ergothioneine|ergothioneine|mesh-list
5660133|NCT03641404|Antioxidants|antioxidants|mesh-ancestor
5660134|NCT03641404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660135|NCT03641404|Protective Agents|protective agents|mesh-ancestor
5660136|NCT03641404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660137|NCT03641326|Sunitinib|sunitinib|mesh-list
5660138|NCT03641326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5660139|NCT03641326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5660140|NCT03641326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5660141|NCT03641326|Growth Substances|growth substances|mesh-ancestor
5839744|NCT02509949|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5839745|NCT02509949|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5839746|NCT02509949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5660142|NCT03641326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660143|NCT03641326|Growth Inhibitors|growth inhibitors|mesh-ancestor
5660144|NCT03641326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5660145|NCT03641326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5660146|NCT03641326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660147|NCT03641313|Irinotecan|irinotecan|mesh-list
5660148|NCT03641313|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5660149|NCT03641313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5839747|NCT02509949|Adrenergic Agents|adrenergic agents|mesh-ancestor
5839748|NCT02509949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5839749|NCT02509949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839750|NCT02509923|Rabeprazole|rabeprazole|mesh-list
5839751|NCT02509923|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5839752|NCT02509923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5839753|NCT02509923|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5839754|NCT02509923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5839755|NCT02509923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839756|NCT02509793|Tetrabenazine|tetrabenazine|mesh-list
5839757|NCT02509793|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5839758|NCT02509793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5839759|NCT02509793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5839760|NCT02509793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839761|NCT02509793|Adrenergic Agents|adrenergic agents|mesh-ancestor
5839762|NCT02509793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5839763|NCT02509793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839764|NCT02509806|Apatinib|apatinib|mesh-list
5839765|NCT02509806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5839766|NCT02509806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5839767|NCT02509806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5839768|NCT02509806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839769|NCT02509728|Choline|choline|mesh-list
5839770|NCT02509728|Lipotropic Agents|lipotropic agents|mesh-ancestor
5839771|NCT02509728|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5839772|NCT02509728|Antimetabolites|antimetabolites|mesh-ancestor
5839773|NCT02509728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839774|NCT02509728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5839775|NCT02509728|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5839776|NCT02509728|Nootropic Agents|nootropic agents|mesh-ancestor
5839777|NCT02509429|Insulin|insulin|mesh-list
5839778|NCT02509429|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5839779|NCT02509429|Insulin Aspart|insulin aspart|mesh-list
5839780|NCT02509429|Insulin, Long-Acting|insulin, long-acting|mesh-list
5839781|NCT02509429|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
5839782|NCT02509429|Insulin Lispro|insulin lispro|mesh-list
5839783|NCT02509429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5903211|NCT05131841|Tubulin Modulators|tubulin modulators|mesh-ancestor
5660150|NCT03641313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5660151|NCT03641313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660152|NCT03641313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5660153|NCT03641209|Acetaminophen|acetaminophen|mesh-list
5660154|NCT03641209|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5839784|NCT02509429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839785|NCT02509273|Clonidine|clonidine|mesh-list
5839786|NCT02509273|Midazolam|midazolam|mesh-list
5839787|NCT02509273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5839788|NCT02509273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5839789|NCT02509273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5839790|NCT02509273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839791|NCT02509273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5839792|NCT02509273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5839793|NCT02509273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5839794|NCT02509273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5839795|NCT02509273|Anesthetics, General|anesthetics, general|mesh-ancestor
5839796|NCT02509273|Anesthetics|anesthetics|mesh-ancestor
5839797|NCT02509273|GABA Modulators|gaba modulators|mesh-ancestor
5839798|NCT02509273|GABA Agents|gaba agents|mesh-ancestor
5839799|NCT02509273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5839800|NCT02509273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839801|NCT02509273|Analgesics|analgesics|mesh-ancestor
5839802|NCT02509273|Sensory System Agents|sensory system agents|mesh-ancestor
5839803|NCT02509273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5839804|NCT02509273|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5839805|NCT02509273|Sympatholytics|sympatholytics|mesh-ancestor
5839806|NCT02509273|Autonomic Agents|autonomic agents|mesh-ancestor
5839807|NCT02509273|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5839808|NCT02509273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5839809|NCT02509273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5839810|NCT02509273|Adrenergic Agents|adrenergic agents|mesh-ancestor
5839811|NCT02509468|Sirolimus|sirolimus|mesh-list
5839812|NCT02509468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5839813|NCT02509468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5839814|NCT02509468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5839815|NCT02509468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5839816|NCT02509468|Antifungal Agents|antifungal agents|mesh-ancestor
5839817|NCT02509468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5839818|NCT02509468|Immunologic Factors|immunologic factors|mesh-ancestor
5839819|NCT02509468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839820|NCT02509546|Adenosine|adenosine|mesh-list
5839821|NCT02509546|Analgesics|analgesics|mesh-ancestor
5839822|NCT02509546|Sensory System Agents|sensory system agents|mesh-ancestor
5839823|NCT02509546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5839824|NCT02509546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839825|NCT02509546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5839826|NCT02509546|Vasodilator Agents|vasodilator agents|mesh-ancestor
5839827|NCT02509546|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5839828|NCT02509546|Purinergic Agonists|purinergic agonists|mesh-ancestor
5839829|NCT02509546|Purinergic Agents|purinergic agents|mesh-ancestor
5660155|NCT03641209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5660156|NCT03641209|Analgesics|analgesics|mesh-ancestor
5660157|NCT03641209|Sensory System Agents|sensory system agents|mesh-ancestor
5660158|NCT03641209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5660159|NCT03641209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660160|NCT03641209|Antipyretics|antipyretics|mesh-ancestor
5660161|NCT03641053|Iodine|iodine|mesh-list
5660162|NCT03641053|Povidone-Iodine|povidone-iodine|mesh-list
5660163|NCT03641053|Povidone|povidone|mesh-list
5660164|NCT03641053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5660165|NCT03641053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5660166|NCT03641053|Trace Elements|trace elements|mesh-ancestor
5660167|NCT03641053|Micronutrients|micronutrients|mesh-ancestor
5660168|NCT03641053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660169|NCT03641053|Plasma Substitutes|plasma substitutes|mesh-ancestor
5660170|NCT03641053|Blood Substitutes|blood substitutes|mesh-ancestor
5695197|NCT03390933|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5695198|NCT03390933|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5695199|NCT03390933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5695200|NCT03390933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695201|NCT03390933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5695202|NCT03390933|Serotonin Agents|serotonin agents|mesh-ancestor
5695203|NCT03390933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839830|NCT02509546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5903212|NCT05131841|Antimitotic Agents|antimitotic agents|mesh-ancestor
5660171|NCT03640728|Tenofovir|tenofovir|mesh-list
5660172|NCT03640728|Entecavir|entecavir|mesh-list
5660173|NCT03640728|Antiviral Agents|antiviral agents|mesh-ancestor
5660174|NCT03640728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5660175|NCT03640728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5660176|NCT03640728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5660177|NCT03640728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5660178|NCT03640728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660179|NCT03640728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5839831|NCT02509546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839832|NCT02509559|Propranolol|propranolol|mesh-list
5839833|NCT02509559|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5839834|NCT02509559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5839835|NCT02509559|Adrenergic Agents|adrenergic agents|mesh-ancestor
5839836|NCT02509559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5839837|NCT02509559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839838|NCT02509559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660180|NCT03640728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5660181|NCT03640650|Triamcinolone|triamcinolone|mesh-list
5660182|NCT03640650|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5660183|NCT03640650|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5660184|NCT03640650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
5660185|NCT03640650|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5660186|NCT03640650|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5660187|NCT03640650|Glucocorticoids|glucocorticoids|mesh-ancestor
5660188|NCT03640650|Hormones|hormones|mesh-ancestor
5660189|NCT03640650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5660190|NCT03640650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660191|NCT03640650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5660192|NCT03640650|Immunologic Factors|immunologic factors|mesh-ancestor
5660193|NCT03640650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5660194|NCT03640650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660195|NCT03640650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5660196|NCT03640468|Lidocaine|lidocaine|mesh-list
5660197|NCT03640468|Midazolam|midazolam|mesh-list
5660198|NCT03640468|Ketamine|ketamine|mesh-list
5660199|NCT03640468|Anesthetics, Local|anesthetics, local|mesh-ancestor
5660200|NCT03640468|Anesthetics|anesthetics|mesh-ancestor
5660201|NCT03640468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5660202|NCT03640468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660203|NCT03640468|Sensory System Agents|sensory system agents|mesh-ancestor
5660204|NCT03640468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5660205|NCT03640468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5660206|NCT03640468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5660207|NCT03640468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5660208|NCT03640468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5660209|NCT03640468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660210|NCT03640468|Analgesics|analgesics|mesh-ancestor
5660211|NCT03640468|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5660212|NCT03640468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5660213|NCT03640468|Anesthetics, General|anesthetics, general|mesh-ancestor
5660214|NCT03640468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5660215|NCT03640468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5660216|NCT03640468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5660217|NCT03640468|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5660218|NCT03640468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5660219|NCT03640468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5660220|NCT03640468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5660221|NCT03640468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5660222|NCT03640468|GABA Modulators|gaba modulators|mesh-ancestor
5660223|NCT03640468|GABA Agents|gaba agents|mesh-ancestor
5660224|NCT03640403|Artesunate|artesunate|mesh-list
5660225|NCT03640403|Piperaquine|piperaquine|mesh-list
5839839|NCT02509559|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5839840|NCT02509559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5839841|NCT02509559|Vasodilator Agents|vasodilator agents|mesh-ancestor
5839842|NCT02509312|Ketorolac|ketorolac|mesh-list
5839843|NCT02509312|Morphine|morphine|mesh-list
5839844|NCT02509312|Hydromorphone|hydromorphone|mesh-list
5839845|NCT02509312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6211955|NCT02180100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6211956|NCT02180100|Hormone Antagonists|hormone antagonists|mesh-ancestor
5660226|NCT03640403|Amodiaquine|amodiaquine|mesh-list
5839846|NCT02509312|Narcotics|narcotics|mesh-ancestor
6212618|NCT02191397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5660227|NCT03640403|Artenimol|artenimol|mesh-list
5660228|NCT03640403|Antimalarials|antimalarials|mesh-ancestor
5660229|NCT03640403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5660230|NCT03640403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5660231|NCT03640403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5660232|NCT03640403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5660233|NCT03640403|Antiviral Agents|antiviral agents|mesh-ancestor
5660234|NCT03640403|Schistosomicides|schistosomicides|mesh-ancestor
5660235|NCT03640403|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6211957|NCT02180100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6211958|NCT02180100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211959|NCT02180100|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6211960|NCT02180100|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5660236|NCT03640403|Anthelmintics|anthelmintics|mesh-ancestor
5660237|NCT03640390|Magnesium Sulfate|magnesium sulfate|mesh-list
5660238|NCT03640390|Dexmedetomidine|dexmedetomidine|mesh-list
5660239|NCT03640390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5660240|NCT03640390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5660241|NCT03640390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660242|NCT03640390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5660243|NCT03640390|Analgesics|analgesics|mesh-ancestor
5660244|NCT03640390|Sensory System Agents|sensory system agents|mesh-ancestor
5660245|NCT03640390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5660246|NCT03640390|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5839847|NCT02509312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5839848|NCT02509312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839849|NCT02509312|Analgesics|analgesics|mesh-ancestor
5839850|NCT02509312|Sensory System Agents|sensory system agents|mesh-ancestor
5839851|NCT02509312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5839852|NCT02509312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5839853|NCT02509312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5839854|NCT02509312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5839855|NCT02509312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5839856|NCT02509312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5839857|NCT02509312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5839858|NCT02509312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839859|NCT02509351|Misoprostol|misoprostol|mesh-list
5839860|NCT02509351|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5839861|NCT02509351|Abortifacient Agents|abortifacient agents|mesh-ancestor
5839862|NCT02509351|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5839863|NCT02509351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211961|NCT02180165|Voriconazole|voriconazole|mesh-list
6211962|NCT02180165|Posaconazole|posaconazole|mesh-list
6211963|NCT02180165|Antifungal Agents|antifungal agents|mesh-ancestor
6211964|NCT02180165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6211965|NCT02180165|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6211966|NCT02180165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6211967|NCT02180165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6211968|NCT02180165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211969|NCT02180165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6211970|NCT02180165|Hormone Antagonists|hormone antagonists|mesh-ancestor
6211971|NCT02180165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6211972|NCT02180165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211973|NCT02180165|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5839864|NCT02509351|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5839865|NCT02509351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5839866|NCT02509351|Oxytocics|oxytocics|mesh-ancestor
5839867|NCT02509286|Leucovorin|leucovorin|mesh-list
5839868|NCT02509286|Paclitaxel|paclitaxel|mesh-list
5839869|NCT02509286|Docetaxel|docetaxel|mesh-list
5839870|NCT02509286|Carboplatin|carboplatin|mesh-list
5839871|NCT02509286|Fluorouracil|fluorouracil|mesh-list
5839872|NCT02509286|Oxaliplatin|oxaliplatin|mesh-list
5660247|NCT03640390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5660248|NCT03640390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5839873|NCT02509286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5839874|NCT02509286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5839875|NCT02509286|Tubulin Modulators|tubulin modulators|mesh-ancestor
5839876|NCT02509286|Antimitotic Agents|antimitotic agents|mesh-ancestor
5839877|NCT02509286|Mitosis Modulators|mitosis modulators|mesh-ancestor
5839878|NCT02509286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839879|NCT02509286|Antimetabolites|antimetabolites|mesh-ancestor
5839880|NCT02509286|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5839881|NCT02509286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5839882|NCT02509286|Immunologic Factors|immunologic factors|mesh-ancestor
5839883|NCT02509286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839884|NCT02509286|Antidotes|antidotes|mesh-ancestor
5839885|NCT02509286|Protective Agents|protective agents|mesh-ancestor
5839886|NCT02509286|Vitamin B Complex|vitamin b complex|mesh-ancestor
5839887|NCT02509286|Vitamins|vitamins|mesh-ancestor
5839888|NCT02509286|Micronutrients|micronutrients|mesh-ancestor
5903213|NCT05131841|Mitosis Modulators|mitosis modulators|mesh-ancestor
5903214|NCT05131841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903215|NCT05131828|Metformin|metformin|mesh-list
5660249|NCT03640390|Adrenergic Agents|adrenergic agents|mesh-ancestor
5660250|NCT03640390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5660251|NCT03640390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660252|NCT03640390|Anesthetics|anesthetics|mesh-ancestor
5660253|NCT03640390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5660254|NCT03640390|Anticonvulsants|anticonvulsants|mesh-ancestor
5660255|NCT03640390|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5660256|NCT03640390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5660257|NCT03640390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5660258|NCT03640390|Tocolytic Agents|tocolytic agents|mesh-ancestor
5660259|NCT03640390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5660260|NCT03640377|Praziquantel|praziquantel|mesh-list
5660261|NCT03640377|Anthelmintics|anthelmintics|mesh-ancestor
5660262|NCT03640377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5660263|NCT03640377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5903216|NCT05131828|Clemastine|clemastine|mesh-list
5903217|NCT05131828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5903218|NCT05131828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903219|NCT05131828|Antipruritics|antipruritics|mesh-ancestor
5903220|NCT05131828|Dermatologic Agents|dermatologic agents|mesh-ancestor
5660264|NCT03640351|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5660265|NCT03640351|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5660266|NCT03640351|Hyaluronic Acid|hyaluronic acid|mesh-list
5660267|NCT03640351|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5660268|NCT03640351|Immunologic Factors|immunologic factors|mesh-ancestor
5660269|NCT03640351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660270|NCT03640351|Viscosupplements|viscosupplements|mesh-ancestor
5660271|NCT03640351|Protective Agents|protective agents|mesh-ancestor
5660272|NCT03640273|Loratadine|loratadine|mesh-list
5660273|NCT03640273|Antipruritics|antipruritics|mesh-ancestor
5660274|NCT03640273|Dermatologic Agents|dermatologic agents|mesh-ancestor
5660275|NCT03640273|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5660276|NCT03640273|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5660277|NCT03640273|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5660278|NCT03640273|Histamine Antagonists|histamine antagonists|mesh-ancestor
5660279|NCT03640273|Histamine Agents|histamine agents|mesh-ancestor
5660280|NCT03640273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5660281|NCT03640273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660282|NCT03640273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660283|NCT03640247|Acetaminophen|acetaminophen|mesh-list
5660284|NCT03640247|Ibuprofen|ibuprofen|mesh-list
5660285|NCT03640247|Oxycodone|oxycodone|mesh-list
5660286|NCT03640247|Tramadol|tramadol|mesh-list
5660287|NCT03640247|Hydrocodone|hydrocodone|mesh-list
5660288|NCT03640247|Narcotics|narcotics|mesh-list
5660289|NCT03640247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5903221|NCT05131828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5903222|NCT05131828|Histamine Antagonists|histamine antagonists|mesh-ancestor
5903223|NCT05131828|Histamine Agents|histamine agents|mesh-ancestor
5660290|NCT03640247|Analgesics|analgesics|mesh-ancestor
5660291|NCT03640247|Sensory System Agents|sensory system agents|mesh-ancestor
5660292|NCT03640247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5660293|NCT03640247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660294|NCT03640247|Antipyretics|antipyretics|mesh-ancestor
5660295|NCT03640247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5660296|NCT03640247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5660297|NCT03640247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5839889|NCT02509234|Irinotecan|irinotecan|mesh-list
5839890|NCT02509234|Trabectedin|trabectedin|mesh-list
5839891|NCT02509234|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5839892|NCT02509234|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5839893|NCT02509234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5839894|NCT02509234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839895|NCT02509234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5839896|NCT02509234|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5839897|NCT02509234|Alkylating Agents|alkylating agents|mesh-ancestor
5839898|NCT02509208|Hemostatics|hemostatics|mesh-list
5839899|NCT02509208|Coagulants|coagulants|mesh-ancestor
5839900|NCT02509195|Lamivudine|lamivudine|mesh-list
5839901|NCT02509195|Abacavir|abacavir|mesh-list
5839902|NCT02509195|Dolutegravir|dolutegravir|mesh-list
5839903|NCT02509195|Triumeq|triumeq|mesh-list
5839904|NCT02509195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5839905|NCT02509195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5839906|NCT02509195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5839907|NCT02509195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839908|NCT02509195|Antiviral Agents|antiviral agents|mesh-ancestor
5839909|NCT02509195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5839910|NCT02509195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5839911|NCT02509195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5839912|NCT02509195|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5839913|NCT02509195|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5839914|NCT02509143|Ramosetron|ramosetron|mesh-list
5839915|NCT02509143|Antiemetics|antiemetics|mesh-list
5839916|NCT02509143|Autonomic Agents|autonomic agents|mesh-ancestor
5839917|NCT02509143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5839918|NCT02509143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839919|NCT02509143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5839920|NCT02509143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5839921|NCT02509143|Serotonin Agents|serotonin agents|mesh-ancestor
5839922|NCT02509143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5839923|NCT02509143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839924|NCT02508870|Azacitidine|azacitidine|mesh-list
5839925|NCT02508870|Atezolizumab|atezolizumab|mesh-list
5839926|NCT02508870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5839927|NCT02508870|Antimetabolites|antimetabolites|mesh-ancestor
5839928|NCT02508870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839929|NCT02508870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5839930|NCT02508870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5839931|NCT02509091|Amikacin|amikacin|mesh-list
5839932|NCT02509091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5839933|NCT02509091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5839934|NCT02509052|Leflunomide|leflunomide|mesh-list
5839935|NCT02509052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5839936|NCT02509052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839937|NCT02509052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5839938|NCT02509052|Immunologic Factors|immunologic factors|mesh-ancestor
5839939|NCT02509052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660298|NCT03640247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5660299|NCT03640247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5660300|NCT03640247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660301|NCT03640247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5660302|NCT03640247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5660303|NCT03640247|Antitussive Agents|antitussive agents|mesh-ancestor
5660304|NCT03640247|Respiratory System Agents|respiratory system agents|mesh-ancestor
5660305|NCT03640221|Ertugliflozin|ertugliflozin|mesh-list
5660306|NCT03640221|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
5660307|NCT03640221|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5660308|NCT03640221|Antihypertensive Agents|antihypertensive agents|mesh-list
5660309|NCT03640221|Diuretics|diuretics|mesh-ancestor
5660310|NCT03640221|Natriuretic Agents|natriuretic agents|mesh-ancestor
5660311|NCT03640221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660312|NCT03640221|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5839940|NCT02508857|Ketorolac|ketorolac|mesh-list
5839941|NCT02508857|Magnesium Sulfate|magnesium sulfate|mesh-list
5839942|NCT02508857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5839943|NCT02508857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5839944|NCT02508857|Analgesics|analgesics|mesh-ancestor
5839945|NCT02508857|Sensory System Agents|sensory system agents|mesh-ancestor
5839946|NCT02508857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5839947|NCT02508857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839948|NCT02508857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5839949|NCT02508857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5839950|NCT02508857|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5839951|NCT02508857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5839952|NCT02508857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839953|NCT02508857|Anesthetics|anesthetics|mesh-ancestor
5660313|NCT03640221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5660314|NCT03640221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660315|NCT03640221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5660316|NCT03640156|Oxytocin|oxytocin|mesh-list
5660317|NCT03640156|Oxytocics|oxytocics|mesh-ancestor
5660318|NCT03640156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5660319|NCT03640156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660320|NCT03640026|Tacrolimus|tacrolimus|mesh-list
5660321|NCT03640026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5660322|NCT03640026|Immunologic Factors|immunologic factors|mesh-ancestor
5660323|NCT03640026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660324|NCT03640026|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5660325|NCT03640026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5660326|NCT03640026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660327|NCT03639922|Imatinib Mesylate|imatinib mesylate|mesh-list
5660328|NCT03639922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5660329|NCT03639922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5660330|NCT03639922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5660331|NCT03639922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660332|NCT03639896|Dexmedetomidine|dexmedetomidine|mesh-list
5660333|NCT03639896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5660334|NCT03639896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5660335|NCT03639896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660336|NCT03639896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5660337|NCT03639896|Analgesics|analgesics|mesh-ancestor
5839954|NCT02508857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5839955|NCT02508857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5839956|NCT02508857|Anticonvulsants|anticonvulsants|mesh-ancestor
5839957|NCT02508857|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5839958|NCT02508857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5839959|NCT02508857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5839960|NCT02508857|Tocolytic Agents|tocolytic agents|mesh-ancestor
5839961|NCT02508857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5839962|NCT02508922|Vitamin D|vitamin d|mesh-list
5839963|NCT02508922|Cholecalciferol|cholecalciferol|mesh-list
5839964|NCT02508922|Vitamins|vitamins|mesh-ancestor
5839965|NCT02508922|Micronutrients|micronutrients|mesh-ancestor
5839966|NCT02508922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839967|NCT02508922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5839968|NCT02508922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5839969|NCT02508805|Diclofenac|diclofenac|mesh-list
5839970|NCT02508805|Tizanidine|tizanidine|mesh-list
5839971|NCT02508805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5839972|NCT02508805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5839973|NCT02508805|Analgesics|analgesics|mesh-ancestor
5839974|NCT02508805|Sensory System Agents|sensory system agents|mesh-ancestor
5839975|NCT02508805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5839976|NCT02508805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5839977|NCT02508805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5839978|NCT02508805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5839979|NCT02508805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5839980|NCT02508805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5839981|NCT02508805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5839982|NCT02508805|Anticonvulsants|anticonvulsants|mesh-ancestor
5839983|NCT02508805|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5839984|NCT02508805|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5839985|NCT02508805|Parasympatholytics|parasympatholytics|mesh-ancestor
5839986|NCT02508805|Autonomic Agents|autonomic agents|mesh-ancestor
5839987|NCT02508805|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5839988|NCT02508805|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5839989|NCT02508805|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5839990|NCT02508805|Adrenergic Agents|adrenergic agents|mesh-ancestor
5839991|NCT02508805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5839992|NCT02509104|Tamsulosin|tamsulosin|mesh-list
5839993|NCT02509104|Dutasteride|dutasteride|mesh-list
5839994|NCT02509104|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5839995|NCT02509104|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5839996|NCT02509104|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5839997|NCT02509104|Adrenergic Agents|adrenergic agents|mesh-ancestor
5839998|NCT02509104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5839999|NCT02509104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5840000|NCT02509104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840001|NCT02509104|Urological Agents|urological agents|mesh-ancestor
5840002|NCT02509104|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
5840003|NCT02509104|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5840004|NCT02509104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5840005|NCT02509104|Hormone Antagonists|hormone antagonists|mesh-ancestor
5840006|NCT02509104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5840007|NCT02508753|Moxifloxacin|moxifloxacin|mesh-list
5840008|NCT02508753|Tazobactam|tazobactam|mesh-list
5840009|NCT02508753|Ceftolozane|ceftolozane|mesh-list
5840010|NCT02508753|Cephalosporins|cephalosporins|mesh-list
5840011|NCT02508753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5840012|NCT02508753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5840013|NCT02508753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5840014|NCT02508753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5840015|NCT02508753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5840016|NCT02508753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5840017|NCT02508753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5840018|NCT02508753|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5840019|NCT02508623|Rifaximin|rifaximin|mesh-list
5840020|NCT02508623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5840021|NCT02508623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5840022|NCT02508623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5840023|NCT02508584|Antibodies|antibodies|mesh-list
5840024|NCT02508584|Immunologic Factors|immunologic factors|mesh-ancestor
5840025|NCT02508584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660338|NCT03639896|Sensory System Agents|sensory system agents|mesh-ancestor
5660339|NCT03639896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5660340|NCT03639896|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5660341|NCT03639896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5660342|NCT03639896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5660343|NCT03639896|Adrenergic Agents|adrenergic agents|mesh-ancestor
5660344|NCT03639896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5660345|NCT03639896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660346|NCT03639740|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5660347|NCT03639740|Immunologic Factors|immunologic factors|mesh-ancestor
5660348|NCT03639740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660349|NCT03639727|Mannitol|mannitol|mesh-list
5660350|NCT03639727|Citric Acid|citric acid|mesh-list
5660351|NCT03639727|Sodium Citrate|sodium citrate|mesh-list
5660352|NCT03639727|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5660353|NCT03639727|Diuretics|diuretics|mesh-ancestor
5660354|NCT03639727|Natriuretic Agents|natriuretic agents|mesh-ancestor
5660355|NCT03639727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660356|NCT03639727|Anticoagulants|anticoagulants|mesh-ancestor
5660357|NCT03639727|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5660358|NCT03639727|Chelating Agents|chelating agents|mesh-ancestor
5660359|NCT03639727|Sequestering Agents|sequestering agents|mesh-ancestor
5660360|NCT03639727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660361|NCT03639714|Nivolumab|nivolumab|mesh-list
5660362|NCT03639714|Ipilimumab|ipilimumab|mesh-list
5660363|NCT03639714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5660364|NCT03639714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5660365|NCT03639714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5660366|NCT03639714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660367|NCT03639571|Ibuprofen|ibuprofen|mesh-list
5840026|NCT02508402|Dexamethasone|dexamethasone|mesh-list
5840027|NCT02508402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5840028|NCT02508402|Antiemetics|antiemetics|mesh-ancestor
5840029|NCT02508402|Autonomic Agents|autonomic agents|mesh-ancestor
5840030|NCT02508402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5840031|NCT02508402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840032|NCT02508402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5840033|NCT02508402|Glucocorticoids|glucocorticoids|mesh-ancestor
5840034|NCT02508402|Hormones|hormones|mesh-ancestor
5840035|NCT02508402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6211974|NCT02180165|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5840036|NCT02508402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5840037|NCT02508402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5840038|NCT02508311|Albuterol|albuterol|mesh-list
5840039|NCT02508311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5660368|NCT03639571|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5660369|NCT03639571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5660370|NCT03639571|Analgesics|analgesics|mesh-ancestor
5660371|NCT03639571|Sensory System Agents|sensory system agents|mesh-ancestor
5660372|NCT03639571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5660373|NCT03639571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660374|NCT03639571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5660375|NCT03639571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5660376|NCT03639571|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5660377|NCT03639571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5840040|NCT02508311|Autonomic Agents|autonomic agents|mesh-ancestor
5840041|NCT02508311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5660378|NCT03639571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660379|NCT03639558|Promethazine|promethazine|mesh-list
5660380|NCT03639558|Diphenhydramine|diphenhydramine|mesh-list
5660381|NCT03639558|Haloperidol|haloperidol|mesh-list
5660382|NCT03639558|Chlorpromazine|chlorpromazine|mesh-list
5660383|NCT03639558|Haloperidol decanoate|haloperidol decanoate|mesh-list
5660384|NCT03639558|Antiemetics|antiemetics|mesh-ancestor
5660385|NCT03639558|Autonomic Agents|autonomic agents|mesh-ancestor
5660386|NCT03639558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5660387|NCT03639558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660388|NCT03639558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5660389|NCT03639558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5660390|NCT03639558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5660391|NCT03639558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5660392|NCT03639558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5660393|NCT03639558|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5660394|NCT03639558|Dopamine Agents|dopamine agents|mesh-ancestor
5660395|NCT03639558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5660396|NCT03639558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660397|NCT03639558|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5660398|NCT03639558|Antipruritics|antipruritics|mesh-ancestor
5660399|NCT03639558|Dermatologic Agents|dermatologic agents|mesh-ancestor
5660400|NCT03639558|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5660401|NCT03639558|Histamine Antagonists|histamine antagonists|mesh-ancestor
5660402|NCT03639558|Histamine Agents|histamine agents|mesh-ancestor
5660403|NCT03639558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5660404|NCT03639558|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5660405|NCT03639558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5660406|NCT03639558|Anesthetics, Local|anesthetics, local|mesh-ancestor
5660407|NCT03639558|Anesthetics|anesthetics|mesh-ancestor
5660408|NCT03639558|Sensory System Agents|sensory system agents|mesh-ancestor
5660409|NCT03639545|Metformin|metformin|mesh-list
5840042|NCT02508311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840043|NCT02508311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5840044|NCT02508311|Respiratory System Agents|respiratory system agents|mesh-ancestor
5840045|NCT02508311|Tocolytic Agents|tocolytic agents|mesh-ancestor
5840046|NCT02508311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5840047|NCT02508311|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5840048|NCT02508311|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5840049|NCT02508311|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5840050|NCT02508311|Adrenergic Agents|adrenergic agents|mesh-ancestor
5840051|NCT02508311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5840052|NCT02508311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5840053|NCT02508350|Daptomycin|daptomycin|mesh-list
5840054|NCT02508350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5840055|NCT02508350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5840056|NCT02508168|Metformin|metformin|mesh-list
5840057|NCT02508168|Alogliptin|alogliptin|mesh-list
5840058|NCT02508168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5660410|NCT03639545|Empagliflozin|empagliflozin|mesh-list
5660411|NCT03639545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5660412|NCT03639545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840059|NCT02508168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840060|NCT02508168|Incretins|incretins|mesh-ancestor
5840061|NCT02508168|Hormones|hormones|mesh-ancestor
5840062|NCT02508168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5840063|NCT02508168|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5840064|NCT02508168|Protease Inhibitors|protease inhibitors|mesh-ancestor
5660413|NCT03639545|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5660414|NCT03639545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660415|NCT03639532|Tacrine|tacrine|mesh-list
5660416|NCT03639532|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5660417|NCT03639532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5660418|NCT03639532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660419|NCT03639532|Cholinergic Agents|cholinergic agents|mesh-ancestor
5660420|NCT03639532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5840065|NCT02508168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5840066|NCT02508168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5840067|NCT02508246|Cisplatin|cisplatin|mesh-list
5840068|NCT02508246|Docetaxel|docetaxel|mesh-list
5840069|NCT02508246|Adavosertib|adavosertib|mesh-list
5840070|NCT02508246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5840071|NCT02508246|Tubulin Modulators|tubulin modulators|mesh-ancestor
5840072|NCT02508246|Antimitotic Agents|antimitotic agents|mesh-ancestor
5840073|NCT02508246|Mitosis Modulators|mitosis modulators|mesh-ancestor
5840074|NCT02508246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5840075|NCT02508246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5840076|NCT02508142|Scopolamine|scopolamine|mesh-list
5840077|NCT02508142|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
5840078|NCT02508142|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5840079|NCT02508142|Antiemetics|antiemetics|mesh-ancestor
5840080|NCT02508142|Autonomic Agents|autonomic agents|mesh-ancestor
5840081|NCT02508142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5840082|NCT02508142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840083|NCT02508142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5840084|NCT02508142|Mydriatics|mydriatics|mesh-ancestor
5840085|NCT02508142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5840086|NCT02508142|Cholinergic Agents|cholinergic agents|mesh-ancestor
5840087|NCT02508142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5840088|NCT02508142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5840089|NCT02508142|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5840090|NCT02508142|Parasympatholytics|parasympatholytics|mesh-ancestor
5660421|NCT03639532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660422|NCT03639532|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5660423|NCT03639532|Autonomic Agents|autonomic agents|mesh-ancestor
5660424|NCT03639532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5660425|NCT03639532|Nootropic Agents|nootropic agents|mesh-ancestor
5660426|NCT03639519|Ascorbic Acid|ascorbic acid|mesh-list
5660427|NCT03639519|Antioxidants|antioxidants|mesh-ancestor
5660428|NCT03639519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660429|NCT03639519|Protective Agents|protective agents|mesh-ancestor
5660430|NCT03639519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840091|NCT02508220|Oxytocin|oxytocin|mesh-list
5840092|NCT02508220|Oxytocics|oxytocics|mesh-ancestor
5840093|NCT02508220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5840094|NCT02508220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840095|NCT02508064|Fostemsavir|fostemsavir|mesh-list
5840096|NCT02508064|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5840097|NCT02508064|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5840098|NCT02508064|Antiviral Agents|antiviral agents|mesh-ancestor
5840099|NCT02508064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5840100|NCT02508064|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5840101|NCT02508064|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5840102|NCT02508064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5840103|NCT02507934|Hyaluronic Acid|hyaluronic acid|mesh-list
5840104|NCT02507934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5840105|NCT02507934|Immunologic Factors|immunologic factors|mesh-ancestor
5840106|NCT02507934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840107|NCT02507934|Viscosupplements|viscosupplements|mesh-ancestor
5840108|NCT02507934|Protective Agents|protective agents|mesh-ancestor
5660431|NCT03639519|Vitamins|vitamins|mesh-ancestor
5660432|NCT03639519|Micronutrients|micronutrients|mesh-ancestor
5660433|NCT03639493|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
5660434|NCT03639493|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5840109|NCT02507843|Vitamin D|vitamin d|mesh-list
5840110|NCT02507843|Cholecalciferol|cholecalciferol|mesh-list
5840111|NCT02507843|Vitamins|vitamins|mesh-ancestor
5840112|NCT02507843|Micronutrients|micronutrients|mesh-ancestor
5840113|NCT02507843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840114|NCT02507843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5840115|NCT02507843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5840116|NCT02507583|Insulin|insulin|mesh-list
5840117|NCT02507583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5660435|NCT03639493|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5840118|NCT02507583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840119|NCT02507648|Oseltamivir|oseltamivir|mesh-list
5840120|NCT02507648|Antiviral Agents|antiviral agents|mesh-ancestor
5840121|NCT02507648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5840122|NCT02507648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5840123|NCT02507648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5840124|NCT02507687|Bimatoprost|bimatoprost|mesh-list
5840125|NCT02507687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5840126|NCT02507635|Levocetirizine|levocetirizine|mesh-list
5840127|NCT02507635|Desloratadine|desloratadine|mesh-list
5840128|NCT02507635|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5660436|NCT03639493|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5660437|NCT03639493|Antimetabolites|antimetabolites|mesh-ancestor
5660438|NCT03639493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660439|NCT03639493|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5660440|NCT03639493|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5660441|NCT03639493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5660442|NCT03639493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5660443|NCT03639480|Amlodipine|amlodipine|mesh-list
5660444|NCT03639480|Valsartan|valsartan|mesh-list
5660445|NCT03639480|Atorvastatin|atorvastatin|mesh-list
5660446|NCT03639480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5660447|NCT03639480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5660448|NCT03639480|Antimetabolites|antimetabolites|mesh-ancestor
5660449|NCT03639480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660450|NCT03639480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5660451|NCT03639480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5840129|NCT02507635|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5840130|NCT02507635|Histamine Antagonists|histamine antagonists|mesh-ancestor
5840131|NCT02507635|Histamine Agents|histamine agents|mesh-ancestor
5840132|NCT02507635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5840133|NCT02507635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5840134|NCT02507635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840135|NCT02507635|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5840136|NCT02507635|Cholinergic Agents|cholinergic agents|mesh-ancestor
5840137|NCT02507570|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
5840138|NCT02507570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5903224|NCT05131828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5903225|NCT05131828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903226|NCT05131828|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5903227|NCT05131646|Axitinib|axitinib|mesh-list
5903228|NCT05131646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5903229|NCT05131646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5903230|NCT05131646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5903231|NCT05131646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903232|NCT05131555|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
5903233|NCT05131555|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
5903234|NCT05131555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903235|NCT05131555|Histamine Antagonists|histamine antagonists|mesh-ancestor
5660452|NCT03639480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5660453|NCT03639480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5660454|NCT03639480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5660455|NCT03639480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5660456|NCT03639480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5660457|NCT03639480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660458|NCT03639480|Vasodilator Agents|vasodilator agents|mesh-ancestor
5660459|NCT03639480|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5660460|NCT03639480|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5660461|NCT03639467|Gemcitabine|gemcitabine|mesh-list
5660462|NCT03639467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5660463|NCT03639467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5660464|NCT03639467|Antimetabolites|antimetabolites|mesh-ancestor
5660465|NCT03639467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660466|NCT03639467|Antiviral Agents|antiviral agents|mesh-ancestor
5660467|NCT03639467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5660468|NCT03639467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5660469|NCT03639467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5660470|NCT03639467|Immunologic Factors|immunologic factors|mesh-ancestor
5660471|NCT03639467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660472|NCT03639428|Midazolam|midazolam|mesh-list
5660473|NCT03639428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5660474|NCT03639428|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5660475|NCT03639428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5660476|NCT03639428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660477|NCT03639428|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5840139|NCT02507479|Thiotepa|thiotepa|mesh-list
5840140|NCT02507479|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5840141|NCT02507479|Alkylating Agents|alkylating agents|mesh-ancestor
5840142|NCT02507479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5840143|NCT02507479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5840144|NCT02507479|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5840145|NCT02507479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5840146|NCT02507479|Immunologic Factors|immunologic factors|mesh-ancestor
5840147|NCT02507479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840148|NCT02507700|Bupivacaine|bupivacaine|mesh-list
5840149|NCT02507700|Sevoflurane|sevoflurane|mesh-list
5840150|NCT02507700|Anesthetics, Local|anesthetics, local|mesh-ancestor
5840151|NCT02507700|Anesthetics|anesthetics|mesh-ancestor
5840152|NCT02507700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5840153|NCT02507700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840154|NCT02507700|Sensory System Agents|sensory system agents|mesh-ancestor
5840155|NCT02507700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5840156|NCT02507700|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5840157|NCT02507700|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5840158|NCT02507700|Anesthetics, General|anesthetics, general|mesh-ancestor
5840159|NCT02507609|Rocuronium|rocuronium|mesh-list
5660478|NCT03639428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5660479|NCT03639428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5660480|NCT03639428|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5660481|NCT03639428|Anesthetics, General|anesthetics, general|mesh-ancestor
5660482|NCT03639428|Anesthetics|anesthetics|mesh-ancestor
5660483|NCT03639428|GABA Modulators|gaba modulators|mesh-ancestor
5840160|NCT02507609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840161|NCT02507609|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5660484|NCT03639428|GABA Agents|gaba agents|mesh-ancestor
5660485|NCT03639428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5660486|NCT03639428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660487|NCT03639415|Oxycodone|oxycodone|mesh-list
5840162|NCT02507609|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5840163|NCT02507609|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5840164|NCT02507609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5840165|NCT02507440|Lidocaine|lidocaine|mesh-list
5840166|NCT02507440|Propofol|propofol|mesh-list
5840167|NCT02507440|Anesthetics, Local|anesthetics, local|mesh-ancestor
5840168|NCT02507440|Anesthetics|anesthetics|mesh-ancestor
5840169|NCT02507440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5840170|NCT02507440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840171|NCT02507440|Sensory System Agents|sensory system agents|mesh-ancestor
5840172|NCT02507440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5840173|NCT02507440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5840174|NCT02507440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5840175|NCT02507440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5840176|NCT02507440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5840177|NCT02507440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5840178|NCT02507440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5840179|NCT02507440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5840180|NCT02507440|Anesthetics, General|anesthetics, general|mesh-ancestor
5660488|NCT03639415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5660489|NCT03639415|Narcotics|narcotics|mesh-ancestor
5660490|NCT03639415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5660491|NCT03639415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660492|NCT03639415|Analgesics|analgesics|mesh-ancestor
5660493|NCT03639415|Sensory System Agents|sensory system agents|mesh-ancestor
5840181|NCT02507362|Riboflavin|riboflavin|mesh-list
5840182|NCT02507362|Dextrans|dextrans|mesh-list
5840183|NCT02507362|Vitamin B Complex|vitamin b complex|mesh-ancestor
5840184|NCT02507362|Vitamins|vitamins|mesh-ancestor
6674618|NCT01570569|Antitussive Agents|antitussive agents|mesh-ancestor
6674619|NCT01570569|Respiratory System Agents|respiratory system agents|mesh-ancestor
6674620|NCT01570569|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6674621|NCT01570569|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6674622|NCT01570582|Gemcitabine|gemcitabine|mesh-list
6674623|NCT01570582|Paclitaxel|paclitaxel|mesh-list
6674624|NCT01570582|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6674625|NCT01570582|Carboplatin|carboplatin|mesh-list
6674626|NCT01570582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6674627|NCT01570582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6674628|NCT01570582|Tubulin Modulators|tubulin modulators|mesh-ancestor
5840185|NCT02507362|Micronutrients|micronutrients|mesh-ancestor
5840186|NCT02507362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674629|NCT01570582|Antimitotic Agents|antimitotic agents|mesh-ancestor
5840187|NCT02507362|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5840188|NCT02507362|Dermatologic Agents|dermatologic agents|mesh-ancestor
5840189|NCT02507362|Anticoagulants|anticoagulants|mesh-ancestor
5840190|NCT02507362|Plasma Substitutes|plasma substitutes|mesh-ancestor
5840191|NCT02507362|Blood Substitutes|blood substitutes|mesh-ancestor
5840192|NCT02507336|Thalidomide|thalidomide|mesh-list
5840193|NCT02507336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5840194|NCT02507336|Immunologic Factors|immunologic factors|mesh-ancestor
5840195|NCT02507336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840196|NCT02507336|Leprostatic Agents|leprostatic agents|mesh-ancestor
5840197|NCT02507336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5840198|NCT02507336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5840199|NCT02507336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5840200|NCT02507336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5840201|NCT02507336|Growth Substances|growth substances|mesh-ancestor
5840202|NCT02507336|Growth Inhibitors|growth inhibitors|mesh-ancestor
5840203|NCT02507336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5840204|NCT02507323|Ticagrelor|ticagrelor|mesh-list
5840205|NCT02507323|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
5840206|NCT02507323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5840207|NCT02507323|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5840208|NCT02507323|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5840209|NCT02507323|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5840210|NCT02507323|Purinergic Agents|purinergic agents|mesh-ancestor
5840211|NCT02507323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5660494|NCT03639415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5660495|NCT03639389|Morphine|morphine|mesh-list
5660496|NCT03639389|Analgesics|analgesics|mesh-list
5660497|NCT03639389|Bupivacaine|bupivacaine|mesh-list
5660498|NCT03639389|Anesthetics, Local|anesthetics, local|mesh-ancestor
5840212|NCT02507323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5840213|NCT02507323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840214|NCT02507245|Hormones|hormones|mesh-list
5840215|NCT02507245|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
5840216|NCT02507245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5840217|NCT02507245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840218|NCT02507232|Temozolomide|temozolomide|mesh-list
5840219|NCT02507232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5840220|NCT02507232|Alkylating Agents|alkylating agents|mesh-ancestor
5840221|NCT02507232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5840222|NCT02507232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5840223|NCT02507284|SRX246|srx246|mesh-list
5660499|NCT03639389|Anesthetics|anesthetics|mesh-ancestor
5660500|NCT03639389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5660501|NCT03639389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660502|NCT03639389|Sensory System Agents|sensory system agents|mesh-ancestor
5660503|NCT03639389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5660504|NCT03639389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5660505|NCT03639389|Narcotics|narcotics|mesh-ancestor
5660506|NCT03639363|Chlorhexidine|chlorhexidine|mesh-list
5660507|NCT03639363|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5660508|NCT03639363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5660509|NCT03639363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5660510|NCT03639363|Disinfectants|disinfectants|mesh-ancestor
5660511|NCT03639363|Dermatologic Agents|dermatologic agents|mesh-ancestor
5695204|NCT03390933|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5840224|NCT02507284|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
5840225|NCT02507284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5840226|NCT02507284|Natriuretic Agents|natriuretic agents|mesh-ancestor
5840227|NCT02507284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840228|NCT02506998|Histamine|histamine|mesh-list
5840229|NCT02506998|Histamine Antagonists|histamine antagonists|mesh-list
5840230|NCT02506998|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
5840231|NCT02506998|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-list
5840232|NCT02506998|Histamine Agonists|histamine agonists|mesh-ancestor
5840233|NCT02506998|Histamine Agents|histamine agents|mesh-ancestor
5840234|NCT02506998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5695205|NCT03390933|Antidepressive Agents|antidepressive agents|mesh-ancestor
5695206|NCT03390933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5695207|NCT03390933|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5695208|NCT03390933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5695209|NCT03390933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5695210|NCT03390790|Lidocaine|lidocaine|mesh-list
5695211|NCT03390790|Anesthetics, Local|anesthetics, local|mesh-ancestor
5840235|NCT02506998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5840236|NCT02506998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840237|NCT02507167|Rifampin|rifampin|mesh-list
5840238|NCT02507167|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5840239|NCT02507167|Antitubercular Agents|antitubercular agents|mesh-ancestor
5840240|NCT02507167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5840241|NCT02507167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5840242|NCT02507167|Leprostatic Agents|leprostatic agents|mesh-ancestor
5840243|NCT02507167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5840244|NCT02507167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5840245|NCT02507167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5840246|NCT02507167|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5840247|NCT02507167|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5840248|NCT02507167|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5840249|NCT02507167|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5840250|NCT02507167|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5840251|NCT02507167|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5840252|NCT02507076|Melphalan|melphalan|mesh-list
5840253|NCT02507076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5840254|NCT02507076|Alkylating Agents|alkylating agents|mesh-ancestor
5840255|NCT02507076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5840256|NCT02507076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5840257|NCT02507076|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5840258|NCT02507076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5840259|NCT02507076|Immunologic Factors|immunologic factors|mesh-ancestor
5840260|NCT02507076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840261|NCT02507206|Dihydrexidine|dihydrexidine|mesh-list
5840262|NCT02507206|Dopamine Agonists|dopamine agonists|mesh-ancestor
5840263|NCT02507206|Dopamine Agents|dopamine agents|mesh-ancestor
5840264|NCT02507206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5840265|NCT02507206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5840266|NCT02507206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840267|NCT02507128|Liraglutide|liraglutide|mesh-list
5840268|NCT02507128|Glucagon|glucagon|mesh-list
5840269|NCT02507128|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5840270|NCT02507128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5840271|NCT02507128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840272|NCT02507128|Incretins|incretins|mesh-ancestor
5840273|NCT02507128|Hormones|hormones|mesh-ancestor
5840274|NCT02507128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5840275|NCT02507128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6211975|NCT02180165|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6493682|NCT00615134|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5840276|NCT02506803|Gemcitabine|gemcitabine|mesh-list
5840277|NCT02506803|Paclitaxel|paclitaxel|mesh-list
5840278|NCT02506803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5840279|NCT02506803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5660512|NCT03639168|Cisplatin|cisplatin|mesh-list
5660513|NCT03639168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5660514|NCT03639155|Glycine|glycine|mesh-list
5660515|NCT03639155|Glycine Agents|glycine agents|mesh-ancestor
5660516|NCT03639155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5660517|NCT03639155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660518|NCT03639155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660519|NCT03638999|Ketorolac|ketorolac|mesh-list
5660520|NCT03638999|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
5660521|NCT03638999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5660522|NCT03638999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5660523|NCT03638999|Analgesics|analgesics|mesh-ancestor
5660524|NCT03638999|Sensory System Agents|sensory system agents|mesh-ancestor
5660525|NCT03638999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5660526|NCT03638999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660527|NCT03638999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5660528|NCT03638999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5660529|NCT03638999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5660530|NCT03638999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5660531|NCT03638999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660532|NCT03638960|Bupivacaine|bupivacaine|mesh-list
5660533|NCT03638960|Anesthetics, Local|anesthetics, local|mesh-ancestor
5840280|NCT02506803|Tubulin Modulators|tubulin modulators|mesh-ancestor
5840281|NCT02506803|Antimitotic Agents|antimitotic agents|mesh-ancestor
5840282|NCT02506803|Mitosis Modulators|mitosis modulators|mesh-ancestor
5840283|NCT02506803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493683|NCT00615134|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6493684|NCT00615134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493685|NCT00615134|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6493686|NCT00615134|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6493687|NCT00615134|Antiviral Agents|antiviral agents|mesh-ancestor
6493688|NCT00615134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6493689|NCT00615147|Fibrin fragment D|fibrin fragment d|mesh-list
6493690|NCT00615147|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6493691|NCT00615147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6493692|NCT00615147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493693|NCT00615147|Hemostatics|hemostatics|mesh-ancestor
6493694|NCT00615147|Coagulants|coagulants|mesh-ancestor
6493695|NCT00615160|Dacarbazine|dacarbazine|mesh-list
6493696|NCT00615160|Vatalanib|vatalanib|mesh-list
6493697|NCT00615160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5840284|NCT02506803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5840285|NCT02506803|Antimetabolites|antimetabolites|mesh-ancestor
5840286|NCT02506803|Antiviral Agents|antiviral agents|mesh-ancestor
5840287|NCT02506803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5840288|NCT02506803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5840289|NCT02506803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5840290|NCT02506803|Immunologic Factors|immunologic factors|mesh-ancestor
5840291|NCT02506803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840292|NCT02507154|Cetuximab|cetuximab|mesh-list
5840293|NCT02507154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5840294|NCT02507154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5840295|NCT02506842|Leucovorin|leucovorin|mesh-list
5840296|NCT02506842|Folic Acid|folic acid|mesh-list
5840297|NCT02506842|Gemcitabine|gemcitabine|mesh-list
5840298|NCT02506842|Fluorouracil|fluorouracil|mesh-list
5840299|NCT02506842|Oxaliplatin|oxaliplatin|mesh-list
5840300|NCT02506842|Levoleucovorin|levoleucovorin|mesh-list
5840301|NCT02506842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5840302|NCT02506842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5840303|NCT02506842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5840304|NCT02506842|Antimetabolites|antimetabolites|mesh-ancestor
5840305|NCT02506842|Antiviral Agents|antiviral agents|mesh-ancestor
5840306|NCT02506842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5840307|NCT02506842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5840308|NCT02506842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5840309|NCT02506842|Immunologic Factors|immunologic factors|mesh-ancestor
5840310|NCT02506842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840311|NCT02506842|Antidotes|antidotes|mesh-ancestor
5840312|NCT02506842|Protective Agents|protective agents|mesh-ancestor
5840313|NCT02506842|Vitamin B Complex|vitamin b complex|mesh-ancestor
5840314|NCT02506842|Vitamins|vitamins|mesh-ancestor
5840315|NCT02506842|Micronutrients|micronutrients|mesh-ancestor
5840316|NCT02506842|Hematinics|hematinics|mesh-ancestor
5840317|NCT02506699|Analgesics|analgesics|mesh-list
6493698|NCT00615160|Alkylating Agents|alkylating agents|mesh-ancestor
5840318|NCT02506699|Sensory System Agents|sensory system agents|mesh-ancestor
5840319|NCT02506699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5840320|NCT02506699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840321|NCT02506777|Metformin|metformin|mesh-list
5840322|NCT02506777|Cyclophosphamide|cyclophosphamide|mesh-list
5840323|NCT02506777|Doxorubicin|doxorubicin|mesh-list
5840324|NCT02506777|Fluorouracil|fluorouracil|mesh-list
5840325|NCT02506777|Melatonin|melatonin|mesh-list
5840326|NCT02506777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5840327|NCT02506777|Immunologic Factors|immunologic factors|mesh-ancestor
5840328|NCT02506777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840329|NCT02506777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5840330|NCT02506777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5840331|NCT02506777|Alkylating Agents|alkylating agents|mesh-ancestor
5840332|NCT02506777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5840333|NCT02506777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5840334|NCT02506777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5840335|NCT02506777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5840336|NCT02506777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5840337|NCT02506777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5840338|NCT02506777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5840339|NCT02506777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5840340|NCT02506777|Antioxidants|antioxidants|mesh-ancestor
5840341|NCT02506777|Protective Agents|protective agents|mesh-ancestor
5840342|NCT02506777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5840343|NCT02506777|Antimetabolites|antimetabolites|mesh-ancestor
5840344|NCT02506777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5840345|NCT02506647|Insulin|insulin|mesh-list
5840346|NCT02506647|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5840347|NCT02506647|Insulin Glargine|insulin glargine|mesh-list
5840348|NCT02506647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5660534|NCT03638960|Anesthetics|anesthetics|mesh-ancestor
5660535|NCT03638960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5660536|NCT03638960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660537|NCT03638960|Sensory System Agents|sensory system agents|mesh-ancestor
5660538|NCT03638960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5660539|NCT03638947|Povidone-Iodine|povidone-iodine|mesh-list
5660540|NCT03638947|Povidone|povidone|mesh-list
5840349|NCT02506647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840350|NCT02506790|Toremifene|toremifene|mesh-list
5840351|NCT02506790|Metformin|metformin|mesh-list
5660541|NCT03638947|Plasma Substitutes|plasma substitutes|mesh-ancestor
5660542|NCT03638947|Blood Substitutes|blood substitutes|mesh-ancestor
5660543|NCT03638947|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5660544|NCT03638947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5660545|NCT03638869|Methadone|methadone|mesh-list
5660546|NCT03638869|D-methadone|d-methadone|mesh-list
5660547|NCT03638869|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5660548|NCT03638869|Narcotics|narcotics|mesh-ancestor
5660549|NCT03638869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5660550|NCT03638869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660551|NCT03638869|Analgesics|analgesics|mesh-ancestor
5660552|NCT03638869|Sensory System Agents|sensory system agents|mesh-ancestor
5660553|NCT03638869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5660554|NCT03638869|Antitussive Agents|antitussive agents|mesh-ancestor
5660555|NCT03638869|Respiratory System Agents|respiratory system agents|mesh-ancestor
5660556|NCT03638869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5840352|NCT02506790|Melatonin|melatonin|mesh-list
5660557|NCT03638856|Misoprostol|misoprostol|mesh-list
5660558|NCT03638856|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5660559|NCT03638856|Abortifacient Agents|abortifacient agents|mesh-ancestor
5840353|NCT02506790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5840354|NCT02506790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660560|NCT03638856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5660561|NCT03638856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660562|NCT03638856|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5660563|NCT03638856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5660564|NCT03638856|Oxytocics|oxytocics|mesh-ancestor
5660565|NCT03638726|Atropine|atropine|mesh-list
5660566|NCT03638726|Phenylephrine|phenylephrine|mesh-list
5660567|NCT03638726|Epinephrine|epinephrine|mesh-list
5660568|NCT03638726|Racepinephrine|racepinephrine|mesh-list
5660569|NCT03638726|Oxymetazoline|oxymetazoline|mesh-list
5660570|NCT03638726|Cyclopentolate|cyclopentolate|mesh-list
5660571|NCT03638726|Epinephryl borate|epinephryl borate|mesh-list
5660572|NCT03638726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5840355|NCT02506790|Antioxidants|antioxidants|mesh-ancestor
5840356|NCT02506790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5840357|NCT02506790|Protective Agents|protective agents|mesh-ancestor
5660573|NCT03638726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5660574|NCT03638726|Adrenergic Agents|adrenergic agents|mesh-ancestor
5660575|NCT03638726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5660576|NCT03638726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660577|NCT03638726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660578|NCT03638726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5660579|NCT03638726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5660580|NCT03638726|Autonomic Agents|autonomic agents|mesh-ancestor
5660581|NCT03638726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5660582|NCT03638726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5840358|NCT02506790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5840359|NCT02506790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5840360|NCT02506790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5840361|NCT02506790|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5840362|NCT02506790|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5840363|NCT02506790|Hormone Antagonists|hormone antagonists|mesh-ancestor
5840364|NCT02506790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5840365|NCT02506790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5840366|NCT02506894|Magnesium Sulfate|magnesium sulfate|mesh-list
5840367|NCT02506894|Analgesics|analgesics|mesh-ancestor
5840368|NCT02506894|Sensory System Agents|sensory system agents|mesh-ancestor
5840369|NCT02506894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5840370|NCT02506894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840371|NCT02506894|Anesthetics|anesthetics|mesh-ancestor
5840372|NCT02506894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5840373|NCT02506894|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5840374|NCT02506894|Anticonvulsants|anticonvulsants|mesh-ancestor
5840375|NCT02506894|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5840376|NCT02506894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5840377|NCT02506894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5840378|NCT02506894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5840379|NCT02506894|Tocolytic Agents|tocolytic agents|mesh-ancestor
5840380|NCT02506894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5840381|NCT02506829|Nicotine|nicotine|mesh-list
5660583|NCT03638726|Respiratory System Agents|respiratory system agents|mesh-ancestor
5660584|NCT03638726|Mydriatics|mydriatics|mesh-ancestor
5660585|NCT03638726|Sympathomimetics|sympathomimetics|mesh-ancestor
5840382|NCT02506829|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5840383|NCT02506829|Autonomic Agents|autonomic agents|mesh-ancestor
5840384|NCT02506829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5840385|NCT02506829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840386|NCT02506829|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5840387|NCT02506829|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5840388|NCT02506829|Cholinergic Agents|cholinergic agents|mesh-ancestor
5840389|NCT02506829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5840390|NCT02506829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5840391|NCT02506686|Meropenem|meropenem|mesh-list
5840392|NCT02506686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5840393|NCT02506686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5840394|NCT02506855|Ropivacaine|ropivacaine|mesh-list
5840395|NCT02506855|Anesthetics, Local|anesthetics, local|mesh-ancestor
5840396|NCT02506855|Anesthetics|anesthetics|mesh-ancestor
5840397|NCT02506855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5840398|NCT02506855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660586|NCT03638726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5660587|NCT03638726|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5660588|NCT03638726|Nasal Decongestants|nasal decongestants|mesh-ancestor
5660589|NCT03638726|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5660590|NCT03638726|Protective Agents|protective agents|mesh-ancestor
5660591|NCT03638726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5660592|NCT03638726|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5660593|NCT03638726|Parasympatholytics|parasympatholytics|mesh-ancestor
5660594|NCT03638726|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5660595|NCT03638726|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5660596|NCT03638726|Cholinergic Agents|cholinergic agents|mesh-ancestor
5660597|NCT03638648|Capecitabine|capecitabine|mesh-list
5660598|NCT03638648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5660599|NCT03638648|Antimetabolites|antimetabolites|mesh-ancestor
5660600|NCT03638648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660601|NCT03638648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5660602|NCT03638440|Naloxegol|naloxegol|mesh-list
5660603|NCT03638440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5660604|NCT03638440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660605|NCT03638440|Sensory System Agents|sensory system agents|mesh-ancestor
5660606|NCT03638440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5660607|NCT03638401|Morphine|morphine|mesh-list
5660608|NCT03638401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5660609|NCT03638401|Narcotics|narcotics|mesh-ancestor
5660610|NCT03638401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5840399|NCT02506855|Sensory System Agents|sensory system agents|mesh-ancestor
5840400|NCT02506855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5840401|NCT02506517|Afatinib|afatinib|mesh-list
5840402|NCT02506517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5660611|NCT03638401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660612|NCT03638401|Analgesics|analgesics|mesh-ancestor
5660613|NCT03638401|Sensory System Agents|sensory system agents|mesh-ancestor
5660614|NCT03638401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5660615|NCT03638375|Interferons|interferons|mesh-list
5840403|NCT02506517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5840404|NCT02506517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5840405|NCT02506517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5840406|NCT02506348|Diclofenac|diclofenac|mesh-list
5840407|NCT02506348|Nepafenac|nepafenac|mesh-list
5840408|NCT02506348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5840409|NCT02506348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5840410|NCT02506348|Analgesics|analgesics|mesh-ancestor
5840411|NCT02506348|Sensory System Agents|sensory system agents|mesh-ancestor
5840412|NCT02506348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5840413|NCT02506348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840414|NCT02506348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5840415|NCT02506348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5840416|NCT02506348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5840417|NCT02506348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5840418|NCT02506348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5840419|NCT02506192|Prednisone|prednisone|mesh-list
5840420|NCT02506192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5840421|NCT02506192|Glucocorticoids|glucocorticoids|mesh-ancestor
5840422|NCT02506192|Hormones|hormones|mesh-ancestor
5840423|NCT02506192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5840424|NCT02506192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840425|NCT02506192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5840426|NCT02506192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5840427|NCT02506439|Vitamin D|vitamin d|mesh-list
5840428|NCT02506439|Ergocalciferols|ergocalciferols|mesh-list
5840429|NCT02506439|Cholecalciferol|cholecalciferol|mesh-list
5660616|NCT03638375|Interferon-alpha|interferon-alpha|mesh-list
5660617|NCT03638375|Nivolumab|nivolumab|mesh-list
5660618|NCT03638375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5660619|NCT03638375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5660620|NCT03638375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5660621|NCT03638375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660622|NCT03638375|Antiviral Agents|antiviral agents|mesh-ancestor
5660623|NCT03638375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5660624|NCT03638375|Immunologic Factors|immunologic factors|mesh-ancestor
5660625|NCT03638375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660626|NCT03638310|Gentamicins|gentamicins|mesh-list
5660627|NCT03638310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5660628|NCT03638310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5660629|NCT03638310|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5660630|NCT03638310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5660631|NCT03638310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5840430|NCT02506439|Vitamins|vitamins|mesh-list
5840431|NCT02506439|Micronutrients|micronutrients|mesh-ancestor
5840432|NCT02506439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840433|NCT02506439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5840434|NCT02506439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5840435|NCT02506231|Leucovorin|leucovorin|mesh-list
5660632|NCT03638297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
5660633|NCT03638297|Antibodies|antibodies|mesh-list
5660634|NCT03638297|Immunologic Factors|immunologic factors|mesh-ancestor
5660635|NCT03638297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660636|NCT03638297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5660637|NCT03638297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660638|NCT03638297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5840436|NCT02506231|Folic Acid|folic acid|mesh-list
5660639|NCT03638297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5840437|NCT02506231|Levoleucovorin|levoleucovorin|mesh-list
5840438|NCT02506231|Antidotes|antidotes|mesh-ancestor
5840439|NCT02506231|Protective Agents|protective agents|mesh-ancestor
5840440|NCT02506231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840441|NCT02506231|Vitamin B Complex|vitamin b complex|mesh-ancestor
5840442|NCT02506231|Vitamins|vitamins|mesh-ancestor
5840443|NCT02506231|Micronutrients|micronutrients|mesh-ancestor
5840444|NCT02506231|Hematinics|hematinics|mesh-ancestor
5840445|NCT02506296|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
5840446|NCT02506296|Protease Inhibitors|protease inhibitors|mesh-ancestor
5840447|NCT02506296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5840448|NCT02506296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660640|NCT03638297|Analgesics|analgesics|mesh-ancestor
5660641|NCT03638297|Sensory System Agents|sensory system agents|mesh-ancestor
5660642|NCT03638297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5660643|NCT03638297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5660644|NCT03638297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5660645|NCT03638141|Durvalumab|durvalumab|mesh-list
5660646|NCT03638141|Ipilimumab|ipilimumab|mesh-list
5660647|NCT03638141|Tremelimumab|tremelimumab|mesh-list
5660648|NCT03638141|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5660649|NCT03638141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5660650|NCT03638141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5660651|NCT03638141|Immunologic Factors|immunologic factors|mesh-ancestor
5660652|NCT03638141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660653|NCT03638141|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5660654|NCT03638141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660655|NCT03638076|Ritonavir|ritonavir|mesh-list
5660656|NCT03638076|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5660657|NCT03638076|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5840449|NCT02506296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5840450|NCT02506296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840451|NCT02506140|Aspirin|aspirin|mesh-list
5840452|NCT02506140|Clopidogrel|clopidogrel|mesh-list
5840453|NCT02506140|Ticagrelor|ticagrelor|mesh-list
5840454|NCT02506140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5840455|NCT02506140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5840456|NCT02506140|Analgesics|analgesics|mesh-ancestor
5840457|NCT02506140|Sensory System Agents|sensory system agents|mesh-ancestor
5840458|NCT02506140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5840459|NCT02506140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840460|NCT02506140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5840461|NCT02506140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5840462|NCT02506140|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5840463|NCT02506140|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5840464|NCT02506140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5840465|NCT02506140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5840466|NCT02506140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5840467|NCT02506140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5840468|NCT02506140|Antipyretics|antipyretics|mesh-ancestor
5840469|NCT02506140|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5903236|NCT05131555|Histamine Agents|histamine agents|mesh-ancestor
5660658|NCT03638076|Protease Inhibitors|protease inhibitors|mesh-ancestor
5660659|NCT03638076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5660660|NCT03638076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660661|NCT03638076|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5660662|NCT03638076|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5660663|NCT03638076|Antiviral Agents|antiviral agents|mesh-ancestor
5660664|NCT03638076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5660665|NCT03638076|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5660666|NCT03638076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5660667|NCT03638063|Adenosine|adenosine|mesh-list
5660668|NCT03638063|Capsaicin|capsaicin|mesh-list
5660669|NCT03638063|Antipruritics|antipruritics|mesh-ancestor
5660670|NCT03638063|Dermatologic Agents|dermatologic agents|mesh-ancestor
5660671|NCT03638063|Sensory System Agents|sensory system agents|mesh-ancestor
5660672|NCT03638063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5660673|NCT03638063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660674|NCT03638063|Analgesics|analgesics|mesh-ancestor
5660675|NCT03638063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5660676|NCT03638063|Vasodilator Agents|vasodilator agents|mesh-ancestor
5660677|NCT03638063|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5660678|NCT03638063|Purinergic Agonists|purinergic agonists|mesh-ancestor
5660679|NCT03638063|Purinergic Agents|purinergic agents|mesh-ancestor
5660680|NCT03638063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5660681|NCT03638063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660682|NCT03638037|Vitamin D|vitamin d|mesh-list
5660683|NCT03638037|Vitamins|vitamins|mesh-ancestor
5660684|NCT03638037|Micronutrients|micronutrients|mesh-ancestor
5660685|NCT03638037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660686|NCT03638037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5840470|NCT02506140|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5840471|NCT02506140|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5840472|NCT02506140|Purinergic Agents|purinergic agents|mesh-ancestor
5840473|NCT02506140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5840474|NCT02506023|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
5840475|NCT02506023|Hemostatics|hemostatics|mesh-ancestor
5840476|NCT02506023|Coagulants|coagulants|mesh-ancestor
5840477|NCT02506023|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5840478|NCT02506023|Natriuretic Agents|natriuretic agents|mesh-ancestor
5660687|NCT03637972|Nicotine|nicotine|mesh-list
5660688|NCT03637972|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5660689|NCT03637972|Autonomic Agents|autonomic agents|mesh-ancestor
5660690|NCT03637972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5660691|NCT03637972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660692|NCT03637972|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5660693|NCT03637972|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5840479|NCT02506023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840480|NCT02505997|Midazolam|midazolam|mesh-list
5840481|NCT02505997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5840482|NCT02505997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5840483|NCT02505997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5840484|NCT02505997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840485|NCT02505997|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5840486|NCT02505997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5840487|NCT02505997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5840488|NCT02505997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5840489|NCT02505997|Anesthetics, General|anesthetics, general|mesh-ancestor
5840490|NCT02505997|Anesthetics|anesthetics|mesh-ancestor
5840491|NCT02505997|GABA Modulators|gaba modulators|mesh-ancestor
5840492|NCT02505997|GABA Agents|gaba agents|mesh-ancestor
5840493|NCT02505997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5840494|NCT02505997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5840495|NCT02505984|Oxytocin|oxytocin|mesh-list
5840496|NCT02505984|Oxytocics|oxytocics|mesh-ancestor
5840497|NCT02505984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5840498|NCT02505984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840499|NCT02505815|Hydrocortisone|hydrocortisone|mesh-list
5840500|NCT02505815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5840501|NCT02505802|Botulinum Toxins|botulinum toxins|mesh-list
5840502|NCT02505802|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5840503|NCT02505802|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5840504|NCT02505802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5840505|NCT02505802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5840506|NCT02505802|Cholinergic Agents|cholinergic agents|mesh-ancestor
5840507|NCT02505802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5660694|NCT03637972|Cholinergic Agents|cholinergic agents|mesh-ancestor
5660695|NCT03637972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5840508|NCT02505802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840509|NCT02505802|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5660696|NCT03637972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660697|NCT03637803|Pembrolizumab|pembrolizumab|mesh-list
5660698|NCT03637803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5660699|NCT03637803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5660700|NCT03637790|Rifampin|rifampin|mesh-list
5660701|NCT03637790|Abrocitinib|abrocitinib|mesh-list
5660702|NCT03637790|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5660703|NCT03637790|Antitubercular Agents|antitubercular agents|mesh-ancestor
5660704|NCT03637790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5660705|NCT03637790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5660706|NCT03637790|Leprostatic Agents|leprostatic agents|mesh-ancestor
5660707|NCT03637790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5660708|NCT03637790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5840510|NCT02505802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5903237|NCT05131555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5903238|NCT05131555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903239|NCT05131295|Dapsone|dapsone|mesh-list
5903240|NCT05131295|Aluminum Hydroxide|aluminum hydroxide|mesh-list
5903241|NCT05131295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5903242|NCT05131295|Antimalarials|antimalarials|mesh-ancestor
5903243|NCT05131295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5903244|NCT05131295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5903245|NCT05131295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5903246|NCT05131295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5903247|NCT05131295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903248|NCT05131295|Leprostatic Agents|leprostatic agents|mesh-ancestor
5903249|NCT05131295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5903250|NCT05131295|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5903251|NCT05131295|Immunologic Factors|immunologic factors|mesh-ancestor
5903252|NCT05131295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903253|NCT05131295|Antacids|antacids|mesh-ancestor
5903254|NCT05131295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5903255|NCT05131178|Bupivacaine|bupivacaine|mesh-list
5903256|NCT05131178|Anesthetics, Local|anesthetics, local|mesh-ancestor
5660709|NCT03637790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660710|NCT03637790|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5660711|NCT03637790|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5660712|NCT03637790|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5660713|NCT03637790|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5660714|NCT03637790|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5660715|NCT03637790|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5660716|NCT03637790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5695212|NCT03390790|Anesthetics|anesthetics|mesh-ancestor
5903257|NCT05131178|Anesthetics|anesthetics|mesh-ancestor
5903258|NCT05131178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5903259|NCT05131178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903260|NCT05131178|Sensory System Agents|sensory system agents|mesh-ancestor
5903261|NCT05131178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5903262|NCT05130892|Tranilast|tranilast|mesh-list
5903263|NCT05130892|Colchicine|colchicine|mesh-list
5903264|NCT05130892|Gout Suppressants|gout suppressants|mesh-ancestor
5903265|NCT05130892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5903266|NCT05130892|Tubulin Modulators|tubulin modulators|mesh-ancestor
5695213|NCT03390790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5695214|NCT03390790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695215|NCT03390790|Sensory System Agents|sensory system agents|mesh-ancestor
5695216|NCT03390790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5695217|NCT03390790|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5695218|NCT03390790|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5695219|NCT03390790|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5695220|NCT03390790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5695221|NCT03390790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695222|NCT03390738|Nivolumab|nivolumab|mesh-list
5695223|NCT03390738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5695224|NCT03390738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5695225|NCT03390738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5695226|NCT03390738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695227|NCT03390712|Risperidone|risperidone|mesh-list
5695228|NCT03390712|Paliperidone Palmitate|paliperidone palmitate|mesh-list
5903267|NCT05130892|Antimitotic Agents|antimitotic agents|mesh-ancestor
5903268|NCT05130892|Mitosis Modulators|mitosis modulators|mesh-ancestor
5903269|NCT05130892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660717|NCT03637582|Lidocaine|lidocaine|mesh-list
5660718|NCT03637582|Anesthetics, Local|anesthetics, local|mesh-ancestor
5660719|NCT03637582|Anesthetics|anesthetics|mesh-ancestor
5660720|NCT03637582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5660721|NCT03637582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660722|NCT03637582|Sensory System Agents|sensory system agents|mesh-ancestor
5660723|NCT03637582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5660724|NCT03637582|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5660725|NCT03637582|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5660726|NCT03637582|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5660727|NCT03637582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5660728|NCT03637582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660729|NCT03637543|Nivolumab|nivolumab|mesh-list
5660730|NCT03637543|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5660731|NCT03637543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5660732|NCT03637543|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5660733|NCT03637543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660734|NCT03637400|Doxycycline|doxycycline|mesh-list
5660735|NCT03637400|Trimethoprim|trimethoprim|mesh-list
5660736|NCT03637400|Sulfamethoxazole|sulfamethoxazole|mesh-list
5660737|NCT03637400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5660738|NCT03637400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5660739|NCT03637400|Antimalarials|antimalarials|mesh-ancestor
5660740|NCT03637400|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5660741|NCT03637400|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5660742|NCT03637400|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5660743|NCT03637400|Renal Agents|renal agents|mesh-ancestor
5660744|NCT03637400|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5660745|NCT03637400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5660746|NCT03637400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660747|NCT03637400|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5660748|NCT03637400|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
5660749|NCT03637400|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5660750|NCT03637361|Methadone|methadone|mesh-list
5660751|NCT03637361|D-methadone|d-methadone|mesh-list
5660752|NCT03637361|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5840511|NCT02505841|Ropivacaine|ropivacaine|mesh-list
5840512|NCT02505841|Succinylcholine|succinylcholine|mesh-list
5840513|NCT02505841|Anesthetics, Local|anesthetics, local|mesh-ancestor
5840514|NCT02505841|Anesthetics|anesthetics|mesh-ancestor
5840515|NCT02505841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5840516|NCT02505841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840517|NCT02505841|Sensory System Agents|sensory system agents|mesh-ancestor
5840518|NCT02505841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5840519|NCT02505841|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
5840520|NCT02505841|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5840521|NCT02505841|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5840522|NCT02505776|Bimatoprost|bimatoprost|mesh-list
5840523|NCT02505776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5840524|NCT02505893|Sirolimus|sirolimus|mesh-list
5840525|NCT02505893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5840526|NCT02505893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5840527|NCT02505893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5840528|NCT02505893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5840529|NCT02505893|Antifungal Agents|antifungal agents|mesh-ancestor
5840530|NCT02505893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5840531|NCT02505893|Immunologic Factors|immunologic factors|mesh-ancestor
5660753|NCT03637361|Narcotics|narcotics|mesh-ancestor
5660754|NCT03637361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5660755|NCT03637361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660756|NCT03637361|Analgesics|analgesics|mesh-ancestor
5660757|NCT03637361|Sensory System Agents|sensory system agents|mesh-ancestor
5660758|NCT03637361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5660759|NCT03637361|Antitussive Agents|antitussive agents|mesh-ancestor
5660760|NCT03637361|Respiratory System Agents|respiratory system agents|mesh-ancestor
5660761|NCT03637361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5660762|NCT03637335|Carboplatin|carboplatin|mesh-list
5660763|NCT03637335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5660764|NCT03637283|Bevacizumab|bevacizumab|mesh-list
5660765|NCT03637283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5660766|NCT03637283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5660767|NCT03637283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5660768|NCT03637283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5660769|NCT03637283|Growth Substances|growth substances|mesh-ancestor
6211976|NCT02180165|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5840532|NCT02505893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840533|NCT02505971|Propranolol|propranolol|mesh-list
5840534|NCT02505971|Nadolol|nadolol|mesh-list
5660770|NCT03637283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660771|NCT03637283|Growth Inhibitors|growth inhibitors|mesh-ancestor
5660772|NCT03637075|Insulin|insulin|mesh-list
5660773|NCT03637075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5660774|NCT03637075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660775|NCT03637062|Progesterone|progesterone|mesh-list
5660776|NCT03637062|Progestins|progestins|mesh-ancestor
5660777|NCT03637062|Hormones|hormones|mesh-ancestor
5660778|NCT03637062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5660779|NCT03637062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660780|NCT03637049|Midazolam|midazolam|mesh-list
5660781|NCT03637049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5660782|NCT03637049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5660783|NCT03637049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5660784|NCT03637049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660785|NCT03637049|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5840535|NCT02505971|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5840536|NCT02505971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5840537|NCT02505971|Adrenergic Agents|adrenergic agents|mesh-ancestor
5840538|NCT02505971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5840539|NCT02505971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5840540|NCT02505971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840541|NCT02505971|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5840542|NCT02505971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5840543|NCT02505971|Vasodilator Agents|vasodilator agents|mesh-ancestor
5840544|NCT02505971|Sympatholytics|sympatholytics|mesh-ancestor
5840545|NCT02505971|Autonomic Agents|autonomic agents|mesh-ancestor
5840546|NCT02505971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5840547|NCT02505880|Anesthetics|anesthetics|mesh-list
5840548|NCT02505880|Anesthetics, Local|anesthetics, local|mesh-list
5840549|NCT02505880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5840550|NCT02505880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840551|NCT02505880|Sensory System Agents|sensory system agents|mesh-ancestor
5840552|NCT02505880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5840553|NCT02505633|Lidocaine|lidocaine|mesh-list
5840554|NCT02505633|Epinephrine|epinephrine|mesh-list
5840555|NCT02505633|Racepinephrine|racepinephrine|mesh-list
5840556|NCT02505633|Epinephryl borate|epinephryl borate|mesh-list
5840557|NCT02505633|Anesthetics, Local|anesthetics, local|mesh-ancestor
5840558|NCT02505633|Anesthetics|anesthetics|mesh-ancestor
5840559|NCT02505633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5840560|NCT02505633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840561|NCT02505633|Sensory System Agents|sensory system agents|mesh-ancestor
5840562|NCT02505633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5840563|NCT02505633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5840564|NCT02505633|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5840565|NCT02505633|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5660786|NCT03637049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5660787|NCT03637049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5660788|NCT03637049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5660789|NCT03637049|Anesthetics, General|anesthetics, general|mesh-ancestor
5660790|NCT03637049|Anesthetics|anesthetics|mesh-ancestor
5660791|NCT03637049|GABA Modulators|gaba modulators|mesh-ancestor
5660792|NCT03637049|GABA Agents|gaba agents|mesh-ancestor
5660793|NCT03637049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5660794|NCT03637049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660795|NCT03636971|Mannitol|mannitol|mesh-list
5660796|NCT03636971|Sorbitol|sorbitol|mesh-list
5840566|NCT02505633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5840567|NCT02505633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5840568|NCT02505633|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5840569|NCT02505633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5840570|NCT02505633|Adrenergic Agents|adrenergic agents|mesh-ancestor
5840571|NCT02505633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5840572|NCT02505633|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5840573|NCT02505633|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5840574|NCT02505633|Autonomic Agents|autonomic agents|mesh-ancestor
5840575|NCT02505633|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5840576|NCT02505633|Respiratory System Agents|respiratory system agents|mesh-ancestor
5840577|NCT02505633|Mydriatics|mydriatics|mesh-ancestor
5840578|NCT02505633|Sympathomimetics|sympathomimetics|mesh-ancestor
5840579|NCT02505633|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5840580|NCT02505451|Dobutamine|dobutamine|mesh-list
5840581|NCT02505451|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5840582|NCT02505451|Sympathomimetics|sympathomimetics|mesh-ancestor
5840583|NCT02505451|Autonomic Agents|autonomic agents|mesh-ancestor
5840584|NCT02505451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5840585|NCT02505451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840586|NCT02505451|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5840587|NCT02505451|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5840588|NCT02505451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5840589|NCT02505451|Adrenergic Agents|adrenergic agents|mesh-ancestor
5840590|NCT02505451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5840591|NCT02505451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5840592|NCT02505451|Protective Agents|protective agents|mesh-ancestor
5840593|NCT02505477|Acetylcysteine|acetylcysteine|mesh-list
5840594|NCT02505477|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5840595|NCT02505477|Antiviral Agents|antiviral agents|mesh-ancestor
5840596|NCT02505477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5840597|NCT02505477|Expectorants|expectorants|mesh-ancestor
5840598|NCT02505477|Respiratory System Agents|respiratory system agents|mesh-ancestor
5840599|NCT02505477|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5840600|NCT02505477|Antioxidants|antioxidants|mesh-ancestor
5840601|NCT02505477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5840602|NCT02505477|Protective Agents|protective agents|mesh-ancestor
5840603|NCT02505477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840604|NCT02505477|Antidotes|antidotes|mesh-ancestor
5660797|NCT03636971|Hyaluronic Acid|hyaluronic acid|mesh-list
5660798|NCT03636971|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5660799|NCT03636971|Immunologic Factors|immunologic factors|mesh-ancestor
5660800|NCT03636971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660801|NCT03636971|Viscosupplements|viscosupplements|mesh-ancestor
5660802|NCT03636971|Protective Agents|protective agents|mesh-ancestor
5660803|NCT03636971|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5660804|NCT03636971|Diuretics|diuretics|mesh-ancestor
5660805|NCT03636971|Natriuretic Agents|natriuretic agents|mesh-ancestor
5660806|NCT03636971|Cathartics|cathartics|mesh-ancestor
5660807|NCT03636971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5660808|NCT03636958|Anticonvulsants|anticonvulsants|mesh-list
5660809|NCT03636932|Acetylcysteine|acetylcysteine|mesh-list
5660810|NCT03636932|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5840605|NCT02505516|Metformin|metformin|mesh-list
5840606|NCT02505516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5840607|NCT02505516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840608|NCT02505568|Infliximab|infliximab|mesh-list
5840609|NCT02505568|Dermatologic Agents|dermatologic agents|mesh-ancestor
5840610|NCT02505568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5840611|NCT02505568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5840612|NCT02505581|Metronidazole|metronidazole|mesh-list
5840613|NCT02505581|Ciprofloxacin|ciprofloxacin|mesh-list
5840614|NCT02505581|Cefuroxime|cefuroxime|mesh-list
5840615|NCT02505581|Cefuroxime axetil|cefuroxime axetil|mesh-list
5840616|NCT02505581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5840617|NCT02505581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5840618|NCT02505581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5840619|NCT02505581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5840620|NCT02505581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5840621|NCT02505581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5840622|NCT02505581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5840623|NCT02505581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5840624|NCT02505581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5840625|NCT02505581|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5840626|NCT02505581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5660811|NCT03636932|Antiviral Agents|antiviral agents|mesh-ancestor
5840627|NCT02505360|Hyaluronic Acid|hyaluronic acid|mesh-list
5840628|NCT02505360|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5660812|NCT03636932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5660813|NCT03636932|Expectorants|expectorants|mesh-ancestor
5660814|NCT03636932|Respiratory System Agents|respiratory system agents|mesh-ancestor
5660815|NCT03636932|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5660816|NCT03636932|Antioxidants|antioxidants|mesh-ancestor
5660817|NCT03636932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660818|NCT03636932|Protective Agents|protective agents|mesh-ancestor
5660819|NCT03636932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660820|NCT03636932|Antidotes|antidotes|mesh-ancestor
5840629|NCT02505360|Immunologic Factors|immunologic factors|mesh-ancestor
5840630|NCT02505360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840631|NCT02505360|Viscosupplements|viscosupplements|mesh-ancestor
5840632|NCT02505360|Protective Agents|protective agents|mesh-ancestor
5840633|NCT02505295|Selenium|selenium|mesh-list
5840634|NCT02505295|Antioxidants|antioxidants|mesh-ancestor
5840635|NCT02505295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5840636|NCT02505295|Protective Agents|protective agents|mesh-ancestor
5840637|NCT02505295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660821|NCT03636711|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5660822|NCT03636711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5660823|NCT03636685|Paclitaxel|paclitaxel|mesh-list
5660824|NCT03636685|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5660825|NCT03636685|Carboplatin|carboplatin|mesh-list
5660826|NCT03636685|Pemetrexed|pemetrexed|mesh-list
5660827|NCT03636685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5660828|NCT03636685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5660829|NCT03636685|Tubulin Modulators|tubulin modulators|mesh-ancestor
5660830|NCT03636685|Antimitotic Agents|antimitotic agents|mesh-ancestor
5660831|NCT03636685|Mitosis Modulators|mitosis modulators|mesh-ancestor
5660832|NCT03636685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660833|NCT03636685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5660834|NCT03636685|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5660835|NCT03636685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5660836|NCT03636659|Amphotericin B|amphotericin b|mesh-list
5660837|NCT03636659|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
5660838|NCT03636659|Amebicides|amebicides|mesh-ancestor
5660839|NCT03636659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5840638|NCT02505295|Trace Elements|trace elements|mesh-ancestor
5840639|NCT02505295|Micronutrients|micronutrients|mesh-ancestor
5840640|NCT02505282|Vitamin K|vitamin k|mesh-list
5840641|NCT02505282|Vitamins|vitamins|mesh-ancestor
5840642|NCT02505282|Micronutrients|micronutrients|mesh-ancestor
5840643|NCT02505282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840644|NCT02505282|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5840645|NCT02505282|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5840646|NCT02505282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5840647|NCT02505282|Hemostatics|hemostatics|mesh-ancestor
5840648|NCT02505282|Coagulants|coagulants|mesh-ancestor
5840649|NCT02505399|Clopidogrel|clopidogrel|mesh-list
5840650|NCT02505399|Ticagrelor|ticagrelor|mesh-list
5840651|NCT02505399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5840652|NCT02505399|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5840653|NCT02505399|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5840654|NCT02505399|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5840655|NCT02505399|Purinergic Agents|purinergic agents|mesh-ancestor
5840656|NCT02505399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5840657|NCT02505399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5840658|NCT02505399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840659|NCT02505386|Ertapenem|ertapenem|mesh-list
5840660|NCT02505386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5840661|NCT02505386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5840662|NCT02505009|Tenofovir|tenofovir|mesh-list
5840663|NCT02505009|Entecavir|entecavir|mesh-list
5840664|NCT02505009|Antiviral Agents|antiviral agents|mesh-ancestor
5840665|NCT02505009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5660840|NCT03636659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5660841|NCT03636659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5660842|NCT03636659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5660843|NCT03636659|Antifungal Agents|antifungal agents|mesh-ancestor
5660844|NCT03636555|Oxytocin|oxytocin|mesh-list
5660845|NCT03636555|Oxytocics|oxytocics|mesh-ancestor
5660846|NCT03636555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5660847|NCT03636555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840666|NCT02505009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5840667|NCT02505009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5660848|NCT03636542|Bupivacaine|bupivacaine|mesh-list
5660849|NCT03636542|Anesthetics, Local|anesthetics, local|mesh-ancestor
5660850|NCT03636542|Anesthetics|anesthetics|mesh-ancestor
5840668|NCT02505009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5840669|NCT02505009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5840670|NCT02505009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5840671|NCT02505009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5840672|NCT02505048|Rucaparib|rucaparib|mesh-list
5840673|NCT02505048|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5840674|NCT02505048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5840675|NCT02505048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5840676|NCT02505048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5840677|NCT02505113|Montelukast|montelukast|mesh-list
5840678|NCT02505113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5840679|NCT02505113|Respiratory System Agents|respiratory system agents|mesh-ancestor
5840680|NCT02505113|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5660851|NCT03636542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5660852|NCT03636542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660853|NCT03636542|Sensory System Agents|sensory system agents|mesh-ancestor
5660854|NCT03636542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5660855|NCT03636503|Rituximab|rituximab|mesh-list
5660856|NCT03636503|Avelumab|avelumab|mesh-list
5660857|NCT03636503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5840681|NCT02505113|Hormone Antagonists|hormone antagonists|mesh-ancestor
5840682|NCT02505113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5840683|NCT02505113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840684|NCT02505113|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5840685|NCT02505113|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5840686|NCT02505113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5840687|NCT02504944|Propranolol|propranolol|mesh-list
5660858|NCT03636503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5660859|NCT03636503|Immunologic Factors|immunologic factors|mesh-ancestor
5660860|NCT03636503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660861|NCT03636503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5660862|NCT03636477|Nivolumab|nivolumab|mesh-list
5660863|NCT03636477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5660864|NCT03636477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5660865|NCT03636477|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5660866|NCT03636477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660867|NCT03636373|Triamcinolone|triamcinolone|mesh-list
5660868|NCT03636373|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5660869|NCT03636373|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5660870|NCT03636373|Etanercept|etanercept|mesh-list
5660871|NCT03636373|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5660872|NCT03636373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5660873|NCT03636373|Glucocorticoids|glucocorticoids|mesh-ancestor
5660874|NCT03636373|Hormones|hormones|mesh-ancestor
5660875|NCT03636373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5660876|NCT03636373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660877|NCT03636373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5660878|NCT03636373|Immunologic Factors|immunologic factors|mesh-ancestor
5660879|NCT03636373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5660880|NCT03636373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695229|NCT03390712|Antipsychotic Agents|antipsychotic agents|mesh-list
5840688|NCT02504944|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5840689|NCT02504944|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5840690|NCT02504944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5840691|NCT02504944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5840692|NCT02504944|Adrenergic Agents|adrenergic agents|mesh-ancestor
5840693|NCT02504944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5840694|NCT02504944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5840695|NCT02504944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840696|NCT02504944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5840697|NCT02504944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5840698|NCT02504944|Vasodilator Agents|vasodilator agents|mesh-ancestor
5840699|NCT02504996|Acetaminophen|acetaminophen|mesh-list
5840700|NCT02504996|Morphine|morphine|mesh-list
5840701|NCT02504996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5840702|NCT02504996|Narcotics|narcotics|mesh-ancestor
5840703|NCT02504996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5840704|NCT02504996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840705|NCT02504996|Analgesics|analgesics|mesh-ancestor
5840706|NCT02504996|Sensory System Agents|sensory system agents|mesh-ancestor
5840707|NCT02504996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5840708|NCT02504996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5840709|NCT02504996|Antipyretics|antipyretics|mesh-ancestor
5840710|NCT02504983|Sorafenib|sorafenib|mesh-list
5840711|NCT02504983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5840712|NCT02504983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5840713|NCT02504983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5840714|NCT02504983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5840715|NCT02505087|Acetylcysteine|acetylcysteine|mesh-list
5840716|NCT02505087|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5840717|NCT02505087|Antiviral Agents|antiviral agents|mesh-ancestor
5840718|NCT02505087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5840719|NCT02505087|Expectorants|expectorants|mesh-ancestor
5840720|NCT02505087|Respiratory System Agents|respiratory system agents|mesh-ancestor
5840721|NCT02505087|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5840722|NCT02505087|Antioxidants|antioxidants|mesh-ancestor
5840723|NCT02505087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5840724|NCT02505087|Protective Agents|protective agents|mesh-ancestor
5840725|NCT02505087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840726|NCT02505087|Antidotes|antidotes|mesh-ancestor
5840727|NCT02504801|Budesonide|budesonide|mesh-list
5840728|NCT02504801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5840729|NCT02504801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5840730|NCT02504801|Autonomic Agents|autonomic agents|mesh-ancestor
5840731|NCT02504801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5840732|NCT02504801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840733|NCT02504801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5840734|NCT02504801|Respiratory System Agents|respiratory system agents|mesh-ancestor
5840735|NCT02504801|Glucocorticoids|glucocorticoids|mesh-ancestor
5840736|NCT02504801|Hormones|hormones|mesh-ancestor
5840737|NCT02504801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5840738|NCT02504450|Haloperidol|haloperidol|mesh-list
5840739|NCT02504450|Ziprasidone|ziprasidone|mesh-list
5840740|NCT02504450|Loxapine|loxapine|mesh-list
5840741|NCT02504450|Antiemetics|antiemetics|mesh-ancestor
5840742|NCT02504450|Autonomic Agents|autonomic agents|mesh-ancestor
5840743|NCT02504450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5840744|NCT02504450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840745|NCT02504450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5840746|NCT02504450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5840747|NCT02504450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5840748|NCT02504450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5840749|NCT02504450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5840750|NCT02504450|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5840751|NCT02504450|Dopamine Agents|dopamine agents|mesh-ancestor
5840752|NCT02504450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5840753|NCT02504450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5840754|NCT02504450|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5840755|NCT02504450|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5840756|NCT02504450|Serotonin Agents|serotonin agents|mesh-ancestor
5840757|NCT02504489|Docetaxel|docetaxel|mesh-list
5840758|NCT02504489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5840759|NCT02504489|Tubulin Modulators|tubulin modulators|mesh-ancestor
5840760|NCT02504489|Antimitotic Agents|antimitotic agents|mesh-ancestor
5840761|NCT02504489|Mitosis Modulators|mitosis modulators|mesh-ancestor
5840762|NCT02504489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5840763|NCT02504476|Midazolam|midazolam|mesh-list
5840764|NCT02504476|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5840765|NCT02504476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5840766|NCT02504476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5840767|NCT02504476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840768|NCT02504476|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5840769|NCT02504476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5840770|NCT02504476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5840771|NCT02504476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5660881|NCT03636373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5660882|NCT03636373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5660883|NCT03636373|Analgesics|analgesics|mesh-ancestor
5660884|NCT03636373|Sensory System Agents|sensory system agents|mesh-ancestor
5660885|NCT03636373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5660886|NCT03636373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5660887|NCT03636373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5660888|NCT03636308|Gemcitabine|gemcitabine|mesh-list
5660889|NCT03636308|Paclitaxel|paclitaxel|mesh-list
5660890|NCT03636308|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5660891|NCT03636308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5660892|NCT03636308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5660893|NCT03636308|Tubulin Modulators|tubulin modulators|mesh-ancestor
5660894|NCT03636308|Antimitotic Agents|antimitotic agents|mesh-ancestor
5660895|NCT03636308|Mitosis Modulators|mitosis modulators|mesh-ancestor
5660896|NCT03636308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660897|NCT03636308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5660898|NCT03636308|Antimetabolites|antimetabolites|mesh-ancestor
5660899|NCT03636308|Antiviral Agents|antiviral agents|mesh-ancestor
5840772|NCT02504476|Anesthetics, General|anesthetics, general|mesh-ancestor
5840773|NCT02504476|Anesthetics|anesthetics|mesh-ancestor
5840774|NCT02504476|GABA Modulators|gaba modulators|mesh-ancestor
5840775|NCT02504476|GABA Agents|gaba agents|mesh-ancestor
5840776|NCT02504476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5840777|NCT02504476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5840778|NCT02504463|Naltrexone|naltrexone|mesh-list
5840779|NCT02504463|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5840780|NCT02504463|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5840781|NCT02504463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840782|NCT02504463|Sensory System Agents|sensory system agents|mesh-ancestor
5840783|NCT02504463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5840784|NCT02504398|Methamphetamine|methamphetamine|mesh-list
5840785|NCT02504398|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5840786|NCT02504398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660900|NCT03636308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5660901|NCT03636308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5660902|NCT03636308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5660903|NCT03636308|Immunologic Factors|immunologic factors|mesh-ancestor
5840787|NCT02504398|Sympathomimetics|sympathomimetics|mesh-ancestor
5840788|NCT02504398|Autonomic Agents|autonomic agents|mesh-ancestor
5840789|NCT02504398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5840790|NCT02504398|Dopamine Agents|dopamine agents|mesh-ancestor
5840791|NCT02504398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5840792|NCT02504398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5840793|NCT02504398|Adrenergic Agents|adrenergic agents|mesh-ancestor
5840794|NCT02504398|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5840795|NCT02504398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5840796|NCT02504398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5840797|NCT02504398|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5840798|NCT02504372|Pembrolizumab|pembrolizumab|mesh-list
5840799|NCT02504372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5840800|NCT02504372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5840801|NCT02504359|Cytarabine|cytarabine|mesh-list
5840802|NCT02504359|Methotrexate|methotrexate|mesh-list
5840803|NCT02504359|Etoposide|etoposide|mesh-list
5840804|NCT02504359|Etoposide phosphate|etoposide phosphate|mesh-list
5840805|NCT02504359|Melphalan|melphalan|mesh-list
5840806|NCT02504359|Mechlorethamine|mechlorethamine|mesh-list
5840807|NCT02504359|Carmustine|carmustine|mesh-list
5840808|NCT02504359|Ixazomib|ixazomib|mesh-list
5840809|NCT02504359|Podophyllotoxin|podophyllotoxin|mesh-list
5840810|NCT02504359|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
5840811|NCT02504359|Tacrolimus|tacrolimus|mesh-list
5660904|NCT03636308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660905|NCT03636178|Daminozide|daminozide|mesh-list
5660906|NCT03636178|Plant Growth Regulators|plant growth regulators|mesh-ancestor
5660907|NCT03636178|Growth Substances|growth substances|mesh-ancestor
5660908|NCT03636178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660909|NCT03636152|Hydroxychloroquine|hydroxychloroquine|mesh-list
5660910|NCT03636152|Chloroquine|chloroquine|mesh-list
5660911|NCT03636152|Antimalarials|antimalarials|mesh-ancestor
5660912|NCT03636152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5840812|NCT02504359|Glycine|glycine|mesh-list
5840813|NCT02504359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5840814|NCT02504359|Abortifacient Agents|abortifacient agents|mesh-ancestor
5840815|NCT02504359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5840816|NCT02504359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660913|NCT03636152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5660914|NCT03636152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5660915|NCT03636152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5660916|NCT03636152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660917|NCT03636152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5660918|NCT03636152|Amebicides|amebicides|mesh-ancestor
5660919|NCT03636048|Bupivacaine|bupivacaine|mesh-list
5660920|NCT03636048|Anesthetics|anesthetics|mesh-list
5660921|NCT03636048|Propofol|propofol|mesh-list
5660922|NCT03636048|Anesthetics, Local|anesthetics, local|mesh-ancestor
5660923|NCT03636048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5660924|NCT03636048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660925|NCT03636048|Sensory System Agents|sensory system agents|mesh-ancestor
5660926|NCT03636048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5660927|NCT03636048|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5660928|NCT03636048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5840817|NCT02504359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5840818|NCT02504359|Antimetabolites|antimetabolites|mesh-ancestor
5840819|NCT02504359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5840820|NCT02504359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5840821|NCT02504359|Dermatologic Agents|dermatologic agents|mesh-ancestor
5840822|NCT02504359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5840823|NCT02504359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5840824|NCT02504359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5840825|NCT02504359|Immunologic Factors|immunologic factors|mesh-ancestor
5840826|NCT02504359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5840827|NCT02504359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5840828|NCT02504359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5840829|NCT02504359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5840830|NCT02504359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5840831|NCT02504359|Antiviral Agents|antiviral agents|mesh-ancestor
5840832|NCT02504359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5840833|NCT02504359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5660929|NCT03636048|Anesthetics, General|anesthetics, general|mesh-ancestor
5695230|NCT03390712|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5695231|NCT03390712|Serotonin Agents|serotonin agents|mesh-ancestor
5695232|NCT03390712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5695233|NCT03390712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695234|NCT03390712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695235|NCT03390712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5695236|NCT03390712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5695237|NCT03390712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5695238|NCT03390712|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5695239|NCT03390712|Dopamine Agents|dopamine agents|mesh-ancestor
5695240|NCT03390712|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5695241|NCT03390712|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5695242|NCT03390686|Paclitaxel|paclitaxel|mesh-list
5695243|NCT03390686|Bevacizumab|bevacizumab|mesh-list
5695244|NCT03390686|Carboplatin|carboplatin|mesh-list
5695245|NCT03390686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5695246|NCT03390686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5840834|NCT02504359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5840835|NCT02504359|Alkylating Agents|alkylating agents|mesh-ancestor
5840836|NCT02504359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5840837|NCT02504359|Protease Inhibitors|protease inhibitors|mesh-ancestor
5840838|NCT02504359|Keratolytic Agents|keratolytic agents|mesh-ancestor
5840839|NCT02504359|Tubulin Modulators|tubulin modulators|mesh-ancestor
5840840|NCT02504359|Antimitotic Agents|antimitotic agents|mesh-ancestor
5840841|NCT02504359|Mitosis Modulators|mitosis modulators|mesh-ancestor
5840842|NCT02504359|Glycine Agents|glycine agents|mesh-ancestor
5840843|NCT02504359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5840844|NCT02504307|Sirolimus|sirolimus|mesh-list
5840845|NCT02504307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5840846|NCT02504307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5840847|NCT02504307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5840848|NCT02504307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5840849|NCT02504307|Antifungal Agents|antifungal agents|mesh-ancestor
5840850|NCT02504307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5840851|NCT02504307|Immunologic Factors|immunologic factors|mesh-ancestor
5840852|NCT02504307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840853|NCT02504346|Osimertinib|osimertinib|mesh-list
5840854|NCT02504346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5840855|NCT02504346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5840856|NCT02504346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6211977|NCT02180438|Tenofovir|tenofovir|mesh-list
5695247|NCT03390686|Tubulin Modulators|tubulin modulators|mesh-ancestor
5840857|NCT02504346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660930|NCT03635931|Mitogens|mitogens|mesh-list
5660931|NCT03635931|Mitosis Modulators|mitosis modulators|mesh-ancestor
5660932|NCT03635931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660933|NCT03635905|Gabapentin|gabapentin|mesh-list
5660934|NCT03635905|Analgesics|analgesics|mesh-ancestor
5660935|NCT03635905|Sensory System Agents|sensory system agents|mesh-ancestor
5660936|NCT03635905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5660937|NCT03635905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660938|NCT03635905|Anticonvulsants|anticonvulsants|mesh-ancestor
5840858|NCT02504229|Oxaliplatin|oxaliplatin|mesh-list
5840859|NCT02504229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5840860|NCT02504333|Gemcitabine|gemcitabine|mesh-list
5840861|NCT02504333|Paclitaxel|paclitaxel|mesh-list
5840862|NCT02504333|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5840863|NCT02504333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5840864|NCT02504333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5840865|NCT02504333|Tubulin Modulators|tubulin modulators|mesh-ancestor
5840866|NCT02504333|Antimitotic Agents|antimitotic agents|mesh-ancestor
5840867|NCT02504333|Mitosis Modulators|mitosis modulators|mesh-ancestor
5840868|NCT02504333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5840869|NCT02504333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5840870|NCT02504333|Antimetabolites|antimetabolites|mesh-ancestor
5840871|NCT02504333|Antiviral Agents|antiviral agents|mesh-ancestor
5840872|NCT02504333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5840873|NCT02504333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5840874|NCT02504333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5840875|NCT02504333|Immunologic Factors|immunologic factors|mesh-ancestor
5840876|NCT02504333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840877|NCT02504177|Anticoagulants|anticoagulants|mesh-list
5903270|NCT05130892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5903271|NCT05130892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5903272|NCT05130892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5903273|NCT05130892|Analgesics|analgesics|mesh-ancestor
5903274|NCT05130892|Sensory System Agents|sensory system agents|mesh-ancestor
5903275|NCT05130892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5903276|NCT05130892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903277|NCT05130892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5903278|NCT05130892|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5903279|NCT05130892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5903280|NCT05130892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5903281|NCT05130892|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5903282|NCT05130892|Histamine Antagonists|histamine antagonists|mesh-ancestor
5903283|NCT05130892|Histamine Agents|histamine agents|mesh-ancestor
5903284|NCT05130892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5903285|NCT05130892|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5903286|NCT05130892|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5660939|NCT03635905|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5660940|NCT03635905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5660941|NCT03635905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5660942|NCT03635905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5660943|NCT03635905|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5660944|NCT03635905|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5660945|NCT03635905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5660946|NCT03635905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908390|NCT04598815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5908391|NCT04598815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5908392|NCT04598815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5908393|NCT04598815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5908394|NCT04598815|Antifungal Agents|antifungal agents|mesh-ancestor
5908395|NCT04598815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5908396|NCT04598815|Immunologic Factors|immunologic factors|mesh-ancestor
5908397|NCT04598815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5908398|NCT04585789|Tenofovir|tenofovir|mesh-list
5908399|NCT04585789|Entecavir|entecavir|mesh-list
5908400|NCT04585789|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5908401|NCT04585789|Antiviral Agents|antiviral agents|mesh-ancestor
5908402|NCT04585789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5908403|NCT04585789|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5908404|NCT04585789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5908405|NCT04585789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5908406|NCT04585789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908407|NCT04585789|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5908408|NCT04585789|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5660947|NCT03635905|Antimanic Agents|antimanic agents|mesh-ancestor
5660948|NCT03635827|Xenon|xenon|mesh-list
5660949|NCT03635827|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5660950|NCT03635827|Anesthetics, General|anesthetics, general|mesh-ancestor
5660951|NCT03635827|Anesthetics|anesthetics|mesh-ancestor
5660952|NCT03635827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5660953|NCT03635827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840878|NCT02504164|Midazolam|midazolam|mesh-list
5840879|NCT02504164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5840880|NCT02504164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5840881|NCT02504164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5840882|NCT02504164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840883|NCT02504164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5840884|NCT02504164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5840885|NCT02504164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5840886|NCT02504164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5840887|NCT02504164|Anesthetics, General|anesthetics, general|mesh-ancestor
5840888|NCT02504164|Anesthetics|anesthetics|mesh-ancestor
5840889|NCT02504164|GABA Modulators|gaba modulators|mesh-ancestor
5840890|NCT02504164|GABA Agents|gaba agents|mesh-ancestor
5840891|NCT02504164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5840892|NCT02504164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5840893|NCT02504138|Anesthetics|anesthetics|mesh-list
5840894|NCT02504138|Propofol|propofol|mesh-list
5840895|NCT02504138|Desflurane|desflurane|mesh-list
5840896|NCT02504138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5840897|NCT02504138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840898|NCT02504138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5840899|NCT02504138|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5840900|NCT02504138|Anesthetics, General|anesthetics, general|mesh-ancestor
5840901|NCT02504138|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5840902|NCT02504125|Tranexamic Acid|tranexamic acid|mesh-list
5840903|NCT02504125|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5840904|NCT02504125|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5840905|NCT02504125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5840906|NCT02504125|Hemostatics|hemostatics|mesh-ancestor
5840907|NCT02504125|Coagulants|coagulants|mesh-ancestor
5840908|NCT02503826|Midazolam|midazolam|mesh-list
5840909|NCT02503826|Sufentanil|sufentanil|mesh-list
5840910|NCT02503826|Dsuvia|dsuvia|mesh-list
5840911|NCT02503826|Propofol|propofol|mesh-list
5840912|NCT02503826|Cisatracurium|cisatracurium|mesh-list
5840913|NCT02503826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5840914|NCT02503826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5840915|NCT02503826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840916|NCT02503826|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5660954|NCT03635684|Acetaminophen|acetaminophen|mesh-list
5660955|NCT03635684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5660956|NCT03635684|Analgesics|analgesics|mesh-ancestor
5840917|NCT02503826|Anesthetics, General|anesthetics, general|mesh-ancestor
5840918|NCT02503826|Anesthetics|anesthetics|mesh-ancestor
5840919|NCT02503826|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5840920|NCT02503826|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5840921|NCT02503826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5660957|NCT03635684|Sensory System Agents|sensory system agents|mesh-ancestor
5660958|NCT03635684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5660959|NCT03635684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660960|NCT03635684|Antipyretics|antipyretics|mesh-ancestor
5660961|NCT03635567|Paclitaxel|paclitaxel|mesh-list
5660962|NCT03635567|Bevacizumab|bevacizumab|mesh-list
5660963|NCT03635567|Carboplatin|carboplatin|mesh-list
5660964|NCT03635567|Pembrolizumab|pembrolizumab|mesh-list
5660965|NCT03635567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5840922|NCT02503826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5840923|NCT02503826|GABA Modulators|gaba modulators|mesh-ancestor
5840924|NCT02503826|GABA Agents|gaba agents|mesh-ancestor
5840925|NCT02503826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5840926|NCT02503826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5840927|NCT02503826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5840928|NCT02503826|Narcotics|narcotics|mesh-ancestor
5840929|NCT02503826|Analgesics|analgesics|mesh-ancestor
5840930|NCT02503826|Sensory System Agents|sensory system agents|mesh-ancestor
5840931|NCT02503826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5840932|NCT02503826|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5840933|NCT02503826|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5840934|NCT02503839|Etoricoxib|etoricoxib|mesh-list
5840935|NCT02503839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5840936|NCT02503839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5840937|NCT02503839|Analgesics|analgesics|mesh-ancestor
5840938|NCT02503839|Sensory System Agents|sensory system agents|mesh-ancestor
5840939|NCT02503839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5840940|NCT02503839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840941|NCT02503839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5840942|NCT02503839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5840943|NCT02503839|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5840944|NCT02503839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5840945|NCT02503839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5840946|NCT02503839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5840947|NCT02504008|Zoledronic Acid|zoledronic acid|mesh-list
5840948|NCT02504008|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5840949|NCT02504008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493699|NCT00615160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493700|NCT00615160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6493701|NCT00615160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6493702|NCT00615160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6493703|NCT00615173|Cyclophosphamide|cyclophosphamide|mesh-list
6493704|NCT00615173|Azathioprine|azathioprine|mesh-list
6493705|NCT00615173|Tacrolimus|tacrolimus|mesh-list
6493706|NCT00615173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6493707|NCT00615173|Immunologic Factors|immunologic factors|mesh-ancestor
6493708|NCT00615173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493709|NCT00615173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6493710|NCT00615173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6493711|NCT00615173|Alkylating Agents|alkylating agents|mesh-ancestor
5840950|NCT02503904|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5840951|NCT02503904|Metronidazole|metronidazole|mesh-list
5840952|NCT02503904|Lidocaine|lidocaine|mesh-list
5840953|NCT02503904|Epinephrine|epinephrine|mesh-list
5840954|NCT02503904|Anesthetics, Local|anesthetics, local|mesh-ancestor
5840955|NCT02503904|Anesthetics|anesthetics|mesh-ancestor
5840956|NCT02503904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5840957|NCT02503904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840958|NCT02503904|Sensory System Agents|sensory system agents|mesh-ancestor
5840959|NCT02503904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5840960|NCT02503904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5840961|NCT02503904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5840962|NCT02503904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5660966|NCT03635567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5660967|NCT03635567|Tubulin Modulators|tubulin modulators|mesh-ancestor
5660968|NCT03635567|Antimitotic Agents|antimitotic agents|mesh-ancestor
5660969|NCT03635567|Mitosis Modulators|mitosis modulators|mesh-ancestor
5660970|NCT03635567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660971|NCT03635567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5660972|NCT03635567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5840963|NCT02503904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5840964|NCT02503904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5840965|NCT02503904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5840966|NCT02503904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5840967|NCT02503904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5840968|NCT02503904|Adrenergic Agents|adrenergic agents|mesh-ancestor
5840969|NCT02503904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5840970|NCT02503904|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5840971|NCT02503904|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5840972|NCT02503904|Autonomic Agents|autonomic agents|mesh-ancestor
5840973|NCT02503904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5840974|NCT02503904|Respiratory System Agents|respiratory system agents|mesh-ancestor
5840975|NCT02503904|Mydriatics|mydriatics|mesh-ancestor
5840976|NCT02503904|Sympathomimetics|sympathomimetics|mesh-ancestor
5840977|NCT02503904|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5840978|NCT02503904|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5840979|NCT02503904|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5840980|NCT02503943|Metformin|metformin|mesh-list
6493712|NCT00615173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660973|NCT03635567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5660974|NCT03635567|Growth Substances|growth substances|mesh-ancestor
5660975|NCT03635567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660976|NCT03635567|Growth Inhibitors|growth inhibitors|mesh-ancestor
5660977|NCT03635437|Alprazolam|alprazolam|mesh-list
5660978|NCT03635437|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
5660979|NCT03635437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5660980|NCT03635437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5660981|NCT03635437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660982|NCT03635437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5660983|NCT03635437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5840981|NCT02503943|Liraglutide|liraglutide|mesh-list
5840982|NCT02503943|Mitiglinide|mitiglinide|mesh-list
5840983|NCT02503943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5840984|NCT02503943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5840985|NCT02503943|Incretins|incretins|mesh-ancestor
5840986|NCT02503943|Hormones|hormones|mesh-ancestor
5840987|NCT02503943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5840988|NCT02503761|Meropenem|meropenem|mesh-list
5840989|NCT02503761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5840990|NCT02503761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5840991|NCT02503722|Osimertinib|osimertinib|mesh-list
5840992|NCT02503722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5840993|NCT02503722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5840994|NCT02503722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5840995|NCT02503722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5840996|NCT02503709|Cyclin-Dependent Kinase Inhibitor Proteins|cyclin-dependent kinase inhibitor proteins|mesh-list
5840997|NCT02503709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5840998|NCT02503709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5840999|NCT02503709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841000|NCT02503462|Ritonavir|ritonavir|mesh-list
5841001|NCT02503462|Darunavir|darunavir|mesh-list
5841002|NCT02503462|Cobicistat|cobicistat|mesh-list
5841003|NCT02503462|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5841004|NCT02503462|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5660984|NCT03635437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5660985|NCT03635437|GABA Modulators|gaba modulators|mesh-ancestor
5660986|NCT03635437|GABA Agents|gaba agents|mesh-ancestor
5660987|NCT03635437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5660988|NCT03635437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660989|NCT03635411|Niacinamide|niacinamide|mesh-list
5660990|NCT03635411|Niacin|niacin|mesh-list
5660991|NCT03635411|Nicotinic Acids|nicotinic acids|mesh-list
5660992|NCT03635411|Vitamin B Complex|vitamin b complex|mesh-ancestor
5660993|NCT03635411|Vitamins|vitamins|mesh-ancestor
5660994|NCT03635411|Micronutrients|micronutrients|mesh-ancestor
5660995|NCT03635411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660996|NCT03635411|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5660997|NCT03635411|Antimetabolites|antimetabolites|mesh-ancestor
5841005|NCT02503462|Protease Inhibitors|protease inhibitors|mesh-ancestor
5841006|NCT02503462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5841007|NCT02503462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841008|NCT02503462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5841009|NCT02503462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5841010|NCT02503462|Antiviral Agents|antiviral agents|mesh-ancestor
5841011|NCT02503462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5841012|NCT02503462|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5841013|NCT02503462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5841014|NCT02503319|Tranexamic Acid|tranexamic acid|mesh-list
5841015|NCT02503319|Oxytocin|oxytocin|mesh-list
5841016|NCT02503319|Oxytocics|oxytocics|mesh-ancestor
5841017|NCT02503319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5841018|NCT02503319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5660998|NCT03635411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5660999|NCT03635411|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5661000|NCT03635411|Vasodilator Agents|vasodilator agents|mesh-ancestor
5661001|NCT03635398|Midazolam|midazolam|mesh-list
5661002|NCT03635398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5661003|NCT03635398|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5661004|NCT03635398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5841019|NCT02503319|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5661005|NCT03635398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661006|NCT03635398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5661007|NCT03635398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5661008|NCT03635398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5661009|NCT03635398|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5661010|NCT03635398|Anesthetics, General|anesthetics, general|mesh-ancestor
5661011|NCT03635398|Anesthetics|anesthetics|mesh-ancestor
5661012|NCT03635398|GABA Modulators|gaba modulators|mesh-ancestor
5661013|NCT03635398|GABA Agents|gaba agents|mesh-ancestor
5661014|NCT03635398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5661015|NCT03635398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661016|NCT03635372|Sucralfate|sucralfate|mesh-list
5661017|NCT03635372|Hydrotalcite|hydrotalcite|mesh-list
5661018|NCT03635372|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5661019|NCT03635372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5661020|NCT03635372|Antacids|antacids|mesh-ancestor
5841020|NCT02503319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5841021|NCT02503319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841022|NCT02503319|Hemostatics|hemostatics|mesh-ancestor
5841023|NCT02503319|Coagulants|coagulants|mesh-ancestor
5841024|NCT02503358|Paclitaxel|paclitaxel|mesh-list
5841025|NCT02503358|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5841026|NCT02503358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5841027|NCT02503358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5841028|NCT02503358|Tubulin Modulators|tubulin modulators|mesh-ancestor
5841029|NCT02503358|Antimitotic Agents|antimitotic agents|mesh-ancestor
5841030|NCT02503358|Mitosis Modulators|mitosis modulators|mesh-ancestor
5841031|NCT02503358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841032|NCT02503189|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5841033|NCT02503189|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5841034|NCT02503176|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5841035|NCT02503176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5841036|NCT02503163|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5841037|NCT02503163|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5841038|NCT02502968|Cytarabine|cytarabine|mesh-list
5841039|NCT02502968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5841040|NCT02502968|Antimetabolites|antimetabolites|mesh-ancestor
5841041|NCT02502968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661021|NCT03635372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661022|NCT03635333|Nicotine|nicotine|mesh-list
5661023|NCT03635333|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5841042|NCT02502968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5841043|NCT02502968|Antiviral Agents|antiviral agents|mesh-ancestor
5841044|NCT02502968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5841045|NCT02502968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5841046|NCT02502968|Immunologic Factors|immunologic factors|mesh-ancestor
5841047|NCT02502968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841048|NCT02502981|Chlorthalidone|chlorthalidone|mesh-list
5841049|NCT02502981|Spironolactone|spironolactone|mesh-list
5841050|NCT02502981|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
5841051|NCT02502981|Diuretics|diuretics|mesh-list
5841052|NCT02502981|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
5841053|NCT02502981|Mineralocorticoids|mineralocorticoids|mesh-list
5841054|NCT02502981|Hormone Antagonists|hormone antagonists|mesh-ancestor
5841055|NCT02502981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5841056|NCT02502981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841057|NCT02502981|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5841058|NCT02502981|Natriuretic Agents|natriuretic agents|mesh-ancestor
5841059|NCT02502981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5841060|NCT02502981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5841061|NCT02502981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841062|NCT02502981|Hormones|hormones|mesh-ancestor
5661024|NCT03635333|Autonomic Agents|autonomic agents|mesh-ancestor
5661025|NCT03635333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5661026|NCT03635333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661027|NCT03635333|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5661028|NCT03635333|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5661029|NCT03635333|Cholinergic Agents|cholinergic agents|mesh-ancestor
5661030|NCT03635333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5661031|NCT03635333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661032|NCT03635125|Metoprolol|metoprolol|mesh-list
5661033|NCT03635125|Nebivolol|nebivolol|mesh-list
5841063|NCT02502682|Chlorhexidine|chlorhexidine|mesh-list
5841064|NCT02502682|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5841065|NCT02502682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5661034|NCT03635125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5841066|NCT02502682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5841067|NCT02502682|Disinfectants|disinfectants|mesh-ancestor
5841068|NCT02502682|Dermatologic Agents|dermatologic agents|mesh-ancestor
5841069|NCT02502747|Sargramostim|sargramostim|mesh-list
5841070|NCT02502747|Immunologic Factors|immunologic factors|mesh-ancestor
5841071|NCT02502747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841072|NCT02502643|Picibanil|picibanil|mesh-list
5841073|NCT02502643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5841074|NCT02502565|Uric Acid|uric acid|mesh-list
5841075|NCT02502565|Antioxidants|antioxidants|mesh-ancestor
5841076|NCT02502565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841077|NCT02502565|Protective Agents|protective agents|mesh-ancestor
5841078|NCT02502565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661035|NCT03635125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5661036|NCT03635125|Sympatholytics|sympatholytics|mesh-ancestor
5661037|NCT03635125|Autonomic Agents|autonomic agents|mesh-ancestor
5661038|NCT03635125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5661039|NCT03635125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661040|NCT03635125|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5661041|NCT03635125|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5661042|NCT03635125|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5661043|NCT03635125|Adrenergic Agents|adrenergic agents|mesh-ancestor
5661044|NCT03635125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5661045|NCT03635125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661046|NCT03635125|Vasodilator Agents|vasodilator agents|mesh-ancestor
5661047|NCT03635125|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5661048|NCT03635125|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5661049|NCT03635125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5661050|NCT03635021|Bevacizumab|bevacizumab|mesh-list
5661051|NCT03635021|Panitumumab|panitumumab|mesh-list
5661052|NCT03635021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5661053|NCT03635021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5661054|NCT03635021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5841079|NCT02502825|Methacholine Chloride|methacholine chloride|mesh-list
5841080|NCT02502825|Miotics|miotics|mesh-ancestor
5841081|NCT02502825|Autonomic Agents|autonomic agents|mesh-ancestor
5841082|NCT02502825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5841083|NCT02502825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841084|NCT02502825|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5841085|NCT02502825|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
5841086|NCT02502825|Respiratory System Agents|respiratory system agents|mesh-ancestor
5841087|NCT02502825|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
5841088|NCT02502825|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5841089|NCT02502825|Cholinergic Agents|cholinergic agents|mesh-ancestor
5841090|NCT02502825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5841091|NCT02502825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841092|NCT02502799|Methylphenidate|methylphenidate|mesh-list
5841093|NCT02502799|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5841094|NCT02502799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841095|NCT02502799|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5841096|NCT02502799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5841097|NCT02502799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5841098|NCT02502799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841099|NCT02502799|Dopamine Agents|dopamine agents|mesh-ancestor
5841100|NCT02502799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5903287|NCT05130814|Hyaluronic Acid|hyaluronic acid|mesh-list
5903288|NCT05130814|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5903289|NCT05130814|Immunologic Factors|immunologic factors|mesh-ancestor
5903290|NCT05130814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903291|NCT05130814|Viscosupplements|viscosupplements|mesh-ancestor
5903292|NCT05130814|Protective Agents|protective agents|mesh-ancestor
5903293|NCT05130684|Paclitaxel|paclitaxel|mesh-list
5903294|NCT05130684|Cisplatin|cisplatin|mesh-list
5903295|NCT05130684|Nivolumab|nivolumab|mesh-list
5903296|NCT05130684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5903297|NCT05130684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5903298|NCT05130684|Tubulin Modulators|tubulin modulators|mesh-ancestor
5903299|NCT05130684|Antimitotic Agents|antimitotic agents|mesh-ancestor
5903300|NCT05130684|Mitosis Modulators|mitosis modulators|mesh-ancestor
5661055|NCT03635021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5661056|NCT03635021|Growth Substances|growth substances|mesh-ancestor
5661057|NCT03635021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661058|NCT03635021|Growth Inhibitors|growth inhibitors|mesh-ancestor
5903301|NCT05130684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908409|NCT04570332|Pembrolizumab|pembrolizumab|mesh-list
5841101|NCT02502877|Midazolam|midazolam|mesh-list
5841102|NCT02502877|Propofol|propofol|mesh-list
5841103|NCT02502877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5841104|NCT02502877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5841105|NCT02502877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841106|NCT02502877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5841107|NCT02502877|Anesthetics, General|anesthetics, general|mesh-ancestor
5841108|NCT02502877|Anesthetics|anesthetics|mesh-ancestor
5841109|NCT02502877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5841110|NCT02502877|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5841111|NCT02502877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5841112|NCT02502877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5841113|NCT02502877|GABA Modulators|gaba modulators|mesh-ancestor
5661059|NCT03634917|Calcium, Dietary|calcium, dietary|mesh-list
5661060|NCT03634917|Acamprosate|acamprosate|mesh-list
5661061|NCT03634917|Calcium Carbonate|calcium carbonate|mesh-list
5661062|NCT03634917|Calcium|calcium|mesh-list
5661063|NCT03634917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5661064|NCT03634917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661065|NCT03634917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5661066|NCT03634917|Antacids|antacids|mesh-ancestor
5841114|NCT02502877|GABA Agents|gaba agents|mesh-ancestor
5841115|NCT02502877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5841116|NCT02502877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841117|NCT02502500|Celecoxib|celecoxib|mesh-list
5841118|NCT02502500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5841119|NCT02502500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5841120|NCT02502500|Analgesics|analgesics|mesh-ancestor
5841121|NCT02502500|Sensory System Agents|sensory system agents|mesh-ancestor
5841122|NCT02502500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5841123|NCT02502500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841124|NCT02502500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5841125|NCT02502500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5841126|NCT02502500|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5841127|NCT02502500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5841128|NCT02502500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5841129|NCT02502500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841130|NCT02502253|Resveratrol|resveratrol|mesh-list
5841131|NCT02502253|Antioxidants|antioxidants|mesh-ancestor
5841132|NCT02502253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841133|NCT02502253|Protective Agents|protective agents|mesh-ancestor
5841134|NCT02502253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841135|NCT02502253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5841136|NCT02502253|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5841137|NCT02502110|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5841138|NCT02502110|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5841139|NCT02502110|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5841140|NCT02502110|Antimetabolites|antimetabolites|mesh-ancestor
5841141|NCT02502110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841142|NCT02502110|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5841143|NCT02502110|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5841144|NCT02502110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5841145|NCT02502344|Metformin|metformin|mesh-list
5841146|NCT02502344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6211978|NCT02180438|Emtricitabine|emtricitabine|mesh-list
5661067|NCT03634917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661068|NCT03634917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5661069|NCT03634917|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5661070|NCT03634852|Moxifloxacin|moxifloxacin|mesh-list
5661071|NCT03634852|Dexamethasone|dexamethasone|mesh-list
5661072|NCT03634852|Triamcinolone|triamcinolone|mesh-list
5661073|NCT03634852|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5661074|NCT03634852|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5661075|NCT03634852|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5661076|NCT03634852|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
5661077|NCT03634852|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5661078|NCT03634852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5661079|NCT03634852|Antiemetics|antiemetics|mesh-ancestor
5661080|NCT03634852|Autonomic Agents|autonomic agents|mesh-ancestor
5661081|NCT03634852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5661082|NCT03634852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661083|NCT03634852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5661084|NCT03634852|Glucocorticoids|glucocorticoids|mesh-ancestor
5661085|NCT03634852|Hormones|hormones|mesh-ancestor
5661086|NCT03634852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5661087|NCT03634852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5661088|NCT03634852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5661089|NCT03634852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5661090|NCT03634852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5661091|NCT03634852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5661092|NCT03634852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5661093|NCT03634852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5661094|NCT03634852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661095|NCT03634852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5661096|NCT03634852|Contraceptive Agents|contraceptive agents|mesh-ancestor
5661097|NCT03634852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5661098|NCT03634852|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5661099|NCT03634852|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5661100|NCT03634852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5661101|NCT03634852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5661102|NCT03634852|Immunologic Factors|immunologic factors|mesh-ancestor
5661103|NCT03634852|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5661104|NCT03634839|Nicotine|nicotine|mesh-list
5661105|NCT03634839|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5661106|NCT03634839|Autonomic Agents|autonomic agents|mesh-ancestor
5661107|NCT03634839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5661108|NCT03634839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661109|NCT03634839|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5661110|NCT03634839|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5661111|NCT03634839|Cholinergic Agents|cholinergic agents|mesh-ancestor
5661112|NCT03634839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5661113|NCT03634839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661114|NCT03634735|Thiamine|thiamine|mesh-list
5661115|NCT03634735|Vitamins|vitamins|mesh-ancestor
5661116|NCT03634735|Micronutrients|micronutrients|mesh-ancestor
5661117|NCT03634735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661118|NCT03634735|Vitamin B Complex|vitamin b complex|mesh-ancestor
5661119|NCT03634605|Tetracycline|tetracycline|mesh-list
5661120|NCT03634605|Lidocaine|lidocaine|mesh-list
5661121|NCT03634605|Anesthetics, Local|anesthetics, local|mesh-ancestor
5661122|NCT03634605|Anesthetics|anesthetics|mesh-ancestor
5661123|NCT03634605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5661124|NCT03634605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661125|NCT03634605|Sensory System Agents|sensory system agents|mesh-ancestor
5661126|NCT03634605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5661127|NCT03634605|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5661128|NCT03634605|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5661129|NCT03634605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5661130|NCT03634605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5661131|NCT03634605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661132|NCT03634605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5661133|NCT03634605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5661134|NCT03634605|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5661135|NCT03634605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5661136|NCT03634514|Hormones|hormones|mesh-list
5661137|NCT03634514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5661138|NCT03634514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695248|NCT03390686|Antimitotic Agents|antimitotic agents|mesh-ancestor
5695249|NCT03390686|Mitosis Modulators|mitosis modulators|mesh-ancestor
5695250|NCT03390686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695251|NCT03390686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5695252|NCT03390686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5695253|NCT03390686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5695254|NCT03390686|Growth Substances|growth substances|mesh-ancestor
5695255|NCT03390686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695256|NCT03390686|Growth Inhibitors|growth inhibitors|mesh-ancestor
5695257|NCT03390673|Bevacizumab|bevacizumab|mesh-list
5695258|NCT03390673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5695259|NCT03390673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5695260|NCT03390673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5695261|NCT03390673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5695262|NCT03390673|Growth Substances|growth substances|mesh-ancestor
5695263|NCT03390673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695264|NCT03390673|Growth Inhibitors|growth inhibitors|mesh-ancestor
5695265|NCT03390608|Trastuzumab|trastuzumab|mesh-list
5695266|NCT03390608|Estrogens|estrogens|mesh-list
5695267|NCT03390608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5695268|NCT03390608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5841147|NCT02502344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841148|NCT02502175|Methadone|methadone|mesh-list
6211979|NCT02180438|Cobicistat|cobicistat|mesh-list
6211980|NCT02180438|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6211981|NCT02180438|Elvitegravir|elvitegravir|mesh-list
5661139|NCT03634345|Fluconazole|fluconazole|mesh-list
5661140|NCT03634345|Fluvoxamine|fluvoxamine|mesh-list
5661141|NCT03634345|Abrocitinib|abrocitinib|mesh-list
5661142|NCT03634345|Antifungal Agents|antifungal agents|mesh-ancestor
5661143|NCT03634345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5661144|NCT03634345|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5661145|NCT03634345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5661146|NCT03634345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5661147|NCT03634345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661148|NCT03634345|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5661149|NCT03634345|Hormone Antagonists|hormone antagonists|mesh-ancestor
5661150|NCT03634345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5661151|NCT03634345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661152|NCT03634345|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5661153|NCT03634345|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5661154|NCT03634345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5661155|NCT03634345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5661156|NCT03634345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5661157|NCT03634345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6211982|NCT02180438|Antiviral Agents|antiviral agents|mesh-ancestor
6211983|NCT02180438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6211984|NCT02180438|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6211985|NCT02180438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6211986|NCT02180438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6211987|NCT02180438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211988|NCT02180438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6211989|NCT02180438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6211990|NCT02180438|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6211991|NCT02180438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6211992|NCT02180438|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5841149|NCT02502175|Opium|opium|mesh-list
5841150|NCT02502175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5841151|NCT02502175|Narcotics|narcotics|mesh-ancestor
5841152|NCT02502175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5841153|NCT02502175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841154|NCT02502175|Analgesics|analgesics|mesh-ancestor
5841155|NCT02502175|Sensory System Agents|sensory system agents|mesh-ancestor
5841156|NCT02502175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5841157|NCT02502175|Antitussive Agents|antitussive agents|mesh-ancestor
5841158|NCT02502175|Respiratory System Agents|respiratory system agents|mesh-ancestor
5841159|NCT02502175|Antidiarrheals|antidiarrheals|mesh-ancestor
5661158|NCT03634345|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5661159|NCT03634345|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5661160|NCT03634345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5661161|NCT03634345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5661162|NCT03634345|Serotonin Agents|serotonin agents|mesh-ancestor
5661163|NCT03634345|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5661164|NCT03634345|Antidepressive Agents|antidepressive agents|mesh-ancestor
5661165|NCT03634345|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5661166|NCT03634345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5661167|NCT03634332|Pembrolizumab|pembrolizumab|mesh-list
5661168|NCT03634332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5661169|NCT03634332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5661170|NCT03634202|Capecitabine|capecitabine|mesh-list
5661171|NCT03634202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5661172|NCT03634202|Antimetabolites|antimetabolites|mesh-ancestor
5841160|NCT02502175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5841161|NCT02502032|Cisatracurium|cisatracurium|mesh-list
5841162|NCT02502032|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5841163|NCT02502032|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5841164|NCT02502032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5841165|NCT02502032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841166|NCT02502708|Cyclophosphamide|cyclophosphamide|mesh-list
5841167|NCT02502708|Temozolomide|temozolomide|mesh-list
5841168|NCT02502708|Etoposide|etoposide|mesh-list
5841169|NCT02502708|Tryptophan|tryptophan|mesh-list
5841170|NCT02502708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5841171|NCT02502708|Immunologic Factors|immunologic factors|mesh-ancestor
5841172|NCT02502708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841173|NCT02502708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5841174|NCT02502708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5841175|NCT02502708|Alkylating Agents|alkylating agents|mesh-ancestor
5841176|NCT02502708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841177|NCT02502708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5841178|NCT02502708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5841179|NCT02502708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5841180|NCT02502708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5841181|NCT02502708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5841182|NCT02502708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5841183|NCT02502708|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5841184|NCT02502708|Antidepressive Agents|antidepressive agents|mesh-ancestor
5841185|NCT02502708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5841186|NCT02501941|Ketamine|ketamine|mesh-list
5841187|NCT02501941|Analgesics|analgesics|mesh-ancestor
5841188|NCT02501941|Sensory System Agents|sensory system agents|mesh-ancestor
5841189|NCT02501941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5841190|NCT02501941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841191|NCT02501941|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5841192|NCT02501941|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5841193|NCT02501941|Anesthetics, General|anesthetics, general|mesh-ancestor
5841194|NCT02501941|Anesthetics|anesthetics|mesh-ancestor
5841195|NCT02501941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5841196|NCT02501941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5841197|NCT02501941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5841198|NCT02501941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5841199|NCT02501941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841200|NCT02501954|Paclitaxel|paclitaxel|mesh-list
5841201|NCT02501954|Carboplatin|carboplatin|mesh-list
5841202|NCT02501954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5841203|NCT02501954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5841204|NCT02501954|Tubulin Modulators|tubulin modulators|mesh-ancestor
5841205|NCT02501954|Antimitotic Agents|antimitotic agents|mesh-ancestor
5841206|NCT02501954|Mitosis Modulators|mitosis modulators|mesh-ancestor
5841207|NCT02501954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841208|NCT02501837|Oxytocin|oxytocin|mesh-list
5841209|NCT02501837|Oxytocics|oxytocics|mesh-ancestor
5841210|NCT02501837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5841211|NCT02501837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841212|NCT02501863|Fentanyl|fentanyl|mesh-list
5841213|NCT02501863|Ropivacaine|ropivacaine|mesh-list
5841214|NCT02501863|Anesthetics, Local|anesthetics, local|mesh-ancestor
5841215|NCT02501863|Anesthetics|anesthetics|mesh-ancestor
5841216|NCT02501863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5841217|NCT02501863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841218|NCT02501863|Sensory System Agents|sensory system agents|mesh-ancestor
5841219|NCT02501863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5841220|NCT02501863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5841221|NCT02501863|Narcotics|narcotics|mesh-ancestor
5841222|NCT02501863|Analgesics|analgesics|mesh-ancestor
5841223|NCT02501863|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5841224|NCT02501863|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5841225|NCT02501863|Anesthetics, General|anesthetics, general|mesh-ancestor
5661173|NCT03634202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661174|NCT03634202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5661175|NCT03634189|Cannabidiol|cannabidiol|mesh-list
5661176|NCT03634189|Anticonvulsants|anticonvulsants|mesh-ancestor
5661177|NCT03634137|Afamelanotide|afamelanotide|mesh-list
5661178|NCT03634137|alpha-MSH|alpha-msh|mesh-list
5661179|NCT03634137|Dermatologic Agents|dermatologic agents|mesh-ancestor
5661180|NCT03634137|Hormones|hormones|mesh-ancestor
5661181|NCT03634137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5841226|NCT02501798|Methylphenidate|methylphenidate|mesh-list
6493713|NCT00615173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6493714|NCT00615173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6493715|NCT00615173|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6493716|NCT00615173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6493717|NCT00615173|Antimetabolites|antimetabolites|mesh-ancestor
6493718|NCT00615173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5661182|NCT03634137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661183|NCT03634111|Morphine|morphine|mesh-list
5661184|NCT03634111|Ropivacaine|ropivacaine|mesh-list
5661185|NCT03634111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5661186|NCT03634111|Narcotics|narcotics|mesh-ancestor
5841227|NCT02501798|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5661187|NCT03634111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5661188|NCT03634111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661189|NCT03634111|Analgesics|analgesics|mesh-ancestor
5661190|NCT03634111|Sensory System Agents|sensory system agents|mesh-ancestor
5661191|NCT03634111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5661192|NCT03634111|Anesthetics, Local|anesthetics, local|mesh-ancestor
5661193|NCT03634111|Anesthetics|anesthetics|mesh-ancestor
5661194|NCT03634059|Apatinib|apatinib|mesh-list
5661195|NCT03634059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5841228|NCT02501798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841229|NCT02501798|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5841230|NCT02501798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5841231|NCT02501798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5841232|NCT02501798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841233|NCT02501798|Dopamine Agents|dopamine agents|mesh-ancestor
5841234|NCT02501798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5841235|NCT02501850|Metformin|metformin|mesh-list
5841236|NCT02501850|Liraglutide|liraglutide|mesh-list
5841237|NCT02501850|Exenatide|exenatide|mesh-list
5841238|NCT02501850|Lixisenatide|lixisenatide|mesh-list
5841239|NCT02501850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5841240|NCT02501850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841241|NCT02501850|Incretins|incretins|mesh-ancestor
5841242|NCT02501850|Hormones|hormones|mesh-ancestor
5841243|NCT02501850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5841244|NCT02501850|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5841245|NCT02501564|Naproxen|naproxen|mesh-list
5841246|NCT02501564|Codeine|codeine|mesh-list
6493719|NCT00615186|Temozolomide|temozolomide|mesh-list
5661196|NCT03634059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5661197|NCT03634059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5661198|NCT03634059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661199|NCT03634020|Sirolimus|sirolimus|mesh-list
5661200|NCT03634020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5661201|NCT03634020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5661202|NCT03634020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5661203|NCT03634020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5661204|NCT03634020|Antifungal Agents|antifungal agents|mesh-ancestor
5661205|NCT03634020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5661206|NCT03634020|Immunologic Factors|immunologic factors|mesh-ancestor
5661207|NCT03634020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661208|NCT03633994|Heparin|heparin|mesh-list
5661209|NCT03633994|Anticoagulants|anticoagulants|mesh-ancestor
5661210|NCT03633994|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5661211|NCT03633994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5661212|NCT03633994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661213|NCT03633812|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
5661214|NCT03633812|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5661215|NCT03633812|Adrenergic Agents|adrenergic agents|mesh-ancestor
5661216|NCT03633812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5661217|NCT03633812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661218|NCT03633812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661219|NCT03633747|Propranolol|propranolol|mesh-list
5661220|NCT03633747|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5661221|NCT03633747|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5661222|NCT03633747|Adrenergic Agents|adrenergic agents|mesh-ancestor
5661223|NCT03633747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5661224|NCT03633747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661225|NCT03633747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661226|NCT03633747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5661227|NCT03633747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5661228|NCT03633747|Vasodilator Agents|vasodilator agents|mesh-ancestor
5661229|NCT03633734|Folfirinox|folfirinox|mesh-list
5661230|NCT03633734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5661231|NCT03633630|Magnesium Oxide|magnesium oxide|mesh-list
5661232|NCT03633630|Antacids|antacids|mesh-ancestor
5661233|NCT03633630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661234|NCT03633630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5661235|NCT03633604|HBOC 201|hboc 201|mesh-list
5661236|NCT03633604|Blood Substitutes|blood substitutes|mesh-ancestor
5661237|NCT03633591|Tolcapone|tolcapone|mesh-list
5661238|NCT03633591|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5661239|NCT03633591|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5661240|NCT03633591|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
5661241|NCT03633591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5695269|NCT03390608|Hormones|hormones|mesh-ancestor
5841247|NCT02501564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5841248|NCT02501564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5841249|NCT02501564|Analgesics|analgesics|mesh-ancestor
5841250|NCT02501564|Sensory System Agents|sensory system agents|mesh-ancestor
5841251|NCT02501564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5841252|NCT02501564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841253|NCT02501564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5841254|NCT02501564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5841255|NCT02501564|Gout Suppressants|gout suppressants|mesh-ancestor
5841256|NCT02501564|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5841257|NCT02501564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5841258|NCT02501564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841259|NCT02501564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5841260|NCT02501564|Narcotics|narcotics|mesh-ancestor
5841261|NCT02501564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5841262|NCT02501564|Antitussive Agents|antitussive agents|mesh-ancestor
5841263|NCT02501564|Respiratory System Agents|respiratory system agents|mesh-ancestor
5841264|NCT02501434|Heparin|heparin|mesh-list
5841265|NCT02501434|Calcium heparin|calcium heparin|mesh-list
5841266|NCT02501434|Anticoagulants|anticoagulants|mesh-ancestor
5841267|NCT02501434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5841268|NCT02501434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5841269|NCT02501434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841270|NCT02501616|Metformin|metformin|mesh-list
5841271|NCT02501616|Dapagliflozin|dapagliflozin|mesh-list
5661242|NCT03633591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661243|NCT03633565|Prednisolone|prednisolone|mesh-list
5661244|NCT03633565|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5661245|NCT03633565|Methylprednisolone|methylprednisolone|mesh-list
5661246|NCT03633565|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5661247|NCT03633565|Prednisolone acetate|prednisolone acetate|mesh-list
5661248|NCT03633565|Sildenafil Citrate|sildenafil citrate|mesh-list
5661249|NCT03633565|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5661250|NCT03633565|Prednisolone phosphate|prednisolone phosphate|mesh-list
5661251|NCT03633565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
5661252|NCT03633565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5661253|NCT03633565|Glucocorticoids|glucocorticoids|mesh-ancestor
5661254|NCT03633565|Hormones|hormones|mesh-ancestor
5661255|NCT03633565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5661256|NCT03633565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841272|NCT02501616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5841273|NCT02501616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841274|NCT02501616|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5841275|NCT02501616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841276|NCT02501603|Paclitaxel|paclitaxel|mesh-list
5841277|NCT02501603|Afatinib|afatinib|mesh-list
5841278|NCT02501603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5841279|NCT02501603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5841280|NCT02501603|Tubulin Modulators|tubulin modulators|mesh-ancestor
5841281|NCT02501603|Antimitotic Agents|antimitotic agents|mesh-ancestor
5841282|NCT02501603|Mitosis Modulators|mitosis modulators|mesh-ancestor
5661257|NCT03633565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5661258|NCT03633565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5661259|NCT03633565|Antiemetics|antiemetics|mesh-ancestor
5661260|NCT03633565|Autonomic Agents|autonomic agents|mesh-ancestor
5661261|NCT03633565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5661262|NCT03633565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5661263|NCT03633565|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5661264|NCT03633565|Protective Agents|protective agents|mesh-ancestor
5661265|NCT03633565|Vasodilator Agents|vasodilator agents|mesh-ancestor
5661266|NCT03633565|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5661267|NCT03633565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5661268|NCT03633565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661269|NCT03633565|Urological Agents|urological agents|mesh-ancestor
5661270|NCT03633552|Temozolomide|temozolomide|mesh-list
5661271|NCT03633552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5661272|NCT03633552|Alkylating Agents|alkylating agents|mesh-ancestor
5661273|NCT03633552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661274|NCT03633552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5661275|NCT03633305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
5661276|NCT03633305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5841283|NCT02501603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211993|NCT02180659|Buprenorphine|buprenorphine|mesh-list
5841284|NCT02501603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5841285|NCT02501603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5841286|NCT02501213|Furosemide|furosemide|mesh-list
5841287|NCT02501213|Spironolactone|spironolactone|mesh-list
5841288|NCT02501213|Diuretics|diuretics|mesh-ancestor
5841289|NCT02501213|Natriuretic Agents|natriuretic agents|mesh-ancestor
5841290|NCT02501213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841291|NCT02501213|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5841292|NCT02501213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5841293|NCT02501213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841294|NCT02501213|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5841295|NCT02501213|Hormone Antagonists|hormone antagonists|mesh-ancestor
5841296|NCT02501213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5841297|NCT02501213|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5841298|NCT02501200|Ezetimibe|ezetimibe|mesh-list
5841299|NCT02501200|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5841300|NCT02501200|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5841301|NCT02501200|Antimetabolites|antimetabolites|mesh-ancestor
5841302|NCT02501200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841303|NCT02501200|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5841304|NCT02501291|Thalidomide|thalidomide|mesh-list
5841305|NCT02501291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5841306|NCT02501291|Immunologic Factors|immunologic factors|mesh-ancestor
5841307|NCT02501291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661277|NCT03633305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661278|NCT03633292|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
5661279|NCT03633292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5661280|NCT03633266|Bevacizumab|bevacizumab|mesh-list
5661281|NCT03633266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5661282|NCT03633266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5661283|NCT03633266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5661284|NCT03633266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5661285|NCT03633266|Growth Substances|growth substances|mesh-ancestor
5841308|NCT02501291|Leprostatic Agents|leprostatic agents|mesh-ancestor
5841309|NCT02501291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5841310|NCT02501291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5841311|NCT02501291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5841312|NCT02501291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5841313|NCT02501291|Growth Substances|growth substances|mesh-ancestor
5841314|NCT02501291|Growth Inhibitors|growth inhibitors|mesh-ancestor
5841315|NCT02501291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5841316|NCT02501278|Cisplatin|cisplatin|mesh-list
5841317|NCT02501278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5841318|NCT02501109|Aripiprazole|aripiprazole|mesh-list
5841319|NCT02501109|Antidepressive Agents|antidepressive agents|mesh-ancestor
5841320|NCT02501109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5841321|NCT02501109|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5841322|NCT02501109|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5841323|NCT02501109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5661286|NCT03633266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661287|NCT03633266|Growth Inhibitors|growth inhibitors|mesh-ancestor
5661288|NCT03633175|Progesterone|progesterone|mesh-list
5661289|NCT03633175|Progestins|progestins|mesh-ancestor
5661290|NCT03633175|Hormones|hormones|mesh-ancestor
5661291|NCT03633175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5661292|NCT03633175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661293|NCT03633110|Pembrolizumab|pembrolizumab|mesh-list
6493720|NCT00615186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6493721|NCT00615186|Alkylating Agents|alkylating agents|mesh-ancestor
6493722|NCT00615186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493723|NCT00615186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6493724|NCT00615212|Rosiglitazone|rosiglitazone|mesh-list
6493725|NCT00615212|Flurbiprofen|flurbiprofen|mesh-list
6493726|NCT00615212|Midazolam|midazolam|mesh-list
6493727|NCT00615212|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5841324|NCT02501109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661294|NCT03633110|Nivolumab|nivolumab|mesh-list
5661295|NCT03633110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5661296|NCT03633110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5661297|NCT03633110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5661298|NCT03633110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661299|NCT03632915|Lacosamide|lacosamide|mesh-list
5661300|NCT03632915|Phenytoin|phenytoin|mesh-list
5661301|NCT03632915|Ketamine|ketamine|mesh-list
5661302|NCT03632915|Levetiracetam|levetiracetam|mesh-list
5841325|NCT02501109|Dopamine Agonists|dopamine agonists|mesh-ancestor
5841326|NCT02501109|Dopamine Agents|dopamine agents|mesh-ancestor
5841327|NCT02501109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5841328|NCT02501109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841329|NCT02501109|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5841330|NCT02501109|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5841331|NCT02501109|Serotonin Agents|serotonin agents|mesh-ancestor
5841332|NCT02501109|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5841333|NCT02501109|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5841334|NCT02501109|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5841335|NCT02501109|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5841336|NCT02500927|Naquotinib|naquotinib|mesh-list
5841337|NCT02500927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5841338|NCT02500927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5841339|NCT02500927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5841340|NCT02500927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841341|NCT02500784|Formoterol Fumarate|formoterol fumarate|mesh-list
5841342|NCT02500784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5661303|NCT03632915|Valproic Acid|valproic acid|mesh-list
5661304|NCT03632915|Phenobarbital|phenobarbital|mesh-list
5661305|NCT03632915|Analgesics|analgesics|mesh-ancestor
5661306|NCT03632915|Sensory System Agents|sensory system agents|mesh-ancestor
5661307|NCT03632915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5661308|NCT03632915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661309|NCT03632915|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5661310|NCT03632915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5841343|NCT02500784|Autonomic Agents|autonomic agents|mesh-ancestor
5841344|NCT02500784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5841345|NCT02500784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841346|NCT02500784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5841347|NCT02500784|Respiratory System Agents|respiratory system agents|mesh-ancestor
5841348|NCT02500784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5841349|NCT02500784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5841350|NCT02500784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5841351|NCT02500784|Adrenergic Agents|adrenergic agents|mesh-ancestor
5841352|NCT02500784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5841353|NCT02500784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903302|NCT05130684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5903303|NCT05130684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5903304|NCT05130619|Ethanol|ethanol|mesh-list
5903305|NCT05130619|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5903306|NCT05130619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5903307|NCT05130619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5903308|NCT05130619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661311|NCT03632915|Anesthetics, General|anesthetics, general|mesh-ancestor
5661312|NCT03632915|Anesthetics|anesthetics|mesh-ancestor
5661313|NCT03632915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5661314|NCT03632915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5661315|NCT03632915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5661316|NCT03632915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5661317|NCT03632915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661318|NCT03632915|Anticonvulsants|anticonvulsants|mesh-ancestor
5661319|NCT03632915|Nootropic Agents|nootropic agents|mesh-ancestor
5661320|NCT03632915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5661321|NCT03632915|GABA Agents|gaba agents|mesh-ancestor
5661322|NCT03632915|Antimanic Agents|antimanic agents|mesh-ancestor
5661323|NCT03632915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5661324|NCT03632915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5661325|NCT03632915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5661326|NCT03632915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5661327|NCT03632915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5661328|NCT03632915|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5661329|NCT03632915|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5661330|NCT03632915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5661331|NCT03632915|GABA Modulators|gaba modulators|mesh-ancestor
5661332|NCT03632915|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5903309|NCT05130515|Niraparib|niraparib|mesh-list
5903310|NCT05130515|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5903311|NCT05130515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5903312|NCT05130515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903313|NCT05130515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5903314|NCT05130398|Vaccines|vaccines|mesh-list
5903315|NCT05130398|Immunologic Factors|immunologic factors|mesh-ancestor
5841354|NCT02500940|Leucovorin|leucovorin|mesh-list
5841355|NCT02500940|Fluorouracil|fluorouracil|mesh-list
5841356|NCT02500940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5841357|NCT02500940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841358|NCT02500940|Antimetabolites|antimetabolites|mesh-ancestor
5841359|NCT02500940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841360|NCT02500940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5841361|NCT02500940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5841362|NCT02500940|Immunologic Factors|immunologic factors|mesh-ancestor
5841363|NCT02500940|Antidotes|antidotes|mesh-ancestor
5841364|NCT02500940|Protective Agents|protective agents|mesh-ancestor
5841365|NCT02500940|Vitamin B Complex|vitamin b complex|mesh-ancestor
5841366|NCT02500940|Vitamins|vitamins|mesh-ancestor
5841367|NCT02500940|Micronutrients|micronutrients|mesh-ancestor
5841368|NCT02500849|Busulfan|busulfan|mesh-list
5841369|NCT02500849|Alkylating Agents|alkylating agents|mesh-ancestor
5841370|NCT02500849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841371|NCT02500849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5841372|NCT02500849|Immunologic Factors|immunologic factors|mesh-ancestor
5841373|NCT02500849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841374|NCT02500849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5841375|NCT02500849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5841376|NCT02500849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5841377|NCT02500667|Rifampin|rifampin|mesh-list
5841378|NCT02500667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5841379|NCT02500667|Antitubercular Agents|antitubercular agents|mesh-ancestor
5841380|NCT02500667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5841381|NCT02500667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5841382|NCT02500667|Leprostatic Agents|leprostatic agents|mesh-ancestor
5841383|NCT02500667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5841384|NCT02500667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5841385|NCT02500667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841386|NCT02500667|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5841387|NCT02500667|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5841388|NCT02500667|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5841389|NCT02500667|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5661333|NCT03632915|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5661334|NCT03632876|Vitamin A|vitamin a|mesh-list
5661335|NCT03632876|Retinol palmitate|retinol palmitate|mesh-list
5661336|NCT03632876|Antioxidants|antioxidants|mesh-ancestor
5661337|NCT03632876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661338|NCT03632876|Protective Agents|protective agents|mesh-ancestor
5661339|NCT03632876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661340|NCT03632876|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5661341|NCT03632876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5661342|NCT03632876|Vitamins|vitamins|mesh-ancestor
5661343|NCT03632876|Micronutrients|micronutrients|mesh-ancestor
5841390|NCT02500667|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5841391|NCT02500667|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5841392|NCT02500680|Vaccines|vaccines|mesh-list
5841393|NCT02500680|Immunologic Factors|immunologic factors|mesh-ancestor
5841394|NCT02500680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841395|NCT02500446|Dolutegravir|dolutegravir|mesh-list
5841396|NCT02500446|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5841397|NCT02500446|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5841398|NCT02500446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5841399|NCT02500446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661344|NCT03632824|Tranexamic Acid|tranexamic acid|mesh-list
5661345|NCT03632824|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5661346|NCT03632824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5661347|NCT03632824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661348|NCT03632824|Hemostatics|hemostatics|mesh-ancestor
5661349|NCT03632824|Coagulants|coagulants|mesh-ancestor
5661350|NCT03632772|Solifenacin Succinate|solifenacin succinate|mesh-list
5661351|NCT03632772|Mirabegron|mirabegron|mesh-list
5661352|NCT03632772|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5661353|NCT03632772|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5661354|NCT03632772|Cholinergic Agents|cholinergic agents|mesh-ancestor
5661355|NCT03632772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5661356|NCT03632772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661357|NCT03632772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661358|NCT03632772|Urological Agents|urological agents|mesh-ancestor
5661359|NCT03632772|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
5661360|NCT03632772|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5661361|NCT03632772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5841400|NCT02500446|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5661362|NCT03632772|Adrenergic Agents|adrenergic agents|mesh-ancestor
5661363|NCT03632733|Tetracycline|tetracycline|mesh-list
5661364|NCT03632733|Clotrimazole|clotrimazole|mesh-list
5661365|NCT03632733|Miconazole|miconazole|mesh-list
5661366|NCT03632733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5661367|NCT03632733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5661368|NCT03632733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5661369|NCT03632733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5841401|NCT02500446|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5841402|NCT02500446|Antiviral Agents|antiviral agents|mesh-ancestor
5841403|NCT02500446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5841404|NCT02500576|Aldesleukin|aldesleukin|mesh-list
5841405|NCT02500576|Cyclophosphamide|cyclophosphamide|mesh-list
5841406|NCT02500576|Pembrolizumab|pembrolizumab|mesh-list
5841407|NCT02500576|Fludarabine|fludarabine|mesh-list
5841408|NCT02500576|Fludarabine phosphate|fludarabine phosphate|mesh-list
5841409|NCT02500576|Interleukin-2|interleukin-2|mesh-list
5841410|NCT02500576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5841411|NCT02500576|Immunologic Factors|immunologic factors|mesh-ancestor
5841412|NCT02500576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841413|NCT02500576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5841414|NCT02500576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5841415|NCT02500576|Alkylating Agents|alkylating agents|mesh-ancestor
5841416|NCT02500576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841417|NCT02500576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5841418|NCT02500576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5841419|NCT02500576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5841420|NCT02500576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5841421|NCT02500576|Antimetabolites|antimetabolites|mesh-ancestor
5841422|NCT02500576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5841423|NCT02500576|Analgesics|analgesics|mesh-ancestor
5841424|NCT02500576|Sensory System Agents|sensory system agents|mesh-ancestor
5841425|NCT02500576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5841426|NCT02500576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5841427|NCT02500576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5841428|NCT02500576|Antiviral Agents|antiviral agents|mesh-ancestor
5841429|NCT02500576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5841430|NCT02500524|Permethrin|permethrin|mesh-list
5841431|NCT02500524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5841432|NCT02500524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841433|NCT02500563|Caseins|caseins|mesh-list
5841434|NCT02500563|Chelating Agents|chelating agents|mesh-ancestor
5841435|NCT02500563|Sequestering Agents|sequestering agents|mesh-ancestor
5841436|NCT02500563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841437|NCT02500511|Vaccines|vaccines|mesh-list
5841438|NCT02500511|Immunologic Factors|immunologic factors|mesh-ancestor
5841439|NCT02500511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493728|NCT00615212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5841440|NCT02500498|Abatacept|abatacept|mesh-list
5841441|NCT02500498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5841442|NCT02500498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841443|NCT02500498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5841444|NCT02500498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5841445|NCT02500498|Immunologic Factors|immunologic factors|mesh-ancestor
5841446|NCT02500498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841447|NCT02500498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5841448|NCT02500459|Topotecan|topotecan|mesh-list
5841449|NCT02500459|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5841450|NCT02500459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5841451|NCT02500459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5841452|NCT02500459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841453|NCT02500459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5841454|NCT02500329|Acarbose|acarbose|mesh-list
5661370|NCT03632733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661371|NCT03632733|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5661372|NCT03632733|Antifungal Agents|antifungal agents|mesh-ancestor
5698010|NCT03371992|Nivolumab|nivolumab|mesh-list
5841455|NCT02500329|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
5841456|NCT02500329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5841457|NCT02500329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841458|NCT02500329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5841459|NCT02500329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493729|NCT00615212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6493730|NCT00615212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493731|NCT00615212|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5661373|NCT03632733|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5661374|NCT03632733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5661375|NCT03632733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5661376|NCT03632733|Hormone Antagonists|hormone antagonists|mesh-ancestor
5661377|NCT03632733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5661378|NCT03632733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661379|NCT03632733|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5661380|NCT03632733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5661381|NCT03632681|Insulin|insulin|mesh-list
5661382|NCT03632681|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5661383|NCT03632681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5661384|NCT03632681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661385|NCT03632642|Floxacillin|floxacillin|mesh-list
5661386|NCT03632642|Penicillin G|penicillin g|mesh-list
5661387|NCT03632642|Penicillin G Benzathine|penicillin g benzathine|mesh-list
5661388|NCT03632642|Penicillin G Procaine|penicillin g procaine|mesh-list
5661389|NCT03632642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5661390|NCT03632642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5695270|NCT03390608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5695271|NCT03390608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695272|NCT03390595|Gemcitabine|gemcitabine|mesh-list
5695273|NCT03390595|Carboplatin|carboplatin|mesh-list
5695274|NCT03390595|Avelumab|avelumab|mesh-list
5695275|NCT03390595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5695276|NCT03390595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5695277|NCT03390595|Antimetabolites|antimetabolites|mesh-ancestor
5695278|NCT03390595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841460|NCT02500225|Sevoflurane|sevoflurane|mesh-list
5841461|NCT02500225|Etomidate|etomidate|mesh-list
5841462|NCT02500225|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5841463|NCT02500225|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5841464|NCT02500225|Anesthetics, General|anesthetics, general|mesh-ancestor
5841465|NCT02500225|Anesthetics|anesthetics|mesh-ancestor
5841466|NCT02500225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5841467|NCT02500225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841468|NCT02500225|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5841469|NCT02500225|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5841470|NCT02500147|Metformin|metformin|mesh-list
5841471|NCT02500147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5841472|NCT02500147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841473|NCT02500212|Tacrolimus|tacrolimus|mesh-list
5841474|NCT02500212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5841475|NCT02500212|Immunologic Factors|immunologic factors|mesh-ancestor
5841476|NCT02500212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841477|NCT02500212|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5841478|NCT02500212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5841479|NCT02500212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841480|NCT02500017|Melatonin|melatonin|mesh-list
5841481|NCT02500017|Antioxidants|antioxidants|mesh-ancestor
5841482|NCT02500017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6211994|NCT02180659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5695279|NCT03390595|Antiviral Agents|antiviral agents|mesh-ancestor
6211995|NCT02180659|Narcotics|narcotics|mesh-ancestor
6211996|NCT02180659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5695280|NCT03390595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5695281|NCT03390595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5695282|NCT03390595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5695283|NCT03390595|Immunologic Factors|immunologic factors|mesh-ancestor
5695284|NCT03390595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695285|NCT03390595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5695286|NCT03390582|Methimazole|methimazole|mesh-list
5695287|NCT03390582|Antithyroid Agents|antithyroid agents|mesh-ancestor
5695288|NCT03390582|Hormone Antagonists|hormone antagonists|mesh-ancestor
5695289|NCT03390582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5695290|NCT03390582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695291|NCT03390465|Amlodipine|amlodipine|mesh-list
5695292|NCT03390465|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5695293|NCT03390465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6211997|NCT02180659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6211998|NCT02180659|Analgesics|analgesics|mesh-ancestor
6211999|NCT02180659|Sensory System Agents|sensory system agents|mesh-ancestor
6212000|NCT02180659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6212001|NCT02180659|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6212002|NCT02180672|Fluticasone|fluticasone|mesh-list
5661391|NCT03632590|Magnesium Sulfate|magnesium sulfate|mesh-list
5661392|NCT03632590|Magnesium citrate|magnesium citrate|mesh-list
5661393|NCT03632590|Magnesium Oxide|magnesium oxide|mesh-list
5661394|NCT03632590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841483|NCT02500017|Protective Agents|protective agents|mesh-ancestor
5841484|NCT02500017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841485|NCT02500017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5841486|NCT02500108|Domperidone|domperidone|mesh-list
5841487|NCT02500108|Antiemetics|antiemetics|mesh-ancestor
5841488|NCT02500108|Autonomic Agents|autonomic agents|mesh-ancestor
5661395|NCT03632590|Analgesics|analgesics|mesh-ancestor
5661396|NCT03632590|Sensory System Agents|sensory system agents|mesh-ancestor
5661397|NCT03632590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5661398|NCT03632590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841489|NCT02500108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5841490|NCT02500108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841491|NCT02500108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5841492|NCT02500108|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5841493|NCT02500108|Dopamine Agents|dopamine agents|mesh-ancestor
5841494|NCT02500108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5841495|NCT02500108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841496|NCT02500238|Carbon Monoxide|carbon monoxide|mesh-list
5841497|NCT02500238|Antimetabolites|antimetabolites|mesh-ancestor
5841498|NCT02500238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661399|NCT03632590|Anesthetics|anesthetics|mesh-ancestor
5661400|NCT03632590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5661401|NCT03632590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5661402|NCT03632590|Anticonvulsants|anticonvulsants|mesh-ancestor
5661403|NCT03632590|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5661404|NCT03632590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5661405|NCT03632590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5661406|NCT03632590|Tocolytic Agents|tocolytic agents|mesh-ancestor
5661407|NCT03632590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5661408|NCT03632590|Cathartics|cathartics|mesh-ancestor
5841499|NCT02500238|Gasotransmitters|gasotransmitters|mesh-ancestor
5841500|NCT02500238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5841501|NCT02500238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841502|NCT02500121|Pembrolizumab|pembrolizumab|mesh-list
5841503|NCT02500121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5841504|NCT02500121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5841505|NCT02500251|Rituximab|rituximab|mesh-list
5841506|NCT02500251|Bortezomib|bortezomib|mesh-list
5841507|NCT02500251|Belimumab|belimumab|mesh-list
5841508|NCT02500251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5841509|NCT02500251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5841510|NCT02500251|Immunologic Factors|immunologic factors|mesh-ancestor
5841511|NCT02500251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841512|NCT02500251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5841513|NCT02500251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5841514|NCT02500069|Caseins|caseins|mesh-list
5841515|NCT02500069|Chelating Agents|chelating agents|mesh-ancestor
5841516|NCT02500069|Sequestering Agents|sequestering agents|mesh-ancestor
5841517|NCT02500069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841518|NCT02500004|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5841519|NCT02500004|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5841520|NCT02500004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841521|NCT02499874|Tenofovir|tenofovir|mesh-list
5841522|NCT02499874|Lamivudine|lamivudine|mesh-list
5841523|NCT02499874|Zidovudine|zidovudine|mesh-list
5841524|NCT02499874|Emtricitabine|emtricitabine|mesh-list
5841525|NCT02499874|Efavirenz|efavirenz|mesh-list
5841526|NCT02499874|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
5841527|NCT02499874|Antiviral Agents|antiviral agents|mesh-ancestor
5841528|NCT02499874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5841529|NCT02499874|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5841530|NCT02499874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5661409|NCT03632590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5661410|NCT03632590|Antacids|antacids|mesh-ancestor
5661411|NCT03632538|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
5661412|NCT03632538|Protein C Inhibitor|protein c inhibitor|mesh-list
5661413|NCT03632538|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5841531|NCT02499874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5841532|NCT02499874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841533|NCT02499874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5841534|NCT02499874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5841535|NCT02499874|Antimetabolites|antimetabolites|mesh-ancestor
6493732|NCT00615212|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5841536|NCT02499874|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5841537|NCT02499874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5841538|NCT02499874|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5841539|NCT02499874|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5841540|NCT02499874|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5841541|NCT02499874|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5841542|NCT02499835|Pembrolizumab|pembrolizumab|mesh-list
5841543|NCT02499835|Immunoglobulins|immunoglobulins|mesh-list
5661414|NCT03632538|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5661415|NCT03632538|Protease Inhibitors|protease inhibitors|mesh-ancestor
5661416|NCT03632538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5661417|NCT03632538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661418|NCT03632460|Dexmedetomidine|dexmedetomidine|mesh-list
5841544|NCT02499835|Immunoglobulin G|immunoglobulin g|mesh-list
5841545|NCT02499835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5841546|NCT02499835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5841547|NCT02499835|Immunologic Factors|immunologic factors|mesh-ancestor
5841548|NCT02499835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841549|NCT02499978|Darunavir|darunavir|mesh-list
5841550|NCT02499978|Dolutegravir|dolutegravir|mesh-list
5841551|NCT02499978|Cobicistat|cobicistat|mesh-list
5841552|NCT02499978|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5841553|NCT02499978|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5841554|NCT02499978|Protease Inhibitors|protease inhibitors|mesh-ancestor
5841555|NCT02499978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5841556|NCT02499978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841557|NCT02499978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5841558|NCT02499978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5841559|NCT02499978|Antiviral Agents|antiviral agents|mesh-ancestor
5841560|NCT02499978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5841561|NCT02499978|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5661419|NCT03632460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5661420|NCT03632460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5661421|NCT03632460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661422|NCT03632460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5661423|NCT03632460|Analgesics|analgesics|mesh-ancestor
5661424|NCT03632460|Sensory System Agents|sensory system agents|mesh-ancestor
5661425|NCT03632460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5661426|NCT03632460|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5661427|NCT03632460|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5841562|NCT02499978|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5841563|NCT02499978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5841564|NCT02499978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5841565|NCT02499965|Anesthetics|anesthetics|mesh-list
5841566|NCT02499965|Ethyl Chloride|ethyl chloride|mesh-list
5841567|NCT02499965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5841568|NCT02499965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841569|NCT02499965|Anesthetics, Local|anesthetics, local|mesh-ancestor
5841570|NCT02499965|Sensory System Agents|sensory system agents|mesh-ancestor
5841571|NCT02499965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5841572|NCT02499861|Decitabine|decitabine|mesh-list
5841573|NCT02499861|Genistein|genistein|mesh-list
5841574|NCT02499861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5841575|NCT02499861|Antimetabolites|antimetabolites|mesh-ancestor
5841576|NCT02499861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841577|NCT02499861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5841578|NCT02499861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5841579|NCT02499861|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5841580|NCT02499861|Protective Agents|protective agents|mesh-ancestor
5841581|NCT02499861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841582|NCT02499861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5841583|NCT02499861|Phytoestrogens|phytoestrogens|mesh-ancestor
5841584|NCT02499861|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
5841585|NCT02499861|Estrogens|estrogens|mesh-ancestor
5841586|NCT02499861|Hormones|hormones|mesh-ancestor
5841587|NCT02499861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5661428|NCT03632460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5661429|NCT03632460|Adrenergic Agents|adrenergic agents|mesh-ancestor
5841588|NCT02499822|Ramipril|ramipril|mesh-list
5841589|NCT02499822|Nifedipine|nifedipine|mesh-list
5841590|NCT02499822|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5841591|NCT02499822|Protease Inhibitors|protease inhibitors|mesh-ancestor
5841592|NCT02499822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5841593|NCT02499822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841594|NCT02499822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5841595|NCT02499822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5841596|NCT02499822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5661430|NCT03632460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5661431|NCT03632460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661432|NCT03632408|Zopiclone|zopiclone|mesh-list
5661433|NCT03632408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5661434|NCT03632408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5661435|NCT03632408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661436|NCT03632369|Xenon|xenon|mesh-list
5661437|NCT03632369|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5661438|NCT03632369|Anesthetics, General|anesthetics, general|mesh-ancestor
5661439|NCT03632369|Anesthetics|anesthetics|mesh-ancestor
5661440|NCT03632369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5661441|NCT03632369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661442|NCT03632330|Midazolam|midazolam|mesh-list
5661443|NCT03632330|Dexmedetomidine|dexmedetomidine|mesh-list
5661444|NCT03632330|Propofol|propofol|mesh-list
5661445|NCT03632330|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5661446|NCT03632330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5661447|NCT03632330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661448|NCT03632330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5661449|NCT03632330|Anesthetics, General|anesthetics, general|mesh-ancestor
5661450|NCT03632330|Anesthetics|anesthetics|mesh-ancestor
5661451|NCT03632330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5661452|NCT03632330|Analgesics|analgesics|mesh-ancestor
5661453|NCT03632330|Sensory System Agents|sensory system agents|mesh-ancestor
5661454|NCT03632330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5661455|NCT03632330|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5661456|NCT03632330|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5661457|NCT03632330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5661458|NCT03632330|Adrenergic Agents|adrenergic agents|mesh-ancestor
5841597|NCT02499822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5841598|NCT02499822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661459|NCT03632330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5661460|NCT03632330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661461|NCT03632330|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5661462|NCT03632330|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5661463|NCT03632330|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5661464|NCT03632330|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5661465|NCT03632330|GABA Modulators|gaba modulators|mesh-ancestor
5661466|NCT03632330|GABA Agents|gaba agents|mesh-ancestor
5661467|NCT03632317|Everolimus|everolimus|mesh-list
5661468|NCT03632317|Panobinostat|panobinostat|mesh-list
5661469|NCT03632317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5661470|NCT03632317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5661471|NCT03632317|Immunologic Factors|immunologic factors|mesh-ancestor
5661472|NCT03632317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661473|NCT03632317|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5661474|NCT03632317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5661475|NCT03632317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661476|NCT03632304|Anesthetics|anesthetics|mesh-list
5661477|NCT03632304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5661478|NCT03632304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661479|NCT03632213|Losartan|losartan|mesh-list
5661480|NCT03632213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5661481|NCT03632213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5841599|NCT02499822|Vasodilator Agents|vasodilator agents|mesh-ancestor
5841600|NCT02499822|Tocolytic Agents|tocolytic agents|mesh-ancestor
5841601|NCT02499822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5841602|NCT02499757|Nicotine|nicotine|mesh-list
5841603|NCT02499757|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5841604|NCT02499757|Autonomic Agents|autonomic agents|mesh-ancestor
5841605|NCT02499757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5841606|NCT02499757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841607|NCT02499757|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5841608|NCT02499757|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5841609|NCT02499757|Cholinergic Agents|cholinergic agents|mesh-ancestor
5841610|NCT02499757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5841611|NCT02499757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841612|NCT02499627|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5841613|NCT02499627|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5841614|NCT02499627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6212003|NCT02180672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5698011|NCT03371992|Atezolizumab|atezolizumab|mesh-list
5661482|NCT03632213|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5661483|NCT03632213|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5661484|NCT03632213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661485|NCT03632187|Abatacept|abatacept|mesh-list
5661486|NCT03632187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5661487|NCT03632187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661488|NCT03632187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5661489|NCT03632187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5661490|NCT03632187|Immunologic Factors|immunologic factors|mesh-ancestor
5841615|NCT02499627|Alkylating Agents|alkylating agents|mesh-ancestor
5841616|NCT02499627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841617|NCT02499627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5841618|NCT02499627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5841619|NCT02499614|Crizotinib|crizotinib|mesh-list
5841620|NCT02499614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5841621|NCT02499614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5841622|NCT02499614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5841623|NCT02499614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841624|NCT02499666|Clopidogrel|clopidogrel|mesh-list
5841625|NCT02499666|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5841626|NCT02499666|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5841627|NCT02499666|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5841628|NCT02499666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5841629|NCT02499666|Purinergic Agents|purinergic agents|mesh-ancestor
5841630|NCT02499666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5841631|NCT02499666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841632|NCT02499666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841633|NCT02499562|Entecavir|entecavir|mesh-list
5841634|NCT02499562|Antiviral Agents|antiviral agents|mesh-ancestor
5661491|NCT03632187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661492|NCT03632187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5661493|NCT03632161|Dexmedetomidine|dexmedetomidine|mesh-list
5661494|NCT03632161|Bupivacaine|bupivacaine|mesh-list
5661495|NCT03632161|Anesthetics, Local|anesthetics, local|mesh-ancestor
5661496|NCT03632161|Anesthetics|anesthetics|mesh-ancestor
5661497|NCT03632161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5661498|NCT03632161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661499|NCT03632161|Sensory System Agents|sensory system agents|mesh-ancestor
5661500|NCT03632161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5661501|NCT03632161|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5841635|NCT02499562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5841636|NCT02499484|Nitroglycerin|nitroglycerin|mesh-list
5841637|NCT02499484|Vasodilator Agents|vasodilator agents|mesh-ancestor
5841638|NCT02499445|Sufentanil|sufentanil|mesh-list
5841639|NCT02499445|Remifentanil|remifentanil|mesh-list
5841640|NCT02499445|Propofol|propofol|mesh-list
5841641|NCT02499445|Sevoflurane|sevoflurane|mesh-list
5841642|NCT02499445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5841643|NCT02499445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5841644|NCT02499445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841645|NCT02499445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5841646|NCT02499445|Anesthetics, General|anesthetics, general|mesh-ancestor
5841647|NCT02499445|Anesthetics|anesthetics|mesh-ancestor
5841648|NCT02499445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5841649|NCT02499445|Narcotics|narcotics|mesh-ancestor
5841650|NCT02499445|Analgesics|analgesics|mesh-ancestor
5661502|NCT03632161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5661503|NCT03632161|Analgesics|analgesics|mesh-ancestor
5661504|NCT03632161|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5661505|NCT03632161|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5661506|NCT03632161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5661507|NCT03632161|Adrenergic Agents|adrenergic agents|mesh-ancestor
5661508|NCT03632161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5661509|NCT03632161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661510|NCT03632044|Ropivacaine|ropivacaine|mesh-list
5661511|NCT03632044|Anesthetics, Local|anesthetics, local|mesh-ancestor
5661512|NCT03632044|Anesthetics|anesthetics|mesh-ancestor
5661513|NCT03632044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5661514|NCT03632044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661515|NCT03632044|Sensory System Agents|sensory system agents|mesh-ancestor
5661516|NCT03632044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5661517|NCT03631966|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5661518|NCT03631966|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5661519|NCT03631966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5841651|NCT02499445|Sensory System Agents|sensory system agents|mesh-ancestor
5841652|NCT02499445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5841653|NCT02499445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5841654|NCT02499445|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5841655|NCT02499445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5841656|NCT02499237|Zoledronic Acid|zoledronic acid|mesh-list
5841657|NCT02499237|Denosumab|denosumab|mesh-list
5841658|NCT02499237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5841659|NCT02499237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841660|NCT02499393|Magnesium Sulfate|magnesium sulfate|mesh-list
5841661|NCT02499393|Analgesics|analgesics|mesh-ancestor
5841662|NCT02499393|Sensory System Agents|sensory system agents|mesh-ancestor
5841663|NCT02499393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5841664|NCT02499393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841665|NCT02499393|Anesthetics|anesthetics|mesh-ancestor
5841666|NCT02499393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5841667|NCT02499393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5841668|NCT02499393|Anticonvulsants|anticonvulsants|mesh-ancestor
5841669|NCT02499393|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5841670|NCT02499393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5841671|NCT02499393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841672|NCT02499393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5841673|NCT02499393|Tocolytic Agents|tocolytic agents|mesh-ancestor
5841674|NCT02499393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5661520|NCT03631966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661521|NCT03631966|Cholinergic Agents|cholinergic agents|mesh-ancestor
5661522|NCT03631966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5661523|NCT03631966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661524|NCT03631953|Trametinib|trametinib|mesh-list
5661525|NCT03631953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5661526|NCT03631953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5661527|NCT03631953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5661528|NCT03631953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661529|NCT03631901|Diazepam|diazepam|mesh-list
5661530|NCT03631901|Melatonin|melatonin|mesh-list
5661531|NCT03631901|Antioxidants|antioxidants|mesh-ancestor
5661532|NCT03631901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661533|NCT03631901|Protective Agents|protective agents|mesh-ancestor
5661534|NCT03631901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661535|NCT03631901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5661536|NCT03631901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5661537|NCT03631901|Anticonvulsants|anticonvulsants|mesh-ancestor
5661538|NCT03631901|Antiemetics|antiemetics|mesh-ancestor
5661539|NCT03631901|Autonomic Agents|autonomic agents|mesh-ancestor
5661540|NCT03631901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5661541|NCT03631901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5841675|NCT02499367|Cyclophosphamide|cyclophosphamide|mesh-list
5841676|NCT02499367|Doxorubicin|doxorubicin|mesh-list
5841677|NCT02499367|Nivolumab|nivolumab|mesh-list
5841678|NCT02499367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5841679|NCT02499367|Immunologic Factors|immunologic factors|mesh-ancestor
5841680|NCT02499367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841681|NCT02499367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5841682|NCT02499367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5841683|NCT02499367|Alkylating Agents|alkylating agents|mesh-ancestor
5841684|NCT02499367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841685|NCT02499367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5841686|NCT02499367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5841687|NCT02499367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5841688|NCT02499367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5841689|NCT02499367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5841690|NCT02499367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5841691|NCT02499367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5841692|NCT02499367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5841693|NCT02499341|Ketamine|ketamine|mesh-list
5841694|NCT02499341|Tramadol|tramadol|mesh-list
5841695|NCT02499341|Analgesics|analgesics|mesh-ancestor
5841696|NCT02499341|Sensory System Agents|sensory system agents|mesh-ancestor
5841697|NCT02499341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5841698|NCT02499341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841699|NCT02499341|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5841700|NCT02499341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5841701|NCT02499341|Anesthetics, General|anesthetics, general|mesh-ancestor
5841702|NCT02499341|Anesthetics|anesthetics|mesh-ancestor
6493733|NCT00615212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5661542|NCT03631901|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5661543|NCT03631901|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5661544|NCT03631901|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5661545|NCT03631901|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5841703|NCT02499341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5841704|NCT02499341|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5841705|NCT02499341|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5841706|NCT02499341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5841707|NCT02499341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841708|NCT02499341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5841709|NCT02499341|Narcotics|narcotics|mesh-ancestor
5841710|NCT02499354|Iron|iron|mesh-list
5841711|NCT02499354|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
5841712|NCT02499354|Trace Elements|trace elements|mesh-ancestor
5841713|NCT02499354|Micronutrients|micronutrients|mesh-ancestor
5841714|NCT02499354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841715|NCT02499354|Hematinics|hematinics|mesh-ancestor
5841716|NCT02499354|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5841717|NCT02499354|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5903316|NCT05130398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903317|NCT05107557|Vaccines|vaccines|mesh-list
5903318|NCT05107557|Immunologic Factors|immunologic factors|mesh-ancestor
5903319|NCT05107557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903320|NCT05065554|Rituximab|rituximab|mesh-list
5903321|NCT05065554|Acalabrutinib|acalabrutinib|mesh-list
5903322|NCT05065554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5903323|NCT05065554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5903324|NCT05065554|Immunologic Factors|immunologic factors|mesh-ancestor
5903325|NCT05065554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661546|NCT03631901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5661547|NCT03631901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5661548|NCT03631901|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5661549|NCT03631901|Anesthetics, General|anesthetics, general|mesh-ancestor
5661550|NCT03631901|Anesthetics|anesthetics|mesh-ancestor
5661551|NCT03631901|GABA Modulators|gaba modulators|mesh-ancestor
5661552|NCT03631901|GABA Agents|gaba agents|mesh-ancestor
5661553|NCT03631901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5661554|NCT03631875|Ketamine|ketamine|mesh-list
5661555|NCT03631875|Propofol|propofol|mesh-list
5661556|NCT03631875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5661557|NCT03631875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5661558|NCT03631875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661559|NCT03631875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5903326|NCT05065554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5903327|NCT05060913|Lidocaine|lidocaine|mesh-list
5903328|NCT05060913|Prilocaine|prilocaine|mesh-list
5903329|NCT05060913|Benzocaine|benzocaine|mesh-list
5903330|NCT05060913|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
5903331|NCT05060913|Anesthetics, Local|anesthetics, local|mesh-ancestor
5903332|NCT05060913|Anesthetics|anesthetics|mesh-ancestor
5903333|NCT05060913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5903334|NCT05060913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903335|NCT05060913|Sensory System Agents|sensory system agents|mesh-ancestor
5903336|NCT05060913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5661560|NCT03631875|Anesthetics, General|anesthetics, general|mesh-ancestor
5661561|NCT03631875|Anesthetics|anesthetics|mesh-ancestor
5661562|NCT03631875|Analgesics|analgesics|mesh-ancestor
5661563|NCT03631875|Sensory System Agents|sensory system agents|mesh-ancestor
5661564|NCT03631875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5661565|NCT03631875|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5661566|NCT03631875|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5661567|NCT03631875|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5661568|NCT03631875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5661569|NCT03631875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661570|NCT03631862|Apatinib|apatinib|mesh-list
5661571|NCT03631862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5661572|NCT03631862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5903337|NCT05060913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5903338|NCT05060913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5903339|NCT05060913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5661573|NCT03631862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5661574|NCT03631862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661575|NCT03631836|Bevacizumab|bevacizumab|mesh-list
5661576|NCT03631836|Antibodies|antibodies|mesh-list
5661577|NCT03631836|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5661578|NCT03631836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6674630|NCT01570582|Mitosis Modulators|mitosis modulators|mesh-ancestor
5661579|NCT03631836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5661580|NCT03631836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5661581|NCT03631836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5661582|NCT03631836|Growth Substances|growth substances|mesh-ancestor
5661583|NCT03631836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661584|NCT03631836|Growth Inhibitors|growth inhibitors|mesh-ancestor
5661585|NCT03631836|Immunologic Factors|immunologic factors|mesh-ancestor
5661586|NCT03631823|Temozolomide|temozolomide|mesh-list
5661587|NCT03631823|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5661588|NCT03631823|Alkylating Agents|alkylating agents|mesh-ancestor
5661589|NCT03631823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661590|NCT03631823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5661591|NCT03631641|Nivolumab|nivolumab|mesh-list
5661592|NCT03631641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5661593|NCT03631641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5661594|NCT03631641|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5661595|NCT03631641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661596|NCT03631615|Antibodies|antibodies|mesh-list
5661597|NCT03631615|Immunologic Factors|immunologic factors|mesh-ancestor
5661598|NCT03631615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661599|NCT03631602|Antifungal Agents|antifungal agents|mesh-list
5661600|NCT03631602|Clotrimazole|clotrimazole|mesh-list
5661601|NCT03631602|Miconazole|miconazole|mesh-list
5661602|NCT03631602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5661603|NCT03631602|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5661604|NCT03631602|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5661605|NCT03631602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5661606|NCT03631602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5661607|NCT03631602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661608|NCT03631602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5661609|NCT03631602|Hormone Antagonists|hormone antagonists|mesh-ancestor
5661610|NCT03631602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5661611|NCT03631602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661612|NCT03631602|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5661613|NCT03631602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5661614|NCT03631563|Immunosuppressive Agents|immunosuppressive agents|mesh-list
5841718|NCT02498938|Protease Inhibitors|protease inhibitors|mesh-list
5841719|NCT02498938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5841720|NCT02498938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841721|NCT02498977|Cyclosporine|cyclosporine|mesh-list
5841722|NCT02498977|Mycophenolic Acid|mycophenolic acid|mesh-list
5841723|NCT02498977|Azathioprine|azathioprine|mesh-list
5841724|NCT02498977|Tacrolimus|tacrolimus|mesh-list
5841725|NCT02498977|Cyclosporins|cyclosporins|mesh-list
5841726|NCT02498977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5841727|NCT02498977|Immunologic Factors|immunologic factors|mesh-ancestor
5841728|NCT02498977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841729|NCT02498977|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5841730|NCT02498977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5841731|NCT02498977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841732|NCT02498977|Antifungal Agents|antifungal agents|mesh-ancestor
5841733|NCT02498977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5841734|NCT02498977|Dermatologic Agents|dermatologic agents|mesh-ancestor
5841735|NCT02498977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5841736|NCT02498977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5841737|NCT02498977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5841738|NCT02498977|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5841739|NCT02498977|Antitubercular Agents|antitubercular agents|mesh-ancestor
5841740|NCT02498977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5661615|NCT03631563|Immunologic Factors|immunologic factors|mesh-ancestor
5661616|NCT03631563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661617|NCT03631407|Pembrolizumab|pembrolizumab|mesh-list
5661618|NCT03631407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5661619|NCT03631407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5661620|NCT03631316|Valganciclovir|valganciclovir|mesh-list
5661621|NCT03631316|Antiviral Agents|antiviral agents|mesh-ancestor
5661622|NCT03631316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5661623|NCT03631277|Calcium|calcium|mesh-list
5661624|NCT03631277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5661625|NCT03631277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661626|NCT03631173|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5661627|NCT03631173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5841741|NCT02498977|Antimetabolites|antimetabolites|mesh-ancestor
5841742|NCT02498977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5661628|NCT03631147|Rifaximin|rifaximin|mesh-list
5661629|NCT03631147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5661630|NCT03631147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5661631|NCT03631147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5661632|NCT03631134|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
5661633|NCT03631134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661634|NCT03631134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5661635|NCT03631134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661636|NCT03631121|Insulin Glargine|insulin glargine|mesh-list
5661637|NCT03631121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5661638|NCT03631121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695294|NCT03390465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5695295|NCT03390465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5695296|NCT03390465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695297|NCT03390465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5695298|NCT03390465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695299|NCT03390465|Vasodilator Agents|vasodilator agents|mesh-ancestor
5695300|NCT03390465|Diuretics|diuretics|mesh-ancestor
5695301|NCT03390465|Natriuretic Agents|natriuretic agents|mesh-ancestor
5695302|NCT03390465|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5841743|NCT02498756|Ipilimumab|ipilimumab|mesh-list
5841744|NCT02498756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5841745|NCT02498756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5841746|NCT02498756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5841747|NCT02498756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841748|NCT02498860|Pemetrexed|pemetrexed|mesh-list
5841749|NCT02498860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5841750|NCT02498860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5841751|NCT02498860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841752|NCT02498860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5841753|NCT02498860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5841754|NCT02498496|Magnesium Sulfate|magnesium sulfate|mesh-list
5841755|NCT02498496|Analgesics|analgesics|mesh-ancestor
5841756|NCT02498496|Sensory System Agents|sensory system agents|mesh-ancestor
5841757|NCT02498496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5841758|NCT02498496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841759|NCT02498496|Anesthetics|anesthetics|mesh-ancestor
5841760|NCT02498496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5841761|NCT02498496|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5841762|NCT02498496|Anticonvulsants|anticonvulsants|mesh-ancestor
5841763|NCT02498496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5841764|NCT02498496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5841765|NCT02498496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841766|NCT02498496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5841767|NCT02498496|Tocolytic Agents|tocolytic agents|mesh-ancestor
5841768|NCT02498496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5841769|NCT02498535|Nitric Oxide|nitric oxide|mesh-list
5841770|NCT02498535|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5695303|NCT03390387|Dexamethasone|dexamethasone|mesh-list
5695304|NCT03390387|Dexamethasone acetate|dexamethasone acetate|mesh-list
5695305|NCT03390387|Methylprednisolone|methylprednisolone|mesh-list
5695306|NCT03390387|Bortezomib|bortezomib|mesh-list
5695307|NCT03390387|Daunorubicin|daunorubicin|mesh-list
5695308|NCT03390387|Idarubicin|idarubicin|mesh-list
5695309|NCT03390387|BB 1101|bb 1101|mesh-list
5695310|NCT03390387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5695311|NCT03390387|Antiemetics|antiemetics|mesh-ancestor
5695312|NCT03390387|Autonomic Agents|autonomic agents|mesh-ancestor
5841771|NCT02498535|Autonomic Agents|autonomic agents|mesh-ancestor
5841772|NCT02498535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5695313|NCT03390387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5695314|NCT03390387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695315|NCT03390387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5695316|NCT03390387|Glucocorticoids|glucocorticoids|mesh-ancestor
5695317|NCT03390387|Hormones|hormones|mesh-ancestor
5695318|NCT03390387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5695319|NCT03390387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5695320|NCT03390387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5695321|NCT03390387|Protease Inhibitors|protease inhibitors|mesh-ancestor
5695322|NCT03390387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5695323|NCT03390387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695324|NCT03390387|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5695325|NCT03390387|Protective Agents|protective agents|mesh-ancestor
5661639|NCT03630991|Calcium, Dietary|calcium, dietary|mesh-list
5661640|NCT03630991|Edetic Acid|edetic acid|mesh-list
5661641|NCT03630991|Calcium|calcium|mesh-list
5661642|NCT03630991|Pentetic Acid|pentetic acid|mesh-list
5661643|NCT03630991|Succimer|succimer|mesh-list
5661644|NCT03630991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661645|NCT03630991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5661646|NCT03630991|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5841773|NCT02498535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841774|NCT02498535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5841775|NCT02498535|Respiratory System Agents|respiratory system agents|mesh-ancestor
5841776|NCT02498535|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5841777|NCT02498535|Antioxidants|antioxidants|mesh-ancestor
5841778|NCT02498535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841779|NCT02498535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5841780|NCT02498535|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5841781|NCT02498535|Vasodilator Agents|vasodilator agents|mesh-ancestor
5841782|NCT02498535|Gasotransmitters|gasotransmitters|mesh-ancestor
5841783|NCT02498535|Protective Agents|protective agents|mesh-ancestor
5841784|NCT02498457|Calcium|calcium|mesh-list
5841785|NCT02498457|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5841786|NCT02498457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841787|NCT02498509|Mometasone Furoate|mometasone furoate|mesh-list
5841788|NCT02498509|Levocabastine|levocabastine|mesh-list
5841789|NCT02498509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5841790|NCT02498509|Dermatologic Agents|dermatologic agents|mesh-ancestor
5841791|NCT02498509|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5841792|NCT02498509|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5841793|NCT02498509|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5841794|NCT02498509|Histamine Antagonists|histamine antagonists|mesh-ancestor
5841795|NCT02498509|Histamine Agents|histamine agents|mesh-ancestor
5841796|NCT02498509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5841797|NCT02498509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841798|NCT02498509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841799|NCT02498301|Rifaximin|rifaximin|mesh-list
5841800|NCT02498301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5841801|NCT02498301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5841802|NCT02498301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5841803|NCT02498288|Isotretinoin|isotretinoin|mesh-list
5841804|NCT02498288|Dermatologic Agents|dermatologic agents|mesh-ancestor
5841805|NCT02498444|Treprostinil|treprostinil|mesh-list
5841806|NCT02498444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5841807|NCT02498171|Fentanyl|fentanyl|mesh-list
5841808|NCT02498171|Morphine|morphine|mesh-list
5841809|NCT02498171|Bupivacaine|bupivacaine|mesh-list
5841810|NCT02498171|Anesthetics, Local|anesthetics, local|mesh-ancestor
5841811|NCT02498171|Anesthetics|anesthetics|mesh-ancestor
5841812|NCT02498171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5841813|NCT02498171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841814|NCT02498171|Sensory System Agents|sensory system agents|mesh-ancestor
5841815|NCT02498171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5841816|NCT02498171|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5841817|NCT02498171|Narcotics|narcotics|mesh-ancestor
5841818|NCT02498171|Analgesics|analgesics|mesh-ancestor
5841819|NCT02498171|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5841820|NCT02498171|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5841821|NCT02498171|Anesthetics, General|anesthetics, general|mesh-ancestor
5841822|NCT02498145|Nicotine|nicotine|mesh-list
5841823|NCT02498145|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5841824|NCT02498145|Autonomic Agents|autonomic agents|mesh-ancestor
5841825|NCT02498145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5841826|NCT02498145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841827|NCT02498145|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5841828|NCT02498145|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5841829|NCT02498145|Cholinergic Agents|cholinergic agents|mesh-ancestor
5661647|NCT03630991|Anticoagulants|anticoagulants|mesh-ancestor
5841830|NCT02498145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5841831|NCT02498145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841832|NCT02497911|Bupivacaine|bupivacaine|mesh-list
5841833|NCT02497911|Anesthetics, Local|anesthetics, local|mesh-ancestor
5841834|NCT02497911|Anesthetics|anesthetics|mesh-ancestor
5841835|NCT02497911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5841836|NCT02497911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841837|NCT02497911|Sensory System Agents|sensory system agents|mesh-ancestor
5841838|NCT02497911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5841839|NCT02498015|Ribavirin|ribavirin|mesh-list
5841840|NCT02498015|Antimetabolites|antimetabolites|mesh-ancestor
5841841|NCT02498015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841842|NCT02498015|Antiviral Agents|antiviral agents|mesh-ancestor
5841843|NCT02498015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5841844|NCT02498002|Lidocaine|lidocaine|mesh-list
5661648|NCT03630991|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5661649|NCT03630991|Chelating Agents|chelating agents|mesh-ancestor
5661650|NCT03630991|Sequestering Agents|sequestering agents|mesh-ancestor
5661651|NCT03630991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661652|NCT03630991|Antidotes|antidotes|mesh-ancestor
5661653|NCT03630991|Protective Agents|protective agents|mesh-ancestor
5661654|NCT03630991|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5661655|NCT03630952|Aflibercept|aflibercept|mesh-list
5841845|NCT02498002|Anesthetics, Local|anesthetics, local|mesh-ancestor
5841846|NCT02498002|Anesthetics|anesthetics|mesh-ancestor
5841847|NCT02498002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5841848|NCT02498002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841849|NCT02498002|Sensory System Agents|sensory system agents|mesh-ancestor
5841850|NCT02498002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5841851|NCT02498002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6674631|NCT01570582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674632|NCT01570582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5661656|NCT03630952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5661657|NCT03630952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5661658|NCT03630952|Growth Substances|growth substances|mesh-ancestor
5661659|NCT03630952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661660|NCT03630952|Growth Inhibitors|growth inhibitors|mesh-ancestor
5661661|NCT03630952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5661662|NCT03630796|Sevoflurane|sevoflurane|mesh-list
5661663|NCT03630796|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5661664|NCT03630796|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5661665|NCT03630796|Anesthetics, General|anesthetics, general|mesh-ancestor
5661666|NCT03630796|Anesthetics|anesthetics|mesh-ancestor
5661667|NCT03630796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5661668|NCT03630796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674633|NCT01570582|Antimetabolites|antimetabolites|mesh-ancestor
6674634|NCT01570582|Antiviral Agents|antiviral agents|mesh-ancestor
6674635|NCT01570582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6674636|NCT01570582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6674637|NCT01570582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6674638|NCT01570582|Immunologic Factors|immunologic factors|mesh-ancestor
6674639|NCT01570582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674640|NCT01570608|Ranibizumab|ranibizumab|mesh-list
6674641|NCT01570608|Verteporfin|verteporfin|mesh-list
5661669|NCT03630614|Nicotine|nicotine|mesh-list
5661670|NCT03630614|Varenicline|varenicline|mesh-list
5661671|NCT03630614|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5661672|NCT03630614|Autonomic Agents|autonomic agents|mesh-ancestor
5661673|NCT03630614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5661674|NCT03630614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661675|NCT03630614|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6674642|NCT01570608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6674643|NCT01570608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6674644|NCT01570608|Growth Substances|growth substances|mesh-ancestor
5841852|NCT02498002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5841853|NCT02498002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5841854|NCT02498002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5841855|NCT02498002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493734|NCT00615212|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6493735|NCT00615212|Anesthetics, General|anesthetics, general|mesh-ancestor
6493736|NCT00615212|Anesthetics|anesthetics|mesh-ancestor
6493737|NCT00615212|GABA Modulators|gaba modulators|mesh-ancestor
6493738|NCT00615212|GABA Agents|gaba agents|mesh-ancestor
6493739|NCT00615212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6493740|NCT00615212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493741|NCT00615212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6493742|NCT00615212|Analgesics|analgesics|mesh-ancestor
6493743|NCT00615212|Sensory System Agents|sensory system agents|mesh-ancestor
6212004|NCT02180672|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6212005|NCT02180672|Autonomic Agents|autonomic agents|mesh-ancestor
6212006|NCT02180672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6493744|NCT00615212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6493745|NCT00615212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5841856|NCT02497833|Tretinoin|tretinoin|mesh-list
5841857|NCT02497833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5661676|NCT03630614|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6493746|NCT00615212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6493747|NCT00615212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6493748|NCT00615212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6493749|NCT00615212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6493750|NCT00615212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6493751|NCT00615303|Simethicone|simethicone|mesh-list
6493752|NCT00615303|Antifoaming Agents|antifoaming agents|mesh-ancestor
5661677|NCT03630614|Cholinergic Agents|cholinergic agents|mesh-ancestor
5661678|NCT03630614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5661679|NCT03630614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661680|NCT03630367|Dexamethasone|dexamethasone|mesh-list
5661681|NCT03630367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5661682|NCT03630367|Antiemetics|antiemetics|mesh-ancestor
5661683|NCT03630367|Autonomic Agents|autonomic agents|mesh-ancestor
5661684|NCT03630367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5661685|NCT03630367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661686|NCT03630367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5661687|NCT03630367|Glucocorticoids|glucocorticoids|mesh-ancestor
5661688|NCT03630367|Hormones|hormones|mesh-ancestor
5661689|NCT03630367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5661690|NCT03630367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5661691|NCT03630367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5661692|NCT03630341|Clomiphene|clomiphene|mesh-list
5661693|NCT03630341|Enclomiphene|enclomiphene|mesh-list
5661694|NCT03630341|Zuclomiphene|zuclomiphene|mesh-list
5661695|NCT03630341|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5661696|NCT03630341|Hormone Antagonists|hormone antagonists|mesh-ancestor
5661697|NCT03630341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5661698|NCT03630341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661699|NCT03630341|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5661700|NCT03630341|Fertility Agents|fertility agents|mesh-ancestor
5661701|NCT03630341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5661702|NCT03630341|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5661703|NCT03630341|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5661704|NCT03630315|Bevacizumab|bevacizumab|mesh-list
5661705|NCT03630315|Ranibizumab|ranibizumab|mesh-list
5661706|NCT03630315|Aflibercept|aflibercept|mesh-list
5661707|NCT03630315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5661708|NCT03630315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5661709|NCT03630315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5661710|NCT03630315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5661711|NCT03630315|Growth Substances|growth substances|mesh-ancestor
5661712|NCT03630315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661713|NCT03630315|Growth Inhibitors|growth inhibitors|mesh-ancestor
5661714|NCT03630081|Ciprofloxacin|ciprofloxacin|mesh-list
5661715|NCT03630081|Meropenem|meropenem|mesh-list
5661716|NCT03630081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5661717|NCT03630081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5661718|NCT03630081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5661719|NCT03630081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5661720|NCT03630081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5661721|NCT03630081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661722|NCT03630081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5661723|NCT03630081|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5661724|NCT03630081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5661725|NCT03630042|Rituximab|rituximab|mesh-list
5661726|NCT03630042|Pembrolizumab|pembrolizumab|mesh-list
5841858|NCT02497833|Keratolytic Agents|keratolytic agents|mesh-ancestor
5841859|NCT02497833|Dermatologic Agents|dermatologic agents|mesh-ancestor
5841860|NCT02497820|Aspirin|aspirin|mesh-list
5841861|NCT02497820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5841862|NCT02497820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5841863|NCT02497820|Analgesics|analgesics|mesh-ancestor
5841864|NCT02497820|Sensory System Agents|sensory system agents|mesh-ancestor
5841865|NCT02497820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5841866|NCT02497820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841867|NCT02497820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5841868|NCT02497820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5841869|NCT02497820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5841870|NCT02497820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5841871|NCT02497820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841872|NCT02497820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5841873|NCT02497820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5841874|NCT02497820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6493753|NCT00615303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661727|NCT03630042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5841875|NCT02497820|Antipyretics|antipyretics|mesh-ancestor
5841876|NCT02497638|Metformin|metformin|mesh-list
5841877|NCT02497638|Biguanides|biguanides|mesh-list
5841878|NCT02497638|Atorvastatin|atorvastatin|mesh-list
5841879|NCT02497638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5841880|NCT02497638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661728|NCT03630042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5661729|NCT03630042|Immunologic Factors|immunologic factors|mesh-ancestor
5661730|NCT03630042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661731|NCT03630042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5661732|NCT03630029|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
5661733|NCT03630029|Hematinics|hematinics|mesh-ancestor
5661734|NCT03629847|Everolimus|everolimus|mesh-list
5661735|NCT03629847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5661736|NCT03629847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5661737|NCT03629847|Immunologic Factors|immunologic factors|mesh-ancestor
5661738|NCT03629847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661739|NCT03629717|Vitamin D|vitamin d|mesh-list
5661740|NCT03629717|Denosumab|denosumab|mesh-list
5661741|NCT03629717|Calcium|calcium|mesh-list
5661742|NCT03629717|Vitamins|vitamins|mesh-ancestor
5661743|NCT03629717|Micronutrients|micronutrients|mesh-ancestor
5661744|NCT03629717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661745|NCT03629717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5661746|NCT03629717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5661747|NCT03629639|Metformin|metformin|mesh-list
5661748|NCT03629639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5661749|NCT03629639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661750|NCT03629613|Antioxidants|antioxidants|mesh-list
5661751|NCT03629613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661752|NCT03629613|Protective Agents|protective agents|mesh-ancestor
5661753|NCT03629613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661754|NCT03629600|Indomethacin|indomethacin|mesh-list
5661755|NCT03629600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5661756|NCT03629600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5661757|NCT03629600|Analgesics|analgesics|mesh-ancestor
5661758|NCT03629600|Sensory System Agents|sensory system agents|mesh-ancestor
5661759|NCT03629600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5661760|NCT03629600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661761|NCT03629600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5661762|NCT03629600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5661763|NCT03629600|Gout Suppressants|gout suppressants|mesh-ancestor
5661764|NCT03629600|Tocolytic Agents|tocolytic agents|mesh-ancestor
5661765|NCT03629600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5661766|NCT03629600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5661767|NCT03629600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5661768|NCT03629600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661769|NCT03629522|Ondansetron|ondansetron|mesh-list
5661770|NCT03629522|Antiemetics|antiemetics|mesh-ancestor
5661771|NCT03629522|Autonomic Agents|autonomic agents|mesh-ancestor
5661772|NCT03629522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5661773|NCT03629522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661774|NCT03629522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5661775|NCT03629522|Antipruritics|antipruritics|mesh-ancestor
5661776|NCT03629522|Dermatologic Agents|dermatologic agents|mesh-ancestor
5661777|NCT03629522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5661778|NCT03629522|Serotonin Agents|serotonin agents|mesh-ancestor
5661779|NCT03629522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5661780|NCT03629522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841881|NCT02497638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5841882|NCT02497638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5841883|NCT02497638|Antimetabolites|antimetabolites|mesh-ancestor
5841884|NCT02497638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841885|NCT02497638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5841886|NCT02497638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5841887|NCT02497638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5841888|NCT02497716|Rivaroxaban|rivaroxaban|mesh-list
5841889|NCT02497716|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5841890|NCT02497716|Antithrombins|antithrombins|mesh-ancestor
5841891|NCT02497716|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5841892|NCT02497716|Protease Inhibitors|protease inhibitors|mesh-ancestor
5841893|NCT02497716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5661781|NCT03629522|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5841894|NCT02497716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841895|NCT02497716|Anticoagulants|anticoagulants|mesh-ancestor
5841896|NCT02497547|Oxytocin|oxytocin|mesh-list
5841897|NCT02497547|Oxytocics|oxytocics|mesh-ancestor
5841898|NCT02497547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5841899|NCT02497547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841900|NCT02497508|Nivolumab|nivolumab|mesh-list
5841901|NCT02497508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5841902|NCT02497508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5841903|NCT02497508|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5841904|NCT02497508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903340|NCT05060913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5661782|NCT03629522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5661783|NCT03629522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5661784|NCT03629522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5661785|NCT03629522|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5661786|NCT03629483|Dexmedetomidine|dexmedetomidine|mesh-list
5903341|NCT05060913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903342|NCT05060913|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
5903343|NCT05049980|Mifepristone|mifepristone|mesh-list
5903344|NCT05049980|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5903345|NCT05049980|Abortifacient Agents|abortifacient agents|mesh-ancestor
5903346|NCT05049980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6493754|NCT00615303|Emollients|emollients|mesh-ancestor
6493755|NCT00615303|Dermatologic Agents|dermatologic agents|mesh-ancestor
6493756|NCT00615368|Epoetin Alfa|epoetin alfa|mesh-list
6493757|NCT00615368|Hematinics|hematinics|mesh-ancestor
5661787|NCT03629483|Ropivacaine|ropivacaine|mesh-list
5661788|NCT03629483|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5661789|NCT03629483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5661790|NCT03629483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661791|NCT03629483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5661792|NCT03629483|Analgesics|analgesics|mesh-ancestor
5661793|NCT03629483|Sensory System Agents|sensory system agents|mesh-ancestor
5661794|NCT03629483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5661795|NCT03629483|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5661796|NCT03629483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5661797|NCT03629483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5661798|NCT03629483|Adrenergic Agents|adrenergic agents|mesh-ancestor
5661799|NCT03629483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5661800|NCT03629483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661801|NCT03629483|Anesthetics, Local|anesthetics, local|mesh-ancestor
5661802|NCT03629483|Anesthetics|anesthetics|mesh-ancestor
5661803|NCT03629418|Phenylephrine|phenylephrine|mesh-list
5661804|NCT03629418|Norepinephrine|norepinephrine|mesh-list
5661805|NCT03629418|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5661806|NCT03629418|Mydriatics|mydriatics|mesh-ancestor
5661807|NCT03629418|Autonomic Agents|autonomic agents|mesh-ancestor
5661808|NCT03629418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5661809|NCT03629418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661810|NCT03629418|Sympathomimetics|sympathomimetics|mesh-ancestor
5661811|NCT03629418|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5661812|NCT03629418|Nasal Decongestants|nasal decongestants|mesh-ancestor
5661813|NCT03629418|Respiratory System Agents|respiratory system agents|mesh-ancestor
5661814|NCT03629418|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5661815|NCT03629418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5661816|NCT03629418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5661817|NCT03629418|Adrenergic Agents|adrenergic agents|mesh-ancestor
5661818|NCT03629418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5661819|NCT03629418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661820|NCT03629418|Protective Agents|protective agents|mesh-ancestor
5661821|NCT03629379|Ustekinumab|ustekinumab|mesh-list
5661822|NCT03629379|Vedolizumab|vedolizumab|mesh-list
5661823|NCT03629379|Dermatologic Agents|dermatologic agents|mesh-ancestor
5661824|NCT03629379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5661825|NCT03629288|Azithromycin|azithromycin|mesh-list
5661826|NCT03629288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5661827|NCT03629288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5661828|NCT03629262|Sufentanil|sufentanil|mesh-list
5661829|NCT03629262|Dexmedetomidine|dexmedetomidine|mesh-list
5661830|NCT03629262|Dsuvia|dsuvia|mesh-list
6493758|NCT00615381|Insulin|insulin|mesh-list
6493759|NCT00615381|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6493760|NCT00615381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6493761|NCT00615381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493762|NCT00615446|Gemcitabine|gemcitabine|mesh-list
6493763|NCT00615446|Sunitinib|sunitinib|mesh-list
6493764|NCT00615446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5841905|NCT02497313|Metformin|metformin|mesh-list
5841906|NCT02497313|Cholecystokinin|cholecystokinin|mesh-list
5841907|NCT02497313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5841908|NCT02497313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841909|NCT02497313|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5841910|NCT02497313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5841911|NCT02497378|Dexamethasone|dexamethasone|mesh-list
5841912|NCT02497378|Bortezomib|bortezomib|mesh-list
5661831|NCT03629262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5661832|NCT03629262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5661833|NCT03629262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661834|NCT03629262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5661835|NCT03629262|Analgesics|analgesics|mesh-ancestor
5661836|NCT03629262|Sensory System Agents|sensory system agents|mesh-ancestor
5661837|NCT03629262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5661838|NCT03629262|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5661839|NCT03629262|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5661840|NCT03629262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5661841|NCT03629262|Adrenergic Agents|adrenergic agents|mesh-ancestor
5661842|NCT03629262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5841913|NCT02497378|Daratumumab|daratumumab|mesh-list
5841914|NCT02497378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5841915|NCT02497378|Antiemetics|antiemetics|mesh-ancestor
5841916|NCT02497378|Autonomic Agents|autonomic agents|mesh-ancestor
5841917|NCT02497378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5841918|NCT02497378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841919|NCT02497378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5841920|NCT02497378|Glucocorticoids|glucocorticoids|mesh-ancestor
5841921|NCT02497378|Hormones|hormones|mesh-ancestor
5841922|NCT02497378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5841923|NCT02497378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5841924|NCT02497378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5841925|NCT02497326|Heparin|heparin|mesh-list
5841926|NCT02497326|Tramadol|tramadol|mesh-list
5841927|NCT02497326|Anticoagulants|anticoagulants|mesh-ancestor
5841928|NCT02497326|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5841929|NCT02497326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5841930|NCT02497326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841931|NCT02497326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5841932|NCT02497326|Narcotics|narcotics|mesh-ancestor
5841933|NCT02497326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5841934|NCT02497326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841935|NCT02497326|Analgesics|analgesics|mesh-ancestor
5841936|NCT02497326|Sensory System Agents|sensory system agents|mesh-ancestor
5841937|NCT02497326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5841938|NCT02497300|Amiloride|amiloride|mesh-list
5841939|NCT02497300|Spironolactone|spironolactone|mesh-list
5841940|NCT02497300|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5661843|NCT03629262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661844|NCT03629262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5661845|NCT03629262|Narcotics|narcotics|mesh-ancestor
5661846|NCT03629262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5661847|NCT03629262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5661848|NCT03629262|Anesthetics, General|anesthetics, general|mesh-ancestor
5661849|NCT03629262|Anesthetics|anesthetics|mesh-ancestor
5695326|NCT03390387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5695327|NCT03390387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5695328|NCT03390387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5841941|NCT02497300|Hormone Antagonists|hormone antagonists|mesh-ancestor
5841942|NCT02497300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5841943|NCT02497300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841944|NCT02497300|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5841945|NCT02497300|Diuretics|diuretics|mesh-ancestor
5841946|NCT02497300|Natriuretic Agents|natriuretic agents|mesh-ancestor
5841947|NCT02497300|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
5841948|NCT02497300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5841949|NCT02497300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5841950|NCT02497300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841951|NCT02497300|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
5841952|NCT02497118|Vinorelbine|vinorelbine|mesh-list
5841953|NCT02497118|Endostatins|endostatins|mesh-list
5841954|NCT02497118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5841955|NCT02497118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5841956|NCT02497118|Tubulin Modulators|tubulin modulators|mesh-ancestor
5695329|NCT03390374|Nystatin|nystatin|mesh-list
5841957|NCT02497118|Antimitotic Agents|antimitotic agents|mesh-ancestor
5841958|NCT02497118|Mitosis Modulators|mitosis modulators|mesh-ancestor
5841959|NCT02497118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841960|NCT02497118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5661850|NCT03629223|Tepotinib|tepotinib|mesh-list
5661851|NCT03629223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5661852|NCT03629210|Dexamethasone|dexamethasone|mesh-list
5661853|NCT03629210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5661854|NCT03629210|Antiemetics|antiemetics|mesh-ancestor
5661855|NCT03629210|Autonomic Agents|autonomic agents|mesh-ancestor
5661856|NCT03629210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5661857|NCT03629210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661858|NCT03629210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5661859|NCT03629210|Glucocorticoids|glucocorticoids|mesh-ancestor
5661860|NCT03629210|Hormones|hormones|mesh-ancestor
5661861|NCT03629210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5661862|NCT03629210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5661863|NCT03629210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5661864|NCT03629093|Anesthetics|anesthetics|mesh-list
5661865|NCT03629093|Anesthetics, General|anesthetics, general|mesh-list
5661866|NCT03629093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5661867|NCT03629093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661868|NCT03628716|Atezolizumab|atezolizumab|mesh-list
5661869|NCT03628716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5661870|NCT03628625|Letrozole|letrozole|mesh-list
5661871|NCT03628625|Misoprostol|misoprostol|mesh-list
5661872|NCT03628625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5661873|NCT03628625|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5661874|NCT03628625|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5661875|NCT03628625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5661876|NCT03628625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661877|NCT03628625|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5661878|NCT03628625|Hormone Antagonists|hormone antagonists|mesh-ancestor
5661879|NCT03628625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5661880|NCT03628625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661881|NCT03628625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5661882|NCT03628625|Abortifacient Agents|abortifacient agents|mesh-ancestor
5841961|NCT02497118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5841962|NCT02497118|Growth Substances|growth substances|mesh-ancestor
5841963|NCT02497118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841964|NCT02497118|Growth Inhibitors|growth inhibitors|mesh-ancestor
5841965|NCT02497222|RNS60|rns60|mesh-list
5841966|NCT02497222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5841967|NCT02497222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5841968|NCT02497222|Analgesics|analgesics|mesh-ancestor
5841969|NCT02497222|Sensory System Agents|sensory system agents|mesh-ancestor
5841970|NCT02497222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5661883|NCT03628625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5661884|NCT03628625|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5661885|NCT03628625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5661886|NCT03628625|Oxytocics|oxytocics|mesh-ancestor
5661887|NCT03628521|Gemcitabine|gemcitabine|mesh-list
5661888|NCT03628521|Carboplatin|carboplatin|mesh-list
5661889|NCT03628521|Pemetrexed|pemetrexed|mesh-list
5841971|NCT02497222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841972|NCT02497222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5841973|NCT02497222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5841974|NCT02497222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5841975|NCT02497157|Leucovorin|leucovorin|mesh-list
5841976|NCT02497157|Bevacizumab|bevacizumab|mesh-list
5841977|NCT02497157|Fluorouracil|fluorouracil|mesh-list
5841978|NCT02497157|Oxaliplatin|oxaliplatin|mesh-list
5841979|NCT02497157|Irinotecan|irinotecan|mesh-list
5841980|NCT02497157|Calcium|calcium|mesh-list
5841981|NCT02497157|Levoleucovorin|levoleucovorin|mesh-list
5841982|NCT02497157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5841983|NCT02497157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5841984|NCT02497157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5841985|NCT02497157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5841986|NCT02497157|Growth Substances|growth substances|mesh-ancestor
5841987|NCT02497157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5841988|NCT02497157|Growth Inhibitors|growth inhibitors|mesh-ancestor
5841989|NCT02497157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5841990|NCT02497157|Antimetabolites|antimetabolites|mesh-ancestor
5661890|NCT03628521|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5903347|NCT05049980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661891|NCT03628521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5841991|NCT02497157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5841992|NCT02497157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5841993|NCT02497157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5841994|NCT02497157|Immunologic Factors|immunologic factors|mesh-ancestor
5841995|NCT02497157|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5841996|NCT02497157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5841997|NCT02497157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5841998|NCT02497157|Antidotes|antidotes|mesh-ancestor
5841999|NCT02497157|Protective Agents|protective agents|mesh-ancestor
5842000|NCT02497157|Vitamin B Complex|vitamin b complex|mesh-ancestor
5842001|NCT02497157|Vitamins|vitamins|mesh-ancestor
5842002|NCT02497157|Micronutrients|micronutrients|mesh-ancestor
5842003|NCT02497365|Cefazolin|cefazolin|mesh-list
5842004|NCT02497365|Tobramycin|tobramycin|mesh-list
5842005|NCT02497365|Besifloxacin|besifloxacin|mesh-list
5842006|NCT02497365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5842007|NCT02497365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5842008|NCT02497365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5842009|NCT02497365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5842010|NCT02497365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5842011|NCT02497365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842012|NCT02497365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5842013|NCT02497079|Formaldehyde|formaldehyde|mesh-list
5842014|NCT02497079|Disinfectants|disinfectants|mesh-ancestor
5842015|NCT02497079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5842016|NCT02497053|Pemetrexed|pemetrexed|mesh-list
5842017|NCT02497053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5842018|NCT02497053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5842019|NCT02497053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842020|NCT02497053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5842021|NCT02497053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5842022|NCT02496988|Temozolomide|temozolomide|mesh-list
5842023|NCT02496988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5842024|NCT02496988|Alkylating Agents|alkylating agents|mesh-ancestor
5842025|NCT02496988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842026|NCT02496988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5661892|NCT03628521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5661893|NCT03628521|Antimetabolites|antimetabolites|mesh-ancestor
5661894|NCT03628521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661895|NCT03628521|Antiviral Agents|antiviral agents|mesh-ancestor
5661896|NCT03628521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5661897|NCT03628521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5661898|NCT03628521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5661899|NCT03628521|Immunologic Factors|immunologic factors|mesh-ancestor
5661900|NCT03628521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661901|NCT03628521|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5661902|NCT03628521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5661903|NCT03628521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5661904|NCT03628443|Mitogens|mitogens|mesh-list
5661905|NCT03628443|Mitosis Modulators|mitosis modulators|mesh-ancestor
5661906|NCT03628443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661907|NCT03628430|Lidocaine|lidocaine|mesh-list
5661908|NCT03628430|Epinephrine|epinephrine|mesh-list
5661909|NCT03628430|Anesthetics, Local|anesthetics, local|mesh-ancestor
5661910|NCT03628430|Anesthetics|anesthetics|mesh-ancestor
5661911|NCT03628430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5661912|NCT03628430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661913|NCT03628430|Sensory System Agents|sensory system agents|mesh-ancestor
5661914|NCT03628430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5661915|NCT03628430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5661916|NCT03628430|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5661917|NCT03628430|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5661918|NCT03628430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5661919|NCT03628430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661920|NCT03628430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5661921|NCT03628430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5842027|NCT02496962|Atorvastatin|atorvastatin|mesh-list
5661922|NCT03628430|Adrenergic Agents|adrenergic agents|mesh-ancestor
5661923|NCT03628430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5661924|NCT03628430|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5661925|NCT03628430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5661926|NCT03628430|Autonomic Agents|autonomic agents|mesh-ancestor
5661927|NCT03628430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5661928|NCT03628430|Respiratory System Agents|respiratory system agents|mesh-ancestor
5661929|NCT03628430|Mydriatics|mydriatics|mesh-ancestor
5661930|NCT03628430|Sympathomimetics|sympathomimetics|mesh-ancestor
5661931|NCT03628430|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5661932|NCT03628391|Haloperidol|haloperidol|mesh-list
5661933|NCT03628391|Haloperidol decanoate|haloperidol decanoate|mesh-list
5661934|NCT03628391|Antiemetics|antiemetics|mesh-ancestor
5661935|NCT03628391|Autonomic Agents|autonomic agents|mesh-ancestor
5661936|NCT03628391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5661937|NCT03628391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661938|NCT03628391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5661939|NCT03628391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5661940|NCT03628391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5661941|NCT03628391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5661942|NCT03628391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5661943|NCT03628391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5661944|NCT03628391|Dopamine Agents|dopamine agents|mesh-ancestor
5661945|NCT03628391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5661946|NCT03628391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661947|NCT03628391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5661948|NCT03628339|Tepotinib|tepotinib|mesh-list
5661949|NCT03628339|Midazolam|midazolam|mesh-list
5661950|NCT03628339|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5661951|NCT03628339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5661952|NCT03628339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5661953|NCT03628339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5661954|NCT03628339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5661955|NCT03628339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5661956|NCT03628339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5661957|NCT03628339|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5842028|NCT02496962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5842029|NCT02496962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5842030|NCT02496962|Antimetabolites|antimetabolites|mesh-ancestor
5842031|NCT02496962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842032|NCT02496962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5842033|NCT02496962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5842034|NCT02496962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5842035|NCT02496975|Cyclosporine|cyclosporine|mesh-list
5842036|NCT02496975|Cyclosporins|cyclosporins|mesh-list
5661958|NCT03628339|Anesthetics, General|anesthetics, general|mesh-ancestor
5661959|NCT03628339|Anesthetics|anesthetics|mesh-ancestor
5661960|NCT03628339|GABA Modulators|gaba modulators|mesh-ancestor
5661961|NCT03628339|GABA Agents|gaba agents|mesh-ancestor
5661962|NCT03628339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5661963|NCT03628339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661964|NCT03628339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5661965|NCT03628300|Piperacillin|piperacillin|mesh-list
5842037|NCT02496975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5842038|NCT02496975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842039|NCT02496975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5842040|NCT02496975|Immunologic Factors|immunologic factors|mesh-ancestor
5842041|NCT02496975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842042|NCT02496975|Antifungal Agents|antifungal agents|mesh-ancestor
5842043|NCT02496975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5842044|NCT02496975|Dermatologic Agents|dermatologic agents|mesh-ancestor
5842045|NCT02496975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5842046|NCT02496975|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5661966|NCT03628300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5661967|NCT03628300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5661968|NCT03628131|Carboplatin|carboplatin|mesh-list
5661969|NCT03628131|Etoposide|etoposide|mesh-list
5661970|NCT03628131|Ifosfamide|ifosfamide|mesh-list
5661971|NCT03628131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5661972|NCT03628131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5661973|NCT03628131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5661974|NCT03628131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5661975|NCT03628131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5661976|NCT03628131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661977|NCT03628131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5842047|NCT02496754|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
5842048|NCT02496754|Hormones|hormones|mesh-ancestor
5842049|NCT02496754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5842050|NCT02496754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842051|NCT02496910|Amlodipine|amlodipine|mesh-list
5842052|NCT02496910|Telmisartan|telmisartan|mesh-list
5661978|NCT03628131|Alkylating Agents|alkylating agents|mesh-ancestor
5661979|NCT03628079|Mebendazole|mebendazole|mesh-list
5661980|NCT03628079|Antinematodal Agents|antinematodal agents|mesh-ancestor
5661981|NCT03628079|Anthelmintics|anthelmintics|mesh-ancestor
5661982|NCT03628079|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5661983|NCT03628079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5661984|NCT03628079|Tubulin Modulators|tubulin modulators|mesh-ancestor
5661985|NCT03628079|Antimitotic Agents|antimitotic agents|mesh-ancestor
5661986|NCT03628079|Mitosis Modulators|mitosis modulators|mesh-ancestor
5661987|NCT03628079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661988|NCT03628079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5661989|NCT03628066|Letrozole|letrozole|mesh-list
5661990|NCT03628066|Palbociclib|palbociclib|mesh-list
5661991|NCT03628066|Goserelin|goserelin|mesh-list
5661992|NCT03628066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5661993|NCT03628066|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5661994|NCT03628066|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5661995|NCT03628066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5661996|NCT03628066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5661997|NCT03628066|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5661998|NCT03628066|Hormone Antagonists|hormone antagonists|mesh-ancestor
5661999|NCT03628066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5662000|NCT03628066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662001|NCT03628066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5662002|NCT03628066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5842053|NCT02496910|Chlorthalidone|chlorthalidone|mesh-list
5842054|NCT02496910|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
5842055|NCT02496910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5842056|NCT02496910|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5842057|NCT02496910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5842058|NCT02496910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842059|NCT02496910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5842060|NCT02496910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842061|NCT02496910|Vasodilator Agents|vasodilator agents|mesh-ancestor
5842062|NCT02496910|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5842063|NCT02496910|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5842064|NCT02496910|Diuretics|diuretics|mesh-ancestor
5842065|NCT02496910|Natriuretic Agents|natriuretic agents|mesh-ancestor
5842066|NCT02496910|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5842067|NCT02496741|Metformin|metformin|mesh-list
5842068|NCT02496741|Chloroquine|chloroquine|mesh-list
5842069|NCT02496741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5842070|NCT02496741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842071|NCT02496741|Amebicides|amebicides|mesh-ancestor
5842072|NCT02496741|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5842073|NCT02496741|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5662003|NCT03628053|Blinatumomab|blinatumomab|mesh-list
5662004|NCT03628053|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
5662005|NCT03628053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5662006|NCT03628053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5662007|NCT03628053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5662008|NCT03628040|Ropivacaine|ropivacaine|mesh-list
5662009|NCT03628040|Anesthetics, Local|anesthetics, local|mesh-ancestor
5662010|NCT03628040|Anesthetics|anesthetics|mesh-ancestor
5662011|NCT03628040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5662012|NCT03628040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662013|NCT03628040|Sensory System Agents|sensory system agents|mesh-ancestor
5662014|NCT03628040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5662015|NCT03627884|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5662016|NCT03627741|Triamcinolone|triamcinolone|mesh-list
5662017|NCT03627741|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5662018|NCT03627741|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5662019|NCT03627741|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5662020|NCT03627741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5662021|NCT03627741|Glucocorticoids|glucocorticoids|mesh-ancestor
5662022|NCT03627741|Hormones|hormones|mesh-ancestor
5662023|NCT03627741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5662024|NCT03627741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662025|NCT03627741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5662026|NCT03627741|Immunologic Factors|immunologic factors|mesh-ancestor
5842074|NCT02496741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5842075|NCT02496741|Antimalarials|antimalarials|mesh-ancestor
5842076|NCT02496741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5842077|NCT02496832|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
6674645|NCT01570608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674646|NCT01570608|Growth Inhibitors|growth inhibitors|mesh-ancestor
5662027|NCT03627741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5842078|NCT02496832|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5662028|NCT03627741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662029|NCT03627715|Proxigermanium|proxigermanium|mesh-list
5662030|NCT03627715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5662031|NCT03627715|Interferon Inducers|interferon inducers|mesh-ancestor
5662032|NCT03627715|Immunologic Factors|immunologic factors|mesh-ancestor
5662033|NCT03627715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695330|NCT03390374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5695331|NCT03390374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5695332|NCT03390374|Antifungal Agents|antifungal agents|mesh-ancestor
5695333|NCT03390374|Ionophores|ionophores|mesh-ancestor
5695334|NCT03390374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5842079|NCT02496832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842080|NCT02496715|Fluticasone|fluticasone|mesh-list
5842081|NCT02496715|Xhance|xhance|mesh-list
5842082|NCT02496715|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5842083|NCT02496715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5842084|NCT02496715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5842085|NCT02496715|Autonomic Agents|autonomic agents|mesh-ancestor
5842086|NCT02496715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5842087|NCT02496715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842088|NCT02496715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5842089|NCT02496715|Respiratory System Agents|respiratory system agents|mesh-ancestor
5842090|NCT02496715|Dermatologic Agents|dermatologic agents|mesh-ancestor
5842091|NCT02496715|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5842092|NCT02496715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5842093|NCT02496715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5842094|NCT02496715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5842095|NCT02496715|Adrenergic Agents|adrenergic agents|mesh-ancestor
5695335|NCT03390374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695336|NCT03390062|Apatinib|apatinib|mesh-list
5695337|NCT03390062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5695338|NCT03390062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5695339|NCT03390062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5695340|NCT03390062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695341|NCT03390036|Triamcinolone|triamcinolone|mesh-list
5695342|NCT03390036|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5695343|NCT03390036|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5695344|NCT03390036|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5695345|NCT03390036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5695346|NCT03390036|Glucocorticoids|glucocorticoids|mesh-ancestor
5695347|NCT03390036|Hormones|hormones|mesh-ancestor
5695348|NCT03390036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5695349|NCT03390036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695350|NCT03390036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5695351|NCT03390036|Immunologic Factors|immunologic factors|mesh-ancestor
5695352|NCT03390036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5695353|NCT03390036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695354|NCT03390010|Misoprostol|misoprostol|mesh-list
5695355|NCT03390010|Oxytocin|oxytocin|mesh-list
5695356|NCT03390010|Methylergonovine|methylergonovine|mesh-list
5842096|NCT02496715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5842097|NCT02496715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842098|NCT02496650|Dexmedetomidine|dexmedetomidine|mesh-list
5842099|NCT02496650|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5842100|NCT02496650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5842101|NCT02496650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842102|NCT02496650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5842103|NCT02496650|Analgesics|analgesics|mesh-ancestor
5842104|NCT02496650|Sensory System Agents|sensory system agents|mesh-ancestor
5842105|NCT02496650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5842106|NCT02496650|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5842107|NCT02496650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5842108|NCT02496650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5842109|NCT02496650|Adrenergic Agents|adrenergic agents|mesh-ancestor
5842110|NCT02496650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5842111|NCT02496650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842112|NCT02496494|Tacrolimus|tacrolimus|mesh-list
5842113|NCT02496494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5842114|NCT02496494|Immunologic Factors|immunologic factors|mesh-ancestor
5842115|NCT02496494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493765|NCT00615446|Antimetabolites|antimetabolites|mesh-ancestor
6496514|NCT00628290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5842116|NCT02496494|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5842117|NCT02496494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5662034|NCT03627546|Sofosbuvir|sofosbuvir|mesh-list
5662035|NCT03627546|Velpatasvir|velpatasvir|mesh-list
5662036|NCT03627546|Antiviral Agents|antiviral agents|mesh-ancestor
5662037|NCT03627546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5662038|NCT03627468|Bromides|bromides|mesh-list
6493766|NCT00615446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493767|NCT00615446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6493768|NCT00615446|Antiviral Agents|antiviral agents|mesh-ancestor
6493769|NCT00615446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5842118|NCT02496494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662039|NCT03627468|Anticonvulsants|anticonvulsants|mesh-ancestor
5662040|NCT03627390|Molybdenum|molybdenum|mesh-list
5662041|NCT03627390|Trace Elements|trace elements|mesh-ancestor
5662042|NCT03627390|Micronutrients|micronutrients|mesh-ancestor
5662043|NCT03627390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662044|NCT03627260|Sunscreening Agents|sunscreening agents|mesh-list
5662045|NCT03627260|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5662046|NCT03627260|Protective Agents|protective agents|mesh-ancestor
5662047|NCT03627260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662048|NCT03627260|Dermatologic Agents|dermatologic agents|mesh-ancestor
5662049|NCT03627039|Metformin|metformin|mesh-list
5662050|NCT03627039|Dapagliflozin|dapagliflozin|mesh-list
5662051|NCT03627039|Empagliflozin|empagliflozin|mesh-list
5662052|NCT03627039|Canagliflozin|canagliflozin|mesh-list
5662053|NCT03627039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5842119|NCT02496377|Epoetin Alfa|epoetin alfa|mesh-list
5842120|NCT02496377|Glycine|glycine|mesh-list
5842121|NCT02496377|Hematinics|hematinics|mesh-ancestor
5842122|NCT02496377|Glycine Agents|glycine agents|mesh-ancestor
5842123|NCT02496377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5842124|NCT02496377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662054|NCT03627039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662055|NCT03627039|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5662056|NCT03627039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662057|NCT03627013|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5662058|NCT03626922|Folic Acid|folic acid|mesh-list
5662059|NCT03626922|Vitamin B 12|vitamin b 12|mesh-list
5842125|NCT02496377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842126|NCT02496455|Tramadol|tramadol|mesh-list
5842127|NCT02496455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5842128|NCT02496455|Narcotics|narcotics|mesh-ancestor
5842129|NCT02496455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5662060|NCT03626922|Hydroxocobalamin|hydroxocobalamin|mesh-list
5662061|NCT03626922|Dexamethasone|dexamethasone|mesh-list
5662062|NCT03626922|Pembrolizumab|pembrolizumab|mesh-list
5662063|NCT03626922|Oxaliplatin|oxaliplatin|mesh-list
5662064|NCT03626922|Pemetrexed|pemetrexed|mesh-list
5662065|NCT03626922|Vitamins|vitamins|mesh-ancestor
5662066|NCT03626922|Micronutrients|micronutrients|mesh-ancestor
5662067|NCT03626922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662068|NCT03626922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5662069|NCT03626922|Antiemetics|antiemetics|mesh-ancestor
5842130|NCT02496455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842131|NCT02496455|Analgesics|analgesics|mesh-ancestor
5842132|NCT02496455|Sensory System Agents|sensory system agents|mesh-ancestor
5842133|NCT02496455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5842134|NCT02496299|Dexamethasone|dexamethasone|mesh-list
5842135|NCT02496299|Bupivacaine|bupivacaine|mesh-list
5842136|NCT02496299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5842137|NCT02496299|Antiemetics|antiemetics|mesh-ancestor
5842138|NCT02496299|Autonomic Agents|autonomic agents|mesh-ancestor
5842139|NCT02496299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5842140|NCT02496299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493770|NCT00615446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6493771|NCT00615446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6493772|NCT00615446|Immunologic Factors|immunologic factors|mesh-ancestor
6493773|NCT00615446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493774|NCT00615446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6493775|NCT00615446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6493776|NCT00615446|Growth Substances|growth substances|mesh-ancestor
6493777|NCT00615446|Growth Inhibitors|growth inhibitors|mesh-ancestor
6493778|NCT00615446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6493779|NCT00615524|Exemestane|exemestane|mesh-list
6493780|NCT00615524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6493781|NCT00615524|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6493782|NCT00615524|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6493783|NCT00615524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6493784|NCT00615524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493785|NCT00615524|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5842141|NCT02496299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5842142|NCT02496299|Glucocorticoids|glucocorticoids|mesh-ancestor
5842143|NCT02496299|Hormones|hormones|mesh-ancestor
5842144|NCT02496299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5842145|NCT02496299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5842146|NCT02496299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5842147|NCT02496299|Anesthetics, Local|anesthetics, local|mesh-ancestor
5842148|NCT02496299|Anesthetics|anesthetics|mesh-ancestor
5842149|NCT02496299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5842150|NCT02496299|Sensory System Agents|sensory system agents|mesh-ancestor
5842151|NCT02496286|Bevacizumab|bevacizumab|mesh-list
5842152|NCT02496286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5842153|NCT02496286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5842154|NCT02496286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5842155|NCT02496286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5842156|NCT02496286|Growth Substances|growth substances|mesh-ancestor
5842157|NCT02496286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842158|NCT02496286|Growth Inhibitors|growth inhibitors|mesh-ancestor
5842159|NCT02496208|Nivolumab|nivolumab|mesh-list
5842160|NCT02496208|Ipilimumab|ipilimumab|mesh-list
5842161|NCT02496208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5842162|NCT02496208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5842163|NCT02496208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5842164|NCT02496208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842165|NCT02496182|Pirfenidone|pirfenidone|mesh-list
5842166|NCT02496182|Analgesics|analgesics|mesh-ancestor
5842167|NCT02496182|Sensory System Agents|sensory system agents|mesh-ancestor
5842168|NCT02496182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5842169|NCT02496182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662070|NCT03626922|Autonomic Agents|autonomic agents|mesh-ancestor
5662071|NCT03626922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5662072|NCT03626922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5662073|NCT03626922|Glucocorticoids|glucocorticoids|mesh-ancestor
5662074|NCT03626922|Hormones|hormones|mesh-ancestor
5662075|NCT03626922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5662076|NCT03626922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5662077|NCT03626922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5662078|NCT03626922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5662079|NCT03626922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5662080|NCT03626922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662081|NCT03626922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5662082|NCT03626922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5662083|NCT03626922|Hematinics|hematinics|mesh-ancestor
5662084|NCT03626922|Vitamin B Complex|vitamin b complex|mesh-ancestor
5662085|NCT03626831|Evolocumab|evolocumab|mesh-list
5662086|NCT03626831|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5662087|NCT03626831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5662088|NCT03626831|Antimetabolites|antimetabolites|mesh-ancestor
5662089|NCT03626831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662090|NCT03626831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5662091|NCT03626753|Acetaminophen|acetaminophen|mesh-list
5662092|NCT03626753|Piroxicam|piroxicam|mesh-list
5662093|NCT03626753|Nefopam|nefopam|mesh-list
5662094|NCT03626753|Proroxan|proroxan|mesh-list
5662095|NCT03626753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5842170|NCT02496182|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5842171|NCT02496182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5842172|NCT02496182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5842173|NCT02496182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5842174|NCT02496182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5842175|NCT02496078|Asunaprevir|asunaprevir|mesh-list
5842176|NCT02496078|Protease Inhibitors|protease inhibitors|mesh-ancestor
5842177|NCT02496078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5842178|NCT02496078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842179|NCT02495896|Gemcitabine|gemcitabine|mesh-list
5842180|NCT02495896|Paclitaxel|paclitaxel|mesh-list
5842181|NCT02495896|Docetaxel|docetaxel|mesh-list
5842182|NCT02495896|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5842183|NCT02495896|Cisplatin|cisplatin|mesh-list
5842184|NCT02495896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5662096|NCT03626753|Analgesics|analgesics|mesh-ancestor
5842185|NCT02495896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5842186|NCT02495896|Tubulin Modulators|tubulin modulators|mesh-ancestor
5842187|NCT02495896|Antimitotic Agents|antimitotic agents|mesh-ancestor
5842188|NCT02495896|Mitosis Modulators|mitosis modulators|mesh-ancestor
5903348|NCT05049980|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5842189|NCT02495896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842190|NCT02495896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5842191|NCT02495896|Antimetabolites|antimetabolites|mesh-ancestor
5842192|NCT02495896|Antiviral Agents|antiviral agents|mesh-ancestor
5842193|NCT02495896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5842194|NCT02495896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5842195|NCT02495896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5842196|NCT02495896|Immunologic Factors|immunologic factors|mesh-ancestor
5842197|NCT02495896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842198|NCT02495922|Dexamethasone|dexamethasone|mesh-list
5842199|NCT02495922|Lenalidomide|lenalidomide|mesh-list
5842200|NCT02495922|Bortezomib|bortezomib|mesh-list
5842201|NCT02495922|Elotuzumab|elotuzumab|mesh-list
5662097|NCT03626753|Sensory System Agents|sensory system agents|mesh-ancestor
5662098|NCT03626753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5662099|NCT03626753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662100|NCT03626753|Antipyretics|antipyretics|mesh-ancestor
5662101|NCT03626753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5662102|NCT03626753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5662103|NCT03626753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5662104|NCT03626753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5662105|NCT03626753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5662106|NCT03626753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662107|NCT03626753|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5842202|NCT02495922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5842203|NCT02495922|Antiemetics|antiemetics|mesh-ancestor
5842204|NCT02495922|Autonomic Agents|autonomic agents|mesh-ancestor
5662108|NCT03626753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5662109|NCT03626753|Adrenergic Agents|adrenergic agents|mesh-ancestor
5662110|NCT03626753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5662111|NCT03626753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5662112|NCT03626727|Sodium Oxybate|sodium oxybate|mesh-list
5662113|NCT03626727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5662114|NCT03626727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5662115|NCT03626727|Anesthetics, General|anesthetics, general|mesh-ancestor
5662116|NCT03626727|Anesthetics|anesthetics|mesh-ancestor
5842205|NCT02495922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5842206|NCT02495922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842207|NCT02495922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5842208|NCT02495922|Glucocorticoids|glucocorticoids|mesh-ancestor
5842209|NCT02495922|Hormones|hormones|mesh-ancestor
5842210|NCT02495922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5842211|NCT02495922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5842212|NCT02495922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5842213|NCT02495922|Immunologic Factors|immunologic factors|mesh-ancestor
5842214|NCT02495922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5842215|NCT02495922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5842216|NCT02495922|Growth Substances|growth substances|mesh-ancestor
5842217|NCT02495922|Growth Inhibitors|growth inhibitors|mesh-ancestor
5842218|NCT02495688|Anesthetics|anesthetics|mesh-list
5842219|NCT02495688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5842220|NCT02495688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903349|NCT05049980|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5903350|NCT05049980|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5662117|NCT03626727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5662118|NCT03626727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662119|NCT03626571|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5662120|NCT03626571|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5662121|NCT03626571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662122|NCT03626519|Menthol|menthol|mesh-list
5662123|NCT03626519|Antipruritics|antipruritics|mesh-ancestor
5662124|NCT03626519|Dermatologic Agents|dermatologic agents|mesh-ancestor
5662125|NCT03626506|Amlodipine|amlodipine|mesh-list
5662126|NCT03626506|Indapamide|indapamide|mesh-list
5662127|NCT03626506|Spironolactone|spironolactone|mesh-list
5662128|NCT03626506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5662129|NCT03626506|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5662130|NCT03626506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5662131|NCT03626506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662132|NCT03626506|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5903351|NCT05049980|Contraceptive Agents|contraceptive agents|mesh-ancestor
5903352|NCT05049980|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5903353|NCT05049980|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5903354|NCT05049980|Hormone Antagonists|hormone antagonists|mesh-ancestor
5908410|NCT04570332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5842221|NCT02495584|Vitamin D|vitamin d|mesh-list
5842222|NCT02495584|Ergocalciferols|ergocalciferols|mesh-list
5842223|NCT02495584|Cholecalciferol|cholecalciferol|mesh-list
5842224|NCT02495584|Vitamins|vitamins|mesh-list
5842225|NCT02495584|Micronutrients|micronutrients|mesh-ancestor
5662133|NCT03626506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662134|NCT03626506|Vasodilator Agents|vasodilator agents|mesh-ancestor
5662135|NCT03626506|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5662136|NCT03626506|Hormone Antagonists|hormone antagonists|mesh-ancestor
5662137|NCT03626506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5662138|NCT03626506|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5842226|NCT02495584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842227|NCT02495584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5842228|NCT02495584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5842229|NCT02495636|Atezolizumab|atezolizumab|mesh-list
5842230|NCT02495636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5842231|NCT02495818|Lidocaine|lidocaine|mesh-list
5842232|NCT02495818|Anesthetics, Local|anesthetics, local|mesh-ancestor
5842233|NCT02495818|Anesthetics|anesthetics|mesh-ancestor
5842234|NCT02495818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5842235|NCT02495818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842236|NCT02495818|Sensory System Agents|sensory system agents|mesh-ancestor
5842237|NCT02495818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5842238|NCT02495818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5842239|NCT02495818|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5842240|NCT02495818|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5842241|NCT02495818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5842242|NCT02495818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842243|NCT02495662|Prednisolone|prednisolone|mesh-list
5842244|NCT02495662|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5842245|NCT02495662|Methylprednisolone|methylprednisolone|mesh-list
5842246|NCT02495662|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5842247|NCT02495662|Prednisolone acetate|prednisolone acetate|mesh-list
5842248|NCT02495662|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5842249|NCT02495662|Prednisolone phosphate|prednisolone phosphate|mesh-list
5842250|NCT02495662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6674647|NCT01570608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6674648|NCT01570608|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6674649|NCT01570608|Dermatologic Agents|dermatologic agents|mesh-ancestor
6674650|NCT01570660|Pioglitazone|pioglitazone|mesh-list
6674651|NCT01570660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6674652|NCT01570660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674653|NCT01570764|Cyclophosphamide|cyclophosphamide|mesh-list
6674654|NCT01570764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6674655|NCT01570764|Immunologic Factors|immunologic factors|mesh-ancestor
6674656|NCT01570764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674657|NCT01570764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6674658|NCT01570764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6674659|NCT01570764|Alkylating Agents|alkylating agents|mesh-ancestor
6674660|NCT01570764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662139|NCT03626506|Diuretics|diuretics|mesh-ancestor
5662140|NCT03626506|Natriuretic Agents|natriuretic agents|mesh-ancestor
5662141|NCT03626506|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5662142|NCT03626454|Norepinephrine|norepinephrine|mesh-list
5662143|NCT03626454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5662144|NCT03626454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5662145|NCT03626454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5662146|NCT03626454|Adrenergic Agents|adrenergic agents|mesh-ancestor
5662147|NCT03626454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5662148|NCT03626454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662149|NCT03626454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662150|NCT03626454|Sympathomimetics|sympathomimetics|mesh-ancestor
5662151|NCT03626454|Autonomic Agents|autonomic agents|mesh-ancestor
5662152|NCT03626454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5662153|NCT03626454|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5662154|NCT03626298|Niacinamide|niacinamide|mesh-list
5662155|NCT03626298|Niacin|niacin|mesh-list
5662156|NCT03626298|Nicotinic Acids|nicotinic acids|mesh-list
5662157|NCT03626298|Adapalene|adapalene|mesh-list
5662158|NCT03626298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5662159|NCT03626298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5662160|NCT03626298|Analgesics|analgesics|mesh-ancestor
5662161|NCT03626298|Sensory System Agents|sensory system agents|mesh-ancestor
5842251|NCT02495662|Glucocorticoids|glucocorticoids|mesh-ancestor
5842252|NCT02495662|Hormones|hormones|mesh-ancestor
5842253|NCT02495662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5842254|NCT02495662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842255|NCT02495662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5842256|NCT02495662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5842257|NCT02495662|Antiemetics|antiemetics|mesh-ancestor
5842258|NCT02495662|Autonomic Agents|autonomic agents|mesh-ancestor
5842259|NCT02495662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5842260|NCT02495662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5842261|NCT02495662|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5842262|NCT02495662|Protective Agents|protective agents|mesh-ancestor
5842263|NCT02496052|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5842264|NCT02496052|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5842265|NCT02496052|Estradiol|estradiol|mesh-list
5842266|NCT02496052|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5842267|NCT02496052|Dydrogesterone|dydrogesterone|mesh-list
5842268|NCT02496052|Estrogens|estrogens|mesh-ancestor
5842269|NCT02496052|Hormones|hormones|mesh-ancestor
5842270|NCT02496052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5842271|NCT02496052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842272|NCT02496052|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5842273|NCT02496052|Contraceptive Agents|contraceptive agents|mesh-ancestor
5842274|NCT02496052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5842275|NCT02496052|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5842276|NCT02496052|Progestins|progestins|mesh-ancestor
5842277|NCT02495532|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5662162|NCT03626298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5662163|NCT03626298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662164|NCT03626298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5662165|NCT03626298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5662166|NCT03626298|Dermatologic Agents|dermatologic agents|mesh-ancestor
5662167|NCT03626298|Vitamin B Complex|vitamin b complex|mesh-ancestor
5662168|NCT03626298|Vitamins|vitamins|mesh-ancestor
5662169|NCT03626298|Micronutrients|micronutrients|mesh-ancestor
5662170|NCT03626298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5662171|NCT03626298|Antimetabolites|antimetabolites|mesh-ancestor
5842278|NCT02495519|Imatinib Mesylate|imatinib mesylate|mesh-list
5842279|NCT02495519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5842280|NCT02495519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5842281|NCT02495519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5842282|NCT02495519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842283|NCT02495181|Aflibercept|aflibercept|mesh-list
5842284|NCT02495181|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5842285|NCT02495181|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5842286|NCT02495181|Growth Substances|growth substances|mesh-ancestor
5662172|NCT03626298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662173|NCT03626298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5662174|NCT03626298|Vasodilator Agents|vasodilator agents|mesh-ancestor
5662175|NCT03626259|Losartan|losartan|mesh-list
5662176|NCT03626259|Amlodipine|amlodipine|mesh-list
5662177|NCT03626259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5662178|NCT03626259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5662179|NCT03626259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5842287|NCT02495181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674661|NCT01570764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6674662|NCT01570764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6674663|NCT01570790|Fosbretabulin|fosbretabulin|mesh-list
6674664|NCT01570790|Combretastatin|combretastatin|mesh-list
5662180|NCT03626259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842288|NCT02495181|Growth Inhibitors|growth inhibitors|mesh-ancestor
5842289|NCT02495181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5842290|NCT02495324|Valsartan|valsartan|mesh-list
5662181|NCT03626259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5662182|NCT03626259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662183|NCT03626259|Vasodilator Agents|vasodilator agents|mesh-ancestor
5662184|NCT03626259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5662185|NCT03626259|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5662186|NCT03626259|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5662187|NCT03626064|Nicotine|nicotine|mesh-list
5662188|NCT03626064|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5662189|NCT03626064|Autonomic Agents|autonomic agents|mesh-ancestor
5662190|NCT03626064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5662191|NCT03626064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662192|NCT03626064|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5662193|NCT03626064|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6674665|NCT01570790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5662194|NCT03626064|Cholinergic Agents|cholinergic agents|mesh-ancestor
5662195|NCT03626064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5662196|NCT03626064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695357|NCT03390010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5695358|NCT03390010|Abortifacient Agents|abortifacient agents|mesh-ancestor
5695359|NCT03390010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5695360|NCT03390010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695361|NCT03390010|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5695362|NCT03390010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5695363|NCT03390010|Oxytocics|oxytocics|mesh-ancestor
5695364|NCT03389958|Copper|copper|mesh-list
5695365|NCT03389958|Trace Elements|trace elements|mesh-ancestor
5695366|NCT03389958|Micronutrients|micronutrients|mesh-ancestor
5695367|NCT03389958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695368|NCT03389789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5695369|NCT03389776|Anesthetics|anesthetics|mesh-list
5695370|NCT03389776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5695371|NCT03389776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695372|NCT03389763|Remifentanil|remifentanil|mesh-list
5695373|NCT03389763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5695374|NCT03389763|Narcotics|narcotics|mesh-ancestor
5842291|NCT02495324|Olmesartan|olmesartan|mesh-list
5842292|NCT02495324|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
5842293|NCT02495324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5842294|NCT02495324|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5842295|NCT02495324|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5842296|NCT02495324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842297|NCT02495220|Dexmedetomidine|dexmedetomidine|mesh-list
5842298|NCT02495220|Bupivacaine|bupivacaine|mesh-list
5842299|NCT02495220|Anesthetics, Local|anesthetics, local|mesh-ancestor
5842300|NCT02495220|Anesthetics|anesthetics|mesh-ancestor
5842301|NCT02495220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5842302|NCT02495220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842303|NCT02495220|Sensory System Agents|sensory system agents|mesh-ancestor
5842304|NCT02495220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5842305|NCT02495220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5695375|NCT03389763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5695376|NCT03389763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695377|NCT03389763|Analgesics|analgesics|mesh-ancestor
5695378|NCT03389763|Sensory System Agents|sensory system agents|mesh-ancestor
5695379|NCT03389763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5842306|NCT02495220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5842307|NCT02495220|Analgesics|analgesics|mesh-ancestor
5842308|NCT02495220|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5842309|NCT02495220|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5842310|NCT02495220|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5842311|NCT02495220|Adrenergic Agents|adrenergic agents|mesh-ancestor
5842312|NCT02495220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5842313|NCT02495220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842314|NCT02495285|Polygeline|polygeline|mesh-list
5842315|NCT02495285|Plasma Substitutes|plasma substitutes|mesh-ancestor
5842316|NCT02495285|Blood Substitutes|blood substitutes|mesh-ancestor
5842317|NCT02495272|Oxytocin|oxytocin|mesh-list
5842318|NCT02495272|Oxytocics|oxytocics|mesh-ancestor
5842319|NCT02495272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5842320|NCT02495272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842321|NCT02495415|Fenretinide|fenretinide|mesh-list
5842322|NCT02495415|Retinamide|retinamide|mesh-list
5842323|NCT02495415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5842324|NCT02495415|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5842325|NCT02495415|Protective Agents|protective agents|mesh-ancestor
5842326|NCT02495415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842327|NCT02495363|Bupivacaine|bupivacaine|mesh-list
5842328|NCT02495363|Anesthetics, Local|anesthetics, local|mesh-ancestor
5842329|NCT02495363|Anesthetics|anesthetics|mesh-ancestor
5842330|NCT02495363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5842331|NCT02495363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842332|NCT02495363|Sensory System Agents|sensory system agents|mesh-ancestor
5842333|NCT02495363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5842334|NCT02494882|Dexamethasone|dexamethasone|mesh-list
5842335|NCT02494882|Dasatinib|dasatinib|mesh-list
5842336|NCT02494882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5842337|NCT02494882|Antiemetics|antiemetics|mesh-ancestor
5842338|NCT02494882|Autonomic Agents|autonomic agents|mesh-ancestor
5695380|NCT03389750|Oxymorphone|oxymorphone|mesh-list
5695381|NCT03389750|Morphine|morphine|mesh-list
5842339|NCT02494882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5662197|NCT03625960|Cantharidin|cantharidin|mesh-list
5662198|NCT03625960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5662199|NCT03625960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662200|NCT03625830|Paclitaxel|paclitaxel|mesh-list
5662201|NCT03625830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5662202|NCT03625830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5662203|NCT03625830|Tubulin Modulators|tubulin modulators|mesh-ancestor
5842340|NCT02494882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842341|NCT02494882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5842342|NCT02494882|Glucocorticoids|glucocorticoids|mesh-ancestor
5842343|NCT02494882|Hormones|hormones|mesh-ancestor
5842344|NCT02494882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5842345|NCT02494882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5842346|NCT02494882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5842347|NCT02494882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5842348|NCT02494882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5842349|NCT02494882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842350|NCT02494999|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5842351|NCT02494999|Immunologic Factors|immunologic factors|mesh-ancestor
5842352|NCT02494999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842353|NCT02494830|Ketamine|ketamine|mesh-list
5842354|NCT02494830|Analgesics|analgesics|mesh-ancestor
5842355|NCT02494830|Sensory System Agents|sensory system agents|mesh-ancestor
5842356|NCT02494830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5842357|NCT02494830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842358|NCT02494830|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5842359|NCT02494830|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5842360|NCT02494830|Anesthetics, General|anesthetics, general|mesh-ancestor
5842361|NCT02494830|Anesthetics|anesthetics|mesh-ancestor
5842362|NCT02494830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5842363|NCT02494830|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5842364|NCT02494830|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5842365|NCT02494830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5842366|NCT02494830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842367|NCT02494804|Temozolomide|temozolomide|mesh-list
5842368|NCT02494804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5842369|NCT02494804|Alkylating Agents|alkylating agents|mesh-ancestor
5842370|NCT02494804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842371|NCT02494804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5842372|NCT02494973|Oxaliplatin|oxaliplatin|mesh-list
5842373|NCT02494973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5842374|NCT02495077|Acetaminophen|acetaminophen|mesh-list
5842375|NCT02495077|Diphenhydramine|diphenhydramine|mesh-list
5842376|NCT02495077|Promethazine|promethazine|mesh-list
5842377|NCT02495077|Loratadine|loratadine|mesh-list
6493786|NCT00615524|Hormone Antagonists|hormone antagonists|mesh-ancestor
6493787|NCT00615524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6493788|NCT00615524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842378|NCT02495077|Mycophenolic Acid|mycophenolic acid|mesh-list
5842379|NCT02495077|Prednisone|prednisone|mesh-list
5842380|NCT02495077|Methylprednisolone|methylprednisolone|mesh-list
5842381|NCT02495077|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5842382|NCT02495077|Infliximab|infliximab|mesh-list
5842383|NCT02495077|Tacrolimus|tacrolimus|mesh-list
5842384|NCT02495077|Thymoglobulin|thymoglobulin|mesh-list
5842385|NCT02495077|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5842386|NCT02495077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5842387|NCT02495077|Glucocorticoids|glucocorticoids|mesh-ancestor
5662204|NCT03625830|Antimitotic Agents|antimitotic agents|mesh-ancestor
5662205|NCT03625830|Mitosis Modulators|mitosis modulators|mesh-ancestor
5662206|NCT03625830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662207|NCT03625739|Amoxicillin|amoxicillin|mesh-list
5662208|NCT03625739|Moxifloxacin|moxifloxacin|mesh-list
5662209|NCT03625739|Levofloxacin|levofloxacin|mesh-list
5662210|NCT03625739|Isoniazid|isoniazid|mesh-list
5662211|NCT03625739|Cycloserine|cycloserine|mesh-list
5662212|NCT03625739|Clavulanic Acid|clavulanic acid|mesh-list
5662213|NCT03625739|Imipenem|imipenem|mesh-list
5842388|NCT02495077|Hormones|hormones|mesh-ancestor
5842389|NCT02495077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5842390|NCT02495077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842391|NCT02495077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5842392|NCT02495077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6493789|NCT00615602|Cyclophosphamide|cyclophosphamide|mesh-list
6493790|NCT00615602|Docetaxel|docetaxel|mesh-list
5662214|NCT03625739|Amikacin|amikacin|mesh-list
5662215|NCT03625739|Pyrazinamide|pyrazinamide|mesh-list
5662216|NCT03625739|Ethambutol|ethambutol|mesh-list
5662217|NCT03625739|Bedaquiline|bedaquiline|mesh-list
5662218|NCT03625739|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5662219|NCT03625739|Clofazimine|clofazimine|mesh-list
5662220|NCT03625739|Gatifloxacin|gatifloxacin|mesh-list
5662221|NCT03625739|Aminosalicylic Acid|aminosalicylic acid|mesh-list
5842393|NCT02495077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5842394|NCT02495077|Immunologic Factors|immunologic factors|mesh-ancestor
5842395|NCT02495077|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5842396|NCT02495077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5842397|NCT02495077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842398|NCT02495077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5842399|NCT02495077|Analgesics|analgesics|mesh-ancestor
5842400|NCT02495077|Sensory System Agents|sensory system agents|mesh-ancestor
5842401|NCT02495077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5842402|NCT02495077|Antipyretics|antipyretics|mesh-ancestor
5842403|NCT02495077|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5842404|NCT02495077|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5842405|NCT02495077|Antitubercular Agents|antitubercular agents|mesh-ancestor
5842406|NCT02495077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5842407|NCT02495077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5662222|NCT03625739|Streptomycin|streptomycin|mesh-list
5662223|NCT03625739|Kanamycin|kanamycin|mesh-list
5662224|NCT03625739|Ethionamide|ethionamide|mesh-list
5662225|NCT03625739|Capreomycin|capreomycin|mesh-list
5662226|NCT03625739|Thioacetazone|thioacetazone|mesh-list
5662227|NCT03625739|Antitubercular Agents|antitubercular agents|mesh-list
5662228|NCT03625739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5662229|NCT03625739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5662230|NCT03625739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5662231|NCT03625739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5662232|NCT03625739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5662233|NCT03625739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662234|NCT03625739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5662235|NCT03625739|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5662236|NCT03625739|Renal Agents|renal agents|mesh-ancestor
5662237|NCT03625739|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5662238|NCT03625739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5662239|NCT03625739|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5842408|NCT02495077|Antiemetics|antiemetics|mesh-ancestor
5842409|NCT02495077|Autonomic Agents|autonomic agents|mesh-ancestor
5842410|NCT02495077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5842411|NCT02495077|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5842412|NCT02495077|Protective Agents|protective agents|mesh-ancestor
5842413|NCT02495077|Dermatologic Agents|dermatologic agents|mesh-ancestor
5842414|NCT02495077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5842415|NCT02495077|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5842416|NCT02495077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5842417|NCT02495077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5842418|NCT02495077|Anesthetics, Local|anesthetics, local|mesh-ancestor
5842419|NCT02495077|Anesthetics|anesthetics|mesh-ancestor
5842420|NCT02495077|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5842421|NCT02495077|Histamine Antagonists|histamine antagonists|mesh-ancestor
5842422|NCT02495077|Histamine Agents|histamine agents|mesh-ancestor
5842423|NCT02495077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5842424|NCT02495077|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5842425|NCT02495077|Antipruritics|antipruritics|mesh-ancestor
5842426|NCT02495077|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5842427|NCT02494895|Aspirin|aspirin|mesh-list
5842428|NCT02494895|Ticagrelor|ticagrelor|mesh-list
5842429|NCT02494895|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5842430|NCT02494895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5842431|NCT02494895|Analgesics|analgesics|mesh-ancestor
5842432|NCT02494895|Sensory System Agents|sensory system agents|mesh-ancestor
5842433|NCT02494895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5662240|NCT03625739|Leprostatic Agents|leprostatic agents|mesh-ancestor
5662241|NCT03625739|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5662242|NCT03625739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5662243|NCT03625739|Antimetabolites|antimetabolites|mesh-ancestor
5662244|NCT03625739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5662245|NCT03625739|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5662246|NCT03625739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5662247|NCT03625739|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5662248|NCT03625739|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5662249|NCT03625739|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5662250|NCT03625726|Thrombin|thrombin|mesh-list
5842434|NCT02494895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842435|NCT02494895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5842436|NCT02494895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5842437|NCT02494895|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5842438|NCT02494895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5842439|NCT02494895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842440|NCT02494895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5842441|NCT02494895|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5842442|NCT02494895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5842443|NCT02494895|Antipyretics|antipyretics|mesh-ancestor
5842444|NCT02494895|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5842445|NCT02494895|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5842446|NCT02494895|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5842447|NCT02494895|Purinergic Agents|purinergic agents|mesh-ancestor
5842448|NCT02494895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5842449|NCT02494856|Naproxen|naproxen|mesh-list
5662251|NCT03625726|Hemostatics|hemostatics|mesh-ancestor
5662252|NCT03625726|Coagulants|coagulants|mesh-ancestor
5662253|NCT03625687|Antiviral Agents|antiviral agents|mesh-list
5662254|NCT03625687|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
5662255|NCT03625687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5662256|NCT03625531|Letrozole|letrozole|mesh-list
5662257|NCT03625531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5662258|NCT03625531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5662259|NCT03625531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5662260|NCT03625531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5662261|NCT03625531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662262|NCT03625531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5662263|NCT03625531|Hormone Antagonists|hormone antagonists|mesh-ancestor
5662264|NCT03625531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5662265|NCT03625531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662266|NCT03625518|Oxytocin|oxytocin|mesh-list
5662267|NCT03625518|Dinoprostone|dinoprostone|mesh-list
5662268|NCT03625518|Oxytocics|oxytocics|mesh-ancestor
5662269|NCT03625518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5662270|NCT03625518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662271|NCT03625505|Venetoclax|venetoclax|mesh-list
5662272|NCT03625505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5662273|NCT03625310|Listerine|listerine|mesh-list
5662274|NCT03625310|Fluorides|fluorides|mesh-list
5662275|NCT03625310|Sodium Fluoride|sodium fluoride|mesh-list
5662276|NCT03625310|Cariostatic Agents|cariostatic agents|mesh-ancestor
5662277|NCT03625310|Protective Agents|protective agents|mesh-ancestor
5662278|NCT03625310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662279|NCT03625310|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5662280|NCT03625310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5662281|NCT03625219|Prednisone|prednisone|mesh-list
5662282|NCT03625219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5662283|NCT03625219|Glucocorticoids|glucocorticoids|mesh-ancestor
5662284|NCT03625219|Hormones|hormones|mesh-ancestor
5662285|NCT03625219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5662286|NCT03625219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662287|NCT03625219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5662288|NCT03625219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5662289|NCT03625167|Petrolatum|petrolatum|mesh-list
5662290|NCT03625167|Emollients|emollients|mesh-ancestor
5662291|NCT03625167|Dermatologic Agents|dermatologic agents|mesh-ancestor
5662292|NCT03625089|Atorvastatin|atorvastatin|mesh-list
5662293|NCT03625089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5662294|NCT03625089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5662295|NCT03625089|Antimetabolites|antimetabolites|mesh-ancestor
5662296|NCT03625089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662297|NCT03625089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5662298|NCT03625089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5662299|NCT03625089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5662300|NCT03625076|Lidocaine|lidocaine|mesh-list
5662301|NCT03625076|Propofol|propofol|mesh-list
5662302|NCT03625076|Etomidate|etomidate|mesh-list
5662303|NCT03625076|Anesthetics, Local|anesthetics, local|mesh-ancestor
5662304|NCT03625076|Anesthetics|anesthetics|mesh-ancestor
5662305|NCT03625076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5662306|NCT03625076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662307|NCT03625076|Sensory System Agents|sensory system agents|mesh-ancestor
5662308|NCT03625076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5662309|NCT03625076|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5842450|NCT02494856|Esomeprazole|esomeprazole|mesh-list
5842451|NCT02494856|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5662310|NCT03625076|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5842452|NCT02494856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5842453|NCT02494856|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5842454|NCT02494856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5842455|NCT02494856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842456|NCT02494856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5842457|NCT02494856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5842458|NCT02494856|Analgesics|analgesics|mesh-ancestor
5842459|NCT02494856|Sensory System Agents|sensory system agents|mesh-ancestor
5842460|NCT02494856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5662311|NCT03625076|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5662312|NCT03625076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5662313|NCT03625076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662314|NCT03625076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5662315|NCT03625076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5662316|NCT03625076|Anesthetics, General|anesthetics, general|mesh-ancestor
5662317|NCT03625050|Celecoxib|celecoxib|mesh-list
5662318|NCT03625050|Esomeprazole|esomeprazole|mesh-list
5662319|NCT03625050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5662320|NCT03625050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5662321|NCT03625050|Analgesics|analgesics|mesh-ancestor
5662322|NCT03625050|Sensory System Agents|sensory system agents|mesh-ancestor
5662323|NCT03625050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5662324|NCT03625050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662325|NCT03625050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5662326|NCT03625050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5662327|NCT03625050|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5662328|NCT03625050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5842461|NCT02494856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842462|NCT02494856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5842463|NCT02494856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5842464|NCT02494856|Gout Suppressants|gout suppressants|mesh-ancestor
5842465|NCT02494856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5842466|NCT02495064|Mometasone Furoate|mometasone furoate|mesh-list
5842467|NCT02495064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5842468|NCT02495064|Dermatologic Agents|dermatologic agents|mesh-ancestor
5842469|NCT02495064|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5842470|NCT02494687|Domperidone|domperidone|mesh-list
5842471|NCT02494687|Antiemetics|antiemetics|mesh-ancestor
5842472|NCT02494687|Autonomic Agents|autonomic agents|mesh-ancestor
5842473|NCT02494687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5842474|NCT02494687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842475|NCT02494687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5662329|NCT03625050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5662330|NCT03625050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662331|NCT03625050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5662332|NCT03625050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5662333|NCT03625050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5662334|NCT03625011|Gabapentin|gabapentin|mesh-list
5842476|NCT02494687|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5842477|NCT02494687|Dopamine Agents|dopamine agents|mesh-ancestor
5842478|NCT02494687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5842479|NCT02494687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842480|NCT02494609|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
5842481|NCT02494609|Contraceptive Agents|contraceptive agents|mesh-list
5842482|NCT02494609|Contraceptives, Oral|contraceptives, oral|mesh-list
5842483|NCT02494609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5662335|NCT03625011|Analgesics|analgesics|mesh-ancestor
5662336|NCT03625011|Sensory System Agents|sensory system agents|mesh-ancestor
5662337|NCT03625011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5662338|NCT03625011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662339|NCT03625011|Anticonvulsants|anticonvulsants|mesh-ancestor
5662340|NCT03625011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5662341|NCT03625011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5662342|NCT03625011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5662343|NCT03625011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5662344|NCT03625011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5662345|NCT03625011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5662346|NCT03625011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5662347|NCT03625011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662348|NCT03625011|Antimanic Agents|antimanic agents|mesh-ancestor
5662349|NCT03624985|Lidocaine|lidocaine|mesh-list
5662350|NCT03624985|Anesthetics, Local|anesthetics, local|mesh-ancestor
5662351|NCT03624985|Anesthetics|anesthetics|mesh-ancestor
5662352|NCT03624985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5662353|NCT03624985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662354|NCT03624985|Sensory System Agents|sensory system agents|mesh-ancestor
5662355|NCT03624985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5662356|NCT03624985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5662357|NCT03624985|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5662358|NCT03624985|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5662359|NCT03624985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5662360|NCT03624985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662361|NCT03624959|Itraconazole|itraconazole|mesh-list
5662362|NCT03624959|Rifampin|rifampin|mesh-list
5662363|NCT03624959|Gemfibrozil|gemfibrozil|mesh-list
5662364|NCT03624959|Ozanimod|ozanimod|mesh-list
5662365|NCT03624959|Antifungal Agents|antifungal agents|mesh-ancestor
5662366|NCT03624959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5662367|NCT03624959|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5662368|NCT03624959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5662369|NCT03624959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5662370|NCT03624959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662371|NCT03624959|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5662372|NCT03624959|Hormone Antagonists|hormone antagonists|mesh-ancestor
5662373|NCT03624959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5662374|NCT03624959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662375|NCT03624959|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5662376|NCT03624959|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5662377|NCT03624959|Antitubercular Agents|antitubercular agents|mesh-ancestor
5662378|NCT03624959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5662379|NCT03624959|Leprostatic Agents|leprostatic agents|mesh-ancestor
5662380|NCT03624959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5662381|NCT03624959|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5662382|NCT03624959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5662383|NCT03624959|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5662384|NCT03624959|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5662385|NCT03624959|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5662386|NCT03624959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5662387|NCT03624959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5662388|NCT03624959|Antimetabolites|antimetabolites|mesh-ancestor
5662389|NCT03624959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5662390|NCT03624959|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
5662391|NCT03624959|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5662392|NCT03624959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5662393|NCT03624959|Immunologic Factors|immunologic factors|mesh-ancestor
5662394|NCT03624595|Dexmedetomidine|dexmedetomidine|mesh-list
5662395|NCT03624595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5662396|NCT03624595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5695382|NCT03389750|Oxycodone|oxycodone|mesh-list
5842484|NCT02494609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842485|NCT02494609|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5842486|NCT02494609|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5842487|NCT02494609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842488|NCT02494609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5842489|NCT02494531|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5842490|NCT02494531|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5842491|NCT02494531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842492|NCT02494505|Mycophenolic Acid|mycophenolic acid|mesh-list
5842493|NCT02494505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5842494|NCT02494505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5842495|NCT02494505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5842496|NCT02494505|Antitubercular Agents|antitubercular agents|mesh-ancestor
5842497|NCT02494505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5842498|NCT02494505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5842499|NCT02494505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5842500|NCT02494505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842501|NCT02494466|Montelukast|montelukast|mesh-list
5842502|NCT02494466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5842503|NCT02494466|Respiratory System Agents|respiratory system agents|mesh-ancestor
5842504|NCT02494466|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5842505|NCT02494466|Hormone Antagonists|hormone antagonists|mesh-ancestor
5842506|NCT02494466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5842507|NCT02494466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662397|NCT03624595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662398|NCT03624595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5842508|NCT02494466|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5842509|NCT02494466|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5842510|NCT02494466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842511|NCT02494349|Tamsulosin|tamsulosin|mesh-list
5842512|NCT02494349|Solifenacin Succinate|solifenacin succinate|mesh-list
5842513|NCT02494349|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5842514|NCT02494349|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5842515|NCT02494349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5842516|NCT02494349|Adrenergic Agents|adrenergic agents|mesh-ancestor
5842517|NCT02494349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5842518|NCT02494349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842519|NCT02494349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842520|NCT02494349|Urological Agents|urological agents|mesh-ancestor
5842521|NCT02494349|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5662399|NCT03624595|Analgesics|analgesics|mesh-ancestor
5662400|NCT03624595|Sensory System Agents|sensory system agents|mesh-ancestor
5662401|NCT03624595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5662402|NCT03624595|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5662403|NCT03624595|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5842522|NCT02494349|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5842523|NCT02494349|Cholinergic Agents|cholinergic agents|mesh-ancestor
5842524|NCT02494284|Aspirin|aspirin|mesh-list
5842525|NCT02494284|Clopidogrel|clopidogrel|mesh-list
5842526|NCT02494284|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5842527|NCT02494284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5842528|NCT02494284|Analgesics|analgesics|mesh-ancestor
5842529|NCT02494284|Sensory System Agents|sensory system agents|mesh-ancestor
5842530|NCT02494284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5842531|NCT02494284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842532|NCT02494284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5842533|NCT02494284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5842534|NCT02494284|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6212007|NCT02180672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212008|NCT02180672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6212009|NCT02180672|Respiratory System Agents|respiratory system agents|mesh-ancestor
5842535|NCT02494284|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5842536|NCT02494284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842537|NCT02494284|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5842538|NCT02494284|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6212010|NCT02180672|Dermatologic Agents|dermatologic agents|mesh-ancestor
5662404|NCT03624595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5662405|NCT03624595|Adrenergic Agents|adrenergic agents|mesh-ancestor
5662406|NCT03624595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5662407|NCT03624595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695383|NCT03389750|Hydromorphone|hydromorphone|mesh-list
5695384|NCT03389750|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5695385|NCT03389750|Narcotics|narcotics|mesh-ancestor
5695386|NCT03389750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5695387|NCT03389750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695388|NCT03389750|Analgesics|analgesics|mesh-ancestor
5695389|NCT03389750|Sensory System Agents|sensory system agents|mesh-ancestor
5695390|NCT03389750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5695391|NCT03389750|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5695392|NCT03389724|Captopril|captopril|mesh-list
5695393|NCT03389724|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5695394|NCT03389724|Protease Inhibitors|protease inhibitors|mesh-ancestor
5695395|NCT03389724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5695396|NCT03389724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695397|NCT03389724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5695398|NCT03389672|Anesthetics|anesthetics|mesh-list
5695399|NCT03389672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5695400|NCT03389672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695401|NCT03389659|Vitamin D|vitamin d|mesh-list
5695402|NCT03389659|Cholecalciferol|cholecalciferol|mesh-list
5695403|NCT03389659|Vitamins|vitamins|mesh-ancestor
5695404|NCT03389659|Micronutrients|micronutrients|mesh-ancestor
5695405|NCT03389659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695406|NCT03389659|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5695407|NCT03389659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5695408|NCT03389607|Anesthetics|anesthetics|mesh-list
5695409|NCT03389607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5842539|NCT02494284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5842540|NCT02494284|Antipyretics|antipyretics|mesh-ancestor
5842541|NCT02494284|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5842542|NCT02494284|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5842543|NCT02494284|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5842544|NCT02494284|Purinergic Agents|purinergic agents|mesh-ancestor
5842545|NCT02494284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5903355|NCT05049980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5903356|NCT05049980|Luteolytic Agents|luteolytic agents|mesh-ancestor
5903357|NCT05049980|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5903358|NCT05049980|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5903359|NCT05045950|Memantine|memantine|mesh-list
5903360|NCT05045950|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5903361|NCT05045950|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5903362|NCT05045950|Dopamine Agents|dopamine agents|mesh-ancestor
5903363|NCT05045950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5903364|NCT05045950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903365|NCT05045950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903366|NCT05045950|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5903367|NCT05045950|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5903368|NCT05045703|Vitamin A|vitamin a|mesh-list
5903369|NCT05045703|Retinol palmitate|retinol palmitate|mesh-list
5903370|NCT05045703|Vitamins|vitamins|mesh-ancestor
5903371|NCT05045703|Micronutrients|micronutrients|mesh-ancestor
5903372|NCT05045703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903373|NCT05045703|Antioxidants|antioxidants|mesh-ancestor
5903374|NCT05045703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903375|NCT05045703|Protective Agents|protective agents|mesh-ancestor
5662408|NCT03624322|Olanzapine|olanzapine|mesh-list
5662409|NCT03624322|Antiemetics|antiemetics|mesh-ancestor
5662410|NCT03624322|Autonomic Agents|autonomic agents|mesh-ancestor
5662411|NCT03624322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5662412|NCT03624322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662413|NCT03624322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5662414|NCT03624322|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5662415|NCT03624322|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5662416|NCT03624322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5662417|NCT03624322|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5903376|NCT05045703|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5903377|NCT05045703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5903378|NCT05045638|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5903379|NCT05045638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5903380|NCT05045638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5903381|NCT05045638|Antimetabolites|antimetabolites|mesh-ancestor
5662418|NCT03624322|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5662419|NCT03624322|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5662420|NCT03624322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5662421|NCT03624322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662422|NCT03624322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5662423|NCT03624322|Serotonin Agents|serotonin agents|mesh-ancestor
5662424|NCT03624309|Docetaxel|docetaxel|mesh-list
5662425|NCT03624309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5662426|NCT03624309|Tubulin Modulators|tubulin modulators|mesh-ancestor
5662427|NCT03624309|Antimitotic Agents|antimitotic agents|mesh-ancestor
5662428|NCT03624309|Mitosis Modulators|mitosis modulators|mesh-ancestor
5662429|NCT03624309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662430|NCT03624283|Betahistine|betahistine|mesh-list
5662431|NCT03624283|Vasodilator Agents|vasodilator agents|mesh-ancestor
5662432|NCT03624283|Histamine Agonists|histamine agonists|mesh-ancestor
5903382|NCT05045638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903383|NCT05045638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5903384|NCT05045638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5903385|NCT05045638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5903386|NCT05041101|Halichondrin B|halichondrin b|mesh-list
5903387|NCT05041101|Tubulin Modulators|tubulin modulators|mesh-ancestor
5903388|NCT05041101|Antimitotic Agents|antimitotic agents|mesh-ancestor
5903389|NCT05041101|Mitosis Modulators|mitosis modulators|mesh-ancestor
5903390|NCT05041101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903391|NCT05041101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5903392|NCT05039086|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
5903393|NCT05039086|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-list
5903394|NCT05039086|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5903395|NCT05039086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5662433|NCT03624283|Histamine Agents|histamine agents|mesh-ancestor
5842546|NCT02493933|Acetylcysteine|acetylcysteine|mesh-list
5662434|NCT03624283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5662435|NCT03624283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662436|NCT03624283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662437|NCT03624270|Ascorbic Acid|ascorbic acid|mesh-list
5662438|NCT03624270|Arsenic Trioxide|arsenic trioxide|mesh-list
5662439|NCT03624270|Antioxidants|antioxidants|mesh-ancestor
5662440|NCT03624270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662441|NCT03624270|Protective Agents|protective agents|mesh-ancestor
5662442|NCT03624270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842547|NCT02493933|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5842548|NCT02493933|Phytoestrogens|phytoestrogens|mesh-list
5842549|NCT02493933|Antiviral Agents|antiviral agents|mesh-ancestor
5842550|NCT02493933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5842551|NCT02493933|Expectorants|expectorants|mesh-ancestor
5842552|NCT02493933|Respiratory System Agents|respiratory system agents|mesh-ancestor
5842553|NCT02493933|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5842554|NCT02493933|Antioxidants|antioxidants|mesh-ancestor
5842555|NCT02493933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842556|NCT02493933|Protective Agents|protective agents|mesh-ancestor
5842557|NCT02493933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842558|NCT02493933|Antidotes|antidotes|mesh-ancestor
5842559|NCT02493933|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
5842560|NCT02493933|Estrogens|estrogens|mesh-ancestor
5842561|NCT02493933|Hormones|hormones|mesh-ancestor
5842562|NCT02493933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5842563|NCT02493959|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5662443|NCT03624270|Vitamins|vitamins|mesh-ancestor
5662444|NCT03624270|Micronutrients|micronutrients|mesh-ancestor
5662445|NCT03624270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5662446|NCT03624244|Letrozole|letrozole|mesh-list
5662447|NCT03624244|Exemestane|exemestane|mesh-list
5662448|NCT03624244|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5662449|NCT03624244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5662450|NCT03624244|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5662451|NCT03624244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5662452|NCT03624244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662453|NCT03624244|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5662454|NCT03624244|Hormone Antagonists|hormone antagonists|mesh-ancestor
5662455|NCT03624244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5662456|NCT03624244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662457|NCT03624231|Durvalumab|durvalumab|mesh-list
5662458|NCT03624231|Tremelimumab|tremelimumab|mesh-list
5662459|NCT03624231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5662460|NCT03624231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5662461|NCT03624205|Paclitaxel|paclitaxel|mesh-list
5662462|NCT03624205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5662463|NCT03624205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5662464|NCT03624205|Tubulin Modulators|tubulin modulators|mesh-ancestor
5662465|NCT03624205|Antimitotic Agents|antimitotic agents|mesh-ancestor
5662466|NCT03624205|Mitosis Modulators|mitosis modulators|mesh-ancestor
5662467|NCT03624205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662468|NCT03624166|Ketamine|ketamine|mesh-list
5662469|NCT03624166|Anesthetics|anesthetics|mesh-list
5662470|NCT03624166|Anesthetics, General|anesthetics, general|mesh-list
5662471|NCT03624166|Analgesics|analgesics|mesh-ancestor
5662472|NCT03624166|Sensory System Agents|sensory system agents|mesh-ancestor
5662473|NCT03624166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5662474|NCT03624166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662475|NCT03624166|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5662476|NCT03624166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5662477|NCT03624166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5662478|NCT03624166|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5662479|NCT03624166|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5662480|NCT03624166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5662481|NCT03624166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662482|NCT03624062|Insulin|insulin|mesh-list
5662483|NCT03624062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5662484|NCT03624062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662485|NCT03624010|Simendan|simendan|mesh-list
5662486|NCT03624010|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5662487|NCT03624010|Vasodilator Agents|vasodilator agents|mesh-ancestor
5662488|NCT03624010|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5662489|NCT03624010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5842564|NCT02493959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5842565|NCT02493959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842566|NCT02493959|Incretins|incretins|mesh-ancestor
5842567|NCT02493959|Hormones|hormones|mesh-ancestor
5662490|NCT03624010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5662491|NCT03624010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662492|NCT03624010|Protective Agents|protective agents|mesh-ancestor
5662493|NCT03624010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662494|NCT03623854|Nivolumab|nivolumab|mesh-list
5662495|NCT03623854|Immunoglobulins|immunoglobulins|mesh-list
5662496|NCT03623854|Immunoglobulin G|immunoglobulin g|mesh-list
5662497|NCT03623854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5662498|NCT03623854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5662499|NCT03623854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5662500|NCT03623854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662501|NCT03623854|Immunologic Factors|immunologic factors|mesh-ancestor
5662502|NCT03623854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662503|NCT03623789|Tranylcypromine|tranylcypromine|mesh-list
5662504|NCT03623789|Tranexamic Acid|tranexamic acid|mesh-list
5662505|NCT03623789|Hemostatics|hemostatics|mesh-list
5662506|NCT03623789|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5662507|NCT03623789|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5662508|NCT03623789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842568|NCT02493959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5842569|NCT02493959|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5842570|NCT02493959|Protease Inhibitors|protease inhibitors|mesh-ancestor
5842571|NCT02493959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5842572|NCT02493959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842573|NCT02493894|Cefazolin|cefazolin|mesh-list
5842574|NCT02493894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5842575|NCT02493894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5662509|NCT03623789|Coagulants|coagulants|mesh-ancestor
5662510|NCT03623789|Antidepressive Agents|antidepressive agents|mesh-ancestor
5662511|NCT03623789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5662512|NCT03623789|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
5662513|NCT03623789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5662514|NCT03623789|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5662515|NCT03623789|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5842576|NCT02493725|Eculizumab|eculizumab|mesh-list
5842577|NCT02493725|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5842578|NCT02493725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5842579|NCT02493725|Immunologic Factors|immunologic factors|mesh-ancestor
5842580|NCT02493725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842581|NCT02493738|Itraconazole|itraconazole|mesh-list
5842582|NCT02493738|Antifungal Agents|antifungal agents|mesh-ancestor
5842583|NCT02493738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5842584|NCT02493738|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5842585|NCT02493738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5842586|NCT02493738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6493791|NCT00615602|Trastuzumab|trastuzumab|mesh-list
6493792|NCT00615602|Epirubicin|epirubicin|mesh-list
6493793|NCT00615602|Fluorouracil|fluorouracil|mesh-list
6493794|NCT00615602|Mitogens|mitogens|mesh-list
6493795|NCT00615602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6493796|NCT00615602|Immunologic Factors|immunologic factors|mesh-ancestor
5662516|NCT03623789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5662517|NCT03623789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662518|NCT03623776|Carboplatin|carboplatin|mesh-list
5662519|NCT03623776|Pemetrexed|pemetrexed|mesh-list
5662520|NCT03623776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5662521|NCT03623776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5662522|NCT03623776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662523|NCT03623776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5662524|NCT03623776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5662525|NCT03623750|Cyclophosphamide|cyclophosphamide|mesh-list
5662526|NCT03623750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5662527|NCT03623750|Immunologic Factors|immunologic factors|mesh-ancestor
5662528|NCT03623750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662529|NCT03623750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5662530|NCT03623750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5662531|NCT03623750|Alkylating Agents|alkylating agents|mesh-ancestor
5662532|NCT03623750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493797|NCT00615602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493798|NCT00615602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5842587|NCT02493738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842588|NCT02493738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5842589|NCT02493738|Hormone Antagonists|hormone antagonists|mesh-ancestor
5842590|NCT02493738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5842591|NCT02493738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842592|NCT02493738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5842593|NCT02493582|Apatinib|apatinib|mesh-list
5842594|NCT02493582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5662533|NCT03623750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5662534|NCT03623750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5662535|NCT03623711|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5662536|NCT03623711|Citalopram|citalopram|mesh-list
5662537|NCT03623711|Bupropion|bupropion|mesh-list
5662538|NCT03623711|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5842595|NCT02493582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5842596|NCT02493582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5842597|NCT02493582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842598|NCT02493504|Heparin|heparin|mesh-list
5842599|NCT02493504|Anticoagulants|anticoagulants|mesh-ancestor
5842600|NCT02493504|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5662539|NCT03623711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5662540|NCT03623711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5662541|NCT03623711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662542|NCT03623711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5662543|NCT03623711|Serotonin Agents|serotonin agents|mesh-ancestor
5662544|NCT03623711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662545|NCT03623711|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5662546|NCT03623711|Antidepressive Agents|antidepressive agents|mesh-ancestor
5662547|NCT03623711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5662548|NCT03623711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5662549|NCT03623711|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5662550|NCT03623711|Dopamine Agents|dopamine agents|mesh-ancestor
5662551|NCT03623711|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5662552|NCT03623711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5662553|NCT03623711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5662554|NCT03623711|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5662555|NCT03623711|Analgesics|analgesics|mesh-ancestor
5662556|NCT03623711|Sensory System Agents|sensory system agents|mesh-ancestor
5662557|NCT03623633|Denosumab|denosumab|mesh-list
5662558|NCT03623633|Alendronate|alendronate|mesh-list
5662559|NCT03623633|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
5662560|NCT03623633|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5662561|NCT03623633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662562|NCT03623633|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5662563|NCT03623633|Hormone Antagonists|hormone antagonists|mesh-ancestor
5662564|NCT03623633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5662565|NCT03623633|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5662566|NCT03623633|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5662567|NCT03623555|Hydrocortisone|hydrocortisone|mesh-list
5662568|NCT03623555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5662569|NCT03623529|Angiotensin II|angiotensin ii|mesh-list
5662570|NCT03623529|Giapreza|giapreza|mesh-list
5662571|NCT03623529|Angiotensinogen|angiotensinogen|mesh-list
5662572|NCT03623529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5662573|NCT03623529|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5662574|NCT03623529|Protease Inhibitors|protease inhibitors|mesh-ancestor
5662575|NCT03623529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5662576|NCT03623529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662577|NCT03623425|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5842601|NCT02493504|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5842602|NCT02493504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842603|NCT02493465|Everolimus|everolimus|mesh-list
5842604|NCT02493465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5842605|NCT02493465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5842606|NCT02493465|Immunologic Factors|immunologic factors|mesh-ancestor
5842607|NCT02493465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842608|NCT02493335|Budesonide|budesonide|mesh-list
5842609|NCT02493335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5842610|NCT02493335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5842611|NCT02493335|Autonomic Agents|autonomic agents|mesh-ancestor
5842612|NCT02493335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5842613|NCT02493335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842614|NCT02493335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5842615|NCT02493335|Respiratory System Agents|respiratory system agents|mesh-ancestor
5842616|NCT02493335|Glucocorticoids|glucocorticoids|mesh-ancestor
5842617|NCT02493335|Hormones|hormones|mesh-ancestor
5842618|NCT02493335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5842619|NCT02493179|Serratiopeptidase|serratiopeptidase|mesh-list
5842620|NCT02493179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5842621|NCT02493179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5842622|NCT02493179|Analgesics|analgesics|mesh-ancestor
5842623|NCT02493179|Sensory System Agents|sensory system agents|mesh-ancestor
5842624|NCT02493179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5842625|NCT02493179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842626|NCT02493179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5842627|NCT02493179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5842628|NCT02493192|Meperidine|meperidine|mesh-list
5842629|NCT02493192|Haloperidol|haloperidol|mesh-list
5842630|NCT02493192|Haloperidol decanoate|haloperidol decanoate|mesh-list
5842631|NCT02493192|Antiemetics|antiemetics|mesh-ancestor
5842632|NCT02493192|Autonomic Agents|autonomic agents|mesh-ancestor
5842633|NCT02493192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5842634|NCT02493192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842635|NCT02493192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5842636|NCT02493192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5842637|NCT02493192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5842638|NCT02493192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5842639|NCT02493192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5842640|NCT02493192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5842641|NCT02493192|Dopamine Agents|dopamine agents|mesh-ancestor
5842642|NCT02493192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5842643|NCT02493192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662578|NCT03623425|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5662579|NCT03623425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662580|NCT03623256|Fentanyl|fentanyl|mesh-list
5662581|NCT03623256|Bupivacaine|bupivacaine|mesh-list
5662582|NCT03623256|Anesthetics, Local|anesthetics, local|mesh-ancestor
5662583|NCT03623256|Anesthetics|anesthetics|mesh-ancestor
5662584|NCT03623256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5662585|NCT03623256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662586|NCT03623256|Sensory System Agents|sensory system agents|mesh-ancestor
5662587|NCT03623256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5662588|NCT03623256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5842644|NCT02493192|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5842645|NCT02493192|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5842646|NCT02493192|Narcotics|narcotics|mesh-ancestor
5842647|NCT02493192|Analgesics|analgesics|mesh-ancestor
5662589|NCT03623256|Narcotics|narcotics|mesh-ancestor
5662590|NCT03623256|Analgesics|analgesics|mesh-ancestor
5662591|NCT03623256|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5662592|NCT03623256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5662593|NCT03623256|Anesthetics, General|anesthetics, general|mesh-ancestor
5662594|NCT03623230|Bupivacaine|bupivacaine|mesh-list
5662595|NCT03623230|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5662596|NCT03623230|Anesthetics, Local|anesthetics, local|mesh-ancestor
5842648|NCT02493192|Sensory System Agents|sensory system agents|mesh-ancestor
5842649|NCT02493192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5842650|NCT02493283|Dapsone|dapsone|mesh-list
5842651|NCT02493283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5842652|NCT02493283|Antimalarials|antimalarials|mesh-ancestor
5842653|NCT02493283|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5842654|NCT02493283|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5842655|NCT02493283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5842656|NCT02493283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5842657|NCT02493283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842658|NCT02493283|Leprostatic Agents|leprostatic agents|mesh-ancestor
5842659|NCT02493283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5842660|NCT02493231|Ketamine|ketamine|mesh-list
5842661|NCT02493231|Nefopam|nefopam|mesh-list
5662597|NCT03623230|Anesthetics|anesthetics|mesh-ancestor
5662598|NCT03623230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5842662|NCT02493231|Analgesics|analgesics|mesh-ancestor
6493799|NCT00615602|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6493800|NCT00615602|Alkylating Agents|alkylating agents|mesh-ancestor
6493801|NCT00615602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493802|NCT00615602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6493803|NCT00615602|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6493804|NCT00615602|Tubulin Modulators|tubulin modulators|mesh-ancestor
5842663|NCT02493231|Sensory System Agents|sensory system agents|mesh-ancestor
5842664|NCT02493231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5842665|NCT02493231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662599|NCT03623230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662600|NCT03623230|Sensory System Agents|sensory system agents|mesh-ancestor
5662601|NCT03623230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5662602|NCT03623087|Gemcitabine|gemcitabine|mesh-list
5662603|NCT03623087|Dexamethasone|dexamethasone|mesh-list
5662604|NCT03623087|Etoposide|etoposide|mesh-list
5662605|NCT03623087|Asparaginase|asparaginase|mesh-list
5662606|NCT03623087|Ifosfamide|ifosfamide|mesh-list
5662607|NCT03623087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5662608|NCT03623087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5662609|NCT03623087|Antiemetics|antiemetics|mesh-ancestor
5662610|NCT03623087|Autonomic Agents|autonomic agents|mesh-ancestor
5662611|NCT03623087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5662612|NCT03623087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662613|NCT03623087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5662614|NCT03623087|Glucocorticoids|glucocorticoids|mesh-ancestor
5662615|NCT03623087|Hormones|hormones|mesh-ancestor
5662616|NCT03623087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5662617|NCT03623087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5662618|NCT03623087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5842666|NCT02493231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5842667|NCT02493231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5842668|NCT02493231|Anesthetics, General|anesthetics, general|mesh-ancestor
5842669|NCT02493231|Anesthetics|anesthetics|mesh-ancestor
5842670|NCT02493231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5842671|NCT02493231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5842672|NCT02493231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5842673|NCT02493231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5842674|NCT02493231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493805|NCT00615602|Antimitotic Agents|antimitotic agents|mesh-ancestor
6493806|NCT00615602|Mitosis Modulators|mitosis modulators|mesh-ancestor
6493807|NCT00615602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6493808|NCT00615602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6493809|NCT00615602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5662619|NCT03623087|Antimetabolites|antimetabolites|mesh-ancestor
5662620|NCT03623087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662621|NCT03623087|Antiviral Agents|antiviral agents|mesh-ancestor
5662622|NCT03623087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5662623|NCT03623087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5662624|NCT03623087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5662625|NCT03623087|Immunologic Factors|immunologic factors|mesh-ancestor
6493810|NCT00615602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6493811|NCT00615602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6493812|NCT00615602|Antimetabolites|antimetabolites|mesh-ancestor
5842675|NCT02493231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5842676|NCT02493049|Domperidone|domperidone|mesh-list
5842677|NCT02493049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842678|NCT02493049|Antiemetics|antiemetics|mesh-ancestor
5842679|NCT02493049|Autonomic Agents|autonomic agents|mesh-ancestor
5842680|NCT02493049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5842681|NCT02493049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842682|NCT02493049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5842683|NCT02493049|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5842684|NCT02493049|Dopamine Agents|dopamine agents|mesh-ancestor
5842685|NCT02493049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5842686|NCT02493322|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5662626|NCT03623087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5842687|NCT02493322|Olmesartan|olmesartan|mesh-list
5842688|NCT02493322|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
5842689|NCT02493322|Chlorthalidone|chlorthalidone|mesh-list
5842690|NCT02493322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5842691|NCT02493322|Diuretics|diuretics|mesh-ancestor
5842692|NCT02493322|Natriuretic Agents|natriuretic agents|mesh-ancestor
5842693|NCT02493322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842694|NCT02493322|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5842695|NCT02493322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5842696|NCT02493322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842697|NCT02493322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5842698|NCT02493322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5842699|NCT02492945|Lidocaine|lidocaine|mesh-list
5842700|NCT02492945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5842701|NCT02492945|Anesthetics, Local|anesthetics, local|mesh-ancestor
5662627|NCT03623087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5842702|NCT02492945|Anesthetics|anesthetics|mesh-ancestor
5842703|NCT02492945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5842704|NCT02492945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842705|NCT02492945|Sensory System Agents|sensory system agents|mesh-ancestor
5842706|NCT02492945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5842707|NCT02492945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5842708|NCT02492945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5842709|NCT02492945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5842710|NCT02492945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5842711|NCT02492945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842712|NCT02492776|Omeprazole|omeprazole|mesh-list
5842713|NCT02492776|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5842714|NCT02492776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5842715|NCT02492776|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5662628|NCT03623087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5662629|NCT03623087|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5662630|NCT03623087|Alkylating Agents|alkylating agents|mesh-ancestor
5662631|NCT03623048|Chlorhexidine|chlorhexidine|mesh-list
5662632|NCT03623048|Propolis|propolis|mesh-list
5662633|NCT03623048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5662634|NCT03623048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5662635|NCT03623048|Disinfectants|disinfectants|mesh-ancestor
5695410|NCT03389607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695411|NCT03389490|Insulin|insulin|mesh-list
5695412|NCT03389490|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5695413|NCT03389490|Insulin Glargine|insulin glargine|mesh-list
5695414|NCT03389490|Insulin, Isophane|insulin, isophane|mesh-list
5695415|NCT03389490|Isophane Insulin, Human|isophane insulin, human|mesh-list
5695416|NCT03389490|Isophane insulin, beef|isophane insulin, beef|mesh-list
5695417|NCT03389490|Protamines|protamines|mesh-list
5695418|NCT03389490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5695419|NCT03389490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695420|NCT03389490|Heparin Antagonists|heparin antagonists|mesh-ancestor
5695421|NCT03389490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695422|NCT03389490|Coagulants|coagulants|mesh-ancestor
5695423|NCT03389451|Edetic Acid|edetic acid|mesh-list
5695424|NCT03389451|Chelating Agents|chelating agents|mesh-ancestor
5695425|NCT03389451|Sequestering Agents|sequestering agents|mesh-ancestor
5695426|NCT03389451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695427|NCT03389451|Anticoagulants|anticoagulants|mesh-ancestor
5695428|NCT03389451|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5695429|NCT03389412|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
5695430|NCT03389412|Hemostatics|hemostatics|mesh-ancestor
5695431|NCT03389412|Coagulants|coagulants|mesh-ancestor
5695432|NCT03389412|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5695433|NCT03389412|Natriuretic Agents|natriuretic agents|mesh-ancestor
5695434|NCT03389412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698012|NCT03371992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5698013|NCT03371992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5698014|NCT03371992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5698015|NCT03371992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5698016|NCT03371953|Atracurium|atracurium|mesh-list
5698017|NCT03371953|Vecuronium Bromide|vecuronium bromide|mesh-list
5842716|NCT02492776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5842717|NCT02492776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842718|NCT02492503|Paclitaxel|paclitaxel|mesh-list
5842719|NCT02492503|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5842720|NCT02492503|Carboplatin|carboplatin|mesh-list
5842721|NCT02492503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5842722|NCT02492503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5842723|NCT02492503|Tubulin Modulators|tubulin modulators|mesh-ancestor
5842724|NCT02492503|Antimitotic Agents|antimitotic agents|mesh-ancestor
5842725|NCT02492503|Mitosis Modulators|mitosis modulators|mesh-ancestor
5842726|NCT02492503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842727|NCT02492477|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5842728|NCT02492477|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5842729|NCT02492477|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5842730|NCT02492477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662636|NCT03622918|Rifampin|rifampin|mesh-list
5662637|NCT03622918|Colistin|colistin|mesh-list
5662638|NCT03622918|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5662639|NCT03622918|Antitubercular Agents|antitubercular agents|mesh-ancestor
5662640|NCT03622918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5662641|NCT03622918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5662642|NCT03622918|Leprostatic Agents|leprostatic agents|mesh-ancestor
5662643|NCT03622918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5662644|NCT03622918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5662645|NCT03622918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662646|NCT03622918|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5662647|NCT03622918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5662648|NCT03622918|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5662649|NCT03622918|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5662650|NCT03622918|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5662651|NCT03622918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5662652|NCT03622827|Endostar protein|endostar protein|mesh-list
5662653|NCT03622827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5662654|NCT03622827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5662655|NCT03622827|Growth Substances|growth substances|mesh-ancestor
5662656|NCT03622827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662657|NCT03622827|Growth Inhibitors|growth inhibitors|mesh-ancestor
5662658|NCT03622827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5662659|NCT03622541|Sorafenib|sorafenib|mesh-list
5662660|NCT03622541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5662661|NCT03622541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5662662|NCT03622541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5662663|NCT03622541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662664|NCT03622515|Anesthetics|anesthetics|mesh-list
5662665|NCT03622515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5662666|NCT03622515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662667|NCT03622502|Dexmedetomidine|dexmedetomidine|mesh-list
5662668|NCT03622502|Remifentanil|remifentanil|mesh-list
5662669|NCT03622502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5842731|NCT02492464|Red yeast rice|red yeast rice|mesh-list
5842732|NCT02492464|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5842733|NCT02492464|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5842734|NCT02492464|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5842735|NCT02492464|Antimetabolites|antimetabolites|mesh-ancestor
5842736|NCT02492464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842737|NCT02492464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5842738|NCT02492464|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5842739|NCT02492412|Cyclosporine|cyclosporine|mesh-list
5842740|NCT02492412|Cyclosporins|cyclosporins|mesh-list
5842741|NCT02492412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5842742|NCT02492412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842743|NCT02492412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5842744|NCT02492412|Immunologic Factors|immunologic factors|mesh-ancestor
5842745|NCT02492412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842746|NCT02492412|Antifungal Agents|antifungal agents|mesh-ancestor
5842747|NCT02492412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5842748|NCT02492412|Dermatologic Agents|dermatologic agents|mesh-ancestor
5842749|NCT02492412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5842750|NCT02492412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5842751|NCT02492568|Pembrolizumab|pembrolizumab|mesh-list
5842752|NCT02492568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5842753|NCT02492568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5662670|NCT03622502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5662671|NCT03622502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662672|NCT03622502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5662673|NCT03622502|Analgesics|analgesics|mesh-ancestor
5662674|NCT03622502|Sensory System Agents|sensory system agents|mesh-ancestor
5662675|NCT03622502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5662676|NCT03622502|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5662677|NCT03622502|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5662678|NCT03622502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5842754|NCT02492386|Everolimus|everolimus|mesh-list
5842755|NCT02492386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5842756|NCT02492386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5842757|NCT02492386|Immunologic Factors|immunologic factors|mesh-ancestor
5842758|NCT02492386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842759|NCT02492438|Vaccines|vaccines|mesh-list
5842760|NCT02492438|Immunologic Factors|immunologic factors|mesh-ancestor
5662679|NCT03622502|Adrenergic Agents|adrenergic agents|mesh-ancestor
5662680|NCT03622502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5662681|NCT03622502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842761|NCT02492438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842762|NCT02492581|Nalmefene|nalmefene|mesh-list
5842763|NCT02492581|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5842764|NCT02492581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842765|NCT02492581|Sensory System Agents|sensory system agents|mesh-ancestor
5842766|NCT02492581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5842767|NCT02492373|Clobetasol|clobetasol|mesh-list
5842768|NCT02492373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5842769|NCT02492373|Glucocorticoids|glucocorticoids|mesh-ancestor
5842770|NCT02492373|Hormones|hormones|mesh-ancestor
5842771|NCT02492373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5842772|NCT02492373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842773|NCT02492490|Basiliximab|basiliximab|mesh-list
5662682|NCT03622502|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5662683|NCT03622502|Narcotics|narcotics|mesh-ancestor
5662684|NCT03622489|Acetaminophen|acetaminophen|mesh-list
5662685|NCT03622489|Dipyrone|dipyrone|mesh-list
5662686|NCT03622489|Ibuprofen|ibuprofen|mesh-list
5662687|NCT03622489|Morphine|morphine|mesh-list
5662688|NCT03622489|Tramadol|tramadol|mesh-list
5662689|NCT03622489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5662690|NCT03622489|Narcotics|narcotics|mesh-ancestor
5662691|NCT03622489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5662692|NCT03622489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662693|NCT03622489|Analgesics|analgesics|mesh-ancestor
5662694|NCT03622489|Sensory System Agents|sensory system agents|mesh-ancestor
5662695|NCT03622489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5662696|NCT03622489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5662697|NCT03622489|Antipyretics|antipyretics|mesh-ancestor
5662698|NCT03622489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5662699|NCT03622489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5662700|NCT03622489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5662701|NCT03622489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5662702|NCT03622489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5662703|NCT03622489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662704|NCT03622450|Ciprofloxacin|ciprofloxacin|mesh-list
5662705|NCT03622450|Levofloxacin|levofloxacin|mesh-list
5662706|NCT03622450|Gentamicins|gentamicins|mesh-list
5662707|NCT03622450|Meropenem|meropenem|mesh-list
5662708|NCT03622450|Amikacin|amikacin|mesh-list
5662709|NCT03622450|Colistin|colistin|mesh-list
5662710|NCT03622450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5662711|NCT03622450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5662712|NCT03622450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5842774|NCT02492490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5842775|NCT02492490|Immunologic Factors|immunologic factors|mesh-ancestor
5842776|NCT02492490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842777|NCT02492308|Basiliximab|basiliximab|mesh-list
5842778|NCT02492308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5842779|NCT02492308|Immunologic Factors|immunologic factors|mesh-ancestor
5842780|NCT02492308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903396|NCT05039086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903397|NCT05037825|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5903398|NCT05037825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903399|NCT05037825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5903400|NCT05028725|Lugol's solution|lugol's solution|mesh-list
5662713|NCT03622450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5662714|NCT03622450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5662715|NCT03622450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662716|NCT03622450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5662717|NCT03622450|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5662718|NCT03622450|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5842781|NCT02492360|Cisplatin|cisplatin|mesh-list
5842782|NCT02492360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5842783|NCT02492282|Remifentanil|remifentanil|mesh-list
5842784|NCT02492282|Propofol|propofol|mesh-list
5842785|NCT02492282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5842786|NCT02492282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5842787|NCT02492282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842788|NCT02492282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5842789|NCT02492282|Anesthetics, General|anesthetics, general|mesh-ancestor
5842790|NCT02492282|Anesthetics|anesthetics|mesh-ancestor
5842791|NCT02492282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5842792|NCT02492282|Narcotics|narcotics|mesh-ancestor
5842793|NCT02492282|Analgesics|analgesics|mesh-ancestor
5842794|NCT02492282|Sensory System Agents|sensory system agents|mesh-ancestor
5842795|NCT02492282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5842796|NCT02492126|Citric Acid|citric acid|mesh-list
5842797|NCT02492126|Sodium Citrate|sodium citrate|mesh-list
5842798|NCT02492126|Anticoagulants|anticoagulants|mesh-ancestor
5842799|NCT02492126|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5842800|NCT02492126|Chelating Agents|chelating agents|mesh-ancestor
5842801|NCT02492126|Sequestering Agents|sequestering agents|mesh-ancestor
5842802|NCT02492126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842803|NCT02492230|Warfarin|warfarin|mesh-list
5842804|NCT02492230|Anticoagulants|anticoagulants|mesh-ancestor
5842805|NCT02492178|Artesunate|artesunate|mesh-list
5842806|NCT02492178|Quinine|quinine|mesh-list
5842807|NCT02492178|Antimalarials|antimalarials|mesh-ancestor
5842808|NCT02492178|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5842809|NCT02492178|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5842810|NCT02492178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5842811|NCT02492178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5842812|NCT02492178|Antiviral Agents|antiviral agents|mesh-ancestor
5842813|NCT02492178|Schistosomicides|schistosomicides|mesh-ancestor
5842814|NCT02492178|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5842815|NCT02492178|Anthelmintics|anthelmintics|mesh-ancestor
5842816|NCT02492178|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5842817|NCT02492178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662719|NCT03622450|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5662720|NCT03622450|Renal Agents|renal agents|mesh-ancestor
5662721|NCT03622450|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5662722|NCT03622073|Misoprostol|misoprostol|mesh-list
5662723|NCT03622073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5662724|NCT03622073|Abortifacient Agents|abortifacient agents|mesh-ancestor
5662725|NCT03622073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5662726|NCT03622073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662727|NCT03622073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5662728|NCT03622073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5662729|NCT03622073|Oxytocics|oxytocics|mesh-ancestor
5662730|NCT03622060|Nicardipine|nicardipine|mesh-list
5662731|NCT03622060|Nitroglycerin|nitroglycerin|mesh-list
5662732|NCT03622060|Vasodilator Agents|vasodilator agents|mesh-ancestor
5662733|NCT03622060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5662734|NCT03622060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5662735|NCT03622060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5662736|NCT03622060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662737|NCT03622060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5695435|NCT03389321|Macitentan|macitentan|mesh-list
5662738|NCT03622060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662739|NCT03622047|Sufentanil|sufentanil|mesh-list
5662740|NCT03622047|Dexmedetomidine|dexmedetomidine|mesh-list
5662741|NCT03622047|Ropivacaine|ropivacaine|mesh-list
5662742|NCT03622047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5662743|NCT03622047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5662744|NCT03622047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662745|NCT03622047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5842818|NCT02492178|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5842819|NCT02492178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5662746|NCT03622047|Analgesics|analgesics|mesh-ancestor
5662747|NCT03622047|Sensory System Agents|sensory system agents|mesh-ancestor
5662748|NCT03622047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5842820|NCT02492178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5842821|NCT02492178|Analgesics|analgesics|mesh-ancestor
5842822|NCT02492178|Sensory System Agents|sensory system agents|mesh-ancestor
5842823|NCT02492217|Adalimumab|adalimumab|mesh-list
5842824|NCT02492217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5842825|NCT02492217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5842826|NCT02492087|Tranexamic Acid|tranexamic acid|mesh-list
5842827|NCT02492087|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5842828|NCT02492087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5842829|NCT02492087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842830|NCT02492087|Hemostatics|hemostatics|mesh-ancestor
5842831|NCT02492087|Coagulants|coagulants|mesh-ancestor
5842832|NCT02492074|Dronabinol|dronabinol|mesh-list
5842833|NCT02492074|Cannabidiol|cannabidiol|mesh-list
5842834|NCT02492074|Anticonvulsants|anticonvulsants|mesh-ancestor
5842835|NCT02492074|Hallucinogens|hallucinogens|mesh-ancestor
5842836|NCT02492074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842837|NCT02492074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5842838|NCT02492074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5842839|NCT02492074|Analgesics|analgesics|mesh-ancestor
5842840|NCT02492074|Sensory System Agents|sensory system agents|mesh-ancestor
5842841|NCT02492074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5842842|NCT02492074|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5842843|NCT02492074|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5842844|NCT02492074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5842845|NCT02492074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842846|NCT02492074|Hormones|hormones|mesh-ancestor
5842847|NCT02492074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5842848|NCT02491983|Letrozole|letrozole|mesh-list
5842849|NCT02491983|Fulvestrant|fulvestrant|mesh-list
5842850|NCT02491983|Palbociclib|palbociclib|mesh-list
5842851|NCT02491983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5842852|NCT02491983|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5842853|NCT02491983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6493813|NCT00615602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6493814|NCT00615615|Levetiracetam|levetiracetam|mesh-list
5662749|NCT03622047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5842854|NCT02491983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5842855|NCT02491983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842856|NCT02491983|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5842857|NCT02491983|Hormone Antagonists|hormone antagonists|mesh-ancestor
5842858|NCT02491983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5842859|NCT02491983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842860|NCT02491983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5842861|NCT02491983|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5842862|NCT02491983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5842863|NCT02491697|Capecitabine|capecitabine|mesh-list
5662750|NCT03622047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5662751|NCT03622047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5662752|NCT03622047|Adrenergic Agents|adrenergic agents|mesh-ancestor
5662753|NCT03622047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5662754|NCT03622047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662755|NCT03622047|Anesthetics, Local|anesthetics, local|mesh-ancestor
5662756|NCT03622047|Anesthetics|anesthetics|mesh-ancestor
5662757|NCT03622047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5662758|NCT03622047|Narcotics|narcotics|mesh-ancestor
5662759|NCT03622047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5662760|NCT03622047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5662761|NCT03622047|Anesthetics, General|anesthetics, general|mesh-ancestor
5662762|NCT03621995|Catalase|catalase|mesh-list
5842864|NCT02491697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5842865|NCT02491697|Antimetabolites|antimetabolites|mesh-ancestor
5662763|NCT03621995|Antioxidants|antioxidants|mesh-ancestor
5842866|NCT02491697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842867|NCT02491697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5842868|NCT02491749|Anesthetics|anesthetics|mesh-list
5842869|NCT02491749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5842870|NCT02491749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842871|NCT02491736|Ketoprofen|ketoprofen|mesh-list
5662764|NCT03621995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662765|NCT03621995|Protective Agents|protective agents|mesh-ancestor
5662766|NCT03621995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662767|NCT03621904|Tamoxifen|tamoxifen|mesh-list
5662768|NCT03621904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-list
5662769|NCT03621904|Antineoplastic Agents|antineoplastic agents|mesh-list
5662770|NCT03621904|Progesterone|progesterone|mesh-list
5662771|NCT03621904|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5662772|NCT03621904|Progestins|progestins|mesh-ancestor
5662773|NCT03621904|Hormones|hormones|mesh-ancestor
5662774|NCT03621904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5662775|NCT03621904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662776|NCT03621904|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5662777|NCT03621904|Hormone Antagonists|hormone antagonists|mesh-ancestor
5662778|NCT03621904|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5662779|NCT03621904|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5662780|NCT03621904|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5662781|NCT03621904|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5662782|NCT03621904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5662783|NCT03621904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662784|NCT03621800|Menthol|menthol|mesh-list
5662785|NCT03621800|Antipruritics|antipruritics|mesh-ancestor
5662786|NCT03621800|Dermatologic Agents|dermatologic agents|mesh-ancestor
5662787|NCT03621761|Modafinil|modafinil|mesh-list
5662788|NCT03621761|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5662789|NCT03621761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662790|NCT03621761|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
5662791|NCT03621761|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5662792|NCT03621761|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5662793|NCT03621761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662794|NCT03621683|Antioxidants|antioxidants|mesh-list
5662795|NCT03621683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662796|NCT03621683|Protective Agents|protective agents|mesh-ancestor
5662797|NCT03621683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662798|NCT03621618|Dobutamine|dobutamine|mesh-list
5662799|NCT03621618|Norepinephrine|norepinephrine|mesh-list
5662800|NCT03621618|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5662801|NCT03621618|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5662802|NCT03621618|Adrenergic Agents|adrenergic agents|mesh-ancestor
5842872|NCT02491736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5842873|NCT02491736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5842874|NCT02491736|Analgesics|analgesics|mesh-ancestor
5842875|NCT02491736|Sensory System Agents|sensory system agents|mesh-ancestor
5842876|NCT02491736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5842877|NCT02491736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842878|NCT02491736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5842879|NCT02491736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5842880|NCT02491736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5842881|NCT02491736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5842882|NCT02491736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842883|NCT02491970|Fluticasone|fluticasone|mesh-list
5842884|NCT02491970|Xhance|xhance|mesh-list
5842885|NCT02491970|Formoterol Fumarate|formoterol fumarate|mesh-list
5842886|NCT02491970|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5842887|NCT02491970|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
5842888|NCT02491970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5842889|NCT02491970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5842890|NCT02491970|Autonomic Agents|autonomic agents|mesh-ancestor
5842891|NCT02491970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5842892|NCT02491970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842893|NCT02491970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5842894|NCT02491970|Respiratory System Agents|respiratory system agents|mesh-ancestor
5842895|NCT02491970|Dermatologic Agents|dermatologic agents|mesh-ancestor
5842896|NCT02491970|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5842897|NCT02491970|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5842898|NCT02491970|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5842899|NCT02491970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5842900|NCT02491970|Adrenergic Agents|adrenergic agents|mesh-ancestor
5842901|NCT02491970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5842902|NCT02491970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842903|NCT02491970|Glucocorticoids|glucocorticoids|mesh-ancestor
5842904|NCT02491970|Hormones|hormones|mesh-ancestor
5842905|NCT02491970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5842906|NCT02491970|Sympathomimetics|sympathomimetics|mesh-ancestor
5842907|NCT02491879|Ketoprofen|ketoprofen|mesh-list
5842908|NCT02491879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5662803|NCT03621618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5662804|NCT03621618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662805|NCT03621618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842909|NCT02491879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5842910|NCT02491879|Analgesics|analgesics|mesh-ancestor
5842911|NCT02491879|Sensory System Agents|sensory system agents|mesh-ancestor
5842912|NCT02491879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5842913|NCT02491879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842914|NCT02491879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5842915|NCT02491879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5842916|NCT02491879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5842917|NCT02491879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5842918|NCT02491879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842919|NCT02491723|Azithromycin|azithromycin|mesh-list
5842920|NCT02491723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5842921|NCT02491723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5842922|NCT02491320|Letrozole|letrozole|mesh-list
5842923|NCT02491320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5842924|NCT02491320|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5842925|NCT02491320|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5842926|NCT02491320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5842927|NCT02491320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842928|NCT02491320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5842929|NCT02491320|Hormone Antagonists|hormone antagonists|mesh-ancestor
5842930|NCT02491320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5842931|NCT02491320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842932|NCT02491333|Metformin|metformin|mesh-list
5842933|NCT02491333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5842934|NCT02491333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842935|NCT02491242|Dolutegravir|dolutegravir|mesh-list
5842936|NCT02491242|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5842937|NCT02491242|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5842938|NCT02491242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5842939|NCT02491242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842940|NCT02491242|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5842941|NCT02491242|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5842942|NCT02491242|Antiviral Agents|antiviral agents|mesh-ancestor
5842943|NCT02491242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5842944|NCT02491632|Dexamethasone|dexamethasone|mesh-list
5842945|NCT02491632|Dexamethasone acetate|dexamethasone acetate|mesh-list
5842946|NCT02491632|Ichthammol|ichthammol|mesh-list
5662806|NCT03621618|Sympathomimetics|sympathomimetics|mesh-ancestor
5662807|NCT03621618|Autonomic Agents|autonomic agents|mesh-ancestor
5662808|NCT03621618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5662809|NCT03621618|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5662810|NCT03621618|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5662811|NCT03621618|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5662812|NCT03621618|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5842947|NCT02491632|BB 1101|bb 1101|mesh-list
5842948|NCT02491632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5842949|NCT02491632|Antiemetics|antiemetics|mesh-ancestor
5842950|NCT02491632|Autonomic Agents|autonomic agents|mesh-ancestor
5842951|NCT02491632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5842952|NCT02491632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842953|NCT02491632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5842954|NCT02491632|Glucocorticoids|glucocorticoids|mesh-ancestor
5842955|NCT02491632|Hormones|hormones|mesh-ancestor
5842956|NCT02491632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5842957|NCT02491632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5842958|NCT02491632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5842959|NCT02491632|Protease Inhibitors|protease inhibitors|mesh-ancestor
5842960|NCT02491632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5842961|NCT02491632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842962|NCT02491632|Dermatologic Agents|dermatologic agents|mesh-ancestor
5842963|NCT02491268|Cilostazol|cilostazol|mesh-list
5842964|NCT02491268|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5842965|NCT02491268|Autonomic Agents|autonomic agents|mesh-ancestor
5842966|NCT02491268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5842967|NCT02491268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842968|NCT02491268|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5842969|NCT02491268|Respiratory System Agents|respiratory system agents|mesh-ancestor
5842970|NCT02491268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5842971|NCT02491268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5842972|NCT02491268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842973|NCT02491268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5842974|NCT02491268|Vasodilator Agents|vasodilator agents|mesh-ancestor
5842975|NCT02491268|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5842976|NCT02491268|Protective Agents|protective agents|mesh-ancestor
5842977|NCT02491268|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5842978|NCT02491268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5842979|NCT02491268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5842980|NCT02491606|Tafenoquine|tafenoquine|mesh-list
5842981|NCT02491606|Antimalarials|antimalarials|mesh-ancestor
5842982|NCT02491606|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5842983|NCT02491606|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5842984|NCT02491606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5842985|NCT02491515|Denosumab|denosumab|mesh-list
5842986|NCT02491515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5842987|NCT02491515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842988|NCT02491398|Rituximab|rituximab|mesh-list
5842989|NCT02491398|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5842990|NCT02491398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5842991|NCT02491398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5842992|NCT02491398|Immunologic Factors|immunologic factors|mesh-ancestor
5842993|NCT02491398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5842994|NCT02491398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5842995|NCT02491398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5842996|NCT02491398|Alkylating Agents|alkylating agents|mesh-ancestor
5842997|NCT02491398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5842998|NCT02491450|Sofosbuvir|sofosbuvir|mesh-list
5842999|NCT02491450|Antiviral Agents|antiviral agents|mesh-ancestor
5843000|NCT02491450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5843001|NCT02491528|Insulin|insulin|mesh-list
5843002|NCT02491528|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5843003|NCT02491528|Insulin Aspart|insulin aspart|mesh-list
5843004|NCT02491528|Insulin, Long-Acting|insulin, long-acting|mesh-list
5843005|NCT02491528|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
5843006|NCT02491528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5843007|NCT02491528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843008|NCT02491086|Nicotine|nicotine|mesh-list
5843009|NCT02491086|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5843010|NCT02491086|Autonomic Agents|autonomic agents|mesh-ancestor
5843011|NCT02491086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5843012|NCT02491086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843013|NCT02491086|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5843014|NCT02491086|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5843015|NCT02491086|Cholinergic Agents|cholinergic agents|mesh-ancestor
5843016|NCT02491086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5843017|NCT02491086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5843018|NCT02490982|Teriflunomide|teriflunomide|mesh-list
5843019|NCT02490982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5843020|NCT02490982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5843021|NCT02490982|Analgesics|analgesics|mesh-ancestor
5843022|NCT02490982|Sensory System Agents|sensory system agents|mesh-ancestor
5843023|NCT02490982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5843024|NCT02490982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843025|NCT02490982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5843026|NCT02490982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5843027|NCT02490982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5843028|NCT02490982|Immunologic Factors|immunologic factors|mesh-ancestor
5843029|NCT02490930|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
5843030|NCT02490930|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5662813|NCT03621618|Protective Agents|protective agents|mesh-ancestor
5662814|NCT03621553|Vitamin D|vitamin d|mesh-list
5662815|NCT03621553|Ergocalciferols|ergocalciferols|mesh-list
5662816|NCT03621553|Vitamins|vitamins|mesh-list
5662817|NCT03621553|Calcium|calcium|mesh-list
5662818|NCT03621553|Micronutrients|micronutrients|mesh-ancestor
5662819|NCT03621553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662820|NCT03621553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5843031|NCT02490930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5843032|NCT02490930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5843033|NCT02490930|Immunologic Factors|immunologic factors|mesh-ancestor
5843034|NCT02490930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843035|NCT02490904|Eplerenone|eplerenone|mesh-list
5843036|NCT02490904|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5843037|NCT02490904|Hormone Antagonists|hormone antagonists|mesh-ancestor
5843038|NCT02490904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5843039|NCT02490904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843040|NCT02490904|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5843041|NCT02490904|Diuretics|diuretics|mesh-ancestor
5843042|NCT02490904|Natriuretic Agents|natriuretic agents|mesh-ancestor
5843043|NCT02490904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5843044|NCT02490657|Iloprost|iloprost|mesh-list
5843045|NCT02490657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5662821|NCT03621553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5662822|NCT03621527|Remifentanil|remifentanil|mesh-list
5662823|NCT03621527|Anesthetics|anesthetics|mesh-list
5843046|NCT02490657|Vasodilator Agents|vasodilator agents|mesh-ancestor
5903401|NCT05028725|Hemostatics|hemostatics|mesh-ancestor
5903402|NCT05028725|Coagulants|coagulants|mesh-ancestor
5903403|NCT05024253|Tranexamic Acid|tranexamic acid|mesh-list
5903404|NCT05024253|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5903405|NCT05024253|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5903406|NCT05024253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903407|NCT05024253|Hemostatics|hemostatics|mesh-ancestor
5903408|NCT05024253|Coagulants|coagulants|mesh-ancestor
5903409|NCT05008536|Fludarabine|fludarabine|mesh-list
5903410|NCT05008536|Cyclophosphamide|cyclophosphamide|mesh-list
5903411|NCT05008536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5903412|NCT05008536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903413|NCT05008536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5903414|NCT05008536|Immunologic Factors|immunologic factors|mesh-ancestor
5903415|NCT05008536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903416|NCT05008536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5903417|NCT05008536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5903418|NCT05008536|Alkylating Agents|alkylating agents|mesh-ancestor
5903419|NCT05008536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5903420|NCT04991571|Dapagliflozin|dapagliflozin|mesh-list
5903421|NCT04991571|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5903422|NCT04991571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903423|NCT04991571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5903424|NCT04991571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903425|NCT04983901|Vancomycin|vancomycin|mesh-list
5903426|NCT04983901|Meropenem|meropenem|mesh-list
5903427|NCT04983901|Tazobactam|tazobactam|mesh-list
5903428|NCT04983901|Linezolid|linezolid|mesh-list
5903429|NCT04983901|Piperacillin|piperacillin|mesh-list
5903430|NCT04983901|Daptomycin|daptomycin|mesh-list
5903431|NCT04983901|Imipenem|imipenem|mesh-list
5903432|NCT04983901|Cefepime|cefepime|mesh-list
5903433|NCT04983901|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
5903434|NCT04983901|Relebactam|relebactam|mesh-list
5662824|NCT03621527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5662825|NCT03621527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662826|NCT03621527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5903435|NCT04983901|Cilastatin|cilastatin|mesh-list
5903436|NCT04983901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5903437|NCT04983901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5903438|NCT04983901|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5903439|NCT04983901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5903440|NCT04983901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903441|NCT04983901|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5903442|NCT04983901|Protease Inhibitors|protease inhibitors|mesh-ancestor
5903443|NCT04982848|Talazoparib|talazoparib|mesh-list
5903444|NCT04982848|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5903445|NCT04982848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5903446|NCT04982848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903447|NCT04982848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5903448|NCT04968899|Dexamethasone|dexamethasone|mesh-list
5903449|NCT04968899|Immunoglobulins|immunoglobulins|mesh-list
5903450|NCT04968899|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5903451|NCT04968899|Antibodies|antibodies|mesh-list
5662827|NCT03621527|Narcotics|narcotics|mesh-ancestor
5662828|NCT03621527|Analgesics|analgesics|mesh-ancestor
5662829|NCT03621527|Sensory System Agents|sensory system agents|mesh-ancestor
5662830|NCT03621527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5662831|NCT03621514|Lidocaine|lidocaine|mesh-list
5662832|NCT03621514|Anesthetics, Local|anesthetics, local|mesh-ancestor
5662833|NCT03621514|Anesthetics|anesthetics|mesh-ancestor
5662834|NCT03621514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5662835|NCT03621514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662836|NCT03621514|Sensory System Agents|sensory system agents|mesh-ancestor
5662837|NCT03621514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5662838|NCT03621514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5662839|NCT03621514|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5662840|NCT03621514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5662841|NCT03621514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5662842|NCT03621514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695436|NCT03389321|Riociguat|riociguat|mesh-list
5695437|NCT03389321|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
5695438|NCT03389321|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5695439|NCT03389321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695440|NCT03389321|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
5695441|NCT03389321|Enzyme Activators|enzyme activators|mesh-ancestor
5843047|NCT02490592|Fluorides|fluorides|mesh-list
5843048|NCT02490592|Cariostatic Agents|cariostatic agents|mesh-ancestor
5843049|NCT02490592|Protective Agents|protective agents|mesh-ancestor
5843050|NCT02490592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843051|NCT02490774|Levonorgestrel|levonorgestrel|mesh-list
5843052|NCT02490774|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5843053|NCT02490774|Contraceptive Agents|contraceptive agents|mesh-ancestor
5843054|NCT02490774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5843055|NCT02490774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843056|NCT02490774|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5843057|NCT02490774|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5843058|NCT02490774|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5843059|NCT02490865|RNS60|rns60|mesh-list
5843060|NCT02490865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5843061|NCT02490865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5843062|NCT02490865|Analgesics|analgesics|mesh-ancestor
5843063|NCT02490865|Sensory System Agents|sensory system agents|mesh-ancestor
5843064|NCT02490865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5843065|NCT02490865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843066|NCT02490865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5843067|NCT02490865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5843068|NCT02490865|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5843069|NCT02490839|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5843070|NCT02490839|Amoxicillin|amoxicillin|mesh-list
5843071|NCT02490839|Metronidazole|metronidazole|mesh-list
5843072|NCT02490839|Tetracycline|tetracycline|mesh-list
5843073|NCT02490839|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5843074|NCT02490839|Rabeprazole|rabeprazole|mesh-list
6212011|NCT02180672|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5695442|NCT03389295|Cisplatin|cisplatin|mesh-list
5695443|NCT03389295|Docetaxel|docetaxel|mesh-list
5695444|NCT03389295|Fluorouracil|fluorouracil|mesh-list
5695445|NCT03389295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5695446|NCT03389295|Tubulin Modulators|tubulin modulators|mesh-ancestor
5695447|NCT03389295|Antimitotic Agents|antimitotic agents|mesh-ancestor
5695448|NCT03389295|Mitosis Modulators|mitosis modulators|mesh-ancestor
5695449|NCT03389295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695450|NCT03389295|Antimetabolites|antimetabolites|mesh-ancestor
5695451|NCT03389295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5695452|NCT03389295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5695453|NCT03389295|Immunologic Factors|immunologic factors|mesh-ancestor
5695454|NCT03389295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695455|NCT03389256|Apatinib|apatinib|mesh-list
5695456|NCT03389256|Gefitinib|gefitinib|mesh-list
5695457|NCT03389256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5695458|NCT03389256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5695459|NCT03389256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5695460|NCT03389256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695461|NCT03389191|Acyclovir|acyclovir|mesh-list
5695462|NCT03389191|Antiviral Agents|antiviral agents|mesh-ancestor
5695463|NCT03389191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5695464|NCT03389139|Anesthetics|anesthetics|mesh-list
5695465|NCT03389139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5695466|NCT03389139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695467|NCT03389126|Avelumab|avelumab|mesh-list
5695468|NCT03389126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5843075|NCT02490839|Bismuth|bismuth|mesh-list
6212012|NCT02180828|Fluconazole|fluconazole|mesh-list
5662843|NCT03621163|Lithium Carbonate|lithium carbonate|mesh-list
5662844|NCT03621163|Antidepressive Agents|antidepressive agents|mesh-ancestor
5662845|NCT03621163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5662846|NCT03621163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5662847|NCT03621163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662848|NCT03621163|Antimanic Agents|antimanic agents|mesh-ancestor
5662849|NCT03621163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5662850|NCT03621163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5662851|NCT03621163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662852|NCT03621072|Fluconazole|fluconazole|mesh-list
5662853|NCT03621072|Antifungal Agents|antifungal agents|mesh-ancestor
5662854|NCT03621072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5662855|NCT03621072|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5662856|NCT03621072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5662857|NCT03621072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5662858|NCT03621072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662859|NCT03621072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5662860|NCT03621072|Hormone Antagonists|hormone antagonists|mesh-ancestor
5662861|NCT03621072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5662862|NCT03621072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662863|NCT03621072|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5662864|NCT03621072|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5662865|NCT03621046|Zolpidem|zolpidem|mesh-list
5662866|NCT03621046|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5843076|NCT02490839|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
5843077|NCT02490839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5843078|NCT02490839|Antitubercular Agents|antitubercular agents|mesh-ancestor
5843079|NCT02490839|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5843080|NCT02490839|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5843081|NCT02490839|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5843082|NCT02490839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5843083|NCT02490839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5843084|NCT02490839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5843085|NCT02490839|Antacids|antacids|mesh-ancestor
5843086|NCT02490839|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5843087|NCT02490527|Simvastatin|simvastatin|mesh-list
5662867|NCT03621046|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5662868|NCT03621046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5662869|NCT03621046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662870|NCT03621046|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
5662871|NCT03621046|GABA Agonists|gaba agonists|mesh-ancestor
5662872|NCT03621046|GABA Agents|gaba agents|mesh-ancestor
5662873|NCT03621046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5662874|NCT03621046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5843088|NCT02490527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5843089|NCT02490527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5843090|NCT02490527|Antimetabolites|antimetabolites|mesh-ancestor
5843091|NCT02490527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5843092|NCT02490527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5843093|NCT02490527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5843094|NCT02490527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5843095|NCT02490540|Sufentanil|sufentanil|mesh-list
5843096|NCT02490540|Dsuvia|dsuvia|mesh-list
5843097|NCT02490540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5843098|NCT02490540|Narcotics|narcotics|mesh-ancestor
5843099|NCT02490540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5843100|NCT02490540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843101|NCT02490540|Analgesics|analgesics|mesh-ancestor
5843102|NCT02490540|Sensory System Agents|sensory system agents|mesh-ancestor
5843103|NCT02490540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5843104|NCT02490540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5662875|NCT03620942|Phenylephrine|phenylephrine|mesh-list
5662876|NCT03620942|Oxymetazoline|oxymetazoline|mesh-list
5662877|NCT03620942|Ephedrine|ephedrine|mesh-list
5662878|NCT03620942|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
5662879|NCT03620942|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5662880|NCT03620942|Mydriatics|mydriatics|mesh-ancestor
5662881|NCT03620942|Autonomic Agents|autonomic agents|mesh-ancestor
5662882|NCT03620942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5662883|NCT03620942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662884|NCT03620942|Sympathomimetics|sympathomimetics|mesh-ancestor
5662885|NCT03620942|Nasal Decongestants|nasal decongestants|mesh-ancestor
5662886|NCT03620942|Respiratory System Agents|respiratory system agents|mesh-ancestor
5843105|NCT02490540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5843106|NCT02490540|Anesthetics, General|anesthetics, general|mesh-ancestor
5843107|NCT02490540|Anesthetics|anesthetics|mesh-ancestor
5843108|NCT02490436|Cetuximab|cetuximab|mesh-list
5843109|NCT02490436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5843110|NCT02490436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5843111|NCT02490449|Dexlansoprazole|dexlansoprazole|mesh-list
5843112|NCT02490449|Lansoprazole|lansoprazole|mesh-list
5843113|NCT02490449|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5843114|NCT02490449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5843115|NCT02490449|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5843116|NCT02490449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5843117|NCT02490449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5843118|NCT02490605|Salicylic Acid|salicylic acid|mesh-list
5843119|NCT02490605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5843120|NCT02490605|Antifungal Agents|antifungal agents|mesh-ancestor
5843121|NCT02490605|Keratolytic Agents|keratolytic agents|mesh-ancestor
5843122|NCT02490605|Dermatologic Agents|dermatologic agents|mesh-ancestor
5843123|NCT02490345|Gabapentin|gabapentin|mesh-list
5843124|NCT02490345|Analgesics|analgesics|mesh-ancestor
5843125|NCT02490345|Sensory System Agents|sensory system agents|mesh-ancestor
5843126|NCT02490345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5843127|NCT02490345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843128|NCT02490345|Anticonvulsants|anticonvulsants|mesh-ancestor
5843129|NCT02490345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5843130|NCT02490345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5843131|NCT02490345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5662887|NCT03620942|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5662888|NCT03620942|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5662889|NCT03620942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5662890|NCT03620942|Adrenergic Agents|adrenergic agents|mesh-ancestor
5662891|NCT03620942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5662892|NCT03620942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662893|NCT03620942|Protective Agents|protective agents|mesh-ancestor
5662894|NCT03620942|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5662895|NCT03620929|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5662896|NCT03620929|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5662897|NCT03620929|Estradiol|estradiol|mesh-list
5662898|NCT03620929|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5662899|NCT03620929|Dydrogesterone|dydrogesterone|mesh-list
5662900|NCT03620929|Estrogens|estrogens|mesh-ancestor
5662901|NCT03620929|Hormones|hormones|mesh-ancestor
5662902|NCT03620929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5662903|NCT03620929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662904|NCT03620929|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5662905|NCT03620929|Contraceptive Agents|contraceptive agents|mesh-ancestor
5662906|NCT03620929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5662907|NCT03620929|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5843132|NCT02490345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5843133|NCT02490345|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5843134|NCT02490345|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5843135|NCT02490345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5843136|NCT02490345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5843137|NCT02490345|Antimanic Agents|antimanic agents|mesh-ancestor
5843138|NCT02490072|Dexmedetomidine|dexmedetomidine|mesh-list
5843139|NCT02490072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5843140|NCT02490072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5843141|NCT02490072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843142|NCT02490072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5843143|NCT02490072|Analgesics|analgesics|mesh-ancestor
5843144|NCT02490072|Sensory System Agents|sensory system agents|mesh-ancestor
5843145|NCT02490072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5843146|NCT02490072|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5843147|NCT02490072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5662908|NCT03620929|Progestins|progestins|mesh-ancestor
5662909|NCT03620916|Morphine|morphine|mesh-list
5662910|NCT03620916|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5662911|NCT03620916|Narcotics|narcotics|mesh-ancestor
5662912|NCT03620916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5662913|NCT03620916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662914|NCT03620916|Analgesics|analgesics|mesh-ancestor
5662915|NCT03620916|Sensory System Agents|sensory system agents|mesh-ancestor
5843148|NCT02490072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5843149|NCT02490072|Adrenergic Agents|adrenergic agents|mesh-ancestor
5843150|NCT02490072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5843151|NCT02490072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662916|NCT03620916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5843152|NCT02490241|Lithium Carbonate|lithium carbonate|mesh-list
5843153|NCT02490241|Antidepressive Agents|antidepressive agents|mesh-ancestor
5843154|NCT02490241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5843155|NCT02490241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5843156|NCT02490241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5843157|NCT02490241|Antimanic Agents|antimanic agents|mesh-ancestor
5843158|NCT02490241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5843159|NCT02490241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5843160|NCT02490241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843161|NCT02490085|Insulin|insulin|mesh-list
5843162|NCT02490085|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5843163|NCT02490085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5843164|NCT02490085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843165|NCT02489955|Tobramycin|tobramycin|mesh-list
5843166|NCT02489955|Amikacin|amikacin|mesh-list
5843167|NCT02489955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5843168|NCT02489955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5843169|NCT02490176|Liraglutide|liraglutide|mesh-list
5843170|NCT02490176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5843171|NCT02490176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843172|NCT02490176|Incretins|incretins|mesh-ancestor
5843173|NCT02490176|Hormones|hormones|mesh-ancestor
5843174|NCT02490176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5843175|NCT02490098|Insulin|insulin|mesh-list
5843176|NCT02490098|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5843177|NCT02490098|Glucagon|glucagon|mesh-list
5843178|NCT02490098|Hormones|hormones|mesh-list
5843179|NCT02490098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5843180|NCT02490098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843181|NCT02490098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5843182|NCT02490098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5843183|NCT02489604|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
5843184|NCT02489604|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5843185|NCT02489604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5843186|NCT02489695|Axitinib|axitinib|mesh-list
5843187|NCT02489695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5843188|NCT02489695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5843189|NCT02489695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5843190|NCT02489695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5843191|NCT02489786|Digoxin|digoxin|mesh-list
5843192|NCT02489786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5843193|NCT02489786|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5843194|NCT02489786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5843195|NCT02489786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5843196|NCT02489786|Protective Agents|protective agents|mesh-ancestor
5843197|NCT02489786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843198|NCT02489760|Adalimumab|adalimumab|mesh-list
5843199|NCT02489760|Etanercept|etanercept|mesh-list
5843200|NCT02489760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5843201|NCT02489760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5662917|NCT03620838|Contraceptive Agents|contraceptive agents|mesh-list
5662918|NCT03620838|Contraceptives, Oral|contraceptives, oral|mesh-list
5662919|NCT03620838|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
5843202|NCT02489760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5843203|NCT02489760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5843204|NCT02489760|Analgesics|analgesics|mesh-ancestor
5843205|NCT02489760|Sensory System Agents|sensory system agents|mesh-ancestor
5843206|NCT02489760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5843207|NCT02489760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843208|NCT02489760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5843209|NCT02489760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5843210|NCT02489760|Immunologic Factors|immunologic factors|mesh-ancestor
5843211|NCT02489929|Azacitidine|azacitidine|mesh-list
5843212|NCT02489929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5843213|NCT02489929|Antimetabolites|antimetabolites|mesh-ancestor
5843214|NCT02489929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5843215|NCT02489929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5843216|NCT02489929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5662920|NCT03620838|Progesterone|progesterone|mesh-list
5662921|NCT03620838|Progestins|progestins|mesh-ancestor
5662922|NCT03620838|Hormones|hormones|mesh-ancestor
5662923|NCT03620838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5662924|NCT03620838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662925|NCT03620838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5843217|NCT02489864|Terlipressin|terlipressin|mesh-list
5843218|NCT02489864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5843219|NCT02489864|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5662926|NCT03620838|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5662927|NCT03620825|Indomethacin|indomethacin|mesh-list
5662928|NCT03620825|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5662929|NCT03620825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5662930|NCT03620825|Analgesics|analgesics|mesh-ancestor
5662931|NCT03620825|Sensory System Agents|sensory system agents|mesh-ancestor
5662932|NCT03620825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5662933|NCT03620825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662934|NCT03620825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5662935|NCT03620825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5662936|NCT03620825|Gout Suppressants|gout suppressants|mesh-ancestor
5662937|NCT03620825|Tocolytic Agents|tocolytic agents|mesh-ancestor
5662938|NCT03620825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5662939|NCT03620825|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5662940|NCT03620825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5662941|NCT03620825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662942|NCT03620760|Aspirin|aspirin|mesh-list
5662943|NCT03620760|Ticagrelor|ticagrelor|mesh-list
5662944|NCT03620760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5662945|NCT03620760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5662946|NCT03620760|Analgesics|analgesics|mesh-ancestor
5662947|NCT03620760|Sensory System Agents|sensory system agents|mesh-ancestor
5662948|NCT03620760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5662949|NCT03620760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662950|NCT03620760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5662951|NCT03620760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5662952|NCT03620760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5843220|NCT02489240|Vitamin D|vitamin d|mesh-list
5843221|NCT02489240|Cholecalciferol|cholecalciferol|mesh-list
5843222|NCT02489240|Vitamins|vitamins|mesh-ancestor
5843223|NCT02489240|Micronutrients|micronutrients|mesh-ancestor
5843224|NCT02489240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843225|NCT02489240|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5843226|NCT02489240|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6212013|NCT02180828|Clotrimazole|clotrimazole|mesh-list
5662953|NCT03620760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5662954|NCT03620760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662955|NCT03620760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5662956|NCT03620760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5662957|NCT03620760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5662958|NCT03620760|Antipyretics|antipyretics|mesh-ancestor
5662959|NCT03620760|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5662960|NCT03620760|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5662961|NCT03620760|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5662962|NCT03620760|Purinergic Agents|purinergic agents|mesh-ancestor
5662963|NCT03620760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5662964|NCT03620591|Lidocaine|lidocaine|mesh-list
5662965|NCT03620591|Anesthetics, Local|anesthetics, local|mesh-ancestor
5843227|NCT02489461|Efavirenz|efavirenz|mesh-list
5843228|NCT02489461|Elsulfavirine|elsulfavirine|mesh-list
5843229|NCT02489461|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
5843230|NCT02489461|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5843231|NCT02489461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5843232|NCT02489461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5843233|NCT02489461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5843234|NCT02489461|Antiviral Agents|antiviral agents|mesh-ancestor
5843235|NCT02489461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5843236|NCT02489461|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5843237|NCT02489461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5843238|NCT02489461|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5843239|NCT02489461|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5843240|NCT02489461|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5843241|NCT02489461|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5843242|NCT02489461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5843243|NCT02489487|Ritonavir|ritonavir|mesh-list
5843244|NCT02489487|Darunavir|darunavir|mesh-list
5843245|NCT02489487|Raltegravir Potassium|raltegravir potassium|mesh-list
5843246|NCT02489487|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5843247|NCT02489487|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5843248|NCT02489487|Protease Inhibitors|protease inhibitors|mesh-ancestor
5843249|NCT02489487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5843250|NCT02489487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5843251|NCT02489487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5662966|NCT03620591|Anesthetics|anesthetics|mesh-ancestor
5662967|NCT03620591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5662968|NCT03620591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662969|NCT03620591|Sensory System Agents|sensory system agents|mesh-ancestor
5662970|NCT03620591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5662971|NCT03620591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5662972|NCT03620591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5662973|NCT03620591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5662974|NCT03620591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5662975|NCT03620591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662976|NCT03620578|Nivolumab|nivolumab|mesh-list
5662977|NCT03620578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5662978|NCT03620578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5662979|NCT03620578|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5662980|NCT03620578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5662981|NCT03620526|Iloprost|iloprost|mesh-list
5662982|NCT03620526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5662983|NCT03620526|Vasodilator Agents|vasodilator agents|mesh-ancestor
5662984|NCT03620513|Lidocaine|lidocaine|mesh-list
5662985|NCT03620513|Phenylephrine|phenylephrine|mesh-list
5662986|NCT03620513|Oxymetazoline|oxymetazoline|mesh-list
5662987|NCT03620513|Nasal Decongestants|nasal decongestants|mesh-list
5662988|NCT03620513|Pseudoephedrine|pseudoephedrine|mesh-list
5662989|NCT03620513|Ephedrine|ephedrine|mesh-list
5662990|NCT03620513|Anesthetics|anesthetics|mesh-list
5662991|NCT03620513|Anesthetics, Local|anesthetics, local|mesh-ancestor
5662992|NCT03620513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5662993|NCT03620513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5662994|NCT03620513|Sensory System Agents|sensory system agents|mesh-ancestor
5662995|NCT03620513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5662996|NCT03620513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5662997|NCT03620513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5662998|NCT03620513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5662999|NCT03620513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5843252|NCT02489487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5843253|NCT02489487|Antiviral Agents|antiviral agents|mesh-ancestor
5843254|NCT02489487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5843255|NCT02489487|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5843256|NCT02489487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5843257|NCT02489487|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5843258|NCT02489487|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5663000|NCT03620513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663001|NCT03620513|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5663002|NCT03620513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5843259|NCT02489266|Aldesleukin|aldesleukin|mesh-list
5843260|NCT02489266|Cyclophosphamide|cyclophosphamide|mesh-list
5843261|NCT02489266|Fludarabine|fludarabine|mesh-list
5663003|NCT03620513|Adrenergic Agents|adrenergic agents|mesh-ancestor
5663004|NCT03620513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5663005|NCT03620513|Sympathomimetics|sympathomimetics|mesh-ancestor
5663006|NCT03620513|Autonomic Agents|autonomic agents|mesh-ancestor
5663007|NCT03620513|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5663008|NCT03620513|Respiratory System Agents|respiratory system agents|mesh-ancestor
5663009|NCT03620513|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5663010|NCT03620513|Mydriatics|mydriatics|mesh-ancestor
5663011|NCT03620513|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5663012|NCT03620513|Protective Agents|protective agents|mesh-ancestor
5843262|NCT02489266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5843263|NCT02489266|Immunologic Factors|immunologic factors|mesh-ancestor
5843264|NCT02489266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493815|NCT00615615|Anticonvulsants|anticonvulsants|mesh-ancestor
6493816|NCT00615615|Nootropic Agents|nootropic agents|mesh-ancestor
6493817|NCT00615667|Tacrolimus|tacrolimus|mesh-list
6493818|NCT00615667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6493819|NCT00615667|Immunologic Factors|immunologic factors|mesh-ancestor
6493820|NCT00615667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493821|NCT00615667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6493822|NCT00615667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5843265|NCT02489266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5843266|NCT02489266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5843267|NCT02489266|Alkylating Agents|alkylating agents|mesh-ancestor
5843268|NCT02489266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493823|NCT00615667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663013|NCT03620513|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5843269|NCT02489266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5843270|NCT02489266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5843271|NCT02489266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5843272|NCT02489266|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5843273|NCT02489266|Antiviral Agents|antiviral agents|mesh-ancestor
5843274|NCT02489266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5843275|NCT02489513|Ivosidenib|ivosidenib|mesh-list
5843276|NCT02489513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5843277|NCT02489513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5843278|NCT02489513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5843279|NCT02489409|Gemcitabine|gemcitabine|mesh-list
5843280|NCT02489409|Vinorelbine|vinorelbine|mesh-list
5843281|NCT02489409|Endostatins|endostatins|mesh-list
5843282|NCT02489409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5843283|NCT02489409|Antimetabolites|antimetabolites|mesh-ancestor
5843284|NCT02489409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5843285|NCT02489409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5843286|NCT02489409|Antiviral Agents|antiviral agents|mesh-ancestor
5843287|NCT02489409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5843288|NCT02489409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5843289|NCT02489409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6212014|NCT02180828|Miconazole|miconazole|mesh-list
6212015|NCT02180828|Antifungal Agents|antifungal agents|mesh-ancestor
6212016|NCT02180828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6212017|NCT02180828|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6212018|NCT02180828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5843290|NCT02489409|Immunologic Factors|immunologic factors|mesh-ancestor
5843291|NCT02489409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843292|NCT02489409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5843293|NCT02489409|Tubulin Modulators|tubulin modulators|mesh-ancestor
5843294|NCT02489409|Antimitotic Agents|antimitotic agents|mesh-ancestor
5843295|NCT02489409|Mitosis Modulators|mitosis modulators|mesh-ancestor
5843296|NCT02489409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5843297|NCT02489409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5843298|NCT02489409|Growth Substances|growth substances|mesh-ancestor
5843299|NCT02489409|Growth Inhibitors|growth inhibitors|mesh-ancestor
5843300|NCT02489019|Fentanyl|fentanyl|mesh-list
5843301|NCT02489019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5843302|NCT02489019|Narcotics|narcotics|mesh-ancestor
5843303|NCT02489019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5843304|NCT02489019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843305|NCT02489019|Analgesics|analgesics|mesh-ancestor
5843306|NCT02489019|Sensory System Agents|sensory system agents|mesh-ancestor
5843307|NCT02489019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5843308|NCT02489019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5843309|NCT02489019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5843310|NCT02489019|Anesthetics, General|anesthetics, general|mesh-ancestor
5843311|NCT02489019|Anesthetics|anesthetics|mesh-ancestor
5903452|NCT04968899|gamma-Globulins|gamma-globulins|mesh-list
5903453|NCT04968899|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5903454|NCT04968899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5903455|NCT04968899|Antiemetics|antiemetics|mesh-ancestor
5903456|NCT04968899|Autonomic Agents|autonomic agents|mesh-ancestor
5903457|NCT04968899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5903458|NCT04968899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903459|NCT04968899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5903460|NCT04968899|Glucocorticoids|glucocorticoids|mesh-ancestor
5903461|NCT04968899|Hormones|hormones|mesh-ancestor
5903462|NCT04968899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5903463|NCT04968899|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5903464|NCT04968899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5903465|NCT04968899|Immunologic Factors|immunologic factors|mesh-ancestor
5903466|NCT04966663|Gemcitabine|gemcitabine|mesh-list
5903467|NCT04966663|Carboplatin|carboplatin|mesh-list
5903468|NCT04966663|Nivolumab|nivolumab|mesh-list
5903469|NCT04966663|Pemetrexed|pemetrexed|mesh-list
5903470|NCT04966663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5903471|NCT04966663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5903472|NCT04966663|Antimetabolites|antimetabolites|mesh-ancestor
5903473|NCT04966663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903474|NCT04966663|Antiviral Agents|antiviral agents|mesh-ancestor
5903475|NCT04966663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5903476|NCT04966663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5903477|NCT04966663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5903478|NCT04966663|Immunologic Factors|immunologic factors|mesh-ancestor
5903479|NCT04966663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903480|NCT04966663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5843312|NCT02489006|Olaparib|olaparib|mesh-list
5843313|NCT02489006|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5663014|NCT03620513|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5663015|NCT03620513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5663016|NCT03620461|Gemcitabine|gemcitabine|mesh-list
5663017|NCT03620461|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5663018|NCT03620461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5663019|NCT03620461|Antimetabolites|antimetabolites|mesh-ancestor
5663020|NCT03620461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663021|NCT03620461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5663022|NCT03620461|Antiviral Agents|antiviral agents|mesh-ancestor
5663023|NCT03620461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5663024|NCT03620461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5663025|NCT03620461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5663026|NCT03620461|Immunologic Factors|immunologic factors|mesh-ancestor
5663027|NCT03620461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663028|NCT03620435|Atezolizumab|atezolizumab|mesh-list
5663029|NCT03620435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5663030|NCT03620422|Mannitol|mannitol|mesh-list
5663031|NCT03620422|Albuterol|albuterol|mesh-list
5663032|NCT03620422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5663033|NCT03620422|Autonomic Agents|autonomic agents|mesh-ancestor
5663034|NCT03620422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5663035|NCT03620422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663036|NCT03620422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5663037|NCT03620422|Respiratory System Agents|respiratory system agents|mesh-ancestor
5663038|NCT03620422|Tocolytic Agents|tocolytic agents|mesh-ancestor
5663039|NCT03620422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5843314|NCT02489006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5843315|NCT02489006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5843316|NCT02489006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5843317|NCT02488889|Ethanol|ethanol|mesh-list
5843318|NCT02488889|Varenicline|varenicline|mesh-list
5843319|NCT02488889|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5843320|NCT02488889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5843321|NCT02488889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5843322|NCT02488889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843323|NCT02488889|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5843324|NCT02488889|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5843325|NCT02488889|Cholinergic Agents|cholinergic agents|mesh-ancestor
5843326|NCT02488889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5843327|NCT02488889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5843328|NCT02488902|Mefloquine|mefloquine|mesh-list
5843329|NCT02488902|Tafenoquine|tafenoquine|mesh-list
5843330|NCT02488902|Antimalarials|antimalarials|mesh-ancestor
5843331|NCT02488902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5843332|NCT02488902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5663040|NCT03620422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5663041|NCT03620422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5663042|NCT03620422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5663043|NCT03620422|Adrenergic Agents|adrenergic agents|mesh-ancestor
5663044|NCT03620422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5663045|NCT03620422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663046|NCT03620422|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5663047|NCT03620422|Diuretics|diuretics|mesh-ancestor
5663048|NCT03620422|Natriuretic Agents|natriuretic agents|mesh-ancestor
5663049|NCT03620318|Crenolanib|crenolanib|mesh-list
5663050|NCT03620318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5663051|NCT03620292|Bevacizumab|bevacizumab|mesh-list
5663052|NCT03620292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5663053|NCT03620292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5663054|NCT03620292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5663055|NCT03620292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5663056|NCT03620292|Growth Substances|growth substances|mesh-ancestor
5663057|NCT03620292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663058|NCT03620292|Growth Inhibitors|growth inhibitors|mesh-ancestor
5663059|NCT03620253|Modafinil|modafinil|mesh-list
5663060|NCT03620253|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5663061|NCT03620253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663062|NCT03620253|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
5663063|NCT03620253|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5663064|NCT03620253|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5663065|NCT03620253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663066|NCT03620149|Denosumab|denosumab|mesh-list
5843333|NCT02488902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5843334|NCT02488993|Rifaximin|rifaximin|mesh-list
5663067|NCT03620149|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5663068|NCT03620149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663069|NCT03620032|Vinorelbine|vinorelbine|mesh-list
5663070|NCT03620032|Nimotuzumab|nimotuzumab|mesh-list
5663071|NCT03620032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5663072|NCT03620032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5663073|NCT03620032|Tubulin Modulators|tubulin modulators|mesh-ancestor
5663074|NCT03620032|Antimitotic Agents|antimitotic agents|mesh-ancestor
5663075|NCT03620032|Mitosis Modulators|mitosis modulators|mesh-ancestor
5663076|NCT03620032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663077|NCT03620032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5843335|NCT02488993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5843336|NCT02488993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5843337|NCT02488993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5843338|NCT02489097|Nitrous Oxide|nitrous oxide|mesh-list
5843339|NCT02489097|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5843340|NCT02489097|Anesthetics, General|anesthetics, general|mesh-ancestor
5843341|NCT02489097|Anesthetics|anesthetics|mesh-ancestor
5843342|NCT02489097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5663078|NCT03620019|Denosumab|denosumab|mesh-list
5663079|NCT03620019|Pembrolizumab|pembrolizumab|mesh-list
5663080|NCT03620019|Nivolumab|nivolumab|mesh-list
5663081|NCT03620019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5843343|NCT02489097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843344|NCT02489097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5663082|NCT03620019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5663083|NCT03620019|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5663084|NCT03620019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663085|NCT03620019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5663086|NCT03620019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663087|NCT03619876|Adalimumab|adalimumab|mesh-list
5663088|NCT03619876|Abatacept|abatacept|mesh-list
5663089|NCT03619876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5663090|NCT03619876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5663091|NCT03619876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5663092|NCT03619876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663093|NCT03619876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5663094|NCT03619876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5663095|NCT03619876|Immunologic Factors|immunologic factors|mesh-ancestor
5843345|NCT02489097|Analgesics|analgesics|mesh-ancestor
5843346|NCT02489097|Sensory System Agents|sensory system agents|mesh-ancestor
5843347|NCT02489097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5843348|NCT02488694|Pemetrexed|pemetrexed|mesh-list
5843349|NCT02488694|Afatinib|afatinib|mesh-list
5843350|NCT02488694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5843351|NCT02488694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5843352|NCT02488694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5843353|NCT02488694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5843354|NCT02488694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5843355|NCT02488694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5843356|NCT02488473|Dexmedetomidine|dexmedetomidine|mesh-list
5663096|NCT03619876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663097|NCT03619850|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
5663098|NCT03619850|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
5663099|NCT03619850|Hematinics|hematinics|mesh-ancestor
5663100|NCT03619850|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5663101|NCT03619850|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5663102|NCT03619824|Gemcitabine|gemcitabine|mesh-list
5663103|NCT03619824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5663104|NCT03619824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5663105|NCT03619824|Antimetabolites|antimetabolites|mesh-ancestor
5663106|NCT03619824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663107|NCT03619824|Antiviral Agents|antiviral agents|mesh-ancestor
5663108|NCT03619824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5663109|NCT03619824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5663110|NCT03619824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5663111|NCT03619824|Immunologic Factors|immunologic factors|mesh-ancestor
5663112|NCT03619824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663113|NCT03619785|Acetaminophen|acetaminophen|mesh-list
5663114|NCT03619785|Ibuprofen|ibuprofen|mesh-list
5663115|NCT03619785|Ketorolac|ketorolac|mesh-list
5663116|NCT03619785|Fentanyl|fentanyl|mesh-list
5663117|NCT03619785|Morphine|morphine|mesh-list
5663118|NCT03619785|Hydromorphone|hydromorphone|mesh-list
5663119|NCT03619785|Hydrocodone|hydrocodone|mesh-list
5663120|NCT03619785|Ketamine|ketamine|mesh-list
5663121|NCT03619785|Gabapentin|gabapentin|mesh-list
5663122|NCT03619785|Bupivacaine|bupivacaine|mesh-list
5663123|NCT03619785|Anesthetics, Local|anesthetics, local|mesh-ancestor
5843357|NCT02488473|Ropivacaine|ropivacaine|mesh-list
5843358|NCT02488473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5843359|NCT02488473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5843360|NCT02488473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843361|NCT02488473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5843362|NCT02488473|Analgesics|analgesics|mesh-ancestor
5843363|NCT02488473|Sensory System Agents|sensory system agents|mesh-ancestor
5843364|NCT02488473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5843365|NCT02488473|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5843366|NCT02488473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5843367|NCT02488473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5843368|NCT02488473|Adrenergic Agents|adrenergic agents|mesh-ancestor
5843369|NCT02488473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5843370|NCT02488473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5843371|NCT02488473|Anesthetics, Local|anesthetics, local|mesh-ancestor
5843372|NCT02488473|Anesthetics|anesthetics|mesh-ancestor
5843373|NCT02488512|Edotreotide|edotreotide|mesh-list
5843374|NCT02488512|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5843375|NCT02488512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5843376|NCT02488564|Metformin|metformin|mesh-list
5843377|NCT02488564|Docetaxel|docetaxel|mesh-list
5843378|NCT02488564|Doxorubicin|doxorubicin|mesh-list
5843379|NCT02488564|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5843380|NCT02488564|Trastuzumab|trastuzumab|mesh-list
5843381|NCT02488564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5843382|NCT02488564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843383|NCT02488564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5843384|NCT02488564|Tubulin Modulators|tubulin modulators|mesh-ancestor
5843385|NCT02488564|Antimitotic Agents|antimitotic agents|mesh-ancestor
5843386|NCT02488564|Mitosis Modulators|mitosis modulators|mesh-ancestor
5843387|NCT02488564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5843388|NCT02488564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5843389|NCT02488564|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5843390|NCT02488564|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5843391|NCT02488564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5843392|NCT02488564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5843393|NCT02488590|Bronchodilator Agents|bronchodilator agents|mesh-list
5843394|NCT02488590|Autonomic Agents|autonomic agents|mesh-ancestor
5843395|NCT02488590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5843396|NCT02488590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843397|NCT02488590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5843398|NCT02488590|Respiratory System Agents|respiratory system agents|mesh-ancestor
5843399|NCT02488603|Tamoxifen|tamoxifen|mesh-list
5843400|NCT02488603|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5843401|NCT02488603|Hormone Antagonists|hormone antagonists|mesh-ancestor
6212019|NCT02180828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6212020|NCT02180828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212021|NCT02180828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6212022|NCT02180828|Hormone Antagonists|hormone antagonists|mesh-ancestor
6212023|NCT02180828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6212024|NCT02180828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663124|NCT03619785|Anesthetics|anesthetics|mesh-ancestor
5663125|NCT03619785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5663126|NCT03619785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663127|NCT03619785|Sensory System Agents|sensory system agents|mesh-ancestor
5663128|NCT03619785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5663129|NCT03619785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5663130|NCT03619785|Narcotics|narcotics|mesh-ancestor
5663131|NCT03619785|Analgesics|analgesics|mesh-ancestor
5663132|NCT03619785|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5663133|NCT03619785|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5663134|NCT03619785|Anesthetics, General|anesthetics, general|mesh-ancestor
5663135|NCT03619785|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5663136|NCT03619785|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5663137|NCT03619785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5663138|NCT03619785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663139|NCT03619785|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5663140|NCT03619785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5663141|NCT03619785|Antipyretics|antipyretics|mesh-ancestor
5663142|NCT03619785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5663143|NCT03619785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5663144|NCT03619785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5663145|NCT03619785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5663146|NCT03619785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5663147|NCT03619785|Anticonvulsants|anticonvulsants|mesh-ancestor
5663148|NCT03619785|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5663149|NCT03619785|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5663150|NCT03619785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5663151|NCT03619785|Antimanic Agents|antimanic agents|mesh-ancestor
5663152|NCT03619785|Antitussive Agents|antitussive agents|mesh-ancestor
5663153|NCT03619785|Respiratory System Agents|respiratory system agents|mesh-ancestor
5695469|NCT03389126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5695470|NCT03389087|Etoposide|etoposide|mesh-list
5695471|NCT03389087|Apatinib|apatinib|mesh-list
5695472|NCT03389087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5695473|NCT03389087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5695474|NCT03389087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5695475|NCT03389087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5843402|NCT02488603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5843403|NCT02488603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843404|NCT02488603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5843405|NCT02488603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5843406|NCT02488603|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5843407|NCT02488603|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5843408|NCT02488603|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5843409|NCT02488538|Fluoxetine|fluoxetine|mesh-list
5843410|NCT02488538|Contraceptive Agents|contraceptive agents|mesh-list
5843411|NCT02488538|Contraceptives, Oral|contraceptives, oral|mesh-list
5843412|NCT02488538|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
5843413|NCT02488538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5843414|NCT02488538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843415|NCT02488538|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5843416|NCT02488538|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5843417|NCT02488538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5843418|NCT02488538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5843419|NCT02488538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5843420|NCT02488538|Serotonin Agents|serotonin agents|mesh-ancestor
5843421|NCT02488538|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5843422|NCT02488538|Antidepressive Agents|antidepressive agents|mesh-ancestor
5843423|NCT02488538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5843424|NCT02488538|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5843425|NCT02488538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5843426|NCT02488538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5843427|NCT02488538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5843428|NCT02488616|Insulin|insulin|mesh-list
5843429|NCT02488616|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5843430|NCT02488616|Hormones|hormones|mesh-list
5695476|NCT03389087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5695477|NCT03389087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695478|NCT03389087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5695479|NCT03389061|Sofosbuvir|sofosbuvir|mesh-list
5695480|NCT03389061|Velpatasvir|velpatasvir|mesh-list
5695481|NCT03389061|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
5695482|NCT03389061|Antiviral Agents|antiviral agents|mesh-ancestor
5695483|NCT03389061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5695484|NCT03388970|Vitamin K|vitamin k|mesh-list
5695485|NCT03388970|Vitamin K 1|vitamin k 1|mesh-list
5695486|NCT03388970|Vitamins|vitamins|mesh-ancestor
5695487|NCT03388970|Micronutrients|micronutrients|mesh-ancestor
5695488|NCT03388970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695489|NCT03388970|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5695490|NCT03388970|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5663154|NCT03619538|Nefopam|nefopam|mesh-list
5663155|NCT03619538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5663156|NCT03619538|Analgesics|analgesics|mesh-ancestor
5663157|NCT03619538|Sensory System Agents|sensory system agents|mesh-ancestor
5663158|NCT03619538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5663159|NCT03619538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663160|NCT03619408|Antacids|antacids|mesh-list
5663161|NCT03619408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663162|NCT03619408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5663163|NCT03619330|Liraglutide|liraglutide|mesh-list
5663164|NCT03619330|Testosterone|testosterone|mesh-list
5663165|NCT03619330|Androgens|androgens|mesh-ancestor
5663166|NCT03619330|Hormones|hormones|mesh-ancestor
5663167|NCT03619330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5663168|NCT03619330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663169|NCT03619330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5663170|NCT03619330|Incretins|incretins|mesh-ancestor
5663171|NCT03619252|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5663172|NCT03619252|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5663173|NCT03619252|Immunologic Factors|immunologic factors|mesh-ancestor
5663174|NCT03619252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663175|NCT03619252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5663176|NCT03619057|Anesthetics|anesthetics|mesh-list
5663177|NCT03619057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5663178|NCT03619057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663179|NCT03619005|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
5663180|NCT03619005|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5663181|NCT03619005|Immunologic Factors|immunologic factors|mesh-ancestor
5663182|NCT03619005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663183|NCT03618953|Atezolizumab|atezolizumab|mesh-list
5843431|NCT02488616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5843432|NCT02488616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843433|NCT02488616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5843434|NCT02488642|Isosorbide|isosorbide|mesh-list
5843435|NCT02488642|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
5843436|NCT02488642|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
5843437|NCT02488642|Misoprostol|misoprostol|mesh-list
5663184|NCT03618953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5663185|NCT03618797|Fenofibrate|fenofibrate|mesh-list
5663186|NCT03618797|Pitavastatin|pitavastatin|mesh-list
5663187|NCT03618797|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5663188|NCT03618797|Antimetabolites|antimetabolites|mesh-ancestor
5663189|NCT03618797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663190|NCT03618797|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5663191|NCT03618797|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5663192|NCT03618797|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5663193|NCT03618797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5663194|NCT03618758|Paclitaxel|paclitaxel|mesh-list
5843438|NCT02488642|Oxytocin|oxytocin|mesh-list
6212025|NCT02180828|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5663195|NCT03618758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5843439|NCT02488642|Oxytocics|oxytocics|mesh-ancestor
5843440|NCT02488642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5843441|NCT02488642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843442|NCT02488642|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5843443|NCT02488642|Abortifacient Agents|abortifacient agents|mesh-ancestor
5843444|NCT02488642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5843445|NCT02488642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5843446|NCT02488642|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5843447|NCT02488642|Diuretics|diuretics|mesh-ancestor
5843448|NCT02488642|Natriuretic Agents|natriuretic agents|mesh-ancestor
5843449|NCT02488642|Vasodilator Agents|vasodilator agents|mesh-ancestor
5843450|NCT02488642|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5843451|NCT02488642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5843452|NCT02488486|Remifentanil|remifentanil|mesh-list
5843453|NCT02488486|Propofol|propofol|mesh-list
5843454|NCT02488486|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5843455|NCT02488486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5843456|NCT02488486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843457|NCT02488486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5843458|NCT02488486|Anesthetics, General|anesthetics, general|mesh-ancestor
5843459|NCT02488486|Anesthetics|anesthetics|mesh-ancestor
5843460|NCT02488486|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5843461|NCT02488486|Narcotics|narcotics|mesh-ancestor
5843462|NCT02488486|Analgesics|analgesics|mesh-ancestor
5843463|NCT02488486|Sensory System Agents|sensory system agents|mesh-ancestor
5843464|NCT02488486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5843465|NCT02488057|Liraglutide|liraglutide|mesh-list
5843466|NCT02488057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5843467|NCT02488057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843468|NCT02488057|Incretins|incretins|mesh-ancestor
5843469|NCT02488057|Hormones|hormones|mesh-ancestor
5843470|NCT02488057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5843471|NCT02488291|Sufentanil|sufentanil|mesh-list
5843472|NCT02488291|Dsuvia|dsuvia|mesh-list
5843473|NCT02488291|Ropivacaine|ropivacaine|mesh-list
5843474|NCT02488291|Anesthetics, Local|anesthetics, local|mesh-list
5843475|NCT02488291|Anesthetics|anesthetics|mesh-list
5843476|NCT02488291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5843477|NCT02488291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843478|NCT02488291|Sensory System Agents|sensory system agents|mesh-ancestor
5843479|NCT02488291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5843480|NCT02488291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5843481|NCT02488291|Narcotics|narcotics|mesh-ancestor
5843482|NCT02488291|Analgesics|analgesics|mesh-ancestor
5843483|NCT02488291|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5843484|NCT02488291|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5843485|NCT02488291|Anesthetics, General|anesthetics, general|mesh-ancestor
5843486|NCT02488135|Hemostatics|hemostatics|mesh-list
5843487|NCT02488135|Coagulants|coagulants|mesh-ancestor
5843488|NCT02487940|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
5843489|NCT02487940|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
5843490|NCT02487940|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5843491|NCT02487940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5843492|NCT02487953|Nicotine|nicotine|mesh-list
5843493|NCT02487953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5843494|NCT02487953|Autonomic Agents|autonomic agents|mesh-ancestor
5843495|NCT02487953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5843496|NCT02487953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843497|NCT02487953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5843498|NCT02487953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5843499|NCT02487953|Cholinergic Agents|cholinergic agents|mesh-ancestor
5843500|NCT02487953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5843501|NCT02487953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5843502|NCT02487914|Lidocaine|lidocaine|mesh-list
5843503|NCT02487914|Anesthetics, Local|anesthetics, local|mesh-ancestor
5843504|NCT02487914|Anesthetics|anesthetics|mesh-ancestor
5843505|NCT02487914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5843506|NCT02487914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843507|NCT02487914|Sensory System Agents|sensory system agents|mesh-ancestor
5843508|NCT02487914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5843509|NCT02487914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5843510|NCT02487914|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5843511|NCT02487914|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5843512|NCT02487914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5843513|NCT02487914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5843514|NCT02487680|Chromium|chromium|mesh-list
5843515|NCT02487680|Picolinic acid|picolinic acid|mesh-list
5843516|NCT02487680|Trace Elements|trace elements|mesh-ancestor
5843517|NCT02487680|Micronutrients|micronutrients|mesh-ancestor
5843518|NCT02487680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843519|NCT02487680|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5843520|NCT02487680|Chelating Agents|chelating agents|mesh-ancestor
5843521|NCT02487680|Sequestering Agents|sequestering agents|mesh-ancestor
5843522|NCT02487680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5843523|NCT02487706|Dolutegravir|dolutegravir|mesh-list
5843524|NCT02487706|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5843525|NCT02487706|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5843526|NCT02487706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5843527|NCT02487706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5843528|NCT02487706|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5843529|NCT02487706|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5843530|NCT02487706|Antiviral Agents|antiviral agents|mesh-ancestor
5843531|NCT02487706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5843532|NCT02487732|Ticagrelor|ticagrelor|mesh-list
5843533|NCT02487732|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
5843534|NCT02487732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5843535|NCT02487732|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5843536|NCT02487732|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5843537|NCT02487732|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5843538|NCT02487732|Purinergic Agents|purinergic agents|mesh-ancestor
5843539|NCT02487732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5843540|NCT02487732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5843541|NCT02487732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843542|NCT02487823|Bicalutamide|bicalutamide|mesh-list
5843543|NCT02487823|Buserelin|buserelin|mesh-list
5843544|NCT02487823|Androgen Antagonists|androgen antagonists|mesh-ancestor
5843545|NCT02487823|Hormone Antagonists|hormone antagonists|mesh-ancestor
5843546|NCT02487823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6493824|NCT00615745|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6493825|NCT00615745|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5663196|NCT03618758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5663197|NCT03618758|Tubulin Modulators|tubulin modulators|mesh-ancestor
5663198|NCT03618758|Antimitotic Agents|antimitotic agents|mesh-ancestor
5663199|NCT03618758|Mitosis Modulators|mitosis modulators|mesh-ancestor
5663200|NCT03618758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663201|NCT03618654|Metformin|metformin|mesh-list
5663202|NCT03618654|Durvalumab|durvalumab|mesh-list
5663203|NCT03618654|Immunoglobulins|immunoglobulins|mesh-list
5663204|NCT03618654|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5663205|NCT03618654|Immunoglobulin G|immunoglobulin g|mesh-list
5663206|NCT03618654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5663207|NCT03618654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663208|NCT03618654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5663209|NCT03618654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5663210|NCT03618654|Immunologic Factors|immunologic factors|mesh-ancestor
5663211|NCT03618589|Pregabalin|pregabalin|mesh-list
5663212|NCT03618589|Analgesics|analgesics|mesh-ancestor
5843547|NCT02487823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843548|NCT02487823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5843549|NCT02487823|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5843550|NCT02487823|Fertility Agents|fertility agents|mesh-ancestor
5843551|NCT02487823|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5843552|NCT02487719|Teferrol|teferrol|mesh-list
5843553|NCT02487719|Hematinics|hematinics|mesh-ancestor
5843554|NCT02487433|Tofacitinib|tofacitinib|mesh-list
5843555|NCT02487433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5843556|NCT02487433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5843557|NCT02487433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5843558|NCT02487407|Simendan|simendan|mesh-list
5843559|NCT02487407|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5843560|NCT02487407|Vasodilator Agents|vasodilator agents|mesh-ancestor
5843561|NCT02487407|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5843562|NCT02487407|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5843563|NCT02487407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5843564|NCT02487407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5843565|NCT02487407|Protective Agents|protective agents|mesh-ancestor
5843566|NCT02487407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843567|NCT02487381|Dronabinol|dronabinol|mesh-list
5843568|NCT02487381|Cannabidiol|cannabidiol|mesh-list
5663213|NCT03618589|Sensory System Agents|sensory system agents|mesh-ancestor
5843569|NCT02487381|Anticonvulsants|anticonvulsants|mesh-ancestor
5843570|NCT02487381|Hallucinogens|hallucinogens|mesh-ancestor
5663214|NCT03618589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5663215|NCT03618589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663216|NCT03618589|Anticonvulsants|anticonvulsants|mesh-ancestor
5663217|NCT03618589|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5663218|NCT03618589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5663219|NCT03618589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663220|NCT03618589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5663221|NCT03618589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5663222|NCT03618589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5663223|NCT03618589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5663224|NCT03618589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5663225|NCT03618550|Gemcitabine|gemcitabine|mesh-list
5663226|NCT03618550|Doxorubicin|doxorubicin|mesh-list
5663227|NCT03618550|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5663228|NCT03618550|Pembrolizumab|pembrolizumab|mesh-list
5663229|NCT03618550|Vinorelbine|vinorelbine|mesh-list
5663230|NCT03618550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5663231|NCT03618550|Antimetabolites|antimetabolites|mesh-ancestor
5663232|NCT03618550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663233|NCT03618550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5663234|NCT03618550|Antiviral Agents|antiviral agents|mesh-ancestor
5663235|NCT03618550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5663236|NCT03618550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5663237|NCT03618550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5663238|NCT03618550|Immunologic Factors|immunologic factors|mesh-ancestor
5663239|NCT03618550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663240|NCT03618550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5663241|NCT03618550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5663242|NCT03618550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5843571|NCT02487381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843572|NCT02487381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5843573|NCT02487381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5843574|NCT02487381|Analgesics|analgesics|mesh-ancestor
5843575|NCT02487381|Sensory System Agents|sensory system agents|mesh-ancestor
5843576|NCT02487381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5843577|NCT02487381|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5843578|NCT02487381|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5843579|NCT02487381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5843580|NCT02487381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5843581|NCT02487381|Hormones|hormones|mesh-ancestor
5843582|NCT02487381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5903481|NCT04966663|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5903482|NCT04966663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5903483|NCT04966663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5903484|NCT04964063|Listerine|listerine|mesh-list
5903485|NCT04964063|Fluorides|fluorides|mesh-list
5903486|NCT04964063|Sodium Fluoride|sodium fluoride|mesh-list
5903487|NCT04964063|Cariostatic Agents|cariostatic agents|mesh-ancestor
5903488|NCT04964063|Protective Agents|protective agents|mesh-ancestor
5903489|NCT04964063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903490|NCT04964063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5903491|NCT04964063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5903492|NCT04937738|Leucovorin|leucovorin|mesh-list
5903493|NCT04937738|Docetaxel|docetaxel|mesh-list
5903494|NCT04937738|Fluorouracil|fluorouracil|mesh-list
5903495|NCT04937738|Capecitabine|capecitabine|mesh-list
5903496|NCT04937738|Oxaliplatin|oxaliplatin|mesh-list
5903497|NCT04937738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5903498|NCT04937738|Tubulin Modulators|tubulin modulators|mesh-ancestor
5903499|NCT04937738|Antimitotic Agents|antimitotic agents|mesh-ancestor
5903500|NCT04937738|Mitosis Modulators|mitosis modulators|mesh-ancestor
5903501|NCT04937738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903502|NCT04937738|Antimetabolites|antimetabolites|mesh-ancestor
5903503|NCT04937738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5903504|NCT04937738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5903505|NCT04937738|Immunologic Factors|immunologic factors|mesh-ancestor
5903506|NCT04937738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903507|NCT04937738|Antidotes|antidotes|mesh-ancestor
5903508|NCT04937738|Protective Agents|protective agents|mesh-ancestor
5903509|NCT04937738|Vitamin B Complex|vitamin b complex|mesh-ancestor
5903510|NCT04937738|Vitamins|vitamins|mesh-ancestor
5903511|NCT04937738|Micronutrients|micronutrients|mesh-ancestor
5903512|NCT04922593|Paliperidone Palmitate|paliperidone palmitate|mesh-list
5903513|NCT04922593|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5843583|NCT02487849|Carboplatin|carboplatin|mesh-list
5843584|NCT02487849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5843585|NCT02487329|Calcium, Dietary|calcium, dietary|mesh-list
5663243|NCT03618550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5663244|NCT03618550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5663245|NCT03618550|Tubulin Modulators|tubulin modulators|mesh-ancestor
5663246|NCT03618550|Antimitotic Agents|antimitotic agents|mesh-ancestor
5663247|NCT03618550|Mitosis Modulators|mitosis modulators|mesh-ancestor
5663248|NCT03618472|Metformin|metformin|mesh-list
5663249|NCT03618472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5663250|NCT03618472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663251|NCT03618355|Sirolimus|sirolimus|mesh-list
5663252|NCT03618355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5663253|NCT03618355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5663254|NCT03618355|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5663255|NCT03618355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5663256|NCT03618355|Antifungal Agents|antifungal agents|mesh-ancestor
5663257|NCT03618355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5843586|NCT02487329|Calcium|calcium|mesh-list
5843587|NCT02487329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5843588|NCT02487329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843589|NCT02487329|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5843590|NCT02487355|Magnesium Sulfate|magnesium sulfate|mesh-list
5843591|NCT02487355|Dexmedetomidine|dexmedetomidine|mesh-list
5843592|NCT02487355|Bupivacaine|bupivacaine|mesh-list
5843593|NCT02487355|Anesthetics, Local|anesthetics, local|mesh-ancestor
5843594|NCT02487355|Anesthetics|anesthetics|mesh-ancestor
5843595|NCT02487355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5843596|NCT02487355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843597|NCT02487355|Sensory System Agents|sensory system agents|mesh-ancestor
5843598|NCT02487355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5843599|NCT02487355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5843600|NCT02487355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5843601|NCT02487355|Analgesics|analgesics|mesh-ancestor
5843602|NCT02487355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5843603|NCT02487355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5843604|NCT02487355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5843605|NCT02487355|Adrenergic Agents|adrenergic agents|mesh-ancestor
5843606|NCT02487355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5843607|NCT02487355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5843608|NCT02487355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5843609|NCT02487355|Anticonvulsants|anticonvulsants|mesh-ancestor
5843610|NCT02487355|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5843611|NCT02487355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5663258|NCT03618355|Immunologic Factors|immunologic factors|mesh-ancestor
5663259|NCT03618355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843612|NCT02487355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5843613|NCT02487355|Tocolytic Agents|tocolytic agents|mesh-ancestor
5843614|NCT02487355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5663260|NCT03618316|Cimetidine|cimetidine|mesh-list
5663261|NCT03618316|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5663262|NCT03618316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5663263|NCT03618316|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5663264|NCT03618316|Histamine Antagonists|histamine antagonists|mesh-ancestor
5663265|NCT03618316|Histamine Agents|histamine agents|mesh-ancestor
5663266|NCT03618316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5663267|NCT03618316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663268|NCT03618316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663269|NCT03618316|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5663270|NCT03618316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5663271|NCT03618316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5663272|NCT03618264|Dexamethasone|dexamethasone|mesh-list
5663273|NCT03618264|Ropivacaine|ropivacaine|mesh-list
5843615|NCT02487316|Crizotinib|crizotinib|mesh-list
5843616|NCT02487316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5663274|NCT03618264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5843617|NCT02487316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5843618|NCT02487316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5843619|NCT02487316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5843620|NCT02487212|Clobetasol|clobetasol|mesh-list
5843621|NCT02487212|Petrolatum|petrolatum|mesh-list
5843622|NCT02487212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5843623|NCT02487212|Glucocorticoids|glucocorticoids|mesh-ancestor
5843624|NCT02487212|Hormones|hormones|mesh-ancestor
5843625|NCT02487212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5843626|NCT02487212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843627|NCT02487212|Emollients|emollients|mesh-ancestor
5843628|NCT02487212|Dermatologic Agents|dermatologic agents|mesh-ancestor
5843629|NCT02487069|Cyclosporine|cyclosporine|mesh-list
5843630|NCT02487069|Mycophenolic Acid|mycophenolic acid|mesh-list
5843631|NCT02487069|Methotrexate|methotrexate|mesh-list
5843632|NCT02487069|Cyclosporins|cyclosporins|mesh-list
5843633|NCT02487069|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5843634|NCT02487069|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5843635|NCT02487069|Abortifacient Agents|abortifacient agents|mesh-ancestor
5843636|NCT02487069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5843637|NCT02487069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843638|NCT02487069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5843639|NCT02487069|Antimetabolites|antimetabolites|mesh-ancestor
5843640|NCT02487069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663275|NCT03618264|Antiemetics|antiemetics|mesh-ancestor
5663276|NCT03618264|Autonomic Agents|autonomic agents|mesh-ancestor
5663277|NCT03618264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5663278|NCT03618264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663279|NCT03618264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5663280|NCT03618264|Glucocorticoids|glucocorticoids|mesh-ancestor
5663281|NCT03618264|Hormones|hormones|mesh-ancestor
5663282|NCT03618264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5663283|NCT03618264|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5663284|NCT03618264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5663285|NCT03618264|Anesthetics, Local|anesthetics, local|mesh-ancestor
5663286|NCT03618264|Anesthetics|anesthetics|mesh-ancestor
5663287|NCT03618264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5663288|NCT03618264|Sensory System Agents|sensory system agents|mesh-ancestor
5663289|NCT03618173|Dexamethasone|dexamethasone|mesh-list
5663290|NCT03618173|Dexamethasone acetate|dexamethasone acetate|mesh-list
5663291|NCT03618173|BB 1101|bb 1101|mesh-list
5663292|NCT03618173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5663293|NCT03618173|Antiemetics|antiemetics|mesh-ancestor
5663294|NCT03618173|Autonomic Agents|autonomic agents|mesh-ancestor
5663295|NCT03618173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5663296|NCT03618173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663297|NCT03618173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5663298|NCT03618173|Glucocorticoids|glucocorticoids|mesh-ancestor
5663299|NCT03618173|Hormones|hormones|mesh-ancestor
5663300|NCT03618173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5663301|NCT03618173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5663302|NCT03618173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5843641|NCT02487069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5843642|NCT02487069|Dermatologic Agents|dermatologic agents|mesh-ancestor
5843643|NCT02487069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5843644|NCT02487069|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5843645|NCT02487069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5843646|NCT02487069|Immunologic Factors|immunologic factors|mesh-ancestor
5843647|NCT02487069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5663303|NCT03618173|Protease Inhibitors|protease inhibitors|mesh-ancestor
5663304|NCT03618173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5663305|NCT03618173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695491|NCT03388970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695492|NCT03388970|Hemostatics|hemostatics|mesh-ancestor
5695493|NCT03388970|Coagulants|coagulants|mesh-ancestor
5695494|NCT03388957|Propranolol|propranolol|mesh-list
5695495|NCT03388957|Midazolam|midazolam|mesh-list
5695496|NCT03388957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5695497|NCT03388957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5695498|NCT03388957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5695499|NCT03388957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843648|NCT02487069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5843649|NCT02487069|Antifungal Agents|antifungal agents|mesh-ancestor
5843650|NCT02487069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5843651|NCT02487069|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5663306|NCT03618108|Azithromycin|azithromycin|mesh-list
5663307|NCT03618108|Doxycycline|doxycycline|mesh-list
5843652|NCT02487069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5843653|NCT02487069|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5843654|NCT02487069|Antitubercular Agents|antitubercular agents|mesh-ancestor
5843655|NCT02487069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5843656|NCT02487095|Topotecan|topotecan|mesh-list
5843657|NCT02487095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5843658|NCT02487095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5843659|NCT02487095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5843660|NCT02487095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663308|NCT03618108|Rifabutin|rifabutin|mesh-list
5663309|NCT03618108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5663310|NCT03618108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5663311|NCT03618108|Antimalarials|antimalarials|mesh-ancestor
5663312|NCT03618108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5663313|NCT03618108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5663314|NCT03618108|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5663315|NCT03618108|Antitubercular Agents|antitubercular agents|mesh-ancestor
5663316|NCT03618082|Desflurane|desflurane|mesh-list
5843661|NCT02487095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5843662|NCT02487082|Melatonin|melatonin|mesh-list
5663317|NCT03618082|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5663318|NCT03618082|Anesthetics, General|anesthetics, general|mesh-ancestor
5663319|NCT03618082|Anesthetics|anesthetics|mesh-ancestor
5663320|NCT03618082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5663321|NCT03618082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663322|NCT03617900|Acetaminophen|acetaminophen|mesh-list
5663323|NCT03617900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5843663|NCT02487082|Donepezil|donepezil|mesh-list
5843664|NCT02487082|Antioxidants|antioxidants|mesh-ancestor
5843665|NCT02487082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5843666|NCT02487082|Protective Agents|protective agents|mesh-ancestor
5843667|NCT02487082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843668|NCT02487082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5843669|NCT02487082|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5663324|NCT03617900|Analgesics|analgesics|mesh-ancestor
5663325|NCT03617900|Sensory System Agents|sensory system agents|mesh-ancestor
5663326|NCT03617900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5663327|NCT03617900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663328|NCT03617900|Antipyretics|antipyretics|mesh-ancestor
5663329|NCT03617705|Ethanol|ethanol|mesh-list
5663330|NCT03617705|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5663331|NCT03617705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5663332|NCT03617705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5663333|NCT03617705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663334|NCT03617679|Rucaparib|rucaparib|mesh-list
5663335|NCT03617679|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5663336|NCT03617679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5663337|NCT03617679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663338|NCT03617679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5663339|NCT03617666|Avelumab|avelumab|mesh-list
5843670|NCT02487082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5843671|NCT02487082|Cholinergic Agents|cholinergic agents|mesh-ancestor
5843672|NCT02487082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5843673|NCT02487082|Nootropic Agents|nootropic agents|mesh-ancestor
5843674|NCT02486822|Oxytocin|oxytocin|mesh-list
5843675|NCT02486822|Oxytocics|oxytocics|mesh-ancestor
5843676|NCT02486822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5843677|NCT02486822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843678|NCT02486848|Minoxidil|minoxidil|mesh-list
5843679|NCT02486848|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5843680|NCT02486848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5843681|NCT02486848|Vasodilator Agents|vasodilator agents|mesh-ancestor
5843682|NCT02486926|Remifentanil|remifentanil|mesh-list
5843683|NCT02486926|Alfentanil|alfentanil|mesh-list
5843684|NCT02486926|Thiopental|thiopental|mesh-list
5843685|NCT02486926|Sevoflurane|sevoflurane|mesh-list
5843686|NCT02486926|Rocuronium|rocuronium|mesh-list
5843687|NCT02486926|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5843688|NCT02486926|Narcotics|narcotics|mesh-ancestor
5843689|NCT02486926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5843690|NCT02486926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843691|NCT02486926|Analgesics|analgesics|mesh-ancestor
5663340|NCT03617666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5663341|NCT03617666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5843692|NCT02486926|Sensory System Agents|sensory system agents|mesh-ancestor
5843693|NCT02486926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5663342|NCT03617575|Lactoferrin|lactoferrin|mesh-list
5663343|NCT03617575|Fesoterodine|fesoterodine|mesh-list
5663344|NCT03617575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5663345|NCT03617575|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5663346|NCT03617575|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5663347|NCT03617575|Cholinergic Agents|cholinergic agents|mesh-ancestor
5663348|NCT03617575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5663349|NCT03617575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663350|NCT03617575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843694|NCT02486926|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5843695|NCT02486926|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5843696|NCT02486926|Anesthetics, General|anesthetics, general|mesh-ancestor
5843697|NCT02486926|Anesthetics|anesthetics|mesh-ancestor
5843698|NCT02486926|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5843699|NCT02486926|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5843700|NCT02486926|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5843701|NCT02486926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5843702|NCT02486926|Anticonvulsants|anticonvulsants|mesh-ancestor
5663351|NCT03617575|Urological Agents|urological agents|mesh-ancestor
5663352|NCT03617510|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
5663353|NCT03617510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5663354|NCT03617510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5663355|NCT03617510|Analgesics|analgesics|mesh-ancestor
5663356|NCT03617510|Sensory System Agents|sensory system agents|mesh-ancestor
5663357|NCT03617510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5663358|NCT03617510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663359|NCT03617510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5663360|NCT03617510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5663361|NCT03617484|Bortezomib|bortezomib|mesh-list
5663362|NCT03617484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5663363|NCT03617471|Acetaminophen|acetaminophen|mesh-list
5663364|NCT03617471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5663365|NCT03617471|Analgesics|analgesics|mesh-ancestor
5663366|NCT03617471|Sensory System Agents|sensory system agents|mesh-ancestor
5663367|NCT03617471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5663368|NCT03617471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663369|NCT03617471|Antipyretics|antipyretics|mesh-ancestor
5663370|NCT03617458|Metformin|metformin|mesh-list
5663371|NCT03617458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5663372|NCT03617458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663373|NCT03617432|Prednisone|prednisone|mesh-list
5663374|NCT03617432|Cyclophosphamide|cyclophosphamide|mesh-list
5663375|NCT03617432|Doxorubicin|doxorubicin|mesh-list
5843703|NCT02486926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5843704|NCT02486926|GABA Modulators|gaba modulators|mesh-ancestor
5843705|NCT02486926|GABA Agents|gaba agents|mesh-ancestor
5843706|NCT02486926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5843707|NCT02486926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5843708|NCT02486744|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
5843709|NCT02486744|Hormones|hormones|mesh-ancestor
5843710|NCT02486744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5843711|NCT02486744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843712|NCT02486432|Levodopa|levodopa|mesh-list
5843713|NCT02486432|Carbidopa|carbidopa|mesh-list
5843714|NCT02486432|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
5843715|NCT02486432|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5843716|NCT02486432|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5843717|NCT02486432|Dopamine Agents|dopamine agents|mesh-ancestor
5843718|NCT02486432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5663376|NCT03617432|Etoposide|etoposide|mesh-list
5663377|NCT03617432|Vincristine|vincristine|mesh-list
5663378|NCT03617432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5663379|NCT03617432|Immunologic Factors|immunologic factors|mesh-ancestor
5663380|NCT03617432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663381|NCT03617432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5663382|NCT03617432|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5663383|NCT03617432|Alkylating Agents|alkylating agents|mesh-ancestor
5843719|NCT02486432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663384|NCT03617432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663385|NCT03617432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5663386|NCT03617432|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5663387|NCT03617432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5843720|NCT02486432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663388|NCT03617432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5663389|NCT03617432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5663390|NCT03617432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5663391|NCT03617432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5663392|NCT03617432|Glucocorticoids|glucocorticoids|mesh-ancestor
5663393|NCT03617432|Hormones|hormones|mesh-ancestor
5663394|NCT03617432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5663395|NCT03617432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5663396|NCT03617432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5663397|NCT03617432|Tubulin Modulators|tubulin modulators|mesh-ancestor
5663398|NCT03617432|Antimitotic Agents|antimitotic agents|mesh-ancestor
5663399|NCT03617432|Mitosis Modulators|mitosis modulators|mesh-ancestor
5663400|NCT03617328|Poly ICLC|poly iclc|mesh-list
5663401|NCT03617328|Immunologic Factors|immunologic factors|mesh-ancestor
5663402|NCT03617328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663403|NCT03617328|Interferon Inducers|interferon inducers|mesh-ancestor
5843721|NCT02486432|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5843722|NCT02486432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5843723|NCT02486432|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5843724|NCT02486432|Immunologic Factors|immunologic factors|mesh-ancestor
5843725|NCT02486432|Dopamine Agonists|dopamine agonists|mesh-ancestor
5843726|NCT02486445|Rivaroxaban|rivaroxaban|mesh-list
5843727|NCT02486445|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5843728|NCT02486445|Antithrombins|antithrombins|mesh-ancestor
5663404|NCT03617289|Magnesium Sulfate|magnesium sulfate|mesh-list
5663405|NCT03617289|Analgesics|analgesics|mesh-ancestor
5663406|NCT03617289|Sensory System Agents|sensory system agents|mesh-ancestor
5663407|NCT03617289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5663408|NCT03617289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663409|NCT03617289|Anesthetics|anesthetics|mesh-ancestor
5663410|NCT03617289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5663411|NCT03617289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5663412|NCT03617289|Anticonvulsants|anticonvulsants|mesh-ancestor
5663413|NCT03617289|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5663414|NCT03617289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5663415|NCT03617289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663416|NCT03617289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5663417|NCT03617289|Tocolytic Agents|tocolytic agents|mesh-ancestor
5663418|NCT03617289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5663419|NCT03617224|Pembrolizumab|pembrolizumab|mesh-list
5663420|NCT03617224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5663421|NCT03617224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5663422|NCT03617172|Misoprostol|misoprostol|mesh-list
5663423|NCT03617172|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5663424|NCT03617172|Abortifacient Agents|abortifacient agents|mesh-ancestor
5663425|NCT03617172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5663426|NCT03617172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663427|NCT03617172|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5663428|NCT03617172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5843729|NCT02486445|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5843730|NCT02486445|Protease Inhibitors|protease inhibitors|mesh-ancestor
5843731|NCT02486445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5843732|NCT02486445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5843733|NCT02486445|Anticoagulants|anticoagulants|mesh-ancestor
5843734|NCT02486510|Maraviroc|maraviroc|mesh-list
5843735|NCT02486510|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5843736|NCT02486510|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5843737|NCT02486510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5843738|NCT02486510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5843739|NCT02486510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5663429|NCT03617172|Oxytocics|oxytocics|mesh-ancestor
5663430|NCT03617055|Cystatins|cystatins|mesh-list
5663431|NCT03617055|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
5663432|NCT03617055|Protease Inhibitors|protease inhibitors|mesh-ancestor
5663433|NCT03617055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5663434|NCT03617055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663435|NCT03617029|Ethiodized Oil|ethiodized oil|mesh-list
5663436|NCT03617029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5663437|NCT03617016|Domperidone|domperidone|mesh-list
5663438|NCT03617016|Antiemetics|antiemetics|mesh-ancestor
5663439|NCT03617016|Autonomic Agents|autonomic agents|mesh-ancestor
5843740|NCT02486510|Antiviral Agents|antiviral agents|mesh-ancestor
5843741|NCT02486510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5843742|NCT02486510|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
5843743|NCT02486549|Bupivacaine|bupivacaine|mesh-list
5843744|NCT02486549|Anesthetics, Local|anesthetics, local|mesh-ancestor
5843745|NCT02486549|Anesthetics|anesthetics|mesh-ancestor
5843746|NCT02486549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5843747|NCT02486549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843748|NCT02486549|Sensory System Agents|sensory system agents|mesh-ancestor
5843749|NCT02486549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5843750|NCT02486601|Paclitaxel|paclitaxel|mesh-list
5843751|NCT02486601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5843752|NCT02486601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5843753|NCT02486601|Tubulin Modulators|tubulin modulators|mesh-ancestor
5843754|NCT02486601|Antimitotic Agents|antimitotic agents|mesh-ancestor
5843755|NCT02486601|Mitosis Modulators|mitosis modulators|mesh-ancestor
5843756|NCT02486601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5843757|NCT02486640|Interferons|interferons|mesh-list
5843758|NCT02486640|Interferon-beta|interferon-beta|mesh-list
5843759|NCT02486640|Interferon beta-1b|interferon beta-1b|mesh-list
5843760|NCT02486640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5843761|NCT02486640|Antiviral Agents|antiviral agents|mesh-ancestor
5843762|NCT02486640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5843763|NCT02486640|Immunologic Factors|immunologic factors|mesh-ancestor
5843764|NCT02486640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843765|NCT02486640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5843766|NCT02486458|Listerine|listerine|mesh-list
5843767|NCT02486458|Fluorides|fluorides|mesh-list
5843768|NCT02486458|Sodium Fluoride|sodium fluoride|mesh-list
5843769|NCT02486458|Fluorides, Topical|fluorides, topical|mesh-list
5843770|NCT02486458|Cariostatic Agents|cariostatic agents|mesh-ancestor
5843771|NCT02486458|Protective Agents|protective agents|mesh-ancestor
5843772|NCT02486458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843773|NCT02486458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5843774|NCT02486458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5843775|NCT02486484|Aflibercept|aflibercept|mesh-list
5843776|NCT02486484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5843777|NCT02486484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5843778|NCT02486484|Growth Substances|growth substances|mesh-ancestor
5843779|NCT02486484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843780|NCT02486484|Growth Inhibitors|growth inhibitors|mesh-ancestor
5843781|NCT02486484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5843782|NCT02486367|Clopidogrel|clopidogrel|mesh-list
5843783|NCT02486367|Ticagrelor|ticagrelor|mesh-list
5843784|NCT02486367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5843785|NCT02486367|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5843786|NCT02486367|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5843787|NCT02486367|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5843788|NCT02486367|Purinergic Agents|purinergic agents|mesh-ancestor
5843789|NCT02486367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5843790|NCT02486367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663440|NCT03617016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5663441|NCT03617016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663442|NCT03617016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5663443|NCT03617016|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5663444|NCT03617016|Dopamine Agents|dopamine agents|mesh-ancestor
5663445|NCT03617016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5663446|NCT03617016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5843791|NCT02486367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843792|NCT02486341|Insulin|insulin|mesh-list
5843793|NCT02486341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5843794|NCT02486341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843795|NCT02486198|Oxaliplatin|oxaliplatin|mesh-list
5843796|NCT02486198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5843797|NCT02486133|Ritonavir|ritonavir|mesh-list
5843798|NCT02486133|Darunavir|darunavir|mesh-list
5843799|NCT02486133|Tenofovir|tenofovir|mesh-list
5663447|NCT03616808|Hemostatics|hemostatics|mesh-list
5843800|NCT02486133|Lamivudine|lamivudine|mesh-list
5843801|NCT02486133|Emtricitabine|emtricitabine|mesh-list
5843802|NCT02486133|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5843803|NCT02486133|Abacavir|abacavir|mesh-list
5843804|NCT02486133|Dolutegravir|dolutegravir|mesh-list
5843805|NCT02486133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5843806|NCT02486133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5843807|NCT02486133|Protease Inhibitors|protease inhibitors|mesh-ancestor
5843808|NCT02486133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5843809|NCT02486133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5843810|NCT02486133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5843811|NCT02486133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5843812|NCT02486133|Antiviral Agents|antiviral agents|mesh-ancestor
5843813|NCT02486133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5843814|NCT02486133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5903514|NCT04922593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5843815|NCT02486133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5843816|NCT02486133|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5843817|NCT02486133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5843818|NCT02486133|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5843819|NCT02486133|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5843820|NCT02486055|Coenzyme Q10|coenzyme q10|mesh-list
5843821|NCT02486055|Micronutrients|micronutrients|mesh-ancestor
5843822|NCT02486055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843823|NCT02486055|Vitamins|vitamins|mesh-ancestor
5843824|NCT02486289|N,N'-Bis(2-mercaptoethyl)isophthalamide|n,n'-bis(2-mercaptoethyl)isophthalamide|mesh-list
5843825|NCT02486289|Chelating Agents|chelating agents|mesh-ancestor
5843826|NCT02486289|Sequestering Agents|sequestering agents|mesh-ancestor
5843827|NCT02486289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5843828|NCT02486276|Cilostazol|cilostazol|mesh-list
5843829|NCT02486276|Sumatriptan|sumatriptan|mesh-list
5843830|NCT02486276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5663448|NCT03616808|Coagulants|coagulants|mesh-ancestor
5663449|NCT03616782|Ixazomib|ixazomib|mesh-list
5663450|NCT03616782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5663451|NCT03616782|Protease Inhibitors|protease inhibitors|mesh-ancestor
5663452|NCT03616782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5663453|NCT03616782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663454|NCT03616769|Antihypertensive Agents|antihypertensive agents|mesh-list
5663455|NCT03616769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
5663456|NCT03616717|Modafinil|modafinil|mesh-list
5663457|NCT03616717|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5843831|NCT02486276|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5843832|NCT02486276|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5843833|NCT02486276|Serotonin Agents|serotonin agents|mesh-ancestor
5843834|NCT02486276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5843835|NCT02486276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5843836|NCT02486276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843837|NCT02486276|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5843838|NCT02486276|Autonomic Agents|autonomic agents|mesh-ancestor
5843839|NCT02486276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5843840|NCT02486276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5843841|NCT02486276|Respiratory System Agents|respiratory system agents|mesh-ancestor
5843842|NCT02486276|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5843843|NCT02486276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5843844|NCT02486276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5843845|NCT02486276|Vasodilator Agents|vasodilator agents|mesh-ancestor
5843846|NCT02486276|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5663458|NCT03616717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663459|NCT03616717|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
5663460|NCT03616717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5663461|NCT03616717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5663462|NCT03616717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663463|NCT03616691|Bevacizumab|bevacizumab|mesh-list
5663464|NCT03616691|Atezolizumab|atezolizumab|mesh-list
5663465|NCT03616691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5663466|NCT03616691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5663467|NCT03616691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5663468|NCT03616691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5663469|NCT03616691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5663470|NCT03616691|Growth Substances|growth substances|mesh-ancestor
5663471|NCT03616691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663472|NCT03616691|Growth Inhibitors|growth inhibitors|mesh-ancestor
5663473|NCT03616691|Immunologic Factors|immunologic factors|mesh-ancestor
5663474|NCT03616639|Morphine|morphine|mesh-list
5663475|NCT03616639|Oxycodone|oxycodone|mesh-list
5663476|NCT03616639|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5663477|NCT03616639|Narcotics|narcotics|mesh-ancestor
5663478|NCT03616639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5663479|NCT03616639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663480|NCT03616639|Analgesics|analgesics|mesh-ancestor
5663481|NCT03616639|Sensory System Agents|sensory system agents|mesh-ancestor
5663482|NCT03616639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5663483|NCT03616561|Apremilast|apremilast|mesh-list
5663484|NCT03616561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5663485|NCT03616561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5663486|NCT03616561|Analgesics|analgesics|mesh-ancestor
5663487|NCT03616561|Sensory System Agents|sensory system agents|mesh-ancestor
5843847|NCT02486276|Protective Agents|protective agents|mesh-ancestor
5663488|NCT03616561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5663489|NCT03616561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843848|NCT02486276|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5843849|NCT02486276|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5843850|NCT02486276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5843851|NCT02485990|Olaparib|olaparib|mesh-list
5843852|NCT02485990|Tremelimumab|tremelimumab|mesh-list
5843853|NCT02485990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5843854|NCT02485990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5843855|NCT02485990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5843856|NCT02485990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5843857|NCT02485821|Misoprostol|misoprostol|mesh-list
5843858|NCT02485821|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5843859|NCT02485821|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5843860|NCT02485821|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5843861|NCT02485821|Estradiol|estradiol|mesh-list
5843862|NCT02485821|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5843863|NCT02485821|Estrogens|estrogens|mesh-ancestor
5843864|NCT02485821|Hormones|hormones|mesh-ancestor
5843865|NCT02485821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5843866|NCT02485821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843867|NCT02485821|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5843868|NCT02485821|Contraceptive Agents|contraceptive agents|mesh-ancestor
5843869|NCT02485821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5843870|NCT02485821|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5663490|NCT03616561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5663491|NCT03616561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5663492|NCT03616561|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5663493|NCT03616561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5663494|NCT03616561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5663495|NCT03616561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663496|NCT03616509|Hormones|hormones|mesh-list
5663497|NCT03616509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5663498|NCT03616509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663499|NCT03616405|Amoxicillin|amoxicillin|mesh-list
5663500|NCT03616405|Tetracycline|tetracycline|mesh-list
5663501|NCT03616405|Furazolidone|furazolidone|mesh-list
5663502|NCT03616405|Rabeprazole|rabeprazole|mesh-list
5663503|NCT03616405|Bismuth|bismuth|mesh-list
5663504|NCT03616405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5663505|NCT03616405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5663506|NCT03616405|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5663507|NCT03616405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5663508|NCT03616405|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5663509|NCT03616405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5843871|NCT02485821|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5843872|NCT02485821|Abortifacient Agents|abortifacient agents|mesh-ancestor
5843873|NCT02485821|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5843874|NCT02485821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5843875|NCT02485821|Oxytocics|oxytocics|mesh-ancestor
5843876|NCT02485821|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5843877|NCT02485821|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5843878|NCT02485873|Vitamin K|vitamin k|mesh-list
5843879|NCT02485873|Rivaroxaban|rivaroxaban|mesh-list
5843880|NCT02485873|Vitamins|vitamins|mesh-ancestor
5843881|NCT02485873|Micronutrients|micronutrients|mesh-ancestor
5843882|NCT02485873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663510|NCT03616405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663511|NCT03616405|Antacids|antacids|mesh-ancestor
5663512|NCT03616405|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5663513|NCT03616405|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5663514|NCT03616405|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5663515|NCT03616405|Renal Agents|renal agents|mesh-ancestor
5663516|NCT03616405|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
5663517|NCT03616405|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5663518|NCT03616405|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5663519|NCT03616405|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
5695500|NCT03388957|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5695501|NCT03388957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5843883|NCT02485873|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5843884|NCT02485873|Antithrombins|antithrombins|mesh-ancestor
5843885|NCT02485873|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5843886|NCT02485873|Protease Inhibitors|protease inhibitors|mesh-ancestor
5843887|NCT02485873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5843888|NCT02485873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5843889|NCT02485873|Anticoagulants|anticoagulants|mesh-ancestor
5843890|NCT02485873|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5663520|NCT03616301|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5663521|NCT03616301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5663522|NCT03616301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5663523|NCT03616301|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5663524|NCT03616301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5663525|NCT03616301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663526|NCT03616288|Thiamine|thiamine|mesh-list
5663527|NCT03616288|Vitamin B Complex|vitamin b complex|mesh-ancestor
5663528|NCT03616288|Vitamins|vitamins|mesh-ancestor
5663529|NCT03616288|Micronutrients|micronutrients|mesh-ancestor
5663530|NCT03616288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663531|NCT03616262|Lidocaine|lidocaine|mesh-list
5843891|NCT02485873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5843892|NCT02485873|Hemostatics|hemostatics|mesh-ancestor
5843893|NCT02485873|Coagulants|coagulants|mesh-ancestor
5663532|NCT03616262|Anesthetics, Local|anesthetics, local|mesh-ancestor
5663533|NCT03616262|Anesthetics|anesthetics|mesh-ancestor
5663534|NCT03616262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5663535|NCT03616262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663536|NCT03616262|Sensory System Agents|sensory system agents|mesh-ancestor
5663537|NCT03616262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5663538|NCT03616262|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5843894|NCT02485548|Fluorouracil|fluorouracil|mesh-list
5843895|NCT02485548|Raltitrexed|raltitrexed|mesh-list
5843896|NCT02485548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5843897|NCT02485548|Antimetabolites|antimetabolites|mesh-ancestor
5843898|NCT02485548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5843899|NCT02485548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5843900|NCT02485548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5843901|NCT02485548|Immunologic Factors|immunologic factors|mesh-ancestor
5843902|NCT02485548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843903|NCT02485548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5843904|NCT02485548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5903515|NCT04922593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5903516|NCT04922593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903517|NCT04922593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5903518|NCT04922593|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5903519|NCT04922593|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5903520|NCT04922593|Serotonin Agents|serotonin agents|mesh-ancestor
5903521|NCT04922593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5903522|NCT04922593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903523|NCT04922593|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6493826|NCT00615745|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6493827|NCT00615745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6493828|NCT00615745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493829|NCT00615745|Antiviral Agents|antiviral agents|mesh-ancestor
6493830|NCT00615745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6493831|NCT00615745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6493832|NCT00615745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6493833|NCT00615758|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6493834|NCT00615758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6493835|NCT00615758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6493836|NCT00615758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6493837|NCT00615758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493838|NCT00615797|Penicillins|penicillins|mesh-list
6493839|NCT00615797|Penicillin V|penicillin v|mesh-list
6493840|NCT00615797|Haloperidol|haloperidol|mesh-list
6493841|NCT00615797|Haloperidol decanoate|haloperidol decanoate|mesh-list
6493842|NCT00615797|Immunoglobulins|immunoglobulins|mesh-list
6493843|NCT00615797|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6493844|NCT00615797|Antibodies|antibodies|mesh-list
6493845|NCT00615797|gamma-Globulins|gamma-globulins|mesh-list
6493846|NCT00615797|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5843905|NCT02485613|Dexamethasone|dexamethasone|mesh-list
5843906|NCT02485613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5843907|NCT02485613|Antiemetics|antiemetics|mesh-ancestor
5843908|NCT02485613|Autonomic Agents|autonomic agents|mesh-ancestor
5843909|NCT02485613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5843910|NCT02485613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843911|NCT02485613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5843912|NCT02485613|Glucocorticoids|glucocorticoids|mesh-ancestor
5843913|NCT02485613|Hormones|hormones|mesh-ancestor
5663539|NCT03616262|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5663540|NCT03616262|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5663541|NCT03616262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5663542|NCT03616262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663543|NCT03616236|Buprenorphine|buprenorphine|mesh-list
5843914|NCT02485613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5843915|NCT02485613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5843916|NCT02485613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5843917|NCT02485431|Deflazacort|deflazacort|mesh-list
5843918|NCT02485431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5843919|NCT02485431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5843920|NCT02485431|Immunologic Factors|immunologic factors|mesh-ancestor
5843921|NCT02485431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843922|NCT02485444|Oxytocin|oxytocin|mesh-list
5843923|NCT02485444|Oxytocics|oxytocics|mesh-ancestor
5843924|NCT02485444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5843925|NCT02485444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843926|NCT02485340|Isosorbide|isosorbide|mesh-list
5843927|NCT02485340|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
5843928|NCT02485340|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
5843929|NCT02485340|Sumatriptan|sumatriptan|mesh-list
5843930|NCT02485340|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5843931|NCT02485340|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5663544|NCT03616236|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
5663545|NCT03616236|Naloxone|naloxone|mesh-list
5663546|NCT03616236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5663547|NCT03616236|Narcotics|narcotics|mesh-ancestor
5663548|NCT03616236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5663549|NCT03616236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663550|NCT03616236|Analgesics|analgesics|mesh-ancestor
5663551|NCT03616236|Sensory System Agents|sensory system agents|mesh-ancestor
5663552|NCT03616236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5663553|NCT03616236|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5663554|NCT03616132|Sirolimus|sirolimus|mesh-list
5663555|NCT03616132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5663556|NCT03616132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5663557|NCT03616132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5663558|NCT03616132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5663559|NCT03616132|Antifungal Agents|antifungal agents|mesh-ancestor
5663560|NCT03616132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5663561|NCT03616132|Immunologic Factors|immunologic factors|mesh-ancestor
5663562|NCT03616132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663563|NCT03615950|Vitamin D|vitamin d|mesh-list
5663564|NCT03615950|Vitamins|vitamins|mesh-ancestor
5663565|NCT03615950|Micronutrients|micronutrients|mesh-ancestor
5663566|NCT03615950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663567|NCT03615950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5843932|NCT02485340|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5843933|NCT02485340|Serotonin Agents|serotonin agents|mesh-ancestor
5843934|NCT02485340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5843935|NCT02485340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5843936|NCT02485340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843937|NCT02485340|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5843938|NCT02485340|Diuretics|diuretics|mesh-ancestor
5843939|NCT02485340|Natriuretic Agents|natriuretic agents|mesh-ancestor
5843940|NCT02485340|Vasodilator Agents|vasodilator agents|mesh-ancestor
5843941|NCT02485340|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5843942|NCT02485327|Insulin|insulin|mesh-list
5843943|NCT02485327|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5843944|NCT02485327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5843945|NCT02485327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843946|NCT02485249|Dexamethasone|dexamethasone|mesh-list
5843947|NCT02485249|Dexamethasone acetate|dexamethasone acetate|mesh-list
5843948|NCT02485249|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
5843949|NCT02485249|BB 1101|bb 1101|mesh-list
5843950|NCT02485249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5843951|NCT02485249|Antiemetics|antiemetics|mesh-ancestor
5843952|NCT02485249|Autonomic Agents|autonomic agents|mesh-ancestor
5663568|NCT03615833|Vitamin D|vitamin d|mesh-list
5843953|NCT02485249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5843954|NCT02485249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843955|NCT02485249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5843956|NCT02485249|Glucocorticoids|glucocorticoids|mesh-ancestor
5843957|NCT02485249|Hormones|hormones|mesh-ancestor
5843958|NCT02485249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5843959|NCT02485249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5843960|NCT02485249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5663569|NCT03615833|Cholecalciferol|cholecalciferol|mesh-list
5663570|NCT03615833|Vitamins|vitamins|mesh-ancestor
5663571|NCT03615833|Micronutrients|micronutrients|mesh-ancestor
5663572|NCT03615833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663573|NCT03615833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5663574|NCT03615833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5663575|NCT03615768|Clindamycin|clindamycin|mesh-list
5663576|NCT03615768|Clindamycin palmitate|clindamycin palmitate|mesh-list
5663577|NCT03615768|Clindamycin phosphate|clindamycin phosphate|mesh-list
5663578|NCT03615768|Adapalene|adapalene|mesh-list
5843961|NCT02485249|Protease Inhibitors|protease inhibitors|mesh-ancestor
5843962|NCT02485249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5843963|NCT02485249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5843964|NCT02485145|Diclofenac|diclofenac|mesh-list
5843965|NCT02485145|Orphenadrine|orphenadrine|mesh-list
5843966|NCT02485145|Bupivacaine|bupivacaine|mesh-list
5843967|NCT02485145|Baclofen|baclofen|mesh-list
5843968|NCT02485145|Anesthetics, Local|anesthetics, local|mesh-ancestor
5843969|NCT02485145|Anesthetics|anesthetics|mesh-ancestor
5843970|NCT02485145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5843971|NCT02485145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5843972|NCT02485145|Sensory System Agents|sensory system agents|mesh-ancestor
5843973|NCT02485145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5843974|NCT02485145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5843975|NCT02485145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5843976|NCT02485145|Analgesics|analgesics|mesh-ancestor
5843977|NCT02485145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5843978|NCT02485145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5843979|NCT02485145|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5843980|NCT02485145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5843981|NCT02485145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5843982|NCT02485145|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5843983|NCT02485145|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5843984|NCT02485145|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
5843985|NCT02485145|GABA Agonists|gaba agonists|mesh-ancestor
5843986|NCT02485145|GABA Agents|gaba agents|mesh-ancestor
5843987|NCT02485145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5843988|NCT02485145|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5843989|NCT02485145|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5843990|NCT02485145|Parasympatholytics|parasympatholytics|mesh-ancestor
5843991|NCT02485145|Autonomic Agents|autonomic agents|mesh-ancestor
5843992|NCT02485145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5663579|NCT03615768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5663580|NCT03615768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5663581|NCT03615768|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5663582|NCT03615768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5663583|NCT03615768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663584|NCT03615768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5663585|NCT03615768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5663586|NCT03615768|Analgesics|analgesics|mesh-ancestor
5663587|NCT03615768|Sensory System Agents|sensory system agents|mesh-ancestor
5663588|NCT03615768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5663589|NCT03615768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663590|NCT03615768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5663591|NCT03615768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5663592|NCT03615768|Dermatologic Agents|dermatologic agents|mesh-ancestor
5663593|NCT03615677|Esomeprazole|esomeprazole|mesh-list
5663594|NCT03615677|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5663595|NCT03615677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5663596|NCT03615677|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5663597|NCT03615677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5663598|NCT03615677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663599|NCT03615547|Clomiphene|clomiphene|mesh-list
5663600|NCT03615547|Enclomiphene|enclomiphene|mesh-list
5663601|NCT03615547|Zuclomiphene|zuclomiphene|mesh-list
5663602|NCT03615547|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5843993|NCT02485145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5843994|NCT02485145|Cholinergic Agents|cholinergic agents|mesh-ancestor
5843995|NCT02485145|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
5843996|NCT02485145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5843997|NCT02485041|Mirodenafil|mirodenafil|mesh-list
5843998|NCT02485041|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5843999|NCT02485041|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5844000|NCT02485041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5844001|NCT02485041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844002|NCT02485262|Sofosbuvir|sofosbuvir|mesh-list
5844003|NCT02485262|Simeprevir|simeprevir|mesh-list
5844004|NCT02485262|Antiviral Agents|antiviral agents|mesh-ancestor
5844005|NCT02485262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5844006|NCT02485262|Protease Inhibitors|protease inhibitors|mesh-ancestor
5844007|NCT02485262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5844008|NCT02485262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663603|NCT03615547|Hormone Antagonists|hormone antagonists|mesh-ancestor
5663604|NCT03615547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5663605|NCT03615547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663606|NCT03615547|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5663607|NCT03615547|Fertility Agents|fertility agents|mesh-ancestor
5844009|NCT02484885|Xenon|xenon|mesh-list
5844010|NCT02484885|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5844011|NCT02484885|Anesthetics, General|anesthetics, general|mesh-ancestor
5844012|NCT02484885|Anesthetics|anesthetics|mesh-ancestor
5844013|NCT02484885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5844014|NCT02484885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844015|NCT02484963|Zolpidem|zolpidem|mesh-list
5844016|NCT02484963|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5844017|NCT02484963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5844018|NCT02484963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5844019|NCT02484963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844020|NCT02484963|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
5844021|NCT02484963|GABA Agonists|gaba agonists|mesh-ancestor
5844022|NCT02484963|GABA Agents|gaba agents|mesh-ancestor
5844023|NCT02484963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5844024|NCT02484963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844025|NCT02485067|Tolterodine Tartrate|tolterodine tartrate|mesh-list
5844026|NCT02485067|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5844027|NCT02485067|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5844028|NCT02485067|Cholinergic Agents|cholinergic agents|mesh-ancestor
5844029|NCT02485067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5844030|NCT02485067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844031|NCT02485067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844032|NCT02485067|Urological Agents|urological agents|mesh-ancestor
5844033|NCT02485080|Sofosbuvir|sofosbuvir|mesh-list
5844034|NCT02485080|Simeprevir|simeprevir|mesh-list
5844035|NCT02485080|Antiviral Agents|antiviral agents|mesh-ancestor
5844036|NCT02485080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5844037|NCT02485080|Protease Inhibitors|protease inhibitors|mesh-ancestor
5844038|NCT02485080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5844039|NCT02485080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844040|NCT02485184|Propranolol|propranolol|mesh-list
5844041|NCT02485184|Warfarin|warfarin|mesh-list
5844042|NCT02485184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
5844043|NCT02485184|Anticoagulants|anticoagulants|mesh-ancestor
5844044|NCT02485184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5844045|NCT02485184|Adrenergic Agents|adrenergic agents|mesh-ancestor
5844046|NCT02485184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5844047|NCT02485184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844048|NCT02485184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844049|NCT02485184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5844050|NCT02485184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5844051|NCT02485184|Vasodilator Agents|vasodilator agents|mesh-ancestor
5844052|NCT02485106|Rifaximin|rifaximin|mesh-list
5844053|NCT02485106|Pentoxifylline|pentoxifylline|mesh-list
5844054|NCT02485106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5844055|NCT02485106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5844056|NCT02485106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5844057|NCT02485106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5844058|NCT02485106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5844059|NCT02485106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844060|NCT02485106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5663608|NCT03615547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5663609|NCT03615547|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5663610|NCT03615547|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5663611|NCT03615430|Anesthetics|anesthetics|mesh-list
5663612|NCT03615430|Anesthetics, Local|anesthetics, local|mesh-list
5663613|NCT03615430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5844061|NCT02485106|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5844062|NCT02485106|Protective Agents|protective agents|mesh-ancestor
5844063|NCT02485106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844064|NCT02485106|Vasodilator Agents|vasodilator agents|mesh-ancestor
5844065|NCT02485106|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5844066|NCT02485106|Antioxidants|antioxidants|mesh-ancestor
5844067|NCT02485028|Mirodenafil|mirodenafil|mesh-list
5844068|NCT02485028|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5844069|NCT02485028|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5844070|NCT02485028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5844071|NCT02485028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844072|NCT02485015|Apatinib|apatinib|mesh-list
5844073|NCT02485015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5844074|NCT02485015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5844075|NCT02485015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5844076|NCT02485015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844077|NCT02484924|Clopidogrel|clopidogrel|mesh-list
5844078|NCT02484924|Ticagrelor|ticagrelor|mesh-list
5844079|NCT02484924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5844080|NCT02484924|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5844081|NCT02484924|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5844082|NCT02484924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5844083|NCT02484924|Purinergic Agents|purinergic agents|mesh-ancestor
5844084|NCT02484924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5844085|NCT02484924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844086|NCT02484924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844087|NCT02484768|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
5844088|NCT02484768|Hematinics|hematinics|mesh-ancestor
5844089|NCT02484833|Cetuximab|cetuximab|mesh-list
5844090|NCT02484833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5844091|NCT02484833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5844092|NCT02484677|Docetaxel|docetaxel|mesh-list
5844093|NCT02484677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5844094|NCT02484677|Tubulin Modulators|tubulin modulators|mesh-ancestor
5844095|NCT02484677|Antimitotic Agents|antimitotic agents|mesh-ancestor
5844096|NCT02484677|Mitosis Modulators|mitosis modulators|mesh-ancestor
5844097|NCT02484677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844098|NCT02484573|Propranolol|propranolol|mesh-list
5844099|NCT02484573|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5844100|NCT02484573|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5844101|NCT02484573|Adrenergic Agents|adrenergic agents|mesh-ancestor
5844102|NCT02484573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5844103|NCT02484573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844104|NCT02484573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844105|NCT02484573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5844106|NCT02484573|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5844107|NCT02484573|Vasodilator Agents|vasodilator agents|mesh-ancestor
5844108|NCT02484755|Gefitinib|gefitinib|mesh-list
5844109|NCT02484755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5844110|NCT02484755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5663614|NCT03615430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663615|NCT03615430|Sensory System Agents|sensory system agents|mesh-ancestor
5663616|NCT03615430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5663617|NCT03615417|Anesthetics|anesthetics|mesh-list
5663618|NCT03615417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5663619|NCT03615417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663620|NCT03615326|Pembrolizumab|pembrolizumab|mesh-list
5663621|NCT03615326|Capecitabine|capecitabine|mesh-list
5663622|NCT03615326|Oxaliplatin|oxaliplatin|mesh-list
5663623|NCT03615326|Trastuzumab|trastuzumab|mesh-list
5844111|NCT02484755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5844112|NCT02484755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844113|NCT02484248|Ketotifen|ketotifen|mesh-list
5844114|NCT02484248|Antipruritics|antipruritics|mesh-ancestor
5844115|NCT02484248|Dermatologic Agents|dermatologic agents|mesh-ancestor
5844116|NCT02484248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5844117|NCT02484248|Histamine Antagonists|histamine antagonists|mesh-ancestor
5663624|NCT03615326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5663625|NCT03615326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5663626|NCT03615326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5663627|NCT03615326|Antimetabolites|antimetabolites|mesh-ancestor
5695502|NCT03388957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5663628|NCT03615326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663629|NCT03615313|Antibodies|antibodies|mesh-list
5663630|NCT03615313|Immunologic Factors|immunologic factors|mesh-ancestor
5663631|NCT03615313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663632|NCT03615196|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5663633|NCT03615196|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5663634|NCT03614832|Clopidogrel|clopidogrel|mesh-list
5663635|NCT03614832|Ticagrelor|ticagrelor|mesh-list
5663636|NCT03614832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5663637|NCT03614832|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5663638|NCT03614832|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5844118|NCT02484248|Histamine Agents|histamine agents|mesh-ancestor
5844119|NCT02484248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5663639|NCT03614832|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5663640|NCT03614832|Purinergic Agents|purinergic agents|mesh-ancestor
5663641|NCT03614832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5663642|NCT03614832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663643|NCT03614832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844120|NCT02484248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844121|NCT02484248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844122|NCT02484248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5844123|NCT02484287|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5844124|NCT02484287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5844125|NCT02484300|Melatonin|melatonin|mesh-list
5844126|NCT02484300|Antioxidants|antioxidants|mesh-ancestor
5844127|NCT02484300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844128|NCT02484300|Protective Agents|protective agents|mesh-ancestor
5844129|NCT02484300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844130|NCT02484300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5844131|NCT02484352|Oxycodone|oxycodone|mesh-list
5844132|NCT02484352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5844133|NCT02484352|Narcotics|narcotics|mesh-ancestor
5844134|NCT02484352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5663644|NCT03614741|Tinzaparin|tinzaparin|mesh-list
5663645|NCT03614741|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5663646|NCT03614741|Dalteparin|dalteparin|mesh-list
5663647|NCT03614741|Anticoagulants|anticoagulants|mesh-ancestor
5663648|NCT03614741|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5663649|NCT03614741|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5663650|NCT03614741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663651|NCT03614715|Interferons|interferons|mesh-list
5663652|NCT03614715|Interferon-beta|interferon-beta|mesh-list
5663653|NCT03614715|Interferon beta-1a|interferon beta-1a|mesh-list
5663654|NCT03614715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5663655|NCT03614715|Antiviral Agents|antiviral agents|mesh-ancestor
5663656|NCT03614715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5663657|NCT03614715|Immunologic Factors|immunologic factors|mesh-ancestor
5663658|NCT03614715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663659|NCT03614715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5695503|NCT03388957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5695504|NCT03388957|Anesthetics, General|anesthetics, general|mesh-ancestor
5695505|NCT03388957|Anesthetics|anesthetics|mesh-ancestor
5695506|NCT03388957|GABA Modulators|gaba modulators|mesh-ancestor
5695507|NCT03388957|GABA Agents|gaba agents|mesh-ancestor
5695508|NCT03388957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5695509|NCT03388957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695510|NCT03388957|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5695511|NCT03388957|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5695512|NCT03388957|Adrenergic Agents|adrenergic agents|mesh-ancestor
5695513|NCT03388957|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5695514|NCT03388957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5695515|NCT03388957|Vasodilator Agents|vasodilator agents|mesh-ancestor
5695516|NCT03388892|Paclitaxel|paclitaxel|mesh-list
5695517|NCT03388892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5695518|NCT03388892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5695519|NCT03388892|Tubulin Modulators|tubulin modulators|mesh-ancestor
5695520|NCT03388892|Antimitotic Agents|antimitotic agents|mesh-ancestor
5695521|NCT03388892|Mitosis Modulators|mitosis modulators|mesh-ancestor
5695522|NCT03388892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695523|NCT03388866|Immunologic Factors|immunologic factors|mesh-list
5695524|NCT03388866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695525|NCT03388853|Acetylcysteine|acetylcysteine|mesh-list
5695526|NCT03388853|Doxofylline|doxofylline|mesh-list
5844135|NCT02484352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695527|NCT03388853|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5695528|NCT03388853|Antiviral Agents|antiviral agents|mesh-ancestor
5663660|NCT03614533|Vaccines|vaccines|mesh-list
5663661|NCT03614533|Immunologic Factors|immunologic factors|mesh-ancestor
5663662|NCT03614533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663663|NCT03614494|Piroxicam|piroxicam|mesh-list
5663664|NCT03614494|Levonorgestrel|levonorgestrel|mesh-list
5663665|NCT03614494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5663666|NCT03614494|Contraceptive Agents|contraceptive agents|mesh-ancestor
5663667|NCT03614494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5663668|NCT03614494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663669|NCT03614494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5663670|NCT03614494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5663671|NCT03614494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5844136|NCT02484352|Analgesics|analgesics|mesh-ancestor
6212026|NCT02180828|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6212027|NCT02180828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6212028|NCT02180828|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6212029|NCT02180867|Doxorubicin|doxorubicin|mesh-list
6212030|NCT02180867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6212031|NCT02180867|Daunorubicin|daunorubicin|mesh-list
6212032|NCT02180867|Ifosfamide|ifosfamide|mesh-list
6212033|NCT02180867|Isophosphamide mustard|isophosphamide mustard|mesh-list
6212034|NCT02180867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6212035|NCT02180867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5844137|NCT02484352|Sensory System Agents|sensory system agents|mesh-ancestor
5844138|NCT02484352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5844139|NCT02484170|Mannitol|mannitol|mesh-list
5844140|NCT02484170|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5844141|NCT02484170|Diuretics|diuretics|mesh-ancestor
5844142|NCT02484170|Natriuretic Agents|natriuretic agents|mesh-ancestor
5844143|NCT02484170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844144|NCT02484209|Metformin|metformin|mesh-list
5844145|NCT02484209|Glimepiride|glimepiride|mesh-list
5844146|NCT02484209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5844147|NCT02484209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844148|NCT02484209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5844149|NCT02484209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5844150|NCT02484209|Immunologic Factors|immunologic factors|mesh-ancestor
5844151|NCT02484339|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
5844152|NCT02484339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5844153|NCT02484261|Bortezomib|bortezomib|mesh-list
5844154|NCT02484261|Pravastatin|pravastatin|mesh-list
5844155|NCT02484261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5844156|NCT02484261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5844157|NCT02484261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5844158|NCT02484261|Antimetabolites|antimetabolites|mesh-ancestor
5844159|NCT02484261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844160|NCT02484261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5844161|NCT02484261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5844162|NCT02484261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5663672|NCT03614494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5663673|NCT03614494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5663674|NCT03614494|Analgesics|analgesics|mesh-ancestor
5663675|NCT03614494|Sensory System Agents|sensory system agents|mesh-ancestor
5663676|NCT03614494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5663677|NCT03614494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5663678|NCT03614494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5663679|NCT03614494|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5663680|NCT03614494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5663681|NCT03614494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663682|NCT03614455|Itraconazole|itraconazole|mesh-list
5663683|NCT03614455|Posaconazole|posaconazole|mesh-list
5663684|NCT03614455|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-list
5663685|NCT03614455|Antifungal Agents|antifungal agents|mesh-ancestor
5844163|NCT02484053|Rituximab|rituximab|mesh-list
5844164|NCT02484053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6212036|NCT02180867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5663686|NCT03614455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5663687|NCT03614455|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5663688|NCT03614455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5663689|NCT03614455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5663690|NCT03614455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663691|NCT03614455|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5663692|NCT03614455|Hormone Antagonists|hormone antagonists|mesh-ancestor
5663693|NCT03614455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5663694|NCT03614455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844165|NCT02484053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5663695|NCT03614455|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5663696|NCT03614455|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5663697|NCT03614455|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5663698|NCT03614429|Chlorhexidine|chlorhexidine|mesh-list
5663699|NCT03614429|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5663700|NCT03614429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5844166|NCT02484053|Immunologic Factors|immunologic factors|mesh-ancestor
5844167|NCT02484053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844168|NCT02484053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5663701|NCT03614429|Disinfectants|disinfectants|mesh-ancestor
5663702|NCT03614403|Vitamin D|vitamin d|mesh-list
5663703|NCT03614403|Cholecalciferol|cholecalciferol|mesh-list
5663704|NCT03614403|Vitamins|vitamins|mesh-ancestor
5663705|NCT03614403|Micronutrients|micronutrients|mesh-ancestor
5663706|NCT03614403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663707|NCT03614403|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5663708|NCT03614403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5663709|NCT03614273|Epinephrine|epinephrine|mesh-list
5663710|NCT03614273|Racepinephrine|racepinephrine|mesh-list
5663711|NCT03614273|Epinephryl borate|epinephryl borate|mesh-list
5663712|NCT03614273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5663713|NCT03614273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5663714|NCT03614273|Adrenergic Agents|adrenergic agents|mesh-ancestor
5663715|NCT03614273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5663716|NCT03614273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663717|NCT03614273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663718|NCT03614273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5663719|NCT03614273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5663720|NCT03614273|Autonomic Agents|autonomic agents|mesh-ancestor
5663721|NCT03614273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5663722|NCT03614273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5663723|NCT03614273|Respiratory System Agents|respiratory system agents|mesh-ancestor
5663724|NCT03614273|Mydriatics|mydriatics|mesh-ancestor
5663725|NCT03614273|Sympathomimetics|sympathomimetics|mesh-ancestor
5663726|NCT03614273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5663727|NCT03614221|Tacrolimus|tacrolimus|mesh-list
5663728|NCT03614221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5663729|NCT03614221|Immunologic Factors|immunologic factors|mesh-ancestor
5663730|NCT03614221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663731|NCT03614221|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5663732|NCT03614221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5663733|NCT03614221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663734|NCT03614065|Endostar protein|endostar protein|mesh-list
5663735|NCT03614065|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
5663736|NCT03614065|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5663737|NCT03614065|Growth Substances|growth substances|mesh-ancestor
5663738|NCT03614065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663739|NCT03614065|Growth Inhibitors|growth inhibitors|mesh-ancestor
5663740|NCT03614065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5663741|NCT03614052|Tamsulosin|tamsulosin|mesh-list
5663742|NCT03614052|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5663743|NCT03614052|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5844169|NCT02483767|Goserelin|goserelin|mesh-list
5844170|NCT02483767|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5844171|NCT02483767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5844172|NCT02484027|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5844173|NCT02484027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5844174|NCT02484027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5844175|NCT02484027|Antimetabolites|antimetabolites|mesh-ancestor
5844176|NCT02484027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844177|NCT02484027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5844178|NCT02484027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5844179|NCT02484027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5844180|NCT02483715|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5844181|NCT02483715|Amoxicillin|amoxicillin|mesh-list
5844182|NCT02483715|Metronidazole|metronidazole|mesh-list
5844183|NCT02483715|Tetracycline|tetracycline|mesh-list
5844184|NCT02483715|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5844185|NCT02483715|Rabeprazole|rabeprazole|mesh-list
5844186|NCT02483715|Bismuth|bismuth|mesh-list
5844187|NCT02483715|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
5844188|NCT02483715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5663744|NCT03614052|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5663745|NCT03614052|Adrenergic Agents|adrenergic agents|mesh-ancestor
5663746|NCT03614052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5844189|NCT02483715|Antitubercular Agents|antitubercular agents|mesh-ancestor
5844190|NCT02483715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5844191|NCT02483715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5844192|NCT02483715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5844193|NCT02483715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5844194|NCT02483715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5844195|NCT02483715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844196|NCT02483715|Antacids|antacids|mesh-ancestor
5844197|NCT02483715|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5903524|NCT04922593|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5903525|NCT04922593|Dopamine Agents|dopamine agents|mesh-ancestor
5903526|NCT04887857|Azacitidine|azacitidine|mesh-list
5903527|NCT04887857|Venetoclax|venetoclax|mesh-list
5663747|NCT03614052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663748|NCT03614052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663749|NCT03614052|Urological Agents|urological agents|mesh-ancestor
5663750|NCT03613974|Lidocaine|lidocaine|mesh-list
5663751|NCT03613974|Anesthetics, Local|anesthetics, local|mesh-ancestor
5663752|NCT03613974|Anesthetics|anesthetics|mesh-ancestor
5663753|NCT03613974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5663754|NCT03613974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663755|NCT03613974|Sensory System Agents|sensory system agents|mesh-ancestor
5663756|NCT03613974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5663757|NCT03613974|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5663758|NCT03613974|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5663759|NCT03613974|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5663760|NCT03613974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5663761|NCT03613974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663762|NCT03613961|Anesthetics|anesthetics|mesh-list
5663763|NCT03613961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5663764|NCT03613961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663765|NCT03613857|Clopidogrel|clopidogrel|mesh-list
5663766|NCT03613857|Ticagrelor|ticagrelor|mesh-list
5663767|NCT03613857|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5663768|NCT03613857|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5663769|NCT03613857|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5903528|NCT04887857|Cc-486|cc-486|mesh-list
5903529|NCT04887857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5903530|NCT04887857|Antimetabolites|antimetabolites|mesh-ancestor
5903531|NCT04887857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903532|NCT04887857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5903533|NCT04887857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5908411|NCT04570332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5663770|NCT03613857|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5663771|NCT03613857|Purinergic Agents|purinergic agents|mesh-ancestor
5663772|NCT03613857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6493847|NCT00615797|Immunologic Factors|immunologic factors|mesh-ancestor
6493848|NCT00615797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493849|NCT00615797|Antiemetics|antiemetics|mesh-ancestor
6493850|NCT00615797|Autonomic Agents|autonomic agents|mesh-ancestor
6493851|NCT00615797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6493852|NCT00615797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5663773|NCT03613857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663774|NCT03613857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663775|NCT03613792|Fentanyl|fentanyl|mesh-list
5663776|NCT03613792|Midazolam|midazolam|mesh-list
5663777|NCT03613792|Ketamine|ketamine|mesh-list
5663778|NCT03613792|Remifentanil|remifentanil|mesh-list
5663779|NCT03613792|Analgesics|analgesics|mesh-ancestor
5663780|NCT03613792|Sensory System Agents|sensory system agents|mesh-ancestor
5663781|NCT03613792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5908412|NCT04566133|Hydroxychloroquine|hydroxychloroquine|mesh-list
5908413|NCT04566133|Trametinib|trametinib|mesh-list
5908414|NCT04566133|Antimalarials|antimalarials|mesh-ancestor
5908415|NCT04566133|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5908416|NCT04566133|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5908417|NCT04566133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5908418|NCT04566133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5908419|NCT04566133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908420|NCT04566133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5663782|NCT03613792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663783|NCT03613792|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5663784|NCT03613792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5908421|NCT04566133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5908422|NCT04566133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5663785|NCT03613792|Anesthetics, General|anesthetics, general|mesh-ancestor
5663786|NCT03613792|Anesthetics|anesthetics|mesh-ancestor
5663787|NCT03613792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5663788|NCT03613792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5663789|NCT03613792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5663790|NCT03613792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5663791|NCT03613792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663792|NCT03613792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5663793|NCT03613792|Narcotics|narcotics|mesh-ancestor
5844198|NCT02483793|Tamsulosin|tamsulosin|mesh-list
5844199|NCT02483793|Oxybutynin|oxybutynin|mesh-list
5844200|NCT02483793|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5844201|NCT02483793|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5844202|NCT02483793|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5844203|NCT02483793|Adrenergic Agents|adrenergic agents|mesh-ancestor
5844204|NCT02483793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5844205|NCT02483793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844206|NCT02483793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844207|NCT02483793|Urological Agents|urological agents|mesh-ancestor
5844208|NCT02483793|Parasympatholytics|parasympatholytics|mesh-ancestor
5844209|NCT02483793|Autonomic Agents|autonomic agents|mesh-ancestor
5844210|NCT02483793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5844211|NCT02483793|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5844212|NCT02483793|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5844213|NCT02483793|Cholinergic Agents|cholinergic agents|mesh-ancestor
5844214|NCT02483897|Tetracaine|tetracaine|mesh-list
5844215|NCT02483897|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5844216|NCT02483897|Anesthetics, Local|anesthetics, local|mesh-ancestor
5844217|NCT02483897|Anesthetics|anesthetics|mesh-ancestor
5844218|NCT02483897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5844219|NCT02483897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844220|NCT02483897|Sensory System Agents|sensory system agents|mesh-ancestor
5844221|NCT02483897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5844222|NCT02483897|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5663794|NCT03613792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5663795|NCT03613792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5663796|NCT03613792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5663797|NCT03613792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5844223|NCT02483845|Natalizumab|natalizumab|mesh-list
5844224|NCT02483845|Immunologic Factors|immunologic factors|mesh-ancestor
5844225|NCT02483845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844226|NCT02483936|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5844227|NCT02483936|Olmesartan|olmesartan|mesh-list
5844228|NCT02483936|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
5844229|NCT02483936|Chlorthalidone|chlorthalidone|mesh-list
5844230|NCT02483936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5844231|NCT02483936|Diuretics|diuretics|mesh-ancestor
5844232|NCT02483936|Natriuretic Agents|natriuretic agents|mesh-ancestor
5844233|NCT02483936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844234|NCT02483936|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5844235|NCT02483936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5844236|NCT02483936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844237|NCT02483936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5844238|NCT02483936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5844239|NCT02484001|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
5844240|NCT02484001|Anticonvulsants|anticonvulsants|mesh-ancestor
5844241|NCT02484001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5844242|NCT02484001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5844243|NCT02484001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5844244|NCT02484001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844245|NCT02483923|Ropivacaine|ropivacaine|mesh-list
5844246|NCT02483923|Anesthetics, Local|anesthetics, local|mesh-ancestor
5844247|NCT02483923|Anesthetics|anesthetics|mesh-ancestor
5844248|NCT02483923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5844249|NCT02483923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844250|NCT02483923|Sensory System Agents|sensory system agents|mesh-ancestor
5844251|NCT02483923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5844252|NCT02483884|Bombesin|bombesin|mesh-list
5844253|NCT02483884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5844254|NCT02483884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844255|NCT02483884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844256|NCT02483689|Bupivacaine|bupivacaine|mesh-list
5844257|NCT02483689|Anesthetics, Local|anesthetics, local|mesh-list
5844258|NCT02483689|Anesthetics|anesthetics|mesh-list
5663798|NCT03613792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5663799|NCT03613792|GABA Modulators|gaba modulators|mesh-ancestor
5663800|NCT03613792|GABA Agents|gaba agents|mesh-ancestor
5663801|NCT03613753|Irinotecan|irinotecan|mesh-list
5844259|NCT02483689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5844260|NCT02483689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844261|NCT02483689|Sensory System Agents|sensory system agents|mesh-ancestor
5844262|NCT02483689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5844263|NCT02483871|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5844264|NCT02483871|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5844265|NCT02483871|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5844266|NCT02483871|Antimetabolites|antimetabolites|mesh-ancestor
5844267|NCT02483871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844268|NCT02483871|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5844269|NCT02483871|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5844270|NCT02483871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5844271|NCT02483598|Buspirone|buspirone|mesh-list
5844272|NCT02483598|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5844273|NCT02483598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5663802|NCT03613753|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6212037|NCT02180867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6212038|NCT02180867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6212039|NCT02180867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212040|NCT02180867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6212041|NCT02180867|Alkylating Agents|alkylating agents|mesh-ancestor
5663803|NCT03613753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5663804|NCT03613753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5663805|NCT03613753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663806|NCT03613753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5663807|NCT03613597|Etoposide|etoposide|mesh-list
5663808|NCT03613597|Etoposide phosphate|etoposide phosphate|mesh-list
5663809|NCT03613597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5844274|NCT02483598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5844275|NCT02483598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844276|NCT02483598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5844277|NCT02483598|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5844278|NCT02483598|Serotonin Agents|serotonin agents|mesh-ancestor
5844279|NCT02483598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5844280|NCT02483598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844281|NCT02483624|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
5844282|NCT02483624|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5844283|NCT02483624|Protective Agents|protective agents|mesh-ancestor
5844284|NCT02483624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844285|NCT02483624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5663810|NCT03613597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5663811|NCT03613597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5663812|NCT03613597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5844286|NCT02483325|Fludarabine|fludarabine|mesh-list
5844287|NCT02483325|Busulfan|busulfan|mesh-list
5844288|NCT02483325|Thymoglobulin|thymoglobulin|mesh-list
5844289|NCT02483325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5844290|NCT02483325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844291|NCT02483325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5844292|NCT02483325|Immunologic Factors|immunologic factors|mesh-ancestor
5844293|NCT02483325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844294|NCT02483325|Alkylating Agents|alkylating agents|mesh-ancestor
5844295|NCT02483325|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5844296|NCT02483325|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5844297|NCT02483299|Metformin|metformin|mesh-list
5844298|NCT02483299|Liraglutide|liraglutide|mesh-list
5844299|NCT02483299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5844300|NCT02483299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844301|NCT02483299|Incretins|incretins|mesh-ancestor
5844302|NCT02483299|Hormones|hormones|mesh-ancestor
5844303|NCT02483299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5844304|NCT02483182|Acyclovir|acyclovir|mesh-list
5844305|NCT02483182|Antiviral Agents|antiviral agents|mesh-ancestor
5844306|NCT02483182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5844307|NCT02483130|Acetylcysteine|acetylcysteine|mesh-list
5844308|NCT02483130|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5844309|NCT02483130|Antiviral Agents|antiviral agents|mesh-ancestor
5844310|NCT02483130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5844311|NCT02483130|Expectorants|expectorants|mesh-ancestor
5844312|NCT02483130|Respiratory System Agents|respiratory system agents|mesh-ancestor
5663813|NCT03613597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5844313|NCT02483130|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5844314|NCT02483130|Antioxidants|antioxidants|mesh-ancestor
5844315|NCT02483130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844316|NCT02483130|Protective Agents|protective agents|mesh-ancestor
5844317|NCT02483130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844318|NCT02483130|Antidotes|antidotes|mesh-ancestor
5844319|NCT02483143|Acetylcysteine|acetylcysteine|mesh-list
5844320|NCT02483143|Antiviral Agents|antiviral agents|mesh-ancestor
5844321|NCT02483143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5844322|NCT02483143|Expectorants|expectorants|mesh-ancestor
5844323|NCT02483143|Respiratory System Agents|respiratory system agents|mesh-ancestor
5844324|NCT02483143|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5844325|NCT02483143|Antioxidants|antioxidants|mesh-ancestor
5844326|NCT02483143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844327|NCT02483143|Protective Agents|protective agents|mesh-ancestor
5663814|NCT03613597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663815|NCT03613558|Dexmedetomidine|dexmedetomidine|mesh-list
5663816|NCT03613558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5663817|NCT03613558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5663818|NCT03613558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493853|NCT00615797|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6493854|NCT00615797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6493855|NCT00615797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6493856|NCT00615797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6493857|NCT00615797|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6493858|NCT00615797|Dopamine Agents|dopamine agents|mesh-ancestor
6493859|NCT00615797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6493860|NCT00615797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493861|NCT00615797|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6493862|NCT00615797|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5663819|NCT03613558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5663820|NCT03613558|Analgesics|analgesics|mesh-ancestor
5663821|NCT03613558|Sensory System Agents|sensory system agents|mesh-ancestor
5663822|NCT03613558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5663823|NCT03613558|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5663824|NCT03613558|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5663825|NCT03613558|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5663826|NCT03613558|Adrenergic Agents|adrenergic agents|mesh-ancestor
5663827|NCT03613558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5663828|NCT03613558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493863|NCT00615797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6493864|NCT00615810|Efavirenz|efavirenz|mesh-list
6493865|NCT00615810|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6674666|NCT01570790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6674667|NCT01570790|Tubulin Modulators|tubulin modulators|mesh-ancestor
6674668|NCT01570790|Antimitotic Agents|antimitotic agents|mesh-ancestor
5844328|NCT02483143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844329|NCT02483169|Aspirin|aspirin|mesh-list
5844330|NCT02483169|Cilostazol|cilostazol|mesh-list
5844331|NCT02483169|Probucol|probucol|mesh-list
5844332|NCT02483169|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5844333|NCT02483169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5844334|NCT02483169|Analgesics|analgesics|mesh-ancestor
5844335|NCT02483169|Sensory System Agents|sensory system agents|mesh-ancestor
5844336|NCT02483169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5844337|NCT02483169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844338|NCT02483169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5844339|NCT02483169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5844340|NCT02483169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5844341|NCT02483169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5844342|NCT02483169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844343|NCT02483169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6674669|NCT01570790|Mitosis Modulators|mitosis modulators|mesh-ancestor
5663829|NCT03613545|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5663830|NCT03613545|Rifaximin|rifaximin|mesh-list
5663831|NCT03613545|Antidepressive Agents|antidepressive agents|mesh-list
5663832|NCT03613545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5663833|NCT03613545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5663834|NCT03613545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5663835|NCT03613428|Prednisone|prednisone|mesh-list
5663836|NCT03613428|Vincristine|vincristine|mesh-list
5663837|NCT03613428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5663838|NCT03613428|Glucocorticoids|glucocorticoids|mesh-ancestor
5844344|NCT02483169|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5844345|NCT02483169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5844346|NCT02483169|Antipyretics|antipyretics|mesh-ancestor
5844347|NCT02483169|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5844348|NCT02483169|Autonomic Agents|autonomic agents|mesh-ancestor
5844349|NCT02483169|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5844350|NCT02483169|Respiratory System Agents|respiratory system agents|mesh-ancestor
5844351|NCT02483169|Vasodilator Agents|vasodilator agents|mesh-ancestor
5844352|NCT02483169|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5844353|NCT02483169|Protective Agents|protective agents|mesh-ancestor
5844354|NCT02483169|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5844355|NCT02483169|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5844356|NCT02483169|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5844357|NCT02483169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5844358|NCT02483169|Antimetabolites|antimetabolites|mesh-ancestor
5844359|NCT02483169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5844360|NCT02483169|Antioxidants|antioxidants|mesh-ancestor
5844361|NCT02483156|Ribavirin|ribavirin|mesh-list
5844362|NCT02483156|Sofosbuvir|sofosbuvir|mesh-list
5844363|NCT02483156|Antimetabolites|antimetabolites|mesh-ancestor
5663839|NCT03613428|Hormones|hormones|mesh-ancestor
5663840|NCT03613428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5663841|NCT03613428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663842|NCT03613428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5663843|NCT03613428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5844364|NCT02483156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844365|NCT02483156|Antiviral Agents|antiviral agents|mesh-ancestor
5844366|NCT02483156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5844367|NCT02483221|Morphine|morphine|mesh-list
5844368|NCT02483221|Hydromorphone|hydromorphone|mesh-list
5844369|NCT02483221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5844370|NCT02483221|Narcotics|narcotics|mesh-ancestor
5844371|NCT02483221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5844372|NCT02483221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844373|NCT02483221|Analgesics|analgesics|mesh-ancestor
5844374|NCT02483221|Sensory System Agents|sensory system agents|mesh-ancestor
5844375|NCT02483221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5844376|NCT02483195|Minoxidil|minoxidil|mesh-list
5844377|NCT02483195|Spironolactone|spironolactone|mesh-list
5844378|NCT02483195|Finasteride|finasteride|mesh-list
5844379|NCT02483195|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5844380|NCT02483195|Hormone Antagonists|hormone antagonists|mesh-ancestor
5844381|NCT02483195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5844382|NCT02483195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844383|NCT02483195|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5844384|NCT02483195|Diuretics|diuretics|mesh-ancestor
5844385|NCT02483195|Natriuretic Agents|natriuretic agents|mesh-ancestor
5844386|NCT02483195|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
5844387|NCT02483195|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5844388|NCT02483195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5844389|NCT02483195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844390|NCT02483195|Urological Agents|urological agents|mesh-ancestor
5844391|NCT02483195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5844392|NCT02483195|Vasodilator Agents|vasodilator agents|mesh-ancestor
5844393|NCT02483260|Ribavirin|ribavirin|mesh-list
5844394|NCT02483260|Antimetabolites|antimetabolites|mesh-ancestor
5663844|NCT03613428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5663845|NCT03613428|Tubulin Modulators|tubulin modulators|mesh-ancestor
5663846|NCT03613428|Antimitotic Agents|antimitotic agents|mesh-ancestor
5663847|NCT03613428|Mitosis Modulators|mitosis modulators|mesh-ancestor
5663848|NCT03613428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663849|NCT03613389|Vitamin E|vitamin e|mesh-list
5663850|NCT03613389|Vitamins|vitamins|mesh-ancestor
5663851|NCT03613389|Micronutrients|micronutrients|mesh-ancestor
5663852|NCT03613389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663853|NCT03613389|Antioxidants|antioxidants|mesh-ancestor
5663854|NCT03613389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663855|NCT03613389|Protective Agents|protective agents|mesh-ancestor
5663856|NCT03613259|Alovudine|alovudine|mesh-list
5663857|NCT03613259|Antiviral Agents|antiviral agents|mesh-ancestor
5844395|NCT02483260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844396|NCT02483260|Antiviral Agents|antiviral agents|mesh-ancestor
5844397|NCT02483260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5844398|NCT02483026|Vitamin D|vitamin d|mesh-list
5844399|NCT02483026|Vitamins|vitamins|mesh-list
5844400|NCT02483026|Micronutrients|micronutrients|mesh-ancestor
5844401|NCT02483026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844402|NCT02483026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5844403|NCT02483078|Leronlimab|leronlimab|mesh-list
5844404|NCT02483078|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5844405|NCT02483078|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5844406|NCT02483078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844407|NCT02483078|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5844408|NCT02483078|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5844409|NCT02483078|Antiviral Agents|antiviral agents|mesh-ancestor
5844410|NCT02483078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5844411|NCT02483104|Paclitaxel|paclitaxel|mesh-list
5844412|NCT02483104|Carboplatin|carboplatin|mesh-list
5844413|NCT02483104|Veliparib|veliparib|mesh-list
5844414|NCT02483104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5844415|NCT02483104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5844416|NCT02483104|Tubulin Modulators|tubulin modulators|mesh-ancestor
5844417|NCT02483104|Antimitotic Agents|antimitotic agents|mesh-ancestor
5844418|NCT02483104|Mitosis Modulators|mitosis modulators|mesh-ancestor
5844419|NCT02483104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844420|NCT02483104|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5844421|NCT02483104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5844422|NCT02482740|Tamoxifen|tamoxifen|mesh-list
5844423|NCT02482740|Letrozole|letrozole|mesh-list
5844424|NCT02482740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5844425|NCT02482740|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5844426|NCT02482740|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5844427|NCT02482740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5844428|NCT02482740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844429|NCT02482740|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5844430|NCT02482740|Hormone Antagonists|hormone antagonists|mesh-ancestor
5844431|NCT02482740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5844432|NCT02482740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674670|NCT01570790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674671|NCT01570894|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6674672|NCT01570894|Antidepressive Agents|antidepressive agents|mesh-ancestor
6674673|NCT01570894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6674674|NCT01570894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6674675|NCT01570894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5663858|NCT03613259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5663859|NCT03613207|Lidocaine|lidocaine|mesh-list
5663860|NCT03613207|Prilocaine|prilocaine|mesh-list
5663861|NCT03613207|Anesthetics, Local|anesthetics, local|mesh-ancestor
5663862|NCT03613207|Anesthetics|anesthetics|mesh-ancestor
5663863|NCT03613207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5663864|NCT03613207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663865|NCT03613207|Sensory System Agents|sensory system agents|mesh-ancestor
5663866|NCT03613207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5663867|NCT03613207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5663868|NCT03613207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5663869|NCT03613207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5663870|NCT03613207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5663871|NCT03613207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663872|NCT03613168|Trastuzumab|trastuzumab|mesh-list
5663873|NCT03613168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5663874|NCT03613168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5695529|NCT03388853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5695530|NCT03388853|Expectorants|expectorants|mesh-ancestor
5695531|NCT03388853|Respiratory System Agents|respiratory system agents|mesh-ancestor
5695532|NCT03388853|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6674676|NCT01570894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6674677|NCT01570894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674678|NCT01570907|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6674679|NCT01570907|Antidepressive Agents|antidepressive agents|mesh-ancestor
6674680|NCT01570907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5695533|NCT03388853|Antioxidants|antioxidants|mesh-ancestor
5695534|NCT03388853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695535|NCT03388853|Protective Agents|protective agents|mesh-ancestor
5695536|NCT03388853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695537|NCT03388853|Antidotes|antidotes|mesh-ancestor
5695538|NCT03388853|Antitussive Agents|antitussive agents|mesh-ancestor
5695539|NCT03388853|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5695540|NCT03388853|Autonomic Agents|autonomic agents|mesh-ancestor
5695541|NCT03388853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5695542|NCT03388853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5695543|NCT03388853|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5695544|NCT03388853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5695545|NCT03388827|Misoprostol|misoprostol|mesh-list
6212042|NCT02181075|Doxorubicin|doxorubicin|mesh-list
6212043|NCT02181075|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6212044|NCT02181075|Liver Extracts|liver extracts|mesh-list
5663878|NCT03612960|Nicotine|nicotine|mesh-list
5663879|NCT03612960|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5663880|NCT03612960|Autonomic Agents|autonomic agents|mesh-ancestor
5663881|NCT03612960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5663882|NCT03612960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663883|NCT03612960|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5663884|NCT03612960|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5663885|NCT03612960|Cholinergic Agents|cholinergic agents|mesh-ancestor
5663886|NCT03612960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5663887|NCT03612960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663888|NCT03612947|Magnesium Sulfate|magnesium sulfate|mesh-list
5663889|NCT03612947|Bupivacaine|bupivacaine|mesh-list
5663890|NCT03612947|Anesthetics, Local|anesthetics, local|mesh-ancestor
5663891|NCT03612947|Anesthetics|anesthetics|mesh-ancestor
5663892|NCT03612947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5663893|NCT03612947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663894|NCT03612947|Sensory System Agents|sensory system agents|mesh-ancestor
5663895|NCT03612947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5663896|NCT03612947|Analgesics|analgesics|mesh-ancestor
5663897|NCT03612947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5663898|NCT03612947|Anticonvulsants|anticonvulsants|mesh-ancestor
5663899|NCT03612947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5663900|NCT03612947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5663901|NCT03612947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663902|NCT03612947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5663903|NCT03612947|Tocolytic Agents|tocolytic agents|mesh-ancestor
5663904|NCT03612947|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5663905|NCT03612817|Timolol|timolol|mesh-list
5663906|NCT03612817|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5663907|NCT03612817|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5663908|NCT03612817|Adrenergic Agents|adrenergic agents|mesh-ancestor
5663909|NCT03612817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5663910|NCT03612817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663911|NCT03612817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663912|NCT03612817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5663913|NCT03612817|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5663914|NCT03612791|Atezolizumab|atezolizumab|mesh-list
5663915|NCT03612791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5663916|NCT03612739|Azacitidine|azacitidine|mesh-list
5663917|NCT03612739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5663918|NCT03612739|Antimetabolites|antimetabolites|mesh-ancestor
5663919|NCT03612739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663920|NCT03612739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5844433|NCT02482740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5844434|NCT02482740|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5844435|NCT02482740|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5844436|NCT02482740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5844437|NCT02482766|Poractant alfa|poractant alfa|mesh-list
5844438|NCT02482766|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
5844439|NCT02482766|Respiratory System Agents|respiratory system agents|mesh-ancestor
5844440|NCT02482857|Aspirin|aspirin|mesh-list
5844441|NCT02482857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5844442|NCT02482857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5844443|NCT02482857|Analgesics|analgesics|mesh-ancestor
5844444|NCT02482857|Sensory System Agents|sensory system agents|mesh-ancestor
5844445|NCT02482857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5844446|NCT02482857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844447|NCT02482857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5844448|NCT02482857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5844449|NCT02482857|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5844450|NCT02482857|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5844451|NCT02482857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844452|NCT02482857|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5844453|NCT02482857|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5663921|NCT03612739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5663922|NCT03612557|Penicillins|penicillins|mesh-list
5663923|NCT03612557|Penicillin G|penicillin g|mesh-list
5663924|NCT03612557|Penicillin G Benzathine|penicillin g benzathine|mesh-list
5663925|NCT03612557|Penicillin G Procaine|penicillin g procaine|mesh-list
5663926|NCT03612557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5663927|NCT03612557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5844454|NCT02482857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5844455|NCT02482857|Antipyretics|antipyretics|mesh-ancestor
5844456|NCT02482961|Colistin|colistin|mesh-list
5844457|NCT02482961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5844458|NCT02482961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5844459|NCT02482818|Pregabalin|pregabalin|mesh-list
5844460|NCT02482818|Analgesics|analgesics|mesh-ancestor
5844461|NCT02482818|Sensory System Agents|sensory system agents|mesh-ancestor
5844462|NCT02482818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5844463|NCT02482818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844464|NCT02482818|Anticonvulsants|anticonvulsants|mesh-ancestor
5844465|NCT02482818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5844466|NCT02482818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5844467|NCT02482818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844468|NCT02482818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5844469|NCT02482818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5844470|NCT02482818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5844471|NCT02482818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5844472|NCT02482818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5844473|NCT02482649|Methylphenidate|methylphenidate|mesh-list
5844474|NCT02482649|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
5844475|NCT02482649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5844476|NCT02482649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844477|NCT02482649|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5844478|NCT02482649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6674681|NCT01570907|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6674682|NCT01570907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6674683|NCT01570907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6674684|NCT01570907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674685|NCT01570959|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6674686|NCT01570959|Antidepressive Agents|antidepressive agents|mesh-ancestor
6674687|NCT01570959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5663928|NCT03612492|Lidocaine|lidocaine|mesh-list
5663929|NCT03612492|Anesthetics, Local|anesthetics, local|mesh-list
5663930|NCT03612492|Anesthetics|anesthetics|mesh-list
5663931|NCT03612492|Esmolol|esmolol|mesh-list
5663932|NCT03612492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5663933|NCT03612492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663934|NCT03612492|Sensory System Agents|sensory system agents|mesh-ancestor
5663935|NCT03612492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5663936|NCT03612492|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5663937|NCT03612492|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5663938|NCT03612492|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6674688|NCT01570959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6674689|NCT01570959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6674690|NCT01570959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6674691|NCT01570959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674692|NCT01570985|Triamcinolone|triamcinolone|mesh-list
6674693|NCT01570985|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6674694|NCT01570985|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5663939|NCT03612492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5663940|NCT03612492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663941|NCT03612492|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5663942|NCT03612492|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5663943|NCT03612492|Adrenergic Agents|adrenergic agents|mesh-ancestor
5663944|NCT03612492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5663945|NCT03612492|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5663946|NCT03612440|Dexmedetomidine|dexmedetomidine|mesh-list
5663947|NCT03612440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5663948|NCT03612440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5663949|NCT03612440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674695|NCT01570985|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6674696|NCT01570985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6674697|NCT01570985|Glucocorticoids|glucocorticoids|mesh-ancestor
6674698|NCT01570985|Hormones|hormones|mesh-ancestor
6674699|NCT01570985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6674700|NCT01570985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674701|NCT01570985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6674702|NCT01570985|Immunologic Factors|immunologic factors|mesh-ancestor
5663950|NCT03612440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5663951|NCT03612440|Analgesics|analgesics|mesh-ancestor
5663952|NCT03612440|Sensory System Agents|sensory system agents|mesh-ancestor
5663953|NCT03612440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5844479|NCT02482649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5844480|NCT02482649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844481|NCT02482649|Dopamine Agents|dopamine agents|mesh-ancestor
5844482|NCT02482649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5844483|NCT02482649|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5663954|NCT03612440|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5663955|NCT03612440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5663956|NCT03612440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5663957|NCT03612440|Adrenergic Agents|adrenergic agents|mesh-ancestor
5663958|NCT03612440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5663959|NCT03612440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663960|NCT03612401|Mirabegron|mirabegron|mesh-list
5663961|NCT03612401|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
5663962|NCT03612401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5663963|NCT03612401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5663964|NCT03612401|Adrenergic Agents|adrenergic agents|mesh-ancestor
5663965|NCT03612401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5663966|NCT03612401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663967|NCT03612401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663968|NCT03612401|Urological Agents|urological agents|mesh-ancestor
5663969|NCT03612349|Menthol|menthol|mesh-list
5663970|NCT03612349|Antipruritics|antipruritics|mesh-ancestor
5663971|NCT03612349|Dermatologic Agents|dermatologic agents|mesh-ancestor
5663972|NCT03612323|Piroxicam|piroxicam|mesh-list
5663973|NCT03612323|Carticaine|carticaine|mesh-list
5844484|NCT02482649|Adrenergic Agents|adrenergic agents|mesh-ancestor
5844485|NCT02482636|Vaccines|vaccines|mesh-list
5844486|NCT02482636|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5844487|NCT02482636|Immunologic Factors|immunologic factors|mesh-ancestor
5844488|NCT02482636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903534|NCT04884412|Anesthetics|anesthetics|mesh-list
5903535|NCT04884412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5903536|NCT04884412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903537|NCT04868409|Rocuronium|rocuronium|mesh-list
5903538|NCT04868409|Succinylcholine|succinylcholine|mesh-list
5903539|NCT04868409|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5903540|NCT04868409|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5903541|NCT04868409|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5903542|NCT04868409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5903543|NCT04868409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903544|NCT04868409|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
5903545|NCT04862975|Tenofovir|tenofovir|mesh-list
5903546|NCT04862975|Emtricitabine|emtricitabine|mesh-list
5903547|NCT04862975|Efavirenz|efavirenz|mesh-list
5903548|NCT04862975|Dolutegravir|dolutegravir|mesh-list
5903549|NCT04862975|Antiviral Agents|antiviral agents|mesh-ancestor
5903550|NCT04862975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5903551|NCT04862975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5903552|NCT04862975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5903553|NCT04862975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5903554|NCT04862975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903555|NCT04862975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5903556|NCT04862975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5903557|NCT04862975|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5903558|NCT04862975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5903559|NCT04862975|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5903560|NCT04862975|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5903561|NCT04862975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5903562|NCT04862975|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5903563|NCT04862975|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5903564|NCT04862975|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5903565|NCT04860960|Betadex|betadex|mesh-list
5903566|NCT04860960|Sequestering Agents|sequestering agents|mesh-ancestor
5903567|NCT04860960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903568|NCT04859465|Doxorubicin|doxorubicin|mesh-list
5903569|NCT04859465|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5903570|NCT04859465|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5903571|NCT04859465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5903572|NCT04859465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5903573|NCT04859465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5903574|NCT04859465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5903575|NCT04859465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5903576|NCT04859465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903577|NCT04798755|Adalimumab|adalimumab|mesh-list
5844489|NCT02482311|Adavosertib|adavosertib|mesh-list
5844490|NCT02482311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5844491|NCT02482311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844492|NCT02482272|Lamivudine|lamivudine|mesh-list
5844493|NCT02482272|Adefovir|adefovir|mesh-list
5844494|NCT02482272|Entecavir|entecavir|mesh-list
5844495|NCT02482272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5844496|NCT02482272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5844497|NCT02482272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5844498|NCT02482272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844499|NCT02482272|Antiviral Agents|antiviral agents|mesh-ancestor
5844500|NCT02482272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5844501|NCT02482272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5844502|NCT02482272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5844503|NCT02482402|Iloprost|iloprost|mesh-list
5844504|NCT02482402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5844505|NCT02482402|Vasodilator Agents|vasodilator agents|mesh-ancestor
5844506|NCT02482077|Sofosbuvir|sofosbuvir|mesh-list
5844507|NCT02482077|Antiviral Agents|antiviral agents|mesh-ancestor
5844508|NCT02482077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5844509|NCT02482207|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5844510|NCT02482207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5844511|NCT02482207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5844512|NCT02482207|Antimetabolites|antimetabolites|mesh-ancestor
5844513|NCT02482207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844514|NCT02482207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5844515|NCT02482207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5844516|NCT02482207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5844517|NCT02482155|Ibuprofen|ibuprofen|mesh-list
5844518|NCT02482155|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5844519|NCT02482155|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5844520|NCT02482155|Analgesics|analgesics|mesh-ancestor
5844521|NCT02482155|Sensory System Agents|sensory system agents|mesh-ancestor
5844522|NCT02482155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5844523|NCT02482155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844524|NCT02482155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5844525|NCT02482155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5844526|NCT02482155|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5844527|NCT02482155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5844528|NCT02482155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844529|NCT02482090|Cyclophosphamide|cyclophosphamide|mesh-list
5844530|NCT02482090|Fludarabine|fludarabine|mesh-list
5844531|NCT02482090|Interleukin-2|interleukin-2|mesh-list
5844532|NCT02482090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5844533|NCT02482090|Immunologic Factors|immunologic factors|mesh-ancestor
5844534|NCT02482090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844535|NCT02482090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5844536|NCT02482090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5844537|NCT02482090|Alkylating Agents|alkylating agents|mesh-ancestor
5844538|NCT02482090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844539|NCT02482090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5844540|NCT02482090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5844541|NCT02482090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5663974|NCT03612323|Anesthetics, Local|anesthetics, local|mesh-ancestor
5663975|NCT03612323|Anesthetics|anesthetics|mesh-ancestor
5663976|NCT03612323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5663977|NCT03612323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5663978|NCT03612323|Sensory System Agents|sensory system agents|mesh-ancestor
5663979|NCT03612323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5663980|NCT03612323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5663981|NCT03612323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5663982|NCT03612323|Analgesics|analgesics|mesh-ancestor
5663983|NCT03612323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5844542|NCT02482090|Analgesics|analgesics|mesh-ancestor
5663984|NCT03612323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5663985|NCT03612323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5663986|NCT03612323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5663987|NCT03612323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663988|NCT03612297|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5663989|NCT03612297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5663990|NCT03612219|Apatinib|apatinib|mesh-list
5844543|NCT02482090|Sensory System Agents|sensory system agents|mesh-ancestor
5844544|NCT02482090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5844545|NCT02482324|Ibuprofen|ibuprofen|mesh-list
5903578|NCT04798755|Methotrexate|methotrexate|mesh-list
5844546|NCT02482324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5844547|NCT02482324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5844548|NCT02482324|Analgesics|analgesics|mesh-ancestor
5844549|NCT02482324|Sensory System Agents|sensory system agents|mesh-ancestor
5844550|NCT02482324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5844551|NCT02482324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844552|NCT02482324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5844553|NCT02482324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5844554|NCT02482324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5844555|NCT02482324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5844556|NCT02482324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844557|NCT02481960|Irinotecan|irinotecan|mesh-list
5844558|NCT02481960|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5844559|NCT02481960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5844560|NCT02481960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6493866|NCT00615810|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6493867|NCT00615810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6493868|NCT00615810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6493869|NCT00615810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493870|NCT00615810|Antiviral Agents|antiviral agents|mesh-ancestor
6493871|NCT00615810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6493872|NCT00615810|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6493873|NCT00615810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5844561|NCT02481960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844562|NCT02481960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5844563|NCT02481791|Remifentanil|remifentanil|mesh-list
5844564|NCT02481791|Propofol|propofol|mesh-list
5844565|NCT02481791|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5844566|NCT02481791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5663991|NCT03612219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5663992|NCT03612219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5663993|NCT03612219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5663994|NCT03612219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5663995|NCT03612180|Metoprolol|metoprolol|mesh-list
5663996|NCT03612180|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5663997|NCT03612180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5663998|NCT03612180|Sympatholytics|sympatholytics|mesh-ancestor
5663999|NCT03612180|Autonomic Agents|autonomic agents|mesh-ancestor
5664000|NCT03612180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5664001|NCT03612180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664002|NCT03612180|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5664003|NCT03612180|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5664004|NCT03612180|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5844567|NCT02481791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844568|NCT02481791|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5844569|NCT02481791|Anesthetics, General|anesthetics, general|mesh-ancestor
5844570|NCT02481791|Anesthetics|anesthetics|mesh-ancestor
5844571|NCT02481791|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5844572|NCT02481791|Narcotics|narcotics|mesh-ancestor
5844573|NCT02481791|Analgesics|analgesics|mesh-ancestor
5844574|NCT02481791|Sensory System Agents|sensory system agents|mesh-ancestor
5844575|NCT02481791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5664005|NCT03612180|Adrenergic Agents|adrenergic agents|mesh-ancestor
5664006|NCT03612180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5664007|NCT03612180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844576|NCT02481726|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5844577|NCT02481726|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5844578|NCT02481726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664008|NCT03612037|Thioctic Acid|thioctic acid|mesh-list
5664009|NCT03612037|Antioxidants|antioxidants|mesh-ancestor
5664010|NCT03612037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664011|NCT03612037|Protective Agents|protective agents|mesh-ancestor
5664012|NCT03612037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664013|NCT03612037|Vitamin B Complex|vitamin b complex|mesh-ancestor
5664014|NCT03612037|Vitamins|vitamins|mesh-ancestor
5664015|NCT03612037|Micronutrients|micronutrients|mesh-ancestor
5664016|NCT03611985|Taxane|taxane|mesh-list
5664017|NCT03611985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5664018|NCT03611920|Tetracycline|tetracycline|mesh-list
5664019|NCT03611920|Dexamethasone|dexamethasone|mesh-list
5664020|NCT03611920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5664021|NCT03611920|Antiemetics|antiemetics|mesh-ancestor
5664022|NCT03611920|Autonomic Agents|autonomic agents|mesh-ancestor
5664023|NCT03611920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5664024|NCT03611920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664025|NCT03611920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5664026|NCT03611920|Glucocorticoids|glucocorticoids|mesh-ancestor
5664027|NCT03611920|Hormones|hormones|mesh-ancestor
5664028|NCT03611920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5664029|NCT03611920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5664030|NCT03611920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5664031|NCT03611920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5664032|NCT03611920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5664033|NCT03611920|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5664034|NCT03611920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5664035|NCT03611920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664036|NCT03611595|Tretinoin|tretinoin|mesh-list
5664037|NCT03611595|Isotretinoin|isotretinoin|mesh-list
5664038|NCT03611595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5664039|NCT03611595|Keratolytic Agents|keratolytic agents|mesh-ancestor
5664040|NCT03611595|Dermatologic Agents|dermatologic agents|mesh-ancestor
5844579|NCT02481635|Gemcitabine|gemcitabine|mesh-list
5844580|NCT02481635|Paclitaxel|paclitaxel|mesh-list
5844581|NCT02481635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5844582|NCT02481635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5844583|NCT02481635|Tubulin Modulators|tubulin modulators|mesh-ancestor
5844584|NCT02481635|Antimitotic Agents|antimitotic agents|mesh-ancestor
5844585|NCT02481635|Mitosis Modulators|mitosis modulators|mesh-ancestor
5844586|NCT02481635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844587|NCT02481635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5844588|NCT02481635|Antimetabolites|antimetabolites|mesh-ancestor
5844589|NCT02481635|Antiviral Agents|antiviral agents|mesh-ancestor
5844590|NCT02481635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5664041|NCT03611556|Leucovorin|leucovorin|mesh-list
5664042|NCT03611556|Gemcitabine|gemcitabine|mesh-list
5664043|NCT03611556|Paclitaxel|paclitaxel|mesh-list
5664044|NCT03611556|Oxaliplatin|oxaliplatin|mesh-list
5664045|NCT03611556|Fluorouracil|fluorouracil|mesh-list
5664046|NCT03611556|Durvalumab|durvalumab|mesh-list
5664047|NCT03611556|Levoleucovorin|levoleucovorin|mesh-list
5664048|NCT03611556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5664049|NCT03611556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5664050|NCT03611556|Tubulin Modulators|tubulin modulators|mesh-ancestor
5664051|NCT03611556|Antimitotic Agents|antimitotic agents|mesh-ancestor
5664052|NCT03611556|Mitosis Modulators|mitosis modulators|mesh-ancestor
5664053|NCT03611556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664054|NCT03611556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5664055|NCT03611556|Antimetabolites|antimetabolites|mesh-ancestor
5664056|NCT03611556|Antiviral Agents|antiviral agents|mesh-ancestor
6212045|NCT02181075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6212046|NCT02181075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6212047|NCT02181075|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6212048|NCT02181075|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6212049|NCT02181075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5664057|NCT03611556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5664058|NCT03611556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5664059|NCT03611556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5664060|NCT03611556|Immunologic Factors|immunologic factors|mesh-ancestor
5664061|NCT03611556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664062|NCT03611556|Antidotes|antidotes|mesh-ancestor
5664063|NCT03611556|Protective Agents|protective agents|mesh-ancestor
5664064|NCT03611556|Vitamin B Complex|vitamin b complex|mesh-ancestor
5664065|NCT03611556|Vitamins|vitamins|mesh-ancestor
5664066|NCT03611556|Micronutrients|micronutrients|mesh-ancestor
5664067|NCT03611556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5844591|NCT02481635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5844592|NCT02481635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5844593|NCT02481635|Immunologic Factors|immunologic factors|mesh-ancestor
5844594|NCT02481635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844595|NCT02481609|Acetylcysteine|acetylcysteine|mesh-list
5844596|NCT02481609|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5844597|NCT02481609|Antiviral Agents|antiviral agents|mesh-ancestor
5844598|NCT02481609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5844599|NCT02481609|Expectorants|expectorants|mesh-ancestor
5844600|NCT02481609|Respiratory System Agents|respiratory system agents|mesh-ancestor
5844601|NCT02481609|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5844602|NCT02481609|Antioxidants|antioxidants|mesh-ancestor
5844603|NCT02481609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674703|NCT01570985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5664068|NCT03611530|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5664069|NCT03611530|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5844604|NCT02481609|Protective Agents|protective agents|mesh-ancestor
5844605|NCT02481609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844606|NCT02481609|Antidotes|antidotes|mesh-ancestor
5844607|NCT02481453|Sirolimus|sirolimus|mesh-list
5844608|NCT02481453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5844609|NCT02481453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5844610|NCT02481453|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5844611|NCT02481453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5844612|NCT02481453|Antifungal Agents|antifungal agents|mesh-ancestor
5844613|NCT02481453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5844614|NCT02481453|Immunologic Factors|immunologic factors|mesh-ancestor
5664070|NCT03611504|Hemostatics|hemostatics|mesh-list
5664071|NCT03611504|Coagulants|coagulants|mesh-ancestor
5664072|NCT03611491|Lidocaine|lidocaine|mesh-list
5664073|NCT03611491|Anesthetics, Local|anesthetics, local|mesh-ancestor
5664074|NCT03611491|Anesthetics|anesthetics|mesh-ancestor
5664075|NCT03611491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5664076|NCT03611491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664077|NCT03611491|Sensory System Agents|sensory system agents|mesh-ancestor
5664078|NCT03611491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5664079|NCT03611491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5664080|NCT03611491|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5664081|NCT03611491|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5664082|NCT03611491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5664083|NCT03611491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664084|NCT03611426|Thrombin|thrombin|mesh-list
5664085|NCT03611426|Hemostatics|hemostatics|mesh-ancestor
5664086|NCT03611426|Coagulants|coagulants|mesh-ancestor
5664087|NCT03611348|Latanoprost|latanoprost|mesh-list
5664088|NCT03611348|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5664089|NCT03611348|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5844615|NCT02481453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844616|NCT02481323|Cilostazol|cilostazol|mesh-list
5844617|NCT02481323|Isosorbide|isosorbide|mesh-list
5844618|NCT02481323|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
5844619|NCT02481323|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
5844620|NCT02481323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5844621|NCT02481323|Autonomic Agents|autonomic agents|mesh-ancestor
5844622|NCT02481323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5844623|NCT02481323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844624|NCT02481323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5844625|NCT02481323|Respiratory System Agents|respiratory system agents|mesh-ancestor
5844626|NCT02481323|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5844627|NCT02481323|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5844628|NCT02481323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844629|NCT02481323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5844630|NCT02481323|Vasodilator Agents|vasodilator agents|mesh-ancestor
5844631|NCT02481323|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5844632|NCT02481323|Protective Agents|protective agents|mesh-ancestor
5844633|NCT02481323|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5844634|NCT02481323|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5844635|NCT02481323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5844636|NCT02481323|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5844637|NCT02481323|Diuretics|diuretics|mesh-ancestor
5844638|NCT02481323|Natriuretic Agents|natriuretic agents|mesh-ancestor
5844639|NCT02481323|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5844640|NCT02481479|Saxagliptin|saxagliptin|mesh-list
5844641|NCT02481479|Incretins|incretins|mesh-ancestor
5844642|NCT02481479|Hormones|hormones|mesh-ancestor
5844643|NCT02481479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5844644|NCT02481479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844645|NCT02481479|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5844646|NCT02481479|Protease Inhibitors|protease inhibitors|mesh-ancestor
5664090|NCT03611244|Benzocaine|benzocaine|mesh-list
5664091|NCT03611244|Anesthetics, Local|anesthetics, local|mesh-ancestor
5664092|NCT03611244|Anesthetics|anesthetics|mesh-ancestor
5664093|NCT03611244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5664094|NCT03611244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664095|NCT03611244|Sensory System Agents|sensory system agents|mesh-ancestor
5664096|NCT03611244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5664097|NCT03611179|Bevacizumab|bevacizumab|mesh-list
5664098|NCT03611179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5664099|NCT03611179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5664100|NCT03611179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5844647|NCT02481479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5844648|NCT02481479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844649|NCT02481479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5844650|NCT02481193|Cisatracurium|cisatracurium|mesh-list
5844651|NCT02481193|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5844652|NCT02481193|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5844653|NCT02481193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5844654|NCT02481193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844655|NCT02481180|T0001|t0001|mesh-list
5844656|NCT02481180|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
5844657|NCT02481180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844658|NCT02481180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5844659|NCT02481180|Immunologic Factors|immunologic factors|mesh-ancestor
5844660|NCT02480946|Methotrexate|methotrexate|mesh-list
5844661|NCT02480946|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5844662|NCT02480946|Abortifacient Agents|abortifacient agents|mesh-ancestor
5844663|NCT02480946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5844664|NCT02480946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664101|NCT03611179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5664102|NCT03611179|Growth Substances|growth substances|mesh-ancestor
5664103|NCT03611179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664104|NCT03611179|Growth Inhibitors|growth inhibitors|mesh-ancestor
5664105|NCT03611049|Vitamin D|vitamin d|mesh-list
5664106|NCT03611049|Ergocalciferols|ergocalciferols|mesh-list
5664107|NCT03611049|Cholecalciferol|cholecalciferol|mesh-list
5664108|NCT03611049|Vitamins|vitamins|mesh-list
5664109|NCT03611049|Micronutrients|micronutrients|mesh-ancestor
5664110|NCT03611049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664111|NCT03611049|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5664112|NCT03611049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5664113|NCT03610945|Fluconazole|fluconazole|mesh-list
5664114|NCT03610945|Quinidine|quinidine|mesh-list
5664115|NCT03610945|Antifungal Agents|antifungal agents|mesh-ancestor
5664116|NCT03610945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5664117|NCT03610945|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5664118|NCT03610945|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5664119|NCT03610945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5664120|NCT03610945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664121|NCT03610945|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5664122|NCT03610945|Hormone Antagonists|hormone antagonists|mesh-ancestor
5844665|NCT02480946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5844666|NCT02480946|Antimetabolites|antimetabolites|mesh-ancestor
5844667|NCT02480946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844668|NCT02480946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5844669|NCT02480946|Dermatologic Agents|dermatologic agents|mesh-ancestor
5844670|NCT02480946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5844671|NCT02480946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5844672|NCT02480946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5844673|NCT02480946|Immunologic Factors|immunologic factors|mesh-ancestor
5844674|NCT02480946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5844675|NCT02480946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5844676|NCT02481076|Monensin|monensin|mesh-list
5844677|NCT02481076|Antifungal Agents|antifungal agents|mesh-ancestor
5844678|NCT02481076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5844679|NCT02481076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5844680|NCT02481076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5844681|NCT02481076|Coccidiostats|coccidiostats|mesh-ancestor
5844682|NCT02481076|Proton Ionophores|proton ionophores|mesh-ancestor
5844683|NCT02481076|Uncoupling Agents|uncoupling agents|mesh-ancestor
5844684|NCT02481076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6493874|NCT00615810|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6493875|NCT00615810|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6493876|NCT00615810|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6493877|NCT00615810|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6493878|NCT00615810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6493879|NCT00615810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6493880|NCT00615823|Atorvastatin|atorvastatin|mesh-list
6493881|NCT00615823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6493882|NCT00615823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6493883|NCT00615823|Antimetabolites|antimetabolites|mesh-ancestor
6493884|NCT00615823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493885|NCT00615823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6493886|NCT00615823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6493887|NCT00615823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6493888|NCT00615875|Naproxen|naproxen|mesh-list
6493889|NCT00615875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6493890|NCT00615875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5664123|NCT03610945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5664124|NCT03610945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844685|NCT02481076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844686|NCT02481076|Ionophores|ionophores|mesh-ancestor
5844687|NCT02481076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5844688|NCT02481076|Sodium Ionophores|sodium ionophores|mesh-ancestor
5844689|NCT02480894|Maraviroc|maraviroc|mesh-list
5844690|NCT02480894|Fostemsavir|fostemsavir|mesh-list
5844691|NCT02480894|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5844692|NCT02480894|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5664125|NCT03610945|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5664126|NCT03610945|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5664127|NCT03610945|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5664128|NCT03610945|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5664129|NCT03610945|Adrenergic Agents|adrenergic agents|mesh-ancestor
5664130|NCT03610945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5664131|NCT03610945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5664132|NCT03610945|Antimalarials|antimalarials|mesh-ancestor
5664133|NCT03610945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5664134|NCT03610945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5844693|NCT02480894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844694|NCT02480894|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5844695|NCT02480894|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5844696|NCT02480894|Antiviral Agents|antiviral agents|mesh-ancestor
5844697|NCT02480894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5844698|NCT02480894|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
5844699|NCT02480881|Fostemsavir|fostemsavir|mesh-list
5844700|NCT02480881|Contraceptive Agents|contraceptive agents|mesh-list
5844701|NCT02480881|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
5844702|NCT02480881|Contraceptives, Oral|contraceptives, oral|mesh-list
5844703|NCT02480881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5664135|NCT03610945|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5664136|NCT03610945|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5664137|NCT03610945|Cholinergic Agents|cholinergic agents|mesh-ancestor
5844704|NCT02480881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844705|NCT02480881|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5844706|NCT02480881|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5844707|NCT02480881|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5844708|NCT02480881|Antiviral Agents|antiviral agents|mesh-ancestor
5844709|NCT02480881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5844710|NCT02480881|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5844711|NCT02480881|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5844712|NCT02480881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844713|NCT02480881|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5844714|NCT02480881|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5844715|NCT02480881|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5844716|NCT02480881|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
5844717|NCT02480881|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5844718|NCT02480803|Levodopa|levodopa|mesh-list
5844719|NCT02480803|Carbidopa|carbidopa|mesh-list
5844720|NCT02480803|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
5844721|NCT02480803|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5844722|NCT02480803|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5664138|NCT03610945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5664139|NCT03610945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5664140|NCT03610945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5664141|NCT03610945|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5844723|NCT02480803|Dopamine Agents|dopamine agents|mesh-ancestor
5844724|NCT02480803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5844725|NCT02480803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844726|NCT02480803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844727|NCT02480803|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5844728|NCT02480803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5844729|NCT02480803|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5844730|NCT02480803|Immunologic Factors|immunologic factors|mesh-ancestor
5844731|NCT02480803|Dopamine Agonists|dopamine agonists|mesh-ancestor
5664142|NCT03610932|Ascorbic Acid|ascorbic acid|mesh-list
5664143|NCT03610932|Vitamins|vitamins|mesh-ancestor
5664144|NCT03610932|Micronutrients|micronutrients|mesh-ancestor
5664145|NCT03610932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664146|NCT03610932|Antioxidants|antioxidants|mesh-ancestor
5695546|NCT03388827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5664147|NCT03610932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664148|NCT03610932|Protective Agents|protective agents|mesh-ancestor
5664149|NCT03610893|Dexamethasone|dexamethasone|mesh-list
5664150|NCT03610893|Dexmedetomidine|dexmedetomidine|mesh-list
5664151|NCT03610893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5664152|NCT03610893|Antiemetics|antiemetics|mesh-ancestor
5664153|NCT03610893|Autonomic Agents|autonomic agents|mesh-ancestor
5664154|NCT03610893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5664155|NCT03610893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664156|NCT03610893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5664157|NCT03610893|Glucocorticoids|glucocorticoids|mesh-ancestor
5664158|NCT03610893|Hormones|hormones|mesh-ancestor
5664159|NCT03610893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5664160|NCT03610893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5844732|NCT02480647|Levonorgestrel|levonorgestrel|mesh-list
5844733|NCT02480647|Etonogestrel|etonogestrel|mesh-list
5844734|NCT02480647|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5844735|NCT02480647|Contraceptive Agents|contraceptive agents|mesh-ancestor
5844736|NCT02480647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5844737|NCT02480647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844738|NCT02480647|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5844739|NCT02480647|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5844740|NCT02480647|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5903579|NCT04798755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5903580|NCT04798755|Abortifacient Agents|abortifacient agents|mesh-ancestor
5664161|NCT03610893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5664162|NCT03610893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5664163|NCT03610893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5664164|NCT03610893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5664165|NCT03610893|Analgesics|analgesics|mesh-ancestor
5903581|NCT04798755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5903582|NCT04798755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903583|NCT04798755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5903584|NCT04798755|Antimetabolites|antimetabolites|mesh-ancestor
5903585|NCT04798755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903586|NCT04798755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5903587|NCT04798755|Dermatologic Agents|dermatologic agents|mesh-ancestor
5664166|NCT03610893|Sensory System Agents|sensory system agents|mesh-ancestor
5664167|NCT03610893|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5664168|NCT03610893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5664169|NCT03610893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5664170|NCT03610893|Adrenergic Agents|adrenergic agents|mesh-ancestor
5664171|NCT03610893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5664172|NCT03610893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664173|NCT03610880|Yimitasvir|yimitasvir|mesh-list
5664174|NCT03610880|Antiviral Agents|antiviral agents|mesh-ancestor
5664175|NCT03610880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5903588|NCT04798755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5903589|NCT04798755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5903590|NCT04798755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5903591|NCT04798755|Immunologic Factors|immunologic factors|mesh-ancestor
5903592|NCT04798755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5903593|NCT04798755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5903594|NCT04798755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5903595|NCT04777708|Pembrolizumab|pembrolizumab|mesh-list
5903596|NCT04777708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5903597|NCT04777708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5903598|NCT04691505|Hydroxychloroquine|hydroxychloroquine|mesh-list
5903599|NCT04691505|Methotrexate|methotrexate|mesh-list
5903600|NCT04691505|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5903601|NCT04691505|Abortifacient Agents|abortifacient agents|mesh-ancestor
5903602|NCT04691505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5903603|NCT04691505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903604|NCT04691505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5903605|NCT04691505|Antimetabolites|antimetabolites|mesh-ancestor
5903606|NCT04691505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903607|NCT04691505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5903608|NCT04691505|Dermatologic Agents|dermatologic agents|mesh-ancestor
5903609|NCT04691505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5903610|NCT04691505|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5903611|NCT04691505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5903612|NCT04691505|Immunologic Factors|immunologic factors|mesh-ancestor
5903613|NCT04691505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5903614|NCT04691505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5844741|NCT02480608|Imatinib Mesylate|imatinib mesylate|mesh-list
5844742|NCT02480608|Hydroxyurea|hydroxyurea|mesh-list
5844743|NCT02480608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5844744|NCT02480608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5844745|NCT02480608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5844746|NCT02480608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844747|NCT02480608|Antisickling Agents|antisickling agents|mesh-ancestor
5664176|NCT03610711|Nivolumab|nivolumab|mesh-list
5664177|NCT03610711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5664178|NCT03610711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5664179|NCT03610711|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5664180|NCT03610711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664181|NCT03610685|Prednisolone|prednisolone|mesh-list
5664182|NCT03610685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5664183|NCT03610685|Glucocorticoids|glucocorticoids|mesh-ancestor
5664184|NCT03610685|Hormones|hormones|mesh-ancestor
5664185|NCT03610685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5664186|NCT03610685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664187|NCT03610685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5664188|NCT03610685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5664189|NCT03610412|Magnesium Oxide|magnesium oxide|mesh-list
5664190|NCT03610412|Antacids|antacids|mesh-ancestor
5664191|NCT03610412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664192|NCT03610412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5664193|NCT03610347|Paclitaxel|paclitaxel|mesh-list
5664194|NCT03610347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5664195|NCT03610347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5664196|NCT03610347|Tubulin Modulators|tubulin modulators|mesh-ancestor
5664197|NCT03610347|Antimitotic Agents|antimitotic agents|mesh-ancestor
5664198|NCT03610347|Mitosis Modulators|mitosis modulators|mesh-ancestor
5664199|NCT03610347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664200|NCT03610321|Gefarnate|gefarnate|mesh-list
5664201|NCT03610321|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5664202|NCT03610321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5664203|NCT03610282|Propofol|propofol|mesh-list
5664204|NCT03610282|Methylphenidate|methylphenidate|mesh-list
5664205|NCT03610282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5664206|NCT03610282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5664207|NCT03610282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664208|NCT03610282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5664209|NCT03610282|Anesthetics, General|anesthetics, general|mesh-ancestor
5664210|NCT03610282|Anesthetics|anesthetics|mesh-ancestor
5664211|NCT03610282|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5664212|NCT03610282|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5664213|NCT03610282|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5664214|NCT03610282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5664215|NCT03610282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664216|NCT03610282|Dopamine Agents|dopamine agents|mesh-ancestor
5664217|NCT03610282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5664218|NCT03610230|Iron|iron|mesh-list
5664219|NCT03610230|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
5664220|NCT03610230|Ferric Compounds|ferric compounds|mesh-list
5664221|NCT03610230|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
5664222|NCT03610230|Trace Elements|trace elements|mesh-ancestor
5664223|NCT03610230|Micronutrients|micronutrients|mesh-ancestor
5664224|NCT03610230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664225|NCT03610230|Hematinics|hematinics|mesh-ancestor
5844748|NCT02480608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5844749|NCT02480543|Misoprostol|misoprostol|mesh-list
5844750|NCT02480543|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5844751|NCT02480543|Abortifacient Agents|abortifacient agents|mesh-ancestor
5844752|NCT02480543|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5844753|NCT02480543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844754|NCT02480543|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5844755|NCT02480543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5844756|NCT02480543|Oxytocics|oxytocics|mesh-ancestor
5844757|NCT02480686|Sofosbuvir|sofosbuvir|mesh-list
5844758|NCT02480686|Antiviral Agents|antiviral agents|mesh-ancestor
6493891|NCT00615875|Analgesics|analgesics|mesh-ancestor
5664226|NCT03610178|Insulin|insulin|mesh-list
5664227|NCT03610178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5664228|NCT03610178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5664229|NCT03610178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664230|NCT03610139|Vitamin D|vitamin d|mesh-list
5664231|NCT03610139|Cholecalciferol|cholecalciferol|mesh-list
5844759|NCT02480686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5844760|NCT02480634|Zoledronic Acid|zoledronic acid|mesh-list
5664232|NCT03610139|Vitamins|vitamins|mesh-ancestor
5664233|NCT03610139|Micronutrients|micronutrients|mesh-ancestor
5664234|NCT03610139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664235|NCT03610139|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5664236|NCT03610139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5664237|NCT03610100|Gemcitabine|gemcitabine|mesh-list
5664238|NCT03610100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5664239|NCT03610100|Antimetabolites|antimetabolites|mesh-ancestor
5664240|NCT03610100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664241|NCT03610100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5664242|NCT03610100|Antiviral Agents|antiviral agents|mesh-ancestor
5664243|NCT03610100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5664244|NCT03610100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5664245|NCT03610100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5664246|NCT03610100|Immunologic Factors|immunologic factors|mesh-ancestor
5664247|NCT03610100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664248|NCT03610035|Immunoglobulins|immunoglobulins|mesh-list
5664249|NCT03610035|Immunoglobulin G|immunoglobulin g|mesh-list
5664250|NCT03610035|Immunologic Factors|immunologic factors|mesh-ancestor
5664251|NCT03610035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664252|NCT03609996|Ranibizumab|ranibizumab|mesh-list
5664253|NCT03609996|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5664254|NCT03609996|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5844761|NCT02480634|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5844762|NCT02480634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844763|NCT02480751|Beraprost|beraprost|mesh-list
5844764|NCT02480751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5844765|NCT02480751|Vasodilator Agents|vasodilator agents|mesh-ancestor
5844766|NCT02480465|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5844767|NCT02480465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5844768|NCT02480465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844769|NCT02480465|Incretins|incretins|mesh-ancestor
5844770|NCT02480465|Hormones|hormones|mesh-ancestor
5844771|NCT02480465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5844772|NCT02480465|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5844773|NCT02480465|Protease Inhibitors|protease inhibitors|mesh-ancestor
5844774|NCT02480465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5844775|NCT02480465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844776|NCT02480400|Dexetimide|dexetimide|mesh-list
5844777|NCT02480400|Citalopram|citalopram|mesh-list
5844778|NCT02480400|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5844779|NCT02480400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5844780|NCT02480400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5844781|NCT02480400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844782|NCT02480400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5844783|NCT02480400|Serotonin Agents|serotonin agents|mesh-ancestor
5844784|NCT02480400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844785|NCT02480400|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6493892|NCT00615875|Sensory System Agents|sensory system agents|mesh-ancestor
6493893|NCT00615875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6493894|NCT00615875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493895|NCT00615875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6493896|NCT00615875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6493897|NCT00615875|Gout Suppressants|gout suppressants|mesh-ancestor
6493898|NCT00615875|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6493899|NCT00615875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6493900|NCT00615875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674704|NCT01570985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844786|NCT02480400|Antidepressive Agents|antidepressive agents|mesh-ancestor
5844787|NCT02480400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5844788|NCT02480400|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5844789|NCT02480400|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5664255|NCT03609996|Growth Substances|growth substances|mesh-ancestor
5664256|NCT03609996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664257|NCT03609996|Growth Inhibitors|growth inhibitors|mesh-ancestor
5664258|NCT03609996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5664259|NCT03609970|Vitamin D|vitamin d|mesh-list
5664260|NCT03609970|Vitamins|vitamins|mesh-ancestor
5664261|NCT03609970|Micronutrients|micronutrients|mesh-ancestor
6674705|NCT01571024|Leucovorin|leucovorin|mesh-list
6674706|NCT01571024|Fluorouracil|fluorouracil|mesh-list
6674707|NCT01571024|Oxaliplatin|oxaliplatin|mesh-list
6674708|NCT01571024|Antimetabolites|antimetabolites|mesh-ancestor
5664262|NCT03609970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674709|NCT01571024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674710|NCT01571024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5664263|NCT03609970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5664264|NCT03609892|Amoxicillin|amoxicillin|mesh-list
5664265|NCT03609892|Tetracycline|tetracycline|mesh-list
5664266|NCT03609892|Furazolidone|furazolidone|mesh-list
5664267|NCT03609892|Esomeprazole|esomeprazole|mesh-list
5664268|NCT03609892|Bismuth|bismuth|mesh-list
5664269|NCT03609892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5664270|NCT03609892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5664271|NCT03609892|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5664272|NCT03609892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5664273|NCT03609892|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5664274|NCT03609892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5664275|NCT03609892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664276|NCT03609892|Antacids|antacids|mesh-ancestor
5664277|NCT03609892|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5664278|NCT03609892|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5664279|NCT03609892|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5664280|NCT03609892|Renal Agents|renal agents|mesh-ancestor
5664281|NCT03609892|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
5664282|NCT03609892|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5664283|NCT03609892|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5664284|NCT03609892|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
5695547|NCT03388827|Abortifacient Agents|abortifacient agents|mesh-ancestor
5695548|NCT03388827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5695549|NCT03388827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695550|NCT03388827|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5695551|NCT03388827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6674711|NCT01571024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6674712|NCT01571024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6674713|NCT01571024|Immunologic Factors|immunologic factors|mesh-ancestor
6674714|NCT01571024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844790|NCT02480400|Parasympatholytics|parasympatholytics|mesh-ancestor
5844791|NCT02480400|Autonomic Agents|autonomic agents|mesh-ancestor
5844792|NCT02480400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5844793|NCT02480400|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5844794|NCT02480400|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5695552|NCT03388827|Oxytocics|oxytocics|mesh-ancestor
5695553|NCT03388814|Bupivacaine|bupivacaine|mesh-list
5695554|NCT03388814|Anesthetics, Local|anesthetics, local|mesh-ancestor
5695555|NCT03388814|Anesthetics|anesthetics|mesh-ancestor
5695556|NCT03388814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5695557|NCT03388814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695558|NCT03388814|Sensory System Agents|sensory system agents|mesh-ancestor
5695559|NCT03388814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5695560|NCT03388749|Annamycin|annamycin|mesh-list
5695561|NCT03388749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5695562|NCT03388749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5695563|NCT03388697|Insulin|insulin|mesh-list
5695564|NCT03388697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5695565|NCT03388697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844795|NCT02480400|Cholinergic Agents|cholinergic agents|mesh-ancestor
5844796|NCT02480387|Sofosbuvir|sofosbuvir|mesh-list
5844797|NCT02480387|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
5844798|NCT02480387|Ledipasvir|ledipasvir|mesh-list
5844799|NCT02480387|Antiviral Agents|antiviral agents|mesh-ancestor
5844800|NCT02480387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5844801|NCT02480088|Palonosetron|palonosetron|mesh-list
5844802|NCT02480088|Ramosetron|ramosetron|mesh-list
5844803|NCT02480088|Antiemetics|antiemetics|mesh-ancestor
5844804|NCT02480088|Autonomic Agents|autonomic agents|mesh-ancestor
5844805|NCT02480088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5844806|NCT02480088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844807|NCT02480088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5844808|NCT02480088|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5844809|NCT02480088|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5695566|NCT03388671|Bupivacaine|bupivacaine|mesh-list
5695567|NCT03388671|Anesthetics, Local|anesthetics, local|mesh-ancestor
5695568|NCT03388671|Anesthetics|anesthetics|mesh-ancestor
5695569|NCT03388671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5695570|NCT03388671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695571|NCT03388671|Sensory System Agents|sensory system agents|mesh-ancestor
5695572|NCT03388671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5695573|NCT03388541|Dexmedetomidine|dexmedetomidine|mesh-list
5695574|NCT03388541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5844810|NCT02480088|Serotonin Agents|serotonin agents|mesh-ancestor
5844811|NCT02480088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5844812|NCT02480088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844813|NCT02480335|Bosentan|bosentan|mesh-list
5844814|NCT02480335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5844815|NCT02480335|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5844816|NCT02480335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844817|NCT02480049|Montelukast|montelukast|mesh-list
5844818|NCT02480049|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5844819|NCT02480049|Respiratory System Agents|respiratory system agents|mesh-ancestor
5844820|NCT02480049|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5844821|NCT02480049|Hormone Antagonists|hormone antagonists|mesh-ancestor
5844822|NCT02480049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5844823|NCT02480049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844824|NCT02480049|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5844825|NCT02480049|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5844826|NCT02480049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844827|NCT02479971|Clindamycin|clindamycin|mesh-list
5844828|NCT02479971|Clindamycin palmitate|clindamycin palmitate|mesh-list
5844829|NCT02479971|Clindamycin phosphate|clindamycin phosphate|mesh-list
5844830|NCT02479971|Gentamicins|gentamicins|mesh-list
5844831|NCT02479971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5844832|NCT02479971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5844833|NCT02479971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5844834|NCT02479971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5844835|NCT02479971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844836|NCT02479854|Montelukast|montelukast|mesh-list
5844837|NCT02479854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5844838|NCT02479854|Respiratory System Agents|respiratory system agents|mesh-ancestor
5844839|NCT02479854|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5844840|NCT02479854|Hormone Antagonists|hormone antagonists|mesh-ancestor
5844841|NCT02479854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5664285|NCT03609840|Thiotepa|thiotepa|mesh-list
5664286|NCT03609840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-list
5664287|NCT03609840|Antineoplastic Agents|antineoplastic agents|mesh-list
5664288|NCT03609840|Alkylating Agents|alkylating agents|mesh-ancestor
5664289|NCT03609840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664290|NCT03609840|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5664291|NCT03609840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5664292|NCT03609840|Immunologic Factors|immunologic factors|mesh-ancestor
5664293|NCT03609840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664294|NCT03609827|Melphalan|melphalan|mesh-list
5664295|NCT03609827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5664296|NCT03609827|Alkylating Agents|alkylating agents|mesh-ancestor
5664297|NCT03609827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664298|NCT03609827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5664299|NCT03609827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5664300|NCT03609827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5664301|NCT03609827|Immunologic Factors|immunologic factors|mesh-ancestor
5664302|NCT03609827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664303|NCT03609814|Fludarabine|fludarabine|mesh-list
5664304|NCT03609814|Clofarabine|clofarabine|mesh-list
5664305|NCT03609814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5664306|NCT03609814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5664307|NCT03609814|Antimetabolites|antimetabolites|mesh-ancestor
5664308|NCT03609814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664309|NCT03609775|Ethanol|ethanol|mesh-list
5664310|NCT03609775|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5664311|NCT03609775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5664312|NCT03609775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5664313|NCT03609775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664314|NCT03609593|Rituximab|rituximab|mesh-list
5664315|NCT03609593|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5664316|NCT03609593|Venetoclax|venetoclax|mesh-list
5664317|NCT03609593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5664318|NCT03609593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5664319|NCT03609593|Immunologic Factors|immunologic factors|mesh-ancestor
5664320|NCT03609593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664321|NCT03609593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5664322|NCT03609593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5664323|NCT03609593|Alkylating Agents|alkylating agents|mesh-ancestor
5664324|NCT03609593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664325|NCT03609580|Tamsulosin|tamsulosin|mesh-list
5844842|NCT02479854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844843|NCT02479854|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5844844|NCT02479854|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5844845|NCT02479854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844846|NCT02479867|Cefadroxil|cefadroxil|mesh-list
5844847|NCT02479867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5844848|NCT02479867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5844849|NCT02479958|Chlorhexidine|chlorhexidine|mesh-list
5844850|NCT02479958|Anti-Infective Agents|anti-infective agents|mesh-list
5844851|NCT02479958|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5844852|NCT02479958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5844853|NCT02479958|Disinfectants|disinfectants|mesh-ancestor
5844854|NCT02479789|Lidocaine|lidocaine|mesh-list
5844855|NCT02479789|Anesthetics, Local|anesthetics, local|mesh-ancestor
5844856|NCT02479789|Anesthetics|anesthetics|mesh-ancestor
5844857|NCT02479789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5844858|NCT02479789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844859|NCT02479789|Sensory System Agents|sensory system agents|mesh-ancestor
5844860|NCT02479789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5844861|NCT02479789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5844862|NCT02479789|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5844863|NCT02479789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5844864|NCT02479789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5844865|NCT02479789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844866|NCT02479815|Micronutrients|micronutrients|mesh-list
5664326|NCT03609580|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5664327|NCT03609580|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5664328|NCT03609580|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5844867|NCT02479815|Trace Elements|trace elements|mesh-list
5844868|NCT02479815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844869|NCT02479828|Ropivacaine|ropivacaine|mesh-list
5844870|NCT02479828|Anesthetics, Local|anesthetics, local|mesh-ancestor
5844871|NCT02479828|Anesthetics|anesthetics|mesh-ancestor
5844872|NCT02479828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5844873|NCT02479828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844874|NCT02479828|Sensory System Agents|sensory system agents|mesh-ancestor
5844875|NCT02479828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5844876|NCT02479711|Methamphetamine|methamphetamine|mesh-list
5844877|NCT02479711|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5844878|NCT02479711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844879|NCT02479711|Sympathomimetics|sympathomimetics|mesh-ancestor
5844880|NCT02479711|Autonomic Agents|autonomic agents|mesh-ancestor
5844881|NCT02479711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5844882|NCT02479711|Dopamine Agents|dopamine agents|mesh-ancestor
5844883|NCT02479711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5844884|NCT02479711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844885|NCT02479711|Adrenergic Agents|adrenergic agents|mesh-ancestor
5844886|NCT02479711|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5844887|NCT02479711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5844888|NCT02479711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5664329|NCT03609580|Adrenergic Agents|adrenergic agents|mesh-ancestor
5664330|NCT03609580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5664331|NCT03609580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664332|NCT03609580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664333|NCT03609580|Urological Agents|urological agents|mesh-ancestor
5664334|NCT03609489|Capecitabine|capecitabine|mesh-list
5664335|NCT03609489|Apatinib|apatinib|mesh-list
5664336|NCT03609489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5664337|NCT03609489|Antimetabolites|antimetabolites|mesh-ancestor
5664338|NCT03609489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664339|NCT03609489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5844889|NCT02479711|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5844890|NCT02479620|Dexamethasone|dexamethasone|mesh-list
5844891|NCT02479620|Dexamethasone acetate|dexamethasone acetate|mesh-list
5844892|NCT02479620|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
5844893|NCT02479620|BB 1101|bb 1101|mesh-list
5664340|NCT03609489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5664341|NCT03609489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5664342|NCT03609424|Imatinib Mesylate|imatinib mesylate|mesh-list
5664343|NCT03609424|Spartalizumab|spartalizumab|mesh-list
5664344|NCT03609424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5664345|NCT03609424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5844894|NCT02479620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5844895|NCT02479620|Antiemetics|antiemetics|mesh-ancestor
5664346|NCT03609424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5664347|NCT03609424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664348|NCT03609424|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5664349|NCT03609359|Pembrolizumab|pembrolizumab|mesh-list
5664350|NCT03609359|Lenvatinib|lenvatinib|mesh-list
5664351|NCT03609359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5664352|NCT03609359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5664353|NCT03609359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5664354|NCT03609359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5844896|NCT02479620|Autonomic Agents|autonomic agents|mesh-ancestor
5844897|NCT02479620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5844898|NCT02479620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844899|NCT02479620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5844900|NCT02479620|Glucocorticoids|glucocorticoids|mesh-ancestor
5844901|NCT02479620|Hormones|hormones|mesh-ancestor
5844902|NCT02479620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5844903|NCT02479620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5844904|NCT02479620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5844905|NCT02479620|Protease Inhibitors|protease inhibitors|mesh-ancestor
5844906|NCT02479620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5844907|NCT02479620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844908|NCT02479503|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5844909|NCT02479503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5844910|NCT02479490|Prednisone|prednisone|mesh-list
5844911|NCT02479490|Everolimus|everolimus|mesh-list
5844912|NCT02479490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5844913|NCT02479490|Glucocorticoids|glucocorticoids|mesh-ancestor
5844914|NCT02479490|Hormones|hormones|mesh-ancestor
5844915|NCT02479490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5844916|NCT02479490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844917|NCT02479490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5844918|NCT02479490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5844919|NCT02479490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5844920|NCT02479490|Immunologic Factors|immunologic factors|mesh-ancestor
5844921|NCT02479204|Atenolol|atenolol|mesh-list
5844922|NCT02479204|Diltiazem|diltiazem|mesh-list
5844923|NCT02479204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5844924|NCT02479204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5844925|NCT02479204|Sympatholytics|sympatholytics|mesh-ancestor
5844926|NCT02479204|Autonomic Agents|autonomic agents|mesh-ancestor
5844927|NCT02479204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5844928|NCT02479204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844929|NCT02479204|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5844930|NCT02479204|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5844931|NCT02479204|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5844932|NCT02479204|Adrenergic Agents|adrenergic agents|mesh-ancestor
5844933|NCT02479204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5844934|NCT02479204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844935|NCT02479204|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5844936|NCT02479204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5844937|NCT02479204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5844938|NCT02479204|Vasodilator Agents|vasodilator agents|mesh-ancestor
5844939|NCT02479581|Floxacillin|floxacillin|mesh-list
5844940|NCT02479581|Dexamethasone|dexamethasone|mesh-list
5664355|NCT03609359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664356|NCT03609307|Bevacizumab|bevacizumab|mesh-list
5664357|NCT03609307|Propranolol|propranolol|mesh-list
5664358|NCT03609307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5664359|NCT03609307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5844941|NCT02479581|Methylprednisolone|methylprednisolone|mesh-list
5844942|NCT02479581|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5844943|NCT02479581|Scopolamine|scopolamine|mesh-list
5844944|NCT02479581|Morphine|morphine|mesh-list
5844945|NCT02479581|Anesthetics|anesthetics|mesh-list
5844946|NCT02479581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5844947|NCT02479581|Antiemetics|antiemetics|mesh-ancestor
5844948|NCT02479581|Autonomic Agents|autonomic agents|mesh-ancestor
5844949|NCT02479581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5844950|NCT02479581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664360|NCT03609307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5664361|NCT03609307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5664362|NCT03609307|Growth Substances|growth substances|mesh-ancestor
5664363|NCT03609307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664364|NCT03609307|Growth Inhibitors|growth inhibitors|mesh-ancestor
5844951|NCT02479581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5844952|NCT02479581|Glucocorticoids|glucocorticoids|mesh-ancestor
5844953|NCT02479581|Hormones|hormones|mesh-ancestor
5844954|NCT02479581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5844955|NCT02479581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5844956|NCT02479581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5844957|NCT02479581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844958|NCT02479581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5844959|NCT02479581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5844960|NCT02479581|Narcotics|narcotics|mesh-ancestor
5844961|NCT02479581|Analgesics|analgesics|mesh-ancestor
5844962|NCT02479581|Sensory System Agents|sensory system agents|mesh-ancestor
5844963|NCT02479581|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5844964|NCT02479581|Protective Agents|protective agents|mesh-ancestor
5844965|NCT02479581|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5844966|NCT02479581|Mydriatics|mydriatics|mesh-ancestor
5664365|NCT03609307|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5664366|NCT03609307|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5664367|NCT03609307|Adrenergic Agents|adrenergic agents|mesh-ancestor
5664368|NCT03609307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5664369|NCT03609307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664370|NCT03609307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5664371|NCT03609307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5664372|NCT03609307|Vasodilator Agents|vasodilator agents|mesh-ancestor
5664373|NCT03609294|Linagliptin|linagliptin|mesh-list
5844967|NCT02479581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5844968|NCT02479581|Cholinergic Agents|cholinergic agents|mesh-ancestor
5844969|NCT02479581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5844970|NCT02479581|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5844971|NCT02479581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5844972|NCT02479581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5844973|NCT02479256|Tamoxifen|tamoxifen|mesh-list
5844974|NCT02479256|Citric Acid|citric acid|mesh-list
5844975|NCT02479256|Sodium Citrate|sodium citrate|mesh-list
5844976|NCT02479256|Clomiphene|clomiphene|mesh-list
5844977|NCT02479256|Enclomiphene|enclomiphene|mesh-list
5844978|NCT02479256|Zuclomiphene|zuclomiphene|mesh-list
5844979|NCT02479256|Anticoagulants|anticoagulants|mesh-ancestor
5844980|NCT02479256|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5844981|NCT02479256|Chelating Agents|chelating agents|mesh-ancestor
5844982|NCT02479256|Sequestering Agents|sequestering agents|mesh-ancestor
5844983|NCT02479256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5844984|NCT02479256|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5844985|NCT02479256|Hormone Antagonists|hormone antagonists|mesh-ancestor
5844986|NCT02479256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5844987|NCT02479256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5844988|NCT02479256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5844989|NCT02479256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5844990|NCT02479256|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5844991|NCT02479256|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5844992|NCT02479256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5844993|NCT02479256|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5844994|NCT02479256|Fertility Agents|fertility agents|mesh-ancestor
5844995|NCT02479256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5844996|NCT02479451|Theophylline|theophylline|mesh-list
5844997|NCT02479451|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5844998|NCT02479451|Autonomic Agents|autonomic agents|mesh-ancestor
5844999|NCT02479451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5664374|NCT03609294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5664375|NCT03609294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664376|NCT03609294|Incretins|incretins|mesh-ancestor
5664377|NCT03609294|Hormones|hormones|mesh-ancestor
5664378|NCT03609294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5664379|NCT03609294|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5664380|NCT03609294|Protease Inhibitors|protease inhibitors|mesh-ancestor
5664381|NCT03609294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5664382|NCT03609294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664383|NCT03609190|Ketamine|ketamine|mesh-list
5664384|NCT03609190|Analgesics|analgesics|mesh-ancestor
5664385|NCT03609190|Sensory System Agents|sensory system agents|mesh-ancestor
5664386|NCT03609190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5664387|NCT03609190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664388|NCT03609190|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5664389|NCT03609190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5845000|NCT02479451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845001|NCT02479451|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5845002|NCT02479451|Respiratory System Agents|respiratory system agents|mesh-ancestor
5845003|NCT02479451|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5845004|NCT02479451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5845005|NCT02479451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5845006|NCT02479451|Vasodilator Agents|vasodilator agents|mesh-ancestor
5845007|NCT02479451|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5845008|NCT02479451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5845009|NCT02479451|Purinergic Agents|purinergic agents|mesh-ancestor
5845010|NCT02479451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5845011|NCT02479308|Moxifloxacin|moxifloxacin|mesh-list
5845012|NCT02479308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5845013|NCT02479308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5845014|NCT02479308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5845015|NCT02479308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5845016|NCT02479308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5845017|NCT02479308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5845018|NCT02479308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5845019|NCT02479347|Chlorhexidine|chlorhexidine|mesh-list
5845020|NCT02479347|Povidone-Iodine|povidone-iodine|mesh-list
5845021|NCT02479347|Povidone|povidone|mesh-list
5845022|NCT02479347|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5845023|NCT02479347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5845024|NCT02479347|Disinfectants|disinfectants|mesh-ancestor
5845025|NCT02479347|Plasma Substitutes|plasma substitutes|mesh-ancestor
5845026|NCT02479347|Blood Substitutes|blood substitutes|mesh-ancestor
5845027|NCT02479555|Dexamethasone|dexamethasone|mesh-list
5845028|NCT02479555|Dexamethasone acetate|dexamethasone acetate|mesh-list
5845029|NCT02479555|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
5845030|NCT02479555|BB 1101|bb 1101|mesh-list
5845031|NCT02479555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5845032|NCT02479555|Antiemetics|antiemetics|mesh-ancestor
5845033|NCT02479555|Autonomic Agents|autonomic agents|mesh-ancestor
5845034|NCT02479555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5845035|NCT02479555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845036|NCT02479555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5845037|NCT02479555|Glucocorticoids|glucocorticoids|mesh-ancestor
5845038|NCT02479555|Hormones|hormones|mesh-ancestor
5845039|NCT02479555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5845040|NCT02479555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5845041|NCT02479555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5845042|NCT02479555|Protease Inhibitors|protease inhibitors|mesh-ancestor
5845043|NCT02479555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5845044|NCT02479555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5845045|NCT02479399|Ipragliflozin|ipragliflozin|mesh-list
5845046|NCT02479399|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5845047|NCT02479399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5845048|NCT02479399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5845049|NCT02479399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845050|NCT02479178|Docetaxel|docetaxel|mesh-list
5845051|NCT02479178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5845052|NCT02479178|Tubulin Modulators|tubulin modulators|mesh-ancestor
5845053|NCT02479178|Antimitotic Agents|antimitotic agents|mesh-ancestor
5845054|NCT02479178|Mitosis Modulators|mitosis modulators|mesh-ancestor
5845055|NCT02479178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5845056|NCT02479230|Gemcitabine|gemcitabine|mesh-list
5845057|NCT02479230|Vaccines|vaccines|mesh-list
5845058|NCT02479230|Immunologic Factors|immunologic factors|mesh-ancestor
5845059|NCT02479230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845060|NCT02479230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5845061|NCT02479230|Antimetabolites|antimetabolites|mesh-ancestor
5845062|NCT02479230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5845063|NCT02479230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5845064|NCT02479230|Antiviral Agents|antiviral agents|mesh-ancestor
5845065|NCT02479230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5845066|NCT02479230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5845067|NCT02479230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5845068|NCT02479217|Docetaxel|docetaxel|mesh-list
6493901|NCT00616005|Irinotecan|irinotecan|mesh-list
6493902|NCT00616005|Temozolomide|temozolomide|mesh-list
5845069|NCT02479217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5845070|NCT02479217|Tubulin Modulators|tubulin modulators|mesh-ancestor
5845071|NCT02479217|Antimitotic Agents|antimitotic agents|mesh-ancestor
5845072|NCT02479217|Mitosis Modulators|mitosis modulators|mesh-ancestor
5845073|NCT02479217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903615|NCT04691505|Antimalarials|antimalarials|mesh-ancestor
6493903|NCT00616005|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5664390|NCT03609190|Anesthetics, General|anesthetics, general|mesh-ancestor
5664391|NCT03609190|Anesthetics|anesthetics|mesh-ancestor
5664392|NCT03609190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5664393|NCT03609190|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5664394|NCT03609190|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5845074|NCT02479529|Norepinephrine|norepinephrine|mesh-list
5845075|NCT02479529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5845076|NCT02479529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5845077|NCT02479529|Adrenergic Agents|adrenergic agents|mesh-ancestor
5845078|NCT02479529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5845079|NCT02479529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5845080|NCT02479529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845081|NCT02479529|Sympathomimetics|sympathomimetics|mesh-ancestor
5845082|NCT02479529|Autonomic Agents|autonomic agents|mesh-ancestor
5845083|NCT02479529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5845084|NCT02479529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5845085|NCT02479165|Oxycodone|oxycodone|mesh-list
5845086|NCT02479165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5845087|NCT02479165|Narcotics|narcotics|mesh-ancestor
5845088|NCT02479165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5845089|NCT02479165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845090|NCT02479165|Analgesics|analgesics|mesh-ancestor
5845091|NCT02479165|Sensory System Agents|sensory system agents|mesh-ancestor
5845092|NCT02479165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5845093|NCT02479022|Insulin|insulin|mesh-list
5845094|NCT02479022|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5845095|NCT02479022|Insulin Glargine|insulin glargine|mesh-list
5845096|NCT02479022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5845097|NCT02479022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845098|NCT02479074|Prednisolone|prednisolone|mesh-list
5845099|NCT02479074|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5845100|NCT02479074|Methylprednisolone|methylprednisolone|mesh-list
5845101|NCT02479074|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5845102|NCT02479074|Prednisolone acetate|prednisolone acetate|mesh-list
5845103|NCT02479074|Montelukast|montelukast|mesh-list
5845104|NCT02479074|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5845105|NCT02479074|Prednisolone phosphate|prednisolone phosphate|mesh-list
5845106|NCT02479074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5845107|NCT02479074|Glucocorticoids|glucocorticoids|mesh-ancestor
5845108|NCT02479074|Hormones|hormones|mesh-ancestor
5845109|NCT02479074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5845110|NCT02479074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845111|NCT02479074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5845112|NCT02479074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5845113|NCT02479074|Antiemetics|antiemetics|mesh-ancestor
5845114|NCT02479074|Autonomic Agents|autonomic agents|mesh-ancestor
5845115|NCT02479074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5845116|NCT02479074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5845117|NCT02479074|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5845118|NCT02479074|Protective Agents|protective agents|mesh-ancestor
5845119|NCT02479074|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5845120|NCT02479074|Respiratory System Agents|respiratory system agents|mesh-ancestor
5845121|NCT02479074|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5845122|NCT02479074|Hormone Antagonists|hormone antagonists|mesh-ancestor
5845123|NCT02479074|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5845124|NCT02479074|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5845125|NCT02479074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664395|NCT03609190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5664396|NCT03609190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664397|NCT03609125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5664398|NCT03609125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5664399|NCT03609099|Moxifloxacin|moxifloxacin|mesh-list
5664400|NCT03609099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5664401|NCT03609099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5664402|NCT03609099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5664403|NCT03609099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5664404|NCT03609099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5845140|NCT02478879|Teriparatide|teriparatide|mesh-list
5845141|NCT02478879|Parathyroid Hormone|parathyroid hormone|mesh-list
5845142|NCT02478879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845143|NCT02478879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6212050|NCT02181075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212051|NCT02181075|Hematinics|hematinics|mesh-ancestor
6212052|NCT02181127|Glucagon|glucagon|mesh-list
6212053|NCT02181127|Pancrelipase|pancrelipase|mesh-list
6212054|NCT02181127|Pancreatin|pancreatin|mesh-list
6212055|NCT02181127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6212056|NCT02181127|Hormones|hormones|mesh-ancestor
6212057|NCT02181127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6212058|NCT02181127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212059|NCT02181231|Buprenorphine|buprenorphine|mesh-list
5664405|NCT03609099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664406|NCT03609099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5664407|NCT03609086|Melatonin|melatonin|mesh-list
5664408|NCT03609086|Antioxidants|antioxidants|mesh-ancestor
5664409|NCT03609086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212060|NCT02181231|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6212061|NCT02181231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6212062|NCT02181231|Narcotics|narcotics|mesh-ancestor
5664410|NCT03609086|Protective Agents|protective agents|mesh-ancestor
5845144|NCT02478879|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5845145|NCT02478645|Ramosetron|ramosetron|mesh-list
5845146|NCT02478645|Antiemetics|antiemetics|mesh-ancestor
5845147|NCT02478645|Autonomic Agents|autonomic agents|mesh-ancestor
5845148|NCT02478645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5845149|NCT02478645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845150|NCT02478645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5845151|NCT02478645|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5845152|NCT02478645|Serotonin Agents|serotonin agents|mesh-ancestor
5845153|NCT02478645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5845154|NCT02478645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5845155|NCT02478515|Ranibizumab|ranibizumab|mesh-list
5845156|NCT02478515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5845157|NCT02478515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5845158|NCT02478515|Growth Substances|growth substances|mesh-ancestor
5845159|NCT02478515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845160|NCT02478515|Growth Inhibitors|growth inhibitors|mesh-ancestor
5845161|NCT02478515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5845162|NCT02478424|Cyclosporine|cyclosporine|mesh-list
5845163|NCT02478424|Methotrexate|methotrexate|mesh-list
5845164|NCT02478424|Cannabidiol|cannabidiol|mesh-list
5845165|NCT02478424|Cyclosporins|cyclosporins|mesh-list
5845166|NCT02478424|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5845167|NCT02478424|Abortifacient Agents|abortifacient agents|mesh-ancestor
5664411|NCT03609086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664412|NCT03609086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5664413|NCT03609060|Dexamethasone|dexamethasone|mesh-list
5664414|NCT03609060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5845168|NCT02478424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5845169|NCT02478424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845170|NCT02478424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5845171|NCT02478424|Antimetabolites|antimetabolites|mesh-ancestor
5845172|NCT02478424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5845173|NCT02478424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5845174|NCT02478424|Dermatologic Agents|dermatologic agents|mesh-ancestor
5845175|NCT02478424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5845176|NCT02478424|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5845177|NCT02478424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5845178|NCT02478424|Immunologic Factors|immunologic factors|mesh-ancestor
5845179|NCT02478424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5845180|NCT02478424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5845181|NCT02478424|Antifungal Agents|antifungal agents|mesh-ancestor
5845182|NCT02478424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5903616|NCT04691505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6212063|NCT02181231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5845183|NCT02478424|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5664415|NCT03609060|Antiemetics|antiemetics|mesh-ancestor
5664416|NCT03609060|Autonomic Agents|autonomic agents|mesh-ancestor
5664417|NCT03609060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5664418|NCT03609060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664419|NCT03609060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5664420|NCT03609060|Glucocorticoids|glucocorticoids|mesh-ancestor
5664421|NCT03609060|Hormones|hormones|mesh-ancestor
5664422|NCT03609060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5664423|NCT03609060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5664424|NCT03609060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5845184|NCT02478424|Anticonvulsants|anticonvulsants|mesh-ancestor
5845185|NCT02478710|Vancomycin|vancomycin|mesh-list
5845186|NCT02478710|Tobramycin|tobramycin|mesh-list
5845187|NCT02478710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5845188|NCT02478710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5845189|NCT02478320|Ilorasertib|ilorasertib|mesh-list
5845190|NCT02478320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5845191|NCT02478320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5845192|NCT02478320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5845193|NCT02478320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5845194|NCT02478294|Warfarin|warfarin|mesh-list
5845195|NCT02478294|Anticoagulants|anticoagulants|mesh-list
5845196|NCT02478281|Methylene Blue|methylene blue|mesh-list
5845197|NCT02478281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5845198|NCT02478281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5845199|NCT02478268|Xenon|xenon|mesh-list
5845200|NCT02478268|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5845201|NCT02478268|Anesthetics, General|anesthetics, general|mesh-ancestor
5845202|NCT02478268|Anesthetics|anesthetics|mesh-ancestor
5845203|NCT02478268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5845204|NCT02478268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845205|NCT02478125|Docetaxel|docetaxel|mesh-list
5845206|NCT02478125|Sargramostim|sargramostim|mesh-list
5845207|NCT02478125|Lenograstim|lenograstim|mesh-list
5845208|NCT02478125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5845209|NCT02478125|Tubulin Modulators|tubulin modulators|mesh-ancestor
5664425|NCT03609047|Paclitaxel|paclitaxel|mesh-list
5664426|NCT03609047|Docetaxel|docetaxel|mesh-list
5664427|NCT03609047|Cyclophosphamide|cyclophosphamide|mesh-list
5664428|NCT03609047|Doxorubicin|doxorubicin|mesh-list
5664429|NCT03609047|Epirubicin|epirubicin|mesh-list
5664430|NCT03609047|Palbociclib|palbociclib|mesh-list
5664431|NCT03609047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5664432|NCT03609047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5664433|NCT03609047|Tubulin Modulators|tubulin modulators|mesh-ancestor
5664434|NCT03609047|Antimitotic Agents|antimitotic agents|mesh-ancestor
5845210|NCT02478125|Antimitotic Agents|antimitotic agents|mesh-ancestor
5845211|NCT02478125|Mitosis Modulators|mitosis modulators|mesh-ancestor
5845212|NCT02478125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5845213|NCT02478125|Immunologic Factors|immunologic factors|mesh-ancestor
5845214|NCT02478125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845215|NCT02478125|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5845216|NCT02478047|Dexamethasone|dexamethasone|mesh-list
5845217|NCT02478047|Ramosetron|ramosetron|mesh-list
5845218|NCT02478047|Antiemetics|antiemetics|mesh-list
5845219|NCT02478047|Tropisetron|tropisetron|mesh-list
5845220|NCT02478047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5845221|NCT02478047|Autonomic Agents|autonomic agents|mesh-ancestor
5845222|NCT02478047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5845223|NCT02478047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845224|NCT02478047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5845225|NCT02478047|Glucocorticoids|glucocorticoids|mesh-ancestor
5845226|NCT02478047|Hormones|hormones|mesh-ancestor
5845227|NCT02478047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5845228|NCT02478047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5845229|NCT02478047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5845230|NCT02478047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5845231|NCT02478047|Serotonin Agents|serotonin agents|mesh-ancestor
5845232|NCT02478047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5845233|NCT02478047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5845234|NCT02478047|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5664435|NCT03609047|Mitosis Modulators|mitosis modulators|mesh-ancestor
5845235|NCT02478242|Nafamostat|nafamostat|mesh-list
5845236|NCT02478242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5845237|NCT02478242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5845238|NCT02478242|Analgesics|analgesics|mesh-ancestor
5845239|NCT02478242|Sensory System Agents|sensory system agents|mesh-ancestor
5845240|NCT02478242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5845241|NCT02478242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845242|NCT02478242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5845243|NCT02478242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5845244|NCT02478242|Anticoagulants|anticoagulants|mesh-ancestor
5845245|NCT02478242|Protease Inhibitors|protease inhibitors|mesh-ancestor
5845246|NCT02478242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5845247|NCT02478242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5845248|NCT02478242|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5845249|NCT02478242|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5845250|NCT02478242|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5845251|NCT02478242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5845252|NCT02478242|Immunologic Factors|immunologic factors|mesh-ancestor
5845253|NCT02478229|Sofosbuvir|sofosbuvir|mesh-list
5845254|NCT02478229|Ledipasvir|ledipasvir|mesh-list
5845255|NCT02478229|Antiviral Agents|antiviral agents|mesh-ancestor
5845256|NCT02478229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5845257|NCT02478255|Xenon|xenon|mesh-list
5845258|NCT02478255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5664436|NCT03609047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664437|NCT03609047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5664438|NCT03609047|Immunologic Factors|immunologic factors|mesh-ancestor
5664439|NCT03609047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664440|NCT03609047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5664441|NCT03609047|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5664442|NCT03609047|Alkylating Agents|alkylating agents|mesh-ancestor
5664443|NCT03609047|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5664444|NCT03609047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5664445|NCT03609047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5664446|NCT03609047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5664447|NCT03609047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5664448|NCT03609047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5845259|NCT02478255|Anesthetics, General|anesthetics, general|mesh-ancestor
5845260|NCT02478255|Anesthetics|anesthetics|mesh-ancestor
5845261|NCT02478255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5845262|NCT02478255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845263|NCT02478099|Atezolizumab|atezolizumab|mesh-list
5845264|NCT02478099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5845265|NCT02478021|Hydrocortisone|hydrocortisone|mesh-list
5845266|NCT02478021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5845267|NCT02478034|Fludrocortisone|fludrocortisone|mesh-list
5845268|NCT02478034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5845269|NCT02477956|Vitamin D|vitamin d|mesh-list
5845270|NCT02477956|Ergocalciferols|ergocalciferols|mesh-list
5845271|NCT02477956|Cholecalciferol|cholecalciferol|mesh-list
5845272|NCT02477956|Vitamins|vitamins|mesh-list
5845273|NCT02477956|Micronutrients|micronutrients|mesh-ancestor
5845274|NCT02477956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845275|NCT02477956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5845276|NCT02477956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5845277|NCT02477969|Metformin|metformin|mesh-list
5845278|NCT02477969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5845279|NCT02477969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845280|NCT02477995|Vaccines|vaccines|mesh-list
5664449|NCT03609008|Cromakalim|cromakalim|mesh-list
5664450|NCT03609008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5664451|NCT03609008|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5664452|NCT03609008|Autonomic Agents|autonomic agents|mesh-ancestor
5664453|NCT03609008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5664454|NCT03609008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664455|NCT03609008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5664456|NCT03609008|Respiratory System Agents|respiratory system agents|mesh-ancestor
5664457|NCT03609008|Parasympatholytics|parasympatholytics|mesh-ancestor
5664458|NCT03609008|Vasodilator Agents|vasodilator agents|mesh-ancestor
5664459|NCT03608761|Rebamipide|rebamipide|mesh-list
5664460|NCT03608761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5664461|NCT03608761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5664462|NCT03608761|Antioxidants|antioxidants|mesh-ancestor
5664463|NCT03608761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664464|NCT03608761|Protective Agents|protective agents|mesh-ancestor
5664465|NCT03608761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664466|NCT03608761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5664467|NCT03608618|Cyclophosphamide|cyclophosphamide|mesh-list
5845281|NCT02477995|Immunologic Factors|immunologic factors|mesh-ancestor
5845282|NCT02477995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845283|NCT02477891|Daratumumab|daratumumab|mesh-list
5664468|NCT03608618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5664469|NCT03608618|Immunologic Factors|immunologic factors|mesh-ancestor
5664470|NCT03608618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664471|NCT03608618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5664472|NCT03608618|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5664473|NCT03608618|Alkylating Agents|alkylating agents|mesh-ancestor
5664474|NCT03608618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664475|NCT03608618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5664476|NCT03608618|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5664477|NCT03608514|Terlipressin|terlipressin|mesh-list
5845284|NCT02477891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5845285|NCT02477852|Rifampin|rifampin|mesh-list
5845286|NCT02477852|Isoniazid|isoniazid|mesh-list
5845287|NCT02477852|Pyrazinamide|pyrazinamide|mesh-list
5845288|NCT02477852|Ethambutol|ethambutol|mesh-list
5845289|NCT02477852|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5845290|NCT02477852|Antitubercular Agents|antitubercular agents|mesh-ancestor
5845291|NCT02477852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5845292|NCT02477852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5845293|NCT02477852|Leprostatic Agents|leprostatic agents|mesh-ancestor
5845294|NCT02477852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5845295|NCT02477852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5845296|NCT02477852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5845297|NCT02477852|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5845298|NCT02477852|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5845299|NCT02477852|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5845300|NCT02477852|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5845301|NCT02477852|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5845302|NCT02477852|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5845303|NCT02477852|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5845304|NCT02477852|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5845305|NCT02477852|Antimetabolites|antimetabolites|mesh-ancestor
5845306|NCT02477852|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5845307|NCT02477813|Temozolomide|temozolomide|mesh-list
5845308|NCT02477813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5845309|NCT02477813|Alkylating Agents|alkylating agents|mesh-ancestor
5845310|NCT02477813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5845311|NCT02477813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5845312|NCT02477826|Gemcitabine|gemcitabine|mesh-list
5845313|NCT02477826|Paclitaxel|paclitaxel|mesh-list
5845314|NCT02477826|Carboplatin|carboplatin|mesh-list
5845315|NCT02477826|Nivolumab|nivolumab|mesh-list
5845316|NCT02477826|Pemetrexed|pemetrexed|mesh-list
5845317|NCT02477826|Ipilimumab|ipilimumab|mesh-list
5845318|NCT02477826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5845319|NCT02477826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5845320|NCT02477826|Tubulin Modulators|tubulin modulators|mesh-ancestor
5845321|NCT02477826|Antimitotic Agents|antimitotic agents|mesh-ancestor
5845322|NCT02477826|Mitosis Modulators|mitosis modulators|mesh-ancestor
5845323|NCT02477826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5845324|NCT02477826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5845325|NCT02477826|Antimetabolites|antimetabolites|mesh-ancestor
5845326|NCT02477826|Antiviral Agents|antiviral agents|mesh-ancestor
5845327|NCT02477826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5845328|NCT02477826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5845329|NCT02477826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5845330|NCT02477826|Immunologic Factors|immunologic factors|mesh-ancestor
5845331|NCT02477826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845332|NCT02477826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5845333|NCT02477826|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5845334|NCT02477826|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5845335|NCT02477826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5845336|NCT02477566|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5845337|NCT02477566|Luteolytic Agents|luteolytic agents|mesh-ancestor
5845338|NCT02477566|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5845339|NCT02477566|Contraceptive Agents|contraceptive agents|mesh-ancestor
5845340|NCT02477566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5845341|NCT02477566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845342|NCT02477566|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5845343|NCT02477566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5845344|NCT02477566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5903617|NCT04691505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5903618|NCT04691505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5903619|NCT04682405|Melphalan|melphalan|mesh-list
5903620|NCT04682405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5845345|NCT02477631|Deferiprone|deferiprone|mesh-list
5845346|NCT02477631|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5845347|NCT02477631|Chelating Agents|chelating agents|mesh-ancestor
5845348|NCT02477631|Sequestering Agents|sequestering agents|mesh-ancestor
5845349|NCT02477631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5845350|NCT02477514|Tedizolid|tedizolid|mesh-list
5845351|NCT02477514|Tedizolid phosphate|tedizolid phosphate|mesh-list
5845352|NCT02477514|Midazolam|midazolam|mesh-list
5845353|NCT02477514|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5845354|NCT02477514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5845355|NCT02477514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5845356|NCT02477514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5845357|NCT02477514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845358|NCT02477514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5845359|NCT02477514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5845360|NCT02477514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5845361|NCT02477514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5845362|NCT02477514|Anesthetics, General|anesthetics, general|mesh-ancestor
5845363|NCT02477514|Anesthetics|anesthetics|mesh-ancestor
5845364|NCT02477514|GABA Modulators|gaba modulators|mesh-ancestor
5845365|NCT02477514|GABA Agents|gaba agents|mesh-ancestor
5845366|NCT02477514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5845367|NCT02477514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5845368|NCT02477514|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5845369|NCT02477514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5845370|NCT02477514|Antimetabolites|antimetabolites|mesh-ancestor
5845371|NCT02477514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5845372|NCT02477514|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5845373|NCT02477514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5845374|NCT02477514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5845375|NCT02477514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5845376|NCT02477501|Norepinephrine|norepinephrine|mesh-list
5845377|NCT02477501|Ephedrine|ephedrine|mesh-list
5845378|NCT02477501|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5845379|NCT02477501|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5845380|NCT02477501|Adrenergic Agents|adrenergic agents|mesh-ancestor
5845381|NCT02477501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5845382|NCT02477501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5845383|NCT02477501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845384|NCT02477501|Sympathomimetics|sympathomimetics|mesh-ancestor
5845385|NCT02477501|Autonomic Agents|autonomic agents|mesh-ancestor
5845386|NCT02477501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5845387|NCT02477501|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5845388|NCT02477501|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5845389|NCT02477488|Allopurinol|allopurinol|mesh-list
5845390|NCT02477488|Antimetabolites|antimetabolites|mesh-ancestor
5845391|NCT02477488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5845392|NCT02477488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5845393|NCT02477488|Gout Suppressants|gout suppressants|mesh-ancestor
5845394|NCT02477488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5845395|NCT02477488|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5845396|NCT02477488|Antioxidants|antioxidants|mesh-ancestor
5845397|NCT02477488|Protective Agents|protective agents|mesh-ancestor
5845398|NCT02477488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845399|NCT02477436|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
5845400|NCT02477436|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5845401|NCT02477436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5845402|NCT02477436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5845403|NCT02477397|Fluticasone|fluticasone|mesh-list
5845404|NCT02477397|Xhance|xhance|mesh-list
5845405|NCT02477397|Budesonide|budesonide|mesh-list
5845406|NCT02477397|Formoterol Fumarate|formoterol fumarate|mesh-list
5845407|NCT02477397|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5845408|NCT02477397|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
5845409|NCT02477397|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
5664478|NCT03608514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5664479|NCT03608514|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5664480|NCT03608501|Thalidomide|thalidomide|mesh-list
5664481|NCT03608501|Dexamethasone|dexamethasone|mesh-list
5664482|NCT03608501|Ixazomib|ixazomib|mesh-list
5664483|NCT03608501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5664484|NCT03608501|Antiemetics|antiemetics|mesh-ancestor
5664485|NCT03608501|Autonomic Agents|autonomic agents|mesh-ancestor
5664486|NCT03608501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5664487|NCT03608501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664488|NCT03608501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5845410|NCT02477397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5845411|NCT02477397|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5845412|NCT02477397|Autonomic Agents|autonomic agents|mesh-ancestor
5845413|NCT02477397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5845414|NCT02477397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845415|NCT02477397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5845416|NCT02477397|Respiratory System Agents|respiratory system agents|mesh-ancestor
5845417|NCT02477397|Dermatologic Agents|dermatologic agents|mesh-ancestor
5845418|NCT02477397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5845419|NCT02477397|Glucocorticoids|glucocorticoids|mesh-ancestor
5845420|NCT02477397|Hormones|hormones|mesh-ancestor
5845421|NCT02477397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5845422|NCT02477397|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5845423|NCT02477397|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5845424|NCT02477397|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5845425|NCT02477397|Adrenergic Agents|adrenergic agents|mesh-ancestor
5845426|NCT02477397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5845427|NCT02477397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5845428|NCT02477397|Sympathomimetics|sympathomimetics|mesh-ancestor
5845429|NCT02477267|Buprenorphine|buprenorphine|mesh-list
5845430|NCT02477267|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
5845431|NCT02477267|Naloxone|naloxone|mesh-list
5845432|NCT02477267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5845433|NCT02477267|Narcotics|narcotics|mesh-ancestor
5845434|NCT02477267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5845435|NCT02477267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845436|NCT02477267|Analgesics|analgesics|mesh-ancestor
5845437|NCT02477267|Sensory System Agents|sensory system agents|mesh-ancestor
5845438|NCT02477267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5845439|NCT02477267|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5845440|NCT02477280|Methylphenidate|methylphenidate|mesh-list
5845441|NCT02477280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5845442|NCT02477280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664489|NCT03608501|Glucocorticoids|glucocorticoids|mesh-ancestor
5664490|NCT03608501|Hormones|hormones|mesh-ancestor
5664491|NCT03608501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5664492|NCT03608501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5664493|NCT03608501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5664494|NCT03608501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664495|NCT03608501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5664496|NCT03608501|Immunologic Factors|immunologic factors|mesh-ancestor
5664497|NCT03608501|Leprostatic Agents|leprostatic agents|mesh-ancestor
5664498|NCT03608501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5664499|NCT03608501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5664500|NCT03608501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5664501|NCT03608501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5664502|NCT03608501|Growth Substances|growth substances|mesh-ancestor
5664503|NCT03608501|Growth Inhibitors|growth inhibitors|mesh-ancestor
5664504|NCT03608501|Protease Inhibitors|protease inhibitors|mesh-ancestor
5664505|NCT03608501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5664506|NCT03608358|Metformin|metformin|mesh-list
5664507|NCT03608358|Dapagliflozin|dapagliflozin|mesh-list
5664508|NCT03608358|Saxagliptin|saxagliptin|mesh-list
5664509|NCT03608358|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5664510|NCT03608358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664511|NCT03608358|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5664512|NCT03608358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664513|NCT03608358|Incretins|incretins|mesh-ancestor
5664514|NCT03608358|Hormones|hormones|mesh-ancestor
5664515|NCT03608358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5664516|NCT03608358|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5664517|NCT03608358|Protease Inhibitors|protease inhibitors|mesh-ancestor
5845443|NCT02477280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5845444|NCT02477280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5845445|NCT02477280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5845446|NCT02477280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5845447|NCT02477280|Dopamine Agents|dopamine agents|mesh-ancestor
5845448|NCT02477280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5845449|NCT02477306|Rabeprazole|rabeprazole|mesh-list
5845450|NCT02477306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5845451|NCT02477306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5845452|NCT02477306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5845453|NCT02477306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5845454|NCT02477306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5845455|NCT02477202|Levonorgestrel|levonorgestrel|mesh-list
5845456|NCT02477202|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5845457|NCT02477202|Contraceptive Agents|contraceptive agents|mesh-ancestor
5845458|NCT02477202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5845459|NCT02477202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845460|NCT02477202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5845461|NCT02477202|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5845462|NCT02477202|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5845463|NCT02477254|Vaccines|vaccines|mesh-list
5845464|NCT02477254|Immunologic Factors|immunologic factors|mesh-ancestor
5845465|NCT02477254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845466|NCT02476955|Paclitaxel|paclitaxel|mesh-list
5845467|NCT02476955|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5845468|NCT02476955|Carboplatin|carboplatin|mesh-list
5845469|NCT02476955|Anastrozole|anastrozole|mesh-list
5845470|NCT02476955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5845471|NCT02476955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5845472|NCT02476955|Tubulin Modulators|tubulin modulators|mesh-ancestor
5845473|NCT02476955|Antimitotic Agents|antimitotic agents|mesh-ancestor
5664518|NCT03608358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5664519|NCT03608306|Methamphetamine|methamphetamine|mesh-list
5664520|NCT03608306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5664521|NCT03608306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664522|NCT03608306|Sympathomimetics|sympathomimetics|mesh-ancestor
5664523|NCT03608306|Autonomic Agents|autonomic agents|mesh-ancestor
5664524|NCT03608306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5664525|NCT03608306|Dopamine Agents|dopamine agents|mesh-ancestor
5664526|NCT03608306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5664527|NCT03608306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664528|NCT03608306|Adrenergic Agents|adrenergic agents|mesh-ancestor
5664529|NCT03608306|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5664530|NCT03608306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5664531|NCT03608306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5664532|NCT03608306|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5695575|NCT03388541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5695576|NCT03388541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695577|NCT03388541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5695578|NCT03388541|Analgesics|analgesics|mesh-ancestor
5695579|NCT03388541|Sensory System Agents|sensory system agents|mesh-ancestor
5695580|NCT03388541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5695581|NCT03388541|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5695582|NCT03388541|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5695583|NCT03388541|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5695584|NCT03388541|Adrenergic Agents|adrenergic agents|mesh-ancestor
5695585|NCT03388541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5695586|NCT03388541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695587|NCT03388463|Omeprazole|omeprazole|mesh-list
5695588|NCT03388463|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5695589|NCT03388463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5695590|NCT03388463|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5695591|NCT03388463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5695592|NCT03388463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695593|NCT03388372|Temozolomide|temozolomide|mesh-list
5845474|NCT02476955|Mitosis Modulators|mitosis modulators|mesh-ancestor
5845475|NCT02476955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5845476|NCT02476955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5845477|NCT02476955|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5845478|NCT02476955|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5845479|NCT02476955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5845480|NCT02476955|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5845481|NCT02476955|Hormone Antagonists|hormone antagonists|mesh-ancestor
5845482|NCT02476955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5845483|NCT02476955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695594|NCT03388372|Nimotuzumab|nimotuzumab|mesh-list
5695595|NCT03388372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5845484|NCT02477007|Acetaminophen|acetaminophen|mesh-list
5845485|NCT02477007|Ibuprofen|ibuprofen|mesh-list
5845486|NCT02477007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5845487|NCT02477007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5845488|NCT02477007|Analgesics|analgesics|mesh-ancestor
5845489|NCT02477007|Sensory System Agents|sensory system agents|mesh-ancestor
5845490|NCT02477007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5664533|NCT03608241|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5664534|NCT03608241|Contraceptive Agents|contraceptive agents|mesh-list
5664535|NCT03608241|Contraceptives, Oral|contraceptives, oral|mesh-list
5664536|NCT03608241|Estradiol|estradiol|mesh-list
5664537|NCT03608241|Estrogens|estrogens|mesh-ancestor
5664538|NCT03608241|Hormones|hormones|mesh-ancestor
5664539|NCT03608241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5664540|NCT03608241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664541|NCT03608241|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5664542|NCT03608241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5664543|NCT03608241|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5664544|NCT03608241|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5664545|NCT03608098|Oxymetazoline|oxymetazoline|mesh-list
5664546|NCT03608098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5664547|NCT03608098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5664548|NCT03608098|Adrenergic Agents|adrenergic agents|mesh-ancestor
5664549|NCT03608098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5845491|NCT02477007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845492|NCT02477007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5845493|NCT02477007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5845494|NCT02477007|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5845495|NCT02477007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5845496|NCT02477007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5845497|NCT02477007|Antipyretics|antipyretics|mesh-ancestor
5845498|NCT02476799|Ketorolac|ketorolac|mesh-list
5845499|NCT02476799|Fentanyl|fentanyl|mesh-list
5845500|NCT02476799|Ropivacaine|ropivacaine|mesh-list
5845501|NCT02476799|Anesthetics, Local|anesthetics, local|mesh-ancestor
5845502|NCT02476799|Anesthetics|anesthetics|mesh-ancestor
5845503|NCT02476799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5845504|NCT02476799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845505|NCT02476799|Sensory System Agents|sensory system agents|mesh-ancestor
5845506|NCT02476799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5845507|NCT02476799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5845508|NCT02476799|Narcotics|narcotics|mesh-ancestor
5845509|NCT02476799|Analgesics|analgesics|mesh-ancestor
5845510|NCT02476799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5845511|NCT02476799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5845512|NCT02476799|Anesthetics, General|anesthetics, general|mesh-ancestor
5845513|NCT02476799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5845514|NCT02476799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5845515|NCT02476799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5845516|NCT02476799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5845517|NCT02476799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5845518|NCT02476799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5845519|NCT02476799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5845520|NCT02477098|Ropivacaine|ropivacaine|mesh-list
5845521|NCT02477098|Anesthetics, Local|anesthetics, local|mesh-ancestor
5845522|NCT02477098|Anesthetics|anesthetics|mesh-ancestor
5845523|NCT02477098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5845524|NCT02477098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845525|NCT02477098|Sensory System Agents|sensory system agents|mesh-ancestor
5845526|NCT02477098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5845527|NCT02477072|Heparin|heparin|mesh-list
5845528|NCT02477072|Calcium heparin|calcium heparin|mesh-list
5845529|NCT02477072|Anticoagulants|anticoagulants|mesh-ancestor
5845530|NCT02477072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5845531|NCT02477072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5845532|NCT02477072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5845533|NCT02476929|Nitrous Oxide|nitrous oxide|mesh-list
5845534|NCT02476929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5845535|NCT02476929|Anesthetics, General|anesthetics, general|mesh-ancestor
5845536|NCT02476929|Anesthetics|anesthetics|mesh-ancestor
5845537|NCT02476929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5845538|NCT02476929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845539|NCT02476929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5845540|NCT02476929|Analgesics|analgesics|mesh-ancestor
5845541|NCT02476929|Sensory System Agents|sensory system agents|mesh-ancestor
5845542|NCT02476929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5845543|NCT02476903|Hyaluronic Acid|hyaluronic acid|mesh-list
5845544|NCT02476903|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5845545|NCT02476903|Immunologic Factors|immunologic factors|mesh-ancestor
5845546|NCT02476903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845547|NCT02476903|Viscosupplements|viscosupplements|mesh-ancestor
5845548|NCT02476903|Protective Agents|protective agents|mesh-ancestor
5845549|NCT02476864|Macitentan|macitentan|mesh-list
5903621|NCT04682405|Alkylating Agents|alkylating agents|mesh-ancestor
5845550|NCT02476864|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
5845551|NCT02476864|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5845552|NCT02476864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5845553|NCT02476864|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
5845554|NCT02476981|Ephedrine|ephedrine|mesh-list
5845555|NCT02476981|Midazolam|midazolam|mesh-list
5845556|NCT02476981|Dexmedetomidine|dexmedetomidine|mesh-list
5845557|NCT02476981|Remifentanil|remifentanil|mesh-list
5845558|NCT02476981|Propofol|propofol|mesh-list
5845559|NCT02476981|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5845560|NCT02476981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5845561|NCT02476981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845562|NCT02476981|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5845563|NCT02476981|Anesthetics, General|anesthetics, general|mesh-ancestor
5845564|NCT02476981|Anesthetics|anesthetics|mesh-ancestor
5845565|NCT02476981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5845566|NCT02476981|Analgesics|analgesics|mesh-ancestor
5664550|NCT03608098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664551|NCT03608098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664552|NCT03608098|Sympathomimetics|sympathomimetics|mesh-ancestor
5664553|NCT03608098|Autonomic Agents|autonomic agents|mesh-ancestor
5664554|NCT03608098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5664555|NCT03608098|Nasal Decongestants|nasal decongestants|mesh-ancestor
5664556|NCT03608098|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5664557|NCT03608098|Respiratory System Agents|respiratory system agents|mesh-ancestor
5664558|NCT03608046|Irinotecan|irinotecan|mesh-list
5664559|NCT03608046|Cetuximab|cetuximab|mesh-list
5664560|NCT03608046|Avelumab|avelumab|mesh-list
5664561|NCT03608046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5664562|NCT03608046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5664563|NCT03608046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5664564|NCT03608046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664565|NCT03608046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5664566|NCT03608046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5664567|NCT03608007|Ensartinib|ensartinib|mesh-list
5664568|NCT03608007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5664569|NCT03608007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5664570|NCT03608007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5664571|NCT03608007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664572|NCT03607955|Paclitaxel|paclitaxel|mesh-list
5664573|NCT03607955|Carboplatin|carboplatin|mesh-list
5664574|NCT03607955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5664575|NCT03607955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5664576|NCT03607955|Tubulin Modulators|tubulin modulators|mesh-ancestor
5664577|NCT03607955|Antimitotic Agents|antimitotic agents|mesh-ancestor
5664578|NCT03607955|Mitosis Modulators|mitosis modulators|mesh-ancestor
5664579|NCT03607955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664580|NCT03607916|Morphine|morphine|mesh-list
5664581|NCT03607916|Prilocaine|prilocaine|mesh-list
5664582|NCT03607916|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5664583|NCT03607916|Narcotics|narcotics|mesh-ancestor
5664584|NCT03607916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5664585|NCT03607916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664586|NCT03607916|Analgesics|analgesics|mesh-ancestor
5664587|NCT03607916|Sensory System Agents|sensory system agents|mesh-ancestor
5664588|NCT03607916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5664589|NCT03607916|Anesthetics, Local|anesthetics, local|mesh-ancestor
5664590|NCT03607916|Anesthetics|anesthetics|mesh-ancestor
5664591|NCT03607903|Adalimumab|adalimumab|mesh-list
5664592|NCT03607903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5664593|NCT03607903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5664594|NCT03607851|Lacosamide|lacosamide|mesh-list
5664595|NCT03607851|Anticonvulsants|anticonvulsants|mesh-ancestor
5664596|NCT03607851|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5664597|NCT03607851|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5664598|NCT03607851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5664599|NCT03607851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664600|NCT03607734|Amoxicillin|amoxicillin|mesh-list
5664601|NCT03607734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5664602|NCT03607734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5664603|NCT03607656|Docetaxel|docetaxel|mesh-list
5664604|NCT03607656|Capecitabine|capecitabine|mesh-list
5664605|NCT03607656|Oxaliplatin|oxaliplatin|mesh-list
5664606|NCT03607656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5664607|NCT03607656|Tubulin Modulators|tubulin modulators|mesh-ancestor
5664608|NCT03607656|Antimitotic Agents|antimitotic agents|mesh-ancestor
5845567|NCT02476981|Sensory System Agents|sensory system agents|mesh-ancestor
5664609|NCT03607656|Mitosis Modulators|mitosis modulators|mesh-ancestor
5664610|NCT03607656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664611|NCT03607656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5664612|NCT03607656|Antimetabolites|antimetabolites|mesh-ancestor
5664613|NCT03607643|Leucovorin|leucovorin|mesh-list
5664614|NCT03607643|Gemcitabine|gemcitabine|mesh-list
5664615|NCT03607643|Bevacizumab|bevacizumab|mesh-list
5845568|NCT02476981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5845569|NCT02476981|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5845570|NCT02476981|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5845571|NCT02476981|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5845572|NCT02476981|Adrenergic Agents|adrenergic agents|mesh-ancestor
5845573|NCT02476981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5845574|NCT02476981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5845575|NCT02476981|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5845576|NCT02476981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5664616|NCT03607643|Oxaliplatin|oxaliplatin|mesh-list
5664617|NCT03607643|Irinotecan|irinotecan|mesh-list
5664618|NCT03607643|Temozolomide|temozolomide|mesh-list
5664619|NCT03607643|Bortezomib|bortezomib|mesh-list
5664620|NCT03607643|Cannabidiol|cannabidiol|mesh-list
5664621|NCT03607643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5664622|NCT03607643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5664623|NCT03607643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5664624|NCT03607643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5664625|NCT03607643|Growth Substances|growth substances|mesh-ancestor
5664626|NCT03607643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845577|NCT02476981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5845578|NCT02476981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5845579|NCT02476981|GABA Modulators|gaba modulators|mesh-ancestor
5845580|NCT02476981|GABA Agents|gaba agents|mesh-ancestor
5845581|NCT02476981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5845582|NCT02476981|Narcotics|narcotics|mesh-ancestor
5845583|NCT02476981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5845584|NCT02476981|Sympathomimetics|sympathomimetics|mesh-ancestor
5845585|NCT02476981|Autonomic Agents|autonomic agents|mesh-ancestor
5845586|NCT02476981|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5845587|NCT02476825|Fluticasone|fluticasone|mesh-list
5845588|NCT02476825|Xhance|xhance|mesh-list
5845589|NCT02476825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5845590|NCT02476825|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5845591|NCT02476825|Autonomic Agents|autonomic agents|mesh-ancestor
5845592|NCT02476825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5845593|NCT02476825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845594|NCT02476825|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5845595|NCT02476825|Respiratory System Agents|respiratory system agents|mesh-ancestor
5845596|NCT02476825|Dermatologic Agents|dermatologic agents|mesh-ancestor
5845597|NCT02476825|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5845598|NCT02476526|Acetylcysteine|acetylcysteine|mesh-list
5845599|NCT02476526|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5845600|NCT02476526|Antiviral Agents|antiviral agents|mesh-ancestor
5845601|NCT02476526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5845602|NCT02476526|Expectorants|expectorants|mesh-ancestor
5664627|NCT03607643|Growth Inhibitors|growth inhibitors|mesh-ancestor
5664628|NCT03607643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5664629|NCT03607643|Antimetabolites|antimetabolites|mesh-ancestor
5664630|NCT03607643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664631|NCT03607643|Antiviral Agents|antiviral agents|mesh-ancestor
5664632|NCT03607643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5664633|NCT03607643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5664634|NCT03607643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5664635|NCT03607643|Immunologic Factors|immunologic factors|mesh-ancestor
5664636|NCT03607643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5664637|NCT03607643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5664638|NCT03607643|Antidotes|antidotes|mesh-ancestor
5664639|NCT03607643|Protective Agents|protective agents|mesh-ancestor
5664640|NCT03607643|Vitamin B Complex|vitamin b complex|mesh-ancestor
5664641|NCT03607643|Vitamins|vitamins|mesh-ancestor
5664642|NCT03607643|Micronutrients|micronutrients|mesh-ancestor
5664643|NCT03607643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5664644|NCT03607643|Alkylating Agents|alkylating agents|mesh-ancestor
5664645|NCT03607643|Anticonvulsants|anticonvulsants|mesh-ancestor
5664646|NCT03607578|Sunscreening Agents|sunscreening agents|mesh-list
5664647|NCT03607578|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5664648|NCT03607578|Protective Agents|protective agents|mesh-ancestor
5664649|NCT03607578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845603|NCT02476526|Respiratory System Agents|respiratory system agents|mesh-ancestor
5908423|NCT04552847|Octreotide|octreotide|mesh-list
5845604|NCT02476526|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5845605|NCT02476526|Antioxidants|antioxidants|mesh-ancestor
5845606|NCT02476526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5845607|NCT02476526|Protective Agents|protective agents|mesh-ancestor
5845608|NCT02476526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845609|NCT02476526|Antidotes|antidotes|mesh-ancestor
5845610|NCT02476773|Aluminum Hydroxide|aluminum hydroxide|mesh-list
5845611|NCT02476773|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5845612|NCT02476773|Immunologic Factors|immunologic factors|mesh-ancestor
5845613|NCT02476773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845614|NCT02476773|Antacids|antacids|mesh-ancestor
5845615|NCT02476773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5845616|NCT02476773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5845617|NCT02476708|Curcumin|curcumin|mesh-list
5845618|NCT02476708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5845619|NCT02476708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5845620|NCT02476708|Analgesics|analgesics|mesh-ancestor
5845621|NCT02476708|Sensory System Agents|sensory system agents|mesh-ancestor
5845622|NCT02476708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5845623|NCT02476708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845624|NCT02476708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5845625|NCT02476708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5845626|NCT02476708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5845627|NCT02476708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5845628|NCT02476708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5845629|NCT02476760|Insulin|insulin|mesh-list
5845630|NCT02476760|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5845631|NCT02476760|Metformin|metformin|mesh-list
5845632|NCT02476760|Pioglitazone|pioglitazone|mesh-list
5664650|NCT03607578|Dermatologic Agents|dermatologic agents|mesh-ancestor
5664651|NCT03607422|Upadacitinib|upadacitinib|mesh-list
5664652|NCT03607422|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
5664653|NCT03607422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5664654|NCT03607422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5664655|NCT03607422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664656|NCT03607422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5664657|NCT03607383|Red yeast rice|red yeast rice|mesh-list
5664658|NCT03607383|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5845633|NCT02476760|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5845634|NCT02476760|Liraglutide|liraglutide|mesh-list
5845635|NCT02476760|Exenatide|exenatide|mesh-list
5845636|NCT02476760|Glimepiride|glimepiride|mesh-list
5845637|NCT02476760|Rosiglitazone|rosiglitazone|mesh-list
5845638|NCT02476760|Saxagliptin|saxagliptin|mesh-list
5664659|NCT03607383|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5664660|NCT03607383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5664661|NCT03607383|Antimetabolites|antimetabolites|mesh-ancestor
5664662|NCT03607383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664663|NCT03607383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5664664|NCT03607383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5664665|NCT03607331|Citalopram|citalopram|mesh-list
5664666|NCT03607331|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5664667|NCT03607331|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5664668|NCT03607331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5664669|NCT03607331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664670|NCT03607331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5664671|NCT03607331|Serotonin Agents|serotonin agents|mesh-ancestor
5664672|NCT03607331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664673|NCT03607331|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5664674|NCT03607331|Antidepressive Agents|antidepressive agents|mesh-ancestor
5664675|NCT03607331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5664676|NCT03607227|Levobupivacaine|levobupivacaine|mesh-list
5664677|NCT03607227|Anesthetics, Local|anesthetics, local|mesh-ancestor
5664678|NCT03607227|Anesthetics|anesthetics|mesh-ancestor
5664679|NCT03607227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5664680|NCT03607227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664681|NCT03607227|Sensory System Agents|sensory system agents|mesh-ancestor
5845639|NCT02476760|Vildagliptin|vildagliptin|mesh-list
5845640|NCT02476760|Acarbose|acarbose|mesh-list
5845641|NCT02476760|Hypoglycemic Agents|hypoglycemic agents|mesh-list
5845642|NCT02476760|Repaglinide|repaglinide|mesh-list
5845643|NCT02476760|Gliclazide|gliclazide|mesh-list
5845644|NCT02476760|Glipizide|glipizide|mesh-list
5845645|NCT02476760|Tolbutamide|tolbutamide|mesh-list
5664682|NCT03607227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5845646|NCT02476760|Biguanides|biguanides|mesh-list
5845647|NCT02476760|Voglibose|voglibose|mesh-list
5845648|NCT02476760|Nateglinide|nateglinide|mesh-list
5664683|NCT03607175|Triamcinolone|triamcinolone|mesh-list
5845649|NCT02476760|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
5845650|NCT02476760|Miglitol|miglitol|mesh-list
5845651|NCT02476760|Troglitazone|troglitazone|mesh-list
5845652|NCT02476760|Meglitinide|meglitinide|mesh-list
5845653|NCT02476760|Acetohexamide|acetohexamide|mesh-list
5845654|NCT02476760|Phenformin|phenformin|mesh-list
5845655|NCT02476760|Buformin|buformin|mesh-list
5845656|NCT02476760|Chlorpropamide|chlorpropamide|mesh-list
5845657|NCT02476760|Glibornuride|glibornuride|mesh-list
5845658|NCT02476760|Tolazamide|tolazamide|mesh-list
5845659|NCT02476760|Carbutamide|carbutamide|mesh-list
5845660|NCT02476760|Gliquidone|gliquidone|mesh-list
5845661|NCT02476760|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
5845662|NCT02476760|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
5664684|NCT03607175|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5664685|NCT03607175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5664686|NCT03607175|Glucocorticoids|glucocorticoids|mesh-ancestor
5664687|NCT03607175|Hormones|hormones|mesh-ancestor
5664688|NCT03607175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5664689|NCT03607175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845663|NCT02476760|Incretins|incretins|mesh-list
5845664|NCT02476760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845665|NCT02476760|Hormones|hormones|mesh-ancestor
5845666|NCT02476760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5845667|NCT02476760|Protease Inhibitors|protease inhibitors|mesh-ancestor
5845668|NCT02476760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5845669|NCT02476760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5845670|NCT02476760|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5845671|NCT02476760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5845672|NCT02476760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5845673|NCT02476760|Immunologic Factors|immunologic factors|mesh-ancestor
5845674|NCT02476552|Niraparib|niraparib|mesh-list
5845675|NCT02476552|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5845676|NCT02476552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5845677|NCT02476552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664690|NCT03607175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5664691|NCT03607175|Immunologic Factors|immunologic factors|mesh-ancestor
5664692|NCT03607149|Pemetrexed|pemetrexed|mesh-list
5664693|NCT03607149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5664694|NCT03607149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5845678|NCT02476552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5845679|NCT02476279|Indomethacin|indomethacin|mesh-list
5845680|NCT02476279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5845681|NCT02476279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5845682|NCT02476279|Analgesics|analgesics|mesh-ancestor
5845683|NCT02476279|Sensory System Agents|sensory system agents|mesh-ancestor
5845684|NCT02476279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5845685|NCT02476279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845686|NCT02476279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5845687|NCT02476279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5845688|NCT02476279|Gout Suppressants|gout suppressants|mesh-ancestor
5845689|NCT02476279|Tocolytic Agents|tocolytic agents|mesh-ancestor
5845690|NCT02476279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5845691|NCT02476279|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5845692|NCT02476279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5845693|NCT02476279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5845694|NCT02476409|Tolvaptan|tolvaptan|mesh-list
5845695|NCT02476409|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
5845696|NCT02476409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5845697|NCT02476409|Natriuretic Agents|natriuretic agents|mesh-ancestor
5845698|NCT02476409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845699|NCT02476136|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5845700|NCT02476136|Fluoxetine|fluoxetine|mesh-list
5845701|NCT02476136|Paroxetine|paroxetine|mesh-list
5845702|NCT02476136|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
5845703|NCT02476136|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5845704|NCT02476136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5845705|NCT02476136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5845706|NCT02476136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5845707|NCT02476136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5845708|NCT02476136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845709|NCT02476136|Analgesics|analgesics|mesh-ancestor
5845710|NCT02476136|Sensory System Agents|sensory system agents|mesh-ancestor
5845711|NCT02476136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5845712|NCT02476136|Antidepressive Agents|antidepressive agents|mesh-ancestor
5845713|NCT02476136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5845714|NCT02476136|Dopamine Agents|dopamine agents|mesh-ancestor
5845715|NCT02476136|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5845716|NCT02476136|Serotonin Agents|serotonin agents|mesh-ancestor
5845717|NCT02476136|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5845718|NCT02476136|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5845719|NCT02476136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5845720|NCT02476136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5845721|NCT02476123|Nivolumab|nivolumab|mesh-list
5845722|NCT02476123|Mogamulizumab|mogamulizumab|mesh-list
5845723|NCT02476123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5845724|NCT02476123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5845725|NCT02476123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5845726|NCT02476123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5845727|NCT02476045|Leucovorin|leucovorin|mesh-list
5845728|NCT02476045|Fluorouracil|fluorouracil|mesh-list
5845729|NCT02476045|Oxaliplatin|oxaliplatin|mesh-list
5845730|NCT02476045|Panitumumab|panitumumab|mesh-list
5845731|NCT02476045|Levoleucovorin|levoleucovorin|mesh-list
5845732|NCT02476045|Antimetabolites|antimetabolites|mesh-ancestor
5845733|NCT02476045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5845734|NCT02476045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5845735|NCT02476045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5845736|NCT02476045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5845737|NCT02476045|Immunologic Factors|immunologic factors|mesh-ancestor
5845738|NCT02476045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845739|NCT02476045|Antidotes|antidotes|mesh-ancestor
5845740|NCT02476045|Protective Agents|protective agents|mesh-ancestor
5845741|NCT02476045|Vitamin B Complex|vitamin b complex|mesh-ancestor
5845742|NCT02476045|Vitamins|vitamins|mesh-ancestor
5845743|NCT02476045|Micronutrients|micronutrients|mesh-ancestor
5845744|NCT02476045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5845745|NCT02475876|Clindamycin|clindamycin|mesh-list
5845746|NCT02475876|Clindamycin palmitate|clindamycin palmitate|mesh-list
5845747|NCT02475876|Clindamycin phosphate|clindamycin phosphate|mesh-list
5845748|NCT02475876|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
5845749|NCT02475876|Trimethoprim|trimethoprim|mesh-list
5845750|NCT02475876|Sulfamethoxazole|sulfamethoxazole|mesh-list
5664695|NCT03607149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664696|NCT03607149|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5664697|NCT03607149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5664698|NCT03607110|Fentanyl|fentanyl|mesh-list
5664699|NCT03607110|Ketamine|ketamine|mesh-list
5664700|NCT03607110|Analgesics|analgesics|mesh-ancestor
5664701|NCT03607110|Sensory System Agents|sensory system agents|mesh-ancestor
5664702|NCT03607110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5664703|NCT03607110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664704|NCT03607110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5664705|NCT03607110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5664706|NCT03607110|Anesthetics, General|anesthetics, general|mesh-ancestor
5664707|NCT03607110|Anesthetics|anesthetics|mesh-ancestor
5664708|NCT03607110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5664709|NCT03607110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5664710|NCT03607110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5664711|NCT03607110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5845751|NCT02475876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5845752|NCT02475876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5845753|NCT02475876|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5845754|NCT02475876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5845755|NCT02475876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5845756|NCT02475876|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5845757|NCT02475876|Renal Agents|renal agents|mesh-ancestor
5845758|NCT02475876|Antimalarials|antimalarials|mesh-ancestor
5845759|NCT02475876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5845760|NCT02475876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5664712|NCT03607110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664713|NCT03607110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5664714|NCT03607110|Narcotics|narcotics|mesh-ancestor
5664715|NCT03607110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5664716|NCT03607071|Prednisolone|prednisolone|mesh-list
5664717|NCT03607071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5664718|NCT03607071|Glucocorticoids|glucocorticoids|mesh-ancestor
5664719|NCT03607071|Hormones|hormones|mesh-ancestor
5664720|NCT03607071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5664721|NCT03607071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664722|NCT03607071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5664723|NCT03607071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5664724|NCT03606980|Dexamethasone|dexamethasone|mesh-list
5664725|NCT03606980|Dexamethasone acetate|dexamethasone acetate|mesh-list
5664726|NCT03606980|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
5664727|NCT03606980|BB 1101|bb 1101|mesh-list
5664728|NCT03606980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5664729|NCT03606980|Antiemetics|antiemetics|mesh-ancestor
5664730|NCT03606980|Autonomic Agents|autonomic agents|mesh-ancestor
5664731|NCT03606980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5664732|NCT03606980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664733|NCT03606980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5664734|NCT03606980|Glucocorticoids|glucocorticoids|mesh-ancestor
5845761|NCT02475876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5845762|NCT02475876|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5845763|NCT02475876|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
5845764|NCT02475876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5903622|NCT04682405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664735|NCT03606980|Hormones|hormones|mesh-ancestor
5664736|NCT03606980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5664737|NCT03606980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5664738|NCT03606980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5664739|NCT03606980|Protease Inhibitors|protease inhibitors|mesh-ancestor
5903623|NCT04682405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5903624|NCT04682405|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5903625|NCT04682405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5903626|NCT04682405|Immunologic Factors|immunologic factors|mesh-ancestor
5903627|NCT04682405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903628|NCT04682366|Tamsulosin|tamsulosin|mesh-list
5903629|NCT04682366|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5903630|NCT04682366|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5903631|NCT04682366|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5903632|NCT04682366|Adrenergic Agents|adrenergic agents|mesh-ancestor
5903633|NCT04682366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5903634|NCT04682366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903635|NCT04682366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903636|NCT04682366|Urological Agents|urological agents|mesh-ancestor
5903637|NCT04678401|Cyclophosphamide|cyclophosphamide|mesh-list
5903638|NCT04678401|Thiotepa|thiotepa|mesh-list
5903639|NCT04678401|Fludarabine|fludarabine|mesh-list
5903640|NCT04678401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5903641|NCT04678401|Immunologic Factors|immunologic factors|mesh-ancestor
5903642|NCT04678401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903643|NCT04678401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5903644|NCT04678401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5903645|NCT04678401|Alkylating Agents|alkylating agents|mesh-ancestor
5903646|NCT04678401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903647|NCT04678401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5903648|NCT04678401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5903649|NCT04660045|Acalabrutinib|acalabrutinib|mesh-list
5903650|NCT04660045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5903651|NCT04635826|Adderall|adderall|mesh-list
5903652|NCT04635826|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5903653|NCT04635826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903654|NCT04596579|Antibodies|antibodies|mesh-list
5903655|NCT04596579|Immunologic Factors|immunologic factors|mesh-ancestor
5903656|NCT04596579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903657|NCT04590586|Thalidomide|thalidomide|mesh-list
5903658|NCT04590586|Apremilast|apremilast|mesh-list
5903659|NCT04590586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5903660|NCT04590586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5903661|NCT04590586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5903662|NCT04590586|Analgesics|analgesics|mesh-ancestor
5903663|NCT04590586|Sensory System Agents|sensory system agents|mesh-ancestor
5903664|NCT04590586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5903665|NCT04590586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903666|NCT04590586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5903667|NCT04590586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5903668|NCT04590586|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5664740|NCT03606980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5664741|NCT03606980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664742|NCT03606928|Leucovorin|leucovorin|mesh-list
5903669|NCT04590586|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5903670|NCT04590586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5664743|NCT03606928|Docetaxel|docetaxel|mesh-list
5664744|NCT03606928|Oxaliplatin|oxaliplatin|mesh-list
5664745|NCT03606928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5664746|NCT03606928|Tubulin Modulators|tubulin modulators|mesh-ancestor
5664747|NCT03606928|Antimitotic Agents|antimitotic agents|mesh-ancestor
5664748|NCT03606928|Mitosis Modulators|mitosis modulators|mesh-ancestor
5664749|NCT03606928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664750|NCT03606928|Antidotes|antidotes|mesh-ancestor
5664751|NCT03606928|Protective Agents|protective agents|mesh-ancestor
5664752|NCT03606928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664753|NCT03606928|Vitamin B Complex|vitamin b complex|mesh-ancestor
5664754|NCT03606928|Vitamins|vitamins|mesh-ancestor
5664755|NCT03606928|Micronutrients|micronutrients|mesh-ancestor
5664756|NCT03606902|Fentanyl|fentanyl|mesh-list
5664757|NCT03606902|Bupivacaine|bupivacaine|mesh-list
5664758|NCT03606902|Anesthetics, Local|anesthetics, local|mesh-ancestor
5664759|NCT03606902|Anesthetics|anesthetics|mesh-ancestor
5664760|NCT03606902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5664761|NCT03606902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664762|NCT03606902|Sensory System Agents|sensory system agents|mesh-ancestor
5664763|NCT03606902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5845765|NCT02475863|Warfarin|warfarin|mesh-list
5845766|NCT02475863|Anticoagulants|anticoagulants|mesh-ancestor
5845767|NCT02475915|Tenofovir|tenofovir|mesh-list
5845768|NCT02475915|Emtricitabine|emtricitabine|mesh-list
5845769|NCT02475915|Efavirenz|efavirenz|mesh-list
5845770|NCT02475915|Maraviroc|maraviroc|mesh-list
5845771|NCT02475915|Darunavir|darunavir|mesh-list
5845772|NCT02475915|Hydroxychloroquine|hydroxychloroquine|mesh-list
5845773|NCT02475915|Vorinostat|vorinostat|mesh-list
5845774|NCT02475915|Antiviral Agents|antiviral agents|mesh-ancestor
5845775|NCT02475915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5845776|NCT02475915|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5845777|NCT02475915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5845778|NCT02475915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5845779|NCT02475915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5845780|NCT02475915|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5845781|NCT02475915|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5845782|NCT02475915|Antimalarials|antimalarials|mesh-ancestor
5845783|NCT02475915|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5845784|NCT02475915|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5845785|NCT02475915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5845786|NCT02475915|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5845787|NCT02475915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5845788|NCT02475915|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5845789|NCT02475915|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5845790|NCT02475915|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5845791|NCT02475915|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5845792|NCT02475915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5845793|NCT02475915|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5845794|NCT02475915|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5845795|NCT02475915|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5845796|NCT02475915|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
5845797|NCT02475915|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5845798|NCT02475915|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5664764|NCT03606902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5664765|NCT03606902|Narcotics|narcotics|mesh-ancestor
5664766|NCT03606902|Analgesics|analgesics|mesh-ancestor
5664767|NCT03606902|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5664768|NCT03606902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5664769|NCT03606902|Anesthetics, General|anesthetics, general|mesh-ancestor
5664770|NCT03606889|Bupivacaine|bupivacaine|mesh-list
5664771|NCT03606889|Anesthetics, Local|anesthetics, local|mesh-ancestor
5664772|NCT03606889|Anesthetics|anesthetics|mesh-ancestor
5664773|NCT03606889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5664774|NCT03606889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664775|NCT03606889|Sensory System Agents|sensory system agents|mesh-ancestor
5664776|NCT03606889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5845799|NCT02475915|Protease Inhibitors|protease inhibitors|mesh-ancestor
5845800|NCT02475772|Cisplatin|cisplatin|mesh-list
5845801|NCT02475772|Doxorubicin|doxorubicin|mesh-list
5845802|NCT02475772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5845803|NCT02475772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5845804|NCT02475772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6212064|NCT02181231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212065|NCT02181231|Analgesics|analgesics|mesh-ancestor
5664777|NCT03606837|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5664778|NCT03606837|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5664779|NCT03606837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5845805|NCT02475772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5845806|NCT02475772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5845807|NCT02475772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5664780|NCT03606824|Pitavastatin|pitavastatin|mesh-list
5664781|NCT03606824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5664782|NCT03606824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5664783|NCT03606824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5664784|NCT03606824|Antimetabolites|antimetabolites|mesh-ancestor
5664785|NCT03606824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664786|NCT03606824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5664787|NCT03606824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5695596|NCT03388372|Alkylating Agents|alkylating agents|mesh-ancestor
5695597|NCT03388372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695598|NCT03388372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5695599|NCT03388372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5845808|NCT02475772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5845809|NCT02475824|Midazolam|midazolam|mesh-list
5845810|NCT02475824|Meperidine|meperidine|mesh-list
5845811|NCT02475824|Dexmedetomidine|dexmedetomidine|mesh-list
5845812|NCT02475824|Propofol|propofol|mesh-list
5845813|NCT02475824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5845814|NCT02475824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5845815|NCT02475824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845816|NCT02475824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5845817|NCT02475824|Anesthetics, General|anesthetics, general|mesh-ancestor
5845818|NCT02475824|Anesthetics|anesthetics|mesh-ancestor
5845819|NCT02475824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5845820|NCT02475824|Analgesics|analgesics|mesh-ancestor
5845821|NCT02475824|Sensory System Agents|sensory system agents|mesh-ancestor
5845822|NCT02475824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5845823|NCT02475824|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5845824|NCT02475824|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5845825|NCT02475824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5845826|NCT02475824|Adrenergic Agents|adrenergic agents|mesh-ancestor
5845827|NCT02475824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5695600|NCT03388346|Edetic Acid|edetic acid|mesh-list
5695601|NCT03388346|Chelating Agents|chelating agents|mesh-ancestor
5695602|NCT03388346|Sequestering Agents|sequestering agents|mesh-ancestor
5695603|NCT03388346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695604|NCT03388346|Anticoagulants|anticoagulants|mesh-ancestor
5695605|NCT03388346|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5845828|NCT02475824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5845829|NCT02475824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5845830|NCT02475824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5845831|NCT02475824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5845832|NCT02475824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5845833|NCT02475824|GABA Modulators|gaba modulators|mesh-ancestor
5845834|NCT02475824|GABA Agents|gaba agents|mesh-ancestor
5845835|NCT02475824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5845836|NCT02475824|Narcotics|narcotics|mesh-ancestor
5845837|NCT02475746|Itraconazole|itraconazole|mesh-list
5845838|NCT02475746|PF-06372865|pf-06372865|mesh-list
5845839|NCT02475746|Antifungal Agents|antifungal agents|mesh-ancestor
5845840|NCT02475746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5845841|NCT02475746|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5845842|NCT02475746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5845843|NCT02475746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5695606|NCT03388151|Midazolam|midazolam|mesh-list
5695607|NCT03388151|Propofol|propofol|mesh-list
5695608|NCT03388151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5695609|NCT03388151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5695610|NCT03388151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695611|NCT03388151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5695612|NCT03388151|Anesthetics, General|anesthetics, general|mesh-ancestor
5695613|NCT03388151|Anesthetics|anesthetics|mesh-ancestor
5695614|NCT03388151|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5695615|NCT03388151|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5695616|NCT03388151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5695617|NCT03388151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5695618|NCT03388151|GABA Modulators|gaba modulators|mesh-ancestor
5695619|NCT03388151|GABA Agents|gaba agents|mesh-ancestor
5695620|NCT03388151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5695621|NCT03388151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695622|NCT03388125|Ethanolamine oleate|ethanolamine oleate|mesh-list
5845844|NCT02475746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5845845|NCT02475746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5664788|NCT03606785|Tranexamic Acid|tranexamic acid|mesh-list
5664789|NCT03606785|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5664790|NCT03606785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5664791|NCT03606785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664792|NCT03606785|Hemostatics|hemostatics|mesh-ancestor
5664793|NCT03606785|Coagulants|coagulants|mesh-ancestor
5664794|NCT03606694|Metformin|metformin|mesh-list
5664795|NCT03606694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5664796|NCT03606694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664797|NCT03606681|Calcium, Dietary|calcium, dietary|mesh-list
5664798|NCT03606681|Calcium|calcium|mesh-list
5664799|NCT03606681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5664800|NCT03606681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664801|NCT03606681|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5664802|NCT03606590|Sorafenib|sorafenib|mesh-list
5664803|NCT03606590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5664804|NCT03606590|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5664805|NCT03606590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5695623|NCT03388125|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
5845846|NCT02475746|Hormone Antagonists|hormone antagonists|mesh-ancestor
5845847|NCT02475746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5845848|NCT02475746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845849|NCT02475746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5845850|NCT02475746|GABA Modulators|gaba modulators|mesh-ancestor
5845851|NCT02475746|GABA Agents|gaba agents|mesh-ancestor
6674715|NCT01571024|Antidotes|antidotes|mesh-ancestor
6674716|NCT01571024|Protective Agents|protective agents|mesh-ancestor
6674717|NCT01571024|Vitamin B Complex|vitamin b complex|mesh-ancestor
6674718|NCT01571024|Vitamins|vitamins|mesh-ancestor
6674719|NCT01571024|Micronutrients|micronutrients|mesh-ancestor
5845852|NCT02475746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5845853|NCT02475499|Metformin|metformin|mesh-list
5845854|NCT02475499|Pioglitazone|pioglitazone|mesh-list
5845855|NCT02475499|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5845856|NCT02475499|Liraglutide|liraglutide|mesh-list
5845857|NCT02475499|Exenatide|exenatide|mesh-list
5845858|NCT02475499|Glimepiride|glimepiride|mesh-list
5845859|NCT02475499|Rosiglitazone|rosiglitazone|mesh-list
5845860|NCT02475499|Saxagliptin|saxagliptin|mesh-list
5845861|NCT02475499|Vildagliptin|vildagliptin|mesh-list
5845862|NCT02475499|Acarbose|acarbose|mesh-list
5845863|NCT02475499|Hypoglycemic Agents|hypoglycemic agents|mesh-list
5845864|NCT02475499|Repaglinide|repaglinide|mesh-list
5845865|NCT02475499|Gliclazide|gliclazide|mesh-list
5845866|NCT02475499|Glipizide|glipizide|mesh-list
5845867|NCT02475499|Tolbutamide|tolbutamide|mesh-list
5845868|NCT02475499|Biguanides|biguanides|mesh-list
5845869|NCT02475499|Voglibose|voglibose|mesh-list
5845870|NCT02475499|Nateglinide|nateglinide|mesh-list
5845871|NCT02475499|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
5845872|NCT02475499|Miglitol|miglitol|mesh-list
5845873|NCT02475499|Troglitazone|troglitazone|mesh-list
5845874|NCT02475499|Meglitinide|meglitinide|mesh-list
5845875|NCT02475499|Acetohexamide|acetohexamide|mesh-list
5845876|NCT02475499|Phenformin|phenformin|mesh-list
6674720|NCT01571037|Milrinone|milrinone|mesh-list
5845877|NCT02475499|Buformin|buformin|mesh-list
5845878|NCT02475499|Chlorpropamide|chlorpropamide|mesh-list
5845879|NCT02475499|Glibornuride|glibornuride|mesh-list
5845880|NCT02475499|Tolazamide|tolazamide|mesh-list
5845881|NCT02475499|Carbutamide|carbutamide|mesh-list
5845882|NCT02475499|Gliquidone|gliquidone|mesh-list
5845883|NCT02475499|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
5845884|NCT02475499|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
5845885|NCT02475499|Incretins|incretins|mesh-list
5845886|NCT02475499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845887|NCT02475499|Hormones|hormones|mesh-ancestor
5845888|NCT02475499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6493904|NCT00616005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6493905|NCT00616005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6493906|NCT00616005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493907|NCT00616005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6493908|NCT00616005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6493909|NCT00616005|Alkylating Agents|alkylating agents|mesh-ancestor
6493910|NCT00616031|Paclitaxel|paclitaxel|mesh-list
6493911|NCT00616031|Carboplatin|carboplatin|mesh-list
6493912|NCT00616031|Nitroglycerin|nitroglycerin|mesh-list
6493913|NCT00616031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6493914|NCT00616031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6493915|NCT00616031|Tubulin Modulators|tubulin modulators|mesh-ancestor
6493916|NCT00616031|Antimitotic Agents|antimitotic agents|mesh-ancestor
6493917|NCT00616031|Mitosis Modulators|mitosis modulators|mesh-ancestor
6674721|NCT01571037|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5845889|NCT02475499|Protease Inhibitors|protease inhibitors|mesh-ancestor
5845890|NCT02475499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5845891|NCT02475499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5845892|NCT02475499|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5845893|NCT02475499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5845894|NCT02475499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5845895|NCT02475499|Immunologic Factors|immunologic factors|mesh-ancestor
5845896|NCT02475421|Glucagon|glucagon|mesh-list
5845897|NCT02475421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5845898|NCT02475421|Hormones|hormones|mesh-ancestor
5845899|NCT02475421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5845900|NCT02475421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845901|NCT02475681|Obinutuzumab|obinutuzumab|mesh-list
5845902|NCT02475681|Acalabrutinib|acalabrutinib|mesh-list
5845903|NCT02475681|Chlorambucil|chlorambucil|mesh-list
5845904|NCT02475681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5845905|NCT02475681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5845906|NCT02475681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5845907|NCT02475681|Alkylating Agents|alkylating agents|mesh-ancestor
5845908|NCT02475681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5845909|NCT02475382|Nivolumab|nivolumab|mesh-list
5845910|NCT02475382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5845911|NCT02475382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5845912|NCT02475382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5845913|NCT02475382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5845914|NCT02475304|Dimethyl Fumarate|dimethyl fumarate|mesh-list
5845915|NCT02475304|Dermatologic Agents|dermatologic agents|mesh-ancestor
5845916|NCT02475304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5845917|NCT02475304|Immunologic Factors|immunologic factors|mesh-ancestor
5845918|NCT02475304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845919|NCT02475343|Riboflavin|riboflavin|mesh-list
5845920|NCT02475343|Vitamin B Complex|vitamin b complex|mesh-ancestor
5845921|NCT02475343|Vitamins|vitamins|mesh-ancestor
5845922|NCT02475343|Micronutrients|micronutrients|mesh-ancestor
5845923|NCT02475343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845924|NCT02475343|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6493918|NCT00616031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493919|NCT00616031|Vasodilator Agents|vasodilator agents|mesh-ancestor
5845925|NCT02475343|Dermatologic Agents|dermatologic agents|mesh-ancestor
5845926|NCT02475356|Levonorgestrel|levonorgestrel|mesh-list
5845927|NCT02475356|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5845928|NCT02475356|Contraceptive Agents|contraceptive agents|mesh-ancestor
5845929|NCT02475356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5845930|NCT02475356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845931|NCT02475356|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5845932|NCT02475356|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5845933|NCT02475356|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5845934|NCT02475135|Tenofovir|tenofovir|mesh-list
6493920|NCT00616044|Anesthetics|anesthetics|mesh-list
6493921|NCT00616044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5664806|NCT03606590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664807|NCT03606577|Dexamethasone|dexamethasone|mesh-list
5664808|NCT03606577|Lenalidomide|lenalidomide|mesh-list
5664809|NCT03606577|Daratumumab|daratumumab|mesh-list
5664810|NCT03606577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5664811|NCT03606577|Antiemetics|antiemetics|mesh-ancestor
5664812|NCT03606577|Autonomic Agents|autonomic agents|mesh-ancestor
5664813|NCT03606577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5664814|NCT03606577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664815|NCT03606577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5664816|NCT03606577|Glucocorticoids|glucocorticoids|mesh-ancestor
5664817|NCT03606577|Hormones|hormones|mesh-ancestor
5664818|NCT03606577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5664819|NCT03606577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5664820|NCT03606577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5664821|NCT03606577|Immunologic Factors|immunologic factors|mesh-ancestor
5664822|NCT03606577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5664823|NCT03606577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5664824|NCT03606577|Growth Substances|growth substances|mesh-ancestor
5664825|NCT03606577|Growth Inhibitors|growth inhibitors|mesh-ancestor
5664826|NCT03606538|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
5664827|NCT03606538|Hallucinogens|hallucinogens|mesh-ancestor
5664828|NCT03606538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845935|NCT02475135|Emtricitabine|emtricitabine|mesh-list
5845936|NCT02475135|Darunavir|darunavir|mesh-list
5845937|NCT02475135|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5845938|NCT02475135|Cobicistat|cobicistat|mesh-list
5845939|NCT02475135|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
5845940|NCT02475135|Elvitegravir|elvitegravir|mesh-list
5845941|NCT02475135|Antiviral Agents|antiviral agents|mesh-ancestor
5845942|NCT02475135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5845943|NCT02475135|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5845944|NCT02475135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5845945|NCT02475135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5845946|NCT02475135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5845947|NCT02475135|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5845948|NCT02475135|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5845949|NCT02475135|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5845950|NCT02475135|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5664829|NCT03606538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5664830|NCT03606538|Serotonin Agents|serotonin agents|mesh-ancestor
5664831|NCT03606538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5664832|NCT03606538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664833|NCT03606538|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5664834|NCT03606538|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5845951|NCT02475135|Protease Inhibitors|protease inhibitors|mesh-ancestor
5845952|NCT02475135|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5845953|NCT02475135|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5845954|NCT02475135|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5845955|NCT02475161|Rabeprazole|rabeprazole|mesh-list
5845956|NCT02475161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5845957|NCT02475161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5845958|NCT02475161|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5845959|NCT02475161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5845960|NCT02475161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5845961|NCT02475213|Pembrolizumab|pembrolizumab|mesh-list
5845962|NCT02475213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5845963|NCT02475213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5845964|NCT02475109|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5845965|NCT02475109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5845966|NCT02475317|Volixibat|volixibat|mesh-list
5845967|NCT02475317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6212066|NCT02181231|Sensory System Agents|sensory system agents|mesh-ancestor
5664835|NCT03606538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5664836|NCT03606538|Adrenergic Agents|adrenergic agents|mesh-ancestor
5664837|NCT03606473|Amphetamine|amphetamine|mesh-list
5664838|NCT03606473|Dextroamphetamine|dextroamphetamine|mesh-list
5664839|NCT03606473|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5664840|NCT03606473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664841|NCT03606473|Sympathomimetics|sympathomimetics|mesh-ancestor
5664842|NCT03606473|Autonomic Agents|autonomic agents|mesh-ancestor
5664843|NCT03606473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5664844|NCT03606473|Dopamine Agents|dopamine agents|mesh-ancestor
5664845|NCT03606473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5664846|NCT03606473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664847|NCT03606473|Adrenergic Agents|adrenergic agents|mesh-ancestor
5664848|NCT03606473|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5664849|NCT03606473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5664850|NCT03606473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5664851|NCT03606473|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5664852|NCT03606369|Ondansetron|ondansetron|mesh-list
5664853|NCT03606369|Palonosetron|palonosetron|mesh-list
5664854|NCT03606369|Antiemetics|antiemetics|mesh-ancestor
5664855|NCT03606369|Autonomic Agents|autonomic agents|mesh-ancestor
5664856|NCT03606369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5664857|NCT03606369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664858|NCT03606369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5664859|NCT03606369|Antipruritics|antipruritics|mesh-ancestor
5664860|NCT03606369|Dermatologic Agents|dermatologic agents|mesh-ancestor
5664861|NCT03606369|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5664862|NCT03606369|Serotonin Agents|serotonin agents|mesh-ancestor
5664863|NCT03606369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5664864|NCT03606369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664865|NCT03606369|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5664866|NCT03606369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5664867|NCT03606369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5664868|NCT03606369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5664869|NCT03606369|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5845968|NCT02474953|Curcumin|curcumin|mesh-list
5845969|NCT02474953|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5845970|NCT02474953|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5845971|NCT02474953|Analgesics|analgesics|mesh-ancestor
5845972|NCT02474953|Sensory System Agents|sensory system agents|mesh-ancestor
5845973|NCT02474953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5845974|NCT02474953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845975|NCT02474953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5845976|NCT02474953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5845977|NCT02474953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5845978|NCT02474953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5845979|NCT02474953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5845980|NCT02474914|Octreotide|octreotide|mesh-list
5845981|NCT02474914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5664870|NCT03606369|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5664871|NCT03606213|Vaccines|vaccines|mesh-list
5664872|NCT03606213|Immunologic Factors|immunologic factors|mesh-ancestor
5664873|NCT03606213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664874|NCT03606174|Pembrolizumab|pembrolizumab|mesh-list
5664875|NCT03606174|Nivolumab|nivolumab|mesh-list
5664876|NCT03606174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5664877|NCT03606174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5664878|NCT03606174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5664879|NCT03606174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664880|NCT03606109|Tranexamic Acid|tranexamic acid|mesh-list
5664881|NCT03606109|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5664882|NCT03606109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5664883|NCT03606109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664884|NCT03606109|Hemostatics|hemostatics|mesh-ancestor
5664885|NCT03606109|Coagulants|coagulants|mesh-ancestor
5664886|NCT03606057|Moxifloxacin|moxifloxacin|mesh-list
5664887|NCT03606057|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
5664888|NCT03606057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5664889|NCT03606057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5664890|NCT03606057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5664891|NCT03606057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5664892|NCT03606057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5845982|NCT02474914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5845983|NCT02474914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5845984|NCT02475057|Hormones|hormones|mesh-list
5845985|NCT02475057|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
5845986|NCT02475057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5845987|NCT02475057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5845988|NCT02474667|Mitogens|mitogens|mesh-list
6493922|NCT00616044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496444|NCT00628056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496445|NCT00628056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6496446|NCT00628056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496447|NCT00628056|Vasodilator Agents|vasodilator agents|mesh-ancestor
6496448|NCT00628121|Cetrorelix|cetrorelix|mesh-list
6496449|NCT00628121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5845989|NCT02474667|Mitosis Modulators|mitosis modulators|mesh-ancestor
5845990|NCT02474667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5845991|NCT02474654|Ketorolac|ketorolac|mesh-list
5845992|NCT02474654|Epinephrine|epinephrine|mesh-list
5664893|NCT03606057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664894|NCT03606057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5664895|NCT03606057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5664896|NCT03606057|Contraceptive Agents|contraceptive agents|mesh-ancestor
5664897|NCT03606057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5664898|NCT03606057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664899|NCT03606057|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5664900|NCT03606057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5664901|NCT03606057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5664902|NCT03606018|Insulin|insulin|mesh-list
5664903|NCT03606018|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5664904|NCT03606018|Insulin Lispro|insulin lispro|mesh-list
5845993|NCT02474654|Racepinephrine|racepinephrine|mesh-list
6496450|NCT00628121|Fertility Agents|fertility agents|mesh-ancestor
6496451|NCT00628121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6496452|NCT00628121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496453|NCT00628121|Hormone Antagonists|hormone antagonists|mesh-ancestor
5664905|NCT03606018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5845994|NCT02474654|Fentanyl|fentanyl|mesh-list
5845995|NCT02474654|Bupivacaine|bupivacaine|mesh-list
5845996|NCT02474654|Epinephryl borate|epinephryl borate|mesh-list
5845997|NCT02474654|Anesthetics, Local|anesthetics, local|mesh-ancestor
5845998|NCT02474654|Anesthetics|anesthetics|mesh-ancestor
5845999|NCT02474654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5846000|NCT02474654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846001|NCT02474654|Sensory System Agents|sensory system agents|mesh-ancestor
5846002|NCT02474654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5846003|NCT02474654|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5846004|NCT02474654|Narcotics|narcotics|mesh-ancestor
5846005|NCT02474654|Analgesics|analgesics|mesh-ancestor
5846006|NCT02474654|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5846007|NCT02474654|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5846008|NCT02474654|Anesthetics, General|anesthetics, general|mesh-ancestor
5846009|NCT02474654|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5846010|NCT02474654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5846011|NCT02474654|Adrenergic Agents|adrenergic agents|mesh-ancestor
5846012|NCT02474654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5846013|NCT02474654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846014|NCT02474654|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5846015|NCT02474654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5846016|NCT02474654|Autonomic Agents|autonomic agents|mesh-ancestor
5846017|NCT02474654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5846018|NCT02474654|Respiratory System Agents|respiratory system agents|mesh-ancestor
5846019|NCT02474654|Mydriatics|mydriatics|mesh-ancestor
5846020|NCT02474654|Sympathomimetics|sympathomimetics|mesh-ancestor
5846021|NCT02474654|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5846022|NCT02474654|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5846023|NCT02474654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5846024|NCT02474654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5846025|NCT02474654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5846026|NCT02474654|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5846027|NCT02474654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5846028|NCT02474706|Imipenem|imipenem|mesh-list
5846029|NCT02474706|Cefoxitin|cefoxitin|mesh-list
5846030|NCT02474706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5846031|NCT02474706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5846032|NCT02474810|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5846033|NCT02474810|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5846034|NCT02474810|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5846035|NCT02474810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846036|NCT02474563|Prednisone|prednisone|mesh-list
5846037|NCT02474563|Bortezomib|bortezomib|mesh-list
5846038|NCT02474563|Melphalan|melphalan|mesh-list
5846039|NCT02474563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5846040|NCT02474563|Glucocorticoids|glucocorticoids|mesh-ancestor
5846041|NCT02474563|Hormones|hormones|mesh-ancestor
5846042|NCT02474563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5846043|NCT02474563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846044|NCT02474563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5846045|NCT02474563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5846046|NCT02474563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5846047|NCT02474563|Alkylating Agents|alkylating agents|mesh-ancestor
5846048|NCT02474563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846049|NCT02474563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5846050|NCT02474563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5846051|NCT02474563|Immunologic Factors|immunologic factors|mesh-ancestor
5846052|NCT02474511|Anesthetics|anesthetics|mesh-list
5846053|NCT02474511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5846054|NCT02474511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846055|NCT02474628|Calcium Carbonate|calcium carbonate|mesh-list
6493923|NCT00616070|Difluprednate|difluprednate|mesh-list
6493924|NCT00616070|Glucocorticoids|glucocorticoids|mesh-ancestor
6493925|NCT00616070|Hormones|hormones|mesh-ancestor
6493926|NCT00616070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6493927|NCT00616070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493928|NCT00616187|Interferons|interferons|mesh-list
6493929|NCT00616187|Interferon-beta|interferon-beta|mesh-list
6493930|NCT00616187|Atorvastatin|atorvastatin|mesh-list
6493931|NCT00616187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6493932|NCT00616187|Antiviral Agents|antiviral agents|mesh-ancestor
6493933|NCT00616187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6493934|NCT00616187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5846056|NCT02474628|Calcium|calcium|mesh-list
5908424|NCT04552847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6493935|NCT00616187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5664906|NCT03606018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664907|NCT03605940|Methoxsalen|methoxsalen|mesh-list
5664908|NCT03605940|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5664909|NCT03605940|Dermatologic Agents|dermatologic agents|mesh-ancestor
5664910|NCT03605927|Sirolimus|sirolimus|mesh-list
5664911|NCT03605927|Tacrolimus|tacrolimus|mesh-list
5664912|NCT03605927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5664913|NCT03605927|Immunologic Factors|immunologic factors|mesh-ancestor
5664914|NCT03605927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664915|NCT03605927|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5664916|NCT03605927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5664917|NCT03605927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493936|NCT00616187|Antimetabolites|antimetabolites|mesh-ancestor
6493937|NCT00616187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493938|NCT00616187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6493939|NCT00616187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6493940|NCT00616187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6493941|NCT00616187|Immunologic Factors|immunologic factors|mesh-ancestor
6493942|NCT00616187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493943|NCT00616213|Lenograstim|lenograstim|mesh-list
6493944|NCT00616213|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5664918|NCT03605927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5664919|NCT03605927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5846057|NCT02474628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5846058|NCT02474628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846059|NCT02474628|Antacids|antacids|mesh-ancestor
5846060|NCT02474628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846061|NCT02474628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5846062|NCT02474433|Misoprostol|misoprostol|mesh-list
5846063|NCT02474433|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5846064|NCT02474433|Abortifacient Agents|abortifacient agents|mesh-ancestor
5846065|NCT02474433|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5846066|NCT02474433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846067|NCT02474433|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5846068|NCT02474433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5846069|NCT02474433|Oxytocics|oxytocics|mesh-ancestor
5846070|NCT02474303|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5846071|NCT02474303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5846072|NCT02474303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5846073|NCT02474303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5846074|NCT02474303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846075|NCT02474303|Antiviral Agents|antiviral agents|mesh-ancestor
5846076|NCT02474303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5846077|NCT02474303|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5846078|NCT02474303|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5846079|NCT02474290|Sorafenib|sorafenib|mesh-list
5846080|NCT02474290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5846081|NCT02474290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5846082|NCT02474290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5664920|NCT03605927|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5664921|NCT03605927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5664922|NCT03605927|Antifungal Agents|antifungal agents|mesh-ancestor
5664923|NCT03605901|Methadone|methadone|mesh-list
5664924|NCT03605901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5664925|NCT03605901|Narcotics|narcotics|mesh-ancestor
5664926|NCT03605901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5664927|NCT03605901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664928|NCT03605901|Analgesics|analgesics|mesh-ancestor
5664929|NCT03605901|Sensory System Agents|sensory system agents|mesh-ancestor
5664930|NCT03605901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5664931|NCT03605901|Antitussive Agents|antitussive agents|mesh-ancestor
5664932|NCT03605901|Respiratory System Agents|respiratory system agents|mesh-ancestor
5664933|NCT03605758|Ivermectin|ivermectin|mesh-list
5664934|NCT03605758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5664935|NCT03605758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5664936|NCT03605654|Mycophenolic Acid|mycophenolic acid|mesh-list
5846083|NCT02474290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846084|NCT02474212|Enoxaparin|enoxaparin|mesh-list
5846085|NCT02474212|Anticoagulants|anticoagulants|mesh-ancestor
5846086|NCT02474212|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5846087|NCT02474212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5846088|NCT02474212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903671|NCT04590586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903672|NCT04590586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5846089|NCT02474225|Bevacizumab|bevacizumab|mesh-list
5846090|NCT02474225|Ranibizumab|ranibizumab|mesh-list
5846091|NCT02474225|Endothelial Growth Factors|endothelial growth factors|mesh-list
5846092|NCT02474225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5846093|NCT02474225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5846094|NCT02474225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5846095|NCT02474225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5846096|NCT02474225|Growth Substances|growth substances|mesh-ancestor
5846097|NCT02474225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846098|NCT02474225|Growth Inhibitors|growth inhibitors|mesh-ancestor
5846099|NCT02474446|Vitamin D|vitamin d|mesh-list
5664937|NCT03605654|Tacrolimus|tacrolimus|mesh-list
5664938|NCT03605654|Immunosuppressive Agents|immunosuppressive agents|mesh-list
5664939|NCT03605654|Immunologic Factors|immunologic factors|mesh-ancestor
5664940|NCT03605654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664941|NCT03605654|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5664942|NCT03605654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5664943|NCT03605654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664944|NCT03605654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5846100|NCT02474446|Vitamins|vitamins|mesh-ancestor
5846101|NCT02474446|Micronutrients|micronutrients|mesh-ancestor
5846102|NCT02474446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846103|NCT02474446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5846104|NCT02474316|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5846105|NCT02474316|Antiviral Agents|antiviral agents|mesh-ancestor
5846106|NCT02474316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5846107|NCT02474420|Amlodipine|amlodipine|mesh-list
5846108|NCT02474420|Deferasirox|deferasirox|mesh-list
5664945|NCT03605654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5664946|NCT03605654|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5664947|NCT03605654|Antitubercular Agents|antitubercular agents|mesh-ancestor
5664948|NCT03605654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5664949|NCT03605654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5664950|NCT03605589|Pembrolizumab|pembrolizumab|mesh-list
5664951|NCT03605589|Blinatumomab|blinatumomab|mesh-list
5664952|NCT03605589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5664953|NCT03605589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5664954|NCT03605537|Mometasone Furoate|mometasone furoate|mesh-list
5664955|NCT03605537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5664956|NCT03605537|Dermatologic Agents|dermatologic agents|mesh-ancestor
5664957|NCT03605537|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5664958|NCT03605511|Complement System Proteins|complement system proteins|mesh-list
5846109|NCT02474420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5846110|NCT02474420|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6493945|NCT00616213|Immunologic Factors|immunologic factors|mesh-ancestor
6493946|NCT00616213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846111|NCT02474420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5846112|NCT02474420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846113|NCT02474420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5846114|NCT02474420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846115|NCT02474420|Vasodilator Agents|vasodilator agents|mesh-ancestor
5846116|NCT02474420|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5846117|NCT02474420|Chelating Agents|chelating agents|mesh-ancestor
5846118|NCT02474420|Sequestering Agents|sequestering agents|mesh-ancestor
5846119|NCT02474368|Cisplatin|cisplatin|mesh-list
5846120|NCT02474368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5664959|NCT03605511|Immunologic Factors|immunologic factors|mesh-ancestor
5664960|NCT03605511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664961|NCT03605433|Rivaroxaban|rivaroxaban|mesh-list
5664962|NCT03605433|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5664963|NCT03605433|Antithrombins|antithrombins|mesh-ancestor
5664964|NCT03605433|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5664965|NCT03605433|Protease Inhibitors|protease inhibitors|mesh-ancestor
5664966|NCT03605433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5664967|NCT03605433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5664968|NCT03605433|Anticoagulants|anticoagulants|mesh-ancestor
5664969|NCT03605342|Buprenorphine|buprenorphine|mesh-list
5664970|NCT03605342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5846121|NCT02474134|Interferons|interferons|mesh-list
5846122|NCT02474134|Interferon-beta|interferon-beta|mesh-list
5846123|NCT02474134|Interferon beta-1b|interferon beta-1b|mesh-list
5846124|NCT02474134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5846125|NCT02474134|Antiviral Agents|antiviral agents|mesh-ancestor
5846126|NCT02474134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5846127|NCT02474134|Immunologic Factors|immunologic factors|mesh-ancestor
6493947|NCT00616382|Indomethacin|indomethacin|mesh-list
5664971|NCT03605342|Narcotics|narcotics|mesh-ancestor
5846128|NCT02474134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846129|NCT02474134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5846130|NCT02474186|Paclitaxel|paclitaxel|mesh-list
5846131|NCT02474186|Docetaxel|docetaxel|mesh-list
5846132|NCT02474186|Capecitabine|capecitabine|mesh-list
5846133|NCT02474186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5846134|NCT02474186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5846135|NCT02474186|Tubulin Modulators|tubulin modulators|mesh-ancestor
5846136|NCT02474186|Antimitotic Agents|antimitotic agents|mesh-ancestor
5846137|NCT02474186|Mitosis Modulators|mitosis modulators|mesh-ancestor
5846138|NCT02474186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846139|NCT02474186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5846140|NCT02474186|Antimetabolites|antimetabolites|mesh-ancestor
5846141|NCT02473900|Oseltamivir|oseltamivir|mesh-list
5846142|NCT02473900|Antiviral Agents|antiviral agents|mesh-ancestor
5664972|NCT03605342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5664973|NCT03605342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664974|NCT03605342|Analgesics|analgesics|mesh-ancestor
5664975|NCT03605342|Sensory System Agents|sensory system agents|mesh-ancestor
5664976|NCT03605342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5664977|NCT03605342|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5664978|NCT03605199|Denosumab|denosumab|mesh-list
5664979|NCT03605199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5664980|NCT03605199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695624|NCT03388125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5695625|NCT03387956|Dexamethasone|dexamethasone|mesh-list
5695626|NCT03387956|Atropine|atropine|mesh-list
5695627|NCT03387956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5695628|NCT03387956|Antiemetics|antiemetics|mesh-ancestor
5695629|NCT03387956|Autonomic Agents|autonomic agents|mesh-ancestor
5695630|NCT03387956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5695631|NCT03387956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695632|NCT03387956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5695633|NCT03387956|Glucocorticoids|glucocorticoids|mesh-ancestor
5695634|NCT03387956|Hormones|hormones|mesh-ancestor
5695635|NCT03387956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5695636|NCT03387956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5695637|NCT03387956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5695638|NCT03387956|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5695639|NCT03387956|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5695640|NCT03387956|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5695641|NCT03387956|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5695642|NCT03387956|Respiratory System Agents|respiratory system agents|mesh-ancestor
5695643|NCT03387956|Mydriatics|mydriatics|mesh-ancestor
5695644|NCT03387956|Parasympatholytics|parasympatholytics|mesh-ancestor
5695645|NCT03387956|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5695646|NCT03387956|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5695647|NCT03387956|Cholinergic Agents|cholinergic agents|mesh-ancestor
5695648|NCT03387956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5695649|NCT03387956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695650|NCT03387943|Cisplatin|cisplatin|mesh-list
5695651|NCT03387943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5846143|NCT02473900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5846144|NCT02473900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5846145|NCT02473900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846146|NCT02473887|Ondansetron|ondansetron|mesh-list
5846147|NCT02473887|Antiemetics|antiemetics|mesh-ancestor
5846148|NCT02473887|Autonomic Agents|autonomic agents|mesh-ancestor
5846149|NCT02473887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5846150|NCT02473887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695652|NCT03387904|Irinotecan|irinotecan|mesh-list
5695653|NCT03387904|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5695654|NCT03387904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5695655|NCT03387904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5695656|NCT03387904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695657|NCT03387904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5695658|NCT03387826|Ticagrelor|ticagrelor|mesh-list
5695659|NCT03387826|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
5695660|NCT03387826|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5846151|NCT02473887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5695661|NCT03387826|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5695662|NCT03387826|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5695663|NCT03387826|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5695664|NCT03387826|Purinergic Agents|purinergic agents|mesh-ancestor
5695665|NCT03387826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5846152|NCT02473887|Antipruritics|antipruritics|mesh-ancestor
5846153|NCT02473887|Dermatologic Agents|dermatologic agents|mesh-ancestor
5846154|NCT02473887|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5846155|NCT02473887|Serotonin Agents|serotonin agents|mesh-ancestor
5846156|NCT02473887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5664981|NCT03605173|Vitamin D|vitamin d|mesh-list
5664982|NCT03605173|Ergocalciferols|ergocalciferols|mesh-list
5664983|NCT03605173|Vitamins|vitamins|mesh-list
5664984|NCT03605173|Micronutrients|micronutrients|mesh-ancestor
5664985|NCT03605173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664986|NCT03605173|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5664987|NCT03605173|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5664988|NCT03605095|Nitroglycerin|nitroglycerin|mesh-list
5664989|NCT03605095|Vasodilator Agents|vasodilator agents|mesh-ancestor
5664990|NCT03605056|Dexamethasone|dexamethasone|mesh-list
5664991|NCT03605056|Lenalidomide|lenalidomide|mesh-list
5664992|NCT03605056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5664993|NCT03605056|Antiemetics|antiemetics|mesh-ancestor
5664994|NCT03605056|Autonomic Agents|autonomic agents|mesh-ancestor
5664995|NCT03605056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5664996|NCT03605056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5664997|NCT03605056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5664998|NCT03605056|Glucocorticoids|glucocorticoids|mesh-ancestor
5664999|NCT03605056|Hormones|hormones|mesh-ancestor
5665000|NCT03605056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5665001|NCT03605056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5846157|NCT02473887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846158|NCT02473887|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5846159|NCT02473887|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5846160|NCT02473887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5846161|NCT02473887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5846162|NCT02473887|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5846163|NCT02473809|Liraglutide|liraglutide|mesh-list
5846164|NCT02473809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5846165|NCT02473809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846166|NCT02473809|Incretins|incretins|mesh-ancestor
5846167|NCT02473809|Hormones|hormones|mesh-ancestor
5846168|NCT02473809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5846169|NCT02473562|Varenicline|varenicline|mesh-list
5846170|NCT02473562|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5846171|NCT02473562|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5846172|NCT02473562|Cholinergic Agents|cholinergic agents|mesh-ancestor
5846173|NCT02473562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5846174|NCT02473562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846175|NCT02473562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846176|NCT02473575|Caffeine|caffeine|mesh-list
5846177|NCT02473575|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5846178|NCT02473575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846179|NCT02473575|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5846180|NCT02473575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5846181|NCT02473575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846182|NCT02473575|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5846183|NCT02473575|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5846184|NCT02473575|Purinergic Agents|purinergic agents|mesh-ancestor
5846185|NCT02473575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5846186|NCT02473627|Pioglitazone|pioglitazone|mesh-list
5846187|NCT02473627|Tolbutamide|tolbutamide|mesh-list
5846188|NCT02473627|Midazolam|midazolam|mesh-list
5846189|NCT02473627|Omeprazole|omeprazole|mesh-list
5846190|NCT02473627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5846191|NCT02473627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5846192|NCT02473627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5846193|NCT02473627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846194|NCT02473627|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5846195|NCT02473627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5846196|NCT02473627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5846197|NCT02473627|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5846198|NCT02473627|Anesthetics, General|anesthetics, general|mesh-ancestor
5846199|NCT02473627|Anesthetics|anesthetics|mesh-ancestor
5846200|NCT02473627|GABA Modulators|gaba modulators|mesh-ancestor
5846201|NCT02473627|GABA Agents|gaba agents|mesh-ancestor
5846202|NCT02473627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5846203|NCT02473627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846204|NCT02473627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5846205|NCT02473627|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5665002|NCT03605056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5665003|NCT03605056|Immunologic Factors|immunologic factors|mesh-ancestor
5665004|NCT03605056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5665005|NCT03605056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5665006|NCT03605056|Growth Substances|growth substances|mesh-ancestor
5665007|NCT03605056|Growth Inhibitors|growth inhibitors|mesh-ancestor
5665008|NCT03604874|Oxytocin|oxytocin|mesh-list
5665009|NCT03604874|Oxytocics|oxytocics|mesh-ancestor
5665010|NCT03604874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5665011|NCT03604874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665012|NCT03604796|Acetaminophen|acetaminophen|mesh-list
5665013|NCT03604796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5665014|NCT03604796|Analgesics|analgesics|mesh-ancestor
5665015|NCT03604796|Sensory System Agents|sensory system agents|mesh-ancestor
5665016|NCT03604796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5665017|NCT03604796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665018|NCT03604796|Antipyretics|antipyretics|mesh-ancestor
5665019|NCT03604757|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5665020|NCT03604757|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5665021|NCT03604757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665022|NCT03604744|Psilocybin|psilocybin|mesh-list
5665023|NCT03604744|Hallucinogens|hallucinogens|mesh-ancestor
5665024|NCT03604744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665025|NCT03604744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5665026|NCT03604679|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5665027|NCT03604679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5665028|NCT03604679|Alkylating Agents|alkylating agents|mesh-ancestor
5665029|NCT03604679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665030|NCT03604679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5665031|NCT03604653|Cisplatin|cisplatin|mesh-list
5665032|NCT03604653|Doxorubicin|doxorubicin|mesh-list
5665033|NCT03604653|Mitomycins|mitomycins|mesh-list
5665034|NCT03604653|Mitomycin|mitomycin|mesh-list
5665035|NCT03604653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5846206|NCT02473627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5846207|NCT02473627|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5846208|NCT02473627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5846209|NCT02473601|Mivacurium|mivacurium|mesh-list
5846210|NCT02473601|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5846211|NCT02473601|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5846212|NCT02473601|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5846213|NCT02473601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5846214|NCT02473601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846215|NCT02473328|Ritonavir|ritonavir|mesh-list
5846216|NCT02473328|Atazanavir Sulfate|atazanavir sulfate|mesh-list
5846217|NCT02473328|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5846218|NCT02473328|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5846219|NCT02473328|Protease Inhibitors|protease inhibitors|mesh-ancestor
5846220|NCT02473328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5846221|NCT02473328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665036|NCT03604653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5665037|NCT03604653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5665038|NCT03604653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5665039|NCT03604653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5846222|NCT02473328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5846223|NCT02473328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5846224|NCT02473328|Antiviral Agents|antiviral agents|mesh-ancestor
5846225|NCT02473328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5846226|NCT02473328|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5846227|NCT02473328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5846228|NCT02473276|Morphine|morphine|mesh-list
5846229|NCT02473276|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5846230|NCT02473276|Narcotics|narcotics|mesh-ancestor
5846231|NCT02473276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5846232|NCT02473276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846233|NCT02473276|Analgesics|analgesics|mesh-ancestor
5846234|NCT02473276|Sensory System Agents|sensory system agents|mesh-ancestor
5846235|NCT02473276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5846236|NCT02473302|Tocopherols|tocopherols|mesh-list
5846237|NCT02473302|Vitamin E|vitamin e|mesh-list
5665040|NCT03604653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665041|NCT03604653|Alkylating Agents|alkylating agents|mesh-ancestor
5665042|NCT03604653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5665043|NCT03604627|Calcium|calcium|mesh-list
5665044|NCT03604627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5846238|NCT02473302|Tocotrienols|tocotrienols|mesh-list
5846239|NCT02473302|alpha-Tocopherol|alpha-tocopherol|mesh-list
5665045|NCT03604627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846240|NCT02473302|Antioxidants|antioxidants|mesh-ancestor
5903673|NCT04590586|Immunologic Factors|immunologic factors|mesh-ancestor
5665046|NCT03604575|Insulin|insulin|mesh-list
5846241|NCT02473302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846242|NCT02473302|Protective Agents|protective agents|mesh-ancestor
5846243|NCT02473302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846244|NCT02473302|Vitamins|vitamins|mesh-ancestor
5846245|NCT02473302|Micronutrients|micronutrients|mesh-ancestor
5846246|NCT02473406|Thymalfasin|thymalfasin|mesh-list
5846247|NCT02473406|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5846248|NCT02473406|Immunologic Factors|immunologic factors|mesh-ancestor
5846249|NCT02473406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846250|NCT02473354|Remifentanil|remifentanil|mesh-list
5665047|NCT03604575|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5665048|NCT03604575|Insulin Lispro|insulin lispro|mesh-list
5665049|NCT03604575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5665050|NCT03604575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665051|NCT03604549|Ethiodized Oil|ethiodized oil|mesh-list
5665052|NCT03604549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5665053|NCT03604471|Atorvastatin|atorvastatin|mesh-list
5665054|NCT03604471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5665055|NCT03604471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5665056|NCT03604471|Antimetabolites|antimetabolites|mesh-ancestor
5846251|NCT02473354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5846252|NCT02473354|Narcotics|narcotics|mesh-ancestor
5846253|NCT02473354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5846254|NCT02473354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846255|NCT02473354|Analgesics|analgesics|mesh-ancestor
5665057|NCT03604471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665058|NCT03604471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5665059|NCT03604471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5665060|NCT03604471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5665061|NCT03604419|Metformin|metformin|mesh-list
5665062|NCT03604419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5665063|NCT03604419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665064|NCT03604406|Vaccines|vaccines|mesh-list
5665065|NCT03604406|Immunologic Factors|immunologic factors|mesh-ancestor
5665066|NCT03604406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665067|NCT03604354|Pregabalin|pregabalin|mesh-list
5665068|NCT03604354|Tapentadol|tapentadol|mesh-list
5665069|NCT03604354|Analgesics|analgesics|mesh-ancestor
5665070|NCT03604354|Sensory System Agents|sensory system agents|mesh-ancestor
5665071|NCT03604354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5665072|NCT03604354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665073|NCT03604354|Anticonvulsants|anticonvulsants|mesh-ancestor
5665074|NCT03604354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5665075|NCT03604354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5665076|NCT03604354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665077|NCT03604354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5665078|NCT03604354|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5665079|NCT03604354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5665080|NCT03604354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5665081|NCT03604354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5665082|NCT03604354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5665083|NCT03604354|Narcotics|narcotics|mesh-ancestor
5665084|NCT03604354|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5665085|NCT03604354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5665086|NCT03604354|Adrenergic Agents|adrenergic agents|mesh-ancestor
5846256|NCT02473354|Sensory System Agents|sensory system agents|mesh-ancestor
5846257|NCT02473354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5665087|NCT03604354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5665088|NCT03604315|Deoxyglucose|deoxyglucose|mesh-list
5846258|NCT02473263|Tazobactam|tazobactam|mesh-list
5846259|NCT02473263|Ceftriaxone|ceftriaxone|mesh-list
5846260|NCT02473263|Piperacillin|piperacillin|mesh-list
5846261|NCT02473263|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
5846262|NCT02473263|Hydrocortisone|hydrocortisone|mesh-list
5846263|NCT02473263|Norepinephrine|norepinephrine|mesh-list
5846264|NCT02473263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5846265|NCT02473263|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5846266|NCT02473263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5846267|NCT02473263|Adrenergic Agents|adrenergic agents|mesh-ancestor
5846268|NCT02473263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5846269|NCT02473263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846270|NCT02473263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493948|NCT00616382|Pentoxifylline|pentoxifylline|mesh-list
6493949|NCT00616382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6493950|NCT00616382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5846271|NCT02473263|Sympathomimetics|sympathomimetics|mesh-ancestor
5846272|NCT02473263|Autonomic Agents|autonomic agents|mesh-ancestor
5846273|NCT02473263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5846274|NCT02473263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5846275|NCT02473263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5846276|NCT02473263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5846277|NCT02473263|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5846278|NCT02473263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5846279|NCT02473237|Tiotropium Bromide|tiotropium bromide|mesh-list
5846280|NCT02473237|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5846281|NCT02473237|Autonomic Agents|autonomic agents|mesh-ancestor
5846282|NCT02473237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5846283|NCT02473237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846284|NCT02473237|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5846285|NCT02473237|Respiratory System Agents|respiratory system agents|mesh-ancestor
5846286|NCT02473237|Parasympatholytics|parasympatholytics|mesh-ancestor
5846287|NCT02473237|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5846288|NCT02473237|Cholinergic Agents|cholinergic agents|mesh-ancestor
5846289|NCT02473237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5846290|NCT02473237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846291|NCT02473211|Sofosbuvir|sofosbuvir|mesh-list
5846292|NCT02473211|Antiviral Agents|antiviral agents|mesh-ancestor
5846293|NCT02473211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5846294|NCT02473185|Methylphenidate|methylphenidate|mesh-list
5846295|NCT02473185|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5846296|NCT02473185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846297|NCT02473185|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5846298|NCT02473185|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5846299|NCT02473185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5846300|NCT02473185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846301|NCT02473185|Dopamine Agents|dopamine agents|mesh-ancestor
5846302|NCT02473185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5846303|NCT02473198|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
5846304|NCT02473198|Morphine|morphine|mesh-list
5846305|NCT02473198|Bupivacaine|bupivacaine|mesh-list
5846306|NCT02473198|Anesthetics, Local|anesthetics, local|mesh-ancestor
5846307|NCT02473198|Anesthetics|anesthetics|mesh-ancestor
5846308|NCT02473198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5846309|NCT02473198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846310|NCT02473198|Sensory System Agents|sensory system agents|mesh-ancestor
5846311|NCT02473198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5846312|NCT02473198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5846313|NCT02473198|Narcotics|narcotics|mesh-ancestor
5846314|NCT02473198|Analgesics|analgesics|mesh-ancestor
5846315|NCT02473198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5846316|NCT02473198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5846317|NCT02473198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5846318|NCT02473198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5846319|NCT02473198|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5846320|NCT02473198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5846321|NCT02473198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846322|NCT02473146|Gemtuzumab|gemtuzumab|mesh-list
5846323|NCT02473146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5846324|NCT02473146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5665089|NCT03604315|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5665090|NCT03604315|Fluorides|fluorides|mesh-list
5665091|NCT03604315|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5665092|NCT03604315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665093|NCT03604315|Cariostatic Agents|cariostatic agents|mesh-ancestor
5665094|NCT03604315|Protective Agents|protective agents|mesh-ancestor
5665095|NCT03604315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665096|NCT03604315|Antimetabolites|antimetabolites|mesh-ancestor
5665097|NCT03604315|Antiviral Agents|antiviral agents|mesh-ancestor
5665098|NCT03604315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5665099|NCT03604224|Canagliflozin|canagliflozin|mesh-list
5665100|NCT03604224|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5665101|NCT03604224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665102|NCT03604224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5665103|NCT03604224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665104|NCT03604016|Tenofovir|tenofovir|mesh-list
5665105|NCT03604016|Antiviral Agents|antiviral agents|mesh-ancestor
5665106|NCT03604016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5665107|NCT03604016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5665108|NCT03604016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5665109|NCT03604016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5665110|NCT03604016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665111|NCT03604016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5665112|NCT03604016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5665113|NCT03604003|Losartan|losartan|mesh-list
5665114|NCT03604003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5665115|NCT03604003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5665116|NCT03604003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5665117|NCT03604003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5665118|NCT03604003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665119|NCT03603938|Losartan|losartan|mesh-list
5665120|NCT03603938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5665121|NCT03603938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5665122|NCT03603938|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5665123|NCT03603938|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5665124|NCT03603938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665125|NCT03603899|Xenon|xenon|mesh-list
5665126|NCT03603899|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5846325|NCT02472873|Ethanol|ethanol|mesh-list
5846326|NCT02472873|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5846327|NCT02472873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5846328|NCT02472873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5846329|NCT02472873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846330|NCT02473094|Metformin|metformin|mesh-list
5846331|NCT02473094|Capecitabine|capecitabine|mesh-list
5846332|NCT02473094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5846333|NCT02473094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846334|NCT02473094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5846335|NCT02473094|Antimetabolites|antimetabolites|mesh-ancestor
5846336|NCT02473094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846337|NCT02473094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5846338|NCT02472938|Dimethyl Fumarate|dimethyl fumarate|mesh-list
5846339|NCT02472938|Dermatologic Agents|dermatologic agents|mesh-ancestor
5846340|NCT02472938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5846341|NCT02472938|Immunologic Factors|immunologic factors|mesh-ancestor
5846342|NCT02472938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846343|NCT02472782|Teriparatide|teriparatide|mesh-list
5846344|NCT02472782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5846345|NCT02472782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846346|NCT02472782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5846347|NCT02472912|Adalimumab|adalimumab|mesh-list
5846348|NCT02472912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5846349|NCT02472912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5846350|NCT02472717|Liraglutide|liraglutide|mesh-list
5846351|NCT02472717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5846352|NCT02472717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846353|NCT02472717|Incretins|incretins|mesh-ancestor
5846354|NCT02472717|Hormones|hormones|mesh-ancestor
5846355|NCT02472717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5846356|NCT02472691|Lenalidomide|lenalidomide|mesh-list
5846357|NCT02472691|Azacitidine|azacitidine|mesh-list
5846358|NCT02472691|Immunologic Factors|immunologic factors|mesh-ancestor
5846359|NCT02472691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846360|NCT02472691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5846361|NCT02472691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5846362|NCT02472691|Growth Substances|growth substances|mesh-ancestor
6493951|NCT00616382|Analgesics|analgesics|mesh-ancestor
6493952|NCT00616382|Sensory System Agents|sensory system agents|mesh-ancestor
6493953|NCT00616382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6493954|NCT00616382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493955|NCT00616382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6493956|NCT00616382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6493957|NCT00616382|Gout Suppressants|gout suppressants|mesh-ancestor
6493958|NCT00616382|Tocolytic Agents|tocolytic agents|mesh-ancestor
6493959|NCT00616382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6493960|NCT00616382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6493961|NCT00616382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6493962|NCT00616382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665127|NCT03603899|Anesthetics, General|anesthetics, general|mesh-ancestor
5665128|NCT03603899|Anesthetics|anesthetics|mesh-ancestor
5665129|NCT03603899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5665130|NCT03603899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665131|NCT03603834|Leucovorin|leucovorin|mesh-list
5665132|NCT03603834|Fluorouracil|fluorouracil|mesh-list
5665133|NCT03603834|Oxaliplatin|oxaliplatin|mesh-list
6493963|NCT00616382|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5665134|NCT03603834|Irinotecan|irinotecan|mesh-list
5665135|NCT03603834|Antimetabolites|antimetabolites|mesh-ancestor
5665136|NCT03603834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665137|NCT03603834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5665138|NCT03603834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5665139|NCT03603834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5665140|NCT03603834|Immunologic Factors|immunologic factors|mesh-ancestor
5665141|NCT03603834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665142|NCT03603834|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5665143|NCT03603834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5665144|NCT03603834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5846363|NCT02472691|Growth Inhibitors|growth inhibitors|mesh-ancestor
5846364|NCT02472691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5846365|NCT02472691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5846366|NCT02472691|Antimetabolites|antimetabolites|mesh-ancestor
5846367|NCT02472691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846368|NCT02472691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5846369|NCT02472613|Fluoxetine|fluoxetine|mesh-list
5846370|NCT02472613|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5846371|NCT02472613|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5846372|NCT02472613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5846373|NCT02472613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846374|NCT02472613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5846375|NCT02472613|Serotonin Agents|serotonin agents|mesh-ancestor
5846376|NCT02472613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846377|NCT02472613|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5846378|NCT02472613|Antidepressive Agents|antidepressive agents|mesh-ancestor
5846379|NCT02472613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5846380|NCT02472613|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5846381|NCT02472613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5846382|NCT02472613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5665145|NCT03603834|Antidotes|antidotes|mesh-ancestor
5665146|NCT03603834|Protective Agents|protective agents|mesh-ancestor
5665147|NCT03603834|Vitamin B Complex|vitamin b complex|mesh-ancestor
5665148|NCT03603834|Vitamins|vitamins|mesh-ancestor
5665149|NCT03603834|Micronutrients|micronutrients|mesh-ancestor
5903674|NCT04590586|Leprostatic Agents|leprostatic agents|mesh-ancestor
5903675|NCT04590586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5903676|NCT04590586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5903677|NCT04590586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5903678|NCT04590586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5903679|NCT04590586|Growth Substances|growth substances|mesh-ancestor
5903680|NCT04590586|Growth Inhibitors|growth inhibitors|mesh-ancestor
5903681|NCT04590586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5903682|NCT04589754|Ifosfamide|ifosfamide|mesh-list
5903683|NCT04589754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5903684|NCT04589754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903685|NCT04589754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5903686|NCT04589754|Alkylating Agents|alkylating agents|mesh-ancestor
5903687|NCT04579523|Cyclophosphamide|cyclophosphamide|mesh-list
5903688|NCT04579523|Fludarabine|fludarabine|mesh-list
5903689|NCT04579523|Fludarabine phosphate|fludarabine phosphate|mesh-list
5903690|NCT04579523|Daratumumab|daratumumab|mesh-list
5903691|NCT04579523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5903692|NCT04579523|Antibodies|antibodies|mesh-list
5903693|NCT04579523|Immunoglobulins|immunoglobulins|mesh-list
5903694|NCT04579523|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5903695|NCT04579523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5903696|NCT04579523|Immunologic Factors|immunologic factors|mesh-ancestor
6493964|NCT00616382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5665150|NCT03603756|Paclitaxel|paclitaxel|mesh-list
5665151|NCT03603756|Irinotecan|irinotecan|mesh-list
5665152|NCT03603756|Apatinib|apatinib|mesh-list
5665153|NCT03603756|Nedaplatin|nedaplatin|mesh-list
5665154|NCT03603756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5665155|NCT03603756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5665156|NCT03603756|Tubulin Modulators|tubulin modulators|mesh-ancestor
5665157|NCT03603756|Antimitotic Agents|antimitotic agents|mesh-ancestor
5665158|NCT03603756|Mitosis Modulators|mitosis modulators|mesh-ancestor
5665159|NCT03603756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665160|NCT03603756|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5665161|NCT03603756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5665162|NCT03603756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5665163|NCT03603756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5665164|NCT03603626|Pregabalin|pregabalin|mesh-list
5665165|NCT03603626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665166|NCT03603626|Analgesics|analgesics|mesh-ancestor
5665167|NCT03603626|Sensory System Agents|sensory system agents|mesh-ancestor
5665168|NCT03603626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5665169|NCT03603626|Anticonvulsants|anticonvulsants|mesh-ancestor
5665170|NCT03603626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5665171|NCT03603626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5665172|NCT03603626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665173|NCT03603626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5665174|NCT03603626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5665175|NCT03603626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5665176|NCT03603626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5665177|NCT03603626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5665178|NCT03603548|Tacrolimus|tacrolimus|mesh-list
5665179|NCT03603548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5665180|NCT03603548|Immunologic Factors|immunologic factors|mesh-ancestor
5665181|NCT03603548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665182|NCT03603548|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5665183|NCT03603548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5665184|NCT03603548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665185|NCT03603496|Nicotine|nicotine|mesh-list
5665186|NCT03603496|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5665187|NCT03603496|Autonomic Agents|autonomic agents|mesh-ancestor
5665188|NCT03603496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5665189|NCT03603496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665190|NCT03603496|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5665191|NCT03603496|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5665192|NCT03603496|Cholinergic Agents|cholinergic agents|mesh-ancestor
5665193|NCT03603496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5665194|NCT03603496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695666|NCT03387826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695667|NCT03387826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698018|NCT03371953|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5698019|NCT03371953|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5698020|NCT03371953|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5698021|NCT03371953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5698022|NCT03371953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698023|NCT03371953|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
5698024|NCT03371953|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5698025|NCT03371953|Cholinergic Agents|cholinergic agents|mesh-ancestor
5698026|NCT03371953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5698027|NCT03371953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5698028|NCT03371862|Liraglutide|liraglutide|mesh-list
5698029|NCT03371862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5698030|NCT03371862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698031|NCT03371862|Incretins|incretins|mesh-ancestor
5698032|NCT03371862|Hormones|hormones|mesh-ancestor
5846383|NCT02472509|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
5846384|NCT02472509|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5846385|NCT02472509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5846386|NCT02472600|Colistin|colistin|mesh-list
5846387|NCT02472600|Polymyxins|polymyxins|mesh-list
5846388|NCT02472600|Neomycin|neomycin|mesh-list
5846389|NCT02472600|Omeprazole|omeprazole|mesh-list
5846390|NCT02472600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5846391|NCT02472600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5846392|NCT02472600|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5846393|NCT02472600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5846394|NCT02472600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846395|NCT02472600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5846396|NCT02472600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5846397|NCT02472600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5846398|NCT02472574|Plasminogen|plasminogen|mesh-list
5846399|NCT02472574|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5846400|NCT02472574|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5846401|NCT02472574|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5846402|NCT02472574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846403|NCT02472626|Thioctic Acid|thioctic acid|mesh-list
5846404|NCT02472626|Cytarabine|cytarabine|mesh-list
5846405|NCT02472626|Daunorubicin|daunorubicin|mesh-list
5846406|NCT02472626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5846407|NCT02472626|Antimetabolites|antimetabolites|mesh-ancestor
5846408|NCT02472626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212067|NCT02181231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5846409|NCT02472626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5846410|NCT02472626|Antiviral Agents|antiviral agents|mesh-ancestor
5846411|NCT02472626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5846412|NCT02472626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5846413|NCT02472626|Immunologic Factors|immunologic factors|mesh-ancestor
5846414|NCT02472626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846415|NCT02472626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5846416|NCT02472626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5665195|NCT03603418|Dexamethasone|dexamethasone|mesh-list
5665196|NCT03603418|Dexamethasone acetate|dexamethasone acetate|mesh-list
5846417|NCT02472626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5846418|NCT02472626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5846419|NCT02472626|Antioxidants|antioxidants|mesh-ancestor
5846420|NCT02472626|Protective Agents|protective agents|mesh-ancestor
5846421|NCT02472626|Vitamin B Complex|vitamin b complex|mesh-ancestor
5846422|NCT02472626|Vitamins|vitamins|mesh-ancestor
5846423|NCT02472626|Micronutrients|micronutrients|mesh-ancestor
5846424|NCT02472392|Cyclophosphamide|cyclophosphamide|mesh-list
5846425|NCT02472392|Melphalan|melphalan|mesh-list
5846426|NCT02472392|Busulfan|busulfan|mesh-list
5665197|NCT03603418|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
5665198|NCT03603418|BB 1101|bb 1101|mesh-list
5665199|NCT03603418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5665200|NCT03603418|Antiemetics|antiemetics|mesh-ancestor
5665201|NCT03603418|Autonomic Agents|autonomic agents|mesh-ancestor
5665202|NCT03603418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5665203|NCT03603418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665204|NCT03603418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5665205|NCT03603418|Glucocorticoids|glucocorticoids|mesh-ancestor
5665206|NCT03603418|Hormones|hormones|mesh-ancestor
5665207|NCT03603418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5665208|NCT03603418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5665209|NCT03603418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5665210|NCT03603418|Protease Inhibitors|protease inhibitors|mesh-ancestor
5665211|NCT03603418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5665212|NCT03603418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665213|NCT03603366|Aspirin|aspirin|mesh-list
5665214|NCT03603366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5665215|NCT03603366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5665216|NCT03603366|Analgesics|analgesics|mesh-ancestor
5665217|NCT03603366|Sensory System Agents|sensory system agents|mesh-ancestor
5665218|NCT03603366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5665219|NCT03603366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665220|NCT03603366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5665221|NCT03603366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5665222|NCT03603366|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5665223|NCT03603366|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5665224|NCT03603366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665225|NCT03603366|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5665226|NCT03603366|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5665227|NCT03603366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5665228|NCT03603366|Antipyretics|antipyretics|mesh-ancestor
5665229|NCT03603327|Antiviral Agents|antiviral agents|mesh-list
5665230|NCT03603327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5665231|NCT03603249|Trimetazidine|trimetazidine|mesh-list
5665232|NCT03603249|Vasodilator Agents|vasodilator agents|mesh-ancestor
5665233|NCT03603223|Pembrolizumab|pembrolizumab|mesh-list
5665234|NCT03603223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5846427|NCT02472392|Fludarabine|fludarabine|mesh-list
5846428|NCT02472392|Thymoglobulin|thymoglobulin|mesh-list
5846429|NCT02472392|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5846430|NCT02472392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5846431|NCT02472392|Immunologic Factors|immunologic factors|mesh-ancestor
5846432|NCT02472392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846433|NCT02472392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5665235|NCT03603223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5665236|NCT03603119|Dexamethasone|dexamethasone|mesh-list
5665237|NCT03603119|Midazolam|midazolam|mesh-list
5665238|NCT03603119|Ondansetron|ondansetron|mesh-list
5665239|NCT03603119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5665240|NCT03603119|Antiemetics|antiemetics|mesh-ancestor
5665241|NCT03603119|Autonomic Agents|autonomic agents|mesh-ancestor
5665242|NCT03603119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5665243|NCT03603119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846434|NCT02472392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5665244|NCT03603119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5665245|NCT03603119|Glucocorticoids|glucocorticoids|mesh-ancestor
5846435|NCT02472392|Alkylating Agents|alkylating agents|mesh-ancestor
5846436|NCT02472392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846437|NCT02472392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5846438|NCT02472392|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5846439|NCT02472054|Cyclosporine|cyclosporine|mesh-list
5846440|NCT02472054|Prednisolone|prednisolone|mesh-list
5846441|NCT02472054|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5846442|NCT02472054|Methylprednisolone|methylprednisolone|mesh-list
5846443|NCT02472054|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5846444|NCT02472054|Prednisolone acetate|prednisolone acetate|mesh-list
5846445|NCT02472054|Alemtuzumab|alemtuzumab|mesh-list
5846446|NCT02472054|Cyclosporins|cyclosporins|mesh-list
5846447|NCT02472054|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5846448|NCT02472054|Prednisolone phosphate|prednisolone phosphate|mesh-list
5846449|NCT02472054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5846450|NCT02472054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846451|NCT02472054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5846452|NCT02472054|Immunologic Factors|immunologic factors|mesh-ancestor
5846453|NCT02472054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846454|NCT02472054|Antifungal Agents|antifungal agents|mesh-ancestor
5846455|NCT02472054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5846456|NCT02472054|Dermatologic Agents|dermatologic agents|mesh-ancestor
5846457|NCT02472054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5846458|NCT02472054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5846459|NCT02472054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5846460|NCT02472054|Glucocorticoids|glucocorticoids|mesh-ancestor
5846461|NCT02472054|Hormones|hormones|mesh-ancestor
5846462|NCT02472054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5846463|NCT02472054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5846464|NCT02472054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5846465|NCT02472054|Antiemetics|antiemetics|mesh-ancestor
5846466|NCT02472054|Autonomic Agents|autonomic agents|mesh-ancestor
5846467|NCT02472054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5846468|NCT02472054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5846469|NCT02472054|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5846470|NCT02472054|Protective Agents|protective agents|mesh-ancestor
5846471|NCT02472054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5846472|NCT02472158|Chlorhexidine|chlorhexidine|mesh-list
5846473|NCT02472158|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5846474|NCT02472158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5846475|NCT02472158|Disinfectants|disinfectants|mesh-ancestor
6493965|NCT00616382|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6493966|NCT00616382|Protective Agents|protective agents|mesh-ancestor
5665246|NCT03603119|Hormones|hormones|mesh-ancestor
5665247|NCT03603119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5665248|NCT03603119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5665249|NCT03603119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5665250|NCT03603119|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5665251|NCT03603119|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5665252|NCT03603119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5665253|NCT03603119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5665254|NCT03603119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5665255|NCT03603119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5665256|NCT03603119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5665257|NCT03603119|Anesthetics, General|anesthetics, general|mesh-ancestor
5665258|NCT03603119|Anesthetics|anesthetics|mesh-ancestor
5665259|NCT03603119|GABA Modulators|gaba modulators|mesh-ancestor
5665260|NCT03603119|GABA Agents|gaba agents|mesh-ancestor
5665261|NCT03603119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5665262|NCT03603119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665263|NCT03603119|Antipruritics|antipruritics|mesh-ancestor
5665264|NCT03603119|Dermatologic Agents|dermatologic agents|mesh-ancestor
5665265|NCT03603119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5665266|NCT03603119|Serotonin Agents|serotonin agents|mesh-ancestor
5665267|NCT03603119|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5665268|NCT03603080|Metformin|metformin|mesh-list
5665269|NCT03603080|Topiramate|topiramate|mesh-list
5665270|NCT03603080|Anti-Obesity Agents|anti-obesity agents|mesh-list
5665271|NCT03603080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5665272|NCT03603080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665273|NCT03603080|Anticonvulsants|anticonvulsants|mesh-ancestor
5665274|NCT03602976|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
6493967|NCT00616382|Vasodilator Agents|vasodilator agents|mesh-ancestor
6493968|NCT00616382|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5846476|NCT02472080|Gemcitabine|gemcitabine|mesh-list
5665275|NCT03602976|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5846477|NCT02472080|Oxaliplatin|oxaliplatin|mesh-list
5846478|NCT02472080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5846479|NCT02472080|Antimetabolites|antimetabolites|mesh-ancestor
5846480|NCT02472080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846481|NCT02472080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5846482|NCT02472080|Antiviral Agents|antiviral agents|mesh-ancestor
5846483|NCT02472080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5846484|NCT02472080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5846485|NCT02472080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5846486|NCT02472080|Immunologic Factors|immunologic factors|mesh-ancestor
5846487|NCT02472080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846488|NCT02472249|Norepinephrine|norepinephrine|mesh-list
5846489|NCT02472249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5846490|NCT02472249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5846491|NCT02472249|Adrenergic Agents|adrenergic agents|mesh-ancestor
5846492|NCT02472249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5846493|NCT02472249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846494|NCT02472249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846495|NCT02472249|Sympathomimetics|sympathomimetics|mesh-ancestor
5846496|NCT02472249|Autonomic Agents|autonomic agents|mesh-ancestor
5846497|NCT02472249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5846498|NCT02472249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5846499|NCT02472210|Botulinum Toxins|botulinum toxins|mesh-list
5846500|NCT02472210|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5846501|NCT02472210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5846502|NCT02472210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846503|NCT02472210|Cholinergic Agents|cholinergic agents|mesh-ancestor
5846504|NCT02472210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5846505|NCT02472210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846506|NCT02472275|Ascorbic Acid|ascorbic acid|mesh-list
5665276|NCT03602976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5665277|NCT03602911|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5665278|NCT03602911|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5665279|NCT03602911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665280|NCT03602898|Cyclosporine|cyclosporine|mesh-list
5665281|NCT03602898|Cyclophosphamide|cyclophosphamide|mesh-list
5665282|NCT03602898|Busulfan|busulfan|mesh-list
5665283|NCT03602898|Methotrexate|methotrexate|mesh-list
5665284|NCT03602898|Fludarabine|fludarabine|mesh-list
5665285|NCT03602898|Fludarabine phosphate|fludarabine phosphate|mesh-list
5665286|NCT03602898|Tacrolimus|tacrolimus|mesh-list
5846507|NCT02472275|Methyltestosterone|methyltestosterone|mesh-list
5846508|NCT02472275|Hormones|hormones|mesh-list
5846509|NCT02472275|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
5846510|NCT02472275|Androgens|androgens|mesh-list
5846511|NCT02472275|Androgen Antagonists|androgen antagonists|mesh-list
5846512|NCT02472275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5846513|NCT02472275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846514|NCT02472275|Antioxidants|antioxidants|mesh-ancestor
5846515|NCT02472275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846516|NCT02472275|Protective Agents|protective agents|mesh-ancestor
5846517|NCT02472275|Vitamins|vitamins|mesh-ancestor
5846518|NCT02472275|Micronutrients|micronutrients|mesh-ancestor
5846519|NCT02472275|Estrogens|estrogens|mesh-ancestor
5846520|NCT02472275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5846521|NCT02472275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5846522|NCT02472275|Anabolic Agents|anabolic agents|mesh-ancestor
5846523|NCT02472275|Hormone Antagonists|hormone antagonists|mesh-ancestor
5846524|NCT02472236|Digoxin|digoxin|mesh-list
5846525|NCT02472236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5846526|NCT02472236|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5846527|NCT02472236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5846528|NCT02472236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846529|NCT02472236|Protective Agents|protective agents|mesh-ancestor
5846530|NCT02472236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665287|NCT03602898|Cyclosporins|cyclosporins|mesh-list
5665288|NCT03602898|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5665289|NCT03602898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5665290|NCT03602898|Immunologic Factors|immunologic factors|mesh-ancestor
5665291|NCT03602898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665292|NCT03602898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5665293|NCT03602898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5665294|NCT03602898|Alkylating Agents|alkylating agents|mesh-ancestor
5665295|NCT03602898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665296|NCT03602898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5665297|NCT03602898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5665298|NCT03602898|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5665299|NCT03602898|Abortifacient Agents|abortifacient agents|mesh-ancestor
5665300|NCT03602898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5846531|NCT02471963|Empagliflozin|empagliflozin|mesh-list
5846532|NCT02471963|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5846533|NCT02471963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846534|NCT02471963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5846535|NCT02471963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846536|NCT02471833|Telmisartan|telmisartan|mesh-list
5846537|NCT02471833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5846538|NCT02471833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5665301|NCT03602898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5665302|NCT03602898|Antimetabolites|antimetabolites|mesh-ancestor
5665303|NCT03602898|Dermatologic Agents|dermatologic agents|mesh-ancestor
5665304|NCT03602898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5665305|NCT03602898|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5665306|NCT03602898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5665307|NCT03602898|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5665308|NCT03602898|Antifungal Agents|antifungal agents|mesh-ancestor
5665309|NCT03602898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5665310|NCT03602859|Niraparib|niraparib|mesh-list
5665311|NCT03602859|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5665312|NCT03602859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5665313|NCT03602859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665314|NCT03602859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5665315|NCT03602846|Hypoglycemic Agents|hypoglycemic agents|mesh-list
5665316|NCT03602846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665317|NCT03602781|Nitric Oxide|nitric oxide|mesh-list
5665318|NCT03602781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5665319|NCT03602781|Autonomic Agents|autonomic agents|mesh-ancestor
5665320|NCT03602781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5665321|NCT03602781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665322|NCT03602781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5846539|NCT02471833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5846540|NCT02471833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846541|NCT02471820|Dexamethasone|dexamethasone|mesh-list
5846542|NCT02471820|Dexamethasone acetate|dexamethasone acetate|mesh-list
5846543|NCT02471820|Doxorubicin|doxorubicin|mesh-list
5846544|NCT02471820|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5846545|NCT02471820|Lenalidomide|lenalidomide|mesh-list
5846546|NCT02471820|BB 1101|bb 1101|mesh-list
5846547|NCT02471820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5846548|NCT02471820|Antiemetics|antiemetics|mesh-ancestor
5846549|NCT02471820|Autonomic Agents|autonomic agents|mesh-ancestor
5846550|NCT02471820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5846551|NCT02471820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846552|NCT02471820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5846553|NCT02471820|Glucocorticoids|glucocorticoids|mesh-ancestor
5846554|NCT02471820|Hormones|hormones|mesh-ancestor
5846555|NCT02471820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5846556|NCT02471820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5846557|NCT02471820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5846558|NCT02471820|Protease Inhibitors|protease inhibitors|mesh-ancestor
5846559|NCT02471820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5846560|NCT02471820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846561|NCT02471820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5846562|NCT02471820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5846563|NCT02471820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5846564|NCT02471820|Immunologic Factors|immunologic factors|mesh-ancestor
5846565|NCT02471820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5846566|NCT02471820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5846567|NCT02471820|Growth Substances|growth substances|mesh-ancestor
5846568|NCT02471820|Growth Inhibitors|growth inhibitors|mesh-ancestor
5846569|NCT02471950|Isoflurane|isoflurane|mesh-list
5846570|NCT02471950|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5846571|NCT02471950|Anesthetics, General|anesthetics, general|mesh-ancestor
5846572|NCT02471950|Anesthetics|anesthetics|mesh-ancestor
6212068|NCT02181231|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6493969|NCT00616382|Antioxidants|antioxidants|mesh-ancestor
6493970|NCT00616408|Octreotide|octreotide|mesh-list
5665323|NCT03602781|Respiratory System Agents|respiratory system agents|mesh-ancestor
5665324|NCT03602781|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5665325|NCT03602781|Antioxidants|antioxidants|mesh-ancestor
5665326|NCT03602781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493971|NCT00616408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6493972|NCT00616408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5665327|NCT03602781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6493973|NCT00616408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6493974|NCT00616460|Bivalirudin|bivalirudin|mesh-list
5846573|NCT02471950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5846574|NCT02471950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846575|NCT02471690|Oritavancin|oritavancin|mesh-list
5846576|NCT02471690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5846577|NCT02471690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5846578|NCT02471677|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5846579|NCT02471677|Hormones|hormones|mesh-ancestor
5846580|NCT02471677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5846581|NCT02471677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846582|NCT02471846|Atezolizumab|atezolizumab|mesh-list
5846583|NCT02471846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5846584|NCT02471911|Dexamethasone|dexamethasone|mesh-list
5846585|NCT02471911|Rituximab|rituximab|mesh-list
5846586|NCT02471911|Carboplatin|carboplatin|mesh-list
5846587|NCT02471911|Etoposide|etoposide|mesh-list
5846588|NCT02471911|Ifosfamide|ifosfamide|mesh-list
5846589|NCT02471911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5846590|NCT02471911|Antiemetics|antiemetics|mesh-ancestor
5846591|NCT02471911|Autonomic Agents|autonomic agents|mesh-ancestor
5846592|NCT02471911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5846593|NCT02471911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846594|NCT02471911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5846595|NCT02471911|Glucocorticoids|glucocorticoids|mesh-ancestor
5846596|NCT02471911|Hormones|hormones|mesh-ancestor
5846597|NCT02471911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5846598|NCT02471911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5846599|NCT02471911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5846600|NCT02471911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5846601|NCT02471911|Immunologic Factors|immunologic factors|mesh-ancestor
5846602|NCT02471911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5846603|NCT02471911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5846604|NCT02471911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5846605|NCT02471911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5846606|NCT02471911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5665328|NCT03602781|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5665329|NCT03602781|Vasodilator Agents|vasodilator agents|mesh-ancestor
5665330|NCT03602781|Gasotransmitters|gasotransmitters|mesh-ancestor
5665331|NCT03602781|Protective Agents|protective agents|mesh-ancestor
5665332|NCT03602690|Ritonavir|ritonavir|mesh-list
5846607|NCT02471911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846608|NCT02471911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5846609|NCT02471911|Alkylating Agents|alkylating agents|mesh-ancestor
5846610|NCT02471560|Dimethyl Fumarate|dimethyl fumarate|mesh-list
5846611|NCT02471560|Dermatologic Agents|dermatologic agents|mesh-ancestor
5846612|NCT02471560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5846613|NCT02471560|Immunologic Factors|immunologic factors|mesh-ancestor
5846614|NCT02471560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846615|NCT02471547|Mitomycins|mitomycins|mesh-list
5846616|NCT02471547|Mitomycin|mitomycin|mesh-list
5846617|NCT02471547|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5846618|NCT02471547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5846619|NCT02471547|Alkylating Agents|alkylating agents|mesh-ancestor
5665333|NCT03602690|Darunavir|darunavir|mesh-list
5665334|NCT03602690|Dolutegravir|dolutegravir|mesh-list
5665335|NCT03602690|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5665336|NCT03602690|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5665337|NCT03602690|Protease Inhibitors|protease inhibitors|mesh-ancestor
5665338|NCT03602690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5665339|NCT03602690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665340|NCT03602690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5665341|NCT03602690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5665342|NCT03602690|Antiviral Agents|antiviral agents|mesh-ancestor
5665343|NCT03602690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5665344|NCT03602690|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5665345|NCT03602690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5665346|NCT03602690|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5665347|NCT03602690|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5665348|NCT03602638|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5665349|NCT03602638|Acarbose|acarbose|mesh-list
5665350|NCT03602638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5846620|NCT02471547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846621|NCT02471547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6493975|NCT00616460|Antithrombins|antithrombins|mesh-ancestor
5665351|NCT03602638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665352|NCT03602638|Incretins|incretins|mesh-ancestor
5665353|NCT03602638|Hormones|hormones|mesh-ancestor
5665354|NCT03602638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5665355|NCT03602638|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5665356|NCT03602638|Protease Inhibitors|protease inhibitors|mesh-ancestor
5665357|NCT03602638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5665358|NCT03602638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665359|NCT03602638|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
5665360|NCT03602586|Pembrolizumab|pembrolizumab|mesh-list
5846622|NCT02471547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5846623|NCT02471274|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
5846624|NCT02471274|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5846625|NCT02471274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846626|NCT02471274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5846627|NCT02471274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846628|NCT02471391|Venetoclax|venetoclax|mesh-list
5846629|NCT02471391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5846630|NCT02471430|Interferons|interferons|mesh-list
5846631|NCT02471430|Interferon-alpha|interferon-alpha|mesh-list
5846632|NCT02471430|Interferon alpha-2|interferon alpha-2|mesh-list
5846633|NCT02471430|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5846634|NCT02471430|Panobinostat|panobinostat|mesh-list
5846635|NCT02471430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5846636|NCT02471430|Antiviral Agents|antiviral agents|mesh-ancestor
5846637|NCT02471430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5846638|NCT02471430|Immunologic Factors|immunologic factors|mesh-ancestor
5846639|NCT02471430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846640|NCT02471430|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5846641|NCT02471430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5846642|NCT02471430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846643|NCT02471209|Sevoflurane|sevoflurane|mesh-list
5846644|NCT02471209|Anesthetics|anesthetics|mesh-ancestor
5846645|NCT02471209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5846646|NCT02471209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846647|NCT02471209|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5846648|NCT02471209|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5846649|NCT02471209|Anesthetics, General|anesthetics, general|mesh-ancestor
5846650|NCT02471105|Bimatoprost|bimatoprost|mesh-list
5846651|NCT02471105|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5846652|NCT02470832|Itraconazole|itraconazole|mesh-list
5846653|NCT02470832|Antifungal Agents|antifungal agents|mesh-ancestor
5846654|NCT02470832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5846655|NCT02470832|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5846656|NCT02470832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5846657|NCT02470832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5846658|NCT02470832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846659|NCT02470832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5846660|NCT02470832|Hormone Antagonists|hormone antagonists|mesh-ancestor
5846661|NCT02470832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5846662|NCT02470832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846663|NCT02470832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5846664|NCT02470923|Nicotine|nicotine|mesh-list
5846665|NCT02470923|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5846666|NCT02470923|Autonomic Agents|autonomic agents|mesh-ancestor
5846667|NCT02470923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5846668|NCT02470923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846669|NCT02470923|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5665361|NCT03602586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5665362|NCT03602586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5665363|NCT03602560|Seladelpar|seladelpar|mesh-list
5665364|NCT03602560|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5665365|NCT03602560|Antimetabolites|antimetabolites|mesh-ancestor
5846670|NCT02470923|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5846671|NCT02470923|Cholinergic Agents|cholinergic agents|mesh-ancestor
5846672|NCT02470923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5846673|NCT02470923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846674|NCT02470858|Sofosbuvir|sofosbuvir|mesh-list
5846675|NCT02470858|Asunaprevir|asunaprevir|mesh-list
5846676|NCT02470858|Antiviral Agents|antiviral agents|mesh-ancestor
5846677|NCT02470858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5846678|NCT02470858|Protease Inhibitors|protease inhibitors|mesh-ancestor
5695668|NCT03387787|Insulin|insulin|mesh-list
5846679|NCT02470858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5846680|NCT02470858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846681|NCT02470780|Rifaximin|rifaximin|mesh-list
5846682|NCT02470780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5846683|NCT02470780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5846684|NCT02470780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5903697|NCT04579523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903698|NCT04579523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5903699|NCT04579523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5903700|NCT04579523|Alkylating Agents|alkylating agents|mesh-ancestor
5903701|NCT04579523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903702|NCT04579523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5903703|NCT04579523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5903704|NCT04579523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5903705|NCT04579523|Antimetabolites|antimetabolites|mesh-ancestor
5903706|NCT04576871|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5903707|NCT04576871|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5903708|NCT04576871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903709|NCT04543071|Gemcitabine|gemcitabine|mesh-list
5903710|NCT04543071|Paclitaxel|paclitaxel|mesh-list
5903711|NCT04543071|Cemiplimab|cemiplimab|mesh-list
5903712|NCT04543071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5903713|NCT04543071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5903714|NCT04543071|Tubulin Modulators|tubulin modulators|mesh-ancestor
5903715|NCT04543071|Antimitotic Agents|antimitotic agents|mesh-ancestor
5903716|NCT04543071|Mitosis Modulators|mitosis modulators|mesh-ancestor
5903717|NCT04543071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903718|NCT04543071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5903719|NCT04543071|Antimetabolites|antimetabolites|mesh-ancestor
5903720|NCT04543071|Antiviral Agents|antiviral agents|mesh-ancestor
5903721|NCT04543071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5903722|NCT04543071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5903723|NCT04543071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5903724|NCT04543071|Immunologic Factors|immunologic factors|mesh-ancestor
5903725|NCT04543071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903726|NCT04543071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5903727|NCT04535141|Olanzapine|olanzapine|mesh-list
5903728|NCT04535141|Antiemetics|antiemetics|mesh-ancestor
5665366|NCT03602560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665367|NCT03602560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5665368|NCT03602547|Vorolanib|vorolanib|mesh-list
5665369|NCT03602547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5665370|NCT03602547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5665371|NCT03602547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665372|NCT03602508|Solifenacin Succinate|solifenacin succinate|mesh-list
5665373|NCT03602508|Mirabegron|mirabegron|mesh-list
5665374|NCT03602508|Fesoterodine|fesoterodine|mesh-list
5665375|NCT03602508|Tolterodine Tartrate|tolterodine tartrate|mesh-list
5665376|NCT03602508|Oxybutynin|oxybutynin|mesh-list
5665377|NCT03602508|Darifenacin|darifenacin|mesh-list
5665378|NCT03602508|Propiverine|propiverine|mesh-list
5665379|NCT03602508|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5665380|NCT03602508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5665381|NCT03602508|Cholinergic Agents|cholinergic agents|mesh-ancestor
5665382|NCT03602508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5665383|NCT03602508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665384|NCT03602508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665385|NCT03602508|Urological Agents|urological agents|mesh-ancestor
5665386|NCT03602508|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
5665387|NCT03602508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5665388|NCT03602508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5665389|NCT03602508|Adrenergic Agents|adrenergic agents|mesh-ancestor
5665390|NCT03602508|Parasympatholytics|parasympatholytics|mesh-ancestor
5665391|NCT03602508|Autonomic Agents|autonomic agents|mesh-ancestor
5665392|NCT03602508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5665393|NCT03602469|Bupivacaine|bupivacaine|mesh-list
5665394|NCT03602469|Propofol|propofol|mesh-list
5665395|NCT03602469|Sevoflurane|sevoflurane|mesh-list
5665396|NCT03602469|Rocuronium|rocuronium|mesh-list
5903729|NCT04535141|Autonomic Agents|autonomic agents|mesh-ancestor
5903730|NCT04535141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5903731|NCT04535141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665397|NCT03602469|Anesthetics, Local|anesthetics, local|mesh-ancestor
5665398|NCT03602469|Anesthetics|anesthetics|mesh-ancestor
5665399|NCT03602469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5695669|NCT03387787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5665400|NCT03602469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665401|NCT03602469|Sensory System Agents|sensory system agents|mesh-ancestor
5665402|NCT03602469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5665403|NCT03602469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5665404|NCT03602469|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5665405|NCT03602469|Anesthetics, General|anesthetics, general|mesh-ancestor
5665406|NCT03602469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5665407|NCT03602469|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5665408|NCT03602469|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5665409|NCT03602469|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5665410|NCT03602469|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5665411|NCT03602430|Vitamin D|vitamin d|mesh-list
5665412|NCT03602430|Cholecalciferol|cholecalciferol|mesh-list
5665413|NCT03602430|Vitamins|vitamins|mesh-ancestor
5665414|NCT03602430|Micronutrients|micronutrients|mesh-ancestor
5665415|NCT03602430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665416|NCT03602430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5665417|NCT03602430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5665418|NCT03602378|Hydrocortisone|hydrocortisone|mesh-list
5665419|NCT03602378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5665420|NCT03602287|Lidocaine|lidocaine|mesh-list
5665421|NCT03602287|Anesthetics, Local|anesthetics, local|mesh-ancestor
5665422|NCT03602287|Anesthetics|anesthetics|mesh-ancestor
5665423|NCT03602287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5665424|NCT03602287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665425|NCT03602287|Sensory System Agents|sensory system agents|mesh-ancestor
5665426|NCT03602287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5665427|NCT03602287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5665428|NCT03602287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5665429|NCT03602287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5665430|NCT03602287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5665431|NCT03602287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665432|NCT03602261|Calcifediol|calcifediol|mesh-list
5665433|NCT03602261|Vitamins|vitamins|mesh-ancestor
5665434|NCT03602261|Micronutrients|micronutrients|mesh-ancestor
5665435|NCT03602261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665436|NCT03602261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5665437|NCT03602248|Methamphetamine|methamphetamine|mesh-list
5665438|NCT03602248|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5665439|NCT03602248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846685|NCT02470767|Anticoagulants|anticoagulants|mesh-list
5846686|NCT02470611|Alendronate|alendronate|mesh-list
5846687|NCT02470611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5846688|NCT02470611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846689|NCT02470559|Aldesleukin|aldesleukin|mesh-list
5846690|NCT02470559|Interleukin-2|interleukin-2|mesh-list
5846691|NCT02470559|Sargramostim|sargramostim|mesh-list
5846692|NCT02470559|Antibodies, Bispecific|antibodies, bispecific|mesh-list
5846693|NCT02470559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5846694|NCT02470559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5846695|NCT02470559|Analgesics|analgesics|mesh-ancestor
5846696|NCT02470559|Sensory System Agents|sensory system agents|mesh-ancestor
5846697|NCT02470559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5846698|NCT02470559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846699|NCT02470559|Immunologic Factors|immunologic factors|mesh-ancestor
5846700|NCT02470559|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5846701|NCT02470559|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5846702|NCT02470559|Antiviral Agents|antiviral agents|mesh-ancestor
5846703|NCT02470559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5846704|NCT02470637|Insulin|insulin|mesh-list
5846705|NCT02470637|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5665440|NCT03602248|Sympathomimetics|sympathomimetics|mesh-ancestor
5665441|NCT03602248|Autonomic Agents|autonomic agents|mesh-ancestor
5665442|NCT03602248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5665443|NCT03602248|Dopamine Agents|dopamine agents|mesh-ancestor
5665444|NCT03602248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5665445|NCT03602248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665446|NCT03602248|Adrenergic Agents|adrenergic agents|mesh-ancestor
5665447|NCT03602248|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5665448|NCT03602248|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5665449|NCT03602248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5665450|NCT03602248|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5665451|NCT03602209|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5665452|NCT03602209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5846706|NCT02470637|Insulin Lispro|insulin lispro|mesh-list
5846707|NCT02470637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5665453|NCT03602131|Gemcitabine|gemcitabine|mesh-list
5665454|NCT03602131|Busulfan|busulfan|mesh-list
5665455|NCT03602131|Cladribine|cladribine|mesh-list
5665456|NCT03602131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5846708|NCT02470637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846709|NCT02470650|Ritonavir|ritonavir|mesh-list
5846710|NCT02470650|Darunavir|darunavir|mesh-list
5846711|NCT02470650|Tenofovir|tenofovir|mesh-list
5846712|NCT02470650|Lamivudine|lamivudine|mesh-list
5846713|NCT02470650|Emtricitabine|emtricitabine|mesh-list
5846714|NCT02470650|Abacavir|abacavir|mesh-list
5846715|NCT02470650|Cobicistat|cobicistat|mesh-list
5846716|NCT02470650|Rilpivirine|rilpivirine|mesh-list
5846717|NCT02470650|Elvitegravir|elvitegravir|mesh-list
5846718|NCT02470650|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5846719|NCT02470650|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5846720|NCT02470650|Protease Inhibitors|protease inhibitors|mesh-ancestor
5846721|NCT02470650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5846722|NCT02470650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665457|NCT03602131|Antimetabolites|antimetabolites|mesh-ancestor
5665458|NCT03602131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665459|NCT03602131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5665460|NCT03602131|Antiviral Agents|antiviral agents|mesh-ancestor
5665461|NCT03602131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5665462|NCT03602131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5665463|NCT03602131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5665464|NCT03602131|Immunologic Factors|immunologic factors|mesh-ancestor
5665465|NCT03602131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665466|NCT03602131|Alkylating Agents|alkylating agents|mesh-ancestor
5665467|NCT03602131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5665468|NCT03602131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5665469|NCT03602118|Phenobarbital|phenobarbital|mesh-list
5665470|NCT03602118|Anticonvulsants|anticonvulsants|mesh-ancestor
5665471|NCT03602118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5665472|NCT03602118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5665473|NCT03602118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665474|NCT03602118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5665475|NCT03602118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5665476|NCT03602118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5665477|NCT03602118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665478|NCT03602118|GABA Modulators|gaba modulators|mesh-ancestor
5665479|NCT03602118|GABA Agents|gaba agents|mesh-ancestor
5665480|NCT03602118|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5665481|NCT03602118|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5665482|NCT03602118|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5665483|NCT03602066|Chlorine dioxide|chlorine dioxide|mesh-list
5665484|NCT03602066|Dental Disinfectants|dental disinfectants|mesh-ancestor
5665485|NCT03602066|Disinfectants|disinfectants|mesh-ancestor
5665486|NCT03602066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5665487|NCT03602027|Gefitinib|gefitinib|mesh-list
5665488|NCT03602027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5665489|NCT03602027|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5665490|NCT03602027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5665491|NCT03602027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665492|NCT03602014|Droxidopa|droxidopa|mesh-list
5665493|NCT03602014|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5665494|NCT03602014|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5846723|NCT02470650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5846724|NCT02470650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5846725|NCT02470650|Antiviral Agents|antiviral agents|mesh-ancestor
5846726|NCT02470650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5665495|NCT03601975|Gemcitabine|gemcitabine|mesh-list
5665496|NCT03601975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5665497|NCT03601975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5665498|NCT03601975|Antimetabolites|antimetabolites|mesh-ancestor
5665499|NCT03601975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665500|NCT03601975|Antiviral Agents|antiviral agents|mesh-ancestor
5665501|NCT03601975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5665502|NCT03601975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5665503|NCT03601975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5665504|NCT03601975|Immunologic Factors|immunologic factors|mesh-ancestor
5665505|NCT03601975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665506|NCT03601923|Niraparib|niraparib|mesh-list
5846727|NCT02470650|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5665507|NCT03601923|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5846728|NCT02470650|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5846729|NCT02470650|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5665508|NCT03601923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5665509|NCT03601923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665510|NCT03601923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5665511|NCT03601897|Paclitaxel|paclitaxel|mesh-list
5665512|NCT03601897|Rebastinib|rebastinib|mesh-list
5846730|NCT02470650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5846731|NCT02470650|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5846732|NCT02470702|Oritavancin|oritavancin|mesh-list
5846733|NCT02470702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5846734|NCT02470702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5846735|NCT02470676|Progesterone|progesterone|mesh-list
5846736|NCT02470676|Progestins|progestins|mesh-ancestor
5846737|NCT02470676|Hormones|hormones|mesh-ancestor
5846738|NCT02470676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5846739|NCT02470676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846740|NCT02470442|Sevoflurane|sevoflurane|mesh-list
5846741|NCT02470442|Desflurane|desflurane|mesh-list
5665513|NCT03601897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5665514|NCT03601897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5665515|NCT03601897|Tubulin Modulators|tubulin modulators|mesh-ancestor
5665516|NCT03601897|Antimitotic Agents|antimitotic agents|mesh-ancestor
5665517|NCT03601897|Mitosis Modulators|mitosis modulators|mesh-ancestor
5846742|NCT02470442|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5846743|NCT02470442|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5846744|NCT02470442|Anesthetics, General|anesthetics, general|mesh-ancestor
5846745|NCT02470442|Anesthetics|anesthetics|mesh-ancestor
5846746|NCT02470442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5846747|NCT02470442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846748|NCT02470455|Atorvastatin|atorvastatin|mesh-list
5846749|NCT02470455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5846750|NCT02470455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5846751|NCT02470455|Antimetabolites|antimetabolites|mesh-ancestor
5846752|NCT02470455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665518|NCT03601897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665519|NCT03601897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5665520|NCT03601897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5665521|NCT03601871|Thalidomide|thalidomide|mesh-list
5665522|NCT03601871|Dexamethasone|dexamethasone|mesh-list
5665523|NCT03601871|Palonosetron|palonosetron|mesh-list
5665524|NCT03601871|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
5665525|NCT03601871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5665526|NCT03601871|Antiemetics|antiemetics|mesh-ancestor
5665527|NCT03601871|Autonomic Agents|autonomic agents|mesh-ancestor
5665528|NCT03601871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5665529|NCT03601871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665530|NCT03601871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5665531|NCT03601871|Glucocorticoids|glucocorticoids|mesh-ancestor
5665532|NCT03601871|Hormones|hormones|mesh-ancestor
5665533|NCT03601871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5665534|NCT03601871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5665535|NCT03601871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5665536|NCT03601871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5665537|NCT03601871|Immunologic Factors|immunologic factors|mesh-ancestor
5665538|NCT03601871|Leprostatic Agents|leprostatic agents|mesh-ancestor
5846753|NCT02470455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5846754|NCT02470455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5846755|NCT02470455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5846756|NCT02470546|Metformin|metformin|mesh-list
5846757|NCT02470546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5846758|NCT02470546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846759|NCT02470663|Calcium Carbonate|calcium carbonate|mesh-list
5846760|NCT02470663|Calcium|calcium|mesh-list
5846761|NCT02470663|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5846762|NCT02470663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846763|NCT02470663|Antacids|antacids|mesh-ancestor
5846764|NCT02470663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846765|NCT02470663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5846766|NCT02470299|Ketorolac|ketorolac|mesh-list
5846767|NCT02470299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5846768|NCT02470299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5846769|NCT02470299|Analgesics|analgesics|mesh-ancestor
5846770|NCT02470299|Sensory System Agents|sensory system agents|mesh-ancestor
5665539|NCT03601871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5665540|NCT03601871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5665541|NCT03601871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5846771|NCT02470299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5846772|NCT02470299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846773|NCT02470299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5846774|NCT02470299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5846775|NCT02470299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5846776|NCT02470299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5846777|NCT02470299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846778|NCT02470117|Antacids|antacids|mesh-list
5846779|NCT02470117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846780|NCT02470117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5846781|NCT02470065|Afatinib|afatinib|mesh-list
5846782|NCT02470065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5846783|NCT02470065|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5846784|NCT02470065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5665542|NCT03601871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5665543|NCT03601871|Growth Substances|growth substances|mesh-ancestor
5665544|NCT03601871|Growth Inhibitors|growth inhibitors|mesh-ancestor
5665545|NCT03601871|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5665546|NCT03601871|Serotonin Agents|serotonin agents|mesh-ancestor
5665547|NCT03601871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5665548|NCT03601871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695670|NCT03387787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695671|NCT03387761|Nivolumab|nivolumab|mesh-list
5695672|NCT03387761|Ipilimumab|ipilimumab|mesh-list
5695673|NCT03387761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5695674|NCT03387761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5695675|NCT03387761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5695676|NCT03387761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695677|NCT03387670|Simvastatin|simvastatin|mesh-list
5695678|NCT03387670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5695679|NCT03387670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5695680|NCT03387670|Antimetabolites|antimetabolites|mesh-ancestor
5695681|NCT03387670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695682|NCT03387670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5695683|NCT03387670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5695684|NCT03387670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5695685|NCT03387657|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
5846785|NCT02470065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846786|NCT02469987|Bevacizumab|bevacizumab|mesh-list
5846787|NCT02469987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5846788|NCT02469987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5846789|NCT02469987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5846790|NCT02469987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5846791|NCT02469987|Growth Substances|growth substances|mesh-ancestor
5846792|NCT02469987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846793|NCT02469987|Growth Inhibitors|growth inhibitors|mesh-ancestor
5846794|NCT02470026|Yohimbine|yohimbine|mesh-list
5846795|NCT02470026|Mydriatics|mydriatics|mesh-ancestor
5846796|NCT02470026|Autonomic Agents|autonomic agents|mesh-ancestor
5846797|NCT02470026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5846798|NCT02470026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846799|NCT02470026|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5846800|NCT02470026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5846801|NCT02470026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5846802|NCT02470026|Adrenergic Agents|adrenergic agents|mesh-ancestor
5846803|NCT02470026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5846804|NCT02470026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846805|NCT02470026|Urological Agents|urological agents|mesh-ancestor
5846806|NCT02469948|Botulinum Toxins|botulinum toxins|mesh-list
5846807|NCT02469948|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5846808|NCT02469948|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5846809|NCT02469948|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5846810|NCT02469948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5846811|NCT02469948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846812|NCT02469948|Cholinergic Agents|cholinergic agents|mesh-ancestor
5846813|NCT02469948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5846814|NCT02469948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846815|NCT02469948|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5846816|NCT02469948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5846817|NCT02469974|Busulfan|busulfan|mesh-list
5846818|NCT02469974|Immunologic Factors|immunologic factors|mesh-ancestor
5846819|NCT02469974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846820|NCT02469974|Alkylating Agents|alkylating agents|mesh-ancestor
5665549|NCT03601806|Thalidomide|thalidomide|mesh-list
5665550|NCT03601806|Pomalidomide|pomalidomide|mesh-list
5665551|NCT03601806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5665552|NCT03601806|Immunologic Factors|immunologic factors|mesh-ancestor
5665553|NCT03601806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665554|NCT03601806|Leprostatic Agents|leprostatic agents|mesh-ancestor
5665555|NCT03601806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5665556|NCT03601806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5665557|NCT03601806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5665558|NCT03601806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5665559|NCT03601806|Growth Substances|growth substances|mesh-ancestor
5665560|NCT03601806|Growth Inhibitors|growth inhibitors|mesh-ancestor
5665561|NCT03601806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5665562|NCT03601741|Anti-Infective Agents|anti-infective agents|mesh-list
5665563|NCT03601741|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5665564|NCT03601624|Dexamethasone|dexamethasone|mesh-list
5665565|NCT03601624|Cyclophosphamide|cyclophosphamide|mesh-list
5665566|NCT03601624|Pomalidomide|pomalidomide|mesh-list
5665567|NCT03601624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5665568|NCT03601624|Immunologic Factors|immunologic factors|mesh-ancestor
5846821|NCT02469974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846822|NCT02469974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5846823|NCT02469974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5846824|NCT02469974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5846825|NCT02469974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5846826|NCT02469831|Rocuronium|rocuronium|mesh-list
5846827|NCT02469831|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5846828|NCT02469831|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5846829|NCT02469831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5846830|NCT02469831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5846831|NCT02469831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846832|NCT02469740|Clopidogrel|clopidogrel|mesh-list
5846833|NCT02469740|Ticagrelor|ticagrelor|mesh-list
5846834|NCT02469740|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5846835|NCT02469740|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5846836|NCT02469740|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5846837|NCT02469740|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5846838|NCT02469740|Purinergic Agents|purinergic agents|mesh-ancestor
5846839|NCT02469740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5665569|NCT03601624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846840|NCT02469740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846841|NCT02469740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846842|NCT02469519|Dexamethasone|dexamethasone|mesh-list
5846843|NCT02469519|Betamethasone|betamethasone|mesh-list
5846844|NCT02469519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5846845|NCT02469519|Antiemetics|antiemetics|mesh-ancestor
5846846|NCT02469519|Autonomic Agents|autonomic agents|mesh-ancestor
5846847|NCT02469519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5846848|NCT02469519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846849|NCT02469519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5846850|NCT02469519|Glucocorticoids|glucocorticoids|mesh-ancestor
5846851|NCT02469519|Hormones|hormones|mesh-ancestor
5846852|NCT02469519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5846853|NCT02469519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5846854|NCT02469519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5846855|NCT02469519|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5846856|NCT02469519|Respiratory System Agents|respiratory system agents|mesh-ancestor
5846857|NCT02469545|Citalopram|citalopram|mesh-list
5846858|NCT02469545|Sertraline|sertraline|mesh-list
5846859|NCT02469545|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5846860|NCT02469545|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5846861|NCT02469545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5846862|NCT02469545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846863|NCT02469545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5846864|NCT02469545|Serotonin Agents|serotonin agents|mesh-ancestor
5665570|NCT03601624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5665571|NCT03601624|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5665572|NCT03601624|Alkylating Agents|alkylating agents|mesh-ancestor
5665573|NCT03601624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665574|NCT03601624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5665575|NCT03601624|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5665576|NCT03601624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5665577|NCT03601624|Antiemetics|antiemetics|mesh-ancestor
5665578|NCT03601624|Autonomic Agents|autonomic agents|mesh-ancestor
5665579|NCT03601624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5665580|NCT03601624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5665581|NCT03601624|Glucocorticoids|glucocorticoids|mesh-ancestor
5665582|NCT03601624|Hormones|hormones|mesh-ancestor
5665583|NCT03601624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5665584|NCT03601624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5665585|NCT03601624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5665586|NCT03601624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5665587|NCT03601624|Growth Substances|growth substances|mesh-ancestor
5846865|NCT02469545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846866|NCT02469545|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5846867|NCT02469545|Antidepressive Agents|antidepressive agents|mesh-ancestor
5846868|NCT02469545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5846869|NCT02469259|Oxytocin|oxytocin|mesh-list
5846870|NCT02469259|Oxytocics|oxytocics|mesh-ancestor
5846871|NCT02469259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5846872|NCT02469259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846873|NCT02469311|Chlorhexidine|chlorhexidine|mesh-list
5846874|NCT02469311|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5846875|NCT02469311|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5846876|NCT02469311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5846877|NCT02469311|Disinfectants|disinfectants|mesh-ancestor
5903732|NCT04535141|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5903733|NCT04535141|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5903734|NCT04535141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5903735|NCT04535141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5903736|NCT04535141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5903737|NCT04535141|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5903738|NCT04535141|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5903739|NCT04535141|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5903740|NCT04535141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903741|NCT04535141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5903742|NCT04535141|Serotonin Agents|serotonin agents|mesh-ancestor
5903743|NCT04530630|Emtricitabine|emtricitabine|mesh-list
5903744|NCT04530630|Antiviral Agents|antiviral agents|mesh-ancestor
5903745|NCT04530630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5903746|NCT04530630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5903747|NCT04530630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5903748|NCT04530630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5903749|NCT04530630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903750|NCT04530630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5903751|NCT04530630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5903752|NCT04530149|Acetaminophen|acetaminophen|mesh-list
5903753|NCT04530149|Bupivacaine|bupivacaine|mesh-list
5903754|NCT04530149|Anesthetics, Local|anesthetics, local|mesh-ancestor
5903755|NCT04530149|Anesthetics|anesthetics|mesh-ancestor
5903756|NCT04530149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5903757|NCT04530149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903758|NCT04530149|Sensory System Agents|sensory system agents|mesh-ancestor
5903759|NCT04530149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5903760|NCT04530149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5903761|NCT04530149|Analgesics|analgesics|mesh-ancestor
5903762|NCT04530149|Antipyretics|antipyretics|mesh-ancestor
5903763|NCT04529902|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
5903764|NCT04529902|Abatacept|abatacept|mesh-list
5903765|NCT04529902|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5903766|NCT04529902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903767|NCT04529902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5903768|NCT04529902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5903769|NCT04529902|Immunologic Factors|immunologic factors|mesh-ancestor
5903770|NCT04529902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903771|NCT04529902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5903772|NCT04529902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5903773|NCT04486118|Lisinopril|lisinopril|mesh-list
5903774|NCT04486118|Benazepril|benazepril|mesh-list
5903775|NCT04486118|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5903776|NCT04486118|Protease Inhibitors|protease inhibitors|mesh-ancestor
5903777|NCT04486118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5903778|NCT04486118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903779|NCT04486118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5665588|NCT03601624|Growth Inhibitors|growth inhibitors|mesh-ancestor
5903780|NCT04486118|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5903781|NCT04486118|Protective Agents|protective agents|mesh-ancestor
5846878|NCT02468999|Insulin|insulin|mesh-list
5846879|NCT02468999|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5846880|NCT02468999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5846881|NCT02468999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846882|NCT02469012|Ribavirin|ribavirin|mesh-list
5846883|NCT02469012|Sofosbuvir|sofosbuvir|mesh-list
5846884|NCT02469012|Ledipasvir|ledipasvir|mesh-list
5846885|NCT02469012|Antimetabolites|antimetabolites|mesh-ancestor
5846886|NCT02469012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846887|NCT02469012|Antiviral Agents|antiviral agents|mesh-ancestor
5846888|NCT02469012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5846889|NCT02468856|Modafinil|modafinil|mesh-list
5846890|NCT02468856|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5846891|NCT02468856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846892|NCT02468856|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
5846893|NCT02468856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5846894|NCT02468856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5846895|NCT02468856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846896|NCT02468908|Molgramostim|molgramostim|mesh-list
5846897|NCT02468908|Sargramostim|sargramostim|mesh-list
5846898|NCT02468908|Immunologic Factors|immunologic factors|mesh-ancestor
5846899|NCT02468908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846900|NCT02468908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5846901|NCT02468791|Rituximab|rituximab|mesh-list
5846902|NCT02468791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5846903|NCT02468791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5846904|NCT02468791|Immunologic Factors|immunologic factors|mesh-ancestor
5846905|NCT02468791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846906|NCT02468791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5846907|NCT02468661|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5846908|NCT02468661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5846909|NCT02468661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5846910|NCT02468661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5846911|NCT02468661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846912|NCT02468518|Vitamin E|vitamin e|mesh-list
5846913|NCT02468518|Vitamins|vitamins|mesh-ancestor
5846914|NCT02468518|Micronutrients|micronutrients|mesh-ancestor
5846915|NCT02468518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846916|NCT02468518|Antioxidants|antioxidants|mesh-ancestor
5846917|NCT02468518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846918|NCT02468518|Protective Agents|protective agents|mesh-ancestor
5846919|NCT02468531|Xenon|xenon|mesh-list
5846920|NCT02468531|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5846921|NCT02468531|Anesthetics, General|anesthetics, general|mesh-ancestor
5846922|NCT02468531|Anesthetics|anesthetics|mesh-ancestor
5846923|NCT02468531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5846924|NCT02468531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846925|NCT02468323|Ondansetron|ondansetron|mesh-list
5846926|NCT02468323|Palonosetron|palonosetron|mesh-list
5846927|NCT02468323|Antiemetics|antiemetics|mesh-ancestor
5846928|NCT02468323|Autonomic Agents|autonomic agents|mesh-ancestor
5846929|NCT02468323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5846930|NCT02468323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846931|NCT02468323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5846932|NCT02468323|Antipruritics|antipruritics|mesh-ancestor
5846933|NCT02468323|Dermatologic Agents|dermatologic agents|mesh-ancestor
5846934|NCT02468323|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5846935|NCT02468323|Serotonin Agents|serotonin agents|mesh-ancestor
5846936|NCT02468323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5846937|NCT02468323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846938|NCT02468323|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5846939|NCT02468323|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5846940|NCT02468323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5846941|NCT02468323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5846942|NCT02468323|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5846943|NCT02468323|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5846944|NCT02468297|Ibuprofen|ibuprofen|mesh-list
5846945|NCT02468297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5846946|NCT02468297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5846947|NCT02468297|Analgesics|analgesics|mesh-ancestor
5846948|NCT02468297|Sensory System Agents|sensory system agents|mesh-ancestor
5846949|NCT02468297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5846950|NCT02468297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846951|NCT02468297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5846952|NCT02468297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5846953|NCT02468297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5846954|NCT02468297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5846955|NCT02468297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846956|NCT02468375|Mirabegron|mirabegron|mesh-list
5846957|NCT02468375|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
5846958|NCT02468375|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5846959|NCT02468375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5846960|NCT02468375|Adrenergic Agents|adrenergic agents|mesh-ancestor
5846961|NCT02468375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5846962|NCT02468375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846963|NCT02468375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846964|NCT02468375|Urological Agents|urological agents|mesh-ancestor
5846965|NCT02468232|Enalapril|enalapril|mesh-list
5846966|NCT02468232|Enalaprilat|enalaprilat|mesh-list
5846967|NCT02468232|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5846968|NCT02468232|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5846969|NCT02468232|Protease Inhibitors|protease inhibitors|mesh-ancestor
5846970|NCT02468232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5846971|NCT02468232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665589|NCT03601611|Prednisolone|prednisolone|mesh-list
5665590|NCT03601611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5665591|NCT03601611|Glucocorticoids|glucocorticoids|mesh-ancestor
5665592|NCT03601611|Hormones|hormones|mesh-ancestor
5665593|NCT03601611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5846972|NCT02468232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5846973|NCT02468232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5846974|NCT02468206|Polidocanol|polidocanol|mesh-list
5846975|NCT02468206|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
5846976|NCT02468206|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5846977|NCT02468128|Nalbuphine|nalbuphine|mesh-list
5846978|NCT02468128|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5846979|NCT02468128|Narcotics|narcotics|mesh-ancestor
5846980|NCT02468128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5846981|NCT02468128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846982|NCT02468128|Analgesics|analgesics|mesh-ancestor
5846983|NCT02468128|Sensory System Agents|sensory system agents|mesh-ancestor
5846984|NCT02468128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5846985|NCT02468089|Sargramostim|sargramostim|mesh-list
5846986|NCT02468089|Immunologic Factors|immunologic factors|mesh-ancestor
5846987|NCT02468089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846988|NCT02468063|Terlipressin|terlipressin|mesh-list
5846989|NCT02468063|Norepinephrine|norepinephrine|mesh-list
5846990|NCT02468063|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5846991|NCT02468063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5846992|NCT02468063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5846993|NCT02468063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6212069|NCT02181231|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6212070|NCT02181231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6212071|NCT02181231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6493976|NCT00616460|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6493977|NCT00616460|Protease Inhibitors|protease inhibitors|mesh-ancestor
5665594|NCT03601611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665595|NCT03601611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5665596|NCT03601611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5665597|NCT03601533|Phenol|phenol|mesh-list
5665598|NCT03601533|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5665599|NCT03601533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5665600|NCT03601533|Disinfectants|disinfectants|mesh-ancestor
5665601|NCT03601533|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
5665602|NCT03601533|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5665603|NCT03601507|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
5665604|NCT03601507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5665605|NCT03601507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665606|NCT03601338|Bemiparin|bemiparin|mesh-list
5665607|NCT03601338|Anticoagulants|anticoagulants|mesh-ancestor
5665608|NCT03601260|Allopurinol|allopurinol|mesh-list
5665609|NCT03601260|Antimetabolites|antimetabolites|mesh-ancestor
6493978|NCT00616460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6493979|NCT00616460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493980|NCT00616460|Anticoagulants|anticoagulants|mesh-ancestor
6493981|NCT00616499|Gefitinib|gefitinib|mesh-list
6493982|NCT00616499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5665610|NCT03601260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846994|NCT02468063|Adrenergic Agents|adrenergic agents|mesh-ancestor
5846995|NCT02468063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5665611|NCT03601260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5665612|NCT03601260|Gout Suppressants|gout suppressants|mesh-ancestor
5665613|NCT03601260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5665614|NCT03601260|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5665615|NCT03601260|Antioxidants|antioxidants|mesh-ancestor
5665616|NCT03601260|Protective Agents|protective agents|mesh-ancestor
5665617|NCT03601260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665618|NCT03601091|Midazolam|midazolam|mesh-list
5665619|NCT03601091|Dexmedetomidine|dexmedetomidine|mesh-list
5665620|NCT03601091|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5665621|NCT03601091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5665622|NCT03601091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665623|NCT03601091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5665624|NCT03601091|Analgesics|analgesics|mesh-ancestor
5665625|NCT03601091|Sensory System Agents|sensory system agents|mesh-ancestor
5846996|NCT02468063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5846997|NCT02468063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5846998|NCT02468063|Sympathomimetics|sympathomimetics|mesh-ancestor
5846999|NCT02468063|Autonomic Agents|autonomic agents|mesh-ancestor
5847000|NCT02468063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5847001|NCT02468102|Rivaroxaban|rivaroxaban|mesh-list
5847002|NCT02468102|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5847003|NCT02468102|Antithrombins|antithrombins|mesh-ancestor
5847004|NCT02468102|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5847005|NCT02468102|Protease Inhibitors|protease inhibitors|mesh-ancestor
5847006|NCT02468102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5847007|NCT02468102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5847008|NCT02468102|Anticoagulants|anticoagulants|mesh-ancestor
5847009|NCT02468167|Polidocanol|polidocanol|mesh-list
5847010|NCT02468167|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
5847011|NCT02468167|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5847012|NCT02467907|Paclitaxel|paclitaxel|mesh-list
5847013|NCT02467907|Bevacizumab|bevacizumab|mesh-list
5847014|NCT02467907|Carboplatin|carboplatin|mesh-list
5847015|NCT02467907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5847016|NCT02467907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5847017|NCT02467907|Tubulin Modulators|tubulin modulators|mesh-ancestor
5847018|NCT02467907|Antimitotic Agents|antimitotic agents|mesh-ancestor
5847019|NCT02467907|Mitosis Modulators|mitosis modulators|mesh-ancestor
5847020|NCT02467907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5847021|NCT02467907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5847022|NCT02467907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5847023|NCT02467907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5847024|NCT02467907|Growth Substances|growth substances|mesh-ancestor
5847025|NCT02467907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847026|NCT02467907|Growth Inhibitors|growth inhibitors|mesh-ancestor
5847027|NCT02467920|Exenatide|exenatide|mesh-list
5847028|NCT02467920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5847029|NCT02467920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847030|NCT02467920|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5847031|NCT02467920|Incretins|incretins|mesh-ancestor
5847032|NCT02467920|Hormones|hormones|mesh-ancestor
5847033|NCT02467920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5847034|NCT02467946|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5847035|NCT02467946|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5847036|NCT02467946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5847037|NCT02467946|Alkylating Agents|alkylating agents|mesh-ancestor
5847038|NCT02467946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5847039|NCT02467946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5847040|NCT02467946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5847041|NCT02467647|Thalidomide|thalidomide|mesh-list
5847042|NCT02467647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5847043|NCT02467647|Immunologic Factors|immunologic factors|mesh-ancestor
5847044|NCT02467647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847045|NCT02467647|Leprostatic Agents|leprostatic agents|mesh-ancestor
5847046|NCT02467647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5847047|NCT02467647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5847048|NCT02467647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5847049|NCT02467647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5847050|NCT02467647|Growth Substances|growth substances|mesh-ancestor
5847051|NCT02467647|Growth Inhibitors|growth inhibitors|mesh-ancestor
5847052|NCT02467647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6212619|NCT02191397|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5665626|NCT03601091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5847053|NCT02467426|Mitoxantrone|mitoxantrone|mesh-list
5847054|NCT02467426|Analgesics|analgesics|mesh-ancestor
5847055|NCT02467426|Sensory System Agents|sensory system agents|mesh-ancestor
5847056|NCT02467426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5847057|NCT02467426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847058|NCT02467426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5847059|NCT02467426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5847060|NCT02467426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5847061|NCT02467426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5847062|NCT02467426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5847063|NCT02467478|Linagliptin|linagliptin|mesh-list
5847064|NCT02467478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5847065|NCT02467478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847066|NCT02467478|Incretins|incretins|mesh-ancestor
5847067|NCT02467478|Hormones|hormones|mesh-ancestor
5847068|NCT02467478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5847069|NCT02467478|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5847070|NCT02467478|Protease Inhibitors|protease inhibitors|mesh-ancestor
5847071|NCT02467478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5847072|NCT02467478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5847073|NCT02467556|Morphine|morphine|mesh-list
5847074|NCT02467556|Memantine|memantine|mesh-list
5847075|NCT02467556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5847076|NCT02467556|Narcotics|narcotics|mesh-ancestor
5847077|NCT02467556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5847078|NCT02467556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847079|NCT02467556|Analgesics|analgesics|mesh-ancestor
5847080|NCT02467556|Sensory System Agents|sensory system agents|mesh-ancestor
5847081|NCT02467556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5847082|NCT02467556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5847083|NCT02467556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5847084|NCT02467556|Dopamine Agents|dopamine agents|mesh-ancestor
5847085|NCT02467556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5847086|NCT02467556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5847087|NCT02467556|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5847088|NCT02467556|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5847089|NCT02467595|Fentanyl|fentanyl|mesh-list
5847090|NCT02467595|Bromides|bromides|mesh-list
5847091|NCT02467595|Propofol|propofol|mesh-list
5847092|NCT02467595|Sevoflurane|sevoflurane|mesh-list
5847093|NCT02467595|Rocuronium|rocuronium|mesh-list
5847094|NCT02467595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5847095|NCT02467595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5847096|NCT02467595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847097|NCT02467595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5847098|NCT02467595|Anesthetics, General|anesthetics, general|mesh-ancestor
5847099|NCT02467595|Anesthetics|anesthetics|mesh-ancestor
5847100|NCT02467595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5665627|NCT03601091|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5665628|NCT03601091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5665629|NCT03601091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5665630|NCT03601091|Adrenergic Agents|adrenergic agents|mesh-ancestor
5665631|NCT03601091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5847101|NCT02467595|Narcotics|narcotics|mesh-ancestor
5847102|NCT02467595|Analgesics|analgesics|mesh-ancestor
5847103|NCT02467595|Sensory System Agents|sensory system agents|mesh-ancestor
5847104|NCT02467595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5847105|NCT02467595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5847106|NCT02467595|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5847107|NCT02467595|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5847108|NCT02467595|Anticonvulsants|anticonvulsants|mesh-ancestor
5847109|NCT02467595|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5847110|NCT02467595|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5665632|NCT03601091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665633|NCT03601091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5665634|NCT03601091|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5665635|NCT03601091|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5665636|NCT03601091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5665637|NCT03601091|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5665638|NCT03601091|Anesthetics, General|anesthetics, general|mesh-ancestor
5665639|NCT03601091|Anesthetics|anesthetics|mesh-ancestor
5665640|NCT03601091|GABA Modulators|gaba modulators|mesh-ancestor
5665641|NCT03601091|GABA Agents|gaba agents|mesh-ancestor
5665642|NCT03600974|Domperidone|domperidone|mesh-list
5665643|NCT03600974|Citalopram|citalopram|mesh-list
5665644|NCT03600974|Esomeprazole|esomeprazole|mesh-list
5665645|NCT03600974|Omeprazole|omeprazole|mesh-list
5665646|NCT03600974|Rabeprazole|rabeprazole|mesh-list
5665647|NCT03600974|Pantoprazole|pantoprazole|mesh-list
5665648|NCT03600974|Lansoprazole|lansoprazole|mesh-list
5665649|NCT03600974|Mosapride|mosapride|mesh-list
5665650|NCT03600974|Neurotransmitter Agents|neurotransmitter agents|mesh-list
5665651|NCT03600974|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5665652|NCT03600974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5665653|NCT03600974|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5665654|NCT03600974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5665655|NCT03600974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665656|NCT03600974|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5665657|NCT03600974|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5665658|NCT03600974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5665659|NCT03600974|Serotonin Agents|serotonin agents|mesh-ancestor
5847111|NCT02467595|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5847112|NCT02467543|Ethanol|ethanol|mesh-list
5847113|NCT02467543|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5847114|NCT02467543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5847115|NCT02467543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5847116|NCT02467543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847117|NCT02467686|Tamoxifen|tamoxifen|mesh-list
5847118|NCT02467686|Exemestane|exemestane|mesh-list
5847119|NCT02467686|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5665660|NCT03600974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665661|NCT03600974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5665662|NCT03600974|Antidepressive Agents|antidepressive agents|mesh-ancestor
5665663|NCT03600974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5847120|NCT02467686|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5847121|NCT02467686|Hormone Antagonists|hormone antagonists|mesh-ancestor
5847122|NCT02467686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5847123|NCT02467686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847124|NCT02467686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5847125|NCT02467686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5847126|NCT02467686|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5847127|NCT02467686|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5847128|NCT02467686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5847129|NCT02467686|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5847130|NCT02467686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5847131|NCT02467686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5847132|NCT02467335|Fostemsavir|fostemsavir|mesh-list
5847133|NCT02467335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5847134|NCT02467335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5847135|NCT02467335|Antiviral Agents|antiviral agents|mesh-ancestor
5847136|NCT02467335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5847137|NCT02467335|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5847138|NCT02467335|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5847139|NCT02467335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5847140|NCT02467400|Propranolol|propranolol|mesh-list
5847141|NCT02467400|Atenolol|atenolol|mesh-list
5847142|NCT02467400|Nebivolol|nebivolol|mesh-list
5847143|NCT02467400|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5847144|NCT02467400|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5847145|NCT02467400|Adrenergic Agents|adrenergic agents|mesh-ancestor
5847146|NCT02467400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5847147|NCT02467400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5847148|NCT02467400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847149|NCT02467400|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5847150|NCT02467400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5847151|NCT02467400|Vasodilator Agents|vasodilator agents|mesh-ancestor
5847152|NCT02467400|Sympatholytics|sympatholytics|mesh-ancestor
5847153|NCT02467400|Autonomic Agents|autonomic agents|mesh-ancestor
5847154|NCT02467400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5665664|NCT03600974|Autonomic Agents|autonomic agents|mesh-ancestor
5665665|NCT03600974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5665666|NCT03600974|Antiemetics|antiemetics|mesh-ancestor
5665667|NCT03600974|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5665668|NCT03600974|Dopamine Agents|dopamine agents|mesh-ancestor
5665669|NCT03600974|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5847155|NCT02467400|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5847156|NCT02467400|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5847157|NCT02467400|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5847158|NCT02467400|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5847159|NCT02467517|Magnesium Sulfate|magnesium sulfate|mesh-list
5847160|NCT02467517|Ketamine|ketamine|mesh-list
6212620|NCT02191397|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5665670|NCT03600961|Sirolimus|sirolimus|mesh-list
5847161|NCT02467517|Analgesics|analgesics|mesh-ancestor
5847162|NCT02467517|Sensory System Agents|sensory system agents|mesh-ancestor
5847163|NCT02467517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5847164|NCT02467517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847165|NCT02467517|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5847166|NCT02467517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5847167|NCT02467517|Anesthetics, General|anesthetics, general|mesh-ancestor
5847168|NCT02467517|Anesthetics|anesthetics|mesh-ancestor
5847169|NCT02467517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5847170|NCT02467517|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5847171|NCT02467517|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5847172|NCT02467517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5847173|NCT02467517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5847174|NCT02467517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5847175|NCT02467517|Anticonvulsants|anticonvulsants|mesh-ancestor
5847176|NCT02467517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5847177|NCT02467517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5847178|NCT02467517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5847179|NCT02467517|Tocolytic Agents|tocolytic agents|mesh-ancestor
5847180|NCT02467517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5847181|NCT02467673|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5847182|NCT02467673|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5847183|NCT02467673|Estradiol|estradiol|mesh-list
5847184|NCT02467673|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5847185|NCT02467673|Progesterone|progesterone|mesh-list
5847186|NCT02467673|Estrogens|estrogens|mesh-ancestor
5847187|NCT02467673|Hormones|hormones|mesh-ancestor
5665671|NCT03600961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5665672|NCT03600961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5665673|NCT03600961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5665674|NCT03600961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5665675|NCT03600961|Antifungal Agents|antifungal agents|mesh-ancestor
5665676|NCT03600961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5665677|NCT03600961|Immunologic Factors|immunologic factors|mesh-ancestor
5665678|NCT03600961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665679|NCT03600948|Sirolimus|sirolimus|mesh-list
5665680|NCT03600948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5665681|NCT03600948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5665682|NCT03600948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5665683|NCT03600948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5665684|NCT03600948|Antifungal Agents|antifungal agents|mesh-ancestor
5665685|NCT03600948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5665686|NCT03600948|Immunologic Factors|immunologic factors|mesh-ancestor
5665687|NCT03600948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665688|NCT03600909|Cyclophosphamide|cyclophosphamide|mesh-list
5665689|NCT03600909|Busulfan|busulfan|mesh-list
5665690|NCT03600909|Fludarabine|fludarabine|mesh-list
5665691|NCT03600909|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5665692|NCT03600909|Thymoglobulin|thymoglobulin|mesh-list
5665693|NCT03600909|Lenograstim|lenograstim|mesh-list
5665694|NCT03600909|Sargramostim|sargramostim|mesh-list
5665695|NCT03600909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5665696|NCT03600909|Immunologic Factors|immunologic factors|mesh-ancestor
5665697|NCT03600909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665698|NCT03600909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5665699|NCT03600909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5665700|NCT03600909|Alkylating Agents|alkylating agents|mesh-ancestor
5665701|NCT03600909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665702|NCT03600909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5665703|NCT03600909|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5665704|NCT03600909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5665705|NCT03600870|Midodrine|midodrine|mesh-list
5665706|NCT03600870|Sympathomimetics|sympathomimetics|mesh-ancestor
5665707|NCT03600870|Autonomic Agents|autonomic agents|mesh-ancestor
5665708|NCT03600870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5665709|NCT03600870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665710|NCT03600870|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5665711|NCT03600870|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5665712|NCT03600870|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5665713|NCT03600870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5665714|NCT03600870|Adrenergic Agents|adrenergic agents|mesh-ancestor
5665715|NCT03600870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5665716|NCT03600870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665717|NCT03600857|Misoprostol|misoprostol|mesh-list
5665718|NCT03600857|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5665719|NCT03600857|Abortifacient Agents|abortifacient agents|mesh-ancestor
5847188|NCT02467673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5847189|NCT02467673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847190|NCT02467673|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5847191|NCT02467673|Contraceptive Agents|contraceptive agents|mesh-ancestor
5847192|NCT02467673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5847193|NCT02467673|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5847194|NCT02467673|Progestins|progestins|mesh-ancestor
5903782|NCT04486118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903783|NCT04460235|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5903784|NCT04460235|Immunologic Factors|immunologic factors|mesh-ancestor
5903785|NCT04460235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665720|NCT03600857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5665721|NCT03600857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665722|NCT03600857|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5665723|NCT03600857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5665724|NCT03600857|Oxytocics|oxytocics|mesh-ancestor
5665725|NCT03600831|Docetaxel|docetaxel|mesh-list
5665726|NCT03600831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5903786|NCT04373603|Tranexamic Acid|tranexamic acid|mesh-list
5903787|NCT04373603|Hyaluronic Acid|hyaluronic acid|mesh-list
5903788|NCT04373603|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5665727|NCT03600831|Tubulin Modulators|tubulin modulators|mesh-ancestor
5665728|NCT03600831|Antimitotic Agents|antimitotic agents|mesh-ancestor
5665729|NCT03600831|Mitosis Modulators|mitosis modulators|mesh-ancestor
5665730|NCT03600831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665731|NCT03600818|Prednisone|prednisone|mesh-list
5903789|NCT04373603|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5903790|NCT04373603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903791|NCT04373603|Hemostatics|hemostatics|mesh-ancestor
5903792|NCT04373603|Coagulants|coagulants|mesh-ancestor
5903793|NCT04373603|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5903794|NCT04373603|Immunologic Factors|immunologic factors|mesh-ancestor
5903795|NCT04373603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903796|NCT04373603|Viscosupplements|viscosupplements|mesh-ancestor
5903797|NCT04373603|Protective Agents|protective agents|mesh-ancestor
5903798|NCT04372940|Tranexamic Acid|tranexamic acid|mesh-list
5903799|NCT04372940|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5903800|NCT04372940|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5665732|NCT03600818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5665733|NCT03600818|Glucocorticoids|glucocorticoids|mesh-ancestor
5665734|NCT03600818|Hormones|hormones|mesh-ancestor
5665735|NCT03600818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5665736|NCT03600818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665737|NCT03600818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5665738|NCT03600818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5665739|NCT03600766|Mirabegron|mirabegron|mesh-list
5665740|NCT03600766|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
5665741|NCT03600766|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5665742|NCT03600766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5665743|NCT03600766|Adrenergic Agents|adrenergic agents|mesh-ancestor
5665744|NCT03600766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5665745|NCT03600766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665746|NCT03600766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903801|NCT04372940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903802|NCT04372940|Hemostatics|hemostatics|mesh-ancestor
5903803|NCT04372940|Coagulants|coagulants|mesh-ancestor
5903804|NCT04370301|Mycophenolic Acid|mycophenolic acid|mesh-list
5903805|NCT04370301|Cyclophosphamide|cyclophosphamide|mesh-list
5903806|NCT04370301|Melphalan|melphalan|mesh-list
5903807|NCT04370301|Mechlorethamine|mechlorethamine|mesh-list
5903808|NCT04370301|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
5903809|NCT04370301|Fludarabine|fludarabine|mesh-list
5903810|NCT04370301|Tacrolimus|tacrolimus|mesh-list
5903811|NCT04370301|Sargramostim|sargramostim|mesh-list
6212072|NCT02181231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212073|NCT02181231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6212074|NCT02181231|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6212075|NCT02181231|Antidepressive Agents|antidepressive agents|mesh-ancestor
6212076|NCT02181231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5903812|NCT04370301|Lenograstim|lenograstim|mesh-list
5903813|NCT04370301|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
6212077|NCT02181296|Ropivacaine|ropivacaine|mesh-list
5903814|NCT04370301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5903815|NCT04370301|Immunologic Factors|immunologic factors|mesh-ancestor
5903816|NCT04370301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493983|NCT00616499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6493984|NCT00616499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6493985|NCT00616499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6493986|NCT00616538|Fluticasone|fluticasone|mesh-list
5665747|NCT03600766|Urological Agents|urological agents|mesh-ancestor
5665748|NCT03600727|Dexmedetomidine|dexmedetomidine|mesh-list
5665749|NCT03600727|Propofol|propofol|mesh-list
5665750|NCT03600727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5665751|NCT03600727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5665752|NCT03600727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665753|NCT03600727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5665754|NCT03600727|Anesthetics, General|anesthetics, general|mesh-ancestor
5665755|NCT03600727|Anesthetics|anesthetics|mesh-ancestor
5665756|NCT03600727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5665757|NCT03600727|Analgesics|analgesics|mesh-ancestor
5665758|NCT03600727|Sensory System Agents|sensory system agents|mesh-ancestor
5665759|NCT03600727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5665760|NCT03600727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5665761|NCT03600727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5665762|NCT03600727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5665763|NCT03600727|Adrenergic Agents|adrenergic agents|mesh-ancestor
5665764|NCT03600727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5665765|NCT03600727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665766|NCT03600623|Gemcitabine|gemcitabine|mesh-list
5665767|NCT03600623|Paclitaxel|paclitaxel|mesh-list
5665768|NCT03600623|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5665769|NCT03600623|Fluorouracil|fluorouracil|mesh-list
5665770|NCT03600623|Oxaliplatin|oxaliplatin|mesh-list
6493987|NCT00616538|Xhance|xhance|mesh-list
6493988|NCT00616538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6493989|NCT00616538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5665771|NCT03600623|Irinotecan|irinotecan|mesh-list
5847195|NCT02467608|Isoniazid|isoniazid|mesh-list
5847196|NCT02467608|Antitubercular Agents|antitubercular agents|mesh-ancestor
5847197|NCT02467608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5847198|NCT02467608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5847199|NCT02467608|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5847200|NCT02467608|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5847201|NCT02467608|Antimetabolites|antimetabolites|mesh-ancestor
5847202|NCT02467608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5847203|NCT02467608|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5847204|NCT02467023|Lidocaine|lidocaine|mesh-list
5665772|NCT03600623|Folfirinox|folfirinox|mesh-list
5665773|NCT03600623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5665774|NCT03600623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5665775|NCT03600623|Tubulin Modulators|tubulin modulators|mesh-ancestor
5665776|NCT03600623|Antimitotic Agents|antimitotic agents|mesh-ancestor
5665777|NCT03600623|Mitosis Modulators|mitosis modulators|mesh-ancestor
5665778|NCT03600623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665779|NCT03600623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5665780|NCT03600623|Antimetabolites|antimetabolites|mesh-ancestor
5665781|NCT03600623|Antiviral Agents|antiviral agents|mesh-ancestor
5665782|NCT03600623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5665783|NCT03600623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5665784|NCT03600623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5665785|NCT03600623|Immunologic Factors|immunologic factors|mesh-ancestor
5665786|NCT03600623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665787|NCT03600623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5665788|NCT03600623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5665789|NCT03600506|Dexmedetomidine|dexmedetomidine|mesh-list
5665790|NCT03600506|Sympatholytics|sympatholytics|mesh-list
5665791|NCT03600506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5665792|NCT03600506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5665793|NCT03600506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665794|NCT03600506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5665795|NCT03600506|Analgesics|analgesics|mesh-ancestor
5665796|NCT03600506|Sensory System Agents|sensory system agents|mesh-ancestor
5665797|NCT03600506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5665798|NCT03600506|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5665799|NCT03600506|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5665800|NCT03600506|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5665801|NCT03600506|Adrenergic Agents|adrenergic agents|mesh-ancestor
5847205|NCT02467023|Fentanyl|fentanyl|mesh-list
5847206|NCT02467023|Midazolam|midazolam|mesh-list
5847207|NCT02467023|Anesthetics, Local|anesthetics, local|mesh-ancestor
5665802|NCT03600506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5847208|NCT02467023|Anesthetics|anesthetics|mesh-ancestor
5847209|NCT02467023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5847210|NCT02467023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847211|NCT02467023|Sensory System Agents|sensory system agents|mesh-ancestor
5847212|NCT02467023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5847213|NCT02467023|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5847214|NCT02467023|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5847215|NCT02467023|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5847216|NCT02467023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5665803|NCT03600506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665804|NCT03600506|Autonomic Agents|autonomic agents|mesh-ancestor
5665805|NCT03600493|Lidocaine|lidocaine|mesh-list
5665806|NCT03600493|Dexmedetomidine|dexmedetomidine|mesh-list
5665807|NCT03600493|Anesthetics, Local|anesthetics, local|mesh-ancestor
5665808|NCT03600493|Anesthetics|anesthetics|mesh-ancestor
5665809|NCT03600493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5665810|NCT03600493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665811|NCT03600493|Sensory System Agents|sensory system agents|mesh-ancestor
5665812|NCT03600493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5665813|NCT03600493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5665814|NCT03600493|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5665815|NCT03600493|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5665816|NCT03600493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5665817|NCT03600493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665818|NCT03600493|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5665819|NCT03600493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5665820|NCT03600493|Analgesics|analgesics|mesh-ancestor
5665821|NCT03600493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5665822|NCT03600493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5665823|NCT03600493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5665824|NCT03600493|Adrenergic Agents|adrenergic agents|mesh-ancestor
5665825|NCT03600493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5665826|NCT03600467|Seviteronel|seviteronel|mesh-list
5665827|NCT03600467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5665828|NCT03600467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5665829|NCT03600467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5665830|NCT03600467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665831|NCT03600454|Anesthetics|anesthetics|mesh-list
5665832|NCT03600454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5665833|NCT03600454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665834|NCT03600441|Abexinostat|abexinostat|mesh-list
5665835|NCT03600441|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5665836|NCT03600441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5665837|NCT03600441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665838|NCT03600363|Metformin|metformin|mesh-list
5665839|NCT03600363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5665840|NCT03600363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695686|NCT03387657|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5695687|NCT03387657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5847217|NCT02467023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5847218|NCT02467023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5847219|NCT02467023|Narcotics|narcotics|mesh-ancestor
5847220|NCT02467023|Analgesics|analgesics|mesh-ancestor
5847221|NCT02467023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5847222|NCT02467023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5847223|NCT02467023|Anesthetics, General|anesthetics, general|mesh-ancestor
5847224|NCT02467023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5847225|NCT02467023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5847226|NCT02467023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5847227|NCT02467023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5695688|NCT03387657|Diuretics|diuretics|mesh-ancestor
5695689|NCT03387657|Natriuretic Agents|natriuretic agents|mesh-ancestor
5695690|NCT03387657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695691|NCT03387657|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5695692|NCT03387657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5695693|NCT03387657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695694|NCT03387657|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5695695|NCT03387657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5847228|NCT02467023|GABA Modulators|gaba modulators|mesh-ancestor
5847229|NCT02467023|GABA Agents|gaba agents|mesh-ancestor
5847230|NCT02467023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5847231|NCT02467127|Vitamin D|vitamin d|mesh-list
5847232|NCT02467127|Vitamins|vitamins|mesh-ancestor
5847233|NCT02467127|Micronutrients|micronutrients|mesh-ancestor
5847234|NCT02467127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847235|NCT02467127|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5847236|NCT02466984|Metoclopramide|metoclopramide|mesh-list
5847237|NCT02466984|Antiemetics|antiemetics|mesh-ancestor
5847238|NCT02466984|Autonomic Agents|autonomic agents|mesh-ancestor
5847239|NCT02466984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5847240|NCT02466984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847241|NCT02466984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5847242|NCT02466984|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5847243|NCT02466984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5847244|NCT02466984|Dopamine Agents|dopamine agents|mesh-ancestor
5847245|NCT02466984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5847246|NCT02466984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5847247|NCT02466997|Tacrolimus|tacrolimus|mesh-list
5847248|NCT02466997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5847249|NCT02466997|Immunologic Factors|immunologic factors|mesh-ancestor
5847250|NCT02466997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847251|NCT02466997|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5847252|NCT02466997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5847253|NCT02466997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5847254|NCT02467010|Dexamethasone|dexamethasone|mesh-list
5847255|NCT02467010|Cyclophosphamide|cyclophosphamide|mesh-list
5847256|NCT02467010|Bortezomib|bortezomib|mesh-list
5847257|NCT02467010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5847258|NCT02467010|Immunologic Factors|immunologic factors|mesh-ancestor
5847259|NCT02467010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847260|NCT02467010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5847261|NCT02467010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5847262|NCT02467010|Alkylating Agents|alkylating agents|mesh-ancestor
5847263|NCT02467010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5847264|NCT02467010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5847265|NCT02467010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5847266|NCT02467010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5847267|NCT02467010|Antiemetics|antiemetics|mesh-ancestor
5847268|NCT02467010|Autonomic Agents|autonomic agents|mesh-ancestor
5847269|NCT02467010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5847270|NCT02467010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5847271|NCT02467010|Glucocorticoids|glucocorticoids|mesh-ancestor
5847272|NCT02467010|Hormones|hormones|mesh-ancestor
5847273|NCT02467010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5847274|NCT02467010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5847275|NCT02466828|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
5847276|NCT02466828|Hematinics|hematinics|mesh-ancestor
5847277|NCT02466828|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5847278|NCT02466828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5847279|NCT02466919|Amoxicillin|amoxicillin|mesh-list
5847280|NCT02466919|Metronidazole|metronidazole|mesh-list
5847281|NCT02466919|Clarithromycin|clarithromycin|mesh-list
5847282|NCT02466919|Levofloxacin|levofloxacin|mesh-list
5847283|NCT02466919|Ofloxacin|ofloxacin|mesh-list
5847284|NCT02466919|Pantoprazole|pantoprazole|mesh-list
5847285|NCT02466919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5847286|NCT02466919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5847287|NCT02466919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5847288|NCT02466919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5847289|NCT02466919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5847290|NCT02466919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5847291|NCT02466919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5847292|NCT02466919|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5847293|NCT02466919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5847294|NCT02466919|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5847295|NCT02466919|Renal Agents|renal agents|mesh-ancestor
5847296|NCT02466919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5847297|NCT02466919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5847298|NCT02466919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5847299|NCT02466919|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5847300|NCT02466919|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5847301|NCT02466919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5847302|NCT02466919|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5847303|NCT02466802|Sildenafil Citrate|sildenafil citrate|mesh-list
5847304|NCT02466802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5847305|NCT02466802|Vasodilator Agents|vasodilator agents|mesh-ancestor
6212078|NCT02181296|Anesthetics, Local|anesthetics, local|mesh-ancestor
6212079|NCT02181296|Anesthetics|anesthetics|mesh-ancestor
5847306|NCT02466802|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5665841|NCT03600311|Vitamin D|vitamin d|mesh-list
5665842|NCT03600311|Calcium|calcium|mesh-list
5665843|NCT03600311|Vitamins|vitamins|mesh-ancestor
5665844|NCT03600311|Micronutrients|micronutrients|mesh-ancestor
5665845|NCT03600311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665846|NCT03600311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5665847|NCT03600311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5665848|NCT03600155|Nivolumab|nivolumab|mesh-list
5665849|NCT03600155|Ipilimumab|ipilimumab|mesh-list
5665850|NCT03600155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5665851|NCT03600155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5665852|NCT03600155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5665853|NCT03600155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665854|NCT03600129|Ropivacaine|ropivacaine|mesh-list
5665855|NCT03600129|Anesthetics, Local|anesthetics, local|mesh-ancestor
5665856|NCT03600129|Anesthetics|anesthetics|mesh-ancestor
5665857|NCT03600129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5665858|NCT03600129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665859|NCT03600129|Sensory System Agents|sensory system agents|mesh-ancestor
5665860|NCT03600129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5665861|NCT03600116|Insulin Lispro|insulin lispro|mesh-list
5665862|NCT03600116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5665863|NCT03600116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665864|NCT03600090|Paclitaxel|paclitaxel|mesh-list
5665865|NCT03600090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5665866|NCT03600090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5665867|NCT03600090|Tubulin Modulators|tubulin modulators|mesh-ancestor
5665868|NCT03600090|Antimitotic Agents|antimitotic agents|mesh-ancestor
5665869|NCT03600090|Mitosis Modulators|mitosis modulators|mesh-ancestor
5665870|NCT03600090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665871|NCT03600064|Misoprostol|misoprostol|mesh-list
5665872|NCT03600064|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5665873|NCT03600064|Abortifacient Agents|abortifacient agents|mesh-ancestor
5665874|NCT03600064|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5665875|NCT03600064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665876|NCT03600064|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6212080|NCT02181296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6212081|NCT02181296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212082|NCT02181296|Sensory System Agents|sensory system agents|mesh-ancestor
6212083|NCT02181296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6212084|NCT02181387|Acetaminophen|acetaminophen|mesh-list
6212085|NCT02181387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5847307|NCT02466802|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5847308|NCT02466802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5847309|NCT02466802|Urological Agents|urological agents|mesh-ancestor
5847310|NCT02466503|Fluticasone|fluticasone|mesh-list
5847311|NCT02466503|Xhance|xhance|mesh-list
5847312|NCT02466503|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5847313|NCT02466503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5847314|NCT02466503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5847315|NCT02466503|Autonomic Agents|autonomic agents|mesh-ancestor
5847316|NCT02466503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5847317|NCT02466503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212086|NCT02181387|Analgesics|analgesics|mesh-ancestor
6212087|NCT02181387|Sensory System Agents|sensory system agents|mesh-ancestor
6212088|NCT02181387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6212089|NCT02181387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212090|NCT02181387|Antipyretics|antipyretics|mesh-ancestor
6212091|NCT02181413|Ixazomib|ixazomib|mesh-list
6212092|NCT02181413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212093|NCT02181413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5665877|NCT03600064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5665878|NCT03600064|Oxytocics|oxytocics|mesh-ancestor
5665879|NCT03599973|Plasma-lyte 148|plasma-lyte 148|mesh-list
5665880|NCT03599973|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5665881|NCT03599973|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5665882|NCT03599778|Apatinib|apatinib|mesh-list
5665883|NCT03599778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5665884|NCT03599778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5665885|NCT03599778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5665886|NCT03599778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665887|NCT03599726|Donepezil|donepezil|mesh-list
5665888|NCT03599726|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6212094|NCT02181413|Protease Inhibitors|protease inhibitors|mesh-ancestor
5665889|NCT03599726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5695696|NCT03387644|Pregabalin|pregabalin|mesh-list
6212095|NCT02181413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6493990|NCT00616538|Autonomic Agents|autonomic agents|mesh-ancestor
6493991|NCT00616538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6493992|NCT00616538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6493993|NCT00616538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6493994|NCT00616538|Respiratory System Agents|respiratory system agents|mesh-ancestor
5665890|NCT03599726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665891|NCT03599726|Cholinergic Agents|cholinergic agents|mesh-ancestor
5665892|NCT03599726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5665893|NCT03599726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665894|NCT03599726|Nootropic Agents|nootropic agents|mesh-ancestor
5665895|NCT03599609|Simvastatin|simvastatin|mesh-list
5665896|NCT03599609|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5665897|NCT03599609|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5665898|NCT03599609|Antimetabolites|antimetabolites|mesh-ancestor
5665899|NCT03599609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665900|NCT03599609|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5665901|NCT03599609|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5665902|NCT03599609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5665903|NCT03599596|Pyrimethamine|pyrimethamine|mesh-list
5665904|NCT03599596|Sulfadoxine|sulfadoxine|mesh-list
5665905|NCT03599596|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
5665906|NCT03599596|Antimalarials|antimalarials|mesh-ancestor
5665907|NCT03599596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5665908|NCT03599596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5665909|NCT03599596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5665910|NCT03599596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5665911|NCT03599596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5665912|NCT03599596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665913|NCT03599596|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5665914|NCT03599596|Renal Agents|renal agents|mesh-ancestor
5847318|NCT02466503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5847319|NCT02466503|Respiratory System Agents|respiratory system agents|mesh-ancestor
5847320|NCT02466503|Dermatologic Agents|dermatologic agents|mesh-ancestor
5847321|NCT02466503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5847322|NCT02466503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5847323|NCT02466503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5847324|NCT02466503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5847325|NCT02466503|Adrenergic Agents|adrenergic agents|mesh-ancestor
5847326|NCT02466503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5847327|NCT02466503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5847328|NCT02466581|Hydroxychloroquine|hydroxychloroquine|mesh-list
5847329|NCT02466581|Sulfasalazine|sulfasalazine|mesh-list
5847330|NCT02466581|Prednisolone|prednisolone|mesh-list
5847331|NCT02466581|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5847332|NCT02466581|Methylprednisolone|methylprednisolone|mesh-list
5847333|NCT02466581|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5847334|NCT02466581|Prednisolone acetate|prednisolone acetate|mesh-list
5847335|NCT02466581|Abatacept|abatacept|mesh-list
5847336|NCT02466581|Certolizumab Pegol|certolizumab pegol|mesh-list
5847337|NCT02466581|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5847338|NCT02466581|Prednisolone phosphate|prednisolone phosphate|mesh-list
5847339|NCT02466581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5847340|NCT02466581|Glucocorticoids|glucocorticoids|mesh-ancestor
5847341|NCT02466581|Hormones|hormones|mesh-ancestor
5847342|NCT02466581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5665915|NCT03599518|Gefitinib|gefitinib|mesh-list
5665916|NCT03599518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5665917|NCT03599518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5665918|NCT03599518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5665919|NCT03599518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665920|NCT03599466|Lisinopril|lisinopril|mesh-list
5665921|NCT03599466|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5665922|NCT03599466|Protease Inhibitors|protease inhibitors|mesh-ancestor
5847343|NCT02466581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847344|NCT02466581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5847345|NCT02466581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5847346|NCT02466581|Antiemetics|antiemetics|mesh-ancestor
5847347|NCT02466581|Autonomic Agents|autonomic agents|mesh-ancestor
5847348|NCT02466581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5847349|NCT02466581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5847350|NCT02466581|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5847351|NCT02466581|Protective Agents|protective agents|mesh-ancestor
5847352|NCT02466581|Antimalarials|antimalarials|mesh-ancestor
5847353|NCT02466581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5847354|NCT02466581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5847355|NCT02466581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5847356|NCT02466581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5847357|NCT02466581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5847358|NCT02466581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5847359|NCT02466581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5847360|NCT02466581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5847361|NCT02466581|Immunologic Factors|immunologic factors|mesh-ancestor
5847362|NCT02466581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5847363|NCT02466581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5847364|NCT02466581|Analgesics|analgesics|mesh-ancestor
5847365|NCT02466581|Sensory System Agents|sensory system agents|mesh-ancestor
5847366|NCT02466568|Nivolumab|nivolumab|mesh-list
5847367|NCT02466568|Vaccines|vaccines|mesh-list
5847368|NCT02466568|Immunologic Factors|immunologic factors|mesh-ancestor
5847369|NCT02466568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847370|NCT02466568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5847371|NCT02466568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5847372|NCT02466568|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5847373|NCT02466568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5847374|NCT02466490|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5847375|NCT02466490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5847376|NCT02466490|Diuretics|diuretics|mesh-ancestor
5847377|NCT02466490|Natriuretic Agents|natriuretic agents|mesh-ancestor
5847378|NCT02466490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847379|NCT02466490|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5847380|NCT02466490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5847381|NCT02466490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5847382|NCT02466542|Esmolol|esmolol|mesh-list
5847383|NCT02466542|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5847384|NCT02466542|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5847385|NCT02466542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5847386|NCT02466542|Adrenergic Agents|adrenergic agents|mesh-ancestor
5847387|NCT02466542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5847388|NCT02466542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5847389|NCT02466542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847390|NCT02466698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5847391|NCT02466698|Metronidazole|metronidazole|mesh-list
5847392|NCT02466698|Vancomycin|vancomycin|mesh-list
5847393|NCT02466698|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5847394|NCT02466698|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
5847395|NCT02466698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5847396|NCT02466698|Antitubercular Agents|antitubercular agents|mesh-ancestor
5847397|NCT02466698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5847398|NCT02466698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5847399|NCT02466698|Laxatives|laxatives|mesh-ancestor
5847400|NCT02466698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5847401|NCT02466477|Psychotropic Drugs|psychotropic drugs|mesh-list
5847402|NCT02466464|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
5847403|NCT02466464|Hemostatics|hemostatics|mesh-ancestor
5847404|NCT02466464|Coagulants|coagulants|mesh-ancestor
5847405|NCT02466334|Calcitonin|calcitonin|mesh-list
5847406|NCT02466334|Salmon calcitonin|salmon calcitonin|mesh-list
5665923|NCT03599466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5665924|NCT03599466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665925|NCT03599466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5665926|NCT03599466|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5665927|NCT03599466|Protective Agents|protective agents|mesh-ancestor
5665928|NCT03599466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665929|NCT03599453|Interferons|interferons|mesh-list
5665930|NCT03599453|Interferon-alpha|interferon-alpha|mesh-list
5665931|NCT03599453|Interferon alpha-2|interferon alpha-2|mesh-list
5665932|NCT03599453|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
5665933|NCT03599453|Poly I-C|poly i-c|mesh-list
5665934|NCT03599453|Celecoxib|celecoxib|mesh-list
5847407|NCT02466334|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
5847408|NCT02466334|Katacalcin|katacalcin|mesh-list
5847409|NCT02466334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5847410|NCT02466334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847411|NCT02466334|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5847412|NCT02466334|Vasodilator Agents|vasodilator agents|mesh-ancestor
5847413|NCT02466373|Clonidine|clonidine|mesh-list
5847414|NCT02466373|Analgesics|analgesics|mesh-ancestor
5847415|NCT02466373|Sensory System Agents|sensory system agents|mesh-ancestor
5847416|NCT02466373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5665935|NCT03599453|Pembrolizumab|pembrolizumab|mesh-list
5665936|NCT03599453|Immunoglobulins|immunoglobulins|mesh-list
5665937|NCT03599453|Immunoglobulin G|immunoglobulin g|mesh-list
5665938|NCT03599453|Benzenesulfonamide|benzenesulfonamide|mesh-list
5665939|NCT03599453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5665940|NCT03599453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5847417|NCT02466373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847418|NCT02466373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5847419|NCT02466373|Sympatholytics|sympatholytics|mesh-ancestor
5847420|NCT02466373|Autonomic Agents|autonomic agents|mesh-ancestor
5847421|NCT02466373|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5847422|NCT02466373|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5847423|NCT02466373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5847424|NCT02466373|Adrenergic Agents|adrenergic agents|mesh-ancestor
5847425|NCT02466373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5847426|NCT02466373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5847427|NCT02466347|Fluticasone|fluticasone|mesh-list
5847428|NCT02466347|Xhance|xhance|mesh-list
5847429|NCT02466347|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5847430|NCT02466347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5847431|NCT02466347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5847432|NCT02466347|Autonomic Agents|autonomic agents|mesh-ancestor
5847433|NCT02466347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5847434|NCT02466347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847435|NCT02466347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5847436|NCT02466347|Respiratory System Agents|respiratory system agents|mesh-ancestor
5847437|NCT02466347|Dermatologic Agents|dermatologic agents|mesh-ancestor
5847438|NCT02466347|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5847439|NCT02466347|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5847440|NCT02466347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5847441|NCT02466347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5847442|NCT02466347|Adrenergic Agents|adrenergic agents|mesh-ancestor
5847443|NCT02466347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5847444|NCT02466347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5847445|NCT02466438|Tazobactam|tazobactam|mesh-list
5847446|NCT02466438|Piperacillin|piperacillin|mesh-list
5847447|NCT02466438|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
5847448|NCT02466438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5847449|NCT02466438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5847450|NCT02466438|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5847451|NCT02466438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5847452|NCT02466438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5847453|NCT02466191|Gabapentin|gabapentin|mesh-list
5847454|NCT02466191|Memantine|memantine|mesh-list
5847455|NCT02466191|Analgesics|analgesics|mesh-ancestor
5847456|NCT02466191|Sensory System Agents|sensory system agents|mesh-ancestor
5847457|NCT02466191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5847458|NCT02466191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847459|NCT02466191|Anticonvulsants|anticonvulsants|mesh-ancestor
5847460|NCT02466191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5847461|NCT02466191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5847462|NCT02466191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5847463|NCT02466191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5665941|NCT03599453|Antiviral Agents|antiviral agents|mesh-ancestor
5665942|NCT03599453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5665943|NCT03599453|Immunologic Factors|immunologic factors|mesh-ancestor
5665944|NCT03599453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665945|NCT03599453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5665946|NCT03599453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5665947|NCT03599453|Analgesics|analgesics|mesh-ancestor
5665948|NCT03599453|Sensory System Agents|sensory system agents|mesh-ancestor
5665949|NCT03599453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5665950|NCT03599453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5665951|NCT03599453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5665952|NCT03599453|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5665953|NCT03599453|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5665954|NCT03599453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5665955|NCT03599453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665956|NCT03599453|Interferon Inducers|interferon inducers|mesh-ancestor
5665957|NCT03599453|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5665958|NCT03599427|Lidocaine|lidocaine|mesh-list
5665959|NCT03599427|Anesthetics, Local|anesthetics, local|mesh-ancestor
5665960|NCT03599427|Anesthetics|anesthetics|mesh-ancestor
5665961|NCT03599427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5847464|NCT02466191|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5847465|NCT02466191|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5847466|NCT02466191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5665962|NCT03599427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665963|NCT03599427|Sensory System Agents|sensory system agents|mesh-ancestor
5665964|NCT03599427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5665965|NCT03599427|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5665966|NCT03599427|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5665967|NCT03599427|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5665968|NCT03599427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5665969|NCT03599427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665970|NCT03599323|Clotrimazole|clotrimazole|mesh-list
5665971|NCT03599323|Miconazole|miconazole|mesh-list
5665972|NCT03599323|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5665973|NCT03599323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5665974|NCT03599323|Antifungal Agents|antifungal agents|mesh-ancestor
5665975|NCT03599323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5665976|NCT03599323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5665977|NCT03599323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5665978|NCT03599323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665979|NCT03599323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5665980|NCT03599323|Hormone Antagonists|hormone antagonists|mesh-ancestor
5665981|NCT03599323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5665982|NCT03599323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665983|NCT03599323|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5665984|NCT03599323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5665985|NCT03599284|Clopidogrel|clopidogrel|mesh-list
5665986|NCT03599284|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5847467|NCT02466191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5847468|NCT02466191|Antimanic Agents|antimanic agents|mesh-ancestor
5847469|NCT02466191|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5665987|NCT03599284|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5665988|NCT03599284|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5665989|NCT03599284|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5665990|NCT03599284|Purinergic Agents|purinergic agents|mesh-ancestor
5665991|NCT03599284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5665992|NCT03599284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5665993|NCT03599284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5665994|NCT03598998|Pembrolizumab|pembrolizumab|mesh-list
5665995|NCT03598998|10-deazaaminopterin|10-deazaaminopterin|mesh-list
5665996|NCT03598998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5665997|NCT03598998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5665998|NCT03598998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5665999|NCT03598998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5666000|NCT03598998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5847470|NCT02466191|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5847471|NCT02466191|Dopamine Agents|dopamine agents|mesh-ancestor
5847472|NCT02466204|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5847473|NCT02466204|Hormones|hormones|mesh-ancestor
5847474|NCT02466204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5847475|NCT02466204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847476|NCT02466022|Fentanyl|fentanyl|mesh-list
5847477|NCT02466022|Midazolam|midazolam|mesh-list
5847478|NCT02466022|Dexmedetomidine|dexmedetomidine|mesh-list
5847479|NCT02466022|Bupivacaine|bupivacaine|mesh-list
5847480|NCT02466022|Anesthetics, Local|anesthetics, local|mesh-ancestor
5666001|NCT03598959|Tofacitinib|tofacitinib|mesh-list
5847481|NCT02466022|Anesthetics|anesthetics|mesh-ancestor
5847482|NCT02466022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5847483|NCT02466022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847484|NCT02466022|Sensory System Agents|sensory system agents|mesh-ancestor
5847485|NCT02466022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5847486|NCT02466022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5847487|NCT02466022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5847488|NCT02466022|Analgesics|analgesics|mesh-ancestor
5847489|NCT02466022|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5847490|NCT02466022|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5847491|NCT02466022|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5847492|NCT02466022|Adrenergic Agents|adrenergic agents|mesh-ancestor
5847493|NCT02466022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5847494|NCT02466022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5847495|NCT02466022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5847496|NCT02466022|Narcotics|narcotics|mesh-ancestor
5847497|NCT02466022|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5847498|NCT02466022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5666002|NCT03598959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5666003|NCT03598959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5666004|NCT03598959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5666005|NCT03598868|Vortioxetine|vortioxetine|mesh-list
5666006|NCT03598868|Antidepressive Agents|antidepressive agents|mesh-ancestor
5666007|NCT03598868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5666008|NCT03598868|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5666009|NCT03598868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5666010|NCT03598868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5666011|NCT03598868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666012|NCT03598868|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5666013|NCT03598868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5847499|NCT02466022|Anesthetics, General|anesthetics, general|mesh-ancestor
5847500|NCT02466022|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5847501|NCT02466022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5666014|NCT03598868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5666015|NCT03598868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5847502|NCT02466022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5847503|NCT02466022|GABA Modulators|gaba modulators|mesh-ancestor
5847504|NCT02466022|GABA Agents|gaba agents|mesh-ancestor
5847505|NCT02466035|Caseins|caseins|mesh-list
5847506|NCT02466035|Chelating Agents|chelating agents|mesh-ancestor
5847507|NCT02466035|Sequestering Agents|sequestering agents|mesh-ancestor
5847508|NCT02466035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5847509|NCT02466074|Acetazolamide|acetazolamide|mesh-list
5847510|NCT02466074|Anticonvulsants|anticonvulsants|mesh-ancestor
5847511|NCT02466074|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5847512|NCT02466074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5847513|NCT02466074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5847514|NCT02466074|Diuretics|diuretics|mesh-ancestor
5847515|NCT02466074|Natriuretic Agents|natriuretic agents|mesh-ancestor
5847516|NCT02466074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847517|NCT02465814|Ulipristal acetate|ulipristal acetate|mesh-list
5847518|NCT02465814|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5847519|NCT02465814|Contraceptive Agents|contraceptive agents|mesh-ancestor
5847520|NCT02465814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5847521|NCT02465814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847522|NCT02465814|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5847523|NCT02465827|Ropivacaine|ropivacaine|mesh-list
5847524|NCT02465827|Anesthetics, Local|anesthetics, local|mesh-ancestor
5847525|NCT02465827|Anesthetics|anesthetics|mesh-ancestor
5666016|NCT03598868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5666017|NCT03598868|Serotonin Agents|serotonin agents|mesh-ancestor
5666018|NCT03598868|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5666019|NCT03598868|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5666020|NCT03598868|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5666021|NCT03598868|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5666022|NCT03598842|Metronidazole|metronidazole|mesh-list
5666023|NCT03598842|Ivermectin|ivermectin|mesh-list
5666024|NCT03598842|Albendazole|albendazole|mesh-list
5666025|NCT03598842|Antiparasitic Agents|antiparasitic agents|mesh-list
5666026|NCT03598842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5666027|NCT03598842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5666028|NCT03598842|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5666029|NCT03598842|Anthelmintics|anthelmintics|mesh-ancestor
5666030|NCT03598842|Anticestodal Agents|anticestodal agents|mesh-ancestor
5666031|NCT03598842|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5666032|NCT03598842|Tubulin Modulators|tubulin modulators|mesh-ancestor
5666033|NCT03598842|Antimitotic Agents|antimitotic agents|mesh-ancestor
5666034|NCT03598842|Mitosis Modulators|mitosis modulators|mesh-ancestor
5695697|NCT03387644|Analgesics|analgesics|mesh-ancestor
5847526|NCT02465827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5847527|NCT02465827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847528|NCT02465827|Sensory System Agents|sensory system agents|mesh-ancestor
5847529|NCT02465827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5847530|NCT02465983|Cyclophosphamide|cyclophosphamide|mesh-list
5847531|NCT02465983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5847532|NCT02465983|Immunologic Factors|immunologic factors|mesh-ancestor
5847533|NCT02465983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847534|NCT02465983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5847535|NCT02465983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5847536|NCT02465983|Alkylating Agents|alkylating agents|mesh-ancestor
6212096|NCT02181426|Ketorolac|ketorolac|mesh-list
5847537|NCT02465983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5847538|NCT02465983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5847539|NCT02465983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5847540|NCT02465749|Vitamins|vitamins|mesh-list
5847541|NCT02465749|Micronutrients|micronutrients|mesh-ancestor
5847542|NCT02465749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903817|NCT04370301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5903818|NCT04370301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5903819|NCT04370301|Alkylating Agents|alkylating agents|mesh-ancestor
5903820|NCT04370301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903821|NCT04370301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5903822|NCT04370301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5903823|NCT04370301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5666035|NCT03598842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5666036|NCT03598842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5666037|NCT03598816|Durvalumab|durvalumab|mesh-list
5666038|NCT03598816|Tremelimumab|tremelimumab|mesh-list
5666039|NCT03598816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5666040|NCT03598816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5666041|NCT03598738|Esomeprazole|esomeprazole|mesh-list
5666042|NCT03598738|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5666043|NCT03598738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5666044|NCT03598738|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5666045|NCT03598738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5903824|NCT04370301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5903825|NCT04370301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5903826|NCT04370301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5903827|NCT04370301|Antitubercular Agents|antitubercular agents|mesh-ancestor
5903828|NCT04370301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5903829|NCT04370301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5903830|NCT04370301|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5903831|NCT04370301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5903832|NCT04353128|Melatonin|melatonin|mesh-list
5903833|NCT04353128|Antioxidants|antioxidants|mesh-ancestor
5903834|NCT04353128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903835|NCT04353128|Protective Agents|protective agents|mesh-ancestor
5903836|NCT04353128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903837|NCT04353128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5903838|NCT04340076|Ixekizumab|ixekizumab|mesh-list
6493995|NCT00616538|Dermatologic Agents|dermatologic agents|mesh-ancestor
6493996|NCT00616538|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6493997|NCT00616551|Octreotide|octreotide|mesh-list
6493998|NCT00616551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6493999|NCT00616551|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5903839|NCT04340076|Brodalumab|brodalumab|mesh-list
5903840|NCT04340076|Dermatologic Agents|dermatologic agents|mesh-ancestor
6494000|NCT00616551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5666046|NCT03598738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695698|NCT03387644|Sensory System Agents|sensory system agents|mesh-ancestor
5695699|NCT03387644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5695700|NCT03387644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695701|NCT03387644|Anticonvulsants|anticonvulsants|mesh-ancestor
5695702|NCT03387644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5695703|NCT03387644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5695704|NCT03387644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695705|NCT03387644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5695706|NCT03387644|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5695707|NCT03387644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5695708|NCT03387644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5695709|NCT03387644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5695710|NCT03387631|Lumefantrine|lumefantrine|mesh-list
5695711|NCT03387631|Artemether|artemether|mesh-list
5695712|NCT03387631|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
5695713|NCT03387631|Antimalarials|antimalarials|mesh-ancestor
5695714|NCT03387631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5695715|NCT03387631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5695716|NCT03387631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5695717|NCT03387592|Leucovorin|leucovorin|mesh-list
5695718|NCT03387592|Fluorouracil|fluorouracil|mesh-list
5695719|NCT03387592|Capecitabine|capecitabine|mesh-list
5695720|NCT03387592|Temozolomide|temozolomide|mesh-list
5695721|NCT03387592|Levoleucovorin|levoleucovorin|mesh-list
5695722|NCT03387592|Antimetabolites|antimetabolites|mesh-ancestor
5695723|NCT03387592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695724|NCT03387592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5695725|NCT03387592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5903841|NCT04325880|Tamsulosin|tamsulosin|mesh-list
5847543|NCT02465736|Cisplatin|cisplatin|mesh-list
5847544|NCT02465736|Docetaxel|docetaxel|mesh-list
5847545|NCT02465736|Vinorelbine|vinorelbine|mesh-list
5847546|NCT02465736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5847547|NCT02465736|Tubulin Modulators|tubulin modulators|mesh-ancestor
5847548|NCT02465736|Antimitotic Agents|antimitotic agents|mesh-ancestor
5847549|NCT02465736|Mitosis Modulators|mitosis modulators|mesh-ancestor
5847550|NCT02465736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5847551|NCT02465736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5847552|NCT02465801|Lenograstim|lenograstim|mesh-list
5847553|NCT02465801|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5847554|NCT02465801|Immunologic Factors|immunologic factors|mesh-ancestor
5847555|NCT02465801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847556|NCT02465645|Carvedilol|carvedilol|mesh-list
5847557|NCT02465645|Simvastatin|simvastatin|mesh-list
5847558|NCT02465645|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5847559|NCT02465645|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5847560|NCT02465645|Antimetabolites|antimetabolites|mesh-ancestor
5847561|NCT02465645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5847562|NCT02465645|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5847563|NCT02465645|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5847564|NCT02465645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5847565|NCT02465645|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5847566|NCT02465645|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5847567|NCT02465645|Adrenergic Agents|adrenergic agents|mesh-ancestor
5666047|NCT03598725|Prednisone|prednisone|mesh-list
5666048|NCT03598725|Rituximab|rituximab|mesh-list
5666049|NCT03598725|Factor VIII|factor viii|mesh-list
5666050|NCT03598725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5666051|NCT03598725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5666052|NCT03598725|Immunologic Factors|immunologic factors|mesh-ancestor
5666053|NCT03598725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666054|NCT03598725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5666055|NCT03598725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5666056|NCT03598725|Glucocorticoids|glucocorticoids|mesh-ancestor
5666057|NCT03598725|Hormones|hormones|mesh-ancestor
5847568|NCT02465645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5847569|NCT02465645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847570|NCT02465645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5847571|NCT02465645|Antioxidants|antioxidants|mesh-ancestor
5847572|NCT02465645|Protective Agents|protective agents|mesh-ancestor
5847573|NCT02465645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5666058|NCT03598725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5666059|NCT03598725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5666060|NCT03598725|Coagulants|coagulants|mesh-ancestor
5666061|NCT03598673|Nebivolol|nebivolol|mesh-list
5666062|NCT03598673|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5666063|NCT03598673|Vasodilator Agents|vasodilator agents|mesh-ancestor
5666064|NCT03598673|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5666065|NCT03598673|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5666066|NCT03598673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5666067|NCT03598673|Adrenergic Agents|adrenergic agents|mesh-ancestor
5666068|NCT03598673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5666069|NCT03598673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5666070|NCT03598673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666071|NCT03598634|Riboflavin|riboflavin|mesh-list
5666072|NCT03598634|Vitamin B Complex|vitamin b complex|mesh-ancestor
5666073|NCT03598634|Vitamins|vitamins|mesh-ancestor
5666074|NCT03598634|Micronutrients|micronutrients|mesh-ancestor
5666075|NCT03598634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666076|NCT03598634|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5666077|NCT03598634|Dermatologic Agents|dermatologic agents|mesh-ancestor
5666078|NCT03598595|Gemcitabine|gemcitabine|mesh-list
5666079|NCT03598595|Hydroxychloroquine|hydroxychloroquine|mesh-list
5666080|NCT03598595|Docetaxel|docetaxel|mesh-list
5847574|NCT02465645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5847575|NCT02465645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5847576|NCT02465645|Vasodilator Agents|vasodilator agents|mesh-ancestor
5847577|NCT02465645|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5847578|NCT02465645|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5847579|NCT02465853|Hyaluronic Acid|hyaluronic acid|mesh-list
5847580|NCT02465853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5847581|NCT02465853|Immunologic Factors|immunologic factors|mesh-ancestor
5666081|NCT03598595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5666082|NCT03598595|Antimetabolites|antimetabolites|mesh-ancestor
5666083|NCT03598595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5847582|NCT02465853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847583|NCT02465853|Viscosupplements|viscosupplements|mesh-ancestor
5847584|NCT02465853|Protective Agents|protective agents|mesh-ancestor
5847585|NCT02465385|Linaclotide|linaclotide|mesh-list
5847586|NCT02465385|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
5847587|NCT02465385|Enzyme Activators|enzyme activators|mesh-ancestor
5847588|NCT02465385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5847589|NCT02465385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5847590|NCT02465333|Lidocaine|lidocaine|mesh-list
5847591|NCT02465333|Epinephrine|epinephrine|mesh-list
5847592|NCT02465333|Anesthetics, Local|anesthetics, local|mesh-list
5847593|NCT02465333|Anesthetics|anesthetics|mesh-list
5847594|NCT02465333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5847595|NCT02465333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847596|NCT02465333|Sensory System Agents|sensory system agents|mesh-ancestor
5847597|NCT02465333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5847598|NCT02465333|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5847599|NCT02465333|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5847600|NCT02465333|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5847601|NCT02465333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5847602|NCT02465333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5847603|NCT02465333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5847604|NCT02465333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5847605|NCT02465333|Adrenergic Agents|adrenergic agents|mesh-ancestor
5847606|NCT02465333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5847607|NCT02465333|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5847608|NCT02465333|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5847609|NCT02465333|Autonomic Agents|autonomic agents|mesh-ancestor
5847610|NCT02465333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5847611|NCT02465333|Respiratory System Agents|respiratory system agents|mesh-ancestor
5847612|NCT02465333|Mydriatics|mydriatics|mesh-ancestor
5847613|NCT02465333|Sympathomimetics|sympathomimetics|mesh-ancestor
5847614|NCT02465333|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5847615|NCT02465359|Immunoglobulins|immunoglobulins|mesh-list
5847616|NCT02465359|Antibodies|antibodies|mesh-list
5847617|NCT02465359|gamma-Globulins|gamma-globulins|mesh-list
5847618|NCT02465359|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5666084|NCT03598595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5666085|NCT03598595|Antiviral Agents|antiviral agents|mesh-ancestor
5666086|NCT03598595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5666087|NCT03598595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5666088|NCT03598595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5666089|NCT03598595|Immunologic Factors|immunologic factors|mesh-ancestor
5666090|NCT03598595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666091|NCT03598595|Tubulin Modulators|tubulin modulators|mesh-ancestor
5666092|NCT03598595|Antimitotic Agents|antimitotic agents|mesh-ancestor
5666093|NCT03598595|Mitosis Modulators|mitosis modulators|mesh-ancestor
5666094|NCT03598595|Antimalarials|antimalarials|mesh-ancestor
5666095|NCT03598595|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5666096|NCT03598595|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5666097|NCT03598595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5847619|NCT02465359|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5847620|NCT02465359|Immunologic Factors|immunologic factors|mesh-ancestor
5847621|NCT02465359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847622|NCT02465320|Lidocaine|lidocaine|mesh-list
5847623|NCT02465320|Anesthetics, Local|anesthetics, local|mesh-ancestor
5847624|NCT02465320|Anesthetics|anesthetics|mesh-ancestor
5666098|NCT03598582|Epoetin Alfa|epoetin alfa|mesh-list
5666099|NCT03598582|Hematinics|hematinics|mesh-ancestor
5666100|NCT03598556|Vitamin D|vitamin d|mesh-list
5666101|NCT03598556|Cholecalciferol|cholecalciferol|mesh-list
5666102|NCT03598556|Vitamins|vitamins|mesh-ancestor
5666103|NCT03598556|Micronutrients|micronutrients|mesh-ancestor
5666104|NCT03598556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666105|NCT03598556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5666106|NCT03598556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5666107|NCT03598452|Ganciclovir|ganciclovir|mesh-list
5666108|NCT03598452|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
5666109|NCT03598452|Antiviral Agents|antiviral agents|mesh-ancestor
5847625|NCT02465320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5847626|NCT02465320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847627|NCT02465320|Sensory System Agents|sensory system agents|mesh-ancestor
5847628|NCT02465320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5666110|NCT03598452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5666111|NCT03598452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5666112|NCT03598452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5847629|NCT02465320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5666113|NCT03598452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5666114|NCT03598426|Dexamethasone|dexamethasone|mesh-list
5666115|NCT03598426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5666116|NCT03598426|Antiemetics|antiemetics|mesh-ancestor
5666117|NCT03598426|Autonomic Agents|autonomic agents|mesh-ancestor
5666118|NCT03598426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5666119|NCT03598426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666120|NCT03598426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5666121|NCT03598426|Glucocorticoids|glucocorticoids|mesh-ancestor
5666122|NCT03598426|Hormones|hormones|mesh-ancestor
5666123|NCT03598426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5666124|NCT03598426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5666125|NCT03598426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5666126|NCT03598374|Folic Acid|folic acid|mesh-list
5666127|NCT03598374|Vitamin B Complex|vitamin b complex|mesh-list
5666128|NCT03598374|Inositol|inositol|mesh-list
5666129|NCT03598374|Hematinics|hematinics|mesh-ancestor
5666130|NCT03598374|Vitamins|vitamins|mesh-ancestor
5666131|NCT03598374|Micronutrients|micronutrients|mesh-ancestor
5847630|NCT02465320|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5847631|NCT02465320|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5847632|NCT02465320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5847633|NCT02465320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5847634|NCT02465307|Hydrocortisone|hydrocortisone|mesh-list
5847635|NCT02465307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5847636|NCT02465008|Levobupivacaine|levobupivacaine|mesh-list
5847637|NCT02465008|Anesthetics, Local|anesthetics, local|mesh-ancestor
5847638|NCT02465008|Anesthetics|anesthetics|mesh-ancestor
5847639|NCT02465008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5847640|NCT02465008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847641|NCT02465008|Sensory System Agents|sensory system agents|mesh-ancestor
5666132|NCT03598374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666133|NCT03598348|Capecitabine|capecitabine|mesh-list
5666134|NCT03598348|Apatinib|apatinib|mesh-list
5666135|NCT03598348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5666136|NCT03598348|Antimetabolites|antimetabolites|mesh-ancestor
5666137|NCT03598348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5666138|NCT03598348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5666139|NCT03598348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5666140|NCT03598348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5666141|NCT03598192|Sufentanil|sufentanil|mesh-list
5666142|NCT03598192|Dsuvia|dsuvia|mesh-list
5666143|NCT03598192|Ropivacaine|ropivacaine|mesh-list
5666144|NCT03598192|Anesthetics, Local|anesthetics, local|mesh-ancestor
5666145|NCT03598192|Anesthetics|anesthetics|mesh-ancestor
5666146|NCT03598192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5666147|NCT03598192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666148|NCT03598192|Sensory System Agents|sensory system agents|mesh-ancestor
5666149|NCT03598192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5666150|NCT03598192|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5666151|NCT03598192|Narcotics|narcotics|mesh-ancestor
5666152|NCT03598192|Analgesics|analgesics|mesh-ancestor
5666153|NCT03598192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5666154|NCT03598192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5666155|NCT03598192|Anesthetics, General|anesthetics, general|mesh-ancestor
5666156|NCT03598075|Pramlintide|pramlintide|mesh-list
5666157|NCT03598075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5847642|NCT02465008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5847643|NCT02465138|Ketorolac|ketorolac|mesh-list
5847644|NCT02465138|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5847645|NCT02465138|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5847646|NCT02465138|Analgesics|analgesics|mesh-ancestor
5847647|NCT02465138|Sensory System Agents|sensory system agents|mesh-ancestor
5847648|NCT02465138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5847649|NCT02465138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847650|NCT02465138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5847651|NCT02465138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5847652|NCT02465138|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5847653|NCT02465138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5847654|NCT02465138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5847655|NCT02465164|Oxytocin|oxytocin|mesh-list
5847656|NCT02465164|Oxytocics|oxytocics|mesh-ancestor
5666158|NCT03598075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666159|NCT03597997|Propofol|propofol|mesh-list
5666160|NCT03597997|Sevoflurane|sevoflurane|mesh-list
5666161|NCT03597997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5666162|NCT03597997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5666163|NCT03597997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666164|NCT03597997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5666165|NCT03597997|Anesthetics, General|anesthetics, general|mesh-ancestor
5666166|NCT03597997|Anesthetics|anesthetics|mesh-ancestor
5666167|NCT03597997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5666168|NCT03597997|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5666169|NCT03597945|Lidocaine|lidocaine|mesh-list
5666170|NCT03597945|Magnesium Sulfate|magnesium sulfate|mesh-list
5666171|NCT03597945|Epinephrine|epinephrine|mesh-list
5666172|NCT03597945|Anesthetics, Local|anesthetics, local|mesh-ancestor
5666173|NCT03597945|Anesthetics|anesthetics|mesh-ancestor
5666174|NCT03597945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5666175|NCT03597945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666176|NCT03597945|Sensory System Agents|sensory system agents|mesh-ancestor
5666177|NCT03597945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5666178|NCT03597945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5666179|NCT03597945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5666180|NCT03597945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5666181|NCT03597945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5666182|NCT03597945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5666183|NCT03597945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5666184|NCT03597945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5666185|NCT03597945|Adrenergic Agents|adrenergic agents|mesh-ancestor
5666186|NCT03597945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5666187|NCT03597945|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5666188|NCT03597945|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5666189|NCT03597945|Autonomic Agents|autonomic agents|mesh-ancestor
5666190|NCT03597945|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5666191|NCT03597945|Respiratory System Agents|respiratory system agents|mesh-ancestor
5666192|NCT03597945|Mydriatics|mydriatics|mesh-ancestor
5666193|NCT03597945|Sympathomimetics|sympathomimetics|mesh-ancestor
5666194|NCT03597945|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5666195|NCT03597945|Analgesics|analgesics|mesh-ancestor
5666196|NCT03597945|Anticonvulsants|anticonvulsants|mesh-ancestor
5666197|NCT03597945|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5666198|NCT03597945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5666199|NCT03597945|Tocolytic Agents|tocolytic agents|mesh-ancestor
5666200|NCT03597945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5666201|NCT03597919|Vaccines|vaccines|mesh-list
5847657|NCT02465164|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5847658|NCT02465164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847659|NCT02465255|Acetaminophen|acetaminophen|mesh-list
5847660|NCT02465255|Ketorolac|ketorolac|mesh-list
5847661|NCT02465255|Tramadol|tramadol|mesh-list
5847662|NCT02465255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5666202|NCT03597919|Immunologic Factors|immunologic factors|mesh-ancestor
5666203|NCT03597919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666204|NCT03597893|Oxytocin|oxytocin|mesh-list
5666205|NCT03597893|Oxytocics|oxytocics|mesh-ancestor
5666206|NCT03597893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5666207|NCT03597893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847663|NCT02465255|Analgesics|analgesics|mesh-ancestor
5847664|NCT02465255|Sensory System Agents|sensory system agents|mesh-ancestor
5847665|NCT02465255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5847666|NCT02465255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847667|NCT02465255|Antipyretics|antipyretics|mesh-ancestor
5847668|NCT02465255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5847669|NCT02465255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5847670|NCT02465255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5847671|NCT02465255|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5847672|NCT02465255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5847673|NCT02465255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494001|NCT00616681|Oxcarbazepine|oxcarbazepine|mesh-list
6494002|NCT00616681|Anticonvulsants|anticonvulsants|mesh-ancestor
6494003|NCT00616681|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6494004|NCT00616681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6494005|NCT00616681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6494006|NCT00616681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494007|NCT00616681|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6494008|NCT00616681|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6494009|NCT00616694|Risedronic Acid|risedronic acid|mesh-list
5847674|NCT02465255|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5666208|NCT03597867|Diclofenac|diclofenac|mesh-list
5847675|NCT02465255|Narcotics|narcotics|mesh-ancestor
5666209|NCT03597867|Indomethacin|indomethacin|mesh-list
5847676|NCT02465255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5847677|NCT02464709|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5847678|NCT02464709|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
5847679|NCT02464709|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5847680|NCT02464709|Dermatologic Agents|dermatologic agents|mesh-ancestor
5847681|NCT02464722|Epinephrine|epinephrine|mesh-list
5847682|NCT02464722|Dexmedetomidine|dexmedetomidine|mesh-list
5847683|NCT02464722|Remifentanil|remifentanil|mesh-list
5847684|NCT02464722|Propofol|propofol|mesh-list
5847685|NCT02464722|Rocuronium|rocuronium|mesh-list
5847686|NCT02464722|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5847687|NCT02464722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5847688|NCT02464722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847689|NCT02464722|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5847690|NCT02464722|Anesthetics, General|anesthetics, general|mesh-ancestor
5847691|NCT02464722|Anesthetics|anesthetics|mesh-ancestor
5847692|NCT02464722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5847693|NCT02464722|Analgesics|analgesics|mesh-ancestor
5847694|NCT02464722|Sensory System Agents|sensory system agents|mesh-ancestor
5847695|NCT02464722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5847696|NCT02464722|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5847697|NCT02464722|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5847698|NCT02464722|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5847699|NCT02464722|Adrenergic Agents|adrenergic agents|mesh-ancestor
5847700|NCT02464722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5847701|NCT02464722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5847702|NCT02464722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5847703|NCT02464722|Narcotics|narcotics|mesh-ancestor
5847704|NCT02464722|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5847705|NCT02464722|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5847706|NCT02464722|Autonomic Agents|autonomic agents|mesh-ancestor
5847707|NCT02464722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5847708|NCT02464722|Respiratory System Agents|respiratory system agents|mesh-ancestor
5847709|NCT02464722|Mydriatics|mydriatics|mesh-ancestor
5847710|NCT02464722|Sympathomimetics|sympathomimetics|mesh-ancestor
5847711|NCT02464722|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5847712|NCT02464722|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5847713|NCT02464722|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5847714|NCT02464722|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5847715|NCT02464761|Verteporfin|verteporfin|mesh-list
5847716|NCT02464761|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5847717|NCT02464761|Dermatologic Agents|dermatologic agents|mesh-ancestor
5847718|NCT02464696|Methylprednisolone|methylprednisolone|mesh-list
5847719|NCT02464696|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5847720|NCT02464696|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5847721|NCT02464696|Prednisolone|prednisolone|mesh-list
5847722|NCT02464696|Prednisolone acetate|prednisolone acetate|mesh-list
5666210|NCT03597867|Nepafenac|nepafenac|mesh-list
5666211|NCT03597867|Bromfenac|bromfenac|mesh-list
5666212|NCT03597867|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5666213|NCT03597867|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5666214|NCT03597867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5666215|NCT03597867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5666216|NCT03597867|Analgesics|analgesics|mesh-ancestor
5666217|NCT03597867|Sensory System Agents|sensory system agents|mesh-ancestor
5666218|NCT03597867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5666219|NCT03597867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666220|NCT03597867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5666221|NCT03597867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5847723|NCT02464696|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5847724|NCT02464696|Prednisolone phosphate|prednisolone phosphate|mesh-list
5847725|NCT02464696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5847726|NCT02464696|Antiemetics|antiemetics|mesh-ancestor
5847727|NCT02464696|Autonomic Agents|autonomic agents|mesh-ancestor
5847728|NCT02464696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5847729|NCT02464696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847730|NCT02464696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5847731|NCT02464696|Glucocorticoids|glucocorticoids|mesh-ancestor
5847732|NCT02464696|Hormones|hormones|mesh-ancestor
5847733|NCT02464696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5847734|NCT02464696|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5847735|NCT02464696|Protective Agents|protective agents|mesh-ancestor
5847736|NCT02464696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5847737|NCT02464696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5847738|NCT02464865|Thiamine|thiamine|mesh-list
5847739|NCT02464865|Vitamin B Complex|vitamin b complex|mesh-ancestor
5666222|NCT03597867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5847740|NCT02464865|Vitamins|vitamins|mesh-ancestor
5847741|NCT02464865|Micronutrients|micronutrients|mesh-ancestor
5847742|NCT02464865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847743|NCT02464813|Pregabalin|pregabalin|mesh-list
5847744|NCT02464813|Oxycodone|oxycodone|mesh-list
5847745|NCT02464813|Analgesics|analgesics|mesh-ancestor
5847746|NCT02464813|Sensory System Agents|sensory system agents|mesh-ancestor
5847747|NCT02464813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5847748|NCT02464813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847749|NCT02464813|Anticonvulsants|anticonvulsants|mesh-ancestor
5847750|NCT02464813|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5666223|NCT03597867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5666224|NCT03597867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5666225|NCT03597867|Gout Suppressants|gout suppressants|mesh-ancestor
5666226|NCT03597867|Tocolytic Agents|tocolytic agents|mesh-ancestor
5666227|NCT03597867|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5666228|NCT03597815|Aflibercept|aflibercept|mesh-list
5666229|NCT03597815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5666230|NCT03597815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5666231|NCT03597815|Growth Substances|growth substances|mesh-ancestor
5666232|NCT03597815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666233|NCT03597815|Growth Inhibitors|growth inhibitors|mesh-ancestor
5666234|NCT03597815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5666235|NCT03597776|Lidocaine|lidocaine|mesh-list
5666236|NCT03597776|Anesthetics, Local|anesthetics, local|mesh-ancestor
5666237|NCT03597776|Anesthetics|anesthetics|mesh-ancestor
5666238|NCT03597776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5666239|NCT03597776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666240|NCT03597776|Sensory System Agents|sensory system agents|mesh-ancestor
5666241|NCT03597776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5666242|NCT03597776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5666243|NCT03597776|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5666244|NCT03597776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5666245|NCT03597776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5666246|NCT03597776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5666247|NCT03597594|Fludarabine|fludarabine|mesh-list
5666248|NCT03597594|Busulfan|busulfan|mesh-list
5666249|NCT03597594|Thiotepa|thiotepa|mesh-list
5666250|NCT03597594|Thymoglobulin|thymoglobulin|mesh-list
5666251|NCT03597594|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5666252|NCT03597594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5666253|NCT03597594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5666254|NCT03597594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5666255|NCT03597594|Immunologic Factors|immunologic factors|mesh-ancestor
5666256|NCT03597594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666257|NCT03597594|Alkylating Agents|alkylating agents|mesh-ancestor
5666258|NCT03597594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5666259|NCT03597594|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5666260|NCT03597555|Sodium Oxybate|sodium oxybate|mesh-list
5666261|NCT03597555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5666262|NCT03597555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5666263|NCT03597555|Anesthetics, General|anesthetics, general|mesh-ancestor
5666264|NCT03597555|Anesthetics|anesthetics|mesh-ancestor
5847751|NCT02464813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5847752|NCT02464813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5847753|NCT02464813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5847754|NCT02464813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5847755|NCT02464813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5847756|NCT02464813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5847757|NCT02464813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5847758|NCT02464813|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5847759|NCT02464813|Narcotics|narcotics|mesh-ancestor
5847760|NCT02464631|Ribavirin|ribavirin|mesh-list
5847761|NCT02464631|Sofosbuvir|sofosbuvir|mesh-list
5847762|NCT02464631|Antimetabolites|antimetabolites|mesh-ancestor
5847763|NCT02464631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5847764|NCT02464631|Antiviral Agents|antiviral agents|mesh-ancestor
5847765|NCT02464631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5847766|NCT02464683|Vitamin D|vitamin d|mesh-list
5847767|NCT02464683|Vitamins|vitamins|mesh-ancestor
5847768|NCT02464683|Micronutrients|micronutrients|mesh-ancestor
5847769|NCT02464683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847770|NCT02464683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5847771|NCT02464501|Paclitaxel|paclitaxel|mesh-list
5847772|NCT02464501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5847773|NCT02464501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5666265|NCT03597555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5847774|NCT02464501|Tubulin Modulators|tubulin modulators|mesh-ancestor
5847775|NCT02464501|Antimitotic Agents|antimitotic agents|mesh-ancestor
5847776|NCT02464501|Mitosis Modulators|mitosis modulators|mesh-ancestor
5847777|NCT02464501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5847778|NCT02464228|Tipifarnib|tipifarnib|mesh-list
5847779|NCT02464228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5847780|NCT02464462|Vitamin D|vitamin d|mesh-list
5847781|NCT02464462|Cholecalciferol|cholecalciferol|mesh-list
5847782|NCT02464462|Calcium|calcium|mesh-list
5847783|NCT02464462|Vitamins|vitamins|mesh-ancestor
5847784|NCT02464462|Micronutrients|micronutrients|mesh-ancestor
5847785|NCT02464462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847786|NCT02464462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5847787|NCT02464462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5847788|NCT02464410|Analgesics, Opioid|analgesics, opioid|mesh-list
5847789|NCT02464410|Narcotics|narcotics|mesh-ancestor
5847790|NCT02464410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5847791|NCT02464410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847792|NCT02464410|Analgesics|analgesics|mesh-ancestor
5847793|NCT02464410|Sensory System Agents|sensory system agents|mesh-ancestor
5847794|NCT02464410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5847795|NCT02464306|Fidaxomicin|fidaxomicin|mesh-list
5847796|NCT02464306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5847797|NCT02464306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5847798|NCT02463929|Diphenhydramine|diphenhydramine|mesh-list
5847799|NCT02463929|Promethazine|promethazine|mesh-list
5847800|NCT02463929|Ketamine|ketamine|mesh-list
5847801|NCT02463929|Bupivacaine|bupivacaine|mesh-list
5847802|NCT02463929|Sevoflurane|sevoflurane|mesh-list
5847803|NCT02463929|Anesthetics, Local|anesthetics, local|mesh-ancestor
5847804|NCT02463929|Anesthetics|anesthetics|mesh-ancestor
5847805|NCT02463929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5847806|NCT02463929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847807|NCT02463929|Sensory System Agents|sensory system agents|mesh-ancestor
5847808|NCT02463929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5847809|NCT02463929|Analgesics|analgesics|mesh-ancestor
5847810|NCT02463929|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5847811|NCT02463929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5847812|NCT02463929|Anesthetics, General|anesthetics, general|mesh-ancestor
5847813|NCT02463929|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5847814|NCT02463929|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5847815|NCT02463929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5847816|NCT02463929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5847817|NCT02463929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5847818|NCT02463929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5847819|NCT02463929|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5847820|NCT02463929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5847821|NCT02463929|Antiemetics|antiemetics|mesh-ancestor
5847822|NCT02463929|Autonomic Agents|autonomic agents|mesh-ancestor
5847823|NCT02463929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5847824|NCT02463929|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5847825|NCT02463929|Histamine Antagonists|histamine antagonists|mesh-ancestor
5847826|NCT02463929|Histamine Agents|histamine agents|mesh-ancestor
5847827|NCT02463929|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5847828|NCT02463929|Antipruritics|antipruritics|mesh-ancestor
5847829|NCT02463929|Dermatologic Agents|dermatologic agents|mesh-ancestor
5847830|NCT02463825|Pimozide|pimozide|mesh-list
5847831|NCT02463825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5847832|NCT02463825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5847833|NCT02463825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5847834|NCT02463825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847835|NCT02463825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5847836|NCT02463825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5847837|NCT02463825|Dopamine Agents|dopamine agents|mesh-ancestor
5847838|NCT02463825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5847839|NCT02463825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5847840|NCT02463825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5847841|NCT02463994|Atezolizumab|atezolizumab|mesh-list
5847842|NCT02463994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5847843|NCT02464020|Vancomycin|vancomycin|mesh-list
5847844|NCT02464020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5847845|NCT02464020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5903842|NCT04325880|Solifenacin Succinate|solifenacin succinate|mesh-list
5903843|NCT04325880|Mirabegron|mirabegron|mesh-list
5903844|NCT04325880|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5903845|NCT04325880|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5903846|NCT04325880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5903847|NCT04325880|Adrenergic Agents|adrenergic agents|mesh-ancestor
5666266|NCT03597555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666267|NCT03597477|Dexmedetomidine|dexmedetomidine|mesh-list
5666268|NCT03597477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5666269|NCT03597477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5666270|NCT03597477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847846|NCT02463747|Vancomycin|vancomycin|mesh-list
5847847|NCT02463747|Meropenem|meropenem|mesh-list
5847848|NCT02463747|Tazobactam|tazobactam|mesh-list
5847849|NCT02463747|Piperacillin|piperacillin|mesh-list
5847850|NCT02463747|Ceftazidime|ceftazidime|mesh-list
5847851|NCT02463747|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
5847852|NCT02463747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5847853|NCT02463747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5847854|NCT02463747|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5847855|NCT02463747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5847856|NCT02463747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5847857|NCT02464124|Nitazoxanide|nitazoxanide|mesh-list
5666271|NCT03597477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5666272|NCT03597477|Analgesics|analgesics|mesh-ancestor
5666273|NCT03597477|Sensory System Agents|sensory system agents|mesh-ancestor
5666274|NCT03597477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5666275|NCT03597477|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5666276|NCT03597477|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5666277|NCT03597477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5666278|NCT03597477|Adrenergic Agents|adrenergic agents|mesh-ancestor
5666279|NCT03597477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5666280|NCT03597477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5666281|NCT03597308|Acetaminophen|acetaminophen|mesh-list
5666282|NCT03597308|Ibuprofen|ibuprofen|mesh-list
5666283|NCT03597308|Oxycodone|oxycodone|mesh-list
5666284|NCT03597308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5666285|NCT03597308|Analgesics|analgesics|mesh-ancestor
5666286|NCT03597308|Sensory System Agents|sensory system agents|mesh-ancestor
5666287|NCT03597308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5666288|NCT03597308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666289|NCT03597308|Antipyretics|antipyretics|mesh-ancestor
5666290|NCT03597308|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5666291|NCT03597308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5666292|NCT03597308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5666293|NCT03597308|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5666294|NCT03597308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5666295|NCT03597308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5666296|NCT03597308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5666297|NCT03597308|Narcotics|narcotics|mesh-ancestor
5666298|NCT03597308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5666299|NCT03597282|Nivolumab|nivolumab|mesh-list
5666300|NCT03597282|Ipilimumab|ipilimumab|mesh-list
5666301|NCT03597282|Poly ICLC|poly iclc|mesh-list
5666302|NCT03597282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5847858|NCT02464124|Lactulose|lactulose|mesh-list
5847859|NCT02464124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5847860|NCT02464124|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5847861|NCT02464124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5847862|NCT02463591|Thrombin|thrombin|mesh-list
5847863|NCT02463591|Hemostatics|hemostatics|mesh-ancestor
5847864|NCT02463591|Coagulants|coagulants|mesh-ancestor
5847865|NCT02463552|Naproxen|naproxen|mesh-list
5847866|NCT02463552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5847867|NCT02463552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5847868|NCT02463552|Analgesics|analgesics|mesh-ancestor
5847869|NCT02463552|Sensory System Agents|sensory system agents|mesh-ancestor
5847870|NCT02463552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5847871|NCT02463552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847872|NCT02463552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5847873|NCT02463552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5847874|NCT02463552|Gout Suppressants|gout suppressants|mesh-ancestor
5847875|NCT02463552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5847876|NCT02463552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5847877|NCT02463552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5847878|NCT02463643|Rabeprazole|rabeprazole|mesh-list
5847879|NCT02463643|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5847880|NCT02463643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5847881|NCT02463643|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5847882|NCT02463643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5847883|NCT02463643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5847884|NCT02463682|Insulin|insulin|mesh-list
5847885|NCT02463682|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5847886|NCT02463682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847887|NCT02463942|Doxycycline|doxycycline|mesh-list
5847888|NCT02463942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5847889|NCT02463942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5847890|NCT02463942|Antimalarials|antimalarials|mesh-ancestor
5847891|NCT02463942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5847892|NCT02463942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5847893|NCT02463812|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
5847894|NCT02463812|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
5847895|NCT02463812|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5847896|NCT02463812|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5847897|NCT02463266|Sulfamethazine|sulfamethazine|mesh-list
5847898|NCT02463266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5847899|NCT02463175|Plasma-lyte 148|plasma-lyte 148|mesh-list
5847900|NCT02463175|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5847901|NCT02463175|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5847902|NCT02463383|Ibuprofen|ibuprofen|mesh-list
5847903|NCT02463383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5847904|NCT02463383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5847905|NCT02463383|Analgesics|analgesics|mesh-ancestor
6212097|NCT02181426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6212098|NCT02181426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6212099|NCT02181426|Analgesics|analgesics|mesh-ancestor
6494010|NCT00616694|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5847906|NCT02463383|Sensory System Agents|sensory system agents|mesh-ancestor
5847907|NCT02463383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5847908|NCT02463383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847909|NCT02463383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5847910|NCT02463383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5847911|NCT02463383|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5847912|NCT02463383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5847913|NCT02463383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5847914|NCT02463513|Vitamins|vitamins|mesh-list
5847915|NCT02463513|Riboflavin|riboflavin|mesh-list
5847916|NCT02463513|Vitamin B Complex|vitamin b complex|mesh-list
5847917|NCT02463513|Micronutrients|micronutrients|mesh-ancestor
5847918|NCT02463513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847919|NCT02463513|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5847920|NCT02463513|Dermatologic Agents|dermatologic agents|mesh-ancestor
5847921|NCT02463318|Hydrogen Peroxide|hydrogen peroxide|mesh-list
5847922|NCT02463318|Melatonin|melatonin|mesh-list
5847923|NCT02463318|Antioxidants|antioxidants|mesh-ancestor
5847924|NCT02463318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5847925|NCT02463318|Protective Agents|protective agents|mesh-ancestor
5847926|NCT02463318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847927|NCT02463318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5847928|NCT02463318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5847929|NCT02463318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5847930|NCT02463110|Sertraline|sertraline|mesh-list
5847931|NCT02463110|Antidepressive Agents|antidepressive agents|mesh-ancestor
5847932|NCT02463110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5847933|NCT02463110|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5666303|NCT03597282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5666304|NCT03597282|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5666305|NCT03597282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5666306|NCT03597282|Interferon Inducers|interferon inducers|mesh-ancestor
5666307|NCT03597282|Immunologic Factors|immunologic factors|mesh-ancestor
5666308|NCT03597282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695726|NCT03387592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5695727|NCT03387592|Immunologic Factors|immunologic factors|mesh-ancestor
5695728|NCT03387592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695729|NCT03387592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5695730|NCT03387592|Alkylating Agents|alkylating agents|mesh-ancestor
5695731|NCT03387592|Antidotes|antidotes|mesh-ancestor
5847934|NCT02463110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5695732|NCT03387592|Protective Agents|protective agents|mesh-ancestor
5695733|NCT03387592|Vitamin B Complex|vitamin b complex|mesh-ancestor
5695734|NCT03387592|Vitamins|vitamins|mesh-ancestor
5695735|NCT03387592|Micronutrients|micronutrients|mesh-ancestor
5695736|NCT03387566|Immunoglobulins|immunoglobulins|mesh-list
5695737|NCT03387566|Endothelial Growth Factors|endothelial growth factors|mesh-list
5695738|NCT03387566|Immunologic Factors|immunologic factors|mesh-ancestor
5695739|NCT03387566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695740|NCT03387566|Growth Substances|growth substances|mesh-ancestor
5695741|NCT03387501|Mitogens|mitogens|mesh-list
5847935|NCT02463110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5666309|NCT03597087|Anesthetics|anesthetics|mesh-list
5666310|NCT03597087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5666311|NCT03597087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666312|NCT03597035|Spironolactone|spironolactone|mesh-list
5847936|NCT02463110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5847937|NCT02463110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5847938|NCT02463110|Serotonin Agents|serotonin agents|mesh-ancestor
5847939|NCT02463110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847940|NCT02462772|Cabotegravir|cabotegravir|mesh-list
5847941|NCT02462772|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
5847942|NCT02462772|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
5847943|NCT02462772|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5847944|NCT02462772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5847945|NCT02462772|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5847946|NCT02462772|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5847947|NCT02462772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5847948|NCT02462772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5847949|NCT02462772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5847950|NCT02462772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5847951|NCT02462772|Antiviral Agents|antiviral agents|mesh-ancestor
5847952|NCT02462772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5847953|NCT02462889|Aflibercept|aflibercept|mesh-list
5847954|NCT02462889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5847955|NCT02462889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5847956|NCT02462889|Growth Substances|growth substances|mesh-ancestor
5847957|NCT02462889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847958|NCT02462889|Growth Inhibitors|growth inhibitors|mesh-ancestor
5847959|NCT02462889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5847960|NCT02463019|Tenofovir|tenofovir|mesh-list
5847961|NCT02463019|Antiviral Agents|antiviral agents|mesh-ancestor
5847962|NCT02463019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5847963|NCT02463019|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5847964|NCT02463019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5847965|NCT02463019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5847966|NCT02463019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5847967|NCT02463019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5847968|NCT02463019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5847969|NCT02463006|Methamphetamine|methamphetamine|mesh-list
5847970|NCT02463006|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5847971|NCT02463006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847972|NCT02463006|Sympathomimetics|sympathomimetics|mesh-ancestor
5847973|NCT02463006|Autonomic Agents|autonomic agents|mesh-ancestor
5847974|NCT02463006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5847975|NCT02463006|Dopamine Agents|dopamine agents|mesh-ancestor
5847976|NCT02463006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5847977|NCT02463006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5847978|NCT02463006|Adrenergic Agents|adrenergic agents|mesh-ancestor
5847979|NCT02463006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5847980|NCT02463006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5847981|NCT02463006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5847982|NCT02463006|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5666313|NCT03597035|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5666314|NCT03597035|Hormone Antagonists|hormone antagonists|mesh-ancestor
5666315|NCT03597035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5666316|NCT03597035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666317|NCT03597035|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5666318|NCT03597035|Diuretics|diuretics|mesh-ancestor
5666319|NCT03597035|Natriuretic Agents|natriuretic agents|mesh-ancestor
5666320|NCT03596970|Everolimus|everolimus|mesh-list
5666321|NCT03596970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5666322|NCT03596970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5666323|NCT03596970|Immunologic Factors|immunologic factors|mesh-ancestor
5666324|NCT03596970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666325|NCT03596957|Tolvaptan|tolvaptan|mesh-list
5666326|NCT03596957|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
5666327|NCT03596957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5666328|NCT03596957|Natriuretic Agents|natriuretic agents|mesh-ancestor
5666329|NCT03596957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666330|NCT03596918|Vincristine|vincristine|mesh-list
5666331|NCT03596918|Bleomycin|bleomycin|mesh-list
5666332|NCT03596918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5666333|NCT03596918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5666334|NCT03596918|Tubulin Modulators|tubulin modulators|mesh-ancestor
5666335|NCT03596918|Antimitotic Agents|antimitotic agents|mesh-ancestor
5666336|NCT03596918|Mitosis Modulators|mitosis modulators|mesh-ancestor
5666337|NCT03596918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5666338|NCT03596918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5666339|NCT03596892|Cyclophosphamide|cyclophosphamide|mesh-list
5666340|NCT03596892|Busulfan|busulfan|mesh-list
5666341|NCT03596892|Decitabine|decitabine|mesh-list
5666342|NCT03596892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5666343|NCT03596892|Immunologic Factors|immunologic factors|mesh-ancestor
5666344|NCT03596892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666345|NCT03596892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5666346|NCT03596892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5666347|NCT03596892|Alkylating Agents|alkylating agents|mesh-ancestor
5666348|NCT03596892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5666349|NCT03596892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5666350|NCT03596892|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5666351|NCT03596892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5666352|NCT03596892|Antimetabolites|antimetabolites|mesh-ancestor
5666353|NCT03596892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5666354|NCT03596775|Dexmedetomidine|dexmedetomidine|mesh-list
5666355|NCT03596775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5666356|NCT03596775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5666357|NCT03596775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666358|NCT03596775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5666359|NCT03596775|Analgesics|analgesics|mesh-ancestor
5666360|NCT03596775|Sensory System Agents|sensory system agents|mesh-ancestor
5666361|NCT03596775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5666362|NCT03596775|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5666363|NCT03596775|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5666364|NCT03596775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5666365|NCT03596775|Adrenergic Agents|adrenergic agents|mesh-ancestor
5666366|NCT03596775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5847983|NCT02462941|Adenosine|adenosine|mesh-list
5847984|NCT02462941|Analgesics|analgesics|mesh-ancestor
5847985|NCT02462941|Sensory System Agents|sensory system agents|mesh-ancestor
5847986|NCT02462941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5847987|NCT02462941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5847988|NCT02462941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5847989|NCT02462941|Vasodilator Agents|vasodilator agents|mesh-ancestor
5847990|NCT02462941|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5847991|NCT02462941|Purinergic Agonists|purinergic agonists|mesh-ancestor
5847992|NCT02462941|Purinergic Agents|purinergic agents|mesh-ancestor
5847993|NCT02462941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5847994|NCT02462941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5847995|NCT02462915|Lidocaine|lidocaine|mesh-list
5847996|NCT02462915|Fentanyl|fentanyl|mesh-list
5847997|NCT02462915|Propofol|propofol|mesh-list
5847998|NCT02462915|Cisatracurium|cisatracurium|mesh-list
5847999|NCT02462915|Anesthetics, Local|anesthetics, local|mesh-ancestor
5848000|NCT02462915|Anesthetics|anesthetics|mesh-ancestor
5848001|NCT02462915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5848002|NCT02462915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848003|NCT02462915|Sensory System Agents|sensory system agents|mesh-ancestor
5848004|NCT02462915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5848005|NCT02462915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5848006|NCT02462915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5848007|NCT02462915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5848008|NCT02462915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5848009|NCT02462915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848010|NCT02462915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5848011|NCT02462915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5848012|NCT02462915|Anesthetics, General|anesthetics, general|mesh-ancestor
5848013|NCT02462915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5848014|NCT02462915|Narcotics|narcotics|mesh-ancestor
5848015|NCT02462915|Analgesics|analgesics|mesh-ancestor
5848016|NCT02462915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5848017|NCT02462915|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5848018|NCT02462915|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5848019|NCT02462837|Mirabegron|mirabegron|mesh-list
5848020|NCT02462837|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
5848021|NCT02462837|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5848022|NCT02462837|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5848023|NCT02462837|Adrenergic Agents|adrenergic agents|mesh-ancestor
5848024|NCT02462837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5848025|NCT02462837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848026|NCT02462837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848027|NCT02462837|Urological Agents|urological agents|mesh-ancestor
5848028|NCT02462525|Dexamethasone|dexamethasone|mesh-list
5666367|NCT03596775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5666368|NCT03596749|Sevelamer|sevelamer|mesh-list
5666369|NCT03596749|Chelating Agents|chelating agents|mesh-ancestor
5666370|NCT03596749|Sequestering Agents|sequestering agents|mesh-ancestor
5666371|NCT03596749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5666372|NCT03596502|Warfarin|warfarin|mesh-list
5666373|NCT03596502|Anticoagulants|anticoagulants|mesh-list
5666374|NCT03596424|Dexmedetomidine|dexmedetomidine|mesh-list
5666375|NCT03596424|Ketamine|ketamine|mesh-list
5666376|NCT03596424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5666377|NCT03596424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5666378|NCT03596424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666379|NCT03596424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5666380|NCT03596424|Analgesics|analgesics|mesh-ancestor
5666381|NCT03596424|Sensory System Agents|sensory system agents|mesh-ancestor
5666382|NCT03596424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5666383|NCT03596424|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5666384|NCT03596424|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5666385|NCT03596424|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5666386|NCT03596424|Adrenergic Agents|adrenergic agents|mesh-ancestor
5848029|NCT02462525|Pomalidomide|pomalidomide|mesh-list
5848030|NCT02462525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5848031|NCT02462525|Antiemetics|antiemetics|mesh-ancestor
5848032|NCT02462525|Autonomic Agents|autonomic agents|mesh-ancestor
5848033|NCT02462525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5848034|NCT02462525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848035|NCT02462525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5848036|NCT02462525|Glucocorticoids|glucocorticoids|mesh-ancestor
5848037|NCT02462525|Hormones|hormones|mesh-ancestor
5848038|NCT02462525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5848039|NCT02462525|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5848040|NCT02462525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5848041|NCT02462525|Immunologic Factors|immunologic factors|mesh-ancestor
5848042|NCT02462525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5848043|NCT02462525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5848044|NCT02462525|Growth Substances|growth substances|mesh-ancestor
5848045|NCT02462525|Growth Inhibitors|growth inhibitors|mesh-ancestor
5848046|NCT02462577|Morphine|morphine|mesh-list
5848047|NCT02462577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5848048|NCT02462577|Narcotics|narcotics|mesh-ancestor
5848049|NCT02462577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5848050|NCT02462577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848051|NCT02462577|Analgesics|analgesics|mesh-ancestor
5848052|NCT02462577|Sensory System Agents|sensory system agents|mesh-ancestor
5848053|NCT02462577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5848054|NCT02462447|Choline|choline|mesh-list
5848055|NCT02462447|Lipotropic Agents|lipotropic agents|mesh-ancestor
5848056|NCT02462447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5848057|NCT02462447|Antimetabolites|antimetabolites|mesh-ancestor
5848058|NCT02462447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848059|NCT02462447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5848060|NCT02462447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5848061|NCT02462447|Nootropic Agents|nootropic agents|mesh-ancestor
5848062|NCT02462681|Ketamine|ketamine|mesh-list
5848063|NCT02462681|Analgesics|analgesics|mesh-ancestor
5848064|NCT02462681|Sensory System Agents|sensory system agents|mesh-ancestor
5848065|NCT02462681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5848066|NCT02462681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848067|NCT02462681|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5848068|NCT02462681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5848069|NCT02462681|Anesthetics, General|anesthetics, general|mesh-ancestor
5848070|NCT02462681|Anesthetics|anesthetics|mesh-ancestor
5848071|NCT02462681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5848072|NCT02462681|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5848073|NCT02462681|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5848074|NCT02462681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5848075|NCT02462681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848076|NCT02462499|Eplerenone|eplerenone|mesh-list
5848077|NCT02462499|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5848078|NCT02462499|Hormone Antagonists|hormone antagonists|mesh-ancestor
5848079|NCT02462499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5848080|NCT02462499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848081|NCT02462499|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5848082|NCT02462499|Diuretics|diuretics|mesh-ancestor
5848083|NCT02462499|Natriuretic Agents|natriuretic agents|mesh-ancestor
5848084|NCT02462499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5848085|NCT02462538|Imatinib Mesylate|imatinib mesylate|mesh-list
5848086|NCT02462538|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5848087|NCT02462538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5848088|NCT02462538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5666387|NCT03596424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5666388|NCT03596424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5666389|NCT03596424|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5666390|NCT03596424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5666391|NCT03596424|Anesthetics, General|anesthetics, general|mesh-ancestor
5666392|NCT03596424|Anesthetics|anesthetics|mesh-ancestor
5666393|NCT03596424|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5666394|NCT03596424|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5666395|NCT03596385|Metoprolol|metoprolol|mesh-list
5666396|NCT03596385|Atenolol|atenolol|mesh-list
5666397|NCT03596385|Carvedilol|carvedilol|mesh-list
5666398|NCT03596385|Bisoprolol|bisoprolol|mesh-list
5666399|NCT03596385|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
5666400|NCT03596385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5666401|NCT03596385|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5666402|NCT03596385|Sympatholytics|sympatholytics|mesh-ancestor
5666403|NCT03596385|Autonomic Agents|autonomic agents|mesh-ancestor
5666404|NCT03596385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5666405|NCT03596385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666406|NCT03596385|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5666407|NCT03596385|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5666408|NCT03596385|Adrenergic Agents|adrenergic agents|mesh-ancestor
5666409|NCT03596385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5666410|NCT03596385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5666411|NCT03596385|Antioxidants|antioxidants|mesh-ancestor
5848089|NCT02462538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5848090|NCT02462538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848091|NCT02462538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5848092|NCT02462369|Glimepiride|glimepiride|mesh-list
5848093|NCT02462369|Saxagliptin|saxagliptin|mesh-list
5848094|NCT02462369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5848095|NCT02462369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5848096|NCT02462369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848097|NCT02462369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5848098|NCT02462369|Immunologic Factors|immunologic factors|mesh-ancestor
5848099|NCT02462369|Incretins|incretins|mesh-ancestor
5848100|NCT02462369|Hormones|hormones|mesh-ancestor
5848101|NCT02462369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5848102|NCT02462369|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5848103|NCT02462369|Protease Inhibitors|protease inhibitors|mesh-ancestor
5848104|NCT02462369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5848105|NCT02462369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848106|NCT02462304|Bevacizumab|bevacizumab|mesh-list
5848107|NCT02462304|Ranibizumab|ranibizumab|mesh-list
5848108|NCT02462304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5848109|NCT02462304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5848110|NCT02462304|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5666412|NCT03596385|Protective Agents|protective agents|mesh-ancestor
5666413|NCT03596385|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5666414|NCT03596385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5666415|NCT03596385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5666416|NCT03596385|Vasodilator Agents|vasodilator agents|mesh-ancestor
5666417|NCT03596385|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5666418|NCT03596385|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5666419|NCT03596294|Rifampin|rifampin|mesh-list
5666420|NCT03596294|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5666421|NCT03596294|Antitubercular Agents|antitubercular agents|mesh-ancestor
5666422|NCT03596294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5666423|NCT03596294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5666424|NCT03596294|Leprostatic Agents|leprostatic agents|mesh-ancestor
5666425|NCT03596294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5666426|NCT03596294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5666427|NCT03596294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848111|NCT02462304|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5848112|NCT02462304|Growth Substances|growth substances|mesh-ancestor
5848113|NCT02462304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848114|NCT02462304|Growth Inhibitors|growth inhibitors|mesh-ancestor
5848115|NCT02462317|Baclofen|baclofen|mesh-list
5848116|NCT02462317|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5848117|NCT02462317|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5848118|NCT02462317|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5848119|NCT02462317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848120|NCT02462317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5848121|NCT02462317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5848122|NCT02462317|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
5848123|NCT02462317|GABA Agonists|gaba agonists|mesh-ancestor
5848124|NCT02462317|GABA Agents|gaba agents|mesh-ancestor
5848125|NCT02462317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5848126|NCT02462317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848127|NCT02462317|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5666428|NCT03596294|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5666429|NCT03596294|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5666430|NCT03596294|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5848128|NCT02462317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5848129|NCT02462317|Cholinergic Agents|cholinergic agents|mesh-ancestor
5903848|NCT04325880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5903849|NCT04325880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903850|NCT04325880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903851|NCT04325880|Urological Agents|urological agents|mesh-ancestor
5903852|NCT04325880|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5903853|NCT04325880|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5903854|NCT04325880|Cholinergic Agents|cholinergic agents|mesh-ancestor
5903855|NCT04325880|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
5903856|NCT04325880|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5903857|NCT04325880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5908425|NCT04552847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5908426|NCT04552847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5908427|NCT04537078|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5908428|NCT04537078|Contraceptive Agents|contraceptive agents|mesh-list
5908429|NCT04537078|Contraceptives, Oral|contraceptives, oral|mesh-list
5908430|NCT04537078|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5908431|NCT04537078|Cetrorelix|cetrorelix|mesh-list
5908432|NCT04537078|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
5908433|NCT04537078|Progesterone|progesterone|mesh-list
5908434|NCT04537078|Dydrogesterone|dydrogesterone|mesh-list
5908435|NCT04537078|Estradiol|estradiol|mesh-list
5908436|NCT04537078|Progestins|progestins|mesh-ancestor
5908437|NCT04537078|Hormones|hormones|mesh-ancestor
5908438|NCT04537078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5908439|NCT04537078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5908440|NCT04537078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5908441|NCT04537078|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5908442|NCT04537078|Luteolytic Agents|luteolytic agents|mesh-ancestor
5908443|NCT04537078|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5908444|NCT04537078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5908445|NCT04537078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5908446|NCT04537078|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5908447|NCT04537078|Fertility Agents|fertility agents|mesh-ancestor
6494011|NCT00616694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6494012|NCT00616694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494013|NCT00616694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5666431|NCT03596294|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5908448|NCT04537078|Hormone Antagonists|hormone antagonists|mesh-ancestor
5908449|NCT04537078|Estrogens|estrogens|mesh-ancestor
5908450|NCT04530383|Metformin|metformin|mesh-list
5666432|NCT03596294|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5666433|NCT03596294|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5666434|NCT03596281|Bevacizumab|bevacizumab|mesh-list
5666435|NCT03596281|Pembrolizumab|pembrolizumab|mesh-list
5908451|NCT04530383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5908452|NCT04530383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5908453|NCT04509401|Vitamins|vitamins|mesh-list
5908454|NCT04509401|Vitamin B 6|vitamin b 6|mesh-list
5908455|NCT04509401|Pyridoxal|pyridoxal|mesh-list
5908456|NCT04509401|Pyridoxine|pyridoxine|mesh-list
5908457|NCT04509401|Vitamin B Complex|vitamin b complex|mesh-list
5908458|NCT04509401|Micronutrients|micronutrients|mesh-ancestor
5908459|NCT04509401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5908460|NCT04503551|Ranibizumab|ranibizumab|mesh-list
5908461|NCT04503551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5908462|NCT04503551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6674722|NCT01571037|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6674723|NCT01571037|Vasodilator Agents|vasodilator agents|mesh-ancestor
6674724|NCT01571037|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6674725|NCT01571037|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6674726|NCT01571037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6674727|NCT01571037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5666436|NCT03596281|Doxorubicin|doxorubicin|mesh-list
5666437|NCT03596281|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5666438|NCT03596281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5666439|NCT03596281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5666440|NCT03596281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5666441|NCT03596281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5666442|NCT03596281|Growth Substances|growth substances|mesh-ancestor
5666443|NCT03596281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666444|NCT03596281|Growth Inhibitors|growth inhibitors|mesh-ancestor
5666445|NCT03596281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5666446|NCT03596281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5848130|NCT02462109|Lorazepam|lorazepam|mesh-list
5848131|NCT02462109|Anticonvulsants|anticonvulsants|mesh-ancestor
5848132|NCT02462109|Antiemetics|antiemetics|mesh-ancestor
5848133|NCT02462109|Autonomic Agents|autonomic agents|mesh-ancestor
5848134|NCT02462109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5848135|NCT02462109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848136|NCT02462109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5848137|NCT02462109|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5848138|NCT02462109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5848139|NCT02462109|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5848140|NCT02462109|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5848141|NCT02462109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5848142|NCT02462109|GABA Modulators|gaba modulators|mesh-ancestor
5848143|NCT02462109|GABA Agents|gaba agents|mesh-ancestor
5848144|NCT02462109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5848145|NCT02462109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848146|NCT02462161|Insulin|insulin|mesh-list
5848147|NCT02462161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5848148|NCT02462161|Insulin Aspart|insulin aspart|mesh-list
5848149|NCT02462161|Insulin, Long-Acting|insulin, long-acting|mesh-list
5848150|NCT02462161|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
5848151|NCT02462161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5848152|NCT02462161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848153|NCT02462174|Ketamine|ketamine|mesh-list
5666447|NCT03596281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5666448|NCT03596281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5666449|NCT03596281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5666450|NCT03596125|Acetylcysteine|acetylcysteine|mesh-list
5666451|NCT03596125|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5666452|NCT03596125|Antiviral Agents|antiviral agents|mesh-ancestor
5666453|NCT03596125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5666454|NCT03596125|Expectorants|expectorants|mesh-ancestor
5666455|NCT03596125|Respiratory System Agents|respiratory system agents|mesh-ancestor
5666456|NCT03596125|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5666457|NCT03596125|Antioxidants|antioxidants|mesh-ancestor
5666458|NCT03596125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5666459|NCT03596125|Protective Agents|protective agents|mesh-ancestor
5666460|NCT03596125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666461|NCT03596125|Antidotes|antidotes|mesh-ancestor
5666462|NCT03596099|Acetic Acid|acetic acid|mesh-list
5666463|NCT03596099|Retinol acetate|retinol acetate|mesh-list
5666464|NCT03596099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5666465|NCT03596099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5666466|NCT03596099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5666467|NCT03596099|Immunologic Factors|immunologic factors|mesh-ancestor
5666468|NCT03596099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666469|NCT03596099|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5848154|NCT02462174|Bupivacaine|bupivacaine|mesh-list
5848155|NCT02462174|Anesthetics, Local|anesthetics, local|mesh-ancestor
5848156|NCT02462174|Anesthetics|anesthetics|mesh-ancestor
5848157|NCT02462174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5848158|NCT02462174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848159|NCT02462174|Sensory System Agents|sensory system agents|mesh-ancestor
5848160|NCT02462174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5848161|NCT02462174|Analgesics|analgesics|mesh-ancestor
5848162|NCT02462174|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5903858|NCT04299880|Leucovorin|leucovorin|mesh-list
5666470|NCT03596099|Protective Agents|protective agents|mesh-ancestor
5666471|NCT03596099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5848163|NCT02462174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5848164|NCT02462174|Anesthetics, General|anesthetics, general|mesh-ancestor
5848165|NCT02462174|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5848166|NCT02462174|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5848167|NCT02462174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5848168|NCT02462174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848169|NCT02462252|Cyclosporine|cyclosporine|mesh-list
5848170|NCT02462252|Methylprednisolone|methylprednisolone|mesh-list
5666472|NCT03596060|Fentanyl|fentanyl|mesh-list
5666473|NCT03596060|Morphine|morphine|mesh-list
5666474|NCT03596060|Propofol|propofol|mesh-list
5666475|NCT03596060|Rocuronium|rocuronium|mesh-list
5666476|NCT03596060|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5666477|NCT03596060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5666478|NCT03596060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666479|NCT03596060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5666480|NCT03596060|Anesthetics, General|anesthetics, general|mesh-ancestor
5666481|NCT03596060|Anesthetics|anesthetics|mesh-ancestor
5666482|NCT03596060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5666483|NCT03596060|Narcotics|narcotics|mesh-ancestor
5666484|NCT03596060|Analgesics|analgesics|mesh-ancestor
5666485|NCT03596060|Sensory System Agents|sensory system agents|mesh-ancestor
5666486|NCT03596060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5666487|NCT03596060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5848171|NCT02462252|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5848172|NCT02462252|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5848173|NCT02462252|Cyclosporins|cyclosporins|mesh-list
5848174|NCT02462252|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5848175|NCT02462252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5848176|NCT02462252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848177|NCT02462252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5848178|NCT02462252|Immunologic Factors|immunologic factors|mesh-ancestor
5848179|NCT02462252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848180|NCT02462252|Antifungal Agents|antifungal agents|mesh-ancestor
5848181|NCT02462252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5666488|NCT03596060|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5666489|NCT03596060|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5666490|NCT03596060|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5666491|NCT03595982|Nifedipine|nifedipine|mesh-list
5666492|NCT03595982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5666493|NCT03595982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5666494|NCT03595982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5666495|NCT03595982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5666496|NCT03595982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666497|NCT03595982|Vasodilator Agents|vasodilator agents|mesh-ancestor
5666498|NCT03595982|Tocolytic Agents|tocolytic agents|mesh-ancestor
5666499|NCT03595982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5666500|NCT03595930|Fluticasone|fluticasone|mesh-list
5666501|NCT03595930|Xhance|xhance|mesh-list
5666502|NCT03595930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5666503|NCT03595930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5666504|NCT03595930|Autonomic Agents|autonomic agents|mesh-ancestor
5666505|NCT03595930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5666506|NCT03595930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666507|NCT03595930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5666508|NCT03595930|Respiratory System Agents|respiratory system agents|mesh-ancestor
5848182|NCT02462252|Dermatologic Agents|dermatologic agents|mesh-ancestor
5848183|NCT02462252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5848184|NCT02462252|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5848185|NCT02462252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5848186|NCT02462252|Antiemetics|antiemetics|mesh-ancestor
5848187|NCT02462252|Autonomic Agents|autonomic agents|mesh-ancestor
5848188|NCT02462252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5848189|NCT02462252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5848190|NCT02462252|Glucocorticoids|glucocorticoids|mesh-ancestor
5848191|NCT02462252|Hormones|hormones|mesh-ancestor
5848192|NCT02462252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5848193|NCT02462252|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5848194|NCT02462252|Protective Agents|protective agents|mesh-ancestor
5848195|NCT02462252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5666509|NCT03595930|Dermatologic Agents|dermatologic agents|mesh-ancestor
5848196|NCT02462252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5848197|NCT02462265|Mitoxantrone|mitoxantrone|mesh-list
5848198|NCT02462265|Antineoplastic Agents|antineoplastic agents|mesh-list
5903859|NCT04299880|Gemcitabine|gemcitabine|mesh-list
5666510|NCT03595930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5666511|NCT03595852|Cefazolin|cefazolin|mesh-list
5666512|NCT03595852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5666513|NCT03595852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5666514|NCT03595683|Pembrolizumab|pembrolizumab|mesh-list
5666515|NCT03595683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5666516|NCT03595683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5666517|NCT03595514|Dexamethasone|dexamethasone|mesh-list
5666518|NCT03595514|Lidocaine|lidocaine|mesh-list
5666519|NCT03595514|Epinephrine|epinephrine|mesh-list
5666520|NCT03595514|Bupivacaine|bupivacaine|mesh-list
5666521|NCT03595514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5666522|NCT03595514|Antiemetics|antiemetics|mesh-ancestor
5666523|NCT03595514|Autonomic Agents|autonomic agents|mesh-ancestor
5848199|NCT02462265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848200|NCT02462265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848201|NCT02462265|Analgesics|analgesics|mesh-ancestor
5848202|NCT02462265|Sensory System Agents|sensory system agents|mesh-ancestor
5666524|NCT03595514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5666525|NCT03595514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666526|NCT03595514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5666527|NCT03595514|Glucocorticoids|glucocorticoids|mesh-ancestor
5666528|NCT03595514|Hormones|hormones|mesh-ancestor
5848203|NCT02462265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5848204|NCT02462265|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5848205|NCT02462265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5848206|NCT02462265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5848207|NCT02462044|Iodine|iodine|mesh-list
5848208|NCT02462044|Cadexomer iodine|cadexomer iodine|mesh-list
5848209|NCT02462044|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5848210|NCT02462044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5848211|NCT02462044|Trace Elements|trace elements|mesh-ancestor
5848212|NCT02462044|Micronutrients|micronutrients|mesh-ancestor
5848213|NCT02462044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848214|NCT02461849|Imatinib Mesylate|imatinib mesylate|mesh-list
5848215|NCT02461849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5848216|NCT02461849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5848217|NCT02461849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5848218|NCT02461849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848219|NCT02461706|Cannabidiol|cannabidiol|mesh-list
5848220|NCT02461706|Anticonvulsants|anticonvulsants|mesh-ancestor
5848221|NCT02461836|Gemcitabine|gemcitabine|mesh-list
5848222|NCT02461836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5848223|NCT02461836|Antimetabolites|antimetabolites|mesh-ancestor
5848224|NCT02461836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848225|NCT02461836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5848226|NCT02461836|Antiviral Agents|antiviral agents|mesh-ancestor
5848227|NCT02461836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5848228|NCT02461836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5848229|NCT02461836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5848230|NCT02461836|Immunologic Factors|immunologic factors|mesh-ancestor
5848231|NCT02461836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848232|NCT02461888|Dexamethasone|dexamethasone|mesh-list
5848233|NCT02461888|Cyclophosphamide|cyclophosphamide|mesh-list
5848234|NCT02461888|Ixazomib|ixazomib|mesh-list
5848235|NCT02461888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5848236|NCT02461888|Immunologic Factors|immunologic factors|mesh-ancestor
5848237|NCT02461888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848238|NCT02461888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5848239|NCT02461888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5848240|NCT02461888|Alkylating Agents|alkylating agents|mesh-ancestor
5848241|NCT02461888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848242|NCT02461888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5848243|NCT02461888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5848244|NCT02461888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5848245|NCT02461888|Antiemetics|antiemetics|mesh-ancestor
5848246|NCT02461888|Autonomic Agents|autonomic agents|mesh-ancestor
5848247|NCT02461888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5848248|NCT02461888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5848249|NCT02461888|Glucocorticoids|glucocorticoids|mesh-ancestor
5848250|NCT02461888|Hormones|hormones|mesh-ancestor
5848251|NCT02461888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5848252|NCT02461888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5848253|NCT02461888|Protease Inhibitors|protease inhibitors|mesh-ancestor
5848254|NCT02461888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5666529|NCT03595514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5848255|NCT02461875|Cabergoline|cabergoline|mesh-list
5848256|NCT02461875|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5848257|NCT02461875|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5848258|NCT02461875|Dopamine Agonists|dopamine agonists|mesh-ancestor
5666530|NCT03595514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5666531|NCT03595514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5666532|NCT03595514|Anesthetics, Local|anesthetics, local|mesh-ancestor
5666533|NCT03595514|Anesthetics|anesthetics|mesh-ancestor
5666534|NCT03595514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5666535|NCT03595514|Sensory System Agents|sensory system agents|mesh-ancestor
5666536|NCT03595514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5666537|NCT03595514|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5666538|NCT03595514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5666539|NCT03595514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5666540|NCT03595514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5666541|NCT03595514|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5666542|NCT03595514|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5666543|NCT03595514|Adrenergic Agents|adrenergic agents|mesh-ancestor
5666544|NCT03595514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5666545|NCT03595514|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5666546|NCT03595514|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5666547|NCT03595514|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5666548|NCT03595514|Respiratory System Agents|respiratory system agents|mesh-ancestor
5848259|NCT02461875|Dopamine Agents|dopamine agents|mesh-ancestor
5848260|NCT02461875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5848261|NCT02461875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848262|NCT02461875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848263|NCT02461719|Cyclosporine|cyclosporine|mesh-list
5848264|NCT02461719|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5848265|NCT02461719|Cyclosporins|cyclosporins|mesh-list
5848266|NCT02461719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5848267|NCT02461719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5666549|NCT03595514|Mydriatics|mydriatics|mesh-ancestor
5666550|NCT03595514|Sympathomimetics|sympathomimetics|mesh-ancestor
5666551|NCT03595514|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5695742|NCT03387501|Mitosis Modulators|mitosis modulators|mesh-ancestor
5695743|NCT03387501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695744|NCT03387475|Deferasirox|deferasirox|mesh-list
5695745|NCT03387475|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5695746|NCT03387475|Chelating Agents|chelating agents|mesh-ancestor
5695747|NCT03387475|Sequestering Agents|sequestering agents|mesh-ancestor
5695748|NCT03387475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695749|NCT03387423|Tofacitinib|tofacitinib|mesh-list
5695750|NCT03387423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5695751|NCT03387423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5695752|NCT03387423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695753|NCT03387241|Fluticasone|fluticasone|mesh-list
5695754|NCT03387241|Xhance|xhance|mesh-list
5848268|NCT02461719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5848269|NCT02461719|Immunologic Factors|immunologic factors|mesh-ancestor
5848270|NCT02461719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848271|NCT02461719|Antifungal Agents|antifungal agents|mesh-ancestor
5848272|NCT02461719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5848273|NCT02461719|Dermatologic Agents|dermatologic agents|mesh-ancestor
5848274|NCT02461719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5848275|NCT02461719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5848276|NCT02461719|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5848277|NCT02461927|Midazolam|midazolam|mesh-list
5848278|NCT02461927|Naltrexone|naltrexone|mesh-list
5848279|NCT02461927|Ketamine|ketamine|mesh-list
5848280|NCT02461927|Analgesics|analgesics|mesh-ancestor
5848281|NCT02461927|Sensory System Agents|sensory system agents|mesh-ancestor
5848282|NCT02461927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5848283|NCT02461927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695755|NCT03387241|Formoterol Fumarate|formoterol fumarate|mesh-list
5695756|NCT03387241|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5695757|NCT03387241|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
5695758|NCT03387241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5695759|NCT03387241|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5695760|NCT03387241|Autonomic Agents|autonomic agents|mesh-ancestor
5695761|NCT03387241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5695762|NCT03387241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848284|NCT02461927|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5848285|NCT02461927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5848286|NCT02461927|Anesthetics, General|anesthetics, general|mesh-ancestor
5848287|NCT02461927|Anesthetics|anesthetics|mesh-ancestor
5848288|NCT02461927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5695763|NCT03387241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5848289|NCT02461927|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5848290|NCT02461927|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5848291|NCT02461927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5848292|NCT02461927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848293|NCT02461927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5848294|NCT02461927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5848295|NCT02461927|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5848296|NCT02461927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5848297|NCT02461927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5848298|NCT02461927|GABA Modulators|gaba modulators|mesh-ancestor
5848299|NCT02461927|GABA Agents|gaba agents|mesh-ancestor
5848300|NCT02461927|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5848301|NCT02461927|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5848302|NCT02461914|Warfarin|warfarin|mesh-list
5848303|NCT02461914|Anticoagulants|anticoagulants|mesh-ancestor
5848304|NCT02461667|Alendronate|alendronate|mesh-list
5848305|NCT02461667|Metformin|metformin|mesh-list
5848306|NCT02461667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5848307|NCT02461667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848308|NCT02461667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5848309|NCT02461329|Polygeline|polygeline|mesh-list
5848310|NCT02461329|Plasma Substitutes|plasma substitutes|mesh-ancestor
5848311|NCT02461329|Blood Substitutes|blood substitutes|mesh-ancestor
5848312|NCT02461368|Triamcinolone|triamcinolone|mesh-list
5848313|NCT02461368|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5848314|NCT02461368|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5848315|NCT02461368|Lidocaine|lidocaine|mesh-list
5848316|NCT02461368|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5848317|NCT02461368|Anesthetics, Local|anesthetics, local|mesh-ancestor
5848318|NCT02461368|Anesthetics|anesthetics|mesh-ancestor
5848319|NCT02461368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5848320|NCT02461368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848321|NCT02461368|Sensory System Agents|sensory system agents|mesh-ancestor
5848322|NCT02461368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5848323|NCT02461368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5848324|NCT02461368|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5848325|NCT02461368|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5848326|NCT02461368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5848327|NCT02461368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848328|NCT02461368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5848329|NCT02461368|Glucocorticoids|glucocorticoids|mesh-ancestor
5848330|NCT02461368|Hormones|hormones|mesh-ancestor
5848331|NCT02461368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5848332|NCT02461368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5848333|NCT02461368|Immunologic Factors|immunologic factors|mesh-ancestor
5848334|NCT02461368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5848335|NCT02461186|Piperaquine|piperaquine|mesh-list
5848336|NCT02461186|Artenimol|artenimol|mesh-list
5848337|NCT02461186|Antimalarials|antimalarials|mesh-ancestor
5848338|NCT02461186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5848339|NCT02461186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5848340|NCT02461186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5848341|NCT02461004|Ezetimibe|ezetimibe|mesh-list
5848342|NCT02461004|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5848343|NCT02461004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5848344|NCT02461004|Antimetabolites|antimetabolites|mesh-ancestor
5848345|NCT02461004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848346|NCT02461004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5848347|NCT02461056|Ibuprofen|ibuprofen|mesh-list
5848348|NCT02461056|Hydromorphone|hydromorphone|mesh-list
5848349|NCT02461056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5848350|NCT02461056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5848351|NCT02461056|Analgesics|analgesics|mesh-ancestor
5848352|NCT02461056|Sensory System Agents|sensory system agents|mesh-ancestor
5848353|NCT02461056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5848354|NCT02461056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848355|NCT02461056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5848356|NCT02461056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5848357|NCT02461056|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5848358|NCT02461056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5848359|NCT02461056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848360|NCT02461056|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5848361|NCT02461056|Narcotics|narcotics|mesh-ancestor
5848362|NCT02461056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6212100|NCT02181426|Sensory System Agents|sensory system agents|mesh-ancestor
5848363|NCT02461121|Cyclosporine|cyclosporine|mesh-list
5848364|NCT02461121|Mycophenolic Acid|mycophenolic acid|mesh-list
5666552|NCT03595397|Magnesium Sulfate|magnesium sulfate|mesh-list
5666553|NCT03595397|Fentanyl|fentanyl|mesh-list
5666554|NCT03595397|Bupivacaine|bupivacaine|mesh-list
5666555|NCT03595397|Anesthetics, Local|anesthetics, local|mesh-ancestor
5666556|NCT03595397|Anesthetics|anesthetics|mesh-ancestor
5666557|NCT03595397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5666558|NCT03595397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666559|NCT03595397|Sensory System Agents|sensory system agents|mesh-ancestor
5666560|NCT03595397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5666561|NCT03595397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5666562|NCT03595397|Narcotics|narcotics|mesh-ancestor
5666563|NCT03595397|Analgesics|analgesics|mesh-ancestor
5666564|NCT03595397|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5666565|NCT03595397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5666566|NCT03595397|Anesthetics, General|anesthetics, general|mesh-ancestor
5666567|NCT03595397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5666568|NCT03595397|Anticonvulsants|anticonvulsants|mesh-ancestor
5666569|NCT03595397|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5848365|NCT02461121|Cyclophosphamide|cyclophosphamide|mesh-list
5848366|NCT02461121|Fludarabine|fludarabine|mesh-list
5848367|NCT02461121|Cyclosporins|cyclosporins|mesh-list
5848368|NCT02461121|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5848369|NCT02461121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5848370|NCT02461121|Immunologic Factors|immunologic factors|mesh-ancestor
5666570|NCT03595397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5666571|NCT03595397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5666572|NCT03595397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5666573|NCT03595397|Tocolytic Agents|tocolytic agents|mesh-ancestor
5666574|NCT03595397|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5666575|NCT03595371|Dapansutrile|dapansutrile|mesh-list
5666576|NCT03595371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5666577|NCT03595319|Sevoflurane|sevoflurane|mesh-list
5666578|NCT03595319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5666579|NCT03595319|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5666580|NCT03595319|Anesthetics, General|anesthetics, general|mesh-ancestor
5666581|NCT03595319|Anesthetics|anesthetics|mesh-ancestor
5666582|NCT03595319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5666583|NCT03595319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666584|NCT03595254|Nicotine|nicotine|mesh-list
5666585|NCT03595254|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5666586|NCT03595254|Autonomic Agents|autonomic agents|mesh-ancestor
5666587|NCT03595254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5666588|NCT03595254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848371|NCT02461121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848372|NCT02461121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5848373|NCT02461121|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5848374|NCT02461121|Alkylating Agents|alkylating agents|mesh-ancestor
5848375|NCT02461121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848376|NCT02461121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6494014|NCT00616694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494015|NCT00616694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6494016|NCT00616720|Interferons|interferons|mesh-list
6494017|NCT00616720|Aldesleukin|aldesleukin|mesh-list
6494018|NCT00616720|Interferon-gamma|interferon-gamma|mesh-list
6494019|NCT00616720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6494020|NCT00616720|Antiviral Agents|antiviral agents|mesh-ancestor
5666589|NCT03595254|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5666590|NCT03595254|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5666591|NCT03595254|Cholinergic Agents|cholinergic agents|mesh-ancestor
5666592|NCT03595254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5666593|NCT03595254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5666594|NCT03595189|Cilastatin|cilastatin|mesh-list
5666595|NCT03595189|Protease Inhibitors|protease inhibitors|mesh-ancestor
5666596|NCT03595189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5666597|NCT03595189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5666598|NCT03595163|Folic Acid|folic acid|mesh-list
5666599|NCT03595163|Vitamin B Complex|vitamin b complex|mesh-list
5666600|NCT03595163|Propofol|propofol|mesh-list
5666601|NCT03595163|Sevoflurane|sevoflurane|mesh-list
5666602|NCT03595163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5666603|NCT03595163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5666604|NCT03595163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494021|NCT00616720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5666605|NCT03595163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5666606|NCT03595163|Anesthetics, General|anesthetics, general|mesh-ancestor
6674728|NCT01571037|Protective Agents|protective agents|mesh-ancestor
5666607|NCT03595163|Anesthetics|anesthetics|mesh-ancestor
5666608|NCT03595163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5666609|NCT03595163|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5666610|NCT03595163|Hematinics|hematinics|mesh-ancestor
5666611|NCT03595163|Vitamins|vitamins|mesh-ancestor
5666612|NCT03595163|Micronutrients|micronutrients|mesh-ancestor
5666613|NCT03595150|Diclofenac|diclofenac|mesh-list
5666614|NCT03595150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5666615|NCT03595150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6494022|NCT00616720|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6494023|NCT00616720|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6494024|NCT00616746|Ethanol|ethanol|mesh-list
6494025|NCT00616746|Nicotine|nicotine|mesh-list
6494026|NCT00616746|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6494027|NCT00616746|Autonomic Agents|autonomic agents|mesh-ancestor
6494028|NCT00616746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6494029|NCT00616746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494030|NCT00616746|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6494031|NCT00616746|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6494032|NCT00616746|Cholinergic Agents|cholinergic agents|mesh-ancestor
6494033|NCT00616746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5848377|NCT02461121|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5848378|NCT02461121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5848379|NCT02461121|Antifungal Agents|antifungal agents|mesh-ancestor
5848380|NCT02461121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5848381|NCT02461121|Dermatologic Agents|dermatologic agents|mesh-ancestor
5848382|NCT02461121|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5848383|NCT02461121|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5848384|NCT02461121|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5848385|NCT02461121|Antitubercular Agents|antitubercular agents|mesh-ancestor
5848386|NCT02461121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5848387|NCT02461043|Paclitaxel|paclitaxel|mesh-list
5848388|NCT02461043|Cisplatin|cisplatin|mesh-list
5848389|NCT02461043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5848390|NCT02461043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5848391|NCT02461043|Tubulin Modulators|tubulin modulators|mesh-ancestor
5848392|NCT02461043|Antimitotic Agents|antimitotic agents|mesh-ancestor
5848393|NCT02461043|Mitosis Modulators|mitosis modulators|mesh-ancestor
5848394|NCT02461043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848395|NCT02461069|Dimethyl Fumarate|dimethyl fumarate|mesh-list
5848396|NCT02461069|Dermatologic Agents|dermatologic agents|mesh-ancestor
5848397|NCT02461069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5848398|NCT02461069|Immunologic Factors|immunologic factors|mesh-ancestor
5848399|NCT02461069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848400|NCT02461030|Listerine|listerine|mesh-list
5848401|NCT02461030|Sodium Fluoride|sodium fluoride|mesh-list
5848402|NCT02461030|Cariostatic Agents|cariostatic agents|mesh-ancestor
5848403|NCT02461030|Protective Agents|protective agents|mesh-ancestor
5848404|NCT02461030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848405|NCT02461030|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5848406|NCT02461030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5848407|NCT02460913|Morphine|morphine|mesh-list
5848408|NCT02460913|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5848409|NCT02460913|Narcotics|narcotics|mesh-ancestor
5848410|NCT02460913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5848411|NCT02460913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848412|NCT02460913|Analgesics|analgesics|mesh-ancestor
5848413|NCT02460913|Sensory System Agents|sensory system agents|mesh-ancestor
5848414|NCT02460913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5848415|NCT02460874|Glyburide|glyburide|mesh-list
5848416|NCT02460874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5666616|NCT03595150|Analgesics|analgesics|mesh-ancestor
5666617|NCT03595150|Sensory System Agents|sensory system agents|mesh-ancestor
5666618|NCT03595150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5666619|NCT03595150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666620|NCT03595150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5666621|NCT03595150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5666622|NCT03595150|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5666623|NCT03595150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5666624|NCT03595150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5666625|NCT03595085|Streptokinase|streptokinase|mesh-list
5666626|NCT03595085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5666627|NCT03595085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5666628|NCT03595085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5666629|NCT03595046|Dexamethasone|dexamethasone|mesh-list
5666630|NCT03595046|Dexamethasone acetate|dexamethasone acetate|mesh-list
5848417|NCT02460874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494034|NCT00616746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848418|NCT02460887|Gemcitabine|gemcitabine|mesh-list
5848419|NCT02460887|Cisplatin|cisplatin|mesh-list
5848420|NCT02460887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5848421|NCT02460887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5848422|NCT02460887|Antimetabolites|antimetabolites|mesh-ancestor
5848423|NCT02460887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848424|NCT02460887|Antiviral Agents|antiviral agents|mesh-ancestor
5848425|NCT02460887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5848426|NCT02460887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5848427|NCT02460887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5848428|NCT02460887|Immunologic Factors|immunologic factors|mesh-ancestor
5848429|NCT02460887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848430|NCT02460497|Minoxidil|minoxidil|mesh-list
5848431|NCT02460497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5848432|NCT02460497|Vasodilator Agents|vasodilator agents|mesh-ancestor
5848433|NCT02460510|Mannitol|mannitol|mesh-list
5848434|NCT02460510|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5848435|NCT02460510|Diuretics|diuretics|mesh-ancestor
5848436|NCT02460510|Natriuretic Agents|natriuretic agents|mesh-ancestor
5848437|NCT02460510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848438|NCT02460588|Prednisolone|prednisolone|mesh-list
5848439|NCT02460588|Cyclophosphamide|cyclophosphamide|mesh-list
5848440|NCT02460588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5848441|NCT02460588|Immunologic Factors|immunologic factors|mesh-ancestor
5666631|NCT03595046|Ropivacaine|ropivacaine|mesh-list
5666632|NCT03595046|BB 1101|bb 1101|mesh-list
5666633|NCT03595046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5666634|NCT03595046|Antiemetics|antiemetics|mesh-ancestor
5666635|NCT03595046|Autonomic Agents|autonomic agents|mesh-ancestor
5848442|NCT02460588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848443|NCT02460588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5848444|NCT02460588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5848445|NCT02460588|Alkylating Agents|alkylating agents|mesh-ancestor
5848446|NCT02460588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848447|NCT02460588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5848448|NCT02460588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5848449|NCT02460588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5848450|NCT02460588|Glucocorticoids|glucocorticoids|mesh-ancestor
5848451|NCT02460588|Hormones|hormones|mesh-ancestor
5848452|NCT02460588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5848453|NCT02460588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5848454|NCT02460627|Lidocaine|lidocaine|mesh-list
5848455|NCT02460627|Anesthetics, Local|anesthetics, local|mesh-ancestor
5848456|NCT02460627|Anesthetics|anesthetics|mesh-ancestor
5848457|NCT02460627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5848458|NCT02460627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848459|NCT02460627|Sensory System Agents|sensory system agents|mesh-ancestor
5848460|NCT02460627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5848461|NCT02460627|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5848462|NCT02460627|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5848463|NCT02460627|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5848464|NCT02460627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5848465|NCT02460627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848466|NCT02460692|Dronabinol|dronabinol|mesh-list
5848467|NCT02460692|Hallucinogens|hallucinogens|mesh-ancestor
5848468|NCT02460692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848469|NCT02460692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5848470|NCT02460692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5848471|NCT02460692|Analgesics|analgesics|mesh-ancestor
5848472|NCT02460692|Sensory System Agents|sensory system agents|mesh-ancestor
5848473|NCT02460692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5848474|NCT02460692|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5848475|NCT02460692|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5848476|NCT02460692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5848477|NCT02460692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848478|NCT02460692|Hormones|hormones|mesh-ancestor
5848479|NCT02460692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5848480|NCT02460640|Morphine|morphine|mesh-list
5848481|NCT02460640|Ropivacaine|ropivacaine|mesh-list
5848482|NCT02460640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5848483|NCT02460640|Narcotics|narcotics|mesh-ancestor
5666636|NCT03595046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5666637|NCT03595046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666638|NCT03595046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5666639|NCT03595046|Glucocorticoids|glucocorticoids|mesh-ancestor
5666640|NCT03595046|Hormones|hormones|mesh-ancestor
5666641|NCT03595046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5666642|NCT03595046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5666643|NCT03595046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5666644|NCT03595046|Protease Inhibitors|protease inhibitors|mesh-ancestor
5666645|NCT03595046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5666646|NCT03595046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5666647|NCT03595046|Anesthetics, Local|anesthetics, local|mesh-ancestor
5666648|NCT03595046|Anesthetics|anesthetics|mesh-ancestor
5666649|NCT03595046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5666650|NCT03595046|Sensory System Agents|sensory system agents|mesh-ancestor
5666651|NCT03594968|Progesterone|progesterone|mesh-list
5666652|NCT03594968|Progestins|progestins|mesh-ancestor
5848484|NCT02460640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5848485|NCT02460640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848486|NCT02460640|Analgesics|analgesics|mesh-ancestor
5848487|NCT02460640|Sensory System Agents|sensory system agents|mesh-ancestor
5848488|NCT02460640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5848489|NCT02460640|Anesthetics, Local|anesthetics, local|mesh-ancestor
5848490|NCT02460640|Anesthetics|anesthetics|mesh-ancestor
5903860|NCT04299880|Paclitaxel|paclitaxel|mesh-list
5903861|NCT04299880|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5903862|NCT04299880|Bevacizumab|bevacizumab|mesh-list
5903863|NCT04299880|Fluorouracil|fluorouracil|mesh-list
5666653|NCT03594968|Hormones|hormones|mesh-ancestor
5666654|NCT03594968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5666655|NCT03594968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666656|NCT03594825|Valsartan|valsartan|mesh-list
5666657|NCT03594825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5903864|NCT04299880|Nivolumab|nivolumab|mesh-list
5903865|NCT04299880|Irinotecan|irinotecan|mesh-list
5903866|NCT04299880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5903867|NCT04299880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5903868|NCT04299880|Tubulin Modulators|tubulin modulators|mesh-ancestor
5903869|NCT04299880|Antimitotic Agents|antimitotic agents|mesh-ancestor
5903870|NCT04299880|Mitosis Modulators|mitosis modulators|mesh-ancestor
5903871|NCT04299880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903872|NCT04299880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5903873|NCT04299880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5903874|NCT04299880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5903875|NCT04299880|Growth Substances|growth substances|mesh-ancestor
5903876|NCT04299880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903877|NCT04299880|Growth Inhibitors|growth inhibitors|mesh-ancestor
5903878|NCT04299880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6494035|NCT00616746|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6494036|NCT00616746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6494037|NCT00616746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6494038|NCT00616785|Irinotecan|irinotecan|mesh-list
6494039|NCT00616785|Etoposide|etoposide|mesh-list
6494040|NCT00616785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5666658|NCT03594825|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5666659|NCT03594825|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5666660|NCT03594825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5666661|NCT03594604|Contraceptive Agents|contraceptive agents|mesh-list
5666662|NCT03594604|Norethindrone|norethindrone|mesh-list
5666663|NCT03594604|Norethindrone Acetate|norethindrone acetate|mesh-list
5666664|NCT03594604|Contraceptives, Oral|contraceptives, oral|mesh-list
5666665|NCT03594604|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
5666666|NCT03594604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5666667|NCT03594604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666668|NCT03594604|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5666669|NCT03594604|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5666670|NCT03594604|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5666671|NCT03594604|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5666672|NCT03594591|Hypoglycemic Agents|hypoglycemic agents|mesh-list
5666673|NCT03594591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666674|NCT03594565|Fluticasone|fluticasone|mesh-list
5666675|NCT03594565|Xhance|xhance|mesh-list
5666676|NCT03594565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5666677|NCT03594565|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5666678|NCT03594565|Autonomic Agents|autonomic agents|mesh-ancestor
5666679|NCT03594565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5666680|NCT03594565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666681|NCT03594565|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5903879|NCT04299880|Antimetabolites|antimetabolites|mesh-ancestor
5848491|NCT02460419|Capecitabine|capecitabine|mesh-list
5848492|NCT02460419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5848493|NCT02460419|Antimetabolites|antimetabolites|mesh-ancestor
5848494|NCT02460419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848495|NCT02460419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5848496|NCT02460276|Rituximab|rituximab|mesh-list
5848497|NCT02460276|Lenalidomide|lenalidomide|mesh-list
5848498|NCT02460276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5848499|NCT02460276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5848500|NCT02460276|Immunologic Factors|immunologic factors|mesh-ancestor
5848501|NCT02460276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848502|NCT02460276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5848503|NCT02460276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5848504|NCT02460276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5848505|NCT02460276|Growth Substances|growth substances|mesh-ancestor
5848506|NCT02460276|Growth Inhibitors|growth inhibitors|mesh-ancestor
5848507|NCT02460432|Paclitaxel|paclitaxel|mesh-list
5848508|NCT02460432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5848509|NCT02460432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5848510|NCT02460432|Tubulin Modulators|tubulin modulators|mesh-ancestor
5848511|NCT02460432|Antimitotic Agents|antimitotic agents|mesh-ancestor
5848512|NCT02460432|Mitosis Modulators|mitosis modulators|mesh-ancestor
5848513|NCT02460432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848514|NCT02460289|Minoxidil|minoxidil|mesh-list
5848515|NCT02460289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5848516|NCT02460289|Vasodilator Agents|vasodilator agents|mesh-ancestor
5848517|NCT02460393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5848518|NCT02460393|Antibodies|antibodies|mesh-list
5848519|NCT02460393|Immunoglobulins|immunoglobulins|mesh-list
5848520|NCT02460393|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5848521|NCT02460393|Immunologic Factors|immunologic factors|mesh-ancestor
5848522|NCT02460393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848523|NCT02460393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5848524|NCT02460354|Metformin|metformin|mesh-list
5848525|NCT02460354|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5848526|NCT02460354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848527|NCT02460367|Docetaxel|docetaxel|mesh-list
5848528|NCT02460367|Tryptophan|tryptophan|mesh-list
5848529|NCT02460367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5848530|NCT02460367|Tubulin Modulators|tubulin modulators|mesh-ancestor
5848531|NCT02460367|Antimitotic Agents|antimitotic agents|mesh-ancestor
5848532|NCT02460367|Mitosis Modulators|mitosis modulators|mesh-ancestor
5848533|NCT02460367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848534|NCT02460367|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5848535|NCT02460367|Antidepressive Agents|antidepressive agents|mesh-ancestor
5848536|NCT02460367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5848537|NCT02460211|Vitamin D|vitamin d|mesh-list
5848538|NCT02460211|Cholecalciferol|cholecalciferol|mesh-list
5848539|NCT02460211|Vitamins|vitamins|mesh-ancestor
5848540|NCT02460211|Micronutrients|micronutrients|mesh-ancestor
5848541|NCT02460211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848542|NCT02460211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5848543|NCT02460211|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5848544|NCT02460341|Ondansetron|ondansetron|mesh-list
5848545|NCT02460341|Antiemetics|antiemetics|mesh-ancestor
5848546|NCT02460341|Autonomic Agents|autonomic agents|mesh-ancestor
5848547|NCT02460341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5848548|NCT02460341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848549|NCT02460341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5848550|NCT02460341|Antipruritics|antipruritics|mesh-ancestor
5848551|NCT02460341|Dermatologic Agents|dermatologic agents|mesh-ancestor
5848552|NCT02460341|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5848553|NCT02460341|Serotonin Agents|serotonin agents|mesh-ancestor
5848554|NCT02460341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5848555|NCT02460341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848556|NCT02460341|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5848557|NCT02460341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5848558|NCT02460341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5848559|NCT02460341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5848560|NCT02460341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5848561|NCT02460107|Botulinum Toxins|botulinum toxins|mesh-list
5848562|NCT02460107|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5848563|NCT02460107|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5848564|NCT02460107|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5848565|NCT02460107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5848566|NCT02460107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848567|NCT02460107|Cholinergic Agents|cholinergic agents|mesh-ancestor
5848568|NCT02460107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5848569|NCT02460107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848570|NCT02460107|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5848571|NCT02460107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5848572|NCT02460133|Ritonavir|ritonavir|mesh-list
5848573|NCT02460133|Ribavirin|ribavirin|mesh-list
5848574|NCT02460133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5848575|NCT02460133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5848576|NCT02460133|Protease Inhibitors|protease inhibitors|mesh-ancestor
5848577|NCT02460133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5848578|NCT02460133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848579|NCT02460133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5848580|NCT02460133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5666682|NCT03594565|Respiratory System Agents|respiratory system agents|mesh-ancestor
5666683|NCT03594565|Dermatologic Agents|dermatologic agents|mesh-ancestor
5666684|NCT03594565|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5666685|NCT03594552|Baclofen|baclofen|mesh-list
5666686|NCT03594552|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5666687|NCT03594552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666688|NCT03594552|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5666689|NCT03594552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5666690|NCT03594552|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
5666691|NCT03594552|GABA Agonists|gaba agonists|mesh-ancestor
5666692|NCT03594552|GABA Agents|gaba agents|mesh-ancestor
5666693|NCT03594552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5666694|NCT03594552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5666695|NCT03594513|Dipyrone|dipyrone|mesh-list
5666696|NCT03594513|Chlorhexidine|chlorhexidine|mesh-list
5666697|NCT03594513|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5666698|NCT03594513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5666699|NCT03594513|Disinfectants|disinfectants|mesh-ancestor
5666700|NCT03594513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5666701|NCT03594513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5666702|NCT03594513|Analgesics|analgesics|mesh-ancestor
5848581|NCT02460133|Antiviral Agents|antiviral agents|mesh-ancestor
5848582|NCT02460133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5848583|NCT02460133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5848584|NCT02460133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5848585|NCT02460133|Antimetabolites|antimetabolites|mesh-ancestor
5848586|NCT02460146|CXA-10|cxa-10|mesh-list
5848587|NCT02460146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5848588|NCT02460302|Progesterone|progesterone|mesh-list
5848589|NCT02460302|Progestins|progestins|mesh-ancestor
5848590|NCT02460302|Hormones|hormones|mesh-ancestor
5848591|NCT02460302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5848592|NCT02460302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848593|NCT02460068|Nivolumab|nivolumab|mesh-list
5848594|NCT02460068|Ipilimumab|ipilimumab|mesh-list
5848595|NCT02460068|Fotemustine|fotemustine|mesh-list
5848596|NCT02460068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5848597|NCT02460068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5666703|NCT03594513|Sensory System Agents|sensory system agents|mesh-ancestor
5666704|NCT03594513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5666705|NCT03594513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666706|NCT03594513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5666707|NCT03594513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5666708|NCT03594513|Antipyretics|antipyretics|mesh-ancestor
5666709|NCT03594461|Aflibercept|aflibercept|mesh-list
5666710|NCT03594461|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5666711|NCT03594461|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5666712|NCT03594461|Growth Substances|growth substances|mesh-ancestor
5666713|NCT03594461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666714|NCT03594461|Growth Inhibitors|growth inhibitors|mesh-ancestor
5666715|NCT03594461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5666716|NCT03594435|Ibudilast|ibudilast|mesh-list
5666717|NCT03594435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5666718|NCT03594435|Autonomic Agents|autonomic agents|mesh-ancestor
5666719|NCT03594435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5666720|NCT03594435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666721|NCT03594435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5666722|NCT03594435|Respiratory System Agents|respiratory system agents|mesh-ancestor
5666723|NCT03594435|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5666724|NCT03594435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5666725|NCT03594435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5666726|NCT03594435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5848598|NCT02460068|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5848599|NCT02460068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848600|NCT02459977|Basiliximab|basiliximab|mesh-list
5848601|NCT02459977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5848602|NCT02459977|Immunologic Factors|immunologic factors|mesh-ancestor
5848603|NCT02459977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848604|NCT02459938|Glucagon|glucagon|mesh-list
5848605|NCT02459938|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5848606|NCT02459938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5848607|NCT02459938|Hormones|hormones|mesh-ancestor
5848608|NCT02459938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5848609|NCT02459938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848610|NCT02459938|Incretins|incretins|mesh-ancestor
5848611|NCT02460055|Dexamethasone|dexamethasone|mesh-list
5848612|NCT02460055|Fentanyl|fentanyl|mesh-list
5848613|NCT02460055|Nitrous Oxide|nitrous oxide|mesh-list
5848614|NCT02460055|Ondansetron|ondansetron|mesh-list
5848615|NCT02460055|Propofol|propofol|mesh-list
5666727|NCT03594435|Vasodilator Agents|vasodilator agents|mesh-ancestor
5666728|NCT03594396|Durvalumab|durvalumab|mesh-list
5666729|NCT03594396|Olaparib|olaparib|mesh-list
5666730|NCT03594396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5666731|NCT03594396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5848616|NCT02460055|Sevoflurane|sevoflurane|mesh-list
5848617|NCT02460055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5848618|NCT02460055|Antiemetics|antiemetics|mesh-ancestor
5848619|NCT02460055|Autonomic Agents|autonomic agents|mesh-ancestor
5848620|NCT02460055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5848621|NCT02460055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848622|NCT02460055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5848623|NCT02460055|Glucocorticoids|glucocorticoids|mesh-ancestor
5666732|NCT03594396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5666733|NCT03594396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5666734|NCT03594396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848624|NCT02460055|Hormones|hormones|mesh-ancestor
5848625|NCT02460055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5848626|NCT02460055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5848627|NCT02460055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5848628|NCT02460055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5848629|NCT02460055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5848630|NCT02460055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5848631|NCT02460055|Anesthetics, General|anesthetics, general|mesh-ancestor
5848632|NCT02460055|Anesthetics|anesthetics|mesh-ancestor
5848633|NCT02460055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5848634|NCT02460055|Narcotics|narcotics|mesh-ancestor
5848635|NCT02460055|Analgesics|analgesics|mesh-ancestor
5848636|NCT02460055|Sensory System Agents|sensory system agents|mesh-ancestor
5848637|NCT02460055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5848638|NCT02460055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5848639|NCT02460055|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5848640|NCT02460055|Antipruritics|antipruritics|mesh-ancestor
5848641|NCT02460055|Dermatologic Agents|dermatologic agents|mesh-ancestor
5848642|NCT02460055|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5848643|NCT02460055|Serotonin Agents|serotonin agents|mesh-ancestor
5666735|NCT03594240|Folic Acid|folic acid|mesh-list
5666736|NCT03594240|Vitamin B Complex|vitamin b complex|mesh-list
5666737|NCT03594240|Vitamins|vitamins|mesh-ancestor
5666738|NCT03594240|Micronutrients|micronutrients|mesh-ancestor
5666739|NCT03594240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666740|NCT03594240|Hematinics|hematinics|mesh-ancestor
5666741|NCT03594214|Vitamin D|vitamin d|mesh-list
5666742|NCT03594214|Vitamins|vitamins|mesh-ancestor
5666743|NCT03594214|Micronutrients|micronutrients|mesh-ancestor
5666744|NCT03594214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666745|NCT03594214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5666746|NCT03594188|Anesthetics|anesthetics|mesh-list
5666747|NCT03594188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5666748|NCT03594188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666749|NCT03594175|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5666750|NCT03594175|Reteplase|reteplase|mesh-list
5666751|NCT03594175|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5666752|NCT03594175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5666753|NCT03594175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5666754|NCT03594149|Levofloxacin|levofloxacin|mesh-list
5666755|NCT03594149|Ofloxacin|ofloxacin|mesh-list
5848644|NCT02460055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5848645|NCT02460055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5666756|NCT03594149|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5848646|NCT02460055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5848647|NCT02460055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5848648|NCT02460055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5848649|NCT02460055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5848650|NCT02460055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5848651|NCT02460042|Paclitaxel|paclitaxel|mesh-list
5848652|NCT02460042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5848653|NCT02460042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5848654|NCT02460042|Tubulin Modulators|tubulin modulators|mesh-ancestor
5848655|NCT02460042|Antimitotic Agents|antimitotic agents|mesh-ancestor
5848656|NCT02460042|Mitosis Modulators|mitosis modulators|mesh-ancestor
5848657|NCT02460042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848658|NCT02459782|Anesthetics|anesthetics|mesh-list
5848659|NCT02459782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5848660|NCT02459782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848661|NCT02460016|Ziresovir|ziresovir|mesh-list
5848662|NCT02460016|Antiviral Agents|antiviral agents|mesh-ancestor
5848663|NCT02460016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5848664|NCT02459600|Cyclopentolate|cyclopentolate|mesh-list
5848665|NCT02459600|Mydriatics|mydriatics|mesh-ancestor
5848666|NCT02459600|Autonomic Agents|autonomic agents|mesh-ancestor
5848667|NCT02459600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5848668|NCT02459600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848669|NCT02459600|Parasympatholytics|parasympatholytics|mesh-ancestor
5848670|NCT02459600|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5848671|NCT02459600|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5848672|NCT02459600|Cholinergic Agents|cholinergic agents|mesh-ancestor
5848673|NCT02459600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5848674|NCT02459600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848675|NCT02459509|Dexmedetomidine|dexmedetomidine|mesh-list
5848676|NCT02459509|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5848677|NCT02459509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5848678|NCT02459509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848679|NCT02459509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5666757|NCT03594149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5666758|NCT03594149|Renal Agents|renal agents|mesh-ancestor
5848680|NCT02459509|Analgesics|analgesics|mesh-ancestor
5848681|NCT02459509|Sensory System Agents|sensory system agents|mesh-ancestor
5848682|NCT02459509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5848683|NCT02459509|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5848684|NCT02459509|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5848685|NCT02459509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5848686|NCT02459509|Adrenergic Agents|adrenergic agents|mesh-ancestor
5848687|NCT02459509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5848688|NCT02459509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848689|NCT02459613|Annexin A5|annexin a5|mesh-list
5848690|NCT02459613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5848691|NCT02459613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848692|NCT02459756|Ascorbic Acid|ascorbic acid|mesh-list
5848693|NCT02459756|Citric Acid|citric acid|mesh-list
5848694|NCT02459756|Sodium Citrate|sodium citrate|mesh-list
5848695|NCT02459756|Vitamins|vitamins|mesh-ancestor
5848696|NCT02459756|Micronutrients|micronutrients|mesh-ancestor
5848697|NCT02459756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848698|NCT02459756|Antioxidants|antioxidants|mesh-ancestor
5666759|NCT03594149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5666760|NCT03594149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5666761|NCT03594149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5666762|NCT03594149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5666763|NCT03594149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5666764|NCT03594149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5666765|NCT03594149|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5666766|NCT03594149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5666767|NCT03593954|Ritonavir|ritonavir|mesh-list
5666768|NCT03593954|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5666769|NCT03593954|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5666770|NCT03593954|Protease Inhibitors|protease inhibitors|mesh-ancestor
5666771|NCT03593954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5666772|NCT03593954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5666773|NCT03593954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5666774|NCT03593954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5666775|NCT03593954|Antiviral Agents|antiviral agents|mesh-ancestor
5666776|NCT03593954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5903880|NCT04299880|Antiviral Agents|antiviral agents|mesh-ancestor
6674729|NCT01571037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674730|NCT01571050|Calcium Carbonate|calcium carbonate|mesh-list
6674731|NCT01571050|Antacids|antacids|mesh-ancestor
6674732|NCT01571050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674733|NCT01571050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6674734|NCT01571063|Vitamin D|vitamin d|mesh-list
6674735|NCT01571063|Cholecalciferol|cholecalciferol|mesh-list
6674736|NCT01571063|Vitamins|vitamins|mesh-ancestor
6674737|NCT01571063|Micronutrients|micronutrients|mesh-ancestor
6674738|NCT01571063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666777|NCT03593954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5666778|NCT03593954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5695764|NCT03387241|Respiratory System Agents|respiratory system agents|mesh-ancestor
5695765|NCT03387241|Dermatologic Agents|dermatologic agents|mesh-ancestor
5695766|NCT03387241|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5695767|NCT03387241|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5695768|NCT03387241|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5695769|NCT03387241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5695770|NCT03387241|Adrenergic Agents|adrenergic agents|mesh-ancestor
5695771|NCT03387241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5695772|NCT03387241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695773|NCT03387241|Glucocorticoids|glucocorticoids|mesh-ancestor
5848699|NCT02459756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848700|NCT02459756|Protective Agents|protective agents|mesh-ancestor
5848701|NCT02459756|Anticoagulants|anticoagulants|mesh-ancestor
5848702|NCT02459756|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5848703|NCT02459756|Chelating Agents|chelating agents|mesh-ancestor
5848704|NCT02459756|Sequestering Agents|sequestering agents|mesh-ancestor
5848705|NCT02459574|Amiodarone|amiodarone|mesh-list
5848706|NCT02459574|Sotalol|sotalol|mesh-list
5848707|NCT02459574|Flecainide|flecainide|mesh-list
5848708|NCT02459574|Propafenone|propafenone|mesh-list
5848709|NCT02459574|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
5848710|NCT02459574|Calcium Channel Blockers|calcium channel blockers|mesh-list
5848711|NCT02459574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5848712|NCT02459574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848713|NCT02459574|Vasodilator Agents|vasodilator agents|mesh-ancestor
5848714|NCT02459574|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5848715|NCT02459574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5848716|NCT02459574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848717|NCT02459574|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5848718|NCT02459574|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5848719|NCT02459574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5848720|NCT02459574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5848721|NCT02459574|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5848722|NCT02459574|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5848723|NCT02459574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5848724|NCT02459574|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5848725|NCT02459574|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5848726|NCT02459574|Adrenergic Agents|adrenergic agents|mesh-ancestor
5848727|NCT02459574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5848728|NCT02459574|Sympatholytics|sympatholytics|mesh-ancestor
5848729|NCT02459574|Autonomic Agents|autonomic agents|mesh-ancestor
5848730|NCT02459574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5848731|NCT02459574|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5848732|NCT02459288|Clopidogrel|clopidogrel|mesh-list
5848733|NCT02459288|Ticagrelor|ticagrelor|mesh-list
5848734|NCT02459288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5848735|NCT02459288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5848736|NCT02459288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5848737|NCT02459288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5848738|NCT02459288|Purinergic Agents|purinergic agents|mesh-ancestor
5848739|NCT02459288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5848740|NCT02459288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695774|NCT03387241|Hormones|hormones|mesh-ancestor
5695775|NCT03387241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5695776|NCT03387241|Sympathomimetics|sympathomimetics|mesh-ancestor
5848741|NCT02459288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848742|NCT02459353|Dapagliflozin|dapagliflozin|mesh-list
5848743|NCT02459353|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5848744|NCT02459353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848745|NCT02459353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5848746|NCT02459353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848747|NCT02458963|Menotropins|menotropins|mesh-list
5848748|NCT02458963|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5848749|NCT02458963|Fertility Agents|fertility agents|mesh-ancestor
5848750|NCT02458963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5848751|NCT02458963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848752|NCT02458742|Morphine|morphine|mesh-list
5848753|NCT02458742|Bupivacaine|bupivacaine|mesh-list
5848754|NCT02458742|Anesthetics, Local|anesthetics, local|mesh-ancestor
5848755|NCT02458742|Anesthetics|anesthetics|mesh-ancestor
5848756|NCT02458742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5848757|NCT02458742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848758|NCT02458742|Sensory System Agents|sensory system agents|mesh-ancestor
5848759|NCT02458742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5848760|NCT02458742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5848761|NCT02458742|Narcotics|narcotics|mesh-ancestor
5848762|NCT02458742|Analgesics|analgesics|mesh-ancestor
5848763|NCT02458755|Atorvastatin|atorvastatin|mesh-list
5848764|NCT02458755|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5848765|NCT02458755|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5848766|NCT02458755|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5848767|NCT02458755|Antimetabolites|antimetabolites|mesh-ancestor
5848768|NCT02458755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848769|NCT02458755|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5848770|NCT02458755|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5848771|NCT02458755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5848772|NCT02458924|Niacin|niacin|mesh-list
5848773|NCT02458924|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5848774|NCT02458924|Antimetabolites|antimetabolites|mesh-ancestor
5848775|NCT02458924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848776|NCT02458924|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5848777|NCT02458924|Vasodilator Agents|vasodilator agents|mesh-ancestor
5848778|NCT02458924|Vitamin B Complex|vitamin b complex|mesh-ancestor
5666779|NCT03593811|Cyproheptadine|cyproheptadine|mesh-list
5666780|NCT03593811|Ondansetron|ondansetron|mesh-list
5666781|NCT03593811|Antiemetics|antiemetics|mesh-ancestor
5666782|NCT03593811|Autonomic Agents|autonomic agents|mesh-ancestor
5666783|NCT03593811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5666784|NCT03593811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848779|NCT02458924|Vitamins|vitamins|mesh-ancestor
5848780|NCT02458924|Micronutrients|micronutrients|mesh-ancestor
5848781|NCT02458924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903881|NCT04299880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5903882|NCT04299880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5903883|NCT04299880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5903884|NCT04299880|Immunologic Factors|immunologic factors|mesh-ancestor
5903885|NCT04299880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5903886|NCT04299880|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5903887|NCT04299880|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5903888|NCT04299880|Antidotes|antidotes|mesh-ancestor
5903889|NCT04299880|Protective Agents|protective agents|mesh-ancestor
5903890|NCT04299880|Vitamin B Complex|vitamin b complex|mesh-ancestor
5903891|NCT04299880|Vitamins|vitamins|mesh-ancestor
5903892|NCT04299880|Micronutrients|micronutrients|mesh-ancestor
5666785|NCT03593811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5666786|NCT03593811|Antipruritics|antipruritics|mesh-ancestor
5666787|NCT03593811|Dermatologic Agents|dermatologic agents|mesh-ancestor
5666788|NCT03593811|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5666789|NCT03593811|Serotonin Agents|serotonin agents|mesh-ancestor
5666790|NCT03593811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5666791|NCT03593811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5666792|NCT03593811|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5666793|NCT03593811|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5666794|NCT03593811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5666795|NCT03593811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5666796|NCT03593811|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5666797|NCT03593811|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5666798|NCT03593811|Histamine Antagonists|histamine antagonists|mesh-ancestor
5666799|NCT03593811|Histamine Agents|histamine agents|mesh-ancestor
5666800|NCT03593811|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5666801|NCT03593707|Metformin|metformin|mesh-list
5666802|NCT03593707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5666803|NCT03593707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666804|NCT03593668|Metformin|metformin|mesh-list
5666805|NCT03593668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5666806|NCT03593668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666807|NCT03593473|Oxytocin|oxytocin|mesh-list
5666808|NCT03593473|Oxytocics|oxytocics|mesh-ancestor
5848782|NCT02459158|Arbekacin|arbekacin|mesh-list
5848783|NCT02459158|Dibekacin|dibekacin|mesh-list
5848784|NCT02459158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5848785|NCT02459158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5848786|NCT02459158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5848787|NCT02458716|Leuprolide|leuprolide|mesh-list
5848788|NCT02458716|Bicalutamide|bicalutamide|mesh-list
5848789|NCT02458716|Androgens|androgens|mesh-list
5848790|NCT02458716|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
5848791|NCT02458716|Hormones|hormones|mesh-ancestor
5848792|NCT02458716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5848793|NCT02458716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848794|NCT02458716|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5848795|NCT02458716|Fertility Agents|fertility agents|mesh-ancestor
5848796|NCT02458716|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5848797|NCT02458716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5848798|NCT02458716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5848799|NCT02458716|Androgen Antagonists|androgen antagonists|mesh-ancestor
5848800|NCT02458716|Hormone Antagonists|hormone antagonists|mesh-ancestor
5848801|NCT02458911|Paclitaxel|paclitaxel|mesh-list
5848802|NCT02458911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5848803|NCT02458911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5848804|NCT02458911|Tubulin Modulators|tubulin modulators|mesh-ancestor
5848805|NCT02458911|Antimitotic Agents|antimitotic agents|mesh-ancestor
5848806|NCT02458911|Mitosis Modulators|mitosis modulators|mesh-ancestor
5848807|NCT02458911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848808|NCT02458781|Metronidazole|metronidazole|mesh-list
5848809|NCT02458781|Ciprofloxacin|ciprofloxacin|mesh-list
5848810|NCT02458781|Fluoroquinolones|fluoroquinolones|mesh-list
5848811|NCT02458781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5848812|NCT02458781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5848813|NCT02458781|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5848814|NCT02458781|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5848815|NCT02458781|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5848816|NCT02458781|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5848817|NCT02458781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5848818|NCT02458781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848819|NCT02458781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5848820|NCT02458781|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5848821|NCT02458781|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5848822|NCT02458781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5848823|NCT02458729|Tranylcypromine|tranylcypromine|mesh-list
5848824|NCT02458729|Rivaroxaban|rivaroxaban|mesh-list
5848825|NCT02458729|Tranexamic Acid|tranexamic acid|mesh-list
5848826|NCT02458729|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5848827|NCT02458729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5848828|NCT02458729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848829|NCT02458729|Hemostatics|hemostatics|mesh-ancestor
5848830|NCT02458729|Coagulants|coagulants|mesh-ancestor
5848831|NCT02458729|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5848832|NCT02458729|Antithrombins|antithrombins|mesh-ancestor
5848833|NCT02458729|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5848834|NCT02458729|Protease Inhibitors|protease inhibitors|mesh-ancestor
5848835|NCT02458729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5848836|NCT02458729|Anticoagulants|anticoagulants|mesh-ancestor
5848837|NCT02458729|Antidepressive Agents|antidepressive agents|mesh-ancestor
5848838|NCT02458729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5848839|NCT02458729|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
5848840|NCT02458729|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5848841|NCT02458729|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5848842|NCT02458729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5666809|NCT03593473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5848843|NCT02458729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848844|NCT02458547|Bupivacaine|bupivacaine|mesh-list
5848845|NCT02458547|Propofol|propofol|mesh-list
5666810|NCT03593473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666811|NCT03593447|Ribavirin|ribavirin|mesh-list
5666812|NCT03593447|Yimitasvir|yimitasvir|mesh-list
5666813|NCT03593447|Antimetabolites|antimetabolites|mesh-ancestor
5666814|NCT03593447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5666815|NCT03593447|Antiviral Agents|antiviral agents|mesh-ancestor
5666816|NCT03593447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5666817|NCT03593434|Xenon|xenon|mesh-list
5666818|NCT03593434|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5666819|NCT03593434|Anesthetics, General|anesthetics, general|mesh-ancestor
5666820|NCT03593434|Anesthetics|anesthetics|mesh-ancestor
5666821|NCT03593434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5695777|NCT03387163|Valsartan|valsartan|mesh-list
5666822|NCT03593434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848846|NCT02458547|Desflurane|desflurane|mesh-list
6494041|NCT00616785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6494042|NCT00616785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6494043|NCT00616785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6494044|NCT00616785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494045|NCT00616785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6494046|NCT00616785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6494047|NCT00616850|Lidocaine|lidocaine|mesh-list
6494048|NCT00616850|Anesthetics, Local|anesthetics, local|mesh-ancestor
6494049|NCT00616850|Anesthetics|anesthetics|mesh-ancestor
6494050|NCT00616850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6494051|NCT00616850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848847|NCT02458547|Anesthetics, Local|anesthetics, local|mesh-ancestor
5848848|NCT02458547|Anesthetics|anesthetics|mesh-ancestor
5848849|NCT02458547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5848850|NCT02458547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494052|NCT00616850|Sensory System Agents|sensory system agents|mesh-ancestor
5666823|NCT03593408|Fentanyl|fentanyl|mesh-list
5666824|NCT03593408|Midazolam|midazolam|mesh-list
5666825|NCT03593408|Dexmedetomidine|dexmedetomidine|mesh-list
5666826|NCT03593408|Morphine|morphine|mesh-list
5666827|NCT03593408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5666828|NCT03593408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5666829|NCT03593408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666830|NCT03593408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5666831|NCT03593408|Analgesics|analgesics|mesh-ancestor
5666832|NCT03593408|Sensory System Agents|sensory system agents|mesh-ancestor
5666833|NCT03593408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6212101|NCT02181426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6212102|NCT02181426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212103|NCT02181426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6212104|NCT02181426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6212105|NCT02181426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6212106|NCT02181426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6212107|NCT02181426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212108|NCT02181504|Ranibizumab|ranibizumab|mesh-list
6212109|NCT02181504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6212110|NCT02181504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5848851|NCT02458547|Sensory System Agents|sensory system agents|mesh-ancestor
5848852|NCT02458547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5848853|NCT02458547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5848854|NCT02458547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5848855|NCT02458547|Anesthetics, General|anesthetics, general|mesh-ancestor
5848856|NCT02458547|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5848857|NCT02458625|Iron|iron|mesh-list
5848858|NCT02458625|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
5848859|NCT02458625|Trace Elements|trace elements|mesh-ancestor
5848860|NCT02458625|Micronutrients|micronutrients|mesh-ancestor
5848861|NCT02458625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848862|NCT02458625|Hematinics|hematinics|mesh-ancestor
5848863|NCT02458482|Albuterol|albuterol|mesh-list
5848864|NCT02458482|Ipratropium|ipratropium|mesh-list
5848865|NCT02458482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5848866|NCT02458482|Autonomic Agents|autonomic agents|mesh-ancestor
5848867|NCT02458482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5848868|NCT02458482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848869|NCT02458482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5848870|NCT02458482|Respiratory System Agents|respiratory system agents|mesh-ancestor
5848871|NCT02458482|Tocolytic Agents|tocolytic agents|mesh-ancestor
5848872|NCT02458482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5848873|NCT02458482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5848874|NCT02458482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5848875|NCT02458482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5848876|NCT02458482|Adrenergic Agents|adrenergic agents|mesh-ancestor
5848877|NCT02458482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5848878|NCT02458482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848879|NCT02458482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5848880|NCT02458482|Cholinergic Agents|cholinergic agents|mesh-ancestor
5848881|NCT02458339|Methotrexate|methotrexate|mesh-list
5848882|NCT02458339|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5848883|NCT02458339|Abortifacient Agents|abortifacient agents|mesh-ancestor
5848884|NCT02458339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5848885|NCT02458339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848886|NCT02458339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5848887|NCT02458339|Antimetabolites|antimetabolites|mesh-ancestor
5848888|NCT02458339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848889|NCT02458339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5848890|NCT02458339|Dermatologic Agents|dermatologic agents|mesh-ancestor
5848891|NCT02458339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5848892|NCT02458339|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5848893|NCT02458339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5848894|NCT02458339|Immunologic Factors|immunologic factors|mesh-ancestor
5848895|NCT02458339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5666834|NCT03593408|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5666835|NCT03593408|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5666836|NCT03593408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5666837|NCT03593408|Adrenergic Agents|adrenergic agents|mesh-ancestor
5666838|NCT03593408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5666839|NCT03593408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5666840|NCT03593408|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5666841|NCT03593408|Narcotics|narcotics|mesh-ancestor
5666842|NCT03593408|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5848896|NCT02458339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5848897|NCT02458209|Bococizumab|bococizumab|mesh-list
5848898|NCT02458209|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5848899|NCT02458209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5848900|NCT02458209|Antimetabolites|antimetabolites|mesh-ancestor
5848901|NCT02458209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848902|NCT02458209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5848903|NCT02458014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5666843|NCT03593408|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5666844|NCT03593408|Anesthetics, General|anesthetics, general|mesh-ancestor
5666845|NCT03593408|Anesthetics|anesthetics|mesh-ancestor
5666846|NCT03593408|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5666847|NCT03593408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5666848|NCT03593408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5666849|NCT03593408|GABA Modulators|gaba modulators|mesh-ancestor
5666850|NCT03593408|GABA Agents|gaba agents|mesh-ancestor
5666851|NCT03593317|Spironolactone|spironolactone|mesh-list
5666852|NCT03593317|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5666853|NCT03593317|Hormone Antagonists|hormone antagonists|mesh-ancestor
5666854|NCT03593317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5666855|NCT03593317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666856|NCT03593317|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5848904|NCT02458014|Blinatumomab|blinatumomab|mesh-list
5848905|NCT02458014|Antibodies|antibodies|mesh-list
5848906|NCT02458014|Immunoglobulins|immunoglobulins|mesh-list
5848907|NCT02458014|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5848908|NCT02458014|Muromonab-CD3|muromonab-cd3|mesh-list
5848909|NCT02458014|Antibodies, Bispecific|antibodies, bispecific|mesh-list
5848910|NCT02458014|Immunologic Factors|immunologic factors|mesh-ancestor
5848911|NCT02458014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848912|NCT02458014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5848913|NCT02458014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5848914|NCT02458183|Vaccines|vaccines|mesh-list
5666857|NCT03593317|Diuretics|diuretics|mesh-ancestor
5666858|NCT03593317|Natriuretic Agents|natriuretic agents|mesh-ancestor
5666859|NCT03593304|Vitamins|vitamins|mesh-list
5666860|NCT03593304|Vitamin B 12|vitamin b 12|mesh-list
5666861|NCT03593304|Pyridoxine|pyridoxine|mesh-list
5666862|NCT03593304|Pyridoxal|pyridoxal|mesh-list
5666863|NCT03593304|Vitamin B 6|vitamin b 6|mesh-list
5666864|NCT03593304|Vitamin B Complex|vitamin b complex|mesh-list
5666865|NCT03593304|Micronutrients|micronutrients|mesh-ancestor
5666866|NCT03593304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666867|NCT03593291|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5666868|NCT03593291|Dalteparin|dalteparin|mesh-list
5666869|NCT03593291|Anticoagulants|anticoagulants|mesh-ancestor
5666870|NCT03593291|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5666871|NCT03593291|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5666872|NCT03593291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848915|NCT02458183|Immunologic Factors|immunologic factors|mesh-ancestor
5848916|NCT02458183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848917|NCT02458196|Mycophenolic Acid|mycophenolic acid|mesh-list
5848918|NCT02458196|Prednisone|prednisone|mesh-list
5666873|NCT03593213|Cariprazine|cariprazine|mesh-list
5666874|NCT03593213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5666875|NCT03593213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5666876|NCT03593213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5666877|NCT03593213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666878|NCT03593213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5666879|NCT03593135|Metformin|metformin|mesh-list
5848919|NCT02458196|Prednisolone|prednisolone|mesh-list
5848920|NCT02458196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5848921|NCT02458196|Glucocorticoids|glucocorticoids|mesh-ancestor
5848922|NCT02458196|Hormones|hormones|mesh-ancestor
5848923|NCT02458196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5848924|NCT02458196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848925|NCT02458196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5848926|NCT02458196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5848927|NCT02458196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5848928|NCT02458196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5848929|NCT02458196|Antitubercular Agents|antitubercular agents|mesh-ancestor
5848930|NCT02458196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5848931|NCT02458196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5848932|NCT02458196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5848933|NCT02458196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848934|NCT02458157|Furosemide|furosemide|mesh-list
5848935|NCT02458157|Diuretics|diuretics|mesh-ancestor
5848936|NCT02458157|Natriuretic Agents|natriuretic agents|mesh-ancestor
5848937|NCT02458157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848938|NCT02458157|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5848939|NCT02458157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5848940|NCT02458157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848941|NCT02457975|Ranibizumab|ranibizumab|mesh-list
5848942|NCT02457975|Aflibercept|aflibercept|mesh-list
5848943|NCT02457975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5848944|NCT02457975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5848945|NCT02457975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5848946|NCT02457975|Growth Substances|growth substances|mesh-ancestor
5848947|NCT02457975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848948|NCT02457975|Growth Inhibitors|growth inhibitors|mesh-ancestor
5848949|NCT02458118|Secretin|secretin|mesh-list
5848950|NCT02458118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5848951|NCT02458118|Hormones|hormones|mesh-ancestor
5848952|NCT02458118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5848953|NCT02458118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848954|NCT02458079|Pentoxifylline|pentoxifylline|mesh-list
5666880|NCT03593135|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5666881|NCT03593135|Acetic Acid|acetic acid|mesh-list
5666882|NCT03593135|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5666883|NCT03593135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666884|NCT03593135|Incretins|incretins|mesh-ancestor
5666885|NCT03593135|Hormones|hormones|mesh-ancestor
5666886|NCT03593135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5666887|NCT03593135|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5666888|NCT03593135|Protease Inhibitors|protease inhibitors|mesh-ancestor
5666889|NCT03593135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5666890|NCT03593135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5666891|NCT03593135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5666892|NCT03593135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5848955|NCT02458079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5848956|NCT02458079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5848957|NCT02458079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848958|NCT02458079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5848959|NCT02458079|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5848960|NCT02458079|Protective Agents|protective agents|mesh-ancestor
5848961|NCT02458079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848962|NCT02458079|Vasodilator Agents|vasodilator agents|mesh-ancestor
5848963|NCT02458079|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5848964|NCT02458079|Antioxidants|antioxidants|mesh-ancestor
5666893|NCT03593044|Atropine|atropine|mesh-list
5666894|NCT03593044|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5666895|NCT03593044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5666896|NCT03593044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5666897|NCT03593044|Autonomic Agents|autonomic agents|mesh-ancestor
5666898|NCT03593044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5666899|NCT03593044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666900|NCT03593044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5666901|NCT03593044|Respiratory System Agents|respiratory system agents|mesh-ancestor
5666902|NCT03593044|Mydriatics|mydriatics|mesh-ancestor
5666903|NCT03593044|Parasympatholytics|parasympatholytics|mesh-ancestor
5666904|NCT03593044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5666905|NCT03593044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5666906|NCT03593044|Cholinergic Agents|cholinergic agents|mesh-ancestor
5666907|NCT03593044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5848965|NCT02457650|Cyclophosphamide|cyclophosphamide|mesh-list
5848966|NCT02457650|Fludarabine|fludarabine|mesh-list
5848967|NCT02457650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5848968|NCT02457650|Immunologic Factors|immunologic factors|mesh-ancestor
5848969|NCT02457650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848970|NCT02457650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5848971|NCT02457650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5848972|NCT02457650|Alkylating Agents|alkylating agents|mesh-ancestor
5848973|NCT02457650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848974|NCT02457650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5848975|NCT02457650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5848976|NCT02457702|Glycerol|glycerol|mesh-list
5848977|NCT02457702|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
5848978|NCT02457702|Protective Agents|protective agents|mesh-ancestor
5848979|NCT02457702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848980|NCT02457806|Phenylephrine|phenylephrine|mesh-list
5848981|NCT02457806|Oxymetazoline|oxymetazoline|mesh-list
5848982|NCT02457806|Tetracaine|tetracaine|mesh-list
5848983|NCT02457806|Anesthetics, Local|anesthetics, local|mesh-ancestor
5848984|NCT02457806|Anesthetics|anesthetics|mesh-ancestor
5848985|NCT02457806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5848986|NCT02457806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5848987|NCT02457806|Sensory System Agents|sensory system agents|mesh-ancestor
5848988|NCT02457806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5848989|NCT02457806|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5848990|NCT02457806|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5848991|NCT02457806|Adrenergic Agents|adrenergic agents|mesh-ancestor
5848992|NCT02457806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5848993|NCT02457806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5848994|NCT02457806|Sympathomimetics|sympathomimetics|mesh-ancestor
5848995|NCT02457806|Autonomic Agents|autonomic agents|mesh-ancestor
5848996|NCT02457806|Nasal Decongestants|nasal decongestants|mesh-ancestor
5848997|NCT02457806|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5848998|NCT02457806|Respiratory System Agents|respiratory system agents|mesh-ancestor
5666908|NCT03593044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5666909|NCT03592992|Morphine|morphine|mesh-list
5666910|NCT03592992|Hydromorphone|hydromorphone|mesh-list
5666911|NCT03592992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5666912|NCT03592992|Narcotics|narcotics|mesh-ancestor
5666913|NCT03592992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5666914|NCT03592992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666915|NCT03592992|Analgesics|analgesics|mesh-ancestor
5666916|NCT03592992|Sensory System Agents|sensory system agents|mesh-ancestor
5666917|NCT03592992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5666918|NCT03592901|Anesthetics|anesthetics|mesh-list
5848999|NCT02457806|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5849000|NCT02457806|Mydriatics|mydriatics|mesh-ancestor
5849001|NCT02457806|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5849002|NCT02457806|Protective Agents|protective agents|mesh-ancestor
5849003|NCT02457585|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
5849004|NCT02457585|Infliximab|infliximab|mesh-list
5849005|NCT02457585|Dermatologic Agents|dermatologic agents|mesh-ancestor
5849006|NCT02457585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5849007|NCT02457585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5849008|NCT02457585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5849009|NCT02457507|Vitamin B 12|vitamin b 12|mesh-list
5849010|NCT02457507|Hydroxocobalamin|hydroxocobalamin|mesh-list
5849011|NCT02457507|Vitamins|vitamins|mesh-ancestor
5849012|NCT02457507|Micronutrients|micronutrients|mesh-ancestor
5849013|NCT02457507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849014|NCT02457507|Vitamin B Complex|vitamin b complex|mesh-ancestor
5849015|NCT02457507|Hematinics|hematinics|mesh-ancestor
5849016|NCT02457286|Metformin|metformin|mesh-list
5666919|NCT03592901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5666920|NCT03592901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849017|NCT02457286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5849018|NCT02457286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849019|NCT02457221|Prednisone|prednisone|mesh-list
5849020|NCT02457221|Cyclophosphamide|cyclophosphamide|mesh-list
5849021|NCT02457221|Tacrolimus|tacrolimus|mesh-list
5849022|NCT02457221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5849023|NCT02457221|Immunologic Factors|immunologic factors|mesh-ancestor
5849024|NCT02457221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666921|NCT03592836|Furosemide|furosemide|mesh-list
5666922|NCT03592836|Diuretics|diuretics|mesh-list
5849025|NCT02457221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5849026|NCT02457221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5849027|NCT02457221|Alkylating Agents|alkylating agents|mesh-ancestor
5849028|NCT02457221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5849029|NCT02457221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5849030|NCT02457221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5849031|NCT02457221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5849032|NCT02457221|Glucocorticoids|glucocorticoids|mesh-ancestor
5849033|NCT02457221|Hormones|hormones|mesh-ancestor
5849034|NCT02457221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5849035|NCT02457221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5849036|NCT02457221|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5849037|NCT02457221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5849038|NCT02457351|Itraconazole|itraconazole|mesh-list
5849039|NCT02457351|Antifungal Agents|antifungal agents|mesh-ancestor
5849040|NCT02457351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5849041|NCT02457351|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5849042|NCT02457351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5849043|NCT02457351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5849044|NCT02457351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5849045|NCT02457351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5849046|NCT02457351|Hormone Antagonists|hormone antagonists|mesh-ancestor
5849047|NCT02457351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5849048|NCT02457351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849049|NCT02457351|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5849050|NCT02457442|Remifentanil|remifentanil|mesh-list
5849051|NCT02457442|Propofol|propofol|mesh-list
5849052|NCT02457442|Sevoflurane|sevoflurane|mesh-list
5849053|NCT02457442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5849054|NCT02457442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5849055|NCT02457442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666923|NCT03592836|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
5666924|NCT03592836|Natriuretic Agents|natriuretic agents|mesh-ancestor
5666925|NCT03592836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666926|NCT03592836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5666927|NCT03592836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5666928|NCT03592823|Hydroxychloroquine|hydroxychloroquine|mesh-list
5666929|NCT03592823|Antimalarials|antimalarials|mesh-ancestor
5666930|NCT03592823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5666931|NCT03592823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5666932|NCT03592823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5666933|NCT03592823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5666934|NCT03592823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5666935|NCT03592823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5666936|NCT03592680|Ascorbic Acid|ascorbic acid|mesh-list
5666937|NCT03592680|Vitamins|vitamins|mesh-ancestor
5666938|NCT03592680|Micronutrients|micronutrients|mesh-ancestor
5666939|NCT03592680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666940|NCT03592680|Antioxidants|antioxidants|mesh-ancestor
5666941|NCT03592680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5666942|NCT03592680|Protective Agents|protective agents|mesh-ancestor
5666943|NCT03592667|Dapagliflozin|dapagliflozin|mesh-list
5666944|NCT03592667|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5666945|NCT03592667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5666946|NCT03592667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5666947|NCT03592667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666948|NCT03592576|Venetoclax|venetoclax|mesh-list
5666949|NCT03592576|Navitoclax|navitoclax|mesh-list
5666950|NCT03592576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5666951|NCT03592537|Fentanyl|fentanyl|mesh-list
5666952|NCT03592537|Midazolam|midazolam|mesh-list
5666953|NCT03592537|Bupivacaine|bupivacaine|mesh-list
5666954|NCT03592537|Anesthetics, Local|anesthetics, local|mesh-ancestor
5849056|NCT02457442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5849057|NCT02457442|Anesthetics, General|anesthetics, general|mesh-ancestor
5849058|NCT02457442|Anesthetics|anesthetics|mesh-ancestor
5849059|NCT02457442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5849060|NCT02457442|Narcotics|narcotics|mesh-ancestor
5849061|NCT02457442|Analgesics|analgesics|mesh-ancestor
5849062|NCT02457442|Sensory System Agents|sensory system agents|mesh-ancestor
5849063|NCT02457442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5849064|NCT02457442|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5666955|NCT03592537|Anesthetics|anesthetics|mesh-ancestor
5666956|NCT03592537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5849065|NCT02457442|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5666957|NCT03592537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666958|NCT03592537|Sensory System Agents|sensory system agents|mesh-ancestor
5849066|NCT02457312|Letrozole|letrozole|mesh-list
5849067|NCT02457312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5849068|NCT02457312|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5849069|NCT02457312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5849070|NCT02457312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5849071|NCT02457312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5849072|NCT02457312|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5849073|NCT02457312|Hormone Antagonists|hormone antagonists|mesh-ancestor
5849074|NCT02457312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5849075|NCT02457312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849076|NCT02457208|Rifampin|rifampin|mesh-list
5849077|NCT02457208|Isoniazid|isoniazid|mesh-list
5849078|NCT02457208|Pyrazinamide|pyrazinamide|mesh-list
5849079|NCT02457208|Ethambutol|ethambutol|mesh-list
5849080|NCT02457208|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5666959|NCT03592537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5666960|NCT03592537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5666961|NCT03592537|Narcotics|narcotics|mesh-ancestor
5849081|NCT02457208|Antitubercular Agents|antitubercular agents|mesh-ancestor
5849082|NCT02457208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5849083|NCT02457208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5849084|NCT02457208|Leprostatic Agents|leprostatic agents|mesh-ancestor
5849085|NCT02457208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5849086|NCT02457208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5849087|NCT02457208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5666962|NCT03592537|Analgesics|analgesics|mesh-ancestor
5666963|NCT03592537|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5666964|NCT03592537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5666965|NCT03592537|Anesthetics, General|anesthetics, general|mesh-ancestor
5666966|NCT03592537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5666967|NCT03592537|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5666968|NCT03592537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5666969|NCT03592537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5666970|NCT03592537|GABA Modulators|gaba modulators|mesh-ancestor
5666971|NCT03592537|GABA Agents|gaba agents|mesh-ancestor
5666972|NCT03592537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5666973|NCT03592537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5666974|NCT03592498|Sulfadiazine|sulfadiazine|mesh-list
5666975|NCT03592498|Silver Sulfadiazine|silver sulfadiazine|mesh-list
5666976|NCT03592498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5666977|NCT03592498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5666978|NCT03592498|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5666979|NCT03592498|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5666980|NCT03592498|Coccidiostats|coccidiostats|mesh-ancestor
5666981|NCT03592498|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5666982|NCT03592485|Acetaminophen|acetaminophen|mesh-list
5666983|NCT03592485|Oxycodone|oxycodone|mesh-list
5666984|NCT03592485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5666985|NCT03592485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5666986|NCT03592485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5666987|NCT03592485|Analgesics|analgesics|mesh-ancestor
5666988|NCT03592485|Sensory System Agents|sensory system agents|mesh-ancestor
5666989|NCT03592485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5666990|NCT03592485|Antipyretics|antipyretics|mesh-ancestor
5666991|NCT03592485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5666992|NCT03592485|Narcotics|narcotics|mesh-ancestor
5666993|NCT03592472|Abexinostat|abexinostat|mesh-list
5666994|NCT03592472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5666995|NCT03592472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5666996|NCT03592472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5666997|NCT03592407|Pembrolizumab|pembrolizumab|mesh-list
5666998|NCT03592407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5666999|NCT03592407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5667000|NCT03592342|Clobetasol|clobetasol|mesh-list
5667001|NCT03592342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5667002|NCT03592342|Glucocorticoids|glucocorticoids|mesh-ancestor
5849088|NCT02457208|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5849089|NCT02457208|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5849090|NCT02457208|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5849091|NCT02457208|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5903893|NCT04291703|Thymoglobulin|thymoglobulin|mesh-list
5667003|NCT03592342|Hormones|hormones|mesh-ancestor
5667004|NCT03592342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5667005|NCT03592342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695778|NCT03387163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5695779|NCT03387163|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5667006|NCT03592277|Vitamins|vitamins|mesh-list
5667007|NCT03592277|Ascorbic Acid|ascorbic acid|mesh-list
5667008|NCT03592277|Thiamine|thiamine|mesh-list
5667009|NCT03592277|Micronutrients|micronutrients|mesh-ancestor
5667010|NCT03592277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667011|NCT03592277|Antioxidants|antioxidants|mesh-ancestor
5667012|NCT03592277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667013|NCT03592277|Protective Agents|protective agents|mesh-ancestor
5667014|NCT03592277|Vitamin B Complex|vitamin b complex|mesh-ancestor
5849092|NCT02457208|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5849093|NCT02457208|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5849094|NCT02457208|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5849095|NCT02457208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5849096|NCT02457208|Antimetabolites|antimetabolites|mesh-ancestor
5849097|NCT02457208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5849098|NCT02456961|Riboflavin|riboflavin|mesh-list
5849099|NCT02456961|Vitamin B Complex|vitamin b complex|mesh-ancestor
5849100|NCT02456961|Vitamins|vitamins|mesh-ancestor
5849101|NCT02456961|Micronutrients|micronutrients|mesh-ancestor
5849102|NCT02456961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849103|NCT02456961|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5849104|NCT02456961|Dermatologic Agents|dermatologic agents|mesh-ancestor
5849105|NCT02456974|Amoxicillin|amoxicillin|mesh-list
5849106|NCT02456974|Vancomycin|vancomycin|mesh-list
5849107|NCT02456974|Ciprofloxacin|ciprofloxacin|mesh-list
5849108|NCT02456974|Meropenem|meropenem|mesh-list
5849109|NCT02456974|Tazobactam|tazobactam|mesh-list
5849110|NCT02456974|Clavulanic Acid|clavulanic acid|mesh-list
5849111|NCT02456974|Amikacin|amikacin|mesh-list
5849112|NCT02456974|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5849113|NCT02456974|Teicoplanin|teicoplanin|mesh-list
5849114|NCT02456974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5849115|NCT02456974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5849116|NCT02456974|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5849117|NCT02456974|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5849118|NCT02456974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5849119|NCT02456974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5849120|NCT02456974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5849121|NCT02456974|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5667015|NCT03592199|Sunitinib|sunitinib|mesh-list
5667016|NCT03592199|Axitinib|axitinib|mesh-list
5667017|NCT03592199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5667018|NCT03592199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5667019|NCT03592199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5667020|NCT03592199|Growth Substances|growth substances|mesh-ancestor
5667021|NCT03592199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667022|NCT03592199|Growth Inhibitors|growth inhibitors|mesh-ancestor
5667023|NCT03592199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5667024|NCT03592199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5849122|NCT02456974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5849123|NCT02456974|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5849124|NCT02457130|Clopidogrel|clopidogrel|mesh-list
5849125|NCT02457130|Ticagrelor|ticagrelor|mesh-list
5849126|NCT02457130|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5849127|NCT02457130|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5849128|NCT02457130|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5849129|NCT02457130|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5849130|NCT02457130|Purinergic Agents|purinergic agents|mesh-ancestor
5849131|NCT02457130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5849132|NCT02457130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5849133|NCT02457130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849134|NCT02456857|Bevacizumab|bevacizumab|mesh-list
5849135|NCT02456857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5849136|NCT02456857|Doxorubicin|doxorubicin|mesh-list
5849137|NCT02456857|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5849138|NCT02456857|Everolimus|everolimus|mesh-list
5849139|NCT02456857|Endothelial Growth Factors|endothelial growth factors|mesh-list
5849140|NCT02456857|Antibodies|antibodies|mesh-list
5849141|NCT02456857|Immunoglobulins|immunoglobulins|mesh-list
5849142|NCT02456857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5849143|NCT02456857|Immunoglobulin G|immunoglobulin g|mesh-list
5849144|NCT02456857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5849145|NCT02456857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5849146|NCT02456857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5667025|NCT03592199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667026|NCT03592082|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5849147|NCT02456857|Growth Substances|growth substances|mesh-ancestor
5667027|NCT03592082|Bismuth|bismuth|mesh-list
5667028|NCT03592082|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
5667029|NCT03592082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5849148|NCT02456857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849149|NCT02456857|Growth Inhibitors|growth inhibitors|mesh-ancestor
5849150|NCT02456857|Immunologic Factors|immunologic factors|mesh-ancestor
5849151|NCT02456857|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5849152|NCT02456857|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5849153|NCT02456857|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5667030|NCT03592082|Antacids|antacids|mesh-ancestor
5667031|NCT03592082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667032|NCT03592082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5667033|NCT03592082|Antidiarrheals|antidiarrheals|mesh-ancestor
5667034|NCT03592069|Amoxicillin|amoxicillin|mesh-list
5849154|NCT02456857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5849155|NCT02456857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5849156|NCT02456857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5849157|NCT02456935|Esomeprazole|esomeprazole|mesh-list
5849158|NCT02456935|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5849159|NCT02456935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5849160|NCT02456935|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5849161|NCT02456935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5849162|NCT02456935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5849163|NCT02457039|Cyclophosphamide|cyclophosphamide|mesh-list
5849164|NCT02457039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5849165|NCT02457039|Immunologic Factors|immunologic factors|mesh-ancestor
5849166|NCT02457039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849167|NCT02457039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5849168|NCT02457039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5849169|NCT02457039|Alkylating Agents|alkylating agents|mesh-ancestor
5849170|NCT02457039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5849171|NCT02457039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5849172|NCT02457039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5849173|NCT02457026|Triamcinolone|triamcinolone|mesh-list
5849174|NCT02457026|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5849175|NCT02457026|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5849176|NCT02457026|Aflibercept|aflibercept|mesh-list
5849177|NCT02457026|Verteporfin|verteporfin|mesh-list
5849178|NCT02457026|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5849179|NCT02457026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5849180|NCT02457026|Glucocorticoids|glucocorticoids|mesh-ancestor
5849181|NCT02457026|Hormones|hormones|mesh-ancestor
5849182|NCT02457026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5849183|NCT02457026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849184|NCT02457026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5849185|NCT02457026|Immunologic Factors|immunologic factors|mesh-ancestor
5849186|NCT02457026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5849187|NCT02457026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5849188|NCT02457026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5849189|NCT02457026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5849190|NCT02457026|Growth Substances|growth substances|mesh-ancestor
5849191|NCT02457026|Growth Inhibitors|growth inhibitors|mesh-ancestor
5849192|NCT02457026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5849193|NCT02457026|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5849194|NCT02457026|Dermatologic Agents|dermatologic agents|mesh-ancestor
5849195|NCT02456948|Minocycline|minocycline|mesh-list
5849196|NCT02456948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5849197|NCT02456948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5849198|NCT02456844|Leucovorin|leucovorin|mesh-list
5849199|NCT02456844|Flurbiprofen|flurbiprofen|mesh-list
5849200|NCT02456844|Methotrexate|methotrexate|mesh-list
5849201|NCT02456844|Digoxin|digoxin|mesh-list
5849202|NCT02456844|Midazolam|midazolam|mesh-list
5849203|NCT02456844|Pravastatin|pravastatin|mesh-list
5849204|NCT02456844|Montelukast|montelukast|mesh-list
5849205|NCT02456844|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5849206|NCT02456844|Abortifacient Agents|abortifacient agents|mesh-ancestor
5667035|NCT03592069|Metronidazole|metronidazole|mesh-list
5667036|NCT03592069|Clarithromycin|clarithromycin|mesh-list
5667037|NCT03592069|Esomeprazole|esomeprazole|mesh-list
5667038|NCT03592069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5667039|NCT03592069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5667040|NCT03592069|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5667041|NCT03592069|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5667042|NCT03592069|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5667043|NCT03592069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5667044|NCT03592069|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5667045|NCT03592069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5849207|NCT02456844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5849208|NCT02456844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849209|NCT02456844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5849210|NCT02456844|Antimetabolites|antimetabolites|mesh-ancestor
5849211|NCT02456844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5849212|NCT02456844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5849213|NCT02456844|Dermatologic Agents|dermatologic agents|mesh-ancestor
5849214|NCT02456844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5849215|NCT02456844|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5849216|NCT02456844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5849217|NCT02456844|Immunologic Factors|immunologic factors|mesh-ancestor
5849218|NCT02456844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5849219|NCT02456844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5849220|NCT02456844|Antidotes|antidotes|mesh-ancestor
5849221|NCT02456844|Protective Agents|protective agents|mesh-ancestor
5667046|NCT03592069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667047|NCT03592069|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5667048|NCT03592069|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5667049|NCT03592069|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5667050|NCT03591991|Empagliflozin|empagliflozin|mesh-list
5667051|NCT03591991|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5667052|NCT03591991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667053|NCT03591991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5667054|NCT03591991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849222|NCT02456844|Vitamin B Complex|vitamin b complex|mesh-ancestor
5849223|NCT02456844|Vitamins|vitamins|mesh-ancestor
5849224|NCT02456844|Micronutrients|micronutrients|mesh-ancestor
5667055|NCT03591913|Misoprostol|misoprostol|mesh-list
5667056|NCT03591913|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5667057|NCT03591913|Abortifacient Agents|abortifacient agents|mesh-ancestor
5667058|NCT03591913|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5667059|NCT03591913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667060|NCT03591913|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5667061|NCT03591913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5667062|NCT03591913|Oxytocics|oxytocics|mesh-ancestor
5667063|NCT03591900|Insulin|insulin|mesh-list
5667064|NCT03591900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5667065|NCT03591900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667066|NCT03591874|Brimonidine Tartrate|brimonidine tartrate|mesh-list
5667067|NCT03591874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5667068|NCT03591874|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5667069|NCT03591874|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5667070|NCT03591874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5667071|NCT03591874|Adrenergic Agents|adrenergic agents|mesh-ancestor
5667072|NCT03591874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5667073|NCT03591874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5849225|NCT02456844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5849226|NCT02456844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5849227|NCT02456844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5849228|NCT02456844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5667074|NCT03591874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667075|NCT03591861|Carmustine|carmustine|mesh-list
5667076|NCT03591861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5667077|NCT03591861|Alkylating Agents|alkylating agents|mesh-ancestor
5667078|NCT03591861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667079|NCT03591861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5667080|NCT03591757|Tolcapone|tolcapone|mesh-list
5667081|NCT03591757|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5667082|NCT03591757|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5667083|NCT03591757|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
5667084|NCT03591757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5667085|NCT03591757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667086|NCT03591744|Dexamethasone|dexamethasone|mesh-list
5667087|NCT03591744|Dexamethasone acetate|dexamethasone acetate|mesh-list
5667088|NCT03591744|Doxorubicin|doxorubicin|mesh-list
5667089|NCT03591744|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5667090|NCT03591744|Lenalidomide|lenalidomide|mesh-list
5667091|NCT03591744|Bortezomib|bortezomib|mesh-list
5667092|NCT03591744|Daratumumab|daratumumab|mesh-list
5667093|NCT03591744|Ichthammol|ichthammol|mesh-list
5667094|NCT03591744|BB 1101|bb 1101|mesh-list
5667095|NCT03591744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5667096|NCT03591744|Antiemetics|antiemetics|mesh-ancestor
5667097|NCT03591744|Autonomic Agents|autonomic agents|mesh-ancestor
5667098|NCT03591744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5849229|NCT02456844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5849230|NCT02456844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5849231|NCT02456844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5849232|NCT02456844|Anesthetics, General|anesthetics, general|mesh-ancestor
5849233|NCT02456844|Anesthetics|anesthetics|mesh-ancestor
5849234|NCT02456844|GABA Modulators|gaba modulators|mesh-ancestor
5849235|NCT02456844|GABA Agents|gaba agents|mesh-ancestor
5849236|NCT02456844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5849237|NCT02456844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5849238|NCT02456844|Respiratory System Agents|respiratory system agents|mesh-ancestor
5849239|NCT02456844|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5849240|NCT02456844|Hormone Antagonists|hormone antagonists|mesh-ancestor
5849241|NCT02456844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5849242|NCT02456844|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5849243|NCT02456844|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5849244|NCT02456844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5849245|NCT02456844|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5849246|NCT02456844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5849247|NCT02456844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5849248|NCT02456844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5849249|NCT02456844|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5849250|NCT02456844|Analgesics|analgesics|mesh-ancestor
5849251|NCT02456844|Sensory System Agents|sensory system agents|mesh-ancestor
5849252|NCT02456844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5849253|NCT02456844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5849254|NCT02456844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5849255|NCT02456844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5849256|NCT02456844|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5849257|NCT02456532|Zolpidem|zolpidem|mesh-list
5667099|NCT03591744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667100|NCT03591744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5667101|NCT03591744|Glucocorticoids|glucocorticoids|mesh-ancestor
5667102|NCT03591744|Hormones|hormones|mesh-ancestor
5667103|NCT03591744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5667104|NCT03591744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5667105|NCT03591744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5667106|NCT03591744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5667107|NCT03591744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5667108|NCT03591744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5667109|NCT03591744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5667110|NCT03591744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667111|NCT03591744|Immunologic Factors|immunologic factors|mesh-ancestor
5667112|NCT03591744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5667113|NCT03591744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5667114|NCT03591744|Growth Substances|growth substances|mesh-ancestor
5667115|NCT03591744|Growth Inhibitors|growth inhibitors|mesh-ancestor
5667116|NCT03591744|Protease Inhibitors|protease inhibitors|mesh-ancestor
5667117|NCT03591744|Dermatologic Agents|dermatologic agents|mesh-ancestor
5667118|NCT03591731|Nivolumab|nivolumab|mesh-list
5667119|NCT03591731|Ipilimumab|ipilimumab|mesh-list
5667120|NCT03591731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5667121|NCT03591731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5667122|NCT03591731|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5667123|NCT03591731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667124|NCT03591679|Oxytocin|oxytocin|mesh-list
5667125|NCT03591679|Oxytocics|oxytocics|mesh-ancestor
5667126|NCT03591679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5667127|NCT03591679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667128|NCT03591575|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5849258|NCT02456532|Eszopiclone|eszopiclone|mesh-list
5849259|NCT02456532|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5849260|NCT02456532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5849261|NCT02456532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5667129|NCT03591575|Deferiprone|deferiprone|mesh-list
5667130|NCT03591575|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5667131|NCT03591575|Chelating Agents|chelating agents|mesh-ancestor
5667132|NCT03591575|Sequestering Agents|sequestering agents|mesh-ancestor
5667133|NCT03591575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667134|NCT03591549|Fulvestrant|fulvestrant|mesh-list
5667135|NCT03591549|Goserelin|goserelin|mesh-list
5667136|NCT03591549|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5667137|NCT03591549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5667138|NCT03591549|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5667139|NCT03591549|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5849262|NCT02456532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849263|NCT02456532|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
5849264|NCT02456532|GABA Agonists|gaba agonists|mesh-ancestor
5849265|NCT02456532|GABA Agents|gaba agents|mesh-ancestor
5849266|NCT02456532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5849267|NCT02456532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5849268|NCT02456597|Lidocaine|lidocaine|mesh-list
5667140|NCT03591549|Hormone Antagonists|hormone antagonists|mesh-ancestor
5667141|NCT03591549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5667142|NCT03591549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667143|NCT03591536|Pentoxifylline|pentoxifylline|mesh-list
5667144|NCT03591536|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5667145|NCT03591536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5667146|NCT03591536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5849269|NCT02456597|Anesthetics, Local|anesthetics, local|mesh-ancestor
5849270|NCT02456597|Anesthetics|anesthetics|mesh-ancestor
5849271|NCT02456597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5849272|NCT02456597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849273|NCT02456597|Sensory System Agents|sensory system agents|mesh-ancestor
5849274|NCT02456597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5849275|NCT02456597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5849276|NCT02456597|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5849277|NCT02456597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5849278|NCT02456597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5849279|NCT02456597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5849280|NCT02456714|Folfirinox|folfirinox|mesh-list
5849281|NCT02456714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5849282|NCT02456454|Valproic Acid|valproic acid|mesh-list
5849283|NCT02456454|Risperidone|risperidone|mesh-list
5849284|NCT02456454|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5849285|NCT02456454|Serotonin Agents|serotonin agents|mesh-ancestor
5849286|NCT02456454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5849287|NCT02456454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5849288|NCT02456454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849289|NCT02456454|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5849290|NCT02456454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5849291|NCT02456454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5849292|NCT02456454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5849293|NCT02456454|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5849294|NCT02456454|Dopamine Agents|dopamine agents|mesh-ancestor
5849295|NCT02456454|Anticonvulsants|anticonvulsants|mesh-ancestor
5849296|NCT02456454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5667147|NCT03591536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5667148|NCT03591536|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5667149|NCT03591536|Protective Agents|protective agents|mesh-ancestor
5667150|NCT03591536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849297|NCT02456454|GABA Agents|gaba agents|mesh-ancestor
5849298|NCT02456454|Antimanic Agents|antimanic agents|mesh-ancestor
5849299|NCT02456584|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
5849300|NCT02456584|Medroxyprogesterone|medroxyprogesterone|mesh-list
5849301|NCT02456584|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5849302|NCT02456584|Contraceptive Agents|contraceptive agents|mesh-ancestor
5849303|NCT02456584|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5849304|NCT02456584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849305|NCT02456584|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5849306|NCT02456584|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5849307|NCT02456584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5849308|NCT02456584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5849309|NCT02456584|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5849310|NCT02456584|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5849311|NCT02456584|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5849312|NCT02456701|Vemurafenib|vemurafenib|mesh-list
5849313|NCT02456701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5667151|NCT03591536|Vasodilator Agents|vasodilator agents|mesh-ancestor
5667152|NCT03591536|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5667153|NCT03591536|Antioxidants|antioxidants|mesh-ancestor
5667154|NCT03591471|Prednisone|prednisone|mesh-list
5667155|NCT03591471|Benazepril|benazepril|mesh-list
5667156|NCT03591471|Heparin|heparin|mesh-list
5849314|NCT02456701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5849315|NCT02456701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5849316|NCT02456701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5849317|NCT02456558|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5849318|NCT02456558|Deferiprone|deferiprone|mesh-list
5667157|NCT03591471|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5667158|NCT03591471|Tinzaparin|tinzaparin|mesh-list
5667159|NCT03591471|Dalteparin|dalteparin|mesh-list
5667160|NCT03591471|Calcium heparin|calcium heparin|mesh-list
5667161|NCT03591471|Dipyridamole|dipyridamole|mesh-list
5667162|NCT03591471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667163|NCT03591471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5667164|NCT03591471|Glucocorticoids|glucocorticoids|mesh-ancestor
5667165|NCT03591471|Hormones|hormones|mesh-ancestor
5667166|NCT03591471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5667167|NCT03591471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5667168|NCT03591471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5849319|NCT02456558|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5849320|NCT02456558|Chelating Agents|chelating agents|mesh-ancestor
5849321|NCT02456558|Sequestering Agents|sequestering agents|mesh-ancestor
5849322|NCT02456558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5849323|NCT02456428|Insulin|insulin|mesh-list
5667169|NCT03591471|Anticoagulants|anticoagulants|mesh-ancestor
5667170|NCT03591471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5667171|NCT03591471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5667172|NCT03591471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667173|NCT03591471|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5667174|NCT03591471|Protease Inhibitors|protease inhibitors|mesh-ancestor
5667175|NCT03591471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5667176|NCT03591471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5849324|NCT02456428|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5849325|NCT02456428|Metformin|metformin|mesh-list
5849326|NCT02456428|Pioglitazone|pioglitazone|mesh-list
5849327|NCT02456428|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5849328|NCT02456428|Liraglutide|liraglutide|mesh-list
5849329|NCT02456428|Exenatide|exenatide|mesh-list
5849330|NCT02456428|Glimepiride|glimepiride|mesh-list
5849331|NCT02456428|Rosiglitazone|rosiglitazone|mesh-list
5849332|NCT02456428|Saxagliptin|saxagliptin|mesh-list
5849333|NCT02456428|Vildagliptin|vildagliptin|mesh-list
5849334|NCT02456428|Acarbose|acarbose|mesh-list
5667177|NCT03591471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5667178|NCT03591471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5667179|NCT03591471|Vasodilator Agents|vasodilator agents|mesh-ancestor
5667180|NCT03591341|Melatonin|melatonin|mesh-list
5667181|NCT03591341|Antioxidants|antioxidants|mesh-ancestor
5667182|NCT03591341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667183|NCT03591341|Protective Agents|protective agents|mesh-ancestor
5667184|NCT03591341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667185|NCT03591341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5667186|NCT03591289|Bromides|bromides|mesh-list
5667187|NCT03591289|Rocuronium|rocuronium|mesh-list
5667188|NCT03591289|Anticonvulsants|anticonvulsants|mesh-ancestor
5667189|NCT03591289|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5667190|NCT03591289|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5667191|NCT03591289|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5667192|NCT03591289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5667193|NCT03591289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667194|NCT03591276|Antineoplastic Agents|antineoplastic agents|mesh-list
5667195|NCT03591172|Propolis|propolis|mesh-list
5667196|NCT03591172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5667197|NCT03591003|Antibodies|antibodies|mesh-list
5667198|NCT03591003|Antibodies, Blocking|antibodies, blocking|mesh-list
5849335|NCT02456428|Hypoglycemic Agents|hypoglycemic agents|mesh-list
5849336|NCT02456428|Repaglinide|repaglinide|mesh-list
5849337|NCT02456428|Gliclazide|gliclazide|mesh-list
5849338|NCT02456428|Glipizide|glipizide|mesh-list
5849339|NCT02456428|Tolbutamide|tolbutamide|mesh-list
5849340|NCT02456428|Biguanides|biguanides|mesh-list
5849341|NCT02456428|Voglibose|voglibose|mesh-list
5849342|NCT02456428|Nateglinide|nateglinide|mesh-list
5849343|NCT02456428|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
5849344|NCT02456428|Miglitol|miglitol|mesh-list
5849345|NCT02456428|Troglitazone|troglitazone|mesh-list
5849346|NCT02456428|Meglitinide|meglitinide|mesh-list
5667199|NCT03591003|Immunologic Factors|immunologic factors|mesh-ancestor
5667200|NCT03591003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667201|NCT03590912|Mometasone Furoate|mometasone furoate|mesh-list
5667202|NCT03590912|Cetirizine|cetirizine|mesh-list
5667203|NCT03590912|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5667204|NCT03590912|Cefpodoxime|cefpodoxime|mesh-list
5667205|NCT03590912|Prednisolone|prednisolone|mesh-list
5667206|NCT03590912|Phenylephrine|phenylephrine|mesh-list
5849347|NCT02456428|Acetohexamide|acetohexamide|mesh-list
5849348|NCT02456428|Phenformin|phenformin|mesh-list
5849349|NCT02456428|Buformin|buformin|mesh-list
5849350|NCT02456428|Chlorpropamide|chlorpropamide|mesh-list
5849351|NCT02456428|Glibornuride|glibornuride|mesh-list
5849352|NCT02456428|Tolazamide|tolazamide|mesh-list
5849353|NCT02456428|Carbutamide|carbutamide|mesh-list
5849354|NCT02456428|Gliquidone|gliquidone|mesh-list
5849355|NCT02456428|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
5849356|NCT02456428|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
5849357|NCT02456428|Incretins|incretins|mesh-list
5849358|NCT02456428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849359|NCT02456428|Hormones|hormones|mesh-ancestor
5849360|NCT02456428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5849361|NCT02456428|Protease Inhibitors|protease inhibitors|mesh-ancestor
5849362|NCT02456428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5849363|NCT02456428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5849364|NCT02456428|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5849365|NCT02456428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5849366|NCT02456428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5849367|NCT02456428|Immunologic Factors|immunologic factors|mesh-ancestor
5849368|NCT02456350|Cyclophosphamide|cyclophosphamide|mesh-list
5849369|NCT02456350|Fludarabine|fludarabine|mesh-list
5849370|NCT02456350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5849371|NCT02456350|Immunologic Factors|immunologic factors|mesh-ancestor
5849372|NCT02456350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849373|NCT02456350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5849374|NCT02456350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5667207|NCT03590912|Oxymetazoline|oxymetazoline|mesh-list
5667208|NCT03590912|Nasal Decongestants|nasal decongestants|mesh-list
5667209|NCT03590912|Levocetirizine|levocetirizine|mesh-list
5667210|NCT03590912|Histamine Antagonists|histamine antagonists|mesh-list
5667211|NCT03590912|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
5667212|NCT03590912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5667213|NCT03590912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5667214|NCT03590912|Glucocorticoids|glucocorticoids|mesh-ancestor
5667215|NCT03590912|Hormones|hormones|mesh-ancestor
5667216|NCT03590912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5667217|NCT03590912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667218|NCT03590912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5849375|NCT02456350|Alkylating Agents|alkylating agents|mesh-ancestor
5849376|NCT02456350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5849377|NCT02456350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5849378|NCT02456350|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5849379|NCT02456363|Sulfasalazine|sulfasalazine|mesh-list
5849380|NCT02456363|Adalimumab|adalimumab|mesh-list
5849381|NCT02456363|Etanercept|etanercept|mesh-list
5849382|NCT02456363|Golimumab|golimumab|mesh-list
5849383|NCT02456363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5667219|NCT03590912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5667220|NCT03590912|Autonomic Agents|autonomic agents|mesh-ancestor
5667221|NCT03590912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5667222|NCT03590912|Protective Agents|protective agents|mesh-ancestor
5667223|NCT03590912|Dermatologic Agents|dermatologic agents|mesh-ancestor
5667224|NCT03590912|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5667225|NCT03590912|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5667226|NCT03590912|Histamine Agents|histamine agents|mesh-ancestor
5667227|NCT03590912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5667228|NCT03590912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667229|NCT03590912|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5667230|NCT03590912|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5667231|NCT03590912|Adrenergic Agents|adrenergic agents|mesh-ancestor
5667232|NCT03590912|Sympathomimetics|sympathomimetics|mesh-ancestor
5667233|NCT03590912|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5667234|NCT03590912|Respiratory System Agents|respiratory system agents|mesh-ancestor
5667235|NCT03590912|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5667236|NCT03590912|Mydriatics|mydriatics|mesh-ancestor
5849384|NCT02456363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5849385|NCT02456363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5849386|NCT02456363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5849387|NCT02456363|Analgesics|analgesics|mesh-ancestor
5849388|NCT02456363|Sensory System Agents|sensory system agents|mesh-ancestor
5849389|NCT02456363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5849390|NCT02456363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849391|NCT02456363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5849392|NCT02456363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5849393|NCT02456363|Immunologic Factors|immunologic factors|mesh-ancestor
5849394|NCT02456363|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
5849395|NCT02456363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5849396|NCT02456142|Morphine|morphine|mesh-list
5849397|NCT02456142|Bupivacaine|bupivacaine|mesh-list
5849398|NCT02456142|Anesthetics, Local|anesthetics, local|mesh-ancestor
5849399|NCT02456142|Anesthetics|anesthetics|mesh-ancestor
5849400|NCT02456142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5667237|NCT03590912|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5667238|NCT03590873|Vasopressins|vasopressins|mesh-list
5667239|NCT03590873|Arginine Vasopressin|arginine vasopressin|mesh-list
5667240|NCT03590873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667241|NCT03590873|Hemostatics|hemostatics|mesh-ancestor
5667242|NCT03590873|Coagulants|coagulants|mesh-ancestor
5667243|NCT03590873|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5667244|NCT03590873|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5667245|NCT03590873|Natriuretic Agents|natriuretic agents|mesh-ancestor
5667246|NCT03590808|Vaccines|vaccines|mesh-list
5667247|NCT03590808|Immunologic Factors|immunologic factors|mesh-ancestor
5667248|NCT03590808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849401|NCT02456142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849402|NCT02456142|Sensory System Agents|sensory system agents|mesh-ancestor
5849403|NCT02456142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5849404|NCT02456142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5849405|NCT02456142|Narcotics|narcotics|mesh-ancestor
5849406|NCT02456142|Analgesics|analgesics|mesh-ancestor
5849407|NCT02456194|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5849408|NCT02456194|Calcium|calcium|mesh-list
5849409|NCT02456194|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5849410|NCT02456194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849411|NCT02456194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5849412|NCT02456129|Itraconazole|itraconazole|mesh-list
5849413|NCT02456129|Antifungal Agents|antifungal agents|mesh-ancestor
5849414|NCT02456129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5849415|NCT02456129|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5849416|NCT02456129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5695780|NCT03387163|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5695781|NCT03387163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695782|NCT03387111|Leucovorin|leucovorin|mesh-list
5695783|NCT03387111|Paclitaxel|paclitaxel|mesh-list
5695784|NCT03387111|Cyclophosphamide|cyclophosphamide|mesh-list
5695785|NCT03387111|Bevacizumab|bevacizumab|mesh-list
5695786|NCT03387111|Fluorouracil|fluorouracil|mesh-list
5695787|NCT03387111|Capecitabine|capecitabine|mesh-list
5695788|NCT03387111|Cetuximab|cetuximab|mesh-list
5695789|NCT03387111|Avelumab|avelumab|mesh-list
5695790|NCT03387111|Necitumumab|necitumumab|mesh-list
5695791|NCT03387111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5695792|NCT03387111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5695793|NCT03387111|Tubulin Modulators|tubulin modulators|mesh-ancestor
5695794|NCT03387111|Antimitotic Agents|antimitotic agents|mesh-ancestor
5695795|NCT03387111|Mitosis Modulators|mitosis modulators|mesh-ancestor
5695796|NCT03387111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695797|NCT03387111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5849417|NCT02456129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5849418|NCT02456129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5849419|NCT02456129|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5849420|NCT02456129|Hormone Antagonists|hormone antagonists|mesh-ancestor
5849421|NCT02456129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5849422|NCT02456129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849423|NCT02456129|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5849424|NCT02456207|Rituximab|rituximab|mesh-list
5849425|NCT02456207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5849426|NCT02456207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5849427|NCT02456207|Immunologic Factors|immunologic factors|mesh-ancestor
5849428|NCT02456207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849429|NCT02456207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5849430|NCT02456116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
5849431|NCT02456116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5849432|NCT02456116|Analgesics|analgesics|mesh-ancestor
5849433|NCT02456116|Sensory System Agents|sensory system agents|mesh-ancestor
5849434|NCT02456116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5849435|NCT02456116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849436|NCT02456116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5849437|NCT02456116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5849438|NCT02456025|Tacrolimus|tacrolimus|mesh-list
5849439|NCT02456025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5849440|NCT02456025|Immunologic Factors|immunologic factors|mesh-ancestor
5849441|NCT02456025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849442|NCT02456025|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5695798|NCT03387111|Immunologic Factors|immunologic factors|mesh-ancestor
5695799|NCT03387111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849443|NCT02456025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5849444|NCT02456025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5849445|NCT02455726|Pregabalin|pregabalin|mesh-list
5849446|NCT02455726|Oxycodone|oxycodone|mesh-list
5849447|NCT02455726|Magnesium Oxide|magnesium oxide|mesh-list
5849448|NCT02455726|Analgesics|analgesics|mesh-ancestor
5849449|NCT02455726|Sensory System Agents|sensory system agents|mesh-ancestor
5849450|NCT02455726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5849451|NCT02455726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849452|NCT02455726|Anticonvulsants|anticonvulsants|mesh-ancestor
5849453|NCT02455726|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5849454|NCT02455726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5849455|NCT02455726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5849456|NCT02455726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5849457|NCT02455726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5849458|NCT02455726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5849459|NCT02455726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5849460|NCT02455726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5849461|NCT02455726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5849462|NCT02455726|Narcotics|narcotics|mesh-ancestor
5849463|NCT02455726|Antacids|antacids|mesh-ancestor
5667249|NCT03590769|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5667250|NCT03590769|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5667251|NCT03590769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667252|NCT03590652|Dexamethasone|dexamethasone|mesh-list
5667253|NCT03590652|Daratumumab|daratumumab|mesh-list
5667254|NCT03590652|Pomalidomide|pomalidomide|mesh-list
5667255|NCT03590652|Ixazomib|ixazomib|mesh-list
5667256|NCT03590652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5667257|NCT03590652|Antiemetics|antiemetics|mesh-ancestor
5667258|NCT03590652|Autonomic Agents|autonomic agents|mesh-ancestor
5667259|NCT03590652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5667260|NCT03590652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667261|NCT03590652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5667262|NCT03590652|Glucocorticoids|glucocorticoids|mesh-ancestor
5849464|NCT02455726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5849465|NCT02455908|Aldesleukin|aldesleukin|mesh-list
5849466|NCT02455908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5849467|NCT02455908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5849468|NCT02455908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5849469|NCT02455908|Antiviral Agents|antiviral agents|mesh-ancestor
5849470|NCT02455908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5849471|NCT02455869|Alendronate|alendronate|mesh-list
5849472|NCT02455869|Atorvastatin|atorvastatin|mesh-list
5849473|NCT02455869|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5849474|NCT02455869|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5849475|NCT02455869|Antimetabolites|antimetabolites|mesh-ancestor
5849476|NCT02455869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5849477|NCT02455869|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5849478|NCT02455869|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5849479|NCT02455869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5849480|NCT02455869|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5849481|NCT02455869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849482|NCT02455856|Itraconazole|itraconazole|mesh-list
5849483|NCT02455856|Antifungal Agents|antifungal agents|mesh-ancestor
5849484|NCT02455856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5849485|NCT02455856|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5849486|NCT02455856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5849487|NCT02455856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5849488|NCT02455856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5849489|NCT02455856|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5849490|NCT02455856|Hormone Antagonists|hormone antagonists|mesh-ancestor
5849491|NCT02455856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5849492|NCT02455856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849493|NCT02455856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5849494|NCT02455921|Atropine|atropine|mesh-list
5849495|NCT02455921|Neostigmine|neostigmine|mesh-list
5849496|NCT02455921|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5849497|NCT02455921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5849498|NCT02455921|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5849499|NCT02455921|Autonomic Agents|autonomic agents|mesh-ancestor
5849500|NCT02455921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5667263|NCT03590652|Hormones|hormones|mesh-ancestor
5667264|NCT03590652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5849501|NCT02455921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849502|NCT02455921|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5849503|NCT02455921|Respiratory System Agents|respiratory system agents|mesh-ancestor
5849504|NCT02455921|Mydriatics|mydriatics|mesh-ancestor
5849505|NCT02455921|Parasympatholytics|parasympatholytics|mesh-ancestor
5849506|NCT02455921|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5849507|NCT02455921|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5849508|NCT02455921|Cholinergic Agents|cholinergic agents|mesh-ancestor
5849509|NCT02455921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5849510|NCT02455921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5849511|NCT02455921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5849512|NCT02455921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5849513|NCT02455921|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5903894|NCT04291703|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5903895|NCT04291703|Immunologic Factors|immunologic factors|mesh-ancestor
5903896|NCT04291703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903897|NCT04291703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5903898|NCT04263350|Atazanavir Sulfate|atazanavir sulfate|mesh-list
5903899|NCT04263350|Cobicistat|cobicistat|mesh-list
5903900|NCT04263350|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5903901|NCT04263350|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5903902|NCT04263350|Protease Inhibitors|protease inhibitors|mesh-ancestor
5903903|NCT04263350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5903904|NCT04263350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903905|NCT04263350|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5903906|NCT04263350|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5903907|NCT04263350|Antiviral Agents|antiviral agents|mesh-ancestor
5903908|NCT04263350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5903909|NCT04263350|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5903910|NCT04263350|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5667265|NCT03590652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5667266|NCT03590652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5667267|NCT03590652|Immunologic Factors|immunologic factors|mesh-ancestor
5667268|NCT03590652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5667269|NCT03590652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5667270|NCT03590652|Growth Substances|growth substances|mesh-ancestor
5667271|NCT03590652|Growth Inhibitors|growth inhibitors|mesh-ancestor
5667272|NCT03590652|Protease Inhibitors|protease inhibitors|mesh-ancestor
5903911|NCT04227028|Bevacizumab|bevacizumab|mesh-list
5908463|NCT04503551|Growth Substances|growth substances|mesh-ancestor
5667273|NCT03590652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5667274|NCT03590652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667275|NCT03590626|Dulaglutide|dulaglutide|mesh-list
5667276|NCT03590626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5667277|NCT03590626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667278|NCT03590587|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
5667279|NCT03590587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5667280|NCT03590587|Glucocorticoids|glucocorticoids|mesh-ancestor
5667281|NCT03590587|Hormones|hormones|mesh-ancestor
5667282|NCT03590587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5667283|NCT03590587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667284|NCT03590496|Calcium|calcium|mesh-list
5667285|NCT03590496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5667286|NCT03590496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667287|NCT03590444|Ranibizumab|ranibizumab|mesh-list
5667288|NCT03590444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5667289|NCT03590444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5667290|NCT03590444|Growth Substances|growth substances|mesh-ancestor
5667291|NCT03590444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667292|NCT03590444|Growth Inhibitors|growth inhibitors|mesh-ancestor
5667293|NCT03590444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5667294|NCT03590431|Iodine|iodine|mesh-list
5667295|NCT03590431|Cadexomer iodine|cadexomer iodine|mesh-list
5667296|NCT03590431|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5667297|NCT03590431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5667298|NCT03590431|Trace Elements|trace elements|mesh-ancestor
5667299|NCT03590431|Micronutrients|micronutrients|mesh-ancestor
5667300|NCT03590431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667301|NCT03590275|Folfirinox|folfirinox|mesh-list
5667302|NCT03590275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5667303|NCT03590262|Metformin|metformin|mesh-list
5667304|NCT03590262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5667305|NCT03590262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667306|NCT03590210|Nivolumab|nivolumab|mesh-list
5667307|NCT03590210|Trabectedin|trabectedin|mesh-list
5667308|NCT03590210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5667309|NCT03590210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5849514|NCT02455687|Budesonide|budesonide|mesh-list
5849515|NCT02455687|Magnesium Sulfate|magnesium sulfate|mesh-list
5849516|NCT02455687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5849517|NCT02455687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5849518|NCT02455687|Autonomic Agents|autonomic agents|mesh-ancestor
5849519|NCT02455687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5849520|NCT02455687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849521|NCT02455687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5849522|NCT02455687|Respiratory System Agents|respiratory system agents|mesh-ancestor
5849523|NCT02455687|Glucocorticoids|glucocorticoids|mesh-ancestor
5849524|NCT02455687|Hormones|hormones|mesh-ancestor
5849525|NCT02455687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5849526|NCT02455687|Analgesics|analgesics|mesh-ancestor
5849527|NCT02455687|Sensory System Agents|sensory system agents|mesh-ancestor
5849528|NCT02455687|Anesthetics|anesthetics|mesh-ancestor
5849529|NCT02455687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5849530|NCT02455687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5849531|NCT02455687|Anticonvulsants|anticonvulsants|mesh-ancestor
5849532|NCT02455687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5849533|NCT02455687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5849534|NCT02455687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5849535|NCT02455687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5667310|NCT03590210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5667311|NCT03590210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667312|NCT03590210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5667313|NCT03590210|Alkylating Agents|alkylating agents|mesh-ancestor
5667314|NCT03590197|Melatonin|melatonin|mesh-list
5667315|NCT03590197|Antioxidants|antioxidants|mesh-ancestor
5667316|NCT03590197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667317|NCT03590197|Protective Agents|protective agents|mesh-ancestor
5667318|NCT03590197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667319|NCT03590197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5667320|NCT03590171|Bortezomib|bortezomib|mesh-list
5667321|NCT03590171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5667322|NCT03590119|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
5667323|NCT03590119|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5667324|NCT03590119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667325|NCT03590080|Methylprednisolone|methylprednisolone|mesh-list
5667326|NCT03590080|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5667327|NCT03590080|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5667328|NCT03590080|Prednisolone|prednisolone|mesh-list
5667329|NCT03590080|Prednisolone acetate|prednisolone acetate|mesh-list
5667330|NCT03590080|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5667331|NCT03590080|Prednisolone phosphate|prednisolone phosphate|mesh-list
5849536|NCT02455687|Tocolytic Agents|tocolytic agents|mesh-ancestor
5849537|NCT02455687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5849538|NCT02455362|Morphine|morphine|mesh-list
5849539|NCT02455362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5849540|NCT02455362|Narcotics|narcotics|mesh-ancestor
5849541|NCT02455362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5849542|NCT02455362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849543|NCT02455362|Analgesics|analgesics|mesh-ancestor
5849544|NCT02455362|Sensory System Agents|sensory system agents|mesh-ancestor
5849545|NCT02455362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5849546|NCT02455609|Dexmedetomidine|dexmedetomidine|mesh-list
5849547|NCT02455609|Ketamine|ketamine|mesh-list
5849548|NCT02455609|Bupivacaine|bupivacaine|mesh-list
5849549|NCT02455609|Anesthetics, Local|anesthetics, local|mesh-ancestor
5849550|NCT02455609|Anesthetics|anesthetics|mesh-ancestor
5849551|NCT02455609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5849552|NCT02455609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849553|NCT02455609|Sensory System Agents|sensory system agents|mesh-ancestor
5849554|NCT02455609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5849555|NCT02455609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5667332|NCT03590080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5667333|NCT03590080|Antiemetics|antiemetics|mesh-ancestor
5667334|NCT03590080|Autonomic Agents|autonomic agents|mesh-ancestor
5667335|NCT03590080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5667336|NCT03590080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667337|NCT03590080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5667338|NCT03590080|Glucocorticoids|glucocorticoids|mesh-ancestor
5667339|NCT03590080|Hormones|hormones|mesh-ancestor
5667340|NCT03590080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5849556|NCT02455609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5849557|NCT02455609|Analgesics|analgesics|mesh-ancestor
5849558|NCT02455609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5849559|NCT02455609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5849560|NCT02455609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5849561|NCT02455609|Adrenergic Agents|adrenergic agents|mesh-ancestor
5849562|NCT02455609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5849563|NCT02455609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5849564|NCT02455609|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5849565|NCT02455609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5849566|NCT02455609|Anesthetics, General|anesthetics, general|mesh-ancestor
5849567|NCT02455609|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5849568|NCT02455609|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5849569|NCT02455401|Remifentanil|remifentanil|mesh-list
5849570|NCT02455401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5849571|NCT02455401|Narcotics|narcotics|mesh-ancestor
5849572|NCT02455401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5849573|NCT02455401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849574|NCT02455401|Analgesics|analgesics|mesh-ancestor
5849575|NCT02455401|Sensory System Agents|sensory system agents|mesh-ancestor
5849576|NCT02455401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5849577|NCT02455596|Interferons|interferons|mesh-list
5849578|NCT02455596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5667341|NCT03590080|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5667342|NCT03590080|Protective Agents|protective agents|mesh-ancestor
5667343|NCT03590080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5667344|NCT03590080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5667345|NCT03590054|Pembrolizumab|pembrolizumab|mesh-list
5849579|NCT02455596|Antiviral Agents|antiviral agents|mesh-ancestor
5849580|NCT02455596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5849581|NCT02455440|Propofol|propofol|mesh-list
5849582|NCT02455440|Sevoflurane|sevoflurane|mesh-list
5849583|NCT02455440|Esmolol|esmolol|mesh-list
5849584|NCT02455440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5667346|NCT03590054|Abexinostat|abexinostat|mesh-list
5667347|NCT03590054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5667348|NCT03590054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5667349|NCT03590054|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5849585|NCT02455440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5667350|NCT03590054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5667351|NCT03590054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667352|NCT03589898|Gabapentin|gabapentin|mesh-list
5667353|NCT03589898|Analgesics|analgesics|mesh-ancestor
5667354|NCT03589898|Sensory System Agents|sensory system agents|mesh-ancestor
5667355|NCT03589898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5667356|NCT03589898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667357|NCT03589898|Anticonvulsants|anticonvulsants|mesh-ancestor
5667358|NCT03589898|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5667359|NCT03589898|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5667360|NCT03589898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5667361|NCT03589898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5667362|NCT03589898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5667363|NCT03589898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5667364|NCT03589898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5667365|NCT03589898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667366|NCT03589898|Antimanic Agents|antimanic agents|mesh-ancestor
5667367|NCT03589833|Methotrexate|methotrexate|mesh-list
5667368|NCT03589833|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5667369|NCT03589833|Abortifacient Agents|abortifacient agents|mesh-ancestor
5667370|NCT03589833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5667371|NCT03589833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667372|NCT03589833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5667373|NCT03589833|Antimetabolites|antimetabolites|mesh-ancestor
5667374|NCT03589833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667375|NCT03589833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5667376|NCT03589833|Dermatologic Agents|dermatologic agents|mesh-ancestor
5667377|NCT03589833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5667378|NCT03589833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5667379|NCT03589833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5667380|NCT03589833|Immunologic Factors|immunologic factors|mesh-ancestor
5667381|NCT03589833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5667382|NCT03589833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5667383|NCT03589690|Thioctic Acid|thioctic acid|mesh-list
5667384|NCT03589690|Antioxidants|antioxidants|mesh-ancestor
5667385|NCT03589690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5849586|NCT02455440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667386|NCT03589690|Protective Agents|protective agents|mesh-ancestor
5667387|NCT03589690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667388|NCT03589690|Vitamin B Complex|vitamin b complex|mesh-ancestor
5667389|NCT03589690|Vitamins|vitamins|mesh-ancestor
5667390|NCT03589690|Micronutrients|micronutrients|mesh-ancestor
5667391|NCT03589547|Durvalumab|durvalumab|mesh-list
5667392|NCT03589547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5667393|NCT03589547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5667394|NCT03589495|Acetylcysteine|acetylcysteine|mesh-list
5667395|NCT03589495|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5667396|NCT03589495|Antiviral Agents|antiviral agents|mesh-ancestor
5667397|NCT03589495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5667398|NCT03589495|Expectorants|expectorants|mesh-ancestor
5667399|NCT03589495|Respiratory System Agents|respiratory system agents|mesh-ancestor
5667400|NCT03589495|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5667401|NCT03589495|Antioxidants|antioxidants|mesh-ancestor
5667402|NCT03589495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667403|NCT03589495|Protective Agents|protective agents|mesh-ancestor
5667404|NCT03589495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849587|NCT02455440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5849588|NCT02455440|Anesthetics, General|anesthetics, general|mesh-ancestor
5849589|NCT02455440|Anesthetics|anesthetics|mesh-ancestor
5849590|NCT02455440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5849591|NCT02455440|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5849592|NCT02455440|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5667405|NCT03589495|Antidotes|antidotes|mesh-ancestor
5667406|NCT03589430|Protein C|protein c|mesh-list
5667407|NCT03589430|Antithrombins|antithrombins|mesh-list
5667408|NCT03589430|Antithrombin III|antithrombin iii|mesh-list
5667409|NCT03589430|Protein S|protein s|mesh-list
5667410|NCT03589430|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5667411|NCT03589430|Protease Inhibitors|protease inhibitors|mesh-ancestor
5849593|NCT02455440|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5849594|NCT02455440|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5849595|NCT02455440|Adrenergic Agents|adrenergic agents|mesh-ancestor
5849596|NCT02455440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5849597|NCT02455440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5849598|NCT02455271|Eszopiclone|eszopiclone|mesh-list
5849599|NCT02455271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5849600|NCT02455271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5849601|NCT02455271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849602|NCT02455232|Lidocaine|lidocaine|mesh-list
5849603|NCT02455232|Anesthetics, Local|anesthetics, local|mesh-ancestor
5849604|NCT02455232|Anesthetics|anesthetics|mesh-ancestor
5849605|NCT02455232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5849606|NCT02455232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849607|NCT02455232|Sensory System Agents|sensory system agents|mesh-ancestor
5849608|NCT02455232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5849609|NCT02455232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5849610|NCT02455232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5849611|NCT02455232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5849612|NCT02455232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5849613|NCT02455232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5849614|NCT02455245|Carboplatin|carboplatin|mesh-list
5849615|NCT02455245|Vincristine|vincristine|mesh-list
5849616|NCT02455245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5849617|NCT02455245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5849618|NCT02455245|Tubulin Modulators|tubulin modulators|mesh-ancestor
5849619|NCT02455245|Antimitotic Agents|antimitotic agents|mesh-ancestor
5849620|NCT02455245|Mitosis Modulators|mitosis modulators|mesh-ancestor
5849621|NCT02455245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5849622|NCT02455141|Cyclophosphamide|cyclophosphamide|mesh-list
5849623|NCT02455141|Carboplatin|carboplatin|mesh-list
5849624|NCT02455141|Epirubicin|epirubicin|mesh-list
5849625|NCT02455141|Taxane|taxane|mesh-list
5849626|NCT02455141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5849627|NCT02455141|Immunologic Factors|immunologic factors|mesh-ancestor
5849628|NCT02455141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849629|NCT02455141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5849630|NCT02455141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5849631|NCT02455141|Alkylating Agents|alkylating agents|mesh-ancestor
5849632|NCT02455141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667412|NCT03589430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5667413|NCT03589430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667414|NCT03589430|Anticoagulants|anticoagulants|mesh-ancestor
5849633|NCT02455141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5667415|NCT03589430|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5849634|NCT02455141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5849635|NCT02455141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5849636|NCT02455141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5849637|NCT02455141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5849638|NCT02455141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5849639|NCT02454855|Melatonin|melatonin|mesh-list
5849640|NCT02454855|Antioxidants|antioxidants|mesh-ancestor
5849641|NCT02454855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5849642|NCT02454855|Protective Agents|protective agents|mesh-ancestor
5849643|NCT02454855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849644|NCT02454855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5849645|NCT02454894|Lidocaine|lidocaine|mesh-list
5849646|NCT02454894|Anesthetics, Local|anesthetics, local|mesh-ancestor
5849647|NCT02454894|Anesthetics|anesthetics|mesh-ancestor
5849648|NCT02454894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5849649|NCT02454894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849650|NCT02454894|Sensory System Agents|sensory system agents|mesh-ancestor
5849651|NCT02454894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5849652|NCT02454894|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5849653|NCT02454894|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5849654|NCT02454894|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5667416|NCT03589430|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5667417|NCT03589222|Dexamethasone|dexamethasone|mesh-list
5667418|NCT03589222|Bortezomib|bortezomib|mesh-list
5667419|NCT03589222|Daratumumab|daratumumab|mesh-list
5667420|NCT03589222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5667421|NCT03589222|Antiemetics|antiemetics|mesh-ancestor
5667422|NCT03589222|Autonomic Agents|autonomic agents|mesh-ancestor
5667423|NCT03589222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5667424|NCT03589222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849655|NCT02454894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5849656|NCT02454894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5849657|NCT02455154|Letrozole|letrozole|mesh-list
5849658|NCT02455154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5849659|NCT02455154|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5849660|NCT02455154|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5849661|NCT02455154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5849662|NCT02455154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494053|NCT00616850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6494054|NCT00616850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6494055|NCT00616850|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6494056|NCT00616850|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6494057|NCT00616850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6494058|NCT00616850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494059|NCT00616863|Oxcarbazepine|oxcarbazepine|mesh-list
6494060|NCT00616863|Anticonvulsants|anticonvulsants|mesh-ancestor
6494061|NCT00616863|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6494062|NCT00616863|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6494063|NCT00616863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6494064|NCT00616863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494065|NCT00616863|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6494066|NCT00616863|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6494067|NCT00616876|Lactulose|lactulose|mesh-list
6494068|NCT00616876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6494069|NCT00616889|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6494070|NCT00616889|Antidepressive Agents|antidepressive agents|mesh-ancestor
5667425|NCT03589222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5667426|NCT03589222|Glucocorticoids|glucocorticoids|mesh-ancestor
5667427|NCT03589222|Hormones|hormones|mesh-ancestor
5667428|NCT03589222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5667429|NCT03589222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5667430|NCT03589222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5695800|NCT03387111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5695801|NCT03387111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5695802|NCT03387111|Alkylating Agents|alkylating agents|mesh-ancestor
5695803|NCT03387111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5695804|NCT03387111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5695805|NCT03387111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5695806|NCT03387111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5695807|NCT03387111|Growth Substances|growth substances|mesh-ancestor
5695808|NCT03387111|Growth Inhibitors|growth inhibitors|mesh-ancestor
5695809|NCT03387111|Antimetabolites|antimetabolites|mesh-ancestor
5667431|NCT03589066|Rotigotine|rotigotine|mesh-list
5667432|NCT03589066|Dopamine Agonists|dopamine agonists|mesh-ancestor
5667433|NCT03589066|Dopamine Agents|dopamine agents|mesh-ancestor
5667434|NCT03589066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5667435|NCT03589066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667436|NCT03589066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667437|NCT03589040|Darunavir|darunavir|mesh-list
5667438|NCT03589040|Rilpivirine|rilpivirine|mesh-list
5667439|NCT03589040|Etonogestrel|etonogestrel|mesh-list
5667440|NCT03589040|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5667441|NCT03589040|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5667442|NCT03589040|Protease Inhibitors|protease inhibitors|mesh-ancestor
5667443|NCT03589040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5667444|NCT03589040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667445|NCT03589040|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5667446|NCT03589040|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5667447|NCT03589040|Antiviral Agents|antiviral agents|mesh-ancestor
5667448|NCT03589040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5667449|NCT03589040|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6494071|NCT00616889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6494072|NCT00616889|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6494073|NCT00616889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6494074|NCT00616889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6494075|NCT00616889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667450|NCT03589040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5667451|NCT03589040|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5667452|NCT03589040|Contraceptive Agents|contraceptive agents|mesh-ancestor
5667453|NCT03589040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5667454|NCT03589040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494076|NCT00616915|Bupropion|bupropion|mesh-list
6494077|NCT00616915|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6494078|NCT00616915|Antidepressive Agents|antidepressive agents|mesh-ancestor
6494079|NCT00616915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6494080|NCT00616915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6494081|NCT00616915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6494082|NCT00616915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6494083|NCT00616915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494084|NCT00616915|Dopamine Agents|dopamine agents|mesh-ancestor
6494085|NCT00616915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6494086|NCT00616915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494087|NCT00616915|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5667455|NCT03589040|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5667456|NCT03589027|Ritonavir|ritonavir|mesh-list
5667457|NCT03589027|Darunavir|darunavir|mesh-list
5667458|NCT03589027|Rilpivirine|rilpivirine|mesh-list
5667459|NCT03589027|Levonorgestrel|levonorgestrel|mesh-list
5667460|NCT03589027|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5667461|NCT03589027|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5667462|NCT03589027|Protease Inhibitors|protease inhibitors|mesh-ancestor
5667463|NCT03589027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5667464|NCT03589027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667465|NCT03589027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5667466|NCT03589027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6494088|NCT00616915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6494089|NCT00616915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6494090|NCT00616993|Difluprednate|difluprednate|mesh-list
6494091|NCT00616993|Glucocorticoids|glucocorticoids|mesh-ancestor
6494092|NCT00616993|Hormones|hormones|mesh-ancestor
6494093|NCT00616993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6674739|NCT01571063|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5667467|NCT03589027|Antiviral Agents|antiviral agents|mesh-ancestor
5849663|NCT02455154|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5849664|NCT02455154|Hormone Antagonists|hormone antagonists|mesh-ancestor
5849665|NCT02455154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5849666|NCT02455154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849667|NCT02455180|Ascorbic Acid|ascorbic acid|mesh-list
5849668|NCT02455180|Vitamins|vitamins|mesh-ancestor
5849669|NCT02455180|Micronutrients|micronutrients|mesh-ancestor
5849670|NCT02455180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849671|NCT02455180|Antioxidants|antioxidants|mesh-ancestor
5849672|NCT02455180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5849673|NCT02455180|Protective Agents|protective agents|mesh-ancestor
5667468|NCT03589027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5849674|NCT02454881|Dexmedetomidine|dexmedetomidine|mesh-list
5849675|NCT02454881|Oxycodone|oxycodone|mesh-list
5849676|NCT02454881|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5849677|NCT02454881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5849678|NCT02454881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849679|NCT02454881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5849680|NCT02454881|Analgesics|analgesics|mesh-ancestor
5849681|NCT02454881|Sensory System Agents|sensory system agents|mesh-ancestor
5849682|NCT02454881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5849683|NCT02454881|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5849684|NCT02454881|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5849685|NCT02454881|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5849686|NCT02454881|Adrenergic Agents|adrenergic agents|mesh-ancestor
5849687|NCT02454881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5849688|NCT02454881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5849689|NCT02454881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5849690|NCT02454881|Narcotics|narcotics|mesh-ancestor
5849691|NCT02455115|Chromium|chromium|mesh-list
5849692|NCT02455115|Norepinephrine|norepinephrine|mesh-list
5849693|NCT02455115|Edetic Acid|edetic acid|mesh-list
5849694|NCT02455115|Pentetic Acid|pentetic acid|mesh-list
5849695|NCT02455115|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5849696|NCT02455115|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5849697|NCT02455115|Adrenergic Agents|adrenergic agents|mesh-ancestor
5849698|NCT02455115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5849699|NCT02455115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5849700|NCT02455115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667469|NCT03589027|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5667470|NCT03589027|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5667471|NCT03589027|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5667472|NCT03589027|Contraceptive Agents|contraceptive agents|mesh-ancestor
5667473|NCT03589027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5667474|NCT03589027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667475|NCT03589027|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5667476|NCT03589027|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5667477|NCT03589027|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5667478|NCT03589027|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5667479|NCT03589027|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6212111|NCT02181504|Growth Substances|growth substances|mesh-ancestor
6212112|NCT02181504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212113|NCT02181504|Growth Inhibitors|growth inhibitors|mesh-ancestor
6212114|NCT02181504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6212115|NCT02181517|Ranibizumab|ranibizumab|mesh-list
6212116|NCT02181517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6212117|NCT02181517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6212118|NCT02181517|Growth Substances|growth substances|mesh-ancestor
5849701|NCT02455115|Sympathomimetics|sympathomimetics|mesh-ancestor
5849702|NCT02455115|Autonomic Agents|autonomic agents|mesh-ancestor
5849703|NCT02455115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5849704|NCT02455115|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5849705|NCT02455115|Trace Elements|trace elements|mesh-ancestor
5849706|NCT02455115|Micronutrients|micronutrients|mesh-ancestor
5849707|NCT02455115|Anticoagulants|anticoagulants|mesh-ancestor
5849708|NCT02455115|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5849709|NCT02455115|Chelating Agents|chelating agents|mesh-ancestor
5849710|NCT02455115|Sequestering Agents|sequestering agents|mesh-ancestor
5849711|NCT02455115|Antidotes|antidotes|mesh-ancestor
5849712|NCT02455115|Protective Agents|protective agents|mesh-ancestor
5849713|NCT02455115|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5849714|NCT02455011|Volagidemab|volagidemab|mesh-list
5849715|NCT02455011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5849716|NCT02455011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849717|NCT02454868|Remifentanil|remifentanil|mesh-list
5849718|NCT02454868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5849719|NCT02454868|Narcotics|narcotics|mesh-ancestor
5849720|NCT02454868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5849721|NCT02454868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849722|NCT02454868|Analgesics|analgesics|mesh-ancestor
6212119|NCT02181517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212120|NCT02181517|Growth Inhibitors|growth inhibitors|mesh-ancestor
5667490|NCT03588988|Dexmedetomidine|dexmedetomidine|mesh-list
5667491|NCT03588988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5667492|NCT03588988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5667493|NCT03588988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849723|NCT02454868|Sensory System Agents|sensory system agents|mesh-ancestor
5849724|NCT02454868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5849725|NCT02454764|Interferons|interferons|mesh-list
5849726|NCT02454764|Tenofovir|tenofovir|mesh-list
5849727|NCT02454764|Interferon-alpha|interferon-alpha|mesh-list
5849728|NCT02454764|Interferon alpha-2|interferon alpha-2|mesh-list
5849729|NCT02454764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5849730|NCT02454764|Antiviral Agents|antiviral agents|mesh-ancestor
5667494|NCT03588988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5667495|NCT03588988|Analgesics|analgesics|mesh-ancestor
5667496|NCT03588988|Sensory System Agents|sensory system agents|mesh-ancestor
5667497|NCT03588988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5667498|NCT03588988|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5667499|NCT03588988|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5667500|NCT03588988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5667501|NCT03588988|Adrenergic Agents|adrenergic agents|mesh-ancestor
5667502|NCT03588988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5667503|NCT03588988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667504|NCT03588936|Nivolumab|nivolumab|mesh-list
5667505|NCT03588936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5667506|NCT03588936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5667507|NCT03588936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5849731|NCT02454764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5849732|NCT02454764|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5849733|NCT02454764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6494094|NCT00616993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849734|NCT02454764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5849735|NCT02454764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5849736|NCT02454764|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5849737|NCT02454764|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5849738|NCT02454764|Immunologic Factors|immunologic factors|mesh-ancestor
5849739|NCT02454764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849740|NCT02454751|Fentanyl|fentanyl|mesh-list
5849741|NCT02454751|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5849742|NCT02454751|Narcotics|narcotics|mesh-ancestor
5849743|NCT02454751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5849744|NCT02454751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849745|NCT02454751|Analgesics|analgesics|mesh-ancestor
5849746|NCT02454751|Sensory System Agents|sensory system agents|mesh-ancestor
5849747|NCT02454751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5849748|NCT02454751|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5849749|NCT02454751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5849750|NCT02454751|Anesthetics, General|anesthetics, general|mesh-ancestor
5849751|NCT02454751|Anesthetics|anesthetics|mesh-ancestor
5849752|NCT02454712|Naltrexone|naltrexone|mesh-list
5849753|NCT02454712|Oxycodone|oxycodone|mesh-list
5849754|NCT02454712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5849755|NCT02454712|Narcotics|narcotics|mesh-ancestor
5849756|NCT02454712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5849757|NCT02454712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849758|NCT02454712|Analgesics|analgesics|mesh-ancestor
5849759|NCT02454712|Sensory System Agents|sensory system agents|mesh-ancestor
5849760|NCT02454712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5849761|NCT02454712|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5849762|NCT02454712|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5849763|NCT02454543|Androgens|androgens|mesh-list
5849764|NCT02454543|Hormones|hormones|mesh-ancestor
5849765|NCT02454543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5849766|NCT02454543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849767|NCT02454491|Verapamil|verapamil|mesh-list
5849768|NCT02454491|Heparin|heparin|mesh-list
5849769|NCT02454491|Anticoagulants|anticoagulants|mesh-ancestor
5849770|NCT02454491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5849771|NCT02454491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5849772|NCT02454491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5849773|NCT02454491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5849774|NCT02454491|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5849775|NCT02454491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5849776|NCT02454491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5849777|NCT02454491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849778|NCT02454491|Vasodilator Agents|vasodilator agents|mesh-ancestor
5849779|NCT02454504|Neostigmine|neostigmine|mesh-list
5849780|NCT02454504|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5849781|NCT02454504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5849782|NCT02454504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5849783|NCT02454504|Cholinergic Agents|cholinergic agents|mesh-ancestor
6494095|NCT00617045|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5849784|NCT02454504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5849785|NCT02454504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849786|NCT02454504|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5849787|NCT02454504|Autonomic Agents|autonomic agents|mesh-ancestor
5849788|NCT02454504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5667508|NCT03588936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667509|NCT03588871|Hydrogen Peroxide|hydrogen peroxide|mesh-list
5667510|NCT03588871|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5667511|NCT03588871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5667512|NCT03588767|Vitamin D|vitamin d|mesh-list
5667513|NCT03588767|Ergocalciferols|ergocalciferols|mesh-list
5667514|NCT03588767|Cholecalciferol|cholecalciferol|mesh-list
5667515|NCT03588767|Vitamins|vitamins|mesh-list
5667516|NCT03588767|Testosterone Congeners|testosterone congeners|mesh-list
5667517|NCT03588767|Micronutrients|micronutrients|mesh-ancestor
5667518|NCT03588767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849789|NCT02454556|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5849790|NCT02454556|Hormones|hormones|mesh-ancestor
5849791|NCT02454556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5849792|NCT02454556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849793|NCT02454426|Vortioxetine|vortioxetine|mesh-list
5849794|NCT02454426|Antidepressive Agents|antidepressive agents|mesh-ancestor
5849795|NCT02454426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5849796|NCT02454426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5849797|NCT02454426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5849798|NCT02454426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5667519|NCT03588767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5667520|NCT03588767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5667521|NCT03588767|Anabolic Agents|anabolic agents|mesh-ancestor
5667522|NCT03588767|Hormones|hormones|mesh-ancestor
5667523|NCT03588767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5667524|NCT03588715|Interferons|interferons|mesh-list
5667525|NCT03588715|Interferon-alpha|interferon-alpha|mesh-list
5667526|NCT03588715|Interferon alpha-2|interferon alpha-2|mesh-list
5667527|NCT03588715|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
5667528|NCT03588715|Antibodies, Blocking|antibodies, blocking|mesh-list
5667529|NCT03588715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5849799|NCT02454426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849800|NCT02454426|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5849801|NCT02454426|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5849802|NCT02454426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5849803|NCT02454426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5849804|NCT02454426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5849805|NCT02454426|Serotonin Agents|serotonin agents|mesh-ancestor
5849806|NCT02454426|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5849807|NCT02454426|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5849808|NCT02454426|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5849809|NCT02454426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5849810|NCT02454348|Vasopressins|vasopressins|mesh-list
5849811|NCT02454348|Arginine Vasopressin|arginine vasopressin|mesh-list
5849812|NCT02454348|Norepinephrine|norepinephrine|mesh-list
5849813|NCT02454348|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5849814|NCT02454348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5849815|NCT02454348|Adrenergic Agents|adrenergic agents|mesh-ancestor
5849816|NCT02454348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5849817|NCT02454348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5849818|NCT02454348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667530|NCT03588715|Antiviral Agents|antiviral agents|mesh-ancestor
5667531|NCT03588715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5667532|NCT03588715|Immunologic Factors|immunologic factors|mesh-ancestor
5667533|NCT03588715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849819|NCT02454348|Sympathomimetics|sympathomimetics|mesh-ancestor
5849820|NCT02454348|Autonomic Agents|autonomic agents|mesh-ancestor
5849821|NCT02454348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5849822|NCT02454348|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5849823|NCT02454348|Hemostatics|hemostatics|mesh-ancestor
5849824|NCT02454348|Coagulants|coagulants|mesh-ancestor
5849825|NCT02454348|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5849826|NCT02454348|Natriuretic Agents|natriuretic agents|mesh-ancestor
5849827|NCT02454322|Magnesium Sulfate|magnesium sulfate|mesh-list
5849828|NCT02454322|Analgesics|analgesics|mesh-ancestor
5849829|NCT02454322|Sensory System Agents|sensory system agents|mesh-ancestor
5849830|NCT02454322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5667534|NCT03588689|Ropivacaine|ropivacaine|mesh-list
5667535|NCT03588689|Anesthetics, Local|anesthetics, local|mesh-ancestor
6212621|NCT02191397|Cholinergic Agents|cholinergic agents|mesh-ancestor
5667536|NCT03588689|Anesthetics|anesthetics|mesh-ancestor
5849831|NCT02454322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849832|NCT02454322|Anesthetics|anesthetics|mesh-ancestor
5849833|NCT02454322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5849834|NCT02454322|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5849835|NCT02454322|Anticonvulsants|anticonvulsants|mesh-ancestor
5849836|NCT02454322|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5849837|NCT02454322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5849838|NCT02454322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667537|NCT03588689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5667538|NCT03588689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667539|NCT03588689|Sensory System Agents|sensory system agents|mesh-ancestor
5667540|NCT03588689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5667541|NCT03588676|Melatonin|melatonin|mesh-list
5667542|NCT03588676|Antioxidants|antioxidants|mesh-ancestor
5667543|NCT03588676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667544|NCT03588676|Protective Agents|protective agents|mesh-ancestor
5667545|NCT03588676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667546|NCT03588676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5667547|NCT03588611|Hirudins|hirudins|mesh-list
5667548|NCT03588611|Bivalirudin|bivalirudin|mesh-list
5667549|NCT03588611|Antithrombins|antithrombins|mesh-ancestor
5667550|NCT03588611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5667551|NCT03588611|Protease Inhibitors|protease inhibitors|mesh-ancestor
5667552|NCT03588611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5849839|NCT02454322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5849840|NCT02454322|Tocolytic Agents|tocolytic agents|mesh-ancestor
5849841|NCT02454322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5849842|NCT02454205|Moxifloxacin|moxifloxacin|mesh-list
5849843|NCT02454205|Levofloxacin|levofloxacin|mesh-list
5849844|NCT02454205|Ofloxacin|ofloxacin|mesh-list
5849845|NCT02454205|Isoniazid|isoniazid|mesh-list
5849846|NCT02454205|Linezolid|linezolid|mesh-list
5849847|NCT02454205|Pyrazinamide|pyrazinamide|mesh-list
5849848|NCT02454205|Bedaquiline|bedaquiline|mesh-list
5849849|NCT02454205|Kanamycin|kanamycin|mesh-list
5849850|NCT02454205|Ethionamide|ethionamide|mesh-list
5849851|NCT02454205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5849852|NCT02454205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5849853|NCT02454205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5849854|NCT02454205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5849855|NCT02454205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5849856|NCT02454205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5849857|NCT02454205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5849858|NCT02454205|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5849859|NCT02454205|Renal Agents|renal agents|mesh-ancestor
5849860|NCT02454205|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5849861|NCT02454205|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5849862|NCT02454205|Antitubercular Agents|antitubercular agents|mesh-ancestor
5849863|NCT02454205|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5849864|NCT02454205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5849865|NCT02454205|Antimetabolites|antimetabolites|mesh-ancestor
5849866|NCT02454205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5849867|NCT02454205|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5903912|NCT04227028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5903913|NCT04227028|Endothelial Growth Factors|endothelial growth factors|mesh-list
5903914|NCT04227028|Antibodies|antibodies|mesh-list
5903915|NCT04227028|Immunoglobulins|immunoglobulins|mesh-list
5903916|NCT04227028|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5903917|NCT04227028|Immunoglobulin G|immunoglobulin g|mesh-list
5903918|NCT04227028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5903919|NCT04227028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5903920|NCT04227028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5903921|NCT04227028|Growth Substances|growth substances|mesh-ancestor
5903922|NCT04227028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903923|NCT04227028|Growth Inhibitors|growth inhibitors|mesh-ancestor
5903924|NCT04227028|Immunologic Factors|immunologic factors|mesh-ancestor
5903925|NCT04214288|Fulvestrant|fulvestrant|mesh-list
5903926|NCT04214288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5903927|NCT04214288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5903928|NCT04214288|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5903929|NCT04214288|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5903930|NCT04214288|Hormone Antagonists|hormone antagonists|mesh-ancestor
5903931|NCT04214288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5903932|NCT04214288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903933|NCT04207086|Pembrolizumab|pembrolizumab|mesh-list
5903934|NCT04207086|Lenvatinib|lenvatinib|mesh-list
5667553|NCT03588611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667554|NCT03588611|Anticoagulants|anticoagulants|mesh-ancestor
5667555|NCT03588611|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5667556|NCT03588611|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5667557|NCT03588533|Capecitabine|capecitabine|mesh-list
5667558|NCT03588533|Trastuzumab|trastuzumab|mesh-list
5667559|NCT03588533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5667560|NCT03588533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5667561|NCT03588533|Antimetabolites|antimetabolites|mesh-ancestor
5667562|NCT03588533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667563|NCT03588533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5667564|NCT03588494|Endostar protein|endostar protein|mesh-list
5667565|NCT03588494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5667566|NCT03588494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5667567|NCT03588494|Growth Substances|growth substances|mesh-ancestor
5667568|NCT03588494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667569|NCT03588494|Growth Inhibitors|growth inhibitors|mesh-ancestor
5667570|NCT03588494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5667571|NCT03588429|Sevoflurane|sevoflurane|mesh-list
5667572|NCT03588429|Isoflurane|isoflurane|mesh-list
5667573|NCT03588429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5667574|NCT03588429|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5667575|NCT03588429|Anesthetics, General|anesthetics, general|mesh-ancestor
5667576|NCT03588429|Anesthetics|anesthetics|mesh-ancestor
5667577|NCT03588429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5667578|NCT03588429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667579|NCT03588351|Chlorhexidine|chlorhexidine|mesh-list
5667580|NCT03588351|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5667581|NCT03588351|Chitosan|chitosan|mesh-list
5667582|NCT03588351|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5667583|NCT03588351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5849868|NCT02453984|Atezolizumab|atezolizumab|mesh-list
5849869|NCT02453984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5849870|NCT02454088|Calcium, Dietary|calcium, dietary|mesh-list
5849871|NCT02454088|Triamcinolone|triamcinolone|mesh-list
5849872|NCT02454088|Calcium|calcium|mesh-list
5849873|NCT02454088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5849874|NCT02454088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849875|NCT02454088|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5667584|NCT03588351|Disinfectants|disinfectants|mesh-ancestor
5667585|NCT03588351|Dermatologic Agents|dermatologic agents|mesh-ancestor
5667586|NCT03588351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5667587|NCT03588351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5667588|NCT03588351|Antimetabolites|antimetabolites|mesh-ancestor
5667589|NCT03588351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667590|NCT03588351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5667591|NCT03588351|Chelating Agents|chelating agents|mesh-ancestor
5667592|NCT03588351|Sequestering Agents|sequestering agents|mesh-ancestor
5667593|NCT03588351|Hemostatics|hemostatics|mesh-ancestor
5667594|NCT03588351|Coagulants|coagulants|mesh-ancestor
5667595|NCT03588338|Acetaminophen|acetaminophen|mesh-list
5849876|NCT02454088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5849877|NCT02454088|Glucocorticoids|glucocorticoids|mesh-ancestor
6212121|NCT02181517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6212122|NCT02181556|Aflibercept|aflibercept|mesh-list
6212123|NCT02181556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6212124|NCT02181556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6212125|NCT02181556|Growth Substances|growth substances|mesh-ancestor
6212126|NCT02181556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212127|NCT02181556|Growth Inhibitors|growth inhibitors|mesh-ancestor
6212128|NCT02181556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6212129|NCT02181634|Gemcitabine|gemcitabine|mesh-list
6212130|NCT02181634|Paclitaxel|paclitaxel|mesh-list
5667596|NCT03588338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5667597|NCT03588338|Analgesics|analgesics|mesh-ancestor
5667598|NCT03588338|Sensory System Agents|sensory system agents|mesh-ancestor
5667599|NCT03588338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5667600|NCT03588338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667601|NCT03588338|Antipyretics|antipyretics|mesh-ancestor
6212131|NCT02181634|Antimetabolites|antimetabolites|mesh-list
6212132|NCT02181634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6212133|NCT02181634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6212134|NCT02181634|Tubulin Modulators|tubulin modulators|mesh-ancestor
6212135|NCT02181634|Antimitotic Agents|antimitotic agents|mesh-ancestor
6212136|NCT02181634|Mitosis Modulators|mitosis modulators|mesh-ancestor
5667602|NCT03588273|Amoxicillin|amoxicillin|mesh-list
5849878|NCT02454088|Hormones|hormones|mesh-ancestor
6212137|NCT02181634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667603|NCT03588273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5667604|NCT03588273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5667605|NCT03588091|Docetaxel|docetaxel|mesh-list
6212138|NCT02181634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6212139|NCT02181634|Antiviral Agents|antiviral agents|mesh-ancestor
6212140|NCT02181634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6212141|NCT02181634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6212142|NCT02181634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6212143|NCT02181634|Immunologic Factors|immunologic factors|mesh-ancestor
5667606|NCT03588091|Trastuzumab|trastuzumab|mesh-list
5849879|NCT02454088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5849880|NCT02453867|Tacrolimus|tacrolimus|mesh-list
5849881|NCT02453867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5849882|NCT02453867|Immunologic Factors|immunologic factors|mesh-ancestor
5849883|NCT02453867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849884|NCT02453867|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5667607|NCT03588091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5667608|NCT03588091|Tubulin Modulators|tubulin modulators|mesh-ancestor
5667609|NCT03588091|Antimitotic Agents|antimitotic agents|mesh-ancestor
5667610|NCT03588091|Mitosis Modulators|mitosis modulators|mesh-ancestor
5667611|NCT03588091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667612|NCT03588091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5849885|NCT02453867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5849886|NCT02453867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5849887|NCT02453932|Donepezil|donepezil|mesh-list
5849888|NCT02453932|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5849889|NCT02453932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5849890|NCT02453932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5849891|NCT02453932|Cholinergic Agents|cholinergic agents|mesh-ancestor
5849892|NCT02453932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5849893|NCT02453932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849894|NCT02453932|Nootropic Agents|nootropic agents|mesh-ancestor
5849895|NCT02453698|Methylphenidate|methylphenidate|mesh-list
5849896|NCT02453698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5849897|NCT02453698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849898|NCT02453698|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5849899|NCT02453698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5849900|NCT02453698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5849901|NCT02453698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5849902|NCT02453698|Dopamine Agents|dopamine agents|mesh-ancestor
5849903|NCT02453698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5849904|NCT02453659|Nicotine|nicotine|mesh-list
5667613|NCT03588078|Azacitidine|azacitidine|mesh-list
5667614|NCT03588078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5667615|NCT03588078|Antimetabolites|antimetabolites|mesh-ancestor
5667616|NCT03588078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667617|NCT03588078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5667618|NCT03588078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5667619|NCT03588039|Paclitaxel|paclitaxel|mesh-list
5667620|NCT03588039|Pembrolizumab|pembrolizumab|mesh-list
5667621|NCT03588039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5667622|NCT03588039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5667623|NCT03588039|Tubulin Modulators|tubulin modulators|mesh-ancestor
5667624|NCT03588039|Antimitotic Agents|antimitotic agents|mesh-ancestor
5667625|NCT03588039|Mitosis Modulators|mitosis modulators|mesh-ancestor
5849905|NCT02453659|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5849906|NCT02453659|Autonomic Agents|autonomic agents|mesh-ancestor
5849907|NCT02453659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5849908|NCT02453659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849909|NCT02453659|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5849910|NCT02453659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5849911|NCT02453659|Cholinergic Agents|cholinergic agents|mesh-ancestor
5849912|NCT02453659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5849913|NCT02453659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5849914|NCT02453893|Risperidone|risperidone|mesh-list
5849915|NCT02453893|Iloperidone|iloperidone|mesh-list
5695810|NCT03387111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5849916|NCT02453893|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5849917|NCT02453893|Serotonin Agents|serotonin agents|mesh-ancestor
5849918|NCT02453893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5849919|NCT02453893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5849920|NCT02453893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849921|NCT02453893|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5667626|NCT03588039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667627|NCT03588039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5667628|NCT03587961|Ivacaftor|ivacaftor|mesh-list
5667629|NCT03587961|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
5667630|NCT03587961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5667631|NCT03587961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667632|NCT03587779|Sevoflurane|sevoflurane|mesh-list
5667633|NCT03587779|Desflurane|desflurane|mesh-list
5667634|NCT03587779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5667635|NCT03587779|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5667636|NCT03587779|Anesthetics, General|anesthetics, general|mesh-ancestor
5667637|NCT03587779|Anesthetics|anesthetics|mesh-ancestor
5667638|NCT03587779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5667639|NCT03587779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667640|NCT03587701|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5667641|NCT03587701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5667642|NCT03587662|Gemcitabine|gemcitabine|mesh-list
5667643|NCT03587662|Doxorubicin|doxorubicin|mesh-list
5667644|NCT03587662|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5667645|NCT03587662|Daunorubicin|daunorubicin|mesh-list
5667646|NCT03587662|Ixazomib|ixazomib|mesh-list
5667647|NCT03587662|Glycine|glycine|mesh-list
5667648|NCT03587662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5667649|NCT03587662|Antimetabolites|antimetabolites|mesh-ancestor
5667650|NCT03587662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667651|NCT03587662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5667652|NCT03587662|Antiviral Agents|antiviral agents|mesh-ancestor
5667653|NCT03587662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5667654|NCT03587662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5667655|NCT03587662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5667656|NCT03587662|Immunologic Factors|immunologic factors|mesh-ancestor
5667657|NCT03587662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667658|NCT03587662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5667659|NCT03587662|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5667660|NCT03587662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5667661|NCT03587662|Protease Inhibitors|protease inhibitors|mesh-ancestor
5667662|NCT03587662|Glycine Agents|glycine agents|mesh-ancestor
5667663|NCT03587662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5695811|NCT03387111|Antidotes|antidotes|mesh-ancestor
5695812|NCT03387111|Protective Agents|protective agents|mesh-ancestor
5695813|NCT03387111|Vitamin B Complex|vitamin b complex|mesh-ancestor
5695814|NCT03387111|Vitamins|vitamins|mesh-ancestor
5695815|NCT03387111|Micronutrients|micronutrients|mesh-ancestor
5695816|NCT03387098|Leucovorin|leucovorin|mesh-list
5695817|NCT03387098|Paclitaxel|paclitaxel|mesh-list
5695818|NCT03387098|Cyclophosphamide|cyclophosphamide|mesh-list
5695819|NCT03387098|Bevacizumab|bevacizumab|mesh-list
5695820|NCT03387098|Fluorouracil|fluorouracil|mesh-list
5695821|NCT03387098|Capecitabine|capecitabine|mesh-list
5849922|NCT02453893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5849923|NCT02453893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5849924|NCT02453893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5849925|NCT02453893|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5849926|NCT02453893|Dopamine Agents|dopamine agents|mesh-ancestor
5849927|NCT02453776|Infliximab|infliximab|mesh-list
5849928|NCT02453776|Dermatologic Agents|dermatologic agents|mesh-ancestor
5849929|NCT02453776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5849930|NCT02453776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5849931|NCT02453607|Infliximab|infliximab|mesh-list
5849932|NCT02453607|Dermatologic Agents|dermatologic agents|mesh-ancestor
5695822|NCT03387098|Oxaliplatin|oxaliplatin|mesh-list
5849933|NCT02453607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6494096|NCT00617045|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6494097|NCT00617045|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6494098|NCT00617045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6494099|NCT00617045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494100|NCT00617045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6494101|NCT00617045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494102|NCT00617045|Analgesics|analgesics|mesh-ancestor
6494103|NCT00617045|Sensory System Agents|sensory system agents|mesh-ancestor
6494104|NCT00617045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6494105|NCT00617045|Antidepressive Agents|antidepressive agents|mesh-ancestor
5695823|NCT03387098|Avelumab|avelumab|mesh-list
5849934|NCT02453607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5695824|NCT03387098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5695825|NCT03387098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5695826|NCT03387098|Tubulin Modulators|tubulin modulators|mesh-ancestor
5849935|NCT02453529|Nafithromycin|nafithromycin|mesh-list
6494106|NCT00617045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6494107|NCT00617045|Dopamine Agents|dopamine agents|mesh-ancestor
6494108|NCT00617253|Sunitinib|sunitinib|mesh-list
6494109|NCT00617253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6674740|NCT01571063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5667664|NCT03587610|Vaccines|vaccines|mesh-list
5667665|NCT03587610|Immunologic Factors|immunologic factors|mesh-ancestor
5667666|NCT03587610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667667|NCT03587558|Flecainide|flecainide|mesh-list
5667668|NCT03587558|Carvedilol|carvedilol|mesh-list
5667669|NCT03587558|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5667670|NCT03587558|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6674741|NCT01571167|Varenicline|varenicline|mesh-list
6674742|NCT01571167|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6674743|NCT01571167|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6674744|NCT01571167|Cholinergic Agents|cholinergic agents|mesh-ancestor
6674745|NCT01571167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6674746|NCT01571167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674747|NCT01571167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674748|NCT01571206|Infliximab|infliximab|mesh-list
6674749|NCT01571206|Dermatologic Agents|dermatologic agents|mesh-ancestor
6674750|NCT01571206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6674751|NCT01571206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6674752|NCT01571219|Infliximab|infliximab|mesh-list
6674753|NCT01571219|Dermatologic Agents|dermatologic agents|mesh-ancestor
6674754|NCT01571219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6674755|NCT01571219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6674756|NCT01571323|Misoprostol|misoprostol|mesh-list
6674757|NCT01571323|Oxytocin|oxytocin|mesh-list
5667671|NCT03587558|Adrenergic Agents|adrenergic agents|mesh-ancestor
5667672|NCT03587558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6494110|NCT00617253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6494111|NCT00617253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5849936|NCT02453529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5849937|NCT02453529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5849938|NCT02453529|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5849939|NCT02453529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5849940|NCT02453529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5849941|NCT02453802|Tranylcypromine|tranylcypromine|mesh-list
5849942|NCT02453802|Rivaroxaban|rivaroxaban|mesh-list
5849943|NCT02453802|Tranexamic Acid|tranexamic acid|mesh-list
5849944|NCT02453802|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5849945|NCT02453802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5849946|NCT02453802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5849947|NCT02453802|Hemostatics|hemostatics|mesh-ancestor
5849948|NCT02453802|Coagulants|coagulants|mesh-ancestor
5849949|NCT02453802|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6494112|NCT00617253|Growth Substances|growth substances|mesh-ancestor
5667673|NCT03587558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667674|NCT03587558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667675|NCT03587558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5667676|NCT03587558|Antioxidants|antioxidants|mesh-ancestor
5667677|NCT03587558|Protective Agents|protective agents|mesh-ancestor
5667678|NCT03587558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5667679|NCT03587558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5667680|NCT03587558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5667681|NCT03587558|Vasodilator Agents|vasodilator agents|mesh-ancestor
5667682|NCT03587558|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5667683|NCT03587558|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5667684|NCT03587558|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5667685|NCT03587558|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5667686|NCT03587558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5667687|NCT03587441|Neostigmine|neostigmine|mesh-list
5667688|NCT03587441|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5667689|NCT03587441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5667690|NCT03587441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667691|NCT03587441|Cholinergic Agents|cholinergic agents|mesh-ancestor
5667692|NCT03587441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5667693|NCT03587441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667694|NCT03587441|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5667695|NCT03587441|Autonomic Agents|autonomic agents|mesh-ancestor
5667696|NCT03587441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6494113|NCT00617253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494114|NCT00617253|Growth Inhibitors|growth inhibitors|mesh-ancestor
6494115|NCT00617253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6674758|NCT01571323|Oxytocics|oxytocics|mesh-ancestor
5667697|NCT03587324|Clopidogrel|clopidogrel|mesh-list
5849950|NCT02453802|Antithrombins|antithrombins|mesh-ancestor
5849951|NCT02453802|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5849952|NCT02453802|Protease Inhibitors|protease inhibitors|mesh-ancestor
5849953|NCT02453802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5849954|NCT02453802|Anticoagulants|anticoagulants|mesh-ancestor
5849955|NCT02453802|Antidepressive Agents|antidepressive agents|mesh-ancestor
5849956|NCT02453802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5849957|NCT02453802|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
5849958|NCT02453802|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5849959|NCT02453802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5849960|NCT02453802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5849961|NCT02453802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667698|NCT03587324|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5667699|NCT03587324|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5667700|NCT03587324|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5849962|NCT02453594|Pembrolizumab|pembrolizumab|mesh-list
5849963|NCT02453594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5849964|NCT02453594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5849965|NCT02453516|Epinephrine|epinephrine|mesh-list
5849966|NCT02453516|Ropivacaine|ropivacaine|mesh-list
5849967|NCT02453516|Anesthetics, Local|anesthetics, local|mesh-ancestor
5849968|NCT02453516|Anesthetics|anesthetics|mesh-ancestor
5849969|NCT02453516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5849970|NCT02453516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849971|NCT02453516|Sensory System Agents|sensory system agents|mesh-ancestor
5849972|NCT02453516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5849973|NCT02453516|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5849974|NCT02453516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5849975|NCT02453516|Adrenergic Agents|adrenergic agents|mesh-ancestor
5849976|NCT02453516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5849977|NCT02453516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5849978|NCT02453516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5849979|NCT02453516|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5849980|NCT02453516|Autonomic Agents|autonomic agents|mesh-ancestor
5849981|NCT02453516|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5849982|NCT02453516|Respiratory System Agents|respiratory system agents|mesh-ancestor
5849983|NCT02453516|Mydriatics|mydriatics|mesh-ancestor
5849984|NCT02453516|Sympathomimetics|sympathomimetics|mesh-ancestor
5849985|NCT02453516|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5849986|NCT02453503|Triamcinolone|triamcinolone|mesh-list
5849987|NCT02453503|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5849988|NCT02453503|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5667701|NCT03587324|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5667702|NCT03587324|Purinergic Agents|purinergic agents|mesh-ancestor
5667703|NCT03587324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5667704|NCT03587324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667705|NCT03587324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667706|NCT03587285|Goserelin|goserelin|mesh-list
5667707|NCT03587285|Abiraterone Acetate|abiraterone acetate|mesh-list
5667708|NCT03587285|Bicalutamide|bicalutamide|mesh-list
5667709|NCT03587285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5667710|NCT03587285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5667711|NCT03587285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5667712|NCT03587285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5667713|NCT03587285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667714|NCT03587285|Hormone Antagonists|hormone antagonists|mesh-ancestor
5667715|NCT03587285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5667716|NCT03587285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667717|NCT03587285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5667718|NCT03587285|Androgen Antagonists|androgen antagonists|mesh-ancestor
5849989|NCT02453503|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5849990|NCT02453503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5849991|NCT02453503|Glucocorticoids|glucocorticoids|mesh-ancestor
5849992|NCT02453503|Hormones|hormones|mesh-ancestor
5849993|NCT02453503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5849994|NCT02453503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5849995|NCT02453503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5849996|NCT02453503|Immunologic Factors|immunologic factors|mesh-ancestor
5849997|NCT02453503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5667719|NCT03587220|Lidocaine|lidocaine|mesh-list
5667720|NCT03587220|Capsaicin|capsaicin|mesh-list
5667721|NCT03587220|Histamine|histamine|mesh-list
5849998|NCT02453503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5849999|NCT02453373|Magnesium Sulfate|magnesium sulfate|mesh-list
5850000|NCT02453373|Plasminogen|plasminogen|mesh-list
5850001|NCT02453373|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5850002|NCT02453373|Propofol|propofol|mesh-list
5850003|NCT02453373|Etomidate|etomidate|mesh-list
5850004|NCT02453373|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5850005|NCT02453373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5850006|NCT02453373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850007|NCT02453373|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5850008|NCT02453373|Anesthetics, General|anesthetics, general|mesh-ancestor
5667722|NCT03587220|Anesthetics, Local|anesthetics, local|mesh-ancestor
5667723|NCT03587220|Anesthetics|anesthetics|mesh-ancestor
5667724|NCT03587220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5850009|NCT02453373|Anesthetics|anesthetics|mesh-ancestor
5850010|NCT02453373|Analgesics|analgesics|mesh-ancestor
5850011|NCT02453373|Sensory System Agents|sensory system agents|mesh-ancestor
5850012|NCT02453373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5850013|NCT02453373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5850014|NCT02453373|Anticonvulsants|anticonvulsants|mesh-ancestor
5850015|NCT02453373|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5850016|NCT02453373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5850017|NCT02453373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850018|NCT02453373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5850019|NCT02453373|Tocolytic Agents|tocolytic agents|mesh-ancestor
5850020|NCT02453373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5850021|NCT02453373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5850022|NCT02453373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5850023|NCT02453490|Fluorouracil|fluorouracil|mesh-list
5850024|NCT02453490|Raltitrexed|raltitrexed|mesh-list
5850025|NCT02453490|Antimetabolites|antimetabolites|mesh-ancestor
5850026|NCT02453490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850027|NCT02453490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5850028|NCT02453490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5850029|NCT02453490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5850030|NCT02453490|Immunologic Factors|immunologic factors|mesh-ancestor
5850031|NCT02453490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850032|NCT02453490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5850033|NCT02453490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5850034|NCT02453464|Leucovorin|leucovorin|mesh-list
5850035|NCT02453464|Irinotecan|irinotecan|mesh-list
5850036|NCT02453464|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5850037|NCT02453464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5850038|NCT02453464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5850039|NCT02453464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850040|NCT02453464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5850041|NCT02453464|Antidotes|antidotes|mesh-ancestor
5850042|NCT02453464|Protective Agents|protective agents|mesh-ancestor
5850043|NCT02453464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850044|NCT02453464|Vitamin B Complex|vitamin b complex|mesh-ancestor
5850045|NCT02453464|Vitamins|vitamins|mesh-ancestor
5850046|NCT02453464|Micronutrients|micronutrients|mesh-ancestor
5850047|NCT02453425|Norepinephrine|norepinephrine|mesh-list
5850048|NCT02453425|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5850049|NCT02453425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5850050|NCT02453425|Adrenergic Agents|adrenergic agents|mesh-ancestor
5850051|NCT02453425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5850052|NCT02453425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850053|NCT02453425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850054|NCT02453425|Sympathomimetics|sympathomimetics|mesh-ancestor
5850055|NCT02453425|Autonomic Agents|autonomic agents|mesh-ancestor
5850056|NCT02453425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5850057|NCT02453425|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5850058|NCT02453087|Rituximab|rituximab|mesh-list
5850059|NCT02453087|Obinutuzumab|obinutuzumab|mesh-list
5850060|NCT02453087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5850061|NCT02453087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5850062|NCT02453087|Immunologic Factors|immunologic factors|mesh-ancestor
5850063|NCT02453087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850064|NCT02453087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5850065|NCT02452905|Nitazoxanide|nitazoxanide|mesh-list
5850066|NCT02452905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5667725|NCT03587220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667726|NCT03587220|Sensory System Agents|sensory system agents|mesh-ancestor
5667727|NCT03587220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5667728|NCT03587220|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5695827|NCT03387098|Antimitotic Agents|antimitotic agents|mesh-ancestor
5850067|NCT02452905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5850068|NCT02453022|Omeprazole|omeprazole|mesh-list
5850069|NCT02453022|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5850070|NCT02453022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5850071|NCT02453022|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5850072|NCT02453022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5850073|NCT02453022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850074|NCT02452970|Gemcitabine|gemcitabine|mesh-list
5850075|NCT02452970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5850076|NCT02452970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5850077|NCT02452970|Antimetabolites|antimetabolites|mesh-ancestor
5850078|NCT02452970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850079|NCT02452970|Antiviral Agents|antiviral agents|mesh-ancestor
5850080|NCT02452970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5850081|NCT02452970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5850082|NCT02452970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5667729|NCT03587220|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5667730|NCT03587220|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5667731|NCT03587220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5667732|NCT03587220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667733|NCT03587220|Antipruritics|antipruritics|mesh-ancestor
5667734|NCT03587220|Dermatologic Agents|dermatologic agents|mesh-ancestor
5667735|NCT03587220|Histamine Agonists|histamine agonists|mesh-ancestor
5667736|NCT03587220|Histamine Agents|histamine agents|mesh-ancestor
5667737|NCT03587220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5667738|NCT03587194|Apremilast|apremilast|mesh-list
5667739|NCT03587194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5667740|NCT03587194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5667741|NCT03587194|Analgesics|analgesics|mesh-ancestor
5667742|NCT03587194|Sensory System Agents|sensory system agents|mesh-ancestor
5667743|NCT03587194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5667744|NCT03587194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667745|NCT03587194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5667746|NCT03587194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5667747|NCT03587194|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5667748|NCT03587194|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5667749|NCT03587194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5667750|NCT03587194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667751|NCT03587129|Apatinib|apatinib|mesh-list
5850083|NCT02452970|Immunologic Factors|immunologic factors|mesh-ancestor
5850084|NCT02452970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850085|NCT02452918|Oritavancin|oritavancin|mesh-list
5850086|NCT02452918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5850087|NCT02452918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5850088|NCT02452879|Solifenacin Succinate|solifenacin succinate|mesh-list
5850089|NCT02452879|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5850090|NCT02452879|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5850091|NCT02452879|Cholinergic Agents|cholinergic agents|mesh-ancestor
5850092|NCT02452879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5850093|NCT02452879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850094|NCT02452879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850095|NCT02452879|Urological Agents|urological agents|mesh-ancestor
5850096|NCT02452983|Sertraline|sertraline|mesh-list
5850097|NCT02452983|Antidepressive Agents|antidepressive agents|mesh-ancestor
5850098|NCT02452983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5850099|NCT02452983|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5850100|NCT02452983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5850101|NCT02452983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5850102|NCT02452983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850103|NCT02452983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5850104|NCT02452983|Serotonin Agents|serotonin agents|mesh-ancestor
5850105|NCT02452983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850106|NCT02453009|Prednisone|prednisone|mesh-list
5850107|NCT02453009|Docetaxel|docetaxel|mesh-list
5850108|NCT02453009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5850109|NCT02453009|Tubulin Modulators|tubulin modulators|mesh-ancestor
5850110|NCT02453009|Antimitotic Agents|antimitotic agents|mesh-ancestor
5850111|NCT02453009|Mitosis Modulators|mitosis modulators|mesh-ancestor
5850112|NCT02453009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850113|NCT02453009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5850114|NCT02453009|Glucocorticoids|glucocorticoids|mesh-ancestor
5850115|NCT02453009|Hormones|hormones|mesh-ancestor
5850116|NCT02453009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5850117|NCT02453009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494116|NCT00617253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5667752|NCT03587129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5667753|NCT03587129|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5667754|NCT03587129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5667755|NCT03587129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667756|NCT03587077|Isosorbide|isosorbide|mesh-list
5667757|NCT03587077|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
5667758|NCT03587077|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
5667759|NCT03587077|Misoprostol|misoprostol|mesh-list
5667760|NCT03587077|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5667761|NCT03587077|Abortifacient Agents|abortifacient agents|mesh-ancestor
5667762|NCT03587077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5667763|NCT03587077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850118|NCT02453009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5850119|NCT02452775|Poly ICLC|poly iclc|mesh-list
5850120|NCT02452775|Interferon Inducers|interferon inducers|mesh-ancestor
5850121|NCT02452775|Immunologic Factors|immunologic factors|mesh-ancestor
5850122|NCT02452775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850123|NCT02452632|Ipragliflozin|ipragliflozin|mesh-list
5850124|NCT02452632|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5850125|NCT02452632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850126|NCT02452632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5850127|NCT02452632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850128|NCT02452515|Fulacimstat|fulacimstat|mesh-list
5850129|NCT02452515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5850130|NCT02452515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667764|NCT03587077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5667765|NCT03587077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5667766|NCT03587077|Oxytocics|oxytocics|mesh-ancestor
5667767|NCT03587077|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5667768|NCT03587077|Diuretics|diuretics|mesh-ancestor
5667769|NCT03587077|Natriuretic Agents|natriuretic agents|mesh-ancestor
5667770|NCT03587077|Vasodilator Agents|vasodilator agents|mesh-ancestor
5667771|NCT03587077|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5667772|NCT03587077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667773|NCT03587038|Temozolomide|temozolomide|mesh-list
5667774|NCT03587038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5667775|NCT03587038|Alkylating Agents|alkylating agents|mesh-ancestor
5667776|NCT03587038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667777|NCT03587038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5667778|NCT03587025|Amitriptyline|amitriptyline|mesh-list
5850131|NCT02452684|Eszopiclone|eszopiclone|mesh-list
5850132|NCT02452684|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5850133|NCT02452684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5850134|NCT02452684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850135|NCT02452437|Oxycodone|oxycodone|mesh-list
5850136|NCT02452437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5850137|NCT02452437|Narcotics|narcotics|mesh-ancestor
5850138|NCT02452437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5850139|NCT02452437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850140|NCT02452437|Analgesics|analgesics|mesh-ancestor
5850141|NCT02452437|Sensory System Agents|sensory system agents|mesh-ancestor
5667779|NCT03587025|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
5667780|NCT03587025|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5667781|NCT03587025|Antidepressive Agents|antidepressive agents|mesh-ancestor
5667782|NCT03587025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5667783|NCT03587025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5667784|NCT03587025|Analgesics|analgesics|mesh-ancestor
5667785|NCT03587025|Sensory System Agents|sensory system agents|mesh-ancestor
5667786|NCT03587025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5667787|NCT03587025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667788|NCT03587025|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5667789|NCT03587025|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5667790|NCT03587025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5667791|NCT03587025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667792|NCT03587025|Adrenergic Agents|adrenergic agents|mesh-ancestor
5667793|NCT03587025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5850142|NCT02452437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5850143|NCT02452606|Levodopa|levodopa|mesh-list
5667794|NCT03587025|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5667795|NCT03587025|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5667796|NCT03587025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5667797|NCT03586947|Vitamin D|vitamin d|mesh-list
5667798|NCT03586947|Ergocalciferols|ergocalciferols|mesh-list
5850144|NCT02452606|Carbidopa|carbidopa|mesh-list
5850145|NCT02452606|Entacapone|entacapone|mesh-list
5850146|NCT02452606|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5850147|NCT02452606|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5850148|NCT02452606|Dopamine Agents|dopamine agents|mesh-ancestor
5850149|NCT02452606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5850150|NCT02452606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850151|NCT02452606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850152|NCT02452606|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5850153|NCT02452606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5850154|NCT02452606|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
5850155|NCT02452502|Atorvastatin|atorvastatin|mesh-list
5850156|NCT02452502|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5850157|NCT02452502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5850158|NCT02452502|Antimetabolites|antimetabolites|mesh-ancestor
5850159|NCT02452502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850160|NCT02452502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5850161|NCT02452502|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5850162|NCT02452502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5850163|NCT02452385|Vorolanib|vorolanib|mesh-list
5850164|NCT02452385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5850165|NCT02452385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5850166|NCT02452385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667799|NCT03586947|Cholecalciferol|cholecalciferol|mesh-list
5667800|NCT03586947|Vitamins|vitamins|mesh-list
5667801|NCT03586947|Micronutrients|micronutrients|mesh-ancestor
5667802|NCT03586947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667803|NCT03586947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5850167|NCT02452450|Acetaminophen|acetaminophen|mesh-list
5850168|NCT02452450|Ibuprofen|ibuprofen|mesh-list
5850169|NCT02452450|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5850170|NCT02452450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5850171|NCT02452450|Analgesics|analgesics|mesh-ancestor
6494117|NCT00617253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494118|NCT00617370|Paclitaxel|paclitaxel|mesh-list
6494119|NCT00617370|Cyclophosphamide|cyclophosphamide|mesh-list
6494120|NCT00617370|Epirubicin|epirubicin|mesh-list
6494121|NCT00617370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5850172|NCT02452450|Sensory System Agents|sensory system agents|mesh-ancestor
5850173|NCT02452450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5667804|NCT03586947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5667805|NCT03586934|Acetaminophen|acetaminophen|mesh-list
5667806|NCT03586934|Celecoxib|celecoxib|mesh-list
5667807|NCT03586934|Ketorolac|ketorolac|mesh-list
5667808|NCT03586934|Meloxicam|meloxicam|mesh-list
5667809|NCT03586934|Morphine|morphine|mesh-list
5667810|NCT03586934|Oxycodone|oxycodone|mesh-list
5667811|NCT03586934|Tramadol|tramadol|mesh-list
5850174|NCT02452450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850175|NCT02452450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5850176|NCT02452450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5850177|NCT02452450|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5850178|NCT02452450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5850179|NCT02452450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850180|NCT02452450|Antipyretics|antipyretics|mesh-ancestor
5903935|NCT04207086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5667812|NCT03586934|Hydrocodone|hydrocodone|mesh-list
5667813|NCT03586934|Ropivacaine|ropivacaine|mesh-list
5667814|NCT03586934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5667815|NCT03586934|Narcotics|narcotics|mesh-ancestor
5667816|NCT03586934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5667817|NCT03586934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667818|NCT03586934|Analgesics|analgesics|mesh-ancestor
5667819|NCT03586934|Sensory System Agents|sensory system agents|mesh-ancestor
5667820|NCT03586934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5903936|NCT04207086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5903937|NCT04207086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5903938|NCT04207086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5903939|NCT04207086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903940|NCT04202458|Tenecteplase|tenecteplase|mesh-list
5903941|NCT04202458|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5903942|NCT04202458|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5903943|NCT04202458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903944|NCT04184453|Deferiprone|deferiprone|mesh-list
6494122|NCT00617370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5667821|NCT03586934|Anesthetics, Local|anesthetics, local|mesh-ancestor
5667822|NCT03586934|Anesthetics|anesthetics|mesh-ancestor
5667823|NCT03586934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6674759|NCT01571323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6674760|NCT01571323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674761|NCT01571323|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6674762|NCT01571323|Abortifacient Agents|abortifacient agents|mesh-ancestor
6674763|NCT01571323|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5667824|NCT03586934|Antipyretics|antipyretics|mesh-ancestor
5667825|NCT03586934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5667826|NCT03586934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5667827|NCT03586934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5667828|NCT03586934|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5667829|NCT03586934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5667830|NCT03586934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5667831|NCT03586934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667832|NCT03586934|Antitussive Agents|antitussive agents|mesh-ancestor
5667833|NCT03586934|Respiratory System Agents|respiratory system agents|mesh-ancestor
5667834|NCT03586908|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5667835|NCT03586908|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5667836|NCT03586869|Leucovorin|leucovorin|mesh-list
5850181|NCT02452281|Ipilimumab|ipilimumab|mesh-list
5850182|NCT02452281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5850183|NCT02452281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5850184|NCT02452281|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5850185|NCT02452281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850186|NCT02452125|Nicotine|nicotine|mesh-list
5850187|NCT02452125|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5850188|NCT02452125|Autonomic Agents|autonomic agents|mesh-ancestor
5850189|NCT02452125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5850190|NCT02452125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667837|NCT03586869|Paclitaxel|paclitaxel|mesh-list
5667838|NCT03586869|Cyclophosphamide|cyclophosphamide|mesh-list
5667839|NCT03586869|Bevacizumab|bevacizumab|mesh-list
5667840|NCT03586869|Fluorouracil|fluorouracil|mesh-list
5667841|NCT03586869|Capecitabine|capecitabine|mesh-list
5667842|NCT03586869|Oxaliplatin|oxaliplatin|mesh-list
5667843|NCT03586869|Avelumab|avelumab|mesh-list
5667844|NCT03586869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5667845|NCT03586869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5667846|NCT03586869|Tubulin Modulators|tubulin modulators|mesh-ancestor
5667847|NCT03586869|Antimitotic Agents|antimitotic agents|mesh-ancestor
5667848|NCT03586869|Mitosis Modulators|mitosis modulators|mesh-ancestor
5667849|NCT03586869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667850|NCT03586869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5850191|NCT02452125|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5850192|NCT02452125|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5850193|NCT02452125|Cholinergic Agents|cholinergic agents|mesh-ancestor
5850194|NCT02452125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5850195|NCT02452125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850196|NCT02452307|Imiquimod|imiquimod|mesh-list
5850197|NCT02452307|Molgramostim|molgramostim|mesh-list
5850198|NCT02452307|Protamines|protamines|mesh-list
5850199|NCT02452307|Sargramostim|sargramostim|mesh-list
5850200|NCT02452307|Immunologic Factors|immunologic factors|mesh-ancestor
5850201|NCT02452307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667851|NCT03586869|Immunologic Factors|immunologic factors|mesh-ancestor
5667852|NCT03586869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667853|NCT03586869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5667854|NCT03586869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5667855|NCT03586869|Alkylating Agents|alkylating agents|mesh-ancestor
5667856|NCT03586869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5667857|NCT03586869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5667858|NCT03586869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5667859|NCT03586869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5667860|NCT03586869|Growth Substances|growth substances|mesh-ancestor
5667861|NCT03586869|Growth Inhibitors|growth inhibitors|mesh-ancestor
5667862|NCT03586869|Antimetabolites|antimetabolites|mesh-ancestor
5667863|NCT03586869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5850202|NCT02452307|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5850203|NCT02452307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5850204|NCT02452307|Interferon Inducers|interferon inducers|mesh-ancestor
5850205|NCT02452307|Heparin Antagonists|heparin antagonists|mesh-ancestor
5850206|NCT02452307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850207|NCT02452307|Coagulants|coagulants|mesh-ancestor
5850208|NCT02452151|Infliximab|infliximab|mesh-list
5667864|NCT03586869|Antidotes|antidotes|mesh-ancestor
5667865|NCT03586869|Protective Agents|protective agents|mesh-ancestor
5667866|NCT03586869|Vitamin B Complex|vitamin b complex|mesh-ancestor
5850209|NCT02452151|Dermatologic Agents|dermatologic agents|mesh-ancestor
5850210|NCT02452151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5850211|NCT02452151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5850212|NCT02452177|Vitamin D|vitamin d|mesh-list
5850213|NCT02452177|Vitamins|vitamins|mesh-ancestor
5850214|NCT02452177|Micronutrients|micronutrients|mesh-ancestor
5850215|NCT02452177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850216|NCT02452177|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5850217|NCT02452255|Propranolol|propranolol|mesh-list
5850218|NCT02452255|Metoprolol|metoprolol|mesh-list
5850219|NCT02452255|Fenofibrate|fenofibrate|mesh-list
5667867|NCT03586869|Vitamins|vitamins|mesh-ancestor
5667868|NCT03586869|Micronutrients|micronutrients|mesh-ancestor
5667869|NCT03586817|Palonosetron|palonosetron|mesh-list
5667870|NCT03586817|Fosaprepitant|fosaprepitant|mesh-list
5667871|NCT03586817|Aprepitant|aprepitant|mesh-list
5667872|NCT03586817|Antiemetics|antiemetics|mesh-ancestor
5667873|NCT03586817|Autonomic Agents|autonomic agents|mesh-ancestor
5667874|NCT03586817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5667875|NCT03586817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667876|NCT03586817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5667877|NCT03586817|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5667878|NCT03586817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5667879|NCT03586817|Serotonin Agents|serotonin agents|mesh-ancestor
5667880|NCT03586817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5667881|NCT03586817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667882|NCT03586817|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5667883|NCT03586791|Anesthetics|anesthetics|mesh-list
5667884|NCT03586791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5667885|NCT03586791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667886|NCT03586687|Triamcinolone|triamcinolone|mesh-list
5667887|NCT03586687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5667888|NCT03586687|Glucocorticoids|glucocorticoids|mesh-ancestor
5667889|NCT03586687|Hormones|hormones|mesh-ancestor
5667890|NCT03586687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5667891|NCT03586687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667892|NCT03586674|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
5850220|NCT02452255|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5850221|NCT02452255|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5850222|NCT02452255|Adrenergic Agents|adrenergic agents|mesh-ancestor
5850223|NCT02452255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5850224|NCT02452255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850225|NCT02452255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850226|NCT02452255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5850227|NCT02452255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5850228|NCT02452255|Vasodilator Agents|vasodilator agents|mesh-ancestor
5667893|NCT03586674|Fenofibrate|fenofibrate|mesh-list
5667894|NCT03586674|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5850229|NCT02452255|Sympatholytics|sympatholytics|mesh-ancestor
5850230|NCT02452255|Autonomic Agents|autonomic agents|mesh-ancestor
5850231|NCT02452255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5850232|NCT02452255|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5850233|NCT02452255|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5850234|NCT02452255|Antimetabolites|antimetabolites|mesh-ancestor
5850235|NCT02452255|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5850236|NCT02452216|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
5850237|NCT02452216|Hematinics|hematinics|mesh-ancestor
5850238|NCT02452216|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5850239|NCT02452216|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5850240|NCT02452112|Lidocaine|lidocaine|mesh-list
5850241|NCT02452112|Anesthetics, Local|anesthetics, local|mesh-ancestor
5850242|NCT02452112|Anesthetics|anesthetics|mesh-ancestor
5850243|NCT02452112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5850244|NCT02452112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850245|NCT02452112|Sensory System Agents|sensory system agents|mesh-ancestor
5850246|NCT02452112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5850247|NCT02452112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5850248|NCT02452112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5850249|NCT02452112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5850250|NCT02452112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5850251|NCT02452112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850252|NCT02452099|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
5850253|NCT02452099|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
5850254|NCT02452099|Protective Agents|protective agents|mesh-ancestor
5850255|NCT02452099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667895|NCT03586674|Antimetabolites|antimetabolites|mesh-ancestor
5695828|NCT03387098|Mitosis Modulators|mitosis modulators|mesh-ancestor
5850256|NCT02452099|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5850257|NCT02452099|Antioxidants|antioxidants|mesh-ancestor
5850258|NCT02452099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667896|NCT03586674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667897|NCT03586674|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5667898|NCT03586674|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5667899|NCT03586674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5667900|NCT03586661|Niraparib|niraparib|mesh-list
5667901|NCT03586661|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5667902|NCT03586661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5667903|NCT03586661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667904|NCT03586661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5667905|NCT03586466|Buprenorphine|buprenorphine|mesh-list
5667906|NCT03586466|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
5667907|NCT03586466|Naloxone|naloxone|mesh-list
5667908|NCT03586466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5667909|NCT03586466|Narcotics|narcotics|mesh-ancestor
5667910|NCT03586466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5667911|NCT03586466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667912|NCT03586466|Analgesics|analgesics|mesh-ancestor
5667913|NCT03586466|Sensory System Agents|sensory system agents|mesh-ancestor
5667914|NCT03586466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5667915|NCT03586466|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5667916|NCT03586453|Osimertinib|osimertinib|mesh-list
5667917|NCT03586453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5850259|NCT02451956|Paclitaxel|paclitaxel|mesh-list
5850260|NCT02451956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5850261|NCT02451956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5667918|NCT03586453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5667919|NCT03586453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5667920|NCT03586453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667921|NCT03586414|Ubiquinone|ubiquinone|mesh-list
5667922|NCT03586414|Micronutrients|micronutrients|mesh-ancestor
5667923|NCT03586414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667924|NCT03586323|Lidocaine|lidocaine|mesh-list
5667925|NCT03586323|Anesthetics, Local|anesthetics, local|mesh-ancestor
5667926|NCT03586323|Anesthetics|anesthetics|mesh-ancestor
5667927|NCT03586323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5667928|NCT03586323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667929|NCT03586323|Sensory System Agents|sensory system agents|mesh-ancestor
5667930|NCT03586323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5667931|NCT03586323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5667932|NCT03586323|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5667933|NCT03586323|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5667934|NCT03586323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5667935|NCT03586323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667936|NCT03586284|Valganciclovir|valganciclovir|mesh-list
5667937|NCT03586284|Ganciclovir|ganciclovir|mesh-list
5667938|NCT03586284|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
5850262|NCT02451956|Tubulin Modulators|tubulin modulators|mesh-ancestor
5850263|NCT02451956|Antimitotic Agents|antimitotic agents|mesh-ancestor
6494123|NCT00617370|Tubulin Modulators|tubulin modulators|mesh-ancestor
6494124|NCT00617370|Antimitotic Agents|antimitotic agents|mesh-ancestor
6494125|NCT00617370|Mitosis Modulators|mitosis modulators|mesh-ancestor
6494126|NCT00617370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212144|NCT02181634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212145|NCT02181673|Golimumab|golimumab|mesh-list
6212146|NCT02181673|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6212147|NCT02181673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6212148|NCT02181673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6212149|NCT02181673|Immunologic Factors|immunologic factors|mesh-ancestor
5850264|NCT02451956|Mitosis Modulators|mitosis modulators|mesh-ancestor
5850265|NCT02451956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850266|NCT02451865|Docetaxel|docetaxel|mesh-list
5850267|NCT02451865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5850268|NCT02451865|Tubulin Modulators|tubulin modulators|mesh-ancestor
5850269|NCT02451865|Antimitotic Agents|antimitotic agents|mesh-ancestor
5667939|NCT03586284|Antiviral Agents|antiviral agents|mesh-ancestor
5667940|NCT03586284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5667941|NCT03586284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5667942|NCT03586284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5667943|NCT03586284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667944|NCT03586219|Analgesics, Opioid|analgesics, opioid|mesh-list
6494127|NCT00617370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5850270|NCT02451865|Mitosis Modulators|mitosis modulators|mesh-ancestor
5850271|NCT02451865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850272|NCT02451787|Vitamin D|vitamin d|mesh-list
5850273|NCT02451787|Cholecalciferol|cholecalciferol|mesh-list
5850274|NCT02451787|Vitamins|vitamins|mesh-ancestor
5850275|NCT02451787|Micronutrients|micronutrients|mesh-ancestor
5850276|NCT02451787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850277|NCT02451787|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5850278|NCT02451787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5850279|NCT02451774|Pentoxifylline|pentoxifylline|mesh-list
5850280|NCT02451774|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5850281|NCT02451774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5850282|NCT02451774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850283|NCT02451774|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5850284|NCT02451774|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5850285|NCT02451774|Protective Agents|protective agents|mesh-ancestor
5850286|NCT02451774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850287|NCT02451774|Vasodilator Agents|vasodilator agents|mesh-ancestor
5850288|NCT02451774|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5850289|NCT02451774|Antioxidants|antioxidants|mesh-ancestor
5850290|NCT02451826|Ulipristal acetate|ulipristal acetate|mesh-list
5850291|NCT02451826|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5850292|NCT02451826|Contraceptive Agents|contraceptive agents|mesh-ancestor
6212150|NCT02181673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212151|NCT02181738|Doxorubicin|doxorubicin|mesh-list
6212152|NCT02181738|Nivolumab|nivolumab|mesh-list
6212153|NCT02181738|Dacarbazine|dacarbazine|mesh-list
6212154|NCT02181738|Vinblastine|vinblastine|mesh-list
6212155|NCT02181738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6212156|NCT02181738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6212157|NCT02181738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6212158|NCT02181738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6212159|NCT02181738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6212160|NCT02181738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212161|NCT02181738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6212162|NCT02181738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6212163|NCT02181738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6212164|NCT02181738|Alkylating Agents|alkylating agents|mesh-ancestor
6212165|NCT02181738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6212166|NCT02181738|Tubulin Modulators|tubulin modulators|mesh-ancestor
6212167|NCT02181738|Antimitotic Agents|antimitotic agents|mesh-ancestor
5667945|NCT03586219|Narcotics|narcotics|mesh-ancestor
5667946|NCT03586219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5667947|NCT03586219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667948|NCT03586219|Analgesics|analgesics|mesh-ancestor
5667949|NCT03586219|Sensory System Agents|sensory system agents|mesh-ancestor
5667950|NCT03586219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5667951|NCT03586154|Ketamine|ketamine|mesh-list
5667952|NCT03586154|Bupivacaine|bupivacaine|mesh-list
5667953|NCT03586154|Anesthetics, Local|anesthetics, local|mesh-ancestor
6212168|NCT02181738|Mitosis Modulators|mitosis modulators|mesh-ancestor
6212169|NCT02181816|Amlodipine|amlodipine|mesh-list
6212170|NCT02181816|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
6212171|NCT02181816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6212172|NCT02181816|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6212173|NCT02181816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6212174|NCT02181816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850293|NCT02451826|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5850294|NCT02451826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850295|NCT02451826|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5850296|NCT02451852|Osimertinib|osimertinib|mesh-list
5850297|NCT02451852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5850298|NCT02451852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5850299|NCT02451852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5850300|NCT02451852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850301|NCT02451748|Hydroxychloroquine|hydroxychloroquine|mesh-list
6212175|NCT02181816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5667954|NCT03586154|Anesthetics|anesthetics|mesh-ancestor
5667955|NCT03586154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5667956|NCT03586154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667957|NCT03586154|Sensory System Agents|sensory system agents|mesh-ancestor
5667958|NCT03586154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5667959|NCT03586154|Analgesics|analgesics|mesh-ancestor
5850302|NCT02451748|Sulfasalazine|sulfasalazine|mesh-list
5850303|NCT02451748|Prednisone|prednisone|mesh-list
6212176|NCT02181816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212177|NCT02181816|Vasodilator Agents|vasodilator agents|mesh-ancestor
6212178|NCT02181816|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6212179|NCT02181816|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6212180|NCT02181842|Pioglitazone|pioglitazone|mesh-list
6212181|NCT02181842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5850304|NCT02451748|Triamcinolone|triamcinolone|mesh-list
5850305|NCT02451748|Naproxen|naproxen|mesh-list
5850306|NCT02451748|Methotrexate|methotrexate|mesh-list
5850307|NCT02451748|Certolizumab Pegol|certolizumab pegol|mesh-list
5850308|NCT02451748|Leflunomide|leflunomide|mesh-list
5850309|NCT02451748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5850310|NCT02451748|Glucocorticoids|glucocorticoids|mesh-ancestor
5850311|NCT02451748|Hormones|hormones|mesh-ancestor
5850312|NCT02451748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5850313|NCT02451748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850314|NCT02451748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5850315|NCT02451748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5850316|NCT02451748|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5850317|NCT02451748|Abortifacient Agents|abortifacient agents|mesh-ancestor
5850318|NCT02451748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5850319|NCT02451748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5850320|NCT02451748|Antimetabolites|antimetabolites|mesh-ancestor
5850321|NCT02451748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850322|NCT02451748|Dermatologic Agents|dermatologic agents|mesh-ancestor
5850323|NCT02451748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5850324|NCT02451748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5850325|NCT02451748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5850326|NCT02451748|Immunologic Factors|immunologic factors|mesh-ancestor
5850327|NCT02451748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5850328|NCT02451748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5850329|NCT02451748|Antimalarials|antimalarials|mesh-ancestor
5850330|NCT02451748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5850331|NCT02451748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5850332|NCT02451748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5850333|NCT02451748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5850334|NCT02451748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5850335|NCT02451748|Analgesics|analgesics|mesh-ancestor
5850336|NCT02451748|Sensory System Agents|sensory system agents|mesh-ancestor
5850337|NCT02451748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5850338|NCT02451748|Gout Suppressants|gout suppressants|mesh-ancestor
5850339|NCT02451748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5850340|NCT02451748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5850341|NCT02451527|Digoxin|digoxin|mesh-list
5850342|NCT02451527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5850343|NCT02451527|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5850344|NCT02451527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5850345|NCT02451527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850346|NCT02451527|Protective Agents|protective agents|mesh-ancestor
5850347|NCT02451527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850348|NCT02451605|Analgesics|analgesics|mesh-list
5850349|NCT02451605|Ropivacaine|ropivacaine|mesh-list
5850350|NCT02451605|Anesthetics|anesthetics|mesh-ancestor
5850351|NCT02451605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5850352|NCT02451605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850353|NCT02451605|Anesthetics, Local|anesthetics, local|mesh-ancestor
5850354|NCT02451605|Sensory System Agents|sensory system agents|mesh-ancestor
5850355|NCT02451605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5850356|NCT02451579|Cetirizine|cetirizine|mesh-list
5850357|NCT02451579|Histamine Antagonists|histamine antagonists|mesh-list
5850358|NCT02451579|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
5850359|NCT02451579|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5850360|NCT02451579|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5850361|NCT02451579|Histamine Agents|histamine agents|mesh-ancestor
5850362|NCT02451579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6212182|NCT02181842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212183|NCT02182115|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
6212184|NCT02182115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6212185|NCT02182492|Clarithromycin|clarithromycin|mesh-list
6212186|NCT02182492|Glucocorticoids|glucocorticoids|mesh-list
6212187|NCT02182492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6212188|NCT02182492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6212189|NCT02182492|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6212190|NCT02182492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6212191|NCT02182492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667960|NCT03586154|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5667961|NCT03586154|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5667962|NCT03586154|Anesthetics, General|anesthetics, general|mesh-ancestor
5667963|NCT03586154|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5667964|NCT03586154|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5667965|NCT03586154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5850363|NCT02451579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850364|NCT02451579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850365|NCT02451475|Amitriptyline|amitriptyline|mesh-list
5850366|NCT02451475|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
5850367|NCT02451475|Paroxetine|paroxetine|mesh-list
5850368|NCT02451475|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
5850369|NCT02451475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5850370|NCT02451475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5850371|NCT02451475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5850372|NCT02451475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850373|NCT02451475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5850374|NCT02451475|Serotonin Agents|serotonin agents|mesh-ancestor
5850375|NCT02451475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850376|NCT02451475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5850377|NCT02451475|Antidepressive Agents|antidepressive agents|mesh-ancestor
5850378|NCT02451475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5850379|NCT02451475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5850380|NCT02451475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5850381|NCT02451475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5850382|NCT02451475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5850383|NCT02451475|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5850384|NCT02451475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5850385|NCT02451475|Analgesics|analgesics|mesh-ancestor
5850386|NCT02451475|Sensory System Agents|sensory system agents|mesh-ancestor
5850387|NCT02451475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5850388|NCT02451475|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5850389|NCT02451475|Adrenergic Agents|adrenergic agents|mesh-ancestor
5850390|NCT02451475|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5850391|NCT02451475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5667966|NCT03586154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667967|NCT03586089|Diazepam|diazepam|mesh-list
5667968|NCT03586089|Phenobarbital|phenobarbital|mesh-list
5667969|NCT03586089|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5667970|NCT03586089|Anticonvulsants|anticonvulsants|mesh-ancestor
5667971|NCT03586089|Antiemetics|antiemetics|mesh-ancestor
5667972|NCT03586089|Autonomic Agents|autonomic agents|mesh-ancestor
5667973|NCT03586089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5667974|NCT03586089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667975|NCT03586089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5667976|NCT03586089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5667977|NCT03586089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5667978|NCT03586089|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5667979|NCT03586089|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5667980|NCT03586089|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5667981|NCT03586089|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5667982|NCT03586089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5667983|NCT03586089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5667984|NCT03586089|Anesthetics, General|anesthetics, general|mesh-ancestor
5667985|NCT03586089|Anesthetics|anesthetics|mesh-ancestor
5667986|NCT03586089|GABA Modulators|gaba modulators|mesh-ancestor
5667987|NCT03586089|GABA Agents|gaba agents|mesh-ancestor
5667988|NCT03586089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5667989|NCT03586089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5667990|NCT03586089|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5667991|NCT03586089|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5667992|NCT03586089|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5667993|NCT03586089|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5667994|NCT03586089|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5695829|NCT03387098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695830|NCT03387098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5695831|NCT03387098|Immunologic Factors|immunologic factors|mesh-ancestor
5695832|NCT03387098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695833|NCT03387098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5695834|NCT03387098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5695835|NCT03387098|Alkylating Agents|alkylating agents|mesh-ancestor
5850392|NCT02451475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5850393|NCT02451462|Zoledronic Acid|zoledronic acid|mesh-list
5850394|NCT02451462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5850395|NCT02451462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5667995|NCT03586024|Pembrolizumab|pembrolizumab|mesh-list
5667996|NCT03586024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5667997|NCT03586024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5667998|NCT03585998|Cisplatin|cisplatin|mesh-list
5667999|NCT03585998|Etoposide|etoposide|mesh-list
5668000|NCT03585998|Durvalumab|durvalumab|mesh-list
5668001|NCT03585998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5668002|NCT03585998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5668003|NCT03585998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5668004|NCT03585998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5668005|NCT03585998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5668006|NCT03585998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668007|NCT03585998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5668008|NCT03585894|Ketorolac|ketorolac|mesh-list
5668009|NCT03585894|Sumatriptan|sumatriptan|mesh-list
5850396|NCT02451423|Atezolizumab|atezolizumab|mesh-list
5850397|NCT02451423|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5850398|NCT02451423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5850399|NCT02451423|Immunologic Factors|immunologic factors|mesh-ancestor
5850400|NCT02451423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850401|NCT02451306|Quetiapine Fumarate|quetiapine fumarate|mesh-list
5850402|NCT02451306|Antidepressive Agents|antidepressive agents|mesh-ancestor
5850403|NCT02451306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5850404|NCT02451306|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5850405|NCT02451306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5850406|NCT02451306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5850407|NCT02451306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850408|NCT02451293|Melatonin|melatonin|mesh-list
5850409|NCT02451293|Antioxidants|antioxidants|mesh-ancestor
5850410|NCT02451293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850411|NCT02451293|Protective Agents|protective agents|mesh-ancestor
5850412|NCT02451293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850413|NCT02451293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5850414|NCT02451072|Ketanserin|ketanserin|mesh-list
5850415|NCT02451072|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
5850416|NCT02451072|Hallucinogens|hallucinogens|mesh-ancestor
5850417|NCT02451072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850418|NCT02451072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5850419|NCT02451072|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5668010|NCT03585894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5668011|NCT03585894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5668012|NCT03585894|Analgesics|analgesics|mesh-ancestor
5668013|NCT03585894|Sensory System Agents|sensory system agents|mesh-ancestor
5668014|NCT03585894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5668015|NCT03585894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668016|NCT03585894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5668017|NCT03585894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5668018|NCT03585894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5668019|NCT03585894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5850420|NCT02451072|Serotonin Agents|serotonin agents|mesh-ancestor
5850421|NCT02451072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5850422|NCT02451072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850423|NCT02451072|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5850424|NCT02451072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5668020|NCT03585894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668021|NCT03585894|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5668022|NCT03585894|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5668023|NCT03585894|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5668024|NCT03585894|Serotonin Agents|serotonin agents|mesh-ancestor
5668025|NCT03585894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5668026|NCT03585829|Prednisolone|prednisolone|mesh-list
5668027|NCT03585829|Hydrocortisone|hydrocortisone|mesh-list
5668028|NCT03585829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5668029|NCT03585829|Glucocorticoids|glucocorticoids|mesh-ancestor
5668030|NCT03585829|Hormones|hormones|mesh-ancestor
5668031|NCT03585829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5668032|NCT03585829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668033|NCT03585829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5668034|NCT03585829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5668035|NCT03585751|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5850425|NCT02451072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5850426|NCT02451111|Rituximab|rituximab|mesh-list
5850427|NCT02451111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5850428|NCT02451111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5850429|NCT02451111|Immunologic Factors|immunologic factors|mesh-ancestor
5850430|NCT02451111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668036|NCT03585751|Simvastatin|simvastatin|mesh-list
5668037|NCT03585751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5668038|NCT03585751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5850431|NCT02451111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5850432|NCT02451033|Hormones|hormones|mesh-list
5850433|NCT02451033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5668039|NCT03585751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5668040|NCT03585751|Antimetabolites|antimetabolites|mesh-ancestor
5668041|NCT03585751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668042|NCT03585751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5668043|NCT03585751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5668044|NCT03585751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5668045|NCT03585738|Folic Acid|folic acid|mesh-list
5668046|NCT03585738|Vitamin B Complex|vitamin b complex|mesh-list
5668047|NCT03585738|Inositol|inositol|mesh-list
5668048|NCT03585738|Hematinics|hematinics|mesh-ancestor
5668049|NCT03585738|Vitamins|vitamins|mesh-ancestor
5668050|NCT03585738|Micronutrients|micronutrients|mesh-ancestor
5850434|NCT02451033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850435|NCT02450994|Dexamethasone|dexamethasone|mesh-list
5850436|NCT02450994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5850437|NCT02450994|Antiemetics|antiemetics|mesh-ancestor
5850438|NCT02450994|Autonomic Agents|autonomic agents|mesh-ancestor
6494128|NCT00617370|Immunologic Factors|immunologic factors|mesh-ancestor
6494129|NCT00617370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668051|NCT03585738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668052|NCT03585725|Ribavirin|ribavirin|mesh-list
5668053|NCT03585725|Antimetabolites|antimetabolites|mesh-ancestor
5668054|NCT03585725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668055|NCT03585725|Antiviral Agents|antiviral agents|mesh-ancestor
5668056|NCT03585725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5668057|NCT03585686|Cytarabine|cytarabine|mesh-list
5668058|NCT03585686|Vemurafenib|vemurafenib|mesh-list
5668059|NCT03585686|Cladribine|cladribine|mesh-list
5668060|NCT03585686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5668061|NCT03585686|Antimetabolites|antimetabolites|mesh-ancestor
5668062|NCT03585686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668063|NCT03585686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6494130|NCT00617370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6494131|NCT00617370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6494132|NCT00617370|Alkylating Agents|alkylating agents|mesh-ancestor
6494133|NCT00617370|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5850439|NCT02450994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5850440|NCT02450994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850441|NCT02450994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6494134|NCT00617370|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6494135|NCT00617370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6494136|NCT00617370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6494137|NCT00617370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6494138|NCT00617448|Anesthetics|anesthetics|mesh-list
6494139|NCT00617448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6494140|NCT00617448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494141|NCT00617474|Epoetin Alfa|epoetin alfa|mesh-list
6494142|NCT00617474|Hematinics|hematinics|mesh-ancestor
6494143|NCT00617500|Hormones|hormones|mesh-list
6494144|NCT00617500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5668064|NCT03585686|Antiviral Agents|antiviral agents|mesh-ancestor
5668065|NCT03585686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5668066|NCT03585686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5668067|NCT03585686|Immunologic Factors|immunologic factors|mesh-ancestor
5668068|NCT03585686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668069|NCT03585686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5668070|NCT03585686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5668071|NCT03585673|Docetaxel|docetaxel|mesh-list
5668072|NCT03585673|Oxaliplatin|oxaliplatin|mesh-list
5668073|NCT03585673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5668074|NCT03585673|Tubulin Modulators|tubulin modulators|mesh-ancestor
5668075|NCT03585673|Antimitotic Agents|antimitotic agents|mesh-ancestor
5668076|NCT03585673|Mitosis Modulators|mitosis modulators|mesh-ancestor
5850442|NCT02450994|Glucocorticoids|glucocorticoids|mesh-ancestor
5668077|NCT03585673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668078|NCT03585569|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5668079|NCT03585569|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5668080|NCT03585569|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5668081|NCT03585569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5668082|NCT03585569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668083|NCT03585569|Cholinergic Agents|cholinergic agents|mesh-ancestor
5668084|NCT03585569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5668085|NCT03585569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668086|NCT03585569|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5668087|NCT03585569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5668088|NCT03585556|Prednisolone|prednisolone|mesh-list
5668089|NCT03585556|Bevacizumab|bevacizumab|mesh-list
5668090|NCT03585556|Ranibizumab|ranibizumab|mesh-list
5668091|NCT03585556|Aflibercept|aflibercept|mesh-list
5850443|NCT02450994|Hormones|hormones|mesh-ancestor
5850444|NCT02450994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5850445|NCT02450994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5850446|NCT02450994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5850447|NCT02450981|Bevacizumab|bevacizumab|mesh-list
5850448|NCT02450981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5850449|NCT02450981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5668092|NCT03585556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5668093|NCT03585556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5668094|NCT03585556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5668095|NCT03585556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5668096|NCT03585556|Growth Substances|growth substances|mesh-ancestor
5668097|NCT03585556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668098|NCT03585556|Growth Inhibitors|growth inhibitors|mesh-ancestor
5668099|NCT03585556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5668100|NCT03585556|Glucocorticoids|glucocorticoids|mesh-ancestor
5668101|NCT03585556|Hormones|hormones|mesh-ancestor
5668102|NCT03585556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5668103|NCT03585556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5668104|NCT03585530|Raltitrexed|raltitrexed|mesh-list
5668105|NCT03585530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5668106|NCT03585530|Antimetabolites|antimetabolites|mesh-ancestor
5668107|NCT03585530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850450|NCT02450981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5850451|NCT02450981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5850452|NCT02450981|Growth Substances|growth substances|mesh-ancestor
5850453|NCT02450981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850454|NCT02450981|Growth Inhibitors|growth inhibitors|mesh-ancestor
5850455|NCT02450968|Dexamethasone|dexamethasone|mesh-list
5850456|NCT02450968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5850457|NCT02450968|Antiemetics|antiemetics|mesh-ancestor
5850458|NCT02450968|Autonomic Agents|autonomic agents|mesh-ancestor
5850459|NCT02450968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5850460|NCT02450968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850461|NCT02450968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5850462|NCT02450968|Glucocorticoids|glucocorticoids|mesh-ancestor
5850463|NCT02450968|Hormones|hormones|mesh-ancestor
5850464|NCT02450968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5850465|NCT02450968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5850466|NCT02450968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5850467|NCT02451098|Atorvastatin|atorvastatin|mesh-list
5850468|NCT02451098|Ezetimibe|ezetimibe|mesh-list
5850469|NCT02451098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5850470|NCT02451098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5850471|NCT02451098|Antimetabolites|antimetabolites|mesh-ancestor
5850472|NCT02451098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850473|NCT02451098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5850474|NCT02451098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5850475|NCT02451098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5850476|NCT02450786|Donepezil|donepezil|mesh-list
5850477|NCT02450786|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5850478|NCT02450786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5850479|NCT02450786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850480|NCT02450786|Cholinergic Agents|cholinergic agents|mesh-ancestor
5850481|NCT02450786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5850482|NCT02450786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850483|NCT02450786|Nootropic Agents|nootropic agents|mesh-ancestor
5850484|NCT02450838|Aluminum Hydroxide|aluminum hydroxide|mesh-list
5668108|NCT03585530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5668109|NCT03585530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5668110|NCT03585530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5668111|NCT03585465|Cyclophosphamide|cyclophosphamide|mesh-list
5668112|NCT03585465|Capecitabine|capecitabine|mesh-list
5668113|NCT03585465|Nivolumab|nivolumab|mesh-list
5668114|NCT03585465|Vinblastine|vinblastine|mesh-list
5668115|NCT03585465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5668116|NCT03585465|Immunologic Factors|immunologic factors|mesh-ancestor
5668117|NCT03585465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668118|NCT03585465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5668119|NCT03585465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5668120|NCT03585465|Alkylating Agents|alkylating agents|mesh-ancestor
5668121|NCT03585465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668122|NCT03585465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5668123|NCT03585465|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5668124|NCT03585465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5668125|NCT03585465|Antimetabolites|antimetabolites|mesh-ancestor
5668126|NCT03585465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5668127|NCT03585465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5668128|NCT03585465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5850485|NCT02450838|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5850486|NCT02450838|Immunologic Factors|immunologic factors|mesh-ancestor
5850487|NCT02450838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850488|NCT02450838|Antacids|antacids|mesh-ancestor
5850489|NCT02450838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850490|NCT02450838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5850491|NCT02450773|Furosemide|furosemide|mesh-list
5850492|NCT02450773|Diuretics|diuretics|mesh-ancestor
5850493|NCT02450773|Natriuretic Agents|natriuretic agents|mesh-ancestor
5850494|NCT02450773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850495|NCT02450773|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5850496|NCT02450773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5850497|NCT02450773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850498|NCT02450877|Azacitidine|azacitidine|mesh-list
5850499|NCT02450877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5668129|NCT03585465|Tubulin Modulators|tubulin modulators|mesh-ancestor
5668130|NCT03585465|Antimitotic Agents|antimitotic agents|mesh-ancestor
5668131|NCT03585465|Mitosis Modulators|mitosis modulators|mesh-ancestor
5668132|NCT03585452|Dexmedetomidine|dexmedetomidine|mesh-list
5668133|NCT03585452|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5668134|NCT03585452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5668135|NCT03585452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668136|NCT03585452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5668137|NCT03585452|Analgesics|analgesics|mesh-ancestor
5850500|NCT02450877|Antimetabolites|antimetabolites|mesh-ancestor
5850501|NCT02450877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850502|NCT02450877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5850503|NCT02450877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5850504|NCT02450682|Warfarin|warfarin|mesh-list
5850505|NCT02450682|Apixaban|apixaban|mesh-list
5850506|NCT02450682|Anticoagulants|anticoagulants|mesh-ancestor
5850507|NCT02450682|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5850508|NCT02450682|Antithrombins|antithrombins|mesh-ancestor
5850509|NCT02450682|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5850510|NCT02450682|Protease Inhibitors|protease inhibitors|mesh-ancestor
5850511|NCT02450682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5850512|NCT02450682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850513|NCT02450656|Docetaxel|docetaxel|mesh-list
5850514|NCT02450656|Afatinib|afatinib|mesh-list
5850515|NCT02450656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5850516|NCT02450656|Tubulin Modulators|tubulin modulators|mesh-ancestor
5850517|NCT02450656|Antimitotic Agents|antimitotic agents|mesh-ancestor
5850518|NCT02450656|Mitosis Modulators|mitosis modulators|mesh-ancestor
5668138|NCT03585452|Sensory System Agents|sensory system agents|mesh-ancestor
5668139|NCT03585452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5668140|NCT03585452|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5668141|NCT03585452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5668142|NCT03585452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5668143|NCT03585452|Adrenergic Agents|adrenergic agents|mesh-ancestor
5668144|NCT03585452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5695836|NCT03387098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5850519|NCT02450656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850520|NCT02450656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5850521|NCT02450656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5850522|NCT02450513|Adalimumab|adalimumab|mesh-list
5850523|NCT02450513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5850524|NCT02450513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5850525|NCT02450188|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
5850526|NCT02450188|Vasodilator Agents|vasodilator agents|mesh-ancestor
5850527|NCT02450188|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5850528|NCT02450188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5850529|NCT02450188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5850530|NCT02450188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850531|NCT02450188|Urological Agents|urological agents|mesh-ancestor
5850532|NCT02450253|Tadalafil|tadalafil|mesh-list
5850533|NCT02450253|Vasodilator Agents|vasodilator agents|mesh-ancestor
5850534|NCT02450253|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5850535|NCT02450253|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5850536|NCT02450253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5850537|NCT02450253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850538|NCT02450253|Urological Agents|urological agents|mesh-ancestor
5850539|NCT02450214|Ketamine|ketamine|mesh-list
5850540|NCT02450214|Analgesics|analgesics|mesh-ancestor
5850541|NCT02450214|Sensory System Agents|sensory system agents|mesh-ancestor
5850542|NCT02450214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5850543|NCT02450214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850544|NCT02450214|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5850545|NCT02450214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5850546|NCT02450214|Anesthetics, General|anesthetics, general|mesh-ancestor
5850547|NCT02450214|Anesthetics|anesthetics|mesh-ancestor
5850548|NCT02450214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5850549|NCT02450214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5850550|NCT02450214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5850551|NCT02450214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5850552|NCT02450214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850553|NCT02450175|Everolimus|everolimus|mesh-list
5850554|NCT02450175|Letrozole|letrozole|mesh-list
5850555|NCT02450175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5850556|NCT02450175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5850557|NCT02450175|Immunologic Factors|immunologic factors|mesh-ancestor
5850558|NCT02450175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850559|NCT02450175|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5850560|NCT02450175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5850561|NCT02450175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5850562|NCT02450175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850563|NCT02450175|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5850564|NCT02450175|Hormone Antagonists|hormone antagonists|mesh-ancestor
5850565|NCT02450175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5850566|NCT02450279|Edetic Acid|edetic acid|mesh-list
5850567|NCT02450279|Pentetic Acid|pentetic acid|mesh-list
5850568|NCT02450279|Antidotes|antidotes|mesh-ancestor
5850569|NCT02450279|Protective Agents|protective agents|mesh-ancestor
5850570|NCT02450279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850571|NCT02450279|Chelating Agents|chelating agents|mesh-ancestor
5850572|NCT02450279|Sequestering Agents|sequestering agents|mesh-ancestor
5850573|NCT02450279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850574|NCT02450279|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5850575|NCT02450279|Anticoagulants|anticoagulants|mesh-ancestor
5850576|NCT02450279|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5850577|NCT02450149|Sorafenib|sorafenib|mesh-list
5850578|NCT02450149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5850579|NCT02450149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5850580|NCT02450149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5850581|NCT02450149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850582|NCT02450123|Sunitinib|sunitinib|mesh-list
5850583|NCT02450123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5850584|NCT02450123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5850585|NCT02450123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5850586|NCT02450123|Growth Substances|growth substances|mesh-ancestor
5850587|NCT02450123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850588|NCT02450123|Growth Inhibitors|growth inhibitors|mesh-ancestor
5850589|NCT02450123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5850590|NCT02450123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5850591|NCT02450123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850592|NCT02450084|Fentanyl|fentanyl|mesh-list
5850593|NCT02450084|Ropivacaine|ropivacaine|mesh-list
5850594|NCT02450084|Anesthetics, Local|anesthetics, local|mesh-ancestor
5850595|NCT02450084|Anesthetics|anesthetics|mesh-ancestor
5850596|NCT02450084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5850597|NCT02450084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850598|NCT02450084|Sensory System Agents|sensory system agents|mesh-ancestor
5850599|NCT02450084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6494145|NCT00617500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494146|NCT00617513|Prucalopride|prucalopride|mesh-list
6494147|NCT00617513|Laxatives|laxatives|mesh-ancestor
6494148|NCT00617513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6494149|NCT00617513|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
6494150|NCT00617513|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6494151|NCT00617513|Serotonin Agents|serotonin agents|mesh-ancestor
6494152|NCT00617513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6494153|NCT00617513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494154|NCT00617513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494155|NCT00617565|Insulin|insulin|mesh-list
5668145|NCT03585452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668146|NCT03585426|Vancomycin|vancomycin|mesh-list
5668147|NCT03585426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5668148|NCT03585426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5668149|NCT03585413|Micronutrients|micronutrients|mesh-list
5668150|NCT03585413|Trace Elements|trace elements|mesh-list
5668151|NCT03585413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668152|NCT03585374|Acetaminophen|acetaminophen|mesh-list
5668153|NCT03585374|Ketoprofen|ketoprofen|mesh-list
5668154|NCT03585374|Morphine|morphine|mesh-list
5668155|NCT03585374|Methoxyflurane|methoxyflurane|mesh-list
5668156|NCT03585374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5668157|NCT03585374|Narcotics|narcotics|mesh-ancestor
5668158|NCT03585374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5668159|NCT03585374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668160|NCT03585374|Analgesics|analgesics|mesh-ancestor
5668161|NCT03585374|Sensory System Agents|sensory system agents|mesh-ancestor
5668162|NCT03585374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6494156|NCT00617565|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6494157|NCT00617565|Insulin Aspart|insulin aspart|mesh-list
6494158|NCT00617565|Biphasic Insulins|biphasic insulins|mesh-list
6494159|NCT00617565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6494160|NCT00617565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494161|NCT00617643|Nevirapine|nevirapine|mesh-list
6494162|NCT00617643|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6494163|NCT00617643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6494164|NCT00617643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6494165|NCT00617643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494166|NCT00617643|Antiviral Agents|antiviral agents|mesh-ancestor
6494167|NCT00617643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6494168|NCT00617643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6494169|NCT00617643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5668163|NCT03585374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5850600|NCT02450084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5850601|NCT02450084|Narcotics|narcotics|mesh-ancestor
5850602|NCT02450084|Analgesics|analgesics|mesh-ancestor
5850603|NCT02450084|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5850604|NCT02450084|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5850605|NCT02450084|Anesthetics, General|anesthetics, general|mesh-ancestor
5850606|NCT02450045|Bupivacaine|bupivacaine|mesh-list
5850607|NCT02450045|Ropivacaine|ropivacaine|mesh-list
5850608|NCT02450045|Anesthetics, Local|anesthetics, local|mesh-list
5850609|NCT02450045|Anesthetics|anesthetics|mesh-list
5850610|NCT02450045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5850611|NCT02450045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850612|NCT02450045|Sensory System Agents|sensory system agents|mesh-ancestor
5850613|NCT02450045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5850614|NCT02449954|Ketorolac|ketorolac|mesh-list
5668164|NCT03585374|Antipyretics|antipyretics|mesh-ancestor
5668165|NCT03585374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5668166|NCT03585374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5668167|NCT03585374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5668168|NCT03585374|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5668169|NCT03585374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5668170|NCT03585374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668171|NCT03585374|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5668172|NCT03585374|Anesthetics, General|anesthetics, general|mesh-ancestor
5668173|NCT03585374|Anesthetics|anesthetics|mesh-ancestor
5668174|NCT03585348|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
5668175|NCT03585348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5668176|NCT03585348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5668177|NCT03585348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668178|NCT03585179|Tranexamic Acid|tranexamic acid|mesh-list
5668179|NCT03585179|Hydroquinone|hydroquinone|mesh-list
5668180|NCT03585179|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5668181|NCT03585179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5668182|NCT03585179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668183|NCT03585179|Hemostatics|hemostatics|mesh-ancestor
5668184|NCT03585179|Coagulants|coagulants|mesh-ancestor
5668185|NCT03585179|Antioxidants|antioxidants|mesh-ancestor
5668186|NCT03585179|Protective Agents|protective agents|mesh-ancestor
5668187|NCT03585179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850615|NCT02449954|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
5850616|NCT02449954|Morphine|morphine|mesh-list
5850617|NCT02449954|Tramadol|tramadol|mesh-list
5850618|NCT02449954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5850619|NCT02449954|Narcotics|narcotics|mesh-ancestor
5850620|NCT02449954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5668188|NCT03585179|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5668189|NCT03585140|Doxycycline|doxycycline|mesh-list
5668190|NCT03585140|Adapalene|adapalene|mesh-list
5668191|NCT03585140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5668192|NCT03585140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5668193|NCT03585140|Antimalarials|antimalarials|mesh-ancestor
5668194|NCT03585140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5668195|NCT03585140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5668196|NCT03585140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5668197|NCT03585140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5668198|NCT03585140|Analgesics|analgesics|mesh-ancestor
5668199|NCT03585140|Sensory System Agents|sensory system agents|mesh-ancestor
5668200|NCT03585140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5668201|NCT03585140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668202|NCT03585140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5850621|NCT02449954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850622|NCT02449954|Analgesics|analgesics|mesh-ancestor
5850623|NCT02449954|Sensory System Agents|sensory system agents|mesh-ancestor
5850624|NCT02449954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5850625|NCT02449954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5850626|NCT02449954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5850627|NCT02449954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5850628|NCT02449954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5850629|NCT02449954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5850630|NCT02449954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5850631|NCT02449954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850632|NCT02449941|Rabeprazole|rabeprazole|mesh-list
5850633|NCT02449941|Pantoprazole|pantoprazole|mesh-list
5850634|NCT02449941|Lansoprazole|lansoprazole|mesh-list
5850635|NCT02449941|Dexlansoprazole|dexlansoprazole|mesh-list
5850636|NCT02449941|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
5850637|NCT02449941|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5850638|NCT02449941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5850639|NCT02449941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5850640|NCT02449941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850641|NCT02449811|Amlodipine|amlodipine|mesh-list
5850642|NCT02449811|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5850643|NCT02449811|Olmesartan|olmesartan|mesh-list
5850644|NCT02449811|Perindopril|perindopril|mesh-list
5850645|NCT02449811|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5850646|NCT02449811|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5850647|NCT02449811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5668203|NCT03585140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5668204|NCT03585140|Dermatologic Agents|dermatologic agents|mesh-ancestor
5668205|NCT03585101|Grazoprevir|grazoprevir|mesh-list
5668206|NCT03585101|Antiviral Agents|antiviral agents|mesh-ancestor
5668207|NCT03585101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5668208|NCT03585062|Paclitaxel|paclitaxel|mesh-list
5668209|NCT03585062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5668210|NCT03585062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5668211|NCT03585062|Tubulin Modulators|tubulin modulators|mesh-ancestor
5668212|NCT03585062|Antimitotic Agents|antimitotic agents|mesh-ancestor
5668213|NCT03585062|Mitosis Modulators|mitosis modulators|mesh-ancestor
5668214|NCT03585062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668215|NCT03585036|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
5668216|NCT03585036|Tramadol|tramadol|mesh-list
5668217|NCT03585036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5668218|NCT03585036|Narcotics|narcotics|mesh-ancestor
5668219|NCT03585036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5850648|NCT02449811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668220|NCT03585036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850649|NCT02449811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5850650|NCT02449811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850651|NCT02449811|Vasodilator Agents|vasodilator agents|mesh-ancestor
5850652|NCT02449811|Diuretics|diuretics|mesh-ancestor
5850653|NCT02449811|Natriuretic Agents|natriuretic agents|mesh-ancestor
5850654|NCT02449811|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5850655|NCT02449811|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5850656|NCT02449811|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5850657|NCT02449811|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5850658|NCT02449811|Protease Inhibitors|protease inhibitors|mesh-ancestor
5850659|NCT02449811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5850660|NCT02449733|Tenofovir|tenofovir|mesh-list
5850661|NCT02449733|Emtricitabine|emtricitabine|mesh-list
5850662|NCT02449733|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5850663|NCT02449733|Antiviral Agents|antiviral agents|mesh-ancestor
5850664|NCT02449733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5850665|NCT02449733|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5850666|NCT02449733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5850667|NCT02449733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5850668|NCT02449733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850669|NCT02449733|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5850670|NCT02449733|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5668221|NCT03585036|Analgesics|analgesics|mesh-ancestor
5668222|NCT03585036|Sensory System Agents|sensory system agents|mesh-ancestor
5668223|NCT03585036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5668224|NCT03585036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5668225|NCT03585036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5668226|NCT03585036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5668227|NCT03585036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5668228|NCT03584984|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
5668229|NCT03584984|Hemostatics|hemostatics|mesh-ancestor
5668230|NCT03584984|Coagulants|coagulants|mesh-ancestor
5850671|NCT02449746|Immunoglobulins|immunoglobulins|mesh-list
5850672|NCT02449746|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5850673|NCT02449746|Antibodies|antibodies|mesh-list
5850674|NCT02449746|gamma-Globulins|gamma-globulins|mesh-list
5850675|NCT02449746|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5850676|NCT02449746|Immunologic Factors|immunologic factors|mesh-ancestor
5850677|NCT02449746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850678|NCT02449538|Everolimus|everolimus|mesh-list
5850679|NCT02449538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5850680|NCT02449538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5850681|NCT02449538|Immunologic Factors|immunologic factors|mesh-ancestor
5850682|NCT02449538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850683|NCT02449564|Sirolimus|sirolimus|mesh-list
6494170|NCT00617643|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6494171|NCT00617643|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6494172|NCT00617656|Gemcitabine|gemcitabine|mesh-list
6494173|NCT00617656|Cisplatin|cisplatin|mesh-list
6494174|NCT00617656|Docetaxel|docetaxel|mesh-list
6494175|NCT00617656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6494176|NCT00617656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6494177|NCT00617656|Antimetabolites|antimetabolites|mesh-ancestor
6494178|NCT00617656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494179|NCT00617656|Antiviral Agents|antiviral agents|mesh-ancestor
6494180|NCT00617656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5668231|NCT03584919|Doxycycline|doxycycline|mesh-list
5668232|NCT03584919|Cefuroxime|cefuroxime|mesh-list
5668233|NCT03584919|Cefuroxime axetil|cefuroxime axetil|mesh-list
5668234|NCT03584919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5668235|NCT03584919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5668236|NCT03584919|Antimalarials|antimalarials|mesh-ancestor
5668237|NCT03584919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5668238|NCT03584919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5668239|NCT03584854|Methylergonovine|methylergonovine|mesh-list
5668240|NCT03584854|Carboprost|carboprost|mesh-list
5668241|NCT03584854|Dinoprost|dinoprost|mesh-list
5668242|NCT03584854|Dinoprost tromethamine|dinoprost tromethamine|mesh-list
5668243|NCT03584854|Oxytocics|oxytocics|mesh-ancestor
5668244|NCT03584854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5668245|NCT03584854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668246|NCT03584854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5668247|NCT03584854|Abortifacient Agents|abortifacient agents|mesh-ancestor
5668248|NCT03584841|Pilocarpine|pilocarpine|mesh-list
5668249|NCT03584841|Miotics|miotics|mesh-ancestor
5668250|NCT03584841|Autonomic Agents|autonomic agents|mesh-ancestor
5668251|NCT03584841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6494181|NCT00617656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6494182|NCT00617656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6494183|NCT00617656|Immunologic Factors|immunologic factors|mesh-ancestor
5668252|NCT03584841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668253|NCT03584841|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
5668254|NCT03584841|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5668255|NCT03584841|Cholinergic Agents|cholinergic agents|mesh-ancestor
5668256|NCT03584841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5668257|NCT03584841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668258|NCT03584711|Panitumumab|panitumumab|mesh-list
5668259|NCT03584711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5668260|NCT03584711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5668261|NCT03584698|Evening primrose oil|evening primrose oil|mesh-list
5668262|NCT03584698|Misoprostol|misoprostol|mesh-list
5668263|NCT03584698|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5668264|NCT03584698|Abortifacient Agents|abortifacient agents|mesh-ancestor
5668265|NCT03584698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5668266|NCT03584698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668267|NCT03584698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5668268|NCT03584698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5668269|NCT03584698|Oxytocics|oxytocics|mesh-ancestor
5668270|NCT03584698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5668271|NCT03584698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6494184|NCT00617656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494185|NCT00617656|Tubulin Modulators|tubulin modulators|mesh-ancestor
6494186|NCT00617656|Antimitotic Agents|antimitotic agents|mesh-ancestor
6494187|NCT00617656|Mitosis Modulators|mitosis modulators|mesh-ancestor
6494188|NCT00617695|Zolmitriptan|zolmitriptan|mesh-list
6494189|NCT00617695|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6494190|NCT00617695|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6494191|NCT00617695|Serotonin Agents|serotonin agents|mesh-ancestor
6494192|NCT00617695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6494193|NCT00617695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494194|NCT00617695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494195|NCT00617747|Zolmitriptan|zolmitriptan|mesh-list
6494196|NCT00617747|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6494197|NCT00617747|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6494198|NCT00617747|Serotonin Agents|serotonin agents|mesh-ancestor
5850684|NCT02449564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5850685|NCT02449564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5850686|NCT02449564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5850687|NCT02449564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5850688|NCT02449564|Antifungal Agents|antifungal agents|mesh-ancestor
5850689|NCT02449564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5850690|NCT02449564|Immunologic Factors|immunologic factors|mesh-ancestor
5668272|NCT03584698|Analgesics|analgesics|mesh-ancestor
5668273|NCT03584698|Sensory System Agents|sensory system agents|mesh-ancestor
5668274|NCT03584698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5668275|NCT03584698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5668276|NCT03584698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5668277|NCT03584698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5668278|NCT03584698|Antimetabolites|antimetabolites|mesh-ancestor
5668279|NCT03584698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668280|NCT03584698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5668281|NCT03584698|Dermatologic Agents|dermatologic agents|mesh-ancestor
5668282|NCT03584529|Vitamin D|vitamin d|mesh-list
5668283|NCT03584529|Cholecalciferol|cholecalciferol|mesh-list
5668284|NCT03584529|Vitamins|vitamins|mesh-ancestor
5668285|NCT03584529|Micronutrients|micronutrients|mesh-ancestor
5668286|NCT03584529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668287|NCT03584529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5668288|NCT03584529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5695837|NCT03387098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5695838|NCT03387098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5695839|NCT03387098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5695840|NCT03387098|Growth Substances|growth substances|mesh-ancestor
5695841|NCT03387098|Growth Inhibitors|growth inhibitors|mesh-ancestor
5695842|NCT03387098|Antimetabolites|antimetabolites|mesh-ancestor
5695843|NCT03387098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5695844|NCT03387098|Antidotes|antidotes|mesh-ancestor
5695845|NCT03387098|Protective Agents|protective agents|mesh-ancestor
5695846|NCT03387098|Vitamin B Complex|vitamin b complex|mesh-ancestor
5695847|NCT03387098|Vitamins|vitamins|mesh-ancestor
5695848|NCT03387098|Micronutrients|micronutrients|mesh-ancestor
6494199|NCT00617747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5850691|NCT02449564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850692|NCT02449720|Ropivacaine|ropivacaine|mesh-list
5850693|NCT02449720|Anesthetics, Local|anesthetics, local|mesh-ancestor
5850694|NCT02449720|Anesthetics|anesthetics|mesh-ancestor
5850695|NCT02449720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5850696|NCT02449720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850697|NCT02449720|Sensory System Agents|sensory system agents|mesh-ancestor
5850698|NCT02449720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5850699|NCT02449603|Insulin Aspart|insulin aspart|mesh-list
5850700|NCT02449603|Exenatide|exenatide|mesh-list
5850701|NCT02449603|Biphasic Insulins|biphasic insulins|mesh-list
5850702|NCT02449603|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
5850703|NCT02449603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5850704|NCT02449603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850705|NCT02449603|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5850706|NCT02449603|Incretins|incretins|mesh-ancestor
5850707|NCT02449603|Hormones|hormones|mesh-ancestor
5850708|NCT02449603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5850709|NCT02450058|Paclitaxel|paclitaxel|mesh-list
5850710|NCT02450058|Cyclophosphamide|cyclophosphamide|mesh-list
5850711|NCT02450058|Fluorouracil|fluorouracil|mesh-list
5850712|NCT02450058|Epirubicin|epirubicin|mesh-list
5850713|NCT02450058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5850714|NCT02450058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5850715|NCT02450058|Tubulin Modulators|tubulin modulators|mesh-ancestor
5850716|NCT02450058|Antimitotic Agents|antimitotic agents|mesh-ancestor
5850717|NCT02450058|Mitosis Modulators|mitosis modulators|mesh-ancestor
5668289|NCT03584373|Acetaminophen|acetaminophen|mesh-list
5668290|NCT03584373|Ketorolac|ketorolac|mesh-list
5668291|NCT03584373|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
5668292|NCT03584373|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
5668293|NCT03584373|Oxycodone|oxycodone|mesh-list
5668294|NCT03584373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5668295|NCT03584373|Analgesics|analgesics|mesh-ancestor
5668296|NCT03584373|Sensory System Agents|sensory system agents|mesh-ancestor
5668297|NCT03584373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5668298|NCT03584373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668299|NCT03584373|Antipyretics|antipyretics|mesh-ancestor
5668300|NCT03584373|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5850718|NCT02450058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850719|NCT02450058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5850720|NCT02450058|Immunologic Factors|immunologic factors|mesh-ancestor
5850721|NCT02450058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850722|NCT02450058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5850723|NCT02450058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5850724|NCT02450058|Alkylating Agents|alkylating agents|mesh-ancestor
5850725|NCT02450058|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5850726|NCT02450058|Antimetabolites|antimetabolites|mesh-ancestor
5850727|NCT02450058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5850728|NCT02450058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5850729|NCT02450058|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5850730|NCT02450058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5850731|NCT02450058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5850732|NCT02449655|Paclitaxel|paclitaxel|mesh-list
5850733|NCT02449655|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5850734|NCT02449655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5668301|NCT03584373|Narcotics|narcotics|mesh-ancestor
5668302|NCT03584373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5668303|NCT03584373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5668304|NCT03584373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5668305|NCT03584373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5668306|NCT03584373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5668307|NCT03584373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5668308|NCT03584373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668309|NCT03584360|Calcitriol|calcitriol|mesh-list
5668310|NCT03584360|Betamethasone|betamethasone|mesh-list
5668311|NCT03584360|Betamethasone Valerate|betamethasone valerate|mesh-list
5668312|NCT03584360|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5668313|NCT03584360|Betamethasone benzoate|betamethasone benzoate|mesh-list
5668314|NCT03584360|Calcipotriene|calcipotriene|mesh-list
5668315|NCT03584360|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
5668316|NCT03584360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5668317|NCT03584360|Glucocorticoids|glucocorticoids|mesh-ancestor
5668318|NCT03584360|Hormones|hormones|mesh-ancestor
5668319|NCT03584360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5850735|NCT02449655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5850736|NCT02449655|Tubulin Modulators|tubulin modulators|mesh-ancestor
5850737|NCT02449655|Antimitotic Agents|antimitotic agents|mesh-ancestor
5850738|NCT02449655|Mitosis Modulators|mitosis modulators|mesh-ancestor
5850739|NCT02449655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850740|NCT02449486|Ropivacaine|ropivacaine|mesh-list
5850741|NCT02449486|Anesthetics, Local|anesthetics, local|mesh-ancestor
5850742|NCT02449486|Anesthetics|anesthetics|mesh-ancestor
5850743|NCT02449486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5850744|NCT02449486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850745|NCT02449486|Sensory System Agents|sensory system agents|mesh-ancestor
5850746|NCT02449486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5850747|NCT02449265|Prednisone|prednisone|mesh-list
5850748|NCT02449265|Cyclophosphamide|cyclophosphamide|mesh-list
5850749|NCT02449265|Doxorubicin|doxorubicin|mesh-list
5850750|NCT02449265|Vincristine|vincristine|mesh-list
5850751|NCT02449265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5850752|NCT02449265|Immunologic Factors|immunologic factors|mesh-ancestor
5668320|NCT03584360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668321|NCT03584360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5668322|NCT03584360|Respiratory System Agents|respiratory system agents|mesh-ancestor
5668323|NCT03584360|Dermatologic Agents|dermatologic agents|mesh-ancestor
5668324|NCT03584360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5668325|NCT03584360|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
5668326|NCT03584360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5850753|NCT02449265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850754|NCT02449265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5850755|NCT02449265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5668327|NCT03584360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668328|NCT03584360|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5668329|NCT03584360|Vitamins|vitamins|mesh-ancestor
5668330|NCT03584360|Micronutrients|micronutrients|mesh-ancestor
5668331|NCT03584360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5668332|NCT03584178|Budesonide|budesonide|mesh-list
5668333|NCT03584178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5668334|NCT03584178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5668335|NCT03584178|Autonomic Agents|autonomic agents|mesh-ancestor
5668336|NCT03584178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5668337|NCT03584178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668338|NCT03584178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5668339|NCT03584178|Respiratory System Agents|respiratory system agents|mesh-ancestor
5850756|NCT02449265|Alkylating Agents|alkylating agents|mesh-ancestor
5850757|NCT02449265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850758|NCT02449265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5850759|NCT02449265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5850760|NCT02449265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5850761|NCT02449265|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5850762|NCT02449265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5850763|NCT02449265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5850764|NCT02449265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5850765|NCT02449265|Glucocorticoids|glucocorticoids|mesh-ancestor
5850766|NCT02449265|Hormones|hormones|mesh-ancestor
5850767|NCT02449265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5850768|NCT02449265|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5850769|NCT02449265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5850770|NCT02449265|Tubulin Modulators|tubulin modulators|mesh-ancestor
5850771|NCT02449265|Antimitotic Agents|antimitotic agents|mesh-ancestor
5668340|NCT03584178|Glucocorticoids|glucocorticoids|mesh-ancestor
5668341|NCT03584178|Hormones|hormones|mesh-ancestor
5668342|NCT03584178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5850772|NCT02449265|Mitosis Modulators|mitosis modulators|mesh-ancestor
5850773|NCT02449187|Calcium, Dietary|calcium, dietary|mesh-list
5850774|NCT02449187|Metformin|metformin|mesh-list
5850775|NCT02449187|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5850776|NCT02449187|Calcium|calcium|mesh-list
5850777|NCT02449187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5850778|NCT02449187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850779|NCT02449187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5850780|NCT02449187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5850781|NCT02449187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5850782|NCT02449187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5850783|NCT02449187|Antimetabolites|antimetabolites|mesh-ancestor
5850784|NCT02449187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668343|NCT03584152|Acetaminophen|acetaminophen|mesh-list
5668344|NCT03584152|Ibuprofen|ibuprofen|mesh-list
5850785|NCT02449187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5850786|NCT02449187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5850787|NCT02449187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5850788|NCT02449161|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
5850789|NCT02449161|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5850790|NCT02449161|Contraceptive Agents|contraceptive agents|mesh-ancestor
5850791|NCT02449161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5850792|NCT02449161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850793|NCT02449161|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5850794|NCT02449161|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5850795|NCT02449161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5850796|NCT02449161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5850797|NCT02449369|Acetaminophen|acetaminophen|mesh-list
5850798|NCT02449369|Oxycodone|oxycodone|mesh-list
5668345|NCT03584152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5668346|NCT03584152|Analgesics|analgesics|mesh-ancestor
5668347|NCT03584152|Sensory System Agents|sensory system agents|mesh-ancestor
5668348|NCT03584152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5668349|NCT03584152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668350|NCT03584152|Antipyretics|antipyretics|mesh-ancestor
5668351|NCT03584152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5668352|NCT03584152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5668353|NCT03584152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5668354|NCT03584152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5668355|NCT03584152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5668356|NCT03584152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668357|NCT03584087|Terlipressin|terlipressin|mesh-list
5668358|NCT03584087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5668359|NCT03584087|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5668360|NCT03584074|Celecoxib|celecoxib|mesh-list
5668361|NCT03584074|Pregabalin|pregabalin|mesh-list
5850799|NCT02449369|Hydromorphone|hydromorphone|mesh-list
5850800|NCT02449369|Orphenadrine|orphenadrine|mesh-list
5850801|NCT02449369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5850802|NCT02449369|Analgesics|analgesics|mesh-ancestor
5850803|NCT02449369|Sensory System Agents|sensory system agents|mesh-ancestor
5850804|NCT02449369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5850805|NCT02449369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850806|NCT02449369|Antipyretics|antipyretics|mesh-ancestor
5850807|NCT02449369|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5850808|NCT02449369|Narcotics|narcotics|mesh-ancestor
5850809|NCT02449369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5850810|NCT02449369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5850811|NCT02449369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5850812|NCT02449369|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5850813|NCT02449369|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5850814|NCT02449369|Parasympatholytics|parasympatholytics|mesh-ancestor
5850815|NCT02449369|Autonomic Agents|autonomic agents|mesh-ancestor
5850816|NCT02449369|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5850817|NCT02449369|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5850818|NCT02449369|Cholinergic Agents|cholinergic agents|mesh-ancestor
5850819|NCT02449369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5850820|NCT02449369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850821|NCT02449369|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
5850822|NCT02449369|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5850823|NCT02449369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5850824|NCT02449252|Prednisone|prednisone|mesh-list
5850825|NCT02449252|Cyclophosphamide|cyclophosphamide|mesh-list
5850826|NCT02449252|Doxorubicin|doxorubicin|mesh-list
5850827|NCT02449252|Vincristine|vincristine|mesh-list
5850828|NCT02449252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5850829|NCT02449252|Immunologic Factors|immunologic factors|mesh-ancestor
5850830|NCT02449252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850831|NCT02449252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5850832|NCT02449252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5850833|NCT02449252|Alkylating Agents|alkylating agents|mesh-ancestor
5850834|NCT02449252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850835|NCT02449252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5850836|NCT02449252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5850837|NCT02449252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5850838|NCT02449252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5850839|NCT02449252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5850840|NCT02449252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5850841|NCT02449252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5850842|NCT02449252|Glucocorticoids|glucocorticoids|mesh-ancestor
5850843|NCT02449252|Hormones|hormones|mesh-ancestor
5668362|NCT03584074|Analgesics|analgesics|mesh-ancestor
5668363|NCT03584074|Sensory System Agents|sensory system agents|mesh-ancestor
5668364|NCT03584074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5668365|NCT03584074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668366|NCT03584074|Anticonvulsants|anticonvulsants|mesh-ancestor
5668367|NCT03584074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5668368|NCT03584074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5668369|NCT03584074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668370|NCT03584074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5668371|NCT03584074|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5668372|NCT03584074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5668373|NCT03584074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5668374|NCT03584074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5668375|NCT03584074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5668376|NCT03584074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5668377|NCT03584074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5668378|NCT03584074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5668379|NCT03584074|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5668380|NCT03584074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5668381|NCT03584074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5668382|NCT03583957|Caffeine|caffeine|mesh-list
5668383|NCT03583957|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5668384|NCT03583957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668385|NCT03583957|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5668386|NCT03583957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5668387|NCT03583957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668388|NCT03583957|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5668389|NCT03583957|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5668390|NCT03583957|Purinergic Agents|purinergic agents|mesh-ancestor
5850844|NCT02449252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5850845|NCT02449252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5850846|NCT02449252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5850847|NCT02449252|Tubulin Modulators|tubulin modulators|mesh-ancestor
5850848|NCT02449252|Antimitotic Agents|antimitotic agents|mesh-ancestor
5850849|NCT02449252|Mitosis Modulators|mitosis modulators|mesh-ancestor
5850850|NCT02449070|Nicorandil|nicorandil|mesh-list
5850851|NCT02449070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5850852|NCT02449070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5850853|NCT02449070|Vasodilator Agents|vasodilator agents|mesh-ancestor
5850854|NCT02449070|Vitamin B Complex|vitamin b complex|mesh-ancestor
5850855|NCT02449070|Vitamins|vitamins|mesh-ancestor
5850856|NCT02449070|Micronutrients|micronutrients|mesh-ancestor
5668391|NCT03583957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5668392|NCT03583892|Gabapentin|gabapentin|mesh-list
5668393|NCT03583892|Analgesics|analgesics|mesh-ancestor
5668394|NCT03583892|Sensory System Agents|sensory system agents|mesh-ancestor
5668395|NCT03583892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5668396|NCT03583892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668397|NCT03583892|Anticonvulsants|anticonvulsants|mesh-ancestor
5668398|NCT03583892|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5668399|NCT03583892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5668400|NCT03583892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5668401|NCT03583892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5668402|NCT03583892|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5668403|NCT03583892|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5668404|NCT03583892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5668405|NCT03583892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668406|NCT03583892|Antimanic Agents|antimanic agents|mesh-ancestor
5668407|NCT03583866|Candesartan|candesartan|mesh-list
5668408|NCT03583866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5668409|NCT03583866|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5668410|NCT03583866|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5850857|NCT02449070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850858|NCT02449278|Prednisone|prednisone|mesh-list
5850859|NCT02449278|Cyclophosphamide|cyclophosphamide|mesh-list
5850860|NCT02449278|Doxorubicin|doxorubicin|mesh-list
5850861|NCT02449278|Vincristine|vincristine|mesh-list
5850862|NCT02449278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5850863|NCT02449278|Immunologic Factors|immunologic factors|mesh-ancestor
5850864|NCT02449278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850865|NCT02449278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5850866|NCT02449278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5850867|NCT02449278|Alkylating Agents|alkylating agents|mesh-ancestor
5668411|NCT03583866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668412|NCT03583749|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5668413|NCT03583749|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5850868|NCT02449278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850869|NCT02449278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5850870|NCT02449278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5850871|NCT02449278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5850872|NCT02449278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5850873|NCT02449278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5850874|NCT02449278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5850875|NCT02449278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5850876|NCT02449278|Glucocorticoids|glucocorticoids|mesh-ancestor
5850877|NCT02449278|Hormones|hormones|mesh-ancestor
5850878|NCT02449278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5850879|NCT02449278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5850880|NCT02449278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5850881|NCT02449278|Tubulin Modulators|tubulin modulators|mesh-ancestor
5850882|NCT02449278|Antimitotic Agents|antimitotic agents|mesh-ancestor
5850883|NCT02449278|Mitosis Modulators|mitosis modulators|mesh-ancestor
5903945|NCT04184453|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5903946|NCT04184453|Chelating Agents|chelating agents|mesh-ancestor
5903947|NCT04184453|Sequestering Agents|sequestering agents|mesh-ancestor
5903948|NCT04184453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903949|NCT04147494|Edetic Acid|edetic acid|mesh-list
5903950|NCT04147494|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5903951|NCT04147494|FAPI-46|fapi-46|mesh-list
5903952|NCT04147494|Chelating Agents|chelating agents|mesh-ancestor
5903953|NCT04147494|Sequestering Agents|sequestering agents|mesh-ancestor
5903954|NCT04147494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903955|NCT04147494|Anticoagulants|anticoagulants|mesh-ancestor
5903956|NCT04147494|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5903957|NCT04147494|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5903958|NCT04108481|Durvalumab|durvalumab|mesh-list
5903959|NCT04108481|Methamphetamine|methamphetamine|mesh-list
5903960|NCT04108481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5903961|NCT04108481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5903962|NCT04108481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5903963|NCT04108481|Immunologic Factors|immunologic factors|mesh-ancestor
5903964|NCT04108481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903965|NCT04108481|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5903966|NCT04108481|Sympathomimetics|sympathomimetics|mesh-ancestor
5903967|NCT04108481|Autonomic Agents|autonomic agents|mesh-ancestor
5903968|NCT04108481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5903969|NCT04108481|Dopamine Agents|dopamine agents|mesh-ancestor
5903970|NCT04108481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5903971|NCT04108481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903972|NCT04108481|Adrenergic Agents|adrenergic agents|mesh-ancestor
5903973|NCT04108481|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5903974|NCT04108481|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5903975|NCT04108481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5903976|NCT04108481|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5903977|NCT04101643|Evolocumab|evolocumab|mesh-list
5903978|NCT04101643|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5903979|NCT04101643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5903980|NCT04101643|Antimetabolites|antimetabolites|mesh-ancestor
5903981|NCT04101643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903982|NCT04101643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5903983|NCT04069312|Azithromycin|azithromycin|mesh-list
5903984|NCT04069312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5668414|NCT03583749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5668415|NCT03583749|Antitubercular Agents|antitubercular agents|mesh-ancestor
5668416|NCT03583710|Cisplatin|cisplatin|mesh-list
5668417|NCT03583710|Etoposide|etoposide|mesh-list
5668418|NCT03583710|Etoposide phosphate|etoposide phosphate|mesh-list
5668419|NCT03583710|Podophyllotoxin|podophyllotoxin|mesh-list
5668420|NCT03583710|Mitotane|mitotane|mesh-list
5668421|NCT03583710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5668422|NCT03583710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5668423|NCT03583710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5668424|NCT03583710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5668425|NCT03583710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5668426|NCT03583710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668427|NCT03583710|Keratolytic Agents|keratolytic agents|mesh-ancestor
5668428|NCT03583710|Dermatologic Agents|dermatologic agents|mesh-ancestor
5850884|NCT02449031|Tobramycin|tobramycin|mesh-list
5850885|NCT02449031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5850886|NCT02449031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5850887|NCT02449005|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
5850888|NCT02449005|Hemostatics|hemostatics|mesh-ancestor
5850889|NCT02449005|Coagulants|coagulants|mesh-ancestor
5850890|NCT02448797|Vinorelbine|vinorelbine|mesh-list
5850891|NCT02448797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5850892|NCT02448797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5850893|NCT02448797|Tubulin Modulators|tubulin modulators|mesh-ancestor
5850894|NCT02448797|Antimitotic Agents|antimitotic agents|mesh-ancestor
5850895|NCT02448797|Mitosis Modulators|mitosis modulators|mesh-ancestor
5850896|NCT02448797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850897|NCT02448784|Donepezil|donepezil|mesh-list
5850898|NCT02448784|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5850899|NCT02448784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5850900|NCT02448784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850901|NCT02448784|Cholinergic Agents|cholinergic agents|mesh-ancestor
5850902|NCT02448784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5850903|NCT02448784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850904|NCT02448784|Nootropic Agents|nootropic agents|mesh-ancestor
5850905|NCT02448901|Edoxaban|edoxaban|mesh-list
5850906|NCT02448901|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5850907|NCT02448901|Antithrombins|antithrombins|mesh-ancestor
5850908|NCT02448901|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5850909|NCT02448901|Protease Inhibitors|protease inhibitors|mesh-ancestor
5850910|NCT02448901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5850911|NCT02448901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850912|NCT02448901|Anticoagulants|anticoagulants|mesh-ancestor
5850913|NCT02448420|Trastuzumab|trastuzumab|mesh-list
5850914|NCT02448420|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
5850915|NCT02448420|Palbociclib|palbociclib|mesh-list
5850916|NCT02448420|Antibodies|antibodies|mesh-list
5850917|NCT02448420|Immunoconjugates|immunoconjugates|mesh-list
5850918|NCT02448420|Immunologic Factors|immunologic factors|mesh-ancestor
5850919|NCT02448420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850920|NCT02448420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5850921|NCT02448420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5850922|NCT02448420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5850923|NCT02448420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6496520|NCT00628316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668429|NCT03583710|Tubulin Modulators|tubulin modulators|mesh-ancestor
5668430|NCT03583710|Antimitotic Agents|antimitotic agents|mesh-ancestor
5668431|NCT03583710|Mitosis Modulators|mitosis modulators|mesh-ancestor
5668432|NCT03583710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5668433|NCT03583658|Ambroxol|ambroxol|mesh-list
5668434|NCT03583658|Expectorants|expectorants|mesh-ancestor
5668435|NCT03583658|Respiratory System Agents|respiratory system agents|mesh-ancestor
5668436|NCT03583567|Chlorpheniramine|chlorpheniramine|mesh-list
5668437|NCT03583567|Ranitidine|ranitidine|mesh-list
5668438|NCT03583567|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
5668439|NCT03583567|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5668440|NCT03583567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5668441|NCT03583567|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5668442|NCT03583567|Histamine Antagonists|histamine antagonists|mesh-ancestor
5668443|NCT03583567|Histamine Agents|histamine agents|mesh-ancestor
5668444|NCT03583567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5668445|NCT03583567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668446|NCT03583567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668447|NCT03583567|Antipruritics|antipruritics|mesh-ancestor
5668448|NCT03583567|Dermatologic Agents|dermatologic agents|mesh-ancestor
5668449|NCT03583567|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5668450|NCT03583567|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5668451|NCT03583489|Ondansetron|ondansetron|mesh-list
5668452|NCT03583489|Antiemetics|antiemetics|mesh-ancestor
5668453|NCT03583489|Autonomic Agents|autonomic agents|mesh-ancestor
5668454|NCT03583489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5668455|NCT03583489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668456|NCT03583489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5668457|NCT03583489|Antipruritics|antipruritics|mesh-ancestor
5668458|NCT03583489|Dermatologic Agents|dermatologic agents|mesh-ancestor
5668459|NCT03583489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5668460|NCT03583489|Serotonin Agents|serotonin agents|mesh-ancestor
5668461|NCT03583489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5668462|NCT03583489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850924|NCT02448420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850925|NCT02448420|Tubulin Modulators|tubulin modulators|mesh-ancestor
5668463|NCT03583489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5668464|NCT03583489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5668465|NCT03583489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5668466|NCT03583489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5668467|NCT03583489|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5668468|NCT03583476|Amoxicillin|amoxicillin|mesh-list
5668469|NCT03583476|Metronidazole|metronidazole|mesh-list
5668470|NCT03583476|Clarithromycin|clarithromycin|mesh-list
5850926|NCT02448420|Antimitotic Agents|antimitotic agents|mesh-ancestor
5850927|NCT02448420|Mitosis Modulators|mitosis modulators|mesh-ancestor
5850928|NCT02448407|Hyaluronic Acid|hyaluronic acid|mesh-list
5850929|NCT02448407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5850930|NCT02448407|Immunologic Factors|immunologic factors|mesh-ancestor
5850931|NCT02448407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850932|NCT02448407|Viscosupplements|viscosupplements|mesh-ancestor
5850933|NCT02448407|Protective Agents|protective agents|mesh-ancestor
5850934|NCT02448550|Heparin|heparin|mesh-list
5850935|NCT02448550|Calcium heparin|calcium heparin|mesh-list
5850936|NCT02448550|Bivalirudin|bivalirudin|mesh-list
5850937|NCT02448550|Anticoagulants|anticoagulants|mesh-ancestor
5850938|NCT02448550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5850939|NCT02448550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5850940|NCT02448550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850941|NCT02448550|Antithrombins|antithrombins|mesh-ancestor
5850942|NCT02448550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5850943|NCT02448550|Protease Inhibitors|protease inhibitors|mesh-ancestor
5850944|NCT02448550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5850945|NCT02448329|Paclitaxel|paclitaxel|mesh-list
5850946|NCT02448329|Adavosertib|adavosertib|mesh-list
5850947|NCT02448329|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5850948|NCT02448329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5850949|NCT02448329|Tubulin Modulators|tubulin modulators|mesh-ancestor
5850950|NCT02448329|Antimitotic Agents|antimitotic agents|mesh-ancestor
5850951|NCT02448329|Mitosis Modulators|mitosis modulators|mesh-ancestor
5850952|NCT02448329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850953|NCT02448329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5850954|NCT02448316|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5850955|NCT02448316|Methylprednisolone|methylprednisolone|mesh-list
5850956|NCT02448316|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5850957|NCT02448316|Prednisolone|prednisolone|mesh-list
5850958|NCT02448316|Prednisolone acetate|prednisolone acetate|mesh-list
5850959|NCT02448316|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5850960|NCT02448316|Prednisolone phosphate|prednisolone phosphate|mesh-list
5850961|NCT02448316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5850962|NCT02448316|Antiemetics|antiemetics|mesh-ancestor
5850963|NCT02448316|Autonomic Agents|autonomic agents|mesh-ancestor
5850964|NCT02448316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5850965|NCT02448316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850966|NCT02448316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5850967|NCT02448316|Glucocorticoids|glucocorticoids|mesh-ancestor
5850968|NCT02448316|Hormones|hormones|mesh-ancestor
5850969|NCT02448316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5668471|NCT03583476|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
5668472|NCT03583476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5668473|NCT03583476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5668474|NCT03583476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5668475|NCT03583476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5668476|NCT03583476|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5668477|NCT03583476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5668478|NCT03583476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850970|NCT02448316|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5850971|NCT02448316|Protective Agents|protective agents|mesh-ancestor
5850972|NCT02448316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5850973|NCT02448316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5850974|NCT02448264|Berotralstat|berotralstat|mesh-list
5850975|NCT02448264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5850976|NCT02448264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850977|NCT02448290|Docetaxel|docetaxel|mesh-list
5850978|NCT02448290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5850979|NCT02448290|Tubulin Modulators|tubulin modulators|mesh-ancestor
5850980|NCT02448290|Antimitotic Agents|antimitotic agents|mesh-ancestor
5850981|NCT02448290|Mitosis Modulators|mitosis modulators|mesh-ancestor
5850982|NCT02448290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850983|NCT02448251|Abivertinib|abivertinib|mesh-list
5668479|NCT03583476|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5850984|NCT02448251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5850985|NCT02448251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5850986|NCT02448251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5850987|NCT02448199|Meloxicam|meloxicam|mesh-list
5850988|NCT02448199|Antirheumatic Agents|antirheumatic agents|mesh-list
5850989|NCT02448199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5850990|NCT02448199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5850991|NCT02448199|Analgesics|analgesics|mesh-ancestor
5850992|NCT02448199|Sensory System Agents|sensory system agents|mesh-ancestor
5850993|NCT02448199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5850994|NCT02448199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5850995|NCT02448199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5850996|NCT02448199|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5850997|NCT02448199|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5850998|NCT02448199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5850999|NCT02448199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851000|NCT02448225|Deoxyglucose|deoxyglucose|mesh-list
5851001|NCT02448225|Fluorides|fluorides|mesh-list
5851002|NCT02448225|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5851003|NCT02448225|Cariostatic Agents|cariostatic agents|mesh-ancestor
5851004|NCT02448225|Protective Agents|protective agents|mesh-ancestor
5851005|NCT02448225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851006|NCT02448225|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5851007|NCT02448225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851008|NCT02448225|Antimetabolites|antimetabolites|mesh-ancestor
5851009|NCT02448225|Antiviral Agents|antiviral agents|mesh-ancestor
5851010|NCT02448225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5851011|NCT02448082|Ichthammol|ichthammol|mesh-list
5851012|NCT02448082|Dermatologic Agents|dermatologic agents|mesh-ancestor
5851013|NCT02448069|Argatroban|argatroban|mesh-list
5851014|NCT02448069|Antithrombins|antithrombins|mesh-ancestor
5851015|NCT02448069|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5668480|NCT03583476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5668481|NCT03583424|Cytarabine|cytarabine|mesh-list
5668482|NCT03583424|Etoposide|etoposide|mesh-list
5668483|NCT03583424|Podophyllotoxin|podophyllotoxin|mesh-list
5668484|NCT03583424|Etoposide phosphate|etoposide phosphate|mesh-list
5668485|NCT03583424|Melphalan|melphalan|mesh-list
5668486|NCT03583424|Mechlorethamine|mechlorethamine|mesh-list
5668487|NCT03583424|Venetoclax|venetoclax|mesh-list
5668488|NCT03583424|Carmustine|carmustine|mesh-list
5668489|NCT03583424|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
5668490|NCT03583424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5668491|NCT03583424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5668492|NCT03583424|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5668493|NCT03583424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5668494|NCT03583424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5668495|NCT03583424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668496|NCT03583424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5668497|NCT03583424|Antimetabolites|antimetabolites|mesh-ancestor
5668498|NCT03583424|Antiviral Agents|antiviral agents|mesh-ancestor
5668499|NCT03583424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5668500|NCT03583424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5668501|NCT03583424|Immunologic Factors|immunologic factors|mesh-ancestor
5668502|NCT03583424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668503|NCT03583424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5668504|NCT03583424|Alkylating Agents|alkylating agents|mesh-ancestor
5668505|NCT03583424|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5668506|NCT03583424|Keratolytic Agents|keratolytic agents|mesh-ancestor
5668507|NCT03583424|Dermatologic Agents|dermatologic agents|mesh-ancestor
5668508|NCT03583424|Tubulin Modulators|tubulin modulators|mesh-ancestor
5668509|NCT03583424|Antimitotic Agents|antimitotic agents|mesh-ancestor
5668510|NCT03583424|Mitosis Modulators|mitosis modulators|mesh-ancestor
6212192|NCT02182492|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6212193|NCT02182492|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6212194|NCT02182492|Hormones|hormones|mesh-ancestor
6212195|NCT02182492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6212196|NCT02182492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212197|NCT02182830|Empagliflozin|empagliflozin|mesh-list
5851016|NCT02448069|Protease Inhibitors|protease inhibitors|mesh-ancestor
6212198|NCT02182830|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6212199|NCT02182830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212200|NCT02182830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6212201|NCT02182830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212202|NCT02182895|Saxagliptin|saxagliptin|mesh-list
6212203|NCT02182895|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
6212204|NCT02182895|Incretins|incretins|mesh-ancestor
6212205|NCT02182895|Hormones|hormones|mesh-ancestor
5851017|NCT02448069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5851018|NCT02448069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851019|NCT02448069|Anticoagulants|anticoagulants|mesh-ancestor
5851020|NCT02448069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5851021|NCT02447965|Bupivacaine|bupivacaine|mesh-list
5851022|NCT02447965|Anesthetics, Local|anesthetics, local|mesh-ancestor
5851023|NCT02447965|Anesthetics|anesthetics|mesh-ancestor
5851024|NCT02447965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5851025|NCT02447965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851026|NCT02447965|Sensory System Agents|sensory system agents|mesh-ancestor
5851027|NCT02447965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5851028|NCT02447939|Trametinib|trametinib|mesh-list
5851029|NCT02447939|Dabrafenib|dabrafenib|mesh-list
5851030|NCT02447939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5851031|NCT02447939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5851032|NCT02447939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5851033|NCT02447939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851034|NCT02447809|Aspirin|aspirin|mesh-list
5851035|NCT02447809|Clopidogrel|clopidogrel|mesh-list
5851036|NCT02447809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5851037|NCT02447809|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5851038|NCT02447809|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5851039|NCT02447809|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5851040|NCT02447809|Purinergic Agents|purinergic agents|mesh-ancestor
5851041|NCT02447809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5851042|NCT02447809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851043|NCT02447809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851044|NCT02447809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5851045|NCT02447809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5851046|NCT02447809|Analgesics|analgesics|mesh-ancestor
6212206|NCT02182895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6212207|NCT02182895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212208|NCT02182895|Protease Inhibitors|protease inhibitors|mesh-ancestor
5668530|NCT03583242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
5668531|NCT03583242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5851047|NCT02447809|Sensory System Agents|sensory system agents|mesh-ancestor
5851048|NCT02447809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5851049|NCT02447809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5851050|NCT02447809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5851051|NCT02447809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5851052|NCT02447809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5851053|NCT02447809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5851054|NCT02447809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5851055|NCT02447809|Antipyretics|antipyretics|mesh-ancestor
5851056|NCT02447822|Thymoglobulin|thymoglobulin|mesh-list
5851057|NCT02447822|Immunologic Factors|immunologic factors|mesh-ancestor
5851058|NCT02447822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851059|NCT02447822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5851060|NCT02447757|Remifentanil|remifentanil|mesh-list
5851061|NCT02447757|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5851062|NCT02447757|Narcotics|narcotics|mesh-ancestor
5851063|NCT02447757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5851064|NCT02447757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851065|NCT02447757|Analgesics|analgesics|mesh-ancestor
5851066|NCT02447757|Sensory System Agents|sensory system agents|mesh-ancestor
5851067|NCT02447757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5851068|NCT02447705|Telbivudine|telbivudine|mesh-list
5851069|NCT02447705|Antiviral Agents|antiviral agents|mesh-ancestor
5851070|NCT02447705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5851071|NCT02447705|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5851072|NCT02447705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5851073|NCT02447705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851074|NCT02447835|Olanzapine|olanzapine|mesh-list
5851075|NCT02447835|Antiemetics|antiemetics|mesh-ancestor
5851076|NCT02447835|Autonomic Agents|autonomic agents|mesh-ancestor
5851077|NCT02447835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5851078|NCT02447835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851079|NCT02447835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5851080|NCT02447835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5851081|NCT02447835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5668532|NCT03583242|Growth Substances|growth substances|mesh-ancestor
5668533|NCT03583242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668534|NCT03583242|Growth Inhibitors|growth inhibitors|mesh-ancestor
5668535|NCT03583242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5851082|NCT02447835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5851083|NCT02447835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5851084|NCT02447835|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5851085|NCT02447835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5851086|NCT02447835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5851087|NCT02447835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851088|NCT02447835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5851089|NCT02447835|Serotonin Agents|serotonin agents|mesh-ancestor
5851090|NCT02447796|Dexmedetomidine|dexmedetomidine|mesh-list
5851091|NCT02447796|Propofol|propofol|mesh-list
5851092|NCT02447796|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5851093|NCT02447796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5851094|NCT02447796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851095|NCT02447796|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5851096|NCT02447796|Anesthetics, General|anesthetics, general|mesh-ancestor
5851097|NCT02447796|Anesthetics|anesthetics|mesh-ancestor
5851098|NCT02447796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5851099|NCT02447796|Analgesics|analgesics|mesh-ancestor
5851100|NCT02447796|Sensory System Agents|sensory system agents|mesh-ancestor
5851101|NCT02447796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5851102|NCT02447796|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5851103|NCT02447796|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5668536|NCT03583229|Aspirin|aspirin|mesh-list
5668537|NCT03583229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5668538|NCT03583229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5668539|NCT03583229|Analgesics|analgesics|mesh-ancestor
5668540|NCT03583229|Sensory System Agents|sensory system agents|mesh-ancestor
5668541|NCT03583229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5668542|NCT03583229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668543|NCT03583229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5668544|NCT03583229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5668545|NCT03583229|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5668546|NCT03583229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5668547|NCT03583229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668548|NCT03583229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5668549|NCT03583229|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5668550|NCT03583229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5668551|NCT03583229|Antipyretics|antipyretics|mesh-ancestor
5668552|NCT03583164|Olorofim|olorofim|mesh-list
5851104|NCT02447796|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5851105|NCT02447796|Adrenergic Agents|adrenergic agents|mesh-ancestor
5851106|NCT02447796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5851107|NCT02447796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851108|NCT02447666|Azacitidine|azacitidine|mesh-list
5851109|NCT02447666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5851110|NCT02447666|Antimetabolites|antimetabolites|mesh-ancestor
5851111|NCT02447666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851112|NCT02447666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5851113|NCT02447666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5851114|NCT02447679|Tegafur|tegafur|mesh-list
5851115|NCT02447679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5851116|NCT02447679|Antimetabolites|antimetabolites|mesh-ancestor
5851117|NCT02447679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851118|NCT02447679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5851119|NCT02447601|Simvastatin|simvastatin|mesh-list
5851120|NCT02447601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5851121|NCT02447601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5851122|NCT02447601|Antimetabolites|antimetabolites|mesh-ancestor
5851123|NCT02447601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674764|NCT01571323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5668553|NCT03583164|Antifungal Agents|antifungal agents|mesh-ancestor
5668554|NCT03583164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5668555|NCT03583138|Buprenorphine|buprenorphine|mesh-list
5668556|NCT03583138|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5668557|NCT03583138|Narcotics|narcotics|mesh-ancestor
5668558|NCT03583138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5668559|NCT03583138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668560|NCT03583138|Analgesics|analgesics|mesh-ancestor
5668561|NCT03583138|Sensory System Agents|sensory system agents|mesh-ancestor
5668562|NCT03583138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5668563|NCT03583138|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5668564|NCT03583086|Nivolumab|nivolumab|mesh-list
5668565|NCT03583086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5668566|NCT03583086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5668567|NCT03583086|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5851124|NCT02447601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5851125|NCT02447601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5851126|NCT02447601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5851127|NCT02447393|Cetirizine|cetirizine|mesh-list
5851128|NCT02447393|Levocetirizine|levocetirizine|mesh-list
5851129|NCT02447393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5851130|NCT02447393|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5851131|NCT02447393|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5851132|NCT02447393|Histamine Antagonists|histamine antagonists|mesh-ancestor
5851133|NCT02447393|Histamine Agents|histamine agents|mesh-ancestor
5851134|NCT02447393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5851135|NCT02447393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851136|NCT02447393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851137|NCT02447406|Docetaxel|docetaxel|mesh-list
5851138|NCT02447406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5851139|NCT02447406|Tubulin Modulators|tubulin modulators|mesh-ancestor
5851140|NCT02447406|Antimitotic Agents|antimitotic agents|mesh-ancestor
5851141|NCT02447406|Mitosis Modulators|mitosis modulators|mesh-ancestor
5851142|NCT02447406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851143|NCT02447510|Mitogens|mitogens|mesh-list
5851144|NCT02447510|Mitosis Modulators|mitosis modulators|mesh-ancestor
5851145|NCT02447510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851146|NCT02447289|Midazolam|midazolam|mesh-list
5851147|NCT02447289|Ketamine|ketamine|mesh-list
5851148|NCT02447289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5851149|NCT02447289|Analgesics|analgesics|mesh-ancestor
5851150|NCT02447289|Sensory System Agents|sensory system agents|mesh-ancestor
5851151|NCT02447289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5851152|NCT02447289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851153|NCT02447289|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5851154|NCT02447289|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5851155|NCT02447289|Anesthetics, General|anesthetics, general|mesh-ancestor
5851156|NCT02447289|Anesthetics|anesthetics|mesh-ancestor
5851157|NCT02447289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5851158|NCT02447289|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5851159|NCT02447289|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5851160|NCT02447289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5851161|NCT02447289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851162|NCT02447289|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5851163|NCT02447289|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5851164|NCT02447289|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5851165|NCT02447289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5851166|NCT02447289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5851167|NCT02447289|GABA Modulators|gaba modulators|mesh-ancestor
5851168|NCT02447289|GABA Agents|gaba agents|mesh-ancestor
5851169|NCT02447380|Docetaxel|docetaxel|mesh-list
5851170|NCT02447380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5851171|NCT02447380|Tubulin Modulators|tubulin modulators|mesh-ancestor
5851172|NCT02447380|Antimitotic Agents|antimitotic agents|mesh-ancestor
5851173|NCT02447380|Mitosis Modulators|mitosis modulators|mesh-ancestor
5851174|NCT02447380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851175|NCT02447315|Pilocarpine|pilocarpine|mesh-list
5851176|NCT02447315|Miotics|miotics|mesh-ancestor
5851177|NCT02447315|Autonomic Agents|autonomic agents|mesh-ancestor
5851178|NCT02447315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5851179|NCT02447315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851180|NCT02447315|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
5668568|NCT03583086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668569|NCT03583021|Neostigmine|neostigmine|mesh-list
5668570|NCT03583021|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5668571|NCT03583021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5668572|NCT03583021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668573|NCT03583021|Cholinergic Agents|cholinergic agents|mesh-ancestor
5668574|NCT03583021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5668575|NCT03583021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851181|NCT02447315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5851182|NCT02447315|Cholinergic Agents|cholinergic agents|mesh-ancestor
5851183|NCT02447315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5851184|NCT02447315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851185|NCT02447224|Metronidazole|metronidazole|mesh-list
5851186|NCT02447224|Ertapenem|ertapenem|mesh-list
5851187|NCT02447224|Cefdinir|cefdinir|mesh-list
5851188|NCT02447224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5851189|NCT02447224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5851190|NCT02447224|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5851191|NCT02447224|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5903985|NCT04069312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5903986|NCT03891953|Spartalizumab|spartalizumab|mesh-list
5903987|NCT03891953|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5903988|NCT03891953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5903989|NCT03891953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5903990|NCT03873493|Venetoclax|venetoclax|mesh-list
5903991|NCT03873493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5903992|NCT03844048|Venetoclax|venetoclax|mesh-list
5903993|NCT03844048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5903994|NCT03741530|Glyburide|glyburide|mesh-list
5903995|NCT03741530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5903996|NCT03741530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5903997|NCT03667846|Topiramate|topiramate|mesh-list
5903998|NCT03667846|Anticonvulsants|anticonvulsants|mesh-ancestor
5903999|NCT03667846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5904000|NCT03667846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674765|NCT01571414|Ritonavir|ritonavir|mesh-list
6674766|NCT01571414|Lopinavir|lopinavir|mesh-list
6674767|NCT01571414|Efavirenz|efavirenz|mesh-list
6674768|NCT01571414|Rifampin|rifampin|mesh-list
6674769|NCT01571414|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6674770|NCT01571414|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6674771|NCT01571414|Protease Inhibitors|protease inhibitors|mesh-ancestor
6674772|NCT01571414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5668576|NCT03583021|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5668577|NCT03583021|Autonomic Agents|autonomic agents|mesh-ancestor
5668578|NCT03583021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5668579|NCT03582930|Calfactant|calfactant|mesh-list
5668580|NCT03582930|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
5668581|NCT03582930|Respiratory System Agents|respiratory system agents|mesh-ancestor
5668582|NCT03582917|Alfacalcidol|alfacalcidol|mesh-list
5668583|NCT03582917|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
5668584|NCT03582917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5668585|NCT03582917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668586|NCT03582917|Vitamins|vitamins|mesh-ancestor
5668587|NCT03582917|Micronutrients|micronutrients|mesh-ancestor
5668588|NCT03582878|Mycophenolic Acid|mycophenolic acid|mesh-list
5668589|NCT03582878|Sirolimus|sirolimus|mesh-list
5668590|NCT03582878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5668591|NCT03582878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5668592|NCT03582878|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5668593|NCT03582878|Antitubercular Agents|antitubercular agents|mesh-ancestor
5668594|NCT03582878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6674773|NCT01571414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674774|NCT01571414|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6674775|NCT01571414|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6674776|NCT01571414|Antiviral Agents|antiviral agents|mesh-ancestor
6674777|NCT01571414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6674778|NCT01571414|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6674779|NCT01571414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6674780|NCT01571414|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6674781|NCT01571414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6674782|NCT01571414|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6674783|NCT01571414|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6674784|NCT01571414|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6674785|NCT01571414|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6674786|NCT01571414|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6674787|NCT01571414|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6674788|NCT01571414|Antitubercular Agents|antitubercular agents|mesh-ancestor
6674789|NCT01571414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6674790|NCT01571414|Leprostatic Agents|leprostatic agents|mesh-ancestor
6674791|NCT01571414|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6674792|NCT01571414|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5904001|NCT03580928|Venetoclax|venetoclax|mesh-list
5904002|NCT03580928|Obinutuzumab|obinutuzumab|mesh-list
5904003|NCT03580928|Acalabrutinib|acalabrutinib|mesh-list
5904004|NCT03580928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5904005|NCT03580928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5904006|NCT03534323|Venetoclax|venetoclax|mesh-list
5904007|NCT03534323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5904008|NCT03520231|Vitamin D|vitamin d|mesh-list
5668595|NCT03582878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5668596|NCT03582878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5904009|NCT03520231|Denosumab|denosumab|mesh-list
5904010|NCT03520231|Gemcitabine|gemcitabine|mesh-list
5851192|NCT02447419|Gefitinib|gefitinib|mesh-list
5851193|NCT02447419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5851194|NCT02447419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5851195|NCT02447419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5851196|NCT02447419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851197|NCT02447211|Doxepin|doxepin|mesh-list
5851198|NCT02447211|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5851199|NCT02447211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5851200|NCT02447211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5851201|NCT02447211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851202|NCT02447211|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5668597|NCT03582878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668598|NCT03582878|Antifungal Agents|antifungal agents|mesh-ancestor
5668599|NCT03582878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5668600|NCT03582878|Immunologic Factors|immunologic factors|mesh-ancestor
5668601|NCT03582878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668602|NCT03582865|Tamoxifen|tamoxifen|mesh-list
5668603|NCT03582865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5668604|NCT03582865|Hormone Antagonists|hormone antagonists|mesh-ancestor
5668605|NCT03582865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5668606|NCT03582865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668607|NCT03582865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5668608|NCT03582865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5668609|NCT03582865|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5668610|NCT03582865|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5668611|NCT03582865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5695849|NCT03387085|Leucovorin|leucovorin|mesh-list
5695850|NCT03387085|Paclitaxel|paclitaxel|mesh-list
5695851|NCT03387085|Cyclophosphamide|cyclophosphamide|mesh-list
5695852|NCT03387085|Bevacizumab|bevacizumab|mesh-list
5695853|NCT03387085|Fluorouracil|fluorouracil|mesh-list
5695854|NCT03387085|Capecitabine|capecitabine|mesh-list
5695855|NCT03387085|Avelumab|avelumab|mesh-list
5695856|NCT03387085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5695857|NCT03387085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5695858|NCT03387085|Tubulin Modulators|tubulin modulators|mesh-ancestor
5695859|NCT03387085|Antimitotic Agents|antimitotic agents|mesh-ancestor
5695860|NCT03387085|Mitosis Modulators|mitosis modulators|mesh-ancestor
5695861|NCT03387085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851203|NCT02447211|Antidepressive Agents|antidepressive agents|mesh-ancestor
5851204|NCT02447211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5851205|NCT02447211|Histamine Antagonists|histamine antagonists|mesh-ancestor
5851206|NCT02447211|Histamine Agents|histamine agents|mesh-ancestor
5851207|NCT02447211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5851208|NCT02447211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851209|NCT02447185|Triamcinolone|triamcinolone|mesh-list
5851210|NCT02447185|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5851211|NCT02447185|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5851212|NCT02447185|Ranibizumab|ranibizumab|mesh-list
5851213|NCT02447185|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5851214|NCT02447185|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5851215|NCT02447185|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5851216|NCT02447185|Growth Substances|growth substances|mesh-ancestor
5851217|NCT02447185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851218|NCT02447185|Growth Inhibitors|growth inhibitors|mesh-ancestor
5851219|NCT02447185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5851220|NCT02447185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5851221|NCT02447185|Glucocorticoids|glucocorticoids|mesh-ancestor
5851222|NCT02447185|Hormones|hormones|mesh-ancestor
5851223|NCT02447185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5851224|NCT02447185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5695862|NCT03387085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5695863|NCT03387085|Immunologic Factors|immunologic factors|mesh-ancestor
5695864|NCT03387085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695865|NCT03387085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5695866|NCT03387085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5695867|NCT03387085|Alkylating Agents|alkylating agents|mesh-ancestor
5695868|NCT03387085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5695869|NCT03387085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5695870|NCT03387085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5695871|NCT03387085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5851225|NCT02447185|Immunologic Factors|immunologic factors|mesh-ancestor
5851226|NCT02447185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5851227|NCT02447185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851228|NCT02446977|Riboflavin|riboflavin|mesh-list
5851229|NCT02446977|Vitamins|vitamins|mesh-ancestor
5668612|NCT03582722|Orlistat|orlistat|mesh-list
5668613|NCT03582722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5668614|NCT03582722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668615|NCT03582722|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5668616|NCT03582722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5668617|NCT03582605|Amoxicillin|amoxicillin|mesh-list
5668618|NCT03582605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5668619|NCT03582605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5668620|NCT03582475|Cisplatin|cisplatin|mesh-list
5668621|NCT03582475|Carboplatin|carboplatin|mesh-list
5851230|NCT02446977|Micronutrients|micronutrients|mesh-ancestor
5851231|NCT02446977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851232|NCT02446977|Vitamin B Complex|vitamin b complex|mesh-ancestor
5851233|NCT02446977|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5851234|NCT02446977|Dermatologic Agents|dermatologic agents|mesh-ancestor
5851235|NCT02447016|Tenofovir|tenofovir|mesh-list
5851236|NCT02447016|Emtricitabine|emtricitabine|mesh-list
5851237|NCT02447016|Efavirenz|efavirenz|mesh-list
5851238|NCT02447016|Rilpivirine|rilpivirine|mesh-list
5851239|NCT02447016|Antiviral Agents|antiviral agents|mesh-ancestor
5851240|NCT02447016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5851241|NCT02447016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5851242|NCT02447016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5668622|NCT03582475|Docetaxel|docetaxel|mesh-list
5668623|NCT03582475|Pembrolizumab|pembrolizumab|mesh-list
5668624|NCT03582475|Etoposide|etoposide|mesh-list
5668625|NCT03582475|Etoposide phosphate|etoposide phosphate|mesh-list
5668626|NCT03582475|Podophyllotoxin|podophyllotoxin|mesh-list
5668627|NCT03582475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5668628|NCT03582475|Tubulin Modulators|tubulin modulators|mesh-ancestor
5668629|NCT03582475|Antimitotic Agents|antimitotic agents|mesh-ancestor
5668630|NCT03582475|Mitosis Modulators|mitosis modulators|mesh-ancestor
5668631|NCT03582475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668632|NCT03582475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5668633|NCT03582475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5668634|NCT03582475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5668635|NCT03582475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5668636|NCT03582475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5668637|NCT03582475|Keratolytic Agents|keratolytic agents|mesh-ancestor
5668638|NCT03582475|Dermatologic Agents|dermatologic agents|mesh-ancestor
5668639|NCT03582332|Indomethacin|indomethacin|mesh-list
5668640|NCT03582332|Etoricoxib|etoricoxib|mesh-list
5668641|NCT03582332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5668642|NCT03582332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5668643|NCT03582332|Analgesics|analgesics|mesh-ancestor
5668644|NCT03582332|Sensory System Agents|sensory system agents|mesh-ancestor
5668645|NCT03582332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5668646|NCT03582332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668647|NCT03582332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5668648|NCT03582332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5668649|NCT03582332|Gout Suppressants|gout suppressants|mesh-ancestor
5668650|NCT03582332|Tocolytic Agents|tocolytic agents|mesh-ancestor
5668651|NCT03582332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5668652|NCT03582332|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5668653|NCT03582332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5668654|NCT03582332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668655|NCT03582332|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5668656|NCT03582319|Formaldehyde|formaldehyde|mesh-list
5668657|NCT03582319|Disinfectants|disinfectants|mesh-ancestor
5668658|NCT03582319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5851243|NCT02447016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5851244|NCT02447016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851245|NCT02447016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5851246|NCT02447016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5851247|NCT02447016|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5851248|NCT02447016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5851249|NCT02447016|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5851250|NCT02447016|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5851251|NCT02447016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5668659|NCT03582306|Chlorophyllin|chlorophyllin|mesh-list
5851252|NCT02447016|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5668660|NCT03582306|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
5668661|NCT03582306|Protective Agents|protective agents|mesh-ancestor
5668662|NCT03582306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668663|NCT03582280|Calcium Carbonate|calcium carbonate|mesh-list
5668664|NCT03582280|Calcium|calcium|mesh-list
5668665|NCT03582280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5668666|NCT03582280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668667|NCT03582280|Antacids|antacids|mesh-ancestor
5668668|NCT03582280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668669|NCT03582280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5668670|NCT03582124|Panitumumab|panitumumab|mesh-list
5668671|NCT03582124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5668672|NCT03582124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5668673|NCT03582098|Rituximab|rituximab|mesh-list
5668674|NCT03582098|Idelalisib|idelalisib|mesh-list
5851253|NCT02447055|Mycophenolic Acid|mycophenolic acid|mesh-list
5851254|NCT02447055|Cyclophosphamide|cyclophosphamide|mesh-list
5851255|NCT02447055|Melphalan|melphalan|mesh-list
5851256|NCT02447055|Fludarabine|fludarabine|mesh-list
5851257|NCT02447055|Fludarabine phosphate|fludarabine phosphate|mesh-list
5851258|NCT02447055|Tacrolimus|tacrolimus|mesh-list
5851259|NCT02447055|Lenograstim|lenograstim|mesh-list
5851260|NCT02447055|Sargramostim|sargramostim|mesh-list
5851261|NCT02447055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5851262|NCT02447055|Immunologic Factors|immunologic factors|mesh-ancestor
5851263|NCT02447055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851264|NCT02447055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5851265|NCT02447055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5851266|NCT02447055|Alkylating Agents|alkylating agents|mesh-ancestor
5851267|NCT02447055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851268|NCT02447055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5851269|NCT02447055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5851270|NCT02447055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5851271|NCT02447055|Antimetabolites|antimetabolites|mesh-ancestor
5851272|NCT02447055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5851273|NCT02447055|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5851274|NCT02447055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5851275|NCT02447055|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5851276|NCT02447055|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5851277|NCT02447055|Antitubercular Agents|antitubercular agents|mesh-ancestor
5851278|NCT02447055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5851279|NCT02447055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5851280|NCT02447094|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5851281|NCT02447094|Plasminogen|plasminogen|mesh-list
5851282|NCT02447094|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5851283|NCT02447094|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5668675|NCT03582098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5668676|NCT03582098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5668677|NCT03582098|Immunologic Factors|immunologic factors|mesh-ancestor
5668678|NCT03582098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668679|NCT03582098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5668680|NCT03582098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5668681|NCT03582098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668682|NCT03582085|BCG Vaccine|bcg vaccine|mesh-list
5668683|NCT03582085|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5668684|NCT03582085|Immunologic Factors|immunologic factors|mesh-ancestor
5668685|NCT03582085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668686|NCT03582007|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5668687|NCT03582007|Murepavadin|murepavadin|mesh-list
5668688|NCT03582007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5668689|NCT03581968|Pancrelipase|pancrelipase|mesh-list
5668690|NCT03581968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5668691|NCT03581916|JNJ-64326067|jnj-64326067|mesh-list
5668692|NCT03581916|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5668693|NCT03581916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668694|NCT03581903|Vaccines|vaccines|mesh-list
5668695|NCT03581903|Immunologic Factors|immunologic factors|mesh-ancestor
5668696|NCT03581903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668697|NCT03581877|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5668698|NCT03581877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5668699|NCT03581877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5668700|NCT03581877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668701|NCT03581773|Folic Acid|folic acid|mesh-list
5668702|NCT03581773|Hematinics|hematinics|mesh-ancestor
5668703|NCT03581773|Vitamin B Complex|vitamin b complex|mesh-ancestor
5668704|NCT03581773|Vitamins|vitamins|mesh-ancestor
5851284|NCT02447094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668705|NCT03581773|Micronutrients|micronutrients|mesh-ancestor
5668706|NCT03581773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668707|NCT03581734|Vaccines|vaccines|mesh-list
5851285|NCT02446860|Nivolumab|nivolumab|mesh-list
5668708|NCT03581734|Immunologic Factors|immunologic factors|mesh-ancestor
5668709|NCT03581734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668710|NCT03581630|Naltrexone|naltrexone|mesh-list
5668711|NCT03581630|Bupropion|bupropion|mesh-list
5668712|NCT03581630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5668713|NCT03581630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5851286|NCT02446860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5851287|NCT02446860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5851288|NCT02446860|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5851289|NCT02446860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851290|NCT02446730|Clopidogrel|clopidogrel|mesh-list
5851291|NCT02446730|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5851292|NCT02446730|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5851293|NCT02446730|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5851294|NCT02446730|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5851295|NCT02446730|Purinergic Agents|purinergic agents|mesh-ancestor
5851296|NCT02446730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5851297|NCT02446730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851298|NCT02446730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851299|NCT02446652|Paclitaxel|paclitaxel|mesh-list
5851300|NCT02446652|Carboplatin|carboplatin|mesh-list
5851301|NCT02446652|Hydralazine|hydralazine|mesh-list
5851302|NCT02446652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5851303|NCT02446652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5851304|NCT02446652|Tubulin Modulators|tubulin modulators|mesh-ancestor
5851305|NCT02446652|Antimitotic Agents|antimitotic agents|mesh-ancestor
5851306|NCT02446652|Mitosis Modulators|mitosis modulators|mesh-ancestor
5851307|NCT02446652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851308|NCT02446652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5851309|NCT02446652|Vasodilator Agents|vasodilator agents|mesh-ancestor
5851310|NCT02446782|Clindamycin|clindamycin|mesh-list
5851311|NCT02446782|Cefazolin|cefazolin|mesh-list
5851312|NCT02446782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5851313|NCT02446782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5851314|NCT02446782|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5851315|NCT02446782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5851316|NCT02446782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851317|NCT02446795|Sunitinib|sunitinib|mesh-list
5851318|NCT02446795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5851319|NCT02446795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6674793|NCT01571414|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6674794|NCT01571466|Vaccines|vaccines|mesh-list
6674795|NCT01571466|Immunologic Factors|immunologic factors|mesh-ancestor
6674796|NCT01571466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675605|NCT01576640|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6675606|NCT01576640|Antidepressive Agents|antidepressive agents|mesh-ancestor
6675607|NCT01576640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6675608|NCT01576640|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5851320|NCT02446795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5851321|NCT02446795|Growth Substances|growth substances|mesh-ancestor
5851322|NCT02446795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851323|NCT02446795|Growth Inhibitors|growth inhibitors|mesh-ancestor
5851324|NCT02446795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5851325|NCT02446795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5851326|NCT02446795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851327|NCT02446834|Metformin|metformin|mesh-list
5851328|NCT02446834|Acarbose|acarbose|mesh-list
5851329|NCT02446834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5851330|NCT02446834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851331|NCT02446834|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
5851332|NCT02446834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5851333|NCT02446834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851334|NCT02446574|Paclitaxel|paclitaxel|mesh-list
5851335|NCT02446574|Cisplatin|cisplatin|mesh-list
5851336|NCT02446574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5851337|NCT02446574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5851338|NCT02446574|Tubulin Modulators|tubulin modulators|mesh-ancestor
5851339|NCT02446574|Antimitotic Agents|antimitotic agents|mesh-ancestor
5668714|NCT03581630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668715|NCT03581630|Sensory System Agents|sensory system agents|mesh-ancestor
5668716|NCT03581630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5668717|NCT03581630|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5668718|NCT03581630|Antidepressive Agents|antidepressive agents|mesh-ancestor
5668719|NCT03581630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5851340|NCT02446574|Mitosis Modulators|mitosis modulators|mesh-ancestor
5851341|NCT02446574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851342|NCT02446704|Temozolomide|temozolomide|mesh-list
5851343|NCT02446704|Olaparib|olaparib|mesh-list
5851344|NCT02446704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5851345|NCT02446704|Alkylating Agents|alkylating agents|mesh-ancestor
5851346|NCT02446704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668720|NCT03581630|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5668721|NCT03581630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5668722|NCT03581630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5668723|NCT03581630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668724|NCT03581630|Dopamine Agents|dopamine agents|mesh-ancestor
5668725|NCT03581630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5668726|NCT03581630|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5668727|NCT03581630|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5668728|NCT03581630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5668729|NCT03581422|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5668730|NCT03581422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5668731|NCT03581422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851347|NCT02446704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5851348|NCT02446704|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5851349|NCT02446704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5851350|NCT02446548|Losartan|losartan|mesh-list
5851351|NCT02446548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5851352|NCT02446548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5851353|NCT02446548|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5851354|NCT02446548|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5851355|NCT02446548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851356|NCT02446457|Rituximab|rituximab|mesh-list
5851357|NCT02446457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5851358|NCT02446457|Pembrolizumab|pembrolizumab|mesh-list
5851359|NCT02446457|Lenalidomide|lenalidomide|mesh-list
6212209|NCT02182895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6212210|NCT02182895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212211|NCT02182895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6212212|NCT02182999|Ropivacaine|ropivacaine|mesh-list
6212213|NCT02182999|Anesthetics, Local|anesthetics, local|mesh-ancestor
5668732|NCT03581409|Aspirin|aspirin|mesh-list
5668733|NCT03581409|Cilostazol|cilostazol|mesh-list
5668734|NCT03581409|Clopidogrel|clopidogrel|mesh-list
5668735|NCT03581409|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
5668736|NCT03581409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5668737|NCT03581409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5668738|NCT03581409|Analgesics|analgesics|mesh-ancestor
5668739|NCT03581409|Sensory System Agents|sensory system agents|mesh-ancestor
5668740|NCT03581409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5668741|NCT03581409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668742|NCT03581409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5668743|NCT03581409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5668744|NCT03581409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5668745|NCT03581409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5668746|NCT03581409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668747|NCT03581409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5668748|NCT03581409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5668749|NCT03581409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5668750|NCT03581409|Antipyretics|antipyretics|mesh-ancestor
5668751|NCT03581409|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5668752|NCT03581409|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5668753|NCT03581409|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5668754|NCT03581409|Purinergic Agents|purinergic agents|mesh-ancestor
5668755|NCT03581409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5668756|NCT03581409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5668757|NCT03581409|Autonomic Agents|autonomic agents|mesh-ancestor
5668758|NCT03581409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5668759|NCT03581409|Respiratory System Agents|respiratory system agents|mesh-ancestor
5668760|NCT03581409|Vasodilator Agents|vasodilator agents|mesh-ancestor
6212214|NCT02182999|Anesthetics|anesthetics|mesh-ancestor
6212215|NCT02182999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6212216|NCT02182999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212217|NCT02182999|Sensory System Agents|sensory system agents|mesh-ancestor
6212218|NCT02182999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6212219|NCT02183519|Capsaicin|capsaicin|mesh-list
6212220|NCT02183519|Antipruritics|antipruritics|mesh-ancestor
5668761|NCT03581409|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5668762|NCT03581409|Protective Agents|protective agents|mesh-ancestor
5668763|NCT03581409|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5668764|NCT03581409|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5668765|NCT03581370|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
5668766|NCT03581370|Cephalosporins|cephalosporins|mesh-list
5668767|NCT03581370|Penicillanic Acid|penicillanic acid|mesh-list
6212221|NCT02183519|Dermatologic Agents|dermatologic agents|mesh-ancestor
6212222|NCT02183519|Sensory System Agents|sensory system agents|mesh-ancestor
6212223|NCT02183519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5851360|NCT02446457|Antibodies|antibodies|mesh-list
5851361|NCT02446457|Immunoglobulins|immunoglobulins|mesh-list
5851362|NCT02446457|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5851363|NCT02446457|Immunologic Factors|immunologic factors|mesh-ancestor
5851364|NCT02446457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851365|NCT02446457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5851366|NCT02446457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5851367|NCT02446457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5851368|NCT02446457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5668768|NCT03581370|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5668769|NCT03581370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5668770|NCT03581370|Renal Agents|renal agents|mesh-ancestor
5668771|NCT03581370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5668772|NCT03581370|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5668773|NCT03581370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5668774|NCT03581370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668775|NCT03581240|Eflornithine|eflornithine|mesh-list
5668776|NCT03581240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5668777|NCT03581240|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5668778|NCT03581240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5851369|NCT02446457|Growth Substances|growth substances|mesh-ancestor
5851370|NCT02446457|Growth Inhibitors|growth inhibitors|mesh-ancestor
5851371|NCT02446431|Sirolimus|sirolimus|mesh-list
5851372|NCT02446431|Cyclophosphamide|cyclophosphamide|mesh-list
5851373|NCT02446431|Bevacizumab|bevacizumab|mesh-list
5851374|NCT02446431|Valproic Acid|valproic acid|mesh-list
5851375|NCT02446431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5851376|NCT02446431|Immunologic Factors|immunologic factors|mesh-ancestor
5851377|NCT02446431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851378|NCT02446431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5851379|NCT02446431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5851380|NCT02446431|Alkylating Agents|alkylating agents|mesh-ancestor
5851381|NCT02446431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851382|NCT02446431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5851383|NCT02446431|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5851384|NCT02446431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5851385|NCT02446431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5851386|NCT02446431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5851387|NCT02446431|Growth Substances|growth substances|mesh-ancestor
5851388|NCT02446431|Growth Inhibitors|growth inhibitors|mesh-ancestor
5851389|NCT02446431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5851390|NCT02446431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5851391|NCT02446431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5668779|NCT03581240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5668780|NCT03581240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5668781|NCT03581240|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
5668782|NCT03581240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5668783|NCT03581240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695872|NCT03387085|Growth Substances|growth substances|mesh-ancestor
5851392|NCT02446431|Antifungal Agents|antifungal agents|mesh-ancestor
5851393|NCT02446431|Anticonvulsants|anticonvulsants|mesh-ancestor
5851394|NCT02446431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5851395|NCT02446431|GABA Agents|gaba agents|mesh-ancestor
5851396|NCT02446431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5851397|NCT02446431|Antimanic Agents|antimanic agents|mesh-ancestor
5851398|NCT02446431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5851399|NCT02446431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5851400|NCT02446431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5851401|NCT02446236|Rituximab|rituximab|mesh-list
5851402|NCT02446236|Lenalidomide|lenalidomide|mesh-list
5851403|NCT02446236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5851404|NCT02446236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5851405|NCT02446236|Immunologic Factors|immunologic factors|mesh-ancestor
6212224|NCT02183519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851406|NCT02446236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851407|NCT02446236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5851408|NCT02446236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5851409|NCT02446236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5851410|NCT02446236|Growth Substances|growth substances|mesh-ancestor
5851411|NCT02446236|Growth Inhibitors|growth inhibitors|mesh-ancestor
5851412|NCT02446379|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5851413|NCT02446379|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5851414|NCT02446379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494200|NCT00617747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494201|NCT00617747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494202|NCT00617760|Vaccines|vaccines|mesh-list
6494203|NCT00617760|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6494204|NCT00617760|Immunologic Factors|immunologic factors|mesh-ancestor
6494205|NCT00617760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494206|NCT00617799|Aldesleukin|aldesleukin|mesh-list
6494207|NCT00617799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6494208|NCT00617799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6494209|NCT00617799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6494210|NCT00617799|Antiviral Agents|antiviral agents|mesh-ancestor
6494211|NCT00617799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6494212|NCT00617877|Losartan|losartan|mesh-list
6494213|NCT00617877|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6494214|NCT00617877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5851415|NCT02446353|Megestrol Acetate|megestrol acetate|mesh-list
5851416|NCT02446353|Megestrol|megestrol|mesh-list
5851417|NCT02446353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6494215|NCT00617877|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6494216|NCT00617877|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6494217|NCT00617877|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6494218|NCT00617877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494219|NCT00617877|Diuretics|diuretics|mesh-ancestor
6494220|NCT00617877|Natriuretic Agents|natriuretic agents|mesh-ancestor
6494221|NCT00617877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851418|NCT02446353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5851419|NCT02446353|Appetite Stimulants|appetite stimulants|mesh-ancestor
5851420|NCT02446353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5851421|NCT02446353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851422|NCT02446353|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5851423|NCT02446353|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5851424|NCT02446353|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5851425|NCT02446353|Contraceptive Agents|contraceptive agents|mesh-ancestor
5851426|NCT02446353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5851427|NCT02446353|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5851428|NCT02446353|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5851429|NCT02446158|Chlorhexidine|chlorhexidine|mesh-list
5851430|NCT02446158|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5851431|NCT02446158|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5851432|NCT02446158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5851433|NCT02446158|Disinfectants|disinfectants|mesh-ancestor
5851434|NCT02446158|Dermatologic Agents|dermatologic agents|mesh-ancestor
5851435|NCT02446301|Nalbuphine|nalbuphine|mesh-list
5851436|NCT02446301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5851437|NCT02446301|Narcotics|narcotics|mesh-ancestor
5851438|NCT02446301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5851439|NCT02446301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851440|NCT02446301|Analgesics|analgesics|mesh-ancestor
5851441|NCT02446301|Sensory System Agents|sensory system agents|mesh-ancestor
5851442|NCT02446301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5851443|NCT02445976|Seviteronel|seviteronel|mesh-list
5851444|NCT02445976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5851445|NCT02445976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5851446|NCT02445976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5851447|NCT02445976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851448|NCT02445989|Contraceptive Agents|contraceptive agents|mesh-list
5851449|NCT02445989|NuvaRing|nuvaring|mesh-list
5668784|NCT03581149|Ascorbic Acid|ascorbic acid|mesh-list
5668785|NCT03581149|Picosulfate sodium|picosulfate sodium|mesh-list
5668786|NCT03581149|Magnesium citrate|magnesium citrate|mesh-list
5668787|NCT03581149|Laxatives|laxatives|mesh-list
5668788|NCT03581149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668789|NCT03581149|Antioxidants|antioxidants|mesh-ancestor
5668790|NCT03581149|Protective Agents|protective agents|mesh-ancestor
5668791|NCT03581149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668792|NCT03581149|Vitamins|vitamins|mesh-ancestor
5851450|NCT02445989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5904011|NCT03520231|Carboplatin|carboplatin|mesh-list
5668793|NCT03581149|Micronutrients|micronutrients|mesh-ancestor
5668794|NCT03581149|Cathartics|cathartics|mesh-ancestor
5668795|NCT03581149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5668796|NCT03580980|Acetaminophen|acetaminophen|mesh-list
5668797|NCT03580980|Morphine|morphine|mesh-list
5668798|NCT03580980|Ketamine|ketamine|mesh-list
5668799|NCT03580980|Levobupivacaine|levobupivacaine|mesh-list
5668800|NCT03580980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5851451|NCT02445989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851452|NCT02445989|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5851453|NCT02446002|Lofexidine|lofexidine|mesh-list
5851454|NCT02446002|Clonidine|clonidine|mesh-list
5851455|NCT02446002|Naltrexone|naltrexone|mesh-list
5851456|NCT02446002|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5851457|NCT02446002|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5851458|NCT02446002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851459|NCT02446002|Sensory System Agents|sensory system agents|mesh-ancestor
5851460|NCT02446002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5851461|NCT02446002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5851462|NCT02446002|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5851463|NCT02446002|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5851464|NCT02446002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5851465|NCT02446002|Adrenergic Agents|adrenergic agents|mesh-ancestor
5851466|NCT02446002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5851467|NCT02446002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851468|NCT02446002|Analgesics|analgesics|mesh-ancestor
5851469|NCT02446002|Sympatholytics|sympatholytics|mesh-ancestor
5668801|NCT03580980|Narcotics|narcotics|mesh-ancestor
5668802|NCT03580980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5668803|NCT03580980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668804|NCT03580980|Analgesics|analgesics|mesh-ancestor
5668805|NCT03580980|Sensory System Agents|sensory system agents|mesh-ancestor
5668806|NCT03580980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5668807|NCT03580980|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5668808|NCT03580980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5851470|NCT02446002|Autonomic Agents|autonomic agents|mesh-ancestor
5851471|NCT02445898|Methylprednisolone|methylprednisolone|mesh-list
5851472|NCT02445898|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5851473|NCT02445898|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5851474|NCT02445898|Prednisolone|prednisolone|mesh-list
5851475|NCT02445898|Prednisolone acetate|prednisolone acetate|mesh-list
5851476|NCT02445898|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5851477|NCT02445898|Prednisolone phosphate|prednisolone phosphate|mesh-list
5851478|NCT02445898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5851479|NCT02445898|Antiemetics|antiemetics|mesh-ancestor
5851480|NCT02445898|Autonomic Agents|autonomic agents|mesh-ancestor
5851481|NCT02445898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5851482|NCT02445898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851483|NCT02445898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5851484|NCT02445898|Glucocorticoids|glucocorticoids|mesh-ancestor
5851485|NCT02445898|Hormones|hormones|mesh-ancestor
5851486|NCT02445898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5851487|NCT02445898|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5851488|NCT02445898|Protective Agents|protective agents|mesh-ancestor
5851489|NCT02445898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5851490|NCT02445898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5851491|NCT02445872|Dexamethasone|dexamethasone|mesh-list
5851492|NCT02445872|Aprepitant|aprepitant|mesh-list
5851493|NCT02445872|Palonosetron|palonosetron|mesh-list
5851494|NCT02445872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5668809|NCT03580980|Anesthetics, General|anesthetics, general|mesh-ancestor
5668810|NCT03580980|Anesthetics|anesthetics|mesh-ancestor
5668811|NCT03580980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5668812|NCT03580980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5668813|NCT03580980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5668814|NCT03580980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668815|NCT03580980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5668816|NCT03580980|Antipyretics|antipyretics|mesh-ancestor
5668817|NCT03580980|Anesthetics, Local|anesthetics, local|mesh-ancestor
5668818|NCT03580967|Vortioxetine|vortioxetine|mesh-list
5668819|NCT03580967|Antidepressive Agents|antidepressive agents|mesh-ancestor
5668820|NCT03580967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5668821|NCT03580967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5851495|NCT02445872|Antiemetics|antiemetics|mesh-ancestor
5851496|NCT02445872|Autonomic Agents|autonomic agents|mesh-ancestor
5668822|NCT03580967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6494222|NCT00617877|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5668823|NCT03580967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5851497|NCT02445872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5851498|NCT02445872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851499|NCT02445872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5851500|NCT02445872|Glucocorticoids|glucocorticoids|mesh-ancestor
5851501|NCT02445872|Hormones|hormones|mesh-ancestor
5851502|NCT02445872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5851503|NCT02445872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5851504|NCT02445872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5851505|NCT02445872|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5851506|NCT02445872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5851507|NCT02445872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851508|NCT02445872|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5851509|NCT02445872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5851510|NCT02445872|Serotonin Agents|serotonin agents|mesh-ancestor
5851511|NCT02446093|Valacyclovir|valacyclovir|mesh-list
5851512|NCT02446093|Antiviral Agents|antiviral agents|mesh-ancestor
5851513|NCT02446093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5851514|NCT02445820|Plasma-lyte 148|plasma-lyte 148|mesh-list
5851515|NCT02445820|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5851516|NCT02445820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5851517|NCT02445599|Dipyrone|dipyrone|mesh-list
5851518|NCT02445599|Diclofenac|diclofenac|mesh-list
5851519|NCT02445599|Atropine|atropine|mesh-list
5851520|NCT02445599|Fentanyl|fentanyl|mesh-list
5851521|NCT02445599|Midazolam|midazolam|mesh-list
5851522|NCT02445599|Tramadol|tramadol|mesh-list
5851523|NCT02445599|Nalbuphine|nalbuphine|mesh-list
5851524|NCT02445599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5851525|NCT02445599|Narcotics|narcotics|mesh-ancestor
5851526|NCT02445599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5851527|NCT02445599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851528|NCT02445599|Analgesics|analgesics|mesh-ancestor
5851529|NCT02445599|Sensory System Agents|sensory system agents|mesh-ancestor
5851530|NCT02445599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5851531|NCT02445599|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5668824|NCT03580967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668825|NCT03580967|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5668826|NCT03580967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5668827|NCT03580967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5668828|NCT03580967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668829|NCT03580967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5668830|NCT03580967|Serotonin Agents|serotonin agents|mesh-ancestor
5668831|NCT03580967|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5668832|NCT03580967|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5668833|NCT03580967|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5668834|NCT03580967|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5668835|NCT03580902|Buprenorphine|buprenorphine|mesh-list
5668836|NCT03580902|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
5668837|NCT03580902|Naloxone|naloxone|mesh-list
5668838|NCT03580902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5668839|NCT03580902|Narcotics|narcotics|mesh-ancestor
5668840|NCT03580902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5668841|NCT03580902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668842|NCT03580902|Analgesics|analgesics|mesh-ancestor
5668843|NCT03580902|Sensory System Agents|sensory system agents|mesh-ancestor
5668844|NCT03580902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5668845|NCT03580902|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5668846|NCT03580889|Atropine|atropine|mesh-list
5668847|NCT03580889|Glycopyrrolate|glycopyrrolate|mesh-list
5668848|NCT03580889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5668849|NCT03580889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5668850|NCT03580889|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5851532|NCT02445599|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5851533|NCT02445599|Anesthetics, General|anesthetics, general|mesh-ancestor
5851534|NCT02445599|Anesthetics|anesthetics|mesh-ancestor
5851535|NCT02445599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5851536|NCT02445599|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5851537|NCT02445599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5851538|NCT02445599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5851539|NCT02445599|GABA Modulators|gaba modulators|mesh-ancestor
5851540|NCT02445599|GABA Agents|gaba agents|mesh-ancestor
5851541|NCT02445599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5851542|NCT02445599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851543|NCT02445599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5851544|NCT02445599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5851545|NCT02445599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5668851|NCT03580889|Autonomic Agents|autonomic agents|mesh-ancestor
5851546|NCT02445599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5851547|NCT02445599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5851548|NCT02445599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5851549|NCT02445599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5851550|NCT02445599|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5851551|NCT02445599|Autonomic Agents|autonomic agents|mesh-ancestor
5851552|NCT02445599|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5851553|NCT02445599|Respiratory System Agents|respiratory system agents|mesh-ancestor
5851554|NCT02445599|Mydriatics|mydriatics|mesh-ancestor
5851555|NCT02445599|Parasympatholytics|parasympatholytics|mesh-ancestor
5851556|NCT02445599|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5851557|NCT02445599|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5851558|NCT02445599|Cholinergic Agents|cholinergic agents|mesh-ancestor
5851559|NCT02445599|Antipyretics|antipyretics|mesh-ancestor
5851560|NCT02445703|Vaccines|vaccines|mesh-list
5851561|NCT02445703|Immunologic Factors|immunologic factors|mesh-ancestor
5851562|NCT02445703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851563|NCT02445716|Methyltestosterone|methyltestosterone|mesh-list
5851564|NCT02445716|Testosterone|testosterone|mesh-list
5851565|NCT02445716|Testosterone undecanoate|testosterone undecanoate|mesh-list
5851566|NCT02445716|Testosterone enanthate|testosterone enanthate|mesh-list
5851567|NCT02445716|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5851568|NCT02445716|Androgens|androgens|mesh-ancestor
5851569|NCT02445716|Hormones|hormones|mesh-ancestor
5851570|NCT02445716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5668852|NCT03580889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5668853|NCT03580889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668854|NCT03580889|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5668855|NCT03580889|Respiratory System Agents|respiratory system agents|mesh-ancestor
5668856|NCT03580889|Mydriatics|mydriatics|mesh-ancestor
5668857|NCT03580889|Parasympatholytics|parasympatholytics|mesh-ancestor
5668858|NCT03580889|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5668859|NCT03580889|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5668860|NCT03580889|Cholinergic Agents|cholinergic agents|mesh-ancestor
5668861|NCT03580889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5668862|NCT03580889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668863|NCT03580876|Azathioprine|azathioprine|mesh-list
5668864|NCT03580876|Antimetabolites|antimetabolites|mesh-ancestor
5668865|NCT03580876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668866|NCT03580876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5668867|NCT03580876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5668868|NCT03580876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5668869|NCT03580876|Immunologic Factors|immunologic factors|mesh-ancestor
5668870|NCT03580876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668871|NCT03580876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5851571|NCT02445716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851572|NCT02445716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5851573|NCT02445716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5851574|NCT02445716|Anabolic Agents|anabolic agents|mesh-ancestor
5668872|NCT03580733|Caspofungin|caspofungin|mesh-list
5668873|NCT03580733|Antifungal Agents|antifungal agents|mesh-list
5668874|NCT03580733|Clotrimazole|clotrimazole|mesh-list
5668875|NCT03580733|Miconazole|miconazole|mesh-list
5668876|NCT03580733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5668877|NCT03580733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5668878|NCT03580733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668879|NCT03580733|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5668880|NCT03580733|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5668881|NCT03580733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5668882|NCT03580733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5668883|NCT03580733|Hormone Antagonists|hormone antagonists|mesh-ancestor
5668884|NCT03580733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5668885|NCT03580733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668886|NCT03580733|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5668887|NCT03580733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5668888|NCT03580694|Cemiplimab|cemiplimab|mesh-list
5668889|NCT03580694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5668890|NCT03580694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5668891|NCT03580681|Vitamin E|vitamin e|mesh-list
5668892|NCT03580681|Vitamins|vitamins|mesh-ancestor
5668893|NCT03580681|Micronutrients|micronutrients|mesh-ancestor
5851575|NCT02445547|Hormones|hormones|mesh-list
5851576|NCT02445547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5851577|NCT02445547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668894|NCT03580681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668895|NCT03580681|Antioxidants|antioxidants|mesh-ancestor
5668896|NCT03580681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668897|NCT03580681|Protective Agents|protective agents|mesh-ancestor
5668898|NCT03580590|Diltiazem|diltiazem|mesh-list
5851578|NCT02445508|Cholecystokinin|cholecystokinin|mesh-list
5851579|NCT02445508|Sevelamer|sevelamer|mesh-list
5851580|NCT02445508|Chelating Agents|chelating agents|mesh-ancestor
5851581|NCT02445508|Sequestering Agents|sequestering agents|mesh-ancestor
5851582|NCT02445508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851583|NCT02445508|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5851584|NCT02445508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5904012|NCT03520231|Calcium|calcium|mesh-list
5904013|NCT03520231|Vitamins|vitamins|mesh-ancestor
5904014|NCT03520231|Micronutrients|micronutrients|mesh-ancestor
5904015|NCT03520231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904016|NCT03520231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5668899|NCT03580590|Tranexamic Acid|tranexamic acid|mesh-list
5668900|NCT03580590|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5668901|NCT03580590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5668902|NCT03580590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668903|NCT03580590|Hemostatics|hemostatics|mesh-ancestor
5668904|NCT03580590|Coagulants|coagulants|mesh-ancestor
5668905|NCT03580590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5668906|NCT03580590|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5668907|NCT03580590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5904017|NCT03520231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5904018|NCT03520231|Antimetabolites|antimetabolites|mesh-ancestor
5904019|NCT03520231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904020|NCT03520231|Antiviral Agents|antiviral agents|mesh-ancestor
5904021|NCT03520231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5668908|NCT03580590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5668909|NCT03580590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668910|NCT03580590|Vasodilator Agents|vasodilator agents|mesh-ancestor
5668911|NCT03580499|Vitamins|vitamins|mesh-list
5668912|NCT03580499|Vitamin B 6|vitamin b 6|mesh-list
5668913|NCT03580499|Pyridoxal|pyridoxal|mesh-list
5668914|NCT03580499|Pyridoxine|pyridoxine|mesh-list
5668915|NCT03580499|Vitamin B Complex|vitamin b complex|mesh-list
5668916|NCT03580499|Micronutrients|micronutrients|mesh-ancestor
5668917|NCT03580499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668918|NCT03580408|Nivolumab|nivolumab|mesh-list
5668919|NCT03580408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5668920|NCT03580408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5668921|NCT03580408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5668922|NCT03580408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668923|NCT03580395|Paclitaxel|paclitaxel|mesh-list
5668924|NCT03580395|Apatinib|apatinib|mesh-list
5668925|NCT03580395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5904022|NCT03520231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5904023|NCT03520231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5904024|NCT03520231|Immunologic Factors|immunologic factors|mesh-ancestor
5904025|NCT03520231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5904026|NCT03520231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5904027|NCT03464097|Ozanimod|ozanimod|mesh-list
5668926|NCT03580395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5668927|NCT03580395|Tubulin Modulators|tubulin modulators|mesh-ancestor
5668928|NCT03580395|Antimitotic Agents|antimitotic agents|mesh-ancestor
5668929|NCT03580395|Mitosis Modulators|mitosis modulators|mesh-ancestor
5668930|NCT03580395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668931|NCT03580395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5668932|NCT03580395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5668933|NCT03580317|Carbamazepine|carbamazepine|mesh-list
5668934|NCT03580317|Anticonvulsants|anticonvulsants|mesh-ancestor
5668935|NCT03580317|Antimanic Agents|antimanic agents|mesh-ancestor
5668936|NCT03580317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5668937|NCT03580317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5668938|NCT03580317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668939|NCT03580317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5668940|NCT03580317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5668941|NCT03580317|Analgesics|analgesics|mesh-ancestor
5668942|NCT03580317|Sensory System Agents|sensory system agents|mesh-ancestor
5668943|NCT03580317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5904028|NCT03464097|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5668944|NCT03580317|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5668945|NCT03580317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5668946|NCT03580317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668947|NCT03580317|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5668948|NCT03580317|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5668949|NCT03580291|Mycophenolic Acid|mycophenolic acid|mesh-list
5668950|NCT03580291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5668951|NCT03580291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5668952|NCT03580291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5668953|NCT03580291|Antitubercular Agents|antitubercular agents|mesh-ancestor
5668954|NCT03580291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5668955|NCT03580291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5668956|NCT03580291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5668957|NCT03580291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668958|NCT03580239|Everolimus|everolimus|mesh-list
5668959|NCT03580239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5668960|NCT03580239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5668961|NCT03580239|Immunologic Factors|immunologic factors|mesh-ancestor
5668962|NCT03580239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668963|NCT03580187|Morphine|morphine|mesh-list
5668964|NCT03580187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5668965|NCT03580187|Narcotics|narcotics|mesh-ancestor
5668966|NCT03580187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5668967|NCT03580187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668968|NCT03580187|Analgesics|analgesics|mesh-ancestor
5668969|NCT03580187|Sensory System Agents|sensory system agents|mesh-ancestor
5668970|NCT03580187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5668971|NCT03580148|Cortisone|cortisone|mesh-list
5668972|NCT03580148|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5668973|NCT03580148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5668974|NCT03580135|Propolis|propolis|mesh-list
5668975|NCT03580135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5668976|NCT03580018|Tranexamic Acid|tranexamic acid|mesh-list
5668977|NCT03580018|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5668978|NCT03580018|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5668979|NCT03580018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668980|NCT03580018|Hemostatics|hemostatics|mesh-ancestor
5668981|NCT03580018|Coagulants|coagulants|mesh-ancestor
5851585|NCT02445352|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5851586|NCT02445352|Ezetimibe|ezetimibe|mesh-list
5851587|NCT02445352|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5851588|NCT02445352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5851589|NCT02445352|Antimetabolites|antimetabolites|mesh-ancestor
5851590|NCT02445352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851591|NCT02445352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5851592|NCT02445352|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6494223|NCT00617877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6494224|NCT00617955|Aprotinin|aprotinin|mesh-list
6494225|NCT00617955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668982|NCT03580005|Methylphenidate|methylphenidate|mesh-list
5668983|NCT03580005|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5668984|NCT03580005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668985|NCT03580005|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5668986|NCT03580005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5668987|NCT03580005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5668988|NCT03580005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668989|NCT03580005|Dopamine Agents|dopamine agents|mesh-ancestor
5668990|NCT03580005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5668991|NCT03579979|Methylene Blue|methylene blue|mesh-list
5668992|NCT03579979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5668993|NCT03579979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5668994|NCT03579966|Amifampridine|amifampridine|mesh-list
5668995|NCT03579966|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5668996|NCT03579966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5668997|NCT03579966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5668998|NCT03579966|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5668999|NCT03579966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5669000|NCT03579966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669001|NCT03579927|Cytarabine|cytarabine|mesh-list
5669002|NCT03579927|Rituximab|rituximab|mesh-list
5669003|NCT03579927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5669004|NCT03579927|Etoposide|etoposide|mesh-list
5669005|NCT03579927|Etoposide phosphate|etoposide phosphate|mesh-list
5669006|NCT03579927|Melphalan|melphalan|mesh-list
5669007|NCT03579927|Mechlorethamine|mechlorethamine|mesh-list
6494226|NCT00617955|Hemostatics|hemostatics|mesh-ancestor
5851593|NCT02445352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5851594|NCT02445300|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
5851595|NCT02445300|Laxatives|laxatives|mesh-ancestor
5851596|NCT02445300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5851597|NCT02445339|Naltrexone|naltrexone|mesh-list
5851598|NCT02445339|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5851599|NCT02445339|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5851600|NCT02445339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851601|NCT02445339|Sensory System Agents|sensory system agents|mesh-ancestor
5851602|NCT02445339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5851603|NCT02445404|Dexamethasone|dexamethasone|mesh-list
5851604|NCT02445404|Prednisone|prednisone|mesh-list
5851605|NCT02445404|Cyclophosphamide|cyclophosphamide|mesh-list
5851606|NCT02445404|Ifosfamide|ifosfamide|mesh-list
5851607|NCT02445404|Carboplatin|carboplatin|mesh-list
5851608|NCT02445404|Etoposide|etoposide|mesh-list
5851609|NCT02445404|Vincristine|vincristine|mesh-list
5851610|NCT02445404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5851611|NCT02445404|Immunologic Factors|immunologic factors|mesh-ancestor
5851612|NCT02445404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851613|NCT02445404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5851614|NCT02445404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5851615|NCT02445404|Alkylating Agents|alkylating agents|mesh-ancestor
5851616|NCT02445404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851617|NCT02445404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5851618|NCT02445404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5851619|NCT02445404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5669008|NCT03579927|Carmustine|carmustine|mesh-list
5669009|NCT03579927|Podophyllotoxin|podophyllotoxin|mesh-list
5669010|NCT03579927|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
5669011|NCT03579927|Antibodies|antibodies|mesh-list
5669012|NCT03579927|Immunoglobulins|immunoglobulins|mesh-list
5669013|NCT03579927|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5669014|NCT03579927|Lenograstim|lenograstim|mesh-list
5669015|NCT03579927|Immunologic Factors|immunologic factors|mesh-ancestor
5669016|NCT03579927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669017|NCT03579927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5669018|NCT03579927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5669019|NCT03579927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5669020|NCT03579927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5669021|NCT03579927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5669022|NCT03579927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5851620|NCT02445404|Antiemetics|antiemetics|mesh-ancestor
5851621|NCT02445404|Autonomic Agents|autonomic agents|mesh-ancestor
5851622|NCT02445404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5851623|NCT02445404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5851624|NCT02445404|Glucocorticoids|glucocorticoids|mesh-ancestor
5851625|NCT02445404|Hormones|hormones|mesh-ancestor
5669023|NCT03579927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669024|NCT03579927|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5669025|NCT03579927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5669026|NCT03579927|Antimetabolites|antimetabolites|mesh-ancestor
5669027|NCT03579927|Antiviral Agents|antiviral agents|mesh-ancestor
5669028|NCT03579927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5669029|NCT03579927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5669030|NCT03579927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5669031|NCT03579927|Alkylating Agents|alkylating agents|mesh-ancestor
5669032|NCT03579927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5669033|NCT03579927|Keratolytic Agents|keratolytic agents|mesh-ancestor
5669034|NCT03579927|Dermatologic Agents|dermatologic agents|mesh-ancestor
5669035|NCT03579927|Tubulin Modulators|tubulin modulators|mesh-ancestor
5851626|NCT02445404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5851627|NCT02445404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5851628|NCT02445404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5851629|NCT02445404|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5851630|NCT02445404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5851631|NCT02445404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5851632|NCT02445404|Tubulin Modulators|tubulin modulators|mesh-ancestor
5851633|NCT02445404|Antimitotic Agents|antimitotic agents|mesh-ancestor
5851634|NCT02445404|Mitosis Modulators|mitosis modulators|mesh-ancestor
5851635|NCT02445391|Cisplatin|cisplatin|mesh-list
5851636|NCT02445391|Carboplatin|carboplatin|mesh-list
5851637|NCT02445391|Capecitabine|capecitabine|mesh-list
5851638|NCT02445391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5669036|NCT03579927|Antimitotic Agents|antimitotic agents|mesh-ancestor
5851639|NCT02445391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5851640|NCT02445391|Antimetabolites|antimetabolites|mesh-ancestor
6674797|NCT01571505|Vaccines|vaccines|mesh-list
5851641|NCT02445391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851642|NCT02445066|Vitamin D|vitamin d|mesh-list
5851643|NCT02445066|Cholecalciferol|cholecalciferol|mesh-list
5851644|NCT02445066|Vitamins|vitamins|mesh-ancestor
5851645|NCT02445066|Micronutrients|micronutrients|mesh-ancestor
5851646|NCT02445066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851647|NCT02445066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5851648|NCT02445066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5851649|NCT02444949|Cisplatin|cisplatin|mesh-list
5851650|NCT02444949|Endostar protein|endostar protein|mesh-list
5851651|NCT02444949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5851652|NCT02444949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5851653|NCT02444949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5851654|NCT02444949|Growth Substances|growth substances|mesh-ancestor
5851655|NCT02444949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851656|NCT02444949|Growth Inhibitors|growth inhibitors|mesh-ancestor
5851657|NCT02445053|Ivacaftor|ivacaftor|mesh-list
5851658|NCT02445053|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
5851659|NCT02445053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5851660|NCT02445053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851661|NCT02444767|Bimatoprost|bimatoprost|mesh-list
5851662|NCT02444767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5851663|NCT02444897|Fentanyl|fentanyl|mesh-list
5851664|NCT02444897|Nefopam|nefopam|mesh-list
5851665|NCT02444897|Ramosetron|ramosetron|mesh-list
5851666|NCT02444897|Ropivacaine|ropivacaine|mesh-list
5851667|NCT02444897|Anesthetics, Local|anesthetics, local|mesh-ancestor
5851668|NCT02444897|Anesthetics|anesthetics|mesh-ancestor
5851669|NCT02444897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5851670|NCT02444897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851671|NCT02444897|Sensory System Agents|sensory system agents|mesh-ancestor
5851672|NCT02444897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5851673|NCT02444897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5851674|NCT02444897|Narcotics|narcotics|mesh-ancestor
6494227|NCT00617955|Coagulants|coagulants|mesh-ancestor
6494228|NCT00617955|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6494229|NCT00617955|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6494230|NCT00617955|Protease Inhibitors|protease inhibitors|mesh-ancestor
6494231|NCT00617955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6494232|NCT00617968|Docetaxel|docetaxel|mesh-list
6494233|NCT00617968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6494234|NCT00617968|Tubulin Modulators|tubulin modulators|mesh-ancestor
6494235|NCT00617968|Antimitotic Agents|antimitotic agents|mesh-ancestor
6494236|NCT00617968|Mitosis Modulators|mitosis modulators|mesh-ancestor
6494237|NCT00617968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494238|NCT00618046|Oxcarbazepine|oxcarbazepine|mesh-list
6494239|NCT00618046|Anticonvulsants|anticonvulsants|mesh-ancestor
6494240|NCT00618046|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6494241|NCT00618046|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6494242|NCT00618046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6494243|NCT00618046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851675|NCT02444897|Analgesics|analgesics|mesh-ancestor
5851676|NCT02444897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5851677|NCT02444897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5851678|NCT02444897|Anesthetics, General|anesthetics, general|mesh-ancestor
5851679|NCT02444897|Antiemetics|antiemetics|mesh-ancestor
5851680|NCT02444897|Autonomic Agents|autonomic agents|mesh-ancestor
5851681|NCT02444897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5851682|NCT02444897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5851683|NCT02444897|Serotonin Agents|serotonin agents|mesh-ancestor
5851684|NCT02444897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5669037|NCT03579927|Mitosis Modulators|mitosis modulators|mesh-ancestor
5669038|NCT03579888|Cyclophosphamide|cyclophosphamide|mesh-list
5669039|NCT03579888|Fludarabine|fludarabine|mesh-list
5669040|NCT03579888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5669041|NCT03579888|Immunologic Factors|immunologic factors|mesh-ancestor
5669042|NCT03579888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669043|NCT03579888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5669044|NCT03579888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5669045|NCT03579888|Alkylating Agents|alkylating agents|mesh-ancestor
5669046|NCT03579888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669047|NCT03579888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5669048|NCT03579888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5851685|NCT02444897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494244|NCT00618046|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5851686|NCT02444897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5851687|NCT02444611|Vaccines|vaccines|mesh-list
5851688|NCT02444611|BCG Vaccine|bcg vaccine|mesh-list
5851689|NCT02444611|Immunologic Factors|immunologic factors|mesh-ancestor
5851690|NCT02444611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851691|NCT02444611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5851692|NCT02444637|Rivastigmine|rivastigmine|mesh-list
5851693|NCT02444637|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5851694|NCT02444637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5851695|NCT02444637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851696|NCT02444637|Cholinergic Agents|cholinergic agents|mesh-ancestor
5851697|NCT02444637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5851698|NCT02444637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851699|NCT02444637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5851700|NCT02444637|Protective Agents|protective agents|mesh-ancestor
5851701|NCT02444728|Hydroxychloroquine|hydroxychloroquine|mesh-list
5851702|NCT02444728|Methylprednisolone|methylprednisolone|mesh-list
5851703|NCT02444728|Cyclophosphamide|cyclophosphamide|mesh-list
5851704|NCT02444728|Azathioprine|azathioprine|mesh-list
5851705|NCT02444728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5851706|NCT02444728|Immunologic Factors|immunologic factors|mesh-ancestor
5851707|NCT02444728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851708|NCT02444728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5851709|NCT02444728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5851710|NCT02444728|Alkylating Agents|alkylating agents|mesh-ancestor
5851711|NCT02444728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851712|NCT02444728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5851713|NCT02444728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5851714|NCT02444728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5851715|NCT02444728|Antiemetics|antiemetics|mesh-ancestor
5851716|NCT02444728|Autonomic Agents|autonomic agents|mesh-ancestor
5851717|NCT02444728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5851718|NCT02444728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5851719|NCT02444728|Glucocorticoids|glucocorticoids|mesh-ancestor
5851720|NCT02444728|Hormones|hormones|mesh-ancestor
5851721|NCT02444728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5669049|NCT03579875|Methylprednisolone|methylprednisolone|mesh-list
5669050|NCT03579875|Cyclophosphamide|cyclophosphamide|mesh-list
5669051|NCT03579875|Busulfan|busulfan|mesh-list
5669052|NCT03579875|Rituximab|rituximab|mesh-list
5669053|NCT03579875|Fludarabine|fludarabine|mesh-list
5669054|NCT03579875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5669055|NCT03579875|Immunologic Factors|immunologic factors|mesh-ancestor
5669056|NCT03579875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669057|NCT03579875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5669058|NCT03579875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5669059|NCT03579875|Alkylating Agents|alkylating agents|mesh-ancestor
5669060|NCT03579875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669061|NCT03579875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5669062|NCT03579875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5669063|NCT03579875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5669064|NCT03579875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5669065|NCT03579875|Antiemetics|antiemetics|mesh-ancestor
5669066|NCT03579875|Autonomic Agents|autonomic agents|mesh-ancestor
5669067|NCT03579875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5669068|NCT03579875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5669069|NCT03579875|Glucocorticoids|glucocorticoids|mesh-ancestor
5669070|NCT03579875|Hormones|hormones|mesh-ancestor
5669071|NCT03579875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5669072|NCT03579875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5669073|NCT03579875|Protective Agents|protective agents|mesh-ancestor
5669074|NCT03579836|Gemcitabine|gemcitabine|mesh-list
5669075|NCT03579836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5851722|NCT02444728|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5851723|NCT02444728|Protective Agents|protective agents|mesh-ancestor
5851724|NCT02444728|Antimalarials|antimalarials|mesh-ancestor
5851725|NCT02444728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5669076|NCT03579836|Antimetabolites|antimetabolites|mesh-ancestor
5669077|NCT03579836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669078|NCT03579836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5669079|NCT03579836|Antiviral Agents|antiviral agents|mesh-ancestor
5669080|NCT03579836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5669081|NCT03579836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5669082|NCT03579836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5669083|NCT03579836|Immunologic Factors|immunologic factors|mesh-ancestor
5669084|NCT03579836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851726|NCT02444728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5851727|NCT02444728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5669085|NCT03579823|Adalimumab|adalimumab|mesh-list
5669086|NCT03579823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5669087|NCT03579823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5669088|NCT03579784|Paclitaxel|paclitaxel|mesh-list
5669089|NCT03579784|Durvalumab|durvalumab|mesh-list
5669090|NCT03579784|Olaparib|olaparib|mesh-list
5669091|NCT03579784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5669092|NCT03579784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5669093|NCT03579784|Tubulin Modulators|tubulin modulators|mesh-ancestor
5669094|NCT03579784|Antimitotic Agents|antimitotic agents|mesh-ancestor
5669095|NCT03579784|Mitosis Modulators|mitosis modulators|mesh-ancestor
5669096|NCT03579784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669097|NCT03579784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5669098|NCT03579784|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5669099|NCT03579784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5669100|NCT03579771|Gemcitabine|gemcitabine|mesh-list
5669101|NCT03579771|Paclitaxel|paclitaxel|mesh-list
5669102|NCT03579771|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5851728|NCT02444728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5851729|NCT02444728|Antimetabolites|antimetabolites|mesh-ancestor
5851730|NCT02444728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5851731|NCT02444585|Denosumab|denosumab|mesh-list
5851732|NCT02444585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5669103|NCT03579771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5669104|NCT03579771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5669105|NCT03579771|Tubulin Modulators|tubulin modulators|mesh-ancestor
5669106|NCT03579771|Antimitotic Agents|antimitotic agents|mesh-ancestor
5669107|NCT03579771|Mitosis Modulators|mitosis modulators|mesh-ancestor
5669108|NCT03579771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669109|NCT03579771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5669110|NCT03579771|Antimetabolites|antimetabolites|mesh-ancestor
5851733|NCT02444585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851734|NCT02444507|Esomeprazole|esomeprazole|mesh-list
5851735|NCT02444507|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5851736|NCT02444507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5851737|NCT02444507|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5851738|NCT02444507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5851739|NCT02444507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851740|NCT02444481|Polymyxins|polymyxins|mesh-list
5851741|NCT02444481|Nystatin|nystatin|mesh-list
5851742|NCT02444481|Neomycin|neomycin|mesh-list
5851743|NCT02444481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5851744|NCT02444481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5851745|NCT02444481|Antifungal Agents|antifungal agents|mesh-ancestor
5851746|NCT02444481|Ionophores|ionophores|mesh-ancestor
5851747|NCT02444481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5851748|NCT02444481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851749|NCT02444481|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5851750|NCT02444481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5851751|NCT02444572|Enoxaparin|enoxaparin|mesh-list
5851752|NCT02444572|Anticoagulants|anticoagulants|mesh-ancestor
5851753|NCT02444572|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5851754|NCT02444572|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5851755|NCT02444572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851756|NCT02444546|Sargramostim|sargramostim|mesh-list
5851757|NCT02444546|Immunologic Factors|immunologic factors|mesh-ancestor
5851758|NCT02444546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851759|NCT02444559|Clonidine|clonidine|mesh-list
5851760|NCT02444559|Ropivacaine|ropivacaine|mesh-list
5851761|NCT02444559|Anesthetics, Local|anesthetics, local|mesh-ancestor
5851762|NCT02444559|Anesthetics|anesthetics|mesh-ancestor
5851763|NCT02444559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5851764|NCT02444559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851765|NCT02444559|Sensory System Agents|sensory system agents|mesh-ancestor
5851766|NCT02444559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5851767|NCT02444559|Analgesics|analgesics|mesh-ancestor
5851768|NCT02444559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5851769|NCT02444559|Sympatholytics|sympatholytics|mesh-ancestor
5851770|NCT02444559|Autonomic Agents|autonomic agents|mesh-ancestor
5851771|NCT02444559|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5851772|NCT02444559|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5851773|NCT02444559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5851774|NCT02444559|Adrenergic Agents|adrenergic agents|mesh-ancestor
5851775|NCT02444559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5851776|NCT02444559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851777|NCT03910452|Sirolimus|sirolimus|mesh-list
5851778|NCT03910452|Cyclophosphamide|cyclophosphamide|mesh-list
5851779|NCT03910452|Busulfan|busulfan|mesh-list
5851780|NCT03910452|Alemtuzumab|alemtuzumab|mesh-list
5851781|NCT03910452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5851782|NCT03910452|Immunologic Factors|immunologic factors|mesh-ancestor
5851783|NCT03910452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851784|NCT03910452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5851785|NCT03910452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5851786|NCT03910452|Alkylating Agents|alkylating agents|mesh-ancestor
5851787|NCT03910452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851788|NCT03910452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5851789|NCT03910452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5851790|NCT03910452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5851791|NCT03910452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5851792|NCT03910452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5851793|NCT03910452|Antifungal Agents|antifungal agents|mesh-ancestor
5851794|NCT03910452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5851795|NCT03840239|Capecitabine|capecitabine|mesh-list
5851796|NCT03840239|Oxaliplatin|oxaliplatin|mesh-list
5851797|NCT03840239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5851798|NCT03840239|Antimetabolites|antimetabolites|mesh-ancestor
5851799|NCT03840239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851800|NCT03840239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5851801|NCT03816358|Gemcitabine|gemcitabine|mesh-list
5851802|NCT03816358|Nivolumab|nivolumab|mesh-list
5851803|NCT03816358|Ipilimumab|ipilimumab|mesh-list
5851804|NCT03816358|Maytansine|maytansine|mesh-list
5851805|NCT03816358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5851806|NCT03816358|Antimetabolites|antimetabolites|mesh-ancestor
5851807|NCT03816358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851808|NCT03816358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5851809|NCT03816358|Antiviral Agents|antiviral agents|mesh-ancestor
5851810|NCT03816358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5851811|NCT03816358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5851812|NCT03816358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5851813|NCT03816358|Immunologic Factors|immunologic factors|mesh-ancestor
5851814|NCT03816358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851815|NCT03816358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5851816|NCT03816358|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5851817|NCT03816358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5851818|NCT03816358|Tubulin Modulators|tubulin modulators|mesh-ancestor
5851819|NCT03816358|Antimitotic Agents|antimitotic agents|mesh-ancestor
5851820|NCT03816358|Mitosis Modulators|mitosis modulators|mesh-ancestor
5851821|NCT03810911|Darbepoetin alfa|darbepoetin alfa|mesh-list
5851822|NCT03810911|Hematinics|hematinics|mesh-ancestor
5851823|NCT03808025|Analgesics, Opioid|analgesics, opioid|mesh-list
5851824|NCT03808025|Narcotics|narcotics|mesh-ancestor
5851825|NCT03808025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5851826|NCT03808025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851827|NCT03808025|Analgesics|analgesics|mesh-ancestor
5851828|NCT03808025|Sensory System Agents|sensory system agents|mesh-ancestor
5851829|NCT03808025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5851830|NCT03776071|Temozolomide|temozolomide|mesh-list
5851831|NCT03776071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5851832|NCT03776071|Alkylating Agents|alkylating agents|mesh-ancestor
5851833|NCT03776071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851834|NCT03776071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5851835|NCT03757715|Dexamethasone|dexamethasone|mesh-list
5851836|NCT03757715|Bupivacaine|bupivacaine|mesh-list
5851837|NCT03757715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5851838|NCT03757715|Antiemetics|antiemetics|mesh-ancestor
5851839|NCT03757715|Autonomic Agents|autonomic agents|mesh-ancestor
5851840|NCT03757715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5851841|NCT03757715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851842|NCT03757715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5851843|NCT03757715|Glucocorticoids|glucocorticoids|mesh-ancestor
5851844|NCT03757715|Hormones|hormones|mesh-ancestor
5669111|NCT03579771|Antiviral Agents|antiviral agents|mesh-ancestor
5669112|NCT03579771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5669113|NCT03579771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5669114|NCT03579771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5669115|NCT03579771|Immunologic Factors|immunologic factors|mesh-ancestor
5669116|NCT03579771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669117|NCT03579758|Gemcitabine|gemcitabine|mesh-list
5669118|NCT03579758|Capecitabine|capecitabine|mesh-list
5851845|NCT03757715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5851846|NCT03757715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5851847|NCT03757715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5851848|NCT03757715|Anesthetics, Local|anesthetics, local|mesh-ancestor
5851849|NCT03757715|Anesthetics|anesthetics|mesh-ancestor
5851850|NCT03757715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5851851|NCT03757715|Sensory System Agents|sensory system agents|mesh-ancestor
5851852|NCT03737604|Bupivacaine|bupivacaine|mesh-list
5851853|NCT03737604|Ropivacaine|ropivacaine|mesh-list
5851854|NCT03737604|Anesthetics, Local|anesthetics, local|mesh-ancestor
5851855|NCT03737604|Anesthetics|anesthetics|mesh-ancestor
5851856|NCT03737604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5851857|NCT03737604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851858|NCT03737604|Sensory System Agents|sensory system agents|mesh-ancestor
5851859|NCT03737604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5851860|NCT03716934|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
5904029|NCT03464097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904030|NCT03464097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5669119|NCT03579758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5669120|NCT03579758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5669121|NCT03579758|Antimetabolites|antimetabolites|mesh-ancestor
5669122|NCT03579758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669123|NCT03579758|Antiviral Agents|antiviral agents|mesh-ancestor
5669124|NCT03579758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5904031|NCT03464097|Immunologic Factors|immunologic factors|mesh-ancestor
5904032|NCT03464097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904033|NCT03451578|alpha-MSH|alpha-msh|mesh-list
5904034|NCT03451578|Hormones|hormones|mesh-ancestor
5904035|NCT03451578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5904036|NCT03451578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904037|NCT03440385|Ozanimod|ozanimod|mesh-list
5904038|NCT03440385|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5904039|NCT03440385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904040|NCT03440385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5904041|NCT03440385|Immunologic Factors|immunologic factors|mesh-ancestor
5904042|NCT03440385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904043|NCT03440372|Ozanimod|ozanimod|mesh-list
5904044|NCT03440372|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5669125|NCT03579758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5669126|NCT03579758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5669127|NCT03579758|Immunologic Factors|immunologic factors|mesh-ancestor
5669128|NCT03579758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669129|NCT03579732|Aspirin|aspirin|mesh-list
5669130|NCT03579732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5669131|NCT03579732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5669132|NCT03579732|Analgesics|analgesics|mesh-ancestor
5669133|NCT03579732|Sensory System Agents|sensory system agents|mesh-ancestor
5669134|NCT03579732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5669135|NCT03579732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669136|NCT03579732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5669137|NCT03579732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5669138|NCT03579732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5669139|NCT03579732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5669140|NCT03579732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669141|NCT03579732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5669142|NCT03579732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5669143|NCT03579732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5669144|NCT03579732|Antipyretics|antipyretics|mesh-ancestor
5669145|NCT03579589|Neostigmine|neostigmine|mesh-list
5669146|NCT03579589|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5669147|NCT03579589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5669148|NCT03579589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669149|NCT03579589|Cholinergic Agents|cholinergic agents|mesh-ancestor
5669150|NCT03579589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5669151|NCT03579589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669152|NCT03579589|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5669153|NCT03579589|Autonomic Agents|autonomic agents|mesh-ancestor
5669154|NCT03579589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5669155|NCT03579576|Ribavirin|ribavirin|mesh-list
5669156|NCT03579576|Sofosbuvir|sofosbuvir|mesh-list
5669157|NCT03579576|Velpatasvir|velpatasvir|mesh-list
5669158|NCT03579576|Antimetabolites|antimetabolites|mesh-ancestor
5669159|NCT03579576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669160|NCT03579576|Antiviral Agents|antiviral agents|mesh-ancestor
5669161|NCT03579576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5669162|NCT03579472|Halichondrin B|halichondrin b|mesh-list
5669163|NCT03579472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5851861|NCT03653364|Baloxavir|baloxavir|mesh-list
5851862|NCT03653364|Antiviral Agents|antiviral agents|mesh-ancestor
5851863|NCT03653364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5851864|NCT03653364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5851865|NCT03653364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851866|NCT03651804|Acetaminophen|acetaminophen|mesh-list
5851867|NCT03651804|Diphosphonates|diphosphonates|mesh-list
5851868|NCT03651804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
5851869|NCT03651804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
5851870|NCT03651804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5851871|NCT03651804|Analgesics|analgesics|mesh-ancestor
5851872|NCT03651804|Sensory System Agents|sensory system agents|mesh-ancestor
5851873|NCT03651804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5851874|NCT03651804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851875|NCT03651804|Antipyretics|antipyretics|mesh-ancestor
5851876|NCT03651804|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5851877|NCT03651804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5851878|NCT03608163|Diazoxide|diazoxide|mesh-list
5851879|NCT03608163|Naloxone|naloxone|mesh-list
5851880|NCT03608163|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5851881|NCT03608163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851882|NCT03608163|Sensory System Agents|sensory system agents|mesh-ancestor
5851883|NCT03608163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5851884|NCT03608163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5851885|NCT03608163|Vasodilator Agents|vasodilator agents|mesh-ancestor
5851886|NCT03578367|Niacinamide|niacinamide|mesh-list
5851887|NCT03578367|Imatinib Mesylate|imatinib mesylate|mesh-list
5851888|NCT03578367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5851889|NCT03578367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5851890|NCT03578367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5851891|NCT03578367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851892|NCT03578367|Vitamin B Complex|vitamin b complex|mesh-ancestor
5851893|NCT03578367|Vitamins|vitamins|mesh-ancestor
5851894|NCT03578367|Micronutrients|micronutrients|mesh-ancestor
5851895|NCT03578367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851896|NCT03578198|Rituximab|rituximab|mesh-list
5851897|NCT03578198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5851898|NCT03578198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5851899|NCT03578198|Immunologic Factors|immunologic factors|mesh-ancestor
5851900|NCT03578198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851901|NCT03578198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5851902|NCT03575793|Nivolumab|nivolumab|mesh-list
5851903|NCT03575793|Ipilimumab|ipilimumab|mesh-list
5851904|NCT03575793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5851905|NCT03575793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5851906|NCT03575793|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5851907|NCT03575793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851908|NCT03572283|Bethanechol|bethanechol|mesh-list
5851909|NCT03572283|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5851910|NCT03572283|Autonomic Agents|autonomic agents|mesh-ancestor
5851911|NCT03572283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5851912|NCT03572283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851913|NCT03572283|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
5851914|NCT03572283|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5851915|NCT03572283|Cholinergic Agents|cholinergic agents|mesh-ancestor
5851916|NCT03572283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5851917|NCT03572283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851918|NCT03555149|Bevacizumab|bevacizumab|mesh-list
5851919|NCT03555149|Atezolizumab|atezolizumab|mesh-list
5851920|NCT03555149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5851921|NCT03555149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5851922|NCT03555149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5851923|NCT03555149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5851924|NCT03555149|Growth Substances|growth substances|mesh-ancestor
5851925|NCT03555149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669164|NCT03579472|Tubulin Modulators|tubulin modulators|mesh-ancestor
5669165|NCT03579472|Antimitotic Agents|antimitotic agents|mesh-ancestor
5669166|NCT03579472|Mitosis Modulators|mitosis modulators|mesh-ancestor
5669167|NCT03579472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695873|NCT03387085|Growth Inhibitors|growth inhibitors|mesh-ancestor
5851926|NCT03555149|Growth Inhibitors|growth inhibitors|mesh-ancestor
5851927|NCT03533283|Atezolizumab|atezolizumab|mesh-list
5851928|NCT03533283|Obinutuzumab|obinutuzumab|mesh-list
5695874|NCT03387085|Antimetabolites|antimetabolites|mesh-ancestor
5851929|NCT03533283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6212225|NCT02183675|Amlodipine|amlodipine|mesh-list
5669168|NCT03579082|Decitabine|decitabine|mesh-list
5669169|NCT03579082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5669170|NCT03579082|Antimetabolites|antimetabolites|mesh-ancestor
5669171|NCT03579082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669172|NCT03579082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5669173|NCT03579082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5669174|NCT03579043|Cocaine|cocaine|mesh-list
5669175|NCT03579043|Anesthetics, Local|anesthetics, local|mesh-ancestor
5851930|NCT03533283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5851931|NCT03523585|Capecitabine|capecitabine|mesh-list
5851932|NCT03523585|Trastuzumab|trastuzumab|mesh-list
5851933|NCT03523585|Lapatinib|lapatinib|mesh-list
5851934|NCT03523585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5851935|NCT03523585|Antimetabolites|antimetabolites|mesh-ancestor
5851936|NCT03523585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851937|NCT03523585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5669176|NCT03579043|Anesthetics|anesthetics|mesh-ancestor
5669177|NCT03579043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5669178|NCT03579043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669179|NCT03579043|Sensory System Agents|sensory system agents|mesh-ancestor
5669180|NCT03579043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5669181|NCT03579043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5669182|NCT03579043|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5669183|NCT03579043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5669184|NCT03579043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5851938|NCT03523585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5851939|NCT03523585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5851940|NCT03523585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5851941|NCT03512197|Midostaurin|midostaurin|mesh-list
5851942|NCT03512197|Staurosporine|staurosporine|mesh-list
5851943|NCT03512197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5851944|NCT03512197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5851945|NCT03512197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5851946|NCT03512197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851947|NCT03506360|Dexamethasone|dexamethasone|mesh-list
5851948|NCT03506360|Dexamethasone acetate|dexamethasone acetate|mesh-list
5851949|NCT03506360|Pembrolizumab|pembrolizumab|mesh-list
5851950|NCT03506360|Ixazomib|ixazomib|mesh-list
5851951|NCT03506360|Ichthammol|ichthammol|mesh-list
5851952|NCT03506360|BB 1101|bb 1101|mesh-list
5851953|NCT03506360|Glycine|glycine|mesh-list
5851954|NCT03506360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5851955|NCT03506360|Antiemetics|antiemetics|mesh-ancestor
5851956|NCT03506360|Autonomic Agents|autonomic agents|mesh-ancestor
5851957|NCT03506360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5851958|NCT03506360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851959|NCT03506360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5851960|NCT03506360|Glucocorticoids|glucocorticoids|mesh-ancestor
5851961|NCT03506360|Hormones|hormones|mesh-ancestor
5669185|NCT03579043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669186|NCT03579043|Dopamine Agents|dopamine agents|mesh-ancestor
5669187|NCT03579043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5669188|NCT03579004|Paclitaxel|paclitaxel|mesh-list
5669189|NCT03579004|Fluorouracil|fluorouracil|mesh-list
5669190|NCT03579004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5669191|NCT03579004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5669192|NCT03579004|Tubulin Modulators|tubulin modulators|mesh-ancestor
5851962|NCT03506360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5851963|NCT03506360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5851964|NCT03506360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5851965|NCT03506360|Protease Inhibitors|protease inhibitors|mesh-ancestor
5851966|NCT03506360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5851967|NCT03506360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851968|NCT03506360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5851969|NCT03506360|Dermatologic Agents|dermatologic agents|mesh-ancestor
5851970|NCT03506360|Glycine Agents|glycine agents|mesh-ancestor
5851971|NCT03506360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5851972|NCT03480672|Pembrolizumab|pembrolizumab|mesh-list
5851973|NCT03480672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5851974|NCT03480672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5851975|NCT03471611|Sargramostim|sargramostim|mesh-list
5851976|NCT03471611|Lenograstim|lenograstim|mesh-list
5851977|NCT03471611|Immunologic Factors|immunologic factors|mesh-ancestor
5851978|NCT03471611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669193|NCT03579004|Antimitotic Agents|antimitotic agents|mesh-ancestor
5851979|NCT03471611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5851980|NCT03459222|Nivolumab|nivolumab|mesh-list
5669194|NCT03579004|Mitosis Modulators|mitosis modulators|mesh-ancestor
5669195|NCT03579004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669196|NCT03579004|Antimetabolites|antimetabolites|mesh-ancestor
5669197|NCT03579004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5669198|NCT03579004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5669199|NCT03579004|Immunologic Factors|immunologic factors|mesh-ancestor
5669200|NCT03579004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669201|NCT03578900|Citric Acid|citric acid|mesh-list
5669202|NCT03578900|Sodium Citrate|sodium citrate|mesh-list
5669203|NCT03578900|Anticoagulants|anticoagulants|mesh-ancestor
5669204|NCT03578900|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5669205|NCT03578900|Chelating Agents|chelating agents|mesh-ancestor
5669206|NCT03578900|Sequestering Agents|sequestering agents|mesh-ancestor
5669207|NCT03578900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669208|NCT03578874|Capecitabine|capecitabine|mesh-list
5669209|NCT03578874|Oxaliplatin|oxaliplatin|mesh-list
5669210|NCT03578874|Sorafenib|sorafenib|mesh-list
5669211|NCT03578874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5669212|NCT03578874|Antimetabolites|antimetabolites|mesh-ancestor
5669213|NCT03578874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669214|NCT03578874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5669215|NCT03578874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5669216|NCT03578874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5669217|NCT03578822|Aspirin|aspirin|mesh-list
5669218|NCT03578822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5669219|NCT03578822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5669220|NCT03578822|Analgesics|analgesics|mesh-ancestor
5669221|NCT03578822|Sensory System Agents|sensory system agents|mesh-ancestor
5669222|NCT03578822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5669223|NCT03578822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669224|NCT03578822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5669225|NCT03578822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5669226|NCT03578822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5669227|NCT03578822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5669228|NCT03578822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669229|NCT03578822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5669230|NCT03578822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5669231|NCT03578822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5669232|NCT03578822|Antipyretics|antipyretics|mesh-ancestor
5669233|NCT03578783|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
5669234|NCT03578783|Anesthetics, Local|anesthetics, local|mesh-ancestor
5669235|NCT03578783|Anesthetics|anesthetics|mesh-ancestor
5669236|NCT03578783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5851981|NCT03459222|Ipilimumab|ipilimumab|mesh-list
5851982|NCT03459222|Linrodostat|linrodostat|mesh-list
5851983|NCT03459222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5851984|NCT03459222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5851985|NCT03459222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5851986|NCT03459222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851987|NCT03459222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5851988|NCT03388788|CGP 12177|cgp 12177|mesh-list
5851989|NCT03388788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5851990|NCT03388788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5851991|NCT03388788|Adrenergic Agents|adrenergic agents|mesh-ancestor
5851992|NCT03388788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5851993|NCT03388788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5851994|NCT03388788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5851995|NCT03388788|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5851996|NCT03388788|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5851997|NCT03369717|Clavulanic Acid|clavulanic acid|mesh-list
5851998|NCT03369717|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5851999|NCT03369717|Clavulanic Acids|clavulanic acids|mesh-list
5852000|NCT03369717|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5852001|NCT03369717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5852002|NCT03369717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669237|NCT03578783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669238|NCT03578783|Sensory System Agents|sensory system agents|mesh-ancestor
5669239|NCT03578783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5669240|NCT03578783|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
5669241|NCT03578679|Ivermectin|ivermectin|mesh-list
5669242|NCT03578679|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5669243|NCT03578679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5852003|NCT03369717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5852004|NCT03369717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5852005|NCT03367741|Nivolumab|nivolumab|mesh-list
5852006|NCT03367741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5852007|NCT03367741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5669244|NCT03578640|Grazoprevir|grazoprevir|mesh-list
5669245|NCT03578640|Antiviral Agents|antiviral agents|mesh-ancestor
5669246|NCT03578640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5669247|NCT03578497|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5669248|NCT03578497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5669249|NCT03578432|Everolimus|everolimus|mesh-list
5669250|NCT03578432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5669251|NCT03578432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5669252|NCT03578432|Immunologic Factors|immunologic factors|mesh-ancestor
5669253|NCT03578432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852008|NCT03367741|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5852009|NCT03367741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852010|NCT03365908|Ropivacaine|ropivacaine|mesh-list
5852011|NCT03365908|Anesthetics, Local|anesthetics, local|mesh-ancestor
5852012|NCT03365908|Anesthetics|anesthetics|mesh-ancestor
5852013|NCT03365908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5852014|NCT03365908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852015|NCT03365908|Sensory System Agents|sensory system agents|mesh-ancestor
5852016|NCT03365908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5852017|NCT03335540|Nivolumab|nivolumab|mesh-list
5852018|NCT03335540|Ipilimumab|ipilimumab|mesh-list
5852019|NCT03335540|Linrodostat|linrodostat|mesh-list
5852020|NCT03335540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5852021|NCT03335540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5852022|NCT03335540|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5852023|NCT03335540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852024|NCT03335540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5852025|NCT03329001|Niraparib|niraparib|mesh-list
5852026|NCT03329001|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5852027|NCT03329001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5852028|NCT03329001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852029|NCT03329001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5852030|NCT03321643|Gemcitabine|gemcitabine|mesh-list
5852031|NCT03321643|Rituximab|rituximab|mesh-list
5852032|NCT03321643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5852033|NCT03321643|Oxaliplatin|oxaliplatin|mesh-list
5852034|NCT03321643|Atezolizumab|atezolizumab|mesh-list
5852035|NCT03321643|Antibodies|antibodies|mesh-list
5852036|NCT03321643|Immunoglobulins|immunoglobulins|mesh-list
5852037|NCT03321643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5852038|NCT03321643|Immunologic Factors|immunologic factors|mesh-ancestor
6212226|NCT02183675|Telmisartan|telmisartan|mesh-list
5669254|NCT03578354|Atenolol|atenolol|mesh-list
5669255|NCT03578354|4-Aminopyridine|4-aminopyridine|mesh-list
5669256|NCT03578354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5669257|NCT03578354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5669258|NCT03578354|Sympatholytics|sympatholytics|mesh-ancestor
5669259|NCT03578354|Autonomic Agents|autonomic agents|mesh-ancestor
5669260|NCT03578354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5669261|NCT03578354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669262|NCT03578354|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5669263|NCT03578354|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5669264|NCT03578354|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5669265|NCT03578354|Adrenergic Agents|adrenergic agents|mesh-ancestor
5669266|NCT03578354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5669267|NCT03578354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669268|NCT03578354|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5852039|NCT03321643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852040|NCT03321643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5852041|NCT03321643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5852042|NCT03321643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5852043|NCT03321643|Antimetabolites|antimetabolites|mesh-ancestor
5852044|NCT03321643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852045|NCT03321643|Antiviral Agents|antiviral agents|mesh-ancestor
5852046|NCT03321643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5852047|NCT03321643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5852048|NCT03321643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5852049|NCT03295240|Rituximab|rituximab|mesh-list
5852050|NCT03295240|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5852051|NCT03295240|Venetoclax|venetoclax|mesh-list
6674798|NCT01571505|Immunologic Factors|immunologic factors|mesh-ancestor
6674799|NCT01571505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674800|NCT01571570|Simeprevir|simeprevir|mesh-list
5852052|NCT03295240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5852053|NCT03295240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5852054|NCT03295240|Immunologic Factors|immunologic factors|mesh-ancestor
5669269|NCT03578354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5669270|NCT03578276|Gatifloxacin|gatifloxacin|mesh-list
5669271|NCT03578276|Prednisolone|prednisolone|mesh-list
5669272|NCT03578276|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5669273|NCT03578276|Methylprednisolone|methylprednisolone|mesh-list
5852055|NCT03295240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852056|NCT03295240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5852057|NCT03295240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5852058|NCT03295240|Alkylating Agents|alkylating agents|mesh-ancestor
5852059|NCT03295240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852060|NCT03279471|Sertraline|sertraline|mesh-list
5852061|NCT03279471|Antidepressive Agents|antidepressive agents|mesh-ancestor
5852062|NCT03279471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5669274|NCT03578276|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5669275|NCT03578276|Prednisolone acetate|prednisolone acetate|mesh-list
5669276|NCT03578276|Bromfenac|bromfenac|mesh-list
5669277|NCT03578276|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5669278|NCT03578276|Prednisolone phosphate|prednisolone phosphate|mesh-list
5669279|NCT03578276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5669280|NCT03578276|Glucocorticoids|glucocorticoids|mesh-ancestor
5669281|NCT03578276|Hormones|hormones|mesh-ancestor
5669282|NCT03578276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5852063|NCT03279471|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5852064|NCT03279471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5852065|NCT03279471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5852066|NCT03279471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852067|NCT03279471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5852068|NCT03279471|Serotonin Agents|serotonin agents|mesh-ancestor
5852069|NCT03279471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852070|NCT03277729|Vidarabine|vidarabine|mesh-list
5852071|NCT03277729|Cyclophosphamide|cyclophosphamide|mesh-list
5852072|NCT03277729|Fludarabine|fludarabine|mesh-list
5852073|NCT03277729|Fludarabine phosphate|fludarabine phosphate|mesh-list
5852074|NCT03277729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5852075|NCT03277729|Immunologic Factors|immunologic factors|mesh-ancestor
5852076|NCT03277729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852077|NCT03277729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5852078|NCT03277729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5852079|NCT03277729|Alkylating Agents|alkylating agents|mesh-ancestor
5852080|NCT03277729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852081|NCT03277729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5852082|NCT03277729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5852083|NCT03277729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5852084|NCT03277729|Antimetabolites|antimetabolites|mesh-ancestor
5852085|NCT03277729|Antiviral Agents|antiviral agents|mesh-ancestor
5852086|NCT03277729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5852087|NCT03260322|Pembrolizumab|pembrolizumab|mesh-list
5852088|NCT03260322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5669283|NCT03578276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669284|NCT03578276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5669285|NCT03578276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5669286|NCT03578276|Antiemetics|antiemetics|mesh-ancestor
5669287|NCT03578276|Autonomic Agents|autonomic agents|mesh-ancestor
5669288|NCT03578276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5669289|NCT03578276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5669290|NCT03578276|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5669291|NCT03578276|Protective Agents|protective agents|mesh-ancestor
5852089|NCT03260322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5852090|NCT03248479|Azacitidine|azacitidine|mesh-list
5852091|NCT03248479|Magrolimab|magrolimab|mesh-list
5852092|NCT03248479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5852093|NCT03248479|Antimetabolites|antimetabolites|mesh-ancestor
5852094|NCT03248479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852095|NCT03248479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5852096|NCT03248479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5852097|NCT03248479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5852098|NCT03241940|Cyclophosphamide|cyclophosphamide|mesh-list
5852099|NCT03241940|Fludarabine|fludarabine|mesh-list
5669292|NCT03578276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5852100|NCT03241940|Fludarabine phosphate|fludarabine phosphate|mesh-list
5852101|NCT03241940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5852102|NCT03241940|Immunologic Factors|immunologic factors|mesh-ancestor
5669293|NCT03578276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5669294|NCT03578276|Analgesics|analgesics|mesh-ancestor
5669295|NCT03578276|Sensory System Agents|sensory system agents|mesh-ancestor
5669296|NCT03578276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5669297|NCT03578276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5669298|NCT03578276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5669299|NCT03578276|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5669300|NCT03578276|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5852103|NCT03241940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852104|NCT03241940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5852105|NCT03241940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5852106|NCT03241940|Alkylating Agents|alkylating agents|mesh-ancestor
5852107|NCT03241940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852108|NCT03241940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5852109|NCT03241940|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5852110|NCT03241940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5852111|NCT03241940|Antimetabolites|antimetabolites|mesh-ancestor
5852112|NCT03190954|Raclopride|raclopride|mesh-list
5852113|NCT03190954|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5852114|NCT03190954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5852115|NCT03190954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5852116|NCT03190954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852117|NCT03190954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5852118|NCT03190954|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5852119|NCT03190954|Dopamine Agents|dopamine agents|mesh-ancestor
5669301|NCT03578276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5669302|NCT03578276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5669303|NCT03578276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5669304|NCT03578276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669305|NCT03578263|Oxytocin|oxytocin|mesh-list
5669306|NCT03578263|Carbetocin|carbetocin|mesh-list
5669307|NCT03578263|Ergonovine|ergonovine|mesh-list
5669308|NCT03578263|Oxytocics|oxytocics|mesh-ancestor
5669309|NCT03578263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5669310|NCT03578263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669311|NCT03578042|Losartan|losartan|mesh-list
5669312|NCT03578042|Amlodipine|amlodipine|mesh-list
5852120|NCT03190954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5852121|NCT03190954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852122|NCT03126630|Pembrolizumab|pembrolizumab|mesh-list
5852123|NCT03126630|Maytansine|maytansine|mesh-list
5852124|NCT03126630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5852125|NCT03126630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5852126|NCT03126630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5852127|NCT03126630|Tubulin Modulators|tubulin modulators|mesh-ancestor
5852128|NCT03126630|Antimitotic Agents|antimitotic agents|mesh-ancestor
5669313|NCT03578042|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5669314|NCT03578042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5669315|NCT03578042|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5852129|NCT03126630|Mitosis Modulators|mitosis modulators|mesh-ancestor
5852130|NCT03126630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852131|NCT03109964|Hemostatics|hemostatics|mesh-list
5852132|NCT03109964|Surgiflo|surgiflo|mesh-list
5852133|NCT03109964|Coagulants|coagulants|mesh-ancestor
5852134|NCT03099486|Leucovorin|leucovorin|mesh-list
5852135|NCT03099486|Antidotes|antidotes|mesh-ancestor
5852136|NCT03099486|Protective Agents|protective agents|mesh-ancestor
5852137|NCT03099486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852138|NCT03099486|Vitamin B Complex|vitamin b complex|mesh-ancestor
5852139|NCT03099486|Vitamins|vitamins|mesh-ancestor
5852140|NCT03099486|Micronutrients|micronutrients|mesh-ancestor
5852141|NCT03037385|Pralsetinib|pralsetinib|mesh-list
5852142|NCT03037385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5852143|NCT03033576|Nivolumab|nivolumab|mesh-list
5852144|NCT03033576|Ipilimumab|ipilimumab|mesh-list
5852145|NCT03033576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5852146|NCT03033576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5852147|NCT03033576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5852148|NCT03033576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852149|NCT03022903|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5852150|NCT03022903|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5852151|NCT03022903|Dermatologic Agents|dermatologic agents|mesh-ancestor
5852152|NCT03017820|Iodine|iodine|mesh-list
5669316|NCT03578042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5669317|NCT03578042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852153|NCT03017820|Interferons|interferons|mesh-list
5852154|NCT03017820|Interferon-beta|interferon-beta|mesh-list
5852155|NCT03017820|Cyclophosphamide|cyclophosphamide|mesh-list
5852156|NCT03017820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5852157|NCT03017820|Immunologic Factors|immunologic factors|mesh-ancestor
5669318|NCT03578042|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5669319|NCT03578042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669320|NCT03578042|Vasodilator Agents|vasodilator agents|mesh-ancestor
5669321|NCT03578042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5669322|NCT03578042|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5669323|NCT03578042|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5669324|NCT03578042|Diuretics|diuretics|mesh-ancestor
5669325|NCT03578042|Natriuretic Agents|natriuretic agents|mesh-ancestor
5669326|NCT03578042|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5669327|NCT03577977|Interferons|interferons|mesh-list
5852158|NCT03017820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852159|NCT03017820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5852160|NCT03017820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5852161|NCT03017820|Alkylating Agents|alkylating agents|mesh-ancestor
5852162|NCT03017820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852163|NCT03017820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5852164|NCT03017820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5852165|NCT03017820|Antiviral Agents|antiviral agents|mesh-ancestor
5852166|NCT03017820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5669328|NCT03577977|Interferon-beta|interferon-beta|mesh-list
5669329|NCT03577977|Interferon beta-1b|interferon beta-1b|mesh-list
5852167|NCT03017820|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5852168|NCT03017820|Trace Elements|trace elements|mesh-ancestor
5852169|NCT03017820|Micronutrients|micronutrients|mesh-ancestor
5852170|NCT02991482|Gemcitabine|gemcitabine|mesh-list
5852171|NCT02991482|Pembrolizumab|pembrolizumab|mesh-list
5852172|NCT02991482|Vinorelbine|vinorelbine|mesh-list
5852173|NCT02991482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5852174|NCT02991482|Antimetabolites|antimetabolites|mesh-ancestor
5852175|NCT02991482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852176|NCT02991482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5852177|NCT02991482|Antiviral Agents|antiviral agents|mesh-ancestor
5852178|NCT02991482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5852179|NCT02991482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5852180|NCT02991482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5852181|NCT02991482|Immunologic Factors|immunologic factors|mesh-ancestor
5852182|NCT02991482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852183|NCT02991482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5852184|NCT02991482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5852185|NCT02991482|Tubulin Modulators|tubulin modulators|mesh-ancestor
5852186|NCT02991482|Antimitotic Agents|antimitotic agents|mesh-ancestor
5852187|NCT02991482|Mitosis Modulators|mitosis modulators|mesh-ancestor
5852188|NCT02964013|Carboplatin|carboplatin|mesh-list
5852189|NCT02964013|Pembrolizumab|pembrolizumab|mesh-list
5852190|NCT02964013|Etoposide|etoposide|mesh-list
5852191|NCT02964013|Pemetrexed|pemetrexed|mesh-list
5669330|NCT03577977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5669331|NCT03577977|Antiviral Agents|antiviral agents|mesh-ancestor
5669332|NCT03577977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5669333|NCT03577977|Immunologic Factors|immunologic factors|mesh-ancestor
5669334|NCT03577977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669335|NCT03577977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5669336|NCT03577912|Anesthetics|anesthetics|mesh-list
5669337|NCT03577912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5669338|NCT03577912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852192|NCT02964013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5852193|NCT02964013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5852194|NCT02964013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5852195|NCT02964013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5852196|NCT02964013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5852197|NCT02964013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5852198|NCT02964013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852199|NCT02964013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5852200|NCT02964013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5852201|NCT02952534|Rucaparib|rucaparib|mesh-list
5852202|NCT02952534|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5852203|NCT02952534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5852204|NCT02952534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852205|NCT02952534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5904045|NCT03440372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904046|NCT03440372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5904047|NCT03440372|Immunologic Factors|immunologic factors|mesh-ancestor
5852206|NCT02906761|Aspirin|aspirin|mesh-list
5669339|NCT03577899|Aflibercept|aflibercept|mesh-list
5669340|NCT03577899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5669341|NCT03577899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5669342|NCT03577899|Growth Substances|growth substances|mesh-ancestor
5669343|NCT03577899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669344|NCT03577899|Growth Inhibitors|growth inhibitors|mesh-ancestor
5669345|NCT03577899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5695875|NCT03387085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5695876|NCT03387085|Antidotes|antidotes|mesh-ancestor
5695877|NCT03387085|Protective Agents|protective agents|mesh-ancestor
5695878|NCT03387085|Vitamin B Complex|vitamin b complex|mesh-ancestor
5695879|NCT03387085|Vitamins|vitamins|mesh-ancestor
5695880|NCT03387085|Micronutrients|micronutrients|mesh-ancestor
5695881|NCT03386929|Palbociclib|palbociclib|mesh-list
5695882|NCT03386929|Avelumab|avelumab|mesh-list
5695883|NCT03386929|Axitinib|axitinib|mesh-list
5695884|NCT03386929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5695885|NCT03386929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5695886|NCT03386929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5695887|NCT03386929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695888|NCT03386929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5695889|NCT03386838|Carboplatin|carboplatin|mesh-list
5695890|NCT03386838|Fluorouracil|fluorouracil|mesh-list
5695891|NCT03386838|Nivolumab|nivolumab|mesh-list
5695892|NCT03386838|Cetuximab|cetuximab|mesh-list
5695893|NCT03386838|Linrodostat|linrodostat|mesh-list
5695894|NCT03386838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5695895|NCT03386838|Antimetabolites|antimetabolites|mesh-ancestor
5695896|NCT03386838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695897|NCT03386838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5695898|NCT03386838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5695899|NCT03386838|Immunologic Factors|immunologic factors|mesh-ancestor
5695900|NCT03386838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695901|NCT03386838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5852207|NCT02906761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5852208|NCT02906761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5852209|NCT02906761|Analgesics|analgesics|mesh-ancestor
5852210|NCT02906761|Sensory System Agents|sensory system agents|mesh-ancestor
5852211|NCT02906761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5852212|NCT02906761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852213|NCT02906761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5852214|NCT02906761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5852215|NCT02906761|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5852216|NCT02906761|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5852217|NCT02906761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852218|NCT02906761|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5852219|NCT02906761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5852220|NCT02906761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5852221|NCT02906761|Antipyretics|antipyretics|mesh-ancestor
5852222|NCT02883062|Paclitaxel|paclitaxel|mesh-list
5852223|NCT02883062|Carboplatin|carboplatin|mesh-list
5852224|NCT02883062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5852225|NCT02883062|Atezolizumab|atezolizumab|mesh-list
5852226|NCT02883062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5852227|NCT02883062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5852228|NCT02883062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5852229|NCT02883062|Tubulin Modulators|tubulin modulators|mesh-ancestor
5852230|NCT02883062|Antimitotic Agents|antimitotic agents|mesh-ancestor
5852231|NCT02883062|Mitosis Modulators|mitosis modulators|mesh-ancestor
5852232|NCT02883062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852233|NCT02883062|Immunologic Factors|immunologic factors|mesh-ancestor
5852234|NCT02883062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695902|NCT03386838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5695903|NCT03386838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5695904|NCT03386656|Tranexamic Acid|tranexamic acid|mesh-list
5695905|NCT03386656|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5695906|NCT03386656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5695907|NCT03386656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852235|NCT02725567|Ivacaftor|ivacaftor|mesh-list
5852236|NCT02725567|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
5852237|NCT02725567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5852238|NCT02725567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852239|NCT02709655|Vortioxetine|vortioxetine|mesh-list
5852240|NCT02709655|Fluoxetine|fluoxetine|mesh-list
5695908|NCT03386656|Hemostatics|hemostatics|mesh-ancestor
6212227|NCT02183675|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5669346|NCT03577860|Bupivacaine|bupivacaine|mesh-list
5669347|NCT03577860|Anesthetics, Local|anesthetics, local|mesh-ancestor
5669348|NCT03577860|Anesthetics|anesthetics|mesh-ancestor
5669349|NCT03577860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5669350|NCT03577860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669351|NCT03577860|Sensory System Agents|sensory system agents|mesh-ancestor
5669352|NCT03577860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5669353|NCT03577834|Acetic Acid|acetic acid|mesh-list
5669354|NCT03577834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5669355|NCT03577834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5669356|NCT03577782|Vedolizumab|vedolizumab|mesh-list
5669357|NCT03577782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5669358|NCT03577743|Bevacizumab|bevacizumab|mesh-list
5669359|NCT03577743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5669360|NCT03577743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5852241|NCT02709655|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5852242|NCT02709655|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5852243|NCT02709655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5852244|NCT02709655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852245|NCT02709655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5852246|NCT02709655|Serotonin Agents|serotonin agents|mesh-ancestor
5852247|NCT02709655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852248|NCT02709655|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5852249|NCT02709655|Antidepressive Agents|antidepressive agents|mesh-ancestor
5852250|NCT02709655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5852251|NCT02709655|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5852252|NCT02709655|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5852253|NCT02709655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5852254|NCT02709655|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5852255|NCT02709655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5852256|NCT02709655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5852257|NCT02709655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5852258|NCT02709655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5852259|NCT02709655|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5852260|NCT02709655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5852261|NCT02648698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5852262|NCT02648698|Levofloxacin|levofloxacin|mesh-list
5852263|NCT02648698|Tinidazole|tinidazole|mesh-list
5852264|NCT02648698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5852265|NCT02648698|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5852266|NCT02648698|Renal Agents|renal agents|mesh-ancestor
5852267|NCT02648698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5852268|NCT02648698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5852269|NCT02648698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5852270|NCT02648698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852271|NCT02648698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5852272|NCT02648698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5669361|NCT03577743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5669362|NCT03577743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5669363|NCT03577743|Growth Substances|growth substances|mesh-ancestor
5669364|NCT03577743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669365|NCT03577743|Growth Inhibitors|growth inhibitors|mesh-ancestor
5669366|NCT03577652|Ticagrelor|ticagrelor|mesh-list
5852273|NCT02648698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5852274|NCT02648698|Alkylating Agents|alkylating agents|mesh-ancestor
5852275|NCT02648698|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
5852276|NCT02648698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5852277|NCT02648698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5852278|NCT02600897|Rituximab|rituximab|mesh-list
5852279|NCT02600897|Obinutuzumab|obinutuzumab|mesh-list
5852280|NCT02600897|Lenalidomide|lenalidomide|mesh-list
5852281|NCT02600897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5852282|NCT02600897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5852283|NCT02600897|Immunologic Factors|immunologic factors|mesh-ancestor
5852284|NCT02600897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852285|NCT02600897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5852286|NCT02600897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5669367|NCT03577652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5669368|NCT03577652|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5669369|NCT03577652|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5669370|NCT03577652|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5669371|NCT03577652|Purinergic Agents|purinergic agents|mesh-ancestor
5669372|NCT03577652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5852287|NCT02600897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5852288|NCT02600897|Growth Substances|growth substances|mesh-ancestor
5852289|NCT02600897|Growth Inhibitors|growth inhibitors|mesh-ancestor
5852293|NCT02532257|Rituximab|rituximab|mesh-list
5852294|NCT02532257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5852295|NCT02532257|Lenalidomide|lenalidomide|mesh-list
5852296|NCT02532257|Antibodies|antibodies|mesh-list
5852297|NCT02532257|Immunoglobulins|immunoglobulins|mesh-list
5852298|NCT02532257|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5852299|NCT02532257|Immunologic Factors|immunologic factors|mesh-ancestor
5852300|NCT02532257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852301|NCT02532257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5852302|NCT02532257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5852303|NCT02532257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5852304|NCT02532257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5852305|NCT02532257|Growth Substances|growth substances|mesh-ancestor
5852306|NCT02532257|Growth Inhibitors|growth inhibitors|mesh-ancestor
5852307|NCT02484404|Durvalumab|durvalumab|mesh-list
5852308|NCT02484404|Olaparib|olaparib|mesh-list
5852309|NCT02484404|Cediranib|cediranib|mesh-list
5852310|NCT02484404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5852311|NCT02484404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5852312|NCT02484404|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5852313|NCT02484404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5852314|NCT02484404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852315|NCT02484404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5852316|NCT02403323|Etrolizumab|etrolizumab|mesh-list
5852317|NCT02403323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5852318|NCT02403323|Immunologic Factors|immunologic factors|mesh-ancestor
5852319|NCT02403323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852320|NCT02392429|Cytarabine|cytarabine|mesh-list
5852321|NCT02392429|Alovudine|alovudine|mesh-list
5852322|NCT02392429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5852323|NCT02392429|Antimetabolites|antimetabolites|mesh-ancestor
5852324|NCT02392429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852325|NCT02392429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5852326|NCT02392429|Antiviral Agents|antiviral agents|mesh-ancestor
5852327|NCT02392429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5852328|NCT02392429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5852329|NCT02392429|Immunologic Factors|immunologic factors|mesh-ancestor
5852330|NCT02392429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852331|NCT02340676|Interleukin-2|interleukin-2|mesh-list
5852332|NCT02340676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5852333|NCT02340676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5852334|NCT02340676|Analgesics|analgesics|mesh-ancestor
5852335|NCT02340676|Sensory System Agents|sensory system agents|mesh-ancestor
5852336|NCT02340676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6674801|NCT01571570|Antiviral Agents|antiviral agents|mesh-ancestor
5852337|NCT02340676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852338|NCT02320292|Rituximab|rituximab|mesh-list
5852339|NCT02320292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5852340|NCT02320292|Antibodies|antibodies|mesh-list
5852341|NCT02320292|Immunoglobulins|immunoglobulins|mesh-list
5852342|NCT02320292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5852343|NCT02320292|Immunologic Factors|immunologic factors|mesh-ancestor
5852344|NCT02320292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852345|NCT02320292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5852346|NCT02320292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5852347|NCT02317783|Deoxyglucose|deoxyglucose|mesh-list
5852348|NCT02317783|Flutemetamol|flutemetamol|mesh-list
5852349|NCT02317783|Antimetabolites|antimetabolites|mesh-ancestor
5852350|NCT02317783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852351|NCT02317783|Antiviral Agents|antiviral agents|mesh-ancestor
5852352|NCT02317783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5852353|NCT02317783|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5852354|NCT02232191|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5852355|NCT02232191|Immunologic Factors|immunologic factors|mesh-ancestor
5852356|NCT02232191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852357|NCT02224781|Nivolumab|nivolumab|mesh-list
5852358|NCT02224781|Ipilimumab|ipilimumab|mesh-list
5852359|NCT02224781|Trametinib|trametinib|mesh-list
5852360|NCT02224781|Dabrafenib|dabrafenib|mesh-list
5852361|NCT02224781|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
5852362|NCT02224781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5852363|NCT02224781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5852364|NCT02224781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5852365|NCT02224781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852366|NCT02224781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5852367|NCT02224781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5852368|NCT02224781|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
5852369|NCT02224781|Protective Agents|protective agents|mesh-ancestor
5852370|NCT02224781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852371|NCT02224781|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5852372|NCT02224781|Antioxidants|antioxidants|mesh-ancestor
5852373|NCT02144584|Memantine|memantine|mesh-list
5852374|NCT02144584|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5852375|NCT02144584|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5852376|NCT02144584|Dopamine Agents|dopamine agents|mesh-ancestor
5852377|NCT02144584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5852378|NCT02144584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852379|NCT02144584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852380|NCT02144584|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5852381|NCT02144584|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5852382|NCT02143466|Durvalumab|durvalumab|mesh-list
5852383|NCT02143466|Osimertinib|osimertinib|mesh-list
5852384|NCT02143466|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5852385|NCT02143466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5852386|NCT02143466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5852387|NCT02143466|Immunologic Factors|immunologic factors|mesh-ancestor
5852388|NCT02143466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852389|NCT02143466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5852390|NCT02143466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5852391|NCT02143466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852392|NCT02079740|Trametinib|trametinib|mesh-list
5852393|NCT02079740|Navitoclax|navitoclax|mesh-list
5852394|NCT02079740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5852395|NCT02079740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5852396|NCT02079740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5852397|NCT02079740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852398|NCT02008656|Leucovorin|leucovorin|mesh-list
5852399|NCT02008656|Fluorouracil|fluorouracil|mesh-list
5852400|NCT02008656|Capecitabine|capecitabine|mesh-list
5852401|NCT02008656|Oxaliplatin|oxaliplatin|mesh-list
5852402|NCT02008656|Antimetabolites|antimetabolites|mesh-ancestor
5852403|NCT02008656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852404|NCT02008656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5852405|NCT02008656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5852406|NCT02008656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5852407|NCT02008656|Immunologic Factors|immunologic factors|mesh-ancestor
5852408|NCT02008656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852409|NCT02008656|Antidotes|antidotes|mesh-ancestor
5852410|NCT02008656|Protective Agents|protective agents|mesh-ancestor
5852411|NCT02008656|Vitamin B Complex|vitamin b complex|mesh-ancestor
5852412|NCT02008656|Vitamins|vitamins|mesh-ancestor
5852413|NCT02008656|Micronutrients|micronutrients|mesh-ancestor
5852414|NCT02000882|Capecitabine|capecitabine|mesh-list
5669373|NCT03577652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669374|NCT03577652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669375|NCT03577626|Hemay005|hemay005|mesh-list
5669376|NCT03577626|Dermatologic Agents|dermatologic agents|mesh-ancestor
5669377|NCT03577626|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5669378|NCT03577626|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5669379|NCT03577626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5669380|NCT03577626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669381|NCT03577574|Anesthetics|anesthetics|mesh-list
5669382|NCT03577574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5669383|NCT03577574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669384|NCT03577496|Peppermint oil|peppermint oil|mesh-list
5669385|NCT03577496|Antiemetics|antiemetics|mesh-ancestor
5669386|NCT03577496|Autonomic Agents|autonomic agents|mesh-ancestor
5669387|NCT03577496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5669388|NCT03577496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669389|NCT03577496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5669390|NCT03577496|Parasympatholytics|parasympatholytics|mesh-ancestor
5669391|NCT03577457|Oxytocin|oxytocin|mesh-list
5669392|NCT03577457|Oxytocics|oxytocics|mesh-ancestor
5669393|NCT03577457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5852415|NCT02000882|Trastuzumab|trastuzumab|mesh-list
5852416|NCT02000882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5852417|NCT02000882|Antimetabolites|antimetabolites|mesh-ancestor
5852418|NCT02000882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852419|NCT02000882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5852420|NCT02000882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5852421|NCT01947023|Lapatinib|lapatinib|mesh-list
5852422|NCT01947023|Dabrafenib|dabrafenib|mesh-list
5852423|NCT01947023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5852424|NCT01947023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5852425|NCT01947023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5852426|NCT01947023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852427|NCT01946477|Dexamethasone|dexamethasone|mesh-list
5852428|NCT01946477|Daratumumab|daratumumab|mesh-list
5852429|NCT01946477|Pomalidomide|pomalidomide|mesh-list
5852430|NCT01946477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5852431|NCT01946477|Antiemetics|antiemetics|mesh-ancestor
5852432|NCT01946477|Autonomic Agents|autonomic agents|mesh-ancestor
5852433|NCT01946477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5852434|NCT01946477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852435|NCT01946477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5852436|NCT01946477|Glucocorticoids|glucocorticoids|mesh-ancestor
5852437|NCT01946477|Hormones|hormones|mesh-ancestor
5852438|NCT01946477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5852439|NCT01946477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5852440|NCT01946477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5852441|NCT01946477|Immunologic Factors|immunologic factors|mesh-ancestor
5852442|NCT01946477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5852443|NCT01946477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5852444|NCT01946477|Growth Substances|growth substances|mesh-ancestor
5852445|NCT01946477|Growth Inhibitors|growth inhibitors|mesh-ancestor
5852446|NCT01932125|Bevacizumab|bevacizumab|mesh-list
5852447|NCT01932125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5852448|NCT01932125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5852449|NCT01932125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5852450|NCT01932125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5852451|NCT01932125|Growth Substances|growth substances|mesh-ancestor
5852452|NCT01932125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852453|NCT01932125|Growth Inhibitors|growth inhibitors|mesh-ancestor
5852454|NCT01877837|Vidarabine|vidarabine|mesh-list
5852455|NCT01877837|Fludarabine|fludarabine|mesh-list
5852456|NCT01877837|Fludarabine phosphate|fludarabine phosphate|mesh-list
5852457|NCT01877837|Melphalan|melphalan|mesh-list
5852458|NCT01877837|Alemtuzumab|alemtuzumab|mesh-list
5852459|NCT01877837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5852460|NCT01877837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5852461|NCT01877837|Antimetabolites|antimetabolites|mesh-ancestor
5852462|NCT01877837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852463|NCT01877837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5852464|NCT01877837|Immunologic Factors|immunologic factors|mesh-ancestor
5852465|NCT01877837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852466|NCT01877837|Antiviral Agents|antiviral agents|mesh-ancestor
5852467|NCT01877837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5852468|NCT01877837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5852469|NCT01877837|Alkylating Agents|alkylating agents|mesh-ancestor
5852470|NCT01877837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5669394|NCT03577457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669395|NCT03577392|Capecitabine|capecitabine|mesh-list
5669396|NCT03577392|Oxaliplatin|oxaliplatin|mesh-list
5669397|NCT03577392|Endostatins|endostatins|mesh-list
5669398|NCT03577392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5669399|NCT03577392|Antimetabolites|antimetabolites|mesh-ancestor
5669400|NCT03577392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669401|NCT03577392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5669402|NCT03577392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5669403|NCT03577392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5669404|NCT03577392|Growth Substances|growth substances|mesh-ancestor
5669405|NCT03577392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669406|NCT03577392|Growth Inhibitors|growth inhibitors|mesh-ancestor
5669407|NCT03577249|Dialysis Solutions|dialysis solutions|mesh-list
5669408|NCT03577249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5669409|NCT03577184|Metformin|metformin|mesh-list
5669410|NCT03577184|Vildagliptin|vildagliptin|mesh-list
5669411|NCT03577184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5669412|NCT03577184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669413|NCT03577184|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5669414|NCT03577184|Protease Inhibitors|protease inhibitors|mesh-ancestor
5669415|NCT03577184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5852471|NCT01877837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5852472|NCT01812252|Azacitidine|azacitidine|mesh-list
5852473|NCT01812252|Decitabine|decitabine|mesh-list
5852474|NCT01812252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5852475|NCT01812252|Antimetabolites|antimetabolites|mesh-ancestor
5852476|NCT01812252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852477|NCT01812252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5852478|NCT01812252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5852479|NCT01748175|Triamcinolone|triamcinolone|mesh-list
5852480|NCT01748175|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5852481|NCT01748175|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5852482|NCT01748175|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5852483|NCT01748175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5852484|NCT01748175|Glucocorticoids|glucocorticoids|mesh-ancestor
5669416|NCT03577184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669417|NCT03577158|Insulin|insulin|mesh-list
5669418|NCT03577158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5852485|NCT01748175|Hormones|hormones|mesh-ancestor
5852486|NCT01748175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5852487|NCT01748175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852488|NCT01748175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5852489|NCT01748175|Immunologic Factors|immunologic factors|mesh-ancestor
5852490|NCT01748175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5852491|NCT01748175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852492|NCT01642004|Docetaxel|docetaxel|mesh-list
5852493|NCT01642004|Nivolumab|nivolumab|mesh-list
5852494|NCT01642004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5852495|NCT01642004|Tubulin Modulators|tubulin modulators|mesh-ancestor
5852496|NCT01642004|Antimitotic Agents|antimitotic agents|mesh-ancestor
5852497|NCT01642004|Mitosis Modulators|mitosis modulators|mesh-ancestor
5852498|NCT01642004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852499|NCT01642004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5852500|NCT01642004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5669419|NCT03577158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669420|NCT03577132|Atezolizumab|atezolizumab|mesh-list
5669421|NCT03577132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6212228|NCT02183675|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
6212229|NCT02183675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6494245|NCT00618046|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5669425|NCT03576963|Nivolumab|nivolumab|mesh-list
5669426|NCT03576963|Guadecitabine|guadecitabine|mesh-list
5669427|NCT03576963|Azacitidine|azacitidine|mesh-list
5669428|NCT03576963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5852501|NCT01453179|Diclofenac|diclofenac|mesh-list
5852502|NCT01453179|Imiquimod|imiquimod|mesh-list
5852503|NCT01453179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5852504|NCT01453179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5852505|NCT01453179|Analgesics|analgesics|mesh-ancestor
5852506|NCT01453179|Sensory System Agents|sensory system agents|mesh-ancestor
5852507|NCT01453179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5852508|NCT01453179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852509|NCT01453179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5852510|NCT01453179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5852511|NCT01453179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5852512|NCT01453179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5852513|NCT01453179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669429|NCT03576963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5669430|NCT03576963|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5669431|NCT03576963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669432|NCT03576963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5669433|NCT03576963|Antimetabolites|antimetabolites|mesh-ancestor
5669434|NCT03576963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5669435|NCT03576911|Ubiquinone|ubiquinone|mesh-list
5669436|NCT03576911|Coenzyme Q10|coenzyme q10|mesh-list
5669437|NCT03576911|Micronutrients|micronutrients|mesh-ancestor
5669438|NCT03576911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669439|NCT03576911|Vitamins|vitamins|mesh-ancestor
5669440|NCT03576885|Nitric Oxide|nitric oxide|mesh-list
5852514|NCT01453179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5852515|NCT01453179|Immunologic Factors|immunologic factors|mesh-ancestor
5852516|NCT01453179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5852517|NCT01453179|Interferon Inducers|interferon inducers|mesh-ancestor
6494246|NCT00618059|Pilocarpine|pilocarpine|mesh-list
5669441|NCT03576885|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5669442|NCT03576885|Autonomic Agents|autonomic agents|mesh-ancestor
5669443|NCT03576885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5852518|NCT01366092|Interleukin-2|interleukin-2|mesh-list
5852519|NCT01366092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5852520|NCT01366092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5852521|NCT01366092|Analgesics|analgesics|mesh-ancestor
5852522|NCT01366092|Sensory System Agents|sensory system agents|mesh-ancestor
5852523|NCT01366092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5852524|NCT01366092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852525|NCT01336530|Oxethazaine|oxethazaine|mesh-list
5852526|NCT01336530|Aluminum Hydroxide|aluminum hydroxide|mesh-list
5852527|NCT01336530|Antacids|antacids|mesh-list
5852528|NCT01336530|Magnesium Hydroxide|magnesium hydroxide|mesh-list
5852529|NCT01336530|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5852530|NCT01336530|Immunologic Factors|immunologic factors|mesh-ancestor
5852531|NCT01336530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852532|NCT01336530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852533|NCT01336530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5852534|NCT01336530|Anesthetics, Local|anesthetics, local|mesh-ancestor
5852535|NCT01336530|Anesthetics|anesthetics|mesh-ancestor
5852536|NCT01336530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5852537|NCT01336530|Sensory System Agents|sensory system agents|mesh-ancestor
5852538|NCT01336530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5852539|NCT01305499|Azacitidine|azacitidine|mesh-list
5852540|NCT01305499|Entinostat|entinostat|mesh-list
5852541|NCT01305499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5852542|NCT01305499|Antimetabolites|antimetabolites|mesh-ancestor
5852543|NCT01305499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852544|NCT01305499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5852545|NCT01305499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5852546|NCT01305499|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5852547|NCT01244815|Asenapine|asenapine|mesh-list
5852548|NCT01244815|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5852549|NCT01244815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5852550|NCT01244815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5852551|NCT01244815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852552|NCT01244815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5852553|NCT01194622|Fluticasone|fluticasone|mesh-list
5852554|NCT01194622|Xhance|xhance|mesh-list
5852555|NCT01194622|Azelastine|azelastine|mesh-list
5852556|NCT01194622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5852557|NCT01194622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5852558|NCT01194622|Autonomic Agents|autonomic agents|mesh-ancestor
5852559|NCT01194622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5852560|NCT01194622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852561|NCT01194622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5852562|NCT01194622|Respiratory System Agents|respiratory system agents|mesh-ancestor
6674802|NCT01571570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6674803|NCT01571570|Protease Inhibitors|protease inhibitors|mesh-ancestor
6674804|NCT01571570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6674805|NCT01571570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674806|NCT01571583|Interferons|interferons|mesh-list
6674807|NCT01571583|Ribavirin|ribavirin|mesh-list
6674808|NCT01571583|Interferon-alpha|interferon-alpha|mesh-list
6674809|NCT01571583|Interferon alpha-2|interferon alpha-2|mesh-list
6674810|NCT01571583|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5669444|NCT03576885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669445|NCT03576885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5669446|NCT03576885|Respiratory System Agents|respiratory system agents|mesh-ancestor
5669447|NCT03576885|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5669448|NCT03576885|Antioxidants|antioxidants|mesh-ancestor
5669449|NCT03576885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669450|NCT03576885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5669451|NCT03576885|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5669452|NCT03576885|Vasodilator Agents|vasodilator agents|mesh-ancestor
5669453|NCT03576885|Gasotransmitters|gasotransmitters|mesh-ancestor
5669454|NCT03576885|Protective Agents|protective agents|mesh-ancestor
5669455|NCT03576820|Lidocaine|lidocaine|mesh-list
5669456|NCT03576820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5669457|NCT03576820|Anesthetics, Local|anesthetics, local|mesh-ancestor
5669458|NCT03576820|Anesthetics|anesthetics|mesh-ancestor
5669459|NCT03576820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5669460|NCT03576820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669461|NCT03576820|Sensory System Agents|sensory system agents|mesh-ancestor
5669462|NCT03576820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5669463|NCT03576820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5852563|NCT01194622|Dermatologic Agents|dermatologic agents|mesh-ancestor
6674811|NCT01571583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5852564|NCT01194622|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5852565|NCT01194622|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
5852566|NCT01194622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5852567|NCT01194622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852568|NCT01194622|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5852569|NCT01194622|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5852570|NCT01194622|Histamine Antagonists|histamine antagonists|mesh-ancestor
5669464|NCT03576820|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5669465|NCT03576820|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5669466|NCT03576820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5669467|NCT03576820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669468|NCT03576794|Prednisolone|prednisolone|mesh-list
5669469|NCT03576794|Leflunomide|leflunomide|mesh-list
5852571|NCT01194622|Histamine Agents|histamine agents|mesh-ancestor
5852572|NCT01194622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5852573|NCT01190852|Fluticasone|fluticasone|mesh-list
5852574|NCT01190852|Azelastine|azelastine|mesh-list
5852575|NCT01190852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5852576|NCT01190852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5852577|NCT01190852|Autonomic Agents|autonomic agents|mesh-ancestor
5852578|NCT01190852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5852579|NCT01190852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852580|NCT01190852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5852581|NCT01190852|Respiratory System Agents|respiratory system agents|mesh-ancestor
5852582|NCT01190852|Dermatologic Agents|dermatologic agents|mesh-ancestor
5852583|NCT01190852|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5852584|NCT01190852|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
5852585|NCT01190852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5852586|NCT01190852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852587|NCT01190852|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5852588|NCT01190852|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5852589|NCT01190852|Histamine Antagonists|histamine antagonists|mesh-ancestor
5852590|NCT01190852|Histamine Agents|histamine agents|mesh-ancestor
5852591|NCT01190852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5852607|NCT01142596|Asenapine|asenapine|mesh-list
5852608|NCT01142596|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5852609|NCT01142596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5852610|NCT01142596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5852611|NCT01142596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852612|NCT01142596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5852613|NCT01098110|Asenapine|asenapine|mesh-list
5852614|NCT01098110|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5852615|NCT01098110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5852616|NCT01098110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5852617|NCT01098110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852618|NCT01098110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5852619|NCT01028716|Vidarabine|vidarabine|mesh-list
5852620|NCT01028716|Mycophenolic Acid|mycophenolic acid|mesh-list
5852621|NCT01028716|Cyclophosphamide|cyclophosphamide|mesh-list
5852622|NCT01028716|Fludarabine|fludarabine|mesh-list
5852623|NCT01028716|Fludarabine phosphate|fludarabine phosphate|mesh-list
6494247|NCT00618059|Miotics|miotics|mesh-ancestor
5669470|NCT03576794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5669471|NCT03576794|Glucocorticoids|glucocorticoids|mesh-ancestor
5669472|NCT03576794|Hormones|hormones|mesh-ancestor
5669473|NCT03576794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5669474|NCT03576794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669475|NCT03576794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5669476|NCT03576794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5669477|NCT03576794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5852624|NCT01028716|Tacrolimus|tacrolimus|mesh-list
5852625|NCT01028716|Lenograstim|lenograstim|mesh-list
5852626|NCT01028716|Sargramostim|sargramostim|mesh-list
5852627|NCT01028716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5852628|NCT01028716|Immunologic Factors|immunologic factors|mesh-ancestor
5852629|NCT01028716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852630|NCT01028716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5852631|NCT01028716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5852632|NCT01028716|Alkylating Agents|alkylating agents|mesh-ancestor
5852633|NCT01028716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852634|NCT01028716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5852635|NCT01028716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5852636|NCT01028716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5852637|NCT01028716|Antimetabolites|antimetabolites|mesh-ancestor
5852638|NCT01028716|Antiviral Agents|antiviral agents|mesh-ancestor
5852639|NCT01028716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5852640|NCT01028716|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5852641|NCT01028716|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5852642|NCT01028716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5852643|NCT01028716|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5852644|NCT01028716|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5852645|NCT01028716|Antitubercular Agents|antitubercular agents|mesh-ancestor
5852646|NCT01028716|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5852647|NCT01006265|Ponesimod|ponesimod|mesh-list
5852648|NCT01006265|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5852649|NCT01006265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852650|NCT01006265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5852651|NCT01006265|Immunologic Factors|immunologic factors|mesh-ancestor
5852652|NCT01006265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212230|NCT02183675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6212231|NCT02183675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6212232|NCT02183675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212233|NCT02183675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6212234|NCT02183675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212235|NCT02183675|Vasodilator Agents|vasodilator agents|mesh-ancestor
6212236|NCT02183675|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6212237|NCT02183675|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6212238|NCT02183675|Diuretics|diuretics|mesh-ancestor
6212239|NCT02183675|Natriuretic Agents|natriuretic agents|mesh-ancestor
6212240|NCT02183675|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6212241|NCT02183792|Furosemide|furosemide|mesh-list
6212242|NCT02183792|Tolvaptan|tolvaptan|mesh-list
6212243|NCT02183792|Diuretics|diuretics|mesh-ancestor
6212244|NCT02183792|Natriuretic Agents|natriuretic agents|mesh-ancestor
6212245|NCT02183792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669478|NCT03576794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669479|NCT03576794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5669480|NCT03576794|Immunologic Factors|immunologic factors|mesh-ancestor
5669481|NCT03576755|Spironolactone|spironolactone|mesh-list
5669482|NCT03576755|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5669483|NCT03576755|Hormone Antagonists|hormone antagonists|mesh-ancestor
5669484|NCT03576755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5669485|NCT03576755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669486|NCT03576755|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5669487|NCT03576755|Diuretics|diuretics|mesh-ancestor
5669488|NCT03576755|Natriuretic Agents|natriuretic agents|mesh-ancestor
5669489|NCT03576677|Simendan|simendan|mesh-list
5669490|NCT03576677|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5669491|NCT03576677|Vasodilator Agents|vasodilator agents|mesh-ancestor
5669492|NCT03576677|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5669493|NCT03576677|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5669494|NCT03576677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5669495|NCT03576677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669496|NCT03576677|Protective Agents|protective agents|mesh-ancestor
5669497|NCT03576677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669498|NCT03576664|Carvedilol|carvedilol|mesh-list
5669499|NCT03576664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5669500|NCT03576664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5669501|NCT03576664|Adrenergic Agents|adrenergic agents|mesh-ancestor
5669502|NCT03576664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5669503|NCT03576664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669504|NCT03576664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669505|NCT03576664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5669506|NCT03576664|Antioxidants|antioxidants|mesh-ancestor
5669507|NCT03576664|Protective Agents|protective agents|mesh-ancestor
5669508|NCT03576664|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5669509|NCT03576664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5669510|NCT03576664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5669511|NCT03576664|Vasodilator Agents|vasodilator agents|mesh-ancestor
5669512|NCT03576664|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5669513|NCT03576664|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5852668|NCT00977483|Thioctic Acid|thioctic acid|mesh-list
5852669|NCT00977483|Antioxidants|antioxidants|mesh-ancestor
5852670|NCT00977483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669514|NCT03576651|Bevacizumab|bevacizumab|mesh-list
5669515|NCT03576651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5669516|NCT03576651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5669517|NCT03576651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5852671|NCT00977483|Protective Agents|protective agents|mesh-ancestor
5852672|NCT00977483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852673|NCT00977483|Vitamin B Complex|vitamin b complex|mesh-ancestor
5852674|NCT00977483|Vitamins|vitamins|mesh-ancestor
5852675|NCT00977483|Micronutrients|micronutrients|mesh-ancestor
5852676|NCT00972309|Vaccines|vaccines|mesh-list
5852677|NCT00972309|Immunologic Factors|immunologic factors|mesh-ancestor
5852678|NCT00972309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852679|NCT00923013|Rituximab|rituximab|mesh-list
5852680|NCT00923013|Cladribine|cladribine|mesh-list
5852681|NCT00923013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5852682|NCT00923013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5852683|NCT00923013|Immunologic Factors|immunologic factors|mesh-ancestor
5852684|NCT00923013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852685|NCT00923013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5852686|NCT00923013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5852687|NCT00777348|Reproterol|reproterol|mesh-list
5852688|NCT00777348|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5852689|NCT00777348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5852690|NCT00777348|Adrenergic Agents|adrenergic agents|mesh-ancestor
5852691|NCT00777348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5852692|NCT00777348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852693|NCT00777348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852694|NCT00777348|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5852695|NCT00777348|Autonomic Agents|autonomic agents|mesh-ancestor
5852696|NCT00777348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5852697|NCT00777348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5852698|NCT00777348|Respiratory System Agents|respiratory system agents|mesh-ancestor
5852699|NCT00777127|Diclofenac|diclofenac|mesh-list
5852700|NCT00777127|Imiquimod|imiquimod|mesh-list
5852701|NCT00777127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5669518|NCT03576651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5669519|NCT03576651|Growth Substances|growth substances|mesh-ancestor
5669520|NCT03576651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669521|NCT03576651|Growth Inhibitors|growth inhibitors|mesh-ancestor
5669522|NCT03576638|Levodopa|levodopa|mesh-list
5669523|NCT03576638|Carbidopa|carbidopa|mesh-list
5669524|NCT03576638|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
5669525|NCT03576638|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5669526|NCT03576638|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5669527|NCT03576638|Dopamine Agents|dopamine agents|mesh-ancestor
5669528|NCT03576638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5669529|NCT03576638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669530|NCT03576638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669531|NCT03576638|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5669532|NCT03576638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5669533|NCT03576638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5669534|NCT03576638|Immunologic Factors|immunologic factors|mesh-ancestor
5669535|NCT03576638|Dopamine Agonists|dopamine agonists|mesh-ancestor
5669536|NCT03576599|Zoledronic Acid|zoledronic acid|mesh-list
5669537|NCT03576599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5669538|NCT03576599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669539|NCT03576547|Dexamethasone|dexamethasone|mesh-list
5669540|NCT03576547|Dexamethasone acetate|dexamethasone acetate|mesh-list
5669541|NCT03576547|Rituximab|rituximab|mesh-list
5669542|NCT03576547|Venetoclax|venetoclax|mesh-list
5669543|NCT03576547|Ponatinib|ponatinib|mesh-list
5669544|NCT03576547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5669545|NCT03576547|Antibodies|antibodies|mesh-list
5669546|NCT03576547|Immunoglobulins|immunoglobulins|mesh-list
5669547|NCT03576547|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5669548|NCT03576547|BB 1101|bb 1101|mesh-list
5669549|NCT03576547|Immunologic Factors|immunologic factors|mesh-ancestor
5669550|NCT03576547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669551|NCT03576547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5669552|NCT03576547|Antiemetics|antiemetics|mesh-ancestor
5669553|NCT03576547|Autonomic Agents|autonomic agents|mesh-ancestor
5669554|NCT03576547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5669555|NCT03576547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5669556|NCT03576547|Glucocorticoids|glucocorticoids|mesh-ancestor
5669557|NCT03576547|Hormones|hormones|mesh-ancestor
5669558|NCT03576547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5669559|NCT03576547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5669560|NCT03576547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5669561|NCT03576547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5669562|NCT03576547|Protease Inhibitors|protease inhibitors|mesh-ancestor
5669563|NCT03576547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5669564|NCT03576547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669565|NCT03576547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5669566|NCT03576508|Lidocaine|lidocaine|mesh-list
5669567|NCT03576508|Epinephrine|epinephrine|mesh-list
5669568|NCT03576508|Capsaicin|capsaicin|mesh-list
5669569|NCT03576508|Anesthetics, Local|anesthetics, local|mesh-ancestor
5669570|NCT03576508|Anesthetics|anesthetics|mesh-ancestor
5669571|NCT03576508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5669572|NCT03576508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669573|NCT03576508|Sensory System Agents|sensory system agents|mesh-ancestor
5669574|NCT03576508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5669575|NCT03576508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5669576|NCT03576508|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5669577|NCT03576508|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5669578|NCT03576508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5669579|NCT03576508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669580|NCT03576508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5669581|NCT03576508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5669582|NCT03576508|Adrenergic Agents|adrenergic agents|mesh-ancestor
5669583|NCT03576508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5669584|NCT03576508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5669585|NCT03576508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5669586|NCT03576508|Autonomic Agents|autonomic agents|mesh-ancestor
5669587|NCT03576508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5669588|NCT03576508|Respiratory System Agents|respiratory system agents|mesh-ancestor
5669589|NCT03576508|Mydriatics|mydriatics|mesh-ancestor
5669590|NCT03576508|Sympathomimetics|sympathomimetics|mesh-ancestor
5669591|NCT03576508|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5669592|NCT03576508|Antipruritics|antipruritics|mesh-ancestor
5669593|NCT03576508|Dermatologic Agents|dermatologic agents|mesh-ancestor
5669594|NCT03576469|Complement C1s|complement c1s|mesh-list
5669595|NCT03576469|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
5852702|NCT00777127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5852703|NCT00777127|Analgesics|analgesics|mesh-ancestor
5852704|NCT00777127|Sensory System Agents|sensory system agents|mesh-ancestor
5852705|NCT00777127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5852706|NCT00777127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852707|NCT00777127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5852708|NCT00777127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5852709|NCT00777127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5669596|NCT03576469|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
5669597|NCT03576469|Immunologic Factors|immunologic factors|mesh-ancestor
5669598|NCT03576469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852710|NCT00777127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5852711|NCT00777127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852712|NCT00777127|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5852713|NCT00777127|Immunologic Factors|immunologic factors|mesh-ancestor
5852714|NCT00777127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5852715|NCT00777127|Interferon Inducers|interferon inducers|mesh-ancestor
5852716|NCT00761371|Imiquimod|imiquimod|mesh-list
5852717|NCT00761371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5852718|NCT00761371|Immunologic Factors|immunologic factors|mesh-ancestor
5852719|NCT00761371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852720|NCT00761371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5852721|NCT00761371|Interferon Inducers|interferon inducers|mesh-ancestor
5904048|NCT03440372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904049|NCT03425331|Nivolumab|nivolumab|mesh-list
5904050|NCT03425331|Ipilimumab|ipilimumab|mesh-list
5904051|NCT03425331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5904052|NCT03425331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5904053|NCT03425331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5904054|NCT03425331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904055|NCT03401398|Hydrocortisone|hydrocortisone|mesh-list
5904056|NCT03401398|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
5904057|NCT03401398|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
5904058|NCT03401398|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
5904059|NCT03401398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5908464|NCT04503551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5908465|NCT04503551|Growth Inhibitors|growth inhibitors|mesh-ancestor
5908466|NCT04503551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5669599|NCT03576469|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5669600|NCT03576469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5669601|NCT03576456|Alprazolam|alprazolam|mesh-list
5669602|NCT03576456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5669603|NCT03576456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5669604|NCT03576456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669605|NCT03576456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5669606|NCT03576456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5908467|NCT04492722|Dapagliflozin|dapagliflozin|mesh-list
5908468|NCT04492722|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5908469|NCT04492722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908470|NCT04492722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5908471|NCT04492722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669607|NCT03576456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5669608|NCT03576456|GABA Modulators|gaba modulators|mesh-ancestor
5669609|NCT03576456|GABA Agents|gaba agents|mesh-ancestor
5669610|NCT03576456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5669611|NCT03576456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908472|NCT04486352|Bevacizumab|bevacizumab|mesh-list
6494248|NCT00618059|Autonomic Agents|autonomic agents|mesh-ancestor
6494249|NCT00618059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6494250|NCT00618059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669612|NCT03576417|Nivolumab|nivolumab|mesh-list
5669613|NCT03576417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5669614|NCT03576417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5669615|NCT03576417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5669616|NCT03576417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669617|NCT03576378|Prednisone|prednisone|mesh-list
5669618|NCT03576378|Cyclophosphamide|cyclophosphamide|mesh-list
5669619|NCT03576378|Etoposide|etoposide|mesh-list
5669620|NCT03576378|Mitoxantrone|mitoxantrone|mesh-list
5669621|NCT03576378|Procarbazine|procarbazine|mesh-list
5669622|NCT03576378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5669623|NCT03576378|Immunologic Factors|immunologic factors|mesh-ancestor
5669624|NCT03576378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669625|NCT03576378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5669626|NCT03576378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5669627|NCT03576378|Alkylating Agents|alkylating agents|mesh-ancestor
5669628|NCT03576378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669629|NCT03576378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5669630|NCT03576378|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5669631|NCT03576378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5669632|NCT03576378|Glucocorticoids|glucocorticoids|mesh-ancestor
5669633|NCT03576378|Hormones|hormones|mesh-ancestor
5669634|NCT03576378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5669635|NCT03576378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5669636|NCT03576378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5669637|NCT03576378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5669638|NCT03576378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5669639|NCT03576378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5669640|NCT03576378|Analgesics|analgesics|mesh-ancestor
5669641|NCT03576378|Sensory System Agents|sensory system agents|mesh-ancestor
5852724|NCT00591227|Insulin|insulin|mesh-list
5852725|NCT00591227|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5852726|NCT00591227|Insulin Aspart|insulin aspart|mesh-list
5852727|NCT00591227|Insulin Detemir|insulin detemir|mesh-list
5852728|NCT00591227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5852729|NCT00591227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852730|NCT00534976|Montelukast|montelukast|mesh-list
5852731|NCT00534976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5852732|NCT00534976|Respiratory System Agents|respiratory system agents|mesh-ancestor
5852733|NCT00534976|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5852734|NCT00534976|Hormone Antagonists|hormone antagonists|mesh-ancestor
5852735|NCT00534976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5852736|NCT00534976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669642|NCT03576378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5695909|NCT03386656|Coagulants|coagulants|mesh-ancestor
5695910|NCT03386643|Clobetasol|clobetasol|mesh-list
5695911|NCT03386643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5695912|NCT03386643|Glucocorticoids|glucocorticoids|mesh-ancestor
5695913|NCT03386643|Hormones|hormones|mesh-ancestor
5695914|NCT03386643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5695915|NCT03386643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695916|NCT03386630|Sufentanil|sufentanil|mesh-list
5695917|NCT03386630|Morphine|morphine|mesh-list
5695918|NCT03386630|Dsuvia|dsuvia|mesh-list
5695919|NCT03386630|Bupivacaine|bupivacaine|mesh-list
5695920|NCT03386630|Anesthetics, Local|anesthetics, local|mesh-ancestor
5852737|NCT00534976|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5852738|NCT00534976|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5852739|NCT00534976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852740|NCT00492999|Leucovorin|leucovorin|mesh-list
5852741|NCT00492999|Dexamethasone|dexamethasone|mesh-list
5852742|NCT00492999|Fluorouracil|fluorouracil|mesh-list
5852743|NCT00492999|Oxaliplatin|oxaliplatin|mesh-list
5852744|NCT00492999|Irinotecan|irinotecan|mesh-list
5852745|NCT00492999|Floxuridine|floxuridine|mesh-list
5852746|NCT00492999|Calcium|calcium|mesh-list
5852747|NCT00492999|Levoleucovorin|levoleucovorin|mesh-list
5852748|NCT00492999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5852749|NCT00492999|Antiemetics|antiemetics|mesh-ancestor
5852750|NCT00492999|Autonomic Agents|autonomic agents|mesh-ancestor
5852751|NCT00492999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5852752|NCT00492999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852753|NCT00492999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5852754|NCT00492999|Glucocorticoids|glucocorticoids|mesh-ancestor
5852755|NCT00492999|Hormones|hormones|mesh-ancestor
5852756|NCT00492999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5852757|NCT00492999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5852758|NCT00492999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5852759|NCT00492999|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5852760|NCT00492999|Antimetabolites|antimetabolites|mesh-ancestor
5852761|NCT00492999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852762|NCT00492999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5852763|NCT00492999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5852764|NCT00492999|Immunologic Factors|immunologic factors|mesh-ancestor
5852765|NCT00492999|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5695921|NCT03386630|Anesthetics|anesthetics|mesh-ancestor
5695922|NCT03386630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5695923|NCT03386630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852766|NCT00492999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5852767|NCT00492999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5852768|NCT00492999|Antidotes|antidotes|mesh-ancestor
6494251|NCT00618059|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6494252|NCT00618059|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6494253|NCT00618059|Cholinergic Agents|cholinergic agents|mesh-ancestor
6494254|NCT00618059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6494255|NCT00618059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494256|NCT00618111|Granisetron|granisetron|mesh-list
5852769|NCT00492999|Protective Agents|protective agents|mesh-ancestor
5695924|NCT03386630|Sensory System Agents|sensory system agents|mesh-ancestor
5852770|NCT00492999|Vitamin B Complex|vitamin b complex|mesh-ancestor
5852771|NCT00492999|Vitamins|vitamins|mesh-ancestor
5852772|NCT00492999|Micronutrients|micronutrients|mesh-ancestor
5852773|NCT00408473|Flecainide|flecainide|mesh-list
5852774|NCT00408473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5852775|NCT00408473|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5852776|NCT00408473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5852777|NCT00408473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5852778|NCT00408473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852779|NCT00337675|Montelukast|montelukast|mesh-list
5852780|NCT00337675|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5852781|NCT00337675|Respiratory System Agents|respiratory system agents|mesh-ancestor
5852782|NCT00337675|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5852783|NCT00337675|Hormone Antagonists|hormone antagonists|mesh-ancestor
5852784|NCT00337675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5852785|NCT00337675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852786|NCT00337675|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5852787|NCT00337675|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5852788|NCT00337675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852789|NCT00328601|Thioctic Acid|thioctic acid|mesh-list
5852790|NCT00328601|Antioxidants|antioxidants|mesh-ancestor
5852791|NCT00328601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852792|NCT00328601|Protective Agents|protective agents|mesh-ancestor
5852793|NCT00328601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852794|NCT00328601|Vitamin B Complex|vitamin b complex|mesh-ancestor
5852795|NCT00328601|Vitamins|vitamins|mesh-ancestor
6494257|NCT00618111|Antiemetics|antiemetics|mesh-ancestor
5852796|NCT00328601|Micronutrients|micronutrients|mesh-ancestor
5852797|NCT00317772|Topotecan|topotecan|mesh-list
5852798|NCT00317772|Gefitinib|gefitinib|mesh-list
5852799|NCT00317772|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5852800|NCT00317772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5852801|NCT00317772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5852802|NCT00317772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669643|NCT03576313|Ivermectin|ivermectin|mesh-list
5669644|NCT03576313|Piperaquine|piperaquine|mesh-list
5669645|NCT03576313|Artenimol|artenimol|mesh-list
5669646|NCT03576313|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5669647|NCT03576313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5669648|NCT03576313|Antimalarials|antimalarials|mesh-ancestor
5669649|NCT03576313|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5669650|NCT03576287|Apremilast|apremilast|mesh-list
5669651|NCT03576287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5669652|NCT03576287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5669653|NCT03576287|Analgesics|analgesics|mesh-ancestor
5669654|NCT03576287|Sensory System Agents|sensory system agents|mesh-ancestor
5669655|NCT03576287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5669656|NCT03576287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669657|NCT03576287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5669658|NCT03576287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5669659|NCT03576287|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5852803|NCT00317772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6494258|NCT00618111|Autonomic Agents|autonomic agents|mesh-ancestor
6494259|NCT00618111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5669660|NCT03576287|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5669661|NCT03576287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5669662|NCT03576287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669663|NCT03576105|Photosensitizing Agents|photosensitizing agents|mesh-list
5669664|NCT03576105|Methylene Blue|methylene blue|mesh-list
5669665|NCT03576105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5669666|NCT03576105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669667|NCT03576105|Dermatologic Agents|dermatologic agents|mesh-ancestor
5669668|NCT03576079|Salicylic Acid|salicylic acid|mesh-list
6494260|NCT00618111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494261|NCT00618111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6494262|NCT00618111|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6494263|NCT00618111|Serotonin Agents|serotonin agents|mesh-ancestor
6494264|NCT00618111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6494265|NCT00618111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494266|NCT00618124|Capecitabine|capecitabine|mesh-list
6494267|NCT00618124|Sunitinib|sunitinib|mesh-list
6494268|NCT00618124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6494269|NCT00618124|Antimetabolites|antimetabolites|mesh-ancestor
6494270|NCT00618124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494271|NCT00618124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6674812|NCT01571583|Antiviral Agents|antiviral agents|mesh-ancestor
6674813|NCT01571583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6674814|NCT01571583|Antimetabolites|antimetabolites|mesh-ancestor
5852804|NCT00317772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5852805|NCT00294320|Imiquimod|imiquimod|mesh-list
5852806|NCT00294320|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5852807|NCT00294320|Immunologic Factors|immunologic factors|mesh-ancestor
5852808|NCT00294320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852809|NCT00294320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5852810|NCT00294320|Interferon Inducers|interferon inducers|mesh-ancestor
5852811|NCT00291486|Capecitabine|capecitabine|mesh-list
5852812|NCT00291486|Antibodies|antibodies|mesh-list
5852813|NCT00291486|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5852814|NCT00291486|Immunologic Factors|immunologic factors|mesh-ancestor
5852815|NCT00291486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852816|NCT00291486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5852817|NCT00291486|Antimetabolites|antimetabolites|mesh-ancestor
5852818|NCT00291486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852819|NCT00291486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5852820|NCT00284856|Fluticasone|fluticasone|mesh-list
5852821|NCT00284856|Montelukast|montelukast|mesh-list
5852822|NCT00284856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5852823|NCT00284856|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5852824|NCT00284856|Autonomic Agents|autonomic agents|mesh-ancestor
5852825|NCT00284856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5852826|NCT00284856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852827|NCT00284856|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5852828|NCT00284856|Respiratory System Agents|respiratory system agents|mesh-ancestor
5852829|NCT00284856|Dermatologic Agents|dermatologic agents|mesh-ancestor
5852830|NCT00284856|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5852831|NCT00284856|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5852832|NCT00284856|Hormone Antagonists|hormone antagonists|mesh-ancestor
5852833|NCT00284856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5852834|NCT00284856|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5852835|NCT00284856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5852836|NCT00284856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852837|NCT00189319|Flecainide|flecainide|mesh-list
5852838|NCT00189319|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5669669|NCT03576079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5669670|NCT03576079|Antifungal Agents|antifungal agents|mesh-ancestor
5669671|NCT03576079|Keratolytic Agents|keratolytic agents|mesh-ancestor
5669672|NCT03576079|Dermatologic Agents|dermatologic agents|mesh-ancestor
5669673|NCT03576053|Lidocaine|lidocaine|mesh-list
5669674|NCT03576053|Serotonin|serotonin|mesh-list
5669675|NCT03576053|Histamine|histamine|mesh-list
5669676|NCT03576053|Anesthetics, Local|anesthetics, local|mesh-ancestor
5669677|NCT03576053|Anesthetics|anesthetics|mesh-ancestor
5669678|NCT03576053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5669679|NCT03576053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669680|NCT03576053|Sensory System Agents|sensory system agents|mesh-ancestor
5669681|NCT03576053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5669682|NCT03576053|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5669683|NCT03576053|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5669684|NCT03576053|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5669685|NCT03576053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5669686|NCT03576053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669687|NCT03576053|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5669688|NCT03576053|Serotonin Agents|serotonin agents|mesh-ancestor
5669689|NCT03576053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5669690|NCT03576053|Histamine Agonists|histamine agonists|mesh-ancestor
5669691|NCT03576053|Histamine Agents|histamine agents|mesh-ancestor
5669692|NCT03576040|Edotreotide|edotreotide|mesh-list
5669693|NCT03576040|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5852839|NCT00189319|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6674815|NCT01571583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674816|NCT01571583|Immunologic Factors|immunologic factors|mesh-ancestor
6674817|NCT01571583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674818|NCT01571609|Insulin|insulin|mesh-list
6674819|NCT01571609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6674820|NCT01571609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674821|NCT01571648|Azacitidine|azacitidine|mesh-list
6674822|NCT01571648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6674823|NCT01571648|Antimetabolites|antimetabolites|mesh-ancestor
6674824|NCT01571648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674825|NCT01571648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5852840|NCT00189319|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5852841|NCT00189319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5852842|NCT00189319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852843|NCT00189293|Imiquimod|imiquimod|mesh-list
5852844|NCT00189293|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5852845|NCT00189293|Immunologic Factors|immunologic factors|mesh-ancestor
5852846|NCT00189293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852847|NCT00189293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6494272|NCT00618124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6494273|NCT00618124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6494274|NCT00618124|Growth Substances|growth substances|mesh-ancestor
6494275|NCT00618124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494276|NCT00618124|Growth Inhibitors|growth inhibitors|mesh-ancestor
6494277|NCT00618124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6494278|NCT00618124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6496454|NCT00628121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6496455|NCT00628160|Terlipressin|terlipressin|mesh-list
6496456|NCT00628160|Dopamine|dopamine|mesh-list
6496457|NCT00628160|Norepinephrine|norepinephrine|mesh-list
6496458|NCT00628160|Adrenergic Agents|adrenergic agents|mesh-list
6496459|NCT00628160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6496460|NCT00628160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6496461|NCT00628160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6496462|NCT00628160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496463|NCT00628160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496464|NCT00628160|Sympathomimetics|sympathomimetics|mesh-ancestor
6496465|NCT00628160|Autonomic Agents|autonomic agents|mesh-ancestor
6674826|NCT01571648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5852848|NCT00189293|Interferon Inducers|interferon inducers|mesh-ancestor
5852849|NCT00189267|Imiquimod|imiquimod|mesh-list
5852850|NCT00189267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5852851|NCT00189267|Immunologic Factors|immunologic factors|mesh-ancestor
5852852|NCT00189267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852853|NCT00189267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5852854|NCT00189267|Interferon Inducers|interferon inducers|mesh-ancestor
5852855|NCT00189254|Imiquimod|imiquimod|mesh-list
5852856|NCT00189254|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5852857|NCT00189254|Immunologic Factors|immunologic factors|mesh-ancestor
5852858|NCT00189254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852859|NCT00189254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5852860|NCT00189254|Interferon Inducers|interferon inducers|mesh-ancestor
5852861|NCT00189241|Imiquimod|imiquimod|mesh-list
5852862|NCT00189241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5852863|NCT00189241|Immunologic Factors|immunologic factors|mesh-ancestor
5852864|NCT00189241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852865|NCT00189241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5852866|NCT00189241|Interferon Inducers|interferon inducers|mesh-ancestor
5852867|NCT00070707|Mometasone Furoate|mometasone furoate|mesh-list
6674827|NCT01571687|Antioxidants|antioxidants|mesh-list
5669694|NCT03576040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669695|NCT03576001|Methyltestosterone|methyltestosterone|mesh-list
5669696|NCT03576001|Testosterone|testosterone|mesh-list
5669697|NCT03576001|Testosterone undecanoate|testosterone undecanoate|mesh-list
5669698|NCT03576001|Testosterone enanthate|testosterone enanthate|mesh-list
5669699|NCT03576001|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5669700|NCT03576001|Androgens|androgens|mesh-ancestor
5669701|NCT03576001|Hormones|hormones|mesh-ancestor
5669702|NCT03576001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5669703|NCT03576001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669704|NCT03576001|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5669705|NCT03576001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5669706|NCT03576001|Anabolic Agents|anabolic agents|mesh-ancestor
5669707|NCT03575949|Deoxyglucose|deoxyglucose|mesh-list
5669708|NCT03575949|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5669709|NCT03575949|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5669710|NCT03575949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669711|NCT03575949|Antimetabolites|antimetabolites|mesh-ancestor
5669712|NCT03575949|Antiviral Agents|antiviral agents|mesh-ancestor
5669713|NCT03575949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5669714|NCT03575780|Tirbanibulin|tirbanibulin|mesh-list
5669715|NCT03575780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5669716|NCT03575780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669717|NCT03575637|Olanzapine|olanzapine|mesh-list
5669718|NCT03575637|Antiemetics|antiemetics|mesh-ancestor
5669719|NCT03575637|Autonomic Agents|autonomic agents|mesh-ancestor
5852868|NCT00070707|Albuterol|albuterol|mesh-list
5852869|NCT00070707|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5852870|NCT00070707|Autonomic Agents|autonomic agents|mesh-ancestor
6494279|NCT00618163|Meloxicam|meloxicam|mesh-list
6494280|NCT00618163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6494281|NCT00618163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5669720|NCT03575637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5669721|NCT03575637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669722|NCT03575637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5669723|NCT03575637|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5669724|NCT03575637|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6494282|NCT00618163|Analgesics|analgesics|mesh-ancestor
6494283|NCT00618163|Sensory System Agents|sensory system agents|mesh-ancestor
6494284|NCT00618163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6494285|NCT00618163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674828|NCT01571687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669725|NCT03575637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5669726|NCT03575637|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5669727|NCT03575637|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5669728|NCT03575637|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5669729|NCT03575637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5669730|NCT03575637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669731|NCT03575637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5669732|NCT03575637|Serotonin Agents|serotonin agents|mesh-ancestor
5669733|NCT03575598|Nivolumab|nivolumab|mesh-list
5669734|NCT03575598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5669735|NCT03575598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5669736|NCT03575598|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5669737|NCT03575598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669738|NCT03575572|Colchicine|colchicine|mesh-list
5669739|NCT03575572|Gout Suppressants|gout suppressants|mesh-ancestor
5669740|NCT03575572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5669741|NCT03575572|Tubulin Modulators|tubulin modulators|mesh-ancestor
5669742|NCT03575572|Antimitotic Agents|antimitotic agents|mesh-ancestor
5669743|NCT03575572|Mitosis Modulators|mitosis modulators|mesh-ancestor
5669744|NCT03575572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669745|NCT03575572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5669746|NCT03575520|Cyclophosphamide|cyclophosphamide|mesh-list
5669747|NCT03575520|Doxorubicin|doxorubicin|mesh-list
6674829|NCT01571687|Protective Agents|protective agents|mesh-ancestor
6674830|NCT01571687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669748|NCT03575520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5669749|NCT03575520|Immunologic Factors|immunologic factors|mesh-ancestor
5669750|NCT03575520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669751|NCT03575520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5669752|NCT03575520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5669753|NCT03575520|Alkylating Agents|alkylating agents|mesh-ancestor
5669754|NCT03575520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669755|NCT03575520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5669756|NCT03575520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5669757|NCT03575520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5669758|NCT03575520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5669759|NCT03575520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5669760|NCT03575520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5669761|NCT03575325|Cytarabine|cytarabine|mesh-list
5669762|NCT03575325|Daunorubicin|daunorubicin|mesh-list
5669763|NCT03575325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5669764|NCT03575325|Antimetabolites|antimetabolites|mesh-ancestor
5669765|NCT03575325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669766|NCT03575325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5669767|NCT03575325|Antiviral Agents|antiviral agents|mesh-ancestor
5669768|NCT03575325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5669769|NCT03575325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5669770|NCT03575325|Immunologic Factors|immunologic factors|mesh-ancestor
5852871|NCT00070707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5852872|NCT00070707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852873|NCT00070707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5852874|NCT00070707|Respiratory System Agents|respiratory system agents|mesh-ancestor
5852875|NCT00070707|Tocolytic Agents|tocolytic agents|mesh-ancestor
5852876|NCT00070707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5852877|NCT00070707|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5852878|NCT00070707|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5852879|NCT00070707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5852880|NCT00070707|Adrenergic Agents|adrenergic agents|mesh-ancestor
6494286|NCT00618163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6494287|NCT00618163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6494288|NCT00618163|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6494289|NCT00618163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6494290|NCT00618163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6494291|NCT00618163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494292|NCT00618176|Lamivudine|lamivudine|mesh-list
6494293|NCT00618176|Zidovudine|zidovudine|mesh-list
6494294|NCT00618176|Nevirapine|nevirapine|mesh-list
6494295|NCT00618176|Stavudine|stavudine|mesh-list
6494296|NCT00618176|Didanosine|didanosine|mesh-list
6494297|NCT00618176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6494298|NCT00618176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6494299|NCT00618176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6494300|NCT00618176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494301|NCT00618176|Antiviral Agents|antiviral agents|mesh-ancestor
5852881|NCT00070707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5852882|NCT00070707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852883|NCT00070707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5852884|NCT00070707|Dermatologic Agents|dermatologic agents|mesh-ancestor
5669771|NCT03575325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669772|NCT03575325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5669773|NCT03575325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5669774|NCT03575325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5669775|NCT03575325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5669776|NCT03575312|Enrofloxacin|enrofloxacin|mesh-list
5669777|NCT03575312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5669778|NCT03575312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5669779|NCT03575247|Glucocorticoids|glucocorticoids|mesh-list
5669780|NCT03575247|Hormones|hormones|mesh-ancestor
5669781|NCT03575247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5669782|NCT03575247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852885|NCT00070707|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6494302|NCT00618176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6494303|NCT00618176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6494304|NCT00618176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6494305|NCT00618176|Antimetabolites|antimetabolites|mesh-ancestor
6494306|NCT00618176|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6494307|NCT00618176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6494308|NCT00618202|Balsalazide|balsalazide|mesh-list
6494309|NCT00618202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6494310|NCT00618202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6494311|NCT00618202|Analgesics|analgesics|mesh-ancestor
6494312|NCT00618202|Sensory System Agents|sensory system agents|mesh-ancestor
6674831|NCT01571791|Ketorolac|ketorolac|mesh-list
5852892|NCT02444169|Hyaluronic Acid|hyaluronic acid|mesh-list
5852893|NCT02444169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5852894|NCT02444169|Immunologic Factors|immunologic factors|mesh-ancestor
5852895|NCT02444169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852896|NCT02444169|Viscosupplements|viscosupplements|mesh-ancestor
5852897|NCT02444169|Protective Agents|protective agents|mesh-ancestor
5852898|NCT02444364|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5852899|NCT02444364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5852900|NCT02444364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852901|NCT02444364|Incretins|incretins|mesh-ancestor
5852902|NCT02444364|Hormones|hormones|mesh-ancestor
5852903|NCT02444364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5852904|NCT02444364|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5852905|NCT02444364|Protease Inhibitors|protease inhibitors|mesh-ancestor
5852906|NCT02444364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5852907|NCT02444364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852908|NCT02444351|Botulinum Toxins|botulinum toxins|mesh-list
5852909|NCT02444351|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5852910|NCT02444351|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5852911|NCT02444351|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5852912|NCT02444351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5852913|NCT02444351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494313|NCT00618202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6674832|NCT01571791|Lidocaine|lidocaine|mesh-list
5852914|NCT02444351|Cholinergic Agents|cholinergic agents|mesh-ancestor
5852915|NCT02444351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5852916|NCT02444351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852917|NCT02444351|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5852918|NCT02444351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5852919|NCT02444091|Cyclophosphamide|cyclophosphamide|mesh-list
5852920|NCT02444091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5852921|NCT02444091|Immunologic Factors|immunologic factors|mesh-ancestor
5852922|NCT02444091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852923|NCT02444091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5852924|NCT02444091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5852925|NCT02444091|Alkylating Agents|alkylating agents|mesh-ancestor
5852926|NCT02444091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852927|NCT02444091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5852928|NCT02444091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5852929|NCT02444260|Lidocaine|lidocaine|mesh-list
5852930|NCT02444260|Midazolam|midazolam|mesh-list
5852931|NCT02444260|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5852932|NCT02444260|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5852933|NCT02444260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5852934|NCT02444260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852935|NCT02444260|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5852936|NCT02444260|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5852937|NCT02444260|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5852938|NCT02444260|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5852939|NCT02444260|Anesthetics, General|anesthetics, general|mesh-ancestor
5852940|NCT02444260|Anesthetics|anesthetics|mesh-ancestor
5852941|NCT02444260|GABA Modulators|gaba modulators|mesh-ancestor
5852942|NCT02444260|GABA Agents|gaba agents|mesh-ancestor
5852943|NCT02444260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5852944|NCT02444260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852945|NCT02444260|Anesthetics, Local|anesthetics, local|mesh-ancestor
5852946|NCT02444260|Sensory System Agents|sensory system agents|mesh-ancestor
5852947|NCT02444260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5852948|NCT02444260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5852949|NCT02444260|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5852950|NCT02444260|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5852951|NCT02444260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5852952|NCT02443935|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
5852953|NCT02443935|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5852954|NCT02443935|Immunologic Factors|immunologic factors|mesh-ancestor
5852955|NCT02443935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852956|NCT02443727|Oxytocin|oxytocin|mesh-list
5852957|NCT02443727|Oxytocics|oxytocics|mesh-ancestor
5852958|NCT02443727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5852959|NCT02443727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852960|NCT02443818|Sirolimus|sirolimus|mesh-list
5852961|NCT02443818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5852962|NCT02443818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5852963|NCT02443818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5852964|NCT02443818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5852965|NCT02443818|Antifungal Agents|antifungal agents|mesh-ancestor
5852966|NCT02443818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5852967|NCT02443818|Immunologic Factors|immunologic factors|mesh-ancestor
5852968|NCT02443818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852969|NCT02444013|Folic Acid|folic acid|mesh-list
5852970|NCT02444013|Uric Acid|uric acid|mesh-list
5852971|NCT02444013|Hematinics|hematinics|mesh-ancestor
5852972|NCT02444013|Vitamin B Complex|vitamin b complex|mesh-ancestor
5852973|NCT02444013|Vitamins|vitamins|mesh-ancestor
5852974|NCT02444013|Micronutrients|micronutrients|mesh-ancestor
5852975|NCT02444013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852976|NCT02444013|Antioxidants|antioxidants|mesh-ancestor
6674833|NCT01571791|Anesthetics, Local|anesthetics, local|mesh-ancestor
6674834|NCT01571791|Anesthetics|anesthetics|mesh-ancestor
6674835|NCT01571791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6674836|NCT01571791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674837|NCT01571791|Sensory System Agents|sensory system agents|mesh-ancestor
6674838|NCT01571791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6674839|NCT01571791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6674840|NCT01571791|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5852977|NCT02444013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852978|NCT02444013|Protective Agents|protective agents|mesh-ancestor
5852979|NCT02443844|Tamsulosin|tamsulosin|mesh-list
5852980|NCT02443844|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6674841|NCT01571791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5669783|NCT03575234|Cyclophosphamide|cyclophosphamide|mesh-list
5669784|NCT03575234|Nivolumab|nivolumab|mesh-list
5669785|NCT03575234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6674842|NCT01571791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5852981|NCT02443844|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5852982|NCT02443844|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5852983|NCT02443844|Adrenergic Agents|adrenergic agents|mesh-ancestor
5852984|NCT02443844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5852985|NCT02443844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5852986|NCT02443844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852987|NCT02443844|Urological Agents|urological agents|mesh-ancestor
5852988|NCT02443922|Metformin|metformin|mesh-list
5852989|NCT02443922|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5852990|NCT02443922|Glimepiride|glimepiride|mesh-list
5852991|NCT02443922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5852992|NCT02443922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5852993|NCT02443922|Incretins|incretins|mesh-ancestor
5669786|NCT03575234|Immunologic Factors|immunologic factors|mesh-ancestor
5669787|NCT03575234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669788|NCT03575234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5669789|NCT03575234|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5852994|NCT02443922|Hormones|hormones|mesh-ancestor
5852995|NCT02443922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5852996|NCT02443922|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5852997|NCT02443922|Protease Inhibitors|protease inhibitors|mesh-ancestor
5852998|NCT02443922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5852999|NCT02443922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5853000|NCT02443922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5853001|NCT02443922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5853002|NCT02443922|Immunologic Factors|immunologic factors|mesh-ancestor
5853003|NCT02443714|Insulin|insulin|mesh-list
5853004|NCT02443714|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5853005|NCT02443714|Insulin Lispro|insulin lispro|mesh-list
5853006|NCT02443714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5853007|NCT02443714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853008|NCT02443623|Vaccines|vaccines|mesh-list
5853009|NCT02443623|Immunologic Factors|immunologic factors|mesh-ancestor
5853010|NCT02443623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853011|NCT02443831|Cyclophosphamide|cyclophosphamide|mesh-list
5853012|NCT02443831|Fludarabine|fludarabine|mesh-list
5853013|NCT02443831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5853014|NCT02443831|Immunologic Factors|immunologic factors|mesh-ancestor
5853015|NCT02443831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853016|NCT02443831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5853017|NCT02443831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5853018|NCT02443831|Alkylating Agents|alkylating agents|mesh-ancestor
5669790|NCT03575234|Alkylating Agents|alkylating agents|mesh-ancestor
5669791|NCT03575234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669792|NCT03575234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5669793|NCT03575234|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5669794|NCT03575234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5669795|NCT03575234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5669796|NCT03575195|Rifaximin|rifaximin|mesh-list
5669797|NCT03575195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5669798|NCT03575195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5669799|NCT03575195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5669800|NCT03575130|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5669801|NCT03575130|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5669802|NCT03575078|Olaparib|olaparib|mesh-list
5669803|NCT03575078|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5669804|NCT03575078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5669805|NCT03575078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669806|NCT03575078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5669807|NCT03575013|Docetaxel|docetaxel|mesh-list
5669808|NCT03575013|Avelumab|avelumab|mesh-list
5853019|NCT02443831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5853020|NCT02443831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5853021|NCT02443831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5853022|NCT02443545|Deferiprone|deferiprone|mesh-list
6674843|NCT01571791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669809|NCT03575013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5669810|NCT03575013|Tubulin Modulators|tubulin modulators|mesh-ancestor
5669811|NCT03575013|Antimitotic Agents|antimitotic agents|mesh-ancestor
5669812|NCT03575013|Mitosis Modulators|mitosis modulators|mesh-ancestor
5695925|NCT03386630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5853023|NCT02443545|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5853024|NCT02443545|Chelating Agents|chelating agents|mesh-ancestor
5853025|NCT02443545|Sequestering Agents|sequestering agents|mesh-ancestor
5853026|NCT02443545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5853027|NCT02443285|Ceftriaxone|ceftriaxone|mesh-list
5853028|NCT02443285|Cefotaxime|cefotaxime|mesh-list
5853029|NCT02443285|Cefoxitin|cefoxitin|mesh-list
5853030|NCT02443285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5853031|NCT02443285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5904060|NCT03171805|Propranolol|propranolol|mesh-list
5904061|NCT03171805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5904062|NCT03171805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5904063|NCT03171805|Adrenergic Agents|adrenergic agents|mesh-ancestor
5904064|NCT03171805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5904065|NCT03171805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904066|NCT03171805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904067|NCT03171805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5904068|NCT03171805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5904069|NCT03171805|Vasodilator Agents|vasodilator agents|mesh-ancestor
5669813|NCT03575013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669814|NCT03575013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5669815|NCT03575000|Bromocriptine|bromocriptine|mesh-list
5904070|NCT03107416|Bumetanide|bumetanide|mesh-list
5904071|NCT03107416|Diuretics|diuretics|mesh-ancestor
5904072|NCT03107416|Natriuretic Agents|natriuretic agents|mesh-ancestor
5904073|NCT03107416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904074|NCT03107416|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5904075|NCT03107416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5904076|NCT03107416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904077|NCT03094234|Propranolol|propranolol|mesh-list
5904078|NCT03094234|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5904079|NCT03094234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5904080|NCT03094234|Adrenergic Agents|adrenergic agents|mesh-ancestor
5904081|NCT03094234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5904082|NCT03094234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904083|NCT03094234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904084|NCT03094234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5904085|NCT03094234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5904086|NCT03094234|Vasodilator Agents|vasodilator agents|mesh-ancestor
5904087|NCT03042468|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5669816|NCT03575000|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5669817|NCT03575000|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5669818|NCT03575000|Hormone Antagonists|hormone antagonists|mesh-ancestor
5669819|NCT03575000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5669820|NCT03575000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669821|NCT03575000|Dopamine Agonists|dopamine agonists|mesh-ancestor
5669822|NCT03575000|Dopamine Agents|dopamine agents|mesh-ancestor
5669823|NCT03575000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5669824|NCT03575000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904088|NCT03042468|177Lu-PSMA-617|177lu-psma-617|mesh-list
5904089|NCT03042468|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5904090|NCT03042468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904091|NCT03034564|Droxidopa|droxidopa|mesh-list
5904092|NCT03034564|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5904093|NCT03034564|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5904094|NCT03034538|Zonisamide|zonisamide|mesh-list
5904095|NCT03034538|Anticonvulsants|anticonvulsants|mesh-ancestor
5904096|NCT03034538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5904097|NCT03034538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5904098|NCT03034538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904099|NCT03034538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5904100|NCT03034538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904101|NCT02918162|Pembrolizumab|pembrolizumab|mesh-list
5904102|NCT02918162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5904103|NCT02918162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5904104|NCT02819518|Gemcitabine|gemcitabine|mesh-list
5904105|NCT02819518|Paclitaxel|paclitaxel|mesh-list
5669825|NCT03574909|Aspirin|aspirin|mesh-list
5669826|NCT03574909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5669827|NCT03574909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5904106|NCT02819518|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5904107|NCT02819518|Carboplatin|carboplatin|mesh-list
5904108|NCT02819518|Pembrolizumab|pembrolizumab|mesh-list
5904109|NCT02819518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5853032|NCT02443246|Vitamin D|vitamin d|mesh-list
5853033|NCT02443246|Cholecalciferol|cholecalciferol|mesh-list
5853034|NCT02443246|Vitamins|vitamins|mesh-ancestor
5853035|NCT02443246|Micronutrients|micronutrients|mesh-ancestor
5853036|NCT02443246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853037|NCT02443246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5853038|NCT02443246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5853039|NCT02443311|Betamethasone|betamethasone|mesh-list
5853040|NCT02443311|Betamethasone Valerate|betamethasone valerate|mesh-list
5853041|NCT02443311|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5853042|NCT02443311|Betamethasone benzoate|betamethasone benzoate|mesh-list
5853043|NCT02443311|Pimecrolimus|pimecrolimus|mesh-list
5853044|NCT02443311|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
5853045|NCT02443311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5853046|NCT02443311|Glucocorticoids|glucocorticoids|mesh-ancestor
5853047|NCT02443311|Hormones|hormones|mesh-ancestor
5853048|NCT02443311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5853049|NCT02443311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853050|NCT02443311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5853051|NCT02443311|Respiratory System Agents|respiratory system agents|mesh-ancestor
5853052|NCT02443311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5853053|NCT02443311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5853054|NCT02443311|Analgesics|analgesics|mesh-ancestor
5853055|NCT02443311|Sensory System Agents|sensory system agents|mesh-ancestor
5853056|NCT02443311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5853057|NCT02443311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5853058|NCT02443311|Dermatologic Agents|dermatologic agents|mesh-ancestor
5853059|NCT02443311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5853060|NCT02443311|Immunologic Factors|immunologic factors|mesh-ancestor
5853061|NCT02443311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5853062|NCT02443311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5853063|NCT02443311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5853064|NCT02443194|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5853065|NCT02443194|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5669828|NCT03574909|Analgesics|analgesics|mesh-ancestor
5669829|NCT03574909|Sensory System Agents|sensory system agents|mesh-ancestor
5669830|NCT03574909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5669831|NCT03574909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669832|NCT03574909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5669833|NCT03574909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5669834|NCT03574909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5669835|NCT03574909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5669836|NCT03574909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5853066|NCT02443194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5853067|NCT02443194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5853068|NCT02443194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5853069|NCT02443194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5853070|NCT02443194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853071|NCT02443194|Analgesics|analgesics|mesh-ancestor
5853072|NCT02443194|Sensory System Agents|sensory system agents|mesh-ancestor
6494314|NCT00618202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494315|NCT00618202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6494316|NCT00618202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6494317|NCT00618202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6494318|NCT00618228|Balsalazide|balsalazide|mesh-list
6494319|NCT00618228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5669837|NCT03574909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5669838|NCT03574909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5669839|NCT03574909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5669840|NCT03574909|Antipyretics|antipyretics|mesh-ancestor
5669841|NCT03574857|Metolazone|metolazone|mesh-list
5669842|NCT03574857|Chlorothiazide|chlorothiazide|mesh-list
5669843|NCT03574857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5669844|NCT03574857|Diuretics|diuretics|mesh-ancestor
5669845|NCT03574857|Natriuretic Agents|natriuretic agents|mesh-ancestor
5669846|NCT03574857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669847|NCT03574857|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5669848|NCT03574857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5669849|NCT03574857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494320|NCT00618228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6494321|NCT00618228|Analgesics|analgesics|mesh-ancestor
6494322|NCT00618228|Sensory System Agents|sensory system agents|mesh-ancestor
6494323|NCT00618228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5853073|NCT02443194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5853074|NCT02443194|Antidepressive Agents|antidepressive agents|mesh-ancestor
5853075|NCT02443194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5853076|NCT02443194|Dopamine Agents|dopamine agents|mesh-ancestor
5853077|NCT02443012|Nepafenac|nepafenac|mesh-list
5853078|NCT02443012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5853079|NCT02443012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5853080|NCT02443012|Analgesics|analgesics|mesh-ancestor
5853081|NCT02443012|Sensory System Agents|sensory system agents|mesh-ancestor
5853082|NCT02443012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5853083|NCT02443012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853084|NCT02443012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5853085|NCT02443012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5853086|NCT02443064|Vancomycin|vancomycin|mesh-list
5853087|NCT02443064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5853088|NCT02443064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5853089|NCT02443142|Acetaminophen|acetaminophen|mesh-list
5853090|NCT02443142|Ibuprofen|ibuprofen|mesh-list
5853091|NCT02443142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5853092|NCT02443142|Analgesics|analgesics|mesh-ancestor
5853093|NCT02443142|Sensory System Agents|sensory system agents|mesh-ancestor
5853094|NCT02443142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5853095|NCT02443142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853096|NCT02443142|Antipyretics|antipyretics|mesh-ancestor
5853097|NCT02443142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6494324|NCT00618228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494325|NCT00618228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6494326|NCT00618228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6494327|NCT00618228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6494328|NCT00618241|Raltegravir Potassium|raltegravir potassium|mesh-list
6494329|NCT00618241|Lamotrigine|lamotrigine|mesh-list
6494330|NCT00618241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5669850|NCT03574779|Bevacizumab|bevacizumab|mesh-list
5669851|NCT03574779|Niraparib|niraparib|mesh-list
5853098|NCT02443142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5853099|NCT02443142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5853100|NCT02443142|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5853101|NCT02443142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5853102|NCT02443142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5853103|NCT02442921|Colchicine|colchicine|mesh-list
5853104|NCT02442921|Gout Suppressants|gout suppressants|mesh-ancestor
5853105|NCT02442921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5853106|NCT02442921|Tubulin Modulators|tubulin modulators|mesh-ancestor
5853107|NCT02442921|Antimitotic Agents|antimitotic agents|mesh-ancestor
5853108|NCT02442921|Mitosis Modulators|mitosis modulators|mesh-ancestor
5853109|NCT02442921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5853110|NCT02442921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5853111|NCT02442791|Exenatide|exenatide|mesh-list
5853112|NCT02442791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5853113|NCT02442791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853114|NCT02442791|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5853115|NCT02442791|Incretins|incretins|mesh-ancestor
5853116|NCT02442791|Hormones|hormones|mesh-ancestor
5669852|NCT03574779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5669853|NCT03574779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5669854|NCT03574779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5853117|NCT02442791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5853118|NCT02442713|Fluvoxamine|fluvoxamine|mesh-list
5853119|NCT02442713|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5853120|NCT02442713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5853121|NCT02442713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5853122|NCT02442713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853123|NCT02442713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6494331|NCT00618241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5669855|NCT03574779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5669856|NCT03574779|Growth Substances|growth substances|mesh-ancestor
5669857|NCT03574779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669858|NCT03574779|Growth Inhibitors|growth inhibitors|mesh-ancestor
5669859|NCT03574779|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5669860|NCT03574779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5669861|NCT03574779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669862|NCT03574701|Vitamin A|vitamin a|mesh-list
5669863|NCT03574701|Vitamins|vitamins|mesh-ancestor
5669864|NCT03574701|Micronutrients|micronutrients|mesh-ancestor
5669865|NCT03574701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695926|NCT03386630|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5853124|NCT02442713|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5853125|NCT02442713|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5853126|NCT02442713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5853127|NCT02442713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669866|NCT03574649|Paclitaxel|paclitaxel|mesh-list
5669867|NCT03574649|Docetaxel|docetaxel|mesh-list
5669868|NCT03574649|Cyclophosphamide|cyclophosphamide|mesh-list
5669869|NCT03574649|Carboplatin|carboplatin|mesh-list
5669870|NCT03574649|Fluorouracil|fluorouracil|mesh-list
5669871|NCT03574649|Avelumab|avelumab|mesh-list
5669872|NCT03574649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5669873|NCT03574649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5669874|NCT03574649|Tubulin Modulators|tubulin modulators|mesh-ancestor
5669875|NCT03574649|Antimitotic Agents|antimitotic agents|mesh-ancestor
5669876|NCT03574649|Mitosis Modulators|mitosis modulators|mesh-ancestor
5669877|NCT03574649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669878|NCT03574649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5669879|NCT03574649|Immunologic Factors|immunologic factors|mesh-ancestor
5669880|NCT03574649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669881|NCT03574649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5669882|NCT03574649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5669883|NCT03574649|Alkylating Agents|alkylating agents|mesh-ancestor
5669884|NCT03574649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5669885|NCT03574649|Antimetabolites|antimetabolites|mesh-ancestor
5669886|NCT03574649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5669887|NCT03574649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5669888|NCT03574402|Gemcitabine|gemcitabine|mesh-list
5669889|NCT03574402|Carboplatin|carboplatin|mesh-list
5669890|NCT03574402|Pemetrexed|pemetrexed|mesh-list
5669891|NCT03574402|Afatinib|afatinib|mesh-list
5669892|NCT03574402|Crizotinib|crizotinib|mesh-list
5669893|NCT03574402|Nimotuzumab|nimotuzumab|mesh-list
5853128|NCT02442713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5853129|NCT02442713|Serotonin Agents|serotonin agents|mesh-ancestor
5853130|NCT02442713|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5853131|NCT02442713|Antidepressive Agents|antidepressive agents|mesh-ancestor
5853132|NCT02442713|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5853133|NCT02442713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5853134|NCT02442713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5853135|NCT02442713|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5853136|NCT02442817|Linagliptin|linagliptin|mesh-list
5853137|NCT02442817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5853138|NCT02442817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853139|NCT02442817|Incretins|incretins|mesh-ancestor
5853140|NCT02442817|Hormones|hormones|mesh-ancestor
5853141|NCT02442817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5853142|NCT02442817|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5669894|NCT03574402|Ensartinib|ensartinib|mesh-list
5669895|NCT03574402|Maleic acid|maleic acid|mesh-list
5669896|NCT03574402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5669897|NCT03574402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5669898|NCT03574402|Antimetabolites|antimetabolites|mesh-ancestor
5669899|NCT03574402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669900|NCT03574402|Antiviral Agents|antiviral agents|mesh-ancestor
5669901|NCT03574402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5669902|NCT03574402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5669903|NCT03574402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5669904|NCT03574402|Immunologic Factors|immunologic factors|mesh-ancestor
5669905|NCT03574402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669906|NCT03574402|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5669907|NCT03574402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5669908|NCT03574402|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5669909|NCT03574402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5669910|NCT03574376|Bupivacaine|bupivacaine|mesh-list
5669911|NCT03574376|Anesthetics, Local|anesthetics, local|mesh-ancestor
5669912|NCT03574376|Anesthetics|anesthetics|mesh-ancestor
5669913|NCT03574376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5853143|NCT02442817|Protease Inhibitors|protease inhibitors|mesh-ancestor
5853144|NCT02442817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5853145|NCT02442817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5853146|NCT02442674|Tolvaptan|tolvaptan|mesh-list
5669914|NCT03574376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669915|NCT03574376|Sensory System Agents|sensory system agents|mesh-ancestor
5669916|NCT03574376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5669917|NCT03574285|Sarpogrelate|sarpogrelate|mesh-list
5669918|NCT03574285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5669919|NCT03574285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5669920|NCT03574285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669921|NCT03574285|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5669922|NCT03574285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5669923|NCT03574285|Serotonin Agents|serotonin agents|mesh-ancestor
5669924|NCT03574285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5669925|NCT03574285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669926|NCT03574246|Chlorhexidine|chlorhexidine|mesh-list
5669927|NCT03574246|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5669928|NCT03574246|Benzydamine|benzydamine|mesh-list
5853147|NCT02442674|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
5853148|NCT02442674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5853149|NCT02442674|Natriuretic Agents|natriuretic agents|mesh-ancestor
5669929|NCT03574246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5669930|NCT03574246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5669931|NCT03574246|Disinfectants|disinfectants|mesh-ancestor
5853150|NCT02442674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853151|NCT02442648|Rituximab|rituximab|mesh-list
5853152|NCT02442648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5853153|NCT02442648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5853154|NCT02442648|Immunologic Factors|immunologic factors|mesh-ancestor
5853155|NCT02442648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853156|NCT02442648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5853157|NCT02442752|Dexlansoprazole|dexlansoprazole|mesh-list
5853158|NCT02442752|Lansoprazole|lansoprazole|mesh-list
5853159|NCT02442752|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5853160|NCT02442752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5853161|NCT02442752|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5853162|NCT02442752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5853163|NCT02442752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5853164|NCT02442362|Paclitaxel|paclitaxel|mesh-list
5669932|NCT03574246|Dermatologic Agents|dermatologic agents|mesh-ancestor
5669933|NCT03574246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5669934|NCT03574220|Pembrolizumab|pembrolizumab|mesh-list
5669935|NCT03574220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5669936|NCT03574220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5669937|NCT03574090|Amoxicillin|amoxicillin|mesh-list
5669938|NCT03574090|Clavulanic Acid|clavulanic acid|mesh-list
5669939|NCT03574090|Clavulanic Acids|clavulanic acids|mesh-list
5669940|NCT03574090|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5669941|NCT03574090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5669942|NCT03574090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5669943|NCT03574090|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5669944|NCT03574090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5669945|NCT03574090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669946|NCT03574064|Glucagon|glucagon|mesh-list
5669947|NCT03574064|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
5669948|NCT03574064|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5669949|NCT03574064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5669950|NCT03574064|Hormones|hormones|mesh-ancestor
5669951|NCT03574064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5669952|NCT03574064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853165|NCT02442362|Fluorouracil|fluorouracil|mesh-list
5853166|NCT02442362|Oxaliplatin|oxaliplatin|mesh-list
5853167|NCT02442362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5853168|NCT02442362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5853169|NCT02442362|Tubulin Modulators|tubulin modulators|mesh-ancestor
5853170|NCT02442362|Antimitotic Agents|antimitotic agents|mesh-ancestor
5853171|NCT02442362|Mitosis Modulators|mitosis modulators|mesh-ancestor
5853172|NCT02442362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5853173|NCT02442362|Antimetabolites|antimetabolites|mesh-ancestor
5853174|NCT02442362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5853175|NCT02442362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5853176|NCT02442362|Immunologic Factors|immunologic factors|mesh-ancestor
5853177|NCT02442362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853178|NCT02442739|Ketamine|ketamine|mesh-list
5853179|NCT02442739|Analgesics|analgesics|mesh-ancestor
5853180|NCT02442739|Sensory System Agents|sensory system agents|mesh-ancestor
5853181|NCT02442739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5853182|NCT02442739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853183|NCT02442739|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5853184|NCT02442739|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5853185|NCT02442739|Anesthetics, General|anesthetics, general|mesh-ancestor
5669953|NCT03574064|Incretins|incretins|mesh-ancestor
5853186|NCT02442739|Anesthetics|anesthetics|mesh-ancestor
5853187|NCT02442739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5669954|NCT03573999|Mannitol|mannitol|mesh-list
5669955|NCT03573999|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5669956|NCT03573999|Diuretics|diuretics|mesh-ancestor
5669957|NCT03573999|Natriuretic Agents|natriuretic agents|mesh-ancestor
5669958|NCT03573999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669959|NCT03573986|Bevacizumab|bevacizumab|mesh-list
5669960|NCT03573986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5669961|NCT03573986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5669962|NCT03573986|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5669963|NCT03573986|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5669964|NCT03573986|Growth Substances|growth substances|mesh-ancestor
5669965|NCT03573986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669966|NCT03573986|Growth Inhibitors|growth inhibitors|mesh-ancestor
5669967|NCT03573947|Paclitaxel|paclitaxel|mesh-list
5669968|NCT03573947|Nivolumab|nivolumab|mesh-list
5669969|NCT03573947|Ipilimumab|ipilimumab|mesh-list
5853188|NCT02442739|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5853189|NCT02442739|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5853190|NCT02442739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5853191|NCT02442739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5853192|NCT02442453|Turmeric extract|turmeric extract|mesh-list
5853193|NCT02442453|Antioxidants|antioxidants|mesh-ancestor
5853194|NCT02442453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5853195|NCT02442453|Protective Agents|protective agents|mesh-ancestor
5853196|NCT02442453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853197|NCT02442531|Docetaxel|docetaxel|mesh-list
5853198|NCT02442531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5853199|NCT02442531|Tubulin Modulators|tubulin modulators|mesh-ancestor
5853200|NCT02442531|Antimitotic Agents|antimitotic agents|mesh-ancestor
5853201|NCT02442531|Mitosis Modulators|mitosis modulators|mesh-ancestor
5853202|NCT02442531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5853203|NCT02442466|BQ 788|bq 788|mesh-list
5853204|NCT02442466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5853205|NCT02442466|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
5853206|NCT02442466|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5853207|NCT02442466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5853208|NCT02442440|Anisodamine|anisodamine|mesh-list
5853209|NCT02442440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5853210|NCT02442440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5853211|NCT02442440|Adrenergic Agents|adrenergic agents|mesh-ancestor
5853212|NCT02442440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5853213|NCT02442440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5853214|NCT02442440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853215|NCT02442440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5853216|NCT02442440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5853217|NCT02442440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5853218|NCT02442440|Analgesics|analgesics|mesh-ancestor
5853219|NCT02442440|Sensory System Agents|sensory system agents|mesh-ancestor
5853220|NCT02442440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5853221|NCT02442440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5853222|NCT02442440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5853223|NCT02442440|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5853224|NCT02442440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5853225|NCT02442440|Parasympatholytics|parasympatholytics|mesh-ancestor
5853226|NCT02442440|Autonomic Agents|autonomic agents|mesh-ancestor
5853227|NCT02442440|Vasodilator Agents|vasodilator agents|mesh-ancestor
5853228|NCT02442440|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5853229|NCT02442440|Antioxidants|antioxidants|mesh-ancestor
5853230|NCT02442440|Protective Agents|protective agents|mesh-ancestor
5853231|NCT02442492|Sildenafil Citrate|sildenafil citrate|mesh-list
5853232|NCT02442492|Vasodilator Agents|vasodilator agents|mesh-ancestor
5853233|NCT02442492|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5853234|NCT02442492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5853235|NCT02442492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5853236|NCT02442492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5853237|NCT02442492|Urological Agents|urological agents|mesh-ancestor
5853238|NCT02442063|Paclitaxel|paclitaxel|mesh-list
5853239|NCT02442063|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
5853240|NCT02442063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5853241|NCT02442063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5853242|NCT02442063|Tubulin Modulators|tubulin modulators|mesh-ancestor
5669970|NCT03573947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5669971|NCT03573947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5853243|NCT02442063|Antimitotic Agents|antimitotic agents|mesh-ancestor
5853244|NCT02442063|Mitosis Modulators|mitosis modulators|mesh-ancestor
5853245|NCT02442063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5853246|NCT02442427|Palivizumab|palivizumab|mesh-list
5853247|NCT02442427|Antiviral Agents|antiviral agents|mesh-ancestor
5853248|NCT02442427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5853249|NCT02442180|Methylprednisolone|methylprednisolone|mesh-list
5853250|NCT02442180|Prednisolone|prednisolone|mesh-list
5853251|NCT02442180|Lenograstim|lenograstim|mesh-list
5853252|NCT02442180|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5853253|NCT02442180|Immunologic Factors|immunologic factors|mesh-ancestor
5853254|NCT02442180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853255|NCT02442180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5853256|NCT02442180|Antiemetics|antiemetics|mesh-ancestor
5853257|NCT02442180|Autonomic Agents|autonomic agents|mesh-ancestor
5853258|NCT02442180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5853259|NCT02442180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5853260|NCT02442180|Glucocorticoids|glucocorticoids|mesh-ancestor
5853261|NCT02442180|Hormones|hormones|mesh-ancestor
5853262|NCT02442180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5853263|NCT02442180|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5853264|NCT02442180|Protective Agents|protective agents|mesh-ancestor
5669972|NCT03573947|Tubulin Modulators|tubulin modulators|mesh-ancestor
5669973|NCT03573947|Antimitotic Agents|antimitotic agents|mesh-ancestor
5669974|NCT03573947|Mitosis Modulators|mitosis modulators|mesh-ancestor
5669975|NCT03573947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669976|NCT03573947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5669977|NCT03573947|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5669978|NCT03573934|Glucagon|glucagon|mesh-list
5669979|NCT03573934|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5669980|NCT03573934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6674844|NCT01571791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6674845|NCT01571791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6674846|NCT01571791|Analgesics|analgesics|mesh-ancestor
6674847|NCT01571791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5669981|NCT03573934|Hormones|hormones|mesh-ancestor
5669982|NCT03573934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5853265|NCT02442180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5853266|NCT02442180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5853267|NCT02442128|Fentanyl|fentanyl|mesh-list
5853268|NCT02442128|Propofol|propofol|mesh-list
5853269|NCT02442128|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5853270|NCT02442128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5853271|NCT02442128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853272|NCT02442128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5853273|NCT02442128|Anesthetics, General|anesthetics, general|mesh-ancestor
5853274|NCT02442128|Anesthetics|anesthetics|mesh-ancestor
5853275|NCT02442128|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5853276|NCT02442128|Narcotics|narcotics|mesh-ancestor
5853277|NCT02442128|Analgesics|analgesics|mesh-ancestor
5853278|NCT02442128|Sensory System Agents|sensory system agents|mesh-ancestor
5853279|NCT02442128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5853280|NCT02442128|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5853281|NCT02441933|Carboplatin|carboplatin|mesh-list
5853282|NCT02441933|Taxane|taxane|mesh-list
5853283|NCT02441933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5853284|NCT02441907|Aflibercept|aflibercept|mesh-list
5853285|NCT02441907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5853286|NCT02441907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5853287|NCT02441907|Growth Substances|growth substances|mesh-ancestor
5853288|NCT02441907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853289|NCT02441907|Growth Inhibitors|growth inhibitors|mesh-ancestor
5853290|NCT02441907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5853291|NCT02441842|Atenolol|atenolol|mesh-list
5853292|NCT02441842|Lisinopril|lisinopril|mesh-list
5853293|NCT02441842|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5853294|NCT02441842|Protease Inhibitors|protease inhibitors|mesh-ancestor
5853295|NCT02441842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5853296|NCT02441842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5853297|NCT02441842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5853298|NCT02441842|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5853299|NCT02441842|Protective Agents|protective agents|mesh-ancestor
5853300|NCT02441842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853301|NCT02441842|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5853302|NCT02441842|Sympatholytics|sympatholytics|mesh-ancestor
5853303|NCT02441842|Autonomic Agents|autonomic agents|mesh-ancestor
6674848|NCT01571791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5853304|NCT02441842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5853305|NCT02441842|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5853306|NCT02441842|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5853307|NCT02441842|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5853308|NCT02441842|Adrenergic Agents|adrenergic agents|mesh-ancestor
5853309|NCT02441842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5853310|NCT02441894|Diphenhydramine|diphenhydramine|mesh-list
5853311|NCT02441894|Promethazine|promethazine|mesh-list
5853312|NCT02441894|Dexamethasone|dexamethasone|mesh-list
5853313|NCT02441894|Prednisolone|prednisolone|mesh-list
5853314|NCT02441894|Ondansetron|ondansetron|mesh-list
5853315|NCT02441894|Metoclopramide|metoclopramide|mesh-list
5853316|NCT02441894|Granisetron|granisetron|mesh-list
5853317|NCT02441894|Ranitidine|ranitidine|mesh-list
5853318|NCT02441894|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
5853319|NCT02441894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5853320|NCT02441894|Antiemetics|antiemetics|mesh-ancestor
5853321|NCT02441894|Autonomic Agents|autonomic agents|mesh-ancestor
5853322|NCT02441894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6494332|NCT00618241|Antiviral Agents|antiviral agents|mesh-ancestor
6494333|NCT00618241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5853323|NCT02441894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853324|NCT02441894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5853325|NCT02441894|Glucocorticoids|glucocorticoids|mesh-ancestor
5853326|NCT02441894|Hormones|hormones|mesh-ancestor
5853327|NCT02441894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5853328|NCT02441894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5853329|NCT02441894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5853330|NCT02441894|Antipruritics|antipruritics|mesh-ancestor
5853331|NCT02441894|Dermatologic Agents|dermatologic agents|mesh-ancestor
5853332|NCT02441894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5853333|NCT02441894|Serotonin Agents|serotonin agents|mesh-ancestor
5853334|NCT02441894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5853335|NCT02441894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5853336|NCT02441894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5853337|NCT02441894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5853338|NCT02441894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5853339|NCT02441894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5853340|NCT02441894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5853341|NCT02441894|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5853342|NCT02441894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5853343|NCT02441894|Anesthetics, Local|anesthetics, local|mesh-ancestor
5853344|NCT02441894|Anesthetics|anesthetics|mesh-ancestor
5853345|NCT02441894|Sensory System Agents|sensory system agents|mesh-ancestor
5853346|NCT02441894|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5853347|NCT02441894|Histamine Antagonists|histamine antagonists|mesh-ancestor
5853348|NCT02441894|Histamine Agents|histamine agents|mesh-ancestor
5853349|NCT02441894|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5853350|NCT02441894|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5853351|NCT02441894|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5853352|NCT02441894|Dopamine Agents|dopamine agents|mesh-ancestor
5853353|NCT02441894|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5853354|NCT02441894|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5904110|NCT02819518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5904111|NCT02819518|Tubulin Modulators|tubulin modulators|mesh-ancestor
5904112|NCT02819518|Antimitotic Agents|antimitotic agents|mesh-ancestor
5904113|NCT02819518|Mitosis Modulators|mitosis modulators|mesh-ancestor
5904114|NCT02819518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904115|NCT02819518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5904116|NCT02819518|Antimetabolites|antimetabolites|mesh-ancestor
5904117|NCT02819518|Antiviral Agents|antiviral agents|mesh-ancestor
5904118|NCT02819518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5904119|NCT02819518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5904120|NCT02819518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5904121|NCT02819518|Immunologic Factors|immunologic factors|mesh-ancestor
5904122|NCT02819518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904123|NCT02819518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5904124|NCT02549833|Poly I-C|poly i-c|mesh-list
5904125|NCT02549833|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
5904126|NCT02549833|Poly ICLC|poly iclc|mesh-list
5904127|NCT02549833|Interferon Inducers|interferon inducers|mesh-ancestor
5904128|NCT02549833|Immunologic Factors|immunologic factors|mesh-ancestor
6494334|NCT00618241|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6494335|NCT00618241|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6494336|NCT00618241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6494337|NCT00618241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494338|NCT00618241|Anticonvulsants|anticonvulsants|mesh-ancestor
5853355|NCT02441660|Capsaicin|capsaicin|mesh-list
5853356|NCT02441660|Antipruritics|antipruritics|mesh-ancestor
5853357|NCT02441660|Dermatologic Agents|dermatologic agents|mesh-ancestor
5853358|NCT02441660|Sensory System Agents|sensory system agents|mesh-ancestor
5853359|NCT02441660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5853360|NCT02441660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853361|NCT02441673|Ephedrine|ephedrine|mesh-list
5853362|NCT02441673|Meperidine|meperidine|mesh-list
5853363|NCT02441673|Tramadol|tramadol|mesh-list
5853364|NCT02441673|Nefopam|nefopam|mesh-list
5853365|NCT02441673|Metoclopramide|metoclopramide|mesh-list
5853366|NCT02441673|Ranitidine|ranitidine|mesh-list
5853367|NCT02441673|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
5853368|NCT02441673|Oxytocin|oxytocin|mesh-list
5853369|NCT02441673|Oxytocics|oxytocics|mesh-ancestor
5853370|NCT02441673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5853371|NCT02441673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853372|NCT02441673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5853373|NCT02441673|Narcotics|narcotics|mesh-ancestor
5853374|NCT02441673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5853375|NCT02441673|Analgesics|analgesics|mesh-ancestor
5853376|NCT02441673|Sensory System Agents|sensory system agents|mesh-ancestor
5853377|NCT02441673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5853378|NCT02441673|Antiemetics|antiemetics|mesh-ancestor
5853379|NCT02441673|Autonomic Agents|autonomic agents|mesh-ancestor
5853380|NCT02441673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5853381|NCT02441673|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5853382|NCT02441673|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5853383|NCT02441673|Dopamine Agents|dopamine agents|mesh-ancestor
5853384|NCT02441673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5853385|NCT02441673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5853386|NCT02441673|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5669983|NCT03573934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669984|NCT03573934|Incretins|incretins|mesh-ancestor
5669985|NCT03573921|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5695927|NCT03386630|Narcotics|narcotics|mesh-ancestor
5695928|NCT03386630|Analgesics|analgesics|mesh-ancestor
5695929|NCT03386630|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5695930|NCT03386630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5695931|NCT03386630|Anesthetics, General|anesthetics, general|mesh-ancestor
5695932|NCT03386591|Naloxone|naloxone|mesh-list
5695933|NCT03386591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5695934|NCT03386591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695935|NCT03386591|Sensory System Agents|sensory system agents|mesh-ancestor
5695936|NCT03386591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5695937|NCT03386565|Lidocaine|lidocaine|mesh-list
5695938|NCT03386565|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5695939|NCT03386565|Anesthetics, Local|anesthetics, local|mesh-ancestor
5695940|NCT03386565|Anesthetics|anesthetics|mesh-ancestor
5695941|NCT03386565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5695942|NCT03386565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695943|NCT03386565|Sensory System Agents|sensory system agents|mesh-ancestor
5695944|NCT03386565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5695945|NCT03386565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5695946|NCT03386565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5695947|NCT03386565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5695948|NCT03386565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5695949|NCT03386565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695950|NCT03386539|Mycophenolic Acid|mycophenolic acid|mesh-list
5695951|NCT03386539|Everolimus|everolimus|mesh-list
5695952|NCT03386539|Tacrolimus|tacrolimus|mesh-list
5853387|NCT02441673|Sympathomimetics|sympathomimetics|mesh-ancestor
5853388|NCT02441673|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5853389|NCT02441673|Adrenergic Agents|adrenergic agents|mesh-ancestor
5853390|NCT02441673|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5853391|NCT02441673|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5853392|NCT02441673|Histamine Antagonists|histamine antagonists|mesh-ancestor
5853393|NCT02441673|Histamine Agents|histamine agents|mesh-ancestor
5853394|NCT02441673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5853395|NCT02441673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5853396|NCT02441803|Cytarabine|cytarabine|mesh-list
5853397|NCT02441803|Mycophenolic Acid|mycophenolic acid|mesh-list
5853398|NCT02441803|Cyclophosphamide|cyclophosphamide|mesh-list
5853399|NCT02441803|Busulfan|busulfan|mesh-list
5853400|NCT02441803|Fludarabine|fludarabine|mesh-list
5853401|NCT02441803|Fludarabine phosphate|fludarabine phosphate|mesh-list
5695953|NCT03386539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5853402|NCT02441803|Decitabine|decitabine|mesh-list
5853403|NCT02441803|Idarubicin|idarubicin|mesh-list
5853404|NCT02441803|Clofarabine|clofarabine|mesh-list
5853405|NCT02441803|Tacrolimus|tacrolimus|mesh-list
5853406|NCT02441803|Thymoglobulin|thymoglobulin|mesh-list
5853407|NCT02441803|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5853408|NCT02441803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5853409|NCT02441803|Immunologic Factors|immunologic factors|mesh-ancestor
5853410|NCT02441803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853411|NCT02441803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5853412|NCT02441803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5853413|NCT02441803|Alkylating Agents|alkylating agents|mesh-ancestor
5853414|NCT02441803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5853415|NCT02441803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5853416|NCT02441803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5853417|NCT02441803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5669986|NCT03573687|Caseins|caseins|mesh-list
5669987|NCT03573687|Chelating Agents|chelating agents|mesh-ancestor
5669988|NCT03573687|Sequestering Agents|sequestering agents|mesh-ancestor
5669989|NCT03573687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669990|NCT03573622|Sarpogrelate|sarpogrelate|mesh-list
5669991|NCT03573622|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5669992|NCT03573622|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5669993|NCT03573622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5669994|NCT03573622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5669995|NCT03573622|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5669996|NCT03573622|Serotonin Agents|serotonin agents|mesh-ancestor
5669997|NCT03573622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5669998|NCT03573622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5669999|NCT03573596|Dasatinib|dasatinib|mesh-list
5670000|NCT03573596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5670001|NCT03573596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5670002|NCT03573596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5670003|NCT03573596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5670004|NCT03573349|Ketamine|ketamine|mesh-list
5670005|NCT03573349|Analgesics|analgesics|mesh-ancestor
5670006|NCT03573349|Sensory System Agents|sensory system agents|mesh-ancestor
5670007|NCT03573349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5670008|NCT03573349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670009|NCT03573349|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5670010|NCT03573349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5670011|NCT03573349|Anesthetics, General|anesthetics, general|mesh-ancestor
5670012|NCT03573349|Anesthetics|anesthetics|mesh-ancestor
5670013|NCT03573349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5670014|NCT03573349|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5670015|NCT03573349|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5670016|NCT03573349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5670017|NCT03573349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5670018|NCT03573297|Cariprazine|cariprazine|mesh-list
5670019|NCT03573297|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5670020|NCT03573297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5670021|NCT03573297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5670022|NCT03573297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670023|NCT03573297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5670024|NCT03573284|Nitric Oxide|nitric oxide|mesh-list
5670025|NCT03573284|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5670026|NCT03573284|Autonomic Agents|autonomic agents|mesh-ancestor
5670027|NCT03573284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5670028|NCT03573284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670029|NCT03573284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5670030|NCT03573284|Respiratory System Agents|respiratory system agents|mesh-ancestor
5670031|NCT03573284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5670032|NCT03573284|Antioxidants|antioxidants|mesh-ancestor
5670033|NCT03573284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5670034|NCT03573284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5670035|NCT03573284|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5670036|NCT03573284|Vasodilator Agents|vasodilator agents|mesh-ancestor
5670037|NCT03573284|Gasotransmitters|gasotransmitters|mesh-ancestor
5670038|NCT03573284|Protective Agents|protective agents|mesh-ancestor
5670039|NCT03573245|Tranexamic Acid|tranexamic acid|mesh-list
5670040|NCT03573245|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5670041|NCT03573245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5670042|NCT03573245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5670043|NCT03573245|Hemostatics|hemostatics|mesh-ancestor
5670044|NCT03573245|Coagulants|coagulants|mesh-ancestor
5670045|NCT03573115|Adapalene|adapalene|mesh-list
5670046|NCT03573115|Benzoyl Peroxide|benzoyl peroxide|mesh-list
5670047|NCT03573115|Dermatologic Agents|dermatologic agents|mesh-ancestor
5670048|NCT03573115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5670049|NCT03573115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5670050|NCT03573115|Analgesics|analgesics|mesh-ancestor
5670051|NCT03573115|Sensory System Agents|sensory system agents|mesh-ancestor
5670052|NCT03573115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5670053|NCT03573115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670054|NCT03573115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5670055|NCT03573115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5670056|NCT03573102|Aspirin|aspirin|mesh-list
5670057|NCT03573102|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
5670058|NCT03573102|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
5670059|NCT03573102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5670060|NCT03573102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5670061|NCT03573102|Analgesics|analgesics|mesh-ancestor
5670062|NCT03573102|Sensory System Agents|sensory system agents|mesh-ancestor
5670063|NCT03573102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5670064|NCT03573102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670065|NCT03573102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5670066|NCT03573102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5670067|NCT03573102|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5853418|NCT02441803|Antimetabolites|antimetabolites|mesh-ancestor
5853419|NCT02441803|Antiviral Agents|antiviral agents|mesh-ancestor
5853420|NCT02441803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5853421|NCT02441803|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5853422|NCT02441803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5853423|NCT02441803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5853424|NCT02441803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5853425|NCT02441803|Antitubercular Agents|antitubercular agents|mesh-ancestor
5853426|NCT02441803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5853427|NCT02441803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5670068|NCT03573102|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5670069|NCT03573102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5670070|NCT03573102|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5670071|NCT03573102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5670072|NCT03573102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5670073|NCT03573102|Antipyretics|antipyretics|mesh-ancestor
5670074|NCT03573102|Protease Inhibitors|protease inhibitors|mesh-ancestor
5670075|NCT03573102|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5670076|NCT03573063|Androgens|androgens|mesh-list
5670077|NCT03573063|Hormones|hormones|mesh-ancestor
5670078|NCT03573063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5670079|NCT03573063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670080|NCT03573050|Rivastigmine|rivastigmine|mesh-list
5853428|NCT02441803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5853429|NCT02441491|Cyclophosphamide|cyclophosphamide|mesh-list
5853430|NCT02441491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5853431|NCT02441491|Immunologic Factors|immunologic factors|mesh-ancestor
5853432|NCT02441491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853433|NCT02441491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5853434|NCT02441491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5853435|NCT02441491|Alkylating Agents|alkylating agents|mesh-ancestor
5853436|NCT02441491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5853437|NCT02441491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5853438|NCT02441491|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5853439|NCT02441816|Aflibercept|aflibercept|mesh-list
5853440|NCT02441816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5853441|NCT02441816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5853442|NCT02441816|Growth Substances|growth substances|mesh-ancestor
5853443|NCT02441816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853444|NCT02441816|Growth Inhibitors|growth inhibitors|mesh-ancestor
5853445|NCT02441816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5853446|NCT02441439|Iron|iron|mesh-list
6674849|NCT01571791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6674850|NCT01571791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5670081|NCT03573050|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5670082|NCT03573050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5670083|NCT03573050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5670084|NCT03573050|Cholinergic Agents|cholinergic agents|mesh-ancestor
5670085|NCT03573050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5670086|NCT03573050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670087|NCT03573050|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5670088|NCT03573050|Protective Agents|protective agents|mesh-ancestor
5670089|NCT03573037|Anticoagulants|anticoagulants|mesh-list
5853447|NCT02441439|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
5670090|NCT03573024|Azacitidine|azacitidine|mesh-list
5670091|NCT03573024|Venetoclax|venetoclax|mesh-list
5853448|NCT02441439|Trace Elements|trace elements|mesh-ancestor
5853449|NCT02441439|Micronutrients|micronutrients|mesh-ancestor
5853450|NCT02441439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853451|NCT02441439|Hematinics|hematinics|mesh-ancestor
5853452|NCT02441465|Vemurafenib|vemurafenib|mesh-list
5853453|NCT02441465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5853454|NCT02441465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5853455|NCT02441465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5853456|NCT02441465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5853457|NCT02441530|Vitamin D|vitamin d|mesh-list
5853458|NCT02441530|Vitamins|vitamins|mesh-list
5853459|NCT02441530|Vitamin E|vitamin e|mesh-list
5853460|NCT02441530|Ibuprofen|ibuprofen|mesh-list
5853461|NCT02441530|Micronutrients|micronutrients|mesh-ancestor
5853462|NCT02441530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853463|NCT02441530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5853464|NCT02441530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5853465|NCT02441530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5853466|NCT02441530|Analgesics|analgesics|mesh-ancestor
5853467|NCT02441530|Sensory System Agents|sensory system agents|mesh-ancestor
5853468|NCT02441530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5853469|NCT02441530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5853470|NCT02441530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5853471|NCT02441530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5853472|NCT02441530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6674851|NCT01571804|Pregabalin|pregabalin|mesh-list
6674852|NCT01571804|Analgesics|analgesics|mesh-ancestor
6674853|NCT01571804|Sensory System Agents|sensory system agents|mesh-ancestor
6674854|NCT01571804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6674855|NCT01571804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674856|NCT01571804|Anticonvulsants|anticonvulsants|mesh-ancestor
6674857|NCT01571804|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5853473|NCT02441530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5853474|NCT02441530|Antioxidants|antioxidants|mesh-ancestor
5853475|NCT02441530|Protective Agents|protective agents|mesh-ancestor
5670092|NCT03573024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5670093|NCT03573024|Antimetabolites|antimetabolites|mesh-ancestor
5670094|NCT03573024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5670095|NCT03573024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5670096|NCT03573024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5695954|NCT03386539|Immunologic Factors|immunologic factors|mesh-ancestor
5695955|NCT03386539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695956|NCT03386539|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5695957|NCT03386539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5695958|NCT03386539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695959|NCT03386539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5695960|NCT03386539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5695961|NCT03386539|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5695962|NCT03386539|Antitubercular Agents|antitubercular agents|mesh-ancestor
5695963|NCT03386539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5695964|NCT03386539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5695965|NCT03386357|Pembrolizumab|pembrolizumab|mesh-list
5695966|NCT03386357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5695967|NCT03386357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5695968|NCT03386318|Oxycodone|oxycodone|mesh-list
5695969|NCT03386318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5695970|NCT03386318|Narcotics|narcotics|mesh-ancestor
5695971|NCT03386318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5695972|NCT03386318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695973|NCT03386318|Analgesics|analgesics|mesh-ancestor
5695974|NCT03386318|Sensory System Agents|sensory system agents|mesh-ancestor
5695975|NCT03386318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5695976|NCT03386305|Tacrolimus|tacrolimus|mesh-list
5695977|NCT03386305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5695978|NCT03386305|Immunologic Factors|immunologic factors|mesh-ancestor
5695979|NCT03386305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5695980|NCT03386305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5695981|NCT03386305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5695982|NCT03386305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695983|NCT03386279|Moxifloxacin|moxifloxacin|mesh-list
5695984|NCT03386279|Abrocitinib|abrocitinib|mesh-list
5853476|NCT02441387|Antidepressive Agents|antidepressive agents|mesh-list
5853477|NCT02441387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5853478|NCT02441270|Cyclophosphamide|cyclophosphamide|mesh-list
6674858|NCT01571804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5853479|NCT02441270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5853480|NCT02441270|Immunologic Factors|immunologic factors|mesh-ancestor
5853481|NCT02441270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853482|NCT02441270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5853483|NCT02441270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5853484|NCT02441270|Alkylating Agents|alkylating agents|mesh-ancestor
5853485|NCT02441270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5853486|NCT02441270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5853487|NCT02441270|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5853488|NCT02441075|Ethanol|ethanol|mesh-list
5853489|NCT02441075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5853490|NCT02441075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5853491|NCT02441075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5853492|NCT02441075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853493|NCT02441088|Octreotide|octreotide|mesh-list
5853494|NCT02441088|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
5853495|NCT02441088|Edotreotide|edotreotide|mesh-list
5670097|NCT03572959|Triamcinolone|triamcinolone|mesh-list
5670098|NCT03572959|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5670099|NCT03572959|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5670100|NCT03572959|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5670101|NCT03572959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5670102|NCT03572959|Glucocorticoids|glucocorticoids|mesh-ancestor
5670103|NCT03572959|Hormones|hormones|mesh-ancestor
5670104|NCT03572959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5670105|NCT03572959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670106|NCT03572959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5670107|NCT03572959|Immunologic Factors|immunologic factors|mesh-ancestor
5853496|NCT02441088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5853497|NCT02441088|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5853498|NCT02441088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5853499|NCT02441088|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5853500|NCT02441088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5853501|NCT02441088|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5853502|NCT02441088|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5853503|NCT02440880|Dexamethasone|dexamethasone|mesh-list
5670108|NCT03572959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5670109|NCT03572959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5670110|NCT03572933|Pregnanolone|pregnanolone|mesh-list
5670111|NCT03572933|Ganaxolone|ganaxolone|mesh-list
5670112|NCT03572933|Neurosteroids|neurosteroids|mesh-ancestor
5670113|NCT03572933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5670114|NCT03572933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5670115|NCT03572933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670116|NCT03572933|GABA Modulators|gaba modulators|mesh-ancestor
5670117|NCT03572933|GABA Agents|gaba agents|mesh-ancestor
5670118|NCT03572933|Anesthetics|anesthetics|mesh-ancestor
5670119|NCT03572933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5670120|NCT03572829|Dexamethasone|dexamethasone|mesh-list
5670121|NCT03572829|Ondansetron|ondansetron|mesh-list
5670122|NCT03572829|Aprepitant|aprepitant|mesh-list
5670123|NCT03572829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5853504|NCT02440880|Dexamethasone acetate|dexamethasone acetate|mesh-list
5853505|NCT02440880|BB 1101|bb 1101|mesh-list
5853506|NCT02440880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5670124|NCT03572829|Antiemetics|antiemetics|mesh-ancestor
5670125|NCT03572829|Autonomic Agents|autonomic agents|mesh-ancestor
5670126|NCT03572829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5670127|NCT03572829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670128|NCT03572829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5670129|NCT03572829|Glucocorticoids|glucocorticoids|mesh-ancestor
5670130|NCT03572829|Hormones|hormones|mesh-ancestor
5670131|NCT03572829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5670132|NCT03572829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5670133|NCT03572829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5670134|NCT03572829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5853507|NCT02440880|Antiemetics|antiemetics|mesh-ancestor
5853508|NCT02440880|Autonomic Agents|autonomic agents|mesh-ancestor
5853509|NCT02440880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5853510|NCT02440880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853511|NCT02440880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5853512|NCT02440880|Glucocorticoids|glucocorticoids|mesh-ancestor
5853513|NCT02440880|Hormones|hormones|mesh-ancestor
5853514|NCT02440880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5908473|NCT04486352|Trastuzumab|trastuzumab|mesh-list
5853515|NCT02440880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5853516|NCT02440880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5853517|NCT02440880|Protease Inhibitors|protease inhibitors|mesh-ancestor
5853518|NCT02440880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5853519|NCT02440880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5853520|NCT02440750|Dienogest|dienogest|mesh-list
5670135|NCT03572829|Antipruritics|antipruritics|mesh-ancestor
5670136|NCT03572829|Dermatologic Agents|dermatologic agents|mesh-ancestor
5670137|NCT03572829|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5670138|NCT03572829|Serotonin Agents|serotonin agents|mesh-ancestor
5670139|NCT03572829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5670140|NCT03572829|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5670141|NCT03572829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5670142|NCT03572829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5670143|NCT03572829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5670144|NCT03572829|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5670145|NCT03572829|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5670146|NCT03572790|Prucalopride|prucalopride|mesh-list
5670147|NCT03572790|Laxatives|laxatives|mesh-ancestor
5670148|NCT03572790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5670149|NCT03572790|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
5670150|NCT03572790|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5670151|NCT03572790|Serotonin Agents|serotonin agents|mesh-ancestor
5670152|NCT03572790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5670153|NCT03572790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5670154|NCT03572790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853521|NCT02440750|Ulipristal acetate|ulipristal acetate|mesh-list
5853522|NCT02440750|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5853523|NCT02440750|Contraceptive Agents|contraceptive agents|mesh-ancestor
5853524|NCT02440750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5853525|NCT02440750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853526|NCT02440750|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5853527|NCT02440750|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5853528|NCT02440750|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5853529|NCT02440750|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5853530|NCT02440750|Hormone Antagonists|hormone antagonists|mesh-ancestor
5853531|NCT02440750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5853532|NCT02440750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5670155|NCT03572764|Cytarabine|cytarabine|mesh-list
5670156|NCT03572764|Daunorubicin|daunorubicin|mesh-list
5670157|NCT03572764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5670158|NCT03572764|Antimetabolites|antimetabolites|mesh-ancestor
5853533|NCT02440750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5853534|NCT02440958|Folfirinox|folfirinox|mesh-list
5853535|NCT02440958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5853536|NCT02440841|Itraconazole|itraconazole|mesh-list
5853537|NCT02440841|Rifampin|rifampin|mesh-list
5853538|NCT02440841|Antifungal Agents|antifungal agents|mesh-ancestor
5853539|NCT02440841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5853540|NCT02440841|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5853541|NCT02440841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5853542|NCT02440841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5853543|NCT02440841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5853544|NCT02440841|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5853545|NCT02440841|Hormone Antagonists|hormone antagonists|mesh-ancestor
5853546|NCT02440841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5853547|NCT02440841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853548|NCT02440841|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5853549|NCT02440841|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5853550|NCT02440841|Antitubercular Agents|antitubercular agents|mesh-ancestor
5853551|NCT02440841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5853552|NCT02440841|Leprostatic Agents|leprostatic agents|mesh-ancestor
5853553|NCT02440841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5670159|NCT03572764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5670160|NCT03572764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5670161|NCT03572764|Antiviral Agents|antiviral agents|mesh-ancestor
5670162|NCT03572764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5670163|NCT03572764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5670164|NCT03572764|Immunologic Factors|immunologic factors|mesh-ancestor
5670165|NCT03572764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670166|NCT03572764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5670167|NCT03572764|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5670168|NCT03572764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5853554|NCT02440841|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5853555|NCT02440841|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5853556|NCT02440841|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5853557|NCT02440841|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5853558|NCT02440841|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5853559|NCT02440841|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5853560|NCT02440581|Alendronate|alendronate|mesh-list
5853561|NCT02440581|Teriparatide|teriparatide|mesh-list
5853562|NCT02440581|Cinacalcet|cinacalcet|mesh-list
5853563|NCT02440581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5853564|NCT02440581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853565|NCT02440581|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5853566|NCT02440581|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
5853567|NCT02440581|Hormone Antagonists|hormone antagonists|mesh-ancestor
5670169|NCT03572764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5670170|NCT03572686|Dexamethasone|dexamethasone|mesh-list
5670171|NCT03572686|Dexamethasone acetate|dexamethasone acetate|mesh-list
5670172|NCT03572686|Ropivacaine|ropivacaine|mesh-list
5670173|NCT03572686|BB 1101|bb 1101|mesh-list
5853568|NCT02440581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5853569|NCT02440828|Tobramycin|tobramycin|mesh-list
5853570|NCT02440828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5853571|NCT02440828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5853572|NCT02440347|Anesthetics|anesthetics|mesh-list
5853573|NCT02440347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5853574|NCT02440347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853575|NCT02440230|Anastrozole|anastrozole|mesh-list
5853576|NCT02440230|Exemestane|exemestane|mesh-list
5853577|NCT02440230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5853578|NCT02440230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5853579|NCT02440230|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5853580|NCT02440230|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5853581|NCT02440230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5670174|NCT03572686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5670175|NCT03572686|Antiemetics|antiemetics|mesh-ancestor
5670176|NCT03572686|Autonomic Agents|autonomic agents|mesh-ancestor
5670177|NCT03572686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5670178|NCT03572686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670179|NCT03572686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5670180|NCT03572686|Glucocorticoids|glucocorticoids|mesh-ancestor
5670181|NCT03572686|Hormones|hormones|mesh-ancestor
5670182|NCT03572686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5853582|NCT02440230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5853583|NCT02440230|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5853584|NCT02440230|Hormone Antagonists|hormone antagonists|mesh-ancestor
5853585|NCT02440230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5853586|NCT02440230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853587|NCT02440399|Acetaminophen|acetaminophen|mesh-list
5853588|NCT02440399|Diclofenac|diclofenac|mesh-list
5853589|NCT02440399|Morphine|morphine|mesh-list
5853590|NCT02440399|Oxycodone|oxycodone|mesh-list
5853591|NCT02440399|Tramadol|tramadol|mesh-list
5853592|NCT02440399|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5853593|NCT02440399|Narcotics|narcotics|mesh-ancestor
5853594|NCT02440399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5853595|NCT02440399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853596|NCT02440399|Analgesics|analgesics|mesh-ancestor
5853597|NCT02440399|Sensory System Agents|sensory system agents|mesh-ancestor
5853598|NCT02440399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5853599|NCT02440399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5670183|NCT03572686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5670184|NCT03572686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5670185|NCT03572686|Protease Inhibitors|protease inhibitors|mesh-ancestor
5670186|NCT03572686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5670187|NCT03572686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5670188|NCT03572686|Anesthetics, Local|anesthetics, local|mesh-ancestor
5670189|NCT03572686|Anesthetics|anesthetics|mesh-ancestor
5670190|NCT03572686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5670191|NCT03572686|Sensory System Agents|sensory system agents|mesh-ancestor
5670192|NCT03572647|Epoetin Alfa|epoetin alfa|mesh-list
5670193|NCT03572647|Hematinics|hematinics|mesh-ancestor
5670194|NCT03572595|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5670195|NCT03572595|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5853600|NCT02440399|Antipyretics|antipyretics|mesh-ancestor
5670196|NCT03572595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5670197|NCT03572582|Nivolumab|nivolumab|mesh-list
5670198|NCT03572582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5670199|NCT03572582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5670200|NCT03572582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5670201|NCT03572582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5670202|NCT03572517|Morphine|morphine|mesh-list
5670203|NCT03572517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5670204|NCT03572517|Narcotics|narcotics|mesh-ancestor
5670205|NCT03572517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5853601|NCT02440399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5853602|NCT02440399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5853603|NCT02440399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5853604|NCT02440399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5853605|NCT02440399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5853606|NCT02440399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904129|NCT02549833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904130|NCT02549833|Laxatives|laxatives|mesh-ancestor
5904131|NCT02549833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5904132|NCT02549833|Antiviral Agents|antiviral agents|mesh-ancestor
5904133|NCT02549833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5904134|NCT02468180|Polidocanol|polidocanol|mesh-list
5904135|NCT02468180|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
5904136|NCT02468180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5904137|NCT02207465|Paclitaxel|paclitaxel|mesh-list
5904138|NCT02207465|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5904139|NCT02207465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5904140|NCT02207465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5904141|NCT02207465|Tubulin Modulators|tubulin modulators|mesh-ancestor
5904142|NCT02207465|Antimitotic Agents|antimitotic agents|mesh-ancestor
5904143|NCT02207465|Mitosis Modulators|mitosis modulators|mesh-ancestor
5904144|NCT02207465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904145|NCT02158507|Lapatinib|lapatinib|mesh-list
5904146|NCT02158507|Veliparib|veliparib|mesh-list
5904147|NCT02158507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5904148|NCT02158507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5904149|NCT02158507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5670206|NCT03572517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670207|NCT03572517|Analgesics|analgesics|mesh-ancestor
5670208|NCT03572517|Sensory System Agents|sensory system agents|mesh-ancestor
5670209|NCT03572517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5670210|NCT03572400|Gemcitabine|gemcitabine|mesh-list
5670211|NCT03572400|Durvalumab|durvalumab|mesh-list
5670212|NCT03572400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5670213|NCT03572400|Antimetabolites|antimetabolites|mesh-ancestor
5670214|NCT03572400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5670215|NCT03572400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5670216|NCT03572400|Antiviral Agents|antiviral agents|mesh-ancestor
5670217|NCT03572400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5670218|NCT03572400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5670219|NCT03572400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5670220|NCT03572400|Immunologic Factors|immunologic factors|mesh-ancestor
5670221|NCT03572400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670222|NCT03572400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5670223|NCT03572387|Azacitidine|azacitidine|mesh-list
5670224|NCT03572387|Tretinoin|tretinoin|mesh-list
5670225|NCT03572387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5904150|NCT02158507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5670226|NCT03572387|Antimetabolites|antimetabolites|mesh-ancestor
5670227|NCT03572387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5670228|NCT03572387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5670229|NCT03572387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5670230|NCT03572387|Keratolytic Agents|keratolytic agents|mesh-ancestor
5670231|NCT03572387|Dermatologic Agents|dermatologic agents|mesh-ancestor
5670232|NCT03572257|Quetiapine Fumarate|quetiapine fumarate|mesh-list
5670233|NCT03572257|Antidepressive Agents|antidepressive agents|mesh-ancestor
5670234|NCT03572257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5670235|NCT03572257|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5670236|NCT03572257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5670237|NCT03572257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5670238|NCT03572257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670239|NCT03572231|Solifenacin Succinate|solifenacin succinate|mesh-list
5670240|NCT03572231|Mirabegron|mirabegron|mesh-list
5670241|NCT03572231|Fesoterodine|fesoterodine|mesh-list
5670242|NCT03572231|Tolterodine Tartrate|tolterodine tartrate|mesh-list
5670243|NCT03572231|Oxybutynin|oxybutynin|mesh-list
5670244|NCT03572231|Darifenacin|darifenacin|mesh-list
5670245|NCT03572231|Propiverine|propiverine|mesh-list
5670246|NCT03572231|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5670247|NCT03572231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5670248|NCT03572231|Cholinergic Agents|cholinergic agents|mesh-ancestor
5670249|NCT03572231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5670250|NCT03572231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5670251|NCT03572231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670252|NCT03572231|Urological Agents|urological agents|mesh-ancestor
5670253|NCT03572231|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
5670254|NCT03572231|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5670255|NCT03572231|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5670256|NCT03572231|Adrenergic Agents|adrenergic agents|mesh-ancestor
5670257|NCT03572231|Parasympatholytics|parasympatholytics|mesh-ancestor
5670258|NCT03572231|Autonomic Agents|autonomic agents|mesh-ancestor
5670259|NCT03572231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5670260|NCT03572088|Terlipressin|terlipressin|mesh-list
5670261|NCT03572088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5853607|NCT02440243|Vaccines|vaccines|mesh-list
5853608|NCT02440243|Immunologic Factors|immunologic factors|mesh-ancestor
5853609|NCT02440243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853610|NCT02440256|Analgesics, Opioid|analgesics, opioid|mesh-list
5853611|NCT02440256|Narcotics|narcotics|mesh-ancestor
5670262|NCT03572088|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5670263|NCT03572010|Fesoterodine|fesoterodine|mesh-list
5670264|NCT03572010|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5670265|NCT03572010|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5670266|NCT03572010|Cholinergic Agents|cholinergic agents|mesh-ancestor
5670267|NCT03572010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5670268|NCT03572010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5670269|NCT03572010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670270|NCT03572010|Urological Agents|urological agents|mesh-ancestor
5670271|NCT03571945|Anesthetics|anesthetics|mesh-list
5670272|NCT03571945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5670273|NCT03571945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670274|NCT03571932|Vaccines|vaccines|mesh-list
5670275|NCT03571932|Immunologic Factors|immunologic factors|mesh-ancestor
5670276|NCT03571932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670277|NCT03571919|Lidocaine|lidocaine|mesh-list
5670278|NCT03571919|Anesthetics, Local|anesthetics, local|mesh-ancestor
5670279|NCT03571919|Anesthetics|anesthetics|mesh-ancestor
5670280|NCT03571919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5670281|NCT03571919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853612|NCT02440256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5853613|NCT02440256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853614|NCT02440256|Analgesics|analgesics|mesh-ancestor
5853615|NCT02440256|Sensory System Agents|sensory system agents|mesh-ancestor
5853616|NCT02440256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5853617|NCT02440100|Midazolam|midazolam|mesh-list
5853618|NCT02440100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5853619|NCT02440100|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5853620|NCT02440100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5853621|NCT02440100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853622|NCT02440100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5853623|NCT02440100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5853624|NCT02440100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5853625|NCT02440100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5853626|NCT02440100|Anesthetics, General|anesthetics, general|mesh-ancestor
5853627|NCT02440100|Anesthetics|anesthetics|mesh-ancestor
5853628|NCT02440100|GABA Modulators|gaba modulators|mesh-ancestor
5853629|NCT02440100|GABA Agents|gaba agents|mesh-ancestor
5853630|NCT02440100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5853631|NCT02440100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5853632|NCT02439944|Nicotine|nicotine|mesh-list
5853633|NCT02439944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5853634|NCT02439944|Autonomic Agents|autonomic agents|mesh-ancestor
5853635|NCT02439944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5853636|NCT02439944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853637|NCT02439944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5853638|NCT02439944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5853639|NCT02439944|Cholinergic Agents|cholinergic agents|mesh-ancestor
5853640|NCT02439944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5853641|NCT02439944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5853642|NCT02439905|Dexmedetomidine|dexmedetomidine|mesh-list
5853643|NCT02439905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5853644|NCT02439905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5853645|NCT02439905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853646|NCT02439905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5853647|NCT02439905|Analgesics|analgesics|mesh-ancestor
5853648|NCT02439905|Sensory System Agents|sensory system agents|mesh-ancestor
5853649|NCT02439905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5853650|NCT02439905|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5853651|NCT02439905|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5853652|NCT02439905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5853653|NCT02439905|Adrenergic Agents|adrenergic agents|mesh-ancestor
5853654|NCT02439905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5853655|NCT02439905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5853656|NCT02439866|Methylprednisolone|methylprednisolone|mesh-list
5853657|NCT02439866|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5853658|NCT02439866|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5853659|NCT02439866|Prednisolone|prednisolone|mesh-list
5853660|NCT02439866|Prednisolone acetate|prednisolone acetate|mesh-list
5853661|NCT02439866|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5853662|NCT02439866|Prednisolone phosphate|prednisolone phosphate|mesh-list
5853663|NCT02439866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5853664|NCT02439866|Antiemetics|antiemetics|mesh-ancestor
5853665|NCT02439866|Autonomic Agents|autonomic agents|mesh-ancestor
5670282|NCT03571919|Sensory System Agents|sensory system agents|mesh-ancestor
5670283|NCT03571919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5670284|NCT03571919|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5670285|NCT03571919|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5670286|NCT03571919|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5670287|NCT03571919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5670288|NCT03571919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5670289|NCT03571815|Listerine|listerine|mesh-list
5670290|NCT03571815|Fluorides|fluorides|mesh-list
5670291|NCT03571815|Sodium Fluoride|sodium fluoride|mesh-list
5670292|NCT03571815|Fluorides, Topical|fluorides, topical|mesh-list
5670293|NCT03571815|Cariostatic Agents|cariostatic agents|mesh-ancestor
5670294|NCT03571815|Protective Agents|protective agents|mesh-ancestor
5670295|NCT03571815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670296|NCT03571815|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5670297|NCT03571815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5670298|NCT03571802|Simvastatin|simvastatin|mesh-list
5853666|NCT02439866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5853667|NCT02439866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853668|NCT02439866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5853669|NCT02439866|Glucocorticoids|glucocorticoids|mesh-ancestor
5853670|NCT02439866|Hormones|hormones|mesh-ancestor
5853671|NCT02439866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5853672|NCT02439866|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5853673|NCT02439866|Protective Agents|protective agents|mesh-ancestor
5670299|NCT03571802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5670300|NCT03571802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5670301|NCT03571802|Antimetabolites|antimetabolites|mesh-ancestor
5670302|NCT03571802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5670303|NCT03571802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5670304|NCT03571802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5670305|NCT03571802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5670306|NCT03571737|Ibuprofen|ibuprofen|mesh-list
5670307|NCT03571737|Lidocaine|lidocaine|mesh-list
5670308|NCT03571737|Anesthetics, Local|anesthetics, local|mesh-ancestor
5670309|NCT03571737|Anesthetics|anesthetics|mesh-ancestor
5670310|NCT03571737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5670311|NCT03571737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670312|NCT03571737|Sensory System Agents|sensory system agents|mesh-ancestor
5670313|NCT03571737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5853674|NCT02439866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5853675|NCT02439866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5853676|NCT02439996|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5853677|NCT02439996|gamma-Globulins|gamma-globulins|mesh-list
5853678|NCT02439996|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5853679|NCT02439996|Immunologic Factors|immunologic factors|mesh-ancestor
5853680|NCT02439996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853681|NCT02440009|Itraconazole|itraconazole|mesh-list
5853682|NCT02440009|Glucocorticoids|glucocorticoids|mesh-list
5853683|NCT02440009|Antifungal Agents|antifungal agents|mesh-ancestor
5853684|NCT02440009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5853685|NCT02440009|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5853686|NCT02440009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5853687|NCT02440009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5670314|NCT03571737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5670315|NCT03571737|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5670316|NCT03571737|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5853688|NCT02440009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5853689|NCT02440009|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5853690|NCT02440009|Hormone Antagonists|hormone antagonists|mesh-ancestor
5670317|NCT03571737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5670318|NCT03571737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5670319|NCT03571737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5670320|NCT03571737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5670321|NCT03571737|Analgesics|analgesics|mesh-ancestor
5670322|NCT03571737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5670323|NCT03571737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5853691|NCT02440009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5853692|NCT02440009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853693|NCT02440009|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5853694|NCT02440009|Hormones|hormones|mesh-ancestor
5853695|NCT02439788|Cyclophosphamide|cyclophosphamide|mesh-list
5853696|NCT02439788|Fludarabine|fludarabine|mesh-list
5853697|NCT02439788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5853698|NCT02439788|Immunologic Factors|immunologic factors|mesh-ancestor
5853699|NCT02439788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853700|NCT02439788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5853701|NCT02439788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5853702|NCT02439788|Alkylating Agents|alkylating agents|mesh-ancestor
5853703|NCT02439788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5670324|NCT03571737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5670325|NCT03571737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5670326|NCT03571711|Meropenem|meropenem|mesh-list
5670327|NCT03571711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5670328|NCT03571711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5670329|NCT03571594|Octreotide|octreotide|mesh-list
5670330|NCT03571594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5670331|NCT03571594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5670332|NCT03571594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5670333|NCT03571568|Rituximab|rituximab|mesh-list
5670334|NCT03571568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5670335|NCT03571568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5670336|NCT03571568|Immunologic Factors|immunologic factors|mesh-ancestor
5853704|NCT02439788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5853705|NCT02439788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5853706|NCT02439697|Darbepoetin alfa|darbepoetin alfa|mesh-list
5853707|NCT02439697|Hematinics|hematinics|mesh-ancestor
5853708|NCT02439632|Levofloxacin|levofloxacin|mesh-list
5853709|NCT02439632|Ofloxacin|ofloxacin|mesh-list
5853710|NCT02439632|Prulifloxacin|prulifloxacin|mesh-list
5853711|NCT02439632|Fluoroquinolones|fluoroquinolones|mesh-list
5670337|NCT03571568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670338|NCT03571568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5670339|NCT03571490|Ropivacaine|ropivacaine|mesh-list
5670340|NCT03571490|Anesthetics, Local|anesthetics, local|mesh-ancestor
5670341|NCT03571490|Anesthetics|anesthetics|mesh-ancestor
5670342|NCT03571490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5670343|NCT03571490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670344|NCT03571490|Sensory System Agents|sensory system agents|mesh-ancestor
5670345|NCT03571490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5670346|NCT03571438|Sirolimus|sirolimus|mesh-list
5670347|NCT03571438|Sunitinib|sunitinib|mesh-list
5670348|NCT03571438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5670349|NCT03571438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5670350|NCT03571438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5670351|NCT03571438|Growth Substances|growth substances|mesh-ancestor
5670352|NCT03571438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670353|NCT03571438|Growth Inhibitors|growth inhibitors|mesh-ancestor
5670354|NCT03571438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5670355|NCT03571438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5670356|NCT03571438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5670357|NCT03571438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5670358|NCT03571438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5670359|NCT03571438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5670360|NCT03571438|Antifungal Agents|antifungal agents|mesh-ancestor
5670361|NCT03571438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5670362|NCT03571438|Immunologic Factors|immunologic factors|mesh-ancestor
5670363|NCT03571321|Cytarabine|cytarabine|mesh-list
5670364|NCT03571321|Dexamethasone|dexamethasone|mesh-list
5670365|NCT03571321|Cyclophosphamide|cyclophosphamide|mesh-list
5853712|NCT02439632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5853713|NCT02439632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5853714|NCT02439632|Renal Agents|renal agents|mesh-ancestor
5853715|NCT02439632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5853716|NCT02439632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5853717|NCT02439632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5853718|NCT02439632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5853719|NCT02439632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5853720|NCT02439632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5853721|NCT02439632|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5853722|NCT02439632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5853723|NCT02439632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5853724|NCT02439450|Pembrolizumab|pembrolizumab|mesh-list
5853725|NCT02439450|Nivolumab|nivolumab|mesh-list
5853726|NCT02439450|Pemetrexed|pemetrexed|mesh-list
5853727|NCT02439450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5853728|NCT02439450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5853729|NCT02439450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5853730|NCT02439450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5853731|NCT02439450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5853732|NCT02439450|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5853733|NCT02439450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5853734|NCT02439658|Sotalol|sotalol|mesh-list
5853735|NCT02439658|Dofetilide|dofetilide|mesh-list
5853736|NCT02439658|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5853737|NCT02439658|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5853738|NCT02439658|Adrenergic Agents|adrenergic agents|mesh-ancestor
5853739|NCT02439658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5670366|NCT03571321|Rituximab|rituximab|mesh-list
5670367|NCT03571321|Doxorubicin|doxorubicin|mesh-list
5670368|NCT03571321|Methotrexate|methotrexate|mesh-list
5670369|NCT03571321|Vincristine|vincristine|mesh-list
5670370|NCT03571321|Mercaptopurine|mercaptopurine|mesh-list
5670371|NCT03571321|Pegaspargase|pegaspargase|mesh-list
5670372|NCT03571321|Thioguanine|thioguanine|mesh-list
5670373|NCT03571321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5670374|NCT03571321|Immunologic Factors|immunologic factors|mesh-ancestor
5670375|NCT03571321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670376|NCT03571321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5670377|NCT03571321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5670378|NCT03571321|Alkylating Agents|alkylating agents|mesh-ancestor
5670379|NCT03571321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5670380|NCT03571321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5670381|NCT03571321|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5670382|NCT03571321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5670383|NCT03571321|Antiemetics|antiemetics|mesh-ancestor
5670384|NCT03571321|Autonomic Agents|autonomic agents|mesh-ancestor
5670385|NCT03571321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5670386|NCT03571321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5670387|NCT03571321|Glucocorticoids|glucocorticoids|mesh-ancestor
5670388|NCT03571321|Hormones|hormones|mesh-ancestor
5670389|NCT03571321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5670390|NCT03571321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5670391|NCT03571321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5670392|NCT03571321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5853740|NCT02439658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5853741|NCT02439658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853742|NCT02439658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5853743|NCT02439658|Sympatholytics|sympatholytics|mesh-ancestor
5853744|NCT02439658|Autonomic Agents|autonomic agents|mesh-ancestor
5853745|NCT02439658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5853746|NCT02439658|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5670393|NCT03571321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5670394|NCT03571321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5670395|NCT03571321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5670396|NCT03571321|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5670397|NCT03571321|Abortifacient Agents|abortifacient agents|mesh-ancestor
5670398|NCT03571321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5670399|NCT03571321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5670400|NCT03571321|Antimetabolites|antimetabolites|mesh-ancestor
5670401|NCT03571321|Dermatologic Agents|dermatologic agents|mesh-ancestor
5670402|NCT03571321|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5670403|NCT03571321|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5670404|NCT03571321|Antiviral Agents|antiviral agents|mesh-ancestor
5670405|NCT03571321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5670406|NCT03571321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5670407|NCT03571321|Tubulin Modulators|tubulin modulators|mesh-ancestor
5670408|NCT03571321|Antimitotic Agents|antimitotic agents|mesh-ancestor
5670409|NCT03571321|Mitosis Modulators|mitosis modulators|mesh-ancestor
5670410|NCT03571308|Prednisolone|prednisolone|mesh-list
5670411|NCT03571308|Cyclophosphamide|cyclophosphamide|mesh-list
5670412|NCT03571308|Doxorubicin|doxorubicin|mesh-list
5670413|NCT03571308|Vincristine|vincristine|mesh-list
5670414|NCT03571308|Acalabrutinib|acalabrutinib|mesh-list
5670415|NCT03571308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5670416|NCT03571308|Immunologic Factors|immunologic factors|mesh-ancestor
5670417|NCT03571308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670418|NCT03571308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5670419|NCT03571308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5670420|NCT03571308|Alkylating Agents|alkylating agents|mesh-ancestor
5670421|NCT03571308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5670422|NCT03571308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5670423|NCT03571308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5670424|NCT03571308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5670425|NCT03571308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5670426|NCT03571308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5670427|NCT03571308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5670428|NCT03571308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5670429|NCT03571308|Tubulin Modulators|tubulin modulators|mesh-ancestor
5670430|NCT03571308|Antimitotic Agents|antimitotic agents|mesh-ancestor
5670431|NCT03571308|Mitosis Modulators|mitosis modulators|mesh-ancestor
5670432|NCT03571308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5670433|NCT03571308|Glucocorticoids|glucocorticoids|mesh-ancestor
5670434|NCT03571308|Hormones|hormones|mesh-ancestor
5670435|NCT03571308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5670436|NCT03571308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5695985|NCT03386279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5853747|NCT02439658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5853748|NCT02439489|Carboplatin|carboplatin|mesh-list
5853749|NCT02439489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5695986|NCT03386279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5695987|NCT03386279|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5695988|NCT03386279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5695989|NCT03386279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5695990|NCT03386279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695991|NCT03386279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5695992|NCT03386279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5695993|NCT03386227|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5695994|NCT03386227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5695995|NCT03386201|Methylene Blue|methylene blue|mesh-list
5695996|NCT03386201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5695997|NCT03386201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5695998|NCT03386162|Fulvestrant|fulvestrant|mesh-list
5695999|NCT03386162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5696000|NCT03386162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5696001|NCT03386162|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5696002|NCT03386162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5696003|NCT03386162|Hormone Antagonists|hormone antagonists|mesh-ancestor
5696004|NCT03386162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5696005|NCT03386162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696006|NCT03386149|Loxoprofen|loxoprofen|mesh-list
5696007|NCT03386149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5696008|NCT03386149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5696009|NCT03386149|Analgesics|analgesics|mesh-ancestor
5696010|NCT03386149|Sensory System Agents|sensory system agents|mesh-ancestor
5696011|NCT03386149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5696012|NCT03386149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696013|NCT03386149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5696014|NCT03386149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5853750|NCT02439190|Aspirin|aspirin|mesh-list
5670437|NCT03571230|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5670438|NCT03571230|Amoxicillin|amoxicillin|mesh-list
5670439|NCT03571230|Metronidazole|metronidazole|mesh-list
5670440|NCT03571230|Clarithromycin|clarithromycin|mesh-list
5670441|NCT03571230|Levofloxacin|levofloxacin|mesh-list
5670442|NCT03571230|Tetracycline|tetracycline|mesh-list
5670443|NCT03571230|Tinidazole|tinidazole|mesh-list
5670444|NCT03571230|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5670445|NCT03571230|Furazolidone|furazolidone|mesh-list
5670446|NCT03571230|Bismuth|bismuth|mesh-list
5670447|NCT03571230|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
5670448|NCT03571230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5670449|NCT03571230|Antitubercular Agents|antitubercular agents|mesh-ancestor
5670450|NCT03571230|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5670451|NCT03571230|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5670452|NCT03571230|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5670453|NCT03571230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5670454|NCT03571230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5670455|NCT03571230|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5670456|NCT03571230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5670457|NCT03571230|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5670458|NCT03571230|Renal Agents|renal agents|mesh-ancestor
5670459|NCT03571230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5670460|NCT03571230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5670461|NCT03571230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5670462|NCT03571230|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5670463|NCT03571230|Antacids|antacids|mesh-ancestor
5670464|NCT03571230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5670465|NCT03571230|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5670466|NCT03571230|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
5670467|NCT03571230|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
5670468|NCT03571230|Alkylating Agents|alkylating agents|mesh-ancestor
5853751|NCT02439190|Clopidogrel|clopidogrel|mesh-list
5853752|NCT02439190|BMS-986120|bms-986120|mesh-list
5853753|NCT02439190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5853754|NCT02439190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5853755|NCT02439190|Analgesics|analgesics|mesh-ancestor
5853756|NCT02439190|Sensory System Agents|sensory system agents|mesh-ancestor
5853757|NCT02439190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5853758|NCT02439190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853759|NCT02439190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5853760|NCT02439190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5853761|NCT02439190|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5853762|NCT02439190|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5853763|NCT02439190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5853764|NCT02439190|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5670469|NCT03571126|Olanzapine|olanzapine|mesh-list
5670470|NCT03571126|Antiemetics|antiemetics|mesh-ancestor
5670471|NCT03571126|Autonomic Agents|autonomic agents|mesh-ancestor
5670472|NCT03571126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5670473|NCT03571126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670474|NCT03571126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5670475|NCT03571126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5670476|NCT03571126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5670477|NCT03571126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5670478|NCT03571126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5670479|NCT03571126|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5670480|NCT03571126|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5670481|NCT03571126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5670482|NCT03571126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5670483|NCT03571126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5670484|NCT03571126|Serotonin Agents|serotonin agents|mesh-ancestor
5670485|NCT03571100|Chlorhexidine|chlorhexidine|mesh-list
5670486|NCT03571100|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5670487|NCT03571100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5670488|NCT03571100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5670489|NCT03571100|Disinfectants|disinfectants|mesh-ancestor
5670490|NCT03571100|Dermatologic Agents|dermatologic agents|mesh-ancestor
5670491|NCT03571087|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5670492|NCT03571087|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5670493|NCT03571087|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5670494|NCT03571087|Antimetabolites|antimetabolites|mesh-ancestor
5670495|NCT03571087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5670496|NCT03571087|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5670497|NCT03571087|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5853765|NCT02439190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5853766|NCT02439190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5670498|NCT03571087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5670499|NCT03570983|Cytarabine|cytarabine|mesh-list
5670500|NCT03570983|Etoposide|etoposide|mesh-list
5670501|NCT03570983|Melphalan|melphalan|mesh-list
5670502|NCT03570983|Carmustine|carmustine|mesh-list
5670503|NCT03570983|Allopurinol|allopurinol|mesh-list
5670504|NCT03570983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5853767|NCT02439190|Antipyretics|antipyretics|mesh-ancestor
5853768|NCT02439190|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5853769|NCT02439190|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5853770|NCT02439190|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5853771|NCT02439190|Purinergic Agents|purinergic agents|mesh-ancestor
5853772|NCT02439190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5853773|NCT02439307|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5853774|NCT02439307|Rifaximin|rifaximin|mesh-list
5853775|NCT02439307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5853776|NCT02439307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5853777|NCT02439411|Trametinib|trametinib|mesh-list
5853778|NCT02439411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5853779|NCT02439411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5853780|NCT02439411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5853781|NCT02439411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5853782|NCT02439125|Eltoprazine|eltoprazine|mesh-list
5853783|NCT02439125|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5853784|NCT02439125|Serotonin Agents|serotonin agents|mesh-ancestor
5853785|NCT02439125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5853786|NCT02439125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5853787|NCT02439125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853788|NCT02439034|Acetaminophen|acetaminophen|mesh-list
5853789|NCT02439034|Ketoprofen|ketoprofen|mesh-list
5853790|NCT02439034|Codeine|codeine|mesh-list
5853791|NCT02439034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5853792|NCT02439034|Analgesics|analgesics|mesh-ancestor
5853793|NCT02439034|Sensory System Agents|sensory system agents|mesh-ancestor
5853794|NCT02439034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5853795|NCT02439034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853796|NCT02439034|Antipyretics|antipyretics|mesh-ancestor
5853797|NCT02439034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5670505|NCT03570983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5670506|NCT03570983|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5670507|NCT03570983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5670508|NCT03570983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5670509|NCT03570983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5670510|NCT03570983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5670511|NCT03570983|Antimetabolites|antimetabolites|mesh-ancestor
5670512|NCT03570983|Antiviral Agents|antiviral agents|mesh-ancestor
5670513|NCT03570983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5670514|NCT03570983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5670515|NCT03570983|Immunologic Factors|immunologic factors|mesh-ancestor
5670516|NCT03570983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670517|NCT03570983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5670518|NCT03570983|Alkylating Agents|alkylating agents|mesh-ancestor
5670519|NCT03570983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5670520|NCT03570983|Gout Suppressants|gout suppressants|mesh-ancestor
5670521|NCT03570983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5670522|NCT03570983|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5670523|NCT03570983|Antioxidants|antioxidants|mesh-ancestor
5670524|NCT03570983|Protective Agents|protective agents|mesh-ancestor
5670525|NCT03570827|Ascorbic Acid|ascorbic acid|mesh-list
5670526|NCT03570827|Methyltestosterone|methyltestosterone|mesh-list
5670527|NCT03570827|Androgens|androgens|mesh-list
5670528|NCT03570827|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
5670529|NCT03570827|Hormones|hormones|mesh-ancestor
5670530|NCT03570827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5670531|NCT03570827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670532|NCT03570827|Antioxidants|antioxidants|mesh-ancestor
5670533|NCT03570827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5670534|NCT03570827|Protective Agents|protective agents|mesh-ancestor
5670535|NCT03570827|Vitamins|vitamins|mesh-ancestor
5670536|NCT03570827|Micronutrients|micronutrients|mesh-ancestor
5670537|NCT03570827|Estrogens|estrogens|mesh-ancestor
5853798|NCT02439034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5670538|NCT03570827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5670539|NCT03570827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5670540|NCT03570827|Anabolic Agents|anabolic agents|mesh-ancestor
5853799|NCT02439034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5853800|NCT02439034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5853801|NCT02439034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5853802|NCT02439034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5670541|NCT03570814|Azithromycin|azithromycin|mesh-list
5670542|NCT03570814|Ivermectin|ivermectin|mesh-list
5670543|NCT03570814|Albendazole|albendazole|mesh-list
5670544|NCT03570814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5670545|NCT03570814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5853803|NCT02439034|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5853804|NCT02439034|Narcotics|narcotics|mesh-ancestor
5853805|NCT02439034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5853806|NCT02439034|Antitussive Agents|antitussive agents|mesh-ancestor
5853807|NCT02439034|Respiratory System Agents|respiratory system agents|mesh-ancestor
5853808|NCT02439385|Curcumin|curcumin|mesh-list
5853809|NCT02439385|Bevacizumab|bevacizumab|mesh-list
5853810|NCT02439385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5853811|NCT02439385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5853812|NCT02439385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5853813|NCT02439385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5853814|NCT02439385|Growth Substances|growth substances|mesh-ancestor
5853815|NCT02439385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853816|NCT02439385|Growth Inhibitors|growth inhibitors|mesh-ancestor
5853817|NCT02439385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5853818|NCT02439385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5853819|NCT02439385|Analgesics|analgesics|mesh-ancestor
5853820|NCT02439385|Sensory System Agents|sensory system agents|mesh-ancestor
5853821|NCT02439385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5853822|NCT02439385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5853823|NCT02439385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5853824|NCT02439385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5853825|NCT02439385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5853826|NCT02438982|Rituximab|rituximab|mesh-list
5853827|NCT02438982|Tacrolimus|tacrolimus|mesh-list
5853828|NCT02438982|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
5670546|NCT03570814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5670547|NCT03570814|Anthelmintics|anthelmintics|mesh-ancestor
5670548|NCT03570814|Anticestodal Agents|anticestodal agents|mesh-ancestor
5670549|NCT03570814|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5670550|NCT03570814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5670551|NCT03570814|Tubulin Modulators|tubulin modulators|mesh-ancestor
5670552|NCT03570814|Antimitotic Agents|antimitotic agents|mesh-ancestor
5670553|NCT03570814|Mitosis Modulators|mitosis modulators|mesh-ancestor
5670554|NCT03570814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5853829|NCT02438982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5853830|NCT02438982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5853831|NCT02438982|Immunologic Factors|immunologic factors|mesh-ancestor
5853832|NCT02438982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853833|NCT02438982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5853834|NCT02438982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5853835|NCT02438982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5853836|NCT02438982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5853837|NCT02438709|Etoricoxib|etoricoxib|mesh-list
6494339|NCT00618241|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5670555|NCT03570814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5670556|NCT03570710|Tranexamic Acid|tranexamic acid|mesh-list
5670557|NCT03570710|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5670558|NCT03570710|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5670559|NCT03570710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5670560|NCT03570710|Hemostatics|hemostatics|mesh-ancestor
5670561|NCT03570710|Coagulants|coagulants|mesh-ancestor
6494340|NCT00618241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6494341|NCT00618241|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6494342|NCT00618241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494343|NCT00618241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6494344|NCT00618241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6494345|NCT00618241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5853838|NCT02438709|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
5853839|NCT02438709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5853840|NCT02438709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5853841|NCT02438709|Analgesics|analgesics|mesh-ancestor
5670562|NCT03570645|Dexamethasone|dexamethasone|mesh-list
6494346|NCT00618241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5670563|NCT03570645|Dexmedetomidine|dexmedetomidine|mesh-list
5670564|NCT03570645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5670565|NCT03570645|Antiemetics|antiemetics|mesh-ancestor
5853842|NCT02438709|Sensory System Agents|sensory system agents|mesh-ancestor
5853843|NCT02438709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5853844|NCT02438709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853845|NCT02438709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5853846|NCT02438709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5853847|NCT02438709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5853848|NCT02438709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5853849|NCT02438709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5853850|NCT02438761|Gedatolisib|gedatolisib|mesh-list
5853851|NCT02438761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5853852|NCT02438761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5853853|NCT02438761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5853854|NCT02438683|BI 409306|bi 409306|mesh-list
5853855|NCT02438683|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5853856|NCT02438683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5853857|NCT02438683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5853858|NCT02438852|Ropivacaine|ropivacaine|mesh-list
5853859|NCT02438852|Anesthetics, Local|anesthetics, local|mesh-ancestor
5853860|NCT02438852|Anesthetics|anesthetics|mesh-ancestor
5853861|NCT02438852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5853862|NCT02438852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853863|NCT02438852|Sensory System Agents|sensory system agents|mesh-ancestor
5853864|NCT02438852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5853865|NCT02438657|Lidocaine|lidocaine|mesh-list
5853866|NCT02438657|Epinephrine|epinephrine|mesh-list
5853867|NCT02438657|Anesthetics, Local|anesthetics, local|mesh-ancestor
5853868|NCT02438657|Anesthetics|anesthetics|mesh-ancestor
5853869|NCT02438657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5853870|NCT02438657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853871|NCT02438657|Sensory System Agents|sensory system agents|mesh-ancestor
5853872|NCT02438657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5853873|NCT02438657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5853874|NCT02438657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5853875|NCT02438657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5853876|NCT02438657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5853877|NCT02438657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5853878|NCT02438657|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5853879|NCT02438657|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5853880|NCT02438657|Adrenergic Agents|adrenergic agents|mesh-ancestor
5853881|NCT02438657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5853882|NCT02438657|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5853883|NCT02438657|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5853884|NCT02438657|Autonomic Agents|autonomic agents|mesh-ancestor
5853885|NCT02438657|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5853886|NCT02438657|Respiratory System Agents|respiratory system agents|mesh-ancestor
5853887|NCT02438657|Mydriatics|mydriatics|mesh-ancestor
5853888|NCT02438657|Sympathomimetics|sympathomimetics|mesh-ancestor
5853889|NCT02438657|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5853890|NCT02438865|Epirubicin|epirubicin|mesh-list
5853891|NCT02438865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5853892|NCT02438865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5853893|NCT02438865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5853894|NCT02438865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5853895|NCT02438865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5853896|NCT02438865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904151|NCT02158507|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5904152|NCT02045901|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
5904153|NCT02045901|Antiemetics|antiemetics|mesh-ancestor
5904154|NCT02045901|Autonomic Agents|autonomic agents|mesh-ancestor
5904155|NCT02045901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5904156|NCT02045901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904157|NCT02045901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5904158|NCT02045901|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5904159|NCT02045901|Histamine Antagonists|histamine antagonists|mesh-ancestor
5904160|NCT02045901|Histamine Agents|histamine agents|mesh-ancestor
5904161|NCT02045901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6494347|NCT00618241|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6494348|NCT00618254|Granisetron|granisetron|mesh-list
6494349|NCT00618254|Antiemetics|antiemetics|mesh-ancestor
6494350|NCT00618254|Autonomic Agents|autonomic agents|mesh-ancestor
6494351|NCT00618254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6494352|NCT00618254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494353|NCT00618254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6494354|NCT00618254|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5670566|NCT03570645|Autonomic Agents|autonomic agents|mesh-ancestor
5853897|NCT02438566|Tranexamic Acid|tranexamic acid|mesh-list
5853898|NCT02438566|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5853899|NCT02438566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5853900|NCT02438566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5853901|NCT02438566|Hemostatics|hemostatics|mesh-ancestor
5853902|NCT02438566|Coagulants|coagulants|mesh-ancestor
5853903|NCT02438345|Leronlimab|leronlimab|mesh-list
5853904|NCT02438345|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5853905|NCT02438345|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5853906|NCT02438345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5853907|NCT02438345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5670567|NCT03570645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5670568|NCT03570645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670569|NCT03570645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5670570|NCT03570645|Glucocorticoids|glucocorticoids|mesh-ancestor
5670571|NCT03570645|Hormones|hormones|mesh-ancestor
5670572|NCT03570645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5670573|NCT03570645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5670574|NCT03570645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5670575|NCT03570645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5670576|NCT03570645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5670577|NCT03570645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5670578|NCT03570645|Analgesics|analgesics|mesh-ancestor
5670579|NCT03570645|Sensory System Agents|sensory system agents|mesh-ancestor
5670580|NCT03570645|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5670581|NCT03570645|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5670582|NCT03570645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5670583|NCT03570645|Adrenergic Agents|adrenergic agents|mesh-ancestor
5670584|NCT03570645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5670585|NCT03570645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5670586|NCT03570541|Acetaminophen|acetaminophen|mesh-list
5670587|NCT03570541|Morphine|morphine|mesh-list
5670588|NCT03570541|Ropivacaine|ropivacaine|mesh-list
5670589|NCT03570541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5670590|NCT03570541|Narcotics|narcotics|mesh-ancestor
5670591|NCT03570541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5670592|NCT03570541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670593|NCT03570541|Analgesics|analgesics|mesh-ancestor
5670594|NCT03570541|Sensory System Agents|sensory system agents|mesh-ancestor
5670595|NCT03570541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5670596|NCT03570541|Anesthetics, Local|anesthetics, local|mesh-ancestor
5670597|NCT03570541|Anesthetics|anesthetics|mesh-ancestor
5670598|NCT03570541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5670599|NCT03570541|Antipyretics|antipyretics|mesh-ancestor
5670600|NCT03570437|Paclitaxel|paclitaxel|mesh-list
5670601|NCT03570437|Olaparib|olaparib|mesh-list
5670602|NCT03570437|Cediranib|cediranib|mesh-list
5670603|NCT03570437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5670604|NCT03570437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5670605|NCT03570437|Tubulin Modulators|tubulin modulators|mesh-ancestor
5670606|NCT03570437|Antimitotic Agents|antimitotic agents|mesh-ancestor
5670607|NCT03570437|Mitosis Modulators|mitosis modulators|mesh-ancestor
5670608|NCT03570437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5670609|NCT03570437|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5670610|NCT03570437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5670611|NCT03570437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5853908|NCT02438345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5853909|NCT02438345|Antiviral Agents|antiviral agents|mesh-ancestor
5853910|NCT02438345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5853911|NCT02438397|Insulin|insulin|mesh-list
5853912|NCT02438397|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5853913|NCT02438397|Metformin|metformin|mesh-list
5853914|NCT02438397|Acarbose|acarbose|mesh-list
5670612|NCT03570359|Interferons|interferons|mesh-list
5670613|NCT03570359|Interferon-beta|interferon-beta|mesh-list
5670614|NCT03570359|Interferon beta-1a|interferon beta-1a|mesh-list
5670615|NCT03570359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5670616|NCT03570359|Antiviral Agents|antiviral agents|mesh-ancestor
5853915|NCT02438397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5853916|NCT02438397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853917|NCT02438397|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
5670617|NCT03570359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5670618|NCT03570359|Immunologic Factors|immunologic factors|mesh-ancestor
5670619|NCT03570359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853918|NCT02438397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5853919|NCT02438397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5853920|NCT02438098|Rivaroxaban|rivaroxaban|mesh-list
5853921|NCT02438098|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5853922|NCT02438098|Antithrombins|antithrombins|mesh-ancestor
5853923|NCT02438098|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5853924|NCT02438098|Protease Inhibitors|protease inhibitors|mesh-ancestor
5853925|NCT02438098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5853926|NCT02438098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5853927|NCT02438098|Anticoagulants|anticoagulants|mesh-ancestor
5853928|NCT02437825|Octreotide|octreotide|mesh-list
5853929|NCT02437825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5853930|NCT02437825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5853931|NCT02437825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5853932|NCT02438072|Fexofenadine|fexofenadine|mesh-list
5853933|NCT02438072|Flurbiprofen|flurbiprofen|mesh-list
5853934|NCT02438072|Midazolam|midazolam|mesh-list
5853935|NCT02438072|Dextromethorphan|dextromethorphan|mesh-list
5853936|NCT02438072|Caffeine|caffeine|mesh-list
5853937|NCT02438072|Bupropion|bupropion|mesh-list
5853938|NCT02438072|Omeprazole|omeprazole|mesh-list
5853939|NCT02438072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5853940|NCT02438072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5853941|NCT02438072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5853942|NCT02438072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853943|NCT02438072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5853944|NCT02438072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5853945|NCT02438072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5853946|NCT02438072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5853947|NCT02438072|Anesthetics, General|anesthetics, general|mesh-ancestor
5853948|NCT02438072|Anesthetics|anesthetics|mesh-ancestor
5853949|NCT02438072|GABA Modulators|gaba modulators|mesh-ancestor
5853950|NCT02438072|GABA Agents|gaba agents|mesh-ancestor
5853951|NCT02438072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5853952|NCT02438072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5853953|NCT02438072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5853954|NCT02438072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5853955|NCT02438072|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5853956|NCT02438072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5853957|NCT02438072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5853958|NCT02438072|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5853959|NCT02438072|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6494355|NCT00618254|Serotonin Agents|serotonin agents|mesh-ancestor
6494356|NCT00618254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6494357|NCT00618254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494358|NCT00618280|Nicotine|nicotine|mesh-list
6494359|NCT00618280|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6494360|NCT00618280|Autonomic Agents|autonomic agents|mesh-ancestor
6494361|NCT00618280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6494362|NCT00618280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494363|NCT00618280|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6494364|NCT00618280|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5670620|NCT03570359|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5670621|NCT03570346|Hemay005|hemay005|mesh-list
5670622|NCT03570346|Dermatologic Agents|dermatologic agents|mesh-ancestor
5670623|NCT03570346|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5670624|NCT03570346|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5670625|NCT03570346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5670626|NCT03570346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5670627|NCT03570320|Analgesics, Opioid|analgesics, opioid|mesh-list
5670628|NCT03570320|Narcotics|narcotics|mesh-ancestor
5670629|NCT03570320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5670630|NCT03570320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670631|NCT03570320|Analgesics|analgesics|mesh-ancestor
5670632|NCT03570320|Sensory System Agents|sensory system agents|mesh-ancestor
5670633|NCT03570320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5670634|NCT03570294|Atosiban|atosiban|mesh-list
6494365|NCT00618280|Cholinergic Agents|cholinergic agents|mesh-ancestor
6494366|NCT00618280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6494367|NCT00618280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494368|NCT00618345|Everolimus|everolimus|mesh-list
6494369|NCT00618345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6494370|NCT00618345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6494371|NCT00618345|Immunologic Factors|immunologic factors|mesh-ancestor
6494372|NCT00618345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494373|NCT00618358|Thrombin|thrombin|mesh-list
6494374|NCT00618358|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
5853960|NCT02438072|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5670635|NCT03570294|Hormone Antagonists|hormone antagonists|mesh-ancestor
5670636|NCT03570294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5670637|NCT03570294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670638|NCT03570294|Tocolytic Agents|tocolytic agents|mesh-ancestor
5670639|NCT03570294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5670640|NCT03570281|Enoxaparin|enoxaparin|mesh-list
5670641|NCT03570281|Edoxaban|edoxaban|mesh-list
5670642|NCT03570281|Anticoagulants|anticoagulants|mesh-ancestor
5670643|NCT03570281|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5670644|NCT03570281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5670645|NCT03570281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5670646|NCT03570281|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5670647|NCT03570281|Antithrombins|antithrombins|mesh-ancestor
5670648|NCT03570281|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5670649|NCT03570281|Protease Inhibitors|protease inhibitors|mesh-ancestor
5670650|NCT03570281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5670651|NCT03570164|Sevoflurane|sevoflurane|mesh-list
5670652|NCT03570164|Desflurane|desflurane|mesh-list
5670653|NCT03570164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5670654|NCT03570164|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5670655|NCT03570164|Anesthetics, General|anesthetics, general|mesh-ancestor
5670656|NCT03570164|Anesthetics|anesthetics|mesh-ancestor
5670657|NCT03570164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5853961|NCT02438072|Purinergic Agents|purinergic agents|mesh-ancestor
5853962|NCT02438072|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6674859|NCT01571804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674860|NCT01571804|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6674861|NCT01571804|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6674862|NCT01571804|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6674863|NCT01571804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6674864|NCT01571804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6674865|NCT01571856|Zinc Sulfate|zinc sulfate|mesh-list
6674866|NCT01571856|Astringents|astringents|mesh-ancestor
6674867|NCT01571856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674868|NCT01571856|Dermatologic Agents|dermatologic agents|mesh-ancestor
6674869|NCT01571882|Policosanol|policosanol|mesh-list
6674870|NCT01571882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6674871|NCT01571882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6674872|NCT01571882|Antimetabolites|antimetabolites|mesh-ancestor
6674873|NCT01571882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674874|NCT01571882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6674875|NCT01571882|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5853963|NCT02438072|Antidepressive Agents|antidepressive agents|mesh-ancestor
5853964|NCT02438072|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5853965|NCT02438072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5853966|NCT02438072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5670658|NCT03570164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670659|NCT03570112|Sofosbuvir|sofosbuvir|mesh-list
5670660|NCT03570112|Velpatasvir|velpatasvir|mesh-list
5670661|NCT03570112|Antiviral Agents|antiviral agents|mesh-ancestor
5670662|NCT03570112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5670663|NCT03570099|Naloxone|naloxone|mesh-list
5670664|NCT03570099|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5670665|NCT03570099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670666|NCT03570099|Sensory System Agents|sensory system agents|mesh-ancestor
5853967|NCT02438072|Dopamine Agents|dopamine agents|mesh-ancestor
5853968|NCT02438072|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5853969|NCT02438072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5853970|NCT02438072|Antitussive Agents|antitussive agents|mesh-ancestor
5853971|NCT02438072|Respiratory System Agents|respiratory system agents|mesh-ancestor
5853972|NCT02438072|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5853973|NCT02438072|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5853974|NCT02438072|Analgesics|analgesics|mesh-ancestor
5670667|NCT03570099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5670668|NCT03569995|Cytarabine|cytarabine|mesh-list
5670669|NCT03569995|Rituximab|rituximab|mesh-list
5670670|NCT03569995|Methotrexate|methotrexate|mesh-list
5670671|NCT03569995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5670672|NCT03569995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5853975|NCT02438072|Sensory System Agents|sensory system agents|mesh-ancestor
5853976|NCT02438072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5670673|NCT03569995|Immunologic Factors|immunologic factors|mesh-ancestor
5670674|NCT03569995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670675|NCT03569995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5853977|NCT02438072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5853978|NCT02438072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5853979|NCT02438072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5853980|NCT02438072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5853981|NCT02438072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5853982|NCT02438072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5853983|NCT02438072|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5853984|NCT02438072|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5853985|NCT02438072|Histamine Antagonists|histamine antagonists|mesh-ancestor
5853986|NCT02438072|Histamine Agents|histamine agents|mesh-ancestor
5853987|NCT02438020|Metformin|metformin|mesh-list
5853988|NCT02438020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5670676|NCT03569995|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5670677|NCT03569995|Abortifacient Agents|abortifacient agents|mesh-ancestor
5670678|NCT03569995|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5853989|NCT02438020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5853990|NCT02437812|Metformin|metformin|mesh-list
5853991|NCT02437812|Paclitaxel|paclitaxel|mesh-list
5853992|NCT02437812|Carboplatin|carboplatin|mesh-list
5853993|NCT02437812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5853994|NCT02437812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5853995|NCT02437812|Tubulin Modulators|tubulin modulators|mesh-ancestor
5853996|NCT02437812|Antimitotic Agents|antimitotic agents|mesh-ancestor
5853997|NCT02437812|Mitosis Modulators|mitosis modulators|mesh-ancestor
5853998|NCT02437812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5853999|NCT02437812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5854000|NCT02437812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854001|NCT02437955|Ferrous fumarate|ferrous fumarate|mesh-list
5670679|NCT03569995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5670680|NCT03569995|Antimetabolites|antimetabolites|mesh-ancestor
5670681|NCT03569995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5670682|NCT03569995|Dermatologic Agents|dermatologic agents|mesh-ancestor
5670683|NCT03569995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5670684|NCT03569995|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5670685|NCT03569995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5670686|NCT03569995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5670687|NCT03569995|Antiviral Agents|antiviral agents|mesh-ancestor
5670688|NCT03569995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5670689|NCT03569839|Propofol|propofol|mesh-list
5670690|NCT03569839|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5670691|NCT03569839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5670692|NCT03569839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670693|NCT03569839|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5670694|NCT03569839|Anesthetics, General|anesthetics, general|mesh-ancestor
5670695|NCT03569839|Anesthetics|anesthetics|mesh-ancestor
5670696|NCT03569696|Nivolumab|nivolumab|mesh-list
5670697|NCT03569696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5670698|NCT03569696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5670699|NCT03569696|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5670700|NCT03569696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5670701|NCT03569683|Hyaluronic Acid|hyaluronic acid|mesh-list
5670702|NCT03569683|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5670703|NCT03569683|Immunologic Factors|immunologic factors|mesh-ancestor
5670704|NCT03569683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670705|NCT03569683|Viscosupplements|viscosupplements|mesh-ancestor
5670706|NCT03569683|Protective Agents|protective agents|mesh-ancestor
5696015|NCT03386071|Trametinib|trametinib|mesh-list
5696016|NCT03386071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5696017|NCT03386071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5696018|NCT03386071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5696019|NCT03386071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696020|NCT03385967|Dexmedetomidine|dexmedetomidine|mesh-list
5696021|NCT03385967|Ropivacaine|ropivacaine|mesh-list
5696022|NCT03385967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5696023|NCT03385967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5696024|NCT03385967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696025|NCT03385967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5696026|NCT03385967|Analgesics|analgesics|mesh-ancestor
5696027|NCT03385967|Sensory System Agents|sensory system agents|mesh-ancestor
5696028|NCT03385967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5696029|NCT03385967|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5696030|NCT03385967|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5854002|NCT02437955|Trace Elements|trace elements|mesh-ancestor
5854003|NCT02437955|Micronutrients|micronutrients|mesh-ancestor
5854004|NCT02437955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854005|NCT02437461|Triamcinolone|triamcinolone|mesh-list
5854006|NCT02437461|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5854007|NCT02437461|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5854008|NCT02437461|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5854009|NCT02437461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5854010|NCT02437461|Glucocorticoids|glucocorticoids|mesh-ancestor
5670707|NCT03569579|Memantine|memantine|mesh-list
5670708|NCT03569579|Donepezil|donepezil|mesh-list
5670709|NCT03569579|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5670710|NCT03569579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5670711|NCT03569579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5670712|NCT03569579|Cholinergic Agents|cholinergic agents|mesh-ancestor
5670713|NCT03569579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5670714|NCT03569579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670715|NCT03569579|Nootropic Agents|nootropic agents|mesh-ancestor
5670716|NCT03569579|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5670717|NCT03569579|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5670718|NCT03569579|Dopamine Agents|dopamine agents|mesh-ancestor
5670719|NCT03569579|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5670720|NCT03569579|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5670721|NCT03569540|Glyburide|glyburide|mesh-list
5670722|NCT03569540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5670723|NCT03569540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670724|NCT03569475|Milnacipran|milnacipran|mesh-list
5670725|NCT03569475|Fluoxetine|fluoxetine|mesh-list
5670726|NCT03569475|Levomilnacipran|levomilnacipran|mesh-list
5854011|NCT02437461|Hormones|hormones|mesh-ancestor
5854012|NCT02437461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5854013|NCT02437461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854014|NCT02437461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5854015|NCT02437461|Immunologic Factors|immunologic factors|mesh-ancestor
5854016|NCT02437461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5854017|NCT02437461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854018|NCT02437721|Folic Acid|folic acid|mesh-list
5854019|NCT02437721|Vitamin B Complex|vitamin b complex|mesh-list
5854020|NCT02437721|Hematinics|hematinics|mesh-ancestor
5854021|NCT02437721|Vitamins|vitamins|mesh-ancestor
5854022|NCT02437721|Micronutrients|micronutrients|mesh-ancestor
5854023|NCT02437721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854024|NCT02437565|Salicylic Acid|salicylic acid|mesh-list
5670727|NCT03569475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5670728|NCT03569475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5670729|NCT03569475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5670730|NCT03569475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5670731|NCT03569475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5854025|NCT02437565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5854026|NCT02437565|Antifungal Agents|antifungal agents|mesh-ancestor
5854027|NCT02437565|Keratolytic Agents|keratolytic agents|mesh-ancestor
5854028|NCT02437565|Dermatologic Agents|dermatologic agents|mesh-ancestor
5854029|NCT02437591|Fidaxomicin|fidaxomicin|mesh-list
5854030|NCT02437591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5854031|NCT02437591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5854032|NCT02437656|Metformin|metformin|mesh-list
5854033|NCT02437656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5854034|NCT02437656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854035|NCT02437045|Meropenem|meropenem|mesh-list
5854036|NCT02437045|Tazobactam|tazobactam|mesh-list
5854037|NCT02437045|Piperacillin|piperacillin|mesh-list
5854038|NCT02437045|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
5854039|NCT02437045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5854040|NCT02437045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5854041|NCT02437045|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5854042|NCT02437045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5854043|NCT02437045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854044|NCT02437279|Nivolumab|nivolumab|mesh-list
5854045|NCT02437279|Ipilimumab|ipilimumab|mesh-list
5854046|NCT02437279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5854047|NCT02437279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5854048|NCT02437279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5854049|NCT02437279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854050|NCT02436993|Paclitaxel|paclitaxel|mesh-list
5854051|NCT02436993|Bevacizumab|bevacizumab|mesh-list
5854052|NCT02436993|Carboplatin|carboplatin|mesh-list
5854053|NCT02436993|Trastuzumab|trastuzumab|mesh-list
5670732|NCT03569475|Serotonin Agents|serotonin agents|mesh-ancestor
5854054|NCT02436993|Pertuzumab|pertuzumab|mesh-list
5854055|NCT02436993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5854056|NCT02436993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5854057|NCT02436993|Tubulin Modulators|tubulin modulators|mesh-ancestor
5854058|NCT02436993|Antimitotic Agents|antimitotic agents|mesh-ancestor
5854059|NCT02436993|Mitosis Modulators|mitosis modulators|mesh-ancestor
5854060|NCT02436993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854061|NCT02436993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5854062|NCT02436993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5854063|NCT02436993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5854064|NCT02436993|Growth Substances|growth substances|mesh-ancestor
5854065|NCT02436993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854066|NCT02436993|Growth Inhibitors|growth inhibitors|mesh-ancestor
5854067|NCT02437071|Pembrolizumab|pembrolizumab|mesh-list
5854068|NCT02437071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5854069|NCT02437071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5854070|NCT02436980|Midazolam|midazolam|mesh-list
5854071|NCT02436980|Tramadol|tramadol|mesh-list
5854072|NCT02436980|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5854073|NCT02436980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5854074|NCT02436980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5854075|NCT02436980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854076|NCT02436980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5854077|NCT02436980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5854078|NCT02436980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5854079|NCT02436980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5854080|NCT02436980|Anesthetics, General|anesthetics, general|mesh-ancestor
5854081|NCT02436980|Anesthetics|anesthetics|mesh-ancestor
5854082|NCT02436980|GABA Modulators|gaba modulators|mesh-ancestor
5854083|NCT02436980|GABA Agents|gaba agents|mesh-ancestor
5854084|NCT02436980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5854085|NCT02436980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854086|NCT02436980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5854087|NCT02436980|Narcotics|narcotics|mesh-ancestor
5854088|NCT02436980|Analgesics|analgesics|mesh-ancestor
5854089|NCT02436980|Sensory System Agents|sensory system agents|mesh-ancestor
5854090|NCT02436980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5854091|NCT02437032|Menotropins|menotropins|mesh-list
5854092|NCT02437032|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5854093|NCT02437032|Fertility Agents|fertility agents|mesh-ancestor
5854094|NCT02437032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5670733|NCT03569475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670734|NCT03569475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5670735|NCT03569475|Antidepressive Agents|antidepressive agents|mesh-ancestor
5670736|NCT03569475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5670737|NCT03569475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5670738|NCT03569475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5670739|NCT03569475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5696031|NCT03385967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5854095|NCT02437032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854096|NCT02437136|Pembrolizumab|pembrolizumab|mesh-list
5854097|NCT02437136|Entinostat|entinostat|mesh-list
5854098|NCT02437136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5854099|NCT02437136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5854100|NCT02437136|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5854101|NCT02437136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5854102|NCT02437136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904162|NCT02045901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904163|NCT01836068|Enfuvirtide|enfuvirtide|mesh-list
5904164|NCT01836068|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5904165|NCT01836068|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5904166|NCT01836068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904167|NCT01836068|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5904168|NCT01836068|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5904169|NCT01836068|Antiviral Agents|antiviral agents|mesh-ancestor
5904170|NCT01836068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5904171|NCT01308190|Capecitabine|capecitabine|mesh-list
5904172|NCT01308190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5904173|NCT01308190|Antimetabolites|antimetabolites|mesh-ancestor
5904174|NCT01308190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904175|NCT01308190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5904176|NCT01210768|Cyclophosphamide|cyclophosphamide|mesh-list
5904177|NCT01210768|Doxorubicin|doxorubicin|mesh-list
5904178|NCT01210768|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5904179|NCT01210768|Epirubicin|epirubicin|mesh-list
5904180|NCT01210768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5904181|NCT01210768|Immunologic Factors|immunologic factors|mesh-ancestor
5904182|NCT01210768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854103|NCT02436928|Vaccines|vaccines|mesh-list
5854104|NCT02436928|Immunologic Factors|immunologic factors|mesh-ancestor
5854105|NCT02436928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854106|NCT02436902|Sorafenib|sorafenib|mesh-list
5854107|NCT02436902|Chlorotrianisene|chlorotrianisene|mesh-list
5854108|NCT02436902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5854109|NCT02436902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5854110|NCT02436902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5854111|NCT02436902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5670740|NCT03569475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5670741|NCT03569475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5670742|NCT03569475|Analgesics|analgesics|mesh-ancestor
5670743|NCT03569475|Sensory System Agents|sensory system agents|mesh-ancestor
5670744|NCT03569475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5670745|NCT03569241|Androgens|androgens|mesh-list
5670746|NCT03569241|Hormones|hormones|mesh-ancestor
5670747|NCT03569241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5670748|NCT03569241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670749|NCT03569085|Sevoflurane|sevoflurane|mesh-list
5854112|NCT02436902|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
5854113|NCT02436902|Estrogens|estrogens|mesh-ancestor
5854114|NCT02436902|Hormones|hormones|mesh-ancestor
5854115|NCT02436902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5854116|NCT02436902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854117|NCT02436902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5854118|NCT02436538|Hormones|hormones|mesh-list
5854119|NCT02436538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5854120|NCT02436538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854121|NCT02436733|Pemetrexed|pemetrexed|mesh-list
5854122|NCT02436733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5670750|NCT03569085|Isoflurane|isoflurane|mesh-list
5670751|NCT03569085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5670752|NCT03569085|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5670753|NCT03569085|Anesthetics, General|anesthetics, general|mesh-ancestor
5670754|NCT03569085|Anesthetics|anesthetics|mesh-ancestor
5670755|NCT03569085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5670756|NCT03569085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670757|NCT03569046|Antihypertensive Agents|antihypertensive agents|mesh-list
5670758|NCT03569046|Bupivacaine|bupivacaine|mesh-list
5670759|NCT03569046|Anesthetics, Local|anesthetics, local|mesh-list
5670760|NCT03569046|Anesthetics|anesthetics|mesh-list
5670761|NCT03569046|Anesthetics, General|anesthetics, general|mesh-list
5670762|NCT03569046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5670763|NCT03569046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670764|NCT03569046|Sensory System Agents|sensory system agents|mesh-ancestor
5670765|NCT03569046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5670766|NCT03568968|Niacinamide|niacinamide|mesh-list
5670767|NCT03568968|Niacin|niacin|mesh-list
5670768|NCT03568968|Nicotinic Acids|nicotinic acids|mesh-list
5670769|NCT03568968|Vitamin B Complex|vitamin b complex|mesh-ancestor
5670770|NCT03568968|Vitamins|vitamins|mesh-ancestor
5670771|NCT03568968|Micronutrients|micronutrients|mesh-ancestor
5854123|NCT02436733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5854124|NCT02436733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854125|NCT02436733|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5854126|NCT02436733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5854127|NCT02436798|Ondansetron|ondansetron|mesh-list
5854128|NCT02436798|Antiemetics|antiemetics|mesh-ancestor
5854129|NCT02436798|Autonomic Agents|autonomic agents|mesh-ancestor
5854130|NCT02436798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5854131|NCT02436798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854132|NCT02436798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5854133|NCT02436798|Antipruritics|antipruritics|mesh-ancestor
5854134|NCT02436798|Dermatologic Agents|dermatologic agents|mesh-ancestor
5854135|NCT02436798|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5854136|NCT02436798|Serotonin Agents|serotonin agents|mesh-ancestor
5854137|NCT02436798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5854138|NCT02436798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854139|NCT02436798|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5854140|NCT02436798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5854141|NCT02436798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5854142|NCT02436798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5854143|NCT02436798|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5854144|NCT02436694|Dexamethasone|dexamethasone|mesh-list
5854145|NCT02436694|Dexamethasone acetate|dexamethasone acetate|mesh-list
5670772|NCT03568968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670773|NCT03568968|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5670774|NCT03568968|Antimetabolites|antimetabolites|mesh-ancestor
5670775|NCT03568968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854146|NCT02436694|Ropivacaine|ropivacaine|mesh-list
5854147|NCT02436694|Anesthetics, Local|anesthetics, local|mesh-list
5854148|NCT02436694|Anesthetics|anesthetics|mesh-list
5854149|NCT02436694|BB 1101|bb 1101|mesh-list
5854150|NCT02436694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5854151|NCT02436694|Antiemetics|antiemetics|mesh-ancestor
5854152|NCT02436694|Autonomic Agents|autonomic agents|mesh-ancestor
5854153|NCT02436694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5854154|NCT02436694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854155|NCT02436694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5854156|NCT02436694|Glucocorticoids|glucocorticoids|mesh-ancestor
5854157|NCT02436694|Hormones|hormones|mesh-ancestor
5854158|NCT02436694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5854159|NCT02436694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5854160|NCT02436694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5854161|NCT02436694|Protease Inhibitors|protease inhibitors|mesh-ancestor
5854162|NCT02436694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5670776|NCT03568968|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5670777|NCT03568968|Vasodilator Agents|vasodilator agents|mesh-ancestor
5670778|NCT03568916|Rivaroxaban|rivaroxaban|mesh-list
5670779|NCT03568916|Apixaban|apixaban|mesh-list
5670780|NCT03568916|Dabigatran|dabigatran|mesh-list
5854163|NCT02436694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854164|NCT02436694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5854165|NCT02436694|Sensory System Agents|sensory system agents|mesh-ancestor
5854166|NCT02436486|Moxifloxacin|moxifloxacin|mesh-list
5854167|NCT02436486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5854168|NCT02436486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5854169|NCT02436486|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5854170|NCT02436486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5854171|NCT02436486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5854172|NCT02436486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854173|NCT02436486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5854174|NCT02436499|Botulinum Toxins|botulinum toxins|mesh-list
5854175|NCT02436499|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5854176|NCT02436499|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5854177|NCT02436499|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5854178|NCT02436499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5854179|NCT02436499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854180|NCT02436499|Cholinergic Agents|cholinergic agents|mesh-ancestor
5854181|NCT02436499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5854182|NCT02436499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854183|NCT02436499|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5854184|NCT02436499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5854185|NCT02436512|Nitric Oxide|nitric oxide|mesh-list
5854186|NCT02436512|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5854187|NCT02436512|Autonomic Agents|autonomic agents|mesh-ancestor
5854188|NCT02436512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5854189|NCT02436512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854190|NCT02436512|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5854191|NCT02436512|Respiratory System Agents|respiratory system agents|mesh-ancestor
5854192|NCT02436512|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5854193|NCT02436512|Antioxidants|antioxidants|mesh-ancestor
5854194|NCT02436512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854195|NCT02436512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5854196|NCT02436512|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5854197|NCT02436512|Vasodilator Agents|vasodilator agents|mesh-ancestor
5854198|NCT02436512|Gasotransmitters|gasotransmitters|mesh-ancestor
5854199|NCT02436512|Protective Agents|protective agents|mesh-ancestor
5670781|NCT03568916|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5670782|NCT03568916|Antithrombins|antithrombins|mesh-ancestor
5670783|NCT03568916|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5854200|NCT02436395|Povidone-Iodine|povidone-iodine|mesh-list
5854201|NCT02436395|Povidone|povidone|mesh-list
5854202|NCT02436395|Plasma Substitutes|plasma substitutes|mesh-ancestor
5854203|NCT02436395|Blood Substitutes|blood substitutes|mesh-ancestor
5854204|NCT02436395|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5854205|NCT02436395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5854206|NCT02436226|Citric Acid|citric acid|mesh-list
5854207|NCT02436226|Sodium Citrate|sodium citrate|mesh-list
5670784|NCT03568916|Protease Inhibitors|protease inhibitors|mesh-ancestor
5854208|NCT02436226|Clomiphene|clomiphene|mesh-list
5854209|NCT02436226|Enclomiphene|enclomiphene|mesh-list
5854210|NCT02436226|Zuclomiphene|zuclomiphene|mesh-list
5670785|NCT03568916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5670786|NCT03568916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5670787|NCT03568916|Anticoagulants|anticoagulants|mesh-ancestor
5670788|NCT03568890|Aspirin|aspirin|mesh-list
5670789|NCT03568890|Rivaroxaban|rivaroxaban|mesh-list
5670790|NCT03568890|Apixaban|apixaban|mesh-list
5670791|NCT03568890|Edoxaban|edoxaban|mesh-list
5670792|NCT03568890|Dabigatran|dabigatran|mesh-list
5670793|NCT03568890|Clopidogrel|clopidogrel|mesh-list
5670794|NCT03568890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5670795|NCT03568890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5670796|NCT03568890|Analgesics|analgesics|mesh-ancestor
5670797|NCT03568890|Sensory System Agents|sensory system agents|mesh-ancestor
5670798|NCT03568890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5670799|NCT03568890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670800|NCT03568890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5670801|NCT03568890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5670802|NCT03568890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5670803|NCT03568890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5670804|NCT03568890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5670805|NCT03568890|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5670806|NCT03568890|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5670807|NCT03568890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5670808|NCT03568890|Antipyretics|antipyretics|mesh-ancestor
5670809|NCT03568890|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5670810|NCT03568890|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5670811|NCT03568890|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5670812|NCT03568890|Purinergic Agents|purinergic agents|mesh-ancestor
5670813|NCT03568890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5670814|NCT03568890|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5670815|NCT03568890|Antithrombins|antithrombins|mesh-ancestor
5670816|NCT03568890|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5670817|NCT03568890|Protease Inhibitors|protease inhibitors|mesh-ancestor
5670818|NCT03568890|Anticoagulants|anticoagulants|mesh-ancestor
5670819|NCT03568838|Enoxaparin|enoxaparin|mesh-list
5670820|NCT03568838|Anticoagulants|anticoagulants|mesh-ancestor
5670821|NCT03568838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5670822|NCT03568838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5670823|NCT03568838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5670824|NCT03568721|Acetaminophen|acetaminophen|mesh-list
5670825|NCT03568721|Ibuprofen|ibuprofen|mesh-list
5670826|NCT03568721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5670827|NCT03568721|Analgesics|analgesics|mesh-ancestor
5670828|NCT03568721|Sensory System Agents|sensory system agents|mesh-ancestor
5670829|NCT03568721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5854211|NCT02436226|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5854212|NCT02436226|Anticoagulants|anticoagulants|mesh-ancestor
5854213|NCT02436226|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5854214|NCT02436226|Chelating Agents|chelating agents|mesh-ancestor
5854215|NCT02436226|Sequestering Agents|sequestering agents|mesh-ancestor
5854216|NCT02436226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854217|NCT02436226|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5854218|NCT02436226|Hormone Antagonists|hormone antagonists|mesh-ancestor
5854219|NCT02436226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5854220|NCT02436226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854221|NCT02436226|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5854222|NCT02436226|Fertility Agents|fertility agents|mesh-ancestor
5670830|NCT03568721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670831|NCT03568721|Antipyretics|antipyretics|mesh-ancestor
5670832|NCT03568721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5670833|NCT03568721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5670834|NCT03568721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5670835|NCT03568721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5670836|NCT03568721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5670837|NCT03568721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5670838|NCT03568708|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5670839|NCT03568708|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5670840|NCT03568708|Estradiol|estradiol|mesh-list
5670841|NCT03568708|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5670842|NCT03568708|Estrogens|estrogens|mesh-list
5670843|NCT03568708|Hormones|hormones|mesh-ancestor
5670844|NCT03568708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5854223|NCT02436226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5670845|NCT03568708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670846|NCT03568708|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5670847|NCT03568708|Contraceptive Agents|contraceptive agents|mesh-ancestor
5854224|NCT02436226|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5854225|NCT02436226|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5854226|NCT02436083|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5854227|NCT02436083|Cefuroxime|cefuroxime|mesh-list
5854228|NCT02436083|Cefuroxime axetil|cefuroxime axetil|mesh-list
5854229|NCT02436083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5854230|NCT02436044|Leucovorin|leucovorin|mesh-list
5854231|NCT02436044|Fluorouracil|fluorouracil|mesh-list
5854232|NCT02436044|Oxaliplatin|oxaliplatin|mesh-list
5854233|NCT02436044|Levoleucovorin|levoleucovorin|mesh-list
5854234|NCT02436044|Antimetabolites|antimetabolites|mesh-ancestor
5854235|NCT02436044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854236|NCT02436044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5854237|NCT02436044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5854238|NCT02436044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5854239|NCT02436044|Immunologic Factors|immunologic factors|mesh-ancestor
5854240|NCT02436044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854241|NCT02436044|Antidotes|antidotes|mesh-ancestor
5854242|NCT02436044|Protective Agents|protective agents|mesh-ancestor
5854243|NCT02436044|Vitamin B Complex|vitamin b complex|mesh-ancestor
5854244|NCT02436044|Vitamins|vitamins|mesh-ancestor
5854245|NCT02436044|Micronutrients|micronutrients|mesh-ancestor
5854246|NCT02435927|Leucovorin|leucovorin|mesh-list
5854247|NCT02435927|Fluorouracil|fluorouracil|mesh-list
5854248|NCT02435927|Capecitabine|capecitabine|mesh-list
5854249|NCT02435927|Oxaliplatin|oxaliplatin|mesh-list
5854250|NCT02435927|Antimetabolites|antimetabolites|mesh-ancestor
5854251|NCT02435927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854252|NCT02435927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5854253|NCT02435927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5854254|NCT02435927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5854255|NCT02435927|Immunologic Factors|immunologic factors|mesh-ancestor
5854256|NCT02435927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854257|NCT02435927|Antidotes|antidotes|mesh-ancestor
5854258|NCT02435927|Protective Agents|protective agents|mesh-ancestor
5854259|NCT02435927|Vitamin B Complex|vitamin b complex|mesh-ancestor
5854260|NCT02435927|Vitamins|vitamins|mesh-ancestor
5854261|NCT02435927|Micronutrients|micronutrients|mesh-ancestor
5854262|NCT02435797|Nicorandil|nicorandil|mesh-list
5854263|NCT02435797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5854264|NCT02435797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5854265|NCT02435797|Vasodilator Agents|vasodilator agents|mesh-ancestor
5854266|NCT02435797|Vitamin B Complex|vitamin b complex|mesh-ancestor
5854267|NCT02435797|Vitamins|vitamins|mesh-ancestor
5854268|NCT02435797|Micronutrients|micronutrients|mesh-ancestor
5854269|NCT02435797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854270|NCT02435771|Ergocalciferols|ergocalciferols|mesh-list
5854271|NCT02435771|Vitamin D|vitamin d|mesh-list
5854272|NCT02435771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5854273|NCT02435771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854274|NCT02435771|Vitamins|vitamins|mesh-ancestor
5854275|NCT02435771|Micronutrients|micronutrients|mesh-ancestor
5854276|NCT02435771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5854277|NCT02435732|Heparin|heparin|mesh-list
5854278|NCT02435732|Anticoagulants|anticoagulants|mesh-ancestor
5854279|NCT02435732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6674876|NCT01571908|Rocuronium|rocuronium|mesh-list
6674877|NCT01571908|Succinylcholine|succinylcholine|mesh-list
6674878|NCT01571908|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6674879|NCT01571908|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6674880|NCT01571908|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6674881|NCT01571908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6674882|NCT01571908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674883|NCT01571908|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
6674884|NCT01571921|Tocotrienols|tocotrienols|mesh-list
6674885|NCT01571921|Vitamin E|vitamin e|mesh-list
6674886|NCT01571921|Tocopherols|tocopherols|mesh-list
6674887|NCT01571921|Antioxidants|antioxidants|mesh-ancestor
6674888|NCT01571921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674889|NCT01571921|Protective Agents|protective agents|mesh-ancestor
6674890|NCT01571921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674891|NCT01571921|Vitamins|vitamins|mesh-ancestor
6674892|NCT01571921|Micronutrients|micronutrients|mesh-ancestor
5854280|NCT02435732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5854281|NCT02435732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674893|NCT01571960|Vaccines|vaccines|mesh-list
5854282|NCT02435654|Olanzapine|olanzapine|mesh-list
5854283|NCT02435654|Antiemetics|antiemetics|mesh-ancestor
5854284|NCT02435654|Autonomic Agents|autonomic agents|mesh-ancestor
5854285|NCT02435654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5854286|NCT02435654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854287|NCT02435654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5854288|NCT02435654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5854289|NCT02435654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5854290|NCT02435654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5854291|NCT02435654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5854292|NCT02435654|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5854293|NCT02435654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5854294|NCT02435654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5854295|NCT02435654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854296|NCT02435654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6674894|NCT01571960|Immunologic Factors|immunologic factors|mesh-ancestor
6674895|NCT01571960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674896|NCT01572012|Ondansetron|ondansetron|mesh-list
6674897|NCT01572012|Antiemetics|antiemetics|mesh-ancestor
5854297|NCT02435654|Serotonin Agents|serotonin agents|mesh-ancestor
5854298|NCT02435563|Ritonavir|ritonavir|mesh-list
5854299|NCT02435563|Ticagrelor|ticagrelor|mesh-list
5854300|NCT02435563|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5854301|NCT02435563|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5854302|NCT02435563|Protease Inhibitors|protease inhibitors|mesh-ancestor
5854303|NCT02435563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5854304|NCT02435563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854305|NCT02435563|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5854306|NCT02435563|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5854307|NCT02435563|Antiviral Agents|antiviral agents|mesh-ancestor
5854308|NCT02435563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5854309|NCT02435563|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5854310|NCT02435563|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5854311|NCT02435563|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5854312|NCT02435563|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5854313|NCT02435563|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5854314|NCT02435563|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5854315|NCT02435563|Purinergic Agents|purinergic agents|mesh-ancestor
5854316|NCT02435563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5854317|NCT02435563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854318|NCT02435537|Dexmedetomidine|dexmedetomidine|mesh-list
5854319|NCT02435537|Morphine|morphine|mesh-list
5854320|NCT02435537|Bupivacaine|bupivacaine|mesh-list
5854321|NCT02435537|Anesthetics, Local|anesthetics, local|mesh-ancestor
5854322|NCT02435537|Anesthetics|anesthetics|mesh-ancestor
5670848|NCT03568708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5670849|NCT03568708|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5670850|NCT03568643|Amoxicillin|amoxicillin|mesh-list
5670851|NCT03568643|Azithromycin|azithromycin|mesh-list
5670852|NCT03568643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5670853|NCT03568643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5670854|NCT03568604|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
5670855|NCT03568604|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5670856|NCT03568604|Immunologic Factors|immunologic factors|mesh-ancestor
5670857|NCT03568604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670858|NCT03568578|Entecavir|entecavir|mesh-list
5670859|NCT03568578|Antiviral Agents|antiviral agents|mesh-ancestor
5670860|NCT03568578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5670861|NCT03568513|Curcumin|curcumin|mesh-list
5670862|NCT03568513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5670863|NCT03568513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5854323|NCT02435537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5854324|NCT02435537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854325|NCT02435537|Sensory System Agents|sensory system agents|mesh-ancestor
5854326|NCT02435537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5854327|NCT02435537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5854328|NCT02435537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5854329|NCT02435537|Analgesics|analgesics|mesh-ancestor
5854330|NCT02435537|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5854331|NCT02435537|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5854332|NCT02435537|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5854333|NCT02435537|Adrenergic Agents|adrenergic agents|mesh-ancestor
5854334|NCT02435537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5854335|NCT02435537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854336|NCT02435537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5854337|NCT02435537|Narcotics|narcotics|mesh-ancestor
5854338|NCT02435459|Calcium|calcium|mesh-list
5904183|NCT01210768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5670864|NCT03568513|Analgesics|analgesics|mesh-ancestor
5670865|NCT03568513|Sensory System Agents|sensory system agents|mesh-ancestor
5854339|NCT02435459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5854340|NCT02435459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854341|NCT02435368|Mycophenolic Acid|mycophenolic acid|mesh-list
5854342|NCT02435368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5854343|NCT02435368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5854344|NCT02435368|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5854345|NCT02435368|Antitubercular Agents|antitubercular agents|mesh-ancestor
5854346|NCT02435368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6212246|NCT02183792|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6494375|NCT00618358|Hemostatics|hemostatics|mesh-ancestor
5854347|NCT02435368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5854348|NCT02435368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5854349|NCT02435368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5670866|NCT03568513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5670867|NCT03568513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670868|NCT03568513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5670869|NCT03568513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5670870|NCT03568513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5670871|NCT03568513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5670872|NCT03568513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5670873|NCT03568474|Fluorides|fluorides|mesh-list
5670874|NCT03568474|Cariostatic Agents|cariostatic agents|mesh-ancestor
5670875|NCT03568474|Protective Agents|protective agents|mesh-ancestor
5670876|NCT03568474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670877|NCT03568318|Upadacitinib|upadacitinib|mesh-list
5670878|NCT03568318|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
5670879|NCT03568318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5670880|NCT03568318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5670881|NCT03568318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5670882|NCT03568318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5670883|NCT03568136|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5670884|NCT03568136|Immunologic Factors|immunologic factors|mesh-ancestor
5670885|NCT03568136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670886|NCT03568097|Avelumab|avelumab|mesh-list
5670887|NCT03568097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5670888|NCT03568097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5854350|NCT02435303|Sildenafil Citrate|sildenafil citrate|mesh-list
5854351|NCT02435303|Vasodilator Agents|vasodilator agents|mesh-ancestor
5854352|NCT02435303|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5854353|NCT02435303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5854354|NCT02435303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5854355|NCT02435303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854356|NCT02435303|Urological Agents|urological agents|mesh-ancestor
5904184|NCT01210768|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5904185|NCT01210768|Alkylating Agents|alkylating agents|mesh-ancestor
5904186|NCT01210768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904187|NCT01210768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5904188|NCT01210768|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5904189|NCT01210768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5904190|NCT01210768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5904191|NCT01210768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5696032|NCT03385967|Adrenergic Agents|adrenergic agents|mesh-ancestor
5696033|NCT03385967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5696034|NCT03385967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696035|NCT03385967|Anesthetics, Local|anesthetics, local|mesh-ancestor
5696036|NCT03385967|Anesthetics|anesthetics|mesh-ancestor
5696037|NCT03385928|Tranexamic Acid|tranexamic acid|mesh-list
5696038|NCT03385928|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5696039|NCT03385928|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5696040|NCT03385928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696041|NCT03385928|Hemostatics|hemostatics|mesh-ancestor
5696042|NCT03385928|Coagulants|coagulants|mesh-ancestor
5696043|NCT03385863|Pulmonary Surfactants|pulmonary surfactants|mesh-list
5696044|NCT03385863|Poractant alfa|poractant alfa|mesh-list
5904192|NCT01210768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5904193|NCT00782574|Olaparib|olaparib|mesh-list
5904194|NCT00782574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5904195|NCT00782574|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5904196|NCT00782574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5904197|NCT00782574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904198|NCT00719225|Abatacept|abatacept|mesh-list
5904199|NCT00719225|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5696045|NCT03385863|Respiratory System Agents|respiratory system agents|mesh-ancestor
5854357|NCT02435095|Antipsychotic Agents|antipsychotic agents|mesh-list
5854358|NCT02435095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5854359|NCT02435095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5854360|NCT02435095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854361|NCT02435095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5854362|NCT02435186|Paclitaxel|paclitaxel|mesh-list
5854363|NCT02435186|Cisplatin|cisplatin|mesh-list
5854364|NCT02435186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5854365|NCT02435186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5854366|NCT02435186|Tubulin Modulators|tubulin modulators|mesh-ancestor
5854367|NCT02435186|Antimitotic Agents|antimitotic agents|mesh-ancestor
5854368|NCT02435186|Mitosis Modulators|mitosis modulators|mesh-ancestor
5854369|NCT02435186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854370|NCT02435108|Crizotinib|crizotinib|mesh-list
5854371|NCT02435108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5854372|NCT02435108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5854373|NCT02435108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5854374|NCT02435108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854375|NCT02434952|Piperaquine|piperaquine|mesh-list
5854376|NCT02434952|Primaquine|primaquine|mesh-list
5854377|NCT02434952|Artenimol|artenimol|mesh-list
5670889|NCT03567941|Acetaminophen|acetaminophen|mesh-list
5670890|NCT03567941|Hydrocodone|hydrocodone|mesh-list
5670891|NCT03567941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5670892|NCT03567941|Analgesics|analgesics|mesh-ancestor
5670893|NCT03567941|Sensory System Agents|sensory system agents|mesh-ancestor
5670894|NCT03567941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5670895|NCT03567941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670896|NCT03567941|Antipyretics|antipyretics|mesh-ancestor
5670897|NCT03567941|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5670898|NCT03567941|Narcotics|narcotics|mesh-ancestor
5670899|NCT03567941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5670900|NCT03567941|Antitussive Agents|antitussive agents|mesh-ancestor
5670901|NCT03567941|Respiratory System Agents|respiratory system agents|mesh-ancestor
5670902|NCT03567928|Propofol|propofol|mesh-list
5670903|NCT03567928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5670904|NCT03567928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5670905|NCT03567928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670906|NCT03567928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5670907|NCT03567928|Anesthetics, General|anesthetics, general|mesh-ancestor
5670908|NCT03567928|Anesthetics|anesthetics|mesh-ancestor
5670909|NCT03567681|Oxcarbazepine|oxcarbazepine|mesh-list
5670910|NCT03567681|Anticonvulsants|anticonvulsants|mesh-ancestor
5670911|NCT03567681|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5670912|NCT03567681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5670913|NCT03567681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5670914|NCT03567681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5670915|NCT03567681|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5670916|NCT03567681|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5670917|NCT03567655|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
5670918|NCT03567655|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5670919|NCT03567655|Contraceptive Agents|contraceptive agents|mesh-ancestor
5670920|NCT03567655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5670921|NCT03567655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670922|NCT03567655|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5670923|NCT03567655|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5670924|NCT03567655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5670925|NCT03567655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5670926|NCT03567629|Calcium, Dietary|calcium, dietary|mesh-list
5670927|NCT03567629|Leucovorin|leucovorin|mesh-list
5670928|NCT03567629|Bevacizumab|bevacizumab|mesh-list
5670929|NCT03567629|Cetuximab|cetuximab|mesh-list
5670930|NCT03567629|Fluorouracil|fluorouracil|mesh-list
5670931|NCT03567629|Capecitabine|capecitabine|mesh-list
5670932|NCT03567629|Oxaliplatin|oxaliplatin|mesh-list
5670933|NCT03567629|Irinotecan|irinotecan|mesh-list
5670934|NCT03567629|Calcium|calcium|mesh-list
5670935|NCT03567629|Levoleucovorin|levoleucovorin|mesh-list
5670936|NCT03567629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5670937|NCT03567629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5854378|NCT02434952|Antimalarials|antimalarials|mesh-ancestor
5854379|NCT02434952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5854380|NCT02434952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5854381|NCT02434952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5670938|NCT03567629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5854382|NCT02434861|Sulfasalazine|sulfasalazine|mesh-list
5854383|NCT02434861|Digoxin|digoxin|mesh-list
5854384|NCT02434861|Rolapitant|rolapitant|mesh-list
5854385|NCT02434861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5670939|NCT03567629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5854386|NCT02434861|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5854387|NCT02434861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5854388|NCT02434861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854389|NCT02434861|Protective Agents|protective agents|mesh-ancestor
5670940|NCT03567629|Growth Substances|growth substances|mesh-ancestor
5670941|NCT03567629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670942|NCT03567629|Growth Inhibitors|growth inhibitors|mesh-ancestor
5670943|NCT03567629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5670944|NCT03567629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5854390|NCT02434861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854391|NCT02434861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5854392|NCT02434861|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5854393|NCT02434861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5854394|NCT02434861|Analgesics|analgesics|mesh-ancestor
5854395|NCT02434861|Sensory System Agents|sensory system agents|mesh-ancestor
5854396|NCT02434861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5854397|NCT02434861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5854398|NCT02434861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5854399|NCT02434861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5854400|NCT02434861|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5854401|NCT02434861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5854402|NCT02434549|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5854403|NCT02434549|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5854404|NCT02434549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5854405|NCT02434549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854406|NCT02434549|Cholinergic Agents|cholinergic agents|mesh-ancestor
5854407|NCT02434549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5854408|NCT02434549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854409|NCT02434822|Vaccines|vaccines|mesh-list
5854410|NCT02434822|Immunologic Factors|immunologic factors|mesh-ancestor
5854411|NCT02434822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854412|NCT02434757|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
5854413|NCT02434757|Hormones|hormones|mesh-ancestor
5854414|NCT02434757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5854415|NCT02434757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854416|NCT02434276|Hemagglutinins|hemagglutinins|mesh-list
5854417|NCT02434276|Immunologic Factors|immunologic factors|mesh-ancestor
5854418|NCT02434276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854419|NCT02434276|Agglutinins|agglutinins|mesh-ancestor
5854420|NCT02434614|Cisplatin|cisplatin|mesh-list
5854421|NCT02434614|Docetaxel|docetaxel|mesh-list
5854422|NCT02434614|Fluorouracil|fluorouracil|mesh-list
5670945|NCT03567629|Antimetabolites|antimetabolites|mesh-ancestor
5670946|NCT03567629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5670947|NCT03567629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5670948|NCT03567629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5670949|NCT03567629|Immunologic Factors|immunologic factors|mesh-ancestor
5670950|NCT03567629|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5670951|NCT03567629|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5670952|NCT03567629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6494376|NCT00618358|Coagulants|coagulants|mesh-ancestor
6494377|NCT00618384|Sorafenib|sorafenib|mesh-list
6494378|NCT00618384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6494379|NCT00618384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5854423|NCT02434614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5854424|NCT02434614|Tubulin Modulators|tubulin modulators|mesh-ancestor
5854425|NCT02434614|Antimitotic Agents|antimitotic agents|mesh-ancestor
5854426|NCT02434614|Mitosis Modulators|mitosis modulators|mesh-ancestor
5670953|NCT03567629|Antidotes|antidotes|mesh-ancestor
5670954|NCT03567629|Protective Agents|protective agents|mesh-ancestor
5670955|NCT03567629|Vitamin B Complex|vitamin b complex|mesh-ancestor
5670956|NCT03567629|Vitamins|vitamins|mesh-ancestor
5670957|NCT03567629|Micronutrients|micronutrients|mesh-ancestor
5670958|NCT03567577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5670959|NCT03567473|Dexamethasone|dexamethasone|mesh-list
5670960|NCT03567473|Epinephrine|epinephrine|mesh-list
5670961|NCT03567473|Racepinephrine|racepinephrine|mesh-list
5670962|NCT03567473|Epinephryl borate|epinephryl borate|mesh-list
5670963|NCT03567473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5670964|NCT03567473|Antiemetics|antiemetics|mesh-ancestor
5670965|NCT03567473|Autonomic Agents|autonomic agents|mesh-ancestor
5670966|NCT03567473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5670967|NCT03567473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670968|NCT03567473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5670969|NCT03567473|Glucocorticoids|glucocorticoids|mesh-ancestor
5670970|NCT03567473|Hormones|hormones|mesh-ancestor
5670971|NCT03567473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5670972|NCT03567473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5670973|NCT03567473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5670974|NCT03567473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5670975|NCT03567473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5670976|NCT03567473|Adrenergic Agents|adrenergic agents|mesh-ancestor
5670977|NCT03567473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5670978|NCT03567473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854427|NCT02434614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854428|NCT02434614|Antimetabolites|antimetabolites|mesh-ancestor
5854429|NCT02434614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5854430|NCT02434614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5854431|NCT02434614|Immunologic Factors|immunologic factors|mesh-ancestor
5854432|NCT02434614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854433|NCT02433860|Nicotine|nicotine|mesh-list
5854434|NCT02433860|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5854435|NCT02433860|Autonomic Agents|autonomic agents|mesh-ancestor
5854436|NCT02433860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5854437|NCT02433860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854438|NCT02433860|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5854439|NCT02433860|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5854440|NCT02433860|Cholinergic Agents|cholinergic agents|mesh-ancestor
5854441|NCT02433860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5854442|NCT02433860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5670979|NCT03567473|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5670980|NCT03567473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5670981|NCT03567473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5670982|NCT03567473|Respiratory System Agents|respiratory system agents|mesh-ancestor
5670983|NCT03567473|Mydriatics|mydriatics|mesh-ancestor
5670984|NCT03567473|Sympathomimetics|sympathomimetics|mesh-ancestor
5670985|NCT03567473|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5670986|NCT03567447|Droxidopa|droxidopa|mesh-list
5670987|NCT03567447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5670988|NCT03567447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5854443|NCT02433847|Mosapride|mosapride|mesh-list
5854444|NCT02433847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5854445|NCT02433847|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5854446|NCT02433847|Serotonin Agents|serotonin agents|mesh-ancestor
5854447|NCT02433847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5854448|NCT02433847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854449|NCT02433847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854450|NCT02433808|Neostigmine|neostigmine|mesh-list
5854451|NCT02433808|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5854452|NCT02433808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5854453|NCT02433808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494380|NCT00618384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6494381|NCT00618384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494382|NCT00618397|Ketamine|ketamine|mesh-list
6494383|NCT00618397|Analgesics|analgesics|mesh-ancestor
6494384|NCT00618397|Sensory System Agents|sensory system agents|mesh-ancestor
6494385|NCT00618397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6494386|NCT00618397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494387|NCT00618397|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6494388|NCT00618397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6494389|NCT00618397|Anesthetics, General|anesthetics, general|mesh-ancestor
6494390|NCT00618397|Anesthetics|anesthetics|mesh-ancestor
6494391|NCT00618397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5670989|NCT03567434|Ethanol|ethanol|mesh-list
5670990|NCT03567434|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5670991|NCT03567434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5670992|NCT03567434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5670993|NCT03567434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5670994|NCT03567408|Bivalirudin|bivalirudin|mesh-list
5670995|NCT03567408|Antithrombins|antithrombins|mesh-ancestor
5670996|NCT03567408|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5854454|NCT02433808|Cholinergic Agents|cholinergic agents|mesh-ancestor
5854455|NCT02433808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5854456|NCT02433808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854457|NCT02433808|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5854458|NCT02433808|Autonomic Agents|autonomic agents|mesh-ancestor
5854459|NCT02433808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5854460|NCT02433899|Chlorhexidine|chlorhexidine|mesh-list
5670997|NCT03567408|Protease Inhibitors|protease inhibitors|mesh-ancestor
5670998|NCT03567408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5670999|NCT03567408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671000|NCT03567408|Anticoagulants|anticoagulants|mesh-ancestor
5671001|NCT03567395|Melatonin|melatonin|mesh-list
5671002|NCT03567395|Antioxidants|antioxidants|mesh-ancestor
5671003|NCT03567395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671004|NCT03567395|Protective Agents|protective agents|mesh-ancestor
5671005|NCT03567395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671006|NCT03567395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5671007|NCT03567369|Dexamethasone|dexamethasone|mesh-list
5671008|NCT03567369|Dexamethasone acetate|dexamethasone acetate|mesh-list
5671009|NCT03567369|BB 1101|bb 1101|mesh-list
5671010|NCT03567369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5854461|NCT02433899|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5854462|NCT02433899|Dexamethasone|dexamethasone|mesh-list
5854463|NCT02433899|Epinephrine|epinephrine|mesh-list
5671011|NCT03567369|Antiemetics|antiemetics|mesh-ancestor
5671012|NCT03567369|Autonomic Agents|autonomic agents|mesh-ancestor
5671013|NCT03567369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5671014|NCT03567369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671015|NCT03567369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5671016|NCT03567369|Glucocorticoids|glucocorticoids|mesh-ancestor
5671017|NCT03567369|Hormones|hormones|mesh-ancestor
5671018|NCT03567369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5671019|NCT03567369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5671020|NCT03567369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5671021|NCT03567369|Protease Inhibitors|protease inhibitors|mesh-ancestor
5671022|NCT03567369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5854464|NCT02433899|Mepivacaine|mepivacaine|mesh-list
5854465|NCT02433899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5854466|NCT02433899|Antiemetics|antiemetics|mesh-ancestor
5854467|NCT02433899|Autonomic Agents|autonomic agents|mesh-ancestor
5854468|NCT02433899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5854469|NCT02433899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854470|NCT02433899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5854471|NCT02433899|Glucocorticoids|glucocorticoids|mesh-ancestor
5854472|NCT02433899|Hormones|hormones|mesh-ancestor
5854473|NCT02433899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5854474|NCT02433899|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5854475|NCT02433899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5854476|NCT02433899|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5854477|NCT02433899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5854478|NCT02433899|Disinfectants|disinfectants|mesh-ancestor
5854479|NCT02433899|Dermatologic Agents|dermatologic agents|mesh-ancestor
5854480|NCT02433899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5854481|NCT02433899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5854482|NCT02433899|Adrenergic Agents|adrenergic agents|mesh-ancestor
5854483|NCT02433899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5854484|NCT02433899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854485|NCT02433899|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5854486|NCT02433899|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5854487|NCT02433899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5854488|NCT02433899|Respiratory System Agents|respiratory system agents|mesh-ancestor
5854489|NCT02433899|Mydriatics|mydriatics|mesh-ancestor
5854490|NCT02433899|Sympathomimetics|sympathomimetics|mesh-ancestor
5854491|NCT02433899|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5854492|NCT02433899|Anesthetics, Local|anesthetics, local|mesh-ancestor
5854493|NCT02433899|Anesthetics|anesthetics|mesh-ancestor
5854494|NCT02433899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5854495|NCT02433899|Sensory System Agents|sensory system agents|mesh-ancestor
5671023|NCT03567369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671024|NCT03567343|Melatonin|melatonin|mesh-list
5671025|NCT03567343|Antioxidants|antioxidants|mesh-ancestor
5671026|NCT03567343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671027|NCT03567343|Protective Agents|protective agents|mesh-ancestor
5671028|NCT03567343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671029|NCT03567343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5671030|NCT03567304|Rilpivirine|rilpivirine|mesh-list
5671031|NCT03567304|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5671032|NCT03567304|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5854496|NCT02433795|Rituximab|rituximab|mesh-list
5854497|NCT02433795|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5854498|NCT02433795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5854499|NCT02433795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5854500|NCT02433795|Immunologic Factors|immunologic factors|mesh-ancestor
5854501|NCT02433795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854502|NCT02433795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5854503|NCT02433795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5854504|NCT02433795|Alkylating Agents|alkylating agents|mesh-ancestor
5854505|NCT02433795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671033|NCT03567304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5671034|NCT03567304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671035|NCT03567304|Antiviral Agents|antiviral agents|mesh-ancestor
5671036|NCT03567304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5671037|NCT03567304|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5671038|NCT03567304|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5671039|NCT03567135|Temozolomide|temozolomide|mesh-list
5671040|NCT03567135|Apatinib|apatinib|mesh-list
5671041|NCT03567135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5671042|NCT03567135|Alkylating Agents|alkylating agents|mesh-ancestor
5671043|NCT03567135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671044|NCT03567135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5671045|NCT03567135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5671046|NCT03567135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5671047|NCT03566966|Antiviral Agents|antiviral agents|mesh-list
5671048|NCT03566966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5671049|NCT03566914|Tadalafil|tadalafil|mesh-list
5671050|NCT03566914|Vasodilator Agents|vasodilator agents|mesh-ancestor
5671051|NCT03566914|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5671052|NCT03566914|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5671053|NCT03566914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5671054|NCT03566914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671055|NCT03566914|Urological Agents|urological agents|mesh-ancestor
5671056|NCT03566667|Metoprolol|metoprolol|mesh-list
5671057|NCT03566667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5671058|NCT03566667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5671059|NCT03566667|Sympatholytics|sympatholytics|mesh-ancestor
5671060|NCT03566667|Autonomic Agents|autonomic agents|mesh-ancestor
5671061|NCT03566667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5671062|NCT03566667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854506|NCT02434029|Budesonide|budesonide|mesh-list
5854507|NCT02434029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5854508|NCT02434029|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5854509|NCT02434029|Autonomic Agents|autonomic agents|mesh-ancestor
5671063|NCT03566667|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5671064|NCT03566667|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5671065|NCT03566667|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5671066|NCT03566667|Adrenergic Agents|adrenergic agents|mesh-ancestor
5671067|NCT03566667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5671068|NCT03566667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854510|NCT02434029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5854511|NCT02434029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854512|NCT02434029|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5854513|NCT02434029|Respiratory System Agents|respiratory system agents|mesh-ancestor
5854514|NCT02434029|Glucocorticoids|glucocorticoids|mesh-ancestor
5854515|NCT02434029|Hormones|hormones|mesh-ancestor
5854516|NCT02434029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5854517|NCT02433925|Resveratrol|resveratrol|mesh-list
5854518|NCT02433925|Antioxidants|antioxidants|mesh-ancestor
5854519|NCT02433925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854520|NCT02433925|Protective Agents|protective agents|mesh-ancestor
5854521|NCT02433925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854522|NCT02433925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5854523|NCT02433925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5854524|NCT02433717|Paliperidone Palmitate|paliperidone palmitate|mesh-list
5854525|NCT02433717|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5854526|NCT02433717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5854527|NCT02433717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5854528|NCT02433717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854529|NCT02433717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5854530|NCT02433717|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5671069|NCT03566576|Docetaxel|docetaxel|mesh-list
5671070|NCT03566576|Pemetrexed|pemetrexed|mesh-list
5671071|NCT03566576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5671072|NCT03566576|Tubulin Modulators|tubulin modulators|mesh-ancestor
5671073|NCT03566576|Antimitotic Agents|antimitotic agents|mesh-ancestor
5671074|NCT03566576|Mitosis Modulators|mitosis modulators|mesh-ancestor
5671075|NCT03566576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854531|NCT02433717|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5854532|NCT02433717|Serotonin Agents|serotonin agents|mesh-ancestor
5854533|NCT02433717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5854534|NCT02433717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854535|NCT02433717|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5854536|NCT02433717|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5854537|NCT02433717|Dopamine Agents|dopamine agents|mesh-ancestor
5854538|NCT02433652|Vaccines|vaccines|mesh-list
5854539|NCT02433652|Immunologic Factors|immunologic factors|mesh-ancestor
5854540|NCT02433652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854541|NCT02433626|Cisplatin|cisplatin|mesh-list
5671076|NCT03566576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5671077|NCT03566576|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5671078|NCT03566576|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5671079|NCT03566394|Gabapentin|gabapentin|mesh-list
5671080|NCT03566394|Analgesics|analgesics|mesh-ancestor
5671081|NCT03566394|Sensory System Agents|sensory system agents|mesh-ancestor
5671082|NCT03566394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5671083|NCT03566394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671084|NCT03566394|Anticonvulsants|anticonvulsants|mesh-ancestor
5671085|NCT03566394|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5671086|NCT03566394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5671087|NCT03566394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5671088|NCT03566394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5671089|NCT03566394|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5671090|NCT03566394|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5671091|NCT03566394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5671092|NCT03566394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671093|NCT03566394|Antimanic Agents|antimanic agents|mesh-ancestor
5671094|NCT03566329|Lidocaine|lidocaine|mesh-list
5671095|NCT03566329|Magnesium Sulfate|magnesium sulfate|mesh-list
5854542|NCT02433626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5854543|NCT02433587|Aspirin|aspirin|mesh-list
5854544|NCT02433587|Clopidogrel|clopidogrel|mesh-list
5854545|NCT02433587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5854546|NCT02433587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5854547|NCT02433587|Analgesics|analgesics|mesh-ancestor
5854548|NCT02433587|Sensory System Agents|sensory system agents|mesh-ancestor
5854549|NCT02433587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5854550|NCT02433587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854551|NCT02433587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5854552|NCT02433587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5854553|NCT02433587|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5854554|NCT02433587|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5854555|NCT02433587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854556|NCT02433587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5854557|NCT02433587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5854558|NCT02433587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5854559|NCT02433587|Antipyretics|antipyretics|mesh-ancestor
5854560|NCT02433587|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5854561|NCT02433587|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5854562|NCT02433587|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5854563|NCT02433587|Purinergic Agents|purinergic agents|mesh-ancestor
5854564|NCT02433587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5854565|NCT02433704|Cefazolin|cefazolin|mesh-list
5854566|NCT02433704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5671096|NCT03566329|Anesthetics, Local|anesthetics, local|mesh-ancestor
5671097|NCT03566329|Anesthetics|anesthetics|mesh-ancestor
5671098|NCT03566329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5671099|NCT03566329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671100|NCT03566329|Sensory System Agents|sensory system agents|mesh-ancestor
5671101|NCT03566329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5671102|NCT03566329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5854567|NCT02433704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5854568|NCT02433457|Omeprazole|omeprazole|mesh-list
5854569|NCT02433457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5854570|NCT02433457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5854571|NCT02433457|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5854572|NCT02433457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5854573|NCT02433457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904200|NCT00719225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671103|NCT03566329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5671104|NCT03566329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5671105|NCT03566329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5696046|NCT03385668|Pirfenidone|pirfenidone|mesh-list
5671106|NCT03566329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671107|NCT03566329|Analgesics|analgesics|mesh-ancestor
5671108|NCT03566329|Anticonvulsants|anticonvulsants|mesh-ancestor
5671109|NCT03566329|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5671110|NCT03566329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5671111|NCT03566329|Tocolytic Agents|tocolytic agents|mesh-ancestor
5671112|NCT03566329|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5671113|NCT03566316|Amlodipine|amlodipine|mesh-list
5671114|NCT03566316|Telmisartan|telmisartan|mesh-list
5671115|NCT03566316|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
5671116|NCT03566316|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5854574|NCT02433535|Simvastatin|simvastatin|mesh-list
5854575|NCT02433535|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5854576|NCT02433535|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5854577|NCT02433535|Antimetabolites|antimetabolites|mesh-ancestor
5854578|NCT02433535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671117|NCT03566316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5671118|NCT03566316|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5671119|NCT03566316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5671120|NCT03566316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671121|NCT03566316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5671122|NCT03566316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671123|NCT03566316|Vasodilator Agents|vasodilator agents|mesh-ancestor
5671124|NCT03566316|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5671125|NCT03566316|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5671126|NCT03566316|Antimetabolites|antimetabolites|mesh-ancestor
5671127|NCT03566316|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5671128|NCT03566316|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5671129|NCT03566316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5671130|NCT03566316|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5671131|NCT03566316|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5696047|NCT03385668|Analgesics|analgesics|mesh-ancestor
5696048|NCT03385668|Sensory System Agents|sensory system agents|mesh-ancestor
5696049|NCT03385668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5696050|NCT03385668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696051|NCT03385668|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5696052|NCT03385668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5696053|NCT03385668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5696054|NCT03385668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5696055|NCT03385668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5696056|NCT03385551|Estradiol|estradiol|mesh-list
5696057|NCT03385551|Estrogens|estrogens|mesh-ancestor
5696058|NCT03385551|Hormones|hormones|mesh-ancestor
5696059|NCT03385551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5854579|NCT02433535|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5854580|NCT02433535|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5854581|NCT02433535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5854582|NCT02433522|Rituximab|rituximab|mesh-list
5854583|NCT02433522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5696060|NCT03385551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696061|NCT03385538|Clopidogrel|clopidogrel|mesh-list
5696062|NCT03385538|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5696063|NCT03385538|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5696064|NCT03385538|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5696065|NCT03385538|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5854584|NCT02433522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5854585|NCT02433522|Immunologic Factors|immunologic factors|mesh-ancestor
5854586|NCT02433522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854587|NCT02433522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5854588|NCT02433418|Diclofenac|diclofenac|mesh-list
5854589|NCT02433418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5854590|NCT02433418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5854591|NCT02433418|Analgesics|analgesics|mesh-ancestor
5854592|NCT02433418|Sensory System Agents|sensory system agents|mesh-ancestor
5854593|NCT02433418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5854594|NCT02433418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854595|NCT02433418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5854596|NCT02433418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5854597|NCT02433418|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5854598|NCT02433418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5854599|NCT02433418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854600|NCT02433314|Brexanolone|brexanolone|mesh-list
5854601|NCT02433314|Neurosteroids|neurosteroids|mesh-ancestor
5671132|NCT03566303|Vitamin K|vitamin k|mesh-list
5671133|NCT03566303|Warfarin|warfarin|mesh-list
5671134|NCT03566303|Rivaroxaban|rivaroxaban|mesh-list
5671135|NCT03566303|Vitamins|vitamins|mesh-ancestor
5671136|NCT03566303|Micronutrients|micronutrients|mesh-ancestor
5671137|NCT03566303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671138|NCT03566303|Anticoagulants|anticoagulants|mesh-ancestor
5671139|NCT03566303|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5671140|NCT03566303|Antithrombins|antithrombins|mesh-ancestor
5671141|NCT03566303|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5671142|NCT03566303|Protease Inhibitors|protease inhibitors|mesh-ancestor
5671143|NCT03566303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5671144|NCT03566303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854602|NCT02433314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5854603|NCT02433314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854604|NCT02433314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854605|NCT02433314|GABA Modulators|gaba modulators|mesh-ancestor
5854606|NCT02433314|GABA Agents|gaba agents|mesh-ancestor
5854607|NCT02433353|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
5854608|NCT02433353|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5854609|NCT02433353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5854610|NCT02433353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5854611|NCT02433353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854612|NCT02433353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5854613|NCT02433353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854614|NCT02433353|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5854615|NCT02433353|Antidepressive Agents|antidepressive agents|mesh-ancestor
5854616|NCT02433353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5854617|NCT02433730|Testosterone|testosterone|mesh-list
5854618|NCT02433730|Androgens|androgens|mesh-ancestor
5854619|NCT02433730|Hormones|hormones|mesh-ancestor
5671145|NCT03566303|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5671146|NCT03566303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5671147|NCT03566303|Hemostatics|hemostatics|mesh-ancestor
5671148|NCT03566303|Coagulants|coagulants|mesh-ancestor
5671149|NCT03566225|Metformin|metformin|mesh-list
5671150|NCT03566225|Pioglitazone|pioglitazone|mesh-list
5671151|NCT03566225|Clomiphene|clomiphene|mesh-list
5671152|NCT03566225|Enclomiphene|enclomiphene|mesh-list
5671153|NCT03566225|Zuclomiphene|zuclomiphene|mesh-list
5671154|NCT03566225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5671155|NCT03566225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671156|NCT03566225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5671157|NCT03566225|Hormone Antagonists|hormone antagonists|mesh-ancestor
5671158|NCT03566225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5671159|NCT03566225|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5671160|NCT03566225|Fertility Agents|fertility agents|mesh-ancestor
5671161|NCT03566225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5671162|NCT03566225|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5854620|NCT02433730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5854621|NCT02433730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854622|NCT02433912|Acetaminophen|acetaminophen|mesh-list
5854623|NCT02433912|Chlorhexidine|chlorhexidine|mesh-list
5854624|NCT02433912|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5854625|NCT02433912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5854626|NCT02433912|Analgesics|analgesics|mesh-ancestor
5854627|NCT02433912|Sensory System Agents|sensory system agents|mesh-ancestor
5854628|NCT02433912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5854629|NCT02433912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854630|NCT02433912|Antipyretics|antipyretics|mesh-ancestor
5854631|NCT02433912|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5854632|NCT02433912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5854633|NCT02433912|Disinfectants|disinfectants|mesh-ancestor
5854634|NCT02433912|Dermatologic Agents|dermatologic agents|mesh-ancestor
5854635|NCT02433184|Hydroxychloroquine|hydroxychloroquine|mesh-list
5854636|NCT02433184|Sulfasalazine|sulfasalazine|mesh-list
5671163|NCT03566225|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5671164|NCT03566134|Solifenacin Succinate|solifenacin succinate|mesh-list
5671165|NCT03566134|DA-8010|da-8010|mesh-list
5671166|NCT03566134|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5671167|NCT03566134|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5854637|NCT02433184|Etanercept|etanercept|mesh-list
5854638|NCT02433184|Methotrexate|methotrexate|mesh-list
5854639|NCT02433184|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5671168|NCT03566134|Cholinergic Agents|cholinergic agents|mesh-ancestor
5671169|NCT03566134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5671170|NCT03566134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671171|NCT03566134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671172|NCT03566134|Urological Agents|urological agents|mesh-ancestor
5671173|NCT03566069|Oxytocin|oxytocin|mesh-list
5671174|NCT03566069|Oxytocics|oxytocics|mesh-ancestor
5671175|NCT03566069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5671176|NCT03566069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671177|NCT03566030|Tenofovir|tenofovir|mesh-list
5671178|NCT03566030|Antiviral Agents|antiviral agents|mesh-ancestor
5671179|NCT03566030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5854640|NCT02433184|Abortifacient Agents|abortifacient agents|mesh-ancestor
5854641|NCT02433184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5854642|NCT02433184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854643|NCT02433184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5854644|NCT02433184|Antimetabolites|antimetabolites|mesh-ancestor
5854645|NCT02433184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854646|NCT02433184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5854647|NCT02433184|Dermatologic Agents|dermatologic agents|mesh-ancestor
5854648|NCT02433184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5854649|NCT02433184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5854650|NCT02433184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5854651|NCT02433184|Immunologic Factors|immunologic factors|mesh-ancestor
5854652|NCT02433184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5854653|NCT02433184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5854654|NCT02433184|Antimalarials|antimalarials|mesh-ancestor
5854655|NCT02433184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5854656|NCT02433184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5854657|NCT02433184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5854658|NCT02433184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5854659|NCT02433184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5854660|NCT02433184|Analgesics|analgesics|mesh-ancestor
5854661|NCT02433184|Sensory System Agents|sensory system agents|mesh-ancestor
5854662|NCT02433184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5854663|NCT02433184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5854664|NCT02433184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5854665|NCT02432885|Enalapril|enalapril|mesh-list
5854666|NCT02432885|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5854667|NCT02432885|Protease Inhibitors|protease inhibitors|mesh-ancestor
5854668|NCT02432885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5854669|NCT02432885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854670|NCT02432885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5854671|NCT02432911|Cytarabine|cytarabine|mesh-list
5854672|NCT02432911|Aclacinomycins|aclacinomycins|mesh-list
5854673|NCT02432911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5671180|NCT03566030|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5671181|NCT03566030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5671182|NCT03566030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5671183|NCT03566030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854674|NCT02432911|Antimetabolites|antimetabolites|mesh-ancestor
5854675|NCT02432911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854676|NCT02432911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5854677|NCT02432911|Antiviral Agents|antiviral agents|mesh-ancestor
5854678|NCT02432911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5854679|NCT02432911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5854680|NCT02432911|Immunologic Factors|immunologic factors|mesh-ancestor
5854681|NCT02432911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854682|NCT02432911|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5854683|NCT02432911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5854684|NCT02433041|Ketamine|ketamine|mesh-list
5854685|NCT02433041|Haloperidol|haloperidol|mesh-list
5854686|NCT02433041|Haloperidol decanoate|haloperidol decanoate|mesh-list
5854687|NCT02433041|Analgesics|analgesics|mesh-ancestor
5854688|NCT02433041|Sensory System Agents|sensory system agents|mesh-ancestor
5854689|NCT02433041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5854690|NCT02433041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671184|NCT03566030|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5671185|NCT03566030|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5671186|NCT03565536|Sorafenib|sorafenib|mesh-list
5671187|NCT03565536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5671188|NCT03565536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5671189|NCT03565536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5671190|NCT03565536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671191|NCT03565458|Dapagliflozin|dapagliflozin|mesh-list
5671192|NCT03565458|Empagliflozin|empagliflozin|mesh-list
5671193|NCT03565458|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5854691|NCT02433041|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5854692|NCT02433041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5671194|NCT03565458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671195|NCT03565458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5671196|NCT03565458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671197|NCT03565406|Nivolumab|nivolumab|mesh-list
5671198|NCT03565406|Ipilimumab|ipilimumab|mesh-list
5671199|NCT03565406|Mocetinostat|mocetinostat|mesh-list
5671200|NCT03565406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5671201|NCT03565406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5854693|NCT02433041|Anesthetics, General|anesthetics, general|mesh-ancestor
5854694|NCT02433041|Anesthetics|anesthetics|mesh-ancestor
5854695|NCT02433041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5854696|NCT02433041|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5854697|NCT02433041|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5854698|NCT02433041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5854699|NCT02433041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854700|NCT02433041|Antiemetics|antiemetics|mesh-ancestor
5854701|NCT02433041|Autonomic Agents|autonomic agents|mesh-ancestor
5854702|NCT02433041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5854703|NCT02433041|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5854704|NCT02433041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5854705|NCT02433041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5854706|NCT02433041|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5854707|NCT02433041|Dopamine Agents|dopamine agents|mesh-ancestor
5854708|NCT02433041|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5854709|NCT02432846|Sunitinib|sunitinib|mesh-list
5854710|NCT02432846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5854711|NCT02432846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5854712|NCT02432846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5854713|NCT02432846|Growth Substances|growth substances|mesh-ancestor
5854714|NCT02432846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854715|NCT02432846|Growth Inhibitors|growth inhibitors|mesh-ancestor
5854716|NCT02432846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5854717|NCT02432846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5854718|NCT02432846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854719|NCT02432807|Vancomycin|vancomycin|mesh-list
5854720|NCT02432807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5854721|NCT02432807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5854722|NCT02432976|Insulin|insulin|mesh-list
5854723|NCT02432976|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5854724|NCT02432976|Exenatide|exenatide|mesh-list
5854725|NCT02432976|Insulin Lispro|insulin lispro|mesh-list
5854726|NCT02432976|Incretins|incretins|mesh-list
5854727|NCT02432976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5854728|NCT02432976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854729|NCT02432976|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5854730|NCT02432976|Hormones|hormones|mesh-ancestor
5671202|NCT03565406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5671203|NCT03565406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671204|NCT03565406|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5671205|NCT03565406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5671206|NCT03565354|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
5671207|NCT03565354|Hematinics|hematinics|mesh-ancestor
5671208|NCT03565302|Terbutaline|terbutaline|mesh-list
5671209|NCT03565302|Formoterol Fumarate|formoterol fumarate|mesh-list
5671210|NCT03565302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5671211|NCT03565302|Autonomic Agents|autonomic agents|mesh-ancestor
5671212|NCT03565302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5671213|NCT03565302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671214|NCT03565302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5671215|NCT03565302|Respiratory System Agents|respiratory system agents|mesh-ancestor
5671216|NCT03565302|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5671217|NCT03565302|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5671218|NCT03565302|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5671219|NCT03565302|Adrenergic Agents|adrenergic agents|mesh-ancestor
5671220|NCT03565302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5671221|NCT03565302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854731|NCT02432976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5854732|NCT02432833|Tacrolimus|tacrolimus|mesh-list
5854733|NCT02432833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5854734|NCT02432833|Immunologic Factors|immunologic factors|mesh-ancestor
5854735|NCT02432833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854736|NCT02432833|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5854737|NCT02432833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5854738|NCT02432833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854739|NCT02432872|Cytarabine|cytarabine|mesh-list
5854740|NCT02432872|Daunorubicin|daunorubicin|mesh-list
5854741|NCT02432872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5854742|NCT02432872|Antimetabolites|antimetabolites|mesh-ancestor
5854743|NCT02432872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494392|NCT00618397|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6494393|NCT00618397|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6494394|NCT00618397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6494395|NCT00618397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494396|NCT00618423|Ketamine|ketamine|mesh-list
6494397|NCT00618423|Analgesics|analgesics|mesh-ancestor
6494398|NCT00618423|Sensory System Agents|sensory system agents|mesh-ancestor
6494399|NCT00618423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6494400|NCT00618423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494401|NCT00618423|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6494402|NCT00618423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6494403|NCT00618423|Anesthetics, General|anesthetics, general|mesh-ancestor
6494404|NCT00618423|Anesthetics|anesthetics|mesh-ancestor
6494405|NCT00618423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6494406|NCT00618423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6494407|NCT00618423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6494408|NCT00618423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6494409|NCT00618423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494410|NCT00618501|Leucovorin|leucovorin|mesh-list
6494411|NCT00618501|Cytarabine|cytarabine|mesh-list
5671222|NCT03565302|Sympathomimetics|sympathomimetics|mesh-ancestor
5671223|NCT03565302|Tocolytic Agents|tocolytic agents|mesh-ancestor
5671224|NCT03565302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5671225|NCT03565276|Tranexamic Acid|tranexamic acid|mesh-list
5671226|NCT03565276|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5671227|NCT03565276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5671228|NCT03565276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671229|NCT03565276|Hemostatics|hemostatics|mesh-ancestor
5671230|NCT03565276|Coagulants|coagulants|mesh-ancestor
5671231|NCT03565159|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5671232|NCT03565159|Immunologic Factors|immunologic factors|mesh-ancestor
6494412|NCT00618501|Prednisolone|prednisolone|mesh-list
6494413|NCT00618501|Hydrocortisone|hydrocortisone|mesh-list
6494414|NCT00618501|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6494415|NCT00618501|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6494416|NCT00618501|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6494417|NCT00618501|Methotrexate|methotrexate|mesh-list
6494418|NCT00618501|Etoposide|etoposide|mesh-list
6494419|NCT00618501|Vincristine|vincristine|mesh-list
6494420|NCT00618501|Imatinib Mesylate|imatinib mesylate|mesh-list
6494421|NCT00618501|Daunorubicin|daunorubicin|mesh-list
5854744|NCT02432872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5854745|NCT02432872|Antiviral Agents|antiviral agents|mesh-ancestor
5854746|NCT02432872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5854747|NCT02432872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5854748|NCT02432872|Immunologic Factors|immunologic factors|mesh-ancestor
5854749|NCT02432872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854750|NCT02432872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5854751|NCT02432872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5854752|NCT02432872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5854753|NCT02432872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5671233|NCT03565159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671234|NCT03565133|Quinine|quinine|mesh-list
5671235|NCT03565133|Antimalarials|antimalarials|mesh-ancestor
5671236|NCT03565133|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5671237|NCT03565133|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5671238|NCT03565133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5671239|NCT03565133|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5671240|NCT03565133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671241|NCT03565133|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5671242|NCT03565133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5671243|NCT03565133|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5854754|NCT02432963|Pembrolizumab|pembrolizumab|mesh-list
5854755|NCT02432963|Vaccines|vaccines|mesh-list
5854756|NCT02432963|Immunologic Factors|immunologic factors|mesh-ancestor
5854757|NCT02432963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854758|NCT02432963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5854759|NCT02432963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5854760|NCT02432781|Insulin|insulin|mesh-list
5854761|NCT02432781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5854762|NCT02432781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671244|NCT03565133|Analgesics|analgesics|mesh-ancestor
5854763|NCT02432599|Choline|choline|mesh-list
5671245|NCT03565133|Sensory System Agents|sensory system agents|mesh-ancestor
5671246|NCT03564964|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1H-indole dimesylate monohydrate|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1h-indole dimesylate monohydrate|mesh-list
5671247|NCT03564964|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5671248|NCT03564964|Serotonin Agents|serotonin agents|mesh-ancestor
5671249|NCT03564964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5671250|NCT03564964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671251|NCT03564964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671252|NCT03564912|Capecitabine|capecitabine|mesh-list
5671253|NCT03564912|Oxaliplatin|oxaliplatin|mesh-list
5671254|NCT03564912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5671255|NCT03564912|Antimetabolites|antimetabolites|mesh-ancestor
5671256|NCT03564912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671257|NCT03564912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5671258|NCT03564795|Sulfadiazine|sulfadiazine|mesh-list
5671259|NCT03564795|Silver Sulfadiazine|silver sulfadiazine|mesh-list
5671260|NCT03564795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5671261|NCT03564795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5671262|NCT03564795|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5671263|NCT03564795|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5671264|NCT03564795|Coccidiostats|coccidiostats|mesh-ancestor
5671265|NCT03564795|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5671266|NCT03564756|Ascorbic Acid|ascorbic acid|mesh-list
5671267|NCT03564756|Vitamins|vitamins|mesh-ancestor
5671268|NCT03564756|Micronutrients|micronutrients|mesh-ancestor
5671269|NCT03564756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671270|NCT03564756|Antioxidants|antioxidants|mesh-ancestor
5671271|NCT03564756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671272|NCT03564756|Protective Agents|protective agents|mesh-ancestor
5671273|NCT03564704|Cytarabine|cytarabine|mesh-list
5671274|NCT03564704|Dexamethasone|dexamethasone|mesh-list
5854764|NCT02432599|Lipotropic Agents|lipotropic agents|mesh-ancestor
5854765|NCT02432599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5854766|NCT02432599|Antimetabolites|antimetabolites|mesh-ancestor
5854767|NCT02432599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854768|NCT02432599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5854769|NCT02432599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5854770|NCT02432599|Nootropic Agents|nootropic agents|mesh-ancestor
5854771|NCT02432534|Atorvastatin|atorvastatin|mesh-list
5854772|NCT02432534|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5854773|NCT02432534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5854774|NCT02432534|Antimetabolites|antimetabolites|mesh-ancestor
5854775|NCT02432534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854776|NCT02432534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5854777|NCT02432534|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5854778|NCT02432534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5854779|NCT02432547|Aflibercept|aflibercept|mesh-list
5854780|NCT02432547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5854781|NCT02432547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5854782|NCT02432547|Growth Substances|growth substances|mesh-ancestor
5854783|NCT02432547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854784|NCT02432547|Growth Inhibitors|growth inhibitors|mesh-ancestor
5854785|NCT02432547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5854786|NCT02432612|Nabiximols|nabiximols|mesh-list
5854787|NCT02432612|Analgesics|analgesics|mesh-ancestor
5854788|NCT02432612|Sensory System Agents|sensory system agents|mesh-ancestor
5854789|NCT02432612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5854790|NCT02432612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854791|NCT02432677|Remifentanil|remifentanil|mesh-list
5854792|NCT02432677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5854793|NCT02432677|Narcotics|narcotics|mesh-ancestor
5854794|NCT02432677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5854795|NCT02432677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854796|NCT02432677|Analgesics|analgesics|mesh-ancestor
5854797|NCT02432677|Sensory System Agents|sensory system agents|mesh-ancestor
5854798|NCT02432677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5854799|NCT02432651|Xanthohumol|xanthohumol|mesh-list
5854800|NCT02432651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5854801|NCT02432651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5854802|NCT02432651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5854803|NCT02432651|Growth Substances|growth substances|mesh-ancestor
5854804|NCT02432651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854805|NCT02432651|Growth Inhibitors|growth inhibitors|mesh-ancestor
5854806|NCT02432664|Midazolam|midazolam|mesh-list
5854807|NCT02432664|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5671275|NCT03564704|Cyclophosphamide|cyclophosphamide|mesh-list
5671276|NCT03564704|Methotrexate|methotrexate|mesh-list
5671277|NCT03564704|Etoposide|etoposide|mesh-list
5671278|NCT03564704|Vincristine|vincristine|mesh-list
5671279|NCT03564704|Doxorubicin|doxorubicin|mesh-list
5671280|NCT03564704|Mercaptopurine|mercaptopurine|mesh-list
5671281|NCT03564704|Idarubicin|idarubicin|mesh-list
5671282|NCT03564704|Pegaspargase|pegaspargase|mesh-list
5671283|NCT03564704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5671284|NCT03564704|Immunologic Factors|immunologic factors|mesh-ancestor
5671285|NCT03564704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671286|NCT03564704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5671287|NCT03564704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5671288|NCT03564704|Alkylating Agents|alkylating agents|mesh-ancestor
5671289|NCT03564704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671290|NCT03564704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5671291|NCT03564704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5671292|NCT03564704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5671293|NCT03564704|Antiemetics|antiemetics|mesh-ancestor
5671294|NCT03564704|Autonomic Agents|autonomic agents|mesh-ancestor
5671295|NCT03564704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5671296|NCT03564704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5671297|NCT03564704|Glucocorticoids|glucocorticoids|mesh-ancestor
5671298|NCT03564704|Hormones|hormones|mesh-ancestor
5671299|NCT03564704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5671300|NCT03564704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5671301|NCT03564704|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5671302|NCT03564704|Abortifacient Agents|abortifacient agents|mesh-ancestor
5671303|NCT03564704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5671304|NCT03564704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5671305|NCT03564704|Antimetabolites|antimetabolites|mesh-ancestor
5671306|NCT03564704|Dermatologic Agents|dermatologic agents|mesh-ancestor
5671307|NCT03564704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5671308|NCT03564704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5671309|NCT03564704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5671310|NCT03564704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5671311|NCT03564704|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5671312|NCT03564704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5671313|NCT03564704|Antiviral Agents|antiviral agents|mesh-ancestor
5671314|NCT03564704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5671315|NCT03564704|Tubulin Modulators|tubulin modulators|mesh-ancestor
5671316|NCT03564704|Antimitotic Agents|antimitotic agents|mesh-ancestor
5671317|NCT03564704|Mitosis Modulators|mitosis modulators|mesh-ancestor
5671318|NCT03564704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5671319|NCT03564652|Azithromycin|azithromycin|mesh-list
5671320|NCT03564652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5671321|NCT03564652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5696066|NCT03385538|Purinergic Agents|purinergic agents|mesh-ancestor
5696067|NCT03385538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6674898|NCT01572012|Autonomic Agents|autonomic agents|mesh-ancestor
6674899|NCT01572012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6674900|NCT01572012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674901|NCT01572012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6674902|NCT01572012|Antipruritics|antipruritics|mesh-ancestor
6674903|NCT01572012|Dermatologic Agents|dermatologic agents|mesh-ancestor
6674904|NCT01572012|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6674905|NCT01572012|Serotonin Agents|serotonin agents|mesh-ancestor
6674906|NCT01572012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6674907|NCT01572012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674908|NCT01572012|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5696068|NCT03385538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696069|NCT03385538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696070|NCT03385525|Valproic Acid|valproic acid|mesh-list
5696071|NCT03385525|Anticonvulsants|anticonvulsants|mesh-ancestor
5696072|NCT03385525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5696073|NCT03385525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696074|NCT03385525|GABA Agents|gaba agents|mesh-ancestor
5696075|NCT03385525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5696076|NCT03385525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696077|NCT03385525|Antimanic Agents|antimanic agents|mesh-ancestor
5696078|NCT03385525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5696079|NCT03385525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5696080|NCT03385525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5696081|NCT03385395|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
5854808|NCT02432664|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5696082|NCT03385395|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5671322|NCT03564574|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
5671323|NCT03564574|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
5671324|NCT03564574|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6674909|NCT01572012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5854809|NCT02432664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5854810|NCT02432664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854811|NCT02432664|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5854812|NCT02432664|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5854813|NCT02432664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5854814|NCT02432664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5854815|NCT02432664|Anesthetics, General|anesthetics, general|mesh-ancestor
5854816|NCT02432664|Anesthetics|anesthetics|mesh-ancestor
5854817|NCT02432664|GABA Modulators|gaba modulators|mesh-ancestor
5854818|NCT02432664|GABA Agents|gaba agents|mesh-ancestor
5854819|NCT02432664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5854820|NCT02432664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854821|NCT02432417|Chloroquine|chloroquine|mesh-list
5854822|NCT02432417|Amebicides|amebicides|mesh-ancestor
5854823|NCT02432417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5854824|NCT02432417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5854825|NCT02432417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5854826|NCT02432417|Antimalarials|antimalarials|mesh-ancestor
5854827|NCT02432417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5854828|NCT02432339|Mycophenolic Acid|mycophenolic acid|mesh-list
5854829|NCT02432339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5854830|NCT02432339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5854831|NCT02432339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5854832|NCT02432339|Antitubercular Agents|antitubercular agents|mesh-ancestor
5854833|NCT02432339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5854834|NCT02432339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5854835|NCT02432339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5854836|NCT02432339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854837|NCT02432248|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
5854838|NCT02432248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5854839|NCT02432248|Immunologic Factors|immunologic factors|mesh-ancestor
5854840|NCT02432248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854841|NCT02432365|Paclitaxel|paclitaxel|mesh-list
5854842|NCT02432365|Cisplatin|cisplatin|mesh-list
5854843|NCT02432365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5854844|NCT02432365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5671325|NCT03564574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5671326|NCT03564548|Morphine|morphine|mesh-list
5671327|NCT03564548|Oxycodone|oxycodone|mesh-list
5671328|NCT03564548|Hydromorphone|hydromorphone|mesh-list
5671329|NCT03564548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5671330|NCT03564548|Narcotics|narcotics|mesh-ancestor
5671331|NCT03564548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5671332|NCT03564548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671333|NCT03564548|Analgesics|analgesics|mesh-ancestor
5671334|NCT03564548|Sensory System Agents|sensory system agents|mesh-ancestor
5671335|NCT03564548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5671336|NCT03564509|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5671337|NCT03564509|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5671338|NCT03564509|Hormones|hormones|mesh-ancestor
5671339|NCT03564509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5671340|NCT03564509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671341|NCT03564509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5671342|NCT03564470|Dasatinib|dasatinib|mesh-list
5671343|NCT03564470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5671344|NCT03564470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5671345|NCT03564470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5671346|NCT03564470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671347|NCT03564379|JNJ-42165279|jnj-42165279|mesh-list
5671348|NCT03564379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5671349|NCT03564379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671350|NCT03564301|Metronidazole|metronidazole|mesh-list
5671351|NCT03564301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5671352|NCT03564301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5671353|NCT03564301|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5671354|NCT03564301|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5671355|NCT03564158|Moxifloxacin|moxifloxacin|mesh-list
5671356|NCT03564158|Meropenem|meropenem|mesh-list
5671357|NCT03564158|Vaborbactam|vaborbactam|mesh-list
5671358|NCT03564158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5671359|NCT03564158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5671360|NCT03564158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5671361|NCT03564158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5671362|NCT03564158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5671363|NCT03564158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671364|NCT03564158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5671365|NCT03564158|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5671366|NCT03564106|Methylprednisolone|methylprednisolone|mesh-list
5671367|NCT03564106|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5671368|NCT03564106|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5671369|NCT03564106|Prednisolone|prednisolone|mesh-list
5671370|NCT03564106|Prednisolone acetate|prednisolone acetate|mesh-list
5671371|NCT03564106|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5671372|NCT03564106|Prednisolone phosphate|prednisolone phosphate|mesh-list
5671373|NCT03564106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5671374|NCT03564106|Antiemetics|antiemetics|mesh-ancestor
5671375|NCT03564106|Autonomic Agents|autonomic agents|mesh-ancestor
5854845|NCT02432365|Tubulin Modulators|tubulin modulators|mesh-ancestor
5854846|NCT02432365|Antimitotic Agents|antimitotic agents|mesh-ancestor
5854847|NCT02432365|Mitosis Modulators|mitosis modulators|mesh-ancestor
5854848|NCT02432365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854849|NCT02432053|Tacrolimus|tacrolimus|mesh-list
5854850|NCT02432053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5854851|NCT02432053|Immunologic Factors|immunologic factors|mesh-ancestor
5854852|NCT02432053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671376|NCT03564106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5671377|NCT03564106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671378|NCT03564106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5671379|NCT03564106|Glucocorticoids|glucocorticoids|mesh-ancestor
5671380|NCT03564106|Hormones|hormones|mesh-ancestor
5671381|NCT03564106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5671382|NCT03564106|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5671383|NCT03564106|Protective Agents|protective agents|mesh-ancestor
5671384|NCT03564106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5671385|NCT03564106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5671386|NCT03564093|Dexmedetomidine|dexmedetomidine|mesh-list
5671387|NCT03564093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5671388|NCT03564093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5671389|NCT03564093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671390|NCT03564093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5671391|NCT03564093|Analgesics|analgesics|mesh-ancestor
5671392|NCT03564093|Sensory System Agents|sensory system agents|mesh-ancestor
5671393|NCT03564093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5671394|NCT03564093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5671395|NCT03564093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5854853|NCT02432053|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5854854|NCT02432053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5854855|NCT02432053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854856|NCT02432027|Betamethasone|betamethasone|mesh-list
5854857|NCT02432027|Calcipotriene|calcipotriene|mesh-list
5854858|NCT02432027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5854859|NCT02432027|Glucocorticoids|glucocorticoids|mesh-ancestor
5854860|NCT02432027|Hormones|hormones|mesh-ancestor
5854861|NCT02432027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5854862|NCT02432027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854863|NCT02432027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5854864|NCT02432027|Respiratory System Agents|respiratory system agents|mesh-ancestor
5854865|NCT02432027|Dermatologic Agents|dermatologic agents|mesh-ancestor
5854866|NCT02432261|Methyltestosterone|methyltestosterone|mesh-list
5854867|NCT02432261|ST 1435|st 1435|mesh-list
5854868|NCT02432261|Testosterone|testosterone|mesh-list
5854869|NCT02432261|Testosterone undecanoate|testosterone undecanoate|mesh-list
5854870|NCT02432261|Testosterone enanthate|testosterone enanthate|mesh-list
5854871|NCT02432261|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5854872|NCT02432261|Androgens|androgens|mesh-ancestor
6494422|NCT00618501|Levoleucovorin|levoleucovorin|mesh-list
6494423|NCT00618501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494424|NCT00618501|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5671396|NCT03564093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5671397|NCT03564093|Adrenergic Agents|adrenergic agents|mesh-ancestor
5671398|NCT03564093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5671399|NCT03564093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671400|NCT03563963|Lidocaine|lidocaine|mesh-list
5671401|NCT03563963|Ropivacaine|ropivacaine|mesh-list
5671402|NCT03563963|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6494425|NCT00618501|Abortifacient Agents|abortifacient agents|mesh-ancestor
5854873|NCT02432261|Hormones|hormones|mesh-ancestor
5854874|NCT02432261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5854875|NCT02432261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854876|NCT02432261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5854877|NCT02432261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5854878|NCT02432261|Anabolic Agents|anabolic agents|mesh-ancestor
5854879|NCT02432261|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5854880|NCT02432261|Contraceptive Agents|contraceptive agents|mesh-ancestor
5854881|NCT02432261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5854882|NCT02432261|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5854883|NCT02432066|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
5854884|NCT02432066|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5854885|NCT02432066|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5854886|NCT02432066|Cholinergic Agents|cholinergic agents|mesh-ancestor
5854887|NCT02432066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5854888|NCT02432066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854889|NCT02432066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854890|NCT02431988|Cyclophosphamide|cyclophosphamide|mesh-list
5854891|NCT02431988|Fludarabine|fludarabine|mesh-list
5854892|NCT02431988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5854893|NCT02431988|Immunologic Factors|immunologic factors|mesh-ancestor
5854894|NCT02431988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854895|NCT02431988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5854896|NCT02431988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5854897|NCT02431988|Alkylating Agents|alkylating agents|mesh-ancestor
5854898|NCT02431988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854899|NCT02431988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5854900|NCT02431988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5854901|NCT02431975|Ritonavir|ritonavir|mesh-list
5854902|NCT02431975|Lopinavir|lopinavir|mesh-list
5854903|NCT02431975|Lamivudine|lamivudine|mesh-list
5854904|NCT02431975|Zidovudine|zidovudine|mesh-list
5854905|NCT02431975|Nevirapine|nevirapine|mesh-list
5854906|NCT02431975|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5671403|NCT03563963|Anesthetics, Local|anesthetics, local|mesh-ancestor
5671404|NCT03563963|Anesthetics|anesthetics|mesh-ancestor
5671405|NCT03563963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5671406|NCT03563963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671407|NCT03563963|Sensory System Agents|sensory system agents|mesh-ancestor
5671408|NCT03563963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5671409|NCT03563963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5854907|NCT02431975|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5854908|NCT02431975|Protease Inhibitors|protease inhibitors|mesh-ancestor
6674910|NCT01572012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6674911|NCT01572012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6674912|NCT01572012|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6674913|NCT01572025|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
6674914|NCT01572025|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6674915|NCT01572025|Immunologic Factors|immunologic factors|mesh-ancestor
5671410|NCT03563963|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5671411|NCT03563963|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5671412|NCT03563963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5671413|NCT03563963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671414|NCT03563950|Rifampin|rifampin|mesh-list
5671415|NCT03563950|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5671416|NCT03563950|Antitubercular Agents|antitubercular agents|mesh-ancestor
5671417|NCT03563950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5671418|NCT03563950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5671419|NCT03563950|Leprostatic Agents|leprostatic agents|mesh-ancestor
5671420|NCT03563950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5671421|NCT03563950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5671422|NCT03563950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671423|NCT03563950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5671424|NCT03563950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5671425|NCT03563950|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5671426|NCT03563950|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5671427|NCT03563950|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5671428|NCT03563950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5671429|NCT03563937|Rivaroxaban|rivaroxaban|mesh-list
5671430|NCT03563937|Apixaban|apixaban|mesh-list
5671431|NCT03563937|Edoxaban|edoxaban|mesh-list
5671432|NCT03563937|Phenprocoumon|phenprocoumon|mesh-list
5671433|NCT03563937|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5671434|NCT03563937|Antithrombins|antithrombins|mesh-ancestor
5854909|NCT02431975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5854910|NCT02431975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854911|NCT02431975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5671435|NCT03563937|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5671436|NCT03563937|Protease Inhibitors|protease inhibitors|mesh-ancestor
5671437|NCT03563937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5854912|NCT02431975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5854913|NCT02431975|Antiviral Agents|antiviral agents|mesh-ancestor
5854914|NCT02431975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5854915|NCT02431975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5854916|NCT02431975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5854917|NCT02431975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5854918|NCT02431975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5854919|NCT02431975|Antimetabolites|antimetabolites|mesh-ancestor
5854920|NCT02431975|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5854921|NCT02431975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5854927|NCT02431936|Prazosin|prazosin|mesh-list
5854928|NCT02431936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5854929|NCT02431936|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5854930|NCT02431936|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5854931|NCT02431936|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5854932|NCT02431936|Adrenergic Agents|adrenergic agents|mesh-ancestor
5854933|NCT02431936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5854934|NCT02431936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854935|NCT02431936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904201|NCT00719225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5904202|NCT00719225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5904203|NCT00719225|Immunologic Factors|immunologic factors|mesh-ancestor
5904204|NCT00719225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904205|NCT00719225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5904206|NCT00516373|Olaparib|olaparib|mesh-list
5904207|NCT00516373|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
5904208|NCT00516373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5904209|NCT00516373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904210|NCT00516373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5904211|NCT00094016|Beclomethasone|beclomethasone|mesh-list
5904212|NCT00094016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5904213|NCT00094016|Glucocorticoids|glucocorticoids|mesh-ancestor
5904214|NCT00094016|Hormones|hormones|mesh-ancestor
5904215|NCT00094016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5904216|NCT00094016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904217|NCT00094016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5904218|NCT00094016|Respiratory System Agents|respiratory system agents|mesh-ancestor
5904219|NCT05134363|Dexmedetomidine|dexmedetomidine|mesh-list
5904220|NCT05134363|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5904221|NCT05134363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5904222|NCT05134363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904223|NCT05134363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5904224|NCT05134363|Analgesics|analgesics|mesh-ancestor
5904225|NCT05134363|Sensory System Agents|sensory system agents|mesh-ancestor
5904226|NCT05134363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5904227|NCT05134363|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5904228|NCT05134363|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5904229|NCT05134363|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5904230|NCT05134363|Adrenergic Agents|adrenergic agents|mesh-ancestor
5671438|NCT03563937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671439|NCT03563937|Anticoagulants|anticoagulants|mesh-ancestor
5671440|NCT03563833|Anesthetics|anesthetics|mesh-list
5671441|NCT03563833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5671442|NCT03563833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671443|NCT03563794|Insulin Lispro|insulin lispro|mesh-list
5671444|NCT03563794|Vildagliptin|vildagliptin|mesh-list
5671445|NCT03563794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5671446|NCT03563794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671447|NCT03563794|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5671448|NCT03563794|Protease Inhibitors|protease inhibitors|mesh-ancestor
5671449|NCT03563794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5671450|NCT03563794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671451|NCT03563729|Pembrolizumab|pembrolizumab|mesh-list
5671452|NCT03563729|Nivolumab|nivolumab|mesh-list
5671453|NCT03563729|Ipilimumab|ipilimumab|mesh-list
5671454|NCT03563729|Trametinib|trametinib|mesh-list
5671455|NCT03563729|Dabrafenib|dabrafenib|mesh-list
5671456|NCT03563729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5671457|NCT03563729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5854936|NCT02431845|Fluoxetine|fluoxetine|mesh-list
5854937|NCT02431845|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5854938|NCT02431845|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5854939|NCT02431845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5854940|NCT02431845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854941|NCT02431845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5854942|NCT02431845|Serotonin Agents|serotonin agents|mesh-ancestor
5854943|NCT02431845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854944|NCT02431845|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5854945|NCT02431845|Antidepressive Agents|antidepressive agents|mesh-ancestor
5854946|NCT02431845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5854947|NCT02431845|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5854948|NCT02431845|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5854949|NCT02431845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5854950|NCT02431832|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5854951|NCT02431832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5854952|NCT02431832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5854953|NCT02431832|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5854954|NCT02431832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5854955|NCT02431832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854956|NCT02431728|Melatonin|melatonin|mesh-list
5854957|NCT02431728|Antioxidants|antioxidants|mesh-ancestor
5671458|NCT03563729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5671459|NCT03563729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671460|NCT03563729|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5671461|NCT03563729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5671462|NCT03563690|Celecoxib|celecoxib|mesh-list
5671463|NCT03563690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5671464|NCT03563690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5671465|NCT03563690|Analgesics|analgesics|mesh-ancestor
5671466|NCT03563690|Sensory System Agents|sensory system agents|mesh-ancestor
5671467|NCT03563690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5671468|NCT03563690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671469|NCT03563690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5671470|NCT03563690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5671471|NCT03563690|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5671472|NCT03563690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5671473|NCT03563690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5671474|NCT03563690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671475|NCT03563664|Danazol|danazol|mesh-list
5671476|NCT03563664|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5671477|NCT03563664|Hormone Antagonists|hormone antagonists|mesh-ancestor
5671478|NCT03563664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5671479|NCT03563664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671480|NCT03563625|Bupivacaine|bupivacaine|mesh-list
5671481|NCT03563625|Anesthetics, Local|anesthetics, local|mesh-ancestor
5671482|NCT03563625|Anesthetics|anesthetics|mesh-ancestor
5671483|NCT03563625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5671484|NCT03563625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671485|NCT03563625|Sensory System Agents|sensory system agents|mesh-ancestor
5671486|NCT03563625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5671487|NCT03563586|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5671488|NCT03563586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5671489|NCT03563560|Cytarabine|cytarabine|mesh-list
5671490|NCT03563560|Mitoxantrone|mitoxantrone|mesh-list
5671491|NCT03563560|Alvocidib|alvocidib|mesh-list
5671492|NCT03563560|Daunorubicin|daunorubicin|mesh-list
5671493|NCT03563560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5671494|NCT03563560|Antimetabolites|antimetabolites|mesh-ancestor
5671495|NCT03563560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671496|NCT03563560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5671497|NCT03563560|Antiviral Agents|antiviral agents|mesh-ancestor
5671498|NCT03563560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5854958|NCT02431728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671499|NCT03563560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5854959|NCT02431728|Protective Agents|protective agents|mesh-ancestor
5854960|NCT02431728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854961|NCT02431728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5854962|NCT02431663|Ketamine|ketamine|mesh-list
5854963|NCT02431663|Analgesics|analgesics|mesh-ancestor
5671500|NCT03563560|Immunologic Factors|immunologic factors|mesh-ancestor
5671501|NCT03563560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671502|NCT03563560|Analgesics|analgesics|mesh-ancestor
5671503|NCT03563560|Sensory System Agents|sensory system agents|mesh-ancestor
5671504|NCT03563560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5671505|NCT03563560|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5671506|NCT03563560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5671507|NCT03563560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5671508|NCT03563560|Growth Inhibitors|growth inhibitors|mesh-ancestor
5671509|NCT03563560|Growth Substances|growth substances|mesh-ancestor
5671510|NCT03563560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5671511|NCT03563560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5671512|NCT03563534|Fluorides|fluorides|mesh-list
5671513|NCT03563534|Cariostatic Agents|cariostatic agents|mesh-ancestor
5671514|NCT03563534|Protective Agents|protective agents|mesh-ancestor
5671515|NCT03563534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671516|NCT03563365|Adapalene|adapalene|mesh-list
5671517|NCT03563365|Benzoyl Peroxide|benzoyl peroxide|mesh-list
5671518|NCT03563365|Resveratrol|resveratrol|mesh-list
5671519|NCT03563365|Antioxidants|antioxidants|mesh-ancestor
5671520|NCT03563365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671521|NCT03563365|Protective Agents|protective agents|mesh-ancestor
5671522|NCT03563365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671523|NCT03563365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5671524|NCT03563365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5671525|NCT03563365|Dermatologic Agents|dermatologic agents|mesh-ancestor
5671526|NCT03563365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5671527|NCT03563365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5671528|NCT03563365|Analgesics|analgesics|mesh-ancestor
5671529|NCT03563365|Sensory System Agents|sensory system agents|mesh-ancestor
5854964|NCT02431663|Sensory System Agents|sensory system agents|mesh-ancestor
5854965|NCT02431663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5854966|NCT02431663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854967|NCT02431663|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5854968|NCT02431663|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5854969|NCT02431663|Anesthetics, General|anesthetics, general|mesh-ancestor
5854970|NCT02431663|Anesthetics|anesthetics|mesh-ancestor
5854971|NCT02431663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5854972|NCT02431663|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5854973|NCT02431663|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5854974|NCT02431663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5854975|NCT02431663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854976|NCT02431429|Miltefosine|miltefosine|mesh-list
5854977|NCT02431429|Antifungal Agents|antifungal agents|mesh-ancestor
5854978|NCT02431429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6212247|NCT02183792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5671530|NCT03563365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5671531|NCT03563365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5671532|NCT03563365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5671533|NCT03563248|Nivolumab|nivolumab|mesh-list
5671534|NCT03563248|Folfirinox|folfirinox|mesh-list
5671535|NCT03563248|Losartan|losartan|mesh-list
5671536|NCT03563248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5671537|NCT03563248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5671538|NCT03563248|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5671539|NCT03563248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671540|NCT03563248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5671541|NCT03563248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5671542|NCT03563248|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5671543|NCT03563248|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5671544|NCT03563235|Calcitriol|calcitriol|mesh-list
5671545|NCT03563235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5671546|NCT03563235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671547|NCT03563235|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
5671548|NCT03563235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5671549|NCT03563235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671550|NCT03563235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5671551|NCT03563235|Vitamins|vitamins|mesh-ancestor
5671552|NCT03563235|Micronutrients|micronutrients|mesh-ancestor
5854979|NCT02431429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5854980|NCT02431429|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5854981|NCT02431429|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5854982|NCT02431416|Hormones|hormones|mesh-list
5854983|NCT02431416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5854984|NCT02431416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854985|NCT02431403|Imatinib Mesylate|imatinib mesylate|mesh-list
5854986|NCT02431403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5854987|NCT02431403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5854988|NCT02431403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5854989|NCT02431403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5854990|NCT02431325|Teduglutide|teduglutide|mesh-list
5854991|NCT02431325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5854992|NCT02431325|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5854993|NCT02431325|Protective Agents|protective agents|mesh-ancestor
5854994|NCT02431325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5854995|NCT02431286|Dexamethasone|dexamethasone|mesh-list
5854996|NCT02431286|Aprepitant|aprepitant|mesh-list
5854997|NCT02431286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5854998|NCT02431286|Antiemetics|antiemetics|mesh-ancestor
5854999|NCT02431286|Autonomic Agents|autonomic agents|mesh-ancestor
5671553|NCT03563235|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5671554|NCT03563222|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
5671555|NCT03563222|SMOFlipid|smoflipid|mesh-list
5671556|NCT03563222|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
5671557|NCT03563222|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5671558|NCT03563222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5671559|NCT03563170|Leucovorin|leucovorin|mesh-list
5671560|NCT03563170|Paclitaxel|paclitaxel|mesh-list
5671561|NCT03563170|Cyclophosphamide|cyclophosphamide|mesh-list
5671562|NCT03563170|Fluorouracil|fluorouracil|mesh-list
5671563|NCT03563170|Capecitabine|capecitabine|mesh-list
5671564|NCT03563170|Cetuximab|cetuximab|mesh-list
5671565|NCT03563170|Sorafenib|sorafenib|mesh-list
5671566|NCT03563170|Avelumab|avelumab|mesh-list
5671567|NCT03563170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5671568|NCT03563170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5671569|NCT03563170|Tubulin Modulators|tubulin modulators|mesh-ancestor
5855000|NCT02431286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5855001|NCT02431286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855002|NCT02431286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5855003|NCT02431286|Glucocorticoids|glucocorticoids|mesh-ancestor
5855004|NCT02431286|Hormones|hormones|mesh-ancestor
5855005|NCT02431286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5671570|NCT03563170|Antimitotic Agents|antimitotic agents|mesh-ancestor
5671571|NCT03563170|Mitosis Modulators|mitosis modulators|mesh-ancestor
5671572|NCT03563170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671573|NCT03563170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5671574|NCT03563170|Immunologic Factors|immunologic factors|mesh-ancestor
5671575|NCT03563170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671576|NCT03563170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5671577|NCT03563170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5671578|NCT03563170|Alkylating Agents|alkylating agents|mesh-ancestor
5671579|NCT03563170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5671580|NCT03563170|Antimetabolites|antimetabolites|mesh-ancestor
5671581|NCT03563170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5671582|NCT03563170|Antidotes|antidotes|mesh-ancestor
5671583|NCT03563170|Protective Agents|protective agents|mesh-ancestor
5671584|NCT03563170|Vitamin B Complex|vitamin b complex|mesh-ancestor
5671585|NCT03563170|Vitamins|vitamins|mesh-ancestor
5671586|NCT03563170|Micronutrients|micronutrients|mesh-ancestor
5671587|NCT03563170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5671588|NCT03563170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5671589|NCT03563170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5671590|NCT03563157|Leucovorin|leucovorin|mesh-list
5855006|NCT02431286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5855007|NCT02431286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5855008|NCT02431286|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6494426|NCT00618501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6494427|NCT00618501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6494428|NCT00618501|Antimetabolites|antimetabolites|mesh-ancestor
5671591|NCT03563157|Paclitaxel|paclitaxel|mesh-list
5671592|NCT03563157|Cyclophosphamide|cyclophosphamide|mesh-list
5671593|NCT03563157|Fluorouracil|fluorouracil|mesh-list
5671594|NCT03563157|Capecitabine|capecitabine|mesh-list
5671595|NCT03563157|Oxaliplatin|oxaliplatin|mesh-list
5671596|NCT03563157|Cetuximab|cetuximab|mesh-list
5855009|NCT02431286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5855010|NCT02431286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855011|NCT02431221|Perhexiline|perhexiline|mesh-list
5855012|NCT02431221|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5855013|NCT02431221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5855014|NCT02431221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855015|NCT02431221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5855016|NCT02431221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855017|NCT02431221|Vasodilator Agents|vasodilator agents|mesh-ancestor
5855018|NCT02431208|Dexamethasone|dexamethasone|mesh-list
5855019|NCT02431208|Lenalidomide|lenalidomide|mesh-list
5855020|NCT02431208|Atezolizumab|atezolizumab|mesh-list
5855021|NCT02431208|Daratumumab|daratumumab|mesh-list
5855022|NCT02431208|Pomalidomide|pomalidomide|mesh-list
5671597|NCT03563157|Avelumab|avelumab|mesh-list
5671598|NCT03563157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5671599|NCT03563157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5671600|NCT03563157|Tubulin Modulators|tubulin modulators|mesh-ancestor
5671601|NCT03563157|Antimitotic Agents|antimitotic agents|mesh-ancestor
5671602|NCT03563157|Mitosis Modulators|mitosis modulators|mesh-ancestor
5855023|NCT02431208|Antibodies|antibodies|mesh-list
5855024|NCT02431208|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5855025|NCT02431208|Immunologic Factors|immunologic factors|mesh-ancestor
5855026|NCT02431208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855027|NCT02431208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5855028|NCT02431208|Antiemetics|antiemetics|mesh-ancestor
5855029|NCT02431208|Autonomic Agents|autonomic agents|mesh-ancestor
5855030|NCT02431208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5855031|NCT02431208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5855032|NCT02431208|Glucocorticoids|glucocorticoids|mesh-ancestor
5855033|NCT02431208|Hormones|hormones|mesh-ancestor
5855034|NCT02431208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5855035|NCT02431208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5855036|NCT02431208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5855037|NCT02431208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5855038|NCT02431208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5855039|NCT02431208|Growth Substances|growth substances|mesh-ancestor
5855040|NCT02431208|Growth Inhibitors|growth inhibitors|mesh-ancestor
5855041|NCT02431143|Miltefosine|miltefosine|mesh-list
5855042|NCT02431143|Antifungal Agents|antifungal agents|mesh-ancestor
5855043|NCT02431143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5855044|NCT02431143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5855045|NCT02431143|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5855046|NCT02431143|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5855047|NCT02431013|Cilostazol|cilostazol|mesh-list
5855048|NCT02431013|Simvastatin|simvastatin|mesh-list
5855049|NCT02431013|Pravastatin|pravastatin|mesh-list
5855050|NCT02431013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5855051|NCT02431013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5855052|NCT02431013|Antimetabolites|antimetabolites|mesh-ancestor
5855053|NCT02431013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855054|NCT02431013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5855055|NCT02431013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5855056|NCT02431013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5855057|NCT02431013|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5855058|NCT02431013|Autonomic Agents|autonomic agents|mesh-ancestor
5855059|NCT02431013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5855060|NCT02431013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855061|NCT02431013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5855062|NCT02431013|Respiratory System Agents|respiratory system agents|mesh-ancestor
5855063|NCT02431013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5855064|NCT02431013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5855065|NCT02431013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5855066|NCT02431013|Vasodilator Agents|vasodilator agents|mesh-ancestor
5855067|NCT02431013|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5855068|NCT02431013|Protective Agents|protective agents|mesh-ancestor
5855069|NCT02431013|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5855070|NCT02431013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5855071|NCT02431039|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5855072|NCT02431039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5855073|NCT02431065|Ropivacaine|ropivacaine|mesh-list
5855074|NCT02431065|Anesthetics|anesthetics|mesh-ancestor
5855075|NCT02431065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5855076|NCT02431065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671603|NCT03563157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671604|NCT03563157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5855077|NCT02431065|Anesthetics, Local|anesthetics, local|mesh-ancestor
5671605|NCT03563157|Immunologic Factors|immunologic factors|mesh-ancestor
5671606|NCT03563157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671607|NCT03563157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5671608|NCT03563157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5671609|NCT03563157|Alkylating Agents|alkylating agents|mesh-ancestor
5671610|NCT03563157|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5671611|NCT03563157|Antimetabolites|antimetabolites|mesh-ancestor
5671612|NCT03563157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5671613|NCT03563157|Antidotes|antidotes|mesh-ancestor
5671614|NCT03563157|Protective Agents|protective agents|mesh-ancestor
5671615|NCT03563157|Vitamin B Complex|vitamin b complex|mesh-ancestor
5671616|NCT03563157|Vitamins|vitamins|mesh-ancestor
5671617|NCT03563157|Micronutrients|micronutrients|mesh-ancestor
5671618|NCT03563157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5671619|NCT03563144|Leucovorin|leucovorin|mesh-list
5671620|NCT03563144|Gemcitabine|gemcitabine|mesh-list
5671621|NCT03563144|Paclitaxel|paclitaxel|mesh-list
5671622|NCT03563144|Cyclophosphamide|cyclophosphamide|mesh-list
5671623|NCT03563144|Bevacizumab|bevacizumab|mesh-list
5671624|NCT03563144|Fluorouracil|fluorouracil|mesh-list
5671625|NCT03563144|Capecitabine|capecitabine|mesh-list
5671626|NCT03563144|Oxaliplatin|oxaliplatin|mesh-list
5671627|NCT03563144|Avelumab|avelumab|mesh-list
5671628|NCT03563144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5671629|NCT03563144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5671630|NCT03563144|Tubulin Modulators|tubulin modulators|mesh-ancestor
5671631|NCT03563144|Antimitotic Agents|antimitotic agents|mesh-ancestor
5671632|NCT03563144|Mitosis Modulators|mitosis modulators|mesh-ancestor
5671633|NCT03563144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671634|NCT03563144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5671635|NCT03563144|Immunologic Factors|immunologic factors|mesh-ancestor
5671636|NCT03563144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671637|NCT03563144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5671638|NCT03563144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5671639|NCT03563144|Alkylating Agents|alkylating agents|mesh-ancestor
5671640|NCT03563144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5671641|NCT03563144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5671642|NCT03563144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5671643|NCT03563144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5671644|NCT03563144|Growth Substances|growth substances|mesh-ancestor
5671645|NCT03563144|Growth Inhibitors|growth inhibitors|mesh-ancestor
5671646|NCT03563144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5855078|NCT02431065|Sensory System Agents|sensory system agents|mesh-ancestor
5855079|NCT02431065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5855080|NCT02430909|Certolizumab Pegol|certolizumab pegol|mesh-list
5855081|NCT02430909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5855082|NCT02430909|Immunologic Factors|immunologic factors|mesh-ancestor
5855083|NCT02430909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855084|NCT02430909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5855085|NCT02430714|Lenvatinib|lenvatinib|mesh-list
5855086|NCT02430714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5855087|NCT02430714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5855088|NCT02430714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5855089|NCT02430714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855090|NCT02430896|Methylphenidate|methylphenidate|mesh-list
5855091|NCT02430896|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
5855092|NCT02430896|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5855093|NCT02430896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855094|NCT02430896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5855095|NCT02430896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5855096|NCT02430896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5855097|NCT02430896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855098|NCT02430896|Dopamine Agents|dopamine agents|mesh-ancestor
5855099|NCT02430896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5855100|NCT02430896|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5855101|NCT02430896|Adrenergic Agents|adrenergic agents|mesh-ancestor
5855102|NCT02430545|Rifampin|rifampin|mesh-list
5855103|NCT02430545|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5855104|NCT02430545|Antitubercular Agents|antitubercular agents|mesh-ancestor
5855105|NCT02430545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5855106|NCT02430545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5855107|NCT02430545|Leprostatic Agents|leprostatic agents|mesh-ancestor
5855108|NCT02430545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5855109|NCT02430545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5671647|NCT03563144|Antimetabolites|antimetabolites|mesh-ancestor
5671648|NCT03563144|Antiviral Agents|antiviral agents|mesh-ancestor
5855110|NCT02430545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855111|NCT02430545|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5855112|NCT02430545|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5855113|NCT02430545|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5855114|NCT02430545|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5855115|NCT02430545|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5855116|NCT02430545|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5855117|NCT02430272|Glycopyrrolate|glycopyrrolate|mesh-list
5855118|NCT02430272|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5855119|NCT02430272|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5855120|NCT02430272|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5855121|NCT02430272|Cholinergic Agents|cholinergic agents|mesh-ancestor
6494429|NCT00618501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494430|NCT00618501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6494431|NCT00618501|Dermatologic Agents|dermatologic agents|mesh-ancestor
6494432|NCT00618501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6494433|NCT00618501|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6494434|NCT00618501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6494435|NCT00618501|Immunologic Factors|immunologic factors|mesh-ancestor
6494436|NCT00618501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6494437|NCT00618501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5671649|NCT03563144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5855122|NCT02430272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5855123|NCT02430272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855124|NCT02430272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671650|NCT03563144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5671651|NCT03563144|Antidotes|antidotes|mesh-ancestor
5671652|NCT03563144|Protective Agents|protective agents|mesh-ancestor
5671653|NCT03563144|Vitamin B Complex|vitamin b complex|mesh-ancestor
5671654|NCT03563144|Vitamins|vitamins|mesh-ancestor
5671655|NCT03563144|Micronutrients|micronutrients|mesh-ancestor
5855125|NCT02430298|Melatonin|melatonin|mesh-list
5855126|NCT02430298|Antioxidants|antioxidants|mesh-ancestor
5855127|NCT02430298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855128|NCT02430298|Protective Agents|protective agents|mesh-ancestor
5855129|NCT02430298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855130|NCT02430298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5855131|NCT02430259|Isoniazid|isoniazid|mesh-list
5855132|NCT02430259|Rifapentine|rifapentine|mesh-list
5855133|NCT02430259|Antitubercular Agents|antitubercular agents|mesh-ancestor
5855134|NCT02430259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5696083|NCT03385395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5696084|NCT03385395|Protease Inhibitors|protease inhibitors|mesh-ancestor
5696085|NCT03385395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5696086|NCT03385395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696087|NCT03385382|Dexamethasone|dexamethasone|mesh-list
5855135|NCT02430259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5855136|NCT02430259|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5696088|NCT03385382|Ranibizumab|ranibizumab|mesh-list
5696089|NCT03385382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5696090|NCT03385382|Antiemetics|antiemetics|mesh-ancestor
5696091|NCT03385382|Autonomic Agents|autonomic agents|mesh-ancestor
5696092|NCT03385382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5696093|NCT03385382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696094|NCT03385382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5696095|NCT03385382|Glucocorticoids|glucocorticoids|mesh-ancestor
5696096|NCT03385382|Hormones|hormones|mesh-ancestor
5696097|NCT03385382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5696098|NCT03385382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5696099|NCT03385382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5696100|NCT03385382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5696101|NCT03385382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5696102|NCT03385382|Growth Substances|growth substances|mesh-ancestor
5696103|NCT03385382|Growth Inhibitors|growth inhibitors|mesh-ancestor
5696104|NCT03385356|Vitamin D|vitamin d|mesh-list
5855137|NCT02430259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5855138|NCT02430259|Antimetabolites|antimetabolites|mesh-ancestor
5855139|NCT02430259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855140|NCT02430259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5855141|NCT02430259|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5855142|NCT02430259|Leprostatic Agents|leprostatic agents|mesh-ancestor
5855143|NCT02430181|Interferons|interferons|mesh-list
5696105|NCT03385356|Vitamins|vitamins|mesh-ancestor
5696106|NCT03385356|Micronutrients|micronutrients|mesh-ancestor
5855144|NCT02430181|Ritonavir|ritonavir|mesh-list
5855145|NCT02430181|Interferon-alpha|interferon-alpha|mesh-list
5855146|NCT02430181|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5855147|NCT02430181|Lonafarnib|lonafarnib|mesh-list
5855148|NCT02430181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5855149|NCT02430181|Antiviral Agents|antiviral agents|mesh-ancestor
5855150|NCT02430181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5855151|NCT02430181|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5855152|NCT02430181|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5855153|NCT02430181|Protease Inhibitors|protease inhibitors|mesh-ancestor
5855154|NCT02430181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5855155|NCT02430181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855156|NCT02430181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5855157|NCT02430181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5855158|NCT02430181|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5855159|NCT02430181|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5855160|NCT02430181|Immunologic Factors|immunologic factors|mesh-ancestor
5855161|NCT02430181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855162|NCT02430194|Interferons|interferons|mesh-list
5855163|NCT02430194|Ritonavir|ritonavir|mesh-list
5855164|NCT02430194|Interferon-alpha|interferon-alpha|mesh-list
5855165|NCT02430194|Interferon alpha-2|interferon alpha-2|mesh-list
5855166|NCT02430194|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5855167|NCT02430194|Lonafarnib|lonafarnib|mesh-list
5855168|NCT02430194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5855169|NCT02430194|Antiviral Agents|antiviral agents|mesh-ancestor
5855170|NCT02430194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6494438|NCT00618501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6494439|NCT00618501|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6494440|NCT00618501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6494441|NCT00618501|Antiviral Agents|antiviral agents|mesh-ancestor
6494442|NCT00618501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6494443|NCT00618501|Antidotes|antidotes|mesh-ancestor
6494444|NCT00618501|Protective Agents|protective agents|mesh-ancestor
6494445|NCT00618501|Vitamin B Complex|vitamin b complex|mesh-ancestor
6494446|NCT00618501|Vitamins|vitamins|mesh-ancestor
6494447|NCT00618501|Micronutrients|micronutrients|mesh-ancestor
6494448|NCT00618501|Tubulin Modulators|tubulin modulators|mesh-ancestor
6494449|NCT00618501|Antimitotic Agents|antimitotic agents|mesh-ancestor
6494450|NCT00618501|Mitosis Modulators|mitosis modulators|mesh-ancestor
6494451|NCT00618501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5855171|NCT02430194|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5855172|NCT02430194|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5855173|NCT02430194|Protease Inhibitors|protease inhibitors|mesh-ancestor
5855174|NCT02430194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5855175|NCT02430194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855176|NCT02430194|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5855177|NCT02430194|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6494452|NCT00618501|Glucocorticoids|glucocorticoids|mesh-ancestor
5671656|NCT03563040|Methoxsalen|methoxsalen|mesh-list
5671657|NCT03563040|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5671658|NCT03563040|Dermatologic Agents|dermatologic agents|mesh-ancestor
5671659|NCT03563014|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
5671660|NCT03563014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5671661|NCT03563001|Budesonide|budesonide|mesh-list
5671662|NCT03563001|Formoterol Fumarate|formoterol fumarate|mesh-list
5671663|NCT03563001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5671664|NCT03563001|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5671665|NCT03563001|Autonomic Agents|autonomic agents|mesh-ancestor
5671666|NCT03563001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5671667|NCT03563001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671668|NCT03563001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5671669|NCT03563001|Respiratory System Agents|respiratory system agents|mesh-ancestor
5671670|NCT03563001|Glucocorticoids|glucocorticoids|mesh-ancestor
5671671|NCT03563001|Hormones|hormones|mesh-ancestor
5671672|NCT03563001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5671673|NCT03563001|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5671674|NCT03563001|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5671675|NCT03563001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5671676|NCT03563001|Adrenergic Agents|adrenergic agents|mesh-ancestor
5671677|NCT03563001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5671678|NCT03563001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671679|NCT03562975|Ocrelizumab|ocrelizumab|mesh-list
5671680|NCT03562975|Immunologic Factors|immunologic factors|mesh-ancestor
5671681|NCT03562975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855178|NCT02430194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6494453|NCT00618501|Hormones|hormones|mesh-ancestor
5671682|NCT03562923|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
5671683|NCT03562923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5671684|NCT03562923|Autonomic Agents|autonomic agents|mesh-ancestor
5671685|NCT03562923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5671686|NCT03562923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671687|NCT03562923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5671688|NCT03562923|Respiratory System Agents|respiratory system agents|mesh-ancestor
5671689|NCT03562923|Glucocorticoids|glucocorticoids|mesh-ancestor
5671690|NCT03562923|Hormones|hormones|mesh-ancestor
5671691|NCT03562923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5671692|NCT03562923|Sympathomimetics|sympathomimetics|mesh-ancestor
5671693|NCT03562871|Carboplatin|carboplatin|mesh-list
5671694|NCT03562871|Pembrolizumab|pembrolizumab|mesh-list
5671695|NCT03562871|Pemetrexed|pemetrexed|mesh-list
5671696|NCT03562871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5671697|NCT03562871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5671698|NCT03562871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5671699|NCT03562871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671700|NCT03562871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5671701|NCT03562871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5671702|NCT03562780|Acetaminophen|acetaminophen|mesh-list
5671703|NCT03562780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5671704|NCT03562780|Analgesics|analgesics|mesh-ancestor
5671705|NCT03562780|Sensory System Agents|sensory system agents|mesh-ancestor
5671706|NCT03562780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5671707|NCT03562780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671708|NCT03562780|Antipyretics|antipyretics|mesh-ancestor
5671709|NCT03562754|Heparin|heparin|mesh-list
5671710|NCT03562754|Anticoagulants|anticoagulants|mesh-ancestor
5671711|NCT03562754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671712|NCT03562754|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5671713|NCT03562754|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5671714|NCT03562611|Flurbiprofen|flurbiprofen|mesh-list
5671715|NCT03562611|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
5671716|NCT03562611|Nalbuphine|nalbuphine|mesh-list
5671717|NCT03562611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5671718|NCT03562611|Narcotics|narcotics|mesh-ancestor
5671719|NCT03562611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5671720|NCT03562611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671721|NCT03562611|Analgesics|analgesics|mesh-ancestor
5671722|NCT03562611|Sensory System Agents|sensory system agents|mesh-ancestor
5671723|NCT03562611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5671724|NCT03562611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5671725|NCT03562611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5671726|NCT03562611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5671727|NCT03562611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5855179|NCT02430194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5855180|NCT02430194|Immunologic Factors|immunologic factors|mesh-ancestor
5855181|NCT02430194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855182|NCT02430350|Edaravone|edaravone|mesh-list
5855183|NCT02430350|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5855184|NCT02430350|Antioxidants|antioxidants|mesh-ancestor
5855185|NCT02430350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855186|NCT02430350|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5855187|NCT02430350|Protective Agents|protective agents|mesh-ancestor
5855188|NCT02430350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671728|NCT03562611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5671729|NCT03562611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5671730|NCT03562611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671731|NCT03562585|Antibodies|antibodies|mesh-list
5671732|NCT03562585|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5671733|NCT03562585|Immunologic Factors|immunologic factors|mesh-ancestor
5855189|NCT02430363|Pembrolizumab|pembrolizumab|mesh-list
5855190|NCT02430363|Dactolisib|dactolisib|mesh-list
5855191|NCT02430363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5855192|NCT02430363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5855193|NCT02430233|Progesterone|progesterone|mesh-list
5855194|NCT02430233|Progestins|progestins|mesh-ancestor
5855195|NCT02430233|Hormones|hormones|mesh-ancestor
5855196|NCT02430233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5855197|NCT02430233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904231|NCT05134363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5671734|NCT03562585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671735|NCT03562533|Paclitaxel|paclitaxel|mesh-list
5671736|NCT03562533|Carboplatin|carboplatin|mesh-list
5855198|NCT02430103|Goserelin|goserelin|mesh-list
5855199|NCT02430103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5855200|NCT02430103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5855201|NCT02429973|Gemcitabine|gemcitabine|mesh-list
5855202|NCT02429973|Sirolimus|sirolimus|mesh-list
5855203|NCT02429973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5855204|NCT02429973|Antimetabolites|antimetabolites|mesh-ancestor
5855205|NCT02429973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855206|NCT02429973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5855207|NCT02429973|Antiviral Agents|antiviral agents|mesh-ancestor
5855208|NCT02429973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5855209|NCT02429973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5855210|NCT02429973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5855211|NCT02429973|Immunologic Factors|immunologic factors|mesh-ancestor
5855212|NCT02429973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855213|NCT02429973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5855214|NCT02429973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5855215|NCT02429973|Antifungal Agents|antifungal agents|mesh-ancestor
5855216|NCT02429960|Remifentanil|remifentanil|mesh-list
5855217|NCT02429960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5855218|NCT02429960|Narcotics|narcotics|mesh-ancestor
5855219|NCT02429960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5855220|NCT02429960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855221|NCT02429960|Analgesics|analgesics|mesh-ancestor
5855222|NCT02429960|Sensory System Agents|sensory system agents|mesh-ancestor
5855223|NCT02429960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5855224|NCT02429921|Selenium|selenium|mesh-list
5855225|NCT02429921|Antioxidants|antioxidants|mesh-ancestor
5855226|NCT02429921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855227|NCT02429921|Protective Agents|protective agents|mesh-ancestor
5855228|NCT02429921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855229|NCT02429921|Trace Elements|trace elements|mesh-ancestor
5855230|NCT02429921|Micronutrients|micronutrients|mesh-ancestor
5855231|NCT02429804|Listerine|listerine|mesh-list
5855232|NCT02429804|Deoxyglucose|deoxyglucose|mesh-list
5855233|NCT02429804|Fluorides|fluorides|mesh-list
5855234|NCT02429804|Sodium Fluoride|sodium fluoride|mesh-list
5855235|NCT02429804|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5855236|NCT02429804|Cariostatic Agents|cariostatic agents|mesh-ancestor
5855237|NCT02429804|Protective Agents|protective agents|mesh-ancestor
5855238|NCT02429804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855239|NCT02429804|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5855240|NCT02429804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855241|NCT02429804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5855242|NCT02429804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5855243|NCT02429804|Antimetabolites|antimetabolites|mesh-ancestor
5855244|NCT02429804|Antiviral Agents|antiviral agents|mesh-ancestor
5855245|NCT02429726|Cisplatin|cisplatin|mesh-list
5855246|NCT02429726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5855247|NCT02429700|Paclitaxel|paclitaxel|mesh-list
5855248|NCT02429700|Etoposide|etoposide|mesh-list
5855249|NCT02429700|Carboplatin|carboplatin|mesh-list
5855250|NCT02429700|Bleomycin|bleomycin|mesh-list
5855251|NCT02429700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5855252|NCT02429700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5855253|NCT02429700|Tubulin Modulators|tubulin modulators|mesh-ancestor
5855254|NCT02429700|Antimitotic Agents|antimitotic agents|mesh-ancestor
5855255|NCT02429700|Mitosis Modulators|mitosis modulators|mesh-ancestor
5855256|NCT02429700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671737|NCT03562533|Doxorubicin|doxorubicin|mesh-list
5671738|NCT03562533|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5855257|NCT02429700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5855258|NCT02429700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5855259|NCT02429700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5855260|NCT02429700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5855261|NCT02429713|Oxymetazoline|oxymetazoline|mesh-list
5855262|NCT02429713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5855263|NCT02429713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6674916|NCT01572025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674917|NCT01572090|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6674918|NCT01572090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674919|NCT01572116|Lidocaine|lidocaine|mesh-list
5671739|NCT03562533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5671740|NCT03562533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5671741|NCT03562533|Tubulin Modulators|tubulin modulators|mesh-ancestor
5671742|NCT03562533|Antimitotic Agents|antimitotic agents|mesh-ancestor
5671743|NCT03562533|Mitosis Modulators|mitosis modulators|mesh-ancestor
5671744|NCT03562533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671745|NCT03562533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5671746|NCT03562533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5671747|NCT03562533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5671748|NCT03562533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5671749|NCT03562507|Nivolumab|nivolumab|mesh-list
5671750|NCT03562507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5671751|NCT03562507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5671752|NCT03562507|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5671753|NCT03562507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671754|NCT03562468|Niacinamide|niacinamide|mesh-list
5671755|NCT03562468|Niacin|niacin|mesh-list
5671756|NCT03562468|Nicotinic Acids|nicotinic acids|mesh-list
5671757|NCT03562468|Vitamin B Complex|vitamin b complex|mesh-ancestor
5671758|NCT03562468|Vitamins|vitamins|mesh-ancestor
5671759|NCT03562468|Micronutrients|micronutrients|mesh-ancestor
5671760|NCT03562468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671761|NCT03562468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5671762|NCT03562468|Antimetabolites|antimetabolites|mesh-ancestor
5671763|NCT03562468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671764|NCT03562468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5671765|NCT03562468|Vasodilator Agents|vasodilator agents|mesh-ancestor
5671766|NCT03562416|Nintedanib|nintedanib|mesh-list
5671767|NCT03562416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5671768|NCT03562416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5855264|NCT02429713|Adrenergic Agents|adrenergic agents|mesh-ancestor
5855265|NCT02429713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5855266|NCT02429713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855267|NCT02429713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855268|NCT02429713|Sympathomimetics|sympathomimetics|mesh-ancestor
5855269|NCT02429713|Autonomic Agents|autonomic agents|mesh-ancestor
5855270|NCT02429713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5855271|NCT02429713|Nasal Decongestants|nasal decongestants|mesh-ancestor
5855272|NCT02429713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5855273|NCT02429713|Respiratory System Agents|respiratory system agents|mesh-ancestor
5855274|NCT02429817|Edetic Acid|edetic acid|mesh-list
5855275|NCT02429817|Pentetic Acid|pentetic acid|mesh-list
5855276|NCT02429817|Antidotes|antidotes|mesh-ancestor
5855277|NCT02429817|Protective Agents|protective agents|mesh-ancestor
5855278|NCT02429817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855279|NCT02429817|Chelating Agents|chelating agents|mesh-ancestor
5855280|NCT02429817|Sequestering Agents|sequestering agents|mesh-ancestor
5855281|NCT02429817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855282|NCT02429817|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5855283|NCT02429817|Anticoagulants|anticoagulants|mesh-ancestor
5855284|NCT02429817|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5855285|NCT02429882|Brodalumab|brodalumab|mesh-list
5855286|NCT02429882|Dermatologic Agents|dermatologic agents|mesh-ancestor
5855287|NCT02429765|Formoterol Fumarate|formoterol fumarate|mesh-list
5855288|NCT02429765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5855289|NCT02429765|Autonomic Agents|autonomic agents|mesh-ancestor
5855290|NCT02429765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5855291|NCT02429765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855292|NCT02429765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5855293|NCT02429765|Respiratory System Agents|respiratory system agents|mesh-ancestor
5855294|NCT02429765|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5855295|NCT02429765|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5855296|NCT02429765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5855297|NCT02429765|Adrenergic Agents|adrenergic agents|mesh-ancestor
5855298|NCT02429765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5855299|NCT02429765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855300|NCT02429687|Paclitaxel|paclitaxel|mesh-list
5671769|NCT03562416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5671770|NCT03562416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671771|NCT03562390|Irinotecan|irinotecan|mesh-list
5671772|NCT03562390|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5671773|NCT03562390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5671774|NCT03562390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5671775|NCT03562390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671776|NCT03562390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5671777|NCT03562169|Thalidomide|thalidomide|mesh-list
5671778|NCT03562169|Dexamethasone|dexamethasone|mesh-list
5671779|NCT03562169|Ixazomib|ixazomib|mesh-list
5671780|NCT03562169|Glycine|glycine|mesh-list
5671781|NCT03562169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5671782|NCT03562169|Antiemetics|antiemetics|mesh-ancestor
5855301|NCT02429687|Etoposide|etoposide|mesh-list
5671783|NCT03562169|Autonomic Agents|autonomic agents|mesh-ancestor
5855302|NCT02429687|Carboplatin|carboplatin|mesh-list
5855303|NCT02429687|Bleomycin|bleomycin|mesh-list
5855304|NCT02429687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5671784|NCT03562169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5671785|NCT03562169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671786|NCT03562169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5671787|NCT03562169|Glucocorticoids|glucocorticoids|mesh-ancestor
5671788|NCT03562169|Hormones|hormones|mesh-ancestor
5671789|NCT03562169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5671790|NCT03562169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5671791|NCT03562169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5671792|NCT03562169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5671793|NCT03562169|Immunologic Factors|immunologic factors|mesh-ancestor
5671794|NCT03562169|Leprostatic Agents|leprostatic agents|mesh-ancestor
5671795|NCT03562169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5671796|NCT03562169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5671797|NCT03562169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5671798|NCT03562169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5671799|NCT03562169|Growth Substances|growth substances|mesh-ancestor
5671800|NCT03562169|Growth Inhibitors|growth inhibitors|mesh-ancestor
5671801|NCT03562169|Protease Inhibitors|protease inhibitors|mesh-ancestor
5671802|NCT03562169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5671803|NCT03562169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855305|NCT02429687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5855306|NCT02429687|Tubulin Modulators|tubulin modulators|mesh-ancestor
5855307|NCT02429687|Antimitotic Agents|antimitotic agents|mesh-ancestor
5855308|NCT02429687|Mitosis Modulators|mitosis modulators|mesh-ancestor
5855309|NCT02429687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855310|NCT02429687|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5855311|NCT02429687|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5855312|NCT02429687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5855313|NCT02429687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5855314|NCT02429622|Paclitaxel|paclitaxel|mesh-list
5855315|NCT02429622|Nedaplatin|nedaplatin|mesh-list
5855316|NCT02429622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5855317|NCT02429622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5855318|NCT02429622|Tubulin Modulators|tubulin modulators|mesh-ancestor
5855319|NCT02429622|Antimitotic Agents|antimitotic agents|mesh-ancestor
5855320|NCT02429622|Mitosis Modulators|mitosis modulators|mesh-ancestor
5855321|NCT02429622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855322|NCT02429596|Lamotrigine|lamotrigine|mesh-list
5855323|NCT02429596|Carbamazepine|carbamazepine|mesh-list
5855324|NCT02429596|Anticonvulsants|anticonvulsants|mesh-ancestor
5855325|NCT02429596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5855326|NCT02429596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5855327|NCT02429596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855328|NCT02429596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5855329|NCT02429596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671804|NCT03562169|Glycine Agents|glycine agents|mesh-ancestor
5671805|NCT03562169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5671806|NCT03562143|Iron|iron|mesh-list
5671807|NCT03562143|Trace Elements|trace elements|mesh-ancestor
5855330|NCT02429596|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5855331|NCT02429596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5855332|NCT02429596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5855333|NCT02429596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5855334|NCT02429596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5855335|NCT02429596|Antimanic Agents|antimanic agents|mesh-ancestor
5855336|NCT02429596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5855337|NCT02429596|Analgesics|analgesics|mesh-ancestor
5855338|NCT02429596|Sensory System Agents|sensory system agents|mesh-ancestor
5855339|NCT02429596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5671808|NCT03562143|Micronutrients|micronutrients|mesh-ancestor
5671809|NCT03562143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671810|NCT03562130|Teduglutide|teduglutide|mesh-list
5671811|NCT03562130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5671812|NCT03562130|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5671813|NCT03562130|Protective Agents|protective agents|mesh-ancestor
5855340|NCT02429596|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5855341|NCT02429596|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5855342|NCT02429570|Meclofenamic Acid|meclofenamic acid|mesh-list
5671814|NCT03562130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855343|NCT02429570|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5855344|NCT02429570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5855345|NCT02429570|Analgesics|analgesics|mesh-ancestor
5671815|NCT03561935|Propafenone|propafenone|mesh-list
5671816|NCT03561935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5671817|NCT03561935|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5671818|NCT03561935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5671819|NCT03561935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5671820|NCT03561935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671821|NCT03561870|Olaparib|olaparib|mesh-list
5671822|NCT03561870|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5671823|NCT03561870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5671824|NCT03561870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671825|NCT03561870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5855346|NCT02429570|Sensory System Agents|sensory system agents|mesh-ancestor
5855347|NCT02429570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5855348|NCT02429570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855349|NCT02429570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5855350|NCT02429570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5855351|NCT02429570|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5855352|NCT02429570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5855353|NCT02429570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855354|NCT02429219|Ethanol|ethanol|mesh-list
5855355|NCT02429219|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5855356|NCT02429219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5855357|NCT02429219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5855358|NCT02429219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855359|NCT02429193|Prednisone|prednisone|mesh-list
5855360|NCT02429193|Abiraterone Acetate|abiraterone acetate|mesh-list
5855361|NCT02429193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5855362|NCT02429193|Glucocorticoids|glucocorticoids|mesh-ancestor
5855363|NCT02429193|Hormones|hormones|mesh-ancestor
5855364|NCT02429193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5855365|NCT02429193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855366|NCT02429193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5855367|NCT02429193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5855368|NCT02429193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5855369|NCT02429193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5855370|NCT02429193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855371|NCT02429193|Hormone Antagonists|hormone antagonists|mesh-ancestor
5855372|NCT02429193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5855373|NCT02429375|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5855374|NCT02429375|Mocetinostat|mocetinostat|mesh-list
5855375|NCT02429375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5855376|NCT02429375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5855377|NCT02429375|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5855378|NCT02429375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5855379|NCT02429375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855380|NCT02429271|Clopidogrel|clopidogrel|mesh-list
5855381|NCT02429271|Ticagrelor|ticagrelor|mesh-list
5855382|NCT02429271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5855383|NCT02429271|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5855384|NCT02429271|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5855385|NCT02429271|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5671826|NCT03561740|Capecitabine|capecitabine|mesh-list
5671827|NCT03561740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5671828|NCT03561740|Antimetabolites|antimetabolites|mesh-ancestor
5671829|NCT03561740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855386|NCT02429271|Purinergic Agents|purinergic agents|mesh-ancestor
5855387|NCT02429271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5855388|NCT02429271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855389|NCT02429271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855390|NCT02429466|Guadecitabine|guadecitabine|mesh-list
5855391|NCT02429466|Azacitidine|azacitidine|mesh-list
5855392|NCT02429466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5855393|NCT02429466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5855394|NCT02429466|Antimetabolites|antimetabolites|mesh-ancestor
5855395|NCT02429466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855396|NCT02429466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5855397|NCT02429531|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5855398|NCT02429531|Immunologic Factors|immunologic factors|mesh-ancestor
5855399|NCT02429531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855400|NCT02429505|Miltefosine|miltefosine|mesh-list
5855401|NCT02429505|Antifungal Agents|antifungal agents|mesh-ancestor
5671830|NCT03561740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5671831|NCT03561675|Acetazolamide|acetazolamide|mesh-list
5671832|NCT03561675|Anticonvulsants|anticonvulsants|mesh-ancestor
5855402|NCT02429505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5855403|NCT02429505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5855404|NCT02429505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5855405|NCT02429505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5855406|NCT02429388|Sodium Channel Blockers|sodium channel blockers|mesh-list
5855407|NCT02429388|Spironolactone|spironolactone|mesh-list
5855408|NCT02429388|Diuretics|diuretics|mesh-list
5855409|NCT02429388|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-list
5855410|NCT02429388|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5855411|NCT02429388|Hormone Antagonists|hormone antagonists|mesh-ancestor
5855412|NCT02429388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5671833|NCT03561675|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5671834|NCT03561675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5671835|NCT03561675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671836|NCT03561675|Diuretics|diuretics|mesh-ancestor
5671837|NCT03561675|Natriuretic Agents|natriuretic agents|mesh-ancestor
5671838|NCT03561675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671839|NCT03561649|Adalimumab|adalimumab|mesh-list
5855413|NCT02429388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855414|NCT02429388|Natriuretic Agents|natriuretic agents|mesh-ancestor
5855415|NCT02429388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5855416|NCT02429388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855417|NCT02429232|Pioglitazone|pioglitazone|mesh-list
5671840|NCT03561649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5671841|NCT03561649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5671842|NCT03561584|Sulfasalazine|sulfasalazine|mesh-list
5671843|NCT03561584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5671844|NCT03561584|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5671845|NCT03561584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5671846|NCT03561584|Analgesics|analgesics|mesh-ancestor
5671847|NCT03561584|Sensory System Agents|sensory system agents|mesh-ancestor
5671848|NCT03561584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5671849|NCT03561584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671850|NCT03561584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5671851|NCT03561584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5671852|NCT03561584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5671853|NCT03561558|Ibuprofen|ibuprofen|mesh-list
5671854|NCT03561558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5671855|NCT03561558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5671856|NCT03561558|Analgesics|analgesics|mesh-ancestor
5671857|NCT03561558|Sensory System Agents|sensory system agents|mesh-ancestor
5671858|NCT03561558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5671859|NCT03561558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671860|NCT03561558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5671861|NCT03561558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5671862|NCT03561558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5671863|NCT03561558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5671864|NCT03561558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696107|NCT03385356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696108|NCT03385356|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5696109|NCT03385304|Iodine|iodine|mesh-list
5696110|NCT03385304|Chlorhexidine|chlorhexidine|mesh-list
5696111|NCT03385304|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5696112|NCT03385304|Povidone-Iodine|povidone-iodine|mesh-list
5696113|NCT03385304|Povidone|povidone|mesh-list
5696114|NCT03385304|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5696115|NCT03385304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5696116|NCT03385304|Disinfectants|disinfectants|mesh-ancestor
5696117|NCT03385304|Dermatologic Agents|dermatologic agents|mesh-ancestor
5696118|NCT03385304|Trace Elements|trace elements|mesh-ancestor
5696119|NCT03385304|Micronutrients|micronutrients|mesh-ancestor
5696120|NCT03385304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696121|NCT03385304|Plasma Substitutes|plasma substitutes|mesh-ancestor
5696122|NCT03385304|Blood Substitutes|blood substitutes|mesh-ancestor
5696123|NCT03385226|Pembrolizumab|pembrolizumab|mesh-list
5696124|NCT03385226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5696125|NCT03385226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5696126|NCT03385174|Carbon Monoxide|carbon monoxide|mesh-list
5696127|NCT03385174|Antimetabolites|antimetabolites|mesh-ancestor
5696128|NCT03385174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696129|NCT03385174|Gasotransmitters|gasotransmitters|mesh-ancestor
5696130|NCT03385174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5855418|NCT02429232|Linagliptin|linagliptin|mesh-list
5855419|NCT02429232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5855420|NCT02429232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855421|NCT02429232|Incretins|incretins|mesh-ancestor
5855422|NCT02429232|Hormones|hormones|mesh-ancestor
5855423|NCT02429232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5855424|NCT02429232|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5855425|NCT02429232|Protease Inhibitors|protease inhibitors|mesh-ancestor
5855426|NCT02429232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5855427|NCT02429232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855428|NCT02429323|Sevoflurane|sevoflurane|mesh-list
5855429|NCT02429323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5671865|NCT03561415|Posaconazole|posaconazole|mesh-list
5671866|NCT03561415|Antifungal Agents|antifungal agents|mesh-ancestor
5671867|NCT03561415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5671868|NCT03561415|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5671869|NCT03561415|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5671870|NCT03561415|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5671871|NCT03561415|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5671872|NCT03561415|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5671873|NCT03561415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5671874|NCT03561415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671875|NCT03561415|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5671876|NCT03561415|Hormone Antagonists|hormone antagonists|mesh-ancestor
5671877|NCT03561415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5671878|NCT03561415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671879|NCT03561402|Teriflunomide|teriflunomide|mesh-list
5671880|NCT03561402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5671881|NCT03561402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5671882|NCT03561402|Analgesics|analgesics|mesh-ancestor
5671883|NCT03561402|Sensory System Agents|sensory system agents|mesh-ancestor
5671884|NCT03561402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5671885|NCT03561402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671886|NCT03561402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5671887|NCT03561402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5671888|NCT03561402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5671889|NCT03561402|Immunologic Factors|immunologic factors|mesh-ancestor
5671890|NCT03561376|Petrolatum|petrolatum|mesh-list
5855430|NCT02429323|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5855431|NCT02429323|Anesthetics, General|anesthetics, general|mesh-ancestor
5855432|NCT02429323|Anesthetics|anesthetics|mesh-ancestor
5855433|NCT02429323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5855434|NCT02429323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855435|NCT02429440|Molgramostim|molgramostim|mesh-list
5855436|NCT02429440|Sargramostim|sargramostim|mesh-list
5855437|NCT02429440|Immunologic Factors|immunologic factors|mesh-ancestor
5855438|NCT02429440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855439|NCT02429440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5855440|NCT02429453|Thrombin|thrombin|mesh-list
5671891|NCT03561376|Zinc Oxide|zinc oxide|mesh-list
5671892|NCT03561376|Emollients|emollients|mesh-ancestor
5671893|NCT03561376|Dermatologic Agents|dermatologic agents|mesh-ancestor
5671894|NCT03561376|Sunscreening Agents|sunscreening agents|mesh-ancestor
5671895|NCT03561376|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5671896|NCT03561376|Protective Agents|protective agents|mesh-ancestor
5671897|NCT03561376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671898|NCT03561298|Zanubrutinib|zanubrutinib|mesh-list
5671899|NCT03561298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5671900|NCT03561298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5671901|NCT03561298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5671902|NCT03561298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671903|NCT03561233|Omeprazole|omeprazole|mesh-list
5671904|NCT03561233|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5671905|NCT03561233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5671906|NCT03561233|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5671907|NCT03561233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5855441|NCT02429453|Hemostatics|hemostatics|mesh-ancestor
5855442|NCT02429453|Coagulants|coagulants|mesh-ancestor
5855443|NCT02429518|Miltefosine|miltefosine|mesh-list
5855444|NCT02429518|Antifungal Agents|antifungal agents|mesh-ancestor
5855445|NCT02429518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5671908|NCT03561233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671909|NCT03561181|Vaccines|vaccines|mesh-list
5671910|NCT03561181|Immunologic Factors|immunologic factors|mesh-ancestor
5855446|NCT02429518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5855447|NCT02429518|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5855448|NCT02429518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5855449|NCT02428751|Prednisone|prednisone|mesh-list
5855450|NCT02428751|Rituximab|rituximab|mesh-list
5855451|NCT02428751|Doxorubicin|doxorubicin|mesh-list
5855452|NCT02428751|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5855453|NCT02428751|Vincristine|vincristine|mesh-list
5855454|NCT02428751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5855455|NCT02428751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5855456|NCT02428751|Immunologic Factors|immunologic factors|mesh-ancestor
5855457|NCT02428751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855458|NCT02428751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5855459|NCT02428751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5855460|NCT02428751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5855461|NCT02428751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5855462|NCT02428751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5671911|NCT03561181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671912|NCT03561025|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5671913|NCT03561025|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5855463|NCT02428751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855464|NCT02428751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5855465|NCT02428751|Glucocorticoids|glucocorticoids|mesh-ancestor
5855466|NCT02428751|Hormones|hormones|mesh-ancestor
5855467|NCT02428751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5855468|NCT02428751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5855469|NCT02428751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5855470|NCT02428751|Tubulin Modulators|tubulin modulators|mesh-ancestor
5855471|NCT02428751|Antimitotic Agents|antimitotic agents|mesh-ancestor
5855472|NCT02428751|Mitosis Modulators|mitosis modulators|mesh-ancestor
5855473|NCT02428764|Gemcitabine|gemcitabine|mesh-list
5855474|NCT02428764|Carboplatin|carboplatin|mesh-list
5855475|NCT02428764|Nimotuzumab|nimotuzumab|mesh-list
5855476|NCT02428764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5855477|NCT02428764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5855478|NCT02428764|Antimetabolites|antimetabolites|mesh-ancestor
5855479|NCT02428764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855480|NCT02428764|Antiviral Agents|antiviral agents|mesh-ancestor
5855481|NCT02428764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5855482|NCT02428764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5855483|NCT02428764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5855484|NCT02428764|Immunologic Factors|immunologic factors|mesh-ancestor
5855485|NCT02428764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671914|NCT03561025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671915|NCT03560973|Gemcitabine|gemcitabine|mesh-list
5671916|NCT03560973|Ramucirumab|ramucirumab|mesh-list
5671917|NCT03560973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5671918|NCT03560973|Antimetabolites|antimetabolites|mesh-ancestor
5671919|NCT03560973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671920|NCT03560973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5671921|NCT03560973|Antiviral Agents|antiviral agents|mesh-ancestor
5671922|NCT03560973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5671923|NCT03560973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5671924|NCT03560973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5671925|NCT03560973|Immunologic Factors|immunologic factors|mesh-ancestor
5671926|NCT03560973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671927|NCT03560934|Dronabinol|dronabinol|mesh-list
5671928|NCT03560934|Hallucinogens|hallucinogens|mesh-ancestor
5671929|NCT03560934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671930|NCT03560934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5671931|NCT03560934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5671932|NCT03560934|Analgesics|analgesics|mesh-ancestor
5671933|NCT03560934|Sensory System Agents|sensory system agents|mesh-ancestor
5671934|NCT03560934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5671935|NCT03560934|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5671936|NCT03560934|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5671937|NCT03560934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5671938|NCT03560934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671939|NCT03560934|Hormones|hormones|mesh-ancestor
5671940|NCT03560934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5671941|NCT03560908|Dasatinib|dasatinib|mesh-list
5671942|NCT03560908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5671943|NCT03560908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5671944|NCT03560908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5671945|NCT03560908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671946|NCT03560882|Atorvastatin|atorvastatin|mesh-list
5671947|NCT03560882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5671948|NCT03560882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5671949|NCT03560882|Antimetabolites|antimetabolites|mesh-ancestor
5671950|NCT03560882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671951|NCT03560882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5671952|NCT03560882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5671953|NCT03560882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5671954|NCT03560856|Fulvestrant|fulvestrant|mesh-list
5671955|NCT03560856|Palbociclib|palbociclib|mesh-list
5671956|NCT03560856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5671957|NCT03560856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5855486|NCT02428764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5855487|NCT02428933|Bromocriptine|bromocriptine|mesh-list
5855488|NCT02428933|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5855489|NCT02428933|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5855490|NCT02428933|Hormone Antagonists|hormone antagonists|mesh-ancestor
5855491|NCT02428933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5855492|NCT02428933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855493|NCT02428933|Dopamine Agonists|dopamine agonists|mesh-ancestor
5855494|NCT02428933|Dopamine Agents|dopamine agents|mesh-ancestor
5855495|NCT02428933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5855496|NCT02428933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855497|NCT02428777|Diclofenac|diclofenac|mesh-list
5855498|NCT02428777|Tramadol|tramadol|mesh-list
5855499|NCT02428777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5855500|NCT02428777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5855501|NCT02428777|Analgesics|analgesics|mesh-ancestor
5855502|NCT02428777|Sensory System Agents|sensory system agents|mesh-ancestor
5855503|NCT02428777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5855504|NCT02428777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855505|NCT02428777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5855506|NCT02428777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5855507|NCT02428777|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5855508|NCT02428777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5855509|NCT02428777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855510|NCT02428777|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5855511|NCT02428777|Narcotics|narcotics|mesh-ancestor
5855512|NCT02428777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5855513|NCT02428959|Amyl Nitrite|amyl nitrite|mesh-list
5855514|NCT02428959|Vasodilator Agents|vasodilator agents|mesh-ancestor
5855515|NCT02429037|Cisplatin|cisplatin|mesh-list
5855516|NCT02429037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5855517|NCT02429076|Propofol|propofol|mesh-list
5855518|NCT02429076|Sevoflurane|sevoflurane|mesh-list
5855519|NCT02429076|Methylphenidate|methylphenidate|mesh-list
5855520|NCT02429076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5671958|NCT03560856|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5671959|NCT03560856|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5671960|NCT03560856|Hormone Antagonists|hormone antagonists|mesh-ancestor
5671961|NCT03560856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5671962|NCT03560856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671963|NCT03560856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5671964|NCT03560856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5671965|NCT03560856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671966|NCT03560804|Olmesartan|olmesartan|mesh-list
5671967|NCT03560804|Chlorthalidone|chlorthalidone|mesh-list
5671968|NCT03560804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5671969|NCT03560804|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5671970|NCT03560804|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5671971|NCT03560804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671972|NCT03560804|Diuretics|diuretics|mesh-ancestor
5671973|NCT03560804|Natriuretic Agents|natriuretic agents|mesh-ancestor
5671974|NCT03560804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671975|NCT03560804|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5671976|NCT03560804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5671977|NCT03560752|Vaccines|vaccines|mesh-list
5671978|NCT03560752|Immunologic Factors|immunologic factors|mesh-ancestor
5671979|NCT03560752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671980|NCT03560583|Metoclopramide|metoclopramide|mesh-list
5671981|NCT03560583|Antiemetics|antiemetics|mesh-ancestor
5671982|NCT03560583|Autonomic Agents|autonomic agents|mesh-ancestor
5671983|NCT03560583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5855521|NCT02429076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5855522|NCT02429076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855523|NCT02429076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5855524|NCT02429076|Anesthetics, General|anesthetics, general|mesh-ancestor
5855525|NCT02429076|Anesthetics|anesthetics|mesh-ancestor
5855526|NCT02429076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5855527|NCT02429076|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5855528|NCT02429076|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5855529|NCT02429076|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5855530|NCT02429076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5855531|NCT02429076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5855532|NCT02429076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855533|NCT02429076|Dopamine Agents|dopamine agents|mesh-ancestor
5855534|NCT02429076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5855535|NCT02429050|Morphine|morphine|mesh-list
5855536|NCT02429050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5855537|NCT02429050|Narcotics|narcotics|mesh-ancestor
5855538|NCT02429050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5855539|NCT02429050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855540|NCT02429050|Analgesics|analgesics|mesh-ancestor
5855541|NCT02429050|Sensory System Agents|sensory system agents|mesh-ancestor
5855542|NCT02429050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5855543|NCT02428972|Propofol|propofol|mesh-list
5855544|NCT02428972|Sevoflurane|sevoflurane|mesh-list
5855545|NCT02428972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5855546|NCT02428972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5855547|NCT02428972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855548|NCT02428972|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5855549|NCT02428972|Anesthetics, General|anesthetics, general|mesh-ancestor
5855550|NCT02428972|Anesthetics|anesthetics|mesh-ancestor
5855551|NCT02428972|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5855552|NCT02428972|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5855553|NCT02428946|Bromocriptine|bromocriptine|mesh-list
5855554|NCT02428946|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5855555|NCT02428946|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5855556|NCT02428946|Hormone Antagonists|hormone antagonists|mesh-ancestor
5855557|NCT02428946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5855558|NCT02428946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855559|NCT02428946|Dopamine Agonists|dopamine agonists|mesh-ancestor
5855560|NCT02428946|Dopamine Agents|dopamine agents|mesh-ancestor
5855561|NCT02428946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5855562|NCT02428946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855563|NCT02428881|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5855564|NCT02428881|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5855565|NCT02428881|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5855566|NCT02428881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5855567|NCT02428881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855568|NCT02428881|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5855569|NCT02428881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5855570|NCT02428881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855571|NCT02428881|Cholinergic Agents|cholinergic agents|mesh-ancestor
5855572|NCT02428881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5855573|NCT02428868|Tranexamic Acid|tranexamic acid|mesh-list
5855574|NCT02428868|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5855575|NCT02428868|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5855576|NCT02428868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855577|NCT02428868|Hemostatics|hemostatics|mesh-ancestor
5855578|NCT02428868|Coagulants|coagulants|mesh-ancestor
5855579|NCT02428686|Epoetin Alfa|epoetin alfa|mesh-list
5855580|NCT02428686|Hematinics|hematinics|mesh-ancestor
5904232|NCT05134363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904233|NCT05134350|Omeprazole|omeprazole|mesh-list
5904234|NCT05134350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5904235|NCT05134350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5904236|NCT05134350|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5904237|NCT05134350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5904238|NCT05134350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904239|NCT05134337|Itraconazole|itraconazole|mesh-list
5904240|NCT05134337|Rifampin|rifampin|mesh-list
5904241|NCT05134337|Antifungal Agents|antifungal agents|mesh-ancestor
5904242|NCT05134337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5904243|NCT05134337|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5904244|NCT05134337|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5904245|NCT05134337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5904246|NCT05134337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855581|NCT02428543|Cytarabine|cytarabine|mesh-list
5855582|NCT02428543|Ponatinib|ponatinib|mesh-list
5855583|NCT02428543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5855584|NCT02428543|Antimetabolites|antimetabolites|mesh-ancestor
5855585|NCT02428543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855586|NCT02428543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5855587|NCT02428543|Antiviral Agents|antiviral agents|mesh-ancestor
5855588|NCT02428543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5855589|NCT02428543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5855590|NCT02428543|Immunologic Factors|immunologic factors|mesh-ancestor
5855591|NCT02428543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855592|NCT02428543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5855593|NCT02428543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5855594|NCT02428439|Lamotrigine|lamotrigine|mesh-list
5855595|NCT02428439|Bupropion|bupropion|mesh-list
5855596|NCT02428439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5855597|NCT02428439|Antidepressive Agents|antidepressive agents|mesh-ancestor
5855598|NCT02428439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5855599|NCT02428439|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5855600|NCT02428439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5855601|NCT02428439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5855602|NCT02428439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855603|NCT02428439|Dopamine Agents|dopamine agents|mesh-ancestor
5855604|NCT02428439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5855605|NCT02428439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855606|NCT02428439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5855607|NCT02428439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5855608|NCT02428439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5855609|NCT02428439|Anticonvulsants|anticonvulsants|mesh-ancestor
5671984|NCT03560583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5671985|NCT03560583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5671986|NCT03560583|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5671987|NCT03560583|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5671988|NCT03560583|Dopamine Agents|dopamine agents|mesh-ancestor
5671989|NCT03560583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5671990|NCT03560583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671991|NCT03560440|Vancomycin|vancomycin|mesh-list
5671992|NCT03560440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5671993|NCT03560440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5855610|NCT02428439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5855611|NCT02428439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5855612|NCT02428439|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5855613|NCT02428439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5855614|NCT02428439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5855615|NCT02428439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5855616|NCT02428270|Trametinib|trametinib|mesh-list
5855617|NCT02428270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5855618|NCT02428270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5855619|NCT02428270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5855620|NCT02428270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855621|NCT02428374|Clopidogrel|clopidogrel|mesh-list
5855622|NCT02428374|Ticagrelor|ticagrelor|mesh-list
5855623|NCT02428374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5855624|NCT02428374|Simvastatin|simvastatin|mesh-list
5855625|NCT02428374|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5855626|NCT02428374|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5855627|NCT02428374|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5855628|NCT02428374|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5855629|NCT02428374|Purinergic Agents|purinergic agents|mesh-ancestor
6494454|NCT00618501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6494455|NCT00618501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6494456|NCT00618501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6494457|NCT00618501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6494458|NCT00618527|Interferons|interferons|mesh-list
6494459|NCT00618527|Interferon-beta|interferon-beta|mesh-list
6494460|NCT00618527|Interferon beta-1a|interferon beta-1a|mesh-list
6494461|NCT00618527|Mycophenolic Acid|mycophenolic acid|mesh-list
6494462|NCT00618527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6494463|NCT00618527|Antiviral Agents|antiviral agents|mesh-ancestor
6494464|NCT00618527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6494465|NCT00618527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6494466|NCT00618527|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6494467|NCT00618527|Antitubercular Agents|antitubercular agents|mesh-ancestor
5671994|NCT03560427|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6494468|NCT00618527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6494469|NCT00618527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6494470|NCT00618527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855630|NCT02428374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5855631|NCT02428374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855632|NCT02428374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855633|NCT02428374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5855634|NCT02428374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5855635|NCT02428374|Antimetabolites|antimetabolites|mesh-ancestor
5855636|NCT02428374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5855637|NCT02428374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5855638|NCT02428374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5855639|NCT02428322|Vitamin D|vitamin d|mesh-list
5855640|NCT02428322|Cholecalciferol|cholecalciferol|mesh-list
5855641|NCT02428322|Vitamins|vitamins|mesh-ancestor
5855642|NCT02428322|Micronutrients|micronutrients|mesh-ancestor
5855643|NCT02428322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855644|NCT02428322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5855645|NCT02428322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5855646|NCT02428257|Ephedrine|ephedrine|mesh-list
5855647|NCT02428257|Bupivacaine|bupivacaine|mesh-list
5855648|NCT02428257|Anesthetics, Local|anesthetics, local|mesh-ancestor
5855649|NCT02428257|Anesthetics|anesthetics|mesh-ancestor
5855650|NCT02428257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5855651|NCT02428257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855652|NCT02428257|Sensory System Agents|sensory system agents|mesh-ancestor
5855653|NCT02428257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5855654|NCT02428257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5855655|NCT02428257|Sympathomimetics|sympathomimetics|mesh-ancestor
5855656|NCT02428257|Autonomic Agents|autonomic agents|mesh-ancestor
5855657|NCT02428257|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5855658|NCT02428257|Adrenergic Agents|adrenergic agents|mesh-ancestor
5855659|NCT02428257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5855660|NCT02428257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855661|NCT02428283|Remifentanil|remifentanil|mesh-list
5855662|NCT02428283|Ropivacaine|ropivacaine|mesh-list
5855663|NCT02428283|Sevoflurane|sevoflurane|mesh-list
5855664|NCT02428283|Anesthetics, Local|anesthetics, local|mesh-ancestor
5855665|NCT02428283|Anesthetics|anesthetics|mesh-ancestor
5855666|NCT02428283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5855667|NCT02428283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855668|NCT02428283|Sensory System Agents|sensory system agents|mesh-ancestor
5855669|NCT02428283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5855670|NCT02428283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5855671|NCT02428283|Narcotics|narcotics|mesh-ancestor
5671995|NCT03560427|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5671996|NCT03560427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5671997|NCT03560427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5671998|NCT03560427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5671999|NCT03560427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5672000|NCT03560427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672001|NCT03560427|Analgesics|analgesics|mesh-ancestor
5672002|NCT03560427|Sensory System Agents|sensory system agents|mesh-ancestor
5672003|NCT03560427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5672004|NCT03560427|Antidepressive Agents|antidepressive agents|mesh-ancestor
5672005|NCT03560427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5672006|NCT03560427|Dopamine Agents|dopamine agents|mesh-ancestor
5672007|NCT03560375|Empagliflozin|empagliflozin|mesh-list
5672008|NCT03560375|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5672009|NCT03560375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855672|NCT02428283|Analgesics|analgesics|mesh-ancestor
5855673|NCT02428283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5855674|NCT02428283|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5855675|NCT02428283|Anesthetics, General|anesthetics, general|mesh-ancestor
5855676|NCT02428218|Dimethyl Fumarate|dimethyl fumarate|mesh-list
5855677|NCT02428218|Dermatologic Agents|dermatologic agents|mesh-ancestor
5855678|NCT02428218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5855679|NCT02428218|Immunologic Factors|immunologic factors|mesh-ancestor
5855680|NCT02428218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855681|NCT02428205|Propranolol|propranolol|mesh-list
5855682|NCT02428205|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5855683|NCT02428205|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5855684|NCT02428205|Adrenergic Agents|adrenergic agents|mesh-ancestor
5855685|NCT02428205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5855686|NCT02428205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855687|NCT02428205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855688|NCT02428205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5855689|NCT02428205|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5855690|NCT02428205|Vasodilator Agents|vasodilator agents|mesh-ancestor
5672010|NCT03560375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5672011|NCT03560375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672012|NCT03560362|Epinephrine|epinephrine|mesh-list
5672013|NCT03560362|Bupivacaine|bupivacaine|mesh-list
5672014|NCT03560362|Anesthetics, Local|anesthetics, local|mesh-ancestor
5672015|NCT03560362|Anesthetics|anesthetics|mesh-ancestor
5672016|NCT03560362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5672017|NCT03560362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672018|NCT03560362|Sensory System Agents|sensory system agents|mesh-ancestor
5672019|NCT03560362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5855691|NCT02428062|Phenylephrine|phenylephrine|mesh-list
5855692|NCT02428062|Dopamine|dopamine|mesh-list
5855693|NCT02428062|Epinephrine|epinephrine|mesh-list
5855694|NCT02428062|Oxymetazoline|oxymetazoline|mesh-list
5855695|NCT02428062|Norepinephrine|norepinephrine|mesh-list
5855696|NCT02428062|Ephedrine|ephedrine|mesh-list
5855697|NCT02428062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
5855698|NCT02428062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855699|NCT02428062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5855700|NCT02428062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5855701|NCT02428062|Adrenergic Agents|adrenergic agents|mesh-ancestor
5855702|NCT02428062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5855703|NCT02428062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855704|NCT02428062|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6494471|NCT00618527|Immunologic Factors|immunologic factors|mesh-ancestor
6494472|NCT00618527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494473|NCT00618527|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6494474|NCT00618579|Warfarin|warfarin|mesh-list
6494475|NCT00618579|Anticoagulants|anticoagulants|mesh-ancestor
6494476|NCT00618631|Carfentanil|carfentanil|mesh-list
6494477|NCT00618631|Nicotine|nicotine|mesh-list
6494478|NCT00618631|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6494479|NCT00618631|Autonomic Agents|autonomic agents|mesh-ancestor
6494480|NCT00618631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6494481|NCT00618631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494482|NCT00618631|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6494483|NCT00618631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6494484|NCT00618631|Cholinergic Agents|cholinergic agents|mesh-ancestor
6494485|NCT00618631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6494486|NCT00618631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494487|NCT00618631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6494488|NCT00618631|Narcotics|narcotics|mesh-ancestor
6494489|NCT00618631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6494490|NCT00618631|Analgesics|analgesics|mesh-ancestor
6494491|NCT00618631|Sensory System Agents|sensory system agents|mesh-ancestor
6494492|NCT00618644|Ranibizumab|ranibizumab|mesh-list
6494493|NCT00618644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5855705|NCT02428062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5855706|NCT02428062|Autonomic Agents|autonomic agents|mesh-ancestor
5855707|NCT02428062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5855708|NCT02428062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5855709|NCT02428062|Respiratory System Agents|respiratory system agents|mesh-ancestor
5855710|NCT02428062|Mydriatics|mydriatics|mesh-ancestor
5855711|NCT02428062|Sympathomimetics|sympathomimetics|mesh-ancestor
5855712|NCT02428062|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5855713|NCT02428062|Nasal Decongestants|nasal decongestants|mesh-ancestor
5855714|NCT02428062|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5855715|NCT02428062|Protective Agents|protective agents|mesh-ancestor
5855716|NCT02428062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5855717|NCT02428062|Dopamine Agents|dopamine agents|mesh-ancestor
5855718|NCT02427932|Gentamicins|gentamicins|mesh-list
5855719|NCT02427932|Ampicillin|ampicillin|mesh-list
5855720|NCT02427932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5855721|NCT02427932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5855722|NCT02427932|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5855723|NCT02427932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5855724|NCT02427932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855725|NCT02427919|Lenograstim|lenograstim|mesh-list
6494494|NCT00618644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5672020|NCT03560362|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5855726|NCT02427919|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5855727|NCT02427919|Immunologic Factors|immunologic factors|mesh-ancestor
5855728|NCT02427919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855729|NCT02427893|Vemurafenib|vemurafenib|mesh-list
5855730|NCT02427893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5855731|NCT02427893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5855732|NCT02427893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5855733|NCT02427893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855734|NCT02427880|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5855735|NCT02427880|Furosemide|furosemide|mesh-list
5855736|NCT02427880|Acetazolamide|acetazolamide|mesh-list
5855737|NCT02427880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5855738|NCT02427880|Diuretics|diuretics|mesh-ancestor
5855739|NCT02427880|Natriuretic Agents|natriuretic agents|mesh-ancestor
5855740|NCT02427880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855741|NCT02427880|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5855742|NCT02427880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5855743|NCT02427880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855744|NCT02427880|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5855745|NCT02427880|Anticonvulsants|anticonvulsants|mesh-ancestor
5855746|NCT02427880|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5855747|NCT02427880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5855748|NCT02427581|Poly I-C|poly i-c|mesh-list
5855749|NCT02427581|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
5855750|NCT02427581|Poly ICLC|poly iclc|mesh-list
5855751|NCT02427581|Interferon Inducers|interferon inducers|mesh-ancestor
5855752|NCT02427581|Immunologic Factors|immunologic factors|mesh-ancestor
5855753|NCT02427581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855754|NCT02427581|Laxatives|laxatives|mesh-ancestor
5855755|NCT02427581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5855756|NCT02427581|Antiviral Agents|antiviral agents|mesh-ancestor
5855757|NCT02427581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5855758|NCT02427620|Cytarabine|cytarabine|mesh-list
5855759|NCT02427620|Dexamethasone|dexamethasone|mesh-list
5855760|NCT02427620|Dexamethasone acetate|dexamethasone acetate|mesh-list
5855761|NCT02427620|Cyclophosphamide|cyclophosphamide|mesh-list
5855762|NCT02427620|Rituximab|rituximab|mesh-list
5855763|NCT02427620|Doxorubicin|doxorubicin|mesh-list
5855764|NCT02427620|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5855765|NCT02427620|Methotrexate|methotrexate|mesh-list
5855766|NCT02427620|Vincristine|vincristine|mesh-list
5855767|NCT02427620|Daunorubicin|daunorubicin|mesh-list
5855768|NCT02427620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5672021|NCT03560362|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5672022|NCT03560362|Adrenergic Agents|adrenergic agents|mesh-ancestor
5672023|NCT03560362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5672024|NCT03560362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5672025|NCT03560362|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5672026|NCT03560362|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5672027|NCT03560362|Autonomic Agents|autonomic agents|mesh-ancestor
5672028|NCT03560362|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5672029|NCT03560362|Respiratory System Agents|respiratory system agents|mesh-ancestor
5672030|NCT03560362|Mydriatics|mydriatics|mesh-ancestor
5672031|NCT03560362|Sympathomimetics|sympathomimetics|mesh-ancestor
5672032|NCT03560362|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5672033|NCT03560349|Lidocaine|lidocaine|mesh-list
5672034|NCT03560349|Anesthetics, Local|anesthetics, local|mesh-ancestor
5672035|NCT03560349|Anesthetics|anesthetics|mesh-ancestor
5672036|NCT03560349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5672037|NCT03560349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672038|NCT03560349|Sensory System Agents|sensory system agents|mesh-ancestor
5672039|NCT03560349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5672040|NCT03560349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5672041|NCT03560349|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5672042|NCT03560349|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5672043|NCT03560349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5672044|NCT03560349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5672045|NCT03560336|Liraglutide|liraglutide|mesh-list
5672046|NCT03560336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5672047|NCT03560336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672048|NCT03560336|Incretins|incretins|mesh-ancestor
5672049|NCT03560336|Hormones|hormones|mesh-ancestor
5672050|NCT03560336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5672051|NCT03560310|Ticagrelor|ticagrelor|mesh-list
5672052|NCT03560310|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5855769|NCT02427620|Antibodies|antibodies|mesh-list
5855770|NCT02427620|Immunoglobulins|immunoglobulins|mesh-list
5672053|NCT03560310|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5672054|NCT03560310|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5672055|NCT03560310|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5672056|NCT03560310|Purinergic Agents|purinergic agents|mesh-ancestor
5672057|NCT03560310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5672058|NCT03560310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5672059|NCT03560310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672060|NCT03560232|Clindamycin|clindamycin|mesh-list
5672061|NCT03560232|Gentamicins|gentamicins|mesh-list
5672062|NCT03560232|Cefazolin|cefazolin|mesh-list
5672063|NCT03560232|Tazobactam|tazobactam|mesh-list
5672064|NCT03560232|Ceftriaxone|ceftriaxone|mesh-list
5672065|NCT03560232|Piperacillin|piperacillin|mesh-list
5672066|NCT03560232|Ampicillin|ampicillin|mesh-list
5672067|NCT03560232|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
5672068|NCT03560232|Sulbactam|sulbactam|mesh-list
5672069|NCT03560232|Sultamicillin|sultamicillin|mesh-list
5672070|NCT03560232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5672071|NCT03560232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5672072|NCT03560232|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5672073|NCT03560232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5672074|NCT03560232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5672075|NCT03560232|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5672076|NCT03560024|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
5672077|NCT03560024|Growth Substances|growth substances|mesh-ancestor
5855771|NCT02427620|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5855772|NCT02427620|BB 1101|bb 1101|mesh-list
5855773|NCT02427620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5855774|NCT02427620|Immunologic Factors|immunologic factors|mesh-ancestor
5855775|NCT02427620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855776|NCT02427620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5855777|NCT02427620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5855778|NCT02427620|Alkylating Agents|alkylating agents|mesh-ancestor
5855779|NCT02427620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855780|NCT02427620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5855781|NCT02427620|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5855782|NCT02427620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5855783|NCT02427620|Antiemetics|antiemetics|mesh-ancestor
5672078|NCT03560024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672079|NCT03560024|Vasodilator Agents|vasodilator agents|mesh-ancestor
5672080|NCT03560024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5672081|NCT03560024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5672082|NCT03560011|Immunoglobulins|immunoglobulins|mesh-list
5672083|NCT03560011|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5672084|NCT03560011|Antibodies|antibodies|mesh-list
5672085|NCT03560011|Immunologic Factors|immunologic factors|mesh-ancestor
5672086|NCT03560011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672087|NCT03559985|Acetaminophen|acetaminophen|mesh-list
5672088|NCT03559985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5672089|NCT03559985|Analgesics|analgesics|mesh-ancestor
5672090|NCT03559985|Sensory System Agents|sensory system agents|mesh-ancestor
5672091|NCT03559985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5672092|NCT03559985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855784|NCT02427620|Autonomic Agents|autonomic agents|mesh-ancestor
5855785|NCT02427620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5855786|NCT02427620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5855787|NCT02427620|Glucocorticoids|glucocorticoids|mesh-ancestor
5855788|NCT02427620|Hormones|hormones|mesh-ancestor
5855789|NCT02427620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5855790|NCT02427620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5855791|NCT02427620|Protease Inhibitors|protease inhibitors|mesh-ancestor
5855792|NCT02427620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5855793|NCT02427620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5855794|NCT02427620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5855795|NCT02427620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5855796|NCT02427620|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5855797|NCT02427620|Abortifacient Agents|abortifacient agents|mesh-ancestor
5855798|NCT02427620|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5855799|NCT02427620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5855800|NCT02427620|Antimetabolites|antimetabolites|mesh-ancestor
5855801|NCT02427620|Dermatologic Agents|dermatologic agents|mesh-ancestor
5855802|NCT02427620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5855803|NCT02427620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5855804|NCT02427620|Antiviral Agents|antiviral agents|mesh-ancestor
5855805|NCT02427620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5855806|NCT02427620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5855807|NCT02427620|Tubulin Modulators|tubulin modulators|mesh-ancestor
5855808|NCT02427620|Antimitotic Agents|antimitotic agents|mesh-ancestor
5855809|NCT02427620|Mitosis Modulators|mitosis modulators|mesh-ancestor
5855810|NCT02427529|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5855811|NCT02427529|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5855812|NCT02427529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855813|NCT02427295|Octreotide|octreotide|mesh-list
5855814|NCT02427295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5855815|NCT02427295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5855816|NCT02427295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5855817|NCT02427334|Dienogest|dienogest|mesh-list
5855818|NCT02427334|Fluoxetine|fluoxetine|mesh-list
5855819|NCT02427334|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5855820|NCT02427334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5855821|NCT02427334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5855822|NCT02427334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855823|NCT02427334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6674920|NCT01572116|Epinephrine|epinephrine|mesh-list
6674921|NCT01572116|Racepinephrine|racepinephrine|mesh-list
6674922|NCT01572116|Sufentanil|sufentanil|mesh-list
6674923|NCT01572116|Epinephryl borate|epinephryl borate|mesh-list
5672093|NCT03559985|Antipyretics|antipyretics|mesh-ancestor
5855824|NCT02427334|Serotonin Agents|serotonin agents|mesh-ancestor
5855825|NCT02427334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855826|NCT02427334|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5855827|NCT02427334|Antidepressive Agents|antidepressive agents|mesh-ancestor
5855828|NCT02427334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6494495|NCT00618644|Growth Substances|growth substances|mesh-ancestor
6494496|NCT00618644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494497|NCT00618644|Growth Inhibitors|growth inhibitors|mesh-ancestor
6494498|NCT00618644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6494499|NCT00618657|Paclitaxel|paclitaxel|mesh-list
5696131|NCT03385174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696132|NCT03385161|Ethanol|ethanol|mesh-list
5696133|NCT03385161|Botulinum Toxins|botulinum toxins|mesh-list
5696134|NCT03385161|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5855829|NCT02427334|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5855830|NCT02427334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5855831|NCT02427334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5855832|NCT02427334|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5855833|NCT02427334|Contraceptive Agents|contraceptive agents|mesh-ancestor
5855834|NCT02427334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5855835|NCT02427334|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5855836|NCT02427334|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5855837|NCT02427334|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5855838|NCT02427334|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5855839|NCT02427334|Hormone Antagonists|hormone antagonists|mesh-ancestor
5855840|NCT02427334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5855841|NCT02427334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5855842|NCT02427334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5855843|NCT02427308|Miltefosine|miltefosine|mesh-list
5855844|NCT02427308|Antifungal Agents|antifungal agents|mesh-ancestor
5855845|NCT02427308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5855846|NCT02427308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5696135|NCT03385161|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5696136|NCT03385161|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5696137|NCT03385161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5855847|NCT02427308|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5855848|NCT02427308|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5855849|NCT02427412|Tranexamic Acid|tranexamic acid|mesh-list
5855850|NCT02427412|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5855851|NCT02427412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5855852|NCT02427412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855853|NCT02427412|Hemostatics|hemostatics|mesh-ancestor
6494500|NCT00618657|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6494501|NCT00618657|Bevacizumab|bevacizumab|mesh-list
5696138|NCT03385161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696139|NCT03385161|Cholinergic Agents|cholinergic agents|mesh-ancestor
5696140|NCT03385161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6494502|NCT00618657|Carboplatin|carboplatin|mesh-list
6494503|NCT00618657|Trastuzumab|trastuzumab|mesh-list
6494504|NCT00618657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6494505|NCT00618657|Antibodies|antibodies|mesh-list
6494506|NCT00618657|Immunoglobulins|immunoglobulins|mesh-list
6674924|NCT01572116|Anesthetics, Local|anesthetics, local|mesh-ancestor
5672094|NCT03559920|Propofol|propofol|mesh-list
5672095|NCT03559920|Sevoflurane|sevoflurane|mesh-list
5672096|NCT03559920|Anesthetics|anesthetics|mesh-list
5672097|NCT03559920|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5672098|NCT03559920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5672099|NCT03559920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672100|NCT03559920|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5672101|NCT03559920|Anesthetics, General|anesthetics, general|mesh-ancestor
5672102|NCT03559920|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5672103|NCT03559920|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5672104|NCT03559868|Digoxin|digoxin|mesh-list
5672105|NCT03559868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5672106|NCT03559868|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5672107|NCT03559868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5672108|NCT03559868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5672109|NCT03559868|Protective Agents|protective agents|mesh-ancestor
5672110|NCT03559868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672111|NCT03559803|Cisplatin|cisplatin|mesh-list
5672112|NCT03559803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5672113|NCT03559790|Tenofovir|tenofovir|mesh-list
5672114|NCT03559790|Antiviral Agents|antiviral agents|mesh-ancestor
5672115|NCT03559790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5672116|NCT03559790|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5672117|NCT03559790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5672118|NCT03559790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5672119|NCT03559790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5672120|NCT03559790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5672121|NCT03559790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5672122|NCT03559751|Nicotine|nicotine|mesh-list
5672123|NCT03559751|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5672124|NCT03559751|Autonomic Agents|autonomic agents|mesh-ancestor
5672125|NCT03559751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5672126|NCT03559751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672127|NCT03559751|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5672128|NCT03559751|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5672129|NCT03559751|Cholinergic Agents|cholinergic agents|mesh-ancestor
5672130|NCT03559751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5672131|NCT03559751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5672132|NCT03559725|Menthol|menthol|mesh-list
5672133|NCT03559725|Nicotine|nicotine|mesh-list
5672134|NCT03559725|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5672135|NCT03559725|Autonomic Agents|autonomic agents|mesh-ancestor
5672136|NCT03559725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5672137|NCT03559725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672138|NCT03559725|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5672139|NCT03559725|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5672140|NCT03559725|Cholinergic Agents|cholinergic agents|mesh-ancestor
5672141|NCT03559725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5672142|NCT03559725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5672143|NCT03559725|Antipruritics|antipruritics|mesh-ancestor
5672144|NCT03559725|Dermatologic Agents|dermatologic agents|mesh-ancestor
5672145|NCT03559686|Certolizumab Pegol|certolizumab pegol|mesh-list
5672146|NCT03559686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5672147|NCT03559686|Immunologic Factors|immunologic factors|mesh-ancestor
5672148|NCT03559686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672149|NCT03559686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5672150|NCT03559673|Lacosamide|lacosamide|mesh-list
5672151|NCT03559673|Anticonvulsants|anticonvulsants|mesh-ancestor
5672152|NCT03559673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5672153|NCT03559673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5672154|NCT03559673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5672155|NCT03559673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5672156|NCT03559660|Certolizumab Pegol|certolizumab pegol|mesh-list
5672157|NCT03559660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5672158|NCT03559660|Immunologic Factors|immunologic factors|mesh-ancestor
5672159|NCT03559660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672160|NCT03559660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5672161|NCT03559504|Sevoflurane|sevoflurane|mesh-list
5672162|NCT03559504|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5672163|NCT03559504|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5672164|NCT03559504|Anesthetics, General|anesthetics, general|mesh-ancestor
5672165|NCT03559504|Anesthetics|anesthetics|mesh-ancestor
5672166|NCT03559504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5672167|NCT03559504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672168|NCT03559426|Antipsychotic Agents|antipsychotic agents|mesh-list
5672169|NCT03559426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5672170|NCT03559426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5672171|NCT03559426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672172|NCT03559426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5672173|NCT03559413|Imiquimod|imiquimod|mesh-list
5672174|NCT03559413|Immunologic Factors|immunologic factors|mesh-ancestor
5672175|NCT03559413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672176|NCT03559413|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5672177|NCT03559413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5672178|NCT03559413|Interferon Inducers|interferon inducers|mesh-ancestor
5672179|NCT03559387|Sargramostim|sargramostim|mesh-list
5672180|NCT03559387|Lenograstim|lenograstim|mesh-list
5672181|NCT03559387|Immunologic Factors|immunologic factors|mesh-ancestor
5672182|NCT03559387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672183|NCT03559387|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5672184|NCT03559348|Leucovorin|leucovorin|mesh-list
5672185|NCT03559348|Gemcitabine|gemcitabine|mesh-list
5672186|NCT03559348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5672187|NCT03559348|Antimetabolites|antimetabolites|mesh-ancestor
5672188|NCT03559348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5672189|NCT03559348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5672190|NCT03559348|Antiviral Agents|antiviral agents|mesh-ancestor
5672191|NCT03559348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5672192|NCT03559348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5672193|NCT03559348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5672194|NCT03559348|Immunologic Factors|immunologic factors|mesh-ancestor
5672195|NCT03559348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672196|NCT03559348|Antidotes|antidotes|mesh-ancestor
5672197|NCT03559348|Protective Agents|protective agents|mesh-ancestor
5672198|NCT03559348|Vitamin B Complex|vitamin b complex|mesh-ancestor
5672199|NCT03559348|Vitamins|vitamins|mesh-ancestor
5672200|NCT03559348|Micronutrients|micronutrients|mesh-ancestor
5672201|NCT03559140|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5672202|NCT03559114|Dalteparin|dalteparin|mesh-list
5855854|NCT02427412|Coagulants|coagulants|mesh-ancestor
5855855|NCT02427386|Estradiol|estradiol|mesh-list
5855856|NCT02427386|Estrogens|estrogens|mesh-list
5855857|NCT02427386|Hormones|hormones|mesh-ancestor
5855858|NCT02427386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5855859|NCT02427386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855860|NCT02427165|Albuterol|albuterol|mesh-list
5855861|NCT02427165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5855862|NCT02427165|Autonomic Agents|autonomic agents|mesh-ancestor
5855863|NCT02427165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5855864|NCT02427165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855865|NCT02427165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5855866|NCT02427165|Respiratory System Agents|respiratory system agents|mesh-ancestor
5855867|NCT02427165|Tocolytic Agents|tocolytic agents|mesh-ancestor
5855868|NCT02427165|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5855869|NCT02427165|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5855870|NCT02427165|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5855871|NCT02427165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5855872|NCT02427165|Adrenergic Agents|adrenergic agents|mesh-ancestor
5855873|NCT02427165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5855874|NCT02427165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5672203|NCT03559114|Tinzaparin|tinzaparin|mesh-list
5672204|NCT03559114|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5672205|NCT03559114|Anticoagulants|anticoagulants|mesh-ancestor
5672206|NCT03559114|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5672207|NCT03559114|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5672208|NCT03559114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5672209|NCT03559049|Carboplatin|carboplatin|mesh-list
5672210|NCT03559049|Pembrolizumab|pembrolizumab|mesh-list
5672211|NCT03559049|Pemetrexed|pemetrexed|mesh-list
5672212|NCT03559049|Rucaparib|rucaparib|mesh-list
5672213|NCT03559049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5672214|NCT03559049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5672215|NCT03559049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5672216|NCT03559049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5672217|NCT03559049|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5672218|NCT03559049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5672219|NCT03559049|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5672220|NCT03558971|Hydrocortisone|hydrocortisone|mesh-list
5672221|NCT03558971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5672222|NCT03558919|Solifenacin Succinate|solifenacin succinate|mesh-list
5672223|NCT03558919|Mirabegron|mirabegron|mesh-list
5672224|NCT03558919|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5855875|NCT02427243|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5855876|NCT02427243|Immunologic Factors|immunologic factors|mesh-ancestor
5855877|NCT02427243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855878|NCT02426840|Calcium, Dietary|calcium, dietary|mesh-list
5855879|NCT02426840|Vitamin D|vitamin d|mesh-list
5855880|NCT02426840|Ergocalciferols|ergocalciferols|mesh-list
5855881|NCT02426840|Vitamins|vitamins|mesh-list
5855882|NCT02426840|Calcium|calcium|mesh-list
5855883|NCT02426840|Micronutrients|micronutrients|mesh-ancestor
5855884|NCT02426840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672225|NCT03558919|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5672226|NCT03558919|Cholinergic Agents|cholinergic agents|mesh-ancestor
5672227|NCT03558919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5672228|NCT03558919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5672229|NCT03558919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672230|NCT03558919|Urological Agents|urological agents|mesh-ancestor
5672231|NCT03558919|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
5672232|NCT03558919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5672233|NCT03558919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5672234|NCT03558919|Adrenergic Agents|adrenergic agents|mesh-ancestor
5672235|NCT03558880|Anesthetics|anesthetics|mesh-list
5672236|NCT03558880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5672237|NCT03558880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672238|NCT03558867|Metformin|metformin|mesh-list
5672239|NCT03558867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5672240|NCT03558867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672241|NCT03558750|Rituximab|rituximab|mesh-list
5672242|NCT03558750|Nivolumab|nivolumab|mesh-list
5672243|NCT03558750|Lenalidomide|lenalidomide|mesh-list
5672244|NCT03558750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5672245|NCT03558750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5672246|NCT03558750|Immunologic Factors|immunologic factors|mesh-ancestor
5672247|NCT03558750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672248|NCT03558750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5672249|NCT03558750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5672250|NCT03558750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5672251|NCT03558750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5672252|NCT03558750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5672253|NCT03558750|Growth Substances|growth substances|mesh-ancestor
5672254|NCT03558750|Growth Inhibitors|growth inhibitors|mesh-ancestor
5672255|NCT03558724|Bevacizumab|bevacizumab|mesh-list
5672256|NCT03558724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5672257|NCT03558724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5855885|NCT02426840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5855886|NCT02426840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5672258|NCT03558724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5672259|NCT03558724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5672260|NCT03558724|Growth Substances|growth substances|mesh-ancestor
5855887|NCT02426905|Trientine|trientine|mesh-list
5855888|NCT02426905|Chelating Agents|chelating agents|mesh-ancestor
5855889|NCT02426905|Sequestering Agents|sequestering agents|mesh-ancestor
5855890|NCT02426905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855891|NCT02426866|Efavirenz|efavirenz|mesh-list
5855892|NCT02426866|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5855893|NCT02426866|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5855894|NCT02426866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5855895|NCT02426866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855896|NCT02426866|Antiviral Agents|antiviral agents|mesh-ancestor
5855897|NCT02426866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5855898|NCT02426866|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5855899|NCT02426866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5855900|NCT02426866|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5855901|NCT02426866|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5855902|NCT02426866|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5855903|NCT02426866|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5855904|NCT02426697|Fentanyl|fentanyl|mesh-list
5855905|NCT02426697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5855906|NCT02426697|Narcotics|narcotics|mesh-ancestor
5855907|NCT02426697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5855908|NCT02426697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855909|NCT02426697|Analgesics|analgesics|mesh-ancestor
5855910|NCT02426697|Sensory System Agents|sensory system agents|mesh-ancestor
5672261|NCT03558724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672262|NCT03558724|Growth Inhibitors|growth inhibitors|mesh-ancestor
5672263|NCT03558477|Esomeprazole|esomeprazole|mesh-list
6494507|NCT00618657|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5855911|NCT02426697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5855912|NCT02426697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5855913|NCT02426697|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5855914|NCT02426697|Anesthetics, General|anesthetics, general|mesh-ancestor
5855915|NCT02426697|Anesthetics|anesthetics|mesh-ancestor
5855916|NCT02426983|Dextromethorphan|dextromethorphan|mesh-list
5855917|NCT02426983|Antitussive Agents|antitussive agents|mesh-ancestor
5855918|NCT02426983|Respiratory System Agents|respiratory system agents|mesh-ancestor
5855919|NCT02426983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5855920|NCT02426983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5855921|NCT02426983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5855922|NCT02426983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855923|NCT02426983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672264|NCT03558477|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5672265|NCT03558477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5672266|NCT03558477|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5672267|NCT03558477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5672268|NCT03558477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5672269|NCT03558412|Decitabine|decitabine|mesh-list
5672270|NCT03558412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5672271|NCT03558412|Antimetabolites|antimetabolites|mesh-ancestor
5672272|NCT03558412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5672273|NCT03558412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5672274|NCT03558412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5672275|NCT03558373|Immunosuppressive Agents|immunosuppressive agents|mesh-list
5672276|NCT03558373|Immunologic Factors|immunologic factors|mesh-ancestor
5672277|NCT03558373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696141|NCT03385161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696142|NCT03385161|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5696143|NCT03385161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5904247|NCT05134337|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5904248|NCT05134337|Hormone Antagonists|hormone antagonists|mesh-ancestor
5904249|NCT05134337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5904250|NCT05134337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904251|NCT05134337|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5904252|NCT05134337|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5904253|NCT05134337|Antitubercular Agents|antitubercular agents|mesh-ancestor
5904254|NCT05134337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5904255|NCT05134337|Leprostatic Agents|leprostatic agents|mesh-ancestor
5904256|NCT05134337|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5904257|NCT05134337|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5904258|NCT05134337|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5904259|NCT05134337|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5904260|NCT05134337|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5904261|NCT05134337|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5904262|NCT05134337|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5904263|NCT05134298|Meropenem|meropenem|mesh-list
5904264|NCT05134298|Tazobactam|tazobactam|mesh-list
5904265|NCT05134298|Piperacillin|piperacillin|mesh-list
5904266|NCT05134298|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
5904267|NCT05134298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5904268|NCT05134298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5904269|NCT05134298|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5904270|NCT05134298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5904271|NCT05134298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904272|NCT05134220|Calcium|calcium|mesh-list
5904273|NCT05134220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5904274|NCT05134220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904275|NCT05134194|Gemcitabine|gemcitabine|mesh-list
5904276|NCT05134194|Capecitabine|capecitabine|mesh-list
5904277|NCT05134194|Vinorelbine|vinorelbine|mesh-list
5904278|NCT05134194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5904279|NCT05134194|Antimetabolites|antimetabolites|mesh-ancestor
5904280|NCT05134194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904281|NCT05134194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5904282|NCT05134194|Antiviral Agents|antiviral agents|mesh-ancestor
5904283|NCT05134194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5904284|NCT05134194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5904285|NCT05134194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5904286|NCT05134194|Immunologic Factors|immunologic factors|mesh-ancestor
5904287|NCT05134194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696144|NCT03385161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5672278|NCT03558295|Anticoagulants|anticoagulants|mesh-list
5672279|NCT03558243|Hemostatics|hemostatics|mesh-list
5672280|NCT03558243|Coagulants|coagulants|mesh-ancestor
5672281|NCT03558139|Avelumab|avelumab|mesh-list
5672282|NCT03558139|Magrolimab|magrolimab|mesh-list
5672283|NCT03558139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5672284|NCT03558139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5672285|NCT03557996|Listerine|listerine|mesh-list
5672286|NCT03557996|Fluorides|fluorides|mesh-list
5672287|NCT03557996|Sodium Fluoride|sodium fluoride|mesh-list
5672288|NCT03557996|Fluorides, Topical|fluorides, topical|mesh-list
5672289|NCT03557996|Cariostatic Agents|cariostatic agents|mesh-ancestor
5672290|NCT03557996|Protective Agents|protective agents|mesh-ancestor
5672291|NCT03557996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672292|NCT03557996|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5672293|NCT03557996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5672294|NCT03557983|Fenofibrate|fenofibrate|mesh-list
5672295|NCT03557983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5672296|NCT03557983|Antimetabolites|antimetabolites|mesh-ancestor
5672297|NCT03557983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5672298|NCT03557983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6212248|NCT02183792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5672301|NCT03557853|Golimumab|golimumab|mesh-list
5672302|NCT03557853|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
5672303|NCT03557853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5672304|NCT03557853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5672305|NCT03557853|Immunologic Factors|immunologic factors|mesh-ancestor
5672306|NCT03557853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672307|NCT03557840|Temocillin|temocillin|mesh-list
5672308|NCT03557840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5672309|NCT03557840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5672310|NCT03557788|Rifaximin|rifaximin|mesh-list
5672311|NCT03557788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5672312|NCT03557788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5672313|NCT03557788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5672314|NCT03557580|Isosorbide|isosorbide|mesh-list
5672315|NCT03557580|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
5672316|NCT03557580|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
5672317|NCT03557580|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5672318|NCT03557580|Diuretics|diuretics|mesh-ancestor
5672319|NCT03557580|Natriuretic Agents|natriuretic agents|mesh-ancestor
5672320|NCT03557580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672321|NCT03557580|Vasodilator Agents|vasodilator agents|mesh-ancestor
5672322|NCT03557580|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5672323|NCT03557580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5672324|NCT03557437|Amoxicillin|amoxicillin|mesh-list
5672325|NCT03557437|Metronidazole|metronidazole|mesh-list
5672326|NCT03557437|Potassium Citrate|potassium citrate|mesh-list
5672327|NCT03557437|Esomeprazole|esomeprazole|mesh-list
5672328|NCT03557437|Bismuth|bismuth|mesh-list
5672329|NCT03557437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5672330|NCT03557437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5672331|NCT03557437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5672332|NCT03557437|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5672333|NCT03557437|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5672334|NCT03557437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5672335|NCT03557437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5672336|NCT03557437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5672337|NCT03557437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5672338|NCT03557437|Antacids|antacids|mesh-ancestor
5672339|NCT03557437|Diuretics|diuretics|mesh-ancestor
5672340|NCT03557437|Natriuretic Agents|natriuretic agents|mesh-ancestor
5672341|NCT03557437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672342|NCT03557437|Expectorants|expectorants|mesh-ancestor
5672343|NCT03557437|Respiratory System Agents|respiratory system agents|mesh-ancestor
5672344|NCT03557424|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
5672345|NCT03557424|Cathartics|cathartics|mesh-ancestor
5672346|NCT03557424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5672347|NCT03557255|Simendan|simendan|mesh-list
5672348|NCT03557255|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5672349|NCT03557255|Vasodilator Agents|vasodilator agents|mesh-ancestor
5672350|NCT03557255|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5672351|NCT03557255|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5672352|NCT03557255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5672353|NCT03557255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5672354|NCT03557255|Protective Agents|protective agents|mesh-ancestor
5672355|NCT03557255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672356|NCT03557229|Vitamins|vitamins|mesh-list
5672357|NCT03557229|Ascorbic Acid|ascorbic acid|mesh-list
5672358|NCT03557229|Vitamin E|vitamin e|mesh-list
5672359|NCT03557229|Acetylcysteine|acetylcysteine|mesh-list
5672360|NCT03557229|Melatonin|melatonin|mesh-list
5672361|NCT03557229|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5672362|NCT03557229|Micronutrients|micronutrients|mesh-ancestor
5672363|NCT03557229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672364|NCT03557229|Antioxidants|antioxidants|mesh-ancestor
5672365|NCT03557229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5672366|NCT03557229|Protective Agents|protective agents|mesh-ancestor
5855924|NCT02426723|Dexamethasone|dexamethasone|mesh-list
5855925|NCT02426723|Lenalidomide|lenalidomide|mesh-list
5855926|NCT02426723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5855927|NCT02426723|Antiemetics|antiemetics|mesh-ancestor
5855928|NCT02426723|Autonomic Agents|autonomic agents|mesh-ancestor
5855929|NCT02426723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5855930|NCT02426723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855931|NCT02426723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5672367|NCT03557229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5672368|NCT03557229|Antiviral Agents|antiviral agents|mesh-ancestor
5672369|NCT03557229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5672370|NCT03557229|Expectorants|expectorants|mesh-ancestor
5672371|NCT03557229|Respiratory System Agents|respiratory system agents|mesh-ancestor
5672372|NCT03557229|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5672373|NCT03557229|Antidotes|antidotes|mesh-ancestor
5672374|NCT03557112|Nimotuzumab|nimotuzumab|mesh-list
5672375|NCT03557112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5672376|NCT03557112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5672377|NCT03556917|Caffeine|caffeine|mesh-list
5672378|NCT03556917|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5672379|NCT03556917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672380|NCT03556917|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5672381|NCT03556917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5672382|NCT03556917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5672383|NCT03556917|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5672384|NCT03556917|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5672385|NCT03556917|Purinergic Agents|purinergic agents|mesh-ancestor
5672386|NCT03556917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5672387|NCT03556852|Misoprostol|misoprostol|mesh-list
5672388|NCT03556852|Carbetocin|carbetocin|mesh-list
5672389|NCT03556852|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5672390|NCT03556852|Abortifacient Agents|abortifacient agents|mesh-ancestor
5672391|NCT03556852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5855932|NCT02426723|Glucocorticoids|glucocorticoids|mesh-ancestor
5855933|NCT02426723|Hormones|hormones|mesh-ancestor
5855934|NCT02426723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5855935|NCT02426723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5855936|NCT02426723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5855937|NCT02426723|Immunologic Factors|immunologic factors|mesh-ancestor
5855938|NCT02426723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5855939|NCT02426723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5855940|NCT02426723|Growth Substances|growth substances|mesh-ancestor
5855941|NCT02426723|Growth Inhibitors|growth inhibitors|mesh-ancestor
5855942|NCT02426736|Dexamethasone|dexamethasone|mesh-list
5855943|NCT02426736|Bupivacaine|bupivacaine|mesh-list
5855944|NCT02426736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5855945|NCT02426736|Antiemetics|antiemetics|mesh-ancestor
5855946|NCT02426736|Autonomic Agents|autonomic agents|mesh-ancestor
5855947|NCT02426736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5855948|NCT02426736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855949|NCT02426736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5855950|NCT02426736|Glucocorticoids|glucocorticoids|mesh-ancestor
5855951|NCT02426736|Hormones|hormones|mesh-ancestor
5855952|NCT02426736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5855953|NCT02426736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5855954|NCT02426736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5672392|NCT03556852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672393|NCT03556852|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5672394|NCT03556852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5855955|NCT02426736|Anesthetics, Local|anesthetics, local|mesh-ancestor
5672395|NCT03556852|Oxytocics|oxytocics|mesh-ancestor
5672396|NCT03556839|Paclitaxel|paclitaxel|mesh-list
5672397|NCT03556839|Bevacizumab|bevacizumab|mesh-list
5855956|NCT02426736|Anesthetics|anesthetics|mesh-ancestor
5672398|NCT03556839|Carboplatin|carboplatin|mesh-list
5672399|NCT03556839|Atezolizumab|atezolizumab|mesh-list
5855957|NCT02426736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5672400|NCT03556839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5672401|NCT03556839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5855958|NCT02426736|Sensory System Agents|sensory system agents|mesh-ancestor
5855959|NCT02426619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5855960|NCT02426619|Fluorides|fluorides|mesh-list
5855961|NCT02426619|Sodium Fluoride|sodium fluoride|mesh-list
5855962|NCT02426619|Fluorides, Topical|fluorides, topical|mesh-list
5855963|NCT02426619|Cariostatic Agents|cariostatic agents|mesh-ancestor
5672402|NCT03556839|Tubulin Modulators|tubulin modulators|mesh-ancestor
5672403|NCT03556839|Antimitotic Agents|antimitotic agents|mesh-ancestor
5672404|NCT03556839|Mitosis Modulators|mitosis modulators|mesh-ancestor
5855964|NCT02426619|Protective Agents|protective agents|mesh-ancestor
5855965|NCT02426619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855966|NCT02426502|Cyclosporine|cyclosporine|mesh-list
5855967|NCT02426502|Mycophenolic Acid|mycophenolic acid|mesh-list
5855968|NCT02426502|Prednisone|prednisone|mesh-list
5855969|NCT02426502|Azathioprine|azathioprine|mesh-list
5855970|NCT02426502|Antihypertensive Agents|antihypertensive agents|mesh-list
5855971|NCT02426502|Cyclosporins|cyclosporins|mesh-list
5855972|NCT02426502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5855973|NCT02426502|Glucocorticoids|glucocorticoids|mesh-ancestor
5855974|NCT02426502|Hormones|hormones|mesh-ancestor
5855975|NCT02426502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5855976|NCT02426502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855977|NCT02426502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5855978|NCT02426502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5855979|NCT02426502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5855980|NCT02426502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5855981|NCT02426502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5855982|NCT02426502|Immunologic Factors|immunologic factors|mesh-ancestor
5855983|NCT02426502|Antifungal Agents|antifungal agents|mesh-ancestor
5855984|NCT02426502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5855985|NCT02426502|Dermatologic Agents|dermatologic agents|mesh-ancestor
5855986|NCT02426502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5672405|NCT03556839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5672406|NCT03556839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5672407|NCT03556839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5672408|NCT03556839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5672409|NCT03556839|Growth Substances|growth substances|mesh-ancestor
5672410|NCT03556839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5855987|NCT02426502|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5855988|NCT02426502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5855989|NCT02426502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5855990|NCT02426502|Antitubercular Agents|antitubercular agents|mesh-ancestor
5855991|NCT02426502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5855992|NCT02426502|Antimetabolites|antimetabolites|mesh-ancestor
5855993|NCT02426502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5855994|NCT02426281|Gemcitabine|gemcitabine|mesh-list
5855995|NCT02426281|Paclitaxel|paclitaxel|mesh-list
5855996|NCT02426281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5855997|NCT02426281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5855998|NCT02426281|Tubulin Modulators|tubulin modulators|mesh-ancestor
5855999|NCT02426281|Antimitotic Agents|antimitotic agents|mesh-ancestor
5856000|NCT02426281|Mitosis Modulators|mitosis modulators|mesh-ancestor
5856001|NCT02426281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856002|NCT02426281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5856003|NCT02426281|Antimetabolites|antimetabolites|mesh-ancestor
5856004|NCT02426281|Antiviral Agents|antiviral agents|mesh-ancestor
5856005|NCT02426281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5672411|NCT03556839|Growth Inhibitors|growth inhibitors|mesh-ancestor
5672412|NCT03556592|Metoprolol|metoprolol|mesh-list
5672413|NCT03556592|Midazolam|midazolam|mesh-list
5672414|NCT03556592|Caffeine|caffeine|mesh-list
5672415|NCT03556592|Omeprazole|omeprazole|mesh-list
5672416|NCT03556592|Warfarin|warfarin|mesh-list
5672417|NCT03556592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5672418|NCT03556592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5672419|NCT03556592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5856006|NCT02426281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5856007|NCT02426281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5856008|NCT02426281|Immunologic Factors|immunologic factors|mesh-ancestor
5856009|NCT02426281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856010|NCT02426463|Oxycodone|oxycodone|mesh-list
5856011|NCT02426463|Propofol|propofol|mesh-list
5856012|NCT02426463|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5856013|NCT02426463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5856014|NCT02426463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672420|NCT03556592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856015|NCT02426463|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5856016|NCT02426463|Anesthetics, General|anesthetics, general|mesh-ancestor
5856017|NCT02426463|Anesthetics|anesthetics|mesh-ancestor
5856018|NCT02426463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5856019|NCT02426463|Narcotics|narcotics|mesh-ancestor
5856020|NCT02426463|Analgesics|analgesics|mesh-ancestor
5856021|NCT02426463|Sensory System Agents|sensory system agents|mesh-ancestor
5856022|NCT02426463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5856023|NCT02426294|Pioglitazone|pioglitazone|mesh-list
5856024|NCT02426294|Glimepiride|glimepiride|mesh-list
5856025|NCT02426294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5856026|NCT02426294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856027|NCT02426294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5856028|NCT02426294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5856029|NCT02426294|Immunologic Factors|immunologic factors|mesh-ancestor
5856030|NCT02426450|Leucovorin|leucovorin|mesh-list
5856031|NCT02426450|Fluorouracil|fluorouracil|mesh-list
5856032|NCT02426450|Oxaliplatin|oxaliplatin|mesh-list
5856033|NCT02426450|Antimetabolites|antimetabolites|mesh-ancestor
5856034|NCT02426450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856035|NCT02426450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5856036|NCT02426450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5856037|NCT02426450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5856038|NCT02426450|Immunologic Factors|immunologic factors|mesh-ancestor
5856039|NCT02426450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856040|NCT02426450|Antidotes|antidotes|mesh-ancestor
5856041|NCT02426450|Protective Agents|protective agents|mesh-ancestor
5856042|NCT02426450|Vitamin B Complex|vitamin b complex|mesh-ancestor
5856043|NCT02426450|Vitamins|vitamins|mesh-ancestor
5856044|NCT02426450|Micronutrients|micronutrients|mesh-ancestor
5856045|NCT02426229|Dabigatran|dabigatran|mesh-list
5856046|NCT02426229|Antithrombins|antithrombins|mesh-ancestor
5856047|NCT02426229|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5856048|NCT02426229|Protease Inhibitors|protease inhibitors|mesh-ancestor
5856049|NCT02426229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5672421|NCT03556592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5672422|NCT03556592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5672423|NCT03556592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5672424|NCT03556592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5672425|NCT03556592|Anesthetics, General|anesthetics, general|mesh-ancestor
5672426|NCT03556592|Anesthetics|anesthetics|mesh-ancestor
5672427|NCT03556592|GABA Modulators|gaba modulators|mesh-ancestor
5672428|NCT03556592|GABA Agents|gaba agents|mesh-ancestor
5672429|NCT03556592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5672430|NCT03556592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5672431|NCT03556592|Anticoagulants|anticoagulants|mesh-ancestor
5672432|NCT03556592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5672433|NCT03556592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5856050|NCT02426229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856051|NCT02426229|Anticoagulants|anticoagulants|mesh-ancestor
5856052|NCT02426333|Abiraterone Acetate|abiraterone acetate|mesh-list
5856053|NCT02426333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5856054|NCT02426333|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5856055|NCT02426333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5856056|NCT02426333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856057|NCT02426333|Hormone Antagonists|hormone antagonists|mesh-ancestor
5856058|NCT02426333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5856059|NCT02426333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674925|NCT01572116|Anesthetics|anesthetics|mesh-ancestor
5672434|NCT03556592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5672435|NCT03556592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5672436|NCT03556592|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5672437|NCT03556592|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5672438|NCT03556592|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5672439|NCT03556592|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5672440|NCT03556592|Purinergic Agents|purinergic agents|mesh-ancestor
5672441|NCT03556592|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5672442|NCT03556592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5672443|NCT03556592|Sympatholytics|sympatholytics|mesh-ancestor
5672444|NCT03556592|Autonomic Agents|autonomic agents|mesh-ancestor
5672445|NCT03556592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5672446|NCT03556592|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5672447|NCT03556592|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5672448|NCT03556592|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5672449|NCT03556592|Adrenergic Agents|adrenergic agents|mesh-ancestor
5696145|NCT03385161|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5696146|NCT03385161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5696147|NCT03385135|Allopurinol|allopurinol|mesh-list
5856060|NCT02426333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5856061|NCT02426177|Labetalol|labetalol|mesh-list
5856062|NCT02426177|Nifedipine|nifedipine|mesh-list
5856063|NCT02426177|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5856064|NCT02426177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5856065|NCT02426177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856066|NCT02426177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5856067|NCT02426177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856068|NCT02426177|Vasodilator Agents|vasodilator agents|mesh-ancestor
5672450|NCT03556384|Temozolomide|temozolomide|mesh-list
5672451|NCT03556384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5672452|NCT03556384|Alkylating Agents|alkylating agents|mesh-ancestor
5672453|NCT03556384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5672454|NCT03556384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5672455|NCT03556371|Acetylcysteine|acetylcysteine|mesh-list
5672456|NCT03556371|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5672457|NCT03556371|Antiviral Agents|antiviral agents|mesh-ancestor
5672458|NCT03556371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5672459|NCT03556371|Expectorants|expectorants|mesh-ancestor
5672460|NCT03556371|Respiratory System Agents|respiratory system agents|mesh-ancestor
5672461|NCT03556371|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5672462|NCT03556371|Antioxidants|antioxidants|mesh-ancestor
5672463|NCT03556371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5672464|NCT03556371|Protective Agents|protective agents|mesh-ancestor
5672465|NCT03556371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672466|NCT03556371|Antidotes|antidotes|mesh-ancestor
5672467|NCT03556098|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
5672468|NCT03556098|Hormones|hormones|mesh-list
5856069|NCT02426177|Tocolytic Agents|tocolytic agents|mesh-ancestor
5856070|NCT02426177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5856071|NCT02426177|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5856072|NCT02426177|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5856073|NCT02426177|Adrenergic Agents|adrenergic agents|mesh-ancestor
5856074|NCT02426177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5856075|NCT02426177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5856076|NCT02426177|Sympathomimetics|sympathomimetics|mesh-ancestor
5856077|NCT02426177|Autonomic Agents|autonomic agents|mesh-ancestor
5856078|NCT02426177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5856079|NCT02426177|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5856080|NCT02426177|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5856081|NCT02426164|Methylprednisolone|methylprednisolone|mesh-list
5856082|NCT02426164|Epinephrine|epinephrine|mesh-list
5856083|NCT02426164|Morphine|morphine|mesh-list
5856084|NCT02426164|Bupivacaine|bupivacaine|mesh-list
5856085|NCT02426164|Anesthetics, Local|anesthetics, local|mesh-ancestor
5856086|NCT02426164|Anesthetics|anesthetics|mesh-ancestor
5856087|NCT02426164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5856088|NCT02426164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856089|NCT02426164|Sensory System Agents|sensory system agents|mesh-ancestor
5856090|NCT02426164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5856091|NCT02426164|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5856092|NCT02426164|Narcotics|narcotics|mesh-ancestor
5856093|NCT02426164|Analgesics|analgesics|mesh-ancestor
5856094|NCT02426164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5856095|NCT02426164|Antiemetics|antiemetics|mesh-ancestor
5856096|NCT02426164|Autonomic Agents|autonomic agents|mesh-ancestor
5856097|NCT02426164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5672469|NCT03556098|Incretins|incretins|mesh-list
5672470|NCT03556098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672471|NCT03556098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5672472|NCT03556098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5672473|NCT03556033|Dapagliflozin|dapagliflozin|mesh-list
5672474|NCT03556033|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5672475|NCT03556033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5672476|NCT03556033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5672477|NCT03556033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672478|NCT03555994|Liraglutide|liraglutide|mesh-list
5672479|NCT03555994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5672480|NCT03555994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672481|NCT03555994|Incretins|incretins|mesh-ancestor
5672482|NCT03555994|Hormones|hormones|mesh-ancestor
5672483|NCT03555994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5672484|NCT03555968|Dronabinol|dronabinol|mesh-list
5672485|NCT03555968|Hallucinogens|hallucinogens|mesh-ancestor
5856098|NCT02426164|Glucocorticoids|glucocorticoids|mesh-ancestor
5856099|NCT02426164|Hormones|hormones|mesh-ancestor
5856100|NCT02426164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5672486|NCT03555968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672487|NCT03555968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5672488|NCT03555968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5672489|NCT03555968|Analgesics|analgesics|mesh-ancestor
5672490|NCT03555968|Sensory System Agents|sensory system agents|mesh-ancestor
5672491|NCT03555968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5672492|NCT03555968|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5672493|NCT03555968|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5672494|NCT03555968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5696148|NCT03385135|Antimetabolites|antimetabolites|mesh-ancestor
5856101|NCT02426164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5856102|NCT02426164|Protective Agents|protective agents|mesh-ancestor
5856103|NCT02426164|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5856104|NCT02426164|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5856105|NCT02426164|Adrenergic Agents|adrenergic agents|mesh-ancestor
5856106|NCT02426164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5856107|NCT02426164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856108|NCT02426164|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5856109|NCT02426164|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5856110|NCT02426164|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5856111|NCT02426164|Respiratory System Agents|respiratory system agents|mesh-ancestor
5856112|NCT02426164|Mydriatics|mydriatics|mesh-ancestor
5856113|NCT02426164|Sympathomimetics|sympathomimetics|mesh-ancestor
5856114|NCT02426164|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5856115|NCT02426099|Antihypertensive Agents|antihypertensive agents|mesh-list
5856116|NCT02426099|Spironolactone|spironolactone|mesh-list
5856117|NCT02426099|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5856118|NCT02426099|Hormone Antagonists|hormone antagonists|mesh-ancestor
5856119|NCT02426099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5856120|NCT02426099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856121|NCT02426099|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5856122|NCT02426099|Diuretics|diuretics|mesh-ancestor
5856123|NCT02426099|Natriuretic Agents|natriuretic agents|mesh-ancestor
5856124|NCT02426060|Warfarin|warfarin|mesh-list
5856125|NCT02426060|Anticoagulants|anticoagulants|mesh-ancestor
5856126|NCT02426021|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5856127|NCT02426021|Immunologic Factors|immunologic factors|mesh-ancestor
5856128|NCT02426021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856129|NCT02426008|Mitogens|mitogens|mesh-list
5856130|NCT02426008|Mitosis Modulators|mitosis modulators|mesh-ancestor
5856131|NCT02426008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856132|NCT02425813|Methylprednisolone|methylprednisolone|mesh-list
5856133|NCT02425813|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5856134|NCT02425813|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5856135|NCT02425813|Prednisolone|prednisolone|mesh-list
5856136|NCT02425813|Prednisolone acetate|prednisolone acetate|mesh-list
5856137|NCT02425813|Budesonide|budesonide|mesh-list
5856138|NCT02425813|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5856139|NCT02425813|Prednisolone phosphate|prednisolone phosphate|mesh-list
5856140|NCT02425813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5856141|NCT02425813|Antiemetics|antiemetics|mesh-ancestor
5856142|NCT02425813|Autonomic Agents|autonomic agents|mesh-ancestor
5856143|NCT02425813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5856144|NCT02425813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856145|NCT02425813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5856146|NCT02425813|Glucocorticoids|glucocorticoids|mesh-ancestor
5856147|NCT02425813|Hormones|hormones|mesh-ancestor
5856148|NCT02425813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5856149|NCT02425813|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5856150|NCT02425813|Protective Agents|protective agents|mesh-ancestor
5856151|NCT02425813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5856152|NCT02425813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5856153|NCT02425813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5856154|NCT02425813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5856155|NCT02425813|Respiratory System Agents|respiratory system agents|mesh-ancestor
5856156|NCT02425852|Prednisolone|prednisolone|mesh-list
5856157|NCT02425852|Hydrocortisone|hydrocortisone|mesh-list
5856158|NCT02425852|Azathioprine|azathioprine|mesh-list
5856159|NCT02425852|Infliximab|infliximab|mesh-list
5856160|NCT02425852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5856161|NCT02425852|Glucocorticoids|glucocorticoids|mesh-ancestor
5856162|NCT02425852|Hormones|hormones|mesh-ancestor
5856163|NCT02425852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5856164|NCT02425852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856165|NCT02425852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5856166|NCT02425852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5856167|NCT02425852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5856168|NCT02425852|Dermatologic Agents|dermatologic agents|mesh-ancestor
5856169|NCT02425852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5856170|NCT02425852|Antimetabolites|antimetabolites|mesh-ancestor
5856171|NCT02425852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856172|NCT02425852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5672495|NCT03555968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5672496|NCT03555968|Hormones|hormones|mesh-ancestor
5672497|NCT03555968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5672498|NCT03555929|Dexamethasone|dexamethasone|mesh-list
5672499|NCT03555929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5672500|NCT03555929|Antiemetics|antiemetics|mesh-ancestor
5672501|NCT03555929|Autonomic Agents|autonomic agents|mesh-ancestor
5672502|NCT03555929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5672503|NCT03555929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672504|NCT03555929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5672505|NCT03555929|Glucocorticoids|glucocorticoids|mesh-ancestor
5672506|NCT03555929|Hormones|hormones|mesh-ancestor
5672507|NCT03555929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5672508|NCT03555929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5672509|NCT03555929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5672510|NCT03555916|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5672511|NCT03555916|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5672512|NCT03555916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5672513|NCT03555916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672514|NCT03555916|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5672515|NCT03555916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5672516|NCT03555916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5672517|NCT03555916|Cholinergic Agents|cholinergic agents|mesh-ancestor
5672518|NCT03555916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5672519|NCT03555877|Letrozole|letrozole|mesh-list
5856173|NCT02425852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5856174|NCT02425852|Immunologic Factors|immunologic factors|mesh-ancestor
5856175|NCT02425878|Ulipristal acetate|ulipristal acetate|mesh-list
5856176|NCT02425878|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5856177|NCT02425878|Contraceptive Agents|contraceptive agents|mesh-ancestor
5856178|NCT02425878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5856179|NCT02425878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672520|NCT03555877|Fulvestrant|fulvestrant|mesh-list
5672521|NCT03555877|Anastrozole|anastrozole|mesh-list
5672522|NCT03555877|Exemestane|exemestane|mesh-list
5672523|NCT03555877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5672524|NCT03555877|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5672525|NCT03555877|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5672526|NCT03555877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5672527|NCT03555877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5672528|NCT03555877|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5672529|NCT03555877|Hormone Antagonists|hormone antagonists|mesh-ancestor
5672530|NCT03555877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5672531|NCT03555877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672532|NCT03555877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5672533|NCT03555877|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5672534|NCT03555617|Itraconazole|itraconazole|mesh-list
5672535|NCT03555617|Antifungal Agents|antifungal agents|mesh-ancestor
5672536|NCT03555617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5672537|NCT03555617|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5672538|NCT03555617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5672539|NCT03555617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5672540|NCT03555617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5672541|NCT03555617|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5672542|NCT03555617|Hormone Antagonists|hormone antagonists|mesh-ancestor
5672543|NCT03555617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5672544|NCT03555617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672545|NCT03555617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5672546|NCT03555526|Amoxicillin|amoxicillin|mesh-list
5672547|NCT03555526|Metronidazole|metronidazole|mesh-list
5672548|NCT03555526|Clarithromycin|clarithromycin|mesh-list
5672549|NCT03555526|Levofloxacin|levofloxacin|mesh-list
5672550|NCT03555526|Ofloxacin|ofloxacin|mesh-list
5672551|NCT03555526|Tetracycline|tetracycline|mesh-list
5856180|NCT02425878|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5856181|NCT02425722|Linaclotide|linaclotide|mesh-list
5856182|NCT02425722|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
5856183|NCT02425722|Enzyme Activators|enzyme activators|mesh-ancestor
5856184|NCT02425722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856185|NCT02425722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5856186|NCT02425774|Prucalopride|prucalopride|mesh-list
5856187|NCT02425774|Laxatives|laxatives|mesh-ancestor
5856188|NCT02425774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5856189|NCT02425774|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
5856190|NCT02425774|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5856191|NCT02425774|Serotonin Agents|serotonin agents|mesh-ancestor
5856192|NCT02425774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5856193|NCT02425774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856194|NCT02425774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856195|NCT02425930|Oxaliplatin|oxaliplatin|mesh-list
5856196|NCT02425930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5856197|NCT02425943|Mannitol|mannitol|mesh-list
5856198|NCT02425943|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5856199|NCT02425943|Diuretics|diuretics|mesh-ancestor
5856200|NCT02425943|Natriuretic Agents|natriuretic agents|mesh-ancestor
5856201|NCT02425943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856202|NCT02425709|Diclofenac|diclofenac|mesh-list
5856203|NCT02425709|Tramadol|tramadol|mesh-list
5856204|NCT02425709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5856205|NCT02425709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5856206|NCT02425709|Analgesics|analgesics|mesh-ancestor
5856207|NCT02425709|Sensory System Agents|sensory system agents|mesh-ancestor
5856208|NCT02425709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5856209|NCT02425709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856210|NCT02425709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5856211|NCT02425709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5856212|NCT02425709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5856213|NCT02425709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5856214|NCT02425709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856215|NCT02425709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5856216|NCT02425709|Narcotics|narcotics|mesh-ancestor
5856217|NCT02425709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5672552|NCT03555526|Esomeprazole|esomeprazole|mesh-list
5672553|NCT03555526|Bismuth|bismuth|mesh-list
5672554|NCT03555526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5672555|NCT03555526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5672556|NCT03555526|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5672557|NCT03555526|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5672558|NCT03555526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5672559|NCT03555526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5672560|NCT03555526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5672561|NCT03555526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5672562|NCT03555526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5672563|NCT03555526|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5672564|NCT03555526|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5672565|NCT03555526|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5672566|NCT03555526|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5672567|NCT03555526|Renal Agents|renal agents|mesh-ancestor
5672568|NCT03555526|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5672569|NCT03555526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5672570|NCT03555526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5672571|NCT03555526|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5672572|NCT03555526|Antacids|antacids|mesh-ancestor
5672573|NCT03555487|Choline|choline|mesh-list
5856218|NCT02425566|Trimethaphan|trimethaphan|mesh-list
5856219|NCT02425566|Nitroglycerin|nitroglycerin|mesh-list
6494508|NCT00618657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5672574|NCT03555487|Lipotropic Agents|lipotropic agents|mesh-ancestor
5672575|NCT03555487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5672576|NCT03555487|Antimetabolites|antimetabolites|mesh-ancestor
5672577|NCT03555487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5672578|NCT03555487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5672579|NCT03555487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5672580|NCT03555487|Nootropic Agents|nootropic agents|mesh-ancestor
5672581|NCT03555383|Hemostatics|hemostatics|mesh-list
5672582|NCT03555383|Coagulants|coagulants|mesh-ancestor
5672583|NCT03555188|Ondansetron|ondansetron|mesh-list
5672584|NCT03555188|Antiemetics|antiemetics|mesh-ancestor
5672585|NCT03555188|Autonomic Agents|autonomic agents|mesh-ancestor
5856220|NCT02425566|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
5856221|NCT02425566|Vasodilator Agents|vasodilator agents|mesh-ancestor
5672586|NCT03555188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5672587|NCT03555188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672588|NCT03555188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5672589|NCT03555188|Antipruritics|antipruritics|mesh-ancestor
5672590|NCT03555188|Dermatologic Agents|dermatologic agents|mesh-ancestor
5672591|NCT03555188|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5672592|NCT03555188|Serotonin Agents|serotonin agents|mesh-ancestor
5856222|NCT02425566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5856223|NCT02425566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5856224|NCT02425566|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
5856225|NCT02425566|Autonomic Agents|autonomic agents|mesh-ancestor
5856226|NCT02425566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5856227|NCT02425566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856228|NCT02425566|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
5856229|NCT02425566|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5856230|NCT02425566|Cholinergic Agents|cholinergic agents|mesh-ancestor
5856231|NCT02425566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5856232|NCT02425566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856233|NCT02425488|Coal Tar|coal tar|mesh-list
5856234|NCT02425488|Keratolytic Agents|keratolytic agents|mesh-ancestor
5856235|NCT02425488|Dermatologic Agents|dermatologic agents|mesh-ancestor
5856236|NCT02425605|Sorafenib|sorafenib|mesh-list
5856237|NCT02425605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5856238|NCT02425605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5856239|NCT02425605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5856240|NCT02425605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856241|NCT02425579|Carbon Monoxide|carbon monoxide|mesh-list
5856242|NCT02425579|Antimetabolites|antimetabolites|mesh-ancestor
5672593|NCT03555188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5672594|NCT03555188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5672595|NCT03555188|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5672596|NCT03555188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5672597|NCT03555188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5672598|NCT03555188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5672599|NCT03555188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5672600|NCT03555136|Vortioxetine|vortioxetine|mesh-list
5672601|NCT03555136|Antidepressive Agents|antidepressive agents|mesh-ancestor
5672602|NCT03555136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5672603|NCT03555136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5672604|NCT03555136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5672605|NCT03555136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5672606|NCT03555136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856243|NCT02425579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856244|NCT02425579|Gasotransmitters|gasotransmitters|mesh-ancestor
5856245|NCT02425579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5856246|NCT02425579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856247|NCT02426112|Azithromycin|azithromycin|mesh-list
5856248|NCT02426112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5672607|NCT03555136|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5672608|NCT03555136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5672609|NCT03555136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5672610|NCT03555136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856249|NCT02426112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5856250|NCT02425865|Golimumab|golimumab|mesh-list
5856251|NCT02425865|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
5856252|NCT02425865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5856253|NCT02425865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5856254|NCT02425865|Immunologic Factors|immunologic factors|mesh-ancestor
5672611|NCT03555136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5672612|NCT03555136|Serotonin Agents|serotonin agents|mesh-ancestor
5856255|NCT02425865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856256|NCT02425462|Dienogest|dienogest|mesh-list
5856257|NCT02425462|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5856258|NCT02425462|Contraceptive Agents|contraceptive agents|mesh-ancestor
5856259|NCT02425462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5856260|NCT02425462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856261|NCT02425462|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5856262|NCT02425462|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5856263|NCT02425462|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5672613|NCT03555136|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5672614|NCT03555136|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5672615|NCT03555136|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5672616|NCT03555136|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5856264|NCT02425462|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5856265|NCT02425462|Hormone Antagonists|hormone antagonists|mesh-ancestor
5856266|NCT02425462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5856267|NCT02425462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5856268|NCT02425462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5856269|NCT02425501|Aflibercept|aflibercept|mesh-list
5856270|NCT02425501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5856271|NCT02425501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5856272|NCT02425501|Growth Substances|growth substances|mesh-ancestor
5856273|NCT02425501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856274|NCT02425501|Growth Inhibitors|growth inhibitors|mesh-ancestor
5856275|NCT02425501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5672617|NCT03555071|Vaccines|vaccines|mesh-list
5672618|NCT03555071|Immunologic Factors|immunologic factors|mesh-ancestor
5672619|NCT03555071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672620|NCT03555032|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
5672621|NCT03555032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5672622|NCT03555032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5672623|NCT03554980|Listerine|listerine|mesh-list
5672624|NCT03554980|Fluorides|fluorides|mesh-list
5672625|NCT03554980|Sodium Fluoride|sodium fluoride|mesh-list
5672626|NCT03554980|Fluorides, Topical|fluorides, topical|mesh-list
5672627|NCT03554980|Cariostatic Agents|cariostatic agents|mesh-ancestor
5672628|NCT03554980|Protective Agents|protective agents|mesh-ancestor
5672629|NCT03554980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672630|NCT03554980|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5904288|NCT05134194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5904289|NCT05134194|Tubulin Modulators|tubulin modulators|mesh-ancestor
5672631|NCT03554980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5696149|NCT03385135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696150|NCT03385135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5696151|NCT03385135|Gout Suppressants|gout suppressants|mesh-ancestor
5696152|NCT03385135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5696153|NCT03385135|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5696154|NCT03385135|Antioxidants|antioxidants|mesh-ancestor
5696155|NCT03385135|Protective Agents|protective agents|mesh-ancestor
5696156|NCT03385135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696157|NCT03385096|Cyclophosphamide|cyclophosphamide|mesh-list
5904290|NCT05134194|Antimitotic Agents|antimitotic agents|mesh-ancestor
5904291|NCT05134194|Mitosis Modulators|mitosis modulators|mesh-ancestor
5904292|NCT05133895|Prednisone|prednisone|mesh-list
5904293|NCT05133895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5904294|NCT05133895|Glucocorticoids|glucocorticoids|mesh-ancestor
5904295|NCT05133895|Hormones|hormones|mesh-ancestor
5904296|NCT05133895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5904297|NCT05133895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904298|NCT05133895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5904299|NCT05133895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5904300|NCT05133791|Annexin A5|annexin a5|mesh-list
5904301|NCT05133791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5904302|NCT05133791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904303|NCT05133687|Bupivacaine|bupivacaine|mesh-list
5904304|NCT05133687|Anesthetics, Local|anesthetics, local|mesh-ancestor
5904305|NCT05133687|Anesthetics|anesthetics|mesh-ancestor
5904306|NCT05133687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5904307|NCT05133687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904308|NCT05133687|Sensory System Agents|sensory system agents|mesh-ancestor
5904309|NCT05133687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5904310|NCT05133674|Tamoxifen|tamoxifen|mesh-list
5904311|NCT05133674|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5904312|NCT05133674|Hormone Antagonists|hormone antagonists|mesh-ancestor
5904313|NCT05133674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5904314|NCT05133674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904315|NCT05133674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5904316|NCT05133674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5904317|NCT05133674|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5904318|NCT05133674|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5904319|NCT05133674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5904320|NCT05133635|Methylprednisolone|methylprednisolone|mesh-list
5904321|NCT05133635|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5904322|NCT05133635|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5904323|NCT05133635|Prednisolone|prednisolone|mesh-list
5696158|NCT03385096|Melphalan|melphalan|mesh-list
5696159|NCT03385096|Busulfan|busulfan|mesh-list
5696160|NCT03385096|Etoposide|etoposide|mesh-list
5672632|NCT03554915|Midazolam|midazolam|mesh-list
5672633|NCT03554915|Ketamine|ketamine|mesh-list
5672634|NCT03554915|Analgesics|analgesics|mesh-ancestor
5672635|NCT03554915|Sensory System Agents|sensory system agents|mesh-ancestor
5672636|NCT03554915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5672637|NCT03554915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672638|NCT03554915|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5672639|NCT03554915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5672640|NCT03554915|Anesthetics, General|anesthetics, general|mesh-ancestor
5672641|NCT03554915|Anesthetics|anesthetics|mesh-ancestor
5672642|NCT03554915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5672643|NCT03554915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5672644|NCT03554915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5672645|NCT03554915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5672646|NCT03554915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5672647|NCT03554915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5672648|NCT03554915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5672649|NCT03554915|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5672650|NCT03554915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5672651|NCT03554915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5672652|NCT03554915|GABA Modulators|gaba modulators|mesh-ancestor
5672653|NCT03554915|GABA Agents|gaba agents|mesh-ancestor
5672654|NCT03554889|Nimotuzumab|nimotuzumab|mesh-list
5672655|NCT03554889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5672656|NCT03554889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5672657|NCT03554590|Insulin|insulin|mesh-list
5672658|NCT03554590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5672659|NCT03554590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672660|NCT03554447|Pentoxifylline|pentoxifylline|mesh-list
5672661|NCT03554447|Dexetimide|dexetimide|mesh-list
5672662|NCT03554447|Citalopram|citalopram|mesh-list
5672663|NCT03554447|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5672664|NCT03554447|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5672665|NCT03554447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5856276|NCT02425241|Vaccines|vaccines|mesh-list
5856277|NCT02425241|Immunologic Factors|immunologic factors|mesh-ancestor
5856278|NCT02425241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856279|NCT02425137|Gemcitabine|gemcitabine|mesh-list
5856280|NCT02425137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5856281|NCT02425137|Antimetabolites|antimetabolites|mesh-ancestor
5856282|NCT02425137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856283|NCT02425137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5856284|NCT02425137|Antiviral Agents|antiviral agents|mesh-ancestor
5856285|NCT02425137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5856286|NCT02425137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5856287|NCT02425137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5856288|NCT02425137|Immunologic Factors|immunologic factors|mesh-ancestor
5856289|NCT02425137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856290|NCT02425176|Botulinum Toxins|botulinum toxins|mesh-list
5856291|NCT02425176|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5856292|NCT02425176|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5856293|NCT02425176|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
5856294|NCT02425176|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5856295|NCT02425176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5856296|NCT02425176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856297|NCT02425176|Cholinergic Agents|cholinergic agents|mesh-ancestor
5856298|NCT02425176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5856299|NCT02425176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856300|NCT02425176|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5856301|NCT02425176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5856302|NCT02425202|Ketamine|ketamine|mesh-list
5856303|NCT02425202|Analgesics|analgesics|mesh-ancestor
5856304|NCT02425202|Sensory System Agents|sensory system agents|mesh-ancestor
5856305|NCT02425202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5856306|NCT02425202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856307|NCT02425202|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5856308|NCT02425202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5856309|NCT02425202|Anesthetics, General|anesthetics, general|mesh-ancestor
5856310|NCT02425202|Anesthetics|anesthetics|mesh-ancestor
5856311|NCT02425202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5856312|NCT02425202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5856313|NCT02425202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5856314|NCT02425202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5672666|NCT03554447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904324|NCT05133635|Prednisolone acetate|prednisolone acetate|mesh-list
5672667|NCT03554447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5672668|NCT03554447|Serotonin Agents|serotonin agents|mesh-ancestor
5672669|NCT03554447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672670|NCT03554447|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5672671|NCT03554447|Antidepressive Agents|antidepressive agents|mesh-ancestor
5672672|NCT03554447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5672673|NCT03554447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5672674|NCT03554447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5672675|NCT03554447|Parasympatholytics|parasympatholytics|mesh-ancestor
5672676|NCT03554447|Autonomic Agents|autonomic agents|mesh-ancestor
5672677|NCT03554447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5672678|NCT03554447|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5672679|NCT03554447|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5672680|NCT03554447|Cholinergic Agents|cholinergic agents|mesh-ancestor
5672681|NCT03554447|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5672682|NCT03554447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5672683|NCT03554447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5672684|NCT03554447|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5856315|NCT02425202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856316|NCT02425254|Acetaminophen|acetaminophen|mesh-list
5856317|NCT02425254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5856318|NCT02425254|Analgesics|analgesics|mesh-ancestor
5856319|NCT02425254|Sensory System Agents|sensory system agents|mesh-ancestor
5856320|NCT02425254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5856321|NCT02425254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856322|NCT02425254|Antipyretics|antipyretics|mesh-ancestor
5856323|NCT02424656|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5856324|NCT02424656|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5856325|NCT02424656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856326|NCT02424552|Vitamin D|vitamin d|mesh-list
5856327|NCT02424552|Cholecalciferol|cholecalciferol|mesh-list
5856328|NCT02424552|Vitamins|vitamins|mesh-ancestor
5856329|NCT02424552|Micronutrients|micronutrients|mesh-ancestor
5856330|NCT02424552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856331|NCT02424552|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5856332|NCT02424552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5856333|NCT02424695|Gabapentin|gabapentin|mesh-list
5856334|NCT02424695|Analgesics|analgesics|mesh-ancestor
5856335|NCT02424695|Sensory System Agents|sensory system agents|mesh-ancestor
5856336|NCT02424695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5856337|NCT02424695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856338|NCT02424695|Anticonvulsants|anticonvulsants|mesh-ancestor
5856339|NCT02424695|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5856340|NCT02424695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5856341|NCT02424695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5856342|NCT02424695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5856343|NCT02424695|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5856344|NCT02424695|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5672685|NCT03554447|Protective Agents|protective agents|mesh-ancestor
5672686|NCT03554447|Vasodilator Agents|vasodilator agents|mesh-ancestor
5672687|NCT03554447|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5672688|NCT03554447|Antioxidants|antioxidants|mesh-ancestor
5672689|NCT03554408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5672690|NCT03554408|Antibodies|antibodies|mesh-list
5672691|NCT03554408|Immunoglobulins|immunoglobulins|mesh-list
5672692|NCT03554408|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5672693|NCT03554408|Immunologic Factors|immunologic factors|mesh-ancestor
5672694|NCT03554408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672695|NCT03554408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5672696|NCT03554395|Antibodies|antibodies|mesh-list
5672697|NCT03554395|Antibodies, Bispecific|antibodies, bispecific|mesh-list
5672698|NCT03554395|Immunologic Factors|immunologic factors|mesh-ancestor
5672699|NCT03554395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672700|NCT03554304|Moxifloxacin|moxifloxacin|mesh-list
5672701|NCT03554304|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
5672702|NCT03554304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5672703|NCT03554304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5672704|NCT03554304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5672705|NCT03554304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5856345|NCT02424695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5856346|NCT02424695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856347|NCT02424695|Antimanic Agents|antimanic agents|mesh-ancestor
5856348|NCT02424318|Topiramate|topiramate|mesh-list
5672706|NCT03554304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5672707|NCT03554304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856349|NCT02424318|Anticonvulsants|anticonvulsants|mesh-ancestor
5856350|NCT02424318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5856351|NCT02424318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856352|NCT02424214|Ionophores|ionophores|mesh-list
5856353|NCT02424214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5856354|NCT02424214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856355|NCT02424201|Ascorbic Acid|ascorbic acid|mesh-list
5672708|NCT03554304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5672709|NCT03554304|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5672710|NCT03554304|Contraceptive Agents|contraceptive agents|mesh-ancestor
5672711|NCT03554304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5856356|NCT02424201|Misoprostol|misoprostol|mesh-list
5856357|NCT02424201|Vitamins|vitamins|mesh-ancestor
5856358|NCT02424201|Micronutrients|micronutrients|mesh-ancestor
5856359|NCT02424201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856360|NCT02424201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5856361|NCT02424201|Abortifacient Agents|abortifacient agents|mesh-ancestor
5856362|NCT02424201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5856363|NCT02424201|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5856364|NCT02424201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5856365|NCT02424201|Oxytocics|oxytocics|mesh-ancestor
5672712|NCT03554304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672713|NCT03554304|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5856366|NCT02424201|Antioxidants|antioxidants|mesh-ancestor
5856367|NCT02424201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856368|NCT02424201|Protective Agents|protective agents|mesh-ancestor
5856369|NCT02424461|Ceftriaxone|ceftriaxone|mesh-list
5856370|NCT02424461|Ofloxacin|ofloxacin|mesh-list
5856371|NCT02424461|Levofloxacin|levofloxacin|mesh-list
5856372|NCT02424461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5856373|NCT02424461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5856374|NCT02424461|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5856375|NCT02424461|Renal Agents|renal agents|mesh-ancestor
5856376|NCT02424461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5856377|NCT02424461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5856378|NCT02424461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5856379|NCT02424461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856380|NCT02424461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5856381|NCT02424461|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5856382|NCT02424461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5856383|NCT02424435|Methylprednisolone|methylprednisolone|mesh-list
5856384|NCT02424435|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5856385|NCT02424435|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5856386|NCT02424435|Prednisolone|prednisolone|mesh-list
5856387|NCT02424435|Prednisolone acetate|prednisolone acetate|mesh-list
5856388|NCT02424435|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5856389|NCT02424435|Prednisolone phosphate|prednisolone phosphate|mesh-list
5856390|NCT02424435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5856391|NCT02424435|Antiemetics|antiemetics|mesh-ancestor
5856392|NCT02424435|Autonomic Agents|autonomic agents|mesh-ancestor
5856393|NCT02424435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5856394|NCT02424435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856395|NCT02424435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5856396|NCT02424435|Glucocorticoids|glucocorticoids|mesh-ancestor
5856397|NCT02424435|Hormones|hormones|mesh-ancestor
5856398|NCT02424435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5856399|NCT02424435|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5856400|NCT02424435|Protective Agents|protective agents|mesh-ancestor
5856401|NCT02424435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5672714|NCT03554304|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5672715|NCT03554304|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5672716|NCT03554291|Famotidine|famotidine|mesh-list
5672717|NCT03554291|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5672718|NCT03554291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5672719|NCT03554291|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5672720|NCT03554291|Histamine Antagonists|histamine antagonists|mesh-ancestor
5672721|NCT03554291|Histamine Agents|histamine agents|mesh-ancestor
5856402|NCT02424435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5856403|NCT02424136|Nitric Oxide|nitric oxide|mesh-list
5856404|NCT02424136|Immunoglobulins|immunoglobulins|mesh-list
5856405|NCT02424136|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5856406|NCT02424136|Antibodies|antibodies|mesh-list
5856407|NCT02424136|Immunologic Factors|immunologic factors|mesh-ancestor
5856408|NCT02424136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856409|NCT02424136|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5856410|NCT02424136|Autonomic Agents|autonomic agents|mesh-ancestor
5856411|NCT02424136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5856412|NCT02424136|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5856413|NCT02424136|Respiratory System Agents|respiratory system agents|mesh-ancestor
5856414|NCT02424136|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5856415|NCT02424136|Antioxidants|antioxidants|mesh-ancestor
5856416|NCT02424136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5672722|NCT03554291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5672723|NCT03554291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5672724|NCT03554291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672725|NCT03554200|Empagliflozin|empagliflozin|mesh-list
5672726|NCT03554200|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5672727|NCT03554200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856417|NCT02424136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5856418|NCT02424136|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5856419|NCT02424136|Vasodilator Agents|vasodilator agents|mesh-ancestor
5856420|NCT02424136|Gasotransmitters|gasotransmitters|mesh-ancestor
5856421|NCT02424136|Protective Agents|protective agents|mesh-ancestor
5856422|NCT02423928|Cyclophosphamide|cyclophosphamide|mesh-list
5856423|NCT02423928|Ipilimumab|ipilimumab|mesh-list
5856424|NCT02423928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5856425|NCT02423928|Immunologic Factors|immunologic factors|mesh-ancestor
5856426|NCT02423928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856427|NCT02423928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5856428|NCT02423928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5856429|NCT02423928|Alkylating Agents|alkylating agents|mesh-ancestor
5856430|NCT02423928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856431|NCT02423928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5856432|NCT02423928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5856433|NCT02423928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5856434|NCT02423928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5856435|NCT02424071|Melatonin|melatonin|mesh-list
5856436|NCT02424071|Antioxidants|antioxidants|mesh-ancestor
5672728|NCT03554200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5672729|NCT03554200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672730|NCT03554109|Leucovorin|leucovorin|mesh-list
5672731|NCT03554109|Paclitaxel|paclitaxel|mesh-list
5672732|NCT03554109|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5672733|NCT03554109|Cyclophosphamide|cyclophosphamide|mesh-list
5672734|NCT03554109|Doxorubicin|doxorubicin|mesh-list
5672735|NCT03554109|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5672736|NCT03554109|Fluorouracil|fluorouracil|mesh-list
5672737|NCT03554109|Avelumab|avelumab|mesh-list
5672738|NCT03554109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5672739|NCT03554109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5672740|NCT03554109|Tubulin Modulators|tubulin modulators|mesh-ancestor
5856437|NCT02424071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856438|NCT02424071|Protective Agents|protective agents|mesh-ancestor
5856439|NCT02424071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856440|NCT02424071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5856441|NCT02423954|Sirolimus|sirolimus|mesh-list
5856442|NCT02423954|Capecitabine|capecitabine|mesh-list
5856443|NCT02423954|Nivolumab|nivolumab|mesh-list
5856444|NCT02423954|Irinotecan|irinotecan|mesh-list
5856445|NCT02423954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5856446|NCT02423954|Antimetabolites|antimetabolites|mesh-ancestor
5856447|NCT02423954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856448|NCT02423954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5856449|NCT02423954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5856450|NCT02423954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5672741|NCT03554109|Antimitotic Agents|antimitotic agents|mesh-ancestor
5672742|NCT03554109|Mitosis Modulators|mitosis modulators|mesh-ancestor
5672743|NCT03554109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5672744|NCT03554109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5672745|NCT03554109|Immunologic Factors|immunologic factors|mesh-ancestor
5672746|NCT03554109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856451|NCT02423954|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5672747|NCT03554109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5672748|NCT03554109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5672749|NCT03554109|Alkylating Agents|alkylating agents|mesh-ancestor
5672750|NCT03554109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5672751|NCT03554109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5672752|NCT03554109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5672753|NCT03554109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5672754|NCT03554109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5856452|NCT02423954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5856453|NCT02423954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5856454|NCT02423954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5856455|NCT02423954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5856456|NCT02423954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5856457|NCT02423954|Antifungal Agents|antifungal agents|mesh-ancestor
5856458|NCT02423954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5856459|NCT02423954|Immunologic Factors|immunologic factors|mesh-ancestor
5856460|NCT02423954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856461|NCT02423915|Vidarabine|vidarabine|mesh-list
5856462|NCT02423915|Mycophenolic Acid|mycophenolic acid|mesh-list
5672755|NCT03554109|Antimetabolites|antimetabolites|mesh-ancestor
5672756|NCT03554109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5672757|NCT03554109|Antidotes|antidotes|mesh-ancestor
5672758|NCT03554109|Protective Agents|protective agents|mesh-ancestor
5672759|NCT03554109|Vitamin B Complex|vitamin b complex|mesh-ancestor
5672760|NCT03554109|Vitamins|vitamins|mesh-ancestor
5672761|NCT03554109|Micronutrients|micronutrients|mesh-ancestor
5672762|NCT03554109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5672763|NCT03554083|Atezolizumab|atezolizumab|mesh-list
5672764|NCT03554083|Vemurafenib|vemurafenib|mesh-list
5672765|NCT03554083|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5672766|NCT03554083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5672767|NCT03554083|Immunologic Factors|immunologic factors|mesh-ancestor
5672768|NCT03554083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672769|NCT03554083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5672770|NCT03554083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5672771|NCT03554083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5672772|NCT03554031|Hormones|hormones|mesh-list
5856463|NCT02423915|Sirolimus|sirolimus|mesh-list
5856464|NCT02423915|Cyclophosphamide|cyclophosphamide|mesh-list
5856465|NCT02423915|Rituximab|rituximab|mesh-list
5672773|NCT03554031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5672774|NCT03554031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672775|NCT03553875|Memantine|memantine|mesh-list
5672776|NCT03553875|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5672777|NCT03553875|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5672778|NCT03553875|Dopamine Agents|dopamine agents|mesh-ancestor
5672779|NCT03553875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5672780|NCT03553875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5672781|NCT03553875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672782|NCT03553875|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5672783|NCT03553875|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5672784|NCT03553836|Pembrolizumab|pembrolizumab|mesh-list
5672785|NCT03553836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5672786|NCT03553836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5672787|NCT03553810|Valsartan|valsartan|mesh-list
5672788|NCT03553810|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5672789|NCT03553810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5672790|NCT03553810|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5672791|NCT03553810|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5672792|NCT03553810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5672793|NCT03553628|Chlorhexidine|chlorhexidine|mesh-list
5672794|NCT03553628|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5672795|NCT03553628|Propolis|propolis|mesh-list
5672796|NCT03553628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5856466|NCT02423915|Fludarabine|fludarabine|mesh-list
5856467|NCT02423915|Fludarabine phosphate|fludarabine phosphate|mesh-list
5856468|NCT02423915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5856469|NCT02423915|Immunologic Factors|immunologic factors|mesh-ancestor
5856470|NCT02423915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672797|NCT03553628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5672798|NCT03553628|Disinfectants|disinfectants|mesh-ancestor
5672799|NCT03553628|Dermatologic Agents|dermatologic agents|mesh-ancestor
5856471|NCT02423915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5856472|NCT02423915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5856473|NCT02423915|Alkylating Agents|alkylating agents|mesh-ancestor
5856474|NCT02423915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856475|NCT02423915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5856476|NCT02423915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5856477|NCT02423915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5856478|NCT02423915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5856479|NCT02423915|Antimetabolites|antimetabolites|mesh-ancestor
5856480|NCT02423915|Antiviral Agents|antiviral agents|mesh-ancestor
5856481|NCT02423915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5856482|NCT02423915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5856483|NCT02423915|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5856484|NCT02423915|Antitubercular Agents|antitubercular agents|mesh-ancestor
5856485|NCT02423915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5856486|NCT02423915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5856487|NCT02423915|Antifungal Agents|antifungal agents|mesh-ancestor
5856488|NCT02424045|Dexamethasone|dexamethasone|mesh-list
5856489|NCT02424045|Carboplatin|carboplatin|mesh-list
5856490|NCT02424045|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5856491|NCT02424045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5856492|NCT02424045|Antiemetics|antiemetics|mesh-ancestor
5856493|NCT02424045|Autonomic Agents|autonomic agents|mesh-ancestor
5856494|NCT02424045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5856495|NCT02424045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856496|NCT02424045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5856497|NCT02424045|Glucocorticoids|glucocorticoids|mesh-ancestor
5856498|NCT02424045|Hormones|hormones|mesh-ancestor
5856499|NCT02424045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5856500|NCT02424045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5856501|NCT02424045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5856502|NCT02424045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5856503|NCT02424045|Alkylating Agents|alkylating agents|mesh-ancestor
5856504|NCT02424045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856505|NCT02423837|Rituximab|rituximab|mesh-list
5856506|NCT02423837|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5856507|NCT02423837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5856508|NCT02423837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5856509|NCT02423837|Immunologic Factors|immunologic factors|mesh-ancestor
5856510|NCT02423837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856511|NCT02423837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5856512|NCT02423837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5856513|NCT02423837|Alkylating Agents|alkylating agents|mesh-ancestor
5856514|NCT02423837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856515|NCT02423863|Pembrolizumab|pembrolizumab|mesh-list
5856516|NCT02423863|Nivolumab|nivolumab|mesh-list
5856517|NCT02423863|Durvalumab|durvalumab|mesh-list
5856518|NCT02423863|Cemiplimab|cemiplimab|mesh-list
5672800|NCT03553615|Ivermectin|ivermectin|mesh-list
5672801|NCT03553615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5672802|NCT03553615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5672803|NCT03553537|Prednisone|prednisone|mesh-list
5672804|NCT03553537|Cyclophosphamide|cyclophosphamide|mesh-list
5672805|NCT03553537|Doxorubicin|doxorubicin|mesh-list
5672806|NCT03553537|Vincristine|vincristine|mesh-list
5672807|NCT03553537|Decitabine|decitabine|mesh-list
5672808|NCT03553537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5672809|NCT03553537|Immunologic Factors|immunologic factors|mesh-ancestor
5672810|NCT03553537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672811|NCT03553537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5672812|NCT03553537|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5672813|NCT03553537|Alkylating Agents|alkylating agents|mesh-ancestor
5672814|NCT03553537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5672815|NCT03553537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5672816|NCT03553537|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5672817|NCT03553537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5672818|NCT03553537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5672819|NCT03553537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5672820|NCT03553537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5672821|NCT03553537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5672822|NCT03553537|Glucocorticoids|glucocorticoids|mesh-ancestor
5672823|NCT03553537|Hormones|hormones|mesh-ancestor
5672824|NCT03553537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5672825|NCT03553537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5672826|NCT03553537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5672827|NCT03553537|Tubulin Modulators|tubulin modulators|mesh-ancestor
5672828|NCT03553537|Antimitotic Agents|antimitotic agents|mesh-ancestor
5672829|NCT03553537|Mitosis Modulators|mitosis modulators|mesh-ancestor
5672830|NCT03553537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5672831|NCT03553537|Antimetabolites|antimetabolites|mesh-ancestor
5672832|NCT03553498|Acetaminophen|acetaminophen|mesh-list
5672833|NCT03553498|Hydromorphone|hydromorphone|mesh-list
5672834|NCT03553498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5672835|NCT03553498|Analgesics|analgesics|mesh-ancestor
5672836|NCT03553498|Sensory System Agents|sensory system agents|mesh-ancestor
5672837|NCT03553498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5856519|NCT02423863|Atezolizumab|atezolizumab|mesh-list
5856520|NCT02423863|Poly ICLC|poly iclc|mesh-list
5856521|NCT02423863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5856522|NCT02423863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5856523|NCT02423863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5856524|NCT02423863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856525|NCT02423863|Interferon Inducers|interferon inducers|mesh-ancestor
5856526|NCT02423863|Immunologic Factors|immunologic factors|mesh-ancestor
5856527|NCT02423863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856528|NCT02423811|Fursultiamin|fursultiamin|mesh-list
5856529|NCT02423811|Vitamin B Complex|vitamin b complex|mesh-ancestor
5856530|NCT02423811|Vitamins|vitamins|mesh-ancestor
5856531|NCT02423811|Micronutrients|micronutrients|mesh-ancestor
5856532|NCT02423811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856533|NCT02423759|Ciprofloxacin|ciprofloxacin|mesh-list
5856534|NCT02423759|Gentamicins|gentamicins|mesh-list
5856535|NCT02423759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5856536|NCT02423759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5856537|NCT02423759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5856538|NCT02423759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5856539|NCT02423759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5856540|NCT02423759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5672838|NCT03553498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672839|NCT03553498|Antipyretics|antipyretics|mesh-ancestor
5672840|NCT03553498|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5672841|NCT03553498|Narcotics|narcotics|mesh-ancestor
5672842|NCT03553498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5672843|NCT03553446|Sevoflurane|sevoflurane|mesh-list
5672844|NCT03553446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5672845|NCT03553446|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5672846|NCT03553446|Anesthetics, General|anesthetics, general|mesh-ancestor
5672847|NCT03553446|Anesthetics|anesthetics|mesh-ancestor
5672848|NCT03553446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5856541|NCT02423759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5856542|NCT02423759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5672849|NCT03553446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672850|NCT03553433|Apremilast|apremilast|mesh-list
5672851|NCT03553433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5672852|NCT03553433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5672853|NCT03553433|Analgesics|analgesics|mesh-ancestor
5672854|NCT03553433|Sensory System Agents|sensory system agents|mesh-ancestor
5672855|NCT03553433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5672856|NCT03553433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672857|NCT03553433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5672858|NCT03553433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5856543|NCT02423759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5856544|NCT02423759|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5856545|NCT02423694|Dexetimide|dexetimide|mesh-list
5856546|NCT02423694|Citalopram|citalopram|mesh-list
5856547|NCT02423694|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5856548|NCT02423694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5856549|NCT02423694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5856550|NCT02423694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856551|NCT02423694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5856552|NCT02423694|Serotonin Agents|serotonin agents|mesh-ancestor
5856553|NCT02423694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856554|NCT02423694|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5856555|NCT02423694|Antidepressive Agents|antidepressive agents|mesh-ancestor
5856556|NCT02423694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5856557|NCT02423694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5856558|NCT02423694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5856559|NCT02423694|Parasympatholytics|parasympatholytics|mesh-ancestor
5856560|NCT02423694|Autonomic Agents|autonomic agents|mesh-ancestor
5856561|NCT02423694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5856562|NCT02423694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5856563|NCT02423694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5856564|NCT02423694|Cholinergic Agents|cholinergic agents|mesh-ancestor
5856565|NCT02423590|Gemcitabine|gemcitabine|mesh-list
5672859|NCT03553433|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5672860|NCT03553433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5672861|NCT03553433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5672862|NCT03553433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5672863|NCT03553329|Trametinib|trametinib|mesh-list
5672864|NCT03553329|Dabrafenib|dabrafenib|mesh-list
5672865|NCT03553329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5672866|NCT03553329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5672867|NCT03553329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5672868|NCT03553329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696161|NCT03385096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5696162|NCT03385096|Immunologic Factors|immunologic factors|mesh-ancestor
5696163|NCT03385096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696164|NCT03385096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5696165|NCT03385096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5696166|NCT03385096|Alkylating Agents|alkylating agents|mesh-ancestor
5696167|NCT03385096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696168|NCT03385096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5696169|NCT03385096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5696170|NCT03385096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5696171|NCT03385096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5696172|NCT03385096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5696173|NCT03385096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5696174|NCT03385057|Acetaminophen|acetaminophen|mesh-list
5696175|NCT03385057|Ibuprofen|ibuprofen|mesh-list
5696176|NCT03385057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5696177|NCT03385057|Analgesics|analgesics|mesh-ancestor
5696178|NCT03385057|Sensory System Agents|sensory system agents|mesh-ancestor
5696179|NCT03385057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5696180|NCT03385057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856566|NCT02423590|Carboplatin|carboplatin|mesh-list
5856567|NCT02423590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5856568|NCT02423590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5856569|NCT02423590|Antimetabolites|antimetabolites|mesh-ancestor
5856570|NCT02423590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856571|NCT02423590|Antiviral Agents|antiviral agents|mesh-ancestor
5856572|NCT02423590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5856573|NCT02423590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5856574|NCT02423590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5856575|NCT02423590|Immunologic Factors|immunologic factors|mesh-ancestor
5856576|NCT02423590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856577|NCT02423642|Heparin|heparin|mesh-list
5856578|NCT02423642|Anticoagulants|anticoagulants|mesh-ancestor
5856579|NCT02423642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856580|NCT02423642|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5856581|NCT02423642|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5856582|NCT02423603|Paclitaxel|paclitaxel|mesh-list
5856583|NCT02423603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5856584|NCT02423603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5856585|NCT02423603|Tubulin Modulators|tubulin modulators|mesh-ancestor
5856586|NCT02423603|Antimitotic Agents|antimitotic agents|mesh-ancestor
5856587|NCT02423603|Mitosis Modulators|mitosis modulators|mesh-ancestor
5856588|NCT02423603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904325|NCT05133635|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5904326|NCT05133635|Prednisolone phosphate|prednisolone phosphate|mesh-list
5904327|NCT05133635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5904328|NCT05133635|Antiemetics|antiemetics|mesh-ancestor
5904329|NCT05133635|Autonomic Agents|autonomic agents|mesh-ancestor
5904330|NCT05133635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5904331|NCT05133635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904332|NCT05133635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5904333|NCT05133635|Glucocorticoids|glucocorticoids|mesh-ancestor
5904334|NCT05133635|Hormones|hormones|mesh-ancestor
5904335|NCT05133635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5904336|NCT05133635|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5904337|NCT05133635|Protective Agents|protective agents|mesh-ancestor
5904338|NCT05133635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5904339|NCT05133635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5908474|NCT04486352|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
5908475|NCT04486352|Atezolizumab|atezolizumab|mesh-list
5908476|NCT04486352|Talazoparib|talazoparib|mesh-list
5908477|NCT04486352|Maytansine|maytansine|mesh-list
5908478|NCT04486352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5908479|NCT04486352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5908480|NCT04486352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5908481|NCT04486352|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5908482|NCT04486352|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5908483|NCT04486352|Growth Substances|growth substances|mesh-ancestor
5908484|NCT04486352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5908485|NCT04486352|Growth Inhibitors|growth inhibitors|mesh-ancestor
5908486|NCT04486352|Immunologic Factors|immunologic factors|mesh-ancestor
5908487|NCT04486352|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5672869|NCT03553303|Valsartan|valsartan|mesh-list
5672870|NCT03553303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5672871|NCT03553303|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5672872|NCT03553303|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5672873|NCT03553303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5672874|NCT03553238|Cytarabine|cytarabine|mesh-list
5672875|NCT03553238|Dexamethasone|dexamethasone|mesh-list
5672876|NCT03553238|Cyclophosphamide|cyclophosphamide|mesh-list
5672877|NCT03553238|Methotrexate|methotrexate|mesh-list
5672878|NCT03553238|Etoposide|etoposide|mesh-list
5672879|NCT03553238|Vincristine|vincristine|mesh-list
5672880|NCT03553238|Doxorubicin|doxorubicin|mesh-list
5672881|NCT03553238|Mercaptopurine|mercaptopurine|mesh-list
5672882|NCT03553238|Idarubicin|idarubicin|mesh-list
5672883|NCT03553238|Pegaspargase|pegaspargase|mesh-list
5672884|NCT03553238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5856589|NCT02423824|Liraglutide|liraglutide|mesh-list
5856590|NCT02423824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5856591|NCT02423824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856592|NCT02423824|Incretins|incretins|mesh-ancestor
5856593|NCT02423824|Hormones|hormones|mesh-ancestor
5856594|NCT02423824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5856595|NCT02423395|Orphenadrine|orphenadrine|mesh-list
5856596|NCT02423395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856597|NCT02423395|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5856598|NCT02423395|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5856599|NCT02423395|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5856600|NCT02423395|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5856601|NCT02423395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5856602|NCT02423395|Parasympatholytics|parasympatholytics|mesh-ancestor
5856603|NCT02423395|Autonomic Agents|autonomic agents|mesh-ancestor
5856604|NCT02423395|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5856605|NCT02423395|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5856606|NCT02423395|Cholinergic Agents|cholinergic agents|mesh-ancestor
5856607|NCT02423395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5856608|NCT02423395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856609|NCT02423395|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
5856610|NCT02423395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5856611|NCT02423395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5856612|NCT02423278|Oxaliplatin|oxaliplatin|mesh-list
5856613|NCT02423278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5856614|NCT02423525|Afatinib|afatinib|mesh-list
5856615|NCT02423525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5856616|NCT02423525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5856617|NCT02423525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5856618|NCT02423525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856619|NCT02423265|Ranolazine|ranolazine|mesh-list
5856620|NCT02423265|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5856621|NCT02423265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5856622|NCT02423265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856623|NCT02423239|Gemcitabine|gemcitabine|mesh-list
5856624|NCT02423239|Paclitaxel|paclitaxel|mesh-list
5856625|NCT02423239|Sorafenib|sorafenib|mesh-list
5856626|NCT02423239|HU 211|hu 211|mesh-list
5856627|NCT02423239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5856628|NCT02423239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5856629|NCT02423239|Tubulin Modulators|tubulin modulators|mesh-ancestor
5856630|NCT02423239|Antimitotic Agents|antimitotic agents|mesh-ancestor
5856631|NCT02423239|Mitosis Modulators|mitosis modulators|mesh-ancestor
5856632|NCT02423239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856633|NCT02423239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5856634|NCT02423239|Antimetabolites|antimetabolites|mesh-ancestor
5856635|NCT02423239|Antiviral Agents|antiviral agents|mesh-ancestor
5856636|NCT02423239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5856637|NCT02423239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5856638|NCT02423239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5856639|NCT02423239|Immunologic Factors|immunologic factors|mesh-ancestor
5856640|NCT02423239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856641|NCT02423239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5856642|NCT02423239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5856643|NCT02423239|Antiemetics|antiemetics|mesh-ancestor
5856644|NCT02423239|Autonomic Agents|autonomic agents|mesh-ancestor
5856645|NCT02423239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5672885|NCT03553238|Immunologic Factors|immunologic factors|mesh-ancestor
5672886|NCT03553238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856646|NCT02423239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5856647|NCT02423239|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5672887|NCT03553238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5672888|NCT03553238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5672889|NCT03553238|Alkylating Agents|alkylating agents|mesh-ancestor
5672890|NCT03553238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5672891|NCT03553238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5672892|NCT03553238|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5856648|NCT02423239|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5856649|NCT02423239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5856650|NCT02423239|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5856651|NCT02423239|Protective Agents|protective agents|mesh-ancestor
5856652|NCT02422784|Vitamin D|vitamin d|mesh-list
6212249|NCT02183792|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6212250|NCT02184195|Olaparib|olaparib|mesh-list
5856653|NCT02422784|Ergocalciferols|ergocalciferols|mesh-list
5856654|NCT02422784|Cholecalciferol|cholecalciferol|mesh-list
5856655|NCT02422784|Vitamins|vitamins|mesh-list
5856656|NCT02422784|Micronutrients|micronutrients|mesh-ancestor
5856657|NCT02422784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856658|NCT02422784|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5856659|NCT02422784|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5856660|NCT02422836|Sunscreening Agents|sunscreening agents|mesh-list
5856661|NCT02422836|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5856662|NCT02422836|Protective Agents|protective agents|mesh-ancestor
5856663|NCT02422836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856664|NCT02422836|Dermatologic Agents|dermatologic agents|mesh-ancestor
5856665|NCT02422901|Ascorbic Acid|ascorbic acid|mesh-list
5856666|NCT02422901|Vitamins|vitamins|mesh-ancestor
5856667|NCT02422901|Micronutrients|micronutrients|mesh-ancestor
5856668|NCT02422901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856669|NCT02422901|Antioxidants|antioxidants|mesh-ancestor
5856670|NCT02422901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856671|NCT02422901|Protective Agents|protective agents|mesh-ancestor
5856672|NCT02422966|Acetaminophen|acetaminophen|mesh-list
5856673|NCT02422966|Ibuprofen|ibuprofen|mesh-list
5856674|NCT02422966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5856675|NCT02422966|Analgesics|analgesics|mesh-ancestor
5856676|NCT02422966|Sensory System Agents|sensory system agents|mesh-ancestor
5856677|NCT02422966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5856678|NCT02422966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856679|NCT02422966|Antipyretics|antipyretics|mesh-ancestor
5856680|NCT02422966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5856681|NCT02422966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5856682|NCT02422966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5856683|NCT02422966|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5856684|NCT02422966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5856685|NCT02422966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856686|NCT02422953|Micronutrients|micronutrients|mesh-list
5856687|NCT02422953|Trace Elements|trace elements|mesh-list
5856688|NCT02422953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856689|NCT02422888|Ticagrelor|ticagrelor|mesh-list
5856690|NCT02422888|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
5672893|NCT03553238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5672894|NCT03553238|Antiemetics|antiemetics|mesh-ancestor
5672895|NCT03553238|Autonomic Agents|autonomic agents|mesh-ancestor
5672896|NCT03553238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5672897|NCT03553238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5672898|NCT03553238|Glucocorticoids|glucocorticoids|mesh-ancestor
5672899|NCT03553238|Hormones|hormones|mesh-ancestor
5672900|NCT03553238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5672901|NCT03553238|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5672902|NCT03553238|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5672903|NCT03553238|Abortifacient Agents|abortifacient agents|mesh-ancestor
5672904|NCT03553238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5672905|NCT03553238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5672906|NCT03553238|Antimetabolites|antimetabolites|mesh-ancestor
5672907|NCT03553238|Dermatologic Agents|dermatologic agents|mesh-ancestor
5672908|NCT03553238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5672909|NCT03553238|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5672910|NCT03553238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5672911|NCT03553238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5856691|NCT02422888|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5856692|NCT02422888|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5856693|NCT02422888|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5856694|NCT02422888|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5856695|NCT02422888|Purinergic Agents|purinergic agents|mesh-ancestor
5856696|NCT02422888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5856697|NCT02422888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856698|NCT02422888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856699|NCT02422823|Epinephrine|epinephrine|mesh-list
5856700|NCT02422823|Carticaine|carticaine|mesh-list
5856701|NCT02422823|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5856702|NCT02422823|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5856703|NCT02422823|Adrenergic Agents|adrenergic agents|mesh-ancestor
5672912|NCT03553238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5672913|NCT03553238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5672914|NCT03553238|Antiviral Agents|antiviral agents|mesh-ancestor
5672915|NCT03553238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5672916|NCT03553238|Tubulin Modulators|tubulin modulators|mesh-ancestor
5672917|NCT03553238|Antimitotic Agents|antimitotic agents|mesh-ancestor
5672918|NCT03553238|Mitosis Modulators|mitosis modulators|mesh-ancestor
5672919|NCT03553238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5672920|NCT03553186|Tranexamic Acid|tranexamic acid|mesh-list
5672921|NCT03553186|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5856704|NCT02422823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5856705|NCT02422823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856706|NCT02422823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856707|NCT02422823|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5856708|NCT02422823|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5856709|NCT02422823|Autonomic Agents|autonomic agents|mesh-ancestor
5856710|NCT02422823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5856711|NCT02422823|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5856712|NCT02422823|Respiratory System Agents|respiratory system agents|mesh-ancestor
5856713|NCT02422823|Mydriatics|mydriatics|mesh-ancestor
5856714|NCT02422823|Sympathomimetics|sympathomimetics|mesh-ancestor
5856715|NCT02422823|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5672922|NCT03553186|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5672923|NCT03553186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5672924|NCT03553186|Hemostatics|hemostatics|mesh-ancestor
5672925|NCT03553186|Coagulants|coagulants|mesh-ancestor
5672926|NCT03553173|Bupropion|bupropion|mesh-list
5672927|NCT03553173|Varenicline|varenicline|mesh-list
5672928|NCT03553173|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5672929|NCT03553173|Antidepressive Agents|antidepressive agents|mesh-ancestor
5672930|NCT03553173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5672931|NCT03553173|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5672932|NCT03553173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5672933|NCT03553173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5672934|NCT03553173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5672935|NCT03553173|Dopamine Agents|dopamine agents|mesh-ancestor
5672936|NCT03553173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5672937|NCT03553173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672938|NCT03553173|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5672939|NCT03553173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5672940|NCT03553173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5672941|NCT03553173|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5856716|NCT02422823|Anesthetics, Local|anesthetics, local|mesh-ancestor
5856717|NCT02422823|Anesthetics|anesthetics|mesh-ancestor
5856718|NCT02422823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5856719|NCT02422823|Sensory System Agents|sensory system agents|mesh-ancestor
5856720|NCT02423096|Haloperidol|haloperidol|mesh-list
5856721|NCT02423096|Olanzapine|olanzapine|mesh-list
5672942|NCT03553173|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5672943|NCT03553173|Cholinergic Agents|cholinergic agents|mesh-ancestor
5672944|NCT03553108|Olaparib|olaparib|mesh-list
5672945|NCT03553108|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5672946|NCT03553108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5672947|NCT03553108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5672948|NCT03553108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5672949|NCT03553082|Propofol|propofol|mesh-list
5672950|NCT03553082|Sevoflurane|sevoflurane|mesh-list
5672951|NCT03553082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5672952|NCT03553082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5672953|NCT03553082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672954|NCT03553082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5856722|NCT02423096|Risperidone|risperidone|mesh-list
5856723|NCT02423096|Quetiapine Fumarate|quetiapine fumarate|mesh-list
5856724|NCT02423096|Sulpiride|sulpiride|mesh-list
5856725|NCT02423096|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5856726|NCT02423096|Serotonin Agents|serotonin agents|mesh-ancestor
5856727|NCT02423096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5856728|NCT02423096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856729|NCT02423096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856730|NCT02423096|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5856731|NCT02423096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5672955|NCT03553082|Anesthetics, General|anesthetics, general|mesh-ancestor
5856732|NCT02423096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5856733|NCT02423096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5856734|NCT02423096|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5856735|NCT02423096|Dopamine Agents|dopamine agents|mesh-ancestor
5856736|NCT02423096|Antiemetics|antiemetics|mesh-ancestor
5856737|NCT02423096|Autonomic Agents|autonomic agents|mesh-ancestor
5856738|NCT02423096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5856739|NCT02423096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5856740|NCT02423096|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5856741|NCT02423096|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5856742|NCT02423096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5856743|NCT02423096|Antidepressive Agents|antidepressive agents|mesh-ancestor
5856744|NCT02423096|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5856745|NCT02423096|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5856746|NCT02423018|Pregabalin|pregabalin|mesh-list
5672956|NCT03553082|Anesthetics|anesthetics|mesh-ancestor
5672957|NCT03553082|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5672958|NCT03553082|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5672959|NCT03553004|Niraparib|niraparib|mesh-list
5856747|NCT02423018|Analgesics|analgesics|mesh-ancestor
5856748|NCT02423018|Sensory System Agents|sensory system agents|mesh-ancestor
5856749|NCT02423018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5856750|NCT02423018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856751|NCT02423018|Anticonvulsants|anticonvulsants|mesh-ancestor
5856752|NCT02423018|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5856753|NCT02423018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5856754|NCT02423018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856755|NCT02423018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5856756|NCT02423018|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5856757|NCT02423018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5856758|NCT02423018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5856759|NCT02423018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5856760|NCT02423083|Guanabenz|guanabenz|mesh-list
5856761|NCT02423083|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5856762|NCT02423083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5856763|NCT02423083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5856764|NCT02423083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5856765|NCT02423083|Adrenergic Agents|adrenergic agents|mesh-ancestor
5856766|NCT02423083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5856767|NCT02423083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856768|NCT02423083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856769|NCT02422563|Paclitaxel|paclitaxel|mesh-list
5856770|NCT02422563|Carboplatin|carboplatin|mesh-list
5856771|NCT02422563|Ifosfamide|ifosfamide|mesh-list
5856772|NCT02422563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5672960|NCT03553004|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5672961|NCT03553004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5672962|NCT03553004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5672963|NCT03553004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5672964|NCT03552770|Bevacizumab|bevacizumab|mesh-list
5672965|NCT03552770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5672966|NCT03552770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5672967|NCT03552770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5672968|NCT03552770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5672969|NCT03552770|Growth Substances|growth substances|mesh-ancestor
5672970|NCT03552770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672971|NCT03552770|Growth Inhibitors|growth inhibitors|mesh-ancestor
5672972|NCT03552705|Tranexamic Acid|tranexamic acid|mesh-list
5672973|NCT03552705|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5672974|NCT03552705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5672975|NCT03552705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5672976|NCT03552705|Hemostatics|hemostatics|mesh-ancestor
5672977|NCT03552705|Coagulants|coagulants|mesh-ancestor
5672978|NCT03552666|Vitamin D|vitamin d|mesh-list
5672979|NCT03552666|Cholecalciferol|cholecalciferol|mesh-list
5672980|NCT03552666|Vitamins|vitamins|mesh-ancestor
5672981|NCT03552666|Micronutrients|micronutrients|mesh-ancestor
5672982|NCT03552666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672983|NCT03552666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5672984|NCT03552666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5672985|NCT03552653|Vitamin D|vitamin d|mesh-list
5672986|NCT03552653|Ergocalciferols|ergocalciferols|mesh-list
5672987|NCT03552653|Vitamins|vitamins|mesh-list
5672988|NCT03552653|Micronutrients|micronutrients|mesh-ancestor
5672989|NCT03552653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672990|NCT03552653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5672991|NCT03552653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5672992|NCT03552601|Methamphetamine|methamphetamine|mesh-list
5672993|NCT03552601|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5672994|NCT03552601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5672995|NCT03552601|Sympathomimetics|sympathomimetics|mesh-ancestor
5672996|NCT03552601|Autonomic Agents|autonomic agents|mesh-ancestor
5672997|NCT03552601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5672998|NCT03552601|Dopamine Agents|dopamine agents|mesh-ancestor
5672999|NCT03552601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5856773|NCT02422563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5856774|NCT02422563|Tubulin Modulators|tubulin modulators|mesh-ancestor
5856775|NCT02422563|Antimitotic Agents|antimitotic agents|mesh-ancestor
5856776|NCT02422563|Mitosis Modulators|mitosis modulators|mesh-ancestor
5856777|NCT02422563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856778|NCT02422563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5856779|NCT02422563|Alkylating Agents|alkylating agents|mesh-ancestor
5856780|NCT02422706|Metronidazole|metronidazole|mesh-list
5856781|NCT02422706|Clarithromycin|clarithromycin|mesh-list
5856782|NCT02422706|Levofloxacin|levofloxacin|mesh-list
5856783|NCT02422706|Ofloxacin|ofloxacin|mesh-list
5856784|NCT02422706|Nitazoxanide|nitazoxanide|mesh-list
5856785|NCT02422706|Doxycycline|doxycycline|mesh-list
5856786|NCT02422706|Omeprazole|omeprazole|mesh-list
5856787|NCT02422706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5856788|NCT02422706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5856789|NCT02422706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5856790|NCT02422706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5856791|NCT02422706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5856792|NCT02422706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5856793|NCT02422706|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5856794|NCT02422706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5856795|NCT02422706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856796|NCT02422706|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5856797|NCT02422706|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5856798|NCT02422706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5856799|NCT02422706|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5856800|NCT02422706|Renal Agents|renal agents|mesh-ancestor
5856801|NCT02422706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5856802|NCT02422706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5856803|NCT02422706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5856804|NCT02422706|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5856805|NCT02422706|Antimalarials|antimalarials|mesh-ancestor
5856806|NCT02422485|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
5856807|NCT02422485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5856808|NCT02422485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5856809|NCT02422485|Analgesics|analgesics|mesh-ancestor
5856810|NCT02422485|Sensory System Agents|sensory system agents|mesh-ancestor
5673000|NCT03552601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673001|NCT03552601|Adrenergic Agents|adrenergic agents|mesh-ancestor
5673002|NCT03552601|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5673003|NCT03552601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5673004|NCT03552601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5673005|NCT03552601|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5673006|NCT03552575|Valsartan|valsartan|mesh-list
5673007|NCT03552575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5856811|NCT02422485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5856812|NCT02422485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856813|NCT02422485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5856814|NCT02422485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5673008|NCT03552575|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5673009|NCT03552575|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5673010|NCT03552575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673011|NCT03552471|Rucaparib|rucaparib|mesh-list
5673012|NCT03552471|Maytansine|maytansine|mesh-list
5673013|NCT03552471|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5856815|NCT02422589|Ceritinib|ceritinib|mesh-list
5856816|NCT02422589|Midazolam|midazolam|mesh-list
5856817|NCT02422589|Warfarin|warfarin|mesh-list
5856818|NCT02422589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5856819|NCT02422589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5856820|NCT02422589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5856821|NCT02422589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856822|NCT02422589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5856823|NCT02422589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5856824|NCT02422589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5856825|NCT02422589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5673014|NCT03552471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5673015|NCT03552471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673016|NCT03552471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5673017|NCT03552471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5673018|NCT03552471|Tubulin Modulators|tubulin modulators|mesh-ancestor
5673019|NCT03552471|Antimitotic Agents|antimitotic agents|mesh-ancestor
5673020|NCT03552471|Mitosis Modulators|mitosis modulators|mesh-ancestor
5673021|NCT03552406|Cetuximab|cetuximab|mesh-list
5856826|NCT02422589|Anesthetics, General|anesthetics, general|mesh-ancestor
5856827|NCT02422589|Anesthetics|anesthetics|mesh-ancestor
5856828|NCT02422589|GABA Modulators|gaba modulators|mesh-ancestor
5856829|NCT02422589|GABA Agents|gaba agents|mesh-ancestor
5856830|NCT02422589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5856831|NCT02422589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856832|NCT02422589|Anticoagulants|anticoagulants|mesh-ancestor
5856833|NCT02422589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5856834|NCT02422589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5856835|NCT02422589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5856836|NCT02422498|Cisplatin|cisplatin|mesh-list
5856837|NCT02422498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5856838|NCT02422602|Rivaroxaban|rivaroxaban|mesh-list
5856839|NCT02422602|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5856840|NCT02422602|Antithrombins|antithrombins|mesh-ancestor
5856841|NCT02422602|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5856842|NCT02422602|Protease Inhibitors|protease inhibitors|mesh-ancestor
5856843|NCT02422602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5856844|NCT02422602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856845|NCT02422602|Anticoagulants|anticoagulants|mesh-ancestor
5856846|NCT02422654|Eliglustat|eliglustat|mesh-list
5856847|NCT02422654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5856848|NCT02422654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856849|NCT02422056|Tranexamic Acid|tranexamic acid|mesh-list
5856850|NCT02422056|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5856851|NCT02422056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5856852|NCT02422056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856853|NCT02422056|Hemostatics|hemostatics|mesh-ancestor
5856854|NCT02422056|Coagulants|coagulants|mesh-ancestor
5856855|NCT02422199|Capecitabine|capecitabine|mesh-list
5856856|NCT02422199|Lapatinib|lapatinib|mesh-list
5856857|NCT02422199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5856858|NCT02422199|Antimetabolites|antimetabolites|mesh-ancestor
5856859|NCT02422199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856860|NCT02422199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5856861|NCT02422199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5856862|NCT02422199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5856863|NCT02422017|Timolol|timolol|mesh-list
5856864|NCT02422017|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5673022|NCT03552406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5673023|NCT03552406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5673024|NCT03552354|Argatroban|argatroban|mesh-list
5673025|NCT03552354|Antithrombins|antithrombins|mesh-ancestor
5673026|NCT03552354|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5673027|NCT03552354|Protease Inhibitors|protease inhibitors|mesh-ancestor
5673028|NCT03552354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5856865|NCT02422017|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5856866|NCT02422017|Adrenergic Agents|adrenergic agents|mesh-ancestor
5856867|NCT02422017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5673029|NCT03552354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673030|NCT03552354|Anticoagulants|anticoagulants|mesh-ancestor
5673031|NCT03552354|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5673032|NCT03552315|Chromium|chromium|mesh-list
5673033|NCT03552315|Trace Elements|trace elements|mesh-ancestor
5673034|NCT03552315|Micronutrients|micronutrients|mesh-ancestor
5673035|NCT03552315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673036|NCT03552211|Biotin|biotin|mesh-list
5673037|NCT03552211|Vitamin B Complex|vitamin b complex|mesh-ancestor
5673038|NCT03552211|Vitamins|vitamins|mesh-ancestor
5673039|NCT03552211|Micronutrients|micronutrients|mesh-ancestor
5673040|NCT03552211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856868|NCT02422017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856869|NCT02422017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856870|NCT02422017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5856871|NCT02422017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5856872|NCT02422030|Atorvastatin|atorvastatin|mesh-list
5856873|NCT02422030|Fenofibric acid|fenofibric acid|mesh-list
5856874|NCT02422030|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5856875|NCT02422030|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5856876|NCT02422030|Antimetabolites|antimetabolites|mesh-ancestor
5856877|NCT02422030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673041|NCT03552146|Dexmedetomidine|dexmedetomidine|mesh-list
5673042|NCT03552146|Propofol|propofol|mesh-list
5673043|NCT03552146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5673044|NCT03552146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5673045|NCT03552146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673046|NCT03552146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5673047|NCT03552146|Anesthetics, General|anesthetics, general|mesh-ancestor
5673048|NCT03552146|Anesthetics|anesthetics|mesh-ancestor
5673049|NCT03552146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5673050|NCT03552146|Analgesics|analgesics|mesh-ancestor
5673051|NCT03552146|Sensory System Agents|sensory system agents|mesh-ancestor
5673052|NCT03552146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5673053|NCT03552146|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5673054|NCT03552146|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5673055|NCT03552146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5673056|NCT03552146|Adrenergic Agents|adrenergic agents|mesh-ancestor
5673057|NCT03552146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5673058|NCT03552146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673059|NCT03552016|Riboflavin|riboflavin|mesh-list
5673060|NCT03552016|Vitamins|vitamins|mesh-ancestor
5673061|NCT03552016|Micronutrients|micronutrients|mesh-ancestor
5673062|NCT03552016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673063|NCT03552016|Vitamin B Complex|vitamin b complex|mesh-ancestor
5673064|NCT03552016|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5673065|NCT03552016|Dermatologic Agents|dermatologic agents|mesh-ancestor
5673066|NCT03551964|Ticagrelor|ticagrelor|mesh-list
5856878|NCT02422030|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5856879|NCT02422030|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5856880|NCT02422030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5856881|NCT02422108|Denosumab|denosumab|mesh-list
5856882|NCT02422108|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5856883|NCT02422108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856884|NCT02421913|Ketamine|ketamine|mesh-list
5856885|NCT02421913|Analgesics|analgesics|mesh-ancestor
5856886|NCT02421913|Sensory System Agents|sensory system agents|mesh-ancestor
5856887|NCT02421913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5856888|NCT02421913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856889|NCT02421913|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5856890|NCT02421913|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5856891|NCT02421913|Anesthetics, General|anesthetics, general|mesh-ancestor
5856892|NCT02421913|Anesthetics|anesthetics|mesh-ancestor
5856893|NCT02421913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5856894|NCT02421913|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5856895|NCT02421913|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5856896|NCT02421913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5856897|NCT02421913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904340|NCT05133258|Ciprofloxacin|ciprofloxacin|mesh-list
5904341|NCT05133258|Dexamethasone|dexamethasone|mesh-list
5904342|NCT05133258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5904343|NCT05133258|Antiemetics|antiemetics|mesh-ancestor
5904344|NCT05133258|Autonomic Agents|autonomic agents|mesh-ancestor
5673067|NCT03551964|Cangrelor|cangrelor|mesh-list
5673068|NCT03551964|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5673069|NCT03551964|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5673070|NCT03551964|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5673071|NCT03551964|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5673072|NCT03551964|Purinergic Agents|purinergic agents|mesh-ancestor
5673073|NCT03551964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5673074|NCT03551964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673075|NCT03551964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673076|NCT03551873|Plecanatide|plecanatide|mesh-list
5673077|NCT03551873|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
5673078|NCT03551873|Enzyme Activators|enzyme activators|mesh-ancestor
5673079|NCT03551873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673080|NCT03551873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5673081|NCT03551847|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5856898|NCT02421926|Imatinib Mesylate|imatinib mesylate|mesh-list
5856899|NCT02421926|Dasatinib|dasatinib|mesh-list
5856900|NCT02421926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5856901|NCT02421926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5856902|NCT02421926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5856903|NCT02421926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856904|NCT02421575|Hydroxychloroquine|hydroxychloroquine|mesh-list
5856905|NCT02421575|Antimalarials|antimalarials|mesh-ancestor
5856906|NCT02421575|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5856907|NCT02421575|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5856908|NCT02421575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5856909|NCT02421575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5856910|NCT02421575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856911|NCT02421575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5856912|NCT02421640|Cisplatin|cisplatin|mesh-list
5856913|NCT02421640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5856914|NCT02422277|Sildenafil Citrate|sildenafil citrate|mesh-list
5856915|NCT02422277|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
5856916|NCT02422277|Vasodilator Agents|vasodilator agents|mesh-ancestor
5856917|NCT02422277|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5856918|NCT02422277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5856919|NCT02422277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856920|NCT02422277|Urological Agents|urological agents|mesh-ancestor
5673082|NCT03551847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5673083|NCT03551847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5673084|NCT03551847|Antitubercular Agents|antitubercular agents|mesh-ancestor
5673085|NCT03551808|Ketorolac|ketorolac|mesh-list
5673086|NCT03551808|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
5673087|NCT03551808|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5673088|NCT03551808|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5673089|NCT03551808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5673090|NCT03551808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5673091|NCT03551808|Analgesics|analgesics|mesh-ancestor
5673092|NCT03551808|Sensory System Agents|sensory system agents|mesh-ancestor
5673093|NCT03551808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5673094|NCT03551808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673095|NCT03551808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5673096|NCT03551808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5673097|NCT03551808|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5673098|NCT03551808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5673099|NCT03551808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696181|NCT03385057|Antipyretics|antipyretics|mesh-ancestor
5696182|NCT03385057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5696183|NCT03385057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5696184|NCT03385057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5696185|NCT03385057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5696186|NCT03385057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5856921|NCT02422121|RNS60|rns60|mesh-list
5856922|NCT02422121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5856923|NCT02422121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5856924|NCT02422121|Analgesics|analgesics|mesh-ancestor
5856925|NCT02422121|Sensory System Agents|sensory system agents|mesh-ancestor
5856926|NCT02422121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5856927|NCT02422121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856928|NCT02422121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5856929|NCT02422121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5856930|NCT02422121|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5856931|NCT02421289|Efavirenz|efavirenz|mesh-list
5856932|NCT02421289|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5856933|NCT02421289|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5856934|NCT02421289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5856935|NCT02421289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673100|NCT03551691|Omeprazole|omeprazole|mesh-list
5673101|NCT03551691|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5673102|NCT03551691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5673103|NCT03551691|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5856936|NCT02421289|Antiviral Agents|antiviral agents|mesh-ancestor
5856937|NCT02421289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5856938|NCT02421289|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5856939|NCT02421289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5856940|NCT02421289|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5856941|NCT02421289|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5856942|NCT02421289|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5856943|NCT02421289|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5856944|NCT02420938|Rituximab|rituximab|mesh-list
5856945|NCT02420938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5856946|NCT02420938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5856947|NCT02420938|Immunologic Factors|immunologic factors|mesh-ancestor
5856948|NCT02420938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856949|NCT02420938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5856950|NCT02421042|Lenvatinib|lenvatinib|mesh-list
5856951|NCT02421042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5856952|NCT02421042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5856953|NCT02421042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5856954|NCT02421042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856955|NCT02420899|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5856956|NCT02420899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5856957|NCT02420899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5856958|NCT02420899|Antimetabolites|antimetabolites|mesh-ancestor
5856959|NCT02420899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856960|NCT02420899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5856961|NCT02420899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5856962|NCT02420899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5856963|NCT02421029|Calcium, Dietary|calcium, dietary|mesh-list
5856964|NCT02421029|Edetic Acid|edetic acid|mesh-list
5856965|NCT02421029|Calcium|calcium|mesh-list
5856966|NCT02421029|Pentetic Acid|pentetic acid|mesh-list
5856967|NCT02421029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5856968|NCT02421029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5856969|NCT02421029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5856970|NCT02421029|Anticoagulants|anticoagulants|mesh-ancestor
5856971|NCT02421029|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5856972|NCT02421029|Chelating Agents|chelating agents|mesh-ancestor
5856973|NCT02421029|Sequestering Agents|sequestering agents|mesh-ancestor
5856974|NCT02421029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5856975|NCT02421029|Antidotes|antidotes|mesh-ancestor
5856976|NCT02421029|Protective Agents|protective agents|mesh-ancestor
5856977|NCT02421029|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5856978|NCT02420834|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
5856979|NCT02420834|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5856980|NCT02420834|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5856981|NCT02420834|Laxatives|laxatives|mesh-ancestor
5856982|NCT02420834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5856983|NCT02420717|Leucovorin|leucovorin|mesh-list
5856984|NCT02420717|Cytarabine|cytarabine|mesh-list
5856985|NCT02420717|Dexamethasone|dexamethasone|mesh-list
5856986|NCT02420717|Dexamethasone acetate|dexamethasone acetate|mesh-list
5673104|NCT03551691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5673105|NCT03551691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673106|NCT03551652|Rocuronium|rocuronium|mesh-list
5673107|NCT03551652|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5673108|NCT03551652|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5673109|NCT03551652|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5673110|NCT03551652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5856987|NCT02420717|Prednisone|prednisone|mesh-list
5856988|NCT02420717|Cortisone|cortisone|mesh-list
5856989|NCT02420717|Cyclophosphamide|cyclophosphamide|mesh-list
5856990|NCT02420717|Rituximab|rituximab|mesh-list
5856991|NCT02420717|Doxorubicin|doxorubicin|mesh-list
5856992|NCT02420717|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5856993|NCT02420717|Methotrexate|methotrexate|mesh-list
5856994|NCT02420717|Vincristine|vincristine|mesh-list
5856995|NCT02420717|Daunorubicin|daunorubicin|mesh-list
5856996|NCT02420717|Dasatinib|dasatinib|mesh-list
5673111|NCT03551652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673112|NCT03551561|Chlorhexidine|chlorhexidine|mesh-list
5856997|NCT02420717|Mercaptopurine|mercaptopurine|mesh-list
5856998|NCT02420717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5856999|NCT02420717|Antibodies|antibodies|mesh-list
5857000|NCT02420717|Immunoglobulins|immunoglobulins|mesh-list
5857001|NCT02420717|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5857002|NCT02420717|BB 1101|bb 1101|mesh-list
5857003|NCT02420717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5857004|NCT02420717|Immunologic Factors|immunologic factors|mesh-ancestor
5857005|NCT02420717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857006|NCT02420717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5857007|NCT02420717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5857008|NCT02420717|Alkylating Agents|alkylating agents|mesh-ancestor
5857009|NCT02420717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5857010|NCT02420717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5857011|NCT02420717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5673113|NCT03551561|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5673114|NCT03551561|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5673115|NCT03551561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5673116|NCT03551561|Disinfectants|disinfectants|mesh-ancestor
5673117|NCT03551561|Dermatologic Agents|dermatologic agents|mesh-ancestor
5857012|NCT02420717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5857013|NCT02420717|Antiemetics|antiemetics|mesh-ancestor
5857014|NCT02420717|Autonomic Agents|autonomic agents|mesh-ancestor
5857015|NCT02420717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5857016|NCT02420717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5857017|NCT02420717|Glucocorticoids|glucocorticoids|mesh-ancestor
5857018|NCT02420717|Hormones|hormones|mesh-ancestor
5857019|NCT02420717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5857020|NCT02420717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5673118|NCT03551548|Spironolactone|spironolactone|mesh-list
5673119|NCT03551548|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5673120|NCT03551548|Hormone Antagonists|hormone antagonists|mesh-ancestor
5673121|NCT03551548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5673122|NCT03551548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673123|NCT03551548|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5673124|NCT03551548|Diuretics|diuretics|mesh-ancestor
5673125|NCT03551548|Natriuretic Agents|natriuretic agents|mesh-ancestor
5673126|NCT03551210|Levofloxacin|levofloxacin|mesh-list
5673127|NCT03551210|Ofloxacin|ofloxacin|mesh-list
5673128|NCT03551210|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5673129|NCT03551210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5673130|NCT03551210|Renal Agents|renal agents|mesh-ancestor
5673131|NCT03551210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5673132|NCT03551210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5857021|NCT02420717|Protease Inhibitors|protease inhibitors|mesh-ancestor
5857022|NCT02420717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5857023|NCT02420717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5857024|NCT02420717|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5857025|NCT02420717|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5857026|NCT02420717|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5857027|NCT02420717|Abortifacient Agents|abortifacient agents|mesh-ancestor
5857028|NCT02420717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5857029|NCT02420717|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5857030|NCT02420717|Antimetabolites|antimetabolites|mesh-ancestor
5857031|NCT02420717|Dermatologic Agents|dermatologic agents|mesh-ancestor
5857032|NCT02420717|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5857033|NCT02420717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5857034|NCT02420717|Antiviral Agents|antiviral agents|mesh-ancestor
5857035|NCT02420717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5857036|NCT02420717|Antidotes|antidotes|mesh-ancestor
5857037|NCT02420717|Protective Agents|protective agents|mesh-ancestor
5857038|NCT02420717|Vitamin B Complex|vitamin b complex|mesh-ancestor
5857039|NCT02420717|Vitamins|vitamins|mesh-ancestor
5857040|NCT02420717|Micronutrients|micronutrients|mesh-ancestor
5857041|NCT02420717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5857042|NCT02420717|Tubulin Modulators|tubulin modulators|mesh-ancestor
5857043|NCT02420717|Antimitotic Agents|antimitotic agents|mesh-ancestor
5857044|NCT02420717|Mitosis Modulators|mitosis modulators|mesh-ancestor
5857045|NCT02420717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5857046|NCT02420795|TIC10 compound|tic10 compound|mesh-list
5857047|NCT02420795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5857048|NCT02420665|Acetic Acid|acetic acid|mesh-list
5857049|NCT02420665|Proflavine|proflavine|mesh-list
5857050|NCT02420665|Retinol acetate|retinol acetate|mesh-list
5857051|NCT02420665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5857052|NCT02420665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5857053|NCT02420665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5857054|NCT02420665|Immunologic Factors|immunologic factors|mesh-ancestor
5857055|NCT02420665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673133|NCT03551210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5857056|NCT02420665|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5857057|NCT02420665|Protective Agents|protective agents|mesh-ancestor
5857058|NCT02420665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5857059|NCT02420665|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5857060|NCT02420782|Itraconazole|itraconazole|mesh-list
5857061|NCT02420782|Midazolam|midazolam|mesh-list
5857062|NCT02420782|Pilocarpine|pilocarpine|mesh-list
5857063|NCT02420782|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5857064|NCT02420782|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5857065|NCT02420782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5857066|NCT02420782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857067|NCT02420782|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5857068|NCT02420782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5857069|NCT02420782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5857070|NCT02420782|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5857071|NCT02420782|Anesthetics, General|anesthetics, general|mesh-ancestor
5857072|NCT02420782|Anesthetics|anesthetics|mesh-ancestor
5857073|NCT02420782|GABA Modulators|gaba modulators|mesh-ancestor
5857074|NCT02420782|GABA Agents|gaba agents|mesh-ancestor
5857075|NCT02420782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5857076|NCT02420782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5857077|NCT02420782|Antifungal Agents|antifungal agents|mesh-ancestor
5857078|NCT02420782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5857079|NCT02420782|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5857080|NCT02420782|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5857081|NCT02420782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5857082|NCT02420782|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5857083|NCT02420782|Hormone Antagonists|hormone antagonists|mesh-ancestor
5857084|NCT02420782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5857085|NCT02420782|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5857086|NCT02420782|Miotics|miotics|mesh-ancestor
5857087|NCT02420782|Autonomic Agents|autonomic agents|mesh-ancestor
5857088|NCT02420782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5857089|NCT02420782|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
5857090|NCT02420782|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5857091|NCT02420782|Cholinergic Agents|cholinergic agents|mesh-ancestor
5857092|NCT02420652|Aspirin|aspirin|mesh-list
5857093|NCT02420652|Metformin|metformin|mesh-list
5857094|NCT02420652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5857095|NCT02420652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857096|NCT02420652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5857097|NCT02420652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5857098|NCT02420652|Analgesics|analgesics|mesh-ancestor
5857099|NCT02420652|Sensory System Agents|sensory system agents|mesh-ancestor
5857100|NCT02420652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5857101|NCT02420652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5857102|NCT02420652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5857103|NCT02420652|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5857104|NCT02420652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5857105|NCT02420652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5857106|NCT02420652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5857107|NCT02420652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5857108|NCT02420652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5857109|NCT02420652|Antipyretics|antipyretics|mesh-ancestor
5857110|NCT02420509|Leucovorin|leucovorin|mesh-list
5857111|NCT02420509|Capecitabine|capecitabine|mesh-list
5857112|NCT02420509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5857113|NCT02420509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857114|NCT02420509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5857115|NCT02420509|Antimetabolites|antimetabolites|mesh-ancestor
5857116|NCT02420509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5857117|NCT02420509|Antidotes|antidotes|mesh-ancestor
5857118|NCT02420509|Protective Agents|protective agents|mesh-ancestor
5857119|NCT02420509|Vitamin B Complex|vitamin b complex|mesh-ancestor
5857120|NCT02420509|Vitamins|vitamins|mesh-ancestor
5857121|NCT02420509|Micronutrients|micronutrients|mesh-ancestor
5857122|NCT02420496|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
5857123|NCT02420496|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5857124|NCT02420496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5857125|NCT02420392|Dapagliflozin|dapagliflozin|mesh-list
5857126|NCT02420392|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5857127|NCT02420392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5857128|NCT02420392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5857129|NCT02420392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857130|NCT02420444|BCG Vaccine|bcg vaccine|mesh-list
5673134|NCT03551210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5673135|NCT03551210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673136|NCT03551210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5673137|NCT03551210|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5673138|NCT03551210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5673139|NCT03551197|Budesonide|budesonide|mesh-list
5673140|NCT03551197|Formoterol Fumarate|formoterol fumarate|mesh-list
5673141|NCT03551197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5673142|NCT03551197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5673143|NCT03551197|Autonomic Agents|autonomic agents|mesh-ancestor
5673144|NCT03551197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5673145|NCT03551197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673146|NCT03551197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5673147|NCT03551197|Respiratory System Agents|respiratory system agents|mesh-ancestor
5673148|NCT03551197|Glucocorticoids|glucocorticoids|mesh-ancestor
5673149|NCT03551197|Hormones|hormones|mesh-ancestor
5673150|NCT03551197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5673151|NCT03551197|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5673152|NCT03551197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5673153|NCT03551197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5673154|NCT03551197|Adrenergic Agents|adrenergic agents|mesh-ancestor
5673155|NCT03551197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5673156|NCT03551197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673157|NCT03551171|Niraparib|niraparib|mesh-list
5673158|NCT03551171|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5673159|NCT03551171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5673160|NCT03551171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673161|NCT03551171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5857131|NCT02420444|Immunologic Factors|immunologic factors|mesh-ancestor
5857132|NCT02420444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857133|NCT02420444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5857134|NCT02420418|Acetylcysteine|acetylcysteine|mesh-list
5857135|NCT02420418|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5857136|NCT02420418|Antiviral Agents|antiviral agents|mesh-ancestor
5857137|NCT02420418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5857138|NCT02420418|Expectorants|expectorants|mesh-ancestor
5857139|NCT02420418|Respiratory System Agents|respiratory system agents|mesh-ancestor
5857140|NCT02420418|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5857141|NCT02420418|Antioxidants|antioxidants|mesh-ancestor
5857142|NCT02420418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5857143|NCT02420418|Protective Agents|protective agents|mesh-ancestor
5857144|NCT02420418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857145|NCT02420418|Antidotes|antidotes|mesh-ancestor
5857146|NCT02420171|Insulin|insulin|mesh-list
5857147|NCT02420171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5857148|NCT02420171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904345|NCT05133258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5904346|NCT05133258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904347|NCT05133258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5904348|NCT05133258|Glucocorticoids|glucocorticoids|mesh-ancestor
5904349|NCT05133258|Hormones|hormones|mesh-ancestor
5904350|NCT05133258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5904351|NCT05133258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5904352|NCT05133258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5904353|NCT05133258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5904354|NCT05133258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5673162|NCT03551067|Midazolam|midazolam|mesh-list
5673163|NCT03551067|Dexmedetomidine|dexmedetomidine|mesh-list
5673164|NCT03551067|Ketamine|ketamine|mesh-list
5673165|NCT03551067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5857149|NCT02420132|Ranibizumab|ranibizumab|mesh-list
5857150|NCT02420132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5857151|NCT02420132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5857152|NCT02420132|Growth Substances|growth substances|mesh-ancestor
5857153|NCT02420132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857154|NCT02420132|Growth Inhibitors|growth inhibitors|mesh-ancestor
5857155|NCT02420132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5857156|NCT02420080|Brincidofovir|brincidofovir|mesh-list
5857157|NCT02420080|Antiviral Agents|antiviral agents|mesh-ancestor
5857158|NCT02420080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5857159|NCT02419742|Paclitaxel|paclitaxel|mesh-list
5857160|NCT02419742|Docetaxel|docetaxel|mesh-list
5857161|NCT02419742|Cyclophosphamide|cyclophosphamide|mesh-list
5857162|NCT02419742|Carboplatin|carboplatin|mesh-list
5857163|NCT02419742|Doxorubicin|doxorubicin|mesh-list
5857164|NCT02419742|Trastuzumab|trastuzumab|mesh-list
5857165|NCT02419742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5857166|NCT02419742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5857167|NCT02419742|Tubulin Modulators|tubulin modulators|mesh-ancestor
5857168|NCT02419742|Antimitotic Agents|antimitotic agents|mesh-ancestor
5857169|NCT02419742|Mitosis Modulators|mitosis modulators|mesh-ancestor
5857170|NCT02419742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5857171|NCT02419742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5857172|NCT02419742|Immunologic Factors|immunologic factors|mesh-ancestor
5857173|NCT02419742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857174|NCT02419742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5857175|NCT02419742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5857176|NCT02419742|Alkylating Agents|alkylating agents|mesh-ancestor
5857177|NCT02419742|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5857178|NCT02419742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5857179|NCT02419742|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5857180|NCT02419742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5857181|NCT02419742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5857182|NCT02419742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5857183|NCT02419664|Edotreotide|edotreotide|mesh-list
5857184|NCT02419664|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5857185|NCT02419664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5857186|NCT02420002|Nitrous Oxide|nitrous oxide|mesh-list
5857187|NCT02420002|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5857188|NCT02420002|Anesthetics, General|anesthetics, general|mesh-ancestor
5857189|NCT02420002|Anesthetics|anesthetics|mesh-ancestor
5857190|NCT02420002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5857191|NCT02420002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857192|NCT02420002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5857193|NCT02420002|Analgesics|analgesics|mesh-ancestor
5857194|NCT02420002|Sensory System Agents|sensory system agents|mesh-ancestor
5857195|NCT02420002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5857196|NCT02419729|Estrogens|estrogens|mesh-list
5857197|NCT02419729|Hormones|hormones|mesh-ancestor
5857198|NCT02419729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5857199|NCT02419729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857200|NCT02419651|Diclofenac|diclofenac|mesh-list
5857201|NCT02419651|Tramadol|tramadol|mesh-list
5857202|NCT02419651|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5857203|NCT02419651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5857204|NCT02419651|Analgesics|analgesics|mesh-ancestor
5857205|NCT02419651|Sensory System Agents|sensory system agents|mesh-ancestor
5857206|NCT02419651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5857207|NCT02419651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857208|NCT02419651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5857209|NCT02419651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5857210|NCT02419651|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5857211|NCT02419651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5857212|NCT02419651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5857213|NCT02419651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5857214|NCT02419651|Narcotics|narcotics|mesh-ancestor
5857215|NCT02419651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5857216|NCT02419820|Aspirin|aspirin|mesh-list
5857217|NCT02419820|Clopidogrel|clopidogrel|mesh-list
5857218|NCT02419820|APD791|apd791|mesh-list
5857219|NCT02419820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5857220|NCT02419820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5673166|NCT03551067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5857221|NCT02419820|Analgesics|analgesics|mesh-ancestor
5857222|NCT02419820|Sensory System Agents|sensory system agents|mesh-ancestor
5857223|NCT02419820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5857224|NCT02419820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857225|NCT02419820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5857226|NCT02419820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5857227|NCT02419820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5857228|NCT02419820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5673167|NCT03551067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673168|NCT03551067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5673169|NCT03551067|Analgesics|analgesics|mesh-ancestor
5673170|NCT03551067|Sensory System Agents|sensory system agents|mesh-ancestor
5673171|NCT03551067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5673172|NCT03551067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5673173|NCT03551067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5673174|NCT03551067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5673175|NCT03551067|Adrenergic Agents|adrenergic agents|mesh-ancestor
5673176|NCT03551067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5673177|NCT03551067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5857229|NCT02419820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5857230|NCT02419820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5857231|NCT02419820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5857232|NCT02419820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5857233|NCT02419820|Antipyretics|antipyretics|mesh-ancestor
5857234|NCT02419820|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5857235|NCT02419820|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5857236|NCT02419820|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5857237|NCT02419820|Purinergic Agents|purinergic agents|mesh-ancestor
5857238|NCT02419820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5857239|NCT02419820|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5857240|NCT02419820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5857241|NCT02419820|Serotonin Agents|serotonin agents|mesh-ancestor
5857242|NCT02419534|Diltiazem|diltiazem|mesh-list
5857243|NCT02419534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5857244|NCT02419534|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5857245|NCT02419534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5857246|NCT02419534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5857247|NCT02419534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5857248|NCT02419534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857249|NCT02419534|Vasodilator Agents|vasodilator agents|mesh-ancestor
5857250|NCT02419560|Venetoclax|venetoclax|mesh-list
5857251|NCT02419560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5857252|NCT02419638|Dimethyl Fumarate|dimethyl fumarate|mesh-list
5857253|NCT02419638|Dermatologic Agents|dermatologic agents|mesh-ancestor
5857254|NCT02419638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5857255|NCT02419638|Immunologic Factors|immunologic factors|mesh-ancestor
5857256|NCT02419638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857257|NCT02419443|Gabapentin|gabapentin|mesh-list
5857258|NCT02419443|Analgesics|analgesics|mesh-ancestor
5857259|NCT02419443|Sensory System Agents|sensory system agents|mesh-ancestor
5673178|NCT03551067|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5673179|NCT03551067|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5673180|NCT03551067|Anesthetics, General|anesthetics, general|mesh-ancestor
5673181|NCT03551067|Anesthetics|anesthetics|mesh-ancestor
5673182|NCT03551067|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5673183|NCT03551067|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5673184|NCT03551067|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5673185|NCT03551067|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5857260|NCT02419443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5857261|NCT02419443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857262|NCT02419443|Anticonvulsants|anticonvulsants|mesh-ancestor
5857263|NCT02419443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5857264|NCT02419443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5857265|NCT02419443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5857266|NCT02419443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5857267|NCT02419443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5673186|NCT03551067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5673187|NCT03551067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5673188|NCT03551067|GABA Modulators|gaba modulators|mesh-ancestor
5673189|NCT03551067|GABA Agents|gaba agents|mesh-ancestor
5673190|NCT03550859|Telmisartan|telmisartan|mesh-list
5673191|NCT03550859|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5673192|NCT03550859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5857268|NCT02419443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5857269|NCT02419443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5857270|NCT02419443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5857271|NCT02419443|Antimanic Agents|antimanic agents|mesh-ancestor
5857272|NCT02419859|Insulin|insulin|mesh-list
5857273|NCT02419859|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5857274|NCT02419859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5857275|NCT02419859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857276|NCT02419352|Atropine|atropine|mesh-list
5857277|NCT02419352|Neostigmine|neostigmine|mesh-list
5857278|NCT02419352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5857279|NCT02419352|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5857280|NCT02419352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5857281|NCT02419352|Autonomic Agents|autonomic agents|mesh-ancestor
5857282|NCT02419352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5857283|NCT02419352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857284|NCT02419352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5857285|NCT02419352|Respiratory System Agents|respiratory system agents|mesh-ancestor
5857286|NCT02419352|Mydriatics|mydriatics|mesh-ancestor
5857287|NCT02419352|Parasympatholytics|parasympatholytics|mesh-ancestor
5857288|NCT02419352|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5857289|NCT02419352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5857290|NCT02419352|Cholinergic Agents|cholinergic agents|mesh-ancestor
5857291|NCT02419352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5857292|NCT02419352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5857293|NCT02419352|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5857294|NCT02419352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5857295|NCT02419352|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5857296|NCT02419261|Analgesics|analgesics|mesh-list
5673193|NCT03550859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5673194|NCT03550859|Antimetabolites|antimetabolites|mesh-ancestor
5673195|NCT03550859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673196|NCT03550859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5673197|NCT03550859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5673198|NCT03550859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5673199|NCT03550859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5673200|NCT03550859|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5673201|NCT03550859|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5673202|NCT03550794|Thiamine|thiamine|mesh-list
5673203|NCT03550794|Vitamins|vitamins|mesh-ancestor
5673204|NCT03550794|Micronutrients|micronutrients|mesh-ancestor
5673205|NCT03550794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673206|NCT03550794|Vitamin B Complex|vitamin b complex|mesh-ancestor
5857297|NCT02419261|Ropivacaine|ropivacaine|mesh-list
5857298|NCT02419261|Anesthetics, Local|anesthetics, local|mesh-ancestor
5673207|NCT03550781|Prednisone|prednisone|mesh-list
5673208|NCT03550781|Cyclophosphamide|cyclophosphamide|mesh-list
5673209|NCT03550781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5673210|NCT03550781|Immunologic Factors|immunologic factors|mesh-ancestor
5673211|NCT03550781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673212|NCT03550781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5673213|NCT03550781|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5673214|NCT03550781|Alkylating Agents|alkylating agents|mesh-ancestor
5673215|NCT03550781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673216|NCT03550781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5673217|NCT03550781|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5673218|NCT03550781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5857299|NCT02419261|Anesthetics|anesthetics|mesh-ancestor
5857300|NCT02419261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5857301|NCT02419261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857302|NCT02419261|Sensory System Agents|sensory system agents|mesh-ancestor
5857303|NCT02419261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5857304|NCT02419118|Dexamethasone|dexamethasone|mesh-list
5857305|NCT02419118|Lenalidomide|lenalidomide|mesh-list
5857306|NCT02419118|Daratumumab|daratumumab|mesh-list
5857307|NCT02419118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5857308|NCT02419118|Antiemetics|antiemetics|mesh-ancestor
5857309|NCT02419118|Autonomic Agents|autonomic agents|mesh-ancestor
5857310|NCT02419118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5857311|NCT02419118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857312|NCT02419118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5857313|NCT02419118|Glucocorticoids|glucocorticoids|mesh-ancestor
5857314|NCT02419118|Hormones|hormones|mesh-ancestor
5857315|NCT02419118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5673219|NCT03550781|Glucocorticoids|glucocorticoids|mesh-ancestor
5857316|NCT02419118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5857317|NCT02419118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5857318|NCT02419118|Immunologic Factors|immunologic factors|mesh-ancestor
5857319|NCT02419118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5857320|NCT02419118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5857321|NCT02419118|Growth Substances|growth substances|mesh-ancestor
5857322|NCT02419118|Growth Inhibitors|growth inhibitors|mesh-ancestor
5857323|NCT02419040|Lidocaine|lidocaine|mesh-list
5857324|NCT02419040|Anesthetics, Local|anesthetics, local|mesh-ancestor
5857325|NCT02419040|Anesthetics|anesthetics|mesh-ancestor
5857326|NCT02419040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5857327|NCT02419040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857328|NCT02419040|Sensory System Agents|sensory system agents|mesh-ancestor
5857329|NCT02419040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5857330|NCT02419040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5857331|NCT02419040|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5857332|NCT02419040|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5857333|NCT02419040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5857334|NCT02419040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5857335|NCT02419105|Vitamin D|vitamin d|mesh-list
5857336|NCT02419105|Cholecalciferol|cholecalciferol|mesh-list
5857337|NCT02419105|Testosterone|testosterone|mesh-list
5857338|NCT02419105|Vitamins|vitamins|mesh-ancestor
5857339|NCT02419105|Micronutrients|micronutrients|mesh-ancestor
5857340|NCT02419105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857341|NCT02419105|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5857342|NCT02419105|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5857343|NCT02419105|Androgens|androgens|mesh-ancestor
5857344|NCT02419105|Hormones|hormones|mesh-ancestor
5857345|NCT02419105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5857346|NCT02419287|Crizotinib|crizotinib|mesh-list
5857347|NCT02419287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5857348|NCT02419287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5857349|NCT02419287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5857350|NCT02419287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5857351|NCT02419170|Cyclophosphamide|cyclophosphamide|mesh-list
5857352|NCT02419170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5857353|NCT02419170|Immunologic Factors|immunologic factors|mesh-ancestor
5857354|NCT02419170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857355|NCT02419170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5857356|NCT02419170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5857357|NCT02419170|Alkylating Agents|alkylating agents|mesh-ancestor
5857358|NCT02419170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5857359|NCT02419170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5857360|NCT02419170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5857361|NCT02419235|Ethanol|ethanol|mesh-list
5857362|NCT02419235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5857363|NCT02419235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5857364|NCT02419235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5857365|NCT02419235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857366|NCT02418988|Chlorotrianisene|chlorotrianisene|mesh-list
5857367|NCT02418988|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
5857368|NCT02418988|Estrogens|estrogens|mesh-ancestor
5857369|NCT02418988|Hormones|hormones|mesh-ancestor
5857370|NCT02418988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5857371|NCT02418988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857372|NCT02418988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5857373|NCT02418988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5857374|NCT02418572|Testosterone|testosterone|mesh-list
5857375|NCT02418572|Androgens|androgens|mesh-ancestor
5857376|NCT02418572|Hormones|hormones|mesh-ancestor
5857377|NCT02418572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5857378|NCT02418572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857379|NCT02418702|Ketamine|ketamine|mesh-list
5857380|NCT02418702|Analgesics|analgesics|mesh-ancestor
5673220|NCT03550781|Hormones|hormones|mesh-ancestor
5673221|NCT03550781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5673222|NCT03550781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5857381|NCT02418702|Sensory System Agents|sensory system agents|mesh-ancestor
5673223|NCT03550677|Anesthetics|anesthetics|mesh-list
5673224|NCT03550677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5673225|NCT03550677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673226|NCT03550651|Chlorhexidine|chlorhexidine|mesh-list
5673227|NCT03550651|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5673228|NCT03550651|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5857382|NCT02418702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5857383|NCT02418702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857384|NCT02418702|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5857385|NCT02418702|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5857386|NCT02418702|Anesthetics, General|anesthetics, general|mesh-ancestor
5857387|NCT02418702|Anesthetics|anesthetics|mesh-ancestor
5857388|NCT02418702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5857389|NCT02418702|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5857390|NCT02418702|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5857391|NCT02418702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5857392|NCT02418702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5857393|NCT02418884|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5857394|NCT02418884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5857395|NCT02418884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5857396|NCT02418884|Antimetabolites|antimetabolites|mesh-ancestor
5857397|NCT02418884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5857398|NCT02418884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5857399|NCT02418884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5857400|NCT02418884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5857401|NCT02418624|Carboplatin|carboplatin|mesh-list
5857402|NCT02418624|Olaparib|olaparib|mesh-list
5857403|NCT02418624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5857404|NCT02418624|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5857405|NCT02418624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5857406|NCT02418624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5857407|NCT02418533|Menotropins|menotropins|mesh-list
5857408|NCT02418533|Hormones|hormones|mesh-list
5857409|NCT02418533|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5857410|NCT02418533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5857411|NCT02418533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857412|NCT02418533|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5857413|NCT02418533|Fertility Agents|fertility agents|mesh-ancestor
5857414|NCT02418533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5904355|NCT05133258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5904356|NCT05133258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5904357|NCT05133258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5904358|NCT05133258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904359|NCT05133258|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5904360|NCT05133258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5904361|NCT05133050|Ramipril|ramipril|mesh-list
5904362|NCT05133050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5904363|NCT05133050|Protease Inhibitors|protease inhibitors|mesh-ancestor
5904364|NCT05133050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5904365|NCT05133050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904366|NCT05133050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5904367|NCT05132829|Azithromycin|azithromycin|mesh-list
5904368|NCT05132829|Cefazolin|cefazolin|mesh-list
5904369|NCT05132829|Indomethacin|indomethacin|mesh-list
5904370|NCT05132829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5904371|NCT05132829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5904372|NCT05132829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5904373|NCT05132829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5904374|NCT05132829|Analgesics|analgesics|mesh-ancestor
5904375|NCT05132829|Sensory System Agents|sensory system agents|mesh-ancestor
5673229|NCT03550651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5673230|NCT03550651|Disinfectants|disinfectants|mesh-ancestor
5673231|NCT03550651|Dermatologic Agents|dermatologic agents|mesh-ancestor
5673232|NCT03550534|Calcium Carbonate|calcium carbonate|mesh-list
5673233|NCT03550534|Calcium|calcium|mesh-list
5673234|NCT03550534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5673235|NCT03550534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673236|NCT03550534|Antacids|antacids|mesh-ancestor
5904376|NCT05132829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5904377|NCT05132829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904378|NCT05132829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5904379|NCT05132829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5904380|NCT05132829|Gout Suppressants|gout suppressants|mesh-ancestor
5904381|NCT05132829|Tocolytic Agents|tocolytic agents|mesh-ancestor
5904382|NCT05132829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5904383|NCT05132829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5904384|NCT05132829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5673237|NCT03550534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673238|NCT03550534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5673239|NCT03550508|Antibodies|antibodies|mesh-list
5673240|NCT03550508|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5673241|NCT03550508|Immunologic Factors|immunologic factors|mesh-ancestor
5857415|NCT02418273|Denosumab|denosumab|mesh-list
5857416|NCT02418273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5857417|NCT02418273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857418|NCT02418130|Inositol|inositol|mesh-list
5857419|NCT02418130|Thiamine|thiamine|mesh-list
5857420|NCT02418130|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
5857421|NCT02418130|Vitamin B Complex|vitamin b complex|mesh-ancestor
5857422|NCT02418130|Vitamins|vitamins|mesh-ancestor
5857423|NCT02418130|Micronutrients|micronutrients|mesh-ancestor
5857424|NCT02418130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857425|NCT02418130|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5857426|NCT02418130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5857427|NCT02417883|Furosemide|furosemide|mesh-list
5857428|NCT02417883|Diuretics|diuretics|mesh-ancestor
5857429|NCT02417883|Natriuretic Agents|natriuretic agents|mesh-ancestor
5857430|NCT02417883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857431|NCT02417883|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5857432|NCT02417883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5857433|NCT02417883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5857434|NCT02417896|Spironolactone|spironolactone|mesh-list
5857435|NCT02417896|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5857436|NCT02417896|Hormone Antagonists|hormone antagonists|mesh-ancestor
5857437|NCT02417896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5857438|NCT02417896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857439|NCT02417896|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5857440|NCT02417896|Diuretics|diuretics|mesh-ancestor
5857441|NCT02417896|Natriuretic Agents|natriuretic agents|mesh-ancestor
5857442|NCT02418065|Testosterone|testosterone|mesh-list
5857443|NCT02418065|Androgens|androgens|mesh-ancestor
5857444|NCT02418065|Hormones|hormones|mesh-ancestor
5857445|NCT02418065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5857446|NCT02418065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857447|NCT02418078|Anesthetics|anesthetics|mesh-list
5857448|NCT02418078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5857449|NCT02418078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857450|NCT02417610|Hyaluronic Acid|hyaluronic acid|mesh-list
5857451|NCT02417610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5857452|NCT02417610|Immunologic Factors|immunologic factors|mesh-ancestor
5857453|NCT02417610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857454|NCT02417610|Viscosupplements|viscosupplements|mesh-ancestor
5857455|NCT02417610|Protective Agents|protective agents|mesh-ancestor
5857456|NCT02417506|Ibuprofen|ibuprofen|mesh-list
5857457|NCT02417506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5857458|NCT02417506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5857459|NCT02417506|Analgesics|analgesics|mesh-ancestor
5673242|NCT03550508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696187|NCT03385057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696188|NCT03384862|Folic Acid|folic acid|mesh-list
5696189|NCT03384862|Vitamin B 12|vitamin b 12|mesh-list
5696190|NCT03384862|Hydroxocobalamin|hydroxocobalamin|mesh-list
5696191|NCT03384862|Vitamins|vitamins|mesh-ancestor
5696192|NCT03384862|Micronutrients|micronutrients|mesh-ancestor
5696193|NCT03384862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696194|NCT03384862|Hematinics|hematinics|mesh-ancestor
5696195|NCT03384862|Vitamin B Complex|vitamin b complex|mesh-ancestor
5696196|NCT03384589|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5696197|NCT03384589|Immunologic Factors|immunologic factors|mesh-ancestor
5696198|NCT03384589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696199|NCT03384563|Dexmedetomidine|dexmedetomidine|mesh-list
5696200|NCT03384563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5696201|NCT03384563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5696202|NCT03384563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696203|NCT03384563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5696204|NCT03384563|Analgesics|analgesics|mesh-ancestor
5696205|NCT03384563|Sensory System Agents|sensory system agents|mesh-ancestor
5696206|NCT03384563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5696207|NCT03384563|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5696208|NCT03384563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5696209|NCT03384563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5696210|NCT03384563|Adrenergic Agents|adrenergic agents|mesh-ancestor
5696211|NCT03384563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5696212|NCT03384563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5857460|NCT02417506|Sensory System Agents|sensory system agents|mesh-ancestor
5857461|NCT02417506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5857462|NCT02417506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857463|NCT02417506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5857464|NCT02417506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5857465|NCT02417506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5857466|NCT02417506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5857467|NCT02417506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5857468|NCT02417493|Epinephrine|epinephrine|mesh-list
5857469|NCT02417493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5857470|NCT02417493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5857471|NCT02417493|Adrenergic Agents|adrenergic agents|mesh-ancestor
5857472|NCT02417493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5857473|NCT02417493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5857474|NCT02417493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857475|NCT02417493|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5857476|NCT02417493|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5857477|NCT02417493|Autonomic Agents|autonomic agents|mesh-ancestor
5857478|NCT02417493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5673243|NCT03549975|Botulinum Toxins|botulinum toxins|mesh-list
5673244|NCT03549975|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5673245|NCT03549975|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5673246|NCT03549975|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5673247|NCT03549975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5673248|NCT03549975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673249|NCT03549975|Cholinergic Agents|cholinergic agents|mesh-ancestor
5673250|NCT03549975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5673251|NCT03549975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673252|NCT03549975|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5673253|NCT03549975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5673254|NCT03549923|Esmolol|esmolol|mesh-list
5673255|NCT03549923|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5673256|NCT03549923|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5673257|NCT03549923|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5673258|NCT03549923|Adrenergic Agents|adrenergic agents|mesh-ancestor
5673259|NCT03549923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5673260|NCT03549923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673261|NCT03549923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673262|NCT03549897|Albuterol|albuterol|mesh-list
5673263|NCT03549897|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5673264|NCT03549897|Autonomic Agents|autonomic agents|mesh-ancestor
5673265|NCT03549897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5673266|NCT03549897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673267|NCT03549897|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5673268|NCT03549897|Respiratory System Agents|respiratory system agents|mesh-ancestor
5673269|NCT03549897|Tocolytic Agents|tocolytic agents|mesh-ancestor
5673270|NCT03549897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5857479|NCT02417493|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5857480|NCT02417493|Respiratory System Agents|respiratory system agents|mesh-ancestor
5857481|NCT02417493|Mydriatics|mydriatics|mesh-ancestor
5857482|NCT02417493|Sympathomimetics|sympathomimetics|mesh-ancestor
5857483|NCT02417493|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5857484|NCT02417649|Broncho-Vaxom|broncho-vaxom|mesh-list
5857485|NCT02417649|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5857486|NCT02417649|Immunologic Factors|immunologic factors|mesh-ancestor
5857487|NCT02417649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857488|NCT02417467|Nicotine|nicotine|mesh-list
5857489|NCT02417467|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5857490|NCT02417467|Autonomic Agents|autonomic agents|mesh-ancestor
5857491|NCT02417467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5857492|NCT02417467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857493|NCT02417467|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5857494|NCT02417467|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5857495|NCT02417467|Cholinergic Agents|cholinergic agents|mesh-ancestor
5857496|NCT02417467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5857497|NCT02417467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5857498|NCT02417389|Alendronate|alendronate|mesh-list
5857499|NCT02417389|Cinacalcet|cinacalcet|mesh-list
5857500|NCT02417389|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5857501|NCT02417389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857502|NCT02417389|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5857503|NCT02417389|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
5673271|NCT03549897|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5857504|NCT02417389|Hormone Antagonists|hormone antagonists|mesh-ancestor
5857505|NCT02417389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5673272|NCT03549897|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5673273|NCT03549897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5673274|NCT03549897|Adrenergic Agents|adrenergic agents|mesh-ancestor
5673275|NCT03549897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5673276|NCT03549897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673277|NCT03549832|Ritonavir|ritonavir|mesh-list
5673278|NCT03549832|Ribavirin|ribavirin|mesh-list
5673279|NCT03549832|Sofosbuvir|sofosbuvir|mesh-list
5673280|NCT03549832|Simeprevir|simeprevir|mesh-list
5673281|NCT03549832|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5673282|NCT03549832|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5673283|NCT03549832|Protease Inhibitors|protease inhibitors|mesh-ancestor
5673284|NCT03549832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5673285|NCT03549832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673286|NCT03549832|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5673287|NCT03549832|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5673288|NCT03549832|Antiviral Agents|antiviral agents|mesh-ancestor
5673289|NCT03549832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5673290|NCT03549832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5673291|NCT03549832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5673292|NCT03549832|Antimetabolites|antimetabolites|mesh-ancestor
5673293|NCT03549819|Cannabidiol|cannabidiol|mesh-list
5673294|NCT03549819|Anticonvulsants|anticonvulsants|mesh-ancestor
5673295|NCT03549741|Cabergoline|cabergoline|mesh-list
5673296|NCT03549741|Clomiphene|clomiphene|mesh-list
5857506|NCT02417090|Metformin|metformin|mesh-list
5857507|NCT02417090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5857508|NCT02417090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857509|NCT02417077|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5857510|NCT02417077|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5857511|NCT02417077|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5857512|NCT02417077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5857513|NCT02417077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857514|NCT02417077|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5857515|NCT02417077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5857516|NCT02417077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5857517|NCT02417077|Cholinergic Agents|cholinergic agents|mesh-ancestor
5673297|NCT03549741|Enclomiphene|enclomiphene|mesh-list
5673298|NCT03549741|Zuclomiphene|zuclomiphene|mesh-list
5673299|NCT03549741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5857518|NCT02417077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5857519|NCT02417116|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5857520|NCT02417116|Hyaluronic Acid|hyaluronic acid|mesh-list
5857521|NCT02417116|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5857522|NCT02417116|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5857523|NCT02417116|Immunologic Factors|immunologic factors|mesh-ancestor
5857524|NCT02417116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857525|NCT02417116|Viscosupplements|viscosupplements|mesh-ancestor
5857526|NCT02417116|Protective Agents|protective agents|mesh-ancestor
5857527|NCT02417298|Ketamine|ketamine|mesh-list
5857528|NCT02417298|Analgesics|analgesics|mesh-ancestor
5857529|NCT02417298|Sensory System Agents|sensory system agents|mesh-ancestor
5857530|NCT02417298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5857531|NCT02417298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857532|NCT02417298|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5857533|NCT02417298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5673300|NCT03549741|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5673301|NCT03549741|Hormone Antagonists|hormone antagonists|mesh-ancestor
5673302|NCT03549741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5673303|NCT03549741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673304|NCT03549741|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5673305|NCT03549741|Fertility Agents|fertility agents|mesh-ancestor
5673306|NCT03549741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5673307|NCT03549741|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5673308|NCT03549741|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5673309|NCT03549741|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5673310|NCT03549741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5673311|NCT03549741|Dopamine Agonists|dopamine agonists|mesh-ancestor
5673312|NCT03549741|Dopamine Agents|dopamine agents|mesh-ancestor
5673313|NCT03549741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5673314|NCT03549728|Lenograstim|lenograstim|mesh-list
5673315|NCT03549728|Sargramostim|sargramostim|mesh-list
5857534|NCT02417298|Anesthetics, General|anesthetics, general|mesh-ancestor
5857535|NCT02417298|Anesthetics|anesthetics|mesh-ancestor
5857536|NCT02417298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5857537|NCT02417298|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5857538|NCT02417298|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5857539|NCT02417298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5857540|NCT02417298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5857541|NCT02417103|Liraglutide|liraglutide|mesh-list
5857542|NCT02417103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5857543|NCT02417103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857544|NCT02417103|Incretins|incretins|mesh-ancestor
5857545|NCT02417103|Hormones|hormones|mesh-ancestor
5857546|NCT02417103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5857547|NCT02417207|Entecavir|entecavir|mesh-list
5857548|NCT02417207|Antiviral Agents|antiviral agents|mesh-ancestor
5857549|NCT02417207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5857550|NCT02416999|Bevacizumab|bevacizumab|mesh-list
5857551|NCT02416999|Temozolomide|temozolomide|mesh-list
5857552|NCT02416999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5857553|NCT02416999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5857554|NCT02416999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5857555|NCT02416999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5857556|NCT02416999|Growth Substances|growth substances|mesh-ancestor
5857557|NCT02416999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857558|NCT02416999|Growth Inhibitors|growth inhibitors|mesh-ancestor
5857559|NCT02416999|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5857560|NCT02416999|Alkylating Agents|alkylating agents|mesh-ancestor
5857561|NCT02416999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5857562|NCT02417337|Acetaminophen|acetaminophen|mesh-list
5857563|NCT02417337|Ibuprofen|ibuprofen|mesh-list
5857564|NCT02417337|Diclofenac|diclofenac|mesh-list
5857565|NCT02417337|Mefenamic Acid|mefenamic acid|mesh-list
5857566|NCT02417337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5857567|NCT02417337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5857568|NCT02417337|Analgesics|analgesics|mesh-ancestor
5857569|NCT02417337|Sensory System Agents|sensory system agents|mesh-ancestor
5857570|NCT02417337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5857571|NCT02417337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857572|NCT02417337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5857573|NCT02417337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5857574|NCT02417337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5857575|NCT02417337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5857576|NCT02417337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5857577|NCT02417337|Antipyretics|antipyretics|mesh-ancestor
5857578|NCT02416817|Thrombin|thrombin|mesh-list
5857579|NCT02416817|Hemostatics|hemostatics|mesh-ancestor
5857580|NCT02416817|Coagulants|coagulants|mesh-ancestor
5857581|NCT02416674|Immunosuppressive Agents|immunosuppressive agents|mesh-list
5857582|NCT02416674|Immunologic Factors|immunologic factors|mesh-ancestor
5857583|NCT02416674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857584|NCT02416752|Remifentanil|remifentanil|mesh-list
5857585|NCT02416752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5857586|NCT02416752|Narcotics|narcotics|mesh-ancestor
5857587|NCT02416752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5857588|NCT02416752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857589|NCT02416752|Analgesics|analgesics|mesh-ancestor
5857590|NCT02416752|Sensory System Agents|sensory system agents|mesh-ancestor
5857591|NCT02416752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5673316|NCT03549728|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5673317|NCT03549728|Immunologic Factors|immunologic factors|mesh-ancestor
5673318|NCT03549728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673319|NCT03549702|Povidone-Iodine|povidone-iodine|mesh-list
5673320|NCT03549702|Povidone|povidone|mesh-list
5673321|NCT03549702|Plasma Substitutes|plasma substitutes|mesh-ancestor
5673322|NCT03549702|Blood Substitutes|blood substitutes|mesh-ancestor
5673323|NCT03549702|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5673324|NCT03549702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5673325|NCT03549689|Tenofovir|tenofovir|mesh-list
5857592|NCT02416765|Glucagon|glucagon|mesh-list
5857593|NCT02416765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857594|NCT02416765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5857595|NCT02416765|Hormones|hormones|mesh-ancestor
5857596|NCT02416765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5857597|NCT02416804|Buprenorphine|buprenorphine|mesh-list
5857598|NCT02416804|Tramadol|tramadol|mesh-list
6212251|NCT02184195|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5673326|NCT03549689|Lamivudine|lamivudine|mesh-list
5857599|NCT02416804|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5857600|NCT02416804|Narcotics|narcotics|mesh-ancestor
5673327|NCT03549689|Dolutegravir|dolutegravir|mesh-list
5673328|NCT03549689|Antiviral Agents|antiviral agents|mesh-ancestor
5673329|NCT03549689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5673330|NCT03549689|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5673331|NCT03549689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5673332|NCT03549689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5673333|NCT03549689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673334|NCT03549689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5673335|NCT03549689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5673336|NCT03549689|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5673337|NCT03549689|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5673338|NCT03549663|Prednisone|prednisone|mesh-list
5673339|NCT03549663|Glucocorticoids|glucocorticoids|mesh-list
5857601|NCT02416804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5857602|NCT02416804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857603|NCT02416804|Analgesics|analgesics|mesh-ancestor
5857604|NCT02416804|Sensory System Agents|sensory system agents|mesh-ancestor
5857605|NCT02416804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5857606|NCT02416804|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5857607|NCT02416687|Etonogestrel|etonogestrel|mesh-list
5857608|NCT02416687|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5857609|NCT02416687|Contraceptive Agents|contraceptive agents|mesh-ancestor
5857610|NCT02416687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5857611|NCT02416687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857612|NCT02416687|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5904385|NCT05132829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904386|NCT05132777|Osimertinib|osimertinib|mesh-list
5904387|NCT05132777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5904388|NCT05132777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5904389|NCT05132777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5904390|NCT05132777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904391|NCT05132712|Losartan|losartan|mesh-list
5904392|NCT05132712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5904393|NCT05132712|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5904394|NCT05132712|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5904395|NCT05132712|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5904396|NCT05132712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904400|NCT05132595|Ketorolac|ketorolac|mesh-list
5904401|NCT05132595|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
5904402|NCT05132595|Esketamine|esketamine|mesh-list
5904403|NCT05132595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5904404|NCT05132595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5904405|NCT05132595|Analgesics|analgesics|mesh-ancestor
5904406|NCT05132595|Sensory System Agents|sensory system agents|mesh-ancestor
5904407|NCT05132595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5904408|NCT05132595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904409|NCT05132595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5904410|NCT05132595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5904411|NCT05132595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5904412|NCT05132595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5904413|NCT05132595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904414|NCT05132595|Antidepressive Agents|antidepressive agents|mesh-ancestor
5904415|NCT05132595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5904416|NCT05132504|Pembrolizumab|pembrolizumab|mesh-list
5904417|NCT05132504|Folfirinox|folfirinox|mesh-list
5904418|NCT05132504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5904419|NCT05132504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5673340|NCT03549663|Tacrolimus|tacrolimus|mesh-list
5673341|NCT03549663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5673342|NCT03549663|Hormones|hormones|mesh-ancestor
5673343|NCT03549663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5673344|NCT03549663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673345|NCT03549663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5673346|NCT03549663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5673347|NCT03549663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5673348|NCT03549663|Immunologic Factors|immunologic factors|mesh-ancestor
5673349|NCT03549663|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5673350|NCT03549663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5673351|NCT03549663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673352|NCT03549650|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
5673353|NCT03549650|Anticoagulants|anticoagulants|mesh-ancestor
5673354|NCT03549611|Acetaminophen|acetaminophen|mesh-list
5673355|NCT03549611|Celecoxib|celecoxib|mesh-list
5673356|NCT03549611|Oxycodone|oxycodone|mesh-list
5673357|NCT03549611|Gabapentin|gabapentin|mesh-list
5673358|NCT03549611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5673359|NCT03549611|Analgesics|analgesics|mesh-ancestor
5673360|NCT03549611|Sensory System Agents|sensory system agents|mesh-ancestor
5673361|NCT03549611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5673362|NCT03549611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673363|NCT03549611|Antipyretics|antipyretics|mesh-ancestor
5673364|NCT03549611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5673365|NCT03549611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5673366|NCT03549611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5673367|NCT03549611|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5673368|NCT03549611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5673369|NCT03549611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5673370|NCT03549611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673371|NCT03549611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5673372|NCT03549611|Narcotics|narcotics|mesh-ancestor
5673373|NCT03549611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5673374|NCT03549611|Anticonvulsants|anticonvulsants|mesh-ancestor
5857613|NCT02416869|Dexamethasone|dexamethasone|mesh-list
5857614|NCT02416869|Dexamethasone acetate|dexamethasone acetate|mesh-list
5857615|NCT02416869|BB 1101|bb 1101|mesh-list
5857616|NCT02416869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5857617|NCT02416869|Antiemetics|antiemetics|mesh-ancestor
5857618|NCT02416869|Autonomic Agents|autonomic agents|mesh-ancestor
5857619|NCT02416869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5857620|NCT02416869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857621|NCT02416869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5857622|NCT02416869|Glucocorticoids|glucocorticoids|mesh-ancestor
5857623|NCT02416869|Hormones|hormones|mesh-ancestor
5857624|NCT02416869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5857625|NCT02416869|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5857626|NCT02416869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5857627|NCT02416869|Protease Inhibitors|protease inhibitors|mesh-ancestor
5857628|NCT02416869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5857629|NCT02416869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5857630|NCT02416739|Niacinamide|niacinamide|mesh-list
5857631|NCT02416739|Niacin|niacin|mesh-list
5857632|NCT02416739|Nicotinic Acids|nicotinic acids|mesh-list
5857633|NCT02416739|Vitamin B Complex|vitamin b complex|mesh-ancestor
5857634|NCT02416739|Vitamins|vitamins|mesh-ancestor
5857635|NCT02416739|Micronutrients|micronutrients|mesh-ancestor
5857636|NCT02416739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857637|NCT02416739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5857638|NCT02416739|Antimetabolites|antimetabolites|mesh-ancestor
5857639|NCT02416739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5857640|NCT02416739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5857641|NCT02416739|Vasodilator Agents|vasodilator agents|mesh-ancestor
5857642|NCT02416583|Oxytocin|oxytocin|mesh-list
5857643|NCT02416583|Dinoprostone|dinoprostone|mesh-list
5857644|NCT02416583|Oxytocics|oxytocics|mesh-ancestor
5857645|NCT02416583|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5857646|NCT02416583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857647|NCT02416427|Atorvastatin|atorvastatin|mesh-list
5857648|NCT02416427|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5857649|NCT02416427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5857650|NCT02416427|Antimetabolites|antimetabolites|mesh-ancestor
5857651|NCT02416427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5857652|NCT02416427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5857653|NCT02416427|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5857654|NCT02416427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5857655|NCT02416388|Cytarabine|cytarabine|mesh-list
5857656|NCT02416388|Cyclosporine|cyclosporine|mesh-list
5857657|NCT02416388|Mycophenolic Acid|mycophenolic acid|mesh-list
5857658|NCT02416388|Dexamethasone|dexamethasone|mesh-list
5857659|NCT02416388|Methotrexate|methotrexate|mesh-list
5857660|NCT02416388|Daunorubicin|daunorubicin|mesh-list
5857661|NCT02416388|Venetoclax|venetoclax|mesh-list
5857662|NCT02416388|Idarubicin|idarubicin|mesh-list
5857663|NCT02416388|Cyclosporins|cyclosporins|mesh-list
5857664|NCT02416388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5673375|NCT03549611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5673376|NCT03549611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5673377|NCT03549611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5857665|NCT02416388|Antiemetics|antiemetics|mesh-ancestor
5857666|NCT02416388|Autonomic Agents|autonomic agents|mesh-ancestor
5857667|NCT02416388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5857668|NCT02416388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673378|NCT03549611|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5673379|NCT03549611|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5673380|NCT03549611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5673381|NCT03549611|Antimanic Agents|antimanic agents|mesh-ancestor
5673382|NCT03549312|Tenofovir|tenofovir|mesh-list
5673383|NCT03549312|Emtricitabine|emtricitabine|mesh-list
5673384|NCT03549312|Sofosbuvir|sofosbuvir|mesh-list
5673385|NCT03549312|Cobicistat|cobicistat|mesh-list
5673386|NCT03549312|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
5673387|NCT03549312|Velpatasvir|velpatasvir|mesh-list
5673388|NCT03549312|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
5673389|NCT03549312|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5673390|NCT03549312|Elvitegravir|elvitegravir|mesh-list
5857669|NCT02416388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5857670|NCT02416388|Glucocorticoids|glucocorticoids|mesh-ancestor
5857671|NCT02416388|Hormones|hormones|mesh-ancestor
5857672|NCT02416388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5857673|NCT02416388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5857674|NCT02416388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5857675|NCT02416388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5857676|NCT02416388|Abortifacient Agents|abortifacient agents|mesh-ancestor
5857677|NCT02416388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5857678|NCT02416388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5857679|NCT02416388|Antimetabolites|antimetabolites|mesh-ancestor
5857680|NCT02416388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5857681|NCT02416388|Dermatologic Agents|dermatologic agents|mesh-ancestor
5857682|NCT02416388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5857683|NCT02416388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5857684|NCT02416388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5857685|NCT02416388|Immunologic Factors|immunologic factors|mesh-ancestor
5857686|NCT02416388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5857687|NCT02416388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5857688|NCT02416388|Antiviral Agents|antiviral agents|mesh-ancestor
5857689|NCT02416388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5857690|NCT02416388|Antifungal Agents|antifungal agents|mesh-ancestor
5857691|NCT02416388|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5857692|NCT02416388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5857693|NCT02416388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5857694|NCT02416388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5857695|NCT02416388|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5857696|NCT02416388|Antitubercular Agents|antitubercular agents|mesh-ancestor
5857697|NCT02416388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5857698|NCT02416232|Trametinib|trametinib|mesh-list
5857699|NCT02416232|Dabrafenib|dabrafenib|mesh-list
5857700|NCT02416232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5857701|NCT02416232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5857702|NCT02416232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5857703|NCT02416232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5857704|NCT02416271|Vitamin D|vitamin d|mesh-list
5857705|NCT02416271|Alendronate|alendronate|mesh-list
5857706|NCT02416271|Teriparatide|teriparatide|mesh-list
5857707|NCT02416271|Calcium|calcium|mesh-list
5857708|NCT02416271|Vitamins|vitamins|mesh-ancestor
5857709|NCT02416271|Micronutrients|micronutrients|mesh-ancestor
5857710|NCT02416271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857711|NCT02416271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5857712|NCT02416271|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5857713|NCT02416531|Clobetasol|clobetasol|mesh-list
5857714|NCT02416531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5857715|NCT02416531|Glucocorticoids|glucocorticoids|mesh-ancestor
5857716|NCT02416531|Hormones|hormones|mesh-ancestor
5673391|NCT03549312|Antiviral Agents|antiviral agents|mesh-ancestor
5673392|NCT03549312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5673393|NCT03549312|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5673394|NCT03549312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5673395|NCT03549312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5673396|NCT03549312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673397|NCT03549312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5673398|NCT03549312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5673399|NCT03549312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5673400|NCT03549312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5673401|NCT03549312|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5673402|NCT03549221|Ketorolac|ketorolac|mesh-list
5857717|NCT02416531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5857718|NCT02416531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857719|NCT02416258|Betamethasone|betamethasone|mesh-list
5857720|NCT02416258|Betamethasone Valerate|betamethasone valerate|mesh-list
5857721|NCT02416258|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5857722|NCT02416258|Betamethasone benzoate|betamethasone benzoate|mesh-list
5857723|NCT02416258|Calcipotriene|calcipotriene|mesh-list
5857724|NCT02416258|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
5857725|NCT02416258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5857726|NCT02416258|Glucocorticoids|glucocorticoids|mesh-ancestor
5857727|NCT02416258|Hormones|hormones|mesh-ancestor
5857728|NCT02416258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5857729|NCT02416258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857730|NCT02416258|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5673403|NCT03549221|Epinephrine|epinephrine|mesh-list
5673404|NCT03549221|Levobupivacaine|levobupivacaine|mesh-list
5673405|NCT03549221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5673406|NCT03549221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5673407|NCT03549221|Adrenergic Agents|adrenergic agents|mesh-ancestor
5673408|NCT03549221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5673409|NCT03549221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673410|NCT03549221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673411|NCT03549221|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5673412|NCT03549221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5673413|NCT03549221|Autonomic Agents|autonomic agents|mesh-ancestor
5673414|NCT03549221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5673415|NCT03549221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5673416|NCT03549221|Respiratory System Agents|respiratory system agents|mesh-ancestor
5673417|NCT03549221|Mydriatics|mydriatics|mesh-ancestor
5857731|NCT02416258|Respiratory System Agents|respiratory system agents|mesh-ancestor
5857732|NCT02416258|Dermatologic Agents|dermatologic agents|mesh-ancestor
5857733|NCT02416245|Micronutrients|micronutrients|mesh-list
5857734|NCT02416245|Trace Elements|trace elements|mesh-list
5857735|NCT02416245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857736|NCT02416570|Clarithromycin|clarithromycin|mesh-list
5857737|NCT02416570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5857738|NCT02416570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5673418|NCT03549221|Sympathomimetics|sympathomimetics|mesh-ancestor
5673419|NCT03549221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5673420|NCT03549221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5673421|NCT03549221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5673422|NCT03549221|Analgesics|analgesics|mesh-ancestor
5673423|NCT03549221|Sensory System Agents|sensory system agents|mesh-ancestor
5673424|NCT03549221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5673425|NCT03549221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5673426|NCT03549221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5673427|NCT03549221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5673428|NCT03549221|Anesthetics, Local|anesthetics, local|mesh-ancestor
5673429|NCT03549221|Anesthetics|anesthetics|mesh-ancestor
5673430|NCT03549221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5857739|NCT02416570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5857740|NCT02416570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5857741|NCT02416570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5857742|NCT02416570|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5857743|NCT02416570|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5857744|NCT02416141|Tramadol|tramadol|mesh-list
5857745|NCT02416141|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5857746|NCT02416141|Narcotics|narcotics|mesh-ancestor
5857747|NCT02416141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5857748|NCT02416141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857749|NCT02416141|Analgesics|analgesics|mesh-ancestor
5857750|NCT02416141|Sensory System Agents|sensory system agents|mesh-ancestor
5857751|NCT02416141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5857752|NCT02416167|Dotinurad|dotinurad|mesh-list
5857753|NCT02416167|Uricosuric Agents|uricosuric agents|mesh-ancestor
5857754|NCT02416167|Gout Suppressants|gout suppressants|mesh-ancestor
5857755|NCT02416167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5857756|NCT02416167|Renal Agents|renal agents|mesh-ancestor
5857757|NCT02416115|Morphine|morphine|mesh-list
5857758|NCT02416115|Ramosetron|ramosetron|mesh-list
5857759|NCT02416115|Naloxone|naloxone|mesh-list
5857760|NCT02416115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5857761|NCT02416115|Narcotics|narcotics|mesh-ancestor
5857762|NCT02416115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5673431|NCT03549208|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5673432|NCT03549208|Immunologic Factors|immunologic factors|mesh-ancestor
5857763|NCT02416115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857764|NCT02416115|Analgesics|analgesics|mesh-ancestor
5673433|NCT03549208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673434|NCT03549026|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5673435|NCT03549026|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5673436|NCT03549026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5673437|NCT03549026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5673438|NCT03549026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5857765|NCT02416115|Sensory System Agents|sensory system agents|mesh-ancestor
5857766|NCT02416115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5857767|NCT02416115|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5857768|NCT02416115|Antiemetics|antiemetics|mesh-ancestor
5857769|NCT02416115|Autonomic Agents|autonomic agents|mesh-ancestor
5673439|NCT03549026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5673440|NCT03549026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673441|NCT03549026|Analgesics|analgesics|mesh-ancestor
5673442|NCT03549026|Sensory System Agents|sensory system agents|mesh-ancestor
5673443|NCT03549026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5857770|NCT02416115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5857771|NCT02416115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5857772|NCT02416115|Serotonin Agents|serotonin agents|mesh-ancestor
5857773|NCT02416115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5857774|NCT02416115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5857775|NCT02416063|Dexmedetomidine|dexmedetomidine|mesh-list
5857776|NCT02416063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5857777|NCT02416063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5857778|NCT02416063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857779|NCT02416063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5857780|NCT02416063|Analgesics|analgesics|mesh-ancestor
5857781|NCT02416063|Sensory System Agents|sensory system agents|mesh-ancestor
5857782|NCT02416063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5857783|NCT02416063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5857784|NCT02416063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5857785|NCT02416063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5857786|NCT02416063|Adrenergic Agents|adrenergic agents|mesh-ancestor
5857787|NCT02416063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5857788|NCT02416063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5857789|NCT02416128|Prednisolone|prednisolone|mesh-list
5857790|NCT02416128|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5857791|NCT02416128|Methylprednisolone|methylprednisolone|mesh-list
5857792|NCT02416128|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5857793|NCT02416128|Prednisolone acetate|prednisolone acetate|mesh-list
5857794|NCT02416128|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5857795|NCT02416128|Prednisolone phosphate|prednisolone phosphate|mesh-list
5857796|NCT02416128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5857797|NCT02416128|Glucocorticoids|glucocorticoids|mesh-ancestor
5857798|NCT02416128|Hormones|hormones|mesh-ancestor
5857799|NCT02416128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5857800|NCT02416128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857801|NCT02416128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5857802|NCT02416128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5857803|NCT02416128|Antiemetics|antiemetics|mesh-ancestor
5857804|NCT02416128|Autonomic Agents|autonomic agents|mesh-ancestor
5673444|NCT03549026|Antidepressive Agents|antidepressive agents|mesh-ancestor
5673445|NCT03549026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5673446|NCT03549026|Dopamine Agents|dopamine agents|mesh-ancestor
5673447|NCT03548948|Iron|iron|mesh-list
5857805|NCT02416128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5857806|NCT02416128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5857807|NCT02416128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5857808|NCT02416128|Protective Agents|protective agents|mesh-ancestor
5857809|NCT02415985|Lopinavir|lopinavir|mesh-list
5857810|NCT02415985|Rifabutin|rifabutin|mesh-list
5857811|NCT02415985|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5857812|NCT02415985|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5857813|NCT02415985|Protease Inhibitors|protease inhibitors|mesh-ancestor
5857814|NCT02415985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5857815|NCT02415985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5857816|NCT02415985|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5857817|NCT02415985|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5857818|NCT02415985|Antiviral Agents|antiviral agents|mesh-ancestor
5857819|NCT02415985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5857820|NCT02415985|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5857821|NCT02415985|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5857822|NCT02415985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5857823|NCT02415985|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5857824|NCT02415985|Antitubercular Agents|antitubercular agents|mesh-ancestor
5857825|NCT02415920|Oxytocin|oxytocin|mesh-list
5857826|NCT02415920|Oxytocics|oxytocics|mesh-ancestor
5857827|NCT02415920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5857828|NCT02415920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857829|NCT02415829|Capecitabine|capecitabine|mesh-list
5857830|NCT02415829|Oxaliplatin|oxaliplatin|mesh-list
5857831|NCT02415829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5857832|NCT02415829|Antimetabolites|antimetabolites|mesh-ancestor
5857833|NCT02415829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5857834|NCT02415829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5857835|NCT02415881|Panitumumab|panitumumab|mesh-list
5857836|NCT02415881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5857837|NCT02415881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5857838|NCT02415712|Fomepizole|fomepizole|mesh-list
5857839|NCT02415712|Antidotes|antidotes|mesh-ancestor
5857840|NCT02415712|Protective Agents|protective agents|mesh-ancestor
5857841|NCT02415712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857842|NCT02415712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5857843|NCT02415712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5857844|NCT02415803|Clopidogrel|clopidogrel|mesh-list
5857845|NCT02415803|Ticagrelor|ticagrelor|mesh-list
5857846|NCT02415803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5857847|NCT02415803|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5857848|NCT02415803|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5857849|NCT02415803|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5857850|NCT02415803|Purinergic Agents|purinergic agents|mesh-ancestor
5857851|NCT02415803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5857852|NCT02415803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5857853|NCT02415803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857854|NCT02415777|Riboflavin|riboflavin|mesh-list
5857855|NCT02415777|Thiamine|thiamine|mesh-list
5857856|NCT02415777|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
5857857|NCT02415777|Vitamin B Complex|vitamin b complex|mesh-ancestor
5673448|NCT03548948|Trace Elements|trace elements|mesh-ancestor
5673449|NCT03548948|Micronutrients|micronutrients|mesh-ancestor
5673450|NCT03548948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673451|NCT03548818|Interferons|interferons|mesh-list
5673452|NCT03548818|Interferon-gamma|interferon-gamma|mesh-list
5673453|NCT03548818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5673454|NCT03548818|Antiviral Agents|antiviral agents|mesh-ancestor
5673455|NCT03548818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5673456|NCT03548805|Mitomycins|mitomycins|mesh-list
5673457|NCT03548805|Mitomycin|mitomycin|mesh-list
5673458|NCT03548805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5673459|NCT03548805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5673460|NCT03548805|Alkylating Agents|alkylating agents|mesh-ancestor
5673461|NCT03548805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673462|NCT03548805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5673463|NCT03548805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5673464|NCT03548714|Ethanol|ethanol|mesh-list
5673465|NCT03548714|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5673466|NCT03548714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5673467|NCT03548714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5673468|NCT03548714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673469|NCT03548662|Hyaluronic Acid|hyaluronic acid|mesh-list
5673470|NCT03548662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5673471|NCT03548662|Immunologic Factors|immunologic factors|mesh-ancestor
5673472|NCT03548662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673473|NCT03548662|Viscosupplements|viscosupplements|mesh-ancestor
5673474|NCT03548662|Protective Agents|protective agents|mesh-ancestor
5696213|NCT03384537|Chlorhexidine|chlorhexidine|mesh-list
5696214|NCT03384537|Listerine|listerine|mesh-list
5696215|NCT03384537|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5696216|NCT03384537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5696217|NCT03384537|Disinfectants|disinfectants|mesh-ancestor
5696218|NCT03384524|Metoprolol|metoprolol|mesh-list
5696219|NCT03384524|Bromocriptine|bromocriptine|mesh-list
5696220|NCT03384524|Tamsulosin|tamsulosin|mesh-list
5696221|NCT03384524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5857858|NCT02415777|Vitamins|vitamins|mesh-ancestor
5696222|NCT03384524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5696223|NCT03384524|Sympatholytics|sympatholytics|mesh-ancestor
5696224|NCT03384524|Autonomic Agents|autonomic agents|mesh-ancestor
5696225|NCT03384524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5857859|NCT02415777|Micronutrients|micronutrients|mesh-ancestor
5857860|NCT02415777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857861|NCT02415777|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5673475|NCT03548571|Temozolomide|temozolomide|mesh-list
5673476|NCT03548571|Vaccines|vaccines|mesh-list
5673477|NCT03548571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5673478|NCT03548571|Alkylating Agents|alkylating agents|mesh-ancestor
5673479|NCT03548571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673480|NCT03548571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5673481|NCT03548571|Immunologic Factors|immunologic factors|mesh-ancestor
5673482|NCT03548571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673483|NCT03548493|Magnesium Sulfate|magnesium sulfate|mesh-list
5673484|NCT03548493|Fentanyl|fentanyl|mesh-list
5673485|NCT03548493|Propofol|propofol|mesh-list
5673486|NCT03548493|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5673487|NCT03548493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5673488|NCT03548493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673489|NCT03548493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5673490|NCT03548493|Anesthetics, General|anesthetics, general|mesh-ancestor
5673491|NCT03548493|Anesthetics|anesthetics|mesh-ancestor
5673492|NCT03548493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5673493|NCT03548493|Narcotics|narcotics|mesh-ancestor
5673494|NCT03548493|Analgesics|analgesics|mesh-ancestor
5673495|NCT03548493|Sensory System Agents|sensory system agents|mesh-ancestor
5673496|NCT03548493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5673497|NCT03548493|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5673498|NCT03548493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5673499|NCT03548493|Anticonvulsants|anticonvulsants|mesh-ancestor
5673500|NCT03548493|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5673501|NCT03548493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5673502|NCT03548493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673503|NCT03548493|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5673504|NCT03548493|Tocolytic Agents|tocolytic agents|mesh-ancestor
5673505|NCT03548493|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5673506|NCT03548454|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5673507|NCT03548454|Desipramine|desipramine|mesh-list
5673508|NCT03548454|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5673509|NCT03548454|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5673510|NCT03548454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5673511|NCT03548454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673512|NCT03548454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5673513|NCT03548454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673514|NCT03548454|Analgesics|analgesics|mesh-ancestor
5673515|NCT03548454|Sensory System Agents|sensory system agents|mesh-ancestor
5673516|NCT03548454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5673517|NCT03548454|Antidepressive Agents|antidepressive agents|mesh-ancestor
5673518|NCT03548454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5673519|NCT03548454|Dopamine Agents|dopamine agents|mesh-ancestor
5673520|NCT03548454|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5673521|NCT03548454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5673522|NCT03548454|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5673523|NCT03548454|Adrenergic Agents|adrenergic agents|mesh-ancestor
5673524|NCT03548311|Vitamin B 12|vitamin b 12|mesh-list
5673525|NCT03548311|Vitamin B Complex|vitamin b complex|mesh-ancestor
5857862|NCT02415777|Dermatologic Agents|dermatologic agents|mesh-ancestor
5857863|NCT02415777|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5857864|NCT02415777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5857865|NCT02415569|Bisacodyl|bisacodyl|mesh-list
5857866|NCT02415569|Cathartics|cathartics|mesh-ancestor
5857867|NCT02415569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5857868|NCT02415569|Laxatives|laxatives|mesh-ancestor
5857869|NCT02415699|Leucovorin|leucovorin|mesh-list
5857870|NCT02415699|Fluorouracil|fluorouracil|mesh-list
5857871|NCT02415699|Oxaliplatin|oxaliplatin|mesh-list
5857872|NCT02415699|Antimetabolites|antimetabolites|mesh-ancestor
5857873|NCT02415699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5857874|NCT02415699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5857875|NCT02415699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5857876|NCT02415699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5857877|NCT02415699|Immunologic Factors|immunologic factors|mesh-ancestor
5857878|NCT02415699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857879|NCT02415699|Antidotes|antidotes|mesh-ancestor
5857880|NCT02415699|Protective Agents|protective agents|mesh-ancestor
5857881|NCT02415699|Vitamin B Complex|vitamin b complex|mesh-ancestor
5857882|NCT02415699|Vitamins|vitamins|mesh-ancestor
5857883|NCT02415699|Micronutrients|micronutrients|mesh-ancestor
5857884|NCT02415309|Melatonin|melatonin|mesh-list
5857885|NCT02415309|Antioxidants|antioxidants|mesh-ancestor
5857886|NCT02415309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5857887|NCT02415309|Protective Agents|protective agents|mesh-ancestor
6674926|NCT01572116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6674927|NCT01572116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674928|NCT01572116|Sensory System Agents|sensory system agents|mesh-ancestor
6674929|NCT01572116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6674930|NCT01572116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6674931|NCT01572116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6674932|NCT01572116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6674933|NCT01572116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6674934|NCT01572116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674935|NCT01572116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6674936|NCT01572116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6674937|NCT01572116|Adrenergic Agents|adrenergic agents|mesh-ancestor
6674938|NCT01572116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6674939|NCT01572116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6674940|NCT01572116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6674941|NCT01572116|Autonomic Agents|autonomic agents|mesh-ancestor
6674942|NCT01572116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5857888|NCT02415309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673526|NCT03548311|Vitamins|vitamins|mesh-ancestor
5673527|NCT03548311|Micronutrients|micronutrients|mesh-ancestor
5673528|NCT03548311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673529|NCT03548233|BCG Vaccine|bcg vaccine|mesh-list
5673530|NCT03548233|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5857889|NCT02415309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5857890|NCT02415192|Amlodipine|amlodipine|mesh-list
5857891|NCT02415192|Valsartan|valsartan|mesh-list
5857892|NCT02415192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5857893|NCT02415192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5857894|NCT02415192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5857895|NCT02415192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5857896|NCT02415192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5857897|NCT02415192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857898|NCT02415192|Vasodilator Agents|vasodilator agents|mesh-ancestor
5857899|NCT02415192|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5857900|NCT02415192|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5857901|NCT02415335|Dexamethasone|dexamethasone|mesh-list
5857902|NCT02415335|Dexamethasone acetate|dexamethasone acetate|mesh-list
5857903|NCT02415335|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
5857904|NCT02415335|BB 1101|bb 1101|mesh-list
5857905|NCT02415335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5857906|NCT02415335|Antiemetics|antiemetics|mesh-ancestor
5857907|NCT02415335|Autonomic Agents|autonomic agents|mesh-ancestor
5857908|NCT02415335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5857909|NCT02415335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857910|NCT02415335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5857911|NCT02415335|Glucocorticoids|glucocorticoids|mesh-ancestor
5857912|NCT02415335|Hormones|hormones|mesh-ancestor
5857913|NCT02415335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5857914|NCT02415335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5857915|NCT02415335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5857916|NCT02415335|Protease Inhibitors|protease inhibitors|mesh-ancestor
5857917|NCT02415335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5857918|NCT02415335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5857919|NCT02415413|Dexamethasone|dexamethasone|mesh-list
5857920|NCT02415413|Lenalidomide|lenalidomide|mesh-list
5857921|NCT02415413|Melphalan|melphalan|mesh-list
5857922|NCT02415413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5857923|NCT02415413|Antiemetics|antiemetics|mesh-ancestor
5857924|NCT02415413|Autonomic Agents|autonomic agents|mesh-ancestor
5857925|NCT02415413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5857926|NCT02415413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857927|NCT02415413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5857928|NCT02415413|Glucocorticoids|glucocorticoids|mesh-ancestor
5857929|NCT02415413|Hormones|hormones|mesh-ancestor
5857930|NCT02415413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5857931|NCT02415413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5857932|NCT02415413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5857933|NCT02415413|Immunologic Factors|immunologic factors|mesh-ancestor
5673531|NCT03548233|Immunologic Factors|immunologic factors|mesh-ancestor
5673532|NCT03548233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673533|NCT03548155|Antipsychotic Agents|antipsychotic agents|mesh-list
5857934|NCT02415413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5857935|NCT02415413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5857936|NCT02415413|Growth Substances|growth substances|mesh-ancestor
5857937|NCT02415413|Growth Inhibitors|growth inhibitors|mesh-ancestor
5857938|NCT02415413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5857939|NCT02415413|Alkylating Agents|alkylating agents|mesh-ancestor
5857940|NCT02415413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5857941|NCT02415413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5857942|NCT02415413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5857943|NCT02415270|Menthol|menthol|mesh-list
5857944|NCT02415270|Nicotine|nicotine|mesh-list
5857945|NCT02415270|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5857946|NCT02415270|Autonomic Agents|autonomic agents|mesh-ancestor
5857947|NCT02415270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5857948|NCT02415270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857949|NCT02415270|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5857950|NCT02415270|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5857951|NCT02415270|Cholinergic Agents|cholinergic agents|mesh-ancestor
5857952|NCT02415270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5857953|NCT02415270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5857954|NCT02415270|Antipruritics|antipruritics|mesh-ancestor
5857955|NCT02415270|Dermatologic Agents|dermatologic agents|mesh-ancestor
5857956|NCT02415257|Gentamicins|gentamicins|mesh-list
5857957|NCT02415257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5857958|NCT02415257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5857959|NCT02415257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5857960|NCT02415257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5857961|NCT02415257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5857962|NCT02415179|Fluticasone|fluticasone|mesh-list
5857963|NCT02415179|Mometasone Furoate|mometasone furoate|mesh-list
5857964|NCT02415179|Formoterol Fumarate|formoterol fumarate|mesh-list
5857965|NCT02415179|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5857966|NCT02415179|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
5857967|NCT02415179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5857968|NCT02415179|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5857969|NCT02415179|Autonomic Agents|autonomic agents|mesh-ancestor
5857970|NCT02415179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5857971|NCT02415179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857972|NCT02415179|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5857973|NCT02415179|Respiratory System Agents|respiratory system agents|mesh-ancestor
5857974|NCT02415179|Dermatologic Agents|dermatologic agents|mesh-ancestor
5857975|NCT02415179|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5857976|NCT02415179|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5857977|NCT02415179|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5857978|NCT02415179|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5857979|NCT02415179|Adrenergic Agents|adrenergic agents|mesh-ancestor
5857980|NCT02415179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5857981|NCT02415179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5857982|NCT02415179|Glucocorticoids|glucocorticoids|mesh-ancestor
5857983|NCT02415179|Hormones|hormones|mesh-ancestor
5857984|NCT02415179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5857985|NCT02415179|Sympathomimetics|sympathomimetics|mesh-ancestor
5857986|NCT02415114|Resveratrol|resveratrol|mesh-list
5857987|NCT02415114|Antioxidants|antioxidants|mesh-ancestor
5857988|NCT02415114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5857989|NCT02415114|Protective Agents|protective agents|mesh-ancestor
5857990|NCT02415114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857991|NCT02415114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5857992|NCT02415114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5857993|NCT02414919|Levonorgestrel|levonorgestrel|mesh-list
5857994|NCT02414919|Etonogestrel|etonogestrel|mesh-list
5857995|NCT02414919|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5857996|NCT02414919|Contraceptive Agents|contraceptive agents|mesh-ancestor
5857997|NCT02414919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5857998|NCT02414919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5857999|NCT02414919|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5858000|NCT02414919|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5858001|NCT02414919|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5858002|NCT02415023|Paclitaxel|paclitaxel|mesh-list
5858003|NCT02415023|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5858004|NCT02415023|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5858005|NCT02415023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5858006|NCT02415023|Tubulin Modulators|tubulin modulators|mesh-ancestor
5858007|NCT02415023|Antimitotic Agents|antimitotic agents|mesh-ancestor
5858008|NCT02415023|Mitosis Modulators|mitosis modulators|mesh-ancestor
5858009|NCT02415023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904420|NCT05132413|Bevacizumab|bevacizumab|mesh-list
5673534|NCT03548155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5673535|NCT03548155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5673536|NCT03548155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673537|NCT03548155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5673538|NCT03548129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5673539|NCT03548129|Fosfomycin|fosfomycin|mesh-list
5904421|NCT05132413|Cisplatin|cisplatin|mesh-list
5904422|NCT05132413|Carboplatin|carboplatin|mesh-list
5673540|NCT03548129|Anti-Infective Agents|anti-infective agents|mesh-list
5673541|NCT03547895|Vitamin K|vitamin k|mesh-list
5673542|NCT03547895|Vitamin K 1|vitamin k 1|mesh-list
5673543|NCT03547895|Ribavirin|ribavirin|mesh-list
5673544|NCT03547895|Sofosbuvir|sofosbuvir|mesh-list
5673545|NCT03547895|Furosemide|furosemide|mesh-list
5673546|NCT03547895|Spironolactone|spironolactone|mesh-list
5673547|NCT03547895|Silymarin|silymarin|mesh-list
5673548|NCT03547895|Vitamins|vitamins|mesh-ancestor
5673549|NCT03547895|Micronutrients|micronutrients|mesh-ancestor
5904423|NCT05132413|Pemetrexed|pemetrexed|mesh-list
5904424|NCT05132413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5904425|NCT05132413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5904426|NCT05132413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5904427|NCT05132413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5904428|NCT05132413|Growth Substances|growth substances|mesh-ancestor
5904429|NCT05132413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904430|NCT05132413|Growth Inhibitors|growth inhibitors|mesh-ancestor
5904431|NCT05132413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5904432|NCT05132413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904433|NCT05132413|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5673550|NCT03547895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673551|NCT03547895|Antimetabolites|antimetabolites|mesh-ancestor
5673552|NCT03547895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673553|NCT03547895|Antiviral Agents|antiviral agents|mesh-ancestor
5673554|NCT03547895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5673555|NCT03547895|Diuretics|diuretics|mesh-ancestor
5673556|NCT03547895|Natriuretic Agents|natriuretic agents|mesh-ancestor
5673557|NCT03547895|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5904434|NCT05132413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5904435|NCT05132270|Thalidomide|thalidomide|mesh-list
5904436|NCT05132270|Hydroxyurea|hydroxyurea|mesh-list
5904437|NCT05132270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5904438|NCT05132270|Immunologic Factors|immunologic factors|mesh-ancestor
5904439|NCT05132270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904440|NCT05132270|Leprostatic Agents|leprostatic agents|mesh-ancestor
5904441|NCT05132270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5904442|NCT05132270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5904443|NCT05132270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5904444|NCT05132270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5673558|NCT03547895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5673559|NCT03547895|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5673560|NCT03547895|Hormone Antagonists|hormone antagonists|mesh-ancestor
5673561|NCT03547895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5673562|NCT03547895|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5673563|NCT03547895|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5673564|NCT03547895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5673565|NCT03547895|Hemostatics|hemostatics|mesh-ancestor
5673566|NCT03547895|Coagulants|coagulants|mesh-ancestor
5904445|NCT05132270|Growth Substances|growth substances|mesh-ancestor
5904446|NCT05132270|Growth Inhibitors|growth inhibitors|mesh-ancestor
5673567|NCT03547895|Antioxidants|antioxidants|mesh-ancestor
5673568|NCT03547895|Protective Agents|protective agents|mesh-ancestor
5673569|NCT03547830|Plerixafor|plerixafor|mesh-list
5673570|NCT03547830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5904447|NCT05132270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5904448|NCT05132270|Antisickling Agents|antisickling agents|mesh-ancestor
5904449|NCT05132270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5904450|NCT05132270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904451|NCT05132270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5904452|NCT05132101|Palbociclib|palbociclib|mesh-list
5904453|NCT05132101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5908488|NCT04486352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5673571|NCT03547830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5673572|NCT03547830|Antiviral Agents|antiviral agents|mesh-ancestor
5673573|NCT03547830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5673574|NCT03547804|Apatinib|apatinib|mesh-list
5673575|NCT03547804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5673576|NCT03547804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5673577|NCT03547804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5673578|NCT03547804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5858010|NCT02414880|Rocuronium|rocuronium|mesh-list
5858011|NCT02414880|Neostigmine|neostigmine|mesh-list
5858012|NCT02414880|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5858013|NCT02414880|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5858014|NCT02414880|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5858015|NCT02414880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5673579|NCT03547791|Betamethasone|betamethasone|mesh-list
5673580|NCT03547791|Betamethasone Valerate|betamethasone valerate|mesh-list
5673581|NCT03547791|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5673582|NCT03547791|Betamethasone benzoate|betamethasone benzoate|mesh-list
5673583|NCT03547791|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
5673584|NCT03547791|Glucocorticoids|glucocorticoids|mesh-ancestor
5673585|NCT03547791|Hormones|hormones|mesh-ancestor
5673586|NCT03547791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5673587|NCT03547791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673588|NCT03547791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5673589|NCT03547791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5673590|NCT03547791|Respiratory System Agents|respiratory system agents|mesh-ancestor
5673591|NCT03547778|Misoprostol|misoprostol|mesh-list
5673592|NCT03547778|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5673593|NCT03547778|Abortifacient Agents|abortifacient agents|mesh-ancestor
5673594|NCT03547778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5673595|NCT03547778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673596|NCT03547778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5858016|NCT02414880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858017|NCT02414880|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5858018|NCT02414880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5858019|NCT02414880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5858020|NCT02414880|Cholinergic Agents|cholinergic agents|mesh-ancestor
5858021|NCT02414880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5858022|NCT02414880|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5858023|NCT02414880|Autonomic Agents|autonomic agents|mesh-ancestor
5858024|NCT02414984|Golimumab|golimumab|mesh-list
5858025|NCT02414984|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
5858026|NCT02414984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5858027|NCT02414984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5858028|NCT02414984|Immunologic Factors|immunologic factors|mesh-ancestor
5858029|NCT02414984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858030|NCT02414945|Cyclophosphamide|cyclophosphamide|mesh-list
5858031|NCT02414945|Fludarabine|fludarabine|mesh-list
5858032|NCT02414945|Interleukin-2|interleukin-2|mesh-list
5858033|NCT02414945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5673597|NCT03547778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5673598|NCT03547778|Oxytocics|oxytocics|mesh-ancestor
5673599|NCT03547700|Ixazomib|ixazomib|mesh-list
5673600|NCT03547700|Romidepsin|romidepsin|mesh-list
5673601|NCT03547700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5673602|NCT03547700|Protease Inhibitors|protease inhibitors|mesh-ancestor
5673603|NCT03547700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5673604|NCT03547700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673605|NCT03547700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5673606|NCT03547622|Galantamine|galantamine|mesh-list
5673607|NCT03547622|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5673608|NCT03547622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5673609|NCT03547622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673610|NCT03547622|Cholinergic Agents|cholinergic agents|mesh-ancestor
5673611|NCT03547622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5673612|NCT03547622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673613|NCT03547622|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5673614|NCT03547622|Autonomic Agents|autonomic agents|mesh-ancestor
5673615|NCT03547622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5673616|NCT03547622|Nootropic Agents|nootropic agents|mesh-ancestor
5858034|NCT02414945|Immunologic Factors|immunologic factors|mesh-ancestor
5858035|NCT02414945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858036|NCT02414945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5858037|NCT02414945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5858038|NCT02414945|Alkylating Agents|alkylating agents|mesh-ancestor
5858039|NCT02414945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5858040|NCT02414945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5858041|NCT02414945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5673617|NCT03547505|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
5858042|NCT02414945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5858043|NCT02414945|Analgesics|analgesics|mesh-ancestor
5858044|NCT02414945|Sensory System Agents|sensory system agents|mesh-ancestor
5858045|NCT02414945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5858046|NCT02415062|Donepezil|donepezil|mesh-list
5858047|NCT02415062|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5858048|NCT02415062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5858049|NCT02415062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5858050|NCT02415062|Cholinergic Agents|cholinergic agents|mesh-ancestor
6494509|NCT00618657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6494510|NCT00618657|Tubulin Modulators|tubulin modulators|mesh-ancestor
6494511|NCT00618657|Antimitotic Agents|antimitotic agents|mesh-ancestor
5673618|NCT03547505|Vasodilator Agents|vasodilator agents|mesh-ancestor
5673619|NCT03547505|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
5673620|NCT03547505|Protective Agents|protective agents|mesh-ancestor
5673621|NCT03547505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494512|NCT00618657|Mitosis Modulators|mitosis modulators|mesh-ancestor
5858051|NCT02415062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5858052|NCT02415062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858053|NCT02415062|Nootropic Agents|nootropic agents|mesh-ancestor
5858054|NCT02415036|Melphalan|melphalan|mesh-list
5858055|NCT02415036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5858056|NCT02415036|Alkylating Agents|alkylating agents|mesh-ancestor
5673622|NCT03547427|Acetaminophen|acetaminophen|mesh-list
5673623|NCT03547427|Insulin|insulin|mesh-list
5673624|NCT03547427|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5673625|NCT03547427|Pramlintide|pramlintide|mesh-list
5673626|NCT03547427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5673627|NCT03547427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673628|NCT03547427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5673629|NCT03547427|Analgesics|analgesics|mesh-ancestor
5673630|NCT03547427|Sensory System Agents|sensory system agents|mesh-ancestor
5673631|NCT03547427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5673632|NCT03547427|Antipyretics|antipyretics|mesh-ancestor
5673633|NCT03547375|Apatinib|apatinib|mesh-list
5673634|NCT03547375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5673635|NCT03547375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5673636|NCT03547375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5673637|NCT03547375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673638|NCT03547362|Caseins|caseins|mesh-list
5673639|NCT03547362|Chelating Agents|chelating agents|mesh-ancestor
5673640|NCT03547362|Sequestering Agents|sequestering agents|mesh-ancestor
5673641|NCT03547362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5858057|NCT02415036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5858058|NCT02415036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5858059|NCT02415036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5673642|NCT03547232|Indomethacin|indomethacin|mesh-list
5673643|NCT03547232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5673644|NCT03547232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5673645|NCT03547232|Analgesics|analgesics|mesh-ancestor
5673646|NCT03547232|Sensory System Agents|sensory system agents|mesh-ancestor
5673647|NCT03547232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5673648|NCT03547232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673649|NCT03547232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5673650|NCT03547232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5673651|NCT03547232|Gout Suppressants|gout suppressants|mesh-ancestor
5673652|NCT03547232|Tocolytic Agents|tocolytic agents|mesh-ancestor
5673653|NCT03547232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5673654|NCT03547232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5673655|NCT03547232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5673656|NCT03547232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673657|NCT03547219|Citalopram|citalopram|mesh-list
5858060|NCT02415036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5858061|NCT02415036|Immunologic Factors|immunologic factors|mesh-ancestor
5858062|NCT02415036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858063|NCT02414802|Calcium, Dietary|calcium, dietary|mesh-list
5858064|NCT02414802|Heparin|heparin|mesh-list
5858065|NCT02414802|Calcium heparin|calcium heparin|mesh-list
5858066|NCT02414802|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5858067|NCT02414802|Tinzaparin|tinzaparin|mesh-list
5858068|NCT02414802|Dalteparin|dalteparin|mesh-list
5858069|NCT02414802|Calcium|calcium|mesh-list
6496466|NCT00628160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5673658|NCT03547219|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5673659|NCT03547219|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5858070|NCT02414802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5673660|NCT03547219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5673661|NCT03547219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673662|NCT03547219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5673663|NCT03547219|Serotonin Agents|serotonin agents|mesh-ancestor
5858071|NCT02414802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858072|NCT02414802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5858073|NCT02414802|Anticoagulants|anticoagulants|mesh-ancestor
5858074|NCT02414802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5858075|NCT02414802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5858076|NCT02414802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5858077|NCT02414750|Vemurafenib|vemurafenib|mesh-list
5858078|NCT02414750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5858079|NCT02414750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5858080|NCT02414750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5858081|NCT02414750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5858082|NCT02414503|Oxytocin|oxytocin|mesh-list
5858083|NCT02414503|Oxytocics|oxytocics|mesh-ancestor
5858084|NCT02414503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5858085|NCT02414503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858086|NCT02414555|Phenylephrine|phenylephrine|mesh-list
5858087|NCT02414555|Norepinephrine|norepinephrine|mesh-list
5858088|NCT02414555|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
5858089|NCT02414555|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5858090|NCT02414555|Mydriatics|mydriatics|mesh-ancestor
5858091|NCT02414555|Autonomic Agents|autonomic agents|mesh-ancestor
5858092|NCT02414555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5858093|NCT02414555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858094|NCT02414555|Sympathomimetics|sympathomimetics|mesh-ancestor
5858095|NCT02414555|Nasal Decongestants|nasal decongestants|mesh-ancestor
5858096|NCT02414555|Respiratory System Agents|respiratory system agents|mesh-ancestor
5858097|NCT02414555|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5858098|NCT02414555|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5858099|NCT02414555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5858100|NCT02414555|Adrenergic Agents|adrenergic agents|mesh-ancestor
5858101|NCT02414555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5858102|NCT02414555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5858103|NCT02414555|Protective Agents|protective agents|mesh-ancestor
5858104|NCT02414568|Prednisone|prednisone|mesh-list
5858105|NCT02414568|Doxorubicin|doxorubicin|mesh-list
5858106|NCT02414568|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5858107|NCT02414568|Vinblastine|vinblastine|mesh-list
5858108|NCT02414568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5858109|NCT02414568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5858110|NCT02414568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5858111|NCT02414568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5858112|NCT02414568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5858113|NCT02414568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5858114|NCT02414568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5858115|NCT02414568|Glucocorticoids|glucocorticoids|mesh-ancestor
5858116|NCT02414568|Hormones|hormones|mesh-ancestor
5858117|NCT02414568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5858118|NCT02414568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858119|NCT02414568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5858120|NCT02414568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5673664|NCT03547219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673665|NCT03547219|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5673666|NCT03547219|Antidepressive Agents|antidepressive agents|mesh-ancestor
5673667|NCT03547219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5673668|NCT03547024|Midazolam|midazolam|mesh-list
5673669|NCT03547024|Dextromethorphan|dextromethorphan|mesh-list
5673670|NCT03547024|Omeprazole|omeprazole|mesh-list
5673671|NCT03547024|Levonorgestrel|levonorgestrel|mesh-list
5673672|NCT03547024|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5673673|NCT03547024|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
5673674|NCT03547024|JNJ-55308942|jnj-55308942|mesh-list
5673675|NCT03547024|Estradiol|estradiol|mesh-list
5673676|NCT03547024|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5673677|NCT03547024|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5673678|NCT03547024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5673679|NCT03547024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673680|NCT03547024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5673681|NCT03547024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5673682|NCT03547024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5673683|NCT03547024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5858121|NCT02414568|Alkylating Agents|alkylating agents|mesh-ancestor
5858122|NCT02414568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5858123|NCT02414568|Tubulin Modulators|tubulin modulators|mesh-ancestor
5858124|NCT02414568|Antimitotic Agents|antimitotic agents|mesh-ancestor
5858125|NCT02414568|Mitosis Modulators|mitosis modulators|mesh-ancestor
5858126|NCT02414776|Hydroxychloroquine|hydroxychloroquine|mesh-list
5858127|NCT02414776|Antimalarials|antimalarials|mesh-ancestor
5858128|NCT02414776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5858129|NCT02414776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5858130|NCT02414776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5858131|NCT02414776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5858132|NCT02414776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5858133|NCT02414776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5858134|NCT02414581|Ethanol|ethanol|mesh-list
5858135|NCT02414581|Chlorhexidine|chlorhexidine|mesh-list
5858136|NCT02414581|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5858137|NCT02414581|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5858138|NCT02414581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5858139|NCT02414581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5858140|NCT02414581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858141|NCT02414581|Disinfectants|disinfectants|mesh-ancestor
5858142|NCT02414581|Dermatologic Agents|dermatologic agents|mesh-ancestor
5858143|NCT02414529|Vitamin D|vitamin d|mesh-list
5858144|NCT02414529|Ergocalciferols|ergocalciferols|mesh-list
5858145|NCT02414529|Vitamins|vitamins|mesh-list
5858146|NCT02414529|Micronutrients|micronutrients|mesh-ancestor
5858147|NCT02414529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858148|NCT02414529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5858149|NCT02414529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5673684|NCT03547024|Anesthetics, General|anesthetics, general|mesh-ancestor
5673685|NCT03547024|Anesthetics|anesthetics|mesh-ancestor
5673686|NCT03547024|GABA Modulators|gaba modulators|mesh-ancestor
5673687|NCT03547024|GABA Agents|gaba agents|mesh-ancestor
5673688|NCT03547024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5673689|NCT03547024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673690|NCT03547024|Estrogens|estrogens|mesh-ancestor
5673691|NCT03547024|Hormones|hormones|mesh-ancestor
5673692|NCT03547024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5673693|NCT03547024|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5673694|NCT03547024|Contraceptive Agents|contraceptive agents|mesh-ancestor
5673695|NCT03547024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5673696|NCT03547024|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5673697|NCT03547024|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5673698|NCT03547024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5673699|NCT03547024|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5673700|NCT03547024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5673701|NCT03547024|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5673702|NCT03547024|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5673703|NCT03547024|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5673704|NCT03547024|Antitussive Agents|antitussive agents|mesh-ancestor
5673705|NCT03547024|Respiratory System Agents|respiratory system agents|mesh-ancestor
5673706|NCT03547024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5673707|NCT03547024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5673708|NCT03547024|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5673709|NCT03547024|Purinergic P2X Receptor Antagonists|purinergic p2x receptor antagonists|mesh-ancestor
5673710|NCT03547024|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5858150|NCT02414490|Immunoglobulins|immunoglobulins|mesh-list
5858151|NCT02414490|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5858152|NCT02414490|Antibodies|antibodies|mesh-list
5858153|NCT02414490|gamma-Globulins|gamma-globulins|mesh-list
5858154|NCT02414490|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5858155|NCT02414490|Immunologic Factors|immunologic factors|mesh-ancestor
5858156|NCT02414490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858157|NCT02414685|Paclitaxel|paclitaxel|mesh-list
5858158|NCT02414685|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5858159|NCT02414685|Cisplatin|cisplatin|mesh-list
5858160|NCT02414685|Ifosfamide|ifosfamide|mesh-list
5673711|NCT03547024|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5673712|NCT03547024|Purinergic Agents|purinergic agents|mesh-ancestor
5673713|NCT03546959|Botulinum Toxins|botulinum toxins|mesh-list
5673714|NCT03546959|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5673715|NCT03546959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5858161|NCT02414685|Isophosphamide mustard|isophosphamide mustard|mesh-list
5858162|NCT02414685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5858163|NCT02414685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5858164|NCT02414685|Tubulin Modulators|tubulin modulators|mesh-ancestor
5858165|NCT02414685|Antimitotic Agents|antimitotic agents|mesh-ancestor
5858166|NCT02414685|Mitosis Modulators|mitosis modulators|mesh-ancestor
5858167|NCT02414685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5858168|NCT02414685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5858169|NCT02414685|Alkylating Agents|alkylating agents|mesh-ancestor
5858170|NCT02414724|Gemcitabine|gemcitabine|mesh-list
5858171|NCT02414724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5858172|NCT02414724|Antimetabolites|antimetabolites|mesh-ancestor
5858173|NCT02414724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5858174|NCT02414724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5858175|NCT02414724|Antiviral Agents|antiviral agents|mesh-ancestor
5858176|NCT02414724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5858177|NCT02414724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5858178|NCT02414724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5858179|NCT02414724|Immunologic Factors|immunologic factors|mesh-ancestor
5858180|NCT02414724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858181|NCT02414451|Propranolol|propranolol|mesh-list
5858182|NCT02414451|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5858183|NCT02414451|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5858184|NCT02414451|Adrenergic Agents|adrenergic agents|mesh-ancestor
5858185|NCT02414451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5858186|NCT02414451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5858187|NCT02414451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858188|NCT02414451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5858189|NCT02414451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5858190|NCT02414451|Vasodilator Agents|vasodilator agents|mesh-ancestor
5858191|NCT02414425|Botulinum Toxins|botulinum toxins|mesh-list
5858192|NCT02414425|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5858193|NCT02414425|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5858194|NCT02414425|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5858195|NCT02414425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5858196|NCT02414425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5858197|NCT02414425|Cholinergic Agents|cholinergic agents|mesh-ancestor
5858198|NCT02414425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5858199|NCT02414425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858200|NCT02414425|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5858201|NCT02414425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5858202|NCT02414464|Calcium, Dietary|calcium, dietary|mesh-list
5858203|NCT02414464|Hydrogen Peroxide|hydrogen peroxide|mesh-list
5858204|NCT02414464|Calcium|calcium|mesh-list
5858205|NCT02414464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5858206|NCT02414464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858207|NCT02414464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5858208|NCT02414464|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5858209|NCT02414464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5858210|NCT02414399|Azithromycin|azithromycin|mesh-list
5858211|NCT02414399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5858212|NCT02414399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5858213|NCT02414256|Anesthetics|anesthetics|mesh-list
5858214|NCT02414256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5858215|NCT02414256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673716|NCT03546959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673717|NCT03546959|Cholinergic Agents|cholinergic agents|mesh-ancestor
5673718|NCT03546959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5673719|NCT03546959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696226|NCT03384524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696227|NCT03384524|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5696228|NCT03384524|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5696229|NCT03384524|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5696230|NCT03384524|Adrenergic Agents|adrenergic agents|mesh-ancestor
5696231|NCT03384524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5696232|NCT03384524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696233|NCT03384524|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5696234|NCT03384524|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5696235|NCT03384524|Urological Agents|urological agents|mesh-ancestor
5696236|NCT03384524|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5696237|NCT03384524|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5696238|NCT03384524|Hormone Antagonists|hormone antagonists|mesh-ancestor
5696239|NCT03384524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5696240|NCT03384524|Dopamine Agonists|dopamine agonists|mesh-ancestor
5696241|NCT03384524|Dopamine Agents|dopamine agents|mesh-ancestor
5696242|NCT03384511|Apatinib|apatinib|mesh-list
5858216|NCT02414373|Bupivacaine|bupivacaine|mesh-list
5858217|NCT02414373|Ropivacaine|ropivacaine|mesh-list
5858218|NCT02414373|Anesthetics, Local|anesthetics, local|mesh-ancestor
5858219|NCT02414373|Anesthetics|anesthetics|mesh-ancestor
5858220|NCT02414373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5858221|NCT02414373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858222|NCT02414373|Sensory System Agents|sensory system agents|mesh-ancestor
5858223|NCT02414373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5858224|NCT02414165|Flucytosine|flucytosine|mesh-list
5858225|NCT02414165|Bevacizumab|bevacizumab|mesh-list
5858226|NCT02414165|Temozolomide|temozolomide|mesh-list
5858227|NCT02414165|Lomustine|lomustine|mesh-list
5858228|NCT02414165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5858229|NCT02414165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5858230|NCT02414165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5858231|NCT02414165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5858232|NCT02414165|Growth Substances|growth substances|mesh-ancestor
5858233|NCT02414165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858234|NCT02414165|Growth Inhibitors|growth inhibitors|mesh-ancestor
5858235|NCT02414165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5858236|NCT02414165|Alkylating Agents|alkylating agents|mesh-ancestor
5858237|NCT02414165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5858238|NCT02414165|Antifungal Agents|antifungal agents|mesh-ancestor
5858239|NCT02414165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5858240|NCT02414165|Antimetabolites|antimetabolites|mesh-ancestor
5858241|NCT02414009|Leucovorin|leucovorin|mesh-list
5858242|NCT02414009|Fluorouracil|fluorouracil|mesh-list
5858243|NCT02414009|Capecitabine|capecitabine|mesh-list
5858244|NCT02414009|Irinotecan|irinotecan|mesh-list
5858245|NCT02414009|Temozolomide|temozolomide|mesh-list
5858246|NCT02414009|Antimetabolites|antimetabolites|mesh-ancestor
5673720|NCT03546894|Ceritinib|ceritinib|mesh-list
5673721|NCT03546894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5673722|NCT03546894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5673723|NCT03546894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5673724|NCT03546894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673725|NCT03546855|Apatinib|apatinib|mesh-list
5673726|NCT03546855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5673727|NCT03546855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5673728|NCT03546855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5673729|NCT03546855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673730|NCT03546803|Protective Agents|protective agents|mesh-list
5858247|NCT02414009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5858248|NCT02414009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5858249|NCT02414009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5858250|NCT02414009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5858251|NCT02414009|Immunologic Factors|immunologic factors|mesh-ancestor
5858252|NCT02414009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858253|NCT02414009|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6494513|NCT00618657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494514|NCT00618657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6494515|NCT00618657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6494516|NCT00618657|Growth Substances|growth substances|mesh-ancestor
6494517|NCT00618657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494518|NCT00618657|Growth Inhibitors|growth inhibitors|mesh-ancestor
6494519|NCT00618657|Immunologic Factors|immunologic factors|mesh-ancestor
6494520|NCT00618696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6494521|NCT00618696|Antibodies|antibodies|mesh-list
6494522|NCT00618696|Immunoglobulins|immunoglobulins|mesh-list
6494523|NCT00618696|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6494524|NCT00618696|Immunologic Factors|immunologic factors|mesh-ancestor
6494525|NCT00618696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858254|NCT02414009|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5858255|NCT02414009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5858256|NCT02414009|Antidotes|antidotes|mesh-ancestor
5858257|NCT02414009|Protective Agents|protective agents|mesh-ancestor
5858258|NCT02414009|Vitamin B Complex|vitamin b complex|mesh-ancestor
5858259|NCT02414009|Vitamins|vitamins|mesh-ancestor
5858260|NCT02414009|Micronutrients|micronutrients|mesh-ancestor
5858261|NCT02414009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5858262|NCT02414009|Alkylating Agents|alkylating agents|mesh-ancestor
5858263|NCT02413853|Leucovorin|leucovorin|mesh-list
5858264|NCT02413853|Bevacizumab|bevacizumab|mesh-list
5858265|NCT02413853|Fluorouracil|fluorouracil|mesh-list
5858266|NCT02413853|Oxaliplatin|oxaliplatin|mesh-list
5858267|NCT02413853|Calcium|calcium|mesh-list
5858268|NCT02413853|Levoleucovorin|levoleucovorin|mesh-list
6212252|NCT02184195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5858269|NCT02413853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5858270|NCT02413853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5858271|NCT02413853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5858272|NCT02413853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5858273|NCT02413853|Growth Substances|growth substances|mesh-ancestor
5858274|NCT02413853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858275|NCT02413853|Growth Inhibitors|growth inhibitors|mesh-ancestor
5858276|NCT02413853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5858277|NCT02413853|Antimetabolites|antimetabolites|mesh-ancestor
5858278|NCT02413853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5858279|NCT02413853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5858280|NCT02413853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5858281|NCT02413853|Immunologic Factors|immunologic factors|mesh-ancestor
5858282|NCT02413853|Antidotes|antidotes|mesh-ancestor
5858283|NCT02413853|Protective Agents|protective agents|mesh-ancestor
5858284|NCT02413853|Vitamin B Complex|vitamin b complex|mesh-ancestor
5858285|NCT02413853|Vitamins|vitamins|mesh-ancestor
5858286|NCT02413853|Micronutrients|micronutrients|mesh-ancestor
5858287|NCT02413658|Phenytoin|phenytoin|mesh-list
5858288|NCT02413658|Anticonvulsants|anticonvulsants|mesh-ancestor
5858289|NCT02413658|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5858290|NCT02413658|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5858291|NCT02413658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5858292|NCT02413658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5858293|NCT02413658|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5858294|NCT02413658|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5673731|NCT03546803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673732|NCT03546634|Vaccines|vaccines|mesh-list
5673733|NCT03546634|Immunologic Factors|immunologic factors|mesh-ancestor
5858295|NCT02413268|Nitroglycerin|nitroglycerin|mesh-list
5858296|NCT02413268|Vasodilator Agents|vasodilator agents|mesh-ancestor
5858297|NCT02413281|Buprenorphine|buprenorphine|mesh-list
5858298|NCT02413281|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5858299|NCT02413281|Narcotics|narcotics|mesh-ancestor
5858300|NCT02413281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5858301|NCT02413281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858302|NCT02413281|Analgesics|analgesics|mesh-ancestor
5858303|NCT02413281|Sensory System Agents|sensory system agents|mesh-ancestor
5858304|NCT02413281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5858305|NCT02413281|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5858306|NCT02413515|Nifedipine|nifedipine|mesh-list
5858307|NCT02413515|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5858308|NCT02413515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5858309|NCT02413515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5858310|NCT02413515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5858311|NCT02413515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858312|NCT02413515|Vasodilator Agents|vasodilator agents|mesh-ancestor
5858313|NCT02413515|Tocolytic Agents|tocolytic agents|mesh-ancestor
5858314|NCT02413515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5673734|NCT03546634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673735|NCT03546608|Tepotinib|tepotinib|mesh-list
5673736|NCT03546608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5673737|NCT03546556|Alovudine|alovudine|mesh-list
5673738|NCT03546556|Dideoxynucleosides|dideoxynucleosides|mesh-list
5673739|NCT03546556|Antiviral Agents|antiviral agents|mesh-ancestor
5673740|NCT03546556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5904454|NCT05132101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5904455|NCT05132101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5904456|NCT05132101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904457|NCT05132075|Docetaxel|docetaxel|mesh-list
5673741|NCT03546556|Antimetabolites|antimetabolites|mesh-ancestor
5673742|NCT03546556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673743|NCT03546556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5673744|NCT03546556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5904458|NCT05132075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5904459|NCT05132075|Tubulin Modulators|tubulin modulators|mesh-ancestor
5904460|NCT05132075|Antimitotic Agents|antimitotic agents|mesh-ancestor
5904461|NCT05132075|Mitosis Modulators|mitosis modulators|mesh-ancestor
5904462|NCT05132075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904463|NCT05129176|Metronidazole|metronidazole|mesh-list
5904464|NCT05129176|Levofloxacin|levofloxacin|mesh-list
5904465|NCT05129176|Ofloxacin|ofloxacin|mesh-list
5904466|NCT05129176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5904467|NCT05129176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5904468|NCT05129176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5673745|NCT03546556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5673746|NCT03546530|Interferons|interferons|mesh-list
5673747|NCT03546530|Resveratrol|resveratrol|mesh-list
5673748|NCT03546530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5673749|NCT03546530|Antiviral Agents|antiviral agents|mesh-ancestor
5673750|NCT03546530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5673751|NCT03546530|Antioxidants|antioxidants|mesh-ancestor
5673752|NCT03546530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673753|NCT03546530|Protective Agents|protective agents|mesh-ancestor
5673754|NCT03546530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673755|NCT03546530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5673756|NCT03546530|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5673757|NCT03546426|Pembrolizumab|pembrolizumab|mesh-list
5858315|NCT02413554|Rivastigmine|rivastigmine|mesh-list
5858316|NCT02413554|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5858317|NCT02413554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5858318|NCT02413554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5858319|NCT02413554|Cholinergic Agents|cholinergic agents|mesh-ancestor
5858320|NCT02413554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5858321|NCT02413554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858322|NCT02413554|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5858323|NCT02413554|Protective Agents|protective agents|mesh-ancestor
5858324|NCT02413541|Polymyxins|polymyxins|mesh-list
5858325|NCT02413541|Polymyxin B|polymyxin b|mesh-list
5858326|NCT02413541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5858327|NCT02413541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5858328|NCT02413086|Chitosan|chitosan|mesh-list
5858329|NCT02413086|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5858330|NCT02413086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5858331|NCT02413086|Antimetabolites|antimetabolites|mesh-ancestor
5858332|NCT02413086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5858333|NCT02413086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5858334|NCT02413086|Chelating Agents|chelating agents|mesh-ancestor
5858335|NCT02413086|Sequestering Agents|sequestering agents|mesh-ancestor
5858336|NCT02413086|Hemostatics|hemostatics|mesh-ancestor
5858337|NCT02413086|Coagulants|coagulants|mesh-ancestor
5858338|NCT02413138|Hormones|hormones|mesh-list
5858339|NCT02413138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5858340|NCT02413138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858341|NCT02412930|Tramadol|tramadol|mesh-list
5858342|NCT02412930|Bupivacaine|bupivacaine|mesh-list
5858343|NCT02412930|Anesthetics, Local|anesthetics, local|mesh-ancestor
5858344|NCT02412930|Anesthetics|anesthetics|mesh-ancestor
5858345|NCT02412930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5858346|NCT02412930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858347|NCT02412930|Sensory System Agents|sensory system agents|mesh-ancestor
5858348|NCT02412930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5858349|NCT02412930|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5858350|NCT02412930|Narcotics|narcotics|mesh-ancestor
5858351|NCT02412930|Analgesics|analgesics|mesh-ancestor
5858352|NCT02413021|Cytarabine|cytarabine|mesh-list
5858353|NCT02413021|Deferasirox|deferasirox|mesh-list
5858354|NCT02413021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5858355|NCT02413021|Antimetabolites|antimetabolites|mesh-ancestor
5858356|NCT02413021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5858357|NCT02413021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5858358|NCT02413021|Antiviral Agents|antiviral agents|mesh-ancestor
5858359|NCT02413021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5858360|NCT02413021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5858361|NCT02413021|Immunologic Factors|immunologic factors|mesh-ancestor
5858362|NCT02413021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858363|NCT02413021|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5858364|NCT02413021|Chelating Agents|chelating agents|mesh-ancestor
5858365|NCT02413021|Sequestering Agents|sequestering agents|mesh-ancestor
5858366|NCT02412917|Valacyclovir|valacyclovir|mesh-list
5858367|NCT02412917|Antiviral Agents|antiviral agents|mesh-ancestor
5858368|NCT02412917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5858369|NCT02412904|Menotropins|menotropins|mesh-list
5858370|NCT02412904|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5858371|NCT02412904|Fertility Agents|fertility agents|mesh-ancestor
5673758|NCT03546426|Interleukin-2|interleukin-2|mesh-list
5673759|NCT03546426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5673760|NCT03546426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5673761|NCT03546426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5673762|NCT03546426|Analgesics|analgesics|mesh-ancestor
5673763|NCT03546426|Sensory System Agents|sensory system agents|mesh-ancestor
5858372|NCT02412904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5858373|NCT02412904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858374|NCT02412813|Cobalt|cobalt|mesh-list
5858375|NCT02412813|Trace Elements|trace elements|mesh-ancestor
5858376|NCT02412813|Micronutrients|micronutrients|mesh-ancestor
5858377|NCT02412813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858378|NCT02412683|Oxaliplatin|oxaliplatin|mesh-list
5858379|NCT02412683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5858380|NCT02412618|Misoprostol|misoprostol|mesh-list
5858381|NCT02412618|Mifepristone|mifepristone|mesh-list
5858382|NCT02412618|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5858383|NCT02412618|Abortifacient Agents|abortifacient agents|mesh-ancestor
5858384|NCT02412618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5858385|NCT02412618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858386|NCT02412618|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5858387|NCT02412618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5858388|NCT02412618|Oxytocics|oxytocics|mesh-ancestor
5858389|NCT02412618|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5858390|NCT02412618|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5858391|NCT02412618|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5858392|NCT02412618|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5858393|NCT02412618|Contraceptive Agents|contraceptive agents|mesh-ancestor
5858394|NCT02412618|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5858395|NCT02412618|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5858396|NCT02412618|Hormone Antagonists|hormone antagonists|mesh-ancestor
5858397|NCT02412618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5858398|NCT02412618|Luteolytic Agents|luteolytic agents|mesh-ancestor
5858399|NCT02412618|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5858400|NCT02412618|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5858401|NCT02412566|SMOFlipid|smoflipid|mesh-list
5858402|NCT02412566|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
5858403|NCT02412566|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5858404|NCT02412566|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5858405|NCT02412475|Cytarabine|cytarabine|mesh-list
5858406|NCT02412475|Fludarabine|fludarabine|mesh-list
5858407|NCT02412475|Sorafenib|sorafenib|mesh-list
5858408|NCT02412475|Decitabine|decitabine|mesh-list
5858409|NCT02412475|Vorinostat|vorinostat|mesh-list
5858410|NCT02412475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5858411|NCT02412475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5858412|NCT02412475|Antimetabolites|antimetabolites|mesh-ancestor
5673764|NCT03546426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5673765|NCT03546426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858413|NCT02412475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5858414|NCT02412475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5858415|NCT02412475|Immunologic Factors|immunologic factors|mesh-ancestor
5858416|NCT02412475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858417|NCT02412475|Antiviral Agents|antiviral agents|mesh-ancestor
5858418|NCT02412475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5858419|NCT02412475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5858420|NCT02412475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5858421|NCT02412475|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5858422|NCT02412449|Glycine|glycine|mesh-list
5858423|NCT02412449|Glycine Agents|glycine agents|mesh-ancestor
5673766|NCT03546400|Methylphenidate|methylphenidate|mesh-list
5673767|NCT03546400|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5673768|NCT03546400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673769|NCT03546400|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5673770|NCT03546400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5673771|NCT03546400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5673772|NCT03546400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673773|NCT03546400|Dopamine Agents|dopamine agents|mesh-ancestor
5673774|NCT03546400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5673775|NCT03546361|Pembrolizumab|pembrolizumab|mesh-list
5858424|NCT02412449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5858425|NCT02412449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5858426|NCT02412449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858427|NCT02412423|Cyclophosphamide|cyclophosphamide|mesh-list
5858428|NCT02412423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5858429|NCT02412423|Immunologic Factors|immunologic factors|mesh-ancestor
5858430|NCT02412423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858431|NCT02412423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5858432|NCT02412423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5858433|NCT02412423|Alkylating Agents|alkylating agents|mesh-ancestor
5673776|NCT03546361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5673777|NCT03546361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5673778|NCT03546283|Cardiac Glycosides|cardiac glycosides|mesh-list
5673779|NCT03546283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5673780|NCT03546283|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5673781|NCT03546283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5673782|NCT03546283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673783|NCT03546283|Protective Agents|protective agents|mesh-ancestor
5673784|NCT03546283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673785|NCT03546088|Anesthetics|anesthetics|mesh-list
5673786|NCT03546088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5673787|NCT03546088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673788|NCT03546075|Resveratrol|resveratrol|mesh-list
5858434|NCT02412423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5858435|NCT02412423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5858436|NCT02412423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5858437|NCT02412345|Alprostadil|alprostadil|mesh-list
5858438|NCT02412345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5858439|NCT02412345|Vasodilator Agents|vasodilator agents|mesh-ancestor
5858440|NCT02412345|Urological Agents|urological agents|mesh-ancestor
5858441|NCT02412267|Carboplatin|carboplatin|mesh-list
5858442|NCT02412267|Etoposide|etoposide|mesh-list
5858443|NCT02412267|Ifosfamide|ifosfamide|mesh-list
5858444|NCT02412267|Ofatumumab|ofatumumab|mesh-list
5858445|NCT02412267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5858446|NCT02412267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5858447|NCT02412267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5858448|NCT02412267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5858449|NCT02412267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5858450|NCT02412267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5858451|NCT02412267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5858452|NCT02412267|Alkylating Agents|alkylating agents|mesh-ancestor
5858453|NCT02412059|Prednisolone|prednisolone|mesh-list
5858454|NCT02412059|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5858455|NCT02412059|Methylprednisolone|methylprednisolone|mesh-list
5858456|NCT02412059|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5858457|NCT02412059|Prednisolone acetate|prednisolone acetate|mesh-list
5858458|NCT02412059|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5858459|NCT02412059|Prednisolone phosphate|prednisolone phosphate|mesh-list
5858460|NCT02412059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5858461|NCT02412059|Glucocorticoids|glucocorticoids|mesh-ancestor
5858462|NCT02412059|Hormones|hormones|mesh-ancestor
5858463|NCT02412059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5858464|NCT02412059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858465|NCT02412059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5858466|NCT02412059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5858467|NCT02412059|Antiemetics|antiemetics|mesh-ancestor
5858468|NCT02412059|Autonomic Agents|autonomic agents|mesh-ancestor
5858469|NCT02412059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5858470|NCT02412059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5858471|NCT02412059|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5858472|NCT02412059|Protective Agents|protective agents|mesh-ancestor
5858473|NCT02412150|Dexmedetomidine|dexmedetomidine|mesh-list
5858474|NCT02412150|Remifentanil|remifentanil|mesh-list
5858475|NCT02412150|Desflurane|desflurane|mesh-list
5858476|NCT02412150|Anesthetics|anesthetics|mesh-list
5858477|NCT02412150|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
5858478|NCT02412150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5858479|NCT02412150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5858480|NCT02412150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858481|NCT02412150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5673789|NCT03546075|Antioxidants|antioxidants|mesh-ancestor
5673790|NCT03546075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673791|NCT03546075|Protective Agents|protective agents|mesh-ancestor
5858482|NCT02412150|Analgesics|analgesics|mesh-ancestor
5858483|NCT02412150|Sensory System Agents|sensory system agents|mesh-ancestor
5858484|NCT02412150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5858485|NCT02412150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5858486|NCT02412150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5858487|NCT02412150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5858488|NCT02412150|Adrenergic Agents|adrenergic agents|mesh-ancestor
5858489|NCT02412150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5858490|NCT02412150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5858491|NCT02412150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5673792|NCT03546075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673793|NCT03546075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5673794|NCT03546075|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5673795|NCT03545997|Montelukast|montelukast|mesh-list
5673796|NCT03545997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5858492|NCT02412150|Narcotics|narcotics|mesh-ancestor
5858493|NCT02412150|Anesthetics, General|anesthetics, general|mesh-ancestor
5858494|NCT02412189|Norepinephrine|norepinephrine|mesh-list
5858495|NCT02412189|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5858496|NCT02412189|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5858497|NCT02412189|Adrenergic Agents|adrenergic agents|mesh-ancestor
5673797|NCT03545997|Respiratory System Agents|respiratory system agents|mesh-ancestor
5673798|NCT03545997|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5673799|NCT03545997|Hormone Antagonists|hormone antagonists|mesh-ancestor
5673800|NCT03545997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5673801|NCT03545997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673802|NCT03545997|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5673803|NCT03545997|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5673804|NCT03545997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673805|NCT03545711|Irinotecan|irinotecan|mesh-list
5673806|NCT03545711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5673807|NCT03545711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5673808|NCT03545711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5673809|NCT03545711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673810|NCT03545711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5673811|NCT03545516|Dexmedetomidine|dexmedetomidine|mesh-list
5673812|NCT03545516|Bupivacaine|bupivacaine|mesh-list
5673813|NCT03545516|Anesthetics, Local|anesthetics, local|mesh-ancestor
5673814|NCT03545516|Anesthetics|anesthetics|mesh-ancestor
5673815|NCT03545516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5673816|NCT03545516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673817|NCT03545516|Sensory System Agents|sensory system agents|mesh-ancestor
5673818|NCT03545516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5673819|NCT03545516|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5673820|NCT03545516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5673821|NCT03545516|Analgesics|analgesics|mesh-ancestor
5673822|NCT03545516|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5673823|NCT03545516|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5673824|NCT03545516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5673825|NCT03545516|Adrenergic Agents|adrenergic agents|mesh-ancestor
5673826|NCT03545516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5673827|NCT03545516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696243|NCT03384511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5696244|NCT03384511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5696245|NCT03384511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5696246|NCT03384511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696247|NCT03384277|Cyclophosphamide|cyclophosphamide|mesh-list
5696248|NCT03384277|Rituximab|rituximab|mesh-list
5696249|NCT03384277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5696250|NCT03384277|Immunologic Factors|immunologic factors|mesh-ancestor
5858498|NCT02412189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5858499|NCT02412189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5858500|NCT02412189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858501|NCT02412189|Sympathomimetics|sympathomimetics|mesh-ancestor
5858502|NCT02412189|Autonomic Agents|autonomic agents|mesh-ancestor
5858503|NCT02412189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5858504|NCT02412189|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5858505|NCT02411942|Adapalene|adapalene|mesh-list
5858506|NCT02411942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5858507|NCT02411942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5858508|NCT02411942|Analgesics|analgesics|mesh-ancestor
5696251|NCT03384277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696252|NCT03384277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5858509|NCT02411942|Sensory System Agents|sensory system agents|mesh-ancestor
5673828|NCT03545373|Amoxicillin|amoxicillin|mesh-list
5673829|NCT03545373|Azithromycin|azithromycin|mesh-list
5673830|NCT03545373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5673831|NCT03545373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5673832|NCT03545347|Nandrolone Decanoate|nandrolone decanoate|mesh-list
5673833|NCT03545347|Nandrolone|nandrolone|mesh-list
5673834|NCT03545347|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
5673835|NCT03545347|Androgens|androgens|mesh-ancestor
5673836|NCT03545347|Hormones|hormones|mesh-ancestor
5673837|NCT03545347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5673838|NCT03545347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673839|NCT03545347|Anabolic Agents|anabolic agents|mesh-ancestor
5673840|NCT03545347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5673841|NCT03545308|Rocuronium|rocuronium|mesh-list
5673842|NCT03545308|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5673843|NCT03545308|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5673844|NCT03545308|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5673845|NCT03545308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5673846|NCT03545308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673847|NCT03545243|Pantoprazole|pantoprazole|mesh-list
5673848|NCT03545243|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5673849|NCT03545243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5673850|NCT03545243|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5673851|NCT03545243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5673852|NCT03545243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673853|NCT03545035|Rituximab|rituximab|mesh-list
5673854|NCT03545035|Idelalisib|idelalisib|mesh-list
5673855|NCT03545035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5673856|NCT03545035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5673857|NCT03545035|Immunologic Factors|immunologic factors|mesh-ancestor
5673858|NCT03545035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673859|NCT03545035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5673860|NCT03545035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5673861|NCT03545035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673862|NCT03544996|Insulin|insulin|mesh-list
5673863|NCT03544996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5673864|NCT03544996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858510|NCT02411942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5858511|NCT02411942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858512|NCT02411942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5858513|NCT02411942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5673865|NCT03544827|Atropine|atropine|mesh-list
5673866|NCT03544827|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5673867|NCT03544827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5673868|NCT03544827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5673869|NCT03544827|Autonomic Agents|autonomic agents|mesh-ancestor
5673870|NCT03544827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5673871|NCT03544827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858514|NCT02411942|Dermatologic Agents|dermatologic agents|mesh-ancestor
5858515|NCT02411955|Nicotinic Acids|nicotinic acids|mesh-list
5858516|NCT02411955|Tazarotene|tazarotene|mesh-list
5858517|NCT02411955|Dermatologic Agents|dermatologic agents|mesh-ancestor
5858518|NCT02411955|Keratolytic Agents|keratolytic agents|mesh-ancestor
5858519|NCT02411955|Vitamin B Complex|vitamin b complex|mesh-ancestor
5858520|NCT02411955|Vitamins|vitamins|mesh-ancestor
5858521|NCT02411955|Micronutrients|micronutrients|mesh-ancestor
5858522|NCT02411955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858523|NCT02412085|Golimumab|golimumab|mesh-list
5673872|NCT03544827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5673873|NCT03544827|Respiratory System Agents|respiratory system agents|mesh-ancestor
5673874|NCT03544827|Mydriatics|mydriatics|mesh-ancestor
5673875|NCT03544827|Parasympatholytics|parasympatholytics|mesh-ancestor
5673876|NCT03544827|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5673877|NCT03544827|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5858524|NCT02412085|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
5858525|NCT02412085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5858526|NCT02412085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5858527|NCT02412085|Immunologic Factors|immunologic factors|mesh-ancestor
5858528|NCT02412085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858529|NCT02412033|Misoprostol|misoprostol|mesh-list
5858530|NCT02412033|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5858531|NCT02412033|Abortifacient Agents|abortifacient agents|mesh-ancestor
5858532|NCT02412033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5858533|NCT02412033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858534|NCT02412033|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5858535|NCT02412033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5673878|NCT03544827|Cholinergic Agents|cholinergic agents|mesh-ancestor
5673879|NCT03544827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5673880|NCT03544827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673881|NCT03544814|Cisplatin|cisplatin|mesh-list
5673882|NCT03544814|Pemetrexed|pemetrexed|mesh-list
5673883|NCT03544814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5673884|NCT03544814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5673885|NCT03544814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673886|NCT03544814|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5673887|NCT03544814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5673888|NCT03544775|Anesthetics|anesthetics|mesh-list
5673889|NCT03544775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5673890|NCT03544775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673891|NCT03544723|Pembrolizumab|pembrolizumab|mesh-list
5673892|NCT03544723|Nivolumab|nivolumab|mesh-list
5673893|NCT03544723|Durvalumab|durvalumab|mesh-list
5673894|NCT03544723|Atezolizumab|atezolizumab|mesh-list
5673895|NCT03544723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5673896|NCT03544723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5673897|NCT03544723|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5673898|NCT03544723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673899|NCT03544710|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
5673900|NCT03544710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5673901|NCT03544671|Vitamin D|vitamin d|mesh-list
5673902|NCT03544671|Vitamins|vitamins|mesh-ancestor
5673903|NCT03544671|Micronutrients|micronutrients|mesh-ancestor
5673904|NCT03544671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673905|NCT03544671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5673906|NCT03544606|Pyridoxine|pyridoxine|mesh-list
5673907|NCT03544606|Isosorbide|isosorbide|mesh-list
5858536|NCT02412033|Oxytocics|oxytocics|mesh-ancestor
5858537|NCT02411994|Artesunate|artesunate|mesh-list
5858538|NCT02411994|Lumefantrine|lumefantrine|mesh-list
5858539|NCT02411994|Artemether|artemether|mesh-list
5858540|NCT02411994|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
5858541|NCT02411994|Pyronaridine|pyronaridine|mesh-list
5858542|NCT02411994|Antimalarials|antimalarials|mesh-ancestor
5858543|NCT02411994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5858544|NCT02411994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5858545|NCT02411994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5858546|NCT02411994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5858547|NCT02411994|Antiviral Agents|antiviral agents|mesh-ancestor
5858548|NCT02411994|Schistosomicides|schistosomicides|mesh-ancestor
5858549|NCT02411994|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5858550|NCT02411994|Anthelmintics|anthelmintics|mesh-ancestor
5858551|NCT02411877|Clotrimazole|clotrimazole|mesh-list
5858552|NCT02411877|Miconazole|miconazole|mesh-list
5858553|NCT02411877|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5858554|NCT02411877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5858555|NCT02411877|Antifungal Agents|antifungal agents|mesh-ancestor
5858556|NCT02411877|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5858557|NCT02411877|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5858558|NCT02411877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5858559|NCT02411877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5858560|NCT02411877|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5673908|NCT03544606|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
5673909|NCT03544606|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
5673910|NCT03544606|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5673911|NCT03544606|Diuretics|diuretics|mesh-ancestor
5673912|NCT03544606|Natriuretic Agents|natriuretic agents|mesh-ancestor
5673913|NCT03544606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673914|NCT03544606|Vasodilator Agents|vasodilator agents|mesh-ancestor
5673915|NCT03544606|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5673916|NCT03544606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673917|NCT03544606|Vitamin B Complex|vitamin b complex|mesh-ancestor
5673918|NCT03544606|Vitamins|vitamins|mesh-ancestor
5673919|NCT03544606|Micronutrients|micronutrients|mesh-ancestor
5673920|NCT03544567|Paclitaxel|paclitaxel|mesh-list
5673921|NCT03544567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5673922|NCT03544567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5673923|NCT03544567|Tubulin Modulators|tubulin modulators|mesh-ancestor
5673924|NCT03544567|Antimitotic Agents|antimitotic agents|mesh-ancestor
5673925|NCT03544567|Mitosis Modulators|mitosis modulators|mesh-ancestor
5673926|NCT03544567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673927|NCT03544229|Maleic acid|maleic acid|mesh-list
5673928|NCT03544229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5858561|NCT02411877|Hormone Antagonists|hormone antagonists|mesh-ancestor
5904469|NCT05129176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5858562|NCT02411877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5858563|NCT02411877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858564|NCT02411877|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5858565|NCT02411877|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5858566|NCT02411903|Clopidogrel|clopidogrel|mesh-list
5858567|NCT02411903|Atorvastatin|atorvastatin|mesh-list
5858568|NCT02411903|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5858569|NCT02411903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5673929|NCT03544229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673930|NCT03544125|Durvalumab|durvalumab|mesh-list
5673931|NCT03544125|Olaparib|olaparib|mesh-list
5673932|NCT03544125|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
5673933|NCT03544125|Immunoglobulins|immunoglobulins|mesh-list
5673934|NCT03544125|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5673935|NCT03544125|Immunoglobulin G|immunoglobulin g|mesh-list
5673936|NCT03544125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5673937|NCT03544125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5673938|NCT03544125|Immunologic Factors|immunologic factors|mesh-ancestor
5673939|NCT03544125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673940|NCT03544125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5673941|NCT03544125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673942|NCT03544099|Pembrolizumab|pembrolizumab|mesh-list
5673943|NCT03544099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5858570|NCT02411903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5858571|NCT02411903|Antimetabolites|antimetabolites|mesh-ancestor
5858572|NCT02411903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5858573|NCT02411903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5858574|NCT02411903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5858575|NCT02411903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5858576|NCT02411903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5858577|NCT02411903|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5673944|NCT03544099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5673945|NCT03544073|Leuprolide|leuprolide|mesh-list
5673946|NCT03544073|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5673947|NCT03544073|Fertility Agents|fertility agents|mesh-ancestor
5673948|NCT03544073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5673949|NCT03544073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673950|NCT03544073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5673951|NCT03544073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5858578|NCT02411903|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5858579|NCT02411903|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5858580|NCT02411903|Purinergic Agents|purinergic agents|mesh-ancestor
5858581|NCT02411903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5858582|NCT02411903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858583|NCT02411786|Molgramostim|molgramostim|mesh-list
5858584|NCT02411786|Sargramostim|sargramostim|mesh-list
5858585|NCT02411786|Immunologic Factors|immunologic factors|mesh-ancestor
5858586|NCT02411786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858587|NCT02411786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5858588|NCT02411825|Metformin|metformin|mesh-list
5858589|NCT02411825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5858590|NCT02411825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858591|NCT02411695|Brexpiprazole|brexpiprazole|mesh-list
5858592|NCT02411695|Serotonin Agents|serotonin agents|mesh-ancestor
5858593|NCT02411695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5858594|NCT02411695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5858595|NCT02411695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858596|NCT02411695|Dopamine Agonists|dopamine agonists|mesh-ancestor
5858597|NCT02411695|Dopamine Agents|dopamine agents|mesh-ancestor
5904470|NCT05129176|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5904471|NCT05129176|Renal Agents|renal agents|mesh-ancestor
5904472|NCT05129176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5904473|NCT05129176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5904474|NCT05129176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5904475|NCT05129176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904476|NCT05129176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5904477|NCT05129176|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5904478|NCT05129176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5904479|NCT05122546|Nivolumab|nivolumab|mesh-list
5904480|NCT05122546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5904481|NCT05122546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5904482|NCT05122546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5673952|NCT03544047|Paclitaxel|paclitaxel|mesh-list
5858598|NCT02411604|Tacrolimus|tacrolimus|mesh-list
5858599|NCT02411604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5858600|NCT02411604|Immunologic Factors|immunologic factors|mesh-ancestor
5858601|NCT02411604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858602|NCT02411604|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5858603|NCT02411604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5858604|NCT02411604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5858605|NCT02411149|Epinephrine|epinephrine|mesh-list
5858606|NCT02411149|Racepinephrine|racepinephrine|mesh-list
5858607|NCT02411149|Morphine|morphine|mesh-list
5858608|NCT02411149|Ropivacaine|ropivacaine|mesh-list
5858609|NCT02411149|Epinephryl borate|epinephryl borate|mesh-list
5858610|NCT02411149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5858611|NCT02411149|Narcotics|narcotics|mesh-ancestor
5858612|NCT02411149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5858613|NCT02411149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858614|NCT02411149|Analgesics|analgesics|mesh-ancestor
5858615|NCT02411149|Sensory System Agents|sensory system agents|mesh-ancestor
5858616|NCT02411149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5858617|NCT02411149|Anesthetics, Local|anesthetics, local|mesh-ancestor
5858618|NCT02411149|Anesthetics|anesthetics|mesh-ancestor
5858619|NCT02411149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5858620|NCT02411149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5858621|NCT02411149|Adrenergic Agents|adrenergic agents|mesh-ancestor
5858622|NCT02411149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5858623|NCT02411149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5858624|NCT02411149|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5858625|NCT02411149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5858626|NCT02411149|Autonomic Agents|autonomic agents|mesh-ancestor
5858627|NCT02411149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5858628|NCT02411149|Respiratory System Agents|respiratory system agents|mesh-ancestor
5858629|NCT02411149|Mydriatics|mydriatics|mesh-ancestor
5858630|NCT02411149|Sympathomimetics|sympathomimetics|mesh-ancestor
5858631|NCT02411149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5858632|NCT02411526|Risperidone|risperidone|mesh-list
5858633|NCT02411526|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5858634|NCT02411526|Serotonin Agents|serotonin agents|mesh-ancestor
5858635|NCT02411526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5858636|NCT02411526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5858637|NCT02411526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858638|NCT02411526|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5858639|NCT02411526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5858640|NCT02411526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5858641|NCT02411526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5858642|NCT02411526|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5858643|NCT02411526|Dopamine Agents|dopamine agents|mesh-ancestor
5858644|NCT02411630|Tenofovir|tenofovir|mesh-list
5858645|NCT02411630|Emtricitabine|emtricitabine|mesh-list
5858646|NCT02411630|Antiviral Agents|antiviral agents|mesh-ancestor
5858647|NCT02411630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5858648|NCT02411630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5858649|NCT02411630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5858650|NCT02411630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5858651|NCT02411630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5858652|NCT02411630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5858653|NCT02411630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5858654|NCT02411318|Ethanol|ethanol|mesh-list
5858655|NCT02411318|Caffeine|caffeine|mesh-list
5858656|NCT02411318|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5858657|NCT02411318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858658|NCT02411318|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5858659|NCT02411318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5858660|NCT02411318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5858661|NCT02411318|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5858662|NCT02411318|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5858663|NCT02411318|Purinergic Agents|purinergic agents|mesh-ancestor
5858664|NCT02411318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5858665|NCT02411318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5858666|NCT02411318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5858667|NCT02411318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5858668|NCT02411175|Ethanol|ethanol|mesh-list
5858669|NCT02411175|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5858670|NCT02411175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5858671|NCT02411175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5858672|NCT02411175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858673|NCT02411331|Ethanol|ethanol|mesh-list
5673953|NCT03544047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5858674|NCT02411331|Enoxaparin|enoxaparin|mesh-list
5858675|NCT02411331|Anticoagulants|anticoagulants|mesh-ancestor
5858676|NCT02411331|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5858677|NCT02411331|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5858678|NCT02411331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5858679|NCT02411331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5858680|NCT02411331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5858681|NCT02411331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5858682|NCT02411331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858683|NCT02411344|Pertuzumab|pertuzumab|mesh-list
5858684|NCT02411344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5858685|NCT02411344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5858686|NCT02410863|Trametinib|trametinib|mesh-list
5858687|NCT02410863|Dabrafenib|dabrafenib|mesh-list
5858688|NCT02410863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5858689|NCT02410863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5858690|NCT02410863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5858691|NCT02410863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5858692|NCT02410980|Tretinoin|tretinoin|mesh-list
5858693|NCT02410980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5858694|NCT02410980|Keratolytic Agents|keratolytic agents|mesh-ancestor
5858695|NCT02410980|Dermatologic Agents|dermatologic agents|mesh-ancestor
5858696|NCT02410759|Carbetocin|carbetocin|mesh-list
5858697|NCT02410759|Ergonovine|ergonovine|mesh-list
5858698|NCT02410759|Oxytocics|oxytocics|mesh-ancestor
5858699|NCT02410759|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5858700|NCT02410759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858701|NCT02410694|Thalidomide|thalidomide|mesh-list
5858702|NCT02410694|Dexamethasone|dexamethasone|mesh-list
5858703|NCT02410694|Ixazomib|ixazomib|mesh-list
5858704|NCT02410694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5858705|NCT02410694|Antiemetics|antiemetics|mesh-ancestor
5858706|NCT02410694|Autonomic Agents|autonomic agents|mesh-ancestor
5858707|NCT02410694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5858708|NCT02410694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858709|NCT02410694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5858710|NCT02410694|Glucocorticoids|glucocorticoids|mesh-ancestor
5858711|NCT02410694|Hormones|hormones|mesh-ancestor
5858712|NCT02410694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5858713|NCT02410694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5858714|NCT02410694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5858715|NCT02410694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5858716|NCT02410694|Immunologic Factors|immunologic factors|mesh-ancestor
5858717|NCT02410694|Leprostatic Agents|leprostatic agents|mesh-ancestor
5858718|NCT02410694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5858719|NCT02410694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5858720|NCT02410694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5858721|NCT02410694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5673954|NCT03544047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5673955|NCT03544047|Tubulin Modulators|tubulin modulators|mesh-ancestor
5673956|NCT03544047|Antimitotic Agents|antimitotic agents|mesh-ancestor
5673957|NCT03544047|Mitosis Modulators|mitosis modulators|mesh-ancestor
5673958|NCT03544047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673959|NCT03543969|Vemurafenib|vemurafenib|mesh-list
5673960|NCT03543969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5673961|NCT03543969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5673962|NCT03543969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5673963|NCT03543969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696253|NCT03384277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5696254|NCT03384277|Alkylating Agents|alkylating agents|mesh-ancestor
5696255|NCT03384277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696256|NCT03384277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5696257|NCT03384277|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5696258|NCT03384277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5696259|NCT03384238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5696260|NCT03384238|Panitumumab|panitumumab|mesh-list
5696261|NCT03384238|Antibodies|antibodies|mesh-list
5696262|NCT03384238|Immunoglobulins|immunoglobulins|mesh-list
5696263|NCT03384238|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5696264|NCT03384238|Immunologic Factors|immunologic factors|mesh-ancestor
5696265|NCT03384238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696266|NCT03384238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5696267|NCT03384121|Rifampin|rifampin|mesh-list
5696268|NCT03384121|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5858722|NCT02410694|Growth Substances|growth substances|mesh-ancestor
5858723|NCT02410694|Growth Inhibitors|growth inhibitors|mesh-ancestor
5858724|NCT02410694|Protease Inhibitors|protease inhibitors|mesh-ancestor
5858725|NCT02410694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5858726|NCT02410694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5858727|NCT02410746|Ibuprofen|ibuprofen|mesh-list
5858728|NCT02410746|Morphine|morphine|mesh-list
5858729|NCT02410746|Levobupivacaine|levobupivacaine|mesh-list
5858730|NCT02410746|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5858731|NCT02410746|Narcotics|narcotics|mesh-ancestor
5858732|NCT02410746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5858733|NCT02410746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858734|NCT02410746|Analgesics|analgesics|mesh-ancestor
5858735|NCT02410746|Sensory System Agents|sensory system agents|mesh-ancestor
5858736|NCT02410746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5858737|NCT02410746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5858738|NCT02410746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5858739|NCT02410746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5858740|NCT02410746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5858741|NCT02410746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5858742|NCT02410746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5858743|NCT02410746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5858744|NCT02410746|Anesthetics, Local|anesthetics, local|mesh-ancestor
5858745|NCT02410746|Anesthetics|anesthetics|mesh-ancestor
5858746|NCT02410512|Atezolizumab|atezolizumab|mesh-list
5858747|NCT02410512|Antibodies|antibodies|mesh-list
5858748|NCT02410512|Immunoglobulins|immunoglobulins|mesh-list
5858749|NCT02410512|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5858750|NCT02410512|Immunologic Factors|immunologic factors|mesh-ancestor
5858751|NCT02410512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858752|NCT02410512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5858753|NCT02410590|Atropine|atropine|mesh-list
5858754|NCT02410590|Rocuronium|rocuronium|mesh-list
5858755|NCT02410590|Cisatracurium|cisatracurium|mesh-list
5858756|NCT02410590|Succinylcholine|succinylcholine|mesh-list
5858757|NCT02410590|Neostigmine|neostigmine|mesh-list
5858758|NCT02410590|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5858759|NCT02410590|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5858760|NCT02410590|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5858761|NCT02410590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5858762|NCT02410590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858763|NCT02410590|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5673964|NCT03543826|Rocuronium|rocuronium|mesh-list
5673965|NCT03543826|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5673966|NCT03543826|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5673967|NCT03543826|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5673968|NCT03543826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5673969|NCT03543826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673970|NCT03543774|Simvastatin|simvastatin|mesh-list
5673971|NCT03543774|Ezetimibe|ezetimibe|mesh-list
5673972|NCT03543774|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
5673973|NCT03543774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5673974|NCT03543774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5673975|NCT03543774|Antimetabolites|antimetabolites|mesh-ancestor
5673976|NCT03543774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673977|NCT03543774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5673978|NCT03543774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5673979|NCT03543774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5673980|NCT03543683|Aspirin|aspirin|mesh-list
5673981|NCT03543683|Osimertinib|osimertinib|mesh-list
5673982|NCT03543683|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5673983|NCT03543683|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5673984|NCT03543683|Analgesics|analgesics|mesh-ancestor
5673985|NCT03543683|Sensory System Agents|sensory system agents|mesh-ancestor
5673986|NCT03543683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5673987|NCT03543683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5673988|NCT03543683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5673989|NCT03543683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5673990|NCT03543683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5673991|NCT03543683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5673992|NCT03543683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5673993|NCT03543683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5673994|NCT03543683|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5673995|NCT03543683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5858764|NCT02410590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5673996|NCT03543683|Antipyretics|antipyretics|mesh-ancestor
5673997|NCT03543683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5673998|NCT03543683|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5673999|NCT03543657|Darbepoetin alfa|darbepoetin alfa|mesh-list
5674000|NCT03543657|Hematinics|hematinics|mesh-ancestor
5674001|NCT03543436|Meropenem|meropenem|mesh-list
5674002|NCT03543436|Imipenem|imipenem|mesh-list
5674003|NCT03543436|Temocillin|temocillin|mesh-list
5674004|NCT03543436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5674005|NCT03543436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5674006|NCT03543306|Trametinib|trametinib|mesh-list
5674007|NCT03543306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5674008|NCT03543306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5674009|NCT03543306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5674010|NCT03543306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674011|NCT03543254|Botulinum Toxins|botulinum toxins|mesh-list
5674012|NCT03543254|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5674013|NCT03543254|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5674014|NCT03543254|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5674015|NCT03543254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5674016|NCT03543254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674017|NCT03543254|Cholinergic Agents|cholinergic agents|mesh-ancestor
5858765|NCT02410590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5858766|NCT02410590|Autonomic Agents|autonomic agents|mesh-ancestor
5858767|NCT02410590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5858768|NCT02410590|Respiratory System Agents|respiratory system agents|mesh-ancestor
5858769|NCT02410590|Mydriatics|mydriatics|mesh-ancestor
5858770|NCT02410590|Parasympatholytics|parasympatholytics|mesh-ancestor
5858771|NCT02410590|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5858772|NCT02410590|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5674018|NCT03543254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5674019|NCT03543254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674020|NCT03543254|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5674021|NCT03543254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5674022|NCT03543202|Anesthetics|anesthetics|mesh-list
5674023|NCT03543202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5674024|NCT03543202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674025|NCT03543072|Diphosphonates|diphosphonates|mesh-list
5858773|NCT02410590|Cholinergic Agents|cholinergic agents|mesh-ancestor
5858774|NCT02410590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5858775|NCT02410590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5858776|NCT02410590|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5858777|NCT02410590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5858778|NCT02410590|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5858779|NCT02410590|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
5858780|NCT02410720|Picosulfate sodium|picosulfate sodium|mesh-list
5674026|NCT03543072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5674027|NCT03543072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674028|NCT03542955|Etoricoxib|etoricoxib|mesh-list
5674029|NCT03542955|Analgesics|analgesics|mesh-list
5674030|NCT03542955|Sensory System Agents|sensory system agents|mesh-ancestor
5674031|NCT03542955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5674032|NCT03542955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674033|NCT03542955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5674034|NCT03542955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5674035|NCT03542955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5674036|NCT03542955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5674037|NCT03542955|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5674038|NCT03542955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5674039|NCT03542955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5674040|NCT03542955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674041|NCT03542851|Pentylenetetrazole|pentylenetetrazole|mesh-list
5674042|NCT03542851|Convulsants|convulsants|mesh-ancestor
5674043|NCT03542851|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5674044|NCT03542851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674045|NCT03542851|GABA Antagonists|gaba antagonists|mesh-ancestor
5674046|NCT03542851|GABA Agents|gaba agents|mesh-ancestor
5674047|NCT03542851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5674048|NCT03542851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674049|NCT03542825|Iron|iron|mesh-list
5674050|NCT03542825|Lactoferrin|lactoferrin|mesh-list
5858781|NCT02410720|Cathartics|cathartics|mesh-ancestor
5858782|NCT02410720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5674051|NCT03542825|Iron Chelating Agents|iron chelating agents|mesh-list
5674052|NCT03542825|Trace Elements|trace elements|mesh-ancestor
5674053|NCT03542825|Micronutrients|micronutrients|mesh-ancestor
5858783|NCT02410655|Oxytocin|oxytocin|mesh-list
5858784|NCT02410655|Oxytocics|oxytocics|mesh-ancestor
5858785|NCT02410655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5858786|NCT02410655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858787|NCT02410499|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5858788|NCT02410499|Immunologic Factors|immunologic factors|mesh-ancestor
5858789|NCT02410499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858790|NCT02410460|Lidocaine|lidocaine|mesh-list
5858791|NCT02410460|Clonidine|clonidine|mesh-list
5858792|NCT02410460|Midazolam|midazolam|mesh-list
5858793|NCT02410460|Glycopyrrolate|glycopyrrolate|mesh-list
5858794|NCT02410460|Scopolamine|scopolamine|mesh-list
5858795|NCT02410460|Ketamine|ketamine|mesh-list
5858796|NCT02410460|Ondansetron|ondansetron|mesh-list
5858797|NCT02410460|Metoclopramide|metoclopramide|mesh-list
5858798|NCT02410460|Bupivacaine|bupivacaine|mesh-list
5858799|NCT02410460|Propofol|propofol|mesh-list
5858800|NCT02410460|Sevoflurane|sevoflurane|mesh-list
5858801|NCT02410460|Desflurane|desflurane|mesh-list
5858802|NCT02410460|Famotidine|famotidine|mesh-list
5858803|NCT02410460|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
5858804|NCT02410460|Anesthetics, Local|anesthetics, local|mesh-ancestor
5858805|NCT02410460|Anesthetics|anesthetics|mesh-ancestor
5858806|NCT02410460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5858807|NCT02410460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858808|NCT02410460|Sensory System Agents|sensory system agents|mesh-ancestor
5858809|NCT02410460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5674054|NCT03542825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674055|NCT03542825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5674056|NCT03542825|Chelating Agents|chelating agents|mesh-ancestor
5674057|NCT03542825|Sequestering Agents|sequestering agents|mesh-ancestor
5674058|NCT03542825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674059|NCT03542760|Methylene Blue|methylene blue|mesh-list
5674060|NCT03542760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5674061|NCT03542760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674062|NCT03542617|Dexamethasone|dexamethasone|mesh-list
5858810|NCT02410460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5858811|NCT02410460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5858812|NCT02410460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5858813|NCT02410460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5858814|NCT02410460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5858815|NCT02410460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5674063|NCT03542617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5674064|NCT03542617|Antiemetics|antiemetics|mesh-ancestor
5674065|NCT03542617|Autonomic Agents|autonomic agents|mesh-ancestor
5674066|NCT03542617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5674067|NCT03542617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674068|NCT03542617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5674069|NCT03542617|Glucocorticoids|glucocorticoids|mesh-ancestor
5674070|NCT03542617|Hormones|hormones|mesh-ancestor
5674071|NCT03542617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5674072|NCT03542617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5674073|NCT03542617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5674074|NCT03542552|Magnesium Sulfate|magnesium sulfate|mesh-list
5674075|NCT03542552|Nifedipine|nifedipine|mesh-list
5674076|NCT03542552|Analgesics|analgesics|mesh-ancestor
5674077|NCT03542552|Sensory System Agents|sensory system agents|mesh-ancestor
5674078|NCT03542552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5674079|NCT03542552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674080|NCT03542552|Anesthetics|anesthetics|mesh-ancestor
5674081|NCT03542552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5674082|NCT03542552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5674083|NCT03542552|Anticonvulsants|anticonvulsants|mesh-ancestor
5674084|NCT03542552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5858816|NCT02410460|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5674085|NCT03542552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5858817|NCT02410460|Anesthetics, General|anesthetics, general|mesh-ancestor
5858818|NCT02410460|Analgesics|analgesics|mesh-ancestor
5674086|NCT03542552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674087|NCT03542552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5858819|NCT02410460|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5858820|NCT02410460|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5858821|NCT02410460|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5858822|NCT02410460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5858823|NCT02410460|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5858824|NCT02410460|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5858825|NCT02410460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5858826|NCT02410460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5858827|NCT02410460|GABA Modulators|gaba modulators|mesh-ancestor
5858828|NCT02410460|GABA Agents|gaba agents|mesh-ancestor
5858829|NCT02410460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5858830|NCT02410460|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5858831|NCT02410460|Antiemetics|antiemetics|mesh-ancestor
5858832|NCT02410460|Autonomic Agents|autonomic agents|mesh-ancestor
5858833|NCT02410460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5858834|NCT02410460|Antipruritics|antipruritics|mesh-ancestor
5858835|NCT02410460|Dermatologic Agents|dermatologic agents|mesh-ancestor
5858836|NCT02410460|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5858837|NCT02410460|Serotonin Agents|serotonin agents|mesh-ancestor
5858838|NCT02410460|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5858839|NCT02410460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5858840|NCT02410460|Sympatholytics|sympatholytics|mesh-ancestor
5674088|NCT03542552|Tocolytic Agents|tocolytic agents|mesh-ancestor
5674089|NCT03542552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5674090|NCT03542552|Vasodilator Agents|vasodilator agents|mesh-ancestor
5674091|NCT03542461|Nivolumab|nivolumab|mesh-list
5674092|NCT03542461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5674093|NCT03542461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5674094|NCT03542461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5674095|NCT03542461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674096|NCT03542422|Apatinib|apatinib|mesh-list
5674097|NCT03542422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5674098|NCT03542422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5674099|NCT03542422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5674100|NCT03542422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674101|NCT03542357|Calcitonin|calcitonin|mesh-list
5674102|NCT03542357|Salmon calcitonin|salmon calcitonin|mesh-list
5674103|NCT03542357|Sumatriptan|sumatriptan|mesh-list
5674104|NCT03542357|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
5858841|NCT02410460|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5858842|NCT02410460|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5858843|NCT02410460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5858844|NCT02410460|Adrenergic Agents|adrenergic agents|mesh-ancestor
5858845|NCT02410460|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5858846|NCT02410460|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5858847|NCT02410460|Dopamine Agents|dopamine agents|mesh-ancestor
5858848|NCT02410460|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5858849|NCT02410460|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5858850|NCT02410460|Cholinergic Agents|cholinergic agents|mesh-ancestor
5858851|NCT02410460|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5858852|NCT02410460|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5858853|NCT02410460|Histamine Antagonists|histamine antagonists|mesh-ancestor
5858854|NCT02410460|Histamine Agents|histamine agents|mesh-ancestor
5674105|NCT03542357|Katacalcin|katacalcin|mesh-list
5674106|NCT03542357|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5674107|NCT03542357|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5674108|NCT03542357|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5674109|NCT03542357|Serotonin Agents|serotonin agents|mesh-ancestor
5674110|NCT03542357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5674111|NCT03542357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674112|NCT03542357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674113|NCT03542357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5674114|NCT03542357|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5674115|NCT03542357|Vasodilator Agents|vasodilator agents|mesh-ancestor
5674116|NCT03542331|Ethiodized Oil|ethiodized oil|mesh-list
5674117|NCT03542331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5674118|NCT03542279|Glucocorticoids|glucocorticoids|mesh-list
5674119|NCT03542279|Hormones|hormones|mesh-ancestor
5674120|NCT03542279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5674121|NCT03542279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674122|NCT03542240|Curcumin|curcumin|mesh-list
5674123|NCT03542240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5858855|NCT02410460|Mydriatics|mydriatics|mesh-ancestor
5674124|NCT03542240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5858856|NCT02410460|Parasympatholytics|parasympatholytics|mesh-ancestor
5858857|NCT02410226|Anesthetics|anesthetics|mesh-list
5858858|NCT02410226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5858859|NCT02410226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858860|NCT02410031|Cyproterone Acetate|cyproterone acetate|mesh-list
5858861|NCT02410031|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5858862|NCT02410031|Cyproterone|cyproterone|mesh-list
5858863|NCT02410031|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
5858864|NCT02410031|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5858865|NCT02410031|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5858866|NCT02410031|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5858867|NCT02410031|Contraceptive Agents|contraceptive agents|mesh-ancestor
5858868|NCT02410031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5858869|NCT02410031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858870|NCT02410031|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5858871|NCT02410031|Estrogens|estrogens|mesh-ancestor
5674125|NCT03542240|Analgesics|analgesics|mesh-ancestor
5674126|NCT03542240|Sensory System Agents|sensory system agents|mesh-ancestor
5674127|NCT03542240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5674128|NCT03542240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674129|NCT03542240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5674130|NCT03542240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5674131|NCT03542240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5674132|NCT03542240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5674133|NCT03542240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696269|NCT03384121|Antitubercular Agents|antitubercular agents|mesh-ancestor
5696270|NCT03384121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5696271|NCT03384121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5696272|NCT03384121|Leprostatic Agents|leprostatic agents|mesh-ancestor
5696273|NCT03384121|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5696274|NCT03384121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5696275|NCT03384121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696276|NCT03384121|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5696277|NCT03384121|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5696278|NCT03384121|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5696279|NCT03384121|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5696280|NCT03384121|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5696281|NCT03384121|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5858872|NCT02410031|Hormones|hormones|mesh-ancestor
5858873|NCT02410031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5858874|NCT02410031|Androgen Antagonists|androgen antagonists|mesh-ancestor
5858875|NCT02410031|Hormone Antagonists|hormone antagonists|mesh-ancestor
5858876|NCT02410031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5858877|NCT02410031|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5858878|NCT02410096|Methacholine Chloride|methacholine chloride|mesh-list
5858879|NCT02410096|Miotics|miotics|mesh-ancestor
5858880|NCT02410096|Autonomic Agents|autonomic agents|mesh-ancestor
5858881|NCT02410096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5858882|NCT02410096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858883|NCT02410096|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5858884|NCT02410096|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
5858885|NCT02410096|Respiratory System Agents|respiratory system agents|mesh-ancestor
5858886|NCT02410096|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
5858887|NCT02410096|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5858888|NCT02410096|Cholinergic Agents|cholinergic agents|mesh-ancestor
5858889|NCT02410096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5858890|NCT02410096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5858891|NCT02410317|Morphine|morphine|mesh-list
5696282|NCT03384095|Hyaluronic Acid|hyaluronic acid|mesh-list
5696283|NCT03384095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5696284|NCT03384095|Immunologic Factors|immunologic factors|mesh-ancestor
5696285|NCT03384095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696286|NCT03384095|Viscosupplements|viscosupplements|mesh-ancestor
5696287|NCT03384095|Protective Agents|protective agents|mesh-ancestor
5696288|NCT03383939|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
5696289|NCT03383939|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5696290|NCT03383939|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5696291|NCT03383939|Protease Inhibitors|protease inhibitors|mesh-ancestor
5696292|NCT03383939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5696293|NCT03383939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696294|NCT03383822|Insulin|insulin|mesh-list
5696295|NCT03383822|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5858892|NCT02410317|Ropivacaine|ropivacaine|mesh-list
5858893|NCT02410317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5858894|NCT02410317|Narcotics|narcotics|mesh-ancestor
5858895|NCT02410317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5858896|NCT02410317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858897|NCT02410317|Analgesics|analgesics|mesh-ancestor
5858898|NCT02410317|Sensory System Agents|sensory system agents|mesh-ancestor
5858899|NCT02410317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5858900|NCT02410317|Anesthetics, Local|anesthetics, local|mesh-ancestor
5858901|NCT02410317|Anesthetics|anesthetics|mesh-ancestor
5858902|NCT02410083|Aspirin|aspirin|mesh-list
5858903|NCT02410083|Clopidogrel|clopidogrel|mesh-list
5858904|NCT02410083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5858905|NCT02410083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5858906|NCT02410083|Analgesics|analgesics|mesh-ancestor
5858907|NCT02410083|Sensory System Agents|sensory system agents|mesh-ancestor
5858908|NCT02410083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5858909|NCT02410083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858910|NCT02410083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5858911|NCT02410083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5674134|NCT03542214|Calcium|calcium|mesh-list
5674135|NCT03542214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5674136|NCT03542214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674137|NCT03542149|Tocopherols|tocopherols|mesh-list
5674138|NCT03542149|Vitamin E|vitamin e|mesh-list
5674139|NCT03542149|Tocotrienols|tocotrienols|mesh-list
5674140|NCT03542149|alpha-Tocopherol|alpha-tocopherol|mesh-list
5674141|NCT03542149|Piperaquine|piperaquine|mesh-list
5674142|NCT03542149|Antimalarials|antimalarials|mesh-ancestor
5674143|NCT03542149|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5674144|NCT03542149|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5674145|NCT03542149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5674146|NCT03542149|Antioxidants|antioxidants|mesh-ancestor
5674147|NCT03542149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674148|NCT03542149|Protective Agents|protective agents|mesh-ancestor
5674149|NCT03542149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674150|NCT03542149|Vitamins|vitamins|mesh-ancestor
5674151|NCT03542149|Micronutrients|micronutrients|mesh-ancestor
5674152|NCT03542058|Carvedilol|carvedilol|mesh-list
5674153|NCT03542058|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5674154|NCT03542058|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5674155|NCT03542058|Adrenergic Agents|adrenergic agents|mesh-ancestor
5674156|NCT03542058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5674157|NCT03542058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674158|NCT03542058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674159|NCT03542058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5674160|NCT03542058|Antioxidants|antioxidants|mesh-ancestor
5674161|NCT03542058|Protective Agents|protective agents|mesh-ancestor
5674162|NCT03542058|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5674163|NCT03542058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5674164|NCT03542058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5674165|NCT03542058|Vasodilator Agents|vasodilator agents|mesh-ancestor
5674166|NCT03542058|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5674167|NCT03542058|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5674168|NCT03542006|Brinzolamide|brinzolamide|mesh-list
5674169|NCT03542006|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5674170|NCT03542006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5674171|NCT03542006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674172|NCT03541993|Resveratrol|resveratrol|mesh-list
5674173|NCT03541993|Antioxidants|antioxidants|mesh-ancestor
5674174|NCT03541993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674175|NCT03541993|Protective Agents|protective agents|mesh-ancestor
5674176|NCT03541993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674177|NCT03541993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5674178|NCT03541993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5674179|NCT03541928|Valacyclovir|valacyclovir|mesh-list
5674180|NCT03541928|Leuprolide|leuprolide|mesh-list
5674181|NCT03541928|Bicalutamide|bicalutamide|mesh-list
5674182|NCT03541928|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5674183|NCT03541928|Fertility Agents|fertility agents|mesh-ancestor
5674184|NCT03541928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5674185|NCT03541928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674186|NCT03541928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5674187|NCT03541928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5858912|NCT02410083|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5858913|NCT02410083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5674188|NCT03541928|Androgen Antagonists|androgen antagonists|mesh-ancestor
5858914|NCT02410083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5858915|NCT02410083|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5858916|NCT02410083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5858917|NCT02410083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5858918|NCT02410083|Antipyretics|antipyretics|mesh-ancestor
5858919|NCT02410083|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5858920|NCT02410083|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5858921|NCT02410083|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5858922|NCT02410083|Purinergic Agents|purinergic agents|mesh-ancestor
5858923|NCT02410083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5858924|NCT02410005|Calcitriol|calcitriol|mesh-list
5858925|NCT02410005|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
5858926|NCT02410005|Losartan|losartan|mesh-list
5858927|NCT02410005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5858928|NCT02410005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5858929|NCT02410005|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5858930|NCT02410005|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5858931|NCT02410005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674189|NCT03541928|Hormone Antagonists|hormone antagonists|mesh-ancestor
5674190|NCT03541928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5674191|NCT03541928|Antiviral Agents|antiviral agents|mesh-ancestor
5674192|NCT03541928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5674193|NCT03541915|Magnesium Sulfate|magnesium sulfate|mesh-list
5674194|NCT03541915|Analgesics|analgesics|mesh-ancestor
5674195|NCT03541915|Sensory System Agents|sensory system agents|mesh-ancestor
5674196|NCT03541915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5674197|NCT03541915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674198|NCT03541915|Anesthetics|anesthetics|mesh-ancestor
5674199|NCT03541915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5674200|NCT03541915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5674201|NCT03541915|Anticonvulsants|anticonvulsants|mesh-ancestor
5674202|NCT03541915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5674203|NCT03541915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5674204|NCT03541915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674205|NCT03541915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5674206|NCT03541915|Tocolytic Agents|tocolytic agents|mesh-ancestor
5674207|NCT03541915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5674208|NCT03541902|Sunitinib|sunitinib|mesh-list
5674209|NCT03541902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5858932|NCT02410005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5858933|NCT02410005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858934|NCT02410005|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
5858935|NCT02410005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5858936|NCT02410005|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5858937|NCT02410005|Vitamins|vitamins|mesh-ancestor
5858938|NCT02410005|Micronutrients|micronutrients|mesh-ancestor
5674210|NCT03541902|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5674211|NCT03541902|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5858939|NCT02410005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5858940|NCT02410135|Mirabegron|mirabegron|mesh-list
5858941|NCT02410135|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
5858942|NCT02410135|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5858943|NCT02410135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5858944|NCT02410135|Adrenergic Agents|adrenergic agents|mesh-ancestor
5858945|NCT02410135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5858946|NCT02410135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5858947|NCT02410135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858948|NCT02410135|Urological Agents|urological agents|mesh-ancestor
5858949|NCT02409810|Dexmedetomidine|dexmedetomidine|mesh-list
5674212|NCT03541902|Growth Substances|growth substances|mesh-ancestor
5674213|NCT03541902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674214|NCT03541902|Growth Inhibitors|growth inhibitors|mesh-ancestor
5674215|NCT03541902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5674216|NCT03541902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5674217|NCT03541902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674218|NCT03541837|Ropivacaine|ropivacaine|mesh-list
5674219|NCT03541837|Anesthetics, Local|anesthetics, local|mesh-ancestor
5674220|NCT03541837|Anesthetics|anesthetics|mesh-ancestor
5674221|NCT03541837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5674222|NCT03541837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674223|NCT03541837|Sensory System Agents|sensory system agents|mesh-ancestor
5674224|NCT03541837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5674225|NCT03541798|Anesthetics|anesthetics|mesh-list
5674226|NCT03541798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5674227|NCT03541798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674228|NCT03541759|Hydromorphone|hydromorphone|mesh-list
5674229|NCT03541759|Pirinitramide|pirinitramide|mesh-list
5674230|NCT03541759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5674231|NCT03541759|Narcotics|narcotics|mesh-ancestor
5674232|NCT03541759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5674233|NCT03541759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674234|NCT03541759|Analgesics|analgesics|mesh-ancestor
5674235|NCT03541759|Sensory System Agents|sensory system agents|mesh-ancestor
5674236|NCT03541759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5674237|NCT03541681|Anesthetics|anesthetics|mesh-list
5674238|NCT03541681|Glucocorticoids|glucocorticoids|mesh-list
5674239|NCT03541681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5674240|NCT03541681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674241|NCT03541681|Hormones|hormones|mesh-ancestor
5674242|NCT03541681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5674243|NCT03541668|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5674244|NCT03541668|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5674245|NCT03541668|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5674246|NCT03541668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674247|NCT03541603|Simendan|simendan|mesh-list
5674248|NCT03541603|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5674249|NCT03541603|Vasodilator Agents|vasodilator agents|mesh-ancestor
5674250|NCT03541603|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5674251|NCT03541603|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5674252|NCT03541603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5674253|NCT03541603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674254|NCT03541603|Protective Agents|protective agents|mesh-ancestor
5674255|NCT03541603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674256|NCT03541564|Moxifloxacin|moxifloxacin|mesh-list
5674257|NCT03541564|BMS-986165|bms-986165|mesh-list
5858950|NCT02409810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5858951|NCT02409810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5858952|NCT02409810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858953|NCT02409810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5858954|NCT02409810|Analgesics|analgesics|mesh-ancestor
5858955|NCT02409810|Sensory System Agents|sensory system agents|mesh-ancestor
5858956|NCT02409810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5858957|NCT02409810|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5858958|NCT02409810|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5858959|NCT02409810|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5858960|NCT02409810|Adrenergic Agents|adrenergic agents|mesh-ancestor
5858961|NCT02409810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5858962|NCT02409810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5858963|NCT02409849|Octreotide|octreotide|mesh-list
5858964|NCT02409849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5858965|NCT02409849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5858966|NCT02409849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5858967|NCT02409823|Antipsychotic Agents|antipsychotic agents|mesh-list
5858968|NCT02409823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5674258|NCT03541564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5674259|NCT03541564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5674260|NCT03541564|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5674261|NCT03541564|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5674262|NCT03541564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5674263|NCT03541564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674264|NCT03541564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5674265|NCT03541564|Dermatologic Agents|dermatologic agents|mesh-ancestor
5674266|NCT03541564|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5674267|NCT03541447|Octreotide|octreotide|mesh-list
5674268|NCT03541447|Tolvaptan|tolvaptan|mesh-list
5674269|NCT03541447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5674270|NCT03541447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5858969|NCT02409823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5858970|NCT02409823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858971|NCT02409823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5858972|NCT02409862|Oxytocin|oxytocin|mesh-list
5858973|NCT02409862|Oxytocics|oxytocics|mesh-ancestor
5858974|NCT02409862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5858975|NCT02409862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858976|NCT02409641|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5858977|NCT02409641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5904483|NCT05122546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904484|NCT05121038|Leucovorin|leucovorin|mesh-list
5904485|NCT05121038|Fluorouracil|fluorouracil|mesh-list
5904486|NCT05121038|Oxaliplatin|oxaliplatin|mesh-list
5904487|NCT05121038|Irinotecan|irinotecan|mesh-list
5904488|NCT05121038|Panitumumab|panitumumab|mesh-list
5904489|NCT05121038|Folfirinox|folfirinox|mesh-list
5904490|NCT05121038|Antimetabolites|antimetabolites|mesh-ancestor
5904491|NCT05121038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904492|NCT05121038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5904493|NCT05121038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5904494|NCT05121038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5904495|NCT05121038|Immunologic Factors|immunologic factors|mesh-ancestor
6494526|NCT00618696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6494527|NCT00618852|Furosemide|furosemide|mesh-list
6494528|NCT00618852|Diuretics|diuretics|mesh-ancestor
6494529|NCT00618852|Natriuretic Agents|natriuretic agents|mesh-ancestor
6494530|NCT00618852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494531|NCT00618852|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6494532|NCT00618852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5904496|NCT05121038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904497|NCT05121038|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5904498|NCT05121038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5904499|NCT05121038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5904500|NCT05121038|Antidotes|antidotes|mesh-ancestor
5904501|NCT05121038|Protective Agents|protective agents|mesh-ancestor
5904502|NCT05121038|Vitamin B Complex|vitamin b complex|mesh-ancestor
5904503|NCT05121038|Vitamins|vitamins|mesh-ancestor
5904504|NCT05121038|Micronutrients|micronutrients|mesh-ancestor
5904505|NCT05121038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5904506|NCT05071937|Talazoparib|talazoparib|mesh-list
5904507|NCT05071937|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5904508|NCT05071937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5904509|NCT05071937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904510|NCT05071937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5904511|NCT05062837|Apatinib|apatinib|mesh-list
5904512|NCT05062837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5904513|NCT05062837|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5674271|NCT03541447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5674272|NCT03541447|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
5674273|NCT03541447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674274|NCT03541447|Natriuretic Agents|natriuretic agents|mesh-ancestor
5674275|NCT03541447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674276|NCT03541265|Bupivacaine|bupivacaine|mesh-list
5674277|NCT03541265|Anesthetics, Local|anesthetics, local|mesh-ancestor
5674278|NCT03541265|Anesthetics|anesthetics|mesh-ancestor
5904514|NCT05062837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5904515|NCT05062837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904516|NCT05043714|Nivolumab|nivolumab|mesh-list
5904517|NCT05043714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5904518|NCT05043714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5904519|NCT05043714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5904520|NCT05043714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904521|NCT05038592|Decitabine|decitabine|mesh-list
5904522|NCT05038592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5904523|NCT05038592|Antimetabolites|antimetabolites|mesh-ancestor
5904524|NCT05038592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904525|NCT05038592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5904526|NCT05038592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5908489|NCT04486352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908490|NCT04486352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5908491|NCT04486352|Tubulin Modulators|tubulin modulators|mesh-ancestor
5908492|NCT04486352|Antimitotic Agents|antimitotic agents|mesh-ancestor
5908493|NCT04486352|Mitosis Modulators|mitosis modulators|mesh-ancestor
5908494|NCT04478019|Povidone-Iodine|povidone-iodine|mesh-list
5908495|NCT04478019|Povidone|povidone|mesh-list
5908496|NCT04478019|Plasma Substitutes|plasma substitutes|mesh-ancestor
5674279|NCT03541265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5674280|NCT03541265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674281|NCT03541265|Sensory System Agents|sensory system agents|mesh-ancestor
5674282|NCT03541265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5674283|NCT03541252|Cisplatin|cisplatin|mesh-list
5674284|NCT03541252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5858978|NCT02409498|Bupivacaine|bupivacaine|mesh-list
5858979|NCT02409498|Anesthetics, Local|anesthetics, local|mesh-ancestor
5858980|NCT02409498|Anesthetics|anesthetics|mesh-ancestor
5858981|NCT02409498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5674285|NCT03541031|Micronutrients|micronutrients|mesh-list
5674286|NCT03541031|Trace Elements|trace elements|mesh-list
5674287|NCT03541031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674288|NCT03540979|Letrozole|letrozole|mesh-list
5674289|NCT03540979|Progesterone|progesterone|mesh-list
5674290|NCT03540979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5674291|NCT03540979|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5674292|NCT03540979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5674293|NCT03540979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5858982|NCT02409498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858983|NCT02409498|Sensory System Agents|sensory system agents|mesh-ancestor
5858984|NCT02409498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5858985|NCT02409537|Resveratrol|resveratrol|mesh-list
5858986|NCT02409537|Antioxidants|antioxidants|mesh-ancestor
5858987|NCT02409537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5858988|NCT02409537|Protective Agents|protective agents|mesh-ancestor
5858989|NCT02409537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858990|NCT02409537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5858991|NCT02409537|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5858992|NCT02409407|Alprostadil|alprostadil|mesh-list
5858993|NCT02409407|Misoprostol|misoprostol|mesh-list
5858994|NCT02409407|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5858995|NCT02409407|Abortifacient Agents|abortifacient agents|mesh-ancestor
5858996|NCT02409407|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5858997|NCT02409407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5858998|NCT02409407|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5858999|NCT02409407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5859000|NCT02409407|Oxytocics|oxytocics|mesh-ancestor
5859001|NCT02409407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5859002|NCT02409407|Vasodilator Agents|vasodilator agents|mesh-ancestor
5859003|NCT02409407|Urological Agents|urological agents|mesh-ancestor
5859004|NCT02409563|Budesonide|budesonide|mesh-list
5859005|NCT02409563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5859006|NCT02409563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5859007|NCT02409563|Autonomic Agents|autonomic agents|mesh-ancestor
5859008|NCT02409563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5859009|NCT02409563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859010|NCT02409563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5859011|NCT02409563|Respiratory System Agents|respiratory system agents|mesh-ancestor
5859012|NCT02409563|Glucocorticoids|glucocorticoids|mesh-ancestor
5859013|NCT02409563|Hormones|hormones|mesh-ancestor
5859014|NCT02409563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5859015|NCT02409433|Lacosamide|lacosamide|mesh-list
5859016|NCT02409433|Phenytoin|phenytoin|mesh-list
5859017|NCT02409433|Anticonvulsants|anticonvulsants|mesh-ancestor
5859018|NCT02409433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5859019|NCT02409433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5859020|NCT02409433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5859021|NCT02409433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5859022|NCT02409433|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5859023|NCT02409433|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5859024|NCT02409017|Insulin|insulin|mesh-list
5859025|NCT02409017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5859026|NCT02409017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859027|NCT02408991|Lenograstim|lenograstim|mesh-list
5859028|NCT02408991|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5859029|NCT02408991|Immunologic Factors|immunologic factors|mesh-ancestor
5859030|NCT02408991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859031|NCT02409004|Rifampin|rifampin|mesh-list
5859032|NCT02409004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5859033|NCT02409004|Antitubercular Agents|antitubercular agents|mesh-ancestor
5859034|NCT02409004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5859035|NCT02409004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5674294|NCT03540979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674295|NCT03540979|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5674296|NCT03540979|Hormone Antagonists|hormone antagonists|mesh-ancestor
5674297|NCT03540979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5674298|NCT03540979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674299|NCT03540979|Progestins|progestins|mesh-ancestor
5674300|NCT03540979|Hormones|hormones|mesh-ancestor
5674301|NCT03540953|Mitomycins|mitomycins|mesh-list
5859036|NCT02409004|Leprostatic Agents|leprostatic agents|mesh-ancestor
5859037|NCT02409004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5859038|NCT02409004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5859039|NCT02409004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5859040|NCT02409004|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5859041|NCT02409004|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5859042|NCT02409004|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5859043|NCT02409004|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5859044|NCT02409004|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5859045|NCT02409004|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5859046|NCT02409290|Moxifloxacin|moxifloxacin|mesh-list
5859047|NCT02409290|Levofloxacin|levofloxacin|mesh-list
5859048|NCT02409290|Isoniazid|isoniazid|mesh-list
5674302|NCT03540953|Mitomycin|mitomycin|mesh-list
5674303|NCT03540953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5859049|NCT02409290|Pyrazinamide|pyrazinamide|mesh-list
5859050|NCT02409290|Ethambutol|ethambutol|mesh-list
5859051|NCT02409290|Bedaquiline|bedaquiline|mesh-list
5859052|NCT02409290|Clofazimine|clofazimine|mesh-list
5859053|NCT02409290|Kanamycin|kanamycin|mesh-list
5859054|NCT02409290|Prothionamide|prothionamide|mesh-list
5859055|NCT02409290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5859056|NCT02409290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5674304|NCT03540953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5674305|NCT03540953|Alkylating Agents|alkylating agents|mesh-ancestor
5674306|NCT03540953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5859057|NCT02409290|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5859058|NCT02409290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5859059|NCT02409290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5859060|NCT02409290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5859061|NCT02409290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5859062|NCT02409290|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5859063|NCT02409290|Renal Agents|renal agents|mesh-ancestor
5859064|NCT02409290|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5859065|NCT02409290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5859066|NCT02409290|Antitubercular Agents|antitubercular agents|mesh-ancestor
5859067|NCT02409290|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5859068|NCT02409290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5859069|NCT02409290|Antimetabolites|antimetabolites|mesh-ancestor
5859070|NCT02409290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5859071|NCT02409290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5859072|NCT02409290|Leprostatic Agents|leprostatic agents|mesh-ancestor
5859073|NCT02409290|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5859074|NCT02409199|Docetaxel|docetaxel|mesh-list
5859075|NCT02409199|Apatinib|apatinib|mesh-list
5859076|NCT02409199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5859077|NCT02409199|Tubulin Modulators|tubulin modulators|mesh-ancestor
5859078|NCT02409199|Antimitotic Agents|antimitotic agents|mesh-ancestor
5859079|NCT02409199|Mitosis Modulators|mitosis modulators|mesh-ancestor
5904527|NCT05033756|Pembrolizumab|pembrolizumab|mesh-list
5674307|NCT03540953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5674308|NCT03540953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5674309|NCT03540914|Acetazolamide|acetazolamide|mesh-list
5674310|NCT03540914|Anticonvulsants|anticonvulsants|mesh-ancestor
5674311|NCT03540914|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5674312|NCT03540914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5674313|NCT03540914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674314|NCT03540914|Diuretics|diuretics|mesh-ancestor
5674315|NCT03540914|Natriuretic Agents|natriuretic agents|mesh-ancestor
5674316|NCT03540914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674317|NCT03540849|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5674318|NCT03540849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5674319|NCT03540849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5674320|NCT03540836|Cortisone|cortisone|mesh-list
5674321|NCT03540836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5674322|NCT03540810|Hydroxychloroquine|hydroxychloroquine|mesh-list
5674323|NCT03540810|Antimalarials|antimalarials|mesh-ancestor
5674324|NCT03540810|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5674325|NCT03540810|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5674326|NCT03540810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5674327|NCT03540810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5674328|NCT03540810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674329|NCT03540810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5674330|NCT03540628|Ascorbic Acid|ascorbic acid|mesh-list
5674331|NCT03540628|Thiamine|thiamine|mesh-list
5674332|NCT03540628|Vitamins|vitamins|mesh-ancestor
5674333|NCT03540628|Micronutrients|micronutrients|mesh-ancestor
5674334|NCT03540628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859080|NCT02409199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5859081|NCT02409199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5859082|NCT02409199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5859083|NCT02409147|Aspirin|aspirin|mesh-list
5859084|NCT02409147|Nystatin|nystatin|mesh-list
5859085|NCT02409147|Prednisone|prednisone|mesh-list
5859086|NCT02409147|Thymoglobulin|thymoglobulin|mesh-list
5859087|NCT02409147|Basiliximab|basiliximab|mesh-list
5859088|NCT02409147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5859089|NCT02409147|Glucocorticoids|glucocorticoids|mesh-ancestor
5859090|NCT02409147|Hormones|hormones|mesh-ancestor
5859091|NCT02409147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5859092|NCT02409147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859093|NCT02409147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5859094|NCT02409147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5859095|NCT02409147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5674335|NCT03540628|Antioxidants|antioxidants|mesh-ancestor
5674336|NCT03540628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674337|NCT03540628|Protective Agents|protective agents|mesh-ancestor
5674338|NCT03540628|Vitamin B Complex|vitamin b complex|mesh-ancestor
5696296|NCT03383822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5696297|NCT03383822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696298|NCT03383744|Vitamin A|vitamin a|mesh-list
5696299|NCT03383744|Vitamins|vitamins|mesh-ancestor
5696300|NCT03383744|Micronutrients|micronutrients|mesh-ancestor
5696301|NCT03383744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696302|NCT03383575|Azacitidine|azacitidine|mesh-list
5696303|NCT03383575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5696304|NCT03383575|Antimetabolites|antimetabolites|mesh-ancestor
5696305|NCT03383575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696306|NCT03383575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5859096|NCT02409147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5859097|NCT02409147|Analgesics|analgesics|mesh-ancestor
5859098|NCT02409147|Sensory System Agents|sensory system agents|mesh-ancestor
5859099|NCT02409147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5859100|NCT02409147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6674943|NCT01572116|Respiratory System Agents|respiratory system agents|mesh-ancestor
6674944|NCT01572116|Mydriatics|mydriatics|mesh-ancestor
6674945|NCT01572116|Sympathomimetics|sympathomimetics|mesh-ancestor
6674946|NCT01572116|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6674947|NCT01572116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6674948|NCT01572116|Narcotics|narcotics|mesh-ancestor
6674949|NCT01572116|Analgesics|analgesics|mesh-ancestor
6674950|NCT01572116|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6674951|NCT01572116|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6674952|NCT01572116|Anesthetics, General|anesthetics, general|mesh-ancestor
5696307|NCT03383575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5696308|NCT03383406|Cytarabine|cytarabine|mesh-list
5696309|NCT03383406|Methotrexate|methotrexate|mesh-list
5696310|NCT03383406|Etoposide|etoposide|mesh-list
5696311|NCT03383406|Ifosfamide|ifosfamide|mesh-list
5696312|NCT03383406|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5859101|NCT02409147|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6674953|NCT01572129|Clopidogrel|clopidogrel|mesh-list
6674954|NCT01572129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6674955|NCT01572129|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6674956|NCT01572129|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6674957|NCT01572129|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6674958|NCT01572129|Purinergic Agents|purinergic agents|mesh-ancestor
6674959|NCT01572129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6674960|NCT01572129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674961|NCT01572129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674962|NCT01572181|Fludarabine|fludarabine|mesh-list
6674963|NCT01572181|Busulfan|busulfan|mesh-list
6674964|NCT01572181|Thymoglobulin|thymoglobulin|mesh-list
6674965|NCT01572181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6674966|NCT01572181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6674967|NCT01572181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6674968|NCT01572181|Immunologic Factors|immunologic factors|mesh-ancestor
5859102|NCT02409147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5859103|NCT02409147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5859104|NCT02409147|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5859105|NCT02409147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5859106|NCT02409147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5859107|NCT02409147|Antipyretics|antipyretics|mesh-ancestor
5859108|NCT02409147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5859109|NCT02409147|Immunologic Factors|immunologic factors|mesh-ancestor
5859110|NCT02409147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5674339|NCT03540485|Melatonin|melatonin|mesh-list
5674340|NCT03540485|Antioxidants|antioxidants|mesh-ancestor
5674341|NCT03540485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674342|NCT03540485|Protective Agents|protective agents|mesh-ancestor
5674343|NCT03540485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674344|NCT03540485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5674345|NCT03540472|Tacrolimus|tacrolimus|mesh-list
5674346|NCT03540472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5674347|NCT03540472|Immunologic Factors|immunologic factors|mesh-ancestor
5674348|NCT03540472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674349|NCT03540472|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5674350|NCT03540472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5674351|NCT03540472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674352|NCT03540368|Tranexamic Acid|tranexamic acid|mesh-list
5674353|NCT03540368|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5674354|NCT03540368|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5674355|NCT03540368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674356|NCT03540368|Hemostatics|hemostatics|mesh-ancestor
5674357|NCT03540368|Coagulants|coagulants|mesh-ancestor
5674358|NCT03540355|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5674359|NCT03540355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5674360|NCT03540355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5674361|NCT03540355|Antimetabolites|antimetabolites|mesh-ancestor
5674362|NCT03540355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5859111|NCT02409147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5859112|NCT02409147|Antifungal Agents|antifungal agents|mesh-ancestor
5859113|NCT02409147|Ionophores|ionophores|mesh-ancestor
5859114|NCT02409147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5859115|NCT02409186|Paclitaxel|paclitaxel|mesh-list
5859116|NCT02409186|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5859117|NCT02409186|Cisplatin|cisplatin|mesh-list
5859118|NCT02409186|Nimotuzumab|nimotuzumab|mesh-list
5859119|NCT02409186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5859120|NCT02409186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5859121|NCT02409186|Tubulin Modulators|tubulin modulators|mesh-ancestor
5859122|NCT02409186|Antimitotic Agents|antimitotic agents|mesh-ancestor
5859123|NCT02409186|Mitosis Modulators|mitosis modulators|mesh-ancestor
5859124|NCT02409186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5859125|NCT02409186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5859126|NCT02408978|Naproxen|naproxen|mesh-list
5859127|NCT02408978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5859128|NCT02408978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5859129|NCT02408978|Analgesics|analgesics|mesh-ancestor
5859130|NCT02408978|Sensory System Agents|sensory system agents|mesh-ancestor
5859131|NCT02408978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5859132|NCT02408978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859133|NCT02408978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5859134|NCT02408978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5859135|NCT02408978|Gout Suppressants|gout suppressants|mesh-ancestor
5859136|NCT02408978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5859137|NCT02408978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5904528|NCT05033756|Olaparib|olaparib|mesh-list
6674969|NCT01572181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859138|NCT02408978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5859139|NCT02409238|Metformin|metformin|mesh-list
5859140|NCT02409238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5859141|NCT02409238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859142|NCT02408679|Vitamin D|vitamin d|mesh-list
5859143|NCT02408679|Vitamins|vitamins|mesh-ancestor
5859144|NCT02408679|Micronutrients|micronutrients|mesh-ancestor
5859145|NCT02408679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859146|NCT02408679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5859147|NCT02408705|Acetaminophen|acetaminophen|mesh-list
5859148|NCT02408705|Liraglutide|liraglutide|mesh-list
5859149|NCT02408705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5859150|NCT02408705|Analgesics|analgesics|mesh-ancestor
5859151|NCT02408705|Sensory System Agents|sensory system agents|mesh-ancestor
5859152|NCT02408705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5859153|NCT02408705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859154|NCT02408705|Antipyretics|antipyretics|mesh-ancestor
5859155|NCT02408705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5859156|NCT02408705|Incretins|incretins|mesh-ancestor
5859157|NCT02408705|Hormones|hormones|mesh-ancestor
5859158|NCT02408705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5859159|NCT02408744|Pirfenidone|pirfenidone|mesh-list
5859160|NCT02408744|Analgesics|analgesics|mesh-ancestor
5674363|NCT03540355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5674364|NCT03540355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5674365|NCT03540355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5674366|NCT03540225|Progesterone|progesterone|mesh-list
5674367|NCT03540225|Progestins|progestins|mesh-ancestor
5674368|NCT03540225|Hormones|hormones|mesh-ancestor
5674369|NCT03540225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5674370|NCT03540225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674371|NCT03540212|Sofosbuvir|sofosbuvir|mesh-list
5674372|NCT03540212|Antiviral Agents|antiviral agents|mesh-ancestor
5859161|NCT02408744|Sensory System Agents|sensory system agents|mesh-ancestor
5859162|NCT02408744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5859163|NCT02408744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859164|NCT02408744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5859165|NCT02408744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5859166|NCT02408744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5859167|NCT02408744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5859168|NCT02408744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5859169|NCT02408939|Hydrocortisone|hydrocortisone|mesh-list
5859170|NCT02408939|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6494533|NCT00618852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494534|NCT00618969|Busulfan|busulfan|mesh-list
6494535|NCT00618969|Melphalan|melphalan|mesh-list
5674373|NCT03540212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5674374|NCT03540199|Antibodies|antibodies|mesh-list
5859171|NCT02408939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5859172|NCT02408926|Vaccines|vaccines|mesh-list
5859173|NCT02408926|Immunologic Factors|immunologic factors|mesh-ancestor
5859174|NCT02408926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859175|NCT02408770|Ulipristal acetate|ulipristal acetate|mesh-list
5859176|NCT02408770|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5859177|NCT02408770|Contraceptive Agents|contraceptive agents|mesh-ancestor
5859178|NCT02408770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5859179|NCT02408770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859180|NCT02408770|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5859181|NCT02408562|Becaplermin|becaplermin|mesh-list
5859182|NCT02408562|Anticoagulants|anticoagulants|mesh-ancestor
5859183|NCT02408562|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
5859184|NCT02408562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5859185|NCT02408562|Growth Substances|growth substances|mesh-ancestor
5859186|NCT02408562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859187|NCT02408393|Ropivacaine|ropivacaine|mesh-list
5859188|NCT02408393|Anesthetics, Local|anesthetics, local|mesh-ancestor
5859189|NCT02408393|Anesthetics|anesthetics|mesh-ancestor
5859190|NCT02408393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5859191|NCT02408393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859192|NCT02408393|Sensory System Agents|sensory system agents|mesh-ancestor
5674375|NCT03540199|Antibodies, Bispecific|antibodies, bispecific|mesh-list
5674376|NCT03540199|Immunologic Factors|immunologic factors|mesh-ancestor
5859193|NCT02408393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5859194|NCT02408354|Glycerol|glycerol|mesh-list
5859195|NCT02408354|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
5859196|NCT02408354|Protective Agents|protective agents|mesh-ancestor
5674377|NCT03540199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859197|NCT02408354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859198|NCT02408185|Colistin|colistin|mesh-list
5859199|NCT02408185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5859200|NCT02408185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5859201|NCT02408302|Midazolam|midazolam|mesh-list
5859202|NCT02408302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5859203|NCT02408302|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5859204|NCT02408302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5859205|NCT02408302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859206|NCT02408302|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5859207|NCT02408302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5859208|NCT02408302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5859209|NCT02408302|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5674378|NCT03540095|Bupivacaine|bupivacaine|mesh-list
5674379|NCT03540095|Anesthetics, Local|anesthetics, local|mesh-ancestor
5674380|NCT03540095|Anesthetics|anesthetics|mesh-ancestor
5674381|NCT03540095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5674382|NCT03540095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674383|NCT03540095|Sensory System Agents|sensory system agents|mesh-ancestor
5674384|NCT03540095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5859210|NCT02408302|Anesthetics, General|anesthetics, general|mesh-ancestor
5859211|NCT02408302|Anesthetics|anesthetics|mesh-ancestor
5859212|NCT02408302|GABA Modulators|gaba modulators|mesh-ancestor
5859213|NCT02408302|GABA Agents|gaba agents|mesh-ancestor
5859214|NCT02408302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5859215|NCT02408302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5859216|NCT02408328|Caffeine|caffeine|mesh-list
5859217|NCT02408328|Caffeine citrate|caffeine citrate|mesh-list
5859218|NCT02408328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5859219|NCT02408328|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5859220|NCT02408328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859221|NCT02408328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5859222|NCT02408328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5859223|NCT02408328|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5859224|NCT02408328|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5674385|NCT03540017|Cisplatin|cisplatin|mesh-list
5674386|NCT03540017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5674387|NCT03539952|Penicillamine|penicillamine|mesh-list
5674388|NCT03539952|Trientine|trientine|mesh-list
5674389|NCT03539952|Chelating Agents|chelating agents|mesh-ancestor
5674390|NCT03539952|Sequestering Agents|sequestering agents|mesh-ancestor
5674391|NCT03539952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674392|NCT03539952|Antidotes|antidotes|mesh-ancestor
5674393|NCT03539952|Protective Agents|protective agents|mesh-ancestor
5674394|NCT03539952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674395|NCT03539952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5674396|NCT03539887|Ketamine|ketamine|mesh-list
5674397|NCT03539887|Analgesics|analgesics|mesh-ancestor
5674398|NCT03539887|Sensory System Agents|sensory system agents|mesh-ancestor
5674399|NCT03539887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5859225|NCT02408328|Purinergic Agents|purinergic agents|mesh-ancestor
5859226|NCT02408328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5859227|NCT02408289|Proanthocyanidin|proanthocyanidin|mesh-list
5859228|NCT02408289|Procyanidin|procyanidin|mesh-list
5859229|NCT02408289|Antioxidants|antioxidants|mesh-ancestor
5859230|NCT02408289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5859231|NCT02408289|Protective Agents|protective agents|mesh-ancestor
5859232|NCT02408289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859233|NCT02408289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5859234|NCT02408289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5859235|NCT02408289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5859236|NCT02408419|Bupivacaine|bupivacaine|mesh-list
5859237|NCT02408419|Anesthetics, Local|anesthetics, local|mesh-ancestor
5859238|NCT02408419|Anesthetics|anesthetics|mesh-ancestor
5859239|NCT02408419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5859240|NCT02408419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859241|NCT02408419|Sensory System Agents|sensory system agents|mesh-ancestor
5859242|NCT02408419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5859243|NCT02408172|Metoprolol|metoprolol|mesh-list
5859244|NCT02408172|Amlodipine|amlodipine|mesh-list
5859245|NCT02408172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5859246|NCT02408172|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6674970|NCT01572181|Alkylating Agents|alkylating agents|mesh-ancestor
6674971|NCT01572181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6674972|NCT01572181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5674400|NCT03539887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5908497|NCT04478019|Blood Substitutes|blood substitutes|mesh-ancestor
5859247|NCT02408172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5859248|NCT02408172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5859249|NCT02408172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5859250|NCT02408172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859251|NCT02408172|Vasodilator Agents|vasodilator agents|mesh-ancestor
5859252|NCT02408172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5859253|NCT02408172|Sympatholytics|sympatholytics|mesh-ancestor
5859254|NCT02408172|Autonomic Agents|autonomic agents|mesh-ancestor
5859255|NCT02408172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5859256|NCT02408172|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5859257|NCT02408172|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5859258|NCT02408172|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5859259|NCT02408172|Adrenergic Agents|adrenergic agents|mesh-ancestor
5859260|NCT02408172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5904529|NCT05033756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5904530|NCT05033756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5904531|NCT05033756|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5904532|NCT05033756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5904533|NCT05033756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904534|NCT05031442|Zinc Oxide|zinc oxide|mesh-list
5904535|NCT05031442|Dermatologic Agents|dermatologic agents|mesh-ancestor
5904536|NCT05031442|Sunscreening Agents|sunscreening agents|mesh-ancestor
5674401|NCT03539887|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5674402|NCT03539887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5674403|NCT03539887|Anesthetics, General|anesthetics, general|mesh-ancestor
5674404|NCT03539887|Anesthetics|anesthetics|mesh-ancestor
5674405|NCT03539887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5674406|NCT03539887|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5674407|NCT03539887|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5674408|NCT03539887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5674409|NCT03539887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674410|NCT03539731|Piperazine|piperazine|mesh-list
5674411|NCT03539731|Antinematodal Agents|antinematodal agents|mesh-ancestor
5674412|NCT03539731|Anthelmintics|anthelmintics|mesh-ancestor
5674413|NCT03539731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5674414|NCT03539731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5674415|NCT03539718|Taurolidine|taurolidine|mesh-list
5904537|NCT05031442|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5904538|NCT05031442|Protective Agents|protective agents|mesh-ancestor
5904539|NCT05031442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904540|NCT05030857|Midazolam|midazolam|mesh-list
5904541|NCT05030857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5904542|NCT05030857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5674416|NCT03539718|Heparin|heparin|mesh-list
5674417|NCT03539718|Calcium heparin|calcium heparin|mesh-list
5674418|NCT03539718|Anticoagulants|anticoagulants|mesh-ancestor
5674419|NCT03539718|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5904543|NCT05030857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5904544|NCT05030857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904545|NCT05030857|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5904546|NCT05030857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5904547|NCT05030857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5904548|NCT05030857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5904549|NCT05030857|Anesthetics, General|anesthetics, general|mesh-ancestor
5904550|NCT05030857|Anesthetics|anesthetics|mesh-ancestor
5904551|NCT05030857|GABA Modulators|gaba modulators|mesh-ancestor
5674420|NCT03539718|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5674421|NCT03539718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674422|NCT03539718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5674423|NCT03539718|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5674424|NCT03539718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5904552|NCT05030857|GABA Agents|gaba agents|mesh-ancestor
5904553|NCT05030857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5904554|NCT05030857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904555|NCT05027360|Nitroprusside|nitroprusside|mesh-list
5904556|NCT05027360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5904557|NCT05027360|Vasodilator Agents|vasodilator agents|mesh-ancestor
5904558|NCT05027360|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5904559|NCT05027360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674425|NCT03539627|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
5674426|NCT03539627|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5674427|NCT03539627|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5674428|NCT03539627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5859261|NCT02408146|Celecoxib|celecoxib|mesh-list
5859262|NCT02408146|Parecoxib|parecoxib|mesh-list
5859263|NCT02408146|Fentanyl|fentanyl|mesh-list
5859264|NCT02408146|Ondansetron|ondansetron|mesh-list
5859265|NCT02408146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5859266|NCT02408146|Narcotics|narcotics|mesh-ancestor
5859267|NCT02408146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5859268|NCT02408146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859269|NCT02408146|Analgesics|analgesics|mesh-ancestor
5859270|NCT02408146|Sensory System Agents|sensory system agents|mesh-ancestor
5859271|NCT02408146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5859272|NCT02408146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5859273|NCT02408146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5859274|NCT02408146|Anesthetics, General|anesthetics, general|mesh-ancestor
5859275|NCT02408146|Anesthetics|anesthetics|mesh-ancestor
5859276|NCT02408146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5859277|NCT02408146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5859278|NCT02408146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5859279|NCT02408146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5859280|NCT02408146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5859281|NCT02408146|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5859282|NCT02408146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5859283|NCT02408146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5859284|NCT02408146|Antiemetics|antiemetics|mesh-ancestor
5859285|NCT02408146|Autonomic Agents|autonomic agents|mesh-ancestor
5859286|NCT02408146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5859287|NCT02408146|Antipruritics|antipruritics|mesh-ancestor
5859288|NCT02408146|Dermatologic Agents|dermatologic agents|mesh-ancestor
5859289|NCT02408146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5859290|NCT02408146|Serotonin Agents|serotonin agents|mesh-ancestor
5859291|NCT02408146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5859292|NCT02408146|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5859293|NCT02408146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5859294|NCT02408146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5859295|NCT02408146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5859296|NCT02407899|Vitamin D|vitamin d|mesh-list
5674429|NCT03539614|Prazosin|prazosin|mesh-list
5674430|NCT03539614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5674431|NCT03539614|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5674432|NCT03539614|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5674433|NCT03539614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5674434|NCT03539614|Adrenergic Agents|adrenergic agents|mesh-ancestor
5674435|NCT03539614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5674436|NCT03539614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5859297|NCT02407899|Cholecalciferol|cholecalciferol|mesh-list
5859298|NCT02407899|Insulin|insulin|mesh-list
5859299|NCT02407899|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5859300|NCT02407899|Metformin|metformin|mesh-list
5859301|NCT02407899|Saxagliptin|saxagliptin|mesh-list
5859302|NCT02407899|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
5859303|NCT02407899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5859304|NCT02407899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859305|NCT02407899|Vitamins|vitamins|mesh-ancestor
5859306|NCT02407899|Micronutrients|micronutrients|mesh-ancestor
5859307|NCT02407899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5859308|NCT02407899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5859309|NCT02407899|Incretins|incretins|mesh-ancestor
5859310|NCT02407899|Hormones|hormones|mesh-ancestor
5859311|NCT02407899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5859312|NCT02407899|Protease Inhibitors|protease inhibitors|mesh-ancestor
5859313|NCT02407899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5859314|NCT02407899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5859315|NCT02408042|Rituximab|rituximab|mesh-list
5674437|NCT03539614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674438|NCT03539562|Promethazine|promethazine|mesh-list
5674439|NCT03539562|Diphenhydramine|diphenhydramine|mesh-list
5859316|NCT02408042|Pembrolizumab|pembrolizumab|mesh-list
5859317|NCT02408042|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5859318|NCT02408042|Carboplatin|carboplatin|mesh-list
5859319|NCT02408042|Etoposide|etoposide|mesh-list
5859320|NCT02408042|Ifosfamide|ifosfamide|mesh-list
5859321|NCT02408042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5674440|NCT03539562|Morphine|morphine|mesh-list
5859322|NCT02408042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5674441|NCT03539562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5859323|NCT02408042|Immunologic Factors|immunologic factors|mesh-ancestor
5859324|NCT02408042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859325|NCT02408042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5859326|NCT02408042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5859327|NCT02408042|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5859328|NCT02408042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5859329|NCT02408042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6674973|NCT01572259|Hormones|hormones|mesh-list
5674442|NCT03539562|Narcotics|narcotics|mesh-ancestor
5674443|NCT03539562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5859330|NCT02408042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5859331|NCT02408042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5859332|NCT02408042|Alkylating Agents|alkylating agents|mesh-ancestor
5859333|NCT02408003|Simendan|simendan|mesh-list
5859334|NCT02408003|Milrinone|milrinone|mesh-list
5859335|NCT02408003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5859336|NCT02408003|Vasodilator Agents|vasodilator agents|mesh-ancestor
5859337|NCT02408003|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5859338|NCT02408003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5859339|NCT02408003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5859340|NCT02408003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5859341|NCT02408003|Protective Agents|protective agents|mesh-ancestor
5859342|NCT02408003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859343|NCT02408003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5859344|NCT02407821|Citalopram|citalopram|mesh-list
5859345|NCT02407821|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5859346|NCT02407821|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5859347|NCT02407821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5859348|NCT02407821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5859349|NCT02407821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5859350|NCT02407821|Serotonin Agents|serotonin agents|mesh-ancestor
5674444|NCT03539562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674445|NCT03539562|Analgesics|analgesics|mesh-ancestor
5674446|NCT03539562|Sensory System Agents|sensory system agents|mesh-ancestor
5674447|NCT03539562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5674448|NCT03539562|Antipruritics|antipruritics|mesh-ancestor
5674449|NCT03539562|Dermatologic Agents|dermatologic agents|mesh-ancestor
5674450|NCT03539562|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5674451|NCT03539562|Histamine Antagonists|histamine antagonists|mesh-ancestor
5674452|NCT03539562|Histamine Agents|histamine agents|mesh-ancestor
5674453|NCT03539562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5674454|NCT03539562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674455|NCT03539562|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5859351|NCT02407821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859352|NCT02407821|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5674456|NCT03539562|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5674457|NCT03539562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5674458|NCT03539562|Anesthetics, Local|anesthetics, local|mesh-ancestor
5674459|NCT03539562|Anesthetics|anesthetics|mesh-ancestor
5674460|NCT03539562|Antiemetics|antiemetics|mesh-ancestor
5674461|NCT03539562|Autonomic Agents|autonomic agents|mesh-ancestor
5674462|NCT03539562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5674463|NCT03539445|3-n-butylphthalide|3-n-butylphthalide|mesh-list
5674464|NCT03539445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5674465|NCT03539445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5674466|NCT03539445|Protective Agents|protective agents|mesh-ancestor
5674467|NCT03539445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674468|NCT03539367|Acetazolamide|acetazolamide|mesh-list
5674469|NCT03539367|Anticonvulsants|anticonvulsants|mesh-ancestor
5859353|NCT02407821|Antidepressive Agents|antidepressive agents|mesh-ancestor
5859354|NCT02407821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5859355|NCT02407912|Cisplatin|cisplatin|mesh-list
5859356|NCT02407912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5859357|NCT02407834|Sodium Hypochlorite|sodium hypochlorite|mesh-list
5859358|NCT02407834|Eusol|eusol|mesh-list
5674470|NCT03539367|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5674471|NCT03539367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5674472|NCT03539367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674473|NCT03539367|Diuretics|diuretics|mesh-ancestor
5674474|NCT03539367|Natriuretic Agents|natriuretic agents|mesh-ancestor
5674475|NCT03539367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674476|NCT03539328|Gemcitabine|gemcitabine|mesh-list
5674477|NCT03539328|Paclitaxel|paclitaxel|mesh-list
5674478|NCT03539328|Doxorubicin|doxorubicin|mesh-list
5674479|NCT03539328|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5674480|NCT03539328|Pembrolizumab|pembrolizumab|mesh-list
5674481|NCT03539328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5674482|NCT03539328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5859359|NCT02407834|Disinfectants|disinfectants|mesh-ancestor
5674483|NCT03539328|Tubulin Modulators|tubulin modulators|mesh-ancestor
5674484|NCT03539328|Antimitotic Agents|antimitotic agents|mesh-ancestor
5674485|NCT03539328|Mitosis Modulators|mitosis modulators|mesh-ancestor
5674486|NCT03539328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674487|NCT03539328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5674488|NCT03539328|Antimetabolites|antimetabolites|mesh-ancestor
5674489|NCT03539328|Antiviral Agents|antiviral agents|mesh-ancestor
5674490|NCT03539328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5674491|NCT03539328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5674492|NCT03539328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5674493|NCT03539328|Immunologic Factors|immunologic factors|mesh-ancestor
5674494|NCT03539328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674495|NCT03539328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5674496|NCT03539328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5674497|NCT03539328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5674498|NCT03539328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5674499|NCT03539224|Lamivudine|lamivudine|mesh-list
5674500|NCT03539224|Dolutegravir|dolutegravir|mesh-list
5674501|NCT03539224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5674502|NCT03539224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5674503|NCT03539224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5674504|NCT03539224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674505|NCT03539224|Antiviral Agents|antiviral agents|mesh-ancestor
5674506|NCT03539224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5674507|NCT03539224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5674508|NCT03539224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5674509|NCT03539224|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5674510|NCT03539224|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5674511|NCT03539198|Nivolumab|nivolumab|mesh-list
5674512|NCT03539198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5674513|NCT03539198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5674514|NCT03539198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5674515|NCT03539198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674516|NCT03539172|Apatinib|apatinib|mesh-list
5674517|NCT03539172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5674518|NCT03539172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5674519|NCT03539172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5674520|NCT03539172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674521|NCT03539159|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5674522|NCT03539159|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5674523|NCT03539055|Dabigatran|dabigatran|mesh-list
5674524|NCT03539055|Antithrombins|antithrombins|mesh-ancestor
5674525|NCT03539055|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5674526|NCT03539055|Protease Inhibitors|protease inhibitors|mesh-ancestor
5674527|NCT03539055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5674528|NCT03539055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674529|NCT03539055|Anticoagulants|anticoagulants|mesh-ancestor
5859360|NCT02407834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5859361|NCT02407782|Ivermectin|ivermectin|mesh-list
5859362|NCT02407782|Permethrin|permethrin|mesh-list
5859363|NCT02407782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5859364|NCT02407782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5859365|NCT02407782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5859366|NCT02407782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5859367|NCT02407470|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5674530|NCT03539003|Remifentanil|remifentanil|mesh-list
5674531|NCT03539003|Propofol|propofol|mesh-list
5674532|NCT03539003|Sevoflurane|sevoflurane|mesh-list
5674533|NCT03539003|Desflurane|desflurane|mesh-list
5674534|NCT03539003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5674535|NCT03539003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5674536|NCT03539003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674537|NCT03539003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5674538|NCT03539003|Anesthetics, General|anesthetics, general|mesh-ancestor
5674539|NCT03539003|Anesthetics|anesthetics|mesh-ancestor
5674540|NCT03539003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5674541|NCT03539003|Narcotics|narcotics|mesh-ancestor
5674542|NCT03539003|Analgesics|analgesics|mesh-ancestor
5674543|NCT03539003|Sensory System Agents|sensory system agents|mesh-ancestor
5674544|NCT03539003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5859368|NCT02407470|Immunologic Factors|immunologic factors|mesh-ancestor
5859369|NCT02407470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674545|NCT03539003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5674546|NCT03539003|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5696313|NCT03383406|Abortifacient Agents|abortifacient agents|mesh-ancestor
5696314|NCT03383406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5696315|NCT03383406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859370|NCT02407470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5859371|NCT02407600|Aprepitant|aprepitant|mesh-list
5859372|NCT02407600|Fosaprepitant|fosaprepitant|mesh-list
5859373|NCT02407600|Antiemetics|antiemetics|mesh-ancestor
5859374|NCT02407600|Autonomic Agents|autonomic agents|mesh-ancestor
5859375|NCT02407600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5859376|NCT02407600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859377|NCT02407600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5859378|NCT02407600|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5859379|NCT02407600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5859380|NCT02407600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5859381|NCT02407626|Propofol|propofol|mesh-list
5859382|NCT02407626|Sevoflurane|sevoflurane|mesh-list
5859383|NCT02407626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5859384|NCT02407626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5859385|NCT02407626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859386|NCT02407626|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5859387|NCT02407626|Anesthetics, General|anesthetics, general|mesh-ancestor
5859388|NCT02407626|Anesthetics|anesthetics|mesh-ancestor
5859389|NCT02407626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5859390|NCT02407626|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5859391|NCT02407392|Acetic Acid|acetic acid|mesh-list
5859392|NCT02407392|Retinol acetate|retinol acetate|mesh-list
5859393|NCT02407392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5859394|NCT02407392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5859395|NCT02407392|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5859396|NCT02407392|Immunologic Factors|immunologic factors|mesh-ancestor
5859397|NCT02407392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859398|NCT02407392|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5859399|NCT02407392|Protective Agents|protective agents|mesh-ancestor
5859400|NCT02407392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5859401|NCT02407366|Carboplatin|carboplatin|mesh-list
5859402|NCT02407366|Pemetrexed|pemetrexed|mesh-list
5859403|NCT02407366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5859404|NCT02407366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5859405|NCT02407366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5859406|NCT02407366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5859407|NCT02407366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5859408|NCT02407340|Benzalkonium Compounds|benzalkonium compounds|mesh-list
5859409|NCT02407340|Oxytocin|oxytocin|mesh-list
5859410|NCT02407340|Oxytocics|oxytocics|mesh-ancestor
5859411|NCT02407340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5859412|NCT02407340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859413|NCT02407340|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5859414|NCT02407340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5674547|NCT03538704|Metformin|metformin|mesh-list
5674548|NCT03538704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5674549|NCT03538704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674550|NCT03538691|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5674551|NCT03538691|Dexetimide|dexetimide|mesh-list
5674552|NCT03538691|Citalopram|citalopram|mesh-list
5674553|NCT03538691|Fluoxetine|fluoxetine|mesh-list
5674554|NCT03538691|Paroxetine|paroxetine|mesh-list
5674555|NCT03538691|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
5674556|NCT03538691|Sertraline|sertraline|mesh-list
5674557|NCT03538691|Brexpiprazole|brexpiprazole|mesh-list
5674558|NCT03538691|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5674559|NCT03538691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5674560|NCT03538691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5674561|NCT03538691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674562|NCT03538691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5674563|NCT03538691|Serotonin Agents|serotonin agents|mesh-ancestor
5674564|NCT03538691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674565|NCT03538691|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5674566|NCT03538691|Antidepressive Agents|antidepressive agents|mesh-ancestor
5674567|NCT03538691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5674568|NCT03538691|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5674569|NCT03538691|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5674570|NCT03538691|Parasympatholytics|parasympatholytics|mesh-ancestor
5674571|NCT03538691|Autonomic Agents|autonomic agents|mesh-ancestor
5674572|NCT03538691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5674573|NCT03538691|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5674574|NCT03538691|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5674575|NCT03538691|Cholinergic Agents|cholinergic agents|mesh-ancestor
5674576|NCT03538691|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5674577|NCT03538691|Analgesics|analgesics|mesh-ancestor
5859415|NCT02407509|Everolimus|everolimus|mesh-list
5859416|NCT02407509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5859417|NCT02407509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5859418|NCT02407509|Immunologic Factors|immunologic factors|mesh-ancestor
5859419|NCT02407509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859420|NCT02407548|Vitamin E|vitamin e|mesh-list
5859421|NCT02407548|Coenzyme Q10|coenzyme q10|mesh-list
5859422|NCT02407548|Ubiquinone|ubiquinone|mesh-list
5859423|NCT02407548|Vitamins|vitamins|mesh-ancestor
5859424|NCT02407548|Micronutrients|micronutrients|mesh-ancestor
5859425|NCT02407548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859426|NCT02407548|Antioxidants|antioxidants|mesh-ancestor
5859427|NCT02407548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5859428|NCT02407548|Protective Agents|protective agents|mesh-ancestor
5859429|NCT02407171|Pembrolizumab|pembrolizumab|mesh-list
5859430|NCT02407171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5859431|NCT02407171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5859432|NCT02407210|Olmesartan|olmesartan|mesh-list
5859433|NCT02407210|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
5859434|NCT02407210|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
5859435|NCT02407210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5859436|NCT02407210|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5859437|NCT02407210|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5859438|NCT02407210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5859439|NCT02407119|Amoxicillin|amoxicillin|mesh-list
5859440|NCT02407119|Clarithromycin|clarithromycin|mesh-list
5859441|NCT02407119|Omeprazole|omeprazole|mesh-list
5859442|NCT02407119|Rabeprazole|rabeprazole|mesh-list
5859443|NCT02407119|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
5859444|NCT02407119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5859445|NCT02407119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5859446|NCT02407119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5859447|NCT02407119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5859448|NCT02407119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5859449|NCT02407119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674578|NCT03538691|Sensory System Agents|sensory system agents|mesh-ancestor
5674579|NCT03538691|Dopamine Agents|dopamine agents|mesh-ancestor
5674580|NCT03538691|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5674581|NCT03538691|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5674582|NCT03538691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5674583|NCT03538691|Dopamine Agonists|dopamine agonists|mesh-ancestor
5674584|NCT03538496|Bupivacaine|bupivacaine|mesh-list
5674585|NCT03538496|Anesthetics, Local|anesthetics, local|mesh-ancestor
5674586|NCT03538496|Anesthetics|anesthetics|mesh-ancestor
5674587|NCT03538496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5674588|NCT03538496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674589|NCT03538496|Sensory System Agents|sensory system agents|mesh-ancestor
5674590|NCT03538496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5674591|NCT03538483|Bupivacaine|bupivacaine|mesh-list
5674592|NCT03538483|Anesthetics, Local|anesthetics, local|mesh-ancestor
5674593|NCT03538483|Anesthetics|anesthetics|mesh-ancestor
5674594|NCT03538483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5674595|NCT03538483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674596|NCT03538483|Sensory System Agents|sensory system agents|mesh-ancestor
5674597|NCT03538483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5674598|NCT03538457|Acetaminophen|acetaminophen|mesh-list
5674599|NCT03538457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5674600|NCT03538457|Analgesics|analgesics|mesh-ancestor
5674601|NCT03538457|Sensory System Agents|sensory system agents|mesh-ancestor
5674602|NCT03538457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5674603|NCT03538457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674604|NCT03538457|Antipyretics|antipyretics|mesh-ancestor
5674605|NCT03538327|Silybin|silybin|mesh-list
5674606|NCT03538327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5674607|NCT03538327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5674608|NCT03538327|Protective Agents|protective agents|mesh-ancestor
5674609|NCT03538327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674610|NCT03538171|Exemestane|exemestane|mesh-list
5674611|NCT03538171|Entinostat|entinostat|mesh-list
5674612|NCT03538171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5674613|NCT03538171|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5674614|NCT03538171|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5674615|NCT03538171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5859450|NCT02407119|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5859451|NCT02407119|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5859452|NCT02407119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5674616|NCT03538171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674617|NCT03538171|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5859453|NCT02407314|Aspirin|aspirin|mesh-list
5859454|NCT02407314|Ticagrelor|ticagrelor|mesh-list
5859455|NCT02407314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5859456|NCT02407314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5859457|NCT02407314|Analgesics|analgesics|mesh-ancestor
5859458|NCT02407314|Sensory System Agents|sensory system agents|mesh-ancestor
5859459|NCT02407314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5859460|NCT02407314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859461|NCT02407314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5859462|NCT02407314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5859463|NCT02407314|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5859464|NCT02407314|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5859465|NCT02407314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5859466|NCT02407314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5859467|NCT02407314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6494536|NCT00618969|Alkylating Agents|alkylating agents|mesh-ancestor
6494537|NCT00618969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494538|NCT00618969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6494539|NCT00618969|Immunologic Factors|immunologic factors|mesh-ancestor
5674618|NCT03538171|Hormone Antagonists|hormone antagonists|mesh-ancestor
5859468|NCT02407314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5859469|NCT02407314|Antipyretics|antipyretics|mesh-ancestor
5859470|NCT02407314|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5859471|NCT02407314|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5859472|NCT02407314|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5859473|NCT02407314|Purinergic Agents|purinergic agents|mesh-ancestor
5859474|NCT02407314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5859475|NCT02407080|Interferons|interferons|mesh-list
5859476|NCT02407080|Interferon-alpha|interferon-alpha|mesh-list
5859477|NCT02407080|Interferon alpha-2|interferon alpha-2|mesh-list
5859478|NCT02407080|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5674619|NCT03538171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5674620|NCT03538171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674621|NCT03538171|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5674622|NCT03538054|Dextromethorphan|dextromethorphan|mesh-list
5859479|NCT02407080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5859480|NCT02407080|Antiviral Agents|antiviral agents|mesh-ancestor
5859481|NCT02407080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5859482|NCT02407080|Immunologic Factors|immunologic factors|mesh-ancestor
5859483|NCT02407080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859484|NCT02406950|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5859485|NCT02406950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5859486|NCT02406950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859487|NCT02406950|Incretins|incretins|mesh-ancestor
5859488|NCT02406950|Hormones|hormones|mesh-ancestor
5859489|NCT02406950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5859490|NCT02406950|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5859491|NCT02406950|Protease Inhibitors|protease inhibitors|mesh-ancestor
5674623|NCT03538054|Antitussive Agents|antitussive agents|mesh-ancestor
5674624|NCT03538054|Respiratory System Agents|respiratory system agents|mesh-ancestor
5674625|NCT03538054|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5674626|NCT03538054|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5674627|NCT03538054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5674628|NCT03538054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674629|NCT03538054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674630|NCT03537950|Cannabidiol|cannabidiol|mesh-list
5674631|NCT03537950|Anticonvulsants|anticonvulsants|mesh-ancestor
5674632|NCT03537924|Acetazolamide|acetazolamide|mesh-list
5859492|NCT02406950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5859493|NCT02406950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5859494|NCT02406911|Ticagrelor|ticagrelor|mesh-list
5859495|NCT02406911|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5859496|NCT02406911|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5674633|NCT03537924|Anticonvulsants|anticonvulsants|mesh-ancestor
5674634|NCT03537924|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5674635|NCT03537924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5674636|NCT03537924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674637|NCT03537924|Diuretics|diuretics|mesh-ancestor
5674638|NCT03537924|Natriuretic Agents|natriuretic agents|mesh-ancestor
5859497|NCT02406911|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6494540|NCT00618969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494541|NCT00618969|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6494542|NCT00618969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6494543|NCT00618969|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6494544|NCT00619021|Gemcitabine|gemcitabine|mesh-list
6494545|NCT00619021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5674639|NCT03537924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674640|NCT03537898|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5674641|NCT03537898|Plasma-lyte 148|plasma-lyte 148|mesh-list
5674642|NCT03537898|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5674643|NCT03537807|Riluzole|riluzole|mesh-list
5674644|NCT03537807|Anticonvulsants|anticonvulsants|mesh-ancestor
5674645|NCT03537807|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5674646|NCT03537807|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5674647|NCT03537807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5674648|NCT03537807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674649|NCT03537807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494546|NCT00619021|Antimetabolites|antimetabolites|mesh-ancestor
6494547|NCT00619021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494548|NCT00619021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6494549|NCT00619021|Antiviral Agents|antiviral agents|mesh-ancestor
6494550|NCT00619021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6494551|NCT00619021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5674650|NCT03537807|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5674651|NCT03537807|Protective Agents|protective agents|mesh-ancestor
5674652|NCT03537768|Levonorgestrel|levonorgestrel|mesh-list
5674653|NCT03537768|Ulipristal acetate|ulipristal acetate|mesh-list
5674654|NCT03537768|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5674655|NCT03537768|Contraceptive Agents|contraceptive agents|mesh-ancestor
5674656|NCT03537768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5674657|NCT03537768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674658|NCT03537768|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5674659|NCT03537768|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5674660|NCT03537768|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5674661|NCT03537612|Clonidine|clonidine|mesh-list
5674662|NCT03537612|Morphine|morphine|mesh-list
5674663|NCT03537612|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5674664|NCT03537612|Narcotics|narcotics|mesh-ancestor
5674665|NCT03537612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5674666|NCT03537612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674667|NCT03537612|Analgesics|analgesics|mesh-ancestor
5674668|NCT03537612|Sensory System Agents|sensory system agents|mesh-ancestor
5859498|NCT02406911|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5859499|NCT02406911|Purinergic Agents|purinergic agents|mesh-ancestor
5859500|NCT02406911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5859501|NCT02406911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5859502|NCT02406911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859503|NCT02406872|Propofol|propofol|mesh-list
5859504|NCT02406872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5859505|NCT02406872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5859506|NCT02406872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859507|NCT02406872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5859508|NCT02406872|Anesthetics, General|anesthetics, general|mesh-ancestor
5859509|NCT02406872|Anesthetics|anesthetics|mesh-ancestor
5859510|NCT02406781|Pembrolizumab|pembrolizumab|mesh-list
5859511|NCT02406781|Cyclophosphamide|cyclophosphamide|mesh-list
5859512|NCT02406781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5674669|NCT03537612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5674670|NCT03537612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5674671|NCT03537612|Sympatholytics|sympatholytics|mesh-ancestor
5674672|NCT03537612|Autonomic Agents|autonomic agents|mesh-ancestor
5674673|NCT03537612|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5674674|NCT03537612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5674675|NCT03537612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5674676|NCT03537612|Adrenergic Agents|adrenergic agents|mesh-ancestor
5859513|NCT02406781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5859514|NCT02406781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5859515|NCT02406781|Immunologic Factors|immunologic factors|mesh-ancestor
5859516|NCT02406781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859517|NCT02406781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5859518|NCT02406781|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5859519|NCT02406781|Alkylating Agents|alkylating agents|mesh-ancestor
5859520|NCT02406781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5859521|NCT02406781|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5859522|NCT02406508|Sorafenib|sorafenib|mesh-list
5859523|NCT02406508|Melphalan|melphalan|mesh-list
5859524|NCT02406508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5859525|NCT02406508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5859526|NCT02406508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5859527|NCT02406508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5859528|NCT02406508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5859529|NCT02406508|Alkylating Agents|alkylating agents|mesh-ancestor
5859530|NCT02406508|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5859531|NCT02406508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5859532|NCT02406508|Immunologic Factors|immunologic factors|mesh-ancestor
5674677|NCT03537612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5674678|NCT03537612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674679|NCT03537599|Daratumumab|daratumumab|mesh-list
5674680|NCT03537599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5859533|NCT02406508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859534|NCT02406690|Leuprolide|leuprolide|mesh-list
5859535|NCT02406690|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5674681|NCT03537573|Analgesics, Opioid|analgesics, opioid|mesh-list
5674682|NCT03537573|Narcotics|narcotics|mesh-ancestor
5674683|NCT03537573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5674684|NCT03537573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674685|NCT03537573|Analgesics|analgesics|mesh-ancestor
5674686|NCT03537573|Sensory System Agents|sensory system agents|mesh-ancestor
5674687|NCT03537573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5674688|NCT03537547|Antipsychotic Agents|antipsychotic agents|mesh-list
5674689|NCT03537547|Antidepressive Agents|antidepressive agents|mesh-list
5674690|NCT03537547|Psychotropic Drugs|psychotropic drugs|mesh-list
5674691|NCT03537547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5674692|NCT03537547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5674693|NCT03537547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674694|NCT03537534|Lidocaine|lidocaine|mesh-list
5674695|NCT03537534|Anesthetics, Local|anesthetics, local|mesh-ancestor
5674696|NCT03537534|Anesthetics|anesthetics|mesh-ancestor
5674697|NCT03537534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5674698|NCT03537534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674699|NCT03537534|Sensory System Agents|sensory system agents|mesh-ancestor
5674700|NCT03537534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5859536|NCT02406690|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5859537|NCT02406690|Estradiol|estradiol|mesh-list
5859538|NCT02406690|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5859539|NCT02406690|Progesterone|progesterone|mesh-list
5859540|NCT02406690|Estrogens|estrogens|mesh-ancestor
5859541|NCT02406690|Hormones|hormones|mesh-ancestor
5859542|NCT02406690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5859543|NCT02406690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674701|NCT03537534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5674702|NCT03537534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5674703|NCT03537534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5674704|NCT03537534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5674705|NCT03537534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674706|NCT03537495|Linezolid|linezolid|mesh-list
5674707|NCT03537495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5674708|NCT03537495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5674709|NCT03537495|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5674710|NCT03537495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5674711|NCT03537495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674712|NCT03537443|Vitamin D|vitamin d|mesh-list
5674713|NCT03537443|Cholecalciferol|cholecalciferol|mesh-list
5674714|NCT03537443|Vitamins|vitamins|mesh-ancestor
5674715|NCT03537443|Micronutrients|micronutrients|mesh-ancestor
5674716|NCT03537443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674717|NCT03537443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5674718|NCT03537443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5674719|NCT03537391|Fluorides|fluorides|mesh-list
5859544|NCT02406690|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5859545|NCT02406690|Contraceptive Agents|contraceptive agents|mesh-ancestor
5674720|NCT03537391|Cariostatic Agents|cariostatic agents|mesh-ancestor
5674721|NCT03537391|Protective Agents|protective agents|mesh-ancestor
5674722|NCT03537391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674723|NCT03537326|Budesonide|budesonide|mesh-list
5674724|NCT03537326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5674725|NCT03537326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5674726|NCT03537326|Autonomic Agents|autonomic agents|mesh-ancestor
5674727|NCT03537326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5674728|NCT03537326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674729|NCT03537326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5674730|NCT03537326|Respiratory System Agents|respiratory system agents|mesh-ancestor
5674731|NCT03537326|Glucocorticoids|glucocorticoids|mesh-ancestor
5674732|NCT03537326|Hormones|hormones|mesh-ancestor
5674733|NCT03537326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5674734|NCT03537287|Progesterone|progesterone|mesh-list
5674735|NCT03537287|Dydrogesterone|dydrogesterone|mesh-list
5674736|NCT03537287|Progestins|progestins|mesh-ancestor
5674737|NCT03537287|Hormones|hormones|mesh-ancestor
5674738|NCT03537287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5674739|NCT03537287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696316|NCT03383406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5696317|NCT03383406|Antimetabolites|antimetabolites|mesh-ancestor
5859546|NCT02406690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5859547|NCT02406690|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5859548|NCT02406690|Progestins|progestins|mesh-ancestor
5859549|NCT02406690|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5859550|NCT02406690|Fertility Agents|fertility agents|mesh-ancestor
5859551|NCT02406690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5859552|NCT02406690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5859553|NCT02406703|Mepivacaine|mepivacaine|mesh-list
5859554|NCT02406703|Chloroprocaine|chloroprocaine|mesh-list
5859555|NCT02406703|Anesthetics, Local|anesthetics, local|mesh-ancestor
5859556|NCT02406703|Anesthetics|anesthetics|mesh-ancestor
5859557|NCT02406703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5859558|NCT02406703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859559|NCT02406703|Sensory System Agents|sensory system agents|mesh-ancestor
5859560|NCT02406703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5904560|NCT05027100|Irinotecan|irinotecan|mesh-list
5904561|NCT05027100|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5904562|NCT05027100|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5904563|NCT05027100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5904564|NCT05027100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904565|NCT05027100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5696318|NCT03383406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696319|NCT03383406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5696320|NCT03383406|Dermatologic Agents|dermatologic agents|mesh-ancestor
5696321|NCT03383406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5696322|NCT03383406|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5696323|NCT03383406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5696324|NCT03383406|Immunologic Factors|immunologic factors|mesh-ancestor
5696325|NCT03383406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5696326|NCT03383406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5696327|NCT03383406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5904566|NCT05026606|Nivolumab|nivolumab|mesh-list
5904567|NCT05026606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5904568|NCT05026606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5904569|NCT05026606|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5904570|NCT05026606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904571|NCT05025800|Rituximab|rituximab|mesh-list
5904572|NCT05025800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5904573|NCT05025800|Lenalidomide|lenalidomide|mesh-list
5904574|NCT05025800|Antibodies|antibodies|mesh-list
5696328|NCT03383406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5696329|NCT03383406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5696330|NCT03383406|Antiviral Agents|antiviral agents|mesh-ancestor
5696331|NCT03383406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5696332|NCT03383406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5696333|NCT03383406|Alkylating Agents|alkylating agents|mesh-ancestor
5696334|NCT03383393|Adenosine|adenosine|mesh-list
5696335|NCT03383393|Eptifibatide|eptifibatide|mesh-list
5696336|NCT03383393|Analgesics|analgesics|mesh-ancestor
5696337|NCT03383393|Sensory System Agents|sensory system agents|mesh-ancestor
5696338|NCT03383393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5696339|NCT03383393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696340|NCT03383393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5696341|NCT03383393|Vasodilator Agents|vasodilator agents|mesh-ancestor
5696342|NCT03383393|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5696343|NCT03383393|Purinergic Agonists|purinergic agonists|mesh-ancestor
5696344|NCT03383393|Purinergic Agents|purinergic agents|mesh-ancestor
5696345|NCT03383393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5696346|NCT03383393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696347|NCT03383393|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5696348|NCT03383380|Sirolimus|sirolimus|mesh-list
5859561|NCT02406521|Sorafenib|sorafenib|mesh-list
5859562|NCT02406521|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
5859563|NCT02406521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5859564|NCT02406521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5859565|NCT02406521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5859566|NCT02406521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5859567|NCT02406287|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5859568|NCT02406287|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5859569|NCT02406222|Dexamethasone|dexamethasone|mesh-list
5859570|NCT02406222|Cyclophosphamide|cyclophosphamide|mesh-list
5859571|NCT02406222|Pomalidomide|pomalidomide|mesh-list
5859572|NCT02406222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5859573|NCT02406222|Immunologic Factors|immunologic factors|mesh-ancestor
5859574|NCT02406222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859575|NCT02406222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5859576|NCT02406222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5859577|NCT02406222|Alkylating Agents|alkylating agents|mesh-ancestor
5859578|NCT02406222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5859579|NCT02406222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5859580|NCT02406222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5859581|NCT02406222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5859582|NCT02406222|Antiemetics|antiemetics|mesh-ancestor
5859583|NCT02406222|Autonomic Agents|autonomic agents|mesh-ancestor
5859584|NCT02406222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5859585|NCT02406222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5859586|NCT02406222|Glucocorticoids|glucocorticoids|mesh-ancestor
5859587|NCT02406222|Hormones|hormones|mesh-ancestor
5859588|NCT02406222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5859589|NCT02406222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5859590|NCT02406222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5859591|NCT02406222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5859592|NCT02406222|Growth Substances|growth substances|mesh-ancestor
5859593|NCT02406222|Growth Inhibitors|growth inhibitors|mesh-ancestor
5859594|NCT02406300|Bupivacaine|bupivacaine|mesh-list
5859595|NCT02406300|Ropivacaine|ropivacaine|mesh-list
5859596|NCT02406300|Levobupivacaine|levobupivacaine|mesh-list
5674740|NCT03537196|Ribavirin|ribavirin|mesh-list
5674741|NCT03537196|Sofosbuvir|sofosbuvir|mesh-list
5674742|NCT03537196|Antimetabolites|antimetabolites|mesh-ancestor
5674743|NCT03537196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674744|NCT03537196|Antiviral Agents|antiviral agents|mesh-ancestor
5674745|NCT03537196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5674746|NCT03537157|Rifaximin|rifaximin|mesh-list
5674747|NCT03537157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5674748|NCT03537157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5674749|NCT03537157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5674750|NCT03537144|Acetaminophen|acetaminophen|mesh-list
5674751|NCT03537144|Indomethacin|indomethacin|mesh-list
5674752|NCT03537144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5674753|NCT03537144|Analgesics|analgesics|mesh-ancestor
5674754|NCT03537144|Sensory System Agents|sensory system agents|mesh-ancestor
5674755|NCT03537144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5674756|NCT03537144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674757|NCT03537144|Antipyretics|antipyretics|mesh-ancestor
5859597|NCT02406300|Sevoflurane|sevoflurane|mesh-list
5859598|NCT02406300|Desflurane|desflurane|mesh-list
5859599|NCT02406300|Anesthetics, Local|anesthetics, local|mesh-ancestor
5859600|NCT02406300|Anesthetics|anesthetics|mesh-ancestor
5859601|NCT02406300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5859602|NCT02406300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859603|NCT02406300|Sensory System Agents|sensory system agents|mesh-ancestor
5859604|NCT02406300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5859605|NCT02406300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5859606|NCT02406300|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5859607|NCT02406300|Anesthetics, General|anesthetics, general|mesh-ancestor
5859608|NCT02406183|Ipilimumab|ipilimumab|mesh-list
5859609|NCT02406183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5859610|NCT02406183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5859611|NCT02406183|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5859612|NCT02406183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5859613|NCT02406144|Dexamethasone|dexamethasone|mesh-list
5859614|NCT02406144|Lenalidomide|lenalidomide|mesh-list
5859615|NCT02406144|Ixazomib|ixazomib|mesh-list
5859616|NCT02406144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5674758|NCT03537144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5859617|NCT02406144|Antiemetics|antiemetics|mesh-ancestor
5674759|NCT03537144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5859618|NCT02406144|Autonomic Agents|autonomic agents|mesh-ancestor
5859619|NCT02406144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5859620|NCT02406144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859621|NCT02406144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5859622|NCT02406144|Glucocorticoids|glucocorticoids|mesh-ancestor
5859623|NCT02406144|Hormones|hormones|mesh-ancestor
5859624|NCT02406144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5859625|NCT02406144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5859626|NCT02406144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5859627|NCT02406144|Immunologic Factors|immunologic factors|mesh-ancestor
5859628|NCT02406144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5859629|NCT02406144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5859630|NCT02406144|Growth Substances|growth substances|mesh-ancestor
5859631|NCT02406144|Growth Inhibitors|growth inhibitors|mesh-ancestor
5859632|NCT02406144|Protease Inhibitors|protease inhibitors|mesh-ancestor
5859633|NCT02406144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5859634|NCT02406144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5859635|NCT02406170|Paclitaxel|paclitaxel|mesh-list
5859636|NCT02406170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5859637|NCT02406170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5859638|NCT02406170|Tubulin Modulators|tubulin modulators|mesh-ancestor
5859639|NCT02406170|Antimitotic Agents|antimitotic agents|mesh-ancestor
5859640|NCT02406170|Mitosis Modulators|mitosis modulators|mesh-ancestor
5859641|NCT02406170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5859642|NCT02406014|Diclofenac|diclofenac|mesh-list
5859643|NCT02406014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5859644|NCT02406014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5859645|NCT02406014|Analgesics|analgesics|mesh-ancestor
5674760|NCT03537144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5674761|NCT03537144|Gout Suppressants|gout suppressants|mesh-ancestor
5674762|NCT03537144|Tocolytic Agents|tocolytic agents|mesh-ancestor
5674763|NCT03537144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5674764|NCT03537144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5674765|NCT03537144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5674766|NCT03537144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674767|NCT03537131|Dapagliflozin|dapagliflozin|mesh-list
5859646|NCT02406014|Sensory System Agents|sensory system agents|mesh-ancestor
5859647|NCT02406014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5859648|NCT02406014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859649|NCT02406014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5674768|NCT03537131|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5674769|NCT03537131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674770|NCT03537131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5674771|NCT03537131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674772|NCT03537027|Vitamin D|vitamin d|mesh-list
5674773|NCT03537027|Cholecalciferol|cholecalciferol|mesh-list
5674774|NCT03537027|Vitamins|vitamins|mesh-ancestor
5674775|NCT03537027|Micronutrients|micronutrients|mesh-ancestor
5674776|NCT03537027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674777|NCT03537027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5674778|NCT03537027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5674779|NCT03536910|Arginine Vasopressin|arginine vasopressin|mesh-list
5674780|NCT03536910|Hemostatics|hemostatics|mesh-ancestor
5674781|NCT03536910|Coagulants|coagulants|mesh-ancestor
5674782|NCT03536910|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5674783|NCT03536910|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5674784|NCT03536910|Natriuretic Agents|natriuretic agents|mesh-ancestor
5674785|NCT03536910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674786|NCT03536845|Vitamin D|vitamin d|mesh-list
5674787|NCT03536845|Cholecalciferol|cholecalciferol|mesh-list
5674788|NCT03536845|Vitamins|vitamins|mesh-ancestor
5674789|NCT03536845|Micronutrients|micronutrients|mesh-ancestor
5674790|NCT03536845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674791|NCT03536845|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5674792|NCT03536845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5674793|NCT03536806|Canrenone|canrenone|mesh-list
5859650|NCT02406014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5859651|NCT02406014|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5859652|NCT02406014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5859653|NCT02406014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5859654|NCT02405910|Gemcitabine|gemcitabine|mesh-list
5859655|NCT02405910|Paclitaxel|paclitaxel|mesh-list
5859656|NCT02405910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5674794|NCT03536806|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5859657|NCT02405910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5859658|NCT02405910|Tubulin Modulators|tubulin modulators|mesh-ancestor
5859659|NCT02405910|Antimitotic Agents|antimitotic agents|mesh-ancestor
5674795|NCT03536806|Hormone Antagonists|hormone antagonists|mesh-ancestor
5674796|NCT03536806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5674797|NCT03536806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674798|NCT03536806|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5674799|NCT03536806|Diuretics|diuretics|mesh-ancestor
5674800|NCT03536806|Natriuretic Agents|natriuretic agents|mesh-ancestor
5674801|NCT03536780|Gemcitabine|gemcitabine|mesh-list
5674802|NCT03536780|Avelumab|avelumab|mesh-list
5859660|NCT02405910|Mitosis Modulators|mitosis modulators|mesh-ancestor
5859661|NCT02405910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5859662|NCT02405910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5859663|NCT02405910|Antimetabolites|antimetabolites|mesh-ancestor
5859664|NCT02405910|Antiviral Agents|antiviral agents|mesh-ancestor
5859665|NCT02405910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5859666|NCT02405910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5859667|NCT02405910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5859668|NCT02405910|Immunologic Factors|immunologic factors|mesh-ancestor
5859669|NCT02405910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859670|NCT02406066|Oxazepam|oxazepam|mesh-list
5859671|NCT02406066|Metyrapone|metyrapone|mesh-list
5859672|NCT02406066|Antimetabolites|antimetabolites|mesh-ancestor
5859673|NCT02406066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5859674|NCT02406066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5859675|NCT02406066|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5859676|NCT02406066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5859677|NCT02406066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859678|NCT02406066|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5674803|NCT03536780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5674804|NCT03536780|Antimetabolites|antimetabolites|mesh-ancestor
5674805|NCT03536780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674806|NCT03536780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5674807|NCT03536780|Antiviral Agents|antiviral agents|mesh-ancestor
5674808|NCT03536780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5674809|NCT03536780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5674810|NCT03536780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5674811|NCT03536780|Immunologic Factors|immunologic factors|mesh-ancestor
5859679|NCT02406066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5859680|NCT02406066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5859681|NCT02406066|GABA Modulators|gaba modulators|mesh-ancestor
5859682|NCT02406066|GABA Agents|gaba agents|mesh-ancestor
5859683|NCT02406066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5859684|NCT02406092|Prednisone|prednisone|mesh-list
5859685|NCT02406092|Cyclophosphamide|cyclophosphamide|mesh-list
5859686|NCT02406092|Rituximab|rituximab|mesh-list
5859687|NCT02406092|Doxorubicin|doxorubicin|mesh-list
5859688|NCT02406092|Fludarabine|fludarabine|mesh-list
5859689|NCT02406092|Vincristine|vincristine|mesh-list
5859690|NCT02406092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5859691|NCT02406092|Immunologic Factors|immunologic factors|mesh-ancestor
5859692|NCT02406092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859693|NCT02406092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5859694|NCT02406092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5859695|NCT02406092|Alkylating Agents|alkylating agents|mesh-ancestor
5859696|NCT02406092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5859697|NCT02406092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5859698|NCT02406092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5859699|NCT02406092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5859700|NCT02406092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5859701|NCT02406092|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5859702|NCT02406092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5859703|NCT02406092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5859704|NCT02406092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5859705|NCT02406092|Glucocorticoids|glucocorticoids|mesh-ancestor
5859706|NCT02406092|Hormones|hormones|mesh-ancestor
5859707|NCT02406092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5859708|NCT02406092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5859709|NCT02406092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5859710|NCT02406092|Tubulin Modulators|tubulin modulators|mesh-ancestor
5859711|NCT02406092|Antimitotic Agents|antimitotic agents|mesh-ancestor
5859712|NCT02406092|Mitosis Modulators|mitosis modulators|mesh-ancestor
5859713|NCT02405988|Remifentanil|remifentanil|mesh-list
5859714|NCT02405988|Naloxone|naloxone|mesh-list
5859715|NCT02405988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5859716|NCT02405988|Narcotics|narcotics|mesh-ancestor
5674812|NCT03536780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674813|NCT03536780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5674814|NCT03536741|Anesthetics|anesthetics|mesh-list
5674815|NCT03536741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
5674816|NCT03536741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5674817|NCT03536741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674818|NCT03536741|Anesthetics, General|anesthetics, general|mesh-ancestor
5674819|NCT03536637|Hydrogen Peroxide|hydrogen peroxide|mesh-list
5674820|NCT03536637|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5674821|NCT03536637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5674822|NCT03536611|Warfarin|warfarin|mesh-list
5674823|NCT03536611|Dabigatran|dabigatran|mesh-list
5674824|NCT03536611|Anticoagulants|anticoagulants|mesh-ancestor
5674825|NCT03536611|Antithrombins|antithrombins|mesh-ancestor
5674826|NCT03536611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5674827|NCT03536611|Protease Inhibitors|protease inhibitors|mesh-ancestor
5674828|NCT03536611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5674829|NCT03536611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674830|NCT03536598|Amlodipine|amlodipine|mesh-list
5674831|NCT03536598|Valsartan|valsartan|mesh-list
5674832|NCT03536598|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5674833|NCT03536598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5674834|NCT03536598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5674835|NCT03536598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5674836|NCT03536598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674837|NCT03536598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5674838|NCT03536598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674839|NCT03536598|Vasodilator Agents|vasodilator agents|mesh-ancestor
5674840|NCT03536598|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5674841|NCT03536598|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5859717|NCT02405988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5859718|NCT02405988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859719|NCT02405988|Analgesics|analgesics|mesh-ancestor
5859720|NCT02405988|Sensory System Agents|sensory system agents|mesh-ancestor
5859721|NCT02405988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5859722|NCT02405988|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5859723|NCT02406053|Antioxidants|antioxidants|mesh-list
5859724|NCT02406053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5859725|NCT02406053|Protective Agents|protective agents|mesh-ancestor
5859726|NCT02406053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859727|NCT02405858|Prednisolone|prednisolone|mesh-list
5859728|NCT02405858|Abiraterone Acetate|abiraterone acetate|mesh-list
5859729|NCT02405858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5859730|NCT02405858|Glucocorticoids|glucocorticoids|mesh-ancestor
5859731|NCT02405858|Hormones|hormones|mesh-ancestor
5859732|NCT02405858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5859733|NCT02405858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859734|NCT02405858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5859735|NCT02405858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5859736|NCT02405858|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5859737|NCT02405858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5859738|NCT02405858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5859739|NCT02405858|Hormone Antagonists|hormone antagonists|mesh-ancestor
5859740|NCT02405858|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5859741|NCT02405715|Oxytocin|oxytocin|mesh-list
5859742|NCT02405715|Oxytocics|oxytocics|mesh-ancestor
5859743|NCT02405715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5859744|NCT02405715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859745|NCT02405676|Cytarabine|cytarabine|mesh-list
5859746|NCT02405676|Prednisone|prednisone|mesh-list
5859747|NCT02405676|Cyclophosphamide|cyclophosphamide|mesh-list
5859748|NCT02405676|Ifosfamide|ifosfamide|mesh-list
5859749|NCT02405676|Isophosphamide mustard|isophosphamide mustard|mesh-list
5859750|NCT02405676|Rituximab|rituximab|mesh-list
5859751|NCT02405676|Methotrexate|methotrexate|mesh-list
5859752|NCT02405676|Etoposide|etoposide|mesh-list
5859753|NCT02405676|Etoposide phosphate|etoposide phosphate|mesh-list
5859754|NCT02405676|Vincristine|vincristine|mesh-list
5859755|NCT02405676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5859756|NCT02405676|Immunologic Factors|immunologic factors|mesh-ancestor
5859757|NCT02405676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859758|NCT02405676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5859759|NCT02405676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5674842|NCT03536598|Antimetabolites|antimetabolites|mesh-ancestor
5859760|NCT02405676|Alkylating Agents|alkylating agents|mesh-ancestor
5859761|NCT02405676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5859762|NCT02405676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5859763|NCT02405676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5859764|NCT02405676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5859765|NCT02405676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5859766|NCT02405676|Glucocorticoids|glucocorticoids|mesh-ancestor
5859767|NCT02405676|Hormones|hormones|mesh-ancestor
5859768|NCT02405676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5859769|NCT02405676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5859770|NCT02405676|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5859771|NCT02405676|Abortifacient Agents|abortifacient agents|mesh-ancestor
5859772|NCT02405676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5859773|NCT02405676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5859774|NCT02405676|Antimetabolites|antimetabolites|mesh-ancestor
5859775|NCT02405676|Dermatologic Agents|dermatologic agents|mesh-ancestor
5859776|NCT02405676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5859777|NCT02405676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5859778|NCT02405676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5859779|NCT02405676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5859780|NCT02405676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5859781|NCT02405676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5859782|NCT02405676|Antiviral Agents|antiviral agents|mesh-ancestor
5859783|NCT02405676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5859784|NCT02405676|Tubulin Modulators|tubulin modulators|mesh-ancestor
5859785|NCT02405676|Antimitotic Agents|antimitotic agents|mesh-ancestor
5859786|NCT02405676|Mitosis Modulators|mitosis modulators|mesh-ancestor
5859787|NCT02405598|Albuterol|albuterol|mesh-list
5859788|NCT02405598|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5859789|NCT02405598|Autonomic Agents|autonomic agents|mesh-ancestor
5859790|NCT02405598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5859791|NCT02405598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859792|NCT02405598|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5859793|NCT02405598|Respiratory System Agents|respiratory system agents|mesh-ancestor
5859794|NCT02405598|Tocolytic Agents|tocolytic agents|mesh-ancestor
5859795|NCT02405598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5859796|NCT02405598|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5859797|NCT02405598|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5859798|NCT02405598|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5859799|NCT02405598|Adrenergic Agents|adrenergic agents|mesh-ancestor
5859800|NCT02405598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5859801|NCT02405598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5859802|NCT02405793|Meloxicam|meloxicam|mesh-list
5859803|NCT02405793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5859804|NCT02405793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5859805|NCT02405793|Analgesics|analgesics|mesh-ancestor
5859806|NCT02405793|Sensory System Agents|sensory system agents|mesh-ancestor
5859807|NCT02405793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5859808|NCT02405793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859809|NCT02405793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5859810|NCT02405793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5859811|NCT02405793|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5859812|NCT02405793|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5859813|NCT02405793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5859814|NCT02405793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5859815|NCT02405689|Dexmedetomidine|dexmedetomidine|mesh-list
5859816|NCT02405689|Remifentanil|remifentanil|mesh-list
5859817|NCT02405689|Sevoflurane|sevoflurane|mesh-list
5674843|NCT03536598|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5674844|NCT03536598|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5674845|NCT03536598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5674846|NCT03536598|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5674847|NCT03536598|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5674848|NCT03536494|Mirabegron|mirabegron|mesh-list
5674849|NCT03536494|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
5674850|NCT03536494|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5674851|NCT03536494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5674852|NCT03536494|Adrenergic Agents|adrenergic agents|mesh-ancestor
5674853|NCT03536494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5674854|NCT03536494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674855|NCT03536494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674856|NCT03536494|Urological Agents|urological agents|mesh-ancestor
5674857|NCT03536481|Ensartinib|ensartinib|mesh-list
5674858|NCT03536481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5859818|NCT02405689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5859819|NCT02405689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5859820|NCT02405689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859821|NCT02405689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5859822|NCT02405689|Analgesics|analgesics|mesh-ancestor
5859823|NCT02405689|Sensory System Agents|sensory system agents|mesh-ancestor
5859824|NCT02405689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5859825|NCT02405689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5674859|NCT03536481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5674860|NCT03536481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5674861|NCT03536481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674862|NCT03536390|Methylphenidate|methylphenidate|mesh-list
5674863|NCT03536390|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5674864|NCT03536390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859826|NCT02405689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5859827|NCT02405689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5859828|NCT02405689|Adrenergic Agents|adrenergic agents|mesh-ancestor
5859829|NCT02405689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5859830|NCT02405689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5859831|NCT02405689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5859832|NCT02405689|Narcotics|narcotics|mesh-ancestor
5674865|NCT03536390|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5674866|NCT03536390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5674867|NCT03536390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5696349|NCT03383380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5859833|NCT02405689|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5859834|NCT02405689|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5859835|NCT02405689|Anesthetics, General|anesthetics, general|mesh-ancestor
5859836|NCT02405689|Anesthetics|anesthetics|mesh-ancestor
5859837|NCT02405364|Dexamethasone|dexamethasone|mesh-list
5859838|NCT02405364|Lenalidomide|lenalidomide|mesh-list
5859839|NCT02405364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5859840|NCT02405364|Antiemetics|antiemetics|mesh-ancestor
5859841|NCT02405364|Autonomic Agents|autonomic agents|mesh-ancestor
5859842|NCT02405364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5859843|NCT02405364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859844|NCT02405364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5859845|NCT02405364|Glucocorticoids|glucocorticoids|mesh-ancestor
5859846|NCT02405364|Hormones|hormones|mesh-ancestor
5859847|NCT02405364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5859848|NCT02405364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5859849|NCT02405364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5859850|NCT02405364|Immunologic Factors|immunologic factors|mesh-ancestor
5859851|NCT02405364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5859852|NCT02405364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5859853|NCT02405364|Growth Substances|growth substances|mesh-ancestor
5859854|NCT02405364|Growth Inhibitors|growth inhibitors|mesh-ancestor
5859855|NCT02405156|Letrozole|letrozole|mesh-list
5859856|NCT02405156|Misoprostol|misoprostol|mesh-list
5859857|NCT02405156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5859858|NCT02405156|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5859859|NCT02405156|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5859860|NCT02405156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5859861|NCT02405156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5859862|NCT02405156|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5859863|NCT02405156|Hormone Antagonists|hormone antagonists|mesh-ancestor
5859864|NCT02405156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5859865|NCT02405156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859866|NCT02405156|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5859867|NCT02405156|Abortifacient Agents|abortifacient agents|mesh-ancestor
5859868|NCT02405156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5859869|NCT02405156|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5859870|NCT02405156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5859871|NCT02405156|Oxytocics|oxytocics|mesh-ancestor
5859872|NCT02405130|Epinephrine|epinephrine|mesh-list
5859873|NCT02405130|Racepinephrine|racepinephrine|mesh-list
5859874|NCT02405130|Epinephryl borate|epinephryl borate|mesh-list
5859875|NCT02405130|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5859876|NCT02405130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5859877|NCT02405130|Adrenergic Agents|adrenergic agents|mesh-ancestor
5859878|NCT02405130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5859879|NCT02405130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5859880|NCT02405130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859881|NCT02405130|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5674868|NCT03536390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674869|NCT03536390|Dopamine Agents|dopamine agents|mesh-ancestor
5674870|NCT03536390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5674871|NCT03536325|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5859882|NCT02405130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5859883|NCT02405130|Autonomic Agents|autonomic agents|mesh-ancestor
5859884|NCT02405130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5859885|NCT02405130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5859886|NCT02405130|Respiratory System Agents|respiratory system agents|mesh-ancestor
5859887|NCT02405130|Mydriatics|mydriatics|mesh-ancestor
5859888|NCT02405130|Sympathomimetics|sympathomimetics|mesh-ancestor
5859889|NCT02405130|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5859890|NCT02405338|Vaccines|vaccines|mesh-list
5859891|NCT02405338|Immunologic Factors|immunologic factors|mesh-ancestor
5859892|NCT02405338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859893|NCT02405104|Chlorzoxazone|chlorzoxazone|mesh-list
5859894|NCT02405104|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5859895|NCT02405104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859896|NCT02405104|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5859897|NCT02405104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5859898|NCT02405078|Deoxyglucose|deoxyglucose|mesh-list
5859899|NCT02405078|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5859900|NCT02405078|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5859901|NCT02405078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5859902|NCT02405078|Antimetabolites|antimetabolites|mesh-ancestor
5859903|NCT02405078|Antiviral Agents|antiviral agents|mesh-ancestor
5859904|NCT02405078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5859905|NCT02404844|Tamoxifen|tamoxifen|mesh-list
5859906|NCT02404844|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5859907|NCT02404844|Hormone Antagonists|hormone antagonists|mesh-ancestor
5859908|NCT02404844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5859909|NCT02404844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859910|NCT02404844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5859911|NCT02404844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5859912|NCT02404844|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5859913|NCT02404844|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5859914|NCT02404844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5859915|NCT02404779|Cisatracurium|cisatracurium|mesh-list
5859916|NCT02404779|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5859917|NCT02404779|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5859918|NCT02404779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5859919|NCT02404779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859920|NCT02405013|Ribavirin|ribavirin|mesh-list
5859921|NCT02405013|Sofosbuvir|sofosbuvir|mesh-list
5859922|NCT02405013|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
5859923|NCT02405013|Ledipasvir|ledipasvir|mesh-list
5859924|NCT02405013|Antimetabolites|antimetabolites|mesh-ancestor
5859925|NCT02405013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5859926|NCT02405013|Antiviral Agents|antiviral agents|mesh-ancestor
5859927|NCT02405013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5904575|NCT05025800|Immunoglobulins|immunoglobulins|mesh-list
5904576|NCT05025800|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5904577|NCT05025800|Immunologic Factors|immunologic factors|mesh-ancestor
5904578|NCT05025800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904579|NCT05025800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5904580|NCT05025800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5904581|NCT05025800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5674872|NCT03536325|Immunologic Factors|immunologic factors|mesh-ancestor
5674873|NCT03536325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674874|NCT03536234|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5674875|NCT03536234|Luteolytic Agents|luteolytic agents|mesh-ancestor
5674876|NCT03536234|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5674877|NCT03536234|Contraceptive Agents|contraceptive agents|mesh-ancestor
5674878|NCT03536234|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5674879|NCT03536234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904582|NCT05025800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5904583|NCT05025800|Growth Substances|growth substances|mesh-ancestor
5904584|NCT05025800|Growth Inhibitors|growth inhibitors|mesh-ancestor
5904585|NCT05010772|Decitabine|decitabine|mesh-list
5904586|NCT05010772|Venetoclax|venetoclax|mesh-list
5904587|NCT05010772|Ivosidenib|ivosidenib|mesh-list
5904588|NCT05010772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5904589|NCT05010772|Antimetabolites|antimetabolites|mesh-ancestor
5904590|NCT05010772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674880|NCT03536234|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5674881|NCT03536234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5674882|NCT03536234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5674883|NCT03536208|Warfarin|warfarin|mesh-list
5859928|NCT02404688|Ethanol|ethanol|mesh-list
5859929|NCT02404688|Dronabinol|dronabinol|mesh-list
5859930|NCT02404688|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5859931|NCT02404688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5859932|NCT02404688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5859933|NCT02404688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859934|NCT02404688|Hallucinogens|hallucinogens|mesh-ancestor
5859935|NCT02404688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5859936|NCT02404688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5674884|NCT03536208|Anticoagulants|anticoagulants|mesh-ancestor
5674885|NCT03536065|Analgesics, Opioid|analgesics, opioid|mesh-list
5859937|NCT02404688|Analgesics|analgesics|mesh-ancestor
5859938|NCT02404688|Sensory System Agents|sensory system agents|mesh-ancestor
5859939|NCT02404688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5859940|NCT02404688|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5859941|NCT02404688|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5859942|NCT02404688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5859943|NCT02404688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5859944|NCT02404688|Hormones|hormones|mesh-ancestor
5859945|NCT02404688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5859946|NCT02404454|Hyaluronic Acid|hyaluronic acid|mesh-list
5859947|NCT02404454|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5859948|NCT02404454|Immunologic Factors|immunologic factors|mesh-ancestor
5859949|NCT02404454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859950|NCT02404454|Viscosupplements|viscosupplements|mesh-ancestor
5859951|NCT02404454|Protective Agents|protective agents|mesh-ancestor
5859952|NCT02404337|Betaine|betaine|mesh-list
5674886|NCT03536065|Narcotics|narcotics|mesh-ancestor
5674887|NCT03536065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5674888|NCT03536065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674889|NCT03536065|Analgesics|analgesics|mesh-ancestor
5674890|NCT03536065|Sensory System Agents|sensory system agents|mesh-ancestor
5674891|NCT03536065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5674892|NCT03536039|Prednisone|prednisone|mesh-list
5674893|NCT03536039|Cyclophosphamide|cyclophosphamide|mesh-list
5674894|NCT03536039|Rituximab|rituximab|mesh-list
5674895|NCT03536039|Doxorubicin|doxorubicin|mesh-list
5674896|NCT03536039|Vincristine|vincristine|mesh-list
5674897|NCT03536039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5674898|NCT03536039|Immunologic Factors|immunologic factors|mesh-ancestor
5859953|NCT02404337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5859954|NCT02404337|Lipotropic Agents|lipotropic agents|mesh-ancestor
5859955|NCT02404337|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5674899|NCT03536039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674900|NCT03536039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5674901|NCT03536039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5674902|NCT03536039|Alkylating Agents|alkylating agents|mesh-ancestor
5674903|NCT03536039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674904|NCT03536039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5674905|NCT03536039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5859956|NCT02404337|Antimetabolites|antimetabolites|mesh-ancestor
5859957|NCT02404337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5859958|NCT02404337|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5859959|NCT02404376|Exenatide|exenatide|mesh-list
5859960|NCT02404376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5674906|NCT03536039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5674907|NCT03536039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5674908|NCT03536039|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5674909|NCT03536039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5674910|NCT03536039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5674911|NCT03536039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5674912|NCT03536039|Glucocorticoids|glucocorticoids|mesh-ancestor
5674913|NCT03536039|Hormones|hormones|mesh-ancestor
5674914|NCT03536039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5674915|NCT03536039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5674916|NCT03536039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5674917|NCT03536039|Tubulin Modulators|tubulin modulators|mesh-ancestor
5674918|NCT03536039|Antimitotic Agents|antimitotic agents|mesh-ancestor
5674919|NCT03536039|Mitosis Modulators|mitosis modulators|mesh-ancestor
5674920|NCT03535961|Etoposide|etoposide|mesh-list
5674921|NCT03535961|Apatinib|apatinib|mesh-list
5674922|NCT03535961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5859961|NCT02404376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674923|NCT03535961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5674924|NCT03535961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5674925|NCT03535961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5674926|NCT03535961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5674927|NCT03535961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674928|NCT03535961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5674929|NCT03535883|Anticoagulants|anticoagulants|mesh-list
5674930|NCT03535883|Coagulants|coagulants|mesh-list
5859962|NCT02404376|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5859963|NCT02404376|Incretins|incretins|mesh-ancestor
5859964|NCT02404376|Hormones|hormones|mesh-ancestor
5859965|NCT02404376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5859966|NCT02404623|Vitamin D|vitamin d|mesh-list
5859967|NCT02404623|Vitamins|vitamins|mesh-ancestor
5859968|NCT02404623|Micronutrients|micronutrients|mesh-ancestor
5859969|NCT02404623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859970|NCT02404623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5859971|NCT02404363|Clopidogrel|clopidogrel|mesh-list
5859972|NCT02404363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5859973|NCT02404363|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5859974|NCT02404363|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5859975|NCT02404363|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5859976|NCT02404363|Purinergic Agents|purinergic agents|mesh-ancestor
5859977|NCT02404363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5859978|NCT02404363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5859979|NCT02404363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5859980|NCT02404519|Vitamin K 2|vitamin k 2|mesh-list
5859981|NCT02404519|Vitamin K|vitamin k|mesh-list
5859982|NCT02404519|Vitamin MK 7|vitamin mk 7|mesh-list
5859983|NCT02404519|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5859984|NCT02404519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5859985|NCT02404519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5859986|NCT02404519|Hemostatics|hemostatics|mesh-ancestor
5859987|NCT02404519|Coagulants|coagulants|mesh-ancestor
5859988|NCT02404519|Vitamins|vitamins|mesh-ancestor
5859989|NCT02404519|Micronutrients|micronutrients|mesh-ancestor
5859990|NCT02404519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674931|NCT03535870|Fluticasone|fluticasone|mesh-list
5674932|NCT03535870|Xhance|xhance|mesh-list
5674933|NCT03535870|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5674934|NCT03535870|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
5674935|NCT03535870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5674936|NCT03535870|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5674937|NCT03535870|Autonomic Agents|autonomic agents|mesh-ancestor
5674938|NCT03535870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5674939|NCT03535870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674940|NCT03535870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5674941|NCT03535870|Respiratory System Agents|respiratory system agents|mesh-ancestor
5674942|NCT03535870|Dermatologic Agents|dermatologic agents|mesh-ancestor
5674943|NCT03535870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5674944|NCT03535870|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5674945|NCT03535870|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5674946|NCT03535870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5674947|NCT03535870|Adrenergic Agents|adrenergic agents|mesh-ancestor
5674948|NCT03535870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5674949|NCT03535870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674950|NCT03535870|Glucocorticoids|glucocorticoids|mesh-ancestor
5674951|NCT03535870|Hormones|hormones|mesh-ancestor
5674952|NCT03535870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5674953|NCT03535870|Sympathomimetics|sympathomimetics|mesh-ancestor
5674954|NCT03535792|Fentanyl|fentanyl|mesh-list
5674955|NCT03535792|Nalbuphine|nalbuphine|mesh-list
5674956|NCT03535792|Bupivacaine|bupivacaine|mesh-list
5859991|NCT02404259|Ritonavir|ritonavir|mesh-list
5859992|NCT02404259|Lopinavir|lopinavir|mesh-list
5859993|NCT02404259|Atazanavir Sulfate|atazanavir sulfate|mesh-list
5859994|NCT02404259|Tenofovir|tenofovir|mesh-list
5859995|NCT02404259|Efavirenz|efavirenz|mesh-list
5859996|NCT02404259|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5859997|NCT02404259|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5859998|NCT02404259|Protease Inhibitors|protease inhibitors|mesh-ancestor
5859999|NCT02404259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5860000|NCT02404259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674957|NCT03535792|Anesthetics, Local|anesthetics, local|mesh-ancestor
5674958|NCT03535792|Anesthetics|anesthetics|mesh-ancestor
5860001|NCT02404259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5860002|NCT02404259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5860003|NCT02404259|Antiviral Agents|antiviral agents|mesh-ancestor
5674959|NCT03535792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5674960|NCT03535792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5860004|NCT02404259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5860005|NCT02404259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5860006|NCT02404259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5860007|NCT02404259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5860008|NCT02404259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5860009|NCT02404259|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5860010|NCT02404259|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5860011|NCT02404259|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5860012|NCT02404259|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5860013|NCT02404259|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5860014|NCT02404142|Atracurium|atracurium|mesh-list
5860015|NCT02404142|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5860016|NCT02404142|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5860017|NCT02404142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5860018|NCT02404142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5860019|NCT02404142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5860020|NCT02404142|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
5860021|NCT02404142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5860022|NCT02404142|Cholinergic Agents|cholinergic agents|mesh-ancestor
5860023|NCT02404142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5860024|NCT02404142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5860025|NCT02404077|Clonidine|clonidine|mesh-list
5860026|NCT02404077|Analgesics|analgesics|mesh-ancestor
5860027|NCT02404077|Sensory System Agents|sensory system agents|mesh-ancestor
5860028|NCT02404077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5860029|NCT02404077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5860030|NCT02404077|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5860031|NCT02404077|Sympatholytics|sympatholytics|mesh-ancestor
5860032|NCT02404077|Autonomic Agents|autonomic agents|mesh-ancestor
5860033|NCT02404077|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5860034|NCT02404077|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5860035|NCT02404077|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5860036|NCT02404077|Adrenergic Agents|adrenergic agents|mesh-ancestor
5860037|NCT02404077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5860038|NCT02404077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5860039|NCT02404233|Darunavir|darunavir|mesh-list
5860040|NCT02404233|Cobicistat|cobicistat|mesh-list
5860041|NCT02404233|Rilpivirine|rilpivirine|mesh-list
5860042|NCT02404233|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5860043|NCT02404233|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5860044|NCT02404233|Protease Inhibitors|protease inhibitors|mesh-ancestor
5860045|NCT02404233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5860046|NCT02404233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5860047|NCT02404233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5860048|NCT02404233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5860049|NCT02404233|Antiviral Agents|antiviral agents|mesh-ancestor
5860050|NCT02404233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5860051|NCT02404233|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5860052|NCT02404233|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5674961|NCT03535792|Sensory System Agents|sensory system agents|mesh-ancestor
5674962|NCT03535792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5674963|NCT03535792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5674964|NCT03535792|Narcotics|narcotics|mesh-ancestor
5674965|NCT03535792|Analgesics|analgesics|mesh-ancestor
5674966|NCT03535792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5674967|NCT03535792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5674968|NCT03535792|Anesthetics, General|anesthetics, general|mesh-ancestor
5674969|NCT03535753|Decitabine|decitabine|mesh-list
5674970|NCT03535753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5674971|NCT03535753|Antimetabolites|antimetabolites|mesh-ancestor
5674972|NCT03535753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674973|NCT03535753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5674974|NCT03535753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5674975|NCT03535701|Paclitaxel|paclitaxel|mesh-list
5674976|NCT03535701|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5674977|NCT03535701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5674978|NCT03535701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5674979|NCT03535701|Tubulin Modulators|tubulin modulators|mesh-ancestor
5674980|NCT03535701|Antimitotic Agents|antimitotic agents|mesh-ancestor
5674981|NCT03535701|Mitosis Modulators|mitosis modulators|mesh-ancestor
5674982|NCT03535701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5860053|NCT02404233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5860054|NCT02404233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5860055|NCT02404064|Metronidazole|metronidazole|mesh-list
5860056|NCT02404064|Cefotaxime|cefotaxime|mesh-list
5674983|NCT03535662|Itraconazole|itraconazole|mesh-list
5674984|NCT03535662|Antifungal Agents|antifungal agents|mesh-ancestor
5674985|NCT03535662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5674986|NCT03535662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5674987|NCT03535662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5674988|NCT03535662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5674989|NCT03535662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5674990|NCT03535662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5674991|NCT03535662|Hormone Antagonists|hormone antagonists|mesh-ancestor
5674992|NCT03535662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5674993|NCT03535662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5674994|NCT03535662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5696350|NCT03383380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5696351|NCT03383380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5696352|NCT03383380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5696353|NCT03383380|Antifungal Agents|antifungal agents|mesh-ancestor
5696354|NCT03383380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5696355|NCT03383380|Immunologic Factors|immunologic factors|mesh-ancestor
5860057|NCT02404064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5860058|NCT02404064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5860059|NCT02404064|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5860060|NCT02404064|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5860061|NCT02404038|NuvaRing|nuvaring|mesh-list
5696356|NCT03383380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696357|NCT03383367|TEMPO|tempo|mesh-list
5696358|NCT03383367|Antioxidants|antioxidants|mesh-ancestor
5696359|NCT03383367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696360|NCT03383367|Protective Agents|protective agents|mesh-ancestor
5696361|NCT03383367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696362|NCT03383328|Prednisolone|prednisolone|mesh-list
5696363|NCT03383328|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5696364|NCT03383328|Methylprednisolone|methylprednisolone|mesh-list
5696365|NCT03383328|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5696366|NCT03383328|Prednisolone acetate|prednisolone acetate|mesh-list
5696367|NCT03383328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
5696368|NCT03383328|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5696369|NCT03383328|Prednisolone phosphate|prednisolone phosphate|mesh-list
5860062|NCT02404038|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
5860063|NCT02404038|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5860064|NCT02404038|Contraceptive Agents|contraceptive agents|mesh-ancestor
5860065|NCT02404038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5860066|NCT02404038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5860067|NCT02404038|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5860068|NCT02404038|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5860069|NCT02404038|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5860070|NCT02404038|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5860071|NCT02404038|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5696370|NCT03383328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5696371|NCT03383328|Glucocorticoids|glucocorticoids|mesh-ancestor
5696372|NCT03383328|Hormones|hormones|mesh-ancestor
5696373|NCT03383328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5696374|NCT03383328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696375|NCT03383328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5696376|NCT03383328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5696377|NCT03383328|Antiemetics|antiemetics|mesh-ancestor
5696378|NCT03383328|Autonomic Agents|autonomic agents|mesh-ancestor
5696379|NCT03383328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5696380|NCT03383328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5696381|NCT03383328|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5696382|NCT03383328|Protective Agents|protective agents|mesh-ancestor
5696383|NCT03383328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5696384|NCT03383328|Analgesics|analgesics|mesh-ancestor
5696385|NCT03383328|Sensory System Agents|sensory system agents|mesh-ancestor
5696386|NCT03383328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5696387|NCT03383315|Tramadol|tramadol|mesh-list
5696388|NCT03383315|Metoclopramide|metoclopramide|mesh-list
5696389|NCT03383315|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5860072|NCT02404038|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
5696390|NCT03383315|Narcotics|narcotics|mesh-ancestor
5696391|NCT03383315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5860073|NCT02404038|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5860074|NCT02404038|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5860075|NCT02404051|Everolimus|everolimus|mesh-list
5860076|NCT02404051|Fulvestrant|fulvestrant|mesh-list
5860077|NCT02404051|Exemestane|exemestane|mesh-list
5860078|NCT02404051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5860079|NCT02404051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5860080|NCT02404051|Immunologic Factors|immunologic factors|mesh-ancestor
5860081|NCT02404051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5860082|NCT02404051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6674974|NCT01572259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6674975|NCT01572259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5860083|NCT02404051|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5860084|NCT02404051|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5860085|NCT02404051|Hormone Antagonists|hormone antagonists|mesh-ancestor
5860086|NCT02404051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5860087|NCT02404051|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5860088|NCT02404051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5860089|NCT02404051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5860090|NCT02404051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5860091|NCT02403856|Methylprednisolone|methylprednisolone|mesh-list
5860092|NCT02403856|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5860093|NCT02403856|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5860094|NCT02403856|Prednisolone|prednisolone|mesh-list
5860095|NCT02403856|Prednisolone acetate|prednisolone acetate|mesh-list
5860096|NCT02403856|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5860097|NCT02403856|Prednisolone phosphate|prednisolone phosphate|mesh-list
5860098|NCT02403856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5860099|NCT02403856|Antiemetics|antiemetics|mesh-ancestor
5674995|NCT03535558|Azithromycin|azithromycin|mesh-list
5674996|NCT03535558|Fluoroquinolones|fluoroquinolones|mesh-list
5674997|NCT03535558|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
5674998|NCT03535558|Trimethoprim|trimethoprim|mesh-list
5674999|NCT03535558|Sulfamethoxazole|sulfamethoxazole|mesh-list
5675000|NCT03535558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5675001|NCT03535558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5675002|NCT03535558|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5675003|NCT03535558|Renal Agents|renal agents|mesh-ancestor
5675004|NCT03535558|Antimalarials|antimalarials|mesh-ancestor
5675005|NCT03535558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5675006|NCT03535558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5675007|NCT03535558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5675008|NCT03535558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5860100|NCT02403856|Autonomic Agents|autonomic agents|mesh-ancestor
5860101|NCT02403856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5860102|NCT02403856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5860103|NCT02403856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5860104|NCT02403856|Glucocorticoids|glucocorticoids|mesh-ancestor
5860105|NCT02403856|Hormones|hormones|mesh-ancestor
5860106|NCT02403856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5860107|NCT02403856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5860108|NCT02403856|Protective Agents|protective agents|mesh-ancestor
5860109|NCT02403856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5860110|NCT02403856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5860111|NCT02403804|Betaine|betaine|mesh-list
5860112|NCT02403804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5860113|NCT02403804|Lipotropic Agents|lipotropic agents|mesh-ancestor
5860114|NCT02403804|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5860115|NCT02403804|Antimetabolites|antimetabolites|mesh-ancestor
5860116|NCT02403804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5860117|NCT02403804|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5860118|NCT02403596|Tranexamic Acid|tranexamic acid|mesh-list
5860119|NCT02403596|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5860120|NCT02403596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5860121|NCT02403596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5860122|NCT02403596|Hemostatics|hemostatics|mesh-ancestor
5860123|NCT02403596|Coagulants|coagulants|mesh-ancestor
5675009|NCT03535558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675010|NCT03535558|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5675011|NCT03535558|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
5675012|NCT03535558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5675013|NCT03535558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5860124|NCT02403544|Capecitabine|capecitabine|mesh-list
5675014|NCT03535519|Methotrexate|methotrexate|mesh-list
5860125|NCT02403544|Oxaliplatin|oxaliplatin|mesh-list
5860126|NCT02403544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5675015|NCT03535519|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5675016|NCT03535519|Abortifacient Agents|abortifacient agents|mesh-ancestor
5675017|NCT03535519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5675018|NCT03535519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675019|NCT03535519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5860127|NCT02403544|Antimetabolites|antimetabolites|mesh-ancestor
5860128|NCT02403544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5860129|NCT02403544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5860130|NCT02403687|Topiramate|topiramate|mesh-list
5860131|NCT02403687|Diclofenac|diclofenac|mesh-list
5860132|NCT02403687|Meloxicam|meloxicam|mesh-list
5860133|NCT02403687|Flurbiprofen|flurbiprofen|mesh-list
5860134|NCT02403687|Lidocaine|lidocaine|mesh-list
5675020|NCT03535519|Antimetabolites|antimetabolites|mesh-ancestor
5675021|NCT03535519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675022|NCT03535519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5675023|NCT03535519|Dermatologic Agents|dermatologic agents|mesh-ancestor
5860135|NCT02403687|Clonidine|clonidine|mesh-list
5860136|NCT02403687|Sumatriptan|sumatriptan|mesh-list
5860137|NCT02403687|Ketamine|ketamine|mesh-list
5860138|NCT02403687|Gabapentin|gabapentin|mesh-list
5860139|NCT02403687|Amitriptyline|amitriptyline|mesh-list
5675024|NCT03535519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5675025|NCT03535519|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5675026|NCT03535519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5675027|NCT03535519|Immunologic Factors|immunologic factors|mesh-ancestor
5675028|NCT03535519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5675029|NCT03535519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5675030|NCT03535506|Palbociclib|palbociclib|mesh-list
5675031|NCT03535506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5675032|NCT03535506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5675033|NCT03535506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5675034|NCT03535506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675035|NCT03535480|Sargramostim|sargramostim|mesh-list
5675036|NCT03535480|Lenograstim|lenograstim|mesh-list
5675037|NCT03535480|Immunologic Factors|immunologic factors|mesh-ancestor
5860140|NCT02403687|Tizanidine|tizanidine|mesh-list
5860141|NCT02403687|Bupivacaine|bupivacaine|mesh-list
5860142|NCT02403687|Prilocaine|prilocaine|mesh-list
5860143|NCT02403687|Cyclobenzaprine|cyclobenzaprine|mesh-list
5860144|NCT02403687|Baclofen|baclofen|mesh-list
5860145|NCT02403687|Capsaicin|capsaicin|mesh-list
5860146|NCT02403687|Menthol|menthol|mesh-list
5860147|NCT02403687|Anesthetics, Local|anesthetics, local|mesh-ancestor
5860148|NCT02403687|Anesthetics|anesthetics|mesh-ancestor
5860149|NCT02403687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5860150|NCT02403687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5860151|NCT02403687|Sensory System Agents|sensory system agents|mesh-ancestor
5860152|NCT02403687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5860153|NCT02403687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5860154|NCT02403687|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5860155|NCT02403687|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5860156|NCT02403687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5860157|NCT02403687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5860158|NCT02403687|Analgesics|analgesics|mesh-ancestor
5860159|NCT02403687|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5860160|NCT02403687|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5860161|NCT02403687|Anesthetics, General|anesthetics, general|mesh-ancestor
5860162|NCT02403687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5860163|NCT02403687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5860164|NCT02403687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5860165|NCT02403687|Anticonvulsants|anticonvulsants|mesh-ancestor
5860166|NCT02403687|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5860167|NCT02403687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5860168|NCT02403687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5860169|NCT02403687|Antimanic Agents|antimanic agents|mesh-ancestor
5860170|NCT02403687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5860171|NCT02403687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5860172|NCT02403687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5860173|NCT02403687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5860174|NCT02403687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5860175|NCT02403687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5860176|NCT02403687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5860177|NCT02403687|Antipruritics|antipruritics|mesh-ancestor
5860178|NCT02403687|Dermatologic Agents|dermatologic agents|mesh-ancestor
5860179|NCT02403687|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5675038|NCT03535480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675039|NCT03535480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5675040|NCT03535415|Hormones|hormones|mesh-list
5675041|NCT03535415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5675042|NCT03535415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675043|NCT03535376|Valsartan|valsartan|mesh-list
5675044|NCT03535376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5675045|NCT03535376|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5860180|NCT02403687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5860181|NCT02403687|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
5860182|NCT02403687|GABA Agonists|gaba agonists|mesh-ancestor
5860183|NCT02403687|GABA Agents|gaba agents|mesh-ancestor
5860184|NCT02403687|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5860185|NCT02403687|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5860186|NCT02403687|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5860187|NCT02403687|Serotonin Agents|serotonin agents|mesh-ancestor
5860188|NCT02403687|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5860189|NCT02403687|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5860190|NCT02403687|Antidepressive Agents|antidepressive agents|mesh-ancestor
5860191|NCT02403687|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5860192|NCT02403687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5860193|NCT02403687|Adrenergic Agents|adrenergic agents|mesh-ancestor
5860194|NCT02403687|Parasympatholytics|parasympatholytics|mesh-ancestor
5860195|NCT02403687|Autonomic Agents|autonomic agents|mesh-ancestor
5860196|NCT02403687|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5860197|NCT02403687|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5860198|NCT02403687|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5860199|NCT02403687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5860200|NCT02403687|Sympatholytics|sympatholytics|mesh-ancestor
5860201|NCT02403713|Fluticasone|fluticasone|mesh-list
5860202|NCT02403713|Xhance|xhance|mesh-list
5860203|NCT02403713|Formoterol Fumarate|formoterol fumarate|mesh-list
5860204|NCT02403713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5860205|NCT02403713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5860206|NCT02403713|Autonomic Agents|autonomic agents|mesh-ancestor
5860207|NCT02403713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5860208|NCT02403713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5860209|NCT02403713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5860210|NCT02403713|Respiratory System Agents|respiratory system agents|mesh-ancestor
5860211|NCT02403713|Dermatologic Agents|dermatologic agents|mesh-ancestor
5860212|NCT02403713|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5860213|NCT02403713|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5860214|NCT02403713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5860215|NCT02403713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5860216|NCT02403713|Adrenergic Agents|adrenergic agents|mesh-ancestor
5860217|NCT02403713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5860218|NCT02403713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5860219|NCT02403648|Glucagon|glucagon|mesh-list
5860220|NCT02403648|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5675046|NCT03535376|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5675047|NCT03535376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675048|NCT03535298|Interferons|interferons|mesh-list
5675049|NCT03535298|Interferon-beta|interferon-beta|mesh-list
5675050|NCT03535298|Teriflunomide|teriflunomide|mesh-list
5675051|NCT03535298|Alemtuzumab|alemtuzumab|mesh-list
5675052|NCT03535298|Ofatumumab|ofatumumab|mesh-list
5675053|NCT03535298|Cladribine|cladribine|mesh-list
5675054|NCT03535298|Glatiramer Acetate|glatiramer acetate|mesh-list
5675055|NCT03535298|Dimethyl Fumarate|dimethyl fumarate|mesh-list
5675056|NCT03535298|Ocrelizumab|ocrelizumab|mesh-list
5675057|NCT03535298|Natalizumab|natalizumab|mesh-list
5860221|NCT02403648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5860222|NCT02403648|Hormones|hormones|mesh-ancestor
5860223|NCT02403648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5860224|NCT02403648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5860225|NCT02403648|Incretins|incretins|mesh-ancestor
5860226|NCT02403531|Docetaxel|docetaxel|mesh-list
5675058|NCT03535298|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
5675059|NCT03535298|(T,G)-A-L|(t,g)-a-l|mesh-list
5860227|NCT02403531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5860228|NCT02403531|Tubulin Modulators|tubulin modulators|mesh-ancestor
5860229|NCT02403531|Antimitotic Agents|antimitotic agents|mesh-ancestor
5860230|NCT02403531|Mitosis Modulators|mitosis modulators|mesh-ancestor
5860231|NCT02403531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5860232|NCT02403349|Atenolol|atenolol|mesh-list
5860233|NCT02403349|Valsartan|valsartan|mesh-list
5860234|NCT02403349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5860235|NCT02403349|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5860236|NCT02403349|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5860237|NCT02403349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5860238|NCT02403349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5860239|NCT02403349|Sympatholytics|sympatholytics|mesh-ancestor
5860240|NCT02403349|Autonomic Agents|autonomic agents|mesh-ancestor
5860241|NCT02403349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5860242|NCT02403349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5860243|NCT02403349|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5860244|NCT02403349|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5860245|NCT02403349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5860246|NCT02403349|Adrenergic Agents|adrenergic agents|mesh-ancestor
5860247|NCT02403349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5860248|NCT02403401|Levonorgestrel|levonorgestrel|mesh-list
5860249|NCT02403401|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5860250|NCT02403401|Contraceptive Agents|contraceptive agents|mesh-ancestor
5860251|NCT02403401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5860252|NCT02403401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5860253|NCT02403401|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5860254|NCT02403401|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5860255|NCT02403401|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5860256|NCT02403219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5860257|NCT02403219|Botulinum Toxins|botulinum toxins|mesh-list
5860258|NCT02403219|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5860259|NCT02403219|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5860260|NCT02403219|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5860261|NCT02403219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5860262|NCT02403219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5860263|NCT02403219|Cholinergic Agents|cholinergic agents|mesh-ancestor
5860264|NCT02403219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5860265|NCT02403219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5860266|NCT02403219|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5860267|NCT02403219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5860268|NCT02403284|Liraglutide|liraglutide|mesh-list
5675060|NCT03535298|Ozanimod|ozanimod|mesh-list
5675061|NCT03535298|Ponesimod|ponesimod|mesh-list
5675062|NCT03535298|Siponimod|siponimod|mesh-list
5675063|NCT03535298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5675064|NCT03535298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5675065|NCT03535298|Immunologic Factors|immunologic factors|mesh-ancestor
5675066|NCT03535298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675067|NCT03535298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5675068|NCT03535298|Antiviral Agents|antiviral agents|mesh-ancestor
5675069|NCT03535298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5675070|NCT03535298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5860269|NCT02403284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5860270|NCT02403284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494552|NCT00619021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6494553|NCT00619021|Immunologic Factors|immunologic factors|mesh-ancestor
6494554|NCT00619021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494555|NCT00619034|Diclofenac|diclofenac|mesh-list
6494556|NCT00619034|Dorzolamide|dorzolamide|mesh-list
6494557|NCT00619034|Latanoprost|latanoprost|mesh-list
6494558|NCT00619034|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6494559|NCT00619034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6494560|NCT00619034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6494561|NCT00619034|Analgesics|analgesics|mesh-ancestor
5675071|NCT03535298|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5696392|NCT03383315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675072|NCT03535298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5860271|NCT02403284|Incretins|incretins|mesh-ancestor
5860272|NCT02403284|Hormones|hormones|mesh-ancestor
5860273|NCT02403284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5904591|NCT05010772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5904592|NCT05010772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5904593|NCT05004116|Irinotecan|irinotecan|mesh-list
5904594|NCT05004116|Temozolomide|temozolomide|mesh-list
5904595|NCT05004116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5904596|NCT05004116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5904597|NCT05004116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5904598|NCT05004116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904599|NCT05004116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5904600|NCT05004116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5904601|NCT05004116|Alkylating Agents|alkylating agents|mesh-ancestor
5904602|NCT04939272|Venetoclax|venetoclax|mesh-list
5904603|NCT04939272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5904604|NCT04924374|Pembrolizumab|pembrolizumab|mesh-list
5904605|NCT04924374|Atezolizumab|atezolizumab|mesh-list
5904606|NCT04924374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5904607|NCT04924374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5904608|NCT04924374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5904609|NCT04924374|Immunologic Factors|immunologic factors|mesh-ancestor
5904610|NCT04924374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904611|NCT04912518|Dexmedetomidine|dexmedetomidine|mesh-list
5904612|NCT04912518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5904613|NCT04912518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5904614|NCT04912518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904615|NCT04912518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5904616|NCT04912518|Analgesics|analgesics|mesh-ancestor
5904617|NCT04912518|Sensory System Agents|sensory system agents|mesh-ancestor
5904618|NCT04912518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5904619|NCT04912518|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5675073|NCT03535298|Dermatologic Agents|dermatologic agents|mesh-ancestor
5675074|NCT03535298|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5675075|NCT03535298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5904620|NCT04912518|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5904621|NCT04912518|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5904622|NCT04912518|Adrenergic Agents|adrenergic agents|mesh-ancestor
5675076|NCT03535298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5675077|NCT03535298|Analgesics|analgesics|mesh-ancestor
5675078|NCT03535298|Sensory System Agents|sensory system agents|mesh-ancestor
5675079|NCT03535298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5675080|NCT03535298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5675087|NCT03535259|Sorafenib|sorafenib|mesh-list
5904623|NCT04912518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5904624|NCT04912518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904625|NCT04909021|Vaccines|vaccines|mesh-list
5675088|NCT03535259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5675089|NCT03535259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5675090|NCT03535259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5675091|NCT03535259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675092|NCT03535233|Triamcinolone|triamcinolone|mesh-list
5904626|NCT04909021|Immunologic Factors|immunologic factors|mesh-ancestor
5904627|NCT04909021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904628|NCT04898764|Mometasone Furoate|mometasone furoate|mesh-list
5904629|NCT04898764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5904630|NCT04898764|Dermatologic Agents|dermatologic agents|mesh-ancestor
5904631|NCT04898764|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5904632|NCT04873583|Methylprednisolone|methylprednisolone|mesh-list
5904633|NCT04873583|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5904634|NCT04873583|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5904635|NCT04873583|Prednisolone|prednisolone|mesh-list
5904636|NCT04873583|Prednisolone acetate|prednisolone acetate|mesh-list
6494562|NCT00619034|Sensory System Agents|sensory system agents|mesh-ancestor
6494563|NCT00619034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6494564|NCT00619034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494565|NCT00619034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5675093|NCT03535233|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5675094|NCT03535233|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5675095|NCT03535233|Clobetasol|clobetasol|mesh-list
5675096|NCT03535233|Minoxidil|minoxidil|mesh-list
5675097|NCT03535233|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5675098|NCT03535233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5860274|NCT02403128|Aflibercept|aflibercept|mesh-list
5860275|NCT02403128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5860276|NCT02403128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5860277|NCT02403128|Growth Substances|growth substances|mesh-ancestor
5860278|NCT02403128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5860279|NCT02403128|Growth Inhibitors|growth inhibitors|mesh-ancestor
5860280|NCT02403128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5860281|NCT02403063|Neostigmine|neostigmine|mesh-list
5860282|NCT02403063|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5860283|NCT02403063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5860284|NCT02403063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5860285|NCT02403063|Cholinergic Agents|cholinergic agents|mesh-ancestor
5860286|NCT02403063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5860287|NCT02403063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5860288|NCT02403063|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5860289|NCT02403063|Autonomic Agents|autonomic agents|mesh-ancestor
5860290|NCT02403063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5860291|NCT02403037|Dexamethasone|dexamethasone|mesh-list
5860292|NCT02403037|Dexamethasone acetate|dexamethasone acetate|mesh-list
5860293|NCT02403037|Antiemetics|antiemetics|mesh-list
5860294|NCT02403037|Emetics|emetics|mesh-list
5860295|NCT02403037|BB 1101|bb 1101|mesh-list
5860296|NCT02403037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5860297|NCT02403037|Autonomic Agents|autonomic agents|mesh-ancestor
5860298|NCT02403037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5860299|NCT02403037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675099|NCT03535233|Glucocorticoids|glucocorticoids|mesh-ancestor
5675100|NCT03535233|Hormones|hormones|mesh-ancestor
5675101|NCT03535233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5860300|NCT02403037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5860301|NCT02403037|Glucocorticoids|glucocorticoids|mesh-ancestor
5860302|NCT02403037|Hormones|hormones|mesh-ancestor
5860303|NCT02403037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5860304|NCT02403037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5860305|NCT02403037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5860306|NCT02403037|Protease Inhibitors|protease inhibitors|mesh-ancestor
5860307|NCT02403037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5860308|NCT02403037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5860309|NCT02402842|Docetaxel|docetaxel|mesh-list
5860310|NCT02402842|Fluorouracil|fluorouracil|mesh-list
5860311|NCT02402842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5860312|NCT02402842|Tubulin Modulators|tubulin modulators|mesh-ancestor
5860313|NCT02402842|Antimitotic Agents|antimitotic agents|mesh-ancestor
5860314|NCT02402842|Mitosis Modulators|mitosis modulators|mesh-ancestor
5860315|NCT02402842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5860316|NCT02402842|Antimetabolites|antimetabolites|mesh-ancestor
5860317|NCT02402842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5860318|NCT02402842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5860319|NCT02402842|Immunologic Factors|immunologic factors|mesh-ancestor
5860320|NCT02402842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5860321|NCT02402972|Leucovorin|leucovorin|mesh-list
5860322|NCT02402972|Oxaliplatin|oxaliplatin|mesh-list
5860323|NCT02402972|Floxuridine|floxuridine|mesh-list
5860324|NCT02402972|Levoleucovorin|levoleucovorin|mesh-list
5860325|NCT02402972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5860326|NCT02402972|Antidotes|antidotes|mesh-ancestor
5860327|NCT02402972|Protective Agents|protective agents|mesh-ancestor
5860328|NCT02402972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5860329|NCT02402972|Vitamin B Complex|vitamin b complex|mesh-ancestor
5860330|NCT02402972|Vitamins|vitamins|mesh-ancestor
5860331|NCT02402972|Micronutrients|micronutrients|mesh-ancestor
5860332|NCT02402972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5860333|NCT02402972|Antimetabolites|antimetabolites|mesh-ancestor
5860334|NCT02402972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5860335|NCT02402868|Ketamine|ketamine|mesh-list
5860336|NCT02402868|Analgesics|analgesics|mesh-ancestor
5860337|NCT02402868|Sensory System Agents|sensory system agents|mesh-ancestor
5860338|NCT02402868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5860339|NCT02402868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5860340|NCT02402868|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5860341|NCT02402868|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5860342|NCT02402868|Anesthetics, General|anesthetics, general|mesh-ancestor
5860343|NCT02402868|Anesthetics|anesthetics|mesh-ancestor
5860344|NCT02402868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5860345|NCT02402868|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5860346|NCT02402868|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5860347|NCT02402868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5860348|NCT02402868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5860349|NCT02402725|Dexamethasone|dexamethasone|mesh-list
5860350|NCT02402725|Dexamethasone acetate|dexamethasone acetate|mesh-list
5860351|NCT02402725|BB 1101|bb 1101|mesh-list
5860352|NCT02402725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5860353|NCT02402725|Antiemetics|antiemetics|mesh-ancestor
5860354|NCT02402725|Autonomic Agents|autonomic agents|mesh-ancestor
5860355|NCT02402725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5860356|NCT02402725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5860357|NCT02402725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5860358|NCT02402725|Glucocorticoids|glucocorticoids|mesh-ancestor
5860359|NCT02402725|Hormones|hormones|mesh-ancestor
5860360|NCT02402725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5860361|NCT02402725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5860362|NCT02402725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5675102|NCT03535233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675103|NCT03535233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5675104|NCT03535233|Immunologic Factors|immunologic factors|mesh-ancestor
5675105|NCT03535233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5675106|NCT03535233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675107|NCT03535233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5675108|NCT03535233|Vasodilator Agents|vasodilator agents|mesh-ancestor
5675109|NCT03535220|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
5675110|NCT03535220|Protease Inhibitors|protease inhibitors|mesh-list
5675111|NCT03535220|Proteasome Inhibitors|proteasome inhibitors|mesh-list
5675112|NCT03535220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5675113|NCT03535220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675114|NCT03535220|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5675115|NCT03535220|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5675116|NCT03535220|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5675117|NCT03535220|Antiviral Agents|antiviral agents|mesh-ancestor
5675118|NCT03535220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5675119|NCT03535168|Midazolam|midazolam|mesh-list
5675120|NCT03535168|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5675121|NCT03535168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5675122|NCT03535168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5675123|NCT03535168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675124|NCT03535168|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5675125|NCT03535168|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5675126|NCT03535168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5675127|NCT03535168|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5675128|NCT03535168|Anesthetics, General|anesthetics, general|mesh-ancestor
5675129|NCT03535168|Anesthetics|anesthetics|mesh-ancestor
5675130|NCT03535168|GABA Modulators|gaba modulators|mesh-ancestor
5675131|NCT03535168|GABA Agents|gaba agents|mesh-ancestor
5675132|NCT03535168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5675133|NCT03535168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675134|NCT03535116|Ketorolac|ketorolac|mesh-list
5675135|NCT03535116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5675136|NCT03535116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5675137|NCT03535116|Analgesics|analgesics|mesh-ancestor
5675138|NCT03535116|Sensory System Agents|sensory system agents|mesh-ancestor
5675139|NCT03535116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5675140|NCT03535116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675141|NCT03535116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5675142|NCT03535116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5675143|NCT03535116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5675144|NCT03535116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5675145|NCT03535116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675146|NCT03535103|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5675147|NCT03535103|Hormones|hormones|mesh-ancestor
5675148|NCT03535103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5675149|NCT03535103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675150|NCT03535090|Methylprednisolone|methylprednisolone|mesh-list
5675151|NCT03535090|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5675152|NCT03535090|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5675153|NCT03535090|Prednisolone|prednisolone|mesh-list
5675154|NCT03535090|Prednisolone acetate|prednisolone acetate|mesh-list
5696393|NCT03383315|Analgesics|analgesics|mesh-ancestor
5860363|NCT02402725|Protease Inhibitors|protease inhibitors|mesh-ancestor
5860364|NCT02402725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5860365|NCT02402725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675155|NCT03535090|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5675156|NCT03535090|Prednisolone phosphate|prednisolone phosphate|mesh-list
5675157|NCT03535090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5675158|NCT03535090|Antiemetics|antiemetics|mesh-ancestor
5675159|NCT03535090|Autonomic Agents|autonomic agents|mesh-ancestor
5675160|NCT03535090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5675161|NCT03535090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675162|NCT03535090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5675163|NCT03535090|Glucocorticoids|glucocorticoids|mesh-ancestor
5860366|NCT02402712|Docetaxel|docetaxel|mesh-list
5860367|NCT02402712|Trastuzumab|trastuzumab|mesh-list
5860368|NCT02402712|Pertuzumab|pertuzumab|mesh-list
5860369|NCT02402712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5860370|NCT02402712|Tubulin Modulators|tubulin modulators|mesh-ancestor
5860371|NCT02402712|Antimitotic Agents|antimitotic agents|mesh-ancestor
5860372|NCT02402712|Mitosis Modulators|mitosis modulators|mesh-ancestor
5860373|NCT02402712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5860374|NCT02402712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5860375|NCT02402621|Fentanyl|fentanyl|mesh-list
5860376|NCT02402621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5860377|NCT02402621|Narcotics|narcotics|mesh-ancestor
5860378|NCT02402621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5860379|NCT02402621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5860380|NCT02402621|Analgesics|analgesics|mesh-ancestor
5860381|NCT02402621|Sensory System Agents|sensory system agents|mesh-ancestor
5860382|NCT02402621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5860383|NCT02402621|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5860384|NCT02402621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5860385|NCT02402621|Anesthetics, General|anesthetics, general|mesh-ancestor
5860386|NCT02402621|Anesthetics|anesthetics|mesh-ancestor
5860387|NCT02402660|Vitamin A|vitamin a|mesh-list
5860388|NCT02402660|Retinol acetate|retinol acetate|mesh-list
5860389|NCT02402660|Vitamins|vitamins|mesh-ancestor
5860390|NCT02402660|Micronutrients|micronutrients|mesh-ancestor
5860391|NCT02402660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5860392|NCT02402660|Protective Agents|protective agents|mesh-ancestor
5860393|NCT02402660|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5675164|NCT03535090|Hormones|hormones|mesh-ancestor
5675165|NCT03535090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5675166|NCT03535090|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5675167|NCT03535090|Protective Agents|protective agents|mesh-ancestor
5675168|NCT03535090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5675169|NCT03535090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5675170|NCT03535051|Tacrolimus|tacrolimus|mesh-list
5675171|NCT03535051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5675172|NCT03535051|Immunologic Factors|immunologic factors|mesh-ancestor
5675173|NCT03535051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675174|NCT03535051|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5675175|NCT03535051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5696394|NCT03383315|Sensory System Agents|sensory system agents|mesh-ancestor
5860394|NCT02402660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5860395|NCT02402660|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5860396|NCT02402660|Immunologic Factors|immunologic factors|mesh-ancestor
5860397|NCT02402595|Itraconazole|itraconazole|mesh-list
5860398|NCT02402595|Antifungal Agents|antifungal agents|mesh-ancestor
5860399|NCT02402595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5860400|NCT02402595|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5860401|NCT02402595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5860402|NCT02402595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6494566|NCT00619034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5675176|NCT03535051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675177|NCT03534973|Caffeine|caffeine|mesh-list
5675178|NCT03534973|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5675179|NCT03534973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494567|NCT00619034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6494568|NCT00619034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6494569|NCT00619034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494570|NCT00619034|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6494571|NCT00619034|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6494572|NCT00619034|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6494573|NCT00619203|Acetaminophen|acetaminophen|mesh-list
6494574|NCT00619203|Glycerol|glycerol|mesh-list
6494575|NCT00619203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6494576|NCT00619203|Analgesics|analgesics|mesh-ancestor
6494577|NCT00619203|Sensory System Agents|sensory system agents|mesh-ancestor
6494578|NCT00619203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5860403|NCT02402595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5860404|NCT02402595|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5860405|NCT02402595|Hormone Antagonists|hormone antagonists|mesh-ancestor
5860406|NCT02402595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5860407|NCT02402595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5860408|NCT02402595|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5860409|NCT02402491|Aspirin|aspirin|mesh-list
5860410|NCT02402491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
5860411|NCT02402491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5860412|NCT02402491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5860413|NCT02402491|Analgesics|analgesics|mesh-ancestor
5860414|NCT02402491|Sensory System Agents|sensory system agents|mesh-ancestor
6494579|NCT00619203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5860415|NCT02402491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5860416|NCT02402491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5860417|NCT02402491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5860418|NCT02402491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5860419|NCT02402491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5860420|NCT02402491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5860421|NCT02402491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5860422|NCT02402491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5860423|NCT02402491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5860424|NCT02402491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5860425|NCT02402491|Antipyretics|antipyretics|mesh-ancestor
5860426|NCT02402491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5860427|NCT02402491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5860428|NCT02402491|Purinergic Agents|purinergic agents|mesh-ancestor
5860429|NCT02402491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5860430|NCT02402465|Fluticasone|fluticasone|mesh-list
5860431|NCT02402465|Xhance|xhance|mesh-list
5675180|NCT03534973|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5675181|NCT03534973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5675182|NCT03534973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5860432|NCT02402465|Azelastine|azelastine|mesh-list
5860433|NCT02402465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5675183|NCT03534973|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5675184|NCT03534973|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5675185|NCT03534973|Purinergic Agents|purinergic agents|mesh-ancestor
5675186|NCT03534973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5675187|NCT03534947|Imiquimod|imiquimod|mesh-list
5675188|NCT03534947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5675189|NCT03534947|Immunologic Factors|immunologic factors|mesh-ancestor
5675190|NCT03534947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675191|NCT03534947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5675192|NCT03534947|Interferon Inducers|interferon inducers|mesh-ancestor
5675193|NCT03534895|Midazolam|midazolam|mesh-list
5675194|NCT03534895|Anesthetics|anesthetics|mesh-ancestor
5675195|NCT03534895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5675196|NCT03534895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5860434|NCT02402465|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5860435|NCT02402465|Autonomic Agents|autonomic agents|mesh-ancestor
5860436|NCT02402465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5860437|NCT02402465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5860438|NCT02402465|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5860439|NCT02402465|Respiratory System Agents|respiratory system agents|mesh-ancestor
5860440|NCT02402465|Dermatologic Agents|dermatologic agents|mesh-ancestor
6494580|NCT00619203|Antipyretics|antipyretics|mesh-ancestor
5860441|NCT02402465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5860442|NCT02402465|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
5860443|NCT02402465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5860444|NCT02402465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5860445|NCT02402465|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5860446|NCT02402465|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5860447|NCT02402465|Histamine Antagonists|histamine antagonists|mesh-ancestor
5860448|NCT02402465|Histamine Agents|histamine agents|mesh-ancestor
5860449|NCT02402465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5860450|NCT02402400|Ticagrelor|ticagrelor|mesh-list
5860451|NCT02402400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5860452|NCT02402400|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5860453|NCT02402400|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5860454|NCT02402400|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5860455|NCT02402400|Purinergic Agents|purinergic agents|mesh-ancestor
5860456|NCT02402400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5860457|NCT02402400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5860458|NCT02402400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5860459|NCT02402413|Androgens|androgens|mesh-list
5860460|NCT02402413|Hormones|hormones|mesh-ancestor
5860461|NCT02402413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5860462|NCT02402413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5860463|NCT02402283|Metronidazole|metronidazole|mesh-list
5860464|NCT02402283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5860465|NCT02402283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5860466|NCT02402283|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5860467|NCT02402283|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5860468|NCT02402231|Omalizumab|omalizumab|mesh-list
5860469|NCT02402231|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5860470|NCT02402231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5860471|NCT02402231|Respiratory System Agents|respiratory system agents|mesh-ancestor
5860472|NCT02402543|Acetaminophen|acetaminophen|mesh-list
5860473|NCT02402543|Dexamethasone|dexamethasone|mesh-list
5860474|NCT02402543|Ketamine|ketamine|mesh-list
5860475|NCT02402543|Gabapentin|gabapentin|mesh-list
5860476|NCT02402543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5860477|NCT02402543|Antiemetics|antiemetics|mesh-ancestor
5860478|NCT02402543|Autonomic Agents|autonomic agents|mesh-ancestor
5860479|NCT02402543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5860480|NCT02402543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5860481|NCT02402543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5860482|NCT02402543|Glucocorticoids|glucocorticoids|mesh-ancestor
5860483|NCT02402543|Hormones|hormones|mesh-ancestor
5860484|NCT02402543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5860485|NCT02402543|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5860486|NCT02402543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5860487|NCT02402543|Analgesics|analgesics|mesh-ancestor
5860488|NCT02402543|Sensory System Agents|sensory system agents|mesh-ancestor
5860489|NCT02402543|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5860490|NCT02402543|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5860491|NCT02402543|Anesthetics, General|anesthetics, general|mesh-ancestor
5860492|NCT02402543|Anesthetics|anesthetics|mesh-ancestor
5860493|NCT02402543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5860494|NCT02402543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5860495|NCT02402543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5860496|NCT02402543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5860497|NCT02402543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5860498|NCT02402543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5860499|NCT02402543|Antipyretics|antipyretics|mesh-ancestor
5675197|NCT03534895|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5675198|NCT03534895|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5675199|NCT03534895|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5675200|NCT03534895|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5675201|NCT03534895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5675202|NCT03534895|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5675203|NCT03534895|Anesthetics, General|anesthetics, general|mesh-ancestor
5675204|NCT03534895|GABA Modulators|gaba modulators|mesh-ancestor
5675205|NCT03534895|GABA Agents|gaba agents|mesh-ancestor
5675206|NCT03534895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5675207|NCT03534895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675208|NCT03534869|Analgesics|analgesics|mesh-list
5675209|NCT03534869|Sensory System Agents|sensory system agents|mesh-ancestor
5675210|NCT03534869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5675211|NCT03534869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675212|NCT03534713|Paclitaxel|paclitaxel|mesh-list
5860500|NCT02402543|Anticonvulsants|anticonvulsants|mesh-ancestor
5860501|NCT02402543|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5860502|NCT02402543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5675213|NCT03534713|Carboplatin|carboplatin|mesh-list
5675214|NCT03534713|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5675215|NCT03534713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5675216|NCT03534713|Tubulin Modulators|tubulin modulators|mesh-ancestor
5675217|NCT03534713|Antimitotic Agents|antimitotic agents|mesh-ancestor
5675218|NCT03534713|Mitosis Modulators|mitosis modulators|mesh-ancestor
5675219|NCT03534713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675220|NCT03534674|Vitamin D|vitamin d|mesh-list
5675221|NCT03534674|Cholecalciferol|cholecalciferol|mesh-list
5675222|NCT03534674|Vitamins|vitamins|mesh-ancestor
5675223|NCT03534674|Micronutrients|micronutrients|mesh-ancestor
5675224|NCT03534674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675225|NCT03534674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5675226|NCT03534674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5675227|NCT03534661|Teduglutide|teduglutide|mesh-list
5675228|NCT03534661|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
5675229|NCT03534661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5675230|NCT03534661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675231|NCT03534661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5675232|NCT03534661|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5675233|NCT03534661|Protective Agents|protective agents|mesh-ancestor
5675234|NCT03534661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675235|NCT03534531|Methylprednisolone|methylprednisolone|mesh-list
5675236|NCT03534531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5675237|NCT03534531|Antiemetics|antiemetics|mesh-ancestor
5675238|NCT03534531|Autonomic Agents|autonomic agents|mesh-ancestor
5675239|NCT03534531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5860503|NCT02402543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5860504|NCT02402543|Antimanic Agents|antimanic agents|mesh-ancestor
5860505|NCT02402348|Metformin|metformin|mesh-list
5860506|NCT02402348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5860507|NCT02402348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5860508|NCT02402114|Hydrocortisone|hydrocortisone|mesh-list
5860509|NCT02402114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5860510|NCT02402179|Tryptophan|tryptophan|mesh-list
5860511|NCT02402179|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5860512|NCT02402179|Antidepressive Agents|antidepressive agents|mesh-ancestor
5860513|NCT02402179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5860514|NCT02401945|Aflibercept|aflibercept|mesh-list
5860515|NCT02401945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5860516|NCT02401945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5860517|NCT02401945|Growth Substances|growth substances|mesh-ancestor
5860518|NCT02401945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5860519|NCT02401945|Growth Inhibitors|growth inhibitors|mesh-ancestor
5860520|NCT02401945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5860521|NCT02401971|Thalidomide|thalidomide|mesh-list
5860522|NCT02401971|Irinotecan|irinotecan|mesh-list
5860523|NCT02401971|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5860524|NCT02401971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5860525|NCT02401971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5860526|NCT02401971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5860527|NCT02401971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5860528|NCT02401971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5860529|NCT02401971|Immunologic Factors|immunologic factors|mesh-ancestor
5860530|NCT02401971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5860531|NCT02401971|Leprostatic Agents|leprostatic agents|mesh-ancestor
5860532|NCT02401971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5860533|NCT02401971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5860534|NCT02401971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5860535|NCT02401971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5860536|NCT02401971|Growth Substances|growth substances|mesh-ancestor
5675240|NCT03534531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675241|NCT03534531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5675242|NCT03534531|Glucocorticoids|glucocorticoids|mesh-ancestor
5675243|NCT03534531|Hormones|hormones|mesh-ancestor
5675244|NCT03534531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5860537|NCT02401971|Growth Inhibitors|growth inhibitors|mesh-ancestor
5860538|NCT02401880|Empagliflozin|empagliflozin|mesh-list
5860539|NCT02401880|Linagliptin|linagliptin|mesh-list
5860540|NCT02401880|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5860541|NCT02401880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675245|NCT03534531|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5860542|NCT02401880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5675246|NCT03534531|Protective Agents|protective agents|mesh-ancestor
5675247|NCT03534505|Ketorolac|ketorolac|mesh-list
5675248|NCT03534505|Bupivacaine|bupivacaine|mesh-list
5675249|NCT03534505|Anesthetics, Local|anesthetics, local|mesh-ancestor
5675250|NCT03534505|Anesthetics|anesthetics|mesh-ancestor
5675251|NCT03534505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5675252|NCT03534505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675253|NCT03534505|Sensory System Agents|sensory system agents|mesh-ancestor
5675254|NCT03534505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5675255|NCT03534505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5675256|NCT03534505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5675257|NCT03534505|Analgesics|analgesics|mesh-ancestor
5675258|NCT03534505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5675259|NCT03534505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5675260|NCT03534505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5675261|NCT03534505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5675262|NCT03534505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675263|NCT03534492|Durvalumab|durvalumab|mesh-list
5675264|NCT03534492|Olaparib|olaparib|mesh-list
5675265|NCT03534492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5860543|NCT02401880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5860544|NCT02401880|Incretins|incretins|mesh-ancestor
5860545|NCT02401880|Hormones|hormones|mesh-ancestor
5860546|NCT02401880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5860547|NCT02401880|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5860548|NCT02401880|Protease Inhibitors|protease inhibitors|mesh-ancestor
5860549|NCT02401880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5860550|NCT02401828|Dolutegravir|dolutegravir|mesh-list
5860551|NCT02401828|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5860552|NCT02401828|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5860553|NCT02401828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5860554|NCT02401828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5860555|NCT02401828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5860556|NCT02401828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5860557|NCT02401828|Antiviral Agents|antiviral agents|mesh-ancestor
5860558|NCT02401828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5860559|NCT02401737|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5860560|NCT02401737|Antiviral Agents|antiviral agents|mesh-ancestor
5860561|NCT02401737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5860562|NCT02401477|Amoxicillin|amoxicillin|mesh-list
5860563|NCT02401477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5860564|NCT02401477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5860565|NCT02401594|Enoxaparin|enoxaparin|mesh-list
5860566|NCT02401594|Rivaroxaban|rivaroxaban|mesh-list
5860567|NCT02401594|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5860568|NCT02401594|Antithrombins|antithrombins|mesh-ancestor
5860569|NCT02401594|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5860570|NCT02401594|Protease Inhibitors|protease inhibitors|mesh-ancestor
5860571|NCT02401594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5860572|NCT02401594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5860573|NCT02401594|Anticoagulants|anticoagulants|mesh-ancestor
5860574|NCT02401594|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5860575|NCT02401594|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5860576|NCT02401334|Anti-Infective Agents|anti-infective agents|mesh-list
5860577|NCT02401334|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5904637|NCT04873583|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5904638|NCT04873583|Prednisolone phosphate|prednisolone phosphate|mesh-list
5904639|NCT04873583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5904640|NCT04873583|Antiemetics|antiemetics|mesh-ancestor
5904641|NCT04873583|Autonomic Agents|autonomic agents|mesh-ancestor
5904642|NCT04873583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5904643|NCT04873583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904644|NCT04873583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5904645|NCT04873583|Glucocorticoids|glucocorticoids|mesh-ancestor
5904646|NCT04873583|Hormones|hormones|mesh-ancestor
5904647|NCT04873583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5904648|NCT04873583|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5904649|NCT04873583|Protective Agents|protective agents|mesh-ancestor
5904650|NCT04873583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5675266|NCT03534492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5675267|NCT03534492|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5904651|NCT04873583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5904652|NCT04818320|Favipiravir|favipiravir|mesh-list
5904653|NCT04818320|Antiviral Agents|antiviral agents|mesh-ancestor
5904654|NCT04818320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5904655|NCT04793906|Iron|iron|mesh-list
5675268|NCT03534492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5860578|NCT02401425|Letrozole|letrozole|mesh-list
5860579|NCT02401425|Misoprostol|misoprostol|mesh-list
5860580|NCT02401425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5860581|NCT02401425|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5860582|NCT02401425|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5860583|NCT02401425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5860584|NCT02401425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5860585|NCT02401425|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5860586|NCT02401425|Hormone Antagonists|hormone antagonists|mesh-ancestor
5860587|NCT02401425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5860588|NCT02401425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5860589|NCT02401425|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5860590|NCT02401425|Abortifacient Agents|abortifacient agents|mesh-ancestor
5860591|NCT02401425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5860592|NCT02401425|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5860593|NCT02401425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5860594|NCT02401425|Oxytocics|oxytocics|mesh-ancestor
5860595|NCT02401347|Talazoparib|talazoparib|mesh-list
5860596|NCT02401347|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5860597|NCT02401347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5860598|NCT02401347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5860599|NCT02401347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5860600|NCT02401269|Aspirin|aspirin|mesh-list
6494581|NCT00619203|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6494582|NCT00619203|Protective Agents|protective agents|mesh-ancestor
5860601|NCT02401269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5860602|NCT02401269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5860603|NCT02401269|Analgesics|analgesics|mesh-ancestor
5675269|NCT03534492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675270|NCT03534479|Immunoglobulins|immunoglobulins|mesh-list
5675271|NCT03534479|Immunologic Factors|immunologic factors|mesh-ancestor
5675272|NCT03534479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675273|NCT03534388|Sodium Hypochlorite|sodium hypochlorite|mesh-list
5860604|NCT02401269|Sensory System Agents|sensory system agents|mesh-ancestor
5860605|NCT02401269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5860606|NCT02401269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5860607|NCT02401269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5860608|NCT02401269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5860609|NCT02401269|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5860610|NCT02401269|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5860611|NCT02401269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5860612|NCT02401269|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5860613|NCT02401269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5860614|NCT02401269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5860615|NCT02401269|Antipyretics|antipyretics|mesh-ancestor
5860616|NCT02401295|Itraconazole|itraconazole|mesh-list
5860617|NCT02401295|Celecoxib|celecoxib|mesh-list
5860618|NCT02401295|Tretinoin|tretinoin|mesh-list
5860619|NCT02401295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5860620|NCT02401295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5860621|NCT02401295|Analgesics|analgesics|mesh-ancestor
5860622|NCT02401295|Sensory System Agents|sensory system agents|mesh-ancestor
5860623|NCT02401295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5860624|NCT02401295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5860625|NCT02401295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5860626|NCT02401295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5860627|NCT02401295|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5860628|NCT02401295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5860629|NCT02401295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5860630|NCT02401295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5860631|NCT02401295|Antifungal Agents|antifungal agents|mesh-ancestor
5860632|NCT02401295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5860633|NCT02401295|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5860634|NCT02401295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5675274|NCT03534388|Eusol|eusol|mesh-list
5675275|NCT03534388|Disinfectants|disinfectants|mesh-ancestor
5860635|NCT02401295|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6494583|NCT00619216|Mycophenolic Acid|mycophenolic acid|mesh-list
5675276|NCT03534388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5675277|NCT03534310|Liraglutide|liraglutide|mesh-list
5675278|NCT03534310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5675279|NCT03534310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675280|NCT03534310|Incretins|incretins|mesh-ancestor
5675281|NCT03534310|Hormones|hormones|mesh-ancestor
5860636|NCT02401295|Hormone Antagonists|hormone antagonists|mesh-ancestor
5860637|NCT02401295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5860638|NCT02401295|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5860639|NCT02401295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5860640|NCT02401295|Keratolytic Agents|keratolytic agents|mesh-ancestor
5860641|NCT02401295|Dermatologic Agents|dermatologic agents|mesh-ancestor
5860642|NCT02401503|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5860643|NCT02401503|Venetoclax|venetoclax|mesh-list
5860644|NCT02401503|Obinutuzumab|obinutuzumab|mesh-list
5860645|NCT02401503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5860646|NCT02401503|Alkylating Agents|alkylating agents|mesh-ancestor
5675282|NCT03534310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5675283|NCT03534297|Dapansutrile|dapansutrile|mesh-list
5675284|NCT03534297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5675285|NCT03534180|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5675286|NCT03534180|Venetoclax|venetoclax|mesh-list
5675287|NCT03534180|Romidepsin|romidepsin|mesh-list
5675288|NCT03534180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5860647|NCT02401503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5860648|NCT02401503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5860649|NCT02401503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5860650|NCT02401243|Insulin Glargine|insulin glargine|mesh-list
5860651|NCT02401243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5860652|NCT02401243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5860653|NCT02401035|Pantoprazole|pantoprazole|mesh-list
5860654|NCT02401035|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5860655|NCT02401035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5860656|NCT02401035|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5860657|NCT02401035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5860658|NCT02401035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5860659|NCT02401139|Ketamine|ketamine|mesh-list
5860660|NCT02401139|Analgesics|analgesics|mesh-ancestor
5860661|NCT02401139|Sensory System Agents|sensory system agents|mesh-ancestor
5675289|NCT03534180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5675290|NCT03534180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5675291|NCT03534102|Analgesics, Opioid|analgesics, opioid|mesh-list
5675292|NCT03534102|Narcotics|narcotics|mesh-ancestor
5675293|NCT03534102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5675294|NCT03534102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675295|NCT03534102|Analgesics|analgesics|mesh-ancestor
5675296|NCT03534102|Sensory System Agents|sensory system agents|mesh-ancestor
5675297|NCT03534102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5696395|NCT03383315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5696396|NCT03383315|Antiemetics|antiemetics|mesh-ancestor
5696397|NCT03383315|Autonomic Agents|autonomic agents|mesh-ancestor
5696398|NCT03383315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5696399|NCT03383315|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5696400|NCT03383315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5696401|NCT03383315|Dopamine Agents|dopamine agents|mesh-ancestor
5696402|NCT03383315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5696403|NCT03383315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696404|NCT03383302|Nivolumab|nivolumab|mesh-list
5696405|NCT03383302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5696406|NCT03383302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5696407|NCT03383302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5696408|NCT03383302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696409|NCT03383276|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5696410|NCT03383276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5696411|NCT03383237|Apatinib|apatinib|mesh-list
5696412|NCT03383237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5696413|NCT03383237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5696414|NCT03383237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5696415|NCT03383237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696416|NCT03383185|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
5696417|NCT03383185|Contraceptive Agents|contraceptive agents|mesh-list
5696418|NCT03383185|Medroxyprogesterone|medroxyprogesterone|mesh-list
5696419|NCT03383185|Contraceptives, Oral|contraceptives, oral|mesh-list
5696420|NCT03383185|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
5696421|NCT03383185|Progestins|progestins|mesh-list
5696422|NCT03383185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5860662|NCT02401139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5860663|NCT02401139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5860664|NCT02401139|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5860665|NCT02401139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5675298|NCT03534037|Febuxostat|febuxostat|mesh-list
5675299|NCT03534037|Benzbromarone|benzbromarone|mesh-list
5675300|NCT03534037|Gout Suppressants|gout suppressants|mesh-ancestor
5675301|NCT03534037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5675302|NCT03534037|Uricosuric Agents|uricosuric agents|mesh-ancestor
5675303|NCT03534037|Renal Agents|renal agents|mesh-ancestor
5675304|NCT03534024|Curcumin|curcumin|mesh-list
5675305|NCT03534024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5675306|NCT03534024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5675307|NCT03534024|Analgesics|analgesics|mesh-ancestor
5860666|NCT02401139|Anesthetics, General|anesthetics, general|mesh-ancestor
5860667|NCT02401139|Anesthetics|anesthetics|mesh-ancestor
5860668|NCT02401139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5860669|NCT02401139|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5860670|NCT02401139|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5860671|NCT02401139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5860672|NCT02401139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5860673|NCT02400931|Rocuronium|rocuronium|mesh-list
5860674|NCT02400931|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5860675|NCT02400931|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5860676|NCT02400931|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5860677|NCT02400931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5860678|NCT02400931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5860679|NCT02400879|Sufentanil|sufentanil|mesh-list
5860680|NCT02400879|Remifentanil|remifentanil|mesh-list
5860681|NCT02400879|Sevoflurane|sevoflurane|mesh-list
5860682|NCT02400879|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5860683|NCT02400879|Narcotics|narcotics|mesh-ancestor
5860684|NCT02400879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5860685|NCT02400879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5860686|NCT02400879|Analgesics|analgesics|mesh-ancestor
5860687|NCT02400879|Sensory System Agents|sensory system agents|mesh-ancestor
5860688|NCT02400879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5860689|NCT02400879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5860690|NCT02400879|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5860691|NCT02400879|Anesthetics, General|anesthetics, general|mesh-ancestor
5860692|NCT02400879|Anesthetics|anesthetics|mesh-ancestor
5860693|NCT02400879|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5860694|NCT02400879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5860695|NCT02400645|Ketorolac|ketorolac|mesh-list
5860696|NCT02400645|Bupivacaine|bupivacaine|mesh-list
5860697|NCT02400645|Anesthetics, Local|anesthetics, local|mesh-ancestor
5860698|NCT02400645|Anesthetics|anesthetics|mesh-ancestor
5860699|NCT02400645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5675308|NCT03534024|Sensory System Agents|sensory system agents|mesh-ancestor
5675309|NCT03534024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5675310|NCT03534024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675311|NCT03534024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5675312|NCT03534024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5675313|NCT03534024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5675314|NCT03534024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5675315|NCT03534024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675316|NCT03533803|Indomethacin|indomethacin|mesh-list
5675317|NCT03533803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5675318|NCT03533803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5675319|NCT03533803|Analgesics|analgesics|mesh-ancestor
5675320|NCT03533803|Sensory System Agents|sensory system agents|mesh-ancestor
5675321|NCT03533803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5675322|NCT03533803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675323|NCT03533803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5675324|NCT03533803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5860700|NCT02400645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5860701|NCT02400645|Sensory System Agents|sensory system agents|mesh-ancestor
5860702|NCT02400645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5860703|NCT02400645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5860704|NCT02400645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5860705|NCT02400645|Analgesics|analgesics|mesh-ancestor
5860706|NCT02400645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5860707|NCT02400645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5860708|NCT02400645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5860709|NCT02400645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5860710|NCT02400645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675325|NCT03533803|Gout Suppressants|gout suppressants|mesh-ancestor
5675326|NCT03533803|Tocolytic Agents|tocolytic agents|mesh-ancestor
5675327|NCT03533803|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5860711|NCT02400567|Cyclophosphamide|cyclophosphamide|mesh-list
5675328|NCT03533803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5675329|NCT03533803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5675330|NCT03533803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675331|NCT03533712|Folic Acid|folic acid|mesh-list
5675332|NCT03533712|Hematinics|hematinics|mesh-ancestor
5675333|NCT03533712|Vitamin B Complex|vitamin b complex|mesh-ancestor
5860712|NCT02400567|Letrozole|letrozole|mesh-list
5860713|NCT02400567|Epirubicin|epirubicin|mesh-list
5860714|NCT02400567|Palbociclib|palbociclib|mesh-list
5860715|NCT02400567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5860716|NCT02400567|Immunologic Factors|immunologic factors|mesh-ancestor
5860717|NCT02400567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5860718|NCT02400567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5860719|NCT02400567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5860720|NCT02400567|Alkylating Agents|alkylating agents|mesh-ancestor
5860721|NCT02400567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5860722|NCT02400567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5860723|NCT02400567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5860724|NCT02400567|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5860725|NCT02400567|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5860726|NCT02400567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5860727|NCT02400567|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5860728|NCT02400567|Hormone Antagonists|hormone antagonists|mesh-ancestor
5860729|NCT02400567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5860730|NCT02400567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5860731|NCT02400567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5860732|NCT02400567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5860733|NCT02400567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5860734|NCT02400866|Olanzapine|olanzapine|mesh-list
5860735|NCT02400866|Antiemetics|antiemetics|mesh-ancestor
5860736|NCT02400866|Autonomic Agents|autonomic agents|mesh-ancestor
5860737|NCT02400866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5860738|NCT02400866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5860739|NCT02400866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5860740|NCT02400866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5860741|NCT02400866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5860742|NCT02400866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5860743|NCT02400866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5860744|NCT02400866|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5860745|NCT02400866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5860746|NCT02400866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5860747|NCT02400866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5860748|NCT02400866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5860749|NCT02400866|Serotonin Agents|serotonin agents|mesh-ancestor
5860750|NCT02400775|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
5860751|NCT02400775|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5860752|NCT02400775|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5860753|NCT02400775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5860754|NCT02400788|Sorafenib|sorafenib|mesh-list
5860755|NCT02400788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5860756|NCT02400788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5860757|NCT02400788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5860758|NCT02400788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5860759|NCT02400801|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5860760|NCT02400801|Dienogest|dienogest|mesh-list
5675334|NCT03533712|Vitamins|vitamins|mesh-ancestor
5675335|NCT03533712|Micronutrients|micronutrients|mesh-ancestor
5675336|NCT03533712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5860761|NCT02400801|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5860762|NCT02400801|Luteolytic Agents|luteolytic agents|mesh-ancestor
5860763|NCT02400801|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5860764|NCT02400801|Contraceptive Agents|contraceptive agents|mesh-ancestor
5860765|NCT02400801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5860766|NCT02400801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5860767|NCT02400801|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5860768|NCT02400801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5860769|NCT02400801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5860770|NCT02400801|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5860771|NCT02400801|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5860772|NCT02400801|Estrogens|estrogens|mesh-ancestor
5860773|NCT02400801|Hormones|hormones|mesh-ancestor
5860774|NCT02400801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5860775|NCT02400801|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5860776|NCT02400801|Hormone Antagonists|hormone antagonists|mesh-ancestor
5860777|NCT02400619|Botulinum Toxins|botulinum toxins|mesh-list
5860778|NCT02400619|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5860779|NCT02400619|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5860780|NCT02400619|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5860781|NCT02400619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5860782|NCT02400619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5860783|NCT02400619|Cholinergic Agents|cholinergic agents|mesh-ancestor
5675337|NCT03533699|Propranolol|propranolol|mesh-list
5675338|NCT03533699|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5675339|NCT03533699|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5675340|NCT03533699|Adrenergic Agents|adrenergic agents|mesh-ancestor
5675341|NCT03533699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5675342|NCT03533699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675343|NCT03533699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675344|NCT03533699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5675345|NCT03533699|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5675346|NCT03533699|Vasodilator Agents|vasodilator agents|mesh-ancestor
5675347|NCT03533556|Caffeine|caffeine|mesh-list
5675348|NCT03533556|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5675349|NCT03533556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675350|NCT03533556|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5675351|NCT03533556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5675352|NCT03533556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675353|NCT03533556|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5675354|NCT03533556|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5675355|NCT03533556|Purinergic Agents|purinergic agents|mesh-ancestor
5675356|NCT03533556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5675357|NCT03533452|Ropivacaine|ropivacaine|mesh-list
5675358|NCT03533452|Anesthetics, Local|anesthetics, local|mesh-ancestor
5675359|NCT03533452|Anesthetics|anesthetics|mesh-ancestor
5675360|NCT03533452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5675361|NCT03533452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675362|NCT03533452|Sensory System Agents|sensory system agents|mesh-ancestor
5675363|NCT03533452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5675364|NCT03533387|Ibudilast|ibudilast|mesh-list
5675365|NCT03533387|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5675366|NCT03533387|Autonomic Agents|autonomic agents|mesh-ancestor
5675367|NCT03533387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5675368|NCT03533387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675369|NCT03533387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5675370|NCT03533387|Respiratory System Agents|respiratory system agents|mesh-ancestor
5675371|NCT03533387|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5675372|NCT03533387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5675373|NCT03533387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675374|NCT03533387|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5675375|NCT03533387|Vasodilator Agents|vasodilator agents|mesh-ancestor
5675376|NCT03533361|Lenvatinib|lenvatinib|mesh-list
5675377|NCT03533361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5675378|NCT03533361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5860784|NCT02400619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5860785|NCT02400619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5860786|NCT02400619|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5860787|NCT02400619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5860788|NCT02400476|Budesonide|budesonide|mesh-list
5860789|NCT02400476|Loperamide|loperamide|mesh-list
5860790|NCT02400476|Antidiarrheals|antidiarrheals|mesh-list
5860791|NCT02400476|Colestipol|colestipol|mesh-list
5860792|NCT02400476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5860793|NCT02400476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5860794|NCT02400476|Autonomic Agents|autonomic agents|mesh-ancestor
5860795|NCT02400476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5860796|NCT02400476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5860797|NCT02400476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5675379|NCT03533361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5675380|NCT03533361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675381|NCT03533335|Chlorhexidine|chlorhexidine|mesh-list
5675382|NCT03533335|Chlorine dioxide|chlorine dioxide|mesh-list
5675383|NCT03533335|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5675384|NCT03533335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5860798|NCT02400476|Respiratory System Agents|respiratory system agents|mesh-ancestor
5860799|NCT02400476|Glucocorticoids|glucocorticoids|mesh-ancestor
5860800|NCT02400476|Hormones|hormones|mesh-ancestor
5675385|NCT03533335|Disinfectants|disinfectants|mesh-ancestor
5675386|NCT03533335|Dental Disinfectants|dental disinfectants|mesh-ancestor
5675387|NCT03533231|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5675388|NCT03533231|Metronidazole|metronidazole|mesh-list
5675389|NCT03533231|Ciprofloxacin|ciprofloxacin|mesh-list
5675390|NCT03533231|Propolis|propolis|mesh-list
5675391|NCT03533231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5675392|NCT03533231|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5675393|NCT03533231|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5675394|NCT03533231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5675395|NCT03533231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5675396|NCT03533231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5675397|NCT03533231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675398|NCT03533231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5675399|NCT03533231|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5675400|NCT03533231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5675401|NCT03533179|Glucagon|glucagon|mesh-list
5860801|NCT02400476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5860802|NCT02400476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5860803|NCT02400476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5860804|NCT02400476|Antimetabolites|antimetabolites|mesh-ancestor
5860805|NCT02400476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5860806|NCT02400476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5860807|NCT02400476|Sequestering Agents|sequestering agents|mesh-ancestor
5860808|NCT02400268|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5860809|NCT02400268|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5675402|NCT03533179|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5675403|NCT03533179|Esmolol|esmolol|mesh-list
5675404|NCT03533179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5675405|NCT03533179|Hormones|hormones|mesh-ancestor
5675406|NCT03533179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5675407|NCT03533179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675408|NCT03533179|Incretins|incretins|mesh-ancestor
5675409|NCT03533179|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5675410|NCT03533179|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5675411|NCT03533179|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5860810|NCT02400268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5860811|NCT02400268|Antitubercular Agents|antitubercular agents|mesh-ancestor
5860812|NCT02400151|Vitamin D|vitamin d|mesh-list
5675412|NCT03533179|Adrenergic Agents|adrenergic agents|mesh-ancestor
5675413|NCT03533179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5675414|NCT03533179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675415|NCT03533166|Chlorhexidine|chlorhexidine|mesh-list
5675416|NCT03533166|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5675417|NCT03533166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5675418|NCT03533166|Disinfectants|disinfectants|mesh-ancestor
5675419|NCT03533127|Bevacizumab|bevacizumab|mesh-list
5675420|NCT03533127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5675421|NCT03533127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5675422|NCT03533127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5675423|NCT03533127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5675424|NCT03533127|Growth Substances|growth substances|mesh-ancestor
5675425|NCT03533127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675426|NCT03533127|Growth Inhibitors|growth inhibitors|mesh-ancestor
5675427|NCT03533062|Botulinum Toxins|botulinum toxins|mesh-list
5675428|NCT03533062|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5675429|NCT03533062|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5675430|NCT03533062|Cholinergic Antagonists|cholinergic antagonists|mesh-list
5860813|NCT02400151|Vitamins|vitamins|mesh-ancestor
5675431|NCT03533062|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5675432|NCT03533062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5860814|NCT02400151|Micronutrients|micronutrients|mesh-ancestor
5860815|NCT02400151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5860816|NCT02400151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6494584|NCT00619216|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6494585|NCT00619216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6494586|NCT00619216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6494587|NCT00619216|Antitubercular Agents|antitubercular agents|mesh-ancestor
6494588|NCT00619216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5860817|NCT02400385|Nivolumab|nivolumab|mesh-list
5860818|NCT02400385|Sunitinib|sunitinib|mesh-list
5860819|NCT02400385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5860820|NCT02400385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5860821|NCT02400385|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5675433|NCT03533062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675434|NCT03533062|Cholinergic Agents|cholinergic agents|mesh-ancestor
5675435|NCT03533062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5675436|NCT03533062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675437|NCT03533062|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5675438|NCT03533062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5675439|NCT03533010|Vitamin D|vitamin d|mesh-list
5675440|NCT03533010|Vitamins|vitamins|mesh-ancestor
5675441|NCT03533010|Micronutrients|micronutrients|mesh-ancestor
5675442|NCT03533010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675443|NCT03533010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5675444|NCT03532919|Cystatins|cystatins|mesh-list
5675445|NCT03532919|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
5675446|NCT03532919|Protease Inhibitors|protease inhibitors|mesh-ancestor
5675447|NCT03532919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5860822|NCT02400385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5860823|NCT02400385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5860824|NCT02400385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5860825|NCT02400385|Growth Substances|growth substances|mesh-ancestor
5860826|NCT02400385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675448|NCT03532919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675449|NCT03532906|Bupivacaine|bupivacaine|mesh-list
5675450|NCT03532906|Anesthetics, Local|anesthetics, local|mesh-ancestor
5675451|NCT03532906|Anesthetics|anesthetics|mesh-ancestor
5675452|NCT03532906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5675453|NCT03532906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675454|NCT03532906|Sensory System Agents|sensory system agents|mesh-ancestor
5860827|NCT02400385|Growth Inhibitors|growth inhibitors|mesh-ancestor
5860828|NCT02400385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5860829|NCT02400385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5860830|NCT02400281|Cytarabine|cytarabine|mesh-list
5860831|NCT02400281|Fludarabine|fludarabine|mesh-list
5860832|NCT02400281|Fludarabine phosphate|fludarabine phosphate|mesh-list
5860833|NCT02400281|Etoposide|etoposide|mesh-list
5860834|NCT02400281|Etoposide phosphate|etoposide phosphate|mesh-list
5860835|NCT02400281|Azacitidine|azacitidine|mesh-list
5860836|NCT02400281|Mitoxantrone|mitoxantrone|mesh-list
5675455|NCT03532906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5675456|NCT03532880|Olaparib|olaparib|mesh-list
5675457|NCT03532880|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5675458|NCT03532880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5675459|NCT03532880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5860837|NCT02400281|Idarubicin|idarubicin|mesh-list
5860838|NCT02400281|Crenolanib|crenolanib|mesh-list
5860839|NCT02400281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5860840|NCT02400281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5860841|NCT02400281|Antimetabolites|antimetabolites|mesh-ancestor
5860842|NCT02400281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5860843|NCT02400281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5860844|NCT02400281|Immunologic Factors|immunologic factors|mesh-ancestor
5860845|NCT02400281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675460|NCT03532880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5675461|NCT03532867|Tin Fluorides|tin fluorides|mesh-list
5675462|NCT03532867|Cariostatic Agents|cariostatic agents|mesh-ancestor
5675463|NCT03532867|Protective Agents|protective agents|mesh-ancestor
5675464|NCT03532867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675465|NCT03532854|Valsartan|valsartan|mesh-list
5675466|NCT03532854|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5675467|NCT03532854|Ezetimibe|ezetimibe|mesh-list
5675468|NCT03532854|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5860846|NCT02400281|Antiviral Agents|antiviral agents|mesh-ancestor
5860847|NCT02400281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5860848|NCT02400281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5860849|NCT02400281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5860850|NCT02400281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5860851|NCT02400281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5860852|NCT02400281|Analgesics|analgesics|mesh-ancestor
5860853|NCT02400281|Sensory System Agents|sensory system agents|mesh-ancestor
5860854|NCT02400281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5860855|NCT02400281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5860856|NCT02400255|Crenolanib|crenolanib|mesh-list
5860857|NCT02400255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5860858|NCT02400112|Vancomycin|vancomycin|mesh-list
5860859|NCT02400112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5860860|NCT02400112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5860861|NCT02400021|Progesterone|progesterone|mesh-list
5860862|NCT02400021|Progestins|progestins|mesh-ancestor
5860863|NCT02400021|Hormones|hormones|mesh-ancestor
5860864|NCT02400021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5860865|NCT02400021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5860866|NCT02399943|Panitumumab|panitumumab|mesh-list
5860867|NCT02399943|Trametinib|trametinib|mesh-list
5860868|NCT02399943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5860869|NCT02399943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5860870|NCT02399943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5860871|NCT02399943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5860872|NCT02399943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5860873|NCT02400047|Dexamethasone|dexamethasone|mesh-list
5860874|NCT02400047|Dexamethasone acetate|dexamethasone acetate|mesh-list
5860875|NCT02400047|Ketoprofen|ketoprofen|mesh-list
5860876|NCT02400047|BB 1101|bb 1101|mesh-list
5860877|NCT02400047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5860878|NCT02400047|Antiemetics|antiemetics|mesh-ancestor
5860879|NCT02400047|Autonomic Agents|autonomic agents|mesh-ancestor
5860880|NCT02400047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5860881|NCT02400047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5860882|NCT02400047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5860883|NCT02400047|Glucocorticoids|glucocorticoids|mesh-ancestor
5860884|NCT02400047|Hormones|hormones|mesh-ancestor
5860885|NCT02400047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5860886|NCT02400047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5675469|NCT03532854|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5675470|NCT03532854|Antimetabolites|antimetabolites|mesh-ancestor
5675471|NCT03532854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675472|NCT03532854|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5860887|NCT02400047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5860888|NCT02400047|Protease Inhibitors|protease inhibitors|mesh-ancestor
5860889|NCT02400047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5860890|NCT02400047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5860891|NCT02400047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5860892|NCT02400047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5860893|NCT02400047|Analgesics|analgesics|mesh-ancestor
5860894|NCT02400047|Sensory System Agents|sensory system agents|mesh-ancestor
5860895|NCT02400047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5860896|NCT02400047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5904656|NCT04793906|Trace Elements|trace elements|mesh-ancestor
5904657|NCT04793906|Micronutrients|micronutrients|mesh-ancestor
5904658|NCT04793906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904659|NCT04789070|Sirolimus|sirolimus|mesh-list
5904660|NCT04789070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5904661|NCT04789070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5904662|NCT04789070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5904663|NCT04789070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5675473|NCT03532854|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5675474|NCT03532854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5675475|NCT03532854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5675476|NCT03532854|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5675477|NCT03532854|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5675478|NCT03532841|Tramadol|tramadol|mesh-list
5675479|NCT03532841|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5675480|NCT03532841|Narcotics|narcotics|mesh-ancestor
5675481|NCT03532841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5675482|NCT03532841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675483|NCT03532841|Analgesics|analgesics|mesh-ancestor
5675484|NCT03532841|Sensory System Agents|sensory system agents|mesh-ancestor
5675485|NCT03532841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5675486|NCT03532802|Metoprolol|metoprolol|mesh-list
5675487|NCT03532802|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5860897|NCT02399800|Triamcinolone|triamcinolone|mesh-list
5860898|NCT02399800|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5860899|NCT02399800|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5860900|NCT02399800|Bupivacaine|bupivacaine|mesh-list
5860901|NCT02399800|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5860902|NCT02399800|Anesthetics, Local|anesthetics, local|mesh-ancestor
5860903|NCT02399800|Anesthetics|anesthetics|mesh-ancestor
5860904|NCT02399800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5860905|NCT02399800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5860906|NCT02399800|Sensory System Agents|sensory system agents|mesh-ancestor
5860907|NCT02399800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5860908|NCT02399800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5860909|NCT02399800|Glucocorticoids|glucocorticoids|mesh-ancestor
5860910|NCT02399800|Hormones|hormones|mesh-ancestor
5860911|NCT02399800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5860912|NCT02399800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5860913|NCT02399800|Immunologic Factors|immunologic factors|mesh-ancestor
5860914|NCT02399800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5860915|NCT02399800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5860916|NCT02399566|Pemetrexed|pemetrexed|mesh-list
5860917|NCT02399566|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5860918|NCT02399566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5860919|NCT02399566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5860920|NCT02399566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675488|NCT03532802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5675489|NCT03532802|Sympatholytics|sympatholytics|mesh-ancestor
5675490|NCT03532802|Autonomic Agents|autonomic agents|mesh-ancestor
5675491|NCT03532802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5675492|NCT03532802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675493|NCT03532802|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5675494|NCT03532802|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5675495|NCT03532802|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5675496|NCT03532802|Adrenergic Agents|adrenergic agents|mesh-ancestor
5675497|NCT03532802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5675498|NCT03532802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675499|NCT03532763|Tocotrienols|tocotrienols|mesh-list
5675500|NCT03532763|Vitamin E|vitamin e|mesh-list
5675501|NCT03532763|Tocopherols|tocopherols|mesh-list
5675502|NCT03532763|Tocovid|tocovid|mesh-list
5675503|NCT03532763|Antioxidants|antioxidants|mesh-ancestor
5675504|NCT03532763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675505|NCT03532763|Protective Agents|protective agents|mesh-ancestor
5675506|NCT03532763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675507|NCT03532763|Vitamins|vitamins|mesh-ancestor
5675508|NCT03532763|Micronutrients|micronutrients|mesh-ancestor
5675509|NCT03532737|Pembrolizumab|pembrolizumab|mesh-list
5675510|NCT03532737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5675511|NCT03532737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5675512|NCT03532711|Leucovorin|leucovorin|mesh-list
5675513|NCT03532711|Fluorouracil|fluorouracil|mesh-list
5675514|NCT03532711|Capecitabine|capecitabine|mesh-list
5675515|NCT03532711|Oxaliplatin|oxaliplatin|mesh-list
5675516|NCT03532711|Irinotecan|irinotecan|mesh-list
5675517|NCT03532711|Levoleucovorin|levoleucovorin|mesh-list
5675518|NCT03532711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675519|NCT03532711|Antimetabolites|antimetabolites|mesh-ancestor
5675520|NCT03532711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675521|NCT03532711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5675522|NCT03532711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5675523|NCT03532711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5675524|NCT03532711|Immunologic Factors|immunologic factors|mesh-ancestor
5675525|NCT03532711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5675526|NCT03532711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5675527|NCT03532711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5675528|NCT03532711|Antidotes|antidotes|mesh-ancestor
5675529|NCT03532711|Protective Agents|protective agents|mesh-ancestor
5675530|NCT03532711|Vitamin B Complex|vitamin b complex|mesh-ancestor
5675531|NCT03532711|Vitamins|vitamins|mesh-ancestor
5675532|NCT03532711|Micronutrients|micronutrients|mesh-ancestor
5675533|NCT03532698|Aspirin|aspirin|mesh-list
5675534|NCT03532698|Osimertinib|osimertinib|mesh-list
5675535|NCT03532698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5675536|NCT03532698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5860921|NCT02399566|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5675537|NCT03532698|Analgesics|analgesics|mesh-ancestor
5675538|NCT03532698|Sensory System Agents|sensory system agents|mesh-ancestor
5675539|NCT03532698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5860922|NCT02399566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5860923|NCT02399566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5860924|NCT02399592|Bevacizumab|bevacizumab|mesh-list
5860925|NCT02399592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5860926|NCT02399592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5860927|NCT02399592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5860928|NCT02399592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5860929|NCT02399592|Growth Substances|growth substances|mesh-ancestor
5860930|NCT02399592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5860931|NCT02399592|Growth Inhibitors|growth inhibitors|mesh-ancestor
5860932|NCT02399657|Dexamethasone|dexamethasone|mesh-list
5860933|NCT02399657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5860934|NCT02399657|Antiemetics|antiemetics|mesh-ancestor
5860935|NCT02399657|Autonomic Agents|autonomic agents|mesh-ancestor
5860936|NCT02399657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5860937|NCT02399657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5860938|NCT02399657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5860939|NCT02399657|Glucocorticoids|glucocorticoids|mesh-ancestor
5860940|NCT02399657|Hormones|hormones|mesh-ancestor
5860941|NCT02399657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5860942|NCT02399657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5860943|NCT02399657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5860944|NCT02399709|Simvastatin|simvastatin|mesh-list
5860945|NCT02399709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5675540|NCT03532698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675541|NCT03532698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5675542|NCT03532698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5675543|NCT03532698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5860946|NCT02399709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5860947|NCT02399709|Antimetabolites|antimetabolites|mesh-ancestor
5860948|NCT02399709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5860949|NCT02399709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5675544|NCT03532698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5675545|NCT03532698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675546|NCT03532698|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5675547|NCT03532698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5675548|NCT03532698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5675549|NCT03532698|Antipyretics|antipyretics|mesh-ancestor
5675550|NCT03532698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5675551|NCT03532698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5675552|NCT03532620|Calcium, Dietary|calcium, dietary|mesh-list
5675553|NCT03532620|Atorvastatin|atorvastatin|mesh-list
5675554|NCT03532620|Pitavastatin|pitavastatin|mesh-list
5675555|NCT03532620|Calcium|calcium|mesh-list
5675556|NCT03532620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5860950|NCT02399709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5860951|NCT02399709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5860952|NCT02399462|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
5860953|NCT02399462|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
5860954|NCT02399462|beta-Endorphin|beta-endorphin|mesh-list
5860955|NCT02399462|Hormones|hormones|mesh-ancestor
5860956|NCT02399462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5860957|NCT02399462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5860958|NCT02399462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5860959|NCT02399462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5860960|NCT02399449|Ferric gluconate|ferric gluconate|mesh-list
5860961|NCT02399449|Ferric Compounds|ferric compounds|mesh-list
5860962|NCT02399449|Hematinics|hematinics|mesh-ancestor
5860963|NCT02399397|Fentanyl|fentanyl|mesh-list
5860964|NCT02399397|Midazolam|midazolam|mesh-list
5860965|NCT02399397|Anesthetics|anesthetics|mesh-list
5860966|NCT02399397|Propofol|propofol|mesh-list
5860967|NCT02399397|Rocuronium|rocuronium|mesh-list
5860968|NCT02399397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5860969|NCT02399397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675557|NCT03532620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675558|NCT03532620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5675559|NCT03532620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5675560|NCT03532620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5675561|NCT03532620|Antimetabolites|antimetabolites|mesh-ancestor
5675562|NCT03532620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675563|NCT03532620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5675564|NCT03532620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5860970|NCT02399397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5675565|NCT03532620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5675566|NCT03532581|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5675567|NCT03532516|Brivaracetam|brivaracetam|mesh-list
5675568|NCT03532516|Anticonvulsants|anticonvulsants|mesh-ancestor
5696423|NCT03383185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696424|NCT03383185|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5696425|NCT03383185|Hormones|hormones|mesh-ancestor
5696426|NCT03383185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5696427|NCT03383185|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5696428|NCT03383185|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5696429|NCT03383185|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5696430|NCT03383185|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5860971|NCT02399397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5860972|NCT02399397|Anesthetics, General|anesthetics, general|mesh-ancestor
5860973|NCT02399397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5860974|NCT02399397|Narcotics|narcotics|mesh-ancestor
5860975|NCT02399397|Analgesics|analgesics|mesh-ancestor
5860976|NCT02399397|Sensory System Agents|sensory system agents|mesh-ancestor
5860977|NCT02399397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5860978|NCT02399397|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5860979|NCT02399397|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5860980|NCT02399397|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5860981|NCT02399397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5860982|NCT02399397|GABA Modulators|gaba modulators|mesh-ancestor
5860983|NCT02399397|GABA Agents|gaba agents|mesh-ancestor
5860984|NCT02399397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5860985|NCT02399397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5860986|NCT02399397|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5860987|NCT02399397|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5860988|NCT02399397|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5860989|NCT02399410|Bevacizumab|bevacizumab|mesh-list
5860990|NCT02399410|Oxaliplatin|oxaliplatin|mesh-list
5860991|NCT02399410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5860992|NCT02399410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5860993|NCT02399410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5860994|NCT02399410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5860995|NCT02399410|Growth Substances|growth substances|mesh-ancestor
5860996|NCT02399410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696431|NCT03383185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5696432|NCT03383185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5696433|NCT03383120|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5696434|NCT03383120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5696435|NCT03383094|Pembrolizumab|pembrolizumab|mesh-list
5696436|NCT03383094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5696437|NCT03383094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5696438|NCT03383068|Metformin|metformin|mesh-list
5696439|NCT03383068|Exenatide|exenatide|mesh-list
5696440|NCT03383068|Acarbose|acarbose|mesh-list
5696441|NCT03383068|Orlistat|orlistat|mesh-list
5696442|NCT03383068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5860997|NCT02399410|Growth Inhibitors|growth inhibitors|mesh-ancestor
5860998|NCT02399059|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5860999|NCT02399059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5861000|NCT02399189|Methotrexate|methotrexate|mesh-list
5861001|NCT02399189|Temozolomide|temozolomide|mesh-list
5861002|NCT02399189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5861003|NCT02399189|Immunologic Factors|immunologic factors|mesh-ancestor
5861004|NCT02399189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861005|NCT02399189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5861006|NCT02399189|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5696443|NCT03383068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696444|NCT03383068|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5696445|NCT03383068|Incretins|incretins|mesh-ancestor
5696446|NCT03383068|Hormones|hormones|mesh-ancestor
5696447|NCT03383068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5696448|NCT03383068|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
5696449|NCT03383068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5696450|NCT03383068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696451|NCT03383068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5696452|NCT03383003|Amoxicillin|amoxicillin|mesh-list
5696453|NCT03383003|Metronidazole|metronidazole|mesh-list
5696454|NCT03383003|Clarithromycin|clarithromycin|mesh-list
5696455|NCT03383003|Esomeprazole|esomeprazole|mesh-list
5696456|NCT03383003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5696457|NCT03383003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5696458|NCT03383003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5861007|NCT02399189|Abortifacient Agents|abortifacient agents|mesh-ancestor
5861008|NCT02399189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5861009|NCT02399189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5861010|NCT02399189|Antimetabolites|antimetabolites|mesh-ancestor
5861011|NCT02399189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861012|NCT02399189|Dermatologic Agents|dermatologic agents|mesh-ancestor
5861013|NCT02399189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5861014|NCT02399189|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5861015|NCT02399189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5861016|NCT02399189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5861017|NCT02399189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5861018|NCT02399189|Alkylating Agents|alkylating agents|mesh-ancestor
5861019|NCT02399215|Nintedanib|nintedanib|mesh-list
5861020|NCT02399215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5861021|NCT02399215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5861022|NCT02399215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5861023|NCT02399215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861024|NCT02399137|Gemcitabine|gemcitabine|mesh-list
5861025|NCT02399137|Paclitaxel|paclitaxel|mesh-list
5861026|NCT02399137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5861027|NCT02399137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5861028|NCT02399137|Tubulin Modulators|tubulin modulators|mesh-ancestor
5861029|NCT02399137|Antimitotic Agents|antimitotic agents|mesh-ancestor
5861030|NCT02399137|Mitosis Modulators|mitosis modulators|mesh-ancestor
5861031|NCT02399137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861032|NCT02399137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5861033|NCT02399137|Antimetabolites|antimetabolites|mesh-ancestor
5861034|NCT02399137|Antiviral Agents|antiviral agents|mesh-ancestor
5861035|NCT02399137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5861036|NCT02399137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5861037|NCT02399137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5861038|NCT02399137|Immunologic Factors|immunologic factors|mesh-ancestor
5675569|NCT03532477|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
5675570|NCT03532477|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5675571|NCT03532477|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5675572|NCT03532477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5675573|NCT03532477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675574|NCT03532477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5675575|NCT03532477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675576|NCT03532477|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5675577|NCT03532477|Antidepressive Agents|antidepressive agents|mesh-ancestor
5675578|NCT03532477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5675579|NCT03532464|Azithromycin|azithromycin|mesh-list
5675580|NCT03532464|Doxycycline|doxycycline|mesh-list
5675581|NCT03532464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5675582|NCT03532464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5675583|NCT03532464|Antimalarials|antimalarials|mesh-ancestor
5675584|NCT03532464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5675585|NCT03532464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5861039|NCT02399137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861040|NCT02399371|Pembrolizumab|pembrolizumab|mesh-list
5861041|NCT02399371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5861042|NCT02399371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5861043|NCT02398994|Methylprednisolone|methylprednisolone|mesh-list
5861044|NCT02398994|Immunoglobulins|immunoglobulins|mesh-list
5861045|NCT02398994|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5861046|NCT02398994|Antibodies|antibodies|mesh-list
5861047|NCT02398994|gamma-Globulins|gamma-globulins|mesh-list
5861048|NCT02398994|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5861049|NCT02398994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5861050|NCT02398994|Antiemetics|antiemetics|mesh-ancestor
5861051|NCT02398994|Autonomic Agents|autonomic agents|mesh-ancestor
5861052|NCT02398994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5861053|NCT02398994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861054|NCT02398994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5861055|NCT02398994|Glucocorticoids|glucocorticoids|mesh-ancestor
5861056|NCT02398994|Hormones|hormones|mesh-ancestor
5861057|NCT02398994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5675586|NCT03532425|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5675587|NCT03532425|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5675588|NCT03532425|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5675589|NCT03532425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5675590|NCT03532425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861058|NCT02398994|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5861059|NCT02398994|Protective Agents|protective agents|mesh-ancestor
5861060|NCT02398994|Immunologic Factors|immunologic factors|mesh-ancestor
5861061|NCT02398929|Bisoprolol|bisoprolol|mesh-list
5861062|NCT02398929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5861063|NCT02398929|Sympatholytics|sympatholytics|mesh-ancestor
5861064|NCT02398929|Autonomic Agents|autonomic agents|mesh-ancestor
5861065|NCT02398929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5861066|NCT02398929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861067|NCT02398929|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5861068|NCT02398929|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5861069|NCT02398929|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5861070|NCT02398929|Adrenergic Agents|adrenergic agents|mesh-ancestor
5861071|NCT02398929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5861072|NCT02398929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861073|NCT02398838|Misoprostol|misoprostol|mesh-list
5861074|NCT02398838|Mifepristone|mifepristone|mesh-list
5861075|NCT02398838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5861076|NCT02398838|Abortifacient Agents|abortifacient agents|mesh-ancestor
5861077|NCT02398838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5861078|NCT02398838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861079|NCT02398838|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5861080|NCT02398838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5861081|NCT02398838|Oxytocics|oxytocics|mesh-ancestor
5861082|NCT02398838|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5861083|NCT02398838|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5861084|NCT02398838|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5861085|NCT02398838|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5861086|NCT02398838|Contraceptive Agents|contraceptive agents|mesh-ancestor
5861087|NCT02398838|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5861088|NCT02398838|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5861089|NCT02398838|Hormone Antagonists|hormone antagonists|mesh-ancestor
5861090|NCT02398838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5861091|NCT02398838|Luteolytic Agents|luteolytic agents|mesh-ancestor
5861092|NCT02398838|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5861093|NCT02398838|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5861094|NCT02398656|Tenecteplase|tenecteplase|mesh-list
5861095|NCT02398656|Clopidogrel|clopidogrel|mesh-list
5861096|NCT02398656|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5861097|NCT02398656|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5861098|NCT02398656|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5861099|NCT02398656|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5861100|NCT02398656|Purinergic Agents|purinergic agents|mesh-ancestor
5861101|NCT02398656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5861102|NCT02398656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861103|NCT02398656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861104|NCT02398656|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5861105|NCT02398656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5861106|NCT02398682|Tin Fluorides|tin fluorides|mesh-list
5861107|NCT02398682|Cariostatic Agents|cariostatic agents|mesh-ancestor
5861108|NCT02398682|Protective Agents|protective agents|mesh-ancestor
5861109|NCT02398682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861110|NCT02398448|Allopurinol|allopurinol|mesh-list
5861111|NCT02398448|Antimetabolites|antimetabolites|mesh-ancestor
5861112|NCT02398448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861113|NCT02398448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5675591|NCT03532425|Antiviral Agents|antiviral agents|mesh-ancestor
5675592|NCT03532425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5675593|NCT03532425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5675594|NCT03532425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5675595|NCT03532399|Bivalirudin|bivalirudin|mesh-list
5675596|NCT03532399|Antithrombins|antithrombins|mesh-ancestor
5675597|NCT03532399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5675598|NCT03532399|Protease Inhibitors|protease inhibitors|mesh-ancestor
5675599|NCT03532399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5675600|NCT03532399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675601|NCT03532399|Anticoagulants|anticoagulants|mesh-ancestor
5675602|NCT03532178|Rocuronium|rocuronium|mesh-list
5675603|NCT03532178|Succinylcholine|succinylcholine|mesh-list
5675604|NCT03532178|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5675605|NCT03532178|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5675606|NCT03532178|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5675607|NCT03532178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5675608|NCT03532178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861114|NCT02398448|Gout Suppressants|gout suppressants|mesh-ancestor
5861115|NCT02398448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5861116|NCT02398448|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5861117|NCT02398448|Antioxidants|antioxidants|mesh-ancestor
5861118|NCT02398448|Protective Agents|protective agents|mesh-ancestor
5861119|NCT02398448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861120|NCT02398383|Hypoglycemic Agents|hypoglycemic agents|mesh-list
5861121|NCT02398383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675609|NCT03532178|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
5675610|NCT03532087|Denosumab|denosumab|mesh-list
5675611|NCT03532087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5675612|NCT03532087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675613|NCT03532035|Brincidofovir|brincidofovir|mesh-list
5675614|NCT03532035|Antiviral Agents|antiviral agents|mesh-ancestor
5861122|NCT02398630|Hormones|hormones|mesh-list
5861123|NCT02398630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5861124|NCT02398630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861125|NCT02398487|Nicotine|nicotine|mesh-list
5861126|NCT02398487|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5861127|NCT02398487|Autonomic Agents|autonomic agents|mesh-ancestor
5861128|NCT02398487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5861129|NCT02398487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861130|NCT02398487|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5861131|NCT02398487|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5861132|NCT02398487|Cholinergic Agents|cholinergic agents|mesh-ancestor
5861133|NCT02398487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5861134|NCT02398487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861135|NCT02398552|Sunitinib|sunitinib|mesh-list
5861136|NCT02398552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5861137|NCT02398552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5861138|NCT02398552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5861139|NCT02398552|Growth Substances|growth substances|mesh-ancestor
5861140|NCT02398552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861141|NCT02398552|Growth Inhibitors|growth inhibitors|mesh-ancestor
5861142|NCT02398552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5861143|NCT02398552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5861144|NCT02398552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861145|NCT02398357|Nadroparin|nadroparin|mesh-list
5861146|NCT02398357|Warfarin|warfarin|mesh-list
5861147|NCT02398357|Calcium|calcium|mesh-list
5861148|NCT02398357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5861149|NCT02398357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861150|NCT02398357|Anticoagulants|anticoagulants|mesh-ancestor
5861151|NCT02398357|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5861152|NCT02398357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5861153|NCT02398357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861154|NCT02398474|Ropivacaine|ropivacaine|mesh-list
5675615|NCT03532035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5675616|NCT03531970|Dexamethasone|dexamethasone|mesh-list
5675617|NCT03531970|Dexamethasone acetate|dexamethasone acetate|mesh-list
5675618|NCT03531970|Lidocaine|lidocaine|mesh-list
5675619|NCT03531970|Epinephrine|epinephrine|mesh-list
5675620|NCT03531970|BB 1101|bb 1101|mesh-list
5675621|NCT03531970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5675622|NCT03531970|Antiemetics|antiemetics|mesh-ancestor
5675623|NCT03531970|Autonomic Agents|autonomic agents|mesh-ancestor
5675624|NCT03531970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5675625|NCT03531970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675626|NCT03531970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5675627|NCT03531970|Glucocorticoids|glucocorticoids|mesh-ancestor
5675628|NCT03531970|Hormones|hormones|mesh-ancestor
5675629|NCT03531970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5675630|NCT03531970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5675631|NCT03531970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5675632|NCT03531970|Protease Inhibitors|protease inhibitors|mesh-ancestor
5675633|NCT03531970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5675634|NCT03531970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675635|NCT03531970|Anesthetics, Local|anesthetics, local|mesh-ancestor
5675636|NCT03531970|Anesthetics|anesthetics|mesh-ancestor
5675637|NCT03531970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5861155|NCT02398474|Anesthetics, Local|anesthetics, local|mesh-ancestor
5861156|NCT02398474|Anesthetics|anesthetics|mesh-ancestor
5675638|NCT03531970|Sensory System Agents|sensory system agents|mesh-ancestor
5675639|NCT03531970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5675640|NCT03531970|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5675641|NCT03531970|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5861157|NCT02398474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5861158|NCT02398474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861159|NCT02398474|Sensory System Agents|sensory system agents|mesh-ancestor
6494589|NCT00619216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5675642|NCT03531970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5675643|NCT03531970|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5675644|NCT03531970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5675645|NCT03531970|Adrenergic Agents|adrenergic agents|mesh-ancestor
5675646|NCT03531970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5675647|NCT03531970|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5675648|NCT03531970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5675649|NCT03531970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5675650|NCT03531970|Respiratory System Agents|respiratory system agents|mesh-ancestor
5675651|NCT03531970|Mydriatics|mydriatics|mesh-ancestor
5675652|NCT03531970|Sympathomimetics|sympathomimetics|mesh-ancestor
5675653|NCT03531970|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6494590|NCT00619216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6494591|NCT00619216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494592|NCT00619268|Interferons|interferons|mesh-list
6494593|NCT00619268|Interferon-alpha|interferon-alpha|mesh-list
6494594|NCT00619268|Interferon alpha-2|interferon alpha-2|mesh-list
6494595|NCT00619268|Sirolimus|sirolimus|mesh-list
6494596|NCT00619268|Bevacizumab|bevacizumab|mesh-list
6494597|NCT00619268|Sunitinib|sunitinib|mesh-list
5675654|NCT03531931|Apatinib|apatinib|mesh-list
5861160|NCT02398474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5904664|NCT04789070|Antifungal Agents|antifungal agents|mesh-ancestor
5904665|NCT04789070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5904666|NCT04789070|Immunologic Factors|immunologic factors|mesh-ancestor
5904667|NCT04789070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904668|NCT04741204|Metformin|metformin|mesh-list
5904669|NCT04741204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5904670|NCT04741204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904671|NCT04738318|Dexamethasone|dexamethasone|mesh-list
5904672|NCT04738318|Methylprednisolone|methylprednisolone|mesh-list
5904673|NCT04738318|Glucocorticoids|glucocorticoids|mesh-list
5904674|NCT04738318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5904675|NCT04738318|Antiemetics|antiemetics|mesh-ancestor
5904676|NCT04738318|Autonomic Agents|autonomic agents|mesh-ancestor
5904677|NCT04738318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5904678|NCT04738318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675655|NCT03531931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5675656|NCT03531931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5675657|NCT03531931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5675658|NCT03531931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675659|NCT03531918|Cytarabine|cytarabine|mesh-list
5675660|NCT03531918|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
5675661|NCT03531918|Mitoxantrone|mitoxantrone|mesh-list
5675662|NCT03531918|Cladribine|cladribine|mesh-list
5675663|NCT03531918|Gemtuzumab|gemtuzumab|mesh-list
5675664|NCT03531918|Calicheamicins|calicheamicins|mesh-list
5904679|NCT04738318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5904680|NCT04738318|Hormones|hormones|mesh-ancestor
5904681|NCT04738318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5904682|NCT04738318|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5904683|NCT04738318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5904684|NCT04738318|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5904685|NCT04738318|Protective Agents|protective agents|mesh-ancestor
5904686|NCT04688788|Fexofenadine|fexofenadine|mesh-list
5904687|NCT04688788|Methylprednisolone|methylprednisolone|mesh-list
5904688|NCT04688788|Rituximab|rituximab|mesh-list
5904689|NCT04688788|Ocrelizumab|ocrelizumab|mesh-list
5904690|NCT04688788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5904691|NCT04688788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5904692|NCT04688788|Immunologic Factors|immunologic factors|mesh-ancestor
5904693|NCT04688788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904694|NCT04688788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5904695|NCT04688788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5904696|NCT04688788|Antiemetics|antiemetics|mesh-ancestor
5904697|NCT04688788|Autonomic Agents|autonomic agents|mesh-ancestor
5904698|NCT04688788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5904699|NCT04688788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5904700|NCT04688788|Glucocorticoids|glucocorticoids|mesh-ancestor
5904701|NCT04688788|Hormones|hormones|mesh-ancestor
5904702|NCT04688788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5904703|NCT04688788|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5675665|NCT03531918|Sargramostim|sargramostim|mesh-list
6494598|NCT00619268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5675666|NCT03531918|Lenograstim|lenograstim|mesh-list
5675667|NCT03531918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5675668|NCT03531918|Antimetabolites|antimetabolites|mesh-ancestor
5675669|NCT03531918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675670|NCT03531918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5675671|NCT03531918|Antiviral Agents|antiviral agents|mesh-ancestor
5675672|NCT03531918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5675673|NCT03531918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5675674|NCT03531918|Immunologic Factors|immunologic factors|mesh-ancestor
5675675|NCT03531918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675676|NCT03531918|Analgesics|analgesics|mesh-ancestor
5675677|NCT03531918|Sensory System Agents|sensory system agents|mesh-ancestor
5675678|NCT03531918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5675679|NCT03531918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5675680|NCT03531918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5675681|NCT03531918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5675682|NCT03531918|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5675683|NCT03531918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5675684|NCT03531918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5675685|NCT03531762|Tepotinib|tepotinib|mesh-list
5675686|NCT03531762|Omeprazole|omeprazole|mesh-list
5675687|NCT03531762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5675688|NCT03531762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5675689|NCT03531762|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5861161|NCT02398539|Silver Nitrate|silver nitrate|mesh-list
5861162|NCT02398539|Triamcinolone|triamcinolone|mesh-list
5861163|NCT02398539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5861164|NCT02398539|Glucocorticoids|glucocorticoids|mesh-ancestor
5861165|NCT02398539|Hormones|hormones|mesh-ancestor
5861166|NCT02398539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5861167|NCT02398539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861168|NCT02398539|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5861169|NCT02398539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5861170|NCT02398201|Bezafibrate|bezafibrate|mesh-list
5861171|NCT02398201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5861172|NCT02398201|Antimetabolites|antimetabolites|mesh-ancestor
5861173|NCT02398201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861174|NCT02398201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5861175|NCT02398123|Bupivacaine|bupivacaine|mesh-list
5861176|NCT02398123|Anesthetics, Local|anesthetics, local|mesh-ancestor
5861177|NCT02398123|Anesthetics|anesthetics|mesh-ancestor
5861178|NCT02398123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5861179|NCT02398123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675690|NCT03531762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5675691|NCT03531762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675692|NCT03531762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5675693|NCT03531749|Ascorbic Acid|ascorbic acid|mesh-list
5675694|NCT03531749|Antioxidants|antioxidants|mesh-ancestor
5675695|NCT03531749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675696|NCT03531749|Protective Agents|protective agents|mesh-ancestor
5675697|NCT03531749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675698|NCT03531749|Vitamins|vitamins|mesh-ancestor
5675699|NCT03531749|Micronutrients|micronutrients|mesh-ancestor
5675700|NCT03531697|Loteprednol Etabonate|loteprednol etabonate|mesh-list
5675701|NCT03531697|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5675702|NCT03531645|Fulvestrant|fulvestrant|mesh-list
5675703|NCT03531645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5675704|NCT03531645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5675705|NCT03531645|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5675706|NCT03531645|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5861180|NCT02398123|Sensory System Agents|sensory system agents|mesh-ancestor
5861181|NCT02398123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5861182|NCT02398136|Midazolam|midazolam|mesh-list
5861183|NCT02398136|Ketamine|ketamine|mesh-list
5861184|NCT02398136|Analgesics|analgesics|mesh-ancestor
5861185|NCT02398136|Sensory System Agents|sensory system agents|mesh-ancestor
5861186|NCT02398136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5861187|NCT02398136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861188|NCT02398136|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5861189|NCT02398136|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5861190|NCT02398136|Anesthetics, General|anesthetics, general|mesh-ancestor
5861191|NCT02398136|Anesthetics|anesthetics|mesh-ancestor
5861192|NCT02398136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5861193|NCT02398136|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5675707|NCT03531645|Hormone Antagonists|hormone antagonists|mesh-ancestor
5861194|NCT02398136|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5675708|NCT03531645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5675709|NCT03531645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675710|NCT03531437|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5675711|NCT03531437|Gestodene|gestodene|mesh-list
5675712|NCT03531437|Estradiol|estradiol|mesh-list
5675713|NCT03531437|Estrogens|estrogens|mesh-ancestor
5675714|NCT03531437|Hormones|hormones|mesh-ancestor
5861195|NCT02398136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5861196|NCT02398136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861197|NCT02398136|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5861198|NCT02398136|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5861199|NCT02398136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5861200|NCT02398136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5861201|NCT02398136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5861202|NCT02398136|GABA Modulators|gaba modulators|mesh-ancestor
5861203|NCT02398136|GABA Agents|gaba agents|mesh-ancestor
5861204|NCT02397928|Carboplatin|carboplatin|mesh-list
5861205|NCT02397928|Pemetrexed|pemetrexed|mesh-list
5861206|NCT02397928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5861207|NCT02397928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5861208|NCT02397928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861209|NCT02397928|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5861210|NCT02397928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5861211|NCT02397720|Nivolumab|nivolumab|mesh-list
5861212|NCT02397720|Ipilimumab|ipilimumab|mesh-list
5861213|NCT02397720|Azacitidine|azacitidine|mesh-list
5861214|NCT02397720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5861215|NCT02397720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5861216|NCT02397720|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5861217|NCT02397720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861218|NCT02397720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5861219|NCT02397720|Antimetabolites|antimetabolites|mesh-ancestor
5675715|NCT03531437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5675716|NCT03531437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861220|NCT02397720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5861221|NCT02397772|Albendazole|albendazole|mesh-list
5861222|NCT02397772|Anthelmintics|anthelmintics|mesh-ancestor
5861223|NCT02397772|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5861224|NCT02397772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5861225|NCT02397772|Anticestodal Agents|anticestodal agents|mesh-ancestor
5861226|NCT02397772|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5861227|NCT02397772|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5861228|NCT02397772|Tubulin Modulators|tubulin modulators|mesh-ancestor
5675717|NCT03531437|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5675718|NCT03531437|Contraceptive Agents|contraceptive agents|mesh-ancestor
5675719|NCT03531437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5675720|NCT03531437|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5675721|NCT03531437|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5675722|NCT03531437|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5861229|NCT02397772|Antimitotic Agents|antimitotic agents|mesh-ancestor
5861230|NCT02397772|Mitosis Modulators|mitosis modulators|mesh-ancestor
5861231|NCT02397772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861232|NCT02397772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5861233|NCT02397863|Cannabidiol|cannabidiol|mesh-list
5861234|NCT02397863|Anticonvulsants|anticonvulsants|mesh-ancestor
5861235|NCT02398058|Olaparib|olaparib|mesh-list
5861236|NCT02398058|Trabectedin|trabectedin|mesh-list
5861237|NCT02398058|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5861238|NCT02398058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5861239|NCT02398058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861240|NCT02398058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5861241|NCT02398058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5861242|NCT02398058|Alkylating Agents|alkylating agents|mesh-ancestor
5861243|NCT02397382|Midazolam|midazolam|mesh-list
5861244|NCT02397382|Dextromethorphan|dextromethorphan|mesh-list
5861245|NCT02397382|Caffeine|caffeine|mesh-list
5861246|NCT02397382|Omeprazole|omeprazole|mesh-list
5861247|NCT02397382|Warfarin|warfarin|mesh-list
5861248|NCT02397382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5861249|NCT02397382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5861250|NCT02397382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5861251|NCT02397382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861252|NCT02397382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5861253|NCT02397382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5861254|NCT02397382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5861255|NCT02397382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5861256|NCT02397382|Anesthetics, General|anesthetics, general|mesh-ancestor
5861257|NCT02397382|Anesthetics|anesthetics|mesh-ancestor
5861258|NCT02397382|GABA Modulators|gaba modulators|mesh-ancestor
5861259|NCT02397382|GABA Agents|gaba agents|mesh-ancestor
5861260|NCT02397382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5861261|NCT02397382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861262|NCT02397382|Anticoagulants|anticoagulants|mesh-ancestor
5861263|NCT02397382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5861264|NCT02397382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5861265|NCT02397382|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5861266|NCT02397382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5861267|NCT02397382|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5675723|NCT03531437|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5675724|NCT03531437|Progestins|progestins|mesh-ancestor
5675725|NCT03531372|Antacids|antacids|mesh-list
5675726|NCT03531372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675727|NCT03531372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5675728|NCT03531359|Midazolam|midazolam|mesh-list
5675729|NCT03531359|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5675730|NCT03531359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5675731|NCT03531359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5675732|NCT03531359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675733|NCT03531359|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5675734|NCT03531359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5675735|NCT03531359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5675736|NCT03531359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5675737|NCT03531359|Anesthetics, General|anesthetics, general|mesh-ancestor
5675738|NCT03531359|Anesthetics|anesthetics|mesh-ancestor
5675739|NCT03531359|GABA Modulators|gaba modulators|mesh-ancestor
5675740|NCT03531359|GABA Agents|gaba agents|mesh-ancestor
5675741|NCT03531359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5675742|NCT03531359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675743|NCT03531294|Aflibercept|aflibercept|mesh-list
5675744|NCT03531294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5675745|NCT03531294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5675746|NCT03531294|Growth Substances|growth substances|mesh-ancestor
5675747|NCT03531294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675748|NCT03531294|Growth Inhibitors|growth inhibitors|mesh-ancestor
5675749|NCT03531294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5675750|NCT03531281|Sirolimus|sirolimus|mesh-list
5675751|NCT03531281|Cyclophosphamide|cyclophosphamide|mesh-list
5675752|NCT03531281|Etoposide|etoposide|mesh-list
5675753|NCT03531281|Etoposide phosphate|etoposide phosphate|mesh-list
5675754|NCT03531281|Podophyllotoxin|podophyllotoxin|mesh-list
5675755|NCT03531281|Tacrolimus|tacrolimus|mesh-list
5861268|NCT02397382|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5861269|NCT02397382|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5861270|NCT02397382|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5861271|NCT02397382|Purinergic Agents|purinergic agents|mesh-ancestor
5861272|NCT02397382|Antitussive Agents|antitussive agents|mesh-ancestor
5861273|NCT02397382|Respiratory System Agents|respiratory system agents|mesh-ancestor
5861274|NCT02397382|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5861275|NCT02397382|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5861276|NCT02397603|Dexmedetomidine|dexmedetomidine|mesh-list
5861277|NCT02397603|Bupivacaine|bupivacaine|mesh-list
5861278|NCT02397603|Anesthetics, Local|anesthetics, local|mesh-ancestor
5861279|NCT02397603|Anesthetics|anesthetics|mesh-ancestor
5861280|NCT02397603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5861281|NCT02397603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861282|NCT02397603|Sensory System Agents|sensory system agents|mesh-ancestor
5861283|NCT02397603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5861284|NCT02397603|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5861285|NCT02397603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5861286|NCT02397603|Analgesics|analgesics|mesh-ancestor
5861287|NCT02397603|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5861288|NCT02397603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5861289|NCT02397603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5861290|NCT02397603|Adrenergic Agents|adrenergic agents|mesh-ancestor
5861291|NCT02397603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5861292|NCT02397603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861293|NCT02397395|Simeprevir|simeprevir|mesh-list
5861294|NCT02397395|Antiviral Agents|antiviral agents|mesh-ancestor
5861295|NCT02397395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5675756|NCT03531281|Mitogens|mitogens|mesh-list
5861296|NCT02397395|Protease Inhibitors|protease inhibitors|mesh-ancestor
5861297|NCT02397395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5675757|NCT03531281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5861298|NCT02397395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861299|NCT02397551|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5861300|NCT02397551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5861301|NCT02397551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861302|NCT02397512|Lactulose|lactulose|mesh-list
5861303|NCT02397512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5861304|NCT02397421|Dapagliflozin|dapagliflozin|mesh-list
5861305|NCT02397421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5861306|NCT02397421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861307|NCT02397421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5861308|NCT02397421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861309|NCT02397642|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5861310|NCT02397642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5861311|NCT02397642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861312|NCT02397538|Amlodipine|amlodipine|mesh-list
5861313|NCT02397538|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5861314|NCT02397538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5861315|NCT02397538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5861316|NCT02397538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5861317|NCT02397538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861318|NCT02397538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5861319|NCT02397538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675758|NCT03531281|Immunologic Factors|immunologic factors|mesh-ancestor
5675759|NCT03531281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861320|NCT02397538|Vasodilator Agents|vasodilator agents|mesh-ancestor
5861321|NCT02397538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5861322|NCT02397538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5861323|NCT02397538|Antimetabolites|antimetabolites|mesh-ancestor
5861324|NCT02397538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5861325|NCT02397538|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5861326|NCT02397538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5861327|NCT02397486|Vitamin E|vitamin e|mesh-list
5861328|NCT02397486|Pentoxifylline|pentoxifylline|mesh-list
5861329|NCT02397486|Vitamins|vitamins|mesh-ancestor
5861330|NCT02397486|Micronutrients|micronutrients|mesh-ancestor
5861331|NCT02397486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861332|NCT02397486|Antioxidants|antioxidants|mesh-ancestor
5861333|NCT02397486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861334|NCT02397486|Protective Agents|protective agents|mesh-ancestor
5861335|NCT02397486|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5861336|NCT02397486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5861337|NCT02397486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5861338|NCT02397486|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5861339|NCT02397486|Vasodilator Agents|vasodilator agents|mesh-ancestor
5861340|NCT02397486|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5861341|NCT02397590|Atorvastatin|atorvastatin|mesh-list
5861342|NCT02397590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6494599|NCT00619268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6494600|NCT00619268|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5861343|NCT02397590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5861344|NCT02397590|Antimetabolites|antimetabolites|mesh-ancestor
5861345|NCT02397590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861346|NCT02397590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5861347|NCT02397590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5675760|NCT03531281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5675761|NCT03531281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5675762|NCT03531281|Alkylating Agents|alkylating agents|mesh-ancestor
5675763|NCT03531281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675764|NCT03531281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5675765|NCT03531281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5675766|NCT03531281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5675767|NCT03531281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5861348|NCT02397590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5861349|NCT02397356|Ketamine|ketamine|mesh-list
5861350|NCT02397356|Analgesics|analgesics|mesh-ancestor
5861351|NCT02397356|Sensory System Agents|sensory system agents|mesh-ancestor
5861352|NCT02397356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5861353|NCT02397356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861354|NCT02397356|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5861355|NCT02397356|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5861356|NCT02397356|Anesthetics, General|anesthetics, general|mesh-ancestor
5861357|NCT02397356|Anesthetics|anesthetics|mesh-ancestor
5861358|NCT02397356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5861359|NCT02397356|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5861360|NCT02397356|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5861361|NCT02397356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5861362|NCT02397356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861363|NCT02397499|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5861364|NCT02397499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5861365|NCT02397499|Autonomic Agents|autonomic agents|mesh-ancestor
5861366|NCT02397499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5861367|NCT02397499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861368|NCT02397499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5861369|NCT02397499|Respiratory System Agents|respiratory system agents|mesh-ancestor
5861370|NCT02397499|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5861371|NCT02397499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5861372|NCT02397499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5861373|NCT02397499|Adrenergic Agents|adrenergic agents|mesh-ancestor
5861374|NCT02397499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5861375|NCT02397499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861376|NCT02397330|Morphine|morphine|mesh-list
5861377|NCT02397330|Bupivacaine|bupivacaine|mesh-list
5861378|NCT02397330|Anesthetics, Local|anesthetics, local|mesh-ancestor
5861379|NCT02397330|Anesthetics|anesthetics|mesh-ancestor
5861380|NCT02397330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5861381|NCT02397330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861382|NCT02397330|Sensory System Agents|sensory system agents|mesh-ancestor
5861383|NCT02397330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5861384|NCT02397330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5861385|NCT02397330|Narcotics|narcotics|mesh-ancestor
5861386|NCT02397330|Analgesics|analgesics|mesh-ancestor
5861387|NCT02396979|Methadone|methadone|mesh-list
5861388|NCT02396979|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5861389|NCT02396979|Narcotics|narcotics|mesh-ancestor
5861390|NCT02396979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5861391|NCT02396979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861392|NCT02396979|Analgesics|analgesics|mesh-ancestor
5861393|NCT02396979|Sensory System Agents|sensory system agents|mesh-ancestor
5861394|NCT02396979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5675768|NCT03531281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5675769|NCT03531281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5675770|NCT03531281|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5675771|NCT03531281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5675772|NCT03531281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5675773|NCT03531281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5675774|NCT03531281|Antifungal Agents|antifungal agents|mesh-ancestor
5675775|NCT03531281|Mitosis Modulators|mitosis modulators|mesh-ancestor
5675776|NCT03531281|Keratolytic Agents|keratolytic agents|mesh-ancestor
5675777|NCT03531281|Dermatologic Agents|dermatologic agents|mesh-ancestor
5861395|NCT02396979|Antitussive Agents|antitussive agents|mesh-ancestor
5861396|NCT02396979|Respiratory System Agents|respiratory system agents|mesh-ancestor
5861397|NCT02397070|Salicylic Acid|salicylic acid|mesh-list
5861398|NCT02397070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5861399|NCT02397070|Antifungal Agents|antifungal agents|mesh-ancestor
5861400|NCT02397070|Keratolytic Agents|keratolytic agents|mesh-ancestor
5861401|NCT02397070|Dermatologic Agents|dermatologic agents|mesh-ancestor
5861402|NCT02397213|Cyclosporine|cyclosporine|mesh-list
5861403|NCT02397213|Cyclosporins|cyclosporins|mesh-list
5861404|NCT02397213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5861405|NCT02397213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861406|NCT02397213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5861407|NCT02397213|Immunologic Factors|immunologic factors|mesh-ancestor
5861408|NCT02397213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861409|NCT02397213|Antifungal Agents|antifungal agents|mesh-ancestor
6212253|NCT02184195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861410|NCT02397213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5861411|NCT02397213|Dermatologic Agents|dermatologic agents|mesh-ancestor
5861412|NCT02397213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5861413|NCT02397213|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5861414|NCT02396888|Insulin|insulin|mesh-list
5861415|NCT02396888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5861416|NCT02396888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861417|NCT02396563|Ropivacaine|ropivacaine|mesh-list
5861418|NCT02396563|Anesthetics, Local|anesthetics, local|mesh-ancestor
5861419|NCT02396563|Anesthetics|anesthetics|mesh-ancestor
5861420|NCT02396563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5861421|NCT02396563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861422|NCT02396563|Sensory System Agents|sensory system agents|mesh-ancestor
5861423|NCT02396563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5904704|NCT04688788|Protective Agents|protective agents|mesh-ancestor
5904705|NCT04688788|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5904706|NCT04688788|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5904707|NCT04688788|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5675778|NCT03531281|Tubulin Modulators|tubulin modulators|mesh-ancestor
5675779|NCT03531281|Antimitotic Agents|antimitotic agents|mesh-ancestor
5675780|NCT03531073|Methotrexate|methotrexate|mesh-list
5675781|NCT03531073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5675782|NCT03531073|Abortifacient Agents|abortifacient agents|mesh-ancestor
5675783|NCT03531073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5904708|NCT04688788|Histamine Antagonists|histamine antagonists|mesh-ancestor
5904709|NCT04688788|Histamine Agents|histamine agents|mesh-ancestor
5904710|NCT04688788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5904711|NCT04688788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904712|NCT04673448|Niraparib|niraparib|mesh-list
5904713|NCT04673448|Immunoglobulins|immunoglobulins|mesh-list
5904714|NCT04673448|Immunoglobulin G|immunoglobulin g|mesh-list
5904715|NCT04673448|Immunologic Factors|immunologic factors|mesh-ancestor
5904716|NCT04673448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904717|NCT04673448|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5675784|NCT03531073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675785|NCT03531073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5675786|NCT03531073|Antimetabolites|antimetabolites|mesh-ancestor
5675787|NCT03531073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675788|NCT03531073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5675789|NCT03531073|Dermatologic Agents|dermatologic agents|mesh-ancestor
5675790|NCT03531073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5675791|NCT03531073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5675792|NCT03531073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5675793|NCT03531073|Immunologic Factors|immunologic factors|mesh-ancestor
5675794|NCT03531073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5675795|NCT03531073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5675796|NCT03531047|Riboflavin|riboflavin|mesh-list
5675797|NCT03531047|Vitamin B Complex|vitamin b complex|mesh-ancestor
5904718|NCT04673448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5904719|NCT04673448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904720|NCT04673448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5904721|NCT04656964|Midazolam|midazolam|mesh-list
5904722|NCT04656964|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5904723|NCT04656964|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5904724|NCT04656964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5904725|NCT04656964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904726|NCT04656964|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5904727|NCT04656964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5904728|NCT04656964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5904729|NCT04656964|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5904730|NCT04656964|Anesthetics, General|anesthetics, general|mesh-ancestor
5904731|NCT04656964|Anesthetics|anesthetics|mesh-ancestor
5675798|NCT03531047|Vitamins|vitamins|mesh-ancestor
5675799|NCT03531047|Micronutrients|micronutrients|mesh-ancestor
5675800|NCT03531047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675801|NCT03531047|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5675802|NCT03531047|Dermatologic Agents|dermatologic agents|mesh-ancestor
5696459|NCT03383003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5696460|NCT03383003|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5696461|NCT03383003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5696462|NCT03383003|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5696463|NCT03383003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5696464|NCT03383003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696465|NCT03383003|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5696466|NCT03383003|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5904732|NCT04656964|GABA Modulators|gaba modulators|mesh-ancestor
5904733|NCT04656964|GABA Agents|gaba agents|mesh-ancestor
5904734|NCT04656964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5675803|NCT03530800|Dronabinol|dronabinol|mesh-list
5675804|NCT03530800|Hallucinogens|hallucinogens|mesh-ancestor
5675805|NCT03530800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675806|NCT03530800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5675807|NCT03530800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5675808|NCT03530800|Analgesics|analgesics|mesh-ancestor
5675809|NCT03530800|Sensory System Agents|sensory system agents|mesh-ancestor
5861424|NCT02396862|Factor VIII|factor viii|mesh-list
5861425|NCT02396862|Coagulants|coagulants|mesh-ancestor
5861426|NCT02396225|Voriconazole|voriconazole|mesh-list
5861427|NCT02396225|Antifungal Agents|antifungal agents|mesh-ancestor
5861428|NCT02396225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5861429|NCT02396225|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5861430|NCT02396225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5861431|NCT02396225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5861432|NCT02396225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861433|NCT02396225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5675810|NCT03530800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5675811|NCT03530800|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5675812|NCT03530800|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5675813|NCT03530800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5675814|NCT03530800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675815|NCT03530800|Hormones|hormones|mesh-ancestor
5675816|NCT03530800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5675817|NCT03530670|Midazolam|midazolam|mesh-list
5675818|NCT03530670|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5675819|NCT03530670|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5675820|NCT03530670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5675821|NCT03530670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675822|NCT03530670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5675823|NCT03530670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5675824|NCT03530670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5675825|NCT03530670|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5675826|NCT03530670|Anesthetics, General|anesthetics, general|mesh-ancestor
5675827|NCT03530670|Anesthetics|anesthetics|mesh-ancestor
5675828|NCT03530670|GABA Modulators|gaba modulators|mesh-ancestor
5675829|NCT03530670|GABA Agents|gaba agents|mesh-ancestor
5675830|NCT03530670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5675831|NCT03530670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675832|NCT03530488|Lidocaine|lidocaine|mesh-list
5675833|NCT03530488|Anesthetics, Local|anesthetics, local|mesh-ancestor
5675834|NCT03530488|Anesthetics|anesthetics|mesh-ancestor
5675835|NCT03530488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5675836|NCT03530488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675837|NCT03530488|Sensory System Agents|sensory system agents|mesh-ancestor
5675838|NCT03530488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5675839|NCT03530488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5861434|NCT02396225|Hormone Antagonists|hormone antagonists|mesh-ancestor
5861435|NCT02396225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5861436|NCT02396225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861437|NCT02396225|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5861438|NCT02396303|Carbetocin|carbetocin|mesh-list
5861439|NCT02396303|Oxytocics|oxytocics|mesh-ancestor
5861440|NCT02396303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5861441|NCT02396303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861442|NCT02396329|Chlorhexidine|chlorhexidine|mesh-list
5861443|NCT02396329|Povidone-Iodine|povidone-iodine|mesh-list
5861444|NCT02396329|Povidone|povidone|mesh-list
5861445|NCT02396329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5861446|NCT02396329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5861447|NCT02396329|Disinfectants|disinfectants|mesh-ancestor
5861448|NCT02396329|Plasma Substitutes|plasma substitutes|mesh-ancestor
5861449|NCT02396329|Blood Substitutes|blood substitutes|mesh-ancestor
5861450|NCT02396433|Carboplatin|carboplatin|mesh-list
5861451|NCT02396433|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
5861452|NCT02396433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5861453|NCT02396433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5861454|NCT02396433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861455|NCT02396030|Magnesium Sulfate|magnesium sulfate|mesh-list
5861456|NCT02396030|Analgesics|analgesics|mesh-ancestor
5861457|NCT02396030|Sensory System Agents|sensory system agents|mesh-ancestor
5861458|NCT02396030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5861459|NCT02396030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861460|NCT02396030|Anesthetics|anesthetics|mesh-ancestor
5861461|NCT02396030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5675840|NCT03530488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5675841|NCT03530488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5675842|NCT03530488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5675843|NCT03530488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675844|NCT03530462|Methylprednisolone|methylprednisolone|mesh-list
5675845|NCT03530462|Cyclophosphamide|cyclophosphamide|mesh-list
5675846|NCT03530462|Rituximab|rituximab|mesh-list
5675847|NCT03530462|Immunoglobulins|immunoglobulins|mesh-list
5861462|NCT02396030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5861463|NCT02396030|Anticonvulsants|anticonvulsants|mesh-ancestor
5861464|NCT02396030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5861465|NCT02396030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5861466|NCT02396030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861467|NCT02396030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5861468|NCT02396030|Tocolytic Agents|tocolytic agents|mesh-ancestor
5861469|NCT02396030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5861470|NCT02396108|Paclitaxel|paclitaxel|mesh-list
5861471|NCT02396108|Carboplatin|carboplatin|mesh-list
5861472|NCT02396108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5861473|NCT02396108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5861474|NCT02396108|Tubulin Modulators|tubulin modulators|mesh-ancestor
5861475|NCT02396108|Antimitotic Agents|antimitotic agents|mesh-ancestor
5861476|NCT02396108|Mitosis Modulators|mitosis modulators|mesh-ancestor
5861477|NCT02396108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861478|NCT02396043|Cytarabine|cytarabine|mesh-list
5861479|NCT02396043|Dexamethasone|dexamethasone|mesh-list
5861480|NCT02396043|Prednisone|prednisone|mesh-list
5861481|NCT02396043|Cyclophosphamide|cyclophosphamide|mesh-list
5861482|NCT02396043|Methotrexate|methotrexate|mesh-list
5861483|NCT02396043|Vincristine|vincristine|mesh-list
5861484|NCT02396043|Mercaptopurine|mercaptopurine|mesh-list
5861485|NCT02396043|Pegaspargase|pegaspargase|mesh-list
6212254|NCT02184195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6212255|NCT02184572|Vaccines|vaccines|mesh-list
6212256|NCT02184572|Immunologic Factors|immunologic factors|mesh-ancestor
6212257|NCT02184572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212258|NCT02184611|Bromides|bromides|mesh-list
6212259|NCT02184611|Anticonvulsants|anticonvulsants|mesh-ancestor
6212260|NCT02185014|Adalimumab|adalimumab|mesh-list
6212261|NCT02185014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6212262|NCT02185014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6212263|NCT02185131|Mirtazapine|mirtazapine|mesh-list
6212264|NCT02185131|Antidepressive Agents|antidepressive agents|mesh-ancestor
5861486|NCT02396043|Asparaginase|asparaginase|mesh-list
5861487|NCT02396043|Pirarubicin|pirarubicin|mesh-list
5861488|NCT02396043|Doxorubicin|doxorubicin|mesh-list
5861489|NCT02396043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5861490|NCT02396043|Immunologic Factors|immunologic factors|mesh-ancestor
5861491|NCT02396043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861492|NCT02396043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5861493|NCT02396043|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5861494|NCT02396043|Alkylating Agents|alkylating agents|mesh-ancestor
5861495|NCT02396043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861496|NCT02396043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5861497|NCT02396043|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5861498|NCT02396043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5861499|NCT02396043|Antiemetics|antiemetics|mesh-ancestor
5861500|NCT02396043|Autonomic Agents|autonomic agents|mesh-ancestor
5861501|NCT02396043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5861502|NCT02396043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5861503|NCT02396043|Glucocorticoids|glucocorticoids|mesh-ancestor
5861504|NCT02396043|Hormones|hormones|mesh-ancestor
5861505|NCT02396043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5861506|NCT02396043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5861507|NCT02396043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5861508|NCT02396043|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5861509|NCT02396043|Abortifacient Agents|abortifacient agents|mesh-ancestor
5861510|NCT02396043|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5861511|NCT02396043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6674976|NCT01572285|Dexamethasone|dexamethasone|mesh-list
6674977|NCT01572285|Dexamethasone acetate|dexamethasone acetate|mesh-list
6674978|NCT01572285|BB 1101|bb 1101|mesh-list
6674979|NCT01572285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5861512|NCT02396043|Antimetabolites|antimetabolites|mesh-ancestor
5861513|NCT02396043|Dermatologic Agents|dermatologic agents|mesh-ancestor
6212265|NCT02185131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6674980|NCT01572285|Antiemetics|antiemetics|mesh-ancestor
6674981|NCT01572285|Autonomic Agents|autonomic agents|mesh-ancestor
5675848|NCT03530462|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5675849|NCT03530462|Antibodies|antibodies|mesh-list
5861514|NCT02396043|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5861515|NCT02396043|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5861516|NCT02396043|Antiviral Agents|antiviral agents|mesh-ancestor
5861517|NCT02396043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5861518|NCT02396043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5861519|NCT02396043|Tubulin Modulators|tubulin modulators|mesh-ancestor
5861520|NCT02396043|Antimitotic Agents|antimitotic agents|mesh-ancestor
5861521|NCT02396043|Mitosis Modulators|mitosis modulators|mesh-ancestor
5861522|NCT02396043|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5861523|NCT02396043|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5861524|NCT02396043|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5861525|NCT02395783|Melatonin|melatonin|mesh-list
5861526|NCT02395783|Antioxidants|antioxidants|mesh-ancestor
5861527|NCT02395783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861528|NCT02395783|Protective Agents|protective agents|mesh-ancestor
5861529|NCT02395783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861530|NCT02395783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5861531|NCT02395705|Paclitaxel|paclitaxel|mesh-list
5861532|NCT02395705|Cisplatin|cisplatin|mesh-list
5861533|NCT02395705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5861534|NCT02395705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5861535|NCT02395705|Tubulin Modulators|tubulin modulators|mesh-ancestor
5861536|NCT02395705|Antimitotic Agents|antimitotic agents|mesh-ancestor
5861537|NCT02395705|Mitosis Modulators|mitosis modulators|mesh-ancestor
5861538|NCT02395705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861539|NCT02395848|Fidaxomicin|fidaxomicin|mesh-list
5861540|NCT02395848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5861541|NCT02395848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5861542|NCT02395926|Choline|choline|mesh-list
5861543|NCT02395926|Lipotropic Agents|lipotropic agents|mesh-ancestor
5861544|NCT02395926|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5861545|NCT02395926|Antimetabolites|antimetabolites|mesh-ancestor
5861546|NCT02395926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861547|NCT02395926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6674982|NCT01572285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6674983|NCT01572285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674984|NCT01572285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6674985|NCT01572285|Glucocorticoids|glucocorticoids|mesh-ancestor
6674986|NCT01572285|Hormones|hormones|mesh-ancestor
6674987|NCT01572285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6674988|NCT01572285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6674989|NCT01572285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6674990|NCT01572285|Protease Inhibitors|protease inhibitors|mesh-ancestor
6674991|NCT01572285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6674992|NCT01572285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675850|NCT03530462|gamma-Globulins|gamma-globulins|mesh-list
5675851|NCT03530462|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5675852|NCT03530462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5675853|NCT03530462|Immunologic Factors|immunologic factors|mesh-ancestor
5675854|NCT03530462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675855|NCT03530462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5675856|NCT03530462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5675857|NCT03530462|Alkylating Agents|alkylating agents|mesh-ancestor
5675858|NCT03530462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675859|NCT03530462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5675860|NCT03530462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5675861|NCT03530462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5675862|NCT03530462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5675863|NCT03530462|Antiemetics|antiemetics|mesh-ancestor
5675864|NCT03530462|Autonomic Agents|autonomic agents|mesh-ancestor
6674993|NCT01572324|Leucovorin|leucovorin|mesh-list
6674994|NCT01572324|Fluorouracil|fluorouracil|mesh-list
6674995|NCT01572324|Capecitabine|capecitabine|mesh-list
6674996|NCT01572324|Oxaliplatin|oxaliplatin|mesh-list
6674997|NCT01572324|Antimetabolites|antimetabolites|mesh-ancestor
5861548|NCT02395926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5861549|NCT02395926|Nootropic Agents|nootropic agents|mesh-ancestor
5861550|NCT02395952|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
5861551|NCT02395952|Laxatives|laxatives|mesh-ancestor
5861552|NCT02395952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5861553|NCT02395744|Paclitaxel|paclitaxel|mesh-list
5861554|NCT02395744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5861555|NCT02395744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5861556|NCT02395744|Tubulin Modulators|tubulin modulators|mesh-ancestor
5861557|NCT02395744|Antimitotic Agents|antimitotic agents|mesh-ancestor
5861558|NCT02395744|Mitosis Modulators|mitosis modulators|mesh-ancestor
5861559|NCT02395744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861560|NCT02395601|(R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide|(r)-n-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1h-indole-3-carboxamide|mesh-list
5861561|NCT02395601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5861562|NCT02395601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861563|NCT02395458|Amoxicillin|amoxicillin|mesh-list
5861564|NCT02395458|Metronidazole|metronidazole|mesh-list
5861565|NCT02395458|Clarithromycin|clarithromycin|mesh-list
5861566|NCT02395458|Omeprazole|omeprazole|mesh-list
5861567|NCT02395458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5861568|NCT02395458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5861569|NCT02395458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5861570|NCT02395458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5861571|NCT02395458|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5861572|NCT02395458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5861573|NCT02395458|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5861574|NCT02395458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5861575|NCT02395458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861576|NCT02395458|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5861577|NCT02395458|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5861578|NCT02395458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5861579|NCT02395510|Vortioxetine|vortioxetine|mesh-list
5861580|NCT02395510|Antidepressive Agents|antidepressive agents|mesh-ancestor
5861581|NCT02395510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5861582|NCT02395510|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5861583|NCT02395510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5861584|NCT02395510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5861585|NCT02395510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861586|NCT02395510|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5861587|NCT02395510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5861588|NCT02395510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5861589|NCT02395510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861590|NCT02395510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5861591|NCT02395510|Serotonin Agents|serotonin agents|mesh-ancestor
5861592|NCT02395510|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5861593|NCT02395510|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5861594|NCT02395510|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5861595|NCT02395510|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5861596|NCT02395497|Antibodies|antibodies|mesh-list
5861597|NCT02395497|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5861598|NCT02395497|Tacrolimus|tacrolimus|mesh-list
6494601|NCT00619268|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6494602|NCT00619268|Growth Substances|growth substances|mesh-ancestor
6494603|NCT00619268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494604|NCT00619268|Growth Inhibitors|growth inhibitors|mesh-ancestor
6494605|NCT00619268|Antiviral Agents|antiviral agents|mesh-ancestor
6494606|NCT00619268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6494607|NCT00619268|Immunologic Factors|immunologic factors|mesh-ancestor
5675865|NCT03530462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5861599|NCT02395497|Immunologic Factors|immunologic factors|mesh-ancestor
5861600|NCT02395497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861601|NCT02395497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5861602|NCT02395497|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5861603|NCT02395497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5861604|NCT02395497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861605|NCT02395237|Glimepiride|glimepiride|mesh-list
5861606|NCT02395237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5861607|NCT02395237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5861608|NCT02395237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675866|NCT03530462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5675867|NCT03530462|Glucocorticoids|glucocorticoids|mesh-ancestor
5675868|NCT03530462|Hormones|hormones|mesh-ancestor
5675869|NCT03530462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5675870|NCT03530462|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5675871|NCT03530462|Protective Agents|protective agents|mesh-ancestor
5675872|NCT03530436|Curcumin|curcumin|mesh-list
5675873|NCT03530436|Turmeric extract|turmeric extract|mesh-list
5675874|NCT03530436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5675875|NCT03530436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5861609|NCT02395237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5861610|NCT02395237|Immunologic Factors|immunologic factors|mesh-ancestor
5861611|NCT02394847|Propofol|propofol|mesh-list
5861612|NCT02394847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5861613|NCT02394847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5861614|NCT02394847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861615|NCT02394847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5861616|NCT02394847|Anesthetics, General|anesthetics, general|mesh-ancestor
5861617|NCT02394847|Anesthetics|anesthetics|mesh-ancestor
5861618|NCT02395068|Irinotecan|irinotecan|mesh-list
5861619|NCT02395068|Nimotuzumab|nimotuzumab|mesh-list
5861620|NCT02395068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5861621|NCT02395068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5861622|NCT02395068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5861623|NCT02395068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861624|NCT02395068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5861625|NCT02395068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5904735|NCT04656964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904736|NCT04605796|Bevacizumab|bevacizumab|mesh-list
5904737|NCT04605796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5904738|NCT04605796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5904739|NCT04605796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5904740|NCT04605796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5904741|NCT04605796|Growth Substances|growth substances|mesh-ancestor
5904742|NCT04605796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904743|NCT04605796|Growth Inhibitors|growth inhibitors|mesh-ancestor
5904744|NCT04599868|Magnesium Sulfate|magnesium sulfate|mesh-list
5904745|NCT04599868|Analgesics|analgesics|mesh-ancestor
5675876|NCT03530436|Analgesics|analgesics|mesh-ancestor
5675877|NCT03530436|Sensory System Agents|sensory system agents|mesh-ancestor
5675878|NCT03530436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5675879|NCT03530436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675880|NCT03530436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5675881|NCT03530436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5675882|NCT03530436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5675883|NCT03530436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5904746|NCT04599868|Sensory System Agents|sensory system agents|mesh-ancestor
5904747|NCT04599868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5904748|NCT04599868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904749|NCT04599868|Anesthetics|anesthetics|mesh-ancestor
5904750|NCT04599868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5904751|NCT04599868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5904752|NCT04599868|Anticonvulsants|anticonvulsants|mesh-ancestor
5904753|NCT04599868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5904754|NCT04599868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5904755|NCT04599868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904756|NCT04599868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5904757|NCT04599868|Tocolytic Agents|tocolytic agents|mesh-ancestor
5904758|NCT04599868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6212266|NCT02185131|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6212267|NCT02185131|Histamine Antagonists|histamine antagonists|mesh-ancestor
6212268|NCT02185131|Histamine Agents|histamine agents|mesh-ancestor
6212269|NCT02185131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6212270|NCT02185131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212271|NCT02185131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212272|NCT02185131|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6494608|NCT00619268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5675884|NCT03530436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675885|NCT03530436|Antioxidants|antioxidants|mesh-ancestor
5675886|NCT03530436|Protective Agents|protective agents|mesh-ancestor
5675887|NCT03530371|Dexmedetomidine|dexmedetomidine|mesh-list
5675888|NCT03530371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5675889|NCT03530371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5675890|NCT03530371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675891|NCT03530371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5675892|NCT03530371|Analgesics|analgesics|mesh-ancestor
5675893|NCT03530371|Sensory System Agents|sensory system agents|mesh-ancestor
5675894|NCT03530371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5675895|NCT03530371|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5675896|NCT03530371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5675897|NCT03530371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5675898|NCT03530371|Adrenergic Agents|adrenergic agents|mesh-ancestor
5675899|NCT03530371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6212273|NCT02185131|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6212274|NCT02185131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6212275|NCT02185131|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6212276|NCT02185131|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6212277|NCT02185131|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5675900|NCT03530371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675901|NCT03530319|Azithromycin|azithromycin|mesh-list
5675902|NCT03530319|Doxycycline|doxycycline|mesh-list
5675903|NCT03530319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5675904|NCT03530319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6674998|NCT01572324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861626|NCT02395016|Gemcitabine|gemcitabine|mesh-list
5861627|NCT02395016|Nimotuzumab|nimotuzumab|mesh-list
5861628|NCT02395016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5861629|NCT02395016|Antimetabolites|antimetabolites|mesh-ancestor
5861630|NCT02395016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861631|NCT02395016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5861632|NCT02395016|Antiviral Agents|antiviral agents|mesh-ancestor
5861633|NCT02395016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5861634|NCT02395016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5861635|NCT02395016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5861636|NCT02395016|Immunologic Factors|immunologic factors|mesh-ancestor
5861637|NCT02395016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861638|NCT02395016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5861639|NCT02394821|Metronidazole|metronidazole|mesh-list
5861640|NCT02394821|Polihexanide|polihexanide|mesh-list
5861641|NCT02394821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5675905|NCT03530319|Antimalarials|antimalarials|mesh-ancestor
5675906|NCT03530319|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5675907|NCT03530319|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5675908|NCT03530280|Pregabalin|pregabalin|mesh-list
5675909|NCT03530280|Bupivacaine|bupivacaine|mesh-list
5675910|NCT03530280|Anesthetics, Local|anesthetics, local|mesh-ancestor
5675911|NCT03530280|Anesthetics|anesthetics|mesh-ancestor
5675912|NCT03530280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5675913|NCT03530280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861642|NCT02394821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5861643|NCT02394821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5861644|NCT02394821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5861645|NCT02394821|Disinfectants|disinfectants|mesh-ancestor
5861646|NCT02394743|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5861647|NCT02394743|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5861648|NCT02394743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861649|NCT02394652|Metformin|metformin|mesh-list
5861650|NCT02394652|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
5861651|NCT02394652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5861652|NCT02394652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861653|NCT02394652|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5861654|NCT02394652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861655|NCT02394470|Deuterium Oxide|deuterium oxide|mesh-list
5861656|NCT02394470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5861657|NCT02394470|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5861658|NCT02394470|Protective Agents|protective agents|mesh-ancestor
5675914|NCT03530280|Sensory System Agents|sensory system agents|mesh-ancestor
5675915|NCT03530280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5675916|NCT03530280|Analgesics|analgesics|mesh-ancestor
5675917|NCT03530280|Anticonvulsants|anticonvulsants|mesh-ancestor
5675918|NCT03530280|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5675919|NCT03530280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5675920|NCT03530280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675921|NCT03530280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5675922|NCT03530280|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5675923|NCT03530280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5675924|NCT03530280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5675925|NCT03530267|Aflibercept|aflibercept|mesh-list
5675926|NCT03530267|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5675927|NCT03530267|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5675928|NCT03530267|Growth Substances|growth substances|mesh-ancestor
5675929|NCT03530267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675930|NCT03530267|Growth Inhibitors|growth inhibitors|mesh-ancestor
5675931|NCT03530267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5675932|NCT03530228|Esomeprazole|esomeprazole|mesh-list
5675933|NCT03530228|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5675934|NCT03530228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5861659|NCT02394470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6674999|NCT01572324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5675935|NCT03530228|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5675936|NCT03530228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5861660|NCT02394496|Fulvestrant|fulvestrant|mesh-list
5861661|NCT02394496|Lapatinib|lapatinib|mesh-list
5861662|NCT02394496|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5861663|NCT02394496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5861664|NCT02394496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5861665|NCT02394496|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5861666|NCT02394496|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5675937|NCT03530228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675938|NCT03530215|Antineoplastic Agents|antineoplastic agents|mesh-list
5675939|NCT03530189|Insulin|insulin|mesh-list
5675940|NCT03530189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5675941|NCT03530189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675942|NCT03530176|Listerine|listerine|mesh-list
5675943|NCT03530176|Fluorides|fluorides|mesh-list
5675944|NCT03530176|Sodium Fluoride|sodium fluoride|mesh-list
5675945|NCT03530176|Cariostatic Agents|cariostatic agents|mesh-ancestor
5675946|NCT03530176|Protective Agents|protective agents|mesh-ancestor
5675947|NCT03530176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675948|NCT03530176|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5675949|NCT03530176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5675950|NCT03530150|Pirfenidone|pirfenidone|mesh-list
5675951|NCT03530150|Analgesics|analgesics|mesh-ancestor
5675952|NCT03530150|Sensory System Agents|sensory system agents|mesh-ancestor
5675953|NCT03530150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5675954|NCT03530150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675955|NCT03530150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5861667|NCT02394496|Hormone Antagonists|hormone antagonists|mesh-ancestor
5861668|NCT02394496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5675956|NCT03530150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5675957|NCT03530150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5675958|NCT03530150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5675959|NCT03530150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5675960|NCT03530085|Fludarabine|fludarabine|mesh-list
5675961|NCT03530085|Busulfan|busulfan|mesh-list
5675962|NCT03530085|Decitabine|decitabine|mesh-list
5675963|NCT03530085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5675964|NCT03530085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5675965|NCT03530085|Antimetabolites|antimetabolites|mesh-ancestor
5675966|NCT03530085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675967|NCT03530085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5675968|NCT03530085|Immunologic Factors|immunologic factors|mesh-ancestor
5861669|NCT02394496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861670|NCT02394496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5861671|NCT02394496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5861672|NCT02394496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861673|NCT02394496|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5861674|NCT02394483|Olorofim|olorofim|mesh-list
5861675|NCT02394483|Antifungal Agents|antifungal agents|mesh-ancestor
5861676|NCT02394483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5861677|NCT02394418|Dexmedetomidine|dexmedetomidine|mesh-list
5861678|NCT02394418|Propofol|propofol|mesh-list
5861679|NCT02394418|Sevoflurane|sevoflurane|mesh-list
5861680|NCT02394418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5861681|NCT02394418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5675969|NCT03530085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675970|NCT03530085|Alkylating Agents|alkylating agents|mesh-ancestor
5675971|NCT03530085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5675972|NCT03530085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5675973|NCT03530085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5675974|NCT03530033|Lidocaine|lidocaine|mesh-list
5675975|NCT03530033|Anesthetics, Local|anesthetics, local|mesh-ancestor
5675976|NCT03530033|Anesthetics|anesthetics|mesh-ancestor
5861682|NCT02394418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861683|NCT02394418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5861684|NCT02394418|Anesthetics, General|anesthetics, general|mesh-ancestor
5861685|NCT02394418|Anesthetics|anesthetics|mesh-ancestor
5861686|NCT02394418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5861687|NCT02394418|Analgesics|analgesics|mesh-ancestor
5861688|NCT02394418|Sensory System Agents|sensory system agents|mesh-ancestor
5861689|NCT02394418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5675977|NCT03530033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5861690|NCT02394418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5675978|NCT03530033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675979|NCT03530033|Sensory System Agents|sensory system agents|mesh-ancestor
5675980|NCT03530033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5675981|NCT03530033|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5675982|NCT03530033|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5675983|NCT03530033|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5675984|NCT03530033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5861691|NCT02394418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5861692|NCT02394418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5861693|NCT02394418|Adrenergic Agents|adrenergic agents|mesh-ancestor
5861694|NCT02394418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5861695|NCT02394418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861696|NCT02394418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5861697|NCT02394418|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5861698|NCT02394145|Clopidogrel|clopidogrel|mesh-list
5861699|NCT02394145|Ticagrelor|ticagrelor|mesh-list
5861700|NCT02394145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5861701|NCT02394145|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5861702|NCT02394145|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5861703|NCT02394145|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5861704|NCT02394145|Purinergic Agents|purinergic agents|mesh-ancestor
5861705|NCT02394145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5861706|NCT02394145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861707|NCT02394145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861708|NCT02394158|Metformin|metformin|mesh-list
5861709|NCT02394158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5861710|NCT02394158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861711|NCT02394197|Chloroquine|chloroquine|mesh-list
5861712|NCT02394197|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
5861713|NCT02394197|Primaquine|primaquine|mesh-list
5861714|NCT02394197|Amebicides|amebicides|mesh-ancestor
6494609|NCT00619268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6494610|NCT00619268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494611|NCT00619268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6494612|NCT00619268|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6494613|NCT00619268|Antifungal Agents|antifungal agents|mesh-ancestor
6494614|NCT00619268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5675985|NCT03530033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861715|NCT02394197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5861716|NCT02394197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5861717|NCT02394197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5861718|NCT02394197|Antimalarials|antimalarials|mesh-ancestor
5861719|NCT02394197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5861720|NCT02394197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5861721|NCT02394197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5861722|NCT02394197|Analgesics|analgesics|mesh-ancestor
5861723|NCT02394197|Sensory System Agents|sensory system agents|mesh-ancestor
5861724|NCT02394197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5861725|NCT02394197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861726|NCT02394197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5675986|NCT03530020|Lithium Carbonate|lithium carbonate|mesh-list
5675987|NCT03530020|Antidepressive Agents|antidepressive agents|mesh-ancestor
5861727|NCT02394197|Filaricides|filaricides|mesh-ancestor
5861728|NCT02394197|Antinematodal Agents|antinematodal agents|mesh-ancestor
5861729|NCT02394197|Anthelmintics|anthelmintics|mesh-ancestor
5861730|NCT02394132|Imiquimod|imiquimod|mesh-list
5861731|NCT02394132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5861732|NCT02394132|Immunologic Factors|immunologic factors|mesh-ancestor
5861733|NCT02394132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861734|NCT02394132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5861735|NCT02394132|Interferon Inducers|interferon inducers|mesh-ancestor
5861736|NCT02394119|Rituximab|rituximab|mesh-list
5861737|NCT02394119|Ofatumumab|ofatumumab|mesh-list
5861738|NCT02394119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5861739|NCT02394119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5861740|NCT02394119|Immunologic Factors|immunologic factors|mesh-ancestor
5861741|NCT02394119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861742|NCT02394119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5861743|NCT02394106|Ofatumumab|ofatumumab|mesh-list
5861744|NCT02394106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5861745|NCT02394015|Doxorubicin|doxorubicin|mesh-list
5861746|NCT02394015|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5861747|NCT02394015|Trabectedin|trabectedin|mesh-list
5861748|NCT02394015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5861749|NCT02394015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5861750|NCT02394015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5904759|NCT04515394|Cetuximab|cetuximab|mesh-list
5861751|NCT02394015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5675988|NCT03530020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5675989|NCT03530020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5675990|NCT03530020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5675991|NCT03530020|Antimanic Agents|antimanic agents|mesh-ancestor
5675992|NCT03530020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5675993|NCT03530020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5675994|NCT03530020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5675995|NCT03530007|Ondansetron|ondansetron|mesh-list
5675996|NCT03530007|Antiemetics|antiemetics|mesh-ancestor
5675997|NCT03530007|Autonomic Agents|autonomic agents|mesh-ancestor
5675998|NCT03530007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5861752|NCT02394015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5861753|NCT02394015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861754|NCT02394015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5861755|NCT02394015|Alkylating Agents|alkylating agents|mesh-ancestor
5861756|NCT02393846|Ketoprofen|ketoprofen|mesh-list
5861757|NCT02393846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5861758|NCT02393846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5861759|NCT02393846|Analgesics|analgesics|mesh-ancestor
5675999|NCT03530007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676000|NCT03530007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5676001|NCT03530007|Antipruritics|antipruritics|mesh-ancestor
5676002|NCT03530007|Dermatologic Agents|dermatologic agents|mesh-ancestor
5676003|NCT03530007|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5676004|NCT03530007|Serotonin Agents|serotonin agents|mesh-ancestor
5676005|NCT03530007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5676006|NCT03530007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676007|NCT03530007|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5676008|NCT03530007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5676009|NCT03530007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5676010|NCT03530007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5676011|NCT03530007|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5676012|NCT03529955|Apremilast|apremilast|mesh-list
5676013|NCT03529955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5676014|NCT03529955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5676015|NCT03529955|Analgesics|analgesics|mesh-ancestor
5676016|NCT03529955|Sensory System Agents|sensory system agents|mesh-ancestor
5861760|NCT02393846|Sensory System Agents|sensory system agents|mesh-ancestor
5861761|NCT02393846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5861762|NCT02393846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861763|NCT02393846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5861764|NCT02393846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5676017|NCT03529955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5676018|NCT03529955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676019|NCT03529955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5676020|NCT03529955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5676021|NCT03529955|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5676022|NCT03529955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5676023|NCT03529955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5676024|NCT03529955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676025|NCT03529929|Methylprednisolone|methylprednisolone|mesh-list
5676026|NCT03529929|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5676027|NCT03529929|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5676028|NCT03529929|Prednisolone|prednisolone|mesh-list
5676029|NCT03529929|Prednisolone acetate|prednisolone acetate|mesh-list
5676030|NCT03529929|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5676031|NCT03529929|Prednisolone phosphate|prednisolone phosphate|mesh-list
5676032|NCT03529929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5676033|NCT03529929|Antiemetics|antiemetics|mesh-ancestor
5676034|NCT03529929|Autonomic Agents|autonomic agents|mesh-ancestor
5676035|NCT03529929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5676036|NCT03529929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676037|NCT03529929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5676038|NCT03529929|Glucocorticoids|glucocorticoids|mesh-ancestor
5676039|NCT03529929|Hormones|hormones|mesh-ancestor
5676040|NCT03529929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5861765|NCT02393846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5861766|NCT02393846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5861767|NCT02393846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861768|NCT02394093|Aspirin|aspirin|mesh-list
5861769|NCT02394093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5861770|NCT02394093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5676041|NCT03529929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5861771|NCT02394093|Analgesics|analgesics|mesh-ancestor
5861772|NCT02394093|Sensory System Agents|sensory system agents|mesh-ancestor
5861773|NCT02394093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5861774|NCT02394093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861775|NCT02394093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5861776|NCT02394093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5861777|NCT02394093|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5861778|NCT02394093|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5861779|NCT02394093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861780|NCT02394093|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5861781|NCT02394093|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5861782|NCT02394093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5861783|NCT02394093|Antipyretics|antipyretics|mesh-ancestor
5861784|NCT02393898|Paclitaxel|paclitaxel|mesh-list
5861785|NCT02393898|Bevacizumab|bevacizumab|mesh-list
5861786|NCT02393898|Carboplatin|carboplatin|mesh-list
5861787|NCT02393898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5861788|NCT02393898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5861789|NCT02393898|Tubulin Modulators|tubulin modulators|mesh-ancestor
5861790|NCT02393898|Antimitotic Agents|antimitotic agents|mesh-ancestor
5861791|NCT02393898|Mitosis Modulators|mitosis modulators|mesh-ancestor
5861792|NCT02393898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861793|NCT02393898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5861794|NCT02393898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5861795|NCT02393898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5861796|NCT02393898|Growth Substances|growth substances|mesh-ancestor
5861797|NCT02393898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861798|NCT02393898|Growth Inhibitors|growth inhibitors|mesh-ancestor
5861799|NCT02394028|Etrolizumab|etrolizumab|mesh-list
5861800|NCT02394028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5861801|NCT02394028|Immunologic Factors|immunologic factors|mesh-ancestor
5861802|NCT02394028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861803|NCT02394002|Propofol|propofol|mesh-list
5861804|NCT02394002|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5861805|NCT02394002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5861806|NCT02394002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861807|NCT02394002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5861808|NCT02394002|Anesthetics, General|anesthetics, general|mesh-ancestor
5861809|NCT02394002|Anesthetics|anesthetics|mesh-ancestor
5861810|NCT02394054|Vasopressins|vasopressins|mesh-list
5861811|NCT02394054|Arginine Vasopressin|arginine vasopressin|mesh-list
5861812|NCT02394054|Hemostatics|hemostatics|mesh-ancestor
5861813|NCT02394054|Coagulants|coagulants|mesh-ancestor
5861814|NCT02394054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5861815|NCT02394054|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5861816|NCT02394054|Natriuretic Agents|natriuretic agents|mesh-ancestor
5861817|NCT02394054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861818|NCT02393963|Tranexamic Acid|tranexamic acid|mesh-list
5861819|NCT02393963|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5861820|NCT02393963|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5861821|NCT02393963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861822|NCT02393963|Hemostatics|hemostatics|mesh-ancestor
5861823|NCT02393963|Coagulants|coagulants|mesh-ancestor
5861824|NCT02393664|Bupivacaine|bupivacaine|mesh-list
5861825|NCT02393664|Propofol|propofol|mesh-list
5861826|NCT02393664|Sevoflurane|sevoflurane|mesh-list
5861827|NCT02393664|Rocuronium|rocuronium|mesh-list
5861828|NCT02393664|Anesthetics, Local|anesthetics, local|mesh-ancestor
5861829|NCT02393664|Anesthetics|anesthetics|mesh-ancestor
5861830|NCT02393664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5861831|NCT02393664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861832|NCT02393664|Sensory System Agents|sensory system agents|mesh-ancestor
5861833|NCT02393664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5861834|NCT02393664|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5861835|NCT02393664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5676042|NCT03529929|Protective Agents|protective agents|mesh-ancestor
5676043|NCT03529929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5676044|NCT03529929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5676045|NCT03529643|Dexmedetomidine|dexmedetomidine|mesh-list
5676046|NCT03529643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5676047|NCT03529643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5676048|NCT03529643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861836|NCT02393664|Anesthetics, General|anesthetics, general|mesh-ancestor
5861837|NCT02393664|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5861838|NCT02393664|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5861839|NCT02393664|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5861840|NCT02393664|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5861841|NCT02393664|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5861842|NCT02393599|Cocaine|cocaine|mesh-list
5861843|NCT02393599|Anesthetics, Local|anesthetics, local|mesh-ancestor
5861844|NCT02393599|Anesthetics|anesthetics|mesh-ancestor
5861845|NCT02393599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5861846|NCT02393599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861847|NCT02393599|Sensory System Agents|sensory system agents|mesh-ancestor
5861848|NCT02393599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5861849|NCT02393599|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5861850|NCT02393599|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5861851|NCT02393599|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5861852|NCT02393599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5861853|NCT02393599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861854|NCT02393599|Dopamine Agents|dopamine agents|mesh-ancestor
5861855|NCT02393599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5861856|NCT02393482|Cholecalciferol|cholecalciferol|mesh-list
5676049|NCT03529643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5676050|NCT03529643|Analgesics|analgesics|mesh-ancestor
5676051|NCT03529643|Sensory System Agents|sensory system agents|mesh-ancestor
5676052|NCT03529643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5676053|NCT03529643|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5676054|NCT03529643|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5676055|NCT03529643|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5676056|NCT03529643|Adrenergic Agents|adrenergic agents|mesh-ancestor
5676057|NCT03529643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5676058|NCT03529643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676059|NCT03529487|Phenylephrine|phenylephrine|mesh-list
5676060|NCT03529487|Oxymetazoline|oxymetazoline|mesh-list
5861857|NCT02393482|Leuprolide|leuprolide|mesh-list
5861858|NCT02393482|Tibolone|tibolone|mesh-list
5861859|NCT02393482|Calcium Carbonate|calcium carbonate|mesh-list
5861860|NCT02393482|Hormones|hormones|mesh-list
5861861|NCT02393482|Estradiol|estradiol|mesh-list
5861862|NCT02393482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5861863|NCT02393482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861864|NCT02393482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5861865|NCT02393482|Estrogens|estrogens|mesh-ancestor
5861866|NCT02393482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5861867|NCT02393482|Antacids|antacids|mesh-ancestor
5861868|NCT02393482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676061|NCT03529487|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5676062|NCT03529487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5676063|NCT03529487|Adrenergic Agents|adrenergic agents|mesh-ancestor
5676064|NCT03529487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5676065|NCT03529487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676066|NCT03529487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676067|NCT03529487|Sympathomimetics|sympathomimetics|mesh-ancestor
5676068|NCT03529487|Autonomic Agents|autonomic agents|mesh-ancestor
5676069|NCT03529487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5676070|NCT03529487|Nasal Decongestants|nasal decongestants|mesh-ancestor
5676071|NCT03529487|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5676072|NCT03529487|Respiratory System Agents|respiratory system agents|mesh-ancestor
5676073|NCT03529487|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5676074|NCT03529487|Mydriatics|mydriatics|mesh-ancestor
5676075|NCT03529487|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5676076|NCT03529487|Protective Agents|protective agents|mesh-ancestor
5676077|NCT03529448|Temozolomide|temozolomide|mesh-list
5676078|NCT03529448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5676079|NCT03529448|Alkylating Agents|alkylating agents|mesh-ancestor
5676080|NCT03529448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676081|NCT03529448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5676082|NCT03529422|Durvalumab|durvalumab|mesh-list
5676083|NCT03529422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5676084|NCT03529422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5676085|NCT03529396|Chloroquine|chloroquine|mesh-list
5676086|NCT03529396|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
5676087|NCT03529396|Primaquine|primaquine|mesh-list
5676088|NCT03529396|Amebicides|amebicides|mesh-ancestor
5676089|NCT03529396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5676090|NCT03529396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5676091|NCT03529396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5676092|NCT03529396|Antimalarials|antimalarials|mesh-ancestor
5676093|NCT03529396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5861869|NCT02393482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5676094|NCT03529396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5676095|NCT03529396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5676096|NCT03529396|Analgesics|analgesics|mesh-ancestor
5861870|NCT02393482|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5861871|NCT02393482|Fertility Agents|fertility agents|mesh-ancestor
5861872|NCT02393482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5861873|NCT02393482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5861874|NCT02393482|Androgen Antagonists|androgen antagonists|mesh-ancestor
5861875|NCT02393482|Hormone Antagonists|hormone antagonists|mesh-ancestor
5861876|NCT02393482|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5861877|NCT02393482|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5861878|NCT02393482|Anabolic Agents|anabolic agents|mesh-ancestor
5861879|NCT02393482|Vitamins|vitamins|mesh-ancestor
5861880|NCT02393482|Micronutrients|micronutrients|mesh-ancestor
5861881|NCT02393482|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5861882|NCT02393573|Metformin|metformin|mesh-list
5861883|NCT02393573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5861884|NCT02393573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861885|NCT02393625|Nivolumab|nivolumab|mesh-list
5861886|NCT02393625|Ceritinib|ceritinib|mesh-list
5861887|NCT02393625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5861888|NCT02393625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5861889|NCT02393625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5861890|NCT02393625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861891|NCT02393625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5861892|NCT02393625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5861893|NCT02393586|Amoxicillin|amoxicillin|mesh-list
5861894|NCT02393586|Rifampin|rifampin|mesh-list
5676097|NCT03529396|Sensory System Agents|sensory system agents|mesh-ancestor
5676098|NCT03529396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5676099|NCT03529396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676100|NCT03529396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5676101|NCT03529396|Filaricides|filaricides|mesh-ancestor
5676102|NCT03529396|Antinematodal Agents|antinematodal agents|mesh-ancestor
5676103|NCT03529396|Anthelmintics|anthelmintics|mesh-ancestor
5676104|NCT03529331|Acetaminophen|acetaminophen|mesh-list
5676105|NCT03529331|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
5676106|NCT03529331|Morphine|morphine|mesh-list
5676107|NCT03529331|Oxycodone|oxycodone|mesh-list
5676108|NCT03529331|Hydrocodone|hydrocodone|mesh-list
5676109|NCT03529331|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5861895|NCT02393586|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5861896|NCT02393586|Clavulanic Acids|clavulanic acids|mesh-list
5861897|NCT02393586|Clavulanic Acid|clavulanic acid|mesh-list
5861898|NCT02393586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5861899|NCT02393586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5861900|NCT02393586|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5861901|NCT02393586|Antitubercular Agents|antitubercular agents|mesh-ancestor
5861902|NCT02393586|Leprostatic Agents|leprostatic agents|mesh-ancestor
5861903|NCT02393586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5861904|NCT02393586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5861905|NCT02393586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861906|NCT02393586|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5861907|NCT02393586|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6494615|NCT00619333|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6494616|NCT00619333|Hormones|hormones|mesh-ancestor
5676110|NCT03529331|Narcotics|narcotics|mesh-ancestor
5676111|NCT03529331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5676112|NCT03529331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676113|NCT03529331|Analgesics|analgesics|mesh-ancestor
5676114|NCT03529331|Sensory System Agents|sensory system agents|mesh-ancestor
5676115|NCT03529331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5676116|NCT03529331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5676117|NCT03529331|Antipyretics|antipyretics|mesh-ancestor
5676118|NCT03529331|Antitussive Agents|antitussive agents|mesh-ancestor
5676119|NCT03529331|Respiratory System Agents|respiratory system agents|mesh-ancestor
5676120|NCT03529331|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5676121|NCT03529331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5676122|NCT03529331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5676123|NCT03529266|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
5676124|NCT03529266|Hemostatics|hemostatics|mesh-ancestor
5676125|NCT03529266|Coagulants|coagulants|mesh-ancestor
5676126|NCT03529253|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5676127|NCT03529253|Calcium|calcium|mesh-list
5676128|NCT03529253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5861908|NCT02393586|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5861909|NCT02393586|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5676129|NCT03529253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676130|NCT03529253|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5676131|NCT03529253|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5676132|NCT03529253|Antimetabolites|antimetabolites|mesh-ancestor
5676133|NCT03529253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676134|NCT03529253|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5676135|NCT03529253|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5676136|NCT03529253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5696467|NCT03383003|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5696468|NCT03382938|Dexmedetomidine|dexmedetomidine|mesh-list
5696469|NCT03382938|Ropivacaine|ropivacaine|mesh-list
5696470|NCT03382938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5696471|NCT03382938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5696472|NCT03382938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696473|NCT03382938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5696474|NCT03382938|Analgesics|analgesics|mesh-ancestor
5696475|NCT03382938|Sensory System Agents|sensory system agents|mesh-ancestor
5696476|NCT03382938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5861910|NCT02393586|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5861911|NCT02393586|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5861912|NCT02393586|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5861913|NCT02393456|Oxytocin|oxytocin|mesh-list
5861914|NCT02393456|Oxytocics|oxytocics|mesh-ancestor
5861915|NCT02393456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5696477|NCT03382938|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5696478|NCT03382938|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5696479|NCT03382938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5696480|NCT03382938|Adrenergic Agents|adrenergic agents|mesh-ancestor
5696481|NCT03382938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5696482|NCT03382938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696483|NCT03382938|Anesthetics, Local|anesthetics, local|mesh-ancestor
5696484|NCT03382938|Anesthetics|anesthetics|mesh-ancestor
5861916|NCT02393456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861917|NCT02393612|Sarpogrelate|sarpogrelate|mesh-list
5861918|NCT02393612|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5861919|NCT02393612|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5861920|NCT02393612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861921|NCT02393612|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5861922|NCT02393612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5861923|NCT02393612|Serotonin Agents|serotonin agents|mesh-ancestor
5861924|NCT02393612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5861925|NCT02393612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861926|NCT02393430|Rebamipide|rebamipide|mesh-list
5861927|NCT02393430|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5861928|NCT02393430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5861929|NCT02393430|Antioxidants|antioxidants|mesh-ancestor
5861930|NCT02393430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861931|NCT02393430|Protective Agents|protective agents|mesh-ancestor
5861932|NCT02393430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861933|NCT02393430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5861934|NCT02393443|Oxytocin|oxytocin|mesh-list
5696485|NCT03382886|Bevacizumab|bevacizumab|mesh-list
5696486|NCT03382886|Nivolumab|nivolumab|mesh-list
5696487|NCT03382886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5696488|NCT03382886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5696489|NCT03382886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5696490|NCT03382886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5696491|NCT03382886|Growth Substances|growth substances|mesh-ancestor
5696492|NCT03382886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696493|NCT03382886|Growth Inhibitors|growth inhibitors|mesh-ancestor
5696494|NCT03382886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5696495|NCT03382886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5698033|NCT03371862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5698034|NCT03371849|Montelukast|montelukast|mesh-list
5698035|NCT03371849|Levocetirizine|levocetirizine|mesh-list
5698036|NCT03371849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5698037|NCT03371849|Respiratory System Agents|respiratory system agents|mesh-ancestor
5861935|NCT02393443|Oxytocics|oxytocics|mesh-ancestor
5861936|NCT02393443|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5861937|NCT02393443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861938|NCT02393300|Tranexamic Acid|tranexamic acid|mesh-list
5861939|NCT02393300|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5676137|NCT03529201|Fentanyl|fentanyl|mesh-list
5676138|NCT03529201|Oxycodone|oxycodone|mesh-list
5676139|NCT03529201|Sevoflurane|sevoflurane|mesh-list
5676140|NCT03529201|Rocuronium|rocuronium|mesh-list
5676141|NCT03529201|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5676142|NCT03529201|Narcotics|narcotics|mesh-ancestor
5676143|NCT03529201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5676144|NCT03529201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676145|NCT03529201|Analgesics|analgesics|mesh-ancestor
5676146|NCT03529201|Sensory System Agents|sensory system agents|mesh-ancestor
5676147|NCT03529201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5676148|NCT03529201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5676149|NCT03529201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5676150|NCT03529201|Anesthetics, General|anesthetics, general|mesh-ancestor
5676151|NCT03529201|Anesthetics|anesthetics|mesh-ancestor
5676152|NCT03529201|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5676153|NCT03529201|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5676154|NCT03529201|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5676155|NCT03529201|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5861940|NCT02393300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5861941|NCT02393300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861942|NCT02393300|Hemostatics|hemostatics|mesh-ancestor
5861943|NCT02393300|Coagulants|coagulants|mesh-ancestor
5861944|NCT02393261|Dialysis Solutions|dialysis solutions|mesh-list
5861945|NCT02393261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5861946|NCT02393196|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
5861947|NCT02393196|Plasma Substitutes|plasma substitutes|mesh-ancestor
5861948|NCT02393196|Blood Substitutes|blood substitutes|mesh-ancestor
5861949|NCT02393144|Meperidine|meperidine|mesh-list
5861950|NCT02393144|Analgesics, Opioid|analgesics, opioid|mesh-list
5861951|NCT02393144|Analgesics|analgesics|mesh-list
5861952|NCT02393144|Oxytocin|oxytocin|mesh-list
5861953|NCT02393144|Dinoprostone|dinoprostone|mesh-list
5861954|NCT02393144|Oxytocics|oxytocics|mesh-ancestor
5861955|NCT02393144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5861956|NCT02393144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5861957|NCT02393144|Narcotics|narcotics|mesh-ancestor
5861958|NCT02393144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5861959|NCT02393144|Sensory System Agents|sensory system agents|mesh-ancestor
5861960|NCT02393144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5861961|NCT02393144|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5904760|NCT04515394|Tepotinib|tepotinib|mesh-list
5904761|NCT04515394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5904762|NCT04515394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5904763|NCT04513951|Leucovorin|leucovorin|mesh-list
5904764|NCT04513951|Fluorouracil|fluorouracil|mesh-list
5904765|NCT04513951|Oxaliplatin|oxaliplatin|mesh-list
5904766|NCT04513951|Irinotecan|irinotecan|mesh-list
5904767|NCT04513951|Cetuximab|cetuximab|mesh-list
5904768|NCT04513951|Avelumab|avelumab|mesh-list
5904769|NCT04513951|Levoleucovorin|levoleucovorin|mesh-list
5904770|NCT04513951|Antimetabolites|antimetabolites|mesh-ancestor
5904771|NCT04513951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904772|NCT04513951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5904773|NCT04513951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5904774|NCT04513951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5904775|NCT04513951|Immunologic Factors|immunologic factors|mesh-ancestor
5904776|NCT04513951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904777|NCT04513951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5904778|NCT04513951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5904779|NCT04513951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5904780|NCT04513951|Antidotes|antidotes|mesh-ancestor
5904781|NCT04513951|Protective Agents|protective agents|mesh-ancestor
5904782|NCT04513951|Vitamin B Complex|vitamin b complex|mesh-ancestor
5904783|NCT04513951|Vitamins|vitamins|mesh-ancestor
5904784|NCT04513951|Micronutrients|micronutrients|mesh-ancestor
5904785|NCT04513951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5904786|NCT04414475|Dexamethasone|dexamethasone|mesh-list
5904787|NCT04414475|Bortezomib|bortezomib|mesh-list
5904788|NCT04414475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5904789|NCT04414475|Antiemetics|antiemetics|mesh-ancestor
5904790|NCT04414475|Autonomic Agents|autonomic agents|mesh-ancestor
5904791|NCT04414475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5904792|NCT04414475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676156|NCT03529201|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5904793|NCT04414475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5676157|NCT03529175|Gemcitabine|gemcitabine|mesh-list
5904794|NCT04414475|Glucocorticoids|glucocorticoids|mesh-ancestor
5904795|NCT04414475|Hormones|hormones|mesh-ancestor
5904796|NCT04414475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5861962|NCT02393157|Carboplatin|carboplatin|mesh-list
5861963|NCT02393157|Etoposide|etoposide|mesh-list
5861964|NCT02393157|Ifosfamide|ifosfamide|mesh-list
5861965|NCT02393157|Obinutuzumab|obinutuzumab|mesh-list
5861966|NCT02393157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5861967|NCT02393157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5861968|NCT02393157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5861969|NCT02393157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5861970|NCT02393157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5861971|NCT02393157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861972|NCT02393157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5861973|NCT02393157|Alkylating Agents|alkylating agents|mesh-ancestor
5861974|NCT02393157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5861975|NCT02392910|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
5861976|NCT02392910|Hematinics|hematinics|mesh-ancestor
5861977|NCT02392845|Docetaxel|docetaxel|mesh-list
5861978|NCT02392845|Epirubicin|epirubicin|mesh-list
5861979|NCT02392845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5861980|NCT02392845|Tubulin Modulators|tubulin modulators|mesh-ancestor
5861981|NCT02392845|Antimitotic Agents|antimitotic agents|mesh-ancestor
5861982|NCT02392845|Mitosis Modulators|mitosis modulators|mesh-ancestor
5861983|NCT02392845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861984|NCT02392845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5861985|NCT02392845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5861986|NCT02392845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5861987|NCT02392845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5861988|NCT02392871|Trametinib|trametinib|mesh-list
5861989|NCT02392871|Dabrafenib|dabrafenib|mesh-list
5861990|NCT02392871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5861991|NCT02392871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5861992|NCT02392871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5861993|NCT02392871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5861994|NCT02392780|Methylprednisolone|methylprednisolone|mesh-list
5861995|NCT02392780|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5861996|NCT02392780|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5861997|NCT02392780|Prednisolone|prednisolone|mesh-list
5861998|NCT02392780|Prednisolone acetate|prednisolone acetate|mesh-list
5861999|NCT02392780|Cannabidiol|cannabidiol|mesh-list
5862000|NCT02392780|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5862001|NCT02392780|Prednisolone phosphate|prednisolone phosphate|mesh-list
5862002|NCT02392780|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
5862003|NCT02392780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5862004|NCT02392780|Antiemetics|antiemetics|mesh-ancestor
5862005|NCT02392780|Autonomic Agents|autonomic agents|mesh-ancestor
5862006|NCT02392780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5862007|NCT02392780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862008|NCT02392780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5862009|NCT02392780|Glucocorticoids|glucocorticoids|mesh-ancestor
5862010|NCT02392780|Hormones|hormones|mesh-ancestor
5862011|NCT02392780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5862012|NCT02392780|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5862013|NCT02392780|Protective Agents|protective agents|mesh-ancestor
5676158|NCT03529175|Paclitaxel|paclitaxel|mesh-list
5676159|NCT03529175|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5676160|NCT03529175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5676161|NCT03529175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5676162|NCT03529175|Tubulin Modulators|tubulin modulators|mesh-ancestor
5676163|NCT03529175|Antimitotic Agents|antimitotic agents|mesh-ancestor
5676164|NCT03529175|Mitosis Modulators|mitosis modulators|mesh-ancestor
5676165|NCT03529175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676166|NCT03529175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5676167|NCT03529175|Antimetabolites|antimetabolites|mesh-ancestor
5676168|NCT03529175|Antiviral Agents|antiviral agents|mesh-ancestor
5676169|NCT03529175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5676170|NCT03529175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5676171|NCT03529175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5676172|NCT03529175|Immunologic Factors|immunologic factors|mesh-ancestor
5676173|NCT03529175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676174|NCT03529149|Diltiazem|diltiazem|mesh-list
5676175|NCT03529149|Urapidil|urapidil|mesh-list
5676176|NCT03529149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5676177|NCT03529149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5676178|NCT03529149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5676179|NCT03529149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676180|NCT03529149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5862014|NCT02392780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5862015|NCT02392780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5862016|NCT02392780|Anticonvulsants|anticonvulsants|mesh-ancestor
5862017|NCT02392780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5862018|NCT02392780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862019|NCT02393066|Dexmedetomidine|dexmedetomidine|mesh-list
5862020|NCT02393066|Propofol|propofol|mesh-list
5862021|NCT02393066|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5862022|NCT02393066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5862023|NCT02393066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862024|NCT02393066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5862025|NCT02393066|Anesthetics, General|anesthetics, general|mesh-ancestor
5862026|NCT02393066|Anesthetics|anesthetics|mesh-ancestor
5862027|NCT02393066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5862028|NCT02393066|Analgesics|analgesics|mesh-ancestor
5676181|NCT03529149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676182|NCT03529149|Vasodilator Agents|vasodilator agents|mesh-ancestor
5676183|NCT03529149|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5676184|NCT03529149|Serotonin Agents|serotonin agents|mesh-ancestor
5676185|NCT03529149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5676186|NCT03529149|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5676187|NCT03529149|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5676188|NCT03529149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5862029|NCT02393066|Sensory System Agents|sensory system agents|mesh-ancestor
5862030|NCT02393066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5862031|NCT02393066|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5862032|NCT02393066|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5862033|NCT02393066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5862034|NCT02393066|Adrenergic Agents|adrenergic agents|mesh-ancestor
5862035|NCT02393066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5862036|NCT02393066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862037|NCT02392793|Irinotecan|irinotecan|mesh-list
5676189|NCT03529149|Adrenergic Agents|adrenergic agents|mesh-ancestor
5676190|NCT03529123|Insulin|insulin|mesh-list
5676191|NCT03529123|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5676192|NCT03529123|Metformin|metformin|mesh-list
5676193|NCT03529123|Insulin Glargine|insulin glargine|mesh-list
5676194|NCT03529123|Insulin glulisine|insulin glulisine|mesh-list
5676195|NCT03529123|Lixisenatide|lixisenatide|mesh-list
5676196|NCT03529123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5676197|NCT03529123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676198|NCT03529097|Dipyrone|dipyrone|mesh-list
5676199|NCT03529097|Diclofenac|diclofenac|mesh-list
5676200|NCT03529097|Morphine|morphine|mesh-list
5676201|NCT03529097|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5676202|NCT03529097|Narcotics|narcotics|mesh-ancestor
5676203|NCT03529097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5676204|NCT03529097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676205|NCT03529097|Analgesics|analgesics|mesh-ancestor
5676206|NCT03529097|Sensory System Agents|sensory system agents|mesh-ancestor
5676207|NCT03529097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5676208|NCT03529097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5676209|NCT03529097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5676210|NCT03529097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5676211|NCT03529097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5676212|NCT03529097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5862038|NCT02392793|Temozolomide|temozolomide|mesh-list
5862039|NCT02392793|Talazoparib|talazoparib|mesh-list
5862040|NCT02392793|Lenograstim|lenograstim|mesh-list
5862041|NCT02392793|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5862042|NCT02392793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5862043|NCT02392793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5862044|NCT02392793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862045|NCT02392793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5862046|NCT02392793|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5862047|NCT02392793|Immunologic Factors|immunologic factors|mesh-ancestor
5862048|NCT02392793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676213|NCT03529097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5676214|NCT03529097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676215|NCT03529097|Antipyretics|antipyretics|mesh-ancestor
5862049|NCT02392793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5862050|NCT02392793|Alkylating Agents|alkylating agents|mesh-ancestor
5862051|NCT02392793|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5862052|NCT02392572|Cytarabine|cytarabine|mesh-list
5862053|NCT02392572|TIC10 compound|tic10 compound|mesh-list
5862054|NCT02392572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5676216|NCT03529084|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5862055|NCT02392572|Antimetabolites|antimetabolites|mesh-ancestor
5862056|NCT02392572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862057|NCT02392572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5862058|NCT02392572|Antiviral Agents|antiviral agents|mesh-ancestor
5862059|NCT02392572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5862060|NCT02392572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5862061|NCT02392572|Immunologic Factors|immunologic factors|mesh-ancestor
5862062|NCT02392572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862063|NCT02392390|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
5862064|NCT02392390|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5862065|NCT02392390|Dermatologic Agents|dermatologic agents|mesh-ancestor
5862066|NCT02392520|Cetrorelix|cetrorelix|mesh-list
5862067|NCT02392520|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5862068|NCT02392520|Fertility Agents|fertility agents|mesh-ancestor
5862069|NCT02392520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5862070|NCT02392520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862071|NCT02392520|Hormone Antagonists|hormone antagonists|mesh-ancestor
5862072|NCT02392520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5862073|NCT02392702|Ivacaftor|ivacaftor|mesh-list
5862074|NCT02392702|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
5862075|NCT02392702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5862076|NCT02392702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862077|NCT02392468|BI 409306|bi 409306|mesh-list
5862078|NCT02392468|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5862079|NCT02392468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5862080|NCT02392468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862081|NCT02392364|Aflibercept|aflibercept|mesh-list
5862082|NCT02392364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5862083|NCT02392364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5862084|NCT02392364|Growth Substances|growth substances|mesh-ancestor
5862085|NCT02392364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862086|NCT02392364|Growth Inhibitors|growth inhibitors|mesh-ancestor
5862087|NCT02392364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5862088|NCT02392663|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5862089|NCT02392676|Olaparib|olaparib|mesh-list
5862090|NCT02392676|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5862091|NCT02392676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5862092|NCT02392676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862093|NCT02392676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5862094|NCT02392117|Insulin|insulin|mesh-list
5862095|NCT02392117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5862096|NCT02392117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862097|NCT02392039|Loratadine|loratadine|mesh-list
5862098|NCT02392039|Antipruritics|antipruritics|mesh-ancestor
5862099|NCT02392039|Dermatologic Agents|dermatologic agents|mesh-ancestor
5862100|NCT02392039|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5862101|NCT02392039|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5862102|NCT02392039|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5862103|NCT02392039|Histamine Antagonists|histamine antagonists|mesh-ancestor
5862104|NCT02392039|Histamine Agents|histamine agents|mesh-ancestor
5862105|NCT02392039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5862106|NCT02392039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862107|NCT02392039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862108|NCT02392130|Clobetasol|clobetasol|mesh-list
5862109|NCT02392130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5862110|NCT02392130|Glucocorticoids|glucocorticoids|mesh-ancestor
5862111|NCT02392130|Hormones|hormones|mesh-ancestor
5862112|NCT02392130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5862113|NCT02392130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862114|NCT02392156|Factor VIII|factor viii|mesh-list
5862115|NCT02392156|Coagulants|coagulants|mesh-ancestor
5862116|NCT02392169|Methylphenidate|methylphenidate|mesh-list
5862117|NCT02392169|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5862118|NCT02392169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862119|NCT02392169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5862120|NCT02392169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5862121|NCT02392169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5862122|NCT02392169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862123|NCT02392169|Dopamine Agents|dopamine agents|mesh-ancestor
5862124|NCT02392169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5862125|NCT02391844|Oxycodone|oxycodone|mesh-list
5862126|NCT02391844|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5862127|NCT02391844|Narcotics|narcotics|mesh-ancestor
6212278|NCT02185131|Adrenergic Agents|adrenergic agents|mesh-ancestor
5862128|NCT02391844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5862129|NCT02391844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862130|NCT02391844|Analgesics|analgesics|mesh-ancestor
5862131|NCT02391844|Sensory System Agents|sensory system agents|mesh-ancestor
5862132|NCT02391844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5862133|NCT02391883|Clopidogrel|clopidogrel|mesh-list
5862134|NCT02391883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5862135|NCT02391883|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5862136|NCT02391883|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5862137|NCT02391883|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5862138|NCT02391883|Purinergic Agents|purinergic agents|mesh-ancestor
5862139|NCT02391883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5862140|NCT02391883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862141|NCT02391883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862142|NCT02391805|Tenofovir|tenofovir|mesh-list
5862143|NCT02391805|Entecavir|entecavir|mesh-list
5862144|NCT02391805|Antiviral Agents|antiviral agents|mesh-ancestor
5862145|NCT02391805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5862146|NCT02391805|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5862147|NCT02391805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5862148|NCT02391805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5862149|NCT02391805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862150|NCT02391805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5862151|NCT02391805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5862152|NCT02391662|Gemcitabine|gemcitabine|mesh-list
5862153|NCT02391662|Paclitaxel|paclitaxel|mesh-list
5862154|NCT02391662|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5862155|NCT02391662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5862156|NCT02391662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5862157|NCT02391662|Tubulin Modulators|tubulin modulators|mesh-ancestor
5862158|NCT02391662|Antimitotic Agents|antimitotic agents|mesh-ancestor
5862159|NCT02391662|Mitosis Modulators|mitosis modulators|mesh-ancestor
5862160|NCT02391662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862161|NCT02391662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5862162|NCT02391662|Antimetabolites|antimetabolites|mesh-ancestor
5862163|NCT02391662|Antiviral Agents|antiviral agents|mesh-ancestor
5862164|NCT02391662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5862165|NCT02391662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5862166|NCT02391662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5862167|NCT02391662|Immunologic Factors|immunologic factors|mesh-ancestor
5862168|NCT02391662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862169|NCT02391688|Fexofenadine|fexofenadine|mesh-list
5862170|NCT02391688|Flurbiprofen|flurbiprofen|mesh-list
5862171|NCT02391688|Midazolam|midazolam|mesh-list
5862172|NCT02391688|Dextromethorphan|dextromethorphan|mesh-list
5862173|NCT02391688|Caffeine|caffeine|mesh-list
5862174|NCT02391688|Bupropion|bupropion|mesh-list
5862175|NCT02391688|Omeprazole|omeprazole|mesh-list
5862176|NCT02391688|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5862177|NCT02391688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5862178|NCT02391688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5862179|NCT02391688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862180|NCT02391688|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5862181|NCT02391688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5862182|NCT02391688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5862183|NCT02391688|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6494617|NCT00619333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5862184|NCT02391688|Anesthetics, General|anesthetics, general|mesh-ancestor
5862185|NCT02391688|Anesthetics|anesthetics|mesh-ancestor
5862186|NCT02391688|GABA Modulators|gaba modulators|mesh-ancestor
5862187|NCT02391688|GABA Agents|gaba agents|mesh-ancestor
5862188|NCT02391688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5862189|NCT02391688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862190|NCT02391688|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5862191|NCT02391688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5862192|NCT02391688|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5862193|NCT02391688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5862194|NCT02391688|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5862195|NCT02391688|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5862196|NCT02391688|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5862197|NCT02391688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5862198|NCT02391688|Purinergic Agents|purinergic agents|mesh-ancestor
5862199|NCT02391688|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5862200|NCT02391688|Antidepressive Agents|antidepressive agents|mesh-ancestor
5862201|NCT02391688|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5862202|NCT02391688|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5862203|NCT02391688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5862204|NCT02391688|Dopamine Agents|dopamine agents|mesh-ancestor
5862205|NCT02391688|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5862206|NCT02391688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5862207|NCT02391688|Antitussive Agents|antitussive agents|mesh-ancestor
5862208|NCT02391688|Respiratory System Agents|respiratory system agents|mesh-ancestor
5862209|NCT02391688|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5862210|NCT02391688|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5862211|NCT02391688|Analgesics|analgesics|mesh-ancestor
5862212|NCT02391688|Sensory System Agents|sensory system agents|mesh-ancestor
5862213|NCT02391688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5862214|NCT02391688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5862215|NCT02391688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5862216|NCT02391688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5862217|NCT02391688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5862218|NCT02391688|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5862219|NCT02391688|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5862220|NCT02391688|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5862221|NCT02391688|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5862222|NCT02391688|Histamine Antagonists|histamine antagonists|mesh-ancestor
5862223|NCT02391688|Histamine Agents|histamine agents|mesh-ancestor
5862224|NCT02391636|Oxytocin|oxytocin|mesh-list
5862225|NCT02391636|Carbetocin|carbetocin|mesh-list
5862226|NCT02391636|Oxytocics|oxytocics|mesh-ancestor
5862227|NCT02391636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5862228|NCT02391636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494618|NCT00619333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494619|NCT00619346|Pafuramidine|pafuramidine|mesh-list
6494620|NCT00619346|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6494621|NCT00619346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6494622|NCT00619346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6494623|NCT00619346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6494624|NCT00619372|Muromonab-CD3|muromonab-cd3|mesh-list
5676217|NCT03529084|Gefitinib|gefitinib|mesh-list
5862229|NCT02391480|Venetoclax|venetoclax|mesh-list
5862230|NCT02391480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5904797|NCT04414475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5904798|NCT04414475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5904799|NCT04401995|Nivolumab|nivolumab|mesh-list
5904800|NCT04401995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5904801|NCT04401995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5904802|NCT04401995|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5904803|NCT04401995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908498|NCT04478019|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5908499|NCT04478019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5908500|NCT04471428|Docetaxel|docetaxel|mesh-list
6494625|NCT00619372|Immunologic Factors|immunologic factors|mesh-ancestor
5676218|NCT03529084|Nazartinib|nazartinib|mesh-list
5676219|NCT03529084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5676220|NCT03529084|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5676221|NCT03529084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5676222|NCT03529084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676223|NCT03529032|Methadone|methadone|mesh-list
5676224|NCT03529032|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5676225|NCT03529032|Narcotics|narcotics|mesh-ancestor
5676226|NCT03529032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5676227|NCT03529032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676228|NCT03529032|Analgesics|analgesics|mesh-ancestor
5676229|NCT03529032|Sensory System Agents|sensory system agents|mesh-ancestor
5676230|NCT03529032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5676231|NCT03529032|Antitussive Agents|antitussive agents|mesh-ancestor
5676232|NCT03529032|Respiratory System Agents|respiratory system agents|mesh-ancestor
5676233|NCT03528967|Aspirin|aspirin|mesh-list
5676234|NCT03528967|Enoxaparin|enoxaparin|mesh-list
5676235|NCT03528967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5676236|NCT03528967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5676237|NCT03528967|Analgesics|analgesics|mesh-ancestor
5676238|NCT03528967|Sensory System Agents|sensory system agents|mesh-ancestor
5676239|NCT03528967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5676240|NCT03528967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676241|NCT03528967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5676242|NCT03528967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5676243|NCT03528967|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5676244|NCT03528967|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5862231|NCT02391181|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
5862232|NCT02391181|Hematinics|hematinics|mesh-ancestor
5862233|NCT02391077|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5862234|NCT02391077|Chlorhexidine|chlorhexidine|mesh-list
5862235|NCT02391077|Povidone-Iodine|povidone-iodine|mesh-list
5862236|NCT02391077|Povidone|povidone|mesh-list
5862237|NCT02391077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5862238|NCT02391077|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5862239|NCT02391077|Disinfectants|disinfectants|mesh-ancestor
5676245|NCT03528967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676246|NCT03528967|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5676247|NCT03528967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5676248|NCT03528967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5676249|NCT03528967|Antipyretics|antipyretics|mesh-ancestor
5676250|NCT03528967|Anticoagulants|anticoagulants|mesh-ancestor
5862240|NCT02391077|Plasma Substitutes|plasma substitutes|mesh-ancestor
5862241|NCT02391077|Blood Substitutes|blood substitutes|mesh-ancestor
5862242|NCT02391142|Lidocaine|lidocaine|mesh-list
5862243|NCT02391142|Ropivacaine|ropivacaine|mesh-list
5862244|NCT02391142|Anesthetics, Local|anesthetics, local|mesh-ancestor
5676251|NCT03528954|Propofol|propofol|mesh-list
5676252|NCT03528954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5676253|NCT03528954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5676254|NCT03528954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676255|NCT03528954|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5676256|NCT03528954|Anesthetics, General|anesthetics, general|mesh-ancestor
5676257|NCT03528954|Anesthetics|anesthetics|mesh-ancestor
5676258|NCT03528941|Lamivudine|lamivudine|mesh-list
5676259|NCT03528941|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5862245|NCT02391142|Anesthetics|anesthetics|mesh-ancestor
5862246|NCT02391142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5862247|NCT02391142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862248|NCT02391142|Sensory System Agents|sensory system agents|mesh-ancestor
5862249|NCT02391142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5862250|NCT02391142|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5862251|NCT02391142|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5862252|NCT02391142|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5862253|NCT02391142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5862254|NCT02391142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862255|NCT02390921|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
5862256|NCT02390921|Hematinics|hematinics|mesh-ancestor
5862257|NCT02390882|Tamsulosin|tamsulosin|mesh-list
5862258|NCT02390882|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5862259|NCT02390882|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5862260|NCT02390882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5862261|NCT02390882|Adrenergic Agents|adrenergic agents|mesh-ancestor
5862262|NCT02390882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5862263|NCT02390882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862264|NCT02390882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862265|NCT02390882|Urological Agents|urological agents|mesh-ancestor
6494626|NCT00619372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494627|NCT00619372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6494628|NCT00619398|Tacrolimus|tacrolimus|mesh-list
6494629|NCT00619398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5676260|NCT03528941|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5676261|NCT03528941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5676262|NCT03528941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676263|NCT03528941|Antiviral Agents|antiviral agents|mesh-ancestor
5676264|NCT03528941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5676265|NCT03528941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5676266|NCT03528941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5676267|NCT03528915|Rifamycins|rifamycins|mesh-list
5676268|NCT03528915|Rifamycin SV|rifamycin sv|mesh-list
5676269|NCT03528915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5676270|NCT03528915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5676271|NCT03528915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6494630|NCT00619398|Immunologic Factors|immunologic factors|mesh-ancestor
6494631|NCT00619398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494632|NCT00619398|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6494633|NCT00619398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6494634|NCT00619398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862266|NCT02390700|Golimumab|golimumab|mesh-list
5862267|NCT02390700|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
5862268|NCT02390700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5676272|NCT03528902|Tamoxifen|tamoxifen|mesh-list
5862269|NCT02390700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5862270|NCT02390700|Immunologic Factors|immunologic factors|mesh-ancestor
5862271|NCT02390700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862272|NCT02390635|Deoxyglucose|deoxyglucose|mesh-list
5862273|NCT02390635|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5862274|NCT02390635|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5862275|NCT02390635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862276|NCT02390635|Antimetabolites|antimetabolites|mesh-ancestor
5862277|NCT02390635|Antiviral Agents|antiviral agents|mesh-ancestor
5862278|NCT02390635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5862279|NCT02390674|Cyclosporine|cyclosporine|mesh-list
5862280|NCT02390674|Cyclosporins|cyclosporins|mesh-list
5862281|NCT02390674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6494635|NCT00619424|Pemetrexed|pemetrexed|mesh-list
5676273|NCT03528902|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5676274|NCT03528902|Hormone Antagonists|hormone antagonists|mesh-ancestor
5676275|NCT03528902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5676276|NCT03528902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676277|NCT03528902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5676278|NCT03528902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5676279|NCT03528902|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5676280|NCT03528902|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5676281|NCT03528902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5676282|NCT03528824|Diclofenac|diclofenac|mesh-list
5676283|NCT03528824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5676284|NCT03528824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5676285|NCT03528824|Analgesics|analgesics|mesh-ancestor
5676286|NCT03528824|Sensory System Agents|sensory system agents|mesh-ancestor
5676287|NCT03528824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5676288|NCT03528824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862282|NCT02390674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494636|NCT00619424|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6494637|NCT00619424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6494638|NCT00619424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6494639|NCT00619424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494640|NCT00619424|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6494641|NCT00619424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6494642|NCT00619424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6494643|NCT00619528|Alemtuzumab|alemtuzumab|mesh-list
5862283|NCT02390674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5862284|NCT02390674|Immunologic Factors|immunologic factors|mesh-ancestor
5862285|NCT02390674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862286|NCT02390674|Antifungal Agents|antifungal agents|mesh-ancestor
5862287|NCT02390674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5862288|NCT02390674|Dermatologic Agents|dermatologic agents|mesh-ancestor
5862289|NCT02390674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5862290|NCT02390674|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5862291|NCT02390739|Aldesleukin|aldesleukin|mesh-list
5862292|NCT02390739|Cyclophosphamide|cyclophosphamide|mesh-list
5862293|NCT02390739|Fludarabine|fludarabine|mesh-list
5862294|NCT02390739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5862295|NCT02390739|Immunologic Factors|immunologic factors|mesh-ancestor
5862296|NCT02390739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862297|NCT02390739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5862298|NCT02390739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5862299|NCT02390739|Alkylating Agents|alkylating agents|mesh-ancestor
6494644|NCT00619528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6494645|NCT00619528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6494646|NCT00619541|Fluorouracil|fluorouracil|mesh-list
6494647|NCT00619541|Sorafenib|sorafenib|mesh-list
6494648|NCT00619541|Antimetabolites|antimetabolites|mesh-ancestor
5862300|NCT02390739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862301|NCT02390739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5862302|NCT02390739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5862303|NCT02390739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5862304|NCT02390739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5862305|NCT02390739|Antiviral Agents|antiviral agents|mesh-ancestor
5862306|NCT02390739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5862307|NCT02390843|Cyclophosphamide|cyclophosphamide|mesh-list
5862308|NCT02390843|Topotecan|topotecan|mesh-list
5862309|NCT02390843|Simvastatin|simvastatin|mesh-list
5862310|NCT02390843|Sargramostim|sargramostim|mesh-list
5862311|NCT02390843|Lenograstim|lenograstim|mesh-list
5862312|NCT02390843|Mitogens|mitogens|mesh-list
5862313|NCT02390843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5862314|NCT02390843|Immunologic Factors|immunologic factors|mesh-ancestor
6494649|NCT00619541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676289|NCT03528824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5676290|NCT03528824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5676291|NCT03528824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5676292|NCT03528824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5676293|NCT03528824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676294|NCT03528785|Leucovorin|leucovorin|mesh-list
5676295|NCT03528785|Oxaliplatin|oxaliplatin|mesh-list
5862315|NCT02390843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862316|NCT02390843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5862317|NCT02390843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5862318|NCT02390843|Alkylating Agents|alkylating agents|mesh-ancestor
5862319|NCT02390843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862320|NCT02390843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5862321|NCT02390843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5676296|NCT03528785|Irinotecan|irinotecan|mesh-list
5676297|NCT03528785|Levoleucovorin|levoleucovorin|mesh-list
5676298|NCT03528785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5676299|NCT03528785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5676300|NCT03528785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5676301|NCT03528785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5676302|NCT03528785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676303|NCT03528785|Antidotes|antidotes|mesh-ancestor
5676304|NCT03528785|Protective Agents|protective agents|mesh-ancestor
5676305|NCT03528785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676306|NCT03528785|Vitamin B Complex|vitamin b complex|mesh-ancestor
5676307|NCT03528785|Vitamins|vitamins|mesh-ancestor
5676308|NCT03528785|Micronutrients|micronutrients|mesh-ancestor
5676309|NCT03528772|Minoxidil|minoxidil|mesh-list
5676310|NCT03528772|Nitroglycerin|nitroglycerin|mesh-list
5862322|NCT02390843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5862323|NCT02390843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5862324|NCT02390843|Antimetabolites|antimetabolites|mesh-ancestor
5862325|NCT02390843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5862326|NCT02390843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5862327|NCT02390843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5862328|NCT02390843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5862329|NCT02390843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5862330|NCT02390843|Mitosis Modulators|mitosis modulators|mesh-ancestor
5862331|NCT02390843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5862332|NCT02390544|Melphalan|melphalan|mesh-list
5862333|NCT02390544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5862334|NCT02390544|Alkylating Agents|alkylating agents|mesh-ancestor
5862335|NCT02390544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862336|NCT02390544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5862337|NCT02390544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5862338|NCT02390544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5862339|NCT02390544|Immunologic Factors|immunologic factors|mesh-ancestor
5862340|NCT02390544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862341|NCT02390817|Neostigmine|neostigmine|mesh-list
5862342|NCT02390817|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5862343|NCT02390817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5862344|NCT02390817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862345|NCT02390817|Cholinergic Agents|cholinergic agents|mesh-ancestor
5862346|NCT02390817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5862347|NCT02390817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862348|NCT02390817|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5862349|NCT02390817|Autonomic Agents|autonomic agents|mesh-ancestor
5862350|NCT02390817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5862351|NCT02390596|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5862352|NCT02390596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5862353|NCT02390505|Ascorbic Acid|ascorbic acid|mesh-list
5862354|NCT02390505|Vitamins|vitamins|mesh-ancestor
5862355|NCT02390505|Micronutrients|micronutrients|mesh-ancestor
5862356|NCT02390505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862357|NCT02390505|Antioxidants|antioxidants|mesh-ancestor
5862358|NCT02390505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862359|NCT02390505|Protective Agents|protective agents|mesh-ancestor
5862360|NCT02390440|Bupivacaine|bupivacaine|mesh-list
5862361|NCT02390440|Anesthetics, Local|anesthetics, local|mesh-ancestor
5862362|NCT02390440|Anesthetics|anesthetics|mesh-ancestor
5862363|NCT02390440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5862364|NCT02390440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676311|NCT03528772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5676312|NCT03528772|Vasodilator Agents|vasodilator agents|mesh-ancestor
5676313|NCT03528616|Propranolol|propranolol|mesh-list
5676314|NCT03528616|Digoxin|digoxin|mesh-list
5676315|NCT03528616|Adenosine|adenosine|mesh-list
5676316|NCT03528616|Amiodarone|amiodarone|mesh-list
5676317|NCT03528616|Flecainide|flecainide|mesh-list
5676318|NCT03528616|Procainamide|procainamide|mesh-list
5676319|NCT03528616|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5676320|NCT03528616|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5676321|NCT03528616|Adrenergic Agents|adrenergic agents|mesh-ancestor
5676322|NCT03528616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5676323|NCT03528616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676324|NCT03528616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676325|NCT03528616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5676326|NCT03528616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5676327|NCT03528616|Vasodilator Agents|vasodilator agents|mesh-ancestor
5676328|NCT03528616|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5676329|NCT03528616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5676330|NCT03528616|Protective Agents|protective agents|mesh-ancestor
5676331|NCT03528616|Analgesics|analgesics|mesh-ancestor
5676332|NCT03528616|Sensory System Agents|sensory system agents|mesh-ancestor
5676333|NCT03528616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5676334|NCT03528616|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5676335|NCT03528616|Purinergic Agonists|purinergic agonists|mesh-ancestor
5676336|NCT03528616|Purinergic Agents|purinergic agents|mesh-ancestor
5676337|NCT03528616|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5676338|NCT03528616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5676339|NCT03528616|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5676340|NCT03528616|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5676341|NCT03528616|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5862365|NCT02390440|Sensory System Agents|sensory system agents|mesh-ancestor
5862366|NCT02390440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5862367|NCT02390375|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5862368|NCT02390375|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5862369|NCT02390375|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5862370|NCT02390375|Antimetabolites|antimetabolites|mesh-ancestor
5862371|NCT02390375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862372|NCT02390375|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5676342|NCT03528616|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5676343|NCT03528616|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5676344|NCT03528616|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5676345|NCT03528616|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5676346|NCT03528564|Epoetin Alfa|epoetin alfa|mesh-list
5676347|NCT03528564|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
5676348|NCT03528564|Hematinics|hematinics|mesh-ancestor
5676349|NCT03528538|Fenugreek seed meal|fenugreek seed meal|mesh-list
5676350|NCT03528538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5862373|NCT02390375|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5862374|NCT02390375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5862375|NCT02390258|S66913|s66913|mesh-list
5862376|NCT02390258|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5862377|NCT02390258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5862378|NCT02390258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862379|NCT02390310|Lidocaine|lidocaine|mesh-list
5862380|NCT02390310|Prilocaine|prilocaine|mesh-list
5862381|NCT02390310|Anesthetics|anesthetics|mesh-list
5862382|NCT02390310|Anesthetics, Local|anesthetics, local|mesh-ancestor
5862383|NCT02390310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5862384|NCT02390310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862385|NCT02390310|Sensory System Agents|sensory system agents|mesh-ancestor
5862386|NCT02390310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5862387|NCT02390310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5862388|NCT02390310|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5862389|NCT02390310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5862390|NCT02390310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5676351|NCT03528538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676352|NCT03528421|Cyclophosphamide|cyclophosphamide|mesh-list
5676353|NCT03528421|Fludarabine|fludarabine|mesh-list
5676354|NCT03528421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5676355|NCT03528421|Immunologic Factors|immunologic factors|mesh-ancestor
5676356|NCT03528421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676357|NCT03528421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5676358|NCT03528421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5676359|NCT03528421|Alkylating Agents|alkylating agents|mesh-ancestor
5676360|NCT03528421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676361|NCT03528421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5676362|NCT03528421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5676363|NCT03528070|Tranilast|tranilast|mesh-list
5676364|NCT03528070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5676365|NCT03528070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5676366|NCT03528070|Analgesics|analgesics|mesh-ancestor
5676367|NCT03528070|Sensory System Agents|sensory system agents|mesh-ancestor
5676368|NCT03528070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5676369|NCT03528070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676370|NCT03528070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5676371|NCT03528070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5676372|NCT03528070|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5676373|NCT03528070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5676374|NCT03528070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676375|NCT03528070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5676376|NCT03528070|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5676377|NCT03528070|Histamine Antagonists|histamine antagonists|mesh-ancestor
5676378|NCT03528070|Histamine Agents|histamine agents|mesh-ancestor
5676379|NCT03528070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5676380|NCT03528070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5676381|NCT03528070|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5676382|NCT03528057|Hemostatics|hemostatics|mesh-list
5676383|NCT03528057|Coagulants|coagulants|mesh-ancestor
5676384|NCT03527927|Muscarinic Antagonists|muscarinic antagonists|mesh-list
5676385|NCT03527927|Cholinergic Agents|cholinergic agents|mesh-ancestor
5676386|NCT03527927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5676387|NCT03527927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676388|NCT03527927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676389|NCT03527927|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5676390|NCT03527836|Lidocaine|lidocaine|mesh-list
5676391|NCT03527836|Bupivacaine|bupivacaine|mesh-list
5676392|NCT03527836|Anesthetics, Local|anesthetics, local|mesh-ancestor
5676393|NCT03527836|Anesthetics|anesthetics|mesh-ancestor
5676394|NCT03527836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5676395|NCT03527836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676396|NCT03527836|Sensory System Agents|sensory system agents|mesh-ancestor
5676397|NCT03527836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5676398|NCT03527836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5676399|NCT03527836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5676400|NCT03527836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5676401|NCT03527836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5676402|NCT03527836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676403|NCT03527732|Ivermectin|ivermectin|mesh-list
5676404|NCT03527732|Albendazole|albendazole|mesh-list
5676405|NCT03527732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5676406|NCT03527732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5676407|NCT03527732|Anthelmintics|anthelmintics|mesh-ancestor
5676408|NCT03527732|Anticestodal Agents|anticestodal agents|mesh-ancestor
5676409|NCT03527732|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5676410|NCT03527732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5676411|NCT03527732|Tubulin Modulators|tubulin modulators|mesh-ancestor
5676412|NCT03527732|Antimitotic Agents|antimitotic agents|mesh-ancestor
5676413|NCT03527732|Mitosis Modulators|mitosis modulators|mesh-ancestor
5862391|NCT02390310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862392|NCT02390102|Epoetin Alfa|epoetin alfa|mesh-list
5862393|NCT02390102|Hematinics|hematinics|mesh-ancestor
5862394|NCT02390089|Capsaicin|capsaicin|mesh-list
5862395|NCT02390089|Antipruritics|antipruritics|mesh-ancestor
5862396|NCT02390089|Dermatologic Agents|dermatologic agents|mesh-ancestor
5862397|NCT02390089|Sensory System Agents|sensory system agents|mesh-ancestor
5862398|NCT02390089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5862399|NCT02390089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862400|NCT02389842|Palbociclib|palbociclib|mesh-list
6494650|NCT00619541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6494651|NCT00619541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6494652|NCT00619541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6494653|NCT00619541|Immunologic Factors|immunologic factors|mesh-ancestor
6494654|NCT00619541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494655|NCT00619541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6494656|NCT00619541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6494657|NCT00619671|Rituximab|rituximab|mesh-list
5862401|NCT02389842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6494658|NCT00619671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5676414|NCT03527732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676415|NCT03527732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5696496|NCT03382756|Choline|choline|mesh-list
5862402|NCT02389842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5862403|NCT02389842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5862404|NCT02389842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862405|NCT02389972|Dasatinib|dasatinib|mesh-list
5862406|NCT02389972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5862407|NCT02389972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5862408|NCT02389972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5862409|NCT02389972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862410|NCT02389751|Paclitaxel|paclitaxel|mesh-list
5862411|NCT02389751|Carboplatin|carboplatin|mesh-list
5862412|NCT02389751|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5862413|NCT02389751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5862414|NCT02389751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5862415|NCT02389751|Tubulin Modulators|tubulin modulators|mesh-ancestor
5862416|NCT02389751|Antimitotic Agents|antimitotic agents|mesh-ancestor
5862417|NCT02389751|Mitosis Modulators|mitosis modulators|mesh-ancestor
5862418|NCT02389751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862419|NCT02389868|Lovastatin|lovastatin|mesh-list
5862420|NCT02389868|L 647318|l 647318|mesh-list
5862421|NCT02389868|Dihydromevinolin|dihydromevinolin|mesh-list
5862422|NCT02389868|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5862423|NCT02389868|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5862424|NCT02389868|Antimetabolites|antimetabolites|mesh-ancestor
5862425|NCT02389868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862426|NCT02389868|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5862427|NCT02389868|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5862428|NCT02389868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5862429|NCT02390063|Cyclophosphamide|cyclophosphamide|mesh-list
5862430|NCT02390063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5862431|NCT02390063|Immunologic Factors|immunologic factors|mesh-ancestor
5862432|NCT02390063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862433|NCT02390063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5862434|NCT02390063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5862435|NCT02390063|Alkylating Agents|alkylating agents|mesh-ancestor
5862436|NCT02390063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862437|NCT02390063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5862438|NCT02390063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5862439|NCT02389933|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5862440|NCT02389933|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5862441|NCT02389933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904804|NCT04340947|Nicotine|nicotine|mesh-list
5904805|NCT04340947|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5676416|NCT03527628|Cyclophosphamide|cyclophosphamide|mesh-list
5676417|NCT03527628|Dacarbazine|dacarbazine|mesh-list
5676418|NCT03527628|Doxorubicin|doxorubicin|mesh-list
5676419|NCT03527628|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5676420|NCT03527628|Bleomycin|bleomycin|mesh-list
5676421|NCT03527628|Vinblastine|vinblastine|mesh-list
5676422|NCT03527628|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5676423|NCT03527628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5676424|NCT03527628|Immunologic Factors|immunologic factors|mesh-ancestor
5676425|NCT03527628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676426|NCT03527628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5676427|NCT03527628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5676428|NCT03527628|Alkylating Agents|alkylating agents|mesh-ancestor
5676429|NCT03527628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904806|NCT04340947|Autonomic Agents|autonomic agents|mesh-ancestor
5904807|NCT04340947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5904808|NCT04340947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904809|NCT04340947|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5904810|NCT04340947|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5904811|NCT04340947|Cholinergic Agents|cholinergic agents|mesh-ancestor
5904812|NCT04340947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5904813|NCT04340947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904814|NCT04313608|Gemcitabine|gemcitabine|mesh-list
5904815|NCT04313608|Oxaliplatin|oxaliplatin|mesh-list
5904816|NCT04313608|Obinutuzumab|obinutuzumab|mesh-list
5904817|NCT04313608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5904818|NCT04313608|Antimetabolites|antimetabolites|mesh-ancestor
5904819|NCT04313608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904820|NCT04313608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5904821|NCT04313608|Antiviral Agents|antiviral agents|mesh-ancestor
5676430|NCT03527628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5676431|NCT03527628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5676432|NCT03527628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5676433|NCT03527628|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5676434|NCT03527628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5676435|NCT03527628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5676436|NCT03527628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5676437|NCT03527628|Tubulin Modulators|tubulin modulators|mesh-ancestor
5676438|NCT03527628|Antimitotic Agents|antimitotic agents|mesh-ancestor
5676439|NCT03527628|Mitosis Modulators|mitosis modulators|mesh-ancestor
5676440|NCT03527628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5676441|NCT03527576|Dexamethasone|dexamethasone|mesh-list
5676442|NCT03527576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5676443|NCT03527576|Antiemetics|antiemetics|mesh-ancestor
5676444|NCT03527576|Autonomic Agents|autonomic agents|mesh-ancestor
5676445|NCT03527576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5676446|NCT03527576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676447|NCT03527576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5676448|NCT03527576|Glucocorticoids|glucocorticoids|mesh-ancestor
5676449|NCT03527576|Hormones|hormones|mesh-ancestor
5676450|NCT03527576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5676451|NCT03527576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5676452|NCT03527576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5862442|NCT02389582|Enoxaparin|enoxaparin|mesh-list
5862443|NCT02389582|Dabigatran|dabigatran|mesh-list
5862444|NCT02389582|Anticoagulants|anticoagulants|mesh-ancestor
5862445|NCT02389582|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5862446|NCT02389582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5862447|NCT02389582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862448|NCT02389582|Antithrombins|antithrombins|mesh-ancestor
5862449|NCT02389582|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5862450|NCT02389582|Protease Inhibitors|protease inhibitors|mesh-ancestor
5862451|NCT02389582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5862452|NCT02389543|Dexamethasone|dexamethasone|mesh-list
5862453|NCT02389543|Lenalidomide|lenalidomide|mesh-list
5862454|NCT02389543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5862455|NCT02389543|Antiemetics|antiemetics|mesh-ancestor
5862456|NCT02389543|Autonomic Agents|autonomic agents|mesh-ancestor
5862457|NCT02389543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5862458|NCT02389543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862459|NCT02389543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5862460|NCT02389543|Glucocorticoids|glucocorticoids|mesh-ancestor
5862461|NCT02389543|Hormones|hormones|mesh-ancestor
5862462|NCT02389543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5862463|NCT02389543|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5862464|NCT02389543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5862465|NCT02389543|Immunologic Factors|immunologic factors|mesh-ancestor
5862466|NCT02389543|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5862467|NCT02389543|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5862468|NCT02389543|Growth Substances|growth substances|mesh-ancestor
5862469|NCT02389543|Growth Inhibitors|growth inhibitors|mesh-ancestor
5862470|NCT02389400|Methotrexate|methotrexate|mesh-list
5862471|NCT02389400|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5862472|NCT02389400|Abortifacient Agents|abortifacient agents|mesh-ancestor
5862473|NCT02389400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5862474|NCT02389400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862475|NCT02389400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5862476|NCT02389400|Antimetabolites|antimetabolites|mesh-ancestor
5862477|NCT02389400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862478|NCT02389400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5862479|NCT02389400|Dermatologic Agents|dermatologic agents|mesh-ancestor
5862480|NCT02389400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5862481|NCT02389400|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5862482|NCT02389400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5862483|NCT02389400|Immunologic Factors|immunologic factors|mesh-ancestor
5862484|NCT02389400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5862485|NCT02389400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5862486|NCT02389439|Artesunate|artesunate|mesh-list
5862487|NCT02389439|Pyronaridine|pyronaridine|mesh-list
5862488|NCT02389439|Antimalarials|antimalarials|mesh-ancestor
5862489|NCT02389439|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5862490|NCT02389439|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5676453|NCT03527381|Nitric Oxide|nitric oxide|mesh-list
5676454|NCT03527381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5676455|NCT03527381|Autonomic Agents|autonomic agents|mesh-ancestor
5676456|NCT03527381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5676457|NCT03527381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676458|NCT03527381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5676459|NCT03527381|Respiratory System Agents|respiratory system agents|mesh-ancestor
5676460|NCT03527381|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5676461|NCT03527381|Antioxidants|antioxidants|mesh-ancestor
5676462|NCT03527381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676463|NCT03527381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5676464|NCT03527381|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5676465|NCT03527381|Vasodilator Agents|vasodilator agents|mesh-ancestor
5676466|NCT03527381|Gasotransmitters|gasotransmitters|mesh-ancestor
5676467|NCT03527381|Protective Agents|protective agents|mesh-ancestor
5676468|NCT03527355|Vaccines|vaccines|mesh-list
5676469|NCT03527355|Immunologic Factors|immunologic factors|mesh-ancestor
5862491|NCT02389439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5862492|NCT02389439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5862493|NCT02389439|Antiviral Agents|antiviral agents|mesh-ancestor
5862494|NCT02389439|Schistosomicides|schistosomicides|mesh-ancestor
5862495|NCT02389439|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5862496|NCT02389439|Anthelmintics|anthelmintics|mesh-ancestor
5862497|NCT02389426|Bosentan|bosentan|mesh-list
5862498|NCT02389426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5862499|NCT02389426|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5862500|NCT02389426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862501|NCT02389348|Artefenomel|artefenomel|mesh-list
5862502|NCT02389348|Antimalarials|antimalarials|mesh-ancestor
5862503|NCT02389348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5862504|NCT02389348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5862505|NCT02389348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5862506|NCT02389322|BCG Vaccine|bcg vaccine|mesh-list
5862507|NCT02389322|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5862508|NCT02389322|Immunologic Factors|immunologic factors|mesh-ancestor
5862509|NCT02389322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862510|NCT02389309|Sirolimus|sirolimus|mesh-list
5862511|NCT02389309|Cyclophosphamide|cyclophosphamide|mesh-list
5862512|NCT02389309|Dasatinib|dasatinib|mesh-list
5862513|NCT02389309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5862514|NCT02389309|Immunologic Factors|immunologic factors|mesh-ancestor
5862515|NCT02389309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862516|NCT02389309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5862517|NCT02389309|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5862518|NCT02389309|Alkylating Agents|alkylating agents|mesh-ancestor
5862519|NCT02389309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862520|NCT02389309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5862521|NCT02389309|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5862522|NCT02389309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5676470|NCT03527355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676471|NCT03527264|Nivolumab|nivolumab|mesh-list
5676472|NCT03527264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5676473|NCT03527264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5676474|NCT03527264|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5676475|NCT03527264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676476|NCT03527251|Ipilimumab|ipilimumab|mesh-list
5676477|NCT03527251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5676478|NCT03527251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5676479|NCT03527251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5676480|NCT03527251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862523|NCT02389309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5862524|NCT02389309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5862525|NCT02389309|Antifungal Agents|antifungal agents|mesh-ancestor
5862526|NCT02389309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5862527|NCT02389309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5862528|NCT02389231|Interleukin-2|interleukin-2|mesh-list
5862529|NCT02389231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5862530|NCT02389231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5862531|NCT02389231|Analgesics|analgesics|mesh-ancestor
5862532|NCT02389231|Sensory System Agents|sensory system agents|mesh-ancestor
5862533|NCT02389231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5862534|NCT02389231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862535|NCT02389218|Sotalol|sotalol|mesh-list
5862536|NCT02389218|Flecainide|flecainide|mesh-list
5862537|NCT02389218|Propafenone|propafenone|mesh-list
5862538|NCT02389218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5862539|NCT02389218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6494659|NCT00619671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6494660|NCT00619671|Immunologic Factors|immunologic factors|mesh-ancestor
6494661|NCT00619671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494662|NCT00619671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6494663|NCT00619697|Insulin|insulin|mesh-list
5676481|NCT03527147|Rituximab|rituximab|mesh-list
5676482|NCT03527147|Magrolimab|magrolimab|mesh-list
5676483|NCT03527147|Acalabrutinib|acalabrutinib|mesh-list
5676484|NCT03527147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5676485|NCT03527147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5676486|NCT03527147|Immunologic Factors|immunologic factors|mesh-ancestor
5676487|NCT03527147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676488|NCT03527147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5676489|NCT03527134|Amantadine|amantadine|mesh-list
5676490|NCT03527134|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5676491|NCT03527134|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5676492|NCT03527134|Antiviral Agents|antiviral agents|mesh-ancestor
5676493|NCT03527134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5676494|NCT03527134|Dopamine Agents|dopamine agents|mesh-ancestor
5676495|NCT03527134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5676496|NCT03527134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494664|NCT00619697|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6494665|NCT00619697|Metformin|metformin|mesh-list
6494666|NCT00619697|Insulin Glargine|insulin glargine|mesh-list
6494667|NCT00619697|Insulin Aspart|insulin aspart|mesh-list
6494668|NCT00619697|Glimepiride|glimepiride|mesh-list
6494669|NCT00619697|Biphasic Insulins|biphasic insulins|mesh-list
6494670|NCT00619697|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
5862540|NCT02389218|Adrenergic Agents|adrenergic agents|mesh-ancestor
5862541|NCT02389218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5862542|NCT02389218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862543|NCT02389218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862544|NCT02389218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5862545|NCT02389218|Sympatholytics|sympatholytics|mesh-ancestor
5862546|NCT02389218|Autonomic Agents|autonomic agents|mesh-ancestor
5862547|NCT02389218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5862548|NCT02389218|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5862549|NCT02389218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5862550|NCT02389218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5862551|NCT02389179|Vitamin D|vitamin d|mesh-list
5862552|NCT02389179|Cholecalciferol|cholecalciferol|mesh-list
5862553|NCT02389179|Vitamins|vitamins|mesh-ancestor
5862554|NCT02389179|Micronutrients|micronutrients|mesh-ancestor
5862555|NCT02389179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862556|NCT02389179|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5862557|NCT02389179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5862558|NCT02389036|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5862559|NCT02389036|Ciprofloxacin|ciprofloxacin|mesh-list
5862560|NCT02389036|Ceftriaxone|ceftriaxone|mesh-list
5862561|NCT02389036|Tobramycin|tobramycin|mesh-list
5862562|NCT02389036|Colistin|colistin|mesh-list
5862563|NCT02389036|Nystatin|nystatin|mesh-list
5862564|NCT02389036|Cefotaxime|cefotaxime|mesh-list
5862565|NCT02389036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5862566|NCT02389036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5862567|NCT02389036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5862568|NCT02389036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5862569|NCT02389036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862570|NCT02389036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5862571|NCT02389036|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5676497|NCT03527134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676498|NCT03527134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5676499|NCT03527134|Analgesics|analgesics|mesh-ancestor
5676500|NCT03527134|Sensory System Agents|sensory system agents|mesh-ancestor
5676501|NCT03527134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5676502|NCT03527108|Nivolumab|nivolumab|mesh-list
5676503|NCT03527108|Ramucirumab|ramucirumab|mesh-list
5676504|NCT03527108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5676505|NCT03527108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5676506|NCT03527108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5676507|NCT03527108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676508|NCT03527069|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5676509|NCT03527069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5676510|NCT03527069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5676511|NCT03527069|Antimetabolites|antimetabolites|mesh-ancestor
5676512|NCT03527069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676513|NCT03527069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5676514|NCT03527069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5676515|NCT03527069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5908501|NCT04471428|Atezolizumab|atezolizumab|mesh-list
6494671|NCT00619697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5676516|NCT03527043|Citalopram|citalopram|mesh-list
5676517|NCT03527043|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5676518|NCT03527043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5676519|NCT03527043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5676520|NCT03527043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676521|NCT03527043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5676522|NCT03527043|Serotonin Agents|serotonin agents|mesh-ancestor
5676523|NCT03527043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676524|NCT03527043|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5862572|NCT02389036|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5862573|NCT02389036|Antifungal Agents|antifungal agents|mesh-ancestor
5862574|NCT02389036|Ionophores|ionophores|mesh-ancestor
5862575|NCT02389036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5862576|NCT02388802|Immunosuppressive Agents|immunosuppressive agents|mesh-list
5862577|NCT02388802|Immunologic Factors|immunologic factors|mesh-ancestor
5862578|NCT02388802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862579|NCT02388750|Palonosetron|palonosetron|mesh-list
6675000|NCT01572324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6675001|NCT01572324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6675002|NCT01572324|Immunologic Factors|immunologic factors|mesh-ancestor
6675003|NCT01572324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675004|NCT01572324|Antidotes|antidotes|mesh-ancestor
5676525|NCT03527043|Antidepressive Agents|antidepressive agents|mesh-ancestor
5862580|NCT02388750|Antiemetics|antiemetics|mesh-ancestor
5862581|NCT02388750|Autonomic Agents|autonomic agents|mesh-ancestor
5862582|NCT02388750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5862583|NCT02388750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862584|NCT02388750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5862585|NCT02388750|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5862586|NCT02388750|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5862587|NCT02388750|Serotonin Agents|serotonin agents|mesh-ancestor
5862588|NCT02388750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5862589|NCT02388750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862590|NCT02388594|Cyclophosphamide|cyclophosphamide|mesh-list
5676526|NCT03527043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5676527|NCT03526887|Pembrolizumab|pembrolizumab|mesh-list
5676528|NCT03526887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5676529|NCT03526887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5676530|NCT03526874|Lidocaine|lidocaine|mesh-list
5676531|NCT03526874|Anesthetics, Local|anesthetics, local|mesh-ancestor
5676532|NCT03526874|Anesthetics|anesthetics|mesh-ancestor
5676533|NCT03526874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5676534|NCT03526874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676535|NCT03526874|Sensory System Agents|sensory system agents|mesh-ancestor
5676536|NCT03526874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5676537|NCT03526874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5676538|NCT03526874|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5676539|NCT03526874|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5676540|NCT03526874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5676541|NCT03526874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676542|NCT03526770|Chlorhexidine|chlorhexidine|mesh-list
5676543|NCT03526770|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5862591|NCT02388594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5862592|NCT02388594|Immunologic Factors|immunologic factors|mesh-ancestor
5862593|NCT02388594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862594|NCT02388594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5862595|NCT02388594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5862596|NCT02388594|Alkylating Agents|alkylating agents|mesh-ancestor
5676544|NCT03526770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5676545|NCT03526770|Disinfectants|disinfectants|mesh-ancestor
5676546|NCT03526575|Zaleplon|zaleplon|mesh-list
5676547|NCT03526575|Zolpidem|zolpidem|mesh-list
5676548|NCT03526575|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5676549|NCT03526575|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5676550|NCT03526575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5676551|NCT03526575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676552|NCT03526575|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
5676553|NCT03526575|GABA Agonists|gaba agonists|mesh-ancestor
5676554|NCT03526575|GABA Agents|gaba agents|mesh-ancestor
5676555|NCT03526575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5676556|NCT03526575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676557|NCT03526575|Anticonvulsants|anticonvulsants|mesh-ancestor
5862597|NCT02388594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862598|NCT02388594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5862599|NCT02388594|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5862600|NCT02388581|Amoxicillin|amoxicillin|mesh-list
5862601|NCT02388581|Metronidazole|metronidazole|mesh-list
5676558|NCT03526575|GABA Modulators|gaba modulators|mesh-ancestor
5676559|NCT03526536|Insulin|insulin|mesh-list
5676560|NCT03526536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5676561|NCT03526536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5676562|NCT03526536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676563|NCT03526445|Glucagon|glucagon|mesh-list
5676564|NCT03526445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5676565|NCT03526445|Hormones|hormones|mesh-ancestor
5676566|NCT03526445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5676567|NCT03526445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676568|NCT03526419|Bupivacaine|bupivacaine|mesh-list
5676569|NCT03526419|Anesthetics, Local|anesthetics, local|mesh-ancestor
5676570|NCT03526419|Anesthetics|anesthetics|mesh-ancestor
5676571|NCT03526419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5676572|NCT03526419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676573|NCT03526419|Sensory System Agents|sensory system agents|mesh-ancestor
5676574|NCT03526419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5676575|NCT03526367|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5676576|NCT03526367|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5676577|NCT03526367|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5676578|NCT03526367|Antimetabolites|antimetabolites|mesh-ancestor
5676579|NCT03526367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676580|NCT03526367|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5676581|NCT03526367|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5676582|NCT03526367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5676583|NCT03526315|Fluorides|fluorides|mesh-list
5676584|NCT03526315|Cariostatic Agents|cariostatic agents|mesh-ancestor
5676585|NCT03526315|Protective Agents|protective agents|mesh-ancestor
5676586|NCT03526315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676587|NCT03526276|Fluorides|fluorides|mesh-list
5676588|NCT03526276|Cariostatic Agents|cariostatic agents|mesh-ancestor
5676589|NCT03526276|Protective Agents|protective agents|mesh-ancestor
5676590|NCT03526276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676591|NCT03526224|Teriflunomide|teriflunomide|mesh-list
5676592|NCT03526224|Dimethyl Fumarate|dimethyl fumarate|mesh-list
5676593|NCT03526224|Dermatologic Agents|dermatologic agents|mesh-ancestor
5676594|NCT03526224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5862602|NCT02388581|Clarithromycin|clarithromycin|mesh-list
5862603|NCT02388581|Lansoprazole|lansoprazole|mesh-list
5862604|NCT02388581|Dexlansoprazole|dexlansoprazole|mesh-list
5862605|NCT02388581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5862606|NCT02388581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5862607|NCT02388581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5862608|NCT02388581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5862609|NCT02388581|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5862610|NCT02388581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5862611|NCT02388581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862612|NCT02388581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5862613|NCT02388581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5862614|NCT02388581|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5862615|NCT02388581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5862616|NCT02388581|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5862617|NCT02388490|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5862618|NCT02388490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5862619|NCT02388490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5862620|NCT02388516|Vitamin D|vitamin d|mesh-list
5862621|NCT02388516|Cholecalciferol|cholecalciferol|mesh-list
6675005|NCT01572324|Protective Agents|protective agents|mesh-ancestor
6675006|NCT01572324|Vitamin B Complex|vitamin b complex|mesh-ancestor
6675007|NCT01572324|Vitamins|vitamins|mesh-ancestor
6675008|NCT01572324|Micronutrients|micronutrients|mesh-ancestor
6675009|NCT01572350|Triamcinolone|triamcinolone|mesh-list
6675010|NCT01572350|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6675011|NCT01572350|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5862622|NCT02388516|Vitamins|vitamins|mesh-ancestor
5862623|NCT02388516|Micronutrients|micronutrients|mesh-ancestor
5862624|NCT02388516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862625|NCT02388516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5862626|NCT02388516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5862627|NCT02388477|Doxycycline|doxycycline|mesh-list
5862628|NCT02388477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5862629|NCT02388477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5862630|NCT02388477|Antimalarials|antimalarials|mesh-ancestor
6675012|NCT01572350|Bevacizumab|bevacizumab|mesh-list
5676595|NCT03526224|Immunologic Factors|immunologic factors|mesh-ancestor
5676596|NCT03526224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862631|NCT02388477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5862632|NCT02388477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5862633|NCT02388373|Fluticasone|fluticasone|mesh-list
5862634|NCT02388373|Xhance|xhance|mesh-list
5862635|NCT02388373|Formoterol Fumarate|formoterol fumarate|mesh-list
5862636|NCT02388373|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5862637|NCT02388373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5862638|NCT02388373|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5862639|NCT02388373|Autonomic Agents|autonomic agents|mesh-ancestor
5862640|NCT02388373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5862641|NCT02388373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862642|NCT02388373|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5862643|NCT02388373|Respiratory System Agents|respiratory system agents|mesh-ancestor
5862644|NCT02388373|Dermatologic Agents|dermatologic agents|mesh-ancestor
5862645|NCT02388373|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5676597|NCT03526224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5676598|NCT03526224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5676599|NCT03526224|Analgesics|analgesics|mesh-ancestor
5676600|NCT03526224|Sensory System Agents|sensory system agents|mesh-ancestor
5676601|NCT03526224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5676602|NCT03526224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5676603|NCT03526224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5676604|NCT03526185|Nivolumab|nivolumab|mesh-list
5676605|NCT03526185|Ipilimumab|ipilimumab|mesh-list
5676606|NCT03526185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5676607|NCT03526185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5676608|NCT03526185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5676609|NCT03526185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676610|NCT03526159|Gentamicins|gentamicins|mesh-list
5676611|NCT03526159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5862646|NCT02388373|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5862647|NCT02388373|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5862648|NCT02388373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5862649|NCT02388373|Adrenergic Agents|adrenergic agents|mesh-ancestor
5862650|NCT02388373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5862651|NCT02388373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862652|NCT02388178|Fluorides|fluorides|mesh-list
5862653|NCT02388178|Cariostatic Agents|cariostatic agents|mesh-ancestor
5862654|NCT02388178|Protective Agents|protective agents|mesh-ancestor
5862655|NCT02388178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862656|NCT02388048|Ofatumumab|ofatumumab|mesh-list
5862657|NCT02388048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5676612|NCT03526159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5676613|NCT03526159|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5676614|NCT03526159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5676615|NCT03526159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676616|NCT03526107|Theobromine|theobromine|mesh-list
5676617|NCT03526107|Caffeine|caffeine|mesh-list
5676618|NCT03526107|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5676619|NCT03526107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676620|NCT03526107|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5676621|NCT03526107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5676622|NCT03526107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676623|NCT03526107|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5862658|NCT02388061|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5862659|NCT02388061|Plasminogen|plasminogen|mesh-list
5862660|NCT02388061|Tenecteplase|tenecteplase|mesh-list
5862661|NCT02388061|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5862662|NCT02388061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5862663|NCT02388061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862664|NCT02388035|Cefotaxime|cefotaxime|mesh-list
5862665|NCT02388035|Cefoxitin|cefoxitin|mesh-list
5862666|NCT02388035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5862667|NCT02388035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5904822|NCT04313608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5904823|NCT04313608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5904824|NCT04313608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5904825|NCT04313608|Immunologic Factors|immunologic factors|mesh-ancestor
5904826|NCT04313608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904827|NCT04313608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5904828|NCT04311710|Nivolumab|nivolumab|mesh-list
5904829|NCT04311710|Ipilimumab|ipilimumab|mesh-list
5904830|NCT04311710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5904831|NCT04311710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5676624|NCT03526107|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5676625|NCT03526107|Purinergic Agents|purinergic agents|mesh-ancestor
5676626|NCT03526107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5676627|NCT03526107|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5676628|NCT03526107|Autonomic Agents|autonomic agents|mesh-ancestor
5676629|NCT03526107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5676630|NCT03526107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5676631|NCT03526107|Respiratory System Agents|respiratory system agents|mesh-ancestor
5676632|NCT03526107|Vasodilator Agents|vasodilator agents|mesh-ancestor
5696497|NCT03382756|Atorvastatin|atorvastatin|mesh-list
5696498|NCT03382756|Fenofibrate|fenofibrate|mesh-list
5696499|NCT03382756|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5696500|NCT03382756|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5696501|NCT03382756|Antimetabolites|antimetabolites|mesh-ancestor
5696502|NCT03382756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696503|NCT03382756|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5696504|NCT03382756|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5696505|NCT03382756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5696506|NCT03382756|Lipotropic Agents|lipotropic agents|mesh-ancestor
5696507|NCT03382756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5696508|NCT03382756|Nootropic Agents|nootropic agents|mesh-ancestor
5696509|NCT03382743|Lidocaine|lidocaine|mesh-list
5862668|NCT02387892|Vitamin D|vitamin d|mesh-list
5862669|NCT02387892|Cholecalciferol|cholecalciferol|mesh-list
5862670|NCT02387892|Vitamins|vitamins|mesh-ancestor
5862671|NCT02387892|Micronutrients|micronutrients|mesh-ancestor
5862672|NCT02387892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862673|NCT02387892|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5862674|NCT02387892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5862675|NCT02387931|Vitamin D|vitamin d|mesh-list
5862676|NCT02387931|Ergocalciferols|ergocalciferols|mesh-list
5862677|NCT02387931|Cholecalciferol|cholecalciferol|mesh-list
5696510|NCT03382743|Anesthetics, Local|anesthetics, local|mesh-ancestor
5696511|NCT03382743|Anesthetics|anesthetics|mesh-ancestor
5696512|NCT03382743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5696513|NCT03382743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696514|NCT03382743|Sensory System Agents|sensory system agents|mesh-ancestor
5696515|NCT03382743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5696516|NCT03382743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5696517|NCT03382743|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5696518|NCT03382743|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5696519|NCT03382743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5696520|NCT03382743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696521|NCT03382730|Chlorhexidine|chlorhexidine|mesh-list
5696522|NCT03382730|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5696523|NCT03382730|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5696524|NCT03382730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5862678|NCT02387931|Vitamins|vitamins|mesh-list
5862679|NCT02387931|Micronutrients|micronutrients|mesh-ancestor
5862680|NCT02387931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862681|NCT02387931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5862682|NCT02387931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5862683|NCT02387918|Dexamethasone|dexamethasone|mesh-list
5862684|NCT02387918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5862685|NCT02387918|Antiemetics|antiemetics|mesh-ancestor
5862686|NCT02387918|Autonomic Agents|autonomic agents|mesh-ancestor
5862687|NCT02387918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5862688|NCT02387918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862689|NCT02387918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5862690|NCT02387918|Glucocorticoids|glucocorticoids|mesh-ancestor
5862691|NCT02387918|Hormones|hormones|mesh-ancestor
5862692|NCT02387918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5862693|NCT02387918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5862694|NCT02387918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5862695|NCT02387619|Amlodipine|amlodipine|mesh-list
5862696|NCT02387619|Telmisartan|telmisartan|mesh-list
5862697|NCT02387619|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
5862698|NCT02387619|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5862699|NCT02387619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5862700|NCT02387619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5862701|NCT02387619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5862702|NCT02387619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862703|NCT02387619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5696525|NCT03382730|Disinfectants|disinfectants|mesh-ancestor
5696526|NCT03382730|Dermatologic Agents|dermatologic agents|mesh-ancestor
5862704|NCT02387619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862705|NCT02387619|Vasodilator Agents|vasodilator agents|mesh-ancestor
5862706|NCT02387619|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5862707|NCT02387619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5862708|NCT02387619|Antimetabolites|antimetabolites|mesh-ancestor
5862709|NCT02387619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5862710|NCT02387619|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5862711|NCT02387619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5862712|NCT02387619|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5862713|NCT02387619|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5862714|NCT02387307|Interferons|interferons|mesh-list
5862715|NCT02387307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5862716|NCT02387307|Antiviral Agents|antiviral agents|mesh-ancestor
5862717|NCT02387307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5862718|NCT02387567|Lidocaine|lidocaine|mesh-list
5862719|NCT02387567|Anesthetics, Local|anesthetics, local|mesh-ancestor
5862720|NCT02387567|Anesthetics|anesthetics|mesh-ancestor
5862721|NCT02387567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5862722|NCT02387567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862723|NCT02387567|Sensory System Agents|sensory system agents|mesh-ancestor
5862724|NCT02387567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5862725|NCT02387567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5862726|NCT02387567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5676633|NCT03526042|Losartan|losartan|mesh-list
5676634|NCT03526042|Enalapril|enalapril|mesh-list
5676635|NCT03526042|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
5676636|NCT03526042|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
5676637|NCT03526042|Enzyme Inhibitors|enzyme inhibitors|mesh-list
5676638|NCT03526042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5676639|NCT03526042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5676640|NCT03526042|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5676641|NCT03526042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676642|NCT03526042|Protease Inhibitors|protease inhibitors|mesh-ancestor
5676643|NCT03525925|Nivolumab|nivolumab|mesh-list
5676644|NCT03525925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5676645|NCT03525925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5676646|NCT03525925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5676647|NCT03525925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676648|NCT03525912|Ketamine|ketamine|mesh-list
5676649|NCT03525912|Analgesics|analgesics|mesh-list
5676650|NCT03525912|Sensory System Agents|sensory system agents|mesh-ancestor
5676651|NCT03525912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5676652|NCT03525912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676653|NCT03525912|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5676654|NCT03525912|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5676655|NCT03525912|Anesthetics, General|anesthetics, general|mesh-ancestor
5676656|NCT03525912|Anesthetics|anesthetics|mesh-ancestor
5676657|NCT03525912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5676658|NCT03525912|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5676659|NCT03525912|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5676660|NCT03525912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5676661|NCT03525912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676662|NCT03525821|Ketamine|ketamine|mesh-list
5676663|NCT03525821|Analgesics|analgesics|mesh-ancestor
5676664|NCT03525821|Sensory System Agents|sensory system agents|mesh-ancestor
5676665|NCT03525821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5862727|NCT02387567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5862728|NCT02387567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5862729|NCT02387567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862730|NCT02387242|Rifampin|rifampin|mesh-list
5862731|NCT02387242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5862732|NCT02387242|Antitubercular Agents|antitubercular agents|mesh-ancestor
5862733|NCT02387242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5862734|NCT02387242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5862735|NCT02387242|Leprostatic Agents|leprostatic agents|mesh-ancestor
5862736|NCT02387242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5862737|NCT02387242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5862738|NCT02387242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862739|NCT02387242|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5862740|NCT02387242|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5862741|NCT02387242|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5862742|NCT02387242|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5676666|NCT03525821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676667|NCT03525821|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5676668|NCT03525821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5676669|NCT03525821|Anesthetics, General|anesthetics, general|mesh-ancestor
5676670|NCT03525821|Anesthetics|anesthetics|mesh-ancestor
5676671|NCT03525821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5676672|NCT03525821|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5676673|NCT03525821|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5676674|NCT03525821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5676675|NCT03525821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676676|NCT03525795|Ipilimumab|ipilimumab|mesh-list
5696527|NCT03382717|Amorolfine|amorolfine|mesh-list
5696528|NCT03382717|Antifungal Agents|antifungal agents|mesh-ancestor
5696529|NCT03382717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5862743|NCT02387242|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5862744|NCT02387242|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5862745|NCT02387450|Sildenafil Citrate|sildenafil citrate|mesh-list
5862746|NCT02387450|Vasodilator Agents|vasodilator agents|mesh-ancestor
5862747|NCT02387450|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5862748|NCT02387450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5862749|NCT02387450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5862750|NCT02387450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862751|NCT02387450|Urological Agents|urological agents|mesh-ancestor
5862752|NCT02387229|Rivaroxaban|rivaroxaban|mesh-list
5862753|NCT02387229|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5862754|NCT02387229|Antithrombins|antithrombins|mesh-ancestor
5862755|NCT02387229|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5862756|NCT02387229|Protease Inhibitors|protease inhibitors|mesh-ancestor
5862757|NCT02387229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5862758|NCT02387229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862759|NCT02387229|Anticoagulants|anticoagulants|mesh-ancestor
5862760|NCT02387203|Amoxicillin|amoxicillin|mesh-list
5862761|NCT02387203|Clarithromycin|clarithromycin|mesh-list
5862762|NCT02387203|Lansoprazole|lansoprazole|mesh-list
5862763|NCT02387203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5862764|NCT02387203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5862765|NCT02387203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5862766|NCT02387203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5862767|NCT02387203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862768|NCT02387203|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5862769|NCT02387203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5862770|NCT02387203|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5862771|NCT02387203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5862772|NCT02387203|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5862773|NCT02387086|Aspirin|aspirin|mesh-list
5862774|NCT02387086|Thalidomide|thalidomide|mesh-list
5862775|NCT02387086|Gefitinib|gefitinib|mesh-list
5862776|NCT02387086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5862777|NCT02387086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5862778|NCT02387086|Analgesics|analgesics|mesh-ancestor
5862779|NCT02387086|Sensory System Agents|sensory system agents|mesh-ancestor
5862780|NCT02387086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5862781|NCT02387086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862782|NCT02387086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5862783|NCT02387086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5862784|NCT02387086|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5862785|NCT02387086|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5862786|NCT02387086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862787|NCT02387086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5862788|NCT02387086|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5862789|NCT02387086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5862790|NCT02387086|Antipyretics|antipyretics|mesh-ancestor
5862791|NCT02387086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5862792|NCT02387086|Immunologic Factors|immunologic factors|mesh-ancestor
5862793|NCT02387086|Leprostatic Agents|leprostatic agents|mesh-ancestor
5862794|NCT02387086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5862795|NCT02387086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5862796|NCT02387086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5862797|NCT02387086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5862798|NCT02387086|Growth Substances|growth substances|mesh-ancestor
5862799|NCT02387086|Growth Inhibitors|growth inhibitors|mesh-ancestor
5862800|NCT02387086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5862801|NCT02387086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5862802|NCT02387138|Oxaliplatin|oxaliplatin|mesh-list
5862803|NCT02387138|Irinotecan|irinotecan|mesh-list
5676677|NCT03525795|(R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide|(r)-n-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1h-indole-3-carboxamide|mesh-list
5676678|NCT03525795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5676679|NCT03525795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5676680|NCT03525795|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5676681|NCT03525795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676682|NCT03525795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5676683|NCT03525730|Pyrimethamine|pyrimethamine|mesh-list
5862804|NCT02387138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5862805|NCT02387138|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5862806|NCT02387138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5862807|NCT02387138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5862808|NCT02387138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862809|NCT02387060|Fentanyl|fentanyl|mesh-list
5862810|NCT02387060|Bupivacaine|bupivacaine|mesh-list
5862811|NCT02387060|Anesthetics, Local|anesthetics, local|mesh-ancestor
5862812|NCT02387060|Anesthetics|anesthetics|mesh-ancestor
5862813|NCT02387060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5862814|NCT02387060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862815|NCT02387060|Sensory System Agents|sensory system agents|mesh-ancestor
5862816|NCT02387060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5862817|NCT02387060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5862818|NCT02387060|Narcotics|narcotics|mesh-ancestor
5862819|NCT02387060|Analgesics|analgesics|mesh-ancestor
5862820|NCT02387060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5862821|NCT02387060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5862822|NCT02387060|Anesthetics, General|anesthetics, general|mesh-ancestor
5862823|NCT02387021|Ropivacaine|ropivacaine|mesh-list
5862824|NCT02387021|Anesthetics, Local|anesthetics, local|mesh-ancestor
5862825|NCT02387021|Anesthetics|anesthetics|mesh-ancestor
5862826|NCT02387021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5862827|NCT02387021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862828|NCT02387021|Sensory System Agents|sensory system agents|mesh-ancestor
5862829|NCT02387021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5862830|NCT02386943|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5862831|NCT02386943|Saxagliptin|saxagliptin|mesh-list
5862832|NCT02386943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5862833|NCT02386943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862834|NCT02386943|Incretins|incretins|mesh-ancestor
5862835|NCT02386943|Hormones|hormones|mesh-ancestor
5862836|NCT02386943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5862837|NCT02386943|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5862838|NCT02386943|Protease Inhibitors|protease inhibitors|mesh-ancestor
5862839|NCT02386943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5862840|NCT02386943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862841|NCT02386826|Bevacizumab|bevacizumab|mesh-list
5862842|NCT02386826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5862843|NCT02386826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5862844|NCT02386826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5862845|NCT02386826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5862846|NCT02386826|Growth Substances|growth substances|mesh-ancestor
5862847|NCT02386826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862848|NCT02386826|Growth Inhibitors|growth inhibitors|mesh-ancestor
5862849|NCT02386735|Prednisone|prednisone|mesh-list
5862850|NCT02386735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5862851|NCT02386735|Glucocorticoids|glucocorticoids|mesh-ancestor
5862852|NCT02386735|Hormones|hormones|mesh-ancestor
5862853|NCT02386735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5862854|NCT02386735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862855|NCT02386735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5862856|NCT02386735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5862857|NCT02386358|Benzonidazole|benzonidazole|mesh-list
5862858|NCT02386358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5862859|NCT02386358|Immunologic Factors|immunologic factors|mesh-ancestor
5862860|NCT02386358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862861|NCT02386358|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5862862|NCT02386358|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5862863|NCT02386358|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5862864|NCT02386358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5862865|NCT02386397|Gemcitabine|gemcitabine|mesh-list
5862866|NCT02386397|Oxaliplatin|oxaliplatin|mesh-list
5862867|NCT02386397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5862868|NCT02386397|Antimetabolites|antimetabolites|mesh-ancestor
5904832|NCT04311710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5676684|NCT03525730|Valproic Acid|valproic acid|mesh-list
5862869|NCT02386397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862870|NCT02386397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5862871|NCT02386397|Antiviral Agents|antiviral agents|mesh-ancestor
5862872|NCT02386397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5862873|NCT02386397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5862874|NCT02386397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5862875|NCT02386397|Immunologic Factors|immunologic factors|mesh-ancestor
5862876|NCT02386397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862877|NCT02386488|Vortioxetine|vortioxetine|mesh-list
5862878|NCT02386488|Antidepressive Agents|antidepressive agents|mesh-ancestor
5676685|NCT03525730|Antimalarials|antimalarials|mesh-ancestor
5676686|NCT03525730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5676687|NCT03525730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5676688|NCT03525730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5676689|NCT03525730|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5676690|NCT03525730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5676691|NCT03525730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862879|NCT02386488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5862880|NCT02386488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5862881|NCT02386488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5862882|NCT02386488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5862883|NCT02386488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862884|NCT02386488|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5862885|NCT02386488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5862886|NCT02386488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5862887|NCT02386488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862888|NCT02386488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5862889|NCT02386488|Serotonin Agents|serotonin agents|mesh-ancestor
5862890|NCT02386488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5862891|NCT02386488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5676692|NCT03525730|Anticonvulsants|anticonvulsants|mesh-ancestor
5676693|NCT03525730|GABA Agents|gaba agents|mesh-ancestor
5676694|NCT03525730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5676695|NCT03525730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676696|NCT03525730|Antimanic Agents|antimanic agents|mesh-ancestor
5676697|NCT03525730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5676698|NCT03525730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5676699|NCT03525730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5676700|NCT03525704|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5676701|NCT03525652|Vaccines|vaccines|mesh-list
5676702|NCT03525652|Immunologic Factors|immunologic factors|mesh-ancestor
5676703|NCT03525652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676704|NCT03525574|Ivacaftor|ivacaftor|mesh-list
5676705|NCT03525574|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
5676706|NCT03525574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5676707|NCT03525574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676708|NCT03525561|Acetazolamide|acetazolamide|mesh-list
5676709|NCT03525561|Anticonvulsants|anticonvulsants|mesh-ancestor
5676710|NCT03525561|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5676711|NCT03525561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5862892|NCT02386488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5862893|NCT02386488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5862894|NCT02386462|Dexmedetomidine|dexmedetomidine|mesh-list
5862895|NCT02386462|Propofol|propofol|mesh-list
5862896|NCT02386462|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5862897|NCT02386462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5862898|NCT02386462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862899|NCT02386462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5862900|NCT02386462|Anesthetics, General|anesthetics, general|mesh-ancestor
5862901|NCT02386462|Anesthetics|anesthetics|mesh-ancestor
5862902|NCT02386462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5862903|NCT02386462|Analgesics|analgesics|mesh-ancestor
5862904|NCT02386462|Sensory System Agents|sensory system agents|mesh-ancestor
5862905|NCT02386462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5862906|NCT02386462|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5862907|NCT02386462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5862908|NCT02386462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5862909|NCT02386462|Adrenergic Agents|adrenergic agents|mesh-ancestor
5862910|NCT02386462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5862911|NCT02386462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862912|NCT02386449|Mannitol|mannitol|mesh-list
5676712|NCT03525561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676713|NCT03525561|Diuretics|diuretics|mesh-ancestor
5862913|NCT02386449|Bisacodyl|bisacodyl|mesh-list
5862914|NCT02386449|Picosulfate sodium|picosulfate sodium|mesh-list
5862915|NCT02386449|Magnesium Oxide|magnesium oxide|mesh-list
5862916|NCT02386449|Citric Acid|citric acid|mesh-list
5862917|NCT02386449|Sodium Citrate|sodium citrate|mesh-list
5862918|NCT02386449|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5862919|NCT02386449|Diuretics|diuretics|mesh-ancestor
5862920|NCT02386449|Natriuretic Agents|natriuretic agents|mesh-ancestor
5862921|NCT02386449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862922|NCT02386449|Cathartics|cathartics|mesh-ancestor
5862923|NCT02386449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5676714|NCT03525561|Natriuretic Agents|natriuretic agents|mesh-ancestor
5676715|NCT03525561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676716|NCT03525522|Betamethasone|betamethasone|mesh-list
5676717|NCT03525522|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5676718|NCT03525522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5676719|NCT03525522|Glucocorticoids|glucocorticoids|mesh-ancestor
5676720|NCT03525522|Hormones|hormones|mesh-ancestor
5676721|NCT03525522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5676722|NCT03525522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676723|NCT03525522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5676724|NCT03525522|Respiratory System Agents|respiratory system agents|mesh-ancestor
5676725|NCT03525509|Morphine|morphine|mesh-list
5676726|NCT03525509|Methadone|methadone|mesh-list
5676727|NCT03525509|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5676728|NCT03525509|Narcotics|narcotics|mesh-ancestor
5676729|NCT03525509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5676730|NCT03525509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676731|NCT03525509|Analgesics|analgesics|mesh-ancestor
5676732|NCT03525509|Sensory System Agents|sensory system agents|mesh-ancestor
5676733|NCT03525509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5862924|NCT02386449|Laxatives|laxatives|mesh-ancestor
5862925|NCT02386449|Anticoagulants|anticoagulants|mesh-ancestor
5862926|NCT02386449|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5862927|NCT02386449|Chelating Agents|chelating agents|mesh-ancestor
5862928|NCT02386449|Sequestering Agents|sequestering agents|mesh-ancestor
5862929|NCT02386449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862930|NCT02386449|Antacids|antacids|mesh-ancestor
5862931|NCT02386566|Natalizumab|natalizumab|mesh-list
5862932|NCT02386566|Immunologic Factors|immunologic factors|mesh-ancestor
5862933|NCT02386566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862934|NCT02386293|Irbesartan|irbesartan|mesh-list
5862935|NCT02386293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5862936|NCT02386293|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5862937|NCT02386293|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5862938|NCT02386293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862939|NCT02386592|Chlorhexidine|chlorhexidine|mesh-list
5862940|NCT02386592|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5862941|NCT02386592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5862942|NCT02386592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5862943|NCT02386592|Disinfectants|disinfectants|mesh-ancestor
5862944|NCT02386592|Dermatologic Agents|dermatologic agents|mesh-ancestor
5862945|NCT02386475|Dexetimide|dexetimide|mesh-list
5862946|NCT02386475|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
5862947|NCT02386475|Citalopram|citalopram|mesh-list
5862948|NCT02386475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5862949|NCT02386475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5862950|NCT02386475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5862951|NCT02386475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862952|NCT02386475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5862953|NCT02386475|Serotonin Agents|serotonin agents|mesh-ancestor
5862954|NCT02386475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862955|NCT02386475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5862956|NCT02386475|Antidepressive Agents|antidepressive agents|mesh-ancestor
5862957|NCT02386475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5862958|NCT02386475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5862959|NCT02386475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5862960|NCT02386475|Parasympatholytics|parasympatholytics|mesh-ancestor
5862961|NCT02386475|Autonomic Agents|autonomic agents|mesh-ancestor
5862962|NCT02386475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5862963|NCT02386475|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5862964|NCT02386475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5862965|NCT02386475|Cholinergic Agents|cholinergic agents|mesh-ancestor
5862966|NCT02386475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5862967|NCT02386475|Immunologic Factors|immunologic factors|mesh-ancestor
5676734|NCT03525509|Antitussive Agents|antitussive agents|mesh-ancestor
5862968|NCT02386475|Dopamine Agonists|dopamine agonists|mesh-ancestor
5676735|NCT03525509|Respiratory System Agents|respiratory system agents|mesh-ancestor
5676736|NCT03525379|Resveratrol|resveratrol|mesh-list
5676737|NCT03525379|Antioxidants|antioxidants|mesh-ancestor
5676738|NCT03525379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676739|NCT03525379|Protective Agents|protective agents|mesh-ancestor
5676740|NCT03525379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676741|NCT03525379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5676742|NCT03525379|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5676743|NCT03525223|Dialysis Solutions|dialysis solutions|mesh-list
5862969|NCT02386475|Dopamine Agents|dopamine agents|mesh-ancestor
5862970|NCT02386150|Vaccines|vaccines|mesh-list
5862971|NCT02386150|Immunologic Factors|immunologic factors|mesh-ancestor
5862972|NCT02386150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904833|NCT04311710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904834|NCT04307134|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
5904835|NCT04307134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5904836|NCT04307134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5676744|NCT03525223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5676745|NCT03525028|Metformin|metformin|mesh-list
5676746|NCT03525028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5676747|NCT03525028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676748|NCT03525002|Bromocriptine|bromocriptine|mesh-list
5676749|NCT03525002|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5676750|NCT03525002|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5676751|NCT03525002|Hormone Antagonists|hormone antagonists|mesh-ancestor
5676752|NCT03525002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5676753|NCT03525002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676754|NCT03525002|Dopamine Agonists|dopamine agonists|mesh-ancestor
5676755|NCT03525002|Dopamine Agents|dopamine agents|mesh-ancestor
5676756|NCT03525002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5676757|NCT03525002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904837|NCT04307134|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5904838|NCT04305327|Ustekinumab|ustekinumab|mesh-list
5904839|NCT04305327|Brodalumab|brodalumab|mesh-list
5904840|NCT04305327|Dermatologic Agents|dermatologic agents|mesh-ancestor
5904841|NCT04245865|Leucovorin|leucovorin|mesh-list
5676758|NCT03524950|Dexmedetomidine|dexmedetomidine|mesh-list
5676759|NCT03524950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5676760|NCT03524950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5676761|NCT03524950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676762|NCT03524950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5676763|NCT03524950|Analgesics|analgesics|mesh-ancestor
5676764|NCT03524950|Sensory System Agents|sensory system agents|mesh-ancestor
5676765|NCT03524950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5904842|NCT04245865|Tocotrienols|tocotrienols|mesh-list
5904843|NCT04245865|Vitamin E|vitamin e|mesh-list
5904844|NCT04245865|Tocopherols|tocopherols|mesh-list
5904845|NCT04245865|Bevacizumab|bevacizumab|mesh-list
5904846|NCT04245865|Fluorouracil|fluorouracil|mesh-list
5904847|NCT04245865|Capecitabine|capecitabine|mesh-list
5904848|NCT04245865|Oxaliplatin|oxaliplatin|mesh-list
5904849|NCT04245865|Levoleucovorin|levoleucovorin|mesh-list
5904850|NCT04245865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5904851|NCT04245865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5904852|NCT04245865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5904853|NCT04245865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5904854|NCT04245865|Growth Substances|growth substances|mesh-ancestor
5904855|NCT04245865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904856|NCT04245865|Growth Inhibitors|growth inhibitors|mesh-ancestor
5904857|NCT04245865|Antimetabolites|antimetabolites|mesh-ancestor
5904858|NCT04245865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904859|NCT04245865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5904860|NCT04245865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5904861|NCT04245865|Immunologic Factors|immunologic factors|mesh-ancestor
5904862|NCT04245865|Antidotes|antidotes|mesh-ancestor
5676766|NCT03524950|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5676767|NCT03524950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5676768|NCT03524950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5676769|NCT03524950|Adrenergic Agents|adrenergic agents|mesh-ancestor
5676770|NCT03524950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5676771|NCT03524950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676772|NCT03524937|Melatonin|melatonin|mesh-list
5676773|NCT03524937|Antioxidants|antioxidants|mesh-ancestor
5676774|NCT03524937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676775|NCT03524937|Protective Agents|protective agents|mesh-ancestor
5904863|NCT04245865|Protective Agents|protective agents|mesh-ancestor
5862973|NCT02386111|Sunitinib|sunitinib|mesh-list
5862974|NCT02386111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5862975|NCT02386111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5862976|NCT02386111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5862977|NCT02386111|Growth Substances|growth substances|mesh-ancestor
5676776|NCT03524937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676777|NCT03524937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5676778|NCT03524872|Analgesics|analgesics|mesh-list
5676779|NCT03524872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676780|NCT03524872|Sensory System Agents|sensory system agents|mesh-ancestor
5676781|NCT03524872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5676782|NCT03524846|Vitamins|vitamins|mesh-list
5676783|NCT03524846|Ascorbic Acid|ascorbic acid|mesh-list
5676784|NCT03524846|Micronutrients|micronutrients|mesh-ancestor
5676785|NCT03524846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676786|NCT03524846|Antioxidants|antioxidants|mesh-ancestor
5676787|NCT03524846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676788|NCT03524846|Protective Agents|protective agents|mesh-ancestor
5676789|NCT03524833|Amoxicillin|amoxicillin|mesh-list
5676790|NCT03524833|Metronidazole|metronidazole|mesh-list
5676791|NCT03524833|Lansoprazole|lansoprazole|mesh-list
5676792|NCT03524833|Dexlansoprazole|dexlansoprazole|mesh-list
5676793|NCT03524833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5676794|NCT03524833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5676795|NCT03524833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5676796|NCT03524833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5676797|NCT03524833|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5676798|NCT03524833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5676799|NCT03524833|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5676800|NCT03524833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5676801|NCT03524833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676802|NCT03524820|Cetuximab|cetuximab|mesh-list
5676803|NCT03524820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5676804|NCT03524820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5696530|NCT03382600|Pembrolizumab|pembrolizumab|mesh-list
5696531|NCT03382600|Oxaliplatin|oxaliplatin|mesh-list
5696532|NCT03382600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5696533|NCT03382600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5696534|NCT03382587|Aflibercept|aflibercept|mesh-list
5696535|NCT03382587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5696536|NCT03382587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5696537|NCT03382587|Growth Substances|growth substances|mesh-ancestor
5696538|NCT03382587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696539|NCT03382587|Growth Inhibitors|growth inhibitors|mesh-ancestor
5696540|NCT03382587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5696541|NCT03382548|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5696542|NCT03382548|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5696543|NCT03382548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5696544|NCT03382548|Antitubercular Agents|antitubercular agents|mesh-ancestor
5862978|NCT02386111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5862979|NCT02386111|Growth Inhibitors|growth inhibitors|mesh-ancestor
5862980|NCT02386111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5862981|NCT02386111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5862982|NCT02386111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862983|NCT02386033|Atorvastatin|atorvastatin|mesh-list
5862984|NCT02386033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5862985|NCT02386033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5862986|NCT02386033|Antimetabolites|antimetabolites|mesh-ancestor
5862987|NCT02386033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5862988|NCT02386033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5862989|NCT02386033|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5862990|NCT02386033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5862991|NCT02386059|Dexamethasone|dexamethasone|mesh-list
5862992|NCT02386059|Dexamethasone acetate|dexamethasone acetate|mesh-list
5862993|NCT02386059|Ondansetron|ondansetron|mesh-list
5862994|NCT02386059|BB 1101|bb 1101|mesh-list
5862995|NCT02386059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5862996|NCT02386059|Antiemetics|antiemetics|mesh-ancestor
5862997|NCT02386059|Autonomic Agents|autonomic agents|mesh-ancestor
5862998|NCT02386059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5862999|NCT02386059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863000|NCT02386059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5863001|NCT02386059|Glucocorticoids|glucocorticoids|mesh-ancestor
5863002|NCT02386059|Hormones|hormones|mesh-ancestor
5863003|NCT02386059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5863004|NCT02386059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5863005|NCT02386059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5863006|NCT02386059|Protease Inhibitors|protease inhibitors|mesh-ancestor
5863007|NCT02386059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5863008|NCT02386059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5863009|NCT02386059|Antipruritics|antipruritics|mesh-ancestor
5863010|NCT02386059|Dermatologic Agents|dermatologic agents|mesh-ancestor
5863011|NCT02386059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5863012|NCT02386059|Serotonin Agents|serotonin agents|mesh-ancestor
5863013|NCT02386059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5863014|NCT02386059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5863015|NCT02386059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5863016|NCT02386059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5676805|NCT03524508|Fluorouracil|fluorouracil|mesh-list
5676806|NCT03524508|Irinotecan|irinotecan|mesh-list
5676807|NCT03524508|Antimetabolites|antimetabolites|mesh-ancestor
5676808|NCT03524508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676809|NCT03524508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5676810|NCT03524508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5676811|NCT03524508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5676812|NCT03524508|Immunologic Factors|immunologic factors|mesh-ancestor
5676813|NCT03524508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863017|NCT02386059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5863018|NCT02386059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5863019|NCT02386072|Mirabegron|mirabegron|mesh-list
5863020|NCT02386072|Oxybutynin|oxybutynin|mesh-list
5863021|NCT02386072|Muscarinic Antagonists|muscarinic antagonists|mesh-list
5863022|NCT02386072|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
5863023|NCT02386072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5863024|NCT02386072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5863025|NCT02386072|Adrenergic Agents|adrenergic agents|mesh-ancestor
5863026|NCT02386072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5863027|NCT02386072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5863028|NCT02386072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863029|NCT02386072|Urological Agents|urological agents|mesh-ancestor
5863030|NCT02386072|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5863031|NCT02386072|Cholinergic Agents|cholinergic agents|mesh-ancestor
5863032|NCT02386072|Parasympatholytics|parasympatholytics|mesh-ancestor
5863033|NCT02386072|Autonomic Agents|autonomic agents|mesh-ancestor
5863034|NCT02386072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5863035|NCT02385825|Vaccines|vaccines|mesh-list
5863036|NCT02385825|Immunologic Factors|immunologic factors|mesh-ancestor
5863037|NCT02385825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863038|NCT02385656|Modafinil|modafinil|mesh-list
5863039|NCT02385656|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5863040|NCT02385656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863041|NCT02385656|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
5863042|NCT02385656|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5863043|NCT02385656|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5863044|NCT02385656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5863045|NCT02385617|Octreotide|octreotide|mesh-list
5863046|NCT02385617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5863047|NCT02385617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5863048|NCT02385617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5863049|NCT02385734|Mitogens|mitogens|mesh-list
5863050|NCT02385734|Mitosis Modulators|mitosis modulators|mesh-ancestor
5863051|NCT02385734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5863052|NCT02385513|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5863053|NCT02385513|Immunologic Factors|immunologic factors|mesh-ancestor
5863054|NCT02385513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676814|NCT03524508|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5676815|NCT03524508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5676816|NCT03524508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5676817|NCT03524417|Immunoglobulins|immunoglobulins|mesh-list
5676818|NCT03524417|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5676819|NCT03524417|Antibodies|antibodies|mesh-list
5676820|NCT03524417|Immunologic Factors|immunologic factors|mesh-ancestor
5676821|NCT03524417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676822|NCT03524313|Carbon Monoxide|carbon monoxide|mesh-list
5676823|NCT03524313|Antimetabolites|antimetabolites|mesh-ancestor
5676824|NCT03524313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676825|NCT03524313|Gasotransmitters|gasotransmitters|mesh-ancestor
5676826|NCT03524313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5676827|NCT03524313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676828|NCT03524274|Antibodies|antibodies|mesh-list
5676829|NCT03524274|Antibodies, Bispecific|antibodies, bispecific|mesh-list
5863055|NCT02385539|Levobupivacaine|levobupivacaine|mesh-list
5863056|NCT02385539|Anesthetics, Local|anesthetics, local|mesh-ancestor
5863057|NCT02385539|Anesthetics|anesthetics|mesh-ancestor
5863058|NCT02385539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5863059|NCT02385539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863060|NCT02385539|Sensory System Agents|sensory system agents|mesh-ancestor
5863061|NCT02385539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5863062|NCT02385500|Fesoterodine|fesoterodine|mesh-list
5863063|NCT02385500|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5863064|NCT02385500|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5863065|NCT02385500|Cholinergic Agents|cholinergic agents|mesh-ancestor
5863066|NCT02385500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5863067|NCT02385500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5863068|NCT02385500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863069|NCT02385500|Urological Agents|urological agents|mesh-ancestor
5863070|NCT02385474|Fluorides|fluorides|mesh-list
5863071|NCT02385474|Cariostatic Agents|cariostatic agents|mesh-ancestor
5863072|NCT02385474|Protective Agents|protective agents|mesh-ancestor
5863073|NCT02385474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863074|NCT02385461|Heparin|heparin|mesh-list
5863075|NCT02385461|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5863076|NCT02385461|Tinzaparin|tinzaparin|mesh-list
5863077|NCT02385461|Dalteparin|dalteparin|mesh-list
5863078|NCT02385461|Anticoagulants|anticoagulants|mesh-ancestor
5863079|NCT02385461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5863080|NCT02385461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5863081|NCT02385461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5863082|NCT02385448|Dienogest|dienogest|mesh-list
5863083|NCT02385448|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
5863084|NCT02385448|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
5863085|NCT02385448|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5863086|NCT02385448|Contraceptive Agents|contraceptive agents|mesh-ancestor
5863087|NCT02385448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5863088|NCT02385448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863089|NCT02385448|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5863090|NCT02385448|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5863091|NCT02385448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5863092|NCT02385448|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5863093|NCT02385448|Hormone Antagonists|hormone antagonists|mesh-ancestor
5863094|NCT02385448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5863095|NCT02385448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5863096|NCT02385448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5863097|NCT02385448|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5863098|NCT02385448|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5863099|NCT02385448|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
5863100|NCT02385448|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5863101|NCT02385448|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5863102|NCT02385422|Propranolol|propranolol|mesh-list
5863103|NCT02385422|Carvedilol|carvedilol|mesh-list
5863104|NCT02385422|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5863105|NCT02385422|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5863106|NCT02385422|Adrenergic Agents|adrenergic agents|mesh-ancestor
5863107|NCT02385422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5863108|NCT02385422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5863109|NCT02385422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863110|NCT02385422|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5863111|NCT02385422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5863112|NCT02385422|Vasodilator Agents|vasodilator agents|mesh-ancestor
5863113|NCT02385422|Antioxidants|antioxidants|mesh-ancestor
5863114|NCT02385422|Protective Agents|protective agents|mesh-ancestor
5863115|NCT02385422|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5863116|NCT02385422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5863117|NCT02385422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5863118|NCT02385422|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5863119|NCT02385422|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5863120|NCT02385435|Dexmedetomidine|dexmedetomidine|mesh-list
5863121|NCT02385435|Bupivacaine|bupivacaine|mesh-list
5863122|NCT02385435|Anesthetics, Local|anesthetics, local|mesh-ancestor
5863123|NCT02385435|Anesthetics|anesthetics|mesh-ancestor
5863124|NCT02385435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5863125|NCT02385435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863126|NCT02385435|Sensory System Agents|sensory system agents|mesh-ancestor
5863127|NCT02385435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5676830|NCT03524274|Immunologic Factors|immunologic factors|mesh-ancestor
5676831|NCT03524274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676832|NCT03524261|Antibodies|antibodies|mesh-list
5676833|NCT03524261|Antibodies, Bispecific|antibodies, bispecific|mesh-list
5676834|NCT03524261|Immunologic Factors|immunologic factors|mesh-ancestor
5676835|NCT03524261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676836|NCT03524170|Atezolizumab|atezolizumab|mesh-list
5676837|NCT03524170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5676838|NCT03524079|Ajmaline|ajmaline|mesh-list
5676839|NCT03524079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5676840|NCT03524079|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5863128|NCT02385435|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5863129|NCT02385435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5863130|NCT02385435|Analgesics|analgesics|mesh-ancestor
6675013|NCT01572350|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6675014|NCT01572350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6675015|NCT01572350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6675016|NCT01572350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6675017|NCT01572350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6675018|NCT01572350|Growth Substances|growth substances|mesh-ancestor
6675019|NCT01572350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676841|NCT03524079|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5676842|NCT03524079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5676843|NCT03524079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676844|NCT03523975|Rituximab|rituximab|mesh-list
5676845|NCT03523975|Lenalidomide|lenalidomide|mesh-list
5676846|NCT03523975|Venetoclax|venetoclax|mesh-list
5676847|NCT03523975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5676848|NCT03523975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5676849|NCT03523975|Immunologic Factors|immunologic factors|mesh-ancestor
5676850|NCT03523975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676851|NCT03523975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5676852|NCT03523975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5676853|NCT03523975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5676854|NCT03523975|Growth Substances|growth substances|mesh-ancestor
5676855|NCT03523975|Growth Inhibitors|growth inhibitors|mesh-ancestor
5676856|NCT03523832|Celecoxib|celecoxib|mesh-list
5676857|NCT03523832|Pregabalin|pregabalin|mesh-list
5676858|NCT03523832|Analgesics|analgesics|mesh-ancestor
5676859|NCT03523832|Sensory System Agents|sensory system agents|mesh-ancestor
5676860|NCT03523832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5676861|NCT03523832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676862|NCT03523832|Anticonvulsants|anticonvulsants|mesh-ancestor
5676863|NCT03523832|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5676864|NCT03523832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5676865|NCT03523832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676866|NCT03523832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5676867|NCT03523832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5676868|NCT03523832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5676869|NCT03523832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5676870|NCT03523832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5676871|NCT03523832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5676872|NCT03523832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5676873|NCT03523832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5676874|NCT03523832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5676875|NCT03523832|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5676876|NCT03523832|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5676877|NCT03523832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5676878|NCT03523754|Isosorbide|isosorbide|mesh-list
5676879|NCT03523754|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
5676880|NCT03523754|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
5676881|NCT03523754|Misoprostol|misoprostol|mesh-list
6675020|NCT01572350|Growth Inhibitors|growth inhibitors|mesh-ancestor
6675021|NCT01572350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5676882|NCT03523754|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5676883|NCT03523754|Abortifacient Agents|abortifacient agents|mesh-ancestor
5676884|NCT03523754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5676885|NCT03523754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676886|NCT03523754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5676887|NCT03523754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5676888|NCT03523754|Oxytocics|oxytocics|mesh-ancestor
5676889|NCT03523754|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5863131|NCT02385435|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6675022|NCT01572350|Glucocorticoids|glucocorticoids|mesh-ancestor
5676890|NCT03523754|Diuretics|diuretics|mesh-ancestor
5676891|NCT03523754|Natriuretic Agents|natriuretic agents|mesh-ancestor
6675023|NCT01572350|Hormones|hormones|mesh-ancestor
6675024|NCT01572350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6675025|NCT01572350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6675026|NCT01572350|Immunologic Factors|immunologic factors|mesh-ancestor
6675027|NCT01572350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6675028|NCT01572350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675029|NCT01572363|Sildenafil Citrate|sildenafil citrate|mesh-list
6675030|NCT01572363|Vasodilator Agents|vasodilator agents|mesh-ancestor
5863132|NCT02385435|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5863133|NCT02385435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5863134|NCT02385435|Adrenergic Agents|adrenergic agents|mesh-ancestor
5863135|NCT02385435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5863136|NCT02385435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5863137|NCT02385396|Folic Acid|folic acid|mesh-list
5863138|NCT02385396|Inositol|inositol|mesh-list
5863139|NCT02385396|Hematinics|hematinics|mesh-ancestor
5863140|NCT02385396|Vitamin B Complex|vitamin b complex|mesh-ancestor
5863141|NCT02385396|Vitamins|vitamins|mesh-ancestor
5863142|NCT02385396|Micronutrients|micronutrients|mesh-ancestor
5863143|NCT02385396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863144|NCT02385266|Cycloserine|cycloserine|mesh-list
5863145|NCT02385266|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5863146|NCT02385266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5863147|NCT02385266|Renal Agents|renal agents|mesh-ancestor
5863148|NCT02385266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5863149|NCT02385266|Antitubercular Agents|antitubercular agents|mesh-ancestor
5863150|NCT02385266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5863151|NCT02385266|Antimetabolites|antimetabolites|mesh-ancestor
5863152|NCT02385266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5863153|NCT02385305|Anesthetics|anesthetics|mesh-list
5863154|NCT02385305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5863155|NCT02385305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863156|NCT02385058|Mebendazole|mebendazole|mesh-list
5863157|NCT02385058|Piperazine|piperazine|mesh-list
5863158|NCT02385058|Piperazine citrate|piperazine citrate|mesh-list
5863159|NCT02385058|DMP 777|dmp 777|mesh-list
5676892|NCT03523754|Vasodilator Agents|vasodilator agents|mesh-ancestor
5676893|NCT03523754|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5676894|NCT03523754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676895|NCT03523741|Clozapine|clozapine|mesh-list
5676896|NCT03523741|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5676897|NCT03523741|Serotonin Agents|serotonin agents|mesh-ancestor
5676898|NCT03523741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5676899|NCT03523741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676900|NCT03523741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676901|NCT03523741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5676902|NCT03523741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5676903|NCT03523741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5676904|NCT03523741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5676905|NCT03523741|GABA Antagonists|gaba antagonists|mesh-ancestor
5676906|NCT03523741|GABA Agents|gaba agents|mesh-ancestor
5676907|NCT03523650|Propranolol|propranolol|mesh-list
5676908|NCT03523650|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5676909|NCT03523650|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5676910|NCT03523650|Adrenergic Agents|adrenergic agents|mesh-ancestor
5676911|NCT03523650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5676912|NCT03523650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676913|NCT03523650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863160|NCT02385058|Antinematodal Agents|antinematodal agents|mesh-ancestor
5863161|NCT02385058|Anthelmintics|anthelmintics|mesh-ancestor
5863162|NCT02385058|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5863163|NCT02385058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5863164|NCT02385058|Tubulin Modulators|tubulin modulators|mesh-ancestor
5863165|NCT02385058|Antimitotic Agents|antimitotic agents|mesh-ancestor
5863166|NCT02385058|Mitosis Modulators|mitosis modulators|mesh-ancestor
6675031|NCT01572363|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6675032|NCT01572363|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6675033|NCT01572363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6675034|NCT01572363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675035|NCT01572363|Urological Agents|urological agents|mesh-ancestor
6675036|NCT01572454|Dexmedetomidine|dexmedetomidine|mesh-list
6675037|NCT01572454|Remifentanil|remifentanil|mesh-list
5676914|NCT03523650|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5863167|NCT02385058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5863168|NCT02385058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6675038|NCT01572454|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5863169|NCT02385058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5863170|NCT02385227|Nicotine|nicotine|mesh-list
5863171|NCT02385227|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5863172|NCT02385227|Autonomic Agents|autonomic agents|mesh-ancestor
5863173|NCT02385227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5863174|NCT02385227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863175|NCT02385227|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5863176|NCT02385227|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5863177|NCT02385227|Cholinergic Agents|cholinergic agents|mesh-ancestor
5863178|NCT02385227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5863179|NCT02385227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5863180|NCT02385188|Acetaminophen|acetaminophen|mesh-list
5863181|NCT02385188|Imiquimod|imiquimod|mesh-list
5863182|NCT02385188|Lidocaine|lidocaine|mesh-list
5863183|NCT02385188|Petrolatum|petrolatum|mesh-list
5863184|NCT02385188|Anesthetics, Local|anesthetics, local|mesh-ancestor
5863185|NCT02385188|Anesthetics|anesthetics|mesh-ancestor
5863186|NCT02385188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5863187|NCT02385188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863188|NCT02385188|Sensory System Agents|sensory system agents|mesh-ancestor
5863189|NCT02385188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5863190|NCT02385188|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5863191|NCT02385188|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5863192|NCT02385188|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5863193|NCT02385188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5863194|NCT02385188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5863195|NCT02385188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5863196|NCT02385188|Analgesics|analgesics|mesh-ancestor
5863197|NCT02385188|Antipyretics|antipyretics|mesh-ancestor
5863198|NCT02385188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5863199|NCT02385188|Immunologic Factors|immunologic factors|mesh-ancestor
5863200|NCT02385188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5863201|NCT02385188|Interferon Inducers|interferon inducers|mesh-ancestor
5676915|NCT03523650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5676916|NCT03523650|Vasodilator Agents|vasodilator agents|mesh-ancestor
5676917|NCT03523572|Nivolumab|nivolumab|mesh-list
5863202|NCT02385188|Emollients|emollients|mesh-ancestor
5863203|NCT02385188|Dermatologic Agents|dermatologic agents|mesh-ancestor
5863204|NCT02385032|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
5863205|NCT02385032|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5863206|NCT02385032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5863207|NCT02385136|Temozolomide|temozolomide|mesh-list
5863208|NCT02385136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5863209|NCT02385136|Alkylating Agents|alkylating agents|mesh-ancestor
5676918|NCT03523572|Trastuzumab|trastuzumab|mesh-list
5676919|NCT03523572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5863210|NCT02385136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5863211|NCT02385136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5863212|NCT02385071|Simeprevir|simeprevir|mesh-list
5863213|NCT02385071|Antiviral Agents|antiviral agents|mesh-ancestor
5863214|NCT02385071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6675039|NCT01572454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6675040|NCT01572454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675041|NCT01572454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6675042|NCT01572454|Analgesics|analgesics|mesh-ancestor
6675043|NCT01572454|Sensory System Agents|sensory system agents|mesh-ancestor
5676920|NCT03523572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5676921|NCT03523572|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5676922|NCT03523572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676923|NCT03523520|Naltrexone|naltrexone|mesh-list
5676924|NCT03523520|Bromides|bromides|mesh-list
5676925|NCT03523520|Methylnaltrexone|methylnaltrexone|mesh-list
5676926|NCT03523520|Naloxegol|naloxegol|mesh-list
5676927|NCT03523520|Anticonvulsants|anticonvulsants|mesh-ancestor
5676928|NCT03523520|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5676929|NCT03523520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676930|NCT03523520|Sensory System Agents|sensory system agents|mesh-ancestor
5676931|NCT03523520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5676932|NCT03523520|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5676933|NCT03523455|Iron protein succinylate|iron protein succinylate|mesh-list
5676934|NCT03523455|Hematinics|hematinics|mesh-ancestor
5676935|NCT03523429|Blinatumomab|blinatumomab|mesh-list
5676936|NCT03523429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5676937|NCT03523390|Avelumab|avelumab|mesh-list
5676938|NCT03523390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5676939|NCT03523390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5676940|NCT03523273|Liraglutide|liraglutide|mesh-list
5676941|NCT03523273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5676942|NCT03523273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676943|NCT03523273|Incretins|incretins|mesh-ancestor
5676944|NCT03523273|Hormones|hormones|mesh-ancestor
5676945|NCT03523273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5676946|NCT03523221|Dexamethasone|dexamethasone|mesh-list
5676947|NCT03523221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5676948|NCT03523221|Antiemetics|antiemetics|mesh-ancestor
5676949|NCT03523221|Autonomic Agents|autonomic agents|mesh-ancestor
5676950|NCT03523221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5676951|NCT03523221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676952|NCT03523221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5676953|NCT03523221|Glucocorticoids|glucocorticoids|mesh-ancestor
5676954|NCT03523221|Hormones|hormones|mesh-ancestor
5676955|NCT03523221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5676956|NCT03523221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5676957|NCT03523221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5676958|NCT03522987|Citalopram|citalopram|mesh-list
5676959|NCT03522987|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5676960|NCT03522987|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5676961|NCT03522987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5676962|NCT03522987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676963|NCT03522987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5676964|NCT03522987|Serotonin Agents|serotonin agents|mesh-ancestor
5676965|NCT03522987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676966|NCT03522987|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5676967|NCT03522987|Antidepressive Agents|antidepressive agents|mesh-ancestor
5676968|NCT03522987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5676969|NCT03522961|Nitrofurantoin|nitrofurantoin|mesh-list
5676970|NCT03522961|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5676971|NCT03522961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5676972|NCT03522961|Renal Agents|renal agents|mesh-ancestor
5676973|NCT03522961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5676974|NCT03522935|Elafin|elafin|mesh-list
5863215|NCT02385071|Protease Inhibitors|protease inhibitors|mesh-ancestor
5863216|NCT02385071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5863217|NCT02385071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5863218|NCT02384668|Vitamin D|vitamin d|mesh-list
5863219|NCT02384668|Cholecalciferol|cholecalciferol|mesh-list
5863220|NCT02384668|Vitamins|vitamins|mesh-ancestor
5863221|NCT02384668|Micronutrients|micronutrients|mesh-ancestor
5863222|NCT02384668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863223|NCT02384668|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5863224|NCT02384668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5863225|NCT02384915|Prilocaine|prilocaine|mesh-list
5863226|NCT02384915|Mepivacaine|mepivacaine|mesh-list
5863227|NCT02384915|Anesthetics|anesthetics|mesh-ancestor
5863228|NCT02384915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5863229|NCT02384915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863230|NCT02384915|Anesthetics, Local|anesthetics, local|mesh-ancestor
5863231|NCT02384915|Sensory System Agents|sensory system agents|mesh-ancestor
5863232|NCT02384915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5863233|NCT02384954|Rituximab|rituximab|mesh-list
5863234|NCT02384954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5863235|NCT02384954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5863236|NCT02384954|Immunologic Factors|immunologic factors|mesh-ancestor
5863237|NCT02384954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863238|NCT02384954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5863239|NCT02384967|Darunavir|darunavir|mesh-list
5863240|NCT02384967|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5863241|NCT02384967|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5863242|NCT02384967|Protease Inhibitors|protease inhibitors|mesh-ancestor
5863243|NCT02384967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5863244|NCT02384967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5863245|NCT02384967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5863246|NCT02384967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5863247|NCT02384967|Antiviral Agents|antiviral agents|mesh-ancestor
5863248|NCT02384967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5863249|NCT02384850|Leucovorin|leucovorin|mesh-list
5863250|NCT02384850|Folic Acid|folic acid|mesh-list
5863251|NCT02384850|Oxaliplatin|oxaliplatin|mesh-list
5863252|NCT02384850|Levoleucovorin|levoleucovorin|mesh-list
5676975|NCT03522935|Protease Inhibitors|protease inhibitors|mesh-ancestor
5676976|NCT03522935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5863253|NCT02384850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5863254|NCT02384850|Antidotes|antidotes|mesh-ancestor
5863255|NCT02384850|Protective Agents|protective agents|mesh-ancestor
5863256|NCT02384850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863257|NCT02384850|Vitamin B Complex|vitamin b complex|mesh-ancestor
5863258|NCT02384850|Vitamins|vitamins|mesh-ancestor
5863259|NCT02384850|Micronutrients|micronutrients|mesh-ancestor
5863260|NCT02384850|Hematinics|hematinics|mesh-ancestor
5676977|NCT03522935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696545|NCT03382470|Anti-Infective Agents|anti-infective agents|mesh-list
5696546|NCT03382470|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5696547|NCT03382431|PC-786|pc-786|mesh-list
5696548|NCT03382431|Antiviral Agents|antiviral agents|mesh-ancestor
5863261|NCT02384876|Ephedrine|ephedrine|mesh-list
5863262|NCT02384876|Pseudoephedrine|pseudoephedrine|mesh-list
5863263|NCT02384876|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5863264|NCT02384876|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5863265|NCT02384876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863266|NCT02384876|Sympathomimetics|sympathomimetics|mesh-ancestor
5863267|NCT02384876|Autonomic Agents|autonomic agents|mesh-ancestor
5863268|NCT02384876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5863269|NCT02384876|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5863270|NCT02384876|Adrenergic Agents|adrenergic agents|mesh-ancestor
5863271|NCT02384876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5863272|NCT02384876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5863273|NCT02384876|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5863274|NCT02384876|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5863275|NCT02384876|Respiratory System Agents|respiratory system agents|mesh-ancestor
5863276|NCT02384876|Nasal Decongestants|nasal decongestants|mesh-ancestor
5863277|NCT02384837|Sirolimus|sirolimus|mesh-list
5863278|NCT02384837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5863279|NCT02384837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5863280|NCT02384837|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5863281|NCT02384837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5863282|NCT02384837|Antifungal Agents|antifungal agents|mesh-ancestor
5863283|NCT02384837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5863284|NCT02384837|Immunologic Factors|immunologic factors|mesh-ancestor
5863285|NCT02384837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863286|NCT02384889|Eflornithine|eflornithine|mesh-list
5863287|NCT02384889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5863288|NCT02384889|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5863289|NCT02384889|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5863290|NCT02384889|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5863291|NCT02384889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5863292|NCT02384889|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
5863293|NCT02384889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5863294|NCT02384889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5863295|NCT02384759|Aflibercept|aflibercept|mesh-list
5863296|NCT02384759|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5863297|NCT02384759|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5863298|NCT02384759|Growth Substances|growth substances|mesh-ancestor
5863299|NCT02384759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863300|NCT02384759|Growth Inhibitors|growth inhibitors|mesh-ancestor
5863301|NCT02384759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5863302|NCT02384655|Fenugreek seed meal|fenugreek seed meal|mesh-list
5863303|NCT02384655|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5696549|NCT03382431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5696550|NCT03382431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5696551|NCT03382431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696552|NCT03382314|Cholecalciferol|cholecalciferol|mesh-list
5696553|NCT03382314|Bazedoxifene|bazedoxifene|mesh-list
5696554|NCT03382314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5696555|NCT03382314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696556|NCT03382314|Vitamins|vitamins|mesh-ancestor
5696557|NCT03382314|Micronutrients|micronutrients|mesh-ancestor
5696558|NCT03382314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5696559|NCT03382314|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5696560|NCT03382314|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5696561|NCT03382314|Hormone Antagonists|hormone antagonists|mesh-ancestor
5696562|NCT03382314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5696563|NCT03382275|Iron|iron|mesh-list
5696564|NCT03382275|Ferric maltol|ferric maltol|mesh-list
5696565|NCT03382275|Trace Elements|trace elements|mesh-ancestor
5696566|NCT03382275|Micronutrients|micronutrients|mesh-ancestor
5696567|NCT03382275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696568|NCT03382275|Hematinics|hematinics|mesh-ancestor
5863304|NCT02384655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863305|NCT02384746|Fulvestrant|fulvestrant|mesh-list
5863306|NCT02384746|Ixazomib|ixazomib|mesh-list
5863307|NCT02384746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5863308|NCT02384746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5863309|NCT02384746|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5863310|NCT02384746|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5863311|NCT02384746|Hormone Antagonists|hormone antagonists|mesh-ancestor
5863312|NCT02384746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5863313|NCT02384746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863314|NCT02384746|Protease Inhibitors|protease inhibitors|mesh-ancestor
5863315|NCT02384746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5863316|NCT02384746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5863317|NCT02384239|Palbociclib|palbociclib|mesh-list
5863318|NCT02384239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5676978|NCT03522922|Ascorbic Acid|ascorbic acid|mesh-list
5676979|NCT03522922|Vitamins|vitamins|mesh-ancestor
5676980|NCT03522922|Micronutrients|micronutrients|mesh-ancestor
5676981|NCT03522922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5676982|NCT03522922|Antioxidants|antioxidants|mesh-ancestor
5676983|NCT03522922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676984|NCT03522922|Protective Agents|protective agents|mesh-ancestor
5676985|NCT03522831|Albuterol|albuterol|mesh-list
5676986|NCT03522831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5676987|NCT03522831|Autonomic Agents|autonomic agents|mesh-ancestor
5676988|NCT03522831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5676989|NCT03522831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863319|NCT02384239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5863320|NCT02384239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5863321|NCT02384239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5863322|NCT02384343|Dexmedetomidine|dexmedetomidine|mesh-list
5863323|NCT02384343|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5863324|NCT02384343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5863325|NCT02384343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863326|NCT02384343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5863327|NCT02384343|Analgesics|analgesics|mesh-ancestor
5863328|NCT02384343|Sensory System Agents|sensory system agents|mesh-ancestor
5863329|NCT02384343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5863330|NCT02384343|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5863331|NCT02384343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5863332|NCT02384343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5863333|NCT02384343|Adrenergic Agents|adrenergic agents|mesh-ancestor
5863334|NCT02384343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5863335|NCT02384343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5863336|NCT02384499|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
5863337|NCT02384499|Hemostatics|hemostatics|mesh-ancestor
5863338|NCT02384499|Coagulants|coagulants|mesh-ancestor
5863339|NCT02384512|Rasagiline|rasagiline|mesh-list
5863340|NCT02384512|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
5863341|NCT02384512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5863342|NCT02384512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5863343|NCT02384512|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5863344|NCT02384512|Protective Agents|protective agents|mesh-ancestor
5863345|NCT02384512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863346|NCT02384135|Fibrin fragment D|fibrin fragment d|mesh-list
5863347|NCT02384135|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6675044|NCT01572454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6675045|NCT01572454|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6675046|NCT01572454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6675047|NCT01572454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6675048|NCT01572454|Adrenergic Agents|adrenergic agents|mesh-ancestor
6675049|NCT01572454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6675050|NCT01572454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675051|NCT01572454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6675052|NCT01572454|Narcotics|narcotics|mesh-ancestor
6675053|NCT01572545|Zoledronic Acid|zoledronic acid|mesh-list
6675054|NCT01572545|Denosumab|denosumab|mesh-list
6675055|NCT01572545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6675056|NCT01572545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675057|NCT01572558|Ciprofloxacin|ciprofloxacin|mesh-list
6675058|NCT01572558|Meropenem|meropenem|mesh-list
6675059|NCT01572558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6675060|NCT01572558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6675061|NCT01572558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6675062|NCT01572558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6675063|NCT01572558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5863348|NCT02384135|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5863349|NCT02384135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5863350|NCT02384135|Hemostatics|hemostatics|mesh-ancestor
5863351|NCT02384135|Coagulants|coagulants|mesh-ancestor
5863352|NCT02384122|Octreotide|octreotide|mesh-list
5863353|NCT02384122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5863354|NCT02384122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5863355|NCT02384122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5863356|NCT02383901|Methotrexate|methotrexate|mesh-list
5863357|NCT02383901|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5863358|NCT02383901|Abortifacient Agents|abortifacient agents|mesh-ancestor
5863359|NCT02383901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5863360|NCT02383901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863361|NCT02383901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5863362|NCT02383901|Antimetabolites|antimetabolites|mesh-ancestor
5863363|NCT02383901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5676990|NCT03522831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5676991|NCT03522831|Respiratory System Agents|respiratory system agents|mesh-ancestor
5676992|NCT03522831|Tocolytic Agents|tocolytic agents|mesh-ancestor
5676993|NCT03522831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5676994|NCT03522831|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5676995|NCT03522831|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5676996|NCT03522831|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5676997|NCT03522831|Adrenergic Agents|adrenergic agents|mesh-ancestor
5676998|NCT03522831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5676999|NCT03522831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5677000|NCT03522688|Dexmedetomidine|dexmedetomidine|mesh-list
5677001|NCT03522688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5677002|NCT03522688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5677003|NCT03522688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677004|NCT03522688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5677005|NCT03522688|Analgesics|analgesics|mesh-ancestor
5677006|NCT03522688|Sensory System Agents|sensory system agents|mesh-ancestor
5677007|NCT03522688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5677008|NCT03522688|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5677009|NCT03522688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5677010|NCT03522688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5677011|NCT03522688|Adrenergic Agents|adrenergic agents|mesh-ancestor
5677012|NCT03522688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5677013|NCT03522688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5677014|NCT03522649|Leucovorin|leucovorin|mesh-list
5677015|NCT03522649|Fluorouracil|fluorouracil|mesh-list
5677016|NCT03522649|Irinotecan|irinotecan|mesh-list
5677017|NCT03522649|Antimetabolites|antimetabolites|mesh-ancestor
5677018|NCT03522649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5677019|NCT03522649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5677020|NCT03522649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5677021|NCT03522649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5863364|NCT02383901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5863365|NCT02383901|Dermatologic Agents|dermatologic agents|mesh-ancestor
5863366|NCT02383901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5863367|NCT02383901|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5863368|NCT02383901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5863369|NCT02383901|Immunologic Factors|immunologic factors|mesh-ancestor
5863370|NCT02383901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5863371|NCT02383901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5863372|NCT02383823|Estradiol|estradiol|mesh-list
5863373|NCT02383823|Estrogens|estrogens|mesh-list
5863374|NCT02383823|Hormones|hormones|mesh-ancestor
5863375|NCT02383823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5863376|NCT02383823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863377|NCT02383888|BI 425809|bi 425809|mesh-list
5863378|NCT02383888|Nootropic Agents|nootropic agents|mesh-ancestor
5863379|NCT02383927|Tipifarnib|tipifarnib|mesh-list
5863380|NCT02383927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5863381|NCT02384083|Dexamethasone|dexamethasone|mesh-list
5863382|NCT02384083|Pomalidomide|pomalidomide|mesh-list
5863383|NCT02384083|Filanesib|filanesib|mesh-list
5863384|NCT02384083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5863385|NCT02384083|Antiemetics|antiemetics|mesh-ancestor
5677022|NCT03522649|Immunologic Factors|immunologic factors|mesh-ancestor
5677023|NCT03522649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677024|NCT03522649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5677025|NCT03522649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5677026|NCT03522649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5863386|NCT02384083|Autonomic Agents|autonomic agents|mesh-ancestor
5863387|NCT02384083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5863388|NCT02384083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863389|NCT02384083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5863390|NCT02384083|Glucocorticoids|glucocorticoids|mesh-ancestor
5863391|NCT02384083|Hormones|hormones|mesh-ancestor
5863392|NCT02384083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5863393|NCT02384083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5863394|NCT02384083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5863395|NCT02384083|Immunologic Factors|immunologic factors|mesh-ancestor
5863396|NCT02384083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5863397|NCT02384083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5863398|NCT02384083|Growth Substances|growth substances|mesh-ancestor
5677027|NCT03522649|Antidotes|antidotes|mesh-ancestor
5677028|NCT03522649|Protective Agents|protective agents|mesh-ancestor
5677029|NCT03522649|Vitamin B Complex|vitamin b complex|mesh-ancestor
5677030|NCT03522649|Vitamins|vitamins|mesh-ancestor
5677031|NCT03522649|Micronutrients|micronutrients|mesh-ancestor
5677032|NCT03522532|Zinc|zinc|mesh-list
5677033|NCT03522532|Trace Elements|trace elements|mesh-ancestor
5677034|NCT03522532|Micronutrients|micronutrients|mesh-ancestor
5677035|NCT03522532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863399|NCT02384083|Growth Inhibitors|growth inhibitors|mesh-ancestor
5863400|NCT02384083|Antimitotic Agents|antimitotic agents|mesh-ancestor
5863401|NCT02384083|Mitosis Modulators|mitosis modulators|mesh-ancestor
5863402|NCT02384083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5863403|NCT02384187|Gabapentin|gabapentin|mesh-list
5863404|NCT02384187|Analgesics|analgesics|mesh-ancestor
5863405|NCT02384187|Sensory System Agents|sensory system agents|mesh-ancestor
5863406|NCT02384187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5863407|NCT02384187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863408|NCT02384187|Anticonvulsants|anticonvulsants|mesh-ancestor
5863409|NCT02384187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5863410|NCT02384187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5863411|NCT02384187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5863412|NCT02384187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5863413|NCT02384187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5863414|NCT02384187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5863415|NCT02384187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5863416|NCT02384187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5863417|NCT02384187|Antimanic Agents|antimanic agents|mesh-ancestor
5863418|NCT02383680|Vaccines|vaccines|mesh-list
5863419|NCT02383680|Immunologic Factors|immunologic factors|mesh-ancestor
5863420|NCT02383680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863421|NCT02383771|Aspirin|aspirin|mesh-list
5863422|NCT02383771|Ticagrelor|ticagrelor|mesh-list
5863423|NCT02383771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5863424|NCT02383771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5677036|NCT03522428|Vitamin B 12|vitamin b 12|mesh-list
5677037|NCT03522428|Hydroxocobalamin|hydroxocobalamin|mesh-list
5677038|NCT03522428|Vitamins|vitamins|mesh-ancestor
6675064|NCT01572558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675065|NCT01572558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6675066|NCT01572558|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5863425|NCT02383771|Analgesics|analgesics|mesh-ancestor
5863426|NCT02383771|Sensory System Agents|sensory system agents|mesh-ancestor
5863427|NCT02383771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5863428|NCT02383771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863429|NCT02383771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6675067|NCT01572558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6675068|NCT01572597|Metronidazole|metronidazole|mesh-list
6675069|NCT01572597|Clarithromycin|clarithromycin|mesh-list
5677039|NCT03522428|Micronutrients|micronutrients|mesh-ancestor
5677040|NCT03522428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677041|NCT03522428|Vitamin B Complex|vitamin b complex|mesh-ancestor
5677042|NCT03522428|Hematinics|hematinics|mesh-ancestor
5677043|NCT03522415|Methotrexate|methotrexate|mesh-list
5677044|NCT03522415|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5677045|NCT03522415|Abortifacient Agents|abortifacient agents|mesh-ancestor
5677046|NCT03522415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5677047|NCT03522415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677048|NCT03522415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5677049|NCT03522415|Antimetabolites|antimetabolites|mesh-ancestor
5677050|NCT03522415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5677051|NCT03522415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5863430|NCT02383771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5863431|NCT02383771|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5863432|NCT02383771|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5863433|NCT02383771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5863434|NCT02383771|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5863435|NCT02383771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5863436|NCT02383771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5863437|NCT02383771|Antipyretics|antipyretics|mesh-ancestor
5863438|NCT02383771|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5863439|NCT02383771|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5863440|NCT02383771|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5863441|NCT02383771|Purinergic Agents|purinergic agents|mesh-ancestor
5863442|NCT02383771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5863443|NCT02383563|Metformin|metformin|mesh-list
5863444|NCT02383563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5863445|NCT02383563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863446|NCT02383121|Midodrine|midodrine|mesh-list
5863447|NCT02383121|Sympathomimetics|sympathomimetics|mesh-ancestor
5863448|NCT02383121|Autonomic Agents|autonomic agents|mesh-ancestor
5863449|NCT02383121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5863450|NCT02383121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863451|NCT02383121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5863452|NCT02383121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5863453|NCT02383121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5863454|NCT02383121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5863455|NCT02383121|Adrenergic Agents|adrenergic agents|mesh-ancestor
5863456|NCT02383121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5863457|NCT02383121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5863458|NCT02383212|Paclitaxel|paclitaxel|mesh-list
5863459|NCT02383212|Docetaxel|docetaxel|mesh-list
5863460|NCT02383212|Cyclophosphamide|cyclophosphamide|mesh-list
5863461|NCT02383212|Carboplatin|carboplatin|mesh-list
5863462|NCT02383212|Pemetrexed|pemetrexed|mesh-list
5677052|NCT03522415|Dermatologic Agents|dermatologic agents|mesh-ancestor
5677053|NCT03522415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5677054|NCT03522415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5677055|NCT03522415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5677056|NCT03522415|Immunologic Factors|immunologic factors|mesh-ancestor
5863463|NCT02383212|Cemiplimab|cemiplimab|mesh-list
5863464|NCT02383212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5863465|NCT02383212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5863466|NCT02383212|Tubulin Modulators|tubulin modulators|mesh-ancestor
5863467|NCT02383212|Antimitotic Agents|antimitotic agents|mesh-ancestor
5863468|NCT02383212|Mitosis Modulators|mitosis modulators|mesh-ancestor
5863469|NCT02383212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5863470|NCT02383212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5863471|NCT02383212|Immunologic Factors|immunologic factors|mesh-ancestor
5863472|NCT02383212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863473|NCT02383212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5863474|NCT02383212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5863475|NCT02383212|Alkylating Agents|alkylating agents|mesh-ancestor
5863476|NCT02383212|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5863477|NCT02383212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5863478|NCT02383212|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5863479|NCT02383212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5863480|NCT02383212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5863481|NCT02383238|Dapagliflozin|dapagliflozin|mesh-list
5863482|NCT02383238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5863483|NCT02383238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5863484|NCT02383238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5863485|NCT02383238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863486|NCT02383030|Fulvestrant|fulvestrant|mesh-list
5863487|NCT02383030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5677057|NCT03522415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5677058|NCT03522415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5677059|NCT03522402|Sevoflurane|sevoflurane|mesh-list
5677060|NCT03522402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5677061|NCT03522402|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5677062|NCT03522402|Anesthetics, General|anesthetics, general|mesh-ancestor
5677063|NCT03522402|Anesthetics|anesthetics|mesh-ancestor
5677064|NCT03522402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5677065|NCT03522402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677066|NCT03522298|GDC-0084|gdc-0084|mesh-list
5677067|NCT03522298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5677068|NCT03522298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5677069|NCT03522259|Rivaroxaban|rivaroxaban|mesh-list
5677070|NCT03522259|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5677071|NCT03522259|Antithrombins|antithrombins|mesh-ancestor
5677072|NCT03522259|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5677073|NCT03522259|Protease Inhibitors|protease inhibitors|mesh-ancestor
5677074|NCT03522259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5677075|NCT03522259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5677076|NCT03522259|Anticoagulants|anticoagulants|mesh-ancestor
5677077|NCT03522207|Trazodone|trazodone|mesh-list
5677078|NCT03522207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5677079|NCT03522207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5677080|NCT03522207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5677081|NCT03522207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677082|NCT03522207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5677083|NCT03522207|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5677084|NCT03522207|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5677085|NCT03522207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5677086|NCT03522207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5863488|NCT02383030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5863489|NCT02383030|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5863490|NCT02383030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5863491|NCT02383030|Hormone Antagonists|hormone antagonists|mesh-ancestor
5863492|NCT02383030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5863493|NCT02383030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904864|NCT04245865|Vitamin B Complex|vitamin b complex|mesh-ancestor
5677087|NCT03522207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5677088|NCT03522207|Serotonin Agents|serotonin agents|mesh-ancestor
5677089|NCT03522207|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5904865|NCT04245865|Vitamins|vitamins|mesh-ancestor
5904866|NCT04245865|Micronutrients|micronutrients|mesh-ancestor
5904867|NCT04245865|Antioxidants|antioxidants|mesh-ancestor
5904868|NCT04244877|Rifaximin|rifaximin|mesh-list
5904869|NCT04244877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5904870|NCT04244877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5904871|NCT04244877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5904872|NCT04215120|Epoetin Alfa|epoetin alfa|mesh-list
5904873|NCT04215120|Hematinics|hematinics|mesh-ancestor
5904874|NCT04069897|Botulinum Toxins|botulinum toxins|mesh-list
5904875|NCT04069897|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5904876|NCT04069897|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5904877|NCT04069897|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5904878|NCT04069897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5904879|NCT04069897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904880|NCT04069897|Cholinergic Agents|cholinergic agents|mesh-ancestor
5904881|NCT04069897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5904882|NCT04069897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904883|NCT04069897|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5904884|NCT04069897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5904885|NCT04012957|Darbepoetin alfa|darbepoetin alfa|mesh-list
5904886|NCT04012957|Hematinics|hematinics|mesh-ancestor
5904887|NCT03991884|Prednisone|prednisone|mesh-list
5904888|NCT03991884|Cortisone|cortisone|mesh-list
5677090|NCT03522207|Antidepressive Agents|antidepressive agents|mesh-ancestor
5677091|NCT03522194|Propofol|propofol|mesh-list
5677092|NCT03522194|Sevoflurane|sevoflurane|mesh-list
5677093|NCT03522194|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5677094|NCT03522194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5677095|NCT03522194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677096|NCT03522194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5677097|NCT03522194|Anesthetics, General|anesthetics, general|mesh-ancestor
5677098|NCT03522194|Anesthetics|anesthetics|mesh-ancestor
5677099|NCT03522194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5677100|NCT03522194|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5677101|NCT03522181|Insulin|insulin|mesh-list
5677102|NCT03522181|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5677103|NCT03522181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5677104|NCT03522181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677105|NCT03522168|Risperidone|risperidone|mesh-list
5677106|NCT03522168|Aripiprazole|aripiprazole|mesh-list
5677107|NCT03522168|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5677108|NCT03522168|Serotonin Agents|serotonin agents|mesh-ancestor
5677109|NCT03522168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5677110|NCT03522168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5677111|NCT03522168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677112|NCT03522168|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5677113|NCT03522168|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5904889|NCT03991884|Cyclophosphamide|cyclophosphamide|mesh-list
5677114|NCT03522168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5677115|NCT03522168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5677116|NCT03522168|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5677117|NCT03522168|Dopamine Agents|dopamine agents|mesh-ancestor
5677118|NCT03522168|Antidepressive Agents|antidepressive agents|mesh-ancestor
5677119|NCT03522168|Dopamine Agonists|dopamine agonists|mesh-ancestor
5677120|NCT03522168|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5677121|NCT03522168|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5677122|NCT03522168|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5863494|NCT02382757|Insulin|insulin|mesh-list
5863495|NCT02382757|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5863496|NCT02382757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5863497|NCT02382757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863498|NCT02382653|Piroxicam|piroxicam|mesh-list
5863499|NCT02382653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5863500|NCT02382653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5863501|NCT02382653|Analgesics|analgesics|mesh-ancestor
5863502|NCT02382653|Sensory System Agents|sensory system agents|mesh-ancestor
5863503|NCT02382653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5863504|NCT02382653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863505|NCT02382653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5863506|NCT02382653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5863507|NCT02382653|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5863508|NCT02382653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5863509|NCT02382653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5863510|NCT02382679|Vitamins|vitamins|mesh-list
5863511|NCT02382679|Micronutrients|micronutrients|mesh-ancestor
5863512|NCT02382679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863513|NCT02382666|Rolapitant|rolapitant|mesh-list
5863514|NCT02382666|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5863515|NCT02382666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5863516|NCT02382666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5863517|NCT02382666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863518|NCT02382575|Rituximab|rituximab|mesh-list
5863519|NCT02382575|Tacrolimus|tacrolimus|mesh-list
5863520|NCT02382575|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
5863521|NCT02382575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5863522|NCT02382575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5863523|NCT02382575|Immunologic Factors|immunologic factors|mesh-ancestor
5863524|NCT02382575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863525|NCT02382575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5863526|NCT02382575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5863527|NCT02382575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5863528|NCT02382575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5863529|NCT02382380|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
5863530|NCT02382380|Chelating Agents|chelating agents|mesh-ancestor
5677123|NCT03522168|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5677124|NCT03522077|Hemostatics|hemostatics|mesh-list
5677125|NCT03522077|Coagulants|coagulants|mesh-ancestor
5677126|NCT03522051|Calcium|calcium|mesh-list
5677127|NCT03522051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5677128|NCT03522051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677129|NCT03521960|Buspirone|buspirone|mesh-list
5677130|NCT03521960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5677131|NCT03521960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5677132|NCT03521960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5677133|NCT03521960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677134|NCT03521960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5677135|NCT03521960|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5677136|NCT03521960|Serotonin Agents|serotonin agents|mesh-ancestor
5677137|NCT03521960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5677138|NCT03521960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5677139|NCT03521895|Aflibercept|aflibercept|mesh-list
5677140|NCT03521895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5677141|NCT03521895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5677142|NCT03521895|Growth Substances|growth substances|mesh-ancestor
5677143|NCT03521895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677144|NCT03521895|Growth Inhibitors|growth inhibitors|mesh-ancestor
5677145|NCT03521895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5677146|NCT03521830|Nivolumab|nivolumab|mesh-list
5677147|NCT03521830|Ipilimumab|ipilimumab|mesh-list
5677148|NCT03521830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5677149|NCT03521830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5677150|NCT03521830|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5863531|NCT02382380|Sequestering Agents|sequestering agents|mesh-ancestor
5863532|NCT02382380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5863533|NCT02382549|Trametinib|trametinib|mesh-list
5863534|NCT02382549|Dabrafenib|dabrafenib|mesh-list
5863535|NCT02382549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5863536|NCT02382549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5863537|NCT02382549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5863538|NCT02382549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5863539|NCT02382263|Gemcitabine|gemcitabine|mesh-list
5863540|NCT02382263|Paclitaxel|paclitaxel|mesh-list
5863541|NCT02382263|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5863542|NCT02382263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5863543|NCT02382263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5677151|NCT03521830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5677152|NCT03521726|Amoxicillin|amoxicillin|mesh-list
5677153|NCT03521726|Rabeprazole|rabeprazole|mesh-list
5677154|NCT03521726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5677155|NCT03521726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5677156|NCT03521726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5677157|NCT03521726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5677158|NCT03521726|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5863544|NCT02382263|Tubulin Modulators|tubulin modulators|mesh-ancestor
5863545|NCT02382263|Antimitotic Agents|antimitotic agents|mesh-ancestor
5863546|NCT02382263|Mitosis Modulators|mitosis modulators|mesh-ancestor
5863547|NCT02382263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5863548|NCT02382263|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5863549|NCT02382263|Antimetabolites|antimetabolites|mesh-ancestor
5863550|NCT02382263|Antiviral Agents|antiviral agents|mesh-ancestor
5863551|NCT02382263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5863552|NCT02382263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5863553|NCT02382263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5863554|NCT02382263|Immunologic Factors|immunologic factors|mesh-ancestor
5863555|NCT02382263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863556|NCT02382445|Anesthetics|anesthetics|mesh-list
5863557|NCT02382445|Propofol|propofol|mesh-list
6494672|NCT00619697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494673|NCT00619697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6494674|NCT00619697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6494675|NCT00619697|Immunologic Factors|immunologic factors|mesh-ancestor
6494676|NCT00619710|Meropenem|meropenem|mesh-list
5863558|NCT02382445|Sevoflurane|sevoflurane|mesh-list
5863559|NCT02382445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5863560|NCT02382445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863561|NCT02382445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5863562|NCT02382445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5677159|NCT03521726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5863563|NCT02382445|Anesthetics, General|anesthetics, general|mesh-ancestor
5863564|NCT02382445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5863565|NCT02382445|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5863566|NCT02382354|Remifentanil|remifentanil|mesh-list
5863567|NCT02382354|Propofol|propofol|mesh-list
5863568|NCT02382354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5863569|NCT02382354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5863570|NCT02382354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863571|NCT02382354|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5863572|NCT02382354|Anesthetics, General|anesthetics, general|mesh-ancestor
5863573|NCT02382354|Anesthetics|anesthetics|mesh-ancestor
5863574|NCT02382354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5863575|NCT02382354|Narcotics|narcotics|mesh-ancestor
5863576|NCT02382354|Analgesics|analgesics|mesh-ancestor
5863577|NCT02382354|Sensory System Agents|sensory system agents|mesh-ancestor
5863578|NCT02382354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5863579|NCT02382328|Thioctic Acid|thioctic acid|mesh-list
5863580|NCT02382328|Antioxidants|antioxidants|mesh-ancestor
5863581|NCT02382328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5863582|NCT02382328|Protective Agents|protective agents|mesh-ancestor
5863583|NCT02382328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863584|NCT02382328|Vitamin B Complex|vitamin b complex|mesh-ancestor
5863585|NCT02382328|Vitamins|vitamins|mesh-ancestor
5863586|NCT02382328|Micronutrients|micronutrients|mesh-ancestor
5863587|NCT02382198|Glycopyrrolate|glycopyrrolate|mesh-list
5863588|NCT02382198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5863589|NCT02382198|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5863590|NCT02382198|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5863591|NCT02382198|Cholinergic Agents|cholinergic agents|mesh-ancestor
5863592|NCT02382198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6494677|NCT00619710|Imipenem|imipenem|mesh-list
6675070|NCT01572597|Acetylcysteine|acetylcysteine|mesh-list
5863593|NCT02382198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5863594|NCT02382198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863595|NCT02382523|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
5863596|NCT02382523|Hormones|hormones|mesh-ancestor
5863597|NCT02382523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5863598|NCT02382523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863599|NCT02382432|Meperidine|meperidine|mesh-list
5863600|NCT02382432|Dexmedetomidine|dexmedetomidine|mesh-list
5863601|NCT02382432|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5863602|NCT02382432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5863603|NCT02382432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863604|NCT02382432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5863605|NCT02382432|Analgesics|analgesics|mesh-ancestor
5863606|NCT02382432|Sensory System Agents|sensory system agents|mesh-ancestor
5863607|NCT02382432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5863608|NCT02382432|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5863609|NCT02382432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5863610|NCT02382432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5863611|NCT02382432|Adrenergic Agents|adrenergic agents|mesh-ancestor
5863612|NCT02382432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5863613|NCT02382432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5863614|NCT02382432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5863615|NCT02382432|Narcotics|narcotics|mesh-ancestor
5863616|NCT02382432|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5863617|NCT02382146|Dexamethasone|dexamethasone|mesh-list
5863618|NCT02382146|Dexamethasone acetate|dexamethasone acetate|mesh-list
5863619|NCT02382146|Ondansetron|ondansetron|mesh-list
5863620|NCT02382146|BB 1101|bb 1101|mesh-list
5863621|NCT02382146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5863622|NCT02382146|Antiemetics|antiemetics|mesh-ancestor
5863623|NCT02382146|Autonomic Agents|autonomic agents|mesh-ancestor
6675071|NCT01572597|Rabeprazole|rabeprazole|mesh-list
6675072|NCT01572597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6675073|NCT01572597|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6675074|NCT01572597|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6675075|NCT01572597|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6675076|NCT01572597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6675077|NCT01572597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6675078|NCT01572597|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6675079|NCT01572597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6675080|NCT01572597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675081|NCT01572597|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5863624|NCT02382146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5863625|NCT02382146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863626|NCT02382146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5863627|NCT02382146|Glucocorticoids|glucocorticoids|mesh-ancestor
5863628|NCT02382146|Hormones|hormones|mesh-ancestor
5863629|NCT02382146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5863630|NCT02382146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5863631|NCT02382146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5863632|NCT02382146|Protease Inhibitors|protease inhibitors|mesh-ancestor
5863633|NCT02382146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5863634|NCT02382146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5863635|NCT02382146|Antipruritics|antipruritics|mesh-ancestor
5863636|NCT02382146|Dermatologic Agents|dermatologic agents|mesh-ancestor
5863637|NCT02382146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5863638|NCT02382146|Serotonin Agents|serotonin agents|mesh-ancestor
5863639|NCT02382146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5863640|NCT02382146|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5863641|NCT02382146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5863642|NCT02382146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5863643|NCT02382146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5863644|NCT02382146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5863645|NCT02381964|Coenzyme Q10|coenzyme q10|mesh-list
5863646|NCT02381964|Vitamins|vitamins|mesh-ancestor
5863647|NCT02381964|Micronutrients|micronutrients|mesh-ancestor
5863648|NCT02381964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863649|NCT02382068|Dexamethasone|dexamethasone|mesh-list
5863650|NCT02382068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5863651|NCT02382068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5863652|NCT02382068|Antiemetics|antiemetics|mesh-ancestor
5863653|NCT02382068|Autonomic Agents|autonomic agents|mesh-ancestor
5863654|NCT02382068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5863655|NCT02382068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863656|NCT02382068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5863657|NCT02382068|Glucocorticoids|glucocorticoids|mesh-ancestor
5863658|NCT02382068|Hormones|hormones|mesh-ancestor
5863659|NCT02382068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5863660|NCT02382068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5863661|NCT02382094|Bicalutamide|bicalutamide|mesh-list
6212279|NCT02185131|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6212280|NCT02185131|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6212281|NCT02185131|Serotonin Agents|serotonin agents|mesh-ancestor
6212282|NCT02185131|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6212283|NCT02185339|Rocuronium|rocuronium|mesh-list
6212284|NCT02185339|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6212285|NCT02185339|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6212286|NCT02185339|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6212287|NCT02185339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6212288|NCT02185339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212289|NCT02185534|Clopidogrel|clopidogrel|mesh-list
5677160|NCT03521726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5677161|NCT03521713|Epoetin Alfa|epoetin alfa|mesh-list
5677162|NCT03521713|Hematinics|hematinics|mesh-ancestor
5677163|NCT03521700|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5677164|NCT03521700|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5677165|NCT03521700|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5677166|NCT03521700|Antimetabolites|antimetabolites|mesh-ancestor
6212290|NCT02185534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6212291|NCT02185534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6212292|NCT02185534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6212293|NCT02185534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6212294|NCT02185534|Purinergic Agents|purinergic agents|mesh-ancestor
5863662|NCT02382094|Androgen Antagonists|androgen antagonists|mesh-ancestor
5863663|NCT02382094|Hormone Antagonists|hormone antagonists|mesh-ancestor
5863664|NCT02382094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5863665|NCT02382094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863666|NCT02382094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5863667|NCT02382029|Clonazepam|clonazepam|mesh-list
5863668|NCT02382029|Anticonvulsants|anticonvulsants|mesh-ancestor
5863669|NCT02382029|GABA Modulators|gaba modulators|mesh-ancestor
5863670|NCT02382029|GABA Agents|gaba agents|mesh-ancestor
5863671|NCT02382029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5863672|NCT02382029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5863673|NCT02382029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863674|NCT02381899|Rituximab|rituximab|mesh-list
5863675|NCT02381899|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5863676|NCT02381899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5863677|NCT02381899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5863678|NCT02381899|Immunologic Factors|immunologic factors|mesh-ancestor
5863679|NCT02381899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677167|NCT03521700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5677168|NCT03521700|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5677169|NCT03521700|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5677170|NCT03521700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5677171|NCT03521492|Vitamin D|vitamin d|mesh-list
5677172|NCT03521492|Calcium|calcium|mesh-list
5677173|NCT03521492|Parathyroid Hormone|parathyroid hormone|mesh-list
5677174|NCT03521492|Hormones|hormones|mesh-list
5677175|NCT03521492|Vitamins|vitamins|mesh-ancestor
5677176|NCT03521492|Micronutrients|micronutrients|mesh-ancestor
5677177|NCT03521492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677178|NCT03521492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5677179|NCT03521492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5677180|NCT03521492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5677181|NCT03521414|Sevoflurane|sevoflurane|mesh-list
5677182|NCT03521414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5677183|NCT03521414|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5677184|NCT03521414|Anesthetics, General|anesthetics, general|mesh-ancestor
5677185|NCT03521414|Anesthetics|anesthetics|mesh-ancestor
5677186|NCT03521414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5677187|NCT03521414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696569|NCT03382106|Sildenafil Citrate|sildenafil citrate|mesh-list
5696570|NCT03382106|Vasodilator Agents|vasodilator agents|mesh-ancestor
5696571|NCT03382106|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5696572|NCT03382106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5696573|NCT03382106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5696574|NCT03382106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696575|NCT03382106|Urological Agents|urological agents|mesh-ancestor
5863680|NCT02381899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5863681|NCT02381899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5863682|NCT02381899|Alkylating Agents|alkylating agents|mesh-ancestor
5863683|NCT02381899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5863684|NCT02381600|Vitamin D|vitamin d|mesh-list
5863685|NCT02381600|Vitamins|vitamins|mesh-ancestor
5863686|NCT02381600|Micronutrients|micronutrients|mesh-ancestor
5863687|NCT02381600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863688|NCT02381600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5863689|NCT02381717|Morphine|morphine|mesh-list
5863690|NCT02381717|Bupivacaine|bupivacaine|mesh-list
5863691|NCT02381717|Anesthetics, Local|anesthetics, local|mesh-ancestor
5863692|NCT02381717|Anesthetics|anesthetics|mesh-ancestor
5863693|NCT02381717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5863694|NCT02381717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863695|NCT02381717|Sensory System Agents|sensory system agents|mesh-ancestor
5863696|NCT02381717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5863697|NCT02381717|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5863698|NCT02381717|Narcotics|narcotics|mesh-ancestor
5863699|NCT02381717|Analgesics|analgesics|mesh-ancestor
5863700|NCT02381730|Aflibercept|aflibercept|mesh-list
5863701|NCT02381730|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5863702|NCT02381730|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5863703|NCT02381730|Growth Substances|growth substances|mesh-ancestor
5863704|NCT02381730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863705|NCT02381730|Growth Inhibitors|growth inhibitors|mesh-ancestor
5863706|NCT02381730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5863707|NCT02381548|Belinostat|belinostat|mesh-list
5863708|NCT02381548|Adavosertib|adavosertib|mesh-list
5863709|NCT02381548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5863710|NCT02381548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5863711|NCT02381548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5863712|NCT02381548|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5863713|NCT02381249|Octreotide|octreotide|mesh-list
5863714|NCT02381249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5863715|NCT02381249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5863716|NCT02381249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5863717|NCT02381314|Ipilimumab|ipilimumab|mesh-list
5677188|NCT03521245|Trastuzumab|trastuzumab|mesh-list
5677189|NCT03521245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5677190|NCT03521245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5677191|NCT03521219|Apatinib|apatinib|mesh-list
5677192|NCT03521219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5677193|NCT03521219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5677194|NCT03521219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5677195|NCT03521219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5677196|NCT03521167|Acetaminophen|acetaminophen|mesh-list
5677197|NCT03521167|Lidocaine|lidocaine|mesh-list
5677198|NCT03521167|Dexmedetomidine|dexmedetomidine|mesh-list
5863718|NCT02381314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5863719|NCT02381314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5863720|NCT02381314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5863721|NCT02381314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904890|NCT03991884|Doxorubicin|doxorubicin|mesh-list
5904891|NCT03991884|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5904892|NCT03991884|Etoposide|etoposide|mesh-list
5904893|NCT03991884|Vincristine|vincristine|mesh-list
5904894|NCT03991884|Etoposide phosphate|etoposide phosphate|mesh-list
5904895|NCT03991884|Daunorubicin|daunorubicin|mesh-list
5904896|NCT03991884|Podophyllotoxin|podophyllotoxin|mesh-list
5904897|NCT03991884|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
5904898|NCT03991884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5904899|NCT03991884|Immunologic Factors|immunologic factors|mesh-ancestor
5904900|NCT03991884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904901|NCT03991884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5904902|NCT03991884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5677199|NCT03521167|Ketamine|ketamine|mesh-list
5677200|NCT03521167|Gabapentin|gabapentin|mesh-list
5677201|NCT03521167|Anesthetics, Local|anesthetics, local|mesh-ancestor
5677202|NCT03521167|Anesthetics|anesthetics|mesh-ancestor
5677203|NCT03521167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5677204|NCT03521167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677205|NCT03521167|Sensory System Agents|sensory system agents|mesh-ancestor
5677206|NCT03521167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5904903|NCT03991884|Alkylating Agents|alkylating agents|mesh-ancestor
5904904|NCT03991884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5677207|NCT03521167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5863722|NCT02381275|Tenofovir|tenofovir|mesh-list
5863723|NCT02381275|Antiviral Agents|antiviral agents|mesh-ancestor
5863724|NCT02381275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5863725|NCT02381275|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5863726|NCT02381275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5863727|NCT02381275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5863728|NCT02381275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5863729|NCT02381275|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5863730|NCT02381275|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5863731|NCT02381353|Bupivacaine|bupivacaine|mesh-list
5863732|NCT02381353|Anesthetics, Local|anesthetics, local|mesh-ancestor
5863733|NCT02381353|Anesthetics|anesthetics|mesh-ancestor
5863734|NCT02381353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5863735|NCT02381353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863736|NCT02381353|Sensory System Agents|sensory system agents|mesh-ancestor
5863737|NCT02381353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5863738|NCT02381184|Clomiphene|clomiphene|mesh-list
5863739|NCT02381184|Enclomiphene|enclomiphene|mesh-list
5863740|NCT02381184|Zuclomiphene|zuclomiphene|mesh-list
5863741|NCT02381184|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5863742|NCT02381184|Hormone Antagonists|hormone antagonists|mesh-ancestor
5863743|NCT02381184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5863744|NCT02381184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863745|NCT02381184|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5863746|NCT02381184|Fertility Agents|fertility agents|mesh-ancestor
5863747|NCT02381184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5863748|NCT02381184|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5863749|NCT02381184|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5863750|NCT02381470|Amoxicillin|amoxicillin|mesh-list
5863751|NCT02381470|Rifampin|rifampin|mesh-list
5863752|NCT02381470|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5863753|NCT02381470|Clavulanic Acids|clavulanic acids|mesh-list
5863754|NCT02381470|Clavulanic Acid|clavulanic acid|mesh-list
5863755|NCT02381470|Cefadroxil|cefadroxil|mesh-list
5863756|NCT02381470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5863757|NCT02381470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5863758|NCT02381470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5863759|NCT02381470|Antitubercular Agents|antitubercular agents|mesh-ancestor
5863760|NCT02381470|Leprostatic Agents|leprostatic agents|mesh-ancestor
5863761|NCT02381470|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5863762|NCT02381470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5863763|NCT02381470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5863764|NCT02381470|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5863765|NCT02381470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5863766|NCT02381470|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5863767|NCT02381470|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5863768|NCT02381470|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5863769|NCT02381470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5863770|NCT02381470|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5863771|NCT02381158|Beclomethasone|beclomethasone|mesh-list
5863772|NCT02381158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5863773|NCT02381158|Glucocorticoids|glucocorticoids|mesh-ancestor
5863774|NCT02381158|Hormones|hormones|mesh-ancestor
5863775|NCT02381158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5863776|NCT02381158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863777|NCT02381158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5863778|NCT02381158|Respiratory System Agents|respiratory system agents|mesh-ancestor
5863779|NCT02381028|Emollients|emollients|mesh-list
5863780|NCT02381028|Dermatologic Agents|dermatologic agents|mesh-ancestor
5863781|NCT02381379|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5863782|NCT02381379|Antiviral Agents|antiviral agents|mesh-ancestor
5863783|NCT02381379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5863784|NCT02381145|Resveratrol|resveratrol|mesh-list
5863785|NCT02381145|Antioxidants|antioxidants|mesh-ancestor
5863786|NCT02381145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5863787|NCT02381145|Protective Agents|protective agents|mesh-ancestor
5863788|NCT02381145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863789|NCT02381145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5863790|NCT02381145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5863791|NCT02381080|Voriconazole|voriconazole|mesh-list
5863792|NCT02381080|Erythromycin|erythromycin|mesh-list
5863793|NCT02381080|Erythromycin Estolate|erythromycin estolate|mesh-list
5863794|NCT02381080|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
5863795|NCT02381080|Erythromycin stearate|erythromycin stearate|mesh-list
5863796|NCT02381080|Antifungal Agents|antifungal agents|mesh-ancestor
5863797|NCT02381080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5863798|NCT02381080|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5863799|NCT02381080|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5863800|NCT02381080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5863801|NCT02381080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5863802|NCT02381080|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5863803|NCT02381080|Hormone Antagonists|hormone antagonists|mesh-ancestor
5863804|NCT02381080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5863805|NCT02381080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863806|NCT02381080|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5863807|NCT02381080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5863808|NCT02381080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5863809|NCT02381080|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5863810|NCT02380898|Ketorolac|ketorolac|mesh-list
5863811|NCT02380898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5863812|NCT02380898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5863813|NCT02380898|Analgesics|analgesics|mesh-ancestor
5863814|NCT02380898|Sensory System Agents|sensory system agents|mesh-ancestor
5863815|NCT02380898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5863816|NCT02380898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863817|NCT02380898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5863818|NCT02380898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5863819|NCT02380898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5863820|NCT02380898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5863821|NCT02380898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5863822|NCT02380573|Methylene Blue|methylene blue|mesh-list
5863823|NCT02380573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5863824|NCT02380573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5863825|NCT02380755|Clomiphene|clomiphene|mesh-list
5863826|NCT02380755|Enclomiphene|enclomiphene|mesh-list
5863827|NCT02380755|Zuclomiphene|zuclomiphene|mesh-list
5863828|NCT02380755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5863829|NCT02380755|Hormone Antagonists|hormone antagonists|mesh-ancestor
5863830|NCT02380755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6675082|NCT01572597|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5863831|NCT02380755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677208|NCT03521167|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5677209|NCT03521167|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5677210|NCT03521167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5677211|NCT03521167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5677212|NCT03521167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5677213|NCT03521167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5677214|NCT03521167|Analgesics|analgesics|mesh-ancestor
5677215|NCT03521167|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5677216|NCT03521167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5677217|NCT03521167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5677218|NCT03521167|Adrenergic Agents|adrenergic agents|mesh-ancestor
5677219|NCT03521167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5677220|NCT03521167|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5677221|NCT03521167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5677222|NCT03521167|Anesthetics, General|anesthetics, general|mesh-ancestor
5677223|NCT03521167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5677224|NCT03521167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5677225|NCT03521167|Anticonvulsants|anticonvulsants|mesh-ancestor
5677226|NCT03521167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5677227|NCT03521167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5677228|NCT03521167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5677229|NCT03521167|Antimanic Agents|antimanic agents|mesh-ancestor
5677230|NCT03521167|Antipyretics|antipyretics|mesh-ancestor
5677231|NCT03521063|Budesonide|budesonide|mesh-list
5677232|NCT03521063|Poractant alfa|poractant alfa|mesh-list
5677233|NCT03521063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5677234|NCT03521063|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5677235|NCT03521063|Autonomic Agents|autonomic agents|mesh-ancestor
5677236|NCT03521063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5677237|NCT03521063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677238|NCT03521063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5677239|NCT03521063|Respiratory System Agents|respiratory system agents|mesh-ancestor
5677240|NCT03521063|Glucocorticoids|glucocorticoids|mesh-ancestor
5677241|NCT03521063|Hormones|hormones|mesh-ancestor
5677242|NCT03521063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5677243|NCT03521063|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
5677244|NCT03521024|Lithium Carbonate|lithium carbonate|mesh-list
5677245|NCT03521024|Ether|ether|mesh-list
5677246|NCT03521024|Antidepressive Agents|antidepressive agents|mesh-ancestor
5677247|NCT03521024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5677248|NCT03521024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5863832|NCT02380755|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5863833|NCT02380755|Fertility Agents|fertility agents|mesh-ancestor
5863834|NCT02380755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5863835|NCT02380755|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5863836|NCT02380755|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5863837|NCT02380768|Chlorhexidine|chlorhexidine|mesh-list
5863838|NCT02380768|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5863839|NCT02380768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5863840|NCT02380768|Disinfectants|disinfectants|mesh-ancestor
5863841|NCT02380625|Azithromycin|azithromycin|mesh-list
5863842|NCT02380625|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5863843|NCT02380625|Sunitinib|sunitinib|mesh-list
5863844|NCT02380625|Irbesartan|irbesartan|mesh-list
5863845|NCT02380625|Atorvastatin|atorvastatin|mesh-list
5863846|NCT02380625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5863847|NCT02380625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5863848|NCT02380625|Antimetabolites|antimetabolites|mesh-ancestor
5863849|NCT02380625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494678|NCT00619710|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
5863850|NCT02380625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5863851|NCT02380625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5863852|NCT02380625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5863853|NCT02380625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5863854|NCT02380625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5863855|NCT02380625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5863856|NCT02380625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5863857|NCT02380625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5863858|NCT02380625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5863859|NCT02380625|Growth Substances|growth substances|mesh-ancestor
5863860|NCT02380625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863861|NCT02380625|Growth Inhibitors|growth inhibitors|mesh-ancestor
5863862|NCT02380625|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5863863|NCT02380625|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5863864|NCT02380625|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5863865|NCT02380521|Exenatide|exenatide|mesh-list
5863866|NCT02380521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5863867|NCT02380521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863868|NCT02380521|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5863869|NCT02380521|Incretins|incretins|mesh-ancestor
5863870|NCT02380521|Hormones|hormones|mesh-ancestor
5863871|NCT02380521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5863872|NCT02380586|Anesthetics|anesthetics|mesh-list
5863873|NCT02380586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5863874|NCT02380586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863875|NCT02380508|Vaccines|vaccines|mesh-list
5863876|NCT02380508|Immunologic Factors|immunologic factors|mesh-ancestor
6494679|NCT00619710|Cilastatin|cilastatin|mesh-list
6494680|NCT00619710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6494681|NCT00619710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6494682|NCT00619710|Protease Inhibitors|protease inhibitors|mesh-ancestor
6494683|NCT00619710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6494684|NCT00619710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5863877|NCT02380508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863878|NCT02380417|Ropivacaine|ropivacaine|mesh-list
5863879|NCT02380417|Anesthetics, Local|anesthetics, local|mesh-ancestor
5863880|NCT02380417|Anesthetics|anesthetics|mesh-ancestor
5863881|NCT02380417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5863882|NCT02380417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863883|NCT02380417|Sensory System Agents|sensory system agents|mesh-ancestor
5863884|NCT02380417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5863885|NCT02380313|Prednisone|prednisone|mesh-list
5863886|NCT02380313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5863887|NCT02380313|Glucocorticoids|glucocorticoids|mesh-ancestor
5677249|NCT03521024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5677250|NCT03521024|Antimanic Agents|antimanic agents|mesh-ancestor
5677251|NCT03521024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5677252|NCT03521024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5677253|NCT03521024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677254|NCT03521024|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5677255|NCT03521024|Anesthetics, General|anesthetics, general|mesh-ancestor
5863888|NCT02380313|Hormones|hormones|mesh-ancestor
5863889|NCT02380313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5677256|NCT03521024|Anesthetics|anesthetics|mesh-ancestor
5677257|NCT03520985|Dexamethasone|dexamethasone|mesh-list
5677258|NCT03520985|Pomalidomide|pomalidomide|mesh-list
5677259|NCT03520985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5677260|NCT03520985|Antiemetics|antiemetics|mesh-ancestor
5677261|NCT03520985|Autonomic Agents|autonomic agents|mesh-ancestor
5677262|NCT03520985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5677263|NCT03520985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677264|NCT03520985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5863890|NCT02380313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863891|NCT02380313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5863892|NCT02380313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5863893|NCT02380352|Amoxicillin|amoxicillin|mesh-list
5863894|NCT02380352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5863895|NCT02380352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5677265|NCT03520985|Glucocorticoids|glucocorticoids|mesh-ancestor
5677266|NCT03520985|Hormones|hormones|mesh-ancestor
5677267|NCT03520985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5677268|NCT03520985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5677269|NCT03520985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5677270|NCT03520985|Immunologic Factors|immunologic factors|mesh-ancestor
5677271|NCT03520985|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5677272|NCT03520985|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5677273|NCT03520985|Growth Substances|growth substances|mesh-ancestor
5677274|NCT03520985|Growth Inhibitors|growth inhibitors|mesh-ancestor
5677275|NCT03520946|Ramucirumab|ramucirumab|mesh-list
5677276|NCT03520946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5677277|NCT03520686|Paclitaxel|paclitaxel|mesh-list
5677278|NCT03520686|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5677279|NCT03520686|Cisplatin|cisplatin|mesh-list
5677280|NCT03520686|Carboplatin|carboplatin|mesh-list
5677281|NCT03520686|Pembrolizumab|pembrolizumab|mesh-list
5677282|NCT03520686|Pemetrexed|pemetrexed|mesh-list
5677283|NCT03520686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5677284|NCT03520686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5677285|NCT03520686|Tubulin Modulators|tubulin modulators|mesh-ancestor
5677286|NCT03520686|Antimitotic Agents|antimitotic agents|mesh-ancestor
5863896|NCT02380131|Capecitabine|capecitabine|mesh-list
5863897|NCT02380131|Oxaliplatin|oxaliplatin|mesh-list
5863898|NCT02380131|Trastuzumab|trastuzumab|mesh-list
5863899|NCT02380131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5863900|NCT02380131|Antimetabolites|antimetabolites|mesh-ancestor
5863901|NCT02380131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5863902|NCT02380131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5863903|NCT02380131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5863904|NCT02380118|Midazolam|midazolam|mesh-list
5863905|NCT02380118|Haloperidol|haloperidol|mesh-list
5863906|NCT02380118|Olanzapine|olanzapine|mesh-list
5863907|NCT02380118|Haloperidol decanoate|haloperidol decanoate|mesh-list
5863908|NCT02380118|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5863909|NCT02380118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5863910|NCT02380118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5863911|NCT02380118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863912|NCT02380118|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5863913|NCT02380118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5863914|NCT02380118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5863915|NCT02380118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5863916|NCT02380118|Anesthetics, General|anesthetics, general|mesh-ancestor
5863917|NCT02380118|Anesthetics|anesthetics|mesh-ancestor
5863918|NCT02380118|GABA Modulators|gaba modulators|mesh-ancestor
5863919|NCT02380118|GABA Agents|gaba agents|mesh-ancestor
5863920|NCT02380118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5863921|NCT02380118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5863922|NCT02380118|Antiemetics|antiemetics|mesh-ancestor
5863923|NCT02380118|Autonomic Agents|autonomic agents|mesh-ancestor
5863924|NCT02380118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5863925|NCT02380118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5863926|NCT02380118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5863927|NCT02380118|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5863928|NCT02380118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5863929|NCT02380118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5863930|NCT02380118|Serotonin Agents|serotonin agents|mesh-ancestor
5677287|NCT03520686|Mitosis Modulators|mitosis modulators|mesh-ancestor
5677288|NCT03520686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5677289|NCT03520686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5863931|NCT02380118|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5863932|NCT02380118|Dopamine Agents|dopamine agents|mesh-ancestor
5863933|NCT02380118|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5863934|NCT02380001|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
5863935|NCT02380001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5863936|NCT02380001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5863937|NCT02380001|Analgesics|analgesics|mesh-ancestor
5863938|NCT02380001|Sensory System Agents|sensory system agents|mesh-ancestor
5863939|NCT02380001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5863940|NCT02380001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863941|NCT02380001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5863942|NCT02380001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5863943|NCT02379754|Gentamicins|gentamicins|mesh-list
5863944|NCT02379754|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5863945|NCT02379754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5863946|NCT02379754|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5863947|NCT02379754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5863948|NCT02379754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5863949|NCT02380053|Celiprolol|celiprolol|mesh-list
5863950|NCT02380053|Bisoprolol|bisoprolol|mesh-list
5863951|NCT02380053|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5863952|NCT02380053|Sympatholytics|sympatholytics|mesh-ancestor
5863953|NCT02380053|Autonomic Agents|autonomic agents|mesh-ancestor
5863954|NCT02380053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5863955|NCT02380053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863956|NCT02380053|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5863957|NCT02380053|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5863958|NCT02380053|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5863959|NCT02380053|Adrenergic Agents|adrenergic agents|mesh-ancestor
5863960|NCT02380053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5863961|NCT02380053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5863962|NCT02380053|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5863963|NCT02380053|Sympathomimetics|sympathomimetics|mesh-ancestor
5863964|NCT02380053|Vasodilator Agents|vasodilator agents|mesh-ancestor
5863965|NCT02379806|Enoxaparin|enoxaparin|mesh-list
5863966|NCT02379806|Anticoagulants|anticoagulants|mesh-ancestor
5863967|NCT02379806|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5863968|NCT02379806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5863969|NCT02379806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5863970|NCT02379793|Mineral Oil|mineral oil|mesh-list
5863971|NCT02379793|Emollients|emollients|mesh-ancestor
5863972|NCT02379793|Dermatologic Agents|dermatologic agents|mesh-ancestor
5863973|NCT02379767|Harmine|harmine|mesh-list
5863974|NCT02379767|Hallucinogens|hallucinogens|mesh-ancestor
5863975|NCT02379767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863976|NCT02379767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5863977|NCT02379767|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
5863978|NCT02379767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5863979|NCT02379767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904905|NCT03991884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5904906|NCT03991884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5904907|NCT03991884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5904908|NCT03991884|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5904909|NCT03991884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5904910|NCT03991884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5904911|NCT03991884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5904912|NCT03991884|Glucocorticoids|glucocorticoids|mesh-ancestor
5904913|NCT03991884|Hormones|hormones|mesh-ancestor
6675083|NCT01572597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6675084|NCT01572597|Antiviral Agents|antiviral agents|mesh-ancestor
5677290|NCT03520686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5677291|NCT03520686|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5677292|NCT03520686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5677293|NCT03520595|Diclofenac|diclofenac|mesh-list
5677294|NCT03520595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5677295|NCT03520595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6675085|NCT01572597|Expectorants|expectorants|mesh-ancestor
6675086|NCT01572597|Respiratory System Agents|respiratory system agents|mesh-ancestor
6675087|NCT01572597|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6675088|NCT01572597|Antioxidants|antioxidants|mesh-ancestor
6675089|NCT01572597|Protective Agents|protective agents|mesh-ancestor
5677296|NCT03520595|Analgesics|analgesics|mesh-ancestor
5677297|NCT03520595|Sensory System Agents|sensory system agents|mesh-ancestor
5677298|NCT03520595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5677299|NCT03520595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677300|NCT03520595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5863980|NCT02379715|Remifentanil|remifentanil|mesh-list
5863981|NCT02379715|Desflurane|desflurane|mesh-list
5863982|NCT02379715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5863983|NCT02379715|Narcotics|narcotics|mesh-ancestor
5863984|NCT02379715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5863985|NCT02379715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5863986|NCT02379715|Analgesics|analgesics|mesh-ancestor
5863987|NCT02379715|Sensory System Agents|sensory system agents|mesh-ancestor
5863988|NCT02379715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5863989|NCT02379715|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5863990|NCT02379715|Anesthetics, General|anesthetics, general|mesh-ancestor
5863991|NCT02379715|Anesthetics|anesthetics|mesh-ancestor
5863992|NCT02379663|Enoxaparin|enoxaparin|mesh-list
5863993|NCT02379663|Rivaroxaban|rivaroxaban|mesh-list
5863994|NCT02379663|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5677301|NCT03520595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5677302|NCT03520595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5677303|NCT03520595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5677304|NCT03520595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5863995|NCT02379663|Antithrombins|antithrombins|mesh-ancestor
5863996|NCT02379663|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5863997|NCT02379663|Protease Inhibitors|protease inhibitors|mesh-ancestor
5863998|NCT02379663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5863999|NCT02379663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5864000|NCT02379663|Anticoagulants|anticoagulants|mesh-ancestor
5864001|NCT02379663|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6212295|NCT02185534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6212296|NCT02185534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212297|NCT02185534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212298|NCT02185729|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6212299|NCT02185729|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6212300|NCT02185729|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6212301|NCT02185729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6212302|NCT02186015|Vitamin D|vitamin d|mesh-list
5864002|NCT02379663|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5864003|NCT02379546|Desflurane|desflurane|mesh-list
5864004|NCT02379546|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5864005|NCT02379546|Anesthetics, General|anesthetics, general|mesh-ancestor
5864006|NCT02379546|Anesthetics|anesthetics|mesh-ancestor
5864007|NCT02379546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5864008|NCT02379546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864009|NCT02379650|Hydroxychloroquine|hydroxychloroquine|mesh-list
5864010|NCT02379650|Antimalarials|antimalarials|mesh-ancestor
5864011|NCT02379650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5864012|NCT02379650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5864013|NCT02379650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5864014|NCT02379650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5864015|NCT02379650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5864016|NCT02379650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5864017|NCT02379676|Clopidogrel|clopidogrel|mesh-list
5864018|NCT02379676|Ticagrelor|ticagrelor|mesh-list
5864019|NCT02379676|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5864020|NCT02379676|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5864021|NCT02379676|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5864022|NCT02379676|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5864023|NCT02379676|Purinergic Agents|purinergic agents|mesh-ancestor
5864024|NCT02379676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5864025|NCT02379676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5864026|NCT02379676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864027|NCT02379377|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5864028|NCT02379377|Fluorides|fluorides|mesh-list
5864029|NCT02379377|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5864030|NCT02379377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5864031|NCT02379377|Cariostatic Agents|cariostatic agents|mesh-ancestor
5864032|NCT02379377|Protective Agents|protective agents|mesh-ancestor
5864033|NCT02379377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864034|NCT02379299|Hormones|hormones|mesh-list
5864035|NCT02379299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5864036|NCT02379299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677305|NCT03520569|Octreotide|octreotide|mesh-list
5677306|NCT03520569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5677307|NCT03520569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5677308|NCT03520569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5677309|NCT03520543|Clonidine|clonidine|mesh-list
5677310|NCT03520543|Yohimbine|yohimbine|mesh-list
5677311|NCT03520543|Analgesics|analgesics|mesh-ancestor
5864037|NCT02379000|Triamcinolone|triamcinolone|mesh-list
5864038|NCT02379000|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5864039|NCT02379000|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5864040|NCT02379000|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5864041|NCT02379000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5864042|NCT02379000|Glucocorticoids|glucocorticoids|mesh-ancestor
5677312|NCT03520543|Sensory System Agents|sensory system agents|mesh-ancestor
5677313|NCT03520543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5677314|NCT03520543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677315|NCT03520543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5677316|NCT03520543|Sympatholytics|sympatholytics|mesh-ancestor
5677317|NCT03520543|Autonomic Agents|autonomic agents|mesh-ancestor
5677318|NCT03520543|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5677319|NCT03520543|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5677320|NCT03520543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5677321|NCT03520543|Adrenergic Agents|adrenergic agents|mesh-ancestor
5677322|NCT03520543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5677323|NCT03520543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5864043|NCT02379000|Hormones|hormones|mesh-ancestor
5864044|NCT02379000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5864045|NCT02379000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677324|NCT03520543|Mydriatics|mydriatics|mesh-ancestor
5677325|NCT03520543|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5677326|NCT03520543|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5677327|NCT03520543|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5677328|NCT03520543|Urological Agents|urological agents|mesh-ancestor
5677329|NCT03520478|Bicalutamide|bicalutamide|mesh-list
5677330|NCT03520478|Androgen Antagonists|androgen antagonists|mesh-ancestor
5677331|NCT03520478|Hormone Antagonists|hormone antagonists|mesh-ancestor
5677332|NCT03520478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5677333|NCT03520478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677334|NCT03520478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5677335|NCT03520439|Mifepristone|mifepristone|mesh-list
5677336|NCT03520439|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5677337|NCT03520439|Abortifacient Agents|abortifacient agents|mesh-ancestor
5677338|NCT03520439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5677339|NCT03520439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677340|NCT03520439|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5677341|NCT03520439|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5677342|NCT03520439|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5677343|NCT03520439|Contraceptive Agents|contraceptive agents|mesh-ancestor
5677344|NCT03520439|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5677345|NCT03520439|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5677346|NCT03520439|Hormone Antagonists|hormone antagonists|mesh-ancestor
5677347|NCT03520439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5677348|NCT03520439|Luteolytic Agents|luteolytic agents|mesh-ancestor
5677349|NCT03520439|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5677350|NCT03520439|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5677351|NCT03520361|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5677352|NCT03520257|Apatinib|apatinib|mesh-list
5677353|NCT03520257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5677354|NCT03520257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5677355|NCT03520257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5677356|NCT03520257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5677357|NCT03520062|Liraglutide|liraglutide|mesh-list
5677358|NCT03520062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5864046|NCT02379000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5864047|NCT02379000|Immunologic Factors|immunologic factors|mesh-ancestor
5864048|NCT02379000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5864049|NCT02379000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5864050|NCT02379026|Vitamin D|vitamin d|mesh-list
5864051|NCT02379026|Cholecalciferol|cholecalciferol|mesh-list
5864052|NCT02379026|Vitamins|vitamins|mesh-ancestor
5864053|NCT02379026|Micronutrients|micronutrients|mesh-ancestor
5864054|NCT02379026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864055|NCT02379026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5864056|NCT02379026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5864057|NCT02379156|Midodrine|midodrine|mesh-list
5864058|NCT02379156|Sympathomimetics|sympathomimetics|mesh-ancestor
5864059|NCT02379156|Autonomic Agents|autonomic agents|mesh-ancestor
5864060|NCT02379156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5864061|NCT02379156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864062|NCT02379156|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5677359|NCT03520062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677360|NCT03520062|Incretins|incretins|mesh-ancestor
5677361|NCT03520062|Hormones|hormones|mesh-ancestor
5677362|NCT03520062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5677363|NCT03520049|Oseltamivir|oseltamivir|mesh-list
5677364|NCT03520049|Antiviral Agents|antiviral agents|mesh-ancestor
5677365|NCT03520049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5864063|NCT02379156|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5864064|NCT02379156|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5864065|NCT02379156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5864066|NCT02379156|Adrenergic Agents|adrenergic agents|mesh-ancestor
5864067|NCT02379156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5864068|NCT02379156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5864069|NCT02378623|Apixaban|apixaban|mesh-list
5864070|NCT02378623|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5864071|NCT02378623|Antithrombins|antithrombins|mesh-ancestor
5864072|NCT02378623|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5864073|NCT02378623|Protease Inhibitors|protease inhibitors|mesh-ancestor
5864074|NCT02378623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5864075|NCT02378623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5864076|NCT02378623|Anticoagulants|anticoagulants|mesh-ancestor
5864077|NCT02378740|Ketamine|ketamine|mesh-list
5864078|NCT02378740|Analgesics|analgesics|mesh-ancestor
5864079|NCT02378740|Sensory System Agents|sensory system agents|mesh-ancestor
5864080|NCT02378740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5864081|NCT02378740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864082|NCT02378740|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5864083|NCT02378740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5864084|NCT02378740|Anesthetics, General|anesthetics, general|mesh-ancestor
5864085|NCT02378740|Anesthetics|anesthetics|mesh-ancestor
5864086|NCT02378740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5864087|NCT02378740|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5864088|NCT02378740|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5864089|NCT02378740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5864090|NCT02378740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5864091|NCT02378805|Ramipril|ramipril|mesh-list
5864092|NCT02378805|Spironolactone|spironolactone|mesh-list
5864093|NCT02378805|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
5864094|NCT02378805|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5864095|NCT02378805|Hormone Antagonists|hormone antagonists|mesh-ancestor
5864096|NCT02378805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5864097|NCT02378805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864098|NCT02378805|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5864099|NCT02378805|Diuretics|diuretics|mesh-ancestor
5864100|NCT02378805|Natriuretic Agents|natriuretic agents|mesh-ancestor
5864101|NCT02378805|Protease Inhibitors|protease inhibitors|mesh-ancestor
5864102|NCT02378805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5864103|NCT02378805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5864104|NCT02378805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5864105|NCT02378649|Sildenafil Citrate|sildenafil citrate|mesh-list
5864106|NCT02378649|Vasodilator Agents|vasodilator agents|mesh-ancestor
5864107|NCT02378649|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5677366|NCT03520049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5677367|NCT03520049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5677368|NCT03519906|Metoprolol|metoprolol|mesh-list
5677369|NCT03519906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5677370|NCT03519906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5677371|NCT03519906|Sympatholytics|sympatholytics|mesh-ancestor
5677372|NCT03519906|Autonomic Agents|autonomic agents|mesh-ancestor
5864108|NCT02378649|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5864109|NCT02378649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5864110|NCT02378649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5864111|NCT02378649|Urological Agents|urological agents|mesh-ancestor
5864112|NCT02378428|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
5864113|NCT02378428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5864114|NCT02378428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5677373|NCT03519906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5677374|NCT03519906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677375|NCT03519906|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5677376|NCT03519906|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5677377|NCT03519906|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5677378|NCT03519906|Adrenergic Agents|adrenergic agents|mesh-ancestor
5677379|NCT03519906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5864115|NCT02378428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5864116|NCT02378428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5864117|NCT02378415|Ketamine|ketamine|mesh-list
5864118|NCT02378415|Analgesics|analgesics|mesh-ancestor
5864119|NCT02378415|Sensory System Agents|sensory system agents|mesh-ancestor
5864120|NCT02378415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5864121|NCT02378415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864122|NCT02378415|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5864123|NCT02378415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5864124|NCT02378415|Anesthetics, General|anesthetics, general|mesh-ancestor
5864125|NCT02378415|Anesthetics|anesthetics|mesh-ancestor
5864126|NCT02378415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5864127|NCT02378415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5864128|NCT02378415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5864129|NCT02378415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5864130|NCT02378415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5864131|NCT02378441|Metformin|metformin|mesh-list
5864132|NCT02378441|Atorvastatin|atorvastatin|mesh-list
5864133|NCT02378441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5864134|NCT02378441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864135|NCT02378441|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5864136|NCT02378441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5864137|NCT02378441|Antimetabolites|antimetabolites|mesh-ancestor
5864138|NCT02378441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5864139|NCT02378441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5864140|NCT02378441|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5864141|NCT02378441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5864142|NCT02378532|Chloroquine|chloroquine|mesh-list
6494685|NCT00619840|Methylphenidate|methylphenidate|mesh-list
5677380|NCT03519906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5677381|NCT03519893|Losartan|losartan|mesh-list
6494686|NCT00619840|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5864143|NCT02378532|Temozolomide|temozolomide|mesh-list
5864144|NCT02378532|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5864145|NCT02378532|Alkylating Agents|alkylating agents|mesh-ancestor
5864146|NCT02378532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5864147|NCT02378532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5864148|NCT02378532|Amebicides|amebicides|mesh-ancestor
5864149|NCT02378532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5864150|NCT02378532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5864151|NCT02378532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5864152|NCT02378532|Antimalarials|antimalarials|mesh-ancestor
5864153|NCT02378532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5864154|NCT02378298|Methylprednisolone|methylprednisolone|mesh-list
5864155|NCT02378298|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5864156|NCT02378298|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5864157|NCT02378298|Prednisolone|prednisolone|mesh-list
5864158|NCT02378298|Prednisolone acetate|prednisolone acetate|mesh-list
5864159|NCT02378298|Rituximab|rituximab|mesh-list
5864160|NCT02378298|Methotrexate|methotrexate|mesh-list
5864161|NCT02378298|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5864162|NCT02378298|Prednisolone phosphate|prednisolone phosphate|mesh-list
5864163|NCT02378298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5864164|NCT02378298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5864165|NCT02378298|Immunologic Factors|immunologic factors|mesh-ancestor
5864166|NCT02378298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864167|NCT02378298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5864168|NCT02378298|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5864169|NCT02378298|Abortifacient Agents|abortifacient agents|mesh-ancestor
5864170|NCT02378298|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5864171|NCT02378298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5864172|NCT02378298|Antimetabolites|antimetabolites|mesh-ancestor
5864173|NCT02378298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5864174|NCT02378298|Dermatologic Agents|dermatologic agents|mesh-ancestor
5864175|NCT02378298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5864176|NCT02378298|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5864177|NCT02378298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5677382|NCT03519893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5677383|NCT03519893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5677384|NCT03519893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5677385|NCT03519893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5677386|NCT03519893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5677387|NCT03519776|Progesterone|progesterone|mesh-list
5864178|NCT02378298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5864179|NCT02378298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5864180|NCT02378298|Antiemetics|antiemetics|mesh-ancestor
5864181|NCT02378298|Autonomic Agents|autonomic agents|mesh-ancestor
5864182|NCT02378298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5864183|NCT02378298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5864184|NCT02378298|Glucocorticoids|glucocorticoids|mesh-ancestor
5864185|NCT02378298|Hormones|hormones|mesh-ancestor
5864186|NCT02378298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5864187|NCT02378298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5864188|NCT02378298|Protective Agents|protective agents|mesh-ancestor
5864189|NCT02378298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5864190|NCT02378389|Docetaxel|docetaxel|mesh-list
5864191|NCT02378389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5864192|NCT02378389|Tubulin Modulators|tubulin modulators|mesh-ancestor
5864193|NCT02378389|Antimitotic Agents|antimitotic agents|mesh-ancestor
5864194|NCT02378389|Mitosis Modulators|mitosis modulators|mesh-ancestor
5864195|NCT02378389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5677388|NCT03519776|Progestins|progestins|mesh-ancestor
5677389|NCT03519776|Hormones|hormones|mesh-ancestor
5677390|NCT03519776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5677391|NCT03519776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677392|NCT03519750|Melatonin|melatonin|mesh-list
5677393|NCT03519750|Antioxidants|antioxidants|mesh-ancestor
5677394|NCT03519750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5677395|NCT03519750|Protective Agents|protective agents|mesh-ancestor
5677396|NCT03519750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677397|NCT03519750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5677398|NCT03519724|Neostigmine|neostigmine|mesh-list
5677399|NCT03519724|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5677400|NCT03519724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5677401|NCT03519724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5677402|NCT03519724|Cholinergic Agents|cholinergic agents|mesh-ancestor
5677403|NCT03519724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5677404|NCT03519724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677405|NCT03519724|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5677406|NCT03519724|Autonomic Agents|autonomic agents|mesh-ancestor
5904914|NCT03991884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5904915|NCT03991884|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5904916|NCT03991884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5904917|NCT03991884|Tubulin Modulators|tubulin modulators|mesh-ancestor
5904918|NCT03991884|Antimitotic Agents|antimitotic agents|mesh-ancestor
5904919|NCT03991884|Mitosis Modulators|mitosis modulators|mesh-ancestor
5904920|NCT03991884|Keratolytic Agents|keratolytic agents|mesh-ancestor
5904921|NCT03991884|Dermatologic Agents|dermatologic agents|mesh-ancestor
5904922|NCT03991884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5904923|NCT03989362|Ipilimumab|ipilimumab|mesh-list
5904924|NCT03989362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5904925|NCT03989362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5904926|NCT03989362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5904927|NCT03989362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904928|NCT03883581|Quinidine|quinidine|mesh-list
5904929|NCT03883581|Quinidine gluconate|quinidine gluconate|mesh-list
5904930|NCT03883581|Dextromethorphan|dextromethorphan|mesh-list
5904931|NCT03883581|Antitussive Agents|antitussive agents|mesh-ancestor
5904932|NCT03883581|Respiratory System Agents|respiratory system agents|mesh-ancestor
5904933|NCT03883581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5904934|NCT03883581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5677407|NCT03519724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5677408|NCT03519685|Contraceptive Agents|contraceptive agents|mesh-list
5677409|NCT03519685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5677410|NCT03519685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677411|NCT03519646|Eliglustat|eliglustat|mesh-list
5677412|NCT03519646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5677413|NCT03519646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5677414|NCT03519633|Neostigmine|neostigmine|mesh-list
5677415|NCT03519633|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5677416|NCT03519633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5677417|NCT03519633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5677418|NCT03519633|Cholinergic Agents|cholinergic agents|mesh-ancestor
5677419|NCT03519633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5677420|NCT03519633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864196|NCT02377960|Antihypertensive Agents|antihypertensive agents|mesh-list
5864197|NCT02378129|Methamphetamine|methamphetamine|mesh-list
5864198|NCT02378129|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5864199|NCT02378129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677421|NCT03519633|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5677422|NCT03519633|Autonomic Agents|autonomic agents|mesh-ancestor
5677423|NCT03519633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5677424|NCT03519568|Vaccines|vaccines|mesh-list
5677425|NCT03519568|Immunologic Factors|immunologic factors|mesh-ancestor
5677426|NCT03519568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677427|NCT03519542|Sunitinib|sunitinib|mesh-list
5677428|NCT03519542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5864200|NCT02378129|Sympathomimetics|sympathomimetics|mesh-ancestor
5864201|NCT02378129|Autonomic Agents|autonomic agents|mesh-ancestor
5864202|NCT02378129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5864203|NCT02378129|Dopamine Agents|dopamine agents|mesh-ancestor
5864204|NCT02378129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5864205|NCT02378129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5864206|NCT02378129|Adrenergic Agents|adrenergic agents|mesh-ancestor
5864207|NCT02378129|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5864208|NCT02378129|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5864209|NCT02378129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5864210|NCT02378129|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5864211|NCT02377856|Interferons|interferons|mesh-list
5864212|NCT02377856|Ribavirin|ribavirin|mesh-list
5864213|NCT02377856|Interferon-alpha|interferon-alpha|mesh-list
5864214|NCT02377856|Interferon alpha-2|interferon alpha-2|mesh-list
5864215|NCT02377856|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5864216|NCT02377856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5864217|NCT02377856|Antiviral Agents|antiviral agents|mesh-ancestor
5864218|NCT02377856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5864219|NCT02377856|Antimetabolites|antimetabolites|mesh-ancestor
5864220|NCT02377856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5864221|NCT02377856|Immunologic Factors|immunologic factors|mesh-ancestor
5864222|NCT02377856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864223|NCT02377778|Thiopental|thiopental|mesh-list
5864224|NCT02377778|Propofol|propofol|mesh-list
5864225|NCT02377778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5864226|NCT02377778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5864227|NCT02377778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864228|NCT02377778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5864229|NCT02377778|Anesthetics, General|anesthetics, general|mesh-ancestor
5864230|NCT02377778|Anesthetics|anesthetics|mesh-ancestor
5864231|NCT02377778|Anticonvulsants|anticonvulsants|mesh-ancestor
5864232|NCT02377778|GABA Modulators|gaba modulators|mesh-ancestor
5864233|NCT02377778|GABA Agents|gaba agents|mesh-ancestor
5864234|NCT02377778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5864235|NCT02377778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5864236|NCT02377609|Tacrolimus|tacrolimus|mesh-list
5864237|NCT02377609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5864238|NCT02377609|Immunologic Factors|immunologic factors|mesh-ancestor
5864239|NCT02377609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864240|NCT02377609|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5864241|NCT02377609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5864242|NCT02377609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5864243|NCT02377648|Everolimus|everolimus|mesh-list
5864244|NCT02377648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5864245|NCT02377648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5864246|NCT02377648|Immunologic Factors|immunologic factors|mesh-ancestor
5864247|NCT02377648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864248|NCT02377635|Selenious Acid|selenious acid|mesh-list
5864249|NCT02377635|Sodium Selenite|sodium selenite|mesh-list
5864250|NCT02377635|Trace Elements|trace elements|mesh-ancestor
5864251|NCT02377635|Micronutrients|micronutrients|mesh-ancestor
5864252|NCT02377635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864253|NCT02377492|Vasopressins|vasopressins|mesh-list
5864254|NCT02377492|Arginine Vasopressin|arginine vasopressin|mesh-list
5864255|NCT02377492|Hemostatics|hemostatics|mesh-ancestor
5864256|NCT02377492|Coagulants|coagulants|mesh-ancestor
5864257|NCT02377492|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5864258|NCT02377492|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5864259|NCT02377492|Natriuretic Agents|natriuretic agents|mesh-ancestor
5677429|NCT03519542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5677430|NCT03519542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5677431|NCT03519542|Growth Substances|growth substances|mesh-ancestor
5864260|NCT02377492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864261|NCT02377661|Amlodipine|amlodipine|mesh-list
5864262|NCT02377661|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5864263|NCT02377661|Olmesartan|olmesartan|mesh-list
5864264|NCT02377661|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
5864265|NCT02377661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5864266|NCT02377661|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5864267|NCT02377661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5864268|NCT02377661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5864269|NCT02377661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5864270|NCT02377661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864271|NCT02377661|Vasodilator Agents|vasodilator agents|mesh-ancestor
5864272|NCT02377661|Diuretics|diuretics|mesh-ancestor
5864273|NCT02377661|Natriuretic Agents|natriuretic agents|mesh-ancestor
5864274|NCT02377661|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5864275|NCT02377661|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5864276|NCT02377661|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5864277|NCT02377479|Letrozole|letrozole|mesh-list
5864278|NCT02377479|Clomiphene|clomiphene|mesh-list
5864279|NCT02377479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5864280|NCT02377479|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5864281|NCT02377479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5864282|NCT02377479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5864283|NCT02377479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5864284|NCT02377479|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5864285|NCT02377479|Hormone Antagonists|hormone antagonists|mesh-ancestor
5864286|NCT02377479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5864287|NCT02377479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864288|NCT02377479|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5864289|NCT02377479|Fertility Agents|fertility agents|mesh-ancestor
5864290|NCT02377479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5864291|NCT02377479|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5864292|NCT02377479|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5864293|NCT02377401|Zanamivir|zanamivir|mesh-list
5864294|NCT02377401|Antiviral Agents|antiviral agents|mesh-ancestor
5864295|NCT02377401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5864296|NCT02377401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5677432|NCT03519542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677433|NCT03519542|Growth Inhibitors|growth inhibitors|mesh-ancestor
5677434|NCT03519542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5864297|NCT02377401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5864298|NCT02377388|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5864299|NCT02377388|Saxagliptin|saxagliptin|mesh-list
5864300|NCT02377388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5864301|NCT02377388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864302|NCT02377388|Incretins|incretins|mesh-ancestor
5864303|NCT02377388|Hormones|hormones|mesh-ancestor
5864304|NCT02377388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5677435|NCT03519542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5677436|NCT03519542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696576|NCT03382041|Carbon Fiber|carbon fiber|mesh-list
5696577|NCT03382041|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5696578|NCT03382041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5696579|NCT03381859|Grazoprevir|grazoprevir|mesh-list
5864305|NCT02377388|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5864306|NCT02377388|Protease Inhibitors|protease inhibitors|mesh-ancestor
5864307|NCT02377388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5864308|NCT02377388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5864309|NCT02377271|Bosentan|bosentan|mesh-list
5864310|NCT02377271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5864311|NCT02377271|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5864312|NCT02377271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5864313|NCT02377193|Mycophenolic Acid|mycophenolic acid|mesh-list
5864314|NCT02377193|Tacrolimus|tacrolimus|mesh-list
5864315|NCT02377193|Basiliximab|basiliximab|mesh-list
5696580|NCT03381859|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
5696581|NCT03381859|Antiviral Agents|antiviral agents|mesh-ancestor
5696582|NCT03381859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5696583|NCT03381833|Hepcidins|hepcidins|mesh-list
5696584|NCT03381833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5696585|NCT03381781|Cytarabine|cytarabine|mesh-list
5864316|NCT02377193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6494687|NCT00619840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696586|NCT03381781|Decitabine|decitabine|mesh-list
5696587|NCT03381781|Arsenic Trioxide|arsenic trioxide|mesh-list
5696588|NCT03381781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5696589|NCT03381781|Antimetabolites|antimetabolites|mesh-ancestor
5864317|NCT02377193|Immunologic Factors|immunologic factors|mesh-ancestor
5864318|NCT02377193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864319|NCT02377193|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5864320|NCT02377193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5864321|NCT02377193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5864322|NCT02377193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5864323|NCT02377193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5864324|NCT02377193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5864325|NCT02377193|Antitubercular Agents|antitubercular agents|mesh-ancestor
5864326|NCT02377193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5864327|NCT02377193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5864328|NCT02377180|Anesthetics|anesthetics|mesh-list
5864329|NCT02377180|Anesthetics, Local|anesthetics, local|mesh-list
5864330|NCT02377180|Capsaicin|capsaicin|mesh-list
5864331|NCT02377180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5677437|NCT03519412|Pembrolizumab|pembrolizumab|mesh-list
5677438|NCT03519412|Temozolomide|temozolomide|mesh-list
5677439|NCT03519412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5677440|NCT03519412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5677441|NCT03519412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5677442|NCT03519412|Alkylating Agents|alkylating agents|mesh-ancestor
5677443|NCT03519412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5677444|NCT03519386|Travoprost|travoprost|mesh-list
5677445|NCT03519386|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5677446|NCT03519386|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5677447|NCT03519386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5677448|NCT03519308|Gemcitabine|gemcitabine|mesh-list
5677449|NCT03519308|Paclitaxel|paclitaxel|mesh-list
5677450|NCT03519308|Nivolumab|nivolumab|mesh-list
5677451|NCT03519308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5677452|NCT03519308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5677453|NCT03519308|Tubulin Modulators|tubulin modulators|mesh-ancestor
5677454|NCT03519308|Antimitotic Agents|antimitotic agents|mesh-ancestor
5677455|NCT03519308|Mitosis Modulators|mitosis modulators|mesh-ancestor
5677456|NCT03519308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5677457|NCT03519308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5677458|NCT03519308|Antimetabolites|antimetabolites|mesh-ancestor
5677459|NCT03519308|Antiviral Agents|antiviral agents|mesh-ancestor
5677460|NCT03519308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5677461|NCT03519308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5677462|NCT03519308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5677463|NCT03519308|Immunologic Factors|immunologic factors|mesh-ancestor
5677464|NCT03519308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677465|NCT03519308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5677466|NCT03519308|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5864332|NCT02377180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864333|NCT02377180|Sensory System Agents|sensory system agents|mesh-ancestor
5864334|NCT02377180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5864335|NCT02377180|Antipruritics|antipruritics|mesh-ancestor
5864336|NCT02377180|Dermatologic Agents|dermatologic agents|mesh-ancestor
5864337|NCT02377076|Calcium, Dietary|calcium, dietary|mesh-list
5864338|NCT02377076|Calcium|calcium|mesh-list
5677467|NCT03519256|Nivolumab|nivolumab|mesh-list
5677468|NCT03519256|Linrodostat|linrodostat|mesh-list
5677469|NCT03519256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5677470|NCT03519256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5677471|NCT03519256|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5677472|NCT03519256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5677473|NCT03519256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5677474|NCT03519152|Diclofenac|diclofenac|mesh-list
5677475|NCT03519152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5864339|NCT02377076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5864340|NCT02377076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864341|NCT02377076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5677476|NCT03519152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5677477|NCT03519152|Analgesics|analgesics|mesh-ancestor
5677478|NCT03519152|Sensory System Agents|sensory system agents|mesh-ancestor
5677479|NCT03519152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5677480|NCT03519152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677481|NCT03519152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5677482|NCT03519152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5677483|NCT03519152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5677484|NCT03519152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5677485|NCT03519152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5864342|NCT02376972|Rifaximin|rifaximin|mesh-list
5864343|NCT02376972|Metronidazole|metronidazole|mesh-list
5864344|NCT02376972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5864345|NCT02376972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5864346|NCT02376972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5864347|NCT02376972|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5864348|NCT02376972|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5864349|NCT02376881|Epoetin Alfa|epoetin alfa|mesh-list
5864350|NCT02376881|Hematinics|hematinics|mesh-ancestor
5864351|NCT02376985|Everolimus|everolimus|mesh-list
5864352|NCT02376985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5864353|NCT02376985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5864354|NCT02376985|Immunologic Factors|immunologic factors|mesh-ancestor
5864355|NCT02376985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864356|NCT02376803|Warfarin|warfarin|mesh-list
5864357|NCT02376803|Anticoagulants|anticoagulants|mesh-ancestor
5864358|NCT02376478|Folic Acid|folic acid|mesh-list
5864359|NCT02376478|Sulfasalazine|sulfasalazine|mesh-list
5864360|NCT02376478|Adalimumab|adalimumab|mesh-list
5864361|NCT02376478|Etanercept|etanercept|mesh-list
5864362|NCT02376478|Methotrexate|methotrexate|mesh-list
5677486|NCT03519074|Cisplatin|cisplatin|mesh-list
5677487|NCT03519074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5677488|NCT03519061|Budesonide|budesonide|mesh-list
5677489|NCT03519061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5677490|NCT03519061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5677491|NCT03519061|Autonomic Agents|autonomic agents|mesh-ancestor
5677492|NCT03519061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5677493|NCT03519061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677494|NCT03519061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5677495|NCT03519061|Respiratory System Agents|respiratory system agents|mesh-ancestor
5677496|NCT03519061|Glucocorticoids|glucocorticoids|mesh-ancestor
5677497|NCT03519061|Hormones|hormones|mesh-ancestor
5677498|NCT03519061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5677499|NCT03519022|Cocaine|cocaine|mesh-list
5677500|NCT03519022|Methylphenidate|methylphenidate|mesh-list
5677501|NCT03519022|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5677502|NCT03519022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677503|NCT03519022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5677504|NCT03519022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5677505|NCT03519022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5677506|NCT03519022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5864363|NCT02376478|Mercaptopurine|mercaptopurine|mesh-list
5864364|NCT02376478|Infliximab|infliximab|mesh-list
5864365|NCT02376478|Folic Acid Antagonists|folic acid antagonists|mesh-list
5864366|NCT02376478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5864367|NCT02376478|Abortifacient Agents|abortifacient agents|mesh-ancestor
5864368|NCT02376478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5864369|NCT02376478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864370|NCT02376478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5864371|NCT02376478|Antimetabolites|antimetabolites|mesh-ancestor
5864372|NCT02376478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5864373|NCT02376478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5864374|NCT02376478|Dermatologic Agents|dermatologic agents|mesh-ancestor
5864375|NCT02376478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5864376|NCT02376478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5864377|NCT02376478|Immunologic Factors|immunologic factors|mesh-ancestor
5864378|NCT02376478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5864379|NCT02376478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5864380|NCT02376478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5864381|NCT02376478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5864382|NCT02376478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5864383|NCT02376478|Analgesics|analgesics|mesh-ancestor
5864384|NCT02376478|Sensory System Agents|sensory system agents|mesh-ancestor
5677507|NCT03519022|Dopamine Agents|dopamine agents|mesh-ancestor
5677508|NCT03519022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5677509|NCT03519022|Anesthetics, Local|anesthetics, local|mesh-ancestor
5677510|NCT03519022|Anesthetics|anesthetics|mesh-ancestor
5677511|NCT03519022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5677512|NCT03519022|Sensory System Agents|sensory system agents|mesh-ancestor
5677513|NCT03519022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5677514|NCT03519022|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5677515|NCT03518801|Cannabidiol|cannabidiol|mesh-list
5864385|NCT02376478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5864386|NCT02376478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5864387|NCT02376478|Hematinics|hematinics|mesh-ancestor
5864388|NCT02376478|Vitamin B Complex|vitamin b complex|mesh-ancestor
5864389|NCT02376478|Vitamins|vitamins|mesh-ancestor
5864390|NCT02376478|Micronutrients|micronutrients|mesh-ancestor
5864391|NCT02376478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5864392|NCT02376595|Bromides|bromides|mesh-list
5864393|NCT02376595|Rocuronium|rocuronium|mesh-list
5864394|NCT02376595|Anticonvulsants|anticonvulsants|mesh-ancestor
5864395|NCT02376595|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5864396|NCT02376595|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5864397|NCT02376595|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5864398|NCT02376595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5864399|NCT02376595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864400|NCT02376452|Leucovorin|leucovorin|mesh-list
5677516|NCT03518801|Anticonvulsants|anticonvulsants|mesh-ancestor
5677517|NCT03518528|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5677518|NCT03518528|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5677519|NCT03518528|Estradiol|estradiol|mesh-list
5677520|NCT03518528|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5864401|NCT02376452|Fluorouracil|fluorouracil|mesh-list
5864402|NCT02376452|Raltitrexed|raltitrexed|mesh-list
5864403|NCT02376452|Irinotecan|irinotecan|mesh-list
5864404|NCT02376452|Antimetabolites|antimetabolites|mesh-ancestor
5864405|NCT02376452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5864406|NCT02376452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5864407|NCT02376452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5864408|NCT02376452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5864409|NCT02376452|Immunologic Factors|immunologic factors|mesh-ancestor
5864410|NCT02376452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864411|NCT02376452|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5864412|NCT02376452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5864413|NCT02376452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5864414|NCT02376452|Antidotes|antidotes|mesh-ancestor
5677521|NCT03518528|Estrogens|estrogens|mesh-ancestor
5677522|NCT03518528|Hormones|hormones|mesh-ancestor
5677523|NCT03518528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5677524|NCT03518528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677525|NCT03518528|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5677526|NCT03518528|Contraceptive Agents|contraceptive agents|mesh-ancestor
5677527|NCT03518528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5677528|NCT03518528|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5677529|NCT03518502|Sorafenib|sorafenib|mesh-list
5677530|NCT03518502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5677531|NCT03518502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5864415|NCT02376452|Protective Agents|protective agents|mesh-ancestor
5864416|NCT02376452|Vitamin B Complex|vitamin b complex|mesh-ancestor
5864417|NCT02376452|Vitamins|vitamins|mesh-ancestor
5864418|NCT02376452|Micronutrients|micronutrients|mesh-ancestor
5864419|NCT02376452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5904935|NCT03883581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5904936|NCT03883581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904937|NCT03883581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904938|NCT03883581|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5904939|NCT03883581|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5904940|NCT03883581|Adrenergic Agents|adrenergic agents|mesh-ancestor
5904941|NCT03883581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5677532|NCT03518502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5677533|NCT03518502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5677534|NCT03518489|Lappaconitine|lappaconitine|mesh-list
5677535|NCT03518489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5677536|NCT03518489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5677537|NCT03518489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5677538|NCT03518489|Analgesics|analgesics|mesh-ancestor
5677539|NCT03518489|Sensory System Agents|sensory system agents|mesh-ancestor
5677540|NCT03518489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5677541|NCT03518489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677542|NCT03518320|Gemcitabine|gemcitabine|mesh-list
5677543|NCT03518320|Nivolumab|nivolumab|mesh-list
5904942|NCT03883581|Antimalarials|antimalarials|mesh-ancestor
5904943|NCT03883581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5904944|NCT03883581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5904945|NCT03883581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5904946|NCT03883581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5904947|NCT03883581|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5677544|NCT03518320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5677545|NCT03518320|Antimetabolites|antimetabolites|mesh-ancestor
5698038|NCT03371849|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5904948|NCT03883581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5904949|NCT03883581|Cholinergic Agents|cholinergic agents|mesh-ancestor
5904950|NCT03883581|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5864420|NCT02376413|Trastuzumab|trastuzumab|mesh-list
5864421|NCT02376413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6494688|NCT00619840|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6494689|NCT00619840|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6494690|NCT00619840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6494691|NCT00619840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494692|NCT00619840|Dopamine Agents|dopamine agents|mesh-ancestor
6494693|NCT00619840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6494694|NCT00619905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6675090|NCT01572597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864422|NCT02376413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5864423|NCT02376309|Nandrolone|nandrolone|mesh-list
5864424|NCT02376309|Androgens|androgens|mesh-ancestor
5864425|NCT02376309|Hormones|hormones|mesh-ancestor
5864426|NCT02376309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5864427|NCT02376309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864428|NCT02376309|Anabolic Agents|anabolic agents|mesh-ancestor
5864429|NCT02376088|Methimazole|methimazole|mesh-list
5864430|NCT02376088|Antithyroid Agents|antithyroid agents|mesh-ancestor
5864431|NCT02376088|Hormone Antagonists|hormone antagonists|mesh-ancestor
5864432|NCT02376088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5864433|NCT02376088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677546|NCT03518320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5677547|NCT03518320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5677548|NCT03518320|Antiviral Agents|antiviral agents|mesh-ancestor
5677549|NCT03518320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5677550|NCT03518320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5677551|NCT03518320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5677552|NCT03518320|Immunologic Factors|immunologic factors|mesh-ancestor
5677553|NCT03518320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677554|NCT03518320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5864434|NCT02376296|Docetaxel|docetaxel|mesh-list
5864435|NCT02376296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5864436|NCT02376296|Tubulin Modulators|tubulin modulators|mesh-ancestor
5864437|NCT02376296|Antimitotic Agents|antimitotic agents|mesh-ancestor
5864438|NCT02376296|Mitosis Modulators|mitosis modulators|mesh-ancestor
5864439|NCT02376296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5864440|NCT02376374|Vaccines|vaccines|mesh-list
6675091|NCT01572623|Clopidogrel|clopidogrel|mesh-list
6675092|NCT01572623|Atorvastatin|atorvastatin|mesh-list
6675093|NCT01572623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5864441|NCT02376374|Immunologic Factors|immunologic factors|mesh-ancestor
5864442|NCT02376374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864443|NCT02376192|Phenylephrine|phenylephrine|mesh-list
5677555|NCT03518320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5677556|NCT03518242|Cyclophosphamide|cyclophosphamide|mesh-list
5677557|NCT03518242|Capecitabine|capecitabine|mesh-list
5677558|NCT03518242|Methotrexate|methotrexate|mesh-list
5677559|NCT03518242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5677560|NCT03518242|Immunologic Factors|immunologic factors|mesh-ancestor
5677561|NCT03518242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677562|NCT03518242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5677563|NCT03518242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5864444|NCT02376192|Oxymetazoline|oxymetazoline|mesh-list
5864445|NCT02376192|Ephedrine|ephedrine|mesh-list
5864446|NCT02376192|Bupivacaine|bupivacaine|mesh-list
5864447|NCT02376192|Anesthetics, Local|anesthetics, local|mesh-ancestor
5864448|NCT02376192|Anesthetics|anesthetics|mesh-ancestor
5864449|NCT02376192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5864450|NCT02376192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864451|NCT02376192|Sensory System Agents|sensory system agents|mesh-ancestor
5864452|NCT02376192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5864453|NCT02376192|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5864454|NCT02376192|Mydriatics|mydriatics|mesh-ancestor
5864455|NCT02376192|Autonomic Agents|autonomic agents|mesh-ancestor
5864456|NCT02376192|Sympathomimetics|sympathomimetics|mesh-ancestor
5864457|NCT02376192|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5864458|NCT02376192|Nasal Decongestants|nasal decongestants|mesh-ancestor
5864459|NCT02376192|Respiratory System Agents|respiratory system agents|mesh-ancestor
5864460|NCT02376192|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5864461|NCT02376192|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5677564|NCT03518242|Alkylating Agents|alkylating agents|mesh-ancestor
5864462|NCT02376192|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5864463|NCT02376192|Adrenergic Agents|adrenergic agents|mesh-ancestor
5864464|NCT02376192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6212303|NCT02186015|Ergocalciferols|ergocalciferols|mesh-list
5677565|NCT03518242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5677566|NCT03518242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5677567|NCT03518242|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5677568|NCT03518242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5677569|NCT03518242|Antimetabolites|antimetabolites|mesh-ancestor
5677570|NCT03518242|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5864465|NCT02376192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5864466|NCT02376192|Protective Agents|protective agents|mesh-ancestor
5864467|NCT02376192|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5864468|NCT02376049|Betamethasone|betamethasone|mesh-list
5864469|NCT02376049|Betamethasone Valerate|betamethasone valerate|mesh-list
5864470|NCT02376049|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5864471|NCT02376049|Betamethasone benzoate|betamethasone benzoate|mesh-list
5864472|NCT02376049|Clobetasol|clobetasol|mesh-list
5864473|NCT02376049|Pimecrolimus|pimecrolimus|mesh-list
5864474|NCT02376049|Emollients|emollients|mesh-list
5864475|NCT02376049|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
5864476|NCT02376049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5864477|NCT02376049|Glucocorticoids|glucocorticoids|mesh-ancestor
5864478|NCT02376049|Hormones|hormones|mesh-ancestor
5864479|NCT02376049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5677571|NCT03518242|Abortifacient Agents|abortifacient agents|mesh-ancestor
5677572|NCT03518242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5864480|NCT02376049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864481|NCT02376049|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5864482|NCT02376049|Respiratory System Agents|respiratory system agents|mesh-ancestor
5864483|NCT02376049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5864484|NCT02376049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5864485|NCT02376049|Analgesics|analgesics|mesh-ancestor
5864486|NCT02376049|Sensory System Agents|sensory system agents|mesh-ancestor
5864487|NCT02376049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5864488|NCT02376049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5864489|NCT02376049|Dermatologic Agents|dermatologic agents|mesh-ancestor
5864490|NCT02376049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5864491|NCT02376049|Immunologic Factors|immunologic factors|mesh-ancestor
5864492|NCT02376049|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5864493|NCT02376049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6494695|NCT00619905|Immunologic Factors|immunologic factors|mesh-ancestor
6494696|NCT00619905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494697|NCT00619931|APD791|apd791|mesh-list
6494698|NCT00619931|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6494699|NCT00619931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6494700|NCT00619931|Serotonin Agents|serotonin agents|mesh-ancestor
6494701|NCT00619931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5864494|NCT02376049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5864495|NCT02376205|Bupivacaine|bupivacaine|mesh-list
5864496|NCT02376205|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5864497|NCT02376205|Anesthetics, Local|anesthetics, local|mesh-ancestor
5864498|NCT02376205|Anesthetics|anesthetics|mesh-ancestor
5864499|NCT02376205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5864500|NCT02376205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864501|NCT02376205|Sensory System Agents|sensory system agents|mesh-ancestor
5864502|NCT02376205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5864503|NCT02376075|Linagliptin|linagliptin|mesh-list
5864504|NCT02376075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5864505|NCT02376075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864506|NCT02376075|Incretins|incretins|mesh-ancestor
5864507|NCT02376075|Hormones|hormones|mesh-ancestor
5864508|NCT02376075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5864509|NCT02376075|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5864510|NCT02376075|Protease Inhibitors|protease inhibitors|mesh-ancestor
5864511|NCT02376075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5864512|NCT02376075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5864513|NCT02375828|Glyburide|glyburide|mesh-list
5864514|NCT02375828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5864515|NCT02375828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864516|NCT02376335|Rituximab|rituximab|mesh-list
5864517|NCT02376335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5864518|NCT02376335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5864519|NCT02376335|Immunologic Factors|immunologic factors|mesh-ancestor
5864520|NCT02376335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864521|NCT02376335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5864522|NCT02375880|Gemcitabine|gemcitabine|mesh-list
5864523|NCT02375880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5677573|NCT03518242|Dermatologic Agents|dermatologic agents|mesh-ancestor
5864524|NCT02375880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5864525|NCT02375880|Antimetabolites|antimetabolites|mesh-ancestor
5864526|NCT02375880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5864527|NCT02375880|Antiviral Agents|antiviral agents|mesh-ancestor
5864528|NCT02375880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5864529|NCT02375880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5864530|NCT02375880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5864531|NCT02375880|Immunologic Factors|immunologic factors|mesh-ancestor
5864532|NCT02375880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864533|NCT02375867|Methylprednisolone|methylprednisolone|mesh-list
5864534|NCT02375867|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5864535|NCT02375867|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5864536|NCT02375867|Prednisolone|prednisolone|mesh-list
5864537|NCT02375867|Prednisolone acetate|prednisolone acetate|mesh-list
5864538|NCT02375867|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5864539|NCT02375867|Prednisolone phosphate|prednisolone phosphate|mesh-list
5864540|NCT02375867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5864541|NCT02375867|Antiemetics|antiemetics|mesh-ancestor
5864542|NCT02375867|Autonomic Agents|autonomic agents|mesh-ancestor
5864543|NCT02375867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5864544|NCT02375867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864545|NCT02375867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5864546|NCT02375867|Glucocorticoids|glucocorticoids|mesh-ancestor
5864547|NCT02375867|Hormones|hormones|mesh-ancestor
5864548|NCT02375867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5864549|NCT02375867|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5864550|NCT02375867|Protective Agents|protective agents|mesh-ancestor
5864551|NCT02375867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5864552|NCT02375867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5864553|NCT02375646|Heparin|heparin|mesh-list
5677574|NCT03518242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5677575|NCT03518242|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5677576|NCT03518242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5677577|NCT03518112|Calcium, Dietary|calcium, dietary|mesh-list
5677578|NCT03518112|Leucovorin|leucovorin|mesh-list
5677579|NCT03518112|Folic Acid|folic acid|mesh-list
5677580|NCT03518112|Cytarabine|cytarabine|mesh-list
5677581|NCT03518112|Dexamethasone|dexamethasone|mesh-list
5677582|NCT03518112|Dexamethasone acetate|dexamethasone acetate|mesh-list
5864554|NCT02375646|Enoxaparin|enoxaparin|mesh-list
5864555|NCT02375646|Warfarin|warfarin|mesh-list
5864556|NCT02375646|Anticoagulants|anticoagulants|mesh-ancestor
5864557|NCT02375646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5864558|NCT02375646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5864559|NCT02375646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5864560|NCT02375464|Octreotide|octreotide|mesh-list
5864561|NCT02375464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5864562|NCT02375464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5864563|NCT02375464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5864564|NCT02375503|Vitamin D|vitamin d|mesh-list
5864565|NCT02375503|Calcium|calcium|mesh-list
5864566|NCT02375503|Vitamins|vitamins|mesh-ancestor
5864567|NCT02375503|Micronutrients|micronutrients|mesh-ancestor
5864568|NCT02375503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864569|NCT02375503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5864570|NCT02375503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5864571|NCT02375295|Ciprofloxacin|ciprofloxacin|mesh-list
5864572|NCT02375295|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6494702|NCT00619931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494703|NCT00619931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677583|NCT03518112|Cyclophosphamide|cyclophosphamide|mesh-list
5677584|NCT03518112|Rituximab|rituximab|mesh-list
5677585|NCT03518112|Methotrexate|methotrexate|mesh-list
5677586|NCT03518112|Vincristine|vincristine|mesh-list
5677587|NCT03518112|Mercaptopurine|mercaptopurine|mesh-list
5677588|NCT03518112|Blinatumomab|blinatumomab|mesh-list
5677589|NCT03518112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5677590|NCT03518112|Muromonab-CD3|muromonab-cd3|mesh-list
5677591|NCT03518112|Antibodies|antibodies|mesh-list
5677592|NCT03518112|Immunoglobulins|immunoglobulins|mesh-list
5864573|NCT02375295|Nitrofurantoin|nitrofurantoin|mesh-list
6494704|NCT00619944|Ritonavir|ritonavir|mesh-list
6494705|NCT00619944|Lopinavir|lopinavir|mesh-list
6494706|NCT00619944|Lumefantrine|lumefantrine|mesh-list
5677593|NCT03518112|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5677594|NCT03518112|Lenograstim|lenograstim|mesh-list
5677595|NCT03518112|Antibodies, Bispecific|antibodies, bispecific|mesh-list
5677596|NCT03518112|BB 1101|bb 1101|mesh-list
5677597|NCT03518112|Calcium|calcium|mesh-list
5677598|NCT03518112|Levoleucovorin|levoleucovorin|mesh-list
6494707|NCT00619944|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6494708|NCT00619944|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6494709|NCT00619944|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5864574|NCT02375295|Trimethoprim|trimethoprim|mesh-list
5864575|NCT02375295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5864576|NCT02375295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5864577|NCT02375295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5864578|NCT02375295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5864579|NCT02375295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5864580|NCT02375295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5864581|NCT02375295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5864582|NCT02375295|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5864583|NCT02375295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5864584|NCT02375295|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5864585|NCT02375295|Renal Agents|renal agents|mesh-ancestor
5864586|NCT02375295|Antimalarials|antimalarials|mesh-ancestor
5864587|NCT02375295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5677599|NCT03518112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5677600|NCT03518112|Immunologic Factors|immunologic factors|mesh-ancestor
5677601|NCT03518112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677602|NCT03518112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5677603|NCT03518112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5677604|NCT03518112|Alkylating Agents|alkylating agents|mesh-ancestor
5677605|NCT03518112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5677606|NCT03518112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5677607|NCT03518112|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5864588|NCT02375295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5864589|NCT02375295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5864590|NCT02375295|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5864591|NCT02375295|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
5864592|NCT02375243|Dexmedetomidine|dexmedetomidine|mesh-list
5864593|NCT02375243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5864594|NCT02375243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5864595|NCT02375243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864596|NCT02375243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5864597|NCT02375243|Analgesics|analgesics|mesh-ancestor
5864598|NCT02375243|Sensory System Agents|sensory system agents|mesh-ancestor
5864599|NCT02375243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5864600|NCT02375243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5864601|NCT02375243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5864602|NCT02375243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5864603|NCT02375243|Adrenergic Agents|adrenergic agents|mesh-ancestor
5864604|NCT02375243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5864605|NCT02375243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5864606|NCT02375217|Glycopyrrolate|glycopyrrolate|mesh-list
5864607|NCT02375217|Neostigmine|neostigmine|mesh-list
5864608|NCT02375217|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5864609|NCT02375217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5864610|NCT02375217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5864611|NCT02375217|Cholinergic Agents|cholinergic agents|mesh-ancestor
5864612|NCT02375217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5864613|NCT02375217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677608|NCT03518112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5677609|NCT03518112|Antiemetics|antiemetics|mesh-ancestor
5677610|NCT03518112|Autonomic Agents|autonomic agents|mesh-ancestor
5677611|NCT03518112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5677612|NCT03518112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5677613|NCT03518112|Glucocorticoids|glucocorticoids|mesh-ancestor
5677614|NCT03518112|Hormones|hormones|mesh-ancestor
5677615|NCT03518112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5677616|NCT03518112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5677617|NCT03518112|Protease Inhibitors|protease inhibitors|mesh-ancestor
5677618|NCT03518112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5677619|NCT03518112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5677620|NCT03518112|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5677621|NCT03518112|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5677622|NCT03518112|Abortifacient Agents|abortifacient agents|mesh-ancestor
5677623|NCT03518112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5677624|NCT03518112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5677625|NCT03518112|Antimetabolites|antimetabolites|mesh-ancestor
5677626|NCT03518112|Dermatologic Agents|dermatologic agents|mesh-ancestor
5677627|NCT03518112|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5864614|NCT02375217|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5864615|NCT02375217|Autonomic Agents|autonomic agents|mesh-ancestor
5864616|NCT02375217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5864617|NCT02375217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5864618|NCT02375217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5864619|NCT02375217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5864620|NCT02375139|Metformin|metformin|mesh-list
5864621|NCT02375139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5864622|NCT02375139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864623|NCT02375191|Fentanyl|fentanyl|mesh-list
5864624|NCT02375191|Dexmedetomidine|dexmedetomidine|mesh-list
5864625|NCT02375191|Ropivacaine|ropivacaine|mesh-list
5864626|NCT02375191|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5864627|NCT02375191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5864628|NCT02375191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864629|NCT02375191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5864630|NCT02375191|Analgesics|analgesics|mesh-ancestor
5864631|NCT02375191|Sensory System Agents|sensory system agents|mesh-ancestor
5864632|NCT02375191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5864633|NCT02375191|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5864634|NCT02375191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5864635|NCT02375191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5864636|NCT02375191|Adrenergic Agents|adrenergic agents|mesh-ancestor
5864637|NCT02375191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5864638|NCT02375191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5864639|NCT02375191|Anesthetics, Local|anesthetics, local|mesh-ancestor
5864640|NCT02375191|Anesthetics|anesthetics|mesh-ancestor
5864641|NCT02375191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5864642|NCT02375191|Narcotics|narcotics|mesh-ancestor
5864643|NCT02375191|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5864644|NCT02375191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5864645|NCT02375191|Anesthetics, General|anesthetics, general|mesh-ancestor
5864646|NCT02375178|Biguanides|biguanides|mesh-list
5864647|NCT02375178|Chlorhexidine|chlorhexidine|mesh-list
5864648|NCT02375178|Polihexanide|polihexanide|mesh-list
5864649|NCT02375178|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5864650|NCT02375178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5864651|NCT02375178|Disinfectants|disinfectants|mesh-ancestor
5864652|NCT02375178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5677628|NCT03518112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5677629|NCT03518112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5677630|NCT03518112|Antiviral Agents|antiviral agents|mesh-ancestor
5677631|NCT03518112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5677632|NCT03518112|Antidotes|antidotes|mesh-ancestor
5677633|NCT03518112|Protective Agents|protective agents|mesh-ancestor
5677634|NCT03518112|Vitamin B Complex|vitamin b complex|mesh-ancestor
5677635|NCT03518112|Vitamins|vitamins|mesh-ancestor
5677636|NCT03518112|Micronutrients|micronutrients|mesh-ancestor
5677637|NCT03518112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5677638|NCT03518112|Tubulin Modulators|tubulin modulators|mesh-ancestor
5677639|NCT03518112|Antimitotic Agents|antimitotic agents|mesh-ancestor
5677640|NCT03518112|Mitosis Modulators|mitosis modulators|mesh-ancestor
5677641|NCT03518112|Hematinics|hematinics|mesh-ancestor
5677642|NCT03518060|Dolutegravir, rilpivirine drug combination|dolutegravir, rilpivirine drug combination|mesh-list
5677643|NCT03518060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5677644|NCT03518060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5677645|NCT03518060|Antiviral Agents|antiviral agents|mesh-ancestor
5677646|NCT03518060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5677647|NCT03518021|Naloxone|naloxone|mesh-list
5677648|NCT03518021|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5677649|NCT03518021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677650|NCT03518021|Sensory System Agents|sensory system agents|mesh-ancestor
5677651|NCT03518021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5864653|NCT02375178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864654|NCT02375100|Acetaminophen|acetaminophen|mesh-list
5864655|NCT02375100|Tramadol|tramadol|mesh-list
5864656|NCT02375100|Analgesics|analgesics|mesh-list
5864657|NCT02375100|Bupivacaine|bupivacaine|mesh-list
5864658|NCT02375100|Anesthetics, Local|anesthetics, local|mesh-ancestor
5864659|NCT02375100|Anesthetics|anesthetics|mesh-ancestor
5864660|NCT02375100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5864661|NCT02375100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864662|NCT02375100|Sensory System Agents|sensory system agents|mesh-ancestor
5864663|NCT02375100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5677652|NCT03517995|Sulforaphane|sulforaphane|mesh-list
5677653|NCT03517995|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5864664|NCT02375100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5864665|NCT02375100|Antipyretics|antipyretics|mesh-ancestor
5864666|NCT02375100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5864667|NCT02375100|Narcotics|narcotics|mesh-ancestor
5864668|NCT02375022|Endostar protein|endostar protein|mesh-list
5864669|NCT02375022|Endostatins|endostatins|mesh-list
5864670|NCT02375022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5864671|NCT02375022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5864672|NCT02375022|Growth Substances|growth substances|mesh-ancestor
5864673|NCT02375022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864674|NCT02375022|Growth Inhibitors|growth inhibitors|mesh-ancestor
5864675|NCT02375022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5904951|NCT03883581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5904952|NCT03883581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5904953|NCT03883581|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5904954|NCT03883581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5904955|NCT03854578|Citalopram|citalopram|mesh-list
5904956|NCT03854578|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5904957|NCT03854578|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5904958|NCT03854578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5904959|NCT03854578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904960|NCT03854578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5904961|NCT03854578|Serotonin Agents|serotonin agents|mesh-ancestor
5904962|NCT03854578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904963|NCT03854578|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5904964|NCT03854578|Antidepressive Agents|antidepressive agents|mesh-ancestor
5904965|NCT03854578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5904966|NCT03844412|Lidocaine|lidocaine|mesh-list
5904967|NCT03844412|Nortriptyline|nortriptyline|mesh-list
5904968|NCT03844412|Estradiol|estradiol|mesh-list
5904969|NCT03844412|Anesthetics, Local|anesthetics, local|mesh-ancestor
5904970|NCT03844412|Anesthetics|anesthetics|mesh-ancestor
5904971|NCT03844412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5904972|NCT03844412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904973|NCT03844412|Sensory System Agents|sensory system agents|mesh-ancestor
5904974|NCT03844412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5904975|NCT03844412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5677654|NCT03517995|Protective Agents|protective agents|mesh-ancestor
5677655|NCT03517995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677656|NCT03517995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5677657|NCT03517982|Mycophenolic Acid|mycophenolic acid|mesh-list
5677658|NCT03517982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5677659|NCT03517982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5677660|NCT03517982|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5677661|NCT03517982|Antitubercular Agents|antitubercular agents|mesh-ancestor
5677662|NCT03517982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5677663|NCT03517982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5677664|NCT03517982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5677665|NCT03517982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5677666|NCT03517943|Loratadine|loratadine|mesh-list
5677667|NCT03517943|Pseudoephedrine|pseudoephedrine|mesh-list
5677668|NCT03517943|Ephedrine|ephedrine|mesh-list
5677669|NCT03517943|Antipruritics|antipruritics|mesh-ancestor
5677670|NCT03517943|Dermatologic Agents|dermatologic agents|mesh-ancestor
5677671|NCT03517943|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5677672|NCT03517943|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5677673|NCT03517943|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5677674|NCT03517943|Histamine Antagonists|histamine antagonists|mesh-ancestor
5677675|NCT03517943|Histamine Agents|histamine agents|mesh-ancestor
5677676|NCT03517943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5698039|NCT03371849|Hormone Antagonists|hormone antagonists|mesh-ancestor
5904976|NCT03844412|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5904977|NCT03844412|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5904978|NCT03844412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5904979|NCT03844412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5904980|NCT03844412|Estrogens|estrogens|mesh-ancestor
5904981|NCT03844412|Hormones|hormones|mesh-ancestor
5904982|NCT03844412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5904983|NCT03844412|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5904984|NCT03844412|Antidepressive Agents|antidepressive agents|mesh-ancestor
5904985|NCT03844412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5904986|NCT03844412|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5904987|NCT03844412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5904988|NCT03844412|Adrenergic Agents|adrenergic agents|mesh-ancestor
5904989|NCT03844412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5904990|NCT03821246|Atezolizumab|atezolizumab|mesh-list
5904991|NCT03821246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5677677|NCT03517943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5677678|NCT03517943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677679|NCT03517943|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5677680|NCT03517943|Autonomic Agents|autonomic agents|mesh-ancestor
5677681|NCT03517943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5677682|NCT03517943|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5677683|NCT03517943|Respiratory System Agents|respiratory system agents|mesh-ancestor
5677684|NCT03517943|Nasal Decongestants|nasal decongestants|mesh-ancestor
5677685|NCT03517943|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5677686|NCT03517943|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5677687|NCT03517943|Sympathomimetics|sympathomimetics|mesh-ancestor
5864676|NCT02374853|Vancomycin|vancomycin|mesh-list
5864677|NCT02374853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5864678|NCT02374853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5864679|NCT02374736|Immunoglobulins|immunoglobulins|mesh-list
5864680|NCT02374736|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5864681|NCT02374736|Antibodies|antibodies|mesh-list
5864682|NCT02374736|Immunoglobulin G|immunoglobulin g|mesh-list
5864683|NCT02374736|Immunologic Factors|immunologic factors|mesh-ancestor
5864684|NCT02374736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864685|NCT02374931|Estradiol|estradiol|mesh-list
5864686|NCT02374931|Estrogens|estrogens|mesh-ancestor
5864687|NCT02374931|Hormones|hormones|mesh-ancestor
5864688|NCT02374931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5864689|NCT02374931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864690|NCT02374632|Octreotide|octreotide|mesh-list
5864691|NCT02374632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5864692|NCT02374632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5864693|NCT02374632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5864694|NCT02374645|Gefitinib|gefitinib|mesh-list
5864695|NCT02374645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5864696|NCT02374645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5864697|NCT02374645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5864698|NCT02374645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5864699|NCT02374489|Ceritinib|ceritinib|mesh-list
5864700|NCT02374489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5864701|NCT02374489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5864702|NCT02374489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5864703|NCT02374489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5864704|NCT02374320|Bupivacaine|bupivacaine|mesh-list
5677688|NCT03517943|Adrenergic Agents|adrenergic agents|mesh-ancestor
5677689|NCT03517930|Loratadine|loratadine|mesh-list
5677690|NCT03517930|Pseudoephedrine|pseudoephedrine|mesh-list
5677691|NCT03517930|Ephedrine|ephedrine|mesh-list
5677692|NCT03517930|Antipruritics|antipruritics|mesh-ancestor
5677693|NCT03517930|Dermatologic Agents|dermatologic agents|mesh-ancestor
5677694|NCT03517930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5677695|NCT03517930|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5677696|NCT03517930|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5677697|NCT03517930|Histamine Antagonists|histamine antagonists|mesh-ancestor
5677698|NCT03517930|Histamine Agents|histamine agents|mesh-ancestor
5677699|NCT03517930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5677700|NCT03517930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5864705|NCT02374320|Anesthetics, Local|anesthetics, local|mesh-ancestor
5864706|NCT02374320|Anesthetics|anesthetics|mesh-ancestor
5864707|NCT02374320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5864708|NCT02374320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864709|NCT02374320|Sensory System Agents|sensory system agents|mesh-ancestor
5864710|NCT02374320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5864711|NCT02374567|Topiramate|topiramate|mesh-list
5864712|NCT02374567|Diphenhydramine|diphenhydramine|mesh-list
5864713|NCT02374567|Promethazine|promethazine|mesh-list
5864714|NCT02374567|Pregabalin|pregabalin|mesh-list
5864715|NCT02374567|Lamotrigine|lamotrigine|mesh-list
5864716|NCT02374567|Lacosamide|lacosamide|mesh-list
5864717|NCT02374567|Carbamazepine|carbamazepine|mesh-list
5864718|NCT02374567|Phenytoin|phenytoin|mesh-list
5864719|NCT02374567|Oxcarbazepine|oxcarbazepine|mesh-list
5864720|NCT02374567|Nicergoline|nicergoline|mesh-list
5864721|NCT02374567|Midazolam|midazolam|mesh-list
5864722|NCT02374567|Diazepam|diazepam|mesh-list
5864723|NCT02374567|Triazolam|triazolam|mesh-list
5864724|NCT02374567|Acamprosate|acamprosate|mesh-list
5864725|NCT02374567|Gabapentin|gabapentin|mesh-list
5677701|NCT03517930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864726|NCT02374567|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5864727|NCT02374567|Amitriptyline|amitriptyline|mesh-list
5864728|NCT02374567|Methotrimeprazine|methotrimeprazine|mesh-list
5864729|NCT02374567|Levetiracetam|levetiracetam|mesh-list
5864730|NCT02374567|Valproic Acid|valproic acid|mesh-list
5864731|NCT02374567|Lorazepam|lorazepam|mesh-list
5864732|NCT02374567|Clonazepam|clonazepam|mesh-list
5864733|NCT02374567|Phenobarbital|phenobarbital|mesh-list
5864734|NCT02374567|Clobazam|clobazam|mesh-list
5864735|NCT02374567|Zaleplon|zaleplon|mesh-list
5864736|NCT02374567|Nitrazepam|nitrazepam|mesh-list
5864737|NCT02374567|Chlormethiazole|chlormethiazole|mesh-list
5864738|NCT02374567|Memantine|memantine|mesh-list
5864739|NCT02374567|Biperiden|biperiden|mesh-list
5864740|NCT02374567|Haloperidol|haloperidol|mesh-list
5864741|NCT02374567|Pimozide|pimozide|mesh-list
5864742|NCT02374567|Olanzapine|olanzapine|mesh-list
5864743|NCT02374567|Zolpidem|zolpidem|mesh-list
5864744|NCT02374567|Alprazolam|alprazolam|mesh-list
5864745|NCT02374567|Zopiclone|zopiclone|mesh-list
5864746|NCT02374567|S 20098|s 20098|mesh-list
5864747|NCT02374567|Chloral Hydrate|chloral hydrate|mesh-list
5864748|NCT02374567|Doxepin|doxepin|mesh-list
5864749|NCT02374567|Oxazepam|oxazepam|mesh-list
5864750|NCT02374567|Temazepam|temazepam|mesh-list
5864751|NCT02374567|Brotizolam|brotizolam|mesh-list
5864752|NCT02374567|Lormetazepam|lormetazepam|mesh-list
5864753|NCT02374567|Flurazepam|flurazepam|mesh-list
5864754|NCT02374567|Mirtazapine|mirtazapine|mesh-list
5864755|NCT02374567|Buspirone|buspirone|mesh-list
5864756|NCT02374567|Trazodone|trazodone|mesh-list
5677702|NCT03517930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5677703|NCT03517930|Autonomic Agents|autonomic agents|mesh-ancestor
5677704|NCT03517930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5677705|NCT03517930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5677706|NCT03517930|Respiratory System Agents|respiratory system agents|mesh-ancestor
5677707|NCT03517930|Nasal Decongestants|nasal decongestants|mesh-ancestor
5677708|NCT03517930|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5677709|NCT03517930|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5677710|NCT03517930|Sympathomimetics|sympathomimetics|mesh-ancestor
5864757|NCT02374567|Fluvoxamine|fluvoxamine|mesh-list
5864758|NCT02374567|Tranylcypromine|tranylcypromine|mesh-list
5864759|NCT02374567|Bromazepam|bromazepam|mesh-list
5864760|NCT02374567|Risperidone|risperidone|mesh-list
5864761|NCT02374567|Melatonin|melatonin|mesh-list
5864762|NCT02374567|Quetiapine Fumarate|quetiapine fumarate|mesh-list
5864763|NCT02374567|Aripiprazole|aripiprazole|mesh-list
5864764|NCT02374567|Paliperidone Palmitate|paliperidone palmitate|mesh-list
5864765|NCT02374567|Ziprasidone|ziprasidone|mesh-list
5864766|NCT02374567|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
5864767|NCT02374567|Clozapine|clozapine|mesh-list
5864768|NCT02374567|Amisulpride|amisulpride|mesh-list
5864769|NCT02374567|Flupenthixol|flupenthixol|mesh-list
5864770|NCT02374567|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
5864771|NCT02374567|Perphenazine|perphenazine|mesh-list
5864772|NCT02374567|Sertindole|sertindole|mesh-list
5864773|NCT02374567|Fluphenazine|fluphenazine|mesh-list
5864774|NCT02374567|Fluphenazine depot|fluphenazine depot|mesh-list
5864775|NCT02374567|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
5864776|NCT02374567|Sulpiride|sulpiride|mesh-list
5864777|NCT02374567|Thioridazine|thioridazine|mesh-list
5864778|NCT02374567|Pipamperone|pipamperone|mesh-list
5864779|NCT02374567|Clopenthixol|clopenthixol|mesh-list
5864780|NCT02374567|Chlorprothixene|chlorprothixene|mesh-list
5864781|NCT02374567|Tiapride Hydrochloride|tiapride hydrochloride|mesh-list
5864782|NCT02374567|Fluspirilene|fluspirilene|mesh-list
5864783|NCT02374567|Perazine|perazine|mesh-list
5864784|NCT02374567|Bromperidol|bromperidol|mesh-list
5864785|NCT02374567|Benperidol|benperidol|mesh-list
5864786|NCT02374567|Rivastigmine|rivastigmine|mesh-list
5864787|NCT02374567|Piracetam|piracetam|mesh-list
5864788|NCT02374567|Donepezil|donepezil|mesh-list
5864789|NCT02374567|Galantamine|galantamine|mesh-list
5864790|NCT02374567|Citalopram|citalopram|mesh-list
5864791|NCT02374567|Bupropion|bupropion|mesh-list
5864792|NCT02374567|Sertraline|sertraline|mesh-list
5677711|NCT03517930|Adrenergic Agents|adrenergic agents|mesh-ancestor
5696590|NCT03381781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696591|NCT03381781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5696592|NCT03381781|Antiviral Agents|antiviral agents|mesh-ancestor
5864793|NCT02374567|Fluoxetine|fluoxetine|mesh-list
5864794|NCT02374567|Paroxetine|paroxetine|mesh-list
5864795|NCT02374567|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
5864796|NCT02374567|Nortriptyline|nortriptyline|mesh-list
5864797|NCT02374567|Reboxetine|reboxetine|mesh-list
5864798|NCT02374567|Imipramine|imipramine|mesh-list
5864799|NCT02374567|Clomipramine|clomipramine|mesh-list
5864800|NCT02374567|Mianserin|mianserin|mesh-list
5864801|NCT02374567|Moclobemide|moclobemide|mesh-list
5864802|NCT02374567|Opipramol|opipramol|mesh-list
5864803|NCT02374567|Maprotiline|maprotiline|mesh-list
5864804|NCT02374567|Trimipramine|trimipramine|mesh-list
5864805|NCT02374567|Hydroxyzine|hydroxyzine|mesh-list
5864806|NCT02374567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5864807|NCT02374567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5864808|NCT02374567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5864809|NCT02374567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864810|NCT02374567|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5864811|NCT02374567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5864812|NCT02374567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5864813|NCT02374567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5864814|NCT02374567|Anesthetics, General|anesthetics, general|mesh-ancestor
5864815|NCT02374567|Anesthetics|anesthetics|mesh-ancestor
5864816|NCT02374567|GABA Modulators|gaba modulators|mesh-ancestor
5864817|NCT02374567|GABA Agents|gaba agents|mesh-ancestor
5864818|NCT02374567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5864819|NCT02374567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5864820|NCT02374567|Analgesics|analgesics|mesh-ancestor
5864821|NCT02374567|Sensory System Agents|sensory system agents|mesh-ancestor
5864822|NCT02374567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5864823|NCT02374567|Anticonvulsants|anticonvulsants|mesh-ancestor
5864824|NCT02374567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5864825|NCT02374567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5864826|NCT02374567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5864827|NCT02374567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5864828|NCT02374567|Serotonin Agents|serotonin agents|mesh-ancestor
5864829|NCT02374567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5864830|NCT02374567|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5864831|NCT02374567|Dopamine Agents|dopamine agents|mesh-ancestor
5864832|NCT02374567|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5864833|NCT02374567|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5864834|NCT02374567|Antimanic Agents|antimanic agents|mesh-ancestor
5864835|NCT02374567|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5864836|NCT02374567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5864837|NCT02374567|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5864838|NCT02374567|Antidepressive Agents|antidepressive agents|mesh-ancestor
5864839|NCT02374567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5864840|NCT02374567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5864841|NCT02374567|Parasympatholytics|parasympatholytics|mesh-ancestor
5864842|NCT02374567|Autonomic Agents|autonomic agents|mesh-ancestor
5864843|NCT02374567|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5864844|NCT02374567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5864845|NCT02374567|Cholinergic Agents|cholinergic agents|mesh-ancestor
5864846|NCT02374567|Antioxidants|antioxidants|mesh-ancestor
5864847|NCT02374567|Protective Agents|protective agents|mesh-ancestor
5864848|NCT02374567|Antiemetics|antiemetics|mesh-ancestor
5864849|NCT02374567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5864850|NCT02374567|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5864851|NCT02374567|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5864852|NCT02374567|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5864853|NCT02374567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5864854|NCT02374567|Dopamine Agonists|dopamine agonists|mesh-ancestor
5864855|NCT02374567|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5864856|NCT02374567|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5864857|NCT02374567|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5864858|NCT02374567|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5864859|NCT02374567|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5864860|NCT02374567|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5864861|NCT02374567|Nootropic Agents|nootropic agents|mesh-ancestor
6212304|NCT02186015|Cholecalciferol|cholecalciferol|mesh-list
6212305|NCT02186015|Vitamins|vitamins|mesh-list
6212306|NCT02186015|Micronutrients|micronutrients|mesh-ancestor
6212307|NCT02186015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212308|NCT02186015|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5677712|NCT03517748|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5677713|NCT03517748|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5677714|NCT03517722|Ustekinumab|ustekinumab|mesh-list
5677715|NCT03517722|Dermatologic Agents|dermatologic agents|mesh-ancestor
5677716|NCT03517683|Methamphetamine|methamphetamine|mesh-list
5677717|NCT03517683|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5677718|NCT03517683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677719|NCT03517683|Sympathomimetics|sympathomimetics|mesh-ancestor
5677720|NCT03517683|Autonomic Agents|autonomic agents|mesh-ancestor
5677721|NCT03517683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5677722|NCT03517683|Dopamine Agents|dopamine agents|mesh-ancestor
5677723|NCT03517683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5677724|NCT03517683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5677725|NCT03517683|Adrenergic Agents|adrenergic agents|mesh-ancestor
5677726|NCT03517683|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5677727|NCT03517683|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5677728|NCT03517683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5864862|NCT02374567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5864863|NCT02374567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5864864|NCT02374567|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5864865|NCT02374567|Anesthetics, Local|anesthetics, local|mesh-ancestor
5864866|NCT02374567|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5864867|NCT02374567|Histamine Antagonists|histamine antagonists|mesh-ancestor
5864868|NCT02374567|Histamine Agents|histamine agents|mesh-ancestor
5864869|NCT02374567|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5677729|NCT03517683|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5677730|NCT03517670|Milrinone|milrinone|mesh-list
5677731|NCT03517670|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5677732|NCT03517670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5677733|NCT03517670|Vasodilator Agents|vasodilator agents|mesh-ancestor
5677734|NCT03517670|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5677735|NCT03517670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5677736|NCT03517670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5677737|NCT03517670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5677738|NCT03517670|Protective Agents|protective agents|mesh-ancestor
5677739|NCT03517670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677740|NCT03517631|Busulfan|busulfan|mesh-list
5677741|NCT03517631|Alkylating Agents|alkylating agents|mesh-ancestor
5864870|NCT02374567|Antipruritics|antipruritics|mesh-ancestor
5864871|NCT02374567|Dermatologic Agents|dermatologic agents|mesh-ancestor
5864872|NCT02374567|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
5864873|NCT02374567|GABA Agonists|gaba agonists|mesh-ancestor
5864874|NCT02374567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5864875|NCT02374567|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5864876|NCT02374567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5864877|NCT02374567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5864878|NCT02374567|Adrenergic Agents|adrenergic agents|mesh-ancestor
5864879|NCT02374567|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5864880|NCT02374567|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5864881|NCT02374567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5864882|NCT02374567|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5677742|NCT03517631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5677743|NCT03517631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5677744|NCT03517631|Immunologic Factors|immunologic factors|mesh-ancestor
5677745|NCT03517631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677746|NCT03517631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5677747|NCT03517631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5677748|NCT03517631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5677749|NCT03517618|Leucovorin|leucovorin|mesh-list
5677750|NCT03517618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677751|NCT03517618|Antidotes|antidotes|mesh-ancestor
5864883|NCT02374567|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5864884|NCT02374567|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5864885|NCT02374567|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5864886|NCT02374567|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5864887|NCT02374567|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5864888|NCT02374567|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5677752|NCT03517618|Protective Agents|protective agents|mesh-ancestor
5677753|NCT03517618|Vitamin B Complex|vitamin b complex|mesh-ancestor
5677754|NCT03517618|Vitamins|vitamins|mesh-ancestor
5677755|NCT03517618|Micronutrients|micronutrients|mesh-ancestor
5677756|NCT03517462|Ivermectin|ivermectin|mesh-list
5677757|NCT03517462|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5677758|NCT03517462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5677759|NCT03517423|Brivaracetam|brivaracetam|mesh-list
5677760|NCT03517423|Anticonvulsants|anticonvulsants|mesh-ancestor
5677761|NCT03517319|Botulinum Toxins|botulinum toxins|mesh-list
5677762|NCT03517319|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5677763|NCT03517319|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5677764|NCT03517319|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5677765|NCT03517319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5677766|NCT03517319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5677767|NCT03517319|Cholinergic Agents|cholinergic agents|mesh-ancestor
5677768|NCT03517319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5677769|NCT03517319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864889|NCT02374567|GABA Antagonists|gaba antagonists|mesh-ancestor
5864890|NCT02374567|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5864891|NCT02374567|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6212309|NCT02186015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5677770|NCT03517319|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5677771|NCT03517319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5677772|NCT03517176|Gemcitabine|gemcitabine|mesh-list
5677773|NCT03517176|Paclitaxel|paclitaxel|mesh-list
5864892|NCT02374567|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5864893|NCT02374567|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5864894|NCT02374567|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5864895|NCT02374567|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
5864896|NCT02374567|Vasodilator Agents|vasodilator agents|mesh-ancestor
5864897|NCT02374242|Nivolumab|nivolumab|mesh-list
5864898|NCT02374242|Ipilimumab|ipilimumab|mesh-list
5864899|NCT02374242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5864900|NCT02374242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5864901|NCT02374242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5864902|NCT02374242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5864903|NCT02374424|Obinutuzumab|obinutuzumab|mesh-list
5864904|NCT02374424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5864905|NCT02374424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5677774|NCT03517176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5677775|NCT03517176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5677776|NCT03517176|Tubulin Modulators|tubulin modulators|mesh-ancestor
5677777|NCT03517176|Antimitotic Agents|antimitotic agents|mesh-ancestor
5677778|NCT03517176|Mitosis Modulators|mitosis modulators|mesh-ancestor
5677779|NCT03517176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5677780|NCT03517176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5677781|NCT03517176|Antimetabolites|antimetabolites|mesh-ancestor
5677782|NCT03517176|Antiviral Agents|antiviral agents|mesh-ancestor
5677783|NCT03517176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5677784|NCT03517176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5677785|NCT03517176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5677786|NCT03517176|Immunologic Factors|immunologic factors|mesh-ancestor
5677787|NCT03517176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677788|NCT03517137|Cyclophosphamide|cyclophosphamide|mesh-list
5677789|NCT03517137|Dacarbazine|dacarbazine|mesh-list
5677790|NCT03517137|Etoposide|etoposide|mesh-list
5677791|NCT03517137|Doxorubicin|doxorubicin|mesh-list
5677792|NCT03517137|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5677793|NCT03517137|Vinblastine|vinblastine|mesh-list
5677794|NCT03517137|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5677795|NCT03517137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5677796|NCT03517137|Immunologic Factors|immunologic factors|mesh-ancestor
5677797|NCT03517137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677798|NCT03517137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5677799|NCT03517137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5677800|NCT03517137|Alkylating Agents|alkylating agents|mesh-ancestor
5677801|NCT03517137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5677802|NCT03517137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5677803|NCT03517137|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5677804|NCT03517137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5677805|NCT03517137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5677806|NCT03517137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5677807|NCT03517137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5677808|NCT03517137|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5677809|NCT03517137|Tubulin Modulators|tubulin modulators|mesh-ancestor
5677810|NCT03517137|Antimitotic Agents|antimitotic agents|mesh-ancestor
5677811|NCT03517137|Mitosis Modulators|mitosis modulators|mesh-ancestor
5677812|NCT03517137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5677813|NCT03517033|Nebivolol|nebivolol|mesh-list
5677814|NCT03517033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5677815|NCT03517033|Vasodilator Agents|vasodilator agents|mesh-ancestor
5677816|NCT03517033|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5677817|NCT03517033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5677818|NCT03517033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5677819|NCT03517033|Adrenergic Agents|adrenergic agents|mesh-ancestor
5677820|NCT03517033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5677821|NCT03517033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5677822|NCT03517033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677823|NCT03517020|Nebivolol|nebivolol|mesh-list
5677824|NCT03517020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5677825|NCT03517020|Vasodilator Agents|vasodilator agents|mesh-ancestor
5677826|NCT03517020|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5677827|NCT03517020|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5677828|NCT03517020|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5677829|NCT03517020|Adrenergic Agents|adrenergic agents|mesh-ancestor
5677830|NCT03517020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5696593|NCT03381781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5677831|NCT03517020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5677832|NCT03517020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677833|NCT03516968|Cholecalciferol|cholecalciferol|mesh-list
5677834|NCT03516968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5677835|NCT03516968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677836|NCT03516968|Vitamins|vitamins|mesh-ancestor
5677837|NCT03516968|Micronutrients|micronutrients|mesh-ancestor
5677838|NCT03516968|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5677839|NCT03516955|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5677840|NCT03516955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5677841|NCT03516955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5677842|NCT03516955|Antimetabolites|antimetabolites|mesh-ancestor
5677843|NCT03516955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5677844|NCT03516955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5677845|NCT03516955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5677846|NCT03516955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5677847|NCT03516903|Folic Acid|folic acid|mesh-list
5864906|NCT02374047|Atorvastatin|atorvastatin|mesh-list
5864907|NCT02374047|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5864908|NCT02374047|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5864909|NCT02374047|Antimetabolites|antimetabolites|mesh-ancestor
5864910|NCT02374047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5864911|NCT02374047|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5864912|NCT02374047|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5864913|NCT02374047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5864914|NCT02373943|Carotenoids|carotenoids|mesh-list
5864915|NCT02373943|Antioxidants|antioxidants|mesh-ancestor
5864916|NCT02373943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5864917|NCT02373943|Protective Agents|protective agents|mesh-ancestor
5864918|NCT02373943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864919|NCT02374008|Dexamethasone|dexamethasone|mesh-list
5864920|NCT02374008|Ketorolac|ketorolac|mesh-list
5864921|NCT02374008|Ropivacaine|ropivacaine|mesh-list
5864922|NCT02374008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5864923|NCT02374008|Antiemetics|antiemetics|mesh-ancestor
5864924|NCT02374008|Autonomic Agents|autonomic agents|mesh-ancestor
5864925|NCT02374008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5864926|NCT02374008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864927|NCT02374008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5864928|NCT02374008|Glucocorticoids|glucocorticoids|mesh-ancestor
5864929|NCT02374008|Hormones|hormones|mesh-ancestor
5864930|NCT02374008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5864931|NCT02374008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5864932|NCT02374008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5864933|NCT02374008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5864934|NCT02374008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5864935|NCT02374008|Anesthetics, Local|anesthetics, local|mesh-ancestor
5864936|NCT02374008|Anesthetics|anesthetics|mesh-ancestor
5864937|NCT02374008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5864938|NCT02374008|Sensory System Agents|sensory system agents|mesh-ancestor
5677848|NCT03516903|Methotrexate|methotrexate|mesh-list
5677849|NCT03516903|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5677850|NCT03516903|Abortifacient Agents|abortifacient agents|mesh-ancestor
5677851|NCT03516903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5677852|NCT03516903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677853|NCT03516903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5677854|NCT03516903|Antimetabolites|antimetabolites|mesh-ancestor
5677855|NCT03516903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5677856|NCT03516903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5677857|NCT03516903|Dermatologic Agents|dermatologic agents|mesh-ancestor
5677858|NCT03516903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5677859|NCT03516903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5864939|NCT02374008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5864940|NCT02374008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5864941|NCT02374008|Analgesics|analgesics|mesh-ancestor
5864942|NCT02374008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5864943|NCT02374008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5864944|NCT02374021|Hydroxychloroquine|hydroxychloroquine|mesh-list
5864945|NCT02374021|Sulfasalazine|sulfasalazine|mesh-list
5864946|NCT02374021|Adalimumab|adalimumab|mesh-list
6212310|NCT02186301|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5677860|NCT03516903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5677861|NCT03516903|Immunologic Factors|immunologic factors|mesh-ancestor
5864947|NCT02374021|Etanercept|etanercept|mesh-list
5864948|NCT02374021|Methotrexate|methotrexate|mesh-list
5677862|NCT03516903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5864949|NCT02374021|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5864950|NCT02374021|Abortifacient Agents|abortifacient agents|mesh-ancestor
5864951|NCT02374021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5864952|NCT02374021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864953|NCT02374021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5864954|NCT02374021|Antimetabolites|antimetabolites|mesh-ancestor
5864955|NCT02374021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5864956|NCT02374021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5864957|NCT02374021|Dermatologic Agents|dermatologic agents|mesh-ancestor
5864958|NCT02374021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5864959|NCT02374021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5864960|NCT02374021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5864961|NCT02374021|Immunologic Factors|immunologic factors|mesh-ancestor
5864962|NCT02374021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5864963|NCT02374021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5864964|NCT02374021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5864965|NCT02374021|Antimalarials|antimalarials|mesh-ancestor
5864966|NCT02374021|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5864967|NCT02374021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5864968|NCT02374021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5864969|NCT02374021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5864970|NCT02374021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5864971|NCT02374021|Analgesics|analgesics|mesh-ancestor
5864972|NCT02374021|Sensory System Agents|sensory system agents|mesh-ancestor
5864973|NCT02374021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5864974|NCT02374021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5864975|NCT02373735|Mannitol|mannitol|mesh-list
5864976|NCT02373735|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5864977|NCT02373735|Diuretics|diuretics|mesh-ancestor
5864978|NCT02373735|Natriuretic Agents|natriuretic agents|mesh-ancestor
5864979|NCT02373735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864980|NCT02373449|Ketamine|ketamine|mesh-list
5864981|NCT02373449|Analgesics|analgesics|mesh-ancestor
5864982|NCT02373449|Sensory System Agents|sensory system agents|mesh-ancestor
5864983|NCT02373449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5864984|NCT02373449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5864985|NCT02373449|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5864986|NCT02373449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5864987|NCT02373449|Anesthetics, General|anesthetics, general|mesh-ancestor
5864988|NCT02373449|Anesthetics|anesthetics|mesh-ancestor
5864989|NCT02373449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5864990|NCT02373449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5864991|NCT02373449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5864992|NCT02373449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5864993|NCT02373449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5864994|NCT02373722|Petrolatum|petrolatum|mesh-list
5864995|NCT02373722|Mineral Oil|mineral oil|mesh-list
5864996|NCT02373722|Emollients|emollients|mesh-ancestor
5864997|NCT02373722|Dermatologic Agents|dermatologic agents|mesh-ancestor
5864998|NCT02373514|Acetaminophen|acetaminophen|mesh-list
5864999|NCT02373514|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
5865000|NCT02373514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5865001|NCT02373514|Analgesics|analgesics|mesh-ancestor
5677863|NCT03516903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5677864|NCT03516903|Hematinics|hematinics|mesh-ancestor
5677865|NCT03516903|Vitamin B Complex|vitamin b complex|mesh-ancestor
5677866|NCT03516903|Vitamins|vitamins|mesh-ancestor
5677867|NCT03516903|Micronutrients|micronutrients|mesh-ancestor
5677868|NCT03516812|Methyltestosterone|methyltestosterone|mesh-list
5677869|NCT03516812|Olaparib|olaparib|mesh-list
5677870|NCT03516812|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
5677871|NCT03516812|Testosterone|testosterone|mesh-list
5677872|NCT03516812|Testosterone undecanoate|testosterone undecanoate|mesh-list
5677873|NCT03516812|Testosterone enanthate|testosterone enanthate|mesh-list
5677874|NCT03516812|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5677875|NCT03516812|Androgens|androgens|mesh-ancestor
5677876|NCT03516812|Hormones|hormones|mesh-ancestor
5677877|NCT03516812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5677878|NCT03516812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677879|NCT03516812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5677880|NCT03516812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5677881|NCT03516812|Anabolic Agents|anabolic agents|mesh-ancestor
5677882|NCT03516812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5677883|NCT03516812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865002|NCT02373514|Sensory System Agents|sensory system agents|mesh-ancestor
5865003|NCT02373514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5865004|NCT02373514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865005|NCT02373514|Antipyretics|antipyretics|mesh-ancestor
5865006|NCT02373514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5865007|NCT02373514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5865008|NCT02373514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5865009|NCT02373384|Allopurinol|allopurinol|mesh-list
5865010|NCT02373384|Potassium Citrate|potassium citrate|mesh-list
5865011|NCT02373384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865012|NCT02373384|Antimetabolites|antimetabolites|mesh-ancestor
5865013|NCT02373384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5865014|NCT02373384|Gout Suppressants|gout suppressants|mesh-ancestor
5865015|NCT02373384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5865016|NCT02373384|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5865017|NCT02373384|Antioxidants|antioxidants|mesh-ancestor
5865018|NCT02373384|Protective Agents|protective agents|mesh-ancestor
5865019|NCT02373384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865020|NCT02373384|Diuretics|diuretics|mesh-ancestor
5865021|NCT02373384|Natriuretic Agents|natriuretic agents|mesh-ancestor
5865022|NCT02373384|Expectorants|expectorants|mesh-ancestor
5865023|NCT02373384|Respiratory System Agents|respiratory system agents|mesh-ancestor
5865024|NCT02373579|Methotrexate|methotrexate|mesh-list
5865025|NCT02373579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5865026|NCT02373579|Abortifacient Agents|abortifacient agents|mesh-ancestor
5865027|NCT02373579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5865028|NCT02373579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865029|NCT02373579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5865030|NCT02373579|Antimetabolites|antimetabolites|mesh-ancestor
5865031|NCT02373579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865032|NCT02373579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5865033|NCT02373579|Dermatologic Agents|dermatologic agents|mesh-ancestor
5865034|NCT02373579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5865035|NCT02373579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5865036|NCT02373579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5865037|NCT02373579|Immunologic Factors|immunologic factors|mesh-ancestor
5865038|NCT02373579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5865039|NCT02373579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5904992|NCT03821246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5677884|NCT03516773|Parathyroid Hormone|parathyroid hormone|mesh-list
5677885|NCT03516773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5904993|NCT03821246|Immunologic Factors|immunologic factors|mesh-ancestor
5904994|NCT03821246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5904995|NCT03776760|Sofosbuvir|sofosbuvir|mesh-list
5904996|NCT03776760|Antiviral Agents|antiviral agents|mesh-ancestor
5904997|NCT03776760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5904998|NCT03769155|Nivolumab|nivolumab|mesh-list
5904999|NCT03769155|Ipilimumab|ipilimumab|mesh-list
5905000|NCT03769155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5905001|NCT03769155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5905002|NCT03769155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5905003|NCT03769155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905004|NCT03747484|Pembrolizumab|pembrolizumab|mesh-list
5905005|NCT03747484|Avelumab|avelumab|mesh-list
5905006|NCT03747484|Immunoglobulins|immunoglobulins|mesh-list
5905007|NCT03747484|Immunoglobulin G|immunoglobulin g|mesh-list
5905008|NCT03747484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5905009|NCT03747484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5677886|NCT03516773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677887|NCT03516747|Hormones|hormones|mesh-list
5677888|NCT03516747|Parathyroid Hormone|parathyroid hormone|mesh-list
5677889|NCT03516747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5677890|NCT03516747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677891|NCT03516747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5677892|NCT03516669|Amoxicillin|amoxicillin|mesh-list
5677893|NCT03516669|Clarithromycin|clarithromycin|mesh-list
5677894|NCT03516669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5677895|NCT03516669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5677896|NCT03516669|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5677897|NCT03516669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5677898|NCT03516669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905010|NCT03747484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5905011|NCT03747484|Immunologic Factors|immunologic factors|mesh-ancestor
6494710|NCT00619944|Protease Inhibitors|protease inhibitors|mesh-ancestor
6494711|NCT00619944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5677899|NCT03516669|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5677900|NCT03516669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5677901|NCT03516656|Heparin|heparin|mesh-list
5677902|NCT03516656|Calcium heparin|calcium heparin|mesh-list
5677903|NCT03516656|Anticoagulants|anticoagulants|mesh-ancestor
5677904|NCT03516656|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5865040|NCT02373410|Bupivacaine|bupivacaine|mesh-list
5865041|NCT02373410|Anesthetics, Local|anesthetics, local|mesh-ancestor
5865042|NCT02373410|Anesthetics|anesthetics|mesh-ancestor
5677905|NCT03516656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5677906|NCT03516656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5677907|NCT03516630|Moxifloxacin|moxifloxacin|mesh-list
5677908|NCT03516630|Trazodone|trazodone|mesh-list
5677909|NCT03516630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5677910|NCT03516630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5677911|NCT03516630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5677912|NCT03516630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5677913|NCT03516630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5677914|NCT03516630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5677915|NCT03516630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5677916|NCT03516630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677917|NCT03516630|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5677918|NCT03516630|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5677919|NCT03516630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5677920|NCT03516630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5677921|NCT03516630|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5677922|NCT03516630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5677923|NCT03516630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5677924|NCT03516630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5677925|NCT03516630|Serotonin Agents|serotonin agents|mesh-ancestor
5677926|NCT03516630|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5677927|NCT03516630|Antidepressive Agents|antidepressive agents|mesh-ancestor
5865043|NCT02373410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5865044|NCT02373410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865045|NCT02373410|Sensory System Agents|sensory system agents|mesh-ancestor
5865046|NCT02373410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5865047|NCT02373462|Olmesartan|olmesartan|mesh-list
5865048|NCT02373462|Antihypertensive Agents|antihypertensive agents|mesh-list
5865049|NCT02373462|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5865050|NCT02373462|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5865051|NCT02373462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865052|NCT02373241|Losartan|losartan|mesh-list
5865053|NCT02373241|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5865054|NCT02373241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5865055|NCT02373241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5865056|NCT02373241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5865057|NCT02373241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865058|NCT02373215|Nalbuphine|nalbuphine|mesh-list
5865059|NCT02373215|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5865060|NCT02373215|Narcotics|narcotics|mesh-ancestor
5865061|NCT02373215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5865062|NCT02373215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865063|NCT02373215|Analgesics|analgesics|mesh-ancestor
5865064|NCT02373215|Sensory System Agents|sensory system agents|mesh-ancestor
5865065|NCT02373215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5865066|NCT02373254|Acetaminophen|acetaminophen|mesh-list
5677928|NCT03516617|Obinutuzumab|obinutuzumab|mesh-list
5677929|NCT03516617|Acalabrutinib|acalabrutinib|mesh-list
5677930|NCT03516617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5677931|NCT03516617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5677932|NCT03516604|Citalopram|citalopram|mesh-list
5677933|NCT03516604|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5677934|NCT03516604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5677935|NCT03516604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5677936|NCT03516604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5677937|NCT03516604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5677938|NCT03516604|Serotonin Agents|serotonin agents|mesh-ancestor
5677939|NCT03516604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677940|NCT03516604|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5677941|NCT03516604|Antidepressive Agents|antidepressive agents|mesh-ancestor
5677942|NCT03516604|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5677943|NCT03516526|Natalizumab|natalizumab|mesh-list
5865067|NCT02373254|Ibuprofen|ibuprofen|mesh-list
5677944|NCT03516526|Immunologic Factors|immunologic factors|mesh-ancestor
5677945|NCT03516526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677946|NCT03516500|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
5677947|NCT03516500|Hematinics|hematinics|mesh-ancestor
5696594|NCT03381781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5696595|NCT03381781|Immunologic Factors|immunologic factors|mesh-ancestor
5696596|NCT03381781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696597|NCT03381781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5696598|NCT03381755|Ticagrelor|ticagrelor|mesh-list
5696599|NCT03381755|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5696600|NCT03381755|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5696601|NCT03381755|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5696602|NCT03381755|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5696603|NCT03381755|Purinergic Agents|purinergic agents|mesh-ancestor
5696604|NCT03381755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5696605|NCT03381755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696606|NCT03381755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696607|NCT03381703|YH12852|yh12852|mesh-list
5696608|NCT03381703|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
5865068|NCT02373254|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
5865069|NCT02373254|Hydrocodone|hydrocodone|mesh-list
5865070|NCT02373254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5865071|NCT02373254|Analgesics|analgesics|mesh-ancestor
5865072|NCT02373254|Sensory System Agents|sensory system agents|mesh-ancestor
5865073|NCT02373254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5865074|NCT02373254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865075|NCT02373254|Antipyretics|antipyretics|mesh-ancestor
5865076|NCT02373254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5865077|NCT02373254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5865078|NCT02373254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5865079|NCT02373254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5865080|NCT02373254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5865081|NCT02373254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865082|NCT02373254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5865083|NCT02373254|Narcotics|narcotics|mesh-ancestor
5865084|NCT02373254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5865085|NCT02373254|Antitussive Agents|antitussive agents|mesh-ancestor
5865086|NCT02373254|Respiratory System Agents|respiratory system agents|mesh-ancestor
5865087|NCT02373046|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
5865088|NCT02373046|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5865089|NCT02373046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865090|NCT02373046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5865091|NCT02373046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865092|NCT02373033|Folic Acid|folic acid|mesh-list
5865093|NCT02373033|Vitamin B Complex|vitamin b complex|mesh-list
5865094|NCT02373033|Hematinics|hematinics|mesh-ancestor
5865095|NCT02373033|Vitamins|vitamins|mesh-ancestor
5865096|NCT02373033|Micronutrients|micronutrients|mesh-ancestor
5865097|NCT02373033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865098|NCT02373085|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5865099|NCT02373085|Anti-Infective Agents|anti-infective agents|mesh-list
5865100|NCT02373072|Trimethobenzamide|trimethobenzamide|mesh-list
5865101|NCT02373072|Antiemetics|antiemetics|mesh-ancestor
5696609|NCT03381703|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5696610|NCT03381703|Serotonin Agents|serotonin agents|mesh-ancestor
5696611|NCT03381703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5696612|NCT03381703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696613|NCT03381703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696614|NCT03381664|Quinidine|quinidine|mesh-list
5696615|NCT03381664|Dextromethorphan|dextromethorphan|mesh-list
5696616|NCT03381664|Antitussive Agents|antitussive agents|mesh-ancestor
5696617|NCT03381664|Respiratory System Agents|respiratory system agents|mesh-ancestor
5696618|NCT03381664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5696619|NCT03381664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5696620|NCT03381664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5696621|NCT03381664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696622|NCT03381664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696623|NCT03381664|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5696624|NCT03381664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5696625|NCT03381664|Adrenergic Agents|adrenergic agents|mesh-ancestor
5696626|NCT03381664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5696627|NCT03381664|Antimalarials|antimalarials|mesh-ancestor
5677948|NCT03516305|Alprazolam|alprazolam|mesh-list
5677949|NCT03516305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5677950|NCT03516305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5677951|NCT03516305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677952|NCT03516305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5677953|NCT03516305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5677954|NCT03516305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5677955|NCT03516305|GABA Modulators|gaba modulators|mesh-ancestor
5677956|NCT03516305|GABA Agents|gaba agents|mesh-ancestor
5677957|NCT03516305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5677958|NCT03516305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5677959|NCT03516214|Trametinib|trametinib|mesh-list
5677960|NCT03516214|Nazartinib|nazartinib|mesh-list
5677961|NCT03516214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5677962|NCT03516214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5677963|NCT03516214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5677964|NCT03516214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865102|NCT02373072|Autonomic Agents|autonomic agents|mesh-ancestor
5865103|NCT02373072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5865104|NCT02373072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865105|NCT02373072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5865106|NCT02373280|Amoxicillin|amoxicillin|mesh-list
5865107|NCT02373280|Moxifloxacin|moxifloxacin|mesh-list
5865108|NCT02373280|Metronidazole|metronidazole|mesh-list
5865109|NCT02373280|Clarithromycin|clarithromycin|mesh-list
5865110|NCT02373280|Esomeprazole|esomeprazole|mesh-list
5865111|NCT02373280|Bismuth|bismuth|mesh-list
5865112|NCT02373280|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
5865113|NCT02373280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5865114|NCT02373280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5865115|NCT02373280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5865116|NCT02373280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5865117|NCT02373280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5865118|NCT02373280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865119|NCT02373280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5677965|NCT03516188|Antacids|antacids|mesh-list
5677966|NCT03516188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5677967|NCT03516188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5677968|NCT03515837|Carboplatin|carboplatin|mesh-list
5677969|NCT03515837|Pembrolizumab|pembrolizumab|mesh-list
5677970|NCT03515837|Pemetrexed|pemetrexed|mesh-list
5677971|NCT03515837|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5677972|NCT03515837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5677973|NCT03515837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5677974|NCT03515837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5677975|NCT03515837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865120|NCT02373280|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5865121|NCT02373280|Contraceptive Agents|contraceptive agents|mesh-ancestor
5865122|NCT02373280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5865123|NCT02373280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865124|NCT02373280|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5865125|NCT02373280|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5865126|NCT02373280|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5865127|NCT02373280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5865128|NCT02373280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5865129|NCT02373280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5677976|NCT03515837|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5677977|NCT03515837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5677978|NCT03515798|Paclitaxel|paclitaxel|mesh-list
5677979|NCT03515798|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5677980|NCT03515798|Cyclophosphamide|cyclophosphamide|mesh-list
5677981|NCT03515798|Pembrolizumab|pembrolizumab|mesh-list
5677982|NCT03515798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5677983|NCT03515798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5677984|NCT03515798|Tubulin Modulators|tubulin modulators|mesh-ancestor
5677985|NCT03515798|Antimitotic Agents|antimitotic agents|mesh-ancestor
5677986|NCT03515798|Mitosis Modulators|mitosis modulators|mesh-ancestor
5677987|NCT03515798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5677988|NCT03515798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5677989|NCT03515798|Immunologic Factors|immunologic factors|mesh-ancestor
5677990|NCT03515798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5677991|NCT03515798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5677992|NCT03515798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5677993|NCT03515798|Alkylating Agents|alkylating agents|mesh-ancestor
5865130|NCT02373280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5865131|NCT02373280|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5865132|NCT02373280|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5865133|NCT02373280|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5865134|NCT02373280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5865135|NCT02373280|Antacids|antacids|mesh-ancestor
5865136|NCT02372942|Progesterone|progesterone|mesh-list
5865137|NCT02372942|Progestins|progestins|mesh-ancestor
5865138|NCT02372942|Hormones|hormones|mesh-ancestor
5865139|NCT02372942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5865140|NCT02372942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865141|NCT02373163|Amlodipine|amlodipine|mesh-list
5865142|NCT02373163|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5865143|NCT02373163|Telmisartan|telmisartan|mesh-list
5865144|NCT02373163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5865145|NCT02373163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5865146|NCT02373163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5865147|NCT02373163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865148|NCT02373163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5865149|NCT02373163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865150|NCT02373163|Vasodilator Agents|vasodilator agents|mesh-ancestor
5865151|NCT02373163|Diuretics|diuretics|mesh-ancestor
5865152|NCT02373163|Natriuretic Agents|natriuretic agents|mesh-ancestor
5677994|NCT03515798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5677995|NCT03515798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5677996|NCT03515772|Darunavir|darunavir|mesh-list
5865153|NCT02373163|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5865154|NCT02373163|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5865155|NCT02373163|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5865156|NCT02372903|Palmidrol|palmidrol|mesh-list
5865157|NCT02372903|Analgesics|analgesics|mesh-ancestor
5865158|NCT02372903|Sensory System Agents|sensory system agents|mesh-ancestor
5677997|NCT03515772|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5677998|NCT03515772|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5677999|NCT03515772|Protease Inhibitors|protease inhibitors|mesh-ancestor
5678000|NCT03515772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5865159|NCT02372903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5865160|NCT02372903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865161|NCT02372903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5865162|NCT02372903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5865163|NCT02372903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5865164|NCT02372903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5678001|NCT03515772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678002|NCT03515772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5678003|NCT03515772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5678004|NCT03515772|Antiviral Agents|antiviral agents|mesh-ancestor
5678005|NCT03515772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5678006|NCT03515707|Etoposide|etoposide|mesh-list
5678007|NCT03515707|Podophyllotoxin|podophyllotoxin|mesh-list
5678008|NCT03515707|Etoposide phosphate|etoposide phosphate|mesh-list
5678009|NCT03515707|Busulfan|busulfan|mesh-list
5678010|NCT03515707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5678011|NCT03515707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5678012|NCT03515707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5678013|NCT03515707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5678014|NCT03515707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5865165|NCT02372903|Antiviral Agents|antiviral agents|mesh-ancestor
5865166|NCT02372903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5865167|NCT02372903|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5865168|NCT02372903|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5865169|NCT02372903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5865170|NCT02372903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865171|NCT02372903|Hormones|hormones|mesh-ancestor
5865172|NCT02372903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5865173|NCT02372955|Dapagliflozin|dapagliflozin|mesh-list
5865174|NCT02372955|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5865175|NCT02372955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865176|NCT02372955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5865177|NCT02372955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865178|NCT02372916|Ranibizumab|ranibizumab|mesh-list
5865179|NCT02372916|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5865180|NCT02372916|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5865181|NCT02372916|Growth Substances|growth substances|mesh-ancestor
5678015|NCT03515707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678016|NCT03515707|Alkylating Agents|alkylating agents|mesh-ancestor
5678017|NCT03515707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5678018|NCT03515707|Immunologic Factors|immunologic factors|mesh-ancestor
5678019|NCT03515707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678020|NCT03515707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5678021|NCT03515707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5678022|NCT03515707|Keratolytic Agents|keratolytic agents|mesh-ancestor
5678023|NCT03515707|Dermatologic Agents|dermatologic agents|mesh-ancestor
5865182|NCT02372916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865183|NCT02372916|Growth Inhibitors|growth inhibitors|mesh-ancestor
5865184|NCT02372916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5865185|NCT02372526|Orlistat|orlistat|mesh-list
5865186|NCT02372526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5865187|NCT02372526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865188|NCT02372526|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5865189|NCT02372526|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5865190|NCT02372656|Metformin|metformin|mesh-list
5865191|NCT02372656|Simvastatin|simvastatin|mesh-list
5678024|NCT03515707|Tubulin Modulators|tubulin modulators|mesh-ancestor
5678025|NCT03515707|Antimitotic Agents|antimitotic agents|mesh-ancestor
5678026|NCT03515707|Mitosis Modulators|mitosis modulators|mesh-ancestor
5678027|NCT03515668|Methylphenidate|methylphenidate|mesh-list
5678028|NCT03515668|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5678029|NCT03515668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678030|NCT03515668|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5678031|NCT03515668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5865192|NCT02372656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5865193|NCT02372656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865194|NCT02372656|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5865195|NCT02372656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5865196|NCT02372656|Antimetabolites|antimetabolites|mesh-ancestor
5865197|NCT02372656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865198|NCT02372656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5865199|NCT02372656|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5865200|NCT02372656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5865201|NCT02372591|Buprenorphine|buprenorphine|mesh-list
5865202|NCT02372591|Hydromorphone|hydromorphone|mesh-list
5865203|NCT02372591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5865204|NCT02372591|Narcotics|narcotics|mesh-ancestor
5865205|NCT02372591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5865206|NCT02372591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865207|NCT02372591|Analgesics|analgesics|mesh-ancestor
5865208|NCT02372591|Sensory System Agents|sensory system agents|mesh-ancestor
5865209|NCT02372591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5865210|NCT02372591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5865211|NCT02372786|Lidocaine|lidocaine|mesh-list
5865212|NCT02372786|Tetracaine|tetracaine|mesh-list
5865213|NCT02372786|Prilocaine|prilocaine|mesh-list
5678032|NCT03515668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5678033|NCT03515668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678034|NCT03515668|Dopamine Agents|dopamine agents|mesh-ancestor
5678035|NCT03515668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5678036|NCT03515629|Pembrolizumab|pembrolizumab|mesh-list
5678037|NCT03515629|Cemiplimab|cemiplimab|mesh-list
5678038|NCT03515629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5678039|NCT03515629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5678040|NCT03515577|Edetic Acid|edetic acid|mesh-list
5678041|NCT03515577|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5678042|NCT03515577|Chelating Agents|chelating agents|mesh-ancestor
5678043|NCT03515577|Sequestering Agents|sequestering agents|mesh-ancestor
5678044|NCT03515577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678045|NCT03515577|Anticoagulants|anticoagulants|mesh-ancestor
5678046|NCT03515577|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5678047|NCT03515577|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5678048|NCT03515538|Cisplatin|cisplatin|mesh-list
5678049|NCT03515538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5678050|NCT03515382|Itraconazole|itraconazole|mesh-list
5678051|NCT03515382|Voriconazole|voriconazole|mesh-list
5678052|NCT03515382|Antifungal Agents|antifungal agents|mesh-ancestor
5678053|NCT03515382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5678054|NCT03515382|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5678055|NCT03515382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5678056|NCT03515382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5678057|NCT03515382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865214|NCT02372786|Anesthetics, Local|anesthetics, local|mesh-ancestor
5865215|NCT02372786|Anesthetics|anesthetics|mesh-ancestor
6675094|NCT01572623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5865216|NCT02372786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5865217|NCT02372786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865218|NCT02372786|Sensory System Agents|sensory system agents|mesh-ancestor
5865219|NCT02372786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5865220|NCT02372786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5865221|NCT02372786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5865222|NCT02372786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5865223|NCT02372786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5865224|NCT02372786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865225|NCT02372487|Sildenafil Citrate|sildenafil citrate|mesh-list
5678058|NCT03515382|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5678059|NCT03515382|Hormone Antagonists|hormone antagonists|mesh-ancestor
5678060|NCT03515382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5678061|NCT03515382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678062|NCT03515382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5678063|NCT03515369|Liver Extracts|liver extracts|mesh-list
5678064|NCT03515369|Hematinics|hematinics|mesh-ancestor
5678065|NCT03515213|Fenofibrate|fenofibrate|mesh-list
5678066|NCT03515213|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5678067|NCT03515213|Antimetabolites|antimetabolites|mesh-ancestor
5678068|NCT03515213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678069|NCT03515213|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5678070|NCT03515200|Cytarabine|cytarabine|mesh-list
5678071|NCT03515200|Dexamethasone|dexamethasone|mesh-list
5678072|NCT03515200|Hydrocortisone|hydrocortisone|mesh-list
5678073|NCT03515200|Doxorubicin|doxorubicin|mesh-list
5678074|NCT03515200|Methotrexate|methotrexate|mesh-list
5678075|NCT03515200|Bortezomib|bortezomib|mesh-list
5678076|NCT03515200|Dasatinib|dasatinib|mesh-list
5678077|NCT03515200|Palbociclib|palbociclib|mesh-list
5678078|NCT03515200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5678079|NCT03515200|Antiemetics|antiemetics|mesh-ancestor
5678080|NCT03515200|Autonomic Agents|autonomic agents|mesh-ancestor
5678081|NCT03515200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5678082|NCT03515200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678083|NCT03515200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5678084|NCT03515200|Glucocorticoids|glucocorticoids|mesh-ancestor
5678085|NCT03515200|Hormones|hormones|mesh-ancestor
5678086|NCT03515200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5678087|NCT03515200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5678088|NCT03515200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5678089|NCT03515200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5678090|NCT03515200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5678091|NCT03515200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5678092|NCT03515200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5678093|NCT03515200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678094|NCT03515200|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5865226|NCT02372487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865227|NCT02372487|Vasodilator Agents|vasodilator agents|mesh-ancestor
5865228|NCT02372487|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5865229|NCT02372487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5865230|NCT02372487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5865231|NCT02372487|Urological Agents|urological agents|mesh-ancestor
5865232|NCT02372669|Chitosan|chitosan|mesh-list
5865233|NCT02372669|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5865234|NCT02372669|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5865235|NCT02372669|Antimetabolites|antimetabolites|mesh-ancestor
5865236|NCT02372669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865237|NCT02372669|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5865238|NCT02372669|Chelating Agents|chelating agents|mesh-ancestor
5865239|NCT02372669|Sequestering Agents|sequestering agents|mesh-ancestor
5865240|NCT02372669|Hemostatics|hemostatics|mesh-ancestor
5865241|NCT02372669|Coagulants|coagulants|mesh-ancestor
5865242|NCT02372760|Lidocaine|lidocaine|mesh-list
5865243|NCT02372760|Anesthetics|anesthetics|mesh-list
5865244|NCT02372760|Anesthetics, Local|anesthetics, local|mesh-ancestor
5865245|NCT02372760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5865246|NCT02372760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865247|NCT02372760|Sensory System Agents|sensory system agents|mesh-ancestor
5865248|NCT02372760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5865249|NCT02372760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5865250|NCT02372760|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5865251|NCT02372760|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5865252|NCT02372760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5678095|NCT03515200|Abortifacient Agents|abortifacient agents|mesh-ancestor
5678096|NCT03515200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5678097|NCT03515200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5678098|NCT03515200|Antimetabolites|antimetabolites|mesh-ancestor
5678099|NCT03515200|Dermatologic Agents|dermatologic agents|mesh-ancestor
5678100|NCT03515200|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5678101|NCT03515200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5678102|NCT03515200|Immunologic Factors|immunologic factors|mesh-ancestor
5678103|NCT03515200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5678104|NCT03515200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5678105|NCT03515200|Antiviral Agents|antiviral agents|mesh-ancestor
5865253|NCT02372760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865254|NCT02372461|Amoxicillin|amoxicillin|mesh-list
5865255|NCT02372461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5865256|NCT02372461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5865257|NCT02372812|Dexamethasone|dexamethasone|mesh-list
5865258|NCT02372812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5865259|NCT02372812|Antiemetics|antiemetics|mesh-ancestor
5865260|NCT02372812|Autonomic Agents|autonomic agents|mesh-ancestor
5865261|NCT02372812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5865262|NCT02372812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865263|NCT02372812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5865264|NCT02372812|Glucocorticoids|glucocorticoids|mesh-ancestor
5865265|NCT02372812|Hormones|hormones|mesh-ancestor
5865266|NCT02372812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5865267|NCT02372812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5678106|NCT03515200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5678107|NCT03515200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5678108|NCT03515187|Bromides|bromides|mesh-list
5678109|NCT03515187|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5678110|NCT03515187|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5678111|NCT03515187|Hyaluronic Acid|hyaluronic acid|mesh-list
5678112|NCT03515187|Anticonvulsants|anticonvulsants|mesh-ancestor
5678113|NCT03515187|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5678114|NCT03515187|Immunologic Factors|immunologic factors|mesh-ancestor
5678115|NCT03515187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678116|NCT03515187|Viscosupplements|viscosupplements|mesh-ancestor
5678117|NCT03515187|Protective Agents|protective agents|mesh-ancestor
5678118|NCT03515018|Imatinib Mesylate|imatinib mesylate|mesh-list
5678119|NCT03515018|Hydroxyurea|hydroxyurea|mesh-list
5678120|NCT03515018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5678121|NCT03515018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5678122|NCT03515018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5678123|NCT03515018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678124|NCT03515018|Antisickling Agents|antisickling agents|mesh-ancestor
5678125|NCT03515018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5678126|NCT03514979|Vaccines|vaccines|mesh-list
5678127|NCT03514979|Immunologic Factors|immunologic factors|mesh-ancestor
5678128|NCT03514979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696628|NCT03381664|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5696629|NCT03381664|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5696630|NCT03381664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5696631|NCT03381664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5865268|NCT02372812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5865269|NCT02372604|Cetirizine|cetirizine|mesh-list
5865270|NCT02372604|Levocetirizine|levocetirizine|mesh-list
5865271|NCT02372604|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5865272|NCT02372604|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5865273|NCT02372604|Histamine Antagonists|histamine antagonists|mesh-ancestor
5696632|NCT03381664|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5696633|NCT03381664|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5696634|NCT03381664|Cholinergic Agents|cholinergic agents|mesh-ancestor
5696635|NCT03381664|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5696636|NCT03381664|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5696637|NCT03381664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5696638|NCT03381664|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5696639|NCT03381664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5696640|NCT03381599|Lenograstim|lenograstim|mesh-list
5696641|NCT03381599|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5865274|NCT02372604|Histamine Agents|histamine agents|mesh-ancestor
5865275|NCT02372604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5865276|NCT02372604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675095|NCT01572623|Antimetabolites|antimetabolites|mesh-ancestor
5696642|NCT03381599|Immunologic Factors|immunologic factors|mesh-ancestor
5696643|NCT03381599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696644|NCT03381495|Sufentanil|sufentanil|mesh-list
5865277|NCT02372604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865278|NCT02372604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5865279|NCT02372409|Doxorubicin|doxorubicin|mesh-list
5865280|NCT02372409|Etoposide|etoposide|mesh-list
5865281|NCT02372409|Etoposide phosphate|etoposide phosphate|mesh-list
5865282|NCT02372409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5865283|NCT02372409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5865284|NCT02372409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5865285|NCT02372409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5865286|NCT02372409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5865287|NCT02372409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865288|NCT02372409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5865289|NCT02372110|Caffeine|caffeine|mesh-list
5865290|NCT02372110|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5865291|NCT02372110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865292|NCT02372110|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5865293|NCT02372110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5865294|NCT02372110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865295|NCT02372110|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5865296|NCT02372110|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5865297|NCT02372110|Purinergic Agents|purinergic agents|mesh-ancestor
5865298|NCT02372110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5865299|NCT02372240|Dexamethasone|dexamethasone|mesh-list
5865300|NCT02372240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5865301|NCT02372240|Antiemetics|antiemetics|mesh-ancestor
5865302|NCT02372240|Autonomic Agents|autonomic agents|mesh-ancestor
5865303|NCT02372240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5865304|NCT02372240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865305|NCT02372240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5865306|NCT02372240|Glucocorticoids|glucocorticoids|mesh-ancestor
5678129|NCT03514836|Cyclophosphamide|cyclophosphamide|mesh-list
5678130|NCT03514836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5678131|NCT03514836|Immunologic Factors|immunologic factors|mesh-ancestor
5678132|NCT03514836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678133|NCT03514836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5678134|NCT03514836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5678135|NCT03514836|Alkylating Agents|alkylating agents|mesh-ancestor
5678136|NCT03514836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678137|NCT03514836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5678138|NCT03514836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5678139|NCT03514810|Ketoprofen|ketoprofen|mesh-list
5678140|NCT03514810|Sertraline|sertraline|mesh-list
5678141|NCT03514810|Antidepressive Agents|antidepressive agents|mesh-ancestor
5678142|NCT03514810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5678143|NCT03514810|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5865307|NCT02372240|Hormones|hormones|mesh-ancestor
5865308|NCT02372240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5865309|NCT02372240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5865310|NCT02372240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5865311|NCT02372188|Caffeine|caffeine|mesh-list
5865312|NCT02372188|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5865313|NCT02372188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865314|NCT02372188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5865315|NCT02372188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5865316|NCT02372188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865317|NCT02372188|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5865318|NCT02372188|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5865319|NCT02372188|Purinergic Agents|purinergic agents|mesh-ancestor
5865320|NCT02372188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5865321|NCT02372292|Furosemide|furosemide|mesh-list
5865322|NCT02372292|Diuretics|diuretics|mesh-ancestor
5865323|NCT02372292|Natriuretic Agents|natriuretic agents|mesh-ancestor
5865324|NCT02372292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865325|NCT02372292|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5865326|NCT02372292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5865327|NCT02372292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865328|NCT02372318|Nalmefene|nalmefene|mesh-list
5865329|NCT02372318|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5865330|NCT02372318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865331|NCT02372318|Sensory System Agents|sensory system agents|mesh-ancestor
5865332|NCT02372318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5865333|NCT02372357|Posaconazole|posaconazole|mesh-list
5678144|NCT03514810|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5865334|NCT02372357|Antifungal Agents|antifungal agents|mesh-ancestor
5865335|NCT02372357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5865336|NCT02372357|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5865337|NCT02372357|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5865338|NCT02372357|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5865339|NCT02372357|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5865340|NCT02372357|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5865341|NCT02372357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5865342|NCT02372357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865343|NCT02372357|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5865344|NCT02372357|Hormone Antagonists|hormone antagonists|mesh-ancestor
5865345|NCT02372357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5865346|NCT02372357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865347|NCT02372149|Immunoglobulins|immunoglobulins|mesh-list
5865348|NCT02372149|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5865349|NCT02372149|Antibodies|antibodies|mesh-list
5865350|NCT02372149|gamma-Globulins|gamma-globulins|mesh-list
5865351|NCT02372149|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5865352|NCT02372149|Immunologic Factors|immunologic factors|mesh-ancestor
5865353|NCT02372149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865354|NCT02371941|Cromolyn Sodium|cromolyn sodium|mesh-list
5865355|NCT02371941|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
5865356|NCT02371941|Immunologic Factors|immunologic factors|mesh-ancestor
5865357|NCT02371941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865358|NCT02371941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5865359|NCT02371941|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5865360|NCT02371941|Respiratory System Agents|respiratory system agents|mesh-ancestor
5905012|NCT03747484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905013|NCT03709680|Cyclophosphamide|cyclophosphamide|mesh-list
5905014|NCT03709680|Temozolomide|temozolomide|mesh-list
5905015|NCT03709680|Irinotecan|irinotecan|mesh-list
5905016|NCT03709680|Topotecan|topotecan|mesh-list
5905017|NCT03709680|Palbociclib|palbociclib|mesh-list
5905018|NCT03709680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5905019|NCT03709680|Immunologic Factors|immunologic factors|mesh-ancestor
5905020|NCT03709680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905021|NCT03709680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5905022|NCT03709680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5905023|NCT03709680|Alkylating Agents|alkylating agents|mesh-ancestor
5905024|NCT03709680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905025|NCT03709680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5905026|NCT03709680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5905027|NCT03709680|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5905028|NCT03709680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5905029|NCT03709680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5905030|NCT03709680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5905031|NCT03660059|Antirheumatic Agents|antirheumatic agents|mesh-list
5905032|NCT03660059|Peficitinib|peficitinib|mesh-list
5905033|NCT03660059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5905034|NCT03660059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905035|NCT03660059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5905036|NCT03660059|Immunologic Factors|immunologic factors|mesh-ancestor
5905037|NCT03660059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905038|NCT03547908|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5905039|NCT03547908|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5905040|NCT03547908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5905041|NCT03547908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5905042|NCT03547908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905043|NCT03547908|Antiviral Agents|antiviral agents|mesh-ancestor
5905044|NCT03547908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5905045|NCT03547908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5905046|NCT03547908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5905047|NCT03512119|Ivacaftor|ivacaftor|mesh-list
5905048|NCT03512119|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
5905049|NCT03512119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5905050|NCT03512119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905051|NCT03505762|Prednisone|prednisone|mesh-list
5905052|NCT03505762|Cortisone|cortisone|mesh-list
5905053|NCT03505762|Cyclophosphamide|cyclophosphamide|mesh-list
5905054|NCT03505762|Rituximab|rituximab|mesh-list
5905055|NCT03505762|Doxorubicin|doxorubicin|mesh-list
5905056|NCT03505762|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5905057|NCT03505762|Vincristine|vincristine|mesh-list
5905058|NCT03505762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5905059|NCT03505762|Antibodies|antibodies|mesh-list
5865361|NCT02371993|Choline|choline|mesh-list
5865362|NCT02371993|Lipotropic Agents|lipotropic agents|mesh-ancestor
5865363|NCT02371993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5865364|NCT02371993|Antimetabolites|antimetabolites|mesh-ancestor
5865365|NCT02371993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865366|NCT02371993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5865367|NCT02371993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5865368|NCT02371993|Nootropic Agents|nootropic agents|mesh-ancestor
5865369|NCT02371577|Lenalidomide|lenalidomide|mesh-list
5865370|NCT02371577|Immunologic Factors|immunologic factors|mesh-ancestor
5865371|NCT02371577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865372|NCT02371577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5865373|NCT02371577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5865374|NCT02371577|Growth Substances|growth substances|mesh-ancestor
5865375|NCT02371577|Growth Inhibitors|growth inhibitors|mesh-ancestor
5865376|NCT02371577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5865377|NCT02371603|Pioglitazone|pioglitazone|mesh-list
5678145|NCT03514810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5678146|NCT03514810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678147|NCT03514810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5678148|NCT03514810|Serotonin Agents|serotonin agents|mesh-ancestor
5678149|NCT03514810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678150|NCT03514810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5678151|NCT03514810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5678152|NCT03514810|Analgesics|analgesics|mesh-ancestor
5678153|NCT03514810|Sensory System Agents|sensory system agents|mesh-ancestor
5678154|NCT03514810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5678155|NCT03514810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5678156|NCT03514810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5678157|NCT03514810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5678158|NCT03514810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5678159|NCT03514771|Valacyclovir|valacyclovir|mesh-list
5678160|NCT03514771|Isotretinoin|isotretinoin|mesh-list
5678161|NCT03514771|Antiviral Agents|antiviral agents|mesh-ancestor
5678162|NCT03514771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5678163|NCT03514771|Dermatologic Agents|dermatologic agents|mesh-ancestor
5678164|NCT03514732|Melatonin|melatonin|mesh-list
5678165|NCT03514732|Antioxidants|antioxidants|mesh-ancestor
5678166|NCT03514732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678167|NCT03514732|Protective Agents|protective agents|mesh-ancestor
5678168|NCT03514732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678169|NCT03514732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5678170|NCT03514667|Curcumin|curcumin|mesh-list
5678171|NCT03514667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5678172|NCT03514667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5678173|NCT03514667|Analgesics|analgesics|mesh-ancestor
5678174|NCT03514667|Sensory System Agents|sensory system agents|mesh-ancestor
5865378|NCT02371603|Trimethoprim|trimethoprim|mesh-list
5865379|NCT02371603|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5865380|NCT02371603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5865381|NCT02371603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5865382|NCT02371603|Antimetabolites|antimetabolites|mesh-ancestor
5865383|NCT02371603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865384|NCT02371603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5865385|NCT02371603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5865386|NCT02371603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5865387|NCT02371603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5865388|NCT02371603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865389|NCT02371603|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5865390|NCT02371603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5865391|NCT02371603|Renal Agents|renal agents|mesh-ancestor
5865392|NCT02371603|Antimalarials|antimalarials|mesh-ancestor
5865393|NCT02371603|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5865394|NCT02371603|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5678175|NCT03514667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5678176|NCT03514667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865395|NCT02371603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5865396|NCT02371603|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5865397|NCT02371603|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
5865398|NCT02371603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5865399|NCT02371590|Lenalidomide|lenalidomide|mesh-list
5865400|NCT02371590|Obinutuzumab|obinutuzumab|mesh-list
5865401|NCT02371590|Immunologic Factors|immunologic factors|mesh-ancestor
5865402|NCT02371590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678177|NCT03514667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5678178|NCT03514667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5678179|NCT03514667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5678180|NCT03514667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5678181|NCT03514667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678182|NCT03514589|Cosyntropin|cosyntropin|mesh-list
5678183|NCT03514589|Hormones|hormones|mesh-ancestor
5678184|NCT03514589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5678185|NCT03514589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678186|NCT03514576|Pasireotide|pasireotide|mesh-list
5678187|NCT03514576|Hormones|hormones|mesh-ancestor
5678188|NCT03514576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5678189|NCT03514576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678190|NCT03514550|Propofol|propofol|mesh-list
5678191|NCT03514550|Sevoflurane|sevoflurane|mesh-list
5678192|NCT03514550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5678193|NCT03514550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5678194|NCT03514550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678195|NCT03514550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5678196|NCT03514550|Anesthetics, General|anesthetics, general|mesh-ancestor
5678197|NCT03514550|Anesthetics|anesthetics|mesh-ancestor
5678198|NCT03514550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5865403|NCT02371590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5865404|NCT02371590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5865405|NCT02371590|Growth Substances|growth substances|mesh-ancestor
5865406|NCT02371590|Growth Inhibitors|growth inhibitors|mesh-ancestor
5865407|NCT02371590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5865408|NCT02371590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5865409|NCT02371473|Acetazolamide|acetazolamide|mesh-list
5865410|NCT02371473|Anticonvulsants|anticonvulsants|mesh-ancestor
5865411|NCT02371473|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5865412|NCT02371473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5865413|NCT02371473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865414|NCT02371473|Diuretics|diuretics|mesh-ancestor
5865415|NCT02371473|Natriuretic Agents|natriuretic agents|mesh-ancestor
5865416|NCT02371473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865417|NCT02371421|Allopurinol|allopurinol|mesh-list
5678199|NCT03514550|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5678200|NCT03514446|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5678201|NCT03514446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5678202|NCT03514381|Doxorubicin|doxorubicin|mesh-list
5678203|NCT03514381|Ifosfamide|ifosfamide|mesh-list
5678204|NCT03514381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5678205|NCT03514381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5678206|NCT03514381|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5678207|NCT03514381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5678208|NCT03514381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5865418|NCT02371421|Antimetabolites|antimetabolites|mesh-ancestor
5865419|NCT02371421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865420|NCT02371421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5865421|NCT02371421|Gout Suppressants|gout suppressants|mesh-ancestor
5865422|NCT02371421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5678209|NCT03514381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678210|NCT03514381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5678211|NCT03514381|Alkylating Agents|alkylating agents|mesh-ancestor
5678212|NCT03514342|Ropivacaine|ropivacaine|mesh-list
5678213|NCT03514342|Anesthetics, Local|anesthetics, local|mesh-ancestor
5678214|NCT03514342|Anesthetics|anesthetics|mesh-ancestor
5865423|NCT02371421|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5865424|NCT02371421|Antioxidants|antioxidants|mesh-ancestor
5865425|NCT02371421|Protective Agents|protective agents|mesh-ancestor
5865426|NCT02371421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865427|NCT02371408|Ribavirin|ribavirin|mesh-list
5865428|NCT02371408|Sofosbuvir|sofosbuvir|mesh-list
5865429|NCT02371408|Antimetabolites|antimetabolites|mesh-ancestor
5865430|NCT02371408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865431|NCT02371408|Antiviral Agents|antiviral agents|mesh-ancestor
5865432|NCT02371408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5865433|NCT02371226|Insulin|insulin|mesh-list
5865434|NCT02371226|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5865435|NCT02371226|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5865436|NCT02371226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865437|NCT02371304|Capecitabine|capecitabine|mesh-list
5865438|NCT02371304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5865439|NCT02371304|Antimetabolites|antimetabolites|mesh-ancestor
5865440|NCT02371304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865441|NCT02371304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5865442|NCT02371096|Rituximab|rituximab|mesh-list
5865443|NCT02371096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5865444|NCT02371096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5865445|NCT02371096|Immunologic Factors|immunologic factors|mesh-ancestor
5865446|NCT02371096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865447|NCT02371096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5865448|NCT02371031|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
6494712|NCT00619944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494713|NCT00619944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6494714|NCT00619944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6494715|NCT00619944|Antiviral Agents|antiviral agents|mesh-ancestor
6494716|NCT00619944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6494717|NCT00619944|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6494718|NCT00619944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6494719|NCT00619944|Antimalarials|antimalarials|mesh-ancestor
6494720|NCT00619944|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6494721|NCT00619944|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6494722|NCT00619996|Docetaxel|docetaxel|mesh-list
5678215|NCT03514342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5865449|NCT02371031|Dopamine Agents|dopamine agents|mesh-ancestor
5865450|NCT02371031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5865451|NCT02371031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865452|NCT02371031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865453|NCT02371148|Rituximab|rituximab|mesh-list
5865454|NCT02371148|Bortezomib|bortezomib|mesh-list
5865455|NCT02371148|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5865456|NCT02371148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5865457|NCT02371148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5865458|NCT02371148|Immunologic Factors|immunologic factors|mesh-ancestor
5865459|NCT02371148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865460|NCT02371148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5865461|NCT02371148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5865462|NCT02371148|Alkylating Agents|alkylating agents|mesh-ancestor
5865463|NCT02371148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865464|NCT02370862|Glycopyrrolate|glycopyrrolate|mesh-list
5865465|NCT02370862|Neostigmine|neostigmine|mesh-list
5865466|NCT02370862|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5865467|NCT02370862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5865468|NCT02370862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865469|NCT02370862|Cholinergic Agents|cholinergic agents|mesh-ancestor
5865470|NCT02370862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5865471|NCT02370862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865472|NCT02370862|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5865473|NCT02370862|Autonomic Agents|autonomic agents|mesh-ancestor
5865474|NCT02370862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5865475|NCT02370862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5865476|NCT02370862|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5678216|NCT03514342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678217|NCT03514342|Sensory System Agents|sensory system agents|mesh-ancestor
5678218|NCT03514342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5678219|NCT03514251|Parathyroid Hormone|parathyroid hormone|mesh-list
5678220|NCT03514251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5678221|NCT03514251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678222|NCT03514108|Metformin|metformin|mesh-list
5678223|NCT03514108|Hydralazine|hydralazine|mesh-list
5678224|NCT03514108|Isosorbide|isosorbide|mesh-list
6494723|NCT00619996|Sorafenib|sorafenib|mesh-list
5678225|NCT03514108|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
5678226|NCT03514108|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
5678227|NCT03514108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5678228|NCT03514108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678229|NCT03514108|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5678230|NCT03514108|Diuretics|diuretics|mesh-ancestor
5678231|NCT03514108|Natriuretic Agents|natriuretic agents|mesh-ancestor
5678232|NCT03514108|Vasodilator Agents|vasodilator agents|mesh-ancestor
5678233|NCT03514108|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5678234|NCT03514108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678235|NCT03514108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5678236|NCT03514030|Antibodies|antibodies|mesh-list
5678237|NCT03514030|Immunologic Factors|immunologic factors|mesh-ancestor
5678238|NCT03514030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678239|NCT03513874|Metformin|metformin|mesh-list
5678240|NCT03513874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5678241|NCT03513874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678242|NCT03513822|Midazolam|midazolam|mesh-list
5678243|NCT03513822|Ketamine|ketamine|mesh-list
5865477|NCT02370862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5865478|NCT02370680|Aspirin|aspirin|mesh-list
5865479|NCT02370680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5865480|NCT02370680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5865481|NCT02370680|Analgesics|analgesics|mesh-ancestor
5865482|NCT02370680|Sensory System Agents|sensory system agents|mesh-ancestor
5865483|NCT02370680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5865484|NCT02370680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865485|NCT02370680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5865486|NCT02370680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5865487|NCT02370680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5865488|NCT02370680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5865489|NCT02370680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865490|NCT02370680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5865491|NCT02370680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5865492|NCT02370680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5865493|NCT02370680|Antipyretics|antipyretics|mesh-ancestor
5865494|NCT02370745|Insulin|insulin|mesh-list
5865495|NCT02370745|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5678244|NCT03513822|Analgesics|analgesics|mesh-ancestor
5678245|NCT03513822|Sensory System Agents|sensory system agents|mesh-ancestor
5678246|NCT03513822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5678247|NCT03513822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678248|NCT03513822|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5678249|NCT03513822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5678250|NCT03513822|Anesthetics, General|anesthetics, general|mesh-ancestor
5678251|NCT03513822|Anesthetics|anesthetics|mesh-ancestor
5678252|NCT03513822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5865496|NCT02370745|Incretins|incretins|mesh-list
5865497|NCT02370745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5865498|NCT02370745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865499|NCT02370745|Hormones|hormones|mesh-ancestor
5865500|NCT02370745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5865501|NCT02370758|Valganciclovir|valganciclovir|mesh-list
5865502|NCT02370758|Ganciclovir|ganciclovir|mesh-list
5865503|NCT02370758|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
5865504|NCT02370758|Antiviral Agents|antiviral agents|mesh-ancestor
5865505|NCT02370758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5865506|NCT02370758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5865507|NCT02370758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5865508|NCT02370758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865509|NCT02370849|Nimotuzumab|nimotuzumab|mesh-list
5865510|NCT02370849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5865511|NCT02370849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5865512|NCT02370550|Cyclosporine|cyclosporine|mesh-list
5865513|NCT02370550|Prednisone|prednisone|mesh-list
5865514|NCT02370550|Calcium Carbonate|calcium carbonate|mesh-list
5865515|NCT02370550|Calcium|calcium|mesh-list
5865516|NCT02370550|Cyclosporins|cyclosporins|mesh-list
5865517|NCT02370550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5865518|NCT02370550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865519|NCT02370550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5865520|NCT02370550|Glucocorticoids|glucocorticoids|mesh-ancestor
5865521|NCT02370550|Hormones|hormones|mesh-ancestor
5865522|NCT02370550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5678253|NCT03513822|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5865523|NCT02370550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5696645|NCT03381495|Ropivacaine|ropivacaine|mesh-list
6494724|NCT00619996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5678254|NCT03513822|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5678255|NCT03513822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5678256|NCT03513822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678257|NCT03513822|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5678258|NCT03513822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5678259|NCT03513822|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5678260|NCT03513822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5678261|NCT03513822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5678262|NCT03513822|GABA Modulators|gaba modulators|mesh-ancestor
5678263|NCT03513822|GABA Agents|gaba agents|mesh-ancestor
5678264|NCT03513601|Rituximab|rituximab|mesh-list
5678265|NCT03513601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5678266|NCT03513601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5678267|NCT03513601|Immunologic Factors|immunologic factors|mesh-ancestor
5678268|NCT03513601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678269|NCT03513601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5678270|NCT03513575|Chlorhexidine|chlorhexidine|mesh-list
5678271|NCT03513575|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5678272|NCT03513575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5865524|NCT02370550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5865525|NCT02370550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5865526|NCT02370550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865527|NCT02370550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5865528|NCT02370550|Immunologic Factors|immunologic factors|mesh-ancestor
5865529|NCT02370550|Antifungal Agents|antifungal agents|mesh-ancestor
5865530|NCT02370550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5865531|NCT02370550|Dermatologic Agents|dermatologic agents|mesh-ancestor
5865532|NCT02370550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5865533|NCT02370550|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5865534|NCT02370550|Antacids|antacids|mesh-ancestor
5678273|NCT03513575|Disinfectants|disinfectants|mesh-ancestor
5678274|NCT03513549|Loxapine|loxapine|mesh-list
5678275|NCT03513549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5678276|NCT03513549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5678277|NCT03513549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5678278|NCT03513549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678279|NCT03513549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5678280|NCT03513549|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5678281|NCT03513549|Dopamine Agents|dopamine agents|mesh-ancestor
5865535|NCT02370550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5865536|NCT02370433|Glycopyrrolate|glycopyrrolate|mesh-list
5865537|NCT02370433|Neostigmine|neostigmine|mesh-list
5865538|NCT02370433|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5865539|NCT02370433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5865540|NCT02370433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678282|NCT03513549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5678283|NCT03513549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678284|NCT03513484|Azacitidine|azacitidine|mesh-list
5678285|NCT03513484|Nintedanib|nintedanib|mesh-list
5678286|NCT03513484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5678287|NCT03513484|Antimetabolites|antimetabolites|mesh-ancestor
5678288|NCT03513484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678289|NCT03513484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5865541|NCT02370433|Cholinergic Agents|cholinergic agents|mesh-ancestor
5865542|NCT02370433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5865543|NCT02370433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865544|NCT02370433|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5865545|NCT02370433|Autonomic Agents|autonomic agents|mesh-ancestor
5865546|NCT02370433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5865547|NCT02370433|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5865548|NCT02370433|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5865549|NCT02370433|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5865550|NCT02370069|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5865551|NCT02370069|Immunologic Factors|immunologic factors|mesh-ancestor
5865552|NCT02370069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905060|NCT03505762|Immunoglobulins|immunoglobulins|mesh-list
5905061|NCT03505762|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5905062|NCT03505762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5905063|NCT03505762|Immunologic Factors|immunologic factors|mesh-ancestor
5905064|NCT03505762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905065|NCT03505762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5905066|NCT03505762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5678290|NCT03513484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5678291|NCT03513484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5865553|NCT02369978|Benzonidazole|benzonidazole|mesh-list
5865554|NCT02369978|Nifurtimox|nifurtimox|mesh-list
5865555|NCT02369978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5865556|NCT02369978|Immunologic Factors|immunologic factors|mesh-ancestor
5865557|NCT02369978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865558|NCT02369978|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5865559|NCT02369978|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6494725|NCT00619996|Tubulin Modulators|tubulin modulators|mesh-ancestor
6494726|NCT00619996|Antimitotic Agents|antimitotic agents|mesh-ancestor
6494727|NCT00619996|Mitosis Modulators|mitosis modulators|mesh-ancestor
6494728|NCT00619996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494729|NCT00619996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5678292|NCT03513471|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5678293|NCT03513471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5678294|NCT03513458|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5678295|NCT03513458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5678296|NCT03513432|Ethanol|ethanol|mesh-list
5678297|NCT03513432|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5678298|NCT03513432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5678299|NCT03513432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5678300|NCT03513432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678301|NCT03513406|Glycopyrrolate|glycopyrrolate|mesh-list
5678302|NCT03513406|Neostigmine|neostigmine|mesh-list
5678303|NCT03513406|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5678304|NCT03513406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5678305|NCT03513406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678306|NCT03513406|Cholinergic Agents|cholinergic agents|mesh-ancestor
5678307|NCT03513406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5678308|NCT03513406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678309|NCT03513406|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5678310|NCT03513406|Autonomic Agents|autonomic agents|mesh-ancestor
5678311|NCT03513406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5678312|NCT03513406|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5678313|NCT03513406|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5678314|NCT03513406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6494730|NCT00619996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5678315|NCT03513393|Velpatasvir|velpatasvir|mesh-list
5678316|NCT03513393|Omeprazole|omeprazole|mesh-list
5865560|NCT02369978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5865561|NCT02369978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5865562|NCT02369861|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5865563|NCT02369861|Lubricant Eye Drops|lubricant eye drops|mesh-list
5865564|NCT02369861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5865565|NCT02369965|Ritonavir|ritonavir|mesh-list
5865566|NCT02369965|Lopinavir|lopinavir|mesh-list
5865567|NCT02369965|Tenofovir|tenofovir|mesh-list
5678317|NCT03513393|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5678318|NCT03513393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5678319|NCT03513393|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5678320|NCT03513393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5678321|NCT03513393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865568|NCT02369965|Lamivudine|lamivudine|mesh-list
5865569|NCT02369965|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5865570|NCT02369965|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5865571|NCT02369965|Protease Inhibitors|protease inhibitors|mesh-ancestor
5865572|NCT02369965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5865573|NCT02369965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865574|NCT02369965|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5865575|NCT02369965|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5865576|NCT02369965|Antiviral Agents|antiviral agents|mesh-ancestor
5865577|NCT02369965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5865578|NCT02369965|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5865579|NCT02369965|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5865580|NCT02369965|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5865581|NCT02369965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5865582|NCT02369939|Fluorouracil|fluorouracil|mesh-list
5865583|NCT02369939|Mitomycins|mitomycins|mesh-list
5865584|NCT02369939|Mitomycin|mitomycin|mesh-list
5865585|NCT02369939|Antimetabolites|antimetabolites|mesh-ancestor
5865586|NCT02369939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865587|NCT02369939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5865588|NCT02369939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6494731|NCT00620100|Docetaxel|docetaxel|mesh-list
5678322|NCT03513393|Antiviral Agents|antiviral agents|mesh-ancestor
5865589|NCT02369939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5865590|NCT02369939|Immunologic Factors|immunologic factors|mesh-ancestor
6494732|NCT00620100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5865591|NCT02369939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865592|NCT02369939|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5865593|NCT02369939|Alkylating Agents|alkylating agents|mesh-ancestor
5865594|NCT02369939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5865595|NCT02369939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5865596|NCT02369822|Ascorbic Acid|ascorbic acid|mesh-list
5865597|NCT02369822|Vitamins|vitamins|mesh-ancestor
5865598|NCT02369822|Micronutrients|micronutrients|mesh-ancestor
5865599|NCT02369822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865600|NCT02369822|Antioxidants|antioxidants|mesh-ancestor
5865601|NCT02369822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865602|NCT02369822|Protective Agents|protective agents|mesh-ancestor
5865603|NCT02369549|Curcumin|curcumin|mesh-list
5865604|NCT02369549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5865605|NCT02369549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5678323|NCT03513393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5678324|NCT03513328|Thiotepa|thiotepa|mesh-list
5678325|NCT03513328|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5678326|NCT03513328|Alkylating Agents|alkylating agents|mesh-ancestor
5678327|NCT03513328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678328|NCT03513328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5678329|NCT03513328|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5678330|NCT03513328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5678331|NCT03513328|Immunologic Factors|immunologic factors|mesh-ancestor
5865606|NCT02369549|Analgesics|analgesics|mesh-ancestor
5865607|NCT02369549|Sensory System Agents|sensory system agents|mesh-ancestor
5865608|NCT02369549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5865609|NCT02369549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865610|NCT02369549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5865611|NCT02369549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5865612|NCT02369549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5865613|NCT02369549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5865614|NCT02369549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865615|NCT02369523|Bupivacaine|bupivacaine|mesh-list
5865616|NCT02369523|Ropivacaine|ropivacaine|mesh-list
5865617|NCT02369523|Anesthetics, Local|anesthetics, local|mesh-ancestor
5865618|NCT02369523|Anesthetics|anesthetics|mesh-ancestor
5865619|NCT02369523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5865620|NCT02369523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865621|NCT02369523|Sensory System Agents|sensory system agents|mesh-ancestor
5865622|NCT02369523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5865623|NCT02369406|Lamivudine|lamivudine|mesh-list
5865624|NCT02369406|Zidovudine|zidovudine|mesh-list
5865625|NCT02369406|Nevirapine|nevirapine|mesh-list
5865626|NCT02369406|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5865627|NCT02369406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5865628|NCT02369406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5865629|NCT02369406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865630|NCT02369406|Antiviral Agents|antiviral agents|mesh-ancestor
5865631|NCT02369406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5865632|NCT02369406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5865633|NCT02369406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5865634|NCT02369406|Antimetabolites|antimetabolites|mesh-ancestor
5865635|NCT02369406|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5865636|NCT02369406|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5865637|NCT02369380|Hyaluronic Acid|hyaluronic acid|mesh-list
5865638|NCT02369380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5865639|NCT02369380|Immunologic Factors|immunologic factors|mesh-ancestor
5678332|NCT03513328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696646|NCT03381495|Anesthetics, Local|anesthetics, local|mesh-ancestor
5696647|NCT03381495|Anesthetics|anesthetics|mesh-ancestor
5696648|NCT03381495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5696649|NCT03381495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696650|NCT03381495|Sensory System Agents|sensory system agents|mesh-ancestor
5696651|NCT03381495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5696652|NCT03381495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5696653|NCT03381495|Narcotics|narcotics|mesh-ancestor
5696654|NCT03381495|Analgesics|analgesics|mesh-ancestor
5696655|NCT03381495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5696656|NCT03381495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5696657|NCT03381495|Anesthetics, General|anesthetics, general|mesh-ancestor
5696658|NCT03381482|Anesthetics|anesthetics|mesh-list
5696659|NCT03381482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5865640|NCT02369380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865641|NCT02369380|Viscosupplements|viscosupplements|mesh-ancestor
5678333|NCT03513276|Epinephrine|epinephrine|mesh-list
5678334|NCT03513276|Racepinephrine|racepinephrine|mesh-list
5678335|NCT03513276|Ropivacaine|ropivacaine|mesh-list
5678336|NCT03513276|Epinephryl borate|epinephryl borate|mesh-list
5678337|NCT03513276|Anesthetics, Local|anesthetics, local|mesh-ancestor
5678338|NCT03513276|Anesthetics|anesthetics|mesh-ancestor
5678339|NCT03513276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5678340|NCT03513276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865642|NCT02369380|Protective Agents|protective agents|mesh-ancestor
5865643|NCT02369133|Acetaminophen|acetaminophen|mesh-list
5865644|NCT02369133|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5865645|NCT02369133|Analgesics|analgesics|mesh-ancestor
5865646|NCT02369133|Sensory System Agents|sensory system agents|mesh-ancestor
5865647|NCT02369133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5865648|NCT02369133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865649|NCT02369133|Antipyretics|antipyretics|mesh-ancestor
5865650|NCT02369250|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5865651|NCT02369250|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5865652|NCT02369250|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5865653|NCT02369250|Antimetabolites|antimetabolites|mesh-ancestor
5865654|NCT02369250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865655|NCT02369250|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5865656|NCT02369250|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5865657|NCT02369250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5865658|NCT02369146|UB-421|ub-421|mesh-list
5865659|NCT02369146|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5865660|NCT02369146|Antiviral Agents|antiviral agents|mesh-ancestor
5865661|NCT02369146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5865662|NCT02369081|Bisoprolol|bisoprolol|mesh-list
5865663|NCT02369081|Doxazosin|doxazosin|mesh-list
5865664|NCT02369081|Spironolactone|spironolactone|mesh-list
5865665|NCT02369081|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5865666|NCT02369081|Hormone Antagonists|hormone antagonists|mesh-ancestor
5865667|NCT02369081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5865668|NCT02369081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865669|NCT02369081|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5865670|NCT02369081|Diuretics|diuretics|mesh-ancestor
5865671|NCT02369081|Natriuretic Agents|natriuretic agents|mesh-ancestor
5865672|NCT02369081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5865673|NCT02369081|Sympatholytics|sympatholytics|mesh-ancestor
5865674|NCT02369081|Autonomic Agents|autonomic agents|mesh-ancestor
5865675|NCT02369081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5865676|NCT02369081|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5865677|NCT02369081|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5678341|NCT03513276|Sensory System Agents|sensory system agents|mesh-ancestor
5678342|NCT03513276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5678343|NCT03513276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5678344|NCT03513276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5678345|NCT03513276|Adrenergic Agents|adrenergic agents|mesh-ancestor
5678346|NCT03513276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5678347|NCT03513276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678348|NCT03513276|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5678349|NCT03513276|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5678350|NCT03513276|Autonomic Agents|autonomic agents|mesh-ancestor
5678351|NCT03513276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5678352|NCT03513276|Respiratory System Agents|respiratory system agents|mesh-ancestor
5678353|NCT03513276|Mydriatics|mydriatics|mesh-ancestor
5678354|NCT03513276|Sympathomimetics|sympathomimetics|mesh-ancestor
5678355|NCT03513276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5678356|NCT03513211|Hydroxychloroquine|hydroxychloroquine|mesh-list
5678357|NCT03513211|Itraconazole|itraconazole|mesh-list
5678358|NCT03513211|Antimalarials|antimalarials|mesh-ancestor
5678359|NCT03513211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5678360|NCT03513211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5678361|NCT03513211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5678362|NCT03513211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5678363|NCT03513211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678364|NCT03513211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5678365|NCT03513211|Antifungal Agents|antifungal agents|mesh-ancestor
5678366|NCT03513211|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5678367|NCT03513211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5678368|NCT03513211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5678369|NCT03513211|Hormone Antagonists|hormone antagonists|mesh-ancestor
5678370|NCT03513211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5678371|NCT03513211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865678|NCT02369081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5865679|NCT02369081|Adrenergic Agents|adrenergic agents|mesh-ancestor
5865680|NCT02369081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5865681|NCT02369081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865682|NCT02369081|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5865683|NCT02369081|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5865684|NCT02368860|Capecitabine|capecitabine|mesh-list
5865685|NCT02368860|Oxaliplatin|oxaliplatin|mesh-list
5865686|NCT02368860|Irinotecan|irinotecan|mesh-list
5865687|NCT02368860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5865688|NCT02368860|Antimetabolites|antimetabolites|mesh-ancestor
5865689|NCT02368860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865690|NCT02368860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5865691|NCT02368860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5865692|NCT02368860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5865693|NCT02368860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5865694|NCT02368730|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
5865695|NCT02368730|Hemostatics|hemostatics|mesh-ancestor
6494733|NCT00620100|Tubulin Modulators|tubulin modulators|mesh-ancestor
6494734|NCT00620100|Antimitotic Agents|antimitotic agents|mesh-ancestor
6494735|NCT00620100|Mitosis Modulators|mitosis modulators|mesh-ancestor
6494736|NCT00620100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494737|NCT00620165|Levetiracetam|levetiracetam|mesh-list
6494738|NCT00620165|Anticonvulsants|anticonvulsants|mesh-ancestor
5678372|NCT03513211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5678373|NCT03513172|Brimonidine Tartrate|brimonidine tartrate|mesh-list
5678374|NCT03513172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5678375|NCT03513172|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5678376|NCT03513172|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5678377|NCT03513172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5678378|NCT03513172|Adrenergic Agents|adrenergic agents|mesh-ancestor
5678379|NCT03513172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5678380|NCT03513172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678381|NCT03513172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678382|NCT03513055|Insulin|insulin|mesh-list
5678383|NCT03513055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5678384|NCT03513055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678385|NCT03512990|Bupivacaine|bupivacaine|mesh-list
5678386|NCT03512990|Anesthetics, Local|anesthetics, local|mesh-ancestor
5678387|NCT03512990|Anesthetics|anesthetics|mesh-ancestor
5678388|NCT03512990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5678389|NCT03512990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678390|NCT03512990|Sensory System Agents|sensory system agents|mesh-ancestor
5678391|NCT03512990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5678392|NCT03512873|Tranilast|tranilast|mesh-list
5678393|NCT03512873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5678394|NCT03512873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5678395|NCT03512873|Analgesics|analgesics|mesh-ancestor
5678396|NCT03512873|Sensory System Agents|sensory system agents|mesh-ancestor
5678397|NCT03512873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5678398|NCT03512873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678399|NCT03512873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5678400|NCT03512873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5678401|NCT03512873|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5678402|NCT03512873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5678403|NCT03512873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678404|NCT03512873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5678405|NCT03512873|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5678406|NCT03512873|Histamine Antagonists|histamine antagonists|mesh-ancestor
5678407|NCT03512873|Histamine Agents|histamine agents|mesh-ancestor
5678408|NCT03512873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5865696|NCT02368730|Coagulants|coagulants|mesh-ancestor
5865697|NCT02368730|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5865698|NCT02368730|Natriuretic Agents|natriuretic agents|mesh-ancestor
5865699|NCT02368730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865700|NCT02368964|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5865701|NCT02368964|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5865702|NCT02368964|Luteolytic Agents|luteolytic agents|mesh-ancestor
5865703|NCT02368964|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5865704|NCT02368964|Contraceptive Agents|contraceptive agents|mesh-ancestor
5865705|NCT02368964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5865706|NCT02368964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865707|NCT02368964|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6494739|NCT00620165|Nootropic Agents|nootropic agents|mesh-ancestor
5678409|NCT03512873|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5678410|NCT03512873|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5678411|NCT03512860|Valproic Acid|valproic acid|mesh-list
5678412|NCT03512860|Anticonvulsants|anticonvulsants|mesh-ancestor
5678413|NCT03512860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5678414|NCT03512860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678415|NCT03512860|GABA Agents|gaba agents|mesh-ancestor
5678416|NCT03512860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5678417|NCT03512860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678418|NCT03512860|Antimanic Agents|antimanic agents|mesh-ancestor
5678419|NCT03512860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5678420|NCT03512860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5865708|NCT02368964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5865709|NCT02368964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5865710|NCT02368795|Indomethacin|indomethacin|mesh-list
5865711|NCT02368795|Isosorbide|isosorbide|mesh-list
5865712|NCT02368795|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
5865713|NCT02368795|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
5865714|NCT02368795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5865715|NCT02368795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5865716|NCT02368795|Analgesics|analgesics|mesh-ancestor
5865717|NCT02368795|Sensory System Agents|sensory system agents|mesh-ancestor
5865718|NCT02368795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5865719|NCT02368795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865720|NCT02368795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5865721|NCT02368795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5865722|NCT02368795|Gout Suppressants|gout suppressants|mesh-ancestor
5865723|NCT02368795|Tocolytic Agents|tocolytic agents|mesh-ancestor
5865724|NCT02368795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5865725|NCT02368795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5865726|NCT02368795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5678421|NCT03512860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5678422|NCT03512834|Paclitaxel|paclitaxel|mesh-list
5678423|NCT03512834|Avelumab|avelumab|mesh-list
5678424|NCT03512834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5678425|NCT03512834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5678426|NCT03512834|Tubulin Modulators|tubulin modulators|mesh-ancestor
5678427|NCT03512834|Antimitotic Agents|antimitotic agents|mesh-ancestor
5678428|NCT03512834|Mitosis Modulators|mitosis modulators|mesh-ancestor
5678429|NCT03512834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678430|NCT03512834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5678431|NCT03512821|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
5678432|NCT03512821|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5678433|NCT03512821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5678434|NCT03512808|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
5678435|NCT03512808|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5678436|NCT03512808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5678437|NCT03512756|Gemcitabine|gemcitabine|mesh-list
5678438|NCT03512756|Sirolimus|sirolimus|mesh-list
5678439|NCT03512756|Capecitabine|capecitabine|mesh-list
5678440|NCT03512756|Phenytoin|phenytoin|mesh-list
5678441|NCT03512756|Methoxsalen|methoxsalen|mesh-list
5678442|NCT03512756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5678443|NCT03512756|Antimetabolites|antimetabolites|mesh-ancestor
5678444|NCT03512756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678445|NCT03512756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5678446|NCT03512756|Antiviral Agents|antiviral agents|mesh-ancestor
5678447|NCT03512756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5678448|NCT03512756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5678449|NCT03512756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5678450|NCT03512756|Immunologic Factors|immunologic factors|mesh-ancestor
5678451|NCT03512756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678452|NCT03512756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5678453|NCT03512756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5678454|NCT03512756|Antifungal Agents|antifungal agents|mesh-ancestor
5678455|NCT03512756|Anticonvulsants|anticonvulsants|mesh-ancestor
5678456|NCT03512756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5678457|NCT03512756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5678458|NCT03512756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5678459|NCT03512756|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5678460|NCT03512756|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5678461|NCT03512756|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5678462|NCT03512756|Dermatologic Agents|dermatologic agents|mesh-ancestor
5678463|NCT03512574|Pregabalin|pregabalin|mesh-list
5678464|NCT03512574|Dexmedetomidine|dexmedetomidine|mesh-list
5865727|NCT02368795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865728|NCT02368795|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5865729|NCT02368795|Diuretics|diuretics|mesh-ancestor
5865730|NCT02368795|Natriuretic Agents|natriuretic agents|mesh-ancestor
5865731|NCT02368795|Vasodilator Agents|vasodilator agents|mesh-ancestor
5865732|NCT02368795|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5865733|NCT02368717|Mesalamine|mesalamine|mesh-list
5865734|NCT02368717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5865735|NCT02368717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5865736|NCT02368717|Analgesics|analgesics|mesh-ancestor
5865737|NCT02368717|Sensory System Agents|sensory system agents|mesh-ancestor
5865738|NCT02368717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6494740|NCT00620178|Losartan|losartan|mesh-list
6494741|NCT00620178|Candesartan|candesartan|mesh-list
6494742|NCT00620178|Candesartan cilexetil|candesartan cilexetil|mesh-list
6494743|NCT00620178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6494744|NCT00620178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5678465|NCT03512574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5678466|NCT03512574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5678467|NCT03512574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678468|NCT03512574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5678469|NCT03512574|Analgesics|analgesics|mesh-ancestor
5678470|NCT03512574|Sensory System Agents|sensory system agents|mesh-ancestor
5678471|NCT03512574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5678472|NCT03512574|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5678473|NCT03512574|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5678474|NCT03512574|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5678475|NCT03512574|Adrenergic Agents|adrenergic agents|mesh-ancestor
5678476|NCT03512574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5678477|NCT03512574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678478|NCT03512574|Anticonvulsants|anticonvulsants|mesh-ancestor
5678479|NCT03512574|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5678480|NCT03512574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5678481|NCT03512574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5678482|NCT03512574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5678483|NCT03512574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5678484|NCT03512574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5678485|NCT03512548|Itraconazole|itraconazole|mesh-list
5678486|NCT03512548|Antifungal Agents|antifungal agents|mesh-ancestor
5678487|NCT03512548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5678488|NCT03512548|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5678489|NCT03512548|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5678490|NCT03512548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5678491|NCT03512548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678492|NCT03512548|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5678493|NCT03512548|Hormone Antagonists|hormone antagonists|mesh-ancestor
5678494|NCT03512548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5678495|NCT03512548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678496|NCT03512548|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5678497|NCT03512496|Caffeine|caffeine|mesh-list
5865739|NCT02368717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865740|NCT02368717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5865741|NCT02368717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5865742|NCT02368743|Mesalamine|mesalamine|mesh-list
5865743|NCT02368743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6494745|NCT00620178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5865744|NCT02368743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5865745|NCT02368743|Analgesics|analgesics|mesh-ancestor
5865746|NCT02368743|Sensory System Agents|sensory system agents|mesh-ancestor
5865747|NCT02368743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5865748|NCT02368743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865749|NCT02368743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5865750|NCT02368743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5865751|NCT02368665|Amlodipine|amlodipine|mesh-list
5865752|NCT02368665|Candesartan|candesartan|mesh-list
5865753|NCT02368665|Candesartan cilexetil|candesartan cilexetil|mesh-list
5865754|NCT02368665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5865755|NCT02368665|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5865756|NCT02368665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5865757|NCT02368665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865758|NCT02368665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5865759|NCT02368665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494746|NCT00620178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5865760|NCT02368665|Vasodilator Agents|vasodilator agents|mesh-ancestor
5678498|NCT03512496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5678499|NCT03512496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678500|NCT03512496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5678501|NCT03512496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5678502|NCT03512496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678503|NCT03512496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5865761|NCT02368665|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5865762|NCT02368665|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5865763|NCT02368652|Amlodipine|amlodipine|mesh-list
5865764|NCT02368652|Candesartan|candesartan|mesh-list
5865765|NCT02368652|Candesartan cilexetil|candesartan cilexetil|mesh-list
5865766|NCT02368652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5865767|NCT02368652|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5865768|NCT02368652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5865769|NCT02368652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865770|NCT02368652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5865771|NCT02368652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865772|NCT02368652|Vasodilator Agents|vasodilator agents|mesh-ancestor
5865773|NCT02368652|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5865774|NCT02368652|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5865775|NCT02368470|Gemifloxacin|gemifloxacin|mesh-list
5865776|NCT02368470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5865777|NCT02368470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5865778|NCT02368470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5865779|NCT02368470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865780|NCT02368470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5865781|NCT02368470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5865782|NCT02368470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5865783|NCT02368561|Hyaluronic Acid|hyaluronic acid|mesh-list
5865784|NCT02368561|Hylan|hylan|mesh-list
5865785|NCT02368561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5865786|NCT02368561|Immunologic Factors|immunologic factors|mesh-ancestor
5865787|NCT02368561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865788|NCT02368561|Viscosupplements|viscosupplements|mesh-ancestor
6494747|NCT00620178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494748|NCT00620204|Atorvastatin|atorvastatin|mesh-list
6494749|NCT00620204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5678504|NCT03512496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5678505|NCT03512496|Purinergic Agents|purinergic agents|mesh-ancestor
5678506|NCT03512496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5678507|NCT03512418|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5678508|NCT03512418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5678509|NCT03512418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5678510|NCT03512418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5678511|NCT03512418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678512|NCT03512418|Antiviral Agents|antiviral agents|mesh-ancestor
5678513|NCT03512418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5678514|NCT03512418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5678515|NCT03512418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5678516|NCT03512405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5678517|NCT03512405|Pembrolizumab|pembrolizumab|mesh-list
5678518|NCT03512405|Blinatumomab|blinatumomab|mesh-list
5678519|NCT03512405|Antibodies|antibodies|mesh-list
5678520|NCT03512405|Immunoglobulins|immunoglobulins|mesh-list
5678521|NCT03512405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5678522|NCT03512405|Muromonab-CD3|muromonab-cd3|mesh-list
5678523|NCT03512405|Antibodies, Bispecific|antibodies, bispecific|mesh-list
5678524|NCT03512405|Immunologic Factors|immunologic factors|mesh-ancestor
5678525|NCT03512405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678526|NCT03512405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5678527|NCT03512405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5678528|NCT03512236|Insulin Lispro|insulin lispro|mesh-list
5678529|NCT03512236|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5678530|NCT03512236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678531|NCT03512171|Amphetamine|amphetamine|mesh-list
5678532|NCT03512171|Dextroamphetamine|dextroamphetamine|mesh-list
5678533|NCT03512171|Fallypride|fallypride|mesh-list
5678534|NCT03512171|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5678535|NCT03512171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678536|NCT03512171|Sympathomimetics|sympathomimetics|mesh-ancestor
5678537|NCT03512171|Autonomic Agents|autonomic agents|mesh-ancestor
5678538|NCT03512171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6494750|NCT00620204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6494751|NCT00620204|Antimetabolites|antimetabolites|mesh-ancestor
6494752|NCT00620204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494753|NCT00620204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6494754|NCT00620204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6494755|NCT00620204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5865789|NCT02368561|Protective Agents|protective agents|mesh-ancestor
5865790|NCT02368288|Entecavir|entecavir|mesh-list
5865791|NCT02368288|Antiviral Agents|antiviral agents|mesh-ancestor
5865792|NCT02368288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5905067|NCT03505762|Alkylating Agents|alkylating agents|mesh-ancestor
5905068|NCT03505762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905069|NCT03505762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5905070|NCT03505762|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5905071|NCT03505762|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5905072|NCT03505762|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5905073|NCT03505762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5905074|NCT03505762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5905075|NCT03505762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5905076|NCT03505762|Glucocorticoids|glucocorticoids|mesh-ancestor
5905077|NCT03505762|Hormones|hormones|mesh-ancestor
5905078|NCT03505762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5905079|NCT03505762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5905080|NCT03505762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5905081|NCT03505762|Tubulin Modulators|tubulin modulators|mesh-ancestor
5905082|NCT03505762|Antimitotic Agents|antimitotic agents|mesh-ancestor
5905083|NCT03505762|Mitosis Modulators|mitosis modulators|mesh-ancestor
5905084|NCT03502148|Cisplatin|cisplatin|mesh-list
5905085|NCT03502148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5905086|NCT03450772|Pancrelipase|pancrelipase|mesh-list
5905087|NCT03450772|Pancreatin|pancreatin|mesh-list
5905088|NCT03450772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5905089|NCT03445728|Nicorandil|nicorandil|mesh-list
5905090|NCT03445728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5905091|NCT03445728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5905092|NCT03445728|Vasodilator Agents|vasodilator agents|mesh-ancestor
5905093|NCT03445728|Vitamin B Complex|vitamin b complex|mesh-ancestor
5905094|NCT03445728|Vitamins|vitamins|mesh-ancestor
5905095|NCT03445728|Micronutrients|micronutrients|mesh-ancestor
5905096|NCT03445728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905097|NCT03424460|Hemostatics|hemostatics|mesh-list
5905098|NCT03424460|Coagulants|coagulants|mesh-ancestor
5905099|NCT03416335|Pembrolizumab|pembrolizumab|mesh-list
5905100|NCT03416335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5905101|NCT03416335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5905102|NCT03341143|Pembrolizumab|pembrolizumab|mesh-list
5905103|NCT03341143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5905104|NCT03341143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5908502|NCT04471428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6496467|NCT00628160|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6496468|NCT00628160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6496469|NCT00628160|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6496470|NCT00628160|Dopamine Agents|dopamine agents|mesh-ancestor
6496471|NCT00628160|Protective Agents|protective agents|mesh-ancestor
6496515|NCT00628290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496516|NCT00628290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6496517|NCT00628290|Antidepressive Agents|antidepressive agents|mesh-ancestor
5678539|NCT03512171|Dopamine Agents|dopamine agents|mesh-ancestor
5678540|NCT03512171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5678541|NCT03512171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678542|NCT03512171|Adrenergic Agents|adrenergic agents|mesh-ancestor
5678543|NCT03512171|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5678544|NCT03512171|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5678545|NCT03512171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5678546|NCT03512171|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5678547|NCT03512171|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5678548|NCT03512171|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5678549|NCT03511976|Methylphenidate|methylphenidate|mesh-list
5678550|NCT03511976|Amphetamine|amphetamine|mesh-list
5678551|NCT03511976|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5678552|NCT03511976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678553|NCT03511976|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5908503|NCT04471428|Tubulin Modulators|tubulin modulators|mesh-ancestor
5908504|NCT04471428|Antimitotic Agents|antimitotic agents|mesh-ancestor
5908505|NCT04471428|Mitosis Modulators|mitosis modulators|mesh-ancestor
6494756|NCT00620269|Irinotecan|irinotecan|mesh-list
6494757|NCT00620269|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6494758|NCT00620269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6494759|NCT00620269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6494760|NCT00620269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6494761|NCT00620269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6494762|NCT00620269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494763|NCT00620269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6494764|NCT00620295|Gemcitabine|gemcitabine|mesh-list
6494765|NCT00620295|Bortezomib|bortezomib|mesh-list
6494766|NCT00620295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5865793|NCT02368171|Nitric Oxide|nitric oxide|mesh-list
5865794|NCT02368171|Carbon Monoxide|carbon monoxide|mesh-list
5865795|NCT02368171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5865796|NCT02368171|Autonomic Agents|autonomic agents|mesh-ancestor
5865797|NCT02368171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5865798|NCT02368171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865799|NCT02368171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5865800|NCT02368171|Respiratory System Agents|respiratory system agents|mesh-ancestor
5865801|NCT02368171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5865802|NCT02368171|Antioxidants|antioxidants|mesh-ancestor
5865803|NCT02368171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865804|NCT02368171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5865805|NCT02368171|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5865806|NCT02368171|Vasodilator Agents|vasodilator agents|mesh-ancestor
5865807|NCT02368171|Gasotransmitters|gasotransmitters|mesh-ancestor
5865808|NCT02368171|Protective Agents|protective agents|mesh-ancestor
5865809|NCT02368171|Antimetabolites|antimetabolites|mesh-ancestor
5865810|NCT02368054|Epinephrine|epinephrine|mesh-list
5865811|NCT02368054|Racepinephrine|racepinephrine|mesh-list
5865812|NCT02368054|Bupivacaine|bupivacaine|mesh-list
5865813|NCT02368054|Epinephryl borate|epinephryl borate|mesh-list
5865814|NCT02368054|Anesthetics, Local|anesthetics, local|mesh-ancestor
5865815|NCT02368054|Anesthetics|anesthetics|mesh-ancestor
5865816|NCT02368054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5865817|NCT02368054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865818|NCT02368054|Sensory System Agents|sensory system agents|mesh-ancestor
5865819|NCT02368054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5865820|NCT02368054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5865821|NCT02368054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5865822|NCT02368054|Adrenergic Agents|adrenergic agents|mesh-ancestor
5865823|NCT02368054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5865824|NCT02368054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865825|NCT02368054|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5865826|NCT02368054|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5865827|NCT02368054|Autonomic Agents|autonomic agents|mesh-ancestor
5865828|NCT02368054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5865829|NCT02368054|Respiratory System Agents|respiratory system agents|mesh-ancestor
5865830|NCT02368054|Mydriatics|mydriatics|mesh-ancestor
5865831|NCT02368054|Sympathomimetics|sympathomimetics|mesh-ancestor
5865832|NCT02368054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5865833|NCT02368379|Metyrapone|metyrapone|mesh-list
5865834|NCT02368379|Antimetabolites|antimetabolites|mesh-ancestor
5865835|NCT02368379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865836|NCT02368379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5865837|NCT02368015|Cefazolin|cefazolin|mesh-list
5865838|NCT02368015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5865839|NCT02368015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5865840|NCT02368197|Paclitaxel|paclitaxel|mesh-list
5865841|NCT02368197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5865842|NCT02368197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5865843|NCT02368197|Tubulin Modulators|tubulin modulators|mesh-ancestor
5865844|NCT02368197|Antimitotic Agents|antimitotic agents|mesh-ancestor
5865845|NCT02368197|Mitosis Modulators|mitosis modulators|mesh-ancestor
5865846|NCT02368197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865847|NCT02368249|Terlipressin|terlipressin|mesh-list
5865848|NCT02368249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5865849|NCT02368249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5865850|NCT02367937|Flurbiprofen|flurbiprofen|mesh-list
5865851|NCT02367937|Midazolam|midazolam|mesh-list
5865852|NCT02367937|Omeprazole|omeprazole|mesh-list
5865853|NCT02367937|Simvastatin|simvastatin|mesh-list
5865854|NCT02367937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5865855|NCT02367937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5865856|NCT02367937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5865857|NCT02367937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865858|NCT02367937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5865859|NCT02367937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5865860|NCT02367937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5865861|NCT02367937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5865862|NCT02367937|Anesthetics, General|anesthetics, general|mesh-ancestor
5865863|NCT02367937|Anesthetics|anesthetics|mesh-ancestor
5865864|NCT02367937|GABA Modulators|gaba modulators|mesh-ancestor
5865865|NCT02367937|GABA Agents|gaba agents|mesh-ancestor
5865866|NCT02367937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5865867|NCT02367937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865868|NCT02367937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5865869|NCT02367937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5865870|NCT02367937|Antimetabolites|antimetabolites|mesh-ancestor
5865871|NCT02367937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5865872|NCT02367937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5865873|NCT02367937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5865874|NCT02367937|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5865875|NCT02367937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5865876|NCT02367937|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5865877|NCT02367937|Analgesics|analgesics|mesh-ancestor
5865878|NCT02367937|Sensory System Agents|sensory system agents|mesh-ancestor
5865879|NCT02367937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5865880|NCT02367937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5865881|NCT02367937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5678554|NCT03511976|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5678555|NCT03511976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5678556|NCT03511976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678557|NCT03511976|Dopamine Agents|dopamine agents|mesh-ancestor
5678558|NCT03511976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5678559|NCT03511976|Sympathomimetics|sympathomimetics|mesh-ancestor
5678560|NCT03511976|Autonomic Agents|autonomic agents|mesh-ancestor
5678561|NCT03511976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5678562|NCT03511976|Adrenergic Agents|adrenergic agents|mesh-ancestor
5678563|NCT03511976|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5678564|NCT03511846|Capsaicin|capsaicin|mesh-list
5865882|NCT02367937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5865883|NCT02367937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5865884|NCT02367937|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5865885|NCT02367924|Trabectedin|trabectedin|mesh-list
5865886|NCT02367924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5865887|NCT02367924|Alkylating Agents|alkylating agents|mesh-ancestor
5865888|NCT02367924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865889|NCT02367924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5865890|NCT02367807|Tenofovir|tenofovir|mesh-list
5865891|NCT02367807|Emtricitabine|emtricitabine|mesh-list
5865892|NCT02367807|Antiviral Agents|antiviral agents|mesh-ancestor
5865893|NCT02367807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5865894|NCT02367807|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5865895|NCT02367807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5865896|NCT02367807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5865897|NCT02367807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865898|NCT02367807|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5865899|NCT02367807|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5865900|NCT02367755|Lorazepam|lorazepam|mesh-list
5865901|NCT02367755|Propofol|propofol|mesh-list
5865902|NCT02367755|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5865903|NCT02367755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5865904|NCT02367755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865905|NCT02367755|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5865906|NCT02367755|Anesthetics, General|anesthetics, general|mesh-ancestor
5865907|NCT02367755|Anesthetics|anesthetics|mesh-ancestor
5865908|NCT02367755|Anticonvulsants|anticonvulsants|mesh-ancestor
5865909|NCT02367755|Antiemetics|antiemetics|mesh-ancestor
5865910|NCT02367755|Autonomic Agents|autonomic agents|mesh-ancestor
5865911|NCT02367755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5865912|NCT02367755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5865913|NCT02367755|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5865914|NCT02367755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5865915|NCT02367755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5865916|NCT02367755|GABA Modulators|gaba modulators|mesh-ancestor
5865917|NCT02367755|GABA Agents|gaba agents|mesh-ancestor
5865918|NCT02367755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5865919|NCT02367755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865920|NCT02367664|Vaccines|vaccines|mesh-list
5865921|NCT02367664|Immunologic Factors|immunologic factors|mesh-ancestor
5865922|NCT02367664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865923|NCT02367846|Contraceptive Agents|contraceptive agents|mesh-list
5865924|NCT02367846|NuvaRing|nuvaring|mesh-list
5865925|NCT02367846|Contraceptives, Oral|contraceptives, oral|mesh-list
5865926|NCT02367846|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
5865927|NCT02367846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5865928|NCT02367846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865929|NCT02367846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5865930|NCT02367846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5865931|NCT02367560|Methylprednisolone|methylprednisolone|mesh-list
5865932|NCT02367560|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5678565|NCT03511846|Antipruritics|antipruritics|mesh-ancestor
5678566|NCT03511846|Dermatologic Agents|dermatologic agents|mesh-ancestor
5678567|NCT03511846|Sensory System Agents|sensory system agents|mesh-ancestor
5678568|NCT03511846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5678569|NCT03511846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865933|NCT02367560|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5865934|NCT02367560|Prednisolone|prednisolone|mesh-list
5865935|NCT02367560|Prednisolone acetate|prednisolone acetate|mesh-list
5865936|NCT02367560|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5865937|NCT02367560|Prednisolone phosphate|prednisolone phosphate|mesh-list
5865938|NCT02367560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5865939|NCT02367560|Antiemetics|antiemetics|mesh-ancestor
5865940|NCT02367560|Autonomic Agents|autonomic agents|mesh-ancestor
5865941|NCT02367560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5865942|NCT02367560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865943|NCT02367560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5865944|NCT02367560|Glucocorticoids|glucocorticoids|mesh-ancestor
5865945|NCT02367560|Hormones|hormones|mesh-ancestor
5865946|NCT02367560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5865947|NCT02367560|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5865948|NCT02367560|Protective Agents|protective agents|mesh-ancestor
5865949|NCT02367560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5865950|NCT02367560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5865951|NCT02367547|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5865952|NCT02367547|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
5865953|NCT02367547|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5865954|NCT02367547|Dermatologic Agents|dermatologic agents|mesh-ancestor
5865955|NCT02367196|Rituximab|rituximab|mesh-list
5865956|NCT02367196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5865957|NCT02367196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5865958|NCT02367196|Immunologic Factors|immunologic factors|mesh-ancestor
5865959|NCT02367196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865960|NCT02367196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5865961|NCT02367404|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5865962|NCT02367404|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5865963|NCT02367404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5865964|NCT02367404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5865965|NCT02367404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865966|NCT02367404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5865967|NCT02367404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865968|NCT02367404|Analgesics|analgesics|mesh-ancestor
5865969|NCT02367404|Sensory System Agents|sensory system agents|mesh-ancestor
5865970|NCT02367404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5865971|NCT02367404|Antidepressive Agents|antidepressive agents|mesh-ancestor
5865972|NCT02367404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5865973|NCT02367404|Dopamine Agents|dopamine agents|mesh-ancestor
5865974|NCT02367248|Deferoxamine|deferoxamine|mesh-list
5865975|NCT02367248|Siderophores|siderophores|mesh-ancestor
5865976|NCT02367248|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5865977|NCT02367248|Chelating Agents|chelating agents|mesh-ancestor
5865978|NCT02367248|Sequestering Agents|sequestering agents|mesh-ancestor
5865979|NCT02367248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865980|NCT02367027|Rivaroxaban|rivaroxaban|mesh-list
5865981|NCT02367027|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5865982|NCT02367027|Antithrombins|antithrombins|mesh-ancestor
5865983|NCT02367027|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5865984|NCT02367027|Protease Inhibitors|protease inhibitors|mesh-ancestor
5678570|NCT03511833|Morphine|morphine|mesh-list
5678571|NCT03511833|Ketamine|ketamine|mesh-list
5678572|NCT03511833|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5678573|NCT03511833|Narcotics|narcotics|mesh-ancestor
5678574|NCT03511833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5678575|NCT03511833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678576|NCT03511833|Analgesics|analgesics|mesh-ancestor
5678577|NCT03511833|Sensory System Agents|sensory system agents|mesh-ancestor
5865985|NCT02367027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5678578|NCT03511833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5678579|NCT03511833|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5865986|NCT02367027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5865987|NCT02367027|Anticoagulants|anticoagulants|mesh-ancestor
5865988|NCT02367053|Glucagon|glucagon|mesh-list
5865989|NCT02367053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5865990|NCT02367053|Hormones|hormones|mesh-ancestor
5865991|NCT02367053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5865992|NCT02367053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5865993|NCT02366884|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5865994|NCT02366884|Antifungal Agents|antifungal agents|mesh-list
5865995|NCT02366884|Clotrimazole|clotrimazole|mesh-list
5865996|NCT02366884|Miconazole|miconazole|mesh-list
5865997|NCT02366884|Antiprotozoal Agents|antiprotozoal agents|mesh-list
5865998|NCT02366884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5865999|NCT02366884|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5866000|NCT02366884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5866001|NCT02366884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5866002|NCT02366884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5866003|NCT02366884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5866004|NCT02366884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5866005|NCT02366884|Hormone Antagonists|hormone antagonists|mesh-ancestor
5866006|NCT02366884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5678580|NCT03511833|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5678581|NCT03511833|Anesthetics, General|anesthetics, general|mesh-ancestor
5678582|NCT03511833|Anesthetics|anesthetics|mesh-ancestor
5678583|NCT03511833|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5678584|NCT03511833|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5678585|NCT03511833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5678586|NCT03511833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5866007|NCT02366884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866008|NCT02366884|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5866009|NCT02366884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5866010|NCT02366884|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5866011|NCT02366975|Testosterone|testosterone|mesh-list
5866012|NCT02366975|Androgens|androgens|mesh-ancestor
6494767|NCT00620295|Antimetabolites|antimetabolites|mesh-ancestor
6494768|NCT00620295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494769|NCT00620295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6494770|NCT00620295|Antiviral Agents|antiviral agents|mesh-ancestor
6494771|NCT00620295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6494772|NCT00620295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6494773|NCT00620295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6494774|NCT00620295|Immunologic Factors|immunologic factors|mesh-ancestor
6494775|NCT00620295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494776|NCT00620347|Sunitinib|sunitinib|mesh-list
6494777|NCT00620347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6494778|NCT00620347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6494779|NCT00620347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6494780|NCT00620347|Growth Substances|growth substances|mesh-ancestor
6212311|NCT02186301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6212312|NCT02186301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6212313|NCT02186301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6212314|NCT02186301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212315|NCT02186652|Pantoprazole|pantoprazole|mesh-list
6212316|NCT02186652|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6212317|NCT02186652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6494781|NCT00620347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494782|NCT00620347|Growth Inhibitors|growth inhibitors|mesh-ancestor
6494783|NCT00620347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5678587|NCT03511820|Amphotericin B|amphotericin b|mesh-list
5678588|NCT03511820|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
5678589|NCT03511820|Amebicides|amebicides|mesh-ancestor
5678590|NCT03511820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5866013|NCT02366975|Hormones|hormones|mesh-ancestor
5866014|NCT02366975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5866015|NCT02366975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212318|NCT02186652|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6212319|NCT02186652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6212320|NCT02186652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212321|NCT02186665|Calcitriol|calcitriol|mesh-list
5678591|NCT03511820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5678592|NCT03511820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5678593|NCT03511820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5678594|NCT03511820|Antifungal Agents|antifungal agents|mesh-ancestor
5678595|NCT03511768|Octreotide|octreotide|mesh-list
5678596|NCT03511768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5678597|NCT03511768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5678598|NCT03511768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5678599|NCT03511755|Neurotransmitter Agents|neurotransmitter agents|mesh-list
5866016|NCT02367118|Prednisone|prednisone|mesh-list
5866017|NCT02367118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5866018|NCT02367118|Glucocorticoids|glucocorticoids|mesh-ancestor
5866019|NCT02367118|Hormones|hormones|mesh-ancestor
5866020|NCT02367118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5866021|NCT02367118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866022|NCT02367118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5866023|NCT02367118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5866024|NCT02366949|Paclitaxel|paclitaxel|mesh-list
5866025|NCT02366949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5866026|NCT02366949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5866027|NCT02366949|Tubulin Modulators|tubulin modulators|mesh-ancestor
5866028|NCT02366949|Antimitotic Agents|antimitotic agents|mesh-ancestor
5866029|NCT02366949|Mitosis Modulators|mitosis modulators|mesh-ancestor
5866030|NCT02366949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5866031|NCT02366819|Leucovorin|leucovorin|mesh-list
5866032|NCT02366819|Fluorouracil|fluorouracil|mesh-list
5866033|NCT02366819|Oxaliplatin|oxaliplatin|mesh-list
5866034|NCT02366819|Irinotecan|irinotecan|mesh-list
5866035|NCT02366819|Calcium|calcium|mesh-list
5678600|NCT03511755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678601|NCT03511755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696660|NCT03381482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696661|NCT03381430|Gefitinib|gefitinib|mesh-list
5696662|NCT03381430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5696663|NCT03381430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5696664|NCT03381430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5696665|NCT03381430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696666|NCT03381352|Capecitabine|capecitabine|mesh-list
5696667|NCT03381352|Mitomycins|mitomycins|mesh-list
5696668|NCT03381352|Mitomycin|mitomycin|mesh-list
5696669|NCT03381352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5696670|NCT03381352|Antimetabolites|antimetabolites|mesh-ancestor
5696671|NCT03381352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696672|NCT03381352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5696673|NCT03381352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5696674|NCT03381352|Alkylating Agents|alkylating agents|mesh-ancestor
5696675|NCT03381352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5696676|NCT03381352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5696677|NCT03381261|Botulinum Toxins|botulinum toxins|mesh-list
5696678|NCT03381261|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5866036|NCT02366819|Levoleucovorin|levoleucovorin|mesh-list
5866037|NCT02366819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5866038|NCT02366819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866039|NCT02366819|Antimetabolites|antimetabolites|mesh-ancestor
5866040|NCT02366819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5866041|NCT02366819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5866042|NCT02366819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5866043|NCT02366819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5866044|NCT02366819|Immunologic Factors|immunologic factors|mesh-ancestor
5866045|NCT02366819|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5866046|NCT02366819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5696679|NCT03381261|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5696680|NCT03381261|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5696681|NCT03381261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5696682|NCT03381261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696683|NCT03381261|Cholinergic Agents|cholinergic agents|mesh-ancestor
5696684|NCT03381261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5696685|NCT03381261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696686|NCT03381261|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5696687|NCT03381261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5698040|NCT03371849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5698041|NCT03371849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698042|NCT03371849|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5866047|NCT02366819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5866048|NCT02366819|Antidotes|antidotes|mesh-ancestor
5866049|NCT02366819|Protective Agents|protective agents|mesh-ancestor
5866050|NCT02366819|Vitamin B Complex|vitamin b complex|mesh-ancestor
5866051|NCT02366819|Vitamins|vitamins|mesh-ancestor
5866052|NCT02366819|Micronutrients|micronutrients|mesh-ancestor
5866053|NCT02366546|Cyclophosphamide|cyclophosphamide|mesh-list
5866054|NCT02366546|Fludarabine|fludarabine|mesh-list
5866055|NCT02366546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5866056|NCT02366546|Immunologic Factors|immunologic factors|mesh-ancestor
5866057|NCT02366546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866058|NCT02366546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5866059|NCT02366546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5866060|NCT02366546|Alkylating Agents|alkylating agents|mesh-ancestor
5866061|NCT02366546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5866062|NCT02366546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5866063|NCT02366546|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5866064|NCT02366676|Hyaluronic Acid|hyaluronic acid|mesh-list
5866065|NCT02366676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5866066|NCT02366676|Immunologic Factors|immunologic factors|mesh-ancestor
5866067|NCT02366676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866068|NCT02366676|Viscosupplements|viscosupplements|mesh-ancestor
5866069|NCT02366676|Protective Agents|protective agents|mesh-ancestor
5866070|NCT02366585|Cyclosporine|cyclosporine|mesh-list
5866071|NCT02366585|Cyclosporins|cyclosporins|mesh-list
5866072|NCT02366585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5866073|NCT02366585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5866074|NCT02366585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5866075|NCT02366585|Immunologic Factors|immunologic factors|mesh-ancestor
5866076|NCT02366585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866077|NCT02366585|Antifungal Agents|antifungal agents|mesh-ancestor
5866078|NCT02366585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5866079|NCT02366585|Dermatologic Agents|dermatologic agents|mesh-ancestor
5866080|NCT02366585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5866081|NCT02366585|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5866082|NCT02366494|Docetaxel|docetaxel|mesh-list
5866083|NCT02366494|Leuprolide|leuprolide|mesh-list
5866084|NCT02366494|Goserelin|goserelin|mesh-list
5866085|NCT02366494|Bicalutamide|bicalutamide|mesh-list
5866086|NCT02366494|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5866087|NCT02366494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5866088|NCT02366494|Tubulin Modulators|tubulin modulators|mesh-ancestor
5866089|NCT02366494|Antimitotic Agents|antimitotic agents|mesh-ancestor
5866090|NCT02366494|Mitosis Modulators|mitosis modulators|mesh-ancestor
5866091|NCT02366494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5866092|NCT02366494|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5678602|NCT03511703|Apatinib|apatinib|mesh-list
5678603|NCT03511703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5678604|NCT03511703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5678605|NCT03511703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5678606|NCT03511703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678607|NCT03511560|Tacrolimus|tacrolimus|mesh-list
5678608|NCT03511560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5678609|NCT03511560|Immunologic Factors|immunologic factors|mesh-ancestor
5678610|NCT03511560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678611|NCT03511560|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5678612|NCT03511560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5678613|NCT03511560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678614|NCT03511391|Pembrolizumab|pembrolizumab|mesh-list
5678615|NCT03511391|Nivolumab|nivolumab|mesh-list
5678616|NCT03511391|Atezolizumab|atezolizumab|mesh-list
5678617|NCT03511391|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5678618|NCT03511391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5678619|NCT03511391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5678620|NCT03511391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678621|NCT03511261|Curcumin|curcumin|mesh-list
5678622|NCT03511261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5866093|NCT02366494|Fertility Agents|fertility agents|mesh-ancestor
5866094|NCT02366494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5866095|NCT02366494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866096|NCT02366494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5678623|NCT03511261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5678624|NCT03511261|Analgesics|analgesics|mesh-ancestor
5678625|NCT03511261|Sensory System Agents|sensory system agents|mesh-ancestor
5678626|NCT03511261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5866097|NCT02366494|Androgen Antagonists|androgen antagonists|mesh-ancestor
5678627|NCT03511261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696688|NCT03381118|Cytarabine|cytarabine|mesh-list
5866098|NCT02366494|Hormone Antagonists|hormone antagonists|mesh-ancestor
5678628|NCT03511261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5678629|NCT03511261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5678630|NCT03511261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5678631|NCT03511261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5678632|NCT03511261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678633|NCT03511222|Pembrolizumab|pembrolizumab|mesh-list
5678634|NCT03511222|Nivolumab|nivolumab|mesh-list
5678635|NCT03511222|Vorolanib|vorolanib|mesh-list
5678636|NCT03511222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5678637|NCT03511222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5678638|NCT03511222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5678639|NCT03511222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678640|NCT03511222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5678641|NCT03511222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5678642|NCT03511183|Bevacizumab|bevacizumab|mesh-list
5678643|NCT03511183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5678644|NCT03511183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5678645|NCT03511183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5678646|NCT03511183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5678647|NCT03511183|Growth Substances|growth substances|mesh-ancestor
5678648|NCT03511183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678649|NCT03511183|Growth Inhibitors|growth inhibitors|mesh-ancestor
5678650|NCT03510975|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
5678651|NCT03510975|Hemostatics|hemostatics|mesh-ancestor
5678652|NCT03510975|Coagulants|coagulants|mesh-ancestor
5678653|NCT03510975|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5678654|NCT03510975|Natriuretic Agents|natriuretic agents|mesh-ancestor
5678655|NCT03510975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678656|NCT03510962|Chlorhexidine|chlorhexidine|mesh-list
5678657|NCT03510962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5678658|NCT03510962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5678659|NCT03510962|Disinfectants|disinfectants|mesh-ancestor
5678660|NCT03510871|Nivolumab|nivolumab|mesh-list
5678661|NCT03510871|Ipilimumab|ipilimumab|mesh-list
5678662|NCT03510871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5678663|NCT03510871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5678664|NCT03510871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5678665|NCT03510871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678666|NCT03510793|Anesthetics|anesthetics|mesh-list
5678667|NCT03510793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5866099|NCT02366494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5866100|NCT02366494|Luteolytic Agents|luteolytic agents|mesh-ancestor
5866101|NCT02366494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5866102|NCT02366494|Contraceptive Agents|contraceptive agents|mesh-ancestor
5866103|NCT02366494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5866104|NCT02366481|Vitamins|vitamins|mesh-list
5866105|NCT02366481|Vitamin K|vitamin k|mesh-list
5866106|NCT02366481|Vitamin K 2|vitamin k 2|mesh-list
5866107|NCT02366481|Vitamin MK 7|vitamin mk 7|mesh-list
5866108|NCT02366481|Micronutrients|micronutrients|mesh-ancestor
5866109|NCT02366481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866110|NCT02366481|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5866111|NCT02366481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5866112|NCT02366481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5866113|NCT02366481|Hemostatics|hemostatics|mesh-ancestor
5866114|NCT02366481|Coagulants|coagulants|mesh-ancestor
5905105|NCT03278691|Ketorolac|ketorolac|mesh-list
5905106|NCT03278691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5905107|NCT03278691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5905108|NCT03278691|Analgesics|analgesics|mesh-ancestor
5905109|NCT03278691|Sensory System Agents|sensory system agents|mesh-ancestor
5905110|NCT03278691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5905111|NCT03278691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905112|NCT03278691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5905113|NCT03278691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5905114|NCT03278691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5905115|NCT03278691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5905116|NCT03278691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905117|NCT03274375|Rituximab|rituximab|mesh-list
5905118|NCT03274375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5905119|NCT03274375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5905120|NCT03274375|Immunologic Factors|immunologic factors|mesh-ancestor
5905121|NCT03274375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905122|NCT03274375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5905123|NCT03257761|Durvalumab|durvalumab|mesh-list
6494784|NCT00620347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5678668|NCT03510793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678669|NCT03510741|Acetylcysteine|acetylcysteine|mesh-list
5678670|NCT03510741|Sodium Benzoate|sodium benzoate|mesh-list
5678671|NCT03510741|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5678672|NCT03510741|Antiviral Agents|antiviral agents|mesh-ancestor
5678673|NCT03510741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5678674|NCT03510741|Expectorants|expectorants|mesh-ancestor
5678675|NCT03510741|Respiratory System Agents|respiratory system agents|mesh-ancestor
5678676|NCT03510741|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5678677|NCT03510741|Antioxidants|antioxidants|mesh-ancestor
5678678|NCT03510741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678679|NCT03510741|Protective Agents|protective agents|mesh-ancestor
5678680|NCT03510741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678681|NCT03510741|Antidotes|antidotes|mesh-ancestor
5678682|NCT03510741|Antifungal Agents|antifungal agents|mesh-ancestor
5678683|NCT03510611|Ensartinib|ensartinib|mesh-list
5678684|NCT03510611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5678685|NCT03510611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5678686|NCT03510611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5678687|NCT03510611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678688|NCT03510546|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
5678689|NCT03510546|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5678690|NCT03510546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5678691|NCT03510546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678692|NCT03510546|Cholinergic Agents|cholinergic agents|mesh-ancestor
5678693|NCT03510546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5866115|NCT02366247|Adefovir|adefovir|mesh-list
5866116|NCT02366247|Thymalfasin|thymalfasin|mesh-list
5866117|NCT02366247|Antiviral Agents|antiviral agents|mesh-ancestor
5866118|NCT02366247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5866119|NCT02366247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5866120|NCT02366247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5866121|NCT02366247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5866122|NCT02366247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5866123|NCT02366247|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5866124|NCT02366247|Immunologic Factors|immunologic factors|mesh-ancestor
5866125|NCT02366247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866126|NCT02366377|Metformin|metformin|mesh-list
5866127|NCT02366377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5866128|NCT02366377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866129|NCT02366299|Dexmedetomidine|dexmedetomidine|mesh-list
5866130|NCT02366299|Propofol|propofol|mesh-list
5866131|NCT02366299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5866132|NCT02366299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5866133|NCT02366299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866134|NCT02366299|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5678694|NCT03510546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678695|NCT03510533|Autoantibodies|autoantibodies|mesh-list
5678696|NCT03510533|alpha-MSH|alpha-msh|mesh-list
5678697|NCT03510533|Immunologic Factors|immunologic factors|mesh-ancestor
5678698|NCT03510533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678699|NCT03510533|Hormones|hormones|mesh-ancestor
5678700|NCT03510533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5866135|NCT02366299|Anesthetics, General|anesthetics, general|mesh-ancestor
5866136|NCT02366299|Anesthetics|anesthetics|mesh-ancestor
5866137|NCT02366299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5866138|NCT02366299|Analgesics|analgesics|mesh-ancestor
5866139|NCT02366299|Sensory System Agents|sensory system agents|mesh-ancestor
5866140|NCT02366299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5866141|NCT02366299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5866142|NCT02366299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5866143|NCT02366299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5866144|NCT02366299|Adrenergic Agents|adrenergic agents|mesh-ancestor
5866145|NCT02366299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5866146|NCT02366299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5866147|NCT02366065|Acetaminophen|acetaminophen|mesh-list
5866148|NCT02366065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5866149|NCT02366065|Analgesics|analgesics|mesh-ancestor
5866150|NCT02366065|Sensory System Agents|sensory system agents|mesh-ancestor
5866151|NCT02366065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5866152|NCT02366065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866153|NCT02366065|Antipyretics|antipyretics|mesh-ancestor
5866154|NCT02366208|Adefovir|adefovir|mesh-list
5866155|NCT02366208|Thymalfasin|thymalfasin|mesh-list
5866156|NCT02366208|Antiviral Agents|antiviral agents|mesh-ancestor
5866157|NCT02366208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5678701|NCT03510416|Apatinib|apatinib|mesh-list
5866158|NCT02366208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5866159|NCT02366208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5866160|NCT02366208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5866161|NCT02366208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5866162|NCT02366208|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5866163|NCT02366208|Immunologic Factors|immunologic factors|mesh-ancestor
5866164|NCT02366208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866165|NCT02365909|Bupivacaine|bupivacaine|mesh-list
5866166|NCT02365909|Anesthetics, Local|anesthetics, local|mesh-ancestor
5866167|NCT02365909|Anesthetics|anesthetics|mesh-ancestor
5866168|NCT02365909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5866169|NCT02365909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866170|NCT02365909|Sensory System Agents|sensory system agents|mesh-ancestor
5866171|NCT02365909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5866172|NCT02365857|Dexmedetomidine|dexmedetomidine|mesh-list
5866173|NCT02365857|Bupivacaine|bupivacaine|mesh-list
5866174|NCT02365857|Anesthetics, Local|anesthetics, local|mesh-ancestor
5866175|NCT02365857|Anesthetics|anesthetics|mesh-ancestor
5866176|NCT02365857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5866177|NCT02365857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866178|NCT02365857|Sensory System Agents|sensory system agents|mesh-ancestor
5866179|NCT02365857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5866180|NCT02365857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5866181|NCT02365857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5866182|NCT02365857|Analgesics|analgesics|mesh-ancestor
5866183|NCT02365857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5866184|NCT02365857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5866185|NCT02365857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5678702|NCT03510416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5678703|NCT03510416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5678704|NCT03510416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5678705|NCT03510416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678706|NCT03510351|Tazobactam|tazobactam|mesh-list
5678707|NCT03510351|Ceftolozane|ceftolozane|mesh-list
5678708|NCT03510351|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
5678709|NCT03510351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5866186|NCT02365857|Adrenergic Agents|adrenergic agents|mesh-ancestor
5866187|NCT02365857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5866188|NCT02365857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5866189|NCT02365935|Paclitaxel|paclitaxel|mesh-list
5866190|NCT02365935|Cisplatin|cisplatin|mesh-list
5866191|NCT02365935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5866192|NCT02365935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5866193|NCT02365935|Tubulin Modulators|tubulin modulators|mesh-ancestor
5866194|NCT02365935|Antimitotic Agents|antimitotic agents|mesh-ancestor
5866195|NCT02365935|Mitosis Modulators|mitosis modulators|mesh-ancestor
5866196|NCT02365935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5866197|NCT02365675|Petrolatum|petrolatum|mesh-list
5866198|NCT02365675|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
5866199|NCT02365675|Laxatives|laxatives|mesh-ancestor
5866200|NCT02365675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5866201|NCT02365675|Emollients|emollients|mesh-ancestor
5866202|NCT02365675|Dermatologic Agents|dermatologic agents|mesh-ancestor
5866203|NCT02365571|Itraconazole|itraconazole|mesh-list
5866204|NCT02365571|Antifungal Agents|antifungal agents|mesh-ancestor
5866205|NCT02365571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5866206|NCT02365571|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5866207|NCT02365571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5866208|NCT02365571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5866209|NCT02365571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5866210|NCT02365571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5866211|NCT02365571|Hormone Antagonists|hormone antagonists|mesh-ancestor
5866212|NCT02365571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5866213|NCT02365571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866214|NCT02365571|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5866215|NCT02365740|Insulin|insulin|mesh-list
5678710|NCT03510351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5678711|NCT03510351|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5678712|NCT03510351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5678713|NCT03510351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678714|NCT03510351|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5678715|NCT03510351|Renal Agents|renal agents|mesh-ancestor
5678716|NCT03510338|Sildenafil Citrate|sildenafil citrate|mesh-list
5866216|NCT02365740|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5866217|NCT02365740|Hormones|hormones|mesh-list
5866218|NCT02365740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5866219|NCT02365740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866220|NCT02365740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5866221|NCT02365948|Certolizumab Pegol|certolizumab pegol|mesh-list
5866222|NCT02365948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5866223|NCT02365948|Immunologic Factors|immunologic factors|mesh-ancestor
5866224|NCT02365948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866225|NCT02365948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5866226|NCT02365727|Clonidine|clonidine|mesh-list
5866227|NCT02365727|Epinephrine|epinephrine|mesh-list
5866228|NCT02365727|Bupivacaine|bupivacaine|mesh-list
5866229|NCT02365727|Ropivacaine|ropivacaine|mesh-list
5866230|NCT02365727|Anesthetics, Local|anesthetics, local|mesh-ancestor
5866231|NCT02365727|Anesthetics|anesthetics|mesh-ancestor
5866232|NCT02365727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5866233|NCT02365727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866234|NCT02365727|Sensory System Agents|sensory system agents|mesh-ancestor
5866235|NCT02365727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5866236|NCT02365727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5866237|NCT02365727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5866238|NCT02365727|Adrenergic Agents|adrenergic agents|mesh-ancestor
5866239|NCT02365727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5866240|NCT02365727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5866241|NCT02365727|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5866242|NCT02365727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5866243|NCT02365727|Autonomic Agents|autonomic agents|mesh-ancestor
5866244|NCT02365727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5866245|NCT02365727|Respiratory System Agents|respiratory system agents|mesh-ancestor
5866246|NCT02365727|Mydriatics|mydriatics|mesh-ancestor
5866247|NCT02365727|Sympathomimetics|sympathomimetics|mesh-ancestor
5866248|NCT02365727|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5866249|NCT02365727|Analgesics|analgesics|mesh-ancestor
5866250|NCT02365727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5678717|NCT03510338|Vasodilator Agents|vasodilator agents|mesh-ancestor
5678718|NCT03510338|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5678719|NCT03510338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5678720|NCT03510338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5678721|NCT03510338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678722|NCT03510338|Urological Agents|urological agents|mesh-ancestor
5866251|NCT02365727|Sympatholytics|sympatholytics|mesh-ancestor
5866252|NCT02365727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5866253|NCT02365805|Paclitaxel|paclitaxel|mesh-list
5866254|NCT02365805|Docetaxel|docetaxel|mesh-list
5866255|NCT02365805|Fluorouracil|fluorouracil|mesh-list
5866256|NCT02365805|Epirubicin|epirubicin|mesh-list
5678723|NCT03510325|Olanzapine|olanzapine|mesh-list
5678724|NCT03510325|Risperidone|risperidone|mesh-list
5678725|NCT03510325|Aripiprazole|aripiprazole|mesh-list
5678726|NCT03510325|Paliperidone Palmitate|paliperidone palmitate|mesh-list
5678727|NCT03510325|Amisulpride|amisulpride|mesh-list
5678728|NCT03510325|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5678729|NCT03510325|Serotonin Agents|serotonin agents|mesh-ancestor
5678730|NCT03510325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5678731|NCT03510325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678732|NCT03510325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678733|NCT03510325|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5678734|NCT03510325|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5678735|NCT03510325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5678736|NCT03510325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5678737|NCT03510325|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5678738|NCT03510325|Dopamine Agents|dopamine agents|mesh-ancestor
5678739|NCT03510325|Antiemetics|antiemetics|mesh-ancestor
5678740|NCT03510325|Autonomic Agents|autonomic agents|mesh-ancestor
5678741|NCT03510325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5678742|NCT03510325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5678743|NCT03510325|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5678744|NCT03510325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5678745|NCT03510325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5678746|NCT03510325|Antidepressive Agents|antidepressive agents|mesh-ancestor
5678747|NCT03510325|Dopamine Agonists|dopamine agonists|mesh-ancestor
5678748|NCT03510325|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5678749|NCT03510325|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5678750|NCT03510325|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5696689|NCT03381118|Nivolumab|nivolumab|mesh-list
5866257|NCT02365805|Cyclophosphamide|cyclophosphamide|mesh-list
5866258|NCT02365805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5866259|NCT02365805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5866260|NCT02365805|Tubulin Modulators|tubulin modulators|mesh-ancestor
5866261|NCT02365805|Antimitotic Agents|antimitotic agents|mesh-ancestor
5866262|NCT02365805|Mitosis Modulators|mitosis modulators|mesh-ancestor
5866263|NCT02365805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5866264|NCT02365805|Antimetabolites|antimetabolites|mesh-ancestor
5866265|NCT02365805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5866266|NCT02365805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5866267|NCT02365805|Immunologic Factors|immunologic factors|mesh-ancestor
5866268|NCT02365805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866269|NCT02365805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5866270|NCT02365805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5866271|NCT02365805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5866272|NCT02365805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5866273|NCT02365805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5866274|NCT02365805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5866275|NCT02365805|Alkylating Agents|alkylating agents|mesh-ancestor
5866276|NCT02365805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5866277|NCT02365623|Bedaquiline|bedaquiline|mesh-list
5866278|NCT02365623|Diarylquinolines|diarylquinolines|mesh-list
5866279|NCT02365623|Antitubercular Agents|antitubercular agents|mesh-ancestor
5866280|NCT02365623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5866281|NCT02365623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5866282|NCT02365766|Gemcitabine|gemcitabine|mesh-list
5866283|NCT02365766|Pembrolizumab|pembrolizumab|mesh-list
5866284|NCT02365766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5866285|NCT02365766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5866286|NCT02365766|Antimetabolites|antimetabolites|mesh-ancestor
5866287|NCT02365766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5866288|NCT02365766|Antiviral Agents|antiviral agents|mesh-ancestor
5866289|NCT02365766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5866290|NCT02365766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5866291|NCT02365766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5866292|NCT02365766|Immunologic Factors|immunologic factors|mesh-ancestor
5866293|NCT02365766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866294|NCT02365766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5866295|NCT02365532|Dofetilide|dofetilide|mesh-list
5866296|NCT02365532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5866297|NCT02365532|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5866298|NCT02365532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5866299|NCT02365532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5866300|NCT02365155|Vitamin D|vitamin d|mesh-list
5866301|NCT02365155|Vitamins|vitamins|mesh-list
5866302|NCT02365155|Micronutrients|micronutrients|mesh-ancestor
5866303|NCT02365155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866304|NCT02365155|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5866305|NCT02365272|Amikacin|amikacin|mesh-list
5866306|NCT02365272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5866307|NCT02365272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5866308|NCT02365415|Sirolimus|sirolimus|mesh-list
5866309|NCT02365415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5866310|NCT02365415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5866311|NCT02365415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5866312|NCT02365415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5866313|NCT02365415|Antifungal Agents|antifungal agents|mesh-ancestor
5866314|NCT02365415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5866315|NCT02365415|Immunologic Factors|immunologic factors|mesh-ancestor
5866316|NCT02365415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866317|NCT02365493|Cefazolin|cefazolin|mesh-list
5866318|NCT02365493|Lactams|lactams|mesh-list
5866319|NCT02365493|beta-Lactams|beta-lactams|mesh-list
5866320|NCT02365493|Floxacillin|floxacillin|mesh-list
5866321|NCT02365493|Cloxacillin|cloxacillin|mesh-list
5866322|NCT02365493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5866323|NCT02365493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5866324|NCT02365402|Entecavir|entecavir|mesh-list
5866325|NCT02365402|Antiviral Agents|antiviral agents|mesh-ancestor
5866326|NCT02365402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5866327|NCT02365441|Imatinib Mesylate|imatinib mesylate|mesh-list
5866328|NCT02365441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5866329|NCT02365441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5866330|NCT02365441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5866331|NCT02365441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5866332|NCT02365181|Ropivacaine|ropivacaine|mesh-list
5866333|NCT02365181|Anesthetics, Local|anesthetics, local|mesh-list
5866334|NCT02365181|Anesthetics|anesthetics|mesh-list
5866335|NCT02365181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5866336|NCT02365181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866337|NCT02365181|Sensory System Agents|sensory system agents|mesh-ancestor
5866338|NCT02365181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5866339|NCT02364986|Interferons|interferons|mesh-list
5866340|NCT02364986|Interferon-beta|interferon-beta|mesh-list
5866341|NCT02364986|Interferon beta-1a|interferon beta-1a|mesh-list
5866342|NCT02364986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5866343|NCT02364986|Antiviral Agents|antiviral agents|mesh-ancestor
5866344|NCT02364986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5866345|NCT02364986|Immunologic Factors|immunologic factors|mesh-ancestor
5866346|NCT02364986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866347|NCT02364986|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5866348|NCT02364934|Propofol|propofol|mesh-list
5866349|NCT02364934|Sevoflurane|sevoflurane|mesh-list
5866350|NCT02364934|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5866351|NCT02364934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5866352|NCT02364934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866353|NCT02364934|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5678751|NCT03510325|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5678752|NCT03510325|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5678753|NCT03510221|Antioxidants|antioxidants|mesh-list
5678754|NCT03510221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678755|NCT03510221|Protective Agents|protective agents|mesh-ancestor
5678756|NCT03510221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678757|NCT03510208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5678758|NCT03510208|Panitumumab|panitumumab|mesh-list
5678759|NCT03510208|Antibodies|antibodies|mesh-list
5678760|NCT03510208|Immunoglobulins|immunoglobulins|mesh-list
5678761|NCT03510208|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5678762|NCT03510208|Immunologic Factors|immunologic factors|mesh-ancestor
5678763|NCT03510208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678764|NCT03510208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5678765|NCT03510078|Insulin|insulin|mesh-list
5678766|NCT03510078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5678767|NCT03510078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678768|NCT03510013|Sevoflurane|sevoflurane|mesh-list
5678769|NCT03510013|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
5678770|NCT03510013|Anesthetics|anesthetics|mesh-list
5866354|NCT02364934|Anesthetics, General|anesthetics, general|mesh-ancestor
5866355|NCT02364934|Anesthetics|anesthetics|mesh-ancestor
5866356|NCT02364934|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5866357|NCT02364934|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5866358|NCT02364882|Sildenafil Citrate|sildenafil citrate|mesh-list
5866359|NCT02364882|Vasodilator Agents|vasodilator agents|mesh-ancestor
5866360|NCT02364882|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5866361|NCT02364882|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5866362|NCT02364882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5866363|NCT02364882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5866364|NCT02364882|Urological Agents|urological agents|mesh-ancestor
5866365|NCT02364804|Aprepitant|aprepitant|mesh-list
5866366|NCT02364804|Antiemetics|antiemetics|mesh-ancestor
5866367|NCT02364804|Autonomic Agents|autonomic agents|mesh-ancestor
5678771|NCT03510013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5678772|NCT03510013|Anesthetics, General|anesthetics, general|mesh-ancestor
5678773|NCT03510013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5678774|NCT03510013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678775|NCT03510000|Empagliflozin|empagliflozin|mesh-list
5678776|NCT03510000|Pancrelipase|pancrelipase|mesh-list
5678777|NCT03510000|Hormones|hormones|mesh-list
5678778|NCT03510000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5866368|NCT02364804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5866369|NCT02364804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866370|NCT02364804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5866371|NCT02364804|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5866372|NCT02364804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5866373|NCT02364804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5866374|NCT02365012|Midodrine|midodrine|mesh-list
5866375|NCT02365012|Sympathomimetics|sympathomimetics|mesh-ancestor
5866376|NCT02365012|Autonomic Agents|autonomic agents|mesh-ancestor
5905124|NCT03257761|Guadecitabine|guadecitabine|mesh-list
5678779|NCT03510000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866377|NCT02365012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5866378|NCT02365012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866379|NCT02365012|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5866380|NCT02365012|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5866381|NCT02365012|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5866382|NCT02365012|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5866383|NCT02365012|Adrenergic Agents|adrenergic agents|mesh-ancestor
5866384|NCT02365012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5866385|NCT02365012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5866386|NCT02364713|Gemcitabine|gemcitabine|mesh-list
5866387|NCT02364713|Paclitaxel|paclitaxel|mesh-list
5866388|NCT02364713|Bevacizumab|bevacizumab|mesh-list
5866389|NCT02364713|Doxorubicin|doxorubicin|mesh-list
5866390|NCT02364713|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5866391|NCT02364713|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5866392|NCT02364713|Topotecan|topotecan|mesh-list
5866393|NCT02364713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5866394|NCT02364713|Endothelial Growth Factors|endothelial growth factors|mesh-list
5866395|NCT02364713|Antibodies|antibodies|mesh-list
5866396|NCT02364713|Immunoglobulins|immunoglobulins|mesh-list
5866397|NCT02364713|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5866398|NCT02364713|Immunoglobulin G|immunoglobulin g|mesh-list
5866399|NCT02364713|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5866400|NCT02364713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5678780|NCT03510000|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5678781|NCT03510000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678782|NCT03510000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5678783|NCT03510000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5696690|NCT03381118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5696691|NCT03381118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5696692|NCT03381118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5696693|NCT03381118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696694|NCT03381118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5696695|NCT03381118|Antimetabolites|antimetabolites|mesh-ancestor
5696696|NCT03381118|Antiviral Agents|antiviral agents|mesh-ancestor
5696697|NCT03381118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5696698|NCT03381118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5696699|NCT03381118|Immunologic Factors|immunologic factors|mesh-ancestor
5696700|NCT03381118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696701|NCT03381066|Cisplatin|cisplatin|mesh-list
5696702|NCT03381066|Pemetrexed|pemetrexed|mesh-list
5866401|NCT02364713|Tubulin Modulators|tubulin modulators|mesh-ancestor
5866402|NCT02364713|Antimitotic Agents|antimitotic agents|mesh-ancestor
5696703|NCT03381066|Vinorelbine|vinorelbine|mesh-list
5696704|NCT03381066|Gefitinib|gefitinib|mesh-list
5696705|NCT03381066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5696706|NCT03381066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5696707|NCT03381066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696708|NCT03381066|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5696709|NCT03381066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5696710|NCT03381066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5866403|NCT02364713|Mitosis Modulators|mitosis modulators|mesh-ancestor
5866404|NCT02364713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5866405|NCT02364713|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5866406|NCT02364713|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5696711|NCT03381066|Tubulin Modulators|tubulin modulators|mesh-ancestor
5696712|NCT03381066|Antimitotic Agents|antimitotic agents|mesh-ancestor
5696713|NCT03381066|Mitosis Modulators|mitosis modulators|mesh-ancestor
5696714|NCT03381066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5696715|NCT03381053|Imatinib Mesylate|imatinib mesylate|mesh-list
5696716|NCT03381053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5696717|NCT03381053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5696718|NCT03381053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5696719|NCT03381053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696720|NCT03381040|Hyaluronic Acid|hyaluronic acid|mesh-list
5696721|NCT03381040|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5696722|NCT03381040|Immunologic Factors|immunologic factors|mesh-ancestor
5696723|NCT03381040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696724|NCT03381040|Viscosupplements|viscosupplements|mesh-ancestor
5696725|NCT03381040|Protective Agents|protective agents|mesh-ancestor
5696726|NCT03380975|Montelukast|montelukast|mesh-list
5866407|NCT02364713|Growth Substances|growth substances|mesh-ancestor
5866408|NCT02364713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866409|NCT02364713|Growth Inhibitors|growth inhibitors|mesh-ancestor
5866410|NCT02364713|Immunologic Factors|immunologic factors|mesh-ancestor
5866411|NCT02364713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5866412|NCT02364713|Antimetabolites|antimetabolites|mesh-ancestor
5866413|NCT02364713|Antiviral Agents|antiviral agents|mesh-ancestor
5866414|NCT02364713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5866415|NCT02364713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5866416|NCT02364713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5866417|NCT02364713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5866418|NCT02364713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5866419|NCT02364713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5866420|NCT02364713|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5678784|NCT03509922|Sarpogrelate|sarpogrelate|mesh-list
5678785|NCT03509922|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5678786|NCT03509922|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5678787|NCT03509922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678788|NCT03509922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5678789|NCT03509922|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5678790|NCT03509922|Serotonin Agents|serotonin agents|mesh-ancestor
5678791|NCT03509922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5678792|NCT03509922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678793|NCT03509831|Irsogladine|irsogladine|mesh-list
5678794|NCT03509831|Nizatidine|nizatidine|mesh-list
5678795|NCT03509831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678796|NCT03509831|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5678797|NCT03509831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5678798|NCT03509831|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5678799|NCT03509831|Histamine Antagonists|histamine antagonists|mesh-ancestor
5678800|NCT03509831|Histamine Agents|histamine agents|mesh-ancestor
5866421|NCT02364765|Remifentanil|remifentanil|mesh-list
5866422|NCT02364765|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5866423|NCT02364765|Narcotics|narcotics|mesh-ancestor
5866424|NCT02364765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5866425|NCT02364765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866426|NCT02364765|Analgesics|analgesics|mesh-ancestor
5866427|NCT02364765|Sensory System Agents|sensory system agents|mesh-ancestor
5866428|NCT02364765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5905125|NCT03257761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5905126|NCT03257761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5905127|NCT03218826|Docetaxel|docetaxel|mesh-list
5905128|NCT03218826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5905129|NCT03218826|Tubulin Modulators|tubulin modulators|mesh-ancestor
5905130|NCT03218826|Antimitotic Agents|antimitotic agents|mesh-ancestor
5905131|NCT03218826|Mitosis Modulators|mitosis modulators|mesh-ancestor
5905132|NCT03218826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905133|NCT03179917|Pembrolizumab|pembrolizumab|mesh-list
5905134|NCT03179917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5905135|NCT03179917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5905136|NCT03110107|Nivolumab|nivolumab|mesh-list
5905137|NCT03110107|Ipilimumab|ipilimumab|mesh-list
5905138|NCT03110107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5905139|NCT03110107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5905140|NCT03110107|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5905141|NCT03110107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905142|NCT03014648|Atezolizumab|atezolizumab|mesh-list
5905143|NCT03014648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5905144|NCT02959619|Ensartinib|ensartinib|mesh-list
5905145|NCT02959619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5905146|NCT02959619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5905147|NCT02959619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5905148|NCT02959619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905149|NCT02908750|Fexofenadine|fexofenadine|mesh-list
5905150|NCT02908750|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5905151|NCT02908750|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5905152|NCT02908750|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5905153|NCT02908750|Histamine Antagonists|histamine antagonists|mesh-ancestor
5905154|NCT02908750|Histamine Agents|histamine agents|mesh-ancestor
5905155|NCT02908750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5905156|NCT02908750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905157|NCT02908750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678801|NCT03509831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5678802|NCT03509831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905158|NCT02795520|OTS167|ots167|mesh-list
5905159|NCT02795520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5905160|NCT02795520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5866429|NCT02364531|Abiraterone Acetate|abiraterone acetate|mesh-list
5866430|NCT02364531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5866431|NCT02364531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5866432|NCT02364531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5866433|NCT02364531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5866434|NCT02364531|Hormone Antagonists|hormone antagonists|mesh-ancestor
5866435|NCT02364531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5866436|NCT02364531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866437|NCT02364531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5866438|NCT02364479|Etanercept|etanercept|mesh-list
5866439|NCT02364479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6494785|NCT00620347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494786|NCT00620438|Efavirenz|efavirenz|mesh-list
6494787|NCT00620438|Nevirapine|nevirapine|mesh-list
6494788|NCT00620438|Rifampin|rifampin|mesh-list
6494789|NCT00620438|Lumefantrine|lumefantrine|mesh-list
6494790|NCT00620438|Artemether|artemether|mesh-list
6494791|NCT00620438|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6494792|NCT00620438|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6494793|NCT00620438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5678803|NCT03509831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5678804|NCT03509831|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5678805|NCT03509831|Protective Agents|protective agents|mesh-ancestor
5866440|NCT02364479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5866441|NCT02364479|Analgesics|analgesics|mesh-ancestor
5866442|NCT02364479|Sensory System Agents|sensory system agents|mesh-ancestor
5678806|NCT03509831|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5678807|NCT03509740|Acetaminophen|acetaminophen|mesh-list
5678808|NCT03509740|Tramadol|tramadol|mesh-list
5678809|NCT03509740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5678810|NCT03509740|Analgesics|analgesics|mesh-ancestor
5678811|NCT03509740|Sensory System Agents|sensory system agents|mesh-ancestor
5678812|NCT03509740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5678813|NCT03509740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678814|NCT03509740|Antipyretics|antipyretics|mesh-ancestor
5678815|NCT03509740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5678816|NCT03509740|Narcotics|narcotics|mesh-ancestor
5678817|NCT03509740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5866443|NCT02364479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5866444|NCT02364479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866445|NCT02364479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5866446|NCT02364479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5866447|NCT02364479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5866448|NCT02364479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5866449|NCT02364479|Immunologic Factors|immunologic factors|mesh-ancestor
5866450|NCT02364752|Diuretics|diuretics|mesh-list
5866451|NCT02364752|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
5866452|NCT02364752|Natriuretic Agents|natriuretic agents|mesh-ancestor
5866453|NCT02364752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866454|NCT02364752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5866455|NCT02364752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678818|NCT03509714|Ascorbic Acid|ascorbic acid|mesh-list
5678819|NCT03509714|Antioxidants|antioxidants|mesh-ancestor
5678820|NCT03509714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678821|NCT03509714|Protective Agents|protective agents|mesh-ancestor
5678822|NCT03509714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678823|NCT03509714|Vitamins|vitamins|mesh-ancestor
5678824|NCT03509714|Micronutrients|micronutrients|mesh-ancestor
5678825|NCT03509701|Antibodies|antibodies|mesh-list
5678826|NCT03509701|Immunologic Factors|immunologic factors|mesh-ancestor
5678827|NCT03509701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678828|NCT03509688|Entecavir|entecavir|mesh-list
5678829|NCT03509688|Resveratrol|resveratrol|mesh-list
5678830|NCT03509688|Antiviral Agents|antiviral agents|mesh-ancestor
5678831|NCT03509688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5866456|NCT02364609|Pembrolizumab|pembrolizumab|mesh-list
5866457|NCT02364609|Afatinib|afatinib|mesh-list
5678832|NCT03509688|Antioxidants|antioxidants|mesh-ancestor
5678833|NCT03509688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678834|NCT03509688|Protective Agents|protective agents|mesh-ancestor
5678835|NCT03509688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678836|NCT03509688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5678837|NCT03509688|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6494794|NCT00620438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5678838|NCT03509662|Ascorbic Acid|ascorbic acid|mesh-list
5678839|NCT03509662|Thiamine|thiamine|mesh-list
5866458|NCT02364609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5866459|NCT02364609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5866460|NCT02364609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5866461|NCT02364609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5866462|NCT02364609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5866463|NCT02364583|Primaquine|primaquine|mesh-list
5866464|NCT02364583|Antimalarials|antimalarials|mesh-ancestor
5866465|NCT02364583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5866466|NCT02364583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5866467|NCT02364583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5866468|NCT02364453|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
5866469|NCT02364453|Growth Substances|growth substances|mesh-ancestor
5866470|NCT02364453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866471|NCT02364453|Vasodilator Agents|vasodilator agents|mesh-ancestor
5866472|NCT02364453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5866473|NCT02364453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5866474|NCT02364206|Temozolomide|temozolomide|mesh-list
5866475|NCT02364206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5866476|NCT02364206|Alkylating Agents|alkylating agents|mesh-ancestor
5866477|NCT02364206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5866478|NCT02364206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5866479|NCT02364258|Atorvastatin|atorvastatin|mesh-list
6212322|NCT02186665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6496472|NCT00628225|Bupropion|bupropion|mesh-list
5678840|NCT03509662|Vitamins|vitamins|mesh-ancestor
5866480|NCT02364258|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5866481|NCT02364258|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5866482|NCT02364258|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5866483|NCT02364258|Antimetabolites|antimetabolites|mesh-ancestor
5866484|NCT02364258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5866485|NCT02364258|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5866486|NCT02364258|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5866487|NCT02364258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5866488|NCT02364362|Docetaxel|docetaxel|mesh-list
5866489|NCT02364362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5866490|NCT02364362|Tubulin Modulators|tubulin modulators|mesh-ancestor
5866491|NCT02364362|Antimitotic Agents|antimitotic agents|mesh-ancestor
5866492|NCT02364362|Mitosis Modulators|mitosis modulators|mesh-ancestor
5866493|NCT02364362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5866494|NCT02364089|Epinephrine|epinephrine|mesh-list
5866495|NCT02364089|Racepinephrine|racepinephrine|mesh-list
5866496|NCT02364089|Epinephryl borate|epinephryl borate|mesh-list
5866497|NCT02364089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5866498|NCT02364089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5866499|NCT02364089|Adrenergic Agents|adrenergic agents|mesh-ancestor
5866500|NCT02364089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5866501|NCT02364089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5866502|NCT02364089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678841|NCT03509662|Micronutrients|micronutrients|mesh-ancestor
5678842|NCT03509662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678843|NCT03509662|Antioxidants|antioxidants|mesh-ancestor
5678844|NCT03509662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678845|NCT03509662|Protective Agents|protective agents|mesh-ancestor
5678846|NCT03509662|Vitamin B Complex|vitamin b complex|mesh-ancestor
5678847|NCT03509584|Nivolumab|nivolumab|mesh-list
5678848|NCT03509584|Ipilimumab|ipilimumab|mesh-list
5678849|NCT03509584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5678850|NCT03509584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5678851|NCT03509584|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5678852|NCT03509584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678853|NCT03509545|Torsemide|torsemide|mesh-list
5678854|NCT03509545|Furosemide|furosemide|mesh-list
5678855|NCT03509545|Diuretics|diuretics|mesh-ancestor
5678856|NCT03509545|Natriuretic Agents|natriuretic agents|mesh-ancestor
5678857|NCT03509545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678858|NCT03509545|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5678859|NCT03509545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5678860|NCT03509545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678861|NCT03509545|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5678862|NCT03509324|Insulin Lispro|insulin lispro|mesh-list
5678863|NCT03509324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5866503|NCT02364089|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5866504|NCT02364089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5866505|NCT02364089|Autonomic Agents|autonomic agents|mesh-ancestor
5678864|NCT03509324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678865|NCT03509298|Antibodies|antibodies|mesh-list
5678866|NCT03509298|Antibodies, Bispecific|antibodies, bispecific|mesh-list
5678867|NCT03509298|Immunologic Factors|immunologic factors|mesh-ancestor
5678868|NCT03509298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678869|NCT03509285|Cenobamate|cenobamate|mesh-list
5678870|NCT03509285|Alprazolam|alprazolam|mesh-list
5678871|NCT03509285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5678872|NCT03509285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5678873|NCT03509285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678874|NCT03509285|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5678875|NCT03509285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5678876|NCT03509285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5866506|NCT02364089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5866507|NCT02364089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5866508|NCT02364089|Respiratory System Agents|respiratory system agents|mesh-ancestor
5866509|NCT02364089|Mydriatics|mydriatics|mesh-ancestor
5866510|NCT02364089|Sympathomimetics|sympathomimetics|mesh-ancestor
5866511|NCT02364089|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5866512|NCT02363985|Vitamin A|vitamin a|mesh-list
5866513|NCT02363985|Vitamins|vitamins|mesh-ancestor
5866514|NCT02363985|Micronutrients|micronutrients|mesh-ancestor
5866515|NCT02363985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866516|NCT02363829|Nelfinavir|nelfinavir|mesh-list
5866517|NCT02363829|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5866518|NCT02363829|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5866519|NCT02363829|Protease Inhibitors|protease inhibitors|mesh-ancestor
5866520|NCT02363829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5866521|NCT02363829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5866522|NCT02363829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5866523|NCT02363829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5866524|NCT02363829|Antiviral Agents|antiviral agents|mesh-ancestor
5866525|NCT02363829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5866526|NCT02363699|Lidocaine|lidocaine|mesh-list
5866527|NCT02363699|Anesthetics, Local|anesthetics, local|mesh-ancestor
5866528|NCT02363699|Anesthetics|anesthetics|mesh-ancestor
5866529|NCT02363699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5866530|NCT02363699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866531|NCT02363699|Sensory System Agents|sensory system agents|mesh-ancestor
5866532|NCT02363699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5866533|NCT02363699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5866534|NCT02363699|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5866535|NCT02363699|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5866536|NCT02363699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5866537|NCT02363699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5866538|NCT02363751|Bevacizumab|bevacizumab|mesh-list
5866539|NCT02363751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5866540|NCT02363751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5866541|NCT02363751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5866542|NCT02363751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5866543|NCT02363751|Growth Substances|growth substances|mesh-ancestor
5866544|NCT02363751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866545|NCT02363751|Growth Inhibitors|growth inhibitors|mesh-ancestor
5866546|NCT02363556|Misoprostol|misoprostol|mesh-list
5866547|NCT02363556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5866548|NCT02363556|Abortifacient Agents|abortifacient agents|mesh-ancestor
5866549|NCT02363556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5866550|NCT02363556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866551|NCT02363556|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5866552|NCT02363556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5866553|NCT02363556|Oxytocics|oxytocics|mesh-ancestor
5866554|NCT02363452|Lamivudine|lamivudine|mesh-list
5866555|NCT02363452|Zidovudine|zidovudine|mesh-list
5866556|NCT02363452|Abacavir|abacavir|mesh-list
5866557|NCT02363452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
5866558|NCT02363452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5866559|NCT02363452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5866560|NCT02363452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5866561|NCT02363452|Antiviral Agents|antiviral agents|mesh-ancestor
5866562|NCT02363452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5866563|NCT02363452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5866564|NCT02363452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5866565|NCT02363452|Antimetabolites|antimetabolites|mesh-ancestor
5866566|NCT02363335|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5866567|NCT02363335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5866568|NCT02363335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678877|NCT03509285|GABA Modulators|gaba modulators|mesh-ancestor
5866569|NCT02363335|Incretins|incretins|mesh-ancestor
5866570|NCT02363335|Hormones|hormones|mesh-ancestor
5866571|NCT02363335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5866572|NCT02363335|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5866573|NCT02363335|Protease Inhibitors|protease inhibitors|mesh-ancestor
5866574|NCT02363335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5866575|NCT02363335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5866576|NCT02363374|Leucovorin|leucovorin|mesh-list
5866577|NCT02363374|Folic Acid|folic acid|mesh-list
5866578|NCT02363374|Fluorouracil|fluorouracil|mesh-list
5866579|NCT02363374|Oxaliplatin|oxaliplatin|mesh-list
5866580|NCT02363374|Levoleucovorin|levoleucovorin|mesh-list
5866581|NCT02363374|Antimetabolites|antimetabolites|mesh-ancestor
5678878|NCT03509285|GABA Agents|gaba agents|mesh-ancestor
5678879|NCT03509285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5678880|NCT03509285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678881|NCT03509285|Anticonvulsants|anticonvulsants|mesh-ancestor
5678882|NCT03509246|Doxorubicin|doxorubicin|mesh-list
5678883|NCT03509246|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5678884|NCT03509246|Bortezomib|bortezomib|mesh-list
5678885|NCT03509246|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5678886|NCT03509246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5678887|NCT03509246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5678888|NCT03509246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5678889|NCT03509246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5678890|NCT03509246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678891|NCT03509168|Misoprostol|misoprostol|mesh-list
5678892|NCT03509168|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5866582|NCT02363374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5866583|NCT02363374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5866584|NCT02363374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5866585|NCT02363374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5866586|NCT02363374|Immunologic Factors|immunologic factors|mesh-ancestor
5866587|NCT02363374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678893|NCT03509168|Abortifacient Agents|abortifacient agents|mesh-ancestor
5678894|NCT03509168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5678895|NCT03509168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678896|NCT03509168|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5678897|NCT03509168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5866588|NCT02363374|Antidotes|antidotes|mesh-ancestor
5866589|NCT02363374|Protective Agents|protective agents|mesh-ancestor
5866590|NCT02363374|Vitamin B Complex|vitamin b complex|mesh-ancestor
5866591|NCT02363374|Vitamins|vitamins|mesh-ancestor
5866592|NCT02363374|Micronutrients|micronutrients|mesh-ancestor
5866593|NCT02363374|Hematinics|hematinics|mesh-ancestor
5866594|NCT02363400|Cisplatin|cisplatin|mesh-list
5866595|NCT02363400|Epirubicin|epirubicin|mesh-list
5866596|NCT02363400|Mitomycins|mitomycins|mesh-list
5866597|NCT02363400|Mitomycin|mitomycin|mesh-list
5866598|NCT02363400|Tegafur|tegafur|mesh-list
5866599|NCT02363400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5866600|NCT02363400|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5866601|NCT02363400|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5866602|NCT02363400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5866603|NCT02363400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5866604|NCT02363400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5866605|NCT02363400|Alkylating Agents|alkylating agents|mesh-ancestor
5866606|NCT02363400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5866607|NCT02363400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5866608|NCT02363400|Antimetabolites|antimetabolites|mesh-ancestor
5866609|NCT02363530|Ethyl cellulose|ethyl cellulose|mesh-list
5866610|NCT02363530|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
5866611|NCT02363530|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5866612|NCT02363517|Sofosbuvir|sofosbuvir|mesh-list
5866613|NCT02363517|Antiviral Agents|antiviral agents|mesh-ancestor
5866614|NCT02363517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5866615|NCT02363361|Imatinib Mesylate|imatinib mesylate|mesh-list
5866616|NCT02363361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5866617|NCT02363361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5866618|NCT02363361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5866619|NCT02363361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5866620|NCT02363075|Dextroamphetamine|dextroamphetamine|mesh-list
6212323|NCT02186665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212324|NCT02186665|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6212325|NCT02186665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6212326|NCT02186665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212327|NCT02186665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5678898|NCT03509168|Oxytocics|oxytocics|mesh-ancestor
5678899|NCT03509142|Sirolimus|sirolimus|mesh-list
5678900|NCT03509142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5678901|NCT03509142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5678902|NCT03509142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5678903|NCT03509142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5678904|NCT03509142|Antifungal Agents|antifungal agents|mesh-ancestor
5678905|NCT03509142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5678906|NCT03509142|Immunologic Factors|immunologic factors|mesh-ancestor
5678907|NCT03509142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678908|NCT03509051|Vaccines|vaccines|mesh-list
5866621|NCT02363075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5866622|NCT02363075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866623|NCT02363075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5866624|NCT02363075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5866625|NCT02363075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5866626|NCT02363075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5866627|NCT02363075|Dopamine Agents|dopamine agents|mesh-ancestor
5866628|NCT02363075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5866629|NCT02362906|Azithromycin|azithromycin|mesh-list
5866630|NCT02362906|Erythromycin|erythromycin|mesh-list
5866631|NCT02362906|Erythromycin Estolate|erythromycin estolate|mesh-list
5866632|NCT02362906|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
5866633|NCT02362906|Erythromycin stearate|erythromycin stearate|mesh-list
5866634|NCT02362906|Cephalosporins|cephalosporins|mesh-list
5866635|NCT02362906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5866636|NCT02362906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5866637|NCT02362906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5866638|NCT02362906|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5866639|NCT02362906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5866640|NCT02362906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905161|NCT02795520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905162|NCT02645149|Trametinib|trametinib|mesh-list
5905163|NCT02645149|Ceritinib|ceritinib|mesh-list
5905164|NCT02645149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5905165|NCT02645149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5905166|NCT02645149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5905167|NCT02645149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905168|NCT02642809|Pembrolizumab|pembrolizumab|mesh-list
5905169|NCT02642809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5905170|NCT02642809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6494795|NCT00620438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678909|NCT03509051|Immunologic Factors|immunologic factors|mesh-ancestor
5678910|NCT03509051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678911|NCT03508999|Metronidazole|metronidazole|mesh-list
5678912|NCT03508999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5678913|NCT03508999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5678914|NCT03508999|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5678915|NCT03508999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5678916|NCT03508921|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5678917|NCT03508921|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5678918|NCT03508921|Trimethoprim|trimethoprim|mesh-list
5678919|NCT03508921|Sulfamethoxazole|sulfamethoxazole|mesh-list
5678920|NCT03508921|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5678921|NCT03508921|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5678922|NCT03508921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5678923|NCT03508921|Antitubercular Agents|antitubercular agents|mesh-ancestor
5678924|NCT03508921|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5678925|NCT03508921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5678926|NCT03508921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678927|NCT03508921|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5678928|NCT03508921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5678929|NCT03508921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494796|NCT00620438|Antiviral Agents|antiviral agents|mesh-ancestor
6494797|NCT00620438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6494798|NCT00620438|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6494799|NCT00620438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6494800|NCT00620438|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6494801|NCT00620438|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6494802|NCT00620438|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6494803|NCT00620438|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6494804|NCT00620438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5678930|NCT03508921|Cholinergic Agents|cholinergic agents|mesh-ancestor
5866641|NCT02362958|Capecitabine|capecitabine|mesh-list
5866642|NCT02362958|Vinorelbine|vinorelbine|mesh-list
5866643|NCT02362958|Lapatinib|lapatinib|mesh-list
5866644|NCT02362958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5866645|NCT02362958|Antimetabolites|antimetabolites|mesh-ancestor
5866646|NCT02362958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5866647|NCT02362958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5866648|NCT02362958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5866649|NCT02362958|Tubulin Modulators|tubulin modulators|mesh-ancestor
5866650|NCT02362958|Antimitotic Agents|antimitotic agents|mesh-ancestor
5866651|NCT02362958|Mitosis Modulators|mitosis modulators|mesh-ancestor
5866652|NCT02362958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5866653|NCT02362958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5866654|NCT02363127|Progesterone|progesterone|mesh-list
5866655|NCT02363127|Progestins|progestins|mesh-ancestor
5866656|NCT02363127|Hormones|hormones|mesh-ancestor
5866657|NCT02363127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5866658|NCT02363127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866659|NCT02362997|Pembrolizumab|pembrolizumab|mesh-list
5866660|NCT02362997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5866661|NCT02362997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5866662|NCT02362945|Oxytocin|oxytocin|mesh-list
5866663|NCT02362945|Oxytocics|oxytocics|mesh-ancestor
5866664|NCT02362945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5866665|NCT02362945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866666|NCT02362711|Levonorgestrel|levonorgestrel|mesh-list
5866667|NCT02362711|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5866668|NCT02362711|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5866669|NCT02362711|Contraceptive Agents|contraceptive agents|mesh-ancestor
5678931|NCT03508921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5678932|NCT03508921|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5678933|NCT03508921|Renal Agents|renal agents|mesh-ancestor
5678934|NCT03508921|Antimalarials|antimalarials|mesh-ancestor
5678935|NCT03508921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5678936|NCT03508921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6494805|NCT00620438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6494806|NCT00620438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6494807|NCT00620438|Antitubercular Agents|antitubercular agents|mesh-ancestor
6494808|NCT00620438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5678937|NCT03508921|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5866670|NCT02362711|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5866671|NCT02362711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866672|NCT02362711|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5866673|NCT02362711|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5866674|NCT02362711|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5866675|NCT02362711|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5866676|NCT02362711|Estrogens|estrogens|mesh-ancestor
5866677|NCT02362711|Hormones|hormones|mesh-ancestor
5866678|NCT02362711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5866679|NCT02362490|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5866680|NCT02362490|Antiviral Agents|antiviral agents|mesh-ancestor
5866681|NCT02362490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5866682|NCT02362516|BI 425809|bi 425809|mesh-list
5866683|NCT02362516|Nootropic Agents|nootropic agents|mesh-ancestor
5866684|NCT02362399|Sildenafil Citrate|sildenafil citrate|mesh-list
5866685|NCT02362399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5866686|NCT02362399|Vasodilator Agents|vasodilator agents|mesh-ancestor
5866687|NCT02362399|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5866688|NCT02362399|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5866689|NCT02362399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6494809|NCT00620438|Leprostatic Agents|leprostatic agents|mesh-ancestor
5678938|NCT03508921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5678939|NCT03508921|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5678940|NCT03508921|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
5678941|NCT03508921|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5678942|NCT03508895|Caseins|caseins|mesh-list
5678943|NCT03508895|Chelating Agents|chelating agents|mesh-ancestor
5678944|NCT03508895|Sequestering Agents|sequestering agents|mesh-ancestor
5678945|NCT03508895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678946|NCT03508882|Botulinum Toxins|botulinum toxins|mesh-list
5678947|NCT03508882|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5678948|NCT03508882|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5678949|NCT03508882|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5678950|NCT03508882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5678951|NCT03508882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5866690|NCT02362399|Urological Agents|urological agents|mesh-ancestor
5866691|NCT02362529|Minocycline|minocycline|mesh-list
5866692|NCT02362529|Celecoxib|celecoxib|mesh-list
5866693|NCT02362529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5866694|NCT02362529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5866695|NCT02362529|Analgesics|analgesics|mesh-ancestor
5866696|NCT02362529|Sensory System Agents|sensory system agents|mesh-ancestor
5866697|NCT02362529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5866698|NCT02362529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866699|NCT02362529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5866700|NCT02362529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5866701|NCT02362529|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5866702|NCT02362529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5866703|NCT02362529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5866704|NCT02362529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5866705|NCT02362529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5866706|NCT02362529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5866707|NCT02362581|Factor VIII|factor viii|mesh-list
5866708|NCT02362581|Coagulants|coagulants|mesh-ancestor
5866709|NCT02362308|Eplerenone|eplerenone|mesh-list
5866710|NCT02362308|Spironolactone|spironolactone|mesh-list
5866711|NCT02362308|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
5866712|NCT02362308|Mineralocorticoids|mineralocorticoids|mesh-list
5866713|NCT02362308|Hormone Antagonists|hormone antagonists|mesh-ancestor
5866714|NCT02362308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5866715|NCT02362308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866716|NCT02362308|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5866717|NCT02362308|Diuretics|diuretics|mesh-ancestor
5678952|NCT03508882|Cholinergic Agents|cholinergic agents|mesh-ancestor
5678953|NCT03508882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5678954|NCT03508882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678955|NCT03508882|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5678956|NCT03508882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5678957|NCT03508869|Brimonidine Tartrate|brimonidine tartrate|mesh-list
5678958|NCT03508869|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5678959|NCT03508869|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5678960|NCT03508869|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5678961|NCT03508869|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5678962|NCT03508869|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5866718|NCT02362308|Natriuretic Agents|natriuretic agents|mesh-ancestor
5866719|NCT02362308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5866720|NCT02362308|Hormones|hormones|mesh-ancestor
5866721|NCT02362256|Clonidine|clonidine|mesh-list
5866722|NCT02362256|Naltrexone|naltrexone|mesh-list
5678963|NCT03508869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5678964|NCT03508869|Adrenergic Agents|adrenergic agents|mesh-ancestor
5678965|NCT03508869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5678966|NCT03508869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678967|NCT03508869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678968|NCT03508869|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5678969|NCT03508869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5678970|NCT03508869|Cholinergic Agents|cholinergic agents|mesh-ancestor
5678971|NCT03508869|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5678972|NCT03508869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5866723|NCT02362256|Lorazepam|lorazepam|mesh-list
5866724|NCT02362256|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5866725|NCT02362256|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5866726|NCT02362256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866727|NCT02362256|Sensory System Agents|sensory system agents|mesh-ancestor
5866728|NCT02362256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5866729|NCT02362256|Analgesics|analgesics|mesh-ancestor
5866730|NCT02362256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5866731|NCT02362256|Sympatholytics|sympatholytics|mesh-ancestor
5866732|NCT02362256|Autonomic Agents|autonomic agents|mesh-ancestor
5866733|NCT02362256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5866734|NCT02362256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5866735|NCT02362256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5866736|NCT02362256|Adrenergic Agents|adrenergic agents|mesh-ancestor
5866737|NCT02362256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5866738|NCT02362256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5866739|NCT02362256|Anticonvulsants|anticonvulsants|mesh-ancestor
5866740|NCT02362256|Antiemetics|antiemetics|mesh-ancestor
5866741|NCT02362256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5866742|NCT02362256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5866743|NCT02362256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5866744|NCT02362256|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5866745|NCT02362256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5866746|NCT02362256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5866747|NCT02362256|GABA Modulators|gaba modulators|mesh-ancestor
5866748|NCT02362256|GABA Agents|gaba agents|mesh-ancestor
5866749|NCT02362152|Diclofenac|diclofenac|mesh-list
5866750|NCT02362152|Fluorouracil|fluorouracil|mesh-list
5866751|NCT02362152|Imiquimod|imiquimod|mesh-list
5866752|NCT02362152|Antimetabolites|antimetabolites|mesh-ancestor
5866753|NCT02362152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5866754|NCT02362152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5866755|NCT02362152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5866756|NCT02362152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5866757|NCT02362152|Immunologic Factors|immunologic factors|mesh-ancestor
5866758|NCT02362152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866759|NCT02362152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5866760|NCT02362152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5866761|NCT02362152|Analgesics|analgesics|mesh-ancestor
5678973|NCT03508817|Atropine|atropine|mesh-list
5678974|NCT03508817|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5678975|NCT03508817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5678976|NCT03508817|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5678977|NCT03508817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5678978|NCT03508817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5678979|NCT03508817|Autonomic Agents|autonomic agents|mesh-ancestor
5678980|NCT03508817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5678981|NCT03508817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678982|NCT03508817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5678983|NCT03508817|Respiratory System Agents|respiratory system agents|mesh-ancestor
5678984|NCT03508817|Mydriatics|mydriatics|mesh-ancestor
5678985|NCT03508817|Parasympatholytics|parasympatholytics|mesh-ancestor
5678986|NCT03508817|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5678987|NCT03508817|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5678988|NCT03508817|Cholinergic Agents|cholinergic agents|mesh-ancestor
5678989|NCT03508817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5678990|NCT03508817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5678991|NCT03508804|Lidocaine|lidocaine|mesh-list
5678992|NCT03508804|Prilocaine|prilocaine|mesh-list
5678993|NCT03508804|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
5678994|NCT03508804|Anesthetics, Local|anesthetics, local|mesh-ancestor
5678995|NCT03508804|Anesthetics|anesthetics|mesh-ancestor
5678996|NCT03508804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5678997|NCT03508804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5678998|NCT03508804|Sensory System Agents|sensory system agents|mesh-ancestor
5678999|NCT03508804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5679000|NCT03508804|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5679001|NCT03508804|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5679002|NCT03508804|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5866762|NCT02362152|Sensory System Agents|sensory system agents|mesh-ancestor
5866763|NCT02362152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5866764|NCT02362152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5866765|NCT02362152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5866766|NCT02362152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5866767|NCT02362152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5866768|NCT02362152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5866769|NCT02362152|Interferon Inducers|interferon inducers|mesh-ancestor
5866770|NCT02362035|Pembrolizumab|pembrolizumab|mesh-list
5866771|NCT02362035|Acalabrutinib|acalabrutinib|mesh-list
5866772|NCT02362035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5866773|NCT02362035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5866774|NCT02362165|Dexamethasone|dexamethasone|mesh-list
5866775|NCT02362165|Cyclophosphamide|cyclophosphamide|mesh-list
5866776|NCT02362165|Doxorubicin|doxorubicin|mesh-list
5866777|NCT02362165|Bortezomib|bortezomib|mesh-list
5866778|NCT02362165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5866779|NCT02362165|Immunologic Factors|immunologic factors|mesh-ancestor
5866780|NCT02362165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866781|NCT02362165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5679003|NCT03508804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5679004|NCT03508804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5679005|NCT03508804|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
5679006|NCT03508726|Ascorbic Acid|ascorbic acid|mesh-list
5679007|NCT03508726|Vitamins|vitamins|mesh-ancestor
5679008|NCT03508726|Micronutrients|micronutrients|mesh-ancestor
5866782|NCT02362165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5866783|NCT02362165|Alkylating Agents|alkylating agents|mesh-ancestor
5905171|NCT02620579|Propranolol|propranolol|mesh-list
5866784|NCT02362165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5866785|NCT02362165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5866786|NCT02362165|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5866787|NCT02362165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5866788|NCT02362165|Antiemetics|antiemetics|mesh-ancestor
5866789|NCT02362165|Autonomic Agents|autonomic agents|mesh-ancestor
5866790|NCT02362165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5866791|NCT02362165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5866792|NCT02362165|Glucocorticoids|glucocorticoids|mesh-ancestor
5866793|NCT02362165|Hormones|hormones|mesh-ancestor
5679009|NCT03508726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679010|NCT03508726|Antioxidants|antioxidants|mesh-ancestor
5679011|NCT03508726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5679012|NCT03508726|Protective Agents|protective agents|mesh-ancestor
5679013|NCT03508713|Antirheumatic Agents|antirheumatic agents|mesh-list
5679014|NCT03508635|Prednisone|prednisone|mesh-list
5679015|NCT03508635|Cortisone|cortisone|mesh-list
5679016|NCT03508635|Mifepristone|mifepristone|mesh-list
5679017|NCT03508635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5679018|NCT03508635|Glucocorticoids|glucocorticoids|mesh-ancestor
5679019|NCT03508635|Hormones|hormones|mesh-ancestor
5679020|NCT03508635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5679021|NCT03508635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679022|NCT03508635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5679023|NCT03508635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5679024|NCT03508635|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5679025|NCT03508635|Abortifacient Agents|abortifacient agents|mesh-ancestor
5679026|NCT03508635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5679027|NCT03508635|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5679028|NCT03508635|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5679029|NCT03508635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5679030|NCT03508635|Contraceptive Agents|contraceptive agents|mesh-ancestor
5679031|NCT03508635|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5679032|NCT03508635|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5866794|NCT02362165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5866795|NCT02362165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5866796|NCT02362165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5866797|NCT02362165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5866798|NCT02362165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5866799|NCT02362165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5866800|NCT02362022|Morphine|morphine|mesh-list
5866801|NCT02362022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5866802|NCT02362022|Narcotics|narcotics|mesh-ancestor
5866803|NCT02362022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5866804|NCT02362022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866805|NCT02362022|Analgesics|analgesics|mesh-ancestor
5866806|NCT02362022|Sensory System Agents|sensory system agents|mesh-ancestor
5866807|NCT02362022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5866808|NCT02361931|Epoetin Alfa|epoetin alfa|mesh-list
5866809|NCT02361931|Hematinics|hematinics|mesh-ancestor
5866810|NCT02361892|Ulipristal acetate|ulipristal acetate|mesh-list
5866811|NCT02361892|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5866812|NCT02361892|Contraceptive Agents|contraceptive agents|mesh-ancestor
5866813|NCT02361892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5866814|NCT02361892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866815|NCT02361892|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5866816|NCT02361801|Dobutamine|dobutamine|mesh-list
5866817|NCT02361801|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5679033|NCT03508635|Hormone Antagonists|hormone antagonists|mesh-ancestor
5679034|NCT03508635|Luteolytic Agents|luteolytic agents|mesh-ancestor
5679035|NCT03508635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5679036|NCT03508635|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5679037|NCT03508440|Prednisone|prednisone|mesh-list
5679038|NCT03508440|Prednisolone|prednisolone|mesh-list
5679039|NCT03508440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5679040|NCT03508440|Glucocorticoids|glucocorticoids|mesh-ancestor
5679041|NCT03508440|Hormones|hormones|mesh-ancestor
5679042|NCT03508440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5679043|NCT03508440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679044|NCT03508440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5679045|NCT03508440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5696727|NCT03380975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5696728|NCT03380975|Respiratory System Agents|respiratory system agents|mesh-ancestor
5696729|NCT03380975|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5866818|NCT02361801|Sympathomimetics|sympathomimetics|mesh-ancestor
5866819|NCT02361801|Autonomic Agents|autonomic agents|mesh-ancestor
5866820|NCT02361801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5866821|NCT02361801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866822|NCT02361801|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5866823|NCT02361801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5866824|NCT02361801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5866825|NCT02361801|Adrenergic Agents|adrenergic agents|mesh-ancestor
5866826|NCT02361801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5866827|NCT02361801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5866828|NCT02361801|Protective Agents|protective agents|mesh-ancestor
5866829|NCT02361567|Acetaminophen|acetaminophen|mesh-list
5866830|NCT02361567|Oxycodone|oxycodone|mesh-list
5866831|NCT02361567|Tramadol|tramadol|mesh-list
5866832|NCT02361567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5866833|NCT02361567|Narcotics|narcotics|mesh-ancestor
5866834|NCT02361567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5866835|NCT02361567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866836|NCT02361567|Analgesics|analgesics|mesh-ancestor
5866837|NCT02361567|Sensory System Agents|sensory system agents|mesh-ancestor
5866838|NCT02361567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5866839|NCT02361567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5866840|NCT02361567|Antipyretics|antipyretics|mesh-ancestor
5866841|NCT02361879|Leuprolide|leuprolide|mesh-list
5866842|NCT02361879|Ulipristal acetate|ulipristal acetate|mesh-list
5866843|NCT02361879|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5866844|NCT02361879|Fertility Agents|fertility agents|mesh-ancestor
5866845|NCT02361879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5866846|NCT02361879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866847|NCT02361879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5866848|NCT02361879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5866849|NCT02361879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5866850|NCT02361879|Contraceptive Agents|contraceptive agents|mesh-ancestor
5866851|NCT02361879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5866852|NCT02361645|Ketorolac|ketorolac|mesh-list
5866853|NCT02361645|Indomethacin|indomethacin|mesh-list
5866854|NCT02361645|Nepafenac|nepafenac|mesh-list
5866855|NCT02361645|Bromfenac|bromfenac|mesh-list
5866856|NCT02361645|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5866857|NCT02361645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5866858|NCT02361645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5866859|NCT02361645|Analgesics|analgesics|mesh-ancestor
5866860|NCT02361645|Sensory System Agents|sensory system agents|mesh-ancestor
5866861|NCT02361645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6494810|NCT00620438|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6494811|NCT00620438|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6494812|NCT00620438|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6494813|NCT00620438|Antimalarials|antimalarials|mesh-ancestor
6494814|NCT00620438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5679046|NCT03508102|Remifentanil|remifentanil|mesh-list
5866862|NCT02361645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866863|NCT02361645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5866864|NCT02361645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5866865|NCT02361645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5866866|NCT02361645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5866867|NCT02361645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5866868|NCT02361645|Gout Suppressants|gout suppressants|mesh-ancestor
5679047|NCT03508102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5679048|NCT03508102|Narcotics|narcotics|mesh-ancestor
5679049|NCT03508102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5679050|NCT03508102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679051|NCT03508102|Analgesics|analgesics|mesh-ancestor
5866869|NCT02361645|Tocolytic Agents|tocolytic agents|mesh-ancestor
5866870|NCT02361645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5866871|NCT02361645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5866872|NCT02361502|Mirabegron|mirabegron|mesh-list
5866873|NCT02361502|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
5866874|NCT02361502|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5866875|NCT02361502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5866876|NCT02361502|Adrenergic Agents|adrenergic agents|mesh-ancestor
5866877|NCT02361502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5866878|NCT02361502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494815|NCT00620438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5679052|NCT03508102|Sensory System Agents|sensory system agents|mesh-ancestor
5679053|NCT03508102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5679054|NCT03507842|Cytarabine|cytarabine|mesh-list
5679055|NCT03507842|Daunorubicin|daunorubicin|mesh-list
5679056|NCT03507842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5679057|NCT03507842|Antimetabolites|antimetabolites|mesh-ancestor
5679058|NCT03507842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5679059|NCT03507842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5679060|NCT03507842|Antiviral Agents|antiviral agents|mesh-ancestor
5679061|NCT03507842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5679062|NCT03507842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5679063|NCT03507842|Immunologic Factors|immunologic factors|mesh-ancestor
5679064|NCT03507842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679065|NCT03507842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5866879|NCT02361502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866880|NCT02361502|Urological Agents|urological agents|mesh-ancestor
5866881|NCT02361905|Leuprolide|leuprolide|mesh-list
5866882|NCT02361905|Ulipristal acetate|ulipristal acetate|mesh-list
5866883|NCT02361905|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5866884|NCT02361905|Fertility Agents|fertility agents|mesh-ancestor
5866885|NCT02361905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5866886|NCT02361905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866887|NCT02361905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5866888|NCT02361905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5866889|NCT02361905|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5866890|NCT02361905|Contraceptive Agents|contraceptive agents|mesh-ancestor
5866891|NCT02361905|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5866892|NCT02361775|Ropivacaine|ropivacaine|mesh-list
5866893|NCT02361775|Anesthetics, Local|anesthetics, local|mesh-ancestor
5866894|NCT02361775|Anesthetics|anesthetics|mesh-ancestor
5866895|NCT02361775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5866896|NCT02361775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866897|NCT02361775|Sensory System Agents|sensory system agents|mesh-ancestor
5866898|NCT02361775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5866899|NCT02361749|Botulinum Toxins|botulinum toxins|mesh-list
5866900|NCT02361749|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5866901|NCT02361749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5866902|NCT02361749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5866903|NCT02361749|Cholinergic Agents|cholinergic agents|mesh-ancestor
5866904|NCT02361749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5679066|NCT03507842|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5679067|NCT03507842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5679068|NCT03507842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5679069|NCT03507829|Insulin|insulin|mesh-list
5679070|NCT03507829|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5679071|NCT03507829|Insulin Lispro|insulin lispro|mesh-list
5679072|NCT03507829|Isophane Insulin, Human|isophane insulin, human|mesh-list
5866905|NCT02361749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866906|NCT02361619|Clarithromycin|clarithromycin|mesh-list
5866907|NCT02361619|Diclofenac|diclofenac|mesh-list
5866908|NCT02361619|Metoprolol|metoprolol|mesh-list
5866909|NCT02361619|Midazolam|midazolam|mesh-list
5866910|NCT02361619|Caffeine|caffeine|mesh-list
5866911|NCT02361619|Esomeprazole|esomeprazole|mesh-list
5866912|NCT02361619|Dabigatran|dabigatran|mesh-list
5866913|NCT02361619|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5866914|NCT02361619|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5866915|NCT02361619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5866916|NCT02361619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866917|NCT02361619|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5866918|NCT02361619|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5866919|NCT02361619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5866920|NCT02361619|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5866921|NCT02361619|Anesthetics, General|anesthetics, general|mesh-ancestor
5866922|NCT02361619|Anesthetics|anesthetics|mesh-ancestor
5866923|NCT02361619|GABA Modulators|gaba modulators|mesh-ancestor
5866924|NCT02361619|GABA Agents|gaba agents|mesh-ancestor
5866925|NCT02361619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5866926|NCT02361619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5866927|NCT02361619|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5866928|NCT02361619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5866929|NCT02361619|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5866930|NCT02361619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5679073|NCT03507829|Insulin, Isophane|insulin, isophane|mesh-list
5679074|NCT03507829|Isophane insulin, beef|isophane insulin, beef|mesh-list
5679075|NCT03507829|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5679076|NCT03507829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679077|NCT03507751|Meropenem|meropenem|mesh-list
5679078|NCT03507751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5679079|NCT03507751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5679080|NCT03507699|Nivolumab|nivolumab|mesh-list
5866931|NCT02361619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5866932|NCT02361619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5866933|NCT02361619|Analgesics|analgesics|mesh-ancestor
5866934|NCT02361619|Sensory System Agents|sensory system agents|mesh-ancestor
5866935|NCT02361619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5866936|NCT02361619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5866937|NCT02361619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5866938|NCT02361619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5866939|NCT02361619|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5866940|NCT02361619|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5866941|NCT02361619|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5866942|NCT02361619|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5866943|NCT02361619|Purinergic Agents|purinergic agents|mesh-ancestor
5866944|NCT02361619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5866945|NCT02361619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5866946|NCT02361619|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5866947|NCT02361619|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5866948|NCT02361619|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5866949|NCT02361619|Antithrombins|antithrombins|mesh-ancestor
5866950|NCT02361619|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5866951|NCT02361619|Protease Inhibitors|protease inhibitors|mesh-ancestor
5866952|NCT02361619|Anticoagulants|anticoagulants|mesh-ancestor
5866953|NCT02361619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5866954|NCT02361619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5866955|NCT02361619|Sympatholytics|sympatholytics|mesh-ancestor
5679081|NCT03507699|Ipilimumab|ipilimumab|mesh-list
5679082|NCT03507699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5679083|NCT03507699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5679084|NCT03507699|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5679085|NCT03507699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5866956|NCT02361619|Autonomic Agents|autonomic agents|mesh-ancestor
5866957|NCT02361619|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5866958|NCT02361619|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5866959|NCT02361619|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5866960|NCT02361619|Adrenergic Agents|adrenergic agents|mesh-ancestor
5866961|NCT02361528|Sargramostim|sargramostim|mesh-list
5866962|NCT02361528|Immunologic Factors|immunologic factors|mesh-ancestor
5679086|NCT03507634|Lidocaine|lidocaine|mesh-list
5679087|NCT03507634|Fentanyl|fentanyl|mesh-list
5679088|NCT03507634|Dexmedetomidine|dexmedetomidine|mesh-list
5679089|NCT03507634|Remifentanil|remifentanil|mesh-list
5679090|NCT03507634|Analgesics, Opioid|analgesics, opioid|mesh-list
5679091|NCT03507634|Anesthetics|anesthetics|mesh-list
5679092|NCT03507634|Anesthetics, Local|anesthetics, local|mesh-ancestor
5679093|NCT03507634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5679094|NCT03507634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679095|NCT03507634|Sensory System Agents|sensory system agents|mesh-ancestor
5679096|NCT03507634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5679097|NCT03507634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5679098|NCT03507634|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5679099|NCT03507634|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5679100|NCT03507634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5679101|NCT03507634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5679102|NCT03507634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5679103|NCT03507634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5679104|NCT03507634|Analgesics|analgesics|mesh-ancestor
5679105|NCT03507634|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5679106|NCT03507634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5679107|NCT03507634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5679108|NCT03507634|Adrenergic Agents|adrenergic agents|mesh-ancestor
5679109|NCT03507634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5679110|NCT03507634|Narcotics|narcotics|mesh-ancestor
5679111|NCT03507634|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5679112|NCT03507634|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5679113|NCT03507634|Anesthetics, General|anesthetics, general|mesh-ancestor
5679114|NCT03507608|Flutamide|flutamide|mesh-list
5679115|NCT03507608|Androgen Antagonists|androgen antagonists|mesh-ancestor
5679116|NCT03507608|Hormone Antagonists|hormone antagonists|mesh-ancestor
5679117|NCT03507608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5679118|NCT03507608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679119|NCT03507608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5679120|NCT03507608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5679121|NCT03507556|Metronidazole|metronidazole|mesh-list
5679122|NCT03507556|Ciprofloxacin|ciprofloxacin|mesh-list
5866963|NCT02361528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905172|NCT02620579|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5905173|NCT02620579|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5905174|NCT02620579|Adrenergic Agents|adrenergic agents|mesh-ancestor
5905175|NCT02620579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5905176|NCT02620579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905177|NCT02620579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905178|NCT02620579|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5905179|NCT02620579|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5905180|NCT02620579|Vasodilator Agents|vasodilator agents|mesh-ancestor
5905181|NCT02598661|Imetelstat|imetelstat|mesh-list
5905182|NCT02598661|Motesanib diphosphate|motesanib diphosphate|mesh-list
5905183|NCT02598661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5905184|NCT02598661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905185|NCT02598661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5905186|NCT02535338|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5905187|NCT02535338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5905188|NCT02535338|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5905189|NCT02535338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5905190|NCT02535338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905191|NCT02420314|Ascorbic Acid|ascorbic acid|mesh-list
5905192|NCT02420314|Paclitaxel|paclitaxel|mesh-list
5905193|NCT02420314|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5905194|NCT02420314|Carboplatin|carboplatin|mesh-list
5679123|NCT03507556|Minocycline|minocycline|mesh-list
5679124|NCT03507556|Zinc Oxide|zinc oxide|mesh-list
5679125|NCT03507556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5679126|NCT03507556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5905195|NCT02420314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5905196|NCT02420314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5905197|NCT02420314|Tubulin Modulators|tubulin modulators|mesh-ancestor
5905198|NCT02420314|Antimitotic Agents|antimitotic agents|mesh-ancestor
5905199|NCT02420314|Mitosis Modulators|mitosis modulators|mesh-ancestor
5905200|NCT02420314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905201|NCT02420314|Vitamins|vitamins|mesh-ancestor
5679127|NCT03507556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5679128|NCT03507556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5679129|NCT03507556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5679130|NCT03507556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5679131|NCT03507556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5905202|NCT02420314|Micronutrients|micronutrients|mesh-ancestor
5905203|NCT02420314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905204|NCT02420314|Antioxidants|antioxidants|mesh-ancestor
5905205|NCT02420314|Protective Agents|protective agents|mesh-ancestor
5905206|NCT02370589|Vaccines|vaccines|mesh-list
5679132|NCT03507556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5679133|NCT03507556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5679134|NCT03507556|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5679135|NCT03507556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5679136|NCT03507556|Dermatologic Agents|dermatologic agents|mesh-ancestor
5679137|NCT03507556|Sunscreening Agents|sunscreening agents|mesh-ancestor
5679138|NCT03507556|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5679139|NCT03507556|Protective Agents|protective agents|mesh-ancestor
5679140|NCT03507556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679141|NCT03507465|Capecitabine|capecitabine|mesh-list
5679142|NCT03507465|Letrozole|letrozole|mesh-list
5905207|NCT02370589|Immunologic Factors|immunologic factors|mesh-ancestor
5905208|NCT02370589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905209|NCT02313194|Buspirone|buspirone|mesh-list
5905210|NCT02313194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5905211|NCT02313194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5905212|NCT02313194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5905213|NCT02313194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905214|NCT02313194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5905215|NCT02313194|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5905216|NCT02313194|Serotonin Agents|serotonin agents|mesh-ancestor
5905217|NCT02313194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5905218|NCT02313194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905219|NCT02100956|Oxytocin|oxytocin|mesh-list
5905220|NCT02100956|Oxytocics|oxytocics|mesh-ancestor
5905221|NCT02100956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5905222|NCT02100956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905223|NCT01752049|Timolol|timolol|mesh-list
5905224|NCT01752049|Maleic acid|maleic acid|mesh-list
5905225|NCT01752049|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5905226|NCT01752049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5866964|NCT02361190|Methyltestosterone|methyltestosterone|mesh-list
5866965|NCT02361190|Testosterone|testosterone|mesh-list
5866966|NCT02361190|Testosterone undecanoate|testosterone undecanoate|mesh-list
5866967|NCT02361190|Testosterone enanthate|testosterone enanthate|mesh-list
5866968|NCT02361190|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5866969|NCT02361190|Androgens|androgens|mesh-ancestor
5866970|NCT02361190|Hormones|hormones|mesh-ancestor
5866971|NCT02361190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5866972|NCT02361190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866973|NCT02361190|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5866974|NCT02361190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5866975|NCT02361190|Anabolic Agents|anabolic agents|mesh-ancestor
5866976|NCT02361112|Capecitabine|capecitabine|mesh-list
5866977|NCT02361112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5866978|NCT02361112|Antimetabolites|antimetabolites|mesh-ancestor
5866979|NCT02361112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5866980|NCT02361112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5866981|NCT02361177|Oxytocin|oxytocin|mesh-list
5866982|NCT02361177|Oxytocics|oxytocics|mesh-ancestor
5866983|NCT02361177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5866984|NCT02361177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5866985|NCT02360956|Olmesartan|olmesartan|mesh-list
5866986|NCT02360956|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
5866987|NCT02360956|Antihypertensive Agents|antihypertensive agents|mesh-list
5866988|NCT02360956|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5866989|NCT02360956|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5679143|NCT03507465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5679144|NCT03507465|Antimetabolites|antimetabolites|mesh-ancestor
5679145|NCT03507465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5679146|NCT03507465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5679147|NCT03507465|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5679148|NCT03507465|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5679149|NCT03507465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5679150|NCT03507465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5679151|NCT03507465|Hormone Antagonists|hormone antagonists|mesh-ancestor
5679152|NCT03507465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5679153|NCT03507465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679154|NCT03507426|Ketamine|ketamine|mesh-list
5679155|NCT03507426|Analgesics|analgesics|mesh-ancestor
5679156|NCT03507426|Sensory System Agents|sensory system agents|mesh-ancestor
5679157|NCT03507426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5679158|NCT03507426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679159|NCT03507426|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5679160|NCT03507426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5679161|NCT03507426|Anesthetics, General|anesthetics, general|mesh-ancestor
5866990|NCT02360956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5866991|NCT02360800|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
5866992|NCT02360800|Hemostatics|hemostatics|mesh-list
5866993|NCT02360800|Coagulants|coagulants|mesh-ancestor
5866994|NCT02360826|Simvastatin|simvastatin|mesh-list
5866995|NCT02360826|Pravastatin|pravastatin|mesh-list
6494816|NCT00620477|Levobupivacaine|levobupivacaine|mesh-list
6494817|NCT00620477|Anesthetics, Local|anesthetics, local|mesh-ancestor
6494818|NCT00620477|Anesthetics|anesthetics|mesh-ancestor
6494819|NCT00620477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6494820|NCT00620477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496473|NCT00628225|Nicotine|nicotine|mesh-list
5679162|NCT03507426|Anesthetics|anesthetics|mesh-ancestor
5679163|NCT03507426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5679164|NCT03507426|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5679165|NCT03507426|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5679166|NCT03507426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5679167|NCT03507426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5679168|NCT03507413|Metformin|metformin|mesh-list
5679169|NCT03507413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5679170|NCT03507413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679171|NCT03507387|Phenylephrine|phenylephrine|mesh-list
5679172|NCT03507387|Oxymetazoline|oxymetazoline|mesh-list
5679173|NCT03507387|Bupivacaine|bupivacaine|mesh-list
5679174|NCT03507387|Anesthetics, Local|anesthetics, local|mesh-ancestor
5679175|NCT03507387|Anesthetics|anesthetics|mesh-ancestor
5679176|NCT03507387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5679177|NCT03507387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679178|NCT03507387|Sensory System Agents|sensory system agents|mesh-ancestor
5696730|NCT03380975|Hormone Antagonists|hormone antagonists|mesh-ancestor
6494821|NCT00620477|Sensory System Agents|sensory system agents|mesh-ancestor
6494822|NCT00620477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6494823|NCT00620490|Ropivacaine|ropivacaine|mesh-list
5679179|NCT03507387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5679180|NCT03507387|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5679181|NCT03507387|Mydriatics|mydriatics|mesh-ancestor
5679182|NCT03507387|Autonomic Agents|autonomic agents|mesh-ancestor
5679183|NCT03507387|Sympathomimetics|sympathomimetics|mesh-ancestor
5679184|NCT03507387|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5679185|NCT03507387|Nasal Decongestants|nasal decongestants|mesh-ancestor
6494824|NCT00620490|Anesthetics, Local|anesthetics, local|mesh-ancestor
6494825|NCT00620490|Anesthetics|anesthetics|mesh-ancestor
6494826|NCT00620490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6494827|NCT00620490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494828|NCT00620490|Sensory System Agents|sensory system agents|mesh-ancestor
6494829|NCT00620490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5866996|NCT02360826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5866997|NCT02360826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5866998|NCT02360826|Antimetabolites|antimetabolites|mesh-ancestor
5866999|NCT02360826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867000|NCT02360826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5867001|NCT02360826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5867002|NCT02360826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5867003|NCT02361060|Atropine|atropine|mesh-list
5867004|NCT02361060|Neostigmine|neostigmine|mesh-list
5867005|NCT02361060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5867006|NCT02361060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5867007|NCT02361060|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5867008|NCT02361060|Autonomic Agents|autonomic agents|mesh-ancestor
5867009|NCT02361060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5867010|NCT02361060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867011|NCT02361060|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5867012|NCT02361060|Respiratory System Agents|respiratory system agents|mesh-ancestor
5679186|NCT03507387|Respiratory System Agents|respiratory system agents|mesh-ancestor
5679187|NCT03507387|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5679188|NCT03507387|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5679189|NCT03507387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5679190|NCT03507387|Adrenergic Agents|adrenergic agents|mesh-ancestor
5679191|NCT03507387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5679192|NCT03507387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5679193|NCT03507387|Protective Agents|protective agents|mesh-ancestor
5679194|NCT03507348|Rituximab|rituximab|mesh-list
5679195|NCT03507348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5679196|NCT03507348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5867013|NCT02361060|Mydriatics|mydriatics|mesh-ancestor
5867014|NCT02361060|Parasympatholytics|parasympatholytics|mesh-ancestor
5867015|NCT02361060|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5867016|NCT02361060|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5867017|NCT02361060|Cholinergic Agents|cholinergic agents|mesh-ancestor
5867018|NCT02361060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5867019|NCT02361060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867020|NCT02361060|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5867021|NCT02361060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5867022|NCT02361060|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5867023|NCT02360982|Fentanyl|fentanyl|mesh-list
5867024|NCT02360982|Propofol|propofol|mesh-list
5867025|NCT02360982|Bupivacaine|bupivacaine|mesh-list
5867026|NCT02360982|Rocuronium|rocuronium|mesh-list
5867027|NCT02360982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5679197|NCT03507348|Immunologic Factors|immunologic factors|mesh-ancestor
5679198|NCT03507348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679199|NCT03507348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5679200|NCT03507257|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5679201|NCT03507257|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5679202|NCT03507257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5679203|NCT03507244|Dexamethasone|dexamethasone|mesh-list
5679204|NCT03507244|Pemetrexed|pemetrexed|mesh-list
5679205|NCT03507244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5679206|NCT03507244|Antiemetics|antiemetics|mesh-ancestor
5867028|NCT02360982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5867029|NCT02360982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867030|NCT02360982|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5867031|NCT02360982|Anesthetics, General|anesthetics, general|mesh-ancestor
5867032|NCT02360982|Anesthetics|anesthetics|mesh-ancestor
5867033|NCT02360982|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5679207|NCT03507244|Autonomic Agents|autonomic agents|mesh-ancestor
5867034|NCT02360982|Narcotics|narcotics|mesh-ancestor
5867035|NCT02360982|Analgesics|analgesics|mesh-ancestor
5867036|NCT02360982|Sensory System Agents|sensory system agents|mesh-ancestor
5867037|NCT02360982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5867038|NCT02360982|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5867039|NCT02360982|Anesthetics, Local|anesthetics, local|mesh-ancestor
5867040|NCT02360982|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5867041|NCT02360982|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5867042|NCT02360982|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5867043|NCT02360709|Sirolimus|sirolimus|mesh-list
5867044|NCT02360709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5867045|NCT02360709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5867046|NCT02360709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5867047|NCT02360709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5867048|NCT02360709|Antifungal Agents|antifungal agents|mesh-ancestor
5867049|NCT02360709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5867050|NCT02360709|Immunologic Factors|immunologic factors|mesh-ancestor
5867051|NCT02360709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867052|NCT02360644|Vitamin D|vitamin d|mesh-list
5867053|NCT02360644|Cholecalciferol|cholecalciferol|mesh-list
5867054|NCT02360644|Vitamins|vitamins|mesh-ancestor
5867055|NCT02360644|Micronutrients|micronutrients|mesh-ancestor
5867056|NCT02360644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867057|NCT02360644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5867058|NCT02360644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5867059|NCT02360501|Docetaxel|docetaxel|mesh-list
5867060|NCT02360501|Capecitabine|capecitabine|mesh-list
5867061|NCT02360501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5867062|NCT02360501|Tubulin Modulators|tubulin modulators|mesh-ancestor
5867063|NCT02360501|Antimitotic Agents|antimitotic agents|mesh-ancestor
5867064|NCT02360501|Mitosis Modulators|mitosis modulators|mesh-ancestor
5867065|NCT02360501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867066|NCT02360501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5867067|NCT02360501|Antimetabolites|antimetabolites|mesh-ancestor
5867068|NCT02360618|Metformin|metformin|mesh-list
5867069|NCT02360618|Simvastatin|simvastatin|mesh-list
5867070|NCT02360618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5867071|NCT02360618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867072|NCT02360618|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5867073|NCT02360618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5867074|NCT02360618|Antimetabolites|antimetabolites|mesh-ancestor
5867075|NCT02360618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867076|NCT02360618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5867077|NCT02360618|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5867078|NCT02360618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5679208|NCT03507244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5679209|NCT03507244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679210|NCT03507244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5867079|NCT02360423|Sirolimus|sirolimus|mesh-list
5867080|NCT02360423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5867081|NCT02360423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5867082|NCT02360423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5867083|NCT02360423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5867084|NCT02360423|Antifungal Agents|antifungal agents|mesh-ancestor
5867085|NCT02360423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5867086|NCT02360423|Immunologic Factors|immunologic factors|mesh-ancestor
5867087|NCT02360423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867088|NCT02360592|Interferons|interferons|mesh-list
5867089|NCT02360592|Interferon-alpha|interferon-alpha|mesh-list
5867090|NCT02360592|Interferon alpha-2|interferon alpha-2|mesh-list
5867091|NCT02360592|Entecavir|entecavir|mesh-list
5867092|NCT02360592|Interleukin-2|interleukin-2|mesh-list
5867093|NCT02360592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5867094|NCT02360592|Antiviral Agents|antiviral agents|mesh-ancestor
5867095|NCT02360592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5867096|NCT02360592|Immunologic Factors|immunologic factors|mesh-ancestor
5867097|NCT02360592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867098|NCT02360592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5867099|NCT02360592|Analgesics|analgesics|mesh-ancestor
5679211|NCT03507244|Glucocorticoids|glucocorticoids|mesh-ancestor
5679212|NCT03507244|Hormones|hormones|mesh-ancestor
5679213|NCT03507244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5679214|NCT03507244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5679215|NCT03507244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5679216|NCT03507244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5698043|NCT03371849|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5867100|NCT02360592|Sensory System Agents|sensory system agents|mesh-ancestor
5905227|NCT01752049|Adrenergic Agents|adrenergic agents|mesh-ancestor
5679217|NCT03507244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5679218|NCT03507244|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5679219|NCT03507244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5679220|NCT03507231|Vaccines|vaccines|mesh-list
5679221|NCT03507231|Immunologic Factors|immunologic factors|mesh-ancestor
5679222|NCT03507231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679223|NCT03507166|Trastuzumab|trastuzumab|mesh-list
5679224|NCT03507166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5867101|NCT02360592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5867102|NCT02360384|Linaclotide|linaclotide|mesh-list
5867103|NCT02360384|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
5867104|NCT02360384|Enzyme Activators|enzyme activators|mesh-ancestor
5867105|NCT02360384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867106|NCT02360384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5867107|NCT02360202|Clobetasol|clobetasol|mesh-list
5867108|NCT02360202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5867109|NCT02360202|Glucocorticoids|glucocorticoids|mesh-ancestor
5867110|NCT02360202|Hormones|hormones|mesh-ancestor
5867111|NCT02360202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5679225|NCT03507166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5679226|NCT03507127|Varenicline|varenicline|mesh-list
5679227|NCT03507127|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5679228|NCT03507127|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5679229|NCT03507127|Cholinergic Agents|cholinergic agents|mesh-ancestor
5679230|NCT03507127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5679231|NCT03507127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5679232|NCT03507127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679233|NCT03507062|Plasma-lyte 148|plasma-lyte 148|mesh-list
5679234|NCT03507062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5679235|NCT03507062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5679236|NCT03506997|Pembrolizumab|pembrolizumab|mesh-list
5679237|NCT03506997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5679238|NCT03506997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5679239|NCT03506919|Allopurinol|allopurinol|mesh-list
5679240|NCT03506919|Antimetabolites|antimetabolites|mesh-ancestor
5867112|NCT02360202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867113|NCT02360046|Hydrocortisone|hydrocortisone|mesh-list
5867114|NCT02360046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5867115|NCT02360254|Insulin|insulin|mesh-list
5867116|NCT02360254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5867117|NCT02360254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867118|NCT02360007|Buprenorphine|buprenorphine|mesh-list
5867119|NCT02360007|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5867120|NCT02360007|Narcotics|narcotics|mesh-ancestor
5679241|NCT03506919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5679242|NCT03506919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5679243|NCT03506919|Gout Suppressants|gout suppressants|mesh-ancestor
5679244|NCT03506919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5679245|NCT03506919|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5679246|NCT03506919|Antioxidants|antioxidants|mesh-ancestor
5679247|NCT03506919|Protective Agents|protective agents|mesh-ancestor
5679248|NCT03506919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696731|NCT03380975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5696732|NCT03380975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696733|NCT03380975|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5696734|NCT03380975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5867121|NCT02360007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5867122|NCT02360007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867123|NCT02360007|Analgesics|analgesics|mesh-ancestor
5867124|NCT02360007|Sensory System Agents|sensory system agents|mesh-ancestor
5867125|NCT02360007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5867126|NCT02360007|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5867127|NCT02359942|Citric Acid|citric acid|mesh-list
5867128|NCT02359942|Sodium Citrate|sodium citrate|mesh-list
5867129|NCT02359942|Anticoagulants|anticoagulants|mesh-ancestor
5867130|NCT02359942|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5867131|NCT02359942|Chelating Agents|chelating agents|mesh-ancestor
5867132|NCT02359942|Sequestering Agents|sequestering agents|mesh-ancestor
5867133|NCT02359942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905228|NCT01752049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5905229|NCT01752049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905230|NCT01752049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905231|NCT01752049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5905232|NCT01752049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5867134|NCT02359604|Esomeprazole|esomeprazole|mesh-list
5867135|NCT02359604|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5867136|NCT02359604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5867137|NCT02359604|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5867138|NCT02359604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5867139|NCT02359604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867140|NCT02359695|Hormones|hormones|mesh-list
5867141|NCT02359695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5867142|NCT02359695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867143|NCT02359643|Aspirin|aspirin|mesh-list
5867144|NCT02359643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5679249|NCT03506841|Cerebrolysin|cerebrolysin|mesh-list
5679250|NCT03506841|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5679251|NCT03506841|Protective Agents|protective agents|mesh-ancestor
5679252|NCT03506841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679253|NCT03506841|Nootropic Agents|nootropic agents|mesh-ancestor
5867145|NCT02359643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5867146|NCT02359643|Analgesics|analgesics|mesh-ancestor
5867147|NCT02359643|Sensory System Agents|sensory system agents|mesh-ancestor
5867148|NCT02359643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5867149|NCT02359643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867150|NCT02359643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5867151|NCT02359643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5867152|NCT02359643|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5867153|NCT02359643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5867154|NCT02359643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867155|NCT02359643|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5867156|NCT02359643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5867157|NCT02359643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5867158|NCT02359643|Antipyretics|antipyretics|mesh-ancestor
5867159|NCT02359721|Clarithromycin|clarithromycin|mesh-list
5679254|NCT03506828|Phenol|phenol|mesh-list
5679255|NCT03506828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5679256|NCT03506828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5679257|NCT03506828|Disinfectants|disinfectants|mesh-ancestor
5679258|NCT03506828|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
5679259|NCT03506828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5679260|NCT03506815|Rivaroxaban|rivaroxaban|mesh-list
5679261|NCT03506815|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5679262|NCT03506815|Antithrombins|antithrombins|mesh-ancestor
5867160|NCT02359721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5867161|NCT02359721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6494830|NCT00620581|Paroxetine|paroxetine|mesh-list
5679263|NCT03506815|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5679264|NCT03506815|Protease Inhibitors|protease inhibitors|mesh-ancestor
5679265|NCT03506815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5679266|NCT03506815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5679267|NCT03506815|Anticoagulants|anticoagulants|mesh-ancestor
5679268|NCT03506802|Aldesleukin|aldesleukin|mesh-list
5679269|NCT03506802|Plerixafor|plerixafor|mesh-list
5679270|NCT03506802|Lenalidomide|lenalidomide|mesh-list
5679271|NCT03506802|Melphalan|melphalan|mesh-list
5679272|NCT03506802|Interleukin-2|interleukin-2|mesh-list
5679273|NCT03506802|Mechlorethamine|mechlorethamine|mesh-list
5679274|NCT03506802|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
5679275|NCT03506802|Lenograstim|lenograstim|mesh-list
5679276|NCT03506802|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5679277|NCT03506802|Immunologic Factors|immunologic factors|mesh-ancestor
5679278|NCT03506802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679279|NCT03506802|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5679280|NCT03506802|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5679281|NCT03506802|Growth Substances|growth substances|mesh-ancestor
5679282|NCT03506802|Growth Inhibitors|growth inhibitors|mesh-ancestor
5679283|NCT03506802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5679284|NCT03506802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5679285|NCT03506802|Alkylating Agents|alkylating agents|mesh-ancestor
6494831|NCT00620581|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6494832|NCT00620581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6494833|NCT00620581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6494834|NCT00620581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494835|NCT00620581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6494836|NCT00620581|Serotonin Agents|serotonin agents|mesh-ancestor
6494837|NCT00620581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494838|NCT00620581|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5679286|NCT03506802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5679287|NCT03506802|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6494839|NCT00620581|Antidepressive Agents|antidepressive agents|mesh-ancestor
6494840|NCT00620581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6494841|NCT00620581|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6494842|NCT00620581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6494843|NCT00620581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6494844|NCT00620594|Dactolisib|dactolisib|mesh-list
6494845|NCT00620594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6494846|NCT00620620|Zaleplon|zaleplon|mesh-list
6494847|NCT00620620|Anticonvulsants|anticonvulsants|mesh-ancestor
6494848|NCT00620620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6494849|NCT00620620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6494850|NCT00620620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494851|NCT00620620|GABA Modulators|gaba modulators|mesh-ancestor
6494852|NCT00620620|GABA Agents|gaba agents|mesh-ancestor
6494853|NCT00620620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6494854|NCT00620620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494855|NCT00620646|Aspirin|aspirin|mesh-list
6494856|NCT00620646|Cilostazol|cilostazol|mesh-list
6494857|NCT00620646|Clopidogrel|clopidogrel|mesh-list
6494858|NCT00620646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6494859|NCT00620646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6494860|NCT00620646|Analgesics|analgesics|mesh-ancestor
6494861|NCT00620646|Sensory System Agents|sensory system agents|mesh-ancestor
5679288|NCT03506802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5679289|NCT03506802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5679290|NCT03506802|Analgesics|analgesics|mesh-ancestor
5679291|NCT03506802|Sensory System Agents|sensory system agents|mesh-ancestor
5867162|NCT02359721|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5867163|NCT02359721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5867164|NCT02359721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867165|NCT02359721|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5867166|NCT02359721|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5867167|NCT02359617|Insulin|insulin|mesh-list
5867168|NCT02359617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5867169|NCT02359617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867170|NCT02359292|Charcoal|charcoal|mesh-list
5867171|NCT02359292|Antidotes|antidotes|mesh-ancestor
5867172|NCT02359292|Protective Agents|protective agents|mesh-ancestor
5867173|NCT02359292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867174|NCT02359214|Vitamin D|vitamin d|mesh-list
5679292|NCT03506802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5679293|NCT03506802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5679294|NCT03506802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5679295|NCT03506802|Antiviral Agents|antiviral agents|mesh-ancestor
5679296|NCT03506802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5679297|NCT03506789|Dexamethasone|dexamethasone|mesh-list
5679298|NCT03506789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5679299|NCT03506789|Antiemetics|antiemetics|mesh-ancestor
5867175|NCT02359214|Cholecalciferol|cholecalciferol|mesh-list
5867176|NCT02359214|Vitamins|vitamins|mesh-ancestor
5867177|NCT02359214|Micronutrients|micronutrients|mesh-ancestor
5867178|NCT02359214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867179|NCT02359214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5867180|NCT02359214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5867181|NCT02359370|Lidocaine|lidocaine|mesh-list
5867182|NCT02359370|Magnesium Sulfate|magnesium sulfate|mesh-list
5867183|NCT02359370|Anesthetics, Local|anesthetics, local|mesh-ancestor
5867184|NCT02359370|Anesthetics|anesthetics|mesh-ancestor
5867185|NCT02359370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5867186|NCT02359370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679300|NCT03506789|Autonomic Agents|autonomic agents|mesh-ancestor
5679301|NCT03506789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6212328|NCT02186665|Vitamins|vitamins|mesh-ancestor
6212329|NCT02186665|Micronutrients|micronutrients|mesh-ancestor
6212330|NCT02186665|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6212331|NCT02186821|Ceritinib|ceritinib|mesh-list
6212332|NCT02186821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6212333|NCT02186821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6212334|NCT02186821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6212335|NCT02186821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5679302|NCT03506789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679303|NCT03506789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5679304|NCT03506789|Glucocorticoids|glucocorticoids|mesh-ancestor
5679305|NCT03506789|Hormones|hormones|mesh-ancestor
5679306|NCT03506789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5867187|NCT02359370|Sensory System Agents|sensory system agents|mesh-ancestor
6496518|NCT00628316|Caffeine|caffeine|mesh-list
5679307|NCT03506789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5679308|NCT03506789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5679309|NCT03506763|Diclofenac|diclofenac|mesh-list
5679310|NCT03506763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5679311|NCT03506763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5679312|NCT03506763|Analgesics|analgesics|mesh-ancestor
5679313|NCT03506763|Sensory System Agents|sensory system agents|mesh-ancestor
5679314|NCT03506763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5867188|NCT02359370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5867189|NCT02359370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5867190|NCT02359370|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5867191|NCT02359370|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5867192|NCT02359370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5867193|NCT02359370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867194|NCT02359370|Analgesics|analgesics|mesh-ancestor
6494862|NCT00620646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6494863|NCT00620646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494864|NCT00620646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6494865|NCT00620646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6494866|NCT00620646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6494867|NCT00620646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6494868|NCT00620646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494869|NCT00620646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5679315|NCT03506763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867195|NCT02359370|Anticonvulsants|anticonvulsants|mesh-ancestor
5867196|NCT02359370|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5867197|NCT02359370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5867198|NCT02359370|Tocolytic Agents|tocolytic agents|mesh-ancestor
5867199|NCT02359370|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5867200|NCT02359448|Melatonin|melatonin|mesh-list
5867201|NCT02359448|Antioxidants|antioxidants|mesh-ancestor
5867202|NCT02359448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867203|NCT02359448|Protective Agents|protective agents|mesh-ancestor
5867204|NCT02359448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867205|NCT02359448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5867206|NCT02359526|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
5867207|NCT02359526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5867208|NCT02359526|Glucocorticoids|glucocorticoids|mesh-ancestor
5867209|NCT02359526|Hormones|hormones|mesh-ancestor
5867210|NCT02359526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5867211|NCT02359526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867212|NCT02359331|Amoxicillin|amoxicillin|mesh-list
5867213|NCT02359331|Moxifloxacin|moxifloxacin|mesh-list
5867214|NCT02359331|Metronidazole|metronidazole|mesh-list
5867215|NCT02359331|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5867216|NCT02359331|Tetracycline|tetracycline|mesh-list
5867217|NCT02359331|Anti-Infective Agents|anti-infective agents|mesh-list
5867218|NCT02359331|Bismuth|bismuth|mesh-list
5867219|NCT02359331|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
5867220|NCT02359331|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5867221|NCT02359331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5867222|NCT02359331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5867223|NCT02359331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867224|NCT02359331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5867225|NCT02359331|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5867226|NCT02359331|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5867227|NCT02359331|Antacids|antacids|mesh-ancestor
5867228|NCT02359331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5867229|NCT02359331|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5867230|NCT02359266|Vitamin D|vitamin d|mesh-list
5867231|NCT02359266|Cholecalciferol|cholecalciferol|mesh-list
5867232|NCT02359266|Vitamins|vitamins|mesh-ancestor
5867233|NCT02359266|Micronutrients|micronutrients|mesh-ancestor
5867234|NCT02359266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867235|NCT02359266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5867236|NCT02359266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5867237|NCT02359149|Endothelial Growth Factors|endothelial growth factors|mesh-list
5679316|NCT03506763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5679317|NCT03506763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5679318|NCT03506763|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5679319|NCT03506763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5679320|NCT03506763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5679321|NCT03506620|Ropivacaine|ropivacaine|mesh-list
5867238|NCT02359149|Growth Substances|growth substances|mesh-ancestor
5867239|NCT02359149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679322|NCT03506620|Anesthetics, Local|anesthetics, local|mesh-ancestor
5679323|NCT03506620|Anesthetics|anesthetics|mesh-ancestor
5679324|NCT03506620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5679325|NCT03506620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679326|NCT03506620|Sensory System Agents|sensory system agents|mesh-ancestor
5867240|NCT02359500|Octreotide|octreotide|mesh-list
5867241|NCT02359500|Edotreotide|edotreotide|mesh-list
5867242|NCT02359500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5867243|NCT02359500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5867244|NCT02359500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5867245|NCT02359500|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5867246|NCT02359500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867247|NCT02359474|Trabectedin|trabectedin|mesh-list
5679327|NCT03506620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5679328|NCT03506542|Mitomycins|mitomycins|mesh-list
5679329|NCT03506542|Mitomycin|mitomycin|mesh-list
5679330|NCT03506542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5679331|NCT03506542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5867248|NCT02359474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5867249|NCT02359474|Alkylating Agents|alkylating agents|mesh-ancestor
5867250|NCT02359474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867251|NCT02359474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5867252|NCT02358824|Amlodipine|amlodipine|mesh-list
5867253|NCT02358824|Telmisartan|telmisartan|mesh-list
5867254|NCT02358824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5867255|NCT02358824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5867256|NCT02358824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5867257|NCT02358824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867258|NCT02358824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5679332|NCT03506542|Alkylating Agents|alkylating agents|mesh-ancestor
5679333|NCT03506542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5679334|NCT03506542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5679335|NCT03506542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5679336|NCT03506516|Ethanol|ethanol|mesh-list
5679337|NCT03506516|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5679338|NCT03506516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5679339|NCT03506516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5867259|NCT02358824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867260|NCT02358824|Vasodilator Agents|vasodilator agents|mesh-ancestor
5867261|NCT02358824|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5867262|NCT02358824|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5679340|NCT03506516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679341|NCT03506399|Levonorgestrel|levonorgestrel|mesh-list
5679342|NCT03506399|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5679343|NCT03506399|Contraceptive Agents|contraceptive agents|mesh-list
5679344|NCT03506399|Contraceptives, Oral|contraceptives, oral|mesh-list
5679345|NCT03506399|Estradiol|estradiol|mesh-list
5679346|NCT03506399|Estrogens|estrogens|mesh-ancestor
5679347|NCT03506399|Hormones|hormones|mesh-ancestor
5679348|NCT03506399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5679349|NCT03506399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679350|NCT03506399|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5679351|NCT03506399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5679352|NCT03506399|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5679353|NCT03506399|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5679354|NCT03506399|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5679355|NCT03506373|Ixazomib|ixazomib|mesh-list
5679356|NCT03506373|Glycine|glycine|mesh-list
5679357|NCT03506373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5679358|NCT03506373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5679359|NCT03506373|Protease Inhibitors|protease inhibitors|mesh-ancestor
5679360|NCT03506373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5679361|NCT03506373|Glycine Agents|glycine agents|mesh-ancestor
5867263|NCT02358993|Ciprofloxacin|ciprofloxacin|mesh-list
5867264|NCT02358993|Methenamine hippurate|methenamine hippurate|mesh-list
5867265|NCT02358993|Methenamine mandelate|methenamine mandelate|mesh-list
5867266|NCT02358993|Methenamine|methenamine|mesh-list
5867267|NCT02358993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5867268|NCT02358993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5867269|NCT02358993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5867270|NCT02358993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5867271|NCT02358993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5679362|NCT03506373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5867272|NCT02358993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867273|NCT02358993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5867274|NCT02358993|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5867275|NCT02358993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5867276|NCT02358993|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5867277|NCT02358993|Renal Agents|renal agents|mesh-ancestor
5867278|NCT02358850|Acetaminophen|acetaminophen|mesh-list
5867279|NCT02358850|Oxycodone|oxycodone|mesh-list
5867280|NCT02358850|Hydromorphone|hydromorphone|mesh-list
5867281|NCT02358850|Hydrocodone|hydrocodone|mesh-list
5867282|NCT02358850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5867283|NCT02358850|Analgesics|analgesics|mesh-ancestor
5867284|NCT02358850|Sensory System Agents|sensory system agents|mesh-ancestor
5867285|NCT02358850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5867286|NCT02358850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867287|NCT02358850|Antipyretics|antipyretics|mesh-ancestor
5867288|NCT02358850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5867289|NCT02358850|Narcotics|narcotics|mesh-ancestor
5867290|NCT02358850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5867291|NCT02358850|Antitussive Agents|antitussive agents|mesh-ancestor
5867292|NCT02358850|Respiratory System Agents|respiratory system agents|mesh-ancestor
5867293|NCT02359136|Epinephrine|epinephrine|mesh-list
5867294|NCT02359136|Analgesics|analgesics|mesh-list
5867295|NCT02359136|Anesthetics|anesthetics|mesh-list
5867296|NCT02359136|Ropivacaine|ropivacaine|mesh-list
5867297|NCT02359136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5867298|NCT02359136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867299|NCT02359136|Anesthetics, Local|anesthetics, local|mesh-ancestor
5867300|NCT02359136|Sensory System Agents|sensory system agents|mesh-ancestor
5867301|NCT02359136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5867302|NCT02359136|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5867303|NCT02359136|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5867304|NCT02359136|Adrenergic Agents|adrenergic agents|mesh-ancestor
5867305|NCT02359136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5867306|NCT02359136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867307|NCT02359136|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5867308|NCT02359136|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5867309|NCT02359136|Autonomic Agents|autonomic agents|mesh-ancestor
5867310|NCT02359136|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5867311|NCT02359136|Respiratory System Agents|respiratory system agents|mesh-ancestor
5867312|NCT02359136|Mydriatics|mydriatics|mesh-ancestor
5867313|NCT02359136|Sympathomimetics|sympathomimetics|mesh-ancestor
5867314|NCT02359136|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5867315|NCT02358967|Vitamin E|vitamin e|mesh-list
5867316|NCT02358967|Tocopherols|tocopherols|mesh-list
5867317|NCT02358967|Tocotrienols|tocotrienols|mesh-list
5867318|NCT02358967|Vitamins|vitamins|mesh-ancestor
5867319|NCT02358967|Micronutrients|micronutrients|mesh-ancestor
5867320|NCT02358967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867321|NCT02358967|Antioxidants|antioxidants|mesh-ancestor
5867322|NCT02358967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867323|NCT02358967|Protective Agents|protective agents|mesh-ancestor
5867324|NCT02359162|Gemcitabine|gemcitabine|mesh-list
5867325|NCT02359162|Prednisone|prednisone|mesh-list
5867326|NCT02359162|Cyclophosphamide|cyclophosphamide|mesh-list
5867327|NCT02359162|Doxorubicin|doxorubicin|mesh-list
5867328|NCT02359162|Oxaliplatin|oxaliplatin|mesh-list
5867329|NCT02359162|Etoposide|etoposide|mesh-list
5867330|NCT02359162|Vincristine|vincristine|mesh-list
5867331|NCT02359162|Pegaspargase|pegaspargase|mesh-list
5867332|NCT02359162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5867333|NCT02359162|Immunologic Factors|immunologic factors|mesh-ancestor
5867334|NCT02359162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867335|NCT02359162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5867336|NCT02359162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5867337|NCT02359162|Alkylating Agents|alkylating agents|mesh-ancestor
5867338|NCT02359162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867339|NCT02359162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5867340|NCT02359162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5867341|NCT02359162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5867342|NCT02359162|Antimetabolites|antimetabolites|mesh-ancestor
5867343|NCT02359162|Antiviral Agents|antiviral agents|mesh-ancestor
5867344|NCT02359162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5867345|NCT02359162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5867346|NCT02359162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5867347|NCT02359162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5867348|NCT02359162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5867349|NCT02359162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5867350|NCT02359162|Glucocorticoids|glucocorticoids|mesh-ancestor
5679363|NCT03506373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679364|NCT03506256|Norfloxacin|norfloxacin|mesh-list
5679365|NCT03506256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5679366|NCT03506256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5679367|NCT03506256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5679368|NCT03506256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5679369|NCT03506256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5679370|NCT03506256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5679371|NCT03506256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5679372|NCT03506256|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5679373|NCT03506256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5679374|NCT03506178|Phenylephrine|phenylephrine|mesh-list
5679375|NCT03506178|Oxymetazoline|oxymetazoline|mesh-list
5679376|NCT03506178|Menthol|menthol|mesh-list
5867351|NCT02359162|Hormones|hormones|mesh-ancestor
5867352|NCT02359162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5679377|NCT03506178|Antipruritics|antipruritics|mesh-ancestor
5679378|NCT03506178|Dermatologic Agents|dermatologic agents|mesh-ancestor
5679379|NCT03506178|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5679380|NCT03506178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5679381|NCT03506178|Adrenergic Agents|adrenergic agents|mesh-ancestor
5867353|NCT02359162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5867354|NCT02359162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5867355|NCT02359162|Tubulin Modulators|tubulin modulators|mesh-ancestor
5867356|NCT02359162|Antimitotic Agents|antimitotic agents|mesh-ancestor
5867357|NCT02359162|Mitosis Modulators|mitosis modulators|mesh-ancestor
5867358|NCT02359097|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
5867359|NCT02359097|Hematinics|hematinics|mesh-ancestor
5867360|NCT02359097|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5867361|NCT02359097|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5867362|NCT02358707|Ibuprofen|ibuprofen|mesh-list
5867363|NCT02358707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5867364|NCT02358707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5867365|NCT02358707|Analgesics|analgesics|mesh-ancestor
5867366|NCT02358707|Sensory System Agents|sensory system agents|mesh-ancestor
5867367|NCT02358707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5867368|NCT02358707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867369|NCT02358707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5867370|NCT02358707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5867371|NCT02358707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5867372|NCT02358707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5867373|NCT02358707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867374|NCT02358694|Immunoglobulins|immunoglobulins|mesh-list
5867375|NCT02358694|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5867376|NCT02358694|Antibodies|antibodies|mesh-list
5867377|NCT02358694|Immunologic Factors|immunologic factors|mesh-ancestor
5679382|NCT03506178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5679383|NCT03506178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5679384|NCT03506178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867378|NCT02358694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867379|NCT02358642|Lisinopril|lisinopril|mesh-list
5867380|NCT02358642|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
5867381|NCT02358642|Enzyme Inhibitors|enzyme inhibitors|mesh-list
5867382|NCT02358642|Protease Inhibitors|protease inhibitors|mesh-ancestor
5867383|NCT02358642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867384|NCT02358642|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5867385|NCT02358642|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5867386|NCT02358642|Protective Agents|protective agents|mesh-ancestor
5867387|NCT02358642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867388|NCT02358499|Posaconazole|posaconazole|mesh-list
6494870|NCT00620646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6494871|NCT00620646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6494872|NCT00620646|Antipyretics|antipyretics|mesh-ancestor
6494873|NCT00620646|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6494874|NCT00620646|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6494875|NCT00620646|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5679385|NCT03506178|Sympathomimetics|sympathomimetics|mesh-ancestor
5679386|NCT03506178|Autonomic Agents|autonomic agents|mesh-ancestor
5679387|NCT03506178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5679388|NCT03506178|Nasal Decongestants|nasal decongestants|mesh-ancestor
5679389|NCT03506178|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5679390|NCT03506178|Respiratory System Agents|respiratory system agents|mesh-ancestor
5679391|NCT03506178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6494876|NCT00620646|Purinergic Agents|purinergic agents|mesh-ancestor
5867389|NCT02358499|Antifungal Agents|antifungal agents|mesh-ancestor
5867390|NCT02358499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5867391|NCT02358499|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5867392|NCT02358499|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5867393|NCT02358499|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5867394|NCT02358499|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5867395|NCT02358499|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5867396|NCT02358499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5867397|NCT02358499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867398|NCT02358499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5867399|NCT02358499|Hormone Antagonists|hormone antagonists|mesh-ancestor
5867400|NCT02358499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5867401|NCT02358499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494877|NCT00620646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6494878|NCT00620646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6494879|NCT00620646|Autonomic Agents|autonomic agents|mesh-ancestor
6494880|NCT00620646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6494881|NCT00620646|Respiratory System Agents|respiratory system agents|mesh-ancestor
5867402|NCT02358395|Sorafenib|sorafenib|mesh-list
5867403|NCT02358395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5867404|NCT02358395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5867405|NCT02358395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5867406|NCT02358395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867407|NCT02358356|Capecitabine|capecitabine|mesh-list
5867408|NCT02358356|Temozolomide|temozolomide|mesh-list
5867409|NCT02358356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5867410|NCT02358356|Antimetabolites|antimetabolites|mesh-ancestor
5867411|NCT02358356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867412|NCT02358356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5867413|NCT02358356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5867414|NCT02358356|Alkylating Agents|alkylating agents|mesh-ancestor
5867415|NCT02358304|Calcitonin|calcitonin|mesh-list
5867416|NCT02358304|Salmon calcitonin|salmon calcitonin|mesh-list
5867417|NCT02358304|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
5867418|NCT02358304|Katacalcin|katacalcin|mesh-list
5867419|NCT02358304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5867420|NCT02358304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867421|NCT02358304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5867422|NCT02358304|Vasodilator Agents|vasodilator agents|mesh-ancestor
5867423|NCT02358265|Cyproheptadine|cyproheptadine|mesh-list
5867424|NCT02358265|Antipruritics|antipruritics|mesh-ancestor
5867425|NCT02358265|Dermatologic Agents|dermatologic agents|mesh-ancestor
5867426|NCT02358265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5867427|NCT02358265|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5867428|NCT02358265|Histamine Antagonists|histamine antagonists|mesh-ancestor
5867429|NCT02358265|Histamine Agents|histamine agents|mesh-ancestor
5867430|NCT02358265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5867431|NCT02358265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867432|NCT02358265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867433|NCT02358265|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5867434|NCT02358265|Serotonin Agents|serotonin agents|mesh-ancestor
5867435|NCT02358265|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5867436|NCT02358057|Dexmedetomidine|dexmedetomidine|mesh-list
5867437|NCT02358057|Alfentanil|alfentanil|mesh-list
5867438|NCT02358057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5867439|NCT02358057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5867440|NCT02358057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494882|NCT00620646|Vasodilator Agents|vasodilator agents|mesh-ancestor
6494883|NCT00620646|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6494884|NCT00620646|Protective Agents|protective agents|mesh-ancestor
6494885|NCT00620646|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6494886|NCT00620646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6494887|NCT00620724|Nifedipine|nifedipine|mesh-list
6494888|NCT00620724|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6494889|NCT00620724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6494890|NCT00620724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494891|NCT00620724|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5679392|NCT03506178|Mydriatics|mydriatics|mesh-ancestor
5679393|NCT03506178|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5679394|NCT03506178|Protective Agents|protective agents|mesh-ancestor
5679395|NCT03506113|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5867441|NCT02358057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5867442|NCT02358057|Analgesics|analgesics|mesh-ancestor
5867443|NCT02358057|Sensory System Agents|sensory system agents|mesh-ancestor
6675096|NCT01572623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675097|NCT01572623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6675098|NCT01572623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6675099|NCT01572623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6675100|NCT01572623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6675101|NCT01572623|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6675102|NCT01572623|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5867444|NCT02358057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5867445|NCT02358057|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5867446|NCT02358057|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5867447|NCT02358057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5867448|NCT02358057|Adrenergic Agents|adrenergic agents|mesh-ancestor
5867449|NCT02358057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5867450|NCT02358057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867451|NCT02358057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5867452|NCT02358057|Narcotics|narcotics|mesh-ancestor
5867453|NCT02358057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5867454|NCT02358057|Anesthetics, General|anesthetics, general|mesh-ancestor
5867455|NCT02358057|Anesthetics|anesthetics|mesh-ancestor
5867456|NCT02358083|Vaccines|vaccines|mesh-list
5867457|NCT02358083|Immunologic Factors|immunologic factors|mesh-ancestor
5867458|NCT02358083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867459|NCT02358161|Gemcitabine|gemcitabine|mesh-list
5867460|NCT02358161|Paclitaxel|paclitaxel|mesh-list
5867461|NCT02358161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5867462|NCT02358161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5867463|NCT02358161|Tubulin Modulators|tubulin modulators|mesh-ancestor
5867464|NCT02358161|Antimitotic Agents|antimitotic agents|mesh-ancestor
5679396|NCT03506113|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5679397|NCT03506113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5679398|NCT03506113|Antitubercular Agents|antitubercular agents|mesh-ancestor
5679399|NCT03506061|Ivacaftor|ivacaftor|mesh-list
5679400|NCT03506061|Elexacaftor|elexacaftor|mesh-list
5679401|NCT03506061|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
5679402|NCT03506061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5867465|NCT02358161|Mitosis Modulators|mitosis modulators|mesh-ancestor
5867466|NCT02358161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867467|NCT02358161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5867468|NCT02358161|Antimetabolites|antimetabolites|mesh-ancestor
5867469|NCT02358161|Antiviral Agents|antiviral agents|mesh-ancestor
5867470|NCT02358161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5867471|NCT02358161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5867472|NCT02358161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5867473|NCT02358161|Immunologic Factors|immunologic factors|mesh-ancestor
5867474|NCT02358161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867475|NCT02357966|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5867476|NCT02357966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5905233|NCT01752049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5679403|NCT03506061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5679404|NCT03506048|Lenvatinib|lenvatinib|mesh-list
5679405|NCT03506048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5679406|NCT03506048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5679407|NCT03506048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5679408|NCT03506048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5679409|NCT03506009|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5679410|NCT03506009|Argatroban|argatroban|mesh-list
5679411|NCT03506009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5679412|NCT03506009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5679413|NCT03506009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5679414|NCT03506009|Antithrombins|antithrombins|mesh-ancestor
5679415|NCT03506009|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5679416|NCT03506009|Protease Inhibitors|protease inhibitors|mesh-ancestor
5679417|NCT03506009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5679418|NCT03506009|Anticoagulants|anticoagulants|mesh-ancestor
5679419|NCT03506009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5905234|NCT01316523|Rituximab|rituximab|mesh-list
6212336|NCT02186847|Metformin|metformin|mesh-list
6212337|NCT02186847|Paclitaxel|paclitaxel|mesh-list
5867477|NCT02358187|Poly ICLC|poly iclc|mesh-list
5867478|NCT02358187|Interferon Inducers|interferon inducers|mesh-ancestor
5867479|NCT02358187|Immunologic Factors|immunologic factors|mesh-ancestor
5867480|NCT02358187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867481|NCT02358200|Paclitaxel|paclitaxel|mesh-list
5867482|NCT02358200|Carboplatin|carboplatin|mesh-list
5867483|NCT02358200|Talazoparib|talazoparib|mesh-list
5867484|NCT02358200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5867485|NCT02358200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5867486|NCT02358200|Tubulin Modulators|tubulin modulators|mesh-ancestor
5867487|NCT02358200|Antimitotic Agents|antimitotic agents|mesh-ancestor
5867488|NCT02358200|Mitosis Modulators|mitosis modulators|mesh-ancestor
5867489|NCT02358200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867490|NCT02358200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5867491|NCT02358200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5867492|NCT02358018|Edotreotide|edotreotide|mesh-list
5867493|NCT02358018|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5867494|NCT02358018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867495|NCT02357797|Vortioxetine|vortioxetine|mesh-list
5867496|NCT02357797|Antidepressive Agents|antidepressive agents|mesh-ancestor
5867497|NCT02357797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5867498|NCT02357797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5867499|NCT02357797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5867500|NCT02357797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5867501|NCT02357797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867502|NCT02357797|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5867503|NCT02357797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5867504|NCT02357797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5867505|NCT02357797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867506|NCT02357797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5867507|NCT02357797|Serotonin Agents|serotonin agents|mesh-ancestor
5867508|NCT02357797|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5867509|NCT02357797|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5867510|NCT02357797|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5867511|NCT02357797|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5867512|NCT02357849|Aripiprazole|aripiprazole|mesh-list
5867513|NCT02357849|Fluoxetine|fluoxetine|mesh-list
5867514|NCT02357849|Antidepressive Agents|antidepressive agents|mesh-ancestor
5867515|NCT02357849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5867516|NCT02357849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5867517|NCT02357849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5867518|NCT02357849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5867519|NCT02357849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867520|NCT02357849|Dopamine Agonists|dopamine agonists|mesh-ancestor
5867521|NCT02357849|Dopamine Agents|dopamine agents|mesh-ancestor
5867522|NCT02357849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5867523|NCT02357849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867524|NCT02357849|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5867525|NCT02357849|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5867526|NCT02357849|Serotonin Agents|serotonin agents|mesh-ancestor
5867527|NCT02357849|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5867528|NCT02357849|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5867529|NCT02357849|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5867530|NCT02357849|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5867531|NCT02357849|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5867532|NCT02357849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5679420|NCT03505788|Acetazolamide|acetazolamide|mesh-list
5867533|NCT02357849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5679421|NCT03505788|Anticonvulsants|anticonvulsants|mesh-ancestor
5679422|NCT03505788|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5679423|NCT03505788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5679424|NCT03505788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5679425|NCT03505788|Diuretics|diuretics|mesh-ancestor
5679426|NCT03505788|Natriuretic Agents|natriuretic agents|mesh-ancestor
5679427|NCT03505788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679428|NCT03505736|Adenosine|adenosine|mesh-list
5679429|NCT03505736|Regadenoson|regadenoson|mesh-list
5679430|NCT03505736|Analgesics|analgesics|mesh-ancestor
5679431|NCT03505736|Sensory System Agents|sensory system agents|mesh-ancestor
5679432|NCT03505736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5679433|NCT03505736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679434|NCT03505736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5679435|NCT03505736|Vasodilator Agents|vasodilator agents|mesh-ancestor
5867534|NCT02357849|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5867535|NCT02357849|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5867536|NCT02357849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5867537|NCT02357849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5867538|NCT02357693|Aprepitant|aprepitant|mesh-list
5867539|NCT02357693|Antiemetics|antiemetics|mesh-ancestor
5867540|NCT02357693|Autonomic Agents|autonomic agents|mesh-ancestor
5867541|NCT02357693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5867542|NCT02357693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867543|NCT02357693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5867544|NCT02357693|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5867545|NCT02357693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5867546|NCT02357693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867547|NCT02357732|Nivolumab|nivolumab|mesh-list
5867548|NCT02357732|Trametinib|trametinib|mesh-list
5867549|NCT02357732|Dabrafenib|dabrafenib|mesh-list
5867550|NCT02357732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5867551|NCT02357732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5867552|NCT02357732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5867553|NCT02357732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867554|NCT02357732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5867555|NCT02357732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5867556|NCT02357524|Oritavancin|oritavancin|mesh-list
5867557|NCT02357524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5867558|NCT02357524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5867559|NCT02357537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
5867560|NCT02357563|Leuprolide|leuprolide|mesh-list
5867561|NCT02357563|Ulipristal acetate|ulipristal acetate|mesh-list
5679436|NCT03505736|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5679437|NCT03505736|Purinergic Agonists|purinergic agonists|mesh-ancestor
5679438|NCT03505736|Purinergic Agents|purinergic agents|mesh-ancestor
5679439|NCT03505736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5679440|NCT03505736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5679441|NCT03505736|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
5679442|NCT03505528|Paclitaxel|paclitaxel|mesh-list
5679443|NCT03505528|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5679444|NCT03505528|Phenelzine|phenelzine|mesh-list
5679445|NCT03505528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5679446|NCT03505528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5679447|NCT03505528|Tubulin Modulators|tubulin modulators|mesh-ancestor
5679448|NCT03505528|Antimitotic Agents|antimitotic agents|mesh-ancestor
5679449|NCT03505528|Mitosis Modulators|mitosis modulators|mesh-ancestor
5679450|NCT03505528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5679451|NCT03505528|Antidepressive Agents|antidepressive agents|mesh-ancestor
5679452|NCT03505528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5679453|NCT03505528|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
5679454|NCT03505528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5679455|NCT03505502|Tranexamic Acid|tranexamic acid|mesh-list
5679456|NCT03505502|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5679457|NCT03505502|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5679458|NCT03505502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867562|NCT02357563|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5867563|NCT02357563|Fertility Agents|fertility agents|mesh-ancestor
5867564|NCT02357563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5867565|NCT02357563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867566|NCT02357563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5867567|NCT02357563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5867568|NCT02357563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5867569|NCT02357563|Contraceptive Agents|contraceptive agents|mesh-ancestor
5867570|NCT02357563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5867571|NCT02357615|Nifedipine|nifedipine|mesh-list
5867572|NCT02357615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5867573|NCT02357615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5867574|NCT02357615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867575|NCT02357615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5867576|NCT02357615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867577|NCT02357615|Vasodilator Agents|vasodilator agents|mesh-ancestor
5867578|NCT02357615|Tocolytic Agents|tocolytic agents|mesh-ancestor
5679459|NCT03505502|Hemostatics|hemostatics|mesh-ancestor
5679460|NCT03505502|Coagulants|coagulants|mesh-ancestor
5679461|NCT03505489|Mannitol|mannitol|mesh-list
5679462|NCT03505489|Methacholine Chloride|methacholine chloride|mesh-list
5679463|NCT03505489|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5679464|NCT03505489|Diuretics|diuretics|mesh-ancestor
5905235|NCT01316523|Lenalidomide|lenalidomide|mesh-list
5679465|NCT03505489|Natriuretic Agents|natriuretic agents|mesh-ancestor
5679466|NCT03505489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679467|NCT03505489|Miotics|miotics|mesh-ancestor
5867579|NCT02357615|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5867580|NCT02357602|Tenofovir|tenofovir|mesh-list
5867581|NCT02357602|Antiviral Agents|antiviral agents|mesh-ancestor
5867582|NCT02357602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5867583|NCT02357602|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5867584|NCT02357602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5867585|NCT02357602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5867586|NCT02357602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867587|NCT02357602|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5867588|NCT02357602|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5679468|NCT03505489|Autonomic Agents|autonomic agents|mesh-ancestor
5679469|NCT03505489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5867589|NCT02357472|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
5867590|NCT02357472|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5867591|NCT02357472|Immunologic Factors|immunologic factors|mesh-ancestor
5867592|NCT02357472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867593|NCT02357303|Acetylcysteine|acetylcysteine|mesh-list
5867594|NCT02357303|Simethicone|simethicone|mesh-list
5867595|NCT02357303|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5867596|NCT02357303|Antiviral Agents|antiviral agents|mesh-ancestor
5867597|NCT02357303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5867598|NCT02357303|Expectorants|expectorants|mesh-ancestor
5867599|NCT02357303|Respiratory System Agents|respiratory system agents|mesh-ancestor
5867600|NCT02357303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5867601|NCT02357303|Antioxidants|antioxidants|mesh-ancestor
5867602|NCT02357303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867603|NCT02357303|Protective Agents|protective agents|mesh-ancestor
5867604|NCT02357303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867605|NCT02357303|Antidotes|antidotes|mesh-ancestor
5867606|NCT02357303|Antifoaming Agents|antifoaming agents|mesh-ancestor
5867607|NCT02357303|Emollients|emollients|mesh-ancestor
5867608|NCT02357303|Dermatologic Agents|dermatologic agents|mesh-ancestor
5867609|NCT02357277|Budesonide|budesonide|mesh-list
5867610|NCT02357277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5867611|NCT02357277|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5867612|NCT02357277|Autonomic Agents|autonomic agents|mesh-ancestor
5867613|NCT02357277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5867614|NCT02357277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679470|NCT03505489|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5679471|NCT03505489|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
5679472|NCT03505489|Respiratory System Agents|respiratory system agents|mesh-ancestor
5679473|NCT03505489|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
5679474|NCT03505489|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5679475|NCT03505489|Cholinergic Agents|cholinergic agents|mesh-ancestor
5867615|NCT02357277|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5867616|NCT02357277|Respiratory System Agents|respiratory system agents|mesh-ancestor
5867617|NCT02357277|Glucocorticoids|glucocorticoids|mesh-ancestor
5867618|NCT02357277|Hormones|hormones|mesh-ancestor
5867619|NCT02357277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5867620|NCT02357407|Ciprofloxacin|ciprofloxacin|mesh-list
5867621|NCT02357407|Ofloxacin|ofloxacin|mesh-list
5867622|NCT02357407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5867623|NCT02357407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5867624|NCT02357407|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5867625|NCT02357407|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5867626|NCT02357407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5867627|NCT02357407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867628|NCT02357407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5867629|NCT02357407|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5867630|NCT02357407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5867631|NCT02357407|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5867632|NCT02357407|Renal Agents|renal agents|mesh-ancestor
5867633|NCT02357225|Bromides|bromides|mesh-list
5867634|NCT02357225|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
5867635|NCT02357225|Anticonvulsants|anticonvulsants|mesh-ancestor
5867636|NCT02357225|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5867637|NCT02357225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5867638|NCT02357225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212338|NCT02186847|Carboplatin|carboplatin|mesh-list
6675103|NCT01572623|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6675104|NCT01572623|Purinergic Agents|purinergic agents|mesh-ancestor
6675105|NCT01572623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6675106|NCT01572623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679476|NCT03505489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5679477|NCT03505489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5679478|NCT03505411|Melatonin|melatonin|mesh-list
5679479|NCT03505411|Antioxidants|antioxidants|mesh-ancestor
5679480|NCT03505411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867639|NCT02357225|Cholinergic Agents|cholinergic agents|mesh-ancestor
5867640|NCT02357225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5867641|NCT02357225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867642|NCT02357212|Adenosine|adenosine|mesh-list
5867643|NCT02357212|Analgesics|analgesics|mesh-ancestor
5867644|NCT02357212|Sensory System Agents|sensory system agents|mesh-ancestor
5867645|NCT02357212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5867646|NCT02357212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867647|NCT02357212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5867648|NCT02357212|Vasodilator Agents|vasodilator agents|mesh-ancestor
5867649|NCT02357212|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5867650|NCT02357212|Purinergic Agonists|purinergic agonists|mesh-ancestor
5867651|NCT02357212|Purinergic Agents|purinergic agents|mesh-ancestor
5867652|NCT02357212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5867653|NCT02357212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867654|NCT02357004|Carvedilol|carvedilol|mesh-list
5867655|NCT02357004|Chlorthalidone|chlorthalidone|mesh-list
5867656|NCT02357004|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5867657|NCT02357004|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5867658|NCT02357004|Adrenergic Agents|adrenergic agents|mesh-ancestor
5867659|NCT02357004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5867660|NCT02357004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867661|NCT02357004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867662|NCT02357004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5867663|NCT02357004|Antioxidants|antioxidants|mesh-ancestor
5867664|NCT02357004|Protective Agents|protective agents|mesh-ancestor
5867665|NCT02357004|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5867666|NCT02357004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5867667|NCT02357004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5867668|NCT02357004|Vasodilator Agents|vasodilator agents|mesh-ancestor
5867669|NCT02357004|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5867670|NCT02357004|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5679481|NCT03505411|Protective Agents|protective agents|mesh-ancestor
5679482|NCT03505411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679483|NCT03505411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5696735|NCT03380975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696736|NCT03380949|Remifentanil|remifentanil|mesh-list
5696737|NCT03380949|Analgesics, Opioid|analgesics, opioid|mesh-list
5696738|NCT03380949|Narcotics|narcotics|mesh-ancestor
5696739|NCT03380949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5696740|NCT03380949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696741|NCT03380949|Analgesics|analgesics|mesh-ancestor
5696742|NCT03380949|Sensory System Agents|sensory system agents|mesh-ancestor
5696743|NCT03380949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5696744|NCT03380936|Tacrolimus|tacrolimus|mesh-list
5696745|NCT03380936|Immunoglobulins|immunoglobulins|mesh-list
5696746|NCT03380936|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5696747|NCT03380936|Antibodies|antibodies|mesh-list
5696748|NCT03380936|gamma-Globulins|gamma-globulins|mesh-list
5696749|NCT03380936|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5696750|NCT03380936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5696751|NCT03380936|Immunologic Factors|immunologic factors|mesh-ancestor
5696752|NCT03380936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696753|NCT03380936|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5696754|NCT03380936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5867671|NCT02357004|Diuretics|diuretics|mesh-ancestor
5867672|NCT02357004|Natriuretic Agents|natriuretic agents|mesh-ancestor
5867673|NCT02357004|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5867674|NCT02357069|Etanercept|etanercept|mesh-list
5867675|NCT02357069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5867676|NCT02357069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5867677|NCT02357069|Analgesics|analgesics|mesh-ancestor
5867678|NCT02357069|Sensory System Agents|sensory system agents|mesh-ancestor
5867679|NCT02357069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5867680|NCT02357069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867681|NCT02357069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5867682|NCT02357069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5867683|NCT02357069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5867684|NCT02357069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5867685|NCT02357069|Immunologic Factors|immunologic factors|mesh-ancestor
5867686|NCT02356913|Nicotine|nicotine|mesh-list
5867687|NCT02356913|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5867688|NCT02356913|Autonomic Agents|autonomic agents|mesh-ancestor
5867689|NCT02356913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5867690|NCT02356913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867691|NCT02356913|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5867692|NCT02356913|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5867693|NCT02356913|Cholinergic Agents|cholinergic agents|mesh-ancestor
5867694|NCT02356913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5867695|NCT02356913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867696|NCT02356965|Ketamine|ketamine|mesh-list
5867697|NCT02356965|Analgesics|analgesics|mesh-ancestor
5867698|NCT02356965|Sensory System Agents|sensory system agents|mesh-ancestor
5867699|NCT02356965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5867700|NCT02356965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867701|NCT02356965|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5867702|NCT02356965|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5867703|NCT02356965|Anesthetics, General|anesthetics, general|mesh-ancestor
5867704|NCT02356965|Anesthetics|anesthetics|mesh-ancestor
5867705|NCT02356965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5867706|NCT02356965|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5679484|NCT03505255|Neostigmine|neostigmine|mesh-list
5679485|NCT03505255|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5679486|NCT03505255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5679487|NCT03505255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867707|NCT02356965|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5867708|NCT02356965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5867709|NCT02356965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867710|NCT02356835|Nitric Oxide|nitric oxide|mesh-list
5867711|NCT02356835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5679488|NCT03505255|Cholinergic Agents|cholinergic agents|mesh-ancestor
5679489|NCT03505255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5679490|NCT03505255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679491|NCT03505255|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5679492|NCT03505255|Autonomic Agents|autonomic agents|mesh-ancestor
5679493|NCT03505255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5679494|NCT03505151|BI 409306|bi 409306|mesh-list
5679495|NCT03505151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5679496|NCT03505151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5679497|NCT03505151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5679498|NCT03505047|Copper|copper|mesh-list
5679499|NCT03505047|Trace Elements|trace elements|mesh-ancestor
5679500|NCT03505047|Micronutrients|micronutrients|mesh-ancestor
5679501|NCT03505047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679502|NCT03505008|Adalimumab|adalimumab|mesh-list
5679503|NCT03505008|Methotrexate|methotrexate|mesh-list
5679504|NCT03505008|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5679505|NCT03505008|Abortifacient Agents|abortifacient agents|mesh-ancestor
5679506|NCT03505008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5679507|NCT03505008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679508|NCT03505008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5679509|NCT03505008|Antimetabolites|antimetabolites|mesh-ancestor
5679510|NCT03505008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5679511|NCT03505008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5679512|NCT03505008|Dermatologic Agents|dermatologic agents|mesh-ancestor
5679513|NCT03505008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5867712|NCT02356835|Autonomic Agents|autonomic agents|mesh-ancestor
5867713|NCT02356835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5867714|NCT02356835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867715|NCT02356835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5867716|NCT02356835|Respiratory System Agents|respiratory system agents|mesh-ancestor
5867717|NCT02356835|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5867718|NCT02356835|Antioxidants|antioxidants|mesh-ancestor
5867719|NCT02356835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867720|NCT02356835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5867721|NCT02356835|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5867722|NCT02356835|Vasodilator Agents|vasodilator agents|mesh-ancestor
5867723|NCT02356835|Gasotransmitters|gasotransmitters|mesh-ancestor
5867724|NCT02356835|Protective Agents|protective agents|mesh-ancestor
5867725|NCT02356445|Methotrexate|methotrexate|mesh-list
5867726|NCT02356445|Azathioprine|azathioprine|mesh-list
5867727|NCT02356445|Infliximab|infliximab|mesh-list
5867728|NCT02356445|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5867729|NCT02356445|Abortifacient Agents|abortifacient agents|mesh-ancestor
5867730|NCT02356445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5867731|NCT02356445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867732|NCT02356445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5867733|NCT02356445|Antimetabolites|antimetabolites|mesh-ancestor
5867734|NCT02356445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867735|NCT02356445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5867736|NCT02356445|Dermatologic Agents|dermatologic agents|mesh-ancestor
5867737|NCT02356445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5867738|NCT02356445|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5867739|NCT02356445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5867740|NCT02356445|Immunologic Factors|immunologic factors|mesh-ancestor
5867741|NCT02356445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5867742|NCT02356445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5867743|NCT02356445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5867744|NCT02356640|Levobupivacaine|levobupivacaine|mesh-list
5867745|NCT02356640|Anesthetics, Local|anesthetics, local|mesh-ancestor
5867746|NCT02356640|Anesthetics|anesthetics|mesh-ancestor
5867747|NCT02356640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5867748|NCT02356640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867749|NCT02356640|Sensory System Agents|sensory system agents|mesh-ancestor
5867750|NCT02356640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5867751|NCT02356458|Bortezomib|bortezomib|mesh-list
5867752|NCT02356458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5867753|NCT02356679|Ethanol|ethanol|mesh-list
5867754|NCT02356679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5867755|NCT02356679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5867756|NCT02356679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5867757|NCT02356679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867758|NCT02356146|Tacrolimus|tacrolimus|mesh-list
5867759|NCT02356146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5679514|NCT03505008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5679515|NCT03505008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5679516|NCT03505008|Immunologic Factors|immunologic factors|mesh-ancestor
5679517|NCT03505008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5679518|NCT03505008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5679519|NCT03505008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5679520|NCT03504982|Moxifloxacin|moxifloxacin|mesh-list
5679521|NCT03504982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5679522|NCT03504982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5679523|NCT03504982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5679524|NCT03504982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5679525|NCT03504982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5679526|NCT03504982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5679527|NCT03504982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5867760|NCT02356146|Immunologic Factors|immunologic factors|mesh-ancestor
5867761|NCT02356146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867762|NCT02356146|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5867763|NCT02356146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5867764|NCT02356146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867765|NCT02356328|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5867766|NCT02356328|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5867767|NCT02356419|Epoetin Alfa|epoetin alfa|mesh-list
5867768|NCT02356419|Hematinics|hematinics|mesh-ancestor
5905236|NCT01316523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5905237|NCT01316523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5905238|NCT01316523|Immunologic Factors|immunologic factors|mesh-ancestor
5679528|NCT03504956|Metoprolol|metoprolol|mesh-list
5679529|NCT03504956|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
5679530|NCT03504956|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5679531|NCT03504956|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5679532|NCT03504956|Sympatholytics|sympatholytics|mesh-ancestor
5679533|NCT03504956|Autonomic Agents|autonomic agents|mesh-ancestor
5905239|NCT01316523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905240|NCT01316523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5905241|NCT01316523|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5905242|NCT01316523|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5905243|NCT01316523|Growth Substances|growth substances|mesh-ancestor
5905244|NCT01316523|Growth Inhibitors|growth inhibitors|mesh-ancestor
5905245|NCT00085774|Albuterol|albuterol|mesh-list
5905246|NCT00085774|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5905247|NCT00085774|Autonomic Agents|autonomic agents|mesh-ancestor
5905248|NCT00085774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5905249|NCT00085774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905250|NCT00085774|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5905251|NCT00085774|Respiratory System Agents|respiratory system agents|mesh-ancestor
5867769|NCT02356341|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5867770|NCT02356341|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5867771|NCT02355756|Maxadilan protein, insect|maxadilan protein, insect|mesh-list
5867772|NCT02355756|Vasodilator Agents|vasodilator agents|mesh-ancestor
5867773|NCT02355938|Vancomycin|vancomycin|mesh-list
5867774|NCT02355938|Fidaxomicin|fidaxomicin|mesh-list
5867775|NCT02355938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5867776|NCT02355938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5867777|NCT02355704|Atorvastatin|atorvastatin|mesh-list
5867778|NCT02355704|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5867779|NCT02355704|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5867780|NCT02355704|Antimetabolites|antimetabolites|mesh-ancestor
5867781|NCT02355704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867782|NCT02355704|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5867783|NCT02355704|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5867784|NCT02355704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5867785|NCT02355678|Acetaminophen|acetaminophen|mesh-list
5867786|NCT02355678|Dexamethasone|dexamethasone|mesh-list
5867787|NCT02355678|Propacetamol|propacetamol|mesh-list
5867788|NCT02355678|Tramadol|tramadol|mesh-list
5867789|NCT02355678|Anesthetics|anesthetics|mesh-list
5867790|NCT02355678|Anesthetics, Local|anesthetics, local|mesh-list
5867791|NCT02355678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5867792|NCT02355678|Antiemetics|antiemetics|mesh-ancestor
5867793|NCT02355678|Autonomic Agents|autonomic agents|mesh-ancestor
5867794|NCT02355678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5867795|NCT02355678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867796|NCT02355678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5867797|NCT02355678|Glucocorticoids|glucocorticoids|mesh-ancestor
5867798|NCT02355678|Hormones|hormones|mesh-ancestor
5867799|NCT02355678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5867800|NCT02355678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5867801|NCT02355678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5867802|NCT02355678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5867803|NCT02355678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5867804|NCT02355678|Analgesics|analgesics|mesh-ancestor
6494892|NCT00620724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494893|NCT00620724|Vasodilator Agents|vasodilator agents|mesh-ancestor
6494894|NCT00620724|Tocolytic Agents|tocolytic agents|mesh-ancestor
6494895|NCT00620724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6494896|NCT00620789|Dexetimide|dexetimide|mesh-list
6494897|NCT00620789|Citalopram|citalopram|mesh-list
6494898|NCT00620789|Antidepressive Agents|antidepressive agents|mesh-list
6494899|NCT00620789|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6494900|NCT00620789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6494901|NCT00620789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6494902|NCT00620789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494903|NCT00620789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6494904|NCT00620789|Serotonin Agents|serotonin agents|mesh-ancestor
6494905|NCT00620789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494906|NCT00620789|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6494907|NCT00620789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6494908|NCT00620789|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5679534|NCT03504956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5679535|NCT03504956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679536|NCT03504956|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5679537|NCT03504956|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5679538|NCT03504956|Adrenergic Agents|adrenergic agents|mesh-ancestor
5679539|NCT03504956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5679540|NCT03504956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5679541|NCT03504865|Bupivacaine|bupivacaine|mesh-list
5679542|NCT03504865|Anesthetics, Local|anesthetics, local|mesh-ancestor
5679543|NCT03504865|Anesthetics|anesthetics|mesh-ancestor
5679544|NCT03504865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5679545|NCT03504865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679546|NCT03504865|Sensory System Agents|sensory system agents|mesh-ancestor
5679547|NCT03504865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5679548|NCT03504735|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
5679549|NCT03504735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5679550|NCT03504735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5679551|NCT03504735|Antimetabolites|antimetabolites|mesh-ancestor
5867805|NCT02355678|Sensory System Agents|sensory system agents|mesh-ancestor
6494909|NCT00620789|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5867806|NCT02355678|Antipyretics|antipyretics|mesh-ancestor
5867807|NCT02355678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5867808|NCT02355678|Narcotics|narcotics|mesh-ancestor
6494910|NCT00620789|Parasympatholytics|parasympatholytics|mesh-ancestor
6494911|NCT00620789|Autonomic Agents|autonomic agents|mesh-ancestor
6494912|NCT00620789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6494913|NCT00620789|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6494914|NCT00620789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6494915|NCT00620789|Cholinergic Agents|cholinergic agents|mesh-ancestor
6494916|NCT00620802|Clopidogrel|clopidogrel|mesh-list
6494917|NCT00620802|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6494918|NCT00620802|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6494919|NCT00620802|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6494920|NCT00620802|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6494921|NCT00620802|Purinergic Agents|purinergic agents|mesh-ancestor
6494922|NCT00620802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6494923|NCT00620802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494924|NCT00620802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494925|NCT00620867|Ibuprofen|ibuprofen|mesh-list
6494926|NCT00620867|Celecoxib|celecoxib|mesh-list
6494927|NCT00620867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6494928|NCT00620867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6494929|NCT00620867|Analgesics|analgesics|mesh-ancestor
6494930|NCT00620867|Sensory System Agents|sensory system agents|mesh-ancestor
6494931|NCT00620867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6494932|NCT00620867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494933|NCT00620867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6494934|NCT00620867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6494935|NCT00620867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6494936|NCT00620867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6494937|NCT00620867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5679552|NCT03504735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5679553|NCT03504735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5679554|NCT03504735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5679555|NCT03504735|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5679556|NCT03504735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5679557|NCT03504735|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6494938|NCT00620867|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6494939|NCT00620893|Lubricant Eye Drops|lubricant eye drops|mesh-list
6494940|NCT00620893|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6494941|NCT00620893|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6494942|NCT00620919|Secretin|secretin|mesh-list
6494943|NCT00620919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6494944|NCT00620919|Hormones|hormones|mesh-ancestor
6494945|NCT00620919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6494946|NCT00620919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494947|NCT00620971|Gemcitabine|gemcitabine|mesh-list
5867809|NCT02355678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5867810|NCT02355678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5867811|NCT02355431|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5867812|NCT02355431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5867813|NCT02355431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5867814|NCT02355431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5867815|NCT02355431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867816|NCT02355522|Lidocaine|lidocaine|mesh-list
5679558|NCT03504735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679559|NCT03504735|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5679560|NCT03504735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5679561|NCT03504644|Vincristine|vincristine|mesh-list
5679562|NCT03504644|Venetoclax|venetoclax|mesh-list
5679563|NCT03504644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5679564|NCT03504644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5679565|NCT03504644|Tubulin Modulators|tubulin modulators|mesh-ancestor
5679566|NCT03504644|Antimitotic Agents|antimitotic agents|mesh-ancestor
5679567|NCT03504644|Mitosis Modulators|mitosis modulators|mesh-ancestor
5679568|NCT03504644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5679569|NCT03504566|Empagliflozin|empagliflozin|mesh-list
5679570|NCT03504566|Linagliptin|linagliptin|mesh-list
5679571|NCT03504566|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
5679572|NCT03504566|Telmisartan|telmisartan|mesh-list
5679573|NCT03504566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5867817|NCT02355522|Anesthetics, Local|anesthetics, local|mesh-ancestor
5867818|NCT02355522|Anesthetics|anesthetics|mesh-ancestor
5867819|NCT02355522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5867820|NCT02355522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867821|NCT02355522|Sensory System Agents|sensory system agents|mesh-ancestor
5867822|NCT02355522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5867823|NCT02355522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5867824|NCT02355522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5867825|NCT02355522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5867826|NCT02355522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5867827|NCT02355522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867828|NCT02355639|Betamethasone|betamethasone|mesh-list
5867829|NCT02355639|Betamethasone Valerate|betamethasone valerate|mesh-list
5867830|NCT02355639|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5867831|NCT02355639|Betamethasone benzoate|betamethasone benzoate|mesh-list
5867832|NCT02355639|Clobetasol|clobetasol|mesh-list
5867833|NCT02355639|Petrolatum|petrolatum|mesh-list
5867834|NCT02355639|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
5679574|NCT03504566|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5679575|NCT03504566|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5679576|NCT03504566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5679577|NCT03504566|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5679578|NCT03504566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5679579|NCT03504566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679580|NCT03504566|Incretins|incretins|mesh-ancestor
5679581|NCT03504566|Hormones|hormones|mesh-ancestor
5679582|NCT03504566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5679583|NCT03504566|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5679584|NCT03504566|Protease Inhibitors|protease inhibitors|mesh-ancestor
5679585|NCT03504566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5679586|NCT03504566|Anticoagulants|anticoagulants|mesh-ancestor
5679587|NCT03504566|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5679588|NCT03504566|Antimetabolites|antimetabolites|mesh-ancestor
5679589|NCT03504566|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5867835|NCT02355639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5867836|NCT02355639|Glucocorticoids|glucocorticoids|mesh-ancestor
5867837|NCT02355639|Hormones|hormones|mesh-ancestor
5867838|NCT02355639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5867839|NCT02355639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867840|NCT02355639|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5867841|NCT02355639|Respiratory System Agents|respiratory system agents|mesh-ancestor
5867842|NCT02355639|Emollients|emollients|mesh-ancestor
5867843|NCT02355639|Dermatologic Agents|dermatologic agents|mesh-ancestor
5867844|NCT02355509|Acarbose|acarbose|mesh-list
5867845|NCT02355509|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
5867846|NCT02355509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5867847|NCT02355509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867848|NCT02355509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5867849|NCT02355509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867850|NCT02355184|Leronlimab|leronlimab|mesh-list
5867851|NCT02355184|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5867852|NCT02355184|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5867853|NCT02355184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867854|NCT02355184|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5867855|NCT02355184|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5867856|NCT02355184|Antiviral Agents|antiviral agents|mesh-ancestor
5867857|NCT02355184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5867858|NCT02355236|Celecoxib|celecoxib|mesh-list
5867859|NCT02355236|Naproxen|naproxen|mesh-list
5867860|NCT02355236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5867861|NCT02355236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5867862|NCT02355236|Analgesics|analgesics|mesh-ancestor
5867863|NCT02355236|Sensory System Agents|sensory system agents|mesh-ancestor
5867864|NCT02355236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5867865|NCT02355236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867866|NCT02355236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5867867|NCT02355236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5867868|NCT02355236|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5867869|NCT02355236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5867870|NCT02355236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5867871|NCT02355236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867872|NCT02355236|Gout Suppressants|gout suppressants|mesh-ancestor
5867873|NCT02355197|Ascorbic Acid|ascorbic acid|mesh-list
5867874|NCT02355197|Vitamins|vitamins|mesh-ancestor
5867875|NCT02355197|Micronutrients|micronutrients|mesh-ancestor
6494948|NCT00620971|Bevacizumab|bevacizumab|mesh-list
6494949|NCT00620971|Cisplatin|cisplatin|mesh-list
5867876|NCT02355197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494950|NCT00620971|Docetaxel|docetaxel|mesh-list
5867877|NCT02355197|Antioxidants|antioxidants|mesh-ancestor
5867878|NCT02355197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867879|NCT02355197|Protective Agents|protective agents|mesh-ancestor
5867880|NCT02355119|Gemcitabine|gemcitabine|mesh-list
5867881|NCT02355119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5867882|NCT02355119|Antimetabolites|antimetabolites|mesh-ancestor
5867883|NCT02355119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867884|NCT02355119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5867885|NCT02355119|Antiviral Agents|antiviral agents|mesh-ancestor
5867886|NCT02355119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5867887|NCT02355119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5867888|NCT02355119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5867889|NCT02355119|Immunologic Factors|immunologic factors|mesh-ancestor
5867890|NCT02355119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867891|NCT02355093|Ropivacaine|ropivacaine|mesh-list
5867892|NCT02355093|Anesthetics, Local|anesthetics, local|mesh-ancestor
5867893|NCT02355093|Anesthetics|anesthetics|mesh-ancestor
5867894|NCT02355093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5679590|NCT03504566|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5679591|NCT03504566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5679592|NCT03504527|Budesonide|budesonide|mesh-list
5679593|NCT03504527|Bromides|bromides|mesh-list
5679594|NCT03504527|Tiotropium Bromide|tiotropium bromide|mesh-list
5679595|NCT03504527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5679596|NCT03504527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5679597|NCT03504527|Autonomic Agents|autonomic agents|mesh-ancestor
5679598|NCT03504527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5679599|NCT03504527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679600|NCT03504527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5679601|NCT03504527|Respiratory System Agents|respiratory system agents|mesh-ancestor
5679602|NCT03504527|Glucocorticoids|glucocorticoids|mesh-ancestor
5679603|NCT03504527|Hormones|hormones|mesh-ancestor
5867895|NCT02355093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867896|NCT02355093|Sensory System Agents|sensory system agents|mesh-ancestor
5867897|NCT02355093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5867898|NCT02355379|Capecitabine|capecitabine|mesh-list
5867899|NCT02355379|Fluorouracil|fluorouracil|mesh-list
5867900|NCT02355379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5679604|NCT03504527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5679605|NCT03504527|Parasympatholytics|parasympatholytics|mesh-ancestor
5679606|NCT03504527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5679607|NCT03504527|Cholinergic Agents|cholinergic agents|mesh-ancestor
5679608|NCT03504527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5679609|NCT03504527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5679610|NCT03504527|Anticonvulsants|anticonvulsants|mesh-ancestor
5679611|NCT03504501|Lamotrigine|lamotrigine|mesh-list
5679612|NCT03504501|Lovastatin|lovastatin|mesh-list
5679613|NCT03504501|L 647318|l 647318|mesh-list
5679614|NCT03504501|Dihydromevinolin|dihydromevinolin|mesh-list
5679615|NCT03504501|Anticonvulsants|anticonvulsants|mesh-ancestor
5867901|NCT02355379|Antimetabolites|antimetabolites|mesh-ancestor
5867902|NCT02355379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867903|NCT02355379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5867904|NCT02355379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5867905|NCT02355379|Immunologic Factors|immunologic factors|mesh-ancestor
5867906|NCT02355379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867907|NCT02355054|Choline|choline|mesh-list
5867908|NCT02355054|Lipotropic Agents|lipotropic agents|mesh-ancestor
5867909|NCT02355054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5679616|NCT03504501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5679617|NCT03504501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5679618|NCT03504501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5679619|NCT03504501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5679620|NCT03504501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679621|NCT03504501|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5679622|NCT03504501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5679623|NCT03504501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5679624|NCT03504501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5679625|NCT03504501|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5679626|NCT03504501|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5679627|NCT03504501|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5679628|NCT03504501|Antimetabolites|antimetabolites|mesh-ancestor
5679629|NCT03504501|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5679630|NCT03504501|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5679631|NCT03504501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5679632|NCT03504488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5867910|NCT02355054|Antimetabolites|antimetabolites|mesh-ancestor
5867911|NCT02355054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867912|NCT02355054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5867913|NCT02355054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5867914|NCT02355054|Nootropic Agents|nootropic agents|mesh-ancestor
5867915|NCT02354885|Tranexamic Acid|tranexamic acid|mesh-list
5867916|NCT02354885|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5679633|NCT03504488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5679634|NCT03504488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5679635|NCT03504475|Paroxetine|paroxetine|mesh-list
5679636|NCT03504475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5679637|NCT03504475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5679638|NCT03504475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5679639|NCT03504475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5679640|NCT03504475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5679641|NCT03504475|Serotonin Agents|serotonin agents|mesh-ancestor
5679642|NCT03504475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867917|NCT02354885|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5867918|NCT02354885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867919|NCT02354885|Hemostatics|hemostatics|mesh-ancestor
5867920|NCT02354885|Coagulants|coagulants|mesh-ancestor
5867921|NCT02354898|Sorafenib|sorafenib|mesh-list
5867922|NCT02354898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5867923|NCT02354898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5867924|NCT02354898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5867925|NCT02354898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867926|NCT02354768|Lanreotide|lanreotide|mesh-list
5867927|NCT02354768|Loperamide|loperamide|mesh-list
5867928|NCT02354768|Antidiarrheals|antidiarrheals|mesh-list
5867929|NCT02354768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5867930|NCT02354768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5867931|NCT02354807|Mirabegron|mirabegron|mesh-list
5867932|NCT02354807|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
5867933|NCT02354807|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5867934|NCT02354807|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5867935|NCT02354807|Adrenergic Agents|adrenergic agents|mesh-ancestor
5867936|NCT02354807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5867937|NCT02354807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867938|NCT02354807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867939|NCT02354807|Urological Agents|urological agents|mesh-ancestor
5867940|NCT02354937|Cabotegravir|cabotegravir|mesh-list
5867941|NCT02354937|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5867942|NCT02354937|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5867943|NCT02354937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5867944|NCT02354937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867945|NCT02354937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5867946|NCT02354937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5867947|NCT02354937|Antiviral Agents|antiviral agents|mesh-ancestor
5867948|NCT02354937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5867949|NCT02354950|Cabotegravir|cabotegravir|mesh-list
5867950|NCT02354950|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5867951|NCT02354950|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5867952|NCT02354950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5867953|NCT02354950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867954|NCT02354950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5867955|NCT02354950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5867956|NCT02354950|Antiviral Agents|antiviral agents|mesh-ancestor
5867957|NCT02354950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5867958|NCT02354872|Nicotine|nicotine|mesh-list
5679643|NCT03504475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5679644|NCT03504475|Antidepressive Agents|antidepressive agents|mesh-ancestor
5679645|NCT03504475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5679646|NCT03504475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5679647|NCT03504475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5679648|NCT03504475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5679649|NCT03504345|Progesterone|progesterone|mesh-list
5867959|NCT02354872|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5867960|NCT02354872|Autonomic Agents|autonomic agents|mesh-ancestor
5867961|NCT02354872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5867962|NCT02354872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867963|NCT02354872|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5867964|NCT02354872|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5867965|NCT02354872|Cholinergic Agents|cholinergic agents|mesh-ancestor
5867966|NCT02354872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5905252|NCT00085774|Tocolytic Agents|tocolytic agents|mesh-ancestor
5679650|NCT03504345|Progestins|progestins|mesh-ancestor
5679651|NCT03504345|Hormones|hormones|mesh-ancestor
5679652|NCT03504345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5679653|NCT03504345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679654|NCT03504280|Cholecalciferol|cholecalciferol|mesh-list
5679655|NCT03504280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5679656|NCT03504280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679657|NCT03504280|Vitamins|vitamins|mesh-ancestor
5679658|NCT03504280|Micronutrients|micronutrients|mesh-ancestor
5679659|NCT03504280|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5679660|NCT03504241|Mycophenolic Acid|mycophenolic acid|mesh-list
5679661|NCT03504241|Sirolimus|sirolimus|mesh-list
5679662|NCT03504241|Prednisone|prednisone|mesh-list
5679663|NCT03504241|Alemtuzumab|alemtuzumab|mesh-list
5679664|NCT03504241|Abatacept|abatacept|mesh-list
5867967|NCT02354872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867968|NCT02354638|Nicotine|nicotine|mesh-list
5867969|NCT02354638|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5867970|NCT02354638|Autonomic Agents|autonomic agents|mesh-ancestor
5679665|NCT03504241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5679666|NCT03504241|Glucocorticoids|glucocorticoids|mesh-ancestor
5679667|NCT03504241|Hormones|hormones|mesh-ancestor
5679668|NCT03504241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5679669|NCT03504241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679670|NCT03504241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5679671|NCT03504241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5679672|NCT03504241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5679673|NCT03504241|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5679674|NCT03504241|Antitubercular Agents|antitubercular agents|mesh-ancestor
5679675|NCT03504241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5679676|NCT03504241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5679677|NCT03504241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5679678|NCT03504241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5679679|NCT03504241|Antifungal Agents|antifungal agents|mesh-ancestor
5679680|NCT03504241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5679681|NCT03504241|Immunologic Factors|immunologic factors|mesh-ancestor
5679682|NCT03504241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5679683|NCT03504241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5679684|NCT03504241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5679685|NCT03504202|Trimetazidine|trimetazidine|mesh-list
5679686|NCT03504202|Vasodilator Agents|vasodilator agents|mesh-ancestor
5679687|NCT03504163|Pembrolizumab|pembrolizumab|mesh-list
5679688|NCT03504163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5679689|NCT03504163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5679690|NCT03504072|Etanercept|etanercept|mesh-list
5679691|NCT03504072|Tofacitinib|tofacitinib|mesh-list
5679692|NCT03504072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5679693|NCT03504072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5679694|NCT03504072|Analgesics|analgesics|mesh-ancestor
5679695|NCT03504072|Sensory System Agents|sensory system agents|mesh-ancestor
5679696|NCT03504072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5679697|NCT03504072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679698|NCT03504072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5679699|NCT03504072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5679700|NCT03504072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5679701|NCT03504072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5679702|NCT03504072|Immunologic Factors|immunologic factors|mesh-ancestor
5679703|NCT03504072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5679704|NCT03504072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5679705|NCT03504072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5679706|NCT03504046|Pancrelipase|pancrelipase|mesh-list
5679707|NCT03504046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5679708|NCT03504033|Desflurane|desflurane|mesh-list
5679709|NCT03504033|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5679710|NCT03504033|Anesthetics, General|anesthetics, general|mesh-ancestor
5679711|NCT03504033|Anesthetics|anesthetics|mesh-ancestor
5679712|NCT03504033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5679713|NCT03504033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679714|NCT03503994|Beclomethasone|beclomethasone|mesh-list
5679715|NCT03503994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5679716|NCT03503994|Glucocorticoids|glucocorticoids|mesh-ancestor
5679717|NCT03503994|Hormones|hormones|mesh-ancestor
5679718|NCT03503994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5679719|NCT03503994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679720|NCT03503994|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5867971|NCT02354638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5867972|NCT02354638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867973|NCT02354638|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5867974|NCT02354638|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5867975|NCT02354638|Cholinergic Agents|cholinergic agents|mesh-ancestor
5867976|NCT02354638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5867977|NCT02354638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905253|NCT00085774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5905254|NCT00085774|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5905255|NCT00085774|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5905256|NCT00085774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5905257|NCT00085774|Adrenergic Agents|adrenergic agents|mesh-ancestor
5905258|NCT00085774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5679721|NCT03503994|Respiratory System Agents|respiratory system agents|mesh-ancestor
5679722|NCT03503942|Metformin|metformin|mesh-list
5679723|NCT03503942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5679724|NCT03503942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679725|NCT03503864|Arsenic Trioxide|arsenic trioxide|mesh-list
5679726|NCT03503864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5679727|NCT03503786|Paclitaxel|paclitaxel|mesh-list
5679728|NCT03503786|Carboplatin|carboplatin|mesh-list
5679729|NCT03503786|Avelumab|avelumab|mesh-list
5679730|NCT03503786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5679731|NCT03503786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5679732|NCT03503786|Tubulin Modulators|tubulin modulators|mesh-ancestor
5679733|NCT03503786|Antimitotic Agents|antimitotic agents|mesh-ancestor
5679734|NCT03503786|Mitosis Modulators|mitosis modulators|mesh-ancestor
5679735|NCT03503786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5679736|NCT03503786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5696755|NCT03380936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696756|NCT03380871|Carboplatin|carboplatin|mesh-list
5696757|NCT03380871|Pembrolizumab|pembrolizumab|mesh-list
5696758|NCT03380871|Pemetrexed|pemetrexed|mesh-list
5696759|NCT03380871|Poly ICLC|poly iclc|mesh-list
5696760|NCT03380871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5696761|NCT03380871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5696762|NCT03380871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5696763|NCT03380871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696764|NCT03380871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5696765|NCT03380871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5696766|NCT03380871|Interferon Inducers|interferon inducers|mesh-ancestor
5696767|NCT03380871|Immunologic Factors|immunologic factors|mesh-ancestor
5696768|NCT03380871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696769|NCT03380728|Ibogaine|ibogaine|mesh-list
5696770|NCT03380728|Hallucinogens|hallucinogens|mesh-ancestor
5696771|NCT03380728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696772|NCT03380728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5696773|NCT03380728|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5696774|NCT03380728|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5696775|NCT03380728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5696776|NCT03380728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696777|NCT03380689|Bevacizumab|bevacizumab|mesh-list
5696778|NCT03380689|Irinotecan|irinotecan|mesh-list
5696779|NCT03380689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5696780|NCT03380689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5696781|NCT03380689|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5696782|NCT03380689|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5696783|NCT03380689|Growth Substances|growth substances|mesh-ancestor
5696784|NCT03380689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696785|NCT03380689|Growth Inhibitors|growth inhibitors|mesh-ancestor
5696786|NCT03380689|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5696787|NCT03380689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5696788|NCT03380689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5696789|NCT03380689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696790|NCT03380559|Botulinum Toxins|botulinum toxins|mesh-list
5696791|NCT03380559|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5696792|NCT03380559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5696793|NCT03380559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696794|NCT03380559|Cholinergic Agents|cholinergic agents|mesh-ancestor
5696795|NCT03380559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5696796|NCT03380559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696797|NCT03380546|Insulin|insulin|mesh-list
5679737|NCT03503604|Leucovorin|leucovorin|mesh-list
5679738|NCT03503604|Gemcitabine|gemcitabine|mesh-list
5679739|NCT03503604|Paclitaxel|paclitaxel|mesh-list
5679740|NCT03503604|Carboplatin|carboplatin|mesh-list
5679741|NCT03503604|Fluorouracil|fluorouracil|mesh-list
5679742|NCT03503604|Oxaliplatin|oxaliplatin|mesh-list
5679743|NCT03503604|Irinotecan|irinotecan|mesh-list
5679744|NCT03503604|Bevacizumab|bevacizumab|mesh-list
5679745|NCT03503604|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5679746|NCT03503604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5679747|NCT03503604|Tubulin Modulators|tubulin modulators|mesh-ancestor
5679748|NCT03503604|Antimitotic Agents|antimitotic agents|mesh-ancestor
5679749|NCT03503604|Mitosis Modulators|mitosis modulators|mesh-ancestor
5679750|NCT03503604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5679751|NCT03503604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5679752|NCT03503604|Antimetabolites|antimetabolites|mesh-ancestor
5867978|NCT02354612|Bevacizumab|bevacizumab|mesh-list
5867979|NCT02354612|Capecitabine|capecitabine|mesh-list
5867980|NCT02354612|Axitinib|axitinib|mesh-list
5867981|NCT02354612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5867982|NCT02354612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5867983|NCT02354612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5867984|NCT02354612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5867985|NCT02354612|Growth Substances|growth substances|mesh-ancestor
5867986|NCT02354612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679753|NCT03503604|Antiviral Agents|antiviral agents|mesh-ancestor
5679754|NCT03503604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5679755|NCT03503604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5679756|NCT03503604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5679757|NCT03503604|Immunologic Factors|immunologic factors|mesh-ancestor
5867987|NCT02354612|Growth Inhibitors|growth inhibitors|mesh-ancestor
5867988|NCT02354612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5867989|NCT02354612|Antimetabolites|antimetabolites|mesh-ancestor
5867990|NCT02354612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5867991|NCT02354612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5867992|NCT02354612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5867993|NCT02354547|Cyclophosphamide|cyclophosphamide|mesh-list
5867994|NCT02354547|Topotecan|topotecan|mesh-list
5867995|NCT02354547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5867996|NCT02354547|Immunologic Factors|immunologic factors|mesh-ancestor
5867997|NCT02354547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5867998|NCT02354547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5867999|NCT02354547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5868000|NCT02354547|Alkylating Agents|alkylating agents|mesh-ancestor
5868001|NCT02354547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868002|NCT02354547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5868003|NCT02354547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5868004|NCT02354547|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5868005|NCT02354547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5868006|NCT02354547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5868007|NCT02354313|Lenalidomide|lenalidomide|mesh-list
5868008|NCT02354313|Immunologic Factors|immunologic factors|mesh-ancestor
5868009|NCT02354313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868010|NCT02354313|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5868011|NCT02354313|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5868012|NCT02354313|Growth Substances|growth substances|mesh-ancestor
5868013|NCT02354313|Growth Inhibitors|growth inhibitors|mesh-ancestor
5868014|NCT02354313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5868015|NCT02354560|Erythromycin|erythromycin|mesh-list
5868016|NCT02354560|Erythromycin Estolate|erythromycin estolate|mesh-list
5868017|NCT02354560|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
5868018|NCT02354560|Erythromycin stearate|erythromycin stearate|mesh-list
5868019|NCT02354560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5868020|NCT02354560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5868021|NCT02354560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5868022|NCT02354560|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5868023|NCT02354560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5679758|NCT03503604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679759|NCT03503604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5679760|NCT03503604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5679761|NCT03503604|Antidotes|antidotes|mesh-ancestor
5679762|NCT03503604|Protective Agents|protective agents|mesh-ancestor
5679763|NCT03503604|Vitamin B Complex|vitamin b complex|mesh-ancestor
6494951|NCT00620971|Vinorelbine|vinorelbine|mesh-list
5679764|NCT03503604|Vitamins|vitamins|mesh-ancestor
5679765|NCT03503604|Micronutrients|micronutrients|mesh-ancestor
5679766|NCT03503604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5679767|NCT03503604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5868024|NCT02354560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868025|NCT02354261|Itraconazole|itraconazole|mesh-list
5868026|NCT02354261|Antifungal Agents|antifungal agents|mesh-ancestor
5868027|NCT02354261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5868028|NCT02354261|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5868029|NCT02354261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5868030|NCT02354261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5868031|NCT02354261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868032|NCT02354261|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5868033|NCT02354261|Hormone Antagonists|hormone antagonists|mesh-ancestor
5868034|NCT02354261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5868035|NCT02354261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868036|NCT02354261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5868037|NCT02354170|Mifepristone|mifepristone|mesh-list
5868038|NCT02354170|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5868039|NCT02354170|Abortifacient Agents|abortifacient agents|mesh-ancestor
5868040|NCT02354170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5868041|NCT02354170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868042|NCT02354170|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5868043|NCT02354170|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5868044|NCT02354170|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5868045|NCT02354170|Contraceptive Agents|contraceptive agents|mesh-ancestor
5868046|NCT02354170|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5868047|NCT02354170|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5868048|NCT02354170|Hormone Antagonists|hormone antagonists|mesh-ancestor
5868049|NCT02354170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5868050|NCT02354170|Luteolytic Agents|luteolytic agents|mesh-ancestor
5868051|NCT02354170|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5868052|NCT02354170|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5868053|NCT02353949|Flutemetamol|flutemetamol|mesh-list
5868054|NCT02353949|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5868055|NCT02353949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868056|NCT02354027|Metformin|metformin|mesh-list
5868057|NCT02354027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5868058|NCT02354027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868059|NCT02354001|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
5868060|NCT02354001|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5868061|NCT02354001|Hormone Antagonists|hormone antagonists|mesh-ancestor
5868062|NCT02354001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5868063|NCT02354001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868064|NCT02354001|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5868065|NCT02354001|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5868066|NCT02354001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5868067|NCT02354053|Triumeq|triumeq|mesh-list
5868068|NCT02354053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5868069|NCT02354053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5868070|NCT02354053|Antiviral Agents|antiviral agents|mesh-ancestor
5868071|NCT02354053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5868072|NCT02353936|Afatinib|afatinib|mesh-list
5868073|NCT02353936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5868074|NCT02353936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5868075|NCT02353936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5868076|NCT02353936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868077|NCT02353858|Fluorouracil|fluorouracil|mesh-list
5868078|NCT02353858|Antimetabolites|antimetabolites|mesh-ancestor
5868079|NCT02353858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868080|NCT02353858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5868081|NCT02353858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5868082|NCT02353858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5868083|NCT02353858|Immunologic Factors|immunologic factors|mesh-ancestor
5868084|NCT02353858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868085|NCT02353988|Bicalutamide|bicalutamide|mesh-list
5868086|NCT02353988|Androgen Antagonists|androgen antagonists|mesh-ancestor
5868087|NCT02353988|Hormone Antagonists|hormone antagonists|mesh-ancestor
5868088|NCT02353988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5868089|NCT02353988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868090|NCT02353988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5868091|NCT02353702|Ropivacaine|ropivacaine|mesh-list
5868092|NCT02353702|Anesthetics, Local|anesthetics, local|mesh-ancestor
5868093|NCT02353702|Anesthetics|anesthetics|mesh-ancestor
5868094|NCT02353702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5868095|NCT02353702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868096|NCT02353702|Sensory System Agents|sensory system agents|mesh-ancestor
5868097|NCT02353702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5868098|NCT02353611|Hydrogen Peroxide|hydrogen peroxide|mesh-list
5679768|NCT03503604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5679769|NCT03503604|Growth Substances|growth substances|mesh-ancestor
5679770|NCT03503604|Growth Inhibitors|growth inhibitors|mesh-ancestor
5679771|NCT03503513|Gentamicins|gentamicins|mesh-list
5679772|NCT03503513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5679773|NCT03503513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5679774|NCT03503513|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5679775|NCT03503513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5679776|NCT03503513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5679777|NCT03503409|Ivosidenib|ivosidenib|mesh-list
5679778|NCT03503409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5679779|NCT03503409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5679780|NCT03503409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5679781|NCT03503227|Aspirin|aspirin|mesh-list
5679782|NCT03503227|Salicylic Acid|salicylic acid|mesh-list
5679783|NCT03503227|Prednisolone|prednisolone|mesh-list
5679784|NCT03503227|Salicylates|salicylates|mesh-list
5679785|NCT03503227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5679786|NCT03503227|Glucocorticoids|glucocorticoids|mesh-ancestor
5679787|NCT03503227|Hormones|hormones|mesh-ancestor
5679788|NCT03503227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5679789|NCT03503227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679790|NCT03503227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5679791|NCT03503227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5679792|NCT03503227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5679793|NCT03503227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6675107|NCT01572649|Lixisenatide|lixisenatide|mesh-list
6675108|NCT01572649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6675109|NCT01572649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675110|NCT01572662|Vidarabine|vidarabine|mesh-list
6675111|NCT01572662|Methotrexate|methotrexate|mesh-list
5868099|NCT02353611|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5868100|NCT02353611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5868101|NCT02353715|Abiraterone Acetate|abiraterone acetate|mesh-list
5868102|NCT02353715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5868103|NCT02353715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5868104|NCT02353715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5868105|NCT02353715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868106|NCT02353715|Hormone Antagonists|hormone antagonists|mesh-ancestor
6675112|NCT01572662|Fludarabine phosphate|fludarabine phosphate|mesh-list
6675113|NCT01572662|Fludarabine|fludarabine|mesh-list
6675114|NCT01572662|Busulfan|busulfan|mesh-list
6675115|NCT01572662|Tacrolimus|tacrolimus|mesh-list
6675116|NCT01572662|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6675117|NCT01572662|Abortifacient Agents|abortifacient agents|mesh-ancestor
6675118|NCT01572662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6675119|NCT01572662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675120|NCT01572662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6675121|NCT01572662|Antimetabolites|antimetabolites|mesh-ancestor
6675122|NCT01572662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675123|NCT01572662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6675124|NCT01572662|Dermatologic Agents|dermatologic agents|mesh-ancestor
6675125|NCT01572662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6675126|NCT01572662|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6675127|NCT01572662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6675128|NCT01572662|Immunologic Factors|immunologic factors|mesh-ancestor
6675129|NCT01572662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6675130|NCT01572662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6675131|NCT01572662|Antiviral Agents|antiviral agents|mesh-ancestor
5679794|NCT03503227|Antifungal Agents|antifungal agents|mesh-ancestor
5679795|NCT03503227|Keratolytic Agents|keratolytic agents|mesh-ancestor
5679796|NCT03503227|Dermatologic Agents|dermatologic agents|mesh-ancestor
5679797|NCT03503227|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5679798|NCT03503227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5679799|NCT03503227|Analgesics|analgesics|mesh-ancestor
5679800|NCT03503227|Sensory System Agents|sensory system agents|mesh-ancestor
5679801|NCT03503227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5679802|NCT03503227|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5679803|NCT03503227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5696798|NCT03380546|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6675132|NCT01572662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6675133|NCT01572662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5868107|NCT02353715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5868108|NCT02353715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868109|NCT02353715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5868110|NCT02353676|Bupivacaine|bupivacaine|mesh-list
5868111|NCT02353676|Anesthetics, Local|anesthetics, local|mesh-ancestor
5868112|NCT02353676|Anesthetics|anesthetics|mesh-ancestor
5868113|NCT02353676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5868114|NCT02353676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868115|NCT02353676|Sensory System Agents|sensory system agents|mesh-ancestor
5868116|NCT02353676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5868117|NCT02353494|Piperaquine|piperaquine|mesh-list
5868118|NCT02353494|Artenimol|artenimol|mesh-list
5868119|NCT02353494|Antimalarials|antimalarials|mesh-ancestor
5868120|NCT02353494|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5868121|NCT02353494|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5868122|NCT02353494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5868123|NCT02353598|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5868124|NCT02353598|Immunologic Factors|immunologic factors|mesh-ancestor
5868125|NCT02353598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868126|NCT02353325|Ascorbic Acid|ascorbic acid|mesh-list
5868127|NCT02353325|Fesoterodine|fesoterodine|mesh-list
5868128|NCT02353325|Antioxidants|antioxidants|mesh-ancestor
5868129|NCT02353325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868130|NCT02353325|Protective Agents|protective agents|mesh-ancestor
5868131|NCT02353325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868132|NCT02353325|Vitamins|vitamins|mesh-ancestor
5868133|NCT02353325|Micronutrients|micronutrients|mesh-ancestor
5868134|NCT02353325|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5868135|NCT02353325|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5868136|NCT02353325|Cholinergic Agents|cholinergic agents|mesh-ancestor
5868137|NCT02353325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5868138|NCT02353325|Urological Agents|urological agents|mesh-ancestor
5868139|NCT02353260|Docetaxel|docetaxel|mesh-list
5868140|NCT02353260|Fluorouracil|fluorouracil|mesh-list
5868141|NCT02353260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5868142|NCT02353260|Tubulin Modulators|tubulin modulators|mesh-ancestor
5868143|NCT02353260|Antimitotic Agents|antimitotic agents|mesh-ancestor
5868144|NCT02353260|Mitosis Modulators|mitosis modulators|mesh-ancestor
5868145|NCT02353260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868146|NCT02353260|Antimetabolites|antimetabolites|mesh-ancestor
5868147|NCT02353260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5868148|NCT02353260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5868149|NCT02353260|Immunologic Factors|immunologic factors|mesh-ancestor
5868150|NCT02353260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868151|NCT02353182|Dexmedetomidine|dexmedetomidine|mesh-list
5868152|NCT02353182|Remifentanil|remifentanil|mesh-list
5868153|NCT02353182|Bupivacaine|bupivacaine|mesh-list
5868154|NCT02353182|Ropivacaine|ropivacaine|mesh-list
5868155|NCT02353182|Anesthetics, Local|anesthetics, local|mesh-ancestor
5868156|NCT02353182|Anesthetics|anesthetics|mesh-ancestor
5868157|NCT02353182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5868158|NCT02353182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868159|NCT02353182|Sensory System Agents|sensory system agents|mesh-ancestor
5868160|NCT02353182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5868161|NCT02353182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5868162|NCT02353182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5868163|NCT02353182|Analgesics|analgesics|mesh-ancestor
5868164|NCT02353182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5868165|NCT02353182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5868166|NCT02353182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5868167|NCT02353182|Adrenergic Agents|adrenergic agents|mesh-ancestor
5868168|NCT02353182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5868169|NCT02353182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868170|NCT02353182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6212339|NCT02186847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5679804|NCT03503227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5679805|NCT03503227|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5679806|NCT03503227|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5679807|NCT03503227|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5679808|NCT03503227|Antipyretics|antipyretics|mesh-ancestor
5679809|NCT03503201|Chromium|chromium|mesh-list
5679810|NCT03503201|Trace Elements|trace elements|mesh-ancestor
5679811|NCT03503201|Micronutrients|micronutrients|mesh-ancestor
5679812|NCT03503201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679813|NCT03503136|Cisplatin|cisplatin|mesh-list
5679814|NCT03503136|Docetaxel|docetaxel|mesh-list
5679815|NCT03503136|Fluorouracil|fluorouracil|mesh-list
5868171|NCT02353182|Narcotics|narcotics|mesh-ancestor
5868172|NCT02353507|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
5868173|NCT02353507|Laxatives|laxatives|mesh-ancestor
5868174|NCT02353507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5868175|NCT02353429|Toremifene|toremifene|mesh-list
5868176|NCT02353429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5868177|NCT02353429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5679816|NCT03503136|Capecitabine|capecitabine|mesh-list
5679817|NCT03503136|Nedaplatin|nedaplatin|mesh-list
5679818|NCT03503136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5679819|NCT03503136|Tubulin Modulators|tubulin modulators|mesh-ancestor
5679820|NCT03503136|Antimitotic Agents|antimitotic agents|mesh-ancestor
5679821|NCT03503136|Mitosis Modulators|mitosis modulators|mesh-ancestor
5679822|NCT03503136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5679823|NCT03503136|Antimetabolites|antimetabolites|mesh-ancestor
5679824|NCT03503136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5679825|NCT03503136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5679826|NCT03503136|Immunologic Factors|immunologic factors|mesh-ancestor
5679827|NCT03503136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679828|NCT03503058|Chloroquine|chloroquine|mesh-list
5679829|NCT03503058|Amebicides|amebicides|mesh-ancestor
5679830|NCT03503058|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5679831|NCT03503058|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5868178|NCT02353429|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5868179|NCT02353429|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5868180|NCT02353429|Hormone Antagonists|hormone antagonists|mesh-ancestor
5868181|NCT02353429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5868182|NCT02353429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868183|NCT02353429|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5868184|NCT02353247|Norethindrone|norethindrone|mesh-list
5868185|NCT02353247|Norethindrone Acetate|norethindrone acetate|mesh-list
5868186|NCT02353247|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5868187|NCT02353247|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5868188|NCT02353247|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5868189|NCT02353247|Contraceptive Agents|contraceptive agents|mesh-ancestor
5868190|NCT02353247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5868191|NCT02353247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868192|NCT02353247|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5868193|NCT02353247|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5905259|NCT00085774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905260|NCT00071552|Fluticasone|fluticasone|mesh-list
5905261|NCT00071552|Xhance|xhance|mesh-list
5905262|NCT00071552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5905263|NCT00071552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5905264|NCT00071552|Autonomic Agents|autonomic agents|mesh-ancestor
5905265|NCT00071552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5905266|NCT00071552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905267|NCT00071552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5905268|NCT00071552|Respiratory System Agents|respiratory system agents|mesh-ancestor
5905269|NCT00071552|Dermatologic Agents|dermatologic agents|mesh-ancestor
5905270|NCT00071552|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5905271|NCT05136066|Peppermint oil|peppermint oil|mesh-list
5905272|NCT05136066|Antiemetics|antiemetics|mesh-ancestor
5905273|NCT05136066|Autonomic Agents|autonomic agents|mesh-ancestor
5905274|NCT05136066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5905275|NCT05136066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905276|NCT05136066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5905277|NCT05136066|Parasympatholytics|parasympatholytics|mesh-ancestor
5905278|NCT05125146|Trazodone|trazodone|mesh-list
5905279|NCT05125146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5905280|NCT05125146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5905281|NCT05125146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5905282|NCT05125146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905283|NCT05125146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5905284|NCT05125146|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5905285|NCT05125146|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5679832|NCT03503058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5679833|NCT03503058|Antimalarials|antimalarials|mesh-ancestor
5679834|NCT03503058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5679835|NCT03502993|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5679836|NCT03502993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5679837|NCT03502889|Ropivacaine|ropivacaine|mesh-list
5679838|NCT03502889|Anesthetics, Local|anesthetics, local|mesh-ancestor
5679839|NCT03502889|Anesthetics|anesthetics|mesh-ancestor
5679840|NCT03502889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5679841|NCT03502889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868194|NCT02353130|Memantine|memantine|mesh-list
5868195|NCT02353130|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5868196|NCT02353130|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5868197|NCT02353130|Dopamine Agents|dopamine agents|mesh-ancestor
5868198|NCT02353130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5868199|NCT02353130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868200|NCT02353130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868201|NCT02353130|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5868202|NCT02353130|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5868203|NCT02353078|Sucralfate|sucralfate|mesh-list
5868204|NCT02353078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5868205|NCT02353078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5868206|NCT02353026|Artesunate|artesunate|mesh-list
5868207|NCT02353026|Antimalarials|antimalarials|mesh-ancestor
5868208|NCT02353026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5868209|NCT02353026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5868210|NCT02353026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5868211|NCT02353026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5868212|NCT02353026|Antiviral Agents|antiviral agents|mesh-ancestor
5679842|NCT03502889|Sensory System Agents|sensory system agents|mesh-ancestor
5679843|NCT03502889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5679844|NCT03502824|Anti-Infective Agents|anti-infective agents|mesh-list
5679845|NCT03502824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5679846|NCT03502746|Nivolumab|nivolumab|mesh-list
5679847|NCT03502746|Ramucirumab|ramucirumab|mesh-list
5679848|NCT03502746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5679849|NCT03502746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5868213|NCT02353026|Schistosomicides|schistosomicides|mesh-ancestor
5868214|NCT02353026|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5868215|NCT02353026|Anthelmintics|anthelmintics|mesh-ancestor
5868216|NCT02352883|Hormones|hormones|mesh-list
5868217|NCT02352883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5868218|NCT02352883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905286|NCT05125146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5905287|NCT05125146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905288|NCT05125146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5905289|NCT05125146|Serotonin Agents|serotonin agents|mesh-ancestor
5679850|NCT03502746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5679851|NCT03502746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5679852|NCT03502733|Nivolumab|nivolumab|mesh-list
5679853|NCT03502733|Ipilimumab|ipilimumab|mesh-list
5679854|NCT03502733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5679855|NCT03502733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5679856|NCT03502733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5679857|NCT03502733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5679858|NCT03502642|Morphine|morphine|mesh-list
5679859|NCT03502642|Ropivacaine|ropivacaine|mesh-list
5679860|NCT03502642|Anesthetics|anesthetics|mesh-ancestor
5679861|NCT03502642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5905290|NCT05125146|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5905291|NCT05125146|Antidepressive Agents|antidepressive agents|mesh-ancestor
5905292|NCT05136703|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
5905293|NCT05136703|Antiviral Agents|antiviral agents|mesh-ancestor
5905294|NCT05136703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5905295|NCT05136677|Carboplatin|carboplatin|mesh-list
5905296|NCT05136677|Nivolumab|nivolumab|mesh-list
5905297|NCT05136677|Pemetrexed|pemetrexed|mesh-list
5905298|NCT05136677|Ipilimumab|ipilimumab|mesh-list
5905299|NCT05136677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5905300|NCT05136677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5905301|NCT05136677|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5905302|NCT05136677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905303|NCT05136677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5905304|NCT05136677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5905305|NCT05136677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5905306|NCT05136534|Anesthetics|anesthetics|mesh-list
5905307|NCT05136534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5905308|NCT05136534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905309|NCT05136521|Trazodone|trazodone|mesh-list
5905310|NCT05136521|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5905311|NCT05136521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5905312|NCT05136521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5679862|NCT03502642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679863|NCT03502642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5679864|NCT03502642|Narcotics|narcotics|mesh-ancestor
5905313|NCT05136521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868219|NCT02352987|Salicylic Acid|salicylic acid|mesh-list
5868220|NCT02352987|Salicylates|salicylates|mesh-list
5868221|NCT02352987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5868222|NCT02352987|Antifungal Agents|antifungal agents|mesh-ancestor
5868223|NCT02352987|Keratolytic Agents|keratolytic agents|mesh-ancestor
5679865|NCT03502642|Analgesics|analgesics|mesh-ancestor
5679866|NCT03502642|Sensory System Agents|sensory system agents|mesh-ancestor
5679867|NCT03502642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5679868|NCT03502642|Anesthetics, Local|anesthetics, local|mesh-ancestor
5679869|NCT03502551|Ketamine|ketamine|mesh-list
5679870|NCT03502551|Analgesics|analgesics|mesh-ancestor
5679871|NCT03502551|Sensory System Agents|sensory system agents|mesh-ancestor
5679872|NCT03502551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5679873|NCT03502551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679874|NCT03502551|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5679875|NCT03502551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5679876|NCT03502551|Anesthetics, General|anesthetics, general|mesh-ancestor
5679877|NCT03502551|Anesthetics|anesthetics|mesh-ancestor
5679878|NCT03502551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5679879|NCT03502551|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5679880|NCT03502551|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5679881|NCT03502551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5679882|NCT03502551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868224|NCT02352987|Dermatologic Agents|dermatologic agents|mesh-ancestor
5868225|NCT02352987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5868226|NCT02352987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5868227|NCT02352987|Analgesics|analgesics|mesh-ancestor
5868228|NCT02352987|Sensory System Agents|sensory system agents|mesh-ancestor
5679883|NCT03502434|Petrolatum|petrolatum|mesh-list
5679884|NCT03502434|Emollients|emollients|mesh-ancestor
5679885|NCT03502434|Dermatologic Agents|dermatologic agents|mesh-ancestor
5679886|NCT03502421|Ketamine|ketamine|mesh-list
5679887|NCT03502421|Analgesics|analgesics|mesh-ancestor
5679888|NCT03502421|Sensory System Agents|sensory system agents|mesh-ancestor
5679889|NCT03502421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5679890|NCT03502421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679891|NCT03502421|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5679892|NCT03502421|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5679893|NCT03502421|Anesthetics, General|anesthetics, general|mesh-ancestor
5679894|NCT03502421|Anesthetics|anesthetics|mesh-ancestor
5679895|NCT03502421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5679896|NCT03502421|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5679897|NCT03502421|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5679898|NCT03502421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5679899|NCT03502421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5679900|NCT03502395|Lidocaine|lidocaine|mesh-list
5679901|NCT03502395|Anesthetics, Local|anesthetics, local|mesh-ancestor
5679902|NCT03502395|Anesthetics|anesthetics|mesh-ancestor
5679903|NCT03502395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5679904|NCT03502395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679905|NCT03502395|Sensory System Agents|sensory system agents|mesh-ancestor
5679906|NCT03502395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5679907|NCT03502395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5679908|NCT03502395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5679909|NCT03502395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5679910|NCT03502395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5679911|NCT03502395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5679912|NCT03502356|Azithromycin|azithromycin|mesh-list
5679913|NCT03502356|Cefazolin|cefazolin|mesh-list
5679914|NCT03502356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5679915|NCT03502356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5679916|NCT03502343|Gemcitabine|gemcitabine|mesh-list
5679917|NCT03502343|Paclitaxel|paclitaxel|mesh-list
5679918|NCT03502343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5679919|NCT03502343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5679920|NCT03502343|Tubulin Modulators|tubulin modulators|mesh-ancestor
5679921|NCT03502343|Antimitotic Agents|antimitotic agents|mesh-ancestor
5679922|NCT03502343|Mitosis Modulators|mitosis modulators|mesh-ancestor
5679923|NCT03502343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5679924|NCT03502343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5679925|NCT03502343|Antimetabolites|antimetabolites|mesh-ancestor
5679926|NCT03502343|Antiviral Agents|antiviral agents|mesh-ancestor
5679927|NCT03502343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5679928|NCT03502343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5868229|NCT02352987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5868230|NCT02352987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868231|NCT02352987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5868232|NCT02352987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5868233|NCT02352987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5868234|NCT02352987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5868235|NCT02352987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868236|NCT02352714|Lidocaine|lidocaine|mesh-list
5868237|NCT02352714|Anesthetics, Local|anesthetics, local|mesh-ancestor
5868238|NCT02352714|Anesthetics|anesthetics|mesh-ancestor
5868239|NCT02352714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5868240|NCT02352714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868241|NCT02352714|Sensory System Agents|sensory system agents|mesh-ancestor
5868242|NCT02352714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5868243|NCT02352714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5679929|NCT03502343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5679930|NCT03502343|Immunologic Factors|immunologic factors|mesh-ancestor
5679931|NCT03502343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679932|NCT03502291|Vaccines|vaccines|mesh-list
5679933|NCT03502291|Immunologic Factors|immunologic factors|mesh-ancestor
5679934|NCT03502291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679935|NCT03502135|Phenylephrine|phenylephrine|mesh-list
5679936|NCT03502135|Oxymetazoline|oxymetazoline|mesh-list
5679937|NCT03502135|Tetracaine|tetracaine|mesh-list
5679938|NCT03502135|Anesthetics, Local|anesthetics, local|mesh-ancestor
5679939|NCT03502135|Anesthetics|anesthetics|mesh-ancestor
5679940|NCT03502135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5679941|NCT03502135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679942|NCT03502135|Sensory System Agents|sensory system agents|mesh-ancestor
5679943|NCT03502135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5679944|NCT03502135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5679945|NCT03502135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5679946|NCT03502135|Adrenergic Agents|adrenergic agents|mesh-ancestor
5679947|NCT03502135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5679948|NCT03502135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868244|NCT02352714|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5868245|NCT02352714|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5868246|NCT02352714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5868247|NCT02352714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868248|NCT02352545|Montelukast|montelukast|mesh-list
5868249|NCT02352545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5868250|NCT02352545|Respiratory System Agents|respiratory system agents|mesh-ancestor
5868251|NCT02352545|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5868252|NCT02352545|Hormone Antagonists|hormone antagonists|mesh-ancestor
5868253|NCT02352545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5868254|NCT02352545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868255|NCT02352545|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5868256|NCT02352545|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5868257|NCT02352545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868258|NCT02352597|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5868259|NCT02352597|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5868260|NCT02352597|Clomiphene|clomiphene|mesh-list
5868261|NCT02352597|Enclomiphene|enclomiphene|mesh-list
5868262|NCT02352597|Zuclomiphene|zuclomiphene|mesh-list
5868263|NCT02352597|Estradiol|estradiol|mesh-list
5868264|NCT02352597|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5868265|NCT02352597|Phytoestrogens|phytoestrogens|mesh-list
5868266|NCT02352597|Estrogens|estrogens|mesh-ancestor
5868267|NCT02352597|Hormones|hormones|mesh-ancestor
5868268|NCT02352597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5868269|NCT02352597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868270|NCT02352597|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5868271|NCT02352597|Contraceptive Agents|contraceptive agents|mesh-ancestor
5868272|NCT02352597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5868273|NCT02352597|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5679949|NCT03502135|Sympathomimetics|sympathomimetics|mesh-ancestor
5679950|NCT03502135|Autonomic Agents|autonomic agents|mesh-ancestor
5679951|NCT03502135|Nasal Decongestants|nasal decongestants|mesh-ancestor
5679952|NCT03502135|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5679953|NCT03502135|Respiratory System Agents|respiratory system agents|mesh-ancestor
5679954|NCT03502135|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5679955|NCT03502135|Mydriatics|mydriatics|mesh-ancestor
5679956|NCT03502135|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5679957|NCT03502135|Protective Agents|protective agents|mesh-ancestor
5696799|NCT03380546|Acarbose|acarbose|mesh-list
5868274|NCT02352597|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5868275|NCT02352597|Hormone Antagonists|hormone antagonists|mesh-ancestor
5868276|NCT02352597|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5868277|NCT02352597|Fertility Agents|fertility agents|mesh-ancestor
5868278|NCT02352597|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5868279|NCT02352597|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5868280|NCT02352597|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
5868281|NCT02352558|Dexamethasone|dexamethasone|mesh-list
5868282|NCT02352558|Bortezomib|bortezomib|mesh-list
5679958|NCT03502018|Bupivacaine|bupivacaine|mesh-list
5679959|NCT03502018|Anesthetics, Local|anesthetics, local|mesh-ancestor
5679960|NCT03502018|Anesthetics|anesthetics|mesh-ancestor
5679961|NCT03502018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5679962|NCT03502018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679963|NCT03502018|Sensory System Agents|sensory system agents|mesh-ancestor
5679964|NCT03502018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5679965|NCT03502005|Tenofovir|tenofovir|mesh-list
5679966|NCT03502005|Emtricitabine|emtricitabine|mesh-list
5679967|NCT03502005|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
5679968|NCT03502005|Antiviral Agents|antiviral agents|mesh-ancestor
5679969|NCT03502005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5679970|NCT03502005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5679971|NCT03502005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5679972|NCT03502005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5679973|NCT03502005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5679974|NCT03502005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5679975|NCT03502005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5679976|NCT03501966|Acetazolamide|acetazolamide|mesh-list
5679977|NCT03501966|Diuretics|diuretics|mesh-list
5679978|NCT03501966|Natriuretic Agents|natriuretic agents|mesh-ancestor
5679979|NCT03501966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679980|NCT03501966|Anticonvulsants|anticonvulsants|mesh-ancestor
5679981|NCT03501966|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5679982|NCT03501966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5679983|NCT03501966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5679984|NCT03501901|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5679985|NCT03501901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5679986|NCT03501680|Insulin|insulin|mesh-list
5679987|NCT03501680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5679988|NCT03501680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679989|NCT03501615|Immunotoxin HA22|immunotoxin ha22|mesh-list
5679990|NCT03501615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5679991|NCT03501498|Loperamide|loperamide|mesh-list
5679992|NCT03501498|Antidiarrheals|antidiarrheals|mesh-list
5679993|NCT03501498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5679994|NCT03501459|Rituximab|rituximab|mesh-list
5679995|NCT03501459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5679996|NCT03501459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5679997|NCT03501459|Immunologic Factors|immunologic factors|mesh-ancestor
5679998|NCT03501459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5679999|NCT03501459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5680000|NCT03501433|Niacinamide|niacinamide|mesh-list
5680001|NCT03501433|Niacin|niacin|mesh-list
5680002|NCT03501433|Nicotinic Acids|nicotinic acids|mesh-list
5680003|NCT03501433|Vitamin B Complex|vitamin b complex|mesh-ancestor
5680004|NCT03501433|Vitamins|vitamins|mesh-ancestor
5680005|NCT03501433|Micronutrients|micronutrients|mesh-ancestor
5680006|NCT03501433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680007|NCT03501433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5680008|NCT03501433|Antimetabolites|antimetabolites|mesh-ancestor
5680009|NCT03501433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680010|NCT03501433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5680011|NCT03501433|Vasodilator Agents|vasodilator agents|mesh-ancestor
5680012|NCT03501251|Albendazole|albendazole|mesh-list
5680013|NCT03501251|Moxidectin|moxidectin|mesh-list
5680014|NCT03501251|Anthelmintics|anthelmintics|mesh-ancestor
5680015|NCT03501251|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5680016|NCT03501251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5680017|NCT03501251|Anticestodal Agents|anticestodal agents|mesh-ancestor
5680018|NCT03501251|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5680019|NCT03501251|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5680020|NCT03501251|Tubulin Modulators|tubulin modulators|mesh-ancestor
5680021|NCT03501251|Antimitotic Agents|antimitotic agents|mesh-ancestor
5680022|NCT03501251|Mitosis Modulators|mitosis modulators|mesh-ancestor
5680023|NCT03501251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680024|NCT03501251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5680025|NCT03501251|Antinematodal Agents|antinematodal agents|mesh-ancestor
5680026|NCT03501212|Anesthetics|anesthetics|mesh-list
5868283|NCT02352558|Imatinib Mesylate|imatinib mesylate|mesh-list
5868284|NCT02352558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5868285|NCT02352558|Antiemetics|antiemetics|mesh-ancestor
5868286|NCT02352558|Autonomic Agents|autonomic agents|mesh-ancestor
5868287|NCT02352558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5868288|NCT02352558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868289|NCT02352558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5868290|NCT02352558|Glucocorticoids|glucocorticoids|mesh-ancestor
5868291|NCT02352558|Hormones|hormones|mesh-ancestor
5868292|NCT02352558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5868293|NCT02352558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5868294|NCT02352558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5868295|NCT02352558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5868296|NCT02352558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5868297|NCT02352558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868298|NCT02352519|Anesthetics|anesthetics|mesh-list
5868299|NCT02352519|Anesthetics, Local|anesthetics, local|mesh-list
5868300|NCT02352519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5868301|NCT02352519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868302|NCT02352519|Sensory System Agents|sensory system agents|mesh-ancestor
5868303|NCT02352519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5868304|NCT02352701|Amoxicillin|amoxicillin|mesh-list
5868305|NCT02352701|Levofloxacin|levofloxacin|mesh-list
5868306|NCT02352701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5868307|NCT02352701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5868308|NCT02352701|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5868309|NCT02352701|Renal Agents|renal agents|mesh-ancestor
5868310|NCT02352701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5868311|NCT02352701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5868312|NCT02352701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5868313|NCT02352701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868314|NCT02352701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5868315|NCT02352701|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5868316|NCT02352701|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5868317|NCT02352402|Ticagrelor|ticagrelor|mesh-list
5680027|NCT03501212|Anesthetics, Local|anesthetics, local|mesh-list
5680028|NCT03501212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5680029|NCT03501212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680030|NCT03501212|Sensory System Agents|sensory system agents|mesh-ancestor
5680031|NCT03501212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5680032|NCT03501056|Antibodies|antibodies|mesh-list
5680033|NCT03501056|Antibodies, Bispecific|antibodies, bispecific|mesh-list
5680034|NCT03501056|Immunologic Factors|immunologic factors|mesh-ancestor
5680035|NCT03501056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680036|NCT03500913|Hormones|hormones|mesh-list
5680037|NCT03500913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5680038|NCT03500913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680039|NCT03500900|Vildagliptin|vildagliptin|mesh-list
5680040|NCT03500900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5680041|NCT03500900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680042|NCT03500900|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5680043|NCT03500900|Protease Inhibitors|protease inhibitors|mesh-ancestor
5680044|NCT03500900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5680045|NCT03500900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680046|NCT03500874|Leucovorin|leucovorin|mesh-list
5680047|NCT03500874|Fluorouracil|fluorouracil|mesh-list
5680048|NCT03500874|Floxuridine|floxuridine|mesh-list
5680049|NCT03500874|Oxaliplatin|oxaliplatin|mesh-list
5680050|NCT03500874|Antimetabolites|antimetabolites|mesh-ancestor
5680051|NCT03500874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680052|NCT03500874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5680053|NCT03500874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5680054|NCT03500874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5680055|NCT03500874|Immunologic Factors|immunologic factors|mesh-ancestor
5680056|NCT03500874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680057|NCT03500874|Antidotes|antidotes|mesh-ancestor
5680058|NCT03500874|Protective Agents|protective agents|mesh-ancestor
5680059|NCT03500874|Vitamin B Complex|vitamin b complex|mesh-ancestor
5680060|NCT03500874|Vitamins|vitamins|mesh-ancestor
5680061|NCT03500874|Micronutrients|micronutrients|mesh-ancestor
5680062|NCT03500848|Mycophenolic Acid|mycophenolic acid|mesh-list
5680063|NCT03500848|Sirolimus|sirolimus|mesh-list
5680064|NCT03500848|Tacrolimus|tacrolimus|mesh-list
5680065|NCT03500848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5680066|NCT03500848|Immunologic Factors|immunologic factors|mesh-ancestor
5680067|NCT03500848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868318|NCT02352402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5868319|NCT02352402|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5868320|NCT02352402|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5868321|NCT02352402|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5868322|NCT02352402|Purinergic Agents|purinergic agents|mesh-ancestor
5868323|NCT02352402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5680068|NCT03500848|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5680069|NCT03500848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5680070|NCT03500848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680071|NCT03500848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5680072|NCT03500848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5680073|NCT03500848|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5680074|NCT03500848|Antitubercular Agents|antitubercular agents|mesh-ancestor
5680075|NCT03500848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5680076|NCT03500848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5680077|NCT03500848|Antifungal Agents|antifungal agents|mesh-ancestor
5680078|NCT03500783|Nitric Oxide|nitric oxide|mesh-list
5680079|NCT03500783|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5680080|NCT03500783|Autonomic Agents|autonomic agents|mesh-ancestor
5680081|NCT03500783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5680082|NCT03500783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680083|NCT03500783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5680084|NCT03500783|Respiratory System Agents|respiratory system agents|mesh-ancestor
5680085|NCT03500783|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5680086|NCT03500783|Antioxidants|antioxidants|mesh-ancestor
5680087|NCT03500783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680088|NCT03500783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5680089|NCT03500783|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5680090|NCT03500783|Vasodilator Agents|vasodilator agents|mesh-ancestor
5680091|NCT03500783|Gasotransmitters|gasotransmitters|mesh-ancestor
5680092|NCT03500783|Protective Agents|protective agents|mesh-ancestor
5680093|NCT03500653|Curcumin|curcumin|mesh-list
5680094|NCT03500653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5680095|NCT03500653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5680096|NCT03500653|Analgesics|analgesics|mesh-ancestor
5680097|NCT03500653|Sensory System Agents|sensory system agents|mesh-ancestor
5680098|NCT03500653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5680099|NCT03500653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680100|NCT03500653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5680101|NCT03500653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5680102|NCT03500653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5680103|NCT03500653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5680104|NCT03500653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680105|NCT03500445|Dexamethasone|dexamethasone|mesh-list
5680106|NCT03500445|Lenalidomide|lenalidomide|mesh-list
5680107|NCT03500445|Daratumumab|daratumumab|mesh-list
5680108|NCT03500445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5680109|NCT03500445|Antiemetics|antiemetics|mesh-ancestor
5680110|NCT03500445|Autonomic Agents|autonomic agents|mesh-ancestor
5680111|NCT03500445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5868324|NCT02352402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868325|NCT02352402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868326|NCT02352285|Tolvaptan|tolvaptan|mesh-list
5868327|NCT02352285|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
5868328|NCT02352285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868329|NCT02352285|Natriuretic Agents|natriuretic agents|mesh-ancestor
5868330|NCT02352285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868331|NCT02352168|Budesonide|budesonide|mesh-list
5868332|NCT02352168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5868333|NCT02352168|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5868334|NCT02352168|Autonomic Agents|autonomic agents|mesh-ancestor
5868335|NCT02352168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5868336|NCT02352168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868337|NCT02352168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5868338|NCT02352168|Respiratory System Agents|respiratory system agents|mesh-ancestor
5868339|NCT02352168|Glucocorticoids|glucocorticoids|mesh-ancestor
5868340|NCT02352168|Hormones|hormones|mesh-ancestor
5868341|NCT02352168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5868342|NCT02352051|Methylphenidate|methylphenidate|mesh-list
5868343|NCT02352051|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
5868344|NCT02352051|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5868345|NCT02352051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680112|NCT03500445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868346|NCT02352051|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5868347|NCT02352051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5868348|NCT02352051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5868349|NCT02352051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868350|NCT02352051|Dopamine Agents|dopamine agents|mesh-ancestor
5868351|NCT02352051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5868352|NCT02352051|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5868353|NCT02352051|Adrenergic Agents|adrenergic agents|mesh-ancestor
5868354|NCT02351973|Amiloride|amiloride|mesh-list
5868355|NCT02351973|Diuretics|diuretics|mesh-ancestor
5868356|NCT02351973|Natriuretic Agents|natriuretic agents|mesh-ancestor
5868357|NCT02351973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868358|NCT02351973|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
5868359|NCT02351973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5868360|NCT02351973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5868361|NCT02351973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868362|NCT02351973|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
5868363|NCT02351973|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5680113|NCT03500445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5680114|NCT03500445|Glucocorticoids|glucocorticoids|mesh-ancestor
5680115|NCT03500445|Hormones|hormones|mesh-ancestor
5680116|NCT03500445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5680117|NCT03500445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5680118|NCT03500445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5680119|NCT03500445|Immunologic Factors|immunologic factors|mesh-ancestor
5680120|NCT03500445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5680121|NCT03500445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5680122|NCT03500445|Growth Substances|growth substances|mesh-ancestor
5868364|NCT02352155|Epinephrine|epinephrine|mesh-list
5868365|NCT02352155|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5868366|NCT02352155|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5868367|NCT02352155|Adrenergic Agents|adrenergic agents|mesh-ancestor
5868368|NCT02352155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5868369|NCT02352155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680123|NCT03500445|Growth Inhibitors|growth inhibitors|mesh-ancestor
5680124|NCT03500432|Lidocaine|lidocaine|mesh-list
5680125|NCT03500432|Anesthetics, Local|anesthetics, local|mesh-ancestor
5680126|NCT03500432|Anesthetics|anesthetics|mesh-ancestor
5680127|NCT03500432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5680128|NCT03500432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680129|NCT03500432|Sensory System Agents|sensory system agents|mesh-ancestor
5680130|NCT03500432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5680131|NCT03500432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5680132|NCT03500432|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5680133|NCT03500432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5680134|NCT03500432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5680135|NCT03500432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696800|NCT03380546|Insulin, Short-Acting|insulin, short-acting|mesh-list
5696801|NCT03380546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5696802|NCT03380546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696803|NCT03380546|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
5696804|NCT03380546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5696805|NCT03380546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696806|NCT03380533|Buprenorphine|buprenorphine|mesh-list
5696807|NCT03380533|Tramadol|tramadol|mesh-list
5696808|NCT03380533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5696809|NCT03380533|Narcotics|narcotics|mesh-ancestor
5696810|NCT03380533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5696811|NCT03380533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696812|NCT03380533|Analgesics|analgesics|mesh-ancestor
5696813|NCT03380533|Sensory System Agents|sensory system agents|mesh-ancestor
5696814|NCT03380533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5696815|NCT03380533|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5696816|NCT03380468|Pemetrexed|pemetrexed|mesh-list
5696817|NCT03380468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5696818|NCT03380468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5696819|NCT03380468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696820|NCT03380468|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5696821|NCT03380468|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5696822|NCT03380455|Cimetidine|cimetidine|mesh-list
5696823|NCT03380455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5696824|NCT03380455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5696825|NCT03380455|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5868370|NCT02352155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868371|NCT02352155|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5868372|NCT02352155|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5868373|NCT02352155|Autonomic Agents|autonomic agents|mesh-ancestor
5680136|NCT03500367|Sirolimus|sirolimus|mesh-list
5680137|NCT03500367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5680138|NCT03500367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5680139|NCT03500367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5680140|NCT03500367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5868374|NCT02352155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5868375|NCT02352155|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5868376|NCT02352155|Respiratory System Agents|respiratory system agents|mesh-ancestor
5868377|NCT02352155|Mydriatics|mydriatics|mesh-ancestor
5868378|NCT02352155|Sympathomimetics|sympathomimetics|mesh-ancestor
5868379|NCT02352155|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5868380|NCT02351895|Copper|copper|mesh-list
5868381|NCT02351895|Trace Elements|trace elements|mesh-ancestor
5868382|NCT02351895|Micronutrients|micronutrients|mesh-ancestor
5868383|NCT02351895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868384|NCT02351882|Nabilone|nabilone|mesh-list
5868385|NCT02351882|Antiemetics|antiemetics|mesh-ancestor
5868386|NCT02351882|Autonomic Agents|autonomic agents|mesh-ancestor
5868387|NCT02351882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5868388|NCT02351882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868389|NCT02351882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5868390|NCT02351882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5868391|NCT02351882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5868392|NCT02351882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5868393|NCT02351882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5868394|NCT02352311|Tadalafil|tadalafil|mesh-list
5680141|NCT03500367|Antifungal Agents|antifungal agents|mesh-ancestor
5680142|NCT03500367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5680143|NCT03500367|Immunologic Factors|immunologic factors|mesh-ancestor
6212340|NCT02186847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6212341|NCT02186847|Tubulin Modulators|tubulin modulators|mesh-ancestor
5680144|NCT03500367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680145|NCT03500146|Cholinergic Antagonists|cholinergic antagonists|mesh-list
5680146|NCT03500146|Cholinergic Agents|cholinergic agents|mesh-ancestor
5680147|NCT03500146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5680148|NCT03500146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680149|NCT03500146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680150|NCT03500133|Cytarabine|cytarabine|mesh-list
5680151|NCT03500133|Methylprednisolone|methylprednisolone|mesh-list
5680152|NCT03500133|Cisplatin|cisplatin|mesh-list
5680153|NCT03500133|Etoposide|etoposide|mesh-list
5680154|NCT03500133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5680155|NCT03500133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5680156|NCT03500133|Antimetabolites|antimetabolites|mesh-ancestor
5680157|NCT03500133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680158|NCT03500133|Antiviral Agents|antiviral agents|mesh-ancestor
5680159|NCT03500133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5680160|NCT03500133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5680161|NCT03500133|Immunologic Factors|immunologic factors|mesh-ancestor
5680162|NCT03500133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680163|NCT03500133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5680164|NCT03500133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5680165|NCT03500133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5680166|NCT03500133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5680167|NCT03500133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5680168|NCT03500133|Antiemetics|antiemetics|mesh-ancestor
5680169|NCT03500133|Autonomic Agents|autonomic agents|mesh-ancestor
5680170|NCT03500133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5680171|NCT03500133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5680172|NCT03500133|Glucocorticoids|glucocorticoids|mesh-ancestor
5680173|NCT03500133|Hormones|hormones|mesh-ancestor
5680174|NCT03500133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5680175|NCT03500133|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5680176|NCT03500133|Protective Agents|protective agents|mesh-ancestor
5680177|NCT03500120|Fludrocortisone|fludrocortisone|mesh-list
5680178|NCT03500120|Captopril|captopril|mesh-list
5680179|NCT03500120|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5680180|NCT03500120|Protease Inhibitors|protease inhibitors|mesh-ancestor
5680181|NCT03500120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5868395|NCT02352311|Dutasteride|dutasteride|mesh-list
5868396|NCT02352311|Vasodilator Agents|vasodilator agents|mesh-ancestor
5905314|NCT05136521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6212342|NCT02186847|Antimitotic Agents|antimitotic agents|mesh-ancestor
6212343|NCT02186847|Mitosis Modulators|mitosis modulators|mesh-ancestor
5868397|NCT02352311|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5868398|NCT02352311|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5868399|NCT02352311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5868400|NCT02352311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868401|NCT02352311|Urological Agents|urological agents|mesh-ancestor
5868402|NCT02352311|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
5868403|NCT02352311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5868404|NCT02352311|Hormone Antagonists|hormone antagonists|mesh-ancestor
5868405|NCT02352311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5868406|NCT02352311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868407|NCT02352025|Equol|equol|mesh-list
5868408|NCT02352025|Phytoestrogens|phytoestrogens|mesh-ancestor
5868409|NCT02352025|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6494952|NCT00620971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6494953|NCT00620971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6494954|NCT00620971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6494955|NCT00620971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6494956|NCT00620971|Growth Substances|growth substances|mesh-ancestor
5680182|NCT03500120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680183|NCT03500120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5680184|NCT03500120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5680185|NCT03500029|Antidepressive Agents|antidepressive agents|mesh-list
5680186|NCT03500029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5680187|NCT03499886|Ketamine|ketamine|mesh-list
5680188|NCT03499886|Analgesics|analgesics|mesh-ancestor
5680189|NCT03499886|Sensory System Agents|sensory system agents|mesh-ancestor
5868410|NCT02352025|Estrogens|estrogens|mesh-ancestor
5868411|NCT02352025|Hormones|hormones|mesh-ancestor
5680190|NCT03499886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5680191|NCT03499886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680192|NCT03499886|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5680193|NCT03499886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5680194|NCT03499886|Anesthetics, General|anesthetics, general|mesh-ancestor
5680195|NCT03499886|Anesthetics|anesthetics|mesh-ancestor
5680196|NCT03499886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5680197|NCT03499886|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5680198|NCT03499886|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5680199|NCT03499886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5680200|NCT03499886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868412|NCT02352025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5868413|NCT02352025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868414|NCT02351908|Tenofovir|tenofovir|mesh-list
5868415|NCT02351908|Raltegravir Potassium|raltegravir potassium|mesh-list
5868416|NCT02351908|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5868417|NCT02351908|Dolutegravir|dolutegravir|mesh-list
5868418|NCT02351908|Cobicistat|cobicistat|mesh-list
5868419|NCT02351908|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5868420|NCT02351908|Elvitegravir|elvitegravir|mesh-list
5868421|NCT02351908|Antiviral Agents|antiviral agents|mesh-ancestor
5868422|NCT02351908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6494957|NCT00620971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494958|NCT00620971|Growth Inhibitors|growth inhibitors|mesh-ancestor
6494959|NCT00620971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6494960|NCT00620971|Antimetabolites|antimetabolites|mesh-ancestor
5680201|NCT03499743|Celecoxib|celecoxib|mesh-list
5680202|NCT03499743|Scopolamine|scopolamine|mesh-list
5680203|NCT03499743|Bromides|bromides|mesh-list
5680204|NCT03499743|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
5680205|NCT03499743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5680206|NCT03499743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5680207|NCT03499743|Analgesics|analgesics|mesh-ancestor
5680208|NCT03499743|Sensory System Agents|sensory system agents|mesh-ancestor
5680209|NCT03499743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5680210|NCT03499743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680211|NCT03499743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5680212|NCT03499743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5680213|NCT03499743|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5680214|NCT03499743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5680215|NCT03499743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5680216|NCT03499743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680217|NCT03499743|Anticonvulsants|anticonvulsants|mesh-ancestor
5680218|NCT03499743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5868423|NCT02351908|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5868424|NCT02351908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5868425|NCT02351908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5868426|NCT02351908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868427|NCT02351908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5868428|NCT02351908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5868429|NCT02351908|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5868430|NCT02351908|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5868431|NCT02351908|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5868432|NCT02351908|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5868433|NCT02352064|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5868434|NCT02352064|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5868435|NCT02352064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868436|NCT02351869|Midazolam|midazolam|mesh-list
5868437|NCT02351869|Nitrous Oxide|nitrous oxide|mesh-list
5868438|NCT02351869|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5868439|NCT02351869|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5868440|NCT02351869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5868441|NCT02351869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868442|NCT02351869|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5868443|NCT02351869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5868444|NCT02351869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5868445|NCT02351869|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5868446|NCT02351869|Anesthetics, General|anesthetics, general|mesh-ancestor
5868447|NCT02351869|Anesthetics|anesthetics|mesh-ancestor
5868448|NCT02351869|GABA Modulators|gaba modulators|mesh-ancestor
5868449|NCT02351869|GABA Agents|gaba agents|mesh-ancestor
5868450|NCT02351869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5868451|NCT02351869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496474|NCT00628225|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5680219|NCT03499743|Antiemetics|antiemetics|mesh-ancestor
5680220|NCT03499743|Autonomic Agents|autonomic agents|mesh-ancestor
5680221|NCT03499743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5680222|NCT03499743|Mydriatics|mydriatics|mesh-ancestor
5680223|NCT03499743|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5680224|NCT03499743|Cholinergic Agents|cholinergic agents|mesh-ancestor
5680225|NCT03499743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5680226|NCT03499743|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5680227|NCT03499743|Parasympatholytics|parasympatholytics|mesh-ancestor
5680228|NCT03499730|Midazolam|midazolam|mesh-list
5680229|NCT03499730|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5680230|NCT03499730|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5680231|NCT03499730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5680232|NCT03499730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680233|NCT03499730|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5680234|NCT03499730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5680235|NCT03499730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5680236|NCT03499730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5680237|NCT03499730|Anesthetics, General|anesthetics, general|mesh-ancestor
5680238|NCT03499730|Anesthetics|anesthetics|mesh-ancestor
5680239|NCT03499730|GABA Modulators|gaba modulators|mesh-ancestor
5680240|NCT03499730|GABA Agents|gaba agents|mesh-ancestor
5680241|NCT03499730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5680242|NCT03499730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680243|NCT03499704|Metformin|metformin|mesh-list
5680244|NCT03499704|Pioglitazone|pioglitazone|mesh-list
5680245|NCT03499704|Dapagliflozin|dapagliflozin|mesh-list
5680246|NCT03499704|Alogliptin|alogliptin|mesh-list
5680247|NCT03499704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5680248|NCT03499704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680249|NCT03499704|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5680250|NCT03499704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680251|NCT03499704|Incretins|incretins|mesh-ancestor
5680252|NCT03499704|Hormones|hormones|mesh-ancestor
5680253|NCT03499704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5680254|NCT03499704|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5680255|NCT03499704|Protease Inhibitors|protease inhibitors|mesh-ancestor
5680256|NCT03499704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5680257|NCT03499639|Ritonavir|ritonavir|mesh-list
5680258|NCT03499639|Ribavirin|ribavirin|mesh-list
5680259|NCT03499639|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5680260|NCT03499639|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5680261|NCT03499639|Protease Inhibitors|protease inhibitors|mesh-ancestor
5680262|NCT03499639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5680263|NCT03499639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680264|NCT03499639|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5680265|NCT03499639|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5680266|NCT03499639|Antiviral Agents|antiviral agents|mesh-ancestor
5680267|NCT03499639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5680268|NCT03499639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5680269|NCT03499639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5680270|NCT03499639|Antimetabolites|antimetabolites|mesh-ancestor
5680271|NCT03499483|Tenofovir|tenofovir|mesh-list
5680272|NCT03499483|Emtricitabine|emtricitabine|mesh-list
5680273|NCT03499483|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
5680274|NCT03499483|Antiviral Agents|antiviral agents|mesh-ancestor
5680275|NCT03499483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5680276|NCT03499483|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5868452|NCT02351869|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5868453|NCT02351869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5868454|NCT02351869|Analgesics|analgesics|mesh-ancestor
6494961|NCT00620971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494962|NCT00620971|Antiviral Agents|antiviral agents|mesh-ancestor
6494963|NCT00620971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6494964|NCT00620971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6675134|NCT01572662|Alkylating Agents|alkylating agents|mesh-ancestor
5680277|NCT03499483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5680278|NCT03499483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5680279|NCT03499483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680280|NCT03499483|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5680281|NCT03499483|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5680282|NCT03499457|Amoxicillin|amoxicillin|mesh-list
5680283|NCT03499457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5680284|NCT03499457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5680285|NCT03499444|Rucaparib|rucaparib|mesh-list
5680286|NCT03499444|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5680287|NCT03499444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5680288|NCT03499444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680289|NCT03499444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5680290|NCT03499379|Levonorgestrel|levonorgestrel|mesh-list
5680291|NCT03499379|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5680292|NCT03499379|Contraceptive Agents|contraceptive agents|mesh-ancestor
5680293|NCT03499379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5680294|NCT03499379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680295|NCT03499379|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5680296|NCT03499379|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5680297|NCT03499379|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5680298|NCT03499249|Acetylcysteine|acetylcysteine|mesh-list
5680299|NCT03499249|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5680300|NCT03499249|Antiviral Agents|antiviral agents|mesh-ancestor
5680301|NCT03499249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5680302|NCT03499249|Expectorants|expectorants|mesh-ancestor
5680303|NCT03499249|Respiratory System Agents|respiratory system agents|mesh-ancestor
5680304|NCT03499249|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5680305|NCT03499249|Antioxidants|antioxidants|mesh-ancestor
5680306|NCT03499249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680307|NCT03499249|Protective Agents|protective agents|mesh-ancestor
5680308|NCT03499249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680309|NCT03499249|Antidotes|antidotes|mesh-ancestor
5680310|NCT03499223|Ranibizumab|ranibizumab|mesh-list
5680311|NCT03499223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5680312|NCT03499223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5680313|NCT03499223|Growth Substances|growth substances|mesh-ancestor
5680314|NCT03499223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680315|NCT03499223|Growth Inhibitors|growth inhibitors|mesh-ancestor
5680316|NCT03499223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5680317|NCT03499184|Metronidazole|metronidazole|mesh-list
5680318|NCT03499184|Amoxicillin|amoxicillin|mesh-list
5680319|NCT03499184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5680320|NCT03499184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5680321|NCT03499184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5680322|NCT03499184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5680323|NCT03499171|Citalopram|citalopram|mesh-list
5680324|NCT03499171|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5680325|NCT03499171|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5680326|NCT03499171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5680327|NCT03499171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680328|NCT03499171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5680329|NCT03499171|Serotonin Agents|serotonin agents|mesh-ancestor
5680330|NCT03499171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868455|NCT02351869|Sensory System Agents|sensory system agents|mesh-ancestor
5868456|NCT02351869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5868457|NCT02351765|Cisplatin|cisplatin|mesh-list
5868458|NCT02351765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5868459|NCT02351687|Pyrimethamine|pyrimethamine|mesh-list
5868460|NCT02351687|Sulfadoxine|sulfadoxine|mesh-list
5868461|NCT02351687|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
5868462|NCT02351687|Albendazole|albendazole|mesh-list
5868463|NCT02351687|Antimalarials|antimalarials|mesh-ancestor
5868464|NCT02351687|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5868465|NCT02351687|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5868466|NCT02351687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5868467|NCT02351687|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5868468|NCT02351687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5868469|NCT02351687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868470|NCT02351687|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5868471|NCT02351687|Renal Agents|renal agents|mesh-ancestor
5868472|NCT02351687|Anthelmintics|anthelmintics|mesh-ancestor
5868473|NCT02351687|Anticestodal Agents|anticestodal agents|mesh-ancestor
5868474|NCT02351687|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5868475|NCT02351687|Tubulin Modulators|tubulin modulators|mesh-ancestor
5868476|NCT02351687|Antimitotic Agents|antimitotic agents|mesh-ancestor
5868477|NCT02351687|Mitosis Modulators|mitosis modulators|mesh-ancestor
5868478|NCT02351687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5868479|NCT02351752|Hydroxychloroquine|hydroxychloroquine|mesh-list
5868480|NCT02351752|Antimalarials|antimalarials|mesh-ancestor
5680331|NCT03499171|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5680332|NCT03499171|Antidepressive Agents|antidepressive agents|mesh-ancestor
5680333|NCT03499171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5680334|NCT03499132|Anesthetics|anesthetics|mesh-list
5868481|NCT02351752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5868482|NCT02351752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5868483|NCT02351752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6494965|NCT00620971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6494966|NCT00620971|Immunologic Factors|immunologic factors|mesh-ancestor
5680335|NCT03499132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5680336|NCT03499132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680337|NCT03499106|Itraconazole|itraconazole|mesh-list
5680338|NCT03499106|Praliciguat|praliciguat|mesh-list
5680339|NCT03499106|Antifungal Agents|antifungal agents|mesh-ancestor
5680340|NCT03499106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5680341|NCT03499106|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5680342|NCT03499106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5680343|NCT03499106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5680344|NCT03499106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680345|NCT03499106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5680346|NCT03499106|Hormone Antagonists|hormone antagonists|mesh-ancestor
5680347|NCT03499106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5680348|NCT03499106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680349|NCT03499106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5680350|NCT03499106|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
5680351|NCT03499106|Enzyme Activators|enzyme activators|mesh-ancestor
5680352|NCT03499106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5680353|NCT03498898|Adrenergic Agents|adrenergic agents|mesh-list
5680354|NCT03498898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5680355|NCT03498898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680356|NCT03498898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680357|NCT03498820|Remifentanil|remifentanil|mesh-list
5680358|NCT03498820|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5680359|NCT03498820|Narcotics|narcotics|mesh-ancestor
5680360|NCT03498820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5680361|NCT03498820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680362|NCT03498820|Analgesics|analgesics|mesh-ancestor
5680363|NCT03498820|Sensory System Agents|sensory system agents|mesh-ancestor
5680364|NCT03498820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5680365|NCT03498703|Azathioprine|azathioprine|mesh-list
5680366|NCT03498703|Antimetabolites|antimetabolites|mesh-ancestor
5680367|NCT03498703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680368|NCT03498703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5680369|NCT03498703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5680370|NCT03498703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5680371|NCT03498703|Immunologic Factors|immunologic factors|mesh-ancestor
5680372|NCT03498703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680373|NCT03498703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5868484|NCT02351752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6494967|NCT00620971|Tubulin Modulators|tubulin modulators|mesh-ancestor
5868485|NCT02351752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868486|NCT02351752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5868487|NCT02351622|Dexamethasone|dexamethasone|mesh-list
5868488|NCT02351622|Caffeic acid|caffeic acid|mesh-list
5868489|NCT02351622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5868490|NCT02351622|Antiemetics|antiemetics|mesh-ancestor
5868491|NCT02351622|Autonomic Agents|autonomic agents|mesh-ancestor
5868492|NCT02351622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5868493|NCT02351622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868494|NCT02351622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5868495|NCT02351622|Glucocorticoids|glucocorticoids|mesh-ancestor
5868496|NCT02351622|Hormones|hormones|mesh-ancestor
5868497|NCT02351622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5868498|NCT02351622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5868499|NCT02351622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5868500|NCT02351622|Antioxidants|antioxidants|mesh-ancestor
5868501|NCT02351622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868502|NCT02351622|Protective Agents|protective agents|mesh-ancestor
5868503|NCT02351804|Dexamethasone|dexamethasone|mesh-list
5868504|NCT02351804|Ropivacaine|ropivacaine|mesh-list
5868505|NCT02351804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5868506|NCT02351804|Antiemetics|antiemetics|mesh-ancestor
5868507|NCT02351804|Autonomic Agents|autonomic agents|mesh-ancestor
5868508|NCT02351804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5868509|NCT02351804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868510|NCT02351804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5868511|NCT02351804|Glucocorticoids|glucocorticoids|mesh-ancestor
5680374|NCT03498534|Isoniazid|isoniazid|mesh-list
5680375|NCT03498534|Antitubercular Agents|antitubercular agents|mesh-ancestor
5680376|NCT03498534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5680377|NCT03498534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5680378|NCT03498534|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5680379|NCT03498534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5680380|NCT03498534|Antimetabolites|antimetabolites|mesh-ancestor
5680381|NCT03498534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680382|NCT03498534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5680383|NCT03498456|Amoxicillin|amoxicillin|mesh-list
5680384|NCT03498456|Clarithromycin|clarithromycin|mesh-list
5680385|NCT03498456|Lansoprazole|lansoprazole|mesh-list
5680386|NCT03498456|Dexlansoprazole|dexlansoprazole|mesh-list
5868512|NCT02351804|Hormones|hormones|mesh-ancestor
5868513|NCT02351804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5868514|NCT02351804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5868515|NCT02351804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5868516|NCT02351804|Anesthetics, Local|anesthetics, local|mesh-ancestor
5868517|NCT02351804|Anesthetics|anesthetics|mesh-ancestor
5868518|NCT02351804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5868519|NCT02351804|Sensory System Agents|sensory system agents|mesh-ancestor
6494968|NCT00620971|Antimitotic Agents|antimitotic agents|mesh-ancestor
5680387|NCT03498456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5680388|NCT03498456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5680389|NCT03498456|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5680390|NCT03498456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5680391|NCT03498456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680392|NCT03498456|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5680393|NCT03498456|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5680394|NCT03498456|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5680395|NCT03498456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5680396|NCT03498456|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5680397|NCT03498417|Antibodies|antibodies|mesh-list
5680398|NCT03498417|Immunologic Factors|immunologic factors|mesh-ancestor
5680399|NCT03498417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680400|NCT03498326|Gemcitabine|gemcitabine|mesh-list
5680401|NCT03498326|Celecoxib|celecoxib|mesh-list
5680402|NCT03498326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5680403|NCT03498326|Antimetabolites|antimetabolites|mesh-ancestor
5680404|NCT03498326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680405|NCT03498326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5680406|NCT03498326|Antiviral Agents|antiviral agents|mesh-ancestor
5680407|NCT03498326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5680408|NCT03498326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5680409|NCT03498326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5680410|NCT03498326|Immunologic Factors|immunologic factors|mesh-ancestor
5680411|NCT03498326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868520|NCT02351544|Botulinum Toxins|botulinum toxins|mesh-list
6494969|NCT00620971|Mitosis Modulators|mitosis modulators|mesh-ancestor
5868521|NCT02351544|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5868522|NCT02351544|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5868523|NCT02351544|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5868524|NCT02351544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5868525|NCT02351544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868526|NCT02351544|Cholinergic Agents|cholinergic agents|mesh-ancestor
5868527|NCT02351544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5868528|NCT02351544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868529|NCT02351544|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5868530|NCT02351544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5868531|NCT02351297|Caseins|caseins|mesh-list
5868532|NCT02351297|Chelating Agents|chelating agents|mesh-ancestor
5868533|NCT02351297|Sequestering Agents|sequestering agents|mesh-ancestor
5868534|NCT02351297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868535|NCT02351232|Liraglutide|liraglutide|mesh-list
5868536|NCT02351232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5868537|NCT02351232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868538|NCT02351232|Incretins|incretins|mesh-ancestor
5868539|NCT02351232|Hormones|hormones|mesh-ancestor
5868540|NCT02351232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5868541|NCT02351427|Bortezomib|bortezomib|mesh-list
5868542|NCT02351427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5868543|NCT02351310|Betamethasone|betamethasone|mesh-list
5868544|NCT02351310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5680412|NCT03498326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5680413|NCT03498326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5680414|NCT03498326|Analgesics|analgesics|mesh-ancestor
5680415|NCT03498326|Sensory System Agents|sensory system agents|mesh-ancestor
5680416|NCT03498326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5680417|NCT03498326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5680418|NCT03498326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5680419|NCT03498326|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5680420|NCT03498326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5680421|NCT03498313|Estradiol|estradiol|mesh-list
5680422|NCT03498313|Progesterone|progesterone|mesh-list
5680423|NCT03498313|Estrogens|estrogens|mesh-ancestor
5680424|NCT03498313|Hormones|hormones|mesh-ancestor
5680425|NCT03498313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5680426|NCT03498313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680427|NCT03498313|Progestins|progestins|mesh-ancestor
5680428|NCT03498261|Gabapentin|gabapentin|mesh-list
5680429|NCT03498261|Analgesics|analgesics|mesh-ancestor
5680430|NCT03498261|Sensory System Agents|sensory system agents|mesh-ancestor
5680431|NCT03498261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5680432|NCT03498261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680433|NCT03498261|Anticonvulsants|anticonvulsants|mesh-ancestor
5680434|NCT03498261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5680435|NCT03498261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5680436|NCT03498261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5680437|NCT03498261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5680438|NCT03498261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5680439|NCT03498261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5680440|NCT03498261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5680441|NCT03498261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680442|NCT03498261|Antimanic Agents|antimanic agents|mesh-ancestor
5680443|NCT03498248|Lenograstim|lenograstim|mesh-list
5868545|NCT02351310|Glucocorticoids|glucocorticoids|mesh-ancestor
5868546|NCT02351310|Hormones|hormones|mesh-ancestor
5868547|NCT02351310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5868548|NCT02351310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868549|NCT02351310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5868550|NCT02351310|Respiratory System Agents|respiratory system agents|mesh-ancestor
5905315|NCT05136521|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5905316|NCT05136521|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5905317|NCT05136521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5905318|NCT05136521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680444|NCT03498248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5680445|NCT03498248|Immunologic Factors|immunologic factors|mesh-ancestor
5680446|NCT03498248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680447|NCT03498235|Propofol|propofol|mesh-list
5680448|NCT03498235|Sevoflurane|sevoflurane|mesh-list
5680449|NCT03498235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5680450|NCT03498235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5680451|NCT03498235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868551|NCT02351180|Beclomethasone|beclomethasone|mesh-list
5868552|NCT02351180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6494970|NCT00620971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6494971|NCT00620997|Proxymetacaine|proxymetacaine|mesh-list
6494972|NCT00620997|Anesthetics, Local|anesthetics, local|mesh-ancestor
6494973|NCT00620997|Anesthetics|anesthetics|mesh-ancestor
6494974|NCT00620997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6494975|NCT00620997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494976|NCT00620997|Sensory System Agents|sensory system agents|mesh-ancestor
5868553|NCT02351180|Glucocorticoids|glucocorticoids|mesh-ancestor
5868554|NCT02351180|Hormones|hormones|mesh-ancestor
5868555|NCT02351180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5868556|NCT02351180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868557|NCT02351180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5868558|NCT02351180|Respiratory System Agents|respiratory system agents|mesh-ancestor
5868559|NCT02351440|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5680452|NCT03498235|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5680453|NCT03498235|Anesthetics, General|anesthetics, general|mesh-ancestor
5680454|NCT03498235|Anesthetics|anesthetics|mesh-ancestor
5680455|NCT03498235|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5680456|NCT03498235|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5680457|NCT03498222|Carboplatin|carboplatin|mesh-list
5680458|NCT03498222|Pemetrexed|pemetrexed|mesh-list
5680459|NCT03498222|Atezolizumab|atezolizumab|mesh-list
5680460|NCT03498222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5680461|NCT03498222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5680462|NCT03498222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680463|NCT03498222|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5680464|NCT03498222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5680465|NCT03498170|Itraconazole|itraconazole|mesh-list
5680466|NCT03498170|Acumapimod|acumapimod|mesh-list
5680467|NCT03498170|Antifungal Agents|antifungal agents|mesh-ancestor
5680468|NCT03498170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5680469|NCT03498170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5680470|NCT03498170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5680471|NCT03498170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5680472|NCT03498170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680473|NCT03498170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5680474|NCT03498170|Hormone Antagonists|hormone antagonists|mesh-ancestor
5680475|NCT03498170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5680476|NCT03498170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680477|NCT03498170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5680478|NCT03498170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5680479|NCT03498131|Melatonin|melatonin|mesh-list
5680480|NCT03498131|Antioxidants|antioxidants|mesh-ancestor
5680481|NCT03498131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680482|NCT03498131|Protective Agents|protective agents|mesh-ancestor
5680483|NCT03498131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680484|NCT03498131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5680485|NCT03498118|Bupivacaine|bupivacaine|mesh-list
5680486|NCT03498118|Anesthetics, Local|anesthetics, local|mesh-ancestor
5680487|NCT03498118|Anesthetics|anesthetics|mesh-ancestor
5680488|NCT03498118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5680489|NCT03498118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680490|NCT03498118|Sensory System Agents|sensory system agents|mesh-ancestor
5680491|NCT03498118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5680492|NCT03498092|Dexmedetomidine|dexmedetomidine|mesh-list
5680493|NCT03498092|Bupivacaine|bupivacaine|mesh-list
5680494|NCT03498092|Anesthetics, Local|anesthetics, local|mesh-ancestor
5680495|NCT03498092|Anesthetics|anesthetics|mesh-ancestor
5680496|NCT03498092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5680497|NCT03498092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680498|NCT03498092|Sensory System Agents|sensory system agents|mesh-ancestor
5680499|NCT03498092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5680500|NCT03498092|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5680501|NCT03498092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5680502|NCT03498092|Analgesics|analgesics|mesh-ancestor
5680503|NCT03498092|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5680504|NCT03498092|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5680505|NCT03498092|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5680506|NCT03498092|Adrenergic Agents|adrenergic agents|mesh-ancestor
5680507|NCT03498092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5680508|NCT03498092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680509|NCT03498001|Liraglutide|liraglutide|mesh-list
6212344|NCT02186847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680510|NCT03498001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5680511|NCT03498001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680512|NCT03498001|Incretins|incretins|mesh-ancestor
5680513|NCT03498001|Hormones|hormones|mesh-ancestor
5680514|NCT03498001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5680515|NCT03497988|Oxytocin|oxytocin|mesh-list
5680516|NCT03497988|Oxytocics|oxytocics|mesh-ancestor
5680517|NCT03497988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5680518|NCT03497988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680519|NCT03497923|Magnesium Sulfate|magnesium sulfate|mesh-list
5680520|NCT03497923|Analgesics|analgesics|mesh-ancestor
5680521|NCT03497923|Sensory System Agents|sensory system agents|mesh-ancestor
5680522|NCT03497923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5680523|NCT03497923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680524|NCT03497923|Anesthetics|anesthetics|mesh-ancestor
6212345|NCT02186847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6212346|NCT02186847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212347|NCT02186873|Golimumab|golimumab|mesh-list
6212348|NCT02186873|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6212349|NCT02186873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5680525|NCT03497923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5680526|NCT03497923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5680527|NCT03497923|Anticonvulsants|anticonvulsants|mesh-ancestor
5680528|NCT03497923|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5680529|NCT03497923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5680530|NCT03497923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680531|NCT03497923|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5680532|NCT03497923|Tocolytic Agents|tocolytic agents|mesh-ancestor
5680533|NCT03497923|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5680534|NCT03497767|Osimertinib|osimertinib|mesh-list
5680535|NCT03497767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5680536|NCT03497767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5680537|NCT03497767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5680538|NCT03497767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680539|NCT03497715|Ibuprofen|ibuprofen|mesh-list
5680540|NCT03497715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5680541|NCT03497715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5680542|NCT03497715|Analgesics|analgesics|mesh-ancestor
5680543|NCT03497715|Sensory System Agents|sensory system agents|mesh-ancestor
5680544|NCT03497715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5680545|NCT03497715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680546|NCT03497715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5680547|NCT03497715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5680548|NCT03497715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5680549|NCT03497715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5680550|NCT03497715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680551|NCT03497702|Cyclophosphamide|cyclophosphamide|mesh-list
5680552|NCT03497702|Docetaxel|docetaxel|mesh-list
5680553|NCT03497702|Doxorubicin|doxorubicin|mesh-list
5680554|NCT03497702|Letrozole|letrozole|mesh-list
5680555|NCT03497702|Leuprolide|leuprolide|mesh-list
5680556|NCT03497702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5680557|NCT03497702|Immunologic Factors|immunologic factors|mesh-ancestor
5680558|NCT03497702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680559|NCT03497702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5680560|NCT03497702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5680561|NCT03497702|Alkylating Agents|alkylating agents|mesh-ancestor
5680562|NCT03497702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680563|NCT03497702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5680564|NCT03497702|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5680565|NCT03497702|Tubulin Modulators|tubulin modulators|mesh-ancestor
5680566|NCT03497702|Antimitotic Agents|antimitotic agents|mesh-ancestor
5680567|NCT03497702|Mitosis Modulators|mitosis modulators|mesh-ancestor
5680568|NCT03497702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5680569|NCT03497702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5680570|NCT03497702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5680571|NCT03497702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5680572|NCT03497702|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5680573|NCT03497702|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5680574|NCT03497702|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5680575|NCT03497702|Hormone Antagonists|hormone antagonists|mesh-ancestor
5680576|NCT03497702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5680577|NCT03497702|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5868560|NCT02351440|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5868561|NCT02351440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5868562|NCT02351440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5868563|NCT02351440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868564|NCT02351440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5868565|NCT02351440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868566|NCT02351440|Analgesics|analgesics|mesh-ancestor
5868567|NCT02351440|Sensory System Agents|sensory system agents|mesh-ancestor
5868568|NCT02351440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5868569|NCT02351440|Antidepressive Agents|antidepressive agents|mesh-ancestor
5868570|NCT02351440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6212350|NCT02186873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6212351|NCT02186873|Immunologic Factors|immunologic factors|mesh-ancestor
5680578|NCT03497702|Fertility Agents|fertility agents|mesh-ancestor
5680579|NCT03497702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5680580|NCT03497702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5680581|NCT03497442|Brimonidine Tartrate|brimonidine tartrate|mesh-list
5680582|NCT03497442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5680583|NCT03497442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5680584|NCT03497442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5680585|NCT03497442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5680586|NCT03497442|Adrenergic Agents|adrenergic agents|mesh-ancestor
5680587|NCT03497442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5680588|NCT03497442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680589|NCT03497442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680590|NCT03497364|Bupivacaine|bupivacaine|mesh-list
5680591|NCT03497364|Ropivacaine|ropivacaine|mesh-list
5680592|NCT03497364|Anesthetics, Local|anesthetics, local|mesh-ancestor
5680593|NCT03497364|Anesthetics|anesthetics|mesh-ancestor
5680594|NCT03497364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5680595|NCT03497364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680596|NCT03497364|Sensory System Agents|sensory system agents|mesh-ancestor
5680597|NCT03497364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5680598|NCT03497351|Nicardipine|nicardipine|mesh-list
5680599|NCT03497351|Urapidil|urapidil|mesh-list
5680600|NCT03497351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6212352|NCT02186873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212353|NCT02187016|Listerine|listerine|mesh-list
6212354|NCT02187016|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6212355|NCT02187016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6212356|NCT02187055|Adalimumab|adalimumab|mesh-list
6212357|NCT02187055|Methotrexate|methotrexate|mesh-list
6212358|NCT02187055|Tofacitinib|tofacitinib|mesh-list
6496475|NCT00628225|Autonomic Agents|autonomic agents|mesh-ancestor
5680601|NCT03497351|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5680602|NCT03497351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5680603|NCT03497351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680604|NCT03497351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5680605|NCT03497351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680606|NCT03497351|Vasodilator Agents|vasodilator agents|mesh-ancestor
5680607|NCT03497351|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5680608|NCT03497351|Serotonin Agents|serotonin agents|mesh-ancestor
5680609|NCT03497351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5680610|NCT03497351|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5680611|NCT03497351|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5680612|NCT03497351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5680613|NCT03497351|Adrenergic Agents|adrenergic agents|mesh-ancestor
5680614|NCT03497169|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
5680615|NCT03497169|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5680616|NCT03497169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680617|NCT03497169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5680618|NCT03497169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5680619|NCT03497169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5680620|NCT03497169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680621|NCT03497169|Dopamine Agents|dopamine agents|mesh-ancestor
5680622|NCT03497169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5680623|NCT03497156|Lercanidipine|lercanidipine|mesh-list
5680624|NCT03497156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5680625|NCT03497156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5680626|NCT03497156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5680627|NCT03497156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680628|NCT03497156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5868571|NCT02351440|Dopamine Agents|dopamine agents|mesh-ancestor
5868572|NCT02351128|Lanreotide|lanreotide|mesh-list
5868573|NCT02351128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5868574|NCT02351102|Valacyclovir|valacyclovir|mesh-list
5868575|NCT02351102|Antiviral Agents|antiviral agents|mesh-ancestor
5868576|NCT02351102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5680629|NCT03497156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680630|NCT03497143|Lamotrigine|lamotrigine|mesh-list
5680631|NCT03497143|Anticonvulsants|anticonvulsants|mesh-ancestor
5680632|NCT03497143|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5680633|NCT03497143|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5680634|NCT03497143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680635|NCT03497143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5680636|NCT03497143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680637|NCT03497143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5680638|NCT03497143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5680639|NCT03497143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5680640|NCT03497143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5680641|NCT03497143|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5696826|NCT03380455|Histamine Antagonists|histamine antagonists|mesh-ancestor
5696827|NCT03380455|Histamine Agents|histamine agents|mesh-ancestor
5696828|NCT03380455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5696829|NCT03380455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696830|NCT03380455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696831|NCT03380455|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5696832|NCT03380455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5696833|NCT03380455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5696834|NCT03380442|Ketamine|ketamine|mesh-list
5696835|NCT03380442|Psilocybin|psilocybin|mesh-list
5696836|NCT03380442|Analgesics|analgesics|mesh-ancestor
5696837|NCT03380442|Sensory System Agents|sensory system agents|mesh-ancestor
5696838|NCT03380442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5696839|NCT03380442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696840|NCT03380442|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5696841|NCT03380442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5696842|NCT03380442|Anesthetics, General|anesthetics, general|mesh-ancestor
5696843|NCT03380442|Anesthetics|anesthetics|mesh-ancestor
5696844|NCT03380442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5696845|NCT03380442|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5696846|NCT03380442|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5696847|NCT03380442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5696848|NCT03380442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696849|NCT03380442|Hallucinogens|hallucinogens|mesh-ancestor
5696850|NCT03380442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5696851|NCT03380403|Ciprofloxacin|ciprofloxacin|mesh-list
5696852|NCT03380403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5696853|NCT03380403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5696854|NCT03380403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5696855|NCT03380403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5696856|NCT03380403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5696857|NCT03380403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696858|NCT03380403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5696859|NCT03380403|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5696860|NCT03380403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5696861|NCT03380325|Iloprost|iloprost|mesh-list
5696862|NCT03380325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5696863|NCT03380325|Vasodilator Agents|vasodilator agents|mesh-ancestor
5696864|NCT03380130|Nivolumab|nivolumab|mesh-list
5696865|NCT03380130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5696866|NCT03380130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5696867|NCT03380130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5696868|NCT03380130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696869|NCT03380039|Cyclophosphamide|cyclophosphamide|mesh-list
5696870|NCT03380039|Fludarabine|fludarabine|mesh-list
5696871|NCT03380039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5696872|NCT03380039|Immunologic Factors|immunologic factors|mesh-ancestor
5696873|NCT03380039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696874|NCT03380039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5696875|NCT03380039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5696876|NCT03380039|Alkylating Agents|alkylating agents|mesh-ancestor
5696877|NCT03380039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696878|NCT03380039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5868577|NCT02350751|MEDI8852|medi8852|mesh-list
5868578|NCT02350751|Antiviral Agents|antiviral agents|mesh-ancestor
5680642|NCT03496870|Levodopa|levodopa|mesh-list
5680643|NCT03496870|Carbidopa|carbidopa|mesh-list
5680644|NCT03496870|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
5680645|NCT03496870|Opicapone|opicapone|mesh-list
5680646|NCT03496870|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5680647|NCT03496870|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5680648|NCT03496870|Dopamine Agents|dopamine agents|mesh-ancestor
5868579|NCT02350751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5868580|NCT02351024|Naproxen|naproxen|mesh-list
5868581|NCT02351024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5868582|NCT02351024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5868583|NCT02351024|Analgesics|analgesics|mesh-ancestor
5868584|NCT02351024|Sensory System Agents|sensory system agents|mesh-ancestor
5868585|NCT02351024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5868586|NCT02351024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868587|NCT02351024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5680649|NCT03496870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5680650|NCT03496870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680651|NCT03496870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680652|NCT03496870|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5680653|NCT03496870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5680654|NCT03496870|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5680655|NCT03496870|Immunologic Factors|immunologic factors|mesh-ancestor
5680656|NCT03496870|Dopamine Agonists|dopamine agonists|mesh-ancestor
5680657|NCT03496870|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
5680658|NCT03496831|Adalimumab|adalimumab|mesh-list
5680659|NCT03496831|Etanercept|etanercept|mesh-list
5680660|NCT03496831|Golimumab|golimumab|mesh-list
5680661|NCT03496831|Abatacept|abatacept|mesh-list
5680662|NCT03496831|Infliximab|infliximab|mesh-list
5680663|NCT03496831|Ustekinumab|ustekinumab|mesh-list
5680664|NCT03496831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5680665|NCT03496831|Immunologic Factors|immunologic factors|mesh-ancestor
5680666|NCT03496831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680667|NCT03496831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5680668|NCT03496831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5680669|NCT03496831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5680670|NCT03496831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5680671|NCT03496831|Analgesics|analgesics|mesh-ancestor
5680672|NCT03496831|Sensory System Agents|sensory system agents|mesh-ancestor
5680673|NCT03496831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5680674|NCT03496831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5680675|NCT03496831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5680676|NCT03496831|Dermatologic Agents|dermatologic agents|mesh-ancestor
5680677|NCT03496831|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5680678|NCT03496831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680679|NCT03496831|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
5680680|NCT03496779|Gemcitabine|gemcitabine|mesh-list
5680681|NCT03496779|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5680682|NCT03496779|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5680683|NCT03496779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5680684|NCT03496779|Antimetabolites|antimetabolites|mesh-ancestor
5680685|NCT03496779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680686|NCT03496779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5680687|NCT03496779|Antiviral Agents|antiviral agents|mesh-ancestor
5680688|NCT03496779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5680689|NCT03496779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5680690|NCT03496779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5680691|NCT03496779|Immunologic Factors|immunologic factors|mesh-ancestor
5680692|NCT03496779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680693|NCT03496779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5680694|NCT03496766|Tipifarnib|tipifarnib|mesh-list
5680695|NCT03496766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5680696|NCT03496740|Bupivacaine|bupivacaine|mesh-list
5680697|NCT03496740|Anesthetics, Local|anesthetics, local|mesh-ancestor
5680698|NCT03496740|Anesthetics|anesthetics|mesh-ancestor
5680699|NCT03496740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5680700|NCT03496740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680701|NCT03496740|Sensory System Agents|sensory system agents|mesh-ancestor
5680702|NCT03496740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5680703|NCT03496649|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5680704|NCT03496649|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5680705|NCT03496649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5680706|NCT03496649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680707|NCT03496649|Cholinergic Agents|cholinergic agents|mesh-ancestor
5680708|NCT03496649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5680709|NCT03496649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680710|NCT03496519|Durvalumab|durvalumab|mesh-list
5680711|NCT03496519|Trabectedin|trabectedin|mesh-list
5680712|NCT03496519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5680713|NCT03496519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5680714|NCT03496519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5680715|NCT03496519|Immunologic Factors|immunologic factors|mesh-ancestor
5680716|NCT03496519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680717|NCT03496519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5680718|NCT03496519|Alkylating Agents|alkylating agents|mesh-ancestor
5680719|NCT03496519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680720|NCT03496506|Selexipag|selexipag|mesh-list
5680721|NCT03496506|Clopidogrel|clopidogrel|mesh-list
5680722|NCT03496506|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5680723|NCT03496506|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5680724|NCT03496506|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5680725|NCT03496506|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5680726|NCT03496506|Purinergic Agents|purinergic agents|mesh-ancestor
5680727|NCT03496506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5680728|NCT03496506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680729|NCT03496506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680730|NCT03496506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5680731|NCT03496389|Acetaminophen|acetaminophen|mesh-list
5680732|NCT03496389|Gabapentin|gabapentin|mesh-list
5680733|NCT03496389|Tramadol|tramadol|mesh-list
5680734|NCT03496389|Analgesics|analgesics|mesh-ancestor
5680735|NCT03496389|Sensory System Agents|sensory system agents|mesh-ancestor
5680736|NCT03496389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5680737|NCT03496389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680738|NCT03496389|Anticonvulsants|anticonvulsants|mesh-ancestor
5680739|NCT03496389|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5680740|NCT03496389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5680741|NCT03496389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5680742|NCT03496389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5680743|NCT03496389|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5680744|NCT03496389|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5680745|NCT03496389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5680746|NCT03496389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680747|NCT03496389|Antimanic Agents|antimanic agents|mesh-ancestor
5680748|NCT03496389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5680749|NCT03496389|Narcotics|narcotics|mesh-ancestor
5680750|NCT03496389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5680751|NCT03496389|Antipyretics|antipyretics|mesh-ancestor
5680752|NCT03496246|Vitamin D|vitamin d|mesh-list
5680753|NCT03496246|Calcifediol|calcifediol|mesh-list
5680754|NCT03496246|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
5680755|NCT03496246|Alfacalcidol|alfacalcidol|mesh-list
5680756|NCT03496246|Calcium|calcium|mesh-list
5680757|NCT03496246|Vitamins|vitamins|mesh-ancestor
5680758|NCT03496246|Micronutrients|micronutrients|mesh-ancestor
5680759|NCT03496246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680760|NCT03496246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5680761|NCT03496246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5680762|NCT03496233|Grazoprevir|grazoprevir|mesh-list
5680763|NCT03496233|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
5680764|NCT03496233|Antiviral Agents|antiviral agents|mesh-ancestor
5680765|NCT03496233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5680766|NCT03495804|Mannitol|mannitol|mesh-list
5680767|NCT03495804|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5680768|NCT03495804|Diuretics|diuretics|mesh-ancestor
5680769|NCT03495804|Natriuretic Agents|natriuretic agents|mesh-ancestor
5680770|NCT03495804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680771|NCT03495765|Ranibizumab|ranibizumab|mesh-list
5680772|NCT03495765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5680773|NCT03495765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5680774|NCT03495765|Growth Substances|growth substances|mesh-ancestor
5680775|NCT03495765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680776|NCT03495765|Growth Inhibitors|growth inhibitors|mesh-ancestor
5680777|NCT03495765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5680778|NCT03495739|Dabigatran|dabigatran|mesh-list
5680779|NCT03495739|Antithrombins|antithrombins|mesh-ancestor
5680780|NCT03495739|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5680781|NCT03495739|Protease Inhibitors|protease inhibitors|mesh-ancestor
5680782|NCT03495739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5680783|NCT03495739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868588|NCT02351024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5868589|NCT02351024|Gout Suppressants|gout suppressants|mesh-ancestor
5868590|NCT02351024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5868591|NCT02351024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5868592|NCT02351024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868593|NCT02350725|Furosemide|furosemide|mesh-list
5868594|NCT02350725|Diuretics|diuretics|mesh-ancestor
5868595|NCT02350725|Natriuretic Agents|natriuretic agents|mesh-ancestor
5868596|NCT02350725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868597|NCT02350725|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5868598|NCT02350725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5868599|NCT02350725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868600|NCT02350959|Atorvastatin|atorvastatin|mesh-list
5868601|NCT02350959|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5868602|NCT02350959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5868603|NCT02350959|Antimetabolites|antimetabolites|mesh-ancestor
5868604|NCT02350959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868605|NCT02350959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5680784|NCT03495739|Anticoagulants|anticoagulants|mesh-ancestor
5680785|NCT03495713|Nivolumab|nivolumab|mesh-list
5680786|NCT03495713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5680787|NCT03495713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5680788|NCT03495713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5680789|NCT03495713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680790|NCT03495609|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5680791|NCT03495609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5680792|NCT03495609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680793|NCT03495466|Anesthetics|anesthetics|mesh-list
5680794|NCT03495466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5680795|NCT03495466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696879|NCT03380039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5696880|NCT03379987|Morphine|morphine|mesh-list
5696881|NCT03379987|Bupivacaine|bupivacaine|mesh-list
5696882|NCT03379987|Anesthetics, Local|anesthetics, local|mesh-ancestor
5696883|NCT03379987|Anesthetics|anesthetics|mesh-ancestor
5696884|NCT03379987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5696885|NCT03379987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696886|NCT03379987|Sensory System Agents|sensory system agents|mesh-ancestor
5696887|NCT03379987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5696888|NCT03379987|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5696889|NCT03379987|Narcotics|narcotics|mesh-ancestor
5696890|NCT03379987|Analgesics|analgesics|mesh-ancestor
5696891|NCT03379974|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
5696892|NCT03379974|Hemostatics|hemostatics|mesh-ancestor
5696893|NCT03379974|Coagulants|coagulants|mesh-ancestor
5696894|NCT03379974|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5696895|NCT03379974|Natriuretic Agents|natriuretic agents|mesh-ancestor
5696896|NCT03379974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696897|NCT03379909|Metformin|metformin|mesh-list
5696898|NCT03379909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5696899|NCT03379909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698044|NCT03371849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5698045|NCT03371849|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5698046|NCT03371849|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5698047|NCT03371849|Histamine Antagonists|histamine antagonists|mesh-ancestor
5698048|NCT03371849|Histamine Agents|histamine agents|mesh-ancestor
5698049|NCT03371849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5698050|NCT03371797|Amlodipine|amlodipine|mesh-list
5698051|NCT03371797|Valsartan|valsartan|mesh-list
5698052|NCT03371797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5698053|NCT03371797|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5698054|NCT03371797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5698055|NCT03371797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5698056|NCT03371797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5698057|NCT03371797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698058|NCT03371797|Vasodilator Agents|vasodilator agents|mesh-ancestor
5698059|NCT03371797|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5698060|NCT03371797|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5698061|NCT03371784|Hydrocortisone|hydrocortisone|mesh-list
5698062|NCT03371784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5698108|NCT03371342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5698109|NCT03371342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5698110|NCT03371342|Cholinergic Agents|cholinergic agents|mesh-ancestor
5698111|NCT03371342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5680796|NCT03495232|Cimetidine|cimetidine|mesh-list
5680797|NCT03495232|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5680798|NCT03495232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5680799|NCT03495232|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5680800|NCT03495232|Histamine Antagonists|histamine antagonists|mesh-ancestor
5680801|NCT03495232|Histamine Agents|histamine agents|mesh-ancestor
5680802|NCT03495232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5680803|NCT03495232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680804|NCT03495232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680805|NCT03495232|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5680806|NCT03495232|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5680807|NCT03495232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5680808|NCT03495206|Edaravone|edaravone|mesh-list
5680809|NCT03495206|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5680810|NCT03495206|Antioxidants|antioxidants|mesh-ancestor
5680811|NCT03495206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680812|NCT03495206|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5680813|NCT03495206|Protective Agents|protective agents|mesh-ancestor
5680814|NCT03495206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680815|NCT03495063|Caffeine|caffeine|mesh-list
5680816|NCT03495063|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5680817|NCT03495063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680818|NCT03495063|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5680819|NCT03495063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5680820|NCT03495063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680821|NCT03495063|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5680822|NCT03495063|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5680823|NCT03495063|Purinergic Agents|purinergic agents|mesh-ancestor
5680824|NCT03495063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5680825|NCT03495024|Varenicline|varenicline|mesh-list
5680826|NCT03495024|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5680827|NCT03495024|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5680828|NCT03495024|Cholinergic Agents|cholinergic agents|mesh-ancestor
5680829|NCT03495024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5680830|NCT03495024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680831|NCT03495024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680832|NCT03494972|Tetracycline|tetracycline|mesh-list
5680833|NCT03494972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5680834|NCT03494972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5680835|NCT03494972|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5680836|NCT03494972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5680837|NCT03494972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680838|NCT03494907|Moxifloxacin|moxifloxacin|mesh-list
5680839|NCT03494907|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
5680840|NCT03494907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5680841|NCT03494907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5680842|NCT03494907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6212359|NCT02187055|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6212360|NCT02187055|Abortifacient Agents|abortifacient agents|mesh-ancestor
6212361|NCT02187055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6212362|NCT02187055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212363|NCT02187055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6212364|NCT02187055|Antimetabolites|antimetabolites|mesh-ancestor
6212365|NCT02187055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212366|NCT02187055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6212367|NCT02187055|Dermatologic Agents|dermatologic agents|mesh-ancestor
6212368|NCT02187055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6212369|NCT02187055|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6212370|NCT02187055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6212371|NCT02187055|Immunologic Factors|immunologic factors|mesh-ancestor
6212372|NCT02187055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6212373|NCT02187055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5680843|NCT03494907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5868606|NCT02350959|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5868607|NCT02350959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5868608|NCT02350985|Propranolol|propranolol|mesh-list
5868609|NCT02350985|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
5868610|NCT02350985|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5868611|NCT02350985|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5868612|NCT02350985|Adrenergic Agents|adrenergic agents|mesh-ancestor
5868613|NCT02350985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5868614|NCT02350985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680844|NCT03494907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5680845|NCT03494907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680846|NCT03494907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5680847|NCT03494907|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5680848|NCT03494907|Contraceptive Agents|contraceptive agents|mesh-ancestor
5680849|NCT03494907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5680850|NCT03494907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680851|NCT03494907|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5680852|NCT03494907|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5680853|NCT03494907|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5680854|NCT03494686|Anesthetics|anesthetics|mesh-list
5680855|NCT03494686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5680856|NCT03494686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680857|NCT03494530|Edoxaban|edoxaban|mesh-list
5680858|NCT03494530|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5680859|NCT03494530|Antithrombins|antithrombins|mesh-ancestor
5680860|NCT03494530|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5680861|NCT03494530|Protease Inhibitors|protease inhibitors|mesh-ancestor
5680862|NCT03494530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5680863|NCT03494530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680864|NCT03494530|Anticoagulants|anticoagulants|mesh-ancestor
5680865|NCT03494517|Magnesium Sulfate|magnesium sulfate|mesh-list
5680866|NCT03494517|Analgesics|analgesics|mesh-ancestor
5680867|NCT03494517|Sensory System Agents|sensory system agents|mesh-ancestor
5680868|NCT03494517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5680869|NCT03494517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680870|NCT03494517|Anesthetics|anesthetics|mesh-ancestor
5680871|NCT03494517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5680872|NCT03494517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5680873|NCT03494517|Anticonvulsants|anticonvulsants|mesh-ancestor
5680874|NCT03494517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5680875|NCT03494517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5680876|NCT03494517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680877|NCT03494517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5680878|NCT03494517|Tocolytic Agents|tocolytic agents|mesh-ancestor
5680879|NCT03494517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5680880|NCT03494426|Pregabalin|pregabalin|mesh-list
5680881|NCT03494426|Tramadol|tramadol|mesh-list
5680882|NCT03494426|Antidepressive Agents|antidepressive agents|mesh-list
5680883|NCT03494426|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
5680884|NCT03494426|Analgesics|analgesics|mesh-ancestor
5680885|NCT03494426|Sensory System Agents|sensory system agents|mesh-ancestor
5680886|NCT03494426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5680887|NCT03494426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680888|NCT03494426|Anticonvulsants|anticonvulsants|mesh-ancestor
5680889|NCT03494426|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5680890|NCT03494426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5680891|NCT03494426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680892|NCT03494426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5680893|NCT03494426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5680894|NCT03494426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5680895|NCT03494426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5680896|NCT03494426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5680897|NCT03494426|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5680898|NCT03494426|Narcotics|narcotics|mesh-ancestor
5680899|NCT03494387|Ascorbic Acid|ascorbic acid|mesh-list
5680900|NCT03494387|Acetylcysteine|acetylcysteine|mesh-list
5680901|NCT03494387|Antioxidants|antioxidants|mesh-list
5680902|NCT03494387|Antiviral Agents|antiviral agents|mesh-ancestor
5680903|NCT03494387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5680904|NCT03494387|Expectorants|expectorants|mesh-ancestor
5680905|NCT03494387|Respiratory System Agents|respiratory system agents|mesh-ancestor
5680906|NCT03494387|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5680907|NCT03494387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680908|NCT03494387|Protective Agents|protective agents|mesh-ancestor
5680909|NCT03494387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680910|NCT03494387|Vitamins|vitamins|mesh-ancestor
5680911|NCT03494387|Micronutrients|micronutrients|mesh-ancestor
5680912|NCT03494322|Cetuximab|cetuximab|mesh-list
5680913|NCT03494322|Avelumab|avelumab|mesh-list
5680914|NCT03494322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5680915|NCT03494322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5680916|NCT03494257|Brimonidine Tartrate|brimonidine tartrate|mesh-list
5680917|NCT03494257|Brinzolamide|brinzolamide|mesh-list
5680918|NCT03494257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5680919|NCT03494257|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5680920|NCT03494257|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5680921|NCT03494257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5680922|NCT03494257|Adrenergic Agents|adrenergic agents|mesh-ancestor
5680923|NCT03494257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5680924|NCT03494257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680925|NCT03494257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680926|NCT03494257|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5680927|NCT03494257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5680928|NCT03493841|Thioctic Acid|thioctic acid|mesh-list
5680929|NCT03493841|Antioxidants|antioxidants|mesh-ancestor
5680930|NCT03493841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680931|NCT03493841|Protective Agents|protective agents|mesh-ancestor
5680932|NCT03493841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680933|NCT03493841|Vitamin B Complex|vitamin b complex|mesh-ancestor
5680934|NCT03493841|Vitamins|vitamins|mesh-ancestor
5680935|NCT03493841|Micronutrients|micronutrients|mesh-ancestor
5680936|NCT03493789|Deoxyglucose|deoxyglucose|mesh-list
5680937|NCT03493789|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5680938|NCT03493789|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5680939|NCT03493789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680940|NCT03493789|Antimetabolites|antimetabolites|mesh-ancestor
5680941|NCT03493789|Antiviral Agents|antiviral agents|mesh-ancestor
5680942|NCT03493789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5680943|NCT03493685|Irbesartan|irbesartan|mesh-list
5680944|NCT03493685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5680945|NCT03493685|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5680946|NCT03493685|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5680947|NCT03493685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680948|NCT03493646|Azacitidine|azacitidine|mesh-list
5680949|NCT03493646|Cc-486|cc-486|mesh-list
5680950|NCT03493646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5680951|NCT03493646|Antimetabolites|antimetabolites|mesh-ancestor
5680952|NCT03493646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680953|NCT03493646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5680954|NCT03493646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5696900|NCT03379441|Pembrolizumab|pembrolizumab|mesh-list
5696901|NCT03379441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5696902|NCT03379441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5696903|NCT03379428|Trastuzumab|trastuzumab|mesh-list
5696904|NCT03379428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5696905|NCT03379428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5696906|NCT03379194|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5696907|NCT03379194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5696908|NCT03379181|Propranolol|propranolol|mesh-list
5696909|NCT03379181|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5696910|NCT03379181|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5696911|NCT03379181|Adrenergic Agents|adrenergic agents|mesh-ancestor
5696912|NCT03379181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5696913|NCT03379181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696914|NCT03379181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696915|NCT03379181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5696916|NCT03379181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5696917|NCT03379181|Vasodilator Agents|vasodilator agents|mesh-ancestor
5696918|NCT03379103|Propofol|propofol|mesh-list
5696919|NCT03379103|Sevoflurane|sevoflurane|mesh-list
5696920|NCT03379103|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5696921|NCT03379103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5696922|NCT03379103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696923|NCT03379103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5696924|NCT03379103|Anesthetics, General|anesthetics, general|mesh-ancestor
5696925|NCT03379103|Anesthetics|anesthetics|mesh-ancestor
5696926|NCT03379103|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5696927|NCT03379103|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5696928|NCT03379012|Sunitinib|sunitinib|mesh-list
5696929|NCT03379012|Methyltestosterone|methyltestosterone|mesh-list
5680955|NCT03493568|Dolutegravir|dolutegravir|mesh-list
5680956|NCT03493568|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5680957|NCT03493568|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5680958|NCT03493568|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5680959|NCT03493568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5680960|NCT03493568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680961|NCT03493568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5680962|NCT03493568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5680963|NCT03493568|Antiviral Agents|antiviral agents|mesh-ancestor
5680964|NCT03493568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5680965|NCT03493503|Albuterol|albuterol|mesh-list
5680966|NCT03493503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5680967|NCT03493503|Autonomic Agents|autonomic agents|mesh-ancestor
5680968|NCT03493503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5680969|NCT03493503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680970|NCT03493503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5680971|NCT03493503|Respiratory System Agents|respiratory system agents|mesh-ancestor
5680972|NCT03493503|Tocolytic Agents|tocolytic agents|mesh-ancestor
5680973|NCT03493503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5680974|NCT03493503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5680975|NCT03493503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5680976|NCT03493503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5680977|NCT03493503|Adrenergic Agents|adrenergic agents|mesh-ancestor
5680978|NCT03493503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5868615|NCT02350985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868616|NCT02350985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5868617|NCT02350985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5868618|NCT02350985|Vasodilator Agents|vasodilator agents|mesh-ancestor
5868619|NCT02350985|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5868620|NCT02350985|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5868621|NCT02350985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5868622|NCT02350985|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5868623|NCT02350985|Antidepressive Agents|antidepressive agents|mesh-ancestor
6494977|NCT00620997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6494978|NCT00621036|Methotrexate|methotrexate|mesh-list
6494979|NCT00621036|Thiotepa|thiotepa|mesh-list
6494980|NCT00621036|Immunoglobulins|immunoglobulins|mesh-list
5680979|NCT03493503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680980|NCT03493490|Diclofenac|diclofenac|mesh-list
5680981|NCT03493490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5680982|NCT03493490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5680983|NCT03493490|Analgesics|analgesics|mesh-ancestor
5680984|NCT03493490|Sensory System Agents|sensory system agents|mesh-ancestor
5680985|NCT03493490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5680986|NCT03493490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680987|NCT03493490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5680988|NCT03493490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5680989|NCT03493490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5680990|NCT03493490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5680991|NCT03493490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680992|NCT03493412|Verapamil|verapamil|mesh-list
5680993|NCT03493412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5680994|NCT03493412|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5680995|NCT03493412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5680996|NCT03493412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5680997|NCT03493412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5680998|NCT03493412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5680999|NCT03493412|Vasodilator Agents|vasodilator agents|mesh-ancestor
5681000|NCT03493269|Midazolam|midazolam|mesh-list
5681001|NCT03493269|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5681002|NCT03493269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5681003|NCT03493269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5681004|NCT03493269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681005|NCT03493269|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5681006|NCT03493269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5681007|NCT03493269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5681008|NCT03493269|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5681009|NCT03493269|Anesthetics, General|anesthetics, general|mesh-ancestor
5681010|NCT03493269|Anesthetics|anesthetics|mesh-ancestor
5868624|NCT02350985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5868625|NCT02350946|Oxytocin|oxytocin|mesh-list
5868626|NCT02350946|Oxytocics|oxytocics|mesh-ancestor
5868627|NCT02350946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5868628|NCT02350946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868629|NCT02350712|Carboplatin|carboplatin|mesh-list
5868630|NCT02350712|Cetuximab|cetuximab|mesh-list
5868631|NCT02350712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5868632|NCT02350712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5868633|NCT02350439|Adenosine|adenosine|mesh-list
5868634|NCT02350439|Analgesics|analgesics|mesh-ancestor
5868635|NCT02350439|Sensory System Agents|sensory system agents|mesh-ancestor
5868636|NCT02350439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5868637|NCT02350439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868638|NCT02350439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5868639|NCT02350439|Vasodilator Agents|vasodilator agents|mesh-ancestor
5868640|NCT02350439|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5868641|NCT02350439|Purinergic Agonists|purinergic agonists|mesh-ancestor
5868642|NCT02350439|Purinergic Agents|purinergic agents|mesh-ancestor
6494981|NCT00621036|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6494982|NCT00621036|Antibodies|antibodies|mesh-list
6494983|NCT00621036|Sargramostim|sargramostim|mesh-list
6494984|NCT00621036|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
6494985|NCT00621036|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6494986|NCT00621036|Abortifacient Agents|abortifacient agents|mesh-ancestor
5868643|NCT02350439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6494987|NCT00621036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6494988|NCT00621036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6494989|NCT00621036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6494990|NCT00621036|Antimetabolites|antimetabolites|mesh-ancestor
6496476|NCT00628225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5868644|NCT02350439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868645|NCT02350686|Capecitabine|capecitabine|mesh-list
5868646|NCT02350686|Oxaliplatin|oxaliplatin|mesh-list
5868647|NCT02350686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5868648|NCT02350686|Antimetabolites|antimetabolites|mesh-ancestor
5681011|NCT03493269|GABA Modulators|gaba modulators|mesh-ancestor
5868649|NCT02350686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868650|NCT02350686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5868651|NCT02350387|Oxymetazoline|oxymetazoline|mesh-list
5868652|NCT02350387|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5681012|NCT03493269|GABA Agents|gaba agents|mesh-ancestor
5681013|NCT03493269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5681014|NCT03493269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681015|NCT03493165|Everolimus|everolimus|mesh-list
5681016|NCT03493165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5681017|NCT03493165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5681018|NCT03493165|Immunologic Factors|immunologic factors|mesh-ancestor
5681019|NCT03493165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681020|NCT03493152|Everolimus|everolimus|mesh-list
5681021|NCT03493152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5681022|NCT03493152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5868653|NCT02350387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5868654|NCT02350387|Adrenergic Agents|adrenergic agents|mesh-ancestor
5868655|NCT02350387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5868656|NCT02350387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868657|NCT02350387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868658|NCT02350387|Sympathomimetics|sympathomimetics|mesh-ancestor
5868659|NCT02350387|Autonomic Agents|autonomic agents|mesh-ancestor
5868660|NCT02350387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5868661|NCT02350387|Nasal Decongestants|nasal decongestants|mesh-ancestor
5868662|NCT02350387|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5681023|NCT03493152|Immunologic Factors|immunologic factors|mesh-ancestor
5681024|NCT03493152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681025|NCT03493087|Vitamin K|vitamin k|mesh-list
5681026|NCT03493087|Vitamins|vitamins|mesh-ancestor
5681027|NCT03493087|Micronutrients|micronutrients|mesh-ancestor
5681028|NCT03493087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681029|NCT03493087|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5681030|NCT03493087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5681031|NCT03493087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868663|NCT02350387|Respiratory System Agents|respiratory system agents|mesh-ancestor
5868664|NCT02350673|Atezolizumab|atezolizumab|mesh-list
5868665|NCT02350673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5868666|NCT02350361|Endostatins|endostatins|mesh-list
5868667|NCT02350361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5868668|NCT02350361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5868669|NCT02350361|Growth Substances|growth substances|mesh-ancestor
5868670|NCT02350361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868671|NCT02350361|Growth Inhibitors|growth inhibitors|mesh-ancestor
5868672|NCT02350361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5868673|NCT02350335|Nicotine|nicotine|mesh-list
5868674|NCT02350335|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5868675|NCT02350335|Autonomic Agents|autonomic agents|mesh-ancestor
5868676|NCT02350335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5868677|NCT02350335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868678|NCT02350335|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5868679|NCT02350335|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5868680|NCT02350335|Cholinergic Agents|cholinergic agents|mesh-ancestor
5868681|NCT02350335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5868682|NCT02350335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868683|NCT02350426|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5868684|NCT02350426|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5868685|NCT02350426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868686|NCT02350530|Bevacizumab|bevacizumab|mesh-list
5868687|NCT02350530|Fluorouracil|fluorouracil|mesh-list
5868688|NCT02350530|Oxaliplatin|oxaliplatin|mesh-list
5868689|NCT02350530|Irinotecan|irinotecan|mesh-list
5868690|NCT02350530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5868691|NCT02350530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5868692|NCT02350530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5681032|NCT03493087|Hemostatics|hemostatics|mesh-ancestor
5681033|NCT03493087|Coagulants|coagulants|mesh-ancestor
5681034|NCT03493061|Oxaliplatin|oxaliplatin|mesh-list
5681035|NCT03493061|Irinotecan|irinotecan|mesh-list
5681036|NCT03493061|Floxuridine|floxuridine|mesh-list
5681037|NCT03493061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5681038|NCT03493061|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5681039|NCT03493061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5681040|NCT03493061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5681041|NCT03493061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681042|NCT03493061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5868693|NCT02350530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5681043|NCT03493061|Antimetabolites|antimetabolites|mesh-ancestor
5868694|NCT02350530|Growth Substances|growth substances|mesh-ancestor
5868695|NCT02350530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681044|NCT03493048|Leucovorin|leucovorin|mesh-list
5681045|NCT03493048|Fluorouracil|fluorouracil|mesh-list
5681046|NCT03493048|Oxaliplatin|oxaliplatin|mesh-list
5681047|NCT03493048|Irinotecan|irinotecan|mesh-list
5681048|NCT03493048|Cetuximab|cetuximab|mesh-list
5681049|NCT03493048|Antimetabolites|antimetabolites|mesh-ancestor
5681050|NCT03493048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681051|NCT03493048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5681052|NCT03493048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5681053|NCT03493048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5681054|NCT03493048|Immunologic Factors|immunologic factors|mesh-ancestor
5681055|NCT03493048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681056|NCT03493048|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5681057|NCT03493048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5681058|NCT03493048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5681059|NCT03493048|Antidotes|antidotes|mesh-ancestor
5681060|NCT03493048|Protective Agents|protective agents|mesh-ancestor
5681061|NCT03493048|Vitamin B Complex|vitamin b complex|mesh-ancestor
5681062|NCT03493048|Vitamins|vitamins|mesh-ancestor
5681063|NCT03493048|Micronutrients|micronutrients|mesh-ancestor
5681064|NCT03493048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5868696|NCT02350530|Growth Inhibitors|growth inhibitors|mesh-ancestor
5868697|NCT02350530|Antimetabolites|antimetabolites|mesh-ancestor
5868698|NCT02350530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868699|NCT02350530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5868700|NCT02350530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5868701|NCT02350530|Immunologic Factors|immunologic factors|mesh-ancestor
5868702|NCT02350530|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5868703|NCT02350530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5868704|NCT02350530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5868705|NCT02350543|Aspirin|aspirin|mesh-list
5868706|NCT02350543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5868707|NCT02350543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5868708|NCT02350543|Analgesics|analgesics|mesh-ancestor
5868709|NCT02350543|Sensory System Agents|sensory system agents|mesh-ancestor
5868710|NCT02350543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5868711|NCT02350543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868712|NCT02350543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5868713|NCT02350543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5868714|NCT02350543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5868715|NCT02350543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5868716|NCT02350543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868717|NCT02350543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5868718|NCT02350543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5868719|NCT02350543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5868720|NCT02350543|Antipyretics|antipyretics|mesh-ancestor
5868721|NCT02350517|Paclitaxel|paclitaxel|mesh-list
5868722|NCT02350517|Endostar protein|endostar protein|mesh-list
5868723|NCT02350517|Endostatins|endostatins|mesh-list
5868724|NCT02350517|Nedaplatin|nedaplatin|mesh-list
5868725|NCT02350517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5868726|NCT02350517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5868727|NCT02350517|Tubulin Modulators|tubulin modulators|mesh-ancestor
5868728|NCT02350517|Antimitotic Agents|antimitotic agents|mesh-ancestor
6494991|NCT00621036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6494992|NCT00621036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6494993|NCT00621036|Dermatologic Agents|dermatologic agents|mesh-ancestor
6494994|NCT00621036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6494995|NCT00621036|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6494996|NCT00621036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6494997|NCT00621036|Immunologic Factors|immunologic factors|mesh-ancestor
6494998|NCT00621036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6494999|NCT00621036|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6495000|NCT00621036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6495001|NCT00621036|Alkylating Agents|alkylating agents|mesh-ancestor
6495002|NCT00621036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5681065|NCT03492996|Delpazolid|delpazolid|mesh-list
5868729|NCT02350517|Mitosis Modulators|mitosis modulators|mesh-ancestor
5868730|NCT02350517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868731|NCT02350517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5868732|NCT02350517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5681066|NCT03492996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5681067|NCT03492996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5681068|NCT03492996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6495003|NCT00621101|Sirolimus|sirolimus|mesh-list
5868733|NCT02350517|Growth Substances|growth substances|mesh-ancestor
5681069|NCT03492996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5681070|NCT03492996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681071|NCT03492970|Melatonin|melatonin|mesh-list
5681072|NCT03492970|Antioxidants|antioxidants|mesh-ancestor
5681073|NCT03492970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681074|NCT03492970|Protective Agents|protective agents|mesh-ancestor
5681075|NCT03492970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681076|NCT03492970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5681077|NCT03492931|Ticagrelor|ticagrelor|mesh-list
5868734|NCT02350517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868735|NCT02350517|Growth Inhibitors|growth inhibitors|mesh-ancestor
5868736|NCT02350400|Irinotecan|irinotecan|mesh-list
5868737|NCT02350400|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5868738|NCT02350400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5868739|NCT02350400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5868740|NCT02350400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868741|NCT02350400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5868742|NCT02350179|Tranexamic Acid|tranexamic acid|mesh-list
5868743|NCT02350179|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5681078|NCT03492931|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5681079|NCT03492931|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5681080|NCT03492931|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5681081|NCT03492931|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5681082|NCT03492931|Purinergic Agents|purinergic agents|mesh-ancestor
5681083|NCT03492931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5681084|NCT03492931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681085|NCT03492931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681086|NCT03492918|Pembrolizumab|pembrolizumab|mesh-list
5681087|NCT03492918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5681088|NCT03492918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5681089|NCT03492866|Gentamicins|gentamicins|mesh-list
5681090|NCT03492866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5681091|NCT03492866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5681092|NCT03492866|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5868744|NCT02350179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5868745|NCT02350179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868746|NCT02350179|Hemostatics|hemostatics|mesh-ancestor
5868747|NCT02350179|Coagulants|coagulants|mesh-ancestor
5868748|NCT02350231|Progesterone|progesterone|mesh-list
5868749|NCT02350231|Progestins|progestins|mesh-ancestor
5868750|NCT02350231|Hormones|hormones|mesh-ancestor
5868751|NCT02350231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5868752|NCT02350231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868753|NCT02350218|Alprostadil|alprostadil|mesh-list
5868754|NCT02350218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5868755|NCT02350218|Vasodilator Agents|vasodilator agents|mesh-ancestor
5868756|NCT02350218|Urological Agents|urological agents|mesh-ancestor
5868757|NCT02349919|Procaterol|procaterol|mesh-list
5868758|NCT02349919|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5868759|NCT02349919|Autonomic Agents|autonomic agents|mesh-ancestor
5868760|NCT02349919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5868761|NCT02349919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868762|NCT02349919|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5868763|NCT02349919|Respiratory System Agents|respiratory system agents|mesh-ancestor
5868764|NCT02349919|Sympathomimetics|sympathomimetics|mesh-ancestor
5868765|NCT02349919|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5868766|NCT02349919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5868767|NCT02349919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5868768|NCT02349919|Adrenergic Agents|adrenergic agents|mesh-ancestor
5868769|NCT02349919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5868770|NCT02349919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681093|NCT03492866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5681094|NCT03492866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681095|NCT03492827|Chlorhexidine|chlorhexidine|mesh-list
5681096|NCT03492827|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5681097|NCT03492827|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5681098|NCT03492827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5681099|NCT03492827|Disinfectants|disinfectants|mesh-ancestor
5681100|NCT03492827|Dermatologic Agents|dermatologic agents|mesh-ancestor
5681101|NCT03492775|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5681102|NCT03492775|Obinutuzumab|obinutuzumab|mesh-list
5681103|NCT03492775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5868771|NCT02350023|Betamethasone|betamethasone|mesh-list
5868772|NCT02350023|Latanoprost|latanoprost|mesh-list
5868773|NCT02350023|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5868774|NCT02350023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5868775|NCT02350023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5868776|NCT02350023|Glucocorticoids|glucocorticoids|mesh-ancestor
5868777|NCT02350023|Hormones|hormones|mesh-ancestor
5868778|NCT02350023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5868779|NCT02350023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868780|NCT02350023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5868781|NCT02350023|Respiratory System Agents|respiratory system agents|mesh-ancestor
5868782|NCT02349802|Exenatide|exenatide|mesh-list
5868783|NCT02349802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5868784|NCT02349802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868785|NCT02349802|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5868786|NCT02349802|Incretins|incretins|mesh-ancestor
5868787|NCT02349802|Hormones|hormones|mesh-ancestor
5868788|NCT02349802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5868789|NCT02349958|Doxorubicin|doxorubicin|mesh-list
5868790|NCT02349958|Cisplatin|cisplatin|mesh-list
5868791|NCT02349958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5868792|NCT02349958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5868793|NCT02349958|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5868794|NCT02349958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5868795|NCT02349958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5868796|NCT02349958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868797|NCT02349763|Dexamethasone|dexamethasone|mesh-list
5868798|NCT02349763|Dexamethasone acetate|dexamethasone acetate|mesh-list
5868799|NCT02349763|BB 1101|bb 1101|mesh-list
5868800|NCT02349763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5868801|NCT02349763|Antiemetics|antiemetics|mesh-ancestor
5868802|NCT02349763|Autonomic Agents|autonomic agents|mesh-ancestor
6495004|NCT00621101|Ezetimibe|ezetimibe|mesh-list
6495005|NCT00621101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6495006|NCT00621101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6495007|NCT00621101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6495008|NCT00621101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6495009|NCT00621101|Antifungal Agents|antifungal agents|mesh-ancestor
6495010|NCT00621101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6495011|NCT00621101|Immunologic Factors|immunologic factors|mesh-ancestor
5868803|NCT02349763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5868804|NCT02349763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868805|NCT02349763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5868806|NCT02349763|Glucocorticoids|glucocorticoids|mesh-ancestor
5868807|NCT02349763|Hormones|hormones|mesh-ancestor
5868808|NCT02349763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5868809|NCT02349763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5868810|NCT02349763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5868811|NCT02349763|Protease Inhibitors|protease inhibitors|mesh-ancestor
6495012|NCT00621101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495013|NCT00621101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6495014|NCT00621101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6495015|NCT00621101|Antimetabolites|antimetabolites|mesh-ancestor
6495016|NCT00621101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868812|NCT02349763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5868813|NCT02349763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868814|NCT02349906|Treosulfan|treosulfan|mesh-list
5868815|NCT02349906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5868816|NCT02349906|Alkylating Agents|alkylating agents|mesh-ancestor
5868817|NCT02349906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868818|NCT02349906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5868819|NCT02349945|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5868820|NCT02349945|Hormones|hormones|mesh-ancestor
5868821|NCT02349945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5868822|NCT02349945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868823|NCT02349841|Amoxicillin|amoxicillin|mesh-list
5868824|NCT02349841|Meropenem|meropenem|mesh-list
5868825|NCT02349841|Clavulanic Acids|clavulanic acids|mesh-list
5868826|NCT02349841|Clavulanic Acid|clavulanic acid|mesh-list
5868827|NCT02349841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5868828|NCT02349841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5868829|NCT02349841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5868830|NCT02349841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868831|NCT02349841|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5868832|NCT02349828|Acyclovir|acyclovir|mesh-list
5868833|NCT02349828|Antiviral Agents|antiviral agents|mesh-ancestor
5681104|NCT03492775|Alkylating Agents|alkylating agents|mesh-ancestor
5681105|NCT03492775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681106|NCT03492775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5681107|NCT03492775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5681108|NCT03492736|Melatonin|melatonin|mesh-list
5681109|NCT03492736|Antioxidants|antioxidants|mesh-ancestor
5681110|NCT03492736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681111|NCT03492736|Protective Agents|protective agents|mesh-ancestor
5681112|NCT03492736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681113|NCT03492736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5681114|NCT03492710|Immunoglobulins|immunoglobulins|mesh-list
5681115|NCT03492710|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5681116|NCT03492710|Antibodies|antibodies|mesh-list
5681117|NCT03492710|Immunologic Factors|immunologic factors|mesh-ancestor
5681118|NCT03492710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681119|NCT03492671|Gemcitabine|gemcitabine|mesh-list
5681120|NCT03492671|Paclitaxel|paclitaxel|mesh-list
5681121|NCT03492671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5681122|NCT03492671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5681123|NCT03492671|Tubulin Modulators|tubulin modulators|mesh-ancestor
5681124|NCT03492671|Antimitotic Agents|antimitotic agents|mesh-ancestor
5681125|NCT03492671|Mitosis Modulators|mitosis modulators|mesh-ancestor
5681126|NCT03492671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681127|NCT03492671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5681128|NCT03492671|Antimetabolites|antimetabolites|mesh-ancestor
5681129|NCT03492671|Antiviral Agents|antiviral agents|mesh-ancestor
5681130|NCT03492671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5681131|NCT03492671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5681132|NCT03492671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5681133|NCT03492671|Immunologic Factors|immunologic factors|mesh-ancestor
6495017|NCT00621101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6495018|NCT00621166|Ritonavir|ritonavir|mesh-list
6495019|NCT00621166|Lopinavir|lopinavir|mesh-list
6495020|NCT00621166|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6495021|NCT00621166|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6495022|NCT00621166|Protease Inhibitors|protease inhibitors|mesh-ancestor
5681134|NCT03492671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681135|NCT03492658|Methotrexate|methotrexate|mesh-list
5681136|NCT03492658|Abatacept|abatacept|mesh-list
5681137|NCT03492658|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5681138|NCT03492658|Abortifacient Agents|abortifacient agents|mesh-ancestor
5681139|NCT03492658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5681140|NCT03492658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681141|NCT03492658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5681142|NCT03492658|Antimetabolites|antimetabolites|mesh-ancestor
5681143|NCT03492658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681144|NCT03492658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5681145|NCT03492658|Dermatologic Agents|dermatologic agents|mesh-ancestor
5681146|NCT03492658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5681147|NCT03492658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5681148|NCT03492658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5681149|NCT03492658|Immunologic Factors|immunologic factors|mesh-ancestor
5681150|NCT03492658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5681151|NCT03492658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5681152|NCT03492658|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5681153|NCT03492632|Hormones|hormones|mesh-list
5681154|NCT03492632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5681155|NCT03492632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681156|NCT03492593|Beta Carotene|beta carotene|mesh-list
5681157|NCT03492593|Lycopene|lycopene|mesh-list
5681158|NCT03492593|Carotenoids|carotenoids|mesh-list
5681159|NCT03492593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5681160|NCT03492593|Antioxidants|antioxidants|mesh-ancestor
5681161|NCT03492593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681162|NCT03492593|Protective Agents|protective agents|mesh-ancestor
5681163|NCT03492593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681164|NCT03492593|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5868834|NCT02349828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5905319|NCT05136521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5905320|NCT05136521|Serotonin Agents|serotonin agents|mesh-ancestor
5905321|NCT05136521|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5905322|NCT05136521|Antidepressive Agents|antidepressive agents|mesh-ancestor
5905323|NCT05136508|Propofol|propofol|mesh-list
5905324|NCT05136508|Sevoflurane|sevoflurane|mesh-list
5905325|NCT05136508|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5905326|NCT05136508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5905327|NCT05136508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905328|NCT05136508|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5905329|NCT05136508|Anesthetics, General|anesthetics, general|mesh-ancestor
5905330|NCT05136508|Anesthetics|anesthetics|mesh-ancestor
5905331|NCT05136508|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5905332|NCT05136508|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5908506|NCT04471428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908507|NCT04464980|Naltrexone|naltrexone|mesh-list
5908508|NCT04464980|Buprenorphine|buprenorphine|mesh-list
5908509|NCT04464980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5908510|NCT04464980|Narcotics|narcotics|mesh-ancestor
5908511|NCT04464980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5908512|NCT04464980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5908513|NCT04464980|Analgesics|analgesics|mesh-ancestor
5908514|NCT04464980|Sensory System Agents|sensory system agents|mesh-ancestor
5908515|NCT04464980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5908516|NCT04464980|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5908517|NCT04464980|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5908518|NCT04460937|Adavosertib|adavosertib|mesh-list
5908519|NCT04460937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5908520|NCT04460937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908521|NCT04460560|Terlipressin|terlipressin|mesh-list
5908522|NCT04460560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5908523|NCT04460560|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5908524|NCT04457596|Trastuzumab|trastuzumab|mesh-list
5908525|NCT04457596|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
5908526|NCT04457596|Maytansine|maytansine|mesh-list
5908527|NCT04457596|Tucatinib|tucatinib|mesh-list
5908528|NCT04457596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5908529|NCT04457596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5908530|NCT04457596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5908531|NCT04457596|Tubulin Modulators|tubulin modulators|mesh-ancestor
5908532|NCT04457596|Antimitotic Agents|antimitotic agents|mesh-ancestor
5908533|NCT04457596|Mitosis Modulators|mitosis modulators|mesh-ancestor
5908534|NCT04457596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908535|NCT04457596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5908536|NCT04457596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5908537|NCT04449874|Bevacizumab|bevacizumab|mesh-list
5908538|NCT04449874|Cetuximab|cetuximab|mesh-list
5908539|NCT04449874|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5908540|NCT04449874|Atezolizumab|atezolizumab|mesh-list
5908541|NCT04449874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5908542|NCT04449874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5908543|NCT04449874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5908544|NCT04449874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5908545|NCT04449874|Growth Substances|growth substances|mesh-ancestor
5908546|NCT04449874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5908547|NCT04449874|Growth Inhibitors|growth inhibitors|mesh-ancestor
5908548|NCT04449874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5908549|NCT04449874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5908550|NCT04449874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908551|NCT04448184|Tranexamic Acid|tranexamic acid|mesh-list
5908552|NCT04448184|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5908553|NCT04448184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6212374|NCT02187055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5868835|NCT02349490|Hemostatics|hemostatics|mesh-list
5868836|NCT02349490|Coagulants|coagulants|mesh-ancestor
5868837|NCT02349386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5868838|NCT02349386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5868839|NCT02349386|Estradiol|estradiol|mesh-list
5868840|NCT02349386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5868841|NCT02349386|Estrogens|estrogens|mesh-ancestor
5681165|NCT03492593|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5681166|NCT03492593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5681167|NCT03492593|Provitamins|provitamins|mesh-ancestor
5681168|NCT03492593|Vitamins|vitamins|mesh-ancestor
5681169|NCT03492593|Micronutrients|micronutrients|mesh-ancestor
5681170|NCT03492580|Dapagliflozin|dapagliflozin|mesh-list
5681171|NCT03492580|Empagliflozin|empagliflozin|mesh-list
5681172|NCT03492580|Canagliflozin|canagliflozin|mesh-list
5868842|NCT02349386|Hormones|hormones|mesh-ancestor
5868843|NCT02349386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5868844|NCT02349386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868845|NCT02349386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5868846|NCT02349386|Contraceptive Agents|contraceptive agents|mesh-ancestor
5868847|NCT02349386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5868848|NCT02349386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5868849|NCT02349516|Squalamine|squalamine|mesh-list
5868850|NCT02349516|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5868851|NCT02349516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5868852|NCT02349516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5868853|NCT02349516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5868854|NCT02349516|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5868855|NCT02349516|Protective Agents|protective agents|mesh-ancestor
5868856|NCT02349516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868857|NCT02349516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5868858|NCT02349516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5868859|NCT02349516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6495023|NCT00621166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6495024|NCT00621166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495025|NCT00621166|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6495026|NCT00621166|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6495027|NCT00621166|Antiviral Agents|antiviral agents|mesh-ancestor
6495028|NCT00621166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6495029|NCT00621166|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5681173|NCT03492580|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
5868860|NCT02349516|Growth Substances|growth substances|mesh-ancestor
5868861|NCT02349516|Growth Inhibitors|growth inhibitors|mesh-ancestor
5868862|NCT02349594|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
5868863|NCT02349594|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
5868864|NCT02349594|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5681174|NCT03492580|Hypoglycemic Agents|hypoglycemic agents|mesh-list
5681175|NCT03492580|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
5681176|NCT03492580|Glucagon|glucagon|mesh-list
5681177|NCT03492580|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5681178|NCT03492580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681179|NCT03492580|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5681180|NCT03492580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681181|NCT03492580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5868865|NCT02349594|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5868866|NCT02349399|Cyproterone Acetate|cyproterone acetate|mesh-list
5868867|NCT02349399|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5868868|NCT02349399|Cyproterone|cyproterone|mesh-list
5868869|NCT02349399|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
5868870|NCT02349399|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5868871|NCT02349399|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5868872|NCT02349399|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5868873|NCT02349399|Contraceptive Agents|contraceptive agents|mesh-ancestor
5868874|NCT02349399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5868875|NCT02349399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868876|NCT02349399|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5868877|NCT02349399|Estrogens|estrogens|mesh-ancestor
5868878|NCT02349399|Hormones|hormones|mesh-ancestor
5868879|NCT02349399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5868880|NCT02349399|Androgen Antagonists|androgen antagonists|mesh-ancestor
5868881|NCT02349399|Hormone Antagonists|hormone antagonists|mesh-ancestor
5868882|NCT02349399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5868883|NCT02349399|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5868884|NCT02349581|Bupivacaine|bupivacaine|mesh-list
5681182|NCT03492580|Hormones|hormones|mesh-ancestor
5868885|NCT02349581|Anesthetics, Local|anesthetics, local|mesh-ancestor
5868886|NCT02349581|Anesthetics|anesthetics|mesh-ancestor
5868887|NCT02349581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5868888|NCT02349581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868889|NCT02349581|Sensory System Agents|sensory system agents|mesh-ancestor
5868890|NCT02349581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5868891|NCT02349607|Ibuprofen|ibuprofen|mesh-list
5868892|NCT02349607|Pregabalin|pregabalin|mesh-list
5868893|NCT02349607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5868894|NCT02349607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5868895|NCT02349607|Analgesics|analgesics|mesh-ancestor
5868896|NCT02349607|Sensory System Agents|sensory system agents|mesh-ancestor
5868897|NCT02349607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5868898|NCT02349607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868899|NCT02349607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5868900|NCT02349607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5868901|NCT02349607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5868902|NCT02349607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5868903|NCT02349607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868904|NCT02349607|Anticonvulsants|anticonvulsants|mesh-ancestor
5868905|NCT02349607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5868906|NCT02349607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5868907|NCT02349607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5868908|NCT02349607|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5868909|NCT02349607|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5681183|NCT03492580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5681184|NCT03492580|Incretins|incretins|mesh-ancestor
5681185|NCT03492580|Protease Inhibitors|protease inhibitors|mesh-ancestor
5681186|NCT03492580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5681187|NCT03492541|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5681188|NCT03492541|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5681189|NCT03492489|Cemiplimab|cemiplimab|mesh-list
5681190|NCT03492489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5681191|NCT03492489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5681192|NCT03492463|Nicotine|nicotine|mesh-list
5681193|NCT03492463|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5681194|NCT03492463|Autonomic Agents|autonomic agents|mesh-ancestor
5681195|NCT03492463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5681196|NCT03492463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681197|NCT03492463|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5681198|NCT03492463|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5681199|NCT03492463|Cholinergic Agents|cholinergic agents|mesh-ancestor
5681200|NCT03492463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5696930|NCT03379012|Testosterone|testosterone|mesh-list
6495030|NCT00621166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6495031|NCT00621218|Tretinoin|tretinoin|mesh-list
6495032|NCT00621218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6495033|NCT00621218|Keratolytic Agents|keratolytic agents|mesh-ancestor
6495034|NCT00621218|Dermatologic Agents|dermatologic agents|mesh-ancestor
6495035|NCT00621283|Secretin|secretin|mesh-list
6495036|NCT00621283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6495037|NCT00621283|Hormones|hormones|mesh-ancestor
6495038|NCT00621283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6495039|NCT00621283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495040|NCT00621361|Etoposide|etoposide|mesh-list
6495041|NCT00621361|Cediranib|cediranib|mesh-list
6495042|NCT00621361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6495043|NCT00621361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5868910|NCT02349607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5868911|NCT02349607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5868912|NCT02349282|Vitamin D|vitamin d|mesh-list
5868913|NCT02349282|Cholecalciferol|cholecalciferol|mesh-list
5868914|NCT02349282|Calcifediol|calcifediol|mesh-list
5868915|NCT02349282|Vitamins|vitamins|mesh-ancestor
5868916|NCT02349282|Micronutrients|micronutrients|mesh-ancestor
5868917|NCT02349282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868918|NCT02349282|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5868919|NCT02349282|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5868920|NCT02349243|Entacapone|entacapone|mesh-list
5868921|NCT02349243|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5868922|NCT02349243|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5868923|NCT02349243|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
5868924|NCT02349243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5905333|NCT05136157|Insulin|insulin|mesh-list
6495044|NCT00621361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6495045|NCT00621361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5868925|NCT02349243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868926|NCT02349204|Zaleplon|zaleplon|mesh-list
5868927|NCT02349204|Anticonvulsants|anticonvulsants|mesh-ancestor
5868928|NCT02349204|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5868929|NCT02349204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5868930|NCT02349204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681201|NCT03492463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681202|NCT03492437|Tepotinib|tepotinib|mesh-list
5681203|NCT03492437|Dabigatran|dabigatran|mesh-list
5681204|NCT03492437|Antithrombins|antithrombins|mesh-ancestor
5868931|NCT02349204|GABA Modulators|gaba modulators|mesh-ancestor
5868932|NCT02349204|GABA Agents|gaba agents|mesh-ancestor
5868933|NCT02349204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5868934|NCT02349204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868935|NCT02349165|Riboflavin|riboflavin|mesh-list
5868936|NCT02349165|Vitamin B Complex|vitamin b complex|mesh-ancestor
5868937|NCT02349165|Vitamins|vitamins|mesh-ancestor
5868938|NCT02349165|Micronutrients|micronutrients|mesh-ancestor
5868939|NCT02349165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868940|NCT02349165|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5868941|NCT02349165|Dermatologic Agents|dermatologic agents|mesh-ancestor
5868942|NCT02348905|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
5868943|NCT02348905|Hormones|hormones|mesh-ancestor
5868944|NCT02348905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5868945|NCT02348905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868946|NCT02349113|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5868947|NCT02349113|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5868948|NCT02349113|Estrogens|estrogens|mesh-list
5868949|NCT02349113|Estradiol|estradiol|mesh-list
5681205|NCT03492437|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5681206|NCT03492437|Protease Inhibitors|protease inhibitors|mesh-ancestor
5681207|NCT03492437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5868950|NCT02349113|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5868951|NCT02349113|Hormones|hormones|mesh-ancestor
5868952|NCT02349113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5868953|NCT02349113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868954|NCT02349113|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5868955|NCT02349113|Contraceptive Agents|contraceptive agents|mesh-ancestor
5868956|NCT02349113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5868957|NCT02349113|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5868958|NCT02348788|Chloroquine|chloroquine|mesh-list
5868959|NCT02348788|Lumefantrine|lumefantrine|mesh-list
5868960|NCT02348788|Artemether|artemether|mesh-list
5868961|NCT02348788|Primaquine|primaquine|mesh-list
5868962|NCT02348788|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
5868963|NCT02348788|Amebicides|amebicides|mesh-ancestor
5868964|NCT02348788|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5868965|NCT02348788|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5868966|NCT02348788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5868967|NCT02348788|Antimalarials|antimalarials|mesh-ancestor
5868968|NCT02348788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5868969|NCT02348528|Dexamethasone|dexamethasone|mesh-list
5868970|NCT02348528|Lenalidomide|lenalidomide|mesh-list
5868971|NCT02348528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5868972|NCT02348528|Antiemetics|antiemetics|mesh-ancestor
5868973|NCT02348528|Autonomic Agents|autonomic agents|mesh-ancestor
5868974|NCT02348528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5868975|NCT02348528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5868976|NCT02348528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5681208|NCT03492437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681209|NCT03492437|Anticoagulants|anticoagulants|mesh-ancestor
5681210|NCT03492437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5681211|NCT03492385|Ticagrelor|ticagrelor|mesh-list
5681212|NCT03492385|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5681213|NCT03492385|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5681214|NCT03492385|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5681215|NCT03492385|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5681216|NCT03492385|Purinergic Agents|purinergic agents|mesh-ancestor
5681217|NCT03492385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5681218|NCT03492385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681219|NCT03492385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681220|NCT03492255|Mycophenolic Acid|mycophenolic acid|mesh-list
5868977|NCT02348528|Glucocorticoids|glucocorticoids|mesh-ancestor
5681221|NCT03492255|Prednisone|prednisone|mesh-list
5868978|NCT02348528|Hormones|hormones|mesh-ancestor
5868979|NCT02348528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5868980|NCT02348528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5868981|NCT02348528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5868982|NCT02348528|Immunologic Factors|immunologic factors|mesh-ancestor
5868983|NCT02348528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5868984|NCT02348528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5868985|NCT02348528|Growth Substances|growth substances|mesh-ancestor
5868986|NCT02348528|Growth Inhibitors|growth inhibitors|mesh-ancestor
5868987|NCT02348463|Clindamycin|clindamycin|mesh-list
5868988|NCT02348463|Clindamycin palmitate|clindamycin palmitate|mesh-list
5868989|NCT02348463|Clindamycin phosphate|clindamycin phosphate|mesh-list
5868990|NCT02348463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5868991|NCT02348463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5868992|NCT02348463|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5868993|NCT02348463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5868994|NCT02348463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5868995|NCT02348255|Bevacizumab|bevacizumab|mesh-list
5868996|NCT02348255|Carmustine|carmustine|mesh-list
5868997|NCT02348255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5868998|NCT02348255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5868999|NCT02348255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5869000|NCT02348255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5869001|NCT02348255|Growth Substances|growth substances|mesh-ancestor
5869002|NCT02348255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869003|NCT02348255|Growth Inhibitors|growth inhibitors|mesh-ancestor
5681222|NCT03492255|Methylprednisolone|methylprednisolone|mesh-list
5681223|NCT03492255|Cyclophosphamide|cyclophosphamide|mesh-list
5681224|NCT03492255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5681225|NCT03492255|Immunologic Factors|immunologic factors|mesh-ancestor
5681226|NCT03492255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681227|NCT03492255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5681228|NCT03492255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5681229|NCT03492255|Alkylating Agents|alkylating agents|mesh-ancestor
5681230|NCT03492255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681231|NCT03492255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5869004|NCT02348255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5869005|NCT02348255|Alkylating Agents|alkylating agents|mesh-ancestor
5869006|NCT02348255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869007|NCT02348268|Analgesics|analgesics|mesh-list
5869008|NCT02348268|Sensory System Agents|sensory system agents|mesh-ancestor
5869009|NCT02348268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5869010|NCT02348268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869011|NCT02348346|Titanium dioxide|titanium dioxide|mesh-list
5869012|NCT02348346|Sunscreening Agents|sunscreening agents|mesh-ancestor
5869013|NCT02348346|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5869014|NCT02348346|Protective Agents|protective agents|mesh-ancestor
5869015|NCT02348346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869016|NCT02348346|Dermatologic Agents|dermatologic agents|mesh-ancestor
5869017|NCT02348346|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5869018|NCT02348333|Dotinurad|dotinurad|mesh-list
5869019|NCT02348333|Uricosuric Agents|uricosuric agents|mesh-ancestor
5869020|NCT02348333|Gout Suppressants|gout suppressants|mesh-ancestor
5869021|NCT02348333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5869022|NCT02348333|Renal Agents|renal agents|mesh-ancestor
5869023|NCT02348307|Dotinurad|dotinurad|mesh-list
5869024|NCT02348307|Uricosuric Agents|uricosuric agents|mesh-ancestor
5869025|NCT02348307|Gout Suppressants|gout suppressants|mesh-ancestor
5869026|NCT02348307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5869027|NCT02348307|Renal Agents|renal agents|mesh-ancestor
5869028|NCT02348424|Solithromycin|solithromycin|mesh-list
5681232|NCT03492255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5681233|NCT03492255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5681234|NCT03492255|Glucocorticoids|glucocorticoids|mesh-ancestor
5681235|NCT03492255|Hormones|hormones|mesh-ancestor
5681236|NCT03492255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5869029|NCT02348424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5869030|NCT02348424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5869031|NCT02348450|Irinotecan|irinotecan|mesh-list
5869032|NCT02348450|Etoposide|etoposide|mesh-list
5869033|NCT02348450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5869034|NCT02348450|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6495046|NCT00621361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6495047|NCT00621361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495048|NCT00621361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6495049|NCT00621387|Ofloxacin|ofloxacin|mesh-list
5869035|NCT02348450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5681237|NCT03492255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5869036|NCT02348450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5869037|NCT02348450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869038|NCT02348450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5869039|NCT02348450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5869040|NCT02348372|Glycine|glycine|mesh-list
5869041|NCT02348372|Glycine Agents|glycine agents|mesh-ancestor
5681238|NCT03492255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5681239|NCT03492255|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5681240|NCT03492255|Antitubercular Agents|antitubercular agents|mesh-ancestor
5681241|NCT03492255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5681242|NCT03492255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5869042|NCT02348372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5869043|NCT02348372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869044|NCT02348372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869045|NCT02348281|Bicalutamide|bicalutamide|mesh-list
5869046|NCT02348281|Androgen Antagonists|androgen antagonists|mesh-ancestor
5869047|NCT02348281|Hormone Antagonists|hormone antagonists|mesh-ancestor
5869048|NCT02348281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5869049|NCT02348281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869050|NCT02348281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5869051|NCT02348398|Topotecan|topotecan|mesh-list
5869052|NCT02348398|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5869053|NCT02348398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5869054|NCT02348398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5869055|NCT02348398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869056|NCT02348398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5869057|NCT02348242|Lubricant Eye Drops|lubricant eye drops|mesh-list
5869058|NCT02348242|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5869059|NCT02348242|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5869060|NCT02348190|Heparin|heparin|mesh-list
5869061|NCT02348190|Anticoagulants|anticoagulants|mesh-ancestor
5869062|NCT02348190|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5869063|NCT02348190|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5869064|NCT02348190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869065|NCT02348177|Ritonavir|ritonavir|mesh-list
5869066|NCT02348177|Lopinavir|lopinavir|mesh-list
5869067|NCT02348177|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5869068|NCT02348177|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5869069|NCT02348177|Protease Inhibitors|protease inhibitors|mesh-ancestor
5869070|NCT02348177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5869071|NCT02348177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869072|NCT02348177|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5869073|NCT02348177|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5869074|NCT02348177|Antiviral Agents|antiviral agents|mesh-ancestor
5869075|NCT02348177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5869076|NCT02348177|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5869077|NCT02348177|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5681243|NCT03492255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5681244|NCT03492255|Antiemetics|antiemetics|mesh-ancestor
5681245|NCT03492255|Autonomic Agents|autonomic agents|mesh-ancestor
5681246|NCT03492255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5869078|NCT02347904|Oxaliplatin|oxaliplatin|mesh-list
5869079|NCT02347904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5869080|NCT02348125|Thioctic Acid|thioctic acid|mesh-list
5869081|NCT02348125|Antioxidants|antioxidants|mesh-ancestor
5869082|NCT02348125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869083|NCT02348125|Protective Agents|protective agents|mesh-ancestor
5869084|NCT02348125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869085|NCT02348125|Vitamin B Complex|vitamin b complex|mesh-ancestor
5869086|NCT02348125|Vitamins|vitamins|mesh-ancestor
5869087|NCT02348125|Micronutrients|micronutrients|mesh-ancestor
5869088|NCT02347878|Aprepitant|aprepitant|mesh-list
5869089|NCT02347878|Antiemetics|antiemetics|mesh-ancestor
5869090|NCT02347878|Autonomic Agents|autonomic agents|mesh-ancestor
5869091|NCT02347878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5869092|NCT02347878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869093|NCT02347878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5869094|NCT02347878|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5869095|NCT02347878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5869096|NCT02347878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905334|NCT05136157|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5905335|NCT05136157|Insulin, Short-Acting|insulin, short-acting|mesh-list
5905336|NCT05136157|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5905337|NCT05136157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905338|NCT05135858|Methotrexate|methotrexate|mesh-list
5681247|NCT03492255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5681248|NCT03492255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5681249|NCT03492255|Protective Agents|protective agents|mesh-ancestor
5681250|NCT03492242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5681251|NCT03492242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681252|NCT03492242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5681253|NCT03492138|Dexamethasone|dexamethasone|mesh-list
5681254|NCT03492138|Ixazomib|ixazomib|mesh-list
5681255|NCT03492138|TIC10 compound|tic10 compound|mesh-list
5681256|NCT03492138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5869097|NCT02347891|Belimumab|belimumab|mesh-list
5869098|NCT02347891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5869099|NCT02347891|Immunologic Factors|immunologic factors|mesh-ancestor
5869100|NCT02347891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869101|NCT02347865|Denosumab|denosumab|mesh-list
5869102|NCT02347865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5869103|NCT02347865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869104|NCT02347501|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5869105|NCT02347501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5869106|NCT02347501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869107|NCT02347501|Incretins|incretins|mesh-ancestor
5869108|NCT02347501|Hormones|hormones|mesh-ancestor
5869109|NCT02347501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5869110|NCT02347501|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5869111|NCT02347501|Protease Inhibitors|protease inhibitors|mesh-ancestor
5869112|NCT02347501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5869113|NCT02347501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869114|NCT02347839|Gefitinib|gefitinib|mesh-list
5869115|NCT02347839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5869116|NCT02347839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5869117|NCT02347839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5869118|NCT02347839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869119|NCT02347319|Silymarin|silymarin|mesh-list
5869120|NCT02347319|Antioxidants|antioxidants|mesh-ancestor
5869121|NCT02347319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869122|NCT02347319|Protective Agents|protective agents|mesh-ancestor
5869123|NCT02347319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869124|NCT02347423|Vaccines|vaccines|mesh-list
5869125|NCT02347423|Immunologic Factors|immunologic factors|mesh-ancestor
5869126|NCT02347423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869127|NCT02347358|Plasminogen|plasminogen|mesh-list
5681257|NCT03492138|Antiemetics|antiemetics|mesh-ancestor
5681258|NCT03492138|Autonomic Agents|autonomic agents|mesh-ancestor
5681259|NCT03492138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5681260|NCT03492138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681261|NCT03492138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5681262|NCT03492138|Glucocorticoids|glucocorticoids|mesh-ancestor
5681263|NCT03492138|Hormones|hormones|mesh-ancestor
5681264|NCT03492138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5681265|NCT03492138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5681266|NCT03492138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5681267|NCT03492138|Protease Inhibitors|protease inhibitors|mesh-ancestor
5869128|NCT02347358|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6495050|NCT00621387|Roxithromycin|roxithromycin|mesh-list
6495051|NCT00621387|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6495052|NCT00621387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6495053|NCT00621387|Renal Agents|renal agents|mesh-ancestor
6495054|NCT00621387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5869129|NCT02347358|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5869130|NCT02347358|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5869131|NCT02347358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869132|NCT02347163|Zoledronic Acid|zoledronic acid|mesh-list
5869133|NCT02347163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5869134|NCT02347163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869135|NCT02347111|Sotalol|sotalol|mesh-list
5869136|NCT02347111|Flecainide|flecainide|mesh-list
5869137|NCT02347111|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5869138|NCT02347111|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5869139|NCT02347111|Adrenergic Agents|adrenergic agents|mesh-ancestor
5869140|NCT02347111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5869141|NCT02347111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495055|NCT00621387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6495056|NCT00621387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5869142|NCT02347111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495057|NCT00621387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5869143|NCT02347111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5869144|NCT02347111|Sympatholytics|sympatholytics|mesh-ancestor
5869145|NCT02347111|Autonomic Agents|autonomic agents|mesh-ancestor
5869146|NCT02347111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5869147|NCT02347111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5869148|NCT02347111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5869149|NCT02347111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5869150|NCT02347046|Dotinurad|dotinurad|mesh-list
5869151|NCT02347046|Uricosuric Agents|uricosuric agents|mesh-ancestor
5869152|NCT02347046|Gout Suppressants|gout suppressants|mesh-ancestor
5681268|NCT03492138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5681269|NCT03492138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696931|NCT03379012|Testosterone undecanoate|testosterone undecanoate|mesh-list
5696932|NCT03379012|Testosterone enanthate|testosterone enanthate|mesh-list
5696933|NCT03379012|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5696934|NCT03379012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5696935|NCT03379012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5696936|NCT03379012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5696937|NCT03379012|Growth Substances|growth substances|mesh-ancestor
5696938|NCT03379012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696939|NCT03379012|Growth Inhibitors|growth inhibitors|mesh-ancestor
5696940|NCT03379012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5696941|NCT03379012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5696942|NCT03379012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869153|NCT02347046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5869154|NCT02347046|Renal Agents|renal agents|mesh-ancestor
5869155|NCT02347059|Dopamine|dopamine|mesh-list
5869156|NCT02347059|Levodopa|levodopa|mesh-list
5869157|NCT02347059|Pramipexole|pramipexole|mesh-list
5869158|NCT02347059|Dopamine Agonists|dopamine agonists|mesh-list
5869159|NCT02347059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5869160|NCT02347059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5869161|NCT02347059|Dopamine Agents|dopamine agents|mesh-ancestor
5869162|NCT02347059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5869163|NCT02347059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869164|NCT02347059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869165|NCT02347059|Antioxidants|antioxidants|mesh-ancestor
5869166|NCT02347059|Protective Agents|protective agents|mesh-ancestor
5869167|NCT02347059|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5869168|NCT02347059|Sympathomimetics|sympathomimetics|mesh-ancestor
5869169|NCT02347059|Autonomic Agents|autonomic agents|mesh-ancestor
5869170|NCT02347059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5869171|NCT02347033|Sertraline|sertraline|mesh-list
5869172|NCT02347033|Antidepressive Agents|antidepressive agents|mesh-ancestor
5869173|NCT02347033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5869174|NCT02347033|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5869175|NCT02347033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5869176|NCT02347033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5869177|NCT02347033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869178|NCT02347033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5869179|NCT02347033|Serotonin Agents|serotonin agents|mesh-ancestor
5869180|NCT02347033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869181|NCT02346890|Sevelamer|sevelamer|mesh-list
6495058|NCT00621387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495059|NCT00621387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6495060|NCT00621387|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6495061|NCT00621387|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6495062|NCT00621400|Dexamethasone|dexamethasone|mesh-list
6495063|NCT00621400|Lenalidomide|lenalidomide|mesh-list
6495064|NCT00621400|Melphalan|melphalan|mesh-list
6495065|NCT00621400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6495066|NCT00621400|Antiemetics|antiemetics|mesh-ancestor
6495067|NCT00621400|Autonomic Agents|autonomic agents|mesh-ancestor
6495068|NCT00621400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6495069|NCT00621400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495070|NCT00621400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6495071|NCT00621400|Glucocorticoids|glucocorticoids|mesh-ancestor
6495072|NCT00621400|Hormones|hormones|mesh-ancestor
6495073|NCT00621400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6495074|NCT00621400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6495075|NCT00621400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6495076|NCT00621400|Immunologic Factors|immunologic factors|mesh-ancestor
5696943|NCT03379012|Androgens|androgens|mesh-ancestor
5696944|NCT03379012|Hormones|hormones|mesh-ancestor
5869182|NCT02346890|Chelating Agents|chelating agents|mesh-ancestor
5869183|NCT02346890|Sequestering Agents|sequestering agents|mesh-ancestor
5681270|NCT03492047|Acetylcysteine|acetylcysteine|mesh-list
5681271|NCT03492047|Paclitaxel|paclitaxel|mesh-list
5681272|NCT03492047|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5681273|NCT03492047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5681274|NCT03492047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5681275|NCT03492047|Tubulin Modulators|tubulin modulators|mesh-ancestor
5681276|NCT03492047|Antimitotic Agents|antimitotic agents|mesh-ancestor
5681277|NCT03492047|Mitosis Modulators|mitosis modulators|mesh-ancestor
5681278|NCT03492047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681279|NCT03492047|Antiviral Agents|antiviral agents|mesh-ancestor
5681280|NCT03492047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5869184|NCT02346890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869185|NCT02346955|Pembrolizumab|pembrolizumab|mesh-list
5869186|NCT02346955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5869187|NCT02346955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5869188|NCT02346682|Clonazepam|clonazepam|mesh-list
5869189|NCT02346682|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
5869190|NCT02346682|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5869191|NCT02346682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5869192|NCT02346682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5869193|NCT02346682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869194|NCT02346682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5869195|NCT02346682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869196|NCT02346682|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5869197|NCT02346682|Antidepressive Agents|antidepressive agents|mesh-ancestor
5869198|NCT02346682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5869199|NCT02346682|Anticonvulsants|anticonvulsants|mesh-ancestor
5869200|NCT02346682|GABA Modulators|gaba modulators|mesh-ancestor
5869201|NCT02346682|GABA Agents|gaba agents|mesh-ancestor
5869202|NCT02346539|Nicotine|nicotine|mesh-list
5869203|NCT02346539|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5869204|NCT02346539|Autonomic Agents|autonomic agents|mesh-ancestor
5869205|NCT02346539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5869206|NCT02346539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869207|NCT02346539|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5869208|NCT02346539|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5869209|NCT02346539|Cholinergic Agents|cholinergic agents|mesh-ancestor
5869210|NCT02346539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5869211|NCT02346539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869212|NCT02346578|Flutamide|flutamide|mesh-list
5869213|NCT02346578|Androgen Antagonists|androgen antagonists|mesh-ancestor
5869214|NCT02346578|Hormone Antagonists|hormone antagonists|mesh-ancestor
5869215|NCT02346578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5869216|NCT02346578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869217|NCT02346578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5869218|NCT02346578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5869219|NCT02346201|Methylphenidate|methylphenidate|mesh-list
5869220|NCT02346201|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5869221|NCT02346201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869222|NCT02346201|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5869223|NCT02346201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5869224|NCT02346201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5869225|NCT02346201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869226|NCT02346201|Dopamine Agents|dopamine agents|mesh-ancestor
5869227|NCT02346201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5869228|NCT02346357|Ropivacaine|ropivacaine|mesh-list
5869229|NCT02346357|Anesthetics, Local|anesthetics, local|mesh-ancestor
5869230|NCT02346357|Anesthetics|anesthetics|mesh-ancestor
5869231|NCT02346357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5869232|NCT02346357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869233|NCT02346357|Sensory System Agents|sensory system agents|mesh-ancestor
5869234|NCT02346357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5869235|NCT02346331|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5869236|NCT02346331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5869237|NCT02346188|Ferrous fumarate|ferrous fumarate|mesh-list
5869238|NCT02346188|Zinc Oxide|zinc oxide|mesh-list
5869239|NCT02346188|Trace Elements|trace elements|mesh-ancestor
5869240|NCT02346188|Micronutrients|micronutrients|mesh-ancestor
6495077|NCT00621400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6495078|NCT00621400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6495079|NCT00621400|Growth Substances|growth substances|mesh-ancestor
6495080|NCT00621400|Growth Inhibitors|growth inhibitors|mesh-ancestor
5681281|NCT03492047|Expectorants|expectorants|mesh-ancestor
5698063|NCT03371589|Dexamethasone|dexamethasone|mesh-list
5681282|NCT03492047|Respiratory System Agents|respiratory system agents|mesh-ancestor
5681283|NCT03492047|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5681284|NCT03492047|Antioxidants|antioxidants|mesh-ancestor
5681285|NCT03492047|Protective Agents|protective agents|mesh-ancestor
5681286|NCT03492047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681287|NCT03492047|Antidotes|antidotes|mesh-ancestor
5869241|NCT02346188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869242|NCT02346188|Dermatologic Agents|dermatologic agents|mesh-ancestor
5869243|NCT02346188|Sunscreening Agents|sunscreening agents|mesh-ancestor
5869244|NCT02346188|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5869245|NCT02346188|Protective Agents|protective agents|mesh-ancestor
5869246|NCT02346253|Leuprolide|leuprolide|mesh-list
5869247|NCT02346253|Goserelin|goserelin|mesh-list
5869248|NCT02346253|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5681288|NCT03491969|Thioctic Acid|thioctic acid|mesh-list
5681289|NCT03491969|Antioxidants|antioxidants|mesh-ancestor
5681290|NCT03491969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681291|NCT03491969|Protective Agents|protective agents|mesh-ancestor
5681292|NCT03491969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681293|NCT03491969|Vitamin B Complex|vitamin b complex|mesh-ancestor
6495081|NCT00621400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6495082|NCT00621400|Alkylating Agents|alkylating agents|mesh-ancestor
6495083|NCT00621400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495084|NCT00621400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6495085|NCT00621400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6495086|NCT00621452|Aldesleukin|aldesleukin|mesh-list
6495087|NCT00621452|Cyclophosphamide|cyclophosphamide|mesh-list
6495088|NCT00621452|Interleukin-2|interleukin-2|mesh-list
6495089|NCT00621452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6495090|NCT00621452|Immunologic Factors|immunologic factors|mesh-ancestor
6495091|NCT00621452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495092|NCT00621452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6495093|NCT00621452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6495094|NCT00621452|Alkylating Agents|alkylating agents|mesh-ancestor
6495095|NCT00621452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495096|NCT00621452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6495097|NCT00621452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6495098|NCT00621452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6495099|NCT00621452|Analgesics|analgesics|mesh-ancestor
6495100|NCT00621452|Sensory System Agents|sensory system agents|mesh-ancestor
6495101|NCT00621452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6495102|NCT00621452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5869249|NCT02346253|Bicalutamide|bicalutamide|mesh-list
5869250|NCT02346253|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5869251|NCT02346253|Fertility Agents|fertility agents|mesh-ancestor
6495103|NCT00621452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6495104|NCT00621452|Antiviral Agents|antiviral agents|mesh-ancestor
6495105|NCT00621452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5869252|NCT02346253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5869253|NCT02346253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869254|NCT02346253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5869255|NCT02346253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5869256|NCT02346253|Androgen Antagonists|androgen antagonists|mesh-ancestor
5869257|NCT02346253|Hormone Antagonists|hormone antagonists|mesh-ancestor
5869258|NCT02346253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5869259|NCT02346253|Luteolytic Agents|luteolytic agents|mesh-ancestor
5869260|NCT02346253|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5869261|NCT02346253|Contraceptive Agents|contraceptive agents|mesh-ancestor
5869262|NCT02346253|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5905339|NCT05135858|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5905340|NCT05135858|Abortifacient Agents|abortifacient agents|mesh-ancestor
5905341|NCT05135858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5905342|NCT05135858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905343|NCT05135858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5905344|NCT05135858|Antimetabolites|antimetabolites|mesh-ancestor
5905345|NCT05135858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905346|NCT05135858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5905347|NCT05135858|Dermatologic Agents|dermatologic agents|mesh-ancestor
5905348|NCT05135858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5905349|NCT05135858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5905350|NCT05135858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5905351|NCT05135858|Immunologic Factors|immunologic factors|mesh-ancestor
5905352|NCT05135858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5681294|NCT03491969|Vitamins|vitamins|mesh-ancestor
5681295|NCT03491969|Micronutrients|micronutrients|mesh-ancestor
5681296|NCT03491904|Fasinumab|fasinumab|mesh-list
5681297|NCT03491904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5869263|NCT02346110|Dexamethasone|dexamethasone|mesh-list
5869264|NCT02346110|Epinephrine|epinephrine|mesh-list
5869265|NCT02346110|Racepinephrine|racepinephrine|mesh-list
5869266|NCT02346110|Bupivacaine|bupivacaine|mesh-list
5869267|NCT02346110|Epinephryl borate|epinephryl borate|mesh-list
5681298|NCT03491904|Analgesics|analgesics|mesh-ancestor
5681299|NCT03491904|Sensory System Agents|sensory system agents|mesh-ancestor
5681300|NCT03491904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5681301|NCT03491904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681302|NCT03491761|Hyaluronic Acid|hyaluronic acid|mesh-list
5681303|NCT03491761|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5681304|NCT03491761|Immunologic Factors|immunologic factors|mesh-ancestor
5681305|NCT03491761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681306|NCT03491761|Viscosupplements|viscosupplements|mesh-ancestor
5681307|NCT03491761|Protective Agents|protective agents|mesh-ancestor
5681308|NCT03491748|Cefpodoxime|cefpodoxime|mesh-list
5681309|NCT03491748|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
5681310|NCT03491748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5681311|NCT03491748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5681312|NCT03491709|Cetuximab|cetuximab|mesh-list
5681313|NCT03491709|Antibodies|antibodies|mesh-list
5681314|NCT03491709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5681315|NCT03491709|Immunologic Factors|immunologic factors|mesh-ancestor
5681316|NCT03491709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681317|NCT03491709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5681318|NCT03491709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5681319|NCT03491696|Metyrapone|metyrapone|mesh-list
5869268|NCT02346110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5869269|NCT02346110|Antiemetics|antiemetics|mesh-ancestor
5869270|NCT02346110|Autonomic Agents|autonomic agents|mesh-ancestor
5869271|NCT02346110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5869272|NCT02346110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869273|NCT02346110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5869274|NCT02346110|Glucocorticoids|glucocorticoids|mesh-ancestor
5681320|NCT03491696|Antimetabolites|antimetabolites|mesh-ancestor
5681321|NCT03491696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681322|NCT03491696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5681323|NCT03491631|Apatinib|apatinib|mesh-list
5681324|NCT03491631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5681325|NCT03491631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5681326|NCT03491631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5681327|NCT03491631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681328|NCT03491579|Cytarabine|cytarabine|mesh-list
5681329|NCT03491579|Cladribine|cladribine|mesh-list
5681330|NCT03491579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5681331|NCT03491579|Antimetabolites|antimetabolites|mesh-ancestor
5681332|NCT03491579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681333|NCT03491579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5681334|NCT03491579|Antiviral Agents|antiviral agents|mesh-ancestor
5681335|NCT03491579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5681336|NCT03491579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5681337|NCT03491579|Immunologic Factors|immunologic factors|mesh-ancestor
5681338|NCT03491579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681339|NCT03491540|Gentamicins|gentamicins|mesh-list
5681340|NCT03491540|Ornidazole|ornidazole|mesh-list
5681341|NCT03491540|Sennosides|sennosides|mesh-list
5681342|NCT03491540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5681343|NCT03491540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5681344|NCT03491540|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5681345|NCT03491540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5681346|NCT03491540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681347|NCT03491540|Laxatives|laxatives|mesh-ancestor
5681348|NCT03491540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5681349|NCT03491540|Amebicides|amebicides|mesh-ancestor
5681350|NCT03491540|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5869275|NCT02346110|Hormones|hormones|mesh-ancestor
5869276|NCT02346110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5869277|NCT02346110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5869278|NCT02346110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5869279|NCT02346110|Anesthetics, Local|anesthetics, local|mesh-ancestor
5869280|NCT02346110|Anesthetics|anesthetics|mesh-ancestor
5869281|NCT02346110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5869282|NCT02346110|Sensory System Agents|sensory system agents|mesh-ancestor
5869283|NCT02346110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5681351|NCT03491540|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5681352|NCT03491540|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
5869284|NCT02346110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5869285|NCT02346110|Adrenergic Agents|adrenergic agents|mesh-ancestor
5869286|NCT02346110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5869287|NCT02346110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869288|NCT02346110|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5869289|NCT02346110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5869290|NCT02346110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5869291|NCT02346110|Respiratory System Agents|respiratory system agents|mesh-ancestor
5869292|NCT02346110|Mydriatics|mydriatics|mesh-ancestor
5869293|NCT02346110|Sympathomimetics|sympathomimetics|mesh-ancestor
5869294|NCT02346110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5869295|NCT02346084|Maraviroc|maraviroc|mesh-list
5869296|NCT02346084|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5869297|NCT02346084|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5869298|NCT02346084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869299|NCT02346084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5869300|NCT02346084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6495106|NCT00621478|Diazepam|diazepam|mesh-list
6495107|NCT00621478|Lorazepam|lorazepam|mesh-list
6495108|NCT00621478|Anticonvulsants|anticonvulsants|mesh-ancestor
6495109|NCT00621478|Antiemetics|antiemetics|mesh-ancestor
6495110|NCT00621478|Autonomic Agents|autonomic agents|mesh-ancestor
6495111|NCT00621478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5869301|NCT02346084|Antiviral Agents|antiviral agents|mesh-ancestor
5869302|NCT02346084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5869303|NCT02346084|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
5869304|NCT02345902|Haloperidol|haloperidol|mesh-list
5869305|NCT02345902|Haloperidol decanoate|haloperidol decanoate|mesh-list
5869306|NCT02345902|Antiemetics|antiemetics|mesh-ancestor
5869307|NCT02345902|Autonomic Agents|autonomic agents|mesh-ancestor
5869308|NCT02345902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5869309|NCT02345902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495112|NCT00621478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495113|NCT00621478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6495114|NCT00621478|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6495115|NCT00621478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6495116|NCT00621478|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5869310|NCT02345902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5869311|NCT02345902|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5869312|NCT02345902|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5681353|NCT03491527|Salicylic Acid|salicylic acid|mesh-list
5681354|NCT03491527|Pemetrexed|pemetrexed|mesh-list
5681355|NCT03491527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5681356|NCT03491527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5681357|NCT03491527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681358|NCT03491527|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5681359|NCT03491527|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5681360|NCT03491527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5681361|NCT03491527|Antifungal Agents|antifungal agents|mesh-ancestor
5681362|NCT03491527|Keratolytic Agents|keratolytic agents|mesh-ancestor
5681363|NCT03491527|Dermatologic Agents|dermatologic agents|mesh-ancestor
5681364|NCT03491475|Ajmaline|ajmaline|mesh-list
5681365|NCT03491475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5681366|NCT03491475|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5681367|NCT03491475|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5681368|NCT03491475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5681369|NCT03491475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869313|NCT02345902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5869314|NCT02345902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5869315|NCT02345902|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5869316|NCT02345902|Dopamine Agents|dopamine agents|mesh-ancestor
5869317|NCT02345902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5869318|NCT02345902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869319|NCT02345902|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5869320|NCT02345837|Clomiphene|clomiphene|mesh-list
5869321|NCT02345837|Enclomiphene|enclomiphene|mesh-list
5869322|NCT02345837|Zuclomiphene|zuclomiphene|mesh-list
5869323|NCT02345837|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5869324|NCT02345837|Hormone Antagonists|hormone antagonists|mesh-ancestor
5869325|NCT02345837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5869326|NCT02345837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869327|NCT02345837|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5869328|NCT02345837|Fertility Agents|fertility agents|mesh-ancestor
5681370|NCT03491410|Aspirin|aspirin|mesh-list
6495117|NCT00621478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6675135|NCT01572662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5869329|NCT02345837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5869330|NCT02345837|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5869331|NCT02345837|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5869332|NCT02345863|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5869333|NCT02345863|Obinutuzumab|obinutuzumab|mesh-list
5869334|NCT02345863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5869335|NCT02345863|Alkylating Agents|alkylating agents|mesh-ancestor
5869336|NCT02345863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869337|NCT02345863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5869338|NCT02345863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5869339|NCT02345993|Beclomethasone|beclomethasone|mesh-list
5869340|NCT02345993|Formoterol Fumarate|formoterol fumarate|mesh-list
5869341|NCT02345993|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5869342|NCT02345993|Autonomic Agents|autonomic agents|mesh-ancestor
5869343|NCT02345993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5869344|NCT02345993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869345|NCT02345993|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5869346|NCT02345993|Respiratory System Agents|respiratory system agents|mesh-ancestor
5869347|NCT02345993|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5869348|NCT02345993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5869349|NCT02345993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5869350|NCT02345993|Adrenergic Agents|adrenergic agents|mesh-ancestor
5869351|NCT02345993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5869352|NCT02345993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869353|NCT02345993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5869354|NCT02345993|Glucocorticoids|glucocorticoids|mesh-ancestor
5869355|NCT02345993|Hormones|hormones|mesh-ancestor
5869356|NCT02345993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5869357|NCT02345980|Sildenafil Citrate|sildenafil citrate|mesh-list
5869358|NCT02345980|Vasodilator Agents|vasodilator agents|mesh-ancestor
5869359|NCT02345980|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5869360|NCT02345980|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5869361|NCT02345980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5869362|NCT02345980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869363|NCT02345980|Urological Agents|urological agents|mesh-ancestor
5869364|NCT02345746|Leucovorin|leucovorin|mesh-list
5869365|NCT02345746|Folic Acid|folic acid|mesh-list
5869366|NCT02345746|Fluorouracil|fluorouracil|mesh-list
5681371|NCT03491410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5681372|NCT03491410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5681373|NCT03491410|Analgesics|analgesics|mesh-ancestor
5681374|NCT03491410|Sensory System Agents|sensory system agents|mesh-ancestor
5681375|NCT03491410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5681376|NCT03491410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681377|NCT03491410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5681378|NCT03491410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5869367|NCT02345746|Oxaliplatin|oxaliplatin|mesh-list
5869368|NCT02345746|Levoleucovorin|levoleucovorin|mesh-list
5869369|NCT02345746|Antimetabolites|antimetabolites|mesh-ancestor
5869370|NCT02345746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869371|NCT02345746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5869372|NCT02345746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5869373|NCT02345746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5869374|NCT02345746|Immunologic Factors|immunologic factors|mesh-ancestor
5869375|NCT02345746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869376|NCT02345746|Antidotes|antidotes|mesh-ancestor
5869377|NCT02345746|Protective Agents|protective agents|mesh-ancestor
5869378|NCT02345746|Vitamin B Complex|vitamin b complex|mesh-ancestor
5869379|NCT02345746|Vitamins|vitamins|mesh-ancestor
5869380|NCT02345746|Micronutrients|micronutrients|mesh-ancestor
5869381|NCT02345746|Hematinics|hematinics|mesh-ancestor
5869382|NCT02345733|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5869383|NCT02345733|Amoxicillin|amoxicillin|mesh-list
5869384|NCT02345733|Metronidazole|metronidazole|mesh-list
5869385|NCT02345733|Doxycycline|doxycycline|mesh-list
5869386|NCT02345733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5869387|NCT02345733|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5869388|NCT02345733|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5869389|NCT02345733|Antimalarials|antimalarials|mesh-ancestor
5869390|NCT02345707|Cabotegravir|cabotegravir|mesh-list
5869391|NCT02345707|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5869392|NCT02345707|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5869393|NCT02345707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5869394|NCT02345707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869395|NCT02345707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5869396|NCT02345707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5869397|NCT02345707|Antiviral Agents|antiviral agents|mesh-ancestor
5869398|NCT02345707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5869399|NCT02345616|Nitric Oxide|nitric oxide|mesh-list
5869400|NCT02345616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5869401|NCT02345616|Autonomic Agents|autonomic agents|mesh-ancestor
5869402|NCT02345616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5869403|NCT02345616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869404|NCT02345616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5869405|NCT02345616|Respiratory System Agents|respiratory system agents|mesh-ancestor
5869406|NCT02345616|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5869407|NCT02345616|Antioxidants|antioxidants|mesh-ancestor
5869408|NCT02345616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869409|NCT02345616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5869410|NCT02345616|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5869411|NCT02345616|Vasodilator Agents|vasodilator agents|mesh-ancestor
5869412|NCT02345616|Gasotransmitters|gasotransmitters|mesh-ancestor
5869413|NCT02345616|Protective Agents|protective agents|mesh-ancestor
5869414|NCT02345681|Furosemide|furosemide|mesh-list
5869415|NCT02345681|Diuretics|diuretics|mesh-ancestor
5869416|NCT02345681|Natriuretic Agents|natriuretic agents|mesh-ancestor
5869417|NCT02345681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869418|NCT02345681|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5869419|NCT02345681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5869420|NCT02345681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869421|NCT02345304|Digoxin|digoxin|mesh-list
5869422|NCT02345304|Midazolam|midazolam|mesh-list
5869423|NCT02345304|Omeprazole|omeprazole|mesh-list
5869424|NCT02345304|Warfarin|warfarin|mesh-list
5869425|NCT02345304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5681379|NCT03491410|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5681380|NCT03491410|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5681381|NCT03491410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681382|NCT03491410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5681383|NCT03491410|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5681384|NCT03491410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5681385|NCT03491410|Antipyretics|antipyretics|mesh-ancestor
5681386|NCT03491371|Apatinib|apatinib|mesh-list
5681387|NCT03491371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5681388|NCT03491371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5681389|NCT03491371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5681390|NCT03491371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681391|NCT03491345|Avelumab|avelumab|mesh-list
5681392|NCT03491345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5681393|NCT03491345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5681394|NCT03491098|Mometasone Furoate|mometasone furoate|mesh-list
5681395|NCT03491098|Prednisolone|prednisolone|mesh-list
5681396|NCT03491098|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5681397|NCT03491098|Methylprednisolone|methylprednisolone|mesh-list
5681398|NCT03491098|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5869426|NCT02345304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5869427|NCT02345304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5869428|NCT02345304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869429|NCT02345304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5869430|NCT02345304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5869431|NCT02345304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5869432|NCT02345304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5869433|NCT02345304|Anesthetics, General|anesthetics, general|mesh-ancestor
5869434|NCT02345304|Anesthetics|anesthetics|mesh-ancestor
5869435|NCT02345304|GABA Modulators|gaba modulators|mesh-ancestor
5869436|NCT02345304|GABA Agents|gaba agents|mesh-ancestor
5869437|NCT02345304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5869438|NCT02345304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869439|NCT02345304|Anticoagulants|anticoagulants|mesh-ancestor
5869440|NCT02345304|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5869441|NCT02345304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5869442|NCT02345304|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5869443|NCT02345304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5869444|NCT02345304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5869445|NCT02345304|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5869446|NCT02345304|Protective Agents|protective agents|mesh-ancestor
5869447|NCT02345343|Apixaban|apixaban|mesh-list
5869448|NCT02345343|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5869449|NCT02345343|Antithrombins|antithrombins|mesh-ancestor
5869450|NCT02345343|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5869451|NCT02345343|Protease Inhibitors|protease inhibitors|mesh-ancestor
5869452|NCT02345343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5905353|NCT05135858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5869453|NCT02345343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869454|NCT02345343|Anticoagulants|anticoagulants|mesh-ancestor
5869455|NCT02345590|Eplerenone|eplerenone|mesh-list
5869456|NCT02345590|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5869457|NCT02345590|Hormone Antagonists|hormone antagonists|mesh-ancestor
5869458|NCT02345590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5869459|NCT02345590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869460|NCT02345590|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5869461|NCT02345590|Diuretics|diuretics|mesh-ancestor
5869462|NCT02345590|Natriuretic Agents|natriuretic agents|mesh-ancestor
5869463|NCT02345590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5869464|NCT02345239|Pantoprazole|pantoprazole|mesh-list
5869465|NCT02345239|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5869466|NCT02345239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5869467|NCT02345239|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5869468|NCT02345239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5869469|NCT02345239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869470|NCT02345148|Esketamine|esketamine|mesh-list
5869471|NCT02345148|Antidepressive Agents|antidepressive agents|mesh-ancestor
5869472|NCT02345148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5869473|NCT02345044|Eplerenone|eplerenone|mesh-list
5869474|NCT02345044|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5869475|NCT02345044|Hormone Antagonists|hormone antagonists|mesh-ancestor
5869476|NCT02345044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5869477|NCT02345044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869478|NCT02345044|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5869479|NCT02345044|Diuretics|diuretics|mesh-ancestor
5869480|NCT02345044|Natriuretic Agents|natriuretic agents|mesh-ancestor
5869481|NCT02345044|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5869482|NCT02345213|Donepezil|donepezil|mesh-list
5869483|NCT02345213|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5869484|NCT02345213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5869485|NCT02345213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869486|NCT02345213|Cholinergic Agents|cholinergic agents|mesh-ancestor
5869487|NCT02345213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5869488|NCT02345213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869489|NCT02345213|Nootropic Agents|nootropic agents|mesh-ancestor
5869490|NCT02344992|Insulin Lispro|insulin lispro|mesh-list
5869491|NCT02344992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6495118|NCT00621478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6495119|NCT00621478|GABA Modulators|gaba modulators|mesh-ancestor
6675136|NCT01572662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6495120|NCT00621478|GABA Agents|gaba agents|mesh-ancestor
6495121|NCT00621478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6495122|NCT00621478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495123|NCT00621478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6495124|NCT00621478|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6495125|NCT00621478|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6495126|NCT00621478|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6495127|NCT00621478|Anesthetics, General|anesthetics, general|mesh-ancestor
6495128|NCT00621478|Anesthetics|anesthetics|mesh-ancestor
6495129|NCT00621491|Warfarin|warfarin|mesh-list
6495130|NCT00621491|Anticoagulants|anticoagulants|mesh-list
6495131|NCT00621556|Secretin|secretin|mesh-list
6495132|NCT00621556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6495133|NCT00621556|Hormones|hormones|mesh-ancestor
6495134|NCT00621556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6495135|NCT00621556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495136|NCT00621647|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6495137|NCT00621647|Antidepressive Agents|antidepressive agents|mesh-ancestor
6495138|NCT00621647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6495139|NCT00621647|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6495140|NCT00621647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6495141|NCT00621647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6495142|NCT00621647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495143|NCT00621673|Factor VIII|factor viii|mesh-list
6495144|NCT00621673|Coagulants|coagulants|mesh-ancestor
6495145|NCT00621699|Ezetimibe|ezetimibe|mesh-list
6495146|NCT00621699|Tacrolimus|tacrolimus|mesh-list
6495147|NCT00621699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6495148|NCT00621699|Immunologic Factors|immunologic factors|mesh-ancestor
6495149|NCT00621699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495150|NCT00621699|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6495151|NCT00621699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6495152|NCT00621699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675137|NCT01572688|Melphalan|melphalan|mesh-list
5869492|NCT02344992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869493|NCT02345187|Micronutrients|micronutrients|mesh-list
5869494|NCT02345187|Trace Elements|trace elements|mesh-list
5869495|NCT02345187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869496|NCT02344940|Tamoxifen|tamoxifen|mesh-list
5869497|NCT02344940|Toremifene|toremifene|mesh-list
5681399|NCT03491098|Prednisolone acetate|prednisolone acetate|mesh-list
5681400|NCT03491098|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5681401|NCT03491098|Prednisolone phosphate|prednisolone phosphate|mesh-list
5681402|NCT03491098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5681403|NCT03491098|Glucocorticoids|glucocorticoids|mesh-ancestor
5681404|NCT03491098|Hormones|hormones|mesh-ancestor
5681405|NCT03491098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5869498|NCT02344940|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5869499|NCT02344940|Hormone Antagonists|hormone antagonists|mesh-ancestor
5869500|NCT02344940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5869501|NCT02344940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869502|NCT02344940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5869503|NCT02344940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5869504|NCT02344940|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5869505|NCT02344940|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5869506|NCT02344940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5869507|NCT02344888|Folic Acid|folic acid|mesh-list
5869508|NCT02344888|Vitamin B Complex|vitamin b complex|mesh-list
5869509|NCT02344888|Prednisolone|prednisolone|mesh-list
5869510|NCT02344888|Citric Acid|citric acid|mesh-list
5869511|NCT02344888|Sodium Citrate|sodium citrate|mesh-list
5869512|NCT02344888|Clomiphene|clomiphene|mesh-list
5869513|NCT02344888|Enclomiphene|enclomiphene|mesh-list
5869514|NCT02344888|Zuclomiphene|zuclomiphene|mesh-list
5869515|NCT02344888|Anticoagulants|anticoagulants|mesh-ancestor
5869516|NCT02344888|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5869517|NCT02344888|Chelating Agents|chelating agents|mesh-ancestor
5869518|NCT02344888|Sequestering Agents|sequestering agents|mesh-ancestor
5869519|NCT02344888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869520|NCT02344888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5869521|NCT02344888|Glucocorticoids|glucocorticoids|mesh-ancestor
5869522|NCT02344888|Hormones|hormones|mesh-ancestor
5869523|NCT02344888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5869524|NCT02344888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869525|NCT02344888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5869526|NCT02344888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5869527|NCT02344888|Hematinics|hematinics|mesh-ancestor
5869528|NCT02344888|Vitamins|vitamins|mesh-ancestor
5869529|NCT02344888|Micronutrients|micronutrients|mesh-ancestor
5869530|NCT02344888|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5869531|NCT02344888|Hormone Antagonists|hormone antagonists|mesh-ancestor
5869532|NCT02344888|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5869533|NCT02344888|Fertility Agents|fertility agents|mesh-ancestor
5869534|NCT02344888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5869535|NCT02344888|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5869536|NCT02344888|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5869537|NCT02344862|Dotinurad|dotinurad|mesh-list
5869538|NCT02344862|Uricosuric Agents|uricosuric agents|mesh-ancestor
5869539|NCT02344862|Gout Suppressants|gout suppressants|mesh-ancestor
5869540|NCT02344862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5869541|NCT02344862|Renal Agents|renal agents|mesh-ancestor
5869542|NCT02344875|Dotinurad|dotinurad|mesh-list
5869543|NCT02344875|Uricosuric Agents|uricosuric agents|mesh-ancestor
5869544|NCT02344875|Gout Suppressants|gout suppressants|mesh-ancestor
5869545|NCT02344875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5869546|NCT02344875|Renal Agents|renal agents|mesh-ancestor
5869547|NCT02344823|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
5869548|NCT02344823|Vasodilator Agents|vasodilator agents|mesh-ancestor
5869549|NCT02344823|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5869550|NCT02344823|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5681406|NCT03491098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681407|NCT03491098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5681408|NCT03491098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5681409|NCT03491098|Antiemetics|antiemetics|mesh-ancestor
5681410|NCT03491098|Autonomic Agents|autonomic agents|mesh-ancestor
5681411|NCT03491098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5681412|NCT03491098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5681413|NCT03491098|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5869551|NCT02344823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5869552|NCT02344823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869553|NCT02344823|Urological Agents|urological agents|mesh-ancestor
5869554|NCT02344810|Leucovorin|leucovorin|mesh-list
5869555|NCT02344810|Fluorouracil|fluorouracil|mesh-list
5869556|NCT02344810|Oxaliplatin|oxaliplatin|mesh-list
5869557|NCT02344810|Calcium|calcium|mesh-list
5869558|NCT02344810|Levoleucovorin|levoleucovorin|mesh-list
5869559|NCT02344810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5869560|NCT02344810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869561|NCT02344810|Antimetabolites|antimetabolites|mesh-ancestor
5869562|NCT02344810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869563|NCT02344810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5869564|NCT02344810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5869565|NCT02344810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5869566|NCT02344810|Immunologic Factors|immunologic factors|mesh-ancestor
5869567|NCT02344810|Antidotes|antidotes|mesh-ancestor
5869568|NCT02344810|Protective Agents|protective agents|mesh-ancestor
5869569|NCT02344810|Vitamin B Complex|vitamin b complex|mesh-ancestor
5869570|NCT02344810|Vitamins|vitamins|mesh-ancestor
5869571|NCT02344810|Micronutrients|micronutrients|mesh-ancestor
5869572|NCT02344511|Vancomycin|vancomycin|mesh-list
5869573|NCT02344511|Cefazolin|cefazolin|mesh-list
5869574|NCT02344511|Dalbavancin|dalbavancin|mesh-list
5869575|NCT02344511|Oxacillin|oxacillin|mesh-list
5681414|NCT03491098|Protective Agents|protective agents|mesh-ancestor
5681415|NCT03491098|Dermatologic Agents|dermatologic agents|mesh-ancestor
5681416|NCT03491098|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5681417|NCT03491085|Amoxicillin|amoxicillin|mesh-list
5681418|NCT03491085|Clavulanic Acid|clavulanic acid|mesh-list
5681419|NCT03491085|Clavulanic Acids|clavulanic acids|mesh-list
5681420|NCT03491085|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5869576|NCT02344511|Nafcillin|nafcillin|mesh-list
5869577|NCT02344511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5869578|NCT02344511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5869579|NCT02344550|Everolimus|everolimus|mesh-list
5869580|NCT02344550|Letrozole|letrozole|mesh-list
5869581|NCT02344550|Leuprolide|leuprolide|mesh-list
5869582|NCT02344550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5869583|NCT02344550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5869584|NCT02344550|Immunologic Factors|immunologic factors|mesh-ancestor
5869585|NCT02344550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869586|NCT02344550|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5869587|NCT02344550|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5869588|NCT02344550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5869589|NCT02344550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869590|NCT02344550|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5869591|NCT02344550|Hormone Antagonists|hormone antagonists|mesh-ancestor
5869592|NCT02344550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5869593|NCT02344550|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5869594|NCT02344550|Fertility Agents|fertility agents|mesh-ancestor
5869595|NCT02344550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5905354|NCT05135845|Spartalizumab|spartalizumab|mesh-list
6495153|NCT00621699|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6495154|NCT00621699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6495155|NCT00621699|Antimetabolites|antimetabolites|mesh-ancestor
6495156|NCT00621699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6495157|NCT00621725|Cediranib|cediranib|mesh-list
6495158|NCT00621725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6495159|NCT00621725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6495160|NCT00621725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6495161|NCT00621725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495162|NCT00621790|Fenoldopam|fenoldopam|mesh-list
6495163|NCT00621790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6495164|NCT00621790|Vasodilator Agents|vasodilator agents|mesh-ancestor
6495165|NCT00621790|Dopamine Agonists|dopamine agonists|mesh-ancestor
6495166|NCT00621790|Dopamine Agents|dopamine agents|mesh-ancestor
6495167|NCT00621790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6495168|NCT00621790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495169|NCT00621790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495170|NCT00621816|Nitroprusside|nitroprusside|mesh-list
6495171|NCT00621816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6495172|NCT00621816|Vasodilator Agents|vasodilator agents|mesh-ancestor
6495173|NCT00621816|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6495174|NCT00621816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495175|NCT00621868|Ipragliflozin|ipragliflozin|mesh-list
6495176|NCT00621868|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6495177|NCT00621868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681421|NCT03491085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5681422|NCT03491085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5681423|NCT03491085|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5681424|NCT03491085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5869596|NCT02344550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5869597|NCT02344784|Methylphenidate|methylphenidate|mesh-list
5869598|NCT02344784|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5869599|NCT02344784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869600|NCT02344784|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5869601|NCT02344784|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5869602|NCT02344784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5869603|NCT02344784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869604|NCT02344784|Dopamine Agents|dopamine agents|mesh-ancestor
5869605|NCT02344784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5869606|NCT02344602|Febuxostat|febuxostat|mesh-list
5869607|NCT02344602|Gout Suppressants|gout suppressants|mesh-ancestor
5681425|NCT03491085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681426|NCT03491072|Fentanyl|fentanyl|mesh-list
5681427|NCT03491072|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5869608|NCT02344602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5869609|NCT02344589|Lidocaine|lidocaine|mesh-list
5869610|NCT02344589|Anesthetics, Local|anesthetics, local|mesh-ancestor
5869611|NCT02344589|Anesthetics|anesthetics|mesh-ancestor
5869612|NCT02344589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5869613|NCT02344589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869614|NCT02344589|Sensory System Agents|sensory system agents|mesh-ancestor
5869615|NCT02344589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5869616|NCT02344589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5869617|NCT02344589|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5869618|NCT02344589|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5869619|NCT02344589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5869620|NCT02344589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869621|NCT02344680|Anti-HIV Agents|anti-hiv agents|mesh-list
5869622|NCT02344680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5869623|NCT02344680|Antiviral Agents|antiviral agents|mesh-ancestor
5869624|NCT02344680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5869625|NCT02344641|Exenatide|exenatide|mesh-list
5869626|NCT02344641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5869627|NCT02344641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869628|NCT02344641|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5869629|NCT02344641|Incretins|incretins|mesh-ancestor
5869630|NCT02344641|Hormones|hormones|mesh-ancestor
5869631|NCT02344641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5869632|NCT02344732|Polymyxins|polymyxins|mesh-list
5869633|NCT02344732|Neomycin|neomycin|mesh-list
5869634|NCT02344732|Polymyxin B|polymyxin b|mesh-list
5869635|NCT02344732|Dexamethasone|dexamethasone|mesh-list
5869636|NCT02344732|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5869637|NCT02344732|Homatropine|homatropine|mesh-list
5681428|NCT03491072|Narcotics|narcotics|mesh-ancestor
5681429|NCT03491072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5681430|NCT03491072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869638|NCT02344732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5869639|NCT02344732|Antiemetics|antiemetics|mesh-ancestor
5869640|NCT02344732|Autonomic Agents|autonomic agents|mesh-ancestor
5869641|NCT02344732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5869642|NCT02344732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869643|NCT02344732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5869644|NCT02344732|Glucocorticoids|glucocorticoids|mesh-ancestor
5869645|NCT02344732|Hormones|hormones|mesh-ancestor
5869646|NCT02344732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5869647|NCT02344732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5869648|NCT02344732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5681431|NCT03491072|Analgesics|analgesics|mesh-ancestor
5681432|NCT03491072|Sensory System Agents|sensory system agents|mesh-ancestor
5681433|NCT03491072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5681434|NCT03491072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5681435|NCT03491072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5681436|NCT03491072|Anesthetics, General|anesthetics, general|mesh-ancestor
5681437|NCT03491072|Anesthetics|anesthetics|mesh-ancestor
5681438|NCT03490994|Warfarin|warfarin|mesh-list
5681439|NCT03490994|Rivaroxaban|rivaroxaban|mesh-list
5681440|NCT03490994|Anticoagulants|anticoagulants|mesh-ancestor
5681441|NCT03490994|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5681442|NCT03490994|Antithrombins|antithrombins|mesh-ancestor
5681443|NCT03490994|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5681444|NCT03490994|Protease Inhibitors|protease inhibitors|mesh-ancestor
5681445|NCT03490994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5681446|NCT03490994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869649|NCT02344732|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5869650|NCT02344732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5869651|NCT02344732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5869652|NCT02344732|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5869653|NCT02344732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5869654|NCT02344732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869655|NCT02344732|Parasympatholytics|parasympatholytics|mesh-ancestor
5905355|NCT05135845|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5905356|NCT05135845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905357|NCT05135845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5905358|NCT05135637|Vaccines|vaccines|mesh-list
5905359|NCT05135637|Immunologic Factors|immunologic factors|mesh-ancestor
5905360|NCT05135637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905361|NCT05135442|Bortezomib|bortezomib|mesh-list
5905362|NCT05135442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5905363|NCT05135286|Brimonidine Tartrate|brimonidine tartrate|mesh-list
5905364|NCT05135286|Carbachol|carbachol|mesh-list
5905365|NCT05135286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5905366|NCT05135286|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5905367|NCT05135286|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5905368|NCT05135286|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5905369|NCT05135286|Adrenergic Agents|adrenergic agents|mesh-ancestor
5905370|NCT05135286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5905371|NCT05135286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905372|NCT05135286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905373|NCT05135286|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5905374|NCT05135286|Miotics|miotics|mesh-ancestor
5905375|NCT05135286|Autonomic Agents|autonomic agents|mesh-ancestor
5905376|NCT05135286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5905377|NCT05135286|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5905378|NCT05135286|Cholinergic Agents|cholinergic agents|mesh-ancestor
5905379|NCT05135286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5905380|NCT05135286|Analgesics|analgesics|mesh-ancestor
5905381|NCT05135286|Sensory System Agents|sensory system agents|mesh-ancestor
5905382|NCT05135286|Protective Agents|protective agents|mesh-ancestor
5905383|NCT05135273|Vaccines|vaccines|mesh-list
5905384|NCT05135273|Immunologic Factors|immunologic factors|mesh-ancestor
5905385|NCT05135273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905386|NCT05135039|Canagliflozin|canagliflozin|mesh-list
5905387|NCT05135039|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5905388|NCT05135039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905389|NCT05135039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5905390|NCT05135039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905391|NCT05135013|Drospirenone|drospirenone|mesh-list
5905392|NCT05135013|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5905393|NCT05135013|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5905394|NCT05135013|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5905395|NCT05135013|Norethindrone|norethindrone|mesh-list
5905396|NCT05135013|Norethindrone Acetate|norethindrone acetate|mesh-list
5905397|NCT05135013|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
5905398|NCT05135013|Estradiol|estradiol|mesh-list
5905399|NCT05135013|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5905400|NCT05135013|Dydrogesterone|dydrogesterone|mesh-list
5905401|NCT05135013|Estrogens|estrogens|mesh-ancestor
5905402|NCT05135013|Hormones|hormones|mesh-ancestor
5905403|NCT05135013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5905404|NCT05135013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905405|NCT05135013|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5905406|NCT05135013|Contraceptive Agents|contraceptive agents|mesh-ancestor
5905407|NCT05135013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5905408|NCT05135013|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5905409|NCT05135013|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5905410|NCT05135013|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5905411|NCT05135013|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5905412|NCT05135013|Hormone Antagonists|hormone antagonists|mesh-ancestor
5905413|NCT05135013|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5905414|NCT05135013|Diuretics|diuretics|mesh-ancestor
5905415|NCT05135013|Natriuretic Agents|natriuretic agents|mesh-ancestor
5905416|NCT05135013|Progestins|progestins|mesh-ancestor
5905417|NCT05135013|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5905418|NCT05134922|Gedatolisib|gedatolisib|mesh-list
5905419|NCT05134922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5905420|NCT05134922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5905421|NCT05134922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905422|NCT05134792|Immunoglobulins|immunoglobulins|mesh-list
5869656|NCT02344498|Tenofovir|tenofovir|mesh-list
5869657|NCT02344498|Antiviral Agents|antiviral agents|mesh-ancestor
5681447|NCT03490825|Melatonin|melatonin|mesh-list
5681448|NCT03490825|Antioxidants|antioxidants|mesh-ancestor
5681449|NCT03490825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681450|NCT03490825|Protective Agents|protective agents|mesh-ancestor
5681451|NCT03490825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681452|NCT03490825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5681453|NCT03490708|Tranilast|tranilast|mesh-list
5681454|NCT03490708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5681455|NCT03490708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5681456|NCT03490708|Analgesics|analgesics|mesh-ancestor
5681457|NCT03490708|Sensory System Agents|sensory system agents|mesh-ancestor
5681458|NCT03490708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5681459|NCT03490708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681460|NCT03490708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5681461|NCT03490708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5681462|NCT03490708|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5681463|NCT03490708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5681464|NCT03490708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681465|NCT03490708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5681466|NCT03490708|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5681467|NCT03490708|Histamine Antagonists|histamine antagonists|mesh-ancestor
5681468|NCT03490708|Histamine Agents|histamine agents|mesh-ancestor
5681469|NCT03490708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5869658|NCT02344498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5869659|NCT02344498|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5869660|NCT02344498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5869661|NCT02344498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5869662|NCT02344498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869663|NCT02344498|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5869664|NCT02344498|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5869665|NCT02344472|Paclitaxel|paclitaxel|mesh-list
5869666|NCT02344472|Vinorelbine|vinorelbine|mesh-list
5869667|NCT02344472|Docetaxel|docetaxel|mesh-list
5869668|NCT02344472|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5869669|NCT02344472|Capecitabine|capecitabine|mesh-list
5869670|NCT02344472|Trastuzumab|trastuzumab|mesh-list
5869671|NCT02344472|Letrozole|letrozole|mesh-list
5869672|NCT02344472|Fulvestrant|fulvestrant|mesh-list
5869673|NCT02344472|Anastrozole|anastrozole|mesh-list
5869674|NCT02344472|Exemestane|exemestane|mesh-list
5869675|NCT02344472|Goserelin|goserelin|mesh-list
5869676|NCT02344472|Pertuzumab|pertuzumab|mesh-list
5869677|NCT02344472|Leuprolide|leuprolide|mesh-list
5869678|NCT02344472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5869679|NCT02344472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5869680|NCT02344472|Tubulin Modulators|tubulin modulators|mesh-ancestor
5869681|NCT02344472|Antimitotic Agents|antimitotic agents|mesh-ancestor
5869682|NCT02344472|Mitosis Modulators|mitosis modulators|mesh-ancestor
5869683|NCT02344472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869684|NCT02344472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5869685|NCT02344472|Antimetabolites|antimetabolites|mesh-ancestor
5869686|NCT02344472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5869687|NCT02344472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5869688|NCT02344472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5869689|NCT02344472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5869690|NCT02344472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5869691|NCT02344472|Hormone Antagonists|hormone antagonists|mesh-ancestor
5869692|NCT02344472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5869693|NCT02344472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495178|NCT00621868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6495179|NCT00621868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495180|NCT00621881|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
6495181|NCT00621881|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5681470|NCT03490708|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5869694|NCT02344472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5681471|NCT03490708|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5681472|NCT03490617|Misoprostol|misoprostol|mesh-list
5681473|NCT03490617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5681474|NCT03490617|Abortifacient Agents|abortifacient agents|mesh-ancestor
5681475|NCT03490617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5681476|NCT03490617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681477|NCT03490617|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5681478|NCT03490617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5681479|NCT03490617|Oxytocics|oxytocics|mesh-ancestor
5681480|NCT03490539|Mycophenolic Acid|mycophenolic acid|mesh-list
5681481|NCT03490539|Azathioprine|azathioprine|mesh-list
5681482|NCT03490539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5681483|NCT03490539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5681484|NCT03490539|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5681485|NCT03490539|Antitubercular Agents|antitubercular agents|mesh-ancestor
5681486|NCT03490539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5681487|NCT03490539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5681488|NCT03490539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5681489|NCT03490539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681490|NCT03490539|Antimetabolites|antimetabolites|mesh-ancestor
5681491|NCT03490539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5681492|NCT03490539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5869695|NCT02344472|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5869696|NCT02344472|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5681493|NCT03490539|Immunologic Factors|immunologic factors|mesh-ancestor
5681494|NCT03490539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681495|NCT03490539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5681496|NCT03490487|Prednisolone|prednisolone|mesh-list
5681497|NCT03490487|Carbamazepine|carbamazepine|mesh-list
5681498|NCT03490487|Oxcarbazepine|oxcarbazepine|mesh-list
5681499|NCT03490487|Levetiracetam|levetiracetam|mesh-list
5681500|NCT03490487|Valproic Acid|valproic acid|mesh-list
5681501|NCT03490487|Anticonvulsants|anticonvulsants|mesh-list
5681502|NCT03490487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5681503|NCT03490487|Glucocorticoids|glucocorticoids|mesh-ancestor
5681504|NCT03490487|Hormones|hormones|mesh-ancestor
5681505|NCT03490487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5681506|NCT03490487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681507|NCT03490487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5681508|NCT03490487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5681509|NCT03490487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5681510|NCT03490487|Nootropic Agents|nootropic agents|mesh-ancestor
5681511|NCT03490487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5681512|NCT03490487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681513|NCT03490487|GABA Agents|gaba agents|mesh-ancestor
5681514|NCT03490487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5681515|NCT03490487|Antimanic Agents|antimanic agents|mesh-ancestor
5681516|NCT03490487|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5681517|NCT03490487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5681518|NCT03490487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5681519|NCT03490487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5681520|NCT03490487|Analgesics|analgesics|mesh-ancestor
5681521|NCT03490487|Sensory System Agents|sensory system agents|mesh-ancestor
5869697|NCT02344472|Fertility Agents|fertility agents|mesh-ancestor
5869698|NCT02344472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5869699|NCT02344264|Ropivacaine|ropivacaine|mesh-list
5869700|NCT02344264|Anesthetics, Local|anesthetics, local|mesh-ancestor
5869701|NCT02344264|Anesthetics|anesthetics|mesh-ancestor
5869702|NCT02344264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5869703|NCT02344264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869704|NCT02344264|Sensory System Agents|sensory system agents|mesh-ancestor
6495182|NCT00621881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495183|NCT00621907|Levobupivacaine|levobupivacaine|mesh-list
6495184|NCT00621907|Anesthetics, Local|anesthetics, local|mesh-ancestor
6495185|NCT00621907|Anesthetics|anesthetics|mesh-ancestor
5681522|NCT03490487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5681523|NCT03490487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5681524|NCT03490487|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5681525|NCT03490487|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5681526|NCT03490487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5696945|NCT03379012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5696946|NCT03379012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5696947|NCT03379012|Anabolic Agents|anabolic agents|mesh-ancestor
5696948|NCT03378960|Omeprazole|omeprazole|mesh-list
5696949|NCT03378960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5869705|NCT02344264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5869706|NCT02344303|Moxifloxacin|moxifloxacin|mesh-list
5869707|NCT02344303|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5869708|NCT02344303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5869709|NCT02344303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5869710|NCT02344303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5869711|NCT02344303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5869712|NCT02344303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869713|NCT02344303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5869714|NCT02344186|Liraglutide|liraglutide|mesh-list
5869715|NCT02344186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5869716|NCT02344186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869717|NCT02344186|Incretins|incretins|mesh-ancestor
5869718|NCT02344186|Hormones|hormones|mesh-ancestor
5869719|NCT02344186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5869720|NCT02344095|Paclitaxel|paclitaxel|mesh-list
5869721|NCT02344095|Cisplatin|cisplatin|mesh-list
5869722|NCT02344095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5869723|NCT02344095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5869724|NCT02344095|Tubulin Modulators|tubulin modulators|mesh-ancestor
5869725|NCT02344095|Antimitotic Agents|antimitotic agents|mesh-ancestor
5869726|NCT02344095|Mitosis Modulators|mitosis modulators|mesh-ancestor
5869727|NCT02344095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869728|NCT02343926|Metformin|metformin|mesh-list
5869729|NCT02343926|Vildagliptin|vildagliptin|mesh-list
5869730|NCT02343926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5869731|NCT02343926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869732|NCT02343926|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5869733|NCT02343926|Protease Inhibitors|protease inhibitors|mesh-ancestor
5869734|NCT02343926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5869735|NCT02343926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869736|NCT02344030|Pyrithione zinc|pyrithione zinc|mesh-list
5869737|NCT02344030|Keratolytic Agents|keratolytic agents|mesh-ancestor
5869738|NCT02344030|Dermatologic Agents|dermatologic agents|mesh-ancestor
5869739|NCT02344017|Prednisone|prednisone|mesh-list
5869740|NCT02344017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5869741|NCT02344017|Glucocorticoids|glucocorticoids|mesh-ancestor
5869742|NCT02344017|Hormones|hormones|mesh-ancestor
5869743|NCT02344017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5869744|NCT02344017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869745|NCT02344017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5869746|NCT02344017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5869747|NCT02343861|Emollients|emollients|mesh-list
5869748|NCT02343861|Dermatologic Agents|dermatologic agents|mesh-ancestor
5869749|NCT02343718|Sirolimus|sirolimus|mesh-list
5869750|NCT02343718|Vinblastine|vinblastine|mesh-list
5869751|NCT02343718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5869752|NCT02343718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5869753|NCT02343718|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5869754|NCT02343718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5869755|NCT02343718|Antifungal Agents|antifungal agents|mesh-ancestor
6495186|NCT00621907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6495187|NCT00621907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495188|NCT00621907|Sensory System Agents|sensory system agents|mesh-ancestor
6495189|NCT00621907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6495190|NCT00621998|Olanzapine|olanzapine|mesh-list
6495191|NCT00621998|Risperidone|risperidone|mesh-list
6495192|NCT00621998|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6495193|NCT00621998|Serotonin Agents|serotonin agents|mesh-ancestor
6495194|NCT00621998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6495195|NCT00621998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495196|NCT00621998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495197|NCT00621998|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6495198|NCT00621998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6495199|NCT00621998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6495200|NCT00621998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6495201|NCT00621998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6495202|NCT00621998|Dopamine Agents|dopamine agents|mesh-ancestor
5681527|NCT03490396|Povidone|povidone|mesh-list
5681528|NCT03490396|Hyaluronic Acid|hyaluronic acid|mesh-list
5681529|NCT03490396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5681530|NCT03490396|Immunologic Factors|immunologic factors|mesh-ancestor
5681531|NCT03490396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681532|NCT03490396|Viscosupplements|viscosupplements|mesh-ancestor
5681533|NCT03490396|Protective Agents|protective agents|mesh-ancestor
5681534|NCT03490396|Plasma Substitutes|plasma substitutes|mesh-ancestor
5681535|NCT03490396|Blood Substitutes|blood substitutes|mesh-ancestor
5681536|NCT03490344|Lenalidomide|lenalidomide|mesh-list
5681537|NCT03490344|Daratumumab|daratumumab|mesh-list
5869756|NCT02343718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5869757|NCT02343718|Immunologic Factors|immunologic factors|mesh-ancestor
5869758|NCT02343718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869759|NCT02343718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5869760|NCT02343718|Tubulin Modulators|tubulin modulators|mesh-ancestor
5869761|NCT02343718|Antimitotic Agents|antimitotic agents|mesh-ancestor
5869762|NCT02343718|Mitosis Modulators|mitosis modulators|mesh-ancestor
5869763|NCT02343718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869764|NCT02343692|Pancrelipase|pancrelipase|mesh-list
5869765|NCT02343692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5869766|NCT02343666|Plerixafor|plerixafor|mesh-list
5869767|NCT02343666|Carmustine|carmustine|mesh-list
5869768|NCT02343666|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
5869769|NCT02343666|Lenograstim|lenograstim|mesh-list
5869770|NCT02343666|Sargramostim|sargramostim|mesh-list
5869771|NCT02343666|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5869772|NCT02343666|Immunologic Factors|immunologic factors|mesh-ancestor
5681538|NCT03490344|Immunologic Factors|immunologic factors|mesh-ancestor
5681539|NCT03490344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681540|NCT03490344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5681541|NCT03490344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5681542|NCT03490344|Growth Substances|growth substances|mesh-ancestor
5681543|NCT03490344|Growth Inhibitors|growth inhibitors|mesh-ancestor
5681544|NCT03490344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5681545|NCT03490292|Paclitaxel|paclitaxel|mesh-list
5681546|NCT03490292|Carboplatin|carboplatin|mesh-list
5869773|NCT02343666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869774|NCT02343666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5869775|NCT02343666|Alkylating Agents|alkylating agents|mesh-ancestor
5869776|NCT02343666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869777|NCT02343666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5869778|NCT02343666|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5869779|NCT02343666|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5869780|NCT02343666|Antiviral Agents|antiviral agents|mesh-ancestor
5869781|NCT02343666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5869782|NCT02343666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5869783|NCT02343679|Ceritinib|ceritinib|mesh-list
5869784|NCT02343679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5869785|NCT02343679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5869786|NCT02343679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5869787|NCT02343679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869788|NCT02343432|Triamcinolone|triamcinolone|mesh-list
5681547|NCT03490292|Avelumab|avelumab|mesh-list
5681548|NCT03490292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5681549|NCT03490292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5681550|NCT03490292|Tubulin Modulators|tubulin modulators|mesh-ancestor
5869789|NCT02343432|Bupivacaine|bupivacaine|mesh-list
5869790|NCT02343432|Anesthetics, Local|anesthetics, local|mesh-ancestor
5869791|NCT02343432|Anesthetics|anesthetics|mesh-ancestor
5869792|NCT02343432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6675138|NCT01572688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5681551|NCT03490292|Antimitotic Agents|antimitotic agents|mesh-ancestor
5681552|NCT03490292|Mitosis Modulators|mitosis modulators|mesh-ancestor
5681553|NCT03490292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681554|NCT03490292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5681555|NCT03490279|Lactoferrin|lactoferrin|mesh-list
5681556|NCT03490279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5681557|NCT03490123|Azithromycin|azithromycin|mesh-list
5681558|NCT03490123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5681559|NCT03490123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5681560|NCT03490097|Sofosbuvir|sofosbuvir|mesh-list
5681561|NCT03490097|Simvastatin|simvastatin|mesh-list
5681562|NCT03490097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5681563|NCT03490097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5681564|NCT03490097|Antimetabolites|antimetabolites|mesh-ancestor
5698112|NCT03371186|Contraceptive Agents|contraceptive agents|mesh-list
5869793|NCT02343432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869794|NCT02343432|Sensory System Agents|sensory system agents|mesh-ancestor
5869795|NCT02343432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5869796|NCT02343432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5869797|NCT02343432|Glucocorticoids|glucocorticoids|mesh-ancestor
5869798|NCT02343432|Hormones|hormones|mesh-ancestor
5869799|NCT02343432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5869800|NCT02343484|Ethanol|ethanol|mesh-list
5869801|NCT02343484|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5869802|NCT02343484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5869803|NCT02343484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5869804|NCT02343484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869805|NCT02343536|Prednisone|prednisone|mesh-list
5869806|NCT02343536|Cyclophosphamide|cyclophosphamide|mesh-list
5869807|NCT02343536|Rituximab|rituximab|mesh-list
5869808|NCT02343536|Vincristine|vincristine|mesh-list
5869809|NCT02343536|Azacitidine|azacitidine|mesh-list
5869810|NCT02343536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5869811|NCT02343536|Immunologic Factors|immunologic factors|mesh-ancestor
5869812|NCT02343536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869813|NCT02343536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5869814|NCT02343536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5869815|NCT02343536|Alkylating Agents|alkylating agents|mesh-ancestor
5869816|NCT02343536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869817|NCT02343536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5869818|NCT02343536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5869819|NCT02343536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5869820|NCT02343536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5869821|NCT02343536|Glucocorticoids|glucocorticoids|mesh-ancestor
5869822|NCT02343536|Hormones|hormones|mesh-ancestor
5869823|NCT02343536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6495203|NCT00621998|Antiemetics|antiemetics|mesh-ancestor
6495204|NCT00621998|Autonomic Agents|autonomic agents|mesh-ancestor
6495205|NCT00621998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6495206|NCT00621998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6495207|NCT00621998|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6495208|NCT00621998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5869824|NCT02343536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5681565|NCT03490097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681566|NCT03490097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5681567|NCT03490097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5681568|NCT03490097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5681569|NCT03490097|Antiviral Agents|antiviral agents|mesh-ancestor
5681570|NCT03490097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5681571|NCT03490019|Metformin|metformin|mesh-list
5681572|NCT03490019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5681573|NCT03490019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681574|NCT03489928|Misoprostol|misoprostol|mesh-list
5681575|NCT03489928|Dinoprostone|dinoprostone|mesh-list
5681576|NCT03489928|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5681577|NCT03489928|Abortifacient Agents|abortifacient agents|mesh-ancestor
5869825|NCT02343536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5869826|NCT02343536|Tubulin Modulators|tubulin modulators|mesh-ancestor
5869827|NCT02343536|Antimitotic Agents|antimitotic agents|mesh-ancestor
5869828|NCT02343536|Mitosis Modulators|mitosis modulators|mesh-ancestor
5869829|NCT02343536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5869830|NCT02343536|Antimetabolites|antimetabolites|mesh-ancestor
5869831|NCT02343536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5869832|NCT02343419|Methacholine Chloride|methacholine chloride|mesh-list
5869833|NCT02343419|Miotics|miotics|mesh-ancestor
5869834|NCT02343419|Autonomic Agents|autonomic agents|mesh-ancestor
5869835|NCT02343419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5869836|NCT02343419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869837|NCT02343419|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5869838|NCT02343419|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
6495209|NCT00621998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5869839|NCT02343419|Respiratory System Agents|respiratory system agents|mesh-ancestor
5869840|NCT02343419|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
5869841|NCT02343419|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5869842|NCT02343419|Cholinergic Agents|cholinergic agents|mesh-ancestor
5869843|NCT02343419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5869844|NCT02343419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869845|NCT02343614|Celecoxib|celecoxib|mesh-list
5869846|NCT02343614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5869847|NCT02343614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5681578|NCT03489928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5681579|NCT03489928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681580|NCT03489928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5869848|NCT02343614|Analgesics|analgesics|mesh-ancestor
5869849|NCT02343614|Sensory System Agents|sensory system agents|mesh-ancestor
5869850|NCT02343614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6675139|NCT01572688|Alkylating Agents|alkylating agents|mesh-ancestor
6675140|NCT01572688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869851|NCT02343614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869852|NCT02343614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5869853|NCT02343614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5869854|NCT02343614|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5869855|NCT02343614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5869856|NCT02343614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5869857|NCT02343614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869858|NCT02343393|Hydralazine|hydralazine|mesh-list
6495210|NCT00622011|Risperidone|risperidone|mesh-list
6495211|NCT00622011|Zotepine|zotepine|mesh-list
6495212|NCT00622011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6495213|NCT00622011|Serotonin Agents|serotonin agents|mesh-ancestor
6495214|NCT00622011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6495215|NCT00622011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495216|NCT00622011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495217|NCT00622011|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6495218|NCT00622011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6495219|NCT00622011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6495220|NCT00622011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6495221|NCT00622011|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6495222|NCT00622011|Dopamine Agents|dopamine agents|mesh-ancestor
6495223|NCT00622037|Lubricant Eye Drops|lubricant eye drops|mesh-list
6495224|NCT00622037|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5869859|NCT02343393|Isosorbide|isosorbide|mesh-list
5869860|NCT02343393|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
5869861|NCT02343393|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
5869862|NCT02343393|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5869863|NCT02343393|Diuretics|diuretics|mesh-ancestor
5869864|NCT02343393|Natriuretic Agents|natriuretic agents|mesh-ancestor
5869865|NCT02343393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869866|NCT02343393|Vasodilator Agents|vasodilator agents|mesh-ancestor
5681581|NCT03489928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5681582|NCT03489928|Oxytocics|oxytocics|mesh-ancestor
5681583|NCT03489889|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
5681584|NCT03489889|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5681585|NCT03489889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5681586|NCT03489837|Dipropizine|dipropizine|mesh-list
5681587|NCT03489837|Antitussive Agents|antitussive agents|mesh-ancestor
5681588|NCT03489837|Respiratory System Agents|respiratory system agents|mesh-ancestor
5681589|NCT03489798|Alprostadil|alprostadil|mesh-list
5681590|NCT03489798|Misoprostol|misoprostol|mesh-list
5681591|NCT03489798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5681592|NCT03489798|Abortifacient Agents|abortifacient agents|mesh-ancestor
5869867|NCT02343393|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5869868|NCT02343393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869869|NCT02343393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5869870|NCT02343120|Zanubrutinib|zanubrutinib|mesh-list
5869871|NCT02343120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6675141|NCT01572688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6675142|NCT01572688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5869872|NCT02343120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5869873|NCT02343120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5869874|NCT02343120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495225|NCT00622037|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5681593|NCT03489798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5681594|NCT03489798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869875|NCT02343211|Immunoglobulins|immunoglobulins|mesh-list
6495226|NCT00622115|Enoxaparin|enoxaparin|mesh-list
6495227|NCT00622115|Anticoagulants|anticoagulants|mesh-ancestor
5869876|NCT02343211|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5869877|NCT02343211|Antibodies|antibodies|mesh-list
5869878|NCT02343211|Immunologic Factors|immunologic factors|mesh-ancestor
5869879|NCT02343211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869880|NCT02343289|Clarithromycin|clarithromycin|mesh-list
5869881|NCT02343289|Esketamine|esketamine|mesh-list
5869882|NCT02343289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5869883|NCT02343289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5869884|NCT02343289|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5869885|NCT02343289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5869886|NCT02343289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869887|NCT02343289|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5869888|NCT02343289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5869889|NCT02343289|Antidepressive Agents|antidepressive agents|mesh-ancestor
5869890|NCT02343289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5869891|NCT02342977|Lacosamide|lacosamide|mesh-list
5869892|NCT02342977|Anticonvulsants|anticonvulsants|mesh-ancestor
5869893|NCT02342977|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5869894|NCT02342977|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5869895|NCT02342977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5869896|NCT02342977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869897|NCT02343250|Valsartan|valsartan|mesh-list
5869898|NCT02343250|Cilnidipine|cilnidipine|mesh-list
5869899|NCT02343250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5869900|NCT02343250|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5869901|NCT02343250|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5869902|NCT02343250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869903|NCT02343250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5869904|NCT02343250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5869905|NCT02343250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5869906|NCT02343250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869907|NCT02342925|Metformin|metformin|mesh-list
5869908|NCT02342925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5869909|NCT02342925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869910|NCT02342769|Abacavir|abacavir|mesh-list
5869911|NCT02342769|Dolutegravir|dolutegravir|mesh-list
5869912|NCT02342769|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5869913|NCT02342769|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5869914|NCT02342769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5869915|NCT02342769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869916|NCT02342769|Antiviral Agents|antiviral agents|mesh-ancestor
5869917|NCT02342769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5869918|NCT02342769|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5869919|NCT02342769|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5869920|NCT02342769|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5681595|NCT03489798|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5681596|NCT03489798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5681597|NCT03489798|Oxytocics|oxytocics|mesh-ancestor
5681598|NCT03489798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5869921|NCT02342769|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5869922|NCT02342717|Itraconazole|itraconazole|mesh-list
5869923|NCT02342717|BI 425809|bi 425809|mesh-list
5869924|NCT02342717|Antifungal Agents|antifungal agents|mesh-ancestor
5869925|NCT02342717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5869926|NCT02342717|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5869927|NCT02342717|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5869928|NCT02342717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5869929|NCT02342717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869930|NCT02342717|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5869931|NCT02342717|Hormone Antagonists|hormone antagonists|mesh-ancestor
5869932|NCT02342717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5869933|NCT02342717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869934|NCT02342717|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6495228|NCT00622115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6495229|NCT00622115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6495230|NCT00622115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681599|NCT03489798|Vasodilator Agents|vasodilator agents|mesh-ancestor
5681600|NCT03489798|Urological Agents|urological agents|mesh-ancestor
5681601|NCT03489668|Metformin|metformin|mesh-list
5681602|NCT03489668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5681603|NCT03489668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681604|NCT03489629|Chlorhexidine|chlorhexidine|mesh-list
5681605|NCT03489629|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6495231|NCT00622141|Saquinavir|saquinavir|mesh-list
6495232|NCT00622141|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6495233|NCT00622141|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6495234|NCT00622141|Protease Inhibitors|protease inhibitors|mesh-ancestor
6495235|NCT00622141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6495236|NCT00622141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495237|NCT00622141|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6495238|NCT00622141|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6495239|NCT00622141|Antiviral Agents|antiviral agents|mesh-ancestor
6495240|NCT00622141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6495241|NCT00622141|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6495242|NCT00622141|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6495243|NCT00622206|Ritonavir|ritonavir|mesh-list
6495244|NCT00622206|Saquinavir|saquinavir|mesh-list
6495245|NCT00622206|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6495246|NCT00622206|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6495247|NCT00622206|Protease Inhibitors|protease inhibitors|mesh-ancestor
6495248|NCT00622206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6495249|NCT00622206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495250|NCT00622206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6495251|NCT00622206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6495252|NCT00622206|Antiviral Agents|antiviral agents|mesh-ancestor
5869935|NCT02342717|Nootropic Agents|nootropic agents|mesh-ancestor
5905423|NCT05134792|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5905424|NCT05134792|Antibodies|antibodies|mesh-list
5905425|NCT05134792|gamma-Globulins|gamma-globulins|mesh-list
5905426|NCT05134792|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5905427|NCT05134792|Immunologic Factors|immunologic factors|mesh-ancestor
5905428|NCT05134792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905429|NCT05134688|Magnesium Sulfate|magnesium sulfate|mesh-list
5905430|NCT05134688|Analgesics|analgesics|mesh-ancestor
5905431|NCT05134688|Sensory System Agents|sensory system agents|mesh-ancestor
5905432|NCT05134688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5905433|NCT05134688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905434|NCT05134688|Anesthetics|anesthetics|mesh-ancestor
5905435|NCT05134688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5905436|NCT05134688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5905437|NCT05134688|Anticonvulsants|anticonvulsants|mesh-ancestor
5905438|NCT05134688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5905439|NCT05134688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5905440|NCT05134688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905441|NCT05134688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5905442|NCT05134688|Tocolytic Agents|tocolytic agents|mesh-ancestor
5681606|NCT03489629|Minocycline|minocycline|mesh-list
5681607|NCT03489629|Trimethoprim|trimethoprim|mesh-list
5681608|NCT03489629|Sulfamethoxazole|sulfamethoxazole|mesh-list
5681609|NCT03489629|Mupirocin|mupirocin|mesh-list
5681610|NCT03489629|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
5681611|NCT03489629|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5681612|NCT03489629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5681613|NCT03489629|Disinfectants|disinfectants|mesh-ancestor
5681614|NCT03489629|Dermatologic Agents|dermatologic agents|mesh-ancestor
5681615|NCT03489629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5681616|NCT03489629|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5681617|NCT03489629|Renal Agents|renal agents|mesh-ancestor
5681618|NCT03489629|Antimalarials|antimalarials|mesh-ancestor
5681619|NCT03489629|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5681620|NCT03489629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5681621|NCT03489629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5681622|NCT03489629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5681623|NCT03489629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681624|NCT03489629|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5681625|NCT03489629|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
5681626|NCT03489629|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5681627|NCT03489629|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5681628|NCT03489616|Pemetrexed|pemetrexed|mesh-list
5681629|NCT03489616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5681630|NCT03489616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5681631|NCT03489616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681632|NCT03489616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5905443|NCT05134688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5905444|NCT05134558|Xenon|xenon|mesh-list
6495253|NCT00622206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5681633|NCT03489616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6495254|NCT00622206|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5869936|NCT02342782|Cytarabine|cytarabine|mesh-list
5869937|NCT02342782|Etoposide|etoposide|mesh-list
5869938|NCT02342782|Melphalan|melphalan|mesh-list
5869939|NCT02342782|Carmustine|carmustine|mesh-list
5869940|NCT02342782|Basiliximab|basiliximab|mesh-list
5869941|NCT02342782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5869942|NCT02342782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5869943|NCT02342782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5869944|NCT02342782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5869945|NCT02342782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5869946|NCT02342782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869947|NCT02342782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5869948|NCT02342782|Antimetabolites|antimetabolites|mesh-ancestor
5869949|NCT02342782|Antiviral Agents|antiviral agents|mesh-ancestor
5869950|NCT02342782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5869951|NCT02342782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5869952|NCT02342782|Immunologic Factors|immunologic factors|mesh-ancestor
5869953|NCT02342782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869954|NCT02342782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5869955|NCT02342782|Alkylating Agents|alkylating agents|mesh-ancestor
5869956|NCT02342782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5869957|NCT02342600|Trametinib|trametinib|mesh-list
5869958|NCT02342600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5869959|NCT02342600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5869960|NCT02342600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5869961|NCT02342600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869962|NCT02342444|Enoxaparin|enoxaparin|mesh-list
5869963|NCT02342444|Enoxaparin sodium|enoxaparin sodium|mesh-list
5869964|NCT02342444|Anticoagulants|anticoagulants|mesh-ancestor
5869965|NCT02342444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5869966|NCT02342444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5869967|NCT02342444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869968|NCT02342587|Lapatinib|lapatinib|mesh-list
5869969|NCT02342587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5869970|NCT02342587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5681634|NCT03489395|Edoxaban|edoxaban|mesh-list
5681635|NCT03489395|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5681636|NCT03489395|Antithrombins|antithrombins|mesh-ancestor
5681637|NCT03489395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5681638|NCT03489395|Protease Inhibitors|protease inhibitors|mesh-ancestor
5681639|NCT03489395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5681640|NCT03489395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681641|NCT03489395|Anticoagulants|anticoagulants|mesh-ancestor
5681642|NCT03489317|Metformin|metformin|mesh-list
5681643|NCT03489317|Amlodipine|amlodipine|mesh-list
5681644|NCT03489317|Simvastatin|simvastatin|mesh-list
5681645|NCT03489317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5681646|NCT03489317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681647|NCT03489317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5681648|NCT03489317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5681649|NCT03489317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5681650|NCT03489317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681651|NCT03489317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5681652|NCT03489317|Vasodilator Agents|vasodilator agents|mesh-ancestor
5681653|NCT03489317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5681654|NCT03489317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5681655|NCT03489317|Antimetabolites|antimetabolites|mesh-ancestor
5681656|NCT03489317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5681657|NCT03489317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5681658|NCT03489317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5681659|NCT03489265|Eluxadoline|eluxadoline|mesh-list
5681660|NCT03489265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5681661|NCT03489239|Tenofovir|tenofovir|mesh-list
5681662|NCT03489239|Antiviral Agents|antiviral agents|mesh-ancestor
5681663|NCT03489239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5681664|NCT03489239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5681665|NCT03489239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5681666|NCT03489239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5681667|NCT03489239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681668|NCT03489239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5681669|NCT03489239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5869971|NCT02342587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5869972|NCT02342587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495255|NCT00622206|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5681670|NCT03489161|Buprenorphine|buprenorphine|mesh-list
5869973|NCT02342509|Sevoflurane|sevoflurane|mesh-list
5681671|NCT03489161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5681672|NCT03489161|Narcotics|narcotics|mesh-ancestor
5681673|NCT03489161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5681674|NCT03489161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869974|NCT02342509|Desflurane|desflurane|mesh-list
5869975|NCT02342509|Isoflurane|isoflurane|mesh-list
5869976|NCT02342509|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5869977|NCT02342509|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5869978|NCT02342509|Anesthetics, General|anesthetics, general|mesh-ancestor
5869979|NCT02342509|Anesthetics|anesthetics|mesh-ancestor
5869980|NCT02342509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5869981|NCT02342509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869982|NCT02342574|Olorofim|olorofim|mesh-list
5869983|NCT02342574|Antifungal Agents|antifungal agents|mesh-ancestor
5869984|NCT02342574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5869985|NCT02342392|Ranibizumab|ranibizumab|mesh-list
5869986|NCT02342392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5869987|NCT02342392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5869988|NCT02342392|Growth Substances|growth substances|mesh-ancestor
5869989|NCT02342392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5869990|NCT02342392|Growth Inhibitors|growth inhibitors|mesh-ancestor
5869991|NCT02342392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5869992|NCT02342353|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5869993|NCT02342353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5869994|NCT02342353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5869995|NCT02342353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5869996|NCT02342353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5869997|NCT02342366|Sodium Oxybate|sodium oxybate|mesh-list
5869998|NCT02342366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5869999|NCT02342366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5870000|NCT02342366|Anesthetics, General|anesthetics, general|mesh-ancestor
5870001|NCT02342366|Anesthetics|anesthetics|mesh-ancestor
5870002|NCT02342366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5870003|NCT02342366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870004|NCT02342275|Propranolol|propranolol|mesh-list
5870005|NCT02342275|Atenolol|atenolol|mesh-list
5870006|NCT02342275|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5870007|NCT02342275|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5870008|NCT02342275|Adrenergic Agents|adrenergic agents|mesh-ancestor
5870009|NCT02342275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5870010|NCT02342275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5870011|NCT02342275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870012|NCT02342275|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5870013|NCT02342275|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5870014|NCT02342275|Vasodilator Agents|vasodilator agents|mesh-ancestor
5870015|NCT02342275|Sympatholytics|sympatholytics|mesh-ancestor
5870016|NCT02342275|Autonomic Agents|autonomic agents|mesh-ancestor
5870017|NCT02342275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5870018|NCT02342275|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5870019|NCT02342184|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5870020|NCT02342184|Immunologic Factors|immunologic factors|mesh-ancestor
5870021|NCT02342184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870022|NCT02342145|Cyclosporine|cyclosporine|mesh-list
5870023|NCT02342145|Mycophenolic Acid|mycophenolic acid|mesh-list
5870024|NCT02342145|Methotrexate|methotrexate|mesh-list
5870025|NCT02342145|Cyclosporins|cyclosporins|mesh-list
5870026|NCT02342145|Basiliximab|basiliximab|mesh-list
5870027|NCT02342145|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5870028|NCT02342145|Abortifacient Agents|abortifacient agents|mesh-ancestor
5681675|NCT03489161|Analgesics|analgesics|mesh-ancestor
5681676|NCT03489161|Sensory System Agents|sensory system agents|mesh-ancestor
5681677|NCT03489161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5681678|NCT03489161|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5681679|NCT03489044|Levetiracetam|levetiracetam|mesh-list
5681680|NCT03489044|Anticonvulsants|anticonvulsants|mesh-ancestor
5681681|NCT03489044|Nootropic Agents|nootropic agents|mesh-ancestor
5681682|NCT03489018|Vaccines|vaccines|mesh-list
5870029|NCT02342145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5870030|NCT02342145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870031|NCT02342145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5870032|NCT02342145|Antimetabolites|antimetabolites|mesh-ancestor
5870033|NCT02342145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5870034|NCT02342145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5870035|NCT02342145|Dermatologic Agents|dermatologic agents|mesh-ancestor
5870036|NCT02342145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5681683|NCT03489018|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5681684|NCT03489018|Immunologic Factors|immunologic factors|mesh-ancestor
5681685|NCT03489018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681686|NCT03489005|Moxifloxacin|moxifloxacin|mesh-list
5681687|NCT03489005|Zamicastat|zamicastat|mesh-list
5681688|NCT03489005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5681689|NCT03489005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5870037|NCT02342145|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5870038|NCT02342145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5870039|NCT02342145|Immunologic Factors|immunologic factors|mesh-ancestor
5870040|NCT02342145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5870041|NCT02342145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5870042|NCT02342145|Antifungal Agents|antifungal agents|mesh-ancestor
5870043|NCT02342145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5870044|NCT02342145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5870045|NCT02342145|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5870046|NCT02342145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5870047|NCT02342145|Antitubercular Agents|antitubercular agents|mesh-ancestor
5870048|NCT02342145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5870049|NCT02342093|Drospirenone|drospirenone|mesh-list
5870050|NCT02342093|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5870051|NCT02342093|Hormone Antagonists|hormone antagonists|mesh-ancestor
5870052|NCT02342093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5870053|NCT02342093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870054|NCT02342093|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5870055|NCT02342093|Diuretics|diuretics|mesh-ancestor
5870056|NCT02342093|Natriuretic Agents|natriuretic agents|mesh-ancestor
5870057|NCT02342067|Pioglitazone|pioglitazone|mesh-list
5870058|NCT02342067|Cenicriviroc|cenicriviroc|mesh-list
5870059|NCT02342067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5870060|NCT02342067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870061|NCT02342067|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
5870062|NCT02342067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681690|NCT03489005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5681691|NCT03489005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5681692|NCT03489005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5681693|NCT03489005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681694|NCT03489005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5681695|NCT03488888|Bupivacaine|bupivacaine|mesh-list
5681696|NCT03488888|Anesthetics, Local|anesthetics, local|mesh-ancestor
5681697|NCT03488888|Anesthetics|anesthetics|mesh-ancestor
5681698|NCT03488888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5870063|NCT02342067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5870064|NCT02342067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5870065|NCT02342067|Antiviral Agents|antiviral agents|mesh-ancestor
5870066|NCT02342067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5870067|NCT02341911|Gemcitabine|gemcitabine|mesh-list
5870068|NCT02341911|Carboplatin|carboplatin|mesh-list
5870069|NCT02341911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5870070|NCT02341911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5870071|NCT02341911|Antimetabolites|antimetabolites|mesh-ancestor
5870072|NCT02341911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5870073|NCT02341911|Antiviral Agents|antiviral agents|mesh-ancestor
5870074|NCT02341911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5870075|NCT02341911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5870076|NCT02341911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5870077|NCT02341911|Immunologic Factors|immunologic factors|mesh-ancestor
5870078|NCT02341911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870079|NCT02341872|Calcium|calcium|mesh-list
5870080|NCT02341872|Fluorides|fluorides|mesh-list
5870081|NCT02341872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5870082|NCT02341872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870083|NCT02341872|Cariostatic Agents|cariostatic agents|mesh-ancestor
5870084|NCT02341872|Protective Agents|protective agents|mesh-ancestor
5870085|NCT02342002|Misoprostol|misoprostol|mesh-list
5870086|NCT02342002|Mifepristone|mifepristone|mesh-list
5870087|NCT02342002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5870088|NCT02342002|Abortifacient Agents|abortifacient agents|mesh-ancestor
5870089|NCT02342002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5870090|NCT02342002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870091|NCT02342002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5870092|NCT02342002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5870093|NCT02342002|Oxytocics|oxytocics|mesh-ancestor
5870094|NCT02342002|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5870095|NCT02342002|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5870096|NCT02342002|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5870097|NCT02342002|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5870098|NCT02342002|Contraceptive Agents|contraceptive agents|mesh-ancestor
5870099|NCT02342002|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5870100|NCT02342002|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5870101|NCT02342002|Hormone Antagonists|hormone antagonists|mesh-ancestor
5870102|NCT02342002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5870103|NCT02342002|Luteolytic Agents|luteolytic agents|mesh-ancestor
5870104|NCT02342002|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5870105|NCT02342002|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5870106|NCT02341833|Sevoflurane|sevoflurane|mesh-list
5870107|NCT02341833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5870108|NCT02341833|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5870109|NCT02341833|Anesthetics, General|anesthetics, general|mesh-ancestor
5681699|NCT03488888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681700|NCT03488888|Sensory System Agents|sensory system agents|mesh-ancestor
5681701|NCT03488888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5681702|NCT03488810|Hormones|hormones|mesh-list
5681703|NCT03488810|Androgens|androgens|mesh-list
5681704|NCT03488810|Androgen Antagonists|androgen antagonists|mesh-list
5681705|NCT03488810|Nonsteroidal Anti-Androgens|nonsteroidal anti-androgens|mesh-list
5681706|NCT03488810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5681707|NCT03488810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681708|NCT03488810|Hormone Antagonists|hormone antagonists|mesh-ancestor
5681709|NCT03488719|Metoprolol|metoprolol|mesh-list
5681710|NCT03488719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5681711|NCT03488719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5681712|NCT03488719|Sympatholytics|sympatholytics|mesh-ancestor
5681713|NCT03488719|Autonomic Agents|autonomic agents|mesh-ancestor
5681714|NCT03488719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5681715|NCT03488719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681716|NCT03488719|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5681717|NCT03488719|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5681718|NCT03488719|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5681719|NCT03488719|Adrenergic Agents|adrenergic agents|mesh-ancestor
5681720|NCT03488719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5870110|NCT02341833|Anesthetics|anesthetics|mesh-ancestor
5870111|NCT02341833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5870112|NCT02341833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870113|NCT02341963|Ketamine|ketamine|mesh-list
5870114|NCT02341963|Analgesics|analgesics|mesh-ancestor
5870115|NCT02341963|Sensory System Agents|sensory system agents|mesh-ancestor
5870116|NCT02341963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6495256|NCT00622245|Quetiapine Fumarate|quetiapine fumarate|mesh-list
5681721|NCT03488719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696950|NCT03378960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5696951|NCT03378960|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5696952|NCT03378960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5696953|NCT03378960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696954|NCT03378934|Aspirin|aspirin|mesh-list
5696955|NCT03378934|Clopidogrel|clopidogrel|mesh-list
5696956|NCT03378934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5696957|NCT03378934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5696958|NCT03378934|Analgesics|analgesics|mesh-ancestor
5696959|NCT03378934|Sensory System Agents|sensory system agents|mesh-ancestor
5696960|NCT03378934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5696961|NCT03378934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696962|NCT03378934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5696963|NCT03378934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5696964|NCT03378934|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5696965|NCT03378934|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5696966|NCT03378934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5696967|NCT03378934|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5696968|NCT03378934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5696969|NCT03378934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5696970|NCT03378934|Antipyretics|antipyretics|mesh-ancestor
5696971|NCT03378934|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5696972|NCT03378934|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5696973|NCT03378934|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5696974|NCT03378934|Purinergic Agents|purinergic agents|mesh-ancestor
5696975|NCT03378934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5696976|NCT03378791|Ferrous fumarate|ferrous fumarate|mesh-list
5696977|NCT03378791|Trace Elements|trace elements|mesh-ancestor
5696978|NCT03378791|Micronutrients|micronutrients|mesh-ancestor
5870117|NCT02341963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870118|NCT02341963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5870119|NCT02341963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5681722|NCT03488667|Pembrolizumab|pembrolizumab|mesh-list
5681723|NCT03488667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5681724|NCT03488667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5681725|NCT03488485|Sofosbuvir|sofosbuvir|mesh-list
5681726|NCT03488485|Antiviral Agents|antiviral agents|mesh-list
5681727|NCT03488485|Ledipasvir|ledipasvir|mesh-list
5870120|NCT02341963|Anesthetics, General|anesthetics, general|mesh-ancestor
5870121|NCT02341963|Anesthetics|anesthetics|mesh-ancestor
5870122|NCT02341963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5870123|NCT02341963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5870124|NCT02341963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5870125|NCT02341963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5870126|NCT02341963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5870127|NCT02341794|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5870128|NCT02341794|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5681728|NCT03488485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5681729|NCT03488316|Calcium|calcium|mesh-list
5681730|NCT03488316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5681731|NCT03488316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681732|NCT03488251|Gemcitabine|gemcitabine|mesh-list
5681733|NCT03488251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5681734|NCT03488251|Antimetabolites|antimetabolites|mesh-ancestor
5681735|NCT03488251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681736|NCT03488251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5681737|NCT03488251|Antiviral Agents|antiviral agents|mesh-ancestor
5681738|NCT03488251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5681739|NCT03488251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5681740|NCT03488251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5681741|NCT03488251|Immunologic Factors|immunologic factors|mesh-ancestor
5681742|NCT03488251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681743|NCT03488186|Lansoprazole|lansoprazole|mesh-list
5870129|NCT02341794|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5870130|NCT02341794|Antimetabolites|antimetabolites|mesh-ancestor
5870131|NCT02341794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5870132|NCT02341794|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5870133|NCT02341794|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5870134|NCT02341794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5870135|NCT02341729|Ticagrelor|ticagrelor|mesh-list
5870136|NCT02341729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5870137|NCT02341729|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5870138|NCT02341729|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5870139|NCT02341729|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5870140|NCT02341729|Purinergic Agents|purinergic agents|mesh-ancestor
5681744|NCT03488186|Dexlansoprazole|dexlansoprazole|mesh-list
5681745|NCT03488186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5681746|NCT03488186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5681747|NCT03488186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5681748|NCT03488186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5681749|NCT03488186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681750|NCT03488173|Lansoprazole|lansoprazole|mesh-list
5681751|NCT03488173|Dexlansoprazole|dexlansoprazole|mesh-list
5870141|NCT02341729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5870142|NCT02341729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5870143|NCT02341729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870144|NCT02341703|Metformin|metformin|mesh-list
5870145|NCT02341703|Pioglitazone|pioglitazone|mesh-list
5870146|NCT02341703|Letrozole|letrozole|mesh-list
5870147|NCT02341703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5870148|NCT02341703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870149|NCT02341703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5870150|NCT02341703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5870151|NCT02341703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5870152|NCT02341703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5870153|NCT02341703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5870154|NCT02341703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5870155|NCT02341703|Hormone Antagonists|hormone antagonists|mesh-ancestor
5870156|NCT02341703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5870157|NCT02341404|Hydroxyflutamide|hydroxyflutamide|mesh-list
5870158|NCT02341404|Androgen Antagonists|androgen antagonists|mesh-ancestor
5870159|NCT02341404|Hormone Antagonists|hormone antagonists|mesh-ancestor
5681752|NCT03488173|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5870160|NCT02341404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5870161|NCT02341404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870162|NCT02341573|Leukotriene Antagonists|leukotriene antagonists|mesh-list
5870163|NCT02341573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5870164|NCT02341573|Respiratory System Agents|respiratory system agents|mesh-ancestor
5870165|NCT02341573|Hormone Antagonists|hormone antagonists|mesh-ancestor
5870166|NCT02341573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5870167|NCT02341573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870168|NCT02341586|Iron|iron|mesh-list
5870169|NCT02341586|Trace Elements|trace elements|mesh-ancestor
5870170|NCT02341586|Micronutrients|micronutrients|mesh-ancestor
5870171|NCT02341586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870172|NCT02341638|Aspirin|aspirin|mesh-list
5870173|NCT02341638|Itraconazole|itraconazole|mesh-list
5870174|NCT02341638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5681753|NCT03488173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5681754|NCT03488173|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5681755|NCT03488173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5681756|NCT03488173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681757|NCT03488147|Esomeprazole|esomeprazole|mesh-list
5681758|NCT03488147|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5681759|NCT03488147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5681760|NCT03488147|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5681761|NCT03488147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5681762|NCT03488147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681763|NCT03487939|Fluorouracil|fluorouracil|mesh-list
5681764|NCT03487939|Oxaliplatin|oxaliplatin|mesh-list
5681765|NCT03487939|Irinotecan|irinotecan|mesh-list
5681766|NCT03487939|Antimetabolites|antimetabolites|mesh-ancestor
5681767|NCT03487939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681768|NCT03487939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5870175|NCT02341638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5870176|NCT02341638|Analgesics|analgesics|mesh-ancestor
5870177|NCT02341638|Sensory System Agents|sensory system agents|mesh-ancestor
5870178|NCT02341638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5870179|NCT02341638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870180|NCT02341638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5870181|NCT02341638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5870182|NCT02341638|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5681769|NCT03487939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5681770|NCT03487939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5681771|NCT03487939|Immunologic Factors|immunologic factors|mesh-ancestor
5681772|NCT03487939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681773|NCT03487939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5681774|NCT03487939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5681775|NCT03487939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5681776|NCT03487874|Ropivacaine|ropivacaine|mesh-list
5681777|NCT03487874|Anesthetics, Local|anesthetics, local|mesh-ancestor
5681778|NCT03487874|Anesthetics|anesthetics|mesh-ancestor
5681779|NCT03487874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5681780|NCT03487874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681781|NCT03487874|Sensory System Agents|sensory system agents|mesh-ancestor
5681782|NCT03487874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5681783|NCT03487809|Budesonide|budesonide|mesh-list
5681784|NCT03487809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5681785|NCT03487809|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5681786|NCT03487809|Autonomic Agents|autonomic agents|mesh-ancestor
5681787|NCT03487809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5681788|NCT03487809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681789|NCT03487809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5681790|NCT03487809|Respiratory System Agents|respiratory system agents|mesh-ancestor
5870183|NCT02341638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5870184|NCT02341638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681791|NCT03487809|Glucocorticoids|glucocorticoids|mesh-ancestor
5681792|NCT03487809|Hormones|hormones|mesh-ancestor
5681793|NCT03487809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5681794|NCT03487783|Aripiprazole|aripiprazole|mesh-list
5681795|NCT03487783|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5681796|NCT03487783|Antidepressive Agents|antidepressive agents|mesh-ancestor
5681797|NCT03487783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5681798|NCT03487783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5681799|NCT03487783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5681800|NCT03487783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5681801|NCT03487783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870185|NCT02341638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5870186|NCT02341638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5870187|NCT02341638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5870188|NCT02341638|Antipyretics|antipyretics|mesh-ancestor
5870189|NCT02341638|Antifungal Agents|antifungal agents|mesh-ancestor
5870190|NCT02341638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5870191|NCT02341638|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5870192|NCT02341638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5870193|NCT02341638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5870194|NCT02341638|Hormone Antagonists|hormone antagonists|mesh-ancestor
5870195|NCT02341638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5870196|NCT02341638|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5870197|NCT02341547|Epoetin Alfa|epoetin alfa|mesh-list
5870198|NCT02341547|Hematinics|hematinics|mesh-ancestor
5870199|NCT02341352|Fluorides|fluorides|mesh-list
5870200|NCT02341352|Fluorides, Topical|fluorides, topical|mesh-list
5870201|NCT02341352|Immunoglobulins|immunoglobulins|mesh-list
5870202|NCT02341352|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5870203|NCT02341352|Antibodies|antibodies|mesh-list
5870204|NCT02341352|Cariostatic Agents|cariostatic agents|mesh-ancestor
5870205|NCT02341352|Protective Agents|protective agents|mesh-ancestor
5870206|NCT02341352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870207|NCT02341352|Immunologic Factors|immunologic factors|mesh-ancestor
5870208|NCT02341365|Vitamin D|vitamin d|mesh-list
5870209|NCT02341365|Vitamins|vitamins|mesh-ancestor
5870210|NCT02341365|Micronutrients|micronutrients|mesh-ancestor
5870211|NCT02341365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870212|NCT02341365|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5870213|NCT02341209|Doxycycline|doxycycline|mesh-list
5870214|NCT02341209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5870215|NCT02341209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5870216|NCT02341209|Antimalarials|antimalarials|mesh-ancestor
5870217|NCT02341209|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5870218|NCT02341209|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5870219|NCT02341300|Iron|iron|mesh-list
5681802|NCT03487783|Dopamine Agonists|dopamine agonists|mesh-ancestor
5681803|NCT03487783|Dopamine Agents|dopamine agents|mesh-ancestor
5681804|NCT03487783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5681805|NCT03487783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681806|NCT03487783|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5681807|NCT03487783|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5681808|NCT03487783|Serotonin Agents|serotonin agents|mesh-ancestor
5681809|NCT03487783|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5681810|NCT03487783|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5681811|NCT03487783|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5681812|NCT03487783|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5681813|NCT03487770|Aripiprazole|aripiprazole|mesh-list
5681814|NCT03487770|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5681815|NCT03487770|Antidepressive Agents|antidepressive agents|mesh-ancestor
5681816|NCT03487770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5681817|NCT03487770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5681818|NCT03487770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5681819|NCT03487770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5681820|NCT03487770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681821|NCT03487770|Dopamine Agonists|dopamine agonists|mesh-ancestor
5681822|NCT03487770|Dopamine Agents|dopamine agents|mesh-ancestor
5681823|NCT03487770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5681824|NCT03487770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681825|NCT03487770|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5681826|NCT03487770|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5681827|NCT03487770|Serotonin Agents|serotonin agents|mesh-ancestor
5681828|NCT03487770|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5681829|NCT03487770|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5681830|NCT03487770|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5681831|NCT03487770|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5681832|NCT03487666|Capecitabine|capecitabine|mesh-list
5681833|NCT03487666|Nivolumab|nivolumab|mesh-list
5681834|NCT03487666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5681835|NCT03487666|Antimetabolites|antimetabolites|mesh-ancestor
5681836|NCT03487666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681837|NCT03487666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5681838|NCT03487666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5681839|NCT03487666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5870220|NCT02341300|Trace Elements|trace elements|mesh-ancestor
5870221|NCT02341300|Micronutrients|micronutrients|mesh-ancestor
5870222|NCT02341300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870223|NCT02341274|Tacrolimus|tacrolimus|mesh-list
5870224|NCT02341274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5870225|NCT02341274|Immunologic Factors|immunologic factors|mesh-ancestor
5870226|NCT02341274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870227|NCT02341274|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5870228|NCT02341274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5870229|NCT02341274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5870230|NCT02341105|Amiodarone|amiodarone|mesh-list
5870231|NCT02341105|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
5681840|NCT03487562|Amoxicillin|amoxicillin|mesh-list
5681841|NCT03487562|Clarithromycin|clarithromycin|mesh-list
5681842|NCT03487562|Lansoprazole|lansoprazole|mesh-list
5681843|NCT03487562|Dexlansoprazole|dexlansoprazole|mesh-list
5681844|NCT03487562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5681845|NCT03487562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5681846|NCT03487562|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5681847|NCT03487562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5681848|NCT03487562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681849|NCT03487562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5681850|NCT03487562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5681851|NCT03487562|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5681852|NCT03487562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5681853|NCT03487562|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5681854|NCT03487406|Aspirin|aspirin|mesh-list
5681855|NCT03487406|Ticagrelor|ticagrelor|mesh-list
5870232|NCT02341105|Vasodilator Agents|vasodilator agents|mesh-ancestor
5870233|NCT02341105|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5870234|NCT02341105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5870235|NCT02341105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5870236|NCT02341105|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5870237|NCT02341105|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5870238|NCT02341105|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5870239|NCT02341105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5870240|NCT02341105|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5870241|NCT02341105|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5870242|NCT02341105|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5870243|NCT02341079|Bupivacaine|bupivacaine|mesh-list
5870244|NCT02341079|Anesthetics, Local|anesthetics, local|mesh-ancestor
5870245|NCT02341079|Anesthetics|anesthetics|mesh-ancestor
5870246|NCT02341079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5870247|NCT02341079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681856|NCT03487406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5681857|NCT03487406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5681858|NCT03487406|Analgesics|analgesics|mesh-ancestor
5681859|NCT03487406|Sensory System Agents|sensory system agents|mesh-ancestor
5681860|NCT03487406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5681861|NCT03487406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681862|NCT03487406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5681863|NCT03487406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5681864|NCT03487406|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5681865|NCT03487406|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5681866|NCT03487406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681867|NCT03487406|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5870248|NCT02341079|Sensory System Agents|sensory system agents|mesh-ancestor
5870249|NCT02341079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5905445|NCT05134558|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5905446|NCT05134558|Anesthetics, General|anesthetics, general|mesh-ancestor
5905447|NCT05134558|Anesthetics|anesthetics|mesh-ancestor
5905448|NCT05134558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5905449|NCT05134558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905450|NCT05134519|Trastuzumab|trastuzumab|mesh-list
5905451|NCT05134519|Antibodies|antibodies|mesh-list
5905452|NCT05134519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5905453|NCT05134519|Immunologic Factors|immunologic factors|mesh-ancestor
5905454|NCT05134519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905455|NCT05134519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5905456|NCT05134519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6495257|NCT00622245|Antidepressive Agents|antidepressive agents|mesh-ancestor
6495258|NCT00622245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6495259|NCT00622245|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6495260|NCT00622245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5905457|NCT05133193|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5681868|NCT03487406|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5870250|NCT02340910|Oxymetazoline|oxymetazoline|mesh-list
5870251|NCT02340910|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5870252|NCT02340910|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5870253|NCT02340910|Adrenergic Agents|adrenergic agents|mesh-ancestor
5870254|NCT02340910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5870255|NCT02340910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5870256|NCT02340910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870257|NCT02340910|Sympathomimetics|sympathomimetics|mesh-ancestor
5870258|NCT02340910|Autonomic Agents|autonomic agents|mesh-ancestor
5870259|NCT02340910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5870260|NCT02340910|Nasal Decongestants|nasal decongestants|mesh-ancestor
5870261|NCT02340910|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5870262|NCT02340910|Respiratory System Agents|respiratory system agents|mesh-ancestor
5870263|NCT02340936|Lenalidomide|lenalidomide|mesh-list
5870264|NCT02340936|Immunologic Factors|immunologic factors|mesh-ancestor
5870265|NCT02340936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870266|NCT02340936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5870267|NCT02340936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5870268|NCT02340936|Growth Substances|growth substances|mesh-ancestor
5870269|NCT02340936|Growth Inhibitors|growth inhibitors|mesh-ancestor
5870270|NCT02340936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5870271|NCT02341027|Contraceptive Agents|contraceptive agents|mesh-list
5870272|NCT02341027|Levonorgestrel|levonorgestrel|mesh-list
5870273|NCT02341027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5870274|NCT02341027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870275|NCT02341027|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5870276|NCT02341027|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5870277|NCT02341027|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5870278|NCT02341027|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5870279|NCT02340988|Oritavancin|oritavancin|mesh-list
5870280|NCT02340988|Warfarin|warfarin|mesh-list
5870281|NCT02340988|Anticoagulants|anticoagulants|mesh-ancestor
5870282|NCT02340988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5870283|NCT02340988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5870284|NCT02340455|Pregabalin|pregabalin|mesh-list
5870285|NCT02340455|Analgesics|analgesics|mesh-ancestor
5870286|NCT02340455|Sensory System Agents|sensory system agents|mesh-ancestor
5870287|NCT02340455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5870288|NCT02340455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870289|NCT02340455|Anticonvulsants|anticonvulsants|mesh-ancestor
5870290|NCT02340455|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5870291|NCT02340455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5681869|NCT03487406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5681870|NCT03487406|Antipyretics|antipyretics|mesh-ancestor
5870292|NCT02340455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5870293|NCT02340455|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5870294|NCT02340455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5870295|NCT02340455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5870296|NCT02340455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5870297|NCT02340455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5870298|NCT02340481|Simethicone|simethicone|mesh-list
5870299|NCT02340481|Loperamide|loperamide|mesh-list
5681871|NCT03487406|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5681872|NCT03487406|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5681873|NCT03487406|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5681874|NCT03487406|Purinergic Agents|purinergic agents|mesh-ancestor
5681875|NCT03487406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5681876|NCT03487354|Misoprostol|misoprostol|mesh-list
5870300|NCT02340481|Antidiarrheals|antidiarrheals|mesh-list
5870301|NCT02340481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5870302|NCT02340481|Antifoaming Agents|antifoaming agents|mesh-ancestor
5870303|NCT02340481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5870304|NCT02340481|Emollients|emollients|mesh-ancestor
5870305|NCT02340481|Dermatologic Agents|dermatologic agents|mesh-ancestor
6495261|NCT00622245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6495262|NCT00622245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496477|NCT00628225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496478|NCT00628225|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6496479|NCT00628225|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6496480|NCT00628225|Cholinergic Agents|cholinergic agents|mesh-ancestor
5870306|NCT02340611|Olaparib|olaparib|mesh-list
5870307|NCT02340611|Cediranib|cediranib|mesh-list
5870308|NCT02340611|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5870309|NCT02340611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5870310|NCT02340611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5870311|NCT02340611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5870312|NCT02340611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5870313|NCT02340325|Kynurenic Acid|kynurenic acid|mesh-list
5870314|NCT02340325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5870315|NCT02340325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5870316|NCT02340325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5870317|NCT02340325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5870318|NCT02340325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870319|NCT02340273|Oxymetazoline|oxymetazoline|mesh-list
5870320|NCT02340273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5870321|NCT02340273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5870322|NCT02340273|Adrenergic Agents|adrenergic agents|mesh-ancestor
5870323|NCT02340273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5870324|NCT02340273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5870325|NCT02340273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870326|NCT02340273|Sympathomimetics|sympathomimetics|mesh-ancestor
5870327|NCT02340273|Autonomic Agents|autonomic agents|mesh-ancestor
5870328|NCT02340273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5870329|NCT02340273|Nasal Decongestants|nasal decongestants|mesh-ancestor
5870330|NCT02340273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5870331|NCT02340273|Respiratory System Agents|respiratory system agents|mesh-ancestor
5870332|NCT02340247|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
5870333|NCT02340247|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
5870334|NCT02340247|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5870335|NCT02340247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5870336|NCT02340247|Cathartics|cathartics|mesh-ancestor
5870337|NCT02340117|Gemcitabine|gemcitabine|mesh-list
5870338|NCT02340117|Paclitaxel|paclitaxel|mesh-list
5870339|NCT02340117|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5681877|NCT03487354|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5681878|NCT03487354|Abortifacient Agents|abortifacient agents|mesh-ancestor
5681879|NCT03487354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5681880|NCT03487354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681881|NCT03487354|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5681882|NCT03487354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5681883|NCT03487354|Oxytocics|oxytocics|mesh-ancestor
5870340|NCT02340117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5870341|NCT02340117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5870342|NCT02340117|Tubulin Modulators|tubulin modulators|mesh-ancestor
5870343|NCT02340117|Antimitotic Agents|antimitotic agents|mesh-ancestor
5870344|NCT02340117|Mitosis Modulators|mitosis modulators|mesh-ancestor
5870345|NCT02340117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5870346|NCT02340117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5870347|NCT02340117|Antimetabolites|antimetabolites|mesh-ancestor
5870348|NCT02340117|Antiviral Agents|antiviral agents|mesh-ancestor
5870349|NCT02340117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5870350|NCT02340117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5870351|NCT02340117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5870352|NCT02340117|Immunologic Factors|immunologic factors|mesh-ancestor
5870353|NCT02340117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681884|NCT03487211|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5681885|NCT03487211|Citalopram|citalopram|mesh-list
5681886|NCT03487211|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5681887|NCT03487211|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5681888|NCT03487211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5870354|NCT02340182|Metronidazole|metronidazole|mesh-list
5870355|NCT02340182|Vancomycin|vancomycin|mesh-list
5870356|NCT02340182|Ciprofloxacin|ciprofloxacin|mesh-list
5870357|NCT02340182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5870358|NCT02340182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6495263|NCT00622258|Everolimus|everolimus|mesh-list
6495264|NCT00622258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6495265|NCT00622258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6495266|NCT00622258|Immunologic Factors|immunologic factors|mesh-ancestor
6495267|NCT00622258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495268|NCT00622349|Gemcitabine|gemcitabine|mesh-list
6495269|NCT00622349|Cisplatin|cisplatin|mesh-list
6495270|NCT00622349|Docetaxel|docetaxel|mesh-list
6495271|NCT00622349|Ifosfamide|ifosfamide|mesh-list
6495272|NCT00622349|Isophosphamide mustard|isophosphamide mustard|mesh-list
6495273|NCT00622349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6495274|NCT00622349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6495275|NCT00622349|Antimetabolites|antimetabolites|mesh-ancestor
5696979|NCT03378791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495276|NCT00622349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495277|NCT00622349|Antiviral Agents|antiviral agents|mesh-ancestor
6495278|NCT00622349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6495279|NCT00622349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6495280|NCT00622349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6495281|NCT00622349|Immunologic Factors|immunologic factors|mesh-ancestor
6675143|NCT01572688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6675144|NCT01572688|Immunologic Factors|immunologic factors|mesh-ancestor
6675145|NCT01572688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675146|NCT01572805|Melatonin|melatonin|mesh-list
6675147|NCT01572805|Antioxidants|antioxidants|mesh-ancestor
6675148|NCT01572805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675149|NCT01572805|Protective Agents|protective agents|mesh-ancestor
6675150|NCT01572805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681889|NCT03487211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495282|NCT00622349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495283|NCT00622349|Tubulin Modulators|tubulin modulators|mesh-ancestor
6495284|NCT00622349|Antimitotic Agents|antimitotic agents|mesh-ancestor
6495285|NCT00622349|Mitosis Modulators|mitosis modulators|mesh-ancestor
5681890|NCT03487211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5681891|NCT03487211|Serotonin Agents|serotonin agents|mesh-ancestor
5681892|NCT03487211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681893|NCT03487211|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5681894|NCT03487211|Antidepressive Agents|antidepressive agents|mesh-ancestor
5681895|NCT03487211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5681896|NCT03487211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5681897|NCT03487211|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5681898|NCT03487211|Analgesics|analgesics|mesh-ancestor
5681899|NCT03487211|Sensory System Agents|sensory system agents|mesh-ancestor
5681900|NCT03487211|Dopamine Agents|dopamine agents|mesh-ancestor
5681901|NCT03487198|Brexpiprazole|brexpiprazole|mesh-list
5681902|NCT03487198|Serotonin Agents|serotonin agents|mesh-ancestor
5681903|NCT03487198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5681904|NCT03487198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681905|NCT03487198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681906|NCT03487198|Dopamine Agonists|dopamine agonists|mesh-ancestor
6495286|NCT00622349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6495287|NCT00622349|Alkylating Agents|alkylating agents|mesh-ancestor
6495288|NCT00622375|Mesalamine|mesalamine|mesh-list
6495289|NCT00622375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6495290|NCT00622375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6495291|NCT00622375|Analgesics|analgesics|mesh-ancestor
6495292|NCT00622375|Sensory System Agents|sensory system agents|mesh-ancestor
6495293|NCT00622375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6495294|NCT00622375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495295|NCT00622375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6495296|NCT00622375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6495297|NCT00622414|Aflibercept|aflibercept|mesh-list
6495298|NCT00622414|Endothelial Growth Factors|endothelial growth factors|mesh-list
5681907|NCT03487198|Dopamine Agents|dopamine agents|mesh-ancestor
5681908|NCT03487172|Mannitol|mannitol|mesh-list
5681909|NCT03487172|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5681910|NCT03487172|Diuretics|diuretics|mesh-ancestor
5681911|NCT03487172|Natriuretic Agents|natriuretic agents|mesh-ancestor
5681912|NCT03487172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681913|NCT03487133|Dexamethasone|dexamethasone|mesh-list
5681914|NCT03487133|Bortezomib|bortezomib|mesh-list
5681915|NCT03487133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5681916|NCT03487133|Antiemetics|antiemetics|mesh-ancestor
5681917|NCT03487133|Autonomic Agents|autonomic agents|mesh-ancestor
5681918|NCT03487133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5681919|NCT03487133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681920|NCT03487133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5681921|NCT03487133|Glucocorticoids|glucocorticoids|mesh-ancestor
5681922|NCT03487133|Hormones|hormones|mesh-ancestor
6495299|NCT00622414|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5681923|NCT03487133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5681924|NCT03487133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5681925|NCT03487133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5681926|NCT03487107|Sofosbuvir|sofosbuvir|mesh-list
5681927|NCT03487107|Yimitasvir|yimitasvir|mesh-list
5681928|NCT03487107|Antiviral Agents|antiviral agents|mesh-ancestor
5681929|NCT03487107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5696980|NCT03378726|Micronutrients|micronutrients|mesh-list
5696981|NCT03378726|Trace Elements|trace elements|mesh-list
5696982|NCT03378726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696983|NCT03378713|Methyltestosterone|methyltestosterone|mesh-list
6675151|NCT01572805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5681930|NCT03487042|Bimatoprost|bimatoprost|mesh-list
5681931|NCT03487042|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5681932|NCT03487042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5681933|NCT03487042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5681934|NCT03487029|Oxymetazoline|oxymetazoline|mesh-list
5681935|NCT03487029|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5681936|NCT03487029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5681937|NCT03487029|Adrenergic Agents|adrenergic agents|mesh-ancestor
6495300|NCT00622414|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6495301|NCT00622414|Growth Substances|growth substances|mesh-ancestor
6495302|NCT00622414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495303|NCT00622414|Growth Inhibitors|growth inhibitors|mesh-ancestor
6495304|NCT00622414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6495305|NCT00622479|Sorafenib|sorafenib|mesh-list
6495306|NCT00622479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5870359|NCT02340182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5870360|NCT02340182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5870361|NCT02340182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5870362|NCT02340182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5870363|NCT02340182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5870364|NCT02340182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5870365|NCT02340182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5870366|NCT02340182|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5870367|NCT02340182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5870368|NCT02340169|Desoximetasone|desoximetasone|mesh-list
5870369|NCT02340169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6495307|NCT00622479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6495308|NCT00622479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6495309|NCT00622479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495310|NCT00622570|Pentobarbital|pentobarbital|mesh-list
6495311|NCT00622570|Thiopental|thiopental|mesh-list
5870370|NCT02340169|Glucocorticoids|glucocorticoids|mesh-ancestor
5870371|NCT02340169|Hormones|hormones|mesh-ancestor
5870372|NCT02340169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5870373|NCT02340169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870374|NCT02340013|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
5870375|NCT02340013|Medroxyprogesterone|medroxyprogesterone|mesh-list
5870376|NCT02340013|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6495312|NCT00622570|Anticonvulsants|anticonvulsants|mesh-ancestor
6495313|NCT00622570|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6495314|NCT00622570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6495315|NCT00622570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495316|NCT00622570|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6495317|NCT00622570|Anesthetics, General|anesthetics, general|mesh-ancestor
6495318|NCT00622570|Anesthetics|anesthetics|mesh-ancestor
6495319|NCT00622570|GABA Modulators|gaba modulators|mesh-ancestor
6495320|NCT00622570|GABA Agents|gaba agents|mesh-ancestor
6495321|NCT00622570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6495322|NCT00622570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495323|NCT00622570|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6495324|NCT00622622|Gemcitabine|gemcitabine|mesh-list
6495325|NCT00622622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6495326|NCT00622622|Antimetabolites|antimetabolites|mesh-ancestor
5681938|NCT03487029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5681939|NCT03487029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681940|NCT03487029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870377|NCT02340013|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5870378|NCT02340013|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5870379|NCT02340013|Contraceptive Agents|contraceptive agents|mesh-ancestor
5681941|NCT03487029|Sympathomimetics|sympathomimetics|mesh-ancestor
5681942|NCT03487029|Autonomic Agents|autonomic agents|mesh-ancestor
5681943|NCT03487029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5681944|NCT03487029|Nasal Decongestants|nasal decongestants|mesh-ancestor
5870380|NCT02340013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5870381|NCT02340013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870382|NCT02340013|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5870383|NCT02340013|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5870384|NCT02340013|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5870385|NCT02340013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5870386|NCT02340013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5870387|NCT02339714|Loratadine|loratadine|mesh-list
5870388|NCT02339714|Antipruritics|antipruritics|mesh-ancestor
5870389|NCT02339714|Dermatologic Agents|dermatologic agents|mesh-ancestor
5870390|NCT02339714|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6675152|NCT01572831|Tin Fluorides|tin fluorides|mesh-list
5870391|NCT02339714|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5870392|NCT02339714|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5870393|NCT02339714|Histamine Antagonists|histamine antagonists|mesh-ancestor
5870394|NCT02339714|Histamine Agents|histamine agents|mesh-ancestor
5870395|NCT02339714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5870396|NCT02339714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5870397|NCT02339714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870398|NCT02339805|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5870399|NCT02339805|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5870400|NCT02339805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5870401|NCT02339753|Carboplatin|carboplatin|mesh-list
5870402|NCT02339753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5870403|NCT02339662|Gabapentin|gabapentin|mesh-list
5870404|NCT02339662|Amitriptyline|amitriptyline|mesh-list
5681945|NCT03487029|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5681946|NCT03487029|Respiratory System Agents|respiratory system agents|mesh-ancestor
5681947|NCT03487016|Gemcitabine|gemcitabine|mesh-list
5681948|NCT03487016|Paclitaxel|paclitaxel|mesh-list
5681949|NCT03487016|Oxaliplatin|oxaliplatin|mesh-list
5681950|NCT03487016|Irinotecan|irinotecan|mesh-list
5681951|NCT03487016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5870405|NCT02339662|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
5870406|NCT02339662|Analgesics|analgesics|mesh-ancestor
5870407|NCT02339662|Sensory System Agents|sensory system agents|mesh-ancestor
5870408|NCT02339662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5870409|NCT02339662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870410|NCT02339662|Anticonvulsants|anticonvulsants|mesh-ancestor
5870411|NCT02339662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5870412|NCT02339662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5870413|NCT02339662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5870414|NCT02339662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5870415|NCT02339662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5870416|NCT02339662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5870417|NCT02339662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5870418|NCT02339662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5870419|NCT02339662|Antimanic Agents|antimanic agents|mesh-ancestor
5870420|NCT02339662|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5870421|NCT02339662|Antidepressive Agents|antidepressive agents|mesh-ancestor
5870422|NCT02339662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5870423|NCT02339662|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5870424|NCT02339662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5870425|NCT02339662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5870426|NCT02339662|Adrenergic Agents|adrenergic agents|mesh-ancestor
6495327|NCT00622622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495328|NCT00622622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6495329|NCT00622622|Antiviral Agents|antiviral agents|mesh-ancestor
6495330|NCT00622622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6495331|NCT00622622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6495332|NCT00622622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6495333|NCT00622622|Immunologic Factors|immunologic factors|mesh-ancestor
6495334|NCT00622622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495335|NCT00622648|Enoxaparin|enoxaparin|mesh-list
6495336|NCT00622648|Anticoagulants|anticoagulants|mesh-ancestor
6495337|NCT00622648|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5681952|NCT03487016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5681953|NCT03487016|Tubulin Modulators|tubulin modulators|mesh-ancestor
5681954|NCT03487016|Antimitotic Agents|antimitotic agents|mesh-ancestor
5681955|NCT03487016|Mitosis Modulators|mitosis modulators|mesh-ancestor
5681956|NCT03487016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681957|NCT03487016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5681958|NCT03487016|Antimetabolites|antimetabolites|mesh-ancestor
5681959|NCT03487016|Antiviral Agents|antiviral agents|mesh-ancestor
5681960|NCT03487016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5681961|NCT03487016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5681962|NCT03487016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5681963|NCT03487016|Immunologic Factors|immunologic factors|mesh-ancestor
5681964|NCT03487016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681965|NCT03487016|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5681966|NCT03487016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5681967|NCT03487003|Bromides|bromides|mesh-list
5681968|NCT03487003|Rocuronium|rocuronium|mesh-list
5681969|NCT03487003|Anticonvulsants|anticonvulsants|mesh-ancestor
5681970|NCT03487003|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5681971|NCT03487003|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5870427|NCT02339662|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5870428|NCT02339844|Aripiprazole|aripiprazole|mesh-list
5870429|NCT02339844|Antidepressive Agents|antidepressive agents|mesh-ancestor
5870430|NCT02339844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5681972|NCT03487003|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5681973|NCT03487003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5681974|NCT03487003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681975|NCT03486964|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
5681976|NCT03486964|Protease Inhibitors|protease inhibitors|mesh-ancestor
5681977|NCT03486964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5681978|NCT03486964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5870431|NCT02339844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5870432|NCT02339844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5870433|NCT02339844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5870434|NCT02339844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870435|NCT02339844|Dopamine Agonists|dopamine agonists|mesh-ancestor
5870436|NCT02339844|Dopamine Agents|dopamine agents|mesh-ancestor
5870437|NCT02339844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5870438|NCT02339844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5870439|NCT02339844|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5870440|NCT02339844|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5870441|NCT02339844|Serotonin Agents|serotonin agents|mesh-ancestor
5870442|NCT02339844|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5870443|NCT02339844|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5870444|NCT02339844|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5870445|NCT02339844|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5870446|NCT02339532|Carboplatin|carboplatin|mesh-list
5870447|NCT02339532|Docetaxel|docetaxel|mesh-list
5870448|NCT02339532|Trastuzumab|trastuzumab|mesh-list
5870449|NCT02339532|Pertuzumab|pertuzumab|mesh-list
5870450|NCT02339532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5870451|NCT02339532|Tubulin Modulators|tubulin modulators|mesh-ancestor
5870452|NCT02339532|Antimitotic Agents|antimitotic agents|mesh-ancestor
5870453|NCT02339532|Mitosis Modulators|mitosis modulators|mesh-ancestor
5870454|NCT02339532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5870455|NCT02339532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5870456|NCT02339350|Methotrexate|methotrexate|mesh-list
5870457|NCT02339350|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5870458|NCT02339350|Abortifacient Agents|abortifacient agents|mesh-ancestor
6495338|NCT00622648|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6675153|NCT01572831|Cariostatic Agents|cariostatic agents|mesh-ancestor
5870459|NCT02339350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5870460|NCT02339350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870461|NCT02339350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5870462|NCT02339350|Antimetabolites|antimetabolites|mesh-ancestor
5870463|NCT02339350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5870464|NCT02339350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5870465|NCT02339350|Dermatologic Agents|dermatologic agents|mesh-ancestor
5870466|NCT02339350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5870467|NCT02339350|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5870468|NCT02339350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5870469|NCT02339350|Immunologic Factors|immunologic factors|mesh-ancestor
5870470|NCT02339350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5870471|NCT02339350|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5870472|NCT02339441|Mycophenolic Acid|mycophenolic acid|mesh-list
5870473|NCT02339441|Cyclophosphamide|cyclophosphamide|mesh-list
5870474|NCT02339441|Methotrexate|methotrexate|mesh-list
5870475|NCT02339441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5870476|NCT02339441|Immunologic Factors|immunologic factors|mesh-ancestor
5870477|NCT02339441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870478|NCT02339441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5870479|NCT02339441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5870480|NCT02339441|Alkylating Agents|alkylating agents|mesh-ancestor
5870481|NCT02339441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5870482|NCT02339441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5681979|NCT03486964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5681980|NCT03486964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681981|NCT03486925|Oxytocin|oxytocin|mesh-list
5681982|NCT03486925|Oxytocics|oxytocics|mesh-ancestor
5681983|NCT03486925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5681984|NCT03486925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681985|NCT03486626|Metformin|metformin|mesh-list
5681986|NCT03486626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5681987|NCT03486626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5681988|NCT03486561|Ranolazine|ranolazine|mesh-list
5870483|NCT02339441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5870484|NCT02339441|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5870485|NCT02339441|Abortifacient Agents|abortifacient agents|mesh-ancestor
5870486|NCT02339441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5870487|NCT02339441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5870488|NCT02339441|Antimetabolites|antimetabolites|mesh-ancestor
5870489|NCT02339441|Dermatologic Agents|dermatologic agents|mesh-ancestor
5870490|NCT02339441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5870491|NCT02339441|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5870492|NCT02339441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5870493|NCT02339441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5870494|NCT02339441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5870495|NCT02339441|Antitubercular Agents|antitubercular agents|mesh-ancestor
5870496|NCT02339441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5870497|NCT02339441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5870498|NCT02339324|Interferons|interferons|mesh-list
5870499|NCT02339324|Interferon-alpha|interferon-alpha|mesh-list
5870500|NCT02339324|Interferon alpha-2|interferon alpha-2|mesh-list
5870501|NCT02339324|Pembrolizumab|pembrolizumab|mesh-list
5870502|NCT02339324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5870503|NCT02339324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5870504|NCT02339324|Antiviral Agents|antiviral agents|mesh-ancestor
5870505|NCT02339324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5870506|NCT02339324|Immunologic Factors|immunologic factors|mesh-ancestor
5870507|NCT02339324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870508|NCT02339428|Diclofenac|diclofenac|mesh-list
5870509|NCT02339428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5870510|NCT02339428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5870511|NCT02339428|Analgesics|analgesics|mesh-ancestor
5870512|NCT02339428|Sensory System Agents|sensory system agents|mesh-ancestor
5870513|NCT02339428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5870514|NCT02339428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870515|NCT02339428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5870516|NCT02339428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5870517|NCT02339428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5870518|NCT02339428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5870519|NCT02339428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905458|NCT05133193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5905459|NCT05133193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5905460|NCT05133193|Antitubercular Agents|antitubercular agents|mesh-ancestor
5905461|NCT05122169|Iodine|iodine|mesh-list
5905462|NCT05122169|Chlorhexidine|chlorhexidine|mesh-list
5905463|NCT05122169|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5905464|NCT05122169|Povidone-Iodine|povidone-iodine|mesh-list
5905465|NCT05122169|Povidone|povidone|mesh-list
5905466|NCT05122169|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5905467|NCT05122169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5905468|NCT05122169|Disinfectants|disinfectants|mesh-ancestor
5905469|NCT05122169|Dermatologic Agents|dermatologic agents|mesh-ancestor
5905470|NCT05122169|Trace Elements|trace elements|mesh-ancestor
5905471|NCT05122169|Micronutrients|micronutrients|mesh-ancestor
5681989|NCT03486561|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5681990|NCT03486561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5681991|NCT03486561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5681992|NCT03486548|Dexamethasone|dexamethasone|mesh-list
5681993|NCT03486548|Lidocaine|lidocaine|mesh-list
5681994|NCT03486548|Bupivacaine|bupivacaine|mesh-list
5681995|NCT03486548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5681996|NCT03486548|Antiemetics|antiemetics|mesh-ancestor
5681997|NCT03486548|Autonomic Agents|autonomic agents|mesh-ancestor
5905472|NCT05122169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905473|NCT05122169|Plasma Substitutes|plasma substitutes|mesh-ancestor
5905474|NCT05122169|Blood Substitutes|blood substitutes|mesh-ancestor
5905475|NCT05121571|Sorafenib|sorafenib|mesh-list
5905476|NCT05121571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5905477|NCT05121571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5905478|NCT05121571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5905479|NCT05121571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905480|NCT05120362|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
5905481|NCT05120362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5905482|NCT05120362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5905483|NCT05120362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905484|NCT05120141|Listerine|listerine|mesh-list
5905485|NCT05120141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5905486|NCT05120141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5681998|NCT03486548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5870520|NCT02339207|Adafosbuvir|adafosbuvir|mesh-list
5870521|NCT02339207|Antiviral Agents|antiviral agents|mesh-ancestor
5870522|NCT02339207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5870523|NCT02339142|Methylprednisolone|methylprednisolone|mesh-list
5870524|NCT02339142|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5870525|NCT02339142|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5870526|NCT02339142|Prednisolone|prednisolone|mesh-list
5870527|NCT02339142|Prednisolone acetate|prednisolone acetate|mesh-list
5870528|NCT02339142|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5870529|NCT02339142|Prednisolone phosphate|prednisolone phosphate|mesh-list
5870530|NCT02339142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5870531|NCT02339142|Antiemetics|antiemetics|mesh-ancestor
5870532|NCT02339142|Autonomic Agents|autonomic agents|mesh-ancestor
5870533|NCT02339142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5870534|NCT02339142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870535|NCT02339142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5870536|NCT02339142|Glucocorticoids|glucocorticoids|mesh-ancestor
5681999|NCT03486548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682000|NCT03486548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5682001|NCT03486548|Glucocorticoids|glucocorticoids|mesh-ancestor
5682002|NCT03486548|Hormones|hormones|mesh-ancestor
5682003|NCT03486548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5682004|NCT03486548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5682005|NCT03486548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5682006|NCT03486548|Anesthetics, Local|anesthetics, local|mesh-ancestor
5682007|NCT03486548|Anesthetics|anesthetics|mesh-ancestor
5682008|NCT03486548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5870537|NCT02339142|Hormones|hormones|mesh-ancestor
5870538|NCT02339142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5870539|NCT02339142|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5870540|NCT02339142|Protective Agents|protective agents|mesh-ancestor
5870541|NCT02339142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5870542|NCT02339142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5870543|NCT02339090|Hormones|hormones|mesh-list
5870544|NCT02339090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5870545|NCT02339090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870546|NCT02339116|Bevacizumab|bevacizumab|mesh-list
5870547|NCT02339116|Oxaliplatin|oxaliplatin|mesh-list
5870548|NCT02339116|Irinotecan|irinotecan|mesh-list
6495339|NCT00622648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495340|NCT00622674|Cetuximab|cetuximab|mesh-list
6495341|NCT00622674|Bortezomib|bortezomib|mesh-list
5682009|NCT03486548|Sensory System Agents|sensory system agents|mesh-ancestor
5682010|NCT03486548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5682011|NCT03486548|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5682012|NCT03486548|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5682013|NCT03486548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5682014|NCT03486548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5682015|NCT03486509|Afatinib|afatinib|mesh-list
5682016|NCT03486509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6495342|NCT00622674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6495343|NCT00622674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6495344|NCT00622687|Iloprost|iloprost|mesh-list
6495345|NCT00622687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5870549|NCT02339116|Fluorouracil|fluorouracil|mesh-list
5870550|NCT02339116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5870551|NCT02339116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5870552|NCT02339116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5870553|NCT02339116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6675154|NCT01572831|Protective Agents|protective agents|mesh-ancestor
6675155|NCT01572831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675156|NCT01572857|Immunoglobulins|immunoglobulins|mesh-list
6675157|NCT01572857|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6675158|NCT01572857|Antibodies|antibodies|mesh-list
6675159|NCT01572857|Immunologic Factors|immunologic factors|mesh-ancestor
6675160|NCT01572857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675161|NCT01572961|Aspirin|aspirin|mesh-list
6495346|NCT00622687|Vasodilator Agents|vasodilator agents|mesh-ancestor
6495347|NCT00622752|Nicotine|nicotine|mesh-list
6495348|NCT00622752|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6495349|NCT00622752|Autonomic Agents|autonomic agents|mesh-ancestor
6495350|NCT00622752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5870554|NCT02339116|Growth Substances|growth substances|mesh-ancestor
6495351|NCT00622752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870555|NCT02339116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682017|NCT03486509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5682018|NCT03486509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5682019|NCT03486509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5682020|NCT03486496|Gefitinib|gefitinib|mesh-list
5682021|NCT03486496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5682022|NCT03486496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5682023|NCT03486496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5682024|NCT03486496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5682025|NCT03486457|Tofacitinib|tofacitinib|mesh-list
5682026|NCT03486457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5682027|NCT03486457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5682028|NCT03486457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5682029|NCT03486353|Azacitidine|azacitidine|mesh-list
5682030|NCT03486353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5682031|NCT03486353|Antimetabolites|antimetabolites|mesh-ancestor
5682032|NCT03486353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5682033|NCT03486353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5682034|NCT03486353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5682035|NCT03486314|Rifampin|rifampin|mesh-list
5682036|NCT03486314|Paclitaxel|paclitaxel|mesh-list
5682037|NCT03486314|Docetaxel|docetaxel|mesh-list
5682038|NCT03486314|Carboplatin|carboplatin|mesh-list
5682039|NCT03486314|Pevonedistat|pevonedistat|mesh-list
5682040|NCT03486314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5682041|NCT03486314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5682042|NCT03486314|Tubulin Modulators|tubulin modulators|mesh-ancestor
5870556|NCT02339116|Growth Inhibitors|growth inhibitors|mesh-ancestor
5870557|NCT02339116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5870558|NCT02339116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5870559|NCT02339116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5870560|NCT02339116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5870561|NCT02339116|Antimetabolites|antimetabolites|mesh-ancestor
5870562|NCT02339116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5870563|NCT02339116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5870564|NCT02339116|Immunologic Factors|immunologic factors|mesh-ancestor
5870565|NCT02338934|Vitamin D|vitamin d|mesh-list
5870566|NCT02338934|Cinacalcet|cinacalcet|mesh-list
5870567|NCT02338934|Vitamins|vitamins|mesh-ancestor
5682043|NCT03486314|Antimitotic Agents|antimitotic agents|mesh-ancestor
5682044|NCT03486314|Mitosis Modulators|mitosis modulators|mesh-ancestor
5682045|NCT03486314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5682046|NCT03486314|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5682047|NCT03486314|Antitubercular Agents|antitubercular agents|mesh-ancestor
5682048|NCT03486314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5682049|NCT03486314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5682050|NCT03486314|Leprostatic Agents|leprostatic agents|mesh-ancestor
5682051|NCT03486314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5870568|NCT02338934|Micronutrients|micronutrients|mesh-ancestor
5870569|NCT02338934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870570|NCT02338934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5870571|NCT02338934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5870572|NCT02338934|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
5870573|NCT02338934|Hormone Antagonists|hormone antagonists|mesh-ancestor
5870574|NCT02338934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5870575|NCT02338856|Beta-lapachone|beta-lapachone|mesh-list
5682052|NCT03486314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5682053|NCT03486314|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5682054|NCT03486314|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5682055|NCT03486314|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5682056|NCT03486314|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5682057|NCT03486314|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5682058|NCT03486314|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5682059|NCT03486236|Ivacaftor|ivacaftor|mesh-list
5682060|NCT03486236|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
5682061|NCT03486236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5682062|NCT03486236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5682063|NCT03486184|Cystatins|cystatins|mesh-list
5682064|NCT03486184|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
5682065|NCT03486184|Protease Inhibitors|protease inhibitors|mesh-ancestor
5682066|NCT03486184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5682067|NCT03486184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5682068|NCT03486119|Nivolumab|nivolumab|mesh-list
5682069|NCT03486119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5870576|NCT02338856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5870577|NCT02338856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5870578|NCT02338856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5870579|NCT02338856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5870580|NCT02338856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5870581|NCT02338856|Antiviral Agents|antiviral agents|mesh-ancestor
5870582|NCT02338830|Progesterone|progesterone|mesh-list
5870583|NCT02338830|Progestins|progestins|mesh-ancestor
5870584|NCT02338830|Hormones|hormones|mesh-ancestor
5870585|NCT02338830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5870586|NCT02338830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870587|NCT02338687|Calcium|calcium|mesh-list
5870588|NCT02338687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5870589|NCT02338687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870590|NCT02338674|Tenofovir|tenofovir|mesh-list
5870591|NCT02338674|Telbivudine|telbivudine|mesh-list
6495352|NCT00622752|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6495353|NCT00622752|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6495354|NCT00622752|Cholinergic Agents|cholinergic agents|mesh-ancestor
6495355|NCT00622752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5870592|NCT02338674|Antiviral Agents|antiviral agents|mesh-ancestor
5870593|NCT02338674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5870594|NCT02338674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5870595|NCT02338674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5870596|NCT02338674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5870597|NCT02338674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5870598|NCT02338674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5870599|NCT02338674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5870600|NCT02338518|Oxaliplatin|oxaliplatin|mesh-list
5870601|NCT02338518|Etoposide|etoposide|mesh-list
5870602|NCT02338518|Epirubicin|epirubicin|mesh-list
5870603|NCT02338518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5870604|NCT02338518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5870605|NCT02338518|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5870606|NCT02338518|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5870607|NCT02338518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5870608|NCT02338518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5870609|NCT02338518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5682070|NCT03486119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5682071|NCT03486119|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5682072|NCT03486119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5682073|NCT03486106|Propofol|propofol|mesh-list
5682074|NCT03486106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5682075|NCT03486106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5682076|NCT03486106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682077|NCT03486106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5682078|NCT03486106|Anesthetics, General|anesthetics, general|mesh-ancestor
5682079|NCT03486106|Anesthetics|anesthetics|mesh-ancestor
5682080|NCT03486080|Lenograstim|lenograstim|mesh-list
5682081|NCT03486080|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5682082|NCT03486080|Immunologic Factors|immunologic factors|mesh-ancestor
5682083|NCT03486080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682084|NCT03485846|Ritonavir|ritonavir|mesh-list
5682085|NCT03485846|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5682086|NCT03485846|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5870610|NCT02338635|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
5870611|NCT02338635|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5870612|NCT02338635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5870613|NCT02338544|Adapalene|adapalene|mesh-list
5870614|NCT02338544|Benzoyl Peroxide|benzoyl peroxide|mesh-list
5870615|NCT02338544|Dermatologic Agents|dermatologic agents|mesh-ancestor
5870616|NCT02338544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5870617|NCT02338544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5870618|NCT02338544|Analgesics|analgesics|mesh-ancestor
5870619|NCT02338544|Sensory System Agents|sensory system agents|mesh-ancestor
5870620|NCT02338544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5870621|NCT02338544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870622|NCT02338544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5870623|NCT02338544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5870624|NCT02338570|Everolimus|everolimus|mesh-list
5870625|NCT02338570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5870626|NCT02338570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5870627|NCT02338570|Immunologic Factors|immunologic factors|mesh-ancestor
5870628|NCT02338570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675162|NCT01572961|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5870629|NCT02338622|Olaparib|olaparib|mesh-list
5870630|NCT02338622|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5870631|NCT02338622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5870632|NCT02338622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5870633|NCT02338622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5870634|NCT02338466|Tenecteplase|tenecteplase|mesh-list
5870635|NCT02338466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5870636|NCT02338466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5682087|NCT03485846|Protease Inhibitors|protease inhibitors|mesh-ancestor
5682088|NCT03485846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5682089|NCT03485846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5682090|NCT03485846|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5682091|NCT03485846|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5682092|NCT03485846|Antiviral Agents|antiviral agents|mesh-ancestor
5682093|NCT03485846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5682094|NCT03485846|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5682095|NCT03485846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5682096|NCT03485729|TIC10 compound|tic10 compound|mesh-list
5682097|NCT03485729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5682098|NCT03485703|Azithromycin|azithromycin|mesh-list
5682099|NCT03485703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5682100|NCT03485703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5682101|NCT03485677|Eliglustat|eliglustat|mesh-list
5682102|NCT03485677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5682103|NCT03485677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5682104|NCT03485625|Acetaminophen|acetaminophen|mesh-list
5682105|NCT03485625|Ketorolac|ketorolac|mesh-list
5682106|NCT03485625|Lidocaine|lidocaine|mesh-list
5682107|NCT03485625|Anesthetics, Local|anesthetics, local|mesh-ancestor
5682108|NCT03485625|Anesthetics|anesthetics|mesh-ancestor
5682109|NCT03485625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5682110|NCT03485625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682111|NCT03485625|Sensory System Agents|sensory system agents|mesh-ancestor
5682112|NCT03485625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5870637|NCT02338466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5870638|NCT02338323|Febuxostat|febuxostat|mesh-list
5870639|NCT02338323|Benzbromarone|benzbromarone|mesh-list
5870640|NCT02338323|Gout Suppressants|gout suppressants|mesh-ancestor
5870641|NCT02338323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5870642|NCT02338323|Uricosuric Agents|uricosuric agents|mesh-ancestor
5870643|NCT02338323|Renal Agents|renal agents|mesh-ancestor
5870644|NCT02338310|Letrozole|letrozole|mesh-list
5870645|NCT02338310|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5870646|NCT02338310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5870647|NCT02338310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5870648|NCT02338310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5870649|NCT02338310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5870650|NCT02338310|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5870651|NCT02338310|Hormone Antagonists|hormone antagonists|mesh-ancestor
5870652|NCT02338310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5870653|NCT02338310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870654|NCT02338024|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
5870655|NCT02338024|Antiviral Agents|antiviral agents|mesh-ancestor
5870656|NCT02338024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5870657|NCT02338089|Oxytocin|oxytocin|mesh-list
5870658|NCT02338089|Oxytocics|oxytocics|mesh-ancestor
5870659|NCT02338089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5870660|NCT02338089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870661|NCT02338232|Telmisartan|telmisartan|mesh-list
5870662|NCT02338232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5870663|NCT02338232|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5870664|NCT02338232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5870665|NCT02338232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5870666|NCT02338245|Capecitabine|capecitabine|mesh-list
5870667|NCT02338245|Lapatinib|lapatinib|mesh-list
5870668|NCT02338245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5870669|NCT02338245|Antimetabolites|antimetabolites|mesh-ancestor
5870670|NCT02338245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5870671|NCT02338245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5870672|NCT02338245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5870673|NCT02338245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5870674|NCT02338206|Hormones|hormones|mesh-list
6495356|NCT00622752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5682113|NCT03485625|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5682114|NCT03485625|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6495357|NCT00622817|Epinephrine|epinephrine|mesh-list
6495358|NCT00622817|Xylometazoline|xylometazoline|mesh-list
5870675|NCT02338206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5870676|NCT02338206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870677|NCT02338011|Gefitinib|gefitinib|mesh-list
5870678|NCT02338011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5870679|NCT02338011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5870680|NCT02338011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5870681|NCT02338011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5870682|NCT02337985|Prednisone|prednisone|mesh-list
5870683|NCT02337985|Cyclophosphamide|cyclophosphamide|mesh-list
5870684|NCT02337985|Rituximab|rituximab|mesh-list
5870685|NCT02337985|Doxorubicin|doxorubicin|mesh-list
5870686|NCT02337985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5870687|NCT02337985|Etoposide|etoposide|mesh-list
5870688|NCT02337985|Vincristine|vincristine|mesh-list
5870689|NCT02337985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5870690|NCT02337985|Immunologic Factors|immunologic factors|mesh-ancestor
5870691|NCT02337985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870692|NCT02337985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5870693|NCT02337985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5870694|NCT02337985|Alkylating Agents|alkylating agents|mesh-ancestor
5870695|NCT02337985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5870696|NCT02337985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5870697|NCT02337985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5870698|NCT02337985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5870699|NCT02337985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5870700|NCT02337985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5870701|NCT02337985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5870702|NCT02337985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5870703|NCT02337985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5870704|NCT02337985|Glucocorticoids|glucocorticoids|mesh-ancestor
5870705|NCT02337985|Hormones|hormones|mesh-ancestor
5870706|NCT02337985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5870707|NCT02337985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5870708|NCT02337985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5870709|NCT02337985|Tubulin Modulators|tubulin modulators|mesh-ancestor
5870710|NCT02337985|Antimitotic Agents|antimitotic agents|mesh-ancestor
5870711|NCT02337985|Mitosis Modulators|mitosis modulators|mesh-ancestor
5870712|NCT02338115|Paclitaxel|paclitaxel|mesh-list
5870713|NCT02338115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5870714|NCT02338115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5870715|NCT02338115|Tubulin Modulators|tubulin modulators|mesh-ancestor
5870716|NCT02338115|Antimitotic Agents|antimitotic agents|mesh-ancestor
6495359|NCT00622817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6495360|NCT00622817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6495361|NCT00622817|Adrenergic Agents|adrenergic agents|mesh-ancestor
6495362|NCT00622817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5682115|NCT03485625|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5870717|NCT02338115|Mitosis Modulators|mitosis modulators|mesh-ancestor
5870718|NCT02338115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5870719|NCT02338050|Immunotoxin HA22|immunotoxin ha22|mesh-list
5870720|NCT02338050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5682116|NCT03485625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5682117|NCT03485625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5682118|NCT03485625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5682119|NCT03485625|Analgesics|analgesics|mesh-ancestor
5682120|NCT03485625|Antipyretics|antipyretics|mesh-ancestor
5682121|NCT03485625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5696984|NCT03378713|Testosterone|testosterone|mesh-list
5870721|NCT02337855|Aluminum Hydroxide|aluminum hydroxide|mesh-list
5870722|NCT02337855|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5870723|NCT02337855|Immunologic Factors|immunologic factors|mesh-ancestor
5870724|NCT02337855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870725|NCT02337855|Antacids|antacids|mesh-ancestor
5870726|NCT02337855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5870727|NCT02337855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5870728|NCT02337881|Sildenafil Citrate|sildenafil citrate|mesh-list
5870729|NCT02337881|Vasodilator Agents|vasodilator agents|mesh-ancestor
5870730|NCT02337881|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5870731|NCT02337881|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5870732|NCT02337881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5870733|NCT02337881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496481|NCT00628225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5870734|NCT02337881|Urological Agents|urological agents|mesh-ancestor
5870735|NCT02337972|Povidone-Iodine|povidone-iodine|mesh-list
5870736|NCT02337972|Povidone|povidone|mesh-list
5870737|NCT02337972|Plasma Substitutes|plasma substitutes|mesh-ancestor
5870738|NCT02337972|Blood Substitutes|blood substitutes|mesh-ancestor
5870739|NCT02337972|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5870740|NCT02337972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5870741|NCT02337712|Etoposide|etoposide|mesh-list
5870742|NCT02337712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5870743|NCT02337712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5870744|NCT02337712|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5870745|NCT02337712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5870746|NCT02337712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5870747|NCT02337712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5682122|NCT03485625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5682123|NCT03485625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5682124|NCT03485625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5870748|NCT02337426|Temozolomide|temozolomide|mesh-list
5870749|NCT02337426|Dimethyl Fumarate|dimethyl fumarate|mesh-list
5870750|NCT02337426|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5870751|NCT02337426|Alkylating Agents|alkylating agents|mesh-ancestor
5870752|NCT02337426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5870753|NCT02337426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5870754|NCT02337426|Dermatologic Agents|dermatologic agents|mesh-ancestor
5682125|NCT03485625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5682126|NCT03485547|Venetoclax|venetoclax|mesh-list
5682127|NCT03485547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5682128|NCT03485534|Tenofovir|tenofovir|mesh-list
5682129|NCT03485534|Antiviral Agents|antiviral agents|mesh-ancestor
5682130|NCT03485534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5682131|NCT03485534|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5682132|NCT03485534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5682133|NCT03485534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5682134|NCT03485534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5682135|NCT03485534|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5682136|NCT03485534|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5696985|NCT03378713|Testosterone undecanoate|testosterone undecanoate|mesh-list
5696986|NCT03378713|Testosterone enanthate|testosterone enanthate|mesh-list
5696987|NCT03378713|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5696988|NCT03378713|Androgens|androgens|mesh-ancestor
5696989|NCT03378713|Hormones|hormones|mesh-ancestor
5696990|NCT03378713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5696991|NCT03378713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5696992|NCT03378713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5696993|NCT03378713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5696994|NCT03378713|Anabolic Agents|anabolic agents|mesh-ancestor
5696995|NCT03378674|Remifentanil|remifentanil|mesh-list
5696996|NCT03378674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5696997|NCT03378674|Narcotics|narcotics|mesh-ancestor
5696998|NCT03378674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5696999|NCT03378674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697000|NCT03378674|Analgesics|analgesics|mesh-ancestor
5870755|NCT02337426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5870756|NCT02337426|Immunologic Factors|immunologic factors|mesh-ancestor
5870757|NCT02337426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905487|NCT05116826|Nitazoxanide|nitazoxanide|mesh-list
5905488|NCT05116826|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5905489|NCT05116826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5905490|NCT05087862|Anesthetics|anesthetics|mesh-list
5905491|NCT05087862|Anesthetics, Local|anesthetics, local|mesh-list
5905492|NCT05087862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5905493|NCT05087862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905494|NCT05087862|Sensory System Agents|sensory system agents|mesh-ancestor
5905495|NCT05087862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5905496|NCT05060523|Tolvaptan|tolvaptan|mesh-list
5905497|NCT05060523|Midodrine|midodrine|mesh-list
5905498|NCT05060523|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
5905499|NCT05060523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905500|NCT05060523|Natriuretic Agents|natriuretic agents|mesh-ancestor
5905501|NCT05060523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905502|NCT05060523|Sympathomimetics|sympathomimetics|mesh-ancestor
5905503|NCT05060523|Autonomic Agents|autonomic agents|mesh-ancestor
5697001|NCT03378674|Sensory System Agents|sensory system agents|mesh-ancestor
5905504|NCT05060523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5905505|NCT05060523|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5870758|NCT02337634|Silymarin|silymarin|mesh-list
5870759|NCT02337634|Antioxidants|antioxidants|mesh-ancestor
5682137|NCT03485482|Bisoprolol|bisoprolol|mesh-list
5682138|NCT03485482|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5682139|NCT03485482|Sympatholytics|sympatholytics|mesh-ancestor
5682140|NCT03485482|Autonomic Agents|autonomic agents|mesh-ancestor
5870760|NCT02337634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5870761|NCT02337634|Protective Agents|protective agents|mesh-ancestor
5870762|NCT02337634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870763|NCT02337413|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
5870764|NCT02337413|Laxatives|laxatives|mesh-ancestor
5870765|NCT02337413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5870766|NCT02337283|BI 425809|bi 425809|mesh-list
5870767|NCT02337283|Nootropic Agents|nootropic agents|mesh-ancestor
5870768|NCT02337257|Vitamin D|vitamin d|mesh-list
5870769|NCT02337257|Cholecalciferol|cholecalciferol|mesh-list
5682141|NCT03485482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5682142|NCT03485482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682143|NCT03485482|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5682144|NCT03485482|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5682145|NCT03485482|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5682146|NCT03485482|Adrenergic Agents|adrenergic agents|mesh-ancestor
5682147|NCT03485482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5682148|NCT03485482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5682149|NCT03485456|Tobramycin|tobramycin|mesh-list
5870770|NCT02337257|Vitamins|vitamins|mesh-ancestor
5870771|NCT02337257|Micronutrients|micronutrients|mesh-ancestor
5870772|NCT02337257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870773|NCT02337257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5870774|NCT02337257|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5870775|NCT02337231|Borage oil|borage oil|mesh-list
5870776|NCT02337231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5870777|NCT02337322|Ritonavir|ritonavir|mesh-list
5870778|NCT02337322|Darunavir|darunavir|mesh-list
5870779|NCT02337322|Dolutegravir|dolutegravir|mesh-list
5870780|NCT02337322|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5870781|NCT02337322|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5870782|NCT02337322|Protease Inhibitors|protease inhibitors|mesh-ancestor
5870783|NCT02337322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5870784|NCT02337322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5870785|NCT02337322|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5870786|NCT02337322|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5870787|NCT02337322|Antiviral Agents|antiviral agents|mesh-ancestor
5870788|NCT02337322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5870789|NCT02337322|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5870790|NCT02337322|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5870791|NCT02337322|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5870792|NCT02337322|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5870793|NCT02337192|Chlorhexidine|chlorhexidine|mesh-list
5870794|NCT02337192|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5870795|NCT02337192|Curcumin|curcumin|mesh-list
5870796|NCT02337192|Pulmonary Surfactants|pulmonary surfactants|mesh-list
5870797|NCT02337192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5870798|NCT02337192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5870799|NCT02337192|Disinfectants|disinfectants|mesh-ancestor
5870800|NCT02337192|Dermatologic Agents|dermatologic agents|mesh-ancestor
5870801|NCT02337192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5870802|NCT02337192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5870803|NCT02337192|Analgesics|analgesics|mesh-ancestor
5870804|NCT02337192|Sensory System Agents|sensory system agents|mesh-ancestor
5870805|NCT02337192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5870806|NCT02337192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870807|NCT02337192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5870808|NCT02337192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5870809|NCT02337192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5682150|NCT03485456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5682151|NCT03485456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5682152|NCT03485417|Aripiprazole|aripiprazole|mesh-list
5682153|NCT03485417|Paliperidone Palmitate|paliperidone palmitate|mesh-list
5682154|NCT03485417|Antidepressive Agents|antidepressive agents|mesh-ancestor
5682155|NCT03485417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5682156|NCT03485417|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5870810|NCT02337192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5870811|NCT02337192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5870812|NCT02337192|Respiratory System Agents|respiratory system agents|mesh-ancestor
5682157|NCT03485417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5682158|NCT03485417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5682159|NCT03485417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682160|NCT03485417|Dopamine Agonists|dopamine agonists|mesh-ancestor
5870813|NCT02337127|Lamivudine|lamivudine|mesh-list
5870814|NCT02337127|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5870815|NCT02337127|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5870816|NCT02337127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5870817|NCT02337127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5870818|NCT02337127|Antiviral Agents|antiviral agents|mesh-ancestor
5870819|NCT02337127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5870820|NCT02337127|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5870821|NCT02337127|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5870822|NCT02337166|Hyaluronic Acid|hyaluronic acid|mesh-list
5870823|NCT02337166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5870824|NCT02337166|Immunologic Factors|immunologic factors|mesh-ancestor
5870825|NCT02337166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870826|NCT02337166|Viscosupplements|viscosupplements|mesh-ancestor
5870827|NCT02337166|Protective Agents|protective agents|mesh-ancestor
5870828|NCT02337205|Tirbanibulin|tirbanibulin|mesh-list
5870829|NCT02337205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5870830|NCT02337205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5870831|NCT02337023|Technetium Tc 99m bicisate|technetium tc 99m bicisate|mesh-list
5870832|NCT02337023|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5870833|NCT02337023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5870834|NCT02337010|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
5870835|NCT02337036|Tacrolimus|tacrolimus|mesh-list
5870836|NCT02337036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5870837|NCT02337036|Immunologic Factors|immunologic factors|mesh-ancestor
5870838|NCT02337036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870839|NCT02337036|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5870840|NCT02337036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5870841|NCT02337036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5870842|NCT02336984|Trastuzumab|trastuzumab|mesh-list
5870843|NCT02336984|Pertuzumab|pertuzumab|mesh-list
5870844|NCT02336984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5870845|NCT02336984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5870846|NCT02336906|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
5870847|NCT02336906|Laxatives|laxatives|mesh-ancestor
5870848|NCT02336906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5870849|NCT02336854|Tacrolimus|tacrolimus|mesh-list
5870850|NCT02336854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5870851|NCT02336854|Immunologic Factors|immunologic factors|mesh-ancestor
5870852|NCT02336854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870853|NCT02336854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5870854|NCT02336854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5870855|NCT02336854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5870856|NCT02336659|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5870857|NCT02336659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5870858|NCT02336659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870859|NCT02336659|Incretins|incretins|mesh-ancestor
5870860|NCT02336659|Hormones|hormones|mesh-ancestor
5870861|NCT02336659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5870862|NCT02336659|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6675163|NCT01572961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6675164|NCT01572961|Analgesics|analgesics|mesh-ancestor
6675165|NCT01572961|Sensory System Agents|sensory system agents|mesh-ancestor
6675166|NCT01572961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6675167|NCT01572961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675168|NCT01572961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5870863|NCT02336659|Protease Inhibitors|protease inhibitors|mesh-ancestor
5870864|NCT02336659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5870865|NCT02336659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5870866|NCT02336633|Resveratrol|resveratrol|mesh-list
5870867|NCT02336633|Antioxidants|antioxidants|mesh-ancestor
6675169|NCT01572961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5682161|NCT03485417|Dopamine Agents|dopamine agents|mesh-ancestor
5682162|NCT03485417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5682163|NCT03485417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5682164|NCT03485417|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5682165|NCT03485417|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5682166|NCT03485417|Serotonin Agents|serotonin agents|mesh-ancestor
5682167|NCT03485417|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5682168|NCT03485417|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5682169|NCT03485417|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5682170|NCT03485417|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5870868|NCT02336633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5870869|NCT02336633|Protective Agents|protective agents|mesh-ancestor
5870870|NCT02336633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870871|NCT02336633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5870872|NCT02336633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5870873|NCT02336750|Aprepitant|aprepitant|mesh-list
5870874|NCT02336750|Fosaprepitant|fosaprepitant|mesh-list
5870875|NCT02336750|Mirtazapine|mirtazapine|mesh-list
5870876|NCT02336750|Antiemetics|antiemetics|mesh-ancestor
5870877|NCT02336750|Autonomic Agents|autonomic agents|mesh-ancestor
5870878|NCT02336750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5870879|NCT02336750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870880|NCT02336750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5870881|NCT02336750|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5870882|NCT02336750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5870883|NCT02336750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5870884|NCT02336750|Antidepressive Agents|antidepressive agents|mesh-ancestor
5870885|NCT02336750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5870886|NCT02336750|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5870887|NCT02336750|Histamine Antagonists|histamine antagonists|mesh-ancestor
5870888|NCT02336750|Histamine Agents|histamine agents|mesh-ancestor
5870889|NCT02336750|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5870890|NCT02336750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5870891|NCT02336750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5870892|NCT02336750|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5870893|NCT02336750|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5870894|NCT02336750|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5870895|NCT02336750|Adrenergic Agents|adrenergic agents|mesh-ancestor
5870896|NCT02336750|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5870897|NCT02336750|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5870898|NCT02336750|Serotonin Agents|serotonin agents|mesh-ancestor
5682171|NCT03485404|Vitamins|vitamins|mesh-list
5682172|NCT03485404|Folic Acid|folic acid|mesh-list
5682173|NCT03485404|Vitamin B 12|vitamin b 12|mesh-list
5682174|NCT03485404|Vitamin B Complex|vitamin b complex|mesh-list
5682175|NCT03485404|Micronutrients|micronutrients|mesh-ancestor
5682176|NCT03485404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682177|NCT03485404|Hematinics|hematinics|mesh-ancestor
5682178|NCT03485300|Warfarin|warfarin|mesh-list
5682179|NCT03485300|Anticoagulants|anticoagulants|mesh-ancestor
5870899|NCT02336750|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5870900|NCT02336477|Mexiletine|mexiletine|mesh-list
5870901|NCT02336477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5870902|NCT02336477|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5870903|NCT02336477|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5870904|NCT02336477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5870905|NCT02336477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5870906|NCT02336568|Oxytocin|oxytocin|mesh-list
5870907|NCT02336568|Oxytocics|oxytocics|mesh-ancestor
5870908|NCT02336568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5870909|NCT02336568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870910|NCT02336529|Bupivacaine|bupivacaine|mesh-list
5870911|NCT02336529|Anesthetics, Local|anesthetics, local|mesh-ancestor
5870912|NCT02336529|Anesthetics|anesthetics|mesh-ancestor
5870913|NCT02336529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5870914|NCT02336529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870915|NCT02336529|Sensory System Agents|sensory system agents|mesh-ancestor
5682180|NCT03485274|Vortioxetine|vortioxetine|mesh-list
5682181|NCT03485274|Antidepressive Agents|antidepressive agents|mesh-ancestor
5682182|NCT03485274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5682183|NCT03485274|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5682184|NCT03485274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5682185|NCT03485274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5682186|NCT03485274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682187|NCT03485274|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5682188|NCT03485274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5682189|NCT03485274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5682190|NCT03485274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5682191|NCT03485274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5682192|NCT03485274|Serotonin Agents|serotonin agents|mesh-ancestor
5682193|NCT03485274|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5682194|NCT03485274|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5682195|NCT03485274|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5682196|NCT03485274|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5682197|NCT03485170|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5682198|NCT03485170|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5682199|NCT03485170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5682200|NCT03485118|Rituximab|rituximab|mesh-list
5682201|NCT03485118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5682202|NCT03485118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5682203|NCT03485118|Immunologic Factors|immunologic factors|mesh-ancestor
5870916|NCT02336529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5870917|NCT02336516|Azithromycin|azithromycin|mesh-list
5870918|NCT02336516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5870919|NCT02336516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5870920|NCT02336308|Ketamine|ketamine|mesh-list
5870921|NCT02336308|Analgesics|analgesics|mesh-ancestor
5682204|NCT03485118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682205|NCT03485118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5682206|NCT03485092|Empagliflozin|empagliflozin|mesh-list
5870922|NCT02336308|Sensory System Agents|sensory system agents|mesh-ancestor
5870923|NCT02336308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5870924|NCT02336308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870925|NCT02336308|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5870926|NCT02336308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5870927|NCT02336308|Anesthetics, General|anesthetics, general|mesh-ancestor
5870928|NCT02336308|Anesthetics|anesthetics|mesh-ancestor
5870929|NCT02336308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5870930|NCT02336308|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5870931|NCT02336308|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5870932|NCT02336308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5870933|NCT02336308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5870934|NCT02336386|Dexamethasone|dexamethasone|mesh-list
5870935|NCT02336386|Cyclophosphamide|cyclophosphamide|mesh-list
5870936|NCT02336386|Doxorubicin|doxorubicin|mesh-list
5870937|NCT02336386|Bortezomib|bortezomib|mesh-list
5870938|NCT02336386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5870939|NCT02336386|Immunologic Factors|immunologic factors|mesh-ancestor
5870940|NCT02336386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870941|NCT02336386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5870942|NCT02336386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5870943|NCT02336386|Alkylating Agents|alkylating agents|mesh-ancestor
5870944|NCT02336386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5870945|NCT02336386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5682207|NCT03485092|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5682208|NCT03485092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5682209|NCT03485092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5682210|NCT03485092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682211|NCT03484962|Antibodies|antibodies|mesh-list
5682212|NCT03484962|Antibodies, Bispecific|antibodies, bispecific|mesh-list
5682213|NCT03484962|Immunologic Factors|immunologic factors|mesh-ancestor
5682214|NCT03484962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682215|NCT03484845|Ferrous fumarate|ferrous fumarate|mesh-list
5870946|NCT02336386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5870947|NCT02336386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5682216|NCT03484845|Lactoferrin|lactoferrin|mesh-list
5682217|NCT03484845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5682218|NCT03484845|Trace Elements|trace elements|mesh-ancestor
5682219|NCT03484845|Micronutrients|micronutrients|mesh-ancestor
5682220|NCT03484845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682221|NCT03484832|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
5682222|NCT03484832|Ethyl Chloride|ethyl chloride|mesh-list
5682223|NCT03484832|Anesthetics, Local|anesthetics, local|mesh-ancestor
5682224|NCT03484832|Anesthetics|anesthetics|mesh-ancestor
5682225|NCT03484832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5682226|NCT03484832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682227|NCT03484832|Sensory System Agents|sensory system agents|mesh-ancestor
5682228|NCT03484832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5682229|NCT03484832|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
5682230|NCT03484754|Botulinum Toxins|botulinum toxins|mesh-list
5682231|NCT03484754|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5682232|NCT03484754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5870948|NCT02336386|Antiemetics|antiemetics|mesh-ancestor
5870949|NCT02336386|Autonomic Agents|autonomic agents|mesh-ancestor
5870950|NCT02336386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5870951|NCT02336386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5870952|NCT02336386|Glucocorticoids|glucocorticoids|mesh-ancestor
5870953|NCT02336386|Hormones|hormones|mesh-ancestor
5870954|NCT02336386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5870955|NCT02336386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5870956|NCT02336386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5870957|NCT02336386|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5870958|NCT02336386|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5870959|NCT02336386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5870960|NCT02336048|Obinutuzumab|obinutuzumab|mesh-list
5870961|NCT02336048|Chlorambucil|chlorambucil|mesh-list
5870962|NCT02336048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5870963|NCT02336048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5870964|NCT02336048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5870965|NCT02336048|Alkylating Agents|alkylating agents|mesh-ancestor
5870966|NCT02336048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675170|NCT01572961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6675171|NCT01572961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6675172|NCT01572961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675173|NCT01572961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6675174|NCT01572961|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6675175|NCT01572961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6675176|NCT01572961|Antipyretics|antipyretics|mesh-ancestor
6675177|NCT01573013|Iron|iron|mesh-list
5870967|NCT02336087|Metformin|metformin|mesh-list
5870968|NCT02336087|Gemcitabine|gemcitabine|mesh-list
5870969|NCT02336087|Paclitaxel|paclitaxel|mesh-list
5870970|NCT02336087|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5870971|NCT02336087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5870972|NCT02336087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5870973|NCT02336087|Tubulin Modulators|tubulin modulators|mesh-ancestor
5870974|NCT02336087|Antimitotic Agents|antimitotic agents|mesh-ancestor
5870975|NCT02336087|Mitosis Modulators|mitosis modulators|mesh-ancestor
5870976|NCT02336087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5870977|NCT02336087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5870978|NCT02336087|Antimetabolites|antimetabolites|mesh-ancestor
5870979|NCT02336087|Antiviral Agents|antiviral agents|mesh-ancestor
5870980|NCT02336087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5870981|NCT02336087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5870982|NCT02336087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5870983|NCT02336087|Immunologic Factors|immunologic factors|mesh-ancestor
5870984|NCT02336087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212375|NCT02187055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6212376|NCT02187159|Pregabalin|pregabalin|mesh-list
6212377|NCT02187159|Analgesics|analgesics|mesh-ancestor
6212378|NCT02187159|Sensory System Agents|sensory system agents|mesh-ancestor
6212379|NCT02187159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6212380|NCT02187159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212381|NCT02187159|Anticonvulsants|anticonvulsants|mesh-ancestor
6212382|NCT02187159|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6212383|NCT02187159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6212384|NCT02187159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212385|NCT02187159|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6212386|NCT02187159|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6212387|NCT02187159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6212388|NCT02187159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6212389|NCT02187159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6212390|NCT02187172|Ustekinumab|ustekinumab|mesh-list
6212391|NCT02187172|Dermatologic Agents|dermatologic agents|mesh-ancestor
6212392|NCT02187471|Pregabalin|pregabalin|mesh-list
6212393|NCT02187471|Analgesics|analgesics|mesh-ancestor
6212394|NCT02187471|Sensory System Agents|sensory system agents|mesh-ancestor
6212395|NCT02187471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6212396|NCT02187471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212397|NCT02187471|Anticonvulsants|anticonvulsants|mesh-ancestor
6212398|NCT02187471|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6212399|NCT02187471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6212400|NCT02187471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212401|NCT02187471|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6212402|NCT02187471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6212403|NCT02187471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6212404|NCT02187471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6212405|NCT02187471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6212406|NCT02187744|Carboplatin|carboplatin|mesh-list
6212407|NCT02187744|Docetaxel|docetaxel|mesh-list
6212408|NCT02187744|Trastuzumab|trastuzumab|mesh-list
6675178|NCT01573013|Trace Elements|trace elements|mesh-ancestor
6675179|NCT01573013|Micronutrients|micronutrients|mesh-ancestor
6495363|NCT00622817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495364|NCT00622817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495365|NCT00622817|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6495366|NCT00622817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6495367|NCT00622817|Autonomic Agents|autonomic agents|mesh-ancestor
6495368|NCT00622817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6495369|NCT00622817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6495370|NCT00622817|Respiratory System Agents|respiratory system agents|mesh-ancestor
6495371|NCT00622817|Mydriatics|mydriatics|mesh-ancestor
6495372|NCT00622817|Sympathomimetics|sympathomimetics|mesh-ancestor
6495373|NCT00622817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6495374|NCT00622817|Nasal Decongestants|nasal decongestants|mesh-ancestor
6495375|NCT00622830|Darapladib|darapladib|mesh-list
6495376|NCT00622830|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
6495377|NCT00622830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6495378|NCT00622830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495379|NCT00622843|Vaccines|vaccines|mesh-list
6495380|NCT00622843|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6495381|NCT00622843|Immunologic Factors|immunologic factors|mesh-ancestor
6495382|NCT00622843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495383|NCT00622934|Epoetin Alfa|epoetin alfa|mesh-list
6495384|NCT00622934|Hematinics|hematinics|mesh-ancestor
5870985|NCT02336087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5682233|NCT03484754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5682234|NCT03484754|Cholinergic Agents|cholinergic agents|mesh-ancestor
5682235|NCT03484754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5682236|NCT03484754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682237|NCT03484650|Lidocaine|lidocaine|mesh-list
5682238|NCT03484650|Anesthetics, Local|anesthetics, local|mesh-ancestor
5682239|NCT03484650|Anesthetics|anesthetics|mesh-ancestor
5682240|NCT03484650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5682241|NCT03484650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682242|NCT03484650|Sensory System Agents|sensory system agents|mesh-ancestor
5682243|NCT03484650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5682244|NCT03484650|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5682245|NCT03484650|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5682246|NCT03484650|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5682247|NCT03484650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5682248|NCT03484650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5682249|NCT03484611|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5682250|NCT03484611|Cetrorelix|cetrorelix|mesh-list
5870986|NCT02336152|Anesthetics|anesthetics|mesh-list
5870987|NCT02336152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5870988|NCT02336152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870989|NCT02336347|Quinidine|quinidine|mesh-list
5870990|NCT02336347|Dextromethorphan|dextromethorphan|mesh-list
5870991|NCT02336347|Antitussive Agents|antitussive agents|mesh-ancestor
5870992|NCT02336347|Respiratory System Agents|respiratory system agents|mesh-ancestor
5870993|NCT02336347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5870994|NCT02336347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5870995|NCT02336347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5870996|NCT02336347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5870997|NCT02336347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5870998|NCT02336347|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5870999|NCT02336347|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5871000|NCT02336347|Adrenergic Agents|adrenergic agents|mesh-ancestor
5871001|NCT02336347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5871002|NCT02336347|Antimalarials|antimalarials|mesh-ancestor
5871003|NCT02336347|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5871004|NCT02336347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5871005|NCT02336347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5871006|NCT02336347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5871007|NCT02336347|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5871008|NCT02336347|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5871009|NCT02336347|Cholinergic Agents|cholinergic agents|mesh-ancestor
5871010|NCT02336347|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5871011|NCT02336347|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5871012|NCT02336347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5871013|NCT02336347|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5871014|NCT02336347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5871015|NCT02336139|Sofosbuvir|sofosbuvir|mesh-list
5871016|NCT02336139|Velpatasvir|velpatasvir|mesh-list
6495385|NCT00623064|Gemcitabine|gemcitabine|mesh-list
5871017|NCT02336139|Antiviral Agents|antiviral agents|mesh-ancestor
5871018|NCT02336139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5905506|NCT05060523|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5905507|NCT05060523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5905508|NCT05060523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5905509|NCT05060523|Adrenergic Agents|adrenergic agents|mesh-ancestor
5905510|NCT05060523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5905517|NCT05024773|Paclitaxel|paclitaxel|mesh-list
5905518|NCT05024773|Hyaluronic Acid|hyaluronic acid|mesh-list
5905519|NCT05024773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5905520|NCT05024773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5905521|NCT05024773|Tubulin Modulators|tubulin modulators|mesh-ancestor
5905522|NCT05024773|Antimitotic Agents|antimitotic agents|mesh-ancestor
5905523|NCT05024773|Mitosis Modulators|mitosis modulators|mesh-ancestor
5905524|NCT05024773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905525|NCT05024773|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5905526|NCT05024773|Immunologic Factors|immunologic factors|mesh-ancestor
5905527|NCT05024773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905528|NCT05024773|Viscosupplements|viscosupplements|mesh-ancestor
5905529|NCT05024773|Protective Agents|protective agents|mesh-ancestor
5905530|NCT05020652|Hydroxyurea|hydroxyurea|mesh-list
5905531|NCT05020652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5905532|NCT05020652|Antisickling Agents|antisickling agents|mesh-ancestor
5905533|NCT05020652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5905534|NCT05020652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905535|NCT05020652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5905536|NCT05014334|Amoxicillin|amoxicillin|mesh-list
5682251|NCT03484611|Menotropins|menotropins|mesh-list
5682252|NCT03484611|Progesterone|progesterone|mesh-list
5682253|NCT03484611|Progestins|progestins|mesh-ancestor
5682254|NCT03484611|Hormones|hormones|mesh-ancestor
5682255|NCT03484611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5682256|NCT03484611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682257|NCT03484611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5682258|NCT03484611|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5682259|NCT03484611|Fertility Agents|fertility agents|mesh-ancestor
5682260|NCT03484611|Hormone Antagonists|hormone antagonists|mesh-ancestor
5682261|NCT03484507|Chlorhexidine|chlorhexidine|mesh-list
5682262|NCT03484507|Povidone-Iodine|povidone-iodine|mesh-list
5682263|NCT03484507|Prednisolone|prednisolone|mesh-list
5682264|NCT03484507|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5682265|NCT03484507|Methylprednisolone|methylprednisolone|mesh-list
5682266|NCT03484507|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5682267|NCT03484507|Prednisolone acetate|prednisolone acetate|mesh-list
5682268|NCT03484507|Povidone|povidone|mesh-list
5682269|NCT03484507|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5682270|NCT03484507|Prednisolone phosphate|prednisolone phosphate|mesh-list
5682271|NCT03484507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5682272|NCT03484507|Glucocorticoids|glucocorticoids|mesh-ancestor
5682273|NCT03484507|Hormones|hormones|mesh-ancestor
5682274|NCT03484507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5682275|NCT03484507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682276|NCT03484507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5682277|NCT03484507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5682278|NCT03484507|Antiemetics|antiemetics|mesh-ancestor
5682279|NCT03484507|Autonomic Agents|autonomic agents|mesh-ancestor
5682280|NCT03484507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5682281|NCT03484507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5682282|NCT03484507|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5682283|NCT03484507|Protective Agents|protective agents|mesh-ancestor
5682284|NCT03484507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5682285|NCT03484507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5682286|NCT03484507|Disinfectants|disinfectants|mesh-ancestor
5682287|NCT03484507|Plasma Substitutes|plasma substitutes|mesh-ancestor
5682288|NCT03484507|Blood Substitutes|blood substitutes|mesh-ancestor
5682289|NCT03484416|Vitamin D|vitamin d|mesh-list
5682290|NCT03484416|Calcium Carbonate|calcium carbonate|mesh-list
5682291|NCT03484416|Calcium|calcium|mesh-list
5682292|NCT03484416|Vitamins|vitamins|mesh-ancestor
5682293|NCT03484416|Micronutrients|micronutrients|mesh-ancestor
5905537|NCT05014334|Clarithromycin|clarithromycin|mesh-list
6495386|NCT00623064|Lapatinib|lapatinib|mesh-list
5682294|NCT03484416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871019|NCT02335736|Cetrorelix|cetrorelix|mesh-list
5871020|NCT02335736|Hormones|hormones|mesh-list
5871021|NCT02335736|Hormone Antagonists|hormone antagonists|mesh-list
5871022|NCT02335736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5871023|NCT02335736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871024|NCT02335736|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5871025|NCT02335736|Fertility Agents|fertility agents|mesh-ancestor
5871026|NCT02335736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5871027|NCT02335580|Somatostatin|somatostatin|mesh-list
5871028|NCT02335580|Hormones|hormones|mesh-ancestor
5871029|NCT02335580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5871030|NCT02335580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871031|NCT02335593|Zinc Sulfate|zinc sulfate|mesh-list
5871032|NCT02335593|Epoetin Alfa|epoetin alfa|mesh-list
5871033|NCT02335593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5871034|NCT02335593|Hematinics|hematinics|mesh-ancestor
5871035|NCT02335593|Astringents|astringents|mesh-ancestor
5871036|NCT02335593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871037|NCT02335593|Dermatologic Agents|dermatologic agents|mesh-ancestor
5871038|NCT02335684|Methamphetamine|methamphetamine|mesh-list
5871039|NCT02335684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5871040|NCT02335684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871041|NCT02335684|Sympathomimetics|sympathomimetics|mesh-ancestor
5871042|NCT02335684|Autonomic Agents|autonomic agents|mesh-ancestor
5871043|NCT02335684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5871044|NCT02335684|Dopamine Agents|dopamine agents|mesh-ancestor
5871045|NCT02335684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5682295|NCT03484416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5682296|NCT03484416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5682297|NCT03484416|Antacids|antacids|mesh-ancestor
5682298|NCT03484416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5871046|NCT02335684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5871047|NCT02335684|Adrenergic Agents|adrenergic agents|mesh-ancestor
6495387|NCT00623064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6495388|NCT00623064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5682299|NCT03484416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5682300|NCT03484299|Gemcitabine|gemcitabine|mesh-list
5682301|NCT03484299|Folfirinox|folfirinox|mesh-list
5682302|NCT03484299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5682303|NCT03484299|Antimetabolites|antimetabolites|mesh-ancestor
5682304|NCT03484299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5682305|NCT03484299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5682306|NCT03484299|Antiviral Agents|antiviral agents|mesh-ancestor
5682307|NCT03484299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5682308|NCT03484299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5682309|NCT03484299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5682310|NCT03484299|Immunologic Factors|immunologic factors|mesh-ancestor
5682311|NCT03484299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682312|NCT03484260|Testosterone|testosterone|mesh-list
5682313|NCT03484260|Androgens|androgens|mesh-ancestor
5871048|NCT02335684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6495389|NCT00623064|Antimetabolites|antimetabolites|mesh-ancestor
6495390|NCT00623064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495391|NCT00623064|Antiviral Agents|antiviral agents|mesh-ancestor
6495392|NCT00623064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6495393|NCT00623064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6495394|NCT00623064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6495395|NCT00623064|Immunologic Factors|immunologic factors|mesh-ancestor
6495396|NCT00623064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495397|NCT00623064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6495398|NCT00623077|Etoposide|etoposide|mesh-list
6495399|NCT00623077|Melphalan|melphalan|mesh-list
6495400|NCT00623077|Busulfan|busulfan|mesh-list
6495401|NCT00623077|Ifosfamide|ifosfamide|mesh-list
6495402|NCT00623077|Thiotepa|thiotepa|mesh-list
6495403|NCT00623077|Sargramostim|sargramostim|mesh-list
6495404|NCT00623077|Mesna|mesna|mesh-list
6495405|NCT00623077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6495406|NCT00623077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5871049|NCT02335684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5871050|NCT02335684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5871051|NCT02335684|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5871052|NCT02335411|Pembrolizumab|pembrolizumab|mesh-list
6495407|NCT00623077|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6495408|NCT00623077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6675180|NCT01573013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682314|NCT03484260|Hormones|hormones|mesh-ancestor
5871053|NCT02335411|Capecitabine|capecitabine|mesh-list
5871054|NCT02335411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5871055|NCT02335411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5871056|NCT02335411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5871057|NCT02335411|Antimetabolites|antimetabolites|mesh-ancestor
5871058|NCT02335411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5871059|NCT02335372|Acetic Acid|acetic acid|mesh-list
5871060|NCT02335372|Proflavine|proflavine|mesh-list
5871061|NCT02335372|Retinol acetate|retinol acetate|mesh-list
5871062|NCT02335372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5871063|NCT02335372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5871064|NCT02335372|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5871065|NCT02335372|Immunologic Factors|immunologic factors|mesh-ancestor
5871066|NCT02335372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871067|NCT02335372|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5871068|NCT02335372|Protective Agents|protective agents|mesh-ancestor
5871069|NCT02335372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5871070|NCT02335372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5871071|NCT02335255|Naftifine|naftifine|mesh-list
5871072|NCT02335255|Antifungal Agents|antifungal agents|mesh-ancestor
5871073|NCT02335255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5682315|NCT03484260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5682316|NCT03484260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682317|NCT03484221|Fluorouracil|fluorouracil|mesh-list
5682318|NCT03484221|Capecitabine|capecitabine|mesh-list
5682319|NCT03484221|Oxaliplatin|oxaliplatin|mesh-list
5682320|NCT03484221|Irinotecan|irinotecan|mesh-list
5682321|NCT03484221|Antimetabolites|antimetabolites|mesh-ancestor
5682322|NCT03484221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5682323|NCT03484221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5682324|NCT03484221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5871074|NCT02335151|Desflurane|desflurane|mesh-list
5871075|NCT02335151|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5871076|NCT02335151|Anesthetics, General|anesthetics, general|mesh-ancestor
5871077|NCT02335151|Anesthetics|anesthetics|mesh-ancestor
5871078|NCT02335151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5871079|NCT02335151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871080|NCT02335281|Mesalamine|mesalamine|mesh-list
5871081|NCT02335281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5871082|NCT02335281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5871083|NCT02335281|Analgesics|analgesics|mesh-ancestor
5871084|NCT02335281|Sensory System Agents|sensory system agents|mesh-ancestor
5871085|NCT02335281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5871086|NCT02335281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871087|NCT02335281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5871088|NCT02335281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5871089|NCT02335359|Tranexamic Acid|tranexamic acid|mesh-list
5871090|NCT02335359|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5871091|NCT02335359|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5871092|NCT02335359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5871093|NCT02335359|Hemostatics|hemostatics|mesh-ancestor
5871094|NCT02335359|Coagulants|coagulants|mesh-ancestor
5871095|NCT02335398|Methadone|methadone|mesh-list
5871096|NCT02335398|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5871097|NCT02335398|Narcotics|narcotics|mesh-ancestor
5871098|NCT02335398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5871099|NCT02335398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871100|NCT02335398|Analgesics|analgesics|mesh-ancestor
5871101|NCT02335398|Sensory System Agents|sensory system agents|mesh-ancestor
5871102|NCT02335398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5871103|NCT02335398|Antitussive Agents|antitussive agents|mesh-ancestor
5871104|NCT02335398|Respiratory System Agents|respiratory system agents|mesh-ancestor
5871105|NCT02335190|Lidocaine|lidocaine|mesh-list
5871106|NCT02335190|Anesthetics, Local|anesthetics, local|mesh-ancestor
5871107|NCT02335190|Anesthetics|anesthetics|mesh-ancestor
5871108|NCT02335190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5871109|NCT02335190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871110|NCT02335190|Sensory System Agents|sensory system agents|mesh-ancestor
5871111|NCT02335190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5871112|NCT02335190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5871113|NCT02335190|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5871114|NCT02335190|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5682325|NCT03484221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5682326|NCT03484221|Immunologic Factors|immunologic factors|mesh-ancestor
5871115|NCT02335190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6675181|NCT01573143|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5682327|NCT03484221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682328|NCT03484221|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5682329|NCT03484221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5682330|NCT03484221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5682331|NCT03484195|Fluorouracil|fluorouracil|mesh-list
5871116|NCT02335190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5871117|NCT02335164|Hemagglutinins|hemagglutinins|mesh-list
5871118|NCT02335164|Agglutinins|agglutinins|mesh-ancestor
5871119|NCT02335164|Immunologic Factors|immunologic factors|mesh-ancestor
5871120|NCT02335164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871121|NCT02335203|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
5871122|NCT02335203|Medroxyprogesterone|medroxyprogesterone|mesh-list
5871123|NCT02335203|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5871124|NCT02335203|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5871125|NCT02335203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5871126|NCT02335203|Contraceptive Agents|contraceptive agents|mesh-ancestor
5871127|NCT02335203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5871128|NCT02335203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871129|NCT02335203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5871130|NCT02335203|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5871131|NCT02335203|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5871132|NCT02335203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5871133|NCT02335203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5871134|NCT02335099|Ticagrelor|ticagrelor|mesh-list
5871135|NCT02335099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5871136|NCT02335099|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5871137|NCT02335099|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5871138|NCT02335099|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5871139|NCT02335099|Purinergic Agents|purinergic agents|mesh-ancestor
6495409|NCT00623077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6495410|NCT00623077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495411|NCT00623077|Immunologic Factors|immunologic factors|mesh-ancestor
6495412|NCT00623077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495413|NCT00623077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5871140|NCT02335099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5871141|NCT02335099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5871142|NCT02335099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871143|NCT02334904|Risperidone|risperidone|mesh-list
5871144|NCT02334904|Aripiprazole|aripiprazole|mesh-list
5871145|NCT02334904|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5871146|NCT02334904|Serotonin Agents|serotonin agents|mesh-ancestor
5871147|NCT02334904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5871148|NCT02334904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5871149|NCT02334904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871150|NCT02334904|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5871151|NCT02334904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6495414|NCT00623077|Alkylating Agents|alkylating agents|mesh-ancestor
6495415|NCT00623077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6495416|NCT00623077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6495417|NCT00623077|Protective Agents|protective agents|mesh-ancestor
6495418|NCT00623116|Testosterone|testosterone|mesh-list
6495419|NCT00623116|Estrogens|estrogens|mesh-list
6495420|NCT00623116|Androgens|androgens|mesh-ancestor
6495421|NCT00623116|Hormones|hormones|mesh-ancestor
6495422|NCT00623116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5871152|NCT02334904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6495423|NCT00623116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682332|NCT03484195|Oxaliplatin|oxaliplatin|mesh-list
5682333|NCT03484195|Irinotecan|irinotecan|mesh-list
5682334|NCT03484195|Antimetabolites|antimetabolites|mesh-ancestor
5682335|NCT03484195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5682336|NCT03484195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5682337|NCT03484195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5682338|NCT03484195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5682339|NCT03484195|Immunologic Factors|immunologic factors|mesh-ancestor
5682340|NCT03484195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682341|NCT03484195|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5682342|NCT03484195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5682343|NCT03484195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5682344|NCT03484091|Hylan|hylan|mesh-list
5682345|NCT03484091|Viscosupplements|viscosupplements|mesh-ancestor
5682346|NCT03484091|Protective Agents|protective agents|mesh-ancestor
5682347|NCT03484091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682348|NCT03483948|Azacitidine|azacitidine|mesh-list
5871153|NCT02334904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5871154|NCT02334904|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5871155|NCT02334904|Dopamine Agents|dopamine agents|mesh-ancestor
5871156|NCT02334904|Antidepressive Agents|antidepressive agents|mesh-ancestor
5871157|NCT02334904|Dopamine Agonists|dopamine agonists|mesh-ancestor
5871158|NCT02334904|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5871159|NCT02334904|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5871160|NCT02334904|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5871161|NCT02334904|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5871162|NCT02334865|Lenalidomide|lenalidomide|mesh-list
5871163|NCT02334865|Sargramostim|sargramostim|mesh-list
5871164|NCT02334865|Freund's Adjuvant|freund's adjuvant|mesh-list
5871165|NCT02334865|Immunologic Factors|immunologic factors|mesh-ancestor
5871166|NCT02334865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871167|NCT02334865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5871168|NCT02334865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5871169|NCT02334865|Growth Substances|growth substances|mesh-ancestor
5871170|NCT02334865|Growth Inhibitors|growth inhibitors|mesh-ancestor
5871171|NCT02334865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5871172|NCT02334865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5871173|NCT02334735|Vaccines|vaccines|mesh-list
5682349|NCT03483948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5682350|NCT03483948|Antimetabolites|antimetabolites|mesh-ancestor
5682351|NCT03483948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5682352|NCT03483948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5682353|NCT03483948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5697002|NCT03378674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5697003|NCT03378661|Benzonidazole|benzonidazole|mesh-list
5697004|NCT03378661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5697005|NCT03378661|Immunologic Factors|immunologic factors|mesh-ancestor
5697006|NCT03378661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697007|NCT03378661|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5697008|NCT03378661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5697009|NCT03378661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5697010|NCT03378661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5697011|NCT03378648|Bromides|bromides|mesh-list
5697012|NCT03378648|Anticonvulsants|anticonvulsants|mesh-ancestor
5697013|NCT03378479|Posaconazole|posaconazole|mesh-list
5871174|NCT02334735|Poly ICLC|poly iclc|mesh-list
5871175|NCT02334735|Immunologic Factors|immunologic factors|mesh-ancestor
5871176|NCT02334735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871177|NCT02334735|Interferon Inducers|interferon inducers|mesh-ancestor
5871178|NCT02334501|Lansoprazole|lansoprazole|mesh-list
5871179|NCT02334501|Dexlansoprazole|dexlansoprazole|mesh-list
5871180|NCT02334501|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5871181|NCT02334501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5871182|NCT02334501|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5697014|NCT03378479|Antifungal Agents|antifungal agents|mesh-ancestor
5697015|NCT03378479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5697016|NCT03378479|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5697017|NCT03378479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5697018|NCT03378479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5697019|NCT03378479|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5697020|NCT03378479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5697021|NCT03378479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5871183|NCT02334501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5871184|NCT02334501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5871185|NCT02334475|Methylprednisolone|methylprednisolone|mesh-list
5871186|NCT02334475|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5871187|NCT02334475|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5871188|NCT02334475|Prednisolone|prednisolone|mesh-list
5871189|NCT02334475|Prednisolone acetate|prednisolone acetate|mesh-list
5871190|NCT02334475|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5871191|NCT02334475|Prednisolone phosphate|prednisolone phosphate|mesh-list
5871192|NCT02334475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5697022|NCT03378479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697023|NCT03378479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5697024|NCT03378479|Hormone Antagonists|hormone antagonists|mesh-ancestor
5697025|NCT03378479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5697026|NCT03378479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697027|NCT03378466|Heparin|heparin|mesh-list
5697028|NCT03378466|Calcium heparin|calcium heparin|mesh-list
5697029|NCT03378466|Anticoagulants|anticoagulants|mesh-ancestor
5871193|NCT02334475|Antiemetics|antiemetics|mesh-ancestor
5697030|NCT03378466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5871194|NCT02334475|Autonomic Agents|autonomic agents|mesh-ancestor
5871195|NCT02334475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5871196|NCT02334475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871197|NCT02334475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5682354|NCT03483883|Gemcitabine|gemcitabine|mesh-list
5682355|NCT03483883|Avelumab|avelumab|mesh-list
5682356|NCT03483883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5682357|NCT03483883|Antimetabolites|antimetabolites|mesh-ancestor
5682358|NCT03483883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5682359|NCT03483883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5682360|NCT03483883|Antiviral Agents|antiviral agents|mesh-ancestor
5682361|NCT03483883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5682362|NCT03483883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5682363|NCT03483883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5682364|NCT03483883|Immunologic Factors|immunologic factors|mesh-ancestor
5682365|NCT03483883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682366|NCT03483883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5682367|NCT03483870|Morphine|morphine|mesh-list
5871198|NCT02334475|Glucocorticoids|glucocorticoids|mesh-ancestor
5871199|NCT02334475|Hormones|hormones|mesh-ancestor
5871200|NCT02334475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5871201|NCT02334475|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5871202|NCT02334475|Protective Agents|protective agents|mesh-ancestor
5871203|NCT02334475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5871204|NCT02334475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5871205|NCT02334605|Capsaicin|capsaicin|mesh-list
5871206|NCT02334605|Antipruritics|antipruritics|mesh-ancestor
5871207|NCT02334605|Dermatologic Agents|dermatologic agents|mesh-ancestor
5871208|NCT02334605|Sensory System Agents|sensory system agents|mesh-ancestor
5871209|NCT02334605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5871210|NCT02334605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871211|NCT02334488|Mycophenolic Acid|mycophenolic acid|mesh-list
5871212|NCT02334488|Everolimus|everolimus|mesh-list
5871213|NCT02334488|Tacrolimus|tacrolimus|mesh-list
5871214|NCT02334488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5871215|NCT02334488|Immunologic Factors|immunologic factors|mesh-ancestor
5871216|NCT02334488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871217|NCT02334488|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5871218|NCT02334488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5871219|NCT02334488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5871220|NCT02334488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5682368|NCT03483870|Granisetron|granisetron|mesh-list
5682369|NCT03483870|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5682370|NCT03483870|Narcotics|narcotics|mesh-ancestor
5682371|NCT03483870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5682372|NCT03483870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682373|NCT03483870|Analgesics|analgesics|mesh-ancestor
5682374|NCT03483870|Sensory System Agents|sensory system agents|mesh-ancestor
5682375|NCT03483870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5682376|NCT03483870|Antiemetics|antiemetics|mesh-ancestor
5682377|NCT03483870|Autonomic Agents|autonomic agents|mesh-ancestor
5871221|NCT02334488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5871222|NCT02334488|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5871223|NCT02334488|Antitubercular Agents|antitubercular agents|mesh-ancestor
6495424|NCT00623155|Pyrimethamine|pyrimethamine|mesh-list
6495425|NCT00623155|Sulfadoxine|sulfadoxine|mesh-list
6495426|NCT00623155|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6495427|NCT00623155|Antimalarials|antimalarials|mesh-ancestor
6495428|NCT00623155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6495429|NCT00623155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6495430|NCT00623155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6495431|NCT00623155|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6495432|NCT00623155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6495433|NCT00623155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495434|NCT00623155|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6495435|NCT00623155|Renal Agents|renal agents|mesh-ancestor
6495436|NCT00623168|Ribavirin|ribavirin|mesh-list
6495437|NCT00623168|Antimetabolites|antimetabolites|mesh-ancestor
5871224|NCT02334488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5871225|NCT02334488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5871226|NCT02334670|Fluconazole|fluconazole|mesh-list
6495438|NCT00623168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495439|NCT00623168|Antiviral Agents|antiviral agents|mesh-ancestor
6495440|NCT00623168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5682378|NCT03483870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6495441|NCT00623207|Atropine|atropine|mesh-list
6495442|NCT00623207|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6495443|NCT00623207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5871227|NCT02334670|Antifungal Agents|antifungal agents|mesh-ancestor
5871228|NCT02334670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5871229|NCT02334670|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5871230|NCT02334670|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5871231|NCT02334670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5871232|NCT02334670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5871233|NCT02334670|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5871234|NCT02334670|Hormone Antagonists|hormone antagonists|mesh-ancestor
5871235|NCT02334670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5871236|NCT02334670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871237|NCT02334670|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5871238|NCT02334670|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5871239|NCT02334631|Simethicone|simethicone|mesh-list
5871240|NCT02334631|Antifoaming Agents|antifoaming agents|mesh-ancestor
5871241|NCT02334631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5871242|NCT02334631|Emollients|emollients|mesh-ancestor
5871243|NCT02334631|Dermatologic Agents|dermatologic agents|mesh-ancestor
5871244|NCT02334462|Aluminum Hydroxide|aluminum hydroxide|mesh-list
5871245|NCT02334462|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5871246|NCT02334462|Immunologic Factors|immunologic factors|mesh-ancestor
5871247|NCT02334462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871248|NCT02334462|Antacids|antacids|mesh-ancestor
5871249|NCT02334462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5871250|NCT02334462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5871251|NCT02334254|Warfarin|warfarin|mesh-list
5871252|NCT02334254|Rivaroxaban|rivaroxaban|mesh-list
5871253|NCT02334254|Clopidogrel|clopidogrel|mesh-list
5871254|NCT02334254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5871255|NCT02334254|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5871256|NCT02334254|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5682379|NCT03483870|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5682380|NCT03483870|Serotonin Agents|serotonin agents|mesh-ancestor
5682381|NCT03483870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5682382|NCT03483870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5682383|NCT03483818|Antiviral Agents|antiviral agents|mesh-list
5682384|NCT03483818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5682385|NCT03483753|Vasopressins|vasopressins|mesh-list
5682386|NCT03483753|Arginine Vasopressin|arginine vasopressin|mesh-list
5682387|NCT03483753|Norepinephrine|norepinephrine|mesh-list
5682388|NCT03483753|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5682389|NCT03483753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5682390|NCT03483753|Adrenergic Agents|adrenergic agents|mesh-ancestor
5871257|NCT02334254|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5871258|NCT02334254|Purinergic Agents|purinergic agents|mesh-ancestor
5871259|NCT02334254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5871260|NCT02334254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5871261|NCT02334254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871262|NCT02334254|Anticoagulants|anticoagulants|mesh-ancestor
5871263|NCT02334254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5871264|NCT02334254|Antithrombins|antithrombins|mesh-ancestor
5871265|NCT02334254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5871266|NCT02334254|Protease Inhibitors|protease inhibitors|mesh-ancestor
5871267|NCT02334254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5871268|NCT02334163|Metronidazole|metronidazole|mesh-list
5871269|NCT02334163|Nitazoxanide|nitazoxanide|mesh-list
5871270|NCT02334163|Lactulose|lactulose|mesh-list
5871271|NCT02334163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5871272|NCT02334163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5871273|NCT02334163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5871274|NCT02334163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5871275|NCT02334163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5871276|NCT02334176|Lidocaine|lidocaine|mesh-list
5871277|NCT02334176|Epinephrine|epinephrine|mesh-list
5871278|NCT02334176|Anesthetics, Local|anesthetics, local|mesh-ancestor
5871279|NCT02334176|Anesthetics|anesthetics|mesh-ancestor
5871280|NCT02334176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5871281|NCT02334176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871282|NCT02334176|Sensory System Agents|sensory system agents|mesh-ancestor
5871283|NCT02334176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5871284|NCT02334176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5871285|NCT02334176|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5871286|NCT02334176|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5871287|NCT02334176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5682391|NCT03483753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5697031|NCT03378466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5871288|NCT02334176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5871289|NCT02334176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5871290|NCT02334176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5871291|NCT02334176|Adrenergic Agents|adrenergic agents|mesh-ancestor
5871292|NCT02334176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5871293|NCT02334176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5871294|NCT02334176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5871295|NCT02334176|Autonomic Agents|autonomic agents|mesh-ancestor
5871296|NCT02334176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5871297|NCT02334176|Respiratory System Agents|respiratory system agents|mesh-ancestor
5871298|NCT02334176|Mydriatics|mydriatics|mesh-ancestor
5871299|NCT02334176|Sympathomimetics|sympathomimetics|mesh-ancestor
5871300|NCT02334176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5871301|NCT02334150|Sufentanil|sufentanil|mesh-list
5871302|NCT02334150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5871303|NCT02334150|Narcotics|narcotics|mesh-ancestor
5871304|NCT02334150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5871305|NCT02334150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871306|NCT02334150|Analgesics|analgesics|mesh-ancestor
5871307|NCT02334150|Sensory System Agents|sensory system agents|mesh-ancestor
5871308|NCT02334150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5871309|NCT02334150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5871310|NCT02334150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5682392|NCT03483753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5682393|NCT03483753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871311|NCT02334150|Anesthetics, General|anesthetics, general|mesh-ancestor
5871312|NCT02334150|Anesthetics|anesthetics|mesh-ancestor
5871313|NCT02334046|Remifentanil|remifentanil|mesh-list
5871314|NCT02334046|Sevoflurane|sevoflurane|mesh-list
5871315|NCT02334046|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5871316|NCT02334046|Narcotics|narcotics|mesh-ancestor
5871317|NCT02334046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5871318|NCT02334046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871319|NCT02334046|Analgesics|analgesics|mesh-ancestor
5871320|NCT02334046|Sensory System Agents|sensory system agents|mesh-ancestor
5871321|NCT02334046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5682394|NCT03483753|Sympathomimetics|sympathomimetics|mesh-ancestor
5682395|NCT03483753|Autonomic Agents|autonomic agents|mesh-ancestor
5682396|NCT03483753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5871322|NCT02334046|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5871323|NCT02334046|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5871324|NCT02334046|Anesthetics, General|anesthetics, general|mesh-ancestor
5871325|NCT02334046|Anesthetics|anesthetics|mesh-ancestor
5905538|NCT05014334|Rabeprazole|rabeprazole|mesh-list
5905539|NCT05014334|Bismuth|bismuth|mesh-list
5905540|NCT05014334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5905541|NCT05014334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5905542|NCT05014334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5682397|NCT03483753|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5682398|NCT03483753|Hemostatics|hemostatics|mesh-ancestor
5682399|NCT03483753|Coagulants|coagulants|mesh-ancestor
5682400|NCT03483753|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5682401|NCT03483753|Natriuretic Agents|natriuretic agents|mesh-ancestor
5682402|NCT03483649|Bevacizumab|bevacizumab|mesh-list
5682403|NCT03483649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5905543|NCT05014334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5905544|NCT05014334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905545|NCT05014334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5905546|NCT05014334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5905547|NCT05014334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5905548|NCT05014334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5905549|NCT05014334|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5905550|NCT05014334|Antacids|antacids|mesh-ancestor
5905551|NCT05014087|Digoxin|digoxin|mesh-list
5905552|NCT05014087|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5905553|NCT05014087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5905554|NCT05014087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5905555|NCT05014087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905556|NCT05014087|Protective Agents|protective agents|mesh-ancestor
5905557|NCT05014087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905558|NCT05007522|Ketotifen|ketotifen|mesh-list
5905559|NCT05007522|Indomethacin|indomethacin|mesh-list
5682404|NCT03483649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5905560|NCT05007522|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5905561|NCT05007522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5905562|NCT05007522|Analgesics|analgesics|mesh-ancestor
5905563|NCT05007522|Sensory System Agents|sensory system agents|mesh-ancestor
5871326|NCT02334124|Ceftriaxone|ceftriaxone|mesh-list
5871327|NCT02334124|Floxacillin|floxacillin|mesh-list
5682405|NCT03483649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5682406|NCT03483649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5682407|NCT03483649|Growth Substances|growth substances|mesh-ancestor
5682408|NCT03483649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682409|NCT03483649|Growth Inhibitors|growth inhibitors|mesh-ancestor
5682410|NCT03483636|Lemborexant|lemborexant|mesh-list
5682411|NCT03483636|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
5682412|NCT03483636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5682413|NCT03483636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5682414|NCT03483636|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5682415|NCT03483636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5682416|NCT03483636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5871328|NCT02334124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5871329|NCT02334124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5871330|NCT02333890|Chloroquine|chloroquine|mesh-list
5682417|NCT03483636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682418|NCT03483545|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5682419|NCT03483545|Hormones|hormones|mesh-ancestor
5682420|NCT03483545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5682421|NCT03483545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871331|NCT02333890|Amebicides|amebicides|mesh-ancestor
5871332|NCT02333890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5871333|NCT02333890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5871334|NCT02333890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5871335|NCT02333890|Antimalarials|antimalarials|mesh-ancestor
5871336|NCT02333890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5871337|NCT02333929|Rivaroxaban|rivaroxaban|mesh-list
5871338|NCT02333929|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5871339|NCT02333929|Antithrombins|antithrombins|mesh-ancestor
5871340|NCT02333929|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5871341|NCT02333929|Protease Inhibitors|protease inhibitors|mesh-ancestor
5871342|NCT02333929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5871343|NCT02333929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5871344|NCT02333929|Anticoagulants|anticoagulants|mesh-ancestor
5871345|NCT02333851|Insulin, pork; isophane insulin, pork drug combination 30:70|insulin, pork; isophane insulin, pork drug combination 30:70|mesh-list
5871346|NCT02333851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5871347|NCT02333851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871348|NCT02333838|Vidarabine|vidarabine|mesh-list
5871349|NCT02333838|Fludarabine|fludarabine|mesh-list
5871350|NCT02333838|Fludarabine phosphate|fludarabine phosphate|mesh-list
5871351|NCT02333838|Busulfan|busulfan|mesh-list
5871352|NCT02333838|Thiotepa|thiotepa|mesh-list
5871353|NCT02333838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5871354|NCT02333838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5871355|NCT02333838|Antimetabolites|antimetabolites|mesh-ancestor
5871356|NCT02333838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675182|NCT01573143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6675183|NCT01573143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6675184|NCT01573143|Antimetabolites|antimetabolites|mesh-ancestor
6675185|NCT01573143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5682422|NCT03483415|Morphine|morphine|mesh-list
5682423|NCT03483415|Bupivacaine|bupivacaine|mesh-list
5682424|NCT03483415|Anesthetics, Local|anesthetics, local|mesh-ancestor
5682425|NCT03483415|Anesthetics|anesthetics|mesh-ancestor
5682426|NCT03483415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5682427|NCT03483415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682428|NCT03483415|Sensory System Agents|sensory system agents|mesh-ancestor
5682429|NCT03483415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5682430|NCT03483415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5682431|NCT03483415|Narcotics|narcotics|mesh-ancestor
5682432|NCT03483415|Analgesics|analgesics|mesh-ancestor
5682433|NCT03483389|Ethanol|ethanol|mesh-list
5682434|NCT03483389|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5682435|NCT03483389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5682436|NCT03483389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5682437|NCT03483389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682438|NCT03483376|Anti-Infective Agents|anti-infective agents|mesh-list
5682439|NCT03483376|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5682440|NCT03483363|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5682441|NCT03483363|Bacitracin|bacitracin|mesh-list
5871357|NCT02333838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5871358|NCT02333838|Immunologic Factors|immunologic factors|mesh-ancestor
5871359|NCT02333838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871360|NCT02333838|Antiviral Agents|antiviral agents|mesh-ancestor
5682442|NCT03483363|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5682443|NCT03483363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5682444|NCT03483363|Antitubercular Agents|antitubercular agents|mesh-ancestor
5871361|NCT02333838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5871362|NCT02333838|Alkylating Agents|alkylating agents|mesh-ancestor
5871363|NCT02333838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5871364|NCT02333838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5871365|NCT02334007|Dalteparin|dalteparin|mesh-list
5871366|NCT02334007|Tinzaparin|tinzaparin|mesh-list
5871367|NCT02334007|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5871368|NCT02334007|Anticoagulants|anticoagulants|mesh-ancestor
5871369|NCT02334007|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5871370|NCT02334007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5871371|NCT02334007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5871372|NCT02333799|Linezolid|linezolid|mesh-list
5871373|NCT02333799|Bedaquiline|bedaquiline|mesh-list
5871374|NCT02333799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5871375|NCT02333799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5871376|NCT02333799|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5871377|NCT02333799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5871378|NCT02333799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5871379|NCT02333799|Antitubercular Agents|antitubercular agents|mesh-ancestor
5871380|NCT02333682|Vitamin D|vitamin d|mesh-list
5871381|NCT02333682|Cholecalciferol|cholecalciferol|mesh-list
5871382|NCT02333682|Calcifediol|calcifediol|mesh-list
5871383|NCT02333682|Vitamins|vitamins|mesh-ancestor
5871384|NCT02333682|Micronutrients|micronutrients|mesh-ancestor
5871385|NCT02333682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871386|NCT02333682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5871387|NCT02333682|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5871388|NCT02333565|Everolimus|everolimus|mesh-list
5871389|NCT02333565|Octreotide|octreotide|mesh-list
5871390|NCT02333565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5871391|NCT02333565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5871392|NCT02333565|Immunologic Factors|immunologic factors|mesh-ancestor
5871393|NCT02333565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871394|NCT02333565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5871395|NCT02333565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5871396|NCT02333344|Zoledronic Acid|zoledronic acid|mesh-list
5871397|NCT02333344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5871398|NCT02333344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871399|NCT02333513|Vincristine|vincristine|mesh-list
5871400|NCT02333513|Lomustine|lomustine|mesh-list
5871401|NCT02333513|Procarbazine|procarbazine|mesh-list
5871402|NCT02333513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5871403|NCT02333513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5871404|NCT02333513|Tubulin Modulators|tubulin modulators|mesh-ancestor
5871405|NCT02333513|Antimitotic Agents|antimitotic agents|mesh-ancestor
5871406|NCT02333513|Mitosis Modulators|mitosis modulators|mesh-ancestor
5871407|NCT02333513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5871408|NCT02333513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5871409|NCT02333513|Alkylating Agents|alkylating agents|mesh-ancestor
5871410|NCT02333253|Cetrorelix|cetrorelix|mesh-list
5871411|NCT02333253|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5871412|NCT02333253|Fertility Agents|fertility agents|mesh-ancestor
5682445|NCT03483363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5682446|NCT03483350|Midazolam|midazolam|mesh-list
5682447|NCT03483350|Granisetron|granisetron|mesh-list
5682448|NCT03483350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5682449|NCT03483350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5682450|NCT03483350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5682451|NCT03483350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682452|NCT03483350|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5682453|NCT03483350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5682454|NCT03483350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5682455|NCT03483350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5682456|NCT03483350|Anesthetics, General|anesthetics, general|mesh-ancestor
5682457|NCT03483350|Anesthetics|anesthetics|mesh-ancestor
5682458|NCT03483350|GABA Modulators|gaba modulators|mesh-ancestor
5871413|NCT02333253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5871414|NCT02333253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495444|NCT00623207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6495445|NCT00623207|Autonomic Agents|autonomic agents|mesh-ancestor
6495446|NCT00623207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6495447|NCT00623207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682459|NCT03483350|GABA Agents|gaba agents|mesh-ancestor
5871415|NCT02333253|Hormone Antagonists|hormone antagonists|mesh-ancestor
5871416|NCT02333253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5871417|NCT02333292|Ritonavir|ritonavir|mesh-list
5871418|NCT02333292|Sofosbuvir|sofosbuvir|mesh-list
5871419|NCT02333292|Grazoprevir|grazoprevir|mesh-list
5871420|NCT02333292|Ledipasvir|ledipasvir|mesh-list
5871421|NCT02333292|Velpatasvir|velpatasvir|mesh-list
5871422|NCT02333292|Simeprevir|simeprevir|mesh-list
5871423|NCT02333292|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5871424|NCT02333292|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5871425|NCT02333292|Protease Inhibitors|protease inhibitors|mesh-ancestor
5871426|NCT02333292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5871427|NCT02333292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5871428|NCT02333292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5871429|NCT02333292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5871430|NCT02333292|Antiviral Agents|antiviral agents|mesh-ancestor
5871431|NCT02333292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5871432|NCT02333292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5871433|NCT02333292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5871434|NCT02333305|Coenzyme Q10|coenzyme q10|mesh-list
5871435|NCT02333305|Vitamins|vitamins|mesh-ancestor
5871436|NCT02333305|Micronutrients|micronutrients|mesh-ancestor
5871437|NCT02333305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871438|NCT02333188|Leucovorin|leucovorin|mesh-list
5871439|NCT02333188|Paclitaxel|paclitaxel|mesh-list
5871440|NCT02333188|Fluorouracil|fluorouracil|mesh-list
5871441|NCT02333188|Irinotecan|irinotecan|mesh-list
5871442|NCT02333188|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5871443|NCT02333188|Calcium|calcium|mesh-list
5871444|NCT02333188|Levoleucovorin|levoleucovorin|mesh-list
5871445|NCT02333188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5682460|NCT03483350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5682461|NCT03483350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5682462|NCT03483350|Antiemetics|antiemetics|mesh-ancestor
5682463|NCT03483350|Autonomic Agents|autonomic agents|mesh-ancestor
5871446|NCT02333188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5871447|NCT02333188|Tubulin Modulators|tubulin modulators|mesh-ancestor
5871448|NCT02333188|Antimitotic Agents|antimitotic agents|mesh-ancestor
5871449|NCT02333188|Mitosis Modulators|mitosis modulators|mesh-ancestor
5871450|NCT02333188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5871451|NCT02333188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5871452|NCT02333188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871453|NCT02333188|Antimetabolites|antimetabolites|mesh-ancestor
5871454|NCT02333188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5871455|NCT02333188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5871456|NCT02333188|Immunologic Factors|immunologic factors|mesh-ancestor
5871457|NCT02333188|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5871458|NCT02333188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5871459|NCT02333188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5871460|NCT02333188|Antidotes|antidotes|mesh-ancestor
5871461|NCT02333188|Protective Agents|protective agents|mesh-ancestor
5871462|NCT02333188|Vitamin B Complex|vitamin b complex|mesh-ancestor
5871463|NCT02333188|Vitamins|vitamins|mesh-ancestor
5871464|NCT02333188|Micronutrients|micronutrients|mesh-ancestor
5871465|NCT02333240|Antihypertensive Agents|antihypertensive agents|mesh-list
5871466|NCT02332941|Rituximab|rituximab|mesh-list
5871467|NCT02332941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5871468|NCT02332941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5871469|NCT02332941|Immunologic Factors|immunologic factors|mesh-ancestor
5871470|NCT02332941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871471|NCT02332941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5871472|NCT02332967|Palmitic Acid|palmitic acid|mesh-list
5871473|NCT02332967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5871474|NCT02332967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5871475|NCT02333123|Aspirin|aspirin|mesh-list
5871476|NCT02333123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5871477|NCT02333123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5871478|NCT02333123|Analgesics|analgesics|mesh-ancestor
6675186|NCT01573143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6675187|NCT01573143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6675188|NCT01573143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5682464|NCT03483350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5682465|NCT03483350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5682466|NCT03483350|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5682467|NCT03483350|Serotonin Agents|serotonin agents|mesh-ancestor
5682468|NCT03483207|Heparin|heparin|mesh-list
5682469|NCT03483207|Warfarin|warfarin|mesh-list
5682470|NCT03483207|Anticoagulants|anticoagulants|mesh-ancestor
5682471|NCT03483207|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5871479|NCT02333123|Sensory System Agents|sensory system agents|mesh-ancestor
5871480|NCT02333123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5871481|NCT02333123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871482|NCT02333123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5871483|NCT02333123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5871484|NCT02333123|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5871485|NCT02333123|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5871486|NCT02333123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5871487|NCT02333123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5871488|NCT02333123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5871489|NCT02333123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5871490|NCT02333123|Antipyretics|antipyretics|mesh-ancestor
5871491|NCT02333058|Treosulfan|treosulfan|mesh-list
5871492|NCT02333058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5682472|NCT03483207|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5682473|NCT03483207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5682474|NCT03483181|Enoxaparin|enoxaparin|mesh-list
5871493|NCT02333058|Alkylating Agents|alkylating agents|mesh-ancestor
5871494|NCT02333058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5871495|NCT02333058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5871496|NCT02332954|Vortioxetine|vortioxetine|mesh-list
5871497|NCT02332954|Antidepressive Agents|antidepressive agents|mesh-ancestor
5871498|NCT02332954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5871499|NCT02332954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5871500|NCT02332954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5871501|NCT02332954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5871502|NCT02332954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871503|NCT02332954|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5871504|NCT02332954|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5871505|NCT02332954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5871506|NCT02332954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5871507|NCT02332954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5871508|NCT02332954|Serotonin Agents|serotonin agents|mesh-ancestor
5871509|NCT02332954|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5871510|NCT02332954|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5871511|NCT02332954|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5871512|NCT02332954|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5871513|NCT02332980|Pembrolizumab|pembrolizumab|mesh-list
5871514|NCT02332980|Idelalisib|idelalisib|mesh-list
5871515|NCT02332980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5871516|NCT02332980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5871517|NCT02332980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5871518|NCT02332980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5871519|NCT02332811|Sevelamer|sevelamer|mesh-list
5871520|NCT02332811|Chelating Agents|chelating agents|mesh-ancestor
5871521|NCT02332811|Sequestering Agents|sequestering agents|mesh-ancestor
5871522|NCT02332811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5871523|NCT02332473|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
5871524|NCT02332473|Molgramostim|molgramostim|mesh-list
5682475|NCT03483181|Rivaroxaban|rivaroxaban|mesh-list
5682476|NCT03483181|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5682477|NCT03483181|Antithrombins|antithrombins|mesh-ancestor
5682478|NCT03483181|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5682479|NCT03483181|Protease Inhibitors|protease inhibitors|mesh-ancestor
5871525|NCT02332473|Sargramostim|sargramostim|mesh-list
5871526|NCT02332473|Immunologic Factors|immunologic factors|mesh-ancestor
5871527|NCT02332473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871528|NCT02332473|Antiviral Agents|antiviral agents|mesh-ancestor
5871529|NCT02332473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5871530|NCT02332473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5871531|NCT02332512|Apatinib|apatinib|mesh-list
6212409|NCT02187744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5682480|NCT03483181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5682481|NCT03483181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5682482|NCT03483181|Anticoagulants|anticoagulants|mesh-ancestor
5682483|NCT03483181|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5682484|NCT03483181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5682485|NCT03483142|Misoprostol|misoprostol|mesh-list
5682486|NCT03483142|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5682487|NCT03483142|Abortifacient Agents|abortifacient agents|mesh-ancestor
5682488|NCT03483142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5682489|NCT03483142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682490|NCT03483142|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5682491|NCT03483142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5871532|NCT02332512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5871533|NCT02332512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5871534|NCT02332512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5871535|NCT02332512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5871536|NCT02332603|Methylprednisolone|methylprednisolone|mesh-list
5871537|NCT02332603|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5871538|NCT02332603|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5871539|NCT02332603|Prednisolone|prednisolone|mesh-list
5871540|NCT02332603|Prednisolone acetate|prednisolone acetate|mesh-list
5871541|NCT02332603|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5871542|NCT02332603|Prednisolone phosphate|prednisolone phosphate|mesh-list
5871543|NCT02332603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5871544|NCT02332603|Antiemetics|antiemetics|mesh-ancestor
5871545|NCT02332603|Autonomic Agents|autonomic agents|mesh-ancestor
5871546|NCT02332603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5871547|NCT02332603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871548|NCT02332603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5871549|NCT02332603|Glucocorticoids|glucocorticoids|mesh-ancestor
5871550|NCT02332603|Hormones|hormones|mesh-ancestor
5871551|NCT02332603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5871552|NCT02332603|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5871553|NCT02332603|Protective Agents|protective agents|mesh-ancestor
5871554|NCT02332603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5871555|NCT02332603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5871556|NCT02332655|Cannabidiol|cannabidiol|mesh-list
5871557|NCT02332655|Anticonvulsants|anticonvulsants|mesh-ancestor
5871558|NCT02332447|Naloxone|naloxone|mesh-list
5871559|NCT02332447|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5871560|NCT02332447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871561|NCT02332447|Sensory System Agents|sensory system agents|mesh-ancestor
5871562|NCT02332447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5905564|NCT05007522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5905565|NCT05007522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905566|NCT05007522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5905567|NCT05007522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5905568|NCT05007522|Gout Suppressants|gout suppressants|mesh-ancestor
5905569|NCT05007522|Tocolytic Agents|tocolytic agents|mesh-ancestor
5905570|NCT05007522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5905571|NCT05007522|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5905572|NCT05007522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5905573|NCT05007522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905574|NCT05007522|Antipruritics|antipruritics|mesh-ancestor
5905575|NCT05007522|Dermatologic Agents|dermatologic agents|mesh-ancestor
5905576|NCT05007522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5905577|NCT05007522|Histamine Antagonists|histamine antagonists|mesh-ancestor
5905578|NCT05007522|Histamine Agents|histamine agents|mesh-ancestor
5905579|NCT05007522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5905580|NCT05007522|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5905581|NCT05002192|Eucalyptol|eucalyptol|mesh-list
5905582|NCT05002192|Ambroxol|ambroxol|mesh-list
5905583|NCT05002192|Expectorants|expectorants|mesh-list
5905584|NCT05002192|Respiratory System Agents|respiratory system agents|mesh-ancestor
5905585|NCT05002192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5905586|NCT05002192|Antitussive Agents|antitussive agents|mesh-ancestor
5905587|NCT05002192|Insect Repellents|insect repellents|mesh-ancestor
5905588|NCT05002192|Protective Agents|protective agents|mesh-ancestor
5905589|NCT05002192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905590|NCT04986605|Methoxsalen|methoxsalen|mesh-list
5905591|NCT04986605|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5905592|NCT04986605|Dermatologic Agents|dermatologic agents|mesh-ancestor
5905593|NCT04975347|Naloxone|naloxone|mesh-list
5905594|NCT04975347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905595|NCT04975347|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5905596|NCT04975347|Sensory System Agents|sensory system agents|mesh-ancestor
5905597|NCT04975347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5905598|NCT04975334|Naloxone|naloxone|mesh-list
5905599|NCT04975334|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
5905600|NCT04975334|Hormones|hormones|mesh-ancestor
5905601|NCT04975334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5905602|NCT04975334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905603|NCT04975334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6495448|NCT00623207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5905604|NCT04975334|Sensory System Agents|sensory system agents|mesh-ancestor
5905605|NCT04975334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5905606|NCT04973020|Efavirenz|efavirenz|mesh-list
5905607|NCT04973020|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5871563|NCT02332629|Methylprednisolone|methylprednisolone|mesh-list
5871564|NCT02332629|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5871565|NCT02332629|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5871566|NCT02332629|Prednisolone|prednisolone|mesh-list
5871567|NCT02332629|Prednisolone acetate|prednisolone acetate|mesh-list
5871568|NCT02332629|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5871569|NCT02332629|Prednisolone phosphate|prednisolone phosphate|mesh-list
5871570|NCT02332629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5871571|NCT02332629|Antiemetics|antiemetics|mesh-ancestor
5871572|NCT02332629|Autonomic Agents|autonomic agents|mesh-ancestor
5871573|NCT02332629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5871574|NCT02332629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871575|NCT02332629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5871576|NCT02332629|Glucocorticoids|glucocorticoids|mesh-ancestor
5871577|NCT02332629|Hormones|hormones|mesh-ancestor
5871578|NCT02332629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5871579|NCT02332629|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5871580|NCT02332629|Protective Agents|protective agents|mesh-ancestor
5871581|NCT02332629|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5871582|NCT02332629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5871583|NCT02332616|Methylprednisolone|methylprednisolone|mesh-list
5871584|NCT02332616|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5871585|NCT02332616|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5871586|NCT02332616|Prednisolone|prednisolone|mesh-list
5871587|NCT02332616|Prednisolone acetate|prednisolone acetate|mesh-list
5871588|NCT02332616|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5871589|NCT02332616|Prednisolone phosphate|prednisolone phosphate|mesh-list
6495449|NCT00623207|Respiratory System Agents|respiratory system agents|mesh-ancestor
5682492|NCT03483142|Oxytocics|oxytocics|mesh-ancestor
5682493|NCT03482960|Xenon|xenon|mesh-list
5682494|NCT03482960|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5682495|NCT03482960|Anesthetics, General|anesthetics, general|mesh-ancestor
5682496|NCT03482960|Anesthetics|anesthetics|mesh-ancestor
5682497|NCT03482960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5682498|NCT03482960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682499|NCT03482752|Molgramostim|molgramostim|mesh-list
5682500|NCT03482752|Sargramostim|sargramostim|mesh-list
5682501|NCT03482752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5682502|NCT03482752|Immunologic Factors|immunologic factors|mesh-ancestor
5682503|NCT03482752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682504|NCT03482544|Pregabalin|pregabalin|mesh-list
5682505|NCT03482544|Analgesics|analgesics|mesh-ancestor
5682506|NCT03482544|Sensory System Agents|sensory system agents|mesh-ancestor
5682507|NCT03482544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5682508|NCT03482544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682509|NCT03482544|Anticonvulsants|anticonvulsants|mesh-ancestor
5682510|NCT03482544|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5682511|NCT03482544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5682512|NCT03482544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5682513|NCT03482544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5682514|NCT03482544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5682515|NCT03482544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5682516|NCT03482544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5682517|NCT03482544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5682518|NCT03482492|Acetaminophen|acetaminophen|mesh-list
5682519|NCT03482492|Tramadol|tramadol|mesh-list
6495450|NCT00623207|Mydriatics|mydriatics|mesh-ancestor
6495451|NCT00623207|Parasympatholytics|parasympatholytics|mesh-ancestor
6495452|NCT00623207|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6495453|NCT00623207|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5871590|NCT02332616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5871591|NCT02332616|Antiemetics|antiemetics|mesh-ancestor
5871592|NCT02332616|Autonomic Agents|autonomic agents|mesh-ancestor
5871593|NCT02332616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5871594|NCT02332616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871595|NCT02332616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5871596|NCT02332616|Glucocorticoids|glucocorticoids|mesh-ancestor
5871597|NCT02332616|Hormones|hormones|mesh-ancestor
5871598|NCT02332616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5871599|NCT02332616|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5871600|NCT02332616|Protective Agents|protective agents|mesh-ancestor
5871601|NCT02332616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5871602|NCT02332616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5682520|NCT03482492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5682521|NCT03482492|Analgesics|analgesics|mesh-ancestor
5871603|NCT02332174|Rufinamide|rufinamide|mesh-list
5871604|NCT02332174|Anticonvulsants|anticonvulsants|mesh-ancestor
5871605|NCT02332174|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5871606|NCT02332174|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5871607|NCT02332174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5871608|NCT02332174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5871609|NCT02332135|Vitamin D|vitamin d|mesh-list
5871610|NCT02332135|Vitamins|vitamins|mesh-ancestor
5871611|NCT02332135|Micronutrients|micronutrients|mesh-ancestor
5871612|NCT02332135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871613|NCT02332135|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5871614|NCT02332356|Adalimumab|adalimumab|mesh-list
5871615|NCT02332356|Azathioprine|azathioprine|mesh-list
6495454|NCT00623207|Cholinergic Agents|cholinergic agents|mesh-ancestor
6495455|NCT00623207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6495456|NCT00623207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495457|NCT00623220|Nitrous Oxide|nitrous oxide|mesh-list
6495458|NCT00623220|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6495459|NCT00623220|Anesthetics, General|anesthetics, general|mesh-ancestor
6495460|NCT00623220|Anesthetics|anesthetics|mesh-ancestor
6495461|NCT00623220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6495462|NCT00623220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495463|NCT00623220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5682522|NCT03482492|Sensory System Agents|sensory system agents|mesh-ancestor
5682523|NCT03482492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5682524|NCT03482492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682525|NCT03482492|Antipyretics|antipyretics|mesh-ancestor
5682526|NCT03482492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5682527|NCT03482492|Narcotics|narcotics|mesh-ancestor
5682528|NCT03482492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5682529|NCT03482440|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
5682530|NCT03482440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5682531|NCT03482440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5682532|NCT03482440|Analgesics|analgesics|mesh-ancestor
5682533|NCT03482440|Sensory System Agents|sensory system agents|mesh-ancestor
5682534|NCT03482440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5682535|NCT03482440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682536|NCT03482440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5682537|NCT03482440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5682538|NCT03482362|Vinorelbine|vinorelbine|mesh-list
5682539|NCT03482362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5682540|NCT03482362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6495464|NCT00623220|Analgesics|analgesics|mesh-ancestor
6495465|NCT00623220|Sensory System Agents|sensory system agents|mesh-ancestor
6495466|NCT00623220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6495467|NCT00623285|Pregabalin|pregabalin|mesh-list
6495468|NCT00623285|Analgesics|analgesics|mesh-ancestor
6495469|NCT00623285|Sensory System Agents|sensory system agents|mesh-ancestor
6495470|NCT00623285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6495471|NCT00623285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675189|NCT01573286|Glucagon|glucagon|mesh-list
6675190|NCT01573286|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6675191|NCT01573286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6675192|NCT01573286|Hormones|hormones|mesh-ancestor
6675193|NCT01573286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6675194|NCT01573286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675195|NCT01573286|Incretins|incretins|mesh-ancestor
5682541|NCT03482362|Tubulin Modulators|tubulin modulators|mesh-ancestor
5871616|NCT02332356|Infliximab|infliximab|mesh-list
5682542|NCT03482362|Antimitotic Agents|antimitotic agents|mesh-ancestor
5682543|NCT03482362|Mitosis Modulators|mitosis modulators|mesh-ancestor
5682544|NCT03482362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5682545|NCT03482336|Immunoconjugates|immunoconjugates|mesh-list
5682546|NCT03482336|Immunologic Factors|immunologic factors|mesh-ancestor
5871617|NCT02332356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5871618|NCT02332356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5871619|NCT02332356|Dermatologic Agents|dermatologic agents|mesh-ancestor
5871620|NCT02332356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5871621|NCT02332356|Antimetabolites|antimetabolites|mesh-ancestor
5871622|NCT02332356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5871623|NCT02332356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6495472|NCT00623285|Anticonvulsants|anticonvulsants|mesh-ancestor
5682547|NCT03482336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697032|NCT03378466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697033|NCT03378427|Doxycycline|doxycycline|mesh-list
5697034|NCT03378427|Ciprofloxacin|ciprofloxacin|mesh-list
5697035|NCT03378427|Levofloxacin|levofloxacin|mesh-list
6675196|NCT01573338|Carboplatin|carboplatin|mesh-list
5682548|NCT03482232|Acetaminophen|acetaminophen|mesh-list
5682549|NCT03482232|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5682550|NCT03482232|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5682551|NCT03482232|Anti-Infective Agents|anti-infective agents|mesh-list
5871624|NCT02332356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5871625|NCT02332356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5871626|NCT02332356|Immunologic Factors|immunologic factors|mesh-ancestor
5871627|NCT02332356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871628|NCT02332057|Diclofenac|diclofenac|mesh-list
5871629|NCT02332057|Lidocaine|lidocaine|mesh-list
5871630|NCT02332057|Anesthetics, Local|anesthetics, local|mesh-ancestor
5871631|NCT02332057|Anesthetics|anesthetics|mesh-ancestor
5871632|NCT02332057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5871633|NCT02332057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871634|NCT02332057|Sensory System Agents|sensory system agents|mesh-ancestor
5871635|NCT02332057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5871636|NCT02332057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5871637|NCT02332057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5871638|NCT02332057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5871639|NCT02332057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5871640|NCT02332057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5871641|NCT02332057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5871642|NCT02332057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5871643|NCT02332057|Analgesics|analgesics|mesh-ancestor
5871644|NCT02332057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5871645|NCT02332057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5871646|NCT02332057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5871647|NCT02332057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5871648|NCT02332044|Bepotastine besilate|bepotastine besilate|mesh-list
5871649|NCT02332044|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5871650|NCT02332031|Sorafenib|sorafenib|mesh-list
6495473|NCT00623285|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6495474|NCT00623285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6495475|NCT00623285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495476|NCT00623285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6495477|NCT00623285|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6495478|NCT00623285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6675197|NCT01573338|Etoposide|etoposide|mesh-list
5871651|NCT02332031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5871652|NCT02332031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5871653|NCT02332031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5871654|NCT02332031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5871655|NCT02331771|Donepezil|donepezil|mesh-list
5871656|NCT02331771|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5871657|NCT02331771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5871658|NCT02331771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5871659|NCT02331771|Cholinergic Agents|cholinergic agents|mesh-ancestor
5871660|NCT02331771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5871661|NCT02331771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871662|NCT02331771|Nootropic Agents|nootropic agents|mesh-ancestor
5871663|NCT02331745|Sargramostim|sargramostim|mesh-list
5871664|NCT02331745|Lenograstim|lenograstim|mesh-list
5871665|NCT02331745|Immunologic Factors|immunologic factors|mesh-ancestor
5871666|NCT02331745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871667|NCT02331745|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5871668|NCT02331823|Moxifloxacin|moxifloxacin|mesh-list
5871669|NCT02331823|Isoniazid|isoniazid|mesh-list
5871670|NCT02331823|Pyrazinamide|pyrazinamide|mesh-list
5871671|NCT02331823|Ethambutol|ethambutol|mesh-list
5871672|NCT02331823|Rifabutin|rifabutin|mesh-list
5871673|NCT02331823|Streptomycin|streptomycin|mesh-list
5871674|NCT02331823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5871675|NCT02331823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5871676|NCT02331823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5871677|NCT02331823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5871678|NCT02331823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5871679|NCT02331823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5871680|NCT02331823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5871681|NCT02331823|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5682552|NCT03482232|Ibuprofen|ibuprofen|mesh-list
5682553|NCT03482232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
5682554|NCT03482232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
5682555|NCT03482232|Hypolipidemic Agents|hypolipidemic agents|mesh-list
5682556|NCT03482232|Expectorants|expectorants|mesh-list
5682557|NCT03482232|Antitubercular Agents|antitubercular agents|mesh-ancestor
5682558|NCT03482232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5871682|NCT02331823|Antitubercular Agents|antitubercular agents|mesh-ancestor
5871683|NCT02331823|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5871684|NCT02331823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5871685|NCT02331823|Antimetabolites|antimetabolites|mesh-ancestor
5871686|NCT02331823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5871687|NCT02331823|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5871688|NCT02331862|Methylprednisolone|methylprednisolone|mesh-list
5871689|NCT02331862|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5871690|NCT02331862|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5871691|NCT02331862|Prednisolone|prednisolone|mesh-list
5871692|NCT02331862|Prednisolone acetate|prednisolone acetate|mesh-list
5871693|NCT02331862|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5871694|NCT02331862|Prednisolone phosphate|prednisolone phosphate|mesh-list
5871695|NCT02331862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5871696|NCT02331862|Antiemetics|antiemetics|mesh-ancestor
5871697|NCT02331862|Autonomic Agents|autonomic agents|mesh-ancestor
5871698|NCT02331862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5871699|NCT02331862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871700|NCT02331862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5871701|NCT02331862|Glucocorticoids|glucocorticoids|mesh-ancestor
5871702|NCT02331862|Hormones|hormones|mesh-ancestor
5871703|NCT02331862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5871704|NCT02331862|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5871705|NCT02331862|Protective Agents|protective agents|mesh-ancestor
5871706|NCT02331862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5871707|NCT02331862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5871708|NCT02331927|Aflibercept|aflibercept|mesh-list
5871709|NCT02331927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5871710|NCT02331927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5871711|NCT02331927|Growth Substances|growth substances|mesh-ancestor
5871712|NCT02331927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871713|NCT02331927|Growth Inhibitors|growth inhibitors|mesh-ancestor
5871714|NCT02331927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5871715|NCT02332005|Choline|choline|mesh-list
5871716|NCT02332005|Lipotropic Agents|lipotropic agents|mesh-ancestor
5871717|NCT02332005|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5871718|NCT02332005|Antimetabolites|antimetabolites|mesh-ancestor
5871719|NCT02332005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5871720|NCT02332005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5871721|NCT02332005|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5871722|NCT02332005|Nootropic Agents|nootropic agents|mesh-ancestor
5871723|NCT02331706|Interferons|interferons|mesh-list
5871724|NCT02331706|Interferon-alpha|interferon-alpha|mesh-list
5871725|NCT02331706|Interferon alpha-2|interferon alpha-2|mesh-list
5871726|NCT02331706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5871727|NCT02331706|Antiviral Agents|antiviral agents|mesh-ancestor
5871728|NCT02331706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5871729|NCT02331706|Immunologic Factors|immunologic factors|mesh-ancestor
5871730|NCT02331706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871731|NCT02331602|Rivaroxaban|rivaroxaban|mesh-list
5871732|NCT02331602|Dabigatran|dabigatran|mesh-list
5871733|NCT02331602|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5871734|NCT02331602|Antithrombins|antithrombins|mesh-ancestor
5871735|NCT02331602|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5871736|NCT02331602|Protease Inhibitors|protease inhibitors|mesh-ancestor
5871737|NCT02331602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5871738|NCT02331602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5871739|NCT02331602|Anticoagulants|anticoagulants|mesh-ancestor
5871740|NCT02331576|Fentanyl|fentanyl|mesh-list
5871741|NCT02331576|Ropivacaine|ropivacaine|mesh-list
5871742|NCT02331576|Anesthetics, Local|anesthetics, local|mesh-ancestor
5871743|NCT02331576|Anesthetics|anesthetics|mesh-ancestor
5871744|NCT02331576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5871745|NCT02331576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871746|NCT02331576|Sensory System Agents|sensory system agents|mesh-ancestor
5871747|NCT02331576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5871748|NCT02331576|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5871749|NCT02331576|Narcotics|narcotics|mesh-ancestor
5871750|NCT02331576|Analgesics|analgesics|mesh-ancestor
5682559|NCT03482232|Analgesics|analgesics|mesh-ancestor
5682560|NCT03482232|Sensory System Agents|sensory system agents|mesh-ancestor
5682561|NCT03482232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5682562|NCT03482232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682563|NCT03482232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5682564|NCT03482232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5682565|NCT03482232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5682566|NCT03482232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5871751|NCT02331576|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5871752|NCT02331576|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5871753|NCT02331576|Anesthetics, General|anesthetics, general|mesh-ancestor
5871754|NCT02331511|Aspirin|aspirin|mesh-list
5871755|NCT02331511|Clopidogrel|clopidogrel|mesh-list
5871756|NCT02331511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5871757|NCT02331511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5871758|NCT02331511|Analgesics|analgesics|mesh-ancestor
5871759|NCT02331511|Sensory System Agents|sensory system agents|mesh-ancestor
5871760|NCT02331511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5871761|NCT02331511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871762|NCT02331511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5871763|NCT02331511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5871764|NCT02331511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5871765|NCT02331511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5871766|NCT02331511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5871767|NCT02331511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5871768|NCT02331511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5871769|NCT02331511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5871770|NCT02331511|Antipyretics|antipyretics|mesh-ancestor
5871771|NCT02331511|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5871772|NCT02331511|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5871773|NCT02331511|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5871774|NCT02331511|Purinergic Agents|purinergic agents|mesh-ancestor
5871775|NCT02331511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5871776|NCT02331563|Dexmedetomidine|dexmedetomidine|mesh-list
5871777|NCT02331563|Bupivacaine|bupivacaine|mesh-list
5871778|NCT02331563|Anesthetics, Local|anesthetics, local|mesh-ancestor
5871779|NCT02331563|Anesthetics|anesthetics|mesh-ancestor
6495479|NCT00623285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6495480|NCT00623285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6495481|NCT00623376|Dronabinol|dronabinol|mesh-list
6495482|NCT00623376|Nabilone|nabilone|mesh-list
6495483|NCT00623376|Antiemetics|antiemetics|mesh-ancestor
6495484|NCT00623376|Autonomic Agents|autonomic agents|mesh-ancestor
6495485|NCT00623376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6495486|NCT00623376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495487|NCT00623376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6495488|NCT00623376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6495489|NCT00623376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6495490|NCT00623376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6495491|NCT00623376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6495492|NCT00623376|Hallucinogens|hallucinogens|mesh-ancestor
6495493|NCT00623376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6495494|NCT00623376|Analgesics|analgesics|mesh-ancestor
6495495|NCT00623376|Sensory System Agents|sensory system agents|mesh-ancestor
6495496|NCT00623376|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6495497|NCT00623376|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6495498|NCT00623376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6495499|NCT00623376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495500|NCT00623376|Hormones|hormones|mesh-ancestor
6495501|NCT00623376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6495502|NCT00623402|Interferons|interferons|mesh-list
6495503|NCT00623402|Sorafenib|sorafenib|mesh-list
6495504|NCT00623402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6495505|NCT00623402|Antiviral Agents|antiviral agents|mesh-ancestor
6495506|NCT00623402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6495507|NCT00623402|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6495508|NCT00623402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6495509|NCT00623402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495510|NCT00623415|Flupirtine|flupirtine|mesh-list
6495511|NCT00623415|Analgesics|analgesics|mesh-ancestor
6495512|NCT00623415|Sensory System Agents|sensory system agents|mesh-ancestor
6495513|NCT00623415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6495514|NCT00623415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495515|NCT00623558|Docetaxel|docetaxel|mesh-list
6495516|NCT00623558|Cetuximab|cetuximab|mesh-list
6495517|NCT00623558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6495518|NCT00623558|Tubulin Modulators|tubulin modulators|mesh-ancestor
6675198|NCT01573338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5871780|NCT02331563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5871781|NCT02331563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871782|NCT02331563|Sensory System Agents|sensory system agents|mesh-ancestor
5871783|NCT02331563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6495519|NCT00623558|Antimitotic Agents|antimitotic agents|mesh-ancestor
6495520|NCT00623558|Mitosis Modulators|mitosis modulators|mesh-ancestor
5871784|NCT02331563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5682567|NCT03482232|Antipyretics|antipyretics|mesh-ancestor
5682568|NCT03482232|Antimetabolites|antimetabolites|mesh-ancestor
5682569|NCT03482232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5682570|NCT03482232|Respiratory System Agents|respiratory system agents|mesh-ancestor
5682571|NCT03482180|Atorvastatin|atorvastatin|mesh-list
5682572|NCT03482180|Calcium|calcium|mesh-list
5871785|NCT02331563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5871786|NCT02331563|Analgesics|analgesics|mesh-ancestor
5871787|NCT02331563|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5871788|NCT02331563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5871789|NCT02331563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5871790|NCT02331563|Adrenergic Agents|adrenergic agents|mesh-ancestor
5871791|NCT02331563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5871792|NCT02331563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5871793|NCT02331303|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
5871794|NCT02331303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5871795|NCT02330926|Ibuprofen|ibuprofen|mesh-list
5871796|NCT02330926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5871797|NCT02330926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5871798|NCT02330926|Analgesics|analgesics|mesh-ancestor
5871799|NCT02330926|Sensory System Agents|sensory system agents|mesh-ancestor
5871800|NCT02330926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5871801|NCT02330926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871802|NCT02330926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5871803|NCT02330926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5871804|NCT02330926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5871805|NCT02330926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5871806|NCT02330926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5871807|NCT02330952|Prednisone|prednisone|mesh-list
5871808|NCT02330952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5871809|NCT02330952|Glucocorticoids|glucocorticoids|mesh-ancestor
5871810|NCT02330952|Hormones|hormones|mesh-ancestor
5871811|NCT02330952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5871812|NCT02330952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871813|NCT02330952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5871814|NCT02330952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5871815|NCT02330991|Temozolomide|temozolomide|mesh-list
5871816|NCT02330991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5871817|NCT02330991|Alkylating Agents|alkylating agents|mesh-ancestor
5871818|NCT02330991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5871819|NCT02330991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5871820|NCT02331173|Dorzolamide|dorzolamide|mesh-list
5871821|NCT02331173|Brinzolamide|brinzolamide|mesh-list
5871822|NCT02331173|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5871823|NCT02331173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6212410|NCT02187744|Tubulin Modulators|tubulin modulators|mesh-ancestor
6495521|NCT00623558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495522|NCT00623558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6495523|NCT00623688|Imidacloprid|imidacloprid|mesh-list
6495524|NCT00623688|Cholinergic Agents|cholinergic agents|mesh-ancestor
6495525|NCT00623688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6495526|NCT00623688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495527|NCT00623688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495528|NCT00623740|Hydrocortisone|hydrocortisone|mesh-list
6495529|NCT00623740|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
5682573|NCT03482180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5682574|NCT03482180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682575|NCT03482180|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6495530|NCT00623740|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6495531|NCT00623740|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6495532|NCT00623740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6495533|NCT00623857|Vitamins|vitamins|mesh-list
6495534|NCT00623857|Zinc|zinc|mesh-list
6495535|NCT00623857|Micronutrients|micronutrients|mesh-ancestor
6495536|NCT00623857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495537|NCT00623857|Trace Elements|trace elements|mesh-ancestor
6495538|NCT00623987|Warfarin|warfarin|mesh-list
6495539|NCT00623987|Anticoagulants|anticoagulants|mesh-ancestor
6495540|NCT00624000|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6495541|NCT00624000|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6495542|NCT00624000|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6495543|NCT00624000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495544|NCT00624026|Memantine|memantine|mesh-list
5871824|NCT02331173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5871825|NCT02331173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5871826|NCT02331030|Ropivacaine|ropivacaine|mesh-list
5871827|NCT02331030|Anesthetics, Local|anesthetics, local|mesh-ancestor
5871828|NCT02331030|Anesthetics|anesthetics|mesh-ancestor
5871829|NCT02331030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5871830|NCT02331030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871831|NCT02331030|Sensory System Agents|sensory system agents|mesh-ancestor
5871832|NCT02331030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5871833|NCT02331251|Gemcitabine|gemcitabine|mesh-list
5871834|NCT02331251|Paclitaxel|paclitaxel|mesh-list
5871835|NCT02331251|Vinorelbine|vinorelbine|mesh-list
5871836|NCT02331251|Docetaxel|docetaxel|mesh-list
5871837|NCT02331251|Doxorubicin|doxorubicin|mesh-list
5871838|NCT02331251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5871839|NCT02331251|Pembrolizumab|pembrolizumab|mesh-list
5871840|NCT02331251|Irinotecan|irinotecan|mesh-list
5871841|NCT02331251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5871842|NCT02331251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5871843|NCT02331251|Tubulin Modulators|tubulin modulators|mesh-ancestor
5871844|NCT02331251|Antimitotic Agents|antimitotic agents|mesh-ancestor
5871845|NCT02331251|Mitosis Modulators|mitosis modulators|mesh-ancestor
5871846|NCT02331251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5871847|NCT02331251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5871848|NCT02331251|Antimetabolites|antimetabolites|mesh-ancestor
5871849|NCT02331251|Antiviral Agents|antiviral agents|mesh-ancestor
5871850|NCT02331251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5871851|NCT02331251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5871852|NCT02331251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5871853|NCT02331251|Immunologic Factors|immunologic factors|mesh-ancestor
5871854|NCT02331251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871855|NCT02331251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5871856|NCT02331251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6675199|NCT01573338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6675200|NCT01573338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6675201|NCT01573338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6675202|NCT01573338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6675203|NCT01573338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675204|NCT01573377|Metformin|metformin|mesh-list
6675205|NCT01573377|Cyproterone Acetate|cyproterone acetate|mesh-list
6675206|NCT01573377|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6675207|NCT01573377|Cyproterone|cyproterone|mesh-list
6675208|NCT01573377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6675209|NCT01573377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675210|NCT01573377|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6675211|NCT01573377|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6675212|NCT01573377|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6675213|NCT01573377|Contraceptive Agents|contraceptive agents|mesh-ancestor
6675214|NCT01573377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5871857|NCT02331251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5871858|NCT02331251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5871859|NCT02331251|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5905608|NCT04973020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5905609|NCT04973020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5905610|NCT04973020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905611|NCT04973020|Antiviral Agents|antiviral agents|mesh-ancestor
5905612|NCT04973020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5905613|NCT04973020|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5905614|NCT04973020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5905615|NCT04973020|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5905616|NCT04973020|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5905617|NCT04973020|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5905618|NCT04973020|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5905619|NCT04955249|Dexmedetomidine|dexmedetomidine|mesh-list
5905620|NCT04955249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5905621|NCT04955249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5905622|NCT04955249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905623|NCT04955249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5905624|NCT04955249|Analgesics|analgesics|mesh-ancestor
5905625|NCT04955249|Sensory System Agents|sensory system agents|mesh-ancestor
5905626|NCT04955249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5905627|NCT04955249|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5905628|NCT04955249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5682576|NCT03482180|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5682577|NCT03482180|Antimetabolites|antimetabolites|mesh-ancestor
5682578|NCT03482180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5682579|NCT03482180|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5682580|NCT03482180|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5682581|NCT03482180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5682582|NCT03482167|Niacinamide|niacinamide|mesh-list
5682583|NCT03482167|Vitamin B Complex|vitamin b complex|mesh-ancestor
5682584|NCT03482167|Vitamins|vitamins|mesh-ancestor
5682585|NCT03482167|Micronutrients|micronutrients|mesh-ancestor
5682586|NCT03482167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682587|NCT03482115|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
5682588|NCT03482115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5682589|NCT03482102|Durvalumab|durvalumab|mesh-list
5682590|NCT03482102|Tremelimumab|tremelimumab|mesh-list
5871860|NCT02330757|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5871861|NCT02330757|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5871862|NCT02330757|Clomiphene|clomiphene|mesh-list
5871863|NCT02330757|Enclomiphene|enclomiphene|mesh-list
5871864|NCT02330757|Zuclomiphene|zuclomiphene|mesh-list
5871865|NCT02330757|Estradiol|estradiol|mesh-list
5871866|NCT02330757|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5871867|NCT02330757|Estrogens|estrogens|mesh-ancestor
5871868|NCT02330757|Hormones|hormones|mesh-ancestor
5871869|NCT02330757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5871870|NCT02330757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871871|NCT02330757|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5871872|NCT02330757|Contraceptive Agents|contraceptive agents|mesh-ancestor
5871873|NCT02330757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5871874|NCT02330757|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5871875|NCT02330757|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5871876|NCT02330757|Hormone Antagonists|hormone antagonists|mesh-ancestor
5682591|NCT03482102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5682592|NCT03482102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5871877|NCT02330757|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5871878|NCT02330757|Fertility Agents|fertility agents|mesh-ancestor
5871879|NCT02330757|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5871880|NCT02330757|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5871881|NCT02330796|Bucillamine|bucillamine|mesh-list
5871882|NCT02330796|Colchicine|colchicine|mesh-list
5871883|NCT02330796|Gout Suppressants|gout suppressants|mesh-ancestor
5871884|NCT02330796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5871885|NCT02330796|Tubulin Modulators|tubulin modulators|mesh-ancestor
5871886|NCT02330796|Antimitotic Agents|antimitotic agents|mesh-ancestor
5871887|NCT02330796|Mitosis Modulators|mitosis modulators|mesh-ancestor
5871888|NCT02330796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5871889|NCT02330796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5871890|NCT02330796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5871891|NCT02330796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5871892|NCT02330796|Analgesics|analgesics|mesh-ancestor
5871893|NCT02330796|Sensory System Agents|sensory system agents|mesh-ancestor
5871894|NCT02330796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5871895|NCT02330796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871896|NCT02330796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5871897|NCT02330796|Antioxidants|antioxidants|mesh-ancestor
5871898|NCT02330796|Protective Agents|protective agents|mesh-ancestor
5871899|NCT02330705|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5871900|NCT02330705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5871901|NCT02330705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871902|NCT02330770|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5871903|NCT02330770|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5871904|NCT02330770|Luteolytic Agents|luteolytic agents|mesh-ancestor
5871905|NCT02330770|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5871906|NCT02330770|Contraceptive Agents|contraceptive agents|mesh-ancestor
5871907|NCT02330770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5871908|NCT02330770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871909|NCT02330770|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5871910|NCT02330770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5871911|NCT02330770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5871912|NCT02330614|Carbamide Peroxide|carbamide peroxide|mesh-list
5871913|NCT02330614|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5871914|NCT02330614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5871915|NCT02330640|Clopidogrel|clopidogrel|mesh-list
5871916|NCT02330640|Ticagrelor|ticagrelor|mesh-list
5682593|NCT03482024|Tirzepatide|tirzepatide|mesh-list
5682594|NCT03482024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5871917|NCT02330640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6675215|NCT01573377|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6675216|NCT01573377|Estrogens|estrogens|mesh-ancestor
6675217|NCT01573377|Hormones|hormones|mesh-ancestor
6675218|NCT01573377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6675219|NCT01573377|Androgen Antagonists|androgen antagonists|mesh-ancestor
6675220|NCT01573377|Hormone Antagonists|hormone antagonists|mesh-ancestor
6675221|NCT01573377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6675222|NCT01573377|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6675223|NCT01573468|Capecitabine|capecitabine|mesh-list
6675224|NCT01573468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6675225|NCT01573468|Antimetabolites|antimetabolites|mesh-ancestor
6675226|NCT01573468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675227|NCT01573468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6675228|NCT01573598|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
6675229|NCT01573598|Antidepressive Agents|antidepressive agents|mesh-ancestor
6675230|NCT01573598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6675231|NCT01573598|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6675232|NCT01573598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6675233|NCT01573598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6675234|NCT01573598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675235|NCT01573598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5682595|NCT03482024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682596|NCT03482024|Incretins|incretins|mesh-ancestor
5682597|NCT03482024|Hormones|hormones|mesh-ancestor
5682598|NCT03482024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5682599|NCT03481998|Letrozole|letrozole|mesh-list
5682600|NCT03481998|Fulvestrant|fulvestrant|mesh-list
5682601|NCT03481998|Anastrozole|anastrozole|mesh-list
5682602|NCT03481998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5682603|NCT03481998|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5682604|NCT03481998|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5682605|NCT03481998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5682606|NCT03481998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5682607|NCT03481998|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5682608|NCT03481998|Hormone Antagonists|hormone antagonists|mesh-ancestor
5682609|NCT03481998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5682610|NCT03481998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682611|NCT03481998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6675236|NCT01573598|Serotonin Agents|serotonin agents|mesh-ancestor
6675237|NCT01573598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675238|NCT01573598|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6675239|NCT01573598|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6675240|NCT01573637|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
6675241|NCT01573637|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6675242|NCT01573637|Hormone Antagonists|hormone antagonists|mesh-ancestor
6675243|NCT01573637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6675244|NCT01573637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675245|NCT01573637|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6675246|NCT01573637|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6675247|NCT01573637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6675248|NCT01573663|Dipropizine|dipropizine|mesh-list
6675249|NCT01573663|Ambroxol|ambroxol|mesh-list
6675250|NCT01573663|Expectorants|expectorants|mesh-ancestor
6675251|NCT01573663|Respiratory System Agents|respiratory system agents|mesh-ancestor
6675252|NCT01573663|Antitussive Agents|antitussive agents|mesh-ancestor
6675253|NCT01573715|Cisatracurium|cisatracurium|mesh-list
6675254|NCT01573715|Atracurium|atracurium|mesh-list
6675255|NCT01573715|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6675256|NCT01573715|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6675257|NCT01573715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6675258|NCT01573715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675259|NCT01573715|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6675260|NCT01573715|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
6675261|NCT01573715|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6675262|NCT01573715|Cholinergic Agents|cholinergic agents|mesh-ancestor
6675263|NCT01573715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6675264|NCT01573715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675265|NCT01573741|Ketamine|ketamine|mesh-list
6675266|NCT01573741|Analgesics|analgesics|mesh-ancestor
6675267|NCT01573741|Sensory System Agents|sensory system agents|mesh-ancestor
6675268|NCT01573741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5682612|NCT03481998|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5682613|NCT03481972|Doxycycline|doxycycline|mesh-list
5682614|NCT03481972|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
5682615|NCT03481972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5682616|NCT03481972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5682617|NCT03481972|Antimalarials|antimalarials|mesh-ancestor
5682618|NCT03481972|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5682619|NCT03481972|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5682620|NCT03481972|Antiviral Agents|antiviral agents|mesh-ancestor
5682621|NCT03481972|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5682622|NCT03481972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5871918|NCT02330640|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5871919|NCT02330640|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5871920|NCT02330640|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5871921|NCT02330640|Purinergic Agents|purinergic agents|mesh-ancestor
5871922|NCT02330640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5871923|NCT02330640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5871924|NCT02330640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495545|NCT00624026|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6495546|NCT00624026|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6495547|NCT00624026|Dopamine Agents|dopamine agents|mesh-ancestor
6495548|NCT00624026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6495549|NCT00624026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495550|NCT00624026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495551|NCT00624026|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6495552|NCT00624026|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6495553|NCT00624039|Pilocarpine|pilocarpine|mesh-list
6495554|NCT00624039|Miotics|miotics|mesh-ancestor
6495555|NCT00624039|Autonomic Agents|autonomic agents|mesh-ancestor
6675269|NCT01573741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675270|NCT01573741|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6675271|NCT01573741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6675272|NCT01573741|Anesthetics, General|anesthetics, general|mesh-ancestor
5682623|NCT03481959|Methylphenidate|methylphenidate|mesh-list
5682624|NCT03481959|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5682625|NCT03481959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675273|NCT01573741|Anesthetics|anesthetics|mesh-ancestor
5682626|NCT03481959|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5871925|NCT02330822|Hyaluronic Acid|hyaluronic acid|mesh-list
5871926|NCT02330822|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5871927|NCT02330822|Immunologic Factors|immunologic factors|mesh-ancestor
5871928|NCT02330822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871929|NCT02330822|Viscosupplements|viscosupplements|mesh-ancestor
5871930|NCT02330822|Protective Agents|protective agents|mesh-ancestor
5871931|NCT02330783|Bevacizumab|bevacizumab|mesh-list
5871932|NCT02330783|Sorafenib|sorafenib|mesh-list
5871933|NCT02330783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5871934|NCT02330783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5871935|NCT02330783|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5871936|NCT02330783|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5871937|NCT02330783|Growth Substances|growth substances|mesh-ancestor
5871938|NCT02330783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871939|NCT02330783|Growth Inhibitors|growth inhibitors|mesh-ancestor
5682627|NCT03481959|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5682628|NCT03481959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5682629|NCT03481959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5682630|NCT03481959|Dopamine Agents|dopamine agents|mesh-ancestor
5682631|NCT03481959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5682632|NCT03481920|Avelumab|avelumab|mesh-list
5682633|NCT03481920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5682634|NCT03481920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5682635|NCT03481790|Folic Acid|folic acid|mesh-list
5682636|NCT03481790|Lactoferrin|lactoferrin|mesh-list
5682637|NCT03481790|Vitamins|vitamins|mesh-ancestor
5682638|NCT03481790|Micronutrients|micronutrients|mesh-ancestor
5682639|NCT03481790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682640|NCT03481790|Hematinics|hematinics|mesh-ancestor
5682641|NCT03481790|Vitamin B Complex|vitamin b complex|mesh-ancestor
5682642|NCT03481790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5682643|NCT03481582|Nitroglycerin|nitroglycerin|mesh-list
5682644|NCT03481582|Vasodilator Agents|vasodilator agents|mesh-ancestor
5682645|NCT03481569|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5682646|NCT03481569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5682647|NCT03481517|Bupivacaine|bupivacaine|mesh-list
5871940|NCT02330783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6495556|NCT00624039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5682648|NCT03481517|Anesthetics, Local|anesthetics, local|mesh-ancestor
5682649|NCT03481517|Anesthetics|anesthetics|mesh-ancestor
5682650|NCT03481517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5682651|NCT03481517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871941|NCT02330783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5871942|NCT02330783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5871943|NCT02330367|Abivertinib|abivertinib|mesh-list
5871944|NCT02330367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5871945|NCT02330367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5871946|NCT02330367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5871947|NCT02330679|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
5871948|NCT02330679|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5871949|NCT02330679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5871950|NCT02330679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5871951|NCT02330679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5871952|NCT02330679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5871953|NCT02330679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871954|NCT02330679|Antidepressive Agents|antidepressive agents|mesh-ancestor
5871955|NCT02330679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5871956|NCT02330380|Adalimumab|adalimumab|mesh-list
5871957|NCT02330380|Etanercept|etanercept|mesh-list
5871958|NCT02330380|Methotrexate|methotrexate|mesh-list
5871959|NCT02330380|Ustekinumab|ustekinumab|mesh-list
5871960|NCT02330380|Acitretin|acitretin|mesh-list
5871961|NCT02330380|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5871962|NCT02330380|Abortifacient Agents|abortifacient agents|mesh-ancestor
5871963|NCT02330380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5871964|NCT02330380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871965|NCT02330380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5871966|NCT02330380|Antimetabolites|antimetabolites|mesh-ancestor
5871967|NCT02330380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5871968|NCT02330380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5871969|NCT02330380|Dermatologic Agents|dermatologic agents|mesh-ancestor
5682652|NCT03481517|Sensory System Agents|sensory system agents|mesh-ancestor
5682653|NCT03481517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5682654|NCT03481400|Calcitonin|calcitonin|mesh-list
5682655|NCT03481400|Salmon calcitonin|salmon calcitonin|mesh-list
5682656|NCT03481400|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
5682657|NCT03481400|Katacalcin|katacalcin|mesh-list
5682658|NCT03481400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5682659|NCT03481400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682660|NCT03481400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5682661|NCT03481400|Vasodilator Agents|vasodilator agents|mesh-ancestor
5871970|NCT02330380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5871971|NCT02330380|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5871972|NCT02330380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5871973|NCT02330380|Immunologic Factors|immunologic factors|mesh-ancestor
5871974|NCT02330380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5871975|NCT02330380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5871976|NCT02330380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5871977|NCT02330380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5871978|NCT02330380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5871979|NCT02330380|Analgesics|analgesics|mesh-ancestor
5871980|NCT02330380|Sensory System Agents|sensory system agents|mesh-ancestor
5871981|NCT02330380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5871982|NCT02330380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5871983|NCT02330380|Keratolytic Agents|keratolytic agents|mesh-ancestor
5871984|NCT02330406|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5871985|NCT02330406|Anagliptin|anagliptin|mesh-list
5871986|NCT02330406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5871987|NCT02330406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5871988|NCT02330406|Incretins|incretins|mesh-ancestor
5871989|NCT02330406|Hormones|hormones|mesh-ancestor
5871990|NCT02330406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5871991|NCT02330406|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5871992|NCT02330406|Protease Inhibitors|protease inhibitors|mesh-ancestor
5871993|NCT02330406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5871994|NCT02330406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5871995|NCT02330302|Ropivacaine|ropivacaine|mesh-list
5871996|NCT02330302|Anesthetics, Local|anesthetics, local|mesh-ancestor
5871997|NCT02330302|Anesthetics|anesthetics|mesh-ancestor
5871998|NCT02330302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5682662|NCT03481036|Antiviral Agents|antiviral agents|mesh-list
5682663|NCT03481036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5682664|NCT03480997|Bromides|bromides|mesh-list
5682665|NCT03480997|Albuterol|albuterol|mesh-list
5682666|NCT03480997|Ipratropium|ipratropium|mesh-list
5682667|NCT03480997|Anticonvulsants|anticonvulsants|mesh-ancestor
5682668|NCT03480997|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5682669|NCT03480997|Autonomic Agents|autonomic agents|mesh-ancestor
5682670|NCT03480997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5682671|NCT03480997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682672|NCT03480997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5682673|NCT03480997|Respiratory System Agents|respiratory system agents|mesh-ancestor
5871999|NCT02330302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872000|NCT02330302|Sensory System Agents|sensory system agents|mesh-ancestor
5872001|NCT02330302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5872002|NCT02330419|Naltrexone|naltrexone|mesh-list
5872003|NCT02330419|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5872004|NCT02330419|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5872005|NCT02330419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872006|NCT02330419|Sensory System Agents|sensory system agents|mesh-ancestor
5872007|NCT02330419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5872008|NCT02330120|Dexmedetomidine|dexmedetomidine|mesh-list
5872009|NCT02330120|Propofol|propofol|mesh-list
5872010|NCT02330120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5872011|NCT02330120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5872012|NCT02330120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872013|NCT02330120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5872014|NCT02330120|Anesthetics, General|anesthetics, general|mesh-ancestor
5872015|NCT02330120|Anesthetics|anesthetics|mesh-ancestor
5872016|NCT02330120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5872017|NCT02330120|Analgesics|analgesics|mesh-ancestor
5872018|NCT02330120|Sensory System Agents|sensory system agents|mesh-ancestor
5872019|NCT02330120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5872020|NCT02330120|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5872021|NCT02330120|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5872022|NCT02330120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5872023|NCT02330120|Adrenergic Agents|adrenergic agents|mesh-ancestor
5872024|NCT02330120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5872025|NCT02330120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872026|NCT02330029|Pinaverium|pinaverium|mesh-list
5872027|NCT02330029|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5872028|NCT02330029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5872029|NCT02330029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872030|NCT02330029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5872031|NCT02330029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872032|NCT02330029|Parasympatholytics|parasympatholytics|mesh-ancestor
5872033|NCT02330029|Autonomic Agents|autonomic agents|mesh-ancestor
5872034|NCT02330029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5872035|NCT02330068|Citalopram|citalopram|mesh-list
5682674|NCT03480997|Tocolytic Agents|tocolytic agents|mesh-ancestor
5682675|NCT03480997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5682676|NCT03480997|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5682677|NCT03480997|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5682678|NCT03480997|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5872036|NCT02330068|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5872037|NCT02330068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5872038|NCT02330068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5872039|NCT02330068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872040|NCT02330068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5872041|NCT02330068|Serotonin Agents|serotonin agents|mesh-ancestor
5872042|NCT02330068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872043|NCT02330068|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5872044|NCT02330068|Antidepressive Agents|antidepressive agents|mesh-ancestor
5872045|NCT02330068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5872046|NCT02329860|Apatinib|apatinib|mesh-list
5872047|NCT02329860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5872048|NCT02329860|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5872049|NCT02329860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5872050|NCT02329860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872051|NCT02329795|Temozolomide|temozolomide|mesh-list
5872052|NCT02329795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5872053|NCT02329795|Alkylating Agents|alkylating agents|mesh-ancestor
5872054|NCT02329795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5682679|NCT03480997|Adrenergic Agents|adrenergic agents|mesh-ancestor
5682680|NCT03480997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5697036|NCT03378427|Ofloxacin|ofloxacin|mesh-list
5872055|NCT02329795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5872056|NCT02329561|Tramadol|tramadol|mesh-list
5872057|NCT02329561|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5872058|NCT02329561|Narcotics|narcotics|mesh-ancestor
5872059|NCT02329561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5872060|NCT02329561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872061|NCT02329561|Analgesics|analgesics|mesh-ancestor
5872062|NCT02329561|Sensory System Agents|sensory system agents|mesh-ancestor
5872063|NCT02329561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5872064|NCT02329626|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5872065|NCT02329626|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5872066|NCT02329626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872067|NCT02329756|Tranexamic Acid|tranexamic acid|mesh-list
5872068|NCT02329756|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5872069|NCT02329756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5872070|NCT02329756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872071|NCT02329756|Hemostatics|hemostatics|mesh-ancestor
5872072|NCT02329756|Coagulants|coagulants|mesh-ancestor
5872073|NCT02329535|Progesterone|progesterone|mesh-list
5872074|NCT02329535|Progestins|progestins|mesh-ancestor
5872075|NCT02329535|Hormones|hormones|mesh-ancestor
5872076|NCT02329535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5872077|NCT02329535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872078|NCT02329405|Rifampin|rifampin|mesh-list
5872079|NCT02329405|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5872080|NCT02329405|Antitubercular Agents|antitubercular agents|mesh-ancestor
5872081|NCT02329405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5872082|NCT02329405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5682681|NCT03480997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5682682|NCT03480997|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5682683|NCT03480997|Cholinergic Agents|cholinergic agents|mesh-ancestor
5682684|NCT03480958|Morphine|morphine|mesh-list
5682685|NCT03480958|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5682686|NCT03480958|Narcotics|narcotics|mesh-ancestor
5872083|NCT02329405|Leprostatic Agents|leprostatic agents|mesh-ancestor
5872084|NCT02329405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5872085|NCT02329405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5872086|NCT02329405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872087|NCT02329405|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5872088|NCT02329405|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5872089|NCT02329405|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5872090|NCT02329405|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5872091|NCT02329405|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5682687|NCT03480958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5682688|NCT03480958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682689|NCT03480958|Analgesics|analgesics|mesh-ancestor
5682690|NCT03480958|Sensory System Agents|sensory system agents|mesh-ancestor
5682691|NCT03480958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5872092|NCT02329405|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5872093|NCT02329288|Triamcinolone|triamcinolone|mesh-list
5872094|NCT02329288|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5872095|NCT02329288|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5872096|NCT02329288|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5872097|NCT02329288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5872098|NCT02329288|Glucocorticoids|glucocorticoids|mesh-ancestor
5872099|NCT02329288|Hormones|hormones|mesh-ancestor
5872100|NCT02329288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6675274|NCT01573741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6675275|NCT01573741|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6675276|NCT01573741|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6675277|NCT01573741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6675278|NCT01573741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872101|NCT02329288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872102|NCT02329288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5872103|NCT02329288|Immunologic Factors|immunologic factors|mesh-ancestor
5872104|NCT02329288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5872105|NCT02329288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872106|NCT02329054|Favipiravir|favipiravir|mesh-list
5682692|NCT03480945|Nitroprusside|nitroprusside|mesh-list
5682693|NCT03480945|Serotonin|serotonin|mesh-list
5682694|NCT03480945|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5682695|NCT03480945|Serotonin Agents|serotonin agents|mesh-ancestor
5682696|NCT03480945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5682697|NCT03480945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5682698|NCT03480945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682699|NCT03480945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5682700|NCT03480945|Vasodilator Agents|vasodilator agents|mesh-ancestor
5682701|NCT03480945|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5682702|NCT03480906|Latanoprost|latanoprost|mesh-list
5682703|NCT03480906|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5682704|NCT03480906|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5872107|NCT02329054|Antiviral Agents|antiviral agents|mesh-ancestor
5872108|NCT02329054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5905629|NCT04955249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5682705|NCT03480867|Temozolomide|temozolomide|mesh-list
5682706|NCT03480867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5682707|NCT03480867|Alkylating Agents|alkylating agents|mesh-ancestor
5682708|NCT03480867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5682709|NCT03480867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5682710|NCT03480789|Dexmedetomidine|dexmedetomidine|mesh-list
5682711|NCT03480789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5682712|NCT03480789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5682713|NCT03480789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682714|NCT03480789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5682715|NCT03480789|Analgesics|analgesics|mesh-ancestor
5682716|NCT03480789|Sensory System Agents|sensory system agents|mesh-ancestor
5682717|NCT03480789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5682718|NCT03480789|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5682719|NCT03480789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5682720|NCT03480789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5682721|NCT03480789|Adrenergic Agents|adrenergic agents|mesh-ancestor
5682722|NCT03480789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5682723|NCT03480789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5682724|NCT03480698|Cerebrolysin|cerebrolysin|mesh-list
5682725|NCT03480698|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5682726|NCT03480698|Protective Agents|protective agents|mesh-ancestor
5905630|NCT04955249|Adrenergic Agents|adrenergic agents|mesh-ancestor
5905631|NCT04955249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5905632|NCT04955249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905633|NCT04910503|Dexamethasone|dexamethasone|mesh-list
5905634|NCT04910503|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
5905635|NCT04910503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5905636|NCT04910503|Antiemetics|antiemetics|mesh-ancestor
5905637|NCT04910503|Autonomic Agents|autonomic agents|mesh-ancestor
5905638|NCT04910503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5905639|NCT04910503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905640|NCT04910503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5905641|NCT04910503|Glucocorticoids|glucocorticoids|mesh-ancestor
5905642|NCT04910503|Hormones|hormones|mesh-ancestor
5905643|NCT04910503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5905644|NCT04910503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5905645|NCT04910503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5905646|NCT04908787|Paclitaxel|paclitaxel|mesh-list
5905647|NCT04908787|Doxorubicin|doxorubicin|mesh-list
5905648|NCT04908787|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5905649|NCT04908787|Topotecan|topotecan|mesh-list
5905650|NCT04908787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5905651|NCT04908787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5905652|NCT04908787|Tubulin Modulators|tubulin modulators|mesh-ancestor
5905653|NCT04908787|Antimitotic Agents|antimitotic agents|mesh-ancestor
5905654|NCT04908787|Mitosis Modulators|mitosis modulators|mesh-ancestor
5905655|NCT04908787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905656|NCT04908787|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5905657|NCT04908787|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5682727|NCT03480698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682728|NCT03480698|Nootropic Agents|nootropic agents|mesh-ancestor
5682729|NCT03480646|Prednisone|prednisone|mesh-list
5697037|NCT03378427|Minocycline|minocycline|mesh-list
5697038|NCT03378427|Rifampin|rifampin|mesh-list
5905658|NCT04908787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5905659|NCT04908787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5905660|NCT04908787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5905661|NCT04908449|Bupivacaine|bupivacaine|mesh-list
5905662|NCT04908449|Anesthetics, Local|anesthetics, local|mesh-ancestor
5905663|NCT04908449|Anesthetics|anesthetics|mesh-ancestor
5905664|NCT04908449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5905665|NCT04908449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905666|NCT04908449|Sensory System Agents|sensory system agents|mesh-ancestor
5872109|NCT02329197|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5682730|NCT03480646|(R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide|(r)-n-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1h-indole-3-carboxamide|mesh-list
5682731|NCT03480646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5682732|NCT03480646|Glucocorticoids|glucocorticoids|mesh-ancestor
5682733|NCT03480646|Hormones|hormones|mesh-ancestor
5682734|NCT03480646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5682735|NCT03480646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682736|NCT03480646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5682737|NCT03480646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5872110|NCT02329197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5872111|NCT02329197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872112|NCT02329080|Cytarabine|cytarabine|mesh-list
5872113|NCT02329080|Rituximab|rituximab|mesh-list
5872114|NCT02329080|Methotrexate|methotrexate|mesh-list
5872115|NCT02329080|Etoposide|etoposide|mesh-list
5872116|NCT02329080|Ifosfamide|ifosfamide|mesh-list
5872117|NCT02329080|Thiotepa|thiotepa|mesh-list
5872118|NCT02329080|Carmustine|carmustine|mesh-list
5872119|NCT02329080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5872120|NCT02329080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5682738|NCT03480646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5682739|NCT03480646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697039|NCT03378427|Clindamycin|clindamycin|mesh-list
5697040|NCT03378427|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
5697041|NCT03378427|Tedizolid|tedizolid|mesh-list
5697042|NCT03378427|Teicoplanin|teicoplanin|mesh-list
5697043|NCT03378427|Tedizolid phosphate|tedizolid phosphate|mesh-list
5697044|NCT03378427|Fusidic Acid|fusidic acid|mesh-list
5697045|NCT03378427|Trimethoprim|trimethoprim|mesh-list
5872121|NCT02329080|Immunologic Factors|immunologic factors|mesh-ancestor
5872122|NCT02329080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872123|NCT02329080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5872124|NCT02329080|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5872125|NCT02329080|Abortifacient Agents|abortifacient agents|mesh-ancestor
5872126|NCT02329080|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5872127|NCT02329080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5872128|NCT02329080|Antimetabolites|antimetabolites|mesh-ancestor
5872129|NCT02329080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872130|NCT02329080|Dermatologic Agents|dermatologic agents|mesh-ancestor
5872131|NCT02329080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5872132|NCT02329080|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5872133|NCT02329080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5697046|NCT03378427|Sulfamethoxazole|sulfamethoxazole|mesh-list
5697047|NCT03378427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5697048|NCT03378427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5697049|NCT03378427|Antimalarials|antimalarials|mesh-ancestor
5697050|NCT03378427|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5697051|NCT03378427|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5697052|NCT03378427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5697053|NCT03378427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5697054|NCT03378427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5697055|NCT03378427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697056|NCT03378427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5697057|NCT03378427|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5697058|NCT03378427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5697059|NCT03378427|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5697060|NCT03378427|Renal Agents|renal agents|mesh-ancestor
5697061|NCT03378427|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5697062|NCT03378427|Antitubercular Agents|antitubercular agents|mesh-ancestor
5697063|NCT03378427|Leprostatic Agents|leprostatic agents|mesh-ancestor
5697064|NCT03378427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5697065|NCT03378427|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5697066|NCT03378427|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5697067|NCT03378427|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5697068|NCT03378427|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5697069|NCT03378427|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5697070|NCT03378427|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5697071|NCT03378427|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5872134|NCT02329080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5872135|NCT02329080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5872136|NCT02329080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6212411|NCT02187744|Antimitotic Agents|antimitotic agents|mesh-ancestor
5872137|NCT02329080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5872138|NCT02329080|Antiviral Agents|antiviral agents|mesh-ancestor
5872139|NCT02329080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5872140|NCT02329080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5872141|NCT02329080|Alkylating Agents|alkylating agents|mesh-ancestor
5872142|NCT02329080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5872143|NCT02329171|Imiquimod|imiquimod|mesh-list
5872144|NCT02329171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5872145|NCT02329171|Immunologic Factors|immunologic factors|mesh-ancestor
5872146|NCT02329171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872147|NCT02329171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5872148|NCT02329171|Interferon Inducers|interferon inducers|mesh-ancestor
5872149|NCT02329132|Ranibizumab|ranibizumab|mesh-list
5872150|NCT02329132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5872151|NCT02329132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5872152|NCT02329132|Growth Substances|growth substances|mesh-ancestor
5872153|NCT02329132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872154|NCT02329132|Growth Inhibitors|growth inhibitors|mesh-ancestor
5872155|NCT02329132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5872156|NCT02328950|Cytarabine|cytarabine|mesh-list
5872157|NCT02328950|Cyclophosphamide|cyclophosphamide|mesh-list
5872158|NCT02328950|Busulfan|busulfan|mesh-list
5872159|NCT02328950|Fludarabine|fludarabine|mesh-list
5872160|NCT02328950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5872161|NCT02328950|Immunologic Factors|immunologic factors|mesh-ancestor
5872162|NCT02328950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872163|NCT02328950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5872164|NCT02328950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5872165|NCT02328950|Alkylating Agents|alkylating agents|mesh-ancestor
5872166|NCT02328950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872167|NCT02328950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5682740|NCT03480607|Dexamethasone|dexamethasone|mesh-list
5682741|NCT03480607|Dexmedetomidine|dexmedetomidine|mesh-list
5682742|NCT03480607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5682743|NCT03480607|Antiemetics|antiemetics|mesh-ancestor
5682744|NCT03480607|Autonomic Agents|autonomic agents|mesh-ancestor
5682745|NCT03480607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5682746|NCT03480607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682747|NCT03480607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5682748|NCT03480607|Glucocorticoids|glucocorticoids|mesh-ancestor
5872168|NCT02328950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5872169|NCT02328950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5872170|NCT02328950|Antimetabolites|antimetabolites|mesh-ancestor
5872171|NCT02328950|Antiviral Agents|antiviral agents|mesh-ancestor
5872172|NCT02328950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5872173|NCT02328729|Epinephrine|epinephrine|mesh-list
5872174|NCT02328729|Racepinephrine|racepinephrine|mesh-list
5872175|NCT02328729|Epinephryl borate|epinephryl borate|mesh-list
5872176|NCT02328729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5872177|NCT02328729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5872178|NCT02328729|Adrenergic Agents|adrenergic agents|mesh-ancestor
5872179|NCT02328729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5872180|NCT02328729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872181|NCT02328729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872182|NCT02328729|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5872183|NCT02328729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5872184|NCT02328729|Autonomic Agents|autonomic agents|mesh-ancestor
5872185|NCT02328729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5872186|NCT02328729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5872187|NCT02328729|Respiratory System Agents|respiratory system agents|mesh-ancestor
5872188|NCT02328729|Mydriatics|mydriatics|mesh-ancestor
5872189|NCT02328729|Sympathomimetics|sympathomimetics|mesh-ancestor
5872190|NCT02328729|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5872191|NCT02328963|Mycophenolic Acid|mycophenolic acid|mesh-list
5872192|NCT02328963|Everolimus|everolimus|mesh-list
5872193|NCT02328963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5872194|NCT02328963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5872195|NCT02328963|Immunologic Factors|immunologic factors|mesh-ancestor
5872196|NCT02328963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872197|NCT02328963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6495557|NCT00624039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495558|NCT00624039|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6495559|NCT00624039|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5682749|NCT03480607|Hormones|hormones|mesh-ancestor
5682750|NCT03480607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5872198|NCT02328963|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5872199|NCT02328963|Antitubercular Agents|antitubercular agents|mesh-ancestor
5872200|NCT02328963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5872201|NCT02328963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5872202|NCT02328963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6495560|NCT00624039|Cholinergic Agents|cholinergic agents|mesh-ancestor
6495561|NCT00624039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6495562|NCT00624039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495563|NCT00624078|Antivenins|antivenins|mesh-list
6495564|NCT00624078|Immunologic Factors|immunologic factors|mesh-ancestor
5872203|NCT02328963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872204|NCT02328794|Varenicline|varenicline|mesh-list
5872205|NCT02328794|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5872206|NCT02328794|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5872207|NCT02328794|Cholinergic Agents|cholinergic agents|mesh-ancestor
5872208|NCT02328794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5872209|NCT02328794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872210|NCT02328794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872211|NCT02328716|Cisplatin|cisplatin|mesh-list
5872212|NCT02328716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5872213|NCT02328651|Ribavirin|ribavirin|mesh-list
5872214|NCT02328651|Antimetabolites|antimetabolites|mesh-ancestor
5872215|NCT02328651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872216|NCT02328651|Antiviral Agents|antiviral agents|mesh-ancestor
5872217|NCT02328651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5872218|NCT02328521|Nicorandil|nicorandil|mesh-list
5872219|NCT02328521|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5872220|NCT02328521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5872221|NCT02328521|Vasodilator Agents|vasodilator agents|mesh-ancestor
5872222|NCT02328521|Vitamin B Complex|vitamin b complex|mesh-ancestor
5872223|NCT02328521|Vitamins|vitamins|mesh-ancestor
5872224|NCT02328521|Micronutrients|micronutrients|mesh-ancestor
5872225|NCT02328521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872226|NCT02328469|Doxycycline|doxycycline|mesh-list
5872227|NCT02328469|Ceftriaxone|ceftriaxone|mesh-list
5872228|NCT02328469|Acyclovir|acyclovir|mesh-list
5872229|NCT02328469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5872230|NCT02328469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5872231|NCT02328469|Antimalarials|antimalarials|mesh-ancestor
5872232|NCT02328469|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5872233|NCT02328469|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5872234|NCT02328469|Antiviral Agents|antiviral agents|mesh-ancestor
5872235|NCT02328456|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5872236|NCT02328456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5872237|NCT02328495|Misoprostol|misoprostol|mesh-list
5872238|NCT02328495|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5872239|NCT02328495|Abortifacient Agents|abortifacient agents|mesh-ancestor
5872240|NCT02328495|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5872241|NCT02328495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872242|NCT02328495|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5872243|NCT02328495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5872244|NCT02328495|Oxytocics|oxytocics|mesh-ancestor
5872245|NCT02328183|Polymyxins|polymyxins|mesh-list
5872246|NCT02328183|Polymyxin B|polymyxin b|mesh-list
5872247|NCT02328183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5872248|NCT02328183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5872249|NCT02328053|Voriconazole|voriconazole|mesh-list
5872250|NCT02328053|Natamycin|natamycin|mesh-list
5872251|NCT02328053|Antifungal Agents|antifungal agents|mesh-list
5872252|NCT02328053|Clotrimazole|clotrimazole|mesh-list
5872253|NCT02328053|Miconazole|miconazole|mesh-list
5872254|NCT02328053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5872255|NCT02328053|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5872256|NCT02328053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6495565|NCT00624078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495566|NCT00624130|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
5682751|NCT03480607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5682752|NCT03480607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5682753|NCT03480607|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5682754|NCT03480607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5682755|NCT03480607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5682756|NCT03480607|Analgesics|analgesics|mesh-ancestor
5682757|NCT03480607|Sensory System Agents|sensory system agents|mesh-ancestor
5682758|NCT03480607|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6495567|NCT00624130|Dacuronium|dacuronium|mesh-list
6495568|NCT00624130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6495569|NCT00624130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495570|NCT00624130|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6495571|NCT00624130|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5872257|NCT02328053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5872258|NCT02328053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872259|NCT02328053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5682759|NCT03480607|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5682760|NCT03480607|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5682761|NCT03480607|Adrenergic Agents|adrenergic agents|mesh-ancestor
5682762|NCT03480607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5872260|NCT02328053|Hormone Antagonists|hormone antagonists|mesh-ancestor
5872261|NCT02328053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5872262|NCT02328053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872263|NCT02328053|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5872264|NCT02328053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5682763|NCT03480607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5682764|NCT03480568|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5682765|NCT03480568|Immunologic Factors|immunologic factors|mesh-ancestor
5682766|NCT03480568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682767|NCT03480516|Fluorides|fluorides|mesh-list
5682768|NCT03480516|Sodium Fluoride|sodium fluoride|mesh-list
5682769|NCT03480516|Fluorides, Topical|fluorides, topical|mesh-list
5682770|NCT03480516|Cariostatic Agents|cariostatic agents|mesh-ancestor
5682771|NCT03480516|Protective Agents|protective agents|mesh-ancestor
5682772|NCT03480516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682773|NCT03480438|Blinatumomab|blinatumomab|mesh-list
5682774|NCT03480438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5872265|NCT02328053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5872266|NCT02328053|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5872267|NCT02328079|Acyclovir|acyclovir|mesh-list
5872268|NCT02328079|Antiviral Agents|antiviral agents|mesh-list
5872269|NCT02328079|Prednisolone|prednisolone|mesh-list
5872270|NCT02328079|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5872271|NCT02328079|Methylprednisolone|methylprednisolone|mesh-list
5872272|NCT02328079|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5872273|NCT02328079|Prednisolone acetate|prednisolone acetate|mesh-list
5872274|NCT02328079|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5872275|NCT02328079|Prednisolone phosphate|prednisolone phosphate|mesh-list
5872276|NCT02328079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5872277|NCT02328079|Glucocorticoids|glucocorticoids|mesh-ancestor
5872278|NCT02328079|Hormones|hormones|mesh-ancestor
5872279|NCT02328079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5872280|NCT02328079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495572|NCT00624130|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6495573|NCT00624130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5682775|NCT03480360|Mycophenolic Acid|mycophenolic acid|mesh-list
5682776|NCT03480360|Cyclophosphamide|cyclophosphamide|mesh-list
5682777|NCT03480360|Fludarabine|fludarabine|mesh-list
5682778|NCT03480360|Tacrolimus|tacrolimus|mesh-list
5682779|NCT03480360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5682780|NCT03480360|Immunologic Factors|immunologic factors|mesh-ancestor
5682781|NCT03480360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682782|NCT03480360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5682783|NCT03480360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5682784|NCT03480360|Alkylating Agents|alkylating agents|mesh-ancestor
5682785|NCT03480360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5682786|NCT03480360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5682787|NCT03480360|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5682788|NCT03480360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5682789|NCT03480360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5682790|NCT03480360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5682791|NCT03480360|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5682792|NCT03480360|Antitubercular Agents|antitubercular agents|mesh-ancestor
5682793|NCT03480360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5682794|NCT03480360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6495574|NCT00624143|Voriconazole|voriconazole|mesh-list
6495575|NCT00624143|Amphotericin B|amphotericin b|mesh-list
6495576|NCT00624143|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6495577|NCT00624143|Antifungal Agents|antifungal agents|mesh-ancestor
6495578|NCT00624143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6495579|NCT00624143|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6495580|NCT00624143|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6495581|NCT00624143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6495582|NCT00624143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495583|NCT00624143|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6495584|NCT00624143|Hormone Antagonists|hormone antagonists|mesh-ancestor
6496519|NCT00628316|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5872281|NCT02328079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5872282|NCT02328079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5872283|NCT02328079|Antiemetics|antiemetics|mesh-ancestor
5872284|NCT02328079|Autonomic Agents|autonomic agents|mesh-ancestor
5872285|NCT02328079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5872286|NCT02328079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5682795|NCT03480334|Nivolumab|nivolumab|mesh-list
5682796|NCT03480334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5682797|NCT03480334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5682798|NCT03480334|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5682799|NCT03480334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5682800|NCT03480321|Cilostazol|cilostazol|mesh-list
5682801|NCT03480321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5682802|NCT03480321|Autonomic Agents|autonomic agents|mesh-ancestor
5682803|NCT03480321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5682804|NCT03480321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682805|NCT03480321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5682806|NCT03480321|Respiratory System Agents|respiratory system agents|mesh-ancestor
5682807|NCT03480321|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5682808|NCT03480321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5682809|NCT03480321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5682810|NCT03480321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5682811|NCT03480321|Vasodilator Agents|vasodilator agents|mesh-ancestor
5682812|NCT03480321|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5682813|NCT03480321|Protective Agents|protective agents|mesh-ancestor
5682814|NCT03480321|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5682815|NCT03480321|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5682816|NCT03480321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5682817|NCT03480308|Dexamethasone|dexamethasone|mesh-list
5682818|NCT03480308|Fentanyl|fentanyl|mesh-list
5872287|NCT02328079|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5872288|NCT02328079|Protective Agents|protective agents|mesh-ancestor
5872289|NCT02328079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5872290|NCT02328209|Ranibizumab|ranibizumab|mesh-list
5872291|NCT02328209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5872292|NCT02328209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5872293|NCT02328209|Growth Substances|growth substances|mesh-ancestor
5872294|NCT02328209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872295|NCT02328209|Growth Inhibitors|growth inhibitors|mesh-ancestor
5872296|NCT02328209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5872297|NCT02328118|Triamcinolone|triamcinolone|mesh-list
5872298|NCT02328118|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5872299|NCT02328118|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5872300|NCT02328118|Ranibizumab|ranibizumab|mesh-list
5872301|NCT02328118|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5872302|NCT02328118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5872303|NCT02328118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5872304|NCT02328118|Growth Substances|growth substances|mesh-ancestor
5872305|NCT02328118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872306|NCT02328118|Growth Inhibitors|growth inhibitors|mesh-ancestor
5872307|NCT02328118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5872308|NCT02328118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5872309|NCT02328118|Glucocorticoids|glucocorticoids|mesh-ancestor
5872310|NCT02328118|Hormones|hormones|mesh-ancestor
5872311|NCT02328118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5872312|NCT02328118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5872313|NCT02328118|Immunologic Factors|immunologic factors|mesh-ancestor
5872314|NCT02328118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5872315|NCT02328118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872316|NCT02328443|Itraconazole|itraconazole|mesh-list
5872317|NCT02328443|Rifampin|rifampin|mesh-list
5872318|NCT02328443|Midazolam|midazolam|mesh-list
5872319|NCT02328443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5872320|NCT02328443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5872321|NCT02328443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5872322|NCT02328443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872323|NCT02328443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5872324|NCT02328443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5872325|NCT02328443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5872326|NCT02328443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5872327|NCT02328443|Anesthetics, General|anesthetics, general|mesh-ancestor
5682819|NCT03480308|Bupivacaine|bupivacaine|mesh-list
5682820|NCT03480308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5872328|NCT02328443|Anesthetics|anesthetics|mesh-ancestor
5872329|NCT02328443|GABA Modulators|gaba modulators|mesh-ancestor
5872330|NCT02328443|GABA Agents|gaba agents|mesh-ancestor
5682821|NCT03480308|Antiemetics|antiemetics|mesh-ancestor
5682822|NCT03480308|Autonomic Agents|autonomic agents|mesh-ancestor
5682823|NCT03480308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5872331|NCT02328443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5872332|NCT02328443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872333|NCT02328443|Antifungal Agents|antifungal agents|mesh-ancestor
5682824|NCT03480308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682825|NCT03480308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5682826|NCT03480308|Glucocorticoids|glucocorticoids|mesh-ancestor
5682827|NCT03480308|Hormones|hormones|mesh-ancestor
5682828|NCT03480308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5682829|NCT03480308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5682830|NCT03480308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5682831|NCT03480308|Anesthetics, Local|anesthetics, local|mesh-ancestor
5682832|NCT03480308|Anesthetics|anesthetics|mesh-ancestor
5682833|NCT03480308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5682834|NCT03480308|Sensory System Agents|sensory system agents|mesh-ancestor
5682835|NCT03480308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5682836|NCT03480308|Narcotics|narcotics|mesh-ancestor
5682837|NCT03480308|Analgesics|analgesics|mesh-ancestor
5682838|NCT03480308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5682839|NCT03480308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5682840|NCT03480308|Anesthetics, General|anesthetics, general|mesh-ancestor
5682841|NCT03480295|Hyaluronic Acid|hyaluronic acid|mesh-list
5682842|NCT03480295|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5682843|NCT03480295|Immunologic Factors|immunologic factors|mesh-ancestor
5682844|NCT03480295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872334|NCT02328443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5872335|NCT02328443|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5872336|NCT02328443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5872337|NCT02328443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5872338|NCT02328443|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6675279|NCT01573754|Hydroxychloroquine|hydroxychloroquine|mesh-list
5872339|NCT02328443|Hormone Antagonists|hormone antagonists|mesh-ancestor
5872340|NCT02328443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5872341|NCT02328443|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5682845|NCT03480295|Viscosupplements|viscosupplements|mesh-ancestor
5682846|NCT03480295|Protective Agents|protective agents|mesh-ancestor
5872342|NCT02328443|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5872343|NCT02328443|Antitubercular Agents|antitubercular agents|mesh-ancestor
5872344|NCT02328443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5872345|NCT02328443|Leprostatic Agents|leprostatic agents|mesh-ancestor
5872346|NCT02328443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5872347|NCT02328443|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5872348|NCT02328443|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5872349|NCT02328443|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5872350|NCT02328443|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5872351|NCT02328443|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5872352|NCT02328443|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5872353|NCT02328144|Metronidazole|metronidazole|mesh-list
5872354|NCT02328144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5872355|NCT02328144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5872356|NCT02328144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5872357|NCT02328144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5872358|NCT02327663|Emtricitabine|emtricitabine|mesh-list
5872359|NCT02327663|Antiviral Agents|antiviral agents|mesh-ancestor
5872360|NCT02327663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5872361|NCT02327663|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6675280|NCT01573754|Antimalarials|antimalarials|mesh-ancestor
5682847|NCT03480191|Daptomycin|daptomycin|mesh-list
5682848|NCT03480191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5682849|NCT03480191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5682850|NCT03480165|Parecoxib|parecoxib|mesh-list
5682851|NCT03480165|Ropivacaine|ropivacaine|mesh-list
5682852|NCT03480165|Anesthetics, Local|anesthetics, local|mesh-ancestor
5682853|NCT03480165|Anesthetics|anesthetics|mesh-ancestor
5682854|NCT03480165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5682855|NCT03480165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682856|NCT03480165|Sensory System Agents|sensory system agents|mesh-ancestor
5682857|NCT03480165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5682858|NCT03480165|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5682859|NCT03480165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5682860|NCT03480165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5682861|NCT03480165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872362|NCT02327663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5872363|NCT02327663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5872364|NCT02327663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872365|NCT02327663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5872366|NCT02327663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5872367|NCT02327676|Emtricitabine|emtricitabine|mesh-list
5872368|NCT02327676|Antiviral Agents|antiviral agents|mesh-ancestor
5872369|NCT02327676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5872370|NCT02327676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5872371|NCT02327676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5872372|NCT02327676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5872373|NCT02327676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5682862|NCT03480165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5682863|NCT03480165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5682864|NCT03480165|Analgesics|analgesics|mesh-ancestor
5682865|NCT03480165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5682866|NCT03480165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5682867|NCT03480100|Xylometazoline|xylometazoline|mesh-list
5682868|NCT03480100|Nasal Decongestants|nasal decongestants|mesh-ancestor
5682869|NCT03480100|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5682870|NCT03480100|Respiratory System Agents|respiratory system agents|mesh-ancestor
5682871|NCT03480061|Dexmedetomidine|dexmedetomidine|mesh-list
5682872|NCT03480061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5682873|NCT03480061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5682874|NCT03480061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682875|NCT03480061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5682876|NCT03480061|Analgesics|analgesics|mesh-ancestor
5682877|NCT03480061|Sensory System Agents|sensory system agents|mesh-ancestor
5682878|NCT03480061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5682879|NCT03480061|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5682880|NCT03480061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5682881|NCT03480061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5682882|NCT03480061|Adrenergic Agents|adrenergic agents|mesh-ancestor
5682883|NCT03480061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5682884|NCT03480061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5682885|NCT03479996|Bupivacaine|bupivacaine|mesh-list
5682886|NCT03479996|Anesthetics, Local|anesthetics, local|mesh-ancestor
5682887|NCT03479996|Anesthetics|anesthetics|mesh-ancestor
5682888|NCT03479996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5682889|NCT03479996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682890|NCT03479996|Sensory System Agents|sensory system agents|mesh-ancestor
5682891|NCT03479996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5682892|NCT03479918|Prednisone|prednisone|mesh-list
5682893|NCT03479918|Cyclophosphamide|cyclophosphamide|mesh-list
5682894|NCT03479918|Doxorubicin|doxorubicin|mesh-list
5682895|NCT03479918|Etoposide|etoposide|mesh-list
5682896|NCT03479918|Vincristine|vincristine|mesh-list
5682897|NCT03479918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5682898|NCT03479918|Immunologic Factors|immunologic factors|mesh-ancestor
5682899|NCT03479918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682900|NCT03479918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5682901|NCT03479918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5872374|NCT02327676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5872375|NCT02327676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5872376|NCT02327728|Botulinum Toxins|botulinum toxins|mesh-list
5872377|NCT02327728|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5872378|NCT02327728|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5872379|NCT02327728|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5872380|NCT02327728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5872381|NCT02327728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872382|NCT02327728|Cholinergic Agents|cholinergic agents|mesh-ancestor
5872383|NCT02327728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5872384|NCT02327728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872385|NCT02327728|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5872386|NCT02327728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5872387|NCT02327624|Clopidogrel|clopidogrel|mesh-list
5872388|NCT02327624|Ticagrelor|ticagrelor|mesh-list
5872389|NCT02327624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5872390|NCT02327624|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5872391|NCT02327624|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5872392|NCT02327624|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5872393|NCT02327624|Purinergic Agents|purinergic agents|mesh-ancestor
5872394|NCT02327624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5682902|NCT03479918|Alkylating Agents|alkylating agents|mesh-ancestor
5872395|NCT02327624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872396|NCT02327624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905667|NCT04908449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5905668|NCT04904549|Vaccines|vaccines|mesh-list
5905669|NCT04904549|Immunologic Factors|immunologic factors|mesh-ancestor
5905670|NCT04904549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5908554|NCT04448184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908555|NCT04448184|Hemostatics|hemostatics|mesh-ancestor
5908556|NCT04448184|Coagulants|coagulants|mesh-ancestor
5908557|NCT04445714|Dapagliflozin|dapagliflozin|mesh-list
5908558|NCT04445714|Saxagliptin|saxagliptin|mesh-list
5908559|NCT04445714|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5908560|NCT04445714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908561|NCT04445714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5908562|NCT04445714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5908563|NCT04445714|Incretins|incretins|mesh-ancestor
5908564|NCT04445714|Hormones|hormones|mesh-ancestor
5908565|NCT04445714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5908566|NCT04445714|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5908567|NCT04445714|Protease Inhibitors|protease inhibitors|mesh-ancestor
5908568|NCT04445714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5908569|NCT04440176|Vaccines|vaccines|mesh-list
5908570|NCT04440176|Immunologic Factors|immunologic factors|mesh-ancestor
5908571|NCT04440176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5908572|NCT04439539|Tenofovir|tenofovir|mesh-list
5908573|NCT04439539|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5908574|NCT04439539|Antiviral Agents|antiviral agents|mesh-ancestor
5908575|NCT04439539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5682903|NCT03479918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5682904|NCT03479918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5682905|NCT03479918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5682906|NCT03479918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5682907|NCT03479918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5682908|NCT03479918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5682909|NCT03479918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5682910|NCT03479918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5908576|NCT04439539|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5908577|NCT04439539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5908578|NCT04439539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5908579|NCT04439539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908580|NCT04439539|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5908581|NCT04439539|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5908582|NCT04430426|Glycolic acid|glycolic acid|mesh-list
5908583|NCT04430426|Keratolytic Agents|keratolytic agents|mesh-ancestor
5908584|NCT04430426|Dermatologic Agents|dermatologic agents|mesh-ancestor
5908585|NCT04428333|Fluorouracil|fluorouracil|mesh-list
5908586|NCT04428333|Pembrolizumab|pembrolizumab|mesh-list
5908587|NCT04428333|Antimetabolites|antimetabolites|mesh-ancestor
6495585|NCT00624143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6495586|NCT00624143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495587|NCT00624143|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6495588|NCT00624143|Amebicides|amebicides|mesh-ancestor
6495589|NCT00624143|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6495590|NCT00624143|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6495591|NCT00624143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6496482|NCT00628225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908588|NCT04428333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908589|NCT04428333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5908590|NCT04428333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5908591|NCT04428333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5908592|NCT04428333|Immunologic Factors|immunologic factors|mesh-ancestor
5908593|NCT04428333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5908594|NCT04428333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5908595|NCT04425252|Brequinar|brequinar|mesh-list
5908596|NCT04425252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5908597|NCT04425252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5908598|NCT04425252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908599|NCT04425252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5908600|NCT04425252|Immunologic Factors|immunologic factors|mesh-ancestor
5908601|NCT04425252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5908602|NCT04424862|Cyclosporine|cyclosporine|mesh-list
5908603|NCT04424862|Mycophenolic Acid|mycophenolic acid|mesh-list
5908604|NCT04424862|Prednisone|prednisone|mesh-list
5872397|NCT02327936|Fesoterodine|fesoterodine|mesh-list
5872398|NCT02327936|Oxybutynin|oxybutynin|mesh-list
5872399|NCT02327936|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5872400|NCT02327936|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5872401|NCT02327936|Cholinergic Agents|cholinergic agents|mesh-ancestor
5872402|NCT02327936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5872403|NCT02327936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872404|NCT02327936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872405|NCT02327936|Urological Agents|urological agents|mesh-ancestor
5872406|NCT02327936|Parasympatholytics|parasympatholytics|mesh-ancestor
5872407|NCT02327936|Autonomic Agents|autonomic agents|mesh-ancestor
5682911|NCT03479918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5682912|NCT03479918|Glucocorticoids|glucocorticoids|mesh-ancestor
5682913|NCT03479918|Hormones|hormones|mesh-ancestor
5682914|NCT03479918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5682915|NCT03479918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5682916|NCT03479918|Tubulin Modulators|tubulin modulators|mesh-ancestor
5682917|NCT03479918|Antimitotic Agents|antimitotic agents|mesh-ancestor
5682918|NCT03479918|Mitosis Modulators|mitosis modulators|mesh-ancestor
5682919|NCT03479879|Misoprostol|misoprostol|mesh-list
5682920|NCT03479879|Estradiol|estradiol|mesh-list
5872408|NCT02327936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5872409|NCT02327793|Labetalol|labetalol|mesh-list
5872410|NCT02327793|Nitroglycerin|nitroglycerin|mesh-list
5872411|NCT02327793|Vasodilator Agents|vasodilator agents|mesh-ancestor
5872412|NCT02327793|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5872413|NCT02327793|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5872414|NCT02327793|Adrenergic Agents|adrenergic agents|mesh-ancestor
5872415|NCT02327793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5872416|NCT02327793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872417|NCT02327793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872418|NCT02327793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5872419|NCT02327793|Sympathomimetics|sympathomimetics|mesh-ancestor
5872420|NCT02327793|Autonomic Agents|autonomic agents|mesh-ancestor
5682921|NCT03479879|Estrogens|estrogens|mesh-ancestor
5682922|NCT03479879|Hormones|hormones|mesh-ancestor
5682923|NCT03479879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5682924|NCT03479879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682925|NCT03479879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5682926|NCT03479879|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5682927|NCT03479879|Abortifacient Agents|abortifacient agents|mesh-ancestor
5682928|NCT03479879|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5682929|NCT03479879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5682930|NCT03479879|Oxytocics|oxytocics|mesh-ancestor
5682931|NCT03479762|Liraglutide|liraglutide|mesh-list
5682932|NCT03479762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5682933|NCT03479762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682934|NCT03479762|Incretins|incretins|mesh-ancestor
5682935|NCT03479762|Hormones|hormones|mesh-ancestor
5682936|NCT03479762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5872421|NCT02327793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5872422|NCT02327793|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5872423|NCT02327793|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5872424|NCT02327754|FYX-051|fyx-051|mesh-list
5872425|NCT02327754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5872426|NCT02327754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872427|NCT02327689|Emtricitabine|emtricitabine|mesh-list
5872428|NCT02327689|Adefovir|adefovir|mesh-list
5872429|NCT02327689|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
5872430|NCT02327689|Antiviral Agents|antiviral agents|mesh-ancestor
5872431|NCT02327689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5872432|NCT02327689|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5872433|NCT02327689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5872434|NCT02327689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5872435|NCT02327689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872436|NCT02327689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5872437|NCT02327689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5872438|NCT02327923|Ketorolac|ketorolac|mesh-list
5872439|NCT02327923|Lidocaine|lidocaine|mesh-list
5872440|NCT02327923|Atropine|atropine|mesh-list
5872441|NCT02327923|Ephedrine|ephedrine|mesh-list
5872442|NCT02327923|Fentanyl|fentanyl|mesh-list
5682937|NCT03479736|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5872443|NCT02327923|Glycopyrrolate|glycopyrrolate|mesh-list
5872444|NCT02327923|Morphine|morphine|mesh-list
5682938|NCT03479736|Fluoroquinolones|fluoroquinolones|mesh-list
5872445|NCT02327923|Tramadol|tramadol|mesh-list
5872446|NCT02327923|Ondansetron|ondansetron|mesh-list
5682939|NCT03479736|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5682940|NCT03479736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5682941|NCT03479736|Antitubercular Agents|antitubercular agents|mesh-ancestor
5682942|NCT03479736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5682943|NCT03479736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5872447|NCT02327923|Bupivacaine|bupivacaine|mesh-list
5872448|NCT02327923|Propofol|propofol|mesh-list
5872449|NCT02327923|Neostigmine|neostigmine|mesh-list
5872450|NCT02327923|Vecuronium Bromide|vecuronium bromide|mesh-list
5872451|NCT02327923|Esmolol|esmolol|mesh-list
5872452|NCT02327923|Anesthetics, Local|anesthetics, local|mesh-ancestor
5872453|NCT02327923|Anesthetics|anesthetics|mesh-ancestor
5872454|NCT02327923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5872455|NCT02327923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872456|NCT02327923|Sensory System Agents|sensory system agents|mesh-ancestor
5872457|NCT02327923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5872458|NCT02327923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5872459|NCT02327923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5872460|NCT02327923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5872461|NCT02327923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5872462|NCT02327923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872463|NCT02327923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5872464|NCT02327923|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5872465|NCT02327923|Anesthetics, General|anesthetics, general|mesh-ancestor
5872466|NCT02327923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5872467|NCT02327923|Narcotics|narcotics|mesh-ancestor
5872468|NCT02327923|Analgesics|analgesics|mesh-ancestor
5872469|NCT02327923|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5872470|NCT02327923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5872471|NCT02327923|Antiemetics|antiemetics|mesh-ancestor
5872472|NCT02327923|Autonomic Agents|autonomic agents|mesh-ancestor
5872473|NCT02327923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5872474|NCT02327923|Antipruritics|antipruritics|mesh-ancestor
5872475|NCT02327923|Dermatologic Agents|dermatologic agents|mesh-ancestor
5872476|NCT02327923|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5872477|NCT02327923|Serotonin Agents|serotonin agents|mesh-ancestor
5872478|NCT02327923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5872479|NCT02327923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5872480|NCT02327923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5872481|NCT02327923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5872482|NCT02327923|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5872483|NCT02327923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5872484|NCT02327923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5872485|NCT02327923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5872486|NCT02327923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5872487|NCT02327923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5872488|NCT02327923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5872489|NCT02327923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5872490|NCT02327923|Respiratory System Agents|respiratory system agents|mesh-ancestor
5872491|NCT02327923|Mydriatics|mydriatics|mesh-ancestor
5872492|NCT02327923|Parasympatholytics|parasympatholytics|mesh-ancestor
5872493|NCT02327923|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5872494|NCT02327923|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5872495|NCT02327923|Cholinergic Agents|cholinergic agents|mesh-ancestor
5872496|NCT02327923|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5872497|NCT02327923|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5872498|NCT02327923|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5872499|NCT02327923|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5872500|NCT02327923|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5872501|NCT02327923|Adrenergic Agents|adrenergic agents|mesh-ancestor
5872502|NCT02327923|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5872503|NCT02327923|Sympathomimetics|sympathomimetics|mesh-ancestor
5872504|NCT02327923|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5872505|NCT02327923|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5872506|NCT02327923|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5872507|NCT02327923|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5872508|NCT02327923|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
5872509|NCT02327715|Emtricitabine|emtricitabine|mesh-list
5872510|NCT02327715|Antiviral Agents|antiviral agents|mesh-ancestor
5872511|NCT02327715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5872512|NCT02327715|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5872513|NCT02327715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5682944|NCT03479736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872514|NCT02327715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5682945|NCT03479684|Warfarin|warfarin|mesh-list
5682946|NCT03479684|Anticoagulants|anticoagulants|mesh-ancestor
5872515|NCT02327715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872516|NCT02327715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5872517|NCT02327715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5872518|NCT02327702|Emtricitabine|emtricitabine|mesh-list
5872519|NCT02327702|Antiviral Agents|antiviral agents|mesh-ancestor
5872520|NCT02327702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5872521|NCT02327702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5872522|NCT02327702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5872523|NCT02327702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5872524|NCT02327702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872525|NCT02327702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5872526|NCT02327702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5872527|NCT02327338|Ibuprofen|ibuprofen|mesh-list
5872528|NCT02327338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5872529|NCT02327338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5872530|NCT02327338|Analgesics|analgesics|mesh-ancestor
5872531|NCT02327338|Sensory System Agents|sensory system agents|mesh-ancestor
5872532|NCT02327338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5872533|NCT02327338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872534|NCT02327338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5872535|NCT02327338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5872536|NCT02327338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5872537|NCT02327338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5872538|NCT02327338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872539|NCT02327299|Fesoterodine|fesoterodine|mesh-list
5872540|NCT02327299|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5872541|NCT02327299|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5872542|NCT02327299|Cholinergic Agents|cholinergic agents|mesh-ancestor
5872543|NCT02327299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5872544|NCT02327299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872545|NCT02327299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872546|NCT02327299|Urological Agents|urological agents|mesh-ancestor
5872547|NCT02327416|Entecavir|entecavir|mesh-list
5872548|NCT02327416|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
5682947|NCT03479554|Antihypertensive Agents|antihypertensive agents|mesh-list
5682948|NCT03479502|Doxycycline|doxycycline|mesh-list
5682949|NCT03479502|Prednisone|prednisone|mesh-list
5682950|NCT03479502|Methylprednisolone|methylprednisolone|mesh-list
5682951|NCT03479502|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5682952|NCT03479502|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5682953|NCT03479502|Prednisolone|prednisolone|mesh-list
5682954|NCT03479502|Prednisolone acetate|prednisolone acetate|mesh-list
5682955|NCT03479502|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5682956|NCT03479502|Prednisolone phosphate|prednisolone phosphate|mesh-list
5682957|NCT03479502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5682958|NCT03479502|Glucocorticoids|glucocorticoids|mesh-ancestor
5682959|NCT03479502|Hormones|hormones|mesh-ancestor
5682960|NCT03479502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5872549|NCT02327416|Interferon-alpha|interferon-alpha|mesh-list
5872550|NCT02327416|Adefovir|adefovir|mesh-list
5872551|NCT02327416|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
5872552|NCT02327416|Molgramostim|molgramostim|mesh-list
5872553|NCT02327416|Sargramostim|sargramostim|mesh-list
5872554|NCT02327416|Immunologic Factors|immunologic factors|mesh-ancestor
5872555|NCT02327416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872556|NCT02327416|Antiviral Agents|antiviral agents|mesh-ancestor
5872557|NCT02327416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5872558|NCT02327416|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5872559|NCT02327416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5872560|NCT02327416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5872561|NCT02327416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872562|NCT02327416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5872563|NCT02327403|Abatacept|abatacept|mesh-list
5872564|NCT02327403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5872565|NCT02327403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5682961|NCT03479502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682962|NCT03479502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5682963|NCT03479502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5682964|NCT03479502|Antiemetics|antiemetics|mesh-ancestor
5682965|NCT03479502|Autonomic Agents|autonomic agents|mesh-ancestor
5682966|NCT03479502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5682967|NCT03479502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5682968|NCT03479502|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5682969|NCT03479502|Protective Agents|protective agents|mesh-ancestor
5682970|NCT03479502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5872566|NCT02327403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5872567|NCT02327403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5872568|NCT02327403|Immunologic Factors|immunologic factors|mesh-ancestor
5872569|NCT02327403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872570|NCT02327403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5872571|NCT02327455|Dobutamine|dobutamine|mesh-list
5872572|NCT02327455|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5872573|NCT02327455|Sympathomimetics|sympathomimetics|mesh-ancestor
5872574|NCT02327455|Autonomic Agents|autonomic agents|mesh-ancestor
5872575|NCT02327455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5872576|NCT02327455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872577|NCT02327455|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5872578|NCT02327455|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5872579|NCT02327455|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5872580|NCT02327455|Adrenergic Agents|adrenergic agents|mesh-ancestor
5682971|NCT03479502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5682972|NCT03479502|Antimalarials|antimalarials|mesh-ancestor
5682973|NCT03479502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5682974|NCT03479502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5682975|NCT03479476|Metformin|metformin|mesh-list
5682976|NCT03479476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5682977|NCT03479476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682978|NCT03479450|Pulmonary Surfactants|pulmonary surfactants|mesh-list
5682979|NCT03479450|Respiratory System Agents|respiratory system agents|mesh-ancestor
5682980|NCT03479411|Itraconazole|itraconazole|mesh-list
5682981|NCT03479411|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
5682982|NCT03479411|Antifungal Agents|antifungal agents|mesh-ancestor
5682983|NCT03479411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5682984|NCT03479411|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5682985|NCT03479411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5682986|NCT03479411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5682987|NCT03479411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5682988|NCT03479411|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5682989|NCT03479411|Hormone Antagonists|hormone antagonists|mesh-ancestor
5682990|NCT03479411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5682991|NCT03479411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5682992|NCT03479411|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5682993|NCT03479372|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5682994|NCT03479372|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5872581|NCT02327455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5872582|NCT02327455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872583|NCT02327455|Protective Agents|protective agents|mesh-ancestor
5872584|NCT02327234|Ibuprofen|ibuprofen|mesh-list
5872585|NCT02327234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5872586|NCT02327234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5872587|NCT02327234|Analgesics|analgesics|mesh-ancestor
5872588|NCT02327234|Sensory System Agents|sensory system agents|mesh-ancestor
5872589|NCT02327234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5872590|NCT02327234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872591|NCT02327234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5872592|NCT02327234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5872593|NCT02327234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5872594|NCT02327234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5872595|NCT02327234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872596|NCT02327247|Felodipine|felodipine|mesh-list
5872597|NCT02327247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5872598|NCT02327247|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5872599|NCT02327247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5872600|NCT02327247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5872601|NCT02327247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872602|NCT02327247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5872603|NCT02327247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872604|NCT02327247|Vasodilator Agents|vasodilator agents|mesh-ancestor
5682995|NCT03479320|Lidocaine|lidocaine|mesh-list
5682996|NCT03479320|Anesthetics, Local|anesthetics, local|mesh-ancestor
5682997|NCT03479320|Anesthetics|anesthetics|mesh-ancestor
5682998|NCT03479320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5872605|NCT02327195|Methylphenidate|methylphenidate|mesh-list
5872606|NCT02327195|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5872607|NCT02327195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872608|NCT02327195|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5872609|NCT02327195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5682999|NCT03479320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872610|NCT02327195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5872611|NCT02327195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872612|NCT02327195|Dopamine Agents|dopamine agents|mesh-ancestor
5872613|NCT02327195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5872614|NCT02327156|Dexmedetomidine|dexmedetomidine|mesh-list
5872615|NCT02327156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5872616|NCT02327156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5872617|NCT02327156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872618|NCT02327156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5872619|NCT02327156|Analgesics|analgesics|mesh-ancestor
5872620|NCT02327156|Sensory System Agents|sensory system agents|mesh-ancestor
5872621|NCT02327156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5872622|NCT02327156|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5872623|NCT02327156|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5683000|NCT03479320|Sensory System Agents|sensory system agents|mesh-ancestor
5683001|NCT03479320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5683002|NCT03479320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5872624|NCT02327156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5872625|NCT02327156|Adrenergic Agents|adrenergic agents|mesh-ancestor
5872626|NCT02327156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5872627|NCT02327156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872628|NCT02327000|Pregabalin|pregabalin|mesh-list
5872629|NCT02327000|Analgesics|analgesics|mesh-ancestor
5872630|NCT02327000|Sensory System Agents|sensory system agents|mesh-ancestor
5872631|NCT02327000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5872632|NCT02327000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872633|NCT02327000|Anticonvulsants|anticonvulsants|mesh-ancestor
5872634|NCT02327000|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5872635|NCT02327000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5872636|NCT02327000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872637|NCT02327000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5872638|NCT02327000|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5872639|NCT02327000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5872640|NCT02327000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5872641|NCT02327000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5872642|NCT02327091|Alfacalcidol|alfacalcidol|mesh-list
5872643|NCT02327091|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
5872644|NCT02327091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5872645|NCT02327091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872646|NCT02327091|Vitamins|vitamins|mesh-ancestor
5872647|NCT02327091|Micronutrients|micronutrients|mesh-ancestor
5872648|NCT02326922|Levonorgestrel|levonorgestrel|mesh-list
5872649|NCT02326922|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5872650|NCT02326922|Contraceptive Agents|contraceptive agents|mesh-ancestor
5872651|NCT02326922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5683003|NCT03479320|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5683004|NCT03479320|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5683005|NCT03479320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5683006|NCT03479320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683007|NCT03479268|Enzyme Inhibitors|enzyme inhibitors|mesh-list
5683008|NCT03479268|Pevonedistat|pevonedistat|mesh-list
5683009|NCT03479268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683010|NCT03479086|Topiramate|topiramate|mesh-list
5683011|NCT03479086|Naltrexone|naltrexone|mesh-list
5683012|NCT03479086|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5683013|NCT03479086|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5683014|NCT03479086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683015|NCT03479086|Sensory System Agents|sensory system agents|mesh-ancestor
5683016|NCT03479086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5683017|NCT03479086|Anticonvulsants|anticonvulsants|mesh-ancestor
5683018|NCT03479086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5697072|NCT03378427|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5697073|NCT03378427|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5697074|NCT03378427|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
5697075|NCT03378401|Octenidine|octenidine|mesh-list
5697076|NCT03378401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5697077|NCT03378401|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5697078|NCT03378323|Anesthetics|anesthetics|mesh-list
5697079|NCT03378323|Anesthetics, Local|anesthetics, local|mesh-list
5697080|NCT03378323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5697081|NCT03378323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697082|NCT03378323|Sensory System Agents|sensory system agents|mesh-ancestor
5697083|NCT03378323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5683019|NCT03478709|Norepinephrine|norepinephrine|mesh-list
5683020|NCT03478709|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5872652|NCT02326922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872653|NCT02326922|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5872654|NCT02326922|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5872655|NCT02326922|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5872656|NCT02326987|Pregabalin|pregabalin|mesh-list
5683021|NCT03478709|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5683022|NCT03478709|Adrenergic Agents|adrenergic agents|mesh-ancestor
5683023|NCT03478709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5683024|NCT03478709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683025|NCT03478709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683026|NCT03478709|Sympathomimetics|sympathomimetics|mesh-ancestor
5683027|NCT03478709|Autonomic Agents|autonomic agents|mesh-ancestor
5683028|NCT03478709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5683029|NCT03478709|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5872657|NCT02326987|Analgesics|analgesics|mesh-ancestor
5872658|NCT02326987|Sensory System Agents|sensory system agents|mesh-ancestor
5872659|NCT02326987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5872660|NCT02326987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872661|NCT02326987|Anticonvulsants|anticonvulsants|mesh-ancestor
5872662|NCT02326987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5872663|NCT02326987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5872664|NCT02326987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872665|NCT02326987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5872666|NCT02326987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5872667|NCT02326987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5872668|NCT02326987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5872669|NCT02326987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5872670|NCT02327039|Dapagliflozin|dapagliflozin|mesh-list
5872671|NCT02327039|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5872672|NCT02327039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872673|NCT02327039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5683030|NCT03478605|Dexamethasone|dexamethasone|mesh-list
5683031|NCT03478605|Ondansetron|ondansetron|mesh-list
5683032|NCT03478605|Olanzapine|olanzapine|mesh-list
5683033|NCT03478605|Aprepitant|aprepitant|mesh-list
5683034|NCT03478605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5683035|NCT03478605|Antiemetics|antiemetics|mesh-ancestor
5683036|NCT03478605|Autonomic Agents|autonomic agents|mesh-ancestor
5683037|NCT03478605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5683038|NCT03478605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683039|NCT03478605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5683040|NCT03478605|Glucocorticoids|glucocorticoids|mesh-ancestor
5683041|NCT03478605|Hormones|hormones|mesh-ancestor
5683042|NCT03478605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5683043|NCT03478605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5683044|NCT03478605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5683045|NCT03478605|Antipruritics|antipruritics|mesh-ancestor
5683046|NCT03478605|Dermatologic Agents|dermatologic agents|mesh-ancestor
5683047|NCT03478605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5683048|NCT03478605|Serotonin Agents|serotonin agents|mesh-ancestor
5683049|NCT03478605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5683050|NCT03478605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683051|NCT03478605|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5683052|NCT03478605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5683053|NCT03478605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5683054|NCT03478605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5683055|NCT03478605|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5683056|NCT03478605|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5683057|NCT03478605|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5683058|NCT03478605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5683059|NCT03478605|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5683060|NCT03478540|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
5683061|NCT03478540|Antiviral Agents|antiviral agents|mesh-ancestor
5683062|NCT03478540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5683063|NCT03478514|Palbociclib|palbociclib|mesh-list
5683064|NCT03478514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5683065|NCT03478514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5683066|NCT03478514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5683067|NCT03478514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683068|NCT03478488|Gemcitabine|gemcitabine|mesh-list
5905671|NCT04886453|Morphine|morphine|mesh-list
6212412|NCT02187744|Mitosis Modulators|mitosis modulators|mesh-ancestor
5683069|NCT03478488|Oxaliplatin|oxaliplatin|mesh-list
5872674|NCT02327039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872675|NCT02327078|Nivolumab|nivolumab|mesh-list
5872676|NCT02327078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5872677|NCT02327078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5872678|NCT02327078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5872679|NCT02327078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872680|NCT02326779|Aspirin|aspirin|mesh-list
5872681|NCT02326779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5872682|NCT02326779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5872683|NCT02326779|Analgesics|analgesics|mesh-ancestor
5872684|NCT02326779|Sensory System Agents|sensory system agents|mesh-ancestor
5872685|NCT02326779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5872686|NCT02326779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872687|NCT02326779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5872688|NCT02326779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5872689|NCT02326779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5872690|NCT02326779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5872691|NCT02326779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872692|NCT02326779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5872693|NCT02326779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5872694|NCT02326779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5872695|NCT02326779|Antipyretics|antipyretics|mesh-ancestor
5683070|NCT03478488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5683071|NCT03478488|Antimetabolites|antimetabolites|mesh-ancestor
5683072|NCT03478488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683073|NCT03478488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5683074|NCT03478488|Antiviral Agents|antiviral agents|mesh-ancestor
5683075|NCT03478488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5683076|NCT03478488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5683077|NCT03478488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5683078|NCT03478488|Immunologic Factors|immunologic factors|mesh-ancestor
5683079|NCT03478488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683080|NCT03478475|Cholecalciferol|cholecalciferol|mesh-list
5683081|NCT03478475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5683082|NCT03478475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683083|NCT03478475|Vitamins|vitamins|mesh-ancestor
5683084|NCT03478475|Micronutrients|micronutrients|mesh-ancestor
5683085|NCT03478475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5683086|NCT03478436|Doxycycline|doxycycline|mesh-list
5872696|NCT02326727|Fentanyl|fentanyl|mesh-list
5872697|NCT02326727|Nitrous Oxide|nitrous oxide|mesh-list
5872698|NCT02326727|Propofol|propofol|mesh-list
5872699|NCT02326727|Ropivacaine|ropivacaine|mesh-list
5872700|NCT02326727|Isoflurane|isoflurane|mesh-list
5872701|NCT02326727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5872702|NCT02326727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5872703|NCT02326727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872704|NCT02326727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5683087|NCT03478436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5683088|NCT03478436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5683089|NCT03478436|Antimalarials|antimalarials|mesh-ancestor
5872705|NCT02326727|Anesthetics, General|anesthetics, general|mesh-ancestor
5872706|NCT02326727|Anesthetics|anesthetics|mesh-ancestor
5683090|NCT03478436|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5683091|NCT03478436|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5683092|NCT03478423|Oxycodone|oxycodone|mesh-list
5683093|NCT03478423|Hydromorphone|hydromorphone|mesh-list
5683094|NCT03478423|Codeine|codeine|mesh-list
5683095|NCT03478423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5683096|NCT03478423|Narcotics|narcotics|mesh-ancestor
5872707|NCT02326727|Anesthetics, Local|anesthetics, local|mesh-ancestor
5872708|NCT02326727|Sensory System Agents|sensory system agents|mesh-ancestor
5872709|NCT02326727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5872710|NCT02326727|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5872711|NCT02326727|Narcotics|narcotics|mesh-ancestor
5683097|NCT03478423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5683098|NCT03478423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683099|NCT03478423|Analgesics|analgesics|mesh-ancestor
5683100|NCT03478423|Sensory System Agents|sensory system agents|mesh-ancestor
5683101|NCT03478423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5683102|NCT03478423|Antitussive Agents|antitussive agents|mesh-ancestor
5683103|NCT03478423|Respiratory System Agents|respiratory system agents|mesh-ancestor
5683104|NCT03478358|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
5683105|NCT03478358|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
5683106|NCT03478358|(177)Lu-DOTA-EB-TATE|(177)lu-dota-eb-tate|mesh-list
5683107|NCT03478358|Chelating Agents|chelating agents|mesh-ancestor
5683108|NCT03478358|Sequestering Agents|sequestering agents|mesh-ancestor
5683109|NCT03478358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683110|NCT03478358|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5683111|NCT03478345|Endocrine Disruptors|endocrine disruptors|mesh-list
5683112|NCT03478345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683113|NCT03478332|Nitroglycerin|nitroglycerin|mesh-list
5683114|NCT03478332|Vasodilator Agents|vasodilator agents|mesh-ancestor
5683115|NCT03478306|Melatonin|melatonin|mesh-list
5683116|NCT03478306|Antioxidants|antioxidants|mesh-ancestor
5683117|NCT03478306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683118|NCT03478306|Protective Agents|protective agents|mesh-ancestor
5683119|NCT03478306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683120|NCT03478306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5683121|NCT03478280|Brodalumab|brodalumab|mesh-list
5683122|NCT03478280|Dermatologic Agents|dermatologic agents|mesh-ancestor
5683123|NCT03478150|Zinc Oxide|zinc oxide|mesh-list
5683124|NCT03478150|Dermatologic Agents|dermatologic agents|mesh-ancestor
5683125|NCT03478150|Sunscreening Agents|sunscreening agents|mesh-ancestor
5872712|NCT02326727|Analgesics|analgesics|mesh-ancestor
5872713|NCT02326727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5872714|NCT02326727|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5872715|NCT02326727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5872716|NCT02326428|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5872717|NCT02326428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5872718|NCT02326428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5872719|NCT02326428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872720|NCT02326441|KX2-361|kx2-361|mesh-list
5872721|NCT02326441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5872722|NCT02326441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5872723|NCT02326441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872724|NCT02326441|Tubulin Modulators|tubulin modulators|mesh-ancestor
5872725|NCT02326441|Antimitotic Agents|antimitotic agents|mesh-ancestor
5872726|NCT02326441|Mitosis Modulators|mitosis modulators|mesh-ancestor
5872727|NCT02326441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5872728|NCT02326584|Cytarabine|cytarabine|mesh-list
5872729|NCT02326584|Daunorubicin|daunorubicin|mesh-list
5872730|NCT02326584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5872731|NCT02326584|Antimetabolites|antimetabolites|mesh-ancestor
5872732|NCT02326584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872733|NCT02326584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5872734|NCT02326584|Antiviral Agents|antiviral agents|mesh-ancestor
5872735|NCT02326584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5872736|NCT02326584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5872737|NCT02326584|Immunologic Factors|immunologic factors|mesh-ancestor
5872738|NCT02326584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872739|NCT02326584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5872740|NCT02326584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5872741|NCT02326584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5872742|NCT02326584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5872743|NCT02326311|Imatinib Mesylate|imatinib mesylate|mesh-list
5872744|NCT02326311|Dasatinib|dasatinib|mesh-list
5872745|NCT02326311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5872746|NCT02326311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5872747|NCT02326311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5872748|NCT02326311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872749|NCT02326623|Anesthetics|anesthetics|mesh-list
5872750|NCT02326623|Anesthetics, Local|anesthetics, local|mesh-list
5872751|NCT02326623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5872752|NCT02326623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872753|NCT02326623|Sensory System Agents|sensory system agents|mesh-ancestor
5872754|NCT02326623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5872755|NCT02326610|Hormones|hormones|mesh-list
5872756|NCT02326610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5872757|NCT02326610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872758|NCT02326376|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5872759|NCT02326376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5872760|NCT02326350|Aspirin|aspirin|mesh-list
5683126|NCT03478150|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5683127|NCT03478150|Protective Agents|protective agents|mesh-ancestor
5683128|NCT03478150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683129|NCT03478111|Methotrexate|methotrexate|mesh-list
5683130|NCT03478111|Infliximab|infliximab|mesh-list
5683131|NCT03478111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5683132|NCT03478111|Abortifacient Agents|abortifacient agents|mesh-ancestor
5872761|NCT02326350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5872762|NCT02326350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5872763|NCT02326350|Analgesics|analgesics|mesh-ancestor
5872764|NCT02326350|Sensory System Agents|sensory system agents|mesh-ancestor
5872765|NCT02326350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5872766|NCT02326350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683133|NCT03478111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5683134|NCT03478111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683135|NCT03478111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5683136|NCT03478111|Antimetabolites|antimetabolites|mesh-ancestor
5683137|NCT03478111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683138|NCT03478111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5683139|NCT03478111|Dermatologic Agents|dermatologic agents|mesh-ancestor
5683140|NCT03478111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5683141|NCT03478111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5683142|NCT03478111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5683143|NCT03478111|Immunologic Factors|immunologic factors|mesh-ancestor
5683144|NCT03478111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5872767|NCT02326350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5872768|NCT02326350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5872769|NCT02326350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5872770|NCT02326350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5872771|NCT02326350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872772|NCT02326350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5872773|NCT02326350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5872774|NCT02326350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5872775|NCT02326350|Antipyretics|antipyretics|mesh-ancestor
5872776|NCT02326285|Docetaxel|docetaxel|mesh-list
5872777|NCT02326285|Gefitinib|gefitinib|mesh-list
5872778|NCT02326285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5872779|NCT02326285|Tubulin Modulators|tubulin modulators|mesh-ancestor
5872780|NCT02326285|Antimitotic Agents|antimitotic agents|mesh-ancestor
5872781|NCT02326285|Mitosis Modulators|mitosis modulators|mesh-ancestor
5872782|NCT02326285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872783|NCT02326285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5872784|NCT02326285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5872785|NCT02326090|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5872786|NCT02326090|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5872787|NCT02326103|Ciprofloxacin|ciprofloxacin|mesh-list
5872788|NCT02326103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5872789|NCT02326103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5872790|NCT02326103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5872791|NCT02326103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5872792|NCT02326103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5872793|NCT02326103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872794|NCT02326103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5872795|NCT02326103|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5872796|NCT02326103|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5872797|NCT02326194|Vaccines|vaccines|mesh-list
5872798|NCT02326194|Immunologic Factors|immunologic factors|mesh-ancestor
5872799|NCT02326194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872800|NCT02325986|Fluorouracil|fluorouracil|mesh-list
5872801|NCT02325986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5872802|NCT02325986|Antimetabolites|antimetabolites|mesh-ancestor
5872803|NCT02325986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872804|NCT02325986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5872805|NCT02325986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5872806|NCT02325986|Immunologic Factors|immunologic factors|mesh-ancestor
5872807|NCT02325986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872808|NCT02326038|Methylphenidate|methylphenidate|mesh-list
5872809|NCT02326038|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5872810|NCT02326038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872811|NCT02326038|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5872812|NCT02326038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5872813|NCT02326038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5872814|NCT02326038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872815|NCT02326038|Dopamine Agents|dopamine agents|mesh-ancestor
5872816|NCT02326038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5872817|NCT02326051|Enoxaparin|enoxaparin|mesh-list
5872818|NCT02326051|Enoxaparin sodium|enoxaparin sodium|mesh-list
5872819|NCT02326051|Anticoagulants|anticoagulants|mesh-ancestor
5872820|NCT02326051|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5872821|NCT02326051|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5872822|NCT02326051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905672|NCT04886453|Anesthetics|anesthetics|mesh-list
5683145|NCT03478111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5683146|NCT03478111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5683147|NCT03478033|Rifampin|rifampin|mesh-list
5872823|NCT02326168|BCG Vaccine|bcg vaccine|mesh-list
5872824|NCT02326168|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5872825|NCT02326168|Immunologic Factors|immunologic factors|mesh-ancestor
5872826|NCT02326168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872827|NCT05076981|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5872828|NCT05076981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5872829|NCT05076981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872830|NCT05076955|Vancomycin|vancomycin|mesh-list
5872831|NCT05076955|Tobramycin|tobramycin|mesh-list
5872832|NCT05076955|Itraconazole|itraconazole|mesh-list
5872833|NCT05076955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5872834|NCT05076955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5683148|NCT03478033|Rifabutin|rifabutin|mesh-list
5683149|NCT03478033|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5683150|NCT03478033|Antitubercular Agents|antitubercular agents|mesh-ancestor
5683151|NCT03478033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5683152|NCT03478033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5683153|NCT03478033|Leprostatic Agents|leprostatic agents|mesh-ancestor
5683154|NCT03478033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5683155|NCT03478033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5683156|NCT03478033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683157|NCT03478033|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5683158|NCT03478033|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5683159|NCT03478033|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5683160|NCT03478033|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5683161|NCT03478033|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5683162|NCT03478033|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5683163|NCT03478020|Contraceptive Agents|contraceptive agents|mesh-list
5683164|NCT03478020|Contraceptives, Oral|contraceptives, oral|mesh-list
5683165|NCT03478020|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
5697084|NCT03378310|Linrodostat|linrodostat|mesh-list
5872835|NCT05076955|Antifungal Agents|antifungal agents|mesh-ancestor
5872836|NCT05076955|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5872837|NCT05076955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5872838|NCT05076955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5872839|NCT05076955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872840|NCT05076955|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5872841|NCT05076955|Hormone Antagonists|hormone antagonists|mesh-ancestor
5872842|NCT05076955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5872843|NCT05076955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872844|NCT05076955|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5872845|NCT05076942|Cisplatin|cisplatin|mesh-list
5872846|NCT05076942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5872847|NCT05076799|Lactulose|lactulose|mesh-list
5872848|NCT05076799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5872849|NCT05076773|Morphine|morphine|mesh-list
5872850|NCT05076773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5872851|NCT05076773|Narcotics|narcotics|mesh-ancestor
5872852|NCT05076773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5872853|NCT05076773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872854|NCT05076773|Analgesics|analgesics|mesh-ancestor
5872855|NCT05076773|Sensory System Agents|sensory system agents|mesh-ancestor
5872856|NCT05076773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5872857|NCT05076695|Trastuzumab|trastuzumab|mesh-list
5872858|NCT05076695|Fulvestrant|fulvestrant|mesh-list
5872859|NCT05076695|Palbociclib|palbociclib|mesh-list
5872860|NCT05076695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5872861|NCT05076695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5872862|NCT05076695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5872863|NCT05076695|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5872864|NCT05076695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5872865|NCT05076695|Hormone Antagonists|hormone antagonists|mesh-ancestor
5872866|NCT05076695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5872867|NCT05076695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872868|NCT05076695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5872869|NCT05076695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5872870|NCT05076695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872871|NCT05076682|Cromolyn Sodium|cromolyn sodium|mesh-list
5872872|NCT05076682|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5872873|NCT05076682|Choline|choline|mesh-list
5872874|NCT05076682|Lipotropic Agents|lipotropic agents|mesh-ancestor
5683166|NCT03478020|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5683167|NCT03478020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683168|NCT03478020|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5683169|NCT03477994|Clonidine|clonidine|mesh-list
5683170|NCT03477994|Dexmedetomidine|dexmedetomidine|mesh-list
5683171|NCT03477994|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5683172|NCT03477994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5683173|NCT03477994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683174|NCT03477994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5683175|NCT03477994|Analgesics|analgesics|mesh-ancestor
5683176|NCT03477994|Sensory System Agents|sensory system agents|mesh-ancestor
5683177|NCT03477994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5683178|NCT03477994|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5683179|NCT03477994|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5872875|NCT05076682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5872876|NCT05076682|Antimetabolites|antimetabolites|mesh-ancestor
5872877|NCT05076682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872878|NCT05076682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5872879|NCT05076682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5872880|NCT05076682|Nootropic Agents|nootropic agents|mesh-ancestor
5872881|NCT05076682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5872882|NCT05076682|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
5872883|NCT05076682|Immunologic Factors|immunologic factors|mesh-ancestor
5872884|NCT05076682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872885|NCT05076682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5872886|NCT05076682|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5872887|NCT05076682|Respiratory System Agents|respiratory system agents|mesh-ancestor
5872888|NCT05076604|Cardioplegic Solutions|cardioplegic solutions|mesh-list
5872889|NCT05076604|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5872890|NCT05076526|Hyaluronic Acid|hyaluronic acid|mesh-list
5872891|NCT05076526|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5872892|NCT05076526|Immunologic Factors|immunologic factors|mesh-ancestor
5872893|NCT05076526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872894|NCT05076526|Viscosupplements|viscosupplements|mesh-ancestor
5872895|NCT05076526|Protective Agents|protective agents|mesh-ancestor
5872896|NCT05076474|Orlistat|orlistat|mesh-list
5872897|NCT05076474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5872898|NCT05076474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872899|NCT05076474|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5872900|NCT05076474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5872901|NCT05076461|Ondansetron|ondansetron|mesh-list
5872902|NCT05076461|Antiemetics|antiemetics|mesh-ancestor
5872903|NCT05076461|Autonomic Agents|autonomic agents|mesh-ancestor
5872904|NCT05076461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5872905|NCT05076461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872906|NCT05076461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5872907|NCT05076461|Antipruritics|antipruritics|mesh-ancestor
5872908|NCT05076461|Dermatologic Agents|dermatologic agents|mesh-ancestor
5872909|NCT05076461|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5872910|NCT05076461|Serotonin Agents|serotonin agents|mesh-ancestor
5872911|NCT05076461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5872912|NCT05076461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872913|NCT05076461|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5872914|NCT05076461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5872915|NCT05076461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5872916|NCT05076461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5872917|NCT05076461|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5872918|NCT05076292|Glucagon|glucagon|mesh-list
5872919|NCT05076292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5872920|NCT05076292|Hormones|hormones|mesh-ancestor
5872921|NCT05076292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5683180|NCT03477994|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5683181|NCT03477994|Adrenergic Agents|adrenergic agents|mesh-ancestor
5683182|NCT03477994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5683183|NCT03477994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683184|NCT03477994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5683185|NCT03477994|Sympatholytics|sympatholytics|mesh-ancestor
5683186|NCT03477994|Autonomic Agents|autonomic agents|mesh-ancestor
5683187|NCT03477955|Silicon|silicon|mesh-list
5683188|NCT03477955|Trace Elements|trace elements|mesh-ancestor
5683189|NCT03477955|Micronutrients|micronutrients|mesh-ancestor
5683190|NCT03477955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683191|NCT03477929|Cetrorelix|cetrorelix|mesh-list
5683192|NCT03477929|Ganirelix|ganirelix|mesh-list
5872922|NCT05076292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683193|NCT03477929|Hormone Antagonists|hormone antagonists|mesh-ancestor
5872923|NCT05076227|Vaccines|vaccines|mesh-list
5872924|NCT05076227|Immunologic Factors|immunologic factors|mesh-ancestor
5872925|NCT05076227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872926|NCT05076175|Ozanimod|ozanimod|mesh-list
5872927|NCT05076175|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5872928|NCT05076175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872929|NCT05076175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5872930|NCT05076175|Immunologic Factors|immunologic factors|mesh-ancestor
5872931|NCT05076175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872932|NCT05076019|Atorvastatin|atorvastatin|mesh-list
5872933|NCT05076019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5872934|NCT05076019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5872935|NCT05076019|Antimetabolites|antimetabolites|mesh-ancestor
5872936|NCT05076019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872937|NCT05076019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5872938|NCT05076019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5872939|NCT05076019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5872940|NCT05076006|PF-06700841|pf-06700841|mesh-list
5872941|NCT05076006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5872942|NCT05076006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5872943|NCT05076006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872944|NCT05069857|Apatinib|apatinib|mesh-list
5683194|NCT03477929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5683195|NCT03477929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683196|NCT03477929|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5683197|NCT03477929|Fertility Agents|fertility agents|mesh-ancestor
5683198|NCT03477929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5683199|NCT03477864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5683200|NCT03477864|Ipilimumab|ipilimumab|mesh-list
5683201|NCT03477864|Cemiplimab|cemiplimab|mesh-list
5872945|NCT05069857|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5872946|NCT05069857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5872947|NCT05069857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5872948|NCT05069857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5872949|NCT05069857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872950|NCT05063136|Capecitabine|capecitabine|mesh-list
5872951|NCT05063136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5872952|NCT05063136|Antimetabolites|antimetabolites|mesh-ancestor
5872953|NCT05063136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872954|NCT05063136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5872955|NCT05034809|Melatonin|melatonin|mesh-list
5872956|NCT05034809|Antioxidants|antioxidants|mesh-ancestor
5872957|NCT05034809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872958|NCT05034809|Protective Agents|protective agents|mesh-ancestor
5872959|NCT05034809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872960|NCT05034809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5872961|NCT04998032|Metformin|metformin|mesh-list
5872962|NCT04998032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5872963|NCT04998032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872964|NCT04993924|Cetrorelix|cetrorelix|mesh-list
5872965|NCT04993924|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5872966|NCT04993924|Fertility Agents|fertility agents|mesh-ancestor
5872967|NCT04993924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5872968|NCT04993924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872969|NCT04993924|Hormone Antagonists|hormone antagonists|mesh-ancestor
5872970|NCT04993924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5872971|NCT04982614|Vaccines|vaccines|mesh-list
5872972|NCT04982614|Immunologic Factors|immunologic factors|mesh-ancestor
5872973|NCT04982614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872974|NCT04978259|Remdesivir|remdesivir|mesh-list
5683202|NCT03477864|Antibodies|antibodies|mesh-list
5683203|NCT03477864|Immunoglobulins|immunoglobulins|mesh-list
5872975|NCT04978259|Antimetabolites|antimetabolites|mesh-ancestor
5872976|NCT04978259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872977|NCT04978259|Antiviral Agents|antiviral agents|mesh-ancestor
5872978|NCT04978259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5872979|NCT04956042|Cytarabine|cytarabine|mesh-list
5872980|NCT04956042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5872981|NCT04956042|Antimetabolites|antimetabolites|mesh-ancestor
5872982|NCT04956042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872983|NCT04956042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5872984|NCT04956042|Antiviral Agents|antiviral agents|mesh-ancestor
5872985|NCT04956042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5683204|NCT03477864|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5872986|NCT04956042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5683205|NCT03477864|Immunologic Factors|immunologic factors|mesh-ancestor
5683206|NCT03477864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683207|NCT03477864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5683208|NCT03477864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5683209|NCT03477864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683210|NCT03477630|Hyaluronic Acid|hyaluronic acid|mesh-list
5683211|NCT03477630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5683212|NCT03477630|Immunologic Factors|immunologic factors|mesh-ancestor
5683213|NCT03477630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683214|NCT03477630|Viscosupplements|viscosupplements|mesh-ancestor
5872987|NCT04956042|Immunologic Factors|immunologic factors|mesh-ancestor
5872988|NCT04956042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872989|NCT04951323|Vaccines|vaccines|mesh-list
5872990|NCT04951323|Immunologic Factors|immunologic factors|mesh-ancestor
5872991|NCT04951323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905673|NCT04886453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5905674|NCT04886453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905675|NCT04886453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5905676|NCT04886453|Narcotics|narcotics|mesh-ancestor
5905677|NCT04886453|Analgesics|analgesics|mesh-ancestor
5905678|NCT04886453|Sensory System Agents|sensory system agents|mesh-ancestor
5905679|NCT04886453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5905680|NCT04883346|Liraglutide|liraglutide|mesh-list
5905681|NCT04883346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5905682|NCT04883346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905683|NCT04883346|Incretins|incretins|mesh-ancestor
5905684|NCT04883346|Hormones|hormones|mesh-ancestor
5905685|NCT04883346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5905686|NCT04877522|Niacinamide|niacinamide|mesh-list
5905687|NCT04877522|Imatinib Mesylate|imatinib mesylate|mesh-list
5905688|NCT04877522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5905689|NCT04877522|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5905690|NCT04877522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5905691|NCT04877522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905692|NCT04877522|Vitamin B Complex|vitamin b complex|mesh-ancestor
5905693|NCT04877522|Vitamins|vitamins|mesh-ancestor
5683215|NCT03477630|Protective Agents|protective agents|mesh-ancestor
5683216|NCT03477539|Lenalidomide|lenalidomide|mesh-list
5683217|NCT03477539|Daratumumab|daratumumab|mesh-list
5683218|NCT03477539|Immunologic Factors|immunologic factors|mesh-ancestor
5683219|NCT03477539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683220|NCT03477539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5683221|NCT03477539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5683222|NCT03477539|Growth Substances|growth substances|mesh-ancestor
5683223|NCT03477539|Growth Inhibitors|growth inhibitors|mesh-ancestor
5683224|NCT03477539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5683225|NCT03477500|Cyclophosphamide|cyclophosphamide|mesh-list
5683226|NCT03477500|Alemtuzumab|alemtuzumab|mesh-list
5683227|NCT03477500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5905694|NCT04877522|Micronutrients|micronutrients|mesh-ancestor
5905695|NCT04877522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905696|NCT04865887|Pembrolizumab|pembrolizumab|mesh-list
5905697|NCT04865887|Lenvatinib|lenvatinib|mesh-list
5905698|NCT04865887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5905699|NCT04865887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5905700|NCT04865887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5905701|NCT04865887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5905702|NCT04865887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905703|NCT04849832|Fesoterodine|fesoterodine|mesh-list
5905704|NCT04849832|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5905705|NCT04849832|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5905706|NCT04849832|Cholinergic Agents|cholinergic agents|mesh-ancestor
5905707|NCT04849832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5905708|NCT04849832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905709|NCT04849832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905710|NCT04849832|Urological Agents|urological agents|mesh-ancestor
5905711|NCT04781192|Durvalumab|durvalumab|mesh-list
5905712|NCT04781192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5905713|NCT04781192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5905714|NCT04780932|Macitentan|macitentan|mesh-list
5905715|NCT04780932|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
5905716|NCT04780932|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5908605|NCT04424862|Cyclosporins|cyclosporins|mesh-list
5683228|NCT03477500|Immunologic Factors|immunologic factors|mesh-ancestor
5683229|NCT03477500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5872992|NCT04893785|Temozolomide|temozolomide|mesh-list
5872993|NCT04893785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5872994|NCT04893785|Alkylating Agents|alkylating agents|mesh-ancestor
5872995|NCT04893785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5872996|NCT04893785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5872997|NCT04879849|Pembrolizumab|pembrolizumab|mesh-list
5872998|NCT04879849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5872999|NCT04879849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5873000|NCT04873323|Moxifloxacin|moxifloxacin|mesh-list
5873001|NCT04873323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5873002|NCT04873323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5873003|NCT04873323|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5873004|NCT04873323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5873005|NCT04873323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5873006|NCT04873323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873007|NCT04873323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5873008|NCT04848714|Antivenins|antivenins|mesh-list
5873009|NCT04848714|Immunologic Factors|immunologic factors|mesh-ancestor
5873010|NCT04848714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873011|NCT04805541|Tropicamide|tropicamide|mesh-list
5873012|NCT04805541|Mydriatics|mydriatics|mesh-list
5873013|NCT04805541|Autonomic Agents|autonomic agents|mesh-ancestor
5873014|NCT04805541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5873015|NCT04805541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873016|NCT04805541|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5873017|NCT04805541|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5873018|NCT04805541|Cholinergic Agents|cholinergic agents|mesh-ancestor
5873019|NCT04805541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5873020|NCT04805541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873021|NCT04803591|Tranexamic Acid|tranexamic acid|mesh-list
5873022|NCT04803591|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5873023|NCT04803591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5873024|NCT04803591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873025|NCT04803591|Hemostatics|hemostatics|mesh-ancestor
5873026|NCT04803591|Coagulants|coagulants|mesh-ancestor
5683230|NCT03477500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5683231|NCT03477500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5683232|NCT03477500|Alkylating Agents|alkylating agents|mesh-ancestor
5683233|NCT03477500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683234|NCT03477500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5683235|NCT03477500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5683236|NCT03477500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5683237|NCT03477461|Terlipressin|terlipressin|mesh-list
5683238|NCT03477461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5683239|NCT03477461|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5683240|NCT03477448|Bleomycin|bleomycin|mesh-list
5683241|NCT03477448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5683242|NCT03477448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5683243|NCT03477422|Meropenem|meropenem|mesh-list
5683244|NCT03477422|Ceftriaxone|ceftriaxone|mesh-list
5683245|NCT03477422|Sulbactam|sulbactam|mesh-list
5873027|NCT04746547|Dolutegravir|dolutegravir|mesh-list
5873028|NCT04746547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5873029|NCT04746547|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5873030|NCT04746547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5873031|NCT04746547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873032|NCT04746547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5873033|NCT04746547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5873034|NCT04746547|Antiviral Agents|antiviral agents|mesh-ancestor
5873035|NCT04746547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5873036|NCT04736602|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5873037|NCT04736602|Luteolytic Agents|luteolytic agents|mesh-ancestor
5873038|NCT04736602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5873039|NCT04736602|Contraceptive Agents|contraceptive agents|mesh-ancestor
5873040|NCT04736602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5873041|NCT04736602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873042|NCT04736602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5873043|NCT04736602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5873044|NCT04736602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5873045|NCT04713709|Naloxone|naloxone|mesh-list
5873046|NCT04713709|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5873047|NCT04713709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683246|NCT03477422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5683247|NCT03477422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5683248|NCT03477422|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5873048|NCT04713709|Sensory System Agents|sensory system agents|mesh-ancestor
5873049|NCT04713709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5873053|NCT04696822|Epinephrine|epinephrine|mesh-list
5873054|NCT04696822|Racepinephrine|racepinephrine|mesh-list
5873055|NCT04696822|Epinephryl borate|epinephryl borate|mesh-list
5873056|NCT04696822|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5873057|NCT04696822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5873058|NCT04696822|Adrenergic Agents|adrenergic agents|mesh-ancestor
5873059|NCT04696822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5873060|NCT04696822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873061|NCT04696822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873062|NCT04696822|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5873063|NCT04696822|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5873064|NCT04696822|Autonomic Agents|autonomic agents|mesh-ancestor
5873065|NCT04696822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5873066|NCT04696822|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5873067|NCT04696822|Respiratory System Agents|respiratory system agents|mesh-ancestor
5873068|NCT04696822|Mydriatics|mydriatics|mesh-ancestor
5873069|NCT04696822|Sympathomimetics|sympathomimetics|mesh-ancestor
5873070|NCT04696822|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5873071|NCT04608487|Cyclophosphamide|cyclophosphamide|mesh-list
5873072|NCT04608487|Fludarabine|fludarabine|mesh-list
5873073|NCT04608487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5873074|NCT04608487|Immunologic Factors|immunologic factors|mesh-ancestor
5873075|NCT04608487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873076|NCT04608487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5873077|NCT04608487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5873078|NCT04608487|Alkylating Agents|alkylating agents|mesh-ancestor
5873079|NCT04608487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873080|NCT04608487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5873081|NCT04608487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5873082|NCT04596917|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
5873083|NCT04596917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5873084|NCT04596917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873085|NCT04501861|Vasopressins|vasopressins|mesh-list
5873086|NCT04501861|Arginine Vasopressin|arginine vasopressin|mesh-list
5683249|NCT03477422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5683250|NCT03477422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697085|NCT03378310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5697086|NCT03378310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873087|NCT04501861|Norepinephrine|norepinephrine|mesh-list
5873088|NCT04501861|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5873089|NCT04501861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5873090|NCT04501861|Adrenergic Agents|adrenergic agents|mesh-ancestor
5873091|NCT04501861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5873092|NCT04501861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873093|NCT04501861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873094|NCT04501861|Sympathomimetics|sympathomimetics|mesh-ancestor
5873095|NCT04501861|Autonomic Agents|autonomic agents|mesh-ancestor
5873096|NCT04501861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5873097|NCT04501861|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5873098|NCT04501861|Hemostatics|hemostatics|mesh-ancestor
5873099|NCT04501861|Coagulants|coagulants|mesh-ancestor
5873100|NCT04501861|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5873101|NCT04501861|Natriuretic Agents|natriuretic agents|mesh-ancestor
5873102|NCT04498741|Midazolam|midazolam|mesh-list
5873103|NCT04498741|Dabigatran|dabigatran|mesh-list
5873104|NCT04498741|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5873105|NCT04498741|Tacrolimus|tacrolimus|mesh-list
5873106|NCT04498741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5873107|NCT04498741|Immunologic Factors|immunologic factors|mesh-ancestor
5697087|NCT03378297|Aspirin|aspirin|mesh-list
5697088|NCT03378297|Metformin|metformin|mesh-list
5697089|NCT03378297|Letrozole|letrozole|mesh-list
5697090|NCT03378297|Olaparib|olaparib|mesh-list
5697091|NCT03378297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5697092|NCT03378297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697093|NCT03378297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5697094|NCT03378297|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5697095|NCT03378297|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5697096|NCT03378297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5697097|NCT03378297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697098|NCT03378297|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5697099|NCT03378297|Hormone Antagonists|hormone antagonists|mesh-ancestor
5873108|NCT04498741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873109|NCT04498741|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5873110|NCT04498741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5873111|NCT04498741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873112|NCT04498741|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5873113|NCT04498741|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5873114|NCT04498741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5873115|NCT04498741|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5873116|NCT04498741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5873117|NCT04498741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5873118|NCT04498741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5873119|NCT04498741|Anesthetics, General|anesthetics, general|mesh-ancestor
5873120|NCT04498741|Anesthetics|anesthetics|mesh-ancestor
5873121|NCT04498741|GABA Modulators|gaba modulators|mesh-ancestor
5873122|NCT04498741|GABA Agents|gaba agents|mesh-ancestor
5873123|NCT04498741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5873124|NCT04498741|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5873125|NCT04498741|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5873126|NCT04498741|Antimetabolites|antimetabolites|mesh-ancestor
5873127|NCT04498741|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5873128|NCT04498741|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5873129|NCT04498741|Antithrombins|antithrombins|mesh-ancestor
5873130|NCT04498741|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5873131|NCT04498741|Protease Inhibitors|protease inhibitors|mesh-ancestor
5873132|NCT04498741|Anticoagulants|anticoagulants|mesh-ancestor
5873133|NCT04455815|Camostat|camostat|mesh-list
5873134|NCT04455815|Protease Inhibitors|protease inhibitors|mesh-ancestor
5873135|NCT04455815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5873136|NCT04455815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873137|NCT04455815|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5873138|NCT04455815|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5873139|NCT04407988|Letrozole|letrozole|mesh-list
5873140|NCT04407988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5873141|NCT04407988|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5683251|NCT03477344|Dexmedetomidine|dexmedetomidine|mesh-list
5683252|NCT03477344|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5683253|NCT03477344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5683254|NCT03477344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683255|NCT03477344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5683256|NCT03477344|Analgesics|analgesics|mesh-ancestor
5683257|NCT03477344|Sensory System Agents|sensory system agents|mesh-ancestor
5683258|NCT03477344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5683259|NCT03477344|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5683260|NCT03477344|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5873142|NCT04407988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5873143|NCT04407988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5873144|NCT04407988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873145|NCT04407988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5873146|NCT04407988|Hormone Antagonists|hormone antagonists|mesh-ancestor
5873147|NCT04407988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5873148|NCT04407988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873149|NCT04342078|Vitamin D|vitamin d|mesh-list
5873150|NCT04342078|Vitamins|vitamins|mesh-ancestor
5873151|NCT04342078|Micronutrients|micronutrients|mesh-ancestor
5873152|NCT04342078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873153|NCT04342078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5873154|NCT04231760|Nitric Oxide|nitric oxide|mesh-list
5873155|NCT04231760|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5873156|NCT04231760|Autonomic Agents|autonomic agents|mesh-ancestor
5873157|NCT04231760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5873158|NCT04231760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873159|NCT04231760|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5873160|NCT04231760|Respiratory System Agents|respiratory system agents|mesh-ancestor
5873161|NCT04231760|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5873162|NCT04231760|Antioxidants|antioxidants|mesh-ancestor
5873163|NCT04231760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873164|NCT04231760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5873165|NCT04231760|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5873166|NCT04231760|Vasodilator Agents|vasodilator agents|mesh-ancestor
5873167|NCT04231760|Gasotransmitters|gasotransmitters|mesh-ancestor
5873168|NCT04231760|Protective Agents|protective agents|mesh-ancestor
5873169|NCT04218266|Apixaban|apixaban|mesh-list
6675281|NCT01573754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6675282|NCT01573754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6675283|NCT01573754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5683261|NCT03477344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5683262|NCT03477344|Adrenergic Agents|adrenergic agents|mesh-ancestor
5683263|NCT03477344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5683264|NCT03477344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683265|NCT03477292|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5683266|NCT03477292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5683267|NCT03477266|Mosapride|mosapride|mesh-list
5683268|NCT03477266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5683269|NCT03477266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5683270|NCT03477266|Serotonin Agents|serotonin agents|mesh-ancestor
5683271|NCT03477266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5683272|NCT03477266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683273|NCT03477266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683274|NCT03477175|Sorafenib|sorafenib|mesh-list
5683275|NCT03477175|Lenvatinib|lenvatinib|mesh-list
5683276|NCT03477175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5873170|NCT04218266|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5873171|NCT04218266|Antithrombins|antithrombins|mesh-ancestor
5873172|NCT04218266|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5873173|NCT04218266|Protease Inhibitors|protease inhibitors|mesh-ancestor
5873174|NCT04218266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5873175|NCT04218266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873176|NCT04218266|Anticoagulants|anticoagulants|mesh-ancestor
5873177|NCT04102241|Hemay005|hemay005|mesh-list
5873178|NCT04102241|Dermatologic Agents|dermatologic agents|mesh-ancestor
5873179|NCT04102241|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5873180|NCT04102241|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5873181|NCT04102241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5873182|NCT04102241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873183|NCT04083014|Bortezomib|bortezomib|mesh-list
5873184|NCT04083014|Antibodies|antibodies|mesh-list
5873185|NCT04083014|Immunologic Factors|immunologic factors|mesh-ancestor
5873186|NCT04083014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873187|NCT04083014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5873188|NCT04039750|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5873189|NCT04039750|Clindamycin|clindamycin|mesh-list
5873190|NCT04039750|Gentamicins|gentamicins|mesh-list
5873191|NCT04039750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5873192|NCT04039750|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5873193|NCT04039750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5873194|NCT04039750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873195|NCT04026945|Lidocaine|lidocaine|mesh-list
5873196|NCT04026945|Anesthetics, Local|anesthetics, local|mesh-ancestor
5873197|NCT04026945|Anesthetics|anesthetics|mesh-ancestor
5873198|NCT04026945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5873199|NCT04026945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873200|NCT04026945|Sensory System Agents|sensory system agents|mesh-ancestor
5873201|NCT04026945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5873202|NCT04026945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5873203|NCT04026945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5873204|NCT04026945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5873205|NCT04026945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5873206|NCT04026945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873207|NCT04007991|Ecopipam|ecopipam|mesh-list
5873208|NCT04007991|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5873209|NCT04007991|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5873210|NCT04007991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5873211|NCT04007991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873212|NCT04007991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5873213|NCT04007991|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5873214|NCT04007991|Dopamine Agents|dopamine agents|mesh-ancestor
5873215|NCT04007991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5873216|NCT04007991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873217|NCT03990467|Tazobactam|tazobactam|mesh-list
5873218|NCT03990467|Piperacillin|piperacillin|mesh-list
5873219|NCT03990467|Amikacin|amikacin|mesh-list
6495592|NCT00624182|Gemcitabine|gemcitabine|mesh-list
5683277|NCT03477175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6495593|NCT00624182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6495594|NCT00624182|Antimetabolites|antimetabolites|mesh-ancestor
6495595|NCT00624182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495596|NCT00624182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6495597|NCT00624182|Antiviral Agents|antiviral agents|mesh-ancestor
6495598|NCT00624182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6495599|NCT00624182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5683278|NCT03477175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5683279|NCT03477175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683280|NCT03477136|Vitamin D|vitamin d|mesh-list
5683281|NCT03477136|Vitamins|vitamins|mesh-ancestor
5683282|NCT03477136|Micronutrients|micronutrients|mesh-ancestor
5683283|NCT03477136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683284|NCT03477136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5683285|NCT03477110|Temozolomide|temozolomide|mesh-list
5683286|NCT03477110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5683287|NCT03477110|Alkylating Agents|alkylating agents|mesh-ancestor
5683288|NCT03477110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683289|NCT03477110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5683290|NCT03476941|Clindamycin|clindamycin|mesh-list
5683291|NCT03476941|Clindamycin palmitate|clindamycin palmitate|mesh-list
5683292|NCT03476941|Clindamycin phosphate|clindamycin phosphate|mesh-list
5683293|NCT03476941|Gentamicins|gentamicins|mesh-list
5683294|NCT03476941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5683295|NCT03476941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5683296|NCT03476941|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5683297|NCT03476941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5683298|NCT03476941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683299|NCT03476811|Analgesics|analgesics|mesh-list
6495600|NCT00624182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6495601|NCT00624182|Immunologic Factors|immunologic factors|mesh-ancestor
6495602|NCT00624182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683300|NCT03476811|Bupivacaine|bupivacaine|mesh-list
5683301|NCT03476811|Anesthetics, Local|anesthetics, local|mesh-ancestor
5683302|NCT03476811|Anesthetics|anesthetics|mesh-ancestor
5683303|NCT03476811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5683304|NCT03476811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683305|NCT03476811|Sensory System Agents|sensory system agents|mesh-ancestor
5683306|NCT03476811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5683307|NCT03476772|Nalbuphine|nalbuphine|mesh-list
5683308|NCT03476772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5873220|NCT03990467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5873221|NCT03990467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5873222|NCT03990467|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5873223|NCT03990467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5873224|NCT03990467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873225|NCT03980561|Varenicline|varenicline|mesh-list
5873226|NCT03980561|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5873227|NCT03980561|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5873228|NCT03980561|Cholinergic Agents|cholinergic agents|mesh-ancestor
5873229|NCT03980561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5873230|NCT03980561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873231|NCT03980561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683309|NCT03476772|Narcotics|narcotics|mesh-ancestor
5683310|NCT03476772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5683311|NCT03476772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683312|NCT03476772|Analgesics|analgesics|mesh-ancestor
5683313|NCT03476772|Sensory System Agents|sensory system agents|mesh-ancestor
5683314|NCT03476772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5683315|NCT03476616|Valsartan|valsartan|mesh-list
5683316|NCT03476616|Eplerenone|eplerenone|mesh-list
5683317|NCT03476616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5683318|NCT03476616|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5683319|NCT03476616|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5683320|NCT03476616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683321|NCT03476616|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5683322|NCT03476616|Hormone Antagonists|hormone antagonists|mesh-ancestor
5683323|NCT03476616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5683324|NCT03476616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873232|NCT03978767|Acetaminophen|acetaminophen|mesh-list
5873233|NCT03978767|Ibuprofen|ibuprofen|mesh-list
5873234|NCT03978767|Ketorolac|ketorolac|mesh-list
5873235|NCT03978767|Oxycodone|oxycodone|mesh-list
5873236|NCT03978767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5873237|NCT03978767|Analgesics|analgesics|mesh-ancestor
5873238|NCT03978767|Sensory System Agents|sensory system agents|mesh-ancestor
6675284|NCT01573754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6675285|NCT01573754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675286|NCT01573754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6675287|NCT01573780|Gemcitabine|gemcitabine|mesh-list
6675288|NCT01573780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6675289|NCT01573780|Antimetabolites|antimetabolites|mesh-ancestor
6675290|NCT01573780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675291|NCT01573780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5873239|NCT03978767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5873240|NCT03978767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873241|NCT03978767|Antipyretics|antipyretics|mesh-ancestor
5873242|NCT03978767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5873243|NCT03978767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5873244|NCT03978767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5873245|NCT03978767|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5873246|NCT03978767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5873247|NCT03978767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873248|NCT03978767|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5873249|NCT03978767|Narcotics|narcotics|mesh-ancestor
5873250|NCT03978767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5873251|NCT03971669|Vaccines|vaccines|mesh-list
5873252|NCT03971669|Immunologic Factors|immunologic factors|mesh-ancestor
5873253|NCT03971669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873254|NCT03970993|Vaccines|vaccines|mesh-list
5873255|NCT03970993|Immunologic Factors|immunologic factors|mesh-ancestor
5873256|NCT03970993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873257|NCT03936309|Lidocaine|lidocaine|mesh-list
5873258|NCT03936309|Anesthetics, Local|anesthetics, local|mesh-ancestor
5873259|NCT03936309|Anesthetics|anesthetics|mesh-ancestor
5873260|NCT03936309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5873261|NCT03936309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873262|NCT03936309|Sensory System Agents|sensory system agents|mesh-ancestor
5873263|NCT03936309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5873264|NCT03936309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5873265|NCT03936309|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5873266|NCT03936309|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5873267|NCT03936309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5873268|NCT03936309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905717|NCT04780932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905718|NCT04780932|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
5905719|NCT04769453|Hyaluronic Acid|hyaluronic acid|mesh-list
5905720|NCT04769453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5905721|NCT04769453|Immunologic Factors|immunologic factors|mesh-ancestor
5905722|NCT04769453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905723|NCT04769453|Viscosupplements|viscosupplements|mesh-ancestor
5905724|NCT04769453|Protective Agents|protective agents|mesh-ancestor
5905725|NCT04745988|Pembrolizumab|pembrolizumab|mesh-list
5905726|NCT04745988|Lenvatinib|lenvatinib|mesh-list
5905727|NCT04745988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5905728|NCT04745988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5905729|NCT04745988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5905730|NCT04745988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5905731|NCT04745988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683325|NCT03476616|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5683326|NCT03476616|Diuretics|diuretics|mesh-ancestor
5683327|NCT03476616|Natriuretic Agents|natriuretic agents|mesh-ancestor
5683328|NCT03476603|Irbesartan|irbesartan|mesh-list
5683329|NCT03476603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5683330|NCT03476603|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5905732|NCT04717154|Nivolumab|nivolumab|mesh-list
5905733|NCT04717154|Ipilimumab|ipilimumab|mesh-list
5905734|NCT04717154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6675292|NCT01573780|Antiviral Agents|antiviral agents|mesh-ancestor
6675293|NCT01573780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5683331|NCT03476603|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5683332|NCT03476603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683333|NCT03476577|Ibuprofen|ibuprofen|mesh-list
5698064|NCT03371589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5873269|NCT03838692|Ponatinib|ponatinib|mesh-list
5873270|NCT03838692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5873271|NCT03838692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5873272|NCT03838692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5873273|NCT03838692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873274|NCT03774186|Pancrelipase|pancrelipase|mesh-list
5873275|NCT03774186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5873276|NCT03770260|Ixazomib|ixazomib|mesh-list
5873277|NCT03770260|Enzyme Inhibitors|enzyme inhibitors|mesh-list
5873278|NCT03770260|Pevonedistat|pevonedistat|mesh-list
5873279|NCT03770260|Glycine|glycine|mesh-list
5873280|NCT03770260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873281|NCT03770260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5873282|NCT03770260|Protease Inhibitors|protease inhibitors|mesh-ancestor
5873283|NCT03770260|Glycine Agents|glycine agents|mesh-ancestor
5873284|NCT03770260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5873285|NCT03770260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873286|NCT03760718|Chloroprocaine|chloroprocaine|mesh-list
5873287|NCT03760718|Procaine|procaine|mesh-list
5873288|NCT03760718|Anesthetics, Local|anesthetics, local|mesh-ancestor
5873289|NCT03760718|Anesthetics|anesthetics|mesh-ancestor
5873290|NCT03760718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5873291|NCT03760718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873292|NCT03760718|Sensory System Agents|sensory system agents|mesh-ancestor
5683334|NCT03476577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5683335|NCT03476577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5683336|NCT03476577|Analgesics|analgesics|mesh-ancestor
5683337|NCT03476577|Sensory System Agents|sensory system agents|mesh-ancestor
5683338|NCT03476577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5683339|NCT03476577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683340|NCT03476577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5683341|NCT03476577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5683342|NCT03476577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5683343|NCT03476577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5683344|NCT03476577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683345|NCT03476564|Pentoxifylline|pentoxifylline|mesh-list
5683346|NCT03476564|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5683347|NCT03476564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5683348|NCT03476564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683349|NCT03476564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5683350|NCT03476564|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5873293|NCT03760718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5873294|NCT03744975|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5873295|NCT03744975|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5873296|NCT03744975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873297|NCT03739268|Sevelamer|sevelamer|mesh-list
5873298|NCT03739268|Chelating Agents|chelating agents|mesh-ancestor
5873299|NCT03739268|Sequestering Agents|sequestering agents|mesh-ancestor
5873300|NCT03739268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873301|NCT03734263|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
5873302|NCT03734263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6495603|NCT00624208|Droperidol|droperidol|mesh-list
6495604|NCT00624208|Ondansetron|ondansetron|mesh-list
6495605|NCT00624208|Antiemetics|antiemetics|mesh-ancestor
6495606|NCT00624208|Autonomic Agents|autonomic agents|mesh-ancestor
6495607|NCT00624208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6495608|NCT00624208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495609|NCT00624208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6495610|NCT00624208|Antipruritics|antipruritics|mesh-ancestor
6495611|NCT00624208|Dermatologic Agents|dermatologic agents|mesh-ancestor
6495612|NCT00624208|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6495613|NCT00624208|Serotonin Agents|serotonin agents|mesh-ancestor
6495614|NCT00624208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6495615|NCT00624208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495616|NCT00624208|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6495617|NCT00624208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6495618|NCT00624208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6495619|NCT00624208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6495620|NCT00624208|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6495621|NCT00624208|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6495622|NCT00624208|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6495623|NCT00624208|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6495624|NCT00624208|Dopamine Agents|dopamine agents|mesh-ancestor
6495625|NCT00624273|Sildenafil Citrate|sildenafil citrate|mesh-list
6495626|NCT00624273|Vasodilator Agents|vasodilator agents|mesh-ancestor
5683351|NCT03476564|Protective Agents|protective agents|mesh-ancestor
5683352|NCT03476564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683353|NCT03476564|Vasodilator Agents|vasodilator agents|mesh-ancestor
5683354|NCT03476564|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5683355|NCT03476564|Antioxidants|antioxidants|mesh-ancestor
5683356|NCT03476551|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5683357|NCT03476551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5683358|NCT03476551|Diuretics|diuretics|mesh-ancestor
5683359|NCT03476551|Natriuretic Agents|natriuretic agents|mesh-ancestor
5683360|NCT03476551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683361|NCT03476551|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5683362|NCT03476551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5683363|NCT03476551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683364|NCT03476538|Gabapentin|gabapentin|mesh-list
5683365|NCT03476538|Analgesics|analgesics|mesh-ancestor
5683366|NCT03476538|Sensory System Agents|sensory system agents|mesh-ancestor
5683367|NCT03476538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5683368|NCT03476538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683369|NCT03476538|Anticonvulsants|anticonvulsants|mesh-ancestor
5683370|NCT03476538|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5683371|NCT03476538|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5683372|NCT03476538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5683373|NCT03476538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5683374|NCT03476538|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5683375|NCT03476538|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5683376|NCT03476538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5683377|NCT03476538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683378|NCT03476538|Antimanic Agents|antimanic agents|mesh-ancestor
5683379|NCT03476525|Fluoxetine|fluoxetine|mesh-list
5683380|NCT03476525|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5873303|NCT03730974|Snake venom protein C activator|snake venom protein c activator|mesh-list
5873304|NCT03730974|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5873305|NCT03730974|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5873306|NCT03730974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873307|NCT03672630|Azithromycin|azithromycin|mesh-list
5873308|NCT03672630|Rifampin|rifampin|mesh-list
5873309|NCT03672630|Ethambutol|ethambutol|mesh-list
5873310|NCT03672630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5873311|NCT03672630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5873312|NCT03672630|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5873313|NCT03672630|Antitubercular Agents|antitubercular agents|mesh-ancestor
5873314|NCT03672630|Leprostatic Agents|leprostatic agents|mesh-ancestor
5873315|NCT03672630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5873316|NCT03672630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5873317|NCT03672630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873318|NCT03672630|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5873319|NCT03672630|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5873320|NCT03672630|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5873321|NCT03672630|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5873322|NCT03672630|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5873323|NCT03672630|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5873324|NCT03671525|Nimodipine|nimodipine|mesh-list
5873325|NCT03671525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5873326|NCT03671525|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5873327|NCT03671525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5873328|NCT03671525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873329|NCT03671525|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5873330|NCT03671525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873331|NCT03671525|Vasodilator Agents|vasodilator agents|mesh-ancestor
5683381|NCT03476525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5683382|NCT03476525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5683383|NCT03476525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683384|NCT03476525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5683385|NCT03476525|Serotonin Agents|serotonin agents|mesh-ancestor
5683386|NCT03476525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683387|NCT03476525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5683388|NCT03476525|Antidepressive Agents|antidepressive agents|mesh-ancestor
5683389|NCT03476525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5683390|NCT03476525|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5683391|NCT03476525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5683392|NCT03476525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5683393|NCT03476356|Clomiphene|clomiphene|mesh-list
5873332|NCT03660553|Insulin|insulin|mesh-list
5873333|NCT03660553|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5873334|NCT03660553|Insulin Glargine|insulin glargine|mesh-list
5873335|NCT03660553|Insulin Aspart|insulin aspart|mesh-list
5683394|NCT03476356|Enclomiphene|enclomiphene|mesh-list
5683395|NCT03476356|Zuclomiphene|zuclomiphene|mesh-list
5683396|NCT03476356|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5683397|NCT03476356|Hormone Antagonists|hormone antagonists|mesh-ancestor
5683398|NCT03476356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5683399|NCT03476356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873336|NCT03660553|Insulin Lispro|insulin lispro|mesh-list
5873337|NCT03660553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5873338|NCT03660553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873339|NCT03576443|Idelalisib|idelalisib|mesh-list
5873340|NCT03576443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5873341|NCT03576443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5873342|NCT03576443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873343|NCT03505944|Venetoclax|venetoclax|mesh-list
5873344|NCT03505944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5873345|NCT03480776|Aspirin|aspirin|mesh-list
5873346|NCT03480776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5873347|NCT03480776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5873348|NCT03480776|Analgesics|analgesics|mesh-ancestor
5873349|NCT03480776|Sensory System Agents|sensory system agents|mesh-ancestor
5873350|NCT03480776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5873351|NCT03480776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873352|NCT03480776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5873353|NCT03480776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5683400|NCT03476356|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5683401|NCT03476356|Fertility Agents|fertility agents|mesh-ancestor
5683402|NCT03476356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5683403|NCT03476356|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5683404|NCT03476356|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5683405|NCT03476174|Pembrolizumab|pembrolizumab|mesh-list
5683406|NCT03476174|Interleukin-2|interleukin-2|mesh-list
5873354|NCT03480776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6495627|NCT00624273|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6495628|NCT00624273|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6495629|NCT00624273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6495630|NCT00624273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495631|NCT00624273|Urological Agents|urological agents|mesh-ancestor
6495632|NCT00624312|Epoetin Alfa|epoetin alfa|mesh-list
6495633|NCT00624312|Hematinics|hematinics|mesh-ancestor
6495634|NCT00624325|Interferons|interferons|mesh-list
5873355|NCT03480776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5873356|NCT03480776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873357|NCT03480776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5873358|NCT03480776|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5873359|NCT03480776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5873360|NCT03480776|Antipyretics|antipyretics|mesh-ancestor
5873361|NCT03466294|Azacitidine|azacitidine|mesh-list
5873362|NCT03466294|Venetoclax|venetoclax|mesh-list
5873363|NCT03466294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5873364|NCT03466294|Antimetabolites|antimetabolites|mesh-ancestor
5873365|NCT03466294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873366|NCT03466294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5873367|NCT03466294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5873368|NCT03353259|Tranexamic Acid|tranexamic acid|mesh-list
5873369|NCT03353259|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5873370|NCT03353259|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5873371|NCT03353259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683407|NCT03476174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5683408|NCT03476174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5683409|NCT03476174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5683410|NCT03476174|Analgesics|analgesics|mesh-ancestor
5683411|NCT03476174|Sensory System Agents|sensory system agents|mesh-ancestor
5683412|NCT03476174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5683413|NCT03476174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683414|NCT03476109|Omalizumab|omalizumab|mesh-list
5683415|NCT03476109|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5683416|NCT03476109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5683417|NCT03476109|Respiratory System Agents|respiratory system agents|mesh-ancestor
5683418|NCT03476083|Tenofovir|tenofovir|mesh-list
5873372|NCT03353259|Hemostatics|hemostatics|mesh-ancestor
5873373|NCT03353259|Coagulants|coagulants|mesh-ancestor
5873374|NCT03247569|Edoxaban|edoxaban|mesh-list
6495635|NCT00624325|Interferon-alpha|interferon-alpha|mesh-list
5873375|NCT03247569|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5873376|NCT03247569|Antithrombins|antithrombins|mesh-ancestor
5873377|NCT03247569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5873378|NCT03247569|Protease Inhibitors|protease inhibitors|mesh-ancestor
5873379|NCT03247569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5873380|NCT03247569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873381|NCT03247569|Anticoagulants|anticoagulants|mesh-ancestor
5873382|NCT03245840|Budesonide|budesonide|mesh-list
5873383|NCT03245840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5873384|NCT03245840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5873385|NCT03245840|Autonomic Agents|autonomic agents|mesh-ancestor
5873386|NCT03245840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5873387|NCT03245840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873388|NCT03245840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5873389|NCT03245840|Respiratory System Agents|respiratory system agents|mesh-ancestor
5873390|NCT03245840|Glucocorticoids|glucocorticoids|mesh-ancestor
5873391|NCT03245840|Hormones|hormones|mesh-ancestor
5873392|NCT03245840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5873393|NCT03174184|Amoxicillin|amoxicillin|mesh-list
5873394|NCT03174184|Rifampin|rifampin|mesh-list
5873395|NCT03174184|Meropenem|meropenem|mesh-list
5873396|NCT03174184|Clavulanic Acid|clavulanic acid|mesh-list
5873397|NCT03174184|Clavulanic Acids|clavulanic acids|mesh-list
5873398|NCT03174184|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5873399|NCT03174184|Rifamycins|rifamycins|mesh-list
5873400|NCT03174184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5873401|NCT03174184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5873402|NCT03174184|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5873403|NCT03174184|Antitubercular Agents|antitubercular agents|mesh-ancestor
5873404|NCT03174184|Leprostatic Agents|leprostatic agents|mesh-ancestor
5873405|NCT03174184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5873406|NCT03174184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5873407|NCT03174184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683419|NCT03476083|Antiviral Agents|antiviral agents|mesh-ancestor
5683420|NCT03476083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5683421|NCT03476083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5683422|NCT03476083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5683423|NCT03476083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5683424|NCT03476083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683425|NCT03476083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5683426|NCT03476083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5683427|NCT03476044|Selenium|selenium|mesh-list
5683428|NCT03476044|Antioxidants|antioxidants|mesh-ancestor
5683429|NCT03476044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683430|NCT03476044|Protective Agents|protective agents|mesh-ancestor
5683431|NCT03476044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683432|NCT03476044|Trace Elements|trace elements|mesh-ancestor
5683433|NCT03476044|Micronutrients|micronutrients|mesh-ancestor
5873408|NCT03174184|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5873409|NCT03174184|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5873410|NCT03174184|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5873411|NCT03174184|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5873412|NCT03174184|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5873413|NCT03174184|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5873414|NCT03174184|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5873415|NCT03128905|Prednisone|prednisone|mesh-list
5873416|NCT03128905|Colchicine|colchicine|mesh-list
6495636|NCT00624325|Interferon alpha-2|interferon alpha-2|mesh-list
6495637|NCT00624325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6495638|NCT00624325|Antiviral Agents|antiviral agents|mesh-ancestor
6495639|NCT00624325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6495640|NCT00624325|Immunologic Factors|immunologic factors|mesh-ancestor
6495641|NCT00624325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495642|NCT00624364|Metformin|metformin|mesh-list
6495643|NCT00624364|Insulin Aspart|insulin aspart|mesh-list
6495644|NCT00624364|Biphasic Insulins|biphasic insulins|mesh-list
6495645|NCT00624364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6495646|NCT00624364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495647|NCT00624429|Budesonide|budesonide|mesh-list
6495648|NCT00624429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6495649|NCT00624429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6495650|NCT00624429|Autonomic Agents|autonomic agents|mesh-ancestor
6495651|NCT00624429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6495652|NCT00624429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495653|NCT00624429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6495654|NCT00624429|Respiratory System Agents|respiratory system agents|mesh-ancestor
5873417|NCT03128905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5873418|NCT03128905|Glucocorticoids|glucocorticoids|mesh-ancestor
5873419|NCT03128905|Hormones|hormones|mesh-ancestor
5873420|NCT03128905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5873421|NCT03128905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873422|NCT03128905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5873423|NCT03128905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5873424|NCT03128905|Gout Suppressants|gout suppressants|mesh-ancestor
5873425|NCT03128905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5873426|NCT03128905|Tubulin Modulators|tubulin modulators|mesh-ancestor
5873427|NCT03128905|Antimitotic Agents|antimitotic agents|mesh-ancestor
5873428|NCT03128905|Mitosis Modulators|mitosis modulators|mesh-ancestor
5873429|NCT03128905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873430|NCT03121586|Pimavanserin|pimavanserin|mesh-list
5873431|NCT03121586|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6495655|NCT00624429|Glucocorticoids|glucocorticoids|mesh-ancestor
6495656|NCT00624429|Hormones|hormones|mesh-ancestor
6495657|NCT00624429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6495658|NCT00624455|Gabapentin|gabapentin|mesh-list
5873432|NCT03121586|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5873433|NCT03121586|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5873434|NCT03121586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5873435|NCT03121586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5873436|NCT03121586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873437|NCT03121586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5873438|NCT03121586|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5873439|NCT03121586|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5873440|NCT03121586|Serotonin Agents|serotonin agents|mesh-ancestor
5873441|NCT03121586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5873442|NCT03121586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873443|NCT03110926|Leucovorin|leucovorin|mesh-list
5873444|NCT03110926|Paclitaxel|paclitaxel|mesh-list
5873445|NCT03110926|Carboplatin|carboplatin|mesh-list
5873446|NCT03110926|Oxaliplatin|oxaliplatin|mesh-list
5873447|NCT03110926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5873448|NCT03110926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5873449|NCT03110926|Tubulin Modulators|tubulin modulators|mesh-ancestor
5873450|NCT03110926|Antimitotic Agents|antimitotic agents|mesh-ancestor
5873451|NCT03110926|Mitosis Modulators|mitosis modulators|mesh-ancestor
5873452|NCT03110926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873453|NCT03110926|Antidotes|antidotes|mesh-ancestor
5873454|NCT03110926|Protective Agents|protective agents|mesh-ancestor
5873455|NCT03110926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873456|NCT03110926|Vitamin B Complex|vitamin b complex|mesh-ancestor
5873457|NCT03110926|Vitamins|vitamins|mesh-ancestor
5873458|NCT03110926|Micronutrients|micronutrients|mesh-ancestor
5873459|NCT03010176|Pembrolizumab|pembrolizumab|mesh-list
5873460|NCT03010176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5873461|NCT03010176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5873462|NCT02997761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5873463|NCT02997761|Blinatumomab|blinatumomab|mesh-list
5873464|NCT02997761|Antibodies|antibodies|mesh-list
5873465|NCT02997761|Immunoglobulins|immunoglobulins|mesh-list
5873466|NCT02997761|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5873467|NCT02997761|Muromonab-CD3|muromonab-cd3|mesh-list
5873468|NCT02997761|Antibodies, Bispecific|antibodies, bispecific|mesh-list
5873469|NCT02997761|Immunologic Factors|immunologic factors|mesh-ancestor
5873470|NCT02997761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873471|NCT02997761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5873472|NCT02997761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5873473|NCT02913495|Progesterone|progesterone|mesh-list
5873474|NCT02913495|Progestins|progestins|mesh-ancestor
5873475|NCT02913495|Hormones|hormones|mesh-ancestor
5873476|NCT02913495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5873477|NCT02913495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873478|NCT02823990|Nivolumab|nivolumab|mesh-list
5873479|NCT02823990|Interleukin-2|interleukin-2|mesh-list
5873480|NCT02823990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873481|NCT02823990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5873482|NCT02823990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5873483|NCT02823990|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5873484|NCT02823990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873485|NCT02823990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5873486|NCT02823990|Analgesics|analgesics|mesh-ancestor
5873487|NCT02823990|Sensory System Agents|sensory system agents|mesh-ancestor
6495659|NCT00624455|Analgesics|analgesics|mesh-ancestor
5683434|NCT03475862|Oxycodone|oxycodone|mesh-list
5683435|NCT03475862|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5683436|NCT03475862|Narcotics|narcotics|mesh-ancestor
5683437|NCT03475862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5683438|NCT03475862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683439|NCT03475862|Analgesics|analgesics|mesh-ancestor
5873488|NCT02823990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5873489|NCT02633098|Artesunate|artesunate|mesh-list
5873490|NCT02633098|Antimalarials|antimalarials|mesh-ancestor
5873491|NCT02633098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5873492|NCT02633098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5873493|NCT02633098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5873494|NCT02633098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5873495|NCT02633098|Antiviral Agents|antiviral agents|mesh-ancestor
5873496|NCT02633098|Schistosomicides|schistosomicides|mesh-ancestor
5873497|NCT02633098|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5873498|NCT02633098|Anthelmintics|anthelmintics|mesh-ancestor
5873499|NCT02624128|Cetuximab|cetuximab|mesh-list
5873500|NCT02624128|Valproic Acid|valproic acid|mesh-list
5873501|NCT02624128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5873502|NCT02624128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5873503|NCT02624128|Anticonvulsants|anticonvulsants|mesh-ancestor
5873504|NCT02624128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5873505|NCT02624128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873506|NCT02624128|GABA Agents|gaba agents|mesh-ancestor
5873507|NCT02624128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5873508|NCT02624128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873509|NCT02624128|Antimanic Agents|antimanic agents|mesh-ancestor
5873510|NCT02624128|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5873511|NCT02624128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5873512|NCT02624128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5873513|NCT02592707|Dexamethasone|dexamethasone|mesh-list
5873514|NCT02592707|Ondansetron|ondansetron|mesh-list
5873515|NCT02592707|Antiemetics|antiemetics|mesh-list
5873516|NCT02592707|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
5873517|NCT02592707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5873518|NCT02592707|Autonomic Agents|autonomic agents|mesh-ancestor
5873519|NCT02592707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5873520|NCT02592707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873521|NCT02592707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5873522|NCT02592707|Glucocorticoids|glucocorticoids|mesh-ancestor
5873523|NCT02592707|Hormones|hormones|mesh-ancestor
5873524|NCT02592707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5873525|NCT02592707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5873526|NCT02592707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5873527|NCT02592707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873528|NCT02592707|Antipruritics|antipruritics|mesh-ancestor
5873529|NCT02592707|Dermatologic Agents|dermatologic agents|mesh-ancestor
5873530|NCT02592707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5873531|NCT02592707|Serotonin Agents|serotonin agents|mesh-ancestor
5873532|NCT02592707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5873533|NCT02592707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5873534|NCT02592707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5873535|NCT02592707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5873536|NCT02592707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5873537|NCT02592707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5873538|NCT02592707|Chelating Agents|chelating agents|mesh-ancestor
5873539|NCT02592707|Sequestering Agents|sequestering agents|mesh-ancestor
5873540|NCT02578069|Sirolimus|sirolimus|mesh-list
5873541|NCT02578069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5873542|NCT02578069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5873543|NCT02578069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5873544|NCT02578069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5873545|NCT02578069|Antifungal Agents|antifungal agents|mesh-ancestor
5873546|NCT02578069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5873547|NCT02578069|Immunologic Factors|immunologic factors|mesh-ancestor
5873548|NCT02578069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873549|NCT02514031|Gemcitabine|gemcitabine|mesh-list
5873550|NCT02514031|Beta-lapachone|beta-lapachone|mesh-list
5873551|NCT02514031|Paclitaxel|paclitaxel|mesh-list
6212413|NCT02187744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683440|NCT03475862|Sensory System Agents|sensory system agents|mesh-ancestor
5683441|NCT03475862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5683442|NCT03475810|Midazolam|midazolam|mesh-list
5683443|NCT03475810|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5683444|NCT03475810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5683445|NCT03475810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5683446|NCT03475810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683447|NCT03475810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5683448|NCT03475810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5683449|NCT03475810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5683450|NCT03475810|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5683451|NCT03475810|Anesthetics, General|anesthetics, general|mesh-ancestor
5683452|NCT03475810|Anesthetics|anesthetics|mesh-ancestor
5683453|NCT03475810|GABA Modulators|gaba modulators|mesh-ancestor
5683454|NCT03475810|GABA Agents|gaba agents|mesh-ancestor
5683455|NCT03475810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5683456|NCT03475810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697100|NCT03378297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5697101|NCT03378297|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5697102|NCT03378297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5697103|NCT03378297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5697104|NCT03378297|Analgesics|analgesics|mesh-ancestor
5697105|NCT03378297|Sensory System Agents|sensory system agents|mesh-ancestor
5697106|NCT03378297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5697107|NCT03378297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5697108|NCT03378297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5697109|NCT03378297|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5697110|NCT03378297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5697111|NCT03378297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5697112|NCT03378297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5697113|NCT03378297|Antipyretics|antipyretics|mesh-ancestor
5697114|NCT03378102|Interferon-gamma|interferon-gamma|mesh-list
5697115|NCT03378102|Antiviral Agents|antiviral agents|mesh-ancestor
5697116|NCT03378102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5698065|NCT03371589|Antiemetics|antiemetics|mesh-ancestor
5698066|NCT03371589|Autonomic Agents|autonomic agents|mesh-ancestor
5698067|NCT03371589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5698068|NCT03371589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698069|NCT03371589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5698070|NCT03371589|Glucocorticoids|glucocorticoids|mesh-ancestor
5698071|NCT03371589|Hormones|hormones|mesh-ancestor
5873552|NCT02514031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5873553|NCT02514031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5873554|NCT02514031|Tubulin Modulators|tubulin modulators|mesh-ancestor
5873555|NCT02514031|Antimitotic Agents|antimitotic agents|mesh-ancestor
5873556|NCT02514031|Mitosis Modulators|mitosis modulators|mesh-ancestor
5873557|NCT02514031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873558|NCT02514031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5873559|NCT02514031|Antimetabolites|antimetabolites|mesh-ancestor
5873560|NCT02514031|Antiviral Agents|antiviral agents|mesh-ancestor
5873561|NCT02514031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5873562|NCT02514031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5873563|NCT02514031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5873564|NCT02514031|Immunologic Factors|immunologic factors|mesh-ancestor
5873565|NCT02514031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873566|NCT02514031|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5873567|NCT02514031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5873568|NCT02427126|Aspirin|aspirin|mesh-list
5873569|NCT02427126|Apixaban|apixaban|mesh-list
5873570|NCT02427126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5873571|NCT02427126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5873572|NCT02427126|Analgesics|analgesics|mesh-ancestor
5698072|NCT03371589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5698073|NCT03371589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5698074|NCT03371589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5698075|NCT03371563|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5698076|NCT03371563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5698077|NCT03371550|Docetaxel|docetaxel|mesh-list
5698078|NCT03371550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5698079|NCT03371550|Tubulin Modulators|tubulin modulators|mesh-ancestor
5698080|NCT03371550|Antimitotic Agents|antimitotic agents|mesh-ancestor
5698081|NCT03371550|Mitosis Modulators|mitosis modulators|mesh-ancestor
5698082|NCT03371550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5698083|NCT03371498|Methylprednisolone|methylprednisolone|mesh-list
5698084|NCT03371498|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5698085|NCT03371498|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5698086|NCT03371498|Prednisolone|prednisolone|mesh-list
5698087|NCT03371498|Prednisolone acetate|prednisolone acetate|mesh-list
5873573|NCT02427126|Sensory System Agents|sensory system agents|mesh-ancestor
5873574|NCT02427126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5698088|NCT03371498|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5873575|NCT02427126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873576|NCT02427126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5873577|NCT02427126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5873578|NCT02427126|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5873579|NCT02427126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5873580|NCT02427126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873581|NCT02427126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5683457|NCT03475758|Goserelin|goserelin|mesh-list
5683458|NCT03475758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5683459|NCT03475758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5683460|NCT03475693|Acetaminophen|acetaminophen|mesh-list
5683461|NCT03475693|Ondansetron|ondansetron|mesh-list
5683462|NCT03475693|Magnesium Oxide|magnesium oxide|mesh-list
5683463|NCT03475693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5683464|NCT03475693|Analgesics|analgesics|mesh-ancestor
5683465|NCT03475693|Sensory System Agents|sensory system agents|mesh-ancestor
5683466|NCT03475693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5683467|NCT03475693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683468|NCT03475693|Antipyretics|antipyretics|mesh-ancestor
5873582|NCT02427126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5873583|NCT02427126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5873584|NCT02427126|Antipyretics|antipyretics|mesh-ancestor
5873585|NCT02427126|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5873586|NCT02427126|Antithrombins|antithrombins|mesh-ancestor
5873587|NCT02427126|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5873588|NCT02427126|Protease Inhibitors|protease inhibitors|mesh-ancestor
5873589|NCT02427126|Anticoagulants|anticoagulants|mesh-ancestor
5873590|NCT05080569|Progesterone|progesterone|mesh-list
5873591|NCT05080569|Progestins|progestins|mesh-ancestor
5873592|NCT05080569|Hormones|hormones|mesh-ancestor
5873593|NCT05080569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5873594|NCT05080569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873595|NCT05080556|Carboplatin|carboplatin|mesh-list
5873596|NCT05080556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5873597|NCT05080543|Terlipressin|terlipressin|mesh-list
5873598|NCT05080543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5873599|NCT05080543|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5873600|NCT05080530|Vitamin D|vitamin d|mesh-list
5873601|NCT05080530|Cholecalciferol|cholecalciferol|mesh-list
5873602|NCT05080530|Vitamins|vitamins|mesh-ancestor
5873603|NCT05080530|Micronutrients|micronutrients|mesh-ancestor
5873604|NCT05080530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873605|NCT05080530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5873606|NCT05080530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5873607|NCT05080478|Clopidogrel|clopidogrel|mesh-list
5873608|NCT05080478|Ticagrelor|ticagrelor|mesh-list
5873609|NCT05080478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5873610|NCT05080478|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6675294|NCT01573780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6675295|NCT01573780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6675296|NCT01573780|Immunologic Factors|immunologic factors|mesh-ancestor
6675297|NCT01573780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675298|NCT01573806|Exenatide|exenatide|mesh-list
6675299|NCT01573806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6675300|NCT01573806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873611|NCT05080478|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5873612|NCT05080478|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5873613|NCT05080478|Purinergic Agents|purinergic agents|mesh-ancestor
5873614|NCT05080478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5683469|NCT03475693|Antiemetics|antiemetics|mesh-ancestor
5683470|NCT03475693|Autonomic Agents|autonomic agents|mesh-ancestor
5683471|NCT03475693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5683472|NCT03475693|Antipruritics|antipruritics|mesh-ancestor
5683473|NCT03475693|Dermatologic Agents|dermatologic agents|mesh-ancestor
5683474|NCT03475693|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5683475|NCT03475693|Serotonin Agents|serotonin agents|mesh-ancestor
5683476|NCT03475693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5683477|NCT03475693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683478|NCT03475693|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5683479|NCT03475693|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5873615|NCT05080478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873616|NCT05080478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905735|NCT04717154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5905736|NCT04717154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5905737|NCT04717154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905738|NCT04702464|Fluconazole|fluconazole|mesh-list
5683480|NCT03475693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5683481|NCT03475693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5683482|NCT03475693|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5683483|NCT03475693|Antacids|antacids|mesh-ancestor
5683484|NCT03475680|Gentamicins|gentamicins|mesh-list
5683485|NCT03475680|Ornidazole|ornidazole|mesh-list
5905739|NCT04702464|Antifungal Agents|antifungal agents|mesh-ancestor
5905740|NCT04702464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5905741|NCT04702464|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5905742|NCT04702464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5905743|NCT04702464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5905744|NCT04702464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905745|NCT04702464|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5683486|NCT03475680|Sennosides|sennosides|mesh-list
5683487|NCT03475680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5683488|NCT03475680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5683489|NCT03475680|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5683490|NCT03475680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5683491|NCT03475680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683492|NCT03475680|Laxatives|laxatives|mesh-ancestor
5683493|NCT03475680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5683494|NCT03475680|Amebicides|amebicides|mesh-ancestor
5683495|NCT03475680|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5683496|NCT03475680|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5683497|NCT03475680|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
5683498|NCT03475628|Daratumumab|daratumumab|mesh-list
5683499|NCT03475628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5683500|NCT03475615|Paclitaxel|paclitaxel|mesh-list
5905746|NCT04702464|Hormone Antagonists|hormone antagonists|mesh-ancestor
5905747|NCT04702464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5905748|NCT04702464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905749|NCT04702464|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5905750|NCT04702464|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5905751|NCT04698057|Amoxicillin|amoxicillin|mesh-list
5905752|NCT04698057|Ciprofloxacin|ciprofloxacin|mesh-list
5905753|NCT04698057|Clavulanic Acid|clavulanic acid|mesh-list
5905754|NCT04698057|Clavulanic Acids|clavulanic acids|mesh-list
5905755|NCT04698057|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5905756|NCT04698057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5905757|NCT04698057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5905758|NCT04698057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5905759|NCT04698057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5905760|NCT04698057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5905761|NCT04698057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905762|NCT04698057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5905763|NCT04698057|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5905764|NCT04698057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5905765|NCT04698057|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5905766|NCT04697654|Hydroxychloroquine|hydroxychloroquine|mesh-list
5905767|NCT04697654|Antimalarials|antimalarials|mesh-ancestor
5905768|NCT04697654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6495660|NCT00624455|Sensory System Agents|sensory system agents|mesh-ancestor
6675301|NCT01573806|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5683501|NCT03475615|Oxaliplatin|oxaliplatin|mesh-list
5683502|NCT03475615|Tegafur|tegafur|mesh-list
5683503|NCT03475615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5873617|NCT05080348|Ropivacaine|ropivacaine|mesh-list
5873618|NCT05080348|Anesthetics, Local|anesthetics, local|mesh-ancestor
5873619|NCT05080348|Anesthetics|anesthetics|mesh-ancestor
5873620|NCT05080348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5873621|NCT05080348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873622|NCT05080348|Sensory System Agents|sensory system agents|mesh-ancestor
5873623|NCT05080348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5873624|NCT05080322|Fluticasone|fluticasone|mesh-list
5873625|NCT05080322|Xhance|xhance|mesh-list
5873626|NCT05080322|Azelastine|azelastine|mesh-list
5873627|NCT05080322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5873628|NCT05080322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5683504|NCT03475615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5683505|NCT03475615|Tubulin Modulators|tubulin modulators|mesh-ancestor
5683506|NCT03475615|Antimitotic Agents|antimitotic agents|mesh-ancestor
5683507|NCT03475615|Mitosis Modulators|mitosis modulators|mesh-ancestor
5683508|NCT03475615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683509|NCT03475615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5683510|NCT03475615|Antimetabolites|antimetabolites|mesh-ancestor
5683511|NCT03475589|Apatinib|apatinib|mesh-list
5683512|NCT03475589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5683513|NCT03475589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5683514|NCT03475589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5683515|NCT03475589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873629|NCT05080322|Autonomic Agents|autonomic agents|mesh-ancestor
5873630|NCT05080322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5873631|NCT05080322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873632|NCT05080322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5873633|NCT05080322|Respiratory System Agents|respiratory system agents|mesh-ancestor
5873634|NCT05080322|Dermatologic Agents|dermatologic agents|mesh-ancestor
5873635|NCT05080322|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5873636|NCT05080322|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6495661|NCT00624455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6495662|NCT00624455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495663|NCT00624455|Anticonvulsants|anticonvulsants|mesh-ancestor
6495664|NCT00624455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6495665|NCT00624455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6495666|NCT00624455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6495667|NCT00624455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6495668|NCT00624455|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6495669|NCT00624455|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6495670|NCT00624455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6495671|NCT00624455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495672|NCT00624455|Antimanic Agents|antimanic agents|mesh-ancestor
6495673|NCT00624481|Teriparatide|teriparatide|mesh-list
6495674|NCT00624481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6495675|NCT00624481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495676|NCT00624481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6495677|NCT00624546|Lansoprazole|lansoprazole|mesh-list
5873637|NCT05080322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5873638|NCT05080322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873639|NCT05080322|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5873640|NCT05080322|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5873641|NCT05080322|Histamine Antagonists|histamine antagonists|mesh-ancestor
5873642|NCT05080322|Histamine Agents|histamine agents|mesh-ancestor
5873643|NCT05080322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5873644|NCT05080192|Fenofibrate|fenofibrate|mesh-list
5873645|NCT05080192|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5873646|NCT05080192|Antimetabolites|antimetabolites|mesh-ancestor
5873647|NCT05080192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873648|NCT05080192|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5873649|NCT05080140|Ezetimibe|ezetimibe|mesh-list
5873650|NCT05080140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5873651|NCT05080140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5873652|NCT05080140|Antimetabolites|antimetabolites|mesh-ancestor
5873653|NCT05080140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873654|NCT05080140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5873655|NCT05080049|Epoetin Alfa|epoetin alfa|mesh-list
5873656|NCT05080049|Hematinics|hematinics|mesh-ancestor
5873657|NCT05080010|Carboplatin|carboplatin|mesh-list
5873658|NCT05080010|Etoposide|etoposide|mesh-list
5873659|NCT05080010|Vincristine|vincristine|mesh-list
5873660|NCT05080010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5873661|NCT05080010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5905769|NCT04697654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5873662|NCT05080010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5873663|NCT05080010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5873664|NCT05080010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5873665|NCT05080010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873666|NCT05080010|Tubulin Modulators|tubulin modulators|mesh-ancestor
5873667|NCT05080010|Antimitotic Agents|antimitotic agents|mesh-ancestor
5873668|NCT05080010|Mitosis Modulators|mitosis modulators|mesh-ancestor
5873669|NCT05079880|Caffeine|caffeine|mesh-list
5873670|NCT05079880|Caffeine citrate|caffeine citrate|mesh-list
5873671|NCT05079880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873672|NCT05079880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5873673|NCT05079880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873674|NCT05079880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5873675|NCT05079880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5873676|NCT05079880|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5873677|NCT05079880|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5873678|NCT05079880|Purinergic Agents|purinergic agents|mesh-ancestor
5873679|NCT05079880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5873680|NCT05079828|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5873681|NCT05079828|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5873682|NCT05079828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873683|NCT05079789|Amiloride|amiloride|mesh-list
5873684|NCT05079789|Furosemide|furosemide|mesh-list
5873685|NCT05079789|Diuretics|diuretics|mesh-ancestor
5873686|NCT05079789|Natriuretic Agents|natriuretic agents|mesh-ancestor
5873687|NCT05079789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873688|NCT05079789|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5873689|NCT05079789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5873690|NCT05079789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873691|NCT05079789|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
5873692|NCT05079789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5873693|NCT05079789|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
5873694|NCT05079789|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5873695|NCT05079763|Monolaurin|monolaurin|mesh-list
5873696|NCT05079763|Cariostatic Agents|cariostatic agents|mesh-ancestor
5873697|NCT05079763|Protective Agents|protective agents|mesh-ancestor
5873698|NCT05079763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873699|NCT05079087|Midazolam|midazolam|mesh-list
5873700|NCT05079087|Ketamine|ketamine|mesh-list
5873701|NCT05079087|Analgesics|analgesics|mesh-ancestor
5873702|NCT05079087|Sensory System Agents|sensory system agents|mesh-ancestor
5873703|NCT05079087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6212414|NCT02187744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6212415|NCT02187809|Clobazam|clobazam|mesh-list
6212416|NCT02187809|Anticonvulsants|anticonvulsants|mesh-ancestor
6212417|NCT02187809|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6212418|NCT02187809|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6212419|NCT02187809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6212420|NCT02187809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212421|NCT02187809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6212422|NCT02187809|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6212423|NCT02187809|GABA Agonists|gaba agonists|mesh-ancestor
6212424|NCT02187809|GABA Agents|gaba agents|mesh-ancestor
6212425|NCT02187809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6212426|NCT02187809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212427|NCT02187861|Rituximab|rituximab|mesh-list
6212428|NCT02187861|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6212429|NCT02187861|Venetoclax|venetoclax|mesh-list
6212430|NCT02187861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6212431|NCT02187861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6212432|NCT02187861|Immunologic Factors|immunologic factors|mesh-ancestor
6212433|NCT02187861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212434|NCT02187861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6212435|NCT02187861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6212436|NCT02187861|Alkylating Agents|alkylating agents|mesh-ancestor
6212437|NCT02187861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212607|NCT02191397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212608|NCT02191397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6212609|NCT02191397|Serotonin Agents|serotonin agents|mesh-ancestor
6212610|NCT02191397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212611|NCT02191397|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6212612|NCT02191397|Antidepressive Agents|antidepressive agents|mesh-ancestor
5683516|NCT03475524|Metformin|metformin|mesh-list
5873704|NCT05079087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873705|NCT05079087|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5873706|NCT05079087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5873707|NCT05079087|Anesthetics, General|anesthetics, general|mesh-ancestor
5873708|NCT05079087|Anesthetics|anesthetics|mesh-ancestor
5873709|NCT05079087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5873710|NCT05079087|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5873711|NCT05079087|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5873712|NCT05079087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5683517|NCT03475524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5683518|NCT03475524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683519|NCT03475459|Melatonin|melatonin|mesh-list
5683520|NCT03475459|Antioxidants|antioxidants|mesh-ancestor
5683521|NCT03475459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683522|NCT03475459|Protective Agents|protective agents|mesh-ancestor
5683523|NCT03475459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683524|NCT03475459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5683525|NCT03475407|Dexamethasone|dexamethasone|mesh-list
5683526|NCT03475407|Dexamethasone acetate|dexamethasone acetate|mesh-list
5683527|NCT03475407|BB 1101|bb 1101|mesh-list
5683528|NCT03475407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5683529|NCT03475407|Antiemetics|antiemetics|mesh-ancestor
5683530|NCT03475407|Autonomic Agents|autonomic agents|mesh-ancestor
5683531|NCT03475407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5683532|NCT03475407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683533|NCT03475407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5683534|NCT03475407|Glucocorticoids|glucocorticoids|mesh-ancestor
5683535|NCT03475407|Hormones|hormones|mesh-ancestor
5683536|NCT03475407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5683537|NCT03475407|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5683538|NCT03475407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5683539|NCT03475407|Protease Inhibitors|protease inhibitors|mesh-ancestor
5683540|NCT03475407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5683541|NCT03475407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683542|NCT03475394|Chlorhexidine|chlorhexidine|mesh-list
5683543|NCT03475394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5683544|NCT03475394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5683545|NCT03475394|Disinfectants|disinfectants|mesh-ancestor
5873713|NCT05079087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873714|NCT05079087|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5873715|NCT05079087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5683546|NCT03475342|Tranexamic Acid|tranexamic acid|mesh-list
5683547|NCT03475342|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5683548|NCT03475342|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5683549|NCT03475342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683550|NCT03475342|Hemostatics|hemostatics|mesh-ancestor
5683551|NCT03475342|Coagulants|coagulants|mesh-ancestor
5683552|NCT03475225|Cholecalciferol|cholecalciferol|mesh-list
5683553|NCT03475225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5683554|NCT03475225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683555|NCT03475225|Vitamins|vitamins|mesh-ancestor
5873716|NCT05079087|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5873717|NCT05079087|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5873718|NCT05079087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5873719|NCT05079087|GABA Modulators|gaba modulators|mesh-ancestor
5873720|NCT05079087|GABA Agents|gaba agents|mesh-ancestor
5873721|NCT05079061|Misoprostol|misoprostol|mesh-list
5873722|NCT05079061|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5873723|NCT05079061|Abortifacient Agents|abortifacient agents|mesh-ancestor
5873724|NCT05079061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5873725|NCT05079061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683556|NCT03475225|Micronutrients|micronutrients|mesh-ancestor
5683557|NCT03475225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5683558|NCT03475186|Ramipril|ramipril|mesh-list
5683559|NCT03475186|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5683560|NCT03475186|Protease Inhibitors|protease inhibitors|mesh-ancestor
5683561|NCT03475186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5683562|NCT03475186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683563|NCT03475186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5683564|NCT03475160|Sildenafil Citrate|sildenafil citrate|mesh-list
5683565|NCT03475160|Citric Acid|citric acid|mesh-list
5683566|NCT03475160|Sodium Citrate|sodium citrate|mesh-list
5683567|NCT03475160|Anticoagulants|anticoagulants|mesh-ancestor
5683568|NCT03475160|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5683569|NCT03475160|Chelating Agents|chelating agents|mesh-ancestor
5683570|NCT03475160|Sequestering Agents|sequestering agents|mesh-ancestor
5873726|NCT05079061|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5873727|NCT05079061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5873728|NCT05079061|Oxytocics|oxytocics|mesh-ancestor
5873729|NCT05079022|Aflutinib|aflutinib|mesh-list
5873730|NCT05079022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5873731|NCT05079022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5873732|NCT05079022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873733|NCT05078944|Donepezil|donepezil|mesh-list
5873734|NCT05078944|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5873735|NCT05078944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5873736|NCT05078944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873737|NCT05078944|Cholinergic Agents|cholinergic agents|mesh-ancestor
5873738|NCT05078944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5873739|NCT05078944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873740|NCT05078944|Nootropic Agents|nootropic agents|mesh-ancestor
5873741|NCT05078827|Fluorouracil|fluorouracil|mesh-list
5873742|NCT05078827|Antimetabolites|antimetabolites|mesh-ancestor
5873743|NCT05078827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873744|NCT05078827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5873745|NCT05078827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5873746|NCT05078827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5683571|NCT03475160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683572|NCT03475160|Vasodilator Agents|vasodilator agents|mesh-ancestor
5683573|NCT03475160|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5683574|NCT03475160|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5683575|NCT03475160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5683576|NCT03475160|Urological Agents|urological agents|mesh-ancestor
5683577|NCT03475121|Topotecan|topotecan|mesh-list
5683578|NCT03475121|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5683579|NCT03475121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5683580|NCT03475121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5683581|NCT03475121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683582|NCT03475121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5683583|NCT03475017|Curcumin|curcumin|mesh-list
5873747|NCT05078827|Immunologic Factors|immunologic factors|mesh-ancestor
5873748|NCT05078827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873749|NCT05078788|Triamcinolone|triamcinolone|mesh-list
5873750|NCT05078788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5873751|NCT05078788|Glucocorticoids|glucocorticoids|mesh-ancestor
5873752|NCT05078788|Hormones|hormones|mesh-ancestor
5873753|NCT05078788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5873754|NCT05078788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873755|NCT05078710|Immunosuppressive Agents|immunosuppressive agents|mesh-list
5873756|NCT05078710|Immunologic Factors|immunologic factors|mesh-ancestor
5873757|NCT05078710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873758|NCT05078372|Midazolam|midazolam|mesh-list
5873759|NCT05078372|Ropivacaine|ropivacaine|mesh-list
5873760|NCT05078372|Anesthetics, Local|anesthetics, local|mesh-ancestor
5873761|NCT05078372|Anesthetics|anesthetics|mesh-ancestor
5873762|NCT05078372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5873763|NCT05078372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873764|NCT05078372|Sensory System Agents|sensory system agents|mesh-ancestor
5873765|NCT05078372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5873766|NCT05078372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5873767|NCT05078372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5873768|NCT05078372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5873769|NCT05078372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5683584|NCT03475017|Piperine|piperine|mesh-list
5683585|NCT03475017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5683586|NCT03475017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5683587|NCT03475017|Analgesics|analgesics|mesh-ancestor
5683588|NCT03475017|Sensory System Agents|sensory system agents|mesh-ancestor
5683589|NCT03475017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5683590|NCT03475017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683591|NCT03475017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5683592|NCT03475017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5683593|NCT03475017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5683594|NCT03475017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5683595|NCT03475017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683596|NCT03475017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5873770|NCT05078372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5873771|NCT05078372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5873772|NCT05078372|Anesthetics, General|anesthetics, general|mesh-ancestor
5873773|NCT05078372|GABA Modulators|gaba modulators|mesh-ancestor
5873774|NCT05078372|GABA Agents|gaba agents|mesh-ancestor
5873775|NCT05078372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5683597|NCT03474939|Midazolam|midazolam|mesh-list
5683598|NCT03474939|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5683599|NCT03474939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5683600|NCT03474939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5683601|NCT03474939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683602|NCT03474939|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5683603|NCT03474939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5683604|NCT03474939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5683605|NCT03474939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5683606|NCT03474939|Anesthetics, General|anesthetics, general|mesh-ancestor
5873776|NCT05078372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873777|NCT05078255|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
5873778|NCT05078255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5873779|NCT05078255|Incretins|incretins|mesh-ancestor
5873780|NCT05078255|Hormones|hormones|mesh-ancestor
5873781|NCT05078255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5873782|NCT05078255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873783|NCT05078177|Rituximab|rituximab|mesh-list
5873784|NCT05078177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5873785|NCT05078177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5873786|NCT05078177|Immunologic Factors|immunologic factors|mesh-ancestor
5873787|NCT05078177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683607|NCT03474939|Anesthetics|anesthetics|mesh-ancestor
5683608|NCT03474939|GABA Modulators|gaba modulators|mesh-ancestor
5683609|NCT03474939|GABA Agents|gaba agents|mesh-ancestor
5683610|NCT03474939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5683611|NCT03474939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683612|NCT03474770|Huperzine A|huperzine a|mesh-list
5683613|NCT03474770|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5683614|NCT03474770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5683615|NCT03474770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683616|NCT03474770|Cholinergic Agents|cholinergic agents|mesh-ancestor
5683617|NCT03474770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5683618|NCT03474770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683619|NCT03474770|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5683620|NCT03474770|Protective Agents|protective agents|mesh-ancestor
5683621|NCT03474614|Propranolol|propranolol|mesh-list
5683622|NCT03474614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5873788|NCT05078177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5873789|NCT05078138|Epoetin Alfa|epoetin alfa|mesh-list
5873790|NCT05078138|Hematinics|hematinics|mesh-ancestor
5873791|NCT05077813|Vitamin D|vitamin d|mesh-list
5873792|NCT05077813|Ergocalciferols|ergocalciferols|mesh-list
5873793|NCT05077813|Vitamins|vitamins|mesh-list
5873794|NCT05077813|Minocycline|minocycline|mesh-list
5873795|NCT05077813|Tretinoin|tretinoin|mesh-list
5873796|NCT05077813|Alitretinoin|alitretinoin|mesh-list
5873797|NCT05077813|Isotretinoin|isotretinoin|mesh-list
5873798|NCT05077813|Micronutrients|micronutrients|mesh-ancestor
5873799|NCT05077813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873800|NCT05077813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5873801|NCT05077813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5873802|NCT05077813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5873803|NCT05077813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5873804|NCT05077813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5873805|NCT05077813|Keratolytic Agents|keratolytic agents|mesh-ancestor
5873806|NCT05077813|Dermatologic Agents|dermatologic agents|mesh-ancestor
5905770|NCT04697654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5905771|NCT04697654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5905772|NCT04697654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905773|NCT04697654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5905774|NCT04664972|Cyclophosphamide|cyclophosphamide|mesh-list
5905775|NCT04664972|Docetaxel|docetaxel|mesh-list
5905776|NCT04664972|Doxorubicin|doxorubicin|mesh-list
5905777|NCT04664972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5905778|NCT04664972|Immunologic Factors|immunologic factors|mesh-ancestor
5905779|NCT04664972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905780|NCT04664972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5905781|NCT04664972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5905782|NCT04664972|Alkylating Agents|alkylating agents|mesh-ancestor
5683623|NCT03474614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5905783|NCT04664972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683624|NCT03474614|Adrenergic Agents|adrenergic agents|mesh-ancestor
5905784|NCT04664972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5905785|NCT04664972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5873807|NCT05077592|Povidone-Iodine|povidone-iodine|mesh-list
5873808|NCT05077592|Povidone|povidone|mesh-list
5873809|NCT05077592|Plasma Substitutes|plasma substitutes|mesh-ancestor
5873810|NCT05077592|Blood Substitutes|blood substitutes|mesh-ancestor
5873811|NCT05077592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5873812|NCT05077592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5873813|NCT05077527|Cyclophosphamide|cyclophosphamide|mesh-list
5873814|NCT05077527|Fludarabine|fludarabine|mesh-list
5873815|NCT05077527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5873816|NCT05077527|Immunologic Factors|immunologic factors|mesh-ancestor
5873817|NCT05077527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873818|NCT05077527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5873819|NCT05077527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5873820|NCT05077527|Alkylating Agents|alkylating agents|mesh-ancestor
5873821|NCT05077527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873822|NCT05077527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5873823|NCT05077527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5873824|NCT05077475|Cryptophycin 52|cryptophycin 52|mesh-list
5873825|NCT05077475|Antimitotic Agents|antimitotic agents|mesh-ancestor
5873826|NCT05077475|Mitosis Modulators|mitosis modulators|mesh-ancestor
5683625|NCT03474614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5683626|NCT03474614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683627|NCT03474614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683628|NCT03474614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5683629|NCT03474614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5683630|NCT03474614|Vasodilator Agents|vasodilator agents|mesh-ancestor
5683631|NCT03474601|Hormones|hormones|mesh-list
5683632|NCT03474601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5683633|NCT03474601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683634|NCT03474510|Bupivacaine|bupivacaine|mesh-list
5683635|NCT03474510|Ropivacaine|ropivacaine|mesh-list
5683636|NCT03474510|Anesthetics, Local|anesthetics, local|mesh-ancestor
5683637|NCT03474510|Anesthetics|anesthetics|mesh-ancestor
5683638|NCT03474510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5683639|NCT03474510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683640|NCT03474510|Sensory System Agents|sensory system agents|mesh-ancestor
5683641|NCT03474510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5683642|NCT03474458|Doxycycline|doxycycline|mesh-list
5683643|NCT03474458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5683644|NCT03474458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5683645|NCT03474458|Antimalarials|antimalarials|mesh-ancestor
5683646|NCT03474458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5683647|NCT03474458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5683648|NCT03474341|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5683649|NCT03474341|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5683650|NCT03474341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683651|NCT03474276|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5683652|NCT03474276|Azithromycin|azithromycin|mesh-list
5683653|NCT03474276|Albendazole|albendazole|mesh-list
5683654|NCT03474276|Antiparasitic Agents|antiparasitic agents|mesh-list
5683655|NCT03474276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5683656|NCT03474276|Anthelmintics|anthelmintics|mesh-ancestor
5683657|NCT03474276|Anticestodal Agents|anticestodal agents|mesh-ancestor
5683658|NCT03474276|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5873827|NCT05077475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873828|NCT05077475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5873829|NCT05077462|Cryptophycin 52|cryptophycin 52|mesh-list
5873830|NCT05077462|Antimitotic Agents|antimitotic agents|mesh-ancestor
5873831|NCT05077462|Mitosis Modulators|mitosis modulators|mesh-ancestor
5873832|NCT05077462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873833|NCT05077462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5873834|NCT05077215|Pembrolizumab|pembrolizumab|mesh-list
5873835|NCT05077215|Lenvatinib|lenvatinib|mesh-list
5873836|NCT05077215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5873837|NCT05077215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5873838|NCT05077215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5873839|NCT05077215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5873840|NCT05077215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873841|NCT05077137|Vaccines|vaccines|mesh-list
5873842|NCT05077137|Immunologic Factors|immunologic factors|mesh-ancestor
5873843|NCT05077137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873844|NCT05077111|Anesthetics|anesthetics|mesh-list
5683659|NCT03474276|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5683660|NCT03474276|Tubulin Modulators|tubulin modulators|mesh-ancestor
5683661|NCT03474276|Antimitotic Agents|antimitotic agents|mesh-ancestor
5683662|NCT03474276|Mitosis Modulators|mitosis modulators|mesh-ancestor
5683663|NCT03474276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683664|NCT03474276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5683665|NCT03474263|Antibodies|antibodies|mesh-list
5683666|NCT03474263|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5683667|NCT03474263|Immunologic Factors|immunologic factors|mesh-ancestor
5683668|NCT03474263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873845|NCT05077111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5873846|NCT05077111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873847|NCT05075863|Letrozole|letrozole|mesh-list
5873848|NCT05075863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5873849|NCT05075863|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5873850|NCT05075863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5873851|NCT05075863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5873852|NCT05075863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873853|NCT05075863|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5873854|NCT05075863|Hormone Antagonists|hormone antagonists|mesh-ancestor
5873855|NCT05075863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5873856|NCT05075863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873857|NCT05069740|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
5873858|NCT05069740|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5873859|NCT05069740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5873860|NCT05069740|Analgesics|analgesics|mesh-ancestor
5873861|NCT05069740|Sensory System Agents|sensory system agents|mesh-ancestor
5873862|NCT05069740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5873863|NCT05069740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873864|NCT05069740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5873865|NCT05069740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5873866|NCT05068141|Paclitaxel|paclitaxel|mesh-list
5873867|NCT05068141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5873868|NCT05068141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5873869|NCT05068141|Tubulin Modulators|tubulin modulators|mesh-ancestor
5873870|NCT05068141|Antimitotic Agents|antimitotic agents|mesh-ancestor
5873871|NCT05068141|Mitosis Modulators|mitosis modulators|mesh-ancestor
5873872|NCT05068141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873873|NCT05068037|Antiemetics|antiemetics|mesh-list
5873874|NCT05068037|Autonomic Agents|autonomic agents|mesh-ancestor
5873875|NCT05068037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5873876|NCT05068037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873877|NCT05068037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5873878|NCT05065424|Atropine|atropine|mesh-list
5873879|NCT05065424|Fentanyl|fentanyl|mesh-list
5873880|NCT05065424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5873881|NCT05065424|Narcotics|narcotics|mesh-ancestor
5873882|NCT05065424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5873883|NCT05065424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873884|NCT05065424|Analgesics|analgesics|mesh-ancestor
5873885|NCT05065424|Sensory System Agents|sensory system agents|mesh-ancestor
5873886|NCT05065424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5873887|NCT05065424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5873888|NCT05065424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5873889|NCT05065424|Anesthetics, General|anesthetics, general|mesh-ancestor
5873890|NCT05065424|Anesthetics|anesthetics|mesh-ancestor
5873891|NCT05065424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873892|NCT05065424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5683669|NCT03474237|Hormones|hormones|mesh-list
5683670|NCT03474237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5683671|NCT03474237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697117|NCT03377907|Lidocaine|lidocaine|mesh-list
5697118|NCT03377907|Ketamine|ketamine|mesh-list
5697119|NCT03377907|Anesthetics, Local|anesthetics, local|mesh-ancestor
5697120|NCT03377907|Anesthetics|anesthetics|mesh-ancestor
5697121|NCT03377907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5697122|NCT03377907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697123|NCT03377907|Sensory System Agents|sensory system agents|mesh-ancestor
5697124|NCT03377907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5697125|NCT03377907|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5697126|NCT03377907|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5697127|NCT03377907|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5697128|NCT03377907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5697129|NCT03377907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697130|NCT03377907|Analgesics|analgesics|mesh-ancestor
5697131|NCT03377907|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5683672|NCT03474198|Levofloxacin|levofloxacin|mesh-list
5683673|NCT03474198|Rifampin|rifampin|mesh-list
5683674|NCT03474198|Isoniazid|isoniazid|mesh-list
5683675|NCT03474198|Linezolid|linezolid|mesh-list
5683676|NCT03474198|Pyrazinamide|pyrazinamide|mesh-list
5683677|NCT03474198|Ethambutol|ethambutol|mesh-list
5873893|NCT05065424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5873894|NCT05065424|Autonomic Agents|autonomic agents|mesh-ancestor
5873895|NCT05065424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5873896|NCT05065424|Respiratory System Agents|respiratory system agents|mesh-ancestor
5873897|NCT05065424|Mydriatics|mydriatics|mesh-ancestor
5873898|NCT05065424|Parasympatholytics|parasympatholytics|mesh-ancestor
5873899|NCT05065424|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5873900|NCT05065424|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5873901|NCT05065424|Cholinergic Agents|cholinergic agents|mesh-ancestor
5873902|NCT05065424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5873903|NCT05062356|Ketorolac|ketorolac|mesh-list
5873904|NCT05062356|Epinephrine|epinephrine|mesh-list
5873905|NCT05062356|Bupivacaine|bupivacaine|mesh-list
5873906|NCT05062356|Prilocaine|prilocaine|mesh-list
5873907|NCT05062356|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5873908|NCT05062356|Anesthetics, Local|anesthetics, local|mesh-ancestor
5873909|NCT05062356|Anesthetics|anesthetics|mesh-ancestor
5873910|NCT05062356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5873911|NCT05062356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873912|NCT05062356|Sensory System Agents|sensory system agents|mesh-ancestor
5873913|NCT05062356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5873914|NCT05062356|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5873915|NCT05062356|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5873916|NCT05062356|Adrenergic Agents|adrenergic agents|mesh-ancestor
5873917|NCT05062356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5873918|NCT05062356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873919|NCT05062356|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5873920|NCT05062356|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5873921|NCT05062356|Autonomic Agents|autonomic agents|mesh-ancestor
5873922|NCT05062356|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5873923|NCT05062356|Respiratory System Agents|respiratory system agents|mesh-ancestor
5873924|NCT05062356|Mydriatics|mydriatics|mesh-ancestor
5873925|NCT05062356|Sympathomimetics|sympathomimetics|mesh-ancestor
5873926|NCT05062356|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5873927|NCT05062356|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5873928|NCT05062356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5873929|NCT05062356|Analgesics|analgesics|mesh-ancestor
5873930|NCT05062356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5873931|NCT05062356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5873932|NCT05062356|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5873933|NCT05062356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5873934|NCT05062317|Leucovorin|leucovorin|mesh-list
5873935|NCT05062317|Bevacizumab|bevacizumab|mesh-list
5873936|NCT05062317|Fluorouracil|fluorouracil|mesh-list
5873937|NCT05062317|Capecitabine|capecitabine|mesh-list
5873938|NCT05062317|Oxaliplatin|oxaliplatin|mesh-list
5873939|NCT05062317|Irinotecan|irinotecan|mesh-list
5873940|NCT05062317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5873941|NCT05062317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5873942|NCT05062317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5873943|NCT05062317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5873944|NCT05062317|Growth Substances|growth substances|mesh-ancestor
5873945|NCT05062317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873946|NCT05062317|Growth Inhibitors|growth inhibitors|mesh-ancestor
6495678|NCT00624546|Dexlansoprazole|dexlansoprazole|mesh-list
6495679|NCT00624546|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6495680|NCT00624546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6495681|NCT00624546|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6495682|NCT00624546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6495683|NCT00624546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495684|NCT00624663|Rivastigmine|rivastigmine|mesh-list
6495685|NCT00624663|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6495686|NCT00624663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6495687|NCT00624663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683678|NCT03474198|Rifapentine|rifapentine|mesh-list
5683679|NCT03474198|Bedaquiline|bedaquiline|mesh-list
5683680|NCT03474198|Clofazimine|clofazimine|mesh-list
5683681|NCT03474198|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6495688|NCT00624663|Cholinergic Agents|cholinergic agents|mesh-ancestor
6495689|NCT00624663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5683682|NCT03474198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5683683|NCT03474198|Renal Agents|renal agents|mesh-ancestor
5698089|NCT03371498|Prednisolone phosphate|prednisolone phosphate|mesh-list
5873947|NCT05062317|Antimetabolites|antimetabolites|mesh-ancestor
5873948|NCT05062317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683684|NCT03474198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5683685|NCT03474198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5683686|NCT03474198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5683687|NCT03474198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5683688|NCT03474198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683689|NCT03474198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5683690|NCT03474198|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5683691|NCT03474198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5683692|NCT03474198|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5683693|NCT03474198|Antitubercular Agents|antitubercular agents|mesh-ancestor
5683694|NCT03474198|Leprostatic Agents|leprostatic agents|mesh-ancestor
5683695|NCT03474198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5683696|NCT03474198|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5683697|NCT03474198|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5683698|NCT03474198|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5683699|NCT03474198|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5683700|NCT03474198|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5683701|NCT03474198|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5683702|NCT03474198|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5683703|NCT03474198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5683704|NCT03474198|Antimetabolites|antimetabolites|mesh-ancestor
5683705|NCT03474198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5683706|NCT03474198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5683707|NCT03474198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5683708|NCT03474146|Chlorhexidine|chlorhexidine|mesh-list
5683709|NCT03474146|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5683710|NCT03474146|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5683711|NCT03474146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5683712|NCT03474146|Disinfectants|disinfectants|mesh-ancestor
5683713|NCT03474146|Dermatologic Agents|dermatologic agents|mesh-ancestor
5683714|NCT03474133|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5683715|NCT03474133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5683716|NCT03474133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5683717|NCT03474094|Atezolizumab|atezolizumab|mesh-list
5683718|NCT03474094|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5683719|NCT03474094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5683720|NCT03474094|Immunologic Factors|immunologic factors|mesh-ancestor
5683721|NCT03474094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683722|NCT03473964|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
5873949|NCT05062317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5873950|NCT05062317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5873951|NCT05062317|Immunologic Factors|immunologic factors|mesh-ancestor
5873952|NCT05062317|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5873953|NCT05062317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5873954|NCT05062317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5873955|NCT05062317|Antidotes|antidotes|mesh-ancestor
5873956|NCT05062317|Protective Agents|protective agents|mesh-ancestor
5873957|NCT05062317|Vitamin B Complex|vitamin b complex|mesh-ancestor
5873958|NCT05062317|Vitamins|vitamins|mesh-ancestor
5873959|NCT05062317|Micronutrients|micronutrients|mesh-ancestor
5873960|NCT05061368|Sildenafil Citrate|sildenafil citrate|mesh-list
5873961|NCT05061368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873962|NCT05061368|Vasodilator Agents|vasodilator agents|mesh-ancestor
5873963|NCT05061368|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5873964|NCT05061368|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5873965|NCT05061368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5873966|NCT05061368|Urological Agents|urological agents|mesh-ancestor
5683723|NCT03473964|Hormones|hormones|mesh-ancestor
5683724|NCT03473964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5683725|NCT03473964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683726|NCT03473925|Pembrolizumab|pembrolizumab|mesh-list
5683727|NCT03473925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5683728|NCT03473925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5683731|NCT03473691|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
5683732|NCT03473691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5683733|NCT03473691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5683734|NCT03473639|Capecitabine|capecitabine|mesh-list
5683735|NCT03473639|Entinostat|entinostat|mesh-list
5683736|NCT03473639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5683737|NCT03473639|Antimetabolites|antimetabolites|mesh-ancestor
5873967|NCT05053425|Cytarabine|cytarabine|mesh-list
5873968|NCT05053425|Azacitidine|azacitidine|mesh-list
5873969|NCT05053425|Venetoclax|venetoclax|mesh-list
5873970|NCT05053425|Idarubicin|idarubicin|mesh-list
5873971|NCT05053425|Cladribine|cladribine|mesh-list
5873972|NCT05053425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5873973|NCT05053425|Antimetabolites|antimetabolites|mesh-ancestor
5683738|NCT03473639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683739|NCT03473639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5683740|NCT03473639|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5683741|NCT03473639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5683742|NCT03473626|Alicaforsen|alicaforsen|mesh-list
5683743|NCT03473626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5683744|NCT03473626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5683745|NCT03473626|Immunologic Factors|immunologic factors|mesh-ancestor
5683746|NCT03473626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873974|NCT05053425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873975|NCT05053425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5873976|NCT05053425|Antiviral Agents|antiviral agents|mesh-ancestor
5873977|NCT05053425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5873978|NCT05053425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5873979|NCT05053425|Immunologic Factors|immunologic factors|mesh-ancestor
5873980|NCT05053425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873981|NCT05053425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5873982|NCT05053425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5873983|NCT05053425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5873984|NCT05053425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5873985|NCT05044871|Paclitaxel|paclitaxel|mesh-list
5873986|NCT05044871|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5873987|NCT05044871|Bevacizumab|bevacizumab|mesh-list
5873988|NCT05044871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5873989|NCT05044871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5873990|NCT05044871|Tubulin Modulators|tubulin modulators|mesh-ancestor
5873991|NCT05044871|Antimitotic Agents|antimitotic agents|mesh-ancestor
5873992|NCT05044871|Mitosis Modulators|mitosis modulators|mesh-ancestor
5873993|NCT05044871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5873994|NCT05044871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5873995|NCT05044871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5873996|NCT05044871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5873997|NCT05044871|Growth Substances|growth substances|mesh-ancestor
5873998|NCT05044871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5873999|NCT05044871|Growth Inhibitors|growth inhibitors|mesh-ancestor
5874000|NCT05021562|Niraparib|niraparib|mesh-list
5874001|NCT05021562|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6495690|NCT00624663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495691|NCT00624663|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6495692|NCT00624663|Protective Agents|protective agents|mesh-ancestor
6495693|NCT00624676|Salicylic Acid|salicylic acid|mesh-list
6495694|NCT00624676|Benzoic Acid|benzoic acid|mesh-list
6495695|NCT00624676|Salicylates|salicylates|mesh-list
6495696|NCT00624676|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6495697|NCT00624676|Dermatologic Agents|dermatologic agents|mesh-ancestor
6495698|NCT00624676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6495699|NCT00624676|Antifungal Agents|antifungal agents|mesh-ancestor
6495700|NCT00624676|Keratolytic Agents|keratolytic agents|mesh-ancestor
6495701|NCT00624676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6495702|NCT00624676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6495703|NCT00624676|Analgesics|analgesics|mesh-ancestor
6495704|NCT00624676|Sensory System Agents|sensory system agents|mesh-ancestor
6495705|NCT00624676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6495706|NCT00624676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495707|NCT00624676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6495708|NCT00624676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6495709|NCT00624676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6495710|NCT00624676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6495711|NCT00624676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495712|NCT00624702|Maleic acid|maleic acid|mesh-list
6495713|NCT00624702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5874002|NCT05021562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5874003|NCT05021562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5874004|NCT05021562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5874005|NCT05015686|Vaccines|vaccines|mesh-list
5874006|NCT05015686|Immunologic Factors|immunologic factors|mesh-ancestor
5874007|NCT05015686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495714|NCT00624702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495715|NCT00624741|Pergolide|pergolide|mesh-list
5683747|NCT03473613|Calcium, Dietary|calcium, dietary|mesh-list
5683748|NCT03473613|Cabergoline|cabergoline|mesh-list
5683749|NCT03473613|Calcium|calcium|mesh-list
5683750|NCT03473613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5683751|NCT03473613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683752|NCT03473613|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6675302|NCT01573806|Incretins|incretins|mesh-ancestor
6675303|NCT01573806|Hormones|hormones|mesh-ancestor
6675304|NCT01573806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6675305|NCT01573975|Clarithromycin|clarithromycin|mesh-list
6675306|NCT01573975|Rabeprazole|rabeprazole|mesh-list
6675307|NCT01573975|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5874008|NCT05005260|Bupivacaine|bupivacaine|mesh-list
5874009|NCT05005260|Anesthetics, Local|anesthetics, local|mesh-ancestor
5874010|NCT05005260|Anesthetics|anesthetics|mesh-ancestor
5874011|NCT05005260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5874012|NCT05005260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874013|NCT05005260|Sensory System Agents|sensory system agents|mesh-ancestor
5874014|NCT05005260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5874015|NCT04997941|Tamoxifen|tamoxifen|mesh-list
5874016|NCT04997941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5874017|NCT04997941|Hormone Antagonists|hormone antagonists|mesh-ancestor
5874018|NCT04997941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5683753|NCT03473613|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5683754|NCT03473613|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5683755|NCT03473613|Dopamine Agonists|dopamine agonists|mesh-ancestor
5683756|NCT03473613|Dopamine Agents|dopamine agents|mesh-ancestor
5683757|NCT03473613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5683758|NCT03473613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683759|NCT03473600|Triamcinolone|triamcinolone|mesh-list
5683760|NCT03473600|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5683761|NCT03473600|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5683762|NCT03473600|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5683763|NCT03473600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5683764|NCT03473600|Glucocorticoids|glucocorticoids|mesh-ancestor
5683765|NCT03473600|Hormones|hormones|mesh-ancestor
5683766|NCT03473600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5683767|NCT03473600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683768|NCT03473600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5683769|NCT03473600|Immunologic Factors|immunologic factors|mesh-ancestor
5683770|NCT03473600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5683771|NCT03473600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683772|NCT03473431|Ketamine|ketamine|mesh-list
5683773|NCT03473431|Analgesics|analgesics|mesh-ancestor
5683774|NCT03473431|Sensory System Agents|sensory system agents|mesh-ancestor
5683775|NCT03473431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5683776|NCT03473431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683777|NCT03473431|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5683778|NCT03473431|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5683779|NCT03473431|Anesthetics, General|anesthetics, general|mesh-ancestor
5683780|NCT03473431|Anesthetics|anesthetics|mesh-ancestor
5683781|NCT03473431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5683782|NCT03473431|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5683783|NCT03473431|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5683784|NCT03473431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5683785|NCT03473431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683786|NCT03473418|Ketoconazole|ketoconazole|mesh-list
5683787|NCT03473418|Terconazole|terconazole|mesh-list
5874019|NCT04997941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874020|NCT04997941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5874021|NCT04997941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5874022|NCT04997941|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5874023|NCT04997941|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5874024|NCT04997941|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5874025|NCT04996199|Zileuton|zileuton|mesh-list
6675308|NCT01573975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5683788|NCT03473418|Antifungal Agents|antifungal agents|mesh-ancestor
5683789|NCT03473418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5683790|NCT03473418|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5683791|NCT03473418|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5683792|NCT03473418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5683793|NCT03473418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683794|NCT03473418|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5874026|NCT04996199|Carbamazepine|carbamazepine|mesh-list
5874027|NCT04996199|Oxcarbazepine|oxcarbazepine|mesh-list
5874028|NCT04996199|Anticonvulsants|anticonvulsants|mesh-ancestor
5874029|NCT04996199|Antimanic Agents|antimanic agents|mesh-ancestor
5874030|NCT04996199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5874031|NCT04996199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5874032|NCT04996199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874033|NCT04996199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5874034|NCT04996199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5874035|NCT04996199|Analgesics|analgesics|mesh-ancestor
5874036|NCT04996199|Sensory System Agents|sensory system agents|mesh-ancestor
5874037|NCT04996199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5874038|NCT04996199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5874039|NCT04996199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5874040|NCT04996199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5874041|NCT04996199|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5874042|NCT04996199|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5874043|NCT04996199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5874044|NCT04996199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5874045|NCT04996199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5874046|NCT04996199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5874047|NCT04996199|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
5874048|NCT04996199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5874049|NCT04996199|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5874050|NCT04996199|Hormone Antagonists|hormone antagonists|mesh-ancestor
5874051|NCT04996199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5874052|NCT04990284|Levodopa|levodopa|mesh-list
5874053|NCT04990284|Opicapone|opicapone|mesh-list
5874054|NCT04990284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5874055|NCT04990284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5874056|NCT04990284|Dopamine Agents|dopamine agents|mesh-ancestor
5874057|NCT04990284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5874058|NCT04990284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5874059|NCT04990284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874060|NCT04990284|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
5683795|NCT03473418|Hormone Antagonists|hormone antagonists|mesh-ancestor
5683796|NCT03473418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5683797|NCT03473418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683798|NCT03473418|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5683799|NCT03473314|Nitric Oxide|nitric oxide|mesh-list
5683800|NCT03473314|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5683801|NCT03473314|Autonomic Agents|autonomic agents|mesh-ancestor
5683802|NCT03473314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5683803|NCT03473314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683804|NCT03473314|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5874061|NCT04990284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5874062|NCT04988971|Corticosterone|corticosterone|mesh-list
5874063|NCT04988971|Fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether|fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether|mesh-list
5874064|NCT04988971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5874065|NCT04988971|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5874066|NCT04988971|Anesthetics, General|anesthetics, general|mesh-ancestor
5874067|NCT04988971|Anesthetics|anesthetics|mesh-ancestor
5874068|NCT04988971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5874069|NCT04988971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874070|NCT04984733|Nivolumab|nivolumab|mesh-list
5874071|NCT04984733|Temozolomide|temozolomide|mesh-list
5874072|NCT04984733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5874073|NCT04984733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5874074|NCT04984733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5874075|NCT04984733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5874076|NCT04984733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5874077|NCT04984733|Alkylating Agents|alkylating agents|mesh-ancestor
5874078|NCT04973826|Aztreonam|aztreonam|mesh-list
5874079|NCT04973826|Avibactam|avibactam|mesh-list
5874080|NCT04973826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5874081|NCT04973826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5874082|NCT04973826|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5874083|NCT04973826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5874084|NCT04973826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905786|NCT04664972|Tubulin Modulators|tubulin modulators|mesh-ancestor
5905787|NCT04664972|Antimitotic Agents|antimitotic agents|mesh-ancestor
5905788|NCT04664972|Mitosis Modulators|mitosis modulators|mesh-ancestor
5874085|NCT04954313|Chlorhexidine|chlorhexidine|mesh-list
5874086|NCT04954313|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5874087|NCT04954313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5874088|NCT04954313|Disinfectants|disinfectants|mesh-ancestor
5874089|NCT04940637|Niraparib|niraparib|mesh-list
5874090|NCT04940637|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5874091|NCT04940637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5874092|NCT04940637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5874093|NCT04940637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5874094|NCT04926454|Dexmedetomidine|dexmedetomidine|mesh-list
5874095|NCT04926454|Bupivacaine|bupivacaine|mesh-list
5874096|NCT04926454|Anesthetics, Local|anesthetics, local|mesh-ancestor
5874097|NCT04926454|Anesthetics|anesthetics|mesh-ancestor
5874098|NCT04926454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5874099|NCT04926454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874100|NCT04926454|Sensory System Agents|sensory system agents|mesh-ancestor
5874101|NCT04926454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5874102|NCT04926454|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5874103|NCT04926454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5874104|NCT04926454|Analgesics|analgesics|mesh-ancestor
5874105|NCT04926454|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5874106|NCT04926454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5874107|NCT04926454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5874108|NCT04926454|Adrenergic Agents|adrenergic agents|mesh-ancestor
5874109|NCT04926454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5683805|NCT03473314|Respiratory System Agents|respiratory system agents|mesh-ancestor
5683806|NCT03473314|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5683807|NCT03473314|Antioxidants|antioxidants|mesh-ancestor
5683808|NCT03473314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683809|NCT03473314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5683810|NCT03473314|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5683811|NCT03473314|Vasodilator Agents|vasodilator agents|mesh-ancestor
5683812|NCT03473314|Gasotransmitters|gasotransmitters|mesh-ancestor
5683813|NCT03473314|Protective Agents|protective agents|mesh-ancestor
5683814|NCT03473210|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5683815|NCT03473210|Erythromycin|erythromycin|mesh-list
5683816|NCT03473210|Ampicillin|ampicillin|mesh-list
5683817|NCT03473210|Dexamethasone|dexamethasone|mesh-list
5683818|NCT03473210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5683819|NCT03473210|Antiemetics|antiemetics|mesh-ancestor
5683820|NCT03473210|Autonomic Agents|autonomic agents|mesh-ancestor
5683821|NCT03473210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5683822|NCT03473210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683823|NCT03473210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5683824|NCT03473210|Glucocorticoids|glucocorticoids|mesh-ancestor
5683825|NCT03473210|Hormones|hormones|mesh-ancestor
5683826|NCT03473210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5683827|NCT03473210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5683828|NCT03473210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5683829|NCT03473210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5683830|NCT03473210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683831|NCT03473210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5683832|NCT03473210|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5683833|NCT03473132|Thrombin|thrombin|mesh-list
5683834|NCT03473132|Hemostatics|hemostatics|mesh-ancestor
5683835|NCT03473132|Coagulants|coagulants|mesh-ancestor
5683836|NCT03473093|Pregabalin|pregabalin|mesh-list
5683837|NCT03473093|Morphine|morphine|mesh-list
5683838|NCT03473093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5683839|NCT03473093|Narcotics|narcotics|mesh-ancestor
5874110|NCT04926454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5874111|NCT04925427|Naloxone|naloxone|mesh-list
5874112|NCT04925427|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5683840|NCT03473093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5683841|NCT03473093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683842|NCT03473093|Analgesics|analgesics|mesh-ancestor
5683843|NCT03473093|Sensory System Agents|sensory system agents|mesh-ancestor
5683844|NCT03473093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5683845|NCT03473093|Anticonvulsants|anticonvulsants|mesh-ancestor
5683846|NCT03473093|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5683847|NCT03473093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5683848|NCT03473093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683849|NCT03473093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5683850|NCT03473093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5874113|NCT04925427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683851|NCT03473093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5874114|NCT04925427|Sensory System Agents|sensory system agents|mesh-ancestor
5874115|NCT04925427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5874116|NCT04913025|Pembrolizumab|pembrolizumab|mesh-list
5874117|NCT04913025|Nivolumab|nivolumab|mesh-list
5874118|NCT04913025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5874119|NCT04913025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5874120|NCT04913025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5874121|NCT04913025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5874122|NCT04905654|Cromakalim|cromakalim|mesh-list
5874123|NCT04905654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5874124|NCT04905654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5874125|NCT04905654|Autonomic Agents|autonomic agents|mesh-ancestor
5874126|NCT04905654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5683852|NCT03473093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5683853|NCT03472976|Imiquimod|imiquimod|mesh-list
5683854|NCT03472976|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5683855|NCT03472976|Immunologic Factors|immunologic factors|mesh-ancestor
5683856|NCT03472976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683857|NCT03472976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5683858|NCT03472976|Interferon Inducers|interferon inducers|mesh-ancestor
5683859|NCT03472963|Darunavir|darunavir|mesh-list
5683860|NCT03472963|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5683861|NCT03472963|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5874127|NCT04905654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874128|NCT04905654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5874129|NCT04905654|Respiratory System Agents|respiratory system agents|mesh-ancestor
5874130|NCT04905654|Parasympatholytics|parasympatholytics|mesh-ancestor
5874131|NCT04905654|Vasodilator Agents|vasodilator agents|mesh-ancestor
5874137|NCT04833764|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5874138|NCT04833764|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5874139|NCT04833764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5874140|NCT04833764|Antimetabolites|antimetabolites|mesh-ancestor
5874141|NCT04833764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5874142|NCT04833764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5874143|NCT04833764|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5874144|NCT04833764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5874145|NCT04824131|Tenofovir|tenofovir|mesh-list
5874146|NCT04824131|Emtricitabine|emtricitabine|mesh-list
5874147|NCT04824131|Cabotegravir|cabotegravir|mesh-list
5874148|NCT04824131|Antiviral Agents|antiviral agents|mesh-ancestor
5874149|NCT04824131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5874150|NCT04824131|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5874151|NCT04824131|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5874152|NCT04824131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5874153|NCT04824131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5874154|NCT04824131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5874155|NCT04824131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5874156|NCT04824131|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5874157|NCT04824131|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5874158|NCT04807920|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5874159|NCT04807920|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5874160|NCT04807920|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5874161|NCT04807920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5874162|NCT04807920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874163|NCT04807920|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5874164|NCT04807920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5874165|NCT04807920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5874166|NCT04807920|Cholinergic Agents|cholinergic agents|mesh-ancestor
5874167|NCT04807920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5874168|NCT04798482|Dexmedetomidine|dexmedetomidine|mesh-list
5874169|NCT04798482|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5874170|NCT04798482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5874171|NCT04798482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874172|NCT04798482|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5874173|NCT04798482|Analgesics|analgesics|mesh-ancestor
5874174|NCT04798482|Sensory System Agents|sensory system agents|mesh-ancestor
5874175|NCT04798482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5874176|NCT04798482|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6675309|NCT01573975|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6675310|NCT01573975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6675311|NCT01573975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5874177|NCT04798482|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5683862|NCT03472963|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5683863|NCT03472963|Protease Inhibitors|protease inhibitors|mesh-ancestor
5683864|NCT03472963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5683865|NCT03472963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683866|NCT03472963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5683867|NCT03472963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5683868|NCT03472963|Antiviral Agents|antiviral agents|mesh-ancestor
5683869|NCT03472963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5683870|NCT03472950|Ranolazine|ranolazine|mesh-list
5683871|NCT03472950|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5683872|NCT03472950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5683873|NCT03472950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683874|NCT03472872|Acetaminophen|acetaminophen|mesh-list
5683875|NCT03472872|Ketorolac|ketorolac|mesh-list
5874178|NCT04798482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5874179|NCT04798482|Adrenergic Agents|adrenergic agents|mesh-ancestor
5874180|NCT04798482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5874181|NCT04798482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5874182|NCT04797312|Sufentanil|sufentanil|mesh-list
5874183|NCT04797312|Remifentanil|remifentanil|mesh-list
5874184|NCT04797312|Analgesics, Opioid|analgesics, opioid|mesh-list
5874185|NCT04797312|Anesthetics|anesthetics|mesh-ancestor
5874186|NCT04797312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5874187|NCT04797312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874188|NCT04797312|Narcotics|narcotics|mesh-ancestor
5874189|NCT04797312|Analgesics|analgesics|mesh-ancestor
5874190|NCT04797312|Sensory System Agents|sensory system agents|mesh-ancestor
5874191|NCT04797312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5874192|NCT04797312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5874193|NCT04797312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5874194|NCT04797312|Anesthetics, General|anesthetics, general|mesh-ancestor
5874195|NCT04771156|Ketorolac|ketorolac|mesh-list
5874196|NCT04771156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5874197|NCT04771156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5874198|NCT04771156|Analgesics|analgesics|mesh-ancestor
5874199|NCT04771156|Sensory System Agents|sensory system agents|mesh-ancestor
5874200|NCT04771156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5874201|NCT04771156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874202|NCT04771156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5874203|NCT04771156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5874204|NCT04771156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5874205|NCT04771156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5874206|NCT04771156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5874207|NCT04750343|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5683876|NCT03472872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5683877|NCT03472872|Analgesics|analgesics|mesh-ancestor
5683878|NCT03472872|Sensory System Agents|sensory system agents|mesh-ancestor
5683879|NCT03472872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5683880|NCT03472872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683881|NCT03472872|Antipyretics|antipyretics|mesh-ancestor
5683882|NCT03472872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5683883|NCT03472872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5683884|NCT03472872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5683885|NCT03472872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5683886|NCT03472872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5683887|NCT03472872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683888|NCT03472846|Teriparatide|teriparatide|mesh-list
5683889|NCT03472846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5683890|NCT03472846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683891|NCT03472846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5683892|NCT03472677|Capsaicin|capsaicin|mesh-list
5683893|NCT03472677|Antipruritics|antipruritics|mesh-ancestor
5683894|NCT03472677|Dermatologic Agents|dermatologic agents|mesh-ancestor
5683895|NCT03472677|Sensory System Agents|sensory system agents|mesh-ancestor
5683896|NCT03472677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5683897|NCT03472677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683898|NCT03472651|Flupenthixol|flupenthixol|mesh-list
5683899|NCT03472651|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
5683900|NCT03472651|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5683901|NCT03472651|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5683902|NCT03472651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5683903|NCT03472651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683904|NCT03472651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5683905|NCT03472651|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5683906|NCT03472651|Dopamine Agents|dopamine agents|mesh-ancestor
5683907|NCT03472651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5683908|NCT03472651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683909|NCT03472573|Dexamethasone|dexamethasone|mesh-list
5683910|NCT03472573|Palbociclib|palbociclib|mesh-list
5683911|NCT03472573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5683912|NCT03472573|Antiemetics|antiemetics|mesh-ancestor
5683913|NCT03472573|Autonomic Agents|autonomic agents|mesh-ancestor
5683914|NCT03472573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5683915|NCT03472573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683916|NCT03472573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5683917|NCT03472573|Glucocorticoids|glucocorticoids|mesh-ancestor
5874208|NCT04742738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5874209|NCT04742738|Aluminum sulfate|aluminum sulfate|mesh-list
5874210|NCT04742738|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5874211|NCT04742738|Immunologic Factors|immunologic factors|mesh-ancestor
5874212|NCT04742738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874213|NCT04735861|Bevacizumab|bevacizumab|mesh-list
5874214|NCT04735861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5874215|NCT04735861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5874216|NCT04735861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5874217|NCT04735861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5874218|NCT04735861|Growth Substances|growth substances|mesh-ancestor
5874219|NCT04735861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874220|NCT04735861|Growth Inhibitors|growth inhibitors|mesh-ancestor
5874221|NCT04735263|Atorvastatin|atorvastatin|mesh-list
5874222|NCT04735263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5874223|NCT04735263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5874224|NCT04735263|Antimetabolites|antimetabolites|mesh-ancestor
5874225|NCT04735263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5874226|NCT04735263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5874227|NCT04735263|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5874228|NCT04735263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5874229|NCT04734886|Vitamin D|vitamin d|mesh-list
5874230|NCT04734886|Ergocalciferols|ergocalciferols|mesh-list
5874231|NCT04734886|Vitamins|vitamins|mesh-list
5874232|NCT04734886|Micronutrients|micronutrients|mesh-ancestor
5874233|NCT04734886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874234|NCT04734886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5874235|NCT04734886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5874236|NCT04705259|Anti-Infective Agents|anti-infective agents|mesh-list
5874237|NCT04705259|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5874238|NCT04668157|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
5874239|NCT04668157|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5874240|NCT04668157|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5874241|NCT04668157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5874242|NCT04664959|Denosumab|denosumab|mesh-list
5874243|NCT04664959|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5874244|NCT04664959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905789|NCT04664972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5905790|NCT04664972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5683918|NCT03472573|Hormones|hormones|mesh-ancestor
5683919|NCT03472573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5683920|NCT03472573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5683921|NCT03472573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5683922|NCT03472573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5683923|NCT03472573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5683924|NCT03472573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683925|NCT03472560|Avelumab|avelumab|mesh-list
5683926|NCT03472560|Axitinib|axitinib|mesh-list
5683927|NCT03472560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5683928|NCT03472560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5683929|NCT03472560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5683930|NCT03472560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5683931|NCT03472560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683932|NCT03472508|Folic Acid|folic acid|mesh-list
5683933|NCT03472508|Vitamin B Complex|vitamin b complex|mesh-list
5683934|NCT03472508|Enalapril|enalapril|mesh-list
5683935|NCT03472508|Enalaprilat|enalaprilat|mesh-list
5683936|NCT03472508|Hematinics|hematinics|mesh-ancestor
5874245|NCT04662723|Dapagliflozin|dapagliflozin|mesh-list
5874246|NCT04662723|Empagliflozin|empagliflozin|mesh-list
5874247|NCT04662723|Canagliflozin|canagliflozin|mesh-list
5683937|NCT03472508|Vitamins|vitamins|mesh-ancestor
5683938|NCT03472508|Micronutrients|micronutrients|mesh-ancestor
5683939|NCT03472508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683940|NCT03472508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5683941|NCT03472508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683942|NCT03472508|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5683943|NCT03472508|Protease Inhibitors|protease inhibitors|mesh-ancestor
5683944|NCT03472508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5683945|NCT03472495|Diltiazem|diltiazem|mesh-list
5683946|NCT03472495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5683947|NCT03472495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5683948|NCT03472495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5683949|NCT03472495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683950|NCT03472495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5683951|NCT03472495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683952|NCT03472495|Vasodilator Agents|vasodilator agents|mesh-ancestor
5683953|NCT03472456|Eugenol|eugenol|mesh-list
5683954|NCT03472456|Carticaine|carticaine|mesh-list
5683955|NCT03472456|Anesthetics, Local|anesthetics, local|mesh-ancestor
5874248|NCT04662723|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
5874249|NCT04662723|Methylprednisolone|methylprednisolone|mesh-list
5874250|NCT04662723|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5874251|NCT04662723|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5874252|NCT04662723|Prednisolone|prednisolone|mesh-list
5874253|NCT04662723|Prednisolone acetate|prednisolone acetate|mesh-list
5683956|NCT03472456|Anesthetics|anesthetics|mesh-ancestor
5683957|NCT03472456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5683958|NCT03472456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683959|NCT03472456|Sensory System Agents|sensory system agents|mesh-ancestor
5683960|NCT03472456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5683961|NCT03472456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5697132|NCT03377907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5697133|NCT03377907|Anesthetics, General|anesthetics, general|mesh-ancestor
5697134|NCT03377907|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5874254|NCT04662723|Losartan|losartan|mesh-list
5874255|NCT04662723|Ramipril|ramipril|mesh-list
5874256|NCT04662723|Lisinopril|lisinopril|mesh-list
5874257|NCT04662723|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5874258|NCT04662723|Prednisolone phosphate|prednisolone phosphate|mesh-list
5874259|NCT04662723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5874260|NCT04662723|Antiemetics|antiemetics|mesh-ancestor
5874261|NCT04662723|Autonomic Agents|autonomic agents|mesh-ancestor
5874262|NCT04662723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5874263|NCT04662723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874264|NCT04662723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5874265|NCT04662723|Glucocorticoids|glucocorticoids|mesh-ancestor
5874266|NCT04662723|Hormones|hormones|mesh-ancestor
5874267|NCT04662723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5874268|NCT04662723|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5874269|NCT04662723|Protective Agents|protective agents|mesh-ancestor
5874270|NCT04662723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5874271|NCT04662723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5874272|NCT04662723|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5874273|NCT04662723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5874274|NCT04662723|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5874275|NCT04662723|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5874276|NCT04662723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5874277|NCT04662723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5874278|NCT04662723|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5874279|NCT04662723|Protease Inhibitors|protease inhibitors|mesh-ancestor
5874280|NCT04662723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5874281|NCT04662723|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5874282|NCT04654429|Ondansetron|ondansetron|mesh-list
5874283|NCT04654429|Antiemetics|antiemetics|mesh-ancestor
5874284|NCT04654429|Autonomic Agents|autonomic agents|mesh-ancestor
5874285|NCT04654429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5874286|NCT04654429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874287|NCT04654429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5874288|NCT04654429|Antipruritics|antipruritics|mesh-ancestor
5874289|NCT04654429|Dermatologic Agents|dermatologic agents|mesh-ancestor
6212438|NCT02188160|Loteprednol Etabonate|loteprednol etabonate|mesh-list
5874290|NCT04654429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6212439|NCT02188160|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5874291|NCT04654429|Serotonin Agents|serotonin agents|mesh-ancestor
5874292|NCT04654429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5874293|NCT04654429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5874294|NCT04654429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5874295|NCT04654429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5874296|NCT04654429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5874297|NCT04654429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5874298|NCT04654429|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5874299|NCT04650698|Tranexamic Acid|tranexamic acid|mesh-list
5874300|NCT04650698|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5874301|NCT04650698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5874302|NCT04650698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5874303|NCT04650698|Hemostatics|hemostatics|mesh-ancestor
5874304|NCT04650698|Coagulants|coagulants|mesh-ancestor
5874305|NCT04629534|Cholecalciferol|cholecalciferol|mesh-list
5874306|NCT04629534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5874307|NCT04629534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874308|NCT04629534|Vitamins|vitamins|mesh-ancestor
5874309|NCT04629534|Micronutrients|micronutrients|mesh-ancestor
5874310|NCT04629534|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5874311|NCT04617457|Leucovorin|leucovorin|mesh-list
5874312|NCT04617457|Folic Acid|folic acid|mesh-list
5874313|NCT04617457|Oxaliplatin|oxaliplatin|mesh-list
5874314|NCT04617457|Irinotecan|irinotecan|mesh-list
5683962|NCT03472378|Celecoxib|celecoxib|mesh-list
6495716|NCT00624741|Dopamine Agonists|dopamine agonists|mesh-ancestor
6495717|NCT00624741|Dopamine Agents|dopamine agents|mesh-ancestor
6495718|NCT00624741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6495719|NCT00624741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495720|NCT00624741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495721|NCT00624754|Budesonide|budesonide|mesh-list
6495722|NCT00624754|Formoterol Fumarate|formoterol fumarate|mesh-list
6495723|NCT00624754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6495724|NCT00624754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6495725|NCT00624754|Autonomic Agents|autonomic agents|mesh-ancestor
5683963|NCT03472378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5874315|NCT04617457|Fluorouracil|fluorouracil|mesh-list
5874316|NCT04617457|Levoleucovorin|levoleucovorin|mesh-list
5874317|NCT04617457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5874318|NCT04617457|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5874319|NCT04617457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5874320|NCT04617457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5874321|NCT04617457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5874322|NCT04617457|Antidotes|antidotes|mesh-ancestor
5874323|NCT04617457|Protective Agents|protective agents|mesh-ancestor
5683964|NCT03472378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5683965|NCT03472378|Analgesics|analgesics|mesh-ancestor
5683966|NCT03472378|Sensory System Agents|sensory system agents|mesh-ancestor
5683967|NCT03472378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5683968|NCT03472378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683969|NCT03472378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5683970|NCT03472378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5683971|NCT03472378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5683972|NCT03472378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5683973|NCT03472378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5683974|NCT03472378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683975|NCT03472365|Capecitabine|capecitabine|mesh-list
5683976|NCT03472365|Oxaliplatin|oxaliplatin|mesh-list
5683977|NCT03472365|Apatinib|apatinib|mesh-list
5874324|NCT04617457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874325|NCT04617457|Vitamin B Complex|vitamin b complex|mesh-ancestor
5874326|NCT04617457|Vitamins|vitamins|mesh-ancestor
5874327|NCT04617457|Micronutrients|micronutrients|mesh-ancestor
5874328|NCT04617457|Hematinics|hematinics|mesh-ancestor
5874329|NCT04617457|Antimetabolites|antimetabolites|mesh-ancestor
5874330|NCT04617457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5874331|NCT04617457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5874332|NCT04617457|Immunologic Factors|immunologic factors|mesh-ancestor
5874333|NCT04596995|Rozanolixizumab|rozanolixizumab|mesh-list
5874334|NCT04596995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5874335|NCT04596995|Immunologic Factors|immunologic factors|mesh-ancestor
5874336|NCT04596995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874337|NCT04593563|Psilocybin|psilocybin|mesh-list
5874338|NCT04593563|Hallucinogens|hallucinogens|mesh-ancestor
5874339|NCT04593563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874340|NCT04593563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5874341|NCT04581343|Gemcitabine|gemcitabine|mesh-list
5874342|NCT04581343|Paclitaxel|paclitaxel|mesh-list
5874343|NCT04581343|Spartalizumab|spartalizumab|mesh-list
5874344|NCT04581343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5874345|NCT04581343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5874346|NCT04581343|Tubulin Modulators|tubulin modulators|mesh-ancestor
5874347|NCT04581343|Antimitotic Agents|antimitotic agents|mesh-ancestor
5874348|NCT04581343|Mitosis Modulators|mitosis modulators|mesh-ancestor
5874349|NCT04581343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5874350|NCT04581343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5874351|NCT04581343|Antimetabolites|antimetabolites|mesh-ancestor
5874352|NCT04581343|Antiviral Agents|antiviral agents|mesh-ancestor
5874353|NCT04581343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5874354|NCT04581343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5874355|NCT04581343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5874356|NCT04581343|Immunologic Factors|immunologic factors|mesh-ancestor
5874357|NCT04581343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874358|NCT04581343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5874359|NCT04579120|Corticosterone|corticosterone|mesh-list
5874360|NCT04579120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5874361|NCT04554836|Cetuximab|cetuximab|mesh-list
5874362|NCT04554836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5874363|NCT04554836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5874364|NCT04551911|Calcifediol|calcifediol|mesh-list
5874365|NCT04551911|Vitamins|vitamins|mesh-ancestor
5874366|NCT04551911|Micronutrients|micronutrients|mesh-ancestor
5874367|NCT04551911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874368|NCT04551911|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5874369|NCT04536272|Heparin|heparin|mesh-list
5874370|NCT04536272|Calcium heparin|calcium heparin|mesh-list
5874371|NCT04536272|Enoxaparin|enoxaparin|mesh-list
5874372|NCT04536272|Nadroparin|nadroparin|mesh-list
5683978|NCT03472365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5683979|NCT03472365|Antimetabolites|antimetabolites|mesh-ancestor
5683980|NCT03472365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683981|NCT03472365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5683982|NCT03472365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5683983|NCT03472365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5874373|NCT04536272|Anticoagulants|anticoagulants|mesh-ancestor
5874374|NCT04536272|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5874375|NCT04536272|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5683984|NCT03472339|Diclofenac|diclofenac|mesh-list
5683985|NCT03472339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5683986|NCT03472339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5683987|NCT03472339|Analgesics|analgesics|mesh-ancestor
5683988|NCT03472339|Sensory System Agents|sensory system agents|mesh-ancestor
5683989|NCT03472339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5683990|NCT03472339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683991|NCT03472339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5683992|NCT03472339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5683993|NCT03472339|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5683994|NCT03472339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5683995|NCT03472339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5683996|NCT03472261|Botulinum Toxins|botulinum toxins|mesh-list
5683997|NCT03472261|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5683998|NCT03472261|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5874376|NCT04536272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5874377|NCT04533880|Calcium|calcium|mesh-list
5874378|NCT04533880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5874379|NCT04533880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874380|NCT04529460|Antibodies|antibodies|mesh-list
5874381|NCT04529460|Immunologic Factors|immunologic factors|mesh-ancestor
5874382|NCT04529460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5683999|NCT03472261|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5874383|NCT04478721|Meropenem|meropenem|mesh-list
5874384|NCT04478721|Temocillin|temocillin|mesh-list
5684000|NCT03472261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5684001|NCT03472261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684002|NCT03472261|Cholinergic Agents|cholinergic agents|mesh-ancestor
5684003|NCT03472261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5684004|NCT03472261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684005|NCT03472261|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5684006|NCT03472261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5684007|NCT03472170|Lactoferrin|lactoferrin|mesh-list
5684008|NCT03472170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5684009|NCT03472144|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5684010|NCT03472144|Levofloxacin|levofloxacin|mesh-list
5684011|NCT03472144|Ofloxacin|ofloxacin|mesh-list
5684012|NCT03472144|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5684013|NCT03472144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5684014|NCT03472144|Antitubercular Agents|antitubercular agents|mesh-ancestor
5684015|NCT03472144|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5684016|NCT03472144|Renal Agents|renal agents|mesh-ancestor
5684017|NCT03472144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5684018|NCT03472144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5684019|NCT03472144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5684020|NCT03472144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684021|NCT03472144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5684022|NCT03472144|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5684023|NCT03472144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5684024|NCT03472040|Berotralstat|berotralstat|mesh-list
5684025|NCT03472040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5684026|NCT03472040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684027|NCT03471988|Voriconazole|voriconazole|mesh-list
5684028|NCT03471988|Antifungal Agents|antifungal agents|mesh-ancestor
5684029|NCT03471988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5684030|NCT03471988|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5684031|NCT03471988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5684032|NCT03471988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5874385|NCT04478721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5874386|NCT04478721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5874387|NCT04428203|Cannabidiol|cannabidiol|mesh-list
5874388|NCT04428203|Anticonvulsants|anticonvulsants|mesh-ancestor
5874389|NCT04427956|Riboflavin|riboflavin|mesh-list
5874390|NCT04427956|Vitamin B Complex|vitamin b complex|mesh-ancestor
5874391|NCT04427956|Vitamins|vitamins|mesh-ancestor
5874392|NCT04427956|Micronutrients|micronutrients|mesh-ancestor
5874393|NCT04427956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874394|NCT04427956|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5874395|NCT04427956|Dermatologic Agents|dermatologic agents|mesh-ancestor
5684033|NCT03471988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684034|NCT03471988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5684035|NCT03471988|Hormone Antagonists|hormone antagonists|mesh-ancestor
5684036|NCT03471988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5684037|NCT03471988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684038|NCT03471988|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5684039|NCT03471819|Serotonin|serotonin|mesh-list
5684040|NCT03471819|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5684041|NCT03471819|Serotonin Agents|serotonin agents|mesh-ancestor
5684042|NCT03471819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5684043|NCT03471819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5874396|NCT04417062|Olaparib|olaparib|mesh-list
5874397|NCT04417062|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5874398|NCT04417062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5874399|NCT04417062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5874400|NCT04417062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5874401|NCT04416984|Cyclophosphamide|cyclophosphamide|mesh-list
5874402|NCT04416984|Fludarabine|fludarabine|mesh-list
5874403|NCT04416984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5874404|NCT04416984|Immunologic Factors|immunologic factors|mesh-ancestor
5874405|NCT04416984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874406|NCT04416984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5874407|NCT04416984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5874408|NCT04416984|Alkylating Agents|alkylating agents|mesh-ancestor
5874409|NCT04416984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5874410|NCT04416984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5874411|NCT04416984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5874412|NCT04397107|Aldesleukin|aldesleukin|mesh-list
5874413|NCT04397107|Interleukin-2|interleukin-2|mesh-list
6212440|NCT02188459|Bupropion|bupropion|mesh-list
5684044|NCT03471819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874414|NCT04397107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5874415|NCT04397107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5874416|NCT04397107|Analgesics|analgesics|mesh-ancestor
5874417|NCT04397107|Sensory System Agents|sensory system agents|mesh-ancestor
5874418|NCT04397107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5874419|NCT04397107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874420|NCT04397107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5684045|NCT03471585|Dronabinol|dronabinol|mesh-list
5684046|NCT03471585|Hallucinogens|hallucinogens|mesh-ancestor
5684047|NCT03471585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684048|NCT03471585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5684049|NCT03471585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5684050|NCT03471585|Analgesics|analgesics|mesh-ancestor
5684051|NCT03471585|Sensory System Agents|sensory system agents|mesh-ancestor
5684052|NCT03471585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5684053|NCT03471585|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5684054|NCT03471585|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5684055|NCT03471585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5684056|NCT03471585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684057|NCT03471585|Hormones|hormones|mesh-ancestor
5684058|NCT03471585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5684059|NCT03471559|Cannabidiol|cannabidiol|mesh-list
5684060|NCT03471559|Anticonvulsants|anticonvulsants|mesh-ancestor
5684061|NCT03471507|Diclofenac|diclofenac|mesh-list
5684062|NCT03471507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5684063|NCT03471507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5684064|NCT03471507|Analgesics|analgesics|mesh-ancestor
5684065|NCT03471507|Sensory System Agents|sensory system agents|mesh-ancestor
5684066|NCT03471507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5684067|NCT03471507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684068|NCT03471507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5684069|NCT03471507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5684070|NCT03471507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5684071|NCT03471507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5684072|NCT03471507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5874421|NCT04397107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5874422|NCT04397107|Antiviral Agents|antiviral agents|mesh-ancestor
5874423|NCT04397107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5874424|NCT04387942|Aldesleukin|aldesleukin|mesh-list
5874425|NCT04387942|Interleukin-2|interleukin-2|mesh-list
5874426|NCT04387942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5874427|NCT04387942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5874428|NCT04387942|Analgesics|analgesics|mesh-ancestor
5874429|NCT04387942|Sensory System Agents|sensory system agents|mesh-ancestor
5874430|NCT04387942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5874431|NCT04387942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874432|NCT04387942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5874433|NCT04387942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5874434|NCT04387942|Antiviral Agents|antiviral agents|mesh-ancestor
5874435|NCT04387942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5874436|NCT04386317|Terazosin|terazosin|mesh-list
5874437|NCT04386317|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5874438|NCT04386317|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5874439|NCT04386317|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5874440|NCT04386317|Adrenergic Agents|adrenergic agents|mesh-ancestor
5874441|NCT04386317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5874442|NCT04386317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5874443|NCT04386317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874444|NCT04386317|Urological Agents|urological agents|mesh-ancestor
5874445|NCT04380142|Levodopa|levodopa|mesh-list
5874446|NCT04380142|Carbidopa|carbidopa|mesh-list
5874447|NCT04380142|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5874448|NCT04380142|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5874449|NCT04380142|Dopamine Agents|dopamine agents|mesh-ancestor
5874450|NCT04380142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5874451|NCT04380142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5874452|NCT04380142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874453|NCT04380142|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5874454|NCT04380142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5905791|NCT04664972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5905792|NCT04664972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5905793|NCT04652544|Vitamin D|vitamin d|mesh-list
6212441|NCT02188459|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5905794|NCT04652544|Cholecalciferol|cholecalciferol|mesh-list
5874455|NCT04342572|Melphalan|melphalan|mesh-list
5874456|NCT04342572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5874457|NCT04342572|Alkylating Agents|alkylating agents|mesh-ancestor
5874458|NCT04342572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5874459|NCT04342572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5874460|NCT04342572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5874461|NCT04342572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5874462|NCT04342572|Immunologic Factors|immunologic factors|mesh-ancestor
5874463|NCT04342572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874464|NCT04303559|Antibodies, Bispecific|antibodies, bispecific|mesh-list
5874465|NCT04303559|Immunologic Factors|immunologic factors|mesh-ancestor
5874466|NCT04303559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874467|NCT04278573|Vitamin D|vitamin d|mesh-list
5874468|NCT04278573|Cholecalciferol|cholecalciferol|mesh-list
5874469|NCT04278573|Vitamins|vitamins|mesh-ancestor
5874470|NCT04278573|Micronutrients|micronutrients|mesh-ancestor
5874471|NCT04278573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874472|NCT04278573|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5874473|NCT04278573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5874474|NCT04273737|Amantadine|amantadine|mesh-list
5874475|NCT04273737|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5874476|NCT04273737|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5874477|NCT04273737|Antiviral Agents|antiviral agents|mesh-ancestor
5874478|NCT04273737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5874479|NCT04273737|Dopamine Agents|dopamine agents|mesh-ancestor
5874480|NCT04273737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5874481|NCT04273737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5874482|NCT04273737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874483|NCT04273737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5874484|NCT04273737|Analgesics|analgesics|mesh-ancestor
5874485|NCT04273737|Sensory System Agents|sensory system agents|mesh-ancestor
5874486|NCT04273737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5874487|NCT04266795|Azacitidine|azacitidine|mesh-list
5874488|NCT04266795|Venetoclax|venetoclax|mesh-list
5874489|NCT04266795|Pevonedistat|pevonedistat|mesh-list
5874490|NCT04266795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5874491|NCT04266795|Antimetabolites|antimetabolites|mesh-ancestor
5874492|NCT04266795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5874493|NCT04266795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5874494|NCT04266795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5874495|NCT04260529|Pembrolizumab|pembrolizumab|mesh-list
5874496|NCT04260529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5874497|NCT04260529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5874498|NCT04259944|Capecitabine|capecitabine|mesh-list
5684073|NCT03471455|Itraconazole|itraconazole|mesh-list
5684074|NCT03471455|Terbinafine|terbinafine|mesh-list
5684075|NCT03471455|Isotretinoin|isotretinoin|mesh-list
5684076|NCT03471455|Antifungal Agents|antifungal agents|mesh-ancestor
5684077|NCT03471455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5684078|NCT03471455|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5684079|NCT03471455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5684080|NCT03471455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5684081|NCT03471455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684082|NCT03471455|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5684083|NCT03471455|Hormone Antagonists|hormone antagonists|mesh-ancestor
5684084|NCT03471455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5684085|NCT03471455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684086|NCT03471455|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5684087|NCT03471455|Dermatologic Agents|dermatologic agents|mesh-ancestor
5684088|NCT03471442|Bupivacaine|bupivacaine|mesh-list
5684089|NCT03471442|Ropivacaine|ropivacaine|mesh-list
5684090|NCT03471442|Anesthetics, Local|anesthetics, local|mesh-list
5684091|NCT03471442|Anesthetics|anesthetics|mesh-list
5684092|NCT03471442|Anesthetics, General|anesthetics, general|mesh-list
5684093|NCT03471442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5684094|NCT03471442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684095|NCT03471442|Sensory System Agents|sensory system agents|mesh-ancestor
5684096|NCT03471442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5684097|NCT03471351|Pembrolizumab|pembrolizumab|mesh-list
5684098|NCT03471351|Tenalisib|tenalisib|mesh-list
5684099|NCT03471351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5684100|NCT03471351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5684101|NCT03471351|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
5874499|NCT04259944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5874500|NCT04259944|Antimetabolites|antimetabolites|mesh-ancestor
5684102|NCT03471351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5684103|NCT03471351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684104|NCT03471325|Methamphetamine|methamphetamine|mesh-list
5684105|NCT03471325|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5684106|NCT03471325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684107|NCT03471325|Sympathomimetics|sympathomimetics|mesh-ancestor
5684108|NCT03471325|Autonomic Agents|autonomic agents|mesh-ancestor
5684109|NCT03471325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5684110|NCT03471325|Dopamine Agents|dopamine agents|mesh-ancestor
5684111|NCT03471325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5684112|NCT03471325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684113|NCT03471325|Adrenergic Agents|adrenergic agents|mesh-ancestor
5684114|NCT03471325|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5684115|NCT03471325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5684116|NCT03471325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5684117|NCT03471325|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5874501|NCT04259944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5874502|NCT04259944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5874503|NCT04231773|Nitric Oxide|nitric oxide|mesh-list
5874504|NCT04231773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5874505|NCT04231773|Autonomic Agents|autonomic agents|mesh-ancestor
5874506|NCT04231773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5874507|NCT04231773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874508|NCT04231773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5874509|NCT04231773|Respiratory System Agents|respiratory system agents|mesh-ancestor
5874510|NCT04231773|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5874511|NCT04231773|Antioxidants|antioxidants|mesh-ancestor
5874512|NCT04231773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5874513|NCT04231773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5874514|NCT04231773|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5874515|NCT04231773|Vasodilator Agents|vasodilator agents|mesh-ancestor
5874516|NCT04231773|Gasotransmitters|gasotransmitters|mesh-ancestor
5874517|NCT04231773|Protective Agents|protective agents|mesh-ancestor
5874518|NCT04217278|Cytarabine|cytarabine|mesh-list
5874519|NCT04217278|Fludarabine|fludarabine|mesh-list
5874520|NCT04217278|Busulfan|busulfan|mesh-list
5874521|NCT04217278|Thiotepa|thiotepa|mesh-list
5874522|NCT04217278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5874523|NCT04217278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5874524|NCT04217278|Antimetabolites|antimetabolites|mesh-ancestor
5874525|NCT04217278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5874526|NCT04217278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5874527|NCT04217278|Immunologic Factors|immunologic factors|mesh-ancestor
5874528|NCT04217278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874529|NCT04217278|Antiviral Agents|antiviral agents|mesh-ancestor
5874530|NCT04217278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5874531|NCT04217278|Alkylating Agents|alkylating agents|mesh-ancestor
5874532|NCT04217278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5874533|NCT04217278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5874534|NCT04205266|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
5874535|NCT04205266|Hematinics|hematinics|mesh-ancestor
5874536|NCT04205266|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5874537|NCT04205266|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5874538|NCT04202263|Minocycline|minocycline|mesh-list
6212442|NCT02188459|Antidepressive Agents|antidepressive agents|mesh-ancestor
5684118|NCT03471260|Azacitidine|azacitidine|mesh-list
5684119|NCT03471260|Venetoclax|venetoclax|mesh-list
5684120|NCT03471260|Ivosidenib|ivosidenib|mesh-list
5684121|NCT03471260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5684122|NCT03471260|Antimetabolites|antimetabolites|mesh-ancestor
5684123|NCT03471260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684124|NCT03471260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5684125|NCT03471260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5684126|NCT03471182|Cocaine|cocaine|mesh-list
5684127|NCT03471182|Anesthetics, Local|anesthetics, local|mesh-ancestor
5684128|NCT03471182|Anesthetics|anesthetics|mesh-ancestor
5684129|NCT03471182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5684130|NCT03471182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684131|NCT03471182|Sensory System Agents|sensory system agents|mesh-ancestor
5684132|NCT03471182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5684133|NCT03471182|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5684134|NCT03471182|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5684135|NCT03471182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5874539|NCT04202263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5874540|NCT04202263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5874541|NCT04192955|Salicylates|salicylates|mesh-list
5874542|NCT04192955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5874543|NCT04192955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5874544|NCT04192955|Analgesics|analgesics|mesh-ancestor
5874545|NCT04192955|Sensory System Agents|sensory system agents|mesh-ancestor
5874546|NCT04192955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5684136|NCT03471182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5684137|NCT03471182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684138|NCT03471182|Dopamine Agents|dopamine agents|mesh-ancestor
5684139|NCT03471182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5684140|NCT03471143|Betadex|betadex|mesh-list
5684141|NCT03471143|Sequestering Agents|sequestering agents|mesh-ancestor
5684142|NCT03471143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684143|NCT03471117|Pioglitazone|pioglitazone|mesh-list
5684144|NCT03471117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5684145|NCT03471117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684146|NCT03471039|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
5684147|NCT03471039|Growth Substances|growth substances|mesh-ancestor
5684148|NCT03471039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684149|NCT03471039|Vasodilator Agents|vasodilator agents|mesh-ancestor
5874547|NCT04192955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874548|NCT04192955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5874549|NCT04192955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5874550|NCT04192955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5874551|NCT04192955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5874552|NCT04192955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5874553|NCT04170517|Progesterone|progesterone|mesh-list
5874554|NCT04170517|Progestins|progestins|mesh-ancestor
5874555|NCT04170517|Hormones|hormones|mesh-ancestor
5874556|NCT04170517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5874557|NCT04170517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874558|NCT04162756|Cyclophosphamide|cyclophosphamide|mesh-list
5874559|NCT04162756|Fludarabine|fludarabine|mesh-list
5874560|NCT04162756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5874561|NCT04162756|Immunologic Factors|immunologic factors|mesh-ancestor
5874562|NCT04162756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874563|NCT04162756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5874564|NCT04162756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5874565|NCT04162756|Alkylating Agents|alkylating agents|mesh-ancestor
5874566|NCT04162756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675312|NCT01573975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5684150|NCT03471039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5874567|NCT04162756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5874568|NCT04162756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5874569|NCT04156581|Dexamethasone|dexamethasone|mesh-list
5684151|NCT03471039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684152|NCT03470961|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5684153|NCT03470961|Immunologic Factors|immunologic factors|mesh-ancestor
5684154|NCT03470961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684155|NCT03470961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5684156|NCT03470922|Nivolumab|nivolumab|mesh-list
5684157|NCT03470922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5684158|NCT03470922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5684159|NCT03470922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5684160|NCT03470922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697135|NCT03377907|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5874570|NCT04156581|Bupivacaine|bupivacaine|mesh-list
5874571|NCT04156581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5874572|NCT04156581|Antiemetics|antiemetics|mesh-ancestor
5874573|NCT04156581|Autonomic Agents|autonomic agents|mesh-ancestor
5874574|NCT04156581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5874575|NCT04156581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697136|NCT03377907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5697137|NCT03377842|Leucovorin|leucovorin|mesh-list
5697138|NCT03377842|Apatinib|apatinib|mesh-list
5697139|NCT03377842|Fluorouracil|fluorouracil|mesh-list
5697140|NCT03377842|Oxaliplatin|oxaliplatin|mesh-list
5697141|NCT03377842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5697142|NCT03377842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5697143|NCT03377842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5874576|NCT04156581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5874577|NCT04156581|Glucocorticoids|glucocorticoids|mesh-ancestor
6212443|NCT02188459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5874578|NCT04156581|Hormones|hormones|mesh-ancestor
5874579|NCT04156581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5874580|NCT04156581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5874581|NCT04156581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5874582|NCT04156581|Anesthetics, Local|anesthetics, local|mesh-ancestor
5874583|NCT04156581|Anesthetics|anesthetics|mesh-ancestor
6495726|NCT00624754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6495727|NCT00624754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874584|NCT04156581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5874585|NCT04156581|Sensory System Agents|sensory system agents|mesh-ancestor
5874586|NCT04153136|Valsartan|valsartan|mesh-list
5874587|NCT04153136|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5874588|NCT04153136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5874589|NCT04153136|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5874590|NCT04153136|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5874591|NCT04153136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5874592|NCT04149990|Valsartan|valsartan|mesh-list
5874593|NCT04149990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5874594|NCT04149990|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5874595|NCT04149990|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5874596|NCT04149990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5874597|NCT04149964|Acetaminophen|acetaminophen|mesh-list
5874598|NCT04149964|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
5874599|NCT04149964|Oxycodone|oxycodone|mesh-list
5874600|NCT04149964|Hydrocodone|hydrocodone|mesh-list
5874601|NCT04149964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5874602|NCT04149964|Analgesics|analgesics|mesh-ancestor
5874603|NCT04149964|Sensory System Agents|sensory system agents|mesh-ancestor
5874604|NCT04149964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5874605|NCT04149964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874606|NCT04149964|Antipyretics|antipyretics|mesh-ancestor
5874607|NCT04149964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5874608|NCT04149964|Narcotics|narcotics|mesh-ancestor
5874609|NCT04149964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5874610|NCT04149964|Antitussive Agents|antitussive agents|mesh-ancestor
5874611|NCT04149964|Respiratory System Agents|respiratory system agents|mesh-ancestor
5874612|NCT04149964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5874613|NCT04149964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5874614|NCT04149964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5874615|NCT04123561|Dexamethasone|dexamethasone|mesh-list
5874616|NCT04123561|Dexamethasone acetate|dexamethasone acetate|mesh-list
5874617|NCT04123561|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
5874618|NCT04123561|BB 1101|bb 1101|mesh-list
5874619|NCT04123561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5874620|NCT04123561|Antiemetics|antiemetics|mesh-ancestor
5874621|NCT04123561|Autonomic Agents|autonomic agents|mesh-ancestor
5874622|NCT04123561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5874623|NCT04123561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874624|NCT04123561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5874625|NCT04123561|Glucocorticoids|glucocorticoids|mesh-ancestor
5874626|NCT04123561|Hormones|hormones|mesh-ancestor
5874627|NCT04123561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5874628|NCT04123561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5874629|NCT04123561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5874630|NCT04123561|Protease Inhibitors|protease inhibitors|mesh-ancestor
5874631|NCT04123561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5874632|NCT04123561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5874633|NCT04123379|Nivolumab|nivolumab|mesh-list
5874634|NCT04123379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5874635|NCT04123379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5874636|NCT04123379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5874637|NCT04123379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5874638|NCT04093596|Cyclophosphamide|cyclophosphamide|mesh-list
6495728|NCT00624754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5684161|NCT03470805|Olaparib|olaparib|mesh-list
5684162|NCT03470805|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5684163|NCT03470805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5684164|NCT03470805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684165|NCT03470805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5684166|NCT03470727|Dialysis Solutions|dialysis solutions|mesh-list
5684167|NCT03470727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5684168|NCT03470649|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
5684169|NCT03470649|Hematinics|hematinics|mesh-ancestor
5874639|NCT04093596|Fludarabine|fludarabine|mesh-list
5874640|NCT04093596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5684170|NCT03470610|Estradiol|estradiol|mesh-list
5684171|NCT03470610|Progesterone|progesterone|mesh-list
5684172|NCT03470610|Estrogens|estrogens|mesh-ancestor
5684173|NCT03470610|Hormones|hormones|mesh-ancestor
5684174|NCT03470610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5684175|NCT03470610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684176|NCT03470610|Progestins|progestins|mesh-ancestor
5684177|NCT03470597|Iodine|iodine|mesh-list
5684178|NCT03470597|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5684179|NCT03470597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5684180|NCT03470597|Trace Elements|trace elements|mesh-ancestor
5684181|NCT03470597|Micronutrients|micronutrients|mesh-ancestor
5684182|NCT03470597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684183|NCT03470532|Epinephrine|epinephrine|mesh-list
5684184|NCT03470532|Racepinephrine|racepinephrine|mesh-list
5684185|NCT03470532|Mepivacaine|mepivacaine|mesh-list
5684186|NCT03470532|Carticaine|carticaine|mesh-list
5684187|NCT03470532|Epinephryl borate|epinephryl borate|mesh-list
5684188|NCT03470532|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5684189|NCT03470532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5684190|NCT03470532|Adrenergic Agents|adrenergic agents|mesh-ancestor
5684191|NCT03470532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5684192|NCT03470532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684193|NCT03470532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684194|NCT03470532|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5684195|NCT03470532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5684196|NCT03470532|Autonomic Agents|autonomic agents|mesh-ancestor
5684197|NCT03470532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5684198|NCT03470532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5684199|NCT03470532|Respiratory System Agents|respiratory system agents|mesh-ancestor
5684200|NCT03470532|Mydriatics|mydriatics|mesh-ancestor
5684201|NCT03470532|Sympathomimetics|sympathomimetics|mesh-ancestor
5684202|NCT03470532|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5684203|NCT03470532|Anesthetics, Local|anesthetics, local|mesh-ancestor
5684204|NCT03470532|Anesthetics|anesthetics|mesh-ancestor
5684205|NCT03470532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5684206|NCT03470532|Sensory System Agents|sensory system agents|mesh-ancestor
5684207|NCT03470480|Methamphetamine|methamphetamine|mesh-list
5874641|NCT04093596|Immunologic Factors|immunologic factors|mesh-ancestor
5874642|NCT04093596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874643|NCT04093596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5684208|NCT03470480|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5684209|NCT03470480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684210|NCT03470480|Sympathomimetics|sympathomimetics|mesh-ancestor
5684211|NCT03470480|Autonomic Agents|autonomic agents|mesh-ancestor
5684212|NCT03470480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5684213|NCT03470480|Dopamine Agents|dopamine agents|mesh-ancestor
5684214|NCT03470480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5684215|NCT03470480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684216|NCT03470480|Adrenergic Agents|adrenergic agents|mesh-ancestor
5684217|NCT03470480|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5684218|NCT03470480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5684219|NCT03470480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5684220|NCT03470480|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5684221|NCT03470454|Linagliptin|linagliptin|mesh-list
5684222|NCT03470454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5684223|NCT03470454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874644|NCT04093596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5874645|NCT04093596|Alkylating Agents|alkylating agents|mesh-ancestor
5874646|NCT04093596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5874647|NCT04093596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5874648|NCT04093596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5874649|NCT04066491|Gemcitabine|gemcitabine|mesh-list
5874650|NCT04066491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5874651|NCT04066491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5874652|NCT04066491|Antimetabolites|antimetabolites|mesh-ancestor
5874653|NCT04066491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5874654|NCT04066491|Antiviral Agents|antiviral agents|mesh-ancestor
5684224|NCT03470454|Incretins|incretins|mesh-ancestor
5684225|NCT03470454|Hormones|hormones|mesh-ancestor
5874655|NCT04066491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5874656|NCT04066491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5874657|NCT04066491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5684226|NCT03470454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5874658|NCT04066491|Immunologic Factors|immunologic factors|mesh-ancestor
5874659|NCT04066491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874660|NCT04039464|Bosentan|bosentan|mesh-list
5874661|NCT04039464|Sildenafil Citrate|sildenafil citrate|mesh-list
5874662|NCT04039464|Vasodilator Agents|vasodilator agents|mesh-ancestor
5874663|NCT04039464|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5874664|NCT04039464|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5874665|NCT04039464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5874666|NCT04039464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5874667|NCT04039464|Urological Agents|urological agents|mesh-ancestor
5874668|NCT04039464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5874669|NCT04039464|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5874670|NCT04037605|Ketoconazole|ketoconazole|mesh-list
5874671|NCT04037605|Dexamethasone|dexamethasone|mesh-list
5874672|NCT04037605|Dexamethasone acetate|dexamethasone acetate|mesh-list
5874673|NCT04037605|Hydrocortisone|hydrocortisone|mesh-list
5684227|NCT03470454|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5684228|NCT03470454|Protease Inhibitors|protease inhibitors|mesh-ancestor
5684229|NCT03470454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5684230|NCT03470454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684231|NCT03470363|Sufentanil|sufentanil|mesh-list
5684232|NCT03470363|Bupivacaine|bupivacaine|mesh-list
5874674|NCT04037605|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
5874675|NCT04037605|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5874676|NCT04037605|Hormones|hormones|mesh-list
5874677|NCT04037605|Cosyntropin|cosyntropin|mesh-list
5874678|NCT04037605|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
5874679|NCT04037605|BB 1101|bb 1101|mesh-list
5874680|NCT04037605|Ganirelix|ganirelix|mesh-list
5874681|NCT04037605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5874682|NCT04037605|Antiemetics|antiemetics|mesh-ancestor
5874683|NCT04037605|Autonomic Agents|autonomic agents|mesh-ancestor
5874684|NCT04037605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5874685|NCT04037605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874686|NCT04037605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5874687|NCT04037605|Glucocorticoids|glucocorticoids|mesh-ancestor
5684233|NCT03470363|Sevoflurane|sevoflurane|mesh-list
5684234|NCT03470363|Anesthetics, Local|anesthetics, local|mesh-ancestor
5684235|NCT03470363|Anesthetics|anesthetics|mesh-ancestor
5684236|NCT03470363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5684237|NCT03470363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684238|NCT03470363|Sensory System Agents|sensory system agents|mesh-ancestor
5684239|NCT03470363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5684240|NCT03470363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5684241|NCT03470363|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5684242|NCT03470363|Anesthetics, General|anesthetics, general|mesh-ancestor
5684243|NCT03470363|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5684244|NCT03470363|Narcotics|narcotics|mesh-ancestor
5684245|NCT03470363|Analgesics|analgesics|mesh-ancestor
5684246|NCT03470363|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5684247|NCT03470363|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5684248|NCT03470350|Capecitabine|capecitabine|mesh-list
5684249|NCT03470350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5684250|NCT03470350|Antimetabolites|antimetabolites|mesh-ancestor
5684251|NCT03470350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684252|NCT03470350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5684253|NCT03470337|Wobenzym|wobenzym|mesh-list
5684254|NCT03470337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5684255|NCT03470337|Immunologic Factors|immunologic factors|mesh-ancestor
5684256|NCT03470337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684257|NCT03470311|Benralizumab|benralizumab|mesh-list
5684258|NCT03470311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5684259|NCT03470311|Respiratory System Agents|respiratory system agents|mesh-ancestor
5684260|NCT03470103|Aflibercept|aflibercept|mesh-list
5684261|NCT03470103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5684262|NCT03470103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5684263|NCT03470103|Growth Substances|growth substances|mesh-ancestor
5874688|NCT04037605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5874689|NCT04037605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5874690|NCT04037605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5684264|NCT03470103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684265|NCT03470103|Growth Inhibitors|growth inhibitors|mesh-ancestor
5684266|NCT03470103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5684267|NCT03470077|Nalbuphine|nalbuphine|mesh-list
5874691|NCT04037605|Protease Inhibitors|protease inhibitors|mesh-ancestor
5684268|NCT03470077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5874692|NCT04037605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5874693|NCT04037605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5874694|NCT04037605|Antifungal Agents|antifungal agents|mesh-ancestor
5874695|NCT04037605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5874696|NCT04037605|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5874697|NCT04037605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5874698|NCT04037605|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5874699|NCT04037605|Hormone Antagonists|hormone antagonists|mesh-ancestor
5874700|NCT04037605|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5874701|NCT04022967|Ritonavir|ritonavir|mesh-list
5874702|NCT04022967|Atazanavir Sulfate|atazanavir sulfate|mesh-list
5874703|NCT04022967|Tenofovir|tenofovir|mesh-list
5874704|NCT04022967|Lamivudine|lamivudine|mesh-list
5874705|NCT04022967|Dolutegravir|dolutegravir|mesh-list
5874706|NCT04022967|Efavirenz|efavirenz|mesh-list
5874707|NCT04022967|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5874708|NCT04022967|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5874709|NCT04022967|Protease Inhibitors|protease inhibitors|mesh-ancestor
5874710|NCT04022967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5874711|NCT04022967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5874712|NCT04022967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5874713|NCT04022967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5874714|NCT04022967|Antiviral Agents|antiviral agents|mesh-ancestor
5874715|NCT04022967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5874716|NCT04022967|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5874717|NCT04022967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5874718|NCT04022967|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5874719|NCT04022967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5874720|NCT04022967|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5874721|NCT04022967|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5874722|NCT04022967|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5874723|NCT04022967|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5874724|NCT04022967|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5874725|NCT04022967|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5874726|NCT04022967|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5874727|NCT04006210|Levodopa|levodopa|mesh-list
5874728|NCT04006210|Carbidopa|carbidopa|mesh-list
5874729|NCT04006210|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5874730|NCT04006210|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5874731|NCT04006210|Dopamine Agents|dopamine agents|mesh-ancestor
5874732|NCT04006210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5874733|NCT04006210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5874734|NCT04006210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874735|NCT04006210|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5874736|NCT04006210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5874737|NCT03995004|Dexamethasone|dexamethasone|mesh-list
5874738|NCT03995004|Melatonin|melatonin|mesh-list
5874739|NCT03995004|Sodium sulfate|sodium sulfate|mesh-list
5874740|NCT03995004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5874741|NCT03995004|Antiemetics|antiemetics|mesh-ancestor
5874742|NCT03995004|Autonomic Agents|autonomic agents|mesh-ancestor
5874743|NCT03995004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5874744|NCT03995004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874745|NCT03995004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5874746|NCT03995004|Glucocorticoids|glucocorticoids|mesh-ancestor
5874747|NCT03995004|Hormones|hormones|mesh-ancestor
5874748|NCT03995004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5874749|NCT03995004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5874750|NCT03995004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5874751|NCT03995004|Antioxidants|antioxidants|mesh-ancestor
5874752|NCT03995004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5874753|NCT03995004|Protective Agents|protective agents|mesh-ancestor
5874754|NCT03995004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5874755|NCT03995004|Cathartics|cathartics|mesh-ancestor
5905795|NCT04652544|Vitamins|vitamins|mesh-ancestor
5905796|NCT04652544|Micronutrients|micronutrients|mesh-ancestor
5684269|NCT03470077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684270|NCT03470077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5684271|NCT03470077|Narcotics|narcotics|mesh-ancestor
5684272|NCT03470077|Analgesics|analgesics|mesh-ancestor
5684273|NCT03470077|Sensory System Agents|sensory system agents|mesh-ancestor
5684274|NCT03470077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5684275|NCT03470038|Mitogens|mitogens|mesh-list
5684276|NCT03470038|Mitosis Modulators|mitosis modulators|mesh-ancestor
5684277|NCT03470038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684278|NCT03469960|Nivolumab|nivolumab|mesh-list
5874756|NCT03980769|Vidarabine|vidarabine|mesh-list
5874757|NCT03980769|Fludarabine|fludarabine|mesh-list
5874758|NCT03980769|Fludarabine phosphate|fludarabine phosphate|mesh-list
5874759|NCT03980769|Thiotepa|thiotepa|mesh-list
5874760|NCT03980769|Treosulfan|treosulfan|mesh-list
5874761|NCT03980769|Busulfan|busulfan|mesh-list
5874762|NCT03980769|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5874763|NCT03980769|Thymoglobulin|thymoglobulin|mesh-list
5874764|NCT03980769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5874765|NCT03980769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5874766|NCT03980769|Antimetabolites|antimetabolites|mesh-ancestor
5874767|NCT03980769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5874768|NCT03980769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5874769|NCT03980769|Immunologic Factors|immunologic factors|mesh-ancestor
5874770|NCT03980769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874771|NCT03980769|Antiviral Agents|antiviral agents|mesh-ancestor
5874772|NCT03980769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5874773|NCT03980769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5874774|NCT03980769|Alkylating Agents|alkylating agents|mesh-ancestor
5874775|NCT03980769|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5874776|NCT03971474|Gemcitabine|gemcitabine|mesh-list
5874777|NCT03971474|Docetaxel|docetaxel|mesh-list
5874778|NCT03971474|Pembrolizumab|pembrolizumab|mesh-list
5874779|NCT03971474|Pemetrexed|pemetrexed|mesh-list
5874780|NCT03971474|Ramucirumab|ramucirumab|mesh-list
5874781|NCT03971474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5874782|NCT03971474|Antibodies|antibodies|mesh-list
5874783|NCT03971474|Immunoglobulins|immunoglobulins|mesh-list
5874784|NCT03971474|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5874785|NCT03971474|Immunologic Factors|immunologic factors|mesh-ancestor
5874786|NCT03971474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874787|NCT03971474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5874788|NCT03971474|Antimetabolites|antimetabolites|mesh-ancestor
5874789|NCT03971474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5874790|NCT03971474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5874791|NCT03971474|Antiviral Agents|antiviral agents|mesh-ancestor
5874792|NCT03971474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5874793|NCT03971474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5874794|NCT03971474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5874795|NCT03971474|Tubulin Modulators|tubulin modulators|mesh-ancestor
5874796|NCT03971474|Antimitotic Agents|antimitotic agents|mesh-ancestor
5874797|NCT03971474|Mitosis Modulators|mitosis modulators|mesh-ancestor
5874798|NCT03971474|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5874799|NCT03971474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5874800|NCT03970655|Dexamethasone|dexamethasone|mesh-list
5874801|NCT03970655|Dexamethasone acetate|dexamethasone acetate|mesh-list
5874802|NCT03970655|Epinephrine|epinephrine|mesh-list
5874803|NCT03970655|Racepinephrine|racepinephrine|mesh-list
5874804|NCT03970655|Bupivacaine|bupivacaine|mesh-list
5874805|NCT03970655|Epinephryl borate|epinephryl borate|mesh-list
5874806|NCT03970655|BB 1101|bb 1101|mesh-list
5874807|NCT03970655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5874808|NCT03970655|Antiemetics|antiemetics|mesh-ancestor
5874809|NCT03970655|Autonomic Agents|autonomic agents|mesh-ancestor
5874810|NCT03970655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5874811|NCT03970655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874812|NCT03970655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5874813|NCT03970655|Glucocorticoids|glucocorticoids|mesh-ancestor
5874814|NCT03970655|Hormones|hormones|mesh-ancestor
5874815|NCT03970655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5874816|NCT03970655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5874817|NCT03970655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5874818|NCT03970655|Protease Inhibitors|protease inhibitors|mesh-ancestor
5874819|NCT03970655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5874820|NCT03970655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5874821|NCT03970655|Anesthetics, Local|anesthetics, local|mesh-ancestor
5874822|NCT03970655|Anesthetics|anesthetics|mesh-ancestor
5874823|NCT03970655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5874824|NCT03970655|Sensory System Agents|sensory system agents|mesh-ancestor
5874825|NCT03970655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5874826|NCT03970655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5874827|NCT03970655|Adrenergic Agents|adrenergic agents|mesh-ancestor
5874828|NCT03970655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5874829|NCT03970655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6212444|NCT02188459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5874830|NCT03970655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5874831|NCT03970655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5874832|NCT03970655|Respiratory System Agents|respiratory system agents|mesh-ancestor
5874833|NCT03970655|Mydriatics|mydriatics|mesh-ancestor
5684279|NCT03469960|Ipilimumab|ipilimumab|mesh-list
5684280|NCT03469960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5684281|NCT03469960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5684282|NCT03469960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5684283|NCT03469960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684284|NCT03469947|Tranexamic Acid|tranexamic acid|mesh-list
5684285|NCT03469947|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5684286|NCT03469947|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5684287|NCT03469947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684288|NCT03469947|Hemostatics|hemostatics|mesh-ancestor
5684289|NCT03469947|Coagulants|coagulants|mesh-ancestor
5684290|NCT03469895|Idelalisib|idelalisib|mesh-list
5684291|NCT03469895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5684292|NCT03469895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5684293|NCT03469895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684294|NCT03469856|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
5684295|NCT03469856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5684296|NCT03469804|Pembrolizumab|pembrolizumab|mesh-list
5684297|NCT03469804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5684298|NCT03469804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5684299|NCT03469713|Nivolumab|nivolumab|mesh-list
5684300|NCT03469713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5684301|NCT03469713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5684302|NCT03469713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5684303|NCT03469713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5874834|NCT03970655|Sympathomimetics|sympathomimetics|mesh-ancestor
5874835|NCT03970655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5874836|NCT03970096|Cyclosporine|cyclosporine|mesh-list
5874837|NCT03970096|Sirolimus|sirolimus|mesh-list
5874838|NCT03970096|Cyclophosphamide|cyclophosphamide|mesh-list
5874839|NCT03970096|Busulfan|busulfan|mesh-list
5874840|NCT03970096|Thiotepa|thiotepa|mesh-list
5874841|NCT03970096|Methotrexate|methotrexate|mesh-list
5874842|NCT03970096|Fludarabine|fludarabine|mesh-list
5874843|NCT03970096|Tacrolimus|tacrolimus|mesh-list
5874844|NCT03970096|Cyclosporins|cyclosporins|mesh-list
5874845|NCT03970096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5874846|NCT03970096|Immunologic Factors|immunologic factors|mesh-ancestor
5874847|NCT03970096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874848|NCT03970096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5874849|NCT03970096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5874850|NCT03970096|Alkylating Agents|alkylating agents|mesh-ancestor
5874851|NCT03970096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5874852|NCT03970096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5874853|NCT03970096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5874854|NCT03970096|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5874855|NCT03970096|Abortifacient Agents|abortifacient agents|mesh-ancestor
5874856|NCT03970096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5874857|NCT03970096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5874858|NCT03970096|Antimetabolites|antimetabolites|mesh-ancestor
5874859|NCT03970096|Dermatologic Agents|dermatologic agents|mesh-ancestor
5874860|NCT03970096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5874861|NCT03970096|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5874862|NCT03970096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5874863|NCT03970096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5874864|NCT03970096|Antifungal Agents|antifungal agents|mesh-ancestor
5874865|NCT03970096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5874866|NCT03970096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5874867|NCT03970096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5874868|NCT03968822|Lidocaine|lidocaine|mesh-list
5874869|NCT03968822|Bupivacaine|bupivacaine|mesh-list
5874870|NCT03968822|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5874871|NCT03968822|Anesthetics, Local|anesthetics, local|mesh-ancestor
5874872|NCT03968822|Anesthetics|anesthetics|mesh-ancestor
5874873|NCT03968822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5874874|NCT03968822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874875|NCT03968822|Sensory System Agents|sensory system agents|mesh-ancestor
5874876|NCT03968822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5874877|NCT03968822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5874878|NCT03968822|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5874879|NCT03968822|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5874880|NCT03968822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5684304|NCT03469700|Anesthetics|anesthetics|mesh-list
5684305|NCT03469700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5874881|NCT03968822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684306|NCT03469700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684307|NCT03469583|Entecavir|entecavir|mesh-list
5684308|NCT03469583|Antiviral Agents|antiviral agents|mesh-ancestor
5684309|NCT03469583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5684310|NCT03469557|Capecitabine|capecitabine|mesh-list
5684311|NCT03469557|Oxaliplatin|oxaliplatin|mesh-list
5684312|NCT03469557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5684313|NCT03469557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5684314|NCT03469557|Antimetabolites|antimetabolites|mesh-ancestor
5684315|NCT03469557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684316|NCT03469544|Hormones|hormones|mesh-list
5684317|NCT03469544|Antibodies|antibodies|mesh-list
5684318|NCT03469544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5684319|NCT03469544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684320|NCT03469544|Immunologic Factors|immunologic factors|mesh-ancestor
5684321|NCT03469531|Cisplatin|cisplatin|mesh-list
5684322|NCT03469531|Nimotuzumab|nimotuzumab|mesh-list
5684323|NCT03469531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5684324|NCT03469531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5874882|NCT03968562|Doxycycline|doxycycline|mesh-list
5874883|NCT03968562|Petrolatum|petrolatum|mesh-list
5874884|NCT03968562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5874885|NCT03968562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6495729|NCT00624754|Respiratory System Agents|respiratory system agents|mesh-ancestor
6495730|NCT00624754|Glucocorticoids|glucocorticoids|mesh-ancestor
5874886|NCT03968562|Antimalarials|antimalarials|mesh-ancestor
5874887|NCT03968562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5874888|NCT03968562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5874889|NCT03968562|Emollients|emollients|mesh-ancestor
5874890|NCT03968562|Dermatologic Agents|dermatologic agents|mesh-ancestor
5874891|NCT03939026|Cyclophosphamide|cyclophosphamide|mesh-list
5874892|NCT03939026|Fludarabine|fludarabine|mesh-list
5874893|NCT03939026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5874894|NCT03939026|Immunologic Factors|immunologic factors|mesh-ancestor
5874895|NCT03939026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874896|NCT03939026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5874897|NCT03939026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5874898|NCT03939026|Alkylating Agents|alkylating agents|mesh-ancestor
5874899|NCT03939026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5874900|NCT03939026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5874901|NCT03939026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5874902|NCT03934541|Vaccines|vaccines|mesh-list
5874903|NCT03934541|Immunologic Factors|immunologic factors|mesh-ancestor
5874904|NCT03934541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684325|NCT03469492|Insulin|insulin|mesh-list
5684326|NCT03469492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5684327|NCT03469492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697144|NCT03377842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697145|NCT03377842|Antimetabolites|antimetabolites|mesh-ancestor
5697146|NCT03377842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5697147|NCT03377842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5697148|NCT03377842|Immunologic Factors|immunologic factors|mesh-ancestor
5697149|NCT03377842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697150|NCT03377842|Antidotes|antidotes|mesh-ancestor
5697151|NCT03377842|Protective Agents|protective agents|mesh-ancestor
5697152|NCT03377842|Vitamin B Complex|vitamin b complex|mesh-ancestor
5697153|NCT03377842|Vitamins|vitamins|mesh-ancestor
5697154|NCT03377842|Micronutrients|micronutrients|mesh-ancestor
5697155|NCT03377725|Decitabine|decitabine|mesh-list
5697156|NCT03377725|Arsenic Trioxide|arsenic trioxide|mesh-list
5697157|NCT03377725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5697158|NCT03377725|Antimetabolites|antimetabolites|mesh-ancestor
5874905|NCT03915613|Insulin|insulin|mesh-list
5874906|NCT03915613|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5874907|NCT03915613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5874908|NCT03915613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874909|NCT03868150|Amiodarone|amiodarone|mesh-list
5874910|NCT03868150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5874911|NCT03868150|Vasodilator Agents|vasodilator agents|mesh-ancestor
5874912|NCT03868150|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5874913|NCT03868150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5874914|NCT03868150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5874915|NCT03868150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5874916|NCT03868150|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5697159|NCT03377725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5874917|NCT03868150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5874918|NCT03868150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5874919|NCT03868150|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5874920|NCT03868150|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5874921|NCT03868150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5874922|NCT03864276|Propofol|propofol|mesh-list
5874923|NCT03864276|Desflurane|desflurane|mesh-list
5874924|NCT03864276|Anesthetics|anesthetics|mesh-ancestor
5874925|NCT03864276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5874926|NCT03864276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874927|NCT03864276|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5874928|NCT03864276|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5874929|NCT03864276|Anesthetics, General|anesthetics, general|mesh-ancestor
5874930|NCT03864276|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5874931|NCT03856788|Bupivacaine|bupivacaine|mesh-list
5874932|NCT03856788|Anesthetics, Local|anesthetics, local|mesh-ancestor
5874933|NCT03856788|Anesthetics|anesthetics|mesh-ancestor
5874934|NCT03856788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5874935|NCT03856788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874936|NCT03856788|Sensory System Agents|sensory system agents|mesh-ancestor
5874937|NCT03856788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5874938|NCT03840902|Paclitaxel|paclitaxel|mesh-list
5874939|NCT03840902|Etoposide|etoposide|mesh-list
5874940|NCT03840902|Carboplatin|carboplatin|mesh-list
5874941|NCT03840902|Pemetrexed|pemetrexed|mesh-list
5874942|NCT03840902|Durvalumab|durvalumab|mesh-list
5874943|NCT03840902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5874944|NCT03840902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5874945|NCT03840902|Tubulin Modulators|tubulin modulators|mesh-ancestor
5874946|NCT03840902|Antimitotic Agents|antimitotic agents|mesh-ancestor
5874947|NCT03840902|Mitosis Modulators|mitosis modulators|mesh-ancestor
5874948|NCT03840902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5874949|NCT03840902|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5874950|NCT03840902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5874951|NCT03840902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5874952|NCT03840902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5874953|NCT03840902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5874954|NCT03840902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5874955|NCT03821610|Cyclophosphamide|cyclophosphamide|mesh-list
5874956|NCT03821610|Melphalan|melphalan|mesh-list
5874957|NCT03821610|Fludarabine|fludarabine|mesh-list
5874958|NCT03821610|Alemtuzumab|alemtuzumab|mesh-list
5874959|NCT03821610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5874960|NCT03821610|Immunologic Factors|immunologic factors|mesh-ancestor
5874961|NCT03821610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874962|NCT03821610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5874963|NCT03821610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5874964|NCT03821610|Alkylating Agents|alkylating agents|mesh-ancestor
5874965|NCT03821610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5874966|NCT03821610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5874967|NCT03821610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5874968|NCT03821610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5874969|NCT03815929|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5874970|NCT03815929|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5874971|NCT03815929|Estradiol|estradiol|mesh-list
5874972|NCT03815929|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5874973|NCT03815929|Estrogens|estrogens|mesh-ancestor
5874974|NCT03815929|Hormones|hormones|mesh-ancestor
5874975|NCT03815929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5874976|NCT03815929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874977|NCT03815929|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5874978|NCT03815929|Contraceptive Agents|contraceptive agents|mesh-ancestor
5874979|NCT03815929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5874980|NCT03815929|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5874981|NCT03813836|Pembrolizumab|pembrolizumab|mesh-list
5874982|NCT03813836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5874983|NCT03813836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5874984|NCT03811756|Coenzyme Q10|coenzyme q10|mesh-list
5874985|NCT03811756|Vitamins|vitamins|mesh-ancestor
5874986|NCT03811756|Micronutrients|micronutrients|mesh-ancestor
5874987|NCT03811756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5874988|NCT03792516|Artesunate|artesunate|mesh-list
5874989|NCT03792516|Antimalarials|antimalarials|mesh-ancestor
5874990|NCT03792516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5874991|NCT03792516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5874992|NCT03792516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5874993|NCT03792516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5874994|NCT03792516|Antiviral Agents|antiviral agents|mesh-ancestor
5874995|NCT03792516|Schistosomicides|schistosomicides|mesh-ancestor
5684328|NCT03469375|Folfirinox|folfirinox|mesh-list
5684329|NCT03469375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5684330|NCT03469323|Succinylcholine|succinylcholine|mesh-list
5684331|NCT03469323|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
5684332|NCT03469323|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5874996|NCT03792516|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5874997|NCT03792516|Anthelmintics|anthelmintics|mesh-ancestor
5874998|NCT03768414|Gemcitabine|gemcitabine|mesh-list
5874999|NCT03768414|Paclitaxel|paclitaxel|mesh-list
5875000|NCT03768414|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5875001|NCT03768414|Cisplatin|cisplatin|mesh-list
5875002|NCT03768414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5875003|NCT03768414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5875004|NCT03768414|Tubulin Modulators|tubulin modulators|mesh-ancestor
5875005|NCT03768414|Antimitotic Agents|antimitotic agents|mesh-ancestor
5875006|NCT03768414|Mitosis Modulators|mitosis modulators|mesh-ancestor
5875007|NCT03768414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875008|NCT03768414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5875009|NCT03768414|Antimetabolites|antimetabolites|mesh-ancestor
5684333|NCT03469323|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5684334|NCT03469323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5684335|NCT03469323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684336|NCT03469310|Acetaminophen|acetaminophen|mesh-list
5684337|NCT03469310|Tramadol|tramadol|mesh-list
5684338|NCT03469310|Codeine|codeine|mesh-list
5875010|NCT03768414|Antiviral Agents|antiviral agents|mesh-ancestor
5875011|NCT03768414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5875012|NCT03768414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5875013|NCT03768414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5875014|NCT03768414|Immunologic Factors|immunologic factors|mesh-ancestor
5875015|NCT03768414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875016|NCT03764137|Panitumumab|panitumumab|mesh-list
5875017|NCT03764137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5875018|NCT03764137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5875019|NCT03757130|Liraglutide|liraglutide|mesh-list
5875020|NCT03757130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5875021|NCT03757130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875022|NCT03757130|Incretins|incretins|mesh-ancestor
5875023|NCT03757130|Hormones|hormones|mesh-ancestor
5875024|NCT03757130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5875025|NCT03733418|Vitamin D|vitamin d|mesh-list
5875026|NCT03733418|Cholecalciferol|cholecalciferol|mesh-list
5875027|NCT03733418|Vitamins|vitamins|mesh-ancestor
5875028|NCT03733418|Micronutrients|micronutrients|mesh-ancestor
5684339|NCT03469310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5684340|NCT03469310|Analgesics|analgesics|mesh-ancestor
5684341|NCT03469310|Sensory System Agents|sensory system agents|mesh-ancestor
5684342|NCT03469310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5684343|NCT03469310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684344|NCT03469310|Antipyretics|antipyretics|mesh-ancestor
5684345|NCT03469310|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5684346|NCT03469310|Narcotics|narcotics|mesh-ancestor
5875029|NCT03733418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875030|NCT03733418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5875031|NCT03733418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5875032|NCT03732664|Pembrolizumab|pembrolizumab|mesh-list
5875033|NCT03732664|Nivolumab|nivolumab|mesh-list
5875034|NCT03732664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5875035|NCT03732664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5875036|NCT03732664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5684347|NCT03469310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5684348|NCT03469310|Antitussive Agents|antitussive agents|mesh-ancestor
5684349|NCT03469310|Respiratory System Agents|respiratory system agents|mesh-ancestor
5684350|NCT03469284|Methylene Blue|methylene blue|mesh-list
5684351|NCT03469284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5684352|NCT03469284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684353|NCT03469271|Calcitriol|calcitriol|mesh-list
5684354|NCT03469271|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
5684355|NCT03469271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5684356|NCT03469271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684357|NCT03469271|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
5684358|NCT03469271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5684359|NCT03469271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684360|NCT03469271|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5684361|NCT03469271|Vitamins|vitamins|mesh-ancestor
5684362|NCT03469271|Micronutrients|micronutrients|mesh-ancestor
5905797|NCT04652544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875037|NCT03732664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875038|NCT03684694|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
5875039|NCT03684694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5875040|NCT03684694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5875041|NCT03675256|Vaccines|vaccines|mesh-list
5875042|NCT03675256|Immunologic Factors|immunologic factors|mesh-ancestor
5875043|NCT03675256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875044|NCT03670966|Mycophenolic Acid|mycophenolic acid|mesh-list
5875045|NCT03670966|Cyclophosphamide|cyclophosphamide|mesh-list
5875046|NCT03670966|Fludarabine|fludarabine|mesh-list
5875047|NCT03670966|Fludarabine phosphate|fludarabine phosphate|mesh-list
5875048|NCT03670966|Tacrolimus|tacrolimus|mesh-list
5875049|NCT03670966|Antibodies|antibodies|mesh-list
5875050|NCT03670966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5875051|NCT03670966|Sargramostim|sargramostim|mesh-list
5875052|NCT03670966|Lenograstim|lenograstim|mesh-list
5875053|NCT03670966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5875054|NCT03670966|Immunologic Factors|immunologic factors|mesh-ancestor
5875055|NCT03670966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875056|NCT03670966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5875057|NCT03670966|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5875058|NCT03670966|Alkylating Agents|alkylating agents|mesh-ancestor
5875059|NCT03670966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875060|NCT03670966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5875061|NCT03670966|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5875062|NCT03670966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5875063|NCT03670966|Antimetabolites|antimetabolites|mesh-ancestor
5875064|NCT03670966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5875065|NCT03670966|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5875066|NCT03670966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5875067|NCT03670966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5875068|NCT03670966|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5875069|NCT03670966|Antitubercular Agents|antitubercular agents|mesh-ancestor
5875070|NCT03670966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5875071|NCT03670966|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5875072|NCT03647163|Pembrolizumab|pembrolizumab|mesh-list
5875073|NCT03647163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5684363|NCT03469271|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5684364|NCT03469167|Epinephrine|epinephrine|mesh-list
5684365|NCT03469167|CEGP-003|cegp-003|mesh-list
5684366|NCT03469167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5684367|NCT03469167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5684368|NCT03469167|Adrenergic Agents|adrenergic agents|mesh-ancestor
5684369|NCT03469167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5684370|NCT03469167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684371|NCT03469167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684372|NCT03469167|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5684373|NCT03469167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5684374|NCT03469167|Autonomic Agents|autonomic agents|mesh-ancestor
5684375|NCT03469167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5684376|NCT03469167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5875074|NCT03647163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5875075|NCT03620201|Atezolizumab|atezolizumab|mesh-list
5875076|NCT03620201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5875077|NCT03618225|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5875078|NCT03618225|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5875079|NCT03618225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5875080|NCT03618225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5875081|NCT03618225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875082|NCT03618225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5875083|NCT03618225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875084|NCT03618225|Analgesics|analgesics|mesh-ancestor
5875085|NCT03618225|Sensory System Agents|sensory system agents|mesh-ancestor
5875086|NCT03618225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5875087|NCT03618225|Antidepressive Agents|antidepressive agents|mesh-ancestor
5875088|NCT03618225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5875089|NCT03618225|Dopamine Agents|dopamine agents|mesh-ancestor
5875090|NCT03587272|Sirolimus|sirolimus|mesh-list
5875091|NCT03587272|Alemtuzumab|alemtuzumab|mesh-list
6495731|NCT00624754|Hormones|hormones|mesh-ancestor
6495732|NCT00624754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6495733|NCT00624754|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6495734|NCT00624754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5875092|NCT03587272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5875093|NCT03587272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5875094|NCT03587272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5875095|NCT03587272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5875096|NCT03587272|Antifungal Agents|antifungal agents|mesh-ancestor
5875097|NCT03587272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5875098|NCT03587272|Immunologic Factors|immunologic factors|mesh-ancestor
5875099|NCT03587272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875100|NCT03587272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5875101|NCT03566199|Panobinostat|panobinostat|mesh-list
6212445|NCT02188459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6212446|NCT02188459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6212447|NCT02188459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212448|NCT02188459|Dopamine Agents|dopamine agents|mesh-ancestor
6212449|NCT02188459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5875102|NCT03566199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5875103|NCT03566199|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5875104|NCT03566199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6495735|NCT00624754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6495736|NCT00624754|Adrenergic Agents|adrenergic agents|mesh-ancestor
6495737|NCT00624754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6495738|NCT00624754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495739|NCT00624767|Insulin|insulin|mesh-list
6495740|NCT00624767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5875105|NCT03566199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875106|NCT03561831|Propofol|propofol|mesh-list
5875107|NCT03561831|Sevoflurane|sevoflurane|mesh-list
5875108|NCT03561831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5875109|NCT03561831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5875110|NCT03561831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875111|NCT03561831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5875112|NCT03561831|Anesthetics, General|anesthetics, general|mesh-ancestor
5875113|NCT03561831|Anesthetics|anesthetics|mesh-ancestor
5875114|NCT03561831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5875115|NCT03561831|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6495741|NCT00624767|Insulin Aspart|insulin aspart|mesh-list
6495742|NCT00624767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5684377|NCT03469167|Respiratory System Agents|respiratory system agents|mesh-ancestor
5684378|NCT03469167|Mydriatics|mydriatics|mesh-ancestor
5684379|NCT03469167|Sympathomimetics|sympathomimetics|mesh-ancestor
5684380|NCT03469167|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5684381|NCT03469167|Hemostatics|hemostatics|mesh-ancestor
5875116|NCT03551626|Trametinib|trametinib|mesh-list
5875117|NCT03551626|Dabrafenib|dabrafenib|mesh-list
5875118|NCT03551626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5875119|NCT03551626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5875120|NCT03551626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5875121|NCT03551626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875122|NCT03544736|Paclitaxel|paclitaxel|mesh-list
5875123|NCT03544736|Carboplatin|carboplatin|mesh-list
5875124|NCT03544736|Nivolumab|nivolumab|mesh-list
5875125|NCT03544736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5875126|NCT03544736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5875127|NCT03544736|Tubulin Modulators|tubulin modulators|mesh-ancestor
5684382|NCT03469167|Coagulants|coagulants|mesh-ancestor
5684383|NCT03469128|Sertraline|sertraline|mesh-list
5684384|NCT03469128|Antidepressive Agents|antidepressive agents|mesh-ancestor
5684385|NCT03469128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5684386|NCT03469128|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5684387|NCT03469128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5875128|NCT03544736|Antimitotic Agents|antimitotic agents|mesh-ancestor
5875129|NCT03544736|Mitosis Modulators|mitosis modulators|mesh-ancestor
5875130|NCT03544736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875131|NCT03544736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5875132|NCT03544736|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5905798|NCT04652544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5905799|NCT04652544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5905800|NCT04644705|Niclosamide|niclosamide|mesh-list
5905801|NCT04644705|Anticestodal Agents|anticestodal agents|mesh-ancestor
5905802|NCT04644705|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5905803|NCT04644705|Anthelmintics|anthelmintics|mesh-ancestor
6212450|NCT02188459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212451|NCT02188459|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6212452|NCT02188459|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6212453|NCT02188459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6212454|NCT02188576|Tranexamic Acid|tranexamic acid|mesh-list
6212455|NCT02188576|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5684388|NCT03469128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5684389|NCT03469128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684390|NCT03469128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5684391|NCT03469128|Serotonin Agents|serotonin agents|mesh-ancestor
5684392|NCT03469128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684393|NCT03469089|Ketamine|ketamine|mesh-list
5684394|NCT03469089|Modafinil|modafinil|mesh-list
5684395|NCT03469089|Analgesics|analgesics|mesh-ancestor
5684396|NCT03469089|Sensory System Agents|sensory system agents|mesh-ancestor
5684397|NCT03469089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5875133|NCT03508232|Doxycycline|doxycycline|mesh-list
5875134|NCT03508232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5875135|NCT03508232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5875136|NCT03508232|Antimalarials|antimalarials|mesh-ancestor
5684398|NCT03469089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684399|NCT03469089|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5684400|NCT03469089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5684401|NCT03469089|Anesthetics, General|anesthetics, general|mesh-ancestor
5684402|NCT03469089|Anesthetics|anesthetics|mesh-ancestor
5684403|NCT03469089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5684404|NCT03469089|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5684405|NCT03469089|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5684406|NCT03469089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5684407|NCT03469089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684408|NCT03469089|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5684409|NCT03469089|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
5684410|NCT03469089|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5684411|NCT03469089|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5684412|NCT03469011|Imatinib Mesylate|imatinib mesylate|mesh-list
5684413|NCT03469011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5684414|NCT03469011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5684415|NCT03469011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5684416|NCT03469011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684417|NCT03468972|Immunosuppressive Agents|immunosuppressive agents|mesh-list
5684418|NCT03468972|Immunologic Factors|immunologic factors|mesh-ancestor
5684419|NCT03468972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684420|NCT03468946|Caffeine|caffeine|mesh-list
5684421|NCT03468946|Citric Acid|citric acid|mesh-list
5875137|NCT03508232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5875138|NCT03508232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5875139|NCT03501979|Capecitabine|capecitabine|mesh-list
5875140|NCT03501979|Trastuzumab|trastuzumab|mesh-list
5875141|NCT03501979|Tucatinib|tucatinib|mesh-list
5875142|NCT03501979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5875143|NCT03501979|Antimetabolites|antimetabolites|mesh-ancestor
5875144|NCT03501979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875145|NCT03501979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5875146|NCT03501979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5875147|NCT03501979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5875148|NCT03501979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5875149|NCT03491059|Nicotine|nicotine|mesh-list
5875150|NCT03491059|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5875151|NCT03491059|Autonomic Agents|autonomic agents|mesh-ancestor
5875152|NCT03491059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5875153|NCT03491059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875154|NCT03491059|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5875155|NCT03491059|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5875156|NCT03491059|Cholinergic Agents|cholinergic agents|mesh-ancestor
5875157|NCT03491059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5875158|NCT03491059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875159|NCT03473574|Gemcitabine|gemcitabine|mesh-list
5875160|NCT03473574|Durvalumab|durvalumab|mesh-list
5875161|NCT03473574|Tremelimumab|tremelimumab|mesh-list
5875162|NCT03473574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5875163|NCT03473574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5875164|NCT03473574|Antimetabolites|antimetabolites|mesh-ancestor
5875165|NCT03473574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875166|NCT03473574|Antiviral Agents|antiviral agents|mesh-ancestor
5875167|NCT03473574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5875168|NCT03473574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5875169|NCT03473574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5875170|NCT03473574|Immunologic Factors|immunologic factors|mesh-ancestor
5875171|NCT03473574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684422|NCT03468946|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5905804|NCT04644705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5875172|NCT03473574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5875173|NCT03469999|Botulinum Toxins|botulinum toxins|mesh-list
5875174|NCT03469999|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5875175|NCT03469999|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5875176|NCT03469999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5875177|NCT03469999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5875178|NCT03469999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875179|NCT03469999|Cholinergic Agents|cholinergic agents|mesh-ancestor
5684423|NCT03468946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684424|NCT03468946|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5684425|NCT03468946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5684426|NCT03468946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684427|NCT03468946|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5684428|NCT03468946|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5684429|NCT03468946|Purinergic Agents|purinergic agents|mesh-ancestor
5684430|NCT03468946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5875180|NCT03469999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5875181|NCT03469999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875182|NCT03469999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5875183|NCT03469999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5875184|NCT03466151|Sirolimus|sirolimus|mesh-list
5875185|NCT03466151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5875186|NCT03466151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5875187|NCT03466151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5875188|NCT03466151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5875189|NCT03466151|Antifungal Agents|antifungal agents|mesh-ancestor
5684431|NCT03468946|Anticoagulants|anticoagulants|mesh-ancestor
5684432|NCT03468946|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5684433|NCT03468946|Chelating Agents|chelating agents|mesh-ancestor
5684434|NCT03468946|Sequestering Agents|sequestering agents|mesh-ancestor
5684435|NCT03468907|Tenofovir|tenofovir|mesh-list
5684436|NCT03468907|Telbivudine|telbivudine|mesh-list
5684437|NCT03468907|Antiviral Agents|antiviral agents|mesh-ancestor
5684438|NCT03468907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5875190|NCT03466151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5875191|NCT03466151|Immunologic Factors|immunologic factors|mesh-ancestor
5875192|NCT03466151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875193|NCT03391466|Cyclophosphamide|cyclophosphamide|mesh-list
5875194|NCT03391466|Fludarabine|fludarabine|mesh-list
5875195|NCT03391466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5875196|NCT03391466|Immunologic Factors|immunologic factors|mesh-ancestor
5875197|NCT03391466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875198|NCT03391466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5875199|NCT03391466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5875200|NCT03391466|Alkylating Agents|alkylating agents|mesh-ancestor
5875201|NCT03391466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875202|NCT03391466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5875203|NCT03391466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5875204|NCT03370263|Belimumab|belimumab|mesh-list
5875205|NCT03370263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5875206|NCT03370263|Immunologic Factors|immunologic factors|mesh-ancestor
5875207|NCT03370263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875208|NCT03351439|Celecoxib|celecoxib|mesh-list
5875209|NCT03351439|Naproxen|naproxen|mesh-list
5875210|NCT03351439|Gabapentin|gabapentin|mesh-list
5875211|NCT03351439|Zopiclone|zopiclone|mesh-list
5875212|NCT03351439|Analgesics|analgesics|mesh-ancestor
5875213|NCT03351439|Sensory System Agents|sensory system agents|mesh-ancestor
5875214|NCT03351439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5875215|NCT03351439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875216|NCT03351439|Anticonvulsants|anticonvulsants|mesh-ancestor
5875217|NCT03351439|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5875218|NCT03351439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5875219|NCT03351439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5875220|NCT03351439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5875221|NCT03351439|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5875222|NCT03351439|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5875223|NCT03351439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5875224|NCT03351439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875225|NCT03351439|Antimanic Agents|antimanic agents|mesh-ancestor
5875226|NCT03351439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5875227|NCT03351439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5875228|NCT03351439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5875229|NCT03351439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5875230|NCT03351439|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5875231|NCT03351439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5875232|NCT03351439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5875233|NCT03351439|Gout Suppressants|gout suppressants|mesh-ancestor
5875234|NCT03351439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5875235|NCT03330847|Olaparib|olaparib|mesh-list
5875236|NCT03330847|Adavosertib|adavosertib|mesh-list
5875237|NCT03330847|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5875238|NCT03330847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5875239|NCT03330847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875240|NCT03330847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5875241|NCT03319667|Acetaminophen|acetaminophen|mesh-list
5875242|NCT03319667|Diphenhydramine|diphenhydramine|mesh-list
5875243|NCT03319667|Promethazine|promethazine|mesh-list
5875244|NCT03319667|Dexamethasone|dexamethasone|mesh-list
5875245|NCT03319667|Lenalidomide|lenalidomide|mesh-list
5875246|NCT03319667|Bortezomib|bortezomib|mesh-list
5875247|NCT03319667|Ranitidine|ranitidine|mesh-list
5875248|NCT03319667|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
5875249|NCT03319667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5875250|NCT03319667|Antiemetics|antiemetics|mesh-ancestor
5875251|NCT03319667|Autonomic Agents|autonomic agents|mesh-ancestor
5875252|NCT03319667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5875253|NCT03319667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875254|NCT03319667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5875255|NCT03319667|Glucocorticoids|glucocorticoids|mesh-ancestor
5875256|NCT03319667|Hormones|hormones|mesh-ancestor
5875257|NCT03319667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5875258|NCT03319667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5875259|NCT03319667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5875260|NCT03319667|Immunologic Factors|immunologic factors|mesh-ancestor
5875261|NCT03319667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5875262|NCT03319667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5875263|NCT03319667|Growth Substances|growth substances|mesh-ancestor
5875264|NCT03319667|Growth Inhibitors|growth inhibitors|mesh-ancestor
5875265|NCT03319667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5875266|NCT03319667|Analgesics|analgesics|mesh-ancestor
5875267|NCT03319667|Sensory System Agents|sensory system agents|mesh-ancestor
5875268|NCT03319667|Antipyretics|antipyretics|mesh-ancestor
5875269|NCT03319667|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5684439|NCT03468907|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5684440|NCT03468907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5684441|NCT03468907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5684442|NCT03468907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684443|NCT03468907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5875270|NCT03319667|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5875271|NCT03319667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5875272|NCT03319667|Anesthetics, Local|anesthetics, local|mesh-ancestor
5875273|NCT03319667|Anesthetics|anesthetics|mesh-ancestor
5875274|NCT03319667|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5875275|NCT03319667|Histamine Antagonists|histamine antagonists|mesh-ancestor
5875276|NCT03319667|Histamine Agents|histamine agents|mesh-ancestor
5875277|NCT03319667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6495743|NCT00624767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495744|NCT00624871|Ascorbic Acid|ascorbic acid|mesh-list
6495745|NCT00624871|Ibuprofen|ibuprofen|mesh-list
6495746|NCT00624871|Vitamins|vitamins|mesh-ancestor
6495747|NCT00624871|Micronutrients|micronutrients|mesh-ancestor
5684444|NCT03468907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5875278|NCT03319667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875279|NCT03319667|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5875280|NCT03319667|Antipruritics|antipruritics|mesh-ancestor
5875281|NCT03319667|Dermatologic Agents|dermatologic agents|mesh-ancestor
5875282|NCT03319667|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5875283|NCT03319667|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5875284|NCT03316274|Nivolumab|nivolumab|mesh-list
5875285|NCT03316274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5875286|NCT03316274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5875287|NCT03316274|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5875288|NCT03316274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684445|NCT03468829|Gontivimab|gontivimab|mesh-list
5684446|NCT03468829|Antiviral Agents|antiviral agents|mesh-ancestor
5684447|NCT03468829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5684448|NCT03468790|Fluticasone|fluticasone|mesh-list
5875289|NCT03252626|Alprostadil|alprostadil|mesh-list
5875290|NCT03252626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5875291|NCT03252626|Vasodilator Agents|vasodilator agents|mesh-ancestor
5875292|NCT03252626|Urological Agents|urological agents|mesh-ancestor
6495748|NCT00624871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875293|NCT03246906|Cyclosporine|cyclosporine|mesh-list
5875294|NCT03246906|Sirolimus|sirolimus|mesh-list
5875295|NCT03246906|Mycophenolic Acid|mycophenolic acid|mesh-list
5875296|NCT03246906|Cyclophosphamide|cyclophosphamide|mesh-list
5875297|NCT03246906|Cyclosporins|cyclosporins|mesh-list
5875298|NCT03246906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5875299|NCT03246906|Immunologic Factors|immunologic factors|mesh-ancestor
5875300|NCT03246906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875301|NCT03246906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5875302|NCT03246906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5875303|NCT03246906|Alkylating Agents|alkylating agents|mesh-ancestor
5875304|NCT03246906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875305|NCT03246906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5875306|NCT03246906|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5875307|NCT03246906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5875308|NCT03246906|Antifungal Agents|antifungal agents|mesh-ancestor
5875309|NCT03246906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5875310|NCT03246906|Dermatologic Agents|dermatologic agents|mesh-ancestor
5875311|NCT03246906|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5875312|NCT03246906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5875313|NCT03246906|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5875314|NCT03246906|Antitubercular Agents|antitubercular agents|mesh-ancestor
5875315|NCT03246906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5875316|NCT03245008|Fasinumab|fasinumab|mesh-list
5875317|NCT03245008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5875318|NCT03245008|Analgesics|analgesics|mesh-ancestor
5875319|NCT03245008|Sensory System Agents|sensory system agents|mesh-ancestor
5875320|NCT03245008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5875321|NCT03245008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875322|NCT03238300|Acetylcysteine|acetylcysteine|mesh-list
5875323|NCT03238300|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5875324|NCT03238300|Antiviral Agents|antiviral agents|mesh-ancestor
5875325|NCT03238300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5875326|NCT03238300|Expectorants|expectorants|mesh-ancestor
5875327|NCT03238300|Respiratory System Agents|respiratory system agents|mesh-ancestor
5875328|NCT03238300|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6495749|NCT00624871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6495750|NCT00624871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6495751|NCT00624871|Analgesics|analgesics|mesh-ancestor
5684449|NCT03468790|Xhance|xhance|mesh-list
5684450|NCT03468790|Budesonide|budesonide|mesh-list
5684451|NCT03468790|Albuterol|albuterol|mesh-list
5684452|NCT03468790|Formoterol Fumarate|formoterol fumarate|mesh-list
5684453|NCT03468790|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5684454|NCT03468790|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
5684455|NCT03468790|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
5684456|NCT03468790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5684457|NCT03468790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5684458|NCT03468790|Autonomic Agents|autonomic agents|mesh-ancestor
5684459|NCT03468790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5684460|NCT03468790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684461|NCT03468790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5684462|NCT03468790|Respiratory System Agents|respiratory system agents|mesh-ancestor
5684463|NCT03468790|Dermatologic Agents|dermatologic agents|mesh-ancestor
5684464|NCT03468790|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5684465|NCT03468790|Glucocorticoids|glucocorticoids|mesh-ancestor
5684466|NCT03468790|Hormones|hormones|mesh-ancestor
5684467|NCT03468790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5684468|NCT03468790|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5684469|NCT03468790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5684470|NCT03468790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5684471|NCT03468790|Adrenergic Agents|adrenergic agents|mesh-ancestor
5684472|NCT03468790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5684473|NCT03468790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495752|NCT00624871|Sensory System Agents|sensory system agents|mesh-ancestor
5684474|NCT03468790|Tocolytic Agents|tocolytic agents|mesh-ancestor
5684475|NCT03468790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5684476|NCT03468790|Sympathomimetics|sympathomimetics|mesh-ancestor
5684477|NCT03468777|Lansoprazole|lansoprazole|mesh-list
5684478|NCT03468777|Dexlansoprazole|dexlansoprazole|mesh-list
5684479|NCT03468777|Ranitidine|ranitidine|mesh-list
5684480|NCT03468777|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
5684481|NCT03468777|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5684482|NCT03468777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5684483|NCT03468777|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5875329|NCT03238300|Antioxidants|antioxidants|mesh-ancestor
6212613|NCT02191397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5875330|NCT03238300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875331|NCT03238300|Protective Agents|protective agents|mesh-ancestor
5875332|NCT03238300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875333|NCT03238300|Antidotes|antidotes|mesh-ancestor
5875334|NCT03237377|Durvalumab|durvalumab|mesh-list
5875335|NCT03237377|Tremelimumab|tremelimumab|mesh-list
5875336|NCT03237377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5875337|NCT03237377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5875338|NCT03236545|Estradiol|estradiol|mesh-list
5875339|NCT03236545|Estrogens|estrogens|mesh-list
5875340|NCT03236545|Hormones|hormones|mesh-ancestor
5875341|NCT03236545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5875342|NCT03236545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875343|NCT03199755|Lumefantrine|lumefantrine|mesh-list
5875344|NCT03199755|Artemether|artemether|mesh-list
5875345|NCT03199755|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
5875346|NCT03199755|Antimalarials|antimalarials|mesh-ancestor
5875347|NCT03199755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5875348|NCT03199755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5875349|NCT03199755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5875350|NCT03184571|Pembrolizumab|pembrolizumab|mesh-list
5875351|NCT03184571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5875352|NCT03184571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5875353|NCT03181126|Venetoclax|venetoclax|mesh-list
5875354|NCT03181126|Navitoclax|navitoclax|mesh-list
5875355|NCT03181126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5875356|NCT03174405|Avelumab|avelumab|mesh-list
5875357|NCT03174405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5875358|NCT03174405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5875359|NCT03139747|Everolimus|everolimus|mesh-list
5875360|NCT03139747|Lenvatinib|lenvatinib|mesh-list
5875361|NCT03139747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5875362|NCT03139747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5875363|NCT03139747|Immunologic Factors|immunologic factors|mesh-ancestor
5875364|NCT03139747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875365|NCT03139747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5875366|NCT03139747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5875367|NCT03139747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875368|NCT03128619|Letrozole|letrozole|mesh-list
5875369|NCT03128619|Palbociclib|palbociclib|mesh-list
5875370|NCT03128619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5875371|NCT03128619|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5875372|NCT03128619|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5875373|NCT03128619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5875374|NCT03128619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875375|NCT03128619|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5875376|NCT03128619|Hormone Antagonists|hormone antagonists|mesh-ancestor
5684484|NCT03468777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5684485|NCT03468777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684486|NCT03468777|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5684487|NCT03468777|Histamine Antagonists|histamine antagonists|mesh-ancestor
5684488|NCT03468777|Histamine Agents|histamine agents|mesh-ancestor
5684489|NCT03468777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5684490|NCT03468777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684491|NCT03468595|Listerine|listerine|mesh-list
5684492|NCT03468595|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5684493|NCT03468595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5684494|NCT03468478|Mycophenolic Acid|mycophenolic acid|mesh-list
5684495|NCT03468478|Sirolimus|sirolimus|mesh-list
5684496|NCT03468478|Everolimus|everolimus|mesh-list
5684497|NCT03468478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5684498|NCT03468478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5684499|NCT03468478|Immunologic Factors|immunologic factors|mesh-ancestor
5684500|NCT03468478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684501|NCT03468478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5684502|NCT03468478|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5684503|NCT03468478|Antitubercular Agents|antitubercular agents|mesh-ancestor
5684504|NCT03468478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5684505|NCT03468478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5684506|NCT03468478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5684507|NCT03468478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684508|NCT03468478|Antifungal Agents|antifungal agents|mesh-ancestor
5684509|NCT03468465|Solifenacin Succinate|solifenacin succinate|mesh-list
5684510|NCT03468465|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5875377|NCT03128619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6212456|NCT02188576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5875378|NCT03128619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875379|NCT03128619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5875380|NCT03066648|Azacitidine|azacitidine|mesh-list
5875381|NCT03066648|Decitabine|decitabine|mesh-list
5875382|NCT03066648|Spartalizumab|spartalizumab|mesh-list
5875383|NCT03066648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5875384|NCT03066648|Antimetabolites|antimetabolites|mesh-ancestor
5875385|NCT03066648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875386|NCT03066648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5875387|NCT03066648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5875388|NCT03066648|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5875389|NCT03059498|Bupivacaine|bupivacaine|mesh-list
5875390|NCT03059498|Anesthetics, Local|anesthetics, local|mesh-ancestor
5875391|NCT03059498|Anesthetics|anesthetics|mesh-ancestor
5875392|NCT03059498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6495753|NCT00624871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5684511|NCT03468465|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5684512|NCT03468465|Cholinergic Agents|cholinergic agents|mesh-ancestor
5684513|NCT03468465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5684514|NCT03468465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684515|NCT03468465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684516|NCT03468465|Urological Agents|urological agents|mesh-ancestor
5684517|NCT03468439|Phenol|phenol|mesh-list
5684518|NCT03468439|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5684519|NCT03468439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5684520|NCT03468439|Disinfectants|disinfectants|mesh-ancestor
5684521|NCT03468439|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
5684522|NCT03468439|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5684523|NCT03468348|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5684524|NCT03468348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5684525|NCT03468348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5684526|NCT03468348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5684527|NCT03468348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684528|NCT03468348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5684529|NCT03468348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684530|NCT03468348|Analgesics|analgesics|mesh-ancestor
5684531|NCT03468348|Sensory System Agents|sensory system agents|mesh-ancestor
5684532|NCT03468348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5684533|NCT03468348|Antidepressive Agents|antidepressive agents|mesh-ancestor
5684534|NCT03468348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5684535|NCT03468348|Dopamine Agents|dopamine agents|mesh-ancestor
5684536|NCT03468335|Irinotecan|irinotecan|mesh-list
5684537|NCT03468335|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5684538|NCT03468335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5684539|NCT03468335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5684540|NCT03468335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684541|NCT03468335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5684542|NCT03468296|Aflibercept|aflibercept|mesh-list
5684543|NCT03468296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5684544|NCT03468296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5684545|NCT03468296|Growth Substances|growth substances|mesh-ancestor
5684546|NCT03468296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684547|NCT03468296|Growth Inhibitors|growth inhibitors|mesh-ancestor
5684548|NCT03468296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5684549|NCT03468231|Leucovorin|leucovorin|mesh-list
5684550|NCT03468231|Fluorouracil|fluorouracil|mesh-list
5684551|NCT03468231|Oxaliplatin|oxaliplatin|mesh-list
5684552|NCT03468231|Sorafenib|sorafenib|mesh-list
5684553|NCT03468231|Antimetabolites|antimetabolites|mesh-ancestor
5684554|NCT03468231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684555|NCT03468231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5684556|NCT03468231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5684557|NCT03468231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5684558|NCT03468231|Immunologic Factors|immunologic factors|mesh-ancestor
5684559|NCT03468231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684560|NCT03468231|Antidotes|antidotes|mesh-ancestor
5684561|NCT03468231|Protective Agents|protective agents|mesh-ancestor
5684562|NCT03468231|Vitamin B Complex|vitamin b complex|mesh-ancestor
5684563|NCT03468231|Vitamins|vitamins|mesh-ancestor
5684564|NCT03468231|Micronutrients|micronutrients|mesh-ancestor
5684565|NCT03468231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5684566|NCT03468231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5684567|NCT03468140|Eculizumab|eculizumab|mesh-list
5684568|NCT03468140|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5875393|NCT03059498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684569|NCT03468140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5684570|NCT03468140|Immunologic Factors|immunologic factors|mesh-ancestor
5684571|NCT03468140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684572|NCT03468062|Dexmedetomidine|dexmedetomidine|mesh-list
5684573|NCT03468062|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5684574|NCT03468062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5684575|NCT03468062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684576|NCT03468062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5684577|NCT03468062|Analgesics|analgesics|mesh-ancestor
5684578|NCT03468062|Sensory System Agents|sensory system agents|mesh-ancestor
5684579|NCT03468062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5684580|NCT03468062|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5684581|NCT03468062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5684582|NCT03468062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5684583|NCT03468062|Adrenergic Agents|adrenergic agents|mesh-ancestor
5684584|NCT03468062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5684585|NCT03468062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684586|NCT03468023|Calpastatin|calpastatin|mesh-list
5684587|NCT03468023|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
5684588|NCT03468023|Protease Inhibitors|protease inhibitors|mesh-ancestor
5684589|NCT03468023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5684590|NCT03468023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684591|NCT03468010|Paclitaxel|paclitaxel|mesh-list
6495754|NCT00624871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6495755|NCT00624871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6495756|NCT00624871|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6495757|NCT00624871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6495758|NCT00624871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495759|NCT00624871|Antioxidants|antioxidants|mesh-ancestor
6495760|NCT00624871|Protective Agents|protective agents|mesh-ancestor
6495761|NCT00624936|Bortezomib|bortezomib|mesh-list
6495762|NCT00624936|Azacitidine|azacitidine|mesh-list
6495763|NCT00624936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6495764|NCT00624936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5684592|NCT03468010|Cisplatin|cisplatin|mesh-list
5875394|NCT03059498|Sensory System Agents|sensory system agents|mesh-ancestor
5875395|NCT03059498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5875396|NCT02943590|Atorvastatin|atorvastatin|mesh-list
5875397|NCT02943590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5875398|NCT02943590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5875399|NCT02943590|Antimetabolites|antimetabolites|mesh-ancestor
5875400|NCT02943590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875401|NCT02943590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5875402|NCT02943590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5875403|NCT02943590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5875404|NCT02918292|Mycophenolic Acid|mycophenolic acid|mesh-list
5684593|NCT03468010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5684594|NCT03468010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5684595|NCT03468010|Tubulin Modulators|tubulin modulators|mesh-ancestor
5684596|NCT03468010|Antimitotic Agents|antimitotic agents|mesh-ancestor
5684597|NCT03468010|Mitosis Modulators|mitosis modulators|mesh-ancestor
5684598|NCT03468010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684599|NCT03467984|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5684600|NCT03467984|Immunologic Factors|immunologic factors|mesh-ancestor
5684601|NCT03467984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684602|NCT03467932|Insulin|insulin|mesh-list
5684603|NCT03467932|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5684604|NCT03467932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5684605|NCT03467932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684606|NCT03467893|Antacids|antacids|mesh-list
5684607|NCT03467893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684608|NCT03467893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5684609|NCT03467867|Rituximab|rituximab|mesh-list
5684610|NCT03467867|Venetoclax|venetoclax|mesh-list
5684611|NCT03467867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5684612|NCT03467867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5684613|NCT03467867|Immunologic Factors|immunologic factors|mesh-ancestor
5684614|NCT03467867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875405|NCT02918292|Cyclophosphamide|cyclophosphamide|mesh-list
5875406|NCT02918292|Fludarabine|fludarabine|mesh-list
5875407|NCT02918292|Tacrolimus|tacrolimus|mesh-list
5875408|NCT02918292|Thymoglobulin|thymoglobulin|mesh-list
6495765|NCT00624936|Antimetabolites|antimetabolites|mesh-ancestor
5875409|NCT02918292|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6495766|NCT00624936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684615|NCT03467867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5697160|NCT03377725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5697161|NCT03377725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5697162|NCT03377608|Tenofovir|tenofovir|mesh-list
5875410|NCT02918292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5875411|NCT02918292|Immunologic Factors|immunologic factors|mesh-ancestor
5875412|NCT02918292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875413|NCT02918292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5875414|NCT02918292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5875415|NCT02918292|Alkylating Agents|alkylating agents|mesh-ancestor
5875416|NCT02918292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875417|NCT02918292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5875418|NCT02918292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5697163|NCT03377608|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
5697164|NCT03377608|Medroxyprogesterone|medroxyprogesterone|mesh-list
5697165|NCT03377608|Antiviral Agents|antiviral agents|mesh-ancestor
5697166|NCT03377608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5697167|NCT03377608|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5697168|NCT03377608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5697169|NCT03377608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5875419|NCT02918292|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5875420|NCT02918292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5875421|NCT02918292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5875422|NCT02918292|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5875423|NCT02918292|Antitubercular Agents|antitubercular agents|mesh-ancestor
5875424|NCT02918292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5875425|NCT02918292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5875426|NCT02902120|Grazoprevir|grazoprevir|mesh-list
5875427|NCT02902120|Antiviral Agents|antiviral agents|mesh-ancestor
5875428|NCT02902120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5875429|NCT02896712|Modafinil|modafinil|mesh-list
5875430|NCT02896712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5875431|NCT02896712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875432|NCT02896712|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
5875433|NCT02896712|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5875434|NCT02896712|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5875435|NCT02896712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875436|NCT02858869|Pembrolizumab|pembrolizumab|mesh-list
5875437|NCT02858869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5875438|NCT02858869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5875439|NCT02654080|Vaccines|vaccines|mesh-list
5875440|NCT02654080|Immunologic Factors|immunologic factors|mesh-ancestor
5875441|NCT02654080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697170|NCT03377608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697171|NCT03377608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5697172|NCT03377608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5697173|NCT03377608|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5697174|NCT03377608|Contraceptive Agents|contraceptive agents|mesh-ancestor
5697175|NCT03377608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5697176|NCT03377608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697177|NCT03377608|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5697178|NCT03377608|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5697179|NCT03377608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5697180|NCT03377608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5697181|NCT03377608|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5697182|NCT03377608|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5697183|NCT03377608|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5697184|NCT03377543|Aspirin|aspirin|mesh-list
5697185|NCT03377543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
5697186|NCT03377543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
5697187|NCT03377543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5875442|NCT02639026|Durvalumab|durvalumab|mesh-list
5875443|NCT02639026|Tremelimumab|tremelimumab|mesh-list
5875444|NCT02639026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5875445|NCT02639026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5905805|NCT04644705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5905806|NCT04644705|Antinematodal Agents|antinematodal agents|mesh-ancestor
5905807|NCT04637555|Valsartan|valsartan|mesh-list
5905808|NCT04637555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6675313|NCT01573975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6675314|NCT01573975|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6675315|NCT01573975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5697188|NCT03377543|Analgesics|analgesics|mesh-ancestor
5697189|NCT03377543|Sensory System Agents|sensory system agents|mesh-ancestor
5875446|NCT02618148|Estrogens|estrogens|mesh-list
5875447|NCT02618148|Hormones|hormones|mesh-ancestor
5875448|NCT02618148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5875449|NCT02618148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875450|NCT02553447|Vitamin D|vitamin d|mesh-list
5875451|NCT02553447|Cholecalciferol|cholecalciferol|mesh-list
5875452|NCT02553447|Vitamins|vitamins|mesh-ancestor
5875453|NCT02553447|Micronutrients|micronutrients|mesh-ancestor
5875454|NCT02553447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875455|NCT02553447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5875456|NCT02553447|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5875457|NCT02499003|Obinutuzumab|obinutuzumab|mesh-list
5875458|NCT02499003|Pixantrone|pixantrone|mesh-list
5875459|NCT02499003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5875460|NCT02499003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5875461|NCT02499003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5875462|NCT02499003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5875463|NCT02499003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5875464|NCT02499003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875465|NCT02486666|Enoxaparin|enoxaparin|mesh-list
5875466|NCT02486666|Enoxaparin sodium|enoxaparin sodium|mesh-list
5875467|NCT02486666|Anticoagulants|anticoagulants|mesh-ancestor
5875468|NCT02486666|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5875469|NCT02486666|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5875470|NCT02486666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875471|NCT02431767|Interleukin-12|interleukin-12|mesh-list
5875472|NCT02431767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5875473|NCT02431767|Immunologic Factors|immunologic factors|mesh-ancestor
5875474|NCT02431767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875475|NCT02431767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5875476|NCT02431767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5875477|NCT02431767|Growth Substances|growth substances|mesh-ancestor
5875478|NCT02431767|Growth Inhibitors|growth inhibitors|mesh-ancestor
5875479|NCT02431767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5875480|NCT02390284|Timolol|timolol|mesh-list
5875481|NCT02390284|Bimatoprost|bimatoprost|mesh-list
5875482|NCT02390284|Travoprost|travoprost|mesh-list
5875483|NCT02390284|Dorzolamide|dorzolamide|mesh-list
5875484|NCT02390284|Acetazolamide|acetazolamide|mesh-list
5875485|NCT02390284|Methazolamide|methazolamide|mesh-list
5875486|NCT02390284|Latanoprost|latanoprost|mesh-list
5875487|NCT02390284|Brinzolamide|brinzolamide|mesh-list
5875488|NCT02390284|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5875489|NCT02390284|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5875490|NCT02390284|Adrenergic Agents|adrenergic agents|mesh-ancestor
5875491|NCT02390284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5875492|NCT02390284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875493|NCT02390284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875494|NCT02390284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5875495|NCT02390284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5875496|NCT02390284|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5875497|NCT02390284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5875498|NCT02390284|Anticonvulsants|anticonvulsants|mesh-ancestor
5875499|NCT02390284|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5875500|NCT02390284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5875501|NCT02390284|Diuretics|diuretics|mesh-ancestor
5875502|NCT02390284|Natriuretic Agents|natriuretic agents|mesh-ancestor
5875503|NCT02389517|Dexamethasone|dexamethasone|mesh-list
5875504|NCT02389517|Lenalidomide|lenalidomide|mesh-list
5875505|NCT02389517|Ixazomib|ixazomib|mesh-list
5875506|NCT02389517|Glycine|glycine|mesh-list
5875507|NCT02389517|Proteasome Inhibitors|proteasome inhibitors|mesh-list
5875508|NCT02389517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5875509|NCT02389517|Antiemetics|antiemetics|mesh-ancestor
5875510|NCT02389517|Autonomic Agents|autonomic agents|mesh-ancestor
5684616|NCT03467750|Ketorolac|ketorolac|mesh-list
5684617|NCT03467750|Morphine|morphine|mesh-list
5684618|NCT03467750|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5684619|NCT03467750|Narcotics|narcotics|mesh-ancestor
5684620|NCT03467750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5684621|NCT03467750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684622|NCT03467750|Analgesics|analgesics|mesh-ancestor
5684623|NCT03467750|Sensory System Agents|sensory system agents|mesh-ancestor
5684624|NCT03467750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5875511|NCT02389517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5875512|NCT02389517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875513|NCT02389517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5875514|NCT02389517|Glucocorticoids|glucocorticoids|mesh-ancestor
5875515|NCT02389517|Hormones|hormones|mesh-ancestor
6212614|NCT02191397|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5875516|NCT02389517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5875517|NCT02389517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5875518|NCT02389517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5875519|NCT02389517|Immunologic Factors|immunologic factors|mesh-ancestor
5875520|NCT02389517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5875521|NCT02389517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5875522|NCT02389517|Growth Substances|growth substances|mesh-ancestor
5875523|NCT02389517|Growth Inhibitors|growth inhibitors|mesh-ancestor
5875524|NCT02389517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875525|NCT02389517|Protease Inhibitors|protease inhibitors|mesh-ancestor
5875526|NCT02389517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5875527|NCT02389517|Glycine Agents|glycine agents|mesh-ancestor
5875528|NCT02389517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5875529|NCT05082142|Tranexamic Acid|tranexamic acid|mesh-list
5875530|NCT05082142|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5875531|NCT05082142|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5875532|NCT05082142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875533|NCT05082142|Hemostatics|hemostatics|mesh-ancestor
5875534|NCT05082142|Coagulants|coagulants|mesh-ancestor
5875535|NCT05081986|Cycloserine|cycloserine|mesh-list
5875536|NCT05081986|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5875537|NCT05081986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5875538|NCT05081986|Renal Agents|renal agents|mesh-ancestor
5875539|NCT05081986|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5875540|NCT05081986|Antitubercular Agents|antitubercular agents|mesh-ancestor
5875541|NCT05081986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5875542|NCT05081986|Antimetabolites|antimetabolites|mesh-ancestor
5875543|NCT05081986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875544|NCT05081765|Olaparib|olaparib|mesh-list
5875545|NCT05081765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5684625|NCT03467750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5684626|NCT03467750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5684627|NCT03467750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5684628|NCT03467750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5684629|NCT03467750|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5684630|NCT03467750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5684631|NCT03467750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684632|NCT03467620|Cannabidiol|cannabidiol|mesh-list
5684633|NCT03467620|Anticonvulsants|anticonvulsants|mesh-ancestor
5684634|NCT03467438|Polaprezinc|polaprezinc|mesh-list
5684635|NCT03467438|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5684636|NCT03467438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5684637|NCT03467334|Simethicone|simethicone|mesh-list
5684638|NCT03467334|Antifoaming Agents|antifoaming agents|mesh-ancestor
5684639|NCT03467334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684640|NCT03467334|Emollients|emollients|mesh-ancestor
5684641|NCT03467334|Dermatologic Agents|dermatologic agents|mesh-ancestor
5684642|NCT03467256|Cyclophosphamide|cyclophosphamide|mesh-list
5875546|NCT05081765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5875547|NCT05081765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875548|NCT05081765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5875549|NCT05081687|Oxaliplatin|oxaliplatin|mesh-list
5875550|NCT05081687|Irinotecan|irinotecan|mesh-list
5875551|NCT05081687|Folfirinox|folfirinox|mesh-list
5875552|NCT05081687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5875553|NCT05081687|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5875554|NCT05081687|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5875555|NCT05081687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5875556|NCT05081687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875557|NCT05081674|Pembrolizumab|pembrolizumab|mesh-list
5684643|NCT03467256|Fludarabine|fludarabine|mesh-list
5684644|NCT03467256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5684645|NCT03467256|Immunologic Factors|immunologic factors|mesh-ancestor
5684646|NCT03467256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684647|NCT03467256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5684648|NCT03467256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5684649|NCT03467256|Alkylating Agents|alkylating agents|mesh-ancestor
5684650|NCT03467256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684651|NCT03467256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5684652|NCT03467256|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5684653|NCT03467178|Gemcitabine|gemcitabine|mesh-list
5684654|NCT03467178|Paclitaxel|paclitaxel|mesh-list
5875558|NCT05081674|Nivolumab|nivolumab|mesh-list
5875559|NCT05081674|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5875560|NCT05081674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5875561|NCT05081674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5875562|NCT05081674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5875563|NCT05081674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875564|NCT05081674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5875565|NCT05081674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5875566|NCT05081466|Vitamin D|vitamin d|mesh-list
5875567|NCT05081466|Calcium|calcium|mesh-list
5875568|NCT05081466|Vitamins|vitamins|mesh-ancestor
5875569|NCT05081466|Micronutrients|micronutrients|mesh-ancestor
5875570|NCT05081466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875571|NCT05081466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5875572|NCT05081466|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5875573|NCT05081102|Ibuprofen|ibuprofen|mesh-list
5875574|NCT05081102|Oxycodone|oxycodone|mesh-list
5875575|NCT05081102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5875576|NCT05081102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5875577|NCT05081102|Analgesics|analgesics|mesh-ancestor
5875578|NCT05081102|Sensory System Agents|sensory system agents|mesh-ancestor
5875579|NCT05081102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5875580|NCT05081102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875581|NCT05081102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6675316|NCT01573975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6675317|NCT01574014|Hydrocortisone|hydrocortisone|mesh-list
6675318|NCT01574014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6675319|NCT01574027|Vitamin D|vitamin d|mesh-list
6675320|NCT01574027|Cholecalciferol|cholecalciferol|mesh-list
6675321|NCT01574027|Vitamins|vitamins|mesh-ancestor
6675322|NCT01574027|Micronutrients|micronutrients|mesh-ancestor
6675323|NCT01574027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675324|NCT01574027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6675325|NCT01574027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6675326|NCT01574092|Irinotecan|irinotecan|mesh-list
6675327|NCT01574092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5875582|NCT05081102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5875583|NCT05081102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5875584|NCT05081102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5875585|NCT05081102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875586|NCT05081102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5875587|NCT05081102|Narcotics|narcotics|mesh-ancestor
5875588|NCT05081102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5875589|NCT05080985|Bupivacaine|bupivacaine|mesh-list
5875590|NCT05080985|Anesthetics, Local|anesthetics, local|mesh-ancestor
5875591|NCT05080985|Anesthetics|anesthetics|mesh-ancestor
5875592|NCT05080985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5875593|NCT05080985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875594|NCT05080985|Sensory System Agents|sensory system agents|mesh-ancestor
5875595|NCT05080985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5875596|NCT05080803|Bevacizumab|bevacizumab|mesh-list
5875597|NCT05080803|Ranibizumab|ranibizumab|mesh-list
5875598|NCT05080803|Aflibercept|aflibercept|mesh-list
5875599|NCT05080803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5875600|NCT05080803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5875601|NCT05080803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5875602|NCT05080803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5875603|NCT05080803|Growth Substances|growth substances|mesh-ancestor
5875604|NCT05080803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875605|NCT05080803|Growth Inhibitors|growth inhibitors|mesh-ancestor
5875606|NCT05071014|Pembrolizumab|pembrolizumab|mesh-list
5875607|NCT05071014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5875608|NCT05071014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5875609|NCT05062278|Hydroxyurea|hydroxyurea|mesh-list
5875610|NCT05062278|Vinblastine|vinblastine|mesh-list
5875611|NCT05062278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5875612|NCT05062278|Antisickling Agents|antisickling agents|mesh-ancestor
5875613|NCT05062278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5875614|NCT05062278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875615|NCT05062278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5875616|NCT05062278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5875617|NCT05062278|Tubulin Modulators|tubulin modulators|mesh-ancestor
5875618|NCT05062278|Antimitotic Agents|antimitotic agents|mesh-ancestor
5875619|NCT05062278|Mitosis Modulators|mitosis modulators|mesh-ancestor
5875620|NCT05059873|Prednisone|prednisone|mesh-list
6675328|NCT01574092|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5875621|NCT05059873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5875622|NCT05059873|Glucocorticoids|glucocorticoids|mesh-ancestor
5875623|NCT05059873|Hormones|hormones|mesh-ancestor
5875624|NCT05059873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5875625|NCT05059873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875626|NCT05059873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5875627|NCT05059873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5875628|NCT05055830|Acetaminophen|acetaminophen|mesh-list
5875629|NCT05055830|Methadone|methadone|mesh-list
5875630|NCT05055830|Caffeine|caffeine|mesh-list
5875631|NCT05055830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5875632|NCT05055830|Analgesics|analgesics|mesh-ancestor
5875633|NCT05055830|Sensory System Agents|sensory system agents|mesh-ancestor
5875634|NCT05055830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5875635|NCT05055830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875636|NCT05055830|Antipyretics|antipyretics|mesh-ancestor
5875637|NCT05055830|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5875638|NCT05055830|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5875639|NCT05055830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5875640|NCT05055830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875641|NCT05055830|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5875642|NCT05055830|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5875643|NCT05055830|Purinergic Agents|purinergic agents|mesh-ancestor
5875644|NCT05055830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5875645|NCT05055830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5875646|NCT05055830|Narcotics|narcotics|mesh-ancestor
5875647|NCT05055830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5875648|NCT05055830|Antitussive Agents|antitussive agents|mesh-ancestor
5875649|NCT05055830|Respiratory System Agents|respiratory system agents|mesh-ancestor
5905809|NCT04637555|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5905810|NCT04637555|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5905811|NCT04637555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905812|NCT04636034|Anesthetics|anesthetics|mesh-list
5905813|NCT04636034|Anesthetics, Local|anesthetics, local|mesh-list
5905814|NCT04636034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5905815|NCT04636034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905816|NCT04636034|Sensory System Agents|sensory system agents|mesh-ancestor
5905817|NCT04636034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5905818|NCT04607122|Landiolol|landiolol|mesh-list
5905819|NCT04607122|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5905820|NCT04607122|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5905821|NCT04607122|Adrenergic Agents|adrenergic agents|mesh-ancestor
5905822|NCT04607122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5905823|NCT04607122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905824|NCT04607122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905825|NCT04607122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5905826|NCT04602377|Pembrolizumab|pembrolizumab|mesh-list
5905827|NCT04602377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5905828|NCT04602377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5905829|NCT04578535|Immunoglobulins|immunoglobulins|mesh-list
5905830|NCT04578535|Immunologic Factors|immunologic factors|mesh-ancestor
5905831|NCT04578535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905832|NCT04576663|Phenylephrine|phenylephrine|mesh-list
5905833|NCT04576663|Oxymetazoline|oxymetazoline|mesh-list
5905834|NCT04576663|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5905835|NCT04576663|Mydriatics|mydriatics|mesh-ancestor
5905836|NCT04576663|Autonomic Agents|autonomic agents|mesh-ancestor
5905837|NCT04576663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5905838|NCT04576663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905839|NCT04576663|Sympathomimetics|sympathomimetics|mesh-ancestor
5905840|NCT04576663|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5905841|NCT04576663|Nasal Decongestants|nasal decongestants|mesh-ancestor
5905842|NCT04576663|Respiratory System Agents|respiratory system agents|mesh-ancestor
5905843|NCT04576663|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5905844|NCT04576663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5905845|NCT04576663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5905846|NCT04576663|Adrenergic Agents|adrenergic agents|mesh-ancestor
5905847|NCT04576663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5905848|NCT04576663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905849|NCT04576663|Protective Agents|protective agents|mesh-ancestor
5905850|NCT04556357|Phenylephrine|phenylephrine|mesh-list
5905851|NCT04556357|Oxymetazoline|oxymetazoline|mesh-list
5905852|NCT04556357|Norepinephrine|norepinephrine|mesh-list
5905853|NCT04556357|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
5905854|NCT04556357|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5905855|NCT04556357|Mydriatics|mydriatics|mesh-ancestor
5905856|NCT04556357|Autonomic Agents|autonomic agents|mesh-ancestor
6495767|NCT00624936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5684655|NCT03467178|Carboplatin|carboplatin|mesh-list
5875650|NCT05048212|Nivolumab|nivolumab|mesh-list
5875651|NCT05048212|Ipilimumab|ipilimumab|mesh-list
5875652|NCT05048212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5875653|NCT05048212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5875654|NCT05048212|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5875655|NCT05048212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875656|NCT05010629|Carboplatin|carboplatin|mesh-list
5875657|NCT05010629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5875658|NCT04997239|Vaccines|vaccines|mesh-list
5875659|NCT04997239|Immunologic Factors|immunologic factors|mesh-ancestor
5875660|NCT04997239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875661|NCT04997174|Celecoxib|celecoxib|mesh-list
5875662|NCT04997174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5875663|NCT04997174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5875664|NCT04997174|Analgesics|analgesics|mesh-ancestor
5875665|NCT04997174|Sensory System Agents|sensory system agents|mesh-ancestor
5875666|NCT04997174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5875667|NCT04997174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875668|NCT04997174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5875669|NCT04997174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5875670|NCT04997174|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5684656|NCT03467178|Doxorubicin|doxorubicin|mesh-list
5684657|NCT03467178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5684658|NCT03467178|Decitabine|decitabine|mesh-list
5684659|NCT03467178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5684660|NCT03467178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5684661|NCT03467178|Tubulin Modulators|tubulin modulators|mesh-ancestor
5684662|NCT03467178|Antimitotic Agents|antimitotic agents|mesh-ancestor
5684663|NCT03467178|Mitosis Modulators|mitosis modulators|mesh-ancestor
5684664|NCT03467178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684665|NCT03467178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5875671|NCT04997174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5875672|NCT04997174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5875673|NCT04997174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875674|NCT04981509|Bevacizumab|bevacizumab|mesh-list
5875675|NCT04981509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5875676|NCT04981509|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5875677|NCT04981509|Atezolizumab|atezolizumab|mesh-list
5875678|NCT04981509|Endothelial Growth Factors|endothelial growth factors|mesh-list
5875679|NCT04981509|Antibodies|antibodies|mesh-list
5875680|NCT04981509|Immunoglobulins|immunoglobulins|mesh-list
5875681|NCT04981509|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5875682|NCT04981509|Immunoglobulin G|immunoglobulin g|mesh-list
5875683|NCT04981509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5875684|NCT04981509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5875685|NCT04981509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5875686|NCT04981509|Growth Substances|growth substances|mesh-ancestor
5875687|NCT04981509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875688|NCT04981509|Growth Inhibitors|growth inhibitors|mesh-ancestor
5875689|NCT04981509|Immunologic Factors|immunologic factors|mesh-ancestor
5875690|NCT04981509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5875691|NCT04981509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5875692|NCT04981509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875693|NCT04976387|Acetaminophen|acetaminophen|mesh-list
5875694|NCT04976387|Ibuprofen|ibuprofen|mesh-list
5875695|NCT04976387|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
5875696|NCT04976387|Hydrocodone|hydrocodone|mesh-list
5875697|NCT04976387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5875698|NCT04976387|Analgesics|analgesics|mesh-ancestor
5875699|NCT04976387|Sensory System Agents|sensory system agents|mesh-ancestor
5875700|NCT04976387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5875701|NCT04976387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875702|NCT04976387|Antipyretics|antipyretics|mesh-ancestor
5875703|NCT04976387|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5875704|NCT04976387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5875705|NCT04976387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5875706|NCT04976387|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5875707|NCT04976387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5875708|NCT04976387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875709|NCT04976387|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5875710|NCT04976387|Narcotics|narcotics|mesh-ancestor
5875711|NCT04976387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5875712|NCT04976387|Antitussive Agents|antitussive agents|mesh-ancestor
5875713|NCT04976387|Respiratory System Agents|respiratory system agents|mesh-ancestor
5875714|NCT04949633|Oxytocin|oxytocin|mesh-list
5684666|NCT03467178|Antimetabolites|antimetabolites|mesh-ancestor
5684667|NCT03467178|Antiviral Agents|antiviral agents|mesh-ancestor
5684668|NCT03467178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5684669|NCT03467178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5684670|NCT03467178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5875715|NCT04949633|Oxytocics|oxytocics|mesh-ancestor
5875716|NCT04949633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5875717|NCT04949633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875718|NCT04912505|Aspirin|aspirin|mesh-list
5875719|NCT04912505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5875720|NCT04912505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5875721|NCT04912505|Analgesics|analgesics|mesh-ancestor
5875722|NCT04912505|Sensory System Agents|sensory system agents|mesh-ancestor
5875723|NCT04912505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5875724|NCT04912505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875725|NCT04912505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5875726|NCT04912505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5875727|NCT04912505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5875728|NCT04912505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5875729|NCT04912505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875730|NCT04912505|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5875731|NCT04912505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5875732|NCT04912505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5875733|NCT04912505|Antipyretics|antipyretics|mesh-ancestor
5875734|NCT04908956|Osimertinib|osimertinib|mesh-list
5875735|NCT04908956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5875736|NCT04908956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5875737|NCT04908956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5875738|NCT04908956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875739|NCT04895488|Vortioxetine|vortioxetine|mesh-list
5875740|NCT04895488|Antipsychotic Agents|antipsychotic agents|mesh-list
5875741|NCT04895488|Antidepressive Agents|antidepressive agents|mesh-ancestor
5875742|NCT04895488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5875743|NCT04895488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5875744|NCT04895488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5875745|NCT04895488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5875746|NCT04895488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875747|NCT04895488|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5875748|NCT04895488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5875749|NCT04895488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5875750|NCT04895488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875751|NCT04895488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5684671|NCT03467178|Immunologic Factors|immunologic factors|mesh-ancestor
5684672|NCT03467178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684673|NCT03467178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5684674|NCT03467178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5684675|NCT03467178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5684676|NCT03467022|Ascorbic Acid|ascorbic acid|mesh-list
5684677|NCT03467022|Vitamins|vitamins|mesh-ancestor
5684678|NCT03467022|Micronutrients|micronutrients|mesh-ancestor
5684679|NCT03467022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875752|NCT04895488|Serotonin Agents|serotonin agents|mesh-ancestor
5875753|NCT04895488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5875754|NCT04895488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5875755|NCT04895488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5875756|NCT04895488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5875757|NCT04830735|Dasatinib|dasatinib|mesh-list
5875758|NCT04830735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5875759|NCT04830735|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5875760|NCT04830735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5875761|NCT04830735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875762|NCT04800692|Verapamil|verapamil|mesh-list
5875763|NCT04800692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5684680|NCT03467022|Antioxidants|antioxidants|mesh-ancestor
5684681|NCT03467022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684682|NCT03467022|Protective Agents|protective agents|mesh-ancestor
5684683|NCT03466983|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
5684684|NCT03466983|Hematinics|hematinics|mesh-ancestor
5684685|NCT03466775|Angiotensin II|angiotensin ii|mesh-list
5684686|NCT03466775|Giapreza|giapreza|mesh-list
5684687|NCT03466775|Antibodies|antibodies|mesh-list
5684688|NCT03466775|Angiotensinogen|angiotensinogen|mesh-list
5684689|NCT03466775|Immunologic Factors|immunologic factors|mesh-ancestor
5684690|NCT03466775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684691|NCT03466775|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5875764|NCT04800692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5875765|NCT04800692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5875766|NCT04800692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684692|NCT03466775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5684693|NCT03466775|Protease Inhibitors|protease inhibitors|mesh-ancestor
5684694|NCT03466775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5684695|NCT03466775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684696|NCT03466749|Paclitaxel|paclitaxel|mesh-list
5684697|NCT03466749|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5684698|NCT03466749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5684699|NCT03466749|Tubulin Modulators|tubulin modulators|mesh-ancestor
5684700|NCT03466749|Antimitotic Agents|antimitotic agents|mesh-ancestor
5684701|NCT03466749|Mitosis Modulators|mitosis modulators|mesh-ancestor
5684702|NCT03466749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684703|NCT03466736|Flutemetamol|flutemetamol|mesh-list
5684704|NCT03466736|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5684705|NCT03466736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684706|NCT03466645|Vancomycin|vancomycin|mesh-list
5875767|NCT04800692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5875768|NCT04800692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875769|NCT04800692|Vasodilator Agents|vasodilator agents|mesh-ancestor
5875770|NCT04745026|Cannabidiol|cannabidiol|mesh-list
5875771|NCT04745026|Anticonvulsants|anticonvulsants|mesh-ancestor
5684707|NCT03466645|Cefazolin|cefazolin|mesh-list
5684708|NCT03466645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5684709|NCT03466645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5684710|NCT03466632|Dexmedetomidine|dexmedetomidine|mesh-list
5684711|NCT03466632|Propofol|propofol|mesh-list
5684712|NCT03466632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5684713|NCT03466632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5684714|NCT03466632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684715|NCT03466632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5875784|NCT04700527|Butyric Acid|butyric acid|mesh-list
5875785|NCT04700527|Histamine Antagonists|histamine antagonists|mesh-ancestor
5875786|NCT04700527|Histamine Agents|histamine agents|mesh-ancestor
5875787|NCT04700527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5875788|NCT04700527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875789|NCT04700527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875790|NCT04665739|Everolimus|everolimus|mesh-list
5875791|NCT04665739|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
5875792|NCT04665739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5875793|NCT04665739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5875794|NCT04665739|Immunologic Factors|immunologic factors|mesh-ancestor
5875795|NCT04665739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875796|NCT04665739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875797|NCT04665739|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5684716|NCT03466632|Anesthetics, General|anesthetics, general|mesh-ancestor
5684717|NCT03466632|Anesthetics|anesthetics|mesh-ancestor
5684718|NCT03466632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5684719|NCT03466632|Analgesics|analgesics|mesh-ancestor
5875798|NCT04585724|Palbociclib|palbociclib|mesh-list
5875799|NCT04585724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5684720|NCT03466632|Sensory System Agents|sensory system agents|mesh-ancestor
5684721|NCT03466632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5684722|NCT03466632|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5684723|NCT03466632|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5684724|NCT03466632|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5684725|NCT03466632|Adrenergic Agents|adrenergic agents|mesh-ancestor
5684726|NCT03466632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5684727|NCT03466632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684728|NCT03466567|Cyclosporine|cyclosporine|mesh-list
5684729|NCT03466567|Probenecid|probenecid|mesh-list
5684730|NCT03466567|Cyclosporins|cyclosporins|mesh-list
5684731|NCT03466567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5875800|NCT04585724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5875801|NCT04585724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5875802|NCT04585724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875803|NCT04571697|Methotrexate|methotrexate|mesh-list
5875804|NCT04571697|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5875805|NCT04571697|Abortifacient Agents|abortifacient agents|mesh-ancestor
5875806|NCT04571697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5875807|NCT04571697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875808|NCT04571697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5875809|NCT04571697|Antimetabolites|antimetabolites|mesh-ancestor
5875810|NCT04571697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875811|NCT04571697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5875812|NCT04571697|Dermatologic Agents|dermatologic agents|mesh-ancestor
5875813|NCT04571697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5875814|NCT04571697|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5875815|NCT04571697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5875816|NCT04571697|Immunologic Factors|immunologic factors|mesh-ancestor
5875817|NCT04571697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5875818|NCT04571697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5875819|NCT04531982|Pimavanserin|pimavanserin|mesh-list
5875820|NCT04531982|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5875821|NCT04531982|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5875822|NCT04531982|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5875823|NCT04531982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5875824|NCT04531982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5875825|NCT04531982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875826|NCT04531982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5875827|NCT04531982|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5875828|NCT04531982|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5875829|NCT04531982|Serotonin Agents|serotonin agents|mesh-ancestor
5875830|NCT04531982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5875831|NCT04531982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875832|NCT04455100|Itraconazole|itraconazole|mesh-list
5875833|NCT04455100|Antifungal Agents|antifungal agents|mesh-ancestor
5875834|NCT04455100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5875835|NCT04455100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5875836|NCT04455100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5875837|NCT04455100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5875838|NCT04455100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875839|NCT04455100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5875840|NCT04455100|Hormone Antagonists|hormone antagonists|mesh-ancestor
5875841|NCT04455100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5875842|NCT04455100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875843|NCT04455100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5875844|NCT04439578|Rifampin|rifampin|mesh-list
6495768|NCT00625014|Haloperidol|haloperidol|mesh-list
5684732|NCT03466567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684733|NCT03466567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5684734|NCT03466567|Immunologic Factors|immunologic factors|mesh-ancestor
5684735|NCT03466567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684736|NCT03466567|Antifungal Agents|antifungal agents|mesh-ancestor
5684737|NCT03466567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5684738|NCT03466567|Dermatologic Agents|dermatologic agents|mesh-ancestor
5684739|NCT03466567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5684740|NCT03466567|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5684741|NCT03466567|Uricosuric Agents|uricosuric agents|mesh-ancestor
5684742|NCT03466567|Gout Suppressants|gout suppressants|mesh-ancestor
5684743|NCT03466567|Renal Agents|renal agents|mesh-ancestor
5684744|NCT03466528|Thiamine|thiamine|mesh-list
5684745|NCT03466528|Vitamin B Complex|vitamin b complex|mesh-list
5684746|NCT03466528|Magnesium Sulfate|magnesium sulfate|mesh-list
5684747|NCT03466528|Vitamins|vitamins|mesh-ancestor
5684748|NCT03466528|Micronutrients|micronutrients|mesh-ancestor
5684749|NCT03466528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684750|NCT03466528|Analgesics|analgesics|mesh-ancestor
5684751|NCT03466528|Sensory System Agents|sensory system agents|mesh-ancestor
5684752|NCT03466528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5684753|NCT03466528|Anesthetics|anesthetics|mesh-ancestor
5684754|NCT03466528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5684755|NCT03466528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5684756|NCT03466528|Anticonvulsants|anticonvulsants|mesh-ancestor
5684757|NCT03466528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5875845|NCT04439578|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5875846|NCT04439578|Antitubercular Agents|antitubercular agents|mesh-ancestor
5875847|NCT04439578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5875848|NCT04439578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5875849|NCT04439578|Leprostatic Agents|leprostatic agents|mesh-ancestor
5875850|NCT04439578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5875851|NCT04439578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5875852|NCT04439578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875853|NCT04439578|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5875854|NCT04439578|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5875855|NCT04439578|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5875856|NCT04439578|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5875857|NCT04439578|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5875858|NCT04439578|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5875859|NCT04423601|Itraconazole|itraconazole|mesh-list
5875860|NCT04423601|Antifungal Agents|antifungal agents|mesh-ancestor
5875861|NCT04423601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5875862|NCT04423601|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5875863|NCT04423601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5875864|NCT04423601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5684758|NCT03466528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5684759|NCT03466528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684760|NCT03466528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5684761|NCT03466528|Tocolytic Agents|tocolytic agents|mesh-ancestor
5684762|NCT03466528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5684763|NCT03466502|Vancomycin|vancomycin|mesh-list
5684764|NCT03466502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5684765|NCT03466502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5684766|NCT03466437|Methamphetamine|methamphetamine|mesh-list
5684767|NCT03466437|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5875865|NCT04423601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875866|NCT04423601|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5875867|NCT04423601|Hormone Antagonists|hormone antagonists|mesh-ancestor
5875868|NCT04423601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5875869|NCT04423601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875870|NCT04423601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5875871|NCT04387071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5875872|NCT04387071|Antibodies|antibodies|mesh-list
5875873|NCT04387071|Immunoglobulins|immunoglobulins|mesh-list
5875874|NCT04387071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5875875|NCT04387071|Immunologic Factors|immunologic factors|mesh-ancestor
5875876|NCT04387071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875877|NCT04387071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5875878|NCT04357457|Almitrine|almitrine|mesh-list
5875879|NCT04357457|Respiratory System Agents|respiratory system agents|mesh-ancestor
5875880|NCT04355858|Paclitaxel|paclitaxel|mesh-list
5875881|NCT04355858|Capecitabine|capecitabine|mesh-list
5875882|NCT04355858|Everolimus|everolimus|mesh-list
5875883|NCT04355858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5684768|NCT03466437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684769|NCT03466437|Sympathomimetics|sympathomimetics|mesh-ancestor
5684770|NCT03466437|Autonomic Agents|autonomic agents|mesh-ancestor
5684771|NCT03466437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5684772|NCT03466437|Dopamine Agents|dopamine agents|mesh-ancestor
5684773|NCT03466437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5684774|NCT03466437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684775|NCT03466437|Adrenergic Agents|adrenergic agents|mesh-ancestor
5684776|NCT03466437|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5684777|NCT03466437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5684778|NCT03466437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5684779|NCT03466437|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5684780|NCT03466359|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
5684781|NCT03466359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5684782|NCT03466359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875884|NCT04355858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5875885|NCT04355858|Tubulin Modulators|tubulin modulators|mesh-ancestor
5875886|NCT04355858|Antimitotic Agents|antimitotic agents|mesh-ancestor
5875887|NCT04355858|Mitosis Modulators|mitosis modulators|mesh-ancestor
5875888|NCT04355858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875889|NCT04355858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5875890|NCT04355858|Antimetabolites|antimetabolites|mesh-ancestor
5875891|NCT04355858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5875892|NCT04355858|Immunologic Factors|immunologic factors|mesh-ancestor
5875893|NCT04355858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875894|NCT04315701|Cemiplimab|cemiplimab|mesh-list
5875895|NCT04315701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5875896|NCT04315701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5905857|NCT04556357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5905858|NCT04556357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905859|NCT04556357|Sympathomimetics|sympathomimetics|mesh-ancestor
5905860|NCT04556357|Nasal Decongestants|nasal decongestants|mesh-ancestor
5905861|NCT04556357|Respiratory System Agents|respiratory system agents|mesh-ancestor
5905862|NCT04556357|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5905863|NCT04556357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5905864|NCT04556357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5905865|NCT04556357|Adrenergic Agents|adrenergic agents|mesh-ancestor
5905866|NCT04556357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5905867|NCT04556357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905868|NCT04556357|Protective Agents|protective agents|mesh-ancestor
5905869|NCT04553939|Gemcitabine|gemcitabine|mesh-list
5905870|NCT04553939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5905871|NCT04553939|Antimetabolites|antimetabolites|mesh-ancestor
5905872|NCT04553939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905873|NCT04553939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5905874|NCT04553939|Antiviral Agents|antiviral agents|mesh-ancestor
5905875|NCT04553939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5905876|NCT04553939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5905877|NCT04553939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5905878|NCT04553939|Immunologic Factors|immunologic factors|mesh-ancestor
5905879|NCT04553939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5908606|NCT04424862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5908607|NCT04424862|Glucocorticoids|glucocorticoids|mesh-ancestor
5908608|NCT04424862|Hormones|hormones|mesh-ancestor
5908609|NCT04424862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5908610|NCT04424862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684783|NCT03466333|Enalapril|enalapril|mesh-list
5684784|NCT03466333|Enalaprilat|enalaprilat|mesh-list
5684785|NCT03466333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5684786|NCT03466333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684787|NCT03466333|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5684788|NCT03466333|Protease Inhibitors|protease inhibitors|mesh-ancestor
5684789|NCT03466333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5684790|NCT03466320|Cyclophosphamide|cyclophosphamide|mesh-list
5684791|NCT03466320|Fludarabine|fludarabine|mesh-list
5908611|NCT04424862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5908612|NCT04424862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5908613|NCT04424862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5908614|NCT04424862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908615|NCT04424862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5908616|NCT04424862|Immunologic Factors|immunologic factors|mesh-ancestor
5908617|NCT04424862|Antifungal Agents|antifungal agents|mesh-ancestor
5908618|NCT04424862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5908619|NCT04424862|Dermatologic Agents|dermatologic agents|mesh-ancestor
5908620|NCT04424862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5908621|NCT04424862|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5908622|NCT04424862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5908623|NCT04424862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5908624|NCT04424862|Antitubercular Agents|antitubercular agents|mesh-ancestor
5908625|NCT04424862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5908626|NCT04404140|Docetaxel|docetaxel|mesh-list
5908627|NCT04404140|Atezolizumab|atezolizumab|mesh-list
5908628|NCT04404140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5908629|NCT04404140|Tubulin Modulators|tubulin modulators|mesh-ancestor
5908630|NCT04404140|Antimitotic Agents|antimitotic agents|mesh-ancestor
5908631|NCT04404140|Mitosis Modulators|mitosis modulators|mesh-ancestor
5908632|NCT04404140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908633|NCT04382898|Cemiplimab|cemiplimab|mesh-list
5908634|NCT04382898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5908635|NCT04382898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5908636|NCT04372108|Ustekinumab|ustekinumab|mesh-list
5908637|NCT04372108|Dermatologic Agents|dermatologic agents|mesh-ancestor
5908638|NCT04338269|Atezolizumab|atezolizumab|mesh-list
5908639|NCT04338269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5908640|NCT04334759|Cisplatin|cisplatin|mesh-list
5684792|NCT03466320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5684793|NCT03466320|Immunologic Factors|immunologic factors|mesh-ancestor
5684794|NCT03466320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684795|NCT03466320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5684796|NCT03466320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5684797|NCT03466320|Alkylating Agents|alkylating agents|mesh-ancestor
5684798|NCT03466320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684799|NCT03466320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5684800|NCT03466320|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5684801|NCT03466242|Dexmedetomidine|dexmedetomidine|mesh-list
5684802|NCT03466242|Ketamine|ketamine|mesh-list
5684803|NCT03466242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5684804|NCT03466242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5684805|NCT03466242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684806|NCT03466242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5684807|NCT03466242|Analgesics|analgesics|mesh-ancestor
5684808|NCT03466242|Sensory System Agents|sensory system agents|mesh-ancestor
5684809|NCT03466242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5684810|NCT03466242|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5684811|NCT03466242|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5684812|NCT03466242|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5684813|NCT03466242|Adrenergic Agents|adrenergic agents|mesh-ancestor
5684814|NCT03466242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5684815|NCT03466242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684816|NCT03466242|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5684817|NCT03466242|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5684818|NCT03466242|Anesthetics, General|anesthetics, general|mesh-ancestor
5684819|NCT03466242|Anesthetics|anesthetics|mesh-ancestor
5684820|NCT03466242|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5684821|NCT03466242|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5684822|NCT03466216|Octreotide|octreotide|mesh-list
5684823|NCT03466216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5684824|NCT03466216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5684825|NCT03466216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5697190|NCT03377543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5697191|NCT03377543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697192|NCT03377543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5697193|NCT03377543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5697194|NCT03377543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5697195|NCT03377543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697196|NCT03377543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5697197|NCT03377543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5697198|NCT03377543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5697199|NCT03377543|Antipyretics|antipyretics|mesh-ancestor
5697200|NCT03377478|Sofosbuvir|sofosbuvir|mesh-list
5697201|NCT03377478|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
5697202|NCT03377478|Velpatasvir|velpatasvir|mesh-list
5697203|NCT03377478|Antiviral Agents|antiviral agents|mesh-ancestor
5697204|NCT03377478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5697205|NCT03377465|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
5697206|NCT03377465|N,N-dimethylarginine|n,n-dimethylarginine|mesh-list
5697207|NCT03377465|Natriuretic Agents|natriuretic agents|mesh-ancestor
5697208|NCT03377465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697209|NCT03377465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5697210|NCT03377465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697211|NCT03377400|Cisplatin|cisplatin|mesh-list
5697212|NCT03377400|Durvalumab|durvalumab|mesh-list
5697213|NCT03377400|Tremelimumab|tremelimumab|mesh-list
5697214|NCT03377400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5697215|NCT03377400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5697216|NCT03377387|Capecitabine|capecitabine|mesh-list
5875897|NCT04249076|Clobetasol|clobetasol|mesh-list
5875898|NCT04249076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5875899|NCT04249076|Glucocorticoids|glucocorticoids|mesh-ancestor
5875900|NCT04249076|Hormones|hormones|mesh-ancestor
5875901|NCT04249076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5875902|NCT04249076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875903|NCT04246801|Clobetasol|clobetasol|mesh-list
5875904|NCT04246801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5875905|NCT04246801|Glucocorticoids|glucocorticoids|mesh-ancestor
5875906|NCT04246801|Hormones|hormones|mesh-ancestor
5875907|NCT04246801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5875908|NCT04246801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875909|NCT04173533|Azacitidine|azacitidine|mesh-list
5875910|NCT04173533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5697217|NCT03377387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5684826|NCT03466021|Liraglutide|liraglutide|mesh-list
5684827|NCT03466021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5684828|NCT03466021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684829|NCT03466021|Incretins|incretins|mesh-ancestor
5684830|NCT03466021|Hormones|hormones|mesh-ancestor
5684831|NCT03466021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5684832|NCT03465969|Tacrolimus|tacrolimus|mesh-list
5875911|NCT04173533|Antimetabolites|antimetabolites|mesh-ancestor
5875912|NCT04173533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875913|NCT04173533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5875914|NCT04173533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5875915|NCT04167033|Hormones|hormones|mesh-list
5875916|NCT04167033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5875917|NCT04167033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875918|NCT04023604|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5875919|NCT04023604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5875920|NCT03971929|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5875921|NCT03971929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5875922|NCT03971929|Diuretics|diuretics|mesh-ancestor
5875923|NCT03971929|Natriuretic Agents|natriuretic agents|mesh-ancestor
5875924|NCT03971929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875925|NCT03971929|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5875926|NCT03971929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5875927|NCT03971929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875928|NCT03971084|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
5875929|NCT03971084|Caseins|caseins|mesh-list
5875930|NCT03971084|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5875931|NCT03971084|Serotonin Agents|serotonin agents|mesh-ancestor
5875932|NCT03971084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5875933|NCT03971084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875934|NCT03971084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875935|NCT03971084|Chelating Agents|chelating agents|mesh-ancestor
5875936|NCT03971084|Sequestering Agents|sequestering agents|mesh-ancestor
5875937|NCT03941743|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
5875938|NCT03941743|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5875939|NCT03941743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875940|NCT03941743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5875941|NCT03941743|Immunologic Factors|immunologic factors|mesh-ancestor
5875942|NCT03941743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875943|NCT03916263|Metformin|metformin|mesh-list
5875944|NCT03916263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5875945|NCT03916263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875946|NCT03848754|Gemtuzumab|gemtuzumab|mesh-list
5875947|NCT03848754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5875948|NCT03848754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5875949|NCT03832647|Salicylic Acid|salicylic acid|mesh-list
5875950|NCT03832647|Salicylates|salicylates|mesh-list
5875951|NCT03832647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5875952|NCT03832647|Antifungal Agents|antifungal agents|mesh-ancestor
5875953|NCT03832647|Keratolytic Agents|keratolytic agents|mesh-ancestor
5875954|NCT03832647|Dermatologic Agents|dermatologic agents|mesh-ancestor
5875955|NCT03832647|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5684833|NCT03465969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5684834|NCT03465969|Immunologic Factors|immunologic factors|mesh-ancestor
5684835|NCT03465969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684836|NCT03465969|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5684837|NCT03465969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5684838|NCT03465969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684839|NCT03465787|Quetiapine Fumarate|quetiapine fumarate|mesh-list
5684840|NCT03465787|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
5684841|NCT03465787|Antidepressive Agents|antidepressive agents|mesh-ancestor
5684842|NCT03465787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5684843|NCT03465787|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5684844|NCT03465787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5684845|NCT03465787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5684846|NCT03465787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684847|NCT03465787|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5684848|NCT03465787|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5684849|NCT03465787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5684850|NCT03465787|Adrenergic Agents|adrenergic agents|mesh-ancestor
5684851|NCT03465787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5684852|NCT03465787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875956|NCT03832647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5875957|NCT03832647|Analgesics|analgesics|mesh-ancestor
5875958|NCT03832647|Sensory System Agents|sensory system agents|mesh-ancestor
5875959|NCT03832647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5875960|NCT03832647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875961|NCT03832647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5875962|NCT03832647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5875963|NCT03832647|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5875964|NCT03832647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5875965|NCT03832647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875966|NCT03778671|Fentanyl|fentanyl|mesh-list
5875967|NCT03778671|Dexmedetomidine|dexmedetomidine|mesh-list
5875968|NCT03778671|Levobupivacaine|levobupivacaine|mesh-list
5875969|NCT03778671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5875970|NCT03778671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5875971|NCT03778671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875972|NCT03778671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5875973|NCT03778671|Analgesics|analgesics|mesh-ancestor
5875974|NCT03778671|Sensory System Agents|sensory system agents|mesh-ancestor
5875975|NCT03778671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5875976|NCT03778671|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5875977|NCT03778671|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5875978|NCT03778671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5875979|NCT03778671|Adrenergic Agents|adrenergic agents|mesh-ancestor
5875980|NCT03778671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5875981|NCT03778671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5875982|NCT03778671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5875983|NCT03778671|Narcotics|narcotics|mesh-ancestor
5875984|NCT03778671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5875985|NCT03778671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5875986|NCT03778671|Anesthetics, General|anesthetics, general|mesh-ancestor
5875987|NCT03778671|Anesthetics|anesthetics|mesh-ancestor
5875988|NCT03778671|Anesthetics, Local|anesthetics, local|mesh-ancestor
5875989|NCT03698162|Bevacizumab|bevacizumab|mesh-list
5875990|NCT03698162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5875991|NCT03698162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5875992|NCT03698162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5875993|NCT03698162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5875994|NCT03698162|Growth Substances|growth substances|mesh-ancestor
5875995|NCT03698162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5875996|NCT03698162|Growth Inhibitors|growth inhibitors|mesh-ancestor
5875997|NCT03692715|Ciprofloxacin|ciprofloxacin|mesh-list
5875998|NCT03692715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5875999|NCT03692715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5876000|NCT03692715|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5876001|NCT03692715|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5876002|NCT03692715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5876003|NCT03692715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876004|NCT03692715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5876005|NCT03692715|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5876006|NCT03692715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5876007|NCT03644186|Paclitaxel|paclitaxel|mesh-list
5876008|NCT03644186|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5876009|NCT03644186|Trastuzumab|trastuzumab|mesh-list
5876010|NCT03644186|Letrozole|letrozole|mesh-list
5876011|NCT03644186|Palbociclib|palbociclib|mesh-list
5876012|NCT03644186|Pertuzumab|pertuzumab|mesh-list
5876013|NCT03644186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5876014|NCT03644186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5876015|NCT03644186|Tubulin Modulators|tubulin modulators|mesh-ancestor
5876016|NCT03644186|Antimitotic Agents|antimitotic agents|mesh-ancestor
5876017|NCT03644186|Mitosis Modulators|mitosis modulators|mesh-ancestor
5876018|NCT03644186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876019|NCT03644186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5876020|NCT03644186|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5876021|NCT03644186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5876022|NCT03644186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5876023|NCT03644186|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5876024|NCT03644186|Hormone Antagonists|hormone antagonists|mesh-ancestor
5876025|NCT03644186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5876026|NCT03644186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876027|NCT03644186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5876028|NCT03563066|Benralizumab|benralizumab|mesh-list
5876029|NCT03563066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5905880|NCT04547946|Trametinib|trametinib|mesh-list
5684853|NCT03465787|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5684854|NCT03465787|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5684855|NCT03465787|Serotonin Agents|serotonin agents|mesh-ancestor
5684856|NCT03465787|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5684857|NCT03465787|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5684858|NCT03465787|Dopamine Agents|dopamine agents|mesh-ancestor
5684859|NCT03465774|Doxycycline|doxycycline|mesh-list
5684860|NCT03465774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5876030|NCT03563066|Respiratory System Agents|respiratory system agents|mesh-ancestor
5876031|NCT03558789|Lactoferrin|lactoferrin|mesh-list
5876032|NCT03558789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5876033|NCT03495921|Irinotecan|irinotecan|mesh-list
5876034|NCT03495921|Camptothecin|camptothecin|mesh-list
5876035|NCT03495921|Temozolomide|temozolomide|mesh-list
5876036|NCT03495921|Immunologic Factors|immunologic factors|mesh-list
5876037|NCT03495921|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5684861|NCT03465774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5684862|NCT03465774|Antimalarials|antimalarials|mesh-ancestor
5684863|NCT03465774|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5684864|NCT03465774|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5684865|NCT03465592|Nivolumab|nivolumab|mesh-list
5684866|NCT03465592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5684867|NCT03465592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5684868|NCT03465592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5684869|NCT03465592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684870|NCT03465579|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5684871|NCT03465579|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5684872|NCT03465579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684873|NCT03465527|Prednisolone|prednisolone|mesh-list
5684874|NCT03465527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5876038|NCT03495921|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5876039|NCT03495921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5876040|NCT03495921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876041|NCT03495921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5876042|NCT03495921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5876043|NCT03495921|Alkylating Agents|alkylating agents|mesh-ancestor
5876044|NCT03495921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876045|NCT03495921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5876046|NCT03414983|Leucovorin|leucovorin|mesh-list
5876047|NCT03414983|Bevacizumab|bevacizumab|mesh-list
5876048|NCT03414983|Nivolumab|nivolumab|mesh-list
5876049|NCT03414983|Fluorouracil|fluorouracil|mesh-list
5876050|NCT03414983|Oxaliplatin|oxaliplatin|mesh-list
5876051|NCT03414983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5876052|NCT03414983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5876053|NCT03414983|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5876054|NCT03414983|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5876055|NCT03414983|Growth Substances|growth substances|mesh-ancestor
5876056|NCT03414983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876057|NCT03414983|Growth Inhibitors|growth inhibitors|mesh-ancestor
5876058|NCT03414983|Antimetabolites|antimetabolites|mesh-ancestor
5876059|NCT03414983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876060|NCT03414983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5876061|NCT03414983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5876062|NCT03414983|Immunologic Factors|immunologic factors|mesh-ancestor
5876063|NCT03414983|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5684875|NCT03465527|Glucocorticoids|glucocorticoids|mesh-ancestor
5684876|NCT03465527|Hormones|hormones|mesh-ancestor
5684877|NCT03465527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5684878|NCT03465527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684879|NCT03465527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5684880|NCT03465527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5876064|NCT03414983|Antidotes|antidotes|mesh-ancestor
5684881|NCT03465488|Albendazole|albendazole|mesh-list
5684882|NCT03465488|Anthelmintics|anthelmintics|mesh-ancestor
5684883|NCT03465488|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5684884|NCT03465488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5684885|NCT03465488|Anticestodal Agents|anticestodal agents|mesh-ancestor
5684886|NCT03465488|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5684887|NCT03465488|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5684888|NCT03465488|Tubulin Modulators|tubulin modulators|mesh-ancestor
5684889|NCT03465488|Antimitotic Agents|antimitotic agents|mesh-ancestor
5684890|NCT03465488|Mitosis Modulators|mitosis modulators|mesh-ancestor
5684891|NCT03465488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876065|NCT03414983|Protective Agents|protective agents|mesh-ancestor
5876066|NCT03414983|Vitamin B Complex|vitamin b complex|mesh-ancestor
5876067|NCT03414983|Vitamins|vitamins|mesh-ancestor
5876068|NCT03414983|Micronutrients|micronutrients|mesh-ancestor
5876069|NCT03383458|Nivolumab|nivolumab|mesh-list
5876070|NCT03383458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5876071|NCT03383458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5876072|NCT03383458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5876073|NCT03383458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876074|NCT03330821|Cytarabine|cytarabine|mesh-list
5876075|NCT03330821|Idarubicin|idarubicin|mesh-list
5876076|NCT03330821|Enzyme Inhibitors|enzyme inhibitors|mesh-list
5876077|NCT03330821|Pevonedistat|pevonedistat|mesh-list
5876078|NCT03330821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5876079|NCT03330821|Antimetabolites|antimetabolites|mesh-ancestor
5876080|NCT03330821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876081|NCT03330821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5876082|NCT03330821|Antiviral Agents|antiviral agents|mesh-ancestor
5876083|NCT03330821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5876084|NCT03330821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5876085|NCT03330821|Immunologic Factors|immunologic factors|mesh-ancestor
5876086|NCT03330821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876087|NCT03330821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5876088|NCT03330821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5876089|NCT03330821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5876090|NCT03322280|Chlorotrianisene|chlorotrianisene|mesh-list
5876091|NCT03322280|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
5684892|NCT03465488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5684893|NCT03465423|Propofol|propofol|mesh-list
5684894|NCT03465423|Anesthetics|anesthetics|mesh-ancestor
5684895|NCT03465423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5684896|NCT03465423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684897|NCT03465423|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5684898|NCT03465423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5684899|NCT03465423|Anesthetics, General|anesthetics, general|mesh-ancestor
5684900|NCT03465410|Tacrolimus|tacrolimus|mesh-list
5684901|NCT03465410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5684902|NCT03465410|Immunologic Factors|immunologic factors|mesh-ancestor
5684903|NCT03465410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684904|NCT03465410|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5684905|NCT03465410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5684906|NCT03465410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684907|NCT03465397|Immunosuppressive Agents|immunosuppressive agents|mesh-list
5684908|NCT03465397|Immunologic Factors|immunologic factors|mesh-ancestor
5684909|NCT03465397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684910|NCT03465345|Metformin|metformin|mesh-list
5684911|NCT03465345|Proanthocyanidin|proanthocyanidin|mesh-list
5684912|NCT03465345|Procyanidin|procyanidin|mesh-list
5684913|NCT03465345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5684914|NCT03465345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684915|NCT03465345|Antioxidants|antioxidants|mesh-ancestor
5684916|NCT03465345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684917|NCT03465345|Protective Agents|protective agents|mesh-ancestor
5684918|NCT03465345|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5684919|NCT03465345|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5684920|NCT03465345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5684921|NCT03465202|Capecitabine|capecitabine|mesh-list
5684922|NCT03465202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5684923|NCT03465202|Antimetabolites|antimetabolites|mesh-ancestor
5684924|NCT03465202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684925|NCT03465202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5684926|NCT03465098|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5684927|NCT03465098|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5684928|NCT03465098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684929|NCT03465085|Heparin|heparin|mesh-list
5684930|NCT03465085|Calcium heparin|calcium heparin|mesh-list
5684931|NCT03465085|Streptokinase|streptokinase|mesh-list
5684932|NCT03465085|Anticoagulants|anticoagulants|mesh-ancestor
5684933|NCT03465085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5684934|NCT03465085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5684935|NCT03465085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876092|NCT03322280|Estrogens|estrogens|mesh-ancestor
5876093|NCT03322280|Hormones|hormones|mesh-ancestor
5876094|NCT03322280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5876095|NCT03322280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876096|NCT03322280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5684936|NCT03465059|Zanubrutinib|zanubrutinib|mesh-list
5684937|NCT03465059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5876097|NCT03322280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5876098|NCT03317223|Amoxicillin|amoxicillin|mesh-list
5876099|NCT03317223|Clarithromycin|clarithromycin|mesh-list
5876100|NCT03317223|Lansoprazole|lansoprazole|mesh-list
5876101|NCT03317223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5876102|NCT03317223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5876103|NCT03317223|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5876104|NCT03317223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5876105|NCT03317223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876106|NCT03317223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5876107|NCT03317223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5876108|NCT03317223|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5876109|NCT03317223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5876110|NCT03317223|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5876111|NCT03304821|Sargramostim|sargramostim|mesh-list
5876112|NCT03304821|Immunologic Factors|immunologic factors|mesh-ancestor
5876113|NCT03304821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684938|NCT03465059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5684939|NCT03465059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5684940|NCT03465059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684941|NCT03465007|Hydrocortisone|hydrocortisone|mesh-list
5684942|NCT03465007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5684943|NCT03464968|Leucovorin|leucovorin|mesh-list
5684944|NCT03464968|Oxaliplatin|oxaliplatin|mesh-list
5876114|NCT03154749|Cyclophosphamide|cyclophosphamide|mesh-list
5876115|NCT03154749|Carboplatin|carboplatin|mesh-list
5876116|NCT03154749|Docetaxel|docetaxel|mesh-list
5876117|NCT03154749|Epirubicin|epirubicin|mesh-list
5876118|NCT03154749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5876119|NCT03154749|Immunologic Factors|immunologic factors|mesh-ancestor
5876120|NCT03154749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876121|NCT03154749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5876122|NCT03154749|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5876123|NCT03154749|Alkylating Agents|alkylating agents|mesh-ancestor
5876124|NCT03154749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876125|NCT03154749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5876126|NCT03154749|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5876127|NCT03154749|Tubulin Modulators|tubulin modulators|mesh-ancestor
5876128|NCT03154749|Antimitotic Agents|antimitotic agents|mesh-ancestor
5876129|NCT03154749|Mitosis Modulators|mitosis modulators|mesh-ancestor
5876130|NCT03154749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5876131|NCT03154749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5876132|NCT03154749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5876133|NCT03154749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5876134|NCT03136731|Antibodies|antibodies|mesh-list
5876135|NCT03136731|Immunologic Factors|immunologic factors|mesh-ancestor
5876136|NCT03136731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876137|NCT02983006|Nivolumab|nivolumab|mesh-list
5876138|NCT02983006|DS-8273a|ds-8273a|mesh-list
5876139|NCT02983006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5876140|NCT02983006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5876141|NCT02983006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5876142|NCT02983006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876143|NCT02936687|Ambrisentan|ambrisentan|mesh-list
5876144|NCT02936687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5876145|NCT02787590|Simvastatin|simvastatin|mesh-list
5876146|NCT02787590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5876147|NCT02787590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5876148|NCT02787590|Antimetabolites|antimetabolites|mesh-ancestor
5876149|NCT02787590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876150|NCT02787590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5876151|NCT02787590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5876152|NCT02787590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5876153|NCT02768701|Cyclophosphamide|cyclophosphamide|mesh-list
5876154|NCT02768701|Pembrolizumab|pembrolizumab|mesh-list
5876155|NCT02768701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5876156|NCT02768701|Immunologic Factors|immunologic factors|mesh-ancestor
5876157|NCT02768701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876158|NCT02768701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5876159|NCT02768701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5876160|NCT02768701|Alkylating Agents|alkylating agents|mesh-ancestor
5876161|NCT02768701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876162|NCT02768701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5876163|NCT02768701|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5684945|NCT03464968|Irinotecan|irinotecan|mesh-list
5684946|NCT03464968|Fluorouracil|fluorouracil|mesh-list
5876164|NCT02768701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5905881|NCT04547946|Dabrafenib|dabrafenib|mesh-list
5905882|NCT04547946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5905883|NCT04547946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5905884|NCT04547946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5905885|NCT04547946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905886|NCT04515901|Lidocaine|lidocaine|mesh-list
5905887|NCT04515901|Anesthetics, Local|anesthetics, local|mesh-ancestor
5905888|NCT04515901|Anesthetics|anesthetics|mesh-ancestor
5905889|NCT04515901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5905890|NCT04515901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905891|NCT04515901|Sensory System Agents|sensory system agents|mesh-ancestor
5905892|NCT04515901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5905893|NCT04515901|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5905894|NCT04515901|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5905895|NCT04515901|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5905896|NCT04515901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5905897|NCT04515901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905898|NCT04501939|Venetoclax|venetoclax|mesh-list
5905899|NCT04501939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5905900|NCT04468425|Tofacitinib|tofacitinib|mesh-list
5684947|NCT03464968|Levoleucovorin|levoleucovorin|mesh-list
5684948|NCT03464968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5905901|NCT04468425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905902|NCT04468425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5905903|NCT04468425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5905904|NCT04434326|Vorolanib|vorolanib|mesh-list
5905905|NCT04434326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5905906|NCT04434326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5905907|NCT04434326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905908|NCT04426968|Interferons|interferons|mesh-list
5905909|NCT04426968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5905910|NCT04426968|Antiviral Agents|antiviral agents|mesh-ancestor
5905911|NCT04426968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5905912|NCT04400695|Paclitaxel|paclitaxel|mesh-list
5905913|NCT04400695|Vinorelbine|vinorelbine|mesh-list
5905914|NCT04400695|Docetaxel|docetaxel|mesh-list
5905915|NCT04400695|Capecitabine|capecitabine|mesh-list
5905916|NCT04400695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5905917|NCT04400695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5905918|NCT04400695|Tubulin Modulators|tubulin modulators|mesh-ancestor
5905919|NCT04400695|Antimitotic Agents|antimitotic agents|mesh-ancestor
5905920|NCT04400695|Mitosis Modulators|mitosis modulators|mesh-ancestor
5905921|NCT04400695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905922|NCT04400695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5905923|NCT04400695|Antimetabolites|antimetabolites|mesh-ancestor
5905924|NCT04359329|Estradiol|estradiol|mesh-list
5905925|NCT04359329|Estrogens|estrogens|mesh-ancestor
5905926|NCT04359329|Hormones|hormones|mesh-ancestor
5905927|NCT04359329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5905928|NCT04359329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905929|NCT04328506|Vorolanib|vorolanib|mesh-list
5905930|NCT04328506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5905931|NCT04328506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5905932|NCT04328506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905933|NCT04303689|Colchicine|colchicine|mesh-list
5905934|NCT04303689|Gout Suppressants|gout suppressants|mesh-ancestor
5905935|NCT04303689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5905936|NCT04303689|Tubulin Modulators|tubulin modulators|mesh-ancestor
5905937|NCT04303689|Antimitotic Agents|antimitotic agents|mesh-ancestor
5905938|NCT04303689|Mitosis Modulators|mitosis modulators|mesh-ancestor
5905939|NCT04303689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905940|NCT04303689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5905941|NCT04287855|Dexamethasone|dexamethasone|mesh-list
5905942|NCT04287855|Pomalidomide|pomalidomide|mesh-list
5905943|NCT04287855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5905944|NCT04287855|Antiemetics|antiemetics|mesh-ancestor
5905945|NCT04287855|Autonomic Agents|autonomic agents|mesh-ancestor
5905946|NCT04287855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5908641|NCT04334759|Carboplatin|carboplatin|mesh-list
5684949|NCT03464968|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5684950|NCT03464968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5684951|NCT03464968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5684952|NCT03464968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684953|NCT03464968|Antidotes|antidotes|mesh-ancestor
5684954|NCT03464968|Protective Agents|protective agents|mesh-ancestor
5876165|NCT02734004|Bevacizumab|bevacizumab|mesh-list
5876166|NCT02734004|Durvalumab|durvalumab|mesh-list
5876167|NCT02734004|Olaparib|olaparib|mesh-list
5876168|NCT02734004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5876169|NCT02734004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5876170|NCT02734004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5876171|NCT02734004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5876172|NCT02734004|Growth Substances|growth substances|mesh-ancestor
5876173|NCT02734004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876174|NCT02734004|Growth Inhibitors|growth inhibitors|mesh-ancestor
5876175|NCT02734004|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5684955|NCT03464968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684956|NCT03464968|Vitamin B Complex|vitamin b complex|mesh-ancestor
5684957|NCT03464968|Vitamins|vitamins|mesh-ancestor
5876176|NCT02734004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5876177|NCT02734004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876178|NCT02659813|Copper|copper|mesh-list
5876179|NCT02659813|Nickel|nickel|mesh-list
5876180|NCT02659813|Trace Elements|trace elements|mesh-ancestor
5876181|NCT02659813|Micronutrients|micronutrients|mesh-ancestor
5876182|NCT02659813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876183|NCT02658890|Nivolumab|nivolumab|mesh-list
5876184|NCT02658890|Ipilimumab|ipilimumab|mesh-list
5876185|NCT02658890|Linrodostat|linrodostat|mesh-list
5876186|NCT02658890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5876187|NCT02658890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5876188|NCT02658890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5876189|NCT02658890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876190|NCT02658890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5876191|NCT02566863|Dexmedetomidine|dexmedetomidine|mesh-list
5876192|NCT02566863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5876193|NCT02566863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5876194|NCT02566863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876195|NCT02566863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5876196|NCT02566863|Analgesics|analgesics|mesh-ancestor
5876197|NCT02566863|Sensory System Agents|sensory system agents|mesh-ancestor
5876198|NCT02566863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5876199|NCT02566863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5876200|NCT02566863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5876201|NCT02566863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5876202|NCT02566863|Adrenergic Agents|adrenergic agents|mesh-ancestor
5876203|NCT02566863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5876204|NCT02566863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876205|NCT02488408|Cytarabine|cytarabine|mesh-list
5876206|NCT02488408|Decitabine|decitabine|mesh-list
5876207|NCT02488408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5876208|NCT02488408|Antimetabolites|antimetabolites|mesh-ancestor
5876209|NCT02488408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876210|NCT02488408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5684958|NCT03464968|Micronutrients|micronutrients|mesh-ancestor
5684959|NCT03464968|Antimetabolites|antimetabolites|mesh-ancestor
5684960|NCT03464968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5684961|NCT03464968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5684962|NCT03464968|Immunologic Factors|immunologic factors|mesh-ancestor
5684963|NCT03464942|Atezolizumab|atezolizumab|mesh-list
5684964|NCT03464942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5684965|NCT03464864|Treprostinil|treprostinil|mesh-list
5684966|NCT03464864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5684967|NCT03464734|Paclitaxel|paclitaxel|mesh-list
5684968|NCT03464734|Pembrolizumab|pembrolizumab|mesh-list
5684969|NCT03464734|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5684970|NCT03464734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5684971|NCT03464734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5684972|NCT03464734|Tubulin Modulators|tubulin modulators|mesh-ancestor
5684973|NCT03464734|Antimitotic Agents|antimitotic agents|mesh-ancestor
5684974|NCT03464734|Mitosis Modulators|mitosis modulators|mesh-ancestor
5684975|NCT03464734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684976|NCT03464734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5684977|NCT03464682|Atorvastatin|atorvastatin|mesh-list
5876211|NCT02488408|Antiviral Agents|antiviral agents|mesh-ancestor
5876212|NCT02488408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5876213|NCT02488408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5876214|NCT02488408|Immunologic Factors|immunologic factors|mesh-ancestor
5876215|NCT02488408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684978|NCT03464682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5684979|NCT03464682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5876216|NCT02488408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5684980|NCT03464682|Antimetabolites|antimetabolites|mesh-ancestor
5684981|NCT03464682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684982|NCT03464682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5684983|NCT03464682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5684984|NCT03464682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5684985|NCT03464656|Antioxidants|antioxidants|mesh-list
5684986|NCT03464656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876217|NCT02424617|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5876218|NCT02424617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5876219|NCT02424617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5876220|NCT02424617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5876221|NCT02424617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876222|NCT02346747|Immunologic Factors|immunologic factors|mesh-list
5876223|NCT02346747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876224|NCT05084456|Docetaxel|docetaxel|mesh-list
5876225|NCT05084456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5876226|NCT05084456|Tubulin Modulators|tubulin modulators|mesh-ancestor
5876227|NCT05084456|Antimitotic Agents|antimitotic agents|mesh-ancestor
5876228|NCT05084456|Mitosis Modulators|mitosis modulators|mesh-ancestor
5876229|NCT05084456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876230|NCT05084378|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5876231|NCT05084378|Chlorhexidine|chlorhexidine|mesh-list
5876232|NCT05084378|Povidone-Iodine|povidone-iodine|mesh-list
5876233|NCT05084378|Povidone|povidone|mesh-list
5876234|NCT05084378|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5876235|NCT05084378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5876236|NCT05084378|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5876237|NCT05084378|Disinfectants|disinfectants|mesh-ancestor
5876238|NCT05084378|Plasma Substitutes|plasma substitutes|mesh-ancestor
5876239|NCT05084378|Blood Substitutes|blood substitutes|mesh-ancestor
5876240|NCT05084365|Sulforaphane|sulforaphane|mesh-list
5876241|NCT05084365|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5876242|NCT05084365|Protective Agents|protective agents|mesh-ancestor
5876243|NCT05084365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876244|NCT05084365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5876245|NCT05084235|Empagliflozin|empagliflozin|mesh-list
5876246|NCT05084235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5876247|NCT05084235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876248|NCT05084235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5876249|NCT05084235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876250|NCT05084196|Melatonin|melatonin|mesh-list
5876251|NCT05084196|Antioxidants|antioxidants|mesh-ancestor
5876252|NCT05084196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5684987|NCT03464656|Protective Agents|protective agents|mesh-ancestor
5684988|NCT03464656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697218|NCT03377387|Antimetabolites|antimetabolites|mesh-ancestor
5697219|NCT03377387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697220|NCT03377387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5697221|NCT03377348|Triamcinolone|triamcinolone|mesh-list
5697222|NCT03377348|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5697223|NCT03377348|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5697224|NCT03377348|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5697225|NCT03377348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5697226|NCT03377348|Glucocorticoids|glucocorticoids|mesh-ancestor
5697227|NCT03377348|Hormones|hormones|mesh-ancestor
5697228|NCT03377348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5876253|NCT05084196|Protective Agents|protective agents|mesh-ancestor
5876254|NCT05084196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876255|NCT05084196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5876256|NCT05084079|Insulin|insulin|mesh-list
5876257|NCT05084079|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5876258|NCT05084079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5876259|NCT05084079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876260|NCT05084001|Listerine|listerine|mesh-list
5876261|NCT05084001|Fluorides|fluorides|mesh-list
5876262|NCT05084001|Sodium Fluoride|sodium fluoride|mesh-list
5876263|NCT05084001|Fluorides, Topical|fluorides, topical|mesh-list
5876264|NCT05084001|Cariostatic Agents|cariostatic agents|mesh-ancestor
5876265|NCT05084001|Protective Agents|protective agents|mesh-ancestor
5876266|NCT05084001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876267|NCT05084001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5876268|NCT05084001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5876269|NCT05083793|Pregabalin|pregabalin|mesh-list
5876270|NCT05083793|Analgesics|analgesics|mesh-ancestor
5876271|NCT05083793|Sensory System Agents|sensory system agents|mesh-ancestor
5684989|NCT03464552|Celecoxib|celecoxib|mesh-list
5684990|NCT03464552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5684991|NCT03464552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5684992|NCT03464552|Analgesics|analgesics|mesh-ancestor
5684993|NCT03464552|Sensory System Agents|sensory system agents|mesh-ancestor
5684994|NCT03464552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5684995|NCT03464552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5684996|NCT03464552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5684997|NCT03464552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5684998|NCT03464552|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5684999|NCT03464552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5685000|NCT03464552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5685001|NCT03464552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685002|NCT03464539|Chitosan|chitosan|mesh-list
5685003|NCT03464539|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5685004|NCT03464539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5685005|NCT03464539|Antimetabolites|antimetabolites|mesh-ancestor
5685006|NCT03464539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685007|NCT03464539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5685008|NCT03464539|Chelating Agents|chelating agents|mesh-ancestor
5685009|NCT03464539|Sequestering Agents|sequestering agents|mesh-ancestor
5685010|NCT03464539|Hemostatics|hemostatics|mesh-ancestor
5685011|NCT03464539|Coagulants|coagulants|mesh-ancestor
5685012|NCT03464461|Ketorolac|ketorolac|mesh-list
5685013|NCT03464461|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
5685014|NCT03464461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5685015|NCT03464461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5685016|NCT03464461|Analgesics|analgesics|mesh-ancestor
5685017|NCT03464461|Sensory System Agents|sensory system agents|mesh-ancestor
5685018|NCT03464461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5685019|NCT03464461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685020|NCT03464461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5685021|NCT03464461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5685022|NCT03464461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5685023|NCT03464461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5685024|NCT03464461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685025|NCT03464448|Teriflunomide|teriflunomide|mesh-list
5685026|NCT03464448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5685027|NCT03464448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5685028|NCT03464448|Analgesics|analgesics|mesh-ancestor
5685029|NCT03464448|Sensory System Agents|sensory system agents|mesh-ancestor
5685030|NCT03464448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5685031|NCT03464448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685032|NCT03464448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5685033|NCT03464448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5685034|NCT03464448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5685035|NCT03464448|Immunologic Factors|immunologic factors|mesh-ancestor
5876272|NCT05083793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5876273|NCT05083793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876274|NCT05083793|Anticonvulsants|anticonvulsants|mesh-ancestor
5685036|NCT03464435|Loteprednol Etabonate|loteprednol etabonate|mesh-list
5685037|NCT03464435|Tobramycin|tobramycin|mesh-list
5685038|NCT03464435|Tacrolimus|tacrolimus|mesh-list
5685039|NCT03464435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5685040|NCT03464435|Immunologic Factors|immunologic factors|mesh-ancestor
5685041|NCT03464435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685042|NCT03464435|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5685043|NCT03464435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5685044|NCT03464435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685045|NCT03464435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5685046|NCT03464435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5876275|NCT05083793|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5876276|NCT05083793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5685047|NCT03464435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5685048|NCT03464305|Aspirin|aspirin|mesh-list
5876277|NCT05083793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876278|NCT05083793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5876279|NCT05083793|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5876280|NCT05083793|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5876281|NCT05083793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6495769|NCT00625014|Haloperidol decanoate|haloperidol decanoate|mesh-list
6495770|NCT00625014|Antiemetics|antiemetics|mesh-ancestor
5685049|NCT03464305|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6495771|NCT00625014|Autonomic Agents|autonomic agents|mesh-ancestor
5876282|NCT05083793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5876283|NCT05083689|Bevacizumab|bevacizumab|mesh-list
5876284|NCT05083689|Timolol|timolol|mesh-list
5876285|NCT05083689|Dorzolamide|dorzolamide|mesh-list
5685050|NCT03464305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5685051|NCT03464305|Analgesics|analgesics|mesh-ancestor
5685052|NCT03464305|Sensory System Agents|sensory system agents|mesh-ancestor
5685053|NCT03464305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5685054|NCT03464305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685055|NCT03464305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5876286|NCT05083689|Lubricant Eye Drops|lubricant eye drops|mesh-list
5876287|NCT05083689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5876288|NCT05083689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5876289|NCT05083689|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5876290|NCT05083689|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5876291|NCT05083689|Growth Substances|growth substances|mesh-ancestor
5876292|NCT05083689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876293|NCT05083689|Growth Inhibitors|growth inhibitors|mesh-ancestor
5876294|NCT05083689|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5876295|NCT05083689|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5876296|NCT05083689|Adrenergic Agents|adrenergic agents|mesh-ancestor
5876297|NCT05083689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5876298|NCT05083689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876299|NCT05083689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5685056|NCT03464305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5685057|NCT03464305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5685058|NCT03464305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5685059|NCT03464305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685060|NCT03464305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5685061|NCT03464305|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5685062|NCT03464305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5685063|NCT03464305|Antipyretics|antipyretics|mesh-ancestor
5685064|NCT03464292|Capsaicin|capsaicin|mesh-list
5685065|NCT03464292|Antipruritics|antipruritics|mesh-ancestor
5685066|NCT03464292|Dermatologic Agents|dermatologic agents|mesh-ancestor
5685067|NCT03464292|Sensory System Agents|sensory system agents|mesh-ancestor
5685068|NCT03464292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5876300|NCT05083689|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5876301|NCT05083689|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5876302|NCT05083689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5876303|NCT05083689|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5876304|NCT05083689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5876305|NCT05083637|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5876306|NCT05083572|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5876307|NCT05083572|Rifaximin|rifaximin|mesh-list
5876308|NCT05083572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5876309|NCT05083572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5876310|NCT05083455|Enoxaparin|enoxaparin|mesh-list
5876311|NCT05083455|Rivaroxaban|rivaroxaban|mesh-list
5876312|NCT05083455|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5876313|NCT05083455|Antithrombins|antithrombins|mesh-ancestor
5876314|NCT05083455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5876315|NCT05083455|Protease Inhibitors|protease inhibitors|mesh-ancestor
5876316|NCT05083455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5876317|NCT05083455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876318|NCT05083455|Anticoagulants|anticoagulants|mesh-ancestor
5876319|NCT05083455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5876320|NCT05083455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5876321|NCT05083429|Tiotropium Bromide|tiotropium bromide|mesh-list
5876322|NCT05083429|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5876323|NCT05083429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5876324|NCT05083429|Autonomic Agents|autonomic agents|mesh-ancestor
5685069|NCT03464292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685070|NCT03464279|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5685071|NCT03464279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5685072|NCT03464266|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5685073|NCT03464266|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5685074|NCT03464266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5685075|NCT03464266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5685076|NCT03464266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685077|NCT03464266|Antiviral Agents|antiviral agents|mesh-ancestor
5685078|NCT03464266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5876325|NCT05083429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5876326|NCT05083429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876327|NCT05083429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5685079|NCT03464266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5685080|NCT03464266|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5685081|NCT03464084|Melatonin|melatonin|mesh-list
5685082|NCT03464084|Antioxidants|antioxidants|mesh-ancestor
5685083|NCT03464084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685084|NCT03464084|Protective Agents|protective agents|mesh-ancestor
5685085|NCT03464084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685086|NCT03464084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5685087|NCT03464058|Rabeprazole|rabeprazole|mesh-list
5685088|NCT03464058|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5685089|NCT03464058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5685090|NCT03464058|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5685091|NCT03464058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5685092|NCT03464058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685093|NCT03464019|Etripamil|etripamil|mesh-list
5685094|NCT03464019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5685095|NCT03464019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5685096|NCT03464019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685097|NCT03464019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5685098|NCT03464019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685099|NCT03463993|Tranexamic Acid|tranexamic acid|mesh-list
5685100|NCT03463993|Oxytocin|oxytocin|mesh-list
5685101|NCT03463993|Oxytocics|oxytocics|mesh-ancestor
5685102|NCT03463993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5685103|NCT03463993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685104|NCT03463993|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5685105|NCT03463993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5685106|NCT03463993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685107|NCT03463993|Hemostatics|hemostatics|mesh-ancestor
5685108|NCT03463993|Coagulants|coagulants|mesh-ancestor
5685109|NCT03463967|Lycopene|lycopene|mesh-list
5685110|NCT03463967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5685111|NCT03463967|Antioxidants|antioxidants|mesh-ancestor
5685112|NCT03463967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685113|NCT03463967|Protective Agents|protective agents|mesh-ancestor
5685114|NCT03463967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685115|NCT03463967|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5685116|NCT03463967|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5685117|NCT03463967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5685118|NCT03463876|Apatinib|apatinib|mesh-list
5685119|NCT03463876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5685120|NCT03463876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5876328|NCT05083429|Respiratory System Agents|respiratory system agents|mesh-ancestor
5876329|NCT05083429|Parasympatholytics|parasympatholytics|mesh-ancestor
5876330|NCT05083429|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5876331|NCT05083429|Cholinergic Agents|cholinergic agents|mesh-ancestor
5876332|NCT05083429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5876333|NCT05083429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876334|NCT05083429|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5876335|NCT05083429|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5876336|NCT05083429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5876337|NCT05083429|Adrenergic Agents|adrenergic agents|mesh-ancestor
5876338|NCT05083299|Sarpogrelate|sarpogrelate|mesh-list
5876339|NCT05083299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5876340|NCT05083299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5876341|NCT05083299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876342|NCT05083299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5876343|NCT05083299|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5876344|NCT05083299|Serotonin Agents|serotonin agents|mesh-ancestor
5876345|NCT05083299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5685121|NCT03463876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5685122|NCT03463876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685123|NCT03463733|Temozolomide|temozolomide|mesh-list
5685124|NCT03463733|Hydroxyurea|hydroxyurea|mesh-list
5685125|NCT03463733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5685126|NCT03463733|Alkylating Agents|alkylating agents|mesh-ancestor
5685127|NCT03463733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685128|NCT03463733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5876346|NCT05083299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876347|NCT05083247|Gemcitabine|gemcitabine|mesh-list
5876348|NCT05083247|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5876349|NCT05083247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5876350|NCT05083247|Antimetabolites|antimetabolites|mesh-ancestor
5908642|NCT04334759|Pemetrexed|pemetrexed|mesh-list
5876351|NCT05083247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876352|NCT05083247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5876353|NCT05083247|Antiviral Agents|antiviral agents|mesh-ancestor
5876354|NCT05083247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5876355|NCT05083247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5876356|NCT05083247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5876357|NCT05083247|Immunologic Factors|immunologic factors|mesh-ancestor
5876358|NCT05083247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876359|NCT05083026|Antibodies|antibodies|mesh-list
5876360|NCT05083026|Antibodies, Blocking|antibodies, blocking|mesh-list
5876361|NCT05083026|Immunologic Factors|immunologic factors|mesh-ancestor
5876362|NCT05083026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876363|NCT05082974|Varenicline|varenicline|mesh-list
5876364|NCT05082974|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5876365|NCT05082974|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5876366|NCT05082974|Cholinergic Agents|cholinergic agents|mesh-ancestor
5876367|NCT05082974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5876368|NCT05082974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876369|NCT05082974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876370|NCT05082909|Probenecid|probenecid|mesh-list
5876371|NCT05082909|Uricosuric Agents|uricosuric agents|mesh-ancestor
5876372|NCT05082909|Gout Suppressants|gout suppressants|mesh-ancestor
5876373|NCT05082909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5876374|NCT05082909|Renal Agents|renal agents|mesh-ancestor
5876375|NCT05082896|Anesthetics|anesthetics|mesh-list
5876376|NCT05082896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5876377|NCT05082896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876378|NCT05082753|Ivermectin|ivermectin|mesh-list
5876379|NCT05082753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5876380|NCT05082753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5876381|NCT05082662|Diclofenac|diclofenac|mesh-list
5876382|NCT05082662|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5876383|NCT05082662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5876384|NCT05082662|Analgesics|analgesics|mesh-ancestor
5876385|NCT05082662|Sensory System Agents|sensory system agents|mesh-ancestor
5876386|NCT05082662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5876387|NCT05082662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876388|NCT05082662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5876389|NCT05082662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5876390|NCT05082662|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5876391|NCT05082662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5876392|NCT05082662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876393|NCT05082441|Bupivacaine|bupivacaine|mesh-list
5876394|NCT05082441|Anesthetics, Local|anesthetics, local|mesh-ancestor
5876395|NCT05082441|Anesthetics|anesthetics|mesh-ancestor
5876396|NCT05082441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5876397|NCT05082441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876398|NCT05082441|Sensory System Agents|sensory system agents|mesh-ancestor
5876399|NCT05082441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5905947|NCT04287855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905948|NCT04287855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5905949|NCT04287855|Glucocorticoids|glucocorticoids|mesh-ancestor
5905950|NCT04287855|Hormones|hormones|mesh-ancestor
5905951|NCT04287855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5905952|NCT04287855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5905953|NCT04287855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5905954|NCT04287855|Immunologic Factors|immunologic factors|mesh-ancestor
5905955|NCT04287855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5905956|NCT04287855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5905957|NCT04287855|Growth Substances|growth substances|mesh-ancestor
5905958|NCT04287855|Growth Inhibitors|growth inhibitors|mesh-ancestor
5685129|NCT03463733|Antisickling Agents|antisickling agents|mesh-ancestor
5685130|NCT03463733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5685131|NCT03463733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5685132|NCT03463642|Vitamin D|vitamin d|mesh-list
5905959|NCT04264897|Metformin|metformin|mesh-list
5905960|NCT04264897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5905961|NCT04264897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905962|NCT04253964|Paclitaxel|paclitaxel|mesh-list
5905963|NCT04253964|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5905964|NCT04253964|Carboplatin|carboplatin|mesh-list
5905965|NCT04253964|Pembrolizumab|pembrolizumab|mesh-list
5685133|NCT03463642|Cholecalciferol|cholecalciferol|mesh-list
5685134|NCT03463642|Mineral Oil|mineral oil|mesh-list
5685135|NCT03463642|Vitamins|vitamins|mesh-ancestor
5685136|NCT03463642|Micronutrients|micronutrients|mesh-ancestor
5685137|NCT03463642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876400|NCT05075941|Vaccines|vaccines|mesh-list
5876401|NCT05075941|Immunologic Factors|immunologic factors|mesh-ancestor
5876402|NCT05075941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876403|NCT05073653|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5876404|NCT05073653|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5876405|NCT05073653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876406|NCT05072054|Atorvastatin|atorvastatin|mesh-list
5876407|NCT05072054|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5876408|NCT05072054|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5876409|NCT05072054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5876410|NCT05072054|Antimetabolites|antimetabolites|mesh-ancestor
5876411|NCT05072054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876412|NCT05072054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5876413|NCT05072054|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5876414|NCT05072054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5876415|NCT05049902|Amoxicillin|amoxicillin|mesh-list
5876416|NCT05049902|Metronidazole|metronidazole|mesh-list
5876417|NCT05049902|Clarithromycin|clarithromycin|mesh-list
5876418|NCT05049902|Tetracycline|tetracycline|mesh-list
5876419|NCT05049902|Potassium Citrate|potassium citrate|mesh-list
5876420|NCT05049902|Bismuth|bismuth|mesh-list
5876421|NCT05049902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876422|NCT05049902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5876423|NCT05049902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5876424|NCT05049902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5876425|NCT05049902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5876426|NCT05049902|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5876427|NCT05049902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5876428|NCT05049902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5876429|NCT05049902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5876430|NCT05049902|Antacids|antacids|mesh-ancestor
5876431|NCT05049902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5876432|NCT05049902|Diuretics|diuretics|mesh-ancestor
5876433|NCT05049902|Natriuretic Agents|natriuretic agents|mesh-ancestor
5876434|NCT05049902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876435|NCT05049902|Expectorants|expectorants|mesh-ancestor
5876436|NCT05049902|Respiratory System Agents|respiratory system agents|mesh-ancestor
5876437|NCT05048069|Rebamipide|rebamipide|mesh-list
5876438|NCT05048069|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5876439|NCT05048069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5876440|NCT05048069|Antioxidants|antioxidants|mesh-ancestor
5876441|NCT05048069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876442|NCT05048069|Protective Agents|protective agents|mesh-ancestor
5876443|NCT05048069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876444|NCT05048069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5876445|NCT05036577|Dexamethasone|dexamethasone|mesh-list
5876446|NCT05036577|Rituximab|rituximab|mesh-list
5876447|NCT05036577|Methotrexate|methotrexate|mesh-list
5876448|NCT05036577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5876449|NCT05036577|Antiemetics|antiemetics|mesh-ancestor
5876450|NCT05036577|Autonomic Agents|autonomic agents|mesh-ancestor
5876451|NCT05036577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5876452|NCT05036577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876453|NCT05036577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5876454|NCT05036577|Glucocorticoids|glucocorticoids|mesh-ancestor
5876455|NCT05036577|Hormones|hormones|mesh-ancestor
5876456|NCT05036577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5876457|NCT05036577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5876458|NCT05036577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5876459|NCT05036577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5876460|NCT05036577|Immunologic Factors|immunologic factors|mesh-ancestor
5876461|NCT05036577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5876462|NCT05036577|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5876463|NCT05036577|Abortifacient Agents|abortifacient agents|mesh-ancestor
5685138|NCT03463642|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5685139|NCT03463642|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5685140|NCT03463642|Emollients|emollients|mesh-ancestor
5685141|NCT03463642|Dermatologic Agents|dermatologic agents|mesh-ancestor
5685142|NCT03463577|Vaccines|vaccines|mesh-list
5685143|NCT03463577|Immunologic Factors|immunologic factors|mesh-ancestor
5685144|NCT03463577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685145|NCT03463564|Insulin|insulin|mesh-list
5685146|NCT03463564|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5685147|NCT03463564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5685148|NCT03463564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685149|NCT03463525|Osimertinib|osimertinib|mesh-list
5685150|NCT03463525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5876464|NCT05036577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5876465|NCT05036577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5876466|NCT05036577|Antimetabolites|antimetabolites|mesh-ancestor
5876467|NCT05036577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876468|NCT05036577|Dermatologic Agents|dermatologic agents|mesh-ancestor
5876469|NCT05036577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5876470|NCT05036577|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5876471|NCT05036577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5876472|NCT05036577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5876473|NCT05025735|Dapagliflozin|dapagliflozin|mesh-list
5876474|NCT05025735|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5876475|NCT05025735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876476|NCT05025735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5876477|NCT05025735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876478|NCT04962230|Ritonavir|ritonavir|mesh-list
5876479|NCT04962230|Carbamazepine|carbamazepine|mesh-list
5876480|NCT04962230|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5876481|NCT04962230|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5876482|NCT04962230|Protease Inhibitors|protease inhibitors|mesh-ancestor
5876483|NCT04962230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5876484|NCT04962230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876485|NCT04962230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5876486|NCT04962230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5876487|NCT04962230|Antiviral Agents|antiviral agents|mesh-ancestor
5876488|NCT04962230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5685151|NCT03463525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5685152|NCT03463525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5685153|NCT03463525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685154|NCT03463499|Hyaluronic Acid|hyaluronic acid|mesh-list
5685155|NCT03463499|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5685156|NCT03463499|Immunologic Factors|immunologic factors|mesh-ancestor
5685157|NCT03463499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685158|NCT03463499|Viscosupplements|viscosupplements|mesh-ancestor
5685159|NCT03463499|Protective Agents|protective agents|mesh-ancestor
5685160|NCT03463460|Pembrolizumab|pembrolizumab|mesh-list
5685161|NCT03463460|Sunitinib|sunitinib|mesh-list
5685162|NCT03463460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5685163|NCT03463460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5685164|NCT03463460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5685165|NCT03463460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5685166|NCT03463460|Growth Substances|growth substances|mesh-ancestor
5876489|NCT04962230|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5876490|NCT04962230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5876491|NCT04962230|Anticonvulsants|anticonvulsants|mesh-ancestor
5876492|NCT04962230|Antimanic Agents|antimanic agents|mesh-ancestor
5876493|NCT04962230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5876494|NCT04962230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5876495|NCT04962230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876496|NCT04962230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5876497|NCT04962230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5876498|NCT04962230|Analgesics|analgesics|mesh-ancestor
5876499|NCT04962230|Sensory System Agents|sensory system agents|mesh-ancestor
5876500|NCT04962230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5685167|NCT03463460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685168|NCT03463460|Growth Inhibitors|growth inhibitors|mesh-ancestor
5685169|NCT03463460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5685170|NCT03463460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5685171|NCT03463460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685172|NCT03463382|Bupivacaine|bupivacaine|mesh-list
5685173|NCT03463382|Anesthetics, Local|anesthetics, local|mesh-ancestor
5685174|NCT03463382|Anesthetics|anesthetics|mesh-ancestor
5685175|NCT03463382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5685176|NCT03463382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685177|NCT03463382|Sensory System Agents|sensory system agents|mesh-ancestor
5685178|NCT03463382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5685179|NCT03463317|Aspirin|aspirin|mesh-list
5685180|NCT03463317|Warfarin|warfarin|mesh-list
5685181|NCT03463317|Rivaroxaban|rivaroxaban|mesh-list
5685182|NCT03463317|Dabigatran|dabigatran|mesh-list
5685183|NCT03463317|Apixaban|apixaban|mesh-list
5685184|NCT03463317|Edoxaban|edoxaban|mesh-list
5876501|NCT04962230|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5876502|NCT04962230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5905966|NCT04253964|Pemetrexed|pemetrexed|mesh-list
5685185|NCT03463317|Phenprocoumon|phenprocoumon|mesh-list
5685186|NCT03463317|Clopidogrel|clopidogrel|mesh-list
5685187|NCT03463317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5685188|NCT03463317|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5685189|NCT03463317|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5685190|NCT03463317|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5685191|NCT03463317|Purinergic Agents|purinergic agents|mesh-ancestor
5876503|NCT04962230|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5876504|NCT04962230|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5876505|NCT04943341|Triamcinolone|triamcinolone|mesh-list
5876506|NCT04943341|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5876507|NCT04943341|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5876508|NCT04943341|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5876509|NCT04943341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5876510|NCT04943341|Glucocorticoids|glucocorticoids|mesh-ancestor
5876511|NCT04943341|Hormones|hormones|mesh-ancestor
5876512|NCT04943341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5876513|NCT04943341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876514|NCT04943341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5876515|NCT04943341|Immunologic Factors|immunologic factors|mesh-ancestor
5685192|NCT03463317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5685193|NCT03463317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685194|NCT03463317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685195|NCT03463317|Anticoagulants|anticoagulants|mesh-ancestor
5685196|NCT03463317|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5685197|NCT03463317|Antithrombins|antithrombins|mesh-ancestor
5685198|NCT03463317|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5685199|NCT03463317|Protease Inhibitors|protease inhibitors|mesh-ancestor
5685200|NCT03463317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5685201|NCT03463317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5685202|NCT03463317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5685203|NCT03463317|Analgesics|analgesics|mesh-ancestor
5685204|NCT03463317|Sensory System Agents|sensory system agents|mesh-ancestor
5685205|NCT03463317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5685206|NCT03463317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5685207|NCT03463317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5685208|NCT03463317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5685209|NCT03463317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5685210|NCT03463317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5876516|NCT04943341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5876517|NCT04943341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876518|NCT04941040|Analgesics, Opioid|analgesics, opioid|mesh-list
5876519|NCT04941040|Anesthetics|anesthetics|mesh-list
5876520|NCT04941040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5876521|NCT04941040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876522|NCT04941040|Narcotics|narcotics|mesh-ancestor
5876523|NCT04941040|Analgesics|analgesics|mesh-ancestor
5876524|NCT04941040|Sensory System Agents|sensory system agents|mesh-ancestor
5876525|NCT04941040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5876526|NCT04934410|Midazolam|midazolam|mesh-list
5876527|NCT04934410|Etomidate|etomidate|mesh-list
5876528|NCT04934410|Sevoflurane|sevoflurane|mesh-list
5876529|NCT04934410|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5876530|NCT04934410|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5876531|NCT04934410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5876532|NCT04934410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876533|NCT04934410|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5876534|NCT04934410|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5876535|NCT04934410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5876536|NCT04934410|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5876537|NCT04934410|Anesthetics, General|anesthetics, general|mesh-ancestor
5876538|NCT04934410|Anesthetics|anesthetics|mesh-ancestor
5876539|NCT04934410|GABA Modulators|gaba modulators|mesh-ancestor
5876540|NCT04934410|GABA Agents|gaba agents|mesh-ancestor
5876541|NCT04934410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5876542|NCT04934410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876543|NCT04934410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5685211|NCT03463317|Antipyretics|antipyretics|mesh-ancestor
5685212|NCT03463265|Sirolimus|sirolimus|mesh-list
5685213|NCT03463265|Bevacizumab|bevacizumab|mesh-list
5685214|NCT03463265|Temozolomide|temozolomide|mesh-list
5685215|NCT03463265|Lomustine|lomustine|mesh-list
5685216|NCT03463265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5685217|NCT03463265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5685218|NCT03463265|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5876544|NCT04934410|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5876545|NCT04923620|Cetuximab|cetuximab|mesh-list
5876546|NCT04923620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5876547|NCT04923620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5876548|NCT04918927|Nitazoxanide|nitazoxanide|mesh-list
5876549|NCT04918927|Favipiravir|favipiravir|mesh-list
5876550|NCT04918927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5876551|NCT04918927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5876552|NCT04918927|Antiviral Agents|antiviral agents|mesh-ancestor
5876553|NCT04896645|Albuterol|albuterol|mesh-list
5876554|NCT04896645|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5685219|NCT03463265|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5685220|NCT03463265|Growth Substances|growth substances|mesh-ancestor
5685221|NCT03463265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685222|NCT03463265|Growth Inhibitors|growth inhibitors|mesh-ancestor
5685223|NCT03463265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5685224|NCT03463265|Alkylating Agents|alkylating agents|mesh-ancestor
5685225|NCT03463265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685226|NCT03463265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5685227|NCT03463265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5685228|NCT03463265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5685229|NCT03463265|Antifungal Agents|antifungal agents|mesh-ancestor
5685230|NCT03463265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5685231|NCT03463265|Immunologic Factors|immunologic factors|mesh-ancestor
5685232|NCT03463252|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
5685233|NCT03463252|Medroxyprogesterone|medroxyprogesterone|mesh-list
5685234|NCT03463252|Progesterone|progesterone|mesh-list
5685235|NCT03463252|Progestins|progestins|mesh-ancestor
5685236|NCT03463252|Hormones|hormones|mesh-ancestor
5685237|NCT03463252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5876555|NCT04896645|Autonomic Agents|autonomic agents|mesh-ancestor
5876556|NCT04896645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5876557|NCT04896645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876558|NCT04896645|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5876559|NCT04896645|Respiratory System Agents|respiratory system agents|mesh-ancestor
5876560|NCT04896645|Tocolytic Agents|tocolytic agents|mesh-ancestor
5876561|NCT04896645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5876562|NCT04896645|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5876563|NCT04896645|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5876564|NCT04896645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5876565|NCT04896645|Adrenergic Agents|adrenergic agents|mesh-ancestor
5876566|NCT04896645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5876567|NCT04896645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876568|NCT04880928|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5876569|NCT04880928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5876570|NCT04873297|Metoclopramide|metoclopramide|mesh-list
5876571|NCT04873297|Antiemetics|antiemetics|mesh-ancestor
5876572|NCT04873297|Autonomic Agents|autonomic agents|mesh-ancestor
5876573|NCT04873297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5876574|NCT04873297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876575|NCT04873297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5876576|NCT04873297|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5876577|NCT04873297|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5876578|NCT04873297|Dopamine Agents|dopamine agents|mesh-ancestor
5876579|NCT04873297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5876580|NCT04873297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876581|NCT04858711|Lidocaine|lidocaine|mesh-list
5876582|NCT04858711|Fentanyl|fentanyl|mesh-list
5876583|NCT04858711|Dexmedetomidine|dexmedetomidine|mesh-list
5876584|NCT04858711|Ketamine|ketamine|mesh-list
5876585|NCT04858711|Anesthetics, Local|anesthetics, local|mesh-ancestor
5876586|NCT04858711|Anesthetics|anesthetics|mesh-ancestor
5876587|NCT04858711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5876588|NCT04858711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876589|NCT04858711|Sensory System Agents|sensory system agents|mesh-ancestor
5876590|NCT04858711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5876591|NCT04858711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5876592|NCT04858711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5876593|NCT04858711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5876594|NCT04858711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5876595|NCT04858711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876596|NCT04858711|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5876597|NCT04858711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5876598|NCT04858711|Analgesics|analgesics|mesh-ancestor
5876599|NCT04858711|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5876600|NCT04858711|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5876601|NCT04858711|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5876602|NCT04858711|Adrenergic Agents|adrenergic agents|mesh-ancestor
5685238|NCT03463252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685239|NCT03463252|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5685240|NCT03463252|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5876603|NCT04858711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5876604|NCT04858711|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5876605|NCT04858711|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5876606|NCT04858711|Anesthetics, General|anesthetics, general|mesh-ancestor
5876607|NCT04858711|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5876608|NCT04858711|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5876609|NCT04858711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5876610|NCT04858711|Narcotics|narcotics|mesh-ancestor
5876611|NCT04858711|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5876612|NCT04852224|Leuprolide|leuprolide|mesh-list
5876613|NCT04852224|Goserelin|goserelin|mesh-list
5876614|NCT04852224|Androgens|androgens|mesh-list
5876615|NCT04852224|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5876616|NCT04852224|Fertility Agents|fertility agents|mesh-ancestor
5876617|NCT04852224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5876618|NCT04852224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876619|NCT04852224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5876620|NCT04852224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5876621|NCT04852224|Hormones|hormones|mesh-ancestor
5876622|NCT04852224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5876623|NCT04826484|Bupivacaine|bupivacaine|mesh-list
5876624|NCT04826484|Anesthetics, Local|anesthetics, local|mesh-ancestor
5876625|NCT04826484|Anesthetics|anesthetics|mesh-ancestor
5876626|NCT04826484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5876627|NCT04826484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876628|NCT04826484|Sensory System Agents|sensory system agents|mesh-ancestor
5876629|NCT04826484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5876630|NCT04810793|Amoxicillin|amoxicillin|mesh-list
5876631|NCT04810793|Levofloxacin|levofloxacin|mesh-list
5876632|NCT04810793|Ofloxacin|ofloxacin|mesh-list
5876633|NCT04810793|Tetracycline|tetracycline|mesh-list
5876634|NCT04810793|Furazolidone|furazolidone|mesh-list
5876635|NCT04810793|Esomeprazole|esomeprazole|mesh-list
5876636|NCT04810793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5876637|NCT04810793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5876638|NCT04810793|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5876639|NCT04810793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5876640|NCT04810793|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5876641|NCT04810793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5876642|NCT04810793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876643|NCT04810793|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5876644|NCT04810793|Renal Agents|renal agents|mesh-ancestor
5876645|NCT04810793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5876646|NCT04810793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5876647|NCT04810793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5876648|NCT04810793|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5876649|NCT04810793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5876650|NCT04810793|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5876651|NCT04810793|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5876652|NCT04810793|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
5876653|NCT04810793|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5685241|NCT03463252|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5685242|NCT03463252|Contraceptive Agents|contraceptive agents|mesh-ancestor
5685243|NCT03463252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5876654|NCT04810793|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5876655|NCT04810793|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
5876656|NCT04791228|Doxorubicin|doxorubicin|mesh-list
5876657|NCT04791228|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5876658|NCT04791228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5876659|NCT04791228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5876660|NCT04791228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5876661|NCT04791228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5876662|NCT04791228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5876663|NCT04791228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876664|NCT04756687|Dimethyl Fumarate|dimethyl fumarate|mesh-list
5876665|NCT04756687|Dermatologic Agents|dermatologic agents|mesh-ancestor
5876666|NCT04756687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5685244|NCT03463252|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5685245|NCT03463252|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5685246|NCT03463252|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5685247|NCT03463252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5685248|NCT03463252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5876667|NCT04756687|Immunologic Factors|immunologic factors|mesh-ancestor
5876668|NCT04756687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876669|NCT04728633|Carmustine|carmustine|mesh-list
5876670|NCT04728633|Ethiodized Oil|ethiodized oil|mesh-list
5876671|NCT04728633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5876672|NCT04728633|Alkylating Agents|alkylating agents|mesh-ancestor
5876673|NCT04728633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876674|NCT04728633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5876675|NCT04725864|Progesterone|progesterone|mesh-list
5876676|NCT04725864|Progestins|progestins|mesh-ancestor
5876677|NCT04725864|Hormones|hormones|mesh-ancestor
5876678|NCT04725864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5876679|NCT04725864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905967|NCT04253964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5905968|NCT04253964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5905969|NCT04253964|Tubulin Modulators|tubulin modulators|mesh-ancestor
5905970|NCT04253964|Antimitotic Agents|antimitotic agents|mesh-ancestor
5905971|NCT04253964|Mitosis Modulators|mitosis modulators|mesh-ancestor
5905972|NCT04253964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905973|NCT04253964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5905974|NCT04253964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5905975|NCT04253964|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5905976|NCT04253964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5905977|NCT04246060|Cysteamine|cysteamine|mesh-list
5905978|NCT04246060|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
5905979|NCT04246060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905980|NCT04235140|Ivacaftor|ivacaftor|mesh-list
5905981|NCT04235140|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
5905982|NCT04235140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5905983|NCT04235140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905984|NCT04203875|Abatacept|abatacept|mesh-list
5905985|NCT04203875|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5905986|NCT04203875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5905987|NCT04203875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5905988|NCT04203875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5905989|NCT04203875|Immunologic Factors|immunologic factors|mesh-ancestor
5905990|NCT04203875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5905991|NCT04203875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5905992|NCT04199026|Sirolimus|sirolimus|mesh-list
5905993|NCT04199026|Doxorubicin|doxorubicin|mesh-list
5685249|NCT03463083|Fentanyl|fentanyl|mesh-list
5685250|NCT03463083|Dexmedetomidine|dexmedetomidine|mesh-list
5685251|NCT03463083|Bupivacaine|bupivacaine|mesh-list
5685252|NCT03463083|Anesthetics, Local|anesthetics, local|mesh-ancestor
5685253|NCT03463083|Anesthetics|anesthetics|mesh-ancestor
5685254|NCT03463083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5685255|NCT03463083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685256|NCT03463083|Sensory System Agents|sensory system agents|mesh-ancestor
5685257|NCT03463083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5685258|NCT03463083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5685259|NCT03463083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5905994|NCT04199026|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5905995|NCT04199026|Daunorubicin|daunorubicin|mesh-list
5905996|NCT04199026|Irinotecan|irinotecan|mesh-list
5685260|NCT03463083|Analgesics|analgesics|mesh-ancestor
5685261|NCT03463083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5685262|NCT03463083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5685263|NCT03463083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5685264|NCT03463083|Adrenergic Agents|adrenergic agents|mesh-ancestor
5685265|NCT03463083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5685266|NCT03463083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685267|NCT03463083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5685268|NCT03463083|Narcotics|narcotics|mesh-ancestor
5685269|NCT03463083|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5685270|NCT03463083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5685271|NCT03463083|Anesthetics, General|anesthetics, general|mesh-ancestor
5685272|NCT03463070|Misoprostol|misoprostol|mesh-list
5685273|NCT03463070|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5685274|NCT03463070|Abortifacient Agents|abortifacient agents|mesh-ancestor
5685275|NCT03463070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5685276|NCT03463070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685277|NCT03463070|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5905997|NCT04199026|Vincristine|vincristine|mesh-list
5905998|NCT04199026|Everolimus|everolimus|mesh-list
5905999|NCT04199026|Temozolomide|temozolomide|mesh-list
5906000|NCT04199026|Ifosfamide|ifosfamide|mesh-list
5876680|NCT04684368|Carboplatin|carboplatin|mesh-list
5876681|NCT04684368|Etoposide|etoposide|mesh-list
5876682|NCT04684368|Etoposide phosphate|etoposide phosphate|mesh-list
5876683|NCT04684368|Ifosfamide|ifosfamide|mesh-list
5876684|NCT04684368|Isophosphamide mustard|isophosphamide mustard|mesh-list
5876685|NCT04684368|Thiotepa|thiotepa|mesh-list
5876686|NCT04684368|Podophyllotoxin|podophyllotoxin|mesh-list
5876687|NCT04684368|Lenograstim|lenograstim|mesh-list
5685278|NCT03463070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5685279|NCT03463070|Oxytocics|oxytocics|mesh-ancestor
5685280|NCT03463044|Nangibotide|nangibotide|mesh-list
5685281|NCT03463044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5685282|NCT03463005|Propolis|propolis|mesh-list
5685283|NCT03463005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5685284|NCT03462940|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
5685285|NCT03462940|Antiviral Agents|antiviral agents|mesh-ancestor
5685286|NCT03462940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5685287|NCT03462940|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5685288|NCT03462940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5685289|NCT03462836|Lidocaine|lidocaine|mesh-list
5685290|NCT03462836|Ketamine|ketamine|mesh-list
5685291|NCT03462836|Anesthetics, Local|anesthetics, local|mesh-ancestor
5685292|NCT03462836|Anesthetics|anesthetics|mesh-ancestor
5685293|NCT03462836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5685294|NCT03462836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685295|NCT03462836|Sensory System Agents|sensory system agents|mesh-ancestor
5685296|NCT03462836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5685297|NCT03462836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5876688|NCT04684368|Mesna|mesna|mesh-list
5876689|NCT04684368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5876690|NCT04684368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5876691|NCT04684368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5876692|NCT04684368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5876693|NCT04684368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5876694|NCT04684368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876695|NCT04684368|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5876696|NCT04684368|Immunologic Factors|immunologic factors|mesh-ancestor
5876697|NCT04684368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876698|NCT04684368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5876699|NCT04684368|Alkylating Agents|alkylating agents|mesh-ancestor
5876700|NCT04684368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5876701|NCT04684368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5876702|NCT04684368|Protective Agents|protective agents|mesh-ancestor
5685298|NCT03462836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5685299|NCT03462836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5685300|NCT03462836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5685301|NCT03462836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685302|NCT03462836|Analgesics|analgesics|mesh-ancestor
5685303|NCT03462836|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5685304|NCT03462836|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5685305|NCT03462836|Anesthetics, General|anesthetics, general|mesh-ancestor
5685306|NCT03462836|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5685307|NCT03462836|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5876703|NCT04684368|Keratolytic Agents|keratolytic agents|mesh-ancestor
5876704|NCT04684368|Dermatologic Agents|dermatologic agents|mesh-ancestor
5876705|NCT04684368|Tubulin Modulators|tubulin modulators|mesh-ancestor
5876706|NCT04684368|Antimitotic Agents|antimitotic agents|mesh-ancestor
5876707|NCT04684368|Mitosis Modulators|mitosis modulators|mesh-ancestor
5876708|NCT04631393|Alfentanil|alfentanil|mesh-list
5876709|NCT04631393|Propofol|propofol|mesh-list
5876710|NCT04631393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5876711|NCT04631393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5685308|NCT03462836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5685309|NCT03462810|Cabotegravir|cabotegravir|mesh-list
5685310|NCT03462810|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5685311|NCT03462810|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5685312|NCT03462810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5685313|NCT03462810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685314|NCT03462810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5685315|NCT03462810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5685316|NCT03462810|Antiviral Agents|antiviral agents|mesh-ancestor
5685317|NCT03462810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5685318|NCT03462641|Flumazenil|flumazenil|mesh-list
5685319|NCT03462641|Antidotes|antidotes|mesh-ancestor
5685320|NCT03462641|Protective Agents|protective agents|mesh-ancestor
5685321|NCT03462641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685322|NCT03462641|GABA Modulators|gaba modulators|mesh-ancestor
5876712|NCT04631393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685323|NCT03462641|GABA Agents|gaba agents|mesh-ancestor
5685324|NCT03462641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5685325|NCT03462641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876713|NCT04631393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5876714|NCT04631393|Anesthetics, General|anesthetics, general|mesh-ancestor
5876715|NCT04631393|Anesthetics|anesthetics|mesh-ancestor
5876716|NCT04631393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5876717|NCT04631393|Narcotics|narcotics|mesh-ancestor
5876718|NCT04631393|Analgesics|analgesics|mesh-ancestor
5876719|NCT04631393|Sensory System Agents|sensory system agents|mesh-ancestor
5876720|NCT04631393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5876721|NCT04562324|Antipsychotic Agents|antipsychotic agents|mesh-list
5876722|NCT04562324|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
5876723|NCT04562324|Antidepressive Agents|antidepressive agents|mesh-list
5876724|NCT04562324|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
5876725|NCT04562324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5876726|NCT04562324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5876727|NCT04562324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5876728|NCT04562324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876729|NCT04537923|Insulin|insulin|mesh-list
5876730|NCT04537923|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5876731|NCT04537923|Insulin Glargine|insulin glargine|mesh-list
5876732|NCT04537923|Insulin Lispro|insulin lispro|mesh-list
5876733|NCT04537923|Tirzepatide|tirzepatide|mesh-list
5876734|NCT04537923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5876735|NCT04537923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876736|NCT04537923|Incretins|incretins|mesh-ancestor
5685326|NCT03462446|Vitamin K|vitamin k|mesh-list
5685327|NCT03462446|Rivaroxaban|rivaroxaban|mesh-list
5685328|NCT03462446|Vitamins|vitamins|mesh-ancestor
5685329|NCT03462446|Micronutrients|micronutrients|mesh-ancestor
5685330|NCT03462446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685331|NCT03462446|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5685332|NCT03462446|Antithrombins|antithrombins|mesh-ancestor
5685333|NCT03462446|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5685334|NCT03462446|Protease Inhibitors|protease inhibitors|mesh-ancestor
5685335|NCT03462446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5685336|NCT03462446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876737|NCT04537923|Hormones|hormones|mesh-ancestor
5876738|NCT04537923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5876739|NCT04530747|Metformin|metformin|mesh-list
5876740|NCT04530747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5876741|NCT04530747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876742|NCT04513314|Valproic Acid|valproic acid|mesh-list
5876743|NCT04513314|Quetiapine Fumarate|quetiapine fumarate|mesh-list
5876744|NCT04513314|Antidepressive Agents|antidepressive agents|mesh-ancestor
5876745|NCT04513314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5876746|NCT04513314|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5876747|NCT04513314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5876748|NCT04513314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5876749|NCT04513314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876750|NCT04513314|Anticonvulsants|anticonvulsants|mesh-ancestor
5876751|NCT04513314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5876752|NCT04513314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876753|NCT04513314|GABA Agents|gaba agents|mesh-ancestor
5876754|NCT04513314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5876755|NCT04513314|Antimanic Agents|antimanic agents|mesh-ancestor
5685337|NCT03462446|Anticoagulants|anticoagulants|mesh-ancestor
5685338|NCT03462446|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5685339|NCT03462446|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5685340|NCT03462446|Hemostatics|hemostatics|mesh-ancestor
5685341|NCT03462446|Coagulants|coagulants|mesh-ancestor
5685342|NCT03462368|Anti-Infective Agents|anti-infective agents|mesh-list
5876756|NCT04497584|Prednisone|prednisone|mesh-list
5876757|NCT04497584|Afatinib|afatinib|mesh-list
5876758|NCT04497584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5876759|NCT04497584|Glucocorticoids|glucocorticoids|mesh-ancestor
5876760|NCT04497584|Hormones|hormones|mesh-ancestor
5876761|NCT04497584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5876762|NCT04497584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876763|NCT04497584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5876764|NCT04497584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5876765|NCT04497584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5876766|NCT04497584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5876767|NCT04497584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685343|NCT03462368|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5685344|NCT03462329|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5876768|NCT04447118|Docetaxel|docetaxel|mesh-list
5685345|NCT03462329|Doxycycline|doxycycline|mesh-list
5876769|NCT04447118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5876770|NCT04447118|Tubulin Modulators|tubulin modulators|mesh-ancestor
5876771|NCT04447118|Antimitotic Agents|antimitotic agents|mesh-ancestor
5876772|NCT04447118|Mitosis Modulators|mitosis modulators|mesh-ancestor
5876773|NCT04447118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876774|NCT04443062|177Lu-PSMA-617|177lu-psma-617|mesh-list
5876775|NCT04443062|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5876776|NCT04443062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876777|NCT04409002|Niraparib|niraparib|mesh-list
5876778|NCT04409002|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5876779|NCT04409002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5876780|NCT04409002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876781|NCT04409002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5876782|NCT04406415|Nafamostat|nafamostat|mesh-list
5876783|NCT04406415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5876784|NCT04406415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5876785|NCT04406415|Analgesics|analgesics|mesh-ancestor
5876786|NCT04406415|Sensory System Agents|sensory system agents|mesh-ancestor
5876787|NCT04406415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5876788|NCT04406415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876789|NCT04406415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5876790|NCT04406415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5876791|NCT04406415|Anticoagulants|anticoagulants|mesh-ancestor
5876792|NCT04406415|Protease Inhibitors|protease inhibitors|mesh-ancestor
5876793|NCT04406415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5876794|NCT04406415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876795|NCT04406415|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5876796|NCT04406415|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5876797|NCT04406415|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5876798|NCT04406415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5876799|NCT04406415|Immunologic Factors|immunologic factors|mesh-ancestor
5876800|NCT04293562|Cytarabine|cytarabine|mesh-list
5876801|NCT04293562|Hydrocortisone|hydrocortisone|mesh-list
5876802|NCT04293562|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
5876803|NCT04293562|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
5876804|NCT04293562|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
5876805|NCT04293562|Methotrexate|methotrexate|mesh-list
5876806|NCT04293562|Etoposide|etoposide|mesh-list
5876807|NCT04293562|Etoposide phosphate|etoposide phosphate|mesh-list
5876808|NCT04293562|Daunorubicin|daunorubicin|mesh-list
5876809|NCT04293562|Asparaginase|asparaginase|mesh-list
5876810|NCT04293562|Mitoxantrone|mitoxantrone|mesh-list
5876811|NCT04293562|Podophyllotoxin|podophyllotoxin|mesh-list
5876812|NCT04293562|Gemtuzumab|gemtuzumab|mesh-list
5876813|NCT04293562|Dexrazoxane|dexrazoxane|mesh-list
5876814|NCT04293562|Razoxane|razoxane|mesh-list
5876815|NCT04293562|Calicheamicins|calicheamicins|mesh-list
5876816|NCT04293562|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5876817|NCT04293562|Abortifacient Agents|abortifacient agents|mesh-ancestor
5876818|NCT04293562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5876819|NCT04293562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876820|NCT04293562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5876821|NCT04293562|Antimetabolites|antimetabolites|mesh-ancestor
5876822|NCT04293562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876823|NCT04293562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5876824|NCT04293562|Dermatologic Agents|dermatologic agents|mesh-ancestor
5876825|NCT04293562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5876826|NCT04293562|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5685346|NCT03462329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5685347|NCT03462329|Antimalarials|antimalarials|mesh-ancestor
5685348|NCT03462329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5685349|NCT03462329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5685350|NCT03462212|Paclitaxel|paclitaxel|mesh-list
5685351|NCT03462212|Bevacizumab|bevacizumab|mesh-list
5685352|NCT03462212|Carboplatin|carboplatin|mesh-list
5685353|NCT03462212|Rucaparib|rucaparib|mesh-list
5685354|NCT03462212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5685355|NCT03462212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5685356|NCT03462212|Tubulin Modulators|tubulin modulators|mesh-ancestor
5685357|NCT03462212|Antimitotic Agents|antimitotic agents|mesh-ancestor
5685358|NCT03462212|Mitosis Modulators|mitosis modulators|mesh-ancestor
5685359|NCT03462212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685360|NCT03462212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5685361|NCT03462212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5685362|NCT03462212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5876827|NCT04293562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5876828|NCT04293562|Immunologic Factors|immunologic factors|mesh-ancestor
5876829|NCT04293562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5876830|NCT04293562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5876831|NCT04293562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5876832|NCT04293562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5876833|NCT04293562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5876834|NCT04293562|Antiviral Agents|antiviral agents|mesh-ancestor
5876835|NCT04293562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5876836|NCT04293562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5876837|NCT04293562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5876838|NCT04293562|Analgesics|analgesics|mesh-ancestor
5876839|NCT04293562|Sensory System Agents|sensory system agents|mesh-ancestor
5685363|NCT03462212|Growth Substances|growth substances|mesh-ancestor
5685364|NCT03462212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685365|NCT03462212|Growth Inhibitors|growth inhibitors|mesh-ancestor
5685366|NCT03462212|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5685367|NCT03462212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5685368|NCT03462173|Yimitasvir|yimitasvir|mesh-list
5876840|NCT04293562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5876841|NCT04293562|Keratolytic Agents|keratolytic agents|mesh-ancestor
5876842|NCT04293562|Tubulin Modulators|tubulin modulators|mesh-ancestor
5876843|NCT04293562|Antimitotic Agents|antimitotic agents|mesh-ancestor
5876844|NCT04293562|Mitosis Modulators|mitosis modulators|mesh-ancestor
5876845|NCT04293562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5876846|NCT04293562|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5876847|NCT04293562|Protective Agents|protective agents|mesh-ancestor
5876848|NCT04277975|Analgesics, Opioid|analgesics, opioid|mesh-list
5876849|NCT04277975|Narcotics|narcotics|mesh-ancestor
5876850|NCT04277975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5876851|NCT04277975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876852|NCT04277975|Analgesics|analgesics|mesh-ancestor
5685369|NCT03462173|Antiviral Agents|antiviral agents|mesh-ancestor
5685370|NCT03462173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5685371|NCT03462069|Empagliflozin|empagliflozin|mesh-list
5685372|NCT03462069|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
5685373|NCT03462069|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5685374|NCT03462069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685375|NCT03462069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5685376|NCT03462069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685377|NCT03462017|Sildenafil Citrate|sildenafil citrate|mesh-list
5685378|NCT03462017|Acetylcholine|acetylcholine|mesh-list
5685379|NCT03462017|Vasodilator Agents|vasodilator agents|mesh-ancestor
5685380|NCT03462017|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5685381|NCT03462017|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5685382|NCT03462017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5685383|NCT03462017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685384|NCT03462017|Urological Agents|urological agents|mesh-ancestor
5685385|NCT03462017|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5876853|NCT04277975|Sensory System Agents|sensory system agents|mesh-ancestor
5876854|NCT04277975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5876855|NCT04275531|Anesthetics|anesthetics|mesh-list
5876856|NCT04275531|Propofol|propofol|mesh-list
5876857|NCT04275531|Sevoflurane|sevoflurane|mesh-list
5876858|NCT04275531|Isoflurane|isoflurane|mesh-list
5876859|NCT04275531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5876860|NCT04275531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876861|NCT04275531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5876862|NCT04275531|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5876863|NCT04275531|Anesthetics, General|anesthetics, general|mesh-ancestor
5876864|NCT04275531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5876865|NCT04275531|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5876866|NCT04262479|Vitamin D|vitamin d|mesh-list
5876867|NCT04262479|Vitamins|vitamins|mesh-ancestor
5685386|NCT03462017|Cholinergic Agents|cholinergic agents|mesh-ancestor
5685387|NCT03462017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5685388|NCT03462017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685389|NCT03461783|Charcoal|charcoal|mesh-list
5685390|NCT03461783|Antidotes|antidotes|mesh-ancestor
5685391|NCT03461783|Protective Agents|protective agents|mesh-ancestor
5685392|NCT03461783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685393|NCT03461718|Fentanyl|fentanyl|mesh-list
5685394|NCT03461718|Midazolam|midazolam|mesh-list
5685395|NCT03461718|Ketamine|ketamine|mesh-list
5685396|NCT03461718|Analgesics|analgesics|mesh-ancestor
5685397|NCT03461718|Sensory System Agents|sensory system agents|mesh-ancestor
5876868|NCT04262479|Micronutrients|micronutrients|mesh-ancestor
5876869|NCT04262479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876870|NCT04262479|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5876871|NCT04239716|Anesthetics|anesthetics|mesh-list
5876872|NCT04239716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5876873|NCT04239716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685398|NCT03461718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5685399|NCT03461718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685400|NCT03461718|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5685401|NCT03461718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5685402|NCT03461718|Anesthetics, General|anesthetics, general|mesh-ancestor
5685403|NCT03461718|Anesthetics|anesthetics|mesh-ancestor
5685404|NCT03461718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5685405|NCT03461718|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5685406|NCT03461718|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5685407|NCT03461718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5685408|NCT03461718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876874|NCT04215848|Budesonide|budesonide|mesh-list
5876875|NCT04215848|Formoterol Fumarate|formoterol fumarate|mesh-list
5876876|NCT04215848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5876877|NCT04215848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5876878|NCT04215848|Autonomic Agents|autonomic agents|mesh-ancestor
5876879|NCT04215848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5876880|NCT04215848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876881|NCT04215848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5876882|NCT04215848|Respiratory System Agents|respiratory system agents|mesh-ancestor
5876883|NCT04215848|Glucocorticoids|glucocorticoids|mesh-ancestor
5876884|NCT04215848|Hormones|hormones|mesh-ancestor
5876885|NCT04215848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5876886|NCT04215848|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5876887|NCT04215848|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5876888|NCT04215848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5876889|NCT04215848|Adrenergic Agents|adrenergic agents|mesh-ancestor
5876890|NCT04215848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5876891|NCT04215848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876892|NCT04200534|Nicotine|nicotine|mesh-list
5876893|NCT04200534|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5876894|NCT04200534|Autonomic Agents|autonomic agents|mesh-ancestor
5876895|NCT04200534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5876896|NCT04200534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876897|NCT04200534|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5876898|NCT04200534|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5876899|NCT04200534|Cholinergic Agents|cholinergic agents|mesh-ancestor
5876900|NCT04200534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5876901|NCT04200534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876902|NCT04107051|Nalmefene|nalmefene|mesh-list
5876903|NCT04107051|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5876904|NCT04107051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876905|NCT04107051|Sensory System Agents|sensory system agents|mesh-ancestor
5876906|NCT04107051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5876907|NCT04090710|Nivolumab|nivolumab|mesh-list
5876908|NCT04090710|Ipilimumab|ipilimumab|mesh-list
5685409|NCT03461718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5685410|NCT03461718|Narcotics|narcotics|mesh-ancestor
5685411|NCT03461718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5685412|NCT03461718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5685413|NCT03461718|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5685414|NCT03461718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5685415|NCT03461718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5876909|NCT04090710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5876910|NCT04090710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5876911|NCT04090710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5876912|NCT04090710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876913|NCT04028388|Docetaxel|docetaxel|mesh-list
5876914|NCT04028388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5876915|NCT04028388|Tubulin Modulators|tubulin modulators|mesh-ancestor
5876916|NCT04028388|Antimitotic Agents|antimitotic agents|mesh-ancestor
5876917|NCT04028388|Mitosis Modulators|mitosis modulators|mesh-ancestor
5876918|NCT04028388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876919|NCT04003506|Bupivacaine|bupivacaine|mesh-list
5876920|NCT04003506|Anesthetics, Local|anesthetics, local|mesh-ancestor
5876921|NCT04003506|Anesthetics|anesthetics|mesh-ancestor
5876922|NCT04003506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5876923|NCT04003506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876924|NCT04003506|Sensory System Agents|sensory system agents|mesh-ancestor
5876925|NCT04003506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5876926|NCT03973593|Contraceptive Agents|contraceptive agents|mesh-list
5685416|NCT03461718|GABA Modulators|gaba modulators|mesh-ancestor
5685417|NCT03461718|GABA Agents|gaba agents|mesh-ancestor
5685418|NCT03461627|Fluticasone|fluticasone|mesh-list
5685419|NCT03461627|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5685420|NCT03461627|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
5685421|NCT03461627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5685422|NCT03461627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5685423|NCT03461627|Autonomic Agents|autonomic agents|mesh-ancestor
5685424|NCT03461627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5876927|NCT03973593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5876928|NCT03973593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906001|NCT04199026|Isophosphamide mustard|isophosphamide mustard|mesh-list
5906002|NCT04199026|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5906003|NCT04199026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5906004|NCT04199026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5906005|NCT04199026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5906006|NCT04199026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5906007|NCT04199026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5906008|NCT04199026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906009|NCT04199026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5906010|NCT04199026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5906011|NCT04199026|Tubulin Modulators|tubulin modulators|mesh-ancestor
5906012|NCT04199026|Antimitotic Agents|antimitotic agents|mesh-ancestor
5906013|NCT04199026|Mitosis Modulators|mitosis modulators|mesh-ancestor
5906014|NCT04199026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5906015|NCT04199026|Immunologic Factors|immunologic factors|mesh-ancestor
5906016|NCT04199026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906017|NCT04199026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5906018|NCT04199026|Alkylating Agents|alkylating agents|mesh-ancestor
5906019|NCT04199026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5906020|NCT04199026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5906021|NCT04199026|Antifungal Agents|antifungal agents|mesh-ancestor
5906022|NCT04139317|Pembrolizumab|pembrolizumab|mesh-list
5906023|NCT04139317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5906024|NCT04139317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5906025|NCT04114539|Ecopipam|ecopipam|mesh-list
5906026|NCT04114539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5906027|NCT04114539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5906028|NCT04114539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5906029|NCT04114539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906030|NCT04114539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5906031|NCT04114539|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5906032|NCT04114539|Dopamine Agents|dopamine agents|mesh-ancestor
5906033|NCT04114539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5906034|NCT04114539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906035|NCT04094298|FX006|fx006|mesh-list
5906036|NCT04094298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5906037|NCT04094298|Glucocorticoids|glucocorticoids|mesh-ancestor
5906038|NCT04094298|Hormones|hormones|mesh-ancestor
5906039|NCT04094298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5906040|NCT04094298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906041|NCT04094298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5906042|NCT04094298|Immunologic Factors|immunologic factors|mesh-ancestor
5906043|NCT04046549|Abatacept|abatacept|mesh-list
5906044|NCT04046549|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5906045|NCT04046549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906046|NCT04046549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5906047|NCT04046549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5906048|NCT04046549|Immunologic Factors|immunologic factors|mesh-ancestor
5906049|NCT04046549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906050|NCT04046549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5908643|NCT04334759|Durvalumab|durvalumab|mesh-list
5908644|NCT04334759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5908645|NCT04334759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5908646|NCT04334759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908647|NCT04334759|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5908648|NCT04334759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5908649|NCT04334759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5908650|NCT04330040|Olaparib|olaparib|mesh-list
5908651|NCT04330040|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5685425|NCT03461627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685426|NCT03461627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5685427|NCT03461627|Respiratory System Agents|respiratory system agents|mesh-ancestor
5685428|NCT03461627|Dermatologic Agents|dermatologic agents|mesh-ancestor
5685429|NCT03461627|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5685430|NCT03461627|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5685431|NCT03461627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5685432|NCT03461627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5685433|NCT03461627|Adrenergic Agents|adrenergic agents|mesh-ancestor
5685434|NCT03461627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5685435|NCT03461627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685436|NCT03461627|Glucocorticoids|glucocorticoids|mesh-ancestor
5685437|NCT03461627|Hormones|hormones|mesh-ancestor
5685438|NCT03461627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5685439|NCT03461627|Sympathomimetics|sympathomimetics|mesh-ancestor
5685440|NCT03461575|Cyclosporine|cyclosporine|mesh-list
5685441|NCT03461575|Cyclosporins|cyclosporins|mesh-list
5685442|NCT03461575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5685443|NCT03461575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685444|NCT03461575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5685445|NCT03461575|Immunologic Factors|immunologic factors|mesh-ancestor
5685446|NCT03461575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685447|NCT03461575|Antifungal Agents|antifungal agents|mesh-ancestor
5685448|NCT03461575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5685449|NCT03461575|Dermatologic Agents|dermatologic agents|mesh-ancestor
5685450|NCT03461575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5685451|NCT03461575|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5697229|NCT03377348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876929|NCT03955640|Olaparib|olaparib|mesh-list
5876930|NCT03955640|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
5876931|NCT03955640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5876932|NCT03955640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876933|NCT03955640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5876934|NCT03954782|Nintedanib|nintedanib|mesh-list
5876935|NCT03954782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5876936|NCT03954782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5876937|NCT03954782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5876938|NCT03954782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876939|NCT03919292|Valproic Acid|valproic acid|mesh-list
5876940|NCT03919292|Anticonvulsants|anticonvulsants|mesh-ancestor
5876941|NCT03919292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5876942|NCT03919292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876943|NCT03919292|GABA Agents|gaba agents|mesh-ancestor
5876944|NCT03919292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5876945|NCT03919292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876946|NCT03919292|Antimanic Agents|antimanic agents|mesh-ancestor
5876947|NCT03919292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5876948|NCT03919292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5876949|NCT03919292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5876950|NCT03910738|Methyltestosterone|methyltestosterone|mesh-list
5876951|NCT03910738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5876952|NCT03910738|Testosterone|testosterone|mesh-list
5876953|NCT03910738|Testosterone undecanoate|testosterone undecanoate|mesh-list
5876954|NCT03910738|Testosterone enanthate|testosterone enanthate|mesh-list
5697230|NCT03377348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5697231|NCT03377348|Immunologic Factors|immunologic factors|mesh-ancestor
6675329|NCT01574092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5876955|NCT03910738|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5876956|NCT03910738|Androgens|androgens|mesh-ancestor
5876957|NCT03910738|Hormones|hormones|mesh-ancestor
5876958|NCT03910738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5876959|NCT03910738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876960|NCT03910738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6675330|NCT01574092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6675331|NCT01574092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675332|NCT01574131|Fenofibrate|fenofibrate|mesh-list
6675333|NCT01574131|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6675334|NCT01574131|Antimetabolites|antimetabolites|mesh-ancestor
6675335|NCT01574131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675336|NCT01574131|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6675337|NCT01574261|Inositol|inositol|mesh-list
6675338|NCT01574261|Vitamin B Complex|vitamin b complex|mesh-ancestor
6675339|NCT01574261|Vitamins|vitamins|mesh-ancestor
6675340|NCT01574261|Micronutrients|micronutrients|mesh-ancestor
5697232|NCT03377348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5876961|NCT03910738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5876962|NCT03910738|Anabolic Agents|anabolic agents|mesh-ancestor
5876963|NCT03890744|Docetaxel|docetaxel|mesh-list
5876964|NCT03890744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5876965|NCT03890744|Tubulin Modulators|tubulin modulators|mesh-ancestor
5876966|NCT03890744|Antimitotic Agents|antimitotic agents|mesh-ancestor
5876967|NCT03890744|Mitosis Modulators|mitosis modulators|mesh-ancestor
5685452|NCT03461328|Magnesium Sulfate|magnesium sulfate|mesh-list
5876968|NCT03890744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876969|NCT03885037|Infliximab|infliximab|mesh-list
5876970|NCT03885037|Dermatologic Agents|dermatologic agents|mesh-ancestor
5876971|NCT03885037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5876972|NCT03885037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5876973|NCT03831503|Antibodies|antibodies|mesh-list
5876974|NCT03831503|Immunologic Factors|immunologic factors|mesh-ancestor
5876975|NCT03831503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876976|NCT03820817|Rifaximin|rifaximin|mesh-list
5876977|NCT03820817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5876978|NCT03820817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5876979|NCT03820817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5876980|NCT03789097|Pembrolizumab|pembrolizumab|mesh-list
5876981|NCT03789097|Poly ICLC|poly iclc|mesh-list
5876982|NCT03789097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5876983|NCT03789097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5876984|NCT03789097|Interferon Inducers|interferon inducers|mesh-ancestor
5876985|NCT03789097|Immunologic Factors|immunologic factors|mesh-ancestor
5876986|NCT03789097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876987|NCT03745430|Ramucirumab|ramucirumab|mesh-list
5876988|NCT03745430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5876989|NCT03742141|Glycopyrrolate|glycopyrrolate|mesh-list
5876990|NCT03742141|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5876991|NCT03742141|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5876992|NCT03742141|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5876993|NCT03742141|Cholinergic Agents|cholinergic agents|mesh-ancestor
5876994|NCT03742141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5876995|NCT03742141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5876996|NCT03742141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5876997|NCT03718793|Nitric Oxide|nitric oxide|mesh-list
5876998|NCT03718793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5876999|NCT03718793|Autonomic Agents|autonomic agents|mesh-ancestor
5877000|NCT03718793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5877001|NCT03718793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877002|NCT03718793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5877003|NCT03718793|Respiratory System Agents|respiratory system agents|mesh-ancestor
5877004|NCT03718793|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5877005|NCT03718793|Antioxidants|antioxidants|mesh-ancestor
5877006|NCT03718793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877007|NCT03718793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5877008|NCT03718793|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5877009|NCT03718793|Vasodilator Agents|vasodilator agents|mesh-ancestor
5877010|NCT03718793|Gasotransmitters|gasotransmitters|mesh-ancestor
5877011|NCT03718793|Protective Agents|protective agents|mesh-ancestor
5877012|NCT03671967|Meropenem|meropenem|mesh-list
5877013|NCT03671967|Tazobactam|tazobactam|mesh-list
5877014|NCT03671967|Piperacillin|piperacillin|mesh-list
5877015|NCT03671967|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
5877016|NCT03671967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5877017|NCT03671967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5877018|NCT03671967|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5877019|NCT03671967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5877020|NCT03671967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877021|NCT03524326|Cetuximab|cetuximab|mesh-list
5877022|NCT03524326|Lenvatinib|lenvatinib|mesh-list
5685453|NCT03461328|Analgesics|analgesics|mesh-ancestor
5685454|NCT03461328|Sensory System Agents|sensory system agents|mesh-ancestor
5685455|NCT03461328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5685456|NCT03461328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685457|NCT03461328|Anesthetics|anesthetics|mesh-ancestor
5685458|NCT03461328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5685459|NCT03461328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5685460|NCT03461328|Anticonvulsants|anticonvulsants|mesh-ancestor
5685461|NCT03461328|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5685462|NCT03461328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5685463|NCT03461328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685464|NCT03461328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5685465|NCT03461328|Tocolytic Agents|tocolytic agents|mesh-ancestor
5877023|NCT03524326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5877024|NCT03524326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5877025|NCT03524326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5877026|NCT03524326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5877027|NCT03524326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877028|NCT03512223|Dexamethasone|dexamethasone|mesh-list
5877029|NCT03512223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5877030|NCT03512223|Antiemetics|antiemetics|mesh-ancestor
5877031|NCT03512223|Autonomic Agents|autonomic agents|mesh-ancestor
5877032|NCT03512223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5877033|NCT03512223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877034|NCT03512223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5877035|NCT03512223|Glucocorticoids|glucocorticoids|mesh-ancestor
5877036|NCT03512223|Hormones|hormones|mesh-ancestor
5877037|NCT03512223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5877038|NCT03512223|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5877039|NCT03512223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5877040|NCT03441139|Analgesics|analgesics|mesh-list
5877041|NCT03441139|Sensory System Agents|sensory system agents|mesh-ancestor
5877042|NCT03441139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5877043|NCT03441139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877044|NCT03426891|Pembrolizumab|pembrolizumab|mesh-list
5877045|NCT03426891|Temozolomide|temozolomide|mesh-list
5877046|NCT03426891|Vorinostat|vorinostat|mesh-list
5877047|NCT03426891|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
5877048|NCT03426891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5877049|NCT03426891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5685466|NCT03461328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5685467|NCT03461302|Coal Tar|coal tar|mesh-list
5685468|NCT03461302|Keratolytic Agents|keratolytic agents|mesh-ancestor
5685469|NCT03461302|Dermatologic Agents|dermatologic agents|mesh-ancestor
5685470|NCT03461185|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
5685471|NCT03461185|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5685472|NCT03461185|Growth Substances|growth substances|mesh-ancestor
5685473|NCT03461185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685474|NCT03461185|Growth Inhibitors|growth inhibitors|mesh-ancestor
5685475|NCT03461185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5685476|NCT03461081|Amlodipine|amlodipine|mesh-list
5685477|NCT03461081|Telmisartan|telmisartan|mesh-list
5877050|NCT03426891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5877051|NCT03426891|Alkylating Agents|alkylating agents|mesh-ancestor
5877052|NCT03426891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877053|NCT03426891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5877054|NCT03426254|Talazoparib|talazoparib|mesh-list
5877055|NCT03426254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5877056|NCT03426254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5877057|NCT03426254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877058|NCT03426254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5877059|NCT03359460|Lenalidomide|lenalidomide|mesh-list
5877060|NCT03359460|Immunologic Factors|immunologic factors|mesh-ancestor
5877061|NCT03359460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685478|NCT03461081|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
5685479|NCT03461081|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
5685480|NCT03461081|Atorvastatin|atorvastatin|mesh-list
5685481|NCT03461081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5685482|NCT03461081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5685483|NCT03461081|Antimetabolites|antimetabolites|mesh-ancestor
5685484|NCT03461081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685485|NCT03461081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5685486|NCT03461081|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5685487|NCT03461081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5685488|NCT03461081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5685489|NCT03461081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5685490|NCT03461081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5685491|NCT03461081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5685492|NCT03461081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685493|NCT03461081|Vasodilator Agents|vasodilator agents|mesh-ancestor
5685494|NCT03461081|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5685495|NCT03461081|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5685496|NCT03461003|Losartan|losartan|mesh-list
5685497|NCT03461003|Amlodipine|amlodipine|mesh-list
5877062|NCT03359460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5877063|NCT03359460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5877064|NCT03359460|Growth Substances|growth substances|mesh-ancestor
5877065|NCT03359460|Growth Inhibitors|growth inhibitors|mesh-ancestor
5877066|NCT03359460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5877067|NCT03351348|Bupivacaine|bupivacaine|mesh-list
5877068|NCT03351348|Anesthetics, Local|anesthetics, local|mesh-ancestor
5877069|NCT03351348|Anesthetics|anesthetics|mesh-ancestor
5877070|NCT03351348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5877071|NCT03351348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877072|NCT03351348|Sensory System Agents|sensory system agents|mesh-ancestor
5877073|NCT03351348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5877074|NCT03339128|Eluxadoline|eluxadoline|mesh-list
5877075|NCT03339128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5877076|NCT03227263|Bevacizumab|bevacizumab|mesh-list
5877077|NCT03227263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5685498|NCT03461003|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5685499|NCT03461003|Lisinopril|lisinopril|mesh-list
5685500|NCT03461003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5685501|NCT03461003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5685502|NCT03461003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5685503|NCT03461003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685504|NCT03461003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5685505|NCT03461003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685506|NCT03461003|Vasodilator Agents|vasodilator agents|mesh-ancestor
5685507|NCT03461003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5685508|NCT03461003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5685509|NCT03461003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5685510|NCT03461003|Diuretics|diuretics|mesh-ancestor
5685511|NCT03461003|Natriuretic Agents|natriuretic agents|mesh-ancestor
5877078|NCT03227263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5877079|NCT03227263|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5877080|NCT03227263|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5877081|NCT03227263|Growth Substances|growth substances|mesh-ancestor
5877082|NCT03227263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877083|NCT03227263|Growth Inhibitors|growth inhibitors|mesh-ancestor
5877084|NCT03222570|Serotonin|serotonin|mesh-list
5877085|NCT03222570|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
5877086|NCT03222570|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5877087|NCT03222570|Serotonin Agents|serotonin agents|mesh-ancestor
5877088|NCT03222570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5877089|NCT03222570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877090|NCT03222570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877091|NCT03222570|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5877092|NCT03222570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5877093|NCT03211416|Pembrolizumab|pembrolizumab|mesh-list
5877094|NCT03211416|Sorafenib|sorafenib|mesh-list
5877095|NCT03211416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5877096|NCT03211416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5877097|NCT03211416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5877098|NCT03211416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5877099|NCT03211416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877100|NCT03150368|Docetaxel|docetaxel|mesh-list
5877101|NCT03150368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5877102|NCT03150368|Tubulin Modulators|tubulin modulators|mesh-ancestor
5877103|NCT03150368|Antimitotic Agents|antimitotic agents|mesh-ancestor
5877104|NCT03150368|Mitosis Modulators|mitosis modulators|mesh-ancestor
5877105|NCT03150368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877106|NCT03147378|Docetaxel|docetaxel|mesh-list
5877107|NCT03147378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5877108|NCT03147378|Tubulin Modulators|tubulin modulators|mesh-ancestor
5877109|NCT03147378|Antimitotic Agents|antimitotic agents|mesh-ancestor
5877110|NCT03147378|Mitosis Modulators|mitosis modulators|mesh-ancestor
5877111|NCT03147378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877112|NCT03147040|Carboplatin|carboplatin|mesh-list
5685512|NCT03461003|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5685513|NCT03461003|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5685514|NCT03461003|Protease Inhibitors|protease inhibitors|mesh-ancestor
5685515|NCT03461003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5685516|NCT03461003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5685517|NCT03461003|Protective Agents|protective agents|mesh-ancestor
5685518|NCT03460964|Pilocarpine|pilocarpine|mesh-list
5685519|NCT03460964|Miotics|miotics|mesh-ancestor
5685520|NCT03460964|Autonomic Agents|autonomic agents|mesh-ancestor
5685521|NCT03460964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5685522|NCT03460964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685523|NCT03460964|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
5877113|NCT03147040|Atezolizumab|atezolizumab|mesh-list
5877114|NCT03147040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5877115|NCT03136640|Docetaxel|docetaxel|mesh-list
5877116|NCT03136640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5877117|NCT03136640|Tubulin Modulators|tubulin modulators|mesh-ancestor
5877118|NCT03136640|Antimitotic Agents|antimitotic agents|mesh-ancestor
5877119|NCT03136640|Mitosis Modulators|mitosis modulators|mesh-ancestor
5877120|NCT03136640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877121|NCT02981628|Calcium, Dietary|calcium, dietary|mesh-list
5877122|NCT02981628|Leucovorin|leucovorin|mesh-list
5877123|NCT02981628|Folic Acid|folic acid|mesh-list
5877124|NCT02981628|Cytarabine|cytarabine|mesh-list
5877125|NCT02981628|Cyclophosphamide|cyclophosphamide|mesh-list
5877126|NCT02981628|Methotrexate|methotrexate|mesh-list
5877127|NCT02981628|Vincristine|vincristine|mesh-list
5877128|NCT02981628|Asparaginase|asparaginase|mesh-list
5877129|NCT02981628|Mercaptopurine|mercaptopurine|mesh-list
5877130|NCT02981628|Pegaspargase|pegaspargase|mesh-list
5877131|NCT02981628|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
5877132|NCT02981628|Calcium|calcium|mesh-list
5877133|NCT02981628|Levoleucovorin|levoleucovorin|mesh-list
5877134|NCT02981628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5877135|NCT02981628|Immunologic Factors|immunologic factors|mesh-ancestor
5877136|NCT02981628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877137|NCT02981628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5877138|NCT02981628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5877139|NCT02981628|Alkylating Agents|alkylating agents|mesh-ancestor
5877140|NCT02981628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877141|NCT02981628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5877142|NCT02981628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5877143|NCT02981628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5877144|NCT02981628|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5877145|NCT02981628|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5877146|NCT02981628|Abortifacient Agents|abortifacient agents|mesh-ancestor
5877147|NCT02981628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5877148|NCT02981628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5877149|NCT02981628|Antimetabolites|antimetabolites|mesh-ancestor
5877150|NCT02981628|Dermatologic Agents|dermatologic agents|mesh-ancestor
5877151|NCT02981628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5877152|NCT02981628|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5877153|NCT02981628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5877154|NCT02981628|Antiviral Agents|antiviral agents|mesh-ancestor
5877155|NCT02981628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5877156|NCT02981628|Antidotes|antidotes|mesh-ancestor
5877157|NCT02981628|Protective Agents|protective agents|mesh-ancestor
5877158|NCT02981628|Vitamin B Complex|vitamin b complex|mesh-ancestor
5877159|NCT02981628|Vitamins|vitamins|mesh-ancestor
5877160|NCT02981628|Micronutrients|micronutrients|mesh-ancestor
5877161|NCT02981628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5877162|NCT02981628|Tubulin Modulators|tubulin modulators|mesh-ancestor
5877163|NCT02981628|Antimitotic Agents|antimitotic agents|mesh-ancestor
5877164|NCT02981628|Mitosis Modulators|mitosis modulators|mesh-ancestor
5877165|NCT02981628|Hematinics|hematinics|mesh-ancestor
5877166|NCT02981628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5877167|NCT02981628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5877168|NCT02972398|Acetylcysteine|acetylcysteine|mesh-list
5877169|NCT02972398|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5877170|NCT02972398|Antiviral Agents|antiviral agents|mesh-ancestor
5877171|NCT02972398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5877172|NCT02972398|Expectorants|expectorants|mesh-ancestor
5877173|NCT02972398|Respiratory System Agents|respiratory system agents|mesh-ancestor
5877174|NCT02972398|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5877175|NCT02972398|Antioxidants|antioxidants|mesh-ancestor
6675341|NCT01574261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685524|NCT03460964|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5685525|NCT03460964|Cholinergic Agents|cholinergic agents|mesh-ancestor
5685526|NCT03460964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5685527|NCT03460964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685528|NCT03460860|Tocopherols|tocopherols|mesh-list
5685529|NCT03460860|Vitamin E|vitamin e|mesh-list
5685530|NCT03460860|Tocotrienols|tocotrienols|mesh-list
5685531|NCT03460860|alpha-Tocopherol|alpha-tocopherol|mesh-list
5685532|NCT03460860|Lycopene|lycopene|mesh-list
5685533|NCT03460860|Antioxidants|antioxidants|mesh-ancestor
5685534|NCT03460860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877176|NCT02972398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877177|NCT02972398|Protective Agents|protective agents|mesh-ancestor
5685535|NCT03460860|Protective Agents|protective agents|mesh-ancestor
5877178|NCT02972398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877179|NCT02972398|Antidotes|antidotes|mesh-ancestor
5877180|NCT02914470|Atezolizumab|atezolizumab|mesh-list
5877181|NCT02914470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5877182|NCT02826512|Niraparib|niraparib|mesh-list
5877183|NCT02826512|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5877184|NCT02826512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5877185|NCT02826512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877186|NCT02826512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5877187|NCT02810743|Olaparib|olaparib|mesh-list
5877188|NCT02810743|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5877189|NCT02810743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5877190|NCT02810743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877191|NCT02810743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5877192|NCT02660710|Rituximab|rituximab|mesh-list
5877193|NCT02660710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5685536|NCT03460860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685537|NCT03460860|Vitamins|vitamins|mesh-ancestor
5685538|NCT03460860|Micronutrients|micronutrients|mesh-ancestor
5685539|NCT03460860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5685540|NCT03460860|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5685541|NCT03460860|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5685542|NCT03460860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5877194|NCT02660710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5877195|NCT02660710|Immunologic Factors|immunologic factors|mesh-ancestor
5877196|NCT02660710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877197|NCT02660710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5877198|NCT02492711|Gemcitabine|gemcitabine|mesh-list
5877199|NCT02492711|Capecitabine|capecitabine|mesh-list
5877200|NCT02492711|Trastuzumab|trastuzumab|mesh-list
5877201|NCT02492711|Vinorelbine|vinorelbine|mesh-list
5877202|NCT02492711|Margetuximab|margetuximab|mesh-list
5877203|NCT02492711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5877204|NCT02492711|Antimetabolites|antimetabolites|mesh-ancestor
5877205|NCT02492711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877206|NCT02492711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5877207|NCT02492711|Antiviral Agents|antiviral agents|mesh-ancestor
5877208|NCT02492711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5877209|NCT02492711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5877210|NCT02492711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5877211|NCT02492711|Immunologic Factors|immunologic factors|mesh-ancestor
5877212|NCT02492711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877213|NCT02492711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5877214|NCT02492711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5877215|NCT02492711|Tubulin Modulators|tubulin modulators|mesh-ancestor
5877216|NCT02492711|Antimitotic Agents|antimitotic agents|mesh-ancestor
5877217|NCT02492711|Mitosis Modulators|mitosis modulators|mesh-ancestor
5906051|NCT04003636|Gemcitabine|gemcitabine|mesh-list
5906052|NCT04003636|Cisplatin|cisplatin|mesh-list
5906053|NCT04003636|Pembrolizumab|pembrolizumab|mesh-list
5906054|NCT04003636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5906055|NCT04003636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5906056|NCT04003636|Antimetabolites|antimetabolites|mesh-ancestor
5906057|NCT04003636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906058|NCT04003636|Antiviral Agents|antiviral agents|mesh-ancestor
5906059|NCT04003636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5906060|NCT04003636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5906061|NCT04003636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5906062|NCT04003636|Immunologic Factors|immunologic factors|mesh-ancestor
5906063|NCT04003636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906064|NCT04003636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5906065|NCT03976934|Tamsulosin|tamsulosin|mesh-list
5906066|NCT03976934|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5685543|NCT03460808|Acetylcysteine|acetylcysteine|mesh-list
5685544|NCT03460808|Atorvastatin|atorvastatin|mesh-list
5685545|NCT03460808|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5685546|NCT03460808|Danazol|danazol|mesh-list
5685547|NCT03460808|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5685548|NCT03460808|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5685549|NCT03460808|Antimetabolites|antimetabolites|mesh-ancestor
5685550|NCT03460808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685551|NCT03460808|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5685552|NCT03460808|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5685553|NCT03460808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5685554|NCT03460808|Antiviral Agents|antiviral agents|mesh-ancestor
5685555|NCT03460808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5685556|NCT03460808|Expectorants|expectorants|mesh-ancestor
5877218|NCT02484716|Timolol|timolol|mesh-list
5877219|NCT02484716|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5877220|NCT02484716|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5877221|NCT02484716|Adrenergic Agents|adrenergic agents|mesh-ancestor
5877222|NCT02484716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5877223|NCT02484716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877224|NCT02484716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877225|NCT02484716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5877226|NCT02484716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5877227|NCT05088369|Adrenomedullin|adrenomedullin|mesh-list
5877228|NCT05088369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5877229|NCT05088369|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5877230|NCT05088369|Autonomic Agents|autonomic agents|mesh-ancestor
5877231|NCT05088369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5877232|NCT05088369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877233|NCT05088369|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5685557|NCT03460808|Respiratory System Agents|respiratory system agents|mesh-ancestor
5685558|NCT03460808|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5685559|NCT03460808|Antioxidants|antioxidants|mesh-ancestor
5685560|NCT03460808|Protective Agents|protective agents|mesh-ancestor
5685561|NCT03460808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685562|NCT03460808|Antidotes|antidotes|mesh-ancestor
5685563|NCT03460808|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5877234|NCT05088369|Respiratory System Agents|respiratory system agents|mesh-ancestor
5877235|NCT05088369|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5877236|NCT05088369|Vasodilator Agents|vasodilator agents|mesh-ancestor
5877237|NCT05088369|Protective Agents|protective agents|mesh-ancestor
5877238|NCT05088343|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5877239|NCT05088343|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5877240|NCT05088343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5877241|NCT05088343|Antimetabolites|antimetabolites|mesh-ancestor
5877242|NCT05088343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877243|NCT05088343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5877244|NCT05088343|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5877245|NCT05088343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5685564|NCT03460808|Hormone Antagonists|hormone antagonists|mesh-ancestor
5685565|NCT03460808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5685566|NCT03460782|Ipilimumab|ipilimumab|mesh-list
5685567|NCT03460782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5685568|NCT03460782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5685569|NCT03460782|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5685570|NCT03460782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685571|NCT03460743|Vaccines|vaccines|mesh-list
5685572|NCT03460743|Hemagglutinins|hemagglutinins|mesh-list
5685573|NCT03460743|Immunologic Factors|immunologic factors|mesh-ancestor
5877246|NCT05088330|Daratumumab|daratumumab|mesh-list
5877247|NCT05088330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5877248|NCT05088239|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5877249|NCT05088239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5877250|NCT05088174|Cyclosporine|cyclosporine|mesh-list
5877251|NCT05088174|Cyclosporins|cyclosporins|mesh-list
5877252|NCT05088174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5877253|NCT05088174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877254|NCT05088174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5877255|NCT05088174|Immunologic Factors|immunologic factors|mesh-ancestor
5877256|NCT05088174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877257|NCT05088174|Antifungal Agents|antifungal agents|mesh-ancestor
5877258|NCT05088174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5877259|NCT05088174|Dermatologic Agents|dermatologic agents|mesh-ancestor
5877260|NCT05088174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5877261|NCT05088174|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5877262|NCT05088083|Paclitaxel|paclitaxel|mesh-list
5877263|NCT05088083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5877264|NCT05088083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5877265|NCT05088083|Tubulin Modulators|tubulin modulators|mesh-ancestor
5877266|NCT05088083|Antimitotic Agents|antimitotic agents|mesh-ancestor
5877267|NCT05088083|Mitosis Modulators|mitosis modulators|mesh-ancestor
5877268|NCT05088083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877269|NCT05088057|Cyclophosphamide|cyclophosphamide|mesh-list
5877270|NCT05088057|Docetaxel|docetaxel|mesh-list
5877271|NCT05088057|Doxorubicin|doxorubicin|mesh-list
5877272|NCT05088057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5685574|NCT03460743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685575|NCT03460743|Agglutinins|agglutinins|mesh-ancestor
5877273|NCT05088057|Immunologic Factors|immunologic factors|mesh-ancestor
5877274|NCT05088057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685576|NCT03460730|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5685577|NCT03460730|Immunologic Factors|immunologic factors|mesh-ancestor
5877275|NCT05088057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5877276|NCT05088057|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5877277|NCT05088057|Alkylating Agents|alkylating agents|mesh-ancestor
5877278|NCT05088057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877279|NCT05088057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5877280|NCT05088057|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5877281|NCT05088057|Tubulin Modulators|tubulin modulators|mesh-ancestor
5877282|NCT05088057|Antimitotic Agents|antimitotic agents|mesh-ancestor
5877283|NCT05088057|Mitosis Modulators|mitosis modulators|mesh-ancestor
5877284|NCT05088057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5877285|NCT05088057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5877286|NCT05088057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5877287|NCT05088057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5877288|NCT05087797|Nicorandil|nicorandil|mesh-list
5877289|NCT05087797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5877290|NCT05087797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5877291|NCT05087797|Vasodilator Agents|vasodilator agents|mesh-ancestor
5877292|NCT05087797|Vitamin B Complex|vitamin b complex|mesh-ancestor
5877293|NCT05087797|Vitamins|vitamins|mesh-ancestor
5877294|NCT05087797|Micronutrients|micronutrients|mesh-ancestor
5877295|NCT05087797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877296|NCT05087771|Naltrexone|naltrexone|mesh-list
5877297|NCT05087771|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5877298|NCT05087771|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5877299|NCT05087771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877300|NCT05087771|Sensory System Agents|sensory system agents|mesh-ancestor
5877301|NCT05087771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5877302|NCT05087706|Bicalutamide|bicalutamide|mesh-list
5877303|NCT05087706|Leuprolide|leuprolide|mesh-list
5877304|NCT05087706|Androgen Antagonists|androgen antagonists|mesh-ancestor
5877305|NCT05087706|Hormone Antagonists|hormone antagonists|mesh-ancestor
5877306|NCT05087706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5685578|NCT03460730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685579|NCT03460678|Pemetrexed|pemetrexed|mesh-list
5685580|NCT03460678|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5685581|NCT03460678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5685582|NCT03460678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5877307|NCT05087706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877308|NCT05087706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5877309|NCT05087706|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5877310|NCT05087706|Fertility Agents|fertility agents|mesh-ancestor
5877311|NCT05087706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5877312|NCT05087706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5877313|NCT05087693|Albuterol|albuterol|mesh-list
5877314|NCT05087693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5877315|NCT05087693|Autonomic Agents|autonomic agents|mesh-ancestor
5877316|NCT05087693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5877317|NCT05087693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877318|NCT05087693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5877319|NCT05087693|Respiratory System Agents|respiratory system agents|mesh-ancestor
5877320|NCT05087693|Tocolytic Agents|tocolytic agents|mesh-ancestor
5877321|NCT05087693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5877322|NCT05087693|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5877323|NCT05087693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5877324|NCT05087693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5877325|NCT05087693|Adrenergic Agents|adrenergic agents|mesh-ancestor
5877326|NCT05087693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5877327|NCT05087693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877328|NCT05087368|Vaccines|vaccines|mesh-list
5877329|NCT05087368|Immunologic Factors|immunologic factors|mesh-ancestor
5877330|NCT05087368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877331|NCT05087134|Choline|choline|mesh-list
5877332|NCT05087134|Lipotropic Agents|lipotropic agents|mesh-ancestor
5877333|NCT05087134|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5877334|NCT05087134|Antimetabolites|antimetabolites|mesh-ancestor
5877335|NCT05087134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877336|NCT05087134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5877337|NCT05087134|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5877338|NCT05087134|Nootropic Agents|nootropic agents|mesh-ancestor
5877339|NCT05086874|3-n-butylphthalide|3-n-butylphthalide|mesh-list
5877340|NCT05086874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5877341|NCT05086874|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5685583|NCT03460678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877342|NCT05086874|Protective Agents|protective agents|mesh-ancestor
5877343|NCT05086874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877344|NCT05086848|Leucovorin|leucovorin|mesh-list
5877345|NCT05086848|Fluorouracil|fluorouracil|mesh-list
5877346|NCT05086848|Irinotecan|irinotecan|mesh-list
5877347|NCT05086848|Antimetabolites|antimetabolites|mesh-ancestor
5877348|NCT05086848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877349|NCT05086848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5877350|NCT05086848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5877351|NCT05086848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5877352|NCT05086848|Immunologic Factors|immunologic factors|mesh-ancestor
5877353|NCT05086848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877354|NCT05086848|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5877355|NCT05086848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5877356|NCT05086848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5877357|NCT05086848|Antidotes|antidotes|mesh-ancestor
5877358|NCT05086848|Protective Agents|protective agents|mesh-ancestor
5877359|NCT05086848|Vitamin B Complex|vitamin b complex|mesh-ancestor
5877360|NCT05086848|Vitamins|vitamins|mesh-ancestor
5877361|NCT05086848|Micronutrients|micronutrients|mesh-ancestor
5877362|NCT05086822|Irinotecan|irinotecan|mesh-list
5877363|NCT05086822|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5877364|NCT05086822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5877365|NCT05086822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5877366|NCT05086822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877367|NCT05086822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5877368|NCT05086627|Capecitabine|capecitabine|mesh-list
5877369|NCT05086627|Oxaliplatin|oxaliplatin|mesh-list
5877370|NCT05086627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5877371|NCT05086627|Antimetabolites|antimetabolites|mesh-ancestor
5877372|NCT05086627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877373|NCT05086627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5877374|NCT05086614|Thymalfasin|thymalfasin|mesh-list
5877375|NCT05086614|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5877376|NCT05086614|Immunologic Factors|immunologic factors|mesh-ancestor
5877377|NCT05086614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906067|NCT03976934|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5906068|NCT03976934|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5906069|NCT03976934|Adrenergic Agents|adrenergic agents|mesh-ancestor
5906070|NCT03976934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5906071|NCT03976934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906072|NCT03976934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906073|NCT03976934|Urological Agents|urological agents|mesh-ancestor
5906074|NCT03971422|Rozanolixizumab|rozanolixizumab|mesh-list
5906075|NCT03971422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5906076|NCT03971422|Immunologic Factors|immunologic factors|mesh-ancestor
5906077|NCT03971422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906078|NCT03969446|Pembrolizumab|pembrolizumab|mesh-list
5906079|NCT03969446|Decitabine|decitabine|mesh-list
5906080|NCT03969446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5906081|NCT03969446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5906082|NCT03969446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5906083|NCT03969446|Antimetabolites|antimetabolites|mesh-ancestor
5685584|NCT03460678|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5685585|NCT03460678|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5685586|NCT03460678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5685587|NCT03460522|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
5685588|NCT03460522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5685589|NCT03460522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5685590|NCT03460522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5685591|NCT03460470|Sildenafil Citrate|sildenafil citrate|mesh-list
5685592|NCT03460470|Vasodilator Agents|vasodilator agents|mesh-ancestor
5685593|NCT03460470|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5685594|NCT03460470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5685595|NCT03460470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5685596|NCT03460470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685597|NCT03460470|Urological Agents|urological agents|mesh-ancestor
5685598|NCT03460405|Vaccines|vaccines|mesh-list
5685599|NCT03460405|Immunologic Factors|immunologic factors|mesh-ancestor
5685600|NCT03460405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685601|NCT03460392|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5685602|NCT03460392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5685603|NCT03460379|Citalopram|citalopram|mesh-list
5906084|NCT03969446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906085|NCT03969446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5906086|NCT03939897|Fulvestrant|fulvestrant|mesh-list
5877378|NCT05086224|Lidocaine|lidocaine|mesh-list
5877379|NCT05086224|Anesthetics, Local|anesthetics, local|mesh-list
5877380|NCT05086224|Anesthetics|anesthetics|mesh-list
5877381|NCT05086224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5877382|NCT05086224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877383|NCT05086224|Sensory System Agents|sensory system agents|mesh-ancestor
5877384|NCT05086224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5877385|NCT05086224|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5877386|NCT05086224|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5877387|NCT05086224|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5877388|NCT05086224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5877389|NCT05086224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877390|NCT05086107|Rifabutin|rifabutin|mesh-list
5877391|NCT05086107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5877392|NCT05086107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5877393|NCT05086107|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5877394|NCT05086107|Antitubercular Agents|antitubercular agents|mesh-ancestor
5877395|NCT05086081|Ticagrelor|ticagrelor|mesh-list
5877396|NCT05086081|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
5877397|NCT05086081|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5877398|NCT05086081|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5877399|NCT05086081|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5877400|NCT05086081|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5877401|NCT05086081|Purinergic Agents|purinergic agents|mesh-ancestor
5877402|NCT05086081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5877403|NCT05086081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877404|NCT05086081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877405|NCT05085912|Ethanol|ethanol|mesh-list
6495772|NCT00625014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6495773|NCT00625014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495774|NCT00625014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6495775|NCT00625014|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6495776|NCT00625014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6495777|NCT00625014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6495778|NCT00625014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6495779|NCT00625014|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6495780|NCT00625014|Dopamine Agents|dopamine agents|mesh-ancestor
6495781|NCT00625014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6495782|NCT00625014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495783|NCT00625014|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5685604|NCT03460379|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5685605|NCT03460379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5685606|NCT03460379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5685607|NCT03460379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685608|NCT03460379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5685609|NCT03460379|Serotonin Agents|serotonin agents|mesh-ancestor
5685610|NCT03460379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685611|NCT03460379|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5685612|NCT03460379|Antidepressive Agents|antidepressive agents|mesh-ancestor
5685613|NCT03460379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5685614|NCT03460366|Enalapril|enalapril|mesh-list
5685615|NCT03460366|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5685616|NCT03460366|Protease Inhibitors|protease inhibitors|mesh-ancestor
5685617|NCT03460366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5685618|NCT03460366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685619|NCT03460366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5685620|NCT03460353|Dextroamphetamine|dextroamphetamine|mesh-list
5877406|NCT05085912|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5877407|NCT05085912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6495784|NCT00625079|Sildenafil Citrate|sildenafil citrate|mesh-list
6495785|NCT00625079|Vasodilator Agents|vasodilator agents|mesh-ancestor
6495786|NCT00625079|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6495787|NCT00625079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6495788|NCT00625079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6495789|NCT00625079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877408|NCT05085912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5877409|NCT05085912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877410|NCT05085808|Quetiapine Fumarate|quetiapine fumarate|mesh-list
5877411|NCT05085808|Trazodone|trazodone|mesh-list
5877412|NCT05085808|Antidepressive Agents|antidepressive agents|mesh-ancestor
5877413|NCT05085808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5877414|NCT05085808|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5685621|NCT03460353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5685622|NCT03460353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685623|NCT03460353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5685624|NCT03460353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5877415|NCT05085808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5877416|NCT05085808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5877417|NCT05085808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877418|NCT05085808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5877419|NCT05085808|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5877420|NCT05085808|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5877421|NCT05085808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5877422|NCT05085808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877423|NCT05085808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5877424|NCT05085808|Serotonin Agents|serotonin agents|mesh-ancestor
5877425|NCT05085808|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5877426|NCT05085782|Propranolol|propranolol|mesh-list
5877427|NCT05085782|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5877428|NCT05085782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5877429|NCT05085782|Adrenergic Agents|adrenergic agents|mesh-ancestor
5877430|NCT05085782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5877431|NCT05085782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877432|NCT05085782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877433|NCT05085782|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5685625|NCT03460353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5685626|NCT03460353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685627|NCT03460353|Dopamine Agents|dopamine agents|mesh-ancestor
5685628|NCT03460353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5685629|NCT03460327|Candesartan|candesartan|mesh-list
5685630|NCT03460327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5685631|NCT03460327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5685632|NCT03460327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5685633|NCT03460327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685634|NCT03460314|Buprenorphine|buprenorphine|mesh-list
5685635|NCT03460314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5685636|NCT03460314|Narcotics|narcotics|mesh-ancestor
5685637|NCT03460314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5685638|NCT03460314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685639|NCT03460314|Analgesics|analgesics|mesh-ancestor
5685640|NCT03460314|Sensory System Agents|sensory system agents|mesh-ancestor
5685641|NCT03460314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5685642|NCT03460314|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5685643|NCT03460275|Osimertinib|osimertinib|mesh-list
5685644|NCT03460275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5685645|NCT03460275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5685646|NCT03460275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5685647|NCT03460275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685648|NCT03460210|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
5685649|NCT03460210|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5685650|NCT03460210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5685651|NCT03460210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5685652|NCT03460210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685653|NCT03460210|Adrenergic Agents|adrenergic agents|mesh-ancestor
5685654|NCT03460210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5685655|NCT03460210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685656|NCT03460145|Propofol|propofol|mesh-list
5685657|NCT03460145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5877434|NCT05085782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5877435|NCT05085782|Vasodilator Agents|vasodilator agents|mesh-ancestor
5877436|NCT05085665|Ivermectin|ivermectin|mesh-list
5877437|NCT05085665|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5877438|NCT05085665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5877439|NCT05085652|Anesthetics|anesthetics|mesh-list
5877440|NCT05085652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5877441|NCT05085652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877442|NCT05085587|Fluticasone|fluticasone|mesh-list
5877443|NCT05085587|Xhance|xhance|mesh-list
5877444|NCT05085587|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5877445|NCT05085587|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
5877446|NCT05085587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5877447|NCT05085587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5877448|NCT05085587|Autonomic Agents|autonomic agents|mesh-ancestor
5877449|NCT05085587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5877450|NCT05085587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877451|NCT05085587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5877452|NCT05085587|Respiratory System Agents|respiratory system agents|mesh-ancestor
5877453|NCT05085587|Dermatologic Agents|dermatologic agents|mesh-ancestor
5877454|NCT05085587|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5877455|NCT05085587|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5877456|NCT05085587|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5877457|NCT05085587|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5877458|NCT05085587|Adrenergic Agents|adrenergic agents|mesh-ancestor
5877459|NCT05085587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5877460|NCT05085587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685658|NCT03460145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5685659|NCT03460145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685660|NCT03460145|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5685661|NCT03460145|Anesthetics, General|anesthetics, general|mesh-ancestor
5685662|NCT03460145|Anesthetics|anesthetics|mesh-ancestor
5685663|NCT03460041|Magnesium Sulfate|magnesium sulfate|mesh-list
5685664|NCT03460041|Bupivacaine|bupivacaine|mesh-list
5685665|NCT03460041|Anesthetics, Local|anesthetics, local|mesh-ancestor
5685666|NCT03460041|Anesthetics|anesthetics|mesh-ancestor
5685667|NCT03460041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5685668|NCT03460041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685669|NCT03460041|Sensory System Agents|sensory system agents|mesh-ancestor
5685670|NCT03460041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5685671|NCT03460041|Analgesics|analgesics|mesh-ancestor
5685672|NCT03460041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5685673|NCT03460041|Anticonvulsants|anticonvulsants|mesh-ancestor
5685674|NCT03460041|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5685675|NCT03460041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5685676|NCT03460041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685677|NCT03460041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5685678|NCT03460041|Tocolytic Agents|tocolytic agents|mesh-ancestor
5685679|NCT03460041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5685680|NCT03460002|Vaccines|vaccines|mesh-list
5685681|NCT03460002|Immunologic Factors|immunologic factors|mesh-ancestor
5685682|NCT03460002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685683|NCT03459911|Losartan|losartan|mesh-list
5685684|NCT03459911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5685685|NCT03459911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5685686|NCT03459911|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6675342|NCT01574274|Pegaspargase|pegaspargase|mesh-list
6675343|NCT01574274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6675344|NCT01574313|Tocopherols|tocopherols|mesh-list
6675345|NCT01574313|Vitamin E|vitamin e|mesh-list
6675346|NCT01574313|Tocotrienols|tocotrienols|mesh-list
6675347|NCT01574313|alpha-Tocopherol|alpha-tocopherol|mesh-list
6675348|NCT01574313|Niacin|niacin|mesh-list
5877461|NCT05085587|Glucocorticoids|glucocorticoids|mesh-ancestor
5877462|NCT05085587|Hormones|hormones|mesh-ancestor
5877463|NCT05085587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5877464|NCT05085587|Sympathomimetics|sympathomimetics|mesh-ancestor
5877465|NCT05085106|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5877466|NCT05085106|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5877467|NCT05085067|Hyaluronic Acid|hyaluronic acid|mesh-list
5877468|NCT05085067|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5877469|NCT05085067|Immunologic Factors|immunologic factors|mesh-ancestor
5877470|NCT05085067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877471|NCT05085067|Viscosupplements|viscosupplements|mesh-ancestor
5877472|NCT05085067|Protective Agents|protective agents|mesh-ancestor
5877473|NCT05085028|Pembrolizumab|pembrolizumab|mesh-list
5877474|NCT05085028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5877475|NCT05085028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5877476|NCT05084872|Hydroxychloroquine|hydroxychloroquine|mesh-list
5877477|NCT05084872|Antimalarials|antimalarials|mesh-ancestor
5877478|NCT05084872|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5877479|NCT05084872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5877480|NCT05084872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5877481|NCT05084872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5877482|NCT05084872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877483|NCT05084872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6675349|NCT01574313|Diphenidol|diphenidol|mesh-list
6675350|NCT01574313|Antioxidants|antioxidants|mesh-ancestor
5685687|NCT03459911|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5685688|NCT03459911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685689|NCT03459833|Hyaluronic Acid|hyaluronic acid|mesh-list
5685690|NCT03459833|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5685691|NCT03459833|Immunologic Factors|immunologic factors|mesh-ancestor
5685692|NCT03459833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685693|NCT03459833|Viscosupplements|viscosupplements|mesh-ancestor
5685694|NCT03459833|Protective Agents|protective agents|mesh-ancestor
5697233|NCT03377348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697234|NCT03377335|Metformin|metformin|mesh-list
5697235|NCT03377335|Dapagliflozin|dapagliflozin|mesh-list
5697236|NCT03377335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5697237|NCT03377335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697238|NCT03377335|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5697239|NCT03377335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697240|NCT03377283|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5697241|NCT03377283|Thymoglobulin|thymoglobulin|mesh-list
5697242|NCT03377283|Immunologic Factors|immunologic factors|mesh-ancestor
5697243|NCT03377283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697244|NCT03377283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5697245|NCT03377257|Oxazolidinones|oxazolidinones|mesh-list
5697246|NCT03377257|Zolmitriptan|zolmitriptan|mesh-list
5697247|NCT03377257|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5697248|NCT03377257|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5697249|NCT03377257|Serotonin Agents|serotonin agents|mesh-ancestor
5697250|NCT03377257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5697251|NCT03377257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697252|NCT03377257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697253|NCT03377257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5877496|NCT05084573|Bupivacaine|bupivacaine|mesh-list
5877497|NCT05084573|Anesthetics, Local|anesthetics, local|mesh-ancestor
5697254|NCT03377257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5697255|NCT03377257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5697256|NCT03377218|Iodine|iodine|mesh-list
5697257|NCT03377218|Selenium|selenium|mesh-list
5697258|NCT03377218|Cadexomer iodine|cadexomer iodine|mesh-list
5697259|NCT03377218|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5697260|NCT03377218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5697261|NCT03377218|Trace Elements|trace elements|mesh-ancestor
5697262|NCT03377218|Micronutrients|micronutrients|mesh-ancestor
5697263|NCT03377218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697264|NCT03377218|Antioxidants|antioxidants|mesh-ancestor
5697265|NCT03377218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697266|NCT03377218|Protective Agents|protective agents|mesh-ancestor
5697267|NCT03377101|Fulvestrant|fulvestrant|mesh-list
5697268|NCT03377101|Palbociclib|palbociclib|mesh-list
5697269|NCT03377101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5697270|NCT03377101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5697271|NCT03377101|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5697272|NCT03377101|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5697273|NCT03377101|Hormone Antagonists|hormone antagonists|mesh-ancestor
5697274|NCT03377101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5697275|NCT03377101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697276|NCT03377101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5697277|NCT03377101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5697278|NCT03377101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697279|NCT03377049|Acetazolamide|acetazolamide|mesh-list
5697280|NCT03377049|Anticonvulsants|anticonvulsants|mesh-ancestor
5697281|NCT03377049|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5697282|NCT03377049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5697283|NCT03377049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697284|NCT03377049|Diuretics|diuretics|mesh-ancestor
5697285|NCT03377049|Natriuretic Agents|natriuretic agents|mesh-ancestor
5697286|NCT03377049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697287|NCT03376958|Apatinib|apatinib|mesh-list
5697288|NCT03376958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5685695|NCT03459807|Antihypertensive Agents|antihypertensive agents|mesh-list
5877498|NCT05084573|Anesthetics|anesthetics|mesh-ancestor
5877499|NCT05084573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5877500|NCT05084573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877501|NCT05084573|Sensory System Agents|sensory system agents|mesh-ancestor
5877502|NCT05084573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5877503|NCT05079672|Dexmedetomidine|dexmedetomidine|mesh-list
5877504|NCT05079672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5877505|NCT05079672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5877506|NCT05079672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877507|NCT05079672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5877508|NCT05079672|Analgesics|analgesics|mesh-ancestor
5877509|NCT05079672|Sensory System Agents|sensory system agents|mesh-ancestor
5877510|NCT05079672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5877511|NCT05079672|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5877512|NCT05079672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5877513|NCT05079672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5685696|NCT03459599|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5685697|NCT03459599|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5685698|NCT03459599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5685699|NCT03459599|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5685700|NCT03459599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5877514|NCT05079672|Adrenergic Agents|adrenergic agents|mesh-ancestor
5877515|NCT05079672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5877516|NCT05079672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877517|NCT05074823|Ketamine|ketamine|mesh-list
5877518|NCT05074823|Analgesics|analgesics|mesh-ancestor
5877519|NCT05074823|Sensory System Agents|sensory system agents|mesh-ancestor
5877520|NCT05074823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5877521|NCT05074823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877522|NCT05074823|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5877523|NCT05074823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5877524|NCT05074823|Anesthetics, General|anesthetics, general|mesh-ancestor
5877525|NCT05074823|Anesthetics|anesthetics|mesh-ancestor
5877526|NCT05074823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5877527|NCT05074823|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5877528|NCT05074823|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5877529|NCT05074823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5877530|NCT05074823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877531|NCT05073939|Oxytocin|oxytocin|mesh-list
5877532|NCT05073939|Oxytocics|oxytocics|mesh-ancestor
5877533|NCT05073939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5877534|NCT05073939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877535|NCT05068206|Bevacizumab|bevacizumab|mesh-list
5877536|NCT05068206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5877537|NCT05068206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5877538|NCT05068206|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5877539|NCT05068206|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5877540|NCT05068206|Growth Substances|growth substances|mesh-ancestor
5877541|NCT05068206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877542|NCT05068206|Growth Inhibitors|growth inhibitors|mesh-ancestor
5906087|NCT03939897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5685701|NCT03459599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685702|NCT03459417|Morphine|morphine|mesh-list
5685703|NCT03459417|Sulpiride|sulpiride|mesh-list
5685704|NCT03459417|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5685705|NCT03459417|Narcotics|narcotics|mesh-ancestor
5685706|NCT03459417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5685707|NCT03459417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685708|NCT03459417|Analgesics|analgesics|mesh-ancestor
5685709|NCT03459417|Sensory System Agents|sensory system agents|mesh-ancestor
5685710|NCT03459417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5685711|NCT03459417|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5685712|NCT03459417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5685713|NCT03459417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5685714|NCT03459417|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5685715|NCT03459417|Dopamine Agents|dopamine agents|mesh-ancestor
5685716|NCT03459417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5685717|NCT03459417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685718|NCT03459417|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5685719|NCT03459417|Antidepressive Agents|antidepressive agents|mesh-ancestor
5685720|NCT03459404|Sufentanil|sufentanil|mesh-list
5685721|NCT03459404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5685722|NCT03459404|Narcotics|narcotics|mesh-ancestor
5685723|NCT03459404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5685724|NCT03459404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685725|NCT03459404|Analgesics|analgesics|mesh-ancestor
5685726|NCT03459404|Sensory System Agents|sensory system agents|mesh-ancestor
5685727|NCT03459404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5685728|NCT03459404|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5877543|NCT05063370|Simendan|simendan|mesh-list
5877544|NCT05063370|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5877545|NCT05063370|Vasodilator Agents|vasodilator agents|mesh-ancestor
5877546|NCT05063370|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5877547|NCT05063370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5685729|NCT03459404|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5685730|NCT03459404|Anesthetics, General|anesthetics, general|mesh-ancestor
5685731|NCT03459404|Anesthetics|anesthetics|mesh-ancestor
5685732|NCT03459248|Anesthetics|anesthetics|mesh-list
5685733|NCT03459248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5685734|NCT03459248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685735|NCT03459144|Ranibizumab|ranibizumab|mesh-list
5685736|NCT03459144|Verteporfin|verteporfin|mesh-list
5685737|NCT03459144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5685738|NCT03459144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5685739|NCT03459144|Growth Substances|growth substances|mesh-ancestor
5685740|NCT03459144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685741|NCT03459144|Growth Inhibitors|growth inhibitors|mesh-ancestor
5877548|NCT05063370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5877549|NCT05063370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877550|NCT05063370|Protective Agents|protective agents|mesh-ancestor
5877551|NCT05063370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877552|NCT05063006|Methamphetamine|methamphetamine|mesh-list
5877553|NCT05063006|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5877554|NCT05063006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877555|NCT05063006|Sympathomimetics|sympathomimetics|mesh-ancestor
5877556|NCT05063006|Autonomic Agents|autonomic agents|mesh-ancestor
5877557|NCT05063006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5877558|NCT05063006|Dopamine Agents|dopamine agents|mesh-ancestor
5877559|NCT05063006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5877560|NCT05063006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877561|NCT05063006|Adrenergic Agents|adrenergic agents|mesh-ancestor
5877562|NCT05063006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5877563|NCT05063006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5877564|NCT05063006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5877565|NCT05063006|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5877566|NCT05032820|Lenalidomide|lenalidomide|mesh-list
5877567|NCT05032820|Immunologic Factors|immunologic factors|mesh-ancestor
5877568|NCT05032820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877569|NCT05032820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5877570|NCT05032820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5877571|NCT05032820|Growth Substances|growth substances|mesh-ancestor
5877572|NCT05032820|Growth Inhibitors|growth inhibitors|mesh-ancestor
5877573|NCT05032820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5877574|NCT05028257|Vaccines|vaccines|mesh-list
5877575|NCT05028257|Immunologic Factors|immunologic factors|mesh-ancestor
5877576|NCT05028257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877577|NCT05020392|Vidarabine|vidarabine|mesh-list
5877578|NCT05020392|Cyclophosphamide|cyclophosphamide|mesh-list
5877579|NCT05020392|Fludarabine|fludarabine|mesh-list
5877580|NCT05020392|Fludarabine phosphate|fludarabine phosphate|mesh-list
5877581|NCT05020392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5877582|NCT05020392|Immunologic Factors|immunologic factors|mesh-ancestor
5877583|NCT05020392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877584|NCT05020392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5877585|NCT05020392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5877586|NCT05020392|Alkylating Agents|alkylating agents|mesh-ancestor
5877587|NCT05020392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877588|NCT05020392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5877589|NCT05020392|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5877590|NCT05020392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5877591|NCT05020392|Antimetabolites|antimetabolites|mesh-ancestor
5877592|NCT05020392|Antiviral Agents|antiviral agents|mesh-ancestor
5877593|NCT05020392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5877594|NCT05018221|Vitamins|vitamins|mesh-list
5877595|NCT05018221|Vitamin K|vitamin k|mesh-list
5877596|NCT05018221|Vitamin K 1|vitamin k 1|mesh-list
5877597|NCT05018221|Sodium thiosulfate|sodium thiosulfate|mesh-list
5877598|NCT05018221|Magnesium citrate|magnesium citrate|mesh-list
5877599|NCT05018221|Citric Acid|citric acid|mesh-list
5877600|NCT05018221|Sodium Citrate|sodium citrate|mesh-list
5877601|NCT05018221|Micronutrients|micronutrients|mesh-ancestor
5877602|NCT05018221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877603|NCT05018221|Anticoagulants|anticoagulants|mesh-ancestor
5877604|NCT05018221|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5877605|NCT05018221|Chelating Agents|chelating agents|mesh-ancestor
5877606|NCT05018221|Sequestering Agents|sequestering agents|mesh-ancestor
5877607|NCT05018221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877608|NCT05018221|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5877609|NCT05018221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5877610|NCT05018221|Hemostatics|hemostatics|mesh-ancestor
5877611|NCT05018221|Coagulants|coagulants|mesh-ancestor
5877612|NCT05018221|Antidotes|antidotes|mesh-ancestor
5877613|NCT05018221|Protective Agents|protective agents|mesh-ancestor
5877614|NCT05018221|Antioxidants|antioxidants|mesh-ancestor
5877615|NCT05018221|Antitubercular Agents|antitubercular agents|mesh-ancestor
5877616|NCT05018221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5877617|NCT05018221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5877618|NCT05018221|Cathartics|cathartics|mesh-ancestor
5877619|NCT05018221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5877620|NCT05016947|Dexamethasone|dexamethasone|mesh-list
5877621|NCT05016947|Venetoclax|venetoclax|mesh-list
5877622|NCT05016947|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
5877623|NCT05016947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5877624|NCT05016947|Antiemetics|antiemetics|mesh-ancestor
5877625|NCT05016947|Autonomic Agents|autonomic agents|mesh-ancestor
5877626|NCT05016947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5877627|NCT05016947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877628|NCT05016947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5877629|NCT05016947|Glucocorticoids|glucocorticoids|mesh-ancestor
5877630|NCT05016947|Hormones|hormones|mesh-ancestor
5877631|NCT05016947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5877632|NCT05016947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5877633|NCT05016947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5877634|NCT05016947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5877635|NCT05016947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5877636|NCT05013242|Goserelin|goserelin|mesh-list
5877637|NCT05013242|Dienogest|dienogest|mesh-list
5877638|NCT05013242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5877639|NCT05013242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5877640|NCT05013242|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5877641|NCT05013242|Contraceptive Agents|contraceptive agents|mesh-ancestor
5877642|NCT05013242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5877643|NCT05013242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877644|NCT05013242|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5877645|NCT05013242|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5877646|NCT05013242|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5877647|NCT05013242|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5877648|NCT05013242|Hormone Antagonists|hormone antagonists|mesh-ancestor
5877649|NCT05013242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5877650|NCT05008510|Camptothecin|camptothecin|mesh-list
5877651|NCT05008510|Immunoconjugates|immunoconjugates|mesh-list
5877652|NCT05008510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5877653|NCT05008510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5877654|NCT05008510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5877655|NCT05008510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5877656|NCT05008510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5877657|NCT05008510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685742|NCT03459144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5685743|NCT03459144|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5685744|NCT03459144|Dermatologic Agents|dermatologic agents|mesh-ancestor
5685745|NCT03459105|Bupivacaine|bupivacaine|mesh-list
5685746|NCT03459105|Anesthetics|anesthetics|mesh-list
5685747|NCT03459105|Anesthetics, Local|anesthetics, local|mesh-ancestor
5685748|NCT03459105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5685749|NCT03459105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685750|NCT03459105|Sensory System Agents|sensory system agents|mesh-ancestor
5685751|NCT03459105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5685752|NCT03459092|Botulinum Toxins|botulinum toxins|mesh-list
5685753|NCT03459092|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5685754|NCT03459092|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5685755|NCT03459092|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5877658|NCT05008510|Immunologic Factors|immunologic factors|mesh-ancestor
5877659|NCT05008510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877660|NCT04978298|Phenelzine|phenelzine|mesh-list
5877661|NCT04978298|Ozanimod|ozanimod|mesh-list
5877662|NCT04978298|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5877663|NCT04978298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877664|NCT04978298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5685756|NCT03459092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5685757|NCT03459092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685758|NCT03459092|Cholinergic Agents|cholinergic agents|mesh-ancestor
5685759|NCT03459092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5685760|NCT03459092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685761|NCT03459092|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5685762|NCT03459092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5685763|NCT03458923|Diclofenac|diclofenac|mesh-list
5685764|NCT03458923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
5685765|NCT03458923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
5685766|NCT03458923|Ranibizumab|ranibizumab|mesh-list
5685767|NCT03458923|Endothelial Growth Factors|endothelial growth factors|mesh-list
5685768|NCT03458923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5685769|NCT03458923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5685770|NCT03458923|Growth Substances|growth substances|mesh-ancestor
5685771|NCT03458923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685772|NCT03458923|Growth Inhibitors|growth inhibitors|mesh-ancestor
5685773|NCT03458923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5685774|NCT03458923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685775|NCT03458923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5685776|NCT03458923|Analgesics|analgesics|mesh-ancestor
5685777|NCT03458923|Sensory System Agents|sensory system agents|mesh-ancestor
5685778|NCT03458923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5685779|NCT03458923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5685780|NCT03458923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5877665|NCT04978298|Immunologic Factors|immunologic factors|mesh-ancestor
5877666|NCT04978298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877667|NCT04978298|Antidepressive Agents|antidepressive agents|mesh-ancestor
5877668|NCT04978298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5877669|NCT04978298|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
5877670|NCT04978298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5877671|NCT04976595|Testosterone|testosterone|mesh-list
5877672|NCT04976595|Androgens|androgens|mesh-ancestor
5877673|NCT04976595|Hormones|hormones|mesh-ancestor
5877674|NCT04976595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5877675|NCT04976595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877676|NCT04973891|Metformin|metformin|mesh-list
5877677|NCT04973891|Canagliflozin|canagliflozin|mesh-list
5877678|NCT04973891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5877679|NCT04973891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877680|NCT04973891|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5877681|NCT04973891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877682|NCT04965272|Cariprazine|cariprazine|mesh-list
5877683|NCT04965272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5877684|NCT04965272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5877685|NCT04965272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5877686|NCT04965272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877687|NCT04965272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5877688|NCT04951050|Sirolimus|sirolimus|mesh-list
5877689|NCT04951050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5877690|NCT04951050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5685781|NCT03458923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5685782|NCT03458715|Empagliflozin|empagliflozin|mesh-list
5685783|NCT03458715|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
5685784|NCT03458715|Linagliptin|linagliptin|mesh-list
5685785|NCT03458715|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
5685786|NCT03458715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685787|NCT03458715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5685788|NCT03458715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685789|NCT03458715|Incretins|incretins|mesh-ancestor
5685790|NCT03458715|Hormones|hormones|mesh-ancestor
5685791|NCT03458715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5685792|NCT03458715|Protease Inhibitors|protease inhibitors|mesh-ancestor
5685793|NCT03458715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5685794|NCT03458689|Analgesics|analgesics|mesh-list
5685795|NCT03458689|Sensory System Agents|sensory system agents|mesh-ancestor
5685796|NCT03458689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5685797|NCT03458689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685798|NCT03458598|Analgesics, Opioid|analgesics, opioid|mesh-list
5685799|NCT03458598|Narcotics|narcotics|mesh-ancestor
5877691|NCT04951050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5877692|NCT04951050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6675351|NCT01574313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675352|NCT01574313|Protective Agents|protective agents|mesh-ancestor
6675353|NCT01574313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675354|NCT01574313|Vitamins|vitamins|mesh-ancestor
5685800|NCT03458598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5685801|NCT03458598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685802|NCT03458598|Analgesics|analgesics|mesh-ancestor
5685803|NCT03458598|Sensory System Agents|sensory system agents|mesh-ancestor
5685804|NCT03458598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5685805|NCT03458559|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
5685806|NCT03458559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6675355|NCT01574313|Micronutrients|micronutrients|mesh-ancestor
6675356|NCT01574313|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6675357|NCT01574313|Antimetabolites|antimetabolites|mesh-ancestor
6675358|NCT01574313|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6675359|NCT01574313|Vasodilator Agents|vasodilator agents|mesh-ancestor
6675360|NCT01574313|Vitamin B Complex|vitamin b complex|mesh-ancestor
6675361|NCT01574313|Antiemetics|antiemetics|mesh-ancestor
6675362|NCT01574313|Autonomic Agents|autonomic agents|mesh-ancestor
6675363|NCT01574313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6675364|NCT01574313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6675365|NCT01574508|Insulin|insulin|mesh-list
6675366|NCT01574508|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6675367|NCT01574508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6675368|NCT01574508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675369|NCT01574638|Rifapentine|rifapentine|mesh-list
6675370|NCT01574638|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6675371|NCT01574638|Antitubercular Agents|antitubercular agents|mesh-ancestor
6675372|NCT01574638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6675373|NCT01574638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6675374|NCT01574638|Leprostatic Agents|leprostatic agents|mesh-ancestor
5877693|NCT04951050|Antifungal Agents|antifungal agents|mesh-ancestor
5877694|NCT04951050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5685807|NCT03458481|Sofosbuvir|sofosbuvir|mesh-list
5685808|NCT03458481|Yimitasvir|yimitasvir|mesh-list
5685809|NCT03458481|Antiviral Agents|antiviral agents|mesh-ancestor
5685810|NCT03458481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5685811|NCT03458468|Tranexamic Acid|tranexamic acid|mesh-list
5877695|NCT04951050|Immunologic Factors|immunologic factors|mesh-ancestor
5877696|NCT04951050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877697|NCT04934072|Denosumab|denosumab|mesh-list
5877698|NCT04934072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5877699|NCT04934072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877700|NCT04930549|Dapagliflozin|dapagliflozin|mesh-list
5877701|NCT04930549|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5877702|NCT04930549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877703|NCT04930549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5877704|NCT04930549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877705|NCT04928846|Docetaxel|docetaxel|mesh-list
5877706|NCT04928846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5877707|NCT04928846|Tubulin Modulators|tubulin modulators|mesh-ancestor
5877708|NCT04928846|Antimitotic Agents|antimitotic agents|mesh-ancestor
5877709|NCT04928846|Mitosis Modulators|mitosis modulators|mesh-ancestor
5877710|NCT04928846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877711|NCT04925648|Dasatinib|dasatinib|mesh-list
5877712|NCT04925648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5877713|NCT04925648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5877714|NCT04925648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5877715|NCT04925648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877716|NCT04916002|Cemiplimab|cemiplimab|mesh-list
5877717|NCT04916002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5877718|NCT04916002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5877719|NCT04915755|Niraparib|niraparib|mesh-list
5877720|NCT04915755|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5877721|NCT04915755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5877722|NCT04915755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877723|NCT04915755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5877724|NCT04912856|Ezogabine|ezogabine|mesh-list
5877725|NCT04912856|Anticonvulsants|anticonvulsants|mesh-ancestor
5877726|NCT04912856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5877727|NCT04912856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877728|NCT04907968|Carboplatin|carboplatin|mesh-list
5685812|NCT03458468|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6675375|NCT01574742|Minocycline|minocycline|mesh-list
5877729|NCT04907968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5877730|NCT04899843|Zinc Sulfate|zinc sulfate|mesh-list
5877731|NCT04899843|Astringents|astringents|mesh-ancestor
5877732|NCT04899843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877733|NCT04899843|Dermatologic Agents|dermatologic agents|mesh-ancestor
5877734|NCT04880863|Docetaxel|docetaxel|mesh-list
5877735|NCT04880863|Obinutuzumab|obinutuzumab|mesh-list
5877736|NCT04880863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5877737|NCT04880863|Tubulin Modulators|tubulin modulators|mesh-ancestor
5877738|NCT04880863|Antimitotic Agents|antimitotic agents|mesh-ancestor
5877739|NCT04880863|Mitosis Modulators|mitosis modulators|mesh-ancestor
5877740|NCT04880863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877741|NCT04880863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5685813|NCT03458468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5685814|NCT03458468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685815|NCT03458468|Hemostatics|hemostatics|mesh-ancestor
5685816|NCT03458468|Coagulants|coagulants|mesh-ancestor
5685817|NCT03458455|Pembrolizumab|pembrolizumab|mesh-list
5685818|NCT03458455|Nivolumab|nivolumab|mesh-list
5685819|NCT03458455|Ipilimumab|ipilimumab|mesh-list
5685820|NCT03458455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5685821|NCT03458455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5685822|NCT03458455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5877742|NCT04880577|Tenofovir|tenofovir|mesh-list
5877743|NCT04880577|Rituximab|rituximab|mesh-list
5877744|NCT04880577|Ocrelizumab|ocrelizumab|mesh-list
5877745|NCT04880577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5877746|NCT04880577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5877747|NCT04880577|Immunologic Factors|immunologic factors|mesh-ancestor
5877748|NCT04880577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877749|NCT04880577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5877750|NCT04880577|Antiviral Agents|antiviral agents|mesh-ancestor
5877751|NCT04880577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5685823|NCT03458455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685824|NCT03458429|Sargramostim|sargramostim|mesh-list
5685825|NCT03458429|Lenograstim|lenograstim|mesh-list
5685826|NCT03458429|Immunologic Factors|immunologic factors|mesh-ancestor
5685827|NCT03458429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685828|NCT03458429|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5685829|NCT03458416|Cannabidiol|cannabidiol|mesh-list
5685830|NCT03458416|Anticonvulsants|anticonvulsants|mesh-ancestor
5697289|NCT03376958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5697290|NCT03376958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5877752|NCT04880577|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5877753|NCT04880577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5877754|NCT04880577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5877755|NCT04880577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877756|NCT04880577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5877757|NCT04880577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5877758|NCT04861558|Fluorouracil|fluorouracil|mesh-list
5877759|NCT04861558|Oxaliplatin|oxaliplatin|mesh-list
5877760|NCT04861558|Irinotecan|irinotecan|mesh-list
5877761|NCT04861558|Antimetabolites|antimetabolites|mesh-ancestor
5877762|NCT04861558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877763|NCT04861558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5877764|NCT04861558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5877765|NCT04861558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5877766|NCT04861558|Immunologic Factors|immunologic factors|mesh-ancestor
5877767|NCT04861558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877768|NCT04861558|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5877769|NCT04861558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5877770|NCT04861558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5877771|NCT04859296|Dronabinol|dronabinol|mesh-list
5877772|NCT04859296|Hallucinogens|hallucinogens|mesh-ancestor
5877773|NCT04859296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877774|NCT04859296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5877775|NCT04859296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5877776|NCT04859296|Analgesics|analgesics|mesh-ancestor
5877777|NCT04859296|Sensory System Agents|sensory system agents|mesh-ancestor
5877778|NCT04859296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5877779|NCT04859296|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5877780|NCT04859296|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5877781|NCT04859296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5697291|NCT03376958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697292|NCT03376932|Albuterol|albuterol|mesh-list
5877782|NCT04859296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877783|NCT04859296|Hormones|hormones|mesh-ancestor
5877784|NCT04859296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5906088|NCT03939897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5906089|NCT03939897|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5906090|NCT03939897|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5906091|NCT03939897|Hormone Antagonists|hormone antagonists|mesh-ancestor
5685831|NCT03458260|Rituximab|rituximab|mesh-list
5685832|NCT03458260|Etoposide|etoposide|mesh-list
5685833|NCT03458260|Ifosfamide|ifosfamide|mesh-list
5685834|NCT03458260|Pixantrone|pixantrone|mesh-list
5685835|NCT03458260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5685836|NCT03458260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5685837|NCT03458260|Immunologic Factors|immunologic factors|mesh-ancestor
5685838|NCT03458260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685839|NCT03458260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5685840|NCT03458260|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5685841|NCT03458260|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5685842|NCT03458260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5685843|NCT03458260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5685844|NCT03458260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906092|NCT03939897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5906093|NCT03939897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906094|NCT03909217|Dexetimide|dexetimide|mesh-list
5906095|NCT03909217|Citalopram|citalopram|mesh-list
5906096|NCT03909217|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5906097|NCT03909217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5906098|NCT03909217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5906099|NCT03909217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906100|NCT03909217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5906101|NCT03909217|Serotonin Agents|serotonin agents|mesh-ancestor
5906102|NCT03909217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906103|NCT03909217|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5906104|NCT03909217|Antidepressive Agents|antidepressive agents|mesh-ancestor
5906105|NCT03909217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5906106|NCT03909217|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5906107|NCT03909217|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5906108|NCT03909217|Parasympatholytics|parasympatholytics|mesh-ancestor
5906109|NCT03909217|Autonomic Agents|autonomic agents|mesh-ancestor
5906110|NCT03909217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5906111|NCT03909217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5906112|NCT03909217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5906113|NCT03909217|Cholinergic Agents|cholinergic agents|mesh-ancestor
5906114|NCT03909165|Atropine|atropine|mesh-list
5906115|NCT03909165|Glycopyrrolate|glycopyrrolate|mesh-list
5906116|NCT03909165|Neostigmine|neostigmine|mesh-list
5906117|NCT03909165|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5906118|NCT03909165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5906119|NCT03909165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5906120|NCT03909165|Autonomic Agents|autonomic agents|mesh-ancestor
5906121|NCT03909165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5906122|NCT03909165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906123|NCT03909165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5906124|NCT03909165|Respiratory System Agents|respiratory system agents|mesh-ancestor
5906125|NCT03909165|Mydriatics|mydriatics|mesh-ancestor
5906126|NCT03909165|Parasympatholytics|parasympatholytics|mesh-ancestor
5906127|NCT03909165|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5906128|NCT03909165|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5906129|NCT03909165|Cholinergic Agents|cholinergic agents|mesh-ancestor
5906130|NCT03909165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5906131|NCT03909165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906132|NCT03909165|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5906133|NCT03909165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5906134|NCT03909165|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5906135|NCT03890289|Obinutuzumab|obinutuzumab|mesh-list
5906136|NCT03890289|Idelalisib|idelalisib|mesh-list
5906137|NCT03890289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5906138|NCT03890289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5906139|NCT03890289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5906140|NCT03890289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906141|NCT03870529|Vitamins|vitamins|mesh-list
5906142|NCT03870529|Vitamin A|vitamin a|mesh-list
5906143|NCT03870529|Anti-Infective Agents|anti-infective agents|mesh-list
5906144|NCT03870529|Retinol palmitate|retinol palmitate|mesh-list
5906145|NCT03870529|Micronutrients|micronutrients|mesh-ancestor
5906146|NCT03870529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906147|NCT03870529|Antioxidants|antioxidants|mesh-ancestor
5877785|NCT04837235|Hemay005|hemay005|mesh-list
5877786|NCT04837235|Dermatologic Agents|dermatologic agents|mesh-ancestor
5877787|NCT04837235|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5877788|NCT04837235|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5877789|NCT04837235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5877790|NCT04837235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685845|NCT03458260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5685846|NCT03458260|Alkylating Agents|alkylating agents|mesh-ancestor
5685847|NCT03458221|Tamoxifen|tamoxifen|mesh-list
5685848|NCT03458221|Itraconazole|itraconazole|mesh-list
5685849|NCT03458221|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5685850|NCT03458221|Hormone Antagonists|hormone antagonists|mesh-ancestor
5685851|NCT03458221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5685852|NCT03458221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685853|NCT03458221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5685854|NCT03458221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5685855|NCT03458221|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5685856|NCT03458221|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5685857|NCT03458221|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5877791|NCT04793646|Acetylcysteine|acetylcysteine|mesh-list
5877792|NCT04793646|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5877793|NCT04793646|Antiviral Agents|antiviral agents|mesh-ancestor
5685858|NCT03458221|Antifungal Agents|antifungal agents|mesh-ancestor
5877794|NCT04793646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6212457|NCT02188576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212458|NCT02188576|Hemostatics|hemostatics|mesh-ancestor
6212459|NCT02188576|Coagulants|coagulants|mesh-ancestor
5877795|NCT04793646|Expectorants|expectorants|mesh-ancestor
5877796|NCT04793646|Respiratory System Agents|respiratory system agents|mesh-ancestor
5877797|NCT04793646|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5877798|NCT04793646|Antioxidants|antioxidants|mesh-ancestor
5877799|NCT04793646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877800|NCT04793646|Protective Agents|protective agents|mesh-ancestor
5877801|NCT04793646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877802|NCT04793646|Antidotes|antidotes|mesh-ancestor
5877803|NCT04775550|Dexamethasone|dexamethasone|mesh-list
5877804|NCT04775550|Lenalidomide|lenalidomide|mesh-list
5877805|NCT04775550|Bortezomib|bortezomib|mesh-list
5877806|NCT04775550|Daratumumab|daratumumab|mesh-list
5877807|NCT04775550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5877808|NCT04775550|Antiemetics|antiemetics|mesh-ancestor
5877809|NCT04775550|Autonomic Agents|autonomic agents|mesh-ancestor
5877810|NCT04775550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5877811|NCT04775550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877812|NCT04775550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5877813|NCT04775550|Glucocorticoids|glucocorticoids|mesh-ancestor
5877814|NCT04775550|Hormones|hormones|mesh-ancestor
5877815|NCT04775550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5877816|NCT04775550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5877817|NCT04775550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5877818|NCT04775550|Immunologic Factors|immunologic factors|mesh-ancestor
5877819|NCT04775550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5877820|NCT04775550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5877821|NCT04775550|Growth Substances|growth substances|mesh-ancestor
5877822|NCT04775550|Growth Inhibitors|growth inhibitors|mesh-ancestor
5877823|NCT04771962|Sevoflurane|sevoflurane|mesh-list
5877824|NCT04771962|Desflurane|desflurane|mesh-list
5877825|NCT04771962|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5877826|NCT04771962|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5877827|NCT04771962|Anesthetics, General|anesthetics, general|mesh-ancestor
5877828|NCT04771962|Anesthetics|anesthetics|mesh-ancestor
5877829|NCT04771962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5877830|NCT04771962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877831|NCT04767022|Paclitaxel|paclitaxel|mesh-list
5877832|NCT04767022|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5877833|NCT04767022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6212460|NCT02188719|Acetaminophen|acetaminophen|mesh-list
6212461|NCT02188719|Diphenhydramine|diphenhydramine|mesh-list
6212462|NCT02188719|Promethazine|promethazine|mesh-list
6212463|NCT02188719|Mycophenolic Acid|mycophenolic acid|mesh-list
6212464|NCT02188719|Valganciclovir|valganciclovir|mesh-list
6212465|NCT02188719|Ganciclovir|ganciclovir|mesh-list
6212466|NCT02188719|Anti-Infective Agents|anti-infective agents|mesh-list
6212467|NCT02188719|Prednisone|prednisone|mesh-list
6212468|NCT02188719|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6212469|NCT02188719|Everolimus|everolimus|mesh-list
6212470|NCT02188719|Liver Extracts|liver extracts|mesh-list
6212471|NCT02188719|Tacrolimus|tacrolimus|mesh-list
5877834|NCT04767022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5877835|NCT04767022|Tubulin Modulators|tubulin modulators|mesh-ancestor
5877836|NCT04767022|Antimitotic Agents|antimitotic agents|mesh-ancestor
5877837|NCT04767022|Mitosis Modulators|mitosis modulators|mesh-ancestor
5877838|NCT04767022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877839|NCT04764097|Dapagliflozin|dapagliflozin|mesh-list
5877840|NCT04764097|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5877841|NCT04764097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877842|NCT04764097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5877843|NCT04764097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877846|NCT04727138|Midazolam|midazolam|mesh-list
5685859|NCT03458221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5685860|NCT03458221|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5685861|NCT03458221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5685862|NCT03458221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5685863|NCT03458221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685864|NCT03458221|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5685865|NCT03458221|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5685866|NCT03458208|Metformin|metformin|mesh-list
5685867|NCT03458208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5685868|NCT03458208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685869|NCT03458143|Ketamine|ketamine|mesh-list
5685870|NCT03458143|Remifentanil|remifentanil|mesh-list
5685871|NCT03458143|Analgesics|analgesics|mesh-ancestor
5685872|NCT03458143|Sensory System Agents|sensory system agents|mesh-ancestor
5685873|NCT03458143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5685874|NCT03458143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877847|NCT04727138|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5877848|NCT04727138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5877849|NCT04727138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5685875|NCT03458143|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5685876|NCT03458143|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5685877|NCT03458143|Anesthetics, General|anesthetics, general|mesh-ancestor
5685878|NCT03458143|Anesthetics|anesthetics|mesh-ancestor
5685879|NCT03458143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5685880|NCT03458143|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5685881|NCT03458143|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5685882|NCT03458143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5685883|NCT03458143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685884|NCT03458143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5685885|NCT03458143|Narcotics|narcotics|mesh-ancestor
5685886|NCT03458078|Magnesium Sulfate|magnesium sulfate|mesh-list
5685887|NCT03458078|Midazolam|midazolam|mesh-list
5685888|NCT03458078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5685889|NCT03458078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5685890|NCT03458078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5685891|NCT03458078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685892|NCT03458078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5685893|NCT03458078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5685894|NCT03458078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5685895|NCT03458078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5685896|NCT03458078|Anesthetics, General|anesthetics, general|mesh-ancestor
5685897|NCT03458078|Anesthetics|anesthetics|mesh-ancestor
6675376|NCT01574742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6675377|NCT01574742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6675609|NCT01576640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6675610|NCT01576640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6675611|NCT01576640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675612|NCT01576640|Dopamine Agents|dopamine agents|mesh-ancestor
6675613|NCT01576640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5877850|NCT04727138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877851|NCT04727138|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5877852|NCT04727138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5877853|NCT04727138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5877854|NCT04727138|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5877855|NCT04727138|Anesthetics, General|anesthetics, general|mesh-ancestor
5877856|NCT04727138|Anesthetics|anesthetics|mesh-ancestor
6675614|NCT01576640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685898|NCT03458078|GABA Modulators|gaba modulators|mesh-ancestor
5685899|NCT03458078|GABA Agents|gaba agents|mesh-ancestor
5685900|NCT03458078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5697293|NCT03376932|Tiotropium Bromide|tiotropium bromide|mesh-list
6675378|NCT01574820|Rosiglitazone|rosiglitazone|mesh-list
6675379|NCT01574820|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6675380|NCT01574820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675381|NCT01575158|Citalopram|citalopram|mesh-list
6675382|NCT01575158|Clomipramine|clomipramine|mesh-list
6675383|NCT01575158|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6675384|NCT01575158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6675385|NCT01575158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5877857|NCT04727138|GABA Modulators|gaba modulators|mesh-ancestor
5877858|NCT04727138|GABA Agents|gaba agents|mesh-ancestor
5877859|NCT04727138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5877860|NCT04727138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877861|NCT04726098|Dexamethasone|dexamethasone|mesh-list
5877862|NCT04726098|Dexamethasone acetate|dexamethasone acetate|mesh-list
5877863|NCT04726098|BB 1101|bb 1101|mesh-list
5877864|NCT04726098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5877865|NCT04726098|Antiemetics|antiemetics|mesh-ancestor
5877866|NCT04726098|Autonomic Agents|autonomic agents|mesh-ancestor
5877867|NCT04726098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5877868|NCT04726098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877869|NCT04726098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5877870|NCT04726098|Glucocorticoids|glucocorticoids|mesh-ancestor
5877871|NCT04726098|Hormones|hormones|mesh-ancestor
5877872|NCT04726098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5877873|NCT04726098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5877874|NCT04726098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5877875|NCT04726098|Protease Inhibitors|protease inhibitors|mesh-ancestor
5877876|NCT04726098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5877877|NCT04726098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877878|NCT04699071|Pembrolizumab|pembrolizumab|mesh-list
5877879|NCT04699071|Lenvatinib|lenvatinib|mesh-list
5877880|NCT04699071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5877881|NCT04699071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5877882|NCT04699071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5685901|NCT03458078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685902|NCT03458078|Analgesics|analgesics|mesh-ancestor
5685903|NCT03458078|Sensory System Agents|sensory system agents|mesh-ancestor
5685904|NCT03458078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5685905|NCT03458078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5685906|NCT03458078|Anticonvulsants|anticonvulsants|mesh-ancestor
5685907|NCT03458078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5877883|NCT04699071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5877884|NCT04699071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877885|NCT04692103|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5877886|NCT04692103|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5877887|NCT04692103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877888|NCT04648189|Cetuximab|cetuximab|mesh-list
5877889|NCT04648189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5877890|NCT04648189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5877891|NCT04643249|Repaglinide|repaglinide|mesh-list
5877892|NCT04643249|Flurbiprofen|flurbiprofen|mesh-list
5877893|NCT04643249|Midazolam|midazolam|mesh-list
5877894|NCT04643249|Dextromethorphan|dextromethorphan|mesh-list
5877895|NCT04643249|Caffeine|caffeine|mesh-list
5877896|NCT04643249|Bupropion|bupropion|mesh-list
5877897|NCT04643249|Omeprazole|omeprazole|mesh-list
5877898|NCT04643249|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5877899|NCT04643249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5685908|NCT03458078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5685909|NCT03458078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5685910|NCT03458078|Tocolytic Agents|tocolytic agents|mesh-ancestor
5685911|NCT03458078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5685912|NCT03457896|Trastuzumab|trastuzumab|mesh-list
5685913|NCT03457896|Cetuximab|cetuximab|mesh-list
5877900|NCT04643249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5877901|NCT04643249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877902|NCT04643249|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6675386|NCT01575158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675387|NCT01575158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6675388|NCT01575158|Serotonin Agents|serotonin agents|mesh-ancestor
6675389|NCT01575158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675390|NCT01575158|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6675391|NCT01575158|Antidepressive Agents|antidepressive agents|mesh-ancestor
5877903|NCT04643249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5877904|NCT04643249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6675392|NCT01575158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5685914|NCT03457896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5685915|NCT03457896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5685916|NCT03457753|Riluzole|riluzole|mesh-list
5685917|NCT03457753|Anticonvulsants|anticonvulsants|mesh-ancestor
5685918|NCT03457753|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5685919|NCT03457753|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5685920|NCT03457753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5685921|NCT03457753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685922|NCT03457753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685923|NCT03457753|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5685924|NCT03457753|Protective Agents|protective agents|mesh-ancestor
5685925|NCT03457597|Pioglitazone|pioglitazone|mesh-list
5685926|NCT03457597|Tolbutamide|tolbutamide|mesh-list
5685927|NCT03457597|Metoprolol|metoprolol|mesh-list
5685928|NCT03457597|Midazolam|midazolam|mesh-list
5685929|NCT03457597|Omeprazole|omeprazole|mesh-list
5685930|NCT03457597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5685931|NCT03457597|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5685932|NCT03457597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5685933|NCT03457597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685934|NCT03457597|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5685935|NCT03457597|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5685936|NCT03457597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5685937|NCT03457597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5685938|NCT03457597|Anesthetics, General|anesthetics, general|mesh-ancestor
5685939|NCT03457597|Anesthetics|anesthetics|mesh-ancestor
5685940|NCT03457597|GABA Modulators|gaba modulators|mesh-ancestor
5685941|NCT03457597|GABA Agents|gaba agents|mesh-ancestor
5685942|NCT03457597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5685943|NCT03457597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685944|NCT03457597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5685945|NCT03457597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5877905|NCT04643249|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5877906|NCT04643249|Anesthetics, General|anesthetics, general|mesh-ancestor
5877907|NCT04643249|Anesthetics|anesthetics|mesh-ancestor
5877908|NCT04643249|GABA Modulators|gaba modulators|mesh-ancestor
5877909|NCT04643249|GABA Agents|gaba agents|mesh-ancestor
5877910|NCT04643249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5877911|NCT04643249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877912|NCT04643249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5877913|NCT04643249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5877914|NCT04643249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5877915|NCT04643249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5877916|NCT04643249|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5877917|NCT04643249|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5877918|NCT04643249|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5877919|NCT04643249|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5877920|NCT04643249|Purinergic Agents|purinergic agents|mesh-ancestor
5877921|NCT04643249|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5877922|NCT04643249|Antidepressive Agents|antidepressive agents|mesh-ancestor
5877923|NCT04643249|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5877924|NCT04643249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5877925|NCT04643249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5877926|NCT04643249|Dopamine Agents|dopamine agents|mesh-ancestor
5877927|NCT04643249|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5877928|NCT04643249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5877929|NCT04643249|Antitussive Agents|antitussive agents|mesh-ancestor
5877930|NCT04643249|Respiratory System Agents|respiratory system agents|mesh-ancestor
5877931|NCT04643249|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5877932|NCT04643249|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5877933|NCT04643249|Analgesics|analgesics|mesh-ancestor
5877934|NCT04643249|Sensory System Agents|sensory system agents|mesh-ancestor
5877935|NCT04643249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5877936|NCT04643249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5877937|NCT04643249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5877938|NCT04643249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5877939|NCT04643249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5877940|NCT04643249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5877941|NCT04643249|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5877942|NCT04583618|Vaccines|vaccines|mesh-list
5877943|NCT04583618|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5877944|NCT04583618|Immunologic Factors|immunologic factors|mesh-ancestor
5877945|NCT04583618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877946|NCT04560595|Caffeine|caffeine|mesh-list
5685946|NCT03457597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5877947|NCT04560595|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5877948|NCT04560595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877949|NCT04560595|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5877950|NCT04560595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5877951|NCT04560595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877952|NCT04560595|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5877953|NCT04560595|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5877954|NCT04560595|Purinergic Agents|purinergic agents|mesh-ancestor
5877955|NCT04560595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5877956|NCT04558294|Ketanserin|ketanserin|mesh-list
5877957|NCT04558294|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
5877958|NCT04558294|Hallucinogens|hallucinogens|mesh-ancestor
5877959|NCT04558294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877960|NCT04558294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5877961|NCT04558294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5877962|NCT04558294|Serotonin Agents|serotonin agents|mesh-ancestor
5877963|NCT04558294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5877964|NCT04558294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877965|NCT04558294|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5877966|NCT04558294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5877967|NCT04558294|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5877968|NCT04551222|Probenecid|probenecid|mesh-list
5877969|NCT04551222|Uricosuric Agents|uricosuric agents|mesh-ancestor
5877970|NCT04551222|Gout Suppressants|gout suppressants|mesh-ancestor
5877971|NCT04551222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5877972|NCT04551222|Renal Agents|renal agents|mesh-ancestor
5877973|NCT04537897|Midazolam|midazolam|mesh-list
5877974|NCT04537897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5877975|NCT04537897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5877976|NCT04537897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5877977|NCT04537897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877978|NCT04537897|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5877979|NCT04537897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5877980|NCT04537897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5877981|NCT04537897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5877982|NCT04537897|Anesthetics, General|anesthetics, general|mesh-ancestor
5877983|NCT04537897|Anesthetics|anesthetics|mesh-ancestor
5877984|NCT04537897|GABA Modulators|gaba modulators|mesh-ancestor
5877985|NCT04537897|GABA Agents|gaba agents|mesh-ancestor
5877986|NCT04537897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5877987|NCT04537897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906148|NCT03870529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906149|NCT03870529|Protective Agents|protective agents|mesh-ancestor
5906150|NCT03870529|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5906151|NCT03870529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5906152|NCT03770546|Betamethasone|betamethasone|mesh-list
5906153|NCT03770546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5906154|NCT03770546|Glucocorticoids|glucocorticoids|mesh-ancestor
5906155|NCT03770546|Hormones|hormones|mesh-ancestor
5906156|NCT03770546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5906157|NCT03770546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906158|NCT03770546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5906159|NCT03770546|Respiratory System Agents|respiratory system agents|mesh-ancestor
5906160|NCT03763643|Rituximab|rituximab|mesh-list
5906161|NCT03763643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5906162|NCT03763643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5906163|NCT03763643|Immunologic Factors|immunologic factors|mesh-ancestor
5906164|NCT03763643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906165|NCT03763643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5906166|NCT03749187|Temozolomide|temozolomide|mesh-list
5906167|NCT03749187|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
5906168|NCT03749187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5906169|NCT03749187|Alkylating Agents|alkylating agents|mesh-ancestor
5906170|NCT03749187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906171|NCT03749187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5906172|NCT03749187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5906173|NCT03728972|Pembrolizumab|pembrolizumab|mesh-list
5906174|NCT03728972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5906175|NCT03728972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5906176|NCT03712202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5906177|NCT03712202|Nivolumab|nivolumab|mesh-list
5906178|NCT03712202|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5906179|NCT03712202|Doxorubicin|doxorubicin|mesh-list
5906180|NCT03712202|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5906181|NCT03712202|Daunorubicin|daunorubicin|mesh-list
5685947|NCT03457597|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5685948|NCT03457597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5685949|NCT03457597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5685950|NCT03457597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5685951|NCT03457597|Sympatholytics|sympatholytics|mesh-ancestor
5685952|NCT03457597|Autonomic Agents|autonomic agents|mesh-ancestor
5685953|NCT03457597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5685954|NCT03457597|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5685955|NCT03457597|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5685956|NCT03457597|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5685957|NCT03457597|Adrenergic Agents|adrenergic agents|mesh-ancestor
5685958|NCT03457467|Apatinib|apatinib|mesh-list
5685959|NCT03457467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5685960|NCT03457467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5685961|NCT03457467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5685962|NCT03457467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685963|NCT03457389|Cabergoline|cabergoline|mesh-list
5685964|NCT03457389|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5877988|NCT04521881|Tranexamic Acid|tranexamic acid|mesh-list
6212472|NCT02188719|Thymoglobulin|thymoglobulin|mesh-list
6212473|NCT02188719|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5877989|NCT04521881|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5877990|NCT04521881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5685965|NCT03457389|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5685966|NCT03457389|Dopamine Agonists|dopamine agonists|mesh-ancestor
5685967|NCT03457389|Dopamine Agents|dopamine agents|mesh-ancestor
5685968|NCT03457389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5685969|NCT03457389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685970|NCT03457389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685971|NCT03457337|Gefitinib|gefitinib|mesh-list
5877991|NCT04521881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5877992|NCT04521881|Hemostatics|hemostatics|mesh-ancestor
5877993|NCT04521881|Coagulants|coagulants|mesh-ancestor
5877994|NCT04507581|Anesthetics|anesthetics|mesh-list
5877995|NCT04507581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5877996|NCT04507581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5877997|NCT04507438|Donepezil|donepezil|mesh-list
5877998|NCT04507438|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5877999|NCT04507438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5878000|NCT04507438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878001|NCT04507438|Cholinergic Agents|cholinergic agents|mesh-ancestor
5878002|NCT04507438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5878003|NCT04507438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878004|NCT04507438|Nootropic Agents|nootropic agents|mesh-ancestor
5878005|NCT04505670|Donepezil|donepezil|mesh-list
5878006|NCT04505670|Zinc Oxide|zinc oxide|mesh-list
5878007|NCT04505670|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5878008|NCT04505670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5878009|NCT04505670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878010|NCT04505670|Cholinergic Agents|cholinergic agents|mesh-ancestor
5878011|NCT04505670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5878012|NCT04505670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878013|NCT04505670|Nootropic Agents|nootropic agents|mesh-ancestor
5878014|NCT04505670|Dermatologic Agents|dermatologic agents|mesh-ancestor
5878015|NCT04505670|Sunscreening Agents|sunscreening agents|mesh-ancestor
5878016|NCT04505670|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5878017|NCT04505670|Protective Agents|protective agents|mesh-ancestor
5878018|NCT04474002|Picosulfate sodium|picosulfate sodium|mesh-list
5878019|NCT04474002|Cathartics|cathartics|mesh-ancestor
5878020|NCT04474002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6212474|NCT02188719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5685972|NCT03457337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5685973|NCT03457337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5685974|NCT03457337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5685975|NCT03457337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5685976|NCT03457233|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5685977|NCT03457233|Cetrorelix|cetrorelix|mesh-list
5685978|NCT03457233|Menotropins|menotropins|mesh-list
5685979|NCT03457233|Progesterone|progesterone|mesh-list
5685980|NCT03457233|Progestins|progestins|mesh-ancestor
5685981|NCT03457233|Hormones|hormones|mesh-ancestor
5685982|NCT03457233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5685983|NCT03457233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5685984|NCT03457233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5878021|NCT04470622|Aprepitant|aprepitant|mesh-list
5878022|NCT04470622|Antiemetics|antiemetics|mesh-ancestor
5878023|NCT04470622|Autonomic Agents|autonomic agents|mesh-ancestor
5878024|NCT04470622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5878025|NCT04470622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878026|NCT04470622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5878027|NCT04470622|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5878028|NCT04470622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5685985|NCT03457233|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5685986|NCT03457233|Fertility Agents|fertility agents|mesh-ancestor
5685987|NCT03457233|Hormone Antagonists|hormone antagonists|mesh-ancestor
5685988|NCT03457194|Vaccines|vaccines|mesh-list
5685989|NCT03457194|Immunologic Factors|immunologic factors|mesh-ancestor
5685990|NCT03457194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495790|NCT00625079|Urological Agents|urological agents|mesh-ancestor
6495791|NCT00625092|Leucovorin|leucovorin|mesh-list
6495792|NCT00625092|Fluorouracil|fluorouracil|mesh-list
6495793|NCT00625092|Oxaliplatin|oxaliplatin|mesh-list
6495794|NCT00625092|Calcium|calcium|mesh-list
6495795|NCT00625092|Levoleucovorin|levoleucovorin|mesh-list
6495796|NCT00625092|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6495797|NCT00625092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495798|NCT00625092|Antimetabolites|antimetabolites|mesh-ancestor
6495799|NCT00625092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878029|NCT04470622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878030|NCT04434040|Atezolizumab|atezolizumab|mesh-list
5878031|NCT04434040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5878032|NCT04405063|Paclitaxel|paclitaxel|mesh-list
5878033|NCT04405063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5878034|NCT04405063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5878035|NCT04405063|Tubulin Modulators|tubulin modulators|mesh-ancestor
5685991|NCT03457142|Dexamethasone|dexamethasone|mesh-list
5685992|NCT03457142|Dexamethasone acetate|dexamethasone acetate|mesh-list
5685993|NCT03457142|Abatacept|abatacept|mesh-list
5685994|NCT03457142|Ixazomib|ixazomib|mesh-list
5685995|NCT03457142|Ichthammol|ichthammol|mesh-list
5685996|NCT03457142|BB 1101|bb 1101|mesh-list
5685997|NCT03457142|Glycine|glycine|mesh-list
5685998|NCT03457142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5685999|NCT03457142|Antiemetics|antiemetics|mesh-ancestor
5686000|NCT03457142|Autonomic Agents|autonomic agents|mesh-ancestor
5686001|NCT03457142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5686002|NCT03457142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686003|NCT03457142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5686004|NCT03457142|Glucocorticoids|glucocorticoids|mesh-ancestor
5686005|NCT03457142|Hormones|hormones|mesh-ancestor
5686006|NCT03457142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5686007|NCT03457142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5878036|NCT04405063|Antimitotic Agents|antimitotic agents|mesh-ancestor
5878037|NCT04405063|Mitosis Modulators|mitosis modulators|mesh-ancestor
5878038|NCT04405063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878039|NCT04396873|11C-PS13|11c-ps13|mesh-list
5878040|NCT04396873|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5878041|NCT04396873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878042|NCT04393753|Avelumab|avelumab|mesh-list
5878043|NCT04393753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5878044|NCT04393753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5878045|NCT04373317|Pimavanserin|pimavanserin|mesh-list
5878046|NCT04373317|Quetiapine Fumarate|quetiapine fumarate|mesh-list
5878047|NCT04373317|Antidepressive Agents|antidepressive agents|mesh-ancestor
5878048|NCT04373317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5878049|NCT04373317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5878050|NCT04373317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5878051|NCT04373317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5878052|NCT04373317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878053|NCT04373317|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5878054|NCT04373317|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5878055|NCT04373317|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5878056|NCT04373317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5878057|NCT04373317|Serotonin Agents|serotonin agents|mesh-ancestor
5878058|NCT04373317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5878059|NCT04373317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878060|NCT04362566|Bupivacaine|bupivacaine|mesh-list
5878061|NCT04362566|Anesthetics, Local|anesthetics, local|mesh-ancestor
5878062|NCT04362566|Anesthetics|anesthetics|mesh-ancestor
5878063|NCT04362566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5906182|NCT03712202|Bleomycin|bleomycin|mesh-list
5686008|NCT03457142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5697294|NCT03376932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5686009|NCT03457142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686010|NCT03457142|Protease Inhibitors|protease inhibitors|mesh-ancestor
5686011|NCT03457142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5686012|NCT03457142|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5686013|NCT03457142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5686014|NCT03457142|Immunologic Factors|immunologic factors|mesh-ancestor
5686015|NCT03457142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5878064|NCT04362566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878065|NCT04362566|Sensory System Agents|sensory system agents|mesh-ancestor
5878066|NCT04362566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5878067|NCT04354649|Hydroxychloroquine|hydroxychloroquine|mesh-list
5878068|NCT04354649|Antimalarials|antimalarials|mesh-ancestor
5878069|NCT04354649|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5878070|NCT04354649|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5878071|NCT04354649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5878072|NCT04354649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5878073|NCT04354649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878074|NCT04354649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5878075|NCT04348864|Antibodies|antibodies|mesh-list
5878076|NCT04348864|Immunologic Factors|immunologic factors|mesh-ancestor
5878077|NCT04348864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878078|NCT04335084|Vitamin D|vitamin d|mesh-list
5878079|NCT04335084|Vitamins|vitamins|mesh-list
5878080|NCT04335084|Ascorbic Acid|ascorbic acid|mesh-list
5878081|NCT04335084|Hydroxychloroquine|hydroxychloroquine|mesh-list
5878082|NCT04335084|Micronutrients|micronutrients|mesh-ancestor
5878083|NCT04335084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878084|NCT04335084|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5878085|NCT04335084|Antimalarials|antimalarials|mesh-ancestor
5878086|NCT04335084|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5878087|NCT04335084|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5878088|NCT04335084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5878089|NCT04335084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5686016|NCT03457142|Dermatologic Agents|dermatologic agents|mesh-ancestor
5686017|NCT03457142|Glycine Agents|glycine agents|mesh-ancestor
5686018|NCT03457142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5686019|NCT03457025|Antiviral Agents|antiviral agents|mesh-list
5686020|NCT03457025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5686021|NCT03456947|Pregabalin|pregabalin|mesh-list
5686022|NCT03456947|Analgesics|analgesics|mesh-ancestor
5686023|NCT03456947|Sensory System Agents|sensory system agents|mesh-ancestor
5686024|NCT03456947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5686025|NCT03456947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686026|NCT03456947|Anticonvulsants|anticonvulsants|mesh-ancestor
5686027|NCT03456947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5878090|NCT04335084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878091|NCT04335084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5878092|NCT04335084|Antioxidants|antioxidants|mesh-ancestor
5878093|NCT04335084|Protective Agents|protective agents|mesh-ancestor
5878094|NCT04318704|Ifenprodil|ifenprodil|mesh-list
5878095|NCT04318704|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5878096|NCT04318704|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5878097|NCT04318704|Adrenergic Agents|adrenergic agents|mesh-ancestor
5878098|NCT04318704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5878099|NCT04318704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878100|NCT04318704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878101|NCT04318704|Vasodilator Agents|vasodilator agents|mesh-ancestor
5878102|NCT04318704|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5878103|NCT04318704|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5878104|NCT04316871|Morphine|morphine|mesh-list
5878105|NCT04316871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5878106|NCT04316871|Narcotics|narcotics|mesh-ancestor
5878107|NCT04316871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5878108|NCT04316871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878109|NCT04316871|Analgesics|analgesics|mesh-ancestor
5878110|NCT04316871|Sensory System Agents|sensory system agents|mesh-ancestor
5878111|NCT04316871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5878112|NCT04295941|Trazodone|trazodone|mesh-list
5878113|NCT04295941|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5878114|NCT04295941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5878115|NCT04295941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5686028|NCT03456947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5686029|NCT03456947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878116|NCT04295941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878117|NCT04295941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5878118|NCT04295941|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5878119|NCT04295941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5878120|NCT04295941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5878121|NCT04295941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878122|NCT04295941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5878123|NCT04295941|Serotonin Agents|serotonin agents|mesh-ancestor
5878124|NCT04295941|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5878125|NCT04295941|Antidepressive Agents|antidepressive agents|mesh-ancestor
5878126|NCT04295902|Pyrithione zinc|pyrithione zinc|mesh-list
5878127|NCT04295902|Keratolytic Agents|keratolytic agents|mesh-ancestor
5878128|NCT04295902|Dermatologic Agents|dermatologic agents|mesh-ancestor
5878129|NCT04280692|Lumefantrine|lumefantrine|mesh-list
5878130|NCT04280692|Artemether|artemether|mesh-list
5878131|NCT04280692|Pyrimethamine|pyrimethamine|mesh-list
5878132|NCT04280692|Piperaquine|piperaquine|mesh-list
5878133|NCT04280692|Primaquine|primaquine|mesh-list
5878134|NCT04280692|Sulfadoxine|sulfadoxine|mesh-list
5878135|NCT04280692|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
5878136|NCT04280692|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
5878137|NCT04280692|Antimalarials|antimalarials|mesh-ancestor
5878138|NCT04280692|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5878139|NCT04280692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5878140|NCT04280692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5878141|NCT04280692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5878142|NCT04280692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5878143|NCT04280692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878144|NCT04280692|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5878145|NCT04280692|Renal Agents|renal agents|mesh-ancestor
5878146|NCT04276233|Prednisone|prednisone|mesh-list
5878147|NCT04276233|Prednisolone|prednisolone|mesh-list
5878148|NCT04276233|Albuterol|albuterol|mesh-list
5878149|NCT04276233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5878150|NCT04276233|Glucocorticoids|glucocorticoids|mesh-ancestor
5878151|NCT04276233|Hormones|hormones|mesh-ancestor
5878152|NCT04276233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5878153|NCT04276233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878154|NCT04276233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5878155|NCT04276233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5878156|NCT04276233|Autonomic Agents|autonomic agents|mesh-ancestor
5878157|NCT04276233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5878158|NCT04276233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5878159|NCT04276233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5878160|NCT04276233|Respiratory System Agents|respiratory system agents|mesh-ancestor
5878161|NCT04276233|Tocolytic Agents|tocolytic agents|mesh-ancestor
5878162|NCT04276233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5878163|NCT04276233|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5878164|NCT04276233|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5878165|NCT04276233|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5878166|NCT04276233|Adrenergic Agents|adrenergic agents|mesh-ancestor
5878167|NCT04276233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5878168|NCT04276233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878169|NCT04240288|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5878170|NCT04240288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5878171|NCT04240288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5878172|NCT04240288|Antitubercular Agents|antitubercular agents|mesh-ancestor
5878173|NCT04233034|Verapamil|verapamil|mesh-list
5878174|NCT04233034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5878175|NCT04233034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5878176|NCT04233034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5878177|NCT04233034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878178|NCT04233034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5878179|NCT04233034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878180|NCT04233034|Vasodilator Agents|vasodilator agents|mesh-ancestor
5878181|NCT04122196|Pregabalin|pregabalin|mesh-list
5878182|NCT04122196|Analgesics|analgesics|mesh-ancestor
5878183|NCT04122196|Sensory System Agents|sensory system agents|mesh-ancestor
5878184|NCT04122196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5878185|NCT04122196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878186|NCT04122196|Anticonvulsants|anticonvulsants|mesh-ancestor
5878187|NCT04122196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5878188|NCT04122196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5878189|NCT04122196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878190|NCT04122196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5878191|NCT04122196|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5878192|NCT04122196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5686030|NCT03456947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5686031|NCT03456947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5686032|NCT03456947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5686033|NCT03456947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5686034|NCT03456947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5686035|NCT03456791|Protease Inhibitors|protease inhibitors|mesh-list
5686036|NCT03456791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5686037|NCT03456791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686038|NCT03456752|Dexamethasone|dexamethasone|mesh-list
5686039|NCT03456752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5686040|NCT03456752|Antiemetics|antiemetics|mesh-ancestor
5686041|NCT03456752|Autonomic Agents|autonomic agents|mesh-ancestor
5686042|NCT03456752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5686043|NCT03456752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686044|NCT03456752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5686045|NCT03456752|Glucocorticoids|glucocorticoids|mesh-ancestor
5686046|NCT03456752|Hormones|hormones|mesh-ancestor
5686047|NCT03456752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5686048|NCT03456752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5686049|NCT03456752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5686050|NCT03456713|Mirikizumab|mirikizumab|mesh-list
5686051|NCT03456713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5686052|NCT03456713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5686053|NCT03456713|Analgesics|analgesics|mesh-ancestor
5686054|NCT03456713|Sensory System Agents|sensory system agents|mesh-ancestor
5686055|NCT03456713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5686056|NCT03456713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686057|NCT03456713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5686058|NCT03456713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5686059|NCT03456713|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5686060|NCT03456713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5686061|NCT03456687|Exenatide|exenatide|mesh-list
5686062|NCT03456687|Glucagon|glucagon|mesh-list
5686063|NCT03456687|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5686064|NCT03456687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5686065|NCT03456687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878193|NCT04122196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5878194|NCT04122196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5906183|NCT03712202|Dacarbazine|dacarbazine|mesh-list
5906184|NCT03712202|Vinblastine|vinblastine|mesh-list
5906185|NCT03712202|Antibodies|antibodies|mesh-list
5906186|NCT03712202|Immunoglobulins|immunoglobulins|mesh-list
5906187|NCT03712202|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5906188|NCT03712202|Immunoconjugates|immunoconjugates|mesh-list
5906189|NCT03712202|Imidazole|imidazole|mesh-list
5906190|NCT03712202|Immunologic Factors|immunologic factors|mesh-ancestor
5906191|NCT03712202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906192|NCT03712202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5906193|NCT03712202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5906194|NCT03712202|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5906195|NCT03712202|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5906196|NCT03712202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5906197|NCT03712202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906198|NCT03712202|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5906199|NCT03712202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5906200|NCT03712202|Alkylating Agents|alkylating agents|mesh-ancestor
5906201|NCT03712202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5906202|NCT03712202|Tubulin Modulators|tubulin modulators|mesh-ancestor
6495800|NCT00625092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6495801|NCT00625092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6495802|NCT00625092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6495803|NCT00625092|Immunologic Factors|immunologic factors|mesh-ancestor
6495804|NCT00625092|Antidotes|antidotes|mesh-ancestor
6495805|NCT00625092|Protective Agents|protective agents|mesh-ancestor
6495806|NCT00625092|Vitamin B Complex|vitamin b complex|mesh-ancestor
6495807|NCT00625092|Vitamins|vitamins|mesh-ancestor
6495808|NCT00625092|Micronutrients|micronutrients|mesh-ancestor
6495809|NCT00625170|Haloperidol|haloperidol|mesh-list
6675393|NCT01575158|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6675394|NCT01575236|Chlorhexidine|chlorhexidine|mesh-list
6675395|NCT01575236|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5686066|NCT03456687|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5686067|NCT03456687|Incretins|incretins|mesh-ancestor
5906203|NCT03712202|Antimitotic Agents|antimitotic agents|mesh-ancestor
5906204|NCT03712202|Mitosis Modulators|mitosis modulators|mesh-ancestor
5686068|NCT03456687|Hormones|hormones|mesh-ancestor
6495810|NCT00625170|Olanzapine|olanzapine|mesh-list
6495811|NCT00625170|Haloperidol decanoate|haloperidol decanoate|mesh-list
6495812|NCT00625170|Antiemetics|antiemetics|mesh-ancestor
6495813|NCT00625170|Autonomic Agents|autonomic agents|mesh-ancestor
5686069|NCT03456687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5686070|NCT03456687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5697295|NCT03376932|Autonomic Agents|autonomic agents|mesh-ancestor
5697296|NCT03376932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5697297|NCT03376932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697298|NCT03376932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5697299|NCT03376932|Respiratory System Agents|respiratory system agents|mesh-ancestor
5697300|NCT03376932|Parasympatholytics|parasympatholytics|mesh-ancestor
5697301|NCT03376932|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5697302|NCT03376932|Cholinergic Agents|cholinergic agents|mesh-ancestor
6495814|NCT00625170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6495815|NCT00625170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495816|NCT00625170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5878195|NCT04094012|Isoniazid|isoniazid|mesh-list
5878196|NCT04094012|Rifapentine|rifapentine|mesh-list
5878197|NCT04094012|Antitubercular Agents|antitubercular agents|mesh-ancestor
5878198|NCT04094012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5878199|NCT04094012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5878200|NCT04094012|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5878201|NCT04094012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5878202|NCT04094012|Antimetabolites|antimetabolites|mesh-ancestor
5878203|NCT04094012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878204|NCT04094012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5878205|NCT04094012|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5878206|NCT04094012|Leprostatic Agents|leprostatic agents|mesh-ancestor
5878207|NCT04076761|Trifluridine|trifluridine|mesh-list
5878208|NCT04076761|Antimetabolites|antimetabolites|mesh-ancestor
5878209|NCT04076761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878210|NCT04076761|Antiviral Agents|antiviral agents|mesh-ancestor
5878211|NCT04076761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5878212|NCT04062266|Azacitidine|azacitidine|mesh-list
5878213|NCT04062266|Venetoclax|venetoclax|mesh-list
5878214|NCT04062266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5878215|NCT04062266|Antimetabolites|antimetabolites|mesh-ancestor
5878216|NCT04062266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878217|NCT04062266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5878218|NCT04062266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5878219|NCT04022980|Nivolumab|nivolumab|mesh-list
5878220|NCT04022980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5878221|NCT04022980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5878222|NCT04022980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5878223|NCT04022980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878224|NCT04021381|Magnesium citrate|magnesium citrate|mesh-list
5878225|NCT04021381|Cathartics|cathartics|mesh-ancestor
6495817|NCT00625170|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6495818|NCT00625170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6495819|NCT00625170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6495820|NCT00625170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6495821|NCT00625170|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6495822|NCT00625170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6495823|NCT00625170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6495824|NCT00625170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878226|NCT04021381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5878227|NCT04004442|Avelumab|avelumab|mesh-list
5878228|NCT04004442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5878229|NCT04004442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5878230|NCT03970304|Vaccines|vaccines|mesh-list
5878231|NCT03970304|Immunologic Factors|immunologic factors|mesh-ancestor
5878232|NCT03970304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878233|NCT03966053|Trifluoperazine|trifluoperazine|mesh-list
5878234|NCT03966053|Antiemetics|antiemetics|mesh-ancestor
5878235|NCT03966053|Autonomic Agents|autonomic agents|mesh-ancestor
5878236|NCT03966053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5878237|NCT03966053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878238|NCT03966053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5878239|NCT03966053|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5878240|NCT03966053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5878241|NCT03966053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5878242|NCT03966053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5878243|NCT03966053|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5878244|NCT03966053|Dopamine Agents|dopamine agents|mesh-ancestor
5878245|NCT03966053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5878246|NCT03966053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878247|NCT03944902|Niraparib|niraparib|mesh-list
5878248|NCT03944902|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5878249|NCT03944902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5878250|NCT03944902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878251|NCT03944902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5878252|NCT03943511|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5878253|NCT03943511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5878254|NCT03911505|Miglustat|miglustat|mesh-list
5878255|NCT03911505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5878256|NCT03911505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878257|NCT03911505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5878258|NCT03911505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5878259|NCT03911505|Antiviral Agents|antiviral agents|mesh-ancestor
5878260|NCT03911505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5878261|NCT03911505|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
5878262|NCT03911505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5878263|NCT03911505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878264|NCT03910387|Gemcitabine|gemcitabine|mesh-list
5878265|NCT03910387|Paclitaxel|paclitaxel|mesh-list
5878266|NCT03910387|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5878267|NCT03910387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5878268|NCT03910387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5878269|NCT03910387|Tubulin Modulators|tubulin modulators|mesh-ancestor
5878270|NCT03910387|Antimitotic Agents|antimitotic agents|mesh-ancestor
5878271|NCT03910387|Mitosis Modulators|mitosis modulators|mesh-ancestor
5878272|NCT03910387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878273|NCT03910387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5878274|NCT03910387|Antimetabolites|antimetabolites|mesh-ancestor
5878275|NCT03910387|Antiviral Agents|antiviral agents|mesh-ancestor
5878276|NCT03910387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5878277|NCT03910387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5878278|NCT03910387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5878279|NCT03910387|Immunologic Factors|immunologic factors|mesh-ancestor
5878280|NCT03910387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878281|NCT03898180|Pembrolizumab|pembrolizumab|mesh-list
5878282|NCT03898180|Lenvatinib|lenvatinib|mesh-list
5878283|NCT03898180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5878284|NCT03898180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5878285|NCT03898180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5878286|NCT03898180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5878287|NCT03898180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878288|NCT03898154|Dexamethasone|dexamethasone|mesh-list
5878289|NCT03898154|Methylprednisolone|methylprednisolone|mesh-list
5878290|NCT03898154|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5878291|NCT03898154|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5878292|NCT03898154|Prednisolone|prednisolone|mesh-list
5878293|NCT03898154|Prednisolone acetate|prednisolone acetate|mesh-list
5878294|NCT03898154|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5878295|NCT03898154|Prednisolone phosphate|prednisolone phosphate|mesh-list
5878296|NCT03898154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5878297|NCT03898154|Antiemetics|antiemetics|mesh-ancestor
5878298|NCT03898154|Autonomic Agents|autonomic agents|mesh-ancestor
5686071|NCT03456661|Dexmedetomidine|dexmedetomidine|mesh-list
5686072|NCT03456661|Levobupivacaine|levobupivacaine|mesh-list
5686073|NCT03456661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5686074|NCT03456661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5686075|NCT03456661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686076|NCT03456661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5686077|NCT03456661|Analgesics|analgesics|mesh-ancestor
5686078|NCT03456661|Sensory System Agents|sensory system agents|mesh-ancestor
5686079|NCT03456661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5686080|NCT03456661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5686081|NCT03456661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5686082|NCT03456661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5686083|NCT03456661|Adrenergic Agents|adrenergic agents|mesh-ancestor
5686084|NCT03456661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5686085|NCT03456661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686086|NCT03456661|Anesthetics, Local|anesthetics, local|mesh-ancestor
5686087|NCT03456661|Anesthetics|anesthetics|mesh-ancestor
5686088|NCT03456648|Apixaban|apixaban|mesh-list
5686089|NCT03456648|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5686090|NCT03456648|Antithrombins|antithrombins|mesh-ancestor
5878299|NCT03898154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5878300|NCT03898154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878301|NCT03898154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5878302|NCT03898154|Glucocorticoids|glucocorticoids|mesh-ancestor
5878303|NCT03898154|Hormones|hormones|mesh-ancestor
5878304|NCT03898154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5878305|NCT03898154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5878306|NCT03898154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5878307|NCT03898154|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5878308|NCT03898154|Protective Agents|protective agents|mesh-ancestor
5878309|NCT03857087|Edetic Acid|edetic acid|mesh-list
5878310|NCT03857087|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5878311|NCT03857087|Chelating Agents|chelating agents|mesh-ancestor
5878312|NCT03857087|Sequestering Agents|sequestering agents|mesh-ancestor
5878313|NCT03857087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878314|NCT03857087|Anticoagulants|anticoagulants|mesh-ancestor
5878315|NCT03857087|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5878316|NCT03857087|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5878317|NCT03845140|Praziquantel|praziquantel|mesh-list
5878318|NCT03845140|Anthelmintics|anthelmintics|mesh-ancestor
5878319|NCT03845140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5878320|NCT03845140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5878321|NCT03827447|Vancomycin|vancomycin|mesh-list
5878322|NCT03827447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5878323|NCT03827447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5878324|NCT03823521|Cardioplegic Solutions|cardioplegic solutions|mesh-list
5878325|NCT03823521|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5878326|NCT03821857|Corticosterone|corticosterone|mesh-list
5878327|NCT03821857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5686091|NCT03456648|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5686092|NCT03456648|Protease Inhibitors|protease inhibitors|mesh-ancestor
5686093|NCT03456648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5686094|NCT03456648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686095|NCT03456648|Anticoagulants|anticoagulants|mesh-ancestor
5686096|NCT03456570|Dydrogesterone|dydrogesterone|mesh-list
5686097|NCT03456570|Progestins|progestins|mesh-ancestor
5686098|NCT03456570|Hormones|hormones|mesh-ancestor
5686099|NCT03456570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5686100|NCT03456570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686101|NCT03456544|Vancomycin|vancomycin|mesh-list
5686102|NCT03456544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5686103|NCT03456544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5686104|NCT03456531|Aspirin|aspirin|mesh-list
5686105|NCT03456531|Analgesics|analgesics|mesh-list
5686106|NCT03456531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5878335|NCT03727724|Cetuximab|cetuximab|mesh-list
5878336|NCT03727724|Afatinib|afatinib|mesh-list
5878337|NCT03727724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6675396|NCT01575236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6675397|NCT01575236|Disinfectants|disinfectants|mesh-ancestor
5878338|NCT03727724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5878339|NCT03727724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5878340|NCT03727724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6212475|NCT02188719|Glucocorticoids|glucocorticoids|mesh-ancestor
5686107|NCT03456531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5686108|NCT03456531|Sensory System Agents|sensory system agents|mesh-ancestor
5686109|NCT03456531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5686110|NCT03456531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686111|NCT03456531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5686112|NCT03456531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5686113|NCT03456531|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5686114|NCT03456531|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5686115|NCT03456531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686116|NCT03456531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5686117|NCT03456531|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5686118|NCT03456531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5686119|NCT03456531|Antipyretics|antipyretics|mesh-ancestor
5686120|NCT03456466|Rituximab|rituximab|mesh-list
5686121|NCT03456466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5686122|NCT03456466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5878341|NCT03727724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878342|NCT03697031|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5878343|NCT03697031|Hormones|hormones|mesh-ancestor
5878344|NCT03697031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5878345|NCT03697031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878346|NCT03672487|Benzonidazole|benzonidazole|mesh-list
5878347|NCT03672487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5878348|NCT03672487|Immunologic Factors|immunologic factors|mesh-ancestor
5878349|NCT03672487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686123|NCT03456466|Immunologic Factors|immunologic factors|mesh-ancestor
5686124|NCT03456466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686125|NCT03456466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5686126|NCT03456401|Sorafenib|sorafenib|mesh-list
5686127|NCT03456401|Sunitinib|sunitinib|mesh-list
5686128|NCT03456401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5686129|NCT03456401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5686130|NCT03456401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5686131|NCT03456401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686132|NCT03456401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5686133|NCT03456401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5686134|NCT03456401|Growth Substances|growth substances|mesh-ancestor
5686135|NCT03456401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686136|NCT03456401|Growth Inhibitors|growth inhibitors|mesh-ancestor
5686137|NCT03456154|Salicylic Acid|salicylic acid|mesh-list
5686138|NCT03456154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5686139|NCT03456154|Antifungal Agents|antifungal agents|mesh-ancestor
5686140|NCT03456154|Keratolytic Agents|keratolytic agents|mesh-ancestor
5686141|NCT03456154|Dermatologic Agents|dermatologic agents|mesh-ancestor
5686142|NCT03456102|Pravastatin|pravastatin|mesh-list
5686143|NCT03456102|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5686144|NCT03456102|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5878350|NCT03672487|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5878351|NCT03672487|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5878352|NCT03672487|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5878353|NCT03672487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5878354|NCT03663712|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
5878355|NCT03663712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5878356|NCT03663712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5878357|NCT03644953|Hydroxyurea|hydroxyurea|mesh-list
5878358|NCT03644953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5878359|NCT03644953|Antisickling Agents|antisickling agents|mesh-ancestor
5878360|NCT03644953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5878361|NCT03644953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878362|NCT03644953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5878363|NCT03637764|Atezolizumab|atezolizumab|mesh-list
5878364|NCT03637764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5878365|NCT03630835|Annexin A5|annexin a5|mesh-list
5878366|NCT03630835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5878367|NCT03630835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906205|NCT03689374|Insulin|insulin|mesh-list
5906206|NCT03689374|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5906207|NCT03689374|Insulin Glargine|insulin glargine|mesh-list
5906208|NCT03689374|Insulin Aspart|insulin aspart|mesh-list
5906209|NCT03689374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5906210|NCT03689374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906211|NCT03659539|Propofol|propofol|mesh-list
5906212|NCT03659539|Desflurane|desflurane|mesh-list
5906213|NCT03659539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5906214|NCT03659539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5906215|NCT03659539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906216|NCT03659539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5906217|NCT03659539|Anesthetics, General|anesthetics, general|mesh-ancestor
5906218|NCT03659539|Anesthetics|anesthetics|mesh-ancestor
5906219|NCT03659539|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5906220|NCT03630224|Plasma-lyte 148|plasma-lyte 148|mesh-list
5906221|NCT03630224|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5906222|NCT03630224|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5906223|NCT03627858|Beclomethasone|beclomethasone|mesh-list
5906224|NCT03627858|Glycopyrrolate|glycopyrrolate|mesh-list
5906225|NCT03627858|Formoterol Fumarate|formoterol fumarate|mesh-list
5906226|NCT03627858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5906227|NCT03627858|Autonomic Agents|autonomic agents|mesh-ancestor
5906228|NCT03627858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5906229|NCT03627858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906230|NCT03627858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5686145|NCT03456102|Antimetabolites|antimetabolites|mesh-ancestor
5906231|NCT03627858|Respiratory System Agents|respiratory system agents|mesh-ancestor
5878368|NCT03541850|Ascorbic Acid|ascorbic acid|mesh-list
5878369|NCT03541850|Methyltestosterone|methyltestosterone|mesh-list
5878370|NCT03541850|Hormones|hormones|mesh-list
5878371|NCT03541850|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
5878372|NCT03541850|Androgens|androgens|mesh-list
5878373|NCT03541850|Androgen Antagonists|androgen antagonists|mesh-list
5878374|NCT03541850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5878375|NCT03541850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878376|NCT03541850|Antioxidants|antioxidants|mesh-ancestor
5878377|NCT03541850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878378|NCT03541850|Protective Agents|protective agents|mesh-ancestor
5686146|NCT03456102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686147|NCT03456102|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5686148|NCT03456102|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5686149|NCT03456102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5686150|NCT03455426|Letrozole|letrozole|mesh-list
5686151|NCT03455426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5686152|NCT03455426|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5686153|NCT03455426|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5686154|NCT03455426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5686155|NCT03455426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686156|NCT03455426|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5686157|NCT03455426|Hormone Antagonists|hormone antagonists|mesh-ancestor
5686158|NCT03455426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5686159|NCT03455426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878379|NCT03541850|Vitamins|vitamins|mesh-ancestor
5878380|NCT03541850|Micronutrients|micronutrients|mesh-ancestor
5878381|NCT03541850|Estrogens|estrogens|mesh-ancestor
5878382|NCT03541850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5878383|NCT03541850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5878384|NCT03541850|Anabolic Agents|anabolic agents|mesh-ancestor
5878385|NCT03541850|Hormone Antagonists|hormone antagonists|mesh-ancestor
5878386|NCT03474497|Pembrolizumab|pembrolizumab|mesh-list
5878387|NCT03474497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5878388|NCT03474497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5878389|NCT03469050|Rifaximin|rifaximin|mesh-list
5878390|NCT03469050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5878391|NCT03469050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5878392|NCT03469050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5878393|NCT03415061|Insulin|insulin|mesh-list
5878394|NCT03415061|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5878395|NCT03415061|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5878396|NCT03415061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878397|NCT03403621|Pentamidine|pentamidine|mesh-list
5686160|NCT03455322|Octreotide|octreotide|mesh-list
5686161|NCT03455322|Norepinephrine|norepinephrine|mesh-list
5686162|NCT03455322|Midodrine|midodrine|mesh-list
5686163|NCT03455322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5686164|NCT03455322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5686165|NCT03455322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5686166|NCT03455322|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5686167|NCT03455322|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5686168|NCT03455322|Adrenergic Agents|adrenergic agents|mesh-ancestor
5686169|NCT03455322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5878398|NCT03403621|Antifungal Agents|antifungal agents|mesh-ancestor
5878399|NCT03403621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5878400|NCT03403621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5878401|NCT03403621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5878402|NCT03403621|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5878403|NCT03367819|Cemiplimab|cemiplimab|mesh-list
5878404|NCT03367819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5878405|NCT03367819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5878406|NCT03327844|Calcium, Dietary|calcium, dietary|mesh-list
5878407|NCT03327844|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5878408|NCT03327844|Metronidazole|metronidazole|mesh-list
5878409|NCT03327844|Ciprofloxacin|ciprofloxacin|mesh-list
5878410|NCT03327844|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5878411|NCT03327844|Calcium|calcium|mesh-list
5878412|NCT03327844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5878413|NCT03327844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878414|NCT03327844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5878415|NCT03327844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5878416|NCT03327844|Antitubercular Agents|antitubercular agents|mesh-ancestor
5878417|NCT03327844|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6212476|NCT02188719|Hormones|hormones|mesh-ancestor
5878418|NCT03327844|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5878419|NCT03327844|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5878420|NCT03327844|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5878421|NCT03327844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5686170|NCT03455322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686171|NCT03455322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686172|NCT03455322|Sympathomimetics|sympathomimetics|mesh-ancestor
5686173|NCT03455322|Autonomic Agents|autonomic agents|mesh-ancestor
5686174|NCT03455322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5686175|NCT03455322|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5686176|NCT03455322|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5686177|NCT03455179|Methamphetamine|methamphetamine|mesh-list
5686178|NCT03455179|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5686179|NCT03455179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686180|NCT03455179|Sympathomimetics|sympathomimetics|mesh-ancestor
5686181|NCT03455179|Autonomic Agents|autonomic agents|mesh-ancestor
5686182|NCT03455179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5686183|NCT03455179|Dopamine Agents|dopamine agents|mesh-ancestor
5686184|NCT03455179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5686185|NCT03455179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686186|NCT03455179|Adrenergic Agents|adrenergic agents|mesh-ancestor
5878422|NCT03327844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878423|NCT03327844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5878424|NCT03327844|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5878425|NCT03327844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5878426|NCT03239340|Osimertinib|osimertinib|mesh-list
5686187|NCT03455179|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5686188|NCT03455179|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5686189|NCT03455179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5686190|NCT03455179|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5686191|NCT03455140|BCT-100|bct-100|mesh-list
5686192|NCT03455140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5697303|NCT03376932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5697304|NCT03376932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697305|NCT03376932|Tocolytic Agents|tocolytic agents|mesh-ancestor
5697306|NCT03376932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5697307|NCT03376932|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5697308|NCT03376932|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5697309|NCT03376932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5697310|NCT03376932|Adrenergic Agents|adrenergic agents|mesh-ancestor
5878427|NCT03239340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5878428|NCT03239340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5878429|NCT03239340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5878430|NCT03239340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878431|NCT03189706|Irinotecan|irinotecan|mesh-list
5878432|NCT03189706|Temozolomide|temozolomide|mesh-list
5878433|NCT03189706|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5878434|NCT03189706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5878435|NCT03189706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5878436|NCT03189706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878437|NCT03189706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5878438|NCT03189706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5878439|NCT03189706|Alkylating Agents|alkylating agents|mesh-ancestor
5878440|NCT03158883|Avelumab|avelumab|mesh-list
5878441|NCT03158883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5878442|NCT03158883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5878443|NCT03113994|Calcium, Dietary|calcium, dietary|mesh-list
5878444|NCT03113994|Vitamin D|vitamin d|mesh-list
5878445|NCT03113994|Coenzyme Q10|coenzyme q10|mesh-list
5878446|NCT03113994|Ubiquinone|ubiquinone|mesh-list
5878447|NCT03113994|Calcium Carbonate|calcium carbonate|mesh-list
5878448|NCT03113994|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5878449|NCT03113994|Calcium|calcium|mesh-list
5878450|NCT03113994|Vitamins|vitamins|mesh-ancestor
5878451|NCT03113994|Micronutrients|micronutrients|mesh-ancestor
5878452|NCT03113994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878453|NCT03113994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5878454|NCT03113994|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5878455|NCT03113994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5878456|NCT03113994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5878457|NCT03113994|Antimetabolites|antimetabolites|mesh-ancestor
5878458|NCT03113994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878459|NCT03113994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5878460|NCT03113994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5878461|NCT03113994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5686193|NCT03455088|Fluoxetine|fluoxetine|mesh-list
5878462|NCT03113994|Antacids|antacids|mesh-ancestor
5878463|NCT03113994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5878464|NCT03082209|Bevacizumab|bevacizumab|mesh-list
5878465|NCT03082209|Venetoclax|venetoclax|mesh-list
5878466|NCT03082209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5878467|NCT03082209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5878468|NCT03082209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5878469|NCT03082209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5878470|NCT03082209|Growth Substances|growth substances|mesh-ancestor
5878471|NCT03082209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878472|NCT03082209|Growth Inhibitors|growth inhibitors|mesh-ancestor
5878473|NCT03008278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5878474|NCT03008278|Olaparib|olaparib|mesh-list
5878475|NCT03008278|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
5878476|NCT03008278|Ramucirumab|ramucirumab|mesh-list
5878477|NCT03008278|Antibodies|antibodies|mesh-list
5878478|NCT03008278|Immunoglobulins|immunoglobulins|mesh-list
6495825|NCT00625170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6495826|NCT00625170|Serotonin Agents|serotonin agents|mesh-ancestor
6495827|NCT00625170|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5878479|NCT03008278|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5878480|NCT03008278|Lexatumumab|lexatumumab|mesh-list
5878481|NCT03008278|Immunologic Factors|immunologic factors|mesh-ancestor
5878482|NCT03008278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878483|NCT03008278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5878484|NCT03008278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5878485|NCT03008278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878486|NCT03000179|Avelumab|avelumab|mesh-list
5878487|NCT03000179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5878488|NCT03000179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5878489|NCT02971956|Pembrolizumab|pembrolizumab|mesh-list
5878490|NCT02971956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5878491|NCT02971956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5878492|NCT02960568|Primaquine|primaquine|mesh-list
5878493|NCT02960568|Antimalarials|antimalarials|mesh-ancestor
5878494|NCT02960568|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5878495|NCT02960568|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5878496|NCT02960568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5878497|NCT02958865|PF-06700841|pf-06700841|mesh-list
5878498|NCT02958865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5878499|NCT02958865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5878500|NCT02958865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878501|NCT02954510|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
5878502|NCT02954510|Hematinics|hematinics|mesh-ancestor
5878503|NCT02954510|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5878504|NCT02954510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5878505|NCT02953665|Liraglutide|liraglutide|mesh-list
5878506|NCT02953665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5878507|NCT02953665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878508|NCT02953665|Incretins|incretins|mesh-ancestor
5878509|NCT02953665|Hormones|hormones|mesh-ancestor
5878510|NCT02953665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5878511|NCT02944071|Paclitaxel|paclitaxel|mesh-list
6495828|NCT00625170|Dopamine Agents|dopamine agents|mesh-ancestor
5686194|NCT03455088|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5686195|NCT03455088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5686196|NCT03455088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6495829|NCT00625170|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6495830|NCT00625196|Fluticasone|fluticasone|mesh-list
6495831|NCT00625196|Xhance|xhance|mesh-list
6495832|NCT00625196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6495833|NCT00625196|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6495834|NCT00625196|Autonomic Agents|autonomic agents|mesh-ancestor
5686197|NCT03455088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686198|NCT03455088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5686199|NCT03455088|Serotonin Agents|serotonin agents|mesh-ancestor
5686200|NCT03455088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686201|NCT03455088|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5686202|NCT03455088|Antidepressive Agents|antidepressive agents|mesh-ancestor
5686203|NCT03455088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5686204|NCT03455088|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5686205|NCT03455088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5686206|NCT03455088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5686207|NCT03455075|Levonorgestrel|levonorgestrel|mesh-list
5686208|NCT03455075|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5686209|NCT03455075|Contraceptive Agents|contraceptive agents|mesh-ancestor
5878512|NCT02944071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5878513|NCT02944071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5878514|NCT02944071|Tubulin Modulators|tubulin modulators|mesh-ancestor
5878515|NCT02944071|Antimitotic Agents|antimitotic agents|mesh-ancestor
5878516|NCT02944071|Mitosis Modulators|mitosis modulators|mesh-ancestor
5878517|NCT02944071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878518|NCT02864004|Apomorphine|apomorphine|mesh-list
5878519|NCT02864004|Emetics|emetics|mesh-ancestor
5878520|NCT02864004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878521|NCT02864004|Autonomic Agents|autonomic agents|mesh-ancestor
5878522|NCT02864004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5878523|NCT02864004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5878524|NCT02864004|Dopamine Agonists|dopamine agonists|mesh-ancestor
5878525|NCT02864004|Dopamine Agents|dopamine agents|mesh-ancestor
5878526|NCT02864004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5878527|NCT02864004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906232|NCT03627858|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5906233|NCT03627858|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5906234|NCT03627858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5906235|NCT03627858|Adrenergic Agents|adrenergic agents|mesh-ancestor
5906236|NCT03627858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5906237|NCT03627858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906238|NCT03627858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5906239|NCT03627858|Glucocorticoids|glucocorticoids|mesh-ancestor
5906240|NCT03627858|Hormones|hormones|mesh-ancestor
5906241|NCT03627858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5906242|NCT03627858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5906243|NCT03627858|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5906244|NCT03627858|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5906245|NCT03627858|Cholinergic Agents|cholinergic agents|mesh-ancestor
5906246|NCT03620123|Docetaxel|docetaxel|mesh-list
5906247|NCT03620123|Nivolumab|nivolumab|mesh-list
5906248|NCT03620123|Ipilimumab|ipilimumab|mesh-list
5906249|NCT03620123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5906250|NCT03620123|Tubulin Modulators|tubulin modulators|mesh-ancestor
5906251|NCT03620123|Antimitotic Agents|antimitotic agents|mesh-ancestor
5906252|NCT03620123|Mitosis Modulators|mitosis modulators|mesh-ancestor
5906253|NCT03620123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906254|NCT03620123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5906255|NCT03620123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5906256|NCT03601637|Ivacaftor|ivacaftor|mesh-list
5906257|NCT03601637|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
5906258|NCT03601637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5906259|NCT03601637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906260|NCT03552692|Venetoclax|venetoclax|mesh-list
5906261|NCT03552692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5686210|NCT03455075|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5686211|NCT03455075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686212|NCT03455075|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5686213|NCT03455075|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5686214|NCT03455075|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5686215|NCT03455049|Andrographolide|andrographolide|mesh-list
5686216|NCT03455049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5686217|NCT03455049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5686218|NCT03455049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5686219|NCT03455049|Analgesics|analgesics|mesh-ancestor
5686220|NCT03455049|Sensory System Agents|sensory system agents|mesh-ancestor
5686221|NCT03455049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5686222|NCT03455049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906262|NCT03467958|Ozanimod|ozanimod|mesh-list
5906263|NCT03467958|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5906264|NCT03467958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906265|NCT03467958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5906266|NCT03467958|Immunologic Factors|immunologic factors|mesh-ancestor
5906267|NCT03467958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906268|NCT03425643|Gemcitabine|gemcitabine|mesh-list
5906269|NCT03425643|Pembrolizumab|pembrolizumab|mesh-list
5906270|NCT03425643|Pemetrexed|pemetrexed|mesh-list
5906271|NCT03425643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5906272|NCT03425643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5906273|NCT03425643|Antimetabolites|antimetabolites|mesh-ancestor
5906274|NCT03425643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906275|NCT03425643|Antiviral Agents|antiviral agents|mesh-ancestor
5906276|NCT03425643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5686223|NCT03455049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5878528|NCT02834403|Aspirin|aspirin|mesh-list
5878529|NCT02834403|Docetaxel|docetaxel|mesh-list
5878530|NCT02834403|Amlodipine|amlodipine|mesh-list
5878531|NCT02834403|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
5878532|NCT02834403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5878533|NCT02834403|Tubulin Modulators|tubulin modulators|mesh-ancestor
5878534|NCT02834403|Antimitotic Agents|antimitotic agents|mesh-ancestor
5878535|NCT02834403|Mitosis Modulators|mitosis modulators|mesh-ancestor
5878536|NCT02834403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878537|NCT02834403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5878538|NCT02834403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5878539|NCT02834403|Analgesics|analgesics|mesh-ancestor
5878540|NCT02834403|Sensory System Agents|sensory system agents|mesh-ancestor
5878541|NCT02834403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5878542|NCT02834403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878543|NCT02834403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5878544|NCT02834403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5878545|NCT02834403|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5878546|NCT02834403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5878547|NCT02834403|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5878548|NCT02834403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5878549|NCT02834403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5878550|NCT02834403|Antipyretics|antipyretics|mesh-ancestor
5878551|NCT02834403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5878552|NCT02834403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5878553|NCT02834403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5878554|NCT02834403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5878555|NCT02834403|Vasodilator Agents|vasodilator agents|mesh-ancestor
5878556|NCT02770040|Infliximab|infliximab|mesh-list
5878557|NCT02770040|Dermatologic Agents|dermatologic agents|mesh-ancestor
5878558|NCT02770040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5878559|NCT02770040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5878560|NCT02766465|Sirolimus|sirolimus|mesh-list
5878561|NCT02766465|Methotrexate|methotrexate|mesh-list
5878562|NCT02766465|Fludarabine|fludarabine|mesh-list
5878563|NCT02766465|Melphalan|melphalan|mesh-list
5878564|NCT02766465|Busulfan|busulfan|mesh-list
5878565|NCT02766465|Alemtuzumab|alemtuzumab|mesh-list
5878566|NCT02766465|Tacrolimus|tacrolimus|mesh-list
5878567|NCT02766465|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5878568|NCT02766465|Thymoglobulin|thymoglobulin|mesh-list
5878569|NCT02766465|Lenograstim|lenograstim|mesh-list
5878570|NCT02766465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5878571|NCT02766465|Abortifacient Agents|abortifacient agents|mesh-ancestor
5878572|NCT02766465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5878573|NCT02766465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878574|NCT02766465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5878575|NCT02766465|Antimetabolites|antimetabolites|mesh-ancestor
5878576|NCT02766465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878577|NCT02766465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5878578|NCT02766465|Dermatologic Agents|dermatologic agents|mesh-ancestor
5878579|NCT02766465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5878580|NCT02766465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6495835|NCT00625196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6495836|NCT00625196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495837|NCT00625196|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6495838|NCT00625196|Respiratory System Agents|respiratory system agents|mesh-ancestor
5686224|NCT03455049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5686225|NCT03455049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5686226|NCT03455049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5686227|NCT03455049|Antiviral Agents|antiviral agents|mesh-ancestor
5686228|NCT03455049|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5686229|NCT03454984|Guadecitabine|guadecitabine|mesh-list
5686230|NCT03454984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5686231|NCT03454945|Doxycycline|doxycycline|mesh-list
5686232|NCT03454945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5686233|NCT03454945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5686234|NCT03454945|Antimalarials|antimalarials|mesh-ancestor
5686235|NCT03454945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5686236|NCT03454945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5686237|NCT03454919|Palbociclib|palbociclib|mesh-list
5686238|NCT03454919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5686239|NCT03454919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5686240|NCT03454919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5686241|NCT03454919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686242|NCT03454841|Ticagrelor|ticagrelor|mesh-list
5686243|NCT03454841|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
5878581|NCT02766465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5878582|NCT02766465|Immunologic Factors|immunologic factors|mesh-ancestor
5878583|NCT02766465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5878584|NCT02766465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5878585|NCT02766465|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5878586|NCT02766465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5878587|NCT02766465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5878588|NCT02766465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5878589|NCT02766465|Antifungal Agents|antifungal agents|mesh-ancestor
5878590|NCT02766465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5878591|NCT02766465|Alkylating Agents|alkylating agents|mesh-ancestor
5878592|NCT02766465|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5878593|NCT02766465|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5878594|NCT02766465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5686244|NCT03454841|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5686245|NCT03454841|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5686246|NCT03454841|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5686247|NCT03454841|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5686248|NCT03454841|Purinergic Agents|purinergic agents|mesh-ancestor
5878609|NCT02748018|Insulin|insulin|mesh-list
5878610|NCT02748018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5878611|NCT02748018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878612|NCT02741128|Vaccines|vaccines|mesh-list
5878613|NCT02741128|Immunologic Factors|immunologic factors|mesh-ancestor
5878614|NCT02741128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878615|NCT02721654|Plasma-lyte 148|plasma-lyte 148|mesh-list
5878616|NCT02721654|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5878617|NCT02721654|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5878618|NCT02712112|Imatinib Mesylate|imatinib mesylate|mesh-list
5878619|NCT02712112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5878620|NCT02712112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5878621|NCT02712112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5878622|NCT02712112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878623|NCT02701088|Mitomycins|mitomycins|mesh-list
5878624|NCT02701088|Mitomycin|mitomycin|mesh-list
5878625|NCT02701088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5878626|NCT02701088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5878627|NCT02701088|Alkylating Agents|alkylating agents|mesh-ancestor
5878628|NCT02701088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878629|NCT02701088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5878630|NCT02701088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5878631|NCT02675465|Miglustat|miglustat|mesh-list
5878632|NCT02675465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5878633|NCT02675465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878634|NCT02675465|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5878635|NCT02675465|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5878636|NCT02675465|Antiviral Agents|antiviral agents|mesh-ancestor
5878637|NCT02675465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5878638|NCT02675465|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
5686249|NCT03454841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5686250|NCT03454841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686251|NCT03454841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878639|NCT02675465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5878640|NCT02675465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878641|NCT02663908|Leuprolide|leuprolide|mesh-list
5878642|NCT02663908|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6495839|NCT00625196|Dermatologic Agents|dermatologic agents|mesh-ancestor
5878643|NCT02663908|Fertility Agents|fertility agents|mesh-ancestor
6495840|NCT00625196|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6495841|NCT00625209|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
5878644|NCT02663908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5878645|NCT02663908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878646|NCT02663908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5878647|NCT02663908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5878648|NCT02634411|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5878649|NCT02634411|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5878650|NCT02634411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5878651|NCT02634411|Antitubercular Agents|antitubercular agents|mesh-ancestor
5878652|NCT02624765|Digoxin|digoxin|mesh-list
5878653|NCT02624765|Sotalol|sotalol|mesh-list
5878654|NCT02624765|Flecainide|flecainide|mesh-list
5878655|NCT02624765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5878656|NCT02624765|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5878657|NCT02624765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5878658|NCT02624765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878659|NCT02624765|Protective Agents|protective agents|mesh-ancestor
5878660|NCT02624765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878661|NCT02624765|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5878662|NCT02624765|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5878663|NCT02624765|Adrenergic Agents|adrenergic agents|mesh-ancestor
5878664|NCT02624765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5878665|NCT02624765|Sympatholytics|sympatholytics|mesh-ancestor
5878666|NCT02624765|Autonomic Agents|autonomic agents|mesh-ancestor
5878667|NCT02624765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5878668|NCT02624765|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5878669|NCT02624765|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5878670|NCT02624765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5878671|NCT02619253|Pembrolizumab|pembrolizumab|mesh-list
5878672|NCT02619253|Vorinostat|vorinostat|mesh-list
5878673|NCT02619253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5878674|NCT02619253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5878675|NCT02619253|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5878676|NCT02619253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5686252|NCT03454789|Lidocaine|lidocaine|mesh-list
5686253|NCT03454789|Anesthetics, Local|anesthetics, local|mesh-ancestor
5686254|NCT03454789|Anesthetics|anesthetics|mesh-ancestor
5686255|NCT03454789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5686256|NCT03454789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686257|NCT03454789|Sensory System Agents|sensory system agents|mesh-ancestor
5686258|NCT03454789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5686259|NCT03454789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5686260|NCT03454789|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5686261|NCT03454789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5686262|NCT03454789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5686263|NCT03454789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686264|NCT03454724|Sirolimus|sirolimus|mesh-list
5686265|NCT03454724|Everolimus|everolimus|mesh-list
5686266|NCT03454724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5686267|NCT03454724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5878677|NCT02619253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878678|NCT02554383|Amoxicillin|amoxicillin|mesh-list
5878679|NCT02554383|Clavulanic Acid|clavulanic acid|mesh-list
5878680|NCT02554383|Clavulanic Acids|clavulanic acids|mesh-list
5878681|NCT02554383|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5878682|NCT02554383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5878683|NCT02554383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5878684|NCT02554383|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5878685|NCT02554383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5878686|NCT02554383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878687|NCT05090449|Losartan|losartan|mesh-list
5878688|NCT05090449|Chlorthalidone|chlorthalidone|mesh-list
5878689|NCT05090449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5878690|NCT05090449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5878691|NCT05090449|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5878692|NCT05090449|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5878693|NCT05090449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878694|NCT05090449|Diuretics|diuretics|mesh-ancestor
5878695|NCT05090449|Natriuretic Agents|natriuretic agents|mesh-ancestor
5878696|NCT05090449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878697|NCT05090449|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5878698|NCT05090449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5878699|NCT05090384|Prednisone|prednisone|mesh-list
5878700|NCT05090384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5686268|NCT03454724|Immunologic Factors|immunologic factors|mesh-ancestor
5878701|NCT05090384|Glucocorticoids|glucocorticoids|mesh-ancestor
5878702|NCT05090384|Hormones|hormones|mesh-ancestor
5878703|NCT05090384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5878704|NCT05090384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878705|NCT05090384|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5878706|NCT05090384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5878707|NCT05090358|Canagliflozin|canagliflozin|mesh-list
5878708|NCT05090358|Fulvestrant|fulvestrant|mesh-list
5878709|NCT05090358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5878710|NCT05090358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5686269|NCT03454724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686270|NCT03454724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5686271|NCT03454724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5878711|NCT05090358|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5878712|NCT05090358|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5878713|NCT05090358|Hormone Antagonists|hormone antagonists|mesh-ancestor
5878714|NCT05090358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5878715|NCT05090358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878716|NCT05090358|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5878717|NCT05090358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878718|NCT05090358|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5878719|NCT05090176|Povidone|povidone|mesh-list
5878720|NCT05090176|Plasma Substitutes|plasma substitutes|mesh-ancestor
5878721|NCT05090176|Blood Substitutes|blood substitutes|mesh-ancestor
5878722|NCT05090137|Diuretics|diuretics|mesh-list
5878723|NCT05090137|Natriuretic Agents|natriuretic agents|mesh-ancestor
5878724|NCT05090137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878725|NCT05090124|Adalimumab|adalimumab|mesh-list
5878726|NCT05090124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5878727|NCT05090124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5878728|NCT05089981|Acetylcysteine|acetylcysteine|mesh-list
5878729|NCT05089981|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5878730|NCT05089981|Antiviral Agents|antiviral agents|mesh-ancestor
5878731|NCT05089981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5878732|NCT05089981|Expectorants|expectorants|mesh-ancestor
5878733|NCT05089981|Respiratory System Agents|respiratory system agents|mesh-ancestor
5878734|NCT05089981|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5878735|NCT05089981|Antioxidants|antioxidants|mesh-ancestor
5878736|NCT05089981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878737|NCT05089981|Protective Agents|protective agents|mesh-ancestor
5686272|NCT03454724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5686273|NCT03454724|Antifungal Agents|antifungal agents|mesh-ancestor
5686274|NCT03454646|Rivastigmine|rivastigmine|mesh-list
5686275|NCT03454646|Donepezil|donepezil|mesh-list
5686276|NCT03454646|Galantamine|galantamine|mesh-list
5686277|NCT03454646|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
5686278|NCT03454646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5686279|NCT03454646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686280|NCT03454646|Cholinergic Agents|cholinergic agents|mesh-ancestor
5878738|NCT05089981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878739|NCT05089981|Antidotes|antidotes|mesh-ancestor
5878740|NCT05089604|Tacrolimus|tacrolimus|mesh-list
5878741|NCT05089604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5878742|NCT05089604|Immunologic Factors|immunologic factors|mesh-ancestor
5878743|NCT05089604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878744|NCT05089604|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5878745|NCT05089604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5878746|NCT05089604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878747|NCT05089539|Valsartan|valsartan|mesh-list
5878748|NCT05089539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5878749|NCT05089539|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5878750|NCT05089539|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5878751|NCT05089539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878752|NCT05089461|Mitoxantrone|mitoxantrone|mesh-list
5878753|NCT05089461|Analgesics|analgesics|mesh-ancestor
5878754|NCT05089461|Sensory System Agents|sensory system agents|mesh-ancestor
5878755|NCT05089461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5878756|NCT05089461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878757|NCT05089461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5878758|NCT05089461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5878759|NCT05089461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5878760|NCT05089461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5906277|NCT03425643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5686281|NCT03454646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5686282|NCT03454646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878761|NCT05089461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878762|NCT05089448|Amlodipine|amlodipine|mesh-list
5878763|NCT05089448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5878764|NCT05089448|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5878765|NCT05089448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5878766|NCT05089448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878767|NCT05089448|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5878768|NCT05089448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878769|NCT05089448|Vasodilator Agents|vasodilator agents|mesh-ancestor
5878770|NCT05089383|Progesterone|progesterone|mesh-list
5878771|NCT05089383|Progestins|progestins|mesh-ancestor
5878772|NCT05089383|Hormones|hormones|mesh-ancestor
5878773|NCT05089383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5878774|NCT05089383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878775|NCT05089344|Clomiphene|clomiphene|mesh-list
5878776|NCT05089344|Enclomiphene|enclomiphene|mesh-list
5686283|NCT03454646|Nootropic Agents|nootropic agents|mesh-ancestor
5686284|NCT03454646|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5686285|NCT03454646|Autonomic Agents|autonomic agents|mesh-ancestor
5686286|NCT03454646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5686287|NCT03454646|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5686288|NCT03454646|Protective Agents|protective agents|mesh-ancestor
5686289|NCT03454620|Irinotecan|irinotecan|mesh-list
5686290|NCT03454620|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5686291|NCT03454620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5686292|NCT03454620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5686293|NCT03454620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878777|NCT05089344|Zuclomiphene|zuclomiphene|mesh-list
5878778|NCT05089344|Hormones|hormones|mesh-list
5878779|NCT05089344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5878780|NCT05089344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878781|NCT05089344|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5878782|NCT05089344|Hormone Antagonists|hormone antagonists|mesh-ancestor
5878783|NCT05089344|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5878784|NCT05089344|Fertility Agents|fertility agents|mesh-ancestor
5878785|NCT05089344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5878786|NCT05089344|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5878787|NCT05089344|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5906278|NCT03425643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6495842|NCT00625209|Hydrocortisone|hydrocortisone|mesh-list
5906279|NCT03425643|Immunologic Factors|immunologic factors|mesh-ancestor
5906280|NCT03425643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906281|NCT03425643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5906282|NCT03425643|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5906283|NCT03425643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5906284|NCT03398655|Paclitaxel|paclitaxel|mesh-list
5906285|NCT03398655|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5906286|NCT03398655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5906287|NCT03398655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5906288|NCT03398655|Tubulin Modulators|tubulin modulators|mesh-ancestor
5906289|NCT03398655|Antimitotic Agents|antimitotic agents|mesh-ancestor
5906290|NCT03398655|Mitosis Modulators|mitosis modulators|mesh-ancestor
5906291|NCT03398655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906292|NCT03370172|Factor VIII|factor viii|mesh-list
5906293|NCT03370172|Coagulants|coagulants|mesh-ancestor
5906294|NCT03292146|Denosumab|denosumab|mesh-list
5906295|NCT03292146|Alendronate|alendronate|mesh-list
5906296|NCT03292146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5906297|NCT03292146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906298|NCT03289325|Dexmedetomidine|dexmedetomidine|mesh-list
5906299|NCT03289325|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5906300|NCT03289325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5906301|NCT03289325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906302|NCT03289325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5906303|NCT03289325|Analgesics|analgesics|mesh-ancestor
5906304|NCT03289325|Sensory System Agents|sensory system agents|mesh-ancestor
5906305|NCT03289325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5906306|NCT03289325|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5906307|NCT03289325|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5906308|NCT03289325|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5906309|NCT03289325|Adrenergic Agents|adrenergic agents|mesh-ancestor
5906310|NCT03289325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5906311|NCT03289325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906312|NCT03274492|Prednisone|prednisone|mesh-list
5878788|NCT05088889|Nivolumab|nivolumab|mesh-list
5878789|NCT05088889|Ipilimumab|ipilimumab|mesh-list
5878790|NCT05088889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5878791|NCT05088889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5878792|NCT05088889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5878793|NCT05088889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878794|NCT05088876|Acetaminophen|acetaminophen|mesh-list
5878795|NCT05088876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5878796|NCT05088876|Analgesics|analgesics|mesh-ancestor
5878797|NCT05088876|Sensory System Agents|sensory system agents|mesh-ancestor
5878798|NCT05088876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5878799|NCT05088876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878800|NCT05088876|Antipyretics|antipyretics|mesh-ancestor
5878801|NCT05088798|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
5878802|NCT05088798|Dopamine Agents|dopamine agents|mesh-ancestor
5878803|NCT05088798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5878804|NCT05088798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878805|NCT05088798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878806|NCT05088720|Misoprostol|misoprostol|mesh-list
5878807|NCT05088720|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5878808|NCT05088720|Abortifacient Agents|abortifacient agents|mesh-ancestor
5686294|NCT03454620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5686295|NCT03454529|Simvastatin|simvastatin|mesh-list
5686296|NCT03454529|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5686297|NCT03454529|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5686298|NCT03454529|Antimetabolites|antimetabolites|mesh-ancestor
5686299|NCT03454529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686300|NCT03454529|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5686301|NCT03454529|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5686302|NCT03454529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5686303|NCT03454503|Imatinib Mesylate|imatinib mesylate|mesh-list
5686304|NCT03454503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5686305|NCT03454503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5686306|NCT03454503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5686307|NCT03454503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686308|NCT03454451|Pembrolizumab|pembrolizumab|mesh-list
5686309|NCT03454451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5686310|NCT03454451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5686311|NCT03454217|Oxycodone|oxycodone|mesh-list
5686312|NCT03454217|Tramadol|tramadol|mesh-list
5686313|NCT03454217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5686314|NCT03454217|Narcotics|narcotics|mesh-ancestor
5686315|NCT03454217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5686316|NCT03454217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686317|NCT03454217|Analgesics|analgesics|mesh-ancestor
5686318|NCT03454217|Sensory System Agents|sensory system agents|mesh-ancestor
5686319|NCT03454217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5686320|NCT03453931|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5686321|NCT03453931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5878809|NCT05088720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5878810|NCT05088720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878811|NCT05088720|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5878812|NCT05088720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5878813|NCT05088720|Oxytocics|oxytocics|mesh-ancestor
5878814|NCT05088707|Misoprostol|misoprostol|mesh-list
5878815|NCT05088707|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5878816|NCT05088707|Abortifacient Agents|abortifacient agents|mesh-ancestor
5878817|NCT05088707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5878818|NCT05088707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878819|NCT05088707|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5878820|NCT05088707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5878821|NCT05088707|Oxytocics|oxytocics|mesh-ancestor
5878822|NCT05084118|Landiolol|landiolol|mesh-list
5878823|NCT05084118|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5878824|NCT05084118|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5878825|NCT05084118|Adrenergic Agents|adrenergic agents|mesh-ancestor
5878826|NCT05084118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5878827|NCT05084118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878828|NCT05084118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878829|NCT05084118|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5878830|NCT05081349|Hydroxyurea|hydroxyurea|mesh-list
5878831|NCT05081349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5878832|NCT05081349|Antisickling Agents|antisickling agents|mesh-ancestor
5878833|NCT05081349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5686322|NCT03453931|Glucocorticoids|glucocorticoids|mesh-ancestor
5878834|NCT05081349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878835|NCT05081349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5878836|NCT05077540|Misoprostol|misoprostol|mesh-list
5878837|NCT05077540|Oxytocin|oxytocin|mesh-list
5878838|NCT05077540|Oxytocics|oxytocics|mesh-ancestor
5878839|NCT05077540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5878840|NCT05077540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878841|NCT05077540|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5878842|NCT05077540|Abortifacient Agents|abortifacient agents|mesh-ancestor
5878843|NCT05077540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5878844|NCT05077540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5878845|NCT05073549|Anti-Infective Agents|anti-infective agents|mesh-list
5878846|NCT05073549|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5878847|NCT05064878|Fenfluramine|fenfluramine|mesh-list
5878848|NCT05064878|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5878849|NCT05064878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5878850|NCT05064878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5878851|NCT05064878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878852|NCT05064878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5878853|NCT05064878|Serotonin Agents|serotonin agents|mesh-ancestor
5878854|NCT05064878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878855|NCT05057468|Cyclosporine|cyclosporine|mesh-list
5878856|NCT05057468|Rituximab|rituximab|mesh-list
5878857|NCT05057468|Cyclosporins|cyclosporins|mesh-list
5878858|NCT05057468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5878859|NCT05057468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5878860|NCT05057468|Immunologic Factors|immunologic factors|mesh-ancestor
5878861|NCT05057468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878862|NCT05057468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5878863|NCT05057468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5878864|NCT05057468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878865|NCT05057468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5878866|NCT05057468|Antifungal Agents|antifungal agents|mesh-ancestor
5878867|NCT05057468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5878868|NCT05057468|Dermatologic Agents|dermatologic agents|mesh-ancestor
5878869|NCT05057468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5878870|NCT05046132|Moxifloxacin|moxifloxacin|mesh-list
5878871|NCT05046132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5878872|NCT05046132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5878873|NCT05046132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5878874|NCT05046132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5878875|NCT05046132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5878876|NCT05046132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878877|NCT05046132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5878878|NCT05043077|Phenylephrine|phenylephrine|mesh-list
5878879|NCT05043077|Oxymetazoline|oxymetazoline|mesh-list
5686323|NCT03453931|Hormones|hormones|mesh-ancestor
5686324|NCT03453931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5686325|NCT03453931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686326|NCT03453931|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5686327|NCT03453931|Protective Agents|protective agents|mesh-ancestor
5686328|NCT03453931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5686329|NCT03453931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5686330|NCT03453892|Pembrolizumab|pembrolizumab|mesh-list
5686331|NCT03453892|Nivolumab|nivolumab|mesh-list
5878880|NCT05043077|Tropicamide|tropicamide|mesh-list
5878881|NCT05043077|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5878882|NCT05043077|Mydriatics|mydriatics|mesh-ancestor
5878883|NCT05043077|Autonomic Agents|autonomic agents|mesh-ancestor
5878884|NCT05043077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5878885|NCT05043077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878886|NCT05043077|Sympathomimetics|sympathomimetics|mesh-ancestor
5878887|NCT05043077|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5878888|NCT05043077|Nasal Decongestants|nasal decongestants|mesh-ancestor
5878889|NCT05043077|Respiratory System Agents|respiratory system agents|mesh-ancestor
5878890|NCT05043077|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5878891|NCT05043077|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5878892|NCT05043077|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5878893|NCT05043077|Adrenergic Agents|adrenergic agents|mesh-ancestor
5878894|NCT05043077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5878895|NCT05043077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878896|NCT05043077|Protective Agents|protective agents|mesh-ancestor
5878897|NCT05043077|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5878898|NCT05043077|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5878899|NCT05043077|Cholinergic Agents|cholinergic agents|mesh-ancestor
5878916|NCT04991103|Dexamethasone|dexamethasone|mesh-list
5878917|NCT04991103|Lenalidomide|lenalidomide|mesh-list
5878918|NCT04991103|Bortezomib|bortezomib|mesh-list
5878919|NCT04991103|Daratumumab|daratumumab|mesh-list
5878920|NCT04991103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5878921|NCT04991103|Antiemetics|antiemetics|mesh-ancestor
5878922|NCT04991103|Autonomic Agents|autonomic agents|mesh-ancestor
5878923|NCT04991103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5878924|NCT04991103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878925|NCT04991103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5878926|NCT04991103|Glucocorticoids|glucocorticoids|mesh-ancestor
5878927|NCT04991103|Hormones|hormones|mesh-ancestor
5878928|NCT04991103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5878929|NCT04991103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5878930|NCT04991103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5878931|NCT04991103|Immunologic Factors|immunologic factors|mesh-ancestor
5878932|NCT04991103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5878933|NCT04991103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5878934|NCT04991103|Growth Substances|growth substances|mesh-ancestor
5878935|NCT04991103|Growth Inhibitors|growth inhibitors|mesh-ancestor
5878936|NCT04961593|Caspofungin|caspofungin|mesh-list
5878937|NCT04961593|Antifungal Agents|antifungal agents|mesh-ancestor
5878938|NCT04961593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5878939|NCT04961593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5878940|NCT04961593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878941|NCT04961580|Ceftazidime|ceftazidime|mesh-list
5878942|NCT04961580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5878943|NCT04961580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5878944|NCT04945213|Biperiden|biperiden|mesh-list
5878945|NCT04945213|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5686332|NCT03453892|Ipilimumab|ipilimumab|mesh-list
5686333|NCT03453892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5686334|NCT03453892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5686335|NCT03453892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5686336|NCT03453892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878946|NCT04945213|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5878947|NCT04945213|Parasympatholytics|parasympatholytics|mesh-ancestor
5878948|NCT04945213|Autonomic Agents|autonomic agents|mesh-ancestor
5878949|NCT04945213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5878950|NCT04945213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878951|NCT04945213|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5878952|NCT04945213|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5878953|NCT04945213|Cholinergic Agents|cholinergic agents|mesh-ancestor
5878954|NCT04945213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5878955|NCT04945213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878956|NCT04908592|Dexamethasone|dexamethasone|mesh-list
5878957|NCT04908592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5878958|NCT04908592|Antiemetics|antiemetics|mesh-ancestor
5878959|NCT04908592|Autonomic Agents|autonomic agents|mesh-ancestor
5878960|NCT04908592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5878961|NCT04908592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5878962|NCT04908592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5878963|NCT04908592|Glucocorticoids|glucocorticoids|mesh-ancestor
5878964|NCT04908592|Hormones|hormones|mesh-ancestor
5686337|NCT03453840|Lumefantrine|lumefantrine|mesh-list
5686338|NCT03453840|Artemether|artemether|mesh-list
5686339|NCT03453840|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
5686340|NCT03453840|Antimalarials|antimalarials|mesh-ancestor
5686341|NCT03453840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5686342|NCT03453840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5686343|NCT03453840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5686344|NCT03453723|Lidocaine|lidocaine|mesh-list
5878965|NCT04908592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5878966|NCT04908592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5878967|NCT04908592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5878968|NCT04895930|Aflutinib|aflutinib|mesh-list
5878969|NCT04895930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5878970|NCT04895930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5878971|NCT04895930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878972|NCT04870424|Colchicine|colchicine|mesh-list
5878973|NCT04870424|Gout Suppressants|gout suppressants|mesh-ancestor
5878974|NCT04870424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5878975|NCT04870424|Tubulin Modulators|tubulin modulators|mesh-ancestor
5878976|NCT04870424|Antimitotic Agents|antimitotic agents|mesh-ancestor
5878977|NCT04870424|Mitosis Modulators|mitosis modulators|mesh-ancestor
5878978|NCT04870424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878979|NCT04870424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5878980|NCT04862585|Diphenhydramine|diphenhydramine|mesh-list
5878981|NCT04862585|Promethazine|promethazine|mesh-list
5878982|NCT04862585|Dexamethasone|dexamethasone|mesh-list
5878983|NCT04862585|Dexamethasone acetate|dexamethasone acetate|mesh-list
5878984|NCT04862585|Paclitaxel|paclitaxel|mesh-list
5878985|NCT04862585|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5878986|NCT04862585|Famotidine|famotidine|mesh-list
5878987|NCT04862585|Ranitidine|ranitidine|mesh-list
5878988|NCT04862585|Cimetidine|cimetidine|mesh-list
5878989|NCT04862585|BB 1101|bb 1101|mesh-list
5878990|NCT04862585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5878991|NCT04862585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5878992|NCT04862585|Tubulin Modulators|tubulin modulators|mesh-ancestor
5878993|NCT04862585|Antimitotic Agents|antimitotic agents|mesh-ancestor
5878994|NCT04862585|Mitosis Modulators|mitosis modulators|mesh-ancestor
5878995|NCT04862585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5878996|NCT04862585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5878997|NCT04862585|Antiemetics|antiemetics|mesh-ancestor
5878998|NCT04862585|Autonomic Agents|autonomic agents|mesh-ancestor
5878999|NCT04862585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5879000|NCT04862585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879001|NCT04862585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5879002|NCT04862585|Glucocorticoids|glucocorticoids|mesh-ancestor
5879003|NCT04862585|Hormones|hormones|mesh-ancestor
5879004|NCT04862585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5879005|NCT04862585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5686345|NCT03453723|Anesthetics, Local|anesthetics, local|mesh-ancestor
5686346|NCT03453723|Anesthetics|anesthetics|mesh-ancestor
5686347|NCT03453723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5686348|NCT03453723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686349|NCT03453723|Sensory System Agents|sensory system agents|mesh-ancestor
5686350|NCT03453723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5686351|NCT03453723|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5879006|NCT04862585|Protease Inhibitors|protease inhibitors|mesh-ancestor
5879007|NCT04862585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5879008|NCT04862585|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5879009|NCT04862585|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5879010|NCT04862585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5879011|NCT04862585|Anesthetics, Local|anesthetics, local|mesh-ancestor
5879012|NCT04862585|Anesthetics|anesthetics|mesh-ancestor
5879013|NCT04862585|Sensory System Agents|sensory system agents|mesh-ancestor
5879014|NCT04862585|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5879015|NCT04862585|Histamine Antagonists|histamine antagonists|mesh-ancestor
5879016|NCT04862585|Histamine Agents|histamine agents|mesh-ancestor
5879017|NCT04862585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5879018|NCT04862585|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5879019|NCT04862585|Antipruritics|antipruritics|mesh-ancestor
5879020|NCT04862585|Dermatologic Agents|dermatologic agents|mesh-ancestor
5879021|NCT04862585|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5879022|NCT04862585|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5879023|NCT04862585|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5879024|NCT04862585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5906313|NCT03274492|Cyclophosphamide|cyclophosphamide|mesh-list
5906314|NCT03274492|Rituximab|rituximab|mesh-list
5906315|NCT03274492|Doxorubicin|doxorubicin|mesh-list
5906316|NCT03274492|Vincristine|vincristine|mesh-list
5906317|NCT03274492|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5906318|NCT03274492|Immunoconjugates|immunoconjugates|mesh-list
5906319|NCT03274492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5686352|NCT03453723|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5686353|NCT03453723|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5686354|NCT03453723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5879025|NCT04850651|Fluconazole|fluconazole|mesh-list
5879026|NCT04850651|Antifungal Agents|antifungal agents|mesh-ancestor
5879027|NCT04850651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5879028|NCT04850651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5879029|NCT04850651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5879030|NCT04850651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5879031|NCT04850651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879032|NCT04850651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5879033|NCT04850651|Hormone Antagonists|hormone antagonists|mesh-ancestor
5879034|NCT04850651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5879035|NCT04850651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879036|NCT04850651|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5879037|NCT04850651|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5686355|NCT03453723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697311|NCT03376854|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
5697312|NCT03376854|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5697313|NCT03376854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5697314|NCT03376854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697315|NCT03376841|Cenicriviroc|cenicriviroc|mesh-list
5697316|NCT03376841|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
5697317|NCT03376841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697318|NCT03376841|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5697319|NCT03376841|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5879038|NCT04828005|Naloxone|naloxone|mesh-list
5879039|NCT04828005|Nalmefene|nalmefene|mesh-list
5879040|NCT04828005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5879041|NCT04828005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879042|NCT04828005|Sensory System Agents|sensory system agents|mesh-ancestor
5879043|NCT04828005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5879044|NCT04788550|Listerine|listerine|mesh-list
5879045|NCT04788550|Fluorides|fluorides|mesh-list
5879046|NCT04788550|Sodium Fluoride|sodium fluoride|mesh-list
5879047|NCT04788550|Fluorides, Topical|fluorides, topical|mesh-list
5879048|NCT04788550|Cariostatic Agents|cariostatic agents|mesh-ancestor
5879049|NCT04788550|Protective Agents|protective agents|mesh-ancestor
5879050|NCT04788550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879051|NCT04788550|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5879052|NCT04788550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5879053|NCT04759768|Naltrexone|naltrexone|mesh-list
5879054|NCT04759768|Nalmefene|nalmefene|mesh-list
5879055|NCT04759768|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5879056|NCT04759768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879057|NCT04759768|Sensory System Agents|sensory system agents|mesh-ancestor
5879058|NCT04759768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5879059|NCT04759768|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5879060|NCT04757493|Prucalopride|prucalopride|mesh-list
5879061|NCT04757493|Laxatives|laxatives|mesh-ancestor
5879062|NCT04757493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5879063|NCT04757493|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
5879064|NCT04757493|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5697320|NCT03376841|Antiviral Agents|antiviral agents|mesh-ancestor
5879065|NCT04757493|Serotonin Agents|serotonin agents|mesh-ancestor
5879066|NCT04757493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5879067|NCT04757493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879068|NCT04757493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879069|NCT04750291|Botulinum Toxins|botulinum toxins|mesh-list
5879070|NCT04750291|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5879071|NCT04750291|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5879072|NCT04750291|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5879073|NCT04750291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5879074|NCT04750291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697321|NCT03376841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5697322|NCT03376789|MYL-1501D|myl-1501d|mesh-list
5697323|NCT03376789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5686356|NCT03453684|Vancomycin|vancomycin|mesh-list
5686357|NCT03453684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5686358|NCT03453684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5686359|NCT03453632|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5686360|NCT03453632|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5686361|NCT03453632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5686362|NCT03453632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686363|NCT03453632|Cholinergic Agents|cholinergic agents|mesh-ancestor
5686364|NCT03453632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5686365|NCT03453632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686366|NCT03453541|Ketorolac|ketorolac|mesh-list
5686367|NCT03453541|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
5879075|NCT04750291|Cholinergic Agents|cholinergic agents|mesh-ancestor
5879076|NCT04750291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5879077|NCT04750291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879078|NCT04750291|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5879079|NCT04750291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5879080|NCT04731467|Paclitaxel|paclitaxel|mesh-list
5879081|NCT04731467|Nivolumab|nivolumab|mesh-list
5879082|NCT04731467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5879083|NCT04731467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5879084|NCT04731467|Tubulin Modulators|tubulin modulators|mesh-ancestor
5879085|NCT04731467|Antimitotic Agents|antimitotic agents|mesh-ancestor
5879086|NCT04731467|Mitosis Modulators|mitosis modulators|mesh-ancestor
5879087|NCT04731467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879088|NCT04731467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5879089|NCT04731467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5879090|NCT04725331|Pembrolizumab|pembrolizumab|mesh-list
5879091|NCT04725331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5879092|NCT04725331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5879093|NCT04723134|Leucovorin|leucovorin|mesh-list
5879094|NCT04723134|Folic Acid|folic acid|mesh-list
5879095|NCT04723134|Calcium|calcium|mesh-list
5879096|NCT04723134|Levoleucovorin|levoleucovorin|mesh-list
5879097|NCT04723134|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5879098|NCT04723134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879099|NCT04723134|Antidotes|antidotes|mesh-ancestor
5879100|NCT04723134|Protective Agents|protective agents|mesh-ancestor
5879101|NCT04723134|Vitamin B Complex|vitamin b complex|mesh-ancestor
5879102|NCT04723134|Vitamins|vitamins|mesh-ancestor
5879103|NCT04723134|Micronutrients|micronutrients|mesh-ancestor
5879104|NCT04723134|Hematinics|hematinics|mesh-ancestor
5879105|NCT04713319|Calcium|calcium|mesh-list
5879106|NCT04713319|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5879107|NCT04713319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879108|NCT04705662|Lactulose|lactulose|mesh-list
5879109|NCT04705662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5879110|NCT04691986|Niacinamide|niacinamide|mesh-list
5879111|NCT04691986|Niacin|niacin|mesh-list
5879112|NCT04691986|Nicotinic Acids|nicotinic acids|mesh-list
5879113|NCT04691986|Vitamin B Complex|vitamin b complex|mesh-ancestor
5879114|NCT04691986|Vitamins|vitamins|mesh-ancestor
5879115|NCT04691986|Micronutrients|micronutrients|mesh-ancestor
5879116|NCT04691986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879117|NCT04691986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5879118|NCT04691986|Antimetabolites|antimetabolites|mesh-ancestor
5879119|NCT04691986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879120|NCT04691986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5879121|NCT04691986|Vasodilator Agents|vasodilator agents|mesh-ancestor
5879122|NCT04605081|Naltrexone|naltrexone|mesh-list
5879123|NCT04605081|Bupropion|bupropion|mesh-list
5879124|NCT04605081|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5879125|NCT04605081|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5879126|NCT04605081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879127|NCT04605081|Sensory System Agents|sensory system agents|mesh-ancestor
5879128|NCT04605081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5879129|NCT04605081|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5879130|NCT04605081|Antidepressive Agents|antidepressive agents|mesh-ancestor
5879131|NCT04605081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5879132|NCT04605081|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5879133|NCT04605081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5879134|NCT04605081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5879135|NCT04605081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686368|NCT03453541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5686369|NCT03453541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5879136|NCT04605081|Dopamine Agents|dopamine agents|mesh-ancestor
5879137|NCT04605081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5879138|NCT04605081|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5879139|NCT04605081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5879140|NCT04605081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5879141|NCT04595786|Tranexamic Acid|tranexamic acid|mesh-list
5879142|NCT04595786|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5879143|NCT04595786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5879144|NCT04595786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879145|NCT04595786|Hemostatics|hemostatics|mesh-ancestor
5879146|NCT04595786|Coagulants|coagulants|mesh-ancestor
5879147|NCT04569461|Pembrolizumab|pembrolizumab|mesh-list
5879148|NCT04569461|Androgens|androgens|mesh-list
5879149|NCT04569461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5879150|NCT04569461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5879151|NCT04569461|Hormones|hormones|mesh-ancestor
5879152|NCT04569461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5879153|NCT04569461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879154|NCT04565483|Benralizumab|benralizumab|mesh-list
5879155|NCT04565483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5879156|NCT04565483|Respiratory System Agents|respiratory system agents|mesh-ancestor
5879157|NCT04536194|Dopamine|dopamine|mesh-list
5879158|NCT04536194|Norepinephrine|norepinephrine|mesh-list
5879159|NCT04536194|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5879160|NCT04536194|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5879161|NCT04536194|Adrenergic Agents|adrenergic agents|mesh-ancestor
5879162|NCT04536194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5879163|NCT04536194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879164|NCT04536194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879165|NCT04536194|Sympathomimetics|sympathomimetics|mesh-ancestor
5879166|NCT04536194|Autonomic Agents|autonomic agents|mesh-ancestor
5879167|NCT04536194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5879168|NCT04536194|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5879169|NCT04536194|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5879170|NCT04536194|Dopamine Agents|dopamine agents|mesh-ancestor
5879171|NCT04536194|Protective Agents|protective agents|mesh-ancestor
5879172|NCT04484025|Ebselen|ebselen|mesh-list
5879173|NCT04484025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5879174|NCT04484025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5879175|NCT04484025|Analgesics|analgesics|mesh-ancestor
5879176|NCT04484025|Sensory System Agents|sensory system agents|mesh-ancestor
5879177|NCT04484025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5879178|NCT04484025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879179|NCT04484025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5879180|NCT04484025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5879181|NCT04484025|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5879182|NCT04484025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5879183|NCT04484025|Antioxidants|antioxidants|mesh-ancestor
5879184|NCT04484025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879185|NCT04484025|Protective Agents|protective agents|mesh-ancestor
5879186|NCT04484025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5879187|NCT04484025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5879188|NCT04484025|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5879189|NCT04483973|Ebselen|ebselen|mesh-list
5879190|NCT04483973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5879191|NCT04483973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5879192|NCT04483973|Analgesics|analgesics|mesh-ancestor
5879193|NCT04483973|Sensory System Agents|sensory system agents|mesh-ancestor
5879194|NCT04483973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5879195|NCT04483973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879196|NCT04483973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5879197|NCT04483973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5879198|NCT04483973|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5879199|NCT04483973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5879200|NCT04483973|Antioxidants|antioxidants|mesh-ancestor
5879201|NCT04483973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879202|NCT04483973|Protective Agents|protective agents|mesh-ancestor
5879203|NCT04483973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5879204|NCT04483973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5879205|NCT04483973|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5879206|NCT04449042|Anesthetics|anesthetics|mesh-list
5879207|NCT04449042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5879208|NCT04449042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879209|NCT04429542|Pembrolizumab|pembrolizumab|mesh-list
5879210|NCT04429542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5879211|NCT04429542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5879212|NCT04341090|Apatinib|apatinib|mesh-list
5879213|NCT04341090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5879214|NCT04341090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5879215|NCT04341090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5879216|NCT04341090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879217|NCT04338529|Cholecalciferol|cholecalciferol|mesh-list
5879218|NCT04338529|Calcium Carbonate|calcium carbonate|mesh-list
5879219|NCT04338529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5879220|NCT04338529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879221|NCT04338529|Vitamins|vitamins|mesh-ancestor
5879222|NCT04338529|Micronutrients|micronutrients|mesh-ancestor
5879223|NCT04338529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5879224|NCT04338529|Antacids|antacids|mesh-ancestor
5879225|NCT04338529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879226|NCT04338529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5879227|NCT04263896|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
5879228|NCT04263896|Laxatives|laxatives|mesh-ancestor
5879229|NCT04263896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5879230|NCT04254731|Methadone|methadone|mesh-list
5879231|NCT04254731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5879232|NCT04254731|Narcotics|narcotics|mesh-ancestor
5879233|NCT04254731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5879234|NCT04254731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879235|NCT04254731|Analgesics|analgesics|mesh-ancestor
5879236|NCT04254731|Sensory System Agents|sensory system agents|mesh-ancestor
5879237|NCT04254731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5879238|NCT04254731|Antitussive Agents|antitussive agents|mesh-ancestor
5879239|NCT04254731|Respiratory System Agents|respiratory system agents|mesh-ancestor
6495843|NCT00625209|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6495844|NCT00625209|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6495845|NCT00625209|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6495846|NCT00625209|Fludrocortisone|fludrocortisone|mesh-list
6495847|NCT00625209|Protein C|protein c|mesh-list
6495848|NCT00625209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6495849|NCT00625209|Anticoagulants|anticoagulants|mesh-ancestor
6495850|NCT00625209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6495851|NCT00625209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5879240|NCT04254627|Etanercept|etanercept|mesh-list
5879241|NCT04254627|Mifepristone|mifepristone|mesh-list
5879242|NCT04254627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5879243|NCT04254627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5879244|NCT04254627|Analgesics|analgesics|mesh-ancestor
5879245|NCT04254627|Sensory System Agents|sensory system agents|mesh-ancestor
5879246|NCT04254627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5879247|NCT04254627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879248|NCT04254627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5879249|NCT04254627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6495852|NCT00625209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495853|NCT00625209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6495854|NCT00625248|Anticoagulants|anticoagulants|mesh-list
5879250|NCT04254627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5879251|NCT04254627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5879252|NCT04254627|Immunologic Factors|immunologic factors|mesh-ancestor
5879253|NCT04254627|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5879254|NCT04254627|Abortifacient Agents|abortifacient agents|mesh-ancestor
5879255|NCT04254627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5879256|NCT04254627|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5879257|NCT04254627|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5879258|NCT04254627|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5879259|NCT04254627|Contraceptive Agents|contraceptive agents|mesh-ancestor
5879260|NCT04254627|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5879261|NCT04254627|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5879262|NCT04254627|Hormone Antagonists|hormone antagonists|mesh-ancestor
5879263|NCT04254627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5879264|NCT04254627|Luteolytic Agents|luteolytic agents|mesh-ancestor
5879265|NCT04254627|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5879266|NCT04254627|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5879267|NCT04223570|Protoporphyrin IX|protoporphyrin ix|mesh-list
5879268|NCT04223570|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5879269|NCT04223570|Levulinic acid|levulinic acid|mesh-list
5879270|NCT04223570|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5879271|NCT04223570|Dermatologic Agents|dermatologic agents|mesh-ancestor
5879272|NCT04223570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5879273|NCT04223570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879274|NCT04207918|Nimotuzumab|nimotuzumab|mesh-list
5879275|NCT04207918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5879276|NCT04207918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5906320|NCT03274492|Immunologic Factors|immunologic factors|mesh-ancestor
5906321|NCT03274492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906322|NCT03274492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5686370|NCT03453541|Analgesics|analgesics|mesh-ancestor
5686371|NCT03453541|Sensory System Agents|sensory system agents|mesh-ancestor
5686372|NCT03453541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5686373|NCT03453541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686374|NCT03453541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5686375|NCT03453541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5686376|NCT03453541|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5686377|NCT03453541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5686378|NCT03453541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686379|NCT03453528|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5686380|NCT03453528|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5686381|NCT03453528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686382|NCT03453489|Tryptophan|tryptophan|mesh-list
5686383|NCT03453489|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5686384|NCT03453489|Antidepressive Agents|antidepressive agents|mesh-ancestor
5686385|NCT03453489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5686386|NCT03453346|Ribavirin|ribavirin|mesh-list
5686387|NCT03453346|Sofosbuvir|sofosbuvir|mesh-list
5686388|NCT03453346|Antimetabolites|antimetabolites|mesh-ancestor
5686389|NCT03453346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686390|NCT03453346|Antiviral Agents|antiviral agents|mesh-ancestor
5686391|NCT03453346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5686392|NCT03453281|Bevacizumab|bevacizumab|mesh-list
5686393|NCT03453281|Aflibercept|aflibercept|mesh-list
5686394|NCT03453281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5686395|NCT03453281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5686396|NCT03453281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5686397|NCT03453281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5686398|NCT03453281|Growth Substances|growth substances|mesh-ancestor
5686399|NCT03453281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686400|NCT03453281|Growth Inhibitors|growth inhibitors|mesh-ancestor
5686401|NCT03453190|Apremilast|apremilast|mesh-list
5686402|NCT03453190|Clobetasol|clobetasol|mesh-list
5686403|NCT03453190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5686404|NCT03453190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5906323|NCT03274492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5906324|NCT03274492|Alkylating Agents|alkylating agents|mesh-ancestor
5906325|NCT03274492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906326|NCT03274492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5906327|NCT03274492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5906328|NCT03274492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5906329|NCT03274492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5906330|NCT03274492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5906331|NCT03274492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5906332|NCT03274492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5906333|NCT03274492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5906334|NCT03274492|Glucocorticoids|glucocorticoids|mesh-ancestor
5906335|NCT03274492|Hormones|hormones|mesh-ancestor
5906336|NCT03274492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5906337|NCT03274492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5906338|NCT03274492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5906339|NCT03274492|Tubulin Modulators|tubulin modulators|mesh-ancestor
5906340|NCT03274492|Antimitotic Agents|antimitotic agents|mesh-ancestor
5906341|NCT03274492|Mitosis Modulators|mitosis modulators|mesh-ancestor
5686405|NCT03453190|Analgesics|analgesics|mesh-ancestor
6675398|NCT01575301|Liraglutide|liraglutide|mesh-list
6675399|NCT01575301|Exenatide|exenatide|mesh-list
6675400|NCT01575301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6675401|NCT01575301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675402|NCT01575301|Incretins|incretins|mesh-ancestor
6675403|NCT01575301|Hormones|hormones|mesh-ancestor
6675404|NCT01575301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6675405|NCT01575301|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6675406|NCT01575405|Tenofovir|tenofovir|mesh-list
5686406|NCT03453190|Sensory System Agents|sensory system agents|mesh-ancestor
5686407|NCT03453190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5686408|NCT03453190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686409|NCT03453190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5686410|NCT03453190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5686411|NCT03453190|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5686412|NCT03453190|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5686413|NCT03453190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5686414|NCT03453190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686415|NCT03453190|Glucocorticoids|glucocorticoids|mesh-ancestor
5686416|NCT03453190|Hormones|hormones|mesh-ancestor
5686417|NCT03453190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5686418|NCT03453177|Fosfomycin|fosfomycin|mesh-list
5686419|NCT03453177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5686420|NCT03453177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5686421|NCT03453164|Nivolumab|nivolumab|mesh-list
5686422|NCT03453164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5686423|NCT03453164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5879277|NCT04144517|Pembrolizumab|pembrolizumab|mesh-list
5879278|NCT04144517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5879279|NCT04144517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6675407|NCT01575405|Glycerol|glycerol|mesh-list
6675408|NCT01575405|Antiviral Agents|antiviral agents|mesh-ancestor
6675409|NCT01575405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6675410|NCT01575405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6675411|NCT01575405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5879280|NCT04089150|Leucovorin|leucovorin|mesh-list
5879281|NCT04089150|Gemcitabine|gemcitabine|mesh-list
5879282|NCT04089150|Paclitaxel|paclitaxel|mesh-list
5879283|NCT04089150|Fluorouracil|fluorouracil|mesh-list
5879284|NCT04089150|Capecitabine|capecitabine|mesh-list
5879285|NCT04089150|Oxaliplatin|oxaliplatin|mesh-list
5879286|NCT04089150|Irinotecan|irinotecan|mesh-list
5879287|NCT04089150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5879288|NCT04089150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5879289|NCT04089150|Tubulin Modulators|tubulin modulators|mesh-ancestor
5879290|NCT04089150|Antimitotic Agents|antimitotic agents|mesh-ancestor
5879291|NCT04089150|Mitosis Modulators|mitosis modulators|mesh-ancestor
5879292|NCT04089150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879293|NCT04089150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5879294|NCT04089150|Antimetabolites|antimetabolites|mesh-ancestor
5879295|NCT04089150|Antiviral Agents|antiviral agents|mesh-ancestor
5879296|NCT04089150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5879297|NCT04089150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5879298|NCT04089150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5879299|NCT04089150|Immunologic Factors|immunologic factors|mesh-ancestor
5879300|NCT04089150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879301|NCT04089150|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5879302|NCT04089150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5879303|NCT04089150|Antidotes|antidotes|mesh-ancestor
5879304|NCT04089150|Protective Agents|protective agents|mesh-ancestor
5879305|NCT04089150|Vitamin B Complex|vitamin b complex|mesh-ancestor
5879306|NCT04089150|Vitamins|vitamins|mesh-ancestor
5879307|NCT04089150|Micronutrients|micronutrients|mesh-ancestor
5879308|NCT04082780|Rifamycins|rifamycins|mesh-list
5879309|NCT04082780|Rifamycin SV|rifamycin sv|mesh-list
5879310|NCT04082780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6675412|NCT01575405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5686424|NCT03453164|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5686425|NCT03453164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686426|NCT03452930|Benzimidazole|benzimidazole|mesh-list
5686427|NCT03452930|Anthelmintics|anthelmintics|mesh-ancestor
5686428|NCT03452930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5686429|NCT03452930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5686430|NCT03452891|Simvastatin|simvastatin|mesh-list
5686431|NCT03452891|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5879311|NCT04082780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5879312|NCT04082780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5879313|NCT04036929|Bazedoxifene|bazedoxifene|mesh-list
5879314|NCT04036929|Estrogens|estrogens|mesh-list
5879315|NCT04036929|Hormones|hormones|mesh-ancestor
5879316|NCT04036929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5879317|NCT04036929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879318|NCT04036929|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5879319|NCT04036929|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5879320|NCT04036929|Hormone Antagonists|hormone antagonists|mesh-ancestor
5879321|NCT04036929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5686432|NCT03452891|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5686433|NCT03452891|Antimetabolites|antimetabolites|mesh-ancestor
5686434|NCT03452891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686435|NCT03452891|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5686436|NCT03452891|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5686437|NCT03452891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5686438|NCT03452722|Plasminogen|plasminogen|mesh-list
5686439|NCT03452722|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5879322|NCT03925727|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5879323|NCT03925727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5879324|NCT03925350|Niraparib|niraparib|mesh-list
5879325|NCT03925350|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5879326|NCT03925350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5879327|NCT03925350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879328|NCT03925350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5879329|NCT03906526|Nivolumab|nivolumab|mesh-list
5879330|NCT03906526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5879331|NCT03906526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5879332|NCT03906526|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5879333|NCT03906526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879334|NCT03829332|Pembrolizumab|pembrolizumab|mesh-list
5879335|NCT03829332|Lenvatinib|lenvatinib|mesh-list
5879336|NCT03829332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5686440|NCT03452722|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5686441|NCT03452722|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5686442|NCT03452722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686443|NCT03452696|Calcium|calcium|mesh-list
5686444|NCT03452696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5686445|NCT03452696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686446|NCT03452657|Ranibizumab|ranibizumab|mesh-list
5686447|NCT03452657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5686448|NCT03452657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5686449|NCT03452657|Growth Substances|growth substances|mesh-ancestor
5686450|NCT03452657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686451|NCT03452657|Growth Inhibitors|growth inhibitors|mesh-ancestor
5686452|NCT03452657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5686453|NCT03452579|Bevacizumab|bevacizumab|mesh-list
5686454|NCT03452579|Nivolumab|nivolumab|mesh-list
5686455|NCT03452579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5686456|NCT03452579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5686457|NCT03452579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5879337|NCT03829332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5879338|NCT03829332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5879339|NCT03829332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5879340|NCT03829332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879341|NCT03798626|Leucovorin|leucovorin|mesh-list
5879342|NCT03798626|Paclitaxel|paclitaxel|mesh-list
5879343|NCT03798626|Bevacizumab|bevacizumab|mesh-list
5879344|NCT03798626|Fluorouracil|fluorouracil|mesh-list
5879345|NCT03798626|Oxaliplatin|oxaliplatin|mesh-list
5879346|NCT03798626|Irinotecan|irinotecan|mesh-list
5879347|NCT03798626|Ramucirumab|ramucirumab|mesh-list
5879348|NCT03798626|Levoleucovorin|levoleucovorin|mesh-list
5879349|NCT03798626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5879350|NCT03798626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5879351|NCT03798626|Tubulin Modulators|tubulin modulators|mesh-ancestor
5879352|NCT03798626|Antimitotic Agents|antimitotic agents|mesh-ancestor
5879353|NCT03798626|Mitosis Modulators|mitosis modulators|mesh-ancestor
5879354|NCT03798626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879355|NCT03798626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5879356|NCT03798626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5879357|NCT03798626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5879358|NCT03798626|Growth Substances|growth substances|mesh-ancestor
5879359|NCT03798626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879360|NCT03798626|Growth Inhibitors|growth inhibitors|mesh-ancestor
5879361|NCT03798626|Antimetabolites|antimetabolites|mesh-ancestor
5879362|NCT03798626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5879363|NCT03798626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5879364|NCT03798626|Immunologic Factors|immunologic factors|mesh-ancestor
5879365|NCT03798626|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5879366|NCT03798626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5879367|NCT03798626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5879368|NCT03798626|Antidotes|antidotes|mesh-ancestor
5879369|NCT03798626|Protective Agents|protective agents|mesh-ancestor
5879370|NCT03798626|Vitamin B Complex|vitamin b complex|mesh-ancestor
5879371|NCT03798626|Vitamins|vitamins|mesh-ancestor
5879372|NCT03798626|Micronutrients|micronutrients|mesh-ancestor
5879373|NCT03789604|Antibodies|antibodies|mesh-list
5879374|NCT03789604|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5879375|NCT03789604|Immunologic Factors|immunologic factors|mesh-ancestor
5879376|NCT03789604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879377|NCT03633058|Ketamine|ketamine|mesh-list
5879378|NCT03633058|Analgesics|analgesics|mesh-ancestor
5879379|NCT03633058|Sensory System Agents|sensory system agents|mesh-ancestor
5879380|NCT03633058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5879381|NCT03633058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879382|NCT03633058|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5879383|NCT03633058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5879384|NCT03633058|Anesthetics, General|anesthetics, general|mesh-ancestor
5879385|NCT03633058|Anesthetics|anesthetics|mesh-ancestor
5879386|NCT03633058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5879387|NCT03633058|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5879388|NCT03633058|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5879389|NCT03633058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5879390|NCT03633058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879391|NCT03575208|Interferons|interferons|mesh-list
5879392|NCT03575208|Interferon-alpha|interferon-alpha|mesh-list
5879393|NCT03575208|Immunoglobulins|immunoglobulins|mesh-list
5879394|NCT03575208|Antibodies|antibodies|mesh-list
5879395|NCT03575208|gamma-Globulins|gamma-globulins|mesh-list
5879396|NCT03575208|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5879397|NCT03575208|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5879398|NCT03575208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5879399|NCT03575208|Antiviral Agents|antiviral agents|mesh-ancestor
5879400|NCT03575208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5879401|NCT03575208|Immunologic Factors|immunologic factors|mesh-ancestor
5879402|NCT03575208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879403|NCT03542175|Rucaparib|rucaparib|mesh-list
5879404|NCT03542175|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5879405|NCT03542175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5879406|NCT03542175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879407|NCT03542175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5879408|NCT03522064|Carboplatin|carboplatin|mesh-list
5879409|NCT03522064|Methyltestosterone|methyltestosterone|mesh-list
5879410|NCT03522064|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5879411|NCT03522064|Testosterone|testosterone|mesh-list
5879412|NCT03522064|Testosterone undecanoate|testosterone undecanoate|mesh-list
5879413|NCT03522064|Testosterone enanthate|testosterone enanthate|mesh-list
5879414|NCT03522064|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5879415|NCT03522064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5879416|NCT03522064|Androgens|androgens|mesh-ancestor
5879417|NCT03522064|Hormones|hormones|mesh-ancestor
5879418|NCT03522064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5879419|NCT03522064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879420|NCT03522064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5879421|NCT03522064|Anabolic Agents|anabolic agents|mesh-ancestor
5879422|NCT03476681|Pembrolizumab|pembrolizumab|mesh-list
5879423|NCT03476681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5879424|NCT03476681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5879425|NCT03419481|Pembrolizumab|pembrolizumab|mesh-list
5879426|NCT03419481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5879427|NCT03419481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5686458|NCT03452579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5686459|NCT03452579|Growth Substances|growth substances|mesh-ancestor
5686460|NCT03452579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686461|NCT03452579|Growth Inhibitors|growth inhibitors|mesh-ancestor
5686462|NCT03452579|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5686463|NCT03452579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686464|NCT03452553|Doxorubicin|doxorubicin|mesh-list
5686465|NCT03452553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5686466|NCT03452553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5686467|NCT03452553|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5686468|NCT03452553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5686469|NCT03452553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5686470|NCT03452553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686471|NCT03452501|Infliximab|infliximab|mesh-list
5686472|NCT03452501|Dermatologic Agents|dermatologic agents|mesh-ancestor
5686473|NCT03452501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5686474|NCT03452501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5686475|NCT03452475|Lumefantrine|lumefantrine|mesh-list
5686476|NCT03452475|Artemether|artemether|mesh-list
5686477|NCT03452475|Piperaquine|piperaquine|mesh-list
5879428|NCT03408652|Zoledronic Acid|zoledronic acid|mesh-list
5879429|NCT03408652|Denosumab|denosumab|mesh-list
5879430|NCT03408652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5879431|NCT03408652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879432|NCT03372941|Dalbavancin|dalbavancin|mesh-list
5879433|NCT03372941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5879434|NCT03372941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5879435|NCT03292861|Mycophenolic Acid|mycophenolic acid|mesh-list
5879436|NCT03292861|Sirolimus|sirolimus|mesh-list
5879437|NCT03292861|Tacrolimus|tacrolimus|mesh-list
5879438|NCT03292861|Thymoglobulin|thymoglobulin|mesh-list
5879439|NCT03292861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6495855|NCT00625248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
6495856|NCT00625274|Esomeprazole|esomeprazole|mesh-list
6495857|NCT00625274|Pantoprazole|pantoprazole|mesh-list
6495858|NCT00625274|Lansoprazole|lansoprazole|mesh-list
6495859|NCT00625274|Dexlansoprazole|dexlansoprazole|mesh-list
6495860|NCT00625274|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6495861|NCT00625274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6495862|NCT00625274|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6495863|NCT00625274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5879440|NCT03292861|Immunologic Factors|immunologic factors|mesh-ancestor
5879441|NCT03292861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879442|NCT03292861|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5879443|NCT03292861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5879444|NCT03292861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879445|NCT03292861|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5879446|NCT03292861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5879447|NCT03292861|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5879448|NCT03292861|Antitubercular Agents|antitubercular agents|mesh-ancestor
5879449|NCT03292861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5879450|NCT03292861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5879451|NCT03292861|Antifungal Agents|antifungal agents|mesh-ancestor
5879452|NCT03263117|Anesthetics|anesthetics|mesh-list
5879453|NCT03263117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5879454|NCT03263117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879455|NCT03215030|Dexamethasone|dexamethasone|mesh-list
5879456|NCT03215030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5879457|NCT03215030|Antiemetics|antiemetics|mesh-ancestor
5879458|NCT03215030|Autonomic Agents|autonomic agents|mesh-ancestor
5879459|NCT03215030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5879460|NCT03215030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879461|NCT03215030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5879462|NCT03215030|Glucocorticoids|glucocorticoids|mesh-ancestor
5879463|NCT03215030|Hormones|hormones|mesh-ancestor
5879464|NCT03215030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5879465|NCT03215030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5686478|NCT03452475|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
5686479|NCT03452475|Mefloquine|mefloquine|mesh-list
5686480|NCT03452475|Antimalarials|antimalarials|mesh-ancestor
5686481|NCT03452475|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5686482|NCT03452475|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5686483|NCT03452475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5879466|NCT03215030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5686484|NCT03452345|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5686485|NCT03452345|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6495864|NCT00625274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879467|NCT03181035|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
5879468|NCT03181035|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5879469|NCT03181035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879470|NCT03165994|Paclitaxel|paclitaxel|mesh-list
5879471|NCT03165994|Carboplatin|carboplatin|mesh-list
5879472|NCT03165994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5879473|NCT03165994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5879474|NCT03165994|Tubulin Modulators|tubulin modulators|mesh-ancestor
5879475|NCT03165994|Antimitotic Agents|antimitotic agents|mesh-ancestor
5879476|NCT03165994|Mitosis Modulators|mitosis modulators|mesh-ancestor
5879477|NCT03165994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879478|NCT03056755|Letrozole|letrozole|mesh-list
5879479|NCT03056755|Fulvestrant|fulvestrant|mesh-list
5879480|NCT03056755|Leuprolide|leuprolide|mesh-list
5879481|NCT03056755|Goserelin|goserelin|mesh-list
5879482|NCT03056755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5879483|NCT03056755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5879484|NCT03056755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5879485|NCT03056755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5879486|NCT03056755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879487|NCT03056755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5879488|NCT03056755|Hormone Antagonists|hormone antagonists|mesh-ancestor
5879489|NCT03056755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5879490|NCT03056755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879491|NCT03056755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5879492|NCT03056755|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5879493|NCT03056755|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5879494|NCT03056755|Fertility Agents|fertility agents|mesh-ancestor
5879495|NCT03056755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5879496|NCT03030261|Dexamethasone|dexamethasone|mesh-list
5879497|NCT03030261|Pomalidomide|pomalidomide|mesh-list
5879498|NCT03030261|Elotuzumab|elotuzumab|mesh-list
5879499|NCT03030261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5879500|NCT03030261|Antiemetics|antiemetics|mesh-ancestor
5879501|NCT03030261|Autonomic Agents|autonomic agents|mesh-ancestor
5879502|NCT03030261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5879503|NCT03030261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879504|NCT03030261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5879505|NCT03030261|Glucocorticoids|glucocorticoids|mesh-ancestor
5879506|NCT03030261|Hormones|hormones|mesh-ancestor
5879507|NCT03030261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5879508|NCT03030261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5879509|NCT03030261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5879510|NCT03030261|Immunologic Factors|immunologic factors|mesh-ancestor
5879511|NCT03030261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5879512|NCT03030261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5879513|NCT03030261|Growth Substances|growth substances|mesh-ancestor
5879514|NCT03030261|Growth Inhibitors|growth inhibitors|mesh-ancestor
5879515|NCT02969850|Vitamin D|vitamin d|mesh-list
5879516|NCT02969850|Calcium|calcium|mesh-list
5879517|NCT02969850|Vitamins|vitamins|mesh-ancestor
5879518|NCT02969850|Micronutrients|micronutrients|mesh-ancestor
5879519|NCT02969850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495865|NCT00625339|Lamivudine|lamivudine|mesh-list
5879520|NCT02969850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5879521|NCT02969850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5879522|NCT02955290|Pembrolizumab|pembrolizumab|mesh-list
5879523|NCT02955290|Nivolumab|nivolumab|mesh-list
5879524|NCT02955290|Vaccines|vaccines|mesh-list
5879525|NCT02955290|Mitogens|mitogens|mesh-list
5879526|NCT02955290|Immunologic Factors|immunologic factors|mesh-ancestor
5879527|NCT02955290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879528|NCT02955290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5879529|NCT02955290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5879530|NCT02955290|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5879531|NCT02955290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879532|NCT02955290|Mitosis Modulators|mitosis modulators|mesh-ancestor
5879533|NCT02947386|Nivolumab|nivolumab|mesh-list
5879534|NCT02947386|Nimotuzumab|nimotuzumab|mesh-list
5879535|NCT02947386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5879536|NCT02947386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5879537|NCT02947386|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5879538|NCT02947386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879539|NCT02939989|Ribavirin|ribavirin|mesh-list
5879540|NCT02939989|Sofosbuvir|sofosbuvir|mesh-list
6495866|NCT00625339|Entecavir|entecavir|mesh-list
5686486|NCT03452345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5686487|NCT03452345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686488|NCT03452345|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5686489|NCT03452345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5686490|NCT03452345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686491|NCT03452345|Cholinergic Agents|cholinergic agents|mesh-ancestor
5686492|NCT03452345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5686493|NCT03452332|Durvalumab|durvalumab|mesh-list
5686494|NCT03452332|Ipilimumab|ipilimumab|mesh-list
5686495|NCT03452332|Tremelimumab|tremelimumab|mesh-list
5879541|NCT02939989|Antimetabolites|antimetabolites|mesh-ancestor
5879542|NCT02939989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879543|NCT02939989|Antiviral Agents|antiviral agents|mesh-ancestor
5879544|NCT02939989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5879545|NCT02837432|Hydrocortisone|hydrocortisone|mesh-list
5879546|NCT02837432|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
5879547|NCT02837432|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
5879548|NCT02837432|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
5879549|NCT02837432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5906342|NCT03270501|Golimumab|golimumab|mesh-list
5906343|NCT03270501|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
5906344|NCT03270501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5906345|NCT03270501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5906346|NCT03270501|Immunologic Factors|immunologic factors|mesh-ancestor
5906347|NCT03270501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906348|NCT03251651|Dexmedetomidine|dexmedetomidine|mesh-list
5906349|NCT03251651|Propofol|propofol|mesh-list
5906350|NCT03251651|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5906351|NCT03251651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5906352|NCT03251651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906353|NCT03251651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5906354|NCT03251651|Anesthetics, General|anesthetics, general|mesh-ancestor
5906355|NCT03251651|Anesthetics|anesthetics|mesh-ancestor
5906356|NCT03251651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5906357|NCT03251651|Analgesics|analgesics|mesh-ancestor
5906358|NCT03251651|Sensory System Agents|sensory system agents|mesh-ancestor
5906359|NCT03251651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5906360|NCT03251651|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5906361|NCT03251651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5906362|NCT03251651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5906363|NCT03251651|Adrenergic Agents|adrenergic agents|mesh-ancestor
5906364|NCT03251651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5906365|NCT03251651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906366|NCT03248570|Pembrolizumab|pembrolizumab|mesh-list
5906367|NCT03248570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5906368|NCT03248570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5908652|NCT04330040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5908653|NCT04330040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908654|NCT04330040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5908655|NCT04313166|Copper|copper|mesh-list
5908656|NCT04313166|Trace Elements|trace elements|mesh-ancestor
5908657|NCT04313166|Micronutrients|micronutrients|mesh-ancestor
5908658|NCT04313166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5908825|NCT04094688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5908826|NCT04094688|Immunologic Factors|immunologic factors|mesh-ancestor
5908827|NCT04094688|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5908828|NCT04094688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5908829|NCT04094688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5908830|NCT04094688|Antidotes|antidotes|mesh-ancestor
5686496|NCT03452332|Immunoglobulins|immunoglobulins|mesh-list
5686497|NCT03452332|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5686498|NCT03452332|Immunoglobulin G|immunoglobulin g|mesh-list
5908831|NCT04094688|Protective Agents|protective agents|mesh-ancestor
5908832|NCT04094688|Vitamin B Complex|vitamin b complex|mesh-ancestor
5908833|NCT04093323|Interferons|interferons|mesh-list
5908834|NCT04093323|Interferon-alpha|interferon-alpha|mesh-list
5908835|NCT04093323|Interferon alpha-2|interferon alpha-2|mesh-list
5908836|NCT04093323|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
5908837|NCT04093323|Celecoxib|celecoxib|mesh-list
5908838|NCT04093323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5908839|NCT04093323|Benzenesulfonamide|benzenesulfonamide|mesh-list
5908840|NCT04093323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5908841|NCT04093323|Antiviral Agents|antiviral agents|mesh-ancestor
5908842|NCT04093323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5908843|NCT04093323|Immunologic Factors|immunologic factors|mesh-ancestor
5908844|NCT04093323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879550|NCT02603328|Atorvastatin|atorvastatin|mesh-list
5879551|NCT02603328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5879552|NCT02603328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5879553|NCT02603328|Antimetabolites|antimetabolites|mesh-ancestor
5879554|NCT02603328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879555|NCT02603328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5879556|NCT02603328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5879557|NCT02603328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5879558|NCT02349867|Gemcitabine|gemcitabine|mesh-list
5879559|NCT02349867|Sorafenib|sorafenib|mesh-list
5879560|NCT02349867|Vorinostat|vorinostat|mesh-list
5879561|NCT02349867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5879562|NCT02349867|Antimetabolites|antimetabolites|mesh-ancestor
5879563|NCT02349867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879564|NCT02349867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5879565|NCT02349867|Antiviral Agents|antiviral agents|mesh-ancestor
5879566|NCT02349867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5879567|NCT02349867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5879568|NCT02349867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5879569|NCT02349867|Immunologic Factors|immunologic factors|mesh-ancestor
5879570|NCT02349867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879571|NCT02349867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5879572|NCT02349867|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5879573|NCT02339766|Morphine|morphine|mesh-list
5879574|NCT02339766|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5879575|NCT02339766|Narcotics|narcotics|mesh-ancestor
5879576|NCT02339766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5879577|NCT02339766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879578|NCT02339766|Analgesics|analgesics|mesh-ancestor
5879579|NCT02339766|Sensory System Agents|sensory system agents|mesh-ancestor
5879580|NCT02339766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5879581|NCT05092386|Vaccines|vaccines|mesh-list
5879582|NCT05092386|Immunologic Factors|immunologic factors|mesh-ancestor
5879583|NCT05092386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879584|NCT05091866|Progesterone|progesterone|mesh-list
5879585|NCT05091866|Progestins|progestins|mesh-list
5879586|NCT05091866|Hormones|hormones|mesh-ancestor
5879587|NCT05091866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5686499|NCT03452332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5686500|NCT03452332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5686501|NCT03452332|Immunologic Factors|immunologic factors|mesh-ancestor
5686502|NCT03452332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686503|NCT03452332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5686504|NCT03452332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686505|NCT03452306|Metformin|metformin|mesh-list
5686506|NCT03452306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5686507|NCT03452306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686508|NCT03452267|Metformin|metformin|mesh-list
5686509|NCT03452267|Pioglitazone|pioglitazone|mesh-list
5879588|NCT05091866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879589|NCT05091775|Mesalamine|mesalamine|mesh-list
5879590|NCT05091775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5879591|NCT05091775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5879592|NCT05091775|Analgesics|analgesics|mesh-ancestor
5879593|NCT05091775|Sensory System Agents|sensory system agents|mesh-ancestor
5879594|NCT05091775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5879595|NCT05091775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879596|NCT05091775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5879597|NCT05091775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5879598|NCT05091606|Anesthetics|anesthetics|mesh-list
5879599|NCT05091606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5879600|NCT05091606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879601|NCT05091463|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
5879602|NCT05091463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5879603|NCT05091463|Immunologic Factors|immunologic factors|mesh-ancestor
5879604|NCT05091463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879605|NCT05091359|Calcium|calcium|mesh-list
5879606|NCT05091359|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5879607|NCT05091359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879608|NCT05091203|Vitamin D|vitamin d|mesh-list
5879609|NCT05091203|Vitamins|vitamins|mesh-ancestor
5879610|NCT05091203|Micronutrients|micronutrients|mesh-ancestor
5879611|NCT05091203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686510|NCT03452267|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5879612|NCT05091203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5879613|NCT05091177|Acetylcholine|acetylcholine|mesh-list
5879614|NCT05091177|Antibodies|antibodies|mesh-list
5879615|NCT05091177|Neostigmine|neostigmine|mesh-list
5686511|NCT03452267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697324|NCT03376789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697325|NCT03376737|Pemetrexed|pemetrexed|mesh-list
5697326|NCT03376737|Apatinib|apatinib|mesh-list
5879616|NCT05091177|Immunologic Factors|immunologic factors|mesh-ancestor
5879617|NCT05091177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879618|NCT05091177|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5879619|NCT05091177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5879620|NCT05091177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879621|NCT05091177|Cholinergic Agents|cholinergic agents|mesh-ancestor
5879622|NCT05091177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5879623|NCT05091177|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5879624|NCT05091177|Autonomic Agents|autonomic agents|mesh-ancestor
5879625|NCT05091177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5879626|NCT05091177|Vasodilator Agents|vasodilator agents|mesh-ancestor
5879627|NCT05091177|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5879628|NCT05091151|Dexmedetomidine|dexmedetomidine|mesh-list
5879629|NCT05091151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5879630|NCT05091151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5879631|NCT05091151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879632|NCT05091151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5879633|NCT05091151|Analgesics|analgesics|mesh-ancestor
5879634|NCT05091151|Sensory System Agents|sensory system agents|mesh-ancestor
5879635|NCT05091151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5879636|NCT05091151|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5879637|NCT05091151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5879638|NCT05091151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5879639|NCT05091151|Adrenergic Agents|adrenergic agents|mesh-ancestor
5879640|NCT05091151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5879641|NCT05091151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879642|NCT05091138|Buprenorphine|buprenorphine|mesh-list
5879643|NCT05091138|Bupivacaine|bupivacaine|mesh-list
5879644|NCT05091138|Anesthetics, Local|anesthetics, local|mesh-ancestor
5879645|NCT05091138|Anesthetics|anesthetics|mesh-ancestor
5879646|NCT05091138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5879647|NCT05091138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879648|NCT05091138|Sensory System Agents|sensory system agents|mesh-ancestor
5879649|NCT05091138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5879650|NCT05091138|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5879651|NCT05091138|Narcotics|narcotics|mesh-ancestor
5879652|NCT05091138|Analgesics|analgesics|mesh-ancestor
5879653|NCT05091138|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5879654|NCT05091099|Zoledronic Acid|zoledronic acid|mesh-list
5879655|NCT05091099|Alendronate|alendronate|mesh-list
5879656|NCT05091099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5879657|NCT05091099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879658|NCT05091086|Zoledronic Acid|zoledronic acid|mesh-list
5879659|NCT05091086|Denosumab|denosumab|mesh-list
5879660|NCT05091086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5879661|NCT05091086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879662|NCT05091008|Sofosbuvir|sofosbuvir|mesh-list
5879663|NCT05091008|Ledipasvir|ledipasvir|mesh-list
5697327|NCT03376737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5697328|NCT03376737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5697329|NCT03376737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697330|NCT03376737|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5697331|NCT03376737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5697332|NCT03376737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5697333|NCT03376698|Colchicine|colchicine|mesh-list
5697334|NCT03376698|Gout Suppressants|gout suppressants|mesh-ancestor
5697335|NCT03376698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5697336|NCT03376698|Tubulin Modulators|tubulin modulators|mesh-ancestor
5697337|NCT03376698|Antimitotic Agents|antimitotic agents|mesh-ancestor
5697338|NCT03376698|Mitosis Modulators|mitosis modulators|mesh-ancestor
5697339|NCT03376698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697340|NCT03376698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5697341|NCT03376672|Dexamethasone|dexamethasone|mesh-list
5697342|NCT03376672|Lenalidomide|lenalidomide|mesh-list
5697343|NCT03376672|Ixazomib|ixazomib|mesh-list
5697344|NCT03376672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5697345|NCT03376672|Antiemetics|antiemetics|mesh-ancestor
5697346|NCT03376672|Autonomic Agents|autonomic agents|mesh-ancestor
5879664|NCT05091008|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
5697347|NCT03376672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5879665|NCT05091008|Antiviral Agents|antiviral agents|mesh-ancestor
5686512|NCT03451981|Chlorhexidine|chlorhexidine|mesh-list
5686513|NCT03451981|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5686514|NCT03451981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5686515|NCT03451981|Disinfectants|disinfectants|mesh-ancestor
5686516|NCT03451903|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5686517|NCT03451903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5686518|NCT03451903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5686519|NCT03451903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686520|NCT03451734|Metformin|metformin|mesh-list
5686521|NCT03451734|Antipsychotic Agents|antipsychotic agents|mesh-list
5686522|NCT03451734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5686523|NCT03451734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686524|NCT03451734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5879666|NCT05091008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5879667|NCT05090761|Magnesium Sulfate|magnesium sulfate|mesh-list
5879668|NCT05090761|Buprenorphine|buprenorphine|mesh-list
5879669|NCT05090761|Bupivacaine|bupivacaine|mesh-list
5879670|NCT05090761|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5879671|NCT05090761|Anesthetics, Local|anesthetics, local|mesh-ancestor
5879672|NCT05090761|Anesthetics|anesthetics|mesh-ancestor
5879673|NCT05090761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5879674|NCT05090761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879675|NCT05090761|Sensory System Agents|sensory system agents|mesh-ancestor
5879676|NCT05090761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5879677|NCT05090761|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5879678|NCT05090761|Narcotics|narcotics|mesh-ancestor
5879679|NCT05090761|Analgesics|analgesics|mesh-ancestor
5879680|NCT05090761|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5879681|NCT05090761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5879682|NCT05090761|Anticonvulsants|anticonvulsants|mesh-ancestor
5879683|NCT05090761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5879684|NCT05090761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5879685|NCT05090761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879686|NCT05090761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5879687|NCT05090761|Tocolytic Agents|tocolytic agents|mesh-ancestor
5879688|NCT05090761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5879689|NCT05090592|Atropine|atropine|mesh-list
5879690|NCT05090592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5879691|NCT05090592|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5879692|NCT05090592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5879693|NCT05090592|Autonomic Agents|autonomic agents|mesh-ancestor
5879694|NCT05090592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5879695|NCT05090592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879696|NCT05090592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5879697|NCT05090592|Respiratory System Agents|respiratory system agents|mesh-ancestor
5879698|NCT05090592|Mydriatics|mydriatics|mesh-ancestor
5879699|NCT05090592|Parasympatholytics|parasympatholytics|mesh-ancestor
5879700|NCT05090592|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5879701|NCT05090592|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5879702|NCT05090592|Cholinergic Agents|cholinergic agents|mesh-ancestor
5879703|NCT05090592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5879704|NCT05090592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906369|NCT03159000|Lidocaine|lidocaine|mesh-list
5906370|NCT03159000|Bupivacaine|bupivacaine|mesh-list
5906371|NCT03159000|Anesthetics, Local|anesthetics, local|mesh-ancestor
5906372|NCT03159000|Anesthetics|anesthetics|mesh-ancestor
5906373|NCT03159000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5906374|NCT03159000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906375|NCT03159000|Sensory System Agents|sensory system agents|mesh-ancestor
5906376|NCT03159000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5906377|NCT03159000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5906378|NCT03159000|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5906379|NCT03159000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5906380|NCT03159000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5906381|NCT03159000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906382|NCT03126643|Nivolumab|nivolumab|mesh-list
5906383|NCT03126643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5906384|NCT03126643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5906385|NCT03126643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5906386|NCT03126643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906387|NCT03126617|Elotuzumab|elotuzumab|mesh-list
5906388|NCT03126617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5906389|NCT03054792|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
5686525|NCT03451734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5686526|NCT03451734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5879705|NCT05081583|Midazolam|midazolam|mesh-list
5879706|NCT05081583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5879707|NCT05081583|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5879708|NCT05081583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5879709|NCT05081583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879710|NCT05081583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5879711|NCT05081583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5879712|NCT05081583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5879713|NCT05081583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5879714|NCT05081583|Anesthetics, General|anesthetics, general|mesh-ancestor
5879715|NCT05081583|Anesthetics|anesthetics|mesh-ancestor
5879716|NCT05081583|GABA Modulators|gaba modulators|mesh-ancestor
5879717|NCT05081583|GABA Agents|gaba agents|mesh-ancestor
5879718|NCT05081583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5879719|NCT05081583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879720|NCT05081336|Ezetimibe|ezetimibe|mesh-list
5879721|NCT05081336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5879722|NCT05081336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5686527|NCT03451695|Morphine|morphine|mesh-list
5686528|NCT03451695|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5686529|NCT03451695|Narcotics|narcotics|mesh-ancestor
5686530|NCT03451695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5686531|NCT03451695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686532|NCT03451695|Analgesics|analgesics|mesh-ancestor
5686533|NCT03451695|Sensory System Agents|sensory system agents|mesh-ancestor
5686534|NCT03451695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5686535|NCT03451682|Procyanidin|procyanidin|mesh-list
5686536|NCT03451682|Antioxidants|antioxidants|mesh-ancestor
5686537|NCT03451682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686538|NCT03451682|Protective Agents|protective agents|mesh-ancestor
5686539|NCT03451682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879723|NCT05081336|Antimetabolites|antimetabolites|mesh-ancestor
5879724|NCT05081336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879725|NCT05081336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5879726|NCT05079217|Vaccines|vaccines|mesh-list
5879727|NCT05079217|Immunologic Factors|immunologic factors|mesh-ancestor
5879728|NCT05079217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879729|NCT05077839|Trifluridine|trifluridine|mesh-list
5879730|NCT05077839|Antimetabolites|antimetabolites|mesh-ancestor
5879731|NCT05077839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879732|NCT05077839|Antiviral Agents|antiviral agents|mesh-ancestor
5879733|NCT05077839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5879734|NCT05077683|Rivaroxaban|rivaroxaban|mesh-list
5879735|NCT05077683|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5879736|NCT05077683|Antithrombins|antithrombins|mesh-ancestor
5879737|NCT05077683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5879738|NCT05077683|Protease Inhibitors|protease inhibitors|mesh-ancestor
6495867|NCT00625339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6495868|NCT00625339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5686540|NCT03451591|Cilostazol|cilostazol|mesh-list
5686541|NCT03451591|Isosorbide|isosorbide|mesh-list
5686542|NCT03451591|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
5686543|NCT03451591|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
5686544|NCT03451591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5686545|NCT03451591|Autonomic Agents|autonomic agents|mesh-ancestor
5686546|NCT03451591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5686547|NCT03451591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686548|NCT03451591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5686549|NCT03451591|Respiratory System Agents|respiratory system agents|mesh-ancestor
6495869|NCT00625339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6495870|NCT00625339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495871|NCT00625339|Antiviral Agents|antiviral agents|mesh-ancestor
5686550|NCT03451591|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5686551|NCT03451591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5686552|NCT03451591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879739|NCT05077683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6495872|NCT00625339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6495873|NCT00625339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6495874|NCT00625339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6495875|NCT00625352|Gemcitabine|gemcitabine|mesh-list
6495876|NCT00625352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6495877|NCT00625352|Antimetabolites|antimetabolites|mesh-ancestor
6495878|NCT00625352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495879|NCT00625352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6495880|NCT00625352|Antiviral Agents|antiviral agents|mesh-ancestor
6495881|NCT00625352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5686553|NCT03451591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5686554|NCT03451591|Vasodilator Agents|vasodilator agents|mesh-ancestor
5686555|NCT03451591|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5686556|NCT03451591|Protective Agents|protective agents|mesh-ancestor
5686557|NCT03451591|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5686558|NCT03451591|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5686559|NCT03451591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5686560|NCT03451591|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5686561|NCT03451591|Diuretics|diuretics|mesh-ancestor
5686562|NCT03451591|Natriuretic Agents|natriuretic agents|mesh-ancestor
5686563|NCT03451591|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5686564|NCT03451500|Levodopa|levodopa|mesh-list
5686565|NCT03451500|Carbidopa|carbidopa|mesh-list
5686566|NCT03451500|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
5686567|NCT03451500|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5686568|NCT03451500|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6495882|NCT00625352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6495883|NCT00625352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6495884|NCT00625352|Immunologic Factors|immunologic factors|mesh-ancestor
6495885|NCT00625352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495886|NCT00625378|Sorafenib|sorafenib|mesh-list
5879740|NCT05077683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879741|NCT05077683|Anticoagulants|anticoagulants|mesh-ancestor
5879742|NCT05077085|Vancomycin|vancomycin|mesh-list
5879743|NCT05077085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5879744|NCT05077085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5879745|NCT05069129|Vaccines|vaccines|mesh-list
5879746|NCT05069129|Immunologic Factors|immunologic factors|mesh-ancestor
5879747|NCT05069129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879748|NCT05067985|Anesthetics|anesthetics|mesh-list
5879749|NCT05067985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5879750|NCT05067985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879751|NCT05056259|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5686569|NCT03451500|Dopamine Agents|dopamine agents|mesh-ancestor
5686570|NCT03451500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5686571|NCT03451500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686572|NCT03451500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686573|NCT03451500|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5686574|NCT03451500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5686575|NCT03451500|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5686576|NCT03451500|Immunologic Factors|immunologic factors|mesh-ancestor
5686577|NCT03451500|Dopamine Agonists|dopamine agonists|mesh-ancestor
5686578|NCT03451487|Acetaminophen|acetaminophen|mesh-list
5686579|NCT03451487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5686580|NCT03451487|Analgesics|analgesics|mesh-ancestor
5686581|NCT03451487|Sensory System Agents|sensory system agents|mesh-ancestor
5686582|NCT03451487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5686583|NCT03451487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686584|NCT03451487|Antipyretics|antipyretics|mesh-ancestor
5686585|NCT03451435|Acetylcysteine|acetylcysteine|mesh-list
5686586|NCT03451435|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5686587|NCT03451435|Antiviral Agents|antiviral agents|mesh-ancestor
5686588|NCT03451435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5686589|NCT03451435|Expectorants|expectorants|mesh-ancestor
5686590|NCT03451435|Respiratory System Agents|respiratory system agents|mesh-ancestor
5686591|NCT03451435|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5686592|NCT03451435|Antioxidants|antioxidants|mesh-ancestor
5879752|NCT05056259|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5879753|NCT05056259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879754|NCT05044117|Capecitabine|capecitabine|mesh-list
5879755|NCT05044117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5879756|NCT05044117|Antimetabolites|antimetabolites|mesh-ancestor
5879757|NCT05044117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879758|NCT05044117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5879759|NCT05004896|Midazolam|midazolam|mesh-list
5686593|NCT03451435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686594|NCT03451435|Protective Agents|protective agents|mesh-ancestor
5686595|NCT03451435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495887|NCT00625378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6495888|NCT00625378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6495889|NCT00625378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6495890|NCT00625378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495891|NCT00625430|Vidarabine|vidarabine|mesh-list
6495892|NCT00625430|Fludarabine|fludarabine|mesh-list
6495893|NCT00625430|Fludarabine phosphate|fludarabine phosphate|mesh-list
6495894|NCT00625430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5879760|NCT05004896|Ketamine|ketamine|mesh-list
5879761|NCT05004896|Analgesics|analgesics|mesh-ancestor
5879762|NCT05004896|Sensory System Agents|sensory system agents|mesh-ancestor
5879763|NCT05004896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5879764|NCT05004896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879765|NCT05004896|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5879766|NCT05004896|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5879767|NCT05004896|Anesthetics, General|anesthetics, general|mesh-ancestor
5879768|NCT05004896|Anesthetics|anesthetics|mesh-ancestor
5879769|NCT05004896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6675413|NCT01575405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879770|NCT05004896|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5879771|NCT05004896|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5879772|NCT05004896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5879773|NCT05004896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879774|NCT05004896|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5879775|NCT05004896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5879776|NCT05004896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5879777|NCT05004896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5879778|NCT05004896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5879779|NCT05004896|GABA Modulators|gaba modulators|mesh-ancestor
5879780|NCT05004896|GABA Agents|gaba agents|mesh-ancestor
5879781|NCT04997993|Leflunomide|leflunomide|mesh-list
5879782|NCT04997993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5879783|NCT04997993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879784|NCT04997993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5879785|NCT04997993|Immunologic Factors|immunologic factors|mesh-ancestor
5879786|NCT04997993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879787|NCT04988841|Nivolumab|nivolumab|mesh-list
5879788|NCT04988841|Ipilimumab|ipilimumab|mesh-list
5879789|NCT04988841|Laxatives|laxatives|mesh-list
5879790|NCT04988841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5879791|NCT04988841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5879792|NCT04988841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5879793|NCT04988841|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5879794|NCT04988841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879795|NCT04988841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5879796|NCT04985136|Sorafenib|sorafenib|mesh-list
5879797|NCT04985136|Apatinib|apatinib|mesh-list
5879798|NCT04985136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5879799|NCT04985136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5879800|NCT04985136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5879801|NCT04985136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879802|NCT04964843|Acetylcysteine|acetylcysteine|mesh-list
5879803|NCT04964843|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5879804|NCT04964843|Antiviral Agents|antiviral agents|mesh-ancestor
5879805|NCT04964843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5879806|NCT04964843|Expectorants|expectorants|mesh-ancestor
5879807|NCT04964843|Respiratory System Agents|respiratory system agents|mesh-ancestor
5879808|NCT04964843|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5879809|NCT04964843|Antioxidants|antioxidants|mesh-ancestor
5879810|NCT04964843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879811|NCT04964843|Protective Agents|protective agents|mesh-ancestor
5879812|NCT04964843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879813|NCT04964843|Antidotes|antidotes|mesh-ancestor
5879814|NCT04955236|Fentanyl|fentanyl|mesh-list
5879815|NCT04955236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5879816|NCT04955236|Narcotics|narcotics|mesh-ancestor
5879817|NCT04955236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5879818|NCT04955236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879819|NCT04955236|Analgesics|analgesics|mesh-ancestor
5879820|NCT04955236|Sensory System Agents|sensory system agents|mesh-ancestor
5879821|NCT04955236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5879822|NCT04955236|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5879823|NCT04955236|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5879824|NCT04955236|Anesthetics, General|anesthetics, general|mesh-ancestor
5879825|NCT04955236|Anesthetics|anesthetics|mesh-ancestor
5879826|NCT04952350|Atorvastatin|atorvastatin|mesh-list
5879827|NCT04952350|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5879828|NCT04952350|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5879829|NCT04952350|Antimetabolites|antimetabolites|mesh-ancestor
5879830|NCT04952350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879831|NCT04952350|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5879832|NCT04952350|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5879833|NCT04952350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5879834|NCT04928664|Bupivacaine|bupivacaine|mesh-list
5879835|NCT04928664|Anesthetics, Local|anesthetics, local|mesh-ancestor
5879836|NCT04928664|Anesthetics|anesthetics|mesh-ancestor
5879837|NCT04928664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5879838|NCT04928664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879839|NCT04928664|Sensory System Agents|sensory system agents|mesh-ancestor
5879840|NCT04928664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5879841|NCT04899492|Nicotine|nicotine|mesh-list
6495895|NCT00625430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6495896|NCT00625430|Antimetabolites|antimetabolites|mesh-ancestor
6495897|NCT00625430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879842|NCT04899492|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5879843|NCT04899492|Autonomic Agents|autonomic agents|mesh-ancestor
5879844|NCT04899492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5879845|NCT04899492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879846|NCT04899492|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5879847|NCT04899492|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5879848|NCT04899492|Cholinergic Agents|cholinergic agents|mesh-ancestor
5879849|NCT04899492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5879850|NCT04899492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879851|NCT04895735|Pembrolizumab|pembrolizumab|mesh-list
5686596|NCT03451435|Antidotes|antidotes|mesh-ancestor
5686597|NCT03451396|Lifitegrast|lifitegrast|mesh-list
5686598|NCT03451396|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5686599|NCT03451396|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5686600|NCT03451370|Bevacizumab|bevacizumab|mesh-list
5686601|NCT03451370|Capecitabine|capecitabine|mesh-list
5686602|NCT03451370|Oxaliplatin|oxaliplatin|mesh-list
5879852|NCT04895735|Pemetrexed|pemetrexed|mesh-list
5879853|NCT04895735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5879854|NCT04895735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5879855|NCT04895735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5879856|NCT04895735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879857|NCT04895735|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5879858|NCT04895735|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5879859|NCT04866017|Durvalumab|durvalumab|mesh-list
5879860|NCT04866017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5879861|NCT04866017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5879862|NCT04850144|Bromides|bromides|mesh-list
5879863|NCT04850144|Tiotropium Bromide|tiotropium bromide|mesh-list
5879864|NCT04850144|Charcoal|charcoal|mesh-list
5879865|NCT04850144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5879866|NCT04850144|Autonomic Agents|autonomic agents|mesh-ancestor
5879867|NCT04850144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5879868|NCT04850144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879869|NCT04850144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5879870|NCT04850144|Respiratory System Agents|respiratory system agents|mesh-ancestor
5879871|NCT04850144|Parasympatholytics|parasympatholytics|mesh-ancestor
5686603|NCT03451370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5686604|NCT03451370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5686605|NCT03451370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5686606|NCT03451370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5686607|NCT03451370|Growth Substances|growth substances|mesh-ancestor
5686608|NCT03451370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879872|NCT04850144|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5879873|NCT04850144|Cholinergic Agents|cholinergic agents|mesh-ancestor
5879874|NCT04850144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5879875|NCT04850144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879876|NCT04850144|Anticonvulsants|anticonvulsants|mesh-ancestor
5879877|NCT04850144|Antidotes|antidotes|mesh-ancestor
5879878|NCT04850144|Protective Agents|protective agents|mesh-ancestor
5879879|NCT04840472|Panitumumab|panitumumab|mesh-list
5879880|NCT04840472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5879881|NCT04840472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5879882|NCT04812808|Bazedoxifene|bazedoxifene|mesh-list
5879883|NCT04812808|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5879884|NCT04812808|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5879885|NCT04812808|Hormone Antagonists|hormone antagonists|mesh-ancestor
5879886|NCT04812808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5879887|NCT04812808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879888|NCT04812808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5879889|NCT04762199|Osimertinib|osimertinib|mesh-list
5879890|NCT04762199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5686609|NCT03451370|Growth Inhibitors|growth inhibitors|mesh-ancestor
5686610|NCT03451370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5686611|NCT03451370|Antimetabolites|antimetabolites|mesh-ancestor
5879891|NCT04762199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5879892|NCT04762199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5879893|NCT04762199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879894|NCT04759144|Insulin|insulin|mesh-list
5879895|NCT04759144|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5879896|NCT04759144|Insulin Aspart|insulin aspart|mesh-list
5879897|NCT04759144|Insulin, Long-Acting|insulin, long-acting|mesh-list
5879898|NCT04759144|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
5879899|NCT04759144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5879900|NCT04759144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879901|NCT04741139|Acetaminophen|acetaminophen|mesh-list
5879902|NCT04741139|Diphenhydramine|diphenhydramine|mesh-list
5879903|NCT04741139|Promethazine|promethazine|mesh-list
5879904|NCT04741139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5686612|NCT03451370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686613|NCT03451331|Gemcitabine|gemcitabine|mesh-list
5686614|NCT03451331|Carboplatin|carboplatin|mesh-list
5686615|NCT03451331|Oxaliplatin|oxaliplatin|mesh-list
5686616|NCT03451331|Nivolumab|nivolumab|mesh-list
5686617|NCT03451331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5686618|NCT03451331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5686619|NCT03451331|Antimetabolites|antimetabolites|mesh-ancestor
5686620|NCT03451331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686621|NCT03451331|Antiviral Agents|antiviral agents|mesh-ancestor
5686622|NCT03451331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5686623|NCT03451331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5686624|NCT03451331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5686625|NCT03451331|Immunologic Factors|immunologic factors|mesh-ancestor
5686626|NCT03451331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686627|NCT03451331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5686628|NCT03451331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5686629|NCT03451318|Mometasone Furoate|mometasone furoate|mesh-list
5686630|NCT03451318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5686631|NCT03451318|Dermatologic Agents|dermatologic agents|mesh-ancestor
5686632|NCT03451318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5686633|NCT03451266|Ascorbic Acid|ascorbic acid|mesh-list
5686634|NCT03451266|Vitamins|vitamins|mesh-ancestor
5686635|NCT03451266|Micronutrients|micronutrients|mesh-ancestor
5686636|NCT03451266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686637|NCT03451266|Antioxidants|antioxidants|mesh-ancestor
5686638|NCT03451266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686639|NCT03451266|Protective Agents|protective agents|mesh-ancestor
5686640|NCT03451227|Dexmedetomidine|dexmedetomidine|mesh-list
5686641|NCT03451227|Remifentanil|remifentanil|mesh-list
5879905|NCT04741139|Analgesics|analgesics|mesh-ancestor
5879906|NCT04741139|Sensory System Agents|sensory system agents|mesh-ancestor
5879907|NCT04741139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5879908|NCT04741139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879909|NCT04741139|Antipyretics|antipyretics|mesh-ancestor
5879910|NCT04741139|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5879911|NCT04741139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5879912|NCT04741139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5879913|NCT04741139|Anesthetics, Local|anesthetics, local|mesh-ancestor
5879914|NCT04741139|Anesthetics|anesthetics|mesh-ancestor
5879915|NCT04741139|Antiemetics|antiemetics|mesh-ancestor
5879916|NCT04741139|Autonomic Agents|autonomic agents|mesh-ancestor
5879917|NCT04741139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5686642|NCT03451227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5686643|NCT03451227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5686644|NCT03451227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686645|NCT03451227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5686646|NCT03451227|Analgesics|analgesics|mesh-ancestor
5686647|NCT03451227|Sensory System Agents|sensory system agents|mesh-ancestor
5879918|NCT04741139|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5686648|NCT03451227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5686649|NCT03451227|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5686650|NCT03451227|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5686651|NCT03451227|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5686652|NCT03451227|Adrenergic Agents|adrenergic agents|mesh-ancestor
5686653|NCT03451227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5686654|NCT03451227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686655|NCT03451227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5686656|NCT03451227|Narcotics|narcotics|mesh-ancestor
5879919|NCT04741139|Histamine Antagonists|histamine antagonists|mesh-ancestor
5879920|NCT04741139|Histamine Agents|histamine agents|mesh-ancestor
5879921|NCT04741139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5906390|NCT03054792|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5879922|NCT04741139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879923|NCT04741139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5879924|NCT04741139|Antipruritics|antipruritics|mesh-ancestor
5879925|NCT04741139|Dermatologic Agents|dermatologic agents|mesh-ancestor
5879926|NCT04730635|Donepezil|donepezil|mesh-list
5879927|NCT04730635|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5879928|NCT04730635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5879929|NCT04730635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879930|NCT04730635|Cholinergic Agents|cholinergic agents|mesh-ancestor
5879931|NCT04730635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5879932|NCT04730635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879933|NCT04730635|Nootropic Agents|nootropic agents|mesh-ancestor
5879934|NCT04710199|Maraviroc|maraviroc|mesh-list
5879935|NCT04710199|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5879936|NCT04710199|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5879937|NCT04710199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879938|NCT04710199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5879939|NCT04710199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5879940|NCT04710199|Antiviral Agents|antiviral agents|mesh-ancestor
5879941|NCT04710199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5879942|NCT04710199|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
5906391|NCT03054792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906392|NCT03016819|Dacarbazine|dacarbazine|mesh-list
5906393|NCT03016819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5906394|NCT03016819|Alkylating Agents|alkylating agents|mesh-ancestor
5906395|NCT03016819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906396|NCT03016819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5906397|NCT02978625|Nivolumab|nivolumab|mesh-list
5906398|NCT02978625|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
5906399|NCT02978625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5906400|NCT02978625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5906401|NCT02978625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5906402|NCT02978625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906403|NCT02951364|Sofosbuvir|sofosbuvir|mesh-list
5686657|NCT03451110|Fluconazole|fluconazole|mesh-list
5686658|NCT03451110|Lemborexant|lemborexant|mesh-list
5686659|NCT03451110|Famotidine|famotidine|mesh-list
5686660|NCT03451110|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
5686661|NCT03451110|Antifungal Agents|antifungal agents|mesh-ancestor
5686662|NCT03451110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5686663|NCT03451110|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5686664|NCT03451110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5906404|NCT02951364|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
5906405|NCT02951364|Ledipasvir|ledipasvir|mesh-list
5906406|NCT02951364|Antiviral Agents|antiviral agents|mesh-ancestor
5906407|NCT02951364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5906408|NCT02927067|Valganciclovir|valganciclovir|mesh-list
5906409|NCT02927067|Maribavir|maribavir|mesh-list
5906410|NCT02927067|Antiviral Agents|antiviral agents|mesh-ancestor
5906411|NCT02927067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5906412|NCT02889237|Calcium, Dietary|calcium, dietary|mesh-list
5906413|NCT02889237|Vitamin D|vitamin d|mesh-list
5906414|NCT02889237|Ergocalciferols|ergocalciferols|mesh-list
5906415|NCT02889237|Vitamins|vitamins|mesh-list
5906416|NCT02889237|Calcium|calcium|mesh-list
5906417|NCT02889237|Micronutrients|micronutrients|mesh-ancestor
5906418|NCT02889237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906419|NCT02889237|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5906420|NCT02889237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5906421|NCT02873962|Bevacizumab|bevacizumab|mesh-list
5906422|NCT02873962|Nivolumab|nivolumab|mesh-list
5906423|NCT02873962|Rucaparib|rucaparib|mesh-list
5906424|NCT02873962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5906425|NCT02873962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5906426|NCT02873962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5906427|NCT02873962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5906428|NCT02873962|Growth Substances|growth substances|mesh-ancestor
5906429|NCT02873962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906430|NCT02873962|Growth Inhibitors|growth inhibitors|mesh-ancestor
5906431|NCT02873962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5906432|NCT02873962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906433|NCT02873962|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5906434|NCT02873962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5906435|NCT02856438|Dexamethasone|dexamethasone|mesh-list
5906436|NCT02856438|Lenalidomide|lenalidomide|mesh-list
5879943|NCT04648696|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5879944|NCT04648696|Vancomycin|vancomycin|mesh-list
5879945|NCT04648696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5879946|NCT04648696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5879947|NCT04648696|Antitubercular Agents|antitubercular agents|mesh-ancestor
5879948|NCT04639310|Ezogabine|ezogabine|mesh-list
5879949|NCT04639310|Anticonvulsants|anticonvulsants|mesh-ancestor
5879950|NCT04639310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5879951|NCT04639310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879952|NCT04604548|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
5879953|NCT04604548|Antioxidants|antioxidants|mesh-ancestor
5879954|NCT04604548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879955|NCT04604548|Protective Agents|protective agents|mesh-ancestor
5879956|NCT04604548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879957|NCT04602845|Flurbiprofen|flurbiprofen|mesh-list
5879958|NCT04602845|Fentanyl|fentanyl|mesh-list
5879959|NCT04602845|Midazolam|midazolam|mesh-list
5879960|NCT04602845|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5879961|NCT04602845|Narcotics|narcotics|mesh-ancestor
5879962|NCT04602845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5879963|NCT04602845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5879964|NCT04602845|Analgesics|analgesics|mesh-ancestor
5879965|NCT04602845|Sensory System Agents|sensory system agents|mesh-ancestor
5879966|NCT04602845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5879967|NCT04602845|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5879968|NCT04602845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5879969|NCT04602845|Anesthetics, General|anesthetics, general|mesh-ancestor
5879970|NCT04602845|Anesthetics|anesthetics|mesh-ancestor
5879971|NCT04602845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5879972|NCT04602845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5879973|NCT04602845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5879974|NCT04602845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5879975|NCT04602845|GABA Modulators|gaba modulators|mesh-ancestor
5879976|NCT04602845|GABA Agents|gaba agents|mesh-ancestor
5879977|NCT04602845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5879978|NCT04602845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879979|NCT04602845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5879980|NCT04602845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5879981|NCT04602845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5879982|NCT04602845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5879983|NCT04602845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5879984|NCT04602845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5879985|NCT04590794|Plasminogen|plasminogen|mesh-list
5879986|NCT04590794|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5879987|NCT04590794|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5879988|NCT04590794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879989|NCT04573478|Atrasentan|atrasentan|mesh-list
5879990|NCT04573478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5879991|NCT04573478|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
5879992|NCT04573478|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5879993|NCT04573478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5879994|NCT04543643|Carvedilol|carvedilol|mesh-list
5879995|NCT04543643|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5879996|NCT04543643|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5879997|NCT04543643|Adrenergic Agents|adrenergic agents|mesh-ancestor
5879998|NCT04543643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5879999|NCT04543643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5880000|NCT04543643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880001|NCT04543643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5880002|NCT04543643|Antioxidants|antioxidants|mesh-ancestor
5880003|NCT04543643|Protective Agents|protective agents|mesh-ancestor
5880004|NCT04543643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5880005|NCT04543643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5880006|NCT04543643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5880007|NCT04543643|Vasodilator Agents|vasodilator agents|mesh-ancestor
5880008|NCT04543643|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5880009|NCT04543643|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5880010|NCT04526652|Dexmedetomidine|dexmedetomidine|mesh-list
5880011|NCT04526652|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5880012|NCT04526652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5880013|NCT04526652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880014|NCT04526652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5880015|NCT04526652|Analgesics|analgesics|mesh-ancestor
5880016|NCT04526652|Sensory System Agents|sensory system agents|mesh-ancestor
5880017|NCT04526652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5880018|NCT04526652|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5880019|NCT04526652|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5880020|NCT04526652|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5880021|NCT04526652|Adrenergic Agents|adrenergic agents|mesh-ancestor
6495898|NCT00625430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6495899|NCT00625430|Immunologic Factors|immunologic factors|mesh-ancestor
6495900|NCT00625430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495901|NCT00625430|Antiviral Agents|antiviral agents|mesh-ancestor
6495902|NCT00625430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6495903|NCT00625456|Molgramostim|molgramostim|mesh-list
6495904|NCT00625456|Sargramostim|sargramostim|mesh-list
6495905|NCT00625456|Immunologic Factors|immunologic factors|mesh-ancestor
6495906|NCT00625456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495907|NCT00625456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5880022|NCT04526652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5880023|NCT04526652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5880024|NCT04516993|Tenecteplase|tenecteplase|mesh-list
5880025|NCT04516993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5880026|NCT04516993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5880027|NCT04516993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5880028|NCT04475432|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5880029|NCT04475432|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5880030|NCT04448834|Vincristine|vincristine|mesh-list
5880031|NCT04448834|Blinatumomab|blinatumomab|mesh-list
5880032|NCT04448834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5880033|NCT04448834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5880034|NCT04448834|Tubulin Modulators|tubulin modulators|mesh-ancestor
5880035|NCT04448834|Antimitotic Agents|antimitotic agents|mesh-ancestor
5880036|NCT04448834|Mitosis Modulators|mitosis modulators|mesh-ancestor
5880037|NCT04448834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5880038|NCT04401800|Lenvatinib|lenvatinib|mesh-list
5880039|NCT04401800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5880040|NCT04401800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5880041|NCT04401800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5880042|NCT04401800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5880043|NCT04341467|Olanzapine|olanzapine|mesh-list
5880044|NCT04341467|Amisulpride|amisulpride|mesh-list
5880045|NCT04341467|Antiemetics|antiemetics|mesh-ancestor
5880046|NCT04341467|Autonomic Agents|autonomic agents|mesh-ancestor
5880047|NCT04341467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5880048|NCT04341467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880049|NCT04341467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5880050|NCT04341467|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5880051|NCT04341467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5880052|NCT04341467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5880053|NCT04341467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5880054|NCT04341467|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5880055|NCT04341467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5880056|NCT04341467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5880057|NCT04341467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5880058|NCT04341467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5686665|NCT03451110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5686666|NCT03451110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686667|NCT03451110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5686668|NCT03451110|Hormone Antagonists|hormone antagonists|mesh-ancestor
5686669|NCT03451110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5686670|NCT03451110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686671|NCT03451110|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5686672|NCT03451110|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5686673|NCT03451110|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5686674|NCT03451110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5686675|NCT03451110|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5686676|NCT03451110|Histamine Antagonists|histamine antagonists|mesh-ancestor
5686677|NCT03451110|Histamine Agents|histamine agents|mesh-ancestor
5686678|NCT03451110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5686679|NCT03451110|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
5880059|NCT04341467|Serotonin Agents|serotonin agents|mesh-ancestor
5880060|NCT04341467|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5880061|NCT04341467|Dopamine Agents|dopamine agents|mesh-ancestor
5880062|NCT04341467|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5880063|NCT04341467|Antidepressive Agents|antidepressive agents|mesh-ancestor
5880064|NCT04287660|Clarithromycin|clarithromycin|mesh-list
5880065|NCT04287660|Dexamethasone|dexamethasone|mesh-list
5880066|NCT04287660|Lenalidomide|lenalidomide|mesh-list
5880067|NCT04287660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5880068|NCT04287660|Antiemetics|antiemetics|mesh-ancestor
5880069|NCT04287660|Autonomic Agents|autonomic agents|mesh-ancestor
5880070|NCT04287660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5880071|NCT04287660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880072|NCT04287660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5880073|NCT04287660|Glucocorticoids|glucocorticoids|mesh-ancestor
5880074|NCT04287660|Hormones|hormones|mesh-ancestor
5880075|NCT04287660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5880076|NCT04287660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5880077|NCT04287660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5880078|NCT04287660|Immunologic Factors|immunologic factors|mesh-ancestor
5880079|NCT04287660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5880080|NCT04287660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5880081|NCT04287660|Growth Substances|growth substances|mesh-ancestor
5880082|NCT04287660|Growth Inhibitors|growth inhibitors|mesh-ancestor
5880083|NCT04287660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5880084|NCT04287660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5880085|NCT04287660|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5880086|NCT04287660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5880087|NCT04287660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5880088|NCT04287660|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5880089|NCT04287660|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5880090|NCT04255277|Moxifloxacin|moxifloxacin|mesh-list
5880091|NCT04255277|Levonorgestrel|levonorgestrel|mesh-list
5880092|NCT04255277|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5880093|NCT04255277|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
5880094|NCT04255277|Contraceptive Agents|contraceptive agents|mesh-list
5880095|NCT04255277|Contraceptives, Oral|contraceptives, oral|mesh-list
5880096|NCT04255277|Charcoal|charcoal|mesh-list
5880097|NCT04255277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5880098|NCT04255277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5686680|NCT03451110|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5686681|NCT03451110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5686682|NCT03451110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5686683|NCT03451110|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5686684|NCT03451110|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5686685|NCT03451110|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5686686|NCT03451110|Contraceptive Agents|contraceptive agents|mesh-ancestor
5880099|NCT04255277|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5880100|NCT04255277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5880101|NCT04255277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5880102|NCT04255277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5880103|NCT04255277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5880104|NCT04255277|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5880105|NCT04255277|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5880106|NCT04255277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686687|NCT03451110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5686688|NCT03451110|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5686689|NCT03451110|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5686690|NCT03451110|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
5686691|NCT03451110|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5686692|NCT03451019|Sevelamer|sevelamer|mesh-list
5686693|NCT03451019|Chelating Agents|chelating agents|mesh-ancestor
5686694|NCT03451019|Sequestering Agents|sequestering agents|mesh-ancestor
5686695|NCT03451019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686696|NCT03450967|Durvalumab|durvalumab|mesh-list
5686697|NCT03450967|Tremelimumab|tremelimumab|mesh-list
5686698|NCT03450967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5686699|NCT03450967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5686700|NCT03450863|Insulin Aspart|insulin aspart|mesh-list
5686701|NCT03450863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5686702|NCT03450863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686703|NCT03450798|Anesthetics|anesthetics|mesh-list
5686704|NCT03450798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5686705|NCT03450798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686706|NCT03450499|Ketamine|ketamine|mesh-list
5686707|NCT03450499|Analgesics|analgesics|mesh-ancestor
5686708|NCT03450499|Sensory System Agents|sensory system agents|mesh-ancestor
5880107|NCT04255277|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5686709|NCT03450499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5880108|NCT04255277|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5880109|NCT04255277|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5880110|NCT04255277|Estrogens|estrogens|mesh-ancestor
5880111|NCT04255277|Hormones|hormones|mesh-ancestor
5880112|NCT04255277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5880113|NCT04255277|Antidotes|antidotes|mesh-ancestor
5880114|NCT04255277|Protective Agents|protective agents|mesh-ancestor
5880115|NCT04218539|Psilocybin|psilocybin|mesh-list
5880116|NCT04218539|Hallucinogens|hallucinogens|mesh-ancestor
5880117|NCT04218539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880118|NCT04218539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5880119|NCT04149587|Brodalumab|brodalumab|mesh-list
5880120|NCT04149587|Dermatologic Agents|dermatologic agents|mesh-ancestor
5880121|NCT04086147|Tenecteplase|tenecteplase|mesh-list
5880122|NCT04086147|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5880123|NCT04086147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5880124|NCT04086147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5880125|NCT04058158|Eculizumab|eculizumab|mesh-list
5880126|NCT04058158|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5880127|NCT04058158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5880128|NCT04058158|Immunologic Factors|immunologic factors|mesh-ancestor
5880129|NCT04058158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880130|NCT04012177|Niacinamide|niacinamide|mesh-list
5880131|NCT04012177|Niacin|niacin|mesh-list
5880132|NCT04012177|Nicotinic Acids|nicotinic acids|mesh-list
5880133|NCT04012177|Azithromycin|azithromycin|mesh-list
5880134|NCT04012177|Choline|choline|mesh-list
5880135|NCT04012177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5880136|NCT04012177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5880137|NCT04012177|Lipotropic Agents|lipotropic agents|mesh-ancestor
5880138|NCT04012177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5880139|NCT04012177|Antimetabolites|antimetabolites|mesh-ancestor
5880140|NCT04012177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5880141|NCT04012177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5880142|NCT04012177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5880143|NCT04012177|Nootropic Agents|nootropic agents|mesh-ancestor
5880144|NCT04012177|Vitamin B Complex|vitamin b complex|mesh-ancestor
5880145|NCT04012177|Vitamins|vitamins|mesh-ancestor
5880146|NCT04012177|Micronutrients|micronutrients|mesh-ancestor
5880147|NCT04012177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880148|NCT04012177|Vasodilator Agents|vasodilator agents|mesh-ancestor
5880149|NCT03979742|Lithium Carbonate|lithium carbonate|mesh-list
5880150|NCT03979742|Antidepressive Agents|antidepressive agents|mesh-ancestor
5880151|NCT03979742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5880152|NCT03979742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5880153|NCT03979742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5880154|NCT03979742|Antimanic Agents|antimanic agents|mesh-ancestor
5880155|NCT03979742|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5880156|NCT03979742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5880157|NCT03979742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880158|NCT03966807|Nicotine|nicotine|mesh-list
5880159|NCT03966807|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5880160|NCT03966807|Autonomic Agents|autonomic agents|mesh-ancestor
5880161|NCT03966807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5880162|NCT03966807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880163|NCT03966807|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5880164|NCT03966807|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5880165|NCT03966807|Cholinergic Agents|cholinergic agents|mesh-ancestor
5880166|NCT03966807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5880167|NCT03966807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5880168|NCT03936829|Cyclophosphamide|cyclophosphamide|mesh-list
5880169|NCT03936829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5880170|NCT03936829|Immunologic Factors|immunologic factors|mesh-ancestor
5880171|NCT03936829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880172|NCT03936829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5880173|NCT03936829|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5880174|NCT03936829|Alkylating Agents|alkylating agents|mesh-ancestor
5880175|NCT03936829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5880176|NCT03936829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5880177|NCT03936829|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5880178|NCT03924986|Gemcitabine|gemcitabine|mesh-list
5880179|NCT03924986|Cisplatin|cisplatin|mesh-list
5880180|NCT03924986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5880181|NCT03924986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6675414|NCT01575405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6675415|NCT01575405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6675416|NCT01575405|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
5880182|NCT03924986|Antimetabolites|antimetabolites|mesh-ancestor
5880183|NCT03924986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5880184|NCT03924986|Antiviral Agents|antiviral agents|mesh-ancestor
5880185|NCT03924986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5880186|NCT03924986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5880187|NCT03924986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5880188|NCT03924986|Immunologic Factors|immunologic factors|mesh-ancestor
5880189|NCT03924986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880190|NCT03922620|Bupivacaine|bupivacaine|mesh-list
5880191|NCT03922620|Anesthetics, Local|anesthetics, local|mesh-ancestor
5880192|NCT03922620|Anesthetics|anesthetics|mesh-ancestor
5880193|NCT03922620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5880194|NCT03922620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880195|NCT03922620|Sensory System Agents|sensory system agents|mesh-ancestor
5880196|NCT03922620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5880197|NCT03901573|Atezolizumab|atezolizumab|mesh-list
5880198|NCT03901573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5906437|NCT02856438|Elotuzumab|elotuzumab|mesh-list
5906438|NCT02856438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5906439|NCT02856438|Antiemetics|antiemetics|mesh-ancestor
5906440|NCT02856438|Autonomic Agents|autonomic agents|mesh-ancestor
5906441|NCT02856438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5906442|NCT02856438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906443|NCT02856438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5906444|NCT02856438|Glucocorticoids|glucocorticoids|mesh-ancestor
5906445|NCT02856438|Hormones|hormones|mesh-ancestor
5906446|NCT02856438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5906447|NCT02856438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5906448|NCT02856438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5906449|NCT02856438|Immunologic Factors|immunologic factors|mesh-ancestor
5906450|NCT02856438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5906451|NCT02856438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6212477|NCT02188719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6212478|NCT02188719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212479|NCT02188719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6212480|NCT02188719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5686710|NCT03450499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686711|NCT03450499|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5686712|NCT03450499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5686713|NCT03450499|Anesthetics, General|anesthetics, general|mesh-ancestor
5686714|NCT03450499|Anesthetics|anesthetics|mesh-ancestor
6212481|NCT02188719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5906452|NCT02856438|Growth Substances|growth substances|mesh-ancestor
5906453|NCT02856438|Growth Inhibitors|growth inhibitors|mesh-ancestor
5906454|NCT02844816|Atezolizumab|atezolizumab|mesh-list
5906455|NCT02844816|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5906456|NCT02844816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5906457|NCT02844816|Immunologic Factors|immunologic factors|mesh-ancestor
5906458|NCT02844816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906459|NCT02808182|Niacin|niacin|mesh-list
5906460|NCT02808182|Nicotinic Acids|nicotinic acids|mesh-list
5906461|NCT02808182|Niacinamide|niacinamide|mesh-list
5906462|NCT02808182|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5906463|NCT02808182|Antimetabolites|antimetabolites|mesh-ancestor
5906464|NCT02808182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906465|NCT02808182|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5906466|NCT02808182|Vasodilator Agents|vasodilator agents|mesh-ancestor
5906467|NCT02808182|Vitamin B Complex|vitamin b complex|mesh-ancestor
5906468|NCT02808182|Vitamins|vitamins|mesh-ancestor
5906469|NCT02808182|Micronutrients|micronutrients|mesh-ancestor
5906470|NCT02808182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906471|NCT02689167|Sunitinib|sunitinib|mesh-list
5906472|NCT02689167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5906473|NCT02689167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5906474|NCT02689167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5906475|NCT02689167|Growth Substances|growth substances|mesh-ancestor
5686715|NCT03450499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5686716|NCT03450499|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5686717|NCT03450499|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5686718|NCT03450499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5686719|NCT03450499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686720|NCT03450434|Histamine|histamine|mesh-list
5686721|NCT03450434|Glutarimide|glutarimide|mesh-list
5686722|NCT03450434|Histamine Agonists|histamine agonists|mesh-ancestor
5686723|NCT03450434|Histamine Agents|histamine agents|mesh-ancestor
5880199|NCT03853187|Durvalumab|durvalumab|mesh-list
5880200|NCT03853187|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5880201|NCT03853187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5880202|NCT03853187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5880203|NCT03853187|Immunologic Factors|immunologic factors|mesh-ancestor
5880204|NCT03853187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880205|NCT03841110|Aldesleukin|aldesleukin|mesh-list
5880206|NCT03841110|Cyclophosphamide|cyclophosphamide|mesh-list
5880207|NCT03841110|Pembrolizumab|pembrolizumab|mesh-list
5880208|NCT03841110|Nivolumab|nivolumab|mesh-list
5880209|NCT03841110|Fludarabine|fludarabine|mesh-list
5880210|NCT03841110|Atezolizumab|atezolizumab|mesh-list
5880211|NCT03841110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5880212|NCT03841110|Immunologic Factors|immunologic factors|mesh-ancestor
5880213|NCT03841110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880214|NCT03841110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5880215|NCT03841110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5880216|NCT03841110|Alkylating Agents|alkylating agents|mesh-ancestor
5880217|NCT03841110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5880218|NCT03841110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5880219|NCT03841110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5880220|NCT03841110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5880221|NCT03841110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5880222|NCT03841110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5880223|NCT03841110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5880224|NCT03841110|Antiviral Agents|antiviral agents|mesh-ancestor
5880225|NCT03841110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5880233|NCT03713294|Dexamethasone|dexamethasone|mesh-list
5880234|NCT03713294|Dexamethasone acetate|dexamethasone acetate|mesh-list
5880235|NCT03713294|Pomalidomide|pomalidomide|mesh-list
5880236|NCT03713294|Elotuzumab|elotuzumab|mesh-list
5686724|NCT03450434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5686725|NCT03450434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686726|NCT03450434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686727|NCT03450434|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5686728|NCT03450434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5697348|NCT03376672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697349|NCT03376672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5880237|NCT03713294|Ichthammol|ichthammol|mesh-list
5880238|NCT03713294|BB 1101|bb 1101|mesh-list
5880239|NCT03713294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5880240|NCT03713294|Antiemetics|antiemetics|mesh-ancestor
5880241|NCT03713294|Autonomic Agents|autonomic agents|mesh-ancestor
5880242|NCT03713294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5880243|NCT03713294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880244|NCT03713294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5880245|NCT03713294|Glucocorticoids|glucocorticoids|mesh-ancestor
5880246|NCT03713294|Hormones|hormones|mesh-ancestor
5880247|NCT03713294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5880248|NCT03713294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5880249|NCT03713294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5880250|NCT03713294|Protease Inhibitors|protease inhibitors|mesh-ancestor
5880251|NCT03713294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5880252|NCT03713294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5880253|NCT03713294|Immunologic Factors|immunologic factors|mesh-ancestor
5880254|NCT03713294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5880255|NCT03713294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5880256|NCT03713294|Growth Substances|growth substances|mesh-ancestor
5880257|NCT03713294|Growth Inhibitors|growth inhibitors|mesh-ancestor
5880258|NCT03713294|Dermatologic Agents|dermatologic agents|mesh-ancestor
5880259|NCT03663205|Cisplatin|cisplatin|mesh-list
5880260|NCT03663205|Carboplatin|carboplatin|mesh-list
5880261|NCT03663205|Pemetrexed|pemetrexed|mesh-list
5880262|NCT03663205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5880263|NCT03663205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5880264|NCT03663205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5880265|NCT03663205|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5880266|NCT03663205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5880267|NCT03621696|Cisplatin|cisplatin|mesh-list
5880268|NCT03621696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5880269|NCT03597581|Bevacizumab|bevacizumab|mesh-list
5880270|NCT03597581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5880271|NCT03597581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5880272|NCT03597581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5880273|NCT03597581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5880274|NCT03597581|Growth Substances|growth substances|mesh-ancestor
5880275|NCT03597581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880276|NCT03597581|Growth Inhibitors|growth inhibitors|mesh-ancestor
5880277|NCT03593915|Azacitidine|azacitidine|mesh-list
5880278|NCT03593915|Decitabine|decitabine|mesh-list
5880279|NCT03593915|Alvocidib|alvocidib|mesh-list
5880280|NCT03593915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5880281|NCT03593915|Antimetabolites|antimetabolites|mesh-ancestor
5880282|NCT03593915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5880283|NCT03593915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5880284|NCT03593915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5880285|NCT03593915|Growth Inhibitors|growth inhibitors|mesh-ancestor
5880286|NCT03593915|Growth Substances|growth substances|mesh-ancestor
5880287|NCT03593915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880288|NCT03593915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5880289|NCT03472586|Nivolumab|nivolumab|mesh-list
5880290|NCT03472586|Ipilimumab|ipilimumab|mesh-list
5880291|NCT03472586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5880292|NCT03472586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5686729|NCT03450317|Aspirin|aspirin|mesh-list
5686730|NCT03450317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5686731|NCT03450317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5686732|NCT03450317|Analgesics|analgesics|mesh-ancestor
5686733|NCT03450317|Sensory System Agents|sensory system agents|mesh-ancestor
5686734|NCT03450317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5686735|NCT03450317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686736|NCT03450317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5686737|NCT03450317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5686738|NCT03450317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5686739|NCT03450317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5686740|NCT03450317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686741|NCT03450317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5686742|NCT03450317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5686743|NCT03450317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5686744|NCT03450317|Antipyretics|antipyretics|mesh-ancestor
5686745|NCT03450226|Bupivacaine|bupivacaine|mesh-list
5686746|NCT03450226|Anesthetics, Local|anesthetics, local|mesh-ancestor
5686747|NCT03450226|Anesthetics|anesthetics|mesh-ancestor
5686748|NCT03450226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5686749|NCT03450226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686750|NCT03450226|Sensory System Agents|sensory system agents|mesh-ancestor
5880293|NCT03472586|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5880294|NCT03472586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5880295|NCT03425565|Pembrolizumab|pembrolizumab|mesh-list
5880296|NCT03425565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5880297|NCT03425565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5880298|NCT03423680|Aripiprazole|aripiprazole|mesh-list
5880299|NCT03423680|Antidepressive Agents|antidepressive agents|mesh-ancestor
5880300|NCT03423680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5880301|NCT03423680|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5880302|NCT03423680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5686751|NCT03450226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5686752|NCT03450161|Fentanyl|fentanyl|mesh-list
5686753|NCT03450161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5686754|NCT03450161|Narcotics|narcotics|mesh-ancestor
5686755|NCT03450161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5686756|NCT03450161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686757|NCT03450161|Analgesics|analgesics|mesh-ancestor
5686758|NCT03450161|Sensory System Agents|sensory system agents|mesh-ancestor
5686759|NCT03450161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5686760|NCT03450161|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5686761|NCT03450161|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5686762|NCT03450161|Anesthetics, General|anesthetics, general|mesh-ancestor
5880303|NCT03423680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5880304|NCT03423680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880305|NCT03423680|Dopamine Agonists|dopamine agonists|mesh-ancestor
5880306|NCT03423680|Dopamine Agents|dopamine agents|mesh-ancestor
5880307|NCT03423680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5880308|NCT03423680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686763|NCT03450161|Anesthetics|anesthetics|mesh-ancestor
5880309|NCT03423680|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5880310|NCT03423680|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5880311|NCT03423680|Serotonin Agents|serotonin agents|mesh-ancestor
5880312|NCT03423680|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5880313|NCT03423680|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5880314|NCT03423680|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5880315|NCT03423680|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5880316|NCT03393468|Dapivirine|dapivirine|mesh-list
5880317|NCT03393468|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5880318|NCT03393468|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5880319|NCT03393468|Antiviral Agents|antiviral agents|mesh-ancestor
5880320|NCT03393468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5880321|NCT03371667|Methotrexate|methotrexate|mesh-list
5880322|NCT03371667|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5880323|NCT03371667|Abortifacient Agents|abortifacient agents|mesh-ancestor
5880324|NCT03371667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5880325|NCT03371667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880326|NCT03371667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5880327|NCT03371667|Antimetabolites|antimetabolites|mesh-ancestor
5880328|NCT03371667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5880329|NCT03371667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5880330|NCT03371667|Dermatologic Agents|dermatologic agents|mesh-ancestor
6675417|NCT01575405|Protective Agents|protective agents|mesh-ancestor
6675418|NCT01575405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675419|NCT01575418|Tenofovir|tenofovir|mesh-list
6675420|NCT01575418|Glycerol|glycerol|mesh-list
6675421|NCT01575418|Antiviral Agents|antiviral agents|mesh-ancestor
6675422|NCT01575418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6675423|NCT01575418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6675424|NCT01575418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6675425|NCT01575418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6675426|NCT01575418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675427|NCT01575418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6675428|NCT01575418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6675429|NCT01575418|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6675430|NCT01575418|Protective Agents|protective agents|mesh-ancestor
6675431|NCT01575418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880331|NCT03371667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5880332|NCT03371667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5880333|NCT03371667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5880334|NCT03371667|Immunologic Factors|immunologic factors|mesh-ancestor
5880335|NCT03371667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5880336|NCT03371667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5880337|NCT03318900|Aldesleukin|aldesleukin|mesh-list
5880338|NCT03318900|Cyclophosphamide|cyclophosphamide|mesh-list
5880339|NCT03318900|Interleukin-2|interleukin-2|mesh-list
5880340|NCT03318900|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5880341|NCT03318900|Immunoglobulin G|immunoglobulin g|mesh-list
5880342|NCT03318900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5880343|NCT03318900|Immunologic Factors|immunologic factors|mesh-ancestor
5880344|NCT03318900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880345|NCT03318900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5880346|NCT03318900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5880347|NCT03318900|Alkylating Agents|alkylating agents|mesh-ancestor
5880348|NCT03318900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5880349|NCT03318900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5880350|NCT03318900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5880351|NCT03318900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5880352|NCT03318900|Analgesics|analgesics|mesh-ancestor
5880353|NCT03318900|Sensory System Agents|sensory system agents|mesh-ancestor
5880354|NCT03318900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5880355|NCT03318900|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5880356|NCT03318900|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5880357|NCT03318900|Antiviral Agents|antiviral agents|mesh-ancestor
5880358|NCT03318900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5880359|NCT03295981|Zoledronic Acid|zoledronic acid|mesh-list
5880360|NCT03295981|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5880361|NCT03295981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880362|NCT03121001|Mycophenolic Acid|mycophenolic acid|mesh-list
5880363|NCT03121001|Sirolimus|sirolimus|mesh-list
5880364|NCT03121001|Cyclophosphamide|cyclophosphamide|mesh-list
5880365|NCT03121001|Fludarabine|fludarabine|mesh-list
5880366|NCT03121001|Thymoglobulin|thymoglobulin|mesh-list
6675432|NCT01575483|Saxagliptin|saxagliptin|mesh-list
5880367|NCT03121001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5880368|NCT03121001|Immunologic Factors|immunologic factors|mesh-ancestor
6675433|NCT01575483|Incretins|incretins|mesh-ancestor
5880369|NCT03121001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880370|NCT03121001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5880371|NCT03121001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5880372|NCT03121001|Alkylating Agents|alkylating agents|mesh-ancestor
5880373|NCT03121001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5880374|NCT03121001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5880375|NCT03121001|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5880376|NCT03121001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5880377|NCT03121001|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5880378|NCT03121001|Antitubercular Agents|antitubercular agents|mesh-ancestor
5880379|NCT03121001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5880380|NCT03121001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5880381|NCT03121001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5880382|NCT03121001|Antifungal Agents|antifungal agents|mesh-ancestor
5880383|NCT03073525|Atezolizumab|atezolizumab|mesh-list
5880384|NCT03073525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5880385|NCT03064490|Pembrolizumab|pembrolizumab|mesh-list
5880386|NCT03064490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5880387|NCT03064490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5880388|NCT02965898|Vitamin D|vitamin d|mesh-list
5880389|NCT02965898|Ergocalciferols|ergocalciferols|mesh-list
5880390|NCT02965898|Vitamins|vitamins|mesh-list
5880391|NCT02965898|Micronutrients|micronutrients|mesh-ancestor
5880392|NCT02965898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880393|NCT02965898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5880394|NCT02965898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5880395|NCT02952222|Dexmedetomidine|dexmedetomidine|mesh-list
5880396|NCT02952222|Propofol|propofol|mesh-list
5880397|NCT02952222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5880398|NCT02952222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5880399|NCT02952222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880400|NCT02952222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6495908|NCT00625469|Bosentan|bosentan|mesh-list
6495909|NCT00625469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6495910|NCT00625469|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6495911|NCT00625469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5880401|NCT02952222|Anesthetics, General|anesthetics, general|mesh-ancestor
5880402|NCT02952222|Anesthetics|anesthetics|mesh-ancestor
5880403|NCT02952222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5880404|NCT02952222|Analgesics|analgesics|mesh-ancestor
5880405|NCT02952222|Sensory System Agents|sensory system agents|mesh-ancestor
5880406|NCT02952222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5880407|NCT02952222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5880408|NCT02952222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5880409|NCT02952222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5880410|NCT02952222|Adrenergic Agents|adrenergic agents|mesh-ancestor
5880411|NCT02952222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5880412|NCT02952222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5880413|NCT02922764|Carboplatin|carboplatin|mesh-list
5880414|NCT02922764|Docetaxel|docetaxel|mesh-list
5880415|NCT02922764|Pembrolizumab|pembrolizumab|mesh-list
5880416|NCT02922764|Nivolumab|nivolumab|mesh-list
5880417|NCT02922764|Pemetrexed|pemetrexed|mesh-list
5880418|NCT02922764|Ipilimumab|ipilimumab|mesh-list
5880419|NCT02922764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5880420|NCT02922764|Tubulin Modulators|tubulin modulators|mesh-ancestor
5880421|NCT02922764|Antimitotic Agents|antimitotic agents|mesh-ancestor
5880422|NCT02922764|Mitosis Modulators|mitosis modulators|mesh-ancestor
5880423|NCT02922764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5880424|NCT02922764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5880425|NCT02922764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5880426|NCT02922764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6495912|NCT00625495|Esomeprazole|esomeprazole|mesh-list
5880427|NCT02922764|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5880428|NCT02922764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5880429|NCT02660645|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5880430|NCT02660645|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5880431|NCT02660645|Dermatologic Agents|dermatologic agents|mesh-ancestor
5880432|NCT02563015|Vitamin D|vitamin d|mesh-list
5880433|NCT02563015|Cholecalciferol|cholecalciferol|mesh-list
5880434|NCT02563015|Vitamins|vitamins|mesh-ancestor
5880435|NCT02563015|Micronutrients|micronutrients|mesh-ancestor
5880436|NCT02563015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880437|NCT02563015|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5880438|NCT02563015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5880439|NCT02543255|Prednisone|prednisone|mesh-list
5880440|NCT02543255|Leuprolide|leuprolide|mesh-list
5880441|NCT02543255|Abiraterone Acetate|abiraterone acetate|mesh-list
5880442|NCT02543255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5880443|NCT02543255|Glucocorticoids|glucocorticoids|mesh-ancestor
5880444|NCT02543255|Hormones|hormones|mesh-ancestor
5880445|NCT02543255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5880446|NCT02543255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880447|NCT02543255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5880448|NCT02543255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5880449|NCT02543255|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5880450|NCT02543255|Fertility Agents|fertility agents|mesh-ancestor
5880451|NCT02543255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5880452|NCT02543255|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5880453|NCT02543255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5880454|NCT02543255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5880455|NCT02543255|Hormone Antagonists|hormone antagonists|mesh-ancestor
5880456|NCT02543255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5880457|NCT02531932|Carboplatin|carboplatin|mesh-list
5880458|NCT02531932|Everolimus|everolimus|mesh-list
5880459|NCT02531932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5880460|NCT02531932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5880461|NCT02531932|Immunologic Factors|immunologic factors|mesh-ancestor
5880462|NCT02531932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880463|NCT02344290|Pitavastatin|pitavastatin|mesh-list
5880464|NCT02344290|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5880465|NCT02344290|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5880466|NCT02344290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5880467|NCT02344290|Antimetabolites|antimetabolites|mesh-ancestor
5880468|NCT02344290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686784|NCT03450109|Goserelin|goserelin|mesh-list
5686785|NCT03450109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5686786|NCT03450109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5686787|NCT03450057|Daratumumab|daratumumab|mesh-list
5686788|NCT03450057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5686789|NCT03450018|Gemcitabine|gemcitabine|mesh-list
5880469|NCT02344290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5880470|NCT02344290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5880471|NCT05094947|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
5880472|NCT05094947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5880473|NCT05094947|Adrenergic Agents|adrenergic agents|mesh-ancestor
5880474|NCT05094947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5880475|NCT05094947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5880476|NCT05094947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880477|NCT05094804|Pembrolizumab|pembrolizumab|mesh-list
5880478|NCT05094804|Nivolumab|nivolumab|mesh-list
5880479|NCT05094804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5880480|NCT05094804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5880481|NCT05094804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5880482|NCT05094804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5880483|NCT05094596|Montelukast|montelukast|mesh-list
5880484|NCT05094596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5880485|NCT05094596|Respiratory System Agents|respiratory system agents|mesh-ancestor
6495913|NCT00625495|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5686790|NCT03450018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5686791|NCT03450018|Antimetabolites|antimetabolites|mesh-ancestor
5880486|NCT05094596|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5880487|NCT05094596|Hormone Antagonists|hormone antagonists|mesh-ancestor
5880488|NCT05094596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5880489|NCT05094596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880490|NCT05094596|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5880491|NCT05094596|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5880492|NCT05094596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5880493|NCT05094492|Fluorides|fluorides|mesh-list
5880494|NCT05094492|Fluorides, Topical|fluorides, topical|mesh-list
5880495|NCT05094492|Cariostatic Agents|cariostatic agents|mesh-ancestor
5880496|NCT05094492|Protective Agents|protective agents|mesh-ancestor
5880497|NCT05094492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880498|NCT05094427|Anesthetics|anesthetics|mesh-list
5880499|NCT05094427|Anesthetics, Local|anesthetics, local|mesh-list
5880500|NCT05094427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5686792|NCT03450018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686793|NCT03450018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5686794|NCT03450018|Antiviral Agents|antiviral agents|mesh-ancestor
5686795|NCT03450018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5686796|NCT03450018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5686797|NCT03450018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5686798|NCT03450018|Immunologic Factors|immunologic factors|mesh-ancestor
5686799|NCT03450018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686800|NCT03449940|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5686801|NCT03449940|Ceftriaxone|ceftriaxone|mesh-list
5686802|NCT03449940|Diclofenac|diclofenac|mesh-list
5686803|NCT03449940|Lidocaine|lidocaine|mesh-list
5686804|NCT03449940|Analgesics|analgesics|mesh-list
5686805|NCT03449940|Anesthetics, Local|anesthetics, local|mesh-ancestor
5686806|NCT03449940|Anesthetics|anesthetics|mesh-ancestor
5686807|NCT03449940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5686808|NCT03449940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686809|NCT03449940|Sensory System Agents|sensory system agents|mesh-ancestor
5686810|NCT03449940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5686811|NCT03449940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5686812|NCT03449940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5880501|NCT05094427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880502|NCT05094427|Sensory System Agents|sensory system agents|mesh-ancestor
5880503|NCT05094427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5880504|NCT05094414|Valacyclovir|valacyclovir|mesh-list
5880505|NCT05094414|Antiviral Agents|antiviral agents|mesh-ancestor
5880506|NCT05094414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5880507|NCT05094375|Misoprostol|misoprostol|mesh-list
5880508|NCT05094375|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5880509|NCT05094375|Abortifacient Agents|abortifacient agents|mesh-ancestor
5880510|NCT05094375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5880511|NCT05094375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880512|NCT05094375|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5880513|NCT05094375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5880514|NCT05094375|Oxytocics|oxytocics|mesh-ancestor
5906476|NCT02689167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906477|NCT02689167|Growth Inhibitors|growth inhibitors|mesh-ancestor
5906478|NCT02689167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5906479|NCT02689167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5906480|NCT02689167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906481|NCT02591420|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
5906482|NCT02591420|Antiviral Agents|antiviral agents|mesh-ancestor
5906483|NCT02591420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5906484|NCT02582697|Cisplatin|cisplatin|mesh-list
5906485|NCT02582697|Etoposide|etoposide|mesh-list
5906486|NCT02582697|Etoposide phosphate|etoposide phosphate|mesh-list
5906487|NCT02582697|Bleomycin|bleomycin|mesh-list
5906488|NCT02582697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5906489|NCT02582697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5906490|NCT02582697|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5906491|NCT02582697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5906492|NCT02582697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5686813|NCT03449940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5686814|NCT03449940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5686815|NCT03449940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686816|NCT03449940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5686817|NCT03449940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5686818|NCT03449940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5686819|NCT03449940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5880515|NCT05093907|Capecitabine|capecitabine|mesh-list
5880516|NCT05093907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5880517|NCT05093907|Antimetabolites|antimetabolites|mesh-ancestor
5880518|NCT05093907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5880519|NCT05093907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5880520|NCT05093790|Aspirin|aspirin|mesh-list
5880521|NCT05093790|Ticagrelor|ticagrelor|mesh-list
5880522|NCT05093790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5880523|NCT05093790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5880524|NCT05093790|Analgesics|analgesics|mesh-ancestor
5880525|NCT05093790|Sensory System Agents|sensory system agents|mesh-ancestor
5880526|NCT05093790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5880527|NCT05093790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880528|NCT05093790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5880529|NCT05093790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5880530|NCT05093790|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5880531|NCT05093790|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5880532|NCT05093790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5880533|NCT05093790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5880534|NCT05093790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5880535|NCT05093790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5686820|NCT03449940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5686821|NCT03449940|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5686822|NCT03449940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5686823|NCT03449901|Gemcitabine|gemcitabine|mesh-list
5686824|NCT03449901|Docetaxel|docetaxel|mesh-list
5686825|NCT03449901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5880536|NCT05093790|Antipyretics|antipyretics|mesh-ancestor
5880537|NCT05093790|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5880538|NCT05093790|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5880539|NCT05093790|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5880540|NCT05093790|Purinergic Agents|purinergic agents|mesh-ancestor
5880541|NCT05093790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5880542|NCT05093608|Bevacizumab|bevacizumab|mesh-list
5880543|NCT05093608|Atezolizumab|atezolizumab|mesh-list
5880544|NCT05093608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5880545|NCT05093608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5880546|NCT05093608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5880547|NCT05093608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5880548|NCT05093608|Growth Substances|growth substances|mesh-ancestor
5880549|NCT05093608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880550|NCT05093608|Growth Inhibitors|growth inhibitors|mesh-ancestor
5880551|NCT05093478|Lidocaine|lidocaine|mesh-list
5880552|NCT05093478|Capsaicin|capsaicin|mesh-list
5880553|NCT05093478|Anesthetics, Local|anesthetics, local|mesh-ancestor
5880554|NCT05093478|Anesthetics|anesthetics|mesh-ancestor
5880555|NCT05093478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5880556|NCT05093478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880557|NCT05093478|Sensory System Agents|sensory system agents|mesh-ancestor
5880558|NCT05093478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5686826|NCT03449901|Antimetabolites|antimetabolites|mesh-ancestor
5686827|NCT03449901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686828|NCT03449901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5686829|NCT03449901|Antiviral Agents|antiviral agents|mesh-ancestor
5880559|NCT05093478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5880560|NCT05093478|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5880561|NCT05093478|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5880562|NCT05093478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5880563|NCT05093478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5880564|NCT05093478|Antipruritics|antipruritics|mesh-ancestor
5880565|NCT05093478|Dermatologic Agents|dermatologic agents|mesh-ancestor
5880566|NCT05093387|Carboplatin|carboplatin|mesh-list
5880567|NCT05093387|Pembrolizumab|pembrolizumab|mesh-list
5880568|NCT05093387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5880569|NCT05093387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5880570|NCT05093374|Bevacizumab|bevacizumab|mesh-list
5880571|NCT05093374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6675434|NCT01575483|Hormones|hormones|mesh-ancestor
5686830|NCT03449901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5686831|NCT03449901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5686832|NCT03449901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5686833|NCT03449901|Immunologic Factors|immunologic factors|mesh-ancestor
5686834|NCT03449901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686835|NCT03449901|Tubulin Modulators|tubulin modulators|mesh-ancestor
5686836|NCT03449901|Antimitotic Agents|antimitotic agents|mesh-ancestor
5880572|NCT05093374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5880573|NCT05093374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5880574|NCT05093374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5880575|NCT05093374|Growth Substances|growth substances|mesh-ancestor
5880576|NCT05093374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880577|NCT05093374|Growth Inhibitors|growth inhibitors|mesh-ancestor
5880578|NCT05093231|Pembrolizumab|pembrolizumab|mesh-list
5880579|NCT05093231|Olaparib|olaparib|mesh-list
5880580|NCT05093231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5880581|NCT05093231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5880582|NCT05093231|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5880583|NCT05093231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5880584|NCT05093231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675435|NCT01575483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6675436|NCT01575483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675437|NCT01575483|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6675438|NCT01575483|Protease Inhibitors|protease inhibitors|mesh-ancestor
6675439|NCT01575483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6675615|NCT01576640|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5880585|NCT05093140|Prednisone|prednisone|mesh-list
5880586|NCT05093140|Cyclophosphamide|cyclophosphamide|mesh-list
5880587|NCT05093140|Vincristine|vincristine|mesh-list
5880588|NCT05093140|Doxorubicin|doxorubicin|mesh-list
5880589|NCT05093140|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5880590|NCT05093140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5880591|NCT05093140|Immunologic Factors|immunologic factors|mesh-ancestor
5880592|NCT05093140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880593|NCT05093140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5880594|NCT05093140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5880595|NCT05093140|Alkylating Agents|alkylating agents|mesh-ancestor
5880596|NCT05093140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5880597|NCT05093140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5880598|NCT05093140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5880599|NCT05093140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5880600|NCT05093140|Glucocorticoids|glucocorticoids|mesh-ancestor
5880601|NCT05093140|Hormones|hormones|mesh-ancestor
5880602|NCT05093140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5880603|NCT05093140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5880604|NCT05093140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5880605|NCT05093140|Tubulin Modulators|tubulin modulators|mesh-ancestor
5880606|NCT05093140|Antimitotic Agents|antimitotic agents|mesh-ancestor
5880607|NCT05093140|Mitosis Modulators|mitosis modulators|mesh-ancestor
5880608|NCT05093140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5880609|NCT05093140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5880610|NCT05093140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5880611|NCT05093140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5880612|NCT05092984|Spironolactone|spironolactone|mesh-list
5880613|NCT05092984|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5880614|NCT05092984|Hormone Antagonists|hormone antagonists|mesh-ancestor
5880615|NCT05092984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5880616|NCT05092984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880617|NCT05092984|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5880618|NCT05092984|Diuretics|diuretics|mesh-ancestor
5880619|NCT05092984|Natriuretic Agents|natriuretic agents|mesh-ancestor
5880620|NCT05092945|Niacin|niacin|mesh-list
5880621|NCT05092945|Nicotinic Acids|nicotinic acids|mesh-list
5880622|NCT05092945|Niacinamide|niacinamide|mesh-list
5880623|NCT05092945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5880624|NCT05092945|Antimetabolites|antimetabolites|mesh-ancestor
5880625|NCT05092945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5880626|NCT05092945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5880627|NCT05092945|Vasodilator Agents|vasodilator agents|mesh-ancestor
5880628|NCT05092945|Vitamin B Complex|vitamin b complex|mesh-ancestor
5880629|NCT05092945|Vitamins|vitamins|mesh-ancestor
5880630|NCT05092945|Micronutrients|micronutrients|mesh-ancestor
5880631|NCT05092945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880632|NCT05092841|Naltrexone|naltrexone|mesh-list
5880633|NCT05092841|Baclofen|baclofen|mesh-list
5880634|NCT05092841|Sorbitol|sorbitol|mesh-list
5880635|NCT05092841|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5880636|NCT05092841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5880637|NCT05092841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880638|NCT05092841|Sensory System Agents|sensory system agents|mesh-ancestor
5880639|NCT05092841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5880640|NCT05092841|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5880641|NCT05092841|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5880642|NCT05092841|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
5880643|NCT05092841|GABA Agonists|gaba agonists|mesh-ancestor
5880644|NCT05092841|GABA Agents|gaba agents|mesh-ancestor
5880645|NCT05092841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5880646|NCT05092841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5880647|NCT05092841|Cathartics|cathartics|mesh-ancestor
5880648|NCT05092841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5880649|NCT05090085|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
5880650|NCT05090085|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
5880651|NCT05090085|Protective Agents|protective agents|mesh-ancestor
5880652|NCT05090085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880653|NCT05090085|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5880654|NCT05090085|Antioxidants|antioxidants|mesh-ancestor
5880655|NCT05090085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5880656|NCT05089526|Lidocaine|lidocaine|mesh-list
5880657|NCT05089526|Fentanyl|fentanyl|mesh-list
5880658|NCT05089526|Dexmedetomidine|dexmedetomidine|mesh-list
5880659|NCT05089526|Ketamine|ketamine|mesh-list
5880660|NCT05089526|Anesthetics, Local|anesthetics, local|mesh-ancestor
5880661|NCT05089526|Anesthetics|anesthetics|mesh-ancestor
5880662|NCT05089526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5880663|NCT05089526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880664|NCT05089526|Sensory System Agents|sensory system agents|mesh-ancestor
5880665|NCT05089526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5880666|NCT05089526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5880667|NCT05089526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5880668|NCT05089526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5880669|NCT05089526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5880670|NCT05089526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5880671|NCT05089526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5880672|NCT05089526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5880673|NCT05089526|Analgesics|analgesics|mesh-ancestor
5880674|NCT05089526|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6675440|NCT01575483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675441|NCT01575483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6675442|NCT01575509|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6675443|NCT01575613|Lumefantrine|lumefantrine|mesh-list
6675444|NCT01575613|Artemether|artemether|mesh-list
6675445|NCT01575613|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6675446|NCT01575613|Antimalarials|antimalarials|mesh-ancestor
6675447|NCT01575613|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6675448|NCT01575613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6675449|NCT01575613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6675450|NCT01575626|Sevoflurane|sevoflurane|mesh-list
5880675|NCT05089526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5880676|NCT05089526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5880677|NCT05089526|Adrenergic Agents|adrenergic agents|mesh-ancestor
5880678|NCT05089526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5880679|NCT05089526|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5880680|NCT05089526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5880681|NCT05089526|Anesthetics, General|anesthetics, general|mesh-ancestor
5880682|NCT05089526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5880683|NCT05089526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5880684|NCT05089526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5880685|NCT05089526|Narcotics|narcotics|mesh-ancestor
5880686|NCT05089526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5686837|NCT03449901|Mitosis Modulators|mitosis modulators|mesh-ancestor
5686838|NCT03449836|Fluticasone|fluticasone|mesh-list
5686839|NCT03449836|Mometasone Furoate|mometasone furoate|mesh-list
5686840|NCT03449836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5686841|NCT03449836|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5686842|NCT03449836|Autonomic Agents|autonomic agents|mesh-ancestor
5686843|NCT03449836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5686844|NCT03449836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880687|NCT05082480|Hyaluronic Acid|hyaluronic acid|mesh-list
5880688|NCT05082480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5880689|NCT05082480|Immunologic Factors|immunologic factors|mesh-ancestor
5880690|NCT05082480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880691|NCT05082480|Viscosupplements|viscosupplements|mesh-ancestor
5880692|NCT05082480|Protective Agents|protective agents|mesh-ancestor
5686845|NCT03449836|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5686846|NCT03449836|Respiratory System Agents|respiratory system agents|mesh-ancestor
5686847|NCT03449836|Dermatologic Agents|dermatologic agents|mesh-ancestor
5880693|NCT05080218|Adalimumab|adalimumab|mesh-list
6675451|NCT01575626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5880694|NCT05080218|Etanercept|etanercept|mesh-list
5880695|NCT05080218|Golimumab|golimumab|mesh-list
5880696|NCT05080218|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
5880697|NCT05080218|Abatacept|abatacept|mesh-list
5880698|NCT05080218|Upadacitinib|upadacitinib|mesh-list
5880699|NCT05080218|Tofacitinib|tofacitinib|mesh-list
5880700|NCT05080218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5880701|NCT05080218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5880702|NCT05080218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5880703|NCT05080218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5880704|NCT05080218|Analgesics|analgesics|mesh-ancestor
5880705|NCT05080218|Sensory System Agents|sensory system agents|mesh-ancestor
5880706|NCT05080218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5880707|NCT05080218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880708|NCT05080218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5880709|NCT05080218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5880710|NCT05080218|Immunologic Factors|immunologic factors|mesh-ancestor
5880711|NCT05080218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5686848|NCT03449836|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5686849|NCT03449797|Hydrocortisone|hydrocortisone|mesh-list
5686850|NCT03449797|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
5686851|NCT03449797|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
5686852|NCT03449797|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
5880712|NCT05080218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5880713|NCT05080218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5880714|NCT05080218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5880715|NCT05080218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5686853|NCT03449797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5686854|NCT03449719|Abiraterone Acetate|abiraterone acetate|mesh-list
5686855|NCT03449719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5686856|NCT03449719|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5686857|NCT03449719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5686858|NCT03449719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686859|NCT03449719|Hormone Antagonists|hormone antagonists|mesh-ancestor
5686860|NCT03449719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5686861|NCT03449719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686862|NCT03449719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5686863|NCT03449693|Magnesium Oxide|magnesium oxide|mesh-list
5686864|NCT03449693|Antacids|antacids|mesh-ancestor
5880716|NCT05080218|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
5880717|NCT05077709|Pembrolizumab|pembrolizumab|mesh-list
5880718|NCT05077709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5880719|NCT05077709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5880720|NCT05049616|Nifedipine|nifedipine|mesh-list
5880721|NCT05049616|Diuretics|diuretics|mesh-list
5880722|NCT05049616|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
5880723|NCT05049616|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5880724|NCT05049616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5880725|NCT05049616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5880726|NCT05049616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5880727|NCT05049616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880728|NCT05049616|Vasodilator Agents|vasodilator agents|mesh-ancestor
5880729|NCT05049616|Tocolytic Agents|tocolytic agents|mesh-ancestor
5880730|NCT05049616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5880731|NCT05049616|Natriuretic Agents|natriuretic agents|mesh-ancestor
5880732|NCT05049616|Protease Inhibitors|protease inhibitors|mesh-ancestor
5880733|NCT05049616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5880734|NCT05036876|Insulin Glargine|insulin glargine|mesh-list
5880735|NCT05036876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5880736|NCT05036876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880737|NCT05022810|Acetaminophen|acetaminophen|mesh-list
5880738|NCT05022810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5880739|NCT05022810|Analgesics|analgesics|mesh-ancestor
5880740|NCT05022810|Sensory System Agents|sensory system agents|mesh-ancestor
5880741|NCT05022810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5880742|NCT05022810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880743|NCT05022810|Antipyretics|antipyretics|mesh-ancestor
5906493|NCT02582697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906494|NCT02582697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5906495|NCT02535221|Epirubicin|epirubicin|mesh-list
5906496|NCT02535221|Goserelin|goserelin|mesh-list
5906497|NCT02535221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5906498|NCT02535221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5906499|NCT02535221|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5906500|NCT02535221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5880744|NCT05003349|Salicylic Acid|salicylic acid|mesh-list
5880745|NCT05003349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5880746|NCT05003349|Antifungal Agents|antifungal agents|mesh-ancestor
5880747|NCT05003349|Keratolytic Agents|keratolytic agents|mesh-ancestor
5880748|NCT05003349|Dermatologic Agents|dermatologic agents|mesh-ancestor
5880749|NCT04993560|Vaccines|vaccines|mesh-list
5880750|NCT04993560|Immunologic Factors|immunologic factors|mesh-ancestor
5880751|NCT04993560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880752|NCT04947085|Ketamine|ketamine|mesh-list
5880753|NCT04947085|Analgesics|analgesics|mesh-ancestor
5880754|NCT04947085|Sensory System Agents|sensory system agents|mesh-ancestor
5880755|NCT04947085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5880756|NCT04947085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880757|NCT04947085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5880758|NCT04947085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5880759|NCT04947085|Anesthetics, General|anesthetics, general|mesh-ancestor
5880760|NCT04947085|Anesthetics|anesthetics|mesh-ancestor
5880761|NCT04947085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5880762|NCT04947085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5880763|NCT04947085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5880764|NCT04947085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5880765|NCT04947085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5880766|NCT04885816|Sirolimus|sirolimus|mesh-list
5880767|NCT04885816|Everolimus|everolimus|mesh-list
5880768|NCT04885816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5880769|NCT04885816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5880770|NCT04885816|Immunologic Factors|immunologic factors|mesh-ancestor
5880771|NCT04885816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880772|NCT04885816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5880773|NCT04885816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5880774|NCT04885816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5880775|NCT04885816|Antifungal Agents|antifungal agents|mesh-ancestor
5880776|NCT04865614|Sevoflurane|sevoflurane|mesh-list
5880777|NCT04865614|Etomidate|etomidate|mesh-list
5880778|NCT04865614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5880779|NCT04865614|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5880780|NCT04865614|Anesthetics, General|anesthetics, general|mesh-ancestor
5880781|NCT04865614|Anesthetics|anesthetics|mesh-ancestor
5880782|NCT04865614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5880783|NCT04865614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880784|NCT04865614|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5880785|NCT04865614|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5880786|NCT04854811|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-list
5880787|NCT04854811|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5880788|NCT04854811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5880789|NCT04854811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686865|NCT03449693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686866|NCT03449693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5686867|NCT03449654|Liraglutide|liraglutide|mesh-list
5686868|NCT03449654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5686869|NCT03449654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686870|NCT03449654|Incretins|incretins|mesh-ancestor
5686871|NCT03449654|Hormones|hormones|mesh-ancestor
5880790|NCT04770454|Buspirone|buspirone|mesh-list
5880791|NCT04770454|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5880792|NCT04770454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5880793|NCT04770454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5880794|NCT04770454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880795|NCT04770454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5880796|NCT04770454|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5880797|NCT04770454|Serotonin Agents|serotonin agents|mesh-ancestor
5880798|NCT04770454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5880799|NCT04770454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5880800|NCT04768829|Carbamide Peroxide|carbamide peroxide|mesh-list
5880801|NCT04768829|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6495914|NCT00625495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6495915|NCT00625495|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6495916|NCT00625495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6495917|NCT00625495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495918|NCT00625547|Levodopa|levodopa|mesh-list
6495919|NCT00625547|Cabergoline|cabergoline|mesh-list
6495920|NCT00625547|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6495921|NCT00625547|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5697350|NCT03376672|Glucocorticoids|glucocorticoids|mesh-ancestor
5880802|NCT04768829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5880803|NCT04731025|Vancomycin|vancomycin|mesh-list
5686872|NCT03449654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5686873|NCT03449537|Caseins|caseins|mesh-list
5686874|NCT03449537|Chelating Agents|chelating agents|mesh-ancestor
5686875|NCT03449537|Sequestering Agents|sequestering agents|mesh-ancestor
5686876|NCT03449537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686877|NCT03449524|CXA-10|cxa-10|mesh-list
5880804|NCT04731025|Gentamicins|gentamicins|mesh-list
5880805|NCT04731025|Cefazolin|cefazolin|mesh-list
5686878|NCT03449524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5686879|NCT03449485|Chlorprothixene|chlorprothixene|mesh-list
5686880|NCT03449485|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5686881|NCT03449485|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5686882|NCT03449485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5686883|NCT03449485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686884|NCT03449485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5686885|NCT03449485|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5686886|NCT03449485|Dopamine Agents|dopamine agents|mesh-ancestor
5686887|NCT03449485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5686888|NCT03449485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5880806|NCT04731025|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5880807|NCT04731025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5880808|NCT04731025|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5880809|NCT04731025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5880810|NCT04731025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5880811|NCT04711824|Gemcitabine|gemcitabine|mesh-list
5880812|NCT04711824|Paclitaxel|paclitaxel|mesh-list
5880813|NCT04711824|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5880814|NCT04711824|Cisplatin|cisplatin|mesh-list
5880815|NCT04711824|Carboplatin|carboplatin|mesh-list
5880816|NCT04711824|Capecitabine|capecitabine|mesh-list
5880817|NCT04711824|Durvalumab|durvalumab|mesh-list
5880818|NCT04711824|Olaparib|olaparib|mesh-list
5880819|NCT04711824|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5880820|NCT04711824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5686889|NCT03449472|Quetiapine Fumarate|quetiapine fumarate|mesh-list
5686890|NCT03449472|Antidepressive Agents|antidepressive agents|mesh-ancestor
5686891|NCT03449472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5686892|NCT03449472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5686893|NCT03449472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5686894|NCT03449472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5686895|NCT03449472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686896|NCT03449459|Amikacin|amikacin|mesh-list
5880821|NCT04711824|Tubulin Modulators|tubulin modulators|mesh-ancestor
5880822|NCT04711824|Antimitotic Agents|antimitotic agents|mesh-ancestor
5880823|NCT04711824|Mitosis Modulators|mitosis modulators|mesh-ancestor
5880824|NCT04711824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5880825|NCT04711824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5880826|NCT04711824|Antimetabolites|antimetabolites|mesh-ancestor
5880827|NCT04711824|Antiviral Agents|antiviral agents|mesh-ancestor
5880828|NCT04711824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5880829|NCT04711824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5880830|NCT04711824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5880831|NCT04711824|Immunologic Factors|immunologic factors|mesh-ancestor
5880832|NCT04711824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880833|NCT04711824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5880834|NCT04711824|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5880835|NCT04691128|Anesthetics|anesthetics|mesh-list
5880836|NCT04691128|Propofol|propofol|mesh-list
5880837|NCT04691128|Desflurane|desflurane|mesh-list
5880838|NCT04691128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5880839|NCT04691128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880840|NCT04691128|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5880841|NCT04691128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5880842|NCT04691128|Anesthetics, General|anesthetics, general|mesh-ancestor
5880843|NCT04691128|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5880844|NCT04682522|Metronidazole|metronidazole|mesh-list
5880845|NCT04682522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5880846|NCT04682522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5880847|NCT04682522|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5880848|NCT04682522|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5880849|NCT04657809|Insulin|insulin|mesh-list
5880850|NCT04657809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5686897|NCT03449459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5686898|NCT03449459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5686899|NCT03449251|Verapamil|verapamil|mesh-list
5880851|NCT04657809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880852|NCT04628988|Prednisone|prednisone|mesh-list
5880853|NCT04628988|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
5880854|NCT04628988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5880855|NCT04628988|Glucocorticoids|glucocorticoids|mesh-ancestor
5880856|NCT04628988|Hormones|hormones|mesh-ancestor
5880857|NCT04628988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5880858|NCT04628988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880859|NCT04628988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5880860|NCT04628988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5880861|NCT04628988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5880862|NCT04628988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5880863|NCT04619680|Nintedanib|nintedanib|mesh-list
6675452|NCT01575626|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6675453|NCT01575626|Anesthetics, General|anesthetics, general|mesh-ancestor
6675454|NCT01575626|Anesthetics|anesthetics|mesh-ancestor
6675455|NCT01575626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5880864|NCT04619680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5880865|NCT04619680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5880866|NCT04619680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5880867|NCT04619680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5880868|NCT04601584|Antibodies|antibodies|mesh-list
5880869|NCT04601584|Immunoglobulins|immunoglobulins|mesh-list
5880870|NCT04601584|Immunologic Factors|immunologic factors|mesh-ancestor
5686900|NCT03449251|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
5880871|NCT04601584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880872|NCT04585854|Caffeine|caffeine|mesh-list
5880873|NCT04585854|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5880874|NCT04585854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880875|NCT04585854|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5880876|NCT04585854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5880877|NCT04585854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5880878|NCT04585854|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5880879|NCT04585854|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5880880|NCT04585854|Purinergic Agents|purinergic agents|mesh-ancestor
5880881|NCT04585854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5880882|NCT04582981|Raltitrexed|raltitrexed|mesh-list
5880883|NCT04582981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5880884|NCT04582981|Antimetabolites|antimetabolites|mesh-ancestor
5906501|NCT02535221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6212482|NCT02188719|Immunologic Factors|immunologic factors|mesh-ancestor
6212483|NCT02188719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6212484|NCT02188719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6212485|NCT02188719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686901|NCT03449251|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5686902|NCT03449251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5686903|NCT03449251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5686904|NCT03449251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686905|NCT03449251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5686906|NCT03449251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212486|NCT02188719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6212487|NCT02188719|Analgesics|analgesics|mesh-ancestor
6212488|NCT02188719|Sensory System Agents|sensory system agents|mesh-ancestor
6212489|NCT02188719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6212490|NCT02188719|Antipyretics|antipyretics|mesh-ancestor
6212491|NCT02188719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6212492|NCT02188719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6212493|NCT02188719|Antitubercular Agents|antitubercular agents|mesh-ancestor
6212494|NCT02188719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6212495|NCT02188719|Hematinics|hematinics|mesh-ancestor
6212496|NCT02188719|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5686907|NCT03449251|Vasodilator Agents|vasodilator agents|mesh-ancestor
5880885|NCT04582981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5880886|NCT04582981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5880887|NCT04582981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5880888|NCT04582981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5880889|NCT04548661|Povidone-Iodine|povidone-iodine|mesh-list
5880890|NCT04548661|Povidone|povidone|mesh-list
5880891|NCT04548661|Plasma Substitutes|plasma substitutes|mesh-ancestor
5880892|NCT04548661|Blood Substitutes|blood substitutes|mesh-ancestor
5880893|NCT04548661|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5880894|NCT04548661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5880895|NCT04504240|Famotidine|famotidine|mesh-list
5880896|NCT04504240|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5880897|NCT04504240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5880898|NCT04504240|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5880899|NCT04504240|Histamine Antagonists|histamine antagonists|mesh-ancestor
5880900|NCT04504240|Histamine Agents|histamine agents|mesh-ancestor
5880901|NCT04504240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5880902|NCT04504240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5880903|NCT04504240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880904|NCT04499248|Bimatoprost|bimatoprost|mesh-list
5880905|NCT04499248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5880906|NCT04492306|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
5880907|NCT04492306|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
5880908|NCT04492306|Protective Agents|protective agents|mesh-ancestor
5880909|NCT04492306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880910|NCT04492306|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5880911|NCT04492306|Antioxidants|antioxidants|mesh-ancestor
5880912|NCT04492306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906502|NCT02535221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906503|NCT02535221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5906504|NCT02529904|Vaccines|vaccines|mesh-list
5906505|NCT02529904|Immunologic Factors|immunologic factors|mesh-ancestor
5686908|NCT03449251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5686909|NCT03449238|Pembrolizumab|pembrolizumab|mesh-list
5686910|NCT03449238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5686911|NCT03449238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5686912|NCT03449173|Sunitinib|sunitinib|mesh-list
5686913|NCT03449173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5686914|NCT03449173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5686915|NCT03449173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5686916|NCT03449173|Growth Substances|growth substances|mesh-ancestor
5686917|NCT03449173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686918|NCT03449173|Growth Inhibitors|growth inhibitors|mesh-ancestor
5686919|NCT03449173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5686920|NCT03449173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5686921|NCT03449173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686922|NCT03449082|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
5686923|NCT03449082|Hemostatics|hemostatics|mesh-ancestor
5686924|NCT03449082|Coagulants|coagulants|mesh-ancestor
5686925|NCT03449056|Albuterol|albuterol|mesh-list
5906506|NCT02529904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906507|NCT02525796|Eplerenone|eplerenone|mesh-list
5906508|NCT02525796|Amiloride|amiloride|mesh-list
5906509|NCT02525796|Cinacalcet|cinacalcet|mesh-list
5906510|NCT02525796|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5906511|NCT02525796|Hormone Antagonists|hormone antagonists|mesh-ancestor
5906512|NCT02525796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5906513|NCT02525796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906514|NCT02525796|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5906515|NCT02525796|Diuretics|diuretics|mesh-ancestor
5906516|NCT02525796|Natriuretic Agents|natriuretic agents|mesh-ancestor
5906517|NCT02525796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5906518|NCT02525796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5906519|NCT02525796|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
5906520|NCT02525796|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
5906521|NCT02525796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5906522|NCT02525796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5906523|NCT02525796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906524|NCT02525796|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
5906525|NCT02386839|Mecasermin|mecasermin|mesh-list
5906526|NCT02386839|Growth Substances|growth substances|mesh-ancestor
5906527|NCT02386839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906528|NCT02217345|Hormones|hormones|mesh-list
5686926|NCT03449056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5686927|NCT03449056|Autonomic Agents|autonomic agents|mesh-ancestor
5686928|NCT03449056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5686929|NCT03449056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686930|NCT03449056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5686931|NCT03449056|Respiratory System Agents|respiratory system agents|mesh-ancestor
5686932|NCT03449056|Tocolytic Agents|tocolytic agents|mesh-ancestor
5686933|NCT03449056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5686934|NCT03449056|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5686935|NCT03449056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5686936|NCT03449056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5686937|NCT03449056|Adrenergic Agents|adrenergic agents|mesh-ancestor
5686938|NCT03449056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5686939|NCT03449056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686940|NCT03448978|Cyclophosphamide|cyclophosphamide|mesh-list
5880913|NCT04469179|Immunoglobulins|immunoglobulins|mesh-list
5880914|NCT04469179|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5880915|NCT04469179|Immunologic Factors|immunologic factors|mesh-ancestor
5880916|NCT04469179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880917|NCT04468958|Immunoglobulins|immunoglobulins|mesh-list
5880918|NCT04468958|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5880919|NCT04468958|Immunologic Factors|immunologic factors|mesh-ancestor
5880920|NCT04468958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880921|NCT04459052|Acetylcysteine|acetylcysteine|mesh-list
5880922|NCT04459052|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5880923|NCT04459052|Antiviral Agents|antiviral agents|mesh-ancestor
5880924|NCT04459052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5880925|NCT04459052|Expectorants|expectorants|mesh-ancestor
5880926|NCT04459052|Respiratory System Agents|respiratory system agents|mesh-ancestor
5880927|NCT04459052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5880928|NCT04459052|Antioxidants|antioxidants|mesh-ancestor
5880929|NCT04459052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5880930|NCT04459052|Protective Agents|protective agents|mesh-ancestor
5880931|NCT04459052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880932|NCT04459052|Antidotes|antidotes|mesh-ancestor
5880933|NCT04429802|Prucalopride|prucalopride|mesh-list
5880934|NCT04429802|Laxatives|laxatives|mesh-ancestor
5880935|NCT04429802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5880936|NCT04429802|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
5880937|NCT04429802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5880938|NCT04429802|Serotonin Agents|serotonin agents|mesh-ancestor
5880939|NCT04429802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5880940|NCT04429802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5880941|NCT04429802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880942|NCT04387760|Hydroxychloroquine|hydroxychloroquine|mesh-list
5880943|NCT04387760|Favipiravir|favipiravir|mesh-list
5880944|NCT04387760|Antimalarials|antimalarials|mesh-ancestor
5880945|NCT04387760|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5880946|NCT04387760|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5880947|NCT04387760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5880948|NCT04387760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5880949|NCT04387760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495922|NCT00625547|Dopamine Agents|dopamine agents|mesh-ancestor
5880950|NCT04387760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5880951|NCT04387760|Antiviral Agents|antiviral agents|mesh-ancestor
5880952|NCT04374903|Sirolimus|sirolimus|mesh-list
5880953|NCT04374903|Azithromycin|azithromycin|mesh-list
5880954|NCT04374903|Hydroxychloroquine|hydroxychloroquine|mesh-list
5880955|NCT04374903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5880956|NCT04374903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5880957|NCT04374903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5880958|NCT04374903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5880959|NCT04374903|Antifungal Agents|antifungal agents|mesh-ancestor
5880960|NCT04374903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5880961|NCT04374903|Immunologic Factors|immunologic factors|mesh-ancestor
5880962|NCT04374903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880963|NCT04374903|Antimalarials|antimalarials|mesh-ancestor
5880964|NCT04374903|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5880965|NCT04374903|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5686941|NCT03448978|Fludarabine|fludarabine|mesh-list
5686942|NCT03448978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5686943|NCT03448978|Immunologic Factors|immunologic factors|mesh-ancestor
5686944|NCT03448978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686945|NCT03448978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5880966|NCT04374903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6495923|NCT00625547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6495924|NCT00625547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495925|NCT00625547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880967|NCT04374903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5880968|NCT04374903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5686946|NCT03448978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5686947|NCT03448978|Alkylating Agents|alkylating agents|mesh-ancestor
5686948|NCT03448978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686949|NCT03448978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5686950|NCT03448978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5686951|NCT03448835|Docetaxel|docetaxel|mesh-list
5686952|NCT03448835|Capecitabine|capecitabine|mesh-list
5686953|NCT03448835|Oxaliplatin|oxaliplatin|mesh-list
5686954|NCT03448835|Atezolizumab|atezolizumab|mesh-list
5686955|NCT03448835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5686956|NCT03448835|Tubulin Modulators|tubulin modulators|mesh-ancestor
5686957|NCT03448835|Antimitotic Agents|antimitotic agents|mesh-ancestor
5686958|NCT03448835|Mitosis Modulators|mitosis modulators|mesh-ancestor
5686959|NCT03448835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686960|NCT03448835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5686961|NCT03448835|Antimetabolites|antimetabolites|mesh-ancestor
5697351|NCT03376672|Hormones|hormones|mesh-ancestor
5697352|NCT03376672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5880969|NCT04356534|Antibodies|antibodies|mesh-list
5880970|NCT04356534|Immunologic Factors|immunologic factors|mesh-ancestor
5880971|NCT04356534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880972|NCT04331756|Anesthetics|anesthetics|mesh-list
5880973|NCT04331756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5880974|NCT04331756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5880975|NCT04320342|Beclomethasone|beclomethasone|mesh-list
5880976|NCT04320342|Glycopyrrolate|glycopyrrolate|mesh-list
5880977|NCT04320342|Bromides|bromides|mesh-list
5880978|NCT04320342|Formoterol Fumarate|formoterol fumarate|mesh-list
5880979|NCT04320342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5880980|NCT04320342|Autonomic Agents|autonomic agents|mesh-ancestor
5880981|NCT04320342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5880982|NCT04320342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495926|NCT00625547|Dopamine Agonists|dopamine agonists|mesh-ancestor
6495927|NCT00625560|Lamivudine|lamivudine|mesh-list
6495928|NCT00625560|Entecavir|entecavir|mesh-list
6495929|NCT00625560|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6495930|NCT00625560|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5697353|NCT03376672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5697354|NCT03376672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5697355|NCT03376672|Immunologic Factors|immunologic factors|mesh-ancestor
5697356|NCT03376672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5697357|NCT03376672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5697358|NCT03376672|Growth Substances|growth substances|mesh-ancestor
5697359|NCT03376672|Growth Inhibitors|growth inhibitors|mesh-ancestor
5697360|NCT03376672|Protease Inhibitors|protease inhibitors|mesh-ancestor
5697361|NCT03376672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5697362|NCT03376672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697363|NCT03376594|Loratadine|loratadine|mesh-list
5697364|NCT03376594|Antipruritics|antipruritics|mesh-ancestor
5697365|NCT03376594|Dermatologic Agents|dermatologic agents|mesh-ancestor
5697366|NCT03376594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5697367|NCT03376594|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5697368|NCT03376594|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5697369|NCT03376594|Histamine Antagonists|histamine antagonists|mesh-ancestor
5697370|NCT03376594|Histamine Agents|histamine agents|mesh-ancestor
5697371|NCT03376594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5697372|NCT03376594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697373|NCT03376594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697374|NCT03376555|Nitroglycerin|nitroglycerin|mesh-list
5697375|NCT03376555|Acetylcholine|acetylcholine|mesh-list
5697376|NCT03376555|Vasodilator Agents|vasodilator agents|mesh-ancestor
5697377|NCT03376555|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6495931|NCT00625560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6495932|NCT00625560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495933|NCT00625560|Antiviral Agents|antiviral agents|mesh-ancestor
6495934|NCT00625560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6495935|NCT00625560|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6495936|NCT00625560|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6495937|NCT00625573|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6495938|NCT00625573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6495939|NCT00625677|Vaccines|vaccines|mesh-list
6495940|NCT00625677|Immunologic Factors|immunologic factors|mesh-ancestor
6495941|NCT00625677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697378|NCT03376555|Cholinergic Agents|cholinergic agents|mesh-ancestor
5880983|NCT04320342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5880984|NCT04320342|Respiratory System Agents|respiratory system agents|mesh-ancestor
5880985|NCT04320342|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5880986|NCT04320342|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5880987|NCT04320342|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5880988|NCT04320342|Adrenergic Agents|adrenergic agents|mesh-ancestor
5880989|NCT04320342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5880990|NCT04320342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495942|NCT00625781|Insulin|insulin|mesh-list
6495943|NCT00625781|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6495944|NCT00625781|Insulin Aspart|insulin aspart|mesh-list
6495945|NCT00625781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6495946|NCT00625781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495947|NCT00625794|Nicotine|nicotine|mesh-list
6495948|NCT00625794|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5880991|NCT04320342|Anticonvulsants|anticonvulsants|mesh-ancestor
5880992|NCT04320342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5880993|NCT04320342|Glucocorticoids|glucocorticoids|mesh-ancestor
5880994|NCT04320342|Hormones|hormones|mesh-ancestor
5880995|NCT04320342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5880996|NCT04320342|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5880997|NCT04320342|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5880998|NCT04320342|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5686962|NCT03448783|Apixaban|apixaban|mesh-list
5686963|NCT03448783|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5686964|NCT03448783|Antithrombins|antithrombins|mesh-ancestor
5880999|NCT04320342|Cholinergic Agents|cholinergic agents|mesh-ancestor
5881000|NCT04300244|Nivolumab|nivolumab|mesh-list
5881001|NCT04300244|Ipilimumab|ipilimumab|mesh-list
5881002|NCT04300244|Sargramostim|sargramostim|mesh-list
5881003|NCT04300244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5881004|NCT04300244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5881005|NCT04300244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5881006|NCT04300244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881007|NCT04300244|Immunologic Factors|immunologic factors|mesh-ancestor
5881008|NCT04300244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881009|NCT04298203|Topiramate|topiramate|mesh-list
5881010|NCT04298203|Phentermine|phentermine|mesh-list
5881011|NCT04298203|Anticonvulsants|anticonvulsants|mesh-ancestor
5881012|NCT04298203|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5881013|NCT04298203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881014|NCT04298203|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5881015|NCT04298203|Appetite Depressants|appetite depressants|mesh-ancestor
5881016|NCT04298203|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5881017|NCT04298203|Sympathomimetics|sympathomimetics|mesh-ancestor
5881018|NCT04298203|Autonomic Agents|autonomic agents|mesh-ancestor
5881019|NCT04298203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5881020|NCT04298203|Adrenergic Agents|adrenergic agents|mesh-ancestor
5881021|NCT04298203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5881022|NCT04298203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881023|NCT04214418|Hydroxychloroquine|hydroxychloroquine|mesh-list
5881024|NCT04214418|Atezolizumab|atezolizumab|mesh-list
5881025|NCT04214418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5881026|NCT04214418|Antimalarials|antimalarials|mesh-ancestor
5881027|NCT04214418|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5686965|NCT03448783|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5686966|NCT03448783|Protease Inhibitors|protease inhibitors|mesh-ancestor
5686967|NCT03448783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5686968|NCT03448783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686969|NCT03448783|Anticoagulants|anticoagulants|mesh-ancestor
5686970|NCT03448770|Lactulose|lactulose|mesh-list
5881028|NCT04214418|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5881029|NCT04214418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5881030|NCT04214418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5881031|NCT04214418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881032|NCT04214418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5881033|NCT04204967|Fentanyl|fentanyl|mesh-list
5881034|NCT04204967|Remifentanil|remifentanil|mesh-list
5881035|NCT04204967|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5881036|NCT04204967|Narcotics|narcotics|mesh-ancestor
5881037|NCT04204967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5881038|NCT04204967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881039|NCT04204967|Analgesics|analgesics|mesh-ancestor
5881040|NCT04204967|Sensory System Agents|sensory system agents|mesh-ancestor
6495949|NCT00625794|Autonomic Agents|autonomic agents|mesh-ancestor
6495950|NCT00625794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6495951|NCT00625794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881041|NCT04204967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5881042|NCT04204967|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5881043|NCT04204967|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5881044|NCT04204967|Anesthetics, General|anesthetics, general|mesh-ancestor
5881045|NCT04204967|Anesthetics|anesthetics|mesh-ancestor
5881046|NCT04182672|Triamcinolone|triamcinolone|mesh-list
5881047|NCT04182672|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5881048|NCT04182672|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5881049|NCT04182672|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5881050|NCT04182672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5881051|NCT04182672|Glucocorticoids|glucocorticoids|mesh-ancestor
5881052|NCT04182672|Hormones|hormones|mesh-ancestor
5881053|NCT04182672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5881054|NCT04182672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881055|NCT04182672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5881056|NCT04182672|Immunologic Factors|immunologic factors|mesh-ancestor
5881057|NCT04182672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5881058|NCT04182672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881059|NCT04169373|Upadacitinib|upadacitinib|mesh-list
5881060|NCT04169373|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
5881061|NCT04169373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5881062|NCT04169373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5881063|NCT04169373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881064|NCT04169373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5881065|NCT04085445|Paclitaxel|paclitaxel|mesh-list
5881066|NCT04085445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5881067|NCT04085445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5881068|NCT04085445|Tubulin Modulators|tubulin modulators|mesh-ancestor
5881069|NCT04085445|Antimitotic Agents|antimitotic agents|mesh-ancestor
5881070|NCT04085445|Mitosis Modulators|mitosis modulators|mesh-ancestor
5881071|NCT04085445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881072|NCT04080804|Nivolumab|nivolumab|mesh-list
5686971|NCT03448770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5686972|NCT03448744|Entecavir|entecavir|mesh-list
5686973|NCT03448744|Thymalfasin|thymalfasin|mesh-list
5686974|NCT03448744|Antiviral Agents|antiviral agents|mesh-ancestor
5686975|NCT03448744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5686976|NCT03448744|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5686977|NCT03448744|Immunologic Factors|immunologic factors|mesh-ancestor
5686978|NCT03448744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686979|NCT03448731|Doxycycline|doxycycline|mesh-list
5686980|NCT03448731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5686981|NCT03448731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5686982|NCT03448731|Antimalarials|antimalarials|mesh-ancestor
5686983|NCT03448731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5686984|NCT03448731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5686985|NCT03448705|Vaccines|vaccines|mesh-list
5686986|NCT03448705|Immunologic Factors|immunologic factors|mesh-ancestor
5686987|NCT03448705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686988|NCT03448640|Tropicamide|tropicamide|mesh-list
5881073|NCT04080804|Ipilimumab|ipilimumab|mesh-list
5881074|NCT04080804|Antibodies|antibodies|mesh-list
5881075|NCT04080804|Immunoglobulins|immunoglobulins|mesh-list
5881076|NCT04080804|Immunologic Factors|immunologic factors|mesh-ancestor
5881077|NCT04080804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881078|NCT04080804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5881079|NCT04080804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5881080|NCT04080804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5881081|NCT04080804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686989|NCT03448640|Mydriatics|mydriatics|mesh-ancestor
5686990|NCT03448640|Autonomic Agents|autonomic agents|mesh-ancestor
5881082|NCT04069273|Paclitaxel|paclitaxel|mesh-list
5881083|NCT04069273|Pembrolizumab|pembrolizumab|mesh-list
5881084|NCT04069273|Ramucirumab|ramucirumab|mesh-list
5881085|NCT04069273|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5881086|NCT04069273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5881087|NCT04069273|Tubulin Modulators|tubulin modulators|mesh-ancestor
5881088|NCT04069273|Antimitotic Agents|antimitotic agents|mesh-ancestor
5881089|NCT04069273|Mitosis Modulators|mitosis modulators|mesh-ancestor
5881090|NCT04069273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686991|NCT03448640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5686992|NCT03448640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5686993|NCT03448640|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5686994|NCT03448640|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5686995|NCT03448640|Cholinergic Agents|cholinergic agents|mesh-ancestor
5881091|NCT04069273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5881092|NCT04052568|Psilocybin|psilocybin|mesh-list
5881093|NCT04052568|Hallucinogens|hallucinogens|mesh-ancestor
5881094|NCT04052568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881095|NCT04052568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5881096|NCT03976362|Paclitaxel|paclitaxel|mesh-list
5881097|NCT03976362|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5881098|NCT03976362|Carboplatin|carboplatin|mesh-list
5881099|NCT03976362|Pembrolizumab|pembrolizumab|mesh-list
5881100|NCT03976362|Olaparib|olaparib|mesh-list
5881101|NCT03976362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5686996|NCT03448640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5686997|NCT03448640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5686998|NCT03448588|Selenium|selenium|mesh-list
5686999|NCT03448588|Antioxidants|antioxidants|mesh-ancestor
5687000|NCT03448588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687001|NCT03448588|Protective Agents|protective agents|mesh-ancestor
5687002|NCT03448588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687003|NCT03448588|Trace Elements|trace elements|mesh-ancestor
5687004|NCT03448588|Micronutrients|micronutrients|mesh-ancestor
5687005|NCT03448549|Capecitabine|capecitabine|mesh-list
5687006|NCT03448549|Tegafur|tegafur|mesh-list
5687007|NCT03448549|Oxaliplatin|oxaliplatin|mesh-list
5687008|NCT03448549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5687009|NCT03448549|Antimetabolites|antimetabolites|mesh-ancestor
5687010|NCT03448549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687011|NCT03448549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5687012|NCT03448159|Fluoxetine|fluoxetine|mesh-list
5687013|NCT03448159|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5881102|NCT03976362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5881103|NCT03976362|Tubulin Modulators|tubulin modulators|mesh-ancestor
5881104|NCT03976362|Antimitotic Agents|antimitotic agents|mesh-ancestor
5881105|NCT03976362|Mitosis Modulators|mitosis modulators|mesh-ancestor
5881106|NCT03976362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881107|NCT03976362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5881108|NCT03976362|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5881109|NCT03976362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5881110|NCT03920267|BMS-986165|bms-986165|mesh-list
5881111|NCT03920267|Dermatologic Agents|dermatologic agents|mesh-ancestor
5881112|NCT03920267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5881113|NCT03920267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5881114|NCT03920267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881115|NCT03854032|Nivolumab|nivolumab|mesh-list
5881116|NCT03854032|Linrodostat|linrodostat|mesh-list
5881117|NCT03854032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5881118|NCT03854032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5881119|NCT03854032|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5881120|NCT03854032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881121|NCT03854032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5881122|NCT03818763|Factor VIII|factor viii|mesh-list
5687014|NCT03448159|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5687015|NCT03448159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5687016|NCT03448159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687017|NCT03448159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5687018|NCT03448159|Serotonin Agents|serotonin agents|mesh-ancestor
5687019|NCT03448159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687020|NCT03448159|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5687021|NCT03448159|Antidepressive Agents|antidepressive agents|mesh-ancestor
5687022|NCT03448159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5881123|NCT03818763|Coagulants|coagulants|mesh-ancestor
5881124|NCT03710876|Gemcitabine|gemcitabine|mesh-list
6675456|NCT01575626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881125|NCT03710876|Celecoxib|celecoxib|mesh-list
5881126|NCT03710876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5881127|NCT03710876|Antimetabolites|antimetabolites|mesh-ancestor
5881128|NCT03710876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881129|NCT03710876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5881130|NCT03710876|Antiviral Agents|antiviral agents|mesh-ancestor
5881131|NCT03710876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5881132|NCT03710876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5881133|NCT03710876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5881134|NCT03710876|Immunologic Factors|immunologic factors|mesh-ancestor
5881135|NCT03710876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881136|NCT03710876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5881137|NCT03710876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5881138|NCT03710876|Analgesics|analgesics|mesh-ancestor
5881139|NCT03710876|Sensory System Agents|sensory system agents|mesh-ancestor
5881140|NCT03710876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5881141|NCT03710876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5687023|NCT03448159|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5687024|NCT03448159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5687025|NCT03448159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5687026|NCT03448107|Fluorides|fluorides|mesh-list
5687027|NCT03448107|Fluorides, Topical|fluorides, topical|mesh-list
5687028|NCT03448107|Cariostatic Agents|cariostatic agents|mesh-ancestor
5687029|NCT03448107|Protective Agents|protective agents|mesh-ancestor
5687030|NCT03448107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687031|NCT03448094|Resveratrol|resveratrol|mesh-list
5687032|NCT03448094|Antioxidants|antioxidants|mesh-ancestor
5881142|NCT03710876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5881143|NCT03710876|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5881144|NCT03710876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5881145|NCT03688828|Amoxicillin|amoxicillin|mesh-list
5881146|NCT03688828|Clarithromycin|clarithromycin|mesh-list
5881147|NCT03688828|Potassium Citrate|potassium citrate|mesh-list
5881148|NCT03688828|Esomeprazole|esomeprazole|mesh-list
5881149|NCT03688828|Bismuth|bismuth|mesh-list
5881150|NCT03688828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881151|NCT03688828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5881152|NCT03688828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5881153|NCT03688828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5881154|NCT03688828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5881155|NCT03688828|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5881156|NCT03688828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5881157|NCT03688828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5881158|NCT03688828|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5687033|NCT03448094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687034|NCT03448094|Protective Agents|protective agents|mesh-ancestor
5687035|NCT03448094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687036|NCT03448094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5881159|NCT03688828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5881160|NCT03688828|Antacids|antacids|mesh-ancestor
5881161|NCT03688828|Diuretics|diuretics|mesh-ancestor
5881162|NCT03688828|Natriuretic Agents|natriuretic agents|mesh-ancestor
5881163|NCT03688828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881164|NCT03688828|Expectorants|expectorants|mesh-ancestor
5881165|NCT03688828|Respiratory System Agents|respiratory system agents|mesh-ancestor
5906529|NCT02217345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5906530|NCT02217345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906531|NCT02101944|Dexamethasone|dexamethasone|mesh-list
5906532|NCT02101944|Dexamethasone acetate|dexamethasone acetate|mesh-list
5906533|NCT02101944|Ichthammol|ichthammol|mesh-list
5906534|NCT02101944|BB 1101|bb 1101|mesh-list
5906535|NCT02101944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5906536|NCT02101944|Antiemetics|antiemetics|mesh-ancestor
5906537|NCT02101944|Autonomic Agents|autonomic agents|mesh-ancestor
5906538|NCT02101944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6675457|NCT01575639|Prednisolone|prednisolone|mesh-list
5687037|NCT03448094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5687038|NCT03447925|Salicylic Acid|salicylic acid|mesh-list
5687039|NCT03447925|Salicylates|salicylates|mesh-list
5687040|NCT03447925|Petrolatum|petrolatum|mesh-list
6675458|NCT01575639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6675459|NCT01575639|Glucocorticoids|glucocorticoids|mesh-ancestor
5687041|NCT03447925|Emollients|emollients|mesh-ancestor
6675460|NCT01575639|Hormones|hormones|mesh-ancestor
6675461|NCT01575639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6675462|NCT01575639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687042|NCT03447925|Dermatologic Agents|dermatologic agents|mesh-ancestor
5881166|NCT03643822|Dexamethasone|dexamethasone|mesh-list
5881167|NCT03643822|Dexamethasone acetate|dexamethasone acetate|mesh-list
5881168|NCT03643822|Dexmedetomidine|dexmedetomidine|mesh-list
5687043|NCT03447925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5687044|NCT03447925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5687045|NCT03447925|Analgesics|analgesics|mesh-ancestor
5687046|NCT03447925|Sensory System Agents|sensory system agents|mesh-ancestor
5687047|NCT03447925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5687048|NCT03447925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687049|NCT03447925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5881169|NCT03643822|BB 1101|bb 1101|mesh-list
5881170|NCT03643822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6675463|NCT01575639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6675464|NCT01575639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6675465|NCT01575652|Lisinopril|lisinopril|mesh-list
5881171|NCT03643822|Antiemetics|antiemetics|mesh-ancestor
5881172|NCT03643822|Autonomic Agents|autonomic agents|mesh-ancestor
5881173|NCT03643822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5881174|NCT03643822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881175|NCT03643822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5881176|NCT03643822|Glucocorticoids|glucocorticoids|mesh-ancestor
5881177|NCT03643822|Hormones|hormones|mesh-ancestor
5881178|NCT03643822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5881179|NCT03643822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5881180|NCT03643822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5881181|NCT03643822|Protease Inhibitors|protease inhibitors|mesh-ancestor
5881182|NCT03643822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5881183|NCT03643822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881184|NCT03643822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5881185|NCT03643822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5881186|NCT03643822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5881187|NCT03643822|Analgesics|analgesics|mesh-ancestor
5881188|NCT03643822|Sensory System Agents|sensory system agents|mesh-ancestor
5687050|NCT03447925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5687051|NCT03447925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5687052|NCT03447925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5687053|NCT03447925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881189|NCT03643822|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5881190|NCT03643822|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5881191|NCT03643822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5881192|NCT03643822|Adrenergic Agents|adrenergic agents|mesh-ancestor
5881193|NCT03643822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5881194|NCT03634150|Doxorubicin|doxorubicin|mesh-list
5881195|NCT03634150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5881196|NCT03634150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5881197|NCT03634150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5881198|NCT03634150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5881199|NCT03634150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5881200|NCT03634150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881201|NCT03593759|Prednisone|prednisone|mesh-list
5881202|NCT03593759|Prednisolone|prednisolone|mesh-list
5881203|NCT03593759|Methotrexate|methotrexate|mesh-list
5881204|NCT03593759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5881205|NCT03593759|Glucocorticoids|glucocorticoids|mesh-ancestor
5881206|NCT03593759|Hormones|hormones|mesh-ancestor
5881207|NCT03593759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6675466|NCT01575652|Perindopril|perindopril|mesh-list
6675467|NCT01575652|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6675468|NCT01575652|Enzyme Inhibitors|enzyme inhibitors|mesh-list
6675469|NCT01575652|Protease Inhibitors|protease inhibitors|mesh-ancestor
6675470|NCT01575652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675471|NCT01575652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6675472|NCT01575652|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6675473|NCT01575652|Protective Agents|protective agents|mesh-ancestor
6675474|NCT01575652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675475|NCT01575678|Melatonin|melatonin|mesh-list
6675476|NCT01575678|Antioxidants|antioxidants|mesh-ancestor
5881208|NCT03593759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881209|NCT03593759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5881210|NCT03593759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5881211|NCT03593759|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5881212|NCT03593759|Abortifacient Agents|abortifacient agents|mesh-ancestor
5881213|NCT03593759|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5908659|NCT04302766|Remdesivir|remdesivir|mesh-list
6675616|NCT01576640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5881214|NCT03593759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5881215|NCT03593759|Antimetabolites|antimetabolites|mesh-ancestor
5881216|NCT03593759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881217|NCT03593759|Dermatologic Agents|dermatologic agents|mesh-ancestor
5881218|NCT03593759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5881219|NCT03593759|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5881220|NCT03593759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5881221|NCT03593759|Immunologic Factors|immunologic factors|mesh-ancestor
5881222|NCT03593759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5881223|NCT03593759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5881224|NCT03564821|Ivosidenib|ivosidenib|mesh-list
5881225|NCT03564821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5881226|NCT03564821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5881227|NCT03564821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881228|NCT03350815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5881229|NCT03350815|Immunologic Factors|immunologic factors|mesh-ancestor
5881230|NCT03350815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881231|NCT03329378|Paclitaxel|paclitaxel|mesh-list
5881232|NCT03329378|Docetaxel|docetaxel|mesh-list
5881233|NCT03329378|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5881234|NCT03329378|Cyclophosphamide|cyclophosphamide|mesh-list
5881235|NCT03329378|Carboplatin|carboplatin|mesh-list
5687054|NCT03447925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5687055|NCT03447925|Antifungal Agents|antifungal agents|mesh-ancestor
5687056|NCT03447925|Keratolytic Agents|keratolytic agents|mesh-ancestor
5687057|NCT03447873|Lamivudine|lamivudine|mesh-list
5687058|NCT03447873|Cobicistat|cobicistat|mesh-list
5687059|NCT03447873|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5687060|NCT03447873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5687061|NCT03447873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5687062|NCT03447873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687063|NCT03447873|Antiviral Agents|antiviral agents|mesh-ancestor
5687064|NCT03447873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5687065|NCT03447873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5687066|NCT03447873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5687067|NCT03447873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5687068|NCT03447873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5687071|NCT03447782|Naltrexone|naltrexone|mesh-list
5687072|NCT03447782|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5687073|NCT03447782|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5687074|NCT03447782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687075|NCT03447782|Sensory System Agents|sensory system agents|mesh-ancestor
5687076|NCT03447782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5687077|NCT03447691|Remifentanil|remifentanil|mesh-list
5687078|NCT03447691|Anesthetics|anesthetics|mesh-list
5687079|NCT03447691|Propofol|propofol|mesh-list
5687080|NCT03447691|Desflurane|desflurane|mesh-list
5687081|NCT03447691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5687082|NCT03447691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687083|NCT03447691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5687084|NCT03447691|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5687085|NCT03447691|Anesthetics, General|anesthetics, general|mesh-ancestor
5687086|NCT03447691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5687087|NCT03447691|Narcotics|narcotics|mesh-ancestor
5687088|NCT03447691|Analgesics|analgesics|mesh-ancestor
5687089|NCT03447691|Sensory System Agents|sensory system agents|mesh-ancestor
5687090|NCT03447691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5687091|NCT03447691|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5687092|NCT03447678|Pembrolizumab|pembrolizumab|mesh-list
5881236|NCT03329378|Doxorubicin|doxorubicin|mesh-list
5881237|NCT03329378|Trastuzumab|trastuzumab|mesh-list
5881238|NCT03329378|Pertuzumab|pertuzumab|mesh-list
5881239|NCT03329378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5881240|NCT03329378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5881241|NCT03329378|Tubulin Modulators|tubulin modulators|mesh-ancestor
5881242|NCT03329378|Antimitotic Agents|antimitotic agents|mesh-ancestor
5881243|NCT03329378|Mitosis Modulators|mitosis modulators|mesh-ancestor
5881244|NCT03329378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881245|NCT03329378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5881246|NCT03329378|Immunologic Factors|immunologic factors|mesh-ancestor
5881247|NCT03329378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881248|NCT03329378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5881249|NCT03329378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5881250|NCT03329378|Alkylating Agents|alkylating agents|mesh-ancestor
5687093|NCT03447678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5881251|NCT03329378|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5881252|NCT03329378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5881253|NCT03329378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5881254|NCT03329378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5881255|NCT03329378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5881256|NCT03329378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5881257|NCT03270059|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
5881258|NCT03270059|Hematinics|hematinics|mesh-ancestor
5881259|NCT03270059|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5881260|NCT03270059|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5881261|NCT03268083|Vaccines|vaccines|mesh-list
5881262|NCT03268083|Immunologic Factors|immunologic factors|mesh-ancestor
5881263|NCT03268083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881264|NCT03206047|Poly I-C|poly i-c|mesh-list
5881265|NCT03206047|Atezolizumab|atezolizumab|mesh-list
5881266|NCT03206047|Guadecitabine|guadecitabine|mesh-list
5881267|NCT03206047|Azacitidine|azacitidine|mesh-list
5881268|NCT03206047|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
5881269|NCT03206047|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5881270|NCT03206047|Poly ICLC|poly iclc|mesh-list
5881271|NCT03206047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5881272|NCT03206047|Immunologic Factors|immunologic factors|mesh-ancestor
5881273|NCT03206047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881274|NCT03206047|Interferon Inducers|interferon inducers|mesh-ancestor
5881275|NCT03206047|Laxatives|laxatives|mesh-ancestor
6495952|NCT00625794|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6495953|NCT00625794|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6495954|NCT00625794|Cholinergic Agents|cholinergic agents|mesh-ancestor
6495955|NCT00625794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6495956|NCT00625794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495957|NCT00625859|Bupropion|bupropion|mesh-list
6495958|NCT00625859|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5687094|NCT03447678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5687095|NCT03447470|Nivolumab|nivolumab|mesh-list
5687096|NCT03447470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5687097|NCT03447470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5687098|NCT03447470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5687099|NCT03447470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495959|NCT00625859|Antidepressive Agents|antidepressive agents|mesh-ancestor
6495960|NCT00625859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6495961|NCT00625859|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6495962|NCT00625859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6495963|NCT00625859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6495964|NCT00625859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495965|NCT00625859|Dopamine Agents|dopamine agents|mesh-ancestor
6495966|NCT00625859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6495967|NCT00625859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495968|NCT00625859|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6495969|NCT00625859|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6495970|NCT00625859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6495971|NCT00625898|Cyclophosphamide|cyclophosphamide|mesh-list
6495972|NCT00625898|Bevacizumab|bevacizumab|mesh-list
6495973|NCT00625898|Carboplatin|carboplatin|mesh-list
6495974|NCT00625898|Docetaxel|docetaxel|mesh-list
6495975|NCT00625898|Fluorouracil|fluorouracil|mesh-list
6495976|NCT00625898|Trastuzumab|trastuzumab|mesh-list
6495977|NCT00625898|Epirubicin|epirubicin|mesh-list
6495978|NCT00625898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6495979|NCT00625898|Immunologic Factors|immunologic factors|mesh-ancestor
6495980|NCT00625898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6495981|NCT00625898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6495982|NCT00625898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6495983|NCT00625898|Alkylating Agents|alkylating agents|mesh-ancestor
6495984|NCT00625898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495985|NCT00625898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5687100|NCT03447184|Androgens|androgens|mesh-list
5687101|NCT03447184|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5687102|NCT03447184|Hormones|hormones|mesh-ancestor
5687103|NCT03447184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5687104|NCT03447184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687105|NCT03447184|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5687106|NCT03447184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5687107|NCT03447184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687108|NCT03447184|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5687109|NCT03447184|Hormone Antagonists|hormone antagonists|mesh-ancestor
5881276|NCT03206047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5881277|NCT03206047|Antiviral Agents|antiviral agents|mesh-ancestor
5881278|NCT03206047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5687110|NCT03447132|Fulvestrant|fulvestrant|mesh-list
5687111|NCT03447132|Goserelin|goserelin|mesh-list
5687112|NCT03447132|Palbociclib|palbociclib|mesh-list
5687113|NCT03447132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5687114|NCT03447132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5687115|NCT03447132|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5687116|NCT03447132|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5687117|NCT03447132|Hormone Antagonists|hormone antagonists|mesh-ancestor
5687118|NCT03447132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5687119|NCT03447132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687120|NCT03447132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5881279|NCT03206047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5881280|NCT03206047|Antimetabolites|antimetabolites|mesh-ancestor
5881281|NCT03206047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881282|NCT03206047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5881283|NCT03170817|Regadenoson|regadenoson|mesh-list
5881284|NCT03170817|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
5881285|NCT03170817|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5881286|NCT03170817|Purinergic Agonists|purinergic agonists|mesh-ancestor
5687121|NCT03447132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5687122|NCT03447132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687123|NCT03447093|Methimazole|methimazole|mesh-list
5687124|NCT03447093|Propylthiouracil|propylthiouracil|mesh-list
5687125|NCT03447093|Antithyroid Agents|antithyroid agents|mesh-ancestor
5687126|NCT03447093|Hormone Antagonists|hormone antagonists|mesh-ancestor
5687127|NCT03447093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5687128|NCT03447093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687129|NCT03447093|Antimetabolites|antimetabolites|mesh-ancestor
5687130|NCT03447093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687131|NCT03446976|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5687132|NCT03446976|Immunologic Factors|immunologic factors|mesh-ancestor
5687133|NCT03446976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687134|NCT03446937|Dexamethasone|dexamethasone|mesh-list
5687135|NCT03446937|Betamethasone|betamethasone|mesh-list
5687136|NCT03446937|Betamethasone Valerate|betamethasone valerate|mesh-list
5881287|NCT03170817|Purinergic Agents|purinergic agents|mesh-ancestor
5881288|NCT03170817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5881289|NCT03170817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881290|NCT03170817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881291|NCT03148275|Trametinib|trametinib|mesh-list
5881292|NCT03148275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5881293|NCT03148275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5881294|NCT03148275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5881295|NCT03148275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881296|NCT02979860|Oxymetazoline|oxymetazoline|mesh-list
5881297|NCT02979860|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5881298|NCT02979860|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5881299|NCT02979860|Adrenergic Agents|adrenergic agents|mesh-ancestor
5881300|NCT02979860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5881301|NCT02979860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881302|NCT02979860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881303|NCT02979860|Sympathomimetics|sympathomimetics|mesh-ancestor
5881304|NCT02979860|Autonomic Agents|autonomic agents|mesh-ancestor
5881305|NCT02979860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5881306|NCT02979860|Nasal Decongestants|nasal decongestants|mesh-ancestor
5881307|NCT02979860|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5881308|NCT02979860|Respiratory System Agents|respiratory system agents|mesh-ancestor
5881309|NCT02960659|Metformin|metformin|mesh-list
5881310|NCT02960659|Liraglutide|liraglutide|mesh-list
5881311|NCT02960659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5881312|NCT02960659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881313|NCT02960659|Incretins|incretins|mesh-ancestor
5881314|NCT02960659|Hormones|hormones|mesh-ancestor
5881315|NCT02960659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5881316|NCT02926651|Tranexamic Acid|tranexamic acid|mesh-list
5881317|NCT02926651|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5881318|NCT02926651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5881319|NCT02926651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881320|NCT02926651|Hemostatics|hemostatics|mesh-ancestor
5881321|NCT02926651|Coagulants|coagulants|mesh-ancestor
5881322|NCT02896335|Palbociclib|palbociclib|mesh-list
5881323|NCT02896335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5881324|NCT02896335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5881325|NCT02896335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5881326|NCT02896335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881327|NCT02843074|Dexamethasone|dexamethasone|mesh-list
5881328|NCT02843074|Lenalidomide|lenalidomide|mesh-list
5881329|NCT02843074|Elotuzumab|elotuzumab|mesh-list
5881330|NCT02843074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5881331|NCT02843074|Antiemetics|antiemetics|mesh-ancestor
5881332|NCT02843074|Autonomic Agents|autonomic agents|mesh-ancestor
5881333|NCT02843074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5881334|NCT02843074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881335|NCT02843074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5881336|NCT02843074|Glucocorticoids|glucocorticoids|mesh-ancestor
5881337|NCT02843074|Hormones|hormones|mesh-ancestor
5881338|NCT02843074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5881339|NCT02843074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5881340|NCT02843074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5881341|NCT02843074|Immunologic Factors|immunologic factors|mesh-ancestor
5881342|NCT02843074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5881343|NCT02843074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5881344|NCT02843074|Growth Substances|growth substances|mesh-ancestor
5881345|NCT02843074|Growth Inhibitors|growth inhibitors|mesh-ancestor
5881346|NCT02817633|Carboplatin|carboplatin|mesh-list
5881347|NCT02817633|Docetaxel|docetaxel|mesh-list
5881348|NCT02817633|Nivolumab|nivolumab|mesh-list
5881349|NCT02817633|Pemetrexed|pemetrexed|mesh-list
5881350|NCT02817633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5881351|NCT02817633|Tubulin Modulators|tubulin modulators|mesh-ancestor
5881352|NCT02817633|Antimitotic Agents|antimitotic agents|mesh-ancestor
5881353|NCT02817633|Mitosis Modulators|mitosis modulators|mesh-ancestor
5881354|NCT02817633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881355|NCT02817633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5881356|NCT02817633|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5881357|NCT02817633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5881358|NCT02817633|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5881359|NCT02817633|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5881360|NCT02805504|Bupivacaine|bupivacaine|mesh-list
5881361|NCT02805504|Anesthetics, Local|anesthetics, local|mesh-ancestor
5687137|NCT03446937|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5687138|NCT03446937|Betamethasone benzoate|betamethasone benzoate|mesh-list
5687139|NCT03446937|Dexamethasone acetate|dexamethasone acetate|mesh-list
5687140|NCT03446937|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
5687141|NCT03446937|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
5687142|NCT03446937|BB 1101|bb 1101|mesh-list
5687143|NCT03446937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5687144|NCT03446937|Antiemetics|antiemetics|mesh-ancestor
5687145|NCT03446937|Autonomic Agents|autonomic agents|mesh-ancestor
5687146|NCT03446937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5687147|NCT03446937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881362|NCT02805504|Anesthetics|anesthetics|mesh-ancestor
5881363|NCT02805504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5881364|NCT02805504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881365|NCT02805504|Sensory System Agents|sensory system agents|mesh-ancestor
5881366|NCT02805504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5881367|NCT02790723|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5881368|NCT02790723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5881369|NCT02715609|Copper|copper|mesh-list
5881370|NCT02715609|Temozolomide|temozolomide|mesh-list
5881371|NCT02715609|Disulfiram|disulfiram|mesh-list
5881372|NCT02715609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5881373|NCT02715609|Alkylating Agents|alkylating agents|mesh-ancestor
5881374|NCT02715609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687148|NCT03446937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5687149|NCT03446937|Glucocorticoids|glucocorticoids|mesh-ancestor
5687150|NCT03446937|Hormones|hormones|mesh-ancestor
5687151|NCT03446937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5687152|NCT03446937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5687153|NCT03446937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5687154|NCT03446937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5687155|NCT03446937|Respiratory System Agents|respiratory system agents|mesh-ancestor
5687156|NCT03446937|Protease Inhibitors|protease inhibitors|mesh-ancestor
5687157|NCT03446937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5687158|NCT03446937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687159|NCT03446911|Pembrolizumab|pembrolizumab|mesh-list
5881375|NCT02715609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5687160|NCT03446911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5687161|NCT03446911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5687162|NCT03446872|Leucovorin|leucovorin|mesh-list
5687163|NCT03446872|Fluorouracil|fluorouracil|mesh-list
5687164|NCT03446872|Antimetabolites|antimetabolites|mesh-ancestor
5687165|NCT03446872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687166|NCT03446872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5687167|NCT03446872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5687168|NCT03446872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5687169|NCT03446872|Immunologic Factors|immunologic factors|mesh-ancestor
5687170|NCT03446872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687171|NCT03446872|Antidotes|antidotes|mesh-ancestor
5687172|NCT03446872|Protective Agents|protective agents|mesh-ancestor
5687173|NCT03446872|Vitamin B Complex|vitamin b complex|mesh-ancestor
5687174|NCT03446872|Vitamins|vitamins|mesh-ancestor
5687175|NCT03446872|Micronutrients|micronutrients|mesh-ancestor
5687176|NCT03446807|Droxidopa|droxidopa|mesh-list
5687177|NCT03446807|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5687178|NCT03446807|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5881376|NCT02715609|Trace Elements|trace elements|mesh-ancestor
5881377|NCT02715609|Micronutrients|micronutrients|mesh-ancestor
5881378|NCT02715609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881379|NCT02715609|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5881380|NCT02715609|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
5881381|NCT02715609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5881382|NCT02605148|Vitamin D|vitamin d|mesh-list
5881383|NCT02605148|Vitamins|vitamins|mesh-ancestor
5687179|NCT03446638|Cytarabine|cytarabine|mesh-list
5687180|NCT03446638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5687181|NCT03446638|Antimetabolites|antimetabolites|mesh-ancestor
5687182|NCT03446638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687183|NCT03446638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5687184|NCT03446638|Antiviral Agents|antiviral agents|mesh-ancestor
5687185|NCT03446638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5687186|NCT03446638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5687187|NCT03446638|Immunologic Factors|immunologic factors|mesh-ancestor
5687188|NCT03446638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687189|NCT03446625|Resveratrol|resveratrol|mesh-list
5881384|NCT02605148|Micronutrients|micronutrients|mesh-ancestor
5881385|NCT02605148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881386|NCT02605148|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5881387|NCT02505750|Capecitabine|capecitabine|mesh-list
5881388|NCT02505750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5881389|NCT02505750|Antimetabolites|antimetabolites|mesh-ancestor
5881390|NCT02505750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881391|NCT02505750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5881392|NCT02419378|Alemtuzumab|alemtuzumab|mesh-list
5881393|NCT02419378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5881394|NCT02419378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5881395|NCT02395640|Capecitabine|capecitabine|mesh-list
5687190|NCT03446625|Antioxidants|antioxidants|mesh-ancestor
5687191|NCT03446625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687192|NCT03446625|Protective Agents|protective agents|mesh-ancestor
5687193|NCT03446625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687194|NCT03446625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5687195|NCT03446625|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5687196|NCT03446599|Hydroxocobalamin|hydroxocobalamin|mesh-list
5687197|NCT03446599|Vitamin B 12|vitamin b 12|mesh-list
5687198|NCT03446599|Methylene Blue|methylene blue|mesh-list
5687199|NCT03446599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5687200|NCT03446599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687201|NCT03446599|Hematinics|hematinics|mesh-ancestor
5881396|NCT02395640|Oxaliplatin|oxaliplatin|mesh-list
5881397|NCT02395640|Epirubicin|epirubicin|mesh-list
5881398|NCT02395640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5881399|NCT02395640|Antimetabolites|antimetabolites|mesh-ancestor
5881400|NCT02395640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881401|NCT02395640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5881402|NCT02395640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5881403|NCT02395640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5881404|NCT02395640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5881405|NCT02395640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5881406|NCT02381535|Cisplatin|cisplatin|mesh-list
5881407|NCT02381535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5881408|NCT05097079|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
5881409|NCT05097079|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5881410|NCT05097079|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5881411|NCT05097079|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5881412|NCT05097079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5881413|NCT05097079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881414|NCT05097079|Cholinergic Agents|cholinergic agents|mesh-ancestor
5881415|NCT05097079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5881416|NCT05097079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881417|NCT05097079|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5881418|NCT05097079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5881419|NCT05096715|Bevacizumab|bevacizumab|mesh-list
5881420|NCT05096715|Atezolizumab|atezolizumab|mesh-list
5881421|NCT05096715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5881422|NCT05096715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5881423|NCT05096715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5881424|NCT05096715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5881425|NCT05096715|Growth Substances|growth substances|mesh-ancestor
5881426|NCT05096715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881427|NCT05096715|Growth Inhibitors|growth inhibitors|mesh-ancestor
5881428|NCT05096702|Primaquine|primaquine|mesh-list
5881429|NCT05096702|Tafenoquine|tafenoquine|mesh-list
5881430|NCT05096702|Antimalarials|antimalarials|mesh-ancestor
5881431|NCT05096702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5881432|NCT05096702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5881433|NCT05096702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5881434|NCT05096676|Oxytocin|oxytocin|mesh-list
5881435|NCT05096676|Oxytocics|oxytocics|mesh-ancestor
5881436|NCT05096676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5881437|NCT05096676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881438|NCT05096663|Vitamins|vitamins|mesh-list
5881439|NCT05096663|Folic Acid|folic acid|mesh-list
5881440|NCT05096663|Hydroxocobalamin|hydroxocobalamin|mesh-list
5881441|NCT05096663|Vitamin B 12|vitamin b 12|mesh-list
5881442|NCT05096663|Vitamin B Complex|vitamin b complex|mesh-list
5881443|NCT05096663|Gemcitabine|gemcitabine|mesh-list
5881444|NCT05096663|Dexamethasone|dexamethasone|mesh-list
5881445|NCT05096663|Dexamethasone acetate|dexamethasone acetate|mesh-list
5881446|NCT05096663|Docetaxel|docetaxel|mesh-list
5881447|NCT05096663|Pembrolizumab|pembrolizumab|mesh-list
5881448|NCT05096663|Pemetrexed|pemetrexed|mesh-list
5881449|NCT05096663|Ramucirumab|ramucirumab|mesh-list
5881450|NCT05096663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5881451|NCT05096663|Antibodies|antibodies|mesh-list
5881452|NCT05096663|Immunoglobulins|immunoglobulins|mesh-list
5881453|NCT05096663|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5881454|NCT05096663|BB 1101|bb 1101|mesh-list
5881455|NCT05096663|Micronutrients|micronutrients|mesh-ancestor
5881456|NCT05096663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881457|NCT05096663|Immunologic Factors|immunologic factors|mesh-ancestor
5881458|NCT05096663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5687202|NCT03446599|Vitamin B Complex|vitamin b complex|mesh-ancestor
5687203|NCT03446599|Vitamins|vitamins|mesh-ancestor
5687204|NCT03446599|Micronutrients|micronutrients|mesh-ancestor
5687205|NCT03446599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687206|NCT03446547|Durvalumab|durvalumab|mesh-list
5687207|NCT03446547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5687208|NCT03446547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5687209|NCT03446534|Amoxicillin|amoxicillin|mesh-list
5687210|NCT03446534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5687211|NCT03446534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5687212|NCT03446495|Trabectedin|trabectedin|mesh-list
5687213|NCT03446495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5687214|NCT03446495|Alkylating Agents|alkylating agents|mesh-ancestor
5687215|NCT03446495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687216|NCT03446495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5687217|NCT03446443|Metronidazole|metronidazole|mesh-list
5687218|NCT03446443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5687219|NCT03446443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5687220|NCT03446443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5687221|NCT03446443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5687222|NCT03446001|Methylene Blue|methylene blue|mesh-list
5687223|NCT03446001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5687224|NCT03446001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687225|NCT03445910|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5687226|NCT03445910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5881459|NCT05096663|Antiemetics|antiemetics|mesh-ancestor
5881460|NCT05096663|Autonomic Agents|autonomic agents|mesh-ancestor
5881461|NCT05096663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5881462|NCT05096663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5881463|NCT05096663|Glucocorticoids|glucocorticoids|mesh-ancestor
5881464|NCT05096663|Hormones|hormones|mesh-ancestor
5906539|NCT02101944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881465|NCT05096663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5881466|NCT05096663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5881467|NCT05096663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5881468|NCT05096663|Protease Inhibitors|protease inhibitors|mesh-ancestor
5881469|NCT05096663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5881470|NCT05096663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881471|NCT05096663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5881472|NCT05096663|Antimetabolites|antimetabolites|mesh-ancestor
5881473|NCT05096663|Antiviral Agents|antiviral agents|mesh-ancestor
5881474|NCT05096663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5881475|NCT05096663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5881476|NCT05096663|Tubulin Modulators|tubulin modulators|mesh-ancestor
5881477|NCT05096663|Antimitotic Agents|antimitotic agents|mesh-ancestor
5881478|NCT05096663|Mitosis Modulators|mitosis modulators|mesh-ancestor
5881479|NCT05096663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5881480|NCT05096663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5881481|NCT05096663|Hematinics|hematinics|mesh-ancestor
5906540|NCT02101944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5906541|NCT02101944|Glucocorticoids|glucocorticoids|mesh-ancestor
5906542|NCT02101944|Hormones|hormones|mesh-ancestor
5906543|NCT02101944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5906544|NCT02101944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5906545|NCT02101944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5906546|NCT02101944|Protease Inhibitors|protease inhibitors|mesh-ancestor
5906547|NCT02101944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5906548|NCT02101944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687227|NCT03445910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687228|NCT03445897|Miltefosine|miltefosine|mesh-list
5687229|NCT03445897|Pentamidine|pentamidine|mesh-list
5687230|NCT03445897|Antifungal Agents|antifungal agents|mesh-ancestor
5687231|NCT03445897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5687232|NCT03445897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5687233|NCT03445897|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5687234|NCT03445897|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5687235|NCT03445897|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5687236|NCT03445845|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
5687237|NCT03445845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5687238|NCT03445780|Ethyl Chloride|ethyl chloride|mesh-list
5687239|NCT03445780|Anesthetics, Local|anesthetics, local|mesh-ancestor
5687240|NCT03445780|Anesthetics|anesthetics|mesh-ancestor
5687241|NCT03445780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5687242|NCT03445780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687243|NCT03445780|Sensory System Agents|sensory system agents|mesh-ancestor
5687244|NCT03445780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5687245|NCT03445702|Metformin|metformin|mesh-list
5687246|NCT03445702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5687247|NCT03445702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687248|NCT03445624|Infliximab|infliximab|mesh-list
5687249|NCT03445624|Dermatologic Agents|dermatologic agents|mesh-ancestor
5687250|NCT03445624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5687251|NCT03445624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5906549|NCT02101944|Dermatologic Agents|dermatologic agents|mesh-ancestor
5906550|NCT01996605|Oxytocin|oxytocin|mesh-list
5906551|NCT01996605|Oxytocics|oxytocics|mesh-ancestor
5906552|NCT01996605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5906553|NCT01996605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906554|NCT01729455|Belimumab|belimumab|mesh-list
5906555|NCT01729455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5906556|NCT01729455|Immunologic Factors|immunologic factors|mesh-ancestor
6675477|NCT01575678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675478|NCT01575678|Protective Agents|protective agents|mesh-ancestor
5906557|NCT01729455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906558|NCT01669915|Vitamin D|vitamin d|mesh-list
5906559|NCT01669915|Ergocalciferols|ergocalciferols|mesh-list
5906560|NCT01669915|Cholecalciferol|cholecalciferol|mesh-list
5906561|NCT01669915|Vitamins|vitamins|mesh-list
5906562|NCT01669915|Micronutrients|micronutrients|mesh-ancestor
5906563|NCT01669915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906564|NCT01669915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5906565|NCT01669915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5906566|NCT01529593|Metformin|metformin|mesh-list
5906567|NCT01529593|Sirolimus|sirolimus|mesh-list
5906568|NCT01529593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5906569|NCT01529593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687252|NCT03445611|Lidocaine|lidocaine|mesh-list
5687253|NCT03445611|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5881482|NCT05096520|Lidocaine|lidocaine|mesh-list
5881483|NCT05096520|Anesthetics, Local|anesthetics, local|mesh-ancestor
5881484|NCT05096520|Anesthetics|anesthetics|mesh-ancestor
5881485|NCT05096520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5881486|NCT05096520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881487|NCT05096520|Sensory System Agents|sensory system agents|mesh-ancestor
5881488|NCT05096520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5881489|NCT05096520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5881490|NCT05096520|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5881491|NCT05096520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5881492|NCT05096520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5881493|NCT05096520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881494|NCT05096390|Pembrolizumab|pembrolizumab|mesh-list
5881495|NCT05096390|Axitinib|axitinib|mesh-list
5881496|NCT05096390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5881497|NCT05096390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5881498|NCT05096390|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5881499|NCT05096390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5881500|NCT05096390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881501|NCT05096312|Zinc|zinc|mesh-list
5687254|NCT03445611|Anesthetics, Local|anesthetics, local|mesh-ancestor
5687255|NCT03445611|Anesthetics|anesthetics|mesh-ancestor
5687256|NCT03445611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5687257|NCT03445611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687258|NCT03445611|Sensory System Agents|sensory system agents|mesh-ancestor
5687259|NCT03445611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5687260|NCT03445611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5687261|NCT03445611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5687262|NCT03445611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5687263|NCT03445611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5687264|NCT03445611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687265|NCT03445533|Ipilimumab|ipilimumab|mesh-list
5687266|NCT03445533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5881502|NCT05096312|Adapalene|adapalene|mesh-list
5881503|NCT05096312|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
5881504|NCT05096312|Benzoyl Peroxide|benzoyl peroxide|mesh-list
5881505|NCT05096312|Trace Elements|trace elements|mesh-ancestor
5881506|NCT05096312|Micronutrients|micronutrients|mesh-ancestor
5881507|NCT05096312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881508|NCT05096312|Dermatologic Agents|dermatologic agents|mesh-ancestor
5881509|NCT05096312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5881510|NCT05096312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5881511|NCT05096312|Analgesics|analgesics|mesh-ancestor
5881512|NCT05096312|Sensory System Agents|sensory system agents|mesh-ancestor
5881513|NCT05096312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5881514|NCT05096312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5881515|NCT05096312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5881516|NCT05096195|Calcium, Dietary|calcium, dietary|mesh-list
5881517|NCT05096195|Vitamin D|vitamin d|mesh-list
5881518|NCT05096195|Denosumab|denosumab|mesh-list
5881519|NCT05096195|Calcium|calcium|mesh-list
5881520|NCT05096195|Vitamins|vitamins|mesh-ancestor
5881521|NCT05096195|Micronutrients|micronutrients|mesh-ancestor
5881522|NCT05096195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881523|NCT05096195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5881524|NCT05096195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5881525|NCT05095714|Liver Extracts|liver extracts|mesh-list
5881526|NCT05095714|Hematinics|hematinics|mesh-ancestor
5881527|NCT05095636|Apatinib|apatinib|mesh-list
5881528|NCT05095636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5881529|NCT05095636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5881530|NCT05095636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5881531|NCT05095636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881532|NCT05095571|Niacinamide|niacinamide|mesh-list
5881533|NCT05095571|Niacin|niacin|mesh-list
5881534|NCT05095571|Nicotinic Acids|nicotinic acids|mesh-list
5881535|NCT05095571|Vitamin B Complex|vitamin b complex|mesh-ancestor
5881536|NCT05095571|Vitamins|vitamins|mesh-ancestor
5881537|NCT05095571|Micronutrients|micronutrients|mesh-ancestor
5881538|NCT05095571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881539|NCT05095571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5881540|NCT05095571|Antimetabolites|antimetabolites|mesh-ancestor
5881541|NCT05095571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881542|NCT05095571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5881543|NCT05095571|Vasodilator Agents|vasodilator agents|mesh-ancestor
6675617|NCT01576640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5881544|NCT05095480|Red yeast rice|red yeast rice|mesh-list
5881545|NCT05095480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5881546|NCT05095480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5881547|NCT05095480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5881548|NCT05095480|Antimetabolites|antimetabolites|mesh-ancestor
5881549|NCT05095480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881550|NCT05095480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5881551|NCT05095480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5881552|NCT05095467|Paclitaxel|paclitaxel|mesh-list
5881553|NCT05095467|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5881554|NCT05095467|Tegafur|tegafur|mesh-list
5881555|NCT05095467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5881556|NCT05095467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5687267|NCT03445533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5687268|NCT03445533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5687269|NCT03445533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697379|NCT03376555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5697380|NCT03376555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697381|NCT03376555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698090|NCT03371498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5698091|NCT03371498|Antiemetics|antiemetics|mesh-ancestor
5698092|NCT03371498|Autonomic Agents|autonomic agents|mesh-ancestor
5881557|NCT05095467|Tubulin Modulators|tubulin modulators|mesh-ancestor
5881558|NCT05095467|Antimitotic Agents|antimitotic agents|mesh-ancestor
5881559|NCT05095467|Mitosis Modulators|mitosis modulators|mesh-ancestor
5881560|NCT05095467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881561|NCT05095467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5881562|NCT05095467|Antimetabolites|antimetabolites|mesh-ancestor
5881563|NCT05095259|Insulin|insulin|mesh-list
5881564|NCT05095259|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5881565|NCT05095259|Epinephrine|epinephrine|mesh-list
5881566|NCT05095259|Glucagon|glucagon|mesh-list
5881567|NCT05095259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5881568|NCT05095259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881569|NCT05095259|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5881570|NCT05095259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5881571|NCT05095259|Adrenergic Agents|adrenergic agents|mesh-ancestor
5881572|NCT05095259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5881573|NCT05095259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881574|NCT05095259|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5881575|NCT05095259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5881576|NCT05095259|Autonomic Agents|autonomic agents|mesh-ancestor
5881577|NCT05095259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5881578|NCT05095259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5698093|NCT03371498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5698094|NCT03371498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698095|NCT03371498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5698096|NCT03371498|Glucocorticoids|glucocorticoids|mesh-ancestor
5698097|NCT03371498|Hormones|hormones|mesh-ancestor
5698098|NCT03371498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5698099|NCT03371498|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5698100|NCT03371498|Protective Agents|protective agents|mesh-ancestor
5698101|NCT03371498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5698102|NCT03371498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5698103|NCT03371342|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5881579|NCT05095259|Respiratory System Agents|respiratory system agents|mesh-ancestor
5881580|NCT05095259|Mydriatics|mydriatics|mesh-ancestor
5881581|NCT05095259|Sympathomimetics|sympathomimetics|mesh-ancestor
5881582|NCT05095259|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5881583|NCT05095259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5881584|NCT05095259|Hormones|hormones|mesh-ancestor
5881585|NCT05095259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5881586|NCT05095207|Bicalutamide|bicalutamide|mesh-list
5881587|NCT05095207|Androgen Antagonists|androgen antagonists|mesh-ancestor
5881588|NCT05095207|Hormone Antagonists|hormone antagonists|mesh-ancestor
5881589|NCT05095207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5881590|NCT05095207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881591|NCT05095207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5881592|NCT05095116|Fluticasone|fluticasone|mesh-list
5881593|NCT05095116|Xhance|xhance|mesh-list
5881594|NCT05095116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5881595|NCT05095116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5881596|NCT05095116|Autonomic Agents|autonomic agents|mesh-ancestor
5908660|NCT04302766|Antimetabolites|antimetabolites|mesh-ancestor
5881597|NCT05095116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5881598|NCT05095116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881599|NCT05095116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5881600|NCT05095116|Respiratory System Agents|respiratory system agents|mesh-ancestor
5881601|NCT05095116|Dermatologic Agents|dermatologic agents|mesh-ancestor
5881602|NCT05095116|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5881603|NCT05095077|Tadalafil|tadalafil|mesh-list
5881604|NCT05095077|Vasodilator Agents|vasodilator agents|mesh-ancestor
5881605|NCT05095077|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5881606|NCT05095077|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5881607|NCT05095077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5881608|NCT05095077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881609|NCT05095077|Urological Agents|urological agents|mesh-ancestor
5881610|NCT05095025|Bupivacaine|bupivacaine|mesh-list
5881611|NCT05095025|Anesthetics, Local|anesthetics, local|mesh-ancestor
5881612|NCT05095025|Anesthetics|anesthetics|mesh-ancestor
5881613|NCT05095025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5881614|NCT05095025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881615|NCT05095025|Sensory System Agents|sensory system agents|mesh-ancestor
5881616|NCT05095025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5881617|NCT05091619|Vaccines|vaccines|mesh-list
5881618|NCT05091619|Immunologic Factors|immunologic factors|mesh-ancestor
5881619|NCT05091619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881620|NCT05086770|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
5881621|NCT05086770|Hemostatics|hemostatics|mesh-ancestor
5881622|NCT05086770|Coagulants|coagulants|mesh-ancestor
5881623|NCT05084027|Fludarabine|fludarabine|mesh-list
5881624|NCT05084027|Melphalan|melphalan|mesh-list
5881625|NCT05084027|Venetoclax|venetoclax|mesh-list
5881626|NCT05084027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5881627|NCT05084027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6495986|NCT00625898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6495987|NCT00625898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5881628|NCT05084027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5881629|NCT05084027|Immunologic Factors|immunologic factors|mesh-ancestor
5881630|NCT05084027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881631|NCT05084027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5881632|NCT05084027|Alkylating Agents|alkylating agents|mesh-ancestor
5881633|NCT05084027|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5881634|NCT05083312|Fluticasone|fluticasone|mesh-list
5881635|NCT05083312|Xhance|xhance|mesh-list
5881636|NCT05083312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5881637|NCT05083312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5881638|NCT05083312|Autonomic Agents|autonomic agents|mesh-ancestor
5881639|NCT05083312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5881640|NCT05083312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881641|NCT05083312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5881642|NCT05083312|Respiratory System Agents|respiratory system agents|mesh-ancestor
5881643|NCT05083312|Dermatologic Agents|dermatologic agents|mesh-ancestor
5881644|NCT05083312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5881645|NCT05083286|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5881646|NCT05083286|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5881647|NCT05083286|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5881648|NCT05083286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5881649|NCT05083286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881650|NCT05083286|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5881651|NCT05083286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5881652|NCT05083286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881653|NCT05083286|Cholinergic Agents|cholinergic agents|mesh-ancestor
5881654|NCT05083286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5881655|NCT05082259|Pembrolizumab|pembrolizumab|mesh-list
5881656|NCT05082259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5881657|NCT05082259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5881658|NCT05079074|Fulvestrant|fulvestrant|mesh-list
5881659|NCT05079074|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
5881660|NCT05079074|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
5881661|NCT05079074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5881662|NCT05079074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5881663|NCT05079074|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5881664|NCT05079074|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5881665|NCT05079074|Hormone Antagonists|hormone antagonists|mesh-ancestor
5881666|NCT05079074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5881667|NCT05079074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881668|NCT05079074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5881669|NCT05079074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881670|NCT05057481|Mycophenolic Acid|mycophenolic acid|mesh-list
5881671|NCT05057481|Rituximab|rituximab|mesh-list
5881672|NCT05057481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5881673|NCT05057481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5881674|NCT05057481|Immunologic Factors|immunologic factors|mesh-ancestor
5881675|NCT05057481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881676|NCT05057481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5881677|NCT05057481|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5881678|NCT05057481|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5881679|NCT05057481|Antitubercular Agents|antitubercular agents|mesh-ancestor
5881680|NCT05057481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5881681|NCT05057481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5881682|NCT05057481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5881683|NCT05057481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906570|NCT01529593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5906571|NCT01529593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5906572|NCT01529593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5906573|NCT01529593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5906574|NCT01529593|Antifungal Agents|antifungal agents|mesh-ancestor
5906575|NCT01529593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5906576|NCT01529593|Immunologic Factors|immunologic factors|mesh-ancestor
5906577|NCT01503489|Norepinephrine|norepinephrine|mesh-list
5906578|NCT01503489|Antidepressive Agents|antidepressive agents|mesh-list
5906579|NCT01503489|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
5687270|NCT03445468|Vaccines|vaccines|mesh-list
5687271|NCT03445468|Immunologic Factors|immunologic factors|mesh-ancestor
5687272|NCT03445468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687273|NCT03445286|Fluorides|fluorides|mesh-list
5687274|NCT03445286|Cariostatic Agents|cariostatic agents|mesh-ancestor
5687275|NCT03445286|Protective Agents|protective agents|mesh-ancestor
5687276|NCT03445286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687277|NCT03445182|Anesthetics|anesthetics|mesh-list
5687278|NCT03445182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5906580|NCT01503489|Serotonin|serotonin|mesh-list
5906581|NCT01503489|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
5906582|NCT01503489|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5906583|NCT01503489|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5906584|NCT01503489|Adrenergic Agents|adrenergic agents|mesh-ancestor
5906585|NCT01503489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5906586|NCT01503489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906587|NCT01503489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906588|NCT01503489|Sympathomimetics|sympathomimetics|mesh-ancestor
5906589|NCT01503489|Autonomic Agents|autonomic agents|mesh-ancestor
5906590|NCT01503489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5906591|NCT01503489|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5906592|NCT01503489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5906593|NCT01503489|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5687279|NCT03445182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687280|NCT03445104|Huperzine A|huperzine a|mesh-list
5687281|NCT03445104|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5687282|NCT03445104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5687283|NCT03445104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687284|NCT03445104|Cholinergic Agents|cholinergic agents|mesh-ancestor
5687285|NCT03445104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5687286|NCT03445104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687287|NCT03445104|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5687288|NCT03445104|Protective Agents|protective agents|mesh-ancestor
5687289|NCT03445078|Selenium|selenium|mesh-list
5687290|NCT03445078|Antioxidants|antioxidants|mesh-ancestor
5687291|NCT03445078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687292|NCT03445078|Protective Agents|protective agents|mesh-ancestor
5687293|NCT03445078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687294|NCT03445078|Trace Elements|trace elements|mesh-ancestor
5687295|NCT03445078|Micronutrients|micronutrients|mesh-ancestor
5687296|NCT03444831|Buspirone|buspirone|mesh-list
5687297|NCT03444831|Omeprazole|omeprazole|mesh-list
5687298|NCT03444831|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5687299|NCT03444831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5687300|NCT03444831|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5687301|NCT03444831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5687302|NCT03444831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687303|NCT03444831|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5687304|NCT03444831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5687305|NCT03444831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5687306|NCT03444831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687307|NCT03444831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5687308|NCT03444831|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5687309|NCT03444831|Serotonin Agents|serotonin agents|mesh-ancestor
5687310|NCT03444831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5687311|NCT03444662|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
5687312|NCT03444662|Nootropic Agents|nootropic agents|mesh-ancestor
5687313|NCT03444649|Cytarabine|cytarabine|mesh-list
5687314|NCT03444649|Daunorubicin|daunorubicin|mesh-list
5687315|NCT03444649|Idarubicin|idarubicin|mesh-list
5881684|NCT05001360|Nivolumab|nivolumab|mesh-list
5881685|NCT05001360|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5881686|NCT05001360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5881687|NCT05001360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5881688|NCT05001360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881689|NCT04986839|Acetaminophen|acetaminophen|mesh-list
5881690|NCT04986839|Ibuprofen|ibuprofen|mesh-list
5881691|NCT04986839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5687316|NCT03444649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5687317|NCT03444649|Antimetabolites|antimetabolites|mesh-ancestor
5687318|NCT03444649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881692|NCT04986839|Analgesics|analgesics|mesh-ancestor
5881693|NCT04986839|Sensory System Agents|sensory system agents|mesh-ancestor
5881694|NCT04986839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5687319|NCT03444649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5687320|NCT03444649|Antiviral Agents|antiviral agents|mesh-ancestor
5687321|NCT03444649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5687322|NCT03444649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5687323|NCT03444649|Immunologic Factors|immunologic factors|mesh-ancestor
5687324|NCT03444649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687325|NCT03444649|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5687326|NCT03444649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5687327|NCT03444649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5881695|NCT04986839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881696|NCT04986839|Antipyretics|antipyretics|mesh-ancestor
5881697|NCT04986839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5881698|NCT04986839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5881699|NCT04986839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5881700|NCT04986839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5881701|NCT04986839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5881702|NCT04986839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881703|NCT04913467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
5687328|NCT03444649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5687329|NCT03444636|Fentanyl|fentanyl|mesh-list
5687330|NCT03444636|Bupivacaine|bupivacaine|mesh-list
5687331|NCT03444636|Ropivacaine|ropivacaine|mesh-list
5687332|NCT03444636|Anesthetics, Local|anesthetics, local|mesh-ancestor
5687333|NCT03444636|Anesthetics|anesthetics|mesh-ancestor
5687334|NCT03444636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5687335|NCT03444636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687336|NCT03444636|Sensory System Agents|sensory system agents|mesh-ancestor
5687337|NCT03444636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5687338|NCT03444636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5881704|NCT04901299|Fulvestrant|fulvestrant|mesh-list
5881705|NCT04901299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5881706|NCT04901299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5881707|NCT04901299|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5881708|NCT04901299|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5881709|NCT04901299|Hormone Antagonists|hormone antagonists|mesh-ancestor
5906594|NCT01503489|Serotonin Agents|serotonin agents|mesh-ancestor
5687339|NCT03444636|Narcotics|narcotics|mesh-ancestor
5687340|NCT03444636|Analgesics|analgesics|mesh-ancestor
5687341|NCT03444636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5687342|NCT03444636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5687343|NCT03444636|Anesthetics, General|anesthetics, general|mesh-ancestor
5687344|NCT03444519|Mannitol|mannitol|mesh-list
5687345|NCT03444519|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5687346|NCT03444519|Diuretics|diuretics|mesh-ancestor
5687347|NCT03444519|Natriuretic Agents|natriuretic agents|mesh-ancestor
5687348|NCT03444519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687349|NCT03444506|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
5687350|NCT03444506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5687351|NCT03444506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5687352|NCT03444506|Analgesics|analgesics|mesh-ancestor
5687353|NCT03444506|Sensory System Agents|sensory system agents|mesh-ancestor
5687354|NCT03444506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5687355|NCT03444506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881710|NCT04901299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5687356|NCT03444506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5687357|NCT03444506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5687358|NCT03444506|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5687359|NCT03444506|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5687360|NCT03444506|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5687361|NCT03444506|Histamine Antagonists|histamine antagonists|mesh-ancestor
5687362|NCT03444506|Histamine Agents|histamine agents|mesh-ancestor
5687363|NCT03444506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5687364|NCT03444506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881711|NCT04901299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881712|NCT04895761|Cyclophosphamide|cyclophosphamide|mesh-list
5881713|NCT04895761|Letrozole|letrozole|mesh-list
5881714|NCT04895761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5881715|NCT04895761|Immunologic Factors|immunologic factors|mesh-ancestor
5881716|NCT04895761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881717|NCT04895761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5881718|NCT04895761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5881719|NCT04895761|Alkylating Agents|alkylating agents|mesh-ancestor
5881720|NCT04895761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881721|NCT04895761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5881722|NCT04895761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5881723|NCT04895761|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5881724|NCT04895761|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5881725|NCT04895761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5881726|NCT04895761|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5881727|NCT04895761|Hormone Antagonists|hormone antagonists|mesh-ancestor
5881728|NCT04895761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5881729|NCT04877678|Bepotastine besilate|bepotastine besilate|mesh-list
5881730|NCT04877678|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5881731|NCT04829383|Bevacizumab|bevacizumab|mesh-list
5881732|NCT04829383|Atezolizumab|atezolizumab|mesh-list
5881733|NCT04829383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5881734|NCT04829383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5881735|NCT04829383|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5881736|NCT04829383|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5881737|NCT04829383|Growth Substances|growth substances|mesh-ancestor
5881738|NCT04829383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881739|NCT04829383|Growth Inhibitors|growth inhibitors|mesh-ancestor
5881740|NCT04793100|Aflibercept|aflibercept|mesh-list
5881741|NCT04793100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5881742|NCT04793100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5881743|NCT04793100|Growth Substances|growth substances|mesh-ancestor
5881744|NCT04793100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881745|NCT04793100|Growth Inhibitors|growth inhibitors|mesh-ancestor
5881746|NCT04793100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5881747|NCT04762979|Fulvestrant|fulvestrant|mesh-list
5881748|NCT04762979|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5881749|NCT04762979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5881750|NCT04762979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5881751|NCT04762979|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5881752|NCT04762979|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5881753|NCT04762979|Hormone Antagonists|hormone antagonists|mesh-ancestor
5881754|NCT04762979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5881755|NCT04762979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881756|NCT04762979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5881757|NCT04762979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5881758|NCT04762979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881759|NCT04760028|Anesthetics|anesthetics|mesh-list
5881760|NCT04760028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5881761|NCT04760028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687365|NCT03444467|Glucagon|glucagon|mesh-list
5687366|NCT03444467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5881762|NCT04756505|Interleukin-12|interleukin-12|mesh-list
5881763|NCT04756505|Immunoglobulin G|immunoglobulin g|mesh-list
5881764|NCT04756505|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5881765|NCT04756505|Immunologic Factors|immunologic factors|mesh-ancestor
5881766|NCT04756505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881767|NCT04756505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5881768|NCT04756505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5881769|NCT04756505|Growth Substances|growth substances|mesh-ancestor
5881770|NCT04756505|Growth Inhibitors|growth inhibitors|mesh-ancestor
5687367|NCT03444467|Hormones|hormones|mesh-ancestor
5697382|NCT03376529|Tazobactam|tazobactam|mesh-list
5881771|NCT04756505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5881772|NCT04737109|Androgens|androgens|mesh-list
5881773|NCT04737109|Hormones|hormones|mesh-ancestor
5881774|NCT04737109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5881775|NCT04737109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881776|NCT04735354|Valsartan|valsartan|mesh-list
5881777|NCT04735354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5881778|NCT04735354|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5881779|NCT04735354|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5881780|NCT04735354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881781|NCT04699838|Carboplatin|carboplatin|mesh-list
5881782|NCT04699838|Etoposide|etoposide|mesh-list
5881783|NCT04699838|Durvalumab|durvalumab|mesh-list
5881784|NCT04699838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5881785|NCT04699838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5881786|NCT04699838|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5881787|NCT04699838|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5881788|NCT04699838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5881789|NCT04699838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881790|NCT04699838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5881791|NCT04677569|Azithromycin|azithromycin|mesh-list
5881792|NCT04677569|Amikacin|amikacin|mesh-list
5687368|NCT03444467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5687369|NCT03444467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687370|NCT03444402|Esomeprazole|esomeprazole|mesh-list
5687371|NCT03444402|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5687372|NCT03444402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5687373|NCT03444402|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5687374|NCT03444402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5687375|NCT03444402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687376|NCT03444376|Pembrolizumab|pembrolizumab|mesh-list
5687377|NCT03444376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5687378|NCT03444376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5687379|NCT03444298|Vitamin E|vitamin e|mesh-list
5687380|NCT03444298|Tocopherols|tocopherols|mesh-list
5687381|NCT03444298|Tocotrienols|tocotrienols|mesh-list
5687382|NCT03444298|alpha-Tocopherol|alpha-tocopherol|mesh-list
5687383|NCT03444298|gamma-Tocopherol|gamma-tocopherol|mesh-list
5687384|NCT03444298|Vitamins|vitamins|mesh-ancestor
5687385|NCT03444298|Micronutrients|micronutrients|mesh-ancestor
5687386|NCT03444298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687387|NCT03444298|Antioxidants|antioxidants|mesh-ancestor
5687388|NCT03444298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687389|NCT03444298|Protective Agents|protective agents|mesh-ancestor
5687390|NCT03444272|Sofosbuvir|sofosbuvir|mesh-list
5881793|NCT04677569|Ethambutol|ethambutol|mesh-list
5881794|NCT04677569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5881795|NCT04677569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5881796|NCT04677569|Antitubercular Agents|antitubercular agents|mesh-ancestor
5881797|NCT04675788|Ibutilide|ibutilide|mesh-list
5881798|NCT04675788|Testosterone|testosterone|mesh-list
5881799|NCT04675788|Progesterone|progesterone|mesh-list
5881800|NCT04675788|Androgens|androgens|mesh-ancestor
5881801|NCT04675788|Hormones|hormones|mesh-ancestor
5881802|NCT04675788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5881803|NCT04675788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881804|NCT04675788|Progestins|progestins|mesh-ancestor
5881805|NCT04675788|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5881806|NCT04603365|Temozolomide|temozolomide|mesh-list
5881807|NCT04603365|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
5881808|NCT04603365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5881809|NCT04603365|Alkylating Agents|alkylating agents|mesh-ancestor
5881810|NCT04603365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881811|NCT04603365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5881812|NCT04603365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5881813|NCT04593680|Tenofovir|tenofovir|mesh-list
5881814|NCT04593680|Emtricitabine|emtricitabine|mesh-list
5881815|NCT04593680|Antiviral Agents|antiviral agents|mesh-ancestor
5881816|NCT04593680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5881817|NCT04593680|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5881818|NCT04593680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5687391|NCT03444272|Antiviral Agents|antiviral agents|mesh-ancestor
5687392|NCT03444272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5687393|NCT03444246|Iodine|iodine|mesh-list
5687394|NCT03444246|Cadexomer iodine|cadexomer iodine|mesh-list
5687395|NCT03444246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5687396|NCT03444246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5687397|NCT03444246|Trace Elements|trace elements|mesh-ancestor
5687398|NCT03444246|Micronutrients|micronutrients|mesh-ancestor
5687399|NCT03444246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687400|NCT03444142|Exenatide|exenatide|mesh-list
5687401|NCT03444142|Dulaglutide|dulaglutide|mesh-list
5687402|NCT03444142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5687403|NCT03444142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687404|NCT03444142|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5687405|NCT03444142|Incretins|incretins|mesh-ancestor
5687406|NCT03444142|Hormones|hormones|mesh-ancestor
5687407|NCT03444142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5687408|NCT03444025|Goserelin|goserelin|mesh-list
5687409|NCT03444025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5687410|NCT03444025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5687411|NCT03444012|Ticagrelor|ticagrelor|mesh-list
5687412|NCT03444012|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5687413|NCT03444012|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5687414|NCT03444012|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5687415|NCT03444012|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5687416|NCT03444012|Purinergic Agents|purinergic agents|mesh-ancestor
5687417|NCT03444012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5687418|NCT03444012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687419|NCT03444012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687420|NCT03443999|Sirolimus|sirolimus|mesh-list
5687421|NCT03443999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5687422|NCT03443999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5687423|NCT03443999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5687424|NCT03443999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5687425|NCT03443999|Antifungal Agents|antifungal agents|mesh-ancestor
5687426|NCT03443999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5687427|NCT03443999|Immunologic Factors|immunologic factors|mesh-ancestor
5687428|NCT03443999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687429|NCT03443960|Amitriptyline|amitriptyline|mesh-list
5687430|NCT03443960|Cyclobenzaprine|cyclobenzaprine|mesh-list
5687431|NCT03443960|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5687432|NCT03443960|Antidepressive Agents|antidepressive agents|mesh-ancestor
5687433|NCT03443960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5687434|NCT03443960|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5687435|NCT03443960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687436|NCT03443960|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5687437|NCT03443960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5687438|NCT03443960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5687439|NCT03443960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5687440|NCT03443960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5687441|NCT03443960|Analgesics|analgesics|mesh-ancestor
5687442|NCT03443960|Sensory System Agents|sensory system agents|mesh-ancestor
5687443|NCT03443960|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5687444|NCT03443960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5687445|NCT03443960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5687446|NCT03443960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687447|NCT03443960|Adrenergic Agents|adrenergic agents|mesh-ancestor
5687448|NCT03443960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5687449|NCT03443921|Paclitaxel|paclitaxel|mesh-list
5687450|NCT03443921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5687451|NCT03443921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5881819|NCT04593680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5881820|NCT04593680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881821|NCT04593680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5881822|NCT04593680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5881823|NCT04590417|Cyproterone Acetate|cyproterone acetate|mesh-list
5881824|NCT04590417|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5881825|NCT04590417|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6495988|NCT00625898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6495989|NCT00625898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6495990|NCT00625898|Growth Substances|growth substances|mesh-ancestor
5687452|NCT03443921|Tubulin Modulators|tubulin modulators|mesh-ancestor
5687453|NCT03443921|Antimitotic Agents|antimitotic agents|mesh-ancestor
5687454|NCT03443921|Mitosis Modulators|mitosis modulators|mesh-ancestor
5687455|NCT03443921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697383|NCT03376529|Piperacillin|piperacillin|mesh-list
6495991|NCT00625898|Growth Inhibitors|growth inhibitors|mesh-ancestor
6495992|NCT00625898|Tubulin Modulators|tubulin modulators|mesh-ancestor
6495993|NCT00625898|Antimitotic Agents|antimitotic agents|mesh-ancestor
6495994|NCT00625898|Mitosis Modulators|mitosis modulators|mesh-ancestor
5687456|NCT03443869|Valganciclovir|valganciclovir|mesh-list
5687457|NCT03443869|Acyclovir|acyclovir|mesh-list
5687458|NCT03443869|Letermovir|letermovir|mesh-list
5687459|NCT03443869|Antiviral Agents|antiviral agents|mesh-ancestor
5687460|NCT03443869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5687461|NCT03443869|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6495995|NCT00625898|Antimetabolites|antimetabolites|mesh-ancestor
6495996|NCT00625898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6495997|NCT00625898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6495998|NCT00625898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5881826|NCT04590417|Estradiol|estradiol|mesh-list
5881827|NCT04590417|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5881828|NCT04590417|Cyproterone|cyproterone|mesh-list
5881829|NCT04590417|Estrogens|estrogens|mesh-ancestor
5881830|NCT04590417|Hormones|hormones|mesh-ancestor
5881831|NCT04590417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5687462|NCT03443869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5687463|NCT03443869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687464|NCT03443869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5687465|NCT03443856|Nivolumab|nivolumab|mesh-list
5687466|NCT03443856|Ipilimumab|ipilimumab|mesh-list
5687467|NCT03443856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5687468|NCT03443856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5687469|NCT03443856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5687470|NCT03443856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687471|NCT03443843|Fluticasone|fluticasone|mesh-list
5687472|NCT03443843|Xhance|xhance|mesh-list
5687473|NCT03443843|Loratadine|loratadine|mesh-list
5687474|NCT03443843|Pseudoephedrine|pseudoephedrine|mesh-list
5687475|NCT03443843|Ephedrine|ephedrine|mesh-list
5687476|NCT03443843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5687477|NCT03443843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5687478|NCT03443843|Autonomic Agents|autonomic agents|mesh-ancestor
5687479|NCT03443843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5687480|NCT03443843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687481|NCT03443843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5687482|NCT03443843|Respiratory System Agents|respiratory system agents|mesh-ancestor
5687483|NCT03443843|Dermatologic Agents|dermatologic agents|mesh-ancestor
5687484|NCT03443843|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5687485|NCT03443843|Antipruritics|antipruritics|mesh-ancestor
5687486|NCT03443843|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5687487|NCT03443843|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5687488|NCT03443843|Histamine Antagonists|histamine antagonists|mesh-ancestor
5687489|NCT03443843|Histamine Agents|histamine agents|mesh-ancestor
5687490|NCT03443843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5687491|NCT03443843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687492|NCT03443843|Nasal Decongestants|nasal decongestants|mesh-ancestor
5881832|NCT04590417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881833|NCT04590417|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5881834|NCT04590417|Contraceptive Agents|contraceptive agents|mesh-ancestor
5881835|NCT04590417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5881836|NCT04590417|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5881837|NCT04590417|Androgen Antagonists|androgen antagonists|mesh-ancestor
5881838|NCT04590417|Hormone Antagonists|hormone antagonists|mesh-ancestor
5881839|NCT04590417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5881840|NCT04590417|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5881841|NCT04514302|Immunoglobulins|immunoglobulins|mesh-list
5881842|NCT04514302|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5881843|NCT04514302|Antibodies|antibodies|mesh-list
5881844|NCT04514302|Immunologic Factors|immunologic factors|mesh-ancestor
5881845|NCT04514302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881846|NCT04492891|Cyclosporine|cyclosporine|mesh-list
5881847|NCT04492891|Cyclosporins|cyclosporins|mesh-list
5881848|NCT04492891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5881849|NCT04492891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881850|NCT04492891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5881851|NCT04492891|Immunologic Factors|immunologic factors|mesh-ancestor
5881852|NCT04492891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881853|NCT04492891|Antifungal Agents|antifungal agents|mesh-ancestor
5881854|NCT04492891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5881855|NCT04492891|Dermatologic Agents|dermatologic agents|mesh-ancestor
5881856|NCT04492891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5881857|NCT04492891|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5881858|NCT04478734|Thiamine|thiamine|mesh-list
5687493|NCT03443843|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5881859|NCT04478734|Biotin|biotin|mesh-list
5881860|NCT04478734|Vitamin B Complex|vitamin b complex|mesh-ancestor
5881861|NCT04478734|Vitamins|vitamins|mesh-ancestor
5687494|NCT03443843|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5687495|NCT03443843|Sympathomimetics|sympathomimetics|mesh-ancestor
5687496|NCT03443843|Adrenergic Agents|adrenergic agents|mesh-ancestor
5687497|NCT03443778|Dexamethasone|dexamethasone|mesh-list
5687498|NCT03443778|Bupivacaine|bupivacaine|mesh-list
5881862|NCT04478734|Micronutrients|micronutrients|mesh-ancestor
5881863|NCT04478734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881864|NCT04452136|Edetic Acid|edetic acid|mesh-list
5881865|NCT04452136|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5881866|NCT04452136|Anticoagulants|anticoagulants|mesh-ancestor
5881867|NCT04452136|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5881868|NCT04452136|Chelating Agents|chelating agents|mesh-ancestor
5881869|NCT04452136|Sequestering Agents|sequestering agents|mesh-ancestor
5881870|NCT04452136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881871|NCT04452136|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5881872|NCT04431635|Rituximab|rituximab|mesh-list
5881873|NCT04431635|Nivolumab|nivolumab|mesh-list
5881874|NCT04431635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5881875|NCT04431635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5881876|NCT04431635|Immunologic Factors|immunologic factors|mesh-ancestor
5881877|NCT04431635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881878|NCT04431635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5881879|NCT04431635|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5881880|NCT04431635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881881|NCT04430985|Leucovorin|leucovorin|mesh-list
5881882|NCT04430985|Fluorouracil|fluorouracil|mesh-list
5687499|NCT03443778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5687500|NCT03443778|Antiemetics|antiemetics|mesh-ancestor
5881883|NCT04430985|Oxaliplatin|oxaliplatin|mesh-list
5881884|NCT04430985|Nivolumab|nivolumab|mesh-list
5881885|NCT04430985|Ipilimumab|ipilimumab|mesh-list
5881886|NCT04430985|Antimetabolites|antimetabolites|mesh-ancestor
5881887|NCT04430985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881888|NCT04430985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5881889|NCT04430985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5881890|NCT04430985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5881891|NCT04430985|Immunologic Factors|immunologic factors|mesh-ancestor
5881892|NCT04430985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881893|NCT04430985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5881894|NCT04430985|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5881895|NCT04430985|Antidotes|antidotes|mesh-ancestor
5881896|NCT04430985|Protective Agents|protective agents|mesh-ancestor
5881897|NCT04430985|Vitamin B Complex|vitamin b complex|mesh-ancestor
5881898|NCT04430985|Vitamins|vitamins|mesh-ancestor
5881899|NCT04430985|Micronutrients|micronutrients|mesh-ancestor
5906595|NCT01503489|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5906596|NCT01503489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5906597|NCT01059188|Docetaxel|docetaxel|mesh-list
5906598|NCT01059188|Cetuximab|cetuximab|mesh-list
5687501|NCT03443778|Autonomic Agents|autonomic agents|mesh-ancestor
5687502|NCT03443778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5687503|NCT03443778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687504|NCT03443778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5687505|NCT03443778|Glucocorticoids|glucocorticoids|mesh-ancestor
5687506|NCT03443778|Hormones|hormones|mesh-ancestor
5687507|NCT03443778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5687508|NCT03443778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5687509|NCT03443778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5687510|NCT03443778|Anesthetics, Local|anesthetics, local|mesh-ancestor
5687511|NCT03443778|Anesthetics|anesthetics|mesh-ancestor
5687512|NCT03443778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5687513|NCT03443778|Sensory System Agents|sensory system agents|mesh-ancestor
5687514|NCT03443765|Vitamin D|vitamin d|mesh-list
5906599|NCT01059188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5906600|NCT01059188|Tubulin Modulators|tubulin modulators|mesh-ancestor
5906601|NCT01059188|Antimitotic Agents|antimitotic agents|mesh-ancestor
5906602|NCT01059188|Mitosis Modulators|mitosis modulators|mesh-ancestor
5906603|NCT01059188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906604|NCT01059188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5906605|NCT01019616|Paclitaxel|paclitaxel|mesh-list
5906606|NCT01019616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5906607|NCT01019616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5906608|NCT01019616|Tubulin Modulators|tubulin modulators|mesh-ancestor
5906609|NCT01019616|Antimitotic Agents|antimitotic agents|mesh-ancestor
5906610|NCT01019616|Mitosis Modulators|mitosis modulators|mesh-ancestor
5687515|NCT03443765|Immunoglobulins|immunoglobulins|mesh-list
5906611|NCT01019616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881900|NCT04367311|Docetaxel|docetaxel|mesh-list
5881901|NCT04367311|Pemetrexed|pemetrexed|mesh-list
5881902|NCT04367311|Atezolizumab|atezolizumab|mesh-list
5881903|NCT04367311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5881904|NCT04367311|Tubulin Modulators|tubulin modulators|mesh-ancestor
5881905|NCT04367311|Antimitotic Agents|antimitotic agents|mesh-ancestor
5881906|NCT04367311|Mitosis Modulators|mitosis modulators|mesh-ancestor
5881907|NCT04367311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881908|NCT04367311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5881909|NCT04367311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5881910|NCT04367311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5881911|NCT04262869|Paclitaxel|paclitaxel|mesh-list
5881912|NCT04262869|Carboplatin|carboplatin|mesh-list
5881913|NCT04262869|Pemetrexed|pemetrexed|mesh-list
5881914|NCT04262869|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5881915|NCT04262869|Durvalumab|durvalumab|mesh-list
5881916|NCT04262869|Immunoglobulins|immunoglobulins|mesh-list
5881917|NCT04262869|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5881918|NCT04262869|Immunoglobulin G|immunoglobulin g|mesh-list
5881919|NCT04262869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5881920|NCT04262869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5881921|NCT04262869|Tubulin Modulators|tubulin modulators|mesh-ancestor
5881922|NCT04262869|Antimitotic Agents|antimitotic agents|mesh-ancestor
5881923|NCT04262869|Mitosis Modulators|mitosis modulators|mesh-ancestor
5881924|NCT04262869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881925|NCT04262869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5881926|NCT04262869|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5881927|NCT04262869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5881928|NCT04262869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5881929|NCT04262869|Immunologic Factors|immunologic factors|mesh-ancestor
5881930|NCT04262869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881931|NCT04230109|Pembrolizumab|pembrolizumab|mesh-list
5881932|NCT04230109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5881933|NCT04230109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5881934|NCT04189952|Rituximab|rituximab|mesh-list
5881935|NCT04189952|Carboplatin|carboplatin|mesh-list
5881936|NCT04189952|Etoposide|etoposide|mesh-list
5881937|NCT04189952|Ifosfamide|ifosfamide|mesh-list
5881938|NCT04189952|Acalabrutinib|acalabrutinib|mesh-list
5881939|NCT04189952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5881940|NCT04189952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5881941|NCT04189952|Immunologic Factors|immunologic factors|mesh-ancestor
5881942|NCT04189952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881943|NCT04189952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5881944|NCT04189952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5881945|NCT04189952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5881946|NCT04189952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5881947|NCT04189952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5881948|NCT04189952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881949|NCT04189952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5881950|NCT04189952|Alkylating Agents|alkylating agents|mesh-ancestor
5881951|NCT04182360|Carbetocin|carbetocin|mesh-list
5881952|NCT04182360|Oxytocics|oxytocics|mesh-ancestor
5881953|NCT04182360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5881954|NCT04182360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881955|NCT04088786|Irinotecan|irinotecan|mesh-list
5881956|NCT04088786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5881957|NCT04088786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5881958|NCT04088786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5881959|NCT04088786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881960|NCT04088786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5881961|NCT04064814|Thioctic Acid|thioctic acid|mesh-list
5881962|NCT04064814|Flunarizine|flunarizine|mesh-list
5881963|NCT04064814|Antioxidants|antioxidants|mesh-ancestor
5881964|NCT04064814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881965|NCT04064814|Protective Agents|protective agents|mesh-ancestor
5881966|NCT04064814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881967|NCT04064814|Vitamin B Complex|vitamin b complex|mesh-ancestor
5881968|NCT04064814|Vitamins|vitamins|mesh-ancestor
5881969|NCT04064814|Micronutrients|micronutrients|mesh-ancestor
5881970|NCT04064814|Anticonvulsants|anticonvulsants|mesh-ancestor
5881971|NCT04064814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5881972|NCT04064814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5881973|NCT04064814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5881974|NCT04064814|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5881975|NCT04064814|Histamine Antagonists|histamine antagonists|mesh-ancestor
5881976|NCT04064814|Histamine Agents|histamine agents|mesh-ancestor
5881977|NCT04064814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5881978|NCT04064814|Vasodilator Agents|vasodilator agents|mesh-ancestor
5881979|NCT04039230|Talazoparib|talazoparib|mesh-list
5881980|NCT04039230|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5881981|NCT04039230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5881982|NCT04039230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881983|NCT04039230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5881984|NCT03998735|Lobeline|lobeline|mesh-list
5881985|NCT03998735|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5881986|NCT03998735|Autonomic Agents|autonomic agents|mesh-ancestor
5881987|NCT03998735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5881988|NCT03998735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881989|NCT03998735|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5881990|NCT03998735|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5881991|NCT03998735|Cholinergic Agents|cholinergic agents|mesh-ancestor
5881992|NCT03998735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5687516|NCT03443765|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5687517|NCT03443765|Antibodies|antibodies|mesh-list
5687518|NCT03443765|Vitamins|vitamins|mesh-ancestor
5881993|NCT03998735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5881994|NCT03998735|Respiratory System Agents|respiratory system agents|mesh-ancestor
5881995|NCT03981952|Vaccines|vaccines|mesh-list
5881996|NCT03981952|Immunologic Factors|immunologic factors|mesh-ancestor
5881997|NCT03981952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5881998|NCT03968939|Diphenhydramine|diphenhydramine|mesh-list
5881999|NCT03968939|Promethazine|promethazine|mesh-list
5882000|NCT03968939|Melatonin|melatonin|mesh-list
5882001|NCT03968939|Antioxidants|antioxidants|mesh-ancestor
5882002|NCT03968939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687519|NCT03443765|Micronutrients|micronutrients|mesh-ancestor
5687520|NCT03443765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687521|NCT03443765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5687522|NCT03443765|Immunologic Factors|immunologic factors|mesh-ancestor
5687523|NCT03443726|Epinephrine|epinephrine|mesh-list
5687524|NCT03443726|Carticaine|carticaine|mesh-list
5687525|NCT03443726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5687526|NCT03443726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5687527|NCT03443726|Adrenergic Agents|adrenergic agents|mesh-ancestor
5687528|NCT03443726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5687529|NCT03443726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687530|NCT03443726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687531|NCT03443726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5687532|NCT03443726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5687533|NCT03443726|Autonomic Agents|autonomic agents|mesh-ancestor
5687534|NCT03443726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5687535|NCT03443726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5687536|NCT03443726|Respiratory System Agents|respiratory system agents|mesh-ancestor
5687537|NCT03443726|Mydriatics|mydriatics|mesh-ancestor
5687538|NCT03443726|Sympathomimetics|sympathomimetics|mesh-ancestor
5687539|NCT03443726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5882003|NCT03968939|Protective Agents|protective agents|mesh-ancestor
5882004|NCT03968939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882005|NCT03968939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5882006|NCT03968939|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5882007|NCT03968939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5882008|NCT03968939|Anesthetics, Local|anesthetics, local|mesh-ancestor
5882009|NCT03968939|Anesthetics|anesthetics|mesh-ancestor
5882010|NCT03968939|Sensory System Agents|sensory system agents|mesh-ancestor
5882011|NCT03968939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5882012|NCT03968939|Antiemetics|antiemetics|mesh-ancestor
5882013|NCT03968939|Autonomic Agents|autonomic agents|mesh-ancestor
5882014|NCT03968939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5882015|NCT03968939|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5882016|NCT03968939|Histamine Antagonists|histamine antagonists|mesh-ancestor
5882017|NCT03968939|Histamine Agents|histamine agents|mesh-ancestor
5882018|NCT03968939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5882019|NCT03968939|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5882020|NCT03968939|Antipruritics|antipruritics|mesh-ancestor
5882021|NCT03968939|Dermatologic Agents|dermatologic agents|mesh-ancestor
5882022|NCT03959891|Letrozole|letrozole|mesh-list
5882023|NCT03959891|Fulvestrant|fulvestrant|mesh-list
5882024|NCT03959891|Palbociclib|palbociclib|mesh-list
5882025|NCT03959891|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5882026|NCT03959891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5882027|NCT03959891|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5687540|NCT03443726|Anesthetics, Local|anesthetics, local|mesh-ancestor
5882028|NCT03959891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5882029|NCT03959891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5882030|NCT03959891|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5882031|NCT03959891|Hormone Antagonists|hormone antagonists|mesh-ancestor
5882032|NCT03959891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5882033|NCT03959891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882034|NCT03959891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5882035|NCT03959891|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5882036|NCT03959891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5882037|NCT03950609|Everolimus|everolimus|mesh-list
5882038|NCT03950609|Lenvatinib|lenvatinib|mesh-list
5882039|NCT03950609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5882040|NCT03950609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5882041|NCT03950609|Immunologic Factors|immunologic factors|mesh-ancestor
5882042|NCT03950609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882043|NCT03950609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5882044|NCT03950609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5882045|NCT03950609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5882046|NCT03943875|Vaccines|vaccines|mesh-list
5882047|NCT03943875|Immunologic Factors|immunologic factors|mesh-ancestor
5882048|NCT03943875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882049|NCT03866538|Budesonide|budesonide|mesh-list
5882050|NCT03866538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5882051|NCT03866538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5882052|NCT03866538|Autonomic Agents|autonomic agents|mesh-ancestor
5882053|NCT03866538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5882054|NCT03866538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882055|NCT03866538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5882056|NCT03866538|Respiratory System Agents|respiratory system agents|mesh-ancestor
5882057|NCT03866538|Glucocorticoids|glucocorticoids|mesh-ancestor
5882058|NCT03866538|Hormones|hormones|mesh-ancestor
5882059|NCT03866538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5882060|NCT03861702|Irinotecan|irinotecan|mesh-list
5882061|NCT03861702|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5882062|NCT03861702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5882063|NCT03861702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5882064|NCT03861702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5882065|NCT03861702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5882066|NCT03856619|Teriflunomide|teriflunomide|mesh-list
5882067|NCT03856619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5882068|NCT03856619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5882069|NCT03856619|Analgesics|analgesics|mesh-ancestor
5882070|NCT03856619|Sensory System Agents|sensory system agents|mesh-ancestor
5882071|NCT03856619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5882072|NCT03856619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882073|NCT03856619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5882074|NCT03856619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5882075|NCT03856619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5882076|NCT03856619|Immunologic Factors|immunologic factors|mesh-ancestor
5882077|NCT03821272|Vaccines|vaccines|mesh-list
5882078|NCT03821272|Immunologic Factors|immunologic factors|mesh-ancestor
5882079|NCT03821272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882080|NCT03806309|Leucovorin|leucovorin|mesh-list
5882081|NCT03806309|Fluorouracil|fluorouracil|mesh-list
5882082|NCT03806309|Irinotecan|irinotecan|mesh-list
5882083|NCT03806309|Antimetabolites|antimetabolites|mesh-ancestor
5882084|NCT03806309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5882085|NCT03806309|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5882086|NCT03806309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5882087|NCT03806309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5882088|NCT03806309|Immunologic Factors|immunologic factors|mesh-ancestor
5882089|NCT03806309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882090|NCT03806309|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5882091|NCT03806309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5882092|NCT03806309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5882093|NCT03806309|Antidotes|antidotes|mesh-ancestor
5882094|NCT03806309|Protective Agents|protective agents|mesh-ancestor
5687541|NCT03443726|Anesthetics|anesthetics|mesh-ancestor
5687542|NCT03443726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5687543|NCT03443726|Sensory System Agents|sensory system agents|mesh-ancestor
5687544|NCT03443570|Rituximab|rituximab|mesh-list
5687545|NCT03443570|Bortezomib|bortezomib|mesh-list
5687546|NCT03443570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5687547|NCT03443570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5687548|NCT03443570|Immunologic Factors|immunologic factors|mesh-ancestor
5687549|NCT03443570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882095|NCT03806309|Vitamin B Complex|vitamin b complex|mesh-ancestor
5882096|NCT03806309|Vitamins|vitamins|mesh-ancestor
5882097|NCT03806309|Micronutrients|micronutrients|mesh-ancestor
5882098|NCT03782532|Prednisone|prednisone|mesh-list
5882099|NCT03782532|Prednisolone|prednisolone|mesh-list
5882100|NCT03782532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5882101|NCT03782532|Glucocorticoids|glucocorticoids|mesh-ancestor
5882102|NCT03782532|Hormones|hormones|mesh-ancestor
5882103|NCT03782532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5882104|NCT03782532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882105|NCT03782532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5882106|NCT03782532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5882107|NCT03714815|Macitentan|macitentan|mesh-list
5882108|NCT03714815|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
5882109|NCT03714815|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5882110|NCT03714815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5882111|NCT03714815|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
5882112|NCT03636165|Methylprednisolone|methylprednisolone|mesh-list
5882113|NCT03636165|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5882114|NCT03636165|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5882115|NCT03636165|Prednisolone|prednisolone|mesh-list
5882116|NCT03636165|Prednisolone acetate|prednisolone acetate|mesh-list
5882117|NCT03636165|Ropivacaine|ropivacaine|mesh-list
5882118|NCT03636165|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5882119|NCT03636165|Prednisolone phosphate|prednisolone phosphate|mesh-list
5882120|NCT03636165|Anesthetics, Local|anesthetics, local|mesh-ancestor
5882121|NCT03636165|Anesthetics|anesthetics|mesh-ancestor
5882122|NCT03636165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5882123|NCT03636165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882124|NCT03636165|Sensory System Agents|sensory system agents|mesh-ancestor
5882125|NCT03636165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5882126|NCT03636165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5882127|NCT03636165|Antiemetics|antiemetics|mesh-ancestor
5687550|NCT03443570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5687551|NCT03443518|Remifentanil|remifentanil|mesh-list
5687552|NCT03443518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5687553|NCT03443518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687554|NCT03443518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5687555|NCT03443518|Narcotics|narcotics|mesh-ancestor
5882128|NCT03636165|Autonomic Agents|autonomic agents|mesh-ancestor
5882129|NCT03636165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5882130|NCT03636165|Glucocorticoids|glucocorticoids|mesh-ancestor
5882131|NCT03636165|Hormones|hormones|mesh-ancestor
5882132|NCT03636165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5882133|NCT03636165|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5882134|NCT03636165|Protective Agents|protective agents|mesh-ancestor
5882135|NCT03636165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5882136|NCT03636165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5882137|NCT03564873|Azacitidine|azacitidine|mesh-list
5882138|NCT03564873|Homoharringtonine|homoharringtonine|mesh-list
5882139|NCT03564873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5882140|NCT03564873|Antimetabolites|antimetabolites|mesh-ancestor
5882141|NCT03564873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5882142|NCT03564873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5882143|NCT03564873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5882144|NCT03564873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5882145|NCT03564873|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5882146|NCT03557619|Venetoclax|venetoclax|mesh-list
5882147|NCT03557619|Levonorgestrel|levonorgestrel|mesh-list
5882148|NCT03557619|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5882149|NCT03557619|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
5882150|NCT03557619|Estradiol|estradiol|mesh-list
5882151|NCT03557619|Estrogens|estrogens|mesh-ancestor
5882152|NCT03557619|Hormones|hormones|mesh-ancestor
5882153|NCT03557619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5882154|NCT03557619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882155|NCT03557619|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5882156|NCT03557619|Contraceptive Agents|contraceptive agents|mesh-ancestor
5687556|NCT03443518|Analgesics|analgesics|mesh-ancestor
5687557|NCT03443518|Sensory System Agents|sensory system agents|mesh-ancestor
5687558|NCT03443518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5687559|NCT03443492|Leucovorin|leucovorin|mesh-list
5687560|NCT03443492|Gemcitabine|gemcitabine|mesh-list
5687561|NCT03443492|Oxaliplatin|oxaliplatin|mesh-list
5687562|NCT03443492|Irinotecan|irinotecan|mesh-list
5687563|NCT03443492|Levoleucovorin|levoleucovorin|mesh-list
5697384|NCT03376529|Ceftazidime|ceftazidime|mesh-list
5882157|NCT03557619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5882158|NCT03557619|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5882159|NCT03557619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5882160|NCT03557619|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5882161|NCT03557619|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5882162|NCT03557619|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5882163|NCT03557619|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5882164|NCT03539822|Durvalumab|durvalumab|mesh-list
5882165|NCT03539822|Tremelimumab|tremelimumab|mesh-list
5882166|NCT03539822|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5882167|NCT03539822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5882168|NCT03539822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5882169|NCT03539822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5882170|NCT03528408|Nivolumab|nivolumab|mesh-list
5882171|NCT03528408|Ipilimumab|ipilimumab|mesh-list
5882172|NCT03528408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5882173|NCT03528408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5882174|NCT03528408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5882175|NCT03528408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5882176|NCT03523312|Capecitabine|capecitabine|mesh-list
5882177|NCT03523312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5687564|NCT03443492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5687565|NCT03443492|Antimetabolites|antimetabolites|mesh-ancestor
5687566|NCT03443492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687567|NCT03443492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5687568|NCT03443492|Antiviral Agents|antiviral agents|mesh-ancestor
5687569|NCT03443492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5687570|NCT03443492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5882178|NCT03523312|Antimetabolites|antimetabolites|mesh-ancestor
5882179|NCT03523312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5882180|NCT03523312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5882181|NCT03521037|Rucaparib|rucaparib|mesh-list
5882182|NCT03521037|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5882183|NCT03521037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5882184|NCT03521037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5882185|NCT03521037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5882186|NCT03422094|Nivolumab|nivolumab|mesh-list
5882187|NCT03422094|Ipilimumab|ipilimumab|mesh-list
5882188|NCT03422094|Poly ICLC|poly iclc|mesh-list
5882189|NCT03422094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5882190|NCT03422094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5882191|NCT03422094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5882192|NCT03422094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5882193|NCT03422094|Interferon Inducers|interferon inducers|mesh-ancestor
5882194|NCT03422094|Immunologic Factors|immunologic factors|mesh-ancestor
5882195|NCT03422094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882196|NCT03391869|Nivolumab|nivolumab|mesh-list
5882197|NCT03391869|Ipilimumab|ipilimumab|mesh-list
5882198|NCT03391869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5882199|NCT03391869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5882200|NCT03391869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5882201|NCT03391869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5882202|NCT03384836|Pembrolizumab|pembrolizumab|mesh-list
5882203|NCT03384836|Propranolol|propranolol|mesh-list
5882204|NCT03384836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5882205|NCT03384836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5882206|NCT03384836|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5882207|NCT03384836|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5882208|NCT03384836|Adrenergic Agents|adrenergic agents|mesh-ancestor
5882209|NCT03384836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5882210|NCT03384836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5882211|NCT03384836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882212|NCT03384836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5882213|NCT03384836|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5882214|NCT03384836|Vasodilator Agents|vasodilator agents|mesh-ancestor
5882215|NCT03311555|Docetaxel|docetaxel|mesh-list
5882216|NCT03311555|Androgens|androgens|mesh-list
5882217|NCT03311555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5882218|NCT03311555|Tubulin Modulators|tubulin modulators|mesh-ancestor
5882219|NCT03311555|Antimitotic Agents|antimitotic agents|mesh-ancestor
5882220|NCT03311555|Mitosis Modulators|mitosis modulators|mesh-ancestor
5882221|NCT03311555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5882222|NCT03311555|Hormones|hormones|mesh-ancestor
5906612|NCT00000587|Epoetin Alfa|epoetin alfa|mesh-list
5687571|NCT03443492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5882223|NCT03311555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5882224|NCT03311555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882225|NCT03264404|Pembrolizumab|pembrolizumab|mesh-list
5882226|NCT03264404|Azacitidine|azacitidine|mesh-list
5882227|NCT03264404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5882228|NCT03264404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5882229|NCT03264404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5882230|NCT03264404|Antimetabolites|antimetabolites|mesh-ancestor
5687572|NCT03443492|Immunologic Factors|immunologic factors|mesh-ancestor
5687573|NCT03443492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687574|NCT03443492|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5687575|NCT03443492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5687576|NCT03443492|Antidotes|antidotes|mesh-ancestor
5687577|NCT03443492|Protective Agents|protective agents|mesh-ancestor
5687578|NCT03443492|Vitamin B Complex|vitamin b complex|mesh-ancestor
5687579|NCT03443492|Vitamins|vitamins|mesh-ancestor
5687580|NCT03443492|Micronutrients|micronutrients|mesh-ancestor
5687581|NCT03443271|Bupivacaine|bupivacaine|mesh-list
5687582|NCT03443271|Anesthetics, Local|anesthetics, local|mesh-ancestor
5687583|NCT03443271|Anesthetics|anesthetics|mesh-ancestor
5687584|NCT03443271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5687585|NCT03443271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687586|NCT03443271|Sensory System Agents|sensory system agents|mesh-ancestor
5687587|NCT03443271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5687588|NCT03443180|Trypsin Inhibitors|trypsin inhibitors|mesh-list
5687589|NCT03443180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5687590|NCT03443180|Protease Inhibitors|protease inhibitors|mesh-ancestor
5687591|NCT03443180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5687592|NCT03443180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687593|NCT03443141|Vitamin E|vitamin e|mesh-list
5687594|NCT03443141|Vitamins|vitamins|mesh-ancestor
5687595|NCT03443141|Micronutrients|micronutrients|mesh-ancestor
5687596|NCT03443141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687597|NCT03443141|Antioxidants|antioxidants|mesh-ancestor
5882231|NCT03264404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5882232|NCT03264404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5882233|NCT03246074|Paclitaxel|paclitaxel|mesh-list
5882234|NCT03246074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5882235|NCT03246074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5882236|NCT03246074|Tubulin Modulators|tubulin modulators|mesh-ancestor
5882237|NCT03246074|Antimitotic Agents|antimitotic agents|mesh-ancestor
5882238|NCT03246074|Mitosis Modulators|mitosis modulators|mesh-ancestor
5882239|NCT03246074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5882240|NCT03238326|Brexpiprazole|brexpiprazole|mesh-list
5882241|NCT03238326|Serotonin Agents|serotonin agents|mesh-ancestor
5882242|NCT03238326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5882243|NCT03238326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687598|NCT03443141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687599|NCT03443141|Protective Agents|protective agents|mesh-ancestor
5687600|NCT03443128|Vinorelbine|vinorelbine|mesh-list
5687601|NCT03443128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5687602|NCT03443128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5687603|NCT03443128|Tubulin Modulators|tubulin modulators|mesh-ancestor
5687604|NCT03443128|Antimitotic Agents|antimitotic agents|mesh-ancestor
5687605|NCT03443128|Mitosis Modulators|mitosis modulators|mesh-ancestor
5687606|NCT03443128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687607|NCT03443037|Amantadine|amantadine|mesh-list
5687608|NCT03443037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5687609|NCT03443037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5687610|NCT03443037|Antiviral Agents|antiviral agents|mesh-ancestor
5687611|NCT03443037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5687612|NCT03443037|Dopamine Agents|dopamine agents|mesh-ancestor
5882244|NCT03238326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882245|NCT03238326|Dopamine Agonists|dopamine agonists|mesh-ancestor
5882246|NCT03238326|Dopamine Agents|dopamine agents|mesh-ancestor
5906613|NCT00000587|Hematinics|hematinics|mesh-ancestor
5906614|NCT05138146|Doxorubicin|doxorubicin|mesh-list
5906615|NCT05138146|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5906616|NCT05138146|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5906617|NCT05138146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5906618|NCT05138146|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5906619|NCT05138146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5906620|NCT05138146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5687613|NCT03443037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6212497|NCT02188719|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5687614|NCT03443037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687615|NCT03443037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687616|NCT03443037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5687617|NCT03443037|Analgesics|analgesics|mesh-ancestor
5687618|NCT03443037|Sensory System Agents|sensory system agents|mesh-ancestor
5882247|NCT03223298|Botulinum Toxins|botulinum toxins|mesh-list
5882248|NCT03223298|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5882249|NCT03223298|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5882250|NCT03223298|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5882251|NCT03223298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5882252|NCT03223298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5882253|NCT03223298|Cholinergic Agents|cholinergic agents|mesh-ancestor
5882254|NCT03223298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5882255|NCT03223298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882256|NCT03223298|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5882257|NCT03223298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5882258|NCT03198078|Aripiprazole|aripiprazole|mesh-list
5882259|NCT03198078|Brexpiprazole|brexpiprazole|mesh-list
5882260|NCT03198078|Antidepressive Agents|antidepressive agents|mesh-ancestor
5882261|NCT03198078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5882262|NCT03198078|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5882263|NCT03198078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5882264|NCT03198078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5882265|NCT03198078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882266|NCT03198078|Dopamine Agonists|dopamine agonists|mesh-ancestor
5687619|NCT03443037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5687620|NCT03442972|Teduglutide|teduglutide|mesh-list
5687621|NCT03442972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5687622|NCT03442972|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5687623|NCT03442972|Protective Agents|protective agents|mesh-ancestor
5687624|NCT03442972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687625|NCT03442907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
5687626|NCT03442673|Gemcitabine|gemcitabine|mesh-list
5882267|NCT03198078|Dopamine Agents|dopamine agents|mesh-ancestor
5882268|NCT03198078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5882269|NCT03198078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5882270|NCT03198078|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5882271|NCT03198078|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5882272|NCT03198078|Serotonin Agents|serotonin agents|mesh-ancestor
5882273|NCT03198078|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5882274|NCT03198078|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5882275|NCT03198078|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5882276|NCT03198078|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5882277|NCT03148327|Durvalumab|durvalumab|mesh-list
5882278|NCT03148327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6495999|NCT00625898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6496000|NCT00625898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6496001|NCT00625911|Morphine|morphine|mesh-list
6496002|NCT00625911|Ketamine|ketamine|mesh-list
6496003|NCT00625911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6496004|NCT00625911|Narcotics|narcotics|mesh-ancestor
6496005|NCT00625911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6496006|NCT00625911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496007|NCT00625911|Analgesics|analgesics|mesh-ancestor
6496008|NCT00625911|Sensory System Agents|sensory system agents|mesh-ancestor
6496009|NCT00625911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6496010|NCT00625911|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6496011|NCT00625911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6496012|NCT00625911|Anesthetics, General|anesthetics, general|mesh-ancestor
6496013|NCT00625911|Anesthetics|anesthetics|mesh-ancestor
6496014|NCT00625911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6496015|NCT00625911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6496016|NCT00625911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6496017|NCT00625911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496018|NCT00625937|Docetaxel|docetaxel|mesh-list
6496019|NCT00625937|Tegafur|tegafur|mesh-list
5882279|NCT03148327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5882280|NCT03046862|Gemcitabine|gemcitabine|mesh-list
5882281|NCT03046862|Durvalumab|durvalumab|mesh-list
5882282|NCT03046862|Tremelimumab|tremelimumab|mesh-list
5882283|NCT03046862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5882284|NCT03046862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5882285|NCT03046862|Antimetabolites|antimetabolites|mesh-ancestor
5882286|NCT03046862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687627|NCT03442673|Vinorelbine|vinorelbine|mesh-list
5687628|NCT03442673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5687629|NCT03442673|Antimetabolites|antimetabolites|mesh-ancestor
5687630|NCT03442673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687631|NCT03442673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5882287|NCT03046862|Antiviral Agents|antiviral agents|mesh-ancestor
5882288|NCT03046862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5882289|NCT03046862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5882290|NCT03046862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5882291|NCT03046862|Immunologic Factors|immunologic factors|mesh-ancestor
5882292|NCT03046862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882293|NCT03046862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5882294|NCT02936596|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
5882295|NCT02936596|Immunosuppressive Agents|immunosuppressive agents|mesh-list
5882296|NCT02936596|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5882297|NCT02936596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5882298|NCT02936596|Immunologic Factors|immunologic factors|mesh-ancestor
5882299|NCT02936596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687632|NCT03442673|Antiviral Agents|antiviral agents|mesh-ancestor
5687633|NCT03442673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5687634|NCT03442673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5687635|NCT03442673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5687636|NCT03442673|Immunologic Factors|immunologic factors|mesh-ancestor
5687637|NCT03442673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687638|NCT03442673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5687639|NCT03442673|Tubulin Modulators|tubulin modulators|mesh-ancestor
5687640|NCT03442673|Antimitotic Agents|antimitotic agents|mesh-ancestor
5687641|NCT03442673|Mitosis Modulators|mitosis modulators|mesh-ancestor
5882300|NCT02925234|Bevacizumab|bevacizumab|mesh-list
5882301|NCT02925234|Pembrolizumab|pembrolizumab|mesh-list
5882302|NCT02925234|Nivolumab|nivolumab|mesh-list
5882303|NCT02925234|Trastuzumab|trastuzumab|mesh-list
5882304|NCT02925234|Ipilimumab|ipilimumab|mesh-list
5882305|NCT02925234|Durvalumab|durvalumab|mesh-list
5882306|NCT02925234|Panitumumab|panitumumab|mesh-list
5882307|NCT02925234|Pertuzumab|pertuzumab|mesh-list
5882308|NCT02925234|Sunitinib|sunitinib|mesh-list
5882309|NCT02925234|Atezolizumab|atezolizumab|mesh-list
5882310|NCT02925234|Olaparib|olaparib|mesh-list
5882311|NCT02925234|Palbociclib|palbociclib|mesh-list
5882312|NCT02925234|Lenvatinib|lenvatinib|mesh-list
5882313|NCT02925234|Trametinib|trametinib|mesh-list
5882314|NCT02925234|Axitinib|axitinib|mesh-list
5882315|NCT02925234|Afatinib|afatinib|mesh-list
5882316|NCT02925234|Vemurafenib|vemurafenib|mesh-list
5882317|NCT02925234|Dabrafenib|dabrafenib|mesh-list
5882318|NCT02925234|Crizotinib|crizotinib|mesh-list
5882319|NCT02925234|Talazoparib|talazoparib|mesh-list
5882320|NCT02925234|Rucaparib|rucaparib|mesh-list
5882321|NCT02925234|Entrectinib|entrectinib|mesh-list
5882322|NCT02925234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5882323|NCT02925234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5882324|NCT02925234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5882325|NCT02925234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5882326|NCT02925234|Growth Substances|growth substances|mesh-ancestor
5882327|NCT02925234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882328|NCT02925234|Growth Inhibitors|growth inhibitors|mesh-ancestor
5882329|NCT02925234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5882330|NCT02925234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5882331|NCT02925234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5882332|NCT02925234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5882333|NCT02925234|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5882334|NCT02758431|Methyltestosterone|methyltestosterone|mesh-list
5882335|NCT02758431|Anastrozole|anastrozole|mesh-list
5882336|NCT02758431|Testosterone|testosterone|mesh-list
5882337|NCT02758431|Testosterone undecanoate|testosterone undecanoate|mesh-list
5882338|NCT02758431|Testosterone enanthate|testosterone enanthate|mesh-list
5882339|NCT02758431|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5882340|NCT02758431|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5882341|NCT02758431|Acyline|acyline|mesh-list
5882342|NCT02758431|Hormone Antagonists|hormone antagonists|mesh-list
5882343|NCT02758431|Hormones|hormones|mesh-ancestor
5882344|NCT02758431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5882345|NCT02758431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882346|NCT02758431|Androgens|androgens|mesh-ancestor
6496020|NCT00625937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5882347|NCT02758431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5882348|NCT02758431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5882349|NCT02758431|Anabolic Agents|anabolic agents|mesh-ancestor
5882350|NCT02758431|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5882351|NCT02758431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5882352|NCT02758431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5882353|NCT02758431|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5882354|NCT02698293|Vitamin D|vitamin d|mesh-list
5882355|NCT02698293|Ergocalciferols|ergocalciferols|mesh-list
5882356|NCT02698293|Cholecalciferol|cholecalciferol|mesh-list
5882357|NCT02698293|Vitamins|vitamins|mesh-list
5882358|NCT02698293|Micronutrients|micronutrients|mesh-ancestor
5882359|NCT02698293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882360|NCT02698293|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5882361|NCT02698293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5882362|NCT02643056|Panitumumab|panitumumab|mesh-list
5882363|NCT02643056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5882364|NCT02643056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5882365|NCT02513186|Dexamethasone|dexamethasone|mesh-list
5882366|NCT02513186|Cyclophosphamide|cyclophosphamide|mesh-list
5882367|NCT02513186|Lenalidomide|lenalidomide|mesh-list
5882368|NCT02513186|Bortezomib|bortezomib|mesh-list
5882369|NCT02513186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5882370|NCT02513186|Immunologic Factors|immunologic factors|mesh-ancestor
5882371|NCT02513186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882372|NCT02513186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5882373|NCT02513186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5882374|NCT02513186|Alkylating Agents|alkylating agents|mesh-ancestor
5882375|NCT02513186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5882376|NCT02513186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5882377|NCT02513186|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5882378|NCT02513186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5687642|NCT03442621|Cortisone|cortisone|mesh-list
5687643|NCT03442621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5687644|NCT03442491|Hemostatics|hemostatics|mesh-list
5687645|NCT03442491|Coagulants|coagulants|mesh-ancestor
5687646|NCT03442309|Fluorides|fluorides|mesh-list
5687647|NCT03442309|Fluorides, Topical|fluorides, topical|mesh-list
5687648|NCT03442309|Cariostatic Agents|cariostatic agents|mesh-ancestor
5687649|NCT03442309|Protective Agents|protective agents|mesh-ancestor
5687650|NCT03442309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687651|NCT03442283|Vitamins|vitamins|mesh-list
5687652|NCT03442283|Micronutrients|micronutrients|mesh-ancestor
5687653|NCT03442283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697385|NCT03376529|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
5697386|NCT03376529|Aztreonam|aztreonam|mesh-list
5697387|NCT03376529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5697388|NCT03376529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5697389|NCT03376529|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5697390|NCT03376529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5697391|NCT03376529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697392|NCT03376464|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
5882379|NCT02513186|Antiemetics|antiemetics|mesh-ancestor
5882380|NCT02513186|Autonomic Agents|autonomic agents|mesh-ancestor
5882381|NCT02513186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5882382|NCT02513186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5882383|NCT02513186|Glucocorticoids|glucocorticoids|mesh-ancestor
5882384|NCT02513186|Hormones|hormones|mesh-ancestor
5882385|NCT02513186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5882386|NCT02513186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5882387|NCT02513186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5882388|NCT02513186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5882389|NCT02513186|Growth Substances|growth substances|mesh-ancestor
5882390|NCT02513186|Growth Inhibitors|growth inhibitors|mesh-ancestor
5697393|NCT03376464|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5697394|NCT03376464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5697395|NCT03376464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697396|NCT03376464|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5697397|NCT03376464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5697398|NCT03376464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697399|NCT03376464|Cholinergic Agents|cholinergic agents|mesh-ancestor
5697400|NCT03376464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5697401|NCT03376438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
5882391|NCT02471118|Adalimumab|adalimumab|mesh-list
5882392|NCT02471118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5882393|NCT02471118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5697402|NCT03376243|Emollients|emollients|mesh-list
5697403|NCT03376243|Dermatologic Agents|dermatologic agents|mesh-ancestor
5697404|NCT03376191|Apatinib|apatinib|mesh-list
5697405|NCT03376191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5882394|NCT02417285|Obinutuzumab|obinutuzumab|mesh-list
5882395|NCT02417285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6212498|NCT02188719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6212499|NCT02188719|Anesthetics, Local|anesthetics, local|mesh-ancestor
6212500|NCT02188719|Anesthetics|anesthetics|mesh-ancestor
6212501|NCT02188719|Antiemetics|antiemetics|mesh-ancestor
6212502|NCT02188719|Autonomic Agents|autonomic agents|mesh-ancestor
6212503|NCT02188719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5687660|NCT03442101|Antipsychotic Agents|antipsychotic agents|mesh-list
5687661|NCT03442101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5687662|NCT03442101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5687663|NCT03442101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687664|NCT03442101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5687665|NCT03442023|Chlorhexidine|chlorhexidine|mesh-list
5687666|NCT03442023|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5687667|NCT03442023|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5687668|NCT03442023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5687669|NCT03442023|Disinfectants|disinfectants|mesh-ancestor
5687670|NCT03442023|Dermatologic Agents|dermatologic agents|mesh-ancestor
5687671|NCT03441893|Nitazoxanide|nitazoxanide|mesh-list
5687672|NCT03441893|Mesalamine|mesalamine|mesh-list
5687673|NCT03441893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5687674|NCT03441893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5687675|NCT03441893|Analgesics|analgesics|mesh-ancestor
5687676|NCT03441893|Sensory System Agents|sensory system agents|mesh-ancestor
5687677|NCT03441893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5687678|NCT03441893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687679|NCT03441893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5687680|NCT03441893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5687681|NCT03441893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5687682|NCT03441893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5687683|NCT03441841|Lidocaine|lidocaine|mesh-list
5687684|NCT03441841|Prilocaine|prilocaine|mesh-list
5687685|NCT03441841|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
5687686|NCT03441841|Anesthetics, Local|anesthetics, local|mesh-ancestor
5687687|NCT03441841|Anesthetics|anesthetics|mesh-ancestor
5687688|NCT03441841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5687689|NCT03441841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687690|NCT03441841|Sensory System Agents|sensory system agents|mesh-ancestor
5687691|NCT03441841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5687692|NCT03441841|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5687693|NCT03441841|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5687694|NCT03441841|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5687695|NCT03441841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5687696|NCT03441841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687697|NCT03441841|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
5687698|NCT03441815|Histamine|histamine|mesh-list
5687699|NCT03441815|Glutarimide|glutarimide|mesh-list
5687700|NCT03441815|Histamine Agonists|histamine agonists|mesh-ancestor
5687701|NCT03441815|Histamine Agents|histamine agents|mesh-ancestor
5687702|NCT03441815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5687703|NCT03441815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687704|NCT03441815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687705|NCT03441815|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5882396|NCT02417285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5882397|NCT02398396|Lactitol|lactitol|mesh-list
5882398|NCT02398396|Cathartics|cathartics|mesh-ancestor
5882399|NCT02398396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5882400|NCT02359968|Paclitaxel|paclitaxel|mesh-list
5882401|NCT02359968|Fluorouracil|fluorouracil|mesh-list
5882402|NCT02359968|Oxaliplatin|oxaliplatin|mesh-list
5882403|NCT02359968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5882404|NCT02359968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5882405|NCT02359968|Tubulin Modulators|tubulin modulators|mesh-ancestor
5882406|NCT02359968|Antimitotic Agents|antimitotic agents|mesh-ancestor
5882407|NCT02359968|Mitosis Modulators|mitosis modulators|mesh-ancestor
5882408|NCT02359968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5882409|NCT02359968|Antimetabolites|antimetabolites|mesh-ancestor
5882410|NCT02359968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5882411|NCT02359968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5882412|NCT02359968|Immunologic Factors|immunologic factors|mesh-ancestor
5882413|NCT02359968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882414|NCT05098704|Clopidogrel|clopidogrel|mesh-list
5882415|NCT05098704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5882416|NCT05098704|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5687706|NCT03441815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5882417|NCT05098704|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6212504|NCT02188719|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5687707|NCT03441529|Tazobactam|tazobactam|mesh-list
5687708|NCT03441529|Piperacillin|piperacillin|mesh-list
5687709|NCT03441529|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
5687710|NCT03441529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5687711|NCT03441529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5687712|NCT03441529|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5687713|NCT03441529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5687714|NCT03441529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687715|NCT03441412|Metoprolol|metoprolol|mesh-list
5687716|NCT03441412|Epinephrine|epinephrine|mesh-list
5687717|NCT03441412|Ticagrelor|ticagrelor|mesh-list
5687718|NCT03441412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5687719|NCT03441412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5687720|NCT03441412|Adrenergic Agents|adrenergic agents|mesh-ancestor
5687721|NCT03441412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5687722|NCT03441412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687723|NCT03441412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687724|NCT03441412|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5687725|NCT03441412|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5687726|NCT03441412|Autonomic Agents|autonomic agents|mesh-ancestor
5687727|NCT03441412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5687728|NCT03441412|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5687729|NCT03441412|Respiratory System Agents|respiratory system agents|mesh-ancestor
5687730|NCT03441412|Mydriatics|mydriatics|mesh-ancestor
5687731|NCT03441412|Sympathomimetics|sympathomimetics|mesh-ancestor
5687732|NCT03441412|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5687733|NCT03441412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5882418|NCT05098704|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5882419|NCT05098704|Purinergic Agents|purinergic agents|mesh-ancestor
5882420|NCT05098704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5882421|NCT05098704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5882422|NCT05098704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882423|NCT05098574|Drospirenone|drospirenone|mesh-list
5882424|NCT05098574|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5882425|NCT05098574|Estradiol|estradiol|mesh-list
5882426|NCT05098574|Estrogens|estrogens|mesh-ancestor
5882427|NCT05098574|Hormones|hormones|mesh-ancestor
5882428|NCT05098574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5882429|NCT05098574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882430|NCT05098574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5882431|NCT05098574|Contraceptive Agents|contraceptive agents|mesh-ancestor
5882432|NCT05098574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5882433|NCT05098574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5882434|NCT05098574|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5882435|NCT05098574|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5882436|NCT05098574|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5882437|NCT05098574|Hormone Antagonists|hormone antagonists|mesh-ancestor
5882438|NCT05098574|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5687734|NCT03441412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5687735|NCT03441412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5687736|NCT03441412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5882439|NCT05098574|Diuretics|diuretics|mesh-ancestor
5882440|NCT05098574|Natriuretic Agents|natriuretic agents|mesh-ancestor
5882441|NCT05098366|Furosemide|furosemide|mesh-list
5882442|NCT05098366|Diuretics|diuretics|mesh-ancestor
5882443|NCT05098366|Natriuretic Agents|natriuretic agents|mesh-ancestor
5882444|NCT05098366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882445|NCT05098366|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5882446|NCT05098366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5882447|NCT05098366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5882448|NCT05098353|Quetiapine Fumarate|quetiapine fumarate|mesh-list
5882449|NCT05098353|Antidepressive Agents|antidepressive agents|mesh-ancestor
5882450|NCT05098353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5882451|NCT05098353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5882452|NCT05098353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5882453|NCT05098353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5882454|NCT05098353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882455|NCT05098327|Pioglitazone|pioglitazone|mesh-list
5882456|NCT05098327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5882457|NCT05098327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882458|NCT05098119|Paclitaxel|paclitaxel|mesh-list
5882459|NCT05098119|Carboplatin|carboplatin|mesh-list
5882460|NCT05098119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5687737|NCT03441412|Purinergic Agents|purinergic agents|mesh-ancestor
5882461|NCT05098119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5882462|NCT05098119|Tubulin Modulators|tubulin modulators|mesh-ancestor
5882463|NCT05098119|Antimitotic Agents|antimitotic agents|mesh-ancestor
5882464|NCT05098119|Mitosis Modulators|mitosis modulators|mesh-ancestor
5882465|NCT05098119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5882466|NCT05098067|Ondansetron|ondansetron|mesh-list
5882467|NCT05098067|Metoclopramide|metoclopramide|mesh-list
5882468|NCT05098067|Capsaicin|capsaicin|mesh-list
5882469|NCT05098067|Antiemetics|antiemetics|mesh-ancestor
5882470|NCT05098067|Autonomic Agents|autonomic agents|mesh-ancestor
5882471|NCT05098067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5882472|NCT05098067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882473|NCT05098067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5882474|NCT05098067|Antipruritics|antipruritics|mesh-ancestor
5882475|NCT05098067|Dermatologic Agents|dermatologic agents|mesh-ancestor
5882476|NCT05098067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5882477|NCT05098067|Serotonin Agents|serotonin agents|mesh-ancestor
5882478|NCT05098067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5882479|NCT05098067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5882480|NCT05098067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5882481|NCT05098067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5882482|NCT05098067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5882483|NCT05098067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5882484|NCT05098067|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5882485|NCT05098067|Sensory System Agents|sensory system agents|mesh-ancestor
5882486|NCT05098067|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5882487|NCT05098067|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5882488|NCT05098067|Dopamine Agents|dopamine agents|mesh-ancestor
5882489|NCT05098028|Rifaximin|rifaximin|mesh-list
5882490|NCT05098028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5882491|NCT05098028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5882492|NCT05098028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5882493|NCT05097950|Acetaminophen|acetaminophen|mesh-list
5882494|NCT05097950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5882495|NCT05097950|Analgesics|analgesics|mesh-ancestor
5882496|NCT05097950|Sensory System Agents|sensory system agents|mesh-ancestor
5882497|NCT05097950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5882498|NCT05097950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882499|NCT05097950|Antipyretics|antipyretics|mesh-ancestor
5882500|NCT05097911|Bevacizumab|bevacizumab|mesh-list
5882501|NCT05097911|Atezolizumab|atezolizumab|mesh-list
5882502|NCT05097911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5882503|NCT05097911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5882504|NCT05097911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5882505|NCT05097911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5882506|NCT05097911|Growth Substances|growth substances|mesh-ancestor
5882507|NCT05097911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882508|NCT05097911|Growth Inhibitors|growth inhibitors|mesh-ancestor
5882509|NCT05097781|Antibodies|antibodies|mesh-list
5882510|NCT05097781|Antibodies, Blocking|antibodies, blocking|mesh-list
5687738|NCT03441412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5687739|NCT03441412|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5687740|NCT03441412|Sympatholytics|sympatholytics|mesh-ancestor
5687741|NCT03441412|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5687742|NCT03441412|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5687743|NCT03441412|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5687744|NCT03441373|Histamine|histamine|mesh-list
5687745|NCT03441373|Histamine phosphate|histamine phosphate|mesh-list
5687746|NCT03441373|Glutarimide|glutarimide|mesh-list
5687747|NCT03441373|Histamine Agonists|histamine agonists|mesh-ancestor
5687748|NCT03441373|Histamine Agents|histamine agents|mesh-ancestor
5687749|NCT03441373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5687750|NCT03441373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5882511|NCT05097781|Immunologic Factors|immunologic factors|mesh-ancestor
5882512|NCT05097781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882513|NCT05097508|Bromides|bromides|mesh-list
5882514|NCT05097508|Rocuronium|rocuronium|mesh-list
5882515|NCT05097508|Atracurium|atracurium|mesh-list
5882516|NCT05097508|Anticonvulsants|anticonvulsants|mesh-ancestor
5882517|NCT05097508|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5687751|NCT03441373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687752|NCT03441373|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5687753|NCT03441373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5882518|NCT05097508|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5687754|NCT03441217|Scopolamine|scopolamine|mesh-list
5882519|NCT05097508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5882520|NCT05097508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5882521|NCT05097508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882522|NCT05097508|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
5882523|NCT05097508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5882524|NCT05097508|Cholinergic Agents|cholinergic agents|mesh-ancestor
5882525|NCT05097508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5882526|NCT05097508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5882527|NCT05097365|Folic Acid|folic acid|mesh-list
5882528|NCT05097365|Vitamin B 12|vitamin b 12|mesh-list
5882529|NCT05097365|Hydroxocobalamin|hydroxocobalamin|mesh-list
5882530|NCT05097365|Vitamins|vitamins|mesh-ancestor
5882531|NCT05097365|Micronutrients|micronutrients|mesh-ancestor
5882532|NCT05097365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882533|NCT05097365|Hematinics|hematinics|mesh-ancestor
5882534|NCT05097365|Vitamin B Complex|vitamin b complex|mesh-ancestor
5882535|NCT05097274|Choline|choline|mesh-list
5882536|NCT05097274|Lipotropic Agents|lipotropic agents|mesh-ancestor
5882537|NCT05097274|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5882538|NCT05097274|Antimetabolites|antimetabolites|mesh-ancestor
5882539|NCT05097274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5882540|NCT05097274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5882541|NCT05097274|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5882542|NCT05097274|Nootropic Agents|nootropic agents|mesh-ancestor
5882543|NCT05097261|Ketamine|ketamine|mesh-list
5882544|NCT05097261|Analgesics|analgesics|mesh-ancestor
5882545|NCT05097261|Sensory System Agents|sensory system agents|mesh-ancestor
5882546|NCT05097261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5882547|NCT05097261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882548|NCT05097261|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5882549|NCT05097261|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5882550|NCT05097261|Anesthetics, General|anesthetics, general|mesh-ancestor
5882551|NCT05097261|Anesthetics|anesthetics|mesh-ancestor
5882552|NCT05097261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5882553|NCT05097261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5882554|NCT05097261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5882555|NCT05097261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5882556|NCT05097261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5882557|NCT05097248|Doxorubicin|doxorubicin|mesh-list
5882558|NCT05097248|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5882559|NCT05097248|Losartan|losartan|mesh-list
5882560|NCT05097248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5882561|NCT05097248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5882562|NCT05097248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5882563|NCT05097248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5882564|NCT05097248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5882565|NCT05097248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5882566|NCT05097248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5882567|NCT05097248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5882568|NCT05097248|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5882569|NCT05097248|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5882570|NCT05097209|Gemcitabine|gemcitabine|mesh-list
5882571|NCT05097209|Cisplatin|cisplatin|mesh-list
5882572|NCT05097209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5882573|NCT05097209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5882574|NCT05097209|Antimetabolites|antimetabolites|mesh-ancestor
5687755|NCT03441217|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
5687756|NCT03441217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5687757|NCT03441217|Antiemetics|antiemetics|mesh-ancestor
5687758|NCT03441217|Autonomic Agents|autonomic agents|mesh-ancestor
5687759|NCT03441217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5687760|NCT03441217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687761|NCT03441217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5687762|NCT03441217|Mydriatics|mydriatics|mesh-ancestor
5687763|NCT03441217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5687764|NCT03441217|Cholinergic Agents|cholinergic agents|mesh-ancestor
5687765|NCT03441217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5687766|NCT03441217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687767|NCT03441217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5687768|NCT03441217|Parasympatholytics|parasympatholytics|mesh-ancestor
5687769|NCT03441048|Cytarabine|cytarabine|mesh-list
5687770|NCT03441048|Mitoxantrone|mitoxantrone|mesh-list
5687771|NCT03441048|Cladribine|cladribine|mesh-list
5687772|NCT03441048|Lintuzumab|lintuzumab|mesh-list
5687773|NCT03441048|Sargramostim|sargramostim|mesh-list
5687774|NCT03441048|Lenograstim|lenograstim|mesh-list
5687775|NCT03441048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5687776|NCT03441048|Antimetabolites|antimetabolites|mesh-ancestor
5687777|NCT03441048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5698104|NCT03371342|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5882575|NCT05097209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5882576|NCT05097209|Antiviral Agents|antiviral agents|mesh-ancestor
5882577|NCT05097209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5882578|NCT05097209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5882579|NCT05097209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5882580|NCT05097209|Immunologic Factors|immunologic factors|mesh-ancestor
5882581|NCT05097209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906621|NCT05138146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687778|NCT03441048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5687779|NCT03441048|Antiviral Agents|antiviral agents|mesh-ancestor
5687780|NCT03441048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5687781|NCT03441048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5687782|NCT03441048|Immunologic Factors|immunologic factors|mesh-ancestor
5906622|NCT05138068|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
5906623|NCT05138068|Hallucinogens|hallucinogens|mesh-ancestor
5906624|NCT05138068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906625|NCT05138068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5906626|NCT05138068|Serotonin Agents|serotonin agents|mesh-ancestor
5906627|NCT05138068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5906628|NCT05138068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906629|NCT05138068|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5906630|NCT05138068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5906631|NCT05138068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5906632|NCT05138068|Adrenergic Agents|adrenergic agents|mesh-ancestor
5906633|NCT05137964|Vitamin D|vitamin d|mesh-list
5906634|NCT05137964|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
5906635|NCT05137964|Vitamins|vitamins|mesh-ancestor
5906636|NCT05137964|Micronutrients|micronutrients|mesh-ancestor
5906637|NCT05137964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906638|NCT05137964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5906639|NCT05137847|Denileukin diftitox|denileukin diftitox|mesh-list
5906640|NCT05137847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5908661|NCT04302766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908662|NCT04302766|Antiviral Agents|antiviral agents|mesh-ancestor
5908663|NCT04302766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5908664|NCT04298229|Dapagliflozin|dapagliflozin|mesh-list
5908665|NCT04298229|Diuretics|diuretics|mesh-list
5908666|NCT04298229|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5687783|NCT03441048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687784|NCT03441048|Analgesics|analgesics|mesh-ancestor
5687785|NCT03441048|Sensory System Agents|sensory system agents|mesh-ancestor
5908667|NCT04298229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908668|NCT04298229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5908669|NCT04298229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5908670|NCT04298229|Natriuretic Agents|natriuretic agents|mesh-ancestor
5908671|NCT04278898|Acetylcysteine|acetylcysteine|mesh-list
5908672|NCT04278898|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5908673|NCT04278898|Antiviral Agents|antiviral agents|mesh-ancestor
5687786|NCT03441048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5687787|NCT03441048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5687788|NCT03441048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5687789|NCT03441048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5687790|NCT03441048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5687791|NCT03441048|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5687792|NCT03441035|Anesthetics|anesthetics|mesh-list
5687793|NCT03441035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5687794|NCT03441035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687795|NCT03440996|Listerine|listerine|mesh-list
5687796|NCT03440996|Sodium Fluoride|sodium fluoride|mesh-list
5687797|NCT03440996|Cariostatic Agents|cariostatic agents|mesh-ancestor
5687798|NCT03440996|Protective Agents|protective agents|mesh-ancestor
5687799|NCT03440996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687800|NCT03440996|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5687801|NCT03440996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5687802|NCT03440892|Sulfasalazine|sulfasalazine|mesh-list
5687803|NCT03440892|Methotrexate|methotrexate|mesh-list
5687804|NCT03440892|Abatacept|abatacept|mesh-list
5687805|NCT03440892|Tofacitinib|tofacitinib|mesh-list
5687806|NCT03440892|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5687807|NCT03440892|Abortifacient Agents|abortifacient agents|mesh-ancestor
5687808|NCT03440892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5687809|NCT03440892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5908674|NCT04278898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5908675|NCT04278898|Expectorants|expectorants|mesh-ancestor
5908676|NCT04278898|Respiratory System Agents|respiratory system agents|mesh-ancestor
5882582|NCT05090280|Nafamostat|nafamostat|mesh-list
5882583|NCT05090280|Naltrexone|naltrexone|mesh-list
5882584|NCT05090280|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5882585|NCT05090280|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5882586|NCT05090280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882587|NCT05090280|Sensory System Agents|sensory system agents|mesh-ancestor
5882588|NCT05090280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5882589|NCT05090280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5882590|NCT05090280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5882591|NCT05090280|Analgesics|analgesics|mesh-ancestor
5882592|NCT05090280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5882593|NCT05090280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5882594|NCT05090280|Anticoagulants|anticoagulants|mesh-ancestor
5882595|NCT05090280|Protease Inhibitors|protease inhibitors|mesh-ancestor
5882596|NCT05090280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5882597|NCT05090280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5882598|NCT05090280|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5882599|NCT05090280|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5882600|NCT05090280|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5882601|NCT05090280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5882602|NCT05090280|Immunologic Factors|immunologic factors|mesh-ancestor
5882603|NCT05089851|Sunscreening Agents|sunscreening agents|mesh-list
5882604|NCT05089851|Botulinum Toxins|botulinum toxins|mesh-list
5882605|NCT05089851|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5882606|NCT05089851|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5882607|NCT05089851|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5882608|NCT05089851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5882609|NCT05089851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5882610|NCT05089851|Cholinergic Agents|cholinergic agents|mesh-ancestor
5882611|NCT05089851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5882612|NCT05089851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882613|NCT05089851|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5882614|NCT05089851|Protective Agents|protective agents|mesh-ancestor
5882615|NCT05089851|Dermatologic Agents|dermatologic agents|mesh-ancestor
5882616|NCT05089851|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5882617|NCT05089851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5882618|NCT05087940|Diuretics|diuretics|mesh-list
5882619|NCT05087940|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
5882620|NCT05087940|Natriuretic Agents|natriuretic agents|mesh-ancestor
5882621|NCT05087940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882622|NCT05087940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5882623|NCT05087940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5882624|NCT05086939|Hyaluronic Acid|hyaluronic acid|mesh-list
5882625|NCT05086939|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5882626|NCT05086939|Immunologic Factors|immunologic factors|mesh-ancestor
5882627|NCT05086939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882628|NCT05086939|Viscosupplements|viscosupplements|mesh-ancestor
5882629|NCT05086939|Protective Agents|protective agents|mesh-ancestor
5882630|NCT05083325|Oseltamivir|oseltamivir|mesh-list
5882631|NCT05083325|Antiviral Agents|antiviral agents|mesh-ancestor
5882632|NCT05083325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5687810|NCT03440892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5687811|NCT03440892|Antimetabolites|antimetabolites|mesh-ancestor
5687812|NCT03440892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687813|NCT03440892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5687814|NCT03440892|Dermatologic Agents|dermatologic agents|mesh-ancestor
5687815|NCT03440892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5687816|NCT03440892|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5687817|NCT03440892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5687818|NCT03440892|Immunologic Factors|immunologic factors|mesh-ancestor
5687819|NCT03440892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5687820|NCT03440892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5687821|NCT03440892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5687822|NCT03440892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5687823|NCT03440892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5687824|NCT03440892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5687825|NCT03440892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5687826|NCT03440892|Analgesics|analgesics|mesh-ancestor
5687827|NCT03440892|Sensory System Agents|sensory system agents|mesh-ancestor
5687828|NCT03440892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5687829|NCT03440892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5687830|NCT03440892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5687831|NCT03440879|Goserelin|goserelin|mesh-list
5687832|NCT03440879|Androgens|androgens|mesh-list
5687833|NCT03440879|Hormones|hormones|mesh-ancestor
5687834|NCT03440879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5687835|NCT03440879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687836|NCT03440879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5687837|NCT03440879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5687838|NCT03440788|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5687839|NCT03440788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5687840|NCT03440788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5697406|NCT03376191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5882633|NCT05083325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5882634|NCT05083325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5882635|NCT05060484|Vaccines|vaccines|mesh-list
5882636|NCT05060484|Immunologic Factors|immunologic factors|mesh-ancestor
5882637|NCT05060484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882638|NCT05057572|Carvedilol|carvedilol|mesh-list
5882639|NCT05057572|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5882640|NCT05057572|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5882641|NCT05057572|Adrenergic Agents|adrenergic agents|mesh-ancestor
5882642|NCT05057572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5882643|NCT05057572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5882644|NCT05057572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882645|NCT05057572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5882646|NCT05057572|Antioxidants|antioxidants|mesh-ancestor
5882647|NCT05057572|Protective Agents|protective agents|mesh-ancestor
5882648|NCT05057572|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5882649|NCT05057572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5882650|NCT05057572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5882651|NCT05057572|Vasodilator Agents|vasodilator agents|mesh-ancestor
5882652|NCT05057572|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5882653|NCT05057572|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5882654|NCT05055713|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
5882655|NCT05055713|Somatostatin|somatostatin|mesh-list
5882656|NCT05055713|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5882657|NCT05055713|Adrenergic Agents|adrenergic agents|mesh-ancestor
5882658|NCT05055713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5882659|NCT05055713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5882660|NCT05055713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882661|NCT05055713|Hormones|hormones|mesh-ancestor
5882662|NCT05055713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5697407|NCT03376191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5697408|NCT03376191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697409|NCT03376178|Lidocaine|lidocaine|mesh-list
5697410|NCT03376178|Ropivacaine|ropivacaine|mesh-list
5697411|NCT03376178|Anesthetics, Local|anesthetics, local|mesh-ancestor
5697412|NCT03376178|Anesthetics|anesthetics|mesh-ancestor
5697413|NCT03376178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5697414|NCT03376178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882663|NCT05026801|Azithromycin|azithromycin|mesh-list
5882664|NCT05026801|Hydroxychloroquine|hydroxychloroquine|mesh-list
5882665|NCT05026801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5882666|NCT05026801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5882667|NCT05026801|Antimalarials|antimalarials|mesh-ancestor
5882668|NCT05026801|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5882669|NCT05026801|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5882670|NCT05026801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5882671|NCT05026801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687841|NCT03440567|Rituximab|rituximab|mesh-list
5687842|NCT03440567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5687843|NCT03440567|Avelumab|avelumab|mesh-list
5687844|NCT03440567|Carboplatin|carboplatin|mesh-list
5687845|NCT03440567|Etoposide|etoposide|mesh-list
5687846|NCT03440567|Ifosfamide|ifosfamide|mesh-list
5687847|NCT03440567|Isophosphamide mustard|isophosphamide mustard|mesh-list
5687848|NCT03440567|Etoposide phosphate|etoposide phosphate|mesh-list
5687849|NCT03440567|Antibodies|antibodies|mesh-list
5687850|NCT03440567|Immunoglobulins|immunoglobulins|mesh-list
5687851|NCT03440567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5687852|NCT03440567|Immunoglobulin G|immunoglobulin g|mesh-list
5687853|NCT03440567|Immunologic Factors|immunologic factors|mesh-ancestor
5687854|NCT03440567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687855|NCT03440567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5687856|NCT03440567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5882672|NCT05026801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5882673|NCT05019885|Ketamine|ketamine|mesh-list
5882674|NCT05019885|Analgesics|analgesics|mesh-ancestor
5882675|NCT05019885|Sensory System Agents|sensory system agents|mesh-ancestor
5882676|NCT05019885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5882677|NCT05019885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882678|NCT05019885|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5882679|NCT05019885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5882680|NCT05019885|Anesthetics, General|anesthetics, general|mesh-ancestor
5882681|NCT05019885|Anesthetics|anesthetics|mesh-ancestor
5882682|NCT05019885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5882683|NCT05019885|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5882684|NCT05019885|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5882685|NCT05019885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5882686|NCT05019885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5882687|NCT04999631|Ethanol|ethanol|mesh-list
5882688|NCT04999631|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
5882689|NCT04999631|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5882690|NCT04999631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5882691|NCT04999631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5882692|NCT04999631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882693|NCT04999631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5882694|NCT04999631|Immunologic Factors|immunologic factors|mesh-ancestor
5882695|NCT04985955|Tofacitinib|tofacitinib|mesh-list
5882696|NCT04985955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5882697|NCT04985955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5882698|NCT04985955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5882699|NCT04950660|Caffeine|caffeine|mesh-list
5882700|NCT04950660|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5882701|NCT04950660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882702|NCT04950660|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5882703|NCT04950660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5882704|NCT04950660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5882705|NCT04950660|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5687857|NCT03440567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5687858|NCT03440567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5687859|NCT03440567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5687860|NCT03440567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5687861|NCT03440567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687862|NCT03440567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5687863|NCT03440567|Alkylating Agents|alkylating agents|mesh-ancestor
5687864|NCT03440515|Prednisone|prednisone|mesh-list
5882706|NCT04950660|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5882707|NCT04950660|Purinergic Agents|purinergic agents|mesh-ancestor
5882708|NCT04950660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5882709|NCT04919369|Vitamins|vitamins|mesh-list
5882710|NCT04919369|Vitamin A|vitamin a|mesh-list
5882711|NCT04919369|Atezolizumab|atezolizumab|mesh-list
5882712|NCT04919369|Retinol palmitate|retinol palmitate|mesh-list
6496021|NCT00625937|Tubulin Modulators|tubulin modulators|mesh-ancestor
6496022|NCT00625937|Antimitotic Agents|antimitotic agents|mesh-ancestor
6496023|NCT00625937|Mitosis Modulators|mitosis modulators|mesh-ancestor
5687865|NCT03440515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5687866|NCT03440515|Glucocorticoids|glucocorticoids|mesh-ancestor
5687867|NCT03440515|Hormones|hormones|mesh-ancestor
5687868|NCT03440515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5687869|NCT03440515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687870|NCT03440515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5687871|NCT03440515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5882713|NCT04919369|Tretinoin|tretinoin|mesh-list
6496024|NCT00625937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496025|NCT00625937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6496026|NCT00625937|Antimetabolites|antimetabolites|mesh-ancestor
6496027|NCT00626015|Temozolomide|temozolomide|mesh-list
6496028|NCT00626015|Daclizumab|daclizumab|mesh-list
6496029|NCT00626015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6496030|NCT00626015|Alkylating Agents|alkylating agents|mesh-ancestor
5882714|NCT04919369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5882715|NCT04919369|Micronutrients|micronutrients|mesh-ancestor
6496031|NCT00626015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5882716|NCT04919369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882717|NCT04919369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5882718|NCT04919369|Immunologic Factors|immunologic factors|mesh-ancestor
5882719|NCT04919369|Antioxidants|antioxidants|mesh-ancestor
5882720|NCT04919369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5882721|NCT04919369|Protective Agents|protective agents|mesh-ancestor
5882722|NCT04919369|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5882723|NCT04919369|Keratolytic Agents|keratolytic agents|mesh-ancestor
5882724|NCT04919369|Dermatologic Agents|dermatologic agents|mesh-ancestor
5882725|NCT04912791|Anesthetics|anesthetics|mesh-list
5882726|NCT04912791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5882727|NCT04912791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882728|NCT04908293|Listerine|listerine|mesh-list
5882729|NCT04908293|Sodium Fluoride|sodium fluoride|mesh-list
5882730|NCT04908293|Cariostatic Agents|cariostatic agents|mesh-ancestor
5882731|NCT04908293|Protective Agents|protective agents|mesh-ancestor
5882732|NCT04908293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882733|NCT04908293|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5882734|NCT04908293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5882735|NCT04903223|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5882736|NCT04903223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5882737|NCT04903223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5882738|NCT04903223|Antimetabolites|antimetabolites|mesh-ancestor
5882739|NCT04903223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5882740|NCT04903223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5882741|NCT04903223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5882742|NCT04903223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5882743|NCT04858854|Sulforaphane|sulforaphane|mesh-list
5882744|NCT04858854|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5882745|NCT04858854|Protective Agents|protective agents|mesh-ancestor
5882746|NCT04858854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882747|NCT04858854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5882748|NCT04853004|Antibodies|antibodies|mesh-list
5882749|NCT04853004|Immunologic Factors|immunologic factors|mesh-ancestor
5882750|NCT04853004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882751|NCT04839185|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
5882752|NCT04839185|Hematinics|hematinics|mesh-ancestor
5882753|NCT04839185|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5882754|NCT04839185|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5882755|NCT04815876|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5882756|NCT04815876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5882757|NCT04814940|Menotropins|menotropins|mesh-list
5882758|NCT04814940|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5882759|NCT04814940|Fertility Agents|fertility agents|mesh-ancestor
5882760|NCT04814940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5882761|NCT04814940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882762|NCT04806100|Carbon Fiber|carbon fiber|mesh-list
5882763|NCT04806100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5882764|NCT04806100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5882765|NCT04801368|Anesthetics|anesthetics|mesh-list
5882766|NCT04801368|Anesthetics, Local|anesthetics, local|mesh-list
5882767|NCT04801368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5882768|NCT04801368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882769|NCT04801368|Sensory System Agents|sensory system agents|mesh-ancestor
5882770|NCT04801368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5882771|NCT04796636|Ascorbic Acid|ascorbic acid|mesh-list
5882772|NCT04796636|Antioxidants|antioxidants|mesh-ancestor
5882773|NCT04796636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5882774|NCT04796636|Protective Agents|protective agents|mesh-ancestor
5882775|NCT04796636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882776|NCT04796636|Vitamins|vitamins|mesh-ancestor
5882777|NCT04796636|Micronutrients|micronutrients|mesh-ancestor
5882778|NCT04759274|Diuretics|diuretics|mesh-list
5882779|NCT04759274|Natriuretic Agents|natriuretic agents|mesh-ancestor
5882780|NCT04759274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882781|NCT04718636|Moxifloxacin|moxifloxacin|mesh-list
5882782|NCT04718636|Contraceptive Agents|contraceptive agents|mesh-list
5882783|NCT04718636|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
5882784|NCT04718636|Contraceptives, Oral|contraceptives, oral|mesh-list
5882785|NCT04718636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5882786|NCT04718636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882787|NCT04718636|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5882788|NCT04718636|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5882789|NCT04718636|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5882790|NCT04718636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5882791|NCT04718636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5882792|NCT04718636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5882793|NCT04718636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5882794|NCT04718636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5882795|NCT04718636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5882796|NCT04718636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5882797|NCT04707261|Dapagliflozin|dapagliflozin|mesh-list
5882798|NCT04707261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5882799|NCT04707261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687872|NCT03440502|Anesthetics|anesthetics|mesh-list
5687873|NCT03440502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5687874|NCT03440502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687875|NCT03440359|Letrozole|letrozole|mesh-list
5687876|NCT03440359|Progesterone|progesterone|mesh-list
5687877|NCT03440359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5687878|NCT03440359|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5687879|NCT03440359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5687880|NCT03440359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5882800|NCT04707261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5882801|NCT04707261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882802|NCT04689945|Morphine|morphine|mesh-list
5882803|NCT04689945|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5882804|NCT04689945|Narcotics|narcotics|mesh-ancestor
5882805|NCT04689945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5882806|NCT04689945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882807|NCT04689945|Analgesics|analgesics|mesh-ancestor
5882808|NCT04689945|Sensory System Agents|sensory system agents|mesh-ancestor
5882809|NCT04689945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5882810|NCT04676412|Pembrolizumab|pembrolizumab|mesh-list
5687881|NCT03440359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687882|NCT03440359|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5687883|NCT03440359|Hormone Antagonists|hormone antagonists|mesh-ancestor
5687884|NCT03440359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5687885|NCT03440359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687886|NCT03440359|Progestins|progestins|mesh-ancestor
5687887|NCT03440359|Hormones|hormones|mesh-ancestor
5687888|NCT03440333|Pulmonary Surfactants|pulmonary surfactants|mesh-list
5687889|NCT03440333|Respiratory System Agents|respiratory system agents|mesh-ancestor
5687890|NCT03440268|Acetylcysteine|acetylcysteine|mesh-list
5687891|NCT03440268|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5687892|NCT03440268|Antiviral Agents|antiviral agents|mesh-ancestor
5687893|NCT03440268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5687894|NCT03440268|Expectorants|expectorants|mesh-ancestor
5687895|NCT03440268|Respiratory System Agents|respiratory system agents|mesh-ancestor
5687896|NCT03440268|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5687897|NCT03440268|Antioxidants|antioxidants|mesh-ancestor
5687898|NCT03440268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687899|NCT03440268|Protective Agents|protective agents|mesh-ancestor
5687900|NCT03440268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687901|NCT03440268|Antidotes|antidotes|mesh-ancestor
5687902|NCT03440216|Meropenem|meropenem|mesh-list
5687903|NCT03440216|Ceftriaxone|ceftriaxone|mesh-list
5687904|NCT03440216|Temocillin|temocillin|mesh-list
5882811|NCT04676412|Lenvatinib|lenvatinib|mesh-list
5882812|NCT04676412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5882813|NCT04676412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5882814|NCT04676412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5882815|NCT04676412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5882816|NCT04676412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5882817|NCT04655755|Decitabine|decitabine|mesh-list
5882818|NCT04655755|Venetoclax|venetoclax|mesh-list
5882819|NCT04655755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5882820|NCT04655755|Antimetabolites|antimetabolites|mesh-ancestor
5882821|NCT04655755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687905|NCT03440216|Penicillins|penicillins|mesh-list
5687906|NCT03440216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5687907|NCT03440216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5687908|NCT03440190|Methylphenidate|methylphenidate|mesh-list
5687909|NCT03440190|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5687910|NCT03440190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882822|NCT04655755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5882823|NCT04655755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5906648|NCT05137587|Ketamine|ketamine|mesh-list
5906649|NCT05137587|Propofol|propofol|mesh-list
5906650|NCT05137587|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5906651|NCT05137587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5906652|NCT05137587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906653|NCT05137587|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5906654|NCT05137587|Anesthetics, General|anesthetics, general|mesh-ancestor
5687911|NCT03440190|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5687912|NCT03440190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5687913|NCT03440190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5687914|NCT03440190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687915|NCT03440190|Dopamine Agents|dopamine agents|mesh-ancestor
5906655|NCT05137587|Anesthetics|anesthetics|mesh-ancestor
5906656|NCT05137587|Analgesics|analgesics|mesh-ancestor
5906657|NCT05137587|Sensory System Agents|sensory system agents|mesh-ancestor
5906658|NCT05137587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5906659|NCT05137587|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5906660|NCT05137587|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5906661|NCT05137587|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5906662|NCT05137587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5906663|NCT05137587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906664|NCT05137574|Ketamine|ketamine|mesh-list
5906665|NCT05137574|Propofol|propofol|mesh-list
5906666|NCT05137574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5906667|NCT05137574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5906668|NCT05137574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906669|NCT05137574|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5906670|NCT05137574|Anesthetics, General|anesthetics, general|mesh-ancestor
5906671|NCT05137574|Anesthetics|anesthetics|mesh-ancestor
5906672|NCT05137574|Analgesics|analgesics|mesh-ancestor
5687916|NCT03440190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5687917|NCT03440177|Ramipril|ramipril|mesh-list
5687918|NCT03440177|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5687919|NCT03440177|Protease Inhibitors|protease inhibitors|mesh-ancestor
5687920|NCT03440177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5687921|NCT03440177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687922|NCT03440177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5687923|NCT03440112|Clarithromycin|clarithromycin|mesh-list
5687924|NCT03440112|Flumazenil|flumazenil|mesh-list
5687925|NCT03440112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5687926|NCT03440112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5687927|NCT03440112|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5687928|NCT03440112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5687929|NCT03440112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687930|NCT03440112|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5687931|NCT03440112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5906673|NCT05137574|Sensory System Agents|sensory system agents|mesh-ancestor
5906674|NCT05137574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5906675|NCT05137574|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5906676|NCT05137574|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6496032|NCT00626015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5882824|NCT04644796|Bupivacaine|bupivacaine|mesh-list
5882825|NCT04644796|Anesthetics, Local|anesthetics, local|mesh-ancestor
5882826|NCT04644796|Anesthetics|anesthetics|mesh-ancestor
5882827|NCT04644796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5882828|NCT04644796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882829|NCT04644796|Sensory System Agents|sensory system agents|mesh-ancestor
5882830|NCT04644796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5882831|NCT04616924|Clarithromycin|clarithromycin|mesh-list
5882832|NCT04616924|Rifabutin|rifabutin|mesh-list
5882833|NCT04616924|Clofazimine|clofazimine|mesh-list
5882834|NCT04616924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5882835|NCT04616924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5882836|NCT04616924|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5882837|NCT04616924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5882838|NCT04616924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687932|NCT03440112|Antidotes|antidotes|mesh-ancestor
5687933|NCT03440112|Protective Agents|protective agents|mesh-ancestor
5687934|NCT03440112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882839|NCT04616924|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5882840|NCT04616924|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5882841|NCT04616924|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5882842|NCT04616924|Antitubercular Agents|antitubercular agents|mesh-ancestor
5882843|NCT04616924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5882844|NCT04616924|Leprostatic Agents|leprostatic agents|mesh-ancestor
5882845|NCT04616274|Venetoclax|venetoclax|mesh-list
5882846|NCT04616274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5882847|NCT04613622|Venetoclax|venetoclax|mesh-list
5882848|NCT04613622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5882849|NCT04562792|Daunorubicin|daunorubicin|mesh-list
5882850|NCT04562792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5687935|NCT03440112|GABA Modulators|gaba modulators|mesh-ancestor
5687936|NCT03440112|GABA Agents|gaba agents|mesh-ancestor
5687937|NCT03440112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5687938|NCT03440034|Pioglitazone|pioglitazone|mesh-list
5687939|NCT03440034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5687940|NCT03440034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687941|NCT03439943|Lixisenatide|lixisenatide|mesh-list
5687942|NCT03439943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5687943|NCT03439943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687944|NCT03439891|Nivolumab|nivolumab|mesh-list
5687945|NCT03439891|Sorafenib|sorafenib|mesh-list
5687946|NCT03439891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5687947|NCT03439891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5687948|NCT03439891|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5687949|NCT03439891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687950|NCT03439891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5882851|NCT04562792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5882852|NCT04562792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5882853|NCT04562792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5882854|NCT04562792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5882855|NCT04562792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5882856|NCT04546620|Prednisolone|prednisolone|mesh-list
5882857|NCT04546620|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5882858|NCT04546620|Methylprednisolone|methylprednisolone|mesh-list
5882859|NCT04546620|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5882860|NCT04546620|Prednisolone acetate|prednisolone acetate|mesh-list
5882861|NCT04546620|Prednisone|prednisone|mesh-list
5882862|NCT04546620|Cyclophosphamide|cyclophosphamide|mesh-list
5882863|NCT04546620|Rituximab|rituximab|mesh-list
5687951|NCT03439891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5687952|NCT03439865|Ivacaftor|ivacaftor|mesh-list
5687953|NCT03439865|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
5687954|NCT03439865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5687955|NCT03439865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687956|NCT03439787|Epinephrine|epinephrine|mesh-list
5687957|NCT03439787|Bupivacaine|bupivacaine|mesh-list
5687958|NCT03439787|Anesthetics, Local|anesthetics, local|mesh-ancestor
5687959|NCT03439787|Anesthetics|anesthetics|mesh-ancestor
5882864|NCT04546620|Doxorubicin|doxorubicin|mesh-list
5882865|NCT04546620|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5882866|NCT04546620|Vincristine|vincristine|mesh-list
5882867|NCT04546620|Acalabrutinib|acalabrutinib|mesh-list
5882868|NCT04546620|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5882869|NCT04546620|Prednisolone phosphate|prednisolone phosphate|mesh-list
5882870|NCT04546620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5882871|NCT04546620|Immunologic Factors|immunologic factors|mesh-ancestor
5687960|NCT03439787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5687961|NCT03439787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687962|NCT03439787|Sensory System Agents|sensory system agents|mesh-ancestor
5882872|NCT04546620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882873|NCT04546620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5882874|NCT04546620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5882875|NCT04546620|Alkylating Agents|alkylating agents|mesh-ancestor
5882876|NCT04546620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5882877|NCT04546620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5882878|NCT04546620|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5882879|NCT04546620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5882880|NCT04546620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5882881|NCT04546620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5882882|NCT04546620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5882883|NCT04546620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5882884|NCT04546620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5882885|NCT04546620|Tubulin Modulators|tubulin modulators|mesh-ancestor
5882886|NCT04546620|Antimitotic Agents|antimitotic agents|mesh-ancestor
5882887|NCT04546620|Mitosis Modulators|mitosis modulators|mesh-ancestor
5882888|NCT04546620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5882889|NCT04546620|Glucocorticoids|glucocorticoids|mesh-ancestor
5882890|NCT04546620|Hormones|hormones|mesh-ancestor
5882891|NCT04546620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5882892|NCT04546620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5882893|NCT04546620|Antiemetics|antiemetics|mesh-ancestor
5882894|NCT04546620|Autonomic Agents|autonomic agents|mesh-ancestor
5882895|NCT04546620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5882896|NCT04546620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5882897|NCT04546620|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5882898|NCT04546620|Protective Agents|protective agents|mesh-ancestor
5882899|NCT04523935|Topiramate|topiramate|mesh-list
5882900|NCT04523935|Lamotrigine|lamotrigine|mesh-list
5882901|NCT04523935|Diazepam|diazepam|mesh-list
5882902|NCT04523935|Gabapentin|gabapentin|mesh-list
5882903|NCT04523935|Amitriptyline|amitriptyline|mesh-list
5882904|NCT04523935|Anticonvulsants|anticonvulsants|mesh-list
5882905|NCT04523935|Clonazepam|clonazepam|mesh-list
5882906|NCT04523935|Trihexyphenidyl|trihexyphenidyl|mesh-list
5882907|NCT04523935|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
5882908|NCT04523935|Baclofen|baclofen|mesh-list
5882909|NCT04523935|Tetrabenazine|tetrabenazine|mesh-list
5882910|NCT04523935|Analgesics|analgesics|mesh-ancestor
5882911|NCT04523935|Sensory System Agents|sensory system agents|mesh-ancestor
5882912|NCT04523935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5882913|NCT04523935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882914|NCT04523935|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5882915|NCT04523935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5687963|NCT03439787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5687964|NCT03439787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5687965|NCT03439787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5687966|NCT03439787|Adrenergic Agents|adrenergic agents|mesh-ancestor
5882916|NCT04523935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5882917|NCT04523935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5882918|NCT04523935|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5882919|NCT04523935|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5687967|NCT03439787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5687968|NCT03439787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5687969|NCT03439787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5687970|NCT03439787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5687971|NCT03439787|Autonomic Agents|autonomic agents|mesh-ancestor
5687972|NCT03439787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5687973|NCT03439787|Respiratory System Agents|respiratory system agents|mesh-ancestor
5687974|NCT03439787|Mydriatics|mydriatics|mesh-ancestor
5687975|NCT03439787|Sympathomimetics|sympathomimetics|mesh-ancestor
5687976|NCT03439787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5687977|NCT03439709|Lanreotide|lanreotide|mesh-list
5687978|NCT03439709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5687979|NCT03439670|Prednisone|prednisone|mesh-list
5687980|NCT03439670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5687981|NCT03439670|Glucocorticoids|glucocorticoids|mesh-ancestor
5687982|NCT03439670|Hormones|hormones|mesh-ancestor
5687983|NCT03439670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5687984|NCT03439670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687985|NCT03439670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5687986|NCT03439670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5687987|NCT03439501|Avelumab|avelumab|mesh-list
5687988|NCT03439501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5687989|NCT03439501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5687990|NCT03439358|Magnesium Sulfate|magnesium sulfate|mesh-list
5687991|NCT03439358|Analgesics|analgesics|mesh-ancestor
5687992|NCT03439358|Sensory System Agents|sensory system agents|mesh-ancestor
5882920|NCT04523935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5882921|NCT04523935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5882922|NCT04523935|Antimanic Agents|antimanic agents|mesh-ancestor
5882923|NCT04523935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5882924|NCT04523935|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5882925|NCT04523935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5882926|NCT04523935|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5882927|NCT04523935|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5882928|NCT04523935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5882929|NCT04523935|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5882930|NCT04523935|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5882931|NCT04523935|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
5882932|NCT04523935|GABA Agonists|gaba agonists|mesh-ancestor
5882933|NCT04523935|GABA Agents|gaba agents|mesh-ancestor
5882934|NCT04523935|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5882935|NCT04523935|Antidepressive Agents|antidepressive agents|mesh-ancestor
5882936|NCT04523935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5882937|NCT04523935|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5882938|NCT04523935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5882939|NCT04523935|Adrenergic Agents|adrenergic agents|mesh-ancestor
5882940|NCT04523935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5882941|NCT04523935|Antiemetics|antiemetics|mesh-ancestor
5882942|NCT04523935|Autonomic Agents|autonomic agents|mesh-ancestor
5882943|NCT04523935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5882944|NCT04523935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5882945|NCT04523935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5882946|NCT04523935|Anesthetics, General|anesthetics, general|mesh-ancestor
5882947|NCT04523935|Anesthetics|anesthetics|mesh-ancestor
5882948|NCT04523935|GABA Modulators|gaba modulators|mesh-ancestor
5882949|NCT04523935|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5882950|NCT04523935|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5687993|NCT03439358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5687994|NCT03439358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5687995|NCT03439358|Anesthetics|anesthetics|mesh-ancestor
5882951|NCT04523935|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5882952|NCT04523935|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5882953|NCT04523935|Cholinergic Agents|cholinergic agents|mesh-ancestor
5882954|NCT04515186|Miltefosine|miltefosine|mesh-list
5882955|NCT04515186|Meglumine Antimoniate|meglumine antimoniate|mesh-list
5882956|NCT04515186|Antifungal Agents|antifungal agents|mesh-ancestor
5882957|NCT04515186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5882958|NCT04515186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5882959|NCT04515186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5882960|NCT04515186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6675479|NCT01575678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675480|NCT01575678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6675481|NCT01575717|Vitamin D|vitamin d|mesh-list
6675482|NCT01575717|Ergocalciferols|ergocalciferols|mesh-list
6675483|NCT01575717|Cholecalciferol|cholecalciferol|mesh-list
6675484|NCT01575717|Vitamins|vitamins|mesh-list
6675485|NCT01575717|Micronutrients|micronutrients|mesh-ancestor
6675486|NCT01575717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675487|NCT01575717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6675488|NCT01575717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5687996|NCT03439358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5882961|NCT04507841|Niraparib|niraparib|mesh-list
5882962|NCT04507841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5882963|NCT04507841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5882964|NCT04507841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5882965|NCT04507841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5882966|NCT04414241|Hydroxychloroquine|hydroxychloroquine|mesh-list
5882967|NCT04414241|Antimalarials|antimalarials|mesh-ancestor
5882968|NCT04414241|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5882969|NCT04414241|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5882970|NCT04414241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5882971|NCT04414241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5882972|NCT04414241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5882973|NCT04414241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5882974|NCT04399356|Niclosamide|niclosamide|mesh-list
5882975|NCT04399356|Anticestodal Agents|anticestodal agents|mesh-ancestor
5882976|NCT04399356|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5882977|NCT04399356|Anthelmintics|anthelmintics|mesh-ancestor
5882978|NCT04399356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5882979|NCT04399356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5882980|NCT04399356|Antinematodal Agents|antinematodal agents|mesh-ancestor
5882981|NCT04395222|Fludarabine|fludarabine|mesh-list
5882982|NCT04395222|Melphalan|melphalan|mesh-list
5882983|NCT04395222|Thymoglobulin|thymoglobulin|mesh-list
5882984|NCT04395222|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5882985|NCT04395222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5882986|NCT04395222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5882987|NCT04395222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5882988|NCT04395222|Immunologic Factors|immunologic factors|mesh-ancestor
5882989|NCT04395222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882990|NCT04395222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5882991|NCT04395222|Alkylating Agents|alkylating agents|mesh-ancestor
5882992|NCT04395222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5882993|NCT04389775|Glucagon|glucagon|mesh-list
5882994|NCT04389775|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5882995|NCT04389775|Incretins|incretins|mesh-ancestor
5882996|NCT04389775|Hormones|hormones|mesh-ancestor
5882997|NCT04389775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5882998|NCT04389775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5882999|NCT04389775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5883000|NCT04368455|Vaccines|vaccines|mesh-list
5883001|NCT04368455|Immunologic Factors|immunologic factors|mesh-ancestor
5883002|NCT04368455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883003|NCT04345887|Spironolactone|spironolactone|mesh-list
5883004|NCT04345887|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5883005|NCT04345887|Hormone Antagonists|hormone antagonists|mesh-ancestor
5883006|NCT04345887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5883007|NCT04345887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883008|NCT04345887|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5883009|NCT04345887|Diuretics|diuretics|mesh-ancestor
5883010|NCT04345887|Natriuretic Agents|natriuretic agents|mesh-ancestor
5883011|NCT04316169|Hydroxychloroquine|hydroxychloroquine|mesh-list
5883012|NCT04316169|Letrozole|letrozole|mesh-list
5883013|NCT04316169|Fulvestrant|fulvestrant|mesh-list
5883014|NCT04316169|Anastrozole|anastrozole|mesh-list
5883015|NCT04316169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5883016|NCT04316169|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5883017|NCT04316169|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5883018|NCT04316169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5883019|NCT04316169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883020|NCT04316169|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5883021|NCT04316169|Hormone Antagonists|hormone antagonists|mesh-ancestor
5883022|NCT04316169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5883023|NCT04316169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883024|NCT04316169|Antimalarials|antimalarials|mesh-ancestor
5883025|NCT04316169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5883026|NCT04316169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5883027|NCT04316169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5883028|NCT04316169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5883029|NCT04316169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5883030|NCT04316169|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5883031|NCT04305145|Prednisone|prednisone|mesh-list
5883032|NCT04305145|Methylprednisolone|methylprednisolone|mesh-list
5883033|NCT04305145|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5883034|NCT04305145|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5883035|NCT04305145|Prednisolone|prednisolone|mesh-list
5883036|NCT04305145|Prednisolone acetate|prednisolone acetate|mesh-list
5883037|NCT04305145|Infliximab|infliximab|mesh-list
5883038|NCT04305145|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5883039|NCT04305145|Prednisolone phosphate|prednisolone phosphate|mesh-list
5883040|NCT04305145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5883041|NCT04305145|Glucocorticoids|glucocorticoids|mesh-ancestor
5883042|NCT04305145|Hormones|hormones|mesh-ancestor
5883043|NCT04305145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5883044|NCT04305145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883045|NCT04305145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5883046|NCT04305145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5883047|NCT04305145|Antiemetics|antiemetics|mesh-ancestor
5883048|NCT04305145|Autonomic Agents|autonomic agents|mesh-ancestor
5883049|NCT04305145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5883050|NCT04305145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5883051|NCT04305145|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5883052|NCT04305145|Protective Agents|protective agents|mesh-ancestor
5883053|NCT04305145|Dermatologic Agents|dermatologic agents|mesh-ancestor
5883054|NCT04305145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5883055|NCT04286529|Calcitriol|calcitriol|mesh-list
5883056|NCT04286529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5883057|NCT04286529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883058|NCT04286529|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
5883059|NCT04286529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5883060|NCT04286529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883061|NCT04286529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5883062|NCT04286529|Vitamins|vitamins|mesh-ancestor
5883063|NCT04286529|Micronutrients|micronutrients|mesh-ancestor
5883064|NCT04286529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5883065|NCT04281108|Fluticasone|fluticasone|mesh-list
5883066|NCT04281108|Xhance|xhance|mesh-list
5883067|NCT04281108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5883068|NCT04281108|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5883069|NCT04281108|Autonomic Agents|autonomic agents|mesh-ancestor
5883070|NCT04281108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5883071|NCT04281108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883072|NCT04281108|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5883073|NCT04281108|Respiratory System Agents|respiratory system agents|mesh-ancestor
5883074|NCT04281108|Dermatologic Agents|dermatologic agents|mesh-ancestor
5883075|NCT04281108|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5883076|NCT04249596|Tianeptine|tianeptine|mesh-list
5883077|NCT04249596|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5883078|NCT04249596|Antidepressive Agents|antidepressive agents|mesh-ancestor
5883079|NCT04249596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5883080|NCT04238091|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5883081|NCT04238091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5883082|NCT04234360|Prednisone|prednisone|mesh-list
5883083|NCT04234360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5883084|NCT04234360|Glucocorticoids|glucocorticoids|mesh-ancestor
5883085|NCT04234360|Hormones|hormones|mesh-ancestor
5883086|NCT04234360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5883087|NCT04234360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883088|NCT04234360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5883089|NCT04234360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5883090|NCT04188405|Decitabine|decitabine|mesh-list
5883091|NCT04188405|Venetoclax|venetoclax|mesh-list
5883092|NCT04188405|Ponatinib|ponatinib|mesh-list
5883093|NCT04188405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5883094|NCT04188405|Antimetabolites|antimetabolites|mesh-ancestor
5883095|NCT04188405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883096|NCT04188405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5883097|NCT04188405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5883098|NCT04188405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5883099|NCT04188145|Bevacizumab|bevacizumab|mesh-list
5883100|NCT04188145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5883101|NCT04188145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5883102|NCT04188145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5883103|NCT04188145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5883104|NCT04188145|Growth Substances|growth substances|mesh-ancestor
5883105|NCT04188145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883106|NCT04188145|Growth Inhibitors|growth inhibitors|mesh-ancestor
5883107|NCT04181606|Esmolol|esmolol|mesh-list
5883108|NCT04181606|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5883109|NCT04181606|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5883110|NCT04181606|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5883111|NCT04181606|Adrenergic Agents|adrenergic agents|mesh-ancestor
5883112|NCT04181606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5883113|NCT04181606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883114|NCT04181606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883115|NCT04143594|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
5883116|NCT04143594|Antiviral Agents|antiviral agents|mesh-ancestor
5883117|NCT04143594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5883118|NCT04143594|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5883119|NCT04143594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5883120|NCT04143594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5883121|NCT04143594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883122|NCT04143594|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5883123|NCT04143594|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5883124|NCT04128774|Dexamethasone|dexamethasone|mesh-list
5883125|NCT04128774|Dexamethasone acetate|dexamethasone acetate|mesh-list
5883126|NCT04128774|BB 1101|bb 1101|mesh-list
5883127|NCT04128774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5883128|NCT04128774|Antiemetics|antiemetics|mesh-ancestor
5883129|NCT04128774|Autonomic Agents|autonomic agents|mesh-ancestor
5883130|NCT04128774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5883131|NCT04128774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883132|NCT04128774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5883133|NCT04128774|Glucocorticoids|glucocorticoids|mesh-ancestor
5883134|NCT04128774|Hormones|hormones|mesh-ancestor
5883135|NCT04128774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5883136|NCT04128774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5883137|NCT04128774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5883138|NCT04128774|Protease Inhibitors|protease inhibitors|mesh-ancestor
5883139|NCT04128774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5883140|NCT04128774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883141|NCT04088123|Ticagrelor|ticagrelor|mesh-list
5883142|NCT04088123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5883143|NCT04088123|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5883144|NCT04088123|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5883145|NCT04088123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5883146|NCT04088123|Purinergic Agents|purinergic agents|mesh-ancestor
5883147|NCT04088123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5883148|NCT04088123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883149|NCT04088123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883150|NCT03945721|Niraparib|niraparib|mesh-list
5883151|NCT03945721|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5883152|NCT03945721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5883153|NCT03945721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883154|NCT03945721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5883155|NCT03921242|Metformin|metformin|mesh-list
5883156|NCT03921242|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
5883157|NCT03921242|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
5883158|NCT03921242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5883159|NCT03921242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883160|NCT03921242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883161|NCT03921242|Protease Inhibitors|protease inhibitors|mesh-ancestor
5883162|NCT03921242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5883163|NCT03891706|Interleukin-2|interleukin-2|mesh-list
5883164|NCT03891706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5883165|NCT03891706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5883166|NCT03891706|Analgesics|analgesics|mesh-ancestor
5883167|NCT03891706|Sensory System Agents|sensory system agents|mesh-ancestor
5883168|NCT03891706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5883169|NCT03891706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883170|NCT03880019|Temozolomide|temozolomide|mesh-list
5883171|NCT03880019|Olaparib|olaparib|mesh-list
5883172|NCT03880019|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
5883173|NCT03880019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5883174|NCT03880019|Alkylating Agents|alkylating agents|mesh-ancestor
5883175|NCT03880019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883176|NCT03880019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5687997|NCT03439358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5687998|NCT03439358|Anticonvulsants|anticonvulsants|mesh-ancestor
5687999|NCT03439358|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5688000|NCT03439358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5688001|NCT03439358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688002|NCT03439358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5688003|NCT03439358|Tocolytic Agents|tocolytic agents|mesh-ancestor
5688004|NCT03439358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5688005|NCT03439345|Fenofibrate|fenofibrate|mesh-list
5688006|NCT03439345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5688007|NCT03439345|Antimetabolites|antimetabolites|mesh-ancestor
5688008|NCT03439345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688009|NCT03439345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5688010|NCT03439280|Dexamethasone|dexamethasone|mesh-list
5688011|NCT03439280|Pomalidomide|pomalidomide|mesh-list
5688012|NCT03439280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5688013|NCT03439280|Antiemetics|antiemetics|mesh-ancestor
5688014|NCT03439280|Autonomic Agents|autonomic agents|mesh-ancestor
5688015|NCT03439280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5688016|NCT03439280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883177|NCT03880019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5906677|NCT05137574|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5688017|NCT03439280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5688018|NCT03439280|Glucocorticoids|glucocorticoids|mesh-ancestor
5688019|NCT03439280|Hormones|hormones|mesh-ancestor
5688020|NCT03439280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5688021|NCT03439280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5688022|NCT03439280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5688023|NCT03439280|Immunologic Factors|immunologic factors|mesh-ancestor
5688024|NCT03439280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5883178|NCT03847181|Vitamin K|vitamin k|mesh-list
5883179|NCT03847181|Warfarin|warfarin|mesh-list
5883180|NCT03847181|Rivaroxaban|rivaroxaban|mesh-list
5883181|NCT03847181|Apixaban|apixaban|mesh-list
5883182|NCT03847181|Anticoagulants|anticoagulants|mesh-list
5883183|NCT03847181|Vitamins|vitamins|mesh-ancestor
5883184|NCT03847181|Micronutrients|micronutrients|mesh-ancestor
5883185|NCT03847181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883186|NCT03847181|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5883187|NCT03847181|Antithrombins|antithrombins|mesh-ancestor
5883188|NCT03847181|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5883189|NCT03847181|Protease Inhibitors|protease inhibitors|mesh-ancestor
5883190|NCT03847181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5883191|NCT03847181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883192|NCT03847181|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5883193|NCT03847181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5883194|NCT03847181|Hemostatics|hemostatics|mesh-ancestor
5883195|NCT03847181|Coagulants|coagulants|mesh-ancestor
5883196|NCT03825796|Cytarabine|cytarabine|mesh-list
5883197|NCT03825796|Daunorubicin|daunorubicin|mesh-list
5883198|NCT03825796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5883199|NCT03825796|Antimetabolites|antimetabolites|mesh-ancestor
5883200|NCT03825796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883201|NCT03825796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5883202|NCT03825796|Antiviral Agents|antiviral agents|mesh-ancestor
6675489|NCT01575782|Chloroquine|chloroquine|mesh-list
5688025|NCT03439280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5688026|NCT03439280|Growth Substances|growth substances|mesh-ancestor
5688027|NCT03439280|Growth Inhibitors|growth inhibitors|mesh-ancestor
5688028|NCT03439267|Calcium|calcium|mesh-list
5688029|NCT03439267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5688030|NCT03439267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688031|NCT03439254|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
5688032|NCT03439254|Cathartics|cathartics|mesh-ancestor
5688033|NCT03439254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5688034|NCT03439033|Edetic Acid|edetic acid|mesh-list
5688035|NCT03439033|N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid|n,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid|mesh-list
5688036|NCT03439033|Chelating Agents|chelating agents|mesh-ancestor
5688037|NCT03439033|Sequestering Agents|sequestering agents|mesh-ancestor
5688038|NCT03439033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688039|NCT03439033|Anticoagulants|anticoagulants|mesh-ancestor
5688040|NCT03439033|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6675490|NCT01575782|Amebicides|amebicides|mesh-ancestor
6675491|NCT01575782|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6675492|NCT01575782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6675493|NCT01575782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6675494|NCT01575782|Antimalarials|antimalarials|mesh-ancestor
6675495|NCT01575782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6675496|NCT01575795|Ticagrelor|ticagrelor|mesh-list
6675497|NCT01575795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6675498|NCT01575795|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6675499|NCT01575795|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6675500|NCT01575795|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6675501|NCT01575795|Purinergic Agents|purinergic agents|mesh-ancestor
6675502|NCT01575795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6675503|NCT01575795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675504|NCT01575795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675505|NCT01575925|Thalidomide|thalidomide|mesh-list
5883203|NCT03825796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5883204|NCT03825796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5883205|NCT03825796|Immunologic Factors|immunologic factors|mesh-ancestor
5883206|NCT03825796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883207|NCT03825796|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5883208|NCT03825796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5883209|NCT03825796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5883210|NCT03825796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5883211|NCT03753204|Furosemide|furosemide|mesh-list
5883212|NCT03753204|Diuretics|diuretics|mesh-ancestor
5883213|NCT03753204|Natriuretic Agents|natriuretic agents|mesh-ancestor
5883214|NCT03753204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675506|NCT01575925|Dexamethasone|dexamethasone|mesh-list
6675507|NCT01575925|Dexamethasone acetate|dexamethasone acetate|mesh-list
5688041|NCT03438955|Telmisartan|telmisartan|mesh-list
5688042|NCT03438955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5688043|NCT03438955|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5688044|NCT03438955|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5688045|NCT03438955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697415|NCT03376178|Sensory System Agents|sensory system agents|mesh-ancestor
5697416|NCT03376178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5697417|NCT03376178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5697418|NCT03376178|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5697419|NCT03376178|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5697420|NCT03376178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5697421|NCT03376178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697422|NCT03376139|Zonisamide|zonisamide|mesh-list
5697423|NCT03376139|Anticonvulsants|anticonvulsants|mesh-ancestor
5697424|NCT03376139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5697425|NCT03376139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5697426|NCT03376139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697427|NCT03376139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5883215|NCT03753204|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5883216|NCT03753204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5697428|NCT03376139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697429|NCT03376048|Ropivacaine|ropivacaine|mesh-list
5697430|NCT03376048|Anesthetics, Local|anesthetics, local|mesh-ancestor
5883217|NCT03753204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883218|NCT03679611|Neostigmine|neostigmine|mesh-list
5883219|NCT03679611|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5883220|NCT03679611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5883221|NCT03679611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883222|NCT03679611|Cholinergic Agents|cholinergic agents|mesh-ancestor
5883223|NCT03679611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5883224|NCT03679611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883225|NCT03679611|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5883226|NCT03679611|Autonomic Agents|autonomic agents|mesh-ancestor
5883227|NCT03679611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5883228|NCT03640754|Lenograstim|lenograstim|mesh-list
5883229|NCT03640754|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5883230|NCT03640754|Immunologic Factors|immunologic factors|mesh-ancestor
5883231|NCT03640754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883232|NCT03608436|Bromides|bromides|mesh-list
5883233|NCT03608436|Rocuronium|rocuronium|mesh-list
5883234|NCT03608436|Anticonvulsants|anticonvulsants|mesh-ancestor
5883235|NCT03608436|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5883236|NCT03608436|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5883237|NCT03608436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5883238|NCT03608436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5883239|NCT03608436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883240|NCT03557385|Adenosine|adenosine|mesh-list
5883241|NCT03557385|Analgesics|analgesics|mesh-ancestor
5883242|NCT03557385|Sensory System Agents|sensory system agents|mesh-ancestor
5883243|NCT03557385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5883244|NCT03557385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883245|NCT03557385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5883246|NCT03557385|Vasodilator Agents|vasodilator agents|mesh-ancestor
5883247|NCT03557385|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5883248|NCT03557385|Purinergic Agonists|purinergic agonists|mesh-ancestor
5883249|NCT03557385|Purinergic Agents|purinergic agents|mesh-ancestor
5697431|NCT03376048|Anesthetics|anesthetics|mesh-ancestor
5697432|NCT03376048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5697433|NCT03376048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697434|NCT03376048|Sensory System Agents|sensory system agents|mesh-ancestor
5697435|NCT03376048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5697436|NCT03375996|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5697437|NCT03375996|Cyclopentolate|cyclopentolate|mesh-list
5697438|NCT03375996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5697439|NCT03375996|Mydriatics|mydriatics|mesh-ancestor
5697440|NCT03375996|Autonomic Agents|autonomic agents|mesh-ancestor
5697441|NCT03375996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5697442|NCT03375996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697443|NCT03375996|Parasympatholytics|parasympatholytics|mesh-ancestor
5883250|NCT03557385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5883251|NCT03557385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883252|NCT03556904|Docetaxel|docetaxel|mesh-list
5883253|NCT03556904|Hormones|hormones|mesh-list
5883254|NCT03556904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5883255|NCT03556904|Tubulin Modulators|tubulin modulators|mesh-ancestor
5883256|NCT03556904|Antimitotic Agents|antimitotic agents|mesh-ancestor
5883257|NCT03556904|Mitosis Modulators|mitosis modulators|mesh-ancestor
5883258|NCT03556904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883259|NCT03556904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5688046|NCT03438942|Folic Acid|folic acid|mesh-list
5688047|NCT03438942|Hematinics|hematinics|mesh-ancestor
5688048|NCT03438942|Vitamin B Complex|vitamin b complex|mesh-ancestor
5688049|NCT03438942|Vitamins|vitamins|mesh-ancestor
5688050|NCT03438942|Micronutrients|micronutrients|mesh-ancestor
5688051|NCT03438942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688052|NCT03438890|Chlorhexidine|chlorhexidine|mesh-list
5688053|NCT03438890|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5688054|NCT03438890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5688055|NCT03438890|Disinfectants|disinfectants|mesh-ancestor
5688056|NCT03438812|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
5688057|NCT03438812|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5688058|NCT03438812|Immunologic Factors|immunologic factors|mesh-ancestor
5688059|NCT03438812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688060|NCT03438773|Tacrolimus|tacrolimus|mesh-list
5688061|NCT03438773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5688062|NCT03438773|Immunologic Factors|immunologic factors|mesh-ancestor
5688063|NCT03438773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883260|NCT03556904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883261|NCT03540758|Niacin|niacin|mesh-list
5883262|NCT03540758|Nicotinic Acids|nicotinic acids|mesh-list
5883263|NCT03540758|Niacinamide|niacinamide|mesh-list
5883264|NCT03540758|Diazoxide|diazoxide|mesh-list
5883265|NCT03540758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5883266|NCT03540758|Antimetabolites|antimetabolites|mesh-ancestor
5883267|NCT03540758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883268|NCT03540758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5883269|NCT03540758|Vasodilator Agents|vasodilator agents|mesh-ancestor
5883270|NCT03540758|Vitamin B Complex|vitamin b complex|mesh-ancestor
5883271|NCT03540758|Vitamins|vitamins|mesh-ancestor
5883272|NCT03540758|Micronutrients|micronutrients|mesh-ancestor
5883273|NCT03540758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883274|NCT03540758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5883275|NCT03477851|Tramadol|tramadol|mesh-list
5883276|NCT03477851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5883277|NCT03477851|Narcotics|narcotics|mesh-ancestor
5883278|NCT03477851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5883279|NCT03477851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883280|NCT03477851|Analgesics|analgesics|mesh-ancestor
5883281|NCT03477851|Sensory System Agents|sensory system agents|mesh-ancestor
5883282|NCT03477851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5883283|NCT03412188|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5883284|NCT03412188|gamma-Globulins|gamma-globulins|mesh-list
5883285|NCT03412188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5883286|NCT03412188|Immunologic Factors|immunologic factors|mesh-ancestor
5883287|NCT03412188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883288|NCT03412188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5883289|NCT03412188|Glucocorticoids|glucocorticoids|mesh-ancestor
5883290|NCT03412188|Hormones|hormones|mesh-ancestor
5883291|NCT03412188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5883292|NCT03412188|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5883293|NCT03412188|Protective Agents|protective agents|mesh-ancestor
5883294|NCT03412188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5883295|NCT03388632|Nivolumab|nivolumab|mesh-list
5883296|NCT03388632|Ipilimumab|ipilimumab|mesh-list
5883297|NCT03388632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5883298|NCT03388632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5883299|NCT03388632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5883300|NCT03388632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883301|NCT03298945|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
5883302|NCT03298945|Laxatives|laxatives|mesh-ancestor
5883303|NCT03298945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5688064|NCT03438773|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5688065|NCT03438773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5688066|NCT03438773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688067|NCT03438708|Axitinib|axitinib|mesh-list
5688068|NCT03438708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5688069|NCT03438708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5688070|NCT03438708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5688071|NCT03438708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883304|NCT03250975|Azithromycin|azithromycin|mesh-list
5883305|NCT03250975|Budesonide|budesonide|mesh-list
5883306|NCT03250975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5883307|NCT03250975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5883308|NCT03250975|Autonomic Agents|autonomic agents|mesh-ancestor
5883309|NCT03250975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5883310|NCT03250975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883311|NCT03250975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5883312|NCT03250975|Respiratory System Agents|respiratory system agents|mesh-ancestor
5883313|NCT03250975|Glucocorticoids|glucocorticoids|mesh-ancestor
5883314|NCT03250975|Hormones|hormones|mesh-ancestor
5883315|NCT03250975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5883316|NCT03250975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5883317|NCT03250975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5883318|NCT03219268|Margetuximab|margetuximab|mesh-list
5883319|NCT03219268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5883320|NCT03218137|Adenosine|adenosine|mesh-list
5883321|NCT03218137|Verapamil|verapamil|mesh-list
5883322|NCT03218137|Analgesics|analgesics|mesh-ancestor
5883323|NCT03218137|Sensory System Agents|sensory system agents|mesh-ancestor
5883324|NCT03218137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5688072|NCT03438604|Donepezil|donepezil|mesh-list
5688073|NCT03438604|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5688074|NCT03438604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5688075|NCT03438604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688076|NCT03438604|Cholinergic Agents|cholinergic agents|mesh-ancestor
5688077|NCT03438604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5688078|NCT03438604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688079|NCT03438604|Nootropic Agents|nootropic agents|mesh-ancestor
5688080|NCT03438487|Vaccines|vaccines|mesh-list
5883325|NCT03218137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883326|NCT03218137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5883327|NCT03218137|Vasodilator Agents|vasodilator agents|mesh-ancestor
5883328|NCT03218137|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5883329|NCT03218137|Purinergic Agonists|purinergic agonists|mesh-ancestor
5883330|NCT03218137|Purinergic Agents|purinergic agents|mesh-ancestor
5883331|NCT03218137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5883332|NCT03218137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883333|NCT03218137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5883334|NCT03218137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5883335|NCT03218137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5883336|NCT03117816|Interferons|interferons|mesh-list
5883337|NCT03117816|Interferon-alpha|interferon-alpha|mesh-list
5883338|NCT03117816|Interferon alpha-2|interferon alpha-2|mesh-list
5883339|NCT03117816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5883340|NCT03117816|Antiviral Agents|antiviral agents|mesh-ancestor
5883341|NCT03117816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5883342|NCT03117816|Immunologic Factors|immunologic factors|mesh-ancestor
5883343|NCT03117816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883344|NCT03079999|Aspirin|aspirin|mesh-list
5883345|NCT03079999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5883346|NCT03079999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5883347|NCT03079999|Analgesics|analgesics|mesh-ancestor
5883348|NCT03079999|Sensory System Agents|sensory system agents|mesh-ancestor
5883349|NCT03079999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5883350|NCT03079999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883351|NCT03079999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5883352|NCT03079999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5883353|NCT03079999|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5883354|NCT03079999|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5883355|NCT03079999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883356|NCT03079999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5883357|NCT03079999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5883358|NCT03079999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5883359|NCT03079999|Antipyretics|antipyretics|mesh-ancestor
5883360|NCT02958709|Rifampin|rifampin|mesh-list
5883361|NCT02958709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5883362|NCT02958709|Antitubercular Agents|antitubercular agents|mesh-ancestor
5883363|NCT02958709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5883364|NCT02958709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5883365|NCT02958709|Leprostatic Agents|leprostatic agents|mesh-ancestor
5883366|NCT02958709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5883367|NCT02958709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5883368|NCT02958709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496033|NCT00626015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5688081|NCT03438487|Immunologic Factors|immunologic factors|mesh-ancestor
5883369|NCT02958709|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5883370|NCT02958709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5883371|NCT02958709|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5883372|NCT02958709|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5883373|NCT02958709|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5883374|NCT02958709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5883375|NCT02957292|Levonorgestrel|levonorgestrel|mesh-list
5883376|NCT02957292|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5883377|NCT02957292|Contraceptive Agents|contraceptive agents|mesh-ancestor
5883378|NCT02957292|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5883379|NCT02957292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883380|NCT02957292|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5883381|NCT02957292|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5883382|NCT02957292|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5883383|NCT02947581|Albendazole|albendazole|mesh-list
5883384|NCT02947581|Praziquantel|praziquantel|mesh-list
5883385|NCT02947581|Anthelmintics|anthelmintics|mesh-ancestor
5883386|NCT02947581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5883387|NCT02947581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5883388|NCT02947581|Anticestodal Agents|anticestodal agents|mesh-ancestor
5883389|NCT02947581|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5883390|NCT02947581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5883391|NCT02947581|Tubulin Modulators|tubulin modulators|mesh-ancestor
5883392|NCT02947581|Antimitotic Agents|antimitotic agents|mesh-ancestor
5883393|NCT02947581|Mitosis Modulators|mitosis modulators|mesh-ancestor
5883394|NCT02947581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883395|NCT02947581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5883396|NCT02861898|Cetuximab|cetuximab|mesh-list
5883397|NCT02861898|Mannitol|mannitol|mesh-list
5883398|NCT02861898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5883399|NCT02861898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5883400|NCT02861898|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5883401|NCT02861898|Diuretics|diuretics|mesh-ancestor
5883402|NCT02861898|Natriuretic Agents|natriuretic agents|mesh-ancestor
5883403|NCT02861898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688082|NCT03438487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688083|NCT03438344|Vaccines|vaccines|mesh-list
5688084|NCT03438344|Immunologic Factors|immunologic factors|mesh-ancestor
5688085|NCT03438344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688086|NCT03438318|Atezolizumab|atezolizumab|mesh-list
5688087|NCT03438318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5688088|NCT03438253|Anesthetics|anesthetics|mesh-list
5688089|NCT03438253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5688090|NCT03438253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688091|NCT03438240|Fentanyl|fentanyl|mesh-list
5688092|NCT03438240|Dexmedetomidine|dexmedetomidine|mesh-list
5688093|NCT03438240|Bupivacaine|bupivacaine|mesh-list
5883404|NCT02806687|Gemcitabine|gemcitabine|mesh-list
5883405|NCT02806687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5883406|NCT02806687|Antimetabolites|antimetabolites|mesh-ancestor
5883407|NCT02806687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883408|NCT02806687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5883409|NCT02806687|Antiviral Agents|antiviral agents|mesh-ancestor
5883410|NCT02806687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5883411|NCT02806687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5883412|NCT02806687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5883413|NCT02806687|Immunologic Factors|immunologic factors|mesh-ancestor
5883414|NCT02806687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883415|NCT02722525|Pentetic Acid|pentetic acid|mesh-list
5883416|NCT02722525|Antidotes|antidotes|mesh-ancestor
5883417|NCT02722525|Protective Agents|protective agents|mesh-ancestor
5883418|NCT02722525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883419|NCT02722525|Chelating Agents|chelating agents|mesh-ancestor
5883420|NCT02722525|Sequestering Agents|sequestering agents|mesh-ancestor
5883421|NCT02722525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883422|NCT02722525|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5883423|NCT02632396|Rituximab|rituximab|mesh-list
5883424|NCT02632396|Ixazomib|ixazomib|mesh-list
5883425|NCT02632396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5883426|NCT02632396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5883427|NCT02632396|Immunologic Factors|immunologic factors|mesh-ancestor
5883428|NCT02632396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883429|NCT02632396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5883430|NCT02632396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883431|NCT02632396|Protease Inhibitors|protease inhibitors|mesh-ancestor
5688094|NCT03438240|Anesthetics, Local|anesthetics, local|mesh-list
5883432|NCT02632396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5883433|NCT02595060|Molgramostim|molgramostim|mesh-list
5883434|NCT02595060|Sargramostim|sargramostim|mesh-list
5883435|NCT02595060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5883436|NCT02595060|Immunologic Factors|immunologic factors|mesh-ancestor
5883437|NCT02595060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883438|NCT02525757|Paclitaxel|paclitaxel|mesh-list
5883439|NCT02525757|Carboplatin|carboplatin|mesh-list
5883440|NCT02525757|Atezolizumab|atezolizumab|mesh-list
5688095|NCT03438240|Anesthetics|anesthetics|mesh-list
5688096|NCT03438240|Sympathomimetics|sympathomimetics|mesh-list
5688097|NCT03438240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5688098|NCT03438240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688099|NCT03438240|Sensory System Agents|sensory system agents|mesh-ancestor
5688100|NCT03438240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5688101|NCT03438240|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5688102|NCT03438240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5688103|NCT03438240|Analgesics|analgesics|mesh-ancestor
5688104|NCT03438240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5688105|NCT03438240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5688106|NCT03438240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5688107|NCT03438240|Adrenergic Agents|adrenergic agents|mesh-ancestor
5688108|NCT03438240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5688109|NCT03438240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688110|NCT03438240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5688111|NCT03438240|Narcotics|narcotics|mesh-ancestor
5688112|NCT03438240|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5688113|NCT03438240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5688114|NCT03438240|Anesthetics, General|anesthetics, general|mesh-ancestor
5688115|NCT03438240|Autonomic Agents|autonomic agents|mesh-ancestor
5688116|NCT03438227|Dextrans|dextrans|mesh-list
5688117|NCT03438227|Iron-Dextran Complex|iron-dextran complex|mesh-list
5688118|NCT03438227|Anticoagulants|anticoagulants|mesh-ancestor
5688119|NCT03438227|Plasma Substitutes|plasma substitutes|mesh-ancestor
5688120|NCT03438227|Blood Substitutes|blood substitutes|mesh-ancestor
5688121|NCT03438227|Hematinics|hematinics|mesh-ancestor
5688122|NCT03438214|Vancomycin|vancomycin|mesh-list
5883441|NCT02525757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5883442|NCT02525757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5883443|NCT02525757|Tubulin Modulators|tubulin modulators|mesh-ancestor
5883444|NCT02525757|Antimitotic Agents|antimitotic agents|mesh-ancestor
5883445|NCT02525757|Mitosis Modulators|mitosis modulators|mesh-ancestor
5883446|NCT02525757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906678|NCT05137574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5906679|NCT05137574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906680|NCT05137522|Methylprednisolone|methylprednisolone|mesh-list
5906681|NCT05137522|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5906682|NCT05137522|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5906683|NCT05137522|Prednisolone|prednisolone|mesh-list
5906684|NCT05137522|Prednisolone acetate|prednisolone acetate|mesh-list
5906685|NCT05137522|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5906686|NCT05137522|Prednisolone phosphate|prednisolone phosphate|mesh-list
5906687|NCT05137522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5906688|NCT05137522|Antiemetics|antiemetics|mesh-ancestor
5906689|NCT05137522|Autonomic Agents|autonomic agents|mesh-ancestor
5906690|NCT05137522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5906691|NCT05137522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906692|NCT05137522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5906693|NCT05137522|Glucocorticoids|glucocorticoids|mesh-ancestor
5906694|NCT05137522|Hormones|hormones|mesh-ancestor
5906695|NCT05137522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5906696|NCT05137522|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5906697|NCT05137522|Protective Agents|protective agents|mesh-ancestor
5906698|NCT05137522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5906699|NCT05137522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5906700|NCT05137496|Methylprednisolone|methylprednisolone|mesh-list
5906701|NCT05137496|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5906702|NCT05137496|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5906703|NCT05137496|Prednisolone|prednisolone|mesh-list
5906704|NCT05137496|Prednisolone acetate|prednisolone acetate|mesh-list
5906705|NCT05137496|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5906706|NCT05137496|Prednisolone phosphate|prednisolone phosphate|mesh-list
5906707|NCT05137496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5688123|NCT03438214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5688124|NCT03438214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5688125|NCT03437980|Propofol|propofol|mesh-list
5906708|NCT05137496|Antiemetics|antiemetics|mesh-ancestor
5906709|NCT05137496|Autonomic Agents|autonomic agents|mesh-ancestor
5688126|NCT03437980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5688127|NCT03437980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5688128|NCT03437980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688129|NCT03437980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5688130|NCT03437980|Anesthetics, General|anesthetics, general|mesh-ancestor
5688131|NCT03437980|Anesthetics|anesthetics|mesh-ancestor
5688132|NCT03437902|Vitamins|vitamins|mesh-list
5883447|NCT02404155|Clozapine|clozapine|mesh-list
5883448|NCT02404155|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5883449|NCT02404155|Serotonin Agents|serotonin agents|mesh-ancestor
5883450|NCT02404155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5883451|NCT02404155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883452|NCT02404155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883453|NCT02404155|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5883454|NCT02404155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5883455|NCT02404155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5883456|NCT02404155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5883457|NCT02404155|GABA Antagonists|gaba antagonists|mesh-ancestor
5883458|NCT02404155|GABA Agents|gaba agents|mesh-ancestor
5883459|NCT02339922|Rituximab|rituximab|mesh-list
5883460|NCT02339922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5883461|NCT02339922|Ixazomib|ixazomib|mesh-list
5883462|NCT02339922|Antibodies|antibodies|mesh-list
5883463|NCT02339922|Immunoglobulins|immunoglobulins|mesh-list
5883464|NCT02339922|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5688133|NCT03437902|Ascorbic Acid|ascorbic acid|mesh-list
5688134|NCT03437902|Micronutrients|micronutrients|mesh-ancestor
5688135|NCT03437902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688136|NCT03437902|Antioxidants|antioxidants|mesh-ancestor
5688137|NCT03437902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688138|NCT03437902|Protective Agents|protective agents|mesh-ancestor
5688139|NCT03437824|Vitamin B 12|vitamin b 12|mesh-list
5688140|NCT03437824|Hydroxocobalamin|hydroxocobalamin|mesh-list
5688141|NCT03437824|Vitamins|vitamins|mesh-ancestor
5688142|NCT03437824|Micronutrients|micronutrients|mesh-ancestor
5688143|NCT03437824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688144|NCT03437824|Vitamin B Complex|vitamin b complex|mesh-ancestor
5688145|NCT03437824|Hematinics|hematinics|mesh-ancestor
5688146|NCT03437785|Ethanol|ethanol|mesh-list
5688147|NCT03437785|Rebamipide|rebamipide|mesh-list
5688148|NCT03437785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5688149|NCT03437785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5688150|NCT03437785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5688151|NCT03437785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688152|NCT03437785|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5688153|NCT03437785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5688154|NCT03437785|Antioxidants|antioxidants|mesh-ancestor
5688155|NCT03437785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688156|NCT03437785|Protective Agents|protective agents|mesh-ancestor
5688157|NCT03437785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5688158|NCT03437746|Methylprednisolone|methylprednisolone|mesh-list
5688159|NCT03437746|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5688160|NCT03437746|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5688161|NCT03437746|Prednisolone|prednisolone|mesh-list
5688162|NCT03437746|Prednisolone acetate|prednisolone acetate|mesh-list
5688163|NCT03437746|Anesthetics|anesthetics|mesh-list
5688164|NCT03437746|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5688165|NCT03437746|Prednisolone phosphate|prednisolone phosphate|mesh-list
5688166|NCT03437746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5688167|NCT03437746|Antiemetics|antiemetics|mesh-ancestor
5688168|NCT03437746|Autonomic Agents|autonomic agents|mesh-ancestor
5883465|NCT02339922|Glycine|glycine|mesh-list
5883466|NCT02339922|Immunologic Factors|immunologic factors|mesh-ancestor
5883467|NCT02339922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883468|NCT02339922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5883469|NCT02339922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5883470|NCT02339922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883471|NCT02339922|Protease Inhibitors|protease inhibitors|mesh-ancestor
5883472|NCT02339922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5883473|NCT02339922|Glycine Agents|glycine agents|mesh-ancestor
5883474|NCT02339922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5883475|NCT05101005|Sirolimus|sirolimus|mesh-list
5883476|NCT05101005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5883477|NCT05101005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6496034|NCT00626015|Immunologic Factors|immunologic factors|mesh-ancestor
5688169|NCT03437746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5883478|NCT05101005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5883479|NCT05101005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5688170|NCT03437746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883480|NCT05101005|Antifungal Agents|antifungal agents|mesh-ancestor
5883481|NCT05101005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5883482|NCT05101005|Immunologic Factors|immunologic factors|mesh-ancestor
5883483|NCT05101005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883484|NCT05100719|Mebeverine|mebeverine|mesh-list
5883485|NCT05100719|Simethicone|simethicone|mesh-list
5883486|NCT05100719|Citric Acid|citric acid|mesh-list
5883487|NCT05100719|Sodium Citrate|sodium citrate|mesh-list
5688171|NCT03437746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5688172|NCT03437746|Glucocorticoids|glucocorticoids|mesh-ancestor
5688173|NCT03437746|Hormones|hormones|mesh-ancestor
5688174|NCT03437746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5688175|NCT03437746|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5688176|NCT03437746|Protective Agents|protective agents|mesh-ancestor
5688177|NCT03437746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5688178|NCT03437746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5688179|NCT03437746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5688180|NCT03437707|Acetaminophen|acetaminophen|mesh-list
5688181|NCT03437707|Ibuprofen|ibuprofen|mesh-list
5688182|NCT03437707|Morphine|morphine|mesh-list
5688183|NCT03437707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5688184|NCT03437707|Narcotics|narcotics|mesh-ancestor
5688185|NCT03437707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5688186|NCT03437707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688187|NCT03437707|Analgesics|analgesics|mesh-ancestor
5688188|NCT03437707|Sensory System Agents|sensory system agents|mesh-ancestor
5883488|NCT05100719|Alverine|alverine|mesh-list
5883489|NCT05100719|Anticoagulants|anticoagulants|mesh-ancestor
5883490|NCT05100719|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5883491|NCT05100719|Chelating Agents|chelating agents|mesh-ancestor
5883492|NCT05100719|Sequestering Agents|sequestering agents|mesh-ancestor
5883493|NCT05100719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883494|NCT05100719|Antifoaming Agents|antifoaming agents|mesh-ancestor
5883495|NCT05100719|Emollients|emollients|mesh-ancestor
5883496|NCT05100719|Dermatologic Agents|dermatologic agents|mesh-ancestor
5883497|NCT05100719|Parasympatholytics|parasympatholytics|mesh-ancestor
5883498|NCT05100719|Autonomic Agents|autonomic agents|mesh-ancestor
5883499|NCT05100719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5883500|NCT05100719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883501|NCT05100719|Anticonvulsants|anticonvulsants|mesh-ancestor
5883502|NCT05100563|Naltrexone|naltrexone|mesh-list
5883503|NCT05100563|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5883504|NCT05100563|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5883505|NCT05100563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883506|NCT05100563|Sensory System Agents|sensory system agents|mesh-ancestor
5883507|NCT05100563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5883508|NCT05100446|Amoxicillin|amoxicillin|mesh-list
5883509|NCT05100446|Esomeprazole|esomeprazole|mesh-list
5883510|NCT05100446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5883511|NCT05100446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5883512|NCT05100446|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5883513|NCT05100446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5688189|NCT03437707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5688190|NCT03437707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5688191|NCT03437707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5688192|NCT03437707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5688193|NCT03437707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5688194|NCT03437707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5688195|NCT03437707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5883514|NCT05100446|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5883515|NCT05100446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5883516|NCT05100446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883517|NCT05100329|Mitoxantrone|mitoxantrone|mesh-list
5883518|NCT05100329|Analgesics|analgesics|mesh-ancestor
5883519|NCT05100329|Sensory System Agents|sensory system agents|mesh-ancestor
5883520|NCT05100329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5883521|NCT05100329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883522|NCT05100329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5883523|NCT05100329|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5883524|NCT05100329|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5883525|NCT05100329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5883526|NCT05100329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496035|NCT00626015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688196|NCT03437707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883527|NCT05100303|Cytarabine|cytarabine|mesh-list
5883528|NCT05100303|Mitoxantrone|mitoxantrone|mesh-list
5883529|NCT05100303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5883530|NCT05100303|Antimetabolites|antimetabolites|mesh-ancestor
5883531|NCT05100303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883532|NCT05100303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5883533|NCT05100303|Antiviral Agents|antiviral agents|mesh-ancestor
5883534|NCT05100303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5883535|NCT05100303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5883536|NCT05100303|Immunologic Factors|immunologic factors|mesh-ancestor
5883537|NCT05100303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883538|NCT05100303|Analgesics|analgesics|mesh-ancestor
5883539|NCT05100303|Sensory System Agents|sensory system agents|mesh-ancestor
5883540|NCT05100303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5883541|NCT05100303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5883542|NCT05100303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5883543|NCT05100303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5883544|NCT05100186|Dexamethasone|dexamethasone|mesh-list
5883545|NCT05100186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5883546|NCT05100186|Antiemetics|antiemetics|mesh-ancestor
5883547|NCT05100186|Autonomic Agents|autonomic agents|mesh-ancestor
5883548|NCT05100186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5883549|NCT05100186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883550|NCT05100186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5883551|NCT05100186|Glucocorticoids|glucocorticoids|mesh-ancestor
5883552|NCT05100186|Hormones|hormones|mesh-ancestor
5883553|NCT05100186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5883554|NCT05100186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5883555|NCT05100186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5883556|NCT05100160|Gabapentin|gabapentin|mesh-list
5883557|NCT05100160|Analgesics|analgesics|mesh-ancestor
5883558|NCT05100160|Sensory System Agents|sensory system agents|mesh-ancestor
5883559|NCT05100160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5883560|NCT05100160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883561|NCT05100160|Anticonvulsants|anticonvulsants|mesh-ancestor
5883562|NCT05100160|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5883563|NCT05100160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5883564|NCT05100160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5883565|NCT05100160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5883566|NCT05100160|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5883567|NCT05100160|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5883568|NCT05100160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5883569|NCT05100160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883570|NCT05100160|Antimanic Agents|antimanic agents|mesh-ancestor
5883571|NCT05100017|Methocarbamol|methocarbamol|mesh-list
5883572|NCT05100017|Oxybutynin|oxybutynin|mesh-list
5883573|NCT05100017|Parasympatholytics|parasympatholytics|mesh-ancestor
5883574|NCT05100017|Autonomic Agents|autonomic agents|mesh-ancestor
5883575|NCT05100017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5883576|NCT05100017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883577|NCT05100017|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5883578|NCT05100017|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5883579|NCT05100017|Cholinergic Agents|cholinergic agents|mesh-ancestor
5883580|NCT05100017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5883581|NCT05100017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883582|NCT05100017|Urological Agents|urological agents|mesh-ancestor
5883583|NCT05100017|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5883584|NCT05100017|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5883585|NCT05099913|Flupenthixol|flupenthixol|mesh-list
5883586|NCT05099913|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5883587|NCT05099913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5883588|NCT05099913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5883589|NCT05099913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883590|NCT05099913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5883591|NCT05099913|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5883592|NCT05099913|Dopamine Agents|dopamine agents|mesh-ancestor
5883593|NCT05099913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5883594|NCT05099913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883595|NCT05099848|Leucovorin|leucovorin|mesh-list
5883596|NCT05099848|Fluorouracil|fluorouracil|mesh-list
5883597|NCT05099848|Oxaliplatin|oxaliplatin|mesh-list
5883598|NCT05099848|Apatinib|apatinib|mesh-list
5883599|NCT05099848|Antimetabolites|antimetabolites|mesh-ancestor
5883600|NCT05099848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883601|NCT05099848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5883602|NCT05099848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5883603|NCT05099848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5883604|NCT05099848|Immunologic Factors|immunologic factors|mesh-ancestor
6675508|NCT01575925|Pomalidomide|pomalidomide|mesh-list
5883605|NCT05099848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883606|NCT05099848|Antidotes|antidotes|mesh-ancestor
5883607|NCT05099848|Protective Agents|protective agents|mesh-ancestor
5883608|NCT05099848|Vitamin B Complex|vitamin b complex|mesh-ancestor
5883609|NCT05099848|Vitamins|vitamins|mesh-ancestor
5883610|NCT05099848|Micronutrients|micronutrients|mesh-ancestor
5883611|NCT05099848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5883612|NCT05099848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5883613|NCT05099718|Hyaluronic Acid|hyaluronic acid|mesh-list
5883614|NCT05099718|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5883615|NCT05099718|Immunologic Factors|immunologic factors|mesh-ancestor
5883616|NCT05099718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883617|NCT05099718|Viscosupplements|viscosupplements|mesh-ancestor
5883618|NCT05099718|Protective Agents|protective agents|mesh-ancestor
5883619|NCT05099614|Naloxone|naloxone|mesh-list
5883620|NCT05099614|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5883621|NCT05099614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883622|NCT05099614|Sensory System Agents|sensory system agents|mesh-ancestor
5883623|NCT05099614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5883624|NCT05099601|Silymarin|silymarin|mesh-list
5883625|NCT05099601|Antioxidants|antioxidants|mesh-ancestor
5883626|NCT05099601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883627|NCT05099601|Protective Agents|protective agents|mesh-ancestor
5883628|NCT05099601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883629|NCT05099575|Oxytocin|oxytocin|mesh-list
5883630|NCT05099575|Oxytocics|oxytocics|mesh-ancestor
5883631|NCT05099575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5883632|NCT05099575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883633|NCT05099471|Dexamethasone|dexamethasone|mesh-list
5883634|NCT05099471|Cyclophosphamide|cyclophosphamide|mesh-list
5883635|NCT05099471|Rituximab|rituximab|mesh-list
5883636|NCT05099471|Venetoclax|venetoclax|mesh-list
5883637|NCT05099471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5883638|NCT05099471|Immunologic Factors|immunologic factors|mesh-ancestor
5883639|NCT05099471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883640|NCT05099471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5883641|NCT05099471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5883642|NCT05099471|Alkylating Agents|alkylating agents|mesh-ancestor
5883643|NCT05099471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883644|NCT05099471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5883645|NCT05099471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5883646|NCT05099471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5883647|NCT05099471|Antiemetics|antiemetics|mesh-ancestor
5883648|NCT05099471|Autonomic Agents|autonomic agents|mesh-ancestor
5883649|NCT05099471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5883650|NCT05099471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5883651|NCT05099471|Glucocorticoids|glucocorticoids|mesh-ancestor
5883652|NCT05099471|Hormones|hormones|mesh-ancestor
5883653|NCT05099471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5883654|NCT05099471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5883655|NCT05099471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5883656|NCT05099198|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5883657|NCT05099198|Glimepiride|glimepiride|mesh-list
5883658|NCT05099198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5883659|NCT05099198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883660|NCT05099198|Incretins|incretins|mesh-ancestor
5883661|NCT05099198|Hormones|hormones|mesh-ancestor
5883662|NCT05099198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5883663|NCT05099198|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5883664|NCT05099198|Protease Inhibitors|protease inhibitors|mesh-ancestor
5883665|NCT05099198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5883666|NCT05099198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688197|NCT03437707|Antipyretics|antipyretics|mesh-ancestor
5688198|NCT03437655|Eugenol|eugenol|mesh-list
5688199|NCT03437655|Zinc Oxide|zinc oxide|mesh-list
5688200|NCT03437655|Dermatologic Agents|dermatologic agents|mesh-ancestor
5688201|NCT03437655|Sunscreening Agents|sunscreening agents|mesh-ancestor
5688202|NCT03437655|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5688203|NCT03437655|Protective Agents|protective agents|mesh-ancestor
5688204|NCT03437655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688205|NCT03437655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5688206|NCT03437629|Calcium|calcium|mesh-list
5883667|NCT05099198|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5883668|NCT05099198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5883669|NCT05099198|Immunologic Factors|immunologic factors|mesh-ancestor
5688207|NCT03437629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5883670|NCT05099185|Trace Elements|trace elements|mesh-list
5883671|NCT05099185|Micronutrients|micronutrients|mesh-list
5883672|NCT05099185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883673|NCT05099081|Ethanolamine oleate|ethanolamine oleate|mesh-list
5883674|NCT05099081|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
5883675|NCT05099081|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5883676|NCT05099055|Dexmedetomidine|dexmedetomidine|mesh-list
5883677|NCT05099055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6212505|NCT02188719|Histamine Antagonists|histamine antagonists|mesh-ancestor
6212506|NCT02188719|Histamine Agents|histamine agents|mesh-ancestor
6212507|NCT02188719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6212508|NCT02188719|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6212509|NCT02188719|Antipruritics|antipruritics|mesh-ancestor
6212510|NCT02188719|Dermatologic Agents|dermatologic agents|mesh-ancestor
6212511|NCT02188719|Antiviral Agents|antiviral agents|mesh-ancestor
6212512|NCT02188719|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6212513|NCT02188719|Protective Agents|protective agents|mesh-ancestor
5883678|NCT05099055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5883679|NCT05099055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883680|NCT05099055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5883681|NCT05099055|Analgesics|analgesics|mesh-ancestor
5883682|NCT05099055|Sensory System Agents|sensory system agents|mesh-ancestor
5883683|NCT05099055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5883684|NCT05099055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5883685|NCT05099055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5883686|NCT05099055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5883687|NCT05099055|Adrenergic Agents|adrenergic agents|mesh-ancestor
5883688|NCT05099055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5883689|NCT05099055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883690|NCT05092165|Methylene Blue|methylene blue|mesh-list
5883691|NCT05092165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5883692|NCT05092165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883693|NCT05092152|Propofol|propofol|mesh-list
5883694|NCT05092152|Esketamine|esketamine|mesh-list
5883695|NCT05092152|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5883696|NCT05092152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5883697|NCT05092152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883698|NCT05092152|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5883699|NCT05092152|Anesthetics, General|anesthetics, general|mesh-ancestor
5883700|NCT05092152|Anesthetics|anesthetics|mesh-ancestor
5883701|NCT05092152|Antidepressive Agents|antidepressive agents|mesh-ancestor
5883702|NCT05092152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5883703|NCT05088928|Apixaban|apixaban|mesh-list
5883704|NCT05088928|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5883705|NCT05088928|Antithrombins|antithrombins|mesh-ancestor
5883706|NCT05088928|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5883707|NCT05088928|Protease Inhibitors|protease inhibitors|mesh-ancestor
5883708|NCT05088928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5883709|NCT05088928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688208|NCT03437629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688209|NCT03437590|JNJ-55308942|jnj-55308942|mesh-list
5688210|NCT03437590|Purinergic P2X Receptor Antagonists|purinergic p2x receptor antagonists|mesh-ancestor
5688211|NCT03437590|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5688212|NCT03437590|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5883710|NCT05088928|Anticoagulants|anticoagulants|mesh-ancestor
5883711|NCT05088356|Plerixafor|plerixafor|mesh-list
5883712|NCT05088356|Cyclophosphamide|cyclophosphamide|mesh-list
5883713|NCT05088356|Melphalan|melphalan|mesh-list
5883714|NCT05088356|Fludarabine|fludarabine|mesh-list
5883715|NCT05088356|Fludarabine phosphate|fludarabine phosphate|mesh-list
5883716|NCT05088356|Tacrolimus|tacrolimus|mesh-list
5883717|NCT05088356|Alkylating Agents|alkylating agents|mesh-list
5883718|NCT05088356|Lenograstim|lenograstim|mesh-list
5883719|NCT05088356|Sargramostim|sargramostim|mesh-list
5883720|NCT05088356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5883721|NCT05088356|Immunologic Factors|immunologic factors|mesh-ancestor
6212514|NCT02188784|Iron|iron|mesh-list
5688213|NCT03437590|Purinergic Agents|purinergic agents|mesh-ancestor
5688214|NCT03437590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5688215|NCT03437590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688216|NCT03437590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688217|NCT03437473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
5688218|NCT03437473|Cholinergic Agents|cholinergic agents|mesh-list
5883722|NCT05088356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883723|NCT05088356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5883724|NCT05088356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5883725|NCT05088356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212515|NCT02188784|Trace Elements|trace elements|mesh-ancestor
6212516|NCT02188784|Micronutrients|micronutrients|mesh-ancestor
5688219|NCT03437473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5688220|NCT03437473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883726|NCT05088356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5883727|NCT05088356|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5883728|NCT05088356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5883729|NCT05088356|Antimetabolites|antimetabolites|mesh-ancestor
5883730|NCT05088356|Antiviral Agents|antiviral agents|mesh-ancestor
5883731|NCT05088356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5883732|NCT05088356|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5883733|NCT05088356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5883734|NCT05088356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5883735|NCT05088356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5883736|NCT05088356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5906710|NCT05137496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5906711|NCT05137496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906712|NCT05137496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5906713|NCT05137496|Glucocorticoids|glucocorticoids|mesh-ancestor
5906714|NCT05137496|Hormones|hormones|mesh-ancestor
5906715|NCT05137496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5906716|NCT05137496|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5688221|NCT03437473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688222|NCT03437460|Ibuprofen|ibuprofen|mesh-list
5688223|NCT03437460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688224|NCT03437460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5688225|NCT03437460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5688226|NCT03437460|Analgesics|analgesics|mesh-ancestor
5688227|NCT03437460|Sensory System Agents|sensory system agents|mesh-ancestor
5688228|NCT03437460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5688229|NCT03437460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5688230|NCT03437460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5688231|NCT03437460|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5688232|NCT03437460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5906717|NCT05137496|Protective Agents|protective agents|mesh-ancestor
5906718|NCT05137496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5906719|NCT05137496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5906720|NCT05137288|Atropine|atropine|mesh-list
5906721|NCT05137288|Ondansetron|ondansetron|mesh-list
5906722|NCT05137288|Bupivacaine|bupivacaine|mesh-list
5906723|NCT05137288|Anesthetics, Local|anesthetics, local|mesh-ancestor
5906724|NCT05137288|Anesthetics|anesthetics|mesh-ancestor
5906725|NCT05137288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5906726|NCT05137288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906727|NCT05137288|Sensory System Agents|sensory system agents|mesh-ancestor
5906728|NCT05137288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5906729|NCT05137288|Antiemetics|antiemetics|mesh-ancestor
5906730|NCT05137288|Autonomic Agents|autonomic agents|mesh-ancestor
5906731|NCT05137288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5906732|NCT05137288|Antipruritics|antipruritics|mesh-ancestor
5906733|NCT05137288|Dermatologic Agents|dermatologic agents|mesh-ancestor
5688233|NCT03437460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688234|NCT03437356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
5697444|NCT03375996|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5697445|NCT03375996|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5697446|NCT03375996|Cholinergic Agents|cholinergic agents|mesh-ancestor
5697447|NCT03375996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5697448|NCT03375996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697449|NCT03375788|Hormones|hormones|mesh-list
5697450|NCT03375788|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
5906734|NCT05137288|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5906735|NCT05137288|Serotonin Agents|serotonin agents|mesh-ancestor
5906736|NCT05137288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5906737|NCT05137288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906738|NCT05137288|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5906739|NCT05137288|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5906740|NCT05137288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5906741|NCT05137288|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5906742|NCT05137288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5697451|NCT03375788|Tesamorelin|tesamorelin|mesh-list
5697452|NCT03375788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5697453|NCT03375788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697454|NCT03375788|Growth Substances|growth substances|mesh-ancestor
5697455|NCT03375775|Immunologic Factors|immunologic factors|mesh-list
5906743|NCT05137288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5906744|NCT05137288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5688235|NCT03437226|Simendan|simendan|mesh-list
5688236|NCT03437226|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5688237|NCT03437226|Vasodilator Agents|vasodilator agents|mesh-ancestor
5688238|NCT03437226|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5883737|NCT05087615|Ondansetron|ondansetron|mesh-list
5883738|NCT05087615|Metoclopramide|metoclopramide|mesh-list
5883739|NCT05087615|Granisetron|granisetron|mesh-list
5883740|NCT05087615|Antiemetics|antiemetics|mesh-ancestor
5883741|NCT05087615|Autonomic Agents|autonomic agents|mesh-ancestor
5883742|NCT05087615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5883743|NCT05087615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883744|NCT05087615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5883745|NCT05087615|Antipruritics|antipruritics|mesh-ancestor
5883746|NCT05087615|Dermatologic Agents|dermatologic agents|mesh-ancestor
5883747|NCT05087615|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5883748|NCT05087615|Serotonin Agents|serotonin agents|mesh-ancestor
5883749|NCT05087615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5883750|NCT05087615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883751|NCT05087615|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5883752|NCT05087615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5883753|NCT05087615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5883754|NCT05087615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5883755|NCT05087615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5883756|NCT05087615|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5883757|NCT05087615|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5883758|NCT05087615|Dopamine Agents|dopamine agents|mesh-ancestor
5883759|NCT05081700|Ocrelizumab|ocrelizumab|mesh-list
5883760|NCT05081700|Immunologic Factors|immunologic factors|mesh-ancestor
5883761|NCT05081700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883762|NCT05057949|Itraconazole|itraconazole|mesh-list
5883763|NCT05057949|Rifampin|rifampin|mesh-list
5883764|NCT05057949|Antifungal Agents|antifungal agents|mesh-ancestor
5883765|NCT05057949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5883766|NCT05057949|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5883767|NCT05057949|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5883768|NCT05057949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5883769|NCT05057949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883770|NCT05057949|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5883771|NCT05057949|Hormone Antagonists|hormone antagonists|mesh-ancestor
5883772|NCT05057949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5883773|NCT05057949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883774|NCT05057949|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5883775|NCT05057949|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5883776|NCT05057949|Antitubercular Agents|antitubercular agents|mesh-ancestor
5883777|NCT05057949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5883778|NCT05057949|Leprostatic Agents|leprostatic agents|mesh-ancestor
5883779|NCT05057949|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5883780|NCT05057949|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5883781|NCT05057949|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5883782|NCT05057949|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5883783|NCT05057949|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5883784|NCT05057949|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5883785|NCT05057949|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5883786|NCT05033041|Metoclopramide|metoclopramide|mesh-list
6212517|NCT02188784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688239|NCT03437226|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5688240|NCT03437226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5688241|NCT03437226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688242|NCT03437226|Protective Agents|protective agents|mesh-ancestor
5688243|NCT03437226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688244|NCT03437213|Anesthetics|anesthetics|mesh-list
5688245|NCT03437213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5688246|NCT03437213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688247|NCT03437200|Nivolumab|nivolumab|mesh-list
5688248|NCT03437200|Ipilimumab|ipilimumab|mesh-list
5688249|NCT03437200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5688250|NCT03437200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5688251|NCT03437200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5688252|NCT03437200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688253|NCT03437187|Analgesics|analgesics|mesh-list
5688254|NCT03437187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688255|NCT03437187|Sensory System Agents|sensory system agents|mesh-ancestor
5688256|NCT03437187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5883787|NCT05033041|Antiemetics|antiemetics|mesh-ancestor
5883788|NCT05033041|Autonomic Agents|autonomic agents|mesh-ancestor
5883789|NCT05033041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5883790|NCT05033041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688257|NCT03437070|Doxorubicin|doxorubicin|mesh-list
5688258|NCT03437070|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5688259|NCT03437070|Trabectedin|trabectedin|mesh-list
5688260|NCT03437070|Olaratumab|olaratumab|mesh-list
5688261|NCT03437070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5688262|NCT03437070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5688263|NCT03437070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5688264|NCT03437070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5688265|NCT03437070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5688266|NCT03437070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688267|NCT03437070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5688268|NCT03437070|Alkylating Agents|alkylating agents|mesh-ancestor
5688269|NCT03437057|Aspirin|aspirin|mesh-list
5688270|NCT03437057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5688271|NCT03437057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5688272|NCT03437057|Analgesics|analgesics|mesh-ancestor
5688273|NCT03437057|Sensory System Agents|sensory system agents|mesh-ancestor
5688274|NCT03437057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5688275|NCT03437057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688276|NCT03437057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5883791|NCT05033041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5883792|NCT05033041|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5883793|NCT05033041|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5883794|NCT05033041|Dopamine Agents|dopamine agents|mesh-ancestor
5883795|NCT05033041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5883796|NCT05033041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883797|NCT05025397|Propofol|propofol|mesh-list
5883798|NCT05025397|Sevoflurane|sevoflurane|mesh-list
5883799|NCT05025397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5883800|NCT05025397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5883801|NCT05025397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883802|NCT05025397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5883803|NCT05025397|Anesthetics, General|anesthetics, general|mesh-ancestor
5883804|NCT05025397|Anesthetics|anesthetics|mesh-ancestor
5883805|NCT05025397|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5688277|NCT03437057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5688278|NCT03437057|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5688279|NCT03437057|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5688280|NCT03437057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688281|NCT03437057|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5688282|NCT03437057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5688283|NCT03437057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5688284|NCT03437057|Antipyretics|antipyretics|mesh-ancestor
5688285|NCT03437005|Ketoconazole|ketoconazole|mesh-list
5883806|NCT05025397|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5883807|NCT05024214|Sunitinib|sunitinib|mesh-list
5883808|NCT05024214|Lenvatinib|lenvatinib|mesh-list
5883809|NCT05024214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5883810|NCT05024214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5883811|NCT05024214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5883812|NCT05024214|Growth Substances|growth substances|mesh-ancestor
5883813|NCT05024214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883814|NCT05024214|Growth Inhibitors|growth inhibitors|mesh-ancestor
5688286|NCT03437005|Desonide|desonide|mesh-list
5688287|NCT03437005|Antifungal Agents|antifungal agents|mesh-ancestor
5688288|NCT03437005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5688289|NCT03437005|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5688290|NCT03437005|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5688291|NCT03437005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5688292|NCT03437005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883815|NCT05024214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5883816|NCT05024214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5883817|NCT05024214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883818|NCT04956809|Dapagliflozin|dapagliflozin|mesh-list
5883819|NCT04956809|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5883820|NCT04956809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883821|NCT04956809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5883822|NCT04956809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883823|NCT04939467|Pirfenidone|pirfenidone|mesh-list
5883824|NCT04939467|Nintedanib|nintedanib|mesh-list
5883825|NCT04939467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5883826|NCT04939467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5883827|NCT04939467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5883828|NCT04939467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883829|NCT04939467|Analgesics|analgesics|mesh-ancestor
5883830|NCT04939467|Sensory System Agents|sensory system agents|mesh-ancestor
5883831|NCT04939467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5688293|NCT03437005|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5688294|NCT03437005|Hormone Antagonists|hormone antagonists|mesh-ancestor
5688295|NCT03437005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5688296|NCT03437005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688297|NCT03437005|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5688298|NCT03437005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5688299|NCT03436992|Resveratrol|resveratrol|mesh-list
5688300|NCT03436992|Antioxidants|antioxidants|mesh-list
5688301|NCT03436992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688302|NCT03436992|Protective Agents|protective agents|mesh-ancestor
5688303|NCT03436992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688304|NCT03436992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5688305|NCT03436992|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5688306|NCT03436836|Lidocaine|lidocaine|mesh-list
5688307|NCT03436836|Nalbuphine|nalbuphine|mesh-list
5688308|NCT03436836|Bupivacaine|bupivacaine|mesh-list
5688309|NCT03436836|Anesthetics, Local|anesthetics, local|mesh-ancestor
5688310|NCT03436836|Anesthetics|anesthetics|mesh-ancestor
5688311|NCT03436836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5688312|NCT03436836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688313|NCT03436836|Sensory System Agents|sensory system agents|mesh-ancestor
5688314|NCT03436836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5688315|NCT03436836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5883832|NCT04939467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883833|NCT04939467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5883834|NCT04939467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5883835|NCT04939467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5883836|NCT04939467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5883837|NCT04911660|Empagliflozin|empagliflozin|mesh-list
5883838|NCT04911660|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5883839|NCT04911660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883840|NCT04911660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5883841|NCT04911660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883842|NCT04877093|Clonidine|clonidine|mesh-list
5883843|NCT04877093|Analgesics|analgesics|mesh-ancestor
5883844|NCT04877093|Sensory System Agents|sensory system agents|mesh-ancestor
5883845|NCT04877093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5883846|NCT04877093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883847|NCT04877093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5883848|NCT04877093|Sympatholytics|sympatholytics|mesh-ancestor
5883849|NCT04877093|Autonomic Agents|autonomic agents|mesh-ancestor
5883850|NCT04877093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5883851|NCT04877093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5883852|NCT04877093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5883853|NCT04877093|Adrenergic Agents|adrenergic agents|mesh-ancestor
5883854|NCT04877093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5883855|NCT04877093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883856|NCT04856566|Ethanol|ethanol|mesh-list
5883857|NCT04856566|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5883858|NCT04856566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5883859|NCT04856566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5883860|NCT04856566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883861|NCT04825704|Bupivacaine|bupivacaine|mesh-list
5883862|NCT04825704|Anesthetics, Local|anesthetics, local|mesh-ancestor
5883863|NCT04825704|Anesthetics|anesthetics|mesh-ancestor
5883864|NCT04825704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5883865|NCT04825704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883866|NCT04825704|Sensory System Agents|sensory system agents|mesh-ancestor
5883867|NCT04825704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5883868|NCT04770493|Lamotrigine|lamotrigine|mesh-list
5883869|NCT04770493|Anticonvulsants|anticonvulsants|mesh-ancestor
5883870|NCT04770493|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5883871|NCT04770493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5883872|NCT04770493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883873|NCT04770493|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6212518|NCT02189122|Aspirin|aspirin|mesh-list
6212519|NCT02189122|Bradykinin|bradykinin|mesh-list
5883874|NCT04770493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883875|NCT04770493|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5883876|NCT04770493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5883877|NCT04770493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5883878|NCT04770493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5883879|NCT04770493|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5883880|NCT04733040|Felzartamab|felzartamab|mesh-list
5883881|NCT04733040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5883882|NCT04733040|Immunologic Factors|immunologic factors|mesh-ancestor
5883883|NCT04733040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883884|NCT04731974|Melatonin|melatonin|mesh-list
5883885|NCT04731974|Antioxidants|antioxidants|mesh-ancestor
5883886|NCT04731974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883887|NCT04731974|Protective Agents|protective agents|mesh-ancestor
5883888|NCT04731974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883889|NCT04731974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5883890|NCT04730232|Paclitaxel|paclitaxel|mesh-list
5688316|NCT03436836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5688317|NCT03436836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5883891|NCT04730232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5883892|NCT04730232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5883893|NCT04730232|Tubulin Modulators|tubulin modulators|mesh-ancestor
5883894|NCT04730232|Antimitotic Agents|antimitotic agents|mesh-ancestor
5883895|NCT04730232|Mitosis Modulators|mitosis modulators|mesh-ancestor
5883896|NCT04730232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883897|NCT04721353|Prazosin|prazosin|mesh-list
5883898|NCT04721353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5883899|NCT04721353|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5883900|NCT04721353|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5883901|NCT04721353|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5883902|NCT04721353|Adrenergic Agents|adrenergic agents|mesh-ancestor
5883903|NCT04721353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5883904|NCT04721353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883905|NCT04721353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883906|NCT04701918|Pembrolizumab|pembrolizumab|mesh-list
5883907|NCT04701918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5883908|NCT04701918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5883909|NCT04659174|Xanomeline|xanomeline|mesh-list
5883910|NCT04659174|Trospium chloride|trospium chloride|mesh-list
5883911|NCT04659174|Parasympatholytics|parasympatholytics|mesh-ancestor
5883912|NCT04659174|Autonomic Agents|autonomic agents|mesh-ancestor
5883913|NCT04659174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5883914|NCT04659174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883915|NCT04659174|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5883916|NCT04659174|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5688318|NCT03436836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5688319|NCT03436836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688320|NCT03436836|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5688321|NCT03436836|Narcotics|narcotics|mesh-ancestor
5688322|NCT03436836|Analgesics|analgesics|mesh-ancestor
5688323|NCT03436719|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5883917|NCT04659174|Cholinergic Agents|cholinergic agents|mesh-ancestor
5883918|NCT04659174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5883919|NCT04659174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883920|NCT04659174|Urological Agents|urological agents|mesh-ancestor
5883921|NCT04659174|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5883922|NCT04659174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5883923|NCT04659174|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
5883924|NCT04659174|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5883925|NCT04658277|Clarithromycin|clarithromycin|mesh-list
5883926|NCT04658277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5883927|NCT04658277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5883928|NCT04658277|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5883929|NCT04658277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5883930|NCT04658277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883931|NCT04658277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5883932|NCT04658277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5883933|NCT04602117|Paclitaxel|paclitaxel|mesh-list
5688324|NCT03436719|Metronidazole|metronidazole|mesh-list
5688325|NCT03436719|Erythromycin|erythromycin|mesh-list
5688326|NCT03436719|Cefoperazone|cefoperazone|mesh-list
5688327|NCT03436719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5688328|NCT03436719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5688329|NCT03436719|Antitubercular Agents|antitubercular agents|mesh-ancestor
5883934|NCT04602117|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5883935|NCT04602117|Trastuzumab|trastuzumab|mesh-list
5883936|NCT04602117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5883937|NCT04602117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5883938|NCT04602117|Tubulin Modulators|tubulin modulators|mesh-ancestor
5883939|NCT04602117|Antimitotic Agents|antimitotic agents|mesh-ancestor
5883940|NCT04602117|Mitosis Modulators|mitosis modulators|mesh-ancestor
5883941|NCT04602117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883942|NCT04602117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5883943|NCT04573322|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
5883944|NCT04573322|Antioxidants|antioxidants|mesh-ancestor
5883945|NCT04573322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883946|NCT04573322|Protective Agents|protective agents|mesh-ancestor
5883947|NCT04573322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883948|NCT04573322|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5883949|NCT04573322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5883950|NCT04565288|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
5883951|NCT04565288|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5883952|NCT04565288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5883953|NCT04565288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5883954|NCT04565288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883955|NCT04565288|Adrenergic Agents|adrenergic agents|mesh-ancestor
5883956|NCT04565288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5883957|NCT04565288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496036|NCT00626054|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6496037|NCT00626080|Insulin|insulin|mesh-list
5883958|NCT04540848|Bupivacaine|bupivacaine|mesh-list
5883959|NCT04540848|Anesthetics, Local|anesthetics, local|mesh-ancestor
5883960|NCT04540848|Anesthetics|anesthetics|mesh-ancestor
5883961|NCT04540848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5883962|NCT04540848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883963|NCT04540848|Sensory System Agents|sensory system agents|mesh-ancestor
5883964|NCT04540848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5883965|NCT04531592|Valproic Acid|valproic acid|mesh-list
5883966|NCT04531592|Anticonvulsants|anticonvulsants|mesh-ancestor
5883967|NCT04531592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5883968|NCT04531592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883969|NCT04531592|GABA Agents|gaba agents|mesh-ancestor
5883970|NCT04531592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5883971|NCT04531592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883972|NCT04531592|Antimanic Agents|antimanic agents|mesh-ancestor
5883973|NCT04531592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5883974|NCT04531592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5883975|NCT04531592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5883976|NCT04531579|Valproic Acid|valproic acid|mesh-list
5883977|NCT04531579|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5883978|NCT04531579|Anticonvulsants|anticonvulsants|mesh-ancestor
5883979|NCT04531579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5883980|NCT04531579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883981|NCT04531579|GABA Agents|gaba agents|mesh-ancestor
5883982|NCT04531579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5883983|NCT04531579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5883984|NCT04531579|Antimanic Agents|antimanic agents|mesh-ancestor
5883985|NCT04531579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5883986|NCT04531579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6496038|NCT00626080|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6496039|NCT00626080|Insulin Detemir|insulin detemir|mesh-list
6496040|NCT00626080|Isophane Insulin, Human|isophane insulin, human|mesh-list
6496041|NCT00626080|Insulin, Isophane|insulin, isophane|mesh-list
6496042|NCT00626080|Isophane insulin, beef|isophane insulin, beef|mesh-list
6496043|NCT00626080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6496044|NCT00626080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688330|NCT03436719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5688331|NCT03436719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5688332|NCT03436719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5688333|NCT03436719|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5688334|NCT03436719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5688335|NCT03436719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688336|NCT03436693|Canagliflozin|canagliflozin|mesh-list
5688337|NCT03436693|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5688338|NCT03436693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688339|NCT03436693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5688340|NCT03436693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688341|NCT03436498|Insulin|insulin|mesh-list
5883987|NCT04531579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5883988|NCT04517357|Apatinib|apatinib|mesh-list
5883989|NCT04517357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5883990|NCT04517357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5883991|NCT04517357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5883992|NCT04517357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5883993|NCT04510584|Bevacizumab|bevacizumab|mesh-list
5883994|NCT04510584|Atezolizumab|atezolizumab|mesh-list
5883995|NCT04510584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5883996|NCT04510584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5883997|NCT04510584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5883998|NCT04510584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5883999|NCT04510584|Growth Substances|growth substances|mesh-ancestor
5884000|NCT04510584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884001|NCT04510584|Growth Inhibitors|growth inhibitors|mesh-ancestor
5688342|NCT03436498|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5688343|NCT03436498|Insulin Aspart|insulin aspart|mesh-list
5688344|NCT03436498|Insulin, Long-Acting|insulin, long-acting|mesh-list
5688345|NCT03436498|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
5688346|NCT03436498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5688347|NCT03436498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688348|NCT03436472|Dexmedetomidine|dexmedetomidine|mesh-list
5688349|NCT03436472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5688350|NCT03436472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5884002|NCT04486859|Rivaroxaban|rivaroxaban|mesh-list
5884003|NCT04486859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5884004|NCT04486859|Antithrombins|antithrombins|mesh-ancestor
5884005|NCT04486859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5884006|NCT04486859|Protease Inhibitors|protease inhibitors|mesh-ancestor
5884007|NCT04486859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5884008|NCT04486859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5884009|NCT04486859|Anticoagulants|anticoagulants|mesh-ancestor
5884010|NCT04469764|Letrozole|letrozole|mesh-list
5884011|NCT04469764|Anastrozole|anastrozole|mesh-list
5884012|NCT04469764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5884013|NCT04469764|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5884014|NCT04469764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5884015|NCT04469764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5884016|NCT04469764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5884017|NCT04469764|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5884018|NCT04469764|Hormone Antagonists|hormone antagonists|mesh-ancestor
5884019|NCT04469764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5884020|NCT04469764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884021|NCT04469764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5906745|NCT05137288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5906746|NCT05137288|Respiratory System Agents|respiratory system agents|mesh-ancestor
5906747|NCT05137288|Mydriatics|mydriatics|mesh-ancestor
5906748|NCT05137288|Parasympatholytics|parasympatholytics|mesh-ancestor
5906749|NCT05137288|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5906750|NCT05137288|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5906751|NCT05137288|Cholinergic Agents|cholinergic agents|mesh-ancestor
5906752|NCT05137197|Antidepressive Agents|antidepressive agents|mesh-list
5906753|NCT05137197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5906754|NCT05137184|Fentanyl|fentanyl|mesh-list
5906755|NCT05137184|Morphine|morphine|mesh-list
5906756|NCT05137184|Methoxyflurane|methoxyflurane|mesh-list
5906757|NCT05137184|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5906758|NCT05137184|Narcotics|narcotics|mesh-ancestor
5906759|NCT05137184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5906760|NCT05137184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906761|NCT05137184|Analgesics|analgesics|mesh-ancestor
5906762|NCT05137184|Sensory System Agents|sensory system agents|mesh-ancestor
5906763|NCT05137184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5884022|NCT04379024|Bazedoxifene|bazedoxifene|mesh-list
5884023|NCT04379024|Estrogens|estrogens|mesh-list
5884024|NCT04379024|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
5884025|NCT04379024|Hormones|hormones|mesh-ancestor
5884026|NCT04379024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5884027|NCT04379024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884028|NCT04379024|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5884029|NCT04379024|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5884030|NCT04379024|Hormone Antagonists|hormone antagonists|mesh-ancestor
5884031|NCT04379024|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5884032|NCT04336982|Azacitidine|azacitidine|mesh-list
5884033|NCT04336982|Venetoclax|venetoclax|mesh-list
5884034|NCT04336982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5884035|NCT04336982|Antimetabolites|antimetabolites|mesh-ancestor
5884036|NCT04336982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5884037|NCT04336982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5884038|NCT04336982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5884039|NCT04272008|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5884040|NCT04272008|Estradiol|estradiol|mesh-list
5884041|NCT04272008|Estrogens|estrogens|mesh-ancestor
5688351|NCT03436472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688352|NCT03436472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5688353|NCT03436472|Analgesics|analgesics|mesh-ancestor
5688354|NCT03436472|Sensory System Agents|sensory system agents|mesh-ancestor
5688355|NCT03436472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5884042|NCT04272008|Hormones|hormones|mesh-ancestor
5884043|NCT04272008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5884044|NCT04272008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884045|NCT04272008|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5884046|NCT04272008|Contraceptive Agents|contraceptive agents|mesh-ancestor
5884047|NCT04272008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5884048|NCT04272008|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6496045|NCT00626158|Gemcitabine|gemcitabine|mesh-list
6496046|NCT00626158|Capecitabine|capecitabine|mesh-list
6496047|NCT00626158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6496048|NCT00626158|Antimetabolites|antimetabolites|mesh-ancestor
6496049|NCT00626158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496050|NCT00626158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6496051|NCT00626158|Antiviral Agents|antiviral agents|mesh-ancestor
6496052|NCT00626158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6496053|NCT00626158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6496054|NCT00626158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6496055|NCT00626158|Immunologic Factors|immunologic factors|mesh-ancestor
6496056|NCT00626158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496057|NCT00626223|Folic Acid|folic acid|mesh-list
6496058|NCT00626223|Hematinics|hematinics|mesh-ancestor
6496059|NCT00626223|Vitamin B Complex|vitamin b complex|mesh-ancestor
6496060|NCT00626223|Vitamins|vitamins|mesh-ancestor
6496061|NCT00626223|Micronutrients|micronutrients|mesh-ancestor
6496062|NCT00626223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496483|NCT00628225|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6496484|NCT00628225|Antidepressive Agents|antidepressive agents|mesh-ancestor
6496485|NCT00628225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6496486|NCT00628225|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6496487|NCT00628225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6496488|NCT00628225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5688356|NCT03436472|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5688357|NCT03436472|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5688358|NCT03436472|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5688359|NCT03436472|Adrenergic Agents|adrenergic agents|mesh-ancestor
5688360|NCT03436472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5688361|NCT03436472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688362|NCT03436368|Anesthetics|anesthetics|mesh-list
5884049|NCT04272008|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5884050|NCT04272008|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5884051|NCT04269213|Cytarabine|cytarabine|mesh-list
5884052|NCT04269213|Daunorubicin|daunorubicin|mesh-list
5884053|NCT04269213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5884054|NCT04269213|Antimetabolites|antimetabolites|mesh-ancestor
5884055|NCT04269213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5884056|NCT04269213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5884057|NCT04269213|Antiviral Agents|antiviral agents|mesh-ancestor
5884058|NCT04269213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5884059|NCT04269213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5884060|NCT04269213|Immunologic Factors|immunologic factors|mesh-ancestor
5884061|NCT04269213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884062|NCT04269213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5884063|NCT04269213|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5884064|NCT04269213|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5884065|NCT04269213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5884066|NCT04265911|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5884067|NCT04265911|Immunologic Factors|immunologic factors|mesh-ancestor
5884068|NCT04265911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884069|NCT04243122|Aspirin|aspirin|mesh-list
5884070|NCT04243122|Apixaban|apixaban|mesh-list
5884071|NCT04243122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5884072|NCT04243122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5884073|NCT04243122|Analgesics|analgesics|mesh-ancestor
5884074|NCT04243122|Sensory System Agents|sensory system agents|mesh-ancestor
5884075|NCT04243122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5884076|NCT04243122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884077|NCT04243122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5884078|NCT04243122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5884079|NCT04243122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5884080|NCT04243122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5884081|NCT04243122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5884082|NCT04243122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5884083|NCT04243122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5884084|NCT04243122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5884085|NCT04243122|Antipyretics|antipyretics|mesh-ancestor
5884086|NCT04243122|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5884087|NCT04243122|Antithrombins|antithrombins|mesh-ancestor
5884088|NCT04243122|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5884089|NCT04243122|Protease Inhibitors|protease inhibitors|mesh-ancestor
5884090|NCT04243122|Anticoagulants|anticoagulants|mesh-ancestor
5884091|NCT04183205|Sertraline|sertraline|mesh-list
5884092|NCT04183205|Antidepressive Agents|antidepressive agents|mesh-ancestor
5884093|NCT04183205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5884094|NCT04183205|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5884095|NCT04183205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5884096|NCT04183205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5884097|NCT04183205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5884098|NCT04183205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5884099|NCT04183205|Serotonin Agents|serotonin agents|mesh-ancestor
5884100|NCT04183205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884101|NCT04176718|Dexamethasone|dexamethasone|mesh-list
5884102|NCT04176718|Daratumumab|daratumumab|mesh-list
5884103|NCT04176718|Pomalidomide|pomalidomide|mesh-list
5884104|NCT04176718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5884105|NCT04176718|Antiemetics|antiemetics|mesh-ancestor
5884106|NCT04176718|Autonomic Agents|autonomic agents|mesh-ancestor
5884107|NCT04176718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5884108|NCT04176718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884109|NCT04176718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5884110|NCT04176718|Glucocorticoids|glucocorticoids|mesh-ancestor
5884111|NCT04176718|Hormones|hormones|mesh-ancestor
5884112|NCT04176718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5884113|NCT04176718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5884114|NCT04176718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5884115|NCT04176718|Immunologic Factors|immunologic factors|mesh-ancestor
5884116|NCT04176718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5884117|NCT04176718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5884118|NCT04176718|Growth Substances|growth substances|mesh-ancestor
5884119|NCT04176718|Growth Inhibitors|growth inhibitors|mesh-ancestor
6496063|NCT00626262|Esomeprazole|esomeprazole|mesh-list
6496064|NCT00626262|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6496065|NCT00626262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6496066|NCT00626262|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5688363|NCT03436368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5688364|NCT03436368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688365|NCT03436303|Dydrogesterone|dydrogesterone|mesh-list
5688366|NCT03436303|Progestins|progestins|mesh-ancestor
5688367|NCT03436303|Hormones|hormones|mesh-ancestor
5688368|NCT03436303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5688369|NCT03436303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688370|NCT03436225|Dexamethasone|dexamethasone|mesh-list
5688371|NCT03436225|Dexamethasone acetate|dexamethasone acetate|mesh-list
5884120|NCT04163406|Ferrous fumarate|ferrous fumarate|mesh-list
5884121|NCT04163406|Trace Elements|trace elements|mesh-ancestor
5884122|NCT04163406|Micronutrients|micronutrients|mesh-ancestor
5884123|NCT04163406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884124|NCT04120246|Acetic Acid|acetic acid|mesh-list
5884125|NCT04120246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5884126|NCT04120246|Trastuzumab|trastuzumab|mesh-list
5884127|NCT04120246|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
6675509|NCT01575925|BB 1101|bb 1101|mesh-list
6675510|NCT01575925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6675511|NCT01575925|Antiemetics|antiemetics|mesh-ancestor
6675512|NCT01575925|Autonomic Agents|autonomic agents|mesh-ancestor
6675513|NCT01575925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6675514|NCT01575925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675515|NCT01575925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6675516|NCT01575925|Glucocorticoids|glucocorticoids|mesh-ancestor
6675517|NCT01575925|Hormones|hormones|mesh-ancestor
5688372|NCT03436225|Budesonide|budesonide|mesh-list
5884128|NCT04120246|Antibodies|antibodies|mesh-list
5884129|NCT04120246|Immunoglobulins|immunoglobulins|mesh-list
5884130|NCT04120246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5884131|NCT04120246|Immunologic Factors|immunologic factors|mesh-ancestor
5688373|NCT03436225|Albuterol|albuterol|mesh-list
5688374|NCT03436225|BB 1101|bb 1101|mesh-list
5688375|NCT03436225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5688376|NCT03436225|Antiemetics|antiemetics|mesh-ancestor
5688377|NCT03436225|Autonomic Agents|autonomic agents|mesh-ancestor
5688378|NCT03436225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5688379|NCT03436225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688380|NCT03436225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5688381|NCT03436225|Glucocorticoids|glucocorticoids|mesh-ancestor
5688382|NCT03436225|Hormones|hormones|mesh-ancestor
5688383|NCT03436225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5688384|NCT03436225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5688385|NCT03436225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5688386|NCT03436225|Protease Inhibitors|protease inhibitors|mesh-ancestor
5688387|NCT03436225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5688388|NCT03436225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688389|NCT03436225|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5688390|NCT03436225|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5688391|NCT03436225|Respiratory System Agents|respiratory system agents|mesh-ancestor
5884132|NCT04120246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884133|NCT04120246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5884134|NCT04120246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5884135|NCT04120246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5884136|NCT04099355|Dronabinol|dronabinol|mesh-list
5884137|NCT04099355|Hallucinogens|hallucinogens|mesh-ancestor
5884138|NCT04099355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884139|NCT04099355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5884140|NCT04099355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5884141|NCT04099355|Analgesics|analgesics|mesh-ancestor
5884142|NCT04099355|Sensory System Agents|sensory system agents|mesh-ancestor
5884143|NCT04099355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5884144|NCT04099355|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5884145|NCT04099355|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5884146|NCT04099355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5884147|NCT04099355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5884148|NCT04099355|Hormones|hormones|mesh-ancestor
5884149|NCT04099355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5884150|NCT04001504|Vaccines|vaccines|mesh-list
5884151|NCT04001504|Immunologic Factors|immunologic factors|mesh-ancestor
5884152|NCT04001504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884153|NCT03965845|Palbociclib|palbociclib|mesh-list
5884154|NCT03965845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5884155|NCT03965845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5884156|NCT03965845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6675518|NCT01575925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5884157|NCT03965845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5884158|NCT03825289|Hydroxychloroquine|hydroxychloroquine|mesh-list
5884159|NCT03825289|Trametinib|trametinib|mesh-list
5884160|NCT03825289|Antimalarials|antimalarials|mesh-ancestor
5884161|NCT03825289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5884162|NCT03825289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5884163|NCT03825289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5884164|NCT03825289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5884165|NCT03825289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5884166|NCT03825289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5884167|NCT03825289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5884168|NCT03825289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5884169|NCT03809533|Sofosbuvir|sofosbuvir|mesh-list
5884170|NCT03809533|Velpatasvir|velpatasvir|mesh-list
5884171|NCT03809533|Antiviral Agents|antiviral agents|mesh-ancestor
5884172|NCT03809533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5884173|NCT03759366|Eculizumab|eculizumab|mesh-list
5884174|NCT03759366|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5884175|NCT03759366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5884176|NCT03759366|Immunologic Factors|immunologic factors|mesh-ancestor
5884177|NCT03759366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884178|NCT03649321|Gemcitabine|gemcitabine|mesh-list
5884179|NCT03649321|Paclitaxel|paclitaxel|mesh-list
5884180|NCT03649321|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5884181|NCT03649321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5884182|NCT03649321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5884183|NCT03649321|Tubulin Modulators|tubulin modulators|mesh-ancestor
5884184|NCT03649321|Antimitotic Agents|antimitotic agents|mesh-ancestor
5884185|NCT03649321|Mitosis Modulators|mitosis modulators|mesh-ancestor
5884186|NCT03649321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5884187|NCT03649321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5884188|NCT03649321|Antimetabolites|antimetabolites|mesh-ancestor
5884189|NCT03649321|Antiviral Agents|antiviral agents|mesh-ancestor
5884190|NCT03649321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5884191|NCT03649321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5884192|NCT03649321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5884193|NCT03649321|Immunologic Factors|immunologic factors|mesh-ancestor
5884194|NCT03649321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884195|NCT03619551|Busulfan|busulfan|mesh-list
5884196|NCT03619551|Alkylating Agents|alkylating agents|mesh-ancestor
5884197|NCT03619551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5884198|NCT03619551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5884199|NCT03619551|Immunologic Factors|immunologic factors|mesh-ancestor
5884200|NCT03619551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884201|NCT03619551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5884202|NCT03619551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5884203|NCT03619551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5884204|NCT03581292|Temozolomide|temozolomide|mesh-list
5884205|NCT03581292|Veliparib|veliparib|mesh-list
5884206|NCT03581292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5884207|NCT03581292|Alkylating Agents|alkylating agents|mesh-ancestor
5884208|NCT03581292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5884209|NCT03581292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5884210|NCT03581292|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5884211|NCT03581292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5884212|NCT03572530|Azacitidine|azacitidine|mesh-list
5884213|NCT03572530|Decitabine|decitabine|mesh-list
5884214|NCT03572530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5884215|NCT03572530|Antimetabolites|antimetabolites|mesh-ancestor
5884216|NCT03572530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5884217|NCT03572530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5884218|NCT03572530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5884219|NCT03549715|Durvalumab|durvalumab|mesh-list
5884220|NCT03549715|Tremelimumab|tremelimumab|mesh-list
5884221|NCT03549715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5884222|NCT03549715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5884223|NCT03532295|Bevacizumab|bevacizumab|mesh-list
5884224|NCT03532295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5884225|NCT03532295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5884226|NCT03532295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5884227|NCT03532295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5884228|NCT03532295|Growth Substances|growth substances|mesh-ancestor
5884229|NCT03532295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884230|NCT03532295|Growth Inhibitors|growth inhibitors|mesh-ancestor
5884231|NCT03481842|Axitinib|axitinib|mesh-list
5884232|NCT03481842|Afatinib|afatinib|mesh-list
5884233|NCT03481842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5688392|NCT03436225|Tocolytic Agents|tocolytic agents|mesh-ancestor
5688393|NCT03436225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5688394|NCT03436225|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5688395|NCT03436225|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5688396|NCT03436225|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5688397|NCT03436225|Adrenergic Agents|adrenergic agents|mesh-ancestor
5688398|NCT03436225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5688399|NCT03436173|Fluoxetine|fluoxetine|mesh-list
5688400|NCT03436173|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5688401|NCT03436173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5688402|NCT03436173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5688403|NCT03436173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688404|NCT03436173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5688405|NCT03436173|Serotonin Agents|serotonin agents|mesh-ancestor
5688406|NCT03436173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688407|NCT03436173|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5688408|NCT03436173|Antidepressive Agents|antidepressive agents|mesh-ancestor
5688409|NCT03436173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5688410|NCT03436173|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5688411|NCT03436173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5688412|NCT03436173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5688413|NCT03436121|Midazolam|midazolam|mesh-list
5688414|NCT03436121|Ketamine|ketamine|mesh-list
5688415|NCT03436121|Analgesics|analgesics|mesh-ancestor
5688416|NCT03436121|Sensory System Agents|sensory system agents|mesh-ancestor
5688417|NCT03436121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5688418|NCT03436121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688419|NCT03436121|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5688420|NCT03436121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5688421|NCT03436121|Anesthetics, General|anesthetics, general|mesh-ancestor
5688422|NCT03436121|Anesthetics|anesthetics|mesh-ancestor
5688423|NCT03436121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5688424|NCT03436121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5688425|NCT03436121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5688426|NCT03436121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5688427|NCT03436121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688428|NCT03436121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5688429|NCT03436121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5688430|NCT03436121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5688431|NCT03436121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5688432|NCT03436121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5688433|NCT03436121|GABA Modulators|gaba modulators|mesh-ancestor
5688434|NCT03436121|GABA Agents|gaba agents|mesh-ancestor
5688435|NCT03436056|Pembrolizumab|pembrolizumab|mesh-list
5688436|NCT03436056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5688437|NCT03436056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5688438|NCT03435952|Doxycycline|doxycycline|mesh-list
5688439|NCT03435952|Pembrolizumab|pembrolizumab|mesh-list
5688440|NCT03435952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5688441|NCT03435952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5688442|NCT03435952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5688443|NCT03435952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5688444|NCT03435952|Antimalarials|antimalarials|mesh-ancestor
5688445|NCT03435952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5884234|NCT03481842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5884235|NCT03481842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5884236|NCT03481842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5884237|NCT03466346|Fluoxetine|fluoxetine|mesh-list
5884238|NCT03466346|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5884239|NCT03466346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5884240|NCT03466346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5884241|NCT03466346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5884242|NCT03466346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5884243|NCT03466346|Serotonin Agents|serotonin agents|mesh-ancestor
5884244|NCT03466346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884245|NCT03466346|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5884246|NCT03466346|Antidepressive Agents|antidepressive agents|mesh-ancestor
5884247|NCT03466346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5884248|NCT03466346|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5884249|NCT03466346|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5884250|NCT03466346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5884251|NCT03449706|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
5884252|NCT03449706|Antiviral Agents|antiviral agents|mesh-ancestor
5884253|NCT03449706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5884254|NCT03403634|Interferons|interferons|mesh-list
5884255|NCT03403634|Interferon-alpha|interferon-alpha|mesh-list
5884256|NCT03403634|Interferon alpha-2|interferon alpha-2|mesh-list
5884257|NCT03403634|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
5884258|NCT03403634|Celecoxib|celecoxib|mesh-list
5688446|NCT03435952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5688447|NCT03435900|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5688448|NCT03435900|Metronidazole|metronidazole|mesh-list
5688449|NCT03435900|Fosfomycin|fosfomycin|mesh-list
5688450|NCT03435900|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5688451|NCT03435900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5688452|NCT03435900|Antitubercular Agents|antitubercular agents|mesh-ancestor
5688453|NCT03435900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5688454|NCT03435900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5688455|NCT03435744|Simvastatin|simvastatin|mesh-list
5688456|NCT03435744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5688457|NCT03435744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5688458|NCT03435744|Antimetabolites|antimetabolites|mesh-ancestor
5688459|NCT03435744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688460|NCT03435744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5688461|NCT03435744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5688462|NCT03435744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5688463|NCT03435718|Albendazole|albendazole|mesh-list
5688464|NCT03435718|Oxfendazole|oxfendazole|mesh-list
5688465|NCT03435718|Anthelmintics|anthelmintics|mesh-ancestor
5688466|NCT03435718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5688467|NCT03435718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5688468|NCT03435718|Anticestodal Agents|anticestodal agents|mesh-ancestor
5688469|NCT03435718|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5688470|NCT03435718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5688471|NCT03435718|Tubulin Modulators|tubulin modulators|mesh-ancestor
5884259|NCT03403634|Benzenesulfonamide|benzenesulfonamide|mesh-list
5884260|NCT03403634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5884261|NCT03403634|Antiviral Agents|antiviral agents|mesh-ancestor
5884262|NCT03403634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5884263|NCT03403634|Immunologic Factors|immunologic factors|mesh-ancestor
5884264|NCT03403634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884265|NCT03403634|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5884266|NCT03403634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5884267|NCT03403634|Analgesics|analgesics|mesh-ancestor
5884268|NCT03403634|Sensory System Agents|sensory system agents|mesh-ancestor
5884269|NCT03403634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5884270|NCT03403634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5884271|NCT03403634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5884272|NCT03403634|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5884273|NCT03403634|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5884274|NCT03403634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5884275|NCT03403634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5884276|NCT03403634|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5884277|NCT03341962|Calcium|calcium|mesh-list
5884278|NCT03341962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5884279|NCT03341962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884280|NCT03237819|Magnesium Sulfate|magnesium sulfate|mesh-list
5884281|NCT03237819|Analgesics|analgesics|mesh-ancestor
5884282|NCT03237819|Sensory System Agents|sensory system agents|mesh-ancestor
5884283|NCT03237819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5884284|NCT03237819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884285|NCT03237819|Anesthetics|anesthetics|mesh-ancestor
5884286|NCT03237819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5884287|NCT03237819|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5884288|NCT03237819|Anticonvulsants|anticonvulsants|mesh-ancestor
5884289|NCT03237819|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5884290|NCT03237819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5884291|NCT03237819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5884292|NCT03237819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5884293|NCT03237819|Tocolytic Agents|tocolytic agents|mesh-ancestor
5884294|NCT03237819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5906764|NCT05137184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5906765|NCT05137184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5906766|NCT05137184|Anesthetics, General|anesthetics, general|mesh-ancestor
5906767|NCT05137184|Anesthetics|anesthetics|mesh-ancestor
5906768|NCT05137184|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5906769|NCT05137145|Linaclotide|linaclotide|mesh-list
5906770|NCT05137145|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
5688472|NCT03435718|Antimitotic Agents|antimitotic agents|mesh-ancestor
5884295|NCT03207958|Belimumab|belimumab|mesh-list
5884296|NCT03207958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5884297|NCT03207958|Immunologic Factors|immunologic factors|mesh-ancestor
5884298|NCT03207958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884299|NCT03205956|Levodopa|levodopa|mesh-list
5688473|NCT03435718|Mitosis Modulators|mitosis modulators|mesh-ancestor
5688474|NCT03435718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688475|NCT03435718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5688476|NCT03435718|Antinematodal Agents|antinematodal agents|mesh-ancestor
5688477|NCT03435666|Capecitabine|capecitabine|mesh-list
5688478|NCT03435666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5688479|NCT03435666|Antimetabolites|antimetabolites|mesh-ancestor
5688480|NCT03435666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688481|NCT03435666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5697456|NCT03375775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697457|NCT03375671|Midazolam|midazolam|mesh-list
5697458|NCT03375671|Ketamine|ketamine|mesh-list
5697459|NCT03375671|Haloperidol|haloperidol|mesh-list
5697460|NCT03375671|Haloperidol decanoate|haloperidol decanoate|mesh-list
5697461|NCT03375671|Analgesics|analgesics|mesh-ancestor
5697462|NCT03375671|Sensory System Agents|sensory system agents|mesh-ancestor
5697463|NCT03375671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5697464|NCT03375671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697465|NCT03375671|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5697466|NCT03375671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5697467|NCT03375671|Anesthetics, General|anesthetics, general|mesh-ancestor
5697468|NCT03375671|Anesthetics|anesthetics|mesh-ancestor
5697469|NCT03375671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5697470|NCT03375671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5697471|NCT03375671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5697472|NCT03375671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5697473|NCT03375671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697474|NCT03375671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5697475|NCT03375671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5697476|NCT03375671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5697477|NCT03375671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5884300|NCT03205956|Carbidopa|carbidopa|mesh-list
5884301|NCT03205956|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5884302|NCT03205956|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5884303|NCT03205956|Dopamine Agents|dopamine agents|mesh-ancestor
5884304|NCT03205956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5884305|NCT03205956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5884306|NCT03205956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884307|NCT03205956|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5884308|NCT03205956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5884309|NCT03186209|Benralizumab|benralizumab|mesh-list
5884310|NCT03186209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5884311|NCT03186209|Respiratory System Agents|respiratory system agents|mesh-ancestor
5884312|NCT03149029|Pembrolizumab|pembrolizumab|mesh-list
5884313|NCT03149029|Trametinib|trametinib|mesh-list
5884314|NCT03149029|Dabrafenib|dabrafenib|mesh-list
5884315|NCT03149029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5884316|NCT03149029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5884317|NCT03149029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5884318|NCT03149029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5884319|NCT03149029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5884320|NCT03139916|Temozolomide|temozolomide|mesh-list
5884321|NCT03139916|Bavituximab|bavituximab|mesh-list
5884322|NCT03139916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5884323|NCT03139916|Alkylating Agents|alkylating agents|mesh-ancestor
5884324|NCT03139916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5884325|NCT03139916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5697478|NCT03375671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5697479|NCT03375671|GABA Modulators|gaba modulators|mesh-ancestor
5697480|NCT03375671|GABA Agents|gaba agents|mesh-ancestor
5697481|NCT03375671|Antiemetics|antiemetics|mesh-ancestor
5697482|NCT03375671|Autonomic Agents|autonomic agents|mesh-ancestor
5697483|NCT03375671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5884326|NCT03139916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5884327|NCT03019003|Durvalumab|durvalumab|mesh-list
5884328|NCT03019003|Decitabine|decitabine|mesh-list
5884329|NCT03019003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5697484|NCT03375671|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5697485|NCT03375671|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5884330|NCT03019003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5884331|NCT03019003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5688482|NCT03435458|Misoprostol|misoprostol|mesh-list
5688483|NCT03435458|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5688484|NCT03435458|Abortifacient Agents|abortifacient agents|mesh-ancestor
5688485|NCT03435458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5884332|NCT03019003|Antimetabolites|antimetabolites|mesh-ancestor
5884333|NCT03019003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5884334|NCT03019003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5884335|NCT03003962|Gemcitabine|gemcitabine|mesh-list
5884336|NCT03003962|Paclitaxel|paclitaxel|mesh-list
5884337|NCT03003962|Cisplatin|cisplatin|mesh-list
5884338|NCT03003962|Carboplatin|carboplatin|mesh-list
5884339|NCT03003962|Pemetrexed|pemetrexed|mesh-list
5884340|NCT03003962|Durvalumab|durvalumab|mesh-list
5884341|NCT03003962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5884342|NCT03003962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5884343|NCT03003962|Tubulin Modulators|tubulin modulators|mesh-ancestor
5884344|NCT03003962|Antimitotic Agents|antimitotic agents|mesh-ancestor
5884345|NCT03003962|Mitosis Modulators|mitosis modulators|mesh-ancestor
5884346|NCT03003962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5884347|NCT03003962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5884348|NCT03003962|Antimetabolites|antimetabolites|mesh-ancestor
5884349|NCT03003962|Antiviral Agents|antiviral agents|mesh-ancestor
5884350|NCT03003962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5884351|NCT03003962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5884352|NCT03003962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5884353|NCT03003962|Immunologic Factors|immunologic factors|mesh-ancestor
5884354|NCT03003962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688486|NCT03435458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688487|NCT03435458|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5688488|NCT03435458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5688489|NCT03435458|Oxytocics|oxytocics|mesh-ancestor
5688490|NCT03435302|Temozolomide|temozolomide|mesh-list
5688491|NCT03435302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5688492|NCT03435302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5688493|NCT03435302|Alkylating Agents|alkylating agents|mesh-ancestor
5688494|NCT03435302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688495|NCT03435289|Gemcitabine|gemcitabine|mesh-list
5688496|NCT03435289|Paclitaxel|paclitaxel|mesh-list
5688497|NCT03435289|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5688498|NCT03435289|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5688499|NCT03435289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5688500|NCT03435289|Tubulin Modulators|tubulin modulators|mesh-ancestor
5884355|NCT03003962|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5884356|NCT03003962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5884357|NCT03003962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5884358|NCT02951130|Milrinone|milrinone|mesh-list
5884359|NCT02951130|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5884360|NCT02951130|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5884361|NCT02951130|Vasodilator Agents|vasodilator agents|mesh-ancestor
5688501|NCT03435289|Antimitotic Agents|antimitotic agents|mesh-ancestor
5688502|NCT03435289|Mitosis Modulators|mitosis modulators|mesh-ancestor
5688503|NCT03435289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688504|NCT03435289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5688505|NCT03435289|Antimetabolites|antimetabolites|mesh-ancestor
5688506|NCT03435289|Antiviral Agents|antiviral agents|mesh-ancestor
5688507|NCT03435289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5884362|NCT02951130|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5884363|NCT02951130|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5884364|NCT02951130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5884365|NCT02951130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5884366|NCT02951130|Protective Agents|protective agents|mesh-ancestor
5884367|NCT02951130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884368|NCT02905110|Methotrexate|methotrexate|mesh-list
5884369|NCT02905110|Etoposide|etoposide|mesh-list
5884370|NCT02905110|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5884371|NCT02905110|Abortifacient Agents|abortifacient agents|mesh-ancestor
5884372|NCT02905110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5884373|NCT02905110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884374|NCT02905110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5884375|NCT02905110|Antimetabolites|antimetabolites|mesh-ancestor
5884376|NCT02905110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5884377|NCT02905110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5688508|NCT03435289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5688509|NCT03435289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5688510|NCT03435289|Immunologic Factors|immunologic factors|mesh-ancestor
5884378|NCT02905110|Dermatologic Agents|dermatologic agents|mesh-ancestor
5884379|NCT02905110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5884380|NCT02905110|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5884381|NCT02905110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5884382|NCT02905110|Immunologic Factors|immunologic factors|mesh-ancestor
5884383|NCT02905110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5884384|NCT02905110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5884385|NCT02905110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5884386|NCT02905110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5884387|NCT02905110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5884388|NCT02853344|Pembrolizumab|pembrolizumab|mesh-list
5884389|NCT02853344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5884390|NCT02853344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5688511|NCT03435289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688512|NCT03435250|Gemcitabine|gemcitabine|mesh-list
5688513|NCT03435250|Paclitaxel|paclitaxel|mesh-list
5688514|NCT03435250|Docetaxel|docetaxel|mesh-list
5688515|NCT03435250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5688516|NCT03435250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5688517|NCT03435250|Tubulin Modulators|tubulin modulators|mesh-ancestor
5688518|NCT03435250|Antimitotic Agents|antimitotic agents|mesh-ancestor
5688519|NCT03435250|Mitosis Modulators|mitosis modulators|mesh-ancestor
5688520|NCT03435250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688521|NCT03435250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5884391|NCT02813655|Cosyntropin|cosyntropin|mesh-list
5884392|NCT02813655|Hormones|hormones|mesh-ancestor
5884393|NCT02813655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5884394|NCT02813655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884395|NCT02747407|Vaccines|vaccines|mesh-list
5884396|NCT02747407|Immunologic Factors|immunologic factors|mesh-ancestor
5884397|NCT02747407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884398|NCT02718833|Dexamethasone|dexamethasone|mesh-list
5884399|NCT02718833|Bortezomib|bortezomib|mesh-list
5884400|NCT02718833|Pomalidomide|pomalidomide|mesh-list
5884401|NCT02718833|Elotuzumab|elotuzumab|mesh-list
5884402|NCT02718833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5884403|NCT02718833|Antiemetics|antiemetics|mesh-ancestor
5884404|NCT02718833|Autonomic Agents|autonomic agents|mesh-ancestor
5884405|NCT02718833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5884406|NCT02718833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688522|NCT03435250|Antimetabolites|antimetabolites|mesh-ancestor
5688523|NCT03435250|Antiviral Agents|antiviral agents|mesh-ancestor
5688524|NCT03435250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5688525|NCT03435250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5688526|NCT03435250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5688527|NCT03435250|Immunologic Factors|immunologic factors|mesh-ancestor
5688528|NCT03435250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688529|NCT03435133|Ticagrelor|ticagrelor|mesh-list
5688530|NCT03435133|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
5884407|NCT02718833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5884408|NCT02718833|Glucocorticoids|glucocorticoids|mesh-ancestor
5884409|NCT02718833|Hormones|hormones|mesh-ancestor
5884410|NCT02718833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5884411|NCT02718833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5884412|NCT02718833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5884413|NCT02718833|Immunologic Factors|immunologic factors|mesh-ancestor
5884414|NCT02718833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5884415|NCT02718833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5884416|NCT02718833|Growth Substances|growth substances|mesh-ancestor
5884417|NCT02718833|Growth Inhibitors|growth inhibitors|mesh-ancestor
5884418|NCT02700841|Melphalan|melphalan|mesh-list
5884419|NCT02700841|Mechlorethamine|mechlorethamine|mesh-list
5884420|NCT02700841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5884421|NCT02700841|Alkylating Agents|alkylating agents|mesh-ancestor
5884422|NCT02700841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5884423|NCT02700841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5884424|NCT02700841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5884425|NCT02700841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5884426|NCT02700841|Immunologic Factors|immunologic factors|mesh-ancestor
5884427|NCT02700841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884428|NCT02467452|Tiotropium Bromide|tiotropium bromide|mesh-list
5884429|NCT02467452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5884430|NCT02467452|Autonomic Agents|autonomic agents|mesh-ancestor
5688531|NCT03435133|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5884431|NCT02467452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5884432|NCT02467452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884433|NCT02467452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5884434|NCT02467452|Respiratory System Agents|respiratory system agents|mesh-ancestor
5884435|NCT02467452|Parasympatholytics|parasympatholytics|mesh-ancestor
5884436|NCT02467452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5884437|NCT02467452|Cholinergic Agents|cholinergic agents|mesh-ancestor
5884438|NCT02467452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5884439|NCT02467452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5884440|NCT02369458|Mitomycins|mitomycins|mesh-list
5884441|NCT02369458|Mitomycin|mitomycin|mesh-list
5884442|NCT02369458|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5884443|NCT02369458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5884444|NCT02369458|Alkylating Agents|alkylating agents|mesh-ancestor
5884445|NCT02369458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5884446|NCT02369458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5884447|NCT02369458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5884448|NCT05102591|Ketorolac|ketorolac|mesh-list
5884449|NCT05102591|Metoclopramide|metoclopramide|mesh-list
5884450|NCT05102591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5884451|NCT05102591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5884452|NCT05102591|Analgesics|analgesics|mesh-ancestor
5884453|NCT05102591|Sensory System Agents|sensory system agents|mesh-ancestor
5884454|NCT05102591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5884455|NCT05102591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688532|NCT03435133|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5688533|NCT03435133|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5688534|NCT03435133|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5688535|NCT03435133|Purinergic Agents|purinergic agents|mesh-ancestor
5688536|NCT03435133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5688537|NCT03435133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688538|NCT03435133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688539|NCT03435107|Durvalumab|durvalumab|mesh-list
5688540|NCT03435107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5688541|NCT03435107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5688542|NCT03435094|Alendronate|alendronate|mesh-list
5688543|NCT03435094|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5688544|NCT03435094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688545|NCT03434951|Morphine|morphine|mesh-list
5688546|NCT03434951|Bupivacaine|bupivacaine|mesh-list
5688547|NCT03434951|Anesthetics, Local|anesthetics, local|mesh-ancestor
5688548|NCT03434951|Anesthetics|anesthetics|mesh-ancestor
5688549|NCT03434951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5688550|NCT03434951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688551|NCT03434951|Sensory System Agents|sensory system agents|mesh-ancestor
5688552|NCT03434951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5688553|NCT03434951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5688554|NCT03434951|Narcotics|narcotics|mesh-ancestor
5688555|NCT03434951|Analgesics|analgesics|mesh-ancestor
5688556|NCT03434782|Listerine|listerine|mesh-list
5884456|NCT05102591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5884457|NCT05102591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5884458|NCT05102591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5884459|NCT05102591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5884460|NCT05102591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5884461|NCT05102591|Antiemetics|antiemetics|mesh-ancestor
5884462|NCT05102591|Autonomic Agents|autonomic agents|mesh-ancestor
5884463|NCT05102591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5884464|NCT05102591|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5884465|NCT05102591|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5884466|NCT05102591|Dopamine Agents|dopamine agents|mesh-ancestor
5884467|NCT05102591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5884468|NCT05102552|Huperzine A|huperzine a|mesh-list
5884469|NCT05102552|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5884470|NCT05102552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5884471|NCT05102552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5884472|NCT05102552|Cholinergic Agents|cholinergic agents|mesh-ancestor
5884473|NCT05102552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5884474|NCT05102552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884475|NCT05102552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5884476|NCT05102552|Protective Agents|protective agents|mesh-ancestor
6496067|NCT00626262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6496068|NCT00626262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496069|NCT00626288|Mesalamine|mesalamine|mesh-list
5884477|NCT05102448|Methotrexate|methotrexate|mesh-list
5884478|NCT05102448|Tofacitinib|tofacitinib|mesh-list
5906771|NCT05137145|Enzyme Activators|enzyme activators|mesh-ancestor
5884479|NCT05102448|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5884480|NCT05102448|Abortifacient Agents|abortifacient agents|mesh-ancestor
5884481|NCT05102448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5688557|NCT03434782|Hydrogen Peroxide|hydrogen peroxide|mesh-list
5688558|NCT03434782|Fluorides|fluorides|mesh-list
5688559|NCT03434782|Sodium Fluoride|sodium fluoride|mesh-list
5688560|NCT03434782|Cariostatic Agents|cariostatic agents|mesh-ancestor
5688561|NCT03434782|Protective Agents|protective agents|mesh-ancestor
5688562|NCT03434782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688563|NCT03434782|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5688564|NCT03434782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5688565|NCT03434769|Cyclophosphamide|cyclophosphamide|mesh-list
5688566|NCT03434769|Fludarabine|fludarabine|mesh-list
5688567|NCT03434769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5688568|NCT03434769|Immunologic Factors|immunologic factors|mesh-ancestor
5688569|NCT03434769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688570|NCT03434769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5688571|NCT03434769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5688572|NCT03434769|Alkylating Agents|alkylating agents|mesh-ancestor
5688573|NCT03434769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688574|NCT03434769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5688575|NCT03434769|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5688576|NCT03434704|Antifungal Agents|antifungal agents|mesh-list
5688577|NCT03434704|Clotrimazole|clotrimazole|mesh-list
5688578|NCT03434704|Miconazole|miconazole|mesh-list
5688579|NCT03434704|Fludarabine|fludarabine|mesh-list
5688580|NCT03434704|Thiotepa|thiotepa|mesh-list
5688581|NCT03434704|Treosulfan|treosulfan|mesh-list
5688582|NCT03434704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5688583|NCT03434704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688584|NCT03434704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5688585|NCT03434704|Immunologic Factors|immunologic factors|mesh-ancestor
5688586|NCT03434704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688587|NCT03434704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5688588|NCT03434704|Alkylating Agents|alkylating agents|mesh-ancestor
5688589|NCT03434704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5688590|NCT03434704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5884482|NCT05102448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884483|NCT05102448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5884484|NCT05102448|Antimetabolites|antimetabolites|mesh-ancestor
5884485|NCT05102448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5884486|NCT05102448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5884487|NCT05102448|Dermatologic Agents|dermatologic agents|mesh-ancestor
5884488|NCT05102448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5884489|NCT05102448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5884490|NCT05102448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5884491|NCT05102448|Immunologic Factors|immunologic factors|mesh-ancestor
5884492|NCT05102448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5884493|NCT05102448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5884494|NCT05102448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5884495|NCT05102422|Propofol|propofol|mesh-list
5884496|NCT05102422|Sevoflurane|sevoflurane|mesh-list
5884497|NCT05102422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5884498|NCT05102422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5884499|NCT05102422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884500|NCT05102422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5884501|NCT05102422|Anesthetics, General|anesthetics, general|mesh-ancestor
5884502|NCT05102422|Anesthetics|anesthetics|mesh-ancestor
5884503|NCT05102422|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5884504|NCT05102422|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5884505|NCT05102396|Mandelic Acids|mandelic acids|mesh-list
5884506|NCT05102396|Oxybutynin|oxybutynin|mesh-list
5884507|NCT05102396|Parasympatholytics|parasympatholytics|mesh-ancestor
5884508|NCT05102396|Autonomic Agents|autonomic agents|mesh-ancestor
5884509|NCT05102396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5688591|NCT03434704|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5688592|NCT03434704|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5688593|NCT03434704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5688594|NCT03434704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5688595|NCT03434704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5688596|NCT03434704|Hormone Antagonists|hormone antagonists|mesh-ancestor
5688597|NCT03434704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5688598|NCT03434704|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5688599|NCT03434704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6496489|NCT00628225|Dopamine Agents|dopamine agents|mesh-ancestor
5884510|NCT05102396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884511|NCT05102396|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5884512|NCT05102396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5884513|NCT05102396|Cholinergic Agents|cholinergic agents|mesh-ancestor
5884514|NCT05102396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6496070|NCT00626288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6496071|NCT00626288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5884515|NCT05102396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5884516|NCT05102396|Urological Agents|urological agents|mesh-ancestor
5884517|NCT05102396|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5884518|NCT05102396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5884519|NCT05102396|Renal Agents|renal agents|mesh-ancestor
5884520|NCT05102058|Dexmedetomidine|dexmedetomidine|mesh-list
5884521|NCT05102058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5884522|NCT05102058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5884523|NCT05102058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884524|NCT05102058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5884525|NCT05102058|Analgesics|analgesics|mesh-ancestor
5884526|NCT05102058|Sensory System Agents|sensory system agents|mesh-ancestor
5884527|NCT05102058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5884528|NCT05102058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5884529|NCT05102058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5884530|NCT05102058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5884531|NCT05102058|Adrenergic Agents|adrenergic agents|mesh-ancestor
5884532|NCT05102058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5884533|NCT05102058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5884534|NCT05102045|Memantine|memantine|mesh-list
5884535|NCT05102045|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
5884536|NCT05102045|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6496072|NCT00626288|Analgesics|analgesics|mesh-ancestor
6496073|NCT00626288|Sensory System Agents|sensory system agents|mesh-ancestor
5884537|NCT05102045|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5884538|NCT05102045|Dopamine Agents|dopamine agents|mesh-ancestor
5884539|NCT05102045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5884540|NCT05102045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5884541|NCT05102045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884542|NCT05102045|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5884543|NCT05102045|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5884544|NCT05102045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5884545|NCT05102045|Cholinergic Agents|cholinergic agents|mesh-ancestor
5884546|NCT05101954|Mitogens|mitogens|mesh-list
5688600|NCT03434691|Remifentanil|remifentanil|mesh-list
5688601|NCT03434691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5688602|NCT03434691|Narcotics|narcotics|mesh-ancestor
5688603|NCT03434691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5688604|NCT03434691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688605|NCT03434691|Analgesics|analgesics|mesh-ancestor
5688606|NCT03434691|Sensory System Agents|sensory system agents|mesh-ancestor
5688607|NCT03434691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5884547|NCT05101954|Mitosis Modulators|mitosis modulators|mesh-ancestor
5884548|NCT05101954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5884549|NCT05101928|Prednisone|prednisone|mesh-list
5884550|NCT05101928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5884551|NCT05101928|Glucocorticoids|glucocorticoids|mesh-ancestor
5884552|NCT05101928|Hormones|hormones|mesh-ancestor
5908677|NCT04278898|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5688608|NCT03434678|Fentanyl|fentanyl|mesh-list
5688609|NCT03434678|Bupivacaine|bupivacaine|mesh-list
5688610|NCT03434678|Propofol|propofol|mesh-list
5688611|NCT03434678|Rocuronium|rocuronium|mesh-list
5688612|NCT03434678|Anesthetics, Local|anesthetics, local|mesh-ancestor
5688613|NCT03434678|Anesthetics|anesthetics|mesh-ancestor
5688614|NCT03434678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5688615|NCT03434678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688616|NCT03434678|Sensory System Agents|sensory system agents|mesh-ancestor
5688617|NCT03434678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5688618|NCT03434678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5688619|NCT03434678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5688620|NCT03434678|Anesthetics, General|anesthetics, general|mesh-ancestor
5688621|NCT03434678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5688622|NCT03434678|Narcotics|narcotics|mesh-ancestor
5688623|NCT03434678|Analgesics|analgesics|mesh-ancestor
5688624|NCT03434678|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5688625|NCT03434678|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5688626|NCT03434678|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5884553|NCT05101928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5884554|NCT05101928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884555|NCT05101928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5884556|NCT05101928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5884557|NCT05101811|Vitamin D|vitamin d|mesh-list
5884558|NCT05101811|Ergocalciferols|ergocalciferols|mesh-list
5884559|NCT05101811|Vitamins|vitamins|mesh-list
5884560|NCT05101811|Micronutrients|micronutrients|mesh-ancestor
5884561|NCT05101811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884562|NCT05101811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5884563|NCT05101811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5884564|NCT05101798|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5884565|NCT05101798|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5884566|NCT05101798|Dermatologic Agents|dermatologic agents|mesh-ancestor
5884567|NCT05101785|Lidocaine|lidocaine|mesh-list
5884568|NCT05101785|Epinephrine|epinephrine|mesh-list
5884569|NCT05101785|Racepinephrine|racepinephrine|mesh-list
5884570|NCT05101785|Carticaine|carticaine|mesh-list
5884571|NCT05101785|Epinephryl borate|epinephryl borate|mesh-list
5884572|NCT05101785|Anesthetics, Local|anesthetics, local|mesh-ancestor
5884573|NCT05101785|Anesthetics|anesthetics|mesh-ancestor
5884574|NCT05101785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5884575|NCT05101785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884576|NCT05101785|Sensory System Agents|sensory system agents|mesh-ancestor
5884577|NCT05101785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5884578|NCT05101785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5884579|NCT05101785|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5884580|NCT05101785|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5884581|NCT05101785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5884582|NCT05101785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5884583|NCT05101785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5688627|NCT03434678|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5688628|NCT03434613|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5688629|NCT03434613|Ezetimibe|ezetimibe|mesh-list
5688630|NCT03434613|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5688631|NCT03434613|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5688632|NCT03434613|Antimetabolites|antimetabolites|mesh-ancestor
5884584|NCT05101785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5884585|NCT05101785|Adrenergic Agents|adrenergic agents|mesh-ancestor
5884586|NCT05101785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5884587|NCT05101785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5884588|NCT05101785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5884589|NCT05101785|Autonomic Agents|autonomic agents|mesh-ancestor
5884590|NCT05101785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5884591|NCT05101785|Respiratory System Agents|respiratory system agents|mesh-ancestor
5884592|NCT05101785|Mydriatics|mydriatics|mesh-ancestor
5884593|NCT05101785|Sympathomimetics|sympathomimetics|mesh-ancestor
5884594|NCT05101785|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5884595|NCT05101746|Nitric Oxide|nitric oxide|mesh-list
5884596|NCT05101746|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5884597|NCT05101746|Autonomic Agents|autonomic agents|mesh-ancestor
5884598|NCT05101746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5884599|NCT05101746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884600|NCT05101746|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5884601|NCT05101746|Respiratory System Agents|respiratory system agents|mesh-ancestor
5884602|NCT05101746|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5884603|NCT05101746|Antioxidants|antioxidants|mesh-ancestor
5884604|NCT05101746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5884605|NCT05101746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5688633|NCT03434613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688634|NCT03434613|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5688635|NCT03434613|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5688636|NCT03434613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5688637|NCT03434444|Propranolol|propranolol|mesh-list
5688638|NCT03434444|Oxytocin|oxytocin|mesh-list
5688639|NCT03434444|Oxytocics|oxytocics|mesh-ancestor
5688640|NCT03434444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5688641|NCT03434444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884606|NCT05101746|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5884607|NCT05101746|Vasodilator Agents|vasodilator agents|mesh-ancestor
5884608|NCT05101746|Gasotransmitters|gasotransmitters|mesh-ancestor
5884609|NCT05101746|Protective Agents|protective agents|mesh-ancestor
5884610|NCT05101551|Gemcitabine|gemcitabine|mesh-list
5884611|NCT05101551|Topotecan|topotecan|mesh-list
5697486|NCT03375671|Dopamine Agents|dopamine agents|mesh-ancestor
5884612|NCT05101551|Talazoparib|talazoparib|mesh-list
5884613|NCT05101551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5884614|NCT05101551|Antimetabolites|antimetabolites|mesh-ancestor
5884615|NCT05101551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5884616|NCT05101551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5884617|NCT05101551|Antiviral Agents|antiviral agents|mesh-ancestor
5884618|NCT05101551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5884619|NCT05101551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5884620|NCT05101551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5884621|NCT05101551|Immunologic Factors|immunologic factors|mesh-ancestor
5884622|NCT05101551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884623|NCT05101551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5884624|NCT05101551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5884625|NCT05101551|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5884626|NCT05101447|Mycophenolic Acid|mycophenolic acid|mesh-list
5884627|NCT05101447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5884628|NCT05101447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5884629|NCT05101447|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5884630|NCT05101447|Antitubercular Agents|antitubercular agents|mesh-ancestor
5884631|NCT05101447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5884632|NCT05101447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5884633|NCT05101447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5884634|NCT05101447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906772|NCT05137145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906773|NCT05137145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5906774|NCT05137119|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5906775|NCT05137119|Vancomycin|vancomycin|mesh-list
5906776|NCT05137119|Clindamycin|clindamycin|mesh-list
5906777|NCT05137119|Cefazolin|cefazolin|mesh-list
5906778|NCT05137119|Daptomycin|daptomycin|mesh-list
5906779|NCT05137119|Penicillins|penicillins|mesh-list
5906780|NCT05137119|Penicillin G|penicillin g|mesh-list
5906781|NCT05137119|Lincomycin|lincomycin|mesh-list
5688642|NCT03434444|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5688643|NCT03434444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5688644|NCT03434444|Adrenergic Agents|adrenergic agents|mesh-ancestor
5688645|NCT03434444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5688646|NCT03434444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688647|NCT03434444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5906782|NCT05137119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5906783|NCT05137119|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5906784|NCT05137119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5906785|NCT05137119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906786|NCT05137054|Dexamethasone|dexamethasone|mesh-list
5906787|NCT05137054|Lenalidomide|lenalidomide|mesh-list
5906788|NCT05137054|Bortezomib|bortezomib|mesh-list
5906789|NCT05137054|Daratumumab|daratumumab|mesh-list
5906790|NCT05137054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5906791|NCT05137054|Antiemetics|antiemetics|mesh-ancestor
5906792|NCT05137054|Autonomic Agents|autonomic agents|mesh-ancestor
5906793|NCT05137054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5906794|NCT05137054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906795|NCT05137054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5906796|NCT05137054|Glucocorticoids|glucocorticoids|mesh-ancestor
5906797|NCT05137054|Hormones|hormones|mesh-ancestor
5906798|NCT05137054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5906799|NCT05137054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5906800|NCT05137054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5906801|NCT05137054|Immunologic Factors|immunologic factors|mesh-ancestor
5906802|NCT05137054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5906803|NCT05137054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5906804|NCT05137054|Growth Substances|growth substances|mesh-ancestor
5906805|NCT05137054|Growth Inhibitors|growth inhibitors|mesh-ancestor
5906806|NCT05136976|Rituximab|rituximab|mesh-list
5906807|NCT05136976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5906808|NCT05136976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5688648|NCT03434444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5688649|NCT03434444|Vasodilator Agents|vasodilator agents|mesh-ancestor
5688650|NCT03434405|Psychotropic Drugs|psychotropic drugs|mesh-list
5688651|NCT03434366|Dexmedetomidine|dexmedetomidine|mesh-list
5688652|NCT03434366|Ketamine|ketamine|mesh-list
5688653|NCT03434366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5688654|NCT03434366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5688655|NCT03434366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688656|NCT03434366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5688657|NCT03434366|Analgesics|analgesics|mesh-ancestor
5688658|NCT03434366|Sensory System Agents|sensory system agents|mesh-ancestor
5884635|NCT05101291|Bupivacaine|bupivacaine|mesh-list
5884636|NCT05101291|Anesthetics, Local|anesthetics, local|mesh-ancestor
5884637|NCT05101291|Anesthetics|anesthetics|mesh-ancestor
5884638|NCT05101291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5884639|NCT05101291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884640|NCT05101291|Sensory System Agents|sensory system agents|mesh-ancestor
5884641|NCT05101291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5884642|NCT05101187|Amphotericin B|amphotericin b|mesh-list
5884643|NCT05101187|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
5884644|NCT05101187|Olorofim|olorofim|mesh-list
5884645|NCT05101187|Amebicides|amebicides|mesh-ancestor
5688659|NCT03434366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5688660|NCT03434366|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5688661|NCT03434366|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5688662|NCT03434366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5688663|NCT03434366|Adrenergic Agents|adrenergic agents|mesh-ancestor
5688664|NCT03434366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5884646|NCT05101187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5884647|NCT05101187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5884648|NCT05101187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5884649|NCT05101187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5884650|NCT05101187|Antifungal Agents|antifungal agents|mesh-ancestor
5884651|NCT05101122|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
5884652|NCT05101122|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5884653|NCT05101122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5884654|NCT05101122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5884655|NCT05101122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5884656|NCT05101122|Adrenergic Agents|adrenergic agents|mesh-ancestor
5884657|NCT05101122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5884658|NCT05101122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884659|NCT05097976|Methylprednisolone|methylprednisolone|mesh-list
5884660|NCT05097976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5884661|NCT05097976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5884662|NCT05097976|Prednisolone|prednisolone|mesh-list
5884663|NCT05097976|Prednisolone acetate|prednisolone acetate|mesh-list
5884664|NCT05097976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5884665|NCT05097976|Prednisolone phosphate|prednisolone phosphate|mesh-list
5884666|NCT05097976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5884667|NCT05097976|Antiemetics|antiemetics|mesh-ancestor
5884668|NCT05097976|Autonomic Agents|autonomic agents|mesh-ancestor
5884669|NCT05097976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5884670|NCT05097976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884671|NCT05097976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5884672|NCT05097976|Glucocorticoids|glucocorticoids|mesh-ancestor
5884673|NCT05097976|Hormones|hormones|mesh-ancestor
5884674|NCT05097976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5884675|NCT05097976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5884676|NCT05097976|Protective Agents|protective agents|mesh-ancestor
5884677|NCT05097976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5884678|NCT05097976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5884679|NCT05092074|Sofosbuvir|sofosbuvir|mesh-list
5884680|NCT05092074|Velpatasvir|velpatasvir|mesh-list
5884681|NCT05092074|Antiviral Agents|antiviral agents|mesh-ancestor
5884682|NCT05092074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5884683|NCT05091372|Lenalidomide|lenalidomide|mesh-list
5884684|NCT05091372|Immunologic Factors|immunologic factors|mesh-ancestor
5884685|NCT05091372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884686|NCT05091372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5884687|NCT05091372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5884688|NCT05091372|Growth Substances|growth substances|mesh-ancestor
5884689|NCT05091372|Growth Inhibitors|growth inhibitors|mesh-ancestor
5884690|NCT05091372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5884691|NCT05083949|Metformin|metformin|mesh-list
5688665|NCT03434366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688666|NCT03434366|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5688667|NCT03434366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5688668|NCT03434366|Anesthetics, General|anesthetics, general|mesh-ancestor
5688669|NCT03434366|Anesthetics|anesthetics|mesh-ancestor
5688670|NCT03434366|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5688671|NCT03434366|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5688672|NCT03434340|Dexamethasone|dexamethasone|mesh-list
5688673|NCT03434340|Granisetron|granisetron|mesh-list
5688674|NCT03434340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5688675|NCT03434340|Antiemetics|antiemetics|mesh-ancestor
5688676|NCT03434340|Autonomic Agents|autonomic agents|mesh-ancestor
5688677|NCT03434340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5884692|NCT05083949|Empagliflozin|empagliflozin|mesh-list
5884693|NCT05083949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5884694|NCT05083949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884695|NCT05083949|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5884696|NCT05083949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5884697|NCT05058417|Empagliflozin|empagliflozin|mesh-list
5884698|NCT05058417|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5884699|NCT05058417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5884700|NCT05058417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5884701|NCT05058417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884702|NCT05051449|Ketamine|ketamine|mesh-list
5884703|NCT05051449|Analgesics|analgesics|mesh-ancestor
5884704|NCT05051449|Sensory System Agents|sensory system agents|mesh-ancestor
5884705|NCT05051449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5884706|NCT05051449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884707|NCT05051449|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5884708|NCT05051449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5884709|NCT05051449|Anesthetics, General|anesthetics, general|mesh-ancestor
5884710|NCT05051449|Anesthetics|anesthetics|mesh-ancestor
5884711|NCT05051449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5884712|NCT05051449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5884713|NCT05051449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5884714|NCT05051449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5884715|NCT05051449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5884716|NCT05050318|Vaccines|vaccines|mesh-list
5884717|NCT05050318|Immunologic Factors|immunologic factors|mesh-ancestor
5884718|NCT05050318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884719|NCT05037617|Oxytocin|oxytocin|mesh-list
5884720|NCT05037617|Oxytocics|oxytocics|mesh-ancestor
5884721|NCT05037617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5884722|NCT05037617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884723|NCT05036473|Levodopa|levodopa|mesh-list
5884724|NCT05036473|Carbidopa|carbidopa|mesh-list
5884725|NCT05036473|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
5884726|NCT05036473|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5884727|NCT05036473|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5884728|NCT05036473|Dopamine Agents|dopamine agents|mesh-ancestor
5884729|NCT05036473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5884730|NCT05036473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5884731|NCT05036473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884732|NCT05036473|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5884733|NCT05036473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5884734|NCT05036473|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5884735|NCT05036473|Immunologic Factors|immunologic factors|mesh-ancestor
5884736|NCT05036473|Dopamine Agonists|dopamine agonists|mesh-ancestor
5884737|NCT05020574|Cephalexin|cephalexin|mesh-list
5884738|NCT05020574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5884739|NCT05020574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5884740|NCT05020444|Cyclophosphamide|cyclophosphamide|mesh-list
5884741|NCT05020444|Fludarabine|fludarabine|mesh-list
5884742|NCT05020444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5884743|NCT05020444|Immunologic Factors|immunologic factors|mesh-ancestor
5884744|NCT05020444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884745|NCT05020444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5884746|NCT05020444|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5884747|NCT05020444|Alkylating Agents|alkylating agents|mesh-ancestor
5884748|NCT05020444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5884749|NCT05020444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5884750|NCT05020444|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5884751|NCT04971746|Pirfenidone|pirfenidone|mesh-list
5884752|NCT04971746|Nintedanib|nintedanib|mesh-list
5884753|NCT04971746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5884754|NCT04971746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5884755|NCT04971746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5884756|NCT04971746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5884757|NCT04971746|Analgesics|analgesics|mesh-ancestor
5884758|NCT04971746|Sensory System Agents|sensory system agents|mesh-ancestor
5884759|NCT04971746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5884760|NCT04971746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884761|NCT04971746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5884762|NCT04971746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5884763|NCT04971746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5884764|NCT04971746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5884765|NCT04964466|Becaplermin|becaplermin|mesh-list
5884766|NCT04964466|Anticoagulants|anticoagulants|mesh-ancestor
5884767|NCT04964466|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
5884768|NCT04964466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5884769|NCT04964466|Growth Substances|growth substances|mesh-ancestor
5884770|NCT04964466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884771|NCT04945616|Aspirin|aspirin|mesh-list
5884772|NCT04945616|Clopidogrel|clopidogrel|mesh-list
5884773|NCT04945616|Ticagrelor|ticagrelor|mesh-list
5884774|NCT04945616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5884775|NCT04945616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5884776|NCT04945616|Analgesics|analgesics|mesh-ancestor
5884777|NCT04945616|Sensory System Agents|sensory system agents|mesh-ancestor
5884778|NCT04945616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5884779|NCT04945616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884780|NCT04945616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5884781|NCT04945616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5884782|NCT04945616|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5884783|NCT04945616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5884784|NCT04945616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5884785|NCT04945616|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5884786|NCT04945616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5884787|NCT04945616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5884788|NCT04945616|Antipyretics|antipyretics|mesh-ancestor
5884789|NCT04945616|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5884790|NCT04945616|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5884791|NCT04945616|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5884792|NCT04945616|Purinergic Agents|purinergic agents|mesh-ancestor
5884793|NCT04945616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5884794|NCT04940013|Misoprostol|misoprostol|mesh-list
5884795|NCT04940013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5884796|NCT04940013|Abortifacient Agents|abortifacient agents|mesh-ancestor
5884797|NCT04940013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5884798|NCT04940013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884799|NCT04940013|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5884800|NCT04940013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5884801|NCT04940013|Oxytocics|oxytocics|mesh-ancestor
5884802|NCT04923867|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5884803|NCT04923867|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5884804|NCT04923867|Estradiol|estradiol|mesh-list
5884805|NCT04923867|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6675519|NCT01575925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6675520|NCT01575925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6675521|NCT01575925|Protease Inhibitors|protease inhibitors|mesh-ancestor
6675522|NCT01575925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6675523|NCT01575925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5884806|NCT04923867|Estrogens|estrogens|mesh-ancestor
5884807|NCT04923867|Hormones|hormones|mesh-ancestor
5884808|NCT04923867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5884809|NCT04923867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884810|NCT04923867|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5884811|NCT04923867|Contraceptive Agents|contraceptive agents|mesh-ancestor
5884812|NCT04923867|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5884813|NCT04923867|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5884814|NCT04894864|Analgesics, Opioid|analgesics, opioid|mesh-list
5884815|NCT04894864|Anesthetics|anesthetics|mesh-list
5884816|NCT04894864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5884817|NCT04894864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884818|NCT04894864|Narcotics|narcotics|mesh-ancestor
5884819|NCT04894864|Analgesics|analgesics|mesh-ancestor
5884820|NCT04894864|Sensory System Agents|sensory system agents|mesh-ancestor
5884821|NCT04894864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5884822|NCT04862650|Paclitaxel|paclitaxel|mesh-list
5884823|NCT04862650|Carboplatin|carboplatin|mesh-list
5884824|NCT04862650|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5884825|NCT04862650|Cemiplimab|cemiplimab|mesh-list
5884826|NCT04862650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5884827|NCT04862650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5884828|NCT04862650|Tubulin Modulators|tubulin modulators|mesh-ancestor
5884829|NCT04862650|Antimitotic Agents|antimitotic agents|mesh-ancestor
5884830|NCT04862650|Mitosis Modulators|mitosis modulators|mesh-ancestor
5884831|NCT04862650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5884832|NCT04862650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5906809|NCT05136976|Immunologic Factors|immunologic factors|mesh-ancestor
5906810|NCT05136976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884833|NCT04796220|Gemcitabine|gemcitabine|mesh-list
5884834|NCT04796220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5884835|NCT04796220|Antimetabolites|antimetabolites|mesh-ancestor
5884836|NCT04796220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5884837|NCT04796220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5884838|NCT04796220|Antiviral Agents|antiviral agents|mesh-ancestor
5884839|NCT04796220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5884840|NCT04796220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5884841|NCT04796220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5884842|NCT04796220|Immunologic Factors|immunologic factors|mesh-ancestor
5884843|NCT04796220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884844|NCT04787991|Gemcitabine|gemcitabine|mesh-list
5884845|NCT04787991|Hydroxychloroquine|hydroxychloroquine|mesh-list
5884846|NCT04787991|Paclitaxel|paclitaxel|mesh-list
5884847|NCT04787991|Nivolumab|nivolumab|mesh-list
5884848|NCT04787991|Ipilimumab|ipilimumab|mesh-list
5884849|NCT04787991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5884850|NCT04787991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5884851|NCT04787991|Tubulin Modulators|tubulin modulators|mesh-ancestor
5884852|NCT04787991|Antimitotic Agents|antimitotic agents|mesh-ancestor
5884853|NCT04787991|Mitosis Modulators|mitosis modulators|mesh-ancestor
5884854|NCT04787991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5884855|NCT04787991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5884856|NCT04787991|Antimetabolites|antimetabolites|mesh-ancestor
5884857|NCT04787991|Antiviral Agents|antiviral agents|mesh-ancestor
5884858|NCT04787991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5884859|NCT04787991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5884860|NCT04787991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5884861|NCT04787991|Immunologic Factors|immunologic factors|mesh-ancestor
5884862|NCT04787991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884863|NCT04787991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5884864|NCT04787991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5884865|NCT04787991|Antimalarials|antimalarials|mesh-ancestor
5884866|NCT04787991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5884867|NCT04787991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5884868|NCT04787991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5884869|NCT04719065|Mitoxantrone|mitoxantrone|mesh-list
5884870|NCT04719065|Analgesics|analgesics|mesh-ancestor
5884871|NCT04719065|Sensory System Agents|sensory system agents|mesh-ancestor
5884872|NCT04719065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5884873|NCT04719065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884874|NCT04719065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5884875|NCT04719065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5884876|NCT04719065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5884877|NCT04719065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5884878|NCT04719065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5884879|NCT04659811|Pembrolizumab|pembrolizumab|mesh-list
5884880|NCT04659811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5884881|NCT04659811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5688678|NCT03434340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688679|NCT03434340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5688680|NCT03434340|Glucocorticoids|glucocorticoids|mesh-ancestor
5688681|NCT03434340|Hormones|hormones|mesh-ancestor
5688682|NCT03434340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5688683|NCT03434340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5688684|NCT03434340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5688685|NCT03434340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5688686|NCT03434340|Serotonin Agents|serotonin agents|mesh-ancestor
5688687|NCT03434340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5688688|NCT03434340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688689|NCT03434275|Meloxicam|meloxicam|mesh-list
5884882|NCT04645966|Acetaminophen|acetaminophen|mesh-list
5884883|NCT04645966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5884884|NCT04645966|Analgesics|analgesics|mesh-ancestor
5884885|NCT04645966|Sensory System Agents|sensory system agents|mesh-ancestor
5884886|NCT04645966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5884887|NCT04645966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884888|NCT04645966|Antipyretics|antipyretics|mesh-ancestor
5884889|NCT04642430|Rivaroxaban|rivaroxaban|mesh-list
5884890|NCT04642430|Apixaban|apixaban|mesh-list
5884891|NCT04642430|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5884892|NCT04642430|Antithrombins|antithrombins|mesh-ancestor
5884893|NCT04642430|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5884894|NCT04642430|Protease Inhibitors|protease inhibitors|mesh-ancestor
5884895|NCT04642430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5884896|NCT04642430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5884897|NCT04642430|Anticoagulants|anticoagulants|mesh-ancestor
5884898|NCT04622735|Acetaminophen|acetaminophen|mesh-list
5884899|NCT04622735|Nefopam|nefopam|mesh-list
5884900|NCT04622735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5884901|NCT04622735|Analgesics|analgesics|mesh-ancestor
5884902|NCT04622735|Sensory System Agents|sensory system agents|mesh-ancestor
5884903|NCT04622735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5884904|NCT04622735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884905|NCT04622735|Antipyretics|antipyretics|mesh-ancestor
5884906|NCT04610476|Sulfasalazine|sulfasalazine|mesh-list
5884907|NCT04610476|Prednisolone|prednisolone|mesh-list
5884908|NCT04610476|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5884909|NCT04610476|Methylprednisolone|methylprednisolone|mesh-list
5884910|NCT04610476|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5884911|NCT04610476|Prednisolone acetate|prednisolone acetate|mesh-list
5884912|NCT04610476|Adalimumab|adalimumab|mesh-list
5884913|NCT04610476|Etanercept|etanercept|mesh-list
5884914|NCT04610476|Apremilast|apremilast|mesh-list
5884915|NCT04610476|Golimumab|golimumab|mesh-list
5884916|NCT04610476|Methotrexate|methotrexate|mesh-list
5884917|NCT04610476|Abatacept|abatacept|mesh-list
5884918|NCT04610476|Infliximab|infliximab|mesh-list
5884919|NCT04610476|Certolizumab Pegol|certolizumab pegol|mesh-list
5884920|NCT04610476|Ustekinumab|ustekinumab|mesh-list
5884921|NCT04610476|Ixekizumab|ixekizumab|mesh-list
5884922|NCT04610476|Tofacitinib|tofacitinib|mesh-list
5884923|NCT04610476|Leflunomide|leflunomide|mesh-list
5884924|NCT04610476|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5688690|NCT03434275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5688691|NCT03434275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5688692|NCT03434275|Analgesics|analgesics|mesh-ancestor
5688693|NCT03434275|Sensory System Agents|sensory system agents|mesh-ancestor
5688694|NCT03434275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5688695|NCT03434275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688696|NCT03434275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5688697|NCT03434275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5688698|NCT03434275|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5884925|NCT04610476|Prednisolone phosphate|prednisolone phosphate|mesh-list
5884926|NCT04610476|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5884927|NCT04610476|Abortifacient Agents|abortifacient agents|mesh-ancestor
5884928|NCT04610476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5884929|NCT04610476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884930|NCT04610476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5884931|NCT04610476|Antimetabolites|antimetabolites|mesh-ancestor
5884932|NCT04610476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5884933|NCT04610476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5884934|NCT04610476|Dermatologic Agents|dermatologic agents|mesh-ancestor
5884935|NCT04610476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5884936|NCT04610476|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5884937|NCT04610476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5884938|NCT04610476|Immunologic Factors|immunologic factors|mesh-ancestor
5688699|NCT03434275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5688700|NCT03434275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5688701|NCT03434275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5884939|NCT04610476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5884940|NCT04610476|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5884941|NCT04610476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5884942|NCT04610476|Glucocorticoids|glucocorticoids|mesh-ancestor
5884943|NCT04610476|Hormones|hormones|mesh-ancestor
5884944|NCT04610476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5884945|NCT04610476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5884946|NCT04610476|Antiemetics|antiemetics|mesh-ancestor
5884947|NCT04610476|Autonomic Agents|autonomic agents|mesh-ancestor
5884948|NCT04610476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5884949|NCT04610476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5884950|NCT04610476|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5884951|NCT04610476|Protective Agents|protective agents|mesh-ancestor
5884952|NCT04610476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5884953|NCT04610476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5884954|NCT04610476|Analgesics|analgesics|mesh-ancestor
5884955|NCT04610476|Sensory System Agents|sensory system agents|mesh-ancestor
5884956|NCT04610476|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5884957|NCT04610476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5884958|NCT04610476|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5884959|NCT04610476|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5884960|NCT04610476|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
5884961|NCT04610476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5884962|NCT04565574|Rifampin|rifampin|mesh-list
5688702|NCT03434262|Gemcitabine|gemcitabine|mesh-list
5688703|NCT03434262|Trametinib|trametinib|mesh-list
5688704|NCT03434262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5688705|NCT03434262|Antimetabolites|antimetabolites|mesh-ancestor
5688706|NCT03434262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688707|NCT03434262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5688708|NCT03434262|Antiviral Agents|antiviral agents|mesh-ancestor
5688709|NCT03434262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5688710|NCT03434262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5688711|NCT03434262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5688712|NCT03434262|Immunologic Factors|immunologic factors|mesh-ancestor
5688713|NCT03434262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884963|NCT04565574|Rabeprazole|rabeprazole|mesh-list
5884964|NCT04565574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5884965|NCT04565574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5884966|NCT04565574|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5884967|NCT04565574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5884968|NCT04565574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5884969|NCT04565574|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5884970|NCT04565574|Antitubercular Agents|antitubercular agents|mesh-ancestor
5884971|NCT04565574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5884972|NCT04565574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5884973|NCT04565574|Leprostatic Agents|leprostatic agents|mesh-ancestor
5884974|NCT04565574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5884975|NCT04565574|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5884976|NCT04565574|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5884977|NCT04565574|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5688714|NCT03434262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5688715|NCT03434197|Diclofenac|diclofenac|mesh-list
5688716|NCT03434197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5688717|NCT03434197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5688718|NCT03434197|Analgesics|analgesics|mesh-ancestor
5688719|NCT03434197|Sensory System Agents|sensory system agents|mesh-ancestor
5688720|NCT03434197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5688721|NCT03434197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688722|NCT03434197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5688723|NCT03434197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5688724|NCT03434197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5688725|NCT03434197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5688726|NCT03434197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688727|NCT03434106|Dextrans|dextrans|mesh-list
5688728|NCT03434106|Anticoagulants|anticoagulants|mesh-ancestor
5688729|NCT03434106|Plasma Substitutes|plasma substitutes|mesh-ancestor
5688730|NCT03434106|Blood Substitutes|blood substitutes|mesh-ancestor
5688731|NCT03434054|Losartan|losartan|mesh-list
5884978|NCT04565574|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5884979|NCT04565574|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5884980|NCT04565574|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5884981|NCT04560634|Norepinephrine|norepinephrine|mesh-list
5884982|NCT04560634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5884983|NCT04560634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5884984|NCT04560634|Adrenergic Agents|adrenergic agents|mesh-ancestor
5884985|NCT04560634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5884986|NCT04560634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5884987|NCT04560634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884988|NCT04560634|Sympathomimetics|sympathomimetics|mesh-ancestor
5884989|NCT04560634|Autonomic Agents|autonomic agents|mesh-ancestor
5884990|NCT04560634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5884991|NCT04560634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5884992|NCT04521920|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
5884993|NCT04521920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5884994|NCT04521920|Narcotics|narcotics|mesh-ancestor
5884995|NCT04521920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5884996|NCT04521920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5884997|NCT04521920|Analgesics|analgesics|mesh-ancestor
5884998|NCT04521920|Sensory System Agents|sensory system agents|mesh-ancestor
5884999|NCT04521920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5885000|NCT04521920|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5885001|NCT04483544|Pembrolizumab|pembrolizumab|mesh-list
5885002|NCT04483544|Olaparib|olaparib|mesh-list
5885003|NCT04483544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5885004|NCT04483544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5885005|NCT04483544|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5885006|NCT04483544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5885007|NCT04483544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885008|NCT04474353|Temozolomide|temozolomide|mesh-list
5885009|NCT04474353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5885010|NCT04474353|Alkylating Agents|alkylating agents|mesh-ancestor
6212520|NCT02189122|Kininogens|kininogens|mesh-list
6212521|NCT02189122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6212522|NCT02189122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6212523|NCT02189122|Analgesics|analgesics|mesh-ancestor
6212524|NCT02189122|Sensory System Agents|sensory system agents|mesh-ancestor
6212525|NCT02189122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6212526|NCT02189122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212527|NCT02189122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6212528|NCT02189122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6212529|NCT02189122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5688732|NCT03434054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5885011|NCT04474353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885012|NCT04474353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5885013|NCT04433845|Psilocybin|psilocybin|mesh-list
5885014|NCT04433845|Hallucinogens|hallucinogens|mesh-ancestor
5885015|NCT04433845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885016|NCT04433845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5885017|NCT04367233|Anesthetics|anesthetics|mesh-list
5885018|NCT04367233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5885019|NCT04367233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885020|NCT04364776|Durvalumab|durvalumab|mesh-list
5885021|NCT04364776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5885022|NCT04364776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5885023|NCT04357587|Pembrolizumab|pembrolizumab|mesh-list
5885024|NCT04357587|Capecitabine|capecitabine|mesh-list
5885025|NCT04357587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5885026|NCT04357587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5885027|NCT04357587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5885028|NCT04357587|Antimetabolites|antimetabolites|mesh-ancestor
5885029|NCT04357587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885030|NCT04351295|Chloroquine|chloroquine|mesh-list
5885031|NCT04351295|Favipiravir|favipiravir|mesh-list
5885032|NCT04351295|Amebicides|amebicides|mesh-ancestor
5885033|NCT04351295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5885034|NCT04351295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5885035|NCT04351295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5885036|NCT04351295|Antimalarials|antimalarials|mesh-ancestor
5885037|NCT04351295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5885038|NCT04351295|Antiviral Agents|antiviral agents|mesh-ancestor
5688733|NCT03434054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5688734|NCT03434054|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5688735|NCT03434054|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5688736|NCT03434054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688737|NCT03434041|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5688738|NCT03434041|Citalopram|citalopram|mesh-list
5688739|NCT03434041|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
5688740|NCT03434041|Sertraline|sertraline|mesh-list
5688741|NCT03434041|Antidepressive Agents|antidepressive agents|mesh-list
5688742|NCT03434041|Esketamine|esketamine|mesh-list
5688743|NCT03434041|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5688744|NCT03434041|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5688745|NCT03434041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5688746|NCT03434041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688747|NCT03434041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5688748|NCT03434041|Serotonin Agents|serotonin agents|mesh-ancestor
5688749|NCT03434041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688750|NCT03434041|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5885039|NCT04337177|Temozolomide|temozolomide|mesh-list
5885040|NCT04337177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5885041|NCT04337177|Alkylating Agents|alkylating agents|mesh-ancestor
5885042|NCT04337177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885043|NCT04337177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5885044|NCT04316143|Zamicastat|zamicastat|mesh-list
5885045|NCT04316143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5885046|NCT04316143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885047|NCT04315233|Belinostat|belinostat|mesh-list
5885048|NCT04315233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5885049|NCT04315233|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6212530|NCT02189122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5885050|NCT04315233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5885051|NCT04315233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885052|NCT04308330|Vorinostat|vorinostat|mesh-list
5885053|NCT04308330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5885054|NCT04308330|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5885055|NCT04308330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5885056|NCT04308330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885057|NCT04300985|Magnesium Sulfate|magnesium sulfate|mesh-list
5885058|NCT04300985|Dexmedetomidine|dexmedetomidine|mesh-list
5885059|NCT04300985|Anesthetics|anesthetics|mesh-list
5885060|NCT04300985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5885061|NCT04300985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885062|NCT04300985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5885063|NCT04300985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5885064|NCT04300985|Analgesics|analgesics|mesh-ancestor
5885065|NCT04300985|Sensory System Agents|sensory system agents|mesh-ancestor
5885066|NCT04300985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5885067|NCT04300985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5885068|NCT04300985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5885069|NCT04300985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5885070|NCT04300985|Adrenergic Agents|adrenergic agents|mesh-ancestor
5885071|NCT04300985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5885072|NCT04300985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885073|NCT04300985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5885074|NCT04300985|Anticonvulsants|anticonvulsants|mesh-ancestor
5885075|NCT04300985|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5885076|NCT04300985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5885077|NCT04300985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5885078|NCT04300985|Tocolytic Agents|tocolytic agents|mesh-ancestor
5885079|NCT04300985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5885080|NCT04288089|Palbociclib|palbociclib|mesh-list
5885081|NCT04288089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5885082|NCT04288089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5885083|NCT04288089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5885084|NCT04288089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906811|NCT05136976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5906812|NCT05136924|Varenicline|varenicline|mesh-list
5906813|NCT05136924|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5906814|NCT05136924|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5688751|NCT03434041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5688752|NCT03434041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5688753|NCT03434041|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5688754|NCT03434041|Analgesics|analgesics|mesh-ancestor
5688755|NCT03434041|Sensory System Agents|sensory system agents|mesh-ancestor
5688756|NCT03434041|Dopamine Agents|dopamine agents|mesh-ancestor
5688757|NCT03434028|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
5906815|NCT05136924|Cholinergic Agents|cholinergic agents|mesh-ancestor
5906816|NCT05136924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5906817|NCT05136924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906818|NCT05136924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906819|NCT05135715|Trastuzumab|trastuzumab|mesh-list
5906820|NCT05135715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5906821|NCT05135715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5906822|NCT05135182|Metronidazole|metronidazole|mesh-list
5906823|NCT05135182|Furazolidone|furazolidone|mesh-list
5906824|NCT05135182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5906825|NCT05135182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5906826|NCT05135182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5906827|NCT05135182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5906828|NCT05135182|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5906829|NCT05135182|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5906830|NCT05135182|Renal Agents|renal agents|mesh-ancestor
5906831|NCT05135182|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
5906832|NCT05135182|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
5906833|NCT05135182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5906834|NCT05135182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906835|NCT05135143|Antioxidants|antioxidants|mesh-list
5906836|NCT05135143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906837|NCT05135143|Protective Agents|protective agents|mesh-ancestor
5906838|NCT05135143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906839|NCT05133453|Pirfenidone|pirfenidone|mesh-list
5906840|NCT05133453|Analgesics|analgesics|mesh-ancestor
5906841|NCT05133453|Sensory System Agents|sensory system agents|mesh-ancestor
5688758|NCT03433976|Anesthetics|anesthetics|mesh-list
5688759|NCT03433976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5688760|NCT03433976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697487|NCT03375671|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5697488|NCT03375632|Dotinurad|dotinurad|mesh-list
5697489|NCT03375632|Uricosuric Agents|uricosuric agents|mesh-ancestor
5697490|NCT03375632|Gout Suppressants|gout suppressants|mesh-ancestor
5697491|NCT03375632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5697492|NCT03375632|Renal Agents|renal agents|mesh-ancestor
5697493|NCT03375593|Acetaminophen|acetaminophen|mesh-list
5885085|NCT04271293|Edoxaban|edoxaban|mesh-list
5885086|NCT04271293|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5885087|NCT04271293|Antithrombins|antithrombins|mesh-ancestor
5885088|NCT04271293|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5885089|NCT04271293|Protease Inhibitors|protease inhibitors|mesh-ancestor
5885090|NCT04271293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5885091|NCT04271293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885092|NCT04271293|Anticoagulants|anticoagulants|mesh-ancestor
5885093|NCT04260477|Rifampin|rifampin|mesh-list
5885094|NCT04260477|Isoniazid|isoniazid|mesh-list
5885095|NCT04260477|Pyrazinamide|pyrazinamide|mesh-list
5885096|NCT04260477|Ethambutol|ethambutol|mesh-list
5885097|NCT04260477|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5885098|NCT04260477|Antitubercular Agents|antitubercular agents|mesh-ancestor
5885099|NCT04260477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5885100|NCT04260477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5885101|NCT04260477|Leprostatic Agents|leprostatic agents|mesh-ancestor
5885102|NCT04260477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5885103|NCT04260477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5885104|NCT04260477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885105|NCT04260477|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5885106|NCT04260477|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5885107|NCT04260477|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5885108|NCT04260477|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5885109|NCT04260477|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5885110|NCT04260477|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5885111|NCT04260477|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5885112|NCT04260477|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5885113|NCT04260477|Antimetabolites|antimetabolites|mesh-ancestor
5885114|NCT04260477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5885115|NCT04246762|Vitamin K|vitamin k|mesh-list
5885116|NCT04246762|Midazolam|midazolam|mesh-list
5885117|NCT04246762|Caffeine|caffeine|mesh-list
5885118|NCT04246762|Omeprazole|omeprazole|mesh-list
5885119|NCT04246762|Warfarin|warfarin|mesh-list
5885120|NCT04246762|Vitamins|vitamins|mesh-ancestor
5885121|NCT04246762|Micronutrients|micronutrients|mesh-ancestor
5885122|NCT04246762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885123|NCT04246762|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5885124|NCT04246762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5885125|NCT04246762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5885126|NCT04246762|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5885127|NCT04246762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5885128|NCT04246762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5885129|NCT04246762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5885130|NCT04246762|Anesthetics, General|anesthetics, general|mesh-ancestor
5885131|NCT04246762|Anesthetics|anesthetics|mesh-ancestor
5885132|NCT04246762|GABA Modulators|gaba modulators|mesh-ancestor
5885133|NCT04246762|GABA Agents|gaba agents|mesh-ancestor
5885134|NCT04246762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5885135|NCT04246762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885136|NCT04246762|Anticoagulants|anticoagulants|mesh-ancestor
5885137|NCT04246762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5885138|NCT04246762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5885139|NCT04246762|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5885140|NCT04246762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5885141|NCT04246762|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5885142|NCT04246762|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5885143|NCT04246762|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5885144|NCT04246762|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5885145|NCT04246762|Purinergic Agents|purinergic agents|mesh-ancestor
5885146|NCT04246762|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5885147|NCT04246762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5697494|NCT03375593|Ibuprofen|ibuprofen|mesh-list
5697495|NCT03375593|Oxycodone|oxycodone|mesh-list
5697496|NCT03375593|Hydrocodone|hydrocodone|mesh-list
5885148|NCT04246762|Hemostatics|hemostatics|mesh-ancestor
5885149|NCT04246762|Coagulants|coagulants|mesh-ancestor
5885150|NCT04150913|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5885151|NCT04150913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5885152|NCT04150042|Vitamins|vitamins|mesh-list
5885153|NCT04150042|Ascorbic Acid|ascorbic acid|mesh-list
5885154|NCT04150042|Vitamin B 12|vitamin b 12|mesh-list
5885155|NCT04150042|Hydroxocobalamin|hydroxocobalamin|mesh-list
5885156|NCT04150042|Ethanol|ethanol|mesh-list
5885157|NCT04150042|Melphalan|melphalan|mesh-list
5885158|NCT04150042|Carmustine|carmustine|mesh-list
5885159|NCT04150042|Micronutrients|micronutrients|mesh-ancestor
6496074|NCT00626288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6496075|NCT00626288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496076|NCT00626288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6496077|NCT00626288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6496078|NCT00626483|Basiliximab|basiliximab|mesh-list
5688761|NCT03433859|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5688762|NCT03433859|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5688763|NCT03433859|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5688764|NCT03433859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5688765|NCT03433859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496079|NCT00626483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6496080|NCT00626483|Immunologic Factors|immunologic factors|mesh-ancestor
6496081|NCT00626483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496082|NCT00626509|Sunitinib|sunitinib|mesh-list
6496083|NCT00626509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5885160|NCT04150042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885161|NCT04150042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5885162|NCT04150042|Alkylating Agents|alkylating agents|mesh-ancestor
5885163|NCT04150042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885164|NCT04150042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5885165|NCT04150042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5885166|NCT04150042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5885167|NCT04150042|Immunologic Factors|immunologic factors|mesh-ancestor
6496084|NCT00626509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5688766|NCT03433859|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5688767|NCT03433859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5688768|NCT03433859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688769|NCT03433859|Cholinergic Agents|cholinergic agents|mesh-ancestor
5688770|NCT03433859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5688771|NCT03433807|Idebenone|idebenone|mesh-list
5688772|NCT03433807|Antioxidants|antioxidants|mesh-ancestor
6496085|NCT00626509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6496086|NCT00626509|Growth Substances|growth substances|mesh-ancestor
6496087|NCT00626509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496088|NCT00626509|Growth Inhibitors|growth inhibitors|mesh-ancestor
6496089|NCT00626509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6496090|NCT00626509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6496091|NCT00626509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496092|NCT00626535|Esomeprazole|esomeprazole|mesh-list
5688773|NCT03433807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885168|NCT04150042|Antioxidants|antioxidants|mesh-ancestor
5885169|NCT04150042|Protective Agents|protective agents|mesh-ancestor
5885170|NCT04150042|Vitamin B Complex|vitamin b complex|mesh-ancestor
5688774|NCT03433807|Protective Agents|protective agents|mesh-ancestor
5688775|NCT03433807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688776|NCT03433586|Aspirin|aspirin|mesh-list
5688777|NCT03433586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5688778|NCT03433586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5688779|NCT03433586|Analgesics|analgesics|mesh-ancestor
5688780|NCT03433586|Sensory System Agents|sensory system agents|mesh-ancestor
5688781|NCT03433586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5885171|NCT04150042|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5885172|NCT04150042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5885173|NCT04150042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5885174|NCT04150042|Hematinics|hematinics|mesh-ancestor
5885175|NCT04141020|Sirolimus|sirolimus|mesh-list
5885176|NCT04141020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5885177|NCT04141020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5885178|NCT04141020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5885179|NCT04141020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5688782|NCT03433586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688783|NCT03433586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5688784|NCT03433586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5885180|NCT04141020|Antifungal Agents|antifungal agents|mesh-ancestor
5885181|NCT04141020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5885182|NCT04141020|Immunologic Factors|immunologic factors|mesh-ancestor
6496093|NCT00626535|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6496094|NCT00626535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5885183|NCT04141020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885184|NCT04140721|Moxonidine|moxonidine|mesh-list
5885185|NCT04140721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5885186|NCT04138875|Rituximab|rituximab|mesh-list
5885187|NCT04138875|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5885188|NCT04138875|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5885189|NCT04138875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5885190|NCT04138875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5885191|NCT04138875|Immunologic Factors|immunologic factors|mesh-ancestor
5885192|NCT04138875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885193|NCT04138875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5885194|NCT04138875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5885195|NCT04138875|Alkylating Agents|alkylating agents|mesh-ancestor
5885196|NCT04138875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688785|NCT03433586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5688786|NCT03433586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5688787|NCT03433586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688788|NCT03433586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5688789|NCT03433586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5885197|NCT04117763|Empagliflozin|empagliflozin|mesh-list
5885198|NCT04117763|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5885199|NCT04117763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885200|NCT04117763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5885201|NCT04117763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885202|NCT04059562|Irinotecan|irinotecan|mesh-list
5885203|NCT04059562|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5885204|NCT04059562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5885205|NCT04059562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5885206|NCT04059562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885207|NCT04059562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5885208|NCT04046107|Cemiplimab|cemiplimab|mesh-list
5885209|NCT04046107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5885210|NCT04046107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5885211|NCT04019834|Bupivacaine|bupivacaine|mesh-list
5885212|NCT04019834|Anesthetics, Local|anesthetics, local|mesh-ancestor
5885213|NCT04019834|Anesthetics|anesthetics|mesh-ancestor
5885214|NCT04019834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5885215|NCT04019834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885216|NCT04019834|Sensory System Agents|sensory system agents|mesh-ancestor
5688790|NCT03433586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5688791|NCT03433586|Antipyretics|antipyretics|mesh-ancestor
5688792|NCT03433534|Nivolumab|nivolumab|mesh-list
5688793|NCT03433534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5688794|NCT03433534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5688795|NCT03433534|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5688796|NCT03433534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688797|NCT03433469|Osimertinib|osimertinib|mesh-list
5688798|NCT03433469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5688799|NCT03433469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5688800|NCT03433469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5688801|NCT03433469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688802|NCT03433378|Tretinoin|tretinoin|mesh-list
5688803|NCT03433378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5688804|NCT03433378|Keratolytic Agents|keratolytic agents|mesh-ancestor
5688805|NCT03433378|Dermatologic Agents|dermatologic agents|mesh-ancestor
5688806|NCT03433352|Methimazole|methimazole|mesh-list
5688807|NCT03433352|Propylthiouracil|propylthiouracil|mesh-list
5688808|NCT03433352|Antithyroid Agents|antithyroid agents|mesh-ancestor
5688809|NCT03433352|Hormone Antagonists|hormone antagonists|mesh-ancestor
5688810|NCT03433352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5688811|NCT03433352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688812|NCT03433352|Antimetabolites|antimetabolites|mesh-ancestor
5688813|NCT03433352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688814|NCT03433326|Grazoprevir|grazoprevir|mesh-list
5688815|NCT03433326|Antiviral Agents|antiviral agents|mesh-ancestor
5688816|NCT03433326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5688817|NCT03433313|Trastuzumab|trastuzumab|mesh-list
5688818|NCT03433313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5688819|NCT03433313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5688820|NCT03433235|Edoxaban|edoxaban|mesh-list
5688821|NCT03433235|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5688822|NCT03433235|Antithrombins|antithrombins|mesh-ancestor
5885217|NCT04019834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5688823|NCT03433235|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5885218|NCT03959241|Mycophenolic Acid|mycophenolic acid|mesh-list
5885219|NCT03959241|Cyclophosphamide|cyclophosphamide|mesh-list
5885220|NCT03959241|Methotrexate|methotrexate|mesh-list
5885221|NCT03959241|Tacrolimus|tacrolimus|mesh-list
5885222|NCT03959241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5885223|NCT03959241|Immunologic Factors|immunologic factors|mesh-ancestor
5885224|NCT03959241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885225|NCT03959241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5885226|NCT03959241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5885227|NCT03959241|Alkylating Agents|alkylating agents|mesh-ancestor
5885228|NCT03959241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885229|NCT03959241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5885230|NCT03959241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5885231|NCT03959241|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5885232|NCT03959241|Abortifacient Agents|abortifacient agents|mesh-ancestor
5885233|NCT03959241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5885234|NCT03959241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5885235|NCT03959241|Antimetabolites|antimetabolites|mesh-ancestor
5885236|NCT03959241|Dermatologic Agents|dermatologic agents|mesh-ancestor
5885237|NCT03959241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5885238|NCT03959241|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5885239|NCT03959241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5885240|NCT03959241|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5885241|NCT03959241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5885242|NCT03959241|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5885243|NCT03959241|Antitubercular Agents|antitubercular agents|mesh-ancestor
5885244|NCT03959241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5885245|NCT03959241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5885246|NCT03882177|Vitamin B 6|vitamin b 6|mesh-list
5688824|NCT03433235|Protease Inhibitors|protease inhibitors|mesh-ancestor
5688825|NCT03433235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5688826|NCT03433235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688827|NCT03433235|Anticoagulants|anticoagulants|mesh-ancestor
5688828|NCT03433222|Coal Tar|coal tar|mesh-list
5688829|NCT03433222|Keratolytic Agents|keratolytic agents|mesh-ancestor
5688830|NCT03433222|Dermatologic Agents|dermatologic agents|mesh-ancestor
5688831|NCT03433196|Atorvastatin|atorvastatin|mesh-list
5688832|NCT03433196|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5688833|NCT03433196|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5688834|NCT03433196|Antimetabolites|antimetabolites|mesh-ancestor
5688835|NCT03433196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688836|NCT03433196|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5885247|NCT03882177|Pyridoxal|pyridoxal|mesh-list
5885248|NCT03882177|Pyridoxine|pyridoxine|mesh-list
5885249|NCT03882177|Pravastatin|pravastatin|mesh-list
5885250|NCT03882177|Vitamins|vitamins|mesh-ancestor
5885251|NCT03882177|Micronutrients|micronutrients|mesh-ancestor
5885252|NCT03882177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885253|NCT03882177|Vitamin B Complex|vitamin b complex|mesh-ancestor
5885254|NCT03882177|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5885255|NCT03882177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5885256|NCT03882177|Antimetabolites|antimetabolites|mesh-ancestor
5885257|NCT03882177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885258|NCT03882177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5885259|NCT03882177|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5885260|NCT03882177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5885261|NCT03874897|Antibodies|antibodies|mesh-list
5885262|NCT03874897|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5885263|NCT03874897|Immunologic Factors|immunologic factors|mesh-ancestor
5885264|NCT03874897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885265|NCT03863184|Rituximab|rituximab|mesh-list
5885266|NCT03863184|Lenalidomide|lenalidomide|mesh-list
5885267|NCT03863184|Acalabrutinib|acalabrutinib|mesh-list
5885268|NCT03863184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5885269|NCT03863184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5885270|NCT03863184|Immunologic Factors|immunologic factors|mesh-ancestor
5885271|NCT03863184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885272|NCT03863184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5885273|NCT03863184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5885274|NCT03863184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5885275|NCT03863184|Growth Substances|growth substances|mesh-ancestor
5885276|NCT03863184|Growth Inhibitors|growth inhibitors|mesh-ancestor
5885277|NCT03838744|Olaparib|olaparib|mesh-list
5885278|NCT03838744|Trabectedin|trabectedin|mesh-list
5885279|NCT03838744|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5885280|NCT03838744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5885281|NCT03838744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688837|NCT03433196|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5885282|NCT03838744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5885283|NCT03838744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5885284|NCT03838744|Alkylating Agents|alkylating agents|mesh-ancestor
5885285|NCT03736629|Azithromycin|azithromycin|mesh-list
5885286|NCT03736629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5885287|NCT03736629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5885288|NCT03642210|Levonorgestrel|levonorgestrel|mesh-list
5885289|NCT03642210|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5885290|NCT03642210|Contraceptive Agents|contraceptive agents|mesh-ancestor
5885291|NCT03642210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5885292|NCT03642210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885293|NCT03642210|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5885294|NCT03642210|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5885295|NCT03642210|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5885296|NCT03620669|Durvalumab|durvalumab|mesh-list
5885297|NCT03620669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5885298|NCT03620669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5885299|NCT03600701|Atezolizumab|atezolizumab|mesh-list
5885300|NCT03600701|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5885301|NCT03600701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5885302|NCT03600701|Immunologic Factors|immunologic factors|mesh-ancestor
5885303|NCT03600701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885304|NCT03524898|Gemcitabine|gemcitabine|mesh-list
5885305|NCT03524898|Paclitaxel|paclitaxel|mesh-list
5885306|NCT03524898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5885307|NCT03524898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5885308|NCT03524898|Tubulin Modulators|tubulin modulators|mesh-ancestor
5885309|NCT03524898|Antimitotic Agents|antimitotic agents|mesh-ancestor
5885310|NCT03524898|Mitosis Modulators|mitosis modulators|mesh-ancestor
5885311|NCT03524898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885312|NCT03524898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5885313|NCT03524898|Antimetabolites|antimetabolites|mesh-ancestor
5885314|NCT03524898|Antiviral Agents|antiviral agents|mesh-ancestor
5885315|NCT03524898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5885316|NCT03524898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5885317|NCT03524898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5885318|NCT03524898|Immunologic Factors|immunologic factors|mesh-ancestor
5885319|NCT03524898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885320|NCT03522753|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
5885321|NCT03522753|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
5885322|NCT03522753|beta-Endorphin|beta-endorphin|mesh-list
5885323|NCT03522753|Hormones|hormones|mesh-ancestor
5885324|NCT03522753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5885325|NCT03522753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885326|NCT03522753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5885327|NCT03522753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885328|NCT03448666|Pembrolizumab|pembrolizumab|mesh-list
5885329|NCT03448666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5885330|NCT03448666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5885331|NCT03435939|Losartan|losartan|mesh-list
5885332|NCT03435939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5885333|NCT03435939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5885334|NCT03435939|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5885335|NCT03435939|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5688838|NCT03433196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5688839|NCT03433144|Tranexamic Acid|tranexamic acid|mesh-list
5885336|NCT03435939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885337|NCT03430791|Nivolumab|nivolumab|mesh-list
5885338|NCT03430791|Ipilimumab|ipilimumab|mesh-list
5885339|NCT03430791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5885340|NCT03430791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5885341|NCT03430791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5885342|NCT03430791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885343|NCT03383224|Nicotine|nicotine|mesh-list
5885344|NCT03383224|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5885345|NCT03383224|Autonomic Agents|autonomic agents|mesh-ancestor
5688840|NCT03433144|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5688841|NCT03433144|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5688842|NCT03433144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688843|NCT03433144|Hemostatics|hemostatics|mesh-ancestor
5688844|NCT03433144|Coagulants|coagulants|mesh-ancestor
5688845|NCT03433092|Carotenoids|carotenoids|mesh-list
5688846|NCT03433092|Antioxidants|antioxidants|mesh-ancestor
5885346|NCT03383224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5885347|NCT03383224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885348|NCT03383224|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5885349|NCT03383224|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5885350|NCT03383224|Cholinergic Agents|cholinergic agents|mesh-ancestor
5885351|NCT03383224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5885352|NCT03383224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885353|NCT03244059|Belimumab|belimumab|mesh-list
5885354|NCT03244059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5885355|NCT03244059|Immunologic Factors|immunologic factors|mesh-ancestor
5885356|NCT03244059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885357|NCT03229512|Sildenafil Citrate|sildenafil citrate|mesh-list
5885358|NCT03229512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885359|NCT03229512|Vasodilator Agents|vasodilator agents|mesh-ancestor
5885360|NCT03229512|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5885361|NCT03229512|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5885362|NCT03229512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6212531|NCT02189122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212532|NCT02189122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6212533|NCT02189122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5688847|NCT03433092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885363|NCT03229512|Urological Agents|urological agents|mesh-ancestor
5885364|NCT03180502|Temozolomide|temozolomide|mesh-list
5885365|NCT03180502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5688848|NCT03433092|Protective Agents|protective agents|mesh-ancestor
5688849|NCT03433092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688850|NCT03433014|Levobupivacaine|levobupivacaine|mesh-list
5688851|NCT03433014|Anesthetics, Local|anesthetics, local|mesh-ancestor
5688852|NCT03433014|Anesthetics|anesthetics|mesh-ancestor
5688853|NCT03433014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5688854|NCT03433014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688855|NCT03433014|Sensory System Agents|sensory system agents|mesh-ancestor
5688856|NCT03433014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5688857|NCT03433001|Dexamethasone|dexamethasone|mesh-list
5688858|NCT03433001|Lenalidomide|lenalidomide|mesh-list
5688859|NCT03433001|Ixazomib|ixazomib|mesh-list
5688860|NCT03433001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5688861|NCT03433001|Antiemetics|antiemetics|mesh-ancestor
5688862|NCT03433001|Autonomic Agents|autonomic agents|mesh-ancestor
5688863|NCT03433001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5688864|NCT03433001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688865|NCT03433001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5688866|NCT03433001|Glucocorticoids|glucocorticoids|mesh-ancestor
5688867|NCT03433001|Hormones|hormones|mesh-ancestor
5688868|NCT03433001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5688869|NCT03433001|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5688870|NCT03433001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5688871|NCT03433001|Immunologic Factors|immunologic factors|mesh-ancestor
5688872|NCT03433001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5688873|NCT03433001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5688874|NCT03433001|Growth Substances|growth substances|mesh-ancestor
5688875|NCT03433001|Growth Inhibitors|growth inhibitors|mesh-ancestor
5688876|NCT03433001|Protease Inhibitors|protease inhibitors|mesh-ancestor
5688877|NCT03433001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5688878|NCT03433001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688879|NCT03432975|Povidone-Iodine|povidone-iodine|mesh-list
5885366|NCT03180502|Alkylating Agents|alkylating agents|mesh-ancestor
5885367|NCT03180502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885368|NCT03180502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5906842|NCT05133453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5906843|NCT05133453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5908678|NCT04278898|Antioxidants|antioxidants|mesh-ancestor
5688880|NCT03432975|Povidone|povidone|mesh-list
5688881|NCT03432975|Plasma Substitutes|plasma substitutes|mesh-ancestor
5688882|NCT03432975|Blood Substitutes|blood substitutes|mesh-ancestor
5688883|NCT03432975|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5688884|NCT03432975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5688885|NCT03432949|Dexamethasone|dexamethasone|mesh-list
5688886|NCT03432949|Dexamethasone acetate|dexamethasone acetate|mesh-list
5688887|NCT03432949|BB 1101|bb 1101|mesh-list
5688888|NCT03432949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5688889|NCT03432949|Antiemetics|antiemetics|mesh-ancestor
5688890|NCT03432949|Autonomic Agents|autonomic agents|mesh-ancestor
5688891|NCT03432949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5885369|NCT03164057|Cytarabine|cytarabine|mesh-list
5885370|NCT03164057|Hydrocortisone|hydrocortisone|mesh-list
5885371|NCT03164057|Methotrexate|methotrexate|mesh-list
5885372|NCT03164057|Azacitidine|azacitidine|mesh-list
5885373|NCT03164057|Decitabine|decitabine|mesh-list
5885374|NCT03164057|Fludarabine|fludarabine|mesh-list
5885375|NCT03164057|Etoposide|etoposide|mesh-list
5885376|NCT03164057|Etoposide phosphate|etoposide phosphate|mesh-list
5885377|NCT03164057|Sorafenib|sorafenib|mesh-list
5885378|NCT03164057|Daunorubicin|daunorubicin|mesh-list
5885379|NCT03164057|Asparaginase|asparaginase|mesh-list
5885380|NCT03164057|Mitoxantrone|mitoxantrone|mesh-list
5885381|NCT03164057|Idarubicin|idarubicin|mesh-list
5885382|NCT03164057|Dexrazoxane|dexrazoxane|mesh-list
5885383|NCT03164057|Razoxane|razoxane|mesh-list
5885384|NCT03164057|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5885385|NCT03164057|Abortifacient Agents|abortifacient agents|mesh-ancestor
5885386|NCT03164057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5885387|NCT03164057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885388|NCT03164057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5885389|NCT03164057|Antimetabolites|antimetabolites|mesh-ancestor
5885390|NCT03164057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885391|NCT03164057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5885392|NCT03164057|Dermatologic Agents|dermatologic agents|mesh-ancestor
5885393|NCT03164057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5885394|NCT03164057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5885395|NCT03164057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5885396|NCT03164057|Immunologic Factors|immunologic factors|mesh-ancestor
5885397|NCT03164057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5885398|NCT03164057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5885399|NCT03164057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5885400|NCT03164057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5885401|NCT03164057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5885402|NCT03164057|Antiviral Agents|antiviral agents|mesh-ancestor
5885403|NCT03164057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6212534|NCT02189122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6212535|NCT02189122|Antipyretics|antipyretics|mesh-ancestor
6212536|NCT02189122|Vasodilator Agents|vasodilator agents|mesh-ancestor
5688892|NCT03432949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688893|NCT03432949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5688894|NCT03432949|Glucocorticoids|glucocorticoids|mesh-ancestor
5688895|NCT03432949|Hormones|hormones|mesh-ancestor
5688896|NCT03432949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5688897|NCT03432949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5688898|NCT03432949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6212537|NCT02189122|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
6212538|NCT02189122|Protease Inhibitors|protease inhibitors|mesh-ancestor
6212539|NCT02189213|Sertraline|sertraline|mesh-list
6212540|NCT02189213|Antidepressive Agents|antidepressive agents|mesh-ancestor
6212541|NCT02189213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6212542|NCT02189213|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6212543|NCT02189213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6212544|NCT02189213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6212545|NCT02189213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885404|NCT03164057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5885405|NCT03164057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5885406|NCT03164057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5885407|NCT03164057|Analgesics|analgesics|mesh-ancestor
5885408|NCT03164057|Sensory System Agents|sensory system agents|mesh-ancestor
5885409|NCT03164057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5885410|NCT03164057|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5885411|NCT03164057|Protective Agents|protective agents|mesh-ancestor
5885412|NCT03164057|Antimitotic Agents|antimitotic agents|mesh-ancestor
5885413|NCT03164057|Mitosis Modulators|mitosis modulators|mesh-ancestor
5885414|NCT03109353|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5885415|NCT03109353|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5885416|NCT03109353|Dermatologic Agents|dermatologic agents|mesh-ancestor
5885417|NCT03033914|Doxorubicin|doxorubicin|mesh-list
5885418|NCT03033914|Bleomycin|bleomycin|mesh-list
5885419|NCT03033914|Nivolumab|nivolumab|mesh-list
5885420|NCT03033914|Dacarbazine|dacarbazine|mesh-list
5885421|NCT03033914|Vinblastine|vinblastine|mesh-list
5885422|NCT03033914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5885423|NCT03033914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5688899|NCT03432949|Protease Inhibitors|protease inhibitors|mesh-ancestor
5688900|NCT03432949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5885424|NCT03033914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5885425|NCT03033914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5885426|NCT03033914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6496095|NCT00626535|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6496096|NCT00626535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5885427|NCT03033914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885428|NCT03033914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5885429|NCT03033914|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5885430|NCT03033914|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5885431|NCT03033914|Alkylating Agents|alkylating agents|mesh-ancestor
5885432|NCT03033914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5885433|NCT03033914|Tubulin Modulators|tubulin modulators|mesh-ancestor
5885434|NCT03033914|Antimitotic Agents|antimitotic agents|mesh-ancestor
5885435|NCT03033914|Mitosis Modulators|mitosis modulators|mesh-ancestor
5885436|NCT03030118|Hydroxychloroquine|hydroxychloroquine|mesh-list
5885437|NCT03030118|Antimalarials|antimalarials|mesh-ancestor
5885438|NCT03030118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5885439|NCT03030118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5885440|NCT03030118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5885441|NCT03030118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5885442|NCT03030118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885443|NCT03030118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5885444|NCT03023124|Doxorubicin|doxorubicin|mesh-list
5885445|NCT03023124|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5885446|NCT03023124|Dacarbazine|dacarbazine|mesh-list
5885447|NCT03023124|Trabectedin|trabectedin|mesh-list
5885448|NCT03023124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5885449|NCT03023124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5885450|NCT03023124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5885451|NCT03023124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5885452|NCT03023124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5885453|NCT03023124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885454|NCT03023124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5885455|NCT03023124|Alkylating Agents|alkylating agents|mesh-ancestor
5885456|NCT02957968|Paclitaxel|paclitaxel|mesh-list
5885457|NCT02957968|Cyclophosphamide|cyclophosphamide|mesh-list
5885458|NCT02957968|Carboplatin|carboplatin|mesh-list
5885459|NCT02957968|Doxorubicin|doxorubicin|mesh-list
5885460|NCT02957968|Pembrolizumab|pembrolizumab|mesh-list
5885461|NCT02957968|Decitabine|decitabine|mesh-list
5885462|NCT02957968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5885463|NCT02957968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5885464|NCT02957968|Tubulin Modulators|tubulin modulators|mesh-ancestor
5885465|NCT02957968|Antimitotic Agents|antimitotic agents|mesh-ancestor
5885466|NCT02957968|Mitosis Modulators|mitosis modulators|mesh-ancestor
5885467|NCT02957968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885468|NCT02957968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5885469|NCT02957968|Immunologic Factors|immunologic factors|mesh-ancestor
5885470|NCT02957968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885471|NCT02957968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5885472|NCT02957968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5885473|NCT02957968|Alkylating Agents|alkylating agents|mesh-ancestor
5885474|NCT02957968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5885475|NCT02957968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5885476|NCT02957968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5885477|NCT02957968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5885478|NCT02957968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5885479|NCT02957968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5885480|NCT02957968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5885481|NCT02957968|Antimetabolites|antimetabolites|mesh-ancestor
5885482|NCT02733614|SRX246|srx246|mesh-list
5885483|NCT02733614|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
5885484|NCT02733614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885485|NCT02733614|Natriuretic Agents|natriuretic agents|mesh-ancestor
5885486|NCT02733614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885487|NCT02727387|Cyclophosphamide|cyclophosphamide|mesh-list
5885488|NCT02727387|Temozolomide|temozolomide|mesh-list
5885489|NCT02727387|Melphalan|melphalan|mesh-list
5885490|NCT02727387|Busulfan|busulfan|mesh-list
5885491|NCT02727387|Ifosfamide|ifosfamide|mesh-list
5885492|NCT02727387|Irinotecan|irinotecan|mesh-list
5885493|NCT02727387|Etoposide|etoposide|mesh-list
5885494|NCT02727387|Vincristine|vincristine|mesh-list
5885495|NCT02727387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5885496|NCT02727387|Immunologic Factors|immunologic factors|mesh-ancestor
5885497|NCT02727387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885498|NCT02727387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5885499|NCT02727387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5885500|NCT02727387|Alkylating Agents|alkylating agents|mesh-ancestor
5885501|NCT02727387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885502|NCT02727387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5885503|NCT02727387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5885504|NCT02727387|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5885505|NCT02727387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5688901|NCT03432949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688902|NCT03432923|Benzocaine|benzocaine|mesh-list
5688903|NCT03432923|Anesthetics, Local|anesthetics, local|mesh-ancestor
5688904|NCT03432923|Anesthetics|anesthetics|mesh-ancestor
5688905|NCT03432923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5688906|NCT03432923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688907|NCT03432923|Sensory System Agents|sensory system agents|mesh-ancestor
5688908|NCT03432923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5688909|NCT03432884|Moxifloxacin|moxifloxacin|mesh-list
5688910|NCT03432884|Zanubrutinib|zanubrutinib|mesh-list
5688911|NCT03432884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5688912|NCT03432884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5688913|NCT03432884|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5688914|NCT03432884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5688915|NCT03432884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5688916|NCT03432884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688917|NCT03432884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5885506|NCT02727387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5885507|NCT02727387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5885508|NCT02727387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5885509|NCT02727387|Tubulin Modulators|tubulin modulators|mesh-ancestor
5885510|NCT02727387|Antimitotic Agents|antimitotic agents|mesh-ancestor
5885511|NCT02727387|Mitosis Modulators|mitosis modulators|mesh-ancestor
5885512|NCT02683018|Dronabinol|dronabinol|mesh-list
5885513|NCT02683018|Hallucinogens|hallucinogens|mesh-ancestor
5885514|NCT02683018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885515|NCT02683018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5885516|NCT02683018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5885517|NCT02683018|Analgesics|analgesics|mesh-ancestor
5885518|NCT02683018|Sensory System Agents|sensory system agents|mesh-ancestor
5885519|NCT02683018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5885520|NCT02683018|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5885521|NCT02683018|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5885522|NCT02683018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5885523|NCT02683018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885524|NCT02683018|Hormones|hormones|mesh-ancestor
5885525|NCT02683018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5885526|NCT02675842|Dronabinol|dronabinol|mesh-list
5885527|NCT02675842|Hallucinogens|hallucinogens|mesh-ancestor
5885528|NCT02675842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885529|NCT02675842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5885530|NCT02675842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5885531|NCT02675842|Analgesics|analgesics|mesh-ancestor
5885532|NCT02675842|Sensory System Agents|sensory system agents|mesh-ancestor
5885533|NCT02675842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5885534|NCT02675842|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5885535|NCT02675842|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5885536|NCT02675842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5885537|NCT02675842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885538|NCT02675842|Hormones|hormones|mesh-ancestor
5885539|NCT02675842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5885540|NCT02615119|Isoproterenol|isoproterenol|mesh-list
5885541|NCT02615119|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5885542|NCT02615119|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5885543|NCT02615119|Adrenergic Agents|adrenergic agents|mesh-ancestor
5885544|NCT02615119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5885545|NCT02615119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885546|NCT02615119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885547|NCT02615119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5885548|NCT02615119|Autonomic Agents|autonomic agents|mesh-ancestor
5885549|NCT02615119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5885550|NCT02615119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5885551|NCT02615119|Respiratory System Agents|respiratory system agents|mesh-ancestor
5885552|NCT02615119|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5885553|NCT02615119|Sympathomimetics|sympathomimetics|mesh-ancestor
5885554|NCT02615119|Protective Agents|protective agents|mesh-ancestor
5885555|NCT02605486|Palbociclib|palbociclib|mesh-list
5885556|NCT02605486|Bicalutamide|bicalutamide|mesh-list
5885557|NCT02605486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5885558|NCT02605486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5885559|NCT02605486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5885560|NCT02605486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885561|NCT02605486|Androgen Antagonists|androgen antagonists|mesh-ancestor
5885562|NCT02605486|Hormone Antagonists|hormone antagonists|mesh-ancestor
5885563|NCT02605486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5885564|NCT02605486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885565|NCT02598349|Capecitabine|capecitabine|mesh-list
5885566|NCT02598349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5885567|NCT02598349|Antimetabolites|antimetabolites|mesh-ancestor
5885568|NCT02598349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885569|NCT02598349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5885570|NCT02574728|Sirolimus|sirolimus|mesh-list
5885571|NCT02574728|Celecoxib|celecoxib|mesh-list
5885572|NCT02574728|Cyclophosphamide|cyclophosphamide|mesh-list
5885573|NCT02574728|Etoposide|etoposide|mesh-list
5885574|NCT02574728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5885575|NCT02574728|Immunologic Factors|immunologic factors|mesh-ancestor
5885576|NCT02574728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885577|NCT02574728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5885578|NCT02574728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5885579|NCT02574728|Alkylating Agents|alkylating agents|mesh-ancestor
5885580|NCT02574728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885581|NCT02574728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5885582|NCT02574728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5885583|NCT02574728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5885584|NCT02574728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5688918|NCT03432884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5688919|NCT03432871|Niacinamide|niacinamide|mesh-list
5688920|NCT03432871|Niacin|niacin|mesh-list
5688921|NCT03432871|Nicotinic Acids|nicotinic acids|mesh-list
5688922|NCT03432871|Vitamin B Complex|vitamin b complex|mesh-ancestor
5688923|NCT03432871|Vitamins|vitamins|mesh-ancestor
5688924|NCT03432871|Micronutrients|micronutrients|mesh-ancestor
5688925|NCT03432871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688926|NCT03432871|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5688927|NCT03432871|Antimetabolites|antimetabolites|mesh-ancestor
5688928|NCT03432871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688929|NCT03432871|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5688930|NCT03432871|Vasodilator Agents|vasodilator agents|mesh-ancestor
5688931|NCT03432793|Itraconazole|itraconazole|mesh-list
5688932|NCT03432793|Fluvoxamine|fluvoxamine|mesh-list
5688933|NCT03432793|Caffeine|caffeine|mesh-list
5688934|NCT03432793|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5688935|NCT03432793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688936|NCT03432793|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5688937|NCT03432793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5688938|NCT03432793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688939|NCT03432793|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5688940|NCT03432793|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5885585|NCT02574728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5885586|NCT02574728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5885587|NCT02574728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5885588|NCT02574728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5885589|NCT02574728|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5885590|NCT02574728|Antifungal Agents|antifungal agents|mesh-ancestor
5885591|NCT02574728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5885592|NCT02574728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5885593|NCT02574728|Analgesics|analgesics|mesh-ancestor
5885594|NCT02574728|Sensory System Agents|sensory system agents|mesh-ancestor
5885595|NCT02574728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5885596|NCT02574728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5885597|NCT02574728|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5688941|NCT03432793|Purinergic Agents|purinergic agents|mesh-ancestor
5688942|NCT03432793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5688943|NCT03432793|Antifungal Agents|antifungal agents|mesh-ancestor
5688944|NCT03432793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5688945|NCT03432793|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5688946|NCT03432793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5688947|NCT03432793|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5885598|NCT02574728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5885599|NCT02555293|Rifaximin|rifaximin|mesh-list
5688948|NCT03432793|Hormone Antagonists|hormone antagonists|mesh-ancestor
5688949|NCT03432793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5688950|NCT03432793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5688951|NCT03432793|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5688952|NCT03432793|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5885600|NCT02555293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5885601|NCT02555293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5885602|NCT02555293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5885603|NCT02494921|Prednisone|prednisone|mesh-list
5885604|NCT02494921|Docetaxel|docetaxel|mesh-list
5885605|NCT02494921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5885606|NCT02494921|Tubulin Modulators|tubulin modulators|mesh-ancestor
5885607|NCT02494921|Antimitotic Agents|antimitotic agents|mesh-ancestor
5885608|NCT02494921|Mitosis Modulators|mitosis modulators|mesh-ancestor
5885609|NCT02494921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885610|NCT02494921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5885611|NCT02494921|Glucocorticoids|glucocorticoids|mesh-ancestor
5885612|NCT02494921|Hormones|hormones|mesh-ancestor
5885613|NCT02494921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5885614|NCT02494921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885615|NCT02494921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5885616|NCT02414269|Cyclophosphamide|cyclophosphamide|mesh-list
5885617|NCT02414269|Pembrolizumab|pembrolizumab|mesh-list
5885618|NCT02414269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5885619|NCT02414269|Immunologic Factors|immunologic factors|mesh-ancestor
5885620|NCT02414269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885621|NCT02414269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5885622|NCT02414269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5885623|NCT02414269|Alkylating Agents|alkylating agents|mesh-ancestor
5885624|NCT02414269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885625|NCT02414269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5885626|NCT02414269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5885627|NCT02414269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5885628|NCT05104255|Anesthetics|anesthetics|mesh-list
5885629|NCT05104255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5885630|NCT05104255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885631|NCT05104229|Aspirin|aspirin|mesh-list
5885632|NCT05104229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5885633|NCT05104229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5885634|NCT05104229|Analgesics|analgesics|mesh-ancestor
5885635|NCT05104229|Sensory System Agents|sensory system agents|mesh-ancestor
5885636|NCT05104229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5885637|NCT05104229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885638|NCT05104229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5885639|NCT05104229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5885640|NCT05104229|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5885641|NCT05104229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5885642|NCT05104229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885643|NCT05104229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5885644|NCT05104229|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5885645|NCT05104229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5885646|NCT05104229|Antipyretics|antipyretics|mesh-ancestor
5885647|NCT05104138|Eplerenone|eplerenone|mesh-list
5885648|NCT05104138|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5885649|NCT05104138|Hormone Antagonists|hormone antagonists|mesh-ancestor
5885650|NCT05104138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5885651|NCT05104138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885652|NCT05104138|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5885653|NCT05104138|Diuretics|diuretics|mesh-ancestor
5885654|NCT05104138|Natriuretic Agents|natriuretic agents|mesh-ancestor
5688953|NCT03432793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5688954|NCT03432793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5688955|NCT03432793|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5688956|NCT03432793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5688957|NCT03432793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5688958|NCT03432793|Serotonin Agents|serotonin agents|mesh-ancestor
5688959|NCT03432793|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5688960|NCT03432793|Antidepressive Agents|antidepressive agents|mesh-ancestor
5885655|NCT05104138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5885656|NCT05103904|Lenvatinib|lenvatinib|mesh-list
5885657|NCT05103904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5885658|NCT05103904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5885659|NCT05103904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5688961|NCT03432793|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5688962|NCT03432793|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5688963|NCT03432780|Docetaxel|docetaxel|mesh-list
5688964|NCT03432780|Hormones|hormones|mesh-list
5688965|NCT03432780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5688966|NCT03432780|Tubulin Modulators|tubulin modulators|mesh-ancestor
5688967|NCT03432780|Antimitotic Agents|antimitotic agents|mesh-ancestor
5688968|NCT03432780|Mitosis Modulators|mitosis modulators|mesh-ancestor
5688969|NCT03432780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688970|NCT03432780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5688971|NCT03432780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688972|NCT03432728|Anesthetics|anesthetics|mesh-list
5688973|NCT03432728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5688974|NCT03432728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5688975|NCT03432689|Cycloserine|cycloserine|mesh-list
5688976|NCT03432689|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5688977|NCT03432689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5688978|NCT03432689|Renal Agents|renal agents|mesh-ancestor
5688979|NCT03432689|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5885660|NCT05103904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885661|NCT05103813|Beraprost|beraprost|mesh-list
5885662|NCT05103813|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5885663|NCT05103813|Vasodilator Agents|vasodilator agents|mesh-ancestor
5885664|NCT05103696|Propofol|propofol|mesh-list
5885665|NCT05103696|Etomidate|etomidate|mesh-list
5885666|NCT05103696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5885667|NCT05103696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5885668|NCT05103696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885669|NCT05103696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5885670|NCT05103696|Anesthetics, General|anesthetics, general|mesh-ancestor
5885671|NCT05103696|Anesthetics|anesthetics|mesh-ancestor
5885672|NCT05103501|Fluorouracil|fluorouracil|mesh-list
5885673|NCT05103501|Pembrolizumab|pembrolizumab|mesh-list
5885674|NCT05103501|Cisplatin|cisplatin|mesh-list
5885675|NCT05103501|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5885676|NCT05103501|Antimetabolites|antimetabolites|mesh-ancestor
5885677|NCT05103501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885678|NCT05103501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5885679|NCT05103501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5885680|NCT05103501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5885681|NCT05103501|Immunologic Factors|immunologic factors|mesh-ancestor
5885682|NCT05103501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885683|NCT05103501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5885684|NCT05103410|Aripiprazole|aripiprazole|mesh-list
5885685|NCT05103410|Antidepressive Agents|antidepressive agents|mesh-ancestor
5885686|NCT05103410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5885687|NCT05103410|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5885688|NCT05103410|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5885689|NCT05103410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5885690|NCT05103410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885691|NCT05103410|Dopamine Agonists|dopamine agonists|mesh-ancestor
5885692|NCT05103410|Dopamine Agents|dopamine agents|mesh-ancestor
5885693|NCT05103410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5885694|NCT05103410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885695|NCT05103410|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5885696|NCT05103410|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5885697|NCT05103410|Serotonin Agents|serotonin agents|mesh-ancestor
5885698|NCT05103410|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5885699|NCT05103410|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5885700|NCT05103410|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5688980|NCT03432689|Antitubercular Agents|antitubercular agents|mesh-ancestor
5688981|NCT03432689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5688982|NCT03432689|Antimetabolites|antimetabolites|mesh-ancestor
5688983|NCT03432689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688984|NCT03432676|Pembrolizumab|pembrolizumab|mesh-list
5688985|NCT03432676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5688986|NCT03432676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5688987|NCT03432663|Amiodarone|amiodarone|mesh-list
5688988|NCT03432663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5688989|NCT03432663|Vasodilator Agents|vasodilator agents|mesh-ancestor
5688990|NCT03432663|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5688991|NCT03432663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5885701|NCT05103410|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5885702|NCT05103397|Prednisolone|prednisolone|mesh-list
5885703|NCT05103397|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5885704|NCT05103397|Methylprednisolone|methylprednisolone|mesh-list
5885705|NCT05103397|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5688992|NCT03432663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5688993|NCT03432663|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5688994|NCT03432663|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5688995|NCT03432663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5688996|NCT03432663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5688997|NCT03432663|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5688998|NCT03432663|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5688999|NCT03432663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5689000|NCT03432650|Dexamethasone|dexamethasone|mesh-list
5689001|NCT03432650|Bupivacaine|bupivacaine|mesh-list
5689002|NCT03432650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5689003|NCT03432650|Antiemetics|antiemetics|mesh-ancestor
5689004|NCT03432650|Autonomic Agents|autonomic agents|mesh-ancestor
5689005|NCT03432650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5689006|NCT03432650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689007|NCT03432650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5689008|NCT03432650|Glucocorticoids|glucocorticoids|mesh-ancestor
5689009|NCT03432650|Hormones|hormones|mesh-ancestor
5885706|NCT05103397|Prednisolone acetate|prednisolone acetate|mesh-list
5885707|NCT05103397|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5885708|NCT05103397|Prednisolone phosphate|prednisolone phosphate|mesh-list
5885709|NCT05103397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5885710|NCT05103397|Glucocorticoids|glucocorticoids|mesh-ancestor
5885711|NCT05103397|Hormones|hormones|mesh-ancestor
5885712|NCT05103397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5885713|NCT05103397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885714|NCT05103397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5885715|NCT05103397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5885716|NCT05103397|Antiemetics|antiemetics|mesh-ancestor
5885717|NCT05103397|Autonomic Agents|autonomic agents|mesh-ancestor
5885718|NCT05103397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5885719|NCT05103397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5885720|NCT05103397|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5885721|NCT05103397|Protective Agents|protective agents|mesh-ancestor
5885722|NCT05103254|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
5885723|NCT05103254|Ezetimibe|ezetimibe|mesh-list
5885724|NCT05103254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5885725|NCT05103254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5885726|NCT05103254|Antimetabolites|antimetabolites|mesh-ancestor
5885727|NCT05103254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885728|NCT05103254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5885729|NCT05103254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5885730|NCT05103254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5885731|NCT05103254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885732|NCT05103228|Menotropins|menotropins|mesh-list
5885733|NCT05103228|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5885734|NCT05103228|Hormones|hormones|mesh-ancestor
5885735|NCT05103228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5885736|NCT05103228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885737|NCT05103228|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5885738|NCT05103228|Fertility Agents|fertility agents|mesh-ancestor
5885739|NCT05103228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5885740|NCT05103098|Misoprostol|misoprostol|mesh-list
5885741|NCT05103098|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5885742|NCT05103098|Abortifacient Agents|abortifacient agents|mesh-ancestor
5885743|NCT05103098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5885744|NCT05103098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885745|NCT05103098|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5885746|NCT05103098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5885747|NCT05103098|Oxytocics|oxytocics|mesh-ancestor
5906844|NCT05133453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5906845|NCT05133453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5906846|NCT05133453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5906847|NCT05133453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5906848|NCT05133453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5906849|NCT05125978|Dipyrone|dipyrone|mesh-list
5906850|NCT05125978|Tramadol|tramadol|mesh-list
5906851|NCT05125978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5906852|NCT05125978|Narcotics|narcotics|mesh-ancestor
5906853|NCT05125978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5906854|NCT05125978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885748|NCT05103020|Bevacizumab|bevacizumab|mesh-list
5885749|NCT05103020|Cetuximab|cetuximab|mesh-list
5885750|NCT05103020|Oxaliplatin|oxaliplatin|mesh-list
5885751|NCT05103020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5885752|NCT05103020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5885753|NCT05103020|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5885754|NCT05103020|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5885755|NCT05103020|Growth Substances|growth substances|mesh-ancestor
5885756|NCT05103020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885757|NCT05103020|Growth Inhibitors|growth inhibitors|mesh-ancestor
5885758|NCT05103007|Chlorotrianisene|chlorotrianisene|mesh-list
5885759|NCT05103007|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
5885760|NCT05103007|Estrogens|estrogens|mesh-ancestor
5885761|NCT05103007|Hormones|hormones|mesh-ancestor
5885762|NCT05103007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5885763|NCT05103007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885764|NCT05103007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5885765|NCT05103007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5885766|NCT05092555|Fibrin fragment D|fibrin fragment d|mesh-list
5885767|NCT05092555|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5689010|NCT03432650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5689011|NCT03432650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5689012|NCT03432650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5689013|NCT03432650|Anesthetics, Local|anesthetics, local|mesh-ancestor
5689014|NCT03432650|Anesthetics|anesthetics|mesh-ancestor
5689015|NCT03432650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5689016|NCT03432650|Sensory System Agents|sensory system agents|mesh-ancestor
5689017|NCT03432637|Anesthetics|anesthetics|mesh-list
5689018|NCT03432637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5689019|NCT03432637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689020|NCT03432598|Gemcitabine|gemcitabine|mesh-list
5689021|NCT03432598|Paclitaxel|paclitaxel|mesh-list
5689022|NCT03432598|Etoposide|etoposide|mesh-list
5689023|NCT03432598|Carboplatin|carboplatin|mesh-list
5689024|NCT03432598|Pemetrexed|pemetrexed|mesh-list
5689025|NCT03432598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5689026|NCT03432598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5689027|NCT03432598|Tubulin Modulators|tubulin modulators|mesh-ancestor
5885768|NCT05092555|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5885769|NCT05092555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885770|NCT05092555|Hemostatics|hemostatics|mesh-ancestor
5885771|NCT05092555|Coagulants|coagulants|mesh-ancestor
5885772|NCT05092451|Vidarabine|vidarabine|mesh-list
5885773|NCT05092451|Cyclophosphamide|cyclophosphamide|mesh-list
5885774|NCT05092451|Fludarabine|fludarabine|mesh-list
5885775|NCT05092451|Fludarabine phosphate|fludarabine phosphate|mesh-list
5885776|NCT05092451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5689028|NCT03432598|Antimitotic Agents|antimitotic agents|mesh-ancestor
5689029|NCT03432598|Mitosis Modulators|mitosis modulators|mesh-ancestor
5689030|NCT03432598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689031|NCT03432598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5885777|NCT05092451|Immunologic Factors|immunologic factors|mesh-ancestor
5885778|NCT05092451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885779|NCT05092451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5885780|NCT05092451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5885781|NCT05092451|Alkylating Agents|alkylating agents|mesh-ancestor
5885782|NCT05092451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885783|NCT05092451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5885784|NCT05092451|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5885785|NCT05092451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5885786|NCT05092451|Antimetabolites|antimetabolites|mesh-ancestor
5885787|NCT05092451|Antiviral Agents|antiviral agents|mesh-ancestor
5885788|NCT05092451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5885789|NCT05087199|Fibrin fragment D|fibrin fragment d|mesh-list
5885790|NCT05087199|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5885791|NCT05087199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5885792|NCT05087199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885793|NCT05087199|Hemostatics|hemostatics|mesh-ancestor
5885794|NCT05087199|Coagulants|coagulants|mesh-ancestor
5885795|NCT05060666|Ivermectin|ivermectin|mesh-list
5885796|NCT05060666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5885797|NCT05060666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5689032|NCT03432598|Antimetabolites|antimetabolites|mesh-ancestor
5689033|NCT03432598|Antiviral Agents|antiviral agents|mesh-ancestor
5885798|NCT05048134|Trametinib|trametinib|mesh-list
5885799|NCT05048134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5885800|NCT05048134|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5885801|NCT05048134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5885802|NCT05048134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885803|NCT05021900|Tenalisib|tenalisib|mesh-list
5885804|NCT05021900|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
5885805|NCT05021900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5885806|NCT05021900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885807|NCT05019846|Bicalutamide|bicalutamide|mesh-list
5885808|NCT05019846|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5885809|NCT05019846|Androgen Antagonists|androgen antagonists|mesh-ancestor
5885810|NCT05019846|Hormone Antagonists|hormone antagonists|mesh-ancestor
5885811|NCT05019846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5885812|NCT05019846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885813|NCT05019846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5885814|NCT05019846|Luteolytic Agents|luteolytic agents|mesh-ancestor
5885815|NCT05019846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5885816|NCT05019846|Contraceptive Agents|contraceptive agents|mesh-ancestor
5885817|NCT05019846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5885818|NCT05019846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5885819|NCT05019846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5885820|NCT04985851|Durvalumab|durvalumab|mesh-list
5885821|NCT04985851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5885822|NCT04985851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5689034|NCT03432598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5689035|NCT03432598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5689036|NCT03432598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5689037|NCT03432598|Immunologic Factors|immunologic factors|mesh-ancestor
5689038|NCT03432598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689039|NCT03432598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5689040|NCT03432598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5689041|NCT03432598|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5689042|NCT03432598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5689043|NCT03432572|Riboflavin|riboflavin|mesh-list
5689044|NCT03432572|Thiamine|thiamine|mesh-list
5689045|NCT03432572|Vitamin B Complex|vitamin b complex|mesh-ancestor
5885823|NCT04985851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5885824|NCT04985851|Immunologic Factors|immunologic factors|mesh-ancestor
5885825|NCT04985851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885826|NCT04976374|Dexmedetomidine|dexmedetomidine|mesh-list
5885827|NCT04976374|Gabapentin|gabapentin|mesh-list
5885828|NCT04976374|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5885829|NCT04976374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5885830|NCT04976374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885831|NCT04976374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5689046|NCT03432572|Vitamins|vitamins|mesh-ancestor
5689047|NCT03432572|Micronutrients|micronutrients|mesh-ancestor
5689048|NCT03432572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689049|NCT03432572|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5689050|NCT03432572|Dermatologic Agents|dermatologic agents|mesh-ancestor
5885832|NCT04976374|Analgesics|analgesics|mesh-ancestor
5885833|NCT04976374|Sensory System Agents|sensory system agents|mesh-ancestor
5885834|NCT04976374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5885835|NCT04976374|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5885836|NCT04976374|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5885837|NCT04976374|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5885838|NCT04976374|Adrenergic Agents|adrenergic agents|mesh-ancestor
5885839|NCT04976374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5885840|NCT04976374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885841|NCT04976374|Anticonvulsants|anticonvulsants|mesh-ancestor
5885842|NCT04976374|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5885843|NCT04976374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5885844|NCT04976374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5885845|NCT04976374|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5885846|NCT04976374|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5885847|NCT04976374|Antimanic Agents|antimanic agents|mesh-ancestor
5885848|NCT04949412|Vitamin D|vitamin d|mesh-list
5885849|NCT04949412|Vitamins|vitamins|mesh-ancestor
5885850|NCT04949412|Micronutrients|micronutrients|mesh-ancestor
5885851|NCT04949412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885852|NCT04949412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5885853|NCT04947020|Metformin|metformin|mesh-list
5885854|NCT04947020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5885855|NCT04947020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885856|NCT04930653|Mogamulizumab|mogamulizumab|mesh-list
5885857|NCT04930653|Immunoglobulins|immunoglobulins|mesh-list
5885858|NCT04930653|Immunoglobulin G|immunoglobulin g|mesh-list
5689051|NCT03432468|Valsartan|valsartan|mesh-list
5885859|NCT04930653|Immunologic Factors|immunologic factors|mesh-ancestor
5885860|NCT04930653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885861|NCT04930653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5885862|NCT04908423|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
5885863|NCT04908423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5885864|NCT04908423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5885865|NCT04908423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885866|NCT04908423|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5885867|NCT04908423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5885868|NCT04908423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885869|NCT04908423|Cholinergic Agents|cholinergic agents|mesh-ancestor
5885870|NCT04908423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5885871|NCT04904614|Letermovir|letermovir|mesh-list
5885872|NCT04904614|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5885873|NCT04904614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5885874|NCT04904614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885875|NCT04904614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5885876|NCT04904614|Antiviral Agents|antiviral agents|mesh-ancestor
5885877|NCT04904614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5885878|NCT04874935|Lansoprazole|lansoprazole|mesh-list
5885879|NCT04874935|Dexlansoprazole|dexlansoprazole|mesh-list
5885880|NCT04874935|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5885881|NCT04874935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5885882|NCT04874935|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5885883|NCT04874935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5885884|NCT04874935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885885|NCT04834063|Selenium|selenium|mesh-list
5885886|NCT04834063|Antioxidants|antioxidants|mesh-ancestor
5885887|NCT04834063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885888|NCT04834063|Protective Agents|protective agents|mesh-ancestor
5885889|NCT04834063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885890|NCT04834063|Trace Elements|trace elements|mesh-ancestor
5885891|NCT04834063|Micronutrients|micronutrients|mesh-ancestor
5885892|NCT04804059|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5885893|NCT04794205|Caryophyllene|caryophyllene|mesh-list
5885894|NCT04794205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5885895|NCT04794205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5885896|NCT04794205|Analgesics|analgesics|mesh-ancestor
5885897|NCT04794205|Sensory System Agents|sensory system agents|mesh-ancestor
5885898|NCT04794205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5885899|NCT04794205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885900|NCT04794205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5885901|NCT04794205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5689052|NCT03432468|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5689053|NCT03432468|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5689054|NCT03432468|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5689055|NCT03432468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689056|NCT03432442|Ivermectin|ivermectin|mesh-list
5885902|NCT04790474|Dexamethasone|dexamethasone|mesh-list
5885903|NCT04790474|Pomalidomide|pomalidomide|mesh-list
5885904|NCT04790474|Ixazomib|ixazomib|mesh-list
5885905|NCT04790474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5885906|NCT04790474|Antiemetics|antiemetics|mesh-ancestor
5885907|NCT04790474|Autonomic Agents|autonomic agents|mesh-ancestor
5885908|NCT04790474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5885909|NCT04790474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885910|NCT04790474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5885911|NCT04790474|Glucocorticoids|glucocorticoids|mesh-ancestor
5885912|NCT04790474|Hormones|hormones|mesh-ancestor
5689057|NCT03432442|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5689058|NCT03432442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5689059|NCT03432312|Nicotine|nicotine|mesh-list
5689060|NCT03432312|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5689061|NCT03432312|Autonomic Agents|autonomic agents|mesh-ancestor
5689062|NCT03432312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5689063|NCT03432312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689064|NCT03432312|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5689065|NCT03432312|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5885913|NCT04790474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5885914|NCT04790474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5885915|NCT04790474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6675524|NCT01575925|Immunologic Factors|immunologic factors|mesh-ancestor
5689066|NCT03432312|Cholinergic Agents|cholinergic agents|mesh-ancestor
5885916|NCT04790474|Immunologic Factors|immunologic factors|mesh-ancestor
5885917|NCT04790474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5885918|NCT04790474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5885919|NCT04790474|Growth Substances|growth substances|mesh-ancestor
5885920|NCT04790474|Growth Inhibitors|growth inhibitors|mesh-ancestor
5885921|NCT04790474|Protease Inhibitors|protease inhibitors|mesh-ancestor
5885922|NCT04790474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5885923|NCT04790474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885924|NCT04725032|Propofol|propofol|mesh-list
5885925|NCT04725032|Sevoflurane|sevoflurane|mesh-list
5885926|NCT04725032|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5885927|NCT04725032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5885928|NCT04725032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885929|NCT04725032|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5885930|NCT04725032|Anesthetics, General|anesthetics, general|mesh-ancestor
5885931|NCT04725032|Anesthetics|anesthetics|mesh-ancestor
5885932|NCT04725032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5885933|NCT04725032|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5689067|NCT03432312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5689068|NCT03432312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697497|NCT03375593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5697498|NCT03375593|Analgesics|analgesics|mesh-ancestor
5697499|NCT03375593|Sensory System Agents|sensory system agents|mesh-ancestor
5885934|NCT04716114|Cytarabine|cytarabine|mesh-list
5885935|NCT04716114|Fludarabine|fludarabine|mesh-list
5885936|NCT04716114|Azacitidine|azacitidine|mesh-list
5885937|NCT04716114|Homoharringtonine|homoharringtonine|mesh-list
5885938|NCT04716114|Aclarubicin|aclarubicin|mesh-list
5885939|NCT04716114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5885940|NCT04716114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5885941|NCT04716114|Antimetabolites|antimetabolites|mesh-ancestor
5885942|NCT04716114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885943|NCT04716114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5885944|NCT04716114|Immunologic Factors|immunologic factors|mesh-ancestor
5885945|NCT04716114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885946|NCT04716114|Antiviral Agents|antiviral agents|mesh-ancestor
5885947|NCT04716114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5885948|NCT04716114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5885949|NCT04716114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5885950|NCT04716114|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5885951|NCT04716114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5885952|NCT04716114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5885953|NCT04716114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5885954|NCT04701281|Capecitabine|capecitabine|mesh-list
5885955|NCT04701281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5885956|NCT04701281|Antimetabolites|antimetabolites|mesh-ancestor
5885957|NCT04701281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885958|NCT04701281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5885959|NCT04667780|Colchicine|colchicine|mesh-list
5885960|NCT04667780|Gout Suppressants|gout suppressants|mesh-ancestor
5885961|NCT04667780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5885962|NCT04667780|Tubulin Modulators|tubulin modulators|mesh-ancestor
5885963|NCT04667780|Antimitotic Agents|antimitotic agents|mesh-ancestor
5885964|NCT04667780|Mitosis Modulators|mitosis modulators|mesh-ancestor
5885965|NCT04667780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885966|NCT04667780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5885967|NCT04655222|Interferons|interferons|mesh-list
5885968|NCT04655222|Interferon-beta|interferon-beta|mesh-list
5885969|NCT04655222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5885970|NCT04655222|Antiviral Agents|antiviral agents|mesh-ancestor
5885971|NCT04655222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5885972|NCT04655222|Immunologic Factors|immunologic factors|mesh-ancestor
5885973|NCT04655222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906855|NCT05125978|Analgesics|analgesics|mesh-ancestor
5906856|NCT05125978|Sensory System Agents|sensory system agents|mesh-ancestor
5906857|NCT05125978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5906858|NCT05125978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5906859|NCT05125978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5906860|NCT05125978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5906861|NCT05125978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5906862|NCT05125978|Antipyretics|antipyretics|mesh-ancestor
5906863|NCT05125796|Acetaminophen|acetaminophen|mesh-list
5906864|NCT05125796|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
5906865|NCT05125796|Ketoprofen|ketoprofen|mesh-list
5906866|NCT05125796|Lidocaine|lidocaine|mesh-list
5697500|NCT03375593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5697501|NCT03375593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906867|NCT05125796|Anesthetics, Local|anesthetics, local|mesh-ancestor
5906868|NCT05125796|Anesthetics|anesthetics|mesh-ancestor
5689069|NCT03432273|Nicotine|nicotine|mesh-list
5689070|NCT03432273|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5689071|NCT03432273|Autonomic Agents|autonomic agents|mesh-ancestor
5689072|NCT03432273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5689073|NCT03432273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689074|NCT03432273|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5689075|NCT03432273|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5689076|NCT03432273|Cholinergic Agents|cholinergic agents|mesh-ancestor
5689077|NCT03432273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5689078|NCT03432273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689079|NCT03432221|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
5689080|NCT03432221|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5689081|NCT03432221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5689082|NCT03432221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5689083|NCT03432221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689084|NCT03432221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5689085|NCT03432221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689086|NCT03432221|Antidepressive Agents|antidepressive agents|mesh-ancestor
5689087|NCT03432221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5689088|NCT03432195|Donepezil|donepezil|mesh-list
5885974|NCT04620746|Penicillins|penicillins|mesh-list
5885975|NCT04620746|Penicillin G|penicillin g|mesh-list
5885976|NCT04620746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5885977|NCT04620746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5885978|NCT04552327|Diclofenac|diclofenac|mesh-list
5885979|NCT04552327|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5885980|NCT04552327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5885981|NCT04552327|Analgesics|analgesics|mesh-ancestor
5885982|NCT04552327|Sensory System Agents|sensory system agents|mesh-ancestor
5885983|NCT04552327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5885984|NCT04552327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5885985|NCT04552327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5885986|NCT04552327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5885987|NCT04552327|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5885988|NCT04552327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5885989|NCT04552327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885990|NCT04519905|Paclitaxel|paclitaxel|mesh-list
5885991|NCT04519905|Carboplatin|carboplatin|mesh-list
5885992|NCT04519905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5885993|NCT04519905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5885994|NCT04519905|Tubulin Modulators|tubulin modulators|mesh-ancestor
5885995|NCT04519905|Antimitotic Agents|antimitotic agents|mesh-ancestor
5885996|NCT04519905|Mitosis Modulators|mitosis modulators|mesh-ancestor
5885997|NCT04519905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5885998|NCT04482686|Vitamin D|vitamin d|mesh-list
5885999|NCT04482686|Cholecalciferol|cholecalciferol|mesh-list
5886000|NCT04482686|Vitamins|vitamins|mesh-list
5886001|NCT04482686|Ascorbic Acid|ascorbic acid|mesh-list
5886002|NCT04482686|Zinc|zinc|mesh-list
5886003|NCT04482686|Doxycycline|doxycycline|mesh-list
5886004|NCT04482686|Ivermectin|ivermectin|mesh-list
5886005|NCT04482686|Zinc Sulfate|zinc sulfate|mesh-list
5886006|NCT04482686|Micronutrients|micronutrients|mesh-ancestor
5886007|NCT04482686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886008|NCT04482686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5886009|NCT04482686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5886010|NCT04482686|Trace Elements|trace elements|mesh-ancestor
5886011|NCT04482686|Antioxidants|antioxidants|mesh-ancestor
5886012|NCT04482686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886013|NCT04482686|Protective Agents|protective agents|mesh-ancestor
5886014|NCT04482686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5886015|NCT04482686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5886016|NCT04482686|Antimalarials|antimalarials|mesh-ancestor
5689089|NCT03432195|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5689090|NCT03432195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5689091|NCT03432195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886017|NCT04482686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5886018|NCT04482686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5886019|NCT04482686|Astringents|astringents|mesh-ancestor
5886020|NCT04482686|Dermatologic Agents|dermatologic agents|mesh-ancestor
5886021|NCT04459286|Ritonavir|ritonavir|mesh-list
5886022|NCT04459286|Atazanavir Sulfate|atazanavir sulfate|mesh-list
5886023|NCT04459286|Nitazoxanide|nitazoxanide|mesh-list
5886024|NCT04459286|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5886025|NCT04459286|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5886026|NCT04459286|Protease Inhibitors|protease inhibitors|mesh-ancestor
5886027|NCT04459286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5886028|NCT04459286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886029|NCT04459286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5886030|NCT04459286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5886031|NCT04459286|Antiviral Agents|antiviral agents|mesh-ancestor
5886032|NCT04459286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5886033|NCT04459286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5886034|NCT04459286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5886035|NCT04459286|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5886036|NCT04450407|Insulin|insulin|mesh-list
5886037|NCT04450407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5886038|NCT04450407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886039|NCT04423341|Cannabidiol|cannabidiol|mesh-list
5886040|NCT04423341|Anticonvulsants|anticonvulsants|mesh-ancestor
5886041|NCT04323462|Insulin|insulin|mesh-list
5886042|NCT04323462|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5886043|NCT04323462|Insulin Glargine|insulin glargine|mesh-list
5886044|NCT04323462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5886045|NCT04323462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886046|NCT04279535|Ascorbic Acid|ascorbic acid|mesh-list
5886047|NCT04279535|Antioxidants|antioxidants|mesh-ancestor
5886048|NCT04279535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886049|NCT04279535|Protective Agents|protective agents|mesh-ancestor
6496097|NCT00626535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496098|NCT00626600|Oxycodone|oxycodone|mesh-list
6496099|NCT00626600|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6496100|NCT00626600|Narcotics|narcotics|mesh-ancestor
6496101|NCT00626600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6496102|NCT00626600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496103|NCT00626600|Analgesics|analgesics|mesh-ancestor
6496104|NCT00626600|Sensory System Agents|sensory system agents|mesh-ancestor
6496105|NCT00626600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6496106|NCT00626613|Risperidone|risperidone|mesh-list
6496107|NCT00626613|Galantamine|galantamine|mesh-list
6496108|NCT00626613|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6496109|NCT00626613|Serotonin Agents|serotonin agents|mesh-ancestor
5689092|NCT03432195|Cholinergic Agents|cholinergic agents|mesh-ancestor
5689093|NCT03432195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5689094|NCT03432195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689095|NCT03432195|Nootropic Agents|nootropic agents|mesh-ancestor
5689096|NCT03432091|Melatonin|melatonin|mesh-list
6496110|NCT00626613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6496111|NCT00626613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496112|NCT00626613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496113|NCT00626613|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6496114|NCT00626613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6496115|NCT00626613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6496116|NCT00626613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6496117|NCT00626613|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6496118|NCT00626613|Dopamine Agents|dopamine agents|mesh-ancestor
6496119|NCT00626613|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6496120|NCT00626613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6496121|NCT00626613|Cholinergic Agents|cholinergic agents|mesh-ancestor
6496122|NCT00626613|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6496123|NCT00626613|Autonomic Agents|autonomic agents|mesh-ancestor
6496124|NCT00626613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6496125|NCT00626613|Nootropic Agents|nootropic agents|mesh-ancestor
6496126|NCT00626665|Tadalafil|tadalafil|mesh-list
6496127|NCT00626665|Vasodilator Agents|vasodilator agents|mesh-ancestor
6496128|NCT00626665|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6496129|NCT00626665|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6496130|NCT00626665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6496131|NCT00626665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689097|NCT03432091|Antioxidants|antioxidants|mesh-ancestor
5689098|NCT03432091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689099|NCT03432091|Protective Agents|protective agents|mesh-ancestor
5689100|NCT03432091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689101|NCT03432091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5689102|NCT03431987|Ethanol|ethanol|mesh-list
5689103|NCT03431987|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5689104|NCT03431987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5689105|NCT03431987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5689106|NCT03431987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689107|NCT03431974|Aminopterin|aminopterin|mesh-list
5689108|NCT03431974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5689109|NCT03431974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5697502|NCT03375593|Antipyretics|antipyretics|mesh-ancestor
5886050|NCT04279535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886051|NCT04279535|Vitamins|vitamins|mesh-ancestor
5886052|NCT04279535|Micronutrients|micronutrients|mesh-ancestor
5886053|NCT04255927|Triclosan|triclosan|mesh-list
5886054|NCT04255927|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5886055|NCT04255927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5886056|NCT04255927|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5886057|NCT04255927|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5886058|NCT04255927|Antimetabolites|antimetabolites|mesh-ancestor
5886059|NCT04255927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886060|NCT04255927|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5886061|NCT04166669|Itraconazole|itraconazole|mesh-list
5886062|NCT04166669|Rifampin|rifampin|mesh-list
5886063|NCT04166669|Antifungal Agents|antifungal agents|mesh-ancestor
5886064|NCT04166669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5886065|NCT04166669|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5886066|NCT04166669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5886067|NCT04166669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5689110|NCT03431974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689111|NCT03431961|Triamcinolone|triamcinolone|mesh-list
5689112|NCT03431961|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5689113|NCT03431961|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5689114|NCT03431961|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5689115|NCT03431961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6496132|NCT00626665|Urological Agents|urological agents|mesh-ancestor
6496133|NCT00626678|Prednisone|prednisone|mesh-list
6496134|NCT00626678|Azathioprine|azathioprine|mesh-list
6496135|NCT00626678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6496136|NCT00626678|Glucocorticoids|glucocorticoids|mesh-ancestor
6496137|NCT00626678|Hormones|hormones|mesh-ancestor
6496138|NCT00626678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6496139|NCT00626678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496140|NCT00626678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6496141|NCT00626678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6496142|NCT00626678|Antimetabolites|antimetabolites|mesh-ancestor
6496143|NCT00626678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496144|NCT00626678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6496145|NCT00626678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6496146|NCT00626678|Immunologic Factors|immunologic factors|mesh-ancestor
6496147|NCT00626678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6496148|NCT00626717|Riboflavin|riboflavin|mesh-list
6496149|NCT00626717|Vitamin B Complex|vitamin b complex|mesh-ancestor
6496150|NCT00626717|Vitamins|vitamins|mesh-ancestor
6496151|NCT00626717|Micronutrients|micronutrients|mesh-ancestor
6496152|NCT00626717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496153|NCT00626717|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5689116|NCT03431961|Glucocorticoids|glucocorticoids|mesh-ancestor
5689117|NCT03431961|Hormones|hormones|mesh-ancestor
5689118|NCT03431961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5689119|NCT03431961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689120|NCT03431961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5689121|NCT03431961|Immunologic Factors|immunologic factors|mesh-ancestor
5689122|NCT03431961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5689123|NCT03431961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689124|NCT03431948|Nivolumab|nivolumab|mesh-list
5689125|NCT03431948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5689126|NCT03431948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5689127|NCT03431948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5689128|NCT03431948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689129|NCT03431909|Aspirin|aspirin|mesh-list
5689130|NCT03431909|Kallikreins|kallikreins|mesh-list
5689131|NCT03431909|Clopidogrel|clopidogrel|mesh-list
5689132|NCT03431909|Atorvastatin|atorvastatin|mesh-list
6496154|NCT00626717|Dermatologic Agents|dermatologic agents|mesh-ancestor
6496155|NCT00626769|Genistein|genistein|mesh-list
5689133|NCT03431909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5689134|NCT03431909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5689135|NCT03431909|Analgesics|analgesics|mesh-ancestor
5689136|NCT03431909|Sensory System Agents|sensory system agents|mesh-ancestor
5689137|NCT03431909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5689138|NCT03431909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886068|NCT04166669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496156|NCT00626769|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6496157|NCT00626769|Protective Agents|protective agents|mesh-ancestor
6496158|NCT00626769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496159|NCT00626769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6496160|NCT00626769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6496161|NCT00626769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6496162|NCT00626769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496163|NCT00626769|Phytoestrogens|phytoestrogens|mesh-ancestor
6496164|NCT00626769|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6496165|NCT00626769|Estrogens|estrogens|mesh-ancestor
6496166|NCT00626769|Hormones|hormones|mesh-ancestor
6496167|NCT00626769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6496168|NCT00626834|Vigabatrin|vigabatrin|mesh-list
6496169|NCT00626834|Anticonvulsants|anticonvulsants|mesh-ancestor
6496170|NCT00626834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6496171|NCT00626834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496172|NCT00626834|GABA Agents|gaba agents|mesh-ancestor
5886069|NCT04166669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5886070|NCT04166669|Hormone Antagonists|hormone antagonists|mesh-ancestor
5886071|NCT04166669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5886072|NCT04166669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886073|NCT04166669|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5886074|NCT04166669|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5886075|NCT04166669|Antitubercular Agents|antitubercular agents|mesh-ancestor
5886076|NCT04166669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5886077|NCT04166669|Leprostatic Agents|leprostatic agents|mesh-ancestor
5886078|NCT04166669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5886079|NCT04166669|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5886080|NCT04166669|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5886081|NCT04166669|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5886082|NCT04166669|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5886083|NCT04166669|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5886084|NCT04166669|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5886085|NCT04150770|Infliximab|infliximab|mesh-list
5886086|NCT04150770|Dermatologic Agents|dermatologic agents|mesh-ancestor
5886087|NCT04150770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5886088|NCT04150770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5886089|NCT04125771|Diclofenac|diclofenac|mesh-list
5886090|NCT04125771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5886091|NCT04125771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5886092|NCT04125771|Analgesics|analgesics|mesh-ancestor
5886093|NCT04125771|Sensory System Agents|sensory system agents|mesh-ancestor
5886094|NCT04125771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5886095|NCT04125771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886096|NCT04125771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5886097|NCT04125771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6496173|NCT00626834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6496174|NCT00626834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496175|NCT00626977|Clonidine|clonidine|mesh-list
6496176|NCT00626977|Ropivacaine|ropivacaine|mesh-list
6496177|NCT00626977|Anesthetics, Local|anesthetics, local|mesh-ancestor
6496178|NCT00626977|Anesthetics|anesthetics|mesh-ancestor
6496179|NCT00626977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6496180|NCT00626977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496181|NCT00626977|Sensory System Agents|sensory system agents|mesh-ancestor
6496182|NCT00626977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6496183|NCT00626977|Analgesics|analgesics|mesh-ancestor
6496184|NCT00626977|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6496185|NCT00626977|Sympatholytics|sympatholytics|mesh-ancestor
6496186|NCT00626977|Autonomic Agents|autonomic agents|mesh-ancestor
5689139|NCT03431909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5689140|NCT03431909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5689141|NCT03431909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5689142|NCT03431909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5689143|NCT03431909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689144|NCT03431909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5689145|NCT03431909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5689146|NCT03431909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5689147|NCT03431909|Antipyretics|antipyretics|mesh-ancestor
5689148|NCT03431909|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5689149|NCT03431909|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5689150|NCT03431909|Antimetabolites|antimetabolites|mesh-ancestor
5689151|NCT03431909|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5689152|NCT03431909|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5689153|NCT03431909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5689154|NCT03431909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5689155|NCT03431909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5689156|NCT03431909|Purinergic Agents|purinergic agents|mesh-ancestor
5886098|NCT04125771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5886099|NCT04125771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5886100|NCT04125771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886101|NCT04026438|Potassium phosphate|potassium phosphate|mesh-list
5886102|NCT04026438|Cariostatic Agents|cariostatic agents|mesh-ancestor
5886103|NCT04026438|Protective Agents|protective agents|mesh-ancestor
5886104|NCT04026438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886105|NCT03983993|Panitumumab|panitumumab|mesh-list
5886106|NCT03983993|Niraparib|niraparib|mesh-list
5886107|NCT03983993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5886108|NCT03983993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5886109|NCT03983993|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5689157|NCT03431909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5689158|NCT03431909|Coagulants|coagulants|mesh-ancestor
5689159|NCT03431909|Fertility Agents, Male|fertility agents, male|mesh-ancestor
5689160|NCT03431909|Fertility Agents|fertility agents|mesh-ancestor
5689161|NCT03431909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5689162|NCT03431831|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
5689163|NCT03431831|Naltrexone|naltrexone|mesh-list
5689164|NCT03431831|Bupropion|bupropion|mesh-list
5689165|NCT03431831|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5689166|NCT03431831|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5689167|NCT03431831|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5689168|NCT03431831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689169|NCT03431831|Sensory System Agents|sensory system agents|mesh-ancestor
5689170|NCT03431831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5689171|NCT03431831|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5886110|NCT03983993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5886111|NCT03983993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886112|NCT03964532|Avelumab|avelumab|mesh-list
5886113|NCT03964532|Talazoparib|talazoparib|mesh-list
5886114|NCT03964532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5886115|NCT03964532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5886116|NCT03964532|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5886117|NCT03964532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5886118|NCT03964532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886119|NCT03961971|Spartalizumab|spartalizumab|mesh-list
5886120|NCT03961971|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5886121|NCT03961971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886122|NCT03961971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5886123|NCT03897998|Naloxone|naloxone|mesh-list
5886124|NCT03897998|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5886125|NCT03897998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886126|NCT03897998|Sensory System Agents|sensory system agents|mesh-ancestor
5886127|NCT03897998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5886128|NCT03864406|Darunavir|darunavir|mesh-list
5886129|NCT03864406|Cobicistat|cobicistat|mesh-list
5886130|NCT03864406|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
5886131|NCT03864406|Rivaroxaban|rivaroxaban|mesh-list
5886132|NCT03864406|Apixaban|apixaban|mesh-list
5886133|NCT03864406|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5886134|NCT03864406|Antithrombins|antithrombins|mesh-ancestor
5886135|NCT03864406|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5886136|NCT03864406|Protease Inhibitors|protease inhibitors|mesh-ancestor
5689172|NCT03431831|Antidepressive Agents|antidepressive agents|mesh-ancestor
5689173|NCT03431831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5689174|NCT03431831|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5689175|NCT03431831|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5689176|NCT03431831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5689177|NCT03431831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886137|NCT03864406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5886138|NCT03864406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886139|NCT03864406|Anticoagulants|anticoagulants|mesh-ancestor
5886140|NCT03864406|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5886141|NCT03864406|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5886142|NCT03864406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5886143|NCT03864406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5886144|NCT03864406|Antiviral Agents|antiviral agents|mesh-ancestor
5886145|NCT03864406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5886146|NCT03864406|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5886147|NCT03864406|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5886148|NCT03765359|Metformin|metformin|mesh-list
5886149|NCT03765359|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5886150|NCT03765359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689178|NCT03431831|Dopamine Agents|dopamine agents|mesh-ancestor
5689179|NCT03431831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5689180|NCT03431831|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5689181|NCT03431831|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5689182|NCT03431831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5689183|NCT03431805|Tranexamic Acid|tranexamic acid|mesh-list
5689184|NCT03431805|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5689185|NCT03431805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5689186|NCT03431805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689187|NCT03431805|Hemostatics|hemostatics|mesh-ancestor
5689188|NCT03431805|Coagulants|coagulants|mesh-ancestor
5689189|NCT03431766|Chlorhexidine|chlorhexidine|mesh-list
5689190|NCT03431766|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5689191|NCT03431766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5689192|NCT03431766|Disinfectants|disinfectants|mesh-ancestor
5689193|NCT03431714|Artesunate|artesunate|mesh-list
5689194|NCT03431714|Piperaquine|piperaquine|mesh-list
5689195|NCT03431714|Amodiaquine|amodiaquine|mesh-list
5689196|NCT03431714|Artenimol|artenimol|mesh-list
5689197|NCT03431714|Antimalarials|antimalarials|mesh-ancestor
5689198|NCT03431714|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5689199|NCT03431714|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5689200|NCT03431714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5689201|NCT03431714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5689202|NCT03431714|Antiviral Agents|antiviral agents|mesh-ancestor
5689203|NCT03431714|Schistosomicides|schistosomicides|mesh-ancestor
5689204|NCT03431714|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5689205|NCT03431714|Anthelmintics|anthelmintics|mesh-ancestor
5689206|NCT03431701|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5886151|NCT03759041|Vancomycin|vancomycin|mesh-list
5886152|NCT03759041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5886153|NCT03759041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5886154|NCT03711604|Tenalisib|tenalisib|mesh-list
5886155|NCT03711604|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
5886156|NCT03711604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5886157|NCT03711604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906869|NCT05125796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5906870|NCT05125796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906871|NCT05125796|Sensory System Agents|sensory system agents|mesh-ancestor
5906872|NCT05125796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5906873|NCT05125796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5906874|NCT05125796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5906875|NCT05125796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5906876|NCT05125796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5906877|NCT05125796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906878|NCT05125796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5906879|NCT05125796|Analgesics|analgesics|mesh-ancestor
5906880|NCT05125796|Antipyretics|antipyretics|mesh-ancestor
5906881|NCT05125796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5906882|NCT05125796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5906883|NCT05125796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5906884|NCT05125796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5906885|NCT05125796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5906886|NCT05125185|Insulin|insulin|mesh-list
5906887|NCT05125185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5906888|NCT05125185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906889|NCT05124067|Dexamethasone|dexamethasone|mesh-list
5906890|NCT05124067|Dexamethasone acetate|dexamethasone acetate|mesh-list
5906891|NCT05124067|Dexmedetomidine|dexmedetomidine|mesh-list
5906892|NCT05124067|Ondansetron|ondansetron|mesh-list
5906893|NCT05124067|BB 1101|bb 1101|mesh-list
5906894|NCT05124067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5906895|NCT05124067|Antiemetics|antiemetics|mesh-ancestor
5906896|NCT05124067|Autonomic Agents|autonomic agents|mesh-ancestor
5906897|NCT05124067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5906898|NCT05124067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906899|NCT05124067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5906900|NCT05124067|Glucocorticoids|glucocorticoids|mesh-ancestor
5906901|NCT05124067|Hormones|hormones|mesh-ancestor
5906902|NCT05124067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5906903|NCT05124067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5906904|NCT05124067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5689207|NCT03431701|Chlorhexidine|chlorhexidine|mesh-list
5689208|NCT03431701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5689209|NCT03431701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5886158|NCT03645603|Dexmedetomidine|dexmedetomidine|mesh-list
5886159|NCT03645603|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5886160|NCT03645603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5886161|NCT03645603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886162|NCT03645603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5886163|NCT03645603|Analgesics|analgesics|mesh-ancestor
5886164|NCT03645603|Sensory System Agents|sensory system agents|mesh-ancestor
5886165|NCT03645603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5886166|NCT03645603|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5886167|NCT03645603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5886168|NCT03645603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5886169|NCT03645603|Adrenergic Agents|adrenergic agents|mesh-ancestor
5886170|NCT03645603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5886171|NCT03645603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886172|NCT03634228|Cytarabine|cytarabine|mesh-list
5886173|NCT03634228|Venetoclax|venetoclax|mesh-list
5886174|NCT03634228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5886175|NCT03634228|Antimetabolites|antimetabolites|mesh-ancestor
5886176|NCT03634228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886177|NCT03634228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5886178|NCT03634228|Antiviral Agents|antiviral agents|mesh-ancestor
5886179|NCT03634228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5886180|NCT03634228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5886181|NCT03634228|Immunologic Factors|immunologic factors|mesh-ancestor
5886182|NCT03634228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886183|NCT03615742|Budesonide|budesonide|mesh-list
5886184|NCT03615742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5886185|NCT03615742|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5886186|NCT03615742|Autonomic Agents|autonomic agents|mesh-ancestor
5886187|NCT03615742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5886188|NCT03615742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886189|NCT03615742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5886190|NCT03615742|Respiratory System Agents|respiratory system agents|mesh-ancestor
5886191|NCT03615742|Glucocorticoids|glucocorticoids|mesh-ancestor
5886192|NCT03615742|Hormones|hormones|mesh-ancestor
5886193|NCT03615742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5886194|NCT03587584|Bupivacaine|bupivacaine|mesh-list
5886195|NCT03587584|Anesthetics, Local|anesthetics, local|mesh-ancestor
5886196|NCT03587584|Anesthetics|anesthetics|mesh-ancestor
5886197|NCT03587584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5886198|NCT03587584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886199|NCT03587584|Sensory System Agents|sensory system agents|mesh-ancestor
5886200|NCT03587584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5886201|NCT03581487|Durvalumab|durvalumab|mesh-list
5886202|NCT03581487|Ipilimumab|ipilimumab|mesh-list
5689210|NCT03431701|Disinfectants|disinfectants|mesh-ancestor
5689211|NCT03431675|Ciprofloxacin|ciprofloxacin|mesh-list
5689212|NCT03431675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5689213|NCT03431675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5689214|NCT03431675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5689215|NCT03431675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5689216|NCT03431675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5886203|NCT03581487|Tremelimumab|tremelimumab|mesh-list
5886204|NCT03581487|Immunoglobulins|immunoglobulins|mesh-list
5886205|NCT03581487|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5886206|NCT03581487|Immunoglobulin G|immunoglobulin g|mesh-list
5886207|NCT03581487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5886208|NCT03581487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5886209|NCT03581487|Immunologic Factors|immunologic factors|mesh-ancestor
5886210|NCT03581487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886211|NCT03581487|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5886212|NCT03581487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886213|NCT03542695|Alendronate|alendronate|mesh-list
5886214|NCT03542695|Copper|copper|mesh-list
5886215|NCT03542695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5886216|NCT03542695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886217|NCT03542695|Trace Elements|trace elements|mesh-ancestor
5886218|NCT03542695|Micronutrients|micronutrients|mesh-ancestor
5886219|NCT03521102|Acetaminophen|acetaminophen|mesh-list
5886220|NCT03521102|Hydromorphone|hydromorphone|mesh-list
5886221|NCT03521102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5886222|NCT03521102|Analgesics|analgesics|mesh-ancestor
5886223|NCT03521102|Sensory System Agents|sensory system agents|mesh-ancestor
5689217|NCT03431675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689218|NCT03431675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5689219|NCT03431675|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5689220|NCT03431675|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5689221|NCT03431649|Sildenafil Citrate|sildenafil citrate|mesh-list
5689222|NCT03431649|Beraprost|beraprost|mesh-list
5689223|NCT03431649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689224|NCT03431649|Vasodilator Agents|vasodilator agents|mesh-ancestor
5689225|NCT03431649|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5689226|NCT03431649|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5689227|NCT03431649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5689228|NCT03431649|Urological Agents|urological agents|mesh-ancestor
5689229|NCT03431649|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5689230|NCT03431623|Darbepoetin alfa|darbepoetin alfa|mesh-list
5689231|NCT03431623|Hematinics|hematinics|mesh-ancestor
5689232|NCT03431597|Micronutrients|micronutrients|mesh-list
5689233|NCT03431597|Trace Elements|trace elements|mesh-list
5689234|NCT03431597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689235|NCT03431558|Lactoferrin|lactoferrin|mesh-list
5689236|NCT03431558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5886224|NCT03521102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5886225|NCT03521102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886226|NCT03521102|Antipyretics|antipyretics|mesh-ancestor
5886227|NCT03521102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5886228|NCT03521102|Narcotics|narcotics|mesh-ancestor
5886229|NCT03521102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5886230|NCT03414502|Hydroxychloroquine|hydroxychloroquine|mesh-list
5886231|NCT03414502|Minocycline|minocycline|mesh-list
5886232|NCT03414502|Sulfasalazine|sulfasalazine|mesh-list
5886233|NCT03414502|Adalimumab|adalimumab|mesh-list
5886234|NCT03414502|Etanercept|etanercept|mesh-list
5886235|NCT03414502|Golimumab|golimumab|mesh-list
5886236|NCT03414502|Rituximab|rituximab|mesh-list
5886237|NCT03414502|Methotrexate|methotrexate|mesh-list
5886238|NCT03414502|Abatacept|abatacept|mesh-list
5689237|NCT03431285|Morphine|morphine|mesh-list
5689238|NCT03431285|Ketamine|ketamine|mesh-list
5689239|NCT03431285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5689240|NCT03431285|Narcotics|narcotics|mesh-ancestor
5689241|NCT03431285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5689242|NCT03431285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689243|NCT03431285|Analgesics|analgesics|mesh-ancestor
5689244|NCT03431285|Sensory System Agents|sensory system agents|mesh-ancestor
5886239|NCT03414502|Azathioprine|azathioprine|mesh-list
5886240|NCT03414502|Infliximab|infliximab|mesh-list
5886241|NCT03414502|Certolizumab Pegol|certolizumab pegol|mesh-list
5886242|NCT03414502|Leflunomide|leflunomide|mesh-list
5886243|NCT03414502|Tofacitinib|tofacitinib|mesh-list
5886244|NCT03414502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5886245|NCT03414502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5886246|NCT03414502|Immunologic Factors|immunologic factors|mesh-ancestor
5886247|NCT03414502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886248|NCT03414502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5886249|NCT03414502|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5886250|NCT03414502|Abortifacient Agents|abortifacient agents|mesh-ancestor
5886251|NCT03414502|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5886252|NCT03414502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5886253|NCT03414502|Antimetabolites|antimetabolites|mesh-ancestor
5886254|NCT03414502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689245|NCT03431285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5689246|NCT03431285|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5689247|NCT03431285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5689248|NCT03431285|Anesthetics, General|anesthetics, general|mesh-ancestor
5689249|NCT03431285|Anesthetics|anesthetics|mesh-ancestor
5689250|NCT03431285|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5689251|NCT03431285|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5689252|NCT03431285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5689253|NCT03431285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689254|NCT03431272|Lifitegrast|lifitegrast|mesh-list
5689255|NCT03431272|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5689256|NCT03431272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5689257|NCT03431194|Midodrine|midodrine|mesh-list
5689258|NCT03431194|Sympathomimetics|sympathomimetics|mesh-ancestor
5886255|NCT03414502|Dermatologic Agents|dermatologic agents|mesh-ancestor
5689259|NCT03431194|Autonomic Agents|autonomic agents|mesh-ancestor
5689260|NCT03431194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5689261|NCT03431194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886256|NCT03414502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5886257|NCT03414502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5886258|NCT03414502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5886259|NCT03414502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5886260|NCT03414502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5689262|NCT03431194|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5689263|NCT03431194|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5689264|NCT03431194|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5689265|NCT03431194|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5689266|NCT03431194|Adrenergic Agents|adrenergic agents|mesh-ancestor
5886261|NCT03414502|Antimalarials|antimalarials|mesh-ancestor
5886262|NCT03414502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5886263|NCT03414502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5886264|NCT03414502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5886265|NCT03414502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5886266|NCT03414502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5886267|NCT03414502|Analgesics|analgesics|mesh-ancestor
5886268|NCT03414502|Sensory System Agents|sensory system agents|mesh-ancestor
5886269|NCT03414502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5886270|NCT03414502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5886271|NCT03414502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5886272|NCT03414502|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5886273|NCT03414502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5886274|NCT03414502|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
5886275|NCT03266783|Rivaroxaban|rivaroxaban|mesh-list
5886276|NCT03266783|Apixaban|apixaban|mesh-list
5886277|NCT03266783|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5886278|NCT03266783|Antithrombins|antithrombins|mesh-ancestor
5886279|NCT03266783|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5886280|NCT03266783|Protease Inhibitors|protease inhibitors|mesh-ancestor
5886281|NCT03266783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5886282|NCT03266783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886283|NCT03266783|Anticoagulants|anticoagulants|mesh-ancestor
5886284|NCT03246828|Gliclazide|gliclazide|mesh-list
5886285|NCT03246828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5886286|NCT03246828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886287|NCT03199612|Sildenafil Citrate|sildenafil citrate|mesh-list
5886288|NCT03199612|Vasodilator Agents|vasodilator agents|mesh-ancestor
5886289|NCT03199612|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5886290|NCT03199612|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5886291|NCT03199612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5886292|NCT03199612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886293|NCT03199612|Urological Agents|urological agents|mesh-ancestor
5886294|NCT03182751|Tranexamic Acid|tranexamic acid|mesh-list
5886295|NCT03182751|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5886296|NCT03182751|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5886297|NCT03182751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886298|NCT03182751|Hemostatics|hemostatics|mesh-ancestor
5886299|NCT03182751|Coagulants|coagulants|mesh-ancestor
5886300|NCT03113643|Azacitidine|azacitidine|mesh-list
5886301|NCT03113643|Venetoclax|venetoclax|mesh-list
5886302|NCT03113643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5886303|NCT03113643|Antimetabolites|antimetabolites|mesh-ancestor
5886304|NCT03113643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886305|NCT03113643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5886306|NCT03113643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5886307|NCT03055013|Nivolumab|nivolumab|mesh-list
5886308|NCT03055013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5886309|NCT03055013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5886310|NCT03055013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5886311|NCT03055013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886312|NCT03054519|Metformin|metformin|mesh-list
5689267|NCT03431194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5689268|NCT03431194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689269|NCT03431168|Azithromycin|azithromycin|mesh-list
5689270|NCT03431168|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
5689271|NCT03431168|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5689272|NCT03431168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5689273|NCT03431168|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5689274|NCT03431168|Renal Agents|renal agents|mesh-ancestor
5689275|NCT03431168|Antimalarials|antimalarials|mesh-ancestor
5689276|NCT03431168|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5689277|NCT03431168|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5689278|NCT03431142|Aspirin|aspirin|mesh-list
5689279|NCT03431142|Clopidogrel|clopidogrel|mesh-list
5886313|NCT03054519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5886314|NCT03054519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886315|NCT02943733|Temozolomide|temozolomide|mesh-list
5886316|NCT02943733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5689280|NCT03431142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5886317|NCT02943733|Alkylating Agents|alkylating agents|mesh-ancestor
5886318|NCT02943733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886319|NCT02943733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5886320|NCT02850263|Bevacizumab|bevacizumab|mesh-list
5886321|NCT02850263|Aflibercept|aflibercept|mesh-list
5886322|NCT02850263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5886323|NCT02850263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5886324|NCT02850263|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5689281|NCT03431142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5689282|NCT03431142|Analgesics|analgesics|mesh-ancestor
5689283|NCT03431142|Sensory System Agents|sensory system agents|mesh-ancestor
5689284|NCT03431142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5689285|NCT03431142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689286|NCT03431142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5689287|NCT03431142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5689288|NCT03431142|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5689289|NCT03431142|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5689290|NCT03431142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689291|NCT03431142|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5689292|NCT03431142|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5689293|NCT03431142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5689294|NCT03431142|Antipyretics|antipyretics|mesh-ancestor
5689295|NCT03431142|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5689296|NCT03431142|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5689297|NCT03431142|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5689298|NCT03431142|Purinergic Agents|purinergic agents|mesh-ancestor
5689299|NCT03431142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5689300|NCT03431077|Angiotensin II|angiotensin ii|mesh-list
5689301|NCT03431077|Giapreza|giapreza|mesh-list
5689302|NCT03431077|Angiotensinogen|angiotensinogen|mesh-list
5689303|NCT03431077|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5689304|NCT03431077|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5689305|NCT03431077|Protease Inhibitors|protease inhibitors|mesh-ancestor
5689306|NCT03431077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5689307|NCT03431077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689308|NCT03430947|Vemurafenib|vemurafenib|mesh-list
5886325|NCT02850263|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5886326|NCT02850263|Growth Substances|growth substances|mesh-ancestor
5886327|NCT02850263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886328|NCT02850263|Growth Inhibitors|growth inhibitors|mesh-ancestor
5886329|NCT02559856|Rivaroxaban|rivaroxaban|mesh-list
5886330|NCT02559856|Apixaban|apixaban|mesh-list
5886331|NCT02559856|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5886332|NCT02559856|Antithrombins|antithrombins|mesh-ancestor
5886333|NCT02559856|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5886334|NCT02559856|Protease Inhibitors|protease inhibitors|mesh-ancestor
5886335|NCT02559856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5886336|NCT02559856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886337|NCT02559856|Anticoagulants|anticoagulants|mesh-ancestor
5886338|NCT02450812|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
5886339|NCT02450812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5886340|NCT02427451|Venetoclax|venetoclax|mesh-list
5886341|NCT02427451|Obinutuzumab|obinutuzumab|mesh-list
5886342|NCT02427451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5886343|NCT02427451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5886344|NCT02398526|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
5886345|NCT02398526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5886346|NCT02398240|Rituximab|rituximab|mesh-list
5886347|NCT02398240|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5886348|NCT02398240|Doxorubicin|doxorubicin|mesh-list
5886349|NCT02398240|Vincristine|vincristine|mesh-list
5886350|NCT02398240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5886351|NCT02398240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5886352|NCT02398240|Immunologic Factors|immunologic factors|mesh-ancestor
5886353|NCT02398240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886354|NCT02398240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5886355|NCT02398240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5886356|NCT02398240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5886357|NCT02398240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5886358|NCT02398240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5886359|NCT02398240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886360|NCT02398240|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5886361|NCT02398240|Tubulin Modulators|tubulin modulators|mesh-ancestor
5886362|NCT02398240|Antimitotic Agents|antimitotic agents|mesh-ancestor
5886363|NCT02398240|Mitosis Modulators|mitosis modulators|mesh-ancestor
5886364|NCT02330562|Bevacizumab|bevacizumab|mesh-list
5886365|NCT02330562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5886366|NCT02330562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5886367|NCT02330562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5886368|NCT02330562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5886369|NCT02330562|Growth Substances|growth substances|mesh-ancestor
5886370|NCT02330562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886371|NCT02330562|Growth Inhibitors|growth inhibitors|mesh-ancestor
5886372|NCT05106517|Zoledronic Acid|zoledronic acid|mesh-list
5886373|NCT05106517|Denosumab|denosumab|mesh-list
5689309|NCT03430947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5689310|NCT03430947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5689311|NCT03430947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5689312|NCT03430947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689313|NCT03430882|Paclitaxel|paclitaxel|mesh-list
5689314|NCT03430882|Carboplatin|carboplatin|mesh-list
5689315|NCT03430882|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5689316|NCT03430882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5689317|NCT03430882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5689318|NCT03430882|Tubulin Modulators|tubulin modulators|mesh-ancestor
5689319|NCT03430882|Antimitotic Agents|antimitotic agents|mesh-ancestor
5689320|NCT03430882|Mitosis Modulators|mitosis modulators|mesh-ancestor
5689321|NCT03430882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689322|NCT03430817|Amantadine|amantadine|mesh-list
5689323|NCT03430817|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
5689324|NCT03430817|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5689325|NCT03430817|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5689326|NCT03430817|Antiviral Agents|antiviral agents|mesh-ancestor
5689327|NCT03430817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5689328|NCT03430817|Dopamine Agents|dopamine agents|mesh-ancestor
5689329|NCT03430817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5689330|NCT03430817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689331|NCT03430817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689332|NCT03430817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5689333|NCT03430817|Analgesics|analgesics|mesh-ancestor
5689334|NCT03430817|Sensory System Agents|sensory system agents|mesh-ancestor
5689335|NCT03430817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5689336|NCT03430817|Nootropic Agents|nootropic agents|mesh-ancestor
5689337|NCT03430700|Pembrolizumab|pembrolizumab|mesh-list
5689338|NCT03430700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5689339|NCT03430700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5697503|NCT03375593|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5886374|NCT05106517|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5886375|NCT05106517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886376|NCT05106400|Lidocaine|lidocaine|mesh-list
5886377|NCT05106400|Menthol|menthol|mesh-list
5886378|NCT05106400|Anesthetics, Local|anesthetics, local|mesh-ancestor
5886379|NCT05106400|Anesthetics|anesthetics|mesh-ancestor
5886380|NCT05106400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5886381|NCT05106400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886382|NCT05106400|Sensory System Agents|sensory system agents|mesh-ancestor
5886383|NCT05106400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5886384|NCT05106400|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5886385|NCT05106400|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5886386|NCT05106400|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6496187|NCT00626977|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6496188|NCT00626977|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6496189|NCT00626977|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6496190|NCT00626977|Adrenergic Agents|adrenergic agents|mesh-ancestor
6496191|NCT00626977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6496192|NCT00626977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496193|NCT00626990|Temozolomide|temozolomide|mesh-list
6496194|NCT00626990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6496195|NCT00626990|Alkylating Agents|alkylating agents|mesh-ancestor
6496196|NCT00626990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886387|NCT05106400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5886388|NCT05106400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886389|NCT05106400|Antipruritics|antipruritics|mesh-ancestor
5886390|NCT05106400|Dermatologic Agents|dermatologic agents|mesh-ancestor
5886391|NCT05106296|Cyclophosphamide|cyclophosphamide|mesh-list
5886392|NCT05106296|Etoposide|etoposide|mesh-list
5886393|NCT05106296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5886394|NCT05106296|Immunologic Factors|immunologic factors|mesh-ancestor
5886395|NCT05106296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886396|NCT05106296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5886397|NCT05106296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5886398|NCT05106296|Alkylating Agents|alkylating agents|mesh-ancestor
5886399|NCT05106296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886400|NCT05106296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5886401|NCT05106296|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5886402|NCT05106296|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5886403|NCT05106296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5886404|NCT05106296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5886405|NCT05106296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5886406|NCT05106179|Propranolol|propranolol|mesh-list
5886407|NCT05106179|Atenolol|atenolol|mesh-list
5886408|NCT05106179|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5886409|NCT05106179|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5886410|NCT05106179|Adrenergic Agents|adrenergic agents|mesh-ancestor
5886411|NCT05106179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5689340|NCT03430687|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
5689341|NCT03430687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5689342|NCT03430687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5689343|NCT03430661|Clopidogrel|clopidogrel|mesh-list
5689344|NCT03430661|Ticagrelor|ticagrelor|mesh-list
5689345|NCT03430661|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
5886412|NCT05106179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886413|NCT05106179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689346|NCT03430661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5689347|NCT03430661|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5689348|NCT03430661|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5886414|NCT05106179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5886415|NCT05106179|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5886416|NCT05106179|Vasodilator Agents|vasodilator agents|mesh-ancestor
5886417|NCT05106179|Sympatholytics|sympatholytics|mesh-ancestor
5886418|NCT05106179|Autonomic Agents|autonomic agents|mesh-ancestor
5886419|NCT05106179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5886420|NCT05106179|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5886421|NCT05106127|Pembrolizumab|pembrolizumab|mesh-list
5886422|NCT05106127|Lenvatinib|lenvatinib|mesh-list
5886423|NCT05106127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5886424|NCT05106127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5886425|NCT05106127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5886426|NCT05106127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5886427|NCT05106127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886428|NCT05106023|Temozolomide|temozolomide|mesh-list
5689349|NCT03430661|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5689350|NCT03430661|Purinergic Agents|purinergic agents|mesh-ancestor
5689351|NCT03430661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5689352|NCT03430661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689353|NCT03430661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886429|NCT05106023|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5886430|NCT05106023|Alkylating Agents|alkylating agents|mesh-ancestor
5886431|NCT05106023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886432|NCT05106023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5886433|NCT05105997|Dexamethasone|dexamethasone|mesh-list
5886434|NCT05105997|Bupivacaine|bupivacaine|mesh-list
5886435|NCT05105997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5886436|NCT05105997|Antiemetics|antiemetics|mesh-ancestor
5886437|NCT05105997|Autonomic Agents|autonomic agents|mesh-ancestor
5689354|NCT03430609|Hormones|hormones|mesh-list
5689355|NCT03430609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5689356|NCT03430609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689357|NCT03430596|Pramipexole|pramipexole|mesh-list
5689358|NCT03430596|Trihexyphenidyl|trihexyphenidyl|mesh-list
5689359|NCT03430596|Antioxidants|antioxidants|mesh-ancestor
5689360|NCT03430596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689361|NCT03430596|Protective Agents|protective agents|mesh-ancestor
5689362|NCT03430596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689363|NCT03430596|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5689364|NCT03430596|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5689365|NCT03430596|Dopamine Agonists|dopamine agonists|mesh-ancestor
5689366|NCT03430596|Dopamine Agents|dopamine agents|mesh-ancestor
5689367|NCT03430596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5689368|NCT03430596|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5689369|NCT03430596|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5689370|NCT03430596|Cholinergic Agents|cholinergic agents|mesh-ancestor
5689371|NCT03430544|Cariprazine|cariprazine|mesh-list
5886438|NCT05105997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5886439|NCT05105997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886440|NCT05105997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5886441|NCT05105997|Glucocorticoids|glucocorticoids|mesh-ancestor
5886442|NCT05105997|Hormones|hormones|mesh-ancestor
5886443|NCT05105997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5886444|NCT05105997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5886445|NCT05105997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5886446|NCT05105997|Anesthetics, Local|anesthetics, local|mesh-ancestor
5886447|NCT05105997|Anesthetics|anesthetics|mesh-ancestor
5886448|NCT05105997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5886449|NCT05105997|Sensory System Agents|sensory system agents|mesh-ancestor
5886450|NCT05105698|Dapagliflozin|dapagliflozin|mesh-list
5689372|NCT03430544|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5689373|NCT03430544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5689374|NCT03430544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5689375|NCT03430544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689376|NCT03430544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5689377|NCT03430531|Lidocaine|lidocaine|mesh-list
5689378|NCT03430531|Anesthetics, Local|anesthetics, local|mesh-ancestor
5689379|NCT03430531|Anesthetics|anesthetics|mesh-ancestor
5689380|NCT03430531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5689381|NCT03430531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886451|NCT05105698|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
5886452|NCT05105698|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
5886453|NCT05105698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886454|NCT05105698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5886455|NCT05105698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886456|NCT05105698|Protease Inhibitors|protease inhibitors|mesh-ancestor
5886457|NCT05105698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5906905|NCT05124067|Protease Inhibitors|protease inhibitors|mesh-ancestor
5906906|NCT05124067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5906907|NCT05124067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906908|NCT05124067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5906909|NCT05124067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5906910|NCT05124067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5906911|NCT05124067|Analgesics|analgesics|mesh-ancestor
5906912|NCT05124067|Sensory System Agents|sensory system agents|mesh-ancestor
5906913|NCT05124067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5906914|NCT05124067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5906915|NCT05124067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5906916|NCT05124067|Adrenergic Agents|adrenergic agents|mesh-ancestor
5906917|NCT05124067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5906918|NCT05124067|Antipruritics|antipruritics|mesh-ancestor
5906919|NCT05124067|Dermatologic Agents|dermatologic agents|mesh-ancestor
5906920|NCT05124067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5906921|NCT05124067|Serotonin Agents|serotonin agents|mesh-ancestor
5906922|NCT05124067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5906923|NCT05124067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5906924|NCT05124067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5906925|NCT05124067|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5906926|NCT05108974|Choline|choline|mesh-list
5906927|NCT05108974|Lipotropic Agents|lipotropic agents|mesh-ancestor
5906928|NCT05108974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5906929|NCT05108974|Antimetabolites|antimetabolites|mesh-ancestor
5906930|NCT05108974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906931|NCT05108974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5906932|NCT05108974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5906933|NCT05108974|Nootropic Agents|nootropic agents|mesh-ancestor
5906934|NCT05105139|Triclosan|triclosan|mesh-list
5906935|NCT05105139|Coal Tar|coal tar|mesh-list
5906936|NCT05105139|Allantoin|allantoin|mesh-list
5906937|NCT05105139|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5906938|NCT05105139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5906939|NCT05105139|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5906940|NCT05105139|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5906941|NCT05105139|Antimetabolites|antimetabolites|mesh-ancestor
5906942|NCT05105139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906943|NCT05105139|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5906944|NCT05105139|Keratolytic Agents|keratolytic agents|mesh-ancestor
5906945|NCT05105139|Dermatologic Agents|dermatologic agents|mesh-ancestor
5906946|NCT05103215|Lidocaine|lidocaine|mesh-list
5906947|NCT05103215|Anesthetics, Local|anesthetics, local|mesh-ancestor
5906948|NCT05103215|Anesthetics|anesthetics|mesh-ancestor
5906949|NCT05103215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5886458|NCT05105412|Gemcitabine|gemcitabine|mesh-list
5886459|NCT05105412|Lenalidomide|lenalidomide|mesh-list
5886460|NCT05105412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5886461|NCT05105412|Antimetabolites|antimetabolites|mesh-ancestor
5886462|NCT05105412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886463|NCT05105412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5886464|NCT05105412|Antiviral Agents|antiviral agents|mesh-ancestor
5886465|NCT05105412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5886466|NCT05105412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5886467|NCT05105412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5886468|NCT05105412|Immunologic Factors|immunologic factors|mesh-ancestor
5886469|NCT05105412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886470|NCT05105412|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5886471|NCT05105412|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5886472|NCT05105412|Growth Substances|growth substances|mesh-ancestor
5886473|NCT05105412|Growth Inhibitors|growth inhibitors|mesh-ancestor
5886474|NCT05105347|Prednisone|prednisone|mesh-list
5886475|NCT05105347|Adalimumab|adalimumab|mesh-list
5886476|NCT05105347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5886477|NCT05105347|Glucocorticoids|glucocorticoids|mesh-ancestor
5886478|NCT05105347|Hormones|hormones|mesh-ancestor
5886479|NCT05105347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5886480|NCT05105347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886481|NCT05105347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5886482|NCT05105347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5886483|NCT05105347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5886484|NCT05105256|Prednisolone|prednisolone|mesh-list
5886485|NCT05105256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5886486|NCT05105256|Glucocorticoids|glucocorticoids|mesh-ancestor
5886487|NCT05105256|Hormones|hormones|mesh-ancestor
5886488|NCT05105256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5886489|NCT05105256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886490|NCT05105256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5886491|NCT05105256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5886492|NCT05105074|Morphine|morphine|mesh-list
5886493|NCT05105074|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5886494|NCT05105074|Narcotics|narcotics|mesh-ancestor
5886495|NCT05105074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5886496|NCT05105074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886497|NCT05105074|Analgesics|analgesics|mesh-ancestor
5886498|NCT05105074|Sensory System Agents|sensory system agents|mesh-ancestor
5886499|NCT05105074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5886500|NCT05105035|Meropenem|meropenem|mesh-list
5886501|NCT05105035|Ceftazidime|ceftazidime|mesh-list
5886502|NCT05105035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5886503|NCT05105035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5886504|NCT05105022|Propofol|propofol|mesh-list
5886505|NCT05105022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5886506|NCT05105022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5886507|NCT05105022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886508|NCT05105022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5886509|NCT05105022|Anesthetics, General|anesthetics, general|mesh-ancestor
5886510|NCT05105022|Anesthetics|anesthetics|mesh-ancestor
5886511|NCT05105009|Furosemide|furosemide|mesh-list
5886512|NCT05105009|Diuretics|diuretics|mesh-ancestor
5689382|NCT03430531|Sensory System Agents|sensory system agents|mesh-ancestor
5689383|NCT03430531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5689384|NCT03430531|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5689385|NCT03430531|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5689386|NCT03430531|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5689387|NCT03430531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5689388|NCT03430531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689389|NCT03430518|Durvalumab|durvalumab|mesh-list
5689390|NCT03430518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5689391|NCT03430518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5689392|NCT03430505|Albuterol|albuterol|mesh-list
5689393|NCT03430505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5689394|NCT03430505|Autonomic Agents|autonomic agents|mesh-ancestor
5689395|NCT03430505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5689396|NCT03430505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689397|NCT03430505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5689398|NCT03430505|Respiratory System Agents|respiratory system agents|mesh-ancestor
5886513|NCT05105009|Natriuretic Agents|natriuretic agents|mesh-ancestor
5886514|NCT05105009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886515|NCT05105009|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5886516|NCT05105009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5886517|NCT05105009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886518|NCT05104931|Piroxicam|piroxicam|mesh-list
5886519|NCT05104931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5886520|NCT05104931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5886521|NCT05104931|Analgesics|analgesics|mesh-ancestor
5886522|NCT05104931|Sensory System Agents|sensory system agents|mesh-ancestor
5886523|NCT05104931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5886524|NCT05104931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886525|NCT05104931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5886526|NCT05104931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5886527|NCT05104931|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5886528|NCT05104931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5886529|NCT05104931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886530|NCT05104788|Carboplatin|carboplatin|mesh-list
5886531|NCT05104788|Pemetrexed|pemetrexed|mesh-list
5886532|NCT05104788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5886533|NCT05104788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5886534|NCT05104788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886535|NCT05104788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5886536|NCT05104788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5886537|NCT05104762|Immunoglobulins|immunoglobulins|mesh-list
5886538|NCT05104762|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5689399|NCT03430505|Tocolytic Agents|tocolytic agents|mesh-ancestor
5689400|NCT03430505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5689401|NCT03430505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5689402|NCT03430505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5689403|NCT03430505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5689404|NCT03430505|Adrenergic Agents|adrenergic agents|mesh-ancestor
5689405|NCT03430505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5689406|NCT03430505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689407|NCT03430466|Fulvestrant|fulvestrant|mesh-list
5689408|NCT03430466|Tremelimumab|tremelimumab|mesh-list
5689409|NCT03430466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5689410|NCT03430466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5886539|NCT05104762|Antibodies|antibodies|mesh-list
5886540|NCT05104762|gamma-Globulins|gamma-globulins|mesh-list
5886541|NCT05104762|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5886542|NCT05104762|Immunologic Factors|immunologic factors|mesh-ancestor
5886543|NCT05104762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886544|NCT05104437|Vaccines|vaccines|mesh-list
5886545|NCT05104437|Immunologic Factors|immunologic factors|mesh-ancestor
5886546|NCT05104437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886547|NCT05104424|Insulin Aspart|insulin aspart|mesh-list
5886548|NCT05104424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5886549|NCT05104424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689411|NCT03430466|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5689412|NCT03430466|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5689413|NCT03430466|Hormone Antagonists|hormone antagonists|mesh-ancestor
5689414|NCT03430466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5689415|NCT03430466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689416|NCT03430362|Scopolamine|scopolamine|mesh-list
5689417|NCT03430362|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
5689418|NCT03430362|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5689419|NCT03430362|Antiemetics|antiemetics|mesh-ancestor
5689420|NCT03430362|Autonomic Agents|autonomic agents|mesh-ancestor
5886550|NCT05104333|Vaccines|vaccines|mesh-list
5886551|NCT05104333|Immunologic Factors|immunologic factors|mesh-ancestor
5886552|NCT05104333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886553|NCT05104281|Osimertinib|osimertinib|mesh-list
5886554|NCT05104281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5886555|NCT05104281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5886556|NCT05104281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5886557|NCT05104281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886558|NCT05087732|Lidocaine|lidocaine|mesh-list
5886559|NCT05087732|Anesthetics, Local|anesthetics, local|mesh-ancestor
5886560|NCT05087732|Anesthetics|anesthetics|mesh-ancestor
5886561|NCT05087732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5886562|NCT05087732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886563|NCT05087732|Sensory System Agents|sensory system agents|mesh-ancestor
5886564|NCT05087732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5886565|NCT05087732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5886566|NCT05087732|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5886567|NCT05087732|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5689421|NCT03430362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5689422|NCT03430362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689423|NCT03430362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5689424|NCT03430362|Mydriatics|mydriatics|mesh-ancestor
5689425|NCT03430362|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5689426|NCT03430362|Cholinergic Agents|cholinergic agents|mesh-ancestor
5689427|NCT03430362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5886568|NCT05087732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5886569|NCT05087732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886570|NCT05076786|Carboplatin|carboplatin|mesh-list
5886571|NCT05076786|Etoposide|etoposide|mesh-list
5886572|NCT05076786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5886573|NCT05076786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5886574|NCT05076786|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5886575|NCT05076786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5886576|NCT05076786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5886577|NCT05076786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886578|NCT05068752|Sorafenib|sorafenib|mesh-list
5689428|NCT03430362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689429|NCT03430362|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5689430|NCT03430362|Parasympatholytics|parasympatholytics|mesh-ancestor
5689431|NCT03430297|Dacarbazine|dacarbazine|mesh-list
5689432|NCT03430297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5689433|NCT03430297|Alkylating Agents|alkylating agents|mesh-ancestor
5689434|NCT03430297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689435|NCT03430297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5689436|NCT03430219|Calcium|calcium|mesh-list
5689437|NCT03430219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5689438|NCT03430219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689439|NCT03430180|Naloxone|naloxone|mesh-list
5886579|NCT05068752|Vemurafenib|vemurafenib|mesh-list
5886580|NCT05068752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5886581|NCT05068752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5886582|NCT05068752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5886583|NCT05068752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886584|NCT05045183|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6675525|NCT01575925|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6675526|NCT01575925|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6675527|NCT01575925|Growth Substances|growth substances|mesh-ancestor
6675528|NCT01575925|Growth Inhibitors|growth inhibitors|mesh-ancestor
5886585|NCT05045183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
5886586|NCT05045183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5886587|NCT05023967|Metformin|metformin|mesh-list
5886588|NCT05023967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5886589|NCT05023967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886590|NCT05012735|Pantothenic Acid|pantothenic acid|mesh-list
5886591|NCT05012735|Provitamins|provitamins|mesh-list
5886592|NCT05012735|Vitamins|vitamins|mesh-ancestor
5689440|NCT03430180|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5689441|NCT03430180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689442|NCT03430180|Sensory System Agents|sensory system agents|mesh-ancestor
5689443|NCT03430180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5689444|NCT03430024|Estrogens|estrogens|mesh-list
5689445|NCT03430024|Hormones|hormones|mesh-ancestor
5689446|NCT03430024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5689447|NCT03430024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689448|NCT03430011|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5689449|NCT03430011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5689450|NCT03429998|Evolocumab|evolocumab|mesh-list
5689451|NCT03429998|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5689452|NCT03429998|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5689453|NCT03429998|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5689454|NCT03429998|Antimetabolites|antimetabolites|mesh-ancestor
5689455|NCT03429998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689456|NCT03429998|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5689457|NCT03429998|Immunologic Factors|immunologic factors|mesh-ancestor
5689458|NCT03429998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689459|NCT03429972|Paclitaxel|paclitaxel|mesh-list
5689460|NCT03429972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5689461|NCT03429972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5689462|NCT03429972|Tubulin Modulators|tubulin modulators|mesh-ancestor
5689463|NCT03429972|Antimitotic Agents|antimitotic agents|mesh-ancestor
5689464|NCT03429972|Mitosis Modulators|mitosis modulators|mesh-ancestor
5697504|NCT03375593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5886593|NCT05012735|Micronutrients|micronutrients|mesh-ancestor
5886594|NCT05012735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886595|NCT05012735|Vitamin B Complex|vitamin b complex|mesh-ancestor
5886596|NCT04999215|Choline|choline|mesh-list
5886597|NCT04999215|Lipotropic Agents|lipotropic agents|mesh-ancestor
5886598|NCT04999215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5886599|NCT04999215|Antimetabolites|antimetabolites|mesh-ancestor
6675529|NCT01575925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6675530|NCT01575925|Leprostatic Agents|leprostatic agents|mesh-ancestor
6675531|NCT01575925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6675532|NCT01575925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6675533|NCT01576029|Docetaxel|docetaxel|mesh-list
5886600|NCT04999215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886601|NCT04999215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5886602|NCT04999215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5886603|NCT04999215|Nootropic Agents|nootropic agents|mesh-ancestor
5886604|NCT04978428|Cannabidiol|cannabidiol|mesh-list
5886605|NCT04978428|Anticonvulsants|anticonvulsants|mesh-ancestor
5906950|NCT05103215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906951|NCT05103215|Sensory System Agents|sensory system agents|mesh-ancestor
5906952|NCT05103215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5906953|NCT05103215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5906954|NCT05103215|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5906955|NCT05103215|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5906956|NCT05103215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5906957|NCT05103215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906958|NCT05042700|Melatonin|melatonin|mesh-list
5906959|NCT05042700|Antioxidants|antioxidants|mesh-ancestor
5906960|NCT05042700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906961|NCT05042700|Protective Agents|protective agents|mesh-ancestor
5906962|NCT05042700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906963|NCT05042700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5906964|NCT05035862|Interferons|interferons|mesh-list
5906965|NCT05035862|Interferon-gamma|interferon-gamma|mesh-list
5906966|NCT05035862|Prednisone|prednisone|mesh-list
5906967|NCT05035862|Albuterol|albuterol|mesh-list
5906968|NCT05035862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5906969|NCT05035862|Glucocorticoids|glucocorticoids|mesh-ancestor
5906970|NCT05035862|Hormones|hormones|mesh-ancestor
5906971|NCT05035862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5906972|NCT05035862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906973|NCT05035862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5906974|NCT05035862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5906975|NCT05035862|Antiviral Agents|antiviral agents|mesh-ancestor
5906976|NCT05035862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5906977|NCT05035862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5906978|NCT05035862|Autonomic Agents|autonomic agents|mesh-ancestor
5906979|NCT05035862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5906980|NCT05035862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5906981|NCT05035862|Respiratory System Agents|respiratory system agents|mesh-ancestor
5906982|NCT05035862|Tocolytic Agents|tocolytic agents|mesh-ancestor
5906983|NCT05035862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5906984|NCT05035862|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5906985|NCT05035862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5906986|NCT05035862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5906987|NCT05035862|Adrenergic Agents|adrenergic agents|mesh-ancestor
5906988|NCT05035862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5906989|NCT05035862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5906990|NCT05033483|Ferrous fumarate|ferrous fumarate|mesh-list
5906991|NCT05033483|Trace Elements|trace elements|mesh-ancestor
5906992|NCT05033483|Micronutrients|micronutrients|mesh-ancestor
5906993|NCT05033483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5906994|NCT05015608|Carboplatin|carboplatin|mesh-list
5906995|NCT05015608|Pemetrexed|pemetrexed|mesh-list
5906996|NCT05015608|Osimertinib|osimertinib|mesh-list
5906997|NCT05015608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5906998|NCT05015608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5906999|NCT05015608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907000|NCT05015608|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5907001|NCT05015608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5907002|NCT05015608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5907003|NCT05001815|Insulin|insulin|mesh-list
5907004|NCT05001815|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5907005|NCT05001815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5907006|NCT05001815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675534|NCT01576029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5886606|NCT04941443|Ibuprofen|ibuprofen|mesh-list
5886607|NCT04941443|Methadone|methadone|mesh-list
5886608|NCT04941443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5886609|NCT04941443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5886610|NCT04941443|Analgesics|analgesics|mesh-ancestor
5886611|NCT04941443|Sensory System Agents|sensory system agents|mesh-ancestor
5886612|NCT04941443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5886613|NCT04941443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886614|NCT04941443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5886615|NCT04941443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5886616|NCT04941443|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5886617|NCT04941443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5886618|NCT04941443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886619|NCT04941443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5886620|NCT04941443|Narcotics|narcotics|mesh-ancestor
5886621|NCT04941443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5886622|NCT04941443|Antitussive Agents|antitussive agents|mesh-ancestor
5886623|NCT04941443|Respiratory System Agents|respiratory system agents|mesh-ancestor
5886624|NCT04925986|Pembrolizumab|pembrolizumab|mesh-list
5886625|NCT04925986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5886626|NCT04925986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5886627|NCT04893382|Plasma-lyte 148|plasma-lyte 148|mesh-list
5886628|NCT04893382|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5689465|NCT03429972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689466|NCT03429946|Hypoglycemic Agents|hypoglycemic agents|mesh-list
5689467|NCT03429946|Spironolactone|spironolactone|mesh-list
5689468|NCT03429946|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5689469|NCT03429946|Hormone Antagonists|hormone antagonists|mesh-ancestor
5689470|NCT03429946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5689471|NCT03429946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689472|NCT03429946|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5689473|NCT03429946|Diuretics|diuretics|mesh-ancestor
5689474|NCT03429946|Natriuretic Agents|natriuretic agents|mesh-ancestor
5689475|NCT03429738|Ibuprofen|ibuprofen|mesh-list
5689476|NCT03429738|Pseudoephedrine|pseudoephedrine|mesh-list
5886629|NCT04893382|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5886630|NCT04893148|Insulin Glargine|insulin glargine|mesh-list
5886631|NCT04893148|Dulaglutide|dulaglutide|mesh-list
5886632|NCT04893148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5886633|NCT04893148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886634|NCT04884763|Erenumab|erenumab|mesh-list
5886635|NCT04884763|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
5886636|NCT04884763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886637|NCT04884763|Analgesics|analgesics|mesh-ancestor
5886638|NCT04884763|Sensory System Agents|sensory system agents|mesh-ancestor
5886639|NCT04884763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5886640|NCT04884763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886641|NCT04847596|Ofatumumab|ofatumumab|mesh-list
5886642|NCT04847596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5886643|NCT04813016|Dexmedetomidine|dexmedetomidine|mesh-list
5886644|NCT04813016|Tramadol|tramadol|mesh-list
5886645|NCT04813016|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5886646|NCT04813016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5886647|NCT04813016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886648|NCT04813016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5886649|NCT04813016|Analgesics|analgesics|mesh-ancestor
5886650|NCT04813016|Sensory System Agents|sensory system agents|mesh-ancestor
5886651|NCT04813016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5886652|NCT04813016|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5886653|NCT04813016|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5886654|NCT04813016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5886655|NCT04813016|Adrenergic Agents|adrenergic agents|mesh-ancestor
5886656|NCT04813016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5886657|NCT04813016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886658|NCT04813016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5886659|NCT04813016|Narcotics|narcotics|mesh-ancestor
5886660|NCT04798781|Pembrolizumab|pembrolizumab|mesh-list
5886661|NCT04798781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5886662|NCT04798781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5886663|NCT04787250|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5886664|NCT04787250|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5886665|NCT04787250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5886666|NCT04787250|Antitubercular Agents|antitubercular agents|mesh-ancestor
5886667|NCT04777422|Defibrotide|defibrotide|mesh-list
5689477|NCT03429738|Ephedrine|ephedrine|mesh-list
5689478|NCT03429738|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5689479|NCT03429738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5689480|NCT03429738|Analgesics|analgesics|mesh-ancestor
5689481|NCT03429738|Sensory System Agents|sensory system agents|mesh-ancestor
5689482|NCT03429738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5689483|NCT03429738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689484|NCT03429738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5689485|NCT03429738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5689486|NCT03429738|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5689487|NCT03429738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5689488|NCT03429738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689489|NCT03429738|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5689490|NCT03429738|Autonomic Agents|autonomic agents|mesh-ancestor
5689491|NCT03429738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5886668|NCT04777422|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5886669|NCT04777422|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5886670|NCT04777422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886671|NCT04777422|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5886672|NCT04746924|Pembrolizumab|pembrolizumab|mesh-list
5886673|NCT04746924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5886674|NCT04746924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5886675|NCT04699123|Pembrolizumab|pembrolizumab|mesh-list
5886676|NCT04699123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5886677|NCT04699123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5886678|NCT04681105|Acetaminophen|acetaminophen|mesh-list
5886679|NCT04681105|Diphenhydramine|diphenhydramine|mesh-list
5886680|NCT04681105|Promethazine|promethazine|mesh-list
5886681|NCT04681105|Dexamethasone|dexamethasone|mesh-list
5886682|NCT04681105|Dexamethasone acetate|dexamethasone acetate|mesh-list
5886683|NCT04681105|Ibuprofen|ibuprofen|mesh-list
5886684|NCT04681105|Ranitidine|ranitidine|mesh-list
5886685|NCT04681105|Antibodies|antibodies|mesh-list
5886686|NCT04681105|Immunoglobulins|immunoglobulins|mesh-list
5886687|NCT04681105|Antibodies, Bispecific|antibodies, bispecific|mesh-list
5886688|NCT04681105|BB 1101|bb 1101|mesh-list
5886689|NCT04681105|Immunologic Factors|immunologic factors|mesh-ancestor
5886690|NCT04681105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886691|NCT04681105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5886692|NCT04681105|Antiemetics|antiemetics|mesh-ancestor
5886693|NCT04681105|Autonomic Agents|autonomic agents|mesh-ancestor
5886694|NCT04681105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5886695|NCT04681105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5886696|NCT04681105|Glucocorticoids|glucocorticoids|mesh-ancestor
5886697|NCT04681105|Hormones|hormones|mesh-ancestor
5886698|NCT04681105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5886699|NCT04681105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5886700|NCT04681105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5886701|NCT04681105|Protease Inhibitors|protease inhibitors|mesh-ancestor
5886702|NCT04681105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5886703|NCT04681105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886704|NCT04681105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5886705|NCT04681105|Analgesics|analgesics|mesh-ancestor
5886706|NCT04681105|Sensory System Agents|sensory system agents|mesh-ancestor
5886707|NCT04681105|Antipyretics|antipyretics|mesh-ancestor
5886708|NCT04681105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5886709|NCT04681105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5886710|NCT04681105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5886711|NCT04681105|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5886712|NCT04681105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5886713|NCT04681105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5886714|NCT04681105|Anesthetics, Local|anesthetics, local|mesh-ancestor
5886715|NCT04681105|Anesthetics|anesthetics|mesh-ancestor
5886716|NCT04681105|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5886717|NCT04681105|Histamine Antagonists|histamine antagonists|mesh-ancestor
5886718|NCT04681105|Histamine Agents|histamine agents|mesh-ancestor
5886719|NCT04681105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5886720|NCT04681105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5886721|NCT04681105|Antipruritics|antipruritics|mesh-ancestor
5886722|NCT04681105|Dermatologic Agents|dermatologic agents|mesh-ancestor
5886723|NCT04681105|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5886724|NCT04681105|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5886725|NCT04663347|Gemcitabine|gemcitabine|mesh-list
5886726|NCT04663347|Cytarabine|cytarabine|mesh-list
5886727|NCT04663347|Dexamethasone|dexamethasone|mesh-list
5886728|NCT04663347|Prednisone|prednisone|mesh-list
5886729|NCT04663347|Cyclophosphamide|cyclophosphamide|mesh-list
5886730|NCT04663347|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5886731|NCT04663347|Rituximab|rituximab|mesh-list
5886732|NCT04663347|Carboplatin|carboplatin|mesh-list
5886733|NCT04663347|Doxorubicin|doxorubicin|mesh-list
5886734|NCT04663347|Oxaliplatin|oxaliplatin|mesh-list
5886735|NCT04663347|Vincristine|vincristine|mesh-list
5886736|NCT04663347|Lenalidomide|lenalidomide|mesh-list
5886737|NCT04663347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5886738|NCT04663347|Immunologic Factors|immunologic factors|mesh-ancestor
5886739|NCT04663347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886740|NCT04663347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5886741|NCT04663347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5886742|NCT04663347|Alkylating Agents|alkylating agents|mesh-ancestor
5886743|NCT04663347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886744|NCT04663347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5886745|NCT04663347|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5886746|NCT04663347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5886747|NCT04663347|Antiemetics|antiemetics|mesh-ancestor
5886748|NCT04663347|Autonomic Agents|autonomic agents|mesh-ancestor
5886749|NCT04663347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5886750|NCT04663347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5886751|NCT04663347|Glucocorticoids|glucocorticoids|mesh-ancestor
5886752|NCT04663347|Hormones|hormones|mesh-ancestor
5886753|NCT04663347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5886754|NCT04663347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5886755|NCT04663347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5886756|NCT04663347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5886757|NCT04663347|Antimetabolites|antimetabolites|mesh-ancestor
5886758|NCT04663347|Antiviral Agents|antiviral agents|mesh-ancestor
5886759|NCT04663347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5886760|NCT04663347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5886761|NCT04663347|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5886762|NCT04663347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5886763|NCT04663347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5689492|NCT03429738|Respiratory System Agents|respiratory system agents|mesh-ancestor
5689493|NCT03429738|Nasal Decongestants|nasal decongestants|mesh-ancestor
5689494|NCT03429738|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5689495|NCT03429738|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5689496|NCT03429738|Sympathomimetics|sympathomimetics|mesh-ancestor
5689497|NCT03429738|Adrenergic Agents|adrenergic agents|mesh-ancestor
5689498|NCT03429738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5689499|NCT03429621|Simethicone|simethicone|mesh-list
5689500|NCT03429621|Antifoaming Agents|antifoaming agents|mesh-ancestor
5689501|NCT03429621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689502|NCT03429621|Emollients|emollients|mesh-ancestor
5689503|NCT03429621|Dermatologic Agents|dermatologic agents|mesh-ancestor
5689504|NCT03429439|Antiviral Agents|antiviral agents|mesh-list
5689505|NCT03429439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5689506|NCT03429400|Morphine|morphine|mesh-list
5689507|NCT03429400|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5689508|NCT03429400|Narcotics|narcotics|mesh-ancestor
5689509|NCT03429400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5689510|NCT03429400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689511|NCT03429400|Analgesics|analgesics|mesh-ancestor
5689512|NCT03429400|Sensory System Agents|sensory system agents|mesh-ancestor
5689513|NCT03429400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5689514|NCT03429309|Propofol|propofol|mesh-list
5689515|NCT03429309|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5689516|NCT03429309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5689517|NCT03429309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689518|NCT03429309|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5689519|NCT03429309|Anesthetics, General|anesthetics, general|mesh-ancestor
5689520|NCT03429309|Anesthetics|anesthetics|mesh-ancestor
5886764|NCT04663347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5886765|NCT04663347|Tubulin Modulators|tubulin modulators|mesh-ancestor
5886766|NCT04663347|Antimitotic Agents|antimitotic agents|mesh-ancestor
5886767|NCT04663347|Mitosis Modulators|mitosis modulators|mesh-ancestor
5886768|NCT04663347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5886769|NCT04663347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5886770|NCT04663347|Growth Substances|growth substances|mesh-ancestor
5886771|NCT04663347|Growth Inhibitors|growth inhibitors|mesh-ancestor
5886772|NCT04642950|Sargramostim|sargramostim|mesh-list
5886773|NCT04642950|Immunologic Factors|immunologic factors|mesh-ancestor
5689524|NCT03429179|Butorphanol|butorphanol|mesh-list
5689525|NCT03429179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6675535|NCT01576029|Tubulin Modulators|tubulin modulators|mesh-ancestor
5886774|NCT04642950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886775|NCT04593914|Protective Agents|protective agents|mesh-list
5689526|NCT03429179|Narcotics|narcotics|mesh-ancestor
5689527|NCT03429179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5689528|NCT03429179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689529|NCT03429179|Analgesics|analgesics|mesh-ancestor
5689530|NCT03429179|Sensory System Agents|sensory system agents|mesh-ancestor
5689531|NCT03429179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5689532|NCT03429179|Antitussive Agents|antitussive agents|mesh-ancestor
5689533|NCT03429179|Respiratory System Agents|respiratory system agents|mesh-ancestor
5689534|NCT03429179|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5689535|NCT03429127|Plasma-lyte 148|plasma-lyte 148|mesh-list
5689536|NCT03429127|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5689537|NCT03429127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5689538|NCT03429101|Trastuzumab|trastuzumab|mesh-list
5689539|NCT03429101|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
5689540|NCT03429101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5886776|NCT04593914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886777|NCT04578015|Metronidazole|metronidazole|mesh-list
5886778|NCT04578015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5886779|NCT04578015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5886780|NCT04578015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5886781|NCT04578015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5886782|NCT04573504|Clindamycin|clindamycin|mesh-list
5886783|NCT04573504|Clindamycin palmitate|clindamycin palmitate|mesh-list
5886784|NCT04573504|Clindamycin phosphate|clindamycin phosphate|mesh-list
5886785|NCT04573504|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5886786|NCT04573504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5886787|NCT04573504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5886788|NCT04573504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5886789|NCT04573504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5886790|NCT04573504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886791|NCT04573504|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5886792|NCT04570644|Ibuprofen|ibuprofen|mesh-list
5886793|NCT04570644|Cromolyn Sodium|cromolyn sodium|mesh-list
5886794|NCT04570644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5886795|NCT04570644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5886796|NCT04570644|Analgesics|analgesics|mesh-ancestor
5886797|NCT04570644|Sensory System Agents|sensory system agents|mesh-ancestor
5886798|NCT04570644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5886799|NCT04570644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886800|NCT04570644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5886801|NCT04570644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5886802|NCT04570644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5886803|NCT04570644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5886804|NCT04570644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886805|NCT04570644|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
5886806|NCT04570644|Immunologic Factors|immunologic factors|mesh-ancestor
5886807|NCT04570644|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5886808|NCT04570644|Respiratory System Agents|respiratory system agents|mesh-ancestor
5886809|NCT04546230|Anesthetics|anesthetics|mesh-list
5886810|NCT04546230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5886811|NCT04546230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886812|NCT04528667|Abivertinib|abivertinib|mesh-list
5886813|NCT04528667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5886814|NCT04528667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886815|NCT04528667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5886816|NCT04525014|Irinotecan|irinotecan|mesh-list
5886817|NCT04525014|Temozolomide|temozolomide|mesh-list
5886818|NCT04525014|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5886819|NCT04525014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5886820|NCT04525014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5886821|NCT04525014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886822|NCT04525014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5886823|NCT04525014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5886824|NCT04525014|Alkylating Agents|alkylating agents|mesh-ancestor
5886825|NCT04495257|Nivolumab|nivolumab|mesh-list
5886826|NCT04495257|Ipilimumab|ipilimumab|mesh-list
5886827|NCT04495257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5886828|NCT04495257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5886829|NCT04495257|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5886830|NCT04495257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886831|NCT04468776|Zolpidem|zolpidem|mesh-list
5886832|NCT04468776|Trazodone|trazodone|mesh-list
5689541|NCT03429101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5689542|NCT03429101|Tubulin Modulators|tubulin modulators|mesh-ancestor
5689543|NCT03429101|Antimitotic Agents|antimitotic agents|mesh-ancestor
5689544|NCT03429101|Mitosis Modulators|mitosis modulators|mesh-ancestor
5689545|NCT03429101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697505|NCT03375593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5697506|NCT03375593|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5697507|NCT03375593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5697508|NCT03375593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697509|NCT03375593|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5697510|NCT03375593|Narcotics|narcotics|mesh-ancestor
5697511|NCT03375593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5697512|NCT03375593|Antitussive Agents|antitussive agents|mesh-ancestor
5697513|NCT03375593|Respiratory System Agents|respiratory system agents|mesh-ancestor
5886833|NCT04468776|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5886834|NCT04468776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5886835|NCT04468776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5886836|NCT04468776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886837|NCT04468776|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
5886838|NCT04468776|GABA Agonists|gaba agonists|mesh-ancestor
5886839|NCT04468776|GABA Agents|gaba agents|mesh-ancestor
5886840|NCT04468776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5886841|NCT04468776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886842|NCT04468776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5886843|NCT04468776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5886844|NCT04468776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5886845|NCT04468776|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5886846|NCT04468776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5886847|NCT04468776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5886848|NCT04468776|Serotonin Agents|serotonin agents|mesh-ancestor
5886849|NCT04468776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5886850|NCT04468776|Antidepressive Agents|antidepressive agents|mesh-ancestor
5886851|NCT04459611|Paclitaxel|paclitaxel|mesh-list
5886852|NCT04459611|Carboplatin|carboplatin|mesh-list
5886853|NCT04459611|Pemetrexed|pemetrexed|mesh-list
5886854|NCT04459611|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5886855|NCT04459611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5886856|NCT04459611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5886857|NCT04459611|Tubulin Modulators|tubulin modulators|mesh-ancestor
5886858|NCT04459611|Antimitotic Agents|antimitotic agents|mesh-ancestor
5886859|NCT04459611|Mitosis Modulators|mitosis modulators|mesh-ancestor
5886860|NCT04459611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886861|NCT04459611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5886862|NCT04459611|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5886863|NCT04459611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5886864|NCT04440007|Abivertinib|abivertinib|mesh-list
5886865|NCT04440007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5886866|NCT04440007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886867|NCT04440007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5907007|NCT05001555|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
5907008|NCT05001555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907009|NCT05001555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5907010|NCT05001555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5907011|NCT05001555|Analgesics|analgesics|mesh-ancestor
5697514|NCT03375580|Metformin|metformin|mesh-list
5697515|NCT03375580|Simvastatin|simvastatin|mesh-list
5697516|NCT03375580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5697517|NCT03375580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697518|NCT03375580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5907012|NCT05001555|Sensory System Agents|sensory system agents|mesh-ancestor
5907013|NCT05001555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5907014|NCT05001555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5907015|NCT05001555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5907016|NCT04975555|Siltuximab|siltuximab|mesh-list
5907017|NCT04975555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5907018|NCT04968158|Acetaminophen|acetaminophen|mesh-list
5907019|NCT04968158|Etoricoxib|etoricoxib|mesh-list
5907020|NCT04968158|Tramadol|tramadol|mesh-list
5907021|NCT04968158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5907022|NCT04968158|Analgesics|analgesics|mesh-ancestor
5907023|NCT04968158|Sensory System Agents|sensory system agents|mesh-ancestor
5907024|NCT04968158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5907025|NCT04968158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697519|NCT03375580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5697520|NCT03375580|Antimetabolites|antimetabolites|mesh-ancestor
5698105|NCT03371342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5886868|NCT04434001|Thrombin|thrombin|mesh-list
5886869|NCT04434001|Hemostatics|hemostatics|mesh-ancestor
5886870|NCT04434001|Coagulants|coagulants|mesh-ancestor
5886871|NCT04426591|Biotin|biotin|mesh-list
5886872|NCT04426591|Vitamin B Complex|vitamin b complex|mesh-ancestor
5886873|NCT04426591|Vitamins|vitamins|mesh-ancestor
5886874|NCT04426591|Micronutrients|micronutrients|mesh-ancestor
5886875|NCT04426591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689546|NCT03429075|Citalopram|citalopram|mesh-list
5689547|NCT03429075|Psilocybin|psilocybin|mesh-list
5689548|NCT03429075|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5689549|NCT03429075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5689550|NCT03429075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5689551|NCT03429075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689552|NCT03429075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5689553|NCT03429075|Serotonin Agents|serotonin agents|mesh-ancestor
5689554|NCT03429075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689555|NCT03429075|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5689556|NCT03429075|Antidepressive Agents|antidepressive agents|mesh-ancestor
5689557|NCT03429075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5689558|NCT03429075|Hallucinogens|hallucinogens|mesh-ancestor
5689559|NCT03429049|Capsaicin|capsaicin|mesh-list
5689560|NCT03429049|Antipruritics|antipruritics|mesh-ancestor
5689561|NCT03429049|Dermatologic Agents|dermatologic agents|mesh-ancestor
5886880|NCT04374240|Tretazicar|tretazicar|mesh-list
5886881|NCT04374240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5886882|NCT04280328|Daratumumab|daratumumab|mesh-list
5886883|NCT04280328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5886884|NCT04239222|Ibuprofen|ibuprofen|mesh-list
5886885|NCT04239222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5886886|NCT04239222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5886887|NCT04239222|Analgesics|analgesics|mesh-ancestor
5886888|NCT04239222|Sensory System Agents|sensory system agents|mesh-ancestor
5886889|NCT04239222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5886890|NCT04239222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886891|NCT04239222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5886892|NCT04239222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5886893|NCT04239222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5886894|NCT04239222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5886895|NCT04239222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886896|NCT04230746|Trimethoprim|trimethoprim|mesh-list
5886897|NCT04230746|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
5886898|NCT04230746|Sulfamethoxazole|sulfamethoxazole|mesh-list
5886899|NCT04230746|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5886900|NCT04230746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5886901|NCT04230746|Renal Agents|renal agents|mesh-ancestor
5886902|NCT04230746|Antimalarials|antimalarials|mesh-ancestor
5886903|NCT04230746|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5886904|NCT04230746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5886905|NCT04230746|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5886906|NCT04230746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5886907|NCT04230746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886908|NCT04230746|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5886909|NCT04230746|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
5886910|NCT04230746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5886911|NCT04230746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5886912|NCT04201834|Risperidone|risperidone|mesh-list
5886913|NCT04201834|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5886914|NCT04201834|Serotonin Agents|serotonin agents|mesh-ancestor
5886915|NCT04201834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5886916|NCT04201834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886917|NCT04201834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886918|NCT04201834|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5886919|NCT04201834|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5886920|NCT04201834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5886921|NCT04201834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5886922|NCT04201834|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5886923|NCT04201834|Dopamine Agents|dopamine agents|mesh-ancestor
5886924|NCT04194775|Lenvatinib|lenvatinib|mesh-list
5886925|NCT04194775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5886926|NCT04194775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5886927|NCT04194775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5886928|NCT04194775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886929|NCT04147013|Celecoxib|celecoxib|mesh-list
5886930|NCT04147013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5886931|NCT04147013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5886932|NCT04147013|Analgesics|analgesics|mesh-ancestor
5886933|NCT04147013|Sensory System Agents|sensory system agents|mesh-ancestor
5886934|NCT04147013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5886935|NCT04147013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886936|NCT04147013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5886937|NCT04147013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5886938|NCT04147013|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5886939|NCT04147013|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5886940|NCT04147013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5886941|NCT04147013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886942|NCT04141644|Ipilimumab|ipilimumab|mesh-list
5886943|NCT04141644|Osimertinib|osimertinib|mesh-list
5689562|NCT03429049|Sensory System Agents|sensory system agents|mesh-ancestor
5689563|NCT03429049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5689564|NCT03429049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689565|NCT03429010|Anesthetics|anesthetics|mesh-list
5689566|NCT03429010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5886944|NCT04141644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5886945|NCT04141644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5886946|NCT04141644|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5886947|NCT04141644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886948|NCT04141644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5886949|NCT04141644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5886950|NCT04115384|Insulin|insulin|mesh-list
5886951|NCT04115384|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5886952|NCT04115384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5886953|NCT04115384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886954|NCT04104139|Trifluridine|trifluridine|mesh-list
5886955|NCT04104139|Antimetabolites|antimetabolites|mesh-ancestor
5886956|NCT04104139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886957|NCT04104139|Antiviral Agents|antiviral agents|mesh-ancestor
5886958|NCT04104139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5689567|NCT03429010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886959|NCT04077437|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
5886960|NCT04077437|Hallucinogens|hallucinogens|mesh-ancestor
5886961|NCT04077437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886962|NCT04077437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5886963|NCT04077437|Serotonin Agents|serotonin agents|mesh-ancestor
5886964|NCT04077437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5886965|NCT04077437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886966|NCT04077437|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5886967|NCT04077437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5886968|NCT04077437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5886969|NCT04077437|Adrenergic Agents|adrenergic agents|mesh-ancestor
5886970|NCT04058756|Spartalizumab|spartalizumab|mesh-list
5886971|NCT04058756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5886972|NCT04058756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886973|NCT04058756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5886974|NCT04025216|Cyclophosphamide|cyclophosphamide|mesh-list
5886975|NCT04025216|Fludarabine|fludarabine|mesh-list
5886976|NCT04025216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5886977|NCT04025216|Immunologic Factors|immunologic factors|mesh-ancestor
5886978|NCT04025216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886979|NCT04025216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5886980|NCT04025216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5886981|NCT04025216|Alkylating Agents|alkylating agents|mesh-ancestor
5886982|NCT04025216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5886983|NCT04025216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5886984|NCT04025216|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5886985|NCT03991741|Interleukin-2|interleukin-2|mesh-list
5886986|NCT03991741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5886987|NCT03991741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5886988|NCT03991741|Analgesics|analgesics|mesh-ancestor
5886989|NCT03991741|Sensory System Agents|sensory system agents|mesh-ancestor
5886990|NCT03991741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5886991|NCT03991741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5886992|NCT03903692|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
5689568|NCT03428906|Oxytocin|oxytocin|mesh-list
5689569|NCT03428906|Oxytocics|oxytocics|mesh-ancestor
5689570|NCT03428906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5886993|NCT03903692|Laxatives|laxatives|mesh-ancestor
5886994|NCT03903692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5886995|NCT03781817|Ketamine|ketamine|mesh-list
5886996|NCT03781817|Analgesics|analgesics|mesh-ancestor
5689571|NCT03428906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689572|NCT03428880|Morphine|morphine|mesh-list
5689573|NCT03428880|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5689574|NCT03428880|Narcotics|narcotics|mesh-ancestor
5689575|NCT03428880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5689576|NCT03428880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689577|NCT03428880|Analgesics|analgesics|mesh-ancestor
5689578|NCT03428880|Sensory System Agents|sensory system agents|mesh-ancestor
5689579|NCT03428880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5689580|NCT03428802|Pembrolizumab|pembrolizumab|mesh-list
5689581|NCT03428802|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5689582|NCT03428802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5689583|NCT03428685|Dydrogesterone|dydrogesterone|mesh-list
5689584|NCT03428685|Progestins|progestins|mesh-ancestor
5689585|NCT03428685|Hormones|hormones|mesh-ancestor
5689586|NCT03428685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5689587|NCT03428685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689588|NCT03428633|Morphine|morphine|mesh-list
5689589|NCT03428633|Ropivacaine|ropivacaine|mesh-list
5689590|NCT03428633|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5689591|NCT03428633|Narcotics|narcotics|mesh-ancestor
5689592|NCT03428633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5689593|NCT03428633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689594|NCT03428633|Analgesics|analgesics|mesh-ancestor
5886997|NCT03781817|Sensory System Agents|sensory system agents|mesh-ancestor
5886998|NCT03781817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5886999|NCT03781817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5887000|NCT03781817|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5887001|NCT03781817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5887002|NCT03781817|Anesthetics, General|anesthetics, general|mesh-ancestor
5887003|NCT03781817|Anesthetics|anesthetics|mesh-ancestor
5887004|NCT03781817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5887005|NCT03781817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5887006|NCT03781817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5887007|NCT03781817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5887008|NCT03781817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887009|NCT03777982|Prednisone|prednisone|mesh-list
5887010|NCT03777982|Abiraterone Acetate|abiraterone acetate|mesh-list
5887011|NCT03777982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5887012|NCT03777982|Glucocorticoids|glucocorticoids|mesh-ancestor
5887013|NCT03777982|Hormones|hormones|mesh-ancestor
5887014|NCT03777982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5887015|NCT03777982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5887016|NCT03777982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5887017|NCT03777982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5887018|NCT03777982|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5887019|NCT03777982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5887020|NCT03777982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887021|NCT03777982|Hormone Antagonists|hormone antagonists|mesh-ancestor
5887022|NCT03777982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5887023|NCT03769688|Metronidazole|metronidazole|mesh-list
5887024|NCT03769688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5887025|NCT03769688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5887026|NCT03769688|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5887027|NCT03769688|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5887028|NCT03760575|Pembrolizumab|pembrolizumab|mesh-list
5887029|NCT03760575|Pemetrexed|pemetrexed|mesh-list
5887030|NCT03760575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5887031|NCT03760575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5887032|NCT03760575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5887033|NCT03760575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887034|NCT03760575|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5887035|NCT03760575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5887036|NCT03751709|Blinatumomab|blinatumomab|mesh-list
5887037|NCT03751709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5887038|NCT03748953|Ixazomib|ixazomib|mesh-list
5887039|NCT03748953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5887040|NCT03748953|Protease Inhibitors|protease inhibitors|mesh-ancestor
5887041|NCT03748953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5689595|NCT03428633|Sensory System Agents|sensory system agents|mesh-ancestor
5887042|NCT03748953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689596|NCT03428633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5689597|NCT03428633|Anesthetics, Local|anesthetics, local|mesh-ancestor
5689598|NCT03428633|Anesthetics|anesthetics|mesh-ancestor
5689599|NCT03428607|Olaparib|olaparib|mesh-list
5689600|NCT03428607|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5689601|NCT03428607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5689602|NCT03428607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689603|NCT03428607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5689604|NCT03428568|Clarithromycin|clarithromycin|mesh-list
5689605|NCT03428568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5689606|NCT03428568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5689607|NCT03428568|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5689608|NCT03428568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5689609|NCT03428568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689610|NCT03428568|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5689611|NCT03428568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5689612|NCT03428529|Fluorouracil|fluorouracil|mesh-list
5689613|NCT03428529|Capecitabine|capecitabine|mesh-list
6496197|NCT00626990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6496198|NCT00627003|Cabergoline|cabergoline|mesh-list
6496199|NCT00627003|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6496200|NCT00627003|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6496201|NCT00627003|Dopamine Agonists|dopamine agonists|mesh-ancestor
6496202|NCT00627003|Dopamine Agents|dopamine agents|mesh-ancestor
5887043|NCT03748810|Metformin|metformin|mesh-list
5887044|NCT03748810|Dapagliflozin|dapagliflozin|mesh-list
5887045|NCT03748810|Empagliflozin|empagliflozin|mesh-list
5887046|NCT03748810|Glimepiride|glimepiride|mesh-list
5887047|NCT03748810|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
5887048|NCT03748810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5887049|NCT03748810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5887050|NCT03748810|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5887051|NCT03748810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887052|NCT03748810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5887053|NCT03748810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5887054|NCT03748810|Immunologic Factors|immunologic factors|mesh-ancestor
5887055|NCT03748810|Protease Inhibitors|protease inhibitors|mesh-ancestor
5887056|NCT03748810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5887057|NCT03726879|Paclitaxel|paclitaxel|mesh-list
5887058|NCT03726879|Maytansine|maytansine|mesh-list
5887059|NCT03726879|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
5887060|NCT03726879|Cyclophosphamide|cyclophosphamide|mesh-list
5887061|NCT03726879|Doxorubicin|doxorubicin|mesh-list
5887062|NCT03726879|Trastuzumab|trastuzumab|mesh-list
5887063|NCT03726879|Atezolizumab|atezolizumab|mesh-list
5887064|NCT03726879|Pertuzumab|pertuzumab|mesh-list
5887065|NCT03726879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5887066|NCT03726879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5887067|NCT03726879|Tubulin Modulators|tubulin modulators|mesh-ancestor
5887068|NCT03726879|Antimitotic Agents|antimitotic agents|mesh-ancestor
5887069|NCT03726879|Mitosis Modulators|mitosis modulators|mesh-ancestor
5887070|NCT03726879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887071|NCT03726879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5887072|NCT03726879|Immunologic Factors|immunologic factors|mesh-ancestor
5887073|NCT03726879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5887074|NCT03726879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5887075|NCT03726879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5887076|NCT03726879|Alkylating Agents|alkylating agents|mesh-ancestor
5887077|NCT03726879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5887078|NCT03726879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5887079|NCT03726879|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5887080|NCT03726879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5887081|NCT03726879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5887082|NCT03726879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5887083|NCT03691311|Denosumab|denosumab|mesh-list
5887084|NCT03691311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5887085|NCT03691311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5887086|NCT03690453|Ivermectin|ivermectin|mesh-list
5887087|NCT03690453|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5887088|NCT03690453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5887089|NCT03650764|Pembrolizumab|pembrolizumab|mesh-list
5887090|NCT03650764|Ramucirumab|ramucirumab|mesh-list
5887091|NCT03650764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5887092|NCT03650764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5887093|NCT03620643|Fulvestrant|fulvestrant|mesh-list
5689614|NCT03428529|Antimetabolites|antimetabolites|mesh-ancestor
5887094|NCT03620643|Crizotinib|crizotinib|mesh-list
5887095|NCT03620643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6496203|NCT00627003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5689615|NCT03428529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887096|NCT03620643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5887097|NCT03620643|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5887098|NCT03620643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5887099|NCT03620643|Hormone Antagonists|hormone antagonists|mesh-ancestor
5887100|NCT03620643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5887101|NCT03620643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5887102|NCT03620643|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5887103|NCT03620643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5887104|NCT03620643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887105|NCT03593655|Tenofovir|tenofovir|mesh-list
5689616|NCT03428529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5689617|NCT03428529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5689618|NCT03428529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5689619|NCT03428529|Immunologic Factors|immunologic factors|mesh-ancestor
5689620|NCT03428529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689621|NCT03428503|Acetaminophen|acetaminophen|mesh-list
5689622|NCT03428503|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
5689623|NCT03428503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5689624|NCT03428503|Analgesics|analgesics|mesh-ancestor
5689625|NCT03428503|Sensory System Agents|sensory system agents|mesh-ancestor
5689626|NCT03428503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5689627|NCT03428503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689628|NCT03428503|Antipyretics|antipyretics|mesh-ancestor
5689629|NCT03428503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5689630|NCT03428503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5689631|NCT03428503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5689632|NCT03428477|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
5689633|NCT03428477|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5689634|NCT03428477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5689635|NCT03428425|Paclitaxel|paclitaxel|mesh-list
5689636|NCT03428425|Apatinib|apatinib|mesh-list
5689637|NCT03428425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5689638|NCT03428425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5689639|NCT03428425|Tubulin Modulators|tubulin modulators|mesh-ancestor
5689640|NCT03428425|Antimitotic Agents|antimitotic agents|mesh-ancestor
5887106|NCT03593655|Emtricitabine|emtricitabine|mesh-list
5887107|NCT03593655|Dapivirine|dapivirine|mesh-list
5887108|NCT03593655|Antiviral Agents|antiviral agents|mesh-ancestor
5887109|NCT03593655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5887110|NCT03593655|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5887111|NCT03593655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5887112|NCT03593655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5887113|NCT03593655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887114|NCT03593655|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5887115|NCT03593655|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5887116|NCT03572413|Bromides|bromides|mesh-list
5887117|NCT03572413|Rocuronium|rocuronium|mesh-list
5887118|NCT03572413|Anticonvulsants|anticonvulsants|mesh-ancestor
5887119|NCT03572413|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5887120|NCT03572413|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5887121|NCT03572413|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5887122|NCT03572413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5887123|NCT03572413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5887124|NCT03533946|Rucaparib|rucaparib|mesh-list
5887125|NCT03533946|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5887126|NCT03533946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5887127|NCT03533946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887128|NCT03533946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5887129|NCT03500484|Liraglutide|liraglutide|mesh-list
5887130|NCT03500484|Glucagon|glucagon|mesh-list
5887131|NCT03500484|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5887132|NCT03500484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5887133|NCT03500484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5887134|NCT03500484|Incretins|incretins|mesh-ancestor
5887135|NCT03500484|Hormones|hormones|mesh-ancestor
5887136|NCT03500484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5887137|NCT03500484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5887138|NCT03496662|Gemcitabine|gemcitabine|mesh-list
5887139|NCT03496662|Paclitaxel|paclitaxel|mesh-list
5887140|NCT03496662|Nivolumab|nivolumab|mesh-list
5887141|NCT03496662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5887142|NCT03496662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6496490|NCT00628225|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5887143|NCT03496662|Tubulin Modulators|tubulin modulators|mesh-ancestor
5689641|NCT03428425|Mitosis Modulators|mitosis modulators|mesh-ancestor
5689642|NCT03428425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689643|NCT03428425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5689644|NCT03428425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5689645|NCT03428373|Aspirin|aspirin|mesh-list
5689646|NCT03428373|Rivaroxaban|rivaroxaban|mesh-list
5689647|NCT03428373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5689648|NCT03428373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5689649|NCT03428373|Analgesics|analgesics|mesh-ancestor
5689650|NCT03428373|Sensory System Agents|sensory system agents|mesh-ancestor
5689651|NCT03428373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5689652|NCT03428373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689653|NCT03428373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5689654|NCT03428373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5689655|NCT03428373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5689656|NCT03428373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5689657|NCT03428373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689658|NCT03428373|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5689659|NCT03428373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5689660|NCT03428373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5689661|NCT03428373|Antipyretics|antipyretics|mesh-ancestor
5689662|NCT03428373|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5689663|NCT03428373|Antithrombins|antithrombins|mesh-ancestor
5689664|NCT03428373|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5689665|NCT03428373|Protease Inhibitors|protease inhibitors|mesh-ancestor
5689666|NCT03428373|Anticoagulants|anticoagulants|mesh-ancestor
5689667|NCT03428282|Anesthetics|anesthetics|mesh-list
5887144|NCT03496662|Antimitotic Agents|antimitotic agents|mesh-ancestor
5887145|NCT03496662|Mitosis Modulators|mitosis modulators|mesh-ancestor
5887146|NCT03496662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887147|NCT03496662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5887148|NCT03496662|Antimetabolites|antimetabolites|mesh-ancestor
5887149|NCT03496662|Antiviral Agents|antiviral agents|mesh-ancestor
5887150|NCT03496662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5887151|NCT03496662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5887152|NCT03496662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5887153|NCT03496662|Immunologic Factors|immunologic factors|mesh-ancestor
5887154|NCT03496662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5887155|NCT03496662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5887156|NCT03496662|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5689668|NCT03428282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5689669|NCT03428282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689670|NCT03428256|Anesthetics|anesthetics|mesh-list
5689671|NCT03428256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5689672|NCT03428256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689673|NCT03428191|Dexmedetomidine|dexmedetomidine|mesh-list
5689674|NCT03428191|Remifentanil|remifentanil|mesh-list
5689675|NCT03428191|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5689676|NCT03428191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5689677|NCT03428191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689678|NCT03428191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5689679|NCT03428191|Analgesics|analgesics|mesh-ancestor
5689680|NCT03428191|Sensory System Agents|sensory system agents|mesh-ancestor
5689681|NCT03428191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5689682|NCT03428191|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5689683|NCT03428191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5689684|NCT03428191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5689685|NCT03428191|Adrenergic Agents|adrenergic agents|mesh-ancestor
5689686|NCT03428191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5689687|NCT03428191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689688|NCT03428191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5907026|NCT04968158|Antipyretics|antipyretics|mesh-ancestor
5907027|NCT04968158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5907028|NCT04968158|Narcotics|narcotics|mesh-ancestor
5907029|NCT04968158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5907030|NCT04968158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5907031|NCT04968158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5907032|NCT04968158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5907033|NCT04968158|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5907034|NCT04968158|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5907035|NCT04968158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5907036|NCT04968158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908679|NCT04278898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689689|NCT03428191|Narcotics|narcotics|mesh-ancestor
5689690|NCT03428139|Thioctic Acid|thioctic acid|mesh-list
5689691|NCT03428139|Antioxidants|antioxidants|mesh-ancestor
5887157|NCT03416244|Nivolumab|nivolumab|mesh-list
5887158|NCT03416244|Ipilimumab|ipilimumab|mesh-list
5887159|NCT03416244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5887160|NCT03416244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5887161|NCT03416244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5887162|NCT03416244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887163|NCT03386578|Tenofovir|tenofovir|mesh-list
5887164|NCT03386578|Emtricitabine|emtricitabine|mesh-list
5887165|NCT03386578|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5887166|NCT03386578|Antiviral Agents|antiviral agents|mesh-ancestor
5887167|NCT03386578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5887168|NCT03386578|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5887169|NCT03386578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5887170|NCT03386578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5887171|NCT03386578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887172|NCT03386578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5887173|NCT03386578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5887174|NCT03349281|Cytarabine|cytarabine|mesh-list
5887175|NCT03349281|Dexamethasone|dexamethasone|mesh-list
5887176|NCT03349281|Hydrocortisone|hydrocortisone|mesh-list
5887177|NCT03349281|Doxorubicin|doxorubicin|mesh-list
5887178|NCT03349281|Methotrexate|methotrexate|mesh-list
5887179|NCT03349281|Vincristine|vincristine|mesh-list
5887180|NCT03349281|Asparaginase|asparaginase|mesh-list
5887181|NCT03349281|Pegaspargase|pegaspargase|mesh-list
5887182|NCT03349281|Pevonedistat|pevonedistat|mesh-list
5887183|NCT03349281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6496204|NCT00627003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496205|NCT00627003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496206|NCT00627081|Remifentanil|remifentanil|mesh-list
6496207|NCT00627081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6496208|NCT00627081|Narcotics|narcotics|mesh-ancestor
6496209|NCT00627081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6496210|NCT00627081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496211|NCT00627081|Analgesics|analgesics|mesh-ancestor
6496212|NCT00627081|Sensory System Agents|sensory system agents|mesh-ancestor
6496213|NCT00627081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6496214|NCT00627133|Levetiracetam|levetiracetam|mesh-list
6496215|NCT00627133|Anticonvulsants|anticonvulsants|mesh-ancestor
5887184|NCT03349281|Antiemetics|antiemetics|mesh-ancestor
5887185|NCT03349281|Autonomic Agents|autonomic agents|mesh-ancestor
5887186|NCT03349281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5887187|NCT03349281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5887188|NCT03349281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5887189|NCT03349281|Glucocorticoids|glucocorticoids|mesh-ancestor
5887190|NCT03349281|Hormones|hormones|mesh-ancestor
5887191|NCT03349281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5887192|NCT03349281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5887193|NCT03349281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5887194|NCT03349281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5887195|NCT03349281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5887196|NCT03349281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5887197|NCT03349281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5887198|NCT03349281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887199|NCT03349281|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5887200|NCT03349281|Abortifacient Agents|abortifacient agents|mesh-ancestor
5887201|NCT03349281|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5887202|NCT03349281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5887203|NCT03349281|Antimetabolites|antimetabolites|mesh-ancestor
6212546|NCT02189213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6212547|NCT02189213|Serotonin Agents|serotonin agents|mesh-ancestor
6212548|NCT02189213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212549|NCT02189317|Bupivacaine|bupivacaine|mesh-list
6212550|NCT02189317|Anesthetics, Local|anesthetics, local|mesh-ancestor
6212551|NCT02189317|Anesthetics|anesthetics|mesh-ancestor
6212552|NCT02189317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5689692|NCT03428139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689693|NCT03428139|Protective Agents|protective agents|mesh-ancestor
5689694|NCT03428139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689695|NCT03428139|Vitamin B Complex|vitamin b complex|mesh-ancestor
5689696|NCT03428139|Vitamins|vitamins|mesh-ancestor
5689697|NCT03428139|Micronutrients|micronutrients|mesh-ancestor
5689705|NCT03428022|Apatinib|apatinib|mesh-list
5887204|NCT03349281|Dermatologic Agents|dermatologic agents|mesh-ancestor
5887205|NCT03349281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5887206|NCT03349281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5887207|NCT03349281|Immunologic Factors|immunologic factors|mesh-ancestor
5887208|NCT03349281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5887209|NCT03349281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5887210|NCT03349281|Antiviral Agents|antiviral agents|mesh-ancestor
5887211|NCT03349281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5887212|NCT03349281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5887213|NCT03349281|Tubulin Modulators|tubulin modulators|mesh-ancestor
5887214|NCT03349281|Antimitotic Agents|antimitotic agents|mesh-ancestor
5689706|NCT03428022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5689707|NCT03428022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5689708|NCT03428022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5689709|NCT03428022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689710|NCT03427944|Calcium Dobesilate|calcium dobesilate|mesh-list
5689711|NCT03427944|Calcium|calcium|mesh-list
5689712|NCT03427944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5689713|NCT03427944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689714|NCT03427944|Hemostatics|hemostatics|mesh-ancestor
5689715|NCT03427944|Coagulants|coagulants|mesh-ancestor
5689716|NCT03427801|Hematinics|hematinics|mesh-list
5689717|NCT03427632|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
5689718|NCT03427632|Vasodilator Agents|vasodilator agents|mesh-ancestor
5689719|NCT03427632|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
5689720|NCT03427632|Protective Agents|protective agents|mesh-ancestor
5689721|NCT03427632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689722|NCT03427554|Tretinoin|tretinoin|mesh-list
5689723|NCT03427554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5689724|NCT03427554|Keratolytic Agents|keratolytic agents|mesh-ancestor
5689725|NCT03427554|Dermatologic Agents|dermatologic agents|mesh-ancestor
5697521|NCT03375580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697522|NCT03375580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5697523|NCT03375580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5697524|NCT03375580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5697525|NCT03375515|Hydromorphone|hydromorphone|mesh-list
5697526|NCT03375515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5887215|NCT03349281|Mitosis Modulators|mitosis modulators|mesh-ancestor
5887216|NCT03299088|Pembrolizumab|pembrolizumab|mesh-list
5887217|NCT03299088|Trametinib|trametinib|mesh-list
5887218|NCT03299088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5887219|NCT03299088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5887220|NCT03299088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5887221|NCT03299088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5887222|NCT03299088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887223|NCT03292666|Warfarin|warfarin|mesh-list
5887224|NCT03292666|Rivaroxaban|rivaroxaban|mesh-list
5887225|NCT03292666|Dabigatran|dabigatran|mesh-list
5887226|NCT03292666|Apixaban|apixaban|mesh-list
5887227|NCT03292666|Edoxaban|edoxaban|mesh-list
5887228|NCT03292666|Anticoagulants|anticoagulants|mesh-list
5887229|NCT03292666|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5887230|NCT03292666|Antithrombins|antithrombins|mesh-ancestor
5887231|NCT03292666|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5887232|NCT03292666|Protease Inhibitors|protease inhibitors|mesh-ancestor
5887233|NCT03292666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5887234|NCT03292666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887235|NCT03286842|Olaparib|olaparib|mesh-list
5887236|NCT03286842|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5887237|NCT03286842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5887238|NCT03286842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887239|NCT03286842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5887240|NCT03283605|Durvalumab|durvalumab|mesh-list
5887241|NCT03283605|Tremelimumab|tremelimumab|mesh-list
5887242|NCT03283605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5887243|NCT03283605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5887244|NCT03262779|Nivolumab|nivolumab|mesh-list
5887245|NCT03262779|Ipilimumab|ipilimumab|mesh-list
5887246|NCT03262779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5887247|NCT03262779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5887248|NCT03262779|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5887249|NCT03262779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887250|NCT03236428|Daratumumab|daratumumab|mesh-list
5887251|NCT03236428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5697527|NCT03375515|Narcotics|narcotics|mesh-ancestor
5887252|NCT03219775|Nivolumab|nivolumab|mesh-list
5887253|NCT03219775|Ipilimumab|ipilimumab|mesh-list
5887254|NCT03219775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5887255|NCT03219775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5887256|NCT03219775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5887257|NCT03219775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887258|NCT03164564|Tenofovir|tenofovir|mesh-list
5887259|NCT03164564|Emtricitabine|emtricitabine|mesh-list
5887260|NCT03164564|Cabotegravir|cabotegravir|mesh-list
5887261|NCT03164564|Antiviral Agents|antiviral agents|mesh-ancestor
5887262|NCT03164564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5887263|NCT03164564|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5887264|NCT03164564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5887265|NCT03164564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5887266|NCT03164564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887267|NCT03164564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5887268|NCT03164564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5887269|NCT03164564|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5887270|NCT03164564|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5887271|NCT03143270|Nivolumab|nivolumab|mesh-list
5887272|NCT03143270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5887273|NCT03143270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5887274|NCT03143270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5887275|NCT03143270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887276|NCT03142568|Sildenafil Citrate|sildenafil citrate|mesh-list
5887277|NCT03142568|Vasodilator Agents|vasodilator agents|mesh-ancestor
5887278|NCT03142568|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5887279|NCT03142568|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5887280|NCT03142568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5887281|NCT03142568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887282|NCT03142568|Urological Agents|urological agents|mesh-ancestor
5887283|NCT03100045|Artesunate|artesunate|mesh-list
5887284|NCT03100045|Artemisinins|artemisinins|mesh-list
5887285|NCT03100045|Artemisinin|artemisinin|mesh-list
5887286|NCT03100045|Antimalarials|antimalarials|mesh-ancestor
5887287|NCT03100045|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5887288|NCT03100045|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5887289|NCT03100045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5887290|NCT03100045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5887291|NCT03100045|Antiviral Agents|antiviral agents|mesh-ancestor
5887292|NCT03100045|Schistosomicides|schistosomicides|mesh-ancestor
5887293|NCT03100045|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5887294|NCT03100045|Anthelmintics|anthelmintics|mesh-ancestor
5887295|NCT02660281|Cyclophosphamide|cyclophosphamide|mesh-list
5887296|NCT02660281|Melphalan|melphalan|mesh-list
6212553|NCT02189317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212554|NCT02189317|Sensory System Agents|sensory system agents|mesh-ancestor
6212555|NCT02189317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6212556|NCT02189629|Trifarotene|trifarotene|mesh-list
6212557|NCT02189629|Dermatologic Agents|dermatologic agents|mesh-ancestor
5689726|NCT03427502|Epinephrine|epinephrine|mesh-list
5887297|NCT02660281|Busulfan|busulfan|mesh-list
5887298|NCT02660281|Thiotepa|thiotepa|mesh-list
5887299|NCT02660281|Fludarabine|fludarabine|mesh-list
5887300|NCT02660281|Mesna|mesna|mesh-list
5887301|NCT02660281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5887302|NCT02660281|Immunologic Factors|immunologic factors|mesh-ancestor
5887303|NCT02660281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5887304|NCT02660281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5887305|NCT02660281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5887306|NCT02660281|Alkylating Agents|alkylating agents|mesh-ancestor
5907037|NCT04956146|Carboplatin|carboplatin|mesh-list
5689727|NCT03427502|Bupivacaine|bupivacaine|mesh-list
5689728|NCT03427502|Anesthetics, Local|anesthetics, local|mesh-ancestor
5689729|NCT03427502|Anesthetics|anesthetics|mesh-ancestor
5689730|NCT03427502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5689731|NCT03427502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689732|NCT03427502|Sensory System Agents|sensory system agents|mesh-ancestor
5689733|NCT03427502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5689734|NCT03427502|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5689735|NCT03427502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5689736|NCT03427502|Adrenergic Agents|adrenergic agents|mesh-ancestor
5689737|NCT03427502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5689738|NCT03427502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689739|NCT03427502|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5689740|NCT03427502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5689741|NCT03427502|Autonomic Agents|autonomic agents|mesh-ancestor
5689742|NCT03427502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5689743|NCT03427502|Respiratory System Agents|respiratory system agents|mesh-ancestor
5689744|NCT03427502|Mydriatics|mydriatics|mesh-ancestor
5887307|NCT02660281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887308|NCT02660281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5887309|NCT02660281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5887310|NCT02660281|Protective Agents|protective agents|mesh-ancestor
5887311|NCT02571530|Trastuzumab|trastuzumab|mesh-list
5887312|NCT02571530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5887313|NCT02571530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5887314|NCT02489903|Gemcitabine|gemcitabine|mesh-list
5887315|NCT02489903|Paclitaxel|paclitaxel|mesh-list
5887316|NCT02489903|Etoposide|etoposide|mesh-list
5887317|NCT02489903|Vinorelbine|vinorelbine|mesh-list
5887318|NCT02489903|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5887319|NCT02489903|Carboplatin|carboplatin|mesh-list
5887320|NCT02489903|Irinotecan|irinotecan|mesh-list
5887321|NCT02489903|Pemetrexed|pemetrexed|mesh-list
5887322|NCT02489903|Taxane|taxane|mesh-list
5887323|NCT02489903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5887324|NCT02489903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5887325|NCT02489903|Tubulin Modulators|tubulin modulators|mesh-ancestor
5887326|NCT02489903|Antimitotic Agents|antimitotic agents|mesh-ancestor
5887327|NCT02489903|Mitosis Modulators|mitosis modulators|mesh-ancestor
5887328|NCT02489903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887329|NCT02489903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5887330|NCT02489903|Antimetabolites|antimetabolites|mesh-ancestor
5887331|NCT02489903|Antiviral Agents|antiviral agents|mesh-ancestor
5887332|NCT02489903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5887333|NCT02489903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5887334|NCT02489903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5887335|NCT02489903|Immunologic Factors|immunologic factors|mesh-ancestor
5887336|NCT02489903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5887337|NCT02489903|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5689745|NCT03427502|Sympathomimetics|sympathomimetics|mesh-ancestor
5689746|NCT03427502|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5689747|NCT03427463|Morphine|morphine|mesh-list
5689748|NCT03427463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5689749|NCT03427463|Narcotics|narcotics|mesh-ancestor
5689750|NCT03427463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5689751|NCT03427463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689752|NCT03427463|Analgesics|analgesics|mesh-ancestor
5689753|NCT03427463|Sensory System Agents|sensory system agents|mesh-ancestor
5689754|NCT03427463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5689755|NCT03427437|Epinephrine|epinephrine|mesh-list
5689756|NCT03427437|Racepinephrine|racepinephrine|mesh-list
5887338|NCT02489903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5887339|NCT02489903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5887340|NCT02489903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5887341|NCT02489903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5887342|NCT02438995|Cetuximab|cetuximab|mesh-list
5689757|NCT03427437|Bupivacaine|bupivacaine|mesh-list
5689758|NCT03427437|Epinephryl borate|epinephryl borate|mesh-list
5689759|NCT03427437|Anesthetics, Local|anesthetics, local|mesh-ancestor
5689760|NCT03427437|Anesthetics|anesthetics|mesh-ancestor
5887343|NCT02438995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5887344|NCT02438995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5887345|NCT05108389|Hemostatics|hemostatics|mesh-list
5887346|NCT05108389|Coagulants|coagulants|mesh-ancestor
5887347|NCT05108350|Metformin|metformin|mesh-list
5887348|NCT05108350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5887349|NCT05108350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5887350|NCT05108259|Adalimumab|adalimumab|mesh-list
5887351|NCT05108259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5887352|NCT05108259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5887353|NCT05108220|Cannabidiol|cannabidiol|mesh-list
5887354|NCT05108220|Anticonvulsants|anticonvulsants|mesh-ancestor
5887355|NCT05108051|Oseltamivir|oseltamivir|mesh-list
5887356|NCT05108051|Antiviral Agents|antiviral agents|mesh-ancestor
5887357|NCT05108051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5887358|NCT05108051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5887359|NCT05108051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887360|NCT05107999|Antidepressive Agents|antidepressive agents|mesh-list
5887361|NCT05107999|Neurotransmitter Agents|neurotransmitter agents|mesh-list
5887362|NCT05107999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5887363|NCT05107999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689761|NCT03427437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5689762|NCT03427437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5887364|NCT05107999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5887365|NCT05107960|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
5887366|NCT05107960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5887367|NCT05107960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5887368|NCT05107960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887369|NCT05107921|Bromfenac|bromfenac|mesh-list
5887370|NCT05107921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5887371|NCT05107921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5887372|NCT05107921|Analgesics|analgesics|mesh-ancestor
5887373|NCT05107921|Sensory System Agents|sensory system agents|mesh-ancestor
5887374|NCT05107921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5887375|NCT05107921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5887376|NCT05107921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5887377|NCT05107921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5887378|NCT05107791|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5689763|NCT03427437|Sensory System Agents|sensory system agents|mesh-ancestor
5689764|NCT03427437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5689765|NCT03427437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5689766|NCT03427437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5689767|NCT03427437|Adrenergic Agents|adrenergic agents|mesh-ancestor
5887379|NCT05107791|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5887380|NCT05107765|Pioglitazone|pioglitazone|mesh-list
5887381|NCT05107765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5887382|NCT05107765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5887383|NCT05107375|Vaccines|vaccines|mesh-list
5887384|NCT05107375|Immunologic Factors|immunologic factors|mesh-ancestor
5887385|NCT05107375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907038|NCT04956146|Pemetrexed|pemetrexed|mesh-list
5907039|NCT04956146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5907040|NCT04956146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5907041|NCT04956146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907042|NCT04956146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5907043|NCT04956146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5907044|NCT04905251|Misoprostol|misoprostol|mesh-list
5907045|NCT04905251|Mifepristone|mifepristone|mesh-list
5907046|NCT04905251|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5907047|NCT04905251|Abortifacient Agents|abortifacient agents|mesh-ancestor
5907048|NCT04905251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5907049|NCT04905251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907050|NCT04905251|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5907051|NCT04905251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5907052|NCT04905251|Oxytocics|oxytocics|mesh-ancestor
5907053|NCT04905251|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5907054|NCT04905251|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5907055|NCT04905251|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5907056|NCT04905251|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5907057|NCT04905251|Contraceptive Agents|contraceptive agents|mesh-ancestor
5907058|NCT04905251|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5907059|NCT04905251|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5907060|NCT04905251|Hormone Antagonists|hormone antagonists|mesh-ancestor
5907061|NCT04905251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5907062|NCT04905251|Luteolytic Agents|luteolytic agents|mesh-ancestor
5907063|NCT04905251|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5907064|NCT04905251|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5907065|NCT04895098|Ezetimibe|ezetimibe|mesh-list
5907066|NCT04895098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
5907067|NCT04895098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5907068|NCT04895098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5907069|NCT04895098|Antimetabolites|antimetabolites|mesh-ancestor
5907070|NCT04895098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907071|NCT04895098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5907072|NCT04895098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5907073|NCT04889066|Durvalumab|durvalumab|mesh-list
5907074|NCT04889066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5907075|NCT04889066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5907076|NCT04862962|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5907077|NCT04862962|Ezetimibe|ezetimibe|mesh-list
5907078|NCT04862962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5907079|NCT04862962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5907080|NCT04862962|Antimetabolites|antimetabolites|mesh-ancestor
5907081|NCT04862962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689768|NCT03427437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5689769|NCT03427437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689770|NCT03427437|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5689771|NCT03427437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5689772|NCT03427437|Autonomic Agents|autonomic agents|mesh-ancestor
5887386|NCT05107063|Pravastatin|pravastatin|mesh-list
5887387|NCT05107063|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5887388|NCT05107063|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5887389|NCT05107063|Antimetabolites|antimetabolites|mesh-ancestor
5887390|NCT05107063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887391|NCT05107063|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5887392|NCT05107063|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5887393|NCT05107063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5887394|NCT05106803|Amoxicillin|amoxicillin|mesh-list
5887395|NCT05106803|Vancomycin|vancomycin|mesh-list
5887396|NCT05106803|Ciprofloxacin|ciprofloxacin|mesh-list
5887397|NCT05106803|Clindamycin|clindamycin|mesh-list
5887398|NCT05106803|Gentamicins|gentamicins|mesh-list
5887399|NCT05106803|Tetracycline|tetracycline|mesh-list
5887400|NCT05106803|Penicillins|penicillins|mesh-list
5887401|NCT05106803|Erythromycin|erythromycin|mesh-list
5887402|NCT05106803|Ampicillin|ampicillin|mesh-list
5887403|NCT05106803|Clavulanic Acids|clavulanic acids|mesh-list
5887404|NCT05106803|Clavulanic Acid|clavulanic acid|mesh-list
5887405|NCT05106803|Cefepime|cefepime|mesh-list
5887406|NCT05106803|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
5887407|NCT05106803|Norfloxacin|norfloxacin|mesh-list
5887408|NCT05106803|Oxacillin|oxacillin|mesh-list
5887409|NCT05106803|Chloramphenicol|chloramphenicol|mesh-list
5887410|NCT05106803|Trimethoprim|trimethoprim|mesh-list
5887411|NCT05106803|Sulfamethoxazole|sulfamethoxazole|mesh-list
5887412|NCT05106803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5887413|NCT05106803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5887414|NCT05106803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5887415|NCT05106803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5887416|NCT05106803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5887417|NCT05106803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887418|NCT05106803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5887419|NCT05106803|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5887420|NCT05106803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5887421|NCT05106803|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5887422|NCT05106803|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5887423|NCT05106803|Renal Agents|renal agents|mesh-ancestor
5887424|NCT05106803|Antimalarials|antimalarials|mesh-ancestor
5887425|NCT05106803|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5887426|NCT05106803|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5887427|NCT05106803|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5887428|NCT05106803|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5887429|NCT05106803|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
5887430|NCT05106803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5887431|NCT05106803|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5887432|NCT05106751|Hyaluronic Acid|hyaluronic acid|mesh-list
5887433|NCT05106751|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5887434|NCT05106751|Immunologic Factors|immunologic factors|mesh-ancestor
5887435|NCT05106751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5887436|NCT05106751|Viscosupplements|viscosupplements|mesh-ancestor
5887437|NCT05106751|Protective Agents|protective agents|mesh-ancestor
5887438|NCT05106712|Vitamin D|vitamin d|mesh-list
5887439|NCT05106712|Cholecalciferol|cholecalciferol|mesh-list
5887440|NCT05106712|Letrozole|letrozole|mesh-list
5887441|NCT05106712|Clomiphene|clomiphene|mesh-list
5887442|NCT05106712|Enclomiphene|enclomiphene|mesh-list
5887443|NCT05106712|Zuclomiphene|zuclomiphene|mesh-list
5887444|NCT05106712|Vitamins|vitamins|mesh-ancestor
5887445|NCT05106712|Micronutrients|micronutrients|mesh-ancestor
5887446|NCT05106712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5887447|NCT05106712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5887448|NCT05106712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887449|NCT05106712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5887450|NCT05106712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5887451|NCT05106712|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5887452|NCT05106712|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5887453|NCT05106712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5887454|NCT05106712|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5887455|NCT05106712|Hormone Antagonists|hormone antagonists|mesh-ancestor
5887456|NCT05106712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5887457|NCT05106712|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5887458|NCT05106712|Fertility Agents|fertility agents|mesh-ancestor
5887459|NCT05106712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5887460|NCT05106712|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5887461|NCT05106712|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5887462|NCT05093621|Torsemide|torsemide|mesh-list
5887463|NCT05093621|Furosemide|furosemide|mesh-list
5887464|NCT05093621|Diuretics|diuretics|mesh-ancestor
5887465|NCT05093621|Natriuretic Agents|natriuretic agents|mesh-ancestor
5887466|NCT05093621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5887467|NCT05093621|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5887468|NCT05093621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5887469|NCT05093621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887470|NCT05093621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5887471|NCT05083000|Topotecan|topotecan|mesh-list
5887472|NCT05083000|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5887473|NCT05083000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5887474|NCT05083000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5887475|NCT05083000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887476|NCT05083000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5887477|NCT05057273|Adalimumab|adalimumab|mesh-list
5887478|NCT05057273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5887479|NCT05057273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5887480|NCT05031897|Mycophenolic Acid|mycophenolic acid|mesh-list
5887481|NCT05031897|Cyclophosphamide|cyclophosphamide|mesh-list
5887482|NCT05031897|Melphalan|melphalan|mesh-list
5887483|NCT05031897|Fludarabine|fludarabine|mesh-list
5887484|NCT05031897|Tacrolimus|tacrolimus|mesh-list
5887485|NCT05031897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5887486|NCT05031897|Immunologic Factors|immunologic factors|mesh-ancestor
5887487|NCT05031897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5887488|NCT05031897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5887489|NCT05031897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5689773|NCT03427437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5689774|NCT03427437|Respiratory System Agents|respiratory system agents|mesh-ancestor
5689775|NCT03427437|Mydriatics|mydriatics|mesh-ancestor
5689776|NCT03427437|Sympathomimetics|sympathomimetics|mesh-ancestor
5689777|NCT03427437|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5689778|NCT03427385|Ropivacaine|ropivacaine|mesh-list
5689779|NCT03427385|Anesthetics, Local|anesthetics, local|mesh-ancestor
5689780|NCT03427385|Anesthetics|anesthetics|mesh-ancestor
5689781|NCT03427385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5689782|NCT03427385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689783|NCT03427385|Sensory System Agents|sensory system agents|mesh-ancestor
5689784|NCT03427385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5689785|NCT03427359|Capecitabine|capecitabine|mesh-list
5689786|NCT03427359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5689787|NCT03427359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5689788|NCT03427359|Antimetabolites|antimetabolites|mesh-ancestor
5689789|NCT03427359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689790|NCT03427242|Apatinib|apatinib|mesh-list
5689791|NCT03427242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5689792|NCT03427242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5689793|NCT03427242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5689794|NCT03427242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887490|NCT05031897|Alkylating Agents|alkylating agents|mesh-ancestor
5887491|NCT05031897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887492|NCT05031897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5887493|NCT05031897|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5887494|NCT05031897|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5887495|NCT05031897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5887496|NCT05031897|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5887497|NCT05031897|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5887498|NCT05031897|Antitubercular Agents|antitubercular agents|mesh-ancestor
5887499|NCT05031897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5887500|NCT05031897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5887501|NCT05023369|Dexamethasone|dexamethasone|mesh-list
5887502|NCT05023369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5887503|NCT05023369|Antiemetics|antiemetics|mesh-ancestor
5887504|NCT05023369|Autonomic Agents|autonomic agents|mesh-ancestor
5887505|NCT05023369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5887506|NCT05023369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5887507|NCT05023369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5887508|NCT05023369|Glucocorticoids|glucocorticoids|mesh-ancestor
5887509|NCT05023369|Hormones|hormones|mesh-ancestor
5887510|NCT05023369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5887511|NCT05023369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5887512|NCT05023369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5887513|NCT05010421|Clobetasol|clobetasol|mesh-list
5887514|NCT05010421|Emollients|emollients|mesh-list
5887515|NCT05010421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5887516|NCT05010421|Glucocorticoids|glucocorticoids|mesh-ancestor
5887517|NCT05010421|Hormones|hormones|mesh-ancestor
5689795|NCT03427229|Vancomycin|vancomycin|mesh-list
5689796|NCT03427229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5689797|NCT03427229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5887518|NCT05010421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5887519|NCT05010421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5887520|NCT05010421|Dermatologic Agents|dermatologic agents|mesh-ancestor
5887521|NCT05004077|Amiodarone|amiodarone|mesh-list
5887522|NCT05004077|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5887523|NCT05004077|Vasodilator Agents|vasodilator agents|mesh-ancestor
5887524|NCT05004077|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5887525|NCT05004077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5887526|NCT05004077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887527|NCT05004077|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5887528|NCT05004077|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5887529|NCT05004077|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5887530|NCT05004077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5887531|NCT05004077|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5887532|NCT05004077|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5887533|NCT05004077|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5887534|NCT04977024|Vaccines|vaccines|mesh-list
5887535|NCT04977024|Immunologic Factors|immunologic factors|mesh-ancestor
5887536|NCT04977024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5887537|NCT04962126|Atezolizumab|atezolizumab|mesh-list
5887538|NCT04962126|Obinutuzumab|obinutuzumab|mesh-list
5887539|NCT04962126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5887540|NCT04962126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5887541|NCT04962126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5887542|NCT04930042|Ustekinumab|ustekinumab|mesh-list
5887543|NCT04930042|Dermatologic Agents|dermatologic agents|mesh-ancestor
5887544|NCT04903093|Famotidine|famotidine|mesh-list
5887545|NCT04903093|Abrocitinib|abrocitinib|mesh-list
5887546|NCT04903093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5887547|NCT04903093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5887548|NCT04903093|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5887549|NCT04903093|Histamine Antagonists|histamine antagonists|mesh-ancestor
5887550|NCT04903093|Histamine Agents|histamine agents|mesh-ancestor
5887551|NCT04903093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5887552|NCT04903093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887553|NCT04903093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5887554|NCT04903093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5887555|NCT04903093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5887556|NCT04833413|Insulin|insulin|mesh-list
5887557|NCT04833413|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5887558|NCT04833413|Hypoglycemic Agents|hypoglycemic agents|mesh-list
5887559|NCT04833413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5887560|NCT04781426|Tenofovir|tenofovir|mesh-list
5887561|NCT04781426|Lamivudine|lamivudine|mesh-list
5887562|NCT04781426|Antiviral Agents|antiviral agents|mesh-ancestor
5887563|NCT04781426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5887564|NCT04781426|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5887565|NCT04781426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5887566|NCT04781426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5887567|NCT04781426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887568|NCT04781426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5689798|NCT03427216|Diazepam|diazepam|mesh-list
5689799|NCT03427216|Baclofen|baclofen|mesh-list
5689800|NCT03427216|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5689801|NCT03427216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689802|NCT03427216|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5689803|NCT03427216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5887569|NCT04781426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5887570|NCT04771689|Buprenorphine|buprenorphine|mesh-list
5887571|NCT04771689|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
5887572|NCT04771689|Naloxone|naloxone|mesh-list
5887573|NCT04771689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5887574|NCT04771689|Narcotics|narcotics|mesh-ancestor
5887575|NCT04771689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5887576|NCT04771689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5887577|NCT04771689|Analgesics|analgesics|mesh-ancestor
5887578|NCT04771689|Sensory System Agents|sensory system agents|mesh-ancestor
5887579|NCT04771689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5887580|NCT04771689|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5887581|NCT04751877|Dexamethasone|dexamethasone|mesh-list
5887582|NCT04751877|Lenalidomide|lenalidomide|mesh-list
5689804|NCT03427216|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
5689805|NCT03427216|GABA Agonists|gaba agonists|mesh-ancestor
5887583|NCT04751877|Bortezomib|bortezomib|mesh-list
5887584|NCT04751877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5887585|NCT04751877|Antiemetics|antiemetics|mesh-ancestor
5887586|NCT04751877|Autonomic Agents|autonomic agents|mesh-ancestor
5887587|NCT04751877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5887588|NCT04751877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5887589|NCT04751877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5887590|NCT04751877|Glucocorticoids|glucocorticoids|mesh-ancestor
5887591|NCT04751877|Hormones|hormones|mesh-ancestor
5887592|NCT04751877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5887593|NCT04751877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5887594|NCT04751877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5887595|NCT04751877|Immunologic Factors|immunologic factors|mesh-ancestor
5887596|NCT04751877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5887597|NCT04751877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5887598|NCT04751877|Growth Substances|growth substances|mesh-ancestor
5887599|NCT04751877|Growth Inhibitors|growth inhibitors|mesh-ancestor
5907082|NCT04862962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5907083|NCT04862962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5907084|NCT04862962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5907085|NCT04849325|Sirolimus|sirolimus|mesh-list
5907086|NCT04849325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5907087|NCT04849325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5907088|NCT04849325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5907089|NCT04849325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5907090|NCT04849325|Antifungal Agents|antifungal agents|mesh-ancestor
5907091|NCT04849325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5907092|NCT04849325|Immunologic Factors|immunologic factors|mesh-ancestor
5907093|NCT04849325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907094|NCT04848454|Vinorelbine|vinorelbine|mesh-list
5907095|NCT04848454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5907096|NCT04848454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5907097|NCT04848454|Tubulin Modulators|tubulin modulators|mesh-ancestor
5907098|NCT04848454|Antimitotic Agents|antimitotic agents|mesh-ancestor
5907099|NCT04848454|Mitosis Modulators|mitosis modulators|mesh-ancestor
5907100|NCT04848454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907101|NCT04810559|Antibodies|antibodies|mesh-list
5907102|NCT04810559|Immunologic Factors|immunologic factors|mesh-ancestor
5907103|NCT04810559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907104|NCT04799236|Amphotericin B|amphotericin b|mesh-list
5907105|NCT04799236|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
5907106|NCT04799236|Miltefosine|miltefosine|mesh-list
5907107|NCT04799236|Amebicides|amebicides|mesh-ancestor
5907108|NCT04799236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5907109|NCT04799236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5907110|NCT04799236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5907111|NCT04799236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5907112|NCT04799236|Antifungal Agents|antifungal agents|mesh-ancestor
5907113|NCT04799236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5907114|NCT04785326|Ustekinumab|ustekinumab|mesh-list
5689806|NCT03427216|GABA Agents|gaba agents|mesh-ancestor
5689807|NCT03427216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5689808|NCT03427216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689809|NCT03427216|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5689810|NCT03427216|Anticonvulsants|anticonvulsants|mesh-ancestor
5689811|NCT03427216|Antiemetics|antiemetics|mesh-ancestor
5689812|NCT03427216|Autonomic Agents|autonomic agents|mesh-ancestor
5689813|NCT03427216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5907115|NCT04785326|Dermatologic Agents|dermatologic agents|mesh-ancestor
5907116|NCT04771637|Dexmedetomidine|dexmedetomidine|mesh-list
5907117|NCT04771637|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5907118|NCT04771637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5689814|NCT03427216|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5689815|NCT03427216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5689816|NCT03427216|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5689817|NCT03427216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5689818|NCT03427216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5689819|NCT03427216|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5689820|NCT03427216|Anesthetics, General|anesthetics, general|mesh-ancestor
5689821|NCT03427216|Anesthetics|anesthetics|mesh-ancestor
5689822|NCT03427216|GABA Modulators|gaba modulators|mesh-ancestor
5689823|NCT03427086|Biotin|biotin|mesh-list
5689824|NCT03427086|Vitamins|vitamins|mesh-ancestor
5907119|NCT04771637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907120|NCT04771637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5907121|NCT04771637|Analgesics|analgesics|mesh-ancestor
5689825|NCT03427086|Micronutrients|micronutrients|mesh-ancestor
5689826|NCT03427086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5887600|NCT04722978|Gemcitabine|gemcitabine|mesh-list
5887601|NCT04722978|Moxifloxacin|moxifloxacin|mesh-list
5887602|NCT04722978|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5887603|NCT04722978|Carboplatin|carboplatin|mesh-list
5887604|NCT04722978|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
5887605|NCT04722978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5887606|NCT04722978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5887607|NCT04722978|Antimetabolites|antimetabolites|mesh-ancestor
5887608|NCT04722978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887609|NCT04722978|Antiviral Agents|antiviral agents|mesh-ancestor
5887610|NCT04722978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5887611|NCT04722978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5887612|NCT04722978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5887613|NCT04722978|Immunologic Factors|immunologic factors|mesh-ancestor
5887614|NCT04722978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5887615|NCT04722978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5887616|NCT04722978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5887617|NCT04722978|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5887618|NCT04722978|Contraceptive Agents|contraceptive agents|mesh-ancestor
5887619|NCT04722978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5887620|NCT04722978|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5887621|NCT04722978|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5887622|NCT04722978|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5887623|NCT04695106|Aspirin|aspirin|mesh-list
5887624|NCT04695106|Dabigatran|dabigatran|mesh-list
5887625|NCT04695106|Clopidogrel|clopidogrel|mesh-list
5887626|NCT04695106|Ticagrelor|ticagrelor|mesh-list
5887627|NCT04695106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5887628|NCT04695106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5887629|NCT04695106|Analgesics|analgesics|mesh-ancestor
5887630|NCT04695106|Sensory System Agents|sensory system agents|mesh-ancestor
5887631|NCT04695106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5887632|NCT04695106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5887633|NCT04695106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5887634|NCT04695106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5887635|NCT04695106|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5887636|NCT04695106|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5887637|NCT04695106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887638|NCT04695106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5887639|NCT04695106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5887640|NCT04695106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5887641|NCT04695106|Antipyretics|antipyretics|mesh-ancestor
5887642|NCT04695106|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5887643|NCT04695106|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5887644|NCT04695106|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5887645|NCT04695106|Purinergic Agents|purinergic agents|mesh-ancestor
5887646|NCT04695106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5887647|NCT04695106|Antithrombins|antithrombins|mesh-ancestor
5887648|NCT04695106|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5887649|NCT04695106|Protease Inhibitors|protease inhibitors|mesh-ancestor
5887650|NCT04695106|Anticoagulants|anticoagulants|mesh-ancestor
5887651|NCT04681677|Bevacizumab|bevacizumab|mesh-list
5887652|NCT04681677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5887653|NCT04681677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5689827|NCT03427086|Vitamin B Complex|vitamin b complex|mesh-ancestor
5887654|NCT04681677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5887655|NCT04681677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5887656|NCT04681677|Growth Substances|growth substances|mesh-ancestor
5887657|NCT04681677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5887658|NCT04681677|Growth Inhibitors|growth inhibitors|mesh-ancestor
5887659|NCT04658147|Nivolumab|nivolumab|mesh-list
5887660|NCT04658147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5887661|NCT04658147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5887662|NCT04658147|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5689828|NCT03427021|Oxaliplatin|oxaliplatin|mesh-list
5689829|NCT03427021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5689830|NCT03426982|Heparin|heparin|mesh-list
5689831|NCT03426982|Calcium heparin|calcium heparin|mesh-list
5689832|NCT03426982|Anticoagulants|anticoagulants|mesh-ancestor
5689833|NCT03426982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5689834|NCT03426982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5689835|NCT03426982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689836|NCT03426969|Mycophenolic Acid|mycophenolic acid|mesh-list
5689837|NCT03426969|Cyclophosphamide|cyclophosphamide|mesh-list
5689838|NCT03426969|Melphalan|melphalan|mesh-list
5689839|NCT03426969|Mechlorethamine|mechlorethamine|mesh-list
5887663|NCT04658147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887664|NCT04614974|Famotidine|famotidine|mesh-list
5887665|NCT04614974|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5887666|NCT04614974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5887667|NCT04614974|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5887668|NCT04614974|Histamine Antagonists|histamine antagonists|mesh-ancestor
5887669|NCT04614974|Histamine Agents|histamine agents|mesh-ancestor
5887670|NCT04614974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5887671|NCT04614974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689840|NCT03426969|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
5689841|NCT03426969|Fludarabine|fludarabine|mesh-list
5689842|NCT03426969|Fludarabine phosphate|fludarabine phosphate|mesh-list
5689843|NCT03426969|Tacrolimus|tacrolimus|mesh-list
5887672|NCT04614974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5887673|NCT04576767|Anesthetics|anesthetics|mesh-list
5689844|NCT03426969|Lenograstim|lenograstim|mesh-list
5689845|NCT03426969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5689846|NCT03426969|Immunologic Factors|immunologic factors|mesh-ancestor
5689847|NCT03426969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689848|NCT03426969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5689849|NCT03426969|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5689850|NCT03426969|Alkylating Agents|alkylating agents|mesh-ancestor
5689851|NCT03426969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689852|NCT03426969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5689853|NCT03426969|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5689854|NCT03426969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5689855|NCT03426969|Antimetabolites|antimetabolites|mesh-ancestor
5689856|NCT03426969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5689857|NCT03426969|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5689858|NCT03426969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5689859|NCT03426969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5689860|NCT03426969|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5689861|NCT03426969|Antitubercular Agents|antitubercular agents|mesh-ancestor
5887674|NCT04576767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5887675|NCT04576767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5887676|NCT04557644|Dermatologic Agents|dermatologic agents|mesh-list
5887677|NCT04537286|Paclitaxel|paclitaxel|mesh-list
5887678|NCT04537286|Cisplatin|cisplatin|mesh-list
5887679|NCT04537286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5887680|NCT04537286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5887681|NCT04537286|Tubulin Modulators|tubulin modulators|mesh-ancestor
5887682|NCT04537286|Antimitotic Agents|antimitotic agents|mesh-ancestor
5887683|NCT04537286|Mitosis Modulators|mitosis modulators|mesh-ancestor
5887684|NCT04537286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887685|NCT04527887|Dexamethasone|dexamethasone|mesh-list
5887686|NCT04527887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5887687|NCT04527887|Antiemetics|antiemetics|mesh-ancestor
5887688|NCT04527887|Autonomic Agents|autonomic agents|mesh-ancestor
5887689|NCT04527887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5887690|NCT04527887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5887691|NCT04527887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5887692|NCT04527887|Glucocorticoids|glucocorticoids|mesh-ancestor
5887693|NCT04527887|Hormones|hormones|mesh-ancestor
5887694|NCT04527887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5887695|NCT04527887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5887696|NCT04527887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5887697|NCT04486625|Aztreonam|aztreonam|mesh-list
5887698|NCT04486625|Avibactam|avibactam|mesh-list
5887699|NCT04486625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5887700|NCT04486625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5887701|NCT04486625|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5887702|NCT04486625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5887703|NCT04486625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887704|NCT04316364|Paclitaxel|paclitaxel|mesh-list
5887705|NCT04316364|Carboplatin|carboplatin|mesh-list
5887706|NCT04316364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5887707|NCT04316364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5887708|NCT04316364|Tubulin Modulators|tubulin modulators|mesh-ancestor
5887709|NCT04316364|Antimitotic Agents|antimitotic agents|mesh-ancestor
5887710|NCT04316364|Mitosis Modulators|mitosis modulators|mesh-ancestor
5887711|NCT04316364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887712|NCT04235686|Amphetamine|amphetamine|mesh-list
5887713|NCT04235686|Dextroamphetamine|dextroamphetamine|mesh-list
5887714|NCT04235686|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5887715|NCT04235686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5887716|NCT04235686|Sympathomimetics|sympathomimetics|mesh-ancestor
5887717|NCT04235686|Autonomic Agents|autonomic agents|mesh-ancestor
5887718|NCT04235686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5887719|NCT04235686|Dopamine Agents|dopamine agents|mesh-ancestor
5887720|NCT04235686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5887721|NCT04235686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887722|NCT04235686|Adrenergic Agents|adrenergic agents|mesh-ancestor
5887723|NCT04235686|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5887724|NCT04235686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5887725|NCT04235686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5887726|NCT04235686|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5887727|NCT04210141|Antivenins|antivenins|mesh-list
5887728|NCT04210141|Immunologic Factors|immunologic factors|mesh-ancestor
5887729|NCT04210141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5887730|NCT04199767|Insulin|insulin|mesh-list
5887731|NCT04199767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5887732|NCT04199767|Insulin, Isophane|insulin, isophane|mesh-list
5887733|NCT04199767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5887734|NCT04199767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5887735|NCT04168710|Bupivacaine|bupivacaine|mesh-list
5887736|NCT04168710|Anesthetics, Local|anesthetics, local|mesh-ancestor
5887737|NCT04168710|Anesthetics|anesthetics|mesh-ancestor
5887738|NCT04168710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5887739|NCT04168710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5887740|NCT04168710|Sensory System Agents|sensory system agents|mesh-ancestor
5887741|NCT04168710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5887742|NCT04127981|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5887743|NCT04127981|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5887744|NCT04127981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887745|NCT04119024|Cyclophosphamide|cyclophosphamide|mesh-list
5887746|NCT04119024|Fludarabine|fludarabine|mesh-list
5887747|NCT04119024|Fludarabine phosphate|fludarabine phosphate|mesh-list
5887748|NCT04119024|Interleukin-2|interleukin-2|mesh-list
5887749|NCT04119024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5887750|NCT04119024|Immunologic Factors|immunologic factors|mesh-ancestor
5887751|NCT04119024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5887752|NCT04119024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5887753|NCT04119024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5887754|NCT04119024|Alkylating Agents|alkylating agents|mesh-ancestor
5887755|NCT04119024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887756|NCT04119024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5887757|NCT04119024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5887758|NCT04119024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5887759|NCT04119024|Antimetabolites|antimetabolites|mesh-ancestor
5887760|NCT04119024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5887761|NCT04119024|Analgesics|analgesics|mesh-ancestor
5887762|NCT04119024|Sensory System Agents|sensory system agents|mesh-ancestor
5887763|NCT04119024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5887764|NCT04084951|Nivolumab|nivolumab|mesh-list
5887765|NCT04084951|Ipilimumab|ipilimumab|mesh-list
5887766|NCT04084951|Atezolizumab|atezolizumab|mesh-list
5887767|NCT04084951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5887768|NCT04084951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5887769|NCT04084951|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5887770|NCT04084951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887771|NCT04018872|Itraconazole|itraconazole|mesh-list
5887772|NCT04018872|Antifungal Agents|antifungal agents|mesh-ancestor
5887773|NCT04018872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5887774|NCT04018872|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5887775|NCT04018872|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5887776|NCT04018872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5887777|NCT04018872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887778|NCT04018872|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5887779|NCT04018872|Hormone Antagonists|hormone antagonists|mesh-ancestor
5887780|NCT04018872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5887781|NCT04018872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5887782|NCT04018872|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5887783|NCT04001777|Osimertinib|osimertinib|mesh-list
5887784|NCT04001777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5887785|NCT04001777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5887786|NCT04001777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5887787|NCT04001777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887788|NCT03997786|Etanercept|etanercept|mesh-list
5887789|NCT03997786|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5689862|NCT03426969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5689863|NCT03426969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5689864|NCT03426956|Canagliflozin|canagliflozin|mesh-list
5887790|NCT03997786|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5887791|NCT03997786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5887792|NCT03997786|Analgesics|analgesics|mesh-ancestor
5887793|NCT03997786|Sensory System Agents|sensory system agents|mesh-ancestor
5887794|NCT03997786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5689865|NCT03426956|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5689866|NCT03426956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689867|NCT03426956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5689868|NCT03426956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689869|NCT03426904|Leucovorin|leucovorin|mesh-list
5689870|NCT03426904|Fluorouracil|fluorouracil|mesh-list
5689871|NCT03426904|Oxaliplatin|oxaliplatin|mesh-list
5689872|NCT03426904|Antimetabolites|antimetabolites|mesh-ancestor
5689873|NCT03426904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689874|NCT03426904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5689875|NCT03426904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5689876|NCT03426904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5689877|NCT03426904|Immunologic Factors|immunologic factors|mesh-ancestor
5689878|NCT03426904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689879|NCT03426904|Antidotes|antidotes|mesh-ancestor
5689880|NCT03426904|Protective Agents|protective agents|mesh-ancestor
5689881|NCT03426904|Vitamin B Complex|vitamin b complex|mesh-ancestor
5689882|NCT03426904|Vitamins|vitamins|mesh-ancestor
5887795|NCT03997786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5887796|NCT03997786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5887797|NCT03997786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5887798|NCT03997786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5887799|NCT03997786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5887800|NCT03997786|Immunologic Factors|immunologic factors|mesh-ancestor
5887801|NCT03982576|Nicotine|nicotine|mesh-list
5887802|NCT03982576|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5887803|NCT03982576|Autonomic Agents|autonomic agents|mesh-ancestor
5887804|NCT03982576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5887805|NCT03982576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5887806|NCT03982576|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5887807|NCT03982576|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5887808|NCT03982576|Cholinergic Agents|cholinergic agents|mesh-ancestor
5887809|NCT03982576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5887810|NCT03982576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887811|NCT03982407|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5887812|NCT03982407|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5887813|NCT03982407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887814|NCT03969641|Vaccines|vaccines|mesh-list
5887815|NCT03969641|Immunologic Factors|immunologic factors|mesh-ancestor
5887816|NCT03969641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5887817|NCT03965923|Tenofovir|tenofovir|mesh-list
5887818|NCT03965923|Emtricitabine|emtricitabine|mesh-list
5887819|NCT03965923|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5887820|NCT03965923|Dapivirine|dapivirine|mesh-list
5887821|NCT03965923|Antiviral Agents|antiviral agents|mesh-ancestor
5887822|NCT03965923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5887823|NCT03965923|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5887824|NCT03965923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5887825|NCT03965923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5887826|NCT03965923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887827|NCT03965923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5887828|NCT03965923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5907122|NCT04771637|Sensory System Agents|sensory system agents|mesh-ancestor
5907123|NCT04771637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5907124|NCT04771637|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5907125|NCT04771637|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5907126|NCT04771637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5907127|NCT04771637|Adrenergic Agents|adrenergic agents|mesh-ancestor
5907128|NCT04771637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5907129|NCT04771637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907130|NCT04737343|Azathioprine|azathioprine|mesh-list
5907131|NCT04737343|Leflunomide|leflunomide|mesh-list
5689883|NCT03426904|Micronutrients|micronutrients|mesh-ancestor
5689884|NCT03426761|Vancomycin|vancomycin|mesh-list
5689885|NCT03426761|Cefazolin|cefazolin|mesh-list
5907132|NCT04737343|Antimetabolites|antimetabolites|mesh-ancestor
5689886|NCT03426761|Daptomycin|daptomycin|mesh-list
5689887|NCT03426761|Dalbavancin|dalbavancin|mesh-list
5689888|NCT03426761|Nafcillin|nafcillin|mesh-list
5689889|NCT03426761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5689890|NCT03426761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5689891|NCT03426657|Durvalumab|durvalumab|mesh-list
5689892|NCT03426657|Tremelimumab|tremelimumab|mesh-list
5689893|NCT03426657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5689894|NCT03426657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5689895|NCT03426592|Vitamin D|vitamin d|mesh-list
5689896|NCT03426592|Cholecalciferol|cholecalciferol|mesh-list
5689897|NCT03426592|Vitamins|vitamins|mesh-ancestor
5689898|NCT03426592|Micronutrients|micronutrients|mesh-ancestor
5689899|NCT03426592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689900|NCT03426592|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5689901|NCT03426592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5689902|NCT03426553|Riboflavin|riboflavin|mesh-list
5689903|NCT03426553|Vitamin B Complex|vitamin b complex|mesh-ancestor
5689904|NCT03426553|Vitamins|vitamins|mesh-ancestor
5689905|NCT03426553|Micronutrients|micronutrients|mesh-ancestor
5689906|NCT03426553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689907|NCT03426553|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5689908|NCT03426553|Dermatologic Agents|dermatologic agents|mesh-ancestor
5887829|NCT03942328|Vaccines|vaccines|mesh-list
5887830|NCT03942328|Immunologic Factors|immunologic factors|mesh-ancestor
5887831|NCT03942328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5887832|NCT03933813|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
5887833|NCT03933813|Hematinics|hematinics|mesh-ancestor
5887834|NCT03930615|Letermovir|letermovir|mesh-list
5887835|NCT03930615|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5887836|NCT03930615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5887837|NCT03930615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887838|NCT03930615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5887839|NCT03930615|Antiviral Agents|antiviral agents|mesh-ancestor
5887840|NCT03930615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5887841|NCT03875144|Cisplatin|cisplatin|mesh-list
5887842|NCT03875144|Doxorubicin|doxorubicin|mesh-list
5887843|NCT03875144|Pemetrexed|pemetrexed|mesh-list
5887844|NCT03875144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5887845|NCT03875144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5887846|NCT03875144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5887847|NCT03875144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5887848|NCT03875144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5887849|NCT03875144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887850|NCT03875144|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5887851|NCT03875144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5887852|NCT03852433|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5887853|NCT03852433|Antiviral Agents|antiviral agents|mesh-ancestor
5887854|NCT03852433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5887855|NCT03814005|Paclitaxel|paclitaxel|mesh-list
5887856|NCT03814005|Docetaxel|docetaxel|mesh-list
5887857|NCT03814005|Carboplatin|carboplatin|mesh-list
5887858|NCT03814005|Azacitidine|azacitidine|mesh-list
5887859|NCT03814005|Pevonedistat|pevonedistat|mesh-list
5887860|NCT03814005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5887861|NCT03814005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5887862|NCT03814005|Tubulin Modulators|tubulin modulators|mesh-ancestor
5887863|NCT03814005|Antimitotic Agents|antimitotic agents|mesh-ancestor
5887864|NCT03814005|Mitosis Modulators|mitosis modulators|mesh-ancestor
5887865|NCT03814005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887866|NCT03814005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5689909|NCT03426527|Dexmedetomidine|dexmedetomidine|mesh-list
5689910|NCT03426527|Levobupivacaine|levobupivacaine|mesh-list
5689911|NCT03426527|Anesthetics|anesthetics|mesh-ancestor
5689912|NCT03426527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5689913|NCT03426527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5887867|NCT03814005|Antimetabolites|antimetabolites|mesh-ancestor
5887868|NCT03814005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5887869|NCT03773302|Gemcitabine|gemcitabine|mesh-list
5887870|NCT03773302|Infigratinib|infigratinib|mesh-list
5887871|NCT03773302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5887872|NCT03773302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5887873|NCT03773302|Antimetabolites|antimetabolites|mesh-ancestor
5887874|NCT03773302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887875|NCT03773302|Antiviral Agents|antiviral agents|mesh-ancestor
5689914|NCT03426527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5689915|NCT03426527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5887876|NCT03773302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5887877|NCT03773302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5887878|NCT03773302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5887879|NCT03773302|Immunologic Factors|immunologic factors|mesh-ancestor
5887880|NCT03773302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5887881|NCT03740204|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5887882|NCT03740204|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5887883|NCT03740204|Estradiol|estradiol|mesh-list
5887884|NCT03740204|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5887885|NCT03740204|Progesterone|progesterone|mesh-list
5887886|NCT03740204|Estrogens|estrogens|mesh-ancestor
5887887|NCT03740204|Hormones|hormones|mesh-ancestor
5887888|NCT03740204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5887889|NCT03740204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5887890|NCT03740204|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5887891|NCT03740204|Contraceptive Agents|contraceptive agents|mesh-ancestor
5887892|NCT03740204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5887893|NCT03740204|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5887894|NCT03740204|Progestins|progestins|mesh-ancestor
5887895|NCT03726671|Choline|choline|mesh-list
5887896|NCT03726671|Lipotropic Agents|lipotropic agents|mesh-ancestor
5887897|NCT03726671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5887898|NCT03726671|Antimetabolites|antimetabolites|mesh-ancestor
5887899|NCT03726671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887900|NCT03726671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5887901|NCT03726671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5887902|NCT03726671|Nootropic Agents|nootropic agents|mesh-ancestor
5887903|NCT03701711|Lenalidomide|lenalidomide|mesh-list
5887904|NCT03701711|Immunologic Factors|immunologic factors|mesh-ancestor
5887905|NCT03701711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5887906|NCT03701711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5887907|NCT03701711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5887908|NCT03701711|Growth Substances|growth substances|mesh-ancestor
5887909|NCT03701711|Growth Inhibitors|growth inhibitors|mesh-ancestor
5887910|NCT03701711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5887911|NCT03685773|Niacin|niacin|mesh-list
5887912|NCT03685773|Nicotinic Acids|nicotinic acids|mesh-list
5887913|NCT03685773|Niacinamide|niacinamide|mesh-list
5887914|NCT03685773|Diazoxide|diazoxide|mesh-list
5887915|NCT03685773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5887916|NCT03685773|Antimetabolites|antimetabolites|mesh-ancestor
5887917|NCT03685773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887918|NCT03685773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5887919|NCT03685773|Vasodilator Agents|vasodilator agents|mesh-ancestor
5887920|NCT03685773|Vitamin B Complex|vitamin b complex|mesh-ancestor
5887921|NCT03685773|Vitamins|vitamins|mesh-ancestor
5887922|NCT03685773|Micronutrients|micronutrients|mesh-ancestor
5887923|NCT03685773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5887924|NCT03685773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5887925|NCT03643796|Dexmedetomidine|dexmedetomidine|mesh-list
5887926|NCT03643796|Ketamine|ketamine|mesh-list
5887927|NCT03643796|Remifentanil|remifentanil|mesh-list
5887928|NCT03643796|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5887929|NCT03643796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5887930|NCT03643796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5887931|NCT03643796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5887932|NCT03643796|Analgesics|analgesics|mesh-ancestor
5887933|NCT03643796|Sensory System Agents|sensory system agents|mesh-ancestor
5887934|NCT03643796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5887935|NCT03643796|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5887936|NCT03643796|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5887937|NCT03643796|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5887938|NCT03643796|Adrenergic Agents|adrenergic agents|mesh-ancestor
5887939|NCT03643796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5887940|NCT03643796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887941|NCT03643796|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5887942|NCT03643796|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5887943|NCT03643796|Anesthetics, General|anesthetics, general|mesh-ancestor
5887944|NCT03643796|Anesthetics|anesthetics|mesh-ancestor
5887945|NCT03643796|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5887946|NCT03643796|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5887947|NCT03643796|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5887948|NCT03643796|Narcotics|narcotics|mesh-ancestor
5887949|NCT03596073|Calcipotriene|calcipotriene|mesh-list
5887950|NCT03596073|Petrolatum|petrolatum|mesh-list
5887951|NCT03596073|Dermatologic Agents|dermatologic agents|mesh-ancestor
5887952|NCT03596073|Emollients|emollients|mesh-ancestor
5887953|NCT03587844|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5887954|NCT03587844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5887955|NCT03587844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5887956|NCT03587844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5887957|NCT03587844|Immunologic Factors|immunologic factors|mesh-ancestor
5887958|NCT03587844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5887959|NCT03579914|Metoprolol|metoprolol|mesh-list
5887960|NCT03579914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5887961|NCT03579914|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5887962|NCT03579914|Sympatholytics|sympatholytics|mesh-ancestor
5887963|NCT03579914|Autonomic Agents|autonomic agents|mesh-ancestor
5887964|NCT03579914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5887965|NCT03579914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5887966|NCT03579914|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5887967|NCT03579914|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5887968|NCT03579914|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5887969|NCT03579914|Adrenergic Agents|adrenergic agents|mesh-ancestor
5887970|NCT03579914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5887971|NCT03579914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887972|NCT03560258|Vaccines|vaccines|mesh-list
5887973|NCT03560258|Immunologic Factors|immunologic factors|mesh-ancestor
5887974|NCT03560258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5887975|NCT03535363|Osimertinib|osimertinib|mesh-list
5887976|NCT03535363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5887977|NCT03535363|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5887978|NCT03535363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5887979|NCT03535363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5887991|NCT03467386|Cyclophosphamide|cyclophosphamide|mesh-list
5887992|NCT03467386|Tacrolimus|tacrolimus|mesh-list
6496216|NCT00627133|Nootropic Agents|nootropic agents|mesh-ancestor
5689916|NCT03426527|Analgesics|analgesics|mesh-ancestor
5887993|NCT03467386|Lenograstim|lenograstim|mesh-list
5887994|NCT03467386|Sargramostim|sargramostim|mesh-list
5887995|NCT03467386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5887996|NCT03467386|Immunologic Factors|immunologic factors|mesh-ancestor
5887997|NCT03467386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5887998|NCT03467386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5887999|NCT03467386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5888000|NCT03467386|Alkylating Agents|alkylating agents|mesh-ancestor
5888001|NCT03467386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888002|NCT03467386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5888003|NCT03467386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5888004|NCT03467386|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5888005|NCT03467386|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5888006|NCT03467386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5888007|NCT03384784|Galantamine|galantamine|mesh-list
5888008|NCT03384784|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5888009|NCT03384784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5888010|NCT03384784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888011|NCT03384784|Cholinergic Agents|cholinergic agents|mesh-ancestor
5888012|NCT03384784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5888013|NCT03384784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888014|NCT03384784|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5888015|NCT03384784|Autonomic Agents|autonomic agents|mesh-ancestor
5689917|NCT03426527|Sensory System Agents|sensory system agents|mesh-ancestor
5689918|NCT03426527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5689919|NCT03426527|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5689920|NCT03426527|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5689921|NCT03426527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5689922|NCT03426527|Adrenergic Agents|adrenergic agents|mesh-ancestor
5689923|NCT03426527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5689924|NCT03426527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689925|NCT03426527|Anesthetics, Local|anesthetics, local|mesh-ancestor
5689926|NCT03426462|Propofol|propofol|mesh-list
5689927|NCT03426462|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5689928|NCT03426462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5888016|NCT03384784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5888017|NCT03384784|Nootropic Agents|nootropic agents|mesh-ancestor
6496217|NCT00627250|Amantadine|amantadine|mesh-list
5888018|NCT03371979|Pembrolizumab|pembrolizumab|mesh-list
5888019|NCT03371979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5888020|NCT03371979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5888021|NCT03367572|Dexamethasone|dexamethasone|mesh-list
5888022|NCT03367572|Dexamethasone acetate|dexamethasone acetate|mesh-list
5888023|NCT03367572|Olanzapine|olanzapine|mesh-list
5888024|NCT03367572|Palonosetron|palonosetron|mesh-list
5888025|NCT03367572|Prochlorperazine|prochlorperazine|mesh-list
5888026|NCT03367572|Ichthammol|ichthammol|mesh-list
5888027|NCT03367572|BB 1101|bb 1101|mesh-list
5888028|NCT03367572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5888029|NCT03367572|Antiemetics|antiemetics|mesh-ancestor
5888030|NCT03367572|Autonomic Agents|autonomic agents|mesh-ancestor
5888031|NCT03367572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5888032|NCT03367572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888033|NCT03367572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5888034|NCT03367572|Glucocorticoids|glucocorticoids|mesh-ancestor
5888035|NCT03367572|Hormones|hormones|mesh-ancestor
5888036|NCT03367572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5888037|NCT03367572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5888038|NCT03367572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5888039|NCT03367572|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5888040|NCT03367572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5888041|NCT03367572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5888042|NCT03367572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5888043|NCT03367572|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5888044|NCT03367572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5888045|NCT03367572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5888046|NCT03367572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888047|NCT03367572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5888048|NCT03367572|Serotonin Agents|serotonin agents|mesh-ancestor
5888049|NCT03367572|Protease Inhibitors|protease inhibitors|mesh-ancestor
5888050|NCT03367572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5888051|NCT03367572|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5888052|NCT03367572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5888053|NCT03367572|Dermatologic Agents|dermatologic agents|mesh-ancestor
5689929|NCT03426462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689930|NCT03426462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5689931|NCT03426462|Anesthetics, General|anesthetics, general|mesh-ancestor
5689932|NCT03426462|Anesthetics|anesthetics|mesh-ancestor
5689933|NCT03426293|Heparin|heparin|mesh-list
5689934|NCT03426293|Anticoagulants|anticoagulants|mesh-ancestor
5689935|NCT03426293|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5689936|NCT03426293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5888054|NCT03367572|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5689937|NCT03426293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689938|NCT03426202|Modafinil|modafinil|mesh-list
5689939|NCT03426202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5689940|NCT03426202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689941|NCT03426202|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
5888055|NCT03367572|Dopamine Agents|dopamine agents|mesh-ancestor
5888056|NCT03293017|Diazepam|diazepam|mesh-list
5888057|NCT03293017|Baclofen|baclofen|mesh-list
5888058|NCT03293017|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5888059|NCT03293017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888060|NCT03293017|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5888061|NCT03293017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5888062|NCT03293017|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
5888063|NCT03293017|GABA Agonists|gaba agonists|mesh-ancestor
5888064|NCT03293017|GABA Agents|gaba agents|mesh-ancestor
5888065|NCT03293017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5888066|NCT03293017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888067|NCT03293017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5888068|NCT03293017|Anticonvulsants|anticonvulsants|mesh-ancestor
5888069|NCT03293017|Antiemetics|antiemetics|mesh-ancestor
5888070|NCT03293017|Autonomic Agents|autonomic agents|mesh-ancestor
5689942|NCT03426202|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5689943|NCT03426202|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5689944|NCT03426202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689945|NCT03426176|Oxytocin|oxytocin|mesh-list
5689946|NCT03426176|Oxytocics|oxytocics|mesh-ancestor
5689947|NCT03426176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5689948|NCT03426176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689949|NCT03426124|Fibrinolytic Agents|fibrinolytic agents|mesh-list
5689950|NCT03426124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5888071|NCT03293017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5888072|NCT03293017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5888073|NCT03293017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5888074|NCT03293017|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5888075|NCT03293017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5888076|NCT03293017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5888077|NCT03293017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5888078|NCT03293017|Anesthetics, General|anesthetics, general|mesh-ancestor
5888079|NCT03293017|Anesthetics|anesthetics|mesh-ancestor
5888080|NCT03293017|GABA Modulators|gaba modulators|mesh-ancestor
5888081|NCT03198559|Vorinostat|vorinostat|mesh-list
5888082|NCT03198559|Disulfiram|disulfiram|mesh-list
5888083|NCT03198559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5689951|NCT03426124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689952|NCT03426085|Liraglutide|liraglutide|mesh-list
5689953|NCT03426085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5689954|NCT03426085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689955|NCT03426085|Incretins|incretins|mesh-ancestor
5888084|NCT03198559|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5888085|NCT03198559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5888086|NCT03198559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888087|NCT03198559|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5888088|NCT03198559|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
5888089|NCT03179943|Atezolizumab|atezolizumab|mesh-list
5888090|NCT03179943|Guadecitabine|guadecitabine|mesh-list
5888091|NCT03179943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5888092|NCT03136263|Oxytocin|oxytocin|mesh-list
5888093|NCT03136263|Oxytocics|oxytocics|mesh-ancestor
5888094|NCT03136263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5888095|NCT03136263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888096|NCT03129113|Metformin|metformin|mesh-list
5888097|NCT03129113|Maraviroc|maraviroc|mesh-list
5888098|NCT03129113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5888099|NCT03129113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888100|NCT03129113|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5888101|NCT03129113|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5888102|NCT03129113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888103|NCT03129113|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5888104|NCT03129113|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5888105|NCT03129113|Antiviral Agents|antiviral agents|mesh-ancestor
5689956|NCT03426085|Hormones|hormones|mesh-ancestor
5689957|NCT03426085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5689958|NCT03426033|Warfarin|warfarin|mesh-list
5689959|NCT03426033|Anticoagulants|anticoagulants|mesh-ancestor
5689960|NCT03426020|Midazolam|midazolam|mesh-list
5689961|NCT03426020|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5689962|NCT03426020|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5689963|NCT03426020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5888106|NCT03129113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5888107|NCT03129113|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
5888108|NCT03122522|Nivolumab|nivolumab|mesh-list
5888109|NCT03122522|Ipilimumab|ipilimumab|mesh-list
5888110|NCT03122522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5888111|NCT03122522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5888112|NCT03122522|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5888113|NCT03122522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888114|NCT03102125|Regadenoson|regadenoson|mesh-list
5888115|NCT03102125|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
5888116|NCT03102125|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5888117|NCT03102125|Purinergic Agonists|purinergic agonists|mesh-ancestor
5888118|NCT03102125|Purinergic Agents|purinergic agents|mesh-ancestor
5888119|NCT03102125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5888120|NCT03102125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888121|NCT03102125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888122|NCT02982668|Metoclopramide|metoclopramide|mesh-list
5888123|NCT02982668|Mosapride|mosapride|mesh-list
5888124|NCT02982668|Antiemetics|antiemetics|mesh-ancestor
5888125|NCT02982668|Autonomic Agents|autonomic agents|mesh-ancestor
5888126|NCT02982668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5888127|NCT02982668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888128|NCT02982668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5888129|NCT02982668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5888130|NCT02982668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5888131|NCT02982668|Dopamine Agents|dopamine agents|mesh-ancestor
5689964|NCT03426020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888132|NCT02982668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5888133|NCT02982668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888134|NCT02982668|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5888135|NCT02982668|Serotonin Agents|serotonin agents|mesh-ancestor
5888136|NCT02964559|Pembrolizumab|pembrolizumab|mesh-list
5888137|NCT02964559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5888138|NCT02964559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5888139|NCT02924441|Lidocaine|lidocaine|mesh-list
5888140|NCT02924441|Anesthetics, Local|anesthetics, local|mesh-ancestor
5888141|NCT02924441|Anesthetics|anesthetics|mesh-ancestor
5888142|NCT02924441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5888143|NCT02924441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888144|NCT02924441|Sensory System Agents|sensory system agents|mesh-ancestor
5888145|NCT02924441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5888146|NCT02924441|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5689965|NCT03426020|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5689966|NCT03426020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5689967|NCT03426020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5689968|NCT03426020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5689969|NCT03426020|Anesthetics, General|anesthetics, general|mesh-ancestor
5689970|NCT03426020|Anesthetics|anesthetics|mesh-ancestor
5689971|NCT03426020|GABA Modulators|gaba modulators|mesh-ancestor
5689972|NCT03426020|GABA Agents|gaba agents|mesh-ancestor
5689973|NCT03426020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5689974|NCT03426020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689975|NCT03425994|Emtricitabine|emtricitabine|mesh-list
5689976|NCT03425994|Cobicistat|cobicistat|mesh-list
5689977|NCT03425994|Elvitegravir|elvitegravir|mesh-list
5888147|NCT02924441|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5888148|NCT02924441|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5888149|NCT02924441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5888150|NCT02924441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888151|NCT02917096|Vidarabine|vidarabine|mesh-list
5888152|NCT02917096|Sirolimus|sirolimus|mesh-list
5888153|NCT02917096|Fludarabine|fludarabine|mesh-list
5888154|NCT02917096|Fludarabine phosphate|fludarabine phosphate|mesh-list
5888155|NCT02917096|Melphalan|melphalan|mesh-list
5888156|NCT02917096|Mechlorethamine|mechlorethamine|mesh-list
5888157|NCT02917096|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
5888158|NCT02917096|Tacrolimus|tacrolimus|mesh-list
5888159|NCT02917096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5888160|NCT02917096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5888161|NCT02917096|Antimetabolites|antimetabolites|mesh-ancestor
5888162|NCT02917096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888163|NCT02917096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5888164|NCT02917096|Immunologic Factors|immunologic factors|mesh-ancestor
5888165|NCT02917096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888166|NCT02917096|Antiviral Agents|antiviral agents|mesh-ancestor
5888167|NCT02917096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5888168|NCT02917096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5888169|NCT02917096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5888170|NCT02917096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5888171|NCT02917096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5888172|NCT02917096|Antifungal Agents|antifungal agents|mesh-ancestor
5888173|NCT02917096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5888174|NCT02917096|Alkylating Agents|alkylating agents|mesh-ancestor
5888175|NCT02917096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5888176|NCT02917083|Cyclophosphamide|cyclophosphamide|mesh-list
5888177|NCT02917083|Fludarabine|fludarabine|mesh-list
5689978|NCT03425994|Antiviral Agents|antiviral agents|mesh-ancestor
5689979|NCT03425994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5689980|NCT03425994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5689981|NCT03425994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5888178|NCT02917083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5888179|NCT02917083|Immunologic Factors|immunologic factors|mesh-ancestor
5888180|NCT02917083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888181|NCT02917083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5888182|NCT02917083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5888183|NCT02917083|Alkylating Agents|alkylating agents|mesh-ancestor
5888184|NCT02917083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888185|NCT02917083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5888186|NCT02917083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5888187|NCT02913274|Paclitaxel|paclitaxel|mesh-list
5888188|NCT02913274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5888189|NCT02913274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5888190|NCT02913274|Tubulin Modulators|tubulin modulators|mesh-ancestor
5888191|NCT02913274|Antimitotic Agents|antimitotic agents|mesh-ancestor
5689982|NCT03425994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5888192|NCT02913274|Mitosis Modulators|mitosis modulators|mesh-ancestor
5888193|NCT02913274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888194|NCT02908477|Docetaxel|docetaxel|mesh-list
5888195|NCT02908477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5888196|NCT02908477|Tubulin Modulators|tubulin modulators|mesh-ancestor
5888197|NCT02908477|Antimitotic Agents|antimitotic agents|mesh-ancestor
5888198|NCT02908477|Mitosis Modulators|mitosis modulators|mesh-ancestor
5888199|NCT02908477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888200|NCT02906007|Bedaquiline|bedaquiline|mesh-list
5888201|NCT02906007|Antitubercular Agents|antitubercular agents|mesh-ancestor
5888202|NCT02906007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5888203|NCT02906007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5888204|NCT02775812|Cisplatin|cisplatin|mesh-list
5888205|NCT02775812|Pembrolizumab|pembrolizumab|mesh-list
5888206|NCT02775812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5888207|NCT02775812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5888208|NCT02757859|Pancrelipase|pancrelipase|mesh-list
5888209|NCT02757859|Pancreatin|pancreatin|mesh-list
5888210|NCT02757859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5888211|NCT02749513|Itraconazole|itraconazole|mesh-list
5888212|NCT02749513|Antifungal Agents|antifungal agents|mesh-ancestor
5888213|NCT02749513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5888214|NCT02749513|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5888215|NCT02749513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5888216|NCT02749513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5888217|NCT02749513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888218|NCT02749513|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5888219|NCT02749513|Hormone Antagonists|hormone antagonists|mesh-ancestor
5888220|NCT02749513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5888221|NCT02749513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888222|NCT02749513|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5888223|NCT02684227|Paclitaxel|paclitaxel|mesh-list
5888224|NCT02684227|Carboplatin|carboplatin|mesh-list
5888225|NCT02684227|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5888226|NCT02684227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5888227|NCT02684227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5888228|NCT02684227|Tubulin Modulators|tubulin modulators|mesh-ancestor
5888229|NCT02684227|Antimitotic Agents|antimitotic agents|mesh-ancestor
5888230|NCT02684227|Mitosis Modulators|mitosis modulators|mesh-ancestor
5888231|NCT02684227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888232|NCT02682641|Rituximab|rituximab|mesh-list
5888233|NCT02682641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5888234|NCT02682641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5888235|NCT02682641|Immunologic Factors|immunologic factors|mesh-ancestor
5888236|NCT02682641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888237|NCT02682641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5907133|NCT04737343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907134|NCT04737343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5907135|NCT04737343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5907136|NCT04737343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5907137|NCT04737343|Immunologic Factors|immunologic factors|mesh-ancestor
5907138|NCT04737343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907139|NCT04737343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5907140|NCT04737343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5907141|NCT04696445|Morphine|morphine|mesh-list
5907142|NCT04696445|Oxycodone|oxycodone|mesh-list
5907143|NCT04696445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5907144|NCT04696445|Narcotics|narcotics|mesh-ancestor
5907145|NCT04696445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5907146|NCT04696445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907147|NCT04696445|Analgesics|analgesics|mesh-ancestor
5907148|NCT04696445|Sensory System Agents|sensory system agents|mesh-ancestor
5907149|NCT04696445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5907150|NCT04638881|Magnesium Sulfate|magnesium sulfate|mesh-list
5907151|NCT04638881|Analgesics|analgesics|mesh-ancestor
5907152|NCT04638881|Sensory System Agents|sensory system agents|mesh-ancestor
5907153|NCT04638881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5907154|NCT04638881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907155|NCT04638881|Anesthetics|anesthetics|mesh-ancestor
5907156|NCT04638881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5907157|NCT04638881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5907158|NCT04638881|Anticonvulsants|anticonvulsants|mesh-ancestor
5907159|NCT04638881|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5907160|NCT04638881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5907161|NCT04638881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888238|NCT05110339|Dexmedetomidine|dexmedetomidine|mesh-list
6675536|NCT01576029|Antimitotic Agents|antimitotic agents|mesh-ancestor
6675537|NCT01576029|Mitosis Modulators|mitosis modulators|mesh-ancestor
6675538|NCT01576029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675539|NCT01576094|Simendan|simendan|mesh-list
6675540|NCT01576094|Milrinone|milrinone|mesh-list
6675541|NCT01576094|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6675542|NCT01576094|Vasodilator Agents|vasodilator agents|mesh-ancestor
6675543|NCT01576094|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6675544|NCT01576094|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6675545|NCT01576094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6675546|NCT01576094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675547|NCT01576094|Protective Agents|protective agents|mesh-ancestor
6675548|NCT01576094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888239|NCT05110339|Ropivacaine|ropivacaine|mesh-list
5888240|NCT05110339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5888241|NCT05110339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5888242|NCT05110339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888243|NCT05110339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5888244|NCT05110339|Analgesics|analgesics|mesh-ancestor
5888245|NCT05110339|Sensory System Agents|sensory system agents|mesh-ancestor
5888246|NCT05110339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5888247|NCT05110339|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5888248|NCT05110339|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5888249|NCT05110339|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5888250|NCT05110339|Adrenergic Agents|adrenergic agents|mesh-ancestor
5888251|NCT05110339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5888252|NCT05110339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888253|NCT05110339|Anesthetics, Local|anesthetics, local|mesh-ancestor
5888254|NCT05110339|Anesthetics|anesthetics|mesh-ancestor
5888255|NCT05110313|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5888256|NCT05110313|Immunologic Factors|immunologic factors|mesh-ancestor
5888257|NCT05110313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888258|NCT05110170|Goserelin|goserelin|mesh-list
5888259|NCT05110170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5888260|NCT05110170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5888261|NCT05110144|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5888262|NCT05110144|Amitriptyline|amitriptyline|mesh-list
5888263|NCT05110144|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
5888264|NCT05110144|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5888265|NCT05110144|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5888266|NCT05110144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5888267|NCT05110144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888268|NCT05110144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5888269|NCT05110144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888270|NCT05110144|Analgesics|analgesics|mesh-ancestor
5888271|NCT05110144|Sensory System Agents|sensory system agents|mesh-ancestor
5888272|NCT05110144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5888273|NCT05110144|Antidepressive Agents|antidepressive agents|mesh-ancestor
5888274|NCT05110144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5888275|NCT05110144|Dopamine Agents|dopamine agents|mesh-ancestor
5888276|NCT05110144|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5888277|NCT05110144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5888278|NCT05110144|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5888279|NCT05110144|Adrenergic Agents|adrenergic agents|mesh-ancestor
5888280|NCT05110144|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5888281|NCT05110144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5888282|NCT05110144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5888283|NCT05110118|Bevacizumab|bevacizumab|mesh-list
5888284|NCT05110118|Endothelial Growth Factors|endothelial growth factors|mesh-list
5689983|NCT03425994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5689984|NCT03425994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5888285|NCT05110118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5888286|NCT05110118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5888287|NCT05110118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5888288|NCT05110118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6675549|NCT01576094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5689985|NCT03425994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5689986|NCT03425994|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5689987|NCT03425994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5689988|NCT03425994|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5697528|NCT03375515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5888289|NCT05110118|Growth Substances|growth substances|mesh-ancestor
5888290|NCT05110118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888291|NCT05110118|Growth Inhibitors|growth inhibitors|mesh-ancestor
5888292|NCT05109650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5888293|NCT05109650|Antibodies|antibodies|mesh-list
5888294|NCT05109650|Immunoglobulins|immunoglobulins|mesh-list
5689989|NCT03425929|Oxytocin|oxytocin|mesh-list
5689990|NCT03425929|Oxytocics|oxytocics|mesh-ancestor
5689991|NCT03425929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5689992|NCT03425929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5689993|NCT03425838|Letrozole|letrozole|mesh-list
5689994|NCT03425838|Fulvestrant|fulvestrant|mesh-list
5689995|NCT03425838|Palbociclib|palbociclib|mesh-list
5689996|NCT03425838|Anastrozole|anastrozole|mesh-list
5689997|NCT03425838|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5689998|NCT03425838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5888295|NCT05109650|Immunologic Factors|immunologic factors|mesh-ancestor
5888296|NCT05109650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888297|NCT05109585|Antibodies|antibodies|mesh-list
5888298|NCT05109585|Immunoglobulins|immunoglobulins|mesh-list
5888299|NCT05109585|Immunoglobulin G|immunoglobulin g|mesh-list
5689999|NCT03425838|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5690000|NCT03425838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5888300|NCT05109585|Immunologic Factors|immunologic factors|mesh-ancestor
5888301|NCT05109585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888302|NCT05109390|Cyclosporine|cyclosporine|mesh-list
5888303|NCT05109390|Simethicone|simethicone|mesh-list
5888304|NCT05109390|Omeprazole|omeprazole|mesh-list
5888305|NCT05109390|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
5888306|NCT05109390|Calcium Carbonate|calcium carbonate|mesh-list
5888307|NCT05109390|Magnesium Hydroxide|magnesium hydroxide|mesh-list
5888308|NCT05109390|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
5888309|NCT05109390|Antacids|antacids|mesh-list
5888310|NCT05109390|Tacrolimus|tacrolimus|mesh-list
5888311|NCT05109390|Cyclosporins|cyclosporins|mesh-list
5888312|NCT05109390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888313|NCT05109390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5888314|NCT05109390|Immunologic Factors|immunologic factors|mesh-ancestor
5888315|NCT05109390|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5888316|NCT05109390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5888317|NCT05109390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888318|NCT05109390|Antifungal Agents|antifungal agents|mesh-ancestor
5888319|NCT05109390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5888320|NCT05109390|Dermatologic Agents|dermatologic agents|mesh-ancestor
5888321|NCT05109390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5888322|NCT05109390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5888323|NCT05109390|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5888324|NCT05109390|Antifoaming Agents|antifoaming agents|mesh-ancestor
5888325|NCT05109390|Emollients|emollients|mesh-ancestor
5888326|NCT05109377|Tadalafil|tadalafil|mesh-list
5888327|NCT05109377|Vasodilator Agents|vasodilator agents|mesh-ancestor
5888328|NCT05109377|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5888329|NCT05109377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5888330|NCT05109377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5888331|NCT05109377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888332|NCT05109377|Urological Agents|urological agents|mesh-ancestor
5888333|NCT05109312|Acetaminophen|acetaminophen|mesh-list
5888334|NCT05109312|Ibuprofen|ibuprofen|mesh-list
5888335|NCT05109312|Bupivacaine|bupivacaine|mesh-list
5888336|NCT05109312|Anesthetics, Local|anesthetics, local|mesh-ancestor
5888337|NCT05109312|Anesthetics|anesthetics|mesh-ancestor
5888338|NCT05109312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5888339|NCT05109312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888340|NCT05109312|Sensory System Agents|sensory system agents|mesh-ancestor
5888341|NCT05109312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5888342|NCT05109312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5888343|NCT05109312|Analgesics|analgesics|mesh-ancestor
5888344|NCT05109312|Antipyretics|antipyretics|mesh-ancestor
5888345|NCT05109312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5888346|NCT05109312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5888347|NCT05109312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5888348|NCT05109312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5888349|NCT05109312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5888350|NCT05109312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888351|NCT05109299|Fluorides|fluorides|mesh-list
5888352|NCT05109299|Cariostatic Agents|cariostatic agents|mesh-ancestor
5690001|NCT03425838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888353|NCT05109299|Protective Agents|protective agents|mesh-ancestor
5888354|NCT05109299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888355|NCT05109143|Indomethacin|indomethacin|mesh-list
5888356|NCT05109143|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5888357|NCT05109143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5888358|NCT05109143|Analgesics|analgesics|mesh-ancestor
5888359|NCT05109143|Sensory System Agents|sensory system agents|mesh-ancestor
5888360|NCT05109143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5888361|NCT05109143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888362|NCT05109143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5888363|NCT05109143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5888364|NCT05109143|Gout Suppressants|gout suppressants|mesh-ancestor
5888365|NCT05109143|Tocolytic Agents|tocolytic agents|mesh-ancestor
5888366|NCT05109143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5888367|NCT05109143|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5888368|NCT05109143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5888369|NCT05109143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888370|NCT05108870|Paclitaxel|paclitaxel|mesh-list
5888371|NCT05108870|Carboplatin|carboplatin|mesh-list
5888372|NCT05108870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5888373|NCT05108870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5888374|NCT05108870|Tubulin Modulators|tubulin modulators|mesh-ancestor
5888375|NCT05108870|Antimitotic Agents|antimitotic agents|mesh-ancestor
5888376|NCT05108870|Mitosis Modulators|mitosis modulators|mesh-ancestor
5888377|NCT05108870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888378|NCT05108714|Lidocaine|lidocaine|mesh-list
5888379|NCT05108714|Anesthetics, Local|anesthetics, local|mesh-ancestor
5888380|NCT05108714|Anesthetics|anesthetics|mesh-ancestor
5888381|NCT05108714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5888382|NCT05108714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888383|NCT05108714|Sensory System Agents|sensory system agents|mesh-ancestor
5690002|NCT03425838|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5690003|NCT03425838|Hormone Antagonists|hormone antagonists|mesh-ancestor
5690004|NCT03425838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5690005|NCT03425838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690006|NCT03425838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5690007|NCT03425838|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5690008|NCT03425838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5690009|NCT03425812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
5690010|NCT03425812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5888384|NCT05108714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5888385|NCT05108714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5888386|NCT05108714|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5888387|NCT05108714|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5888388|NCT05108714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5888389|NCT05108714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888390|NCT05108597|Misoprostol|misoprostol|mesh-list
5888391|NCT05108597|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5888392|NCT05108597|Abortifacient Agents|abortifacient agents|mesh-ancestor
5888393|NCT05108597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5888394|NCT05108597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888395|NCT05108597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5888396|NCT05108597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5888397|NCT05108597|Oxytocics|oxytocics|mesh-ancestor
5888398|NCT05108545|Amphotericin B|amphotericin b|mesh-list
5888399|NCT05108545|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
5888400|NCT05108545|Amebicides|amebicides|mesh-ancestor
5888401|NCT05108545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5888402|NCT05108545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5888403|NCT05108545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5888404|NCT05108545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5888405|NCT05108545|Antifungal Agents|antifungal agents|mesh-ancestor
5888406|NCT05108428|Capecitabine|capecitabine|mesh-list
5888407|NCT05108428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5888408|NCT05108428|Antimetabolites|antimetabolites|mesh-ancestor
5888409|NCT05108428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888410|NCT05108428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5888411|NCT05102695|Fibrin fragment D|fibrin fragment d|mesh-list
5888412|NCT05102695|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5888413|NCT05102695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5888414|NCT05102695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888415|NCT05102695|Hemostatics|hemostatics|mesh-ancestor
5888416|NCT05102695|Coagulants|coagulants|mesh-ancestor
5888417|NCT05098847|Lenvatinib|lenvatinib|mesh-list
5888418|NCT05098847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5888419|NCT05098847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5888420|NCT05098847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5888421|NCT05098847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888422|NCT05097118|Ketamine|ketamine|mesh-list
5888423|NCT05097118|Bupivacaine|bupivacaine|mesh-list
5888424|NCT05097118|Anesthetics, Local|anesthetics, local|mesh-ancestor
5888425|NCT05097118|Anesthetics|anesthetics|mesh-ancestor
5888426|NCT05097118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5888427|NCT05097118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888428|NCT05097118|Sensory System Agents|sensory system agents|mesh-ancestor
5888429|NCT05097118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5888430|NCT05097118|Analgesics|analgesics|mesh-ancestor
5888431|NCT05097118|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5888432|NCT05097118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5888433|NCT05097118|Anesthetics, General|anesthetics, general|mesh-ancestor
5888434|NCT05097118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5888435|NCT05097118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5888436|NCT05097118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5888437|NCT05097118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888438|NCT05096065|Leuprolide|leuprolide|mesh-list
5888439|NCT05096065|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5888440|NCT05096065|Fertility Agents|fertility agents|mesh-ancestor
5888441|NCT05096065|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5888442|NCT05096065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888443|NCT05096065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5888444|NCT05096065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5888445|NCT05093920|Doxorubicin|doxorubicin|mesh-list
5888446|NCT05093920|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5888447|NCT05093920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5888448|NCT05093920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5888449|NCT05093920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5888450|NCT05093920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5888451|NCT05093920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5888452|NCT05093920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888453|NCT05092373|Paclitaxel|paclitaxel|mesh-list
5888454|NCT05092373|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5888455|NCT05092373|Atezolizumab|atezolizumab|mesh-list
5888456|NCT05092373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5888457|NCT05092373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5888458|NCT05092373|Tubulin Modulators|tubulin modulators|mesh-ancestor
5888459|NCT05092373|Antimitotic Agents|antimitotic agents|mesh-ancestor
5888460|NCT05092373|Mitosis Modulators|mitosis modulators|mesh-ancestor
5888461|NCT05092373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888462|NCT05077254|Mycophenolic Acid|mycophenolic acid|mesh-list
5888463|NCT05077254|Vaccines|vaccines|mesh-list
5888464|NCT05077254|Tacrolimus|tacrolimus|mesh-list
5888465|NCT05077254|Immunologic Factors|immunologic factors|mesh-ancestor
5888466|NCT05077254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888467|NCT05077254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5888468|NCT05077254|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5888469|NCT05077254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5888470|NCT05077254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888471|NCT05077254|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5888472|NCT05077254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5888473|NCT05077254|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5888474|NCT05077254|Antitubercular Agents|antitubercular agents|mesh-ancestor
5888475|NCT05077254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5888476|NCT05077254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5907162|NCT04638881|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5907163|NCT04638881|Tocolytic Agents|tocolytic agents|mesh-ancestor
5907164|NCT04638881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5907165|NCT04635683|Lenalidomide|lenalidomide|mesh-list
5907166|NCT04635683|Immunologic Factors|immunologic factors|mesh-ancestor
5907167|NCT04635683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907168|NCT04635683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5907169|NCT04635683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5907170|NCT04635683|Growth Substances|growth substances|mesh-ancestor
5907171|NCT04635683|Growth Inhibitors|growth inhibitors|mesh-ancestor
5907172|NCT04635683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5907173|NCT04591808|Perindopril|perindopril|mesh-list
5907174|NCT04591808|Atorvastatin|atorvastatin|mesh-list
5907175|NCT04591808|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5907176|NCT04591808|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5907177|NCT04591808|Antimetabolites|antimetabolites|mesh-ancestor
5907178|NCT04591808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907179|NCT04591808|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5888477|NCT05073003|Vaccines|vaccines|mesh-list
5888478|NCT05073003|Immunologic Factors|immunologic factors|mesh-ancestor
5888479|NCT05073003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888480|NCT05053737|Atezolizumab|atezolizumab|mesh-list
5888481|NCT05053737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5888482|NCT05041062|Nivolumab|nivolumab|mesh-list
5888483|NCT05041062|Ipilimumab|ipilimumab|mesh-list
5888484|NCT05041062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5888485|NCT05041062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5888486|NCT05041062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5888487|NCT05041062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888488|NCT05013502|Empagliflozin|empagliflozin|mesh-list
5888489|NCT05013502|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5888490|NCT05013502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888491|NCT05013502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5888492|NCT05013502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888493|NCT05007769|Atezolizumab|atezolizumab|mesh-list
5888494|NCT05007769|Ramucirumab|ramucirumab|mesh-list
5888495|NCT05007769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5888496|NCT04995094|Pembrolizumab|pembrolizumab|mesh-list
5888497|NCT04995094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5888498|NCT04995094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5888499|NCT04977453|Pembrolizumab|pembrolizumab|mesh-list
5888500|NCT04977453|Lenvatinib|lenvatinib|mesh-list
5888501|NCT04977453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5888502|NCT04977453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5888503|NCT04977453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5888504|NCT04977453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5888505|NCT04977453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888506|NCT04961801|Methotrexate|methotrexate|mesh-list
5888507|NCT04961801|Acalabrutinib|acalabrutinib|mesh-list
5888508|NCT04961801|Tacrolimus|tacrolimus|mesh-list
5888509|NCT04961801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5888510|NCT04961801|Abortifacient Agents|abortifacient agents|mesh-ancestor
5888511|NCT04961801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5888512|NCT04961801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888513|NCT04961801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5888514|NCT04961801|Antimetabolites|antimetabolites|mesh-ancestor
5888515|NCT04961801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888516|NCT04961801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5888517|NCT04961801|Dermatologic Agents|dermatologic agents|mesh-ancestor
5888518|NCT04961801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5888519|NCT04961801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5888520|NCT04961801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5888521|NCT04961801|Immunologic Factors|immunologic factors|mesh-ancestor
5888522|NCT04961801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5888523|NCT04961801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5888524|NCT04961801|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5888525|NCT04836910|Metformin|metformin|mesh-list
5888526|NCT04836910|Contraceptive Agents|contraceptive agents|mesh-list
5888527|NCT04836910|Contraceptives, Oral|contraceptives, oral|mesh-list
5888528|NCT04836910|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
5888529|NCT04836910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5888530|NCT04836910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888531|NCT04836910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5888532|NCT04836910|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5888533|NCT04789928|Gentamicins|gentamicins|mesh-list
5888534|NCT04789928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5888535|NCT04789928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5888536|NCT04789928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5888537|NCT04789928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5888538|NCT04789928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888539|NCT04779242|Moxifloxacin|moxifloxacin|mesh-list
5888540|NCT04779242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5888541|NCT04779242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5888542|NCT04779242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5888543|NCT04779242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5888544|NCT04779242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5888545|NCT04779242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888546|NCT04779242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5888547|NCT04772300|Sirolimus|sirolimus|mesh-list
5888548|NCT04772300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5888549|NCT04772300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5888550|NCT04772300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5888551|NCT04772300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5888552|NCT04772300|Antifungal Agents|antifungal agents|mesh-ancestor
5888553|NCT04772300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5690011|NCT03425812|Analgesics|analgesics|mesh-ancestor
5690012|NCT03425812|Sensory System Agents|sensory system agents|mesh-ancestor
5690013|NCT03425812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5690014|NCT03425812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690015|NCT03425812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5690016|NCT03425812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5690017|NCT03425747|Calcium, Dietary|calcium, dietary|mesh-list
5690018|NCT03425747|Calcium Carbonate|calcium carbonate|mesh-list
5690019|NCT03425747|Calcium|calcium|mesh-list
5690020|NCT03425747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5690021|NCT03425747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690022|NCT03425747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5888554|NCT04772300|Immunologic Factors|immunologic factors|mesh-ancestor
5888555|NCT04772300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888556|NCT04762771|Colchicine|colchicine|mesh-list
5888557|NCT04762771|Gout Suppressants|gout suppressants|mesh-ancestor
5888558|NCT04762771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5888559|NCT04762771|Tubulin Modulators|tubulin modulators|mesh-ancestor
5888560|NCT04762771|Antimitotic Agents|antimitotic agents|mesh-ancestor
5888561|NCT04762771|Mitosis Modulators|mitosis modulators|mesh-ancestor
5888562|NCT04762771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888563|NCT04762771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5888564|NCT04760041|Midazolam|midazolam|mesh-list
5888565|NCT04760041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5888566|NCT04760041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5888567|NCT04760041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5888568|NCT04760041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888569|NCT04760041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5888570|NCT04760041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5888571|NCT04760041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5888572|NCT04760041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5888573|NCT04760041|Anesthetics, General|anesthetics, general|mesh-ancestor
5888574|NCT04760041|Anesthetics|anesthetics|mesh-ancestor
5888575|NCT04760041|GABA Modulators|gaba modulators|mesh-ancestor
5888576|NCT04760041|GABA Agents|gaba agents|mesh-ancestor
5888577|NCT04760041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5888578|NCT04760041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888579|NCT04707222|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5888580|NCT04707222|Metronidazole|metronidazole|mesh-list
5888581|NCT04707222|Ciprofloxacin|ciprofloxacin|mesh-list
5888582|NCT04707222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5888583|NCT04707222|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5888584|NCT04707222|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5888585|NCT04707222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5888586|NCT04707222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5888587|NCT04707222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5888588|NCT04707222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888589|NCT04707222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5888590|NCT04707222|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5888591|NCT04707222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5888592|NCT04701060|Apatinib|apatinib|mesh-list
5888593|NCT04701060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5888594|NCT04701060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5888595|NCT04701060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5888596|NCT04701060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888597|NCT04677543|Azithromycin|azithromycin|mesh-list
5888598|NCT04677543|Amikacin|amikacin|mesh-list
5888599|NCT04677543|Ethambutol|ethambutol|mesh-list
5888600|NCT04677543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5888601|NCT04677543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5888602|NCT04677543|Antitubercular Agents|antitubercular agents|mesh-ancestor
5888603|NCT04676477|Osimertinib|osimertinib|mesh-list
5888604|NCT04676477|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
5888605|NCT04676477|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5888606|NCT04676477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5888607|NCT04676477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5888608|NCT04676477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5690023|NCT03425747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5690024|NCT03425747|Antacids|antacids|mesh-ancestor
5690025|NCT03425747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5690026|NCT03425734|Dexmedetomidine|dexmedetomidine|mesh-list
5690027|NCT03425734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5888609|NCT04676477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888610|NCT04676477|Immunologic Factors|immunologic factors|mesh-ancestor
5888611|NCT04676477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888612|NCT04676477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5888613|NCT04674462|Vaccines|vaccines|mesh-list
5888614|NCT04674462|Immunologic Factors|immunologic factors|mesh-ancestor
5888615|NCT04674462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907180|NCT04591808|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5907181|NCT04591808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5907182|NCT04591808|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5907183|NCT04591808|Protease Inhibitors|protease inhibitors|mesh-ancestor
5690028|NCT03425734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5690029|NCT03425734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907184|NCT04591808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5907185|NCT04563338|Bevacizumab|bevacizumab|mesh-list
5907186|NCT04563338|Atezolizumab|atezolizumab|mesh-list
5907187|NCT04563338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5907188|NCT04563338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5907189|NCT04563338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5907190|NCT04563338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5907191|NCT04563338|Growth Substances|growth substances|mesh-ancestor
5907192|NCT04563338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907193|NCT04563338|Growth Inhibitors|growth inhibitors|mesh-ancestor
5907194|NCT04498273|Aspirin|aspirin|mesh-list
5907195|NCT04498273|Apixaban|apixaban|mesh-list
5907196|NCT04498273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5907197|NCT04498273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5907198|NCT04498273|Analgesics|analgesics|mesh-ancestor
5907199|NCT04498273|Sensory System Agents|sensory system agents|mesh-ancestor
5907200|NCT04498273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5907201|NCT04498273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907202|NCT04498273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5907203|NCT04498273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5907204|NCT04498273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5907205|NCT04498273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5907206|NCT04498273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907207|NCT04498273|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5907208|NCT04498273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5907209|NCT04498273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5907210|NCT04498273|Antipyretics|antipyretics|mesh-ancestor
5907211|NCT04498273|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5907212|NCT04498273|Antithrombins|antithrombins|mesh-ancestor
5907213|NCT04498273|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5907214|NCT04498273|Protease Inhibitors|protease inhibitors|mesh-ancestor
5907215|NCT04498273|Anticoagulants|anticoagulants|mesh-ancestor
5907216|NCT04450953|Eplerenone|eplerenone|mesh-list
5907217|NCT04450953|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5907218|NCT04450953|Hormone Antagonists|hormone antagonists|mesh-ancestor
5907219|NCT04450953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5907220|NCT04450953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907221|NCT04450953|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5690030|NCT03425734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5690031|NCT03425734|Analgesics|analgesics|mesh-ancestor
5690032|NCT03425734|Sensory System Agents|sensory system agents|mesh-ancestor
5690033|NCT03425734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5907222|NCT04450953|Diuretics|diuretics|mesh-ancestor
5907223|NCT04450953|Natriuretic Agents|natriuretic agents|mesh-ancestor
5907224|NCT04450953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5907225|NCT04409834|Heparin|heparin|mesh-list
5907226|NCT04409834|Calcium heparin|calcium heparin|mesh-list
5907227|NCT04409834|Enoxaparin|enoxaparin|mesh-list
5907228|NCT04409834|Enoxaparin sodium|enoxaparin sodium|mesh-list
5907229|NCT04409834|Clopidogrel|clopidogrel|mesh-list
5907230|NCT04409834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5907231|NCT04409834|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5907232|NCT04409834|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5907233|NCT04409834|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5907234|NCT04409834|Purinergic Agents|purinergic agents|mesh-ancestor
5907235|NCT04409834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5908680|NCT04278898|Protective Agents|protective agents|mesh-ancestor
5690034|NCT03425734|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5690035|NCT03425734|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5690036|NCT03425734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5690037|NCT03425734|Adrenergic Agents|adrenergic agents|mesh-ancestor
5690038|NCT03425734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5690039|NCT03425734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888616|NCT04626141|Abaloparatide|abaloparatide|mesh-list
5888617|NCT04626141|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5888618|NCT04626141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888619|NCT04595864|Leucovorin|leucovorin|mesh-list
5888620|NCT04595864|Oxaliplatin|oxaliplatin|mesh-list
5888621|NCT04595864|Calcium|calcium|mesh-list
5888622|NCT04595864|Levoleucovorin|levoleucovorin|mesh-list
5888623|NCT04595864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5888624|NCT04595864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888625|NCT04595864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5888626|NCT04595864|Antidotes|antidotes|mesh-ancestor
5888627|NCT04595864|Protective Agents|protective agents|mesh-ancestor
5888628|NCT04595864|Vitamin B Complex|vitamin b complex|mesh-ancestor
5888629|NCT04595864|Vitamins|vitamins|mesh-ancestor
5888630|NCT04595864|Micronutrients|micronutrients|mesh-ancestor
5888631|NCT04583462|Metformin|metformin|mesh-list
5888632|NCT04583462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5888633|NCT04583462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888634|NCT04569383|Vaccines|vaccines|mesh-list
5888635|NCT04569383|Immunologic Factors|immunologic factors|mesh-ancestor
5888636|NCT04569383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888637|NCT04555343|Tranexamic Acid|tranexamic acid|mesh-list
5888638|NCT04555343|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5888639|NCT04555343|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5888640|NCT04555343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888641|NCT04555343|Hemostatics|hemostatics|mesh-ancestor
5888642|NCT04555343|Coagulants|coagulants|mesh-ancestor
5888643|NCT04545411|Dapagliflozin|dapagliflozin|mesh-list
5690040|NCT03425708|Febuxostat|febuxostat|mesh-list
5690041|NCT03425708|Gout Suppressants|gout suppressants|mesh-ancestor
5690042|NCT03425708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5888644|NCT04545411|Volagidemab|volagidemab|mesh-list
5888645|NCT04545411|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5888646|NCT04545411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888647|NCT04545411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5888648|NCT04545411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888649|NCT04495088|Leucovorin|leucovorin|mesh-list
5888650|NCT04495088|Folic Acid|folic acid|mesh-list
5888651|NCT04495088|Capecitabine|capecitabine|mesh-list
5888652|NCT04495088|Fluorouracil|fluorouracil|mesh-list
5888653|NCT04495088|Oxaliplatin|oxaliplatin|mesh-list
5888654|NCT04495088|Levoleucovorin|levoleucovorin|mesh-list
6496218|NCT00627250|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6496219|NCT00627250|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5888655|NCT04495088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5888656|NCT04495088|Antimetabolites|antimetabolites|mesh-ancestor
5888657|NCT04495088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888658|NCT04495088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5888659|NCT04495088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5888660|NCT04495088|Immunologic Factors|immunologic factors|mesh-ancestor
5888661|NCT04495088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888662|NCT04495088|Antidotes|antidotes|mesh-ancestor
5888663|NCT04495088|Protective Agents|protective agents|mesh-ancestor
5888664|NCT04495088|Vitamin B Complex|vitamin b complex|mesh-ancestor
5888665|NCT04495088|Vitamins|vitamins|mesh-ancestor
5690043|NCT03425669|Methylphenidate|methylphenidate|mesh-list
5690044|NCT03425669|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5690045|NCT03425669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690046|NCT03425669|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5690047|NCT03425669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5690048|NCT03425669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5690049|NCT03425669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5690050|NCT03425669|Dopamine Agents|dopamine agents|mesh-ancestor
5888666|NCT04495088|Micronutrients|micronutrients|mesh-ancestor
5888667|NCT04495088|Hematinics|hematinics|mesh-ancestor
5888668|NCT04472494|Abatacept|abatacept|mesh-list
5888669|NCT04472494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5888670|NCT04472494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888671|NCT04472494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5888672|NCT04472494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5888673|NCT04472494|Immunologic Factors|immunologic factors|mesh-ancestor
5888674|NCT04472494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888675|NCT04472494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5888686|NCT04464408|Favipiravir|favipiravir|mesh-list
5888687|NCT04464408|Antiviral Agents|antiviral agents|mesh-ancestor
5888688|NCT04464408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5888689|NCT04456322|Cisplatin|cisplatin|mesh-list
5888690|NCT04456322|Nimotuzumab|nimotuzumab|mesh-list
5888691|NCT04456322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5888692|NCT04456322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5888693|NCT04408664|Cromolyn Sodium|cromolyn sodium|mesh-list
5888694|NCT04408664|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
5888695|NCT04408664|Immunologic Factors|immunologic factors|mesh-ancestor
5888696|NCT04408664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888697|NCT04408664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5888698|NCT04408664|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5888699|NCT04408664|Respiratory System Agents|respiratory system agents|mesh-ancestor
5888700|NCT04405167|Dexamethasone|dexamethasone|mesh-list
5888701|NCT04405167|Lenalidomide|lenalidomide|mesh-list
5888702|NCT04405167|Ixazomib|ixazomib|mesh-list
5888703|NCT04405167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5888704|NCT04405167|Antiemetics|antiemetics|mesh-ancestor
5888705|NCT04405167|Autonomic Agents|autonomic agents|mesh-ancestor
5888706|NCT04405167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5888707|NCT04405167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888708|NCT04405167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5888709|NCT04405167|Glucocorticoids|glucocorticoids|mesh-ancestor
5888710|NCT04405167|Hormones|hormones|mesh-ancestor
5888711|NCT04405167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5888712|NCT04405167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5888713|NCT04405167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5888714|NCT04405167|Protease Inhibitors|protease inhibitors|mesh-ancestor
5888715|NCT04405167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5888716|NCT04405167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888717|NCT04405167|Immunologic Factors|immunologic factors|mesh-ancestor
5888718|NCT04405167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5888719|NCT04405167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5888720|NCT04405167|Growth Substances|growth substances|mesh-ancestor
5888721|NCT04405167|Growth Inhibitors|growth inhibitors|mesh-ancestor
5888722|NCT04383119|Gemcitabine|gemcitabine|mesh-list
5888723|NCT04383119|Trabectedin|trabectedin|mesh-list
5888724|NCT04383119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5888725|NCT04383119|Antimetabolites|antimetabolites|mesh-ancestor
5888726|NCT04383119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888727|NCT04383119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5888728|NCT04383119|Antiviral Agents|antiviral agents|mesh-ancestor
5888729|NCT04383119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5888730|NCT04383119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5888731|NCT04383119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5888732|NCT04383119|Immunologic Factors|immunologic factors|mesh-ancestor
5888733|NCT04383119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888734|NCT04383119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5888735|NCT04383119|Alkylating Agents|alkylating agents|mesh-ancestor
5888736|NCT04339218|Carboplatin|carboplatin|mesh-list
5888737|NCT04339218|Pembrolizumab|pembrolizumab|mesh-list
5888738|NCT04339218|Pemetrexed|pemetrexed|mesh-list
5888739|NCT04339218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5888740|NCT04339218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5888741|NCT04339218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5888742|NCT04339218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888743|NCT04339218|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5888744|NCT04339218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5888745|NCT04309877|Theophylline|theophylline|mesh-list
5888746|NCT04309877|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5888747|NCT04309877|Autonomic Agents|autonomic agents|mesh-ancestor
5888748|NCT04309877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5888749|NCT04309877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888750|NCT04309877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5888751|NCT04309877|Respiratory System Agents|respiratory system agents|mesh-ancestor
5888752|NCT04309877|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5888753|NCT04309877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5888754|NCT04309877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888755|NCT04309877|Vasodilator Agents|vasodilator agents|mesh-ancestor
5888756|NCT04309877|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5888757|NCT04309877|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5888758|NCT04309877|Purinergic Agents|purinergic agents|mesh-ancestor
5888759|NCT04309877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5888760|NCT04305548|Trabectedin|trabectedin|mesh-list
5888761|NCT04305548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5888762|NCT04305548|Alkylating Agents|alkylating agents|mesh-ancestor
5888763|NCT04305548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888764|NCT04305548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5888765|NCT04281420|Niacin|niacin|mesh-list
5888766|NCT04281420|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5888767|NCT04281420|Antimetabolites|antimetabolites|mesh-ancestor
5888768|NCT04281420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888769|NCT04281420|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5888770|NCT04281420|Vasodilator Agents|vasodilator agents|mesh-ancestor
5888771|NCT04281420|Vitamin B Complex|vitamin b complex|mesh-ancestor
5888772|NCT04281420|Vitamins|vitamins|mesh-ancestor
5888773|NCT04281420|Micronutrients|micronutrients|mesh-ancestor
5888774|NCT04281420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888775|NCT04244552|Doxorubicin|doxorubicin|mesh-list
5888776|NCT04244552|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5888777|NCT04244552|Pembrolizumab|pembrolizumab|mesh-list
5888778|NCT04244552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5888779|NCT04244552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5888780|NCT04244552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5888781|NCT04244552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5888782|NCT04244552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5888783|NCT04244552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888784|NCT04244552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5888785|NCT04239339|Citalopram|citalopram|mesh-list
5888786|NCT04239339|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5888787|NCT04239339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5888788|NCT04239339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5888789|NCT04239339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888790|NCT04239339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5888791|NCT04239339|Serotonin Agents|serotonin agents|mesh-ancestor
5888792|NCT04239339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888793|NCT04239339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6496220|NCT00627250|Antiviral Agents|antiviral agents|mesh-ancestor
6496221|NCT00627250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6496222|NCT00627250|Dopamine Agents|dopamine agents|mesh-ancestor
6496223|NCT00627250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5888794|NCT04239339|Antidepressive Agents|antidepressive agents|mesh-ancestor
5888795|NCT04239339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5888796|NCT04200443|Temozolomide|temozolomide|mesh-list
5888797|NCT04200443|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5888798|NCT04200443|Alkylating Agents|alkylating agents|mesh-ancestor
5888799|NCT04200443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888800|NCT04200443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5888801|NCT04195256|Dexmedetomidine|dexmedetomidine|mesh-list
5888802|NCT04195256|Ketamine|ketamine|mesh-list
5888803|NCT04195256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5888804|NCT04195256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5888805|NCT04195256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888806|NCT04195256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5888807|NCT04195256|Analgesics|analgesics|mesh-ancestor
5888808|NCT04195256|Sensory System Agents|sensory system agents|mesh-ancestor
5888809|NCT04195256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5888810|NCT04195256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5888811|NCT04195256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5888812|NCT04195256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5888813|NCT04195256|Adrenergic Agents|adrenergic agents|mesh-ancestor
5888814|NCT04195256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5888815|NCT04195256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888816|NCT04195256|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5888817|NCT04195256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5888818|NCT04195256|Anesthetics, General|anesthetics, general|mesh-ancestor
5888819|NCT04195256|Anesthetics|anesthetics|mesh-ancestor
5888820|NCT04195256|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5888821|NCT04195256|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5888822|NCT04122443|Acetaminophen|acetaminophen|mesh-list
5888823|NCT04122443|Oxycodone|oxycodone|mesh-list
5888824|NCT04122443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6496224|NCT00627250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888825|NCT04122443|Analgesics|analgesics|mesh-ancestor
5888826|NCT04122443|Sensory System Agents|sensory system agents|mesh-ancestor
5888827|NCT04122443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5888828|NCT04122443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888829|NCT04122443|Antipyretics|antipyretics|mesh-ancestor
5888830|NCT04122443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5888831|NCT04122443|Narcotics|narcotics|mesh-ancestor
5888832|NCT04122443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5888833|NCT04121299|Amlodipine|amlodipine|mesh-list
5888834|NCT04121299|Carvedilol|carvedilol|mesh-list
5888835|NCT04121299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5888836|NCT04121299|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5690051|NCT03425669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5690052|NCT03425656|Cyclophosphamide|cyclophosphamide|mesh-list
5888837|NCT04121299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5888838|NCT04121299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888839|NCT04121299|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5888840|NCT04121299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888841|NCT04121299|Vasodilator Agents|vasodilator agents|mesh-ancestor
5888842|NCT04121299|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5888843|NCT04121299|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5888844|NCT04121299|Adrenergic Agents|adrenergic agents|mesh-ancestor
5888845|NCT04121299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5888846|NCT04121299|Antioxidants|antioxidants|mesh-ancestor
5888847|NCT04121299|Protective Agents|protective agents|mesh-ancestor
5888848|NCT04121299|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5888849|NCT04121299|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5888850|NCT04105270|Carboplatin|carboplatin|mesh-list
5888851|NCT04105270|Pemetrexed|pemetrexed|mesh-list
5888852|NCT04105270|Durvalumab|durvalumab|mesh-list
5888853|NCT04105270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5888854|NCT04105270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5888855|NCT04105270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888856|NCT04105270|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5888857|NCT04105270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5888858|NCT04105270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5888859|NCT04097912|Aspirin|aspirin|mesh-list
5888860|NCT04097912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5888861|NCT04097912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5888862|NCT04097912|Analgesics|analgesics|mesh-ancestor
5888863|NCT04097912|Sensory System Agents|sensory system agents|mesh-ancestor
5888864|NCT04097912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5888865|NCT04097912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888866|NCT04097912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5888867|NCT04097912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5888868|NCT04097912|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5888869|NCT04097912|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5888870|NCT04097912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675550|NCT01576185|Sorafenib|sorafenib|mesh-list
6675551|NCT01576185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6675552|NCT01576185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6675553|NCT01576185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6675554|NCT01576185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675555|NCT01576263|Ropivacaine|ropivacaine|mesh-list
6675556|NCT01576263|Anesthetics, Local|anesthetics, local|mesh-ancestor
6675557|NCT01576263|Anesthetics|anesthetics|mesh-ancestor
6675558|NCT01576263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5690053|NCT03425656|Docetaxel|docetaxel|mesh-list
5690054|NCT03425656|Doxorubicin|doxorubicin|mesh-list
5690055|NCT03425656|Trastuzumab|trastuzumab|mesh-list
5690056|NCT03425656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5690057|NCT03425656|Immunologic Factors|immunologic factors|mesh-ancestor
5690058|NCT03425656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690059|NCT03425656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5690060|NCT03425656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5690061|NCT03425656|Alkylating Agents|alkylating agents|mesh-ancestor
5690062|NCT03425656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5690063|NCT03425656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5690064|NCT03425656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5690065|NCT03425656|Tubulin Modulators|tubulin modulators|mesh-ancestor
5690066|NCT03425656|Antimitotic Agents|antimitotic agents|mesh-ancestor
5690067|NCT03425656|Mitosis Modulators|mitosis modulators|mesh-ancestor
5690068|NCT03425656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5690069|NCT03425656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5888871|NCT04097912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5888872|NCT04097912|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5888873|NCT04097912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5888874|NCT04097912|Antipyretics|antipyretics|mesh-ancestor
5888875|NCT04058873|Levonorgestrel|levonorgestrel|mesh-list
5888876|NCT04058873|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5888877|NCT04058873|Contraceptive Agents|contraceptive agents|mesh-ancestor
5888878|NCT04058873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5888879|NCT04058873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888880|NCT04058873|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5888881|NCT04058873|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5888882|NCT04058873|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5888883|NCT04040738|Anesthetics|anesthetics|mesh-list
5888884|NCT04040738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5888885|NCT04040738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888886|NCT04008082|Lenvatinib|lenvatinib|mesh-list
5888887|NCT04008082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5888888|NCT04008082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5888889|NCT04008082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5888890|NCT04008082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888891|NCT04007224|Oxytocin|oxytocin|mesh-list
5888892|NCT04007224|Oxytocics|oxytocics|mesh-ancestor
5888893|NCT04007224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5888894|NCT04007224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888895|NCT04005339|Leucovorin|leucovorin|mesh-list
5888896|NCT04005339|Fluorouracil|fluorouracil|mesh-list
5888897|NCT04005339|Irinotecan|irinotecan|mesh-list
5888898|NCT04005339|Antimetabolites|antimetabolites|mesh-ancestor
5888899|NCT04005339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888900|NCT04005339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5888901|NCT04005339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5888902|NCT04005339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5888903|NCT04005339|Immunologic Factors|immunologic factors|mesh-ancestor
5888904|NCT04005339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888905|NCT04005339|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5888906|NCT04005339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5888907|NCT04005339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5888908|NCT04005339|Antidotes|antidotes|mesh-ancestor
5888909|NCT04005339|Protective Agents|protective agents|mesh-ancestor
5888910|NCT04005339|Vitamin B Complex|vitamin b complex|mesh-ancestor
5888911|NCT04005339|Vitamins|vitamins|mesh-ancestor
5888912|NCT04005339|Micronutrients|micronutrients|mesh-ancestor
5888913|NCT04003649|Nivolumab|nivolumab|mesh-list
5888914|NCT04003649|Ipilimumab|ipilimumab|mesh-list
5888915|NCT04003649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5888916|NCT04003649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5888917|NCT04003649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5888918|NCT04003649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888919|NCT03981796|Paclitaxel|paclitaxel|mesh-list
5888920|NCT03981796|Carboplatin|carboplatin|mesh-list
5888921|NCT03981796|Niraparib|niraparib|mesh-list
5888922|NCT03981796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5888923|NCT03981796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5888924|NCT03981796|Tubulin Modulators|tubulin modulators|mesh-ancestor
5888925|NCT03981796|Antimitotic Agents|antimitotic agents|mesh-ancestor
5888926|NCT03981796|Mitosis Modulators|mitosis modulators|mesh-ancestor
5888927|NCT03981796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888928|NCT03981796|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5690070|NCT03425656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5690071|NCT03425656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5690072|NCT03425656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5690073|NCT03425617|Tiotropium Bromide|tiotropium bromide|mesh-list
5690074|NCT03425617|Olodaterol|olodaterol|mesh-list
5690075|NCT03425617|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5690076|NCT03425617|Autonomic Agents|autonomic agents|mesh-ancestor
5690077|NCT03425617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5690078|NCT03425617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690079|NCT03425617|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5690080|NCT03425617|Respiratory System Agents|respiratory system agents|mesh-ancestor
5690081|NCT03425617|Parasympatholytics|parasympatholytics|mesh-ancestor
5690082|NCT03425617|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5690083|NCT03425617|Cholinergic Agents|cholinergic agents|mesh-ancestor
5690084|NCT03425617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5690085|NCT03425617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5690086|NCT03425552|Paliperidone Palmitate|paliperidone palmitate|mesh-list
5690087|NCT03425552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5690088|NCT03425552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5690089|NCT03425552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5690090|NCT03425552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690091|NCT03425552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5690092|NCT03425552|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5690093|NCT03425552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5690094|NCT03425552|Serotonin Agents|serotonin agents|mesh-ancestor
5690095|NCT03425552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5690096|NCT03425552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5690097|NCT03425552|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5690098|NCT03425552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5888929|NCT03981796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5888930|NCT03973333|Atezolizumab|atezolizumab|mesh-list
5888931|NCT03973333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5907236|NCT04409834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907237|NCT04409834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907238|NCT04409834|Anticoagulants|anticoagulants|mesh-ancestor
5907239|NCT04409834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5907240|NCT04409834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5908681|NCT04278898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5908682|NCT04278898|Antidotes|antidotes|mesh-ancestor
5908683|NCT04268849|Ascorbic Acid|ascorbic acid|mesh-list
5908684|NCT04268849|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
5908685|NCT04268849|Vitamins|vitamins|mesh-ancestor
5908686|NCT04268849|Micronutrients|micronutrients|mesh-ancestor
5908687|NCT04268849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5908688|NCT04268849|Antioxidants|antioxidants|mesh-ancestor
5908689|NCT04268849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908690|NCT04268849|Protective Agents|protective agents|mesh-ancestor
5908691|NCT04268849|Hematinics|hematinics|mesh-ancestor
5908692|NCT04268849|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5908693|NCT04268849|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5908694|NCT04250155|Atezolizumab|atezolizumab|mesh-list
5908695|NCT04250155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5908696|NCT04239703|Antibodies|antibodies|mesh-list
5908697|NCT04239703|Immunologic Factors|immunologic factors|mesh-ancestor
5908698|NCT04239703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5908699|NCT04229004|Gemcitabine|gemcitabine|mesh-list
5908700|NCT04229004|Paclitaxel|paclitaxel|mesh-list
5908701|NCT04229004|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5908702|NCT04229004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5908703|NCT04229004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5908704|NCT04229004|Tubulin Modulators|tubulin modulators|mesh-ancestor
5908705|NCT04229004|Antimitotic Agents|antimitotic agents|mesh-ancestor
5908706|NCT04229004|Mitosis Modulators|mitosis modulators|mesh-ancestor
5908707|NCT04229004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908708|NCT04229004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5908709|NCT04229004|Antimetabolites|antimetabolites|mesh-ancestor
5908710|NCT04229004|Antiviral Agents|antiviral agents|mesh-ancestor
5908711|NCT04229004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5908712|NCT04229004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5908713|NCT04229004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5908714|NCT04229004|Immunologic Factors|immunologic factors|mesh-ancestor
5908715|NCT04229004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690099|NCT03425552|Dopamine Agents|dopamine agents|mesh-ancestor
5690100|NCT03425474|Propofol|propofol|mesh-list
5690101|NCT03425474|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5908716|NCT04183335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
5908717|NCT04183335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5908718|NCT04183335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908719|NCT04159519|Budesonide|budesonide|mesh-list
5908720|NCT04159519|Albuterol|albuterol|mesh-list
5908721|NCT04159519|Formoterol Fumarate|formoterol fumarate|mesh-list
5908722|NCT04159519|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
5908723|NCT04159519|Benralizumab|benralizumab|mesh-list
5908724|NCT04159519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5908725|NCT04159519|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5908726|NCT04159519|Autonomic Agents|autonomic agents|mesh-ancestor
5908727|NCT04159519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5908728|NCT04159519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690102|NCT03425474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5908729|NCT04159519|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5908730|NCT04159519|Respiratory System Agents|respiratory system agents|mesh-ancestor
5908731|NCT04159519|Glucocorticoids|glucocorticoids|mesh-ancestor
5908732|NCT04159519|Hormones|hormones|mesh-ancestor
5888932|NCT03943342|Venetoclax|venetoclax|mesh-list
5888933|NCT03943342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5888934|NCT03783351|Clopidogrel|clopidogrel|mesh-list
5888935|NCT03783351|Ticagrelor|ticagrelor|mesh-list
5888936|NCT03783351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5888937|NCT03783351|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5888938|NCT03783351|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5888939|NCT03783351|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5888940|NCT03783351|Purinergic Agents|purinergic agents|mesh-ancestor
5888941|NCT03783351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5888942|NCT03783351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888943|NCT03783351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888944|NCT03739203|Cariprazine|cariprazine|mesh-list
5888945|NCT03739203|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5888946|NCT03739203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5888947|NCT03739203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5888948|NCT03739203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888949|NCT03739203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5888950|NCT03738215|Cariprazine|cariprazine|mesh-list
5888951|NCT03738215|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5888952|NCT03738215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5888953|NCT03738215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5888954|NCT03738215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888955|NCT03738215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5888956|NCT03682224|Epinephrine|epinephrine|mesh-list
5888957|NCT03682224|Bupivacaine|bupivacaine|mesh-list
5888958|NCT03682224|Anesthetics, Local|anesthetics, local|mesh-ancestor
5888959|NCT03682224|Anesthetics|anesthetics|mesh-ancestor
5888960|NCT03682224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5888961|NCT03682224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888962|NCT03682224|Sensory System Agents|sensory system agents|mesh-ancestor
5888963|NCT03682224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5888964|NCT03682224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5888965|NCT03682224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5888966|NCT03682224|Adrenergic Agents|adrenergic agents|mesh-ancestor
5888967|NCT03682224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5888968|NCT03682224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888969|NCT03682224|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5888970|NCT03682224|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5888971|NCT03682224|Autonomic Agents|autonomic agents|mesh-ancestor
5888972|NCT03682224|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5888973|NCT03682224|Respiratory System Agents|respiratory system agents|mesh-ancestor
5888974|NCT03682224|Mydriatics|mydriatics|mesh-ancestor
5888975|NCT03682224|Sympathomimetics|sympathomimetics|mesh-ancestor
5888976|NCT03682224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5888977|NCT03621748|Anesthetics|anesthetics|mesh-list
5888978|NCT03621748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5888979|NCT03621748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888980|NCT03579693|Niacinamide|niacinamide|mesh-list
5888981|NCT03579693|Niacin|niacin|mesh-list
5888982|NCT03579693|Nicotinic Acids|nicotinic acids|mesh-list
5888983|NCT03579693|Coenzyme Q10|coenzyme q10|mesh-list
5888984|NCT03579693|Vitamin B Complex|vitamin b complex|mesh-ancestor
5888985|NCT03579693|Vitamins|vitamins|mesh-ancestor
5888986|NCT03579693|Micronutrients|micronutrients|mesh-ancestor
5888987|NCT03579693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5888988|NCT03579693|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5888989|NCT03579693|Antimetabolites|antimetabolites|mesh-ancestor
5888990|NCT03579693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888991|NCT03579693|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5888992|NCT03579693|Vasodilator Agents|vasodilator agents|mesh-ancestor
5888993|NCT03557359|Nivolumab|nivolumab|mesh-list
5888994|NCT03557359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5888995|NCT03557359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5888996|NCT03557359|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5888997|NCT03557359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5888998|NCT03540901|Acetazolamide|acetazolamide|mesh-list
5690103|NCT03425474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690104|NCT03425474|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5690105|NCT03425474|Anesthetics, General|anesthetics, general|mesh-ancestor
5690106|NCT03425474|Anesthetics|anesthetics|mesh-ancestor
5690107|NCT03425461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5690108|NCT03425461|Nivolumab|nivolumab|mesh-list
5690109|NCT03425461|Ipilimumab|ipilimumab|mesh-list
5690110|NCT03425461|Antibodies|antibodies|mesh-list
5690111|NCT03425461|Immunoglobulins|immunoglobulins|mesh-list
5888999|NCT03540901|Anticonvulsants|anticonvulsants|mesh-ancestor
5889000|NCT03540901|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5889001|NCT03540901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5889002|NCT03540901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889003|NCT03540901|Diuretics|diuretics|mesh-ancestor
5889004|NCT03540901|Natriuretic Agents|natriuretic agents|mesh-ancestor
5889005|NCT03540901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889006|NCT03540875|Remifentanil|remifentanil|mesh-list
5889007|NCT03540875|Propofol|propofol|mesh-list
5889008|NCT03540875|Anesthetics|anesthetics|mesh-ancestor
5889009|NCT03540875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5889010|NCT03540875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889011|NCT03540875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5889012|NCT03540875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5889013|NCT03540875|Anesthetics, General|anesthetics, general|mesh-ancestor
5889014|NCT03540875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5889015|NCT03540875|Narcotics|narcotics|mesh-ancestor
5889016|NCT03540875|Analgesics|analgesics|mesh-ancestor
5889017|NCT03540875|Sensory System Agents|sensory system agents|mesh-ancestor
5889018|NCT03540875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5889019|NCT03536507|Acetazolamide|acetazolamide|mesh-list
5889020|NCT03536507|Anticonvulsants|anticonvulsants|mesh-ancestor
5889021|NCT03536507|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5889022|NCT03536507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5889023|NCT03536507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889024|NCT03536507|Diuretics|diuretics|mesh-ancestor
5889025|NCT03536507|Natriuretic Agents|natriuretic agents|mesh-ancestor
5889026|NCT03536507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889027|NCT03522246|Nivolumab|nivolumab|mesh-list
5889028|NCT03522246|Rucaparib|rucaparib|mesh-list
5889029|NCT03522246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5889030|NCT03522246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5889031|NCT03522246|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5889032|NCT03522246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889033|NCT03522246|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5889034|NCT03522246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5889035|NCT03517735|Remifentanil|remifentanil|mesh-list
5889036|NCT03517735|Propofol|propofol|mesh-list
5889037|NCT03517735|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5889038|NCT03517735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5889039|NCT03517735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889040|NCT03517735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5889041|NCT03517735|Anesthetics, General|anesthetics, general|mesh-ancestor
5889042|NCT03517735|Anesthetics|anesthetics|mesh-ancestor
5889043|NCT03517735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5889044|NCT03517735|Narcotics|narcotics|mesh-ancestor
6496225|NCT00627250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496226|NCT00627250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6496227|NCT00627250|Analgesics|analgesics|mesh-ancestor
5889045|NCT03517735|Analgesics|analgesics|mesh-ancestor
5889046|NCT03517735|Sensory System Agents|sensory system agents|mesh-ancestor
5889047|NCT03517735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5889048|NCT03513562|Venetoclax|venetoclax|mesh-list
5889049|NCT03513562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5889050|NCT03507491|Gemcitabine|gemcitabine|mesh-list
5889051|NCT03507491|Paclitaxel|paclitaxel|mesh-list
5889052|NCT03507491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5889053|NCT03507491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5889054|NCT03507491|Tubulin Modulators|tubulin modulators|mesh-ancestor
5889055|NCT03507491|Antimitotic Agents|antimitotic agents|mesh-ancestor
5889056|NCT03507491|Mitosis Modulators|mitosis modulators|mesh-ancestor
5889057|NCT03507491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889058|NCT03507491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5889059|NCT03507491|Antimetabolites|antimetabolites|mesh-ancestor
5889060|NCT03507491|Antiviral Agents|antiviral agents|mesh-ancestor
5889061|NCT03507491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5889062|NCT03507491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5889063|NCT03507491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5889064|NCT03507491|Immunologic Factors|immunologic factors|mesh-ancestor
5889065|NCT03507491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889066|NCT03450343|Azacitidine|azacitidine|mesh-list
5889067|NCT03450343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5889068|NCT03450343|Antimetabolites|antimetabolites|mesh-ancestor
5889069|NCT03450343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889070|NCT03450343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5889071|NCT03450343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5889072|NCT03400501|Insulin|insulin|mesh-list
5889073|NCT03400501|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5889074|NCT03400501|Insulin Glargine|insulin glargine|mesh-list
5889075|NCT03400501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5889076|NCT03400501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889077|NCT03395314|Midazolam|midazolam|mesh-list
5889078|NCT03395314|Ketamine|ketamine|mesh-list
5889079|NCT03395314|Analgesics|analgesics|mesh-ancestor
5889080|NCT03395314|Sensory System Agents|sensory system agents|mesh-ancestor
5889081|NCT03395314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5889082|NCT03395314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889083|NCT03395314|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5889084|NCT03395314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5889085|NCT03395314|Anesthetics, General|anesthetics, general|mesh-ancestor
5889086|NCT03395314|Anesthetics|anesthetics|mesh-ancestor
5889087|NCT03395314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5889088|NCT03395314|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5889089|NCT03395314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5889090|NCT03395314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5889091|NCT03395314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889092|NCT03395314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5889093|NCT03395314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5889094|NCT03395314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5889095|NCT03395314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5889096|NCT03395314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5889097|NCT03395314|GABA Modulators|gaba modulators|mesh-ancestor
5889098|NCT03395314|GABA Agents|gaba agents|mesh-ancestor
5889099|NCT03347838|Nivolumab|nivolumab|mesh-list
5889100|NCT03347838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5889101|NCT03347838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5889102|NCT03347838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5889103|NCT03347838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889104|NCT03197194|Aspirin|aspirin|mesh-list
5889105|NCT03197194|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5889106|NCT03197194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5889107|NCT03197194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5889108|NCT03197194|Analgesics|analgesics|mesh-ancestor
5889109|NCT03197194|Sensory System Agents|sensory system agents|mesh-ancestor
5889110|NCT03197194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5889111|NCT03197194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889112|NCT03197194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5889113|NCT03197194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5889114|NCT03197194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5889115|NCT03197194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5907241|NCT04326283|Trametinib|trametinib|mesh-list
5690112|NCT03425461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5690113|NCT03425461|Immunologic Factors|immunologic factors|mesh-ancestor
5690114|NCT03425461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690115|NCT03425461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5690116|NCT03425461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5690117|NCT03425461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5690118|NCT03425448|Heparin|heparin|mesh-list
5690119|NCT03425448|Anticoagulants|anticoagulants|mesh-ancestor
5690120|NCT03425448|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5690121|NCT03425448|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5690122|NCT03425448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5690123|NCT03425292|Bevacizumab|bevacizumab|mesh-list
5690124|NCT03425292|Nivolumab|nivolumab|mesh-list
5690125|NCT03425292|Ipilimumab|ipilimumab|mesh-list
5690126|NCT03425292|Temozolomide|temozolomide|mesh-list
5690127|NCT03425292|Lomustine|lomustine|mesh-list
5690128|NCT03425292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5690129|NCT03425292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5690130|NCT03425292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5690131|NCT03425292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5690132|NCT03425292|Growth Substances|growth substances|mesh-ancestor
5690133|NCT03425292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690134|NCT03425292|Growth Inhibitors|growth inhibitors|mesh-ancestor
5690135|NCT03425292|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5690136|NCT03425292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5690137|NCT03425292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5690138|NCT03425292|Alkylating Agents|alkylating agents|mesh-ancestor
5690139|NCT03425279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5690140|NCT03425279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5690141|NCT03425279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5690142|NCT03425162|Morphine|morphine|mesh-list
5690143|NCT03425162|Bupivacaine|bupivacaine|mesh-list
5690144|NCT03425162|Anesthetics, Local|anesthetics, local|mesh-ancestor
5690145|NCT03425162|Anesthetics|anesthetics|mesh-ancestor
5690146|NCT03425162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5690147|NCT03425162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690148|NCT03425162|Sensory System Agents|sensory system agents|mesh-ancestor
5690149|NCT03425162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5690150|NCT03425162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5690151|NCT03425162|Narcotics|narcotics|mesh-ancestor
5690152|NCT03425162|Analgesics|analgesics|mesh-ancestor
5690153|NCT03425084|Morphine|morphine|mesh-list
5690154|NCT03425084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5690155|NCT03425084|Narcotics|narcotics|mesh-ancestor
5690156|NCT03425084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5690157|NCT03425084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690158|NCT03425084|Analgesics|analgesics|mesh-ancestor
5690159|NCT03425084|Sensory System Agents|sensory system agents|mesh-ancestor
5690160|NCT03425084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5690161|NCT03424928|Thalidomide|thalidomide|mesh-list
5690162|NCT03424928|Pomalidomide|pomalidomide|mesh-list
5690163|NCT03424928|Immunologic Factors|immunologic factors|mesh-ancestor
5690164|NCT03424928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690165|NCT03424928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5690166|NCT03424928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5690167|NCT03424928|Growth Substances|growth substances|mesh-ancestor
5690168|NCT03424928|Growth Inhibitors|growth inhibitors|mesh-ancestor
5690169|NCT03424928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5690170|NCT03424928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5690171|NCT03424928|Leprostatic Agents|leprostatic agents|mesh-ancestor
5889116|NCT03197194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889117|NCT03197194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5889118|NCT03197194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5889119|NCT03197194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5889120|NCT03197194|Antipyretics|antipyretics|mesh-ancestor
5889121|NCT03186638|Ibuprofen|ibuprofen|mesh-list
5889122|NCT03186638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5889123|NCT03186638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5889124|NCT03186638|Analgesics|analgesics|mesh-ancestor
5889125|NCT03186638|Sensory System Agents|sensory system agents|mesh-ancestor
5889126|NCT03186638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5889127|NCT03186638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690172|NCT03424928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5690173|NCT03424928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5690174|NCT03424889|Xylometazoline|xylometazoline|mesh-list
5690175|NCT03424889|Nasal Decongestants|nasal decongestants|mesh-ancestor
5690176|NCT03424889|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5690177|NCT03424889|Respiratory System Agents|respiratory system agents|mesh-ancestor
5690178|NCT03424876|Sunitinib|sunitinib|mesh-list
5690179|NCT03424876|Imatinib Mesylate|imatinib mesylate|mesh-list
5690180|NCT03424876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5889128|NCT03186638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5889129|NCT03186638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5889130|NCT03186638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5889131|NCT03186638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5889132|NCT03186638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889133|NCT03087773|Empagliflozin|empagliflozin|mesh-list
5889134|NCT03087773|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5889135|NCT03087773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889136|NCT03087773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5889137|NCT03087773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889138|NCT03034200|TIC10 compound|tic10 compound|mesh-list
5889139|NCT03034200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5889140|NCT02991807|Everolimus|everolimus|mesh-list
5889141|NCT02991807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5889142|NCT02991807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5889143|NCT02991807|Immunologic Factors|immunologic factors|mesh-ancestor
5889144|NCT02991807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889145|NCT02944799|Vitamin D|vitamin d|mesh-list
5889146|NCT02944799|Alendronate|alendronate|mesh-list
5889147|NCT02944799|Calcium|calcium|mesh-list
5889148|NCT02944799|Vitamins|vitamins|mesh-ancestor
5889149|NCT02944799|Micronutrients|micronutrients|mesh-ancestor
5889150|NCT02944799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889151|NCT02944799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5889152|NCT02944799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5690181|NCT03424876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5690182|NCT03424876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5889153|NCT02859064|Lanreotide|lanreotide|mesh-list
5889154|NCT02859064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5889155|NCT02854436|Niraparib|niraparib|mesh-list
5889156|NCT02854436|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5889157|NCT02854436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5889158|NCT02854436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889159|NCT02854436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5889160|NCT02784262|Botulinum Toxins|botulinum toxins|mesh-list
5889161|NCT02784262|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5889162|NCT02784262|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5889163|NCT02784262|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5889164|NCT02784262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5889165|NCT02784262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889166|NCT02784262|Cholinergic Agents|cholinergic agents|mesh-ancestor
5889167|NCT02784262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5889168|NCT02784262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889169|NCT02784262|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5889170|NCT02784262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5889171|NCT02722668|Mycophenolic Acid|mycophenolic acid|mesh-list
5889172|NCT02722668|Sirolimus|sirolimus|mesh-list
5889173|NCT02722668|Cyclophosphamide|cyclophosphamide|mesh-list
5889174|NCT02722668|Fludarabine|fludarabine|mesh-list
5889175|NCT02722668|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5889176|NCT02722668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5889177|NCT02722668|Immunologic Factors|immunologic factors|mesh-ancestor
5889178|NCT02722668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889179|NCT02722668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5690183|NCT03424876|Growth Substances|growth substances|mesh-ancestor
5690184|NCT03424876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690185|NCT03424876|Growth Inhibitors|growth inhibitors|mesh-ancestor
5690186|NCT03424876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5690187|NCT03424876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5690188|NCT03424876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5690189|NCT03424759|Osimertinib|osimertinib|mesh-list
5690190|NCT03424759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5690191|NCT03424759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5690192|NCT03424759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5690193|NCT03424759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5690194|NCT03424746|Edetic Acid|edetic acid|mesh-list
5690195|NCT03424746|Pentetic Acid|pentetic acid|mesh-list
5690196|NCT03424746|Anticoagulants|anticoagulants|mesh-ancestor
5690197|NCT03424746|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5690198|NCT03424746|Chelating Agents|chelating agents|mesh-ancestor
5690199|NCT03424746|Sequestering Agents|sequestering agents|mesh-ancestor
5690200|NCT03424746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5690201|NCT03424746|Antidotes|antidotes|mesh-ancestor
5690202|NCT03424746|Protective Agents|protective agents|mesh-ancestor
5690203|NCT03424746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690204|NCT03424746|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5690205|NCT03424733|Acetaminophen|acetaminophen|mesh-list
5690206|NCT03424733|Interferons|interferons|mesh-list
5690207|NCT03424733|Interferon-beta|interferon-beta|mesh-list
5690208|NCT03424733|Interferon beta-1a|interferon beta-1a|mesh-list
5690209|NCT03424733|Prednisone|prednisone|mesh-list
5690210|NCT03424733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5690211|NCT03424733|Glucocorticoids|glucocorticoids|mesh-ancestor
5690212|NCT03424733|Hormones|hormones|mesh-ancestor
5690213|NCT03424733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5690214|NCT03424733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690215|NCT03424733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5690216|NCT03424733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5690217|NCT03424733|Antiviral Agents|antiviral agents|mesh-ancestor
5690218|NCT03424733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5690219|NCT03424733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5690220|NCT03424733|Analgesics|analgesics|mesh-ancestor
5690221|NCT03424733|Sensory System Agents|sensory system agents|mesh-ancestor
5690222|NCT03424733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5690223|NCT03424733|Antipyretics|antipyretics|mesh-ancestor
5690224|NCT03424733|Immunologic Factors|immunologic factors|mesh-ancestor
5690225|NCT03424733|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5690226|NCT03424707|Eperisone|eperisone|mesh-list
5690227|NCT03424707|Anticonvulsants|anticonvulsants|mesh-ancestor
5690228|NCT03424707|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5690229|NCT03424707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5690230|NCT03424707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5690231|NCT03424707|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5690232|NCT03424707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690233|NCT03424707|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5690234|NCT03424707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5690235|NCT03424707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5690236|NCT03424707|Parasympatholytics|parasympatholytics|mesh-ancestor
5690237|NCT03424707|Autonomic Agents|autonomic agents|mesh-ancestor
5690238|NCT03424707|Vasodilator Agents|vasodilator agents|mesh-ancestor
5690239|NCT03424629|Methotrexate|methotrexate|mesh-list
5690240|NCT03424629|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5690241|NCT03424629|Abortifacient Agents|abortifacient agents|mesh-ancestor
5690242|NCT03424629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5690243|NCT03424629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690244|NCT03424629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5690245|NCT03424629|Antimetabolites|antimetabolites|mesh-ancestor
5690246|NCT03424629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5690247|NCT03424629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5690248|NCT03424629|Dermatologic Agents|dermatologic agents|mesh-ancestor
5690249|NCT03424629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5690250|NCT03424629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6496228|NCT00627250|Sensory System Agents|sensory system agents|mesh-ancestor
6496229|NCT00627250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6496230|NCT00627354|Prednisone|prednisone|mesh-list
6496231|NCT00627354|Etoposide|etoposide|mesh-list
6496232|NCT00627354|Vinorelbine|vinorelbine|mesh-list
6496233|NCT00627354|Mitoxantrone|mitoxantrone|mesh-list
6496234|NCT00627354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6496235|NCT00627354|Glucocorticoids|glucocorticoids|mesh-ancestor
6496236|NCT00627354|Hormones|hormones|mesh-ancestor
6496237|NCT00627354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6496238|NCT00627354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496239|NCT00627354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6496240|NCT00627354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6496241|NCT00627354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6496242|NCT00627354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6496243|NCT00627354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6496244|NCT00627354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6496245|NCT00627354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496246|NCT00627354|Tubulin Modulators|tubulin modulators|mesh-ancestor
6496247|NCT00627354|Antimitotic Agents|antimitotic agents|mesh-ancestor
5889180|NCT02722668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5889181|NCT02722668|Alkylating Agents|alkylating agents|mesh-ancestor
5889182|NCT02722668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889183|NCT02722668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5889184|NCT02722668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5889185|NCT02722668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5889186|NCT02722668|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5889187|NCT02722668|Antitubercular Agents|antitubercular agents|mesh-ancestor
5889188|NCT02722668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5889189|NCT02722668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5889190|NCT02722668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5889191|NCT02722668|Antifungal Agents|antifungal agents|mesh-ancestor
5889192|NCT02633293|Treprostinil|treprostinil|mesh-list
5889193|NCT02633293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5889194|NCT02599363|Paclitaxel|paclitaxel|mesh-list
5889195|NCT02599363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5889196|NCT02599363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5889197|NCT02599363|Tubulin Modulators|tubulin modulators|mesh-ancestor
5889198|NCT02599363|Antimitotic Agents|antimitotic agents|mesh-ancestor
5889199|NCT02599363|Mitosis Modulators|mitosis modulators|mesh-ancestor
5889200|NCT02599363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889201|NCT02570672|Metformin|metformin|mesh-list
5889202|NCT02570672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5889203|NCT02570672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889204|NCT02521311|Clemastine|clemastine|mesh-list
5889205|NCT02521311|Antipruritics|antipruritics|mesh-ancestor
5889206|NCT02521311|Dermatologic Agents|dermatologic agents|mesh-ancestor
5889207|NCT02521311|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5889208|NCT02521311|Histamine Antagonists|histamine antagonists|mesh-ancestor
5889209|NCT02521311|Histamine Agents|histamine agents|mesh-ancestor
5889210|NCT02521311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5889211|NCT02521311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889212|NCT02521311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496248|NCT00627354|Mitosis Modulators|mitosis modulators|mesh-ancestor
5889213|NCT02521311|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5889214|NCT05112471|Erythritol|erythritol|mesh-list
5889215|NCT05112471|Vasodilator Agents|vasodilator agents|mesh-ancestor
5907242|NCT04326283|Riluzole|riluzole|mesh-list
5907243|NCT04326283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5907244|NCT04326283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5907245|NCT04326283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5907246|NCT04326283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907247|NCT04326283|Anticonvulsants|anticonvulsants|mesh-ancestor
5907248|NCT04326283|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5907249|NCT04326283|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5907250|NCT04326283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5907251|NCT04326283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907252|NCT04326283|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5907253|NCT04326283|Protective Agents|protective agents|mesh-ancestor
5907254|NCT04314895|Paclitaxel|paclitaxel|mesh-list
5907255|NCT04314895|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5907256|NCT04314895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5907257|NCT04314895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5907258|NCT04314895|Tubulin Modulators|tubulin modulators|mesh-ancestor
5690251|NCT03424629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5690252|NCT03424629|Immunologic Factors|immunologic factors|mesh-ancestor
5690253|NCT03424629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5690254|NCT03424629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5690255|NCT03424473|Tucatinib|tucatinib|mesh-list
5690256|NCT03424473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5690257|NCT03424473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5690258|NCT03424473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5690259|NCT03424473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5690260|NCT03424408|Aspirin|aspirin|mesh-list
5690261|NCT03424408|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5690262|NCT03424408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5690263|NCT03424408|Analgesics|analgesics|mesh-ancestor
5690264|NCT03424408|Sensory System Agents|sensory system agents|mesh-ancestor
5690265|NCT03424408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5690266|NCT03424408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907259|NCT04314895|Antimitotic Agents|antimitotic agents|mesh-ancestor
5907260|NCT04314895|Mitosis Modulators|mitosis modulators|mesh-ancestor
5907261|NCT04314895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907262|NCT04296799|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5907263|NCT04268498|Acetaminophen|acetaminophen|mesh-list
5907264|NCT04268498|Diphenhydramine|diphenhydramine|mesh-list
5907265|NCT04268498|Promethazine|promethazine|mesh-list
5907266|NCT04268498|Dexamethasone|dexamethasone|mesh-list
5907267|NCT04268498|Lenalidomide|lenalidomide|mesh-list
5907268|NCT04268498|Bortezomib|bortezomib|mesh-list
5907269|NCT04268498|Daratumumab|daratumumab|mesh-list
5907270|NCT04268498|Montelukast|montelukast|mesh-list
5907271|NCT04268498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5907272|NCT04268498|Antiemetics|antiemetics|mesh-ancestor
5907273|NCT04268498|Autonomic Agents|autonomic agents|mesh-ancestor
5907274|NCT04268498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5907275|NCT04268498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907276|NCT04268498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5907277|NCT04268498|Glucocorticoids|glucocorticoids|mesh-ancestor
5907278|NCT04268498|Hormones|hormones|mesh-ancestor
5907279|NCT04268498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5907280|NCT04268498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5907281|NCT04268498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5907282|NCT04268498|Immunologic Factors|immunologic factors|mesh-ancestor
5907283|NCT04268498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5907284|NCT04268498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5907285|NCT04268498|Growth Substances|growth substances|mesh-ancestor
5907286|NCT04268498|Growth Inhibitors|growth inhibitors|mesh-ancestor
5907287|NCT04268498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5907288|NCT04268498|Analgesics|analgesics|mesh-ancestor
5907289|NCT04268498|Sensory System Agents|sensory system agents|mesh-ancestor
5907290|NCT04268498|Antipyretics|antipyretics|mesh-ancestor
5907291|NCT04268498|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5907292|NCT04268498|Respiratory System Agents|respiratory system agents|mesh-ancestor
5907293|NCT04268498|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5907294|NCT04268498|Hormone Antagonists|hormone antagonists|mesh-ancestor
5907295|NCT04268498|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5907296|NCT04268498|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5907297|NCT04268498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907298|NCT04268498|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5889216|NCT05112081|Botulinum Toxins|botulinum toxins|mesh-list
5889217|NCT05112081|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5889218|NCT05112081|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5889219|NCT05112081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5889220|NCT05112081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5889221|NCT05112081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889222|NCT05112081|Cholinergic Agents|cholinergic agents|mesh-ancestor
5889223|NCT05112081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5889224|NCT05112081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889225|NCT05112081|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5889226|NCT05112081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5889227|NCT05111860|Bevacizumab|bevacizumab|mesh-list
5889228|NCT05111860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5889229|NCT05111860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5889230|NCT05111860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5889231|NCT05111860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5889232|NCT05111860|Growth Substances|growth substances|mesh-ancestor
5889233|NCT05111860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889234|NCT05111860|Growth Inhibitors|growth inhibitors|mesh-ancestor
5889235|NCT05111808|Methylene Blue|methylene blue|mesh-list
5889236|NCT05111808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5889237|NCT05111808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889238|NCT05111769|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
5889239|NCT05111769|Natriuretic Agents|natriuretic agents|mesh-ancestor
5889240|NCT05111769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889241|NCT05111444|Paclitaxel|paclitaxel|mesh-list
5889242|NCT05111444|Capecitabine|capecitabine|mesh-list
5889243|NCT05111444|Oxaliplatin|oxaliplatin|mesh-list
5889244|NCT05111444|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5889245|NCT05111444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5889246|NCT05111444|Tubulin Modulators|tubulin modulators|mesh-ancestor
5889247|NCT05111444|Antimitotic Agents|antimitotic agents|mesh-ancestor
5690267|NCT03424408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5690268|NCT03424408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5690269|NCT03424408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5690270|NCT03424408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5690271|NCT03424408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5690272|NCT03424408|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5889248|NCT05111444|Mitosis Modulators|mitosis modulators|mesh-ancestor
5889249|NCT05111444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889250|NCT05111444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5889251|NCT05111444|Antimetabolites|antimetabolites|mesh-ancestor
5889257|NCT05110911|Vaccines|vaccines|mesh-list
5889258|NCT05110911|Immunologic Factors|immunologic factors|mesh-ancestor
5889259|NCT05110911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889260|NCT05110898|Olmesartan|olmesartan|mesh-list
5889261|NCT05110898|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
5889262|NCT05110898|Indapamide|indapamide|mesh-list
5889263|NCT05110898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5889264|NCT05110898|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5889265|NCT05110898|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5690273|NCT03424408|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5690274|NCT03424408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5690275|NCT03424408|Antipyretics|antipyretics|mesh-ancestor
5690276|NCT03424356|Fentanyl|fentanyl|mesh-list
5690277|NCT03424356|Narcotics|narcotics|mesh-list
5690278|NCT03424356|Analgesics|analgesics|mesh-list
5690279|NCT03424356|Bromides|bromides|mesh-list
5690280|NCT03424356|Propofol|propofol|mesh-list
5690281|NCT03424356|Rocuronium|rocuronium|mesh-list
5889266|NCT05110898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889267|NCT05110898|Diuretics|diuretics|mesh-ancestor
5889268|NCT05110898|Natriuretic Agents|natriuretic agents|mesh-ancestor
5889269|NCT05110898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889270|NCT05110898|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5889271|NCT05110898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5889272|NCT05110742|Vidarabine|vidarabine|mesh-list
5690282|NCT03424356|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5690283|NCT03424356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5889273|NCT05110742|Cyclophosphamide|cyclophosphamide|mesh-list
5889274|NCT05110742|Fludarabine|fludarabine|mesh-list
5889275|NCT05110742|Fludarabine phosphate|fludarabine phosphate|mesh-list
5889276|NCT05110742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5889277|NCT05110742|Immunologic Factors|immunologic factors|mesh-ancestor
5889278|NCT05110742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889279|NCT05110742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5889280|NCT05110742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5889281|NCT05110742|Alkylating Agents|alkylating agents|mesh-ancestor
5889282|NCT05110742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889283|NCT05110742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5889284|NCT05110742|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5889285|NCT05110742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5889286|NCT05110742|Antimetabolites|antimetabolites|mesh-ancestor
5889287|NCT05110742|Antiviral Agents|antiviral agents|mesh-ancestor
5889288|NCT05110742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5889289|NCT05110651|Hydroxychloroquine|hydroxychloroquine|mesh-list
5889290|NCT05110651|Antimalarials|antimalarials|mesh-ancestor
5889291|NCT05110651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5889292|NCT05110651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5889293|NCT05110651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5889294|NCT05110651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5889295|NCT05110651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889296|NCT05110651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5889297|NCT05110638|Luliconazole|luliconazole|mesh-list
5889298|NCT05110638|Antifungal Agents|antifungal agents|mesh-ancestor
5889299|NCT05110638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5889300|NCT05110482|Oxytocin|oxytocin|mesh-list
5889301|NCT05110482|Carbetocin|carbetocin|mesh-list
5889302|NCT05110482|Oxytocics|oxytocics|mesh-ancestor
5889303|NCT05110482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5889304|NCT05110482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889305|NCT05110469|Magnesium Sulfate|magnesium sulfate|mesh-list
5889306|NCT05110469|Meperidine|meperidine|mesh-list
5889307|NCT05110469|Analgesics|analgesics|mesh-ancestor
5889308|NCT05110469|Sensory System Agents|sensory system agents|mesh-ancestor
5889309|NCT05110469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5889310|NCT05110469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889311|NCT05110469|Anesthetics|anesthetics|mesh-ancestor
5889312|NCT05110469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5889313|NCT05110469|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5889314|NCT05110469|Anticonvulsants|anticonvulsants|mesh-ancestor
5889315|NCT05110469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5889316|NCT05110469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5889317|NCT05110469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889318|NCT05110469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5889319|NCT05110469|Tocolytic Agents|tocolytic agents|mesh-ancestor
5889320|NCT05110469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5889321|NCT05110469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5889322|NCT05110469|Narcotics|narcotics|mesh-ancestor
5889323|NCT05110469|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5889324|NCT05110417|Bromides|bromides|mesh-list
5889325|NCT05110417|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
5889326|NCT05110417|Anticonvulsants|anticonvulsants|mesh-ancestor
5889327|NCT05110417|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5889328|NCT05110417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5889329|NCT05110417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889330|NCT05110417|Cholinergic Agents|cholinergic agents|mesh-ancestor
5889331|NCT05110417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5889332|NCT05110417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889333|NCT05110391|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5889334|NCT05110391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5690284|NCT03424356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690285|NCT03424356|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5690286|NCT03424356|Anesthetics, General|anesthetics, general|mesh-ancestor
5690287|NCT03424356|Anesthetics|anesthetics|mesh-ancestor
5690288|NCT03424356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5690289|NCT03424356|Sensory System Agents|sensory system agents|mesh-ancestor
5690290|NCT03424356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5690291|NCT03424356|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5690292|NCT03424356|Anticonvulsants|anticonvulsants|mesh-ancestor
5690293|NCT03424356|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5690294|NCT03424356|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5690295|NCT03424356|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5697529|NCT03375515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697530|NCT03375515|Analgesics|analgesics|mesh-ancestor
5697531|NCT03375515|Sensory System Agents|sensory system agents|mesh-ancestor
5889335|NCT05110391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889336|NCT05109611|Nitric Oxide|nitric oxide|mesh-list
5889337|NCT05109611|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5889338|NCT05109611|Autonomic Agents|autonomic agents|mesh-ancestor
5889339|NCT05109611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5889340|NCT05109611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889341|NCT05109611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5889342|NCT05109611|Respiratory System Agents|respiratory system agents|mesh-ancestor
5889343|NCT05109611|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5889344|NCT05109611|Antioxidants|antioxidants|mesh-ancestor
5889345|NCT05109611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889346|NCT05109611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5889347|NCT05109611|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5889348|NCT05109611|Vasodilator Agents|vasodilator agents|mesh-ancestor
5889349|NCT05109611|Gasotransmitters|gasotransmitters|mesh-ancestor
5889350|NCT05109611|Protective Agents|protective agents|mesh-ancestor
5889351|NCT05103735|Dexmedetomidine|dexmedetomidine|mesh-list
5889352|NCT05103735|Remifentanil|remifentanil|mesh-list
5889353|NCT05103735|Propofol|propofol|mesh-list
5889354|NCT05103735|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5889355|NCT05103735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5889356|NCT05103735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889357|NCT05103735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5889358|NCT05103735|Anesthetics, General|anesthetics, general|mesh-ancestor
5889359|NCT05103735|Anesthetics|anesthetics|mesh-ancestor
5889360|NCT05103735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5889361|NCT05103735|Analgesics|analgesics|mesh-ancestor
5889362|NCT05103735|Sensory System Agents|sensory system agents|mesh-ancestor
5889363|NCT05103735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5889364|NCT05103735|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5889365|NCT05103735|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5889366|NCT05103735|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5889367|NCT05103735|Adrenergic Agents|adrenergic agents|mesh-ancestor
5889368|NCT05103735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5889369|NCT05103735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889370|NCT05103735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5889371|NCT05103735|Narcotics|narcotics|mesh-ancestor
5889372|NCT05101356|Antineoplastic Agents|antineoplastic agents|mesh-list
5889373|NCT05101356|Vaccines|vaccines|mesh-list
5889374|NCT05101356|Sargramostim|sargramostim|mesh-list
5889375|NCT05101356|Immunologic Factors|immunologic factors|mesh-ancestor
5889376|NCT05101356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889377|NCT05101109|Antibodies, Bispecific|antibodies, bispecific|mesh-list
5889378|NCT05101109|Immunologic Factors|immunologic factors|mesh-ancestor
5889379|NCT05101109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889380|NCT05099250|Magnesium Sulfate|magnesium sulfate|mesh-list
5889381|NCT05099250|Bupivacaine|bupivacaine|mesh-list
5889382|NCT05099250|Anesthetics, Local|anesthetics, local|mesh-ancestor
5889383|NCT05099250|Anesthetics|anesthetics|mesh-ancestor
5889384|NCT05099250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5889385|NCT05099250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889386|NCT05099250|Sensory System Agents|sensory system agents|mesh-ancestor
5690296|NCT03424291|Apatinib|apatinib|mesh-list
5690297|NCT03424291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5690298|NCT03424291|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5690299|NCT03424291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5690300|NCT03424291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5690301|NCT03424226|Acetazolamide|acetazolamide|mesh-list
5690302|NCT03424226|Anticonvulsants|anticonvulsants|mesh-ancestor
5690303|NCT03424226|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5690304|NCT03424226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5690305|NCT03424226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889387|NCT05099250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5889388|NCT05099250|Analgesics|analgesics|mesh-ancestor
5889389|NCT05099250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5889390|NCT05099250|Anticonvulsants|anticonvulsants|mesh-ancestor
5889391|NCT05099250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5889392|NCT05099250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5889393|NCT05099250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889394|NCT05099250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5889395|NCT05099250|Tocolytic Agents|tocolytic agents|mesh-ancestor
5889396|NCT05099250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5889397|NCT05094323|Bupivacaine|bupivacaine|mesh-list
5889398|NCT05094323|Anesthetics, Local|anesthetics, local|mesh-ancestor
5889399|NCT05094323|Anesthetics|anesthetics|mesh-ancestor
6212558|NCT02189668|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5889400|NCT05094323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5889401|NCT05094323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889402|NCT05094323|Sensory System Agents|sensory system agents|mesh-ancestor
5889403|NCT05094323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5907299|NCT04268498|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5690306|NCT03424226|Diuretics|diuretics|mesh-ancestor
5690307|NCT03424226|Natriuretic Agents|natriuretic agents|mesh-ancestor
5690308|NCT03424226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690309|NCT03424135|Diphenhydramine|diphenhydramine|mesh-list
5690310|NCT03424135|Promethazine|promethazine|mesh-list
5690311|NCT03424135|Naproxen|naproxen|mesh-list
5907300|NCT04268498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5907301|NCT04268498|Anesthetics, Local|anesthetics, local|mesh-ancestor
5907302|NCT04268498|Anesthetics|anesthetics|mesh-ancestor
5907303|NCT04268498|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5907304|NCT04268498|Histamine Antagonists|histamine antagonists|mesh-ancestor
5907305|NCT04268498|Histamine Agents|histamine agents|mesh-ancestor
5907306|NCT04268498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5907307|NCT04268498|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5907308|NCT04268498|Antipruritics|antipruritics|mesh-ancestor
5907309|NCT04268498|Dermatologic Agents|dermatologic agents|mesh-ancestor
5907310|NCT04248465|Ravulizumab|ravulizumab|mesh-list
5907311|NCT04248465|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5907312|NCT04248465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5907313|NCT04248465|Immunologic Factors|immunologic factors|mesh-ancestor
5907314|NCT04248465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907315|NCT05245227|Misoprostol|misoprostol|mesh-list
5907316|NCT05245227|Oxytocin|oxytocin|mesh-list
5907317|NCT05245227|Oxytocics|oxytocics|mesh-ancestor
5907318|NCT05245227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5907319|NCT05245227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907320|NCT05245227|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5907321|NCT05245227|Abortifacient Agents|abortifacient agents|mesh-ancestor
5907322|NCT05245227|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5907323|NCT05245227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5907324|NCT05245006|Antibodies|antibodies|mesh-list
5907325|NCT05245006|Immunoglobulins|immunoglobulins|mesh-list
5907326|NCT05245006|Immunologic Factors|immunologic factors|mesh-ancestor
5907327|NCT05245006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907328|NCT05244993|Paclitaxel|paclitaxel|mesh-list
5907329|NCT05244993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5907330|NCT05244993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5907331|NCT05244993|Tubulin Modulators|tubulin modulators|mesh-ancestor
5907332|NCT05244993|Antimitotic Agents|antimitotic agents|mesh-ancestor
5907333|NCT05244993|Mitosis Modulators|mitosis modulators|mesh-ancestor
5907334|NCT05244993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907335|NCT05244954|Chloroquine|chloroquine|mesh-list
5907336|NCT05244954|Piperaquine|piperaquine|mesh-list
5907337|NCT05244954|Artenimol|artenimol|mesh-list
5907338|NCT05244954|Amebicides|amebicides|mesh-ancestor
6496249|NCT00627354|Analgesics|analgesics|mesh-ancestor
6496250|NCT00627354|Sensory System Agents|sensory system agents|mesh-ancestor
6496251|NCT00627354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6496252|NCT00627432|Gemcitabine|gemcitabine|mesh-list
6496253|NCT00627432|Oxaliplatin|oxaliplatin|mesh-list
6496254|NCT00627432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6496255|NCT00627432|Antimetabolites|antimetabolites|mesh-ancestor
6496256|NCT00627432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496257|NCT00627432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6496258|NCT00627432|Antiviral Agents|antiviral agents|mesh-ancestor
6496259|NCT00627432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6496260|NCT00627432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6496261|NCT00627432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6496262|NCT00627432|Immunologic Factors|immunologic factors|mesh-ancestor
5907339|NCT05244954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5690312|NCT03424135|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5690313|NCT03424135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5690314|NCT03424135|Analgesics|analgesics|mesh-ancestor
5690315|NCT03424135|Sensory System Agents|sensory system agents|mesh-ancestor
5690316|NCT03424135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5907340|NCT05244954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5907341|NCT05244954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5907342|NCT05244954|Antimalarials|antimalarials|mesh-ancestor
5907343|NCT05244954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5907344|NCT05244837|Paclitaxel|paclitaxel|mesh-list
5907345|NCT05244837|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6496263|NCT00627432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907346|NCT05244837|Carboplatin|carboplatin|mesh-list
5907347|NCT05244837|Pemetrexed|pemetrexed|mesh-list
5889404|NCT05092828|Morphine|morphine|mesh-list
5889405|NCT05092828|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5889406|NCT05092828|Narcotics|narcotics|mesh-ancestor
5889407|NCT05092828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5889408|NCT05092828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889409|NCT05092828|Analgesics|analgesics|mesh-ancestor
5889410|NCT05092828|Sensory System Agents|sensory system agents|mesh-ancestor
5889411|NCT05092828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5889412|NCT05083052|Propolis|propolis|mesh-list
5889413|NCT05083052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5889414|NCT05079802|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5889415|NCT05079802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5889416|NCT05079802|Chitosan|chitosan|mesh-list
5889417|NCT05079802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5889418|NCT05079802|Antitubercular Agents|antitubercular agents|mesh-ancestor
5889419|NCT05079802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5889420|NCT05079802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5889421|NCT05079802|Antimetabolites|antimetabolites|mesh-ancestor
5889422|NCT05079802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889423|NCT05079802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5889424|NCT05079802|Chelating Agents|chelating agents|mesh-ancestor
5889425|NCT05079802|Sequestering Agents|sequestering agents|mesh-ancestor
5889426|NCT05079802|Hemostatics|hemostatics|mesh-ancestor
5889427|NCT05079802|Coagulants|coagulants|mesh-ancestor
5889428|NCT05032794|Bisacodyl|bisacodyl|mesh-list
5889429|NCT05032794|Cathartics|cathartics|mesh-ancestor
5889430|NCT05032794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5889431|NCT05032794|Laxatives|laxatives|mesh-ancestor
5889432|NCT05006599|Insulin|insulin|mesh-list
5889433|NCT05006599|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5889434|NCT05006599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5889435|NCT05006599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889436|NCT04974879|Osimertinib|osimertinib|mesh-list
5889437|NCT04974879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5889438|NCT04974879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5889439|NCT04974879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5889440|NCT04974879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889441|NCT04947553|Dextromethorphan|dextromethorphan|mesh-list
5889442|NCT04947553|Bupropion|bupropion|mesh-list
5889443|NCT04947553|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5690317|NCT03424135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690318|NCT03424135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5889444|NCT04947553|Antidepressive Agents|antidepressive agents|mesh-ancestor
5889445|NCT04947553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5889446|NCT04947553|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5889447|NCT04947553|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5889448|NCT04947553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5889449|NCT04947553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889450|NCT04947553|Dopamine Agents|dopamine agents|mesh-ancestor
5889451|NCT04947553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5889452|NCT04947553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889453|NCT04947553|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5889454|NCT04947553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5889455|NCT04947553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5889456|NCT04947553|Antitussive Agents|antitussive agents|mesh-ancestor
5889457|NCT04947553|Respiratory System Agents|respiratory system agents|mesh-ancestor
5889458|NCT04947553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5690319|NCT03424135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5690320|NCT03424135|Gout Suppressants|gout suppressants|mesh-ancestor
5690321|NCT03424135|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5690322|NCT03424135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5690323|NCT03424135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5690324|NCT03424135|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5690325|NCT03424135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5690326|NCT03424135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5690327|NCT03424135|Anesthetics, Local|anesthetics, local|mesh-ancestor
5690328|NCT03424135|Anesthetics|anesthetics|mesh-ancestor
5690329|NCT03424135|Antiemetics|antiemetics|mesh-ancestor
5690330|NCT03424135|Autonomic Agents|autonomic agents|mesh-ancestor
5690331|NCT03424135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5690332|NCT03424135|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5690333|NCT03424135|Histamine Antagonists|histamine antagonists|mesh-ancestor
5690334|NCT03424135|Histamine Agents|histamine agents|mesh-ancestor
5690335|NCT03424135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5690336|NCT03424135|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5690337|NCT03424135|Antipruritics|antipruritics|mesh-ancestor
5889459|NCT04947553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5889460|NCT04910230|Niacinamide|niacinamide|mesh-list
5889461|NCT04910230|Niacin|niacin|mesh-list
5889462|NCT04910230|Nicotinic Acids|nicotinic acids|mesh-list
5889463|NCT04910230|Vitamin B Complex|vitamin b complex|mesh-ancestor
5889464|NCT04910230|Vitamins|vitamins|mesh-ancestor
5889465|NCT04910230|Micronutrients|micronutrients|mesh-ancestor
5889466|NCT04910230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889467|NCT04910230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5889468|NCT04910230|Antimetabolites|antimetabolites|mesh-ancestor
5889469|NCT04910230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889470|NCT04910230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5889471|NCT04910230|Vasodilator Agents|vasodilator agents|mesh-ancestor
5889472|NCT04887870|Pembrolizumab|pembrolizumab|mesh-list
5889473|NCT04887870|Nivolumab|nivolumab|mesh-list
5889474|NCT04887870|Ipilimumab|ipilimumab|mesh-list
5889475|NCT04887870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5889476|NCT04887870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5889477|NCT04887870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5889478|NCT04887870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889479|NCT04851301|Naloxone|naloxone|mesh-list
5889480|NCT04851301|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5889481|NCT04851301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889482|NCT04851301|Sensory System Agents|sensory system agents|mesh-ancestor
5889483|NCT04851301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5889484|NCT04796779|Ferrous fumarate|ferrous fumarate|mesh-list
5889485|NCT04796779|Trace Elements|trace elements|mesh-ancestor
5889486|NCT04796779|Micronutrients|micronutrients|mesh-ancestor
5889487|NCT04796779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889488|NCT04783857|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
5889489|NCT04783857|Medroxyprogesterone|medroxyprogesterone|mesh-list
5889490|NCT04783857|Progesterone|progesterone|mesh-list
5889491|NCT04783857|Progestins|progestins|mesh-ancestor
5889492|NCT04783857|Hormones|hormones|mesh-ancestor
5889493|NCT04783857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5889494|NCT04783857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889495|NCT04783857|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5889496|NCT04783857|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5889497|NCT04783857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5889498|NCT04783857|Contraceptive Agents|contraceptive agents|mesh-ancestor
5889499|NCT04783857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5889500|NCT04783857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5889501|NCT04783857|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5889502|NCT04783857|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5889503|NCT04783857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5889504|NCT04783857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5889505|NCT04781478|Chlorhexidine|chlorhexidine|mesh-list
5889506|NCT04781478|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5889507|NCT04781478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5889508|NCT04781478|Disinfectants|disinfectants|mesh-ancestor
5889509|NCT04774237|Brimonidine Tartrate|brimonidine tartrate|mesh-list
5889510|NCT04774237|Carbachol|carbachol|mesh-list
5889511|NCT04774237|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5889512|NCT04774237|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5889513|NCT04774237|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5889514|NCT04774237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5889515|NCT04774237|Adrenergic Agents|adrenergic agents|mesh-ancestor
5889516|NCT04774237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5889517|NCT04774237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889518|NCT04774237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889519|NCT04774237|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5889520|NCT04774237|Miotics|miotics|mesh-ancestor
5889521|NCT04774237|Autonomic Agents|autonomic agents|mesh-ancestor
5889522|NCT04774237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5889523|NCT04774237|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5889524|NCT04774237|Cholinergic Agents|cholinergic agents|mesh-ancestor
5889525|NCT04774237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5889526|NCT04774237|Analgesics|analgesics|mesh-ancestor
5889527|NCT04774237|Sensory System Agents|sensory system agents|mesh-ancestor
5889528|NCT04774237|Protective Agents|protective agents|mesh-ancestor
5889529|NCT04768010|Misoprostol|misoprostol|mesh-list
5889530|NCT04768010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5889531|NCT04768010|Abortifacient Agents|abortifacient agents|mesh-ancestor
5889532|NCT04768010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5889533|NCT04768010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889534|NCT04768010|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5889535|NCT04768010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6212559|NCT02189668|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6212560|NCT02189668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6212561|NCT02189668|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6212562|NCT02189668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5889536|NCT04768010|Oxytocics|oxytocics|mesh-ancestor
5889537|NCT04764942|Dexamethasone|dexamethasone|mesh-list
5889538|NCT04764942|Dexamethasone acetate|dexamethasone acetate|mesh-list
5889539|NCT04764942|Pomalidomide|pomalidomide|mesh-list
5889540|NCT04764942|Ichthammol|ichthammol|mesh-list
5889541|NCT04764942|BB 1101|bb 1101|mesh-list
5690338|NCT03424135|Dermatologic Agents|dermatologic agents|mesh-ancestor
5690339|NCT03424018|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
5690340|NCT03424018|Natriuretic Agents|natriuretic agents|mesh-ancestor
5690341|NCT03424018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690342|NCT03423979|Paclitaxel|paclitaxel|mesh-list
5690343|NCT03423979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5690344|NCT03423979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5889542|NCT04764942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5889543|NCT04764942|Antiemetics|antiemetics|mesh-ancestor
5889544|NCT04764942|Autonomic Agents|autonomic agents|mesh-ancestor
5889545|NCT04764942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5889546|NCT04764942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889547|NCT04764942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5889548|NCT04764942|Glucocorticoids|glucocorticoids|mesh-ancestor
5889549|NCT04764942|Hormones|hormones|mesh-ancestor
5889550|NCT04764942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5889551|NCT04764942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5889552|NCT04764942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5889553|NCT04764942|Protease Inhibitors|protease inhibitors|mesh-ancestor
5889554|NCT04764942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5889555|NCT04764942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889556|NCT04764942|Immunologic Factors|immunologic factors|mesh-ancestor
5889557|NCT04764942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5889558|NCT04764942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5889559|NCT04764942|Growth Substances|growth substances|mesh-ancestor
5889560|NCT04764942|Growth Inhibitors|growth inhibitors|mesh-ancestor
5889561|NCT04764942|Dermatologic Agents|dermatologic agents|mesh-ancestor
5889562|NCT04685772|Methylprednisolone|methylprednisolone|mesh-list
5889563|NCT04685772|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5889564|NCT04685772|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5889565|NCT04685772|Prednisolone|prednisolone|mesh-list
5889566|NCT04685772|Prednisolone acetate|prednisolone acetate|mesh-list
5889567|NCT04685772|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5889568|NCT04685772|Prednisolone phosphate|prednisolone phosphate|mesh-list
5889569|NCT04685772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5889570|NCT04685772|Antiemetics|antiemetics|mesh-ancestor
5889571|NCT04685772|Autonomic Agents|autonomic agents|mesh-ancestor
5889572|NCT04685772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5889573|NCT04685772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889574|NCT04685772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5889575|NCT04685772|Glucocorticoids|glucocorticoids|mesh-ancestor
5889576|NCT04685772|Hormones|hormones|mesh-ancestor
5889577|NCT04685772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5889578|NCT04685772|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5889579|NCT04685772|Protective Agents|protective agents|mesh-ancestor
5889580|NCT04685772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5889581|NCT04685772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5690345|NCT03423979|Tubulin Modulators|tubulin modulators|mesh-ancestor
5690346|NCT03423979|Antimitotic Agents|antimitotic agents|mesh-ancestor
5690347|NCT03423979|Mitosis Modulators|mitosis modulators|mesh-ancestor
5690348|NCT03423979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5690349|NCT03423849|Gemcitabine|gemcitabine|mesh-list
5690350|NCT03423849|Capecitabine|capecitabine|mesh-list
5690351|NCT03423849|Vinorelbine|vinorelbine|mesh-list
5889582|NCT04674345|Sorafenib|sorafenib|mesh-list
5889583|NCT04674345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5889584|NCT04674345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6212563|NCT02189668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212564|NCT02189837|Atorvastatin|atorvastatin|mesh-list
6212565|NCT02189837|Evolocumab|evolocumab|mesh-list
6212566|NCT02189837|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6212567|NCT02189837|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6212568|NCT02189837|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6212569|NCT02189837|Antimetabolites|antimetabolites|mesh-ancestor
5690352|NCT03423849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5889585|NCT04674345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5889586|NCT04674345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889587|NCT04634604|Bevacizumab|bevacizumab|mesh-list
5889588|NCT04634604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5889589|NCT04634604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5889590|NCT04634604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5889591|NCT04634604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5889592|NCT04634604|Growth Substances|growth substances|mesh-ancestor
5889593|NCT04634604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889594|NCT04634604|Growth Inhibitors|growth inhibitors|mesh-ancestor
5889595|NCT04634578|Bevacizumab|bevacizumab|mesh-list
5889596|NCT04634578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5889597|NCT04634578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5889598|NCT04634578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5889599|NCT04634578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5889600|NCT04634578|Growth Substances|growth substances|mesh-ancestor
5889601|NCT04634578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889602|NCT04634578|Growth Inhibitors|growth inhibitors|mesh-ancestor
5907348|NCT05244837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5907349|NCT05244837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5907350|NCT05244837|Tubulin Modulators|tubulin modulators|mesh-ancestor
5907351|NCT05244837|Antimitotic Agents|antimitotic agents|mesh-ancestor
5907352|NCT05244837|Mitosis Modulators|mitosis modulators|mesh-ancestor
5907353|NCT05244837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907354|NCT05244837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5907355|NCT05244837|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5907356|NCT05244837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5690353|NCT03423849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5690354|NCT03423849|Antimetabolites|antimetabolites|mesh-ancestor
5690355|NCT03423849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5690356|NCT03423849|Antiviral Agents|antiviral agents|mesh-ancestor
5690357|NCT03423849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5690358|NCT03423849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5690359|NCT03423849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5690360|NCT03423849|Immunologic Factors|immunologic factors|mesh-ancestor
5690361|NCT03423849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690362|NCT03423849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5690363|NCT03423849|Tubulin Modulators|tubulin modulators|mesh-ancestor
5690364|NCT03423849|Antimitotic Agents|antimitotic agents|mesh-ancestor
5690365|NCT03423849|Mitosis Modulators|mitosis modulators|mesh-ancestor
5690366|NCT03423823|Ranibizumab|ranibizumab|mesh-list
5690367|NCT03423823|Aflibercept|aflibercept|mesh-list
5690368|NCT03423823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5907357|NCT05244811|Contraceptive Agents|contraceptive agents|mesh-list
5907358|NCT05244811|Contraceptives, Oral|contraceptives, oral|mesh-list
5907359|NCT05244811|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
5907360|NCT05244811|Progestins|progestins|mesh-list
5907361|NCT05244811|Estradiol|estradiol|mesh-list
5907362|NCT05244811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5907363|NCT05244811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907364|NCT05244811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5907365|NCT05244811|Hormones|hormones|mesh-ancestor
5907366|NCT05244811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5907367|NCT05244811|Estrogens|estrogens|mesh-ancestor
5907368|NCT05244798|Paclitaxel|paclitaxel|mesh-list
5907369|NCT05244798|Cisplatin|cisplatin|mesh-list
5907370|NCT05244798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5907371|NCT05244798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5907372|NCT05244798|Tubulin Modulators|tubulin modulators|mesh-ancestor
5907373|NCT05244798|Antimitotic Agents|antimitotic agents|mesh-ancestor
5907374|NCT05244798|Mitosis Modulators|mitosis modulators|mesh-ancestor
5907375|NCT05244798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907376|NCT05244694|Insulin|insulin|mesh-list
5907377|NCT05244694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5907378|NCT05244694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907379|NCT05244577|Olanzapine|olanzapine|mesh-list
5907380|NCT05244577|Antiemetics|antiemetics|mesh-ancestor
5907381|NCT05244577|Autonomic Agents|autonomic agents|mesh-ancestor
5907382|NCT05244577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5907383|NCT05244577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907384|NCT05244577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5907385|NCT05244577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5907386|NCT05244577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5907387|NCT05244577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5907388|NCT05244577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5907389|NCT05244577|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5889603|NCT04615936|Methylene Blue|methylene blue|mesh-list
5889604|NCT04615936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5889605|NCT04615936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889606|NCT04597697|Insulin|insulin|mesh-list
5889607|NCT04597697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5889608|NCT04597697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889609|NCT04564612|Itraconazole|itraconazole|mesh-list
5889610|NCT04564612|Rabeprazole|rabeprazole|mesh-list
5889611|NCT04564612|Antifungal Agents|antifungal agents|mesh-ancestor
5889612|NCT04564612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5889613|NCT04564612|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5889614|NCT04564612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5889615|NCT04564612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5889616|NCT04564612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889617|NCT04564612|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5889618|NCT04564612|Hormone Antagonists|hormone antagonists|mesh-ancestor
5889619|NCT04564612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5889620|NCT04564612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889621|NCT04564612|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5889622|NCT04564612|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5889623|NCT04564612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5889624|NCT04564612|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5889625|NCT04550832|Moxifloxacin|moxifloxacin|mesh-list
5889626|NCT04550832|Bedaquiline|bedaquiline|mesh-list
6675559|NCT01576263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675560|NCT01576263|Sensory System Agents|sensory system agents|mesh-ancestor
6675561|NCT01576263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6675562|NCT01576315|Itraconazole|itraconazole|mesh-list
6675563|NCT01576315|Voriconazole|voriconazole|mesh-list
5889627|NCT04550832|Delpazolid|delpazolid|mesh-list
5889628|NCT04550832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5889629|NCT04550832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5889630|NCT04550832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5889631|NCT04550832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5889632|NCT04550832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5889633|NCT04550832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889634|NCT04550832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5889635|NCT04550832|Antitubercular Agents|antitubercular agents|mesh-ancestor
5889636|NCT04550832|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5889637|NCT04461028|Dexamethasone|dexamethasone|mesh-list
5889638|NCT04461028|Bupivacaine|bupivacaine|mesh-list
5889639|NCT04461028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5889640|NCT04461028|Antiemetics|antiemetics|mesh-ancestor
5889641|NCT04461028|Autonomic Agents|autonomic agents|mesh-ancestor
5889642|NCT04461028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5889643|NCT04461028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889644|NCT04461028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5889645|NCT04461028|Glucocorticoids|glucocorticoids|mesh-ancestor
5889646|NCT04461028|Hormones|hormones|mesh-ancestor
5889647|NCT04461028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5889648|NCT04461028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5889649|NCT04461028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5889650|NCT04461028|Anesthetics, Local|anesthetics, local|mesh-ancestor
5889651|NCT04461028|Anesthetics|anesthetics|mesh-ancestor
5889652|NCT04461028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5889653|NCT04461028|Sensory System Agents|sensory system agents|mesh-ancestor
5889654|NCT04428775|Cromolyn Sodium|cromolyn sodium|mesh-list
5889655|NCT04428775|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
5889656|NCT04428775|Immunologic Factors|immunologic factors|mesh-ancestor
5889657|NCT04428775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889658|NCT04428775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5889659|NCT04428775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5889660|NCT04428775|Respiratory System Agents|respiratory system agents|mesh-ancestor
5690369|NCT03423823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5690370|NCT03423823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5690371|NCT03423823|Growth Substances|growth substances|mesh-ancestor
5690372|NCT03423823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690373|NCT03423823|Growth Inhibitors|growth inhibitors|mesh-ancestor
5690374|NCT03423810|Hydralazine|hydralazine|mesh-list
5690375|NCT03423810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5690376|NCT03423810|Vasodilator Agents|vasodilator agents|mesh-ancestor
5690377|NCT03423797|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5690378|NCT03423667|Acetylcysteine|acetylcysteine|mesh-list
5690379|NCT03423667|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5690380|NCT03423667|Antiviral Agents|antiviral agents|mesh-ancestor
5889661|NCT04416737|Insulin|insulin|mesh-list
5889662|NCT04416737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5889663|NCT04416737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889664|NCT04367909|Carboplatin|carboplatin|mesh-list
5889665|NCT04367909|Docetaxel|docetaxel|mesh-list
5889666|NCT04367909|Nimotuzumab|nimotuzumab|mesh-list
5889667|NCT04367909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5889668|NCT04367909|Tubulin Modulators|tubulin modulators|mesh-ancestor
5889669|NCT04367909|Antimitotic Agents|antimitotic agents|mesh-ancestor
5889670|NCT04367909|Mitosis Modulators|mitosis modulators|mesh-ancestor
5889671|NCT04367909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889672|NCT04367909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5889673|NCT04342039|Budesonide|budesonide|mesh-list
5889674|NCT04342039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5889675|NCT04342039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5889676|NCT04342039|Autonomic Agents|autonomic agents|mesh-ancestor
5889677|NCT04342039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5889678|NCT04342039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889679|NCT04342039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5889680|NCT04342039|Respiratory System Agents|respiratory system agents|mesh-ancestor
5889681|NCT04342039|Glucocorticoids|glucocorticoids|mesh-ancestor
5889682|NCT04342039|Hormones|hormones|mesh-ancestor
5889683|NCT04342039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5889684|NCT04335058|Iron|iron|mesh-list
5889685|NCT04335058|Lactoferrin|lactoferrin|mesh-list
5889686|NCT04335058|Trace Elements|trace elements|mesh-ancestor
5889687|NCT04335058|Micronutrients|micronutrients|mesh-ancestor
5889688|NCT04335058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889689|NCT04335058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5889690|NCT04329975|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
5889691|NCT04329975|Hemostatics|hemostatics|mesh-ancestor
5889692|NCT04329975|Coagulants|coagulants|mesh-ancestor
5889693|NCT04329975|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5889694|NCT04329975|Natriuretic Agents|natriuretic agents|mesh-ancestor
5889695|NCT04329975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889696|NCT04315311|Pancrelipase|pancrelipase|mesh-list
5889697|NCT04315311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5889698|NCT04285255|Lidocaine|lidocaine|mesh-list
5889699|NCT04285255|Fentanyl|fentanyl|mesh-list
5889700|NCT04285255|Dexmedetomidine|dexmedetomidine|mesh-list
5889701|NCT04285255|Ketamine|ketamine|mesh-list
5889702|NCT04285255|Anesthetics, Local|anesthetics, local|mesh-ancestor
5889703|NCT04285255|Anesthetics|anesthetics|mesh-ancestor
5889704|NCT04285255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5889705|NCT04285255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889706|NCT04285255|Sensory System Agents|sensory system agents|mesh-ancestor
5889707|NCT04285255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5889708|NCT04285255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5889709|NCT04285255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5889710|NCT04285255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5889711|NCT04285255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5889712|NCT04285255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889713|NCT04285255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5889714|NCT04285255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5889715|NCT04285255|Analgesics|analgesics|mesh-ancestor
6496264|NCT00627471|Insulin|insulin|mesh-list
6496265|NCT00627471|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6496266|NCT00627471|Insulin Glargine|insulin glargine|mesh-list
5889716|NCT04285255|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5889717|NCT04285255|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5889718|NCT04285255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5889719|NCT04285255|Adrenergic Agents|adrenergic agents|mesh-ancestor
5889720|NCT04285255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5889721|NCT04285255|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5889722|NCT04285255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5889723|NCT04285255|Anesthetics, General|anesthetics, general|mesh-ancestor
5690381|NCT03423667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5690382|NCT03423667|Expectorants|expectorants|mesh-ancestor
5690383|NCT03423667|Respiratory System Agents|respiratory system agents|mesh-ancestor
5690384|NCT03423667|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5690385|NCT03423667|Antioxidants|antioxidants|mesh-ancestor
5690386|NCT03423667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5690387|NCT03423667|Protective Agents|protective agents|mesh-ancestor
5690388|NCT03423667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690389|NCT03423667|Antidotes|antidotes|mesh-ancestor
5690390|NCT03423537|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5690391|NCT03423537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5690392|NCT03423537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690393|NCT03423472|Vitamin A|vitamin a|mesh-list
5690394|NCT03423472|Vitamins|vitamins|mesh-ancestor
5690395|NCT03423472|Micronutrients|micronutrients|mesh-ancestor
5690396|NCT03423472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889724|NCT04285255|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5889725|NCT04285255|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5889726|NCT04285255|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5889727|NCT04285255|Narcotics|narcotics|mesh-ancestor
5889728|NCT04285255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5889729|NCT04279574|Lithium Carbonate|lithium carbonate|mesh-list
5889730|NCT04279574|Antidepressive Agents|antidepressive agents|mesh-ancestor
5889731|NCT04279574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5889732|NCT04279574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5889733|NCT04279574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889734|NCT04279574|Antimanic Agents|antimanic agents|mesh-ancestor
5889735|NCT04279574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5889736|NCT04279574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5889737|NCT04279574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889738|NCT04196075|Andrographolide|andrographolide|mesh-list
5889739|NCT04196075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5889740|NCT04196075|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5889741|NCT04196075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5889742|NCT04196075|Analgesics|analgesics|mesh-ancestor
5889743|NCT04196075|Sensory System Agents|sensory system agents|mesh-ancestor
5889744|NCT04196075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5889745|NCT04196075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889746|NCT04196075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5889747|NCT04196075|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5690397|NCT03423342|Niacinamide|niacinamide|mesh-list
5690398|NCT03423342|Niacin|niacin|mesh-list
5690399|NCT03423342|Nicotinic Acids|nicotinic acids|mesh-list
5690400|NCT03423342|Vitamin B Complex|vitamin b complex|mesh-ancestor
5690401|NCT03423342|Vitamins|vitamins|mesh-ancestor
5690402|NCT03423342|Micronutrients|micronutrients|mesh-ancestor
5690403|NCT03423342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889748|NCT04196075|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5889749|NCT04196075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5889750|NCT04196075|Antiviral Agents|antiviral agents|mesh-ancestor
5889751|NCT04196075|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5889752|NCT04169828|Leucovorin|leucovorin|mesh-list
5889753|NCT04169828|Folic Acid|folic acid|mesh-list
5889754|NCT04169828|Methotrexate|methotrexate|mesh-list
5889755|NCT04169828|Ondansetron|ondansetron|mesh-list
5889756|NCT04169828|Levoleucovorin|levoleucovorin|mesh-list
5889757|NCT04169828|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5889758|NCT04169828|Abortifacient Agents|abortifacient agents|mesh-ancestor
5889759|NCT04169828|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5889760|NCT04169828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889761|NCT04169828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5889762|NCT04169828|Antimetabolites|antimetabolites|mesh-ancestor
5889763|NCT04169828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889764|NCT04169828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5889765|NCT04169828|Dermatologic Agents|dermatologic agents|mesh-ancestor
5889766|NCT04169828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5889767|NCT04169828|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5889768|NCT04169828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5889769|NCT04169828|Immunologic Factors|immunologic factors|mesh-ancestor
5889770|NCT04169828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5889771|NCT04169828|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5889772|NCT04169828|Antidotes|antidotes|mesh-ancestor
5889773|NCT04169828|Protective Agents|protective agents|mesh-ancestor
5889774|NCT04169828|Vitamin B Complex|vitamin b complex|mesh-ancestor
5889775|NCT04169828|Vitamins|vitamins|mesh-ancestor
5889776|NCT04169828|Micronutrients|micronutrients|mesh-ancestor
5889777|NCT04169828|Antiemetics|antiemetics|mesh-ancestor
5889778|NCT04169828|Autonomic Agents|autonomic agents|mesh-ancestor
5889779|NCT04169828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5889780|NCT04169828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5889781|NCT04169828|Antipruritics|antipruritics|mesh-ancestor
5889782|NCT04169828|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5889783|NCT04169828|Serotonin Agents|serotonin agents|mesh-ancestor
5889784|NCT04169828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5889785|NCT04169828|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5690404|NCT03423342|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5690405|NCT03423342|Antimetabolites|antimetabolites|mesh-ancestor
5690406|NCT03423342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889786|NCT04169828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5889787|NCT04169828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5889788|NCT04169828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5889789|NCT04169828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5889790|NCT04169828|Hematinics|hematinics|mesh-ancestor
5889791|NCT04165824|Edaravone|edaravone|mesh-list
5889792|NCT04165824|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5889793|NCT04165824|Antioxidants|antioxidants|mesh-ancestor
5889794|NCT04165824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889795|NCT04165824|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5889796|NCT04165824|Protective Agents|protective agents|mesh-ancestor
5889797|NCT04165824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889798|NCT04163107|Hydroxychloroquine|hydroxychloroquine|mesh-list
6496267|NCT00627471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6496268|NCT00627471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496269|NCT00627536|Mitogens|mitogens|mesh-list
6496270|NCT00627536|Mitosis Modulators|mitosis modulators|mesh-ancestor
6496271|NCT00627536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496272|NCT00627575|Lamotrigine|lamotrigine|mesh-list
6496273|NCT00627575|Phenytoin|phenytoin|mesh-list
6496274|NCT00627575|Atorvastatin|atorvastatin|mesh-list
5690407|NCT03423342|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5690408|NCT03423342|Vasodilator Agents|vasodilator agents|mesh-ancestor
5690409|NCT03423329|Ibuprofen|ibuprofen|mesh-list
5690410|NCT03423329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5690411|NCT03423329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5690412|NCT03423329|Analgesics|analgesics|mesh-ancestor
5690413|NCT03423329|Sensory System Agents|sensory system agents|mesh-ancestor
5690414|NCT03423329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5690415|NCT03423329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889799|NCT04163107|Dexamethasone|dexamethasone|mesh-list
5889800|NCT04163107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5889801|NCT04163107|Antiemetics|antiemetics|mesh-ancestor
5889802|NCT04163107|Autonomic Agents|autonomic agents|mesh-ancestor
5889803|NCT04163107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5889804|NCT04163107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889805|NCT04163107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5889806|NCT04163107|Glucocorticoids|glucocorticoids|mesh-ancestor
5889807|NCT04163107|Hormones|hormones|mesh-ancestor
5889808|NCT04163107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5889809|NCT04163107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5889810|NCT04163107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5690416|NCT03423329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5690417|NCT03423329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5889811|NCT04163107|Antimalarials|antimalarials|mesh-ancestor
5889812|NCT04163107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5889813|NCT04163107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5889814|NCT04163107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5889815|NCT04163107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5889816|NCT04163107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889817|NCT04163107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5889818|NCT04161898|Prednisolone|prednisolone|mesh-list
5889819|NCT04161898|Upadacitinib|upadacitinib|mesh-list
5889820|NCT04161898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5889821|NCT04161898|Glucocorticoids|glucocorticoids|mesh-ancestor
5889822|NCT04161898|Hormones|hormones|mesh-ancestor
5889823|NCT04161898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5889824|NCT04161898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889825|NCT04161898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5889826|NCT04161898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5889827|NCT04161898|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
5889828|NCT04161898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5889829|NCT04161898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5889830|NCT04161898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889831|NCT04161898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5889832|NCT04158141|Cisplatin|cisplatin|mesh-list
5889833|NCT04158141|Carboplatin|carboplatin|mesh-list
5889834|NCT04158141|Pemetrexed|pemetrexed|mesh-list
5889835|NCT04158141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5889836|NCT04158141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5889837|NCT04158141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889838|NCT04158141|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5889839|NCT04158141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5889840|NCT04053322|Durvalumab|durvalumab|mesh-list
5889841|NCT04053322|Olaparib|olaparib|mesh-list
5889842|NCT04053322|Fulvestrant|fulvestrant|mesh-list
5889843|NCT04053322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6496275|NCT00627575|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5889844|NCT04053322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5889845|NCT04053322|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5889846|NCT04053322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5889847|NCT04053322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889848|NCT04053322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5889849|NCT04053322|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5889850|NCT04053322|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5889851|NCT04053322|Hormone Antagonists|hormone antagonists|mesh-ancestor
5889852|NCT04053322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5889853|NCT04053322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889854|NCT04040439|Dexmedetomidine|dexmedetomidine|mesh-list
5889855|NCT04040439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5889856|NCT04040439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5889857|NCT04040439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889858|NCT04040439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5889859|NCT04040439|Analgesics|analgesics|mesh-ancestor
5889860|NCT04040439|Sensory System Agents|sensory system agents|mesh-ancestor
5889861|NCT04040439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5690418|NCT03423329|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5690419|NCT03423329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5690420|NCT03423329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5690421|NCT03423225|Tacrolimus|tacrolimus|mesh-list
5889862|NCT04040439|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5889863|NCT04040439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5889864|NCT04040439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5889865|NCT04040439|Adrenergic Agents|adrenergic agents|mesh-ancestor
5889866|NCT04040439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5889867|NCT04040439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889868|NCT04030182|Vitamin D|vitamin d|mesh-list
5889869|NCT04030182|Vitamins|vitamins|mesh-ancestor
5889870|NCT04030182|Micronutrients|micronutrients|mesh-ancestor
5889871|NCT04030182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889872|NCT04030182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5889873|NCT04000555|Vancomycin|vancomycin|mesh-list
5889874|NCT04000555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5889875|NCT04000555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5889876|NCT03988933|Rifampin|rifampin|mesh-list
5889877|NCT03988933|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5889878|NCT03988933|Antitubercular Agents|antitubercular agents|mesh-ancestor
5889879|NCT03988933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5889880|NCT03988933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5889881|NCT03988933|Leprostatic Agents|leprostatic agents|mesh-ancestor
5889882|NCT03988933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5690422|NCT03423225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5690423|NCT03423225|Immunologic Factors|immunologic factors|mesh-ancestor
5690424|NCT03423225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690425|NCT03423225|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5690426|NCT03423225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5889883|NCT03988933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5889884|NCT03988933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889885|NCT03988933|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5889886|NCT03988933|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5889887|NCT03988933|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5889888|NCT03988933|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5889889|NCT03988933|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5889890|NCT03988933|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5889891|NCT03978520|Upadacitinib|upadacitinib|mesh-list
5889892|NCT03978520|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
5889893|NCT03978520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5889894|NCT03978520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5889895|NCT03978520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889896|NCT03978520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5889897|NCT03958565|Zoledronic Acid|zoledronic acid|mesh-list
5889898|NCT03958565|Denosumab|denosumab|mesh-list
5889899|NCT03958565|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5889900|NCT03958565|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5889901|NCT03958565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907390|NCT05244577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5907391|NCT05244577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5907392|NCT05244577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907393|NCT05244577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5889902|NCT03875378|Estrogens|estrogens|mesh-list
5889903|NCT03875378|Hormones|hormones|mesh-ancestor
5889904|NCT03875378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5889905|NCT03875378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889906|NCT03865212|Interferons|interferons|mesh-list
5889907|NCT03865212|Interferon-beta|interferon-beta|mesh-list
5889908|NCT03865212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5889909|NCT03865212|Antiviral Agents|antiviral agents|mesh-ancestor
5889910|NCT03865212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5889911|NCT03865212|Immunologic Factors|immunologic factors|mesh-ancestor
5889912|NCT03865212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889913|NCT03863483|Docetaxel|docetaxel|mesh-list
5889914|NCT03863483|Pemetrexed|pemetrexed|mesh-list
5889915|NCT03863483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5889916|NCT03863483|Tubulin Modulators|tubulin modulators|mesh-ancestor
5889917|NCT03863483|Antimitotic Agents|antimitotic agents|mesh-ancestor
5889918|NCT03863483|Mitosis Modulators|mitosis modulators|mesh-ancestor
5889919|NCT03863483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889920|NCT03863483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5889921|NCT03863483|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5889922|NCT03863483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5889923|NCT03854500|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5889924|NCT03854500|Tenecteplase|tenecteplase|mesh-list
5889925|NCT03854500|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5889926|NCT03854500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5889927|NCT03854500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889928|NCT03848845|Pembrolizumab|pembrolizumab|mesh-list
5889929|NCT03848845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5889930|NCT03848845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5889931|NCT03830411|Docetaxel|docetaxel|mesh-list
5889932|NCT03830411|Pemetrexed|pemetrexed|mesh-list
5889933|NCT03830411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5889934|NCT03830411|Tubulin Modulators|tubulin modulators|mesh-ancestor
5889935|NCT03830411|Antimitotic Agents|antimitotic agents|mesh-ancestor
5889936|NCT03830411|Mitosis Modulators|mitosis modulators|mesh-ancestor
5889937|NCT03830411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889938|NCT03830411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5889939|NCT03830411|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5889940|NCT03830411|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5889941|NCT03802305|Anesthetics|anesthetics|mesh-list
5889942|NCT03802305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5889943|NCT03802305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889944|NCT03733119|TIC10 compound|tic10 compound|mesh-list
5889945|NCT03733119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5889946|NCT03661632|Nivolumab|nivolumab|mesh-list
5889947|NCT03661632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5889948|NCT03661632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5889949|NCT03661632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5889950|NCT03661632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889951|NCT03512262|Abaloparatide|abaloparatide|mesh-list
5889952|NCT03512262|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
5889953|NCT03512262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5889954|NCT03512262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889955|NCT03512262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5889956|NCT03456882|RNS60|rns60|mesh-list
5889957|NCT03456882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5889958|NCT03456882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5889959|NCT03456882|Analgesics|analgesics|mesh-ancestor
5690427|NCT03423225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5690428|NCT03423199|Tamoxifen|tamoxifen|mesh-list
5690429|NCT03423199|Goserelin|goserelin|mesh-list
5690430|NCT03423199|Palbociclib|palbociclib|mesh-list
5690431|NCT03423199|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5690432|NCT03423199|Hormone Antagonists|hormone antagonists|mesh-ancestor
5690433|NCT03423199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5889960|NCT03456882|Sensory System Agents|sensory system agents|mesh-ancestor
5889961|NCT03456882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5889962|NCT03456882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889963|NCT03456882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5889964|NCT03456882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5889965|NCT03456882|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5889966|NCT03374956|Liraglutide|liraglutide|mesh-list
5889967|NCT03374956|Topiramate|topiramate|mesh-list
5889968|NCT03374956|Phentermine|phentermine|mesh-list
5889969|NCT03374956|Naltrexone|naltrexone|mesh-list
5889970|NCT03374956|Bupropion|bupropion|mesh-list
5889971|NCT03374956|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5889972|NCT03374956|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5889973|NCT03374956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5889974|NCT03374956|Sensory System Agents|sensory system agents|mesh-ancestor
5889975|NCT03374956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5889976|NCT03374956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5690434|NCT03423199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690435|NCT03423199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5690436|NCT03423199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5690437|NCT03423199|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5690438|NCT03423199|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5690439|NCT03423199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5889977|NCT03374956|Incretins|incretins|mesh-ancestor
5889978|NCT03374956|Hormones|hormones|mesh-ancestor
5889979|NCT03374956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5889980|NCT03374956|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5889981|NCT03374956|Antidepressive Agents|antidepressive agents|mesh-ancestor
5889982|NCT03374956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5889983|NCT03374956|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5889984|NCT03374956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5889985|NCT03374956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5889986|NCT03374956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5889987|NCT03374956|Dopamine Agents|dopamine agents|mesh-ancestor
5889988|NCT03374956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5889989|NCT03374956|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5889990|NCT03374956|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5889991|NCT03374956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5690440|NCT03423199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5690441|NCT03423199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5690442|NCT03423199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5690443|NCT03423030|Macozinone|macozinone|mesh-list
5690444|NCT03423030|Antitubercular Agents|antitubercular agents|mesh-ancestor
5889992|NCT03374956|Anticonvulsants|anticonvulsants|mesh-ancestor
5889993|NCT03374956|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5889994|NCT03374956|Appetite Depressants|appetite depressants|mesh-ancestor
5889995|NCT03374956|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5889996|NCT03374956|Sympathomimetics|sympathomimetics|mesh-ancestor
5889997|NCT03374956|Autonomic Agents|autonomic agents|mesh-ancestor
5889998|NCT03374956|Adrenergic Agents|adrenergic agents|mesh-ancestor
5889999|NCT03366103|Navitoclax|navitoclax|mesh-list
5890000|NCT03366103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5890001|NCT03334253|Atropine|atropine|mesh-list
5890002|NCT03334253|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5890003|NCT03334253|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5890004|NCT03334253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5890005|NCT03334253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5890006|NCT03334253|Autonomic Agents|autonomic agents|mesh-ancestor
5890007|NCT03334253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5890008|NCT03334253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890009|NCT03334253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5890010|NCT03334253|Respiratory System Agents|respiratory system agents|mesh-ancestor
5890011|NCT03334253|Mydriatics|mydriatics|mesh-ancestor
5890012|NCT03334253|Parasympatholytics|parasympatholytics|mesh-ancestor
5890013|NCT03334253|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5890014|NCT03334253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5890015|NCT03334253|Cholinergic Agents|cholinergic agents|mesh-ancestor
5890016|NCT03334253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5690445|NCT03423030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5690446|NCT03423030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5690447|NCT03422978|Dexmedetomidine|dexmedetomidine|mesh-list
5690448|NCT03422978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5690449|NCT03422978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5890017|NCT03334253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890018|NCT03334253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5890019|NCT03300479|Urapidil|urapidil|mesh-list
5890020|NCT03300479|Clevidipine|clevidipine|mesh-list
5890021|NCT03300479|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5890022|NCT03300479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5890023|NCT03300479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890024|NCT03300479|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5890025|NCT03300479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890026|NCT03300479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5890027|NCT03300479|Vasodilator Agents|vasodilator agents|mesh-ancestor
5890028|NCT03300479|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5890029|NCT03300479|Serotonin Agents|serotonin agents|mesh-ancestor
5890030|NCT03300479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5890031|NCT03300479|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5890032|NCT03300479|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5890033|NCT03300479|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5890034|NCT03300479|Adrenergic Agents|adrenergic agents|mesh-ancestor
5890035|NCT03272464|Trametinib|trametinib|mesh-list
5690450|NCT03422978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690451|NCT03422978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5690452|NCT03422978|Analgesics|analgesics|mesh-ancestor
5890036|NCT03272464|Dabrafenib|dabrafenib|mesh-list
5890037|NCT03272464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5890038|NCT03272464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5890039|NCT03272464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5890040|NCT03272464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890041|NCT03262701|Hydrogen Peroxide|hydrogen peroxide|mesh-list
5890042|NCT03262701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5890043|NCT03262701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5890044|NCT03245151|Everolimus|everolimus|mesh-list
5890045|NCT03245151|Lenvatinib|lenvatinib|mesh-list
5890046|NCT03245151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5890047|NCT03245151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5890048|NCT03245151|Immunologic Factors|immunologic factors|mesh-ancestor
5890049|NCT03245151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890050|NCT03245151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5890051|NCT03245151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5890052|NCT03245151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890053|NCT03070184|Metoprolol|metoprolol|mesh-list
5890054|NCT03070184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5890055|NCT03070184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5890056|NCT03070184|Sympatholytics|sympatholytics|mesh-ancestor
5890057|NCT03070184|Autonomic Agents|autonomic agents|mesh-ancestor
5890058|NCT03070184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5890059|NCT03070184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890060|NCT03070184|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5890061|NCT03070184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5890062|NCT03070184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5890063|NCT03070184|Adrenergic Agents|adrenergic agents|mesh-ancestor
5890064|NCT03070184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5890065|NCT03070184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890066|NCT03012425|Hydrocortisone|hydrocortisone|mesh-list
5890067|NCT03012425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5890068|NCT02911142|Prednisone|prednisone|mesh-list
5890069|NCT02911142|Cyclophosphamide|cyclophosphamide|mesh-list
5890070|NCT02911142|Rituximab|rituximab|mesh-list
5890071|NCT02911142|Doxorubicin|doxorubicin|mesh-list
5890072|NCT02911142|Vincristine|vincristine|mesh-list
5890073|NCT02911142|Lenalidomide|lenalidomide|mesh-list
5890074|NCT02911142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5890075|NCT02911142|Immunologic Factors|immunologic factors|mesh-ancestor
5890076|NCT02911142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890077|NCT02911142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5890078|NCT02911142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5890079|NCT02911142|Alkylating Agents|alkylating agents|mesh-ancestor
5890080|NCT02911142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890081|NCT02911142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5890082|NCT02911142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5890083|NCT02911142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5690453|NCT03422978|Sensory System Agents|sensory system agents|mesh-ancestor
5690454|NCT03422978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5690455|NCT03422978|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5690456|NCT03422978|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5690457|NCT03422978|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5690458|NCT03422978|Adrenergic Agents|adrenergic agents|mesh-ancestor
5690459|NCT03422978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5690460|NCT03422978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5690461|NCT03422887|Flurbiprofen|flurbiprofen|mesh-list
5890084|NCT02911142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5890085|NCT02911142|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5890086|NCT02911142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5890087|NCT02911142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5890088|NCT02911142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5890089|NCT02911142|Glucocorticoids|glucocorticoids|mesh-ancestor
5890090|NCT02911142|Hormones|hormones|mesh-ancestor
5907394|NCT05244577|Serotonin Agents|serotonin agents|mesh-ancestor
5690462|NCT03422887|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
5690463|NCT03422887|Nalbuphine|nalbuphine|mesh-list
5690464|NCT03422887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5890091|NCT02911142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5890092|NCT02911142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5890093|NCT02911142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5890094|NCT02911142|Tubulin Modulators|tubulin modulators|mesh-ancestor
5890095|NCT02911142|Antimitotic Agents|antimitotic agents|mesh-ancestor
5890096|NCT02911142|Mitosis Modulators|mitosis modulators|mesh-ancestor
5890097|NCT02911142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5890098|NCT02911142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5690465|NCT03422887|Narcotics|narcotics|mesh-ancestor
5690466|NCT03422887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5690467|NCT03422887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690468|NCT03422887|Analgesics|analgesics|mesh-ancestor
5690469|NCT03422887|Sensory System Agents|sensory system agents|mesh-ancestor
5690470|NCT03422887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5690471|NCT03422887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5690472|NCT03422887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5890099|NCT02911142|Growth Substances|growth substances|mesh-ancestor
5890100|NCT02911142|Growth Inhibitors|growth inhibitors|mesh-ancestor
5890101|NCT02781090|Nicotine|nicotine|mesh-list
5890102|NCT02781090|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5890103|NCT02781090|Autonomic Agents|autonomic agents|mesh-ancestor
5890104|NCT02781090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5890105|NCT02781090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890106|NCT02781090|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5890107|NCT02781090|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5890108|NCT02781090|Cholinergic Agents|cholinergic agents|mesh-ancestor
5890109|NCT02781090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5890110|NCT02781090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890111|NCT02758847|Paclitaxel|paclitaxel|mesh-list
5890112|NCT02758847|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5890113|NCT02758847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5890114|NCT02758847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5890115|NCT02758847|Tubulin Modulators|tubulin modulators|mesh-ancestor
5890116|NCT02758847|Antimitotic Agents|antimitotic agents|mesh-ancestor
5890117|NCT02758847|Mitosis Modulators|mitosis modulators|mesh-ancestor
5890118|NCT02758847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890119|NCT02718066|Nivolumab|nivolumab|mesh-list
5890120|NCT02718066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5890121|NCT02718066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5890122|NCT02718066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5890123|NCT02718066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890124|NCT02390531|Bevacizumab|bevacizumab|mesh-list
5890125|NCT02390531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5890126|NCT02390531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5890127|NCT02390531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5890128|NCT02390531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5890129|NCT02390531|Growth Substances|growth substances|mesh-ancestor
5890130|NCT02390531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890131|NCT02390531|Growth Inhibitors|growth inhibitors|mesh-ancestor
5890132|NCT02369653|Apixaban|apixaban|mesh-list
5890133|NCT02369653|Anticoagulants|anticoagulants|mesh-list
5890134|NCT02369653|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5890135|NCT02369653|Antithrombins|antithrombins|mesh-ancestor
5890136|NCT02369653|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5890137|NCT02369653|Protease Inhibitors|protease inhibitors|mesh-ancestor
5890138|NCT02369653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5890139|NCT02369653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890140|NCT05116254|AZD7648|azd7648|mesh-list
5890141|NCT05116254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5890142|NCT05116254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5890143|NCT05116254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890144|NCT05116228|Rituximab|rituximab|mesh-list
5890145|NCT05116228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5890146|NCT05116228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5890147|NCT05116228|Immunologic Factors|immunologic factors|mesh-ancestor
5890148|NCT05116228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890149|NCT05116228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5890150|NCT05116150|Grape Seed Extract|grape seed extract|mesh-list
5890151|NCT05116150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6212570|NCT02189837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5690473|NCT03422887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5690474|NCT03422887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5690475|NCT03422887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5690476|NCT03422887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5690477|NCT03422887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5690478|NCT03422874|Nelfinavir|nelfinavir|mesh-list
5890152|NCT05116150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5890153|NCT05116150|Antioxidants|antioxidants|mesh-ancestor
5890154|NCT05116150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890155|NCT05116150|Protective Agents|protective agents|mesh-ancestor
5890156|NCT05116150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890157|NCT05116098|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
5890158|NCT05116098|Antioxidants|antioxidants|mesh-ancestor
5890159|NCT05116098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890160|NCT05116098|Protective Agents|protective agents|mesh-ancestor
5890161|NCT05116098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890162|NCT05116098|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
5890163|NCT05116098|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5890164|NCT05116098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5890165|NCT05116098|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5890166|NCT05116007|Carboplatin|carboplatin|mesh-list
5890167|NCT05116007|Etoposide|etoposide|mesh-list
5890168|NCT05116007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5890169|NCT05116007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5890170|NCT05116007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5890171|NCT05116007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5890172|NCT05116007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5890173|NCT05116007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890174|NCT05115994|Antihypertensive Agents|antihypertensive agents|mesh-list
5907395|NCT05244525|Epinephrine|epinephrine|mesh-list
5907396|NCT05244525|Bupivacaine|bupivacaine|mesh-list
5907397|NCT05244525|Anesthetics, Local|anesthetics, local|mesh-ancestor
5907398|NCT05244525|Anesthetics|anesthetics|mesh-ancestor
5907399|NCT05244525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5907400|NCT05244525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907401|NCT05244525|Sensory System Agents|sensory system agents|mesh-ancestor
5907402|NCT05244525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5907403|NCT05244525|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5907404|NCT05244525|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5907405|NCT05244525|Adrenergic Agents|adrenergic agents|mesh-ancestor
5907406|NCT05244525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5907407|NCT05244525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907408|NCT05244525|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5907409|NCT05244525|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5907410|NCT05244525|Autonomic Agents|autonomic agents|mesh-ancestor
5907411|NCT05244525|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5907412|NCT05244525|Respiratory System Agents|respiratory system agents|mesh-ancestor
5907413|NCT05244525|Mydriatics|mydriatics|mesh-ancestor
5907414|NCT05244525|Sympathomimetics|sympathomimetics|mesh-ancestor
5907415|NCT05244525|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5907416|NCT05244473|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5907417|NCT05244473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5907418|NCT05244473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5907419|NCT05244460|Diphenhydramine|diphenhydramine|mesh-list
5907420|NCT05244460|Promethazine|promethazine|mesh-list
5907421|NCT05244460|Droperidol|droperidol|mesh-list
5690479|NCT03422874|Ixazomib|ixazomib|mesh-list
5690480|NCT03422874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5690481|NCT03422874|Protease Inhibitors|protease inhibitors|mesh-ancestor
5690482|NCT03422874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5690483|NCT03422874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5690484|NCT03422874|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5690485|NCT03422874|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5907422|NCT05244460|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5907423|NCT05244460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5907424|NCT05244460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5907425|NCT05244460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907426|NCT05244460|Anesthetics, Local|anesthetics, local|mesh-ancestor
5907427|NCT05244460|Anesthetics|anesthetics|mesh-ancestor
5907428|NCT05244460|Sensory System Agents|sensory system agents|mesh-ancestor
5907429|NCT05244460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5907430|NCT05244460|Antiemetics|antiemetics|mesh-ancestor
5907431|NCT05244460|Autonomic Agents|autonomic agents|mesh-ancestor
5907432|NCT05244460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5690486|NCT03422874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5890175|NCT05115903|Adalimumab|adalimumab|mesh-list
5890176|NCT05115903|Etanercept|etanercept|mesh-list
5890177|NCT05115903|Golimumab|golimumab|mesh-list
5890178|NCT05115903|Infliximab|infliximab|mesh-list
5890179|NCT05115903|Certolizumab Pegol|certolizumab pegol|mesh-list
5690487|NCT03422874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5690488|NCT03422874|Antiviral Agents|antiviral agents|mesh-ancestor
5690489|NCT03422874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5690490|NCT03422861|Nabilone|nabilone|mesh-list
5690491|NCT03422861|Antiemetics|antiemetics|mesh-ancestor
5690492|NCT03422861|Autonomic Agents|autonomic agents|mesh-ancestor
5690493|NCT03422861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5690494|NCT03422861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690495|NCT03422861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5690496|NCT03422861|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5690497|NCT03422861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5690498|NCT03422861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5690499|NCT03422861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5690500|NCT03422796|Cilostazol|cilostazol|mesh-list
5690501|NCT03422796|Sumatriptan|sumatriptan|mesh-list
5690502|NCT03422796|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5690503|NCT03422796|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5890180|NCT05115903|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5890181|NCT05115903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5890182|NCT05115903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5890183|NCT05115903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5890184|NCT05115903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5890185|NCT05115903|Analgesics|analgesics|mesh-ancestor
5890186|NCT05115903|Sensory System Agents|sensory system agents|mesh-ancestor
5890187|NCT05115903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5890188|NCT05115903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890189|NCT05115903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5890190|NCT05115903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5890191|NCT05115903|Immunologic Factors|immunologic factors|mesh-ancestor
5890192|NCT05115903|Dermatologic Agents|dermatologic agents|mesh-ancestor
5890193|NCT05115903|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
5890194|NCT05115578|Midazolam|midazolam|mesh-list
5890195|NCT05115578|Remifentanil|remifentanil|mesh-list
5890196|NCT05115578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5890197|NCT05115578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5890198|NCT05115578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5890199|NCT05115578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890200|NCT05115578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5890201|NCT05115578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5890202|NCT05115578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5890203|NCT05115578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5890204|NCT05115578|Anesthetics, General|anesthetics, general|mesh-ancestor
5890205|NCT05115578|Anesthetics|anesthetics|mesh-ancestor
5890206|NCT05115578|GABA Modulators|gaba modulators|mesh-ancestor
5890207|NCT05115578|GABA Agents|gaba agents|mesh-ancestor
5890208|NCT05115578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5890209|NCT05115578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890210|NCT05115578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5890211|NCT05115578|Narcotics|narcotics|mesh-ancestor
5890212|NCT05115578|Analgesics|analgesics|mesh-ancestor
5890213|NCT05115578|Sensory System Agents|sensory system agents|mesh-ancestor
5890214|NCT05115578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5890215|NCT05115409|Rituximab|rituximab|mesh-list
5890216|NCT05115409|Antibodies|antibodies|mesh-list
5890217|NCT05115409|Immunologic Factors|immunologic factors|mesh-ancestor
5890218|NCT05115409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890219|NCT05115409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5890220|NCT05115409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5890221|NCT05115409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5890222|NCT05115149|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
5890223|NCT05115149|Antioxidants|antioxidants|mesh-ancestor
5890224|NCT05115149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890225|NCT05115149|Protective Agents|protective agents|mesh-ancestor
5890226|NCT05115149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890227|NCT05115149|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5890228|NCT05115149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5890229|NCT05115136|Diphenhydramine|diphenhydramine|mesh-list
5890230|NCT05115136|Promethazine|promethazine|mesh-list
5890231|NCT05115136|Doxepin|doxepin|mesh-list
5890232|NCT05115136|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5890233|NCT05115136|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5890234|NCT05115136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5890235|NCT05115136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890236|NCT05115136|Anesthetics, Local|anesthetics, local|mesh-ancestor
5890237|NCT05115136|Anesthetics|anesthetics|mesh-ancestor
5890238|NCT05115136|Sensory System Agents|sensory system agents|mesh-ancestor
5890239|NCT05115136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5890240|NCT05115136|Antiemetics|antiemetics|mesh-ancestor
5890241|NCT05115136|Autonomic Agents|autonomic agents|mesh-ancestor
5890242|NCT05115136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5890243|NCT05115136|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5890244|NCT05115136|Histamine Antagonists|histamine antagonists|mesh-ancestor
5890245|NCT05115136|Histamine Agents|histamine agents|mesh-ancestor
5890246|NCT05115136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5890247|NCT05115136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890248|NCT05115136|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5890249|NCT05115136|Antipruritics|antipruritics|mesh-ancestor
5890250|NCT05115136|Dermatologic Agents|dermatologic agents|mesh-ancestor
5890251|NCT05115136|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5890252|NCT05115136|Antidepressive Agents|antidepressive agents|mesh-ancestor
5890253|NCT05115136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6496276|NCT00627575|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6496277|NCT00627575|Antimetabolites|antimetabolites|mesh-ancestor
6496278|NCT00627575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496279|NCT00627575|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6496280|NCT00627575|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5890254|NCT05115123|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5890255|NCT05115123|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5890256|NCT05115123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5890257|NCT05115123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5890258|NCT05115123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890259|NCT05115123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5890260|NCT05115123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890261|NCT05115123|Analgesics|analgesics|mesh-ancestor
5890262|NCT05115123|Sensory System Agents|sensory system agents|mesh-ancestor
5890263|NCT05115123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5890264|NCT05115123|Antidepressive Agents|antidepressive agents|mesh-ancestor
5890265|NCT05115123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5890266|NCT05115123|Dopamine Agents|dopamine agents|mesh-ancestor
5890267|NCT05114980|Parathyroid Hormone|parathyroid hormone|mesh-list
5890268|NCT05114980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5890269|NCT05114980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890270|NCT05114499|Donepezil|donepezil|mesh-list
5890271|NCT05114499|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5890272|NCT05114499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5890273|NCT05114499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890274|NCT05114499|Cholinergic Agents|cholinergic agents|mesh-ancestor
5890275|NCT05114499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5890276|NCT05114499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890277|NCT05114499|Nootropic Agents|nootropic agents|mesh-ancestor
5890278|NCT05114239|Timolol|timolol|mesh-list
5890279|NCT05114239|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5890280|NCT05114239|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5890281|NCT05114239|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5890282|NCT05114239|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5890283|NCT05114239|Adrenergic Agents|adrenergic agents|mesh-ancestor
5890284|NCT05114239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5890285|NCT05114239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890286|NCT05114239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890287|NCT05114239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5890288|NCT05114239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5890289|NCT05114096|Betamethasone|betamethasone|mesh-list
5890290|NCT05114096|Betamethasone Valerate|betamethasone valerate|mesh-list
5890291|NCT05114096|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5890292|NCT05114096|Betamethasone benzoate|betamethasone benzoate|mesh-list
5890293|NCT05114096|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
5890294|NCT05114096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5890295|NCT05114096|Glucocorticoids|glucocorticoids|mesh-ancestor
5890296|NCT05114096|Hormones|hormones|mesh-ancestor
5890297|NCT05114096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5890298|NCT05114096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890299|NCT05114096|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5890300|NCT05114096|Respiratory System Agents|respiratory system agents|mesh-ancestor
5890301|NCT05113901|Methylprednisolone|methylprednisolone|mesh-list
5890302|NCT05113901|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6496281|NCT00627575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5890303|NCT05113901|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5890304|NCT05113901|Prednisolone|prednisolone|mesh-list
5890305|NCT05113901|Prednisolone acetate|prednisolone acetate|mesh-list
5890306|NCT05113901|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5890307|NCT05113901|Prednisolone phosphate|prednisolone phosphate|mesh-list
5890308|NCT05113901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5890309|NCT05113901|Antiemetics|antiemetics|mesh-ancestor
5890310|NCT05113901|Autonomic Agents|autonomic agents|mesh-ancestor
5890311|NCT05113901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5890312|NCT05113901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890313|NCT05113901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5890314|NCT05113901|Glucocorticoids|glucocorticoids|mesh-ancestor
5890315|NCT05113901|Hormones|hormones|mesh-ancestor
5890316|NCT05113901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5890317|NCT05113901|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5890318|NCT05113901|Protective Agents|protective agents|mesh-ancestor
5890319|NCT05113901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5890320|NCT05113901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5907433|NCT05244460|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5907434|NCT05244460|Histamine Antagonists|histamine antagonists|mesh-ancestor
5907435|NCT05244460|Histamine Agents|histamine agents|mesh-ancestor
5907436|NCT05244460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5907437|NCT05244460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907438|NCT05244460|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5907439|NCT05244460|Antipruritics|antipruritics|mesh-ancestor
5907440|NCT05244460|Dermatologic Agents|dermatologic agents|mesh-ancestor
5907441|NCT05244460|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5907442|NCT05244460|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5907443|NCT05244460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5907444|NCT05244460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5907445|NCT05244460|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5907446|NCT05244460|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5907447|NCT05244460|Dopamine Agents|dopamine agents|mesh-ancestor
5690504|NCT03422796|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5690505|NCT03422796|Serotonin Agents|serotonin agents|mesh-ancestor
5690506|NCT03422796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5690507|NCT03422796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5690508|NCT03422796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690509|NCT03422796|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5690510|NCT03422796|Autonomic Agents|autonomic agents|mesh-ancestor
5690511|NCT03422796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5690512|NCT03422796|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5690513|NCT03422796|Respiratory System Agents|respiratory system agents|mesh-ancestor
5907448|NCT05244252|Bupivacaine|bupivacaine|mesh-list
5907449|NCT05244252|Anesthetics, Local|anesthetics, local|mesh-ancestor
5907450|NCT05244252|Anesthetics|anesthetics|mesh-ancestor
5907451|NCT05244252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5907452|NCT05244252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907453|NCT05244252|Sensory System Agents|sensory system agents|mesh-ancestor
5907454|NCT05244252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5908733|NCT04159519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5908734|NCT04159519|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5908735|NCT04159519|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5908736|NCT04159519|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5908737|NCT04159519|Adrenergic Agents|adrenergic agents|mesh-ancestor
5908738|NCT04159519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5908739|NCT04159519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908740|NCT04159519|Tocolytic Agents|tocolytic agents|mesh-ancestor
5908741|NCT04159519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5908742|NCT04147325|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
5908743|NCT04147325|Antiviral Agents|antiviral agents|mesh-ancestor
5908744|NCT04147325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5908745|NCT04140903|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5908746|NCT04140903|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5908747|NCT04140903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5908748|NCT04140903|Antitubercular Agents|antitubercular agents|mesh-ancestor
5908749|NCT04133532|Metoprolol|metoprolol|mesh-list
5908750|NCT04133532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5908751|NCT04133532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5908752|NCT04133532|Sympatholytics|sympatholytics|mesh-ancestor
5908753|NCT04133532|Autonomic Agents|autonomic agents|mesh-ancestor
5908754|NCT04133532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5690514|NCT03422796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5908755|NCT04133532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690515|NCT03422796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5690516|NCT03422796|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5690517|NCT03422796|Vasodilator Agents|vasodilator agents|mesh-ancestor
5890321|NCT05113628|Methylene Blue|methylene blue|mesh-list
5890322|NCT05113628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5890323|NCT05113628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890324|NCT05113615|Bromides|bromides|mesh-list
5690518|NCT03422796|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5690519|NCT03422796|Protective Agents|protective agents|mesh-ancestor
5690520|NCT03422796|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5690521|NCT03422796|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5890325|NCT05113615|Tiotropium Bromide|tiotropium bromide|mesh-list
5890326|NCT05113615|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5890327|NCT05113615|Autonomic Agents|autonomic agents|mesh-ancestor
5890328|NCT05113615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5890329|NCT05113615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890330|NCT05113615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5890331|NCT05113615|Respiratory System Agents|respiratory system agents|mesh-ancestor
5890332|NCT05113615|Parasympatholytics|parasympatholytics|mesh-ancestor
5890333|NCT05113615|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5890334|NCT05113615|Cholinergic Agents|cholinergic agents|mesh-ancestor
5890335|NCT05113615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5890336|NCT05113615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890337|NCT05113615|Anticonvulsants|anticonvulsants|mesh-ancestor
5890338|NCT05113511|Bevacizumab|bevacizumab|mesh-list
5890339|NCT05113511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5890340|NCT05113511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5890341|NCT05113511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5890342|NCT05113511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5890343|NCT05113511|Growth Substances|growth substances|mesh-ancestor
5890344|NCT05113511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890345|NCT05113511|Growth Inhibitors|growth inhibitors|mesh-ancestor
5690522|NCT03422796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5690523|NCT03422705|Lisinopril|lisinopril|mesh-list
5690524|NCT03422705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5690525|NCT03422705|Protease Inhibitors|protease inhibitors|mesh-ancestor
5690526|NCT03422705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5690527|NCT03422705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5690528|NCT03422705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5690529|NCT03422705|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5690530|NCT03422705|Protective Agents|protective agents|mesh-ancestor
5690531|NCT03422705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690532|NCT03422666|Teduglutide|teduglutide|mesh-list
5690533|NCT03422666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5690534|NCT03422666|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5690535|NCT03422666|Protective Agents|protective agents|mesh-ancestor
5690536|NCT03422666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690537|NCT03422640|Apremilast|apremilast|mesh-list
5690538|NCT03422640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5690539|NCT03422640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5690540|NCT03422640|Analgesics|analgesics|mesh-ancestor
5690541|NCT03422640|Sensory System Agents|sensory system agents|mesh-ancestor
5690542|NCT03422640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5690543|NCT03422640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690544|NCT03422640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5690545|NCT03422640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5690546|NCT03422640|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5690547|NCT03422640|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5690548|NCT03422640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5690549|NCT03422640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697532|NCT03375515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5697533|NCT03375502|Vaccines|vaccines|mesh-list
5697534|NCT03375502|Immunologic Factors|immunologic factors|mesh-ancestor
5697535|NCT03375502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697536|NCT03375463|Tirzepatide|tirzepatide|mesh-list
5697537|NCT03375463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5697538|NCT03375463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697539|NCT03375463|Incretins|incretins|mesh-ancestor
5697540|NCT03375463|Hormones|hormones|mesh-ancestor
5697541|NCT03375463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5697542|NCT03375424|Vedolizumab|vedolizumab|mesh-list
5697543|NCT03375424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5697544|NCT03375398|PAZ320|paz320|mesh-list
5697545|NCT03375398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5697546|NCT03375398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690550|NCT03422575|Etoricoxib|etoricoxib|mesh-list
5690551|NCT03422575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5690552|NCT03422575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5690553|NCT03422575|Analgesics|analgesics|mesh-ancestor
5690554|NCT03422575|Sensory System Agents|sensory system agents|mesh-ancestor
5690555|NCT03422575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5690556|NCT03422575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690557|NCT03422575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5690558|NCT03422575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5690559|NCT03422575|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5690560|NCT03422575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5690561|NCT03422575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5690562|NCT03422575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5690563|NCT03422536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5690564|NCT03422536|Cetuximab|cetuximab|mesh-list
5690565|NCT03422536|Antibodies|antibodies|mesh-list
5690566|NCT03422536|Immunoglobulins|immunoglobulins|mesh-list
5690567|NCT03422536|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5690568|NCT03422536|Immunologic Factors|immunologic factors|mesh-ancestor
5690569|NCT03422536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690570|NCT03422536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5690571|NCT03422523|Gemcitabine|gemcitabine|mesh-list
5690572|NCT03422523|Rituximab|rituximab|mesh-list
5690573|NCT03422523|Oxaliplatin|oxaliplatin|mesh-list
5690574|NCT03422523|Atezolizumab|atezolizumab|mesh-list
5690575|NCT03422523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5690576|NCT03422523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5890346|NCT05113368|Fulvestrant|fulvestrant|mesh-list
5890347|NCT05113368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5890348|NCT05113368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5890349|NCT05113368|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5890350|NCT05113368|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5890351|NCT05113368|Hormone Antagonists|hormone antagonists|mesh-ancestor
5890352|NCT05113368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5890353|NCT05113368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890354|NCT05113186|Lenvatinib|lenvatinib|mesh-list
5890355|NCT05113186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5890356|NCT05113186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5890357|NCT05113186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5890358|NCT05113186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890359|NCT05113004|Mycophenolic Acid|mycophenolic acid|mesh-list
5890360|NCT05113004|Hydroxychloroquine|hydroxychloroquine|mesh-list
5890361|NCT05113004|Leflunomide|leflunomide|mesh-list
5890362|NCT05113004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5890363|NCT05113004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5890364|NCT05113004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5890365|NCT05113004|Antitubercular Agents|antitubercular agents|mesh-ancestor
5890366|NCT05113004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5890367|NCT05113004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5890368|NCT05113004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5890369|NCT05113004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890370|NCT05113004|Antimalarials|antimalarials|mesh-ancestor
5890371|NCT05113004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5890372|NCT05113004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5890373|NCT05113004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5890374|NCT05113004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5890375|NCT05113004|Immunologic Factors|immunologic factors|mesh-ancestor
5890376|NCT05113004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890377|NCT05112991|Lenvatinib|lenvatinib|mesh-list
5890378|NCT05112991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5690577|NCT03422523|Immunologic Factors|immunologic factors|mesh-ancestor
5690578|NCT03422523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690579|NCT03422523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5690580|NCT03422523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5690581|NCT03422523|Antimetabolites|antimetabolites|mesh-ancestor
5690582|NCT03422523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5690583|NCT03422523|Antiviral Agents|antiviral agents|mesh-ancestor
5690584|NCT03422523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5690585|NCT03422523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5890379|NCT05112991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5890380|NCT05112991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5890381|NCT05112991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890382|NCT05112692|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5890383|NCT05112692|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5890384|NCT05112692|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5690586|NCT03422523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5690587|NCT03422510|CXA-10|cxa-10|mesh-list
5690588|NCT03422510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5690589|NCT03422471|Hypoglycemic Agents|hypoglycemic agents|mesh-list
5690590|NCT03422471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690591|NCT03422445|Temozolomide|temozolomide|mesh-list
5690592|NCT03422445|Apatinib|apatinib|mesh-list
5690593|NCT03422445|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5890385|NCT05112692|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5890386|NCT05112692|Cetrorelix|cetrorelix|mesh-list
5890387|NCT05112692|Menotropins|menotropins|mesh-list
5890388|NCT05112692|Estradiol|estradiol|mesh-list
5890389|NCT05112692|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5890390|NCT05112692|Progesterone|progesterone|mesh-list
5890391|NCT05112692|Dydrogesterone|dydrogesterone|mesh-list
5890392|NCT05112692|Estrogens|estrogens|mesh-ancestor
5690594|NCT03422445|Alkylating Agents|alkylating agents|mesh-ancestor
5690595|NCT03422445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5690596|NCT03422445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5690597|NCT03422445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5690598|NCT03422445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5690599|NCT03422419|Heparin|heparin|mesh-list
5890393|NCT05112692|Hormones|hormones|mesh-ancestor
5890394|NCT05112692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5890395|NCT05112692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890396|NCT05112692|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5890397|NCT05112692|Contraceptive Agents|contraceptive agents|mesh-ancestor
5890398|NCT05112692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5890399|NCT05112692|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5890400|NCT05112692|Progestins|progestins|mesh-ancestor
5890401|NCT05112692|Luteolytic Agents|luteolytic agents|mesh-ancestor
5890402|NCT05112692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5890403|NCT05112692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5890404|NCT05112692|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5890405|NCT05112692|Fertility Agents|fertility agents|mesh-ancestor
5890406|NCT05112692|Hormone Antagonists|hormone antagonists|mesh-ancestor
5890407|NCT05105919|Aspirin|aspirin|mesh-list
5890408|NCT05105919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5890409|NCT05105919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5890410|NCT05105919|Analgesics|analgesics|mesh-ancestor
5890411|NCT05105919|Sensory System Agents|sensory system agents|mesh-ancestor
5890412|NCT05105919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5890413|NCT05105919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890414|NCT05105919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5890415|NCT05105919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5890416|NCT05105919|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5890417|NCT05105919|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5890418|NCT05105919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890419|NCT05105919|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5890420|NCT05105919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5690600|NCT03422419|Anticoagulants|anticoagulants|mesh-ancestor
5690601|NCT03422419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5690602|NCT03422419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5690603|NCT03422419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5690604|NCT03422406|Iodine|iodine|mesh-list
5690605|NCT03422406|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5690606|NCT03422406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5690607|NCT03422406|Trace Elements|trace elements|mesh-ancestor
5690608|NCT03422406|Micronutrients|micronutrients|mesh-ancestor
5690609|NCT03422406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690610|NCT03422393|Venetoclax|venetoclax|mesh-list
5690611|NCT03422393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5690612|NCT03422315|Propofol|propofol|mesh-list
5690613|NCT03422315|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5690614|NCT03422315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5690615|NCT03422315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690616|NCT03422315|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5690617|NCT03422315|Anesthetics, General|anesthetics, general|mesh-ancestor
5690618|NCT03422315|Anesthetics|anesthetics|mesh-ancestor
5690619|NCT03422289|Folic Acid|folic acid|mesh-list
5690620|NCT03422289|Vitamin B Complex|vitamin b complex|mesh-list
5690621|NCT03422289|Inositol|inositol|mesh-list
5690622|NCT03422289|Hematinics|hematinics|mesh-ancestor
5690623|NCT03422289|Vitamins|vitamins|mesh-ancestor
5690624|NCT03422289|Micronutrients|micronutrients|mesh-ancestor
5690625|NCT03422289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890421|NCT05105919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5890422|NCT05105919|Antipyretics|antipyretics|mesh-ancestor
5690626|NCT03422146|Tea Tree Oil|tea tree oil|mesh-list
5890423|NCT05105685|Hormones|hormones|mesh-list
5890424|NCT05105685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5890425|NCT05105685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890426|NCT05103306|Empagliflozin|empagliflozin|mesh-list
5890427|NCT05103306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5890428|NCT05103306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890429|NCT05103306|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5890430|NCT05103306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890431|NCT05102669|Antibodies|antibodies|mesh-list
5890432|NCT05102669|Immunologic Factors|immunologic factors|mesh-ancestor
5890433|NCT05102669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890434|NCT05101629|Pembrolizumab|pembrolizumab|mesh-list
5890435|NCT05101629|Lenvatinib|lenvatinib|mesh-list
5890436|NCT05101629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5890437|NCT05101629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5890438|NCT05101629|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5890439|NCT05101629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5890440|NCT05101629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890441|NCT05100472|Androgens|androgens|mesh-list
5890442|NCT05100472|Hormones|hormones|mesh-ancestor
5890443|NCT05100472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5890444|NCT05100472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890445|NCT05096962|Antibodies|antibodies|mesh-list
5890446|NCT05096962|Immunologic Factors|immunologic factors|mesh-ancestor
5890447|NCT05096962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907455|NCT05244226|Fentanyl|fentanyl|mesh-list
5907456|NCT05244226|Methadone|methadone|mesh-list
5907457|NCT05244226|Hydromorphone|hydromorphone|mesh-list
5907458|NCT05244226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5907459|NCT05244226|Narcotics|narcotics|mesh-ancestor
5907460|NCT05244226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5907461|NCT05244226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907462|NCT05244226|Analgesics|analgesics|mesh-ancestor
5907463|NCT05244226|Sensory System Agents|sensory system agents|mesh-ancestor
5907464|NCT05244226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5907465|NCT05244226|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5907466|NCT05244226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5907467|NCT05244226|Anesthetics, General|anesthetics, general|mesh-ancestor
5907468|NCT05244226|Anesthetics|anesthetics|mesh-ancestor
5907469|NCT05244226|Antitussive Agents|antitussive agents|mesh-ancestor
5907470|NCT05244226|Respiratory System Agents|respiratory system agents|mesh-ancestor
5907471|NCT05244213|Paclitaxel|paclitaxel|mesh-list
5907472|NCT05244213|Carboplatin|carboplatin|mesh-list
5907473|NCT05244213|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5907474|NCT05244213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5907475|NCT05244213|Tubulin Modulators|tubulin modulators|mesh-ancestor
5907476|NCT05244213|Antimitotic Agents|antimitotic agents|mesh-ancestor
5907477|NCT05244213|Mitosis Modulators|mitosis modulators|mesh-ancestor
5907478|NCT05244213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907479|NCT05244200|Insulin|insulin|mesh-list
5907480|NCT05244200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5907481|NCT05244200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690627|NCT03422146|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5690628|NCT03422146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5690629|NCT03422055|Fucoidan|fucoidan|mesh-list
5907482|NCT05244109|Antibodies|antibodies|mesh-list
5907483|NCT05244109|Immunoglobulins|immunoglobulins|mesh-list
5907484|NCT05244109|Immunologic Factors|immunologic factors|mesh-ancestor
5907485|NCT05244109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907486|NCT05244070|Cyclophosphamide|cyclophosphamide|mesh-list
5907487|NCT05244070|Fludarabine|fludarabine|mesh-list
5907488|NCT05244070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5907489|NCT05244070|Immunologic Factors|immunologic factors|mesh-ancestor
5907490|NCT05244070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907491|NCT05244070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5907492|NCT05244070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5907493|NCT05244070|Alkylating Agents|alkylating agents|mesh-ancestor
5690630|NCT03422055|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5690631|NCT03422055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5690632|NCT03422055|Anticoagulants|anticoagulants|mesh-ancestor
5690633|NCT03422055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5690634|NCT03422042|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5690635|NCT03422042|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5690636|NCT03422042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5690637|NCT03422042|Antitubercular Agents|antitubercular agents|mesh-ancestor
5690638|NCT03422029|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
5890448|NCT05091242|Clonidine|clonidine|mesh-list
5890449|NCT05091242|Analgesics|analgesics|mesh-ancestor
5890450|NCT05091242|Sensory System Agents|sensory system agents|mesh-ancestor
5890451|NCT05091242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5890452|NCT05091242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890453|NCT05091242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5890454|NCT05091242|Sympatholytics|sympatholytics|mesh-ancestor
5890455|NCT05091242|Autonomic Agents|autonomic agents|mesh-ancestor
5890456|NCT05091242|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5890457|NCT05091242|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5890458|NCT05091242|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5890459|NCT05091242|Adrenergic Agents|adrenergic agents|mesh-ancestor
5890460|NCT05091242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5890461|NCT05091242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890462|NCT05090566|Dexamethasone|dexamethasone|mesh-list
5890463|NCT05090566|Lenalidomide|lenalidomide|mesh-list
5890464|NCT05090566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5890465|NCT05090566|Antiemetics|antiemetics|mesh-ancestor
5890466|NCT05090566|Autonomic Agents|autonomic agents|mesh-ancestor
5890467|NCT05090566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5890468|NCT05090566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890469|NCT05090566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5890470|NCT05090566|Glucocorticoids|glucocorticoids|mesh-ancestor
5890471|NCT05090566|Hormones|hormones|mesh-ancestor
5890472|NCT05090566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5890473|NCT05090566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5890474|NCT05090566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5890475|NCT05090566|Immunologic Factors|immunologic factors|mesh-ancestor
5890476|NCT05090566|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5890477|NCT05090566|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5890478|NCT05090566|Growth Substances|growth substances|mesh-ancestor
5890479|NCT05090566|Growth Inhibitors|growth inhibitors|mesh-ancestor
5890480|NCT05089916|Osimertinib|osimertinib|mesh-list
5890481|NCT05089916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5890482|NCT05089916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5890483|NCT05089916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5890484|NCT05089916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890485|NCT05088252|Propofol|propofol|mesh-list
5890486|NCT05088252|Desflurane|desflurane|mesh-list
5890487|NCT05088252|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5890488|NCT05088252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5890489|NCT05088252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890490|NCT05088252|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5890491|NCT05088252|Anesthetics, General|anesthetics, general|mesh-ancestor
5890492|NCT05088252|Anesthetics|anesthetics|mesh-ancestor
6675564|NCT01576315|Antifungal Agents|antifungal agents|mesh-ancestor
6675565|NCT01576315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6675566|NCT01576315|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6675567|NCT01576315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5690639|NCT03422029|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5690640|NCT03422029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5690641|NCT03421990|Anesthetics|anesthetics|mesh-list
5690642|NCT03421990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5690643|NCT03421990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690644|NCT03421860|Phenylephrine|phenylephrine|mesh-list
5690645|NCT03421860|Epinephrine|epinephrine|mesh-list
5690646|NCT03421860|Oxymetazoline|oxymetazoline|mesh-list
5690647|NCT03421860|Ephedrine|ephedrine|mesh-list
5690648|NCT03421860|Norepinephrine|norepinephrine|mesh-list
5690649|NCT03421860|Ondansetron|ondansetron|mesh-list
5690650|NCT03421860|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5690651|NCT03421860|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5690652|NCT03421860|Adrenergic Agents|adrenergic agents|mesh-ancestor
5690653|NCT03421860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5690654|NCT03421860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675568|NCT01576315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6675569|NCT01576315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5690655|NCT03421860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890493|NCT05088252|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5890494|NCT05079854|Moxifloxacin|moxifloxacin|mesh-list
5890495|NCT05079854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5890496|NCT05079854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5890497|NCT05079854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5890498|NCT05079854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5890499|NCT05079854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5690656|NCT03421860|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5690657|NCT03421860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5690658|NCT03421860|Autonomic Agents|autonomic agents|mesh-ancestor
5690659|NCT03421860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5690660|NCT03421860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5890500|NCT05079854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890501|NCT05079854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6496282|NCT00627575|Anticonvulsants|anticonvulsants|mesh-ancestor
6496283|NCT00627575|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6496284|NCT00627575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5890502|NCT05077917|Cromolyn Sodium|cromolyn sodium|mesh-list
5890503|NCT05077917|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
5890504|NCT05077917|Immunologic Factors|immunologic factors|mesh-ancestor
5890505|NCT05077917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890506|NCT05077917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5890507|NCT05077917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5890508|NCT05077917|Respiratory System Agents|respiratory system agents|mesh-ancestor
5890509|NCT05073822|Mycophenolic Acid|mycophenolic acid|mesh-list
5890510|NCT05073822|Tacrolimus|tacrolimus|mesh-list
5890511|NCT05073822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5890512|NCT05073822|Immunologic Factors|immunologic factors|mesh-ancestor
5890513|NCT05073822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890514|NCT05073822|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5690661|NCT03421860|Respiratory System Agents|respiratory system agents|mesh-ancestor
5690662|NCT03421860|Mydriatics|mydriatics|mesh-ancestor
5690663|NCT03421860|Sympathomimetics|sympathomimetics|mesh-ancestor
5690664|NCT03421860|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5690665|NCT03421860|Antiemetics|antiemetics|mesh-ancestor
5690666|NCT03421860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5690667|NCT03421860|Antipruritics|antipruritics|mesh-ancestor
5690668|NCT03421860|Dermatologic Agents|dermatologic agents|mesh-ancestor
5690669|NCT03421860|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5690670|NCT03421860|Serotonin Agents|serotonin agents|mesh-ancestor
5690671|NCT03421860|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5690672|NCT03421860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5690673|NCT03421860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5690674|NCT03421860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5890515|NCT05073822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5890516|NCT05073822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890517|NCT05073822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5890518|NCT05073822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5890519|NCT05073822|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5890520|NCT05073822|Antitubercular Agents|antitubercular agents|mesh-ancestor
5890521|NCT05073822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5890522|NCT05073822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5890523|NCT05068336|Anesthetics|anesthetics|mesh-list
5890524|NCT05068336|Sevoflurane|sevoflurane|mesh-list
5890525|NCT05068336|Desflurane|desflurane|mesh-list
5890526|NCT05068336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5890527|NCT05068336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890528|NCT05068336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5890529|NCT05068336|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5890530|NCT05068336|Anesthetics, General|anesthetics, general|mesh-ancestor
5890531|NCT05062785|Insulin|insulin|mesh-list
5890532|NCT05062785|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5890533|NCT05062785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5890534|NCT05062785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890535|NCT05047094|Pembrolizumab|pembrolizumab|mesh-list
5890536|NCT05047094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5890537|NCT05047094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5890538|NCT05040126|Linezolid|linezolid|mesh-list
5890539|NCT05040126|Bedaquiline|bedaquiline|mesh-list
5890540|NCT05040126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5890541|NCT05040126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5890542|NCT05040126|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5890543|NCT05040126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5890544|NCT05040126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890545|NCT05040126|Antitubercular Agents|antitubercular agents|mesh-ancestor
5890546|NCT05036109|Aspirin|aspirin|mesh-list
5890547|NCT05036109|Vitamin D|vitamin d|mesh-list
5890548|NCT05036109|Vitamins|vitamins|mesh-ancestor
5890549|NCT05036109|Micronutrients|micronutrients|mesh-ancestor
5890550|NCT05036109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690675|NCT03421860|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5890551|NCT05036109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5890552|NCT05036109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5890553|NCT05036109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5890554|NCT05036109|Analgesics|analgesics|mesh-ancestor
5890555|NCT05036109|Sensory System Agents|sensory system agents|mesh-ancestor
5890556|NCT05036109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5890557|NCT05036109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5890558|NCT05036109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5890559|NCT05036109|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5890560|NCT05036109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5890561|NCT05036109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890562|NCT05036109|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5890563|NCT05036109|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5890564|NCT05036109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5890565|NCT05036109|Antipyretics|antipyretics|mesh-ancestor
5890566|NCT05024747|Nicotine|nicotine|mesh-list
5890567|NCT05024747|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5890568|NCT05024747|Autonomic Agents|autonomic agents|mesh-ancestor
5890569|NCT05024747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5890570|NCT05024747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890571|NCT05024747|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5890572|NCT05024747|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5890573|NCT05024747|Cholinergic Agents|cholinergic agents|mesh-ancestor
5890574|NCT05024747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5890575|NCT05024747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890576|NCT05015335|Adalimumab|adalimumab|mesh-list
5890577|NCT05015335|Methotrexate|methotrexate|mesh-list
5890578|NCT05015335|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5890579|NCT05015335|Abortifacient Agents|abortifacient agents|mesh-ancestor
5890580|NCT05015335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5890581|NCT05015335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890582|NCT05015335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5890583|NCT05015335|Antimetabolites|antimetabolites|mesh-ancestor
5890584|NCT05015335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5690676|NCT03421860|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5690677|NCT03421860|Nasal Decongestants|nasal decongestants|mesh-ancestor
5690678|NCT03421860|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5890585|NCT05015335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5890586|NCT05015335|Dermatologic Agents|dermatologic agents|mesh-ancestor
5890587|NCT05015335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5890588|NCT05015335|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5890589|NCT05015335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5890590|NCT05015335|Immunologic Factors|immunologic factors|mesh-ancestor
5890591|NCT05015335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5890592|NCT05015335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5890593|NCT05015335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5890594|NCT05011266|Buprenorphine|buprenorphine|mesh-list
5890595|NCT05011266|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
5690679|NCT03421860|Protective Agents|protective agents|mesh-ancestor
5690680|NCT03421860|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5690681|NCT03421821|Ropivacaine|ropivacaine|mesh-list
5690682|NCT03421821|Anesthetics, Local|anesthetics, local|mesh-ancestor
5890596|NCT05011266|Naloxone|naloxone|mesh-list
5890597|NCT05011266|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5890598|NCT05011266|Narcotics|narcotics|mesh-ancestor
5890599|NCT05011266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5890600|NCT05011266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890601|NCT05011266|Analgesics|analgesics|mesh-ancestor
5890602|NCT05011266|Sensory System Agents|sensory system agents|mesh-ancestor
5890603|NCT05011266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5890604|NCT05011266|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5890605|NCT05003102|Fentanyl|fentanyl|mesh-list
5890606|NCT05003102|Dexmedetomidine|dexmedetomidine|mesh-list
5890607|NCT05003102|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5890608|NCT05003102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5890609|NCT05003102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890610|NCT05003102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5890611|NCT05003102|Analgesics|analgesics|mesh-ancestor
5890612|NCT05003102|Sensory System Agents|sensory system agents|mesh-ancestor
5890613|NCT05003102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5890614|NCT05003102|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5890615|NCT05003102|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5890616|NCT05003102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5890617|NCT05003102|Adrenergic Agents|adrenergic agents|mesh-ancestor
5890618|NCT05003102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5890619|NCT05003102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5690683|NCT03421821|Anesthetics|anesthetics|mesh-ancestor
5890620|NCT05003102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5890621|NCT05003102|Narcotics|narcotics|mesh-ancestor
5890622|NCT05003102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5890623|NCT05003102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5890624|NCT05003102|Anesthetics, General|anesthetics, general|mesh-ancestor
5890625|NCT05003102|Anesthetics|anesthetics|mesh-ancestor
5690684|NCT03421821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5690685|NCT03421821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690686|NCT03421821|Sensory System Agents|sensory system agents|mesh-ancestor
5690687|NCT03421821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5690688|NCT03421756|Sirolimus|sirolimus|mesh-list
5690689|NCT03421756|Alemtuzumab|alemtuzumab|mesh-list
5690690|NCT03421756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5890651|NCT04984811|Atezolizumab|atezolizumab|mesh-list
5890652|NCT04984811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5890653|NCT04982796|Psilocybin|psilocybin|mesh-list
5890654|NCT04982796|Hallucinogens|hallucinogens|mesh-ancestor
5890655|NCT04982796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890656|NCT04982796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5890657|NCT04979806|Meropenem|meropenem|mesh-list
5890658|NCT04979806|Cefepime|cefepime|mesh-list
5890659|NCT04979806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5890660|NCT04979806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5890661|NCT04973345|Terbutaline|terbutaline|mesh-list
5890662|NCT04973345|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5890663|NCT04973345|Autonomic Agents|autonomic agents|mesh-ancestor
5890664|NCT04973345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5890665|NCT04973345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890666|NCT04973345|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5890667|NCT04973345|Respiratory System Agents|respiratory system agents|mesh-ancestor
5890668|NCT04973345|Sympathomimetics|sympathomimetics|mesh-ancestor
5890669|NCT04973345|Tocolytic Agents|tocolytic agents|mesh-ancestor
5890670|NCT04973345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5890671|NCT04973345|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5890672|NCT04973345|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5890673|NCT04973345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5890674|NCT04973345|Adrenergic Agents|adrenergic agents|mesh-ancestor
5890675|NCT04973345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5890676|NCT04973345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890677|NCT04964622|Ibuprofen|ibuprofen|mesh-list
5890678|NCT04964622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5890679|NCT04964622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6496285|NCT00627575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6496286|NCT00627575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496287|NCT00627575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5690691|NCT03421756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5690692|NCT03421756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5690693|NCT03421756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5690694|NCT03421756|Antifungal Agents|antifungal agents|mesh-ancestor
5690695|NCT03421756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5690696|NCT03421756|Immunologic Factors|immunologic factors|mesh-ancestor
5690697|NCT03421756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890680|NCT04964622|Analgesics|analgesics|mesh-ancestor
5890681|NCT04964622|Sensory System Agents|sensory system agents|mesh-ancestor
5890682|NCT04964622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5890683|NCT04964622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890684|NCT04964622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5890685|NCT04964622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5890686|NCT04964622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5890687|NCT04964622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5890688|NCT04964622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890689|NCT04954339|Bevacizumab|bevacizumab|mesh-list
5890690|NCT04954339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5890691|NCT04954339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5890692|NCT04954339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5890693|NCT04954339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5890694|NCT04954339|Growth Substances|growth substances|mesh-ancestor
5890695|NCT04954339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890696|NCT04954339|Growth Inhibitors|growth inhibitors|mesh-ancestor
5890697|NCT04953052|Imatinib Mesylate|imatinib mesylate|mesh-list
5890698|NCT04953052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5890699|NCT04953052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5890700|NCT04953052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5890701|NCT04953052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890702|NCT04951804|Bupivacaine|bupivacaine|mesh-list
5890703|NCT04951804|Anesthetics, Local|anesthetics, local|mesh-ancestor
5890704|NCT04951804|Anesthetics|anesthetics|mesh-ancestor
5890705|NCT04951804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5890706|NCT04951804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890707|NCT04951804|Sensory System Agents|sensory system agents|mesh-ancestor
5890708|NCT04951804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5890709|NCT04947514|Tranexamic Acid|tranexamic acid|mesh-list
5890710|NCT04947514|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5890711|NCT04947514|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5690698|NCT03421756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5690699|NCT03421743|Molgramostim|molgramostim|mesh-list
5690700|NCT03421743|Sargramostim|sargramostim|mesh-list
5690701|NCT03421743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5690702|NCT03421743|Immunologic Factors|immunologic factors|mesh-ancestor
5890712|NCT04947514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890713|NCT04947514|Hemostatics|hemostatics|mesh-ancestor
5890714|NCT04947514|Coagulants|coagulants|mesh-ancestor
5890715|NCT04944771|Rabeprazole|rabeprazole|mesh-list
5890716|NCT04944771|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5890717|NCT04944771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5890718|NCT04944771|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5890719|NCT04944771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5890720|NCT04944771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890721|NCT04939753|Sevoflurane|sevoflurane|mesh-list
5890722|NCT04939753|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6496288|NCT00627575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6496289|NCT00627575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6496290|NCT00627575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6496291|NCT00627575|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6496292|NCT00627575|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6496293|NCT00627575|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6496294|NCT00627575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5890723|NCT04939753|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5890724|NCT04939753|Anesthetics, General|anesthetics, general|mesh-ancestor
5890725|NCT04939753|Anesthetics|anesthetics|mesh-ancestor
5890726|NCT04939753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5890727|NCT04939753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890728|NCT04937413|Evolocumab|evolocumab|mesh-list
5890729|NCT04937413|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5890730|NCT04937413|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5890731|NCT04937413|Antimetabolites|antimetabolites|mesh-ancestor
5690703|NCT03421743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690704|NCT03421717|Chitosan|chitosan|mesh-list
5690705|NCT03421717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5690706|NCT03421717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5690707|NCT03421717|Antimetabolites|antimetabolites|mesh-ancestor
5890732|NCT04937413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890733|NCT04937413|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5907494|NCT05244070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5697547|NCT03375385|Dexmedetomidine|dexmedetomidine|mesh-list
5907495|NCT05244070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5890734|NCT04920383|Pembrolizumab|pembrolizumab|mesh-list
5890735|NCT04920383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5890736|NCT04920383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5890737|NCT04913870|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
5890738|NCT04913870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890739|NCT04899206|Antihypertensive Agents|antihypertensive agents|mesh-list
5890740|NCT04899206|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
5890741|NCT04899206|Protease Inhibitors|protease inhibitors|mesh-ancestor
5890742|NCT04899206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5890743|NCT04899206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890744|NCT04871529|Gemcitabine|gemcitabine|mesh-list
5890745|NCT04871529|Carboplatin|carboplatin|mesh-list
5890746|NCT04871529|Avelumab|avelumab|mesh-list
5890747|NCT04871529|Immunoglobulins|immunoglobulins|mesh-list
5890748|NCT04871529|Immunoglobulin G|immunoglobulin g|mesh-list
5890749|NCT04871529|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5890750|NCT04871529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5890751|NCT04871529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5890752|NCT04871529|Antimetabolites|antimetabolites|mesh-ancestor
5890753|NCT04871529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890754|NCT04871529|Antiviral Agents|antiviral agents|mesh-ancestor
5890755|NCT04871529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5890756|NCT04871529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5890757|NCT04871529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5890758|NCT04871529|Immunologic Factors|immunologic factors|mesh-ancestor
5890759|NCT04871529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890760|NCT04871529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5890761|NCT04862468|Dexamethasone|dexamethasone|mesh-list
5890762|NCT04862468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5890763|NCT04862468|Antiemetics|antiemetics|mesh-ancestor
5890764|NCT04862468|Autonomic Agents|autonomic agents|mesh-ancestor
5890765|NCT04862468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5690708|NCT03421717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5690709|NCT03421717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5690710|NCT03421717|Chelating Agents|chelating agents|mesh-ancestor
5690711|NCT03421717|Sequestering Agents|sequestering agents|mesh-ancestor
5690712|NCT03421717|Hemostatics|hemostatics|mesh-ancestor
5690713|NCT03421717|Coagulants|coagulants|mesh-ancestor
5690714|NCT03421652|Nivolumab|nivolumab|mesh-list
5690715|NCT03421652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5690716|NCT03421652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5690717|NCT03421652|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5690718|NCT03421652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5690719|NCT03421496|Cannabidiol|cannabidiol|mesh-list
5690720|NCT03421496|Vigabatrin|vigabatrin|mesh-list
5890766|NCT04862468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890767|NCT04862468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5890768|NCT04862468|Glucocorticoids|glucocorticoids|mesh-ancestor
5890769|NCT04862468|Hormones|hormones|mesh-ancestor
5890770|NCT04862468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5890771|NCT04862468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5890772|NCT04862468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5890773|NCT04858776|Dexamethasone|dexamethasone|mesh-list
5890774|NCT04858776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5890775|NCT04858776|Antiemetics|antiemetics|mesh-ancestor
5890776|NCT04858776|Autonomic Agents|autonomic agents|mesh-ancestor
5890777|NCT04858776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5890778|NCT04858776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890779|NCT04858776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5890780|NCT04858776|Glucocorticoids|glucocorticoids|mesh-ancestor
5890781|NCT04858776|Hormones|hormones|mesh-ancestor
5890782|NCT04858776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5890783|NCT04858776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5890784|NCT04858776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5890785|NCT04828486|Pembrolizumab|pembrolizumab|mesh-list
5890786|NCT04828486|Futibatinib|futibatinib|mesh-list
5890787|NCT04828486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5890788|NCT04828486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5890789|NCT04820686|Tenofovir|tenofovir|mesh-list
5890790|NCT04820686|Entecavir|entecavir|mesh-list
5890791|NCT04820686|Antiviral Agents|antiviral agents|mesh-ancestor
5890792|NCT04820686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5890793|NCT04820686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5890794|NCT04820686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5690721|NCT03421496|Anticonvulsants|anticonvulsants|mesh-ancestor
5690722|NCT03421496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5890795|NCT04820686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5890796|NCT04820686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890797|NCT04820686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5890798|NCT04820686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5890799|NCT04819568|Terlipressin|terlipressin|mesh-list
5890800|NCT04819568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5890801|NCT04819568|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5890802|NCT04818489|Colchicine|colchicine|mesh-list
5890803|NCT04818489|Gout Suppressants|gout suppressants|mesh-ancestor
5890804|NCT04818489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5890805|NCT04818489|Tubulin Modulators|tubulin modulators|mesh-ancestor
5890806|NCT04818489|Antimitotic Agents|antimitotic agents|mesh-ancestor
5890807|NCT04818489|Mitosis Modulators|mitosis modulators|mesh-ancestor
5890808|NCT04818489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890809|NCT04818489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5890810|NCT04802408|Listerine|listerine|mesh-list
5890811|NCT04802408|Sodium Fluoride|sodium fluoride|mesh-list
5890812|NCT04802408|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5690723|NCT03421496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5690724|NCT03421496|GABA Agents|gaba agents|mesh-ancestor
5690725|NCT03421496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5690726|NCT03421496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690727|NCT03421483|Folic Acid|folic acid|mesh-list
5690728|NCT03421483|Hematinics|hematinics|mesh-ancestor
5690729|NCT03421483|Vitamin B Complex|vitamin b complex|mesh-ancestor
5690730|NCT03421483|Vitamins|vitamins|mesh-ancestor
5690731|NCT03421483|Micronutrients|micronutrients|mesh-ancestor
5690732|NCT03421483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890813|NCT04802408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5890814|NCT04802408|Cariostatic Agents|cariostatic agents|mesh-ancestor
5890815|NCT04802408|Protective Agents|protective agents|mesh-ancestor
5890816|NCT04802408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890817|NCT04796467|Edetic Acid|edetic acid|mesh-list
5890818|NCT04796467|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5890819|NCT04796467|Anticoagulants|anticoagulants|mesh-ancestor
5890820|NCT04796467|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5890821|NCT04796467|Chelating Agents|chelating agents|mesh-ancestor
5890822|NCT04796467|Sequestering Agents|sequestering agents|mesh-ancestor
5890823|NCT04796467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890824|NCT04796467|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5890825|NCT04781647|Interferons|interferons|mesh-list
5890826|NCT04781647|Interferon-alpha|interferon-alpha|mesh-list
5890827|NCT04781647|Entecavir|entecavir|mesh-list
5890828|NCT04781647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5890829|NCT04781647|Antiviral Agents|antiviral agents|mesh-ancestor
5890830|NCT04781647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5890831|NCT04781647|Immunologic Factors|immunologic factors|mesh-ancestor
5890832|NCT04781647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890833|NCT04765787|Acetaminophen|acetaminophen|mesh-list
5890834|NCT04765787|Orphenadrine|orphenadrine|mesh-list
5890835|NCT04765787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5890836|NCT04765787|Analgesics|analgesics|mesh-ancestor
5890837|NCT04765787|Sensory System Agents|sensory system agents|mesh-ancestor
5890838|NCT04765787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5890839|NCT04765787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890840|NCT04765787|Antipyretics|antipyretics|mesh-ancestor
5890841|NCT04765787|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5890842|NCT04765787|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5890843|NCT04765787|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5890844|NCT04765787|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5890845|NCT04765787|Parasympatholytics|parasympatholytics|mesh-ancestor
5890846|NCT04765787|Autonomic Agents|autonomic agents|mesh-ancestor
5890847|NCT04765787|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5890848|NCT04765787|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5890849|NCT04765787|Cholinergic Agents|cholinergic agents|mesh-ancestor
5890850|NCT04765787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5890851|NCT04765787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890852|NCT04765787|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
5690733|NCT03421366|Posaconazole|posaconazole|mesh-list
5690734|NCT03421366|Antifungal Agents|antifungal agents|mesh-ancestor
5890853|NCT04765787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5890854|NCT04765787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5890855|NCT04756791|Anesthetics|anesthetics|mesh-list
5690735|NCT03421366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5690736|NCT03421366|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6496295|NCT00627653|Fenofibrate|fenofibrate|mesh-list
5690737|NCT03421366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5690738|NCT03421366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6496296|NCT00627653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5890856|NCT04756791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5890857|NCT04756791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890858|NCT04748250|Phytoestrogens|phytoestrogens|mesh-list
5890859|NCT04748250|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6496297|NCT00627653|Antimetabolites|antimetabolites|mesh-ancestor
6496298|NCT00627653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496299|NCT00627653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6496300|NCT00627666|Leucovorin|leucovorin|mesh-list
6496301|NCT00627666|Methotrexate|methotrexate|mesh-list
6496302|NCT00627666|Fludarabine phosphate|fludarabine phosphate|mesh-list
6496303|NCT00627666|Fludarabine|fludarabine|mesh-list
6496304|NCT00627666|Busulfan|busulfan|mesh-list
5890860|NCT04748250|Estrogens|estrogens|mesh-ancestor
5890861|NCT04748250|Hormones|hormones|mesh-ancestor
5890862|NCT04748250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5890863|NCT04748250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890864|NCT04726878|Acetaminophen|acetaminophen|mesh-list
5890865|NCT04726878|Oxycodone|oxycodone|mesh-list
5890866|NCT04726878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5890867|NCT04726878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890868|NCT04726878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5890869|NCT04726878|Analgesics|analgesics|mesh-ancestor
5890870|NCT04726878|Sensory System Agents|sensory system agents|mesh-ancestor
5890871|NCT04726878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5890872|NCT04726878|Antipyretics|antipyretics|mesh-ancestor
5890873|NCT04726878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5890874|NCT04726878|Narcotics|narcotics|mesh-ancestor
5890875|NCT04718727|Olanzapine|olanzapine|mesh-list
5890876|NCT04718727|Antiemetics|antiemetics|mesh-ancestor
5890877|NCT04718727|Autonomic Agents|autonomic agents|mesh-ancestor
5890878|NCT04718727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5890879|NCT04718727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890880|NCT04718727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5890881|NCT04718727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5890882|NCT04718727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5890883|NCT04718727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5890884|NCT04718727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5890885|NCT04718727|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5890886|NCT04718727|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5890887|NCT04718727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5890888|NCT04718727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890889|NCT04718727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5890890|NCT04718727|Serotonin Agents|serotonin agents|mesh-ancestor
5890891|NCT04714372|Cyclophosphamide|cyclophosphamide|mesh-list
5890892|NCT04714372|Fludarabine|fludarabine|mesh-list
5890893|NCT04714372|Daratumumab|daratumumab|mesh-list
5890894|NCT04714372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5890895|NCT04714372|Immunologic Factors|immunologic factors|mesh-ancestor
5890896|NCT04714372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890897|NCT04714372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5890898|NCT04714372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5890899|NCT04714372|Alkylating Agents|alkylating agents|mesh-ancestor
5890900|NCT04714372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890901|NCT04714372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5890902|NCT04714372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5890903|NCT04682353|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
5890904|NCT04682353|Medroxyprogesterone|medroxyprogesterone|mesh-list
5890905|NCT04682353|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5890906|NCT04682353|Contraceptive Agents|contraceptive agents|mesh-ancestor
5690739|NCT03421366|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5690740|NCT03421366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5690741|NCT03421366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5690742|NCT03421366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5690743|NCT03421366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5690744|NCT03421366|Hormone Antagonists|hormone antagonists|mesh-ancestor
5697548|NCT03375385|Propofol|propofol|mesh-list
5890907|NCT04682353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5890908|NCT04682353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890909|NCT04682353|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5890910|NCT04682353|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5890911|NCT04682353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5890912|NCT04682353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5890913|NCT04682353|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5890914|NCT04682353|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6496305|NCT00627666|Calcium|calcium|mesh-list
5890915|NCT04682353|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5890916|NCT04669002|Olaparib|olaparib|mesh-list
5890917|NCT04669002|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5890918|NCT04669002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5890919|NCT04669002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890920|NCT04669002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5890921|NCT04638803|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
5890922|NCT04638803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690745|NCT03421366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5690746|NCT03421366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690747|NCT03421314|Selenium|selenium|mesh-list
5690748|NCT03421314|Antioxidants|antioxidants|mesh-ancestor
5690749|NCT03421314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5690750|NCT03421314|Protective Agents|protective agents|mesh-ancestor
5690751|NCT03421314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690752|NCT03421314|Trace Elements|trace elements|mesh-ancestor
5690753|NCT03421314|Micronutrients|micronutrients|mesh-ancestor
5890923|NCT04633772|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
5890924|NCT04633772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5890925|NCT04633772|Vasodilator Agents|vasodilator agents|mesh-ancestor
5907496|NCT05244070|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5907497|NCT05244057|Interferons|interferons|mesh-list
5907498|NCT05244057|Tenofovir|tenofovir|mesh-list
5907499|NCT05244057|Interferon-alpha|interferon-alpha|mesh-list
5907500|NCT05244057|Interferon alpha-2|interferon alpha-2|mesh-list
5907501|NCT05244057|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5907502|NCT05244057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5907503|NCT05244057|Antiviral Agents|antiviral agents|mesh-ancestor
5907504|NCT05244057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5907505|NCT05244057|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5907506|NCT05244057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5907507|NCT05244057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5907508|NCT05244057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907509|NCT05244057|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5907510|NCT05244057|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5907511|NCT05244057|Immunologic Factors|immunologic factors|mesh-ancestor
5907512|NCT05244057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907513|NCT05244031|Analgesics, Opioid|analgesics, opioid|mesh-list
5907514|NCT05244031|Narcotics|narcotics|mesh-ancestor
5907515|NCT05244031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5907516|NCT05244031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907517|NCT05244031|Analgesics|analgesics|mesh-ancestor
5907518|NCT05244031|Sensory System Agents|sensory system agents|mesh-ancestor
5907519|NCT05244031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5907520|NCT05244018|Vitamin D|vitamin d|mesh-list
5907521|NCT05244018|Ergocalciferols|ergocalciferols|mesh-list
5907522|NCT05244018|Cholecalciferol|cholecalciferol|mesh-list
5907523|NCT05244018|Vitamins|vitamins|mesh-list
5907524|NCT05244018|Micronutrients|micronutrients|mesh-ancestor
5907525|NCT05244018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907526|NCT05244018|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5907527|NCT05244018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5907528|NCT05243953|Cromakalim|cromakalim|mesh-list
6496306|NCT00627666|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6496307|NCT00627666|Levoleucovorin|levoleucovorin|mesh-list
6496308|NCT00627666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6496309|NCT00627666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907529|NCT05243953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6496310|NCT00627666|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5890926|NCT04605614|Copper|copper|mesh-list
5890927|NCT04605614|Pembrolizumab|pembrolizumab|mesh-list
5890928|NCT04605614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5890929|NCT04605614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5890930|NCT04605614|Trace Elements|trace elements|mesh-ancestor
5890931|NCT04605614|Micronutrients|micronutrients|mesh-ancestor
5890932|NCT04605614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890933|NCT04592783|Antihypertensive Agents|antihypertensive agents|mesh-list
5890934|NCT04585295|Betaine|betaine|mesh-list
5890935|NCT04585295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5890936|NCT04585295|Lipotropic Agents|lipotropic agents|mesh-ancestor
5890937|NCT04585295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5890938|NCT04585295|Antimetabolites|antimetabolites|mesh-ancestor
5890939|NCT04585295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890940|NCT04585295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5890941|NCT04583488|Docetaxel|docetaxel|mesh-list
5890942|NCT04583488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5890943|NCT04583488|Tubulin Modulators|tubulin modulators|mesh-ancestor
5890944|NCT04583488|Antimitotic Agents|antimitotic agents|mesh-ancestor
5890945|NCT04583488|Mitosis Modulators|mitosis modulators|mesh-ancestor
5890946|NCT04583488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890947|NCT04568616|Letrozole|letrozole|mesh-list
5890948|NCT04568616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5890949|NCT04568616|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5890950|NCT04568616|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5890951|NCT04568616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5890952|NCT04568616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890953|NCT04568616|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5890954|NCT04568616|Hormone Antagonists|hormone antagonists|mesh-ancestor
5890955|NCT04568616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5890956|NCT04568616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890957|NCT04560868|Nicotine|nicotine|mesh-list
5890958|NCT04560868|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5890959|NCT04560868|Autonomic Agents|autonomic agents|mesh-ancestor
5890960|NCT04560868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5890961|NCT04560868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890962|NCT04560868|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5890963|NCT04560868|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5890964|NCT04560868|Cholinergic Agents|cholinergic agents|mesh-ancestor
5890965|NCT04560868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5890966|NCT04560868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890967|NCT04557215|Acetylcysteine|acetylcysteine|mesh-list
5890968|NCT04557215|Rifaximin|rifaximin|mesh-list
5890969|NCT04557215|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5890970|NCT04557215|Antiviral Agents|antiviral agents|mesh-ancestor
5890971|NCT04557215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5890972|NCT04557215|Expectorants|expectorants|mesh-ancestor
5890973|NCT04557215|Respiratory System Agents|respiratory system agents|mesh-ancestor
5890974|NCT04557215|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5890975|NCT04557215|Antioxidants|antioxidants|mesh-ancestor
5890976|NCT04557215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890977|NCT04557215|Protective Agents|protective agents|mesh-ancestor
5890978|NCT04557215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890979|NCT04557215|Antidotes|antidotes|mesh-ancestor
5890980|NCT04557215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5890981|NCT04557215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5890982|NCT04551521|Trastuzumab|trastuzumab|mesh-list
5890983|NCT04551521|Pertuzumab|pertuzumab|mesh-list
5890984|NCT04551521|Atezolizumab|atezolizumab|mesh-list
5890985|NCT04551521|Vemurafenib|vemurafenib|mesh-list
5890986|NCT04551521|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5890987|NCT04551521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5890988|NCT04551521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5890989|NCT04551521|Immunologic Factors|immunologic factors|mesh-ancestor
5890990|NCT04551521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5890991|NCT04551521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5890992|NCT04551521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5890993|NCT04551521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890994|NCT04547140|Protease Inhibitors|protease inhibitors|mesh-list
5890995|NCT04547140|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
5890996|NCT04547140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5890997|NCT04547140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5890998|NCT04547140|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5890999|NCT04547140|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5891000|NCT04526197|Celecoxib|celecoxib|mesh-list
5891001|NCT04526197|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
5891002|NCT04526197|Choline|choline|mesh-list
5891003|NCT04526197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5891004|NCT04526197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5891005|NCT04526197|Analgesics|analgesics|mesh-ancestor
5891006|NCT04526197|Sensory System Agents|sensory system agents|mesh-ancestor
5891007|NCT04526197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5891008|NCT04526197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891009|NCT04526197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5891010|NCT04526197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5891011|NCT04526197|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5891012|NCT04526197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5891013|NCT04526197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5891014|NCT04526197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5891015|NCT04526197|Lipotropic Agents|lipotropic agents|mesh-ancestor
5891016|NCT04526197|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5891017|NCT04526197|Antimetabolites|antimetabolites|mesh-ancestor
5891018|NCT04526197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5891019|NCT04526197|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5891020|NCT04526197|Nootropic Agents|nootropic agents|mesh-ancestor
5891021|NCT04526197|Chelating Agents|chelating agents|mesh-ancestor
5891022|NCT04526197|Sequestering Agents|sequestering agents|mesh-ancestor
5690754|NCT03421288|Leucovorin|leucovorin|mesh-list
5690755|NCT03421288|Docetaxel|docetaxel|mesh-list
5690756|NCT03421288|Fluorouracil|fluorouracil|mesh-list
5690757|NCT03421288|Oxaliplatin|oxaliplatin|mesh-list
5690758|NCT03421288|Atezolizumab|atezolizumab|mesh-list
5690759|NCT03421288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5690760|NCT03421288|Tubulin Modulators|tubulin modulators|mesh-ancestor
5690761|NCT03421288|Antimitotic Agents|antimitotic agents|mesh-ancestor
5690762|NCT03421288|Mitosis Modulators|mitosis modulators|mesh-ancestor
5690763|NCT03421288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5690764|NCT03421288|Antimetabolites|antimetabolites|mesh-ancestor
5690765|NCT03421288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5690766|NCT03421288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5690767|NCT03421288|Immunologic Factors|immunologic factors|mesh-ancestor
5690768|NCT03421288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690769|NCT03421288|Antidotes|antidotes|mesh-ancestor
5690770|NCT03421288|Protective Agents|protective agents|mesh-ancestor
5690771|NCT03421288|Vitamin B Complex|vitamin b complex|mesh-ancestor
5690772|NCT03421288|Vitamins|vitamins|mesh-ancestor
5891023|NCT04526197|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5891024|NCT04526197|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5891025|NCT04526197|Growth Substances|growth substances|mesh-ancestor
5891026|NCT04526197|Growth Inhibitors|growth inhibitors|mesh-ancestor
5891027|NCT04526197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5891028|NCT04520711|Pembrolizumab|pembrolizumab|mesh-list
5891029|NCT04520711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5891030|NCT04520711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5891031|NCT04511013|Nivolumab|nivolumab|mesh-list
5891032|NCT04511013|Ipilimumab|ipilimumab|mesh-list
5891033|NCT04511013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5891034|NCT04511013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5891035|NCT04511013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5891036|NCT04511013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5891037|NCT04481919|Diuretics|diuretics|mesh-list
5891038|NCT04481919|Natriuretic Agents|natriuretic agents|mesh-ancestor
5891039|NCT04481919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891040|NCT04479579|Apixaban|apixaban|mesh-list
5891041|NCT04479579|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5891042|NCT04479579|Antithrombins|antithrombins|mesh-ancestor
5891043|NCT04479579|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5891044|NCT04479579|Protease Inhibitors|protease inhibitors|mesh-ancestor
5891045|NCT04479579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5891046|NCT04479579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5891047|NCT04479579|Anticoagulants|anticoagulants|mesh-ancestor
5891048|NCT04477512|Prednisone|prednisone|mesh-list
5891049|NCT04477512|Nivolumab|nivolumab|mesh-list
5891050|NCT04477512|Abiraterone Acetate|abiraterone acetate|mesh-list
5891051|NCT04477512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5891052|NCT04477512|Glucocorticoids|glucocorticoids|mesh-ancestor
5891053|NCT04477512|Hormones|hormones|mesh-ancestor
5891054|NCT04477512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5891055|NCT04477512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891056|NCT04477512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5891057|NCT04477512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6496311|NCT00627666|Abortifacient Agents|abortifacient agents|mesh-ancestor
5690773|NCT03421288|Micronutrients|micronutrients|mesh-ancestor
5690774|NCT03421275|Fentanyl|fentanyl|mesh-list
5690775|NCT03421275|Esketamine|esketamine|mesh-list
5891058|NCT04477512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5891059|NCT04477512|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5891060|NCT04477512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5891061|NCT04477512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5891062|NCT04477512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5891063|NCT04477512|Hormone Antagonists|hormone antagonists|mesh-ancestor
5891064|NCT04477512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5891065|NCT04468230|Nicotine|nicotine|mesh-list
5891066|NCT04468230|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5891067|NCT04468230|Autonomic Agents|autonomic agents|mesh-ancestor
5891068|NCT04468230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5891069|NCT04468230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891070|NCT04468230|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5891071|NCT04468230|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5891072|NCT04468230|Cholinergic Agents|cholinergic agents|mesh-ancestor
5891073|NCT04468230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5891074|NCT04468230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496312|NCT00627666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5690776|NCT03421275|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5891075|NCT04438382|Prednisone|prednisone|mesh-list
5891076|NCT04438382|Cortisone|cortisone|mesh-list
5891077|NCT04438382|Infliximab|infliximab|mesh-list
5891078|NCT04438382|Immunoglobulins|immunoglobulins|mesh-list
5891079|NCT04438382|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5891080|NCT04438382|Antibodies|antibodies|mesh-list
5891081|NCT04438382|gamma-Globulins|gamma-globulins|mesh-list
5891082|NCT04438382|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5891083|NCT04438382|Immunoglobulin G|immunoglobulin g|mesh-list
5690777|NCT03421275|Narcotics|narcotics|mesh-ancestor
5690778|NCT03421275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5690779|NCT03421275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690780|NCT03421275|Analgesics|analgesics|mesh-ancestor
5690781|NCT03421275|Sensory System Agents|sensory system agents|mesh-ancestor
5690782|NCT03421275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5690783|NCT03421275|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5690784|NCT03421275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5690785|NCT03421275|Anesthetics, General|anesthetics, general|mesh-ancestor
5690786|NCT03421275|Anesthetics|anesthetics|mesh-ancestor
5891084|NCT04438382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5891085|NCT04438382|Glucocorticoids|glucocorticoids|mesh-ancestor
5891086|NCT04438382|Hormones|hormones|mesh-ancestor
5891087|NCT04438382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5891088|NCT04438382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891089|NCT04438382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5891090|NCT04438382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5891091|NCT04438382|Immunologic Factors|immunologic factors|mesh-ancestor
5891092|NCT04438382|Dermatologic Agents|dermatologic agents|mesh-ancestor
5891093|NCT04438382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5891094|NCT04438382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5891095|NCT04432857|Pembrolizumab|pembrolizumab|mesh-list
5891096|NCT04432857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5891097|NCT04432857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5891098|NCT04424225|Niacin|niacin|mesh-list
5891099|NCT04424225|Psilocybin|psilocybin|mesh-list
5891100|NCT04424225|Vitamins|vitamins|mesh-ancestor
5891101|NCT04424225|Micronutrients|micronutrients|mesh-ancestor
5891102|NCT04424225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891103|NCT04424225|Vitamin B Complex|vitamin b complex|mesh-ancestor
5891104|NCT04424225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5891105|NCT04424225|Antimetabolites|antimetabolites|mesh-ancestor
5891106|NCT04424225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5891107|NCT04424225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5891108|NCT04424225|Vasodilator Agents|vasodilator agents|mesh-ancestor
5891109|NCT04424225|Hallucinogens|hallucinogens|mesh-ancestor
5891110|NCT04424225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5891111|NCT04418895|Leucovorin|leucovorin|mesh-list
5891112|NCT04418895|Fluorouracil|fluorouracil|mesh-list
5891113|NCT04418895|Capecitabine|capecitabine|mesh-list
5891114|NCT04418895|Oxaliplatin|oxaliplatin|mesh-list
5891115|NCT04418895|Levoleucovorin|levoleucovorin|mesh-list
5891116|NCT04418895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891117|NCT04418895|Antimetabolites|antimetabolites|mesh-ancestor
5891118|NCT04418895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5891119|NCT04418895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5891120|NCT04418895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5891121|NCT04418895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5891122|NCT04418895|Immunologic Factors|immunologic factors|mesh-ancestor
5891123|NCT04418895|Antidotes|antidotes|mesh-ancestor
5891124|NCT04418895|Protective Agents|protective agents|mesh-ancestor
5891125|NCT04418895|Vitamin B Complex|vitamin b complex|mesh-ancestor
5891126|NCT04418895|Vitamins|vitamins|mesh-ancestor
5891127|NCT04418895|Micronutrients|micronutrients|mesh-ancestor
5891128|NCT04414631|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
5891129|NCT04414631|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5891130|NCT04414631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5891131|NCT04414631|Immunologic Factors|immunologic factors|mesh-ancestor
5891132|NCT04414631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891133|NCT04398134|Entecavir|entecavir|mesh-list
5891134|NCT04398134|Antiviral Agents|antiviral agents|mesh-ancestor
5891135|NCT04398134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5891136|NCT04396535|Docetaxel|docetaxel|mesh-list
5891137|NCT04396535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5891138|NCT04396535|Tubulin Modulators|tubulin modulators|mesh-ancestor
5891139|NCT04396535|Antimitotic Agents|antimitotic agents|mesh-ancestor
5891140|NCT04396535|Mitosis Modulators|mitosis modulators|mesh-ancestor
5891141|NCT04396535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5891142|NCT04389671|Pulmonary Surfactants|pulmonary surfactants|mesh-list
5891143|NCT04389671|Respiratory System Agents|respiratory system agents|mesh-ancestor
5891144|NCT04378426|Midazolam|midazolam|mesh-list
5891145|NCT04378426|Nitrous Oxide|nitrous oxide|mesh-list
5891146|NCT04378426|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5891147|NCT04378426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5891148|NCT04378426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5891149|NCT04378426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891150|NCT04378426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5891151|NCT04378426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5891152|NCT04378426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5891153|NCT04378426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5891154|NCT04378426|Anesthetics, General|anesthetics, general|mesh-ancestor
5891155|NCT04378426|Anesthetics|anesthetics|mesh-ancestor
5891156|NCT04378426|GABA Modulators|gaba modulators|mesh-ancestor
5891157|NCT04378426|GABA Agents|gaba agents|mesh-ancestor
5891158|NCT04378426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5891159|NCT04378426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5891160|NCT04378426|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5891161|NCT04378426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5891162|NCT04378426|Analgesics|analgesics|mesh-ancestor
5891163|NCT04378426|Sensory System Agents|sensory system agents|mesh-ancestor
5891164|NCT04378426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5891165|NCT04376281|Norepinephrine|norepinephrine|mesh-list
5891166|NCT04376281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5891167|NCT04376281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5891168|NCT04376281|Adrenergic Agents|adrenergic agents|mesh-ancestor
5891169|NCT04376281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5891170|NCT04376281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5891171|NCT04376281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891172|NCT04376281|Sympathomimetics|sympathomimetics|mesh-ancestor
5690787|NCT03421275|Antidepressive Agents|antidepressive agents|mesh-ancestor
5690788|NCT03421275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5690789|NCT03421119|Insulin|insulin|mesh-list
5690790|NCT03421119|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5690791|NCT03421119|Metformin|metformin|mesh-list
5690792|NCT03421119|Liraglutide|liraglutide|mesh-list
5690793|NCT03421119|Secretagogues|secretagogues|mesh-list
5690794|NCT03421119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5690795|NCT03421119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891173|NCT04376281|Autonomic Agents|autonomic agents|mesh-ancestor
5891174|NCT04376281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5891175|NCT04376281|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5891176|NCT04332445|Hyaluronic Acid|hyaluronic acid|mesh-list
5891177|NCT04332445|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5891178|NCT04332445|Immunologic Factors|immunologic factors|mesh-ancestor
5891179|NCT04332445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891180|NCT04332445|Viscosupplements|viscosupplements|mesh-ancestor
5891181|NCT04332445|Protective Agents|protective agents|mesh-ancestor
6675570|NCT01576315|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5690796|NCT03421119|Incretins|incretins|mesh-ancestor
5690797|NCT03421119|Hormones|hormones|mesh-ancestor
5690798|NCT03421119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5690799|NCT03421002|Micafungin|micafungin|mesh-list
5690800|NCT03421002|Antifungal Agents|antifungal agents|mesh-ancestor
5690801|NCT03421002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6675571|NCT01576315|Hormone Antagonists|hormone antagonists|mesh-ancestor
5690802|NCT03420963|Cyclophosphamide|cyclophosphamide|mesh-list
5690803|NCT03420963|Etoposide|etoposide|mesh-list
5907530|NCT05243953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5907531|NCT05243953|Autonomic Agents|autonomic agents|mesh-ancestor
5891182|NCT04331067|Paclitaxel|paclitaxel|mesh-list
5891183|NCT04331067|Carboplatin|carboplatin|mesh-list
5891184|NCT04331067|Nivolumab|nivolumab|mesh-list
5891185|NCT04331067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5891186|NCT04331067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5891187|NCT04331067|Tubulin Modulators|tubulin modulators|mesh-ancestor
5891188|NCT04331067|Antimitotic Agents|antimitotic agents|mesh-ancestor
5891189|NCT04331067|Mitosis Modulators|mitosis modulators|mesh-ancestor
5891190|NCT04331067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5891191|NCT04331067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5891192|NCT04331067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5891193|NCT04316910|Anesthetics|anesthetics|mesh-list
5891194|NCT04316910|Anesthetics, General|anesthetics, general|mesh-list
5891195|NCT04316910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5891196|NCT04316910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891197|NCT04315272|Azithromycin|azithromycin|mesh-list
5891198|NCT04315272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5891199|NCT04315272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5891200|NCT04314050|Dexmedetomidine|dexmedetomidine|mesh-list
5891201|NCT04314050|Tramadol|tramadol|mesh-list
5891202|NCT04314050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5690804|NCT03420963|Etoposide phosphate|etoposide phosphate|mesh-list
5690805|NCT03420963|Podophyllotoxin|podophyllotoxin|mesh-list
5690806|NCT03420963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5690807|NCT03420963|Immunologic Factors|immunologic factors|mesh-ancestor
5690808|NCT03420963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891203|NCT04314050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5891204|NCT04314050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891205|NCT04314050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5891206|NCT04314050|Analgesics|analgesics|mesh-ancestor
5891207|NCT04314050|Sensory System Agents|sensory system agents|mesh-ancestor
5891208|NCT04314050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5891209|NCT04314050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5891210|NCT04314050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5891211|NCT04314050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5891212|NCT04314050|Adrenergic Agents|adrenergic agents|mesh-ancestor
5891213|NCT04314050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5891214|NCT04314050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5891215|NCT04314050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5891216|NCT04314050|Narcotics|narcotics|mesh-ancestor
5891217|NCT04299490|Analgesics|analgesics|mesh-list
5891218|NCT04299490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891219|NCT04299490|Sensory System Agents|sensory system agents|mesh-ancestor
5891220|NCT04299490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5891221|NCT04299373|Ethanol|ethanol|mesh-list
5891222|NCT04299373|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5891223|NCT04299373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5891224|NCT04299373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5891225|NCT04299373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891226|NCT04282109|Paclitaxel|paclitaxel|mesh-list
5891227|NCT04282109|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5891228|NCT04282109|Nivolumab|nivolumab|mesh-list
5891229|NCT04282109|Cetuximab|cetuximab|mesh-list
5891230|NCT04282109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5891231|NCT04282109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5690809|NCT03420963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5690810|NCT03420963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5690811|NCT03420963|Alkylating Agents|alkylating agents|mesh-ancestor
5690812|NCT03420963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5690813|NCT03420963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5690814|NCT03420963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5690815|NCT03420963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5690816|NCT03420963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5690817|NCT03420963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5891232|NCT04282109|Tubulin Modulators|tubulin modulators|mesh-ancestor
6496313|NCT00627666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6496314|NCT00627666|Antimetabolites|antimetabolites|mesh-ancestor
6496315|NCT00627666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496316|NCT00627666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6496317|NCT00627666|Dermatologic Agents|dermatologic agents|mesh-ancestor
6496318|NCT00627666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6496319|NCT00627666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6496320|NCT00627666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5891233|NCT04282109|Antimitotic Agents|antimitotic agents|mesh-ancestor
6496321|NCT00627666|Immunologic Factors|immunologic factors|mesh-ancestor
6496322|NCT00627666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6496323|NCT00627666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6496324|NCT00627666|Antidotes|antidotes|mesh-ancestor
6496325|NCT00627666|Protective Agents|protective agents|mesh-ancestor
6496326|NCT00627666|Vitamin B Complex|vitamin b complex|mesh-ancestor
5690818|NCT03420963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5690819|NCT03420963|Keratolytic Agents|keratolytic agents|mesh-ancestor
5690820|NCT03420963|Dermatologic Agents|dermatologic agents|mesh-ancestor
5690821|NCT03420963|Tubulin Modulators|tubulin modulators|mesh-ancestor
5690822|NCT03420963|Antimitotic Agents|antimitotic agents|mesh-ancestor
5690823|NCT03420963|Mitosis Modulators|mitosis modulators|mesh-ancestor
5690824|NCT03420937|Atropine|atropine|mesh-list
5690825|NCT03420937|Neostigmine|neostigmine|mesh-list
5690826|NCT03420937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5690827|NCT03420937|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6496327|NCT00627666|Vitamins|vitamins|mesh-ancestor
6496328|NCT00627666|Micronutrients|micronutrients|mesh-ancestor
6496329|NCT00627666|Alkylating Agents|alkylating agents|mesh-ancestor
6496330|NCT00627666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6496331|NCT00627666|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5891234|NCT04282109|Mitosis Modulators|mitosis modulators|mesh-ancestor
5891235|NCT04282109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5891236|NCT04282109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5891237|NCT04282109|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5891238|NCT04279392|Zoledronic Acid|zoledronic acid|mesh-list
5891239|NCT04279392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5891240|NCT04279392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690828|NCT03420937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5690829|NCT03420937|Autonomic Agents|autonomic agents|mesh-ancestor
5690830|NCT03420937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5690831|NCT03420937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690832|NCT03420937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5690833|NCT03420937|Respiratory System Agents|respiratory system agents|mesh-ancestor
5690834|NCT03420937|Mydriatics|mydriatics|mesh-ancestor
5690835|NCT03420937|Parasympatholytics|parasympatholytics|mesh-ancestor
5690836|NCT03420937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5690837|NCT03420937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5690838|NCT03420937|Cholinergic Agents|cholinergic agents|mesh-ancestor
5690839|NCT03420937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5891241|NCT04265534|Folic Acid|folic acid|mesh-list
5891242|NCT04265534|Vitamin B 12|vitamin b 12|mesh-list
5891243|NCT04265534|Hydroxocobalamin|hydroxocobalamin|mesh-list
5891244|NCT04265534|Dexamethasone|dexamethasone|mesh-list
5690840|NCT03420937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5690841|NCT03420937|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5690842|NCT03420937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5690843|NCT03420937|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5690844|NCT03420911|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
5690845|NCT03420911|Midazolam|midazolam|mesh-list
5891245|NCT04265534|Carboplatin|carboplatin|mesh-list
5891246|NCT04265534|Pembrolizumab|pembrolizumab|mesh-list
5891247|NCT04265534|Pemetrexed|pemetrexed|mesh-list
5891248|NCT04265534|Vitamins|vitamins|mesh-ancestor
5891249|NCT04265534|Micronutrients|micronutrients|mesh-ancestor
5891250|NCT04265534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891251|NCT04265534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5891252|NCT04265534|Antiemetics|antiemetics|mesh-ancestor
5891253|NCT04265534|Autonomic Agents|autonomic agents|mesh-ancestor
5891254|NCT04265534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5891255|NCT04265534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5891256|NCT04265534|Glucocorticoids|glucocorticoids|mesh-ancestor
5891257|NCT04265534|Hormones|hormones|mesh-ancestor
5891258|NCT04265534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5891259|NCT04265534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5891260|NCT04265534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5891261|NCT04265534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5891262|NCT04265534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5891263|NCT04265534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5891264|NCT04265534|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5891265|NCT04265534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5891266|NCT04265534|Hematinics|hematinics|mesh-ancestor
5891267|NCT04265534|Vitamin B Complex|vitamin b complex|mesh-ancestor
5891268|NCT04240054|Dexamethasone|dexamethasone|mesh-list
5891269|NCT04240054|Cyclophosphamide|cyclophosphamide|mesh-list
5690846|NCT03420911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5690847|NCT03420911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5891270|NCT04240054|Bortezomib|bortezomib|mesh-list
6496332|NCT00627692|Prucalopride|prucalopride|mesh-list
5891271|NCT04240054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5891272|NCT04240054|Immunologic Factors|immunologic factors|mesh-ancestor
5891273|NCT04240054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891274|NCT04240054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5891275|NCT04240054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5891276|NCT04240054|Alkylating Agents|alkylating agents|mesh-ancestor
5891277|NCT04240054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5891278|NCT04240054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5891279|NCT04240054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5891280|NCT04240054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5891281|NCT04240054|Antiemetics|antiemetics|mesh-ancestor
5891282|NCT04240054|Autonomic Agents|autonomic agents|mesh-ancestor
5891283|NCT04240054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5891284|NCT04240054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5891285|NCT04240054|Glucocorticoids|glucocorticoids|mesh-ancestor
5891286|NCT04240054|Hormones|hormones|mesh-ancestor
5891287|NCT04240054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5891288|NCT04240054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5891289|NCT04233190|Budesonide|budesonide|mesh-list
5891290|NCT04233190|Formoterol Fumarate|formoterol fumarate|mesh-list
5891291|NCT04233190|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5690848|NCT03420911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5690849|NCT03420911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690850|NCT03420911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5690851|NCT03420911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5891292|NCT04233190|Autonomic Agents|autonomic agents|mesh-ancestor
5891293|NCT04233190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5891294|NCT04233190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891295|NCT04233190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5891296|NCT04233190|Respiratory System Agents|respiratory system agents|mesh-ancestor
5891297|NCT04233190|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5891298|NCT04233190|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5891299|NCT04233190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5891300|NCT04233190|Adrenergic Agents|adrenergic agents|mesh-ancestor
5891301|NCT04233190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5891302|NCT04233190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5891303|NCT04233190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5891304|NCT04233190|Glucocorticoids|glucocorticoids|mesh-ancestor
5891305|NCT04233190|Hormones|hormones|mesh-ancestor
5891306|NCT04233190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5891307|NCT04205968|Calcium, Dietary|calcium, dietary|mesh-list
5891308|NCT04205968|Leucovorin|leucovorin|mesh-list
5891309|NCT04205968|Folic Acid|folic acid|mesh-list
5891310|NCT04205968|Paclitaxel|paclitaxel|mesh-list
5891311|NCT04205968|Camptothecin|camptothecin|mesh-list
5690852|NCT03420911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5690853|NCT03420911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5690854|NCT03420911|Anesthetics, General|anesthetics, general|mesh-ancestor
5690855|NCT03420911|Anesthetics|anesthetics|mesh-ancestor
5690856|NCT03420911|GABA Modulators|gaba modulators|mesh-ancestor
5690857|NCT03420911|GABA Agents|gaba agents|mesh-ancestor
5690858|NCT03420911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5690859|NCT03420911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5690860|NCT03420911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5690861|NCT03420911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5690862|NCT03420911|Analgesics|analgesics|mesh-ancestor
5690863|NCT03420911|Sensory System Agents|sensory system agents|mesh-ancestor
5690864|NCT03420911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5690865|NCT03420911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5690866|NCT03420911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5697549|NCT03375385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5697550|NCT03375385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5697551|NCT03375385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5697552|NCT03375385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5697553|NCT03375385|Anesthetics, General|anesthetics, general|mesh-ancestor
5697554|NCT03375385|Anesthetics|anesthetics|mesh-ancestor
5697555|NCT03375385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5697556|NCT03375385|Analgesics|analgesics|mesh-ancestor
5697557|NCT03375385|Sensory System Agents|sensory system agents|mesh-ancestor
5697558|NCT03375385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5697559|NCT03375385|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5697560|NCT03375385|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5697561|NCT03375385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5697562|NCT03375385|Adrenergic Agents|adrenergic agents|mesh-ancestor
5697563|NCT03375385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5891312|NCT04205968|Fluorouracil|fluorouracil|mesh-list
5891313|NCT04205968|Irinotecan|irinotecan|mesh-list
5891314|NCT04205968|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5891315|NCT04205968|Ramucirumab|ramucirumab|mesh-list
5891316|NCT04205968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5891317|NCT04205968|Antibodies|antibodies|mesh-list
5891318|NCT04205968|Immunoglobulins|immunoglobulins|mesh-list
5891319|NCT04205968|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5891320|NCT04205968|Calcium|calcium|mesh-list
5891321|NCT04205968|Levoleucovorin|levoleucovorin|mesh-list
5891322|NCT04205968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5891323|NCT04205968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5891324|NCT04205968|Tubulin Modulators|tubulin modulators|mesh-ancestor
5891325|NCT04205968|Antimitotic Agents|antimitotic agents|mesh-ancestor
5891326|NCT04205968|Mitosis Modulators|mitosis modulators|mesh-ancestor
5891327|NCT04205968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5891328|NCT04205968|Immunologic Factors|immunologic factors|mesh-ancestor
5891329|NCT04205968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891330|NCT04205968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5891331|NCT04205968|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5891332|NCT04205968|Antimetabolites|antimetabolites|mesh-ancestor
5891333|NCT04205968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5891334|NCT04205968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5891335|NCT04205968|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5891336|NCT04205968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5891337|NCT04205968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5891338|NCT04205968|Antidotes|antidotes|mesh-ancestor
5891339|NCT04205968|Protective Agents|protective agents|mesh-ancestor
5891340|NCT04205968|Vitamin B Complex|vitamin b complex|mesh-ancestor
5891341|NCT04205968|Vitamins|vitamins|mesh-ancestor
5891342|NCT04205968|Micronutrients|micronutrients|mesh-ancestor
5891343|NCT04205968|Hematinics|hematinics|mesh-ancestor
5891344|NCT04205786|Vitamin B 12|vitamin b 12|mesh-list
5891345|NCT04205786|Hydroxocobalamin|hydroxocobalamin|mesh-list
5891346|NCT04205786|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5891347|NCT04205786|Vitamins|vitamins|mesh-ancestor
5891348|NCT04205786|Micronutrients|micronutrients|mesh-ancestor
5891349|NCT04205786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891350|NCT04205786|Vitamin B Complex|vitamin b complex|mesh-ancestor
5891351|NCT04205786|Hematinics|hematinics|mesh-ancestor
5891352|NCT04205786|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5891353|NCT04205786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5891354|NCT04205786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5891355|NCT04205786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5891356|NCT04205786|Hormone Antagonists|hormone antagonists|mesh-ancestor
5891357|NCT04205786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5891358|NCT04198961|Analgesics, Opioid|analgesics, opioid|mesh-list
5891359|NCT04198961|Narcotics|narcotics|mesh-ancestor
5891360|NCT04198961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5891361|NCT04198961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891362|NCT04198961|Analgesics|analgesics|mesh-ancestor
5891363|NCT04198961|Sensory System Agents|sensory system agents|mesh-ancestor
5891364|NCT04198961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5891365|NCT04198623|Montelukast|montelukast|mesh-list
5891366|NCT04198623|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5690867|NCT03420794|Analgesics|analgesics|mesh-list
5690868|NCT03420794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
5690869|NCT03420794|Sensory System Agents|sensory system agents|mesh-ancestor
5690870|NCT03420794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5690871|NCT03420794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690872|NCT03420742|Midazolam|midazolam|mesh-list
5690873|NCT03420742|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5690874|NCT03420742|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5690875|NCT03420742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5690876|NCT03420742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690877|NCT03420742|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5690878|NCT03420742|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5690879|NCT03420742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5690880|NCT03420742|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5690881|NCT03420742|Anesthetics, General|anesthetics, general|mesh-ancestor
5690882|NCT03420742|Anesthetics|anesthetics|mesh-ancestor
5690883|NCT03420742|GABA Modulators|gaba modulators|mesh-ancestor
5690884|NCT03420742|GABA Agents|gaba agents|mesh-ancestor
5690885|NCT03420742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5690886|NCT03420742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5690887|NCT03420703|Morphine|morphine|mesh-list
5891367|NCT04198623|Respiratory System Agents|respiratory system agents|mesh-ancestor
5891368|NCT04198623|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5690888|NCT03420703|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5690889|NCT03420703|Narcotics|narcotics|mesh-ancestor
5690890|NCT03420703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5690891|NCT03420703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690892|NCT03420703|Analgesics|analgesics|mesh-ancestor
5690893|NCT03420703|Sensory System Agents|sensory system agents|mesh-ancestor
5690894|NCT03420703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5690895|NCT03420638|Epinephrine|epinephrine|mesh-list
5690896|NCT03420638|Bupivacaine|bupivacaine|mesh-list
5690897|NCT03420638|Anesthetics, Local|anesthetics, local|mesh-ancestor
5891369|NCT04198623|Hormone Antagonists|hormone antagonists|mesh-ancestor
5891370|NCT04198623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5891371|NCT04198623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891372|NCT04198623|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5891373|NCT04198623|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5891374|NCT04198623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5891375|NCT04192630|Hyaluronic Acid|hyaluronic acid|mesh-list
5690898|NCT03420638|Anesthetics|anesthetics|mesh-ancestor
5690899|NCT03420638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5690900|NCT03420638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690901|NCT03420638|Sensory System Agents|sensory system agents|mesh-ancestor
5690902|NCT03420638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5690903|NCT03420638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5690904|NCT03420638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5690905|NCT03420638|Adrenergic Agents|adrenergic agents|mesh-ancestor
5891376|NCT04192630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5891377|NCT04192630|Immunologic Factors|immunologic factors|mesh-ancestor
5891378|NCT04192630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891379|NCT04192630|Viscosupplements|viscosupplements|mesh-ancestor
5891380|NCT04192630|Protective Agents|protective agents|mesh-ancestor
5891381|NCT04189510|Pancrelipase|pancrelipase|mesh-list
5891382|NCT04189510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5891383|NCT04186403|Brexpiprazole|brexpiprazole|mesh-list
5891384|NCT04186403|Serotonin Agents|serotonin agents|mesh-ancestor
5891385|NCT04186403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5891386|NCT04186403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5891387|NCT04186403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891388|NCT04186403|Dopamine Agonists|dopamine agonists|mesh-ancestor
5891389|NCT04186403|Dopamine Agents|dopamine agents|mesh-ancestor
5891390|NCT04134845|Dantrolene|dantrolene|mesh-list
5891391|NCT04134845|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5891392|NCT04134845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891393|NCT04134845|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5891394|NCT04134845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5891395|NCT04123067|Pioglitazone|pioglitazone|mesh-list
5891396|NCT04123067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5891397|NCT04123067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891398|NCT04094558|Lactulose|lactulose|mesh-list
5891399|NCT04094558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5891400|NCT04071457|Lenalidomide|lenalidomide|mesh-list
5891401|NCT04071457|Daratumumab|daratumumab|mesh-list
5891402|NCT04071457|Immunologic Factors|immunologic factors|mesh-ancestor
5891403|NCT04071457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891404|NCT04071457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5891405|NCT04071457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5891406|NCT04071457|Growth Substances|growth substances|mesh-ancestor
5891407|NCT04071457|Growth Inhibitors|growth inhibitors|mesh-ancestor
5891408|NCT04071457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5891409|NCT04050462|Nivolumab|nivolumab|mesh-list
5891410|NCT04050462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5891411|NCT04050462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5891412|NCT04050462|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5891413|NCT04050462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5891414|NCT04038346|Acetaminophen|acetaminophen|mesh-list
5891415|NCT04038346|Naproxen|naproxen|mesh-list
5891416|NCT04038346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5891417|NCT04038346|Analgesics|analgesics|mesh-ancestor
5891418|NCT04038346|Sensory System Agents|sensory system agents|mesh-ancestor
5891419|NCT04038346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5891420|NCT04038346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891421|NCT04038346|Antipyretics|antipyretics|mesh-ancestor
5891422|NCT04038346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5891423|NCT04038346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5891424|NCT04038346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5690906|NCT03420638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5891425|NCT04038346|Gout Suppressants|gout suppressants|mesh-ancestor
5891426|NCT04038346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5891427|NCT04038346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5891428|NCT04038346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5891429|NCT04034927|Olaparib|olaparib|mesh-list
5891430|NCT04034927|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
5891431|NCT04034927|Tremelimumab|tremelimumab|mesh-list
5891432|NCT04034927|Ipilimumab|ipilimumab|mesh-list
5891433|NCT04034927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6496333|NCT00627692|Laxatives|laxatives|mesh-ancestor
6496334|NCT00627692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5891434|NCT04034927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5891435|NCT04034927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5891436|NCT04034927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5891437|NCT04034927|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5891438|NCT04017936|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5891439|NCT04017936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5891440|NCT03996265|Bupropion|bupropion|mesh-list
5891441|NCT03996265|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5891442|NCT03996265|Antidepressive Agents|antidepressive agents|mesh-ancestor
5891443|NCT03996265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5891444|NCT03996265|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5891445|NCT03996265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5891446|NCT03996265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5891447|NCT03996265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5891448|NCT03996265|Dopamine Agents|dopamine agents|mesh-ancestor
5891449|NCT03996265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5891450|NCT03996265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891451|NCT03996265|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5891452|NCT03996265|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5891453|NCT03996265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5891454|NCT03980483|Methotrexate|methotrexate|mesh-list
5891455|NCT03980483|Tofacitinib|tofacitinib|mesh-list
5891456|NCT03980483|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5891457|NCT03980483|Abortifacient Agents|abortifacient agents|mesh-ancestor
5891458|NCT03980483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5891459|NCT03980483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891460|NCT03980483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5690907|NCT03420638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5690908|NCT03420638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5690909|NCT03420638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5690910|NCT03420638|Autonomic Agents|autonomic agents|mesh-ancestor
5690911|NCT03420638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5690912|NCT03420638|Respiratory System Agents|respiratory system agents|mesh-ancestor
5891461|NCT03980483|Antimetabolites|antimetabolites|mesh-ancestor
6496335|NCT00627692|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
5690913|NCT03420638|Mydriatics|mydriatics|mesh-ancestor
5690914|NCT03420638|Sympathomimetics|sympathomimetics|mesh-ancestor
5690915|NCT03420638|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5690916|NCT03420586|Nitrous Oxide|nitrous oxide|mesh-list
5690917|NCT03420586|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5690918|NCT03420586|Anesthetics, General|anesthetics, general|mesh-ancestor
5690919|NCT03420586|Anesthetics|anesthetics|mesh-ancestor
5690920|NCT03420586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5690921|NCT03420586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690922|NCT03420586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5690923|NCT03420586|Analgesics|analgesics|mesh-ancestor
5690924|NCT03420586|Sensory System Agents|sensory system agents|mesh-ancestor
5690925|NCT03420586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5690926|NCT03420534|Iloperidone|iloperidone|mesh-list
5690927|NCT03420534|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5690928|NCT03420534|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5690929|NCT03420534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5690930|NCT03420534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690931|NCT03420534|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5690932|NCT03420469|Bupropion|bupropion|mesh-list
5690933|NCT03420469|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5690934|NCT03420469|Antidepressive Agents|antidepressive agents|mesh-ancestor
5690935|NCT03420469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5690936|NCT03420469|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5690937|NCT03420469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5690938|NCT03420469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5690939|NCT03420469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5891462|NCT03980483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5690940|NCT03420469|Dopamine Agents|dopamine agents|mesh-ancestor
5690941|NCT03420469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5690942|NCT03420469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690943|NCT03420469|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5891463|NCT03980483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5891464|NCT03980483|Dermatologic Agents|dermatologic agents|mesh-ancestor
5891465|NCT03980483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5891466|NCT03980483|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5891467|NCT03980483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5891468|NCT03980483|Immunologic Factors|immunologic factors|mesh-ancestor
5891469|NCT03980483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5891470|NCT03980483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5891471|NCT03980483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5891472|NCT03957590|Paclitaxel|paclitaxel|mesh-list
5891473|NCT03957590|Cisplatin|cisplatin|mesh-list
5891474|NCT03957590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5891475|NCT03957590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5891476|NCT03957590|Tubulin Modulators|tubulin modulators|mesh-ancestor
5891477|NCT03957590|Antimitotic Agents|antimitotic agents|mesh-ancestor
5891478|NCT03957590|Mitosis Modulators|mitosis modulators|mesh-ancestor
5891479|NCT03957590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5690944|NCT03420469|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5690945|NCT03420469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5690946|NCT03420378|Vitamin D|vitamin d|mesh-list
5690947|NCT03420378|Vitamins|vitamins|mesh-ancestor
5690948|NCT03420378|Micronutrients|micronutrients|mesh-ancestor
5690949|NCT03420378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690950|NCT03420378|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5690951|NCT03420339|Adderall|adderall|mesh-list
5690952|NCT03420339|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5690953|NCT03420339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690954|NCT03420313|Buprenorphine|buprenorphine|mesh-list
5690955|NCT03420313|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
5690956|NCT03420313|Naloxone|naloxone|mesh-list
5690957|NCT03420313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5690958|NCT03420313|Narcotics|narcotics|mesh-ancestor
5690959|NCT03420313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5690960|NCT03420313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891480|NCT03943901|Prednisone|prednisone|mesh-list
5891481|NCT03943901|Cyclophosphamide|cyclophosphamide|mesh-list
5891482|NCT03943901|Rituximab|rituximab|mesh-list
5891483|NCT03943901|Doxorubicin|doxorubicin|mesh-list
5891484|NCT03943901|Vincristine|vincristine|mesh-list
5891485|NCT03943901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5891486|NCT03943901|Immunologic Factors|immunologic factors|mesh-ancestor
5891487|NCT03943901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891488|NCT03943901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5891489|NCT03943901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5891490|NCT03943901|Alkylating Agents|alkylating agents|mesh-ancestor
5891491|NCT03943901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5891492|NCT03943901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5891493|NCT03943901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5891494|NCT03943901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5891495|NCT03943901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5891496|NCT03943901|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5891497|NCT03943901|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5891498|NCT03943901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5891499|NCT03943901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5690961|NCT03420313|Analgesics|analgesics|mesh-ancestor
5690962|NCT03420313|Sensory System Agents|sensory system agents|mesh-ancestor
5690963|NCT03420313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5690964|NCT03420313|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5690965|NCT03420144|Hormones|hormones|mesh-list
5690966|NCT03420144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5690967|NCT03420144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690968|NCT03420040|Insulin Glargine|insulin glargine|mesh-list
5690969|NCT03420040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5690970|NCT03420040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690971|NCT03420014|Doxorubicin|doxorubicin|mesh-list
5690972|NCT03420014|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5690973|NCT03420014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5690974|NCT03420014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5891500|NCT03943901|Glucocorticoids|glucocorticoids|mesh-ancestor
5891501|NCT03943901|Hormones|hormones|mesh-ancestor
5690975|NCT03420014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5891502|NCT03943901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5891503|NCT03943901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5891504|NCT03943901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5891505|NCT03943901|Tubulin Modulators|tubulin modulators|mesh-ancestor
5891506|NCT03943901|Antimitotic Agents|antimitotic agents|mesh-ancestor
5891507|NCT03943901|Mitosis Modulators|mitosis modulators|mesh-ancestor
5891508|NCT03932136|Sulforaphane|sulforaphane|mesh-list
5891509|NCT03932136|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5891510|NCT03932136|Protective Agents|protective agents|mesh-ancestor
5891511|NCT03932136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891512|NCT03932136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5907532|NCT05243953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5907533|NCT05243953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907534|NCT05243953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5907535|NCT05243953|Respiratory System Agents|respiratory system agents|mesh-ancestor
5907536|NCT05243953|Parasympatholytics|parasympatholytics|mesh-ancestor
5907537|NCT05243953|Vasodilator Agents|vasodilator agents|mesh-ancestor
5907538|NCT05243940|Lidocaine|lidocaine|mesh-list
5907539|NCT05243940|Dexmedetomidine|dexmedetomidine|mesh-list
5907540|NCT05243940|Ketamine|ketamine|mesh-list
5907541|NCT05243940|Remifentanil|remifentanil|mesh-list
5907542|NCT05243940|Anesthetics, Local|anesthetics, local|mesh-ancestor
5907543|NCT05243940|Anesthetics|anesthetics|mesh-ancestor
5907544|NCT05243940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5907545|NCT05243940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907546|NCT05243940|Sensory System Agents|sensory system agents|mesh-ancestor
5907547|NCT05243940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5907548|NCT05243940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5907549|NCT05243940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5907550|NCT05243940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5907551|NCT05243940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5690976|NCT03420014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5690977|NCT03420014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5690978|NCT03420014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5690979|NCT03419975|Latanoprost|latanoprost|mesh-list
5690980|NCT03419975|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5690981|NCT03419975|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5907552|NCT05243940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907553|NCT05243940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5907554|NCT05243940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5907555|NCT05243940|Analgesics|analgesics|mesh-ancestor
5907556|NCT05243940|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5907557|NCT05243940|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5907558|NCT05243940|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5907559|NCT05243940|Adrenergic Agents|adrenergic agents|mesh-ancestor
5907560|NCT05243940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5907561|NCT05243940|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5907562|NCT05243940|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5907563|NCT05243940|Anesthetics, General|anesthetics, general|mesh-ancestor
5907564|NCT05243940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5907565|NCT05243940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5907566|NCT05243940|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5907567|NCT05243940|Narcotics|narcotics|mesh-ancestor
5907568|NCT05243862|Atezolizumab|atezolizumab|mesh-list
5907569|NCT05243862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5907570|NCT05243797|Lenalidomide|lenalidomide|mesh-list
5907571|NCT05243797|Immunologic Factors|immunologic factors|mesh-ancestor
5907572|NCT05243797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907573|NCT05243797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5907574|NCT05243797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5907575|NCT05243797|Growth Substances|growth substances|mesh-ancestor
5907576|NCT05243797|Growth Inhibitors|growth inhibitors|mesh-ancestor
5907577|NCT05243797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5907578|NCT05243745|Fluorides|fluorides|mesh-list
5907579|NCT05243745|Cariostatic Agents|cariostatic agents|mesh-ancestor
5907580|NCT05243745|Protective Agents|protective agents|mesh-ancestor
5907581|NCT05243745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907582|NCT05243706|Loratadine|loratadine|mesh-list
5907583|NCT05243706|Antipruritics|antipruritics|mesh-ancestor
5907584|NCT05243706|Dermatologic Agents|dermatologic agents|mesh-ancestor
5907585|NCT05243706|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5907586|NCT05243706|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5690982|NCT03419949|Pregabalin|pregabalin|mesh-list
5690983|NCT03419949|Lamotrigine|lamotrigine|mesh-list
5690984|NCT03419949|Analgesics|analgesics|mesh-ancestor
5690985|NCT03419949|Sensory System Agents|sensory system agents|mesh-ancestor
5891513|NCT03919266|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5891514|NCT03919266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5891515|NCT03904199|Insulin|insulin|mesh-list
5891516|NCT03904199|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5891517|NCT03904199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5891518|NCT03904199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891519|NCT03893448|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5891520|NCT03893448|Immunologic Factors|immunologic factors|mesh-ancestor
5891521|NCT03893448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891522|NCT03891849|Octreotide|octreotide|mesh-list
5891523|NCT03891849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5891524|NCT03891849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5891525|NCT03891849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5891526|NCT03890133|Pregabalin|pregabalin|mesh-list
5891527|NCT03890133|Analgesics|analgesics|mesh-ancestor
5891528|NCT03890133|Sensory System Agents|sensory system agents|mesh-ancestor
5690986|NCT03419949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5690987|NCT03419949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5690988|NCT03419949|Anticonvulsants|anticonvulsants|mesh-ancestor
5690989|NCT03419949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5690990|NCT03419949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5690991|NCT03419949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5690992|NCT03419949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5891529|NCT03890133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5891530|NCT03890133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891531|NCT03890133|Anticonvulsants|anticonvulsants|mesh-ancestor
5690993|NCT03419949|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5690994|NCT03419949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5690995|NCT03419949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5690996|NCT03419949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5690997|NCT03419949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5690998|NCT03419949|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5690999|NCT03419923|Citric Acid|citric acid|mesh-list
5691000|NCT03419923|Sodium Citrate|sodium citrate|mesh-list
5691001|NCT03419923|Anticoagulants|anticoagulants|mesh-ancestor
5691002|NCT03419923|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5691003|NCT03419923|Chelating Agents|chelating agents|mesh-ancestor
5691004|NCT03419923|Sequestering Agents|sequestering agents|mesh-ancestor
5691005|NCT03419923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691006|NCT03419910|Cyclosporine|cyclosporine|mesh-list
5691007|NCT03419910|BMS-986165|bms-986165|mesh-list
5691008|NCT03419910|Cyclosporins|cyclosporins|mesh-list
5691009|NCT03419910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5691010|NCT03419910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691011|NCT03419910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5691012|NCT03419910|Immunologic Factors|immunologic factors|mesh-ancestor
5691013|NCT03419910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691014|NCT03419910|Antifungal Agents|antifungal agents|mesh-ancestor
5891532|NCT03890133|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5891533|NCT03890133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5891534|NCT03890133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5891535|NCT03890133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5891536|NCT03890133|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5891537|NCT03890133|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5891538|NCT03890133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5891539|NCT03890133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5891540|NCT03875638|Levetiracetam|levetiracetam|mesh-list
5891541|NCT03875638|Anticonvulsants|anticonvulsants|mesh-ancestor
5891542|NCT03875638|Nootropic Agents|nootropic agents|mesh-ancestor
5891543|NCT03874234|GSK3186899|gsk3186899|mesh-list
5891544|NCT03874234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5891545|NCT03874234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5891546|NCT03874234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5891547|NCT03871647|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
5891548|NCT03871647|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5891549|NCT03871647|Adrenergic Agents|adrenergic agents|mesh-ancestor
5891550|NCT03871647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5891551|NCT03871647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5891552|NCT03871647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891553|NCT03811886|Natalizumab|natalizumab|mesh-list
5891554|NCT03811886|Immunologic Factors|immunologic factors|mesh-ancestor
5891555|NCT03811886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891556|NCT03742414|Fluticasone|fluticasone|mesh-list
5891557|NCT03742414|Xhance|xhance|mesh-list
5691015|NCT03419910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5891558|NCT03742414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5891559|NCT03742414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5891560|NCT03742414|Autonomic Agents|autonomic agents|mesh-ancestor
5891561|NCT03742414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5891562|NCT03742414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891563|NCT03742414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5691016|NCT03419910|Dermatologic Agents|dermatologic agents|mesh-ancestor
5691017|NCT03419910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5691018|NCT03419910|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5691019|NCT03419910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5691020|NCT03419858|Naloxone|naloxone|mesh-list
5691021|NCT03419858|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5691022|NCT03419858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691023|NCT03419858|Sensory System Agents|sensory system agents|mesh-ancestor
5691024|NCT03419858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5691025|NCT03419806|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
5691026|NCT03419806|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5691027|NCT03419806|Immunologic Factors|immunologic factors|mesh-ancestor
5691028|NCT03419806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691029|NCT03419806|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5891564|NCT03742414|Respiratory System Agents|respiratory system agents|mesh-ancestor
5891565|NCT03742414|Dermatologic Agents|dermatologic agents|mesh-ancestor
5891566|NCT03742414|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5891567|NCT03727139|Rasagiline|rasagiline|mesh-list
5891568|NCT03727139|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
5891569|NCT03727139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5891570|NCT03727139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5891571|NCT03727139|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5891572|NCT03727139|Protective Agents|protective agents|mesh-ancestor
5891573|NCT03727139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891574|NCT03723772|Insulin|insulin|mesh-list
5891575|NCT03723772|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5891576|NCT03723772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5891577|NCT03723772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891578|NCT03713580|Venetoclax|venetoclax|mesh-list
5891579|NCT03713580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5891580|NCT03709758|Cytarabine|cytarabine|mesh-list
6496336|NCT00627692|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6496337|NCT00627692|Serotonin Agents|serotonin agents|mesh-ancestor
6496338|NCT00627692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6496339|NCT00627692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496340|NCT00627692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691030|NCT03419806|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5691031|NCT03419806|Dopamine Agonists|dopamine agonists|mesh-ancestor
5691032|NCT03419806|Dopamine Agents|dopamine agents|mesh-ancestor
5691033|NCT03419806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5691034|NCT03419806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691035|NCT03419767|Melatonin|melatonin|mesh-list
5691036|NCT03419767|Antioxidants|antioxidants|mesh-ancestor
5691037|NCT03419767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5891581|NCT03709758|Daunorubicin|daunorubicin|mesh-list
5891582|NCT03709758|Venetoclax|venetoclax|mesh-list
5891583|NCT03709758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5891584|NCT03709758|Antimetabolites|antimetabolites|mesh-ancestor
5891585|NCT03709758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5891586|NCT03709758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5891587|NCT03709758|Antiviral Agents|antiviral agents|mesh-ancestor
5891588|NCT03709758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5891589|NCT03709758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5891590|NCT03709758|Immunologic Factors|immunologic factors|mesh-ancestor
5891591|NCT03709758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891592|NCT03709758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5891593|NCT03709758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5891594|NCT03709758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5891595|NCT03709758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5891596|NCT03678025|Prednisone|prednisone|mesh-list
5891597|NCT03678025|Cortisone|cortisone|mesh-list
5891598|NCT03678025|Docetaxel|docetaxel|mesh-list
5891599|NCT03678025|Leuprolide|leuprolide|mesh-list
5891600|NCT03678025|Goserelin|goserelin|mesh-list
5891601|NCT03678025|Bicalutamide|bicalutamide|mesh-list
5891602|NCT03678025|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5891603|NCT03678025|Flutamide|flutamide|mesh-list
5891604|NCT03678025|Nilutamide|nilutamide|mesh-list
5891605|NCT03678025|Tryptophan|tryptophan|mesh-list
5891606|NCT03678025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5891607|NCT03678025|Tubulin Modulators|tubulin modulators|mesh-ancestor
5891608|NCT03678025|Antimitotic Agents|antimitotic agents|mesh-ancestor
5891609|NCT03678025|Mitosis Modulators|mitosis modulators|mesh-ancestor
5891610|NCT03678025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5891611|NCT03678025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5891612|NCT03678025|Glucocorticoids|glucocorticoids|mesh-ancestor
5891613|NCT03678025|Hormones|hormones|mesh-ancestor
5891614|NCT03678025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5891615|NCT03678025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891616|NCT03678025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5891617|NCT03678025|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5891618|NCT03678025|Fertility Agents|fertility agents|mesh-ancestor
5891619|NCT03678025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5891620|NCT03678025|Androgen Antagonists|androgen antagonists|mesh-ancestor
5891621|NCT03678025|Hormone Antagonists|hormone antagonists|mesh-ancestor
5691038|NCT03419767|Protective Agents|protective agents|mesh-ancestor
5691039|NCT03419767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691040|NCT03419767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5691041|NCT03419715|Bimatoprost|bimatoprost|mesh-list
5691042|NCT03419715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5691043|NCT03419650|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
5691044|NCT03419650|Hormones|hormones|mesh-ancestor
5691045|NCT03419650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5691046|NCT03419650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691047|NCT03419624|Metformin|metformin|mesh-list
5691048|NCT03419624|Dapagliflozin|dapagliflozin|mesh-list
5691049|NCT03419624|Exenatide|exenatide|mesh-list
5691050|NCT03419624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5691051|NCT03419624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891622|NCT03678025|Luteolytic Agents|luteolytic agents|mesh-ancestor
5891623|NCT03678025|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5891624|NCT03678025|Contraceptive Agents|contraceptive agents|mesh-ancestor
5891625|NCT03678025|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5891626|NCT03678025|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5891627|NCT03678025|Antidepressive Agents|antidepressive agents|mesh-ancestor
5891628|NCT03678025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5891629|NCT03669523|Denosumab|denosumab|mesh-list
5891630|NCT03669523|Nivolumab|nivolumab|mesh-list
5891631|NCT03669523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5891632|NCT03669523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5891633|NCT03669523|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5891634|NCT03669523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5891635|NCT03669523|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5891636|NCT03669523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891637|NCT03631784|Paclitaxel|paclitaxel|mesh-list
5891638|NCT03631784|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5891639|NCT03631784|Carboplatin|carboplatin|mesh-list
5891640|NCT03631784|Pembrolizumab|pembrolizumab|mesh-list
5891641|NCT03631784|Pemetrexed|pemetrexed|mesh-list
5891642|NCT03631784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5891643|NCT03631784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5891644|NCT03631784|Tubulin Modulators|tubulin modulators|mesh-ancestor
5891645|NCT03631784|Antimitotic Agents|antimitotic agents|mesh-ancestor
5891646|NCT03631784|Mitosis Modulators|mitosis modulators|mesh-ancestor
5891647|NCT03631784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5891648|NCT03631784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5891649|NCT03631784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5891650|NCT03631784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5891651|NCT03631784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5891652|NCT03625986|Nicotine|nicotine|mesh-list
5891653|NCT03625986|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5891654|NCT03625986|Autonomic Agents|autonomic agents|mesh-ancestor
5891655|NCT03625986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5891656|NCT03625986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891657|NCT03625986|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5891658|NCT03625986|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5891659|NCT03625986|Cholinergic Agents|cholinergic agents|mesh-ancestor
5891660|NCT03625986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5891661|NCT03625986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5891662|NCT03610490|Cyclophosphamide|cyclophosphamide|mesh-list
5891663|NCT03610490|Fludarabine|fludarabine|mesh-list
5891664|NCT03610490|Interleukin-2|interleukin-2|mesh-list
5891665|NCT03610490|Mitogens|mitogens|mesh-list
5891666|NCT03610490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5891667|NCT03610490|Immunologic Factors|immunologic factors|mesh-ancestor
5891668|NCT03610490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891669|NCT03610490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5891670|NCT03610490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5891671|NCT03610490|Alkylating Agents|alkylating agents|mesh-ancestor
5891672|NCT03610490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5891673|NCT03610490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5891674|NCT03610490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5891675|NCT03610490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5891676|NCT03610490|Analgesics|analgesics|mesh-ancestor
5891677|NCT03610490|Sensory System Agents|sensory system agents|mesh-ancestor
5891678|NCT03610490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5891679|NCT03610490|Mitosis Modulators|mitosis modulators|mesh-ancestor
5891680|NCT03580473|Moxifloxacin|moxifloxacin|mesh-list
5891681|NCT03580473|Dexamethasone|dexamethasone|mesh-list
5891682|NCT03580473|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
5891683|NCT03580473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5891684|NCT03580473|Antiemetics|antiemetics|mesh-ancestor
5891685|NCT03580473|Autonomic Agents|autonomic agents|mesh-ancestor
5891686|NCT03580473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5891687|NCT03580473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891688|NCT03580473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5891689|NCT03580473|Glucocorticoids|glucocorticoids|mesh-ancestor
5891690|NCT03580473|Hormones|hormones|mesh-ancestor
5891691|NCT03580473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5891692|NCT03580473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5891693|NCT03580473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5891694|NCT03580473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5891695|NCT03580473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5891696|NCT03580473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5891697|NCT03580473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5891698|NCT03580473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5891699|NCT03580473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5891700|NCT03580473|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5891701|NCT03580473|Contraceptive Agents|contraceptive agents|mesh-ancestor
5891702|NCT03580473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5891703|NCT03580473|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5891704|NCT03580473|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5891705|NCT03580473|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5891706|NCT03567642|Etoposide|etoposide|mesh-list
5891707|NCT03567642|Osimertinib|osimertinib|mesh-list
5891708|NCT03567642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5891709|NCT03567642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5891710|NCT03567642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5891711|NCT03567642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5891712|NCT03567642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5891713|NCT03567642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5891714|NCT03567642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5891715|NCT03546582|Pembrolizumab|pembrolizumab|mesh-list
5891716|NCT03546582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5891717|NCT03546582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5891718|NCT03526900|Atezolizumab|atezolizumab|mesh-list
5891719|NCT03526900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5891720|NCT03504410|Cytarabine|cytarabine|mesh-list
5891721|NCT03504410|Fludarabine|fludarabine|mesh-list
5891722|NCT03504410|Etoposide|etoposide|mesh-list
5891723|NCT03504410|Mitoxantrone|mitoxantrone|mesh-list
5891724|NCT03504410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5891725|NCT03504410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5891726|NCT03504410|Antimetabolites|antimetabolites|mesh-ancestor
5891727|NCT03504410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5891728|NCT03504410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5891729|NCT03504410|Immunologic Factors|immunologic factors|mesh-ancestor
5891730|NCT03504410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891731|NCT03504410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5891732|NCT03504410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5891733|NCT03504410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5891734|NCT03504410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5891735|NCT03504410|Antiviral Agents|antiviral agents|mesh-ancestor
5891736|NCT03504410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5891737|NCT03504410|Analgesics|analgesics|mesh-ancestor
5891738|NCT03504410|Sensory System Agents|sensory system agents|mesh-ancestor
5891739|NCT03504410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5891740|NCT03452826|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5891741|NCT03452826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5891742|NCT03452826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5891743|NCT03452826|Antitubercular Agents|antitubercular agents|mesh-ancestor
5891744|NCT03418961|Carvedilol|carvedilol|mesh-list
5891745|NCT03418961|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5891746|NCT03418961|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5891747|NCT03418961|Adrenergic Agents|adrenergic agents|mesh-ancestor
5891748|NCT03418961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5891749|NCT03418961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5891750|NCT03418961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891751|NCT03418961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5891752|NCT03418961|Antioxidants|antioxidants|mesh-ancestor
5891753|NCT03418961|Protective Agents|protective agents|mesh-ancestor
5891754|NCT03418961|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5891755|NCT03418961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5891756|NCT03418961|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5891757|NCT03418961|Vasodilator Agents|vasodilator agents|mesh-ancestor
5891758|NCT03418961|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5891759|NCT03418961|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5891760|NCT03416855|Insulin|insulin|mesh-list
5891761|NCT03416855|Insulin Aspart|insulin aspart|mesh-list
5891762|NCT03416855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5891763|NCT03416855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891764|NCT03409718|Cimetidine|cimetidine|mesh-list
5891765|NCT03409718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5891766|NCT03409718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5891767|NCT03409718|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5891768|NCT03409718|Histamine Antagonists|histamine antagonists|mesh-ancestor
5891769|NCT03409718|Histamine Agents|histamine agents|mesh-ancestor
5891770|NCT03409718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5891771|NCT03409718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5891772|NCT03409718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891773|NCT03409718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5891774|NCT03409718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5891775|NCT03409718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5891776|NCT03404778|Cimetidine|cimetidine|mesh-list
5891777|NCT03404778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5891778|NCT03404778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5891779|NCT03404778|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5891780|NCT03404778|Histamine Antagonists|histamine antagonists|mesh-ancestor
5891781|NCT03404778|Histamine Agents|histamine agents|mesh-ancestor
5891782|NCT03404778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5891783|NCT03404778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5891784|NCT03404778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891785|NCT03404778|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5891786|NCT03404778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5891787|NCT03404778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5891788|NCT03404180|Dexmedetomidine|dexmedetomidine|mesh-list
5891789|NCT03404180|Propofol|propofol|mesh-list
5891790|NCT03404180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
5891791|NCT03404180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5891792|NCT03404180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891793|NCT03404180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5891794|NCT03404180|Anesthetics, General|anesthetics, general|mesh-ancestor
5891795|NCT03404180|Anesthetics|anesthetics|mesh-ancestor
5891796|NCT03404180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5891797|NCT03404180|Analgesics|analgesics|mesh-ancestor
5891798|NCT03404180|Sensory System Agents|sensory system agents|mesh-ancestor
5891799|NCT03404180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5891800|NCT03404180|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5891801|NCT03404180|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5891802|NCT03404180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5891803|NCT03404180|Adrenergic Agents|adrenergic agents|mesh-ancestor
5891804|NCT03404180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5891805|NCT03404180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907587|NCT05243706|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5907588|NCT05243706|Histamine Antagonists|histamine antagonists|mesh-ancestor
5907589|NCT05243706|Histamine Agents|histamine agents|mesh-ancestor
5907590|NCT05243706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5907591|NCT05243706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907592|NCT05243706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907593|NCT05243693|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5907594|NCT05243693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5907595|NCT05243693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5907596|NCT05243654|Metformin|metformin|mesh-list
5907597|NCT05243654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6496341|NCT00627731|Methylprednisolone|methylprednisolone|mesh-list
5891806|NCT03347617|Pembrolizumab|pembrolizumab|mesh-list
5891807|NCT03347617|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
5891808|NCT03347617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5891809|NCT03347617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5891810|NCT03347617|Hematinics|hematinics|mesh-ancestor
5891811|NCT03347617|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5891812|NCT03347617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5891813|NCT03345784|Cisplatin|cisplatin|mesh-list
5891814|NCT03345784|Adavosertib|adavosertib|mesh-list
5891815|NCT03345784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5891816|NCT03345784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5891817|NCT03345784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5891818|NCT03342417|Nivolumab|nivolumab|mesh-list
5891819|NCT03342417|Ipilimumab|ipilimumab|mesh-list
5891820|NCT03342417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5891821|NCT03342417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5891822|NCT03342417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5891823|NCT03342417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5891824|NCT03328026|Interferons|interferons|mesh-list
5891825|NCT03328026|Cyclophosphamide|cyclophosphamide|mesh-list
5891826|NCT03328026|Vaccines|vaccines|mesh-list
5891827|NCT03328026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5891828|NCT03328026|Immunologic Factors|immunologic factors|mesh-ancestor
5891829|NCT03328026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891830|NCT03328026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5891831|NCT03328026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5891832|NCT03328026|Alkylating Agents|alkylating agents|mesh-ancestor
5891833|NCT03328026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5891834|NCT03328026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5891835|NCT03328026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5891836|NCT03328026|Antiviral Agents|antiviral agents|mesh-ancestor
5891837|NCT03328026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5891838|NCT03297606|Nivolumab|nivolumab|mesh-list
5891839|NCT03297606|Trastuzumab|trastuzumab|mesh-list
5891840|NCT03297606|Ipilimumab|ipilimumab|mesh-list
5891841|NCT03297606|Pertuzumab|pertuzumab|mesh-list
5891842|NCT03297606|Sunitinib|sunitinib|mesh-list
5891843|NCT03297606|Dasatinib|dasatinib|mesh-list
5891844|NCT03297606|Olaparib|olaparib|mesh-list
5891845|NCT03297606|Palbociclib|palbociclib|mesh-list
5891846|NCT03297606|Axitinib|axitinib|mesh-list
5891847|NCT03297606|Vemurafenib|vemurafenib|mesh-list
5891848|NCT03297606|Crizotinib|crizotinib|mesh-list
5891849|NCT03297606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5891850|NCT03297606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5891851|NCT03297606|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5891852|NCT03297606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5891853|NCT03297606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5891854|NCT03297606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5891855|NCT03297606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5891856|NCT03297606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5891857|NCT03297606|Growth Substances|growth substances|mesh-ancestor
5691052|NCT03419624|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5691053|NCT03419624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691054|NCT03419624|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5691055|NCT03419624|Incretins|incretins|mesh-ancestor
5691056|NCT03419624|Hormones|hormones|mesh-ancestor
5691057|NCT03419624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5691058|NCT03419559|Durvalumab|durvalumab|mesh-list
5691059|NCT03419559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5691060|NCT03419559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5691061|NCT03419494|Doxorubicin|doxorubicin|mesh-list
5691062|NCT03419494|Daunorubicin|daunorubicin|mesh-list
5691063|NCT03419494|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5691064|NCT03419494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5691065|NCT03419494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5691066|NCT03419494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5691067|NCT03419494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5691068|NCT03419494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5691069|NCT03419494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691070|NCT03419442|Docetaxel|docetaxel|mesh-list
5691071|NCT03419442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5691072|NCT03419442|Tubulin Modulators|tubulin modulators|mesh-ancestor
5691073|NCT03419442|Antimitotic Agents|antimitotic agents|mesh-ancestor
5691074|NCT03419442|Mitosis Modulators|mitosis modulators|mesh-ancestor
5691075|NCT03419442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5891858|NCT03297606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891859|NCT03297606|Growth Inhibitors|growth inhibitors|mesh-ancestor
5891860|NCT03297606|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5891861|NCT03293784|Nivolumab|nivolumab|mesh-list
5891862|NCT03293784|Ipilimumab|ipilimumab|mesh-list
5891863|NCT03293784|Infliximab|infliximab|mesh-list
5891864|NCT03293784|Certolizumab Pegol|certolizumab pegol|mesh-list
5691076|NCT03419429|Simvastatin|simvastatin|mesh-list
5691077|NCT03419429|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5691078|NCT03419429|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5691079|NCT03419429|Antimetabolites|antimetabolites|mesh-ancestor
5691080|NCT03419429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691081|NCT03419429|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5691082|NCT03419429|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5691083|NCT03419429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5691084|NCT03419364|Niacinamide|niacinamide|mesh-list
5691085|NCT03419364|Niacin|niacin|mesh-list
5891865|NCT03293784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5891866|NCT03293784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5891867|NCT03293784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5891868|NCT03293784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5891869|NCT03293784|Dermatologic Agents|dermatologic agents|mesh-ancestor
5891870|NCT03293784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5891871|NCT03293784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5891872|NCT03293784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5891873|NCT03293784|Immunologic Factors|immunologic factors|mesh-ancestor
5891874|NCT03293784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891875|NCT03234309|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
5891876|NCT03234309|Hematinics|hematinics|mesh-ancestor
5891877|NCT03234309|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5891878|NCT03234309|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5891879|NCT03222609|Navitoclax|navitoclax|mesh-list
5891880|NCT03222609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5891881|NCT03204396|Dulaglutide|dulaglutide|mesh-list
5891882|NCT03204396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5891883|NCT03204396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891884|NCT03121456|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5891885|NCT03121456|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5891886|NCT03121456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5891887|NCT03098563|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
5891888|NCT03098563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891889|NCT03096041|Analgesics|analgesics|mesh-list
5891890|NCT03096041|Sensory System Agents|sensory system agents|mesh-ancestor
5891891|NCT03096041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6496342|NCT00627731|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6496343|NCT00627731|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6496344|NCT00627731|Prednisolone|prednisolone|mesh-list
6496345|NCT00627731|Prednisolone acetate|prednisolone acetate|mesh-list
6496346|NCT00627731|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6496347|NCT00627731|Prednisolone phosphate|prednisolone phosphate|mesh-list
6496348|NCT00627731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6496349|NCT00627731|Antiemetics|antiemetics|mesh-ancestor
6496350|NCT00627731|Autonomic Agents|autonomic agents|mesh-ancestor
6496351|NCT00627731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6496352|NCT00627731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496353|NCT00627731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6496354|NCT00627731|Glucocorticoids|glucocorticoids|mesh-ancestor
6496355|NCT00627731|Hormones|hormones|mesh-ancestor
5691086|NCT03419364|Nicotinic Acids|nicotinic acids|mesh-list
5891892|NCT03096041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891893|NCT03069300|Acetylcysteine|acetylcysteine|mesh-list
5891894|NCT03069300|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5891895|NCT03069300|Antiviral Agents|antiviral agents|mesh-ancestor
5891896|NCT03069300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5891897|NCT03069300|Expectorants|expectorants|mesh-ancestor
5891898|NCT03069300|Respiratory System Agents|respiratory system agents|mesh-ancestor
5891899|NCT03069300|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5891900|NCT03069300|Antioxidants|antioxidants|mesh-ancestor
5891901|NCT03069300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5891902|NCT03069300|Protective Agents|protective agents|mesh-ancestor
5891903|NCT03069300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891904|NCT03069300|Antidotes|antidotes|mesh-ancestor
5891905|NCT03067272|Contraceptive Agents|contraceptive agents|mesh-list
5891906|NCT03067272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5891907|NCT03067272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496356|NCT00627731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5891908|NCT03063450|Nivolumab|nivolumab|mesh-list
5691087|NCT03419364|Vitamin B Complex|vitamin b complex|mesh-ancestor
5691088|NCT03419364|Vitamins|vitamins|mesh-ancestor
5691089|NCT03419364|Micronutrients|micronutrients|mesh-ancestor
5691090|NCT03419364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691091|NCT03419364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5691092|NCT03419364|Antimetabolites|antimetabolites|mesh-ancestor
5691093|NCT03419364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691094|NCT03419364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5691095|NCT03419364|Vasodilator Agents|vasodilator agents|mesh-ancestor
5697564|NCT03375385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5891909|NCT03063450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5891910|NCT03063450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5891911|NCT03063450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5891912|NCT03063450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5891913|NCT03039036|Misoprostol|misoprostol|mesh-list
5891914|NCT03039036|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5891915|NCT03039036|Abortifacient Agents|abortifacient agents|mesh-ancestor
5891916|NCT03039036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5891917|NCT03039036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891918|NCT03039036|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5891919|NCT03039036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5891920|NCT03039036|Oxytocics|oxytocics|mesh-ancestor
5891921|NCT02942355|Palbociclib|palbociclib|mesh-list
5891922|NCT02942355|Anastrozole|anastrozole|mesh-list
5891923|NCT02942355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5891924|NCT02942355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5891925|NCT02942355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5891926|NCT02942355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5891927|NCT02942355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5891928|NCT02942355|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5891929|NCT02942355|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5891930|NCT02942355|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5891931|NCT02942355|Hormone Antagonists|hormone antagonists|mesh-ancestor
5891932|NCT02942355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5891933|NCT02942355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891934|NCT02936388|Cisplatin|cisplatin|mesh-list
5891935|NCT02936388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5891936|NCT02893241|Theodrenaline|theodrenaline|mesh-list
5891937|NCT02893241|Cafedrine|cafedrine|mesh-list
5891938|NCT02893241|Ephedrine|ephedrine|mesh-list
5891939|NCT02893241|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5891940|NCT02893241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891941|NCT02893241|Sympathomimetics|sympathomimetics|mesh-ancestor
5891942|NCT02893241|Autonomic Agents|autonomic agents|mesh-ancestor
5891943|NCT02893241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5891944|NCT02893241|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5891945|NCT02893241|Adrenergic Agents|adrenergic agents|mesh-ancestor
5891946|NCT02893241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5891947|NCT02893241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5891948|NCT02893241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5891949|NCT02893241|Vasodilator Agents|vasodilator agents|mesh-ancestor
5891950|NCT02879695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5891951|NCT02879695|Nivolumab|nivolumab|mesh-list
5891952|NCT02879695|Ipilimumab|ipilimumab|mesh-list
5891953|NCT02879695|Blinatumomab|blinatumomab|mesh-list
5891954|NCT02879695|Antibodies|antibodies|mesh-list
5891955|NCT02879695|Immunoglobulins|immunoglobulins|mesh-list
5891956|NCT02879695|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5891957|NCT02879695|Muromonab-CD3|muromonab-cd3|mesh-list
5891958|NCT02879695|Antibodies, Bispecific|antibodies, bispecific|mesh-list
5891959|NCT02879695|Immunologic Factors|immunologic factors|mesh-ancestor
5891960|NCT02879695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891961|NCT02879695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5891962|NCT02879695|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5891963|NCT02879695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5891964|NCT02879695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5891965|NCT02839265|Flt3 ligand protein|flt3 ligand protein|mesh-list
5891966|NCT02839265|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5891967|NCT02839265|Immunologic Factors|immunologic factors|mesh-ancestor
5891968|NCT02839265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891969|NCT02839265|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5891970|NCT02839265|Protective Agents|protective agents|mesh-ancestor
5891971|NCT02807779|Dexamethasone|dexamethasone|mesh-list
5891972|NCT02807779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5891973|NCT02807779|Antiemetics|antiemetics|mesh-ancestor
5891974|NCT02807779|Autonomic Agents|autonomic agents|mesh-ancestor
5891975|NCT02807779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5891976|NCT02807779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891977|NCT02807779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5891978|NCT02807779|Glucocorticoids|glucocorticoids|mesh-ancestor
5891979|NCT02807779|Hormones|hormones|mesh-ancestor
5891980|NCT02807779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5891981|NCT02807779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5691096|NCT03419130|Pembrolizumab|pembrolizumab|mesh-list
5691097|NCT03419130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5691098|NCT03419130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5691099|NCT03418974|Atorvastatin|atorvastatin|mesh-list
5691100|NCT03418974|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5691101|NCT03418974|Pitavastatin|pitavastatin|mesh-list
5691102|NCT03418974|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5691103|NCT03418974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5691104|NCT03418974|Antimetabolites|antimetabolites|mesh-ancestor
5691105|NCT03418974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691106|NCT03418974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5691107|NCT03418974|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5691108|NCT03418974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5691109|NCT03418935|Niacinamide|niacinamide|mesh-list
5891982|NCT02807779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5891983|NCT02688309|Dexamethasone|dexamethasone|mesh-list
5891984|NCT02688309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5891985|NCT02688309|Antiemetics|antiemetics|mesh-ancestor
5891986|NCT02688309|Autonomic Agents|autonomic agents|mesh-ancestor
5891987|NCT02688309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5891988|NCT02688309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891989|NCT02688309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5891990|NCT02688309|Glucocorticoids|glucocorticoids|mesh-ancestor
5891991|NCT02688309|Hormones|hormones|mesh-ancestor
5891992|NCT02688309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5891993|NCT02688309|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5891994|NCT02688309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5891995|NCT02684578|Metformin|metformin|mesh-list
5891996|NCT02684578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5891997|NCT02684578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5891998|NCT02680561|Fluticasone|fluticasone|mesh-list
5891999|NCT02680561|Xhance|xhance|mesh-list
5892000|NCT02680561|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5892001|NCT02680561|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
5892002|NCT02680561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5892003|NCT02680561|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5892004|NCT02680561|Autonomic Agents|autonomic agents|mesh-ancestor
5892005|NCT02680561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5892006|NCT02680561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892007|NCT02680561|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5892008|NCT02680561|Respiratory System Agents|respiratory system agents|mesh-ancestor
5892009|NCT02680561|Dermatologic Agents|dermatologic agents|mesh-ancestor
5892010|NCT02680561|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5892011|NCT02680561|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5892012|NCT02680561|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5892013|NCT02680561|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5892014|NCT02680561|Adrenergic Agents|adrenergic agents|mesh-ancestor
5892015|NCT02680561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5892016|NCT02680561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892017|NCT02680561|Glucocorticoids|glucocorticoids|mesh-ancestor
5691110|NCT03418935|Niacin|niacin|mesh-list
5691111|NCT03418935|Nicotinic Acids|nicotinic acids|mesh-list
5892018|NCT02680561|Hormones|hormones|mesh-ancestor
5892019|NCT02680561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5892020|NCT02680561|Sympathomimetics|sympathomimetics|mesh-ancestor
5892021|NCT02664935|Docetaxel|docetaxel|mesh-list
5892022|NCT02664935|Durvalumab|durvalumab|mesh-list
5892023|NCT02664935|Palbociclib|palbociclib|mesh-list
5892024|NCT02664935|Osimertinib|osimertinib|mesh-list
5892025|NCT02664935|Crizotinib|crizotinib|mesh-list
5892026|NCT02664935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5892027|NCT02664935|Tubulin Modulators|tubulin modulators|mesh-ancestor
5892028|NCT02664935|Antimitotic Agents|antimitotic agents|mesh-ancestor
5892029|NCT02664935|Mitosis Modulators|mitosis modulators|mesh-ancestor
5892030|NCT02664935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691112|NCT03418935|Vitamin B Complex|vitamin b complex|mesh-ancestor
5691113|NCT03418935|Vitamins|vitamins|mesh-ancestor
5892031|NCT02664935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5892032|NCT02664935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5892033|NCT02664935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5892034|NCT02636036|Nivolumab|nivolumab|mesh-list
5892035|NCT02636036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5892036|NCT02636036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5892037|NCT02636036|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5892038|NCT02636036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892039|NCT02631733|Irinotecan|irinotecan|mesh-list
5892040|NCT02631733|Veliparib|veliparib|mesh-list
5892041|NCT02631733|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
5892042|NCT02631733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5892043|NCT02631733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5892044|NCT02631733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5892045|NCT02631733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892046|NCT02631733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5892047|NCT02631733|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5892048|NCT02631733|Hematinics|hematinics|mesh-ancestor
5892049|NCT02631733|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5892050|NCT02631733|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5892051|NCT02592031|Goserelin|goserelin|mesh-list
5892052|NCT02592031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5892053|NCT02592031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5691114|NCT03418935|Micronutrients|micronutrients|mesh-ancestor
5691115|NCT03418935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691116|NCT03418935|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5691117|NCT03418935|Antimetabolites|antimetabolites|mesh-ancestor
5691118|NCT03418935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691119|NCT03418935|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5691120|NCT03418935|Vasodilator Agents|vasodilator agents|mesh-ancestor
5691121|NCT03418922|Nivolumab|nivolumab|mesh-list
5691122|NCT03418922|Lenvatinib|lenvatinib|mesh-list
5691123|NCT03418922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5691124|NCT03418922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5691125|NCT03418922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5691126|NCT03418922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691127|NCT03418922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5691128|NCT03418922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5691129|NCT03418896|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5691130|NCT03418896|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5691131|NCT03418896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691132|NCT03418831|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
5892054|NCT02568124|Tranexamic Acid|tranexamic acid|mesh-list
5892055|NCT02568124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5892056|NCT02568124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5892057|NCT02568124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892058|NCT02568124|Hemostatics|hemostatics|mesh-ancestor
5892059|NCT02568124|Coagulants|coagulants|mesh-ancestor
5892060|NCT02508038|Zoledronic Acid|zoledronic acid|mesh-list
5691133|NCT03418831|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5691134|NCT03418831|Hormone Antagonists|hormone antagonists|mesh-ancestor
5691135|NCT03418831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5691136|NCT03418831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691137|NCT03418831|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5691138|NCT03418831|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5691139|NCT03418831|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5691140|NCT03418805|Ibuprofen|ibuprofen|mesh-list
5691141|NCT03418805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5691142|NCT03418805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5691143|NCT03418805|Analgesics|analgesics|mesh-ancestor
5691144|NCT03418805|Sensory System Agents|sensory system agents|mesh-ancestor
5892061|NCT02508038|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5892062|NCT02508038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892063|NCT02437604|Fluticasone|fluticasone|mesh-list
5892064|NCT02437604|Xhance|xhance|mesh-list
5892065|NCT02437604|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5691145|NCT03418805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5691146|NCT03418805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892066|NCT02437604|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
5892067|NCT02437604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5892068|NCT02437604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5892069|NCT02437604|Autonomic Agents|autonomic agents|mesh-ancestor
5892070|NCT02437604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5892071|NCT02437604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892072|NCT02437604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5892073|NCT02437604|Respiratory System Agents|respiratory system agents|mesh-ancestor
5892074|NCT02437604|Dermatologic Agents|dermatologic agents|mesh-ancestor
5892075|NCT02437604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5892076|NCT02437604|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5892077|NCT02437604|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5892078|NCT02437604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5892079|NCT02437604|Adrenergic Agents|adrenergic agents|mesh-ancestor
5892080|NCT02437604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5892081|NCT02437604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892082|NCT02437604|Glucocorticoids|glucocorticoids|mesh-ancestor
5892083|NCT02437604|Hormones|hormones|mesh-ancestor
5892084|NCT02437604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5892085|NCT02437604|Sympathomimetics|sympathomimetics|mesh-ancestor
5892086|NCT02404935|Cetuximab|cetuximab|mesh-list
5892087|NCT02404935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5892088|NCT02404935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5691147|NCT03418805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5691148|NCT03418805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5691149|NCT03418805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5691150|NCT03418805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5691151|NCT03418805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691152|NCT03418779|Prednisolone|prednisolone|mesh-list
5691153|NCT03418779|Cyclophosphamide|cyclophosphamide|mesh-list
5691154|NCT03418779|Immunosuppressive Agents|immunosuppressive agents|mesh-list
5691155|NCT03418779|Immunologic Factors|immunologic factors|mesh-ancestor
5691156|NCT03418779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691157|NCT03418779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5691158|NCT03418779|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5691159|NCT03418779|Alkylating Agents|alkylating agents|mesh-ancestor
5691160|NCT03418779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691161|NCT03418779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5691162|NCT03418779|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5691163|NCT03418779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5691164|NCT03418779|Glucocorticoids|glucocorticoids|mesh-ancestor
5691165|NCT03418779|Hormones|hormones|mesh-ancestor
5691166|NCT03418779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5691167|NCT03418779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5691168|NCT03418727|Brimonidine Tartrate|brimonidine tartrate|mesh-list
5691169|NCT03418727|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
5691170|NCT03418727|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5691171|NCT03418727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5892089|NCT02390427|Paclitaxel|paclitaxel|mesh-list
5892090|NCT02390427|Maytansine|maytansine|mesh-list
5892091|NCT02390427|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
5892092|NCT02390427|Trastuzumab|trastuzumab|mesh-list
5892093|NCT02390427|Pertuzumab|pertuzumab|mesh-list
5892094|NCT02390427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5892095|NCT02390427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5892096|NCT02390427|Tubulin Modulators|tubulin modulators|mesh-ancestor
5892097|NCT02390427|Antimitotic Agents|antimitotic agents|mesh-ancestor
5892098|NCT02390427|Mitosis Modulators|mitosis modulators|mesh-ancestor
5892099|NCT02390427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892100|NCT02390427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5892101|NCT02384577|Budesonide|budesonide|mesh-list
5892102|NCT02384577|Formoterol Fumarate|formoterol fumarate|mesh-list
5892103|NCT02384577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5892104|NCT02384577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5892105|NCT02384577|Autonomic Agents|autonomic agents|mesh-ancestor
5892106|NCT02384577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5892107|NCT02384577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892108|NCT02384577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5892109|NCT02384577|Respiratory System Agents|respiratory system agents|mesh-ancestor
5892110|NCT02384577|Glucocorticoids|glucocorticoids|mesh-ancestor
5892111|NCT02384577|Hormones|hormones|mesh-ancestor
5892112|NCT02384577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5892113|NCT02384577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5892114|NCT02384577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5892115|NCT02384577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5892116|NCT02384577|Adrenergic Agents|adrenergic agents|mesh-ancestor
5892117|NCT02384577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5892118|NCT02384577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907598|NCT05243654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907599|NCT05243628|Insulin|insulin|mesh-list
5892119|NCT02203474|Tiotropium Bromide|tiotropium bromide|mesh-list
5892120|NCT02203474|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5892121|NCT02203474|Autonomic Agents|autonomic agents|mesh-ancestor
5892122|NCT02203474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5892123|NCT02203474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892124|NCT02203474|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5892125|NCT02203474|Respiratory System Agents|respiratory system agents|mesh-ancestor
5892126|NCT02203474|Parasympatholytics|parasympatholytics|mesh-ancestor
5892127|NCT02203474|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5892128|NCT02203474|Cholinergic Agents|cholinergic agents|mesh-ancestor
5892129|NCT02203474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5892130|NCT02203474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892131|NCT02150967|Infigratinib|infigratinib|mesh-list
5892132|NCT02150967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5892133|NCT02092571|Progesterone|progesterone|mesh-list
5892134|NCT02092571|Progestins|progestins|mesh-ancestor
5892135|NCT02092571|Hormones|hormones|mesh-ancestor
5892136|NCT02092571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5892137|NCT02092571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892138|NCT02062463|Budesonide|budesonide|mesh-list
5892139|NCT02062463|Formoterol Fumarate|formoterol fumarate|mesh-list
5892140|NCT02062463|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
5892141|NCT02062463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5892142|NCT02062463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5892143|NCT02062463|Autonomic Agents|autonomic agents|mesh-ancestor
5892144|NCT02062463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5892145|NCT02062463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892146|NCT02062463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5892147|NCT02062463|Respiratory System Agents|respiratory system agents|mesh-ancestor
5892148|NCT02062463|Glucocorticoids|glucocorticoids|mesh-ancestor
5892149|NCT02062463|Hormones|hormones|mesh-ancestor
5892150|NCT02062463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5892151|NCT02062463|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5892152|NCT02062463|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5892153|NCT02062463|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5892154|NCT02062463|Adrenergic Agents|adrenergic agents|mesh-ancestor
5892155|NCT02062463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5892156|NCT02062463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892157|NCT02030457|Beclomethasone|beclomethasone|mesh-list
5892158|NCT02030457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5691172|NCT03418727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5691173|NCT03418727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5691174|NCT03418727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5691175|NCT03418727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5691176|NCT03418727|Adrenergic Agents|adrenergic agents|mesh-ancestor
5691177|NCT03418727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5691178|NCT03418727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691179|NCT03418727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691180|NCT03418727|Laxatives|laxatives|mesh-ancestor
5691181|NCT03418727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5691182|NCT03418675|Brexpiprazole|brexpiprazole|mesh-list
5691183|NCT03418675|Serotonin Agents|serotonin agents|mesh-ancestor
5691184|NCT03418675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5691185|NCT03418675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691186|NCT03418675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691187|NCT03418675|Dopamine Agonists|dopamine agonists|mesh-ancestor
5691188|NCT03418675|Dopamine Agents|dopamine agents|mesh-ancestor
5691189|NCT03418610|Azelaic acid|azelaic acid|mesh-list
5691190|NCT03418610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5691191|NCT03418610|Dermatologic Agents|dermatologic agents|mesh-ancestor
5691192|NCT03418597|Anesthetics|anesthetics|mesh-list
5691193|NCT03418597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5691194|NCT03418597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691195|NCT03418558|Trastuzumab|trastuzumab|mesh-list
5691196|NCT03418558|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
5691197|NCT03418558|Maytansine|maytansine|mesh-list
5691198|NCT03418558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5691199|NCT03418558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5691200|NCT03418558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5691201|NCT03418558|Tubulin Modulators|tubulin modulators|mesh-ancestor
5691202|NCT03418558|Antimitotic Agents|antimitotic agents|mesh-ancestor
5691203|NCT03418558|Mitosis Modulators|mitosis modulators|mesh-ancestor
5691204|NCT03418558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691205|NCT03418532|Osimertinib|osimertinib|mesh-list
5892159|NCT02030457|Glucocorticoids|glucocorticoids|mesh-ancestor
5892160|NCT02030457|Hormones|hormones|mesh-ancestor
5892161|NCT02030457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5892162|NCT02030457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892163|NCT02030457|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5892164|NCT02030457|Respiratory System Agents|respiratory system agents|mesh-ancestor
5892165|NCT01975298|Interferons|interferons|mesh-list
5892166|NCT01975298|Interferon beta-1a|interferon beta-1a|mesh-list
5892167|NCT01975298|Interferon-beta|interferon-beta|mesh-list
5892168|NCT01975298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5892169|NCT01975298|Antiviral Agents|antiviral agents|mesh-ancestor
5691206|NCT03418532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5691207|NCT03418532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5691208|NCT03418532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5691209|NCT03418532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691210|NCT03418506|Lobeline|lobeline|mesh-list
5892170|NCT01975298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5892171|NCT01975298|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5892172|NCT01975298|Immunologic Factors|immunologic factors|mesh-ancestor
5892173|NCT01975298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892174|NCT01889199|Flutamide|flutamide|mesh-list
5892175|NCT01889199|Androgen Antagonists|androgen antagonists|mesh-ancestor
5892176|NCT01889199|Hormone Antagonists|hormone antagonists|mesh-ancestor
5892177|NCT01889199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5892178|NCT01889199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892179|NCT01889199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5691211|NCT03418506|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5691212|NCT03418506|Autonomic Agents|autonomic agents|mesh-ancestor
5691213|NCT03418506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5691214|NCT03418506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691215|NCT03418506|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5691216|NCT03418506|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5691217|NCT03418506|Cholinergic Agents|cholinergic agents|mesh-ancestor
5691218|NCT03418506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5691219|NCT03418506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691220|NCT03418506|Respiratory System Agents|respiratory system agents|mesh-ancestor
5691221|NCT03418337|Lansoprazole|lansoprazole|mesh-list
5691222|NCT03418337|Dexlansoprazole|dexlansoprazole|mesh-list
5691223|NCT03418337|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5691224|NCT03418337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5691225|NCT03418337|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5691226|NCT03418337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5691227|NCT03418337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691228|NCT03418246|Calcium|calcium|mesh-list
5691229|NCT03418246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5691230|NCT03418246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691231|NCT03418090|Xenon|xenon|mesh-list
5691232|NCT03418090|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5691233|NCT03418090|Anesthetics, General|anesthetics, general|mesh-ancestor
5691234|NCT03418090|Anesthetics|anesthetics|mesh-ancestor
5691235|NCT03418090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5691236|NCT03418090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691237|NCT03418038|Vitamins|vitamins|mesh-list
5691238|NCT03418038|Ascorbic Acid|ascorbic acid|mesh-list
5691239|NCT03418038|Gemcitabine|gemcitabine|mesh-list
5691240|NCT03418038|Cytarabine|cytarabine|mesh-list
5691241|NCT03418038|Dexamethasone|dexamethasone|mesh-list
5691242|NCT03418038|Dexamethasone acetate|dexamethasone acetate|mesh-list
5691243|NCT03418038|Cisplatin|cisplatin|mesh-list
5691244|NCT03418038|Rituximab|rituximab|mesh-list
5691245|NCT03418038|Carboplatin|carboplatin|mesh-list
5691246|NCT03418038|Oxaliplatin|oxaliplatin|mesh-list
5691247|NCT03418038|Etoposide|etoposide|mesh-list
5691248|NCT03418038|Etoposide phosphate|etoposide phosphate|mesh-list
5691249|NCT03418038|Ifosfamide|ifosfamide|mesh-list
5691250|NCT03418038|Isophosphamide mustard|isophosphamide mustard|mesh-list
5691251|NCT03418038|Podophyllotoxin|podophyllotoxin|mesh-list
5691252|NCT03418038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5691253|NCT03418038|Antibodies|antibodies|mesh-list
5691254|NCT03418038|Immunoglobulins|immunoglobulins|mesh-list
5691255|NCT03418038|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5691256|NCT03418038|BB 1101|bb 1101|mesh-list
5691257|NCT03418038|Micronutrients|micronutrients|mesh-ancestor
5691258|NCT03418038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691259|NCT03418038|Immunologic Factors|immunologic factors|mesh-ancestor
5691260|NCT03418038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5691261|NCT03418038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5691262|NCT03418038|Antiemetics|antiemetics|mesh-ancestor
5691263|NCT03418038|Autonomic Agents|autonomic agents|mesh-ancestor
5892180|NCT01889199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5892181|NCT01729091|Lenalidomide|lenalidomide|mesh-list
5892182|NCT01729091|Melphalan|melphalan|mesh-list
5892183|NCT01729091|Mechlorethamine|mechlorethamine|mesh-list
5892184|NCT01729091|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
5892185|NCT01729091|Elotuzumab|elotuzumab|mesh-list
5892186|NCT01729091|Immunologic Factors|immunologic factors|mesh-ancestor
5892187|NCT01729091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892188|NCT01729091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5892189|NCT01729091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5892190|NCT01729091|Growth Substances|growth substances|mesh-ancestor
5892191|NCT01729091|Growth Inhibitors|growth inhibitors|mesh-ancestor
5892192|NCT01729091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5691264|NCT03418038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5691265|NCT03418038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5691266|NCT03418038|Glucocorticoids|glucocorticoids|mesh-ancestor
5691267|NCT03418038|Hormones|hormones|mesh-ancestor
5691268|NCT03418038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5691269|NCT03418038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5691270|NCT03418038|Protease Inhibitors|protease inhibitors|mesh-ancestor
5691271|NCT03418038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5691272|NCT03418038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691273|NCT03418038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5691274|NCT03418038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5691275|NCT03418038|Antimetabolites|antimetabolites|mesh-ancestor
5691276|NCT03418038|Antiviral Agents|antiviral agents|mesh-ancestor
5691277|NCT03418038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5691278|NCT03418038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5691279|NCT03418038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5691280|NCT03418038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5691281|NCT03418038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5892193|NCT01729091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5892194|NCT01729091|Alkylating Agents|alkylating agents|mesh-ancestor
5892195|NCT01729091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892196|NCT01729091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5892197|NCT01729091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5892198|NCT01624480|Modafinil|modafinil|mesh-list
5892199|NCT01624480|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5691282|NCT03418038|Antioxidants|antioxidants|mesh-ancestor
5691283|NCT03418038|Protective Agents|protective agents|mesh-ancestor
5691284|NCT03418038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5691285|NCT03418038|Alkylating Agents|alkylating agents|mesh-ancestor
5691286|NCT03418038|Keratolytic Agents|keratolytic agents|mesh-ancestor
5691287|NCT03418038|Dermatologic Agents|dermatologic agents|mesh-ancestor
5691288|NCT03418038|Tubulin Modulators|tubulin modulators|mesh-ancestor
5691289|NCT03418038|Antimitotic Agents|antimitotic agents|mesh-ancestor
5691290|NCT03418038|Mitosis Modulators|mitosis modulators|mesh-ancestor
5691291|NCT03417986|Thiethylperazine|thiethylperazine|mesh-list
5691292|NCT03417986|Antiemetics|antiemetics|mesh-ancestor
5691293|NCT03417986|Autonomic Agents|autonomic agents|mesh-ancestor
5691294|NCT03417986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5691295|NCT03417986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691296|NCT03417986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5691297|NCT03417986|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5691298|NCT03417986|Dopamine Agents|dopamine agents|mesh-ancestor
5691299|NCT03417986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5892200|NCT01624480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892201|NCT01624480|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
5892202|NCT01624480|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5892203|NCT01624480|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5892204|NCT01624480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892205|NCT01596621|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5892206|NCT01596621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5892207|NCT01596621|Alkylating Agents|alkylating agents|mesh-ancestor
5892208|NCT01596621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892209|NCT01596621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5892210|NCT01446133|Rituximab|rituximab|mesh-list
5892211|NCT01446133|Lenalidomide|lenalidomide|mesh-list
5892212|NCT01446133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5892213|NCT01446133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5892214|NCT01446133|Immunologic Factors|immunologic factors|mesh-ancestor
5892215|NCT01446133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892216|NCT01446133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5892217|NCT01446133|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5892218|NCT01446133|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5892219|NCT01446133|Growth Substances|growth substances|mesh-ancestor
5892220|NCT01446133|Growth Inhibitors|growth inhibitors|mesh-ancestor
5892221|NCT01349881|Eflornithine|eflornithine|mesh-list
5892222|NCT01349881|Sulindac|sulindac|mesh-list
5892223|NCT01349881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5892224|NCT01349881|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5892225|NCT01349881|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5892226|NCT01349881|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5892227|NCT01349881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5892228|NCT01349881|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
5892229|NCT01349881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5892230|NCT01349881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892231|NCT01349881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5892232|NCT01349881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5892233|NCT01349881|Analgesics|analgesics|mesh-ancestor
5892234|NCT01349881|Sensory System Agents|sensory system agents|mesh-ancestor
5892235|NCT01349881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5892236|NCT01349881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892237|NCT01349881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5892238|NCT01349881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5892239|NCT01349881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5892240|NCT01342952|Ambrisentan|ambrisentan|mesh-list
5892241|NCT01342952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5892242|NCT01236456|Cyclophosphamide|cyclophosphamide|mesh-list
5892243|NCT01236456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5892244|NCT01236456|Immunologic Factors|immunologic factors|mesh-ancestor
5892245|NCT01236456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892246|NCT01236456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5892247|NCT01236456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5892248|NCT01236456|Alkylating Agents|alkylating agents|mesh-ancestor
5892249|NCT01236456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892250|NCT01236456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5892251|NCT01236456|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5892252|NCT01120249|Everolimus|everolimus|mesh-list
5892253|NCT01120249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5892254|NCT01120249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5892255|NCT01120249|Immunologic Factors|immunologic factors|mesh-ancestor
5892256|NCT01120249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892257|NCT01061515|Bevacizumab|bevacizumab|mesh-list
5892258|NCT01061515|Capecitabine|capecitabine|mesh-list
5892259|NCT01061515|Oxaliplatin|oxaliplatin|mesh-list
5892260|NCT01061515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5892261|NCT01061515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5892262|NCT01061515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5892263|NCT01061515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5892264|NCT01061515|Growth Substances|growth substances|mesh-ancestor
5892265|NCT01061515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892266|NCT01061515|Growth Inhibitors|growth inhibitors|mesh-ancestor
5892267|NCT01061515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5892268|NCT01061515|Antimetabolites|antimetabolites|mesh-ancestor
5892269|NCT01061515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892270|NCT00980954|Paclitaxel|paclitaxel|mesh-list
5892271|NCT00980954|Carboplatin|carboplatin|mesh-list
5892272|NCT00980954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5892273|NCT00980954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5892274|NCT00980954|Tubulin Modulators|tubulin modulators|mesh-ancestor
5892275|NCT00980954|Antimitotic Agents|antimitotic agents|mesh-ancestor
5892276|NCT00980954|Mitosis Modulators|mitosis modulators|mesh-ancestor
5892277|NCT00980954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892278|NCT00790010|Bevacizumab|bevacizumab|mesh-list
5892279|NCT00790010|Ipilimumab|ipilimumab|mesh-list
5892280|NCT00790010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5892281|NCT00790010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5892282|NCT00790010|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5892283|NCT00790010|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5892284|NCT00790010|Growth Substances|growth substances|mesh-ancestor
5892285|NCT00790010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892286|NCT00790010|Growth Inhibitors|growth inhibitors|mesh-ancestor
5892287|NCT00790010|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5892288|NCT00790010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892289|NCT00712881|Cyclophosphamide|cyclophosphamide|mesh-list
5892290|NCT00712881|Docetaxel|docetaxel|mesh-list
5892291|NCT00712881|Doxorubicin|doxorubicin|mesh-list
5892292|NCT00712881|Trastuzumab|trastuzumab|mesh-list
5691300|NCT03417986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691301|NCT03417947|Vitamin D|vitamin d|mesh-list
5691302|NCT03417947|Cholecalciferol|cholecalciferol|mesh-list
5691303|NCT03417947|Vitamins|vitamins|mesh-ancestor
5691304|NCT03417947|Micronutrients|micronutrients|mesh-ancestor
5691305|NCT03417947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691306|NCT03417947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5691307|NCT03417947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5691308|NCT03417921|Gemcitabine|gemcitabine|mesh-list
5691309|NCT03417921|Paclitaxel|paclitaxel|mesh-list
5691310|NCT03417921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5691311|NCT03417921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5691312|NCT03417921|Tubulin Modulators|tubulin modulators|mesh-ancestor
5691313|NCT03417921|Antimitotic Agents|antimitotic agents|mesh-ancestor
5691314|NCT03417921|Mitosis Modulators|mitosis modulators|mesh-ancestor
5691315|NCT03417921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691316|NCT03417921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5691317|NCT03417921|Antimetabolites|antimetabolites|mesh-ancestor
5691318|NCT03417921|Antiviral Agents|antiviral agents|mesh-ancestor
5691319|NCT03417921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5691320|NCT03417921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5691321|NCT03417921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5691322|NCT03417921|Immunologic Factors|immunologic factors|mesh-ancestor
5691323|NCT03417921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691324|NCT03417895|Apatinib|apatinib|mesh-list
5691325|NCT03417895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5892293|NCT00712881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5892294|NCT00712881|Immunologic Factors|immunologic factors|mesh-ancestor
5892295|NCT00712881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892296|NCT00712881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5892297|NCT00712881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5892298|NCT00712881|Alkylating Agents|alkylating agents|mesh-ancestor
5892299|NCT00712881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892300|NCT00712881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5892301|NCT00712881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5892302|NCT00712881|Tubulin Modulators|tubulin modulators|mesh-ancestor
5892303|NCT00712881|Antimitotic Agents|antimitotic agents|mesh-ancestor
5892304|NCT00712881|Mitosis Modulators|mitosis modulators|mesh-ancestor
5892305|NCT00712881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5892306|NCT00712881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5892307|NCT00712881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5892308|NCT00712881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5892309|NCT00712881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5892310|NCT00659126|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
5691326|NCT03417895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5691327|NCT03417895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5691328|NCT03417895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691329|NCT03417882|Pembrolizumab|pembrolizumab|mesh-list
5691330|NCT03417882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5691331|NCT03417882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5691332|NCT03417700|Vitamin D|vitamin d|mesh-list
5691333|NCT03417700|Vitamins|vitamins|mesh-ancestor
5892311|NCT00659126|Hematinics|hematinics|mesh-ancestor
5892312|NCT00659126|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5892313|NCT00659126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5892314|NCT00001309|Ascorbic Acid|ascorbic acid|mesh-list
5892315|NCT00001309|Vitamins|vitamins|mesh-ancestor
5892316|NCT00001309|Micronutrients|micronutrients|mesh-ancestor
5892317|NCT00001309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892318|NCT00001309|Antioxidants|antioxidants|mesh-ancestor
5892319|NCT00001309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892320|NCT00001309|Protective Agents|protective agents|mesh-ancestor
5892321|NCT05117983|Antidepressive Agents|antidepressive agents|mesh-list
5892322|NCT05117983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5892323|NCT05117957|Sorafenib|sorafenib|mesh-list
5892324|NCT05117957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5892325|NCT05117957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5892326|NCT05117957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5892327|NCT05117957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892328|NCT05117866|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
5892329|NCT05117866|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5892330|NCT05117853|Parathyroid Hormone|parathyroid hormone|mesh-list
5892331|NCT05117853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5892332|NCT05117853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892333|NCT05117814|Zanubrutinib|zanubrutinib|mesh-list
5892334|NCT05117814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5892335|NCT05117814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5892336|NCT05117814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5892337|NCT05117814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892338|NCT05117489|Cortisone|cortisone|mesh-list
5892339|NCT05117489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5892340|NCT05117476|Pembrolizumab|pembrolizumab|mesh-list
5892341|NCT05117476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5892342|NCT05117476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5907600|NCT05243628|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5907601|NCT05243628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5907602|NCT05243628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907603|NCT05243550|Mitomycins|mitomycins|mesh-list
5907604|NCT05243550|Mitomycin|mitomycin|mesh-list
5907605|NCT05243550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5907606|NCT05243550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5907607|NCT05243550|Alkylating Agents|alkylating agents|mesh-ancestor
5691334|NCT03417700|Micronutrients|micronutrients|mesh-ancestor
5691335|NCT03417700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691336|NCT03417700|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5691337|NCT03417687|Xenon|xenon|mesh-list
5691338|NCT03417687|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5691339|NCT03417687|Anesthetics, General|anesthetics, general|mesh-ancestor
5691340|NCT03417687|Anesthetics|anesthetics|mesh-ancestor
5691341|NCT03417687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5691342|NCT03417687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691343|NCT03417648|Vitamin E|vitamin e|mesh-list
5691344|NCT03417648|Vitamins|vitamins|mesh-ancestor
5691345|NCT03417648|Micronutrients|micronutrients|mesh-ancestor
5691346|NCT03417648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691347|NCT03417648|Antioxidants|antioxidants|mesh-ancestor
5691348|NCT03417648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691349|NCT03417648|Protective Agents|protective agents|mesh-ancestor
5697565|NCT03375242|Crizotinib|crizotinib|mesh-list
5697566|NCT03375242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5697567|NCT03375242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5697568|NCT03375242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5907608|NCT05243550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907609|NCT05243550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5907610|NCT05243550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5907611|NCT05243524|Cyclophosphamide|cyclophosphamide|mesh-list
5907612|NCT05243524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5907613|NCT05243524|Immunologic Factors|immunologic factors|mesh-ancestor
5907614|NCT05243524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907615|NCT05243524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5907616|NCT05243524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5907617|NCT05243524|Alkylating Agents|alkylating agents|mesh-ancestor
5907618|NCT05243524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907619|NCT05243524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5907620|NCT05243524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5907621|NCT05243446|Losartan|losartan|mesh-list
5907622|NCT05243446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5907623|NCT05243446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5907624|NCT05243446|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5907625|NCT05243446|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5907626|NCT05243446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907627|NCT05243355|Endostatins|endostatins|mesh-list
5907628|NCT05243355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5907629|NCT05243355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5907630|NCT05243355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5907631|NCT05243355|Growth Substances|growth substances|mesh-ancestor
5907632|NCT05243355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907633|NCT05243355|Growth Inhibitors|growth inhibitors|mesh-ancestor
5907634|NCT05243342|Daratumumab|daratumumab|mesh-list
5907635|NCT05243342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5907636|NCT05243329|Psilocybin|psilocybin|mesh-list
5907637|NCT05243329|Hallucinogens|hallucinogens|mesh-ancestor
5907638|NCT05243329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907639|NCT05243329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5907640|NCT05243290|Niacinamide|niacinamide|mesh-list
5907641|NCT05243290|Niacin|niacin|mesh-list
5907642|NCT05243290|Nicotinic Acids|nicotinic acids|mesh-list
5907643|NCT05243290|Vitamin B Complex|vitamin b complex|mesh-ancestor
5907644|NCT05243290|Vitamins|vitamins|mesh-ancestor
5907645|NCT05243290|Micronutrients|micronutrients|mesh-ancestor
5907646|NCT05243290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907647|NCT05243290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5892343|NCT05117398|Dalbavancin|dalbavancin|mesh-list
5892344|NCT05117398|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5892345|NCT05117398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5892346|NCT05117125|Heparin|heparin|mesh-list
5892347|NCT05117125|Anticoagulants|anticoagulants|mesh-ancestor
5691350|NCT03417518|Propofol|propofol|mesh-list
5691351|NCT03417518|Desflurane|desflurane|mesh-list
5691352|NCT03417518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5691353|NCT03417518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5691354|NCT03417518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691355|NCT03417518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5691356|NCT03417518|Anesthetics, General|anesthetics, general|mesh-ancestor
5691357|NCT03417518|Anesthetics|anesthetics|mesh-ancestor
5691358|NCT03417518|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5691359|NCT03417492|Sildenafil Citrate|sildenafil citrate|mesh-list
5691360|NCT03417492|Citric Acid|citric acid|mesh-list
5691361|NCT03417492|Sodium Citrate|sodium citrate|mesh-list
5691362|NCT03417492|Anticoagulants|anticoagulants|mesh-ancestor
5691363|NCT03417492|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5691364|NCT03417492|Chelating Agents|chelating agents|mesh-ancestor
5691365|NCT03417492|Sequestering Agents|sequestering agents|mesh-ancestor
5691366|NCT03417492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691367|NCT03417492|Vasodilator Agents|vasodilator agents|mesh-ancestor
5691368|NCT03417492|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5691369|NCT03417492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5691370|NCT03417492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5691371|NCT03417492|Urological Agents|urological agents|mesh-ancestor
5691372|NCT03417453|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5691373|NCT03417453|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5691374|NCT03417427|Cytarabine|cytarabine|mesh-list
5691375|NCT03417427|Decitabine|decitabine|mesh-list
5892348|NCT05117125|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5892349|NCT05117125|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5892350|NCT05117125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892351|NCT05117021|Bupivacaine|bupivacaine|mesh-list
5892352|NCT05117021|Anesthetics, Local|anesthetics, local|mesh-ancestor
5892353|NCT05117021|Anesthetics|anesthetics|mesh-ancestor
5892354|NCT05117021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5892355|NCT05117021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892356|NCT05117021|Sensory System Agents|sensory system agents|mesh-ancestor
5892357|NCT05117021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5892358|NCT05116995|Rivaroxaban|rivaroxaban|mesh-list
5892359|NCT05116995|Ticagrelor|ticagrelor|mesh-list
5892360|NCT05116995|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5892361|NCT05116995|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5892362|NCT05116995|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5892363|NCT05116995|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5892364|NCT05116995|Purinergic Agents|purinergic agents|mesh-ancestor
5892365|NCT05116995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5892366|NCT05116995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892367|NCT05116995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892368|NCT05116995|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5892369|NCT05116995|Antithrombins|antithrombins|mesh-ancestor
5892370|NCT05116995|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5892371|NCT05116995|Protease Inhibitors|protease inhibitors|mesh-ancestor
5892372|NCT05116995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6496357|NCT00627731|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5892373|NCT05116995|Anticoagulants|anticoagulants|mesh-ancestor
5892374|NCT05116917|Nivolumab|nivolumab|mesh-list
5892375|NCT05116917|Ipilimumab|ipilimumab|mesh-list
5892376|NCT05116917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5892377|NCT05116917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5892378|NCT05116917|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5892379|NCT05116917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892380|NCT05116891|Leucovorin|leucovorin|mesh-list
5892381|NCT05116891|Gemcitabine|gemcitabine|mesh-list
5892382|NCT05116891|Cisplatin|cisplatin|mesh-list
5892383|NCT05116891|Docetaxel|docetaxel|mesh-list
5892384|NCT05116891|Fluorouracil|fluorouracil|mesh-list
5892385|NCT05116891|Oxaliplatin|oxaliplatin|mesh-list
5892386|NCT05116891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5892387|NCT05116891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5892388|NCT05116891|Antimetabolites|antimetabolites|mesh-ancestor
5892389|NCT05116891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892390|NCT05116891|Antiviral Agents|antiviral agents|mesh-ancestor
5892391|NCT05116891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5691376|NCT03417427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5691377|NCT03417427|Antimetabolites|antimetabolites|mesh-ancestor
5892392|NCT05116891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5892393|NCT05116891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5892394|NCT05116891|Immunologic Factors|immunologic factors|mesh-ancestor
5892395|NCT05116891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892396|NCT05116891|Tubulin Modulators|tubulin modulators|mesh-ancestor
5892397|NCT05116891|Antimitotic Agents|antimitotic agents|mesh-ancestor
5892398|NCT05116891|Mitosis Modulators|mitosis modulators|mesh-ancestor
5892399|NCT05116891|Antidotes|antidotes|mesh-ancestor
5892400|NCT05116891|Protective Agents|protective agents|mesh-ancestor
5892401|NCT05116891|Vitamin B Complex|vitamin b complex|mesh-ancestor
5892402|NCT05116891|Vitamins|vitamins|mesh-ancestor
5892403|NCT05116891|Micronutrients|micronutrients|mesh-ancestor
5892404|NCT05116462|Gemcitabine|gemcitabine|mesh-list
5892405|NCT05116462|Paclitaxel|paclitaxel|mesh-list
5892406|NCT05116462|Docetaxel|docetaxel|mesh-list
5892407|NCT05116462|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5892408|NCT05116462|Carboplatin|carboplatin|mesh-list
5892409|NCT05116462|Pemetrexed|pemetrexed|mesh-list
5892410|NCT05116462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5892411|NCT05116462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5892412|NCT05116462|Tubulin Modulators|tubulin modulators|mesh-ancestor
5892413|NCT05116462|Antimitotic Agents|antimitotic agents|mesh-ancestor
5892414|NCT05116462|Mitosis Modulators|mitosis modulators|mesh-ancestor
5892415|NCT05116462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892416|NCT05116462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5892417|NCT05116462|Antimetabolites|antimetabolites|mesh-ancestor
5892418|NCT05116462|Antiviral Agents|antiviral agents|mesh-ancestor
5892419|NCT05116462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5892420|NCT05116462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5892421|NCT05116462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5892422|NCT05116462|Immunologic Factors|immunologic factors|mesh-ancestor
5892423|NCT05116462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892424|NCT05116462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5892425|NCT05116462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5892426|NCT05116371|Levonorgestrel|levonorgestrel|mesh-list
5892427|NCT05116371|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5892428|NCT05116371|Contraceptive Agents|contraceptive agents|mesh-list
5892429|NCT05116371|Contraceptives, Oral|contraceptives, oral|mesh-list
5892430|NCT05116371|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
5892431|NCT05116371|Estradiol|estradiol|mesh-list
5892432|NCT05116371|Estrogens|estrogens|mesh-ancestor
5892433|NCT05116371|Hormones|hormones|mesh-ancestor
5892434|NCT05116371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5892435|NCT05116371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892436|NCT05116371|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5892437|NCT05116371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5892438|NCT05116371|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5892439|NCT05116371|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5892440|NCT05116371|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5892441|NCT05116345|Dexamethasone|dexamethasone|mesh-list
5892442|NCT05116345|Dexamethasone acetate|dexamethasone acetate|mesh-list
5892443|NCT05116345|BB 1101|bb 1101|mesh-list
5892444|NCT05116345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5892445|NCT05116345|Antiemetics|antiemetics|mesh-ancestor
5892446|NCT05116345|Autonomic Agents|autonomic agents|mesh-ancestor
5892447|NCT05116345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5892448|NCT05116345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892449|NCT05116345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5892450|NCT05116345|Glucocorticoids|glucocorticoids|mesh-ancestor
5892451|NCT05116345|Hormones|hormones|mesh-ancestor
5892452|NCT05116345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5892453|NCT05116345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5892454|NCT05116345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5892455|NCT05116345|Protease Inhibitors|protease inhibitors|mesh-ancestor
5892456|NCT05116345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5892457|NCT05116345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892458|NCT05116306|Hyaluronic Acid|hyaluronic acid|mesh-list
5892459|NCT05116306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5892460|NCT05116306|Immunologic Factors|immunologic factors|mesh-ancestor
5892461|NCT05116306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892462|NCT05116306|Viscosupplements|viscosupplements|mesh-ancestor
5892463|NCT05116306|Protective Agents|protective agents|mesh-ancestor
5892464|NCT05116293|Acetaminophen|acetaminophen|mesh-list
5892465|NCT05116293|Digoxin|digoxin|mesh-list
5892466|NCT05116293|Midazolam|midazolam|mesh-list
5892467|NCT05116293|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5892468|NCT05116293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5892469|NCT05116293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5892470|NCT05116293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892471|NCT05116293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5892472|NCT05116293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5892473|NCT05116293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5892474|NCT05116293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5892475|NCT05116293|Anesthetics, General|anesthetics, general|mesh-ancestor
5892476|NCT05116293|Anesthetics|anesthetics|mesh-ancestor
5892477|NCT05116293|GABA Modulators|gaba modulators|mesh-ancestor
5892478|NCT05116293|GABA Agents|gaba agents|mesh-ancestor
5892479|NCT05116293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5892480|NCT05116293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892481|NCT05116293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5892482|NCT05116293|Analgesics|analgesics|mesh-ancestor
5892483|NCT05116293|Sensory System Agents|sensory system agents|mesh-ancestor
5892484|NCT05116293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5892485|NCT05116293|Antipyretics|antipyretics|mesh-ancestor
5892486|NCT05116293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5892487|NCT05116293|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5892488|NCT05116293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5892489|NCT05116293|Protective Agents|protective agents|mesh-ancestor
5892490|NCT05114941|Immunoglobulins|immunoglobulins|mesh-list
5892491|NCT05114941|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5892492|NCT05114941|Antibodies|antibodies|mesh-list
5892493|NCT05114941|gamma-Globulins|gamma-globulins|mesh-list
5892494|NCT05114941|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5892495|NCT05114941|Immunologic Factors|immunologic factors|mesh-ancestor
5892496|NCT05114941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892497|NCT05107453|Levobupivacaine|levobupivacaine|mesh-list
5892498|NCT05107453|Anesthetics, Local|anesthetics, local|mesh-ancestor
5892499|NCT05107453|Anesthetics|anesthetics|mesh-ancestor
5892500|NCT05107453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5892501|NCT05107453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892502|NCT05107453|Sensory System Agents|sensory system agents|mesh-ancestor
5892503|NCT05107453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5892504|NCT05104970|Cholecalciferol|cholecalciferol|mesh-list
5892505|NCT05104970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5892506|NCT05104970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892507|NCT05104970|Vitamins|vitamins|mesh-ancestor
5892508|NCT05104970|Micronutrients|micronutrients|mesh-ancestor
5892509|NCT05104970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5892510|NCT05076097|Rituximab|rituximab|mesh-list
5892511|NCT05076097|Lenalidomide|lenalidomide|mesh-list
5892512|NCT05076097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5892513|NCT05076097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5892514|NCT05076097|Immunologic Factors|immunologic factors|mesh-ancestor
5892515|NCT05076097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892516|NCT05076097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5892517|NCT05076097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5892518|NCT05076097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5892519|NCT05076097|Growth Substances|growth substances|mesh-ancestor
5892520|NCT05076097|Growth Inhibitors|growth inhibitors|mesh-ancestor
5892521|NCT05063786|Capecitabine|capecitabine|mesh-list
5892522|NCT05063786|Trastuzumab|trastuzumab|mesh-list
5892523|NCT05063786|Vinorelbine|vinorelbine|mesh-list
5691378|NCT03417427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691379|NCT03417427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5691380|NCT03417427|Antiviral Agents|antiviral agents|mesh-ancestor
5691381|NCT03417427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5691382|NCT03417427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5691383|NCT03417427|Immunologic Factors|immunologic factors|mesh-ancestor
5691384|NCT03417427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691385|NCT03417427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5691386|NCT03417401|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5691387|NCT03417401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5892524|NCT05063786|Fulvestrant|fulvestrant|mesh-list
5892525|NCT05063786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5892526|NCT05063786|Antimetabolites|antimetabolites|mesh-ancestor
5892527|NCT05063786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892528|NCT05063786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5892529|NCT05063786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5892530|NCT05063786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5892531|NCT05063786|Tubulin Modulators|tubulin modulators|mesh-ancestor
5892532|NCT05063786|Antimitotic Agents|antimitotic agents|mesh-ancestor
5892533|NCT05063786|Mitosis Modulators|mitosis modulators|mesh-ancestor
5892534|NCT05063786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5892535|NCT05063786|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5691388|NCT03417401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5892536|NCT05063786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5892537|NCT05063786|Hormone Antagonists|hormone antagonists|mesh-ancestor
5892538|NCT05063786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5892539|NCT05063786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892540|NCT05023980|Rituximab|rituximab|mesh-list
5892541|NCT05023980|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5892542|NCT05023980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5892543|NCT05023980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5892544|NCT05023980|Immunologic Factors|immunologic factors|mesh-ancestor
5892545|NCT05023980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5892546|NCT05023980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5892547|NCT05023980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5892548|NCT05023980|Alkylating Agents|alkylating agents|mesh-ancestor
5892549|NCT05023980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5892550|NCT05016895|Azithromycin|azithromycin|mesh-list
5892551|NCT05016895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5892552|NCT05016895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5907648|NCT05243290|Antimetabolites|antimetabolites|mesh-ancestor
5907649|NCT05243290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907650|NCT05243290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5907651|NCT05243290|Vasodilator Agents|vasodilator agents|mesh-ancestor
5907652|NCT05243251|Olanzapine|olanzapine|mesh-list
5907653|NCT05243251|Antiemetics|antiemetics|mesh-ancestor
5907654|NCT05243251|Autonomic Agents|autonomic agents|mesh-ancestor
5907655|NCT05243251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5907656|NCT05243251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907657|NCT05243251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5907658|NCT05243251|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5907659|NCT05243251|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5907660|NCT05243251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5907661|NCT05243251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5907662|NCT05243251|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5907663|NCT05243251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5907664|NCT05243251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5907665|NCT05243251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5907666|NCT05243251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5907667|NCT05243251|Serotonin Agents|serotonin agents|mesh-ancestor
5907668|NCT05239533|Nivolumab|nivolumab|mesh-list
5907669|NCT05239533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5907670|NCT05239533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5907671|NCT05239533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5907672|NCT05239533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5907673|NCT05239533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691389|NCT03417401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691390|NCT03417388|Aspirin|aspirin|mesh-list
5691391|NCT03417388|Losartan|losartan|mesh-list
5691392|NCT03417388|Lisinopril|lisinopril|mesh-list
5691393|NCT03417388|Atorvastatin|atorvastatin|mesh-list
5691394|NCT03417388|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5691395|NCT03417388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5691396|NCT03417388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5691397|NCT03417388|Analgesics|analgesics|mesh-ancestor
5691398|NCT03417388|Sensory System Agents|sensory system agents|mesh-ancestor
5691399|NCT03417388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5691400|NCT03417388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5691401|NCT03417388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5691402|NCT03417388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5691403|NCT03417388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5691404|NCT03417388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5691405|NCT03417388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5691406|NCT03417388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5691407|NCT03417388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5691408|NCT03417388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5907674|NCT05239533|Immunologic Factors|immunologic factors|mesh-ancestor
5907675|NCT05239533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5907676|NCT05231382|Leucovorin|leucovorin|mesh-list
5907677|NCT05231382|Fluorouracil|fluorouracil|mesh-list
5691409|NCT03417388|Antipyretics|antipyretics|mesh-ancestor
5691410|NCT03417388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5691411|NCT03417388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5691412|NCT03417388|Antimetabolites|antimetabolites|mesh-ancestor
5691413|NCT03417388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5691414|NCT03417388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5908845|NCT04093323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6212622|NCT02191397|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6212623|NCT02191397|Dopamine Agents|dopamine agents|mesh-ancestor
5698113|NCT03371186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6212624|NCT02191397|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6212625|NCT02191397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6212626|NCT02191397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6675621|NCT01576679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908846|NCT04093323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5908847|NCT04093323|Analgesics|analgesics|mesh-ancestor
5908848|NCT04093323|Sensory System Agents|sensory system agents|mesh-ancestor
5908849|NCT04093323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5908850|NCT04093323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5908851|NCT04093323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5908852|NCT04093323|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5908853|NCT04093323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5908854|NCT04093323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5908855|NCT04093323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908856|NCT04093323|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5908857|NCT03997448|Pembrolizumab|pembrolizumab|mesh-list
5908858|NCT03997448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5908859|NCT03997448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5908860|NCT03996473|Pembrolizumab|pembrolizumab|mesh-list
5908861|NCT03996473|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
5908862|NCT03996473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5908863|NCT03996473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5908864|NCT03994796|Entrectinib|entrectinib|mesh-list
5908865|NCT03994796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5908866|NCT03994796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5908867|NCT03994796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908868|NCT03962855|Ifetroban|ifetroban|mesh-list
5908869|NCT03962855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5908870|NCT03944941|Cetuximab|cetuximab|mesh-list
5908871|NCT03944941|Avelumab|avelumab|mesh-list
5908872|NCT03944941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5698114|NCT03371186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698115|NCT03371173|Ferric maltol|ferric maltol|mesh-list
5698116|NCT03371173|Hematinics|hematinics|mesh-ancestor
5698117|NCT03371095|Cyclophosphamide|cyclophosphamide|mesh-list
5698118|NCT03371095|Infliximab|infliximab|mesh-list
5698119|NCT03371095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5698120|NCT03371095|Immunologic Factors|immunologic factors|mesh-ancestor
5698121|NCT03371095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698122|NCT03371095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5698123|NCT03371095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5698124|NCT03371095|Alkylating Agents|alkylating agents|mesh-ancestor
5698125|NCT03371095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5698126|NCT03371095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5698127|NCT03371095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6675622|NCT01576692|Aldesleukin|aldesleukin|mesh-list
6675623|NCT01576692|Antibodies|antibodies|mesh-list
6675624|NCT01576692|Immunoglobulins|immunoglobulins|mesh-list
6675625|NCT01576692|Sargramostim|sargramostim|mesh-list
6675626|NCT01576692|Immunologic Factors|immunologic factors|mesh-ancestor
6675627|NCT01576692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675628|NCT01576692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6675629|NCT01576692|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6675630|NCT01576692|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5698128|NCT03371095|Dermatologic Agents|dermatologic agents|mesh-ancestor
5698129|NCT03371095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5698130|NCT03371069|Methylphenidate|methylphenidate|mesh-list
5698131|NCT03371069|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5698132|NCT03371069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698133|NCT03371069|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5908873|NCT03944941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5908874|NCT03940326|Levetiracetam|levetiracetam|mesh-list
5908875|NCT03940326|Valproic Acid|valproic acid|mesh-list
5908876|NCT03940326|Anticonvulsants|anticonvulsants|mesh-ancestor
5908877|NCT03940326|Nootropic Agents|nootropic agents|mesh-ancestor
5908878|NCT03940326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5908879|NCT03940326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908880|NCT03940326|GABA Agents|gaba agents|mesh-ancestor
5908881|NCT03940326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5908882|NCT03940326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212627|NCT02191579|Topiramate|topiramate|mesh-list
5908883|NCT03940326|Antimanic Agents|antimanic agents|mesh-ancestor
5908884|NCT03940326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5908885|NCT03940326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5908886|NCT03940326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5908887|NCT03932318|Azacitidine|azacitidine|mesh-list
5908888|NCT03932318|Venetoclax|venetoclax|mesh-list
5908889|NCT03932318|Lintuzumab|lintuzumab|mesh-list
5908890|NCT03932318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5908891|NCT03932318|Antimetabolites|antimetabolites|mesh-ancestor
5908892|NCT03932318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908893|NCT03932318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5908894|NCT03932318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5908895|NCT03932318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5908896|NCT03918278|Gemcitabine|gemcitabine|mesh-list
5908897|NCT03918278|Paclitaxel|paclitaxel|mesh-list
5908898|NCT03918278|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5908899|NCT03918278|Carboplatin|carboplatin|mesh-list
5908900|NCT03918278|Pembrolizumab|pembrolizumab|mesh-list
5908901|NCT03918278|Pemetrexed|pemetrexed|mesh-list
5908902|NCT03918278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5908903|NCT03918278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5908904|NCT03918278|Tubulin Modulators|tubulin modulators|mesh-ancestor
5908905|NCT03918278|Antimitotic Agents|antimitotic agents|mesh-ancestor
5908906|NCT03918278|Mitosis Modulators|mitosis modulators|mesh-ancestor
5908907|NCT03918278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908908|NCT03918278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5908909|NCT03918278|Antimetabolites|antimetabolites|mesh-ancestor
5908910|NCT03918278|Antiviral Agents|antiviral agents|mesh-ancestor
5908911|NCT03918278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5908912|NCT03918278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5908913|NCT03918278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5908914|NCT03918278|Immunologic Factors|immunologic factors|mesh-ancestor
5908915|NCT03918278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5908916|NCT03918278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5908917|NCT03918278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5908918|NCT03918278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5908919|NCT03914742|Temozolomide|temozolomide|mesh-list
5908920|NCT03914742|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
5908921|NCT03914742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5908922|NCT03914742|Alkylating Agents|alkylating agents|mesh-ancestor
5908923|NCT03914742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908924|NCT03914742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5908925|NCT03914742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5908926|NCT03892018|Paclitaxel|paclitaxel|mesh-list
5908927|NCT03892018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5908928|NCT03892018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5908929|NCT03892018|Tubulin Modulators|tubulin modulators|mesh-ancestor
5908930|NCT03892018|Antimitotic Agents|antimitotic agents|mesh-ancestor
5908931|NCT03892018|Mitosis Modulators|mitosis modulators|mesh-ancestor
5908932|NCT03892018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908933|NCT03885921|Atorvastatin|atorvastatin|mesh-list
5908934|NCT03885921|Simvastatin|simvastatin|mesh-list
5908935|NCT03885921|Ezetimibe|ezetimibe|mesh-list
5908936|NCT03885921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5908937|NCT03885921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5908938|NCT03885921|Antimetabolites|antimetabolites|mesh-ancestor
5908939|NCT03885921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908940|NCT03885921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5908941|NCT03885921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5908942|NCT03885921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5908943|NCT03884452|Atorvastatin|atorvastatin|mesh-list
5908944|NCT03884452|Simvastatin|simvastatin|mesh-list
5908945|NCT03884452|Ezetimibe|ezetimibe|mesh-list
5908946|NCT03884452|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5908947|NCT03884452|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5908948|NCT03884452|Antimetabolites|antimetabolites|mesh-ancestor
5908949|NCT03884452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908950|NCT03884452|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5908951|NCT03884452|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5908952|NCT03884452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5962820|NCT04607733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962821|NCT04607733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5962822|NCT04607733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5962823|NCT04607733|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5962824|NCT04607733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5962825|NCT04607785|Chlorhexidine|chlorhexidine|mesh-list
5908953|NCT03882996|Atorvastatin|atorvastatin|mesh-list
5908954|NCT03882996|Ezetimibe|ezetimibe|mesh-list
5908955|NCT03882996|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5908956|NCT03882996|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5908957|NCT03882996|Antimetabolites|antimetabolites|mesh-ancestor
5908958|NCT03882996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908959|NCT03882996|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5908960|NCT03882996|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5908961|NCT03882996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5908962|NCT03882905|Ezetimibe|ezetimibe|mesh-list
5908963|NCT03882905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5908964|NCT03882905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5908965|NCT03882905|Antimetabolites|antimetabolites|mesh-ancestor
5908966|NCT03882905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908967|NCT03882905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5908968|NCT03882892|Ezetimibe|ezetimibe|mesh-list
6496521|NCT00628316|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6496522|NCT00628316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6496523|NCT00628316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908969|NCT03882892|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5908970|NCT03882892|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5908971|NCT03882892|Antimetabolites|antimetabolites|mesh-ancestor
5908972|NCT03882892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5908973|NCT03882892|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5908974|NCT03878524|Vitamins|vitamins|mesh-list
5908975|NCT03878524|Leucovorin|leucovorin|mesh-list
5908976|NCT03878524|Vitamin A|vitamin a|mesh-list
5908977|NCT03878524|Sirolimus|sirolimus|mesh-list
5908978|NCT03878524|Celecoxib|celecoxib|mesh-list
5908979|NCT03878524|Paclitaxel|paclitaxel|mesh-list
5908980|NCT03878524|Maytansine|maytansine|mesh-list
5908981|NCT03878524|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
5908982|NCT03878524|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5908983|NCT03878524|Bevacizumab|bevacizumab|mesh-list
5908984|NCT03878524|Carboplatin|carboplatin|mesh-list
5908985|NCT03878524|Doxorubicin|doxorubicin|mesh-list
5908986|NCT03878524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5908987|NCT03878524|Fluorouracil|fluorouracil|mesh-list
5908988|NCT03878524|Pembrolizumab|pembrolizumab|mesh-list
5908989|NCT03878524|Capecitabine|capecitabine|mesh-list
5908990|NCT03878524|Oxaliplatin|oxaliplatin|mesh-list
5908991|NCT03878524|Nivolumab|nivolumab|mesh-list
5908992|NCT03878524|Trastuzumab|trastuzumab|mesh-list
5908993|NCT03878524|Everolimus|everolimus|mesh-list
5908994|NCT03878524|Bortezomib|bortezomib|mesh-list
5908995|NCT03878524|Sorafenib|sorafenib|mesh-list
5908996|NCT03878524|Ipilimumab|ipilimumab|mesh-list
5908997|NCT03878524|Durvalumab|durvalumab|mesh-list
5908998|NCT03878524|Sunitinib|sunitinib|mesh-list
5908999|NCT03878524|Daunorubicin|daunorubicin|mesh-list
5909000|NCT03878524|Dasatinib|dasatinib|mesh-list
5909001|NCT03878524|Olaparib|olaparib|mesh-list
5909002|NCT03878524|Venetoclax|venetoclax|mesh-list
5909003|NCT03878524|Palbociclib|palbociclib|mesh-list
5909004|NCT03878524|Lenvatinib|lenvatinib|mesh-list
5909005|NCT03878524|Vorinostat|vorinostat|mesh-list
5909006|NCT03878524|Pertuzumab|pertuzumab|mesh-list
5909007|NCT03878524|Trametinib|trametinib|mesh-list
5909008|NCT03878524|Retinol palmitate|retinol palmitate|mesh-list
5909009|NCT03878524|Tretinoin|tretinoin|mesh-list
5909010|NCT03878524|Bicalutamide|bicalutamide|mesh-list
5909011|NCT03878524|Afatinib|afatinib|mesh-list
5909012|NCT03878524|Panobinostat|panobinostat|mesh-list
5909013|NCT03878524|Vemurafenib|vemurafenib|mesh-list
5909014|NCT03878524|Dabrafenib|dabrafenib|mesh-list
5909015|NCT03878524|Ponatinib|ponatinib|mesh-list
5909016|NCT03878524|Idelalisib|idelalisib|mesh-list
5909017|NCT03878524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5909018|NCT03878524|Losartan|losartan|mesh-list
5909019|NCT03878524|Endothelial Growth Factors|endothelial growth factors|mesh-list
5909020|NCT03878524|Antibodies|antibodies|mesh-list
5909021|NCT03878524|Immunoglobulins|immunoglobulins|mesh-list
5909022|NCT03878524|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5909023|NCT03878524|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5909024|NCT03878524|Immunoglobulin G|immunoglobulin g|mesh-list
5909025|NCT03878524|Immunoconjugates|immunoconjugates|mesh-list
5909026|NCT03878524|Entrectinib|entrectinib|mesh-list
5909027|NCT03878524|Benzenesulfonamide|benzenesulfonamide|mesh-list
5909028|NCT03878524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5909029|NCT03878524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5909030|NCT03878524|Tubulin Modulators|tubulin modulators|mesh-ancestor
5909031|NCT03878524|Antimitotic Agents|antimitotic agents|mesh-ancestor
5909032|NCT03878524|Mitosis Modulators|mitosis modulators|mesh-ancestor
5909033|NCT03878524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5909034|NCT03878524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5909035|NCT03878524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6496524|NCT00628316|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6496525|NCT00628316|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6496526|NCT00628316|Purinergic Agents|purinergic agents|mesh-ancestor
6496527|NCT00628316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6496528|NCT00628342|Esomeprazole|esomeprazole|mesh-list
6496529|NCT00628342|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6496530|NCT00628342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6675631|NCT01576692|Antiviral Agents|antiviral agents|mesh-ancestor
5909036|NCT03878524|Growth Substances|growth substances|mesh-ancestor
5909037|NCT03878524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5909038|NCT03878524|Growth Inhibitors|growth inhibitors|mesh-ancestor
5909039|NCT03878524|Micronutrients|micronutrients|mesh-ancestor
5909040|NCT03878524|Immunologic Factors|immunologic factors|mesh-ancestor
5698134|NCT03371069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5698135|NCT03371069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5698136|NCT03371069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5698137|NCT03371069|Dopamine Agents|dopamine agents|mesh-ancestor
5698138|NCT03371069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5698139|NCT03371043|Analgesics|analgesics|mesh-list
5698140|NCT03371043|Sensory System Agents|sensory system agents|mesh-ancestor
5698141|NCT03371043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5698142|NCT03371043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698143|NCT03370848|Aspirin|aspirin|mesh-list
5698144|NCT03370848|Psyllium|psyllium|mesh-list
5698145|NCT03370848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5698146|NCT03370848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5909041|NCT03878524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6675632|NCT01576692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6675633|NCT01576731|Tenofovir|tenofovir|mesh-list
6675634|NCT01576731|Emtricitabine|emtricitabine|mesh-list
6675635|NCT01576731|Lopinavir|lopinavir|mesh-list
6675636|NCT01576731|Raltegravir Potassium|raltegravir potassium|mesh-list
6675637|NCT01576731|Antiviral Agents|antiviral agents|mesh-ancestor
6675638|NCT01576731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6675639|NCT01576731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6675640|NCT01576731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6675641|NCT01576731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6675642|NCT01576731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675643|NCT01576731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6675644|NCT01576731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5909042|NCT03878524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5909043|NCT03878524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5909044|NCT03878524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5909045|NCT03878524|Antimetabolites|antimetabolites|mesh-ancestor
5909046|NCT03878524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5909047|NCT03878524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5909048|NCT03878524|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5909049|NCT03878524|Antidotes|antidotes|mesh-ancestor
5909050|NCT03878524|Protective Agents|protective agents|mesh-ancestor
5909051|NCT03878524|Vitamin B Complex|vitamin b complex|mesh-ancestor
5909052|NCT03878524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5909053|NCT03878524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5909054|NCT03878524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5909055|NCT03878524|Antifungal Agents|antifungal agents|mesh-ancestor
5909056|NCT03878524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5909057|NCT03878524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5909058|NCT03878524|Analgesics|analgesics|mesh-ancestor
5909059|NCT03878524|Sensory System Agents|sensory system agents|mesh-ancestor
5909060|NCT03878524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5909061|NCT03878524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5909062|NCT03878524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5909063|NCT03878524|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5909064|NCT03878524|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5909065|NCT03878524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5698147|NCT03370848|Analgesics|analgesics|mesh-ancestor
5698148|NCT03370848|Sensory System Agents|sensory system agents|mesh-ancestor
5698149|NCT03370848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5698150|NCT03370848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698151|NCT03370848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5698152|NCT03370848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5698153|NCT03370848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5698154|NCT03370848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5698155|NCT03370848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5698156|NCT03370848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6675645|NCT01576731|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5909066|NCT03878524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5909067|NCT03878524|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5909068|NCT03878524|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5909069|NCT03878524|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5909070|NCT03878524|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5909071|NCT03878524|Antioxidants|antioxidants|mesh-ancestor
5909072|NCT03878524|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5909073|NCT03878524|Keratolytic Agents|keratolytic agents|mesh-ancestor
5909074|NCT03878524|Dermatologic Agents|dermatologic agents|mesh-ancestor
5909075|NCT03878524|Androgen Antagonists|androgen antagonists|mesh-ancestor
5909076|NCT03878524|Hormone Antagonists|hormone antagonists|mesh-ancestor
5909077|NCT03878524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5909078|NCT03878524|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5909079|NCT03875313|Talazoparib|talazoparib|mesh-list
5909080|NCT03875313|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5909081|NCT03875313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5909082|NCT03875313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5909083|NCT03875313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5909119|NCT03867318|Atorvastatin|atorvastatin|mesh-list
5909120|NCT03867318|Ezetimibe|ezetimibe|mesh-list
6496531|NCT00628342|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6496532|NCT00628342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6496533|NCT00628342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496534|NCT00628459|Micronutrients|micronutrients|mesh-list
5909121|NCT03867318|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5909122|NCT03867318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5909123|NCT03867318|Antimetabolites|antimetabolites|mesh-ancestor
5909124|NCT03867318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5909125|NCT03867318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5909126|NCT03867318|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5909127|NCT03867318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5909128|NCT03867188|Bupivacaine|bupivacaine|mesh-list
5909129|NCT03867188|Anesthetics, Local|anesthetics, local|mesh-ancestor
6496535|NCT00628459|Trace Elements|trace elements|mesh-list
6496536|NCT00628459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496537|NCT00628550|Vasopressins|vasopressins|mesh-list
6496538|NCT00628550|Arginine Vasopressin|arginine vasopressin|mesh-list
6496539|NCT00628550|Epinephrine|epinephrine|mesh-list
6496540|NCT00628550|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6496541|NCT00628550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5909130|NCT03867188|Anesthetics|anesthetics|mesh-ancestor
5909131|NCT03867188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5909132|NCT03867188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5909133|NCT03867188|Sensory System Agents|sensory system agents|mesh-ancestor
5909134|NCT03867188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5909135|NCT03867110|Atorvastatin|atorvastatin|mesh-list
5909136|NCT03867110|Ezetimibe|ezetimibe|mesh-list
5909137|NCT03867110|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5909138|NCT03867110|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5909139|NCT03867110|Antimetabolites|antimetabolites|mesh-ancestor
5909140|NCT03867110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5909141|NCT03867110|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5909142|NCT03867110|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5909143|NCT03867110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5909144|NCT03865082|Nivolumab|nivolumab|mesh-list
6675646|NCT01576731|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6675647|NCT01576731|Protease Inhibitors|protease inhibitors|mesh-ancestor
5909145|NCT03865082|Ipilimumab|ipilimumab|mesh-list
5909146|NCT03865082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5909147|NCT03865082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5909148|NCT03865082|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5909149|NCT03865082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5909150|NCT03860844|Cytarabine|cytarabine|mesh-list
5909151|NCT03860844|Dexamethasone|dexamethasone|mesh-list
5909152|NCT03860844|Cyclophosphamide|cyclophosphamide|mesh-list
5909153|NCT03860844|Doxorubicin|doxorubicin|mesh-list
5909154|NCT03860844|Methotrexate|methotrexate|mesh-list
5909155|NCT03860844|Fludarabine|fludarabine|mesh-list
5909156|NCT03860844|Etoposide|etoposide|mesh-list
5909157|NCT03860844|Vincristine|vincristine|mesh-list
5909158|NCT03860844|Daunorubicin|daunorubicin|mesh-list
5909159|NCT03860844|Asparaginase|asparaginase|mesh-list
5909160|NCT03860844|Mitoxantrone|mitoxantrone|mesh-list
5909161|NCT03860844|Idarubicin|idarubicin|mesh-list
5909162|NCT03860844|Hydroxyurea|hydroxyurea|mesh-list
5909163|NCT03860844|Pegaspargase|pegaspargase|mesh-list
5909164|NCT03860844|Montelukast|montelukast|mesh-list
5909165|NCT03860844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5909166|NCT03860844|Immunologic Factors|immunologic factors|mesh-ancestor
5909167|NCT03860844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5909168|NCT03860844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5909169|NCT03860844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5909170|NCT03860844|Alkylating Agents|alkylating agents|mesh-ancestor
5909171|NCT03860844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5909172|NCT03860844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5909173|NCT03860844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5909174|NCT03860844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6496542|NCT00628550|Adrenergic Agents|adrenergic agents|mesh-ancestor
6496543|NCT00628550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6496544|NCT00628550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496545|NCT00628550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496546|NCT00628550|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6496547|NCT00628550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6496548|NCT00628550|Autonomic Agents|autonomic agents|mesh-ancestor
6496549|NCT00628550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6496550|NCT00628550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6496551|NCT00628550|Respiratory System Agents|respiratory system agents|mesh-ancestor
6496552|NCT00628550|Mydriatics|mydriatics|mesh-ancestor
6496553|NCT00628550|Sympathomimetics|sympathomimetics|mesh-ancestor
5909175|NCT03860844|Antiemetics|antiemetics|mesh-ancestor
5909176|NCT03860844|Autonomic Agents|autonomic agents|mesh-ancestor
5909177|NCT03860844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5909178|NCT03860844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5909179|NCT03860844|Glucocorticoids|glucocorticoids|mesh-ancestor
5909180|NCT03860844|Hormones|hormones|mesh-ancestor
5909181|NCT03860844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5909182|NCT03860844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5909183|NCT03860844|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5909184|NCT03860844|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5909185|NCT03860844|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5909186|NCT03860844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5909187|NCT03860844|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5909188|NCT03860844|Abortifacient Agents|abortifacient agents|mesh-ancestor
5909189|NCT03860844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5909190|NCT03860844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5909191|NCT03860844|Antimetabolites|antimetabolites|mesh-ancestor
5909192|NCT03860844|Dermatologic Agents|dermatologic agents|mesh-ancestor
5909193|NCT03860844|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6212628|NCT02191579|Botulinum Toxins|botulinum toxins|mesh-list
6675648|NCT01576731|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6675649|NCT01576731|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6675650|NCT01576731|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6675651|NCT01576731|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6675652|NCT01576770|Lidocaine|lidocaine|mesh-list
6675653|NCT01576770|Tetracaine|tetracaine|mesh-list
6675654|NCT01576770|Ethyl Chloride|ethyl chloride|mesh-list
6675655|NCT01576770|Anesthetics, Local|anesthetics, local|mesh-ancestor
6675656|NCT01576770|Anesthetics|anesthetics|mesh-ancestor
6675657|NCT01576770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6675658|NCT01576770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675659|NCT01576770|Sensory System Agents|sensory system agents|mesh-ancestor
6675660|NCT01576770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6675661|NCT01576770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6675662|NCT01576770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6675663|NCT01576770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6675664|NCT01576770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6675665|NCT01576770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675666|NCT01576848|Caseins|caseins|mesh-list
6675667|NCT01576848|Chelating Agents|chelating agents|mesh-ancestor
6675668|NCT01576848|Sequestering Agents|sequestering agents|mesh-ancestor
6675669|NCT01576848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675670|NCT01577017|Letrozole|letrozole|mesh-list
6675671|NCT01577017|Aromatase Inhibitors|aromatase inhibitors|mesh-list
6675672|NCT01577017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6675673|NCT01577017|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6675674|NCT01577017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6675675|NCT01577017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675676|NCT01577017|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6675677|NCT01577017|Hormone Antagonists|hormone antagonists|mesh-ancestor
6675678|NCT01577017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6675679|NCT01577017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675680|NCT01577043|Racecadotril|racecadotril|mesh-list
6675681|NCT01577043|Antidiarrheals|antidiarrheals|mesh-ancestor
6675682|NCT01577043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6675683|NCT01577043|Protease Inhibitors|protease inhibitors|mesh-ancestor
6675684|NCT01577043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6675685|NCT01577043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675686|NCT01577095|Rosiglitazone|rosiglitazone|mesh-list
6675687|NCT01577095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6675688|NCT01577095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675689|NCT01577121|Indomethacin|indomethacin|mesh-list
6675690|NCT01577121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6675691|NCT01577121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6675692|NCT01577121|Analgesics|analgesics|mesh-ancestor
5909194|NCT03860844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5909195|NCT03860844|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5909196|NCT03860844|Antiviral Agents|antiviral agents|mesh-ancestor
5909197|NCT03860844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5909198|NCT03860844|Tubulin Modulators|tubulin modulators|mesh-ancestor
5909199|NCT03860844|Antimitotic Agents|antimitotic agents|mesh-ancestor
5909200|NCT03860844|Mitosis Modulators|mitosis modulators|mesh-ancestor
5909201|NCT03860844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5909202|NCT03860844|Respiratory System Agents|respiratory system agents|mesh-ancestor
5909203|NCT03860844|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5909204|NCT03860844|Hormone Antagonists|hormone antagonists|mesh-ancestor
5909205|NCT03860844|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5909206|NCT03860844|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5909207|NCT03860844|Analgesics|analgesics|mesh-ancestor
5909208|NCT03860844|Sensory System Agents|sensory system agents|mesh-ancestor
5909209|NCT03860844|Antisickling Agents|antisickling agents|mesh-ancestor
5909210|NCT03848689|Fluoroquinolones|fluoroquinolones|mesh-list
5909211|NCT03848689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5909212|NCT03848689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5909213|NCT03848689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5909214|NCT03848689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5909215|NCT03848689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5909216|NCT03840915|Gemcitabine|gemcitabine|mesh-list
5909217|NCT03840915|Paclitaxel|paclitaxel|mesh-list
5909218|NCT03840915|Docetaxel|docetaxel|mesh-list
5909219|NCT03840915|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5909220|NCT03840915|Carboplatin|carboplatin|mesh-list
5909221|NCT03840915|Pemetrexed|pemetrexed|mesh-list
5909222|NCT03840915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5698157|NCT03370848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5698158|NCT03370848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5698159|NCT03370848|Antipyretics|antipyretics|mesh-ancestor
5698160|NCT03370848|Cathartics|cathartics|mesh-ancestor
5698161|NCT03370848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5698162|NCT03370835|Metoprolol|metoprolol|mesh-list
5698163|NCT03370835|Carvedilol|carvedilol|mesh-list
5698164|NCT03370835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5698165|NCT03370835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5698166|NCT03370835|Sympatholytics|sympatholytics|mesh-ancestor
6675693|NCT01577121|Sensory System Agents|sensory system agents|mesh-ancestor
5909223|NCT03840915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5909224|NCT03840915|Tubulin Modulators|tubulin modulators|mesh-ancestor
5909225|NCT03840915|Antimitotic Agents|antimitotic agents|mesh-ancestor
5909226|NCT03840915|Mitosis Modulators|mitosis modulators|mesh-ancestor
5909227|NCT03840915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5909228|NCT03840915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5909229|NCT03840915|Antimetabolites|antimetabolites|mesh-ancestor
5909230|NCT03840915|Antiviral Agents|antiviral agents|mesh-ancestor
5909231|NCT03840915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5909232|NCT03840915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5909233|NCT03840915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5909234|NCT03840915|Immunologic Factors|immunologic factors|mesh-ancestor
5909235|NCT03840915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5909236|NCT03840915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5909237|NCT03840915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5909238|NCT03834948|Paclitaxel|paclitaxel|mesh-list
5909239|NCT03834948|Pembrolizumab|pembrolizumab|mesh-list
5909240|NCT03834948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5698167|NCT03370835|Autonomic Agents|autonomic agents|mesh-ancestor
5698168|NCT03370835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5698169|NCT03370835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698170|NCT03370835|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5698171|NCT03370835|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5698172|NCT03370835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5698173|NCT03370835|Adrenergic Agents|adrenergic agents|mesh-ancestor
5698174|NCT03370835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5909241|NCT03834948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5909242|NCT03834948|Tubulin Modulators|tubulin modulators|mesh-ancestor
5909243|NCT03834948|Antimitotic Agents|antimitotic agents|mesh-ancestor
5909244|NCT03834948|Mitosis Modulators|mitosis modulators|mesh-ancestor
5909245|NCT03834948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5909246|NCT03834948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5909250|NCT03833167|Pembrolizumab|pembrolizumab|mesh-list
5909251|NCT03833167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5909252|NCT03833167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5722266|NCT03200080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5909273|NCT03785678|Tenecteplase|tenecteplase|mesh-list
5909274|NCT03785678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5909275|NCT03785678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5909276|NCT03785678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5909277|NCT03778957|Bevacizumab|bevacizumab|mesh-list
5909278|NCT03778957|Durvalumab|durvalumab|mesh-list
5909279|NCT03778957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5909280|NCT03778957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5909281|NCT03778957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5909282|NCT03778957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5909283|NCT03778957|Growth Substances|growth substances|mesh-ancestor
5909284|NCT03778957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5909285|NCT03778957|Growth Inhibitors|growth inhibitors|mesh-ancestor
5909286|NCT03765918|Cisplatin|cisplatin|mesh-list
5909287|NCT03765918|Pembrolizumab|pembrolizumab|mesh-list
5909288|NCT03765918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5909289|NCT03765918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5909290|NCT03746080|Plerixafor|plerixafor|mesh-list
5909291|NCT03746080|Temozolomide|temozolomide|mesh-list
6496554|NCT00628550|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6496555|NCT00628550|Hemostatics|hemostatics|mesh-ancestor
6496556|NCT00628550|Coagulants|coagulants|mesh-ancestor
6496557|NCT00628550|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6496558|NCT00628550|Natriuretic Agents|natriuretic agents|mesh-ancestor
6496559|NCT00628576|Heparin|heparin|mesh-list
6496560|NCT00628576|Calcium heparin|calcium heparin|mesh-list
5909292|NCT03746080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5909293|NCT03746080|Alkylating Agents|alkylating agents|mesh-ancestor
5909294|NCT03746080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5909295|NCT03746080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5909296|NCT03746080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5909297|NCT03746080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5909298|NCT03746080|Antiviral Agents|antiviral agents|mesh-ancestor
5909299|NCT03746080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5909300|NCT03718767|Nivolumab|nivolumab|mesh-list
5909301|NCT03718767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5909302|NCT03718767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5909303|NCT03718767|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5909304|NCT03718767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5909305|NCT03715933|Carboplatin|carboplatin|mesh-list
5909306|NCT03715933|Fluorouracil|fluorouracil|mesh-list
5909307|NCT03715933|Irinotecan|irinotecan|mesh-list
5909308|NCT03715933|Pemetrexed|pemetrexed|mesh-list
5909309|NCT03715933|Temozolomide|temozolomide|mesh-list
5909310|NCT03715933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5909311|NCT03715933|Antimetabolites|antimetabolites|mesh-ancestor
5909312|NCT03715933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5909313|NCT03715933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5909314|NCT03715933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5909315|NCT03715933|Immunologic Factors|immunologic factors|mesh-ancestor
5909316|NCT03715933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5909317|NCT03715933|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5909318|NCT03715933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5909319|NCT03715933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5909320|NCT03715933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5909321|NCT03715933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5909322|NCT03715933|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5909323|NCT03715933|Alkylating Agents|alkylating agents|mesh-ancestor
5909324|NCT03714828|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
5909325|NCT03714828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5909326|NCT03714828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5909327|NCT03713944|Bevacizumab|bevacizumab|mesh-list
5909328|NCT03713944|Carboplatin|carboplatin|mesh-list
5909329|NCT03713944|Pemetrexed|pemetrexed|mesh-list
5909330|NCT03713944|Atezolizumab|atezolizumab|mesh-list
5909331|NCT03713944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5909332|NCT03713944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5909333|NCT03713944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6496561|NCT00628576|Tinzaparin|tinzaparin|mesh-list
6675694|NCT01577121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5909334|NCT03713944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5909335|NCT03713944|Growth Substances|growth substances|mesh-ancestor
5909336|NCT03713944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5909337|NCT03713944|Growth Inhibitors|growth inhibitors|mesh-ancestor
5909338|NCT03713944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5909339|NCT03713944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5909340|NCT03713944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5909341|NCT03713944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5909342|NCT03708224|Atezolizumab|atezolizumab|mesh-list
5909343|NCT03708224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5909344|NCT03689855|Atezolizumab|atezolizumab|mesh-list
5909345|NCT03689855|Ramucirumab|ramucirumab|mesh-list
5909346|NCT03689855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5698175|NCT03370835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5698176|NCT03370835|Antioxidants|antioxidants|mesh-ancestor
5698177|NCT03370835|Protective Agents|protective agents|mesh-ancestor
5698178|NCT03370835|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5698179|NCT03370835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5698180|NCT03370835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5698181|NCT03370835|Vasodilator Agents|vasodilator agents|mesh-ancestor
5698182|NCT03370835|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5909347|NCT03681561|Nivolumab|nivolumab|mesh-list
5909348|NCT03681561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5909349|NCT03681561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5909350|NCT03681561|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5909351|NCT03681561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5909352|NCT03678883|Gemcitabine|gemcitabine|mesh-list
5909353|NCT03678883|Paclitaxel|paclitaxel|mesh-list
5909354|NCT03678883|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5909355|NCT03678883|Carboplatin|carboplatin|mesh-list
5909356|NCT03678883|Doxorubicin|doxorubicin|mesh-list
5909357|NCT03678883|Irinotecan|irinotecan|mesh-list
5909358|NCT03678883|Lomustine|lomustine|mesh-list
5909359|NCT03678883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5909360|NCT03678883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5909361|NCT03678883|Tubulin Modulators|tubulin modulators|mesh-ancestor
5909362|NCT03678883|Antimitotic Agents|antimitotic agents|mesh-ancestor
5909363|NCT03678883|Mitosis Modulators|mitosis modulators|mesh-ancestor
5909364|NCT03678883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5698183|NCT03370835|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5698184|NCT03370783|Ethanol|ethanol|mesh-list
5698185|NCT03370783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5698186|NCT03370783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5698187|NCT03370783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5698188|NCT03370783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698189|NCT03370705|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
5698190|NCT03370705|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
5698191|NCT03370705|Captopril|captopril|mesh-list
5698192|NCT03370705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
5698193|NCT03370705|Atorvastatin|atorvastatin|mesh-list
5698194|NCT03370705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
5698195|NCT03370705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5698196|NCT03370705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5909365|NCT03678883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5909366|NCT03678883|Antimetabolites|antimetabolites|mesh-ancestor
5909367|NCT03678883|Antiviral Agents|antiviral agents|mesh-ancestor
5909368|NCT03678883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5909369|NCT03678883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5909370|NCT03678883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5909371|NCT03678883|Immunologic Factors|immunologic factors|mesh-ancestor
5909372|NCT03678883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5909373|NCT03678883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5909374|NCT03678883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5909375|NCT03678883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5909376|NCT03678883|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5909377|NCT03678883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5909378|NCT03678883|Alkylating Agents|alkylating agents|mesh-ancestor
5909379|NCT03656718|Nivolumab|nivolumab|mesh-list
5909380|NCT03656718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5909381|NCT03656718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5698197|NCT03370705|Antimetabolites|antimetabolites|mesh-ancestor
5698198|NCT03370705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5698199|NCT03370705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5909382|NCT03656718|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5909383|NCT03656718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5909384|NCT03644485|Mycophenolic Acid|mycophenolic acid|mesh-list
5909385|NCT03644485|Tacrolimus|tacrolimus|mesh-list
5909386|NCT03644485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5909387|NCT03644485|Immunologic Factors|immunologic factors|mesh-ancestor
5909388|NCT03644485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5909389|NCT03644485|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5909390|NCT03644485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5909391|NCT03644485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5909392|NCT03644485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5909393|NCT03644485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5909394|NCT03644485|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5909395|NCT03644485|Antitubercular Agents|antitubercular agents|mesh-ancestor
5909396|NCT03644485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5909397|NCT03644485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5698200|NCT03370705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5698201|NCT03370705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5698202|NCT03370705|Protease Inhibitors|protease inhibitors|mesh-ancestor
5698203|NCT03370705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5698204|NCT03370705|Anticoagulants|anticoagulants|mesh-ancestor
5698205|NCT03370705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5698206|NCT03370705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5698207|NCT03370705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5698208|NCT03370705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698209|NCT03370705|Analgesics|analgesics|mesh-ancestor
5698210|NCT03370705|Sensory System Agents|sensory system agents|mesh-ancestor
5698211|NCT03370705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5698212|NCT03370705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5698213|NCT03370705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5698214|NCT03370705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5698215|NCT03370705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5698216|NCT03370705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5698217|NCT03370627|Antibodies|antibodies|mesh-list
5698218|NCT03370627|Immunologic Factors|immunologic factors|mesh-ancestor
5909398|NCT03639246|Paclitaxel|paclitaxel|mesh-list
5909399|NCT03639246|Doxorubicin|doxorubicin|mesh-list
5909400|NCT03639246|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5909401|NCT03639246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5909402|NCT03639246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5909403|NCT03639246|Tubulin Modulators|tubulin modulators|mesh-ancestor
5909404|NCT03639246|Antimitotic Agents|antimitotic agents|mesh-ancestor
5909405|NCT03639246|Mitosis Modulators|mitosis modulators|mesh-ancestor
5909406|NCT03639246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5909407|NCT03639246|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5909408|NCT03639246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5909409|NCT03639246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5909410|NCT03639246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5909411|NCT03621982|Pembrolizumab|pembrolizumab|mesh-list
5909412|NCT03621982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5909413|NCT03621982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5909414|NCT03609216|Gemcitabine|gemcitabine|mesh-list
5909415|NCT03609216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5909416|NCT03609216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5909417|NCT03609216|Antimetabolites|antimetabolites|mesh-ancestor
5909418|NCT03609216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5909419|NCT03609216|Antiviral Agents|antiviral agents|mesh-ancestor
5909420|NCT03609216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5909421|NCT03609216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5909422|NCT03609216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5909423|NCT03609216|Immunologic Factors|immunologic factors|mesh-ancestor
5909424|NCT03609216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5909425|NCT03556202|Mirikizumab|mirikizumab|mesh-list
5909426|NCT03556202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5909427|NCT03556202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5909428|NCT03556202|Analgesics|analgesics|mesh-ancestor
5909429|NCT03556202|Sensory System Agents|sensory system agents|mesh-ancestor
5909430|NCT03556202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5909431|NCT03556202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5909432|NCT03556202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5909433|NCT03556202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5909434|NCT03556202|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5909435|NCT03556202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5909436|NCT03521154|Osimertinib|osimertinib|mesh-list
5698219|NCT03370627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5909437|NCT03521154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5909438|NCT03521154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5909439|NCT03521154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5909440|NCT03521154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5909448|NCT03498378|Cetuximab|cetuximab|mesh-list
5909449|NCT03498378|Avelumab|avelumab|mesh-list
5909450|NCT03498378|Palbociclib|palbociclib|mesh-list
5909451|NCT03498378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5909452|NCT03498378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5909453|NCT03498378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5909454|NCT03498378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5909455|NCT03498378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5909456|NCT03497676|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
5909457|NCT03497676|Rilpivirine|rilpivirine|mesh-list
5909458|NCT03497676|Cabotegravir|cabotegravir|mesh-list
5909459|NCT03497676|Antiviral Agents|antiviral agents|mesh-ancestor
5909460|NCT03497676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5909461|NCT03497676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5909462|NCT03497676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5909463|NCT03497676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5909464|NCT03497676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5909465|NCT03497676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5909466|NCT03497676|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5909467|NCT03497676|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5698220|NCT03370601|Mercaptopurine|mercaptopurine|mesh-list
5698221|NCT03370601|Azathioprine|azathioprine|mesh-list
5698222|NCT03370601|Infliximab|infliximab|mesh-list
5698223|NCT03370601|Dermatologic Agents|dermatologic agents|mesh-ancestor
5698224|NCT03370601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5698225|NCT03370601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5909481|NCT03467373|Prednisone|prednisone|mesh-list
5909482|NCT03467373|Cyclophosphamide|cyclophosphamide|mesh-list
5909483|NCT03467373|Rituximab|rituximab|mesh-list
5909484|NCT03467373|Doxorubicin|doxorubicin|mesh-list
5909485|NCT03467373|Vincristine|vincristine|mesh-list
5909486|NCT03467373|Obinutuzumab|obinutuzumab|mesh-list
5909487|NCT03467373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5909488|NCT03467373|Immunologic Factors|immunologic factors|mesh-ancestor
5909489|NCT03467373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5909490|NCT03467373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5909491|NCT03467373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5909492|NCT03467373|Alkylating Agents|alkylating agents|mesh-ancestor
5909493|NCT03467373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5909494|NCT03467373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5698226|NCT03370601|Antimetabolites|antimetabolites|mesh-ancestor
5698227|NCT03370601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5698228|NCT03370601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5698229|NCT03370601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5698230|NCT03370601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5698231|NCT03370601|Immunologic Factors|immunologic factors|mesh-ancestor
5698232|NCT03370601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698233|NCT03370601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5698234|NCT03370601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5909495|NCT03467373|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5909496|NCT03467373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5909497|NCT03467373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5909498|NCT03467373|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5909499|NCT03467373|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5909500|NCT03467373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5909501|NCT03467373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5909502|NCT03467373|Glucocorticoids|glucocorticoids|mesh-ancestor
5909503|NCT03467373|Hormones|hormones|mesh-ancestor
5909504|NCT03467373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5909505|NCT03467373|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5909506|NCT03467373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5909507|NCT03467373|Tubulin Modulators|tubulin modulators|mesh-ancestor
5909508|NCT03467373|Antimitotic Agents|antimitotic agents|mesh-ancestor
5909509|NCT03467373|Mitosis Modulators|mitosis modulators|mesh-ancestor
5909510|NCT03466801|Prednisone|prednisone|mesh-list
5909511|NCT03466801|Glucocorticoids|glucocorticoids|mesh-list
5909512|NCT03466801|Immunosuppressive Agents|immunosuppressive agents|mesh-list
5909513|NCT03466801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5909514|NCT03466801|Hormones|hormones|mesh-ancestor
5909515|NCT03466801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5909516|NCT03466801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5909517|NCT03466801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5909518|NCT03466801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5909519|NCT03466801|Immunologic Factors|immunologic factors|mesh-ancestor
5909520|NCT03466450|Temozolomide|temozolomide|mesh-list
5909521|NCT03466450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5909522|NCT03466450|Alkylating Agents|alkylating agents|mesh-ancestor
5909523|NCT03466450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5909524|NCT03466450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5909525|NCT03456063|Gemcitabine|gemcitabine|mesh-list
5909526|NCT03456063|Paclitaxel|paclitaxel|mesh-list
5909527|NCT03456063|Carboplatin|carboplatin|mesh-list
5909528|NCT03456063|Pemetrexed|pemetrexed|mesh-list
5909529|NCT03456063|Atezolizumab|atezolizumab|mesh-list
5909530|NCT03456063|Antibodies|antibodies|mesh-list
5909531|NCT03456063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5909532|NCT03456063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5909533|NCT03456063|Tubulin Modulators|tubulin modulators|mesh-ancestor
5909534|NCT03456063|Antimitotic Agents|antimitotic agents|mesh-ancestor
5909535|NCT03456063|Mitosis Modulators|mitosis modulators|mesh-ancestor
5909536|NCT03456063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5909537|NCT03456063|Immunologic Factors|immunologic factors|mesh-ancestor
6675695|NCT01577121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675696|NCT01577121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6675697|NCT01577121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5909538|NCT03456063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5909539|NCT03456063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5909540|NCT03456063|Antimetabolites|antimetabolites|mesh-ancestor
5909541|NCT03456063|Antiviral Agents|antiviral agents|mesh-ancestor
5698235|NCT03370588|Dexmedetomidine|dexmedetomidine|mesh-list
5698236|NCT03370588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5698237|NCT03370588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5698238|NCT03370588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698239|NCT03370588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5698240|NCT03370588|Analgesics|analgesics|mesh-ancestor
5698241|NCT03370588|Sensory System Agents|sensory system agents|mesh-ancestor
5698242|NCT03370588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5698243|NCT03370588|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5698244|NCT03370588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5698245|NCT03370588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5698246|NCT03370588|Adrenergic Agents|adrenergic agents|mesh-ancestor
5909542|NCT03456063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5909543|NCT03456063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5909544|NCT03456063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5909545|NCT03456063|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5909546|NCT03456063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5909547|NCT03449888|Calcium, Dietary|calcium, dietary|mesh-list
5909548|NCT03449888|Calcium|calcium|mesh-list
5909549|NCT03449888|Regadenoson|regadenoson|mesh-list
5909550|NCT03449888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5909551|NCT03449888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5909552|NCT03449888|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5698247|NCT03370588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5698248|NCT03370588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5698249|NCT03370562|Dexmedetomidine|dexmedetomidine|mesh-list
5698250|NCT03370562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5698251|NCT03370562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6242817|NCT02656329|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5909553|NCT03449888|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
5909554|NCT03449888|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5909555|NCT03449888|Purinergic Agonists|purinergic agonists|mesh-ancestor
5909556|NCT03449888|Purinergic Agents|purinergic agents|mesh-ancestor
5909557|NCT03449888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5909558|NCT03449888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5909559|NCT03415854|Gemcitabine|gemcitabine|mesh-list
5909560|NCT03415854|Paclitaxel|paclitaxel|mesh-list
5909561|NCT03415854|Cisplatin|cisplatin|mesh-list
5909562|NCT03415854|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5909563|NCT03415854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5909564|NCT03415854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5909565|NCT03415854|Tubulin Modulators|tubulin modulators|mesh-ancestor
5909566|NCT03415854|Antimitotic Agents|antimitotic agents|mesh-ancestor
5698252|NCT03370562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698253|NCT03370562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5698254|NCT03370562|Analgesics|analgesics|mesh-ancestor
5698255|NCT03370562|Sensory System Agents|sensory system agents|mesh-ancestor
5698256|NCT03370562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5698257|NCT03370562|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5698258|NCT03370562|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5698259|NCT03370562|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5698260|NCT03370562|Adrenergic Agents|adrenergic agents|mesh-ancestor
5698261|NCT03370562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5909567|NCT03415854|Mitosis Modulators|mitosis modulators|mesh-ancestor
5909568|NCT03415854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5909569|NCT03415854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5909570|NCT03415854|Antimetabolites|antimetabolites|mesh-ancestor
5909571|NCT03415854|Antiviral Agents|antiviral agents|mesh-ancestor
5909572|NCT03415854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5909573|NCT03415854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5909574|NCT03415854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5909575|NCT03415854|Immunologic Factors|immunologic factors|mesh-ancestor
5909576|NCT03415854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5909577|NCT03409614|Cemiplimab|cemiplimab|mesh-list
5909578|NCT03409614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5909579|NCT03409614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5909580|NCT03408873|Aripiprazole|aripiprazole|mesh-list
5909581|NCT03408873|Antidepressive Agents|antidepressive agents|mesh-ancestor
5909582|NCT03408873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5909583|NCT03408873|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5909584|NCT03408873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5909585|NCT03408873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5909586|NCT03408873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5909587|NCT03408873|Dopamine Agonists|dopamine agonists|mesh-ancestor
5909588|NCT03408873|Dopamine Agents|dopamine agents|mesh-ancestor
5909589|NCT03408873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5909590|NCT03408873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5909591|NCT03408873|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5909592|NCT03408873|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5909593|NCT03408873|Serotonin Agents|serotonin agents|mesh-ancestor
5909594|NCT03408873|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5909595|NCT03408873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5909596|NCT03408873|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5909597|NCT03408873|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5909598|NCT03407144|Prednisone|prednisone|mesh-list
5909599|NCT03407144|Prednisolone|prednisolone|mesh-list
5909600|NCT03407144|Cyclophosphamide|cyclophosphamide|mesh-list
5909601|NCT03407144|Dacarbazine|dacarbazine|mesh-list
5909602|NCT03407144|Doxorubicin|doxorubicin|mesh-list
5909603|NCT03407144|Pembrolizumab|pembrolizumab|mesh-list
5909604|NCT03407144|Etoposide|etoposide|mesh-list
5909605|NCT03407144|Etoposide phosphate|etoposide phosphate|mesh-list
5909606|NCT03407144|Vincristine|vincristine|mesh-list
5909607|NCT03407144|Bleomycin|bleomycin|mesh-list
5909608|NCT03407144|Vinblastine|vinblastine|mesh-list
5909609|NCT03407144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5909610|NCT03407144|Immunologic Factors|immunologic factors|mesh-ancestor
5909611|NCT03407144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5909612|NCT03407144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5909613|NCT03407144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5909614|NCT03407144|Alkylating Agents|alkylating agents|mesh-ancestor
5909615|NCT03407144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722267|NCT03200080|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5909616|NCT03407144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5909617|NCT03407144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5909618|NCT03407144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5909619|NCT03407144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6675698|NCT01577121|Gout Suppressants|gout suppressants|mesh-ancestor
6675699|NCT01577121|Tocolytic Agents|tocolytic agents|mesh-ancestor
6675700|NCT01577121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6675701|NCT01577121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6675702|NCT01577121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6675703|NCT01577121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675704|NCT01577199|Clomiphene|clomiphene|mesh-list
6675705|NCT01577199|Enclomiphene|enclomiphene|mesh-list
6675706|NCT01577199|Zuclomiphene|zuclomiphene|mesh-list
6675707|NCT01577199|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5909620|NCT03407144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5909621|NCT03407144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5698262|NCT03370562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5698263|NCT03370510|Oxytocin|oxytocin|mesh-list
5698264|NCT03370510|Oxytocics|oxytocics|mesh-ancestor
5909622|NCT03407144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5909623|NCT03407144|Glucocorticoids|glucocorticoids|mesh-ancestor
5909624|NCT03407144|Hormones|hormones|mesh-ancestor
5909625|NCT03407144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5909626|NCT03407144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5909627|NCT03407144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5909628|NCT03407144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5909629|NCT03407144|Tubulin Modulators|tubulin modulators|mesh-ancestor
5909630|NCT03407144|Antimitotic Agents|antimitotic agents|mesh-ancestor
5909631|NCT03407144|Mitosis Modulators|mitosis modulators|mesh-ancestor
5909632|NCT03396471|Pembrolizumab|pembrolizumab|mesh-list
5909633|NCT03396471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5909634|NCT03396471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5909635|NCT03375645|Analgesics, Opioid|analgesics, opioid|mesh-list
5909636|NCT03375645|Narcotics|narcotics|mesh-ancestor
5909637|NCT03375645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5909638|NCT03375645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5909639|NCT03375645|Analgesics|analgesics|mesh-ancestor
5909640|NCT03375645|Sensory System Agents|sensory system agents|mesh-ancestor
5909641|NCT03375645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5909642|NCT03363763|Sirolimus|sirolimus|mesh-list
5909643|NCT03363763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5909644|NCT03363763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5909645|NCT03363763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5909646|NCT03363763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5909647|NCT03363763|Antifungal Agents|antifungal agents|mesh-ancestor
5909648|NCT03363763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5909649|NCT03363763|Immunologic Factors|immunologic factors|mesh-ancestor
5909650|NCT03363763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5909651|NCT03342456|Amoxicillin|amoxicillin|mesh-list
5909652|NCT03342456|Doxycycline|doxycycline|mesh-list
5909653|NCT03342456|Furazolidone|furazolidone|mesh-list
5909654|NCT03342456|Potassium Citrate|potassium citrate|mesh-list
5909655|NCT03342456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5909656|NCT03342456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5909657|NCT03342456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5698265|NCT03370510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5698266|NCT03370510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698267|NCT03370406|Fluorouracil|fluorouracil|mesh-list
5909658|NCT03342456|Antimalarials|antimalarials|mesh-ancestor
5909659|NCT03342456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5909660|NCT03342456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5909661|NCT03342456|Diuretics|diuretics|mesh-ancestor
5909662|NCT03342456|Natriuretic Agents|natriuretic agents|mesh-ancestor
5909663|NCT03342456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5909664|NCT03342456|Expectorants|expectorants|mesh-ancestor
6675708|NCT01577199|Hormone Antagonists|hormone antagonists|mesh-ancestor
5698268|NCT03370406|Imiquimod|imiquimod|mesh-list
5698269|NCT03370406|Antimetabolites|antimetabolites|mesh-ancestor
5698270|NCT03370406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5698271|NCT03370406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5698272|NCT03370406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5698273|NCT03370406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5698274|NCT03370406|Immunologic Factors|immunologic factors|mesh-ancestor
5698275|NCT03370406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698276|NCT03370406|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5698277|NCT03370406|Interferon Inducers|interferon inducers|mesh-ancestor
5698278|NCT03370380|Aflibercept|aflibercept|mesh-list
6675709|NCT01577199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5909665|NCT03342456|Respiratory System Agents|respiratory system agents|mesh-ancestor
5909666|NCT03342456|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5909667|NCT03342456|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5909668|NCT03342456|Renal Agents|renal agents|mesh-ancestor
5909669|NCT03342456|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
5909670|NCT03342456|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
5909671|NCT03342456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5909672|NCT03337698|Linagliptin|linagliptin|mesh-list
5909673|NCT03337698|Gemcitabine|gemcitabine|mesh-list
5909674|NCT03337698|Bevacizumab|bevacizumab|mesh-list
5909675|NCT03337698|Carboplatin|carboplatin|mesh-list
5909676|NCT03337698|Docetaxel|docetaxel|mesh-list
5909677|NCT03337698|Pemetrexed|pemetrexed|mesh-list
5909678|NCT03337698|Atezolizumab|atezolizumab|mesh-list
5909679|NCT03337698|Evolocumab|evolocumab|mesh-list
5909680|NCT03337698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5909681|NCT03337698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5909682|NCT03337698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5909683|NCT03337698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5909684|NCT03337698|Growth Substances|growth substances|mesh-ancestor
5909685|NCT03337698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5909686|NCT03337698|Growth Inhibitors|growth inhibitors|mesh-ancestor
5909687|NCT03337698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5909688|NCT03337698|Antimetabolites|antimetabolites|mesh-ancestor
5909689|NCT03337698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5909690|NCT03337698|Antiviral Agents|antiviral agents|mesh-ancestor
5909691|NCT03337698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5909692|NCT03337698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5909693|NCT03337698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5909694|NCT03337698|Immunologic Factors|immunologic factors|mesh-ancestor
5909695|NCT03337698|Tubulin Modulators|tubulin modulators|mesh-ancestor
5909696|NCT03337698|Antimitotic Agents|antimitotic agents|mesh-ancestor
5909697|NCT03337698|Mitosis Modulators|mitosis modulators|mesh-ancestor
5909698|NCT03337698|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5909699|NCT03337698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5909700|NCT03337698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5909701|NCT03337698|Incretins|incretins|mesh-ancestor
5909702|NCT03337698|Hormones|hormones|mesh-ancestor
5909703|NCT03337698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5909704|NCT03337698|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5909705|NCT03337698|Protease Inhibitors|protease inhibitors|mesh-ancestor
5909706|NCT03337698|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5909707|NCT03337698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5909708|NCT03337698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5962826|NCT04607785|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5962827|NCT04607785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5962828|NCT04607785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5962829|NCT04607785|Disinfectants|disinfectants|mesh-ancestor
5962830|NCT04607785|Dermatologic Agents|dermatologic agents|mesh-ancestor
5962831|NCT04607629|Omalizumab|omalizumab|mesh-list
5962832|NCT04607629|Budesonide|budesonide|mesh-list
5962833|NCT04607629|Formoterol Fumarate|formoterol fumarate|mesh-list
5962834|NCT04607629|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
5962835|NCT04607629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5962836|NCT04607629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5962837|NCT04607629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5962838|NCT04607629|Autonomic Agents|autonomic agents|mesh-ancestor
5962839|NCT04607629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5962840|NCT04607629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962841|NCT04607629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5909709|NCT03332667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5909710|NCT03332667|Vorinostat|vorinostat|mesh-list
5909711|NCT03332667|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
5909712|NCT03332667|Dinutuximab|dinutuximab|mesh-list
5909713|NCT03332667|Antibodies|antibodies|mesh-list
6496562|NCT00628576|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6496563|NCT00628576|Dalteparin|dalteparin|mesh-list
6496564|NCT00628576|Anticoagulants|anticoagulants|mesh-ancestor
6496565|NCT00628576|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6496566|NCT00628576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6496567|NCT00628576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496568|NCT00628667|Esomeprazole|esomeprazole|mesh-list
6496569|NCT00628667|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6496570|NCT00628667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6496571|NCT00628667|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5909714|NCT03332667|Immunoglobulins|immunoglobulins|mesh-list
5909715|NCT03332667|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5909716|NCT03332667|Immunologic Factors|immunologic factors|mesh-ancestor
5909717|NCT03332667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5909718|NCT03332667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5909719|NCT03332667|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5909720|NCT03332667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5909721|NCT03332667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5909722|NCT03332667|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5909723|NCT03321045|Trastuzumab|trastuzumab|mesh-list
5909724|NCT03321045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5909725|NCT03321045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5909726|NCT03308396|Durvalumab|durvalumab|mesh-list
5909727|NCT03308396|Guadecitabine|guadecitabine|mesh-list
5909728|NCT03308396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5909729|NCT03308396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5909730|NCT03290612|Ascorbic Acid|ascorbic acid|mesh-list
5909731|NCT03290612|Vitamins|vitamins|mesh-ancestor
5909732|NCT03290612|Micronutrients|micronutrients|mesh-ancestor
5909733|NCT03290612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5909734|NCT03290612|Antioxidants|antioxidants|mesh-ancestor
5909735|NCT03290612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5909736|NCT03290612|Protective Agents|protective agents|mesh-ancestor
5909737|NCT03290287|Bromides|bromides|mesh-list
5909738|NCT03290287|Anticonvulsants|anticonvulsants|mesh-ancestor
5909739|NCT03285321|Nivolumab|nivolumab|mesh-list
5909740|NCT03285321|Ipilimumab|ipilimumab|mesh-list
5909741|NCT03285321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5909742|NCT03285321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5909743|NCT03285321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5909744|NCT03285321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5909745|NCT03284957|Everolimus|everolimus|mesh-list
5909746|NCT03284957|Palbociclib|palbociclib|mesh-list
5909747|NCT03284957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5909748|NCT03284957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5909749|NCT03284957|Immunologic Factors|immunologic factors|mesh-ancestor
5909750|NCT03284957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5909751|NCT03284957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5909752|NCT03284957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5909753|NCT03284957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5909754|NCT03284866|Vaccines|vaccines|mesh-list
5909755|NCT03284866|Immunologic Factors|immunologic factors|mesh-ancestor
5909756|NCT03284866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5909757|NCT03283761|Leucovorin|leucovorin|mesh-list
5909758|NCT03283761|Paclitaxel|paclitaxel|mesh-list
5909759|NCT03283761|Fluorouracil|fluorouracil|mesh-list
5909760|NCT03283761|Oxaliplatin|oxaliplatin|mesh-list
5909761|NCT03283761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5909762|NCT03283761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5909763|NCT03283761|Tubulin Modulators|tubulin modulators|mesh-ancestor
5909764|NCT03283761|Antimitotic Agents|antimitotic agents|mesh-ancestor
5909765|NCT03283761|Mitosis Modulators|mitosis modulators|mesh-ancestor
5909766|NCT03283761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5909767|NCT03283761|Antimetabolites|antimetabolites|mesh-ancestor
5909768|NCT03283761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5909769|NCT03283761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5909770|NCT03283761|Immunologic Factors|immunologic factors|mesh-ancestor
5909771|NCT03283761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5909772|NCT03283761|Antidotes|antidotes|mesh-ancestor
5909773|NCT03283761|Protective Agents|protective agents|mesh-ancestor
5909774|NCT03283761|Vitamin B Complex|vitamin b complex|mesh-ancestor
5909775|NCT03283761|Vitamins|vitamins|mesh-ancestor
5909776|NCT03283761|Micronutrients|micronutrients|mesh-ancestor
5909777|NCT03251911|Ivacaftor|ivacaftor|mesh-list
5909778|NCT03251911|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
5909779|NCT03251911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5909780|NCT03251911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5909781|NCT03224767|Vemurafenib|vemurafenib|mesh-list
5909782|NCT03224767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5909783|NCT03224767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5909784|NCT03224767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5909785|NCT03224767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5909786|NCT03221400|Leucovorin|leucovorin|mesh-list
5909787|NCT03221400|Folic Acid|folic acid|mesh-list
5909788|NCT03221400|Fluorouracil|fluorouracil|mesh-list
5909789|NCT03221400|Niraparib|niraparib|mesh-list
5909790|NCT03221400|Levoleucovorin|levoleucovorin|mesh-list
5909791|NCT03221400|Antimetabolites|antimetabolites|mesh-ancestor
5909792|NCT03221400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5909793|NCT03221400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5909794|NCT03221400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5909795|NCT03221400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5909796|NCT03221400|Immunologic Factors|immunologic factors|mesh-ancestor
5909797|NCT03221400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5909798|NCT03221400|Antidotes|antidotes|mesh-ancestor
5909799|NCT03221400|Protective Agents|protective agents|mesh-ancestor
5909800|NCT03221400|Vitamin B Complex|vitamin b complex|mesh-ancestor
5909801|NCT03221400|Vitamins|vitamins|mesh-ancestor
5909802|NCT03221400|Micronutrients|micronutrients|mesh-ancestor
5909803|NCT03221400|Hematinics|hematinics|mesh-ancestor
5909804|NCT03221400|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5909805|NCT03221400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5909806|NCT03199040|Durvalumab|durvalumab|mesh-list
5909807|NCT03199040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5909808|NCT03199040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5909809|NCT03197662|Oxytocin|oxytocin|mesh-list
5909810|NCT03197662|Oxytocics|oxytocics|mesh-ancestor
5909811|NCT03197662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5909812|NCT03197662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5909813|NCT03190941|Aldesleukin|aldesleukin|mesh-list
5909814|NCT03190941|Cyclophosphamide|cyclophosphamide|mesh-list
5909815|NCT03190941|Fludarabine|fludarabine|mesh-list
5909816|NCT03190941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5909817|NCT03190941|Immunologic Factors|immunologic factors|mesh-ancestor
5909818|NCT03190941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5909819|NCT03190941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5909820|NCT03190941|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5909821|NCT03190941|Alkylating Agents|alkylating agents|mesh-ancestor
5909822|NCT03190941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5909823|NCT03190941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5909824|NCT03190941|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5909825|NCT03190941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5909826|NCT03190941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5909827|NCT03190941|Antiviral Agents|antiviral agents|mesh-ancestor
6496572|NCT00628667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6496573|NCT00628667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5909828|NCT03190941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5698279|NCT03370380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5698280|NCT03370380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5698281|NCT03370380|Growth Substances|growth substances|mesh-ancestor
5698282|NCT03370380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698283|NCT03370380|Growth Inhibitors|growth inhibitors|mesh-ancestor
5698284|NCT03370380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5698285|NCT03370367|Tretinoin|tretinoin|mesh-list
5698286|NCT03370367|Isotretinoin|isotretinoin|mesh-list
5698287|NCT03370367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5698288|NCT03370367|Keratolytic Agents|keratolytic agents|mesh-ancestor
5698289|NCT03370367|Dermatologic Agents|dermatologic agents|mesh-ancestor
5698290|NCT03370328|Peppermint oil|peppermint oil|mesh-list
5698291|NCT03370328|Antiemetics|antiemetics|mesh-ancestor
5698292|NCT03370328|Autonomic Agents|autonomic agents|mesh-ancestor
5698293|NCT03370328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5698294|NCT03370328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698295|NCT03370328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5698296|NCT03370328|Parasympatholytics|parasympatholytics|mesh-ancestor
5698297|NCT03370276|Nivolumab|nivolumab|mesh-list
5698298|NCT03370276|Cetuximab|cetuximab|mesh-list
5698299|NCT03370276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5698300|NCT03370276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5698301|NCT03370276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5909829|NCT03150693|Cytarabine|cytarabine|mesh-list
5909830|NCT03150693|Dexamethasone|dexamethasone|mesh-list
5698302|NCT03370276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5698303|NCT03370159|Thioctic Acid|thioctic acid|mesh-list
5698304|NCT03370159|Docetaxel|docetaxel|mesh-list
5698305|NCT03370159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5698306|NCT03370159|Tubulin Modulators|tubulin modulators|mesh-ancestor
5698307|NCT03370159|Antimitotic Agents|antimitotic agents|mesh-ancestor
5698308|NCT03370159|Mitosis Modulators|mitosis modulators|mesh-ancestor
5698309|NCT03370159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5698310|NCT03370159|Antioxidants|antioxidants|mesh-ancestor
5698311|NCT03370159|Protective Agents|protective agents|mesh-ancestor
5698312|NCT03370159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698313|NCT03370159|Vitamin B Complex|vitamin b complex|mesh-ancestor
5698314|NCT03370159|Vitamins|vitamins|mesh-ancestor
5698315|NCT03370159|Micronutrients|micronutrients|mesh-ancestor
5720676|NCT03211286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5720677|NCT03211286|Hemostatics|hemostatics|mesh-ancestor
5720678|NCT03211286|Coagulants|coagulants|mesh-ancestor
5720679|NCT03211052|Leuprolide|leuprolide|mesh-list
5720680|NCT03211052|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5720681|NCT03211052|Fertility Agents|fertility agents|mesh-ancestor
5720682|NCT03211052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5720683|NCT03211052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720684|NCT03211052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5720685|NCT03211052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5720686|NCT03211104|Curcumin|curcumin|mesh-list
5720687|NCT03211104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5720688|NCT03211104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5720689|NCT03211104|Analgesics|analgesics|mesh-ancestor
5720690|NCT03211104|Sensory System Agents|sensory system agents|mesh-ancestor
5720691|NCT03211104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5909831|NCT03150693|Cyclophosphamide|cyclophosphamide|mesh-list
5909832|NCT03150693|Rituximab|rituximab|mesh-list
5909833|NCT03150693|Doxorubicin|doxorubicin|mesh-list
5909834|NCT03150693|Methotrexate|methotrexate|mesh-list
5909835|NCT03150693|Vincristine|vincristine|mesh-list
5909836|NCT03150693|Daunorubicin|daunorubicin|mesh-list
5909837|NCT03150693|Asparaginase|asparaginase|mesh-list
5909838|NCT03150693|Mercaptopurine|mercaptopurine|mesh-list
5909839|NCT03150693|Thioguanine|thioguanine|mesh-list
5909840|NCT03150693|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
5909841|NCT03150693|Pegaspargase|pegaspargase|mesh-list
5909842|NCT03150693|Allopurinol|allopurinol|mesh-list
5909843|NCT03150693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5909844|NCT03150693|Immunologic Factors|immunologic factors|mesh-ancestor
5909845|NCT03150693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496574|NCT00628680|Heparin|heparin|mesh-list
6496575|NCT00628680|Anticoagulants|anticoagulants|mesh-ancestor
5909846|NCT03150693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5909847|NCT03150693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5909848|NCT03150693|Alkylating Agents|alkylating agents|mesh-ancestor
5909849|NCT03150693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5909850|NCT03150693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5909851|NCT03150693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5909852|NCT03150693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5909853|NCT03150693|Antiemetics|antiemetics|mesh-ancestor
5909854|NCT03150693|Autonomic Agents|autonomic agents|mesh-ancestor
5909855|NCT03150693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5909856|NCT03150693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5909857|NCT03150693|Glucocorticoids|glucocorticoids|mesh-ancestor
5909858|NCT03150693|Hormones|hormones|mesh-ancestor
5909859|NCT03150693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5909860|NCT03150693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5909861|NCT03150693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5909862|NCT03150693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5909863|NCT03150693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5909864|NCT03150693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5909865|NCT03150693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5909866|NCT03150693|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5909867|NCT03150693|Abortifacient Agents|abortifacient agents|mesh-ancestor
5909868|NCT03150693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5909869|NCT03150693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5720692|NCT03211104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720693|NCT03211104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5720694|NCT03211104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5909870|NCT03150693|Antimetabolites|antimetabolites|mesh-ancestor
5909871|NCT03150693|Dermatologic Agents|dermatologic agents|mesh-ancestor
6496576|NCT00628680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6496577|NCT00628680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5909872|NCT03150693|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5909873|NCT03150693|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5909874|NCT03150693|Antiviral Agents|antiviral agents|mesh-ancestor
5909875|NCT03150693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5909876|NCT03150693|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5909877|NCT03150693|Tubulin Modulators|tubulin modulators|mesh-ancestor
5909878|NCT03150693|Antimitotic Agents|antimitotic agents|mesh-ancestor
5909879|NCT03150693|Mitosis Modulators|mitosis modulators|mesh-ancestor
5909880|NCT03150693|Gout Suppressants|gout suppressants|mesh-ancestor
5909881|NCT03150693|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5909882|NCT03150693|Antioxidants|antioxidants|mesh-ancestor
5909883|NCT03150693|Protective Agents|protective agents|mesh-ancestor
5909884|NCT03148418|Atezolizumab|atezolizumab|mesh-list
5909885|NCT03148418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5909886|NCT03138720|Gemcitabine|gemcitabine|mesh-list
5909887|NCT03138720|Paclitaxel|paclitaxel|mesh-list
5909888|NCT03138720|Cisplatin|cisplatin|mesh-list
5909889|NCT03138720|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5909890|NCT03138720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5909891|NCT03138720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5909892|NCT03138720|Tubulin Modulators|tubulin modulators|mesh-ancestor
5909893|NCT03138720|Antimitotic Agents|antimitotic agents|mesh-ancestor
5909894|NCT03138720|Mitosis Modulators|mitosis modulators|mesh-ancestor
5909895|NCT03138720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5909896|NCT03138720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5909897|NCT03138720|Antimetabolites|antimetabolites|mesh-ancestor
5909898|NCT03138720|Antiviral Agents|antiviral agents|mesh-ancestor
5909899|NCT03138720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5909900|NCT03138720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5909901|NCT03138720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5909902|NCT03138720|Immunologic Factors|immunologic factors|mesh-ancestor
5909903|NCT03138720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5909904|NCT03137888|Temozolomide|temozolomide|mesh-list
5909905|NCT03137888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5909906|NCT03137888|Alkylating Agents|alkylating agents|mesh-ancestor
5909907|NCT03137888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5909908|NCT03137888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5909909|NCT03136809|Copper|copper|mesh-list
5909910|NCT03136809|Trace Elements|trace elements|mesh-ancestor
5909911|NCT03136809|Micronutrients|micronutrients|mesh-ancestor
5909912|NCT03136809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5909913|NCT03132467|Durvalumab|durvalumab|mesh-list
5909914|NCT03132467|Ipilimumab|ipilimumab|mesh-list
5909915|NCT03132467|Tremelimumab|tremelimumab|mesh-list
5909916|NCT03132467|Immunoglobulins|immunoglobulins|mesh-list
5909917|NCT03132467|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5909918|NCT03132467|Immunoglobulin G|immunoglobulin g|mesh-list
5909919|NCT03132467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5909920|NCT03132467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5909921|NCT03132467|Immunologic Factors|immunologic factors|mesh-ancestor
5909922|NCT03132467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5909923|NCT03132467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5909924|NCT03132467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5909925|NCT03107988|Cyclophosphamide|cyclophosphamide|mesh-list
5909926|NCT03107988|Topotecan|topotecan|mesh-list
5909927|NCT03107988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5909928|NCT03107988|Immunologic Factors|immunologic factors|mesh-ancestor
5909929|NCT03107988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5909930|NCT03107988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5909931|NCT03107988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5909932|NCT03107988|Alkylating Agents|alkylating agents|mesh-ancestor
5909933|NCT03107988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5909934|NCT03107988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5909935|NCT03107988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5909936|NCT03107988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5909937|NCT03107988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5909938|NCT03107988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5909939|NCT03096288|Evolocumab|evolocumab|mesh-list
5909940|NCT03096288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5909941|NCT03096288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5909942|NCT03096288|Antimetabolites|antimetabolites|mesh-ancestor
5909943|NCT03096288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5909944|NCT03096288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5909945|NCT03090165|Bicalutamide|bicalutamide|mesh-list
5909946|NCT03090165|Androgen Antagonists|androgen antagonists|mesh-ancestor
5909947|NCT03090165|Hormone Antagonists|hormone antagonists|mesh-ancestor
5962842|NCT04607629|Respiratory System Agents|respiratory system agents|mesh-ancestor
5698316|NCT03369990|Botulinum Toxins|botulinum toxins|mesh-list
5698317|NCT03369990|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5698318|NCT03369990|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5698319|NCT03369990|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5909948|NCT03090165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5909949|NCT03090165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5909950|NCT03090165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5909951|NCT03081156|Glycopyrrolate|glycopyrrolate|mesh-list
5909952|NCT03081156|Formoterol Fumarate|formoterol fumarate|mesh-list
5909953|NCT03081156|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5909954|NCT03081156|Autonomic Agents|autonomic agents|mesh-ancestor
5909955|NCT03081156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5909956|NCT03081156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5909957|NCT03081156|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5909958|NCT03081156|Respiratory System Agents|respiratory system agents|mesh-ancestor
5909959|NCT03081156|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5909960|NCT03081156|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5698320|NCT03369990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5698321|NCT03369990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5698322|NCT03369990|Cholinergic Agents|cholinergic agents|mesh-ancestor
5698323|NCT03369990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5698324|NCT03369990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698325|NCT03369990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5698326|NCT03369990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5698327|NCT03369964|Atezolizumab|atezolizumab|mesh-list
5698328|NCT03369964|Obinutuzumab|obinutuzumab|mesh-list
5698329|NCT03369964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5698330|NCT03369964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5698331|NCT03369925|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
5698332|NCT03369925|Nootropic Agents|nootropic agents|mesh-ancestor
5909961|NCT03081156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5909962|NCT03081156|Adrenergic Agents|adrenergic agents|mesh-ancestor
5909963|NCT03081156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5909964|NCT03081156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5909965|NCT03081156|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5909966|NCT03081156|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5909967|NCT03081156|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5909968|NCT03081156|Cholinergic Agents|cholinergic agents|mesh-ancestor
5909969|NCT03041688|Decitabine|decitabine|mesh-list
5909970|NCT03041688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5909971|NCT03041688|Antimetabolites|antimetabolites|mesh-ancestor
5909972|NCT03041688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5909973|NCT03041688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5909974|NCT03041688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5909975|NCT02942290|Azacitidine|azacitidine|mesh-list
5909976|NCT02942290|Venetoclax|venetoclax|mesh-list
5909977|NCT02942290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5909978|NCT02942290|Antimetabolites|antimetabolites|mesh-ancestor
5909979|NCT02942290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5909980|NCT02942290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5909981|NCT02942290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5909982|NCT02919436|Tamsulosin|tamsulosin|mesh-list
5909983|NCT02919436|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5909984|NCT02919436|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5909985|NCT02919436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5909986|NCT02919436|Adrenergic Agents|adrenergic agents|mesh-ancestor
5909987|NCT02919436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5698333|NCT03369847|Budesonide|budesonide|mesh-list
5698334|NCT03369847|Beclomethasone|beclomethasone|mesh-list
5698335|NCT03369847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5698336|NCT03369847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5698337|NCT03369847|Autonomic Agents|autonomic agents|mesh-ancestor
5698338|NCT03369847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5698339|NCT03369847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698340|NCT03369847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5698341|NCT03369847|Respiratory System Agents|respiratory system agents|mesh-ancestor
5698342|NCT03369847|Glucocorticoids|glucocorticoids|mesh-ancestor
5698343|NCT03369847|Hormones|hormones|mesh-ancestor
5698344|NCT03369847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5698345|NCT03369808|Aluminum Hydroxide|aluminum hydroxide|mesh-list
5698346|NCT03369808|Vaccines|vaccines|mesh-list
5698347|NCT03369808|Immunologic Factors|immunologic factors|mesh-ancestor
5698348|NCT03369808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698349|NCT03369808|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5909988|NCT02919436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5909989|NCT02919436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5909990|NCT02919436|Urological Agents|urological agents|mesh-ancestor
5909991|NCT02879136|Methylphenidate|methylphenidate|mesh-list
5909992|NCT02879136|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
5909993|NCT02879136|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5909994|NCT02879136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5909995|NCT02879136|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5909996|NCT02879136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5909997|NCT02879136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5909998|NCT02879136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5909999|NCT02879136|Dopamine Agents|dopamine agents|mesh-ancestor
5910000|NCT02879136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5910001|NCT02879136|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5910002|NCT02879136|Adrenergic Agents|adrenergic agents|mesh-ancestor
5910003|NCT02877134|Ustekinumab|ustekinumab|mesh-list
5910004|NCT02877134|Dermatologic Agents|dermatologic agents|mesh-ancestor
5910005|NCT02875314|Cyclophosphamide|cyclophosphamide|mesh-list
5910006|NCT02875314|Thiotepa|thiotepa|mesh-list
5910007|NCT02875314|Cisplatin|cisplatin|mesh-list
5910008|NCT02875314|Carboplatin|carboplatin|mesh-list
5910009|NCT02875314|Methotrexate|methotrexate|mesh-list
5910010|NCT02875314|Etoposide|etoposide|mesh-list
5910011|NCT02875314|Etoposide phosphate|etoposide phosphate|mesh-list
5910012|NCT02875314|Vincristine|vincristine|mesh-list
5910013|NCT02875314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5910014|NCT02875314|Immunologic Factors|immunologic factors|mesh-ancestor
5910015|NCT02875314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5910016|NCT02875314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5910017|NCT02875314|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5910018|NCT02875314|Alkylating Agents|alkylating agents|mesh-ancestor
5910019|NCT02875314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910020|NCT02875314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5910021|NCT02875314|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5910022|NCT02875314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5910023|NCT02875314|Abortifacient Agents|abortifacient agents|mesh-ancestor
5910024|NCT02875314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5910025|NCT02875314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5910026|NCT02875314|Antimetabolites|antimetabolites|mesh-ancestor
5698350|NCT03369808|Antacids|antacids|mesh-ancestor
5698351|NCT03369808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5698352|NCT03369808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5698353|NCT03369795|Methotrexate|methotrexate|mesh-list
5698354|NCT03369795|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5698355|NCT03369795|Abortifacient Agents|abortifacient agents|mesh-ancestor
5698356|NCT03369795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5698357|NCT03369795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698358|NCT03369795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5698359|NCT03369795|Antimetabolites|antimetabolites|mesh-ancestor
5698360|NCT03369795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910027|NCT02875314|Dermatologic Agents|dermatologic agents|mesh-ancestor
5910028|NCT02875314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5910029|NCT02875314|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5910030|NCT02875314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5910031|NCT02875314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5910032|NCT02875314|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5910033|NCT02875314|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5910034|NCT02875314|Tubulin Modulators|tubulin modulators|mesh-ancestor
5910035|NCT02875314|Antimitotic Agents|antimitotic agents|mesh-ancestor
5910036|NCT02875314|Mitosis Modulators|mitosis modulators|mesh-ancestor
5910037|NCT02875132|Pembrolizumab|pembrolizumab|mesh-list
5910038|NCT02875132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5910039|NCT02875132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5698361|NCT03369795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5698362|NCT03369795|Dermatologic Agents|dermatologic agents|mesh-ancestor
5698363|NCT03369795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5698364|NCT03369795|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5698365|NCT03369795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5698366|NCT03369795|Immunologic Factors|immunologic factors|mesh-ancestor
5698367|NCT03369795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5698368|NCT03369795|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5698369|NCT03369782|Rocuronium|rocuronium|mesh-list
5698370|NCT03369782|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5698371|NCT03369782|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5698372|NCT03369782|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5698373|NCT03369782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5698374|NCT03369782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698375|NCT03369574|Reslizumab|reslizumab|mesh-list
5698376|NCT03369574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5698377|NCT03369574|Respiratory System Agents|respiratory system agents|mesh-ancestor
5698378|NCT03369379|Cholecalciferol|cholecalciferol|mesh-list
5698379|NCT03369379|Vitamins|vitamins|mesh-ancestor
5910056|NCT02741323|Maraviroc|maraviroc|mesh-list
5910057|NCT02741323|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5910058|NCT02741323|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5910059|NCT02741323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910060|NCT02741323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5910061|NCT02741323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5910062|NCT02741323|Antiviral Agents|antiviral agents|mesh-ancestor
5910063|NCT02741323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5910064|NCT02741323|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
5698380|NCT03369379|Micronutrients|micronutrients|mesh-ancestor
5698381|NCT03369379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698382|NCT03369379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5698383|NCT03369379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5698384|NCT03369327|Sofosbuvir|sofosbuvir|mesh-list
5698385|NCT03369327|Antiviral Agents|antiviral agents|mesh-ancestor
5698386|NCT03369327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5910088|NCT02555787|Tacrolimus|tacrolimus|mesh-list
5910089|NCT02555787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5910090|NCT02555787|Immunologic Factors|immunologic factors|mesh-ancestor
5910091|NCT02555787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5910092|NCT02555787|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5910093|NCT02555787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5910094|NCT02555787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910095|NCT02543983|Ketamine|ketamine|mesh-list
5910096|NCT02543983|Analgesics|analgesics|mesh-ancestor
5910097|NCT02543983|Sensory System Agents|sensory system agents|mesh-ancestor
5910098|NCT02543983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6496578|NCT00628680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496579|NCT00628706|Dronabinol|dronabinol|mesh-list
6496580|NCT00628706|Hallucinogens|hallucinogens|mesh-ancestor
6496581|NCT00628706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496582|NCT00628706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6496583|NCT00628706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6496584|NCT00628706|Analgesics|analgesics|mesh-ancestor
6496585|NCT00628706|Sensory System Agents|sensory system agents|mesh-ancestor
6496586|NCT00628706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6496587|NCT00628706|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5698392|NCT03369262|Atosiban|atosiban|mesh-list
5698393|NCT03369262|Hormone Antagonists|hormone antagonists|mesh-ancestor
5698394|NCT03369262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5698395|NCT03369262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698396|NCT03369262|Tocolytic Agents|tocolytic agents|mesh-ancestor
5698397|NCT03369262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5698398|NCT03369119|Montelukast|montelukast|mesh-list
5698399|NCT03369119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6496588|NCT00628706|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6496589|NCT00628706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6496590|NCT00628706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496591|NCT00628706|Hormones|hormones|mesh-ancestor
6496592|NCT00628706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6496593|NCT00628719|Amphotericin B|amphotericin b|mesh-list
6496594|NCT00628719|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6496595|NCT00628719|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
5910099|NCT02543983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5910100|NCT02543983|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5910101|NCT02543983|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5910102|NCT02543983|Anesthetics, General|anesthetics, general|mesh-ancestor
5910103|NCT02543983|Anesthetics|anesthetics|mesh-ancestor
5910104|NCT02543983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5910105|NCT02543983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5910106|NCT02543983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5910107|NCT02543983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5910108|NCT02543983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910109|NCT02511028|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
5910110|NCT02511028|Hematinics|hematinics|mesh-ancestor
5910111|NCT02511028|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5910112|NCT02511028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5910113|NCT02502266|Paclitaxel|paclitaxel|mesh-list
5910114|NCT02502266|Doxorubicin|doxorubicin|mesh-list
5910115|NCT02502266|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5910116|NCT02502266|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5910117|NCT02502266|Topotecan|topotecan|mesh-list
5910118|NCT02502266|Olaparib|olaparib|mesh-list
5910119|NCT02502266|Cediranib|cediranib|mesh-list
5910120|NCT02502266|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
5910121|NCT02502266|Maleic acid|maleic acid|mesh-list
5910122|NCT02502266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5910123|NCT02502266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5910124|NCT02502266|Tubulin Modulators|tubulin modulators|mesh-ancestor
5910125|NCT02502266|Antimitotic Agents|antimitotic agents|mesh-ancestor
5910126|NCT02502266|Mitosis Modulators|mitosis modulators|mesh-ancestor
5910127|NCT02502266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910128|NCT02502266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5910129|NCT02502266|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5910130|NCT02502266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5910131|NCT02502266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5910132|NCT02502266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5910133|NCT02502266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5910134|NCT02500407|Atezolizumab|atezolizumab|mesh-list
5910135|NCT02500407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5910136|NCT02446600|Gemcitabine|gemcitabine|mesh-list
5910137|NCT02446600|Paclitaxel|paclitaxel|mesh-list
5910138|NCT02446600|Carboplatin|carboplatin|mesh-list
5910139|NCT02446600|Doxorubicin|doxorubicin|mesh-list
5910140|NCT02446600|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5910141|NCT02446600|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5698400|NCT03369119|Respiratory System Agents|respiratory system agents|mesh-ancestor
5910142|NCT02446600|Olaparib|olaparib|mesh-list
5910143|NCT02446600|Cediranib|cediranib|mesh-list
5910144|NCT02446600|Maleic acid|maleic acid|mesh-list
5698401|NCT03369119|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5910145|NCT02446600|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5910146|NCT02446600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5910147|NCT02446600|Tubulin Modulators|tubulin modulators|mesh-ancestor
5910148|NCT02446600|Antimitotic Agents|antimitotic agents|mesh-ancestor
5910149|NCT02446600|Mitosis Modulators|mitosis modulators|mesh-ancestor
5910150|NCT02446600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910151|NCT02446600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5910152|NCT02446600|Antimetabolites|antimetabolites|mesh-ancestor
5910153|NCT02446600|Antiviral Agents|antiviral agents|mesh-ancestor
5910154|NCT02446600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5698402|NCT03369119|Hormone Antagonists|hormone antagonists|mesh-ancestor
5698403|NCT03369119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5698404|NCT03369119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698405|NCT03369119|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5698406|NCT03369119|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5910155|NCT02446600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5910156|NCT02446600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5910157|NCT02446600|Immunologic Factors|immunologic factors|mesh-ancestor
5910158|NCT02446600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5910159|NCT02446600|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5910160|NCT02446600|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5910161|NCT02446600|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5910162|NCT02446600|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5910163|NCT02446600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5910164|NCT02408861|Nivolumab|nivolumab|mesh-list
5910165|NCT02408861|Ipilimumab|ipilimumab|mesh-list
5698407|NCT03369119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5698408|NCT03369093|Amoxicillin|amoxicillin|mesh-list
5698409|NCT03369093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5698410|NCT03369093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5698411|NCT03369067|Insulin|insulin|mesh-list
5698412|NCT03369067|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5698413|NCT03369067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5698414|NCT03369067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698415|NCT03369015|Amphetamine|amphetamine|mesh-list
5910166|NCT02408861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5910167|NCT02408861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5910168|NCT02408861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5910169|NCT02408861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910170|NCT02375204|Paclitaxel|paclitaxel|mesh-list
5910171|NCT02375204|Etoposide|etoposide|mesh-list
5910172|NCT02375204|Carboplatin|carboplatin|mesh-list
5910173|NCT02375204|Ifosfamide|ifosfamide|mesh-list
5910174|NCT02375204|Etoposide phosphate|etoposide phosphate|mesh-list
5910175|NCT02375204|Lenograstim|lenograstim|mesh-list
5910176|NCT02375204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5910177|NCT02375204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5910178|NCT02375204|Tubulin Modulators|tubulin modulators|mesh-ancestor
5910179|NCT02375204|Antimitotic Agents|antimitotic agents|mesh-ancestor
5910180|NCT02375204|Mitosis Modulators|mitosis modulators|mesh-ancestor
5910181|NCT02375204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496596|NCT00628719|Deoxycholic Acid|deoxycholic acid|mesh-list
6496597|NCT00628719|Amebicides|amebicides|mesh-ancestor
6496598|NCT00628719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6496599|NCT00628719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6496600|NCT00628719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6496601|NCT00628719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6496602|NCT00628719|Antifungal Agents|antifungal agents|mesh-ancestor
6496603|NCT00628719|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6496604|NCT00628719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6496605|NCT00628732|Cyclophosphamide|cyclophosphamide|mesh-list
6496606|NCT00628732|Topotecan|topotecan|mesh-list
6496607|NCT00628732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6496608|NCT00628732|Immunologic Factors|immunologic factors|mesh-ancestor
5698416|NCT03369015|Dextroamphetamine|dextroamphetamine|mesh-list
5910182|NCT02375204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5910183|NCT02375204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5910184|NCT02375204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5910185|NCT02375204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5910186|NCT02375204|Immunologic Factors|immunologic factors|mesh-ancestor
5910187|NCT02375204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5910188|NCT02375204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5910189|NCT02375204|Alkylating Agents|alkylating agents|mesh-ancestor
5910190|NCT02178436|Gemcitabine|gemcitabine|mesh-list
5910191|NCT02178436|Paclitaxel|paclitaxel|mesh-list
5910192|NCT02178436|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5910193|NCT02178436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5910194|NCT02178436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5910195|NCT02178436|Tubulin Modulators|tubulin modulators|mesh-ancestor
5910196|NCT02178436|Antimitotic Agents|antimitotic agents|mesh-ancestor
5910197|NCT02178436|Mitosis Modulators|mitosis modulators|mesh-ancestor
5910198|NCT02178436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910199|NCT02178436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5910200|NCT02178436|Antimetabolites|antimetabolites|mesh-ancestor
5910201|NCT02178436|Antiviral Agents|antiviral agents|mesh-ancestor
5910202|NCT02178436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5910203|NCT02178436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5910204|NCT02178436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5910205|NCT02178436|Immunologic Factors|immunologic factors|mesh-ancestor
5910206|NCT02178436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5910207|NCT02135484|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
5698417|NCT03369015|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5698418|NCT03369015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698419|NCT03369015|Sympathomimetics|sympathomimetics|mesh-ancestor
5698420|NCT03369015|Autonomic Agents|autonomic agents|mesh-ancestor
5698421|NCT03369015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5698422|NCT03369015|Dopamine Agents|dopamine agents|mesh-ancestor
5698423|NCT03369015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5698424|NCT03369015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5698425|NCT03369015|Adrenergic Agents|adrenergic agents|mesh-ancestor
5698426|NCT03369015|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5698427|NCT03369015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5698428|NCT03369015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5698429|NCT03369015|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5698430|NCT03369002|Seladelpar|seladelpar|mesh-list
5698431|NCT03369002|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5698432|NCT03369002|Antimetabolites|antimetabolites|mesh-ancestor
5698433|NCT03369002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5698434|NCT03369002|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5698435|NCT03368989|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
5698436|NCT03368989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5698437|NCT03368794|Analgesics, Opioid|analgesics, opioid|mesh-list
5698438|NCT03368794|Narcotics|narcotics|mesh-ancestor
5698439|NCT03368794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5698440|NCT03368794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698441|NCT03368794|Analgesics|analgesics|mesh-ancestor
5698442|NCT03368794|Sensory System Agents|sensory system agents|mesh-ancestor
5698443|NCT03368794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5698444|NCT03368664|Interferons|interferons|mesh-list
5698445|NCT03368664|Acyclovir|acyclovir|mesh-list
5698446|NCT03368664|Interferon-beta|interferon-beta|mesh-list
5698447|NCT03368664|Methylprednisolone|methylprednisolone|mesh-list
5698448|NCT03368664|Prednisolone|prednisolone|mesh-list
5698449|NCT03368664|Alemtuzumab|alemtuzumab|mesh-list
5698450|NCT03368664|Glatiramer Acetate|glatiramer acetate|mesh-list
5698451|NCT03368664|Ranitidine|ranitidine|mesh-list
5698452|NCT03368664|(T,G)-A-L|(t,g)-a-l|mesh-list
5698453|NCT03368664|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
5698454|NCT03368664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5698455|NCT03368664|Antiviral Agents|antiviral agents|mesh-ancestor
5698456|NCT03368664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5698457|NCT03368664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5698458|NCT03368664|Antiemetics|antiemetics|mesh-ancestor
5698459|NCT03368664|Autonomic Agents|autonomic agents|mesh-ancestor
5698460|NCT03368664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5698461|NCT03368664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698462|NCT03368664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5698463|NCT03368664|Glucocorticoids|glucocorticoids|mesh-ancestor
5698464|NCT03368664|Hormones|hormones|mesh-ancestor
5720695|NCT03211104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5910208|NCT02135484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5910209|NCT02133196|Aldesleukin|aldesleukin|mesh-list
5910210|NCT02133196|Cyclophosphamide|cyclophosphamide|mesh-list
5910211|NCT02133196|Fludarabine|fludarabine|mesh-list
5910212|NCT02133196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5910213|NCT02133196|Immunologic Factors|immunologic factors|mesh-ancestor
5910214|NCT02133196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5910215|NCT02133196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5910216|NCT02133196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5910217|NCT02133196|Alkylating Agents|alkylating agents|mesh-ancestor
5910218|NCT02133196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910219|NCT02133196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5910220|NCT02133196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5910221|NCT02133196|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5910222|NCT02133196|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5910223|NCT02133196|Antiviral Agents|antiviral agents|mesh-ancestor
5910224|NCT02133196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5910225|NCT02091960|Trastuzumab|trastuzumab|mesh-list
5910226|NCT02091960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5910227|NCT02091960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5910228|NCT02086604|Lenalidomide|lenalidomide|mesh-list
5910229|NCT02086604|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5910230|NCT02086604|Immunologic Factors|immunologic factors|mesh-ancestor
5910231|NCT02086604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5910232|NCT02086604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5910233|NCT02086604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5910234|NCT02086604|Growth Substances|growth substances|mesh-ancestor
5910235|NCT02086604|Growth Inhibitors|growth inhibitors|mesh-ancestor
5910236|NCT02086604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5910237|NCT02086604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5962843|NCT04607629|Glucocorticoids|glucocorticoids|mesh-ancestor
5962844|NCT04607629|Hormones|hormones|mesh-ancestor
5962845|NCT04607629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5962846|NCT04607629|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5962847|NCT04607629|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5962848|NCT04607629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5962849|NCT04607629|Adrenergic Agents|adrenergic agents|mesh-ancestor
5962850|NCT04607629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5962851|NCT04607629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962852|NCT04607629|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5962853|NCT04607629|Immunologic Factors|immunologic factors|mesh-ancestor
5962854|NCT04607603|Cannabidiol|cannabidiol|mesh-list
5962855|NCT04607603|Anticonvulsants|anticonvulsants|mesh-ancestor
5962856|NCT04607447|Dexamethasone|dexamethasone|mesh-list
5962857|NCT04607447|Atorvastatin|atorvastatin|mesh-list
5962858|NCT04607447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5962859|NCT04607447|Antiemetics|antiemetics|mesh-ancestor
5962860|NCT04607447|Autonomic Agents|autonomic agents|mesh-ancestor
5698465|NCT03368664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5698466|NCT03368664|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5698467|NCT03368664|Protective Agents|protective agents|mesh-ancestor
5698468|NCT03368664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5698469|NCT03368664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5698470|NCT03368664|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5698471|NCT03368664|Immunologic Factors|immunologic factors|mesh-ancestor
5698472|NCT03368664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5698473|NCT03368664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5698474|NCT03368664|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5698475|NCT03368664|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5698476|NCT03368664|Histamine Antagonists|histamine antagonists|mesh-ancestor
5698477|NCT03368664|Histamine Agents|histamine agents|mesh-ancestor
5962861|NCT04607447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5962862|NCT04607447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962863|NCT04607447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5962864|NCT04607447|Glucocorticoids|glucocorticoids|mesh-ancestor
5962865|NCT04607447|Hormones|hormones|mesh-ancestor
5962866|NCT04607447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5962867|NCT04607447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5962868|NCT04607447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5962869|NCT04607447|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5962870|NCT04607447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5962871|NCT04607447|Antimetabolites|antimetabolites|mesh-ancestor
5962872|NCT04607447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962873|NCT04607447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6242818|NCT02656329|Hemostatics|hemostatics|mesh-ancestor
5910238|NCT01983774|Esomeprazole|esomeprazole|mesh-list
5910239|NCT01983774|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5910240|NCT01983774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5910241|NCT01983774|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5910242|NCT01983774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5910243|NCT01983774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910244|NCT01970865|Crizotinib|crizotinib|mesh-list
5698478|NCT03368664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5698479|NCT03368664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5698480|NCT03368664|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5698481|NCT03368547|Edetic Acid|edetic acid|mesh-list
5698482|NCT03368547|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5698483|NCT03368547|Chelating Agents|chelating agents|mesh-ancestor
5910245|NCT01970865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5910246|NCT01970865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5910247|NCT01970865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5910248|NCT01970865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910249|NCT01961375|Levonorgestrel|levonorgestrel|mesh-list
5910250|NCT01961375|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5910251|NCT01961375|Contraceptive Agents|contraceptive agents|mesh-ancestor
5910252|NCT01961375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5910253|NCT01961375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5910254|NCT01961375|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5910255|NCT01961375|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5910256|NCT01961375|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5910257|NCT01950390|Bevacizumab|bevacizumab|mesh-list
5910258|NCT01950390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5910259|NCT01950390|Ipilimumab|ipilimumab|mesh-list
5910260|NCT01950390|Endothelial Growth Factors|endothelial growth factors|mesh-list
5910261|NCT01950390|Antibodies|antibodies|mesh-list
5910262|NCT01950390|Immunoglobulins|immunoglobulins|mesh-list
5910263|NCT01950390|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5910264|NCT01950390|Immunoglobulin G|immunoglobulin g|mesh-list
5910265|NCT01950390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5910266|NCT01950390|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5910267|NCT01950390|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5910268|NCT01950390|Growth Substances|growth substances|mesh-ancestor
5910269|NCT01950390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5910270|NCT01950390|Growth Inhibitors|growth inhibitors|mesh-ancestor
5910271|NCT01950390|Immunologic Factors|immunologic factors|mesh-ancestor
5910272|NCT01950390|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5910273|NCT01950390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910274|NCT01905046|Metformin|metformin|mesh-list
5910275|NCT01905046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5910276|NCT01905046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5910277|NCT01896531|Leucovorin|leucovorin|mesh-list
5910278|NCT01896531|Fluorouracil|fluorouracil|mesh-list
5910279|NCT01896531|Oxaliplatin|oxaliplatin|mesh-list
5910280|NCT01896531|Antimetabolites|antimetabolites|mesh-ancestor
5910281|NCT01896531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910282|NCT01896531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5698484|NCT03368547|Sequestering Agents|sequestering agents|mesh-ancestor
5698485|NCT03368547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5698486|NCT03368547|Anticoagulants|anticoagulants|mesh-ancestor
5698487|NCT03368547|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5698488|NCT03368547|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5698489|NCT03368430|Melatonin|melatonin|mesh-list
5698490|NCT03368430|Antioxidants|antioxidants|mesh-ancestor
5698491|NCT03368430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5698492|NCT03368430|Protective Agents|protective agents|mesh-ancestor
5698493|NCT03368430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698494|NCT03368430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5698495|NCT03368404|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5698496|NCT03368404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5698497|NCT03368391|Lidocaine|lidocaine|mesh-list
5698498|NCT03368391|Phenylephrine|phenylephrine|mesh-list
5698499|NCT03368391|Epinephrine|epinephrine|mesh-list
5698500|NCT03368391|Racepinephrine|racepinephrine|mesh-list
5910283|NCT01896531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5910284|NCT01896531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5910285|NCT01896531|Immunologic Factors|immunologic factors|mesh-ancestor
5910286|NCT01896531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5910287|NCT01896531|Antidotes|antidotes|mesh-ancestor
5910288|NCT01896531|Protective Agents|protective agents|mesh-ancestor
5910289|NCT01896531|Vitamin B Complex|vitamin b complex|mesh-ancestor
5698501|NCT03368391|Oxymetazoline|oxymetazoline|mesh-list
5698502|NCT03368391|Tetracaine|tetracaine|mesh-list
5910290|NCT01896531|Vitamins|vitamins|mesh-ancestor
5910291|NCT01896531|Micronutrients|micronutrients|mesh-ancestor
5910292|NCT01856192|Prednisone|prednisone|mesh-list
5910293|NCT01856192|Cortisone|cortisone|mesh-list
5910294|NCT01856192|Cyclophosphamide|cyclophosphamide|mesh-list
5910295|NCT01856192|Rituximab|rituximab|mesh-list
5910296|NCT01856192|Doxorubicin|doxorubicin|mesh-list
5910297|NCT01856192|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5910298|NCT01856192|Vincristine|vincristine|mesh-list
5910299|NCT01856192|Lenalidomide|lenalidomide|mesh-list
5910300|NCT01856192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5910301|NCT01856192|Antibodies|antibodies|mesh-list
5910302|NCT01856192|Immunoglobulins|immunoglobulins|mesh-list
5910303|NCT01856192|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5910304|NCT01856192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5910305|NCT01856192|Immunologic Factors|immunologic factors|mesh-ancestor
5910306|NCT01856192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5910307|NCT01856192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5910308|NCT01856192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5910309|NCT01856192|Alkylating Agents|alkylating agents|mesh-ancestor
5910310|NCT01856192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910311|NCT01856192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5910312|NCT01856192|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5910313|NCT01856192|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5910314|NCT01856192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5910315|NCT01856192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5910316|NCT01856192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5910317|NCT01856192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5910318|NCT01856192|Glucocorticoids|glucocorticoids|mesh-ancestor
5910319|NCT01856192|Hormones|hormones|mesh-ancestor
5910320|NCT01856192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5910321|NCT01856192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5910322|NCT01856192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5910323|NCT01856192|Tubulin Modulators|tubulin modulators|mesh-ancestor
5910324|NCT01856192|Antimitotic Agents|antimitotic agents|mesh-ancestor
5910325|NCT01856192|Mitosis Modulators|mitosis modulators|mesh-ancestor
5910326|NCT01856192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5910327|NCT01856192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5910328|NCT01856192|Growth Substances|growth substances|mesh-ancestor
5910329|NCT01856192|Growth Inhibitors|growth inhibitors|mesh-ancestor
5910330|NCT01622868|Lapatinib|lapatinib|mesh-list
5910331|NCT01622868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5910332|NCT01622868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5910333|NCT01622868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5910334|NCT01622868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910335|NCT01592370|Dexamethasone|dexamethasone|mesh-list
5910336|NCT01592370|Nivolumab|nivolumab|mesh-list
5910337|NCT01592370|Ipilimumab|ipilimumab|mesh-list
5910338|NCT01592370|Daratumumab|daratumumab|mesh-list
5910339|NCT01592370|Pomalidomide|pomalidomide|mesh-list
5910340|NCT01592370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5910341|NCT01592370|Antiemetics|antiemetics|mesh-ancestor
5910342|NCT01592370|Autonomic Agents|autonomic agents|mesh-ancestor
5910343|NCT01592370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5910344|NCT01592370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5910345|NCT01592370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5910346|NCT01592370|Glucocorticoids|glucocorticoids|mesh-ancestor
5910347|NCT01592370|Hormones|hormones|mesh-ancestor
5910348|NCT01592370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5910349|NCT01592370|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5910350|NCT01592370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5910351|NCT01592370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5910352|NCT01592370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5910353|NCT01592370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910354|NCT01592370|Immunologic Factors|immunologic factors|mesh-ancestor
5910355|NCT01592370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5910356|NCT01592370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5910357|NCT01592370|Growth Substances|growth substances|mesh-ancestor
5910358|NCT01592370|Growth Inhibitors|growth inhibitors|mesh-ancestor
5910359|NCT01554410|Gemcitabine|gemcitabine|mesh-list
5910360|NCT01554410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5910361|NCT01554410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5910362|NCT01554410|Antimetabolites|antimetabolites|mesh-ancestor
5910363|NCT01554410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910364|NCT01554410|Antiviral Agents|antiviral agents|mesh-ancestor
5910365|NCT01554410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5910366|NCT01554410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5698503|NCT03368391|Mepivacaine|mepivacaine|mesh-list
5698504|NCT03368391|Epinephryl borate|epinephryl borate|mesh-list
5698505|NCT03368391|Anesthetics, Local|anesthetics, local|mesh-ancestor
5698506|NCT03368391|Anesthetics|anesthetics|mesh-ancestor
5698507|NCT03368391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5698508|NCT03368391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5910367|NCT01554410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5910368|NCT01554410|Immunologic Factors|immunologic factors|mesh-ancestor
5910369|NCT01554410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698509|NCT03368391|Sensory System Agents|sensory system agents|mesh-ancestor
5698510|NCT03368391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5698511|NCT03368391|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5698512|NCT03368391|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5698513|NCT03368391|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5698514|NCT03368391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5698515|NCT03368391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5698516|NCT03368391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5698517|NCT03368391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5698518|NCT03368391|Adrenergic Agents|adrenergic agents|mesh-ancestor
5698519|NCT03368391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5698520|NCT03368391|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5698521|NCT03368391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5698522|NCT03368391|Autonomic Agents|autonomic agents|mesh-ancestor
5910370|NCT01499888|Sirolimus|sirolimus|mesh-list
5910371|NCT01499888|Alemtuzumab|alemtuzumab|mesh-list
5910372|NCT01499888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5910373|NCT01499888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5910374|NCT01499888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5910375|NCT01499888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5910376|NCT01499888|Antifungal Agents|antifungal agents|mesh-ancestor
5910377|NCT01499888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5910378|NCT01499888|Immunologic Factors|immunologic factors|mesh-ancestor
5910379|NCT01499888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5910380|NCT01499888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5698523|NCT03368391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5698524|NCT03368391|Respiratory System Agents|respiratory system agents|mesh-ancestor
5698525|NCT03368391|Mydriatics|mydriatics|mesh-ancestor
5698526|NCT03368391|Sympathomimetics|sympathomimetics|mesh-ancestor
5698527|NCT03368391|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5698528|NCT03368391|Nasal Decongestants|nasal decongestants|mesh-ancestor
5698529|NCT03368391|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5698530|NCT03368391|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5698531|NCT03368391|Protective Agents|protective agents|mesh-ancestor
5720696|NCT03211104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5720697|NCT03211104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5720698|NCT03211143|Esomeprazole|esomeprazole|mesh-list
5910402|NCT01391962|Sunitinib|sunitinib|mesh-list
5910403|NCT01391962|Cediranib|cediranib|mesh-list
5910404|NCT01391962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5910405|NCT01391962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5910406|NCT01391962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5910407|NCT01391962|Growth Substances|growth substances|mesh-ancestor
5910408|NCT01391962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5910409|NCT01391962|Growth Inhibitors|growth inhibitors|mesh-ancestor
5910410|NCT01391962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5910411|NCT01391962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5910412|NCT01391962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910413|NCT01204684|Vaccines|vaccines|mesh-list
5910414|NCT01204684|Poly ICLC|poly iclc|mesh-list
5910415|NCT01204684|Immunologic Factors|immunologic factors|mesh-ancestor
5910416|NCT01204684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5910417|NCT01204684|Interferon Inducers|interferon inducers|mesh-ancestor
5910418|NCT01015833|Doxorubicin|doxorubicin|mesh-list
5910419|NCT01015833|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5910420|NCT01015833|Sorafenib|sorafenib|mesh-list
5910421|NCT01015833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5910422|NCT01015833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5910423|NCT01015833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5910424|NCT01015833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5910425|NCT01015833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5910426|NCT01015833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910427|NCT01015833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5910428|NCT00980538|Etravirine|etravirine|mesh-list
5910429|NCT00980538|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5910430|NCT00980538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5910431|NCT00980538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5910432|NCT00980538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910433|NCT00980538|Antiviral Agents|antiviral agents|mesh-ancestor
5910434|NCT00980538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5910435|NCT00887146|Vincristine|vincristine|mesh-list
5910436|NCT00887146|Temozolomide|temozolomide|mesh-list
5910437|NCT00887146|Procarbazine|procarbazine|mesh-list
5910438|NCT00887146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5910439|NCT00887146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5910440|NCT00887146|Tubulin Modulators|tubulin modulators|mesh-ancestor
5910441|NCT00887146|Antimitotic Agents|antimitotic agents|mesh-ancestor
5910442|NCT00887146|Mitosis Modulators|mitosis modulators|mesh-ancestor
5910443|NCT00887146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910444|NCT00887146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5910445|NCT00887146|Alkylating Agents|alkylating agents|mesh-ancestor
5910446|NCT00867191|Desloratadine|desloratadine|mesh-list
5910447|NCT00867191|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5910448|NCT00867191|Cholinergic Agents|cholinergic agents|mesh-ancestor
5910449|NCT00867191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5910450|NCT00867191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910451|NCT00867191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5910452|NCT00867191|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5910453|NCT00867191|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5910454|NCT00867191|Histamine Antagonists|histamine antagonists|mesh-ancestor
5910455|NCT00867191|Histamine Agents|histamine agents|mesh-ancestor
5910456|NCT00835094|Mometasone Furoate|mometasone furoate|mesh-list
5910457|NCT00835094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5910458|NCT00835094|Dermatologic Agents|dermatologic agents|mesh-ancestor
5910459|NCT00835094|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5910460|NCT00834119|Mometasone Furoate|mometasone furoate|mesh-list
5910461|NCT00834119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5910462|NCT00834119|Dermatologic Agents|dermatologic agents|mesh-ancestor
5910463|NCT00834119|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5910464|NCT00805584|Desloratadine|desloratadine|mesh-list
5910465|NCT00805584|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5910466|NCT00805584|Cholinergic Agents|cholinergic agents|mesh-ancestor
5910467|NCT00805584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5910468|NCT00805584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910469|NCT00805584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5910470|NCT00805584|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5910471|NCT00805584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5910472|NCT00805584|Histamine Antagonists|histamine antagonists|mesh-ancestor
5910473|NCT00805584|Histamine Agents|histamine agents|mesh-ancestor
5910474|NCT00795522|Desloratadine|desloratadine|mesh-list
5910475|NCT00795522|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5910476|NCT00795522|Cholinergic Agents|cholinergic agents|mesh-ancestor
5910477|NCT00795522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5910478|NCT00795522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910479|NCT00795522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5910480|NCT00795522|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5910481|NCT00795522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5910482|NCT00795522|Histamine Antagonists|histamine antagonists|mesh-ancestor
5910483|NCT00795522|Histamine Agents|histamine agents|mesh-ancestor
5910484|NCT00795158|Desloratadine|desloratadine|mesh-list
5910485|NCT00795158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5910486|NCT00795158|Cholinergic Agents|cholinergic agents|mesh-ancestor
5910487|NCT00795158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5910488|NCT00795158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910489|NCT00795158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5910490|NCT00795158|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5910491|NCT00795158|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5910492|NCT00795158|Histamine Antagonists|histamine antagonists|mesh-ancestor
5910493|NCT00795158|Histamine Agents|histamine agents|mesh-ancestor
5910494|NCT00794846|Cetirizine|cetirizine|mesh-list
5910495|NCT00794846|Desloratadine|desloratadine|mesh-list
5910496|NCT00794846|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5910497|NCT00794846|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5910498|NCT00794846|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5910499|NCT00794846|Histamine Antagonists|histamine antagonists|mesh-ancestor
5910500|NCT00794846|Histamine Agents|histamine agents|mesh-ancestor
5910501|NCT00794846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5910502|NCT00794846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910503|NCT00794846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5910504|NCT00794846|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5910505|NCT00794846|Cholinergic Agents|cholinergic agents|mesh-ancestor
5910506|NCT00794768|Fexofenadine|fexofenadine|mesh-list
5910507|NCT00794768|Desloratadine|desloratadine|mesh-list
5910508|NCT00794768|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5910509|NCT00794768|Cholinergic Agents|cholinergic agents|mesh-ancestor
5910510|NCT00794768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5910511|NCT00794768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910512|NCT00794768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5910513|NCT00794768|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5910514|NCT00794768|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5910515|NCT00794768|Histamine Antagonists|histamine antagonists|mesh-ancestor
5910516|NCT00794768|Histamine Agents|histamine agents|mesh-ancestor
5910517|NCT00794768|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5910518|NCT00794599|Cetirizine|cetirizine|mesh-list
5910519|NCT00794599|Desloratadine|desloratadine|mesh-list
5910520|NCT00794599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5910521|NCT00794599|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5910522|NCT00794599|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5910523|NCT00794599|Histamine Antagonists|histamine antagonists|mesh-ancestor
5910524|NCT00794599|Histamine Agents|histamine agents|mesh-ancestor
5910525|NCT00794599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5910526|NCT00794599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910527|NCT00794599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5910528|NCT00794599|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5910529|NCT00794599|Cholinergic Agents|cholinergic agents|mesh-ancestor
5910530|NCT00794495|Cetirizine|cetirizine|mesh-list
5910531|NCT00794495|Desloratadine|desloratadine|mesh-list
5910532|NCT00794495|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5910533|NCT00794495|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5910534|NCT00794495|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5910535|NCT00794495|Histamine Antagonists|histamine antagonists|mesh-ancestor
5910536|NCT00794495|Histamine Agents|histamine agents|mesh-ancestor
5910537|NCT00794495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5910538|NCT00794495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910539|NCT00794495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5910540|NCT00794495|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5910541|NCT00794495|Cholinergic Agents|cholinergic agents|mesh-ancestor
5910542|NCT00794248|Fexofenadine|fexofenadine|mesh-list
5910543|NCT00794248|Desloratadine|desloratadine|mesh-list
5910544|NCT00794248|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5910545|NCT00794248|Cholinergic Agents|cholinergic agents|mesh-ancestor
5910546|NCT00794248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5910547|NCT00794248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910548|NCT00794248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5910549|NCT00794248|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5910550|NCT00794248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5910551|NCT00794248|Histamine Antagonists|histamine antagonists|mesh-ancestor
5910552|NCT00794248|Histamine Agents|histamine agents|mesh-ancestor
5698532|NCT03368352|Melatonin|melatonin|mesh-list
5698533|NCT03368352|Antioxidants|antioxidants|mesh-ancestor
5698534|NCT03368352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5698535|NCT03368352|Protective Agents|protective agents|mesh-ancestor
5698536|NCT03368352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698537|NCT03368352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5698538|NCT03368274|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
5698539|NCT03368274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5698540|NCT03368274|Glucocorticoids|glucocorticoids|mesh-ancestor
5698541|NCT03368274|Hormones|hormones|mesh-ancestor
5698542|NCT03368274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5698543|NCT03368274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698544|NCT03368131|Capecitabine|capecitabine|mesh-list
5698545|NCT03368131|Oxaliplatin|oxaliplatin|mesh-list
5698546|NCT03368131|Trastuzumab|trastuzumab|mesh-list
5698547|NCT03368131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5698548|NCT03368131|Antimetabolites|antimetabolites|mesh-ancestor
5698549|NCT03368131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5698550|NCT03368131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5698551|NCT03368131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5910553|NCT00794248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5910554|NCT00783354|Loratadine|loratadine|mesh-list
5910555|NCT00783354|Desloratadine|desloratadine|mesh-list
5910556|NCT00783354|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5910557|NCT00783354|Cholinergic Agents|cholinergic agents|mesh-ancestor
5910558|NCT00783354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5910559|NCT00783354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910560|NCT00783354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5910561|NCT00783354|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5910562|NCT00783354|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5910563|NCT00783354|Histamine Antagonists|histamine antagonists|mesh-ancestor
5910564|NCT00783354|Histamine Agents|histamine agents|mesh-ancestor
5910565|NCT00783354|Antipruritics|antipruritics|mesh-ancestor
5910566|NCT00783354|Dermatologic Agents|dermatologic agents|mesh-ancestor
5910567|NCT00783354|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5910568|NCT00783237|Mometasone Furoate|mometasone furoate|mesh-list
5910569|NCT00783237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5910570|NCT00783237|Dermatologic Agents|dermatologic agents|mesh-ancestor
5910571|NCT00783237|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5910572|NCT00783133|Fexofenadine|fexofenadine|mesh-list
5910573|NCT00783133|Desloratadine|desloratadine|mesh-list
5910574|NCT00783133|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5910575|NCT00783133|Cholinergic Agents|cholinergic agents|mesh-ancestor
5910576|NCT00783133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5910577|NCT00783133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910578|NCT00783133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5910579|NCT00783133|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5910580|NCT00783133|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5910581|NCT00783133|Histamine Antagonists|histamine antagonists|mesh-ancestor
5910582|NCT00783133|Histamine Agents|histamine agents|mesh-ancestor
5910583|NCT00783133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5910584|NCT00779636|Desloratadine|desloratadine|mesh-list
5910585|NCT00779636|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5910586|NCT00779636|Cholinergic Agents|cholinergic agents|mesh-ancestor
5698552|NCT03367988|Analgesics, Opioid|analgesics, opioid|mesh-list
5698553|NCT03367988|Anesthetics|anesthetics|mesh-list
5698554|NCT03367988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5698555|NCT03367988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698556|NCT03367988|Narcotics|narcotics|mesh-ancestor
5698557|NCT03367988|Analgesics|analgesics|mesh-ancestor
5698558|NCT03367988|Sensory System Agents|sensory system agents|mesh-ancestor
5698559|NCT03367988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5698560|NCT03367754|Pembrolizumab|pembrolizumab|mesh-list
5698561|NCT03367754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5698562|NCT03367754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5698563|NCT03367728|Ropivacaine|ropivacaine|mesh-list
5698564|NCT03367728|Anesthetics, Local|anesthetics, local|mesh-ancestor
5698565|NCT03367728|Anesthetics|anesthetics|mesh-ancestor
5698566|NCT03367728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5720699|NCT03211143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5910587|NCT00779636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5698567|NCT03367728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698568|NCT03367728|Sensory System Agents|sensory system agents|mesh-ancestor
5698569|NCT03367728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5910588|NCT00779636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910589|NCT00779636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5910590|NCT00779636|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5910591|NCT00779636|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5910592|NCT00779636|Histamine Antagonists|histamine antagonists|mesh-ancestor
5910593|NCT00779636|Histamine Agents|histamine agents|mesh-ancestor
5910594|NCT00763529|Fluticasone|fluticasone|mesh-list
5910595|NCT00763529|Mometasone Furoate|mometasone furoate|mesh-list
5910596|NCT00763529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5910597|NCT00763529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5910598|NCT00763529|Autonomic Agents|autonomic agents|mesh-ancestor
5910599|NCT00763529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5910600|NCT00763529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5910601|NCT00763529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5910602|NCT00763529|Respiratory System Agents|respiratory system agents|mesh-ancestor
5910603|NCT00763529|Dermatologic Agents|dermatologic agents|mesh-ancestor
5910604|NCT00763529|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5910605|NCT00757562|Desloratadine|desloratadine|mesh-list
5910606|NCT00757562|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5910607|NCT00757562|Cholinergic Agents|cholinergic agents|mesh-ancestor
5910608|NCT00757562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5910609|NCT00757562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910610|NCT00757562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5910611|NCT00757562|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5910612|NCT00757562|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5910613|NCT00757562|Histamine Antagonists|histamine antagonists|mesh-ancestor
5910614|NCT00757562|Histamine Agents|histamine agents|mesh-ancestor
5910615|NCT00751075|Mometasone Furoate|mometasone furoate|mesh-list
5910616|NCT00751075|Amoxicillin|amoxicillin|mesh-list
5910617|NCT00751075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5910618|NCT00751075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5910619|NCT00751075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6496609|NCT00628732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496610|NCT00628732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6496611|NCT00628732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6496612|NCT00628732|Alkylating Agents|alkylating agents|mesh-ancestor
5698570|NCT03367689|Olaparib|olaparib|mesh-list
5910620|NCT00751075|Dermatologic Agents|dermatologic agents|mesh-ancestor
5910621|NCT00751075|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5910622|NCT00750750|Mometasone Furoate|mometasone furoate|mesh-list
5910623|NCT00750750|Amoxicillin|amoxicillin|mesh-list
5910624|NCT00750750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5910625|NCT00750750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5910626|NCT00750750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5910627|NCT00750750|Dermatologic Agents|dermatologic agents|mesh-ancestor
5910628|NCT00750750|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5910629|NCT00731185|Mometasone Furoate|mometasone furoate|mesh-list
5910630|NCT00731185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5910631|NCT00731185|Dermatologic Agents|dermatologic agents|mesh-ancestor
5910632|NCT00731185|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5910633|NCT00653835|Simvastatin|simvastatin|mesh-list
5910634|NCT00653835|Ezetimibe|ezetimibe|mesh-list
5910635|NCT00653835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5910636|NCT00653835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5910637|NCT00653835|Antimetabolites|antimetabolites|mesh-ancestor
5910638|NCT00653835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910639|NCT00653835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5910640|NCT00653835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5910641|NCT00653835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5910642|NCT00653796|Atorvastatin|atorvastatin|mesh-list
5910643|NCT00653796|Ezetimibe|ezetimibe|mesh-list
5910644|NCT00653796|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5698571|NCT03367689|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5698572|NCT03367689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5698573|NCT03367689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5698574|NCT03367689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5698575|NCT03367676|Docetaxel|docetaxel|mesh-list
5698576|NCT03367676|Trastuzumab|trastuzumab|mesh-list
5698577|NCT03367676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5698578|NCT03367676|Tubulin Modulators|tubulin modulators|mesh-ancestor
5698579|NCT03367676|Antimitotic Agents|antimitotic agents|mesh-ancestor
5698580|NCT03367676|Mitosis Modulators|mitosis modulators|mesh-ancestor
5910645|NCT00653796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5910646|NCT00653796|Antimetabolites|antimetabolites|mesh-ancestor
5910647|NCT00653796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910648|NCT00653796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5910649|NCT00653796|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5910650|NCT00653796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5910651|NCT00651404|Ezetimibe|ezetimibe|mesh-list
5910652|NCT00651404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5910653|NCT00651404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5910654|NCT00651404|Antimetabolites|antimetabolites|mesh-ancestor
5910655|NCT00651404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910656|NCT00651404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5698581|NCT03367676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5698582|NCT03367676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5698583|NCT03367663|Prednisone|prednisone|mesh-list
5698584|NCT03367663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5698585|NCT03367663|Glucocorticoids|glucocorticoids|mesh-ancestor
5698586|NCT03367663|Hormones|hormones|mesh-ancestor
5698587|NCT03367663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5698588|NCT03367663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698589|NCT03367663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5910657|NCT00651391|Simvastatin|simvastatin|mesh-list
5910658|NCT00651391|Ezetimibe|ezetimibe|mesh-list
5910659|NCT00651391|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5910660|NCT00651391|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5910661|NCT00651391|Antimetabolites|antimetabolites|mesh-ancestor
5910662|NCT00651391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910663|NCT00651391|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5910664|NCT00651391|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5910665|NCT00651391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5910666|NCT00651144|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5910667|NCT00651144|Ezetimibe|ezetimibe|mesh-list
5910668|NCT00651144|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5910669|NCT00651144|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5910670|NCT00651144|Antimetabolites|antimetabolites|mesh-ancestor
5910671|NCT00651144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910672|NCT00651144|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5910673|NCT00651144|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5910674|NCT00651144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5910675|NCT00651014|Ezetimibe|ezetimibe|mesh-list
5910676|NCT00651014|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5910677|NCT00651014|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5910678|NCT00651014|Antimetabolites|antimetabolites|mesh-ancestor
5910679|NCT00651014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910680|NCT00651014|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5910681|NCT00650689|Atorvastatin|atorvastatin|mesh-list
5910682|NCT00650689|Ezetimibe|ezetimibe|mesh-list
5910683|NCT00650689|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5910684|NCT00650689|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5910685|NCT00650689|Antimetabolites|antimetabolites|mesh-ancestor
5910686|NCT00650689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910687|NCT00650689|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5910688|NCT00650689|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5910689|NCT00650689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5910690|NCT00650663|Simvastatin|simvastatin|mesh-list
5910691|NCT00650663|Ezetimibe|ezetimibe|mesh-list
5910692|NCT00650663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5910693|NCT00650663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5910694|NCT00650663|Antimetabolites|antimetabolites|mesh-ancestor
5910695|NCT00650663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910696|NCT00650663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5910697|NCT00650663|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5910698|NCT00650663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5910699|NCT00589420|Docetaxel|docetaxel|mesh-list
5910700|NCT00589420|Sorafenib|sorafenib|mesh-list
5910701|NCT00589420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5910702|NCT00589420|Tubulin Modulators|tubulin modulators|mesh-ancestor
5910703|NCT00589420|Antimitotic Agents|antimitotic agents|mesh-ancestor
5910704|NCT00589420|Mitosis Modulators|mitosis modulators|mesh-ancestor
5910705|NCT00589420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910706|NCT00589420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5910707|NCT00589420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5910708|NCT00588770|Bevacizumab|bevacizumab|mesh-list
5910709|NCT00588770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5910710|NCT00588770|Cisplatin|cisplatin|mesh-list
5910711|NCT00588770|Carboplatin|carboplatin|mesh-list
5698590|NCT03367663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5698591|NCT03367585|Vitamin D|vitamin d|mesh-list
5698592|NCT03367585|Cholecalciferol|cholecalciferol|mesh-list
5698593|NCT03367585|Vitamins|vitamins|mesh-ancestor
5698594|NCT03367585|Micronutrients|micronutrients|mesh-ancestor
5698595|NCT03367585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698596|NCT03367585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5698597|NCT03367585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5698598|NCT03367533|Ketamine|ketamine|mesh-list
5698599|NCT03367533|Analgesics|analgesics|mesh-ancestor
5698600|NCT03367533|Sensory System Agents|sensory system agents|mesh-ancestor
5698601|NCT03367533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5698602|NCT03367533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698603|NCT03367533|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5698604|NCT03367533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5698605|NCT03367533|Anesthetics, General|anesthetics, general|mesh-ancestor
5698606|NCT03367533|Anesthetics|anesthetics|mesh-ancestor
5698607|NCT03367533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5698608|NCT03367533|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5698609|NCT03367533|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5698610|NCT03367533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5698611|NCT03367533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5698612|NCT03367494|Bromides|bromides|mesh-list
5698613|NCT03367494|Anticonvulsants|anticonvulsants|mesh-ancestor
5698614|NCT03367390|Insulin Lispro|insulin lispro|mesh-list
5698615|NCT03367390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5698616|NCT03367390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698617|NCT03367377|Insulin Glargine|insulin glargine|mesh-list
5698618|NCT03367377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5698619|NCT03367377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698620|NCT03367312|Xenon|xenon|mesh-list
5698621|NCT03367312|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5910712|NCT00588770|Docetaxel|docetaxel|mesh-list
5910713|NCT00588770|Fluorouracil|fluorouracil|mesh-list
5910714|NCT00588770|Endothelial Growth Factors|endothelial growth factors|mesh-list
5910715|NCT00588770|Antibodies|antibodies|mesh-list
5910716|NCT00588770|Immunoglobulins|immunoglobulins|mesh-list
5910717|NCT00588770|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5910718|NCT00588770|Immunoglobulin G|immunoglobulin g|mesh-list
5910719|NCT00588770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5910720|NCT00588770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5910721|NCT00588770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5910722|NCT00588770|Growth Substances|growth substances|mesh-ancestor
5910723|NCT00588770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5910724|NCT00588770|Growth Inhibitors|growth inhibitors|mesh-ancestor
5910725|NCT00588770|Immunologic Factors|immunologic factors|mesh-ancestor
5910726|NCT00588770|Tubulin Modulators|tubulin modulators|mesh-ancestor
5910727|NCT00588770|Antimitotic Agents|antimitotic agents|mesh-ancestor
5910728|NCT00588770|Mitosis Modulators|mitosis modulators|mesh-ancestor
5910729|NCT00588770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910730|NCT00588770|Antimetabolites|antimetabolites|mesh-ancestor
5910731|NCT00588770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5910732|NCT00588770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5910733|NCT00552097|Simvastatin|simvastatin|mesh-list
5910734|NCT00552097|Ezetimibe|ezetimibe|mesh-list
5910735|NCT00552097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5910736|NCT00552097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5910737|NCT00552097|Antimetabolites|antimetabolites|mesh-ancestor
5910738|NCT00552097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910739|NCT00552097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5910740|NCT00552097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5910741|NCT00552097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5910742|NCT00433511|Paclitaxel|paclitaxel|mesh-list
6496613|NCT00628732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910743|NCT00433511|Cyclophosphamide|cyclophosphamide|mesh-list
5910744|NCT00433511|Bevacizumab|bevacizumab|mesh-list
5910745|NCT00433511|Doxorubicin|doxorubicin|mesh-list
5910746|NCT00433511|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5910747|NCT00433511|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5910748|NCT00433511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5910749|NCT00433511|Antibodies|antibodies|mesh-list
5698622|NCT03367312|Anesthetics, General|anesthetics, general|mesh-ancestor
5698623|NCT03367312|Anesthetics|anesthetics|mesh-ancestor
5698624|NCT03367312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5722268|NCT03200236|Nicotine|nicotine|mesh-list
5910750|NCT00433511|Immunoglobulins|immunoglobulins|mesh-list
5910751|NCT00433511|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5910752|NCT00433511|Immunoglobulin G|immunoglobulin g|mesh-list
5910753|NCT00433511|Endothelial Growth Factors|endothelial growth factors|mesh-list
5910754|NCT00433511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5910755|NCT00433511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5910756|NCT00433511|Tubulin Modulators|tubulin modulators|mesh-ancestor
5910757|NCT00433511|Antimitotic Agents|antimitotic agents|mesh-ancestor
5910758|NCT00433511|Mitosis Modulators|mitosis modulators|mesh-ancestor
5910759|NCT00433511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910760|NCT00433511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5910761|NCT00433511|Immunologic Factors|immunologic factors|mesh-ancestor
5910762|NCT00433511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5910763|NCT00433511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5910764|NCT00433511|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5910765|NCT00433511|Alkylating Agents|alkylating agents|mesh-ancestor
5910766|NCT00433511|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5910767|NCT00433511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5910768|NCT00433511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5910769|NCT00433511|Growth Substances|growth substances|mesh-ancestor
5910770|NCT00433511|Growth Inhibitors|growth inhibitors|mesh-ancestor
5910771|NCT00433511|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5910772|NCT00433511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5910773|NCT00433511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5910774|NCT00433511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5910775|NCT00398294|Simvastatin|simvastatin|mesh-list
5910776|NCT00398294|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5910777|NCT00398294|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5910778|NCT00398294|Antimetabolites|antimetabolites|mesh-ancestor
5910779|NCT00398294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910780|NCT00398294|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5910781|NCT00398294|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5910782|NCT00398294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5910783|NCT00396175|Finasteride|finasteride|mesh-list
5910784|NCT00396175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910785|NCT00396175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5910786|NCT00396175|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
5910787|NCT00396175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5910788|NCT00396175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5910789|NCT00396175|Hormone Antagonists|hormone antagonists|mesh-ancestor
5910790|NCT00396175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5910791|NCT00396175|Urological Agents|urological agents|mesh-ancestor
5910792|NCT00389896|Oxymetazoline|oxymetazoline|mesh-list
5910793|NCT00389896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5910794|NCT00389896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5910795|NCT00389896|Adrenergic Agents|adrenergic agents|mesh-ancestor
5910796|NCT00389896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5910797|NCT00389896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910798|NCT00389896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5910799|NCT00389896|Sympathomimetics|sympathomimetics|mesh-ancestor
5910800|NCT00389896|Autonomic Agents|autonomic agents|mesh-ancestor
5910801|NCT00389896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5910802|NCT00389896|Nasal Decongestants|nasal decongestants|mesh-ancestor
5910803|NCT00389896|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5910804|NCT00389896|Respiratory System Agents|respiratory system agents|mesh-ancestor
5910805|NCT00370890|Gemcitabine|gemcitabine|mesh-list
5910806|NCT00370890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5910807|NCT00370890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5910808|NCT00370890|Antimetabolites|antimetabolites|mesh-ancestor
5910809|NCT00370890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910810|NCT00370890|Antiviral Agents|antiviral agents|mesh-ancestor
5910811|NCT00370890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5910812|NCT00370890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5910813|NCT00370890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5910814|NCT00370890|Immunologic Factors|immunologic factors|mesh-ancestor
5910815|NCT00370890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5910816|NCT00324805|Gemcitabine|gemcitabine|mesh-list
5910817|NCT00324805|Bevacizumab|bevacizumab|mesh-list
5910818|NCT00324805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5910819|NCT00324805|Cisplatin|cisplatin|mesh-list
5910820|NCT00324805|Docetaxel|docetaxel|mesh-list
5910821|NCT00324805|Pemetrexed|pemetrexed|mesh-list
5910822|NCT00324805|Vinorelbine|vinorelbine|mesh-list
5910823|NCT00324805|Endothelial Growth Factors|endothelial growth factors|mesh-list
5910824|NCT00324805|Antibodies|antibodies|mesh-list
5910825|NCT00324805|Immunoglobulins|immunoglobulins|mesh-list
5910826|NCT00324805|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5910827|NCT00324805|Immunoglobulin G|immunoglobulin g|mesh-list
5910828|NCT00324805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5910829|NCT00324805|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5910830|NCT00324805|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5910831|NCT00324805|Growth Substances|growth substances|mesh-ancestor
5910832|NCT00324805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5910833|NCT00324805|Growth Inhibitors|growth inhibitors|mesh-ancestor
5910834|NCT00324805|Immunologic Factors|immunologic factors|mesh-ancestor
5910835|NCT00324805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5910836|NCT00324805|Antimetabolites|antimetabolites|mesh-ancestor
5910837|NCT00324805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910838|NCT00324805|Antiviral Agents|antiviral agents|mesh-ancestor
5910839|NCT00324805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5910840|NCT00324805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5910841|NCT00324805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5910842|NCT00324805|Tubulin Modulators|tubulin modulators|mesh-ancestor
5910843|NCT00324805|Antimitotic Agents|antimitotic agents|mesh-ancestor
5910844|NCT00324805|Mitosis Modulators|mitosis modulators|mesh-ancestor
5910845|NCT00324805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5910846|NCT00324805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5910847|NCT00324805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5962874|NCT04607447|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5962875|NCT04607447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5962876|NCT04607252|Metformin|metformin|mesh-list
5962877|NCT04607252|Megestrol|megestrol|mesh-list
5962878|NCT04607252|Megestrol Acetate|megestrol acetate|mesh-list
5962879|NCT04607252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5962880|NCT04607252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962881|NCT04607252|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5962882|NCT04607252|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5962883|NCT04607252|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5962884|NCT04607252|Contraceptive Agents|contraceptive agents|mesh-ancestor
5962885|NCT04607252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5962886|NCT04607252|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5962887|NCT04607252|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5962888|NCT04607252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5962889|NCT04607252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5962890|NCT04607252|Appetite Stimulants|appetite stimulants|mesh-ancestor
5962891|NCT04607252|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5962892|NCT04607525|Dexmedetomidine|dexmedetomidine|mesh-list
5962893|NCT04607525|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5962894|NCT04607525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5962895|NCT04607525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962896|NCT04607525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5962897|NCT04607525|Analgesics|analgesics|mesh-ancestor
5962898|NCT04607525|Sensory System Agents|sensory system agents|mesh-ancestor
5962899|NCT04607525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5962900|NCT04607525|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5962901|NCT04607525|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5962902|NCT04607525|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5962903|NCT04607525|Adrenergic Agents|adrenergic agents|mesh-ancestor
5962904|NCT04607525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5962905|NCT04607525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970430|NCT04535271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5970431|NCT04535271|Antimetabolites|antimetabolites|mesh-ancestor
5970432|NCT04535271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970433|NCT04535271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5970434|NCT04535271|Antiviral Agents|antiviral agents|mesh-ancestor
5970435|NCT04535271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5970436|NCT04535271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5970437|NCT04535271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5970438|NCT04535271|Immunologic Factors|immunologic factors|mesh-ancestor
5970439|NCT04535271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970440|NCT04535271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5970441|NCT04535271|Alkylating Agents|alkylating agents|mesh-ancestor
5970442|NCT04535037|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5970443|NCT04535037|Immunologic Factors|immunologic factors|mesh-ancestor
5970444|NCT04535037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970445|NCT04534803|BCG Vaccine|bcg vaccine|mesh-list
5970446|NCT04534803|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5970447|NCT04534803|Immunologic Factors|immunologic factors|mesh-ancestor
5970448|NCT04534803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5910848|NCT00310180|Tamoxifen|tamoxifen|mesh-list
5910849|NCT00310180|Letrozole|letrozole|mesh-list
5910850|NCT00310180|Anastrozole|anastrozole|mesh-list
5910851|NCT00310180|Exemestane|exemestane|mesh-list
5910852|NCT00310180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910853|NCT00310180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5910854|NCT00310180|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5910855|NCT00310180|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5910856|NCT00310180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5910857|NCT00310180|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5910858|NCT00310180|Hormone Antagonists|hormone antagonists|mesh-ancestor
5910859|NCT00310180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5910860|NCT00310180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5910861|NCT00310180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5910862|NCT00310180|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5910863|NCT00310180|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5910864|NCT00310180|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5910865|NCT00006436|Rituximab|rituximab|mesh-list
5910866|NCT00006436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5910867|NCT00006436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5910868|NCT00006436|Immunologic Factors|immunologic factors|mesh-ancestor
5910869|NCT00006436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5910870|NCT00006436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5910871|NCT04231565|Tenofovir|tenofovir|mesh-list
5910872|NCT04231565|Antiviral Agents|antiviral agents|mesh-ancestor
5910873|NCT04231565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5910874|NCT04231565|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5910875|NCT04231565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5910876|NCT04231565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5910877|NCT04231565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910878|NCT04231565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5910879|NCT04231565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5910880|NCT04189445|Futibatinib|futibatinib|mesh-list
5910881|NCT04189445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5910882|NCT04123444|Iloprost|iloprost|mesh-list
5910883|NCT04123444|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5910884|NCT04123444|Vasodilator Agents|vasodilator agents|mesh-ancestor
5910885|NCT04116502|Interferons|interferons|mesh-list
5910886|NCT04116502|Interferon-alpha|interferon-alpha|mesh-list
5698625|NCT03367312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698626|NCT03367195|Omeprazole|omeprazole|mesh-list
5698627|NCT03367195|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5698628|NCT03367195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5698629|NCT03367195|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5698630|NCT03367195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5698631|NCT03367195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910887|NCT04116502|Interferon alpha-2|interferon alpha-2|mesh-list
5910888|NCT04116502|Hydroxyurea|hydroxyurea|mesh-list
5910889|NCT04116502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5910890|NCT04116502|Antiviral Agents|antiviral agents|mesh-ancestor
5910891|NCT04116502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5910892|NCT04116502|Immunologic Factors|immunologic factors|mesh-ancestor
5910893|NCT04116502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5910894|NCT04116502|Antisickling Agents|antisickling agents|mesh-ancestor
5910895|NCT04116502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5910896|NCT04116502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910897|NCT04116502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5910898|NCT04116047|Durvalumab|durvalumab|mesh-list
5910899|NCT04116047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5910900|NCT04116047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5910901|NCT04095845|Tacrine|tacrine|mesh-list
5910902|NCT04095845|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5910903|NCT04095845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5910904|NCT04095845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910905|NCT04095845|Cholinergic Agents|cholinergic agents|mesh-ancestor
5910906|NCT04095845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5910907|NCT04095845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5910908|NCT04095845|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5910909|NCT04095845|Autonomic Agents|autonomic agents|mesh-ancestor
5910910|NCT04095845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5910911|NCT04095845|Nootropic Agents|nootropic agents|mesh-ancestor
5910912|NCT04092179|Venetoclax|venetoclax|mesh-list
5910913|NCT04092179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5910914|NCT04046900|Metronidazole|metronidazole|mesh-list
5698632|NCT03367182|Paclitaxel|paclitaxel|mesh-list
5910915|NCT04046900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5910916|NCT04046900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5910917|NCT04046900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5910918|NCT04046900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5910919|NCT04038099|Lidocaine|lidocaine|mesh-list
5910920|NCT04038099|Anesthetics, Local|anesthetics, local|mesh-ancestor
5910921|NCT04038099|Anesthetics|anesthetics|mesh-ancestor
5910922|NCT04038099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5910923|NCT04038099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5910924|NCT04038099|Sensory System Agents|sensory system agents|mesh-ancestor
5910925|NCT04038099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5910926|NCT04038099|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5910927|NCT04038099|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5910928|NCT04038099|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5910929|NCT04038099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5910930|NCT04038099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910931|NCT03991832|Durvalumab|durvalumab|mesh-list
5910932|NCT03991832|Olaparib|olaparib|mesh-list
5910933|NCT03991832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5910934|NCT03991832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5910935|NCT03991832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5910936|NCT03991832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5910937|NCT03991832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910938|NCT03977896|Carbon-11 methionine|carbon-11 methionine|mesh-list
5910939|NCT03977896|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5910940|NCT03977896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910941|NCT03965741|Rivaroxaban|rivaroxaban|mesh-list
5910942|NCT03965741|Apixaban|apixaban|mesh-list
5910943|NCT03965741|Dabigatran|dabigatran|mesh-list
5910944|NCT03965741|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5910945|NCT03965741|Antithrombins|antithrombins|mesh-ancestor
5910946|NCT03965741|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5910947|NCT03965741|Protease Inhibitors|protease inhibitors|mesh-ancestor
5910948|NCT03965741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5910949|NCT03965741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5910950|NCT03965741|Anticoagulants|anticoagulants|mesh-ancestor
5910951|NCT03961438|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
5910952|NCT03961438|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5910953|NCT03961438|Immunologic Factors|immunologic factors|mesh-ancestor
5910954|NCT03961438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5910955|NCT03945812|Lenograstim|lenograstim|mesh-list
5910956|NCT03945812|Sargramostim|sargramostim|mesh-list
5910957|NCT03945812|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5910958|NCT03945812|Immunologic Factors|immunologic factors|mesh-ancestor
5910959|NCT03945812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5910960|NCT03920007|Trimethoprim|trimethoprim|mesh-list
5910961|NCT03920007|Polymyxins|polymyxins|mesh-list
5910962|NCT03920007|Polymyxin B|polymyxin b|mesh-list
5910963|NCT03920007|Prednisone|prednisone|mesh-list
5910964|NCT03920007|Prednisolone|prednisolone|mesh-list
5910965|NCT03920007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5910966|NCT03920007|Glucocorticoids|glucocorticoids|mesh-ancestor
5910967|NCT03920007|Hormones|hormones|mesh-ancestor
5910968|NCT03920007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5910969|NCT03920007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5910970|NCT03920007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5910971|NCT03920007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5910972|NCT03920007|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5910973|NCT03920007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5910974|NCT03920007|Renal Agents|renal agents|mesh-ancestor
5910975|NCT03920007|Antimalarials|antimalarials|mesh-ancestor
5910976|NCT03920007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5910977|NCT03920007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5698633|NCT03367182|Bevacizumab|bevacizumab|mesh-list
5698634|NCT03367182|Doxorubicin|doxorubicin|mesh-list
5698635|NCT03367182|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5910978|NCT03920007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5910979|NCT03920007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5910980|NCT03920007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5698636|NCT03367182|Topotecan|topotecan|mesh-list
5698637|NCT03367182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5698638|NCT03367182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5698639|NCT03367182|Tubulin Modulators|tubulin modulators|mesh-ancestor
5698640|NCT03367182|Antimitotic Agents|antimitotic agents|mesh-ancestor
5698641|NCT03367182|Mitosis Modulators|mitosis modulators|mesh-ancestor
5698642|NCT03367182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5698643|NCT03367182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6675710|NCT01577199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675711|NCT01577199|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6675712|NCT01577199|Fertility Agents|fertility agents|mesh-ancestor
6675713|NCT01577199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6675714|NCT01577199|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6675715|NCT01577199|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6675716|NCT01577316|Vaccines|vaccines|mesh-list
6675717|NCT01577316|Immunologic Factors|immunologic factors|mesh-ancestor
6675718|NCT01577316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675719|NCT01577342|Moxifloxacin|moxifloxacin|mesh-list
6675720|NCT01577342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6675721|NCT01577342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6675722|NCT01577342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6675723|NCT01577342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6675724|NCT01577342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6675725|NCT01577342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675726|NCT01577342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6675727|NCT01577368|Tazobactam|tazobactam|mesh-list
6675728|NCT01577368|Piperacillin|piperacillin|mesh-list
6675729|NCT01577368|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
6675730|NCT01577368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6675731|NCT01577368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5698644|NCT03367182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5698645|NCT03367182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5910981|NCT03920007|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5910982|NCT03920007|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
5910983|NCT03920007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5910984|NCT03920007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5910985|NCT03913845|Lidocaine|lidocaine|mesh-list
5910986|NCT03913845|Epinephrine|epinephrine|mesh-list
5910987|NCT03913845|Racepinephrine|racepinephrine|mesh-list
5910988|NCT03913845|Epinephryl borate|epinephryl borate|mesh-list
5698646|NCT03367182|Growth Substances|growth substances|mesh-ancestor
5698647|NCT03367182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698648|NCT03367182|Growth Inhibitors|growth inhibitors|mesh-ancestor
5698649|NCT03367182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5698650|NCT03367182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5698651|NCT03367182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5910989|NCT03913845|Anesthetics, Local|anesthetics, local|mesh-ancestor
5910990|NCT03913845|Anesthetics|anesthetics|mesh-ancestor
5910991|NCT03913845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5910992|NCT03913845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5910993|NCT03913845|Sensory System Agents|sensory system agents|mesh-ancestor
5910994|NCT03913845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5910995|NCT03913845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5910996|NCT03913845|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5910997|NCT03913845|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5910998|NCT03913845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5910999|NCT03913845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911000|NCT03913845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5911001|NCT03913845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5911002|NCT03913845|Adrenergic Agents|adrenergic agents|mesh-ancestor
5911003|NCT03913845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5911004|NCT03913845|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5911005|NCT03913845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5911006|NCT03913845|Autonomic Agents|autonomic agents|mesh-ancestor
5911007|NCT03913845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5911008|NCT03913845|Respiratory System Agents|respiratory system agents|mesh-ancestor
5911009|NCT03913845|Mydriatics|mydriatics|mesh-ancestor
5911010|NCT03913845|Sympathomimetics|sympathomimetics|mesh-ancestor
5911011|NCT03913845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5911012|NCT03903939|Iloprost|iloprost|mesh-list
5911013|NCT03903939|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5911014|NCT03903939|Vasodilator Agents|vasodilator agents|mesh-ancestor
5911015|NCT03870438|Lamivudine|lamivudine|mesh-list
5911016|NCT03870438|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5911017|NCT03870438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5911018|NCT03870438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5911019|NCT03870438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911020|NCT03870438|Antiviral Agents|antiviral agents|mesh-ancestor
5911021|NCT03870438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5911022|NCT03870438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5911023|NCT03870438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5911024|NCT03834363|Fentanyl|fentanyl|mesh-list
5698652|NCT03367182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5698653|NCT03367182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5698654|NCT03367143|Carboplatin|carboplatin|mesh-list
5698655|NCT03367143|Etoposide|etoposide|mesh-list
5698656|NCT03367143|Lenalidomide|lenalidomide|mesh-list
5698657|NCT03367143|Ifosfamide|ifosfamide|mesh-list
5698658|NCT03367143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5698659|NCT03367143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5698660|NCT03367143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5698661|NCT03367143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5698662|NCT03367143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5698663|NCT03367143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5698664|NCT03367143|Immunologic Factors|immunologic factors|mesh-ancestor
5698665|NCT03367143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698666|NCT03367143|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5698667|NCT03367143|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5698668|NCT03367143|Growth Substances|growth substances|mesh-ancestor
5698669|NCT03367143|Growth Inhibitors|growth inhibitors|mesh-ancestor
5698670|NCT03367143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5698671|NCT03367143|Alkylating Agents|alkylating agents|mesh-ancestor
5698672|NCT03367013|Lactoferrin|lactoferrin|mesh-list
5698673|NCT03367013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5698674|NCT03366974|Clarithromycin|clarithromycin|mesh-list
5698675|NCT03366974|Midazolam|midazolam|mesh-list
5698676|NCT03366974|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5698677|NCT03366974|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5698678|NCT03366974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5698679|NCT03366974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698680|NCT03366974|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5698681|NCT03366974|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5698682|NCT03366974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5698683|NCT03366974|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5698684|NCT03366974|Anesthetics, General|anesthetics, general|mesh-ancestor
5698685|NCT03366974|Anesthetics|anesthetics|mesh-ancestor
5698686|NCT03366974|GABA Modulators|gaba modulators|mesh-ancestor
5698687|NCT03366974|GABA Agents|gaba agents|mesh-ancestor
5698688|NCT03366974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5698689|NCT03366974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5698690|NCT03366974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5698691|NCT03366974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5698692|NCT03366974|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5698693|NCT03366974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5698694|NCT03366974|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5698695|NCT03366974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5698696|NCT03366883|Paclitaxel|paclitaxel|mesh-list
5698697|NCT03366883|Cisplatin|cisplatin|mesh-list
5698698|NCT03366883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5698699|NCT03366883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5698700|NCT03366883|Tubulin Modulators|tubulin modulators|mesh-ancestor
5911025|NCT03834363|Morphine|morphine|mesh-list
5911026|NCT03834363|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5911027|NCT03834363|Narcotics|narcotics|mesh-ancestor
5911028|NCT03834363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5911029|NCT03834363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911030|NCT03834363|Analgesics|analgesics|mesh-ancestor
5911031|NCT03834363|Sensory System Agents|sensory system agents|mesh-ancestor
5911032|NCT03834363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5911033|NCT03834363|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5911034|NCT03834363|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5911035|NCT03834363|Anesthetics, General|anesthetics, general|mesh-ancestor
5911036|NCT03834363|Anesthetics|anesthetics|mesh-ancestor
5911037|NCT03818776|Durvalumab|durvalumab|mesh-list
5911038|NCT03818776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5911039|NCT03818776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5911040|NCT03809884|Potassium Citrate|potassium citrate|mesh-list
5911041|NCT03809884|Diuretics|diuretics|mesh-ancestor
5911042|NCT03809884|Natriuretic Agents|natriuretic agents|mesh-ancestor
5911043|NCT03809884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911044|NCT03809884|Expectorants|expectorants|mesh-ancestor
5911045|NCT03809884|Respiratory System Agents|respiratory system agents|mesh-ancestor
5911046|NCT03792958|Vorolanib|vorolanib|mesh-list
5911047|NCT03792958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5911048|NCT03792958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5911049|NCT03792958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911050|NCT03782350|Tranexamic Acid|tranexamic acid|mesh-list
5911051|NCT03782350|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5911052|NCT03782350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5911053|NCT03782350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911054|NCT03782350|Hemostatics|hemostatics|mesh-ancestor
5911055|NCT03782350|Coagulants|coagulants|mesh-ancestor
5911056|NCT03767933|Acetaminophen|acetaminophen|mesh-list
5911057|NCT03767933|Ibuprofen|ibuprofen|mesh-list
5911058|NCT03767933|Hydromorphone|hydromorphone|mesh-list
5911059|NCT03767933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5911060|NCT03767933|Analgesics|analgesics|mesh-ancestor
5911061|NCT03767933|Sensory System Agents|sensory system agents|mesh-ancestor
5911062|NCT03767933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5911063|NCT03767933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911064|NCT03767933|Antipyretics|antipyretics|mesh-ancestor
5911065|NCT03767933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5911066|NCT03767933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5911067|NCT03767933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5911068|NCT03767933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5911069|NCT03767933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5911070|NCT03767933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911071|NCT03767933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5911072|NCT03767933|Narcotics|narcotics|mesh-ancestor
5911073|NCT03767933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5911074|NCT03734731|Analgesics, Opioid|analgesics, opioid|mesh-list
5911075|NCT03734731|Narcotics|narcotics|mesh-ancestor
5911076|NCT03734731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5911077|NCT03734731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911078|NCT03734731|Analgesics|analgesics|mesh-ancestor
5911079|NCT03734731|Sensory System Agents|sensory system agents|mesh-ancestor
5911080|NCT03734731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5911081|NCT03691714|Cetuximab|cetuximab|mesh-list
5911082|NCT03691714|Durvalumab|durvalumab|mesh-list
5911083|NCT03691714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5911084|NCT03691714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5911085|NCT03636256|Docetaxel|docetaxel|mesh-list
5911086|NCT03636256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5911087|NCT03636256|Tubulin Modulators|tubulin modulators|mesh-ancestor
5911088|NCT03636256|Antimitotic Agents|antimitotic agents|mesh-ancestor
5911089|NCT03636256|Mitosis Modulators|mitosis modulators|mesh-ancestor
5911090|NCT03636256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962906|NCT04607642|Manganese|manganese|mesh-list
5962907|NCT04607642|Trace Elements|trace elements|mesh-ancestor
5962908|NCT04607642|Micronutrients|micronutrients|mesh-ancestor
5962909|NCT04607642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962910|NCT04607057|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-list
5698701|NCT03366883|Antimitotic Agents|antimitotic agents|mesh-ancestor
5698702|NCT03366883|Mitosis Modulators|mitosis modulators|mesh-ancestor
5698703|NCT03366883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962911|NCT04607057|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5962912|NCT04606914|Maytansine|maytansine|mesh-list
5962913|NCT04606914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5698704|NCT03366766|Gemcitabine|gemcitabine|mesh-list
5698705|NCT03366766|Cisplatin|cisplatin|mesh-list
5698706|NCT03366766|Nivolumab|nivolumab|mesh-list
5698707|NCT03366766|Pemetrexed|pemetrexed|mesh-list
5698708|NCT03366766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5698709|NCT03366766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5698710|NCT03366766|Antimetabolites|antimetabolites|mesh-ancestor
5698711|NCT03366766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5698712|NCT03366766|Antiviral Agents|antiviral agents|mesh-ancestor
5698713|NCT03366766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5698714|NCT03366766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5698715|NCT03366766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5698716|NCT03366766|Immunologic Factors|immunologic factors|mesh-ancestor
5698717|NCT03366766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698718|NCT03366766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5698719|NCT03366766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5698720|NCT03366766|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5698721|NCT03366766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5720700|NCT03211143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5720701|NCT03211143|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5720702|NCT03211143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5720703|NCT03211143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5720704|NCT03211013|Oxytocin|oxytocin|mesh-list
5720705|NCT03211013|Oxytocics|oxytocics|mesh-ancestor
5962914|NCT04606914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5962915|NCT04606914|Tubulin Modulators|tubulin modulators|mesh-ancestor
5962916|NCT04606914|Antimitotic Agents|antimitotic agents|mesh-ancestor
5698722|NCT03366597|Sevoflurane|sevoflurane|mesh-list
5698723|NCT03366597|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5698724|NCT03366597|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5698725|NCT03366597|Anesthetics, General|anesthetics, general|mesh-ancestor
5698726|NCT03366597|Anesthetics|anesthetics|mesh-ancestor
5911091|NCT03578965|Cefazolin|cefazolin|mesh-list
5911092|NCT03578965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5911093|NCT03578965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5911094|NCT03559400|Gentamicins|gentamicins|mesh-list
5911095|NCT03559400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5911096|NCT03559400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5911097|NCT03559400|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5911098|NCT03559400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5911099|NCT03559400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911100|NCT03558087|Gemcitabine|gemcitabine|mesh-list
5911101|NCT03558087|Nivolumab|nivolumab|mesh-list
5911102|NCT03558087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5911103|NCT03558087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6675732|NCT01577368|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6675733|NCT01577368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6675734|NCT01577368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675735|NCT01577407|Nefopam|nefopam|mesh-list
5698727|NCT03366597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5698728|NCT03366597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698729|NCT03366584|Vitamin D|vitamin d|mesh-list
5698730|NCT03366584|Cholecalciferol|cholecalciferol|mesh-list
5698731|NCT03366584|Beta Carotene|beta carotene|mesh-list
5698732|NCT03366584|Zinc|zinc|mesh-list
5698733|NCT03366584|Dexamethasone|dexamethasone|mesh-list
5698734|NCT03366584|Carotenoids|carotenoids|mesh-list
5698735|NCT03366584|Picolinic acid|picolinic acid|mesh-list
5698736|NCT03366584|Vitamins|vitamins|mesh-ancestor
5698737|NCT03366584|Micronutrients|micronutrients|mesh-ancestor
5698738|NCT03366584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698739|NCT03366584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5698740|NCT03366584|Antiemetics|antiemetics|mesh-ancestor
6675736|NCT01577407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5911104|NCT03558087|Antimetabolites|antimetabolites|mesh-ancestor
5911105|NCT03558087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911106|NCT03558087|Antiviral Agents|antiviral agents|mesh-ancestor
5911107|NCT03558087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5911108|NCT03558087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5911109|NCT03558087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5698741|NCT03366584|Autonomic Agents|autonomic agents|mesh-ancestor
5698742|NCT03366584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5698743|NCT03366584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5698744|NCT03366584|Glucocorticoids|glucocorticoids|mesh-ancestor
5698745|NCT03366584|Hormones|hormones|mesh-ancestor
5698746|NCT03366584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5698747|NCT03366584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5698748|NCT03366584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5698749|NCT03366584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5698750|NCT03366584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5698751|NCT03366584|Trace Elements|trace elements|mesh-ancestor
5698752|NCT03366584|Antioxidants|antioxidants|mesh-ancestor
5698753|NCT03366584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5698754|NCT03366584|Protective Agents|protective agents|mesh-ancestor
5698755|NCT03366584|Provitamins|provitamins|mesh-ancestor
5698756|NCT03366584|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5698757|NCT03366584|Chelating Agents|chelating agents|mesh-ancestor
5698758|NCT03366584|Sequestering Agents|sequestering agents|mesh-ancestor
5698759|NCT03366571|Entecavir|entecavir|mesh-list
5698760|NCT03366571|Antiviral Agents|antiviral agents|mesh-ancestor
5698761|NCT03366571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5698762|NCT03366480|Paclitaxel|paclitaxel|mesh-list
5698763|NCT03366480|Carboplatin|carboplatin|mesh-list
5698764|NCT03366480|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5698765|NCT03366480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5698766|NCT03366480|Tubulin Modulators|tubulin modulators|mesh-ancestor
5698767|NCT03366480|Antimitotic Agents|antimitotic agents|mesh-ancestor
5698768|NCT03366480|Mitosis Modulators|mitosis modulators|mesh-ancestor
5698769|NCT03366480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5698770|NCT03366415|Gemcitabine|gemcitabine|mesh-list
5911110|NCT03558087|Immunologic Factors|immunologic factors|mesh-ancestor
5698771|NCT03366415|Cisplatin|cisplatin|mesh-list
5698772|NCT03366415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5698773|NCT03366415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5698774|NCT03366415|Antimetabolites|antimetabolites|mesh-ancestor
6675737|NCT01577407|Analgesics|analgesics|mesh-ancestor
5911111|NCT03558087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911112|NCT03558087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5911113|NCT03558087|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5911114|NCT03519984|Cytarabine|cytarabine|mesh-list
5911115|NCT03519984|Vincristine|vincristine|mesh-list
5911116|NCT03519984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5911117|NCT03519984|Antimetabolites|antimetabolites|mesh-ancestor
5911118|NCT03519984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911119|NCT03519984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5911120|NCT03519984|Antiviral Agents|antiviral agents|mesh-ancestor
5911121|NCT03519984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5911122|NCT03519984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5911123|NCT03519984|Immunologic Factors|immunologic factors|mesh-ancestor
5911124|NCT03519984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911125|NCT03519984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5911126|NCT03519984|Tubulin Modulators|tubulin modulators|mesh-ancestor
5911127|NCT03519984|Antimitotic Agents|antimitotic agents|mesh-ancestor
5911128|NCT03519984|Mitosis Modulators|mitosis modulators|mesh-ancestor
5911129|NCT03418818|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
5911130|NCT03418818|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5911131|NCT03418818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911132|NCT03363893|Fulvestrant|fulvestrant|mesh-list
5911133|NCT03363893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5911134|NCT03363893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5911135|NCT03363893|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5911136|NCT03363893|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5911137|NCT03363893|Hormone Antagonists|hormone antagonists|mesh-ancestor
5911138|NCT03363893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5911139|NCT03363893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911140|NCT03287778|Pyridoxine|pyridoxine|mesh-list
5911141|NCT03287778|Vitamin B 6|vitamin b 6|mesh-list
5911142|NCT03287778|Vitamins|vitamins|mesh-ancestor
5911143|NCT03287778|Micronutrients|micronutrients|mesh-ancestor
5911144|NCT03287778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911145|NCT03287778|Vitamin B Complex|vitamin b complex|mesh-ancestor
5911146|NCT03277170|Montelukast|montelukast|mesh-list
5911147|NCT03277170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5911148|NCT03277170|Respiratory System Agents|respiratory system agents|mesh-ancestor
5911149|NCT03277170|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5911150|NCT03277170|Hormone Antagonists|hormone antagonists|mesh-ancestor
5911151|NCT03277170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5911152|NCT03277170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212629|NCT02191579|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6212630|NCT02191579|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6212631|NCT02191579|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6212632|NCT02191579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6212633|NCT02191579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212634|NCT02191579|Cholinergic Agents|cholinergic agents|mesh-ancestor
5911153|NCT03277170|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5911154|NCT03277170|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5911155|NCT03277170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911156|NCT03271372|Avelumab|avelumab|mesh-list
5911157|NCT03271372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5698775|NCT03366415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5698776|NCT03366415|Antiviral Agents|antiviral agents|mesh-ancestor
5698777|NCT03366415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5698778|NCT03366415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5698779|NCT03366415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5698780|NCT03366415|Immunologic Factors|immunologic factors|mesh-ancestor
5698781|NCT03366415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698782|NCT03366259|Misoprostol|misoprostol|mesh-list
5698783|NCT03366259|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5698784|NCT03366259|Abortifacient Agents|abortifacient agents|mesh-ancestor
5911158|NCT03271372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5911159|NCT03271372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5911160|NCT03271372|Immunologic Factors|immunologic factors|mesh-ancestor
5911161|NCT03271372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911162|NCT03238196|Fulvestrant|fulvestrant|mesh-list
5911163|NCT03238196|Palbociclib|palbociclib|mesh-list
5911164|NCT03238196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5911165|NCT03238196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5911166|NCT03238196|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5911167|NCT03238196|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5911168|NCT03238196|Hormone Antagonists|hormone antagonists|mesh-ancestor
5911169|NCT03238196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5911170|NCT03238196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911171|NCT03238196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5911172|NCT03238196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5911173|NCT03238196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911174|NCT03126331|Nivolumab|nivolumab|mesh-list
5911175|NCT03126331|Ipilimumab|ipilimumab|mesh-list
5911176|NCT03126331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5911177|NCT03126331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5911178|NCT03126331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5911179|NCT03126331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911180|NCT03077685|Paclitaxel|paclitaxel|mesh-list
5911181|NCT03077685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5911182|NCT03077685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5911183|NCT03077685|Tubulin Modulators|tubulin modulators|mesh-ancestor
5911184|NCT03077685|Antimitotic Agents|antimitotic agents|mesh-ancestor
5911185|NCT03077685|Mitosis Modulators|mitosis modulators|mesh-ancestor
5911186|NCT03077685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911187|NCT03029403|Cyclophosphamide|cyclophosphamide|mesh-list
5911188|NCT03029403|Pembrolizumab|pembrolizumab|mesh-list
5911189|NCT03029403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5911190|NCT03029403|Immunologic Factors|immunologic factors|mesh-ancestor
5911191|NCT03029403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911192|NCT03029403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5911193|NCT03029403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5911194|NCT03029403|Alkylating Agents|alkylating agents|mesh-ancestor
5911195|NCT03029403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911196|NCT03029403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5911197|NCT03029403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5911198|NCT03029403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5911199|NCT02989636|Nivolumab|nivolumab|mesh-list
5911200|NCT02989636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5911201|NCT02989636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5911202|NCT02989636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5911203|NCT02989636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911204|NCT02762669|Oxytocin|oxytocin|mesh-list
5911205|NCT02762669|Oxytocics|oxytocics|mesh-ancestor
5911206|NCT02762669|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5911207|NCT02762669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911208|NCT02716948|Nivolumab|nivolumab|mesh-list
5911209|NCT02716948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5911210|NCT02716948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5911211|NCT02716948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5911212|NCT02716948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911213|NCT02681237|Olaparib|olaparib|mesh-list
5911214|NCT02681237|Cediranib|cediranib|mesh-list
5962917|NCT04606914|Mitosis Modulators|mitosis modulators|mesh-ancestor
6675738|NCT01577407|Sensory System Agents|sensory system agents|mesh-ancestor
6675739|NCT01577407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6675740|NCT01577407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675741|NCT01577459|Tedizolid phosphate|tedizolid phosphate|mesh-list
6675742|NCT01577459|Tedizolid|tedizolid|mesh-list
6675743|NCT01577459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6675744|NCT01577459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6675745|NCT01577524|Povidone-Iodine|povidone-iodine|mesh-list
6675746|NCT01577524|Povidone|povidone|mesh-list
6675747|NCT01577524|Plasma Substitutes|plasma substitutes|mesh-ancestor
5911215|NCT02681237|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5911216|NCT02681237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5911217|NCT02681237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911218|NCT02681237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5911219|NCT02681237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5911220|NCT02431897|Estrogens|estrogens|mesh-list
5911221|NCT02431897|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
5911222|NCT02431897|Hormones|hormones|mesh-ancestor
5911223|NCT02431897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5911224|NCT02431897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911225|NCT02154490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5911226|NCT02154490|Nivolumab|nivolumab|mesh-list
5911227|NCT02154490|Ipilimumab|ipilimumab|mesh-list
5911228|NCT02154490|Durvalumab|durvalumab|mesh-list
5911229|NCT02154490|Rilotumumab|rilotumumab|mesh-list
5911230|NCT02154490|Docetaxel|docetaxel|mesh-list
5911231|NCT02154490|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5911232|NCT02154490|Palbociclib|palbociclib|mesh-list
5911233|NCT02154490|Tremelimumab|tremelimumab|mesh-list
5911234|NCT02154490|Talazoparib|talazoparib|mesh-list
5911235|NCT02154490|Antibodies|antibodies|mesh-list
5911236|NCT02154490|Immunoglobulins|immunoglobulins|mesh-list
5911237|NCT02154490|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5911238|NCT02154490|Immunoglobulin G|immunoglobulin g|mesh-list
5911239|NCT02154490|Immunologic Factors|immunologic factors|mesh-ancestor
5911240|NCT02154490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911241|NCT02154490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5911242|NCT02154490|Tubulin Modulators|tubulin modulators|mesh-ancestor
5911243|NCT02154490|Antimitotic Agents|antimitotic agents|mesh-ancestor
5911244|NCT02154490|Mitosis Modulators|mitosis modulators|mesh-ancestor
5911245|NCT02154490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911246|NCT02154490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5911247|NCT02154490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5911248|NCT02154490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5911249|NCT02154490|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5911250|NCT01641107|Ponatinib|ponatinib|mesh-list
5911251|NCT01641107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5911252|NCT01641107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5911253|NCT01641107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5911254|NCT01641107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911255|NCT00843037|Sunitinib|sunitinib|mesh-list
5911256|NCT00843037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5911257|NCT00843037|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5911258|NCT00843037|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5911259|NCT00843037|Growth Substances|growth substances|mesh-ancestor
5911260|NCT00843037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911261|NCT00843037|Growth Inhibitors|growth inhibitors|mesh-ancestor
5911262|NCT00843037|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5911263|NCT00843037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5911264|NCT00843037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911265|NCT00054964|Albuterol|albuterol|mesh-list
5911266|NCT00054964|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5911267|NCT00054964|Autonomic Agents|autonomic agents|mesh-ancestor
5911268|NCT00054964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5911269|NCT00054964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911270|NCT00054964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5911271|NCT00054964|Respiratory System Agents|respiratory system agents|mesh-ancestor
5911272|NCT00054964|Tocolytic Agents|tocolytic agents|mesh-ancestor
5911273|NCT00054964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5911274|NCT00054964|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5911275|NCT00054964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5911276|NCT00054964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5911277|NCT00054964|Adrenergic Agents|adrenergic agents|mesh-ancestor
5911278|NCT00054964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6675748|NCT01577524|Blood Substitutes|blood substitutes|mesh-ancestor
6675749|NCT01577524|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5911279|NCT00054964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911280|NCT00045201|Irinotecan|irinotecan|mesh-list
5911281|NCT00045201|Camptothecin|camptothecin|mesh-list
5911282|NCT00045201|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5911283|NCT00045201|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5911284|NCT00045201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5911285|NCT00045201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5911286|NCT00045201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911287|NCT00045201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5911288|NCT00045201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5911289|NCT00045201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5911290|NCT05073692|Liraglutide|liraglutide|mesh-list
5911291|NCT05073692|Empagliflozin|empagliflozin|mesh-list
5911292|NCT05073692|Exenatide|exenatide|mesh-list
5911293|NCT05073692|Glimepiride|glimepiride|mesh-list
5911294|NCT05073692|Linagliptin|linagliptin|mesh-list
5911295|NCT05073692|Saxagliptin|saxagliptin|mesh-list
5911296|NCT05073692|Alogliptin|alogliptin|mesh-list
5911297|NCT05073692|Glipizide|glipizide|mesh-list
5911298|NCT05073692|Glucagon|glucagon|mesh-list
5911299|NCT05073692|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5911300|NCT05073692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5911301|NCT05073692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911302|NCT05073692|Incretins|incretins|mesh-ancestor
5911303|NCT05073692|Hormones|hormones|mesh-ancestor
5911304|NCT05073692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5911305|NCT05073692|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5911306|NCT05073692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911307|NCT05073692|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5911308|NCT05073692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5911309|NCT05073692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5911310|NCT05073692|Immunologic Factors|immunologic factors|mesh-ancestor
5911311|NCT05073692|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5911312|NCT05073692|Protease Inhibitors|protease inhibitors|mesh-ancestor
5911313|NCT05073692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5911314|NCT05073692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5911315|NCT05073640|Pentoxifylline|pentoxifylline|mesh-list
5911316|NCT05073640|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5911317|NCT05073640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5911318|NCT05073640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911319|NCT05073640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5911320|NCT05073640|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5911321|NCT05073640|Protective Agents|protective agents|mesh-ancestor
5911322|NCT05073640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911323|NCT05073640|Vasodilator Agents|vasodilator agents|mesh-ancestor
5911324|NCT05073640|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5911325|NCT05073640|Antioxidants|antioxidants|mesh-ancestor
5911326|NCT05073744|Morphine|morphine|mesh-list
5911327|NCT05073744|Nalbuphine|nalbuphine|mesh-list
5911328|NCT05073744|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5911329|NCT05073744|Narcotics|narcotics|mesh-ancestor
5911330|NCT05073744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5911331|NCT05073744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911332|NCT05073744|Analgesics|analgesics|mesh-ancestor
5911333|NCT05073744|Sensory System Agents|sensory system agents|mesh-ancestor
5911334|NCT05073744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5911335|NCT05073094|Esmolol|esmolol|mesh-list
5911336|NCT05073094|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5911337|NCT05073094|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5911338|NCT05073094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5911339|NCT05073094|Adrenergic Agents|adrenergic agents|mesh-ancestor
5911340|NCT05073094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5911341|NCT05073094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911342|NCT05073094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911343|NCT05073055|Anesthetics|anesthetics|mesh-list
5911344|NCT05073055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5911345|NCT05073055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911346|NCT05073029|Vitamin D|vitamin d|mesh-list
5911347|NCT05073029|Cholecalciferol|cholecalciferol|mesh-list
5911348|NCT05073029|Vitamins|vitamins|mesh-ancestor
5911349|NCT05073029|Micronutrients|micronutrients|mesh-ancestor
5911350|NCT05073029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911351|NCT05073029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5911352|NCT05073029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5911353|NCT05072938|Nizatidine|nizatidine|mesh-list
5911354|NCT05072938|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5698785|NCT03366259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5698786|NCT03366259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698787|NCT03366259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5698788|NCT03366259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5698789|NCT03366259|Oxytocics|oxytocics|mesh-ancestor
5698790|NCT03366246|Lidocaine|lidocaine|mesh-list
5698791|NCT03366246|Prilocaine|prilocaine|mesh-list
5698792|NCT03366246|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
5698793|NCT03366246|Anesthetics, Local|anesthetics, local|mesh-ancestor
5698794|NCT03366246|Anesthetics|anesthetics|mesh-ancestor
5698795|NCT03366246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5698796|NCT03366246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698797|NCT03366246|Sensory System Agents|sensory system agents|mesh-ancestor
5698798|NCT03366246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5698799|NCT03366246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5698800|NCT03366246|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5698801|NCT03366246|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5698802|NCT03366246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5698803|NCT03366246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5698804|NCT03366246|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
5698805|NCT03366064|Pemetrexed|pemetrexed|mesh-list
5698806|NCT03366064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5698807|NCT03366064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5698808|NCT03366064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911355|NCT05072938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5911356|NCT05072938|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5911357|NCT05072938|Histamine Antagonists|histamine antagonists|mesh-ancestor
5911358|NCT05072938|Histamine Agents|histamine agents|mesh-ancestor
5911359|NCT05072938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5911360|NCT05072938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911361|NCT05072938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962918|NCT04606914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962919|NCT04606836|Bupivacaine|bupivacaine|mesh-list
5962920|NCT04606836|Anesthetics, Local|anesthetics, local|mesh-ancestor
5962921|NCT04606836|Anesthetics|anesthetics|mesh-ancestor
5962922|NCT04606836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5698809|NCT03366064|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5698810|NCT03366064|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5698811|NCT03366025|Progesterone|progesterone|mesh-list
5962923|NCT04606836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962924|NCT04606836|Sensory System Agents|sensory system agents|mesh-ancestor
5962925|NCT04606836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5962926|NCT04606901|Glycopyrrolate|glycopyrrolate|mesh-list
5962927|NCT04606901|Neostigmine|neostigmine|mesh-list
5962928|NCT04606901|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5962929|NCT04606901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5962930|NCT04606901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962931|NCT04606901|Cholinergic Agents|cholinergic agents|mesh-ancestor
5962932|NCT04606901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5962933|NCT04606901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962934|NCT04606901|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5962935|NCT04606901|Autonomic Agents|autonomic agents|mesh-ancestor
5962936|NCT04606901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5962937|NCT04606901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5962938|NCT04606901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5698812|NCT03366025|Progestins|progestins|mesh-ancestor
5698813|NCT03366025|Hormones|hormones|mesh-ancestor
5698814|NCT03366025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5698815|NCT03366025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698816|NCT03365999|Tranexamic Acid|tranexamic acid|mesh-list
5698817|NCT03365999|Aminocaproic Acid|aminocaproic acid|mesh-list
5698818|NCT03365999|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5698819|NCT03365999|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5698820|NCT03365999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5698821|NCT03365999|Hemostatics|hemostatics|mesh-ancestor
5698822|NCT03365999|Coagulants|coagulants|mesh-ancestor
5698823|NCT03365869|Sirolimus|sirolimus|mesh-list
5698824|NCT03365869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5698825|NCT03365869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5698826|NCT03365869|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5698827|NCT03365869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5698828|NCT03365869|Antifungal Agents|antifungal agents|mesh-ancestor
5698829|NCT03365869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5911362|NCT05072899|Hyaluronic Acid|hyaluronic acid|mesh-list
5911363|NCT05072899|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5911364|NCT05072899|Immunologic Factors|immunologic factors|mesh-ancestor
5911365|NCT05072899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911366|NCT05072899|Viscosupplements|viscosupplements|mesh-ancestor
5911367|NCT05072899|Protective Agents|protective agents|mesh-ancestor
5911368|NCT05072860|Tranexamic Acid|tranexamic acid|mesh-list
5911369|NCT05072860|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5911370|NCT05072860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5911371|NCT05072860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911372|NCT05072860|Hemostatics|hemostatics|mesh-ancestor
5911373|NCT05072860|Coagulants|coagulants|mesh-ancestor
5698830|NCT03365869|Immunologic Factors|immunologic factors|mesh-ancestor
5698831|NCT03365869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698832|NCT03365817|Fentanyl|fentanyl|mesh-list
6496614|NCT00628732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6496615|NCT00628732|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6496616|NCT00628732|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6496617|NCT00628732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6496618|NCT00628732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5911374|NCT05072873|Tranexamic Acid|tranexamic acid|mesh-list
5911375|NCT05072873|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5911376|NCT05072873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5911377|NCT05072873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911378|NCT05072873|Hemostatics|hemostatics|mesh-ancestor
5911379|NCT05072873|Coagulants|coagulants|mesh-ancestor
5911380|NCT05072782|Methotrexate|methotrexate|mesh-list
5911381|NCT05072782|Infliximab|infliximab|mesh-list
5911382|NCT05072782|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5911383|NCT05072782|Abortifacient Agents|abortifacient agents|mesh-ancestor
5911384|NCT05072782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5911385|NCT05072782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911386|NCT05072782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5911387|NCT05072782|Antimetabolites|antimetabolites|mesh-ancestor
5911388|NCT05072782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911389|NCT05072782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5911390|NCT05072782|Dermatologic Agents|dermatologic agents|mesh-ancestor
5911391|NCT05072782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5911392|NCT05072782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5911393|NCT05072782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5911394|NCT05072782|Immunologic Factors|immunologic factors|mesh-ancestor
5911395|NCT05072782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5911396|NCT05072782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5911397|NCT05072782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5911398|NCT05072821|Botulinum Toxins|botulinum toxins|mesh-list
5911399|NCT05072821|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5911400|NCT05072821|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5911401|NCT05072821|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5911402|NCT05072821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5911403|NCT05072821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911404|NCT05072821|Cholinergic Agents|cholinergic agents|mesh-ancestor
5911405|NCT05072821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5911406|NCT05072821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911407|NCT05072821|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5911408|NCT05072821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5911409|NCT05072691|Immunoglobulins|immunoglobulins|mesh-list
5911410|NCT05072691|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5911411|NCT05072691|Antibodies|antibodies|mesh-list
5911412|NCT05072691|Immunologic Factors|immunologic factors|mesh-ancestor
5911413|NCT05072691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911414|NCT05072405|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5911415|NCT05072405|Simvastatin|simvastatin|mesh-list
5911416|NCT05072405|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5911417|NCT05072405|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5911418|NCT05072405|Antimetabolites|antimetabolites|mesh-ancestor
5911419|NCT05072405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911420|NCT05072405|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5911421|NCT05072405|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5698833|NCT03365817|Morphine|morphine|mesh-list
5698834|NCT03365817|Oxycodone|oxycodone|mesh-list
5698835|NCT03365817|Analgesics, Opioid|analgesics, opioid|mesh-list
5698836|NCT03365817|Tramadol|tramadol|mesh-list
5698837|NCT03365817|Methadone|methadone|mesh-list
5698838|NCT03365817|Narcotics|narcotics|mesh-ancestor
5698839|NCT03365817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5698840|NCT03365817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911422|NCT05072405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5911423|NCT05072249|Naloxone|naloxone|mesh-list
5911424|NCT05072249|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5911425|NCT05072249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911426|NCT05072249|Sensory System Agents|sensory system agents|mesh-ancestor
5911427|NCT05072249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5911428|NCT05072262|Dexamethasone|dexamethasone|mesh-list
5911429|NCT05072262|Nepafenac|nepafenac|mesh-list
5911430|NCT05072262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5911431|NCT05072262|Antiemetics|antiemetics|mesh-ancestor
5911432|NCT05072262|Autonomic Agents|autonomic agents|mesh-ancestor
5911433|NCT05072262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5911434|NCT05072262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911435|NCT05072262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5911436|NCT05072262|Glucocorticoids|glucocorticoids|mesh-ancestor
5911437|NCT05072262|Hormones|hormones|mesh-ancestor
5911438|NCT05072262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5911439|NCT05072262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5911440|NCT05072262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5911441|NCT05072262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5911442|NCT05072262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5911443|NCT05072262|Analgesics|analgesics|mesh-ancestor
5911444|NCT05072262|Sensory System Agents|sensory system agents|mesh-ancestor
5911445|NCT05072262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5911446|NCT05072314|Lidocaine|lidocaine|mesh-list
5911447|NCT05072314|Anesthetics, Local|anesthetics, local|mesh-ancestor
5911448|NCT05072314|Anesthetics|anesthetics|mesh-ancestor
5911449|NCT05072314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5911450|NCT05072314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911451|NCT05072314|Sensory System Agents|sensory system agents|mesh-ancestor
5911452|NCT05072314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5911453|NCT05072314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5911454|NCT05072314|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5911455|NCT05072314|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6496619|NCT00628810|Leucovorin|leucovorin|mesh-list
6496620|NCT00628810|Bevacizumab|bevacizumab|mesh-list
6496621|NCT00628810|Fluorouracil|fluorouracil|mesh-list
6496622|NCT00628810|Irinotecan|irinotecan|mesh-list
6496623|NCT00628810|Calcium|calcium|mesh-list
6496624|NCT00628810|Levoleucovorin|levoleucovorin|mesh-list
6496625|NCT00628810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6496626|NCT00628810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6496627|NCT00628810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6675750|NCT01577524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6675751|NCT01577550|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6675752|NCT01577550|Immunologic Factors|immunologic factors|mesh-ancestor
6675753|NCT01577550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675754|NCT01577589|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
6675755|NCT01577589|Cephalosporins|cephalosporins|mesh-list
6675756|NCT01577589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6675757|NCT01577589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6496628|NCT00628810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5911456|NCT05072314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5911457|NCT05072314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911458|NCT05072106|Bosentan|bosentan|mesh-list
5911459|NCT05072106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5911460|NCT05072106|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5911461|NCT05072106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911462|NCT05071794|Propofol|propofol|mesh-list
5911463|NCT05071794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5911464|NCT05071794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5911465|NCT05071794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911466|NCT05071794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5911467|NCT05071794|Anesthetics, General|anesthetics, general|mesh-ancestor
5911468|NCT05071794|Anesthetics|anesthetics|mesh-ancestor
5911469|NCT05071716|Rifaximin|rifaximin|mesh-list
5911470|NCT05071716|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5911471|NCT05071716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5911472|NCT05071716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5911473|NCT05071482|Imatinib Mesylate|imatinib mesylate|mesh-list
5911474|NCT05071482|HH-GV-678|hh-gv-678|mesh-list
5911475|NCT05071482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5911476|NCT05071482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5911477|NCT05071482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5970449|NCT04534725|Interferons|interferons|mesh-list
6496629|NCT00628810|Growth Substances|growth substances|mesh-ancestor
6675758|NCT01577693|Dutasteride|dutasteride|mesh-list
5911478|NCT05071482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911479|NCT05071703|Carboplatin|carboplatin|mesh-list
5911480|NCT05071703|Etoposide|etoposide|mesh-list
5911481|NCT05071703|Topotecan|topotecan|mesh-list
5911482|NCT05071703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5911483|NCT05071703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5911484|NCT05071703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5911485|NCT05071703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5911486|NCT05071703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5911487|NCT05071703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911488|NCT05071703|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5911489|NCT05071781|Hormones|hormones|mesh-list
5911490|NCT05071781|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
5911491|NCT05071781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5911492|NCT05071781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911493|NCT05071352|Nefopam|nefopam|mesh-list
6496630|NCT00628810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496631|NCT00628810|Growth Inhibitors|growth inhibitors|mesh-ancestor
6496632|NCT00628810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5911494|NCT05071352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5911495|NCT05071352|Analgesics|analgesics|mesh-ancestor
5911496|NCT05071352|Sensory System Agents|sensory system agents|mesh-ancestor
5911497|NCT05071352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5911498|NCT05071352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911499|NCT05071339|Ganirelix|ganirelix|mesh-list
5911500|NCT05071339|Hormone Antagonists|hormone antagonists|mesh-ancestor
5911501|NCT05071339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5911502|NCT05071339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911503|NCT05071118|Pregabalin|pregabalin|mesh-list
5911504|NCT05071118|Analgesics|analgesics|mesh-ancestor
6496633|NCT00628810|Antimetabolites|antimetabolites|mesh-ancestor
6496634|NCT00628810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496635|NCT00628810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5698841|NCT03365817|Analgesics|analgesics|mesh-ancestor
5698842|NCT03365817|Sensory System Agents|sensory system agents|mesh-ancestor
5698843|NCT03365817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5698844|NCT03365817|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5698845|NCT03365817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5698846|NCT03365817|Anesthetics, General|anesthetics, general|mesh-ancestor
5698847|NCT03365817|Anesthetics|anesthetics|mesh-ancestor
5698848|NCT03365817|Antitussive Agents|antitussive agents|mesh-ancestor
6675759|NCT01577693|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6675760|NCT01577693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6675761|NCT01577693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6675762|NCT01577693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675763|NCT01577693|Hormone Antagonists|hormone antagonists|mesh-ancestor
5911505|NCT05071118|Sensory System Agents|sensory system agents|mesh-ancestor
5911506|NCT05071118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5911507|NCT05071118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911508|NCT05071118|Anticonvulsants|anticonvulsants|mesh-ancestor
5911509|NCT05071118|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5911510|NCT05071118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5911511|NCT05071118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911512|NCT05071118|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5911513|NCT05071118|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5911514|NCT05071118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5911515|NCT05071118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5911516|NCT05071118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5911517|NCT05070520|Lumefantrine|lumefantrine|mesh-list
5911518|NCT05070520|Artemether|artemether|mesh-list
5911519|NCT05070520|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
5911520|NCT05070520|Antimalarials|antimalarials|mesh-ancestor
6496636|NCT00628810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6496637|NCT00628810|Immunologic Factors|immunologic factors|mesh-ancestor
6496638|NCT00628810|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6496639|NCT00628810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6496640|NCT00628810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6496641|NCT00628810|Antidotes|antidotes|mesh-ancestor
6496642|NCT00628810|Protective Agents|protective agents|mesh-ancestor
6496643|NCT00628810|Vitamin B Complex|vitamin b complex|mesh-ancestor
6675764|NCT01577693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5698849|NCT03365817|Respiratory System Agents|respiratory system agents|mesh-ancestor
6496644|NCT00628810|Vitamins|vitamins|mesh-ancestor
6496645|NCT00628810|Micronutrients|micronutrients|mesh-ancestor
6496646|NCT00628914|Dexetimide|dexetimide|mesh-list
6496647|NCT00628914|Eszopiclone|eszopiclone|mesh-list
5911521|NCT05070520|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5911522|NCT05070520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5698850|NCT03365765|Fluorouracil|fluorouracil|mesh-list
5698851|NCT03365765|Oxaliplatin|oxaliplatin|mesh-list
5698852|NCT03365765|Apatinib|apatinib|mesh-list
5698853|NCT03365765|Antimetabolites|antimetabolites|mesh-ancestor
5698854|NCT03365765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5698855|NCT03365765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5698856|NCT03365765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5698857|NCT03365765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5911523|NCT05070520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5911524|NCT05070416|Lithium Carbonate|lithium carbonate|mesh-list
5911525|NCT05070416|Antidepressive Agents|antidepressive agents|mesh-ancestor
5911526|NCT05070416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5911527|NCT05070416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5911528|NCT05070416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911529|NCT05070416|Antimanic Agents|antimanic agents|mesh-ancestor
5911530|NCT05070416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5911531|NCT05070416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5911532|NCT05070416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911533|NCT05070468|Dexamethasone|dexamethasone|mesh-list
5911534|NCT05070468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5911535|NCT05070468|Antiemetics|antiemetics|mesh-ancestor
5911536|NCT05070468|Autonomic Agents|autonomic agents|mesh-ancestor
5911537|NCT05070468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5911538|NCT05070468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911539|NCT05070468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5911540|NCT05070468|Glucocorticoids|glucocorticoids|mesh-ancestor
5911541|NCT05070468|Hormones|hormones|mesh-ancestor
5911542|NCT05070468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5911543|NCT05070468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5911544|NCT05070468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5911545|NCT05070598|Paclitaxel|paclitaxel|mesh-list
5911546|NCT05070598|Tegafur|tegafur|mesh-list
5911547|NCT05070598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5911548|NCT05070598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5911549|NCT05070598|Tubulin Modulators|tubulin modulators|mesh-ancestor
5911550|NCT05070598|Antimitotic Agents|antimitotic agents|mesh-ancestor
5911551|NCT05070598|Mitosis Modulators|mitosis modulators|mesh-ancestor
5911552|NCT05070598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911553|NCT05070598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5911554|NCT05070598|Antimetabolites|antimetabolites|mesh-ancestor
5911555|NCT05070260|Glenzocimab|glenzocimab|mesh-list
5911556|NCT05070260|Anticoagulants|anticoagulants|mesh-ancestor
5911557|NCT05070195|Midazolam|midazolam|mesh-list
5911558|NCT05070195|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5911559|NCT05070195|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5911560|NCT05070195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5911561|NCT05070195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911562|NCT05070195|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5911563|NCT05070195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5911564|NCT05070195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5911565|NCT05070195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5911566|NCT05070195|Anesthetics, General|anesthetics, general|mesh-ancestor
5911567|NCT05070195|Anesthetics|anesthetics|mesh-ancestor
5911568|NCT05070195|GABA Modulators|gaba modulators|mesh-ancestor
5911569|NCT05070195|GABA Agents|gaba agents|mesh-ancestor
5911570|NCT05070195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5911571|NCT05070195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962939|NCT04606901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5962940|NCT04606563|Losartan|losartan|mesh-list
5962941|NCT04606563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5962942|NCT04606563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5962943|NCT04606563|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5962944|NCT04606563|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5962945|NCT04606563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962946|NCT04606537|Itraconazole|itraconazole|mesh-list
5962947|NCT04606537|Rifampin|rifampin|mesh-list
5962948|NCT04606537|Antifungal Agents|antifungal agents|mesh-ancestor
5962949|NCT04606537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5962950|NCT04606537|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5962951|NCT04606537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5962952|NCT04606537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6496648|NCT00628914|Citalopram|citalopram|mesh-list
5911572|NCT05070221|Axitinib|axitinib|mesh-list
5911573|NCT05070221|Antibodies|antibodies|mesh-list
5911574|NCT05070221|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5911575|NCT05070221|Immunologic Factors|immunologic factors|mesh-ancestor
5911576|NCT05070221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911577|NCT05070221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5911578|NCT05070221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5911579|NCT05070221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5911580|NCT05070221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911581|NCT05069870|Itraconazole|itraconazole|mesh-list
5911582|NCT05069870|Rifampin|rifampin|mesh-list
5911583|NCT05069870|Gemfibrozil|gemfibrozil|mesh-list
5911584|NCT05069870|Antifungal Agents|antifungal agents|mesh-ancestor
5911585|NCT05069870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5911586|NCT05069870|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5911587|NCT05069870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5911588|NCT05069870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5911589|NCT05069870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911590|NCT05069870|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5911591|NCT05069870|Hormone Antagonists|hormone antagonists|mesh-ancestor
5911592|NCT05069870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5911593|NCT05069870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911594|NCT05069870|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5911595|NCT05069870|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5911596|NCT05069870|Antitubercular Agents|antitubercular agents|mesh-ancestor
5911597|NCT05069870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5911598|NCT05069870|Leprostatic Agents|leprostatic agents|mesh-ancestor
5911599|NCT05069870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5911600|NCT05069870|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5911601|NCT05069870|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5911602|NCT05069870|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5911603|NCT05069870|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5911604|NCT05069870|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5911605|NCT05069870|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5911606|NCT05069870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5911607|NCT05069870|Antimetabolites|antimetabolites|mesh-ancestor
5911608|NCT05069870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5911609|NCT05069870|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
5911610|NCT05070104|Bevacizumab|bevacizumab|mesh-list
5911611|NCT05070104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5911612|NCT05070104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5911613|NCT05070104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5911614|NCT05070104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5911615|NCT05070104|Growth Substances|growth substances|mesh-ancestor
5911616|NCT05070104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911617|NCT05070104|Growth Inhibitors|growth inhibitors|mesh-ancestor
5698858|NCT03365765|Immunologic Factors|immunologic factors|mesh-ancestor
5698859|NCT03365765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698860|NCT03365765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5698861|NCT03365765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5698862|NCT03365752|Anesthetics|anesthetics|mesh-list
5698863|NCT03365752|Mepivacaine|mepivacaine|mesh-list
5698864|NCT03365752|Chloroprocaine|chloroprocaine|mesh-list
5698865|NCT03365752|Anesthetics, General|anesthetics, general|mesh-list
5911618|NCT05069935|Cyclophosphamide|cyclophosphamide|mesh-list
5911619|NCT05069935|Fludarabine|fludarabine|mesh-list
5911620|NCT05069935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5911621|NCT05069935|Antibodies|antibodies|mesh-list
5911622|NCT05069935|Immunoglobulins|immunoglobulins|mesh-list
5698866|NCT03365752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5698867|NCT03365752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698868|NCT03365752|Anesthetics, Local|anesthetics, local|mesh-ancestor
5698869|NCT03365752|Sensory System Agents|sensory system agents|mesh-ancestor
5698870|NCT03365752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5698871|NCT03365726|Dobutamine|dobutamine|mesh-list
5698872|NCT03365726|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5698873|NCT03365726|Sympathomimetics|sympathomimetics|mesh-ancestor
5698874|NCT03365726|Autonomic Agents|autonomic agents|mesh-ancestor
5698875|NCT03365726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5698876|NCT03365726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698877|NCT03365726|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5911623|NCT05069935|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5698878|NCT03365726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5698879|NCT03365726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5911624|NCT05069935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5911625|NCT05069935|Immunologic Factors|immunologic factors|mesh-ancestor
5911626|NCT05069935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911627|NCT05069935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5911628|NCT05069935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5911629|NCT05069935|Alkylating Agents|alkylating agents|mesh-ancestor
5911630|NCT05069935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911631|NCT05069935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5911632|NCT05069935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5911633|NCT05069779|Diazepam|diazepam|mesh-list
5911634|NCT05069779|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5911635|NCT05069779|Anticonvulsants|anticonvulsants|mesh-ancestor
5911636|NCT05069779|Antiemetics|antiemetics|mesh-ancestor
5911637|NCT05069779|Autonomic Agents|autonomic agents|mesh-ancestor
5911638|NCT05069779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5911639|NCT05069779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911640|NCT05069779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5911641|NCT05069779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5911642|NCT05069779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5911643|NCT05069779|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5911644|NCT05069779|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5911645|NCT05069779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5911646|NCT05069779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5911647|NCT05069779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5911648|NCT05069779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5911649|NCT05069779|Anesthetics, General|anesthetics, general|mesh-ancestor
5911650|NCT05069779|Anesthetics|anesthetics|mesh-ancestor
5911651|NCT05069779|GABA Modulators|gaba modulators|mesh-ancestor
5698880|NCT03365726|Adrenergic Agents|adrenergic agents|mesh-ancestor
5698881|NCT03365726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5698882|NCT03365726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911652|NCT05069779|GABA Agents|gaba agents|mesh-ancestor
5911653|NCT05069779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5911654|NCT05069779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911655|NCT05069454|Vaccines|vaccines|mesh-list
5911656|NCT05069454|Immunologic Factors|immunologic factors|mesh-ancestor
5911657|NCT05069454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911658|NCT05069688|Rifampin|rifampin|mesh-list
5911659|NCT05069688|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5911660|NCT05069688|Antitubercular Agents|antitubercular agents|mesh-ancestor
5911661|NCT05069688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5911662|NCT05069688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5911663|NCT05069688|Leprostatic Agents|leprostatic agents|mesh-ancestor
5911664|NCT05069688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5911665|NCT05069688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5911666|NCT05069688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911667|NCT05069688|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5911668|NCT05069688|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5911669|NCT05069688|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5911670|NCT05069688|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5911671|NCT05069688|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5911672|NCT05069688|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5911673|NCT05069298|Silybin|silybin|mesh-list
5911674|NCT05069298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5911675|NCT05069298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5911676|NCT05069298|Protective Agents|protective agents|mesh-ancestor
5911677|NCT05069298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911678|NCT05069038|Palbociclib|palbociclib|mesh-list
5911679|NCT05069038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5911680|NCT05069038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5911681|NCT05069038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5911682|NCT05069038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911683|NCT05068960|Bupivacaine|bupivacaine|mesh-list
5911684|NCT05068960|Anesthetics, Local|anesthetics, local|mesh-ancestor
5911685|NCT05068960|Anesthetics|anesthetics|mesh-ancestor
5911686|NCT05068960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5911687|NCT05068960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911688|NCT05068960|Sensory System Agents|sensory system agents|mesh-ancestor
5970450|NCT04534725|Interferon-alpha|interferon-alpha|mesh-list
5698883|NCT03365726|Protective Agents|protective agents|mesh-ancestor
5698884|NCT03365687|Vitamin D|vitamin d|mesh-list
5698885|NCT03365687|Cholecalciferol|cholecalciferol|mesh-list
5698886|NCT03365687|Vitamins|vitamins|mesh-ancestor
5698887|NCT03365687|Micronutrients|micronutrients|mesh-ancestor
5698888|NCT03365687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911689|NCT05068960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5911690|NCT05069246|Chlorhexidine|chlorhexidine|mesh-list
5911691|NCT05069246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5911692|NCT05069246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5911693|NCT05069246|Disinfectants|disinfectants|mesh-ancestor
5911694|NCT05068609|Nivolumab|nivolumab|mesh-list
5911695|NCT05068609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5911696|NCT05068609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5911697|NCT05068609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5911698|NCT05068609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911699|NCT05068401|Mycophenolic Acid|mycophenolic acid|mesh-list
5911700|NCT05068401|Sirolimus|sirolimus|mesh-list
5911701|NCT05068401|Cyclophosphamide|cyclophosphamide|mesh-list
5911702|NCT05068401|Busulfan|busulfan|mesh-list
5911703|NCT05068401|Fludarabine|fludarabine|mesh-list
5911704|NCT05068401|Sargramostim|sargramostim|mesh-list
5911705|NCT05068401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5911706|NCT05068401|Immunologic Factors|immunologic factors|mesh-ancestor
5911707|NCT05068401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911708|NCT05068401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5911709|NCT05068401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5911710|NCT05068401|Alkylating Agents|alkylating agents|mesh-ancestor
5911711|NCT05068401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496649|NCT00628914|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6496650|NCT00628914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6496651|NCT00628914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6496652|NCT00628914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496653|NCT00628914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6496654|NCT00628914|Serotonin Agents|serotonin agents|mesh-ancestor
6496655|NCT00628914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496656|NCT00628914|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6496657|NCT00628914|Antidepressive Agents|antidepressive agents|mesh-ancestor
6496658|NCT00628914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5911712|NCT05068401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5911713|NCT05068401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5911714|NCT05068401|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5911715|NCT05068401|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5911716|NCT05068401|Antitubercular Agents|antitubercular agents|mesh-ancestor
5911717|NCT05068401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5911718|NCT05068401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5911719|NCT05068401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5911720|NCT05068401|Antifungal Agents|antifungal agents|mesh-ancestor
5911721|NCT05068440|Zanubrutinib|zanubrutinib|mesh-list
5911722|NCT05068440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5911723|NCT05068440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5911724|NCT05068440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5911725|NCT05068440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911726|NCT05068349|3-n-butylphthalide|3-n-butylphthalide|mesh-list
5911727|NCT05068349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5911728|NCT05068349|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5911729|NCT05068349|Protective Agents|protective agents|mesh-ancestor
5911730|NCT05068349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911731|NCT05068453|Antibodies|antibodies|mesh-list
5911732|NCT05068453|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5911733|NCT05068453|Immunologic Factors|immunologic factors|mesh-ancestor
5911734|NCT05068453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911735|NCT05067699|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
5911736|NCT05067699|Calcifediol|calcifediol|mesh-list
5911737|NCT05067699|Vitamins|vitamins|mesh-ancestor
5911738|NCT05067699|Micronutrients|micronutrients|mesh-ancestor
5911739|NCT05067699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911740|NCT05067699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5962953|NCT04606537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962954|NCT04606537|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5962955|NCT04606537|Hormone Antagonists|hormone antagonists|mesh-ancestor
5962956|NCT04606537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5962957|NCT04606537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962958|NCT04606537|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5962959|NCT04606537|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5962960|NCT04606537|Antitubercular Agents|antitubercular agents|mesh-ancestor
5962961|NCT04606537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5962962|NCT04606537|Leprostatic Agents|leprostatic agents|mesh-ancestor
6242819|NCT02656329|Coagulants|coagulants|mesh-ancestor
5911741|NCT05067530|Paclitaxel|paclitaxel|mesh-list
5911742|NCT05067530|Carboplatin|carboplatin|mesh-list
5911743|NCT05067530|Palbociclib|palbociclib|mesh-list
5911744|NCT05067530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5911745|NCT05067530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5911746|NCT05067530|Tubulin Modulators|tubulin modulators|mesh-ancestor
5911747|NCT05067530|Antimitotic Agents|antimitotic agents|mesh-ancestor
5911748|NCT05067530|Mitosis Modulators|mitosis modulators|mesh-ancestor
5911749|NCT05067530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911750|NCT05067530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5911751|NCT05067530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5911752|NCT05067387|Dronabinol|dronabinol|mesh-list
5911753|NCT05067387|Hallucinogens|hallucinogens|mesh-ancestor
5911754|NCT05067387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911755|NCT05067387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5911756|NCT05067387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5911757|NCT05067387|Analgesics|analgesics|mesh-ancestor
5911758|NCT05067387|Sensory System Agents|sensory system agents|mesh-ancestor
5911759|NCT05067387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5911760|NCT05067387|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5911761|NCT05067387|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5911762|NCT05067387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5911763|NCT05067387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911764|NCT05067387|Hormones|hormones|mesh-ancestor
5911765|NCT05067387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5911766|NCT05067517|Nintedanib|nintedanib|mesh-list
5911767|NCT05067517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5911768|NCT05067517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5911769|NCT05067517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5911770|NCT05067517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911771|NCT05067153|Heparin|heparin|mesh-list
5911772|NCT05067153|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5911773|NCT05067153|Tinzaparin|tinzaparin|mesh-list
5911774|NCT05067153|Dalteparin|dalteparin|mesh-list
5911775|NCT05067153|Anticoagulants|anticoagulants|mesh-ancestor
5911776|NCT05067153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5911777|NCT05067153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5911778|NCT05067153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911779|NCT05067309|Letrozole|letrozole|mesh-list
5911780|NCT05067309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5911781|NCT05067309|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5698889|NCT03365687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5698890|NCT03365687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5698891|NCT03365479|Iloprost|iloprost|mesh-list
5698892|NCT03365479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5698893|NCT03365479|Vasodilator Agents|vasodilator agents|mesh-ancestor
5698894|NCT03365466|Aspirin|aspirin|mesh-list
5698895|NCT03365466|Heparin|heparin|mesh-list
5698896|NCT03365466|Calcium heparin|calcium heparin|mesh-list
5698897|NCT03365466|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5698898|NCT03365466|Tinzaparin|tinzaparin|mesh-list
5698899|NCT03365466|Dalteparin|dalteparin|mesh-list
5698900|NCT03365466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5698901|NCT03365466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5698902|NCT03365466|Analgesics|analgesics|mesh-ancestor
5698903|NCT03365466|Sensory System Agents|sensory system agents|mesh-ancestor
5698904|NCT03365466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5698905|NCT03365466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698906|NCT03365466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5698907|NCT03365466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5698908|NCT03365466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5698909|NCT03365466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5698910|NCT03365466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5698911|NCT03365466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5698912|NCT03365466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5698913|NCT03365466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5698914|NCT03365466|Antipyretics|antipyretics|mesh-ancestor
5698915|NCT03365466|Anticoagulants|anticoagulants|mesh-ancestor
5698916|NCT03365414|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5698917|NCT03365388|Hyaluronic Acid|hyaluronic acid|mesh-list
5911782|NCT05067309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5911783|NCT05067309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5911784|NCT05067309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911785|NCT05067309|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5698918|NCT03365388|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5698919|NCT03365388|Immunologic Factors|immunologic factors|mesh-ancestor
5911786|NCT05067309|Hormone Antagonists|hormone antagonists|mesh-ancestor
5911787|NCT05067309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5911788|NCT05067309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911789|NCT05066958|Antiviral Agents|antiviral agents|mesh-list
5911790|NCT05066958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5911791|NCT05066802|Folfirinox|folfirinox|mesh-list
5911792|NCT05066802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5911793|NCT05066568|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
5911794|NCT05066568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5911795|NCT05066568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911796|NCT05066516|Dapagliflozin|dapagliflozin|mesh-list
5911797|NCT05066516|Linagliptin|linagliptin|mesh-list
5698920|NCT03365388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698921|NCT03365388|Viscosupplements|viscosupplements|mesh-ancestor
5698922|NCT03365388|Protective Agents|protective agents|mesh-ancestor
5698923|NCT03365362|Varenicline|varenicline|mesh-list
5698924|NCT03365362|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5698925|NCT03365362|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5698926|NCT03365362|Cholinergic Agents|cholinergic agents|mesh-ancestor
5698927|NCT03365362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5698928|NCT03365362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911798|NCT05066516|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5911799|NCT05066516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911800|NCT05066516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5911801|NCT05066516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911802|NCT05066516|Incretins|incretins|mesh-ancestor
5911803|NCT05066516|Hormones|hormones|mesh-ancestor
5911804|NCT05066516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5911805|NCT05066516|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5911806|NCT05066516|Protease Inhibitors|protease inhibitors|mesh-ancestor
5911807|NCT05066516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5911808|NCT05066633|Metoprolol|metoprolol|mesh-list
5911809|NCT05066633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5911810|NCT05066633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5911811|NCT05066633|Sympatholytics|sympatholytics|mesh-ancestor
5911812|NCT05066633|Autonomic Agents|autonomic agents|mesh-ancestor
5911813|NCT05066633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5911814|NCT05066633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911815|NCT05066633|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5911816|NCT05066633|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5911817|NCT05066633|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5911818|NCT05066633|Adrenergic Agents|adrenergic agents|mesh-ancestor
5911819|NCT05066633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5911820|NCT05066633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911821|NCT05066607|Dexamethasone|dexamethasone|mesh-list
5911822|NCT05066607|Pomalidomide|pomalidomide|mesh-list
5911823|NCT05066607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5911824|NCT05066607|Antiemetics|antiemetics|mesh-ancestor
5911825|NCT05066607|Autonomic Agents|autonomic agents|mesh-ancestor
5911826|NCT05066607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5911827|NCT05066607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911828|NCT05066607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5911829|NCT05066607|Glucocorticoids|glucocorticoids|mesh-ancestor
5911830|NCT05066607|Hormones|hormones|mesh-ancestor
5911831|NCT05066607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5911832|NCT05066607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5911833|NCT05066607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5911834|NCT05066607|Immunologic Factors|immunologic factors|mesh-ancestor
5911835|NCT05066607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5911836|NCT05066607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5911837|NCT05066607|Growth Substances|growth substances|mesh-ancestor
5911838|NCT05066607|Growth Inhibitors|growth inhibitors|mesh-ancestor
5911839|NCT05066360|Hormones|hormones|mesh-list
5911840|NCT05066360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5911841|NCT05066360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911842|NCT05066061|Analgesics|analgesics|mesh-list
5911843|NCT05066061|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
5911844|NCT05066061|Sensory System Agents|sensory system agents|mesh-ancestor
5911845|NCT05066061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5911846|NCT05066061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496659|NCT00628914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6496660|NCT00628914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6496661|NCT00628914|Parasympatholytics|parasympatholytics|mesh-ancestor
6496662|NCT00628914|Autonomic Agents|autonomic agents|mesh-ancestor
5911847|NCT05066061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5911848|NCT05066061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5911849|NCT05066061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5911850|NCT05065866|Azacitidine|azacitidine|mesh-list
5911851|NCT05065866|Cc-486|cc-486|mesh-list
5911852|NCT05065866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5911853|NCT05065866|Antimetabolites|antimetabolites|mesh-ancestor
5911854|NCT05065866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911855|NCT05065866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5911856|NCT05065866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5911857|NCT05065736|Clofarabine|clofarabine|mesh-list
5911858|NCT05065736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5911859|NCT05065736|Antimetabolites|antimetabolites|mesh-ancestor
5911860|NCT05065736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911861|NCT05065736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5911862|NCT05065957|Capecitabine|capecitabine|mesh-list
5911863|NCT05065957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5911864|NCT05065957|Antimetabolites|antimetabolites|mesh-ancestor
5911865|NCT05065957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911866|NCT05065957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5911867|NCT05065658|Posaconazole|posaconazole|mesh-list
5911868|NCT05065658|Antifungal Agents|antifungal agents|mesh-ancestor
5911869|NCT05065658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5911870|NCT05065658|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5911871|NCT05065658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5911872|NCT05065658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5911873|NCT05065658|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5911874|NCT05065658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5911875|NCT05065658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5911876|NCT05065658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911877|NCT05065658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5911878|NCT05065658|Hormone Antagonists|hormone antagonists|mesh-ancestor
5911879|NCT05065658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5911880|NCT05065658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911881|NCT05065671|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5911882|NCT05065671|Tolcapone|tolcapone|mesh-list
5911883|NCT05065671|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5911884|NCT05065671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5911885|NCT05065671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5911886|NCT05065671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911887|NCT05065671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5911888|NCT05065671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698929|NCT03365362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698930|NCT03365336|Oseltamivir|oseltamivir|mesh-list
5698931|NCT03365336|Antiviral Agents|antiviral agents|mesh-ancestor
5698932|NCT03365336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5698933|NCT03365336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5698934|NCT03365336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5698935|NCT03365141|Triamcinolone|triamcinolone|mesh-list
5698936|NCT03365141|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5698937|NCT03365141|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5911889|NCT05065671|Analgesics|analgesics|mesh-ancestor
5911890|NCT05065671|Sensory System Agents|sensory system agents|mesh-ancestor
5911891|NCT05065671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5911892|NCT05065671|Antidepressive Agents|antidepressive agents|mesh-ancestor
5911893|NCT05065671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5911894|NCT05065671|Dopamine Agents|dopamine agents|mesh-ancestor
6496663|NCT00628914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5911895|NCT05065671|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5911896|NCT05065671|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5911897|NCT05065671|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
5911898|NCT05065671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5911899|NCT05065905|Interferons|interferons|mesh-list
5911900|NCT05065905|Interferon-gamma|interferon-gamma|mesh-list
5911901|NCT05065905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5911902|NCT05065905|Antiviral Agents|antiviral agents|mesh-ancestor
5911903|NCT05065905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5911904|NCT05066035|Neostigmine|neostigmine|mesh-list
5911905|NCT05066035|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5911906|NCT05066035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5911907|NCT05066035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911908|NCT05066035|Cholinergic Agents|cholinergic agents|mesh-ancestor
5698938|NCT03365141|Tacrolimus|tacrolimus|mesh-list
5911909|NCT05066035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5911910|NCT05066035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911911|NCT05066035|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5911912|NCT05066035|Autonomic Agents|autonomic agents|mesh-ancestor
5911913|NCT05066035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5911914|NCT05065645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5962963|NCT04606537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5962964|NCT04606537|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5962965|NCT04606537|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5962966|NCT04606537|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5962967|NCT04606537|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5698939|NCT03365141|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5698940|NCT03365141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5698941|NCT03365141|Immunologic Factors|immunologic factors|mesh-ancestor
5698942|NCT03365141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698943|NCT03365141|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5698944|NCT03365141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5962968|NCT04606537|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5962969|NCT04606537|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5962970|NCT04606212|Losartan|losartan|mesh-list
5962971|NCT04606212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5962972|NCT04606212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5962973|NCT04606212|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5962974|NCT04606212|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5962975|NCT04606212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962976|NCT04606225|Losartan|losartan|mesh-list
5962977|NCT04606225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5962978|NCT04606225|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5962979|NCT04606225|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5962980|NCT04606225|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5962981|NCT04606225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962982|NCT04606264|Lidocaine|lidocaine|mesh-list
5962983|NCT04606264|Morphine|morphine|mesh-list
5962984|NCT04606264|Hydromorphone|hydromorphone|mesh-list
5962985|NCT04606264|Ketamine|ketamine|mesh-list
5962986|NCT04606264|Gabapentin|gabapentin|mesh-list
5962987|NCT04606264|Aprepitant|aprepitant|mesh-list
5962988|NCT04606264|Anesthetics|anesthetics|mesh-list
5962989|NCT04606264|Perphenazine|perphenazine|mesh-list
5962990|NCT04606264|Anesthetics, Local|anesthetics, local|mesh-ancestor
5962991|NCT04606264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5962992|NCT04606264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962993|NCT04606264|Sensory System Agents|sensory system agents|mesh-ancestor
5962994|NCT04606264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5962995|NCT04606264|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5962996|NCT04606264|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5962997|NCT04606264|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5962998|NCT04606264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5962999|NCT04606264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963000|NCT04606264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5963001|NCT04606264|Narcotics|narcotics|mesh-ancestor
5963002|NCT04606264|Analgesics|analgesics|mesh-ancestor
5963003|NCT04606264|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5963004|NCT04606264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5963005|NCT04606264|Anesthetics, General|anesthetics, general|mesh-ancestor
5963006|NCT04606264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5963007|NCT04606264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5963008|NCT04606264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5963009|NCT04606264|Anticonvulsants|anticonvulsants|mesh-ancestor
5963010|NCT04606264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5963011|NCT04606264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5963012|NCT04606264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5963013|NCT04606264|Antimanic Agents|antimanic agents|mesh-ancestor
5963014|NCT04606264|Antiemetics|antiemetics|mesh-ancestor
5963015|NCT04606264|Autonomic Agents|autonomic agents|mesh-ancestor
5963016|NCT04606264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5963017|NCT04606264|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5963018|NCT04606264|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5963019|NCT04606264|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5963020|NCT04606264|Dopamine Agents|dopamine agents|mesh-ancestor
5963021|NCT04606082|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5698945|NCT03365141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5698946|NCT03365141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5698947|NCT03365141|Glucocorticoids|glucocorticoids|mesh-ancestor
5911915|NCT05065164|Denosumab|denosumab|mesh-list
5911916|NCT05065164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5911917|NCT05065164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911918|NCT05065177|Vaccines|vaccines|mesh-list
5911919|NCT05065177|Immunologic Factors|immunologic factors|mesh-ancestor
5911920|NCT05065177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911921|NCT05065567|Droperidol|droperidol|mesh-list
5911922|NCT05065567|Haloperidol|haloperidol|mesh-list
5911923|NCT05065567|Haloperidol decanoate|haloperidol decanoate|mesh-list
5911924|NCT05065567|Antiemetics|antiemetics|mesh-ancestor
5911925|NCT05065567|Autonomic Agents|autonomic agents|mesh-ancestor
5911926|NCT05065567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5911927|NCT05065567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911928|NCT05065567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5911929|NCT05065567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5911930|NCT05065567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5911931|NCT05065567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5911932|NCT05065567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5911933|NCT05065567|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5911934|NCT05065567|Dopamine Agents|dopamine agents|mesh-ancestor
5911935|NCT05065567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5911936|NCT05065567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911937|NCT05065567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5911938|NCT05065567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5911939|NCT05065567|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5911940|NCT05065021|Paclitaxel|paclitaxel|mesh-list
5911941|NCT05065021|Bevacizumab|bevacizumab|mesh-list
5698948|NCT03365141|Hormones|hormones|mesh-ancestor
5698949|NCT03365141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5698950|NCT03365115|Fentanyl|fentanyl|mesh-list
5911942|NCT05065021|Niraparib|niraparib|mesh-list
5911943|NCT05065021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5911944|NCT05065021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5911945|NCT05065021|Tubulin Modulators|tubulin modulators|mesh-ancestor
5911946|NCT05065021|Antimitotic Agents|antimitotic agents|mesh-ancestor
5911947|NCT05065021|Mitosis Modulators|mitosis modulators|mesh-ancestor
5911948|NCT05065021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911949|NCT05065021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5911950|NCT05065021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5911951|NCT05065021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5911952|NCT05065021|Growth Substances|growth substances|mesh-ancestor
5911953|NCT05065021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911954|NCT05065021|Growth Inhibitors|growth inhibitors|mesh-ancestor
5911955|NCT05065021|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5911956|NCT05065021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5911957|NCT05064631|Broncho-Vaxom|broncho-vaxom|mesh-list
5911958|NCT05064631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5911959|NCT05064631|Immunologic Factors|immunologic factors|mesh-ancestor
5911960|NCT05064631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911961|NCT05064020|Tenofovir|tenofovir|mesh-list
5911962|NCT05064020|Emtricitabine|emtricitabine|mesh-list
5911963|NCT05064020|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
5911964|NCT05064020|Antiviral Agents|antiviral agents|mesh-ancestor
5911965|NCT05064020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5911966|NCT05064020|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5911967|NCT05064020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5911968|NCT05064020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5911969|NCT05064020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911970|NCT05064020|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5911971|NCT05064020|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5911972|NCT05064137|Listerine|listerine|mesh-list
5911973|NCT05064137|Fluorides|fluorides|mesh-list
5911974|NCT05064137|Fluorides, Topical|fluorides, topical|mesh-list
5911975|NCT05064137|Sodium Fluoride|sodium fluoride|mesh-list
5911976|NCT05064137|Cariostatic Agents|cariostatic agents|mesh-ancestor
5911977|NCT05064137|Protective Agents|protective agents|mesh-ancestor
5911978|NCT05064137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698951|NCT03365115|Morphine|morphine|mesh-list
5698952|NCT03365115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5698953|NCT03365115|Narcotics|narcotics|mesh-ancestor
5698954|NCT03365115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5698955|NCT03365115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698956|NCT03365115|Analgesics|analgesics|mesh-ancestor
5698957|NCT03365115|Sensory System Agents|sensory system agents|mesh-ancestor
5698958|NCT03365115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5698959|NCT03365115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5911979|NCT05064137|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5911980|NCT05064137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5911981|NCT05064085|Capecitabine|capecitabine|mesh-list
5911982|NCT05064085|Cemiplimab|cemiplimab|mesh-list
5911983|NCT05064085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5911984|NCT05064085|Antimetabolites|antimetabolites|mesh-ancestor
5911985|NCT05064085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5911986|NCT05064085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5911987|NCT05064085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5911988|NCT05063838|Anesthetics|anesthetics|mesh-list
5911989|NCT05063838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5698960|NCT03365115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5698961|NCT03365115|Anesthetics, General|anesthetics, general|mesh-ancestor
5698962|NCT03365115|Anesthetics|anesthetics|mesh-ancestor
5720706|NCT03211013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5720707|NCT03211013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720708|NCT03211351|Dextrans|dextrans|mesh-list
5720709|NCT03211351|Anticoagulants|anticoagulants|mesh-ancestor
5720710|NCT03211351|Plasma Substitutes|plasma substitutes|mesh-ancestor
5720711|NCT03211351|Blood Substitutes|blood substitutes|mesh-ancestor
5720712|NCT03211195|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
5911990|NCT05063838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911991|NCT05063578|Lidocaine|lidocaine|mesh-list
5911992|NCT05063578|Anesthetics, Local|anesthetics, local|mesh-ancestor
5911993|NCT05063578|Anesthetics|anesthetics|mesh-ancestor
5911994|NCT05063578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5911995|NCT05063578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5911996|NCT05063578|Sensory System Agents|sensory system agents|mesh-ancestor
5911997|NCT05063578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5911998|NCT05063578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5911999|NCT05063578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5912000|NCT05063578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5912001|NCT05063578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5912002|NCT05063578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912003|NCT05063604|Citalopram|citalopram|mesh-list
5912004|NCT05063604|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5912005|NCT05063604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5912006|NCT05063604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5912007|NCT05063604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912008|NCT05063604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5912009|NCT05063604|Serotonin Agents|serotonin agents|mesh-ancestor
5720713|NCT03211195|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5720714|NCT03211195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5720715|NCT03211195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5720716|NCT03211195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720717|NCT03210688|Alfacalcidol|alfacalcidol|mesh-list
5720718|NCT03210688|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
5720719|NCT03210688|Prednisone|prednisone|mesh-list
5720720|NCT03210688|Prednisolone|prednisolone|mesh-list
5720721|NCT03210688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5720722|NCT03210688|Glucocorticoids|glucocorticoids|mesh-ancestor
5720723|NCT03210688|Hormones|hormones|mesh-ancestor
5720724|NCT03210688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5720725|NCT03210688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720726|NCT03210688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5720727|NCT03210688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5720728|NCT03210688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5720729|NCT03210688|Vitamins|vitamins|mesh-ancestor
5720730|NCT03210688|Micronutrients|micronutrients|mesh-ancestor
5720731|NCT03210662|Pembrolizumab|pembrolizumab|mesh-list
5720732|NCT03210662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5720733|NCT03210662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5720734|NCT03210610|Colchicine|colchicine|mesh-list
5720735|NCT03210610|Gout Suppressants|gout suppressants|mesh-ancestor
5720736|NCT03210610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5720737|NCT03210610|Tubulin Modulators|tubulin modulators|mesh-ancestor
5720738|NCT03210610|Antimitotic Agents|antimitotic agents|mesh-ancestor
5720739|NCT03210610|Mitosis Modulators|mitosis modulators|mesh-ancestor
5720740|NCT03210610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5720741|NCT03210610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5720742|NCT03210766|Nabilone|nabilone|mesh-list
5720743|NCT03210766|Antiemetics|antiemetics|mesh-ancestor
5912010|NCT05063604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912011|NCT05063604|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5912012|NCT05063604|Antidepressive Agents|antidepressive agents|mesh-ancestor
5912013|NCT05063604|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5912014|NCT05063513|Mycophenolic Acid|mycophenolic acid|mesh-list
5912015|NCT05063513|Rituximab|rituximab|mesh-list
5912016|NCT05063513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5912017|NCT05063513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5912018|NCT05063513|Immunologic Factors|immunologic factors|mesh-ancestor
5912019|NCT05063513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912020|NCT05063513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6212635|NCT02191579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6212636|NCT02191579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212637|NCT02191579|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6212638|NCT02191579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6212639|NCT02191579|Anticonvulsants|anticonvulsants|mesh-ancestor
6212640|NCT02191579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6212641|NCT02191865|Nintedanib|nintedanib|mesh-list
6212642|NCT02191865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6212643|NCT02191865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6212644|NCT02191865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6675765|NCT01577693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675766|NCT01577771|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6675767|NCT01577771|Immunologic Factors|immunologic factors|mesh-ancestor
6675768|NCT01577771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675769|NCT01577849|Vitamin D|vitamin d|mesh-list
6675770|NCT01577849|Cholecalciferol|cholecalciferol|mesh-list
6675771|NCT01577849|Vitamins|vitamins|mesh-ancestor
6675772|NCT01577849|Micronutrients|micronutrients|mesh-ancestor
6675773|NCT01577849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675774|NCT01577849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6675775|NCT01577849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6675776|NCT01577862|Rifampin|rifampin|mesh-list
6675777|NCT01577862|Colistin|colistin|mesh-list
6675778|NCT01577862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6675779|NCT01577862|Antitubercular Agents|antitubercular agents|mesh-ancestor
6212645|NCT02191865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212646|NCT02192190|Celecoxib|celecoxib|mesh-list
6212647|NCT02192190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6212648|NCT02192190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6212649|NCT02192190|Analgesics|analgesics|mesh-ancestor
6212650|NCT02192190|Sensory System Agents|sensory system agents|mesh-ancestor
6212651|NCT02192190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6212652|NCT02192190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212653|NCT02192190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6212654|NCT02192190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6212655|NCT02192190|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6212656|NCT02192190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6212657|NCT02192190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6212658|NCT02192190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212659|NCT02192541|Aflibercept|aflibercept|mesh-list
6212660|NCT02192541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6212661|NCT02192541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6212662|NCT02192541|Growth Substances|growth substances|mesh-ancestor
6212663|NCT02192541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212664|NCT02192541|Growth Inhibitors|growth inhibitors|mesh-ancestor
6212665|NCT02192541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6212666|NCT02192684|Pioglitazone|pioglitazone|mesh-list
6212667|NCT02192684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6212668|NCT02192684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212669|NCT02192814|Lacosamide|lacosamide|mesh-list
6212670|NCT02192814|Anticonvulsants|anticonvulsants|mesh-ancestor
5912021|NCT05063513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5912022|NCT05063513|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5912023|NCT05063513|Antitubercular Agents|antitubercular agents|mesh-ancestor
5912024|NCT05063513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5912025|NCT05063513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5912026|NCT05063513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5912027|NCT05063513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912028|NCT05063422|Trimethoprim|trimethoprim|mesh-list
5912029|NCT05063422|Polymyxins|polymyxins|mesh-list
5912030|NCT05063422|Polymyxin B|polymyxin b|mesh-list
5912031|NCT05063422|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
5912032|NCT05063422|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6675780|NCT01577862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5698963|NCT03364998|Factor VIII|factor viii|mesh-list
5698964|NCT03364998|Coagulants|coagulants|mesh-ancestor
5698965|NCT03364985|Dapagliflozin|dapagliflozin|mesh-list
5912033|NCT05063422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5912034|NCT05063422|Renal Agents|renal agents|mesh-ancestor
5912035|NCT05063422|Antimalarials|antimalarials|mesh-ancestor
5912036|NCT05063422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5912037|NCT05063422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5912038|NCT05063422|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5698966|NCT03364985|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5698967|NCT03364985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5698968|NCT03364985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5698969|NCT03364985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698970|NCT03364868|Insulin|insulin|mesh-list
5698971|NCT03364868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5698972|NCT03364868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698973|NCT03364842|Furosemide|furosemide|mesh-list
5698974|NCT03364842|Diuretics|diuretics|mesh-ancestor
5698975|NCT03364842|Natriuretic Agents|natriuretic agents|mesh-ancestor
5912039|NCT05063422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5912040|NCT05063422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912041|NCT05063422|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5912042|NCT05063422|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
5912043|NCT05063422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5912044|NCT05063422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5912045|NCT05063422|Laxatives|laxatives|mesh-ancestor
5912046|NCT05063422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5912047|NCT05063097|Carbon Monoxide|carbon monoxide|mesh-list
5912048|NCT05063097|Antimetabolites|antimetabolites|mesh-ancestor
5912049|NCT05063097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912050|NCT05063097|Gasotransmitters|gasotransmitters|mesh-ancestor
5912051|NCT05063097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5912052|NCT05063097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912053|NCT05063396|Analgesics, Opioid|analgesics, opioid|mesh-list
5912054|NCT05063396|Anesthetics|anesthetics|mesh-list
5912055|NCT05063396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5912056|NCT05063396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912057|NCT05063396|Narcotics|narcotics|mesh-ancestor
5912058|NCT05063396|Analgesics|analgesics|mesh-ancestor
5912059|NCT05063396|Sensory System Agents|sensory system agents|mesh-ancestor
5912060|NCT05063396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5963022|NCT04606082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5963023|NCT04606082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963024|NCT04606108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5963025|NCT04606108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963026|NCT04606108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5963027|NCT04606017|Calcium Carbonate|calcium carbonate|mesh-list
5963028|NCT04606017|Antacids|antacids|mesh-ancestor
5963029|NCT04606017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963030|NCT04606017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5963031|NCT04605770|Pemetrexed|pemetrexed|mesh-list
5963032|NCT04605770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5963033|NCT04605770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5963034|NCT04605770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963035|NCT04605770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5963036|NCT04605770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5963037|NCT04605978|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5963038|NCT04605887|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
5963039|NCT04605887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5963040|NCT04605887|Vasodilator Agents|vasodilator agents|mesh-ancestor
5963041|NCT04605952|Antibodies|antibodies|mesh-list
5963042|NCT04605952|Immunoglobulin G|immunoglobulin g|mesh-list
5963043|NCT04605952|Immunologic Factors|immunologic factors|mesh-ancestor
5963044|NCT04605952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963045|NCT04605861|Liraglutide|liraglutide|mesh-list
5963046|NCT04605861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5963047|NCT04605861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963048|NCT04605861|Incretins|incretins|mesh-ancestor
5963049|NCT04605861|Hormones|hormones|mesh-ancestor
5970451|NCT04534725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5698976|NCT03364842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698977|NCT03364842|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5698978|NCT03364842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5698979|NCT03364842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5698980|NCT03364829|Glycopyrrolate|glycopyrrolate|mesh-list
5912061|NCT05062980|Docetaxel|docetaxel|mesh-list
5912062|NCT05062980|Pembrolizumab|pembrolizumab|mesh-list
5912063|NCT05062980|Ramucirumab|ramucirumab|mesh-list
5912064|NCT05062980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5912065|NCT05062980|Tubulin Modulators|tubulin modulators|mesh-ancestor
5912066|NCT05062980|Antimitotic Agents|antimitotic agents|mesh-ancestor
5912067|NCT05062980|Mitosis Modulators|mitosis modulators|mesh-ancestor
5912068|NCT05062980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912069|NCT05062980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5912070|NCT05063318|Itraconazole|itraconazole|mesh-list
5912071|NCT05063318|Antifungal Agents|antifungal agents|mesh-ancestor
5912072|NCT05063318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5912073|NCT05063318|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5912074|NCT05063318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5912075|NCT05063318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5912076|NCT05063318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912077|NCT05063318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5912078|NCT05063318|Hormone Antagonists|hormone antagonists|mesh-ancestor
5912079|NCT05063318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6675781|NCT01577862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6675782|NCT01577862|Leprostatic Agents|leprostatic agents|mesh-ancestor
6675783|NCT01577862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6675784|NCT01577862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6675785|NCT01577862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912080|NCT05063318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912081|NCT05063318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5912082|NCT05063071|Tenofovir|tenofovir|mesh-list
5912083|NCT05063071|Antiviral Agents|antiviral agents|mesh-ancestor
5912084|NCT05063071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5912085|NCT05063071|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5912086|NCT05063071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5912087|NCT05063071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5912088|NCT05063071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912089|NCT05063071|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5912090|NCT05063071|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5912091|NCT05062902|Botulinum Toxins|botulinum toxins|mesh-list
5912092|NCT05062902|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5912093|NCT05062902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5912094|NCT05062902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912095|NCT05062902|Cholinergic Agents|cholinergic agents|mesh-ancestor
5912096|NCT05062902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5912097|NCT05062902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912098|NCT05062681|Dexamethasone|dexamethasone|mesh-list
5912099|NCT05062681|Methylprednisolone|methylprednisolone|mesh-list
5912100|NCT05062681|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5912101|NCT05062681|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5912102|NCT05062681|Prednisolone|prednisolone|mesh-list
5912103|NCT05062681|Prednisolone acetate|prednisolone acetate|mesh-list
5912104|NCT05062681|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5912105|NCT05062681|Prednisolone phosphate|prednisolone phosphate|mesh-list
5912106|NCT05062681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5912107|NCT05062681|Antiemetics|antiemetics|mesh-ancestor
5912108|NCT05062681|Autonomic Agents|autonomic agents|mesh-ancestor
5912109|NCT05062681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5912110|NCT05062681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912111|NCT05062681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5912112|NCT05062681|Glucocorticoids|glucocorticoids|mesh-ancestor
5912113|NCT05062681|Hormones|hormones|mesh-ancestor
5912114|NCT05062681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5912115|NCT05062681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5912116|NCT05062681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5912117|NCT05062681|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5912118|NCT05062681|Protective Agents|protective agents|mesh-ancestor
5912119|NCT05062954|Proanthocyanidin|proanthocyanidin|mesh-list
5912120|NCT05062954|Procyanidin|procyanidin|mesh-list
5912121|NCT05062954|Antioxidants|antioxidants|mesh-ancestor
5912122|NCT05062954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912123|NCT05062954|Protective Agents|protective agents|mesh-ancestor
5912124|NCT05062954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912125|NCT05062954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5912126|NCT05062954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5912127|NCT05062954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5912128|NCT05062486|Curcumin|curcumin|mesh-list
5912129|NCT05062486|Resveratrol|resveratrol|mesh-list
5912130|NCT05062486|Quercetin|quercetin|mesh-list
5912131|NCT05062486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5912132|NCT05062486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5912133|NCT05062486|Analgesics|analgesics|mesh-ancestor
5912134|NCT05062486|Sensory System Agents|sensory system agents|mesh-ancestor
5698981|NCT03364829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5912135|NCT05062486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5912136|NCT05062486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912137|NCT05062486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5912138|NCT05062486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5912139|NCT05062486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5912140|NCT05062486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5912141|NCT05062486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912142|NCT05062486|Antioxidants|antioxidants|mesh-ancestor
5912143|NCT05062486|Protective Agents|protective agents|mesh-ancestor
5912144|NCT05062486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5912145|NCT05062395|Deoxyglucose|deoxyglucose|mesh-list
5912146|NCT05062395|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5912147|NCT05062395|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5912148|NCT05062395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912149|NCT05062395|Antimetabolites|antimetabolites|mesh-ancestor
5912150|NCT05062395|Antiviral Agents|antiviral agents|mesh-ancestor
5912151|NCT05062395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5912152|NCT05062304|Fluticasone|fluticasone|mesh-list
5912153|NCT05062304|Xhance|xhance|mesh-list
5912154|NCT05062304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5912155|NCT05062304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5912156|NCT05062304|Autonomic Agents|autonomic agents|mesh-ancestor
5912157|NCT05062304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5912158|NCT05062304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912159|NCT05062304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5912160|NCT05062304|Respiratory System Agents|respiratory system agents|mesh-ancestor
5912161|NCT05062304|Dermatologic Agents|dermatologic agents|mesh-ancestor
5912162|NCT05062304|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5912163|NCT05061732|Amoxicillin|amoxicillin|mesh-list
5912164|NCT05061732|Metronidazole|metronidazole|mesh-list
5912165|NCT05061732|Clarithromycin|clarithromycin|mesh-list
5912166|NCT05061732|Doxycycline|doxycycline|mesh-list
5912167|NCT05061732|Levofloxacin|levofloxacin|mesh-list
5912168|NCT05061732|Tetracycline|tetracycline|mesh-list
5912169|NCT05061732|Potassium Citrate|potassium citrate|mesh-list
5912170|NCT05061732|Rabeprazole|rabeprazole|mesh-list
5912171|NCT05061732|Bismuth|bismuth|mesh-list
5912172|NCT05061732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912173|NCT05061732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5912174|NCT05061732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5912175|NCT05061732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5912176|NCT05061732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5912177|NCT05061732|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5912178|NCT05061732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5912179|NCT05061732|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5912180|NCT05061732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5912181|NCT05061732|Antimalarials|antimalarials|mesh-ancestor
5912182|NCT05061732|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5912183|NCT05061732|Renal Agents|renal agents|mesh-ancestor
5912184|NCT05061732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5912185|NCT05061732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5912186|NCT05061732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5912187|NCT05061732|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5912188|NCT05061732|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5912189|NCT05061732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5912190|NCT05061732|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5912191|NCT05061732|Antacids|antacids|mesh-ancestor
5912192|NCT05061732|Diuretics|diuretics|mesh-ancestor
5912193|NCT05061732|Natriuretic Agents|natriuretic agents|mesh-ancestor
5912194|NCT05061732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912195|NCT05061732|Expectorants|expectorants|mesh-ancestor
5698982|NCT03364829|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5698983|NCT03364829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5698984|NCT03364829|Cholinergic Agents|cholinergic agents|mesh-ancestor
5698985|NCT03364829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5698986|NCT03364829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5698987|NCT03364829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698988|NCT03364764|Sirolimus|sirolimus|mesh-list
5698989|NCT03364764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5698990|NCT03364764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5698991|NCT03364764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5912196|NCT05061732|Respiratory System Agents|respiratory system agents|mesh-ancestor
5912197|NCT05061901|Lisinopril|lisinopril|mesh-list
5912198|NCT05061901|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5912199|NCT05061901|Protease Inhibitors|protease inhibitors|mesh-ancestor
5912200|NCT05061901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5912201|NCT05061901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912202|NCT05061901|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5698992|NCT03364764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5698993|NCT03364764|Antifungal Agents|antifungal agents|mesh-ancestor
5698994|NCT03364764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5698995|NCT03364764|Immunologic Factors|immunologic factors|mesh-ancestor
5698996|NCT03364764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5698997|NCT03364686|Biotin|biotin|mesh-list
5698998|NCT03364686|Vitamin B Complex|vitamin b complex|mesh-ancestor
5698999|NCT03364686|Vitamins|vitamins|mesh-ancestor
5699000|NCT03364686|Micronutrients|micronutrients|mesh-ancestor
5699001|NCT03364686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699002|NCT03364569|Tranexamic Acid|tranexamic acid|mesh-list
5699003|NCT03364569|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5699004|NCT03364569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5912203|NCT05061901|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5912204|NCT05061901|Protective Agents|protective agents|mesh-ancestor
5912205|NCT05061901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912206|NCT05061654|Tazobactam|tazobactam|mesh-list
5912207|NCT05061654|Ceftolozane|ceftolozane|mesh-list
5912208|NCT05061654|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
5912209|NCT05061654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5699005|NCT03364569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699006|NCT03364569|Hemostatics|hemostatics|mesh-ancestor
5699007|NCT03364569|Coagulants|coagulants|mesh-ancestor
5699008|NCT03364530|Gemcitabine|gemcitabine|mesh-list
5699009|NCT03364530|Oxaliplatin|oxaliplatin|mesh-list
5699010|NCT03364530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5699011|NCT03364530|Antimetabolites|antimetabolites|mesh-ancestor
5699012|NCT03364530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699013|NCT03364530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5699014|NCT03364530|Antiviral Agents|antiviral agents|mesh-ancestor
5699015|NCT03364530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5699016|NCT03364530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5699017|NCT03364530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5699018|NCT03364530|Immunologic Factors|immunologic factors|mesh-ancestor
5699019|NCT03364530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699020|NCT03364348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5912210|NCT05061654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5912211|NCT05061654|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5912212|NCT05061654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5912213|NCT05061654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912214|NCT05061654|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5912215|NCT05061654|Renal Agents|renal agents|mesh-ancestor
5912216|NCT05061641|Progesterone|progesterone|mesh-list
5912217|NCT05061641|Progestins|progestins|mesh-ancestor
5912218|NCT05061641|Hormones|hormones|mesh-ancestor
5912219|NCT05061641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5912220|NCT05061641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912221|NCT05061147|Azacitidine|azacitidine|mesh-list
5912222|NCT05061147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5912223|NCT05061147|Antimetabolites|antimetabolites|mesh-ancestor
5912224|NCT05061147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912225|NCT05061147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5912226|NCT05061147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5912227|NCT05060822|Pirfenidone|pirfenidone|mesh-list
5912228|NCT05060822|Analgesics|analgesics|mesh-ancestor
5912229|NCT05060822|Sensory System Agents|sensory system agents|mesh-ancestor
5912230|NCT05060822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5912231|NCT05060822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912232|NCT05060822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5912233|NCT05060822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5912234|NCT05060822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5912235|NCT05060822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5912236|NCT05060822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5912237|NCT05060809|Vitamin K|vitamin k|mesh-list
5912238|NCT05060809|Vitamin K 1|vitamin k 1|mesh-list
5912239|NCT05060809|Vitamins|vitamins|mesh-ancestor
5912240|NCT05060809|Micronutrients|micronutrients|mesh-ancestor
5912241|NCT05060809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496664|NCT00628914|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5912242|NCT05060809|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5912243|NCT05060809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5912244|NCT05060809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912245|NCT05060809|Hemostatics|hemostatics|mesh-ancestor
5912246|NCT05060809|Coagulants|coagulants|mesh-ancestor
5912247|NCT05060731|Iron|iron|mesh-list
5912248|NCT05060731|Trace Elements|trace elements|mesh-ancestor
5912249|NCT05060731|Micronutrients|micronutrients|mesh-ancestor
5912250|NCT05060731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912251|NCT05060588|Valsartan|valsartan|mesh-list
5912252|NCT05060588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5912253|NCT05060588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5912254|NCT05060588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5912255|NCT05060588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963050|NCT04605861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5963051|NCT04605562|Palbociclib|palbociclib|mesh-list
5963052|NCT04605562|Antibodies|antibodies|mesh-list
5963053|NCT04605562|Antibodies, Blocking|antibodies, blocking|mesh-list
5963054|NCT04605562|Immunologic Factors|immunologic factors|mesh-ancestor
5963055|NCT04605562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963056|NCT04605562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5963057|NCT04605562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5963058|NCT04605562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5963059|NCT04605562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963060|NCT04605419|Calcium|calcium|mesh-list
5963061|NCT04605419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5963062|NCT04605419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970452|NCT04534725|Antiviral Agents|antiviral agents|mesh-ancestor
5970453|NCT04534725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5970454|NCT04534725|Immunologic Factors|immunologic factors|mesh-ancestor
5970455|NCT04534725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970456|NCT04534491|Oxybutynin|oxybutynin|mesh-list
5970457|NCT04534491|Parasympatholytics|parasympatholytics|mesh-ancestor
5970458|NCT04534491|Autonomic Agents|autonomic agents|mesh-ancestor
5970459|NCT04534491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5970460|NCT04534491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970461|NCT04534491|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5970462|NCT04534491|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5970463|NCT04534491|Cholinergic Agents|cholinergic agents|mesh-ancestor
5970464|NCT04534491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5970465|NCT04534491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970466|NCT04534491|Urological Agents|urological agents|mesh-ancestor
5970467|NCT04534478|Prednisone|prednisone|mesh-list
5970468|NCT04534478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5970469|NCT04534478|Glucocorticoids|glucocorticoids|mesh-ancestor
5970470|NCT04534478|Hormones|hormones|mesh-ancestor
5970471|NCT04534478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5970472|NCT04534478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970473|NCT04534478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5970474|NCT04534478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5970475|NCT04534465|Mannitol|mannitol|mesh-list
5970476|NCT04534465|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
5970477|NCT04534465|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5970478|NCT04534465|Diuretics|diuretics|mesh-ancestor
5970479|NCT04534465|Natriuretic Agents|natriuretic agents|mesh-ancestor
5970480|NCT04534465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970481|NCT04534465|Laxatives|laxatives|mesh-ancestor
5970482|NCT04534465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5970483|NCT04534218|Aspirin|aspirin|mesh-list
5970484|NCT04534218|Cyclophosphamide|cyclophosphamide|mesh-list
5970485|NCT04534218|Capecitabine|capecitabine|mesh-list
5970486|NCT04534218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5970487|NCT04534218|Immunologic Factors|immunologic factors|mesh-ancestor
5970488|NCT04534218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970489|NCT04534218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5970490|NCT04534218|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5970491|NCT04534218|Alkylating Agents|alkylating agents|mesh-ancestor
5970492|NCT04534218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970493|NCT04534218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5970494|NCT04534218|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5970495|NCT04534218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5970496|NCT04534218|Antimetabolites|antimetabolites|mesh-ancestor
5970497|NCT04534218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5970498|NCT04534218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5970499|NCT04534218|Analgesics|analgesics|mesh-ancestor
5912256|NCT05060419|Meropenem|meropenem|mesh-list
5912257|NCT05060419|Tazobactam|tazobactam|mesh-list
5912258|NCT05060419|Piperacillin|piperacillin|mesh-list
5912259|NCT05060419|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
5912260|NCT05060419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5912261|NCT05060419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5912262|NCT05060419|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5912263|NCT05060419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5912264|NCT05060419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912265|NCT05060744|Antacids|antacids|mesh-list
5912266|NCT05060744|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
5912267|NCT05060744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912268|NCT05060744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5912269|NCT05060432|Pembrolizumab|pembrolizumab|mesh-list
5912270|NCT05060432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5912271|NCT05060432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5912272|NCT05060198|Lumefantrine|lumefantrine|mesh-list
5912273|NCT05060198|Artemether|artemether|mesh-list
5912274|NCT05060198|Piperaquine|piperaquine|mesh-list
5912275|NCT05060198|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
5912276|NCT05060198|Artenimol|artenimol|mesh-list
5912277|NCT05060198|Antimalarials|antimalarials|mesh-ancestor
5912278|NCT05060198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5912279|NCT05060198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5912280|NCT05060198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5912281|NCT05060276|Immunoconjugates|immunoconjugates|mesh-list
5912282|NCT05060276|Immunologic Factors|immunologic factors|mesh-ancestor
5699021|NCT03364348|Trastuzumab|trastuzumab|mesh-list
5699022|NCT03364348|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
5699023|NCT03364348|Maytansine|maytansine|mesh-list
5699024|NCT03364348|Antibodies|antibodies|mesh-list
5699025|NCT03364348|Immunoglobulins|immunoglobulins|mesh-list
5699026|NCT03364348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5699027|NCT03364348|Immunoconjugates|immunoconjugates|mesh-list
5699028|NCT03364348|Immunoglobulin G|immunoglobulin g|mesh-list
5699029|NCT03364348|Immunologic Factors|immunologic factors|mesh-ancestor
5699030|NCT03364348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699031|NCT03364348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5699032|NCT03364348|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5699033|NCT03364348|Tubulin Modulators|tubulin modulators|mesh-ancestor
5699034|NCT03364348|Antimitotic Agents|antimitotic agents|mesh-ancestor
5699035|NCT03364348|Mitosis Modulators|mitosis modulators|mesh-ancestor
5699036|NCT03364348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699037|NCT03364244|Sildenafil Citrate|sildenafil citrate|mesh-list
5699038|NCT03364244|Vasodilator Agents|vasodilator agents|mesh-ancestor
5699039|NCT03364244|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5699040|NCT03364244|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5699041|NCT03364244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5699042|NCT03364244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699043|NCT03364244|Urological Agents|urological agents|mesh-ancestor
5699044|NCT03364218|Acetylcysteine|acetylcysteine|mesh-list
5699045|NCT03364218|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5699046|NCT03364218|Antiviral Agents|antiviral agents|mesh-ancestor
5699047|NCT03364218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5699048|NCT03364218|Expectorants|expectorants|mesh-ancestor
5699049|NCT03364218|Respiratory System Agents|respiratory system agents|mesh-ancestor
5699050|NCT03364218|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5699051|NCT03364218|Antioxidants|antioxidants|mesh-ancestor
5699052|NCT03364218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699053|NCT03364218|Protective Agents|protective agents|mesh-ancestor
5699054|NCT03364218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699055|NCT03364218|Antidotes|antidotes|mesh-ancestor
5699056|NCT03364088|Oxycodone|oxycodone|mesh-list
5912283|NCT05060276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912284|NCT05059535|Acetaminophen|acetaminophen|mesh-list
5912285|NCT05059535|Analgesics|analgesics|mesh-list
5912286|NCT05059535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5912287|NCT05059535|Sensory System Agents|sensory system agents|mesh-ancestor
5912288|NCT05059535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5912289|NCT05059535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912290|NCT05059535|Antipyretics|antipyretics|mesh-ancestor
5912291|NCT05059587|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5912292|NCT05059587|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5912293|NCT05059587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5699057|NCT03364088|Anesthetics|anesthetics|mesh-list
5699058|NCT03364088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5720744|NCT03210766|Autonomic Agents|autonomic agents|mesh-ancestor
5912294|NCT05059587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912295|NCT05059587|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5912296|NCT05059587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5912297|NCT05059587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912298|NCT05059587|Cholinergic Agents|cholinergic agents|mesh-ancestor
5912299|NCT05059587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5912300|NCT05059626|Bazedoxifene|bazedoxifene|mesh-list
5912301|NCT05059626|Simvastatin|simvastatin|mesh-list
5912302|NCT05059626|Estrogens|estrogens|mesh-list
5912303|NCT05059626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5912304|NCT05059626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5912305|NCT05059626|Antimetabolites|antimetabolites|mesh-ancestor
5912306|NCT05059626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912307|NCT05059626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5912308|NCT05059626|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5912309|NCT05059626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5912310|NCT05059626|Hormones|hormones|mesh-ancestor
5912311|NCT05059626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5912312|NCT05059626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912313|NCT05059626|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5912314|NCT05059626|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5912315|NCT05059626|Hormone Antagonists|hormone antagonists|mesh-ancestor
5912316|NCT05059626|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5912317|NCT05059782|Coal Tar|coal tar|mesh-list
5912318|NCT05059782|Keratolytic Agents|keratolytic agents|mesh-ancestor
5912319|NCT05059782|Dermatologic Agents|dermatologic agents|mesh-ancestor
5912320|NCT05059860|Insulin|insulin|mesh-list
5912321|NCT05059860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5912322|NCT05059860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912323|NCT05059418|Clonazepam|clonazepam|mesh-list
5912324|NCT05059418|Capsaicin|capsaicin|mesh-list
5912325|NCT05059418|Antipruritics|antipruritics|mesh-ancestor
5912326|NCT05059418|Dermatologic Agents|dermatologic agents|mesh-ancestor
5912327|NCT05059418|Sensory System Agents|sensory system agents|mesh-ancestor
5912328|NCT05059418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5912329|NCT05059418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912330|NCT05059418|Anticonvulsants|anticonvulsants|mesh-ancestor
5912331|NCT05059418|GABA Modulators|gaba modulators|mesh-ancestor
5912332|NCT05059418|GABA Agents|gaba agents|mesh-ancestor
5912333|NCT05059418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5912334|NCT05059418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912335|NCT05059028|Oxytocin|oxytocin|mesh-list
5912336|NCT05059028|Oxytocics|oxytocics|mesh-ancestor
5912337|NCT05059028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5912338|NCT05059028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912339|NCT05059145|Chlorhexidine|chlorhexidine|mesh-list
5912340|NCT05059145|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5912341|NCT05059145|Fluconazole|fluconazole|mesh-list
5912342|NCT05059145|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5912343|NCT05059145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5912344|NCT05059145|Disinfectants|disinfectants|mesh-ancestor
5912345|NCT05059145|Dermatologic Agents|dermatologic agents|mesh-ancestor
5912346|NCT05059145|Antifungal Agents|antifungal agents|mesh-ancestor
5912347|NCT05059145|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5912348|NCT05059145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5912349|NCT05059145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5912350|NCT05059145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912351|NCT05059145|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5912352|NCT05059145|Hormone Antagonists|hormone antagonists|mesh-ancestor
5912353|NCT05059145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5912354|NCT05059145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912355|NCT05059145|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5912356|NCT05059145|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5912357|NCT05058976|Vitamin D|vitamin d|mesh-list
5912358|NCT05058976|Zoledronic Acid|zoledronic acid|mesh-list
5912359|NCT05058976|Calcium|calcium|mesh-list
5912360|NCT05058976|Vitamins|vitamins|mesh-ancestor
5912361|NCT05058976|Micronutrients|micronutrients|mesh-ancestor
5912362|NCT05058976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912363|NCT05058976|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5912364|NCT05058976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5912365|NCT05058924|Aspirin|aspirin|mesh-list
5912366|NCT05058924|Heparin|heparin|mesh-list
5912367|NCT05058924|Calcium heparin|calcium heparin|mesh-list
5912368|NCT05058924|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5912369|NCT05058924|Tinzaparin|tinzaparin|mesh-list
5912370|NCT05058924|Dalteparin|dalteparin|mesh-list
5912371|NCT05058924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5912372|NCT05058924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5912373|NCT05058924|Analgesics|analgesics|mesh-ancestor
5699059|NCT03364088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699060|NCT03364088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5699061|NCT03364088|Narcotics|narcotics|mesh-ancestor
5699062|NCT03364088|Analgesics|analgesics|mesh-ancestor
5699063|NCT03364088|Sensory System Agents|sensory system agents|mesh-ancestor
5699064|NCT03364088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5699065|NCT03364075|Propranolol|propranolol|mesh-list
5699066|NCT03364075|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5699067|NCT03364075|Serotonin|serotonin|mesh-list
5699068|NCT03364075|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5699069|NCT03364075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5699070|NCT03364075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5699071|NCT03364075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699072|NCT03364075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5699073|NCT03364075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699074|NCT03364075|Analgesics|analgesics|mesh-ancestor
5699075|NCT03364075|Sensory System Agents|sensory system agents|mesh-ancestor
5699076|NCT03364075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5699077|NCT03364075|Antidepressive Agents|antidepressive agents|mesh-ancestor
5699078|NCT03364075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5699079|NCT03364075|Dopamine Agents|dopamine agents|mesh-ancestor
5699080|NCT03364075|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5699081|NCT03364075|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5699082|NCT03364075|Adrenergic Agents|adrenergic agents|mesh-ancestor
5699083|NCT03364075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5699084|NCT03364075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5699085|NCT03364075|Vasodilator Agents|vasodilator agents|mesh-ancestor
5699086|NCT03364075|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5699087|NCT03364075|Serotonin Agents|serotonin agents|mesh-ancestor
5699088|NCT03363984|Midazolam|midazolam|mesh-list
5699089|NCT03363984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5699090|NCT03363984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5699091|NCT03363984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5699092|NCT03363984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699093|NCT03363984|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5912374|NCT05058924|Sensory System Agents|sensory system agents|mesh-ancestor
5912375|NCT05058924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5912376|NCT05058924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912377|NCT05058924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5912378|NCT05058924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5912379|NCT05058924|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5912380|NCT05058924|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5912381|NCT05058924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912382|NCT05058924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5912383|NCT05058924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5912384|NCT05058924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5912385|NCT05058924|Antipyretics|antipyretics|mesh-ancestor
5912386|NCT05058924|Anticoagulants|anticoagulants|mesh-ancestor
5912387|NCT05058677|Lidocaine|lidocaine|mesh-list
5912388|NCT05058677|Anesthetics, Local|anesthetics, local|mesh-ancestor
5912389|NCT05058677|Anesthetics|anesthetics|mesh-ancestor
5912390|NCT05058677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5912391|NCT05058677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912392|NCT05058677|Sensory System Agents|sensory system agents|mesh-ancestor
5912393|NCT05058677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5912394|NCT05058677|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5912395|NCT05058677|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5699094|NCT03363984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5699095|NCT03363984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5699096|NCT03363984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5699097|NCT03363984|Anesthetics, General|anesthetics, general|mesh-ancestor
5912396|NCT05058677|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5912397|NCT05058677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5912398|NCT05058677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963063|NCT04605588|Ribavirin|ribavirin|mesh-list
5963064|NCT04605588|Hydroxychloroquine|hydroxychloroquine|mesh-list
5963065|NCT04605588|Nitazoxanide|nitazoxanide|mesh-list
5963066|NCT04605588|Antimetabolites|antimetabolites|mesh-ancestor
5963067|NCT04605588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963068|NCT04605588|Antiviral Agents|antiviral agents|mesh-ancestor
5699098|NCT03363984|Anesthetics|anesthetics|mesh-ancestor
5963069|NCT04605588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5912399|NCT05058612|Midodrine|midodrine|mesh-list
5699099|NCT03363984|GABA Modulators|gaba modulators|mesh-ancestor
5699100|NCT03363984|GABA Agents|gaba agents|mesh-ancestor
5699101|NCT03363984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5699102|NCT03363984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699103|NCT03363867|Bevacizumab|bevacizumab|mesh-list
5699104|NCT03363867|Atezolizumab|atezolizumab|mesh-list
5699105|NCT03363867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5699106|NCT03363867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5912400|NCT05058612|Sympathomimetics|sympathomimetics|mesh-ancestor
5912401|NCT05058612|Autonomic Agents|autonomic agents|mesh-ancestor
5912402|NCT05058612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5912403|NCT05058612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912404|NCT05058612|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5912405|NCT05058612|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5912406|NCT05058612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5912407|NCT05058612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5912408|NCT05058612|Adrenergic Agents|adrenergic agents|mesh-ancestor
5912409|NCT05058612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5912410|NCT05058612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912411|NCT05058443|Denosumab|denosumab|mesh-list
5912412|NCT05058443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5912413|NCT05058443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912414|NCT05058755|Etoposide|etoposide|mesh-list
5912415|NCT05058755|Lenalidomide|lenalidomide|mesh-list
5912416|NCT05058755|Azacitidine|azacitidine|mesh-list
5912417|NCT05058755|Pegaspargase|pegaspargase|mesh-list
5912418|NCT05058755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5912419|NCT05058755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5912420|NCT05058755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5912421|NCT05058755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5912422|NCT05058755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5912423|NCT05058755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912424|NCT05058755|Immunologic Factors|immunologic factors|mesh-ancestor
5912425|NCT05058755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912426|NCT05058755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5912427|NCT05058755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5912428|NCT05058755|Growth Substances|growth substances|mesh-ancestor
5912429|NCT05058755|Growth Inhibitors|growth inhibitors|mesh-ancestor
5912430|NCT05058755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5912431|NCT05058755|Antimetabolites|antimetabolites|mesh-ancestor
5912432|NCT05058404|Prednisone|prednisone|mesh-list
5912433|NCT05058404|Rituximab|rituximab|mesh-list
5912434|NCT05058404|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5912435|NCT05058404|Cyclophosphamide|cyclophosphamide|mesh-list
5912436|NCT05058404|Vincristine|vincristine|mesh-list
5912437|NCT05058404|Doxorubicin|doxorubicin|mesh-list
5912438|NCT05058404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5912439|NCT05058404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5912440|NCT05058404|Immunologic Factors|immunologic factors|mesh-ancestor
5912441|NCT05058404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912442|NCT05058404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5912443|NCT05058404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5912444|NCT05058404|Alkylating Agents|alkylating agents|mesh-ancestor
5912445|NCT05058404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912446|NCT05058404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5912447|NCT05058404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5912448|NCT05058404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5912449|NCT05058404|Glucocorticoids|glucocorticoids|mesh-ancestor
5912450|NCT05058404|Hormones|hormones|mesh-ancestor
5912451|NCT05058404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5912452|NCT05058404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5912453|NCT05058404|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5912454|NCT05058404|Tubulin Modulators|tubulin modulators|mesh-ancestor
5912455|NCT05058404|Antimitotic Agents|antimitotic agents|mesh-ancestor
5912456|NCT05058404|Mitosis Modulators|mitosis modulators|mesh-ancestor
5912457|NCT05058404|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5699107|NCT03363867|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5699108|NCT03363867|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5699109|NCT03363867|Growth Substances|growth substances|mesh-ancestor
5699110|NCT03363867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699111|NCT03363867|Growth Inhibitors|growth inhibitors|mesh-ancestor
5912458|NCT05058404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5912459|NCT05058404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5912460|NCT05058404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5912461|NCT05058859|Dapagliflozin|dapagliflozin|mesh-list
5912462|NCT05058859|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5912463|NCT05058859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912464|NCT05058859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5912465|NCT05058859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912466|NCT05058209|Triamcinolone|triamcinolone|mesh-list
5912467|NCT05058209|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5912468|NCT05058209|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5912469|NCT05058209|Betamethasone|betamethasone|mesh-list
5912470|NCT05058209|Betamethasone Valerate|betamethasone valerate|mesh-list
5912471|NCT05058209|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5912472|NCT05058209|Betamethasone benzoate|betamethasone benzoate|mesh-list
5912473|NCT05058209|Betamethasone acetate|betamethasone acetate|mesh-list
5912474|NCT05058209|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
5912475|NCT05058209|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5912476|NCT05058209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5912477|NCT05058209|Glucocorticoids|glucocorticoids|mesh-ancestor
5912478|NCT05058209|Hormones|hormones|mesh-ancestor
5912479|NCT05058209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5912480|NCT05058209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912481|NCT05058209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5912482|NCT05058209|Immunologic Factors|immunologic factors|mesh-ancestor
5912483|NCT05058209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5912484|NCT05058209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912485|NCT05058209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5912486|NCT05058209|Respiratory System Agents|respiratory system agents|mesh-ancestor
5912487|NCT05058105|Meropenem|meropenem|mesh-list
5912488|NCT05058105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5912489|NCT05058105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5912490|NCT05058287|Methylprednisolone|methylprednisolone|mesh-list
5912491|NCT05058287|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5912492|NCT05058287|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5912493|NCT05058287|Prednisolone|prednisolone|mesh-list
5912494|NCT05058287|Prednisolone acetate|prednisolone acetate|mesh-list
5912495|NCT05058287|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5912496|NCT05058287|Prednisolone phosphate|prednisolone phosphate|mesh-list
5912497|NCT05058287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5912498|NCT05058287|Antiemetics|antiemetics|mesh-ancestor
5912499|NCT05058287|Autonomic Agents|autonomic agents|mesh-ancestor
5912500|NCT05058287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5912501|NCT05058287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912502|NCT05058287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5912503|NCT05058287|Glucocorticoids|glucocorticoids|mesh-ancestor
5912504|NCT05058287|Hormones|hormones|mesh-ancestor
5912505|NCT05058287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5912506|NCT05058287|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5912507|NCT05058287|Protective Agents|protective agents|mesh-ancestor
5912508|NCT05058287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5912509|NCT05058287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5912510|NCT05057767|Midazolam|midazolam|mesh-list
5912511|NCT05057767|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5912512|NCT05057767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5912513|NCT05057767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5912514|NCT05057767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912515|NCT05057767|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5912516|NCT05057767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5912517|NCT05057767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5912518|NCT05057767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5912519|NCT05057767|Anesthetics, General|anesthetics, general|mesh-ancestor
5912520|NCT05057767|Anesthetics|anesthetics|mesh-ancestor
5912521|NCT05057767|GABA Modulators|gaba modulators|mesh-ancestor
5912522|NCT05057767|GABA Agents|gaba agents|mesh-ancestor
5912523|NCT05057767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5912524|NCT05057767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912525|NCT05057845|Lenvatinib|lenvatinib|mesh-list
5912526|NCT05057845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5912527|NCT05057845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5912528|NCT05057845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5912529|NCT05057845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912530|NCT05057663|Fluorouracil|fluorouracil|mesh-list
5912531|NCT05057663|Bleomycin|bleomycin|mesh-list
5912532|NCT05057663|Antimetabolites|antimetabolites|mesh-ancestor
5912533|NCT05057663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912534|NCT05057663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5912535|NCT05057663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5912536|NCT05057663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5912537|NCT05057663|Immunologic Factors|immunologic factors|mesh-ancestor
5912538|NCT05057663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912539|NCT05057663|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5912540|NCT05057286|Botulinum Toxins|botulinum toxins|mesh-list
5912541|NCT05057286|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5912542|NCT05057286|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6496665|NCT00628914|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6496666|NCT00628914|Cholinergic Agents|cholinergic agents|mesh-ancestor
6496667|NCT00628914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6496668|NCT00628914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6496669|NCT00628953|Esomeprazole|esomeprazole|mesh-list
6496670|NCT00628953|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6496671|NCT00628953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6496672|NCT00628953|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6496673|NCT00628953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6496674|NCT00628953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496675|NCT00629031|Paromomycin|paromomycin|mesh-list
6496676|NCT00629031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5699112|NCT03363841|Ibrexafungerp|ibrexafungerp|mesh-list
5699113|NCT03363841|Antifungal Agents|antifungal agents|mesh-ancestor
5699114|NCT03363841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5699115|NCT03363815|Vitamin K|vitamin k|mesh-list
5699116|NCT03363815|Metformin|metformin|mesh-list
6496677|NCT00629031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6496678|NCT00629031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5699117|NCT03363815|Nintedanib|nintedanib|mesh-list
5912543|NCT05057286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5912544|NCT05057286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912545|NCT05057286|Cholinergic Agents|cholinergic agents|mesh-ancestor
5912546|NCT05057286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5912547|NCT05057286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912548|NCT05057286|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5912549|NCT05057286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5912550|NCT05057351|Glycerol|glycerol|mesh-list
5912551|NCT05057351|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
5912552|NCT05057351|Protective Agents|protective agents|mesh-ancestor
5912553|NCT05057351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912554|NCT05057130|Cisplatin|cisplatin|mesh-list
5912555|NCT05057130|Doxorubicin|doxorubicin|mesh-list
5912556|NCT05057130|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5912557|NCT05057130|Methotrexate|methotrexate|mesh-list
5912558|NCT05057130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5912559|NCT05057130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5912560|NCT05057130|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5912561|NCT05057130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5912562|NCT05057130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5912563|NCT05057130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912564|NCT05057130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5912565|NCT05057130|Abortifacient Agents|abortifacient agents|mesh-ancestor
5912566|NCT05057130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5912567|NCT05057130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912568|NCT05057130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5912569|NCT05057130|Antimetabolites|antimetabolites|mesh-ancestor
5912570|NCT05057130|Dermatologic Agents|dermatologic agents|mesh-ancestor
5912571|NCT05057130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5912572|NCT05057130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5912573|NCT05057130|Immunologic Factors|immunologic factors|mesh-ancestor
5912574|NCT05057130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5912575|NCT05057130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5912576|NCT05057117|Botulinum Toxins|botulinum toxins|mesh-list
5912577|NCT05057117|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5912578|NCT05057117|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5912579|NCT05057117|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5912580|NCT05057117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5912581|NCT05057117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912582|NCT05057117|Cholinergic Agents|cholinergic agents|mesh-ancestor
5699118|NCT03363815|Digoxin|digoxin|mesh-list
5699119|NCT03363815|Midazolam|midazolam|mesh-list
5699120|NCT03363815|Omeprazole|omeprazole|mesh-list
5699121|NCT03363815|Warfarin|warfarin|mesh-list
5699122|NCT03363815|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5699123|NCT03363815|Vitamins|vitamins|mesh-ancestor
5699124|NCT03363815|Micronutrients|micronutrients|mesh-ancestor
5699125|NCT03363815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699126|NCT03363815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5912583|NCT05057117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5912584|NCT05057117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912585|NCT05057117|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5912586|NCT05057117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5912587|NCT05056896|Aspirin|aspirin|mesh-list
5912588|NCT05056896|Salicylic Acid|salicylic acid|mesh-list
5912589|NCT05056896|Salicylates|salicylates|mesh-list
5912590|NCT05056896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5912591|NCT05056896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5912592|NCT05056896|Analgesics|analgesics|mesh-ancestor
5912593|NCT05056896|Sensory System Agents|sensory system agents|mesh-ancestor
5912594|NCT05056896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5912595|NCT05056896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912596|NCT05056896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5912597|NCT05056896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5912598|NCT05056896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5912599|NCT05056896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5912600|NCT05056896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912601|NCT05056896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5912602|NCT05056896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5912603|NCT05056896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5912604|NCT05056896|Antipyretics|antipyretics|mesh-ancestor
5912605|NCT05056896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5912606|NCT05056896|Antifungal Agents|antifungal agents|mesh-ancestor
5912607|NCT05056896|Keratolytic Agents|keratolytic agents|mesh-ancestor
5912608|NCT05056896|Dermatologic Agents|dermatologic agents|mesh-ancestor
5912609|NCT05056389|Oxaliplatin|oxaliplatin|mesh-list
5912610|NCT05056389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5912611|NCT05056402|Vaccines|vaccines|mesh-list
5912612|NCT05056402|Immunologic Factors|immunologic factors|mesh-ancestor
5912613|NCT05056402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963070|NCT04605588|Antimalarials|antimalarials|mesh-ancestor
5963071|NCT04605588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5963072|NCT04605588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5963073|NCT04605588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5963074|NCT04605588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5963075|NCT04605575|Vinorelbine|vinorelbine|mesh-list
5963076|NCT04605575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5963077|NCT04605575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5963078|NCT04605575|Tubulin Modulators|tubulin modulators|mesh-ancestor
5963079|NCT04605575|Antimitotic Agents|antimitotic agents|mesh-ancestor
5963080|NCT04605575|Mitosis Modulators|mitosis modulators|mesh-ancestor
5963081|NCT04605575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963082|NCT04605393|Dronabinol|dronabinol|mesh-list
5963083|NCT04605393|Cannabidiol|cannabidiol|mesh-list
5963084|NCT04605393|Anticonvulsants|anticonvulsants|mesh-ancestor
5963085|NCT04605393|Hallucinogens|hallucinogens|mesh-ancestor
5963086|NCT04605393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963087|NCT04605393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5963088|NCT04605393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5963089|NCT04605393|Analgesics|analgesics|mesh-ancestor
5963090|NCT04605393|Sensory System Agents|sensory system agents|mesh-ancestor
5963091|NCT04605393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5963092|NCT04605393|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5963093|NCT04605393|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5963094|NCT04605393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5963095|NCT04605393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963096|NCT04605393|Hormones|hormones|mesh-ancestor
5963097|NCT04605393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5963098|NCT04605107|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5963099|NCT04605107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5963100|NCT04605107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963101|NCT04605731|Durvalumab|durvalumab|mesh-list
5963102|NCT04605731|Ipilimumab|ipilimumab|mesh-list
5963103|NCT04605731|Tremelimumab|tremelimumab|mesh-list
5963104|NCT04605731|Immunoglobulins|immunoglobulins|mesh-list
5963105|NCT04605731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5963106|NCT04605731|Immunoglobulin G|immunoglobulin g|mesh-list
5963107|NCT04605731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5963108|NCT04605731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5963109|NCT04605731|Immunologic Factors|immunologic factors|mesh-ancestor
5963110|NCT04605731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963111|NCT04605731|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5963112|NCT04605731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963113|NCT04604938|Losartan|losartan|mesh-list
5963114|NCT04604938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5912614|NCT05056142|Anesthetics|anesthetics|mesh-list
5912615|NCT05056142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5912616|NCT05056142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912617|NCT05056584|Glucagon|glucagon|mesh-list
5912618|NCT05056584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5912619|NCT05056584|Hormones|hormones|mesh-ancestor
5912620|NCT05056584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5912621|NCT05056584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912622|NCT05056519|Vaccines|vaccines|mesh-list
5912623|NCT05056519|Immunologic Factors|immunologic factors|mesh-ancestor
5912624|NCT05056519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912625|NCT05056337|Lenvatinib|lenvatinib|mesh-list
5912626|NCT05056337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5912627|NCT05056337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5912628|NCT05056337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5912629|NCT05056337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912630|NCT05055752|Aspirin|aspirin|mesh-list
5912631|NCT05055752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5912632|NCT05055752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5912633|NCT05055752|Analgesics|analgesics|mesh-ancestor
5912634|NCT05055752|Sensory System Agents|sensory system agents|mesh-ancestor
5912635|NCT05055752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5912636|NCT05055752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912637|NCT05055752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5912638|NCT05055752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5912639|NCT05055752|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5912640|NCT05055752|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5912641|NCT05055752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912642|NCT05055752|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5912643|NCT05055752|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5912644|NCT05055752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5912645|NCT05055752|Antipyretics|antipyretics|mesh-ancestor
5912646|NCT05056025|Vitamins|vitamins|mesh-list
5912647|NCT05056025|Micronutrients|micronutrients|mesh-ancestor
5912648|NCT05056025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912649|NCT05055895|Cholinergic Antagonists|cholinergic antagonists|mesh-list
5912650|NCT05055895|Cholinergic Agents|cholinergic agents|mesh-ancestor
5912651|NCT05055895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5912652|NCT05055895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912653|NCT05055895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912654|NCT05055726|Benzydamine|benzydamine|mesh-list
5912655|NCT05055726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5912656|NCT05055544|Fosfomycin|fosfomycin|mesh-list
5912657|NCT05055544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5912658|NCT05055544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5912659|NCT05054868|Ketorolac|ketorolac|mesh-list
5912660|NCT05054868|Oxycodone|oxycodone|mesh-list
5912661|NCT05054868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5912662|NCT05054868|Narcotics|narcotics|mesh-ancestor
5912663|NCT05054868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5699127|NCT03363815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5699128|NCT03363815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5699129|NCT03363815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5699130|NCT03363815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5699131|NCT03363815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5699132|NCT03363815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5912664|NCT05054868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912665|NCT05054868|Analgesics|analgesics|mesh-ancestor
5912666|NCT05054868|Sensory System Agents|sensory system agents|mesh-ancestor
5912667|NCT05054868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5912668|NCT05054868|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5912669|NCT05054868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5912670|NCT05054868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5912671|NCT05054868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5912672|NCT05054868|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5912673|NCT05054868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5912674|NCT05054868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912675|NCT05054998|Deoxyglucose|deoxyglucose|mesh-list
5912676|NCT05054998|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5912677|NCT05054998|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5699133|NCT03363815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5699134|NCT03363815|Anesthetics, General|anesthetics, general|mesh-ancestor
5699135|NCT03363815|Anesthetics|anesthetics|mesh-ancestor
5699136|NCT03363815|GABA Modulators|gaba modulators|mesh-ancestor
5699137|NCT03363815|GABA Agents|gaba agents|mesh-ancestor
6242820|NCT02657031|Diphenhydramine|diphenhydramine|mesh-list
5912678|NCT05054998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912679|NCT05054998|Antimetabolites|antimetabolites|mesh-ancestor
5912680|NCT05054998|Antiviral Agents|antiviral agents|mesh-ancestor
5912681|NCT05054998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5912682|NCT05054842|Metformin|metformin|mesh-list
5912683|NCT05054842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5912684|NCT05054842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912685|NCT05054465|Venetoclax|venetoclax|mesh-list
5912686|NCT05054465|Navitoclax|navitoclax|mesh-list
5912687|NCT05054465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5912688|NCT05054439|Paclitaxel|paclitaxel|mesh-list
5912689|NCT05054439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5912690|NCT05054439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5912691|NCT05054439|Tubulin Modulators|tubulin modulators|mesh-ancestor
5912692|NCT05054439|Antimitotic Agents|antimitotic agents|mesh-ancestor
5912693|NCT05054439|Mitosis Modulators|mitosis modulators|mesh-ancestor
5912694|NCT05054439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912695|NCT05054478|Daratumumab|daratumumab|mesh-list
5912696|NCT05054478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5912697|NCT05054426|Methotrexate|methotrexate|mesh-list
5912698|NCT05054426|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5912699|NCT05054426|Abortifacient Agents|abortifacient agents|mesh-ancestor
5912700|NCT05054426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5912701|NCT05054426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912702|NCT05054426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5912703|NCT05054426|Antimetabolites|antimetabolites|mesh-ancestor
5912704|NCT05054426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912705|NCT05054426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5912706|NCT05054426|Dermatologic Agents|dermatologic agents|mesh-ancestor
5912707|NCT05054426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5912708|NCT05054426|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5912709|NCT05054426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5912710|NCT05054426|Immunologic Factors|immunologic factors|mesh-ancestor
5912711|NCT05054426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5912712|NCT05054426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5963115|NCT04604938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5963116|NCT04604938|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5963117|NCT04604938|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5963118|NCT04604938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963119|NCT04604756|Losartan|losartan|mesh-list
5963120|NCT04604756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5963121|NCT04604756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5963122|NCT04604756|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5963123|NCT04604756|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6242821|NCT02657031|Promethazine|promethazine|mesh-list
5699138|NCT03363815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5699139|NCT03363815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699140|NCT03363815|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5699141|NCT03363815|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5699142|NCT03363815|Antimetabolites|antimetabolites|mesh-ancestor
5699143|NCT03363815|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5699144|NCT03363815|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5699145|NCT03363815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5699146|NCT03363815|Anticoagulants|anticoagulants|mesh-ancestor
5699147|NCT03363815|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5699148|NCT03363815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5699149|NCT03363815|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5699150|NCT03363815|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5699151|NCT03363815|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5699152|NCT03363815|Protective Agents|protective agents|mesh-ancestor
5699153|NCT03363815|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5699154|NCT03363815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5699155|NCT03363815|Hemostatics|hemostatics|mesh-ancestor
5699156|NCT03363815|Coagulants|coagulants|mesh-ancestor
5699157|NCT03363815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5699158|NCT03363815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5699159|NCT03363659|Copper|copper|mesh-list
5699160|NCT03363659|Temozolomide|temozolomide|mesh-list
5699161|NCT03363659|Disulfiram|disulfiram|mesh-list
5699162|NCT03363659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5699163|NCT03363659|Alkylating Agents|alkylating agents|mesh-ancestor
5699164|NCT03363659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699165|NCT03363659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5699166|NCT03363659|Trace Elements|trace elements|mesh-ancestor
5699167|NCT03363659|Micronutrients|micronutrients|mesh-ancestor
5912713|NCT05054751|Fulvestrant|fulvestrant|mesh-list
5912714|NCT05054751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5912715|NCT05054751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5912716|NCT05054751|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5912717|NCT05054751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5912718|NCT05054751|Hormone Antagonists|hormone antagonists|mesh-ancestor
5912719|NCT05054751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5912720|NCT05054751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912721|NCT05054322|Fluticasone|fluticasone|mesh-list
5912722|NCT05054322|Xhance|xhance|mesh-list
5912723|NCT05054322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5912724|NCT05054322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5912725|NCT05054322|Autonomic Agents|autonomic agents|mesh-ancestor
5912726|NCT05054322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5912727|NCT05054322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912728|NCT05054322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5912729|NCT05054322|Respiratory System Agents|respiratory system agents|mesh-ancestor
5912730|NCT05054322|Dermatologic Agents|dermatologic agents|mesh-ancestor
5912731|NCT05054322|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5912732|NCT05054361|Mannitol|mannitol|mesh-list
5912733|NCT05054361|Lactulose|lactulose|mesh-list
5912734|NCT05054361|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5912735|NCT05054361|Diuretics|diuretics|mesh-ancestor
5912736|NCT05054361|Natriuretic Agents|natriuretic agents|mesh-ancestor
5912737|NCT05054361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912738|NCT05054361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5912739|NCT05054114|Interferons|interferons|mesh-list
5912740|NCT05054114|Interferon-gamma|interferon-gamma|mesh-list
5912741|NCT05054114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5912742|NCT05054114|Antiviral Agents|antiviral agents|mesh-ancestor
5912743|NCT05054114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5912744|NCT05054023|Piroxicam|piroxicam|mesh-list
5912745|NCT05054023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5912746|NCT05054023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5912747|NCT05054023|Analgesics|analgesics|mesh-ancestor
5912748|NCT05054023|Sensory System Agents|sensory system agents|mesh-ancestor
5912749|NCT05054023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5912750|NCT05054023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912751|NCT05054023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5912752|NCT05054023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5912753|NCT05054023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5912754|NCT05054023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5912755|NCT05054023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912756|NCT05053854|Talazoparib|talazoparib|mesh-list
5912757|NCT05053854|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5912758|NCT05053854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5912759|NCT05053854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912760|NCT05053854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5912761|NCT05053633|Anesthetics|anesthetics|mesh-list
5912762|NCT05053633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5912763|NCT05053633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912764|NCT05053750|Paclitaxel|paclitaxel|mesh-list
5912765|NCT05053750|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5912766|NCT05053750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5912767|NCT05053750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5912768|NCT05053750|Tubulin Modulators|tubulin modulators|mesh-ancestor
5912769|NCT05053750|Antimitotic Agents|antimitotic agents|mesh-ancestor
5912770|NCT05053750|Mitosis Modulators|mitosis modulators|mesh-ancestor
5912771|NCT05053750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912772|NCT05053594|Neostigmine|neostigmine|mesh-list
5912773|NCT05053594|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5912774|NCT05053594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5912775|NCT05053594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912776|NCT05053594|Cholinergic Agents|cholinergic agents|mesh-ancestor
5912777|NCT05053594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5912778|NCT05053594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912779|NCT05053594|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5912780|NCT05053594|Autonomic Agents|autonomic agents|mesh-ancestor
5912781|NCT05053594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5912782|NCT05053893|Valsartan|valsartan|mesh-list
5912783|NCT05053893|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5912784|NCT05053893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5912785|NCT05053893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5912786|NCT05053893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5912787|NCT05053893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912788|NCT05053841|Metformin|metformin|mesh-list
5912789|NCT05053841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5912790|NCT05053841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912791|NCT05053503|Lofexidine|lofexidine|mesh-list
5912792|NCT05053503|Naltrexone|naltrexone|mesh-list
5912793|NCT05053503|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5912794|NCT05053503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5912795|NCT05053503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912796|NCT05053503|Sensory System Agents|sensory system agents|mesh-ancestor
5912797|NCT05053503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5912798|NCT05053503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5912799|NCT05053503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5912800|NCT05053503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5912801|NCT05053503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5699168|NCT03363659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699169|NCT03363659|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5699170|NCT03363659|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
5699171|NCT03363659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5912802|NCT05053503|Adrenergic Agents|adrenergic agents|mesh-ancestor
5912803|NCT05053503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5912804|NCT05053503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912805|NCT05053126|Pregabalin|pregabalin|mesh-list
5912806|NCT05053126|Oxycodone|oxycodone|mesh-list
5912807|NCT05053126|Analgesics|analgesics|mesh-ancestor
5912808|NCT05053126|Sensory System Agents|sensory system agents|mesh-ancestor
5912809|NCT05053126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5912810|NCT05053126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912811|NCT05053126|Anticonvulsants|anticonvulsants|mesh-ancestor
5912812|NCT05053126|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5912813|NCT05053126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5912814|NCT05053126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912815|NCT05053126|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5912816|NCT05053126|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5912817|NCT05053126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5912818|NCT05053126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5912819|NCT05053126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5912820|NCT05053126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5912821|NCT05053126|Narcotics|narcotics|mesh-ancestor
5912822|NCT05053009|Ibuprofen|ibuprofen|mesh-list
5912823|NCT05053009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5912824|NCT05053009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5912825|NCT05053009|Analgesics|analgesics|mesh-ancestor
5912826|NCT05053009|Sensory System Agents|sensory system agents|mesh-ancestor
5699172|NCT03363477|Enoxaparin|enoxaparin|mesh-list
5699173|NCT03363477|Enoxaparin sodium|enoxaparin sodium|mesh-list
5699174|NCT03363477|Anticoagulants|anticoagulants|mesh-ancestor
5699175|NCT03363477|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5699176|NCT03363477|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5699177|NCT03363477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699178|NCT03363451|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5699179|NCT03363451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5699180|NCT03363425|Lidocaine|lidocaine|mesh-list
5699181|NCT03363425|Dexmedetomidine|dexmedetomidine|mesh-list
5699182|NCT03363425|Anesthetics, Local|anesthetics, local|mesh-ancestor
5912827|NCT05053009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5912828|NCT05053009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912829|NCT05053009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5912830|NCT05053009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5912831|NCT05053009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5912832|NCT05053009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5912833|NCT05053009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912834|NCT05052723|Pembrolizumab|pembrolizumab|mesh-list
5912835|NCT05052723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5912836|NCT05052723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5912837|NCT05053386|Epirubicin|epirubicin|mesh-list
5912838|NCT05053386|Idarubicin|idarubicin|mesh-list
5912839|NCT05053386|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5912840|NCT05053386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5912841|NCT05053386|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5912842|NCT05053386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5912843|NCT05053386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5912844|NCT05053386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912845|NCT05052879|Tadalafil|tadalafil|mesh-list
5912846|NCT05052879|Vasodilator Agents|vasodilator agents|mesh-ancestor
5699183|NCT03363425|Anesthetics|anesthetics|mesh-ancestor
5912847|NCT05052879|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5912848|NCT05052879|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5912849|NCT05052879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5912850|NCT05052879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912851|NCT05052879|Urological Agents|urological agents|mesh-ancestor
5912852|NCT05052515|Ascorbic Acid|ascorbic acid|mesh-list
5912853|NCT05052515|Choline|choline|mesh-list
5912854|NCT05052515|Vitamins|vitamins|mesh-ancestor
5912855|NCT05052515|Micronutrients|micronutrients|mesh-ancestor
5912856|NCT05052515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912857|NCT05052515|Antioxidants|antioxidants|mesh-ancestor
5912858|NCT05052515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675786|NCT01577862|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6675787|NCT01577862|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6675788|NCT01577862|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5912859|NCT05052515|Protective Agents|protective agents|mesh-ancestor
5912860|NCT05052515|Lipotropic Agents|lipotropic agents|mesh-ancestor
5912861|NCT05052515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5912862|NCT05052515|Antimetabolites|antimetabolites|mesh-ancestor
5912863|NCT05052515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5912864|NCT05052515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5912865|NCT05052515|Nootropic Agents|nootropic agents|mesh-ancestor
5912866|NCT05052619|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5912867|NCT05052619|Cefmetazole|cefmetazole|mesh-list
5912868|NCT05052619|Sulperazone|sulperazone|mesh-list
5912869|NCT05052619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5912870|NCT05052619|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5912871|NCT05052619|Renal Agents|renal agents|mesh-ancestor
5912872|NCT05052931|Paclitaxel|paclitaxel|mesh-list
5912873|NCT05052931|Oxaliplatin|oxaliplatin|mesh-list
5912874|NCT05052931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5912875|NCT05052931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5912876|NCT05052931|Tubulin Modulators|tubulin modulators|mesh-ancestor
5912877|NCT05052931|Antimitotic Agents|antimitotic agents|mesh-ancestor
5912878|NCT05052931|Mitosis Modulators|mitosis modulators|mesh-ancestor
5912879|NCT05052931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912880|NCT05052437|Capecitabine|capecitabine|mesh-list
5912881|NCT05052437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5912882|NCT05052437|Antimetabolites|antimetabolites|mesh-ancestor
5912883|NCT05052437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912884|NCT05052437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5912885|NCT05052775|Chlorhexidine|chlorhexidine|mesh-list
5912886|NCT05052775|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5912887|NCT05052775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5912888|NCT05052775|Disinfectants|disinfectants|mesh-ancestor
5912889|NCT05052814|Chlorhexidine|chlorhexidine|mesh-list
5912890|NCT05052814|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5912891|NCT05052814|Root Canal Irrigants|root canal irrigants|mesh-list
5912892|NCT05052814|Calcium|calcium|mesh-list
5912893|NCT05052814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5699184|NCT03363425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5699185|NCT03363425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699186|NCT03363425|Sensory System Agents|sensory system agents|mesh-ancestor
5699187|NCT03363425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5912894|NCT05052814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912895|NCT05052814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5912896|NCT05052814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5912897|NCT05052814|Disinfectants|disinfectants|mesh-ancestor
5912898|NCT05052814|Dermatologic Agents|dermatologic agents|mesh-ancestor
5912899|NCT05052814|Dental Disinfectants|dental disinfectants|mesh-ancestor
5912900|NCT05052541|Dronabinol|dronabinol|mesh-list
5912901|NCT05052541|Hallucinogens|hallucinogens|mesh-ancestor
5912902|NCT05052541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912903|NCT05052541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5912904|NCT05052541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5912905|NCT05052541|Analgesics|analgesics|mesh-ancestor
5912906|NCT05052541|Sensory System Agents|sensory system agents|mesh-ancestor
5912907|NCT05052541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5912908|NCT05052541|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5912909|NCT05052541|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5912910|NCT05052541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5699188|NCT03363425|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5699189|NCT03363425|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5699190|NCT03363425|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5699191|NCT03363425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5912911|NCT05052541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912912|NCT05052541|Hormones|hormones|mesh-ancestor
5912913|NCT05052541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5912914|NCT05052528|Cyclophosphamide|cyclophosphamide|mesh-list
5912915|NCT05052528|Rituximab|rituximab|mesh-list
5912916|NCT05052528|Fludarabine|fludarabine|mesh-list
5912917|NCT05052528|Fludarabine phosphate|fludarabine phosphate|mesh-list
5912918|NCT05052528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5912919|NCT05052528|Antibodies|antibodies|mesh-list
5912920|NCT05052528|Immunoglobulins|immunoglobulins|mesh-list
5912921|NCT05052528|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5912922|NCT05052528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5912923|NCT05052528|Immunologic Factors|immunologic factors|mesh-ancestor
5912924|NCT05052528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912925|NCT05052528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5912926|NCT05052528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5912927|NCT05052528|Alkylating Agents|alkylating agents|mesh-ancestor
5912928|NCT05052528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912929|NCT05052528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5912930|NCT05052528|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5912931|NCT05052528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5912932|NCT05052528|Antimetabolites|antimetabolites|mesh-ancestor
5912933|NCT05052008|Erenumab|erenumab|mesh-list
5912934|NCT05052008|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
5912935|NCT05052008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912936|NCT05052008|Analgesics|analgesics|mesh-ancestor
5912937|NCT05052008|Sensory System Agents|sensory system agents|mesh-ancestor
5912938|NCT05052008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5912939|NCT05052008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963124|NCT04604756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963125|NCT04604886|Dobutamine|dobutamine|mesh-list
5963126|NCT04604886|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5963127|NCT04604886|Sympathomimetics|sympathomimetics|mesh-ancestor
5963128|NCT04604886|Autonomic Agents|autonomic agents|mesh-ancestor
5963129|NCT04604886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5963130|NCT04604886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963131|NCT04604886|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5963132|NCT04604886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5963133|NCT04604886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5963134|NCT04604886|Adrenergic Agents|adrenergic agents|mesh-ancestor
5963135|NCT04604886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5699192|NCT03363425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699193|NCT03363425|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5699194|NCT03363425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5699195|NCT03363425|Analgesics|analgesics|mesh-ancestor
5699196|NCT03363425|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5699197|NCT03363425|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5699198|NCT03363425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5699199|NCT03363425|Adrenergic Agents|adrenergic agents|mesh-ancestor
5699200|NCT03363425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5720745|NCT03210766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5720746|NCT03210766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720747|NCT03210766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5720748|NCT03210766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5720749|NCT03210766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5720750|NCT03210766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5720751|NCT03210766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5720752|NCT03210545|Betamethasone|betamethasone|mesh-list
5720753|NCT03210545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5720754|NCT03210545|Glucocorticoids|glucocorticoids|mesh-ancestor
5720755|NCT03210545|Hormones|hormones|mesh-ancestor
5720756|NCT03210545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5720757|NCT03210545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720758|NCT03210545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5720759|NCT03210545|Respiratory System Agents|respiratory system agents|mesh-ancestor
5720760|NCT03210558|Testosterone|testosterone|mesh-list
5720761|NCT03210558|Androgens|androgens|mesh-ancestor
5963136|NCT04604886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963137|NCT04604886|Protective Agents|protective agents|mesh-ancestor
5963138|NCT04604678|Metformin|metformin|mesh-list
5963139|NCT04604678|Naltrexone|naltrexone|mesh-list
5963140|NCT04604678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5963141|NCT04604678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963142|NCT04604678|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5912940|NCT05052151|Dialysis Solutions|dialysis solutions|mesh-list
5912941|NCT05052151|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5912942|NCT05052359|Lectins|lectins|mesh-list
5912943|NCT05052359|Agglutinins|agglutinins|mesh-ancestor
5912944|NCT05052359|Immunologic Factors|immunologic factors|mesh-ancestor
5912945|NCT05052359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912946|NCT05052359|Coagulants|coagulants|mesh-ancestor
5912947|NCT05051956|Palbociclib|palbociclib|mesh-list
5912948|NCT05051956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5912949|NCT05051956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5912950|NCT05051956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5912951|NCT05051956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912952|NCT05051007|Lidocaine|lidocaine|mesh-list
5912953|NCT05051007|Fentanyl|fentanyl|mesh-list
5912954|NCT05051007|Anesthetics, Local|anesthetics, local|mesh-ancestor
5912955|NCT05051007|Anesthetics|anesthetics|mesh-ancestor
5912956|NCT05051007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5912957|NCT05051007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912958|NCT05051007|Sensory System Agents|sensory system agents|mesh-ancestor
5912959|NCT05051007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5912960|NCT05051007|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5912961|NCT05051007|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5912962|NCT05051007|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5912963|NCT05051007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5912964|NCT05051007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912965|NCT05051007|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5912966|NCT05051007|Narcotics|narcotics|mesh-ancestor
5912967|NCT05051007|Analgesics|analgesics|mesh-ancestor
5912968|NCT05051007|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5912969|NCT05051007|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5912970|NCT05051007|Anesthetics, General|anesthetics, general|mesh-ancestor
5912971|NCT05051150|Epinephrine|epinephrine|mesh-list
5912972|NCT05051150|Racepinephrine|racepinephrine|mesh-list
5912973|NCT05051150|Epinephryl borate|epinephryl borate|mesh-list
5912974|NCT05051150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5912975|NCT05051150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5912976|NCT05051150|Adrenergic Agents|adrenergic agents|mesh-ancestor
5912977|NCT05051150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5912978|NCT05051150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912979|NCT05051150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5912980|NCT05051150|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5912981|NCT05051150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5912982|NCT05051150|Autonomic Agents|autonomic agents|mesh-ancestor
5912983|NCT05051150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5912984|NCT05051150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5912985|NCT05051150|Respiratory System Agents|respiratory system agents|mesh-ancestor
5912986|NCT05051150|Mydriatics|mydriatics|mesh-ancestor
5912987|NCT05051150|Sympathomimetics|sympathomimetics|mesh-ancestor
5912988|NCT05051150|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5912989|NCT05051137|Hydroxychloroquine|hydroxychloroquine|mesh-list
5912990|NCT05051137|Sulfasalazine|sulfasalazine|mesh-list
5912991|NCT05051137|Infliximab|infliximab|mesh-list
5912992|NCT05051137|Antimalarials|antimalarials|mesh-ancestor
5912993|NCT05051137|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5912994|NCT05051137|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5912995|NCT05051137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5912996|NCT05051137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5912997|NCT05051137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5912998|NCT05051137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5912999|NCT05051137|Dermatologic Agents|dermatologic agents|mesh-ancestor
5913000|NCT05051137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5913001|NCT05051137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5913002|NCT05051137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5913003|NCT05051137|Analgesics|analgesics|mesh-ancestor
5913004|NCT05051137|Sensory System Agents|sensory system agents|mesh-ancestor
5913005|NCT05051137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5913006|NCT05051137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913007|NCT05051137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5913008|NCT05051163|Gentamicins|gentamicins|mesh-list
5913009|NCT05051163|Ceftriaxone|ceftriaxone|mesh-list
5913010|NCT05051163|Ampicillin|ampicillin|mesh-list
5913011|NCT05051163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5913012|NCT05051163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5913013|NCT05051163|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5913014|NCT05051163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5913015|NCT05051163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913016|NCT05050656|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5913017|NCT05050656|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5913018|NCT05050656|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5913019|NCT05050656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5913020|NCT05050656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913021|NCT05050656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5913022|NCT05050656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913023|NCT05050656|Analgesics|analgesics|mesh-ancestor
5913024|NCT05050656|Sensory System Agents|sensory system agents|mesh-ancestor
5913025|NCT05050656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5913026|NCT05050656|Antidepressive Agents|antidepressive agents|mesh-ancestor
5913027|NCT05050656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5913028|NCT05050656|Dopamine Agents|dopamine agents|mesh-ancestor
5913029|NCT05050604|Choline|choline|mesh-list
5913030|NCT05050604|Lipotropic Agents|lipotropic agents|mesh-ancestor
5913031|NCT05050604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5913032|NCT05050604|Antimetabolites|antimetabolites|mesh-ancestor
5913033|NCT05050604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913034|NCT05050604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5913035|NCT05050604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5913036|NCT05050604|Nootropic Agents|nootropic agents|mesh-ancestor
5913037|NCT05050357|Norethindrone|norethindrone|mesh-list
5913038|NCT05050357|Norethindrone Acetate|norethindrone acetate|mesh-list
5913039|NCT05050357|Progestins|progestins|mesh-list
5913040|NCT05050357|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5913041|NCT05050357|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5913042|NCT05050357|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5913043|NCT05050357|Contraceptive Agents|contraceptive agents|mesh-ancestor
5913044|NCT05050357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5699201|NCT03363295|Moxifloxacin|moxifloxacin|mesh-list
5699202|NCT03363295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5699203|NCT03363295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5699204|NCT03363295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5699205|NCT03363295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5699206|NCT03363295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5699207|NCT03363295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699208|NCT03363295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5699209|NCT03363217|Trametinib|trametinib|mesh-list
5699210|NCT03363217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5699211|NCT03363217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5699212|NCT03363217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5699213|NCT03363217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913045|NCT05050357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913046|NCT05050357|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5913047|NCT05050357|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5913048|NCT05050357|Hormones|hormones|mesh-ancestor
5913049|NCT05050357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5913050|NCT05050188|Lansoprazole|lansoprazole|mesh-list
5913051|NCT05050188|Dexlansoprazole|dexlansoprazole|mesh-list
5913052|NCT05050188|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5913053|NCT05050188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5913054|NCT05050188|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5913055|NCT05050188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5913056|NCT05050188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913057|NCT05050305|Dexamethasone|dexamethasone|mesh-list
5913058|NCT05050305|Pomalidomide|pomalidomide|mesh-list
5913059|NCT05050305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5913060|NCT05050305|Antiemetics|antiemetics|mesh-ancestor
5913061|NCT05050305|Autonomic Agents|autonomic agents|mesh-ancestor
5913062|NCT05050305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5913063|NCT05050305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913064|NCT05050305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5913065|NCT05050305|Glucocorticoids|glucocorticoids|mesh-ancestor
5913066|NCT05050305|Hormones|hormones|mesh-ancestor
5913067|NCT05050305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5913068|NCT05050305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5913069|NCT05050305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5913070|NCT05050305|Immunologic Factors|immunologic factors|mesh-ancestor
5913071|NCT05050305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5913072|NCT05050305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5913073|NCT05050305|Growth Substances|growth substances|mesh-ancestor
5913074|NCT05050305|Growth Inhibitors|growth inhibitors|mesh-ancestor
5913075|NCT05050071|Calcium, Dietary|calcium, dietary|mesh-list
5913076|NCT05050071|Calcium|calcium|mesh-list
5963143|NCT04604678|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5699214|NCT03363204|Salicylic Acid|salicylic acid|mesh-list
5699215|NCT03363204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5699216|NCT03363204|Antifungal Agents|antifungal agents|mesh-ancestor
5699217|NCT03363204|Keratolytic Agents|keratolytic agents|mesh-ancestor
5699218|NCT03363204|Dermatologic Agents|dermatologic agents|mesh-ancestor
5699219|NCT03363191|Fluticasone|fluticasone|mesh-list
5699220|NCT03363191|Xhance|xhance|mesh-list
5699221|NCT03363191|Albuterol|albuterol|mesh-list
5699222|NCT03363191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5699223|NCT03363191|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5699224|NCT03363191|Autonomic Agents|autonomic agents|mesh-ancestor
5699225|NCT03363191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5699226|NCT03363191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699227|NCT03363191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5699228|NCT03363191|Respiratory System Agents|respiratory system agents|mesh-ancestor
5699229|NCT03363191|Dermatologic Agents|dermatologic agents|mesh-ancestor
5699230|NCT03363191|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5699231|NCT03363191|Tocolytic Agents|tocolytic agents|mesh-ancestor
5699232|NCT03363191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5699233|NCT03363191|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5699234|NCT03363191|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5699235|NCT03363191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5699236|NCT03363191|Adrenergic Agents|adrenergic agents|mesh-ancestor
5699237|NCT03363191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5699238|NCT03363191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699239|NCT03363113|Botulinum Toxins|botulinum toxins|mesh-list
5699240|NCT03363113|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5720762|NCT03210558|Hormones|hormones|mesh-ancestor
5720763|NCT03210558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5720764|NCT03210558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720765|NCT03210506|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5720766|NCT03210506|Antiviral Agents|antiviral agents|mesh-ancestor
5720767|NCT03210506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5720768|NCT03210532|Amlodipine|amlodipine|mesh-list
5720769|NCT03210532|Telmisartan|telmisartan|mesh-list
5720770|NCT03210532|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
5720771|NCT03210532|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5720772|NCT03210532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5720773|NCT03210532|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5720774|NCT03210532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5720775|NCT03210532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5720776|NCT03210532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5720777|NCT03210532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720778|NCT03210532|Vasodilator Agents|vasodilator agents|mesh-ancestor
5720779|NCT03210532|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5720780|NCT03210532|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5720781|NCT03210532|Antimetabolites|antimetabolites|mesh-ancestor
5720782|NCT03210532|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5720783|NCT03210532|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5720784|NCT03210532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5720785|NCT03210532|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5720786|NCT03210532|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5720787|NCT03210246|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
5720788|NCT03210246|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
5720789|NCT03210246|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5720790|NCT03210246|Contraceptive Agents|contraceptive agents|mesh-ancestor
5720791|NCT03210246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5720792|NCT03210246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720793|NCT03210246|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5720794|NCT03210246|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5720795|NCT03210246|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5720796|NCT03210246|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5720797|NCT03210246|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5720798|NCT03210246|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
5720799|NCT03210246|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5720800|NCT03210246|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5720801|NCT03210324|Mifepristone|mifepristone|mesh-list
5720802|NCT03210324|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5720803|NCT03210324|Abortifacient Agents|abortifacient agents|mesh-ancestor
5720804|NCT03210324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5720805|NCT03210324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913077|NCT05050071|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5913078|NCT05050071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913079|NCT05050071|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5913080|NCT05050448|Diclofenac|diclofenac|mesh-list
5913081|NCT05050448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5913082|NCT05050448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5913083|NCT05050448|Analgesics|analgesics|mesh-ancestor
5913084|NCT05050448|Sensory System Agents|sensory system agents|mesh-ancestor
5913085|NCT05050448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5913086|NCT05050448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913087|NCT05050448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5913088|NCT05050448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5913089|NCT05050448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5913090|NCT05050448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5913091|NCT05050448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963144|NCT04604678|Sensory System Agents|sensory system agents|mesh-ancestor
5963145|NCT04604678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5963146|NCT04604795|Itraconazole|itraconazole|mesh-list
5963147|NCT04604795|Antifungal Agents|antifungal agents|mesh-ancestor
5963148|NCT04604795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5963149|NCT04604795|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5963150|NCT04604795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5963151|NCT04604795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5963152|NCT04604795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963153|NCT04604795|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5963154|NCT04604795|Hormone Antagonists|hormone antagonists|mesh-ancestor
5963155|NCT04604795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5963156|NCT04604795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963157|NCT04604795|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5963158|NCT04604704|Niacinamide|niacinamide|mesh-list
5963159|NCT04604704|Naltrexone|naltrexone|mesh-list
5963160|NCT04604704|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5963161|NCT04604704|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5963162|NCT04604704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963163|NCT04604704|Sensory System Agents|sensory system agents|mesh-ancestor
5963164|NCT04604704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5699241|NCT03363113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5699242|NCT03363113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699243|NCT03363113|Cholinergic Agents|cholinergic agents|mesh-ancestor
5699244|NCT03363113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5699245|NCT03363113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963165|NCT04604704|Vitamin B Complex|vitamin b complex|mesh-ancestor
5963166|NCT04604704|Vitamins|vitamins|mesh-ancestor
5963167|NCT04604704|Micronutrients|micronutrients|mesh-ancestor
5963168|NCT04604691|Blinatumomab|blinatumomab|mesh-list
5963169|NCT04604691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5963170|NCT04604509|Bupropion|bupropion|mesh-list
5963171|NCT04604509|Nicotine|nicotine|mesh-list
5963172|NCT04604509|Varenicline|varenicline|mesh-list
5963173|NCT04604509|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5963174|NCT04604509|Autonomic Agents|autonomic agents|mesh-ancestor
5963175|NCT04604509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5963176|NCT04604509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963177|NCT04604509|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5963178|NCT04604509|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5963179|NCT04604509|Cholinergic Agents|cholinergic agents|mesh-ancestor
5963180|NCT04604509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5963181|NCT04604509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963182|NCT04604509|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5963183|NCT04604509|Antidepressive Agents|antidepressive agents|mesh-ancestor
5963184|NCT04604509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5963185|NCT04604509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5963186|NCT04604509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5963187|NCT04604509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5963188|NCT04604509|Dopamine Agents|dopamine agents|mesh-ancestor
5963189|NCT04604509|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5699246|NCT03362905|Lidocaine|lidocaine|mesh-list
5699247|NCT03362905|Anesthetics, Local|anesthetics, local|mesh-ancestor
5699248|NCT03362905|Anesthetics|anesthetics|mesh-ancestor
5699249|NCT03362905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5699250|NCT03362905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963190|NCT04604509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5913092|NCT05049603|Atorvastatin|atorvastatin|mesh-list
5913093|NCT05049603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5913094|NCT05049603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5913095|NCT05049603|Antimetabolites|antimetabolites|mesh-ancestor
5913096|NCT05049603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913097|NCT05049603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5913098|NCT05049603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5913099|NCT05049603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5913100|NCT05049863|Mycophenolic Acid|mycophenolic acid|mesh-list
5913101|NCT05049863|Irinotecan|irinotecan|mesh-list
5913102|NCT05049863|Allopurinol|allopurinol|mesh-list
5913103|NCT05049863|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5913104|NCT05049863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5913105|NCT05049863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5913106|NCT05049863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913107|NCT05049863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5913108|NCT05049863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5913109|NCT05049863|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5913110|NCT05049863|Antitubercular Agents|antitubercular agents|mesh-ancestor
5913111|NCT05049863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5913112|NCT05049863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5913113|NCT05049863|Antimetabolites|antimetabolites|mesh-ancestor
5913114|NCT05049863|Gout Suppressants|gout suppressants|mesh-ancestor
5913115|NCT05049863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5913116|NCT05049863|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5913117|NCT05049863|Antioxidants|antioxidants|mesh-ancestor
5913118|NCT05049863|Protective Agents|protective agents|mesh-ancestor
5913119|NCT05049863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913120|NCT05049707|Magnesium Sulfate|magnesium sulfate|mesh-list
5913121|NCT05049707|Analgesics|analgesics|mesh-ancestor
5913122|NCT05049707|Sensory System Agents|sensory system agents|mesh-ancestor
5913123|NCT05049707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5913124|NCT05049707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913125|NCT05049707|Anesthetics|anesthetics|mesh-ancestor
5913126|NCT05049707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5913127|NCT05049707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5913128|NCT05049707|Anticonvulsants|anticonvulsants|mesh-ancestor
5913129|NCT05049707|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5913130|NCT05049707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5913131|NCT05049707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913132|NCT05049707|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5913133|NCT05049707|Tocolytic Agents|tocolytic agents|mesh-ancestor
5913134|NCT05049707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5913135|NCT05049473|Cytarabine|cytarabine|mesh-list
5913136|NCT05049473|Dexamethasone|dexamethasone|mesh-list
5913137|NCT05049473|Prednisone|prednisone|mesh-list
5913138|NCT05049473|Hydrocortisone|hydrocortisone|mesh-list
5913139|NCT05049473|Cyclophosphamide|cyclophosphamide|mesh-list
5913140|NCT05049473|Rituximab|rituximab|mesh-list
5913141|NCT05049473|Doxorubicin|doxorubicin|mesh-list
5913142|NCT05049473|Methotrexate|methotrexate|mesh-list
5913143|NCT05049473|Etoposide|etoposide|mesh-list
5913144|NCT05049473|Vincristine|vincristine|mesh-list
5913145|NCT05049473|Vindesine|vindesine|mesh-list
5913146|NCT05049473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5913147|NCT05049473|Immunologic Factors|immunologic factors|mesh-ancestor
5913148|NCT05049473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913149|NCT05049473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5913150|NCT05049473|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5913151|NCT05049473|Alkylating Agents|alkylating agents|mesh-ancestor
5913152|NCT05049473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913153|NCT05049473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5913154|NCT05049473|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5913155|NCT05049473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5913156|NCT05049473|Antiemetics|antiemetics|mesh-ancestor
5913157|NCT05049473|Autonomic Agents|autonomic agents|mesh-ancestor
5913158|NCT05049473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5913159|NCT05049473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5913160|NCT05049473|Glucocorticoids|glucocorticoids|mesh-ancestor
5913161|NCT05049473|Hormones|hormones|mesh-ancestor
5913162|NCT05049473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5913163|NCT05049473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5913164|NCT05049473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5913165|NCT05049473|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5913166|NCT05049473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5913167|NCT05049473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5913168|NCT05049473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5913169|NCT05049473|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5913170|NCT05049473|Abortifacient Agents|abortifacient agents|mesh-ancestor
5913171|NCT05049473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5913172|NCT05049473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5913173|NCT05049473|Antimetabolites|antimetabolites|mesh-ancestor
5913174|NCT05049473|Dermatologic Agents|dermatologic agents|mesh-ancestor
5913175|NCT05049473|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5913176|NCT05049473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5913177|NCT05049473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5913178|NCT05049473|Antiviral Agents|antiviral agents|mesh-ancestor
5913179|NCT05049473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5913180|NCT05049473|Tubulin Modulators|tubulin modulators|mesh-ancestor
5913181|NCT05049473|Antimitotic Agents|antimitotic agents|mesh-ancestor
5913182|NCT05049473|Mitosis Modulators|mitosis modulators|mesh-ancestor
5913183|NCT05049213|Povidone-Iodine|povidone-iodine|mesh-list
5913184|NCT05049213|Povidone|povidone|mesh-list
5913185|NCT05049213|Plasma Substitutes|plasma substitutes|mesh-ancestor
5913186|NCT05049213|Blood Substitutes|blood substitutes|mesh-ancestor
5913187|NCT05049213|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5913188|NCT05049213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5913189|NCT05049681|Apatinib|apatinib|mesh-list
5913190|NCT05049681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5913191|NCT05049681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5913192|NCT05049681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5913193|NCT05049681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913194|NCT05048914|Acetaminophen|acetaminophen|mesh-list
5699251|NCT03362905|Sensory System Agents|sensory system agents|mesh-ancestor
5699252|NCT03362905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5699253|NCT03362905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5699254|NCT03362905|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5913195|NCT05048914|Dipyrone|dipyrone|mesh-list
5913196|NCT05048914|Ibuprofen|ibuprofen|mesh-list
5913197|NCT05048914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5913198|NCT05048914|Analgesics|analgesics|mesh-ancestor
5913199|NCT05048914|Sensory System Agents|sensory system agents|mesh-ancestor
5913200|NCT05048914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5913201|NCT05048914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913202|NCT05048914|Antipyretics|antipyretics|mesh-ancestor
5913203|NCT05048914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5913204|NCT05048914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5913205|NCT05048914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5913206|NCT05048914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5913207|NCT05048914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5913208|NCT05048914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913209|NCT05048940|Vaccines|vaccines|mesh-list
5913210|NCT05048940|Immunologic Factors|immunologic factors|mesh-ancestor
5913211|NCT05048940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913212|NCT05048901|Lanreotide|lanreotide|mesh-list
5913213|NCT05048901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5913214|NCT05048615|Itraconazole|itraconazole|mesh-list
5913215|NCT05048615|Azacitidine|azacitidine|mesh-list
5913216|NCT05048615|Venetoclax|venetoclax|mesh-list
5913217|NCT05048615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5913218|NCT05048615|Antimetabolites|antimetabolites|mesh-ancestor
5913219|NCT05048615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913220|NCT05048615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5913221|NCT05048615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5699255|NCT03362905|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5699256|NCT03362905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5699257|NCT03362905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699258|NCT03362853|Moxifloxacin|moxifloxacin|mesh-list
5699259|NCT03362853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5699260|NCT03362853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5699261|NCT03362853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5699262|NCT03362853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5699263|NCT03362853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5699264|NCT03362853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699265|NCT03362853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5699266|NCT03362814|Ritonavir|ritonavir|mesh-list
5699267|NCT03362814|Ribavirin|ribavirin|mesh-list
5699268|NCT03362814|Lactams|lactams|mesh-list
5699269|NCT03362814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5699270|NCT03362814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5699271|NCT03362814|Protease Inhibitors|protease inhibitors|mesh-ancestor
5913222|NCT05048615|Antifungal Agents|antifungal agents|mesh-ancestor
5913223|NCT05048615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5913224|NCT05048615|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5913225|NCT05048615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5913226|NCT05048615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5913227|NCT05048615|Hormone Antagonists|hormone antagonists|mesh-ancestor
5913228|NCT05048615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5913229|NCT05048615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913230|NCT05048615|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5913231|NCT05048511|Vitamin D|vitamin d|mesh-list
5913232|NCT05048511|Vitamins|vitamins|mesh-ancestor
5913233|NCT05048511|Micronutrients|micronutrients|mesh-ancestor
5913234|NCT05048511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913235|NCT05048511|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5913236|NCT05048589|Vaccines|vaccines|mesh-list
5913237|NCT05048589|Immunologic Factors|immunologic factors|mesh-ancestor
5913238|NCT05048589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913239|NCT05048524|Leucovorin|leucovorin|mesh-list
5913240|NCT05048524|Gemcitabine|gemcitabine|mesh-list
5913241|NCT05048524|Oxaliplatin|oxaliplatin|mesh-list
5913242|NCT05048524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5913243|NCT05048524|Antimetabolites|antimetabolites|mesh-ancestor
5913244|NCT05048524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913245|NCT05048524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5913246|NCT05048524|Antiviral Agents|antiviral agents|mesh-ancestor
5913247|NCT05048524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5913248|NCT05048524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5913249|NCT05048524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5913250|NCT05048524|Immunologic Factors|immunologic factors|mesh-ancestor
5913251|NCT05048524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913252|NCT05048524|Antidotes|antidotes|mesh-ancestor
5913253|NCT05048524|Protective Agents|protective agents|mesh-ancestor
5913254|NCT05048524|Vitamin B Complex|vitamin b complex|mesh-ancestor
5913255|NCT05048524|Vitamins|vitamins|mesh-ancestor
5913256|NCT05048524|Micronutrients|micronutrients|mesh-ancestor
5913257|NCT05048498|Azacitidine|azacitidine|mesh-list
5913258|NCT05048498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5913259|NCT05048498|Antimetabolites|antimetabolites|mesh-ancestor
5913260|NCT05048498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913261|NCT05048498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5913262|NCT05048498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5913263|NCT05047952|Vortioxetine|vortioxetine|mesh-list
5913264|NCT05047952|Antidepressive Agents|antidepressive agents|mesh-ancestor
5913265|NCT05047952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5913266|NCT05047952|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5913267|NCT05047952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5913268|NCT05047952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5913269|NCT05047952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913270|NCT05047952|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5913271|NCT05047952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5913272|NCT05047952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5913273|NCT05047952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913274|NCT05047952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5913275|NCT05047952|Serotonin Agents|serotonin agents|mesh-ancestor
5913276|NCT05047952|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5913277|NCT05047952|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5913278|NCT05047952|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5913279|NCT05047952|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5913280|NCT05048017|Pembrolizumab|pembrolizumab|mesh-list
5913281|NCT05048017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5913282|NCT05048017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5913283|NCT05048017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5913284|NCT05048017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913285|NCT05047874|Methylprednisolone|methylprednisolone|mesh-list
5913286|NCT05047874|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5913287|NCT05047874|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5913288|NCT05047874|Prednisolone|prednisolone|mesh-list
5913289|NCT05047874|Prednisolone acetate|prednisolone acetate|mesh-list
5913290|NCT05047874|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5913291|NCT05047874|Prednisolone phosphate|prednisolone phosphate|mesh-list
5913292|NCT05047874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5913293|NCT05047874|Antiemetics|antiemetics|mesh-ancestor
5913294|NCT05047874|Autonomic Agents|autonomic agents|mesh-ancestor
5913295|NCT05047874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5913296|NCT05047874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913297|NCT05047874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5913298|NCT05047874|Glucocorticoids|glucocorticoids|mesh-ancestor
5913299|NCT05047874|Hormones|hormones|mesh-ancestor
5913300|NCT05047874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5913301|NCT05047874|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5913302|NCT05047874|Protective Agents|protective agents|mesh-ancestor
5913303|NCT05047874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5913304|NCT05047874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5963191|NCT04604509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5699272|NCT03362814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5699273|NCT03362814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699274|NCT03362814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5699275|NCT03362814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5699276|NCT03362814|Antiviral Agents|antiviral agents|mesh-ancestor
5699277|NCT03362814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5699278|NCT03362814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5699279|NCT03362814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5699280|NCT03362814|Antimetabolites|antimetabolites|mesh-ancestor
5699281|NCT03362814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5699282|NCT03362788|Vitamin K|vitamin k|mesh-list
5699283|NCT03362788|Anticoagulants|anticoagulants|mesh-list
5699284|NCT03362788|Vitamins|vitamins|mesh-ancestor
5699285|NCT03362788|Micronutrients|micronutrients|mesh-ancestor
5699286|NCT03362788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963192|NCT04604366|Alprostadil|alprostadil|mesh-list
5963193|NCT04604366|Misoprostol|misoprostol|mesh-list
5963194|NCT04604366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5963195|NCT04604366|Abortifacient Agents|abortifacient agents|mesh-ancestor
5963196|NCT04604366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5963197|NCT04604366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963198|NCT04604366|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5963199|NCT04604366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5963200|NCT04604366|Oxytocics|oxytocics|mesh-ancestor
5963201|NCT04604366|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5963202|NCT04604366|Vasodilator Agents|vasodilator agents|mesh-ancestor
5963203|NCT04604366|Urological Agents|urological agents|mesh-ancestor
5963204|NCT04604353|Calcium|calcium|mesh-list
5963205|NCT04604353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5963206|NCT04604353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963207|NCT04604327|Bemiparin|bemiparin|mesh-list
5963208|NCT04604327|Anticoagulants|anticoagulants|mesh-ancestor
5963209|NCT04604223|Pioglitazone|pioglitazone|mesh-list
5963210|NCT04604223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5963211|NCT04604223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963212|NCT04604028|Cyclophosphamide|cyclophosphamide|mesh-list
5963213|NCT04604028|Lenalidomide|lenalidomide|mesh-list
5963214|NCT04604028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5963215|NCT04604028|Immunologic Factors|immunologic factors|mesh-ancestor
5963216|NCT04604028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963217|NCT04604028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5963218|NCT04604028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5963219|NCT04604028|Alkylating Agents|alkylating agents|mesh-ancestor
5963220|NCT04604028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963221|NCT04604028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5963222|NCT04604028|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5963223|NCT04604028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5963224|NCT04604028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5963225|NCT04604028|Growth Substances|growth substances|mesh-ancestor
5699287|NCT03362788|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5699288|NCT03362788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5699289|NCT03362788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699290|NCT03362788|Hemostatics|hemostatics|mesh-ancestor
5699291|NCT03362788|Coagulants|coagulants|mesh-ancestor
5699292|NCT03362775|Propofol|propofol|mesh-list
5699293|NCT03362775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5699294|NCT03362775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5699295|NCT03362775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699296|NCT03362775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5699297|NCT03362775|Anesthetics, General|anesthetics, general|mesh-ancestor
5699298|NCT03362775|Anesthetics|anesthetics|mesh-ancestor
5699299|NCT03362736|Ustekinumab|ustekinumab|mesh-list
5963226|NCT04604028|Growth Inhibitors|growth inhibitors|mesh-ancestor
5963227|NCT04604054|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5963228|NCT04604054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5699300|NCT03362736|Dermatologic Agents|dermatologic agents|mesh-ancestor
5699301|NCT03362697|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6242822|NCT02657031|Ketamine|ketamine|mesh-list
5913305|NCT05047848|Fulvestrant|fulvestrant|mesh-list
5913306|NCT05047848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5913307|NCT05047848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5913308|NCT05047848|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5913309|NCT05047848|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5913310|NCT05047848|Hormone Antagonists|hormone antagonists|mesh-ancestor
5913311|NCT05047848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5913312|NCT05047848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913313|NCT05047991|Leucovorin|leucovorin|mesh-list
5913314|NCT05047991|Gemcitabine|gemcitabine|mesh-list
5913315|NCT05047991|Paclitaxel|paclitaxel|mesh-list
5913316|NCT05047991|Fluorouracil|fluorouracil|mesh-list
5913317|NCT05047991|Oxaliplatin|oxaliplatin|mesh-list
5913318|NCT05047991|Irinotecan|irinotecan|mesh-list
5913319|NCT05047991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5913320|NCT05047991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5913321|NCT05047991|Tubulin Modulators|tubulin modulators|mesh-ancestor
5913322|NCT05047991|Antimitotic Agents|antimitotic agents|mesh-ancestor
5913323|NCT05047991|Mitosis Modulators|mitosis modulators|mesh-ancestor
5913324|NCT05047991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913325|NCT05047991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5913326|NCT05047991|Antimetabolites|antimetabolites|mesh-ancestor
5913327|NCT05047991|Antiviral Agents|antiviral agents|mesh-ancestor
5913328|NCT05047991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5913329|NCT05047991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5913330|NCT05047991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5913331|NCT05047991|Immunologic Factors|immunologic factors|mesh-ancestor
5913332|NCT05047991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913333|NCT05047991|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5913334|NCT05047991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5913335|NCT05047991|Antidotes|antidotes|mesh-ancestor
5913336|NCT05047991|Protective Agents|protective agents|mesh-ancestor
5913337|NCT05047991|Vitamin B Complex|vitamin b complex|mesh-ancestor
5913338|NCT05047991|Vitamins|vitamins|mesh-ancestor
5913339|NCT05047991|Micronutrients|micronutrients|mesh-ancestor
5913340|NCT05047978|Caseins|caseins|mesh-list
5913341|NCT05047978|Chelating Agents|chelating agents|mesh-ancestor
5913342|NCT05047978|Sequestering Agents|sequestering agents|mesh-ancestor
5913343|NCT05047978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913344|NCT05047328|Inolimomab|inolimomab|mesh-list
5913345|NCT05047328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5913346|NCT05047328|Immunologic Factors|immunologic factors|mesh-ancestor
5913347|NCT05047328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913348|NCT05047133|Tranexamic Acid|tranexamic acid|mesh-list
5913349|NCT05047133|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5913350|NCT05047133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5913351|NCT05047133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913352|NCT05047133|Hemostatics|hemostatics|mesh-ancestor
5913353|NCT05047133|Coagulants|coagulants|mesh-ancestor
5913354|NCT05047393|Vitamin D|vitamin d|mesh-list
5913355|NCT05047393|Vitamins|vitamins|mesh-ancestor
5913356|NCT05047393|Micronutrients|micronutrients|mesh-ancestor
5913357|NCT05047393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913358|NCT05047393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5913359|NCT05047211|Dextrans|dextrans|mesh-list
5913360|NCT05047211|Iron-Dextran Complex|iron-dextran complex|mesh-list
5913361|NCT05047211|Anticoagulants|anticoagulants|mesh-ancestor
5913362|NCT05047211|Plasma Substitutes|plasma substitutes|mesh-ancestor
5913363|NCT05047211|Blood Substitutes|blood substitutes|mesh-ancestor
5913364|NCT05047211|Hematinics|hematinics|mesh-ancestor
5913365|NCT05046860|Dalbavancin|dalbavancin|mesh-list
5913366|NCT05046860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5913367|NCT05046860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5913368|NCT05047055|Moxifloxacin|moxifloxacin|mesh-list
5913369|NCT05047055|Rifampin|rifampin|mesh-list
5913370|NCT05047055|Isoniazid|isoniazid|mesh-list
5913371|NCT05047055|Pyrazinamide|pyrazinamide|mesh-list
5913372|NCT05047055|Ethambutol|ethambutol|mesh-list
5913373|NCT05047055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5913374|NCT05047055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5913375|NCT05047055|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5913376|NCT05047055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5913377|NCT05047055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5913378|NCT05047055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913379|NCT05047055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5913380|NCT05047055|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5913381|NCT05047055|Antitubercular Agents|antitubercular agents|mesh-ancestor
5913382|NCT05047055|Leprostatic Agents|leprostatic agents|mesh-ancestor
5913383|NCT05047055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5913384|NCT05047055|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5913385|NCT05047055|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5913386|NCT05047055|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5913387|NCT05047055|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5913388|NCT05047055|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5913389|NCT05047055|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5913390|NCT05047055|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5913391|NCT05047055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5913392|NCT05047055|Antimetabolites|antimetabolites|mesh-ancestor
5913393|NCT05047055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5913394|NCT05046535|Nicotine|nicotine|mesh-list
5913395|NCT05046535|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5913396|NCT05046535|Autonomic Agents|autonomic agents|mesh-ancestor
5913397|NCT05046535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5913398|NCT05046535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913399|NCT05046535|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5913400|NCT05046535|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5913401|NCT05046535|Cholinergic Agents|cholinergic agents|mesh-ancestor
5913402|NCT05046535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5913403|NCT05046535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913404|NCT05046431|Golimumab|golimumab|mesh-list
5913405|NCT05046431|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
5913406|NCT05046431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5913407|NCT05046431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5913408|NCT05046431|Immunologic Factors|immunologic factors|mesh-ancestor
5913409|NCT05046431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913410|NCT05046262|Calcium|calcium|mesh-list
5913411|NCT05046262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5913412|NCT05046262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913413|NCT05046457|Beta-Cryptoxanthin|beta-cryptoxanthin|mesh-list
5913414|NCT05046457|Provitamins|provitamins|mesh-ancestor
5913415|NCT05046457|Vitamins|vitamins|mesh-ancestor
5913416|NCT05046457|Micronutrients|micronutrients|mesh-ancestor
5913417|NCT05046457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913418|NCT05045937|Vitamin D|vitamin d|mesh-list
5913419|NCT05045937|Vitamins|vitamins|mesh-list
5913420|NCT05045937|Ivermectin|ivermectin|mesh-list
5913421|NCT05045937|Remdesivir|remdesivir|mesh-list
5913422|NCT05045937|Ibuprofen|ibuprofen|mesh-list
5913423|NCT05045937|Budesonide|budesonide|mesh-list
5913424|NCT05045937|Melatonin|melatonin|mesh-list
5913425|NCT05045937|Albuterol|albuterol|mesh-list
5913426|NCT05045937|Quercetin|quercetin|mesh-list
5913427|NCT05045937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913428|NCT05045937|Micronutrients|micronutrients|mesh-ancestor
5913429|NCT05045937|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5913430|NCT05045937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5913431|NCT05045937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5913432|NCT05045937|Analgesics|analgesics|mesh-ancestor
5913433|NCT05045937|Sensory System Agents|sensory system agents|mesh-ancestor
5913434|NCT05045937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5913435|NCT05045937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5913436|NCT05045937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5913437|NCT05045937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913438|NCT05045937|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5913439|NCT05045937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5913440|NCT05045937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5913441|NCT05045937|Autonomic Agents|autonomic agents|mesh-ancestor
5913442|NCT05045937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5913443|NCT05045937|Respiratory System Agents|respiratory system agents|mesh-ancestor
5699302|NCT03362697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5699303|NCT03362684|Cetuximab|cetuximab|mesh-list
5699304|NCT03362684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5699305|NCT03362684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5699306|NCT03362632|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5699307|NCT03362632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5699308|NCT03362515|Furosemide|furosemide|mesh-list
5699309|NCT03362515|Diuretics|diuretics|mesh-ancestor
5699310|NCT03362515|Natriuretic Agents|natriuretic agents|mesh-ancestor
5699311|NCT03362515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699312|NCT03362515|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5699313|NCT03362515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5699314|NCT03362515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699315|NCT03362411|Linrodostat|linrodostat|mesh-list
5699316|NCT03362411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5699317|NCT03362411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913444|NCT05045937|Glucocorticoids|glucocorticoids|mesh-ancestor
5913445|NCT05045937|Hormones|hormones|mesh-ancestor
5913446|NCT05045937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5913447|NCT05045937|Antioxidants|antioxidants|mesh-ancestor
5913448|NCT05045937|Protective Agents|protective agents|mesh-ancestor
5699318|NCT03362359|Edetic Acid|edetic acid|mesh-list
5699319|NCT03362359|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5699320|NCT03362359|Chelating Agents|chelating agents|mesh-ancestor
5699321|NCT03362359|Sequestering Agents|sequestering agents|mesh-ancestor
5699322|NCT03362359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699323|NCT03362359|Anticoagulants|anticoagulants|mesh-ancestor
5699324|NCT03362359|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5699325|NCT03362359|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5699326|NCT03362281|Amoxicillin|amoxicillin|mesh-list
5699327|NCT03362281|Clarithromycin|clarithromycin|mesh-list
5699328|NCT03362281|Omeprazole|omeprazole|mesh-list
5699329|NCT03362281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5699330|NCT03362281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5699331|NCT03362281|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5699332|NCT03362281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5699333|NCT03362281|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5699334|NCT03362281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5699335|NCT03362281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699336|NCT03362281|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5699337|NCT03362281|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5699338|NCT03362281|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5699339|NCT03362268|Omeprazole|omeprazole|mesh-list
5699340|NCT03362268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5699341|NCT03362268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5699342|NCT03362268|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5699343|NCT03362268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5699344|NCT03362268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913449|NCT05045937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5913450|NCT05045937|Tocolytic Agents|tocolytic agents|mesh-ancestor
5913451|NCT05045937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5913452|NCT05045937|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5913453|NCT05045937|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5913454|NCT05045937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5913455|NCT05045937|Adrenergic Agents|adrenergic agents|mesh-ancestor
5913456|NCT05045937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5913457|NCT05045937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5913458|NCT05045937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5913459|NCT05045937|Antimetabolites|antimetabolites|mesh-ancestor
5913460|NCT05045937|Antiviral Agents|antiviral agents|mesh-ancestor
5913461|NCT05046041|Misoprostol|misoprostol|mesh-list
5913462|NCT05046041|Mifepristone|mifepristone|mesh-list
5913463|NCT05046041|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5913464|NCT05046041|Abortifacient Agents|abortifacient agents|mesh-ancestor
5913465|NCT05046041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5913466|NCT05046041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913467|NCT05046041|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5913468|NCT05046041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5913469|NCT05046041|Oxytocics|oxytocics|mesh-ancestor
5913470|NCT05046041|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5913471|NCT05046041|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5913472|NCT05046041|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5913473|NCT05046041|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5913474|NCT05046041|Contraceptive Agents|contraceptive agents|mesh-ancestor
5913475|NCT05046041|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5913476|NCT05046041|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5913477|NCT05046041|Hormone Antagonists|hormone antagonists|mesh-ancestor
5913478|NCT05046041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5913479|NCT05046041|Luteolytic Agents|luteolytic agents|mesh-ancestor
5913480|NCT05046041|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5913481|NCT05046041|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5913482|NCT05046015|Carbamide Peroxide|carbamide peroxide|mesh-list
5913483|NCT05046015|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5913484|NCT05046015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5963229|NCT04604054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963230|NCT04603729|Dexamethasone|dexamethasone|mesh-list
5963231|NCT04603729|Methylprednisolone|methylprednisolone|mesh-list
5699345|NCT03362216|Diclofenac|diclofenac|mesh-list
5963232|NCT04603729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5963233|NCT04603729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5963234|NCT04603729|Prednisolone|prednisolone|mesh-list
5963235|NCT04603729|Prednisolone acetate|prednisolone acetate|mesh-list
5913485|NCT05045651|Cimetidine|cimetidine|mesh-list
5913486|NCT05045651|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5913487|NCT05045651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5913488|NCT05045651|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5913489|NCT05045651|Histamine Antagonists|histamine antagonists|mesh-ancestor
5913490|NCT05045651|Histamine Agents|histamine agents|mesh-ancestor
5913491|NCT05045651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5913492|NCT05045651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913493|NCT05045651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913494|NCT05045651|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5913495|NCT05045651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5913496|NCT05045651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5913497|NCT05045508|Varenicline|varenicline|mesh-list
5913498|NCT05045508|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5913499|NCT05045508|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5913500|NCT05045508|Cholinergic Agents|cholinergic agents|mesh-ancestor
5913501|NCT05045508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5913502|NCT05045508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913503|NCT05045508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913504|NCT05045664|Obinutuzumab|obinutuzumab|mesh-list
5913505|NCT05045664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5913506|NCT05045664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5913507|NCT05045248|Apraclonidine|apraclonidine|mesh-list
5913508|NCT05045248|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5913509|NCT05045248|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5913510|NCT05045248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5913511|NCT05045248|Adrenergic Agents|adrenergic agents|mesh-ancestor
5913512|NCT05045248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5913513|NCT05045248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913514|NCT05045248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913515|NCT05045274|Aspirin|aspirin|mesh-list
5913516|NCT05045274|Dapagliflozin|dapagliflozin|mesh-list
5913517|NCT05045274|Angiotensin II|angiotensin ii|mesh-list
5913518|NCT05045274|Giapreza|giapreza|mesh-list
5699346|NCT03362216|Salicylates|salicylates|mesh-list
5699347|NCT03362216|Methyl salicylate|methyl salicylate|mesh-list
5699348|NCT03362216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5699349|NCT03362216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5699350|NCT03362216|Analgesics|analgesics|mesh-ancestor
5699351|NCT03362216|Sensory System Agents|sensory system agents|mesh-ancestor
5699352|NCT03362216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5699353|NCT03362216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699354|NCT03362216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5699355|NCT03362216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5913519|NCT05045274|Clopidogrel|clopidogrel|mesh-list
5913520|NCT05045274|Ticagrelor|ticagrelor|mesh-list
5913521|NCT05045274|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
5913522|NCT05045274|Enzyme Inhibitors|enzyme inhibitors|mesh-list
5913523|NCT05045274|Angiotensinogen|angiotensinogen|mesh-list
5913524|NCT05045274|Diuretics|diuretics|mesh-list
5913525|NCT05045274|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
5913526|NCT05045274|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
5913527|NCT05045274|Mineralocorticoids|mineralocorticoids|mesh-list
5913528|NCT05045274|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
5913529|NCT05045274|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
5913530|NCT05045274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5913531|NCT05045274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5913532|NCT05045274|Analgesics|analgesics|mesh-ancestor
5913533|NCT05045274|Sensory System Agents|sensory system agents|mesh-ancestor
5913534|NCT05045274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5913535|NCT05045274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913536|NCT05045274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5913537|NCT05045274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5913538|NCT05045274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5913539|NCT05045274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5913540|NCT05045274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913541|NCT05045274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5913542|NCT05045274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5913543|NCT05045274|Antipyretics|antipyretics|mesh-ancestor
5913544|NCT05045274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6242823|NCT02657031|Ondansetron|ondansetron|mesh-list
6496679|NCT00629031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6496680|NCT00629135|Moxifloxacin|moxifloxacin|mesh-list
6496681|NCT00629135|Metronidazole|metronidazole|mesh-list
6496682|NCT00629135|Tazobactam|tazobactam|mesh-list
6496683|NCT00629135|Piperacillin|piperacillin|mesh-list
5913545|NCT05045274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5913546|NCT05045274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5913547|NCT05045274|Purinergic Agents|purinergic agents|mesh-ancestor
5913548|NCT05045274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5913549|NCT05045274|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5913550|NCT05045274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5913551|NCT05045274|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5913552|NCT05045274|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5913553|NCT05045274|Antimetabolites|antimetabolites|mesh-ancestor
5913554|NCT05045274|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5913555|NCT05045274|Natriuretic Agents|natriuretic agents|mesh-ancestor
5913556|NCT05045274|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5913557|NCT05045274|Adrenergic Agents|adrenergic agents|mesh-ancestor
5913558|NCT05045274|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5913559|NCT05045274|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5913560|NCT05045274|Protease Inhibitors|protease inhibitors|mesh-ancestor
5913561|NCT05045274|Hormones|hormones|mesh-ancestor
5913562|NCT05045274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5913563|NCT05045274|Hormone Antagonists|hormone antagonists|mesh-ancestor
5913564|NCT05045274|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5913565|NCT05045443|Curcumin|curcumin|mesh-list
5913566|NCT05045443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5913567|NCT05045443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6496684|NCT00629135|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
6496685|NCT00629135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6496686|NCT00629135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6496687|NCT00629135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6496688|NCT00629135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6496689|NCT00629135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6496690|NCT00629135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496691|NCT00629135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5913568|NCT05045443|Analgesics|analgesics|mesh-ancestor
5913569|NCT05045443|Sensory System Agents|sensory system agents|mesh-ancestor
5913570|NCT05045443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5913571|NCT05045443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913572|NCT05045443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5913573|NCT05045443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5913574|NCT05045443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5913575|NCT05045443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5913576|NCT05045443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913577|NCT05044962|Rilpivirine|rilpivirine|mesh-list
5913578|NCT05044962|Cabotegravir|cabotegravir|mesh-list
5913579|NCT05044962|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
5913580|NCT05044962|Levonorgestrel|levonorgestrel|mesh-list
5913581|NCT05044962|Medroxyprogesterone|medroxyprogesterone|mesh-list
5913582|NCT05044962|Etonogestrel|etonogestrel|mesh-list
5913583|NCT05044962|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5913584|NCT05044962|Contraceptive Agents|contraceptive agents|mesh-ancestor
5913585|NCT05044962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5913586|NCT05044962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913587|NCT05044962|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5913588|NCT05044962|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5913589|NCT05044962|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5913590|NCT05044962|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5913591|NCT05044962|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5913592|NCT05044962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5913593|NCT05044962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5913594|NCT05044962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5913595|NCT05044962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5913596|NCT05044962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5913597|NCT05044962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913598|NCT05044962|Antiviral Agents|antiviral agents|mesh-ancestor
5913599|NCT05044962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5913600|NCT05044962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5913601|NCT05044962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5913602|NCT05044962|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5913603|NCT05044962|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5913604|NCT05045053|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5913605|NCT05045053|Lifitegrast|lifitegrast|mesh-list
5913606|NCT05045053|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5913607|NCT05044819|Cannabidiol|cannabidiol|mesh-list
5913608|NCT05044819|Anticonvulsants|anticonvulsants|mesh-ancestor
5913609|NCT05044728|Paclitaxel|paclitaxel|mesh-list
5913610|NCT05044728|Carboplatin|carboplatin|mesh-list
5913611|NCT05044728|Antibodies|antibodies|mesh-list
5913612|NCT05044728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5913613|NCT05044728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5913614|NCT05044728|Tubulin Modulators|tubulin modulators|mesh-ancestor
5913615|NCT05044728|Antimitotic Agents|antimitotic agents|mesh-ancestor
5913616|NCT05044728|Mitosis Modulators|mitosis modulators|mesh-ancestor
5913617|NCT05044728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913618|NCT05044728|Immunologic Factors|immunologic factors|mesh-ancestor
5913619|NCT05044728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913620|NCT05044637|Primaquine|primaquine|mesh-list
5913621|NCT05044637|Antimalarials|antimalarials|mesh-ancestor
5913622|NCT05044637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5913623|NCT05044637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5913624|NCT05044637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5913625|NCT05044169|Broncho-Vaxom|broncho-vaxom|mesh-list
5913626|NCT05044169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5913627|NCT05044169|Immunologic Factors|immunologic factors|mesh-ancestor
5913628|NCT05044169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913629|NCT05044429|Lidocaine|lidocaine|mesh-list
5913630|NCT05044429|Anesthetics, Local|anesthetics, local|mesh-ancestor
5913631|NCT05044429|Anesthetics|anesthetics|mesh-ancestor
5913632|NCT05044429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5913633|NCT05044429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913634|NCT05044429|Sensory System Agents|sensory system agents|mesh-ancestor
5913635|NCT05044429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5913636|NCT05044429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5913637|NCT05044429|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5913638|NCT05044429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5913639|NCT05044429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5913640|NCT05044429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913641|NCT05044468|Lidocaine|lidocaine|mesh-list
5913642|NCT05044468|Bupivacaine|bupivacaine|mesh-list
5913643|NCT05044468|Anesthetics, Local|anesthetics, local|mesh-ancestor
5913644|NCT05044468|Anesthetics|anesthetics|mesh-ancestor
5913645|NCT05044468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5913646|NCT05044468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913647|NCT05044468|Sensory System Agents|sensory system agents|mesh-ancestor
5913648|NCT05044468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5913649|NCT05044468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5913650|NCT05044468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5913651|NCT05044468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5913652|NCT05044468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5913653|NCT05044468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913654|NCT05044364|Clevidipine|clevidipine|mesh-list
5913655|NCT05044364|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5913656|NCT05044364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5913657|NCT05044364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913658|NCT05044364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5913659|NCT05044364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913660|NCT05043935|Anti-Infective Agents|anti-infective agents|mesh-list
5913661|NCT05043935|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5913662|NCT05044091|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
5913663|NCT05044091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5913664|NCT05044091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913665|NCT05044091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5913666|NCT05043766|Naltrexone|naltrexone|mesh-list
5913667|NCT05043766|Oxycodone|oxycodone|mesh-list
5913668|NCT05043766|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5913669|NCT05043766|Narcotics|narcotics|mesh-ancestor
5913670|NCT05043766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5913671|NCT05043766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913672|NCT05043766|Analgesics|analgesics|mesh-ancestor
5913673|NCT05043766|Sensory System Agents|sensory system agents|mesh-ancestor
5913674|NCT05043766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5913675|NCT05043766|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5913676|NCT05043766|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5913677|NCT05043740|Evolocumab|evolocumab|mesh-list
5913678|NCT05043740|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5913679|NCT05043740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5913680|NCT05043740|Antimetabolites|antimetabolites|mesh-ancestor
5913681|NCT05043740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913682|NCT05043740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5913683|NCT05043896|Tadalafil|tadalafil|mesh-list
5913684|NCT05043896|Vasodilator Agents|vasodilator agents|mesh-ancestor
5913685|NCT05043896|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5913686|NCT05043896|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5913687|NCT05043896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5913688|NCT05043896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913689|NCT05043896|Urological Agents|urological agents|mesh-ancestor
5963236|NCT04603729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5963237|NCT04603729|Prednisolone phosphate|prednisolone phosphate|mesh-list
5963238|NCT04603729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5963239|NCT04603729|Antiemetics|antiemetics|mesh-ancestor
5963240|NCT04603729|Autonomic Agents|autonomic agents|mesh-ancestor
5963241|NCT04603729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5963242|NCT04603729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963243|NCT04603729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5963244|NCT04603729|Glucocorticoids|glucocorticoids|mesh-ancestor
5963245|NCT04603729|Hormones|hormones|mesh-ancestor
5963246|NCT04603729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5963247|NCT04603729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5963248|NCT04603729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5699356|NCT03362216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5699357|NCT03362216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5699358|NCT03362216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699359|NCT03362099|Bupropion|bupropion|mesh-list
5699360|NCT03362099|Varenicline|varenicline|mesh-list
5699361|NCT03362099|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5699362|NCT03362099|Antidepressive Agents|antidepressive agents|mesh-ancestor
5699363|NCT03362099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5699364|NCT03362099|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5699365|NCT03362099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5699366|NCT03362099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5699367|NCT03362099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699368|NCT03362099|Dopamine Agents|dopamine agents|mesh-ancestor
5699369|NCT03362099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5699370|NCT03362099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699371|NCT03362099|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5699372|NCT03362099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5699373|NCT03362099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5699374|NCT03362099|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5699375|NCT03362099|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5699376|NCT03362099|Cholinergic Agents|cholinergic agents|mesh-ancestor
5963249|NCT04603729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5963250|NCT04603729|Protective Agents|protective agents|mesh-ancestor
5963251|NCT04603976|Erenumab|erenumab|mesh-list
5963252|NCT04603976|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
5963253|NCT04603976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963254|NCT04603976|Analgesics|analgesics|mesh-ancestor
5963255|NCT04603976|Sensory System Agents|sensory system agents|mesh-ancestor
5963256|NCT04603976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5963257|NCT04603976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963258|NCT04603833|Docetaxel|docetaxel|mesh-list
5963259|NCT04603833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5963260|NCT04603833|Tubulin Modulators|tubulin modulators|mesh-ancestor
5963261|NCT04603833|Antimitotic Agents|antimitotic agents|mesh-ancestor
5963262|NCT04603833|Mitosis Modulators|mitosis modulators|mesh-ancestor
6496692|NCT00629135|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6496693|NCT00629135|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6496694|NCT00629135|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5699377|NCT03362073|Ketamine|ketamine|mesh-list
5699378|NCT03362073|Analgesics|analgesics|mesh-ancestor
5699379|NCT03362073|Sensory System Agents|sensory system agents|mesh-ancestor
5699380|NCT03362073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5699381|NCT03362073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699382|NCT03362073|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5699383|NCT03362073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5699384|NCT03362073|Anesthetics, General|anesthetics, general|mesh-ancestor
5699385|NCT03362073|Anesthetics|anesthetics|mesh-ancestor
5699386|NCT03362073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5699387|NCT03362073|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5699388|NCT03362073|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5699389|NCT03362073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5699390|NCT03362073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699391|NCT03362060|Pembrolizumab|pembrolizumab|mesh-list
5699392|NCT03362060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6496695|NCT00629148|Capecitabine|capecitabine|mesh-list
6496696|NCT00629148|Vinorelbine|vinorelbine|mesh-list
6496697|NCT00629148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6496698|NCT00629148|Antimetabolites|antimetabolites|mesh-ancestor
6496699|NCT00629148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496700|NCT00629148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6496701|NCT00629148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6496702|NCT00629148|Tubulin Modulators|tubulin modulators|mesh-ancestor
5699393|NCT03362060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5699394|NCT03362047|Macitentan|macitentan|mesh-list
5699395|NCT03362047|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
5699396|NCT03362047|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5699397|NCT03362047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699398|NCT03362047|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
5699399|NCT03362008|Varenicline|varenicline|mesh-list
5699400|NCT03362008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5699401|NCT03362008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5699402|NCT03362008|Cholinergic Agents|cholinergic agents|mesh-ancestor
5699403|NCT03362008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5699404|NCT03362008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699405|NCT03362008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720806|NCT03210324|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5720807|NCT03210324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5720808|NCT03210324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5720809|NCT03210324|Contraceptive Agents|contraceptive agents|mesh-ancestor
5720810|NCT03210324|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5913690|NCT05043506|Palbociclib|palbociclib|mesh-list
6496703|NCT00629148|Antimitotic Agents|antimitotic agents|mesh-ancestor
6496704|NCT00629148|Mitosis Modulators|mitosis modulators|mesh-ancestor
6496705|NCT00629187|Temozolomide|temozolomide|mesh-list
6496706|NCT00629187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6496707|NCT00629187|Alkylating Agents|alkylating agents|mesh-ancestor
6496708|NCT00629187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496709|NCT00629187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5913691|NCT05043506|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5913692|NCT05043506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5913693|NCT05043506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5913694|NCT05043506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5913695|NCT05043506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913696|NCT05043506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5913697|NCT05043506|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5913698|NCT05043506|Hormone Antagonists|hormone antagonists|mesh-ancestor
5913699|NCT05043506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5913700|NCT05043506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913701|NCT05043688|Paclitaxel|paclitaxel|mesh-list
5913702|NCT05043688|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5913703|NCT05043688|Carboplatin|carboplatin|mesh-list
5913704|NCT05043688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5913705|NCT05043688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5913706|NCT05043688|Tubulin Modulators|tubulin modulators|mesh-ancestor
5913707|NCT05043688|Antimitotic Agents|antimitotic agents|mesh-ancestor
5913708|NCT05043688|Mitosis Modulators|mitosis modulators|mesh-ancestor
5913709|NCT05043688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913710|NCT05043350|Loratadine|loratadine|mesh-list
5913711|NCT05043350|Famotidine|famotidine|mesh-list
5913712|NCT05043350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5913713|NCT05043350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5913714|NCT05043350|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5913715|NCT05043350|Histamine Antagonists|histamine antagonists|mesh-ancestor
5913716|NCT05043350|Histamine Agents|histamine agents|mesh-ancestor
5913717|NCT05043350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5913718|NCT05043350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913719|NCT05043350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913720|NCT05043350|Antipruritics|antipruritics|mesh-ancestor
5913721|NCT05043350|Dermatologic Agents|dermatologic agents|mesh-ancestor
5913722|NCT05043350|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5913723|NCT05043350|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5913724|NCT05043350|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5913725|NCT05043194|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
5913726|NCT05043194|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5913727|NCT05043194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5913728|NCT05043233|Methimazole|methimazole|mesh-list
5913729|NCT05043233|Antithyroid Agents|antithyroid agents|mesh-ancestor
5913730|NCT05043233|Hormone Antagonists|hormone antagonists|mesh-ancestor
6496710|NCT00629200|Interferons|interferons|mesh-list
5699406|NCT03361878|Metformin|metformin|mesh-list
5699407|NCT03361878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5699408|NCT03361878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699409|NCT03361800|Entinostat|entinostat|mesh-list
5699410|NCT03361800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5699411|NCT03361800|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5913731|NCT05043233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5913732|NCT05043233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913733|NCT05043129|Vaccines|vaccines|mesh-list
5913734|NCT05043129|Immunologic Factors|immunologic factors|mesh-ancestor
5913735|NCT05043129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913736|NCT05043142|Antibodies|antibodies|mesh-list
5913737|NCT05043142|Immunologic Factors|immunologic factors|mesh-ancestor
5913738|NCT05043142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913739|NCT05043116|Vitamin D|vitamin d|mesh-list
5913740|NCT05043116|Cholecalciferol|cholecalciferol|mesh-list
5913741|NCT05043116|Vitamins|vitamins|mesh-ancestor
5913742|NCT05043116|Micronutrients|micronutrients|mesh-ancestor
5913743|NCT05043116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913744|NCT05043116|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5913745|NCT05043116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5913746|NCT05042973|Empagliflozin|empagliflozin|mesh-list
5913747|NCT05042973|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5913748|NCT05042973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913749|NCT05042973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5913750|NCT05042973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913751|NCT05042817|Sufentanil|sufentanil|mesh-list
5913752|NCT05042817|Morphine|morphine|mesh-list
5913753|NCT05042817|Prilocaine|prilocaine|mesh-list
5913754|NCT05042817|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5913755|NCT05042817|Narcotics|narcotics|mesh-ancestor
5913756|NCT05042817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5913757|NCT05042817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913758|NCT05042817|Analgesics|analgesics|mesh-ancestor
5913759|NCT05042817|Sensory System Agents|sensory system agents|mesh-ancestor
5699412|NCT03361800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5699413|NCT03361800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699414|NCT03361774|Fluorides|fluorides|mesh-list
5699415|NCT03361774|Cariostatic Agents|cariostatic agents|mesh-ancestor
5699416|NCT03361774|Protective Agents|protective agents|mesh-ancestor
5699417|NCT03361774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699418|NCT03361735|Leuprolide|leuprolide|mesh-list
5699419|NCT03361735|Goserelin|goserelin|mesh-list
5699420|NCT03361735|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
5699421|NCT03361735|Hormones|hormones|mesh-list
5699422|NCT03361735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5699423|NCT03361735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699424|NCT03361735|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5699425|NCT03361735|Fertility Agents|fertility agents|mesh-ancestor
5699426|NCT03361735|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5699427|NCT03361735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5699428|NCT03361735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5699429|NCT03361709|Dexamethasone|dexamethasone|mesh-list
5699430|NCT03361709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5699431|NCT03361709|Antiemetics|antiemetics|mesh-ancestor
5913760|NCT05042817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5913761|NCT05042817|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5913762|NCT05042817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5913763|NCT05042817|Anesthetics, General|anesthetics, general|mesh-ancestor
5913764|NCT05042817|Anesthetics|anesthetics|mesh-ancestor
5913765|NCT05042817|Anesthetics, Local|anesthetics, local|mesh-ancestor
5913766|NCT05042674|Ergothioneine|ergothioneine|mesh-list
5913767|NCT05042674|Antioxidants|antioxidants|mesh-ancestor
5913768|NCT05042674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913769|NCT05042674|Protective Agents|protective agents|mesh-ancestor
5913770|NCT05042674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913771|NCT05042791|Capecitabine|capecitabine|mesh-list
5913772|NCT05042791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5913773|NCT05042791|Antimetabolites|antimetabolites|mesh-ancestor
5699432|NCT03361709|Autonomic Agents|autonomic agents|mesh-ancestor
5699433|NCT03361709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5699434|NCT03361709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699435|NCT03361709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5699436|NCT03361709|Glucocorticoids|glucocorticoids|mesh-ancestor
5699437|NCT03361709|Hormones|hormones|mesh-ancestor
5699438|NCT03361709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5913774|NCT05042791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913775|NCT05042791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5913776|NCT05042635|Ixekizumab|ixekizumab|mesh-list
5913777|NCT05042635|Dermatologic Agents|dermatologic agents|mesh-ancestor
5913778|NCT05042531|Azacitidine|azacitidine|mesh-list
5913779|NCT05042531|Dasatinib|dasatinib|mesh-list
5913780|NCT05042531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5913781|NCT05042531|Antimetabolites|antimetabolites|mesh-ancestor
5913782|NCT05042531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913783|NCT05042531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5913784|NCT05042531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5913785|NCT05042531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5913786|NCT05042375|Pembrolizumab|pembrolizumab|mesh-list
5913787|NCT05042375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5913788|NCT05042375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5913789|NCT05042336|Lenvatinib|lenvatinib|mesh-list
5913790|NCT05042336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5913791|NCT05042336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5913792|NCT05042336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5913793|NCT05042336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913794|NCT05042271|Meropenem|meropenem|mesh-list
5913795|NCT05042271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5913796|NCT05042271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5913797|NCT05042245|Silymarin|silymarin|mesh-list
5913798|NCT05042245|N-Methylaspartate|n-methylaspartate|mesh-list
5913799|NCT05042245|Antioxidants|antioxidants|mesh-ancestor
5913800|NCT05042245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913801|NCT05042245|Protective Agents|protective agents|mesh-ancestor
5913802|NCT05042245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913803|NCT05042245|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
5913804|NCT05042245|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5913805|NCT05042245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5913806|NCT05041985|Diazepam|diazepam|mesh-list
5913807|NCT05041985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5913808|NCT05041985|Anticonvulsants|anticonvulsants|mesh-ancestor
5913809|NCT05041985|Antiemetics|antiemetics|mesh-ancestor
5913810|NCT05041985|Autonomic Agents|autonomic agents|mesh-ancestor
5913811|NCT05041985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5913812|NCT05041985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913813|NCT05041985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5913814|NCT05041985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5913815|NCT05041985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5913816|NCT05041985|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5913817|NCT05041985|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5913818|NCT05041985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5913819|NCT05041985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5913820|NCT05041985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5913821|NCT05041985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5913822|NCT05041985|Anesthetics, General|anesthetics, general|mesh-ancestor
5913823|NCT05041985|Anesthetics|anesthetics|mesh-ancestor
5913824|NCT05041985|GABA Modulators|gaba modulators|mesh-ancestor
5913825|NCT05041985|GABA Agents|gaba agents|mesh-ancestor
5913826|NCT05041985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5913827|NCT05041985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913828|NCT05042024|N-Methylaspartate|n-methylaspartate|mesh-list
5913829|NCT05042024|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
5913830|NCT05042024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5913831|NCT05042024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5913832|NCT05042024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913833|NCT05042024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913834|NCT05042102|Donepezil|donepezil|mesh-list
5699439|NCT03361709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5699440|NCT03361709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5699441|NCT03361618|Zinc Sulfate|zinc sulfate|mesh-list
5699442|NCT03361618|Astringents|astringents|mesh-ancestor
5699443|NCT03361618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699444|NCT03361618|Dermatologic Agents|dermatologic agents|mesh-ancestor
5699445|NCT03361397|Lidocaine|lidocaine|mesh-list
5699446|NCT03361397|Anesthetics, Local|anesthetics, local|mesh-ancestor
5699447|NCT03361397|Anesthetics|anesthetics|mesh-ancestor
5699448|NCT03361397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5699449|NCT03361397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699450|NCT03361397|Sensory System Agents|sensory system agents|mesh-ancestor
5699451|NCT03361397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5699452|NCT03361397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5913835|NCT05042102|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5699453|NCT03361397|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5699454|NCT03361397|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5699455|NCT03361397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5699456|NCT03361397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699457|NCT03361319|Paclitaxel|paclitaxel|mesh-list
5699458|NCT03361319|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5699459|NCT03361319|Nintedanib|nintedanib|mesh-list
5699460|NCT03361319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5699461|NCT03361319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5699462|NCT03361319|Tubulin Modulators|tubulin modulators|mesh-ancestor
5699463|NCT03361319|Antimitotic Agents|antimitotic agents|mesh-ancestor
5699464|NCT03361319|Mitosis Modulators|mitosis modulators|mesh-ancestor
5699465|NCT03361319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699466|NCT03361319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5699467|NCT03361319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5699468|NCT03361280|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
5913836|NCT05042102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5913837|NCT05042102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913838|NCT05042102|Cholinergic Agents|cholinergic agents|mesh-ancestor
5913839|NCT05042102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5913840|NCT05042102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913841|NCT05042102|Nootropic Agents|nootropic agents|mesh-ancestor
5913842|NCT05041647|Dronabinol|dronabinol|mesh-list
5913843|NCT05041647|Hallucinogens|hallucinogens|mesh-ancestor
5913844|NCT05041647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913845|NCT05041647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5913846|NCT05041647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5913847|NCT05041647|Analgesics|analgesics|mesh-ancestor
5913848|NCT05041647|Sensory System Agents|sensory system agents|mesh-ancestor
5913849|NCT05041647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5913850|NCT05041647|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5913851|NCT05041647|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5913852|NCT05041647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5913853|NCT05041647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913854|NCT05041647|Hormones|hormones|mesh-ancestor
5913855|NCT05041647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5963263|NCT04603833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963264|NCT04603690|Colchicine|colchicine|mesh-list
5963265|NCT04603690|Gout Suppressants|gout suppressants|mesh-ancestor
5963266|NCT04603690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5963267|NCT04603690|Tubulin Modulators|tubulin modulators|mesh-ancestor
5963268|NCT04603690|Antimitotic Agents|antimitotic agents|mesh-ancestor
5963269|NCT04603690|Mitosis Modulators|mitosis modulators|mesh-ancestor
5963270|NCT04603690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963271|NCT04603690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5963272|NCT04603872|Dasatinib|dasatinib|mesh-list
5963273|NCT04603872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5963274|NCT04603872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5963275|NCT04603872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5963276|NCT04603872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970500|NCT04534218|Sensory System Agents|sensory system agents|mesh-ancestor
5970501|NCT04534218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5970502|NCT04534218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5970503|NCT04534218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5970504|NCT04534218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5970505|NCT04534218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5970506|NCT04534218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5699469|NCT03361280|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5699470|NCT03361280|Adrenergic Agents|adrenergic agents|mesh-ancestor
5699471|NCT03361280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5699472|NCT03361280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699473|NCT03361280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699474|NCT03361163|Bromoacetylalprenololmenthane|bromoacetylalprenololmenthane|mesh-list
5699475|NCT03361163|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5699476|NCT03361163|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5699477|NCT03361163|Adrenergic Agents|adrenergic agents|mesh-ancestor
5699478|NCT03361163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5699479|NCT03361163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970507|NCT04534218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5970508|NCT04534218|Antipyretics|antipyretics|mesh-ancestor
5970509|NCT04534023|Idebenone|idebenone|mesh-list
5970510|NCT04534023|Antioxidants|antioxidants|mesh-ancestor
6242824|NCT02657031|Prochlorperazine|prochlorperazine|mesh-list
5913856|NCT05041582|Citalopram|citalopram|mesh-list
5913857|NCT05041582|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5913858|NCT05041582|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5913859|NCT05041582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5913860|NCT05041582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913861|NCT05041582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5913862|NCT05041582|Serotonin Agents|serotonin agents|mesh-ancestor
5913863|NCT05041582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913864|NCT05041582|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5913865|NCT05041582|Antidepressive Agents|antidepressive agents|mesh-ancestor
5913866|NCT05041582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5913867|NCT05041790|Choline|choline|mesh-list
5913868|NCT05041790|Lipotropic Agents|lipotropic agents|mesh-ancestor
5913869|NCT05041790|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5913870|NCT05041790|Antimetabolites|antimetabolites|mesh-ancestor
5913871|NCT05041790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913872|NCT05041790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5913873|NCT05041790|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5913874|NCT05041790|Nootropic Agents|nootropic agents|mesh-ancestor
5913875|NCT05041153|Pembrolizumab|pembrolizumab|mesh-list
5913876|NCT05041153|Lenvatinib|lenvatinib|mesh-list
5913877|NCT05041153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5913878|NCT05041153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5913879|NCT05041153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5913880|NCT05041153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5913881|NCT05041153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913882|NCT05041127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5913883|NCT05041127|Cetuximab|cetuximab|mesh-list
5913884|NCT05041127|Antibodies|antibodies|mesh-list
5913885|NCT05041127|Immunoglobulins|immunoglobulins|mesh-list
5913886|NCT05041127|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5913887|NCT05041127|Immunologic Factors|immunologic factors|mesh-ancestor
5913888|NCT05041127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913889|NCT05041127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5913890|NCT05041270|Dexmedetomidine|dexmedetomidine|mesh-list
5913891|NCT05041270|Nalbuphine|nalbuphine|mesh-list
5913892|NCT05041270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5913893|NCT05041270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5913894|NCT05041270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913895|NCT05041270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5913896|NCT05041270|Analgesics|analgesics|mesh-ancestor
5913897|NCT05041270|Sensory System Agents|sensory system agents|mesh-ancestor
5913898|NCT05041270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5913899|NCT05041270|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5913900|NCT05041270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5913901|NCT05041270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5913902|NCT05041270|Adrenergic Agents|adrenergic agents|mesh-ancestor
5913903|NCT05041270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5913904|NCT05041270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913905|NCT05041270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5913906|NCT05041270|Narcotics|narcotics|mesh-ancestor
5913907|NCT05040906|Rituximab|rituximab|mesh-list
5913908|NCT05040906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5913909|NCT05040906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5913910|NCT05040906|Immunologic Factors|immunologic factors|mesh-ancestor
5913911|NCT05040906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913912|NCT05040906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5913913|NCT05040984|Solifenacin Succinate|solifenacin succinate|mesh-list
5913914|NCT05040984|Mirabegron|mirabegron|mesh-list
5913915|NCT05040984|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5913916|NCT05040984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5913917|NCT05040984|Cholinergic Agents|cholinergic agents|mesh-ancestor
5913918|NCT05040984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5913919|NCT05040984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913920|NCT05040984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913921|NCT05040984|Urological Agents|urological agents|mesh-ancestor
5913922|NCT05040984|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
5913923|NCT05040984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5913924|NCT05040984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5913925|NCT05040984|Adrenergic Agents|adrenergic agents|mesh-ancestor
5913926|NCT05040828|Montelukast|montelukast|mesh-list
5913927|NCT05040828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5913928|NCT05040828|Respiratory System Agents|respiratory system agents|mesh-ancestor
5913929|NCT05040828|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5913930|NCT05040828|Hormone Antagonists|hormone antagonists|mesh-ancestor
5699480|NCT03361163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699481|NCT03361163|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5699482|NCT03361163|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5699483|NCT03361124|Oxytocin|oxytocin|mesh-list
5699484|NCT03361124|Oxytocics|oxytocics|mesh-ancestor
5699485|NCT03361124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5699486|NCT03361124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699487|NCT03361098|Dapagliflozin|dapagliflozin|mesh-list
5699488|NCT03361098|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
5699489|NCT03361098|Exenatide|exenatide|mesh-list
5699490|NCT03361098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699491|NCT03361098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5699492|NCT03361098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699493|NCT03361098|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5699494|NCT03361098|Incretins|incretins|mesh-ancestor
5699495|NCT03361098|Hormones|hormones|mesh-ancestor
5699496|NCT03361098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5699497|NCT03360981|Incretins|incretins|mesh-list
5699498|NCT03360981|Hormones|hormones|mesh-ancestor
5699499|NCT03360981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5699500|NCT03360981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699501|NCT03360955|Anesthetics|anesthetics|mesh-list
5699502|NCT03360955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5699503|NCT03360955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699504|NCT03360916|Atorvastatin|atorvastatin|mesh-list
5913931|NCT05040828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5913932|NCT05040828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913933|NCT05040828|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5913934|NCT05040828|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5913935|NCT05040828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913936|NCT05040724|Ivermectin|ivermectin|mesh-list
5913937|NCT05040724|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5913938|NCT05040724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5913939|NCT05040594|Lidocaine|lidocaine|mesh-list
5913940|NCT05040594|Anesthetics, Local|anesthetics, local|mesh-ancestor
5913941|NCT05040594|Anesthetics|anesthetics|mesh-ancestor
5913942|NCT05040594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5913943|NCT05040594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913944|NCT05040594|Sensory System Agents|sensory system agents|mesh-ancestor
5913945|NCT05040594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5913946|NCT05040594|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5913947|NCT05040594|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5913948|NCT05040594|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5913949|NCT05040594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5913950|NCT05040594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913951|NCT05040217|Mitogens|mitogens|mesh-list
5913952|NCT05040217|Mitosis Modulators|mitosis modulators|mesh-ancestor
5913953|NCT05040217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913954|NCT05040334|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5699505|NCT03360916|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5699506|NCT03360916|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5699507|NCT03360916|Antimetabolites|antimetabolites|mesh-ancestor
5699508|NCT03360916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699509|NCT03360916|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5699510|NCT03360916|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5699511|NCT03360916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5699512|NCT03360760|Doxorubicin|doxorubicin|mesh-list
5699513|NCT03360760|Methotrexate|methotrexate|mesh-list
5699514|NCT03360760|Ifosfamide|ifosfamide|mesh-list
5699515|NCT03360760|Isophosphamide mustard|isophosphamide mustard|mesh-list
5913955|NCT05040334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5913956|NCT05039801|Pembrolizumab|pembrolizumab|mesh-list
5913957|NCT05039801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5913958|NCT05039801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5913959|NCT05039723|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
5913960|NCT05039723|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5913961|NCT05039723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5913962|NCT05039723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913963|NCT05039723|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6496711|NCT00629200|Interferon-alpha|interferon-alpha|mesh-list
6496712|NCT00629200|Interferon alpha-2|interferon alpha-2|mesh-list
6496713|NCT00629200|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
6675789|NCT01577862|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5913964|NCT05039723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5913965|NCT05039723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913966|NCT05039723|Cholinergic Agents|cholinergic agents|mesh-ancestor
5913967|NCT05039723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5963277|NCT04603924|Niclosamide|niclosamide|mesh-list
5963278|NCT04603924|Anticestodal Agents|anticestodal agents|mesh-ancestor
5963279|NCT04603924|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5963280|NCT04603924|Anthelmintics|anthelmintics|mesh-ancestor
5963281|NCT04603924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5963282|NCT04603924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5963283|NCT04603924|Antinematodal Agents|antinematodal agents|mesh-ancestor
5963284|NCT04603937|Aflibercept|aflibercept|mesh-list
5699516|NCT03360760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5699517|NCT03360760|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5699518|NCT03360760|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5699519|NCT03360760|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5699520|NCT03360760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5699521|NCT03360760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699522|NCT03360760|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5699523|NCT03360760|Abortifacient Agents|abortifacient agents|mesh-ancestor
5699524|NCT03360760|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5699525|NCT03360760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699526|NCT03360760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5699527|NCT03360760|Antimetabolites|antimetabolites|mesh-ancestor
5699528|NCT03360760|Dermatologic Agents|dermatologic agents|mesh-ancestor
5963285|NCT04603937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5963286|NCT04603937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5963287|NCT04603937|Growth Substances|growth substances|mesh-ancestor
5963288|NCT04603937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963289|NCT04603937|Growth Inhibitors|growth inhibitors|mesh-ancestor
5963290|NCT04603937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5963291|NCT04603794|Chlorhexidine|chlorhexidine|mesh-list
5699529|NCT03360760|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5699530|NCT03360760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5699531|NCT03360760|Immunologic Factors|immunologic factors|mesh-ancestor
5699532|NCT03360760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5699533|NCT03360760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5699534|NCT03360760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5699535|NCT03360760|Alkylating Agents|alkylating agents|mesh-ancestor
5699536|NCT03360734|Cetuximab|cetuximab|mesh-list
5699537|NCT03360734|Panitumumab|panitumumab|mesh-list
5699538|NCT03360734|Necitumumab|necitumumab|mesh-list
5699539|NCT03360734|Antibodies|antibodies|mesh-list
5699540|NCT03360734|Immunologic Factors|immunologic factors|mesh-ancestor
5699541|NCT03360734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699542|NCT03360734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5699543|NCT03360734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5699544|NCT03360721|Prednisone|prednisone|mesh-list
5699545|NCT03360721|Cortisone|cortisone|mesh-list
5699546|NCT03360721|Abiraterone Acetate|abiraterone acetate|mesh-list
5699547|NCT03360721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5699548|NCT03360721|Glucocorticoids|glucocorticoids|mesh-ancestor
5699549|NCT03360721|Hormones|hormones|mesh-ancestor
5699550|NCT03360721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5699551|NCT03360721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699552|NCT03360721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5699553|NCT03360721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5699554|NCT03360721|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5699555|NCT03360721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5699556|NCT03360721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699557|NCT03360721|Hormone Antagonists|hormone antagonists|mesh-ancestor
5963292|NCT04603794|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5963293|NCT04603794|Povidone-Iodine|povidone-iodine|mesh-list
5963294|NCT04603794|Hydrogen Peroxide|hydrogen peroxide|mesh-list
5963295|NCT04603794|Povidone|povidone|mesh-list
5963296|NCT04603794|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5963297|NCT04603794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5963298|NCT04603794|Disinfectants|disinfectants|mesh-ancestor
5963299|NCT04603794|Dermatologic Agents|dermatologic agents|mesh-ancestor
5963300|NCT04603794|Plasma Substitutes|plasma substitutes|mesh-ancestor
5963301|NCT04603794|Blood Substitutes|blood substitutes|mesh-ancestor
5963302|NCT04603664|Cystatins|cystatins|mesh-list
5963303|NCT04603664|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
5963304|NCT04603664|Protease Inhibitors|protease inhibitors|mesh-ancestor
5963305|NCT04603664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5963306|NCT04603664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5913968|NCT05039580|Dexamethasone|dexamethasone|mesh-list
5913969|NCT05039580|Antibodies|antibodies|mesh-list
5913970|NCT05039580|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5913971|NCT05039580|Immunologic Factors|immunologic factors|mesh-ancestor
5699558|NCT03360721|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5699559|NCT03360682|Tenofovir|tenofovir|mesh-list
5699560|NCT03360682|Lamivudine|lamivudine|mesh-list
5699561|NCT03360682|Emtricitabine|emtricitabine|mesh-list
5699562|NCT03360682|Abacavir|abacavir|mesh-list
5699563|NCT03360682|Dolutegravir|dolutegravir|mesh-list
5699564|NCT03360682|Antiviral Agents|antiviral agents|mesh-ancestor
5699565|NCT03360682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5699566|NCT03360682|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5699567|NCT03360682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5699568|NCT03360682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5913972|NCT05039580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913973|NCT05039580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5913974|NCT05039580|Antiemetics|antiemetics|mesh-ancestor
5913975|NCT05039580|Autonomic Agents|autonomic agents|mesh-ancestor
5913976|NCT05039580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5913977|NCT05039580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5913978|NCT05039580|Glucocorticoids|glucocorticoids|mesh-ancestor
5913979|NCT05039580|Hormones|hormones|mesh-ancestor
5913980|NCT05039580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5913981|NCT05039580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5913982|NCT05039580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5913983|NCT05039606|Nedaplatin|nedaplatin|mesh-list
5913984|NCT05039606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5913985|NCT05039489|Antipsychotic Agents|antipsychotic agents|mesh-list
5913986|NCT05039489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5913987|NCT05039489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5913988|NCT05039489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913989|NCT05039489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5913990|NCT05039476|Vitamin A|vitamin a|mesh-list
5913991|NCT05039476|Vitamins|vitamins|mesh-ancestor
5913992|NCT05039476|Micronutrients|micronutrients|mesh-ancestor
5913993|NCT05039476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5913994|NCT05038969|Esomeprazole|esomeprazole|mesh-list
5913995|NCT05038969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5913996|NCT05038969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5913997|NCT05038969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5913998|NCT05038969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5913999|NCT05038969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914000|NCT05038605|Metronidazole|metronidazole|mesh-list
5914001|NCT05038605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5914002|NCT05038605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5914003|NCT05038605|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5914004|NCT05038605|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5914005|NCT05038657|Atezolizumab|atezolizumab|mesh-list
5914006|NCT05038657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5914007|NCT05038462|Lactoferrin|lactoferrin|mesh-list
5914008|NCT05038462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5914009|NCT05038072|Triamcinolone|triamcinolone|mesh-list
5914010|NCT05038072|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5914011|NCT05038072|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5914012|NCT05038072|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5914013|NCT05038072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5914014|NCT05038072|Glucocorticoids|glucocorticoids|mesh-ancestor
5914015|NCT05038072|Hormones|hormones|mesh-ancestor
5914016|NCT05038072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5914017|NCT05038072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914018|NCT05038072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5914019|NCT05038072|Immunologic Factors|immunologic factors|mesh-ancestor
5914020|NCT05038072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5914021|NCT05038072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914022|NCT05038007|Bupivacaine|bupivacaine|mesh-list
5914023|NCT05038007|Anesthetics, Local|anesthetics, local|mesh-ancestor
5914024|NCT05038007|Anesthetics|anesthetics|mesh-ancestor
5914025|NCT05038007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5914026|NCT05038007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914027|NCT05038007|Sensory System Agents|sensory system agents|mesh-ancestor
5914028|NCT05038007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5914029|NCT05038410|Wobenzym|wobenzym|mesh-list
5914030|NCT05038410|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5914031|NCT05038410|Immunologic Factors|immunologic factors|mesh-ancestor
5914032|NCT05038410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914033|NCT05038111|Dexmedetomidine|dexmedetomidine|mesh-list
5720811|NCT03210324|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5914034|NCT05038111|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5914035|NCT05038111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5914036|NCT05038111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914037|NCT05038111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5914038|NCT05038111|Analgesics|analgesics|mesh-ancestor
5914039|NCT05038111|Sensory System Agents|sensory system agents|mesh-ancestor
5914040|NCT05038111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5914041|NCT05038111|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5914042|NCT05038111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5914043|NCT05038111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5914044|NCT05038111|Adrenergic Agents|adrenergic agents|mesh-ancestor
5914045|NCT05038111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5914046|NCT05038111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914047|NCT05038202|Mometasone Furoate|mometasone furoate|mesh-list
5914048|NCT05038202|Bromides|bromides|mesh-list
5914049|NCT05038202|Anticonvulsants|anticonvulsants|mesh-ancestor
5914050|NCT05038202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5914051|NCT05038202|Dermatologic Agents|dermatologic agents|mesh-ancestor
5914052|NCT05038202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5914053|NCT05038228|Vitamin K|vitamin k|mesh-list
5914054|NCT05038228|Rivaroxaban|rivaroxaban|mesh-list
5914055|NCT05038228|Apixaban|apixaban|mesh-list
5914056|NCT05038228|Dabigatran|dabigatran|mesh-list
5914057|NCT05038228|Vitamins|vitamins|mesh-ancestor
5914058|NCT05038228|Micronutrients|micronutrients|mesh-ancestor
5914059|NCT05038228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914060|NCT05038228|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5914061|NCT05038228|Antithrombins|antithrombins|mesh-ancestor
5914062|NCT05038228|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5914063|NCT05038228|Protease Inhibitors|protease inhibitors|mesh-ancestor
5914064|NCT05038228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5914065|NCT05038228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914066|NCT05038228|Anticoagulants|anticoagulants|mesh-ancestor
5914067|NCT05038228|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5914068|NCT05038228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5914069|NCT05038228|Hemostatics|hemostatics|mesh-ancestor
5914070|NCT05038228|Coagulants|coagulants|mesh-ancestor
5914071|NCT05038449|Colchicine|colchicine|mesh-list
5914072|NCT05038449|Gout Suppressants|gout suppressants|mesh-ancestor
5914073|NCT05038449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5914074|NCT05038449|Tubulin Modulators|tubulin modulators|mesh-ancestor
5914075|NCT05038449|Antimitotic Agents|antimitotic agents|mesh-ancestor
5914076|NCT05038449|Mitosis Modulators|mitosis modulators|mesh-ancestor
5914077|NCT05038449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914078|NCT05038449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5914079|NCT05038059|Acetic Acid|acetic acid|mesh-list
5914080|NCT05038059|Retinol acetate|retinol acetate|mesh-list
5914081|NCT05038059|Ethylene|ethylene|mesh-list
5914082|NCT05038059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5914083|NCT05038059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5914084|NCT05038059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5914085|NCT05038059|Immunologic Factors|immunologic factors|mesh-ancestor
5914086|NCT05038059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914087|NCT05038059|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5699569|NCT03360682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699570|NCT03360682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5699571|NCT03360682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5699572|NCT03360682|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5699573|NCT03360682|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5720812|NCT03210324|Hormone Antagonists|hormone antagonists|mesh-ancestor
5720813|NCT03210324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5720814|NCT03210324|Luteolytic Agents|luteolytic agents|mesh-ancestor
5720815|NCT03210324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5720816|NCT03210324|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5720817|NCT03210480|Lithium Carbonate|lithium carbonate|mesh-list
5720818|NCT03210480|Antidepressive Agents|antidepressive agents|mesh-ancestor
5720819|NCT03210480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5720820|NCT03210480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5720821|NCT03210480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5720822|NCT03210480|Antimanic Agents|antimanic agents|mesh-ancestor
5720823|NCT03210480|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5720824|NCT03210480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5914088|NCT05038059|Protective Agents|protective agents|mesh-ancestor
5914089|NCT05038059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5914090|NCT05038059|Plant Growth Regulators|plant growth regulators|mesh-ancestor
5914091|NCT05038059|Growth Substances|growth substances|mesh-ancestor
5914092|NCT05037812|Ketorolac|ketorolac|mesh-list
5914093|NCT05037812|Clonidine|clonidine|mesh-list
5914094|NCT05037812|Epinephrine|epinephrine|mesh-list
5914095|NCT05037812|Morphine|morphine|mesh-list
5914096|NCT05037812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5914097|NCT05037812|Narcotics|narcotics|mesh-ancestor
5914098|NCT05037812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5914099|NCT05037812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914100|NCT05037812|Analgesics|analgesics|mesh-ancestor
5914101|NCT05037812|Sensory System Agents|sensory system agents|mesh-ancestor
5914102|NCT05037812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5914103|NCT05037812|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5914104|NCT05037812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5914105|NCT05037812|Adrenergic Agents|adrenergic agents|mesh-ancestor
5914106|NCT05037812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5914107|NCT05037812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914108|NCT05037812|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5914109|NCT05037812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5914110|NCT05037812|Autonomic Agents|autonomic agents|mesh-ancestor
5914111|NCT05037812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5914112|NCT05037812|Respiratory System Agents|respiratory system agents|mesh-ancestor
5914113|NCT05037812|Mydriatics|mydriatics|mesh-ancestor
5914114|NCT05037812|Sympathomimetics|sympathomimetics|mesh-ancestor
5914115|NCT05037812|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5914116|NCT05037812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5914117|NCT05037812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5914118|NCT05037812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5914119|NCT05037812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5914120|NCT05037812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5914121|NCT05037812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5699574|NCT03360279|Paclitaxel|paclitaxel|mesh-list
5699575|NCT03360279|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5699576|NCT03360279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5699577|NCT03360279|Tubulin Modulators|tubulin modulators|mesh-ancestor
5699578|NCT03360279|Antimitotic Agents|antimitotic agents|mesh-ancestor
5699579|NCT03360279|Mitosis Modulators|mitosis modulators|mesh-ancestor
5699580|NCT03360279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699581|NCT03360266|Listerine|listerine|mesh-list
5914122|NCT05037812|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5914123|NCT05037812|Sympatholytics|sympatholytics|mesh-ancestor
5914124|NCT05037812|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5914125|NCT05037695|Empagliflozin|empagliflozin|mesh-list
5914126|NCT05037695|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5914127|NCT05037695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914128|NCT05037695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5914129|NCT05037695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963307|NCT04603508|Calcium, Dietary|calcium, dietary|mesh-list
5963308|NCT04603508|Empagliflozin|empagliflozin|mesh-list
5963309|NCT04603508|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5963310|NCT04603508|Calcium|calcium|mesh-list
5963311|NCT04603508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5963312|NCT04603508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963313|NCT04603508|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5963314|NCT04603508|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5963315|NCT04603508|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5963316|NCT04603508|Antimetabolites|antimetabolites|mesh-ancestor
5963317|NCT04603508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963318|NCT04603508|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5963319|NCT04603508|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5963320|NCT04603508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5963321|NCT04603508|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6496714|NCT00629200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6496715|NCT00629200|Antiviral Agents|antiviral agents|mesh-ancestor
5699582|NCT03360266|Fluorides|fluorides|mesh-list
5963322|NCT04603508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5963323|NCT04603573|Listerine|listerine|mesh-list
5963324|NCT04603573|Fluorides|fluorides|mesh-list
5963325|NCT04603573|Sodium Fluoride|sodium fluoride|mesh-list
5963326|NCT04603573|Fluorides, Topical|fluorides, topical|mesh-list
5963327|NCT04603573|Cariostatic Agents|cariostatic agents|mesh-ancestor
5963328|NCT04603573|Protective Agents|protective agents|mesh-ancestor
5963329|NCT04603573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496716|NCT00629200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6496717|NCT00629200|Immunologic Factors|immunologic factors|mesh-ancestor
6496718|NCT00629200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496719|NCT00629200|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6496720|NCT00629200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5914130|NCT05037487|Dronabinol|dronabinol|mesh-list
5914131|NCT05037487|Hallucinogens|hallucinogens|mesh-ancestor
5914132|NCT05037487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914133|NCT05037487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5914134|NCT05037487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5914135|NCT05037487|Analgesics|analgesics|mesh-ancestor
5914136|NCT05037487|Sensory System Agents|sensory system agents|mesh-ancestor
5914137|NCT05037487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5914138|NCT05037487|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5699583|NCT03360266|Sodium Fluoride|sodium fluoride|mesh-list
5699584|NCT03360266|Fluorides, Topical|fluorides, topical|mesh-list
5699585|NCT03360266|Cariostatic Agents|cariostatic agents|mesh-ancestor
5699586|NCT03360266|Protective Agents|protective agents|mesh-ancestor
5699587|NCT03360266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699588|NCT03360266|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5699589|NCT03360266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5699590|NCT03360214|Bupivacaine|bupivacaine|mesh-list
5699591|NCT03360214|Ropivacaine|ropivacaine|mesh-list
5699592|NCT03360214|Anesthetics, Local|anesthetics, local|mesh-ancestor
5699593|NCT03360214|Anesthetics|anesthetics|mesh-ancestor
5699594|NCT03360214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5699595|NCT03360214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699596|NCT03360214|Sensory System Agents|sensory system agents|mesh-ancestor
5699597|NCT03360214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5699598|NCT03360123|Midazolam|midazolam|mesh-list
5699599|NCT03360123|Triazolam|triazolam|mesh-list
5699600|NCT03360123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5699601|NCT03360123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5699602|NCT03360123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5699603|NCT03360123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914139|NCT05037487|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5914140|NCT05037487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5914141|NCT05037487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914142|NCT05037487|Hormones|hormones|mesh-ancestor
5914143|NCT05037487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5914144|NCT05037539|Fentanyl|fentanyl|mesh-list
5914145|NCT05037539|Morphine|morphine|mesh-list
5914146|NCT05037539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5914147|NCT05037539|Narcotics|narcotics|mesh-ancestor
5914148|NCT05037539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5914149|NCT05037539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914150|NCT05037539|Analgesics|analgesics|mesh-ancestor
5914151|NCT05037539|Sensory System Agents|sensory system agents|mesh-ancestor
5914152|NCT05037539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5914153|NCT05037539|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5914154|NCT05037539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5914155|NCT05037539|Anesthetics, General|anesthetics, general|mesh-ancestor
5914156|NCT05037539|Anesthetics|anesthetics|mesh-ancestor
5914157|NCT05037032|Naltrexone|naltrexone|mesh-list
5914158|NCT05037032|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5914159|NCT05037032|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5914160|NCT05037032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914161|NCT05037032|Sensory System Agents|sensory system agents|mesh-ancestor
5914162|NCT05037032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5914163|NCT05037253|Vitamin D|vitamin d|mesh-list
5914164|NCT05037253|Vitamins|vitamins|mesh-ancestor
5914165|NCT05037253|Micronutrients|micronutrients|mesh-ancestor
5914166|NCT05037253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914167|NCT05037253|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5914168|NCT05037240|Quercetin|quercetin|mesh-list
5914169|NCT05037240|Antioxidants|antioxidants|mesh-ancestor
5914170|NCT05037240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914171|NCT05037240|Protective Agents|protective agents|mesh-ancestor
5914172|NCT05037240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914173|NCT05037123|Ketamine|ketamine|mesh-list
5914174|NCT05037123|Analgesics|analgesics|mesh-ancestor
5914175|NCT05037123|Sensory System Agents|sensory system agents|mesh-ancestor
5914176|NCT05037123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5914177|NCT05037123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914178|NCT05037123|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5914179|NCT05037123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5914180|NCT05037123|Anesthetics, General|anesthetics, general|mesh-ancestor
5914181|NCT05037123|Anesthetics|anesthetics|mesh-ancestor
5914182|NCT05037123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5699604|NCT03360123|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6675790|NCT01577862|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5699605|NCT03360123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5699606|NCT03360123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5699607|NCT03360123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5699608|NCT03360123|Anesthetics, General|anesthetics, general|mesh-ancestor
5914183|NCT05037123|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5914184|NCT05037123|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5914185|NCT05037123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5914186|NCT05037123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914187|NCT05037006|Anesthetics|anesthetics|mesh-list
5914188|NCT05037006|Sevoflurane|sevoflurane|mesh-list
5914189|NCT05037006|Neostigmine|neostigmine|mesh-list
5914190|NCT05037006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5914191|NCT05037006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914192|NCT05037006|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5914193|NCT05037006|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5699609|NCT03360123|Anesthetics|anesthetics|mesh-ancestor
5699610|NCT03360123|GABA Modulators|gaba modulators|mesh-ancestor
5699611|NCT03360123|GABA Agents|gaba agents|mesh-ancestor
5699612|NCT03360123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5699613|NCT03360123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699614|NCT03360045|Tranexamic Acid|tranexamic acid|mesh-list
5699615|NCT03360045|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
5914194|NCT05037006|Anesthetics, General|anesthetics, general|mesh-ancestor
5914195|NCT05037006|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5914196|NCT05037006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5914197|NCT05037006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914198|NCT05037006|Cholinergic Agents|cholinergic agents|mesh-ancestor
5914199|NCT05037006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5914200|NCT05037006|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5914201|NCT05037006|Autonomic Agents|autonomic agents|mesh-ancestor
5914202|NCT05037006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5914203|NCT05037162|Fibrin fragment D|fibrin fragment d|mesh-list
5914204|NCT05037162|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5914205|NCT05037162|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5914206|NCT05037162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914207|NCT05037162|Hemostatics|hemostatics|mesh-ancestor
5914208|NCT05037162|Coagulants|coagulants|mesh-ancestor
5914209|NCT05037045|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5914210|NCT05037045|Incretins|incretins|mesh-ancestor
5914211|NCT05037045|Hormones|hormones|mesh-ancestor
5914212|NCT05037045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5914213|NCT05037045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914214|NCT05037279|BCG Vaccine|bcg vaccine|mesh-list
5914215|NCT05037279|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5914216|NCT05037279|Immunologic Factors|immunologic factors|mesh-ancestor
5914217|NCT05037279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914218|NCT05036824|Tinzaparin|tinzaparin|mesh-list
5914219|NCT05036824|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5914220|NCT05036824|Dalteparin|dalteparin|mesh-list
5914221|NCT05036824|Anticoagulants|anticoagulants|mesh-ancestor
5914222|NCT05036824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5914223|NCT05036824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5914224|NCT05036824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914225|NCT05036798|Lenvatinib|lenvatinib|mesh-list
5699616|NCT03360045|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5699617|NCT03360045|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5699618|NCT03360045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699619|NCT03360045|Hemostatics|hemostatics|mesh-ancestor
5699620|NCT03360045|Coagulants|coagulants|mesh-ancestor
5699621|NCT03359967|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5699622|NCT03359967|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5699623|NCT03359967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699624|NCT03359876|Warfarin|warfarin|mesh-list
5699625|NCT03359876|Rivaroxaban|rivaroxaban|mesh-list
5699626|NCT03359876|Anticoagulants|anticoagulants|mesh-ancestor
5699627|NCT03359876|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5699628|NCT03359876|Antithrombins|antithrombins|mesh-ancestor
5699629|NCT03359876|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5699630|NCT03359876|Protease Inhibitors|protease inhibitors|mesh-ancestor
5699631|NCT03359876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5699632|NCT03359876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914226|NCT05036798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5914227|NCT05036798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5914228|NCT05036798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6242825|NCT02657031|Analgesics|analgesics|mesh-ancestor
5699633|NCT03359863|Pirfenidone|pirfenidone|mesh-list
5914229|NCT05036798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914230|NCT05036005|Pertuzumab|pertuzumab|mesh-list
5914231|NCT05036005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6675791|NCT01577862|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6675792|NCT01577914|Carvedilol|carvedilol|mesh-list
6675793|NCT01577914|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6675794|NCT01577914|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6675795|NCT01577914|Adrenergic Agents|adrenergic agents|mesh-ancestor
6675796|NCT01577914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5699634|NCT03359863|Analgesics|analgesics|mesh-ancestor
5914232|NCT05036005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5914233|NCT05035953|Edaravone|edaravone|mesh-list
5914234|NCT05035953|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5914235|NCT05035953|Antioxidants|antioxidants|mesh-ancestor
5914236|NCT05035953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914237|NCT05035953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5914238|NCT05035953|Protective Agents|protective agents|mesh-ancestor
5914239|NCT05035953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914240|NCT05036018|Anesthetics|anesthetics|mesh-list
5914241|NCT05036018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5914242|NCT05036018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914243|NCT05036174|Diphenhydramine|diphenhydramine|mesh-list
5914244|NCT05036174|Promethazine|promethazine|mesh-list
5914245|NCT05036174|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5914246|NCT05036174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5914247|NCT05036174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5699635|NCT03359863|Sensory System Agents|sensory system agents|mesh-ancestor
5699636|NCT03359863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5699637|NCT03359863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699638|NCT03359863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5699639|NCT03359863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5699640|NCT03359863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5914248|NCT05036174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914249|NCT05036174|Anesthetics, Local|anesthetics, local|mesh-ancestor
5914250|NCT05036174|Anesthetics|anesthetics|mesh-ancestor
5914251|NCT05036174|Sensory System Agents|sensory system agents|mesh-ancestor
5914252|NCT05036174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5914253|NCT05036174|Antiemetics|antiemetics|mesh-ancestor
5914254|NCT05036174|Autonomic Agents|autonomic agents|mesh-ancestor
5914255|NCT05036174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5914256|NCT05036174|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5914257|NCT05036174|Histamine Antagonists|histamine antagonists|mesh-ancestor
5914258|NCT05036174|Histamine Agents|histamine agents|mesh-ancestor
5914259|NCT05036174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5914260|NCT05036174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914261|NCT05036174|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5914262|NCT05036174|Antipruritics|antipruritics|mesh-ancestor
5914263|NCT05036174|Dermatologic Agents|dermatologic agents|mesh-ancestor
5914264|NCT05035888|Phenylephrine|phenylephrine|mesh-list
5914265|NCT05035888|Oxymetazoline|oxymetazoline|mesh-list
5914266|NCT05035888|Norepinephrine|norepinephrine|mesh-list
5914267|NCT05035888|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
5914268|NCT05035888|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5914269|NCT05035888|Mydriatics|mydriatics|mesh-ancestor
5914270|NCT05035888|Autonomic Agents|autonomic agents|mesh-ancestor
5914271|NCT05035888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5914272|NCT05035888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914273|NCT05035888|Sympathomimetics|sympathomimetics|mesh-ancestor
5914274|NCT05035888|Nasal Decongestants|nasal decongestants|mesh-ancestor
5914275|NCT05035888|Respiratory System Agents|respiratory system agents|mesh-ancestor
5914276|NCT05035888|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5914277|NCT05035888|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5914278|NCT05035888|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5914279|NCT05035888|Adrenergic Agents|adrenergic agents|mesh-ancestor
5914280|NCT05035888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5914281|NCT05035888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914282|NCT05035888|Protective Agents|protective agents|mesh-ancestor
5914283|NCT05035745|Talazoparib|talazoparib|mesh-list
6496721|NCT00629200|Schistosomicides|schistosomicides|mesh-ancestor
5699641|NCT03359863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5699642|NCT03359863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6496722|NCT00629200|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5699643|NCT03359837|Insulin|insulin|mesh-list
6496723|NCT00629200|Anthelmintics|anthelmintics|mesh-ancestor
6496724|NCT00629213|Acarbose|acarbose|mesh-list
6496725|NCT00629213|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
5914284|NCT05035745|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5914285|NCT05035745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5914286|NCT05035745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914287|NCT05035745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5914288|NCT05035849|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5914289|NCT05035849|Acarbose|acarbose|mesh-list
5914290|NCT05035849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5914291|NCT05035849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914292|NCT05035849|Incretins|incretins|mesh-ancestor
5914293|NCT05035849|Hormones|hormones|mesh-ancestor
5914294|NCT05035849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5914295|NCT05035849|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5914296|NCT05035849|Protease Inhibitors|protease inhibitors|mesh-ancestor
5914297|NCT05035849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5914298|NCT05035849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914299|NCT05035849|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6496726|NCT00629213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6496727|NCT00629213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914300|NCT05035381|Leucovorin|leucovorin|mesh-list
5914301|NCT05035381|Bevacizumab|bevacizumab|mesh-list
5914302|NCT05035381|Pembrolizumab|pembrolizumab|mesh-list
5914303|NCT05035381|Fluorouracil|fluorouracil|mesh-list
5914304|NCT05035381|Irinotecan|irinotecan|mesh-list
5914305|NCT05035381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5914306|NCT05035381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5914307|NCT05035381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5914308|NCT05035381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5914309|NCT05035381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5914310|NCT05035381|Growth Substances|growth substances|mesh-ancestor
5914311|NCT05035381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914312|NCT05035381|Growth Inhibitors|growth inhibitors|mesh-ancestor
5914313|NCT05035381|Antimetabolites|antimetabolites|mesh-ancestor
5914314|NCT05035381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914315|NCT05035381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5914316|NCT05035381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5914317|NCT05035381|Immunologic Factors|immunologic factors|mesh-ancestor
5914318|NCT05035381|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5914319|NCT05035381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5914320|NCT05035381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5914321|NCT05035381|Antidotes|antidotes|mesh-ancestor
5914322|NCT05035381|Protective Agents|protective agents|mesh-ancestor
5914323|NCT05035381|Vitamin B Complex|vitamin b complex|mesh-ancestor
5914324|NCT05035381|Vitamins|vitamins|mesh-ancestor
5914325|NCT05035381|Micronutrients|micronutrients|mesh-ancestor
5914326|NCT05035680|Vaccines|vaccines|mesh-list
5914327|NCT05035680|Immunologic Factors|immunologic factors|mesh-ancestor
5914328|NCT05035680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914329|NCT05035498|Phenylephrine|phenylephrine|mesh-list
5914330|NCT05035498|Oxymetazoline|oxymetazoline|mesh-list
5914331|NCT05035498|Norepinephrine|norepinephrine|mesh-list
5914332|NCT05035498|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
5914333|NCT05035498|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5914334|NCT05035498|Mydriatics|mydriatics|mesh-ancestor
5914335|NCT05035498|Autonomic Agents|autonomic agents|mesh-ancestor
5914336|NCT05035498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5914337|NCT05035498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914338|NCT05035498|Sympathomimetics|sympathomimetics|mesh-ancestor
5914339|NCT05035498|Nasal Decongestants|nasal decongestants|mesh-ancestor
5914340|NCT05035498|Respiratory System Agents|respiratory system agents|mesh-ancestor
6496728|NCT00629213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5699644|NCT03359837|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5699645|NCT03359837|Metformin|metformin|mesh-list
5699646|NCT03359837|Insulin Glargine|insulin glargine|mesh-list
5699647|NCT03359837|Insulin Aspart|insulin aspart|mesh-list
5699648|NCT03359837|Biphasic Insulins|biphasic insulins|mesh-list
5699649|NCT03359837|Acarbose|acarbose|mesh-list
5699650|NCT03359837|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
5699651|NCT03359837|Insulin glulisine|insulin glulisine|mesh-list
5699652|NCT03359837|Repaglinide|repaglinide|mesh-list
5699653|NCT03359837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5699654|NCT03359837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699655|NCT03359837|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
5914341|NCT05035498|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5914342|NCT05035498|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5914343|NCT05035498|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5914344|NCT05035498|Adrenergic Agents|adrenergic agents|mesh-ancestor
5699656|NCT03359837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5914345|NCT05035498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5914346|NCT05035498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914347|NCT05035498|Protective Agents|protective agents|mesh-ancestor
5963330|NCT04603573|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5963331|NCT04603573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5963332|NCT04603456|Calcium Carbonate|calcium carbonate|mesh-list
5963333|NCT04603456|Antacids|antacids|mesh-ancestor
5963334|NCT04603456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963335|NCT04603456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5963336|NCT04603131|Vaccines|vaccines|mesh-list
5963337|NCT04603131|Immunologic Factors|immunologic factors|mesh-ancestor
5963338|NCT04603131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963339|NCT04603066|Ondansetron|ondansetron|mesh-list
5963340|NCT04603066|Antiemetics|antiemetics|mesh-ancestor
5963341|NCT04603066|Autonomic Agents|autonomic agents|mesh-ancestor
5963342|NCT04603066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5963343|NCT04603066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963344|NCT04603066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5963345|NCT04603066|Antipruritics|antipruritics|mesh-ancestor
5963346|NCT04603066|Dermatologic Agents|dermatologic agents|mesh-ancestor
5963347|NCT04603066|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5963348|NCT04603066|Serotonin Agents|serotonin agents|mesh-ancestor
5963349|NCT04603066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5963350|NCT04603066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963351|NCT04603066|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5963352|NCT04603066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5963353|NCT04603066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5963354|NCT04603066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5963355|NCT04603066|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5963356|NCT04602754|Calcium, Dietary|calcium, dietary|mesh-list
5963357|NCT04602754|Empagliflozin|empagliflozin|mesh-list
5963358|NCT04602754|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5963359|NCT04602754|Calcium|calcium|mesh-list
5963360|NCT04602754|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5963361|NCT04602754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963362|NCT04602754|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5963363|NCT04602754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5963364|NCT04602754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5963365|NCT04602754|Antimetabolites|antimetabolites|mesh-ancestor
5963366|NCT04602754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963367|NCT04602754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5963368|NCT04602754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5699657|NCT03359837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699658|NCT03359798|Narcotics|narcotics|mesh-list
5699659|NCT03359798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5699660|NCT03359798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699661|NCT03359798|Analgesics|analgesics|mesh-ancestor
5699662|NCT03359798|Sensory System Agents|sensory system agents|mesh-ancestor
5699663|NCT03359798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5699664|NCT03359746|Grazoprevir|grazoprevir|mesh-list
5699665|NCT03359746|Antiviral Agents|antiviral agents|mesh-ancestor
5699666|NCT03359746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5699667|NCT03359694|Docetaxel|docetaxel|mesh-list
5699668|NCT03359694|Doxorubicin|doxorubicin|mesh-list
5699669|NCT03359694|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5699670|NCT03359694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5699671|NCT03359694|Tubulin Modulators|tubulin modulators|mesh-ancestor
5699672|NCT03359694|Antimitotic Agents|antimitotic agents|mesh-ancestor
5699673|NCT03359694|Mitosis Modulators|mitosis modulators|mesh-ancestor
5699674|NCT03359694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699675|NCT03359694|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5699676|NCT03359694|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5699677|NCT03359694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5699678|NCT03359694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5699679|NCT03359681|Metformin|metformin|mesh-list
5699680|NCT03359681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5699681|NCT03359681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699682|NCT03359655|Scopolamine|scopolamine|mesh-list
5699683|NCT03359655|Bromides|bromides|mesh-list
5699684|NCT03359655|Misoprostol|misoprostol|mesh-list
5699685|NCT03359655|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
5699686|NCT03359655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5963369|NCT04602754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5699687|NCT03359655|Abortifacient Agents|abortifacient agents|mesh-ancestor
5699688|NCT03359655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5914348|NCT05035485|Phenylephrine|phenylephrine|mesh-list
5914349|NCT05035485|Oxymetazoline|oxymetazoline|mesh-list
5914350|NCT05035485|Norepinephrine|norepinephrine|mesh-list
5914351|NCT05035485|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
5914352|NCT05035485|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5914353|NCT05035485|Mydriatics|mydriatics|mesh-ancestor
5914354|NCT05035485|Autonomic Agents|autonomic agents|mesh-ancestor
5914355|NCT05035485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5914356|NCT05035485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914357|NCT05035485|Sympathomimetics|sympathomimetics|mesh-ancestor
5914358|NCT05035485|Nasal Decongestants|nasal decongestants|mesh-ancestor
5914359|NCT05035485|Respiratory System Agents|respiratory system agents|mesh-ancestor
5914360|NCT05035485|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5914361|NCT05035485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5914362|NCT05035485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5914363|NCT05035485|Adrenergic Agents|adrenergic agents|mesh-ancestor
5914364|NCT05035485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5914365|NCT05035485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914366|NCT05035485|Protective Agents|protective agents|mesh-ancestor
5914367|NCT05035472|Phenylephrine|phenylephrine|mesh-list
5914368|NCT05035472|Oxymetazoline|oxymetazoline|mesh-list
5914369|NCT05035472|Norepinephrine|norepinephrine|mesh-list
5914370|NCT05035472|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
5914371|NCT05035472|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5914372|NCT05035472|Mydriatics|mydriatics|mesh-ancestor
5914373|NCT05035472|Autonomic Agents|autonomic agents|mesh-ancestor
5914374|NCT05035472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5914375|NCT05035472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914376|NCT05035472|Sympathomimetics|sympathomimetics|mesh-ancestor
5914377|NCT05035472|Nasal Decongestants|nasal decongestants|mesh-ancestor
5914378|NCT05035472|Respiratory System Agents|respiratory system agents|mesh-ancestor
5914379|NCT05035472|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5914380|NCT05035472|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5914381|NCT05035472|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5914382|NCT05035472|Adrenergic Agents|adrenergic agents|mesh-ancestor
5914383|NCT05035472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5914384|NCT05035472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699689|NCT03359655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699690|NCT03359655|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5699691|NCT03359655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5699692|NCT03359655|Oxytocics|oxytocics|mesh-ancestor
5699693|NCT03359655|Anticonvulsants|anticonvulsants|mesh-ancestor
5699694|NCT03359655|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5699695|NCT03359655|Antiemetics|antiemetics|mesh-ancestor
5699696|NCT03359655|Autonomic Agents|autonomic agents|mesh-ancestor
5699697|NCT03359655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5699698|NCT03359655|Mydriatics|mydriatics|mesh-ancestor
5699699|NCT03359655|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5699700|NCT03359655|Cholinergic Agents|cholinergic agents|mesh-ancestor
5699701|NCT03359655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5699702|NCT03359655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914385|NCT05035472|Protective Agents|protective agents|mesh-ancestor
5914386|NCT05035316|Aspirin|aspirin|mesh-list
5914387|NCT05035316|Calcium|calcium|mesh-list
5914388|NCT05035316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5914389|NCT05035316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914390|NCT05035316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5914391|NCT05035316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5914392|NCT05035316|Analgesics|analgesics|mesh-ancestor
5914393|NCT05035316|Sensory System Agents|sensory system agents|mesh-ancestor
5914394|NCT05035316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5914395|NCT05035316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5914396|NCT05035316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5914397|NCT05035316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5914398|NCT05035316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5914399|NCT05035316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914400|NCT05035316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5914401|NCT05035316|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5914402|NCT05035316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5914403|NCT05035316|Antipyretics|antipyretics|mesh-ancestor
5914404|NCT05035238|Vaccines|vaccines|mesh-list
5914405|NCT05035238|Immunologic Factors|immunologic factors|mesh-ancestor
5914406|NCT05035238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914407|NCT05034965|Hyaluronic Acid|hyaluronic acid|mesh-list
5914408|NCT05034965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5914409|NCT05034965|Immunologic Factors|immunologic factors|mesh-ancestor
5914410|NCT05034965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914411|NCT05034965|Viscosupplements|viscosupplements|mesh-ancestor
5914412|NCT05034965|Protective Agents|protective agents|mesh-ancestor
5914413|NCT05035069|Propofol|propofol|mesh-list
5914414|NCT05035069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5914415|NCT05035069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6496729|NCT00629213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496730|NCT00629226|Cetuximab|cetuximab|mesh-list
6496731|NCT00629226|Bortezomib|bortezomib|mesh-list
6496732|NCT00629226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6496733|NCT00629226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6496734|NCT00629252|Risperidone|risperidone|mesh-list
6496735|NCT00629252|Sertindole|sertindole|mesh-list
6496736|NCT00629252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6496737|NCT00629252|Serotonin Agents|serotonin agents|mesh-ancestor
6496738|NCT00629252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6496739|NCT00629252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496740|NCT00629252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496741|NCT00629252|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6496742|NCT00629252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6496743|NCT00629252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6496744|NCT00629252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6496745|NCT00629252|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6496746|NCT00629252|Dopamine Agents|dopamine agents|mesh-ancestor
6675797|NCT01577914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675798|NCT01577914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675799|NCT01577914|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6675800|NCT01577914|Antioxidants|antioxidants|mesh-ancestor
6675801|NCT01577914|Protective Agents|protective agents|mesh-ancestor
6675802|NCT01577914|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6675803|NCT01577914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6675804|NCT01577914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6675805|NCT01577914|Vasodilator Agents|vasodilator agents|mesh-ancestor
5699703|NCT03359655|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5699704|NCT03359655|Parasympatholytics|parasympatholytics|mesh-ancestor
5699705|NCT03359538|Sirolimus|sirolimus|mesh-list
5699706|NCT03359538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5699707|NCT03359538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5699708|NCT03359538|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5699709|NCT03359538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5699710|NCT03359538|Antifungal Agents|antifungal agents|mesh-ancestor
5699711|NCT03359538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5699712|NCT03359538|Immunologic Factors|immunologic factors|mesh-ancestor
5699713|NCT03359538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699714|NCT03359525|Tranexamic Acid|tranexamic acid|mesh-list
5699715|NCT03359525|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5699716|NCT03359525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5914416|NCT05035069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914417|NCT05035069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5914418|NCT05035069|Anesthetics, General|anesthetics, general|mesh-ancestor
5914419|NCT05035069|Anesthetics|anesthetics|mesh-ancestor
5914420|NCT05035147|Gemcitabine|gemcitabine|mesh-list
5914421|NCT05035147|Paclitaxel|paclitaxel|mesh-list
5914422|NCT05035147|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5914423|NCT05035147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5914424|NCT05035147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5914425|NCT05035147|Tubulin Modulators|tubulin modulators|mesh-ancestor
5914426|NCT05035147|Antimitotic Agents|antimitotic agents|mesh-ancestor
5914427|NCT05035147|Mitosis Modulators|mitosis modulators|mesh-ancestor
5914428|NCT05035147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914429|NCT05035147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5914430|NCT05035147|Antimetabolites|antimetabolites|mesh-ancestor
5914431|NCT05035147|Antiviral Agents|antiviral agents|mesh-ancestor
5914432|NCT05035147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5914433|NCT05035147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5914434|NCT05035147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5914435|NCT05035147|Immunologic Factors|immunologic factors|mesh-ancestor
5914436|NCT05035147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914437|NCT05034783|Exenatide|exenatide|mesh-list
5914438|NCT05034783|Edetic Acid|edetic acid|mesh-list
5914439|NCT05034783|Chelating Agents|chelating agents|mesh-ancestor
5914440|NCT05034783|Sequestering Agents|sequestering agents|mesh-ancestor
5914441|NCT05034783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914442|NCT05034783|Anticoagulants|anticoagulants|mesh-ancestor
5914443|NCT05034783|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6496747|NCT00629278|Tamoxifen|tamoxifen|mesh-list
5914444|NCT05034783|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5914445|NCT05034783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914446|NCT05034783|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5914447|NCT05034783|Incretins|incretins|mesh-ancestor
5914448|NCT05034783|Hormones|hormones|mesh-ancestor
5914449|NCT05034783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5914450|NCT05034887|Trastuzumab|trastuzumab|mesh-list
6675806|NCT01577914|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6675807|NCT01577914|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6675808|NCT01577940|Ropivacaine|ropivacaine|mesh-list
6675809|NCT01577940|Anesthetics, Local|anesthetics, local|mesh-ancestor
6675810|NCT01577940|Anesthetics|anesthetics|mesh-ancestor
6675811|NCT01577940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6675812|NCT01577940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675813|NCT01577940|Sensory System Agents|sensory system agents|mesh-ancestor
6675814|NCT01577940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6675815|NCT01577992|Levodopa|levodopa|mesh-list
6675816|NCT01577992|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6675817|NCT01577992|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6675818|NCT01577992|Dopamine Agents|dopamine agents|mesh-ancestor
6675819|NCT01577992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6675820|NCT01577992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675821|NCT01577992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675822|NCT01578057|Ethanol|ethanol|mesh-list
6675823|NCT01578057|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5914451|NCT05034887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5914452|NCT05034887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5699717|NCT03359525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699718|NCT03359525|Hemostatics|hemostatics|mesh-ancestor
5699719|NCT03359525|Coagulants|coagulants|mesh-ancestor
5699720|NCT03359499|Trimebutine|trimebutine|mesh-list
5699721|NCT03359499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5699722|NCT03359499|Parasympatholytics|parasympatholytics|mesh-ancestor
5699723|NCT03359499|Autonomic Agents|autonomic agents|mesh-ancestor
5699724|NCT03359499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5699725|NCT03359499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699726|NCT03359291|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5914453|NCT05034536|Pembrolizumab|pembrolizumab|mesh-list
5914454|NCT05034536|Infliximab|infliximab|mesh-list
5914455|NCT05034536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5914456|NCT05034536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5914457|NCT05034536|Dermatologic Agents|dermatologic agents|mesh-ancestor
5914458|NCT05034536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5914459|NCT05034536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5914460|NCT05034406|Lidocaine|lidocaine|mesh-list
5914461|NCT05034406|Levobupivacaine|levobupivacaine|mesh-list
5914462|NCT05034406|Anesthetics, Local|anesthetics, local|mesh-ancestor
5914463|NCT05034406|Anesthetics|anesthetics|mesh-ancestor
5914464|NCT05034406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5914465|NCT05034406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914466|NCT05034406|Sensory System Agents|sensory system agents|mesh-ancestor
5914467|NCT05034406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5914468|NCT05034406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5914469|NCT05034406|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5914470|NCT05034406|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5914471|NCT05034406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5914472|NCT05034406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699727|NCT03359291|Macitentan|macitentan|mesh-list
5699728|NCT03359291|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5699729|NCT03359291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5699730|NCT03359291|Antimetabolites|antimetabolites|mesh-ancestor
5699731|NCT03359291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699732|NCT03359291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5699733|NCT03359291|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5914480|NCT05034055|Atezolizumab|atezolizumab|mesh-list
5914481|NCT05034055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5914482|NCT05033665|Benzocaine|benzocaine|mesh-list
5914483|NCT05033665|Anesthetics, Local|anesthetics, local|mesh-ancestor
5914484|NCT05033665|Anesthetics|anesthetics|mesh-ancestor
5914485|NCT05033665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5914486|NCT05033665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699734|NCT03359291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5699735|NCT03359291|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
5699736|NCT03359291|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5699737|NCT03359291|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
5699738|NCT03359239|Atezolizumab|atezolizumab|mesh-list
5699739|NCT03359239|Poly ICLC|poly iclc|mesh-list
5699740|NCT03359239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5914487|NCT05033665|Sensory System Agents|sensory system agents|mesh-ancestor
5914488|NCT05033665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5914489|NCT05033769|Paclitaxel|paclitaxel|mesh-list
5914490|NCT05033769|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5914491|NCT05033769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5914492|NCT05033769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5914493|NCT05033769|Tubulin Modulators|tubulin modulators|mesh-ancestor
5914494|NCT05033769|Antimitotic Agents|antimitotic agents|mesh-ancestor
5914495|NCT05033769|Mitosis Modulators|mitosis modulators|mesh-ancestor
5914496|NCT05033769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914497|NCT05034133|Cisplatin|cisplatin|mesh-list
5914498|NCT05034133|Etoposide|etoposide|mesh-list
5914499|NCT05034133|Durvalumab|durvalumab|mesh-list
5914500|NCT05034133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5914501|NCT05034133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5914502|NCT05034133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5914503|NCT05034133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5914504|NCT05034133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5914505|NCT05034133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914506|NCT05034133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5914507|NCT05033743|Secnidazole|secnidazole|mesh-list
5914508|NCT05033743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5914509|NCT05033743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5914510|NCT05033743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5914511|NCT05033860|Vaccines|vaccines|mesh-list
5914512|NCT05033860|Immunologic Factors|immunologic factors|mesh-ancestor
5914513|NCT05033860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914514|NCT05033314|Rivaroxaban|rivaroxaban|mesh-list
5914515|NCT05033314|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5914516|NCT05033314|Antithrombins|antithrombins|mesh-ancestor
5914517|NCT05033314|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5914518|NCT05033314|Protease Inhibitors|protease inhibitors|mesh-ancestor
5914519|NCT05033314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5914520|NCT05033314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914521|NCT05033314|Anticoagulants|anticoagulants|mesh-ancestor
5914522|NCT05033574|Hormones|hormones|mesh-list
5914523|NCT05033574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5914524|NCT05033574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963370|NCT04602754|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5963371|NCT04602754|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5963372|NCT04602767|Phenylephrine|phenylephrine|mesh-list
5963373|NCT04602767|Vasopressins|vasopressins|mesh-list
5963374|NCT04602767|Arginine Vasopressin|arginine vasopressin|mesh-list
5963375|NCT04602767|Oxymetazoline|oxymetazoline|mesh-list
5963376|NCT04602767|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5963377|NCT04602767|Mydriatics|mydriatics|mesh-ancestor
5963378|NCT04602767|Autonomic Agents|autonomic agents|mesh-ancestor
5963379|NCT04602767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5963380|NCT04602767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963381|NCT04602767|Sympathomimetics|sympathomimetics|mesh-ancestor
5963382|NCT04602767|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5963383|NCT04602767|Nasal Decongestants|nasal decongestants|mesh-ancestor
5963384|NCT04602767|Respiratory System Agents|respiratory system agents|mesh-ancestor
5963385|NCT04602767|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5963386|NCT04602767|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5963387|NCT04602767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5963388|NCT04602767|Adrenergic Agents|adrenergic agents|mesh-ancestor
5963389|NCT04602767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5963390|NCT04602767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963391|NCT04602767|Protective Agents|protective agents|mesh-ancestor
5963392|NCT04602767|Hemostatics|hemostatics|mesh-ancestor
5963393|NCT04602767|Coagulants|coagulants|mesh-ancestor
5963394|NCT04602767|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5963395|NCT04602767|Natriuretic Agents|natriuretic agents|mesh-ancestor
5963396|NCT04602494|Varenicline|varenicline|mesh-list
5963397|NCT04602494|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5699741|NCT03359239|Interferon Inducers|interferon inducers|mesh-ancestor
5963398|NCT04602494|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5699742|NCT03359239|Immunologic Factors|immunologic factors|mesh-ancestor
5699743|NCT03359239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914525|NCT05033704|Plasma protein fraction|plasma protein fraction|mesh-list
5914526|NCT05033704|Plasma Substitutes|plasma substitutes|mesh-ancestor
5699744|NCT03359161|Furosemide|furosemide|mesh-list
5699745|NCT03359161|Diuretics|diuretics|mesh-ancestor
5699746|NCT03359161|Natriuretic Agents|natriuretic agents|mesh-ancestor
5699747|NCT03359161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699748|NCT03359161|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5699749|NCT03359161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5699750|NCT03359161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699751|NCT03359070|Miconazole|miconazole|mesh-list
5699752|NCT03359070|Clotrimazole|clotrimazole|mesh-list
5699753|NCT03359070|Antifungal Agents|antifungal agents|mesh-ancestor
5914527|NCT05033704|Blood Substitutes|blood substitutes|mesh-ancestor
5914528|NCT05033535|Olmesartan|olmesartan|mesh-list
5914529|NCT05033535|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
5914530|NCT05033535|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5914531|NCT05033535|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5914532|NCT05033535|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5914533|NCT05033535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914534|NCT05033106|Bevacizumab|bevacizumab|mesh-list
5914535|NCT05033106|Ranibizumab|ranibizumab|mesh-list
5914536|NCT05033106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5914537|NCT05033106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5914538|NCT05033106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5914539|NCT05033106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5914540|NCT05033106|Growth Substances|growth substances|mesh-ancestor
5914541|NCT05033106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914542|NCT05033106|Growth Inhibitors|growth inhibitors|mesh-ancestor
5914543|NCT05032781|Minocycline|minocycline|mesh-list
5914544|NCT05032781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5914545|NCT05032781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5914546|NCT05032261|Norepinephrine|norepinephrine|mesh-list
5914547|NCT05032261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5914548|NCT05032261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5914549|NCT05032261|Adrenergic Agents|adrenergic agents|mesh-ancestor
5914550|NCT05032261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5914551|NCT05032261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914552|NCT05032261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914553|NCT05032261|Sympathomimetics|sympathomimetics|mesh-ancestor
5914554|NCT05032261|Autonomic Agents|autonomic agents|mesh-ancestor
5914555|NCT05032261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5914556|NCT05032261|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5914557|NCT05032287|Tamsulosin|tamsulosin|mesh-list
5914558|NCT05032287|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5914559|NCT05032287|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5914560|NCT05032287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5914561|NCT05032287|Adrenergic Agents|adrenergic agents|mesh-ancestor
5914562|NCT05032287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5914563|NCT05032287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914564|NCT05032287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914565|NCT05032287|Urological Agents|urological agents|mesh-ancestor
5914566|NCT05032508|Lidocaine|lidocaine|mesh-list
5914567|NCT05032508|Anesthetics, Local|anesthetics, local|mesh-ancestor
5914568|NCT05032508|Anesthetics|anesthetics|mesh-ancestor
5914569|NCT05032508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6496748|NCT00629278|Docetaxel|docetaxel|mesh-list
6496749|NCT00629278|Cyclophosphamide|cyclophosphamide|mesh-list
6496750|NCT00629278|Doxorubicin|doxorubicin|mesh-list
6496751|NCT00629278|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6496752|NCT00629278|Fluorouracil|fluorouracil|mesh-list
5914570|NCT05032508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914571|NCT05032508|Sensory System Agents|sensory system agents|mesh-ancestor
5914572|NCT05032508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5914573|NCT05032508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5914574|NCT05032508|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5914575|NCT05032508|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5914576|NCT05032508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5914577|NCT05032508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914578|NCT05032248|Tacrolimus|tacrolimus|mesh-list
5914579|NCT05032248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6496753|NCT00629278|Trastuzumab|trastuzumab|mesh-list
6496754|NCT00629278|Epirubicin|epirubicin|mesh-list
5699754|NCT03359070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5699755|NCT03359070|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5699756|NCT03359070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5699757|NCT03359070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5699758|NCT03359070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699759|NCT03359070|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5699760|NCT03359070|Hormone Antagonists|hormone antagonists|mesh-ancestor
5699761|NCT03359070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5699762|NCT03359070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699763|NCT03359070|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5699764|NCT03359070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5699765|NCT03359070|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5699766|NCT03359057|Folic Acid|folic acid|mesh-list
5699767|NCT03359057|Vitamin B Complex|vitamin b complex|mesh-list
5699768|NCT03359057|Levonorgestrel|levonorgestrel|mesh-list
5699769|NCT03359057|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5699770|NCT03359057|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
5699771|NCT03359057|Estradiol|estradiol|mesh-list
5699772|NCT03359057|Estrogens|estrogens|mesh-ancestor
5699773|NCT03359057|Hormones|hormones|mesh-ancestor
5699774|NCT03359057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5699775|NCT03359057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699776|NCT03359057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5699777|NCT03359057|Contraceptive Agents|contraceptive agents|mesh-ancestor
5699778|NCT03359057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5699779|NCT03359057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5699780|NCT03359057|Hematinics|hematinics|mesh-ancestor
5699781|NCT03359057|Vitamins|vitamins|mesh-ancestor
5699782|NCT03359057|Micronutrients|micronutrients|mesh-ancestor
5699783|NCT03359057|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5699784|NCT03359057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5699785|NCT03359057|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5699786|NCT03359057|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5914580|NCT05032248|Immunologic Factors|immunologic factors|mesh-ancestor
5914581|NCT05032248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914582|NCT05032248|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5914583|NCT05032248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5914584|NCT05032248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914585|NCT05031923|Anti-Infective Agents|anti-infective agents|mesh-list
5914586|NCT05031923|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5914587|NCT05031936|Ropivacaine|ropivacaine|mesh-list
5914588|NCT05031936|Anesthetics, Local|anesthetics, local|mesh-ancestor
5914589|NCT05031936|Anesthetics|anesthetics|mesh-ancestor
5914590|NCT05031936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5914591|NCT05031936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914592|NCT05031936|Sensory System Agents|sensory system agents|mesh-ancestor
5914593|NCT05031936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5914594|NCT05032001|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
5914595|NCT05032001|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
5914596|NCT05032001|Biguanides|biguanides|mesh-list
5914597|NCT05032001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914598|NCT05032001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5914599|NCT05032001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914600|NCT05032001|Protease Inhibitors|protease inhibitors|mesh-ancestor
5914601|NCT05032001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5914602|NCT05032118|Ketamine|ketamine|mesh-list
5914603|NCT05032118|Propofol|propofol|mesh-list
5914604|NCT05032118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5914605|NCT05032118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5914606|NCT05032118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914607|NCT05032118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5914608|NCT05032118|Anesthetics, General|anesthetics, general|mesh-ancestor
5914609|NCT05032118|Anesthetics|anesthetics|mesh-ancestor
5914610|NCT05032118|Analgesics|analgesics|mesh-ancestor
5914611|NCT05032118|Sensory System Agents|sensory system agents|mesh-ancestor
5914612|NCT05032118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5914613|NCT05032118|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5914614|NCT05032118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5914615|NCT05032118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5914616|NCT05032118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5914617|NCT05032118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699787|NCT03359018|Apatinib|apatinib|mesh-list
5914618|NCT05031975|Irinotecan|irinotecan|mesh-list
5914619|NCT05031975|Temozolomide|temozolomide|mesh-list
5914620|NCT05031975|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5914621|NCT05031975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5914622|NCT05031975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5914623|NCT05031975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914624|NCT05031975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5914625|NCT05031975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5914626|NCT05031975|Alkylating Agents|alkylating agents|mesh-ancestor
5914627|NCT05031689|Sunscreening Agents|sunscreening agents|mesh-list
5914628|NCT05031689|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5914629|NCT05031689|Protective Agents|protective agents|mesh-ancestor
5914630|NCT05031689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914631|NCT05031689|Dermatologic Agents|dermatologic agents|mesh-ancestor
5914632|NCT05031676|Analgesics, Opioid|analgesics, opioid|mesh-list
5914633|NCT05031676|Anesthetics|anesthetics|mesh-list
5914634|NCT05031676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5914635|NCT05031676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914636|NCT05031676|Narcotics|narcotics|mesh-ancestor
5914637|NCT05031676|Analgesics|analgesics|mesh-ancestor
5914638|NCT05031676|Sensory System Agents|sensory system agents|mesh-ancestor
5914639|NCT05031676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5963399|NCT04602494|Cholinergic Agents|cholinergic agents|mesh-ancestor
5963400|NCT04602494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5963401|NCT04602494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963402|NCT04602494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963403|NCT04602273|Azacitidine|azacitidine|mesh-list
5963404|NCT04602273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5963405|NCT04602273|Antimetabolites|antimetabolites|mesh-ancestor
5963406|NCT04602273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963407|NCT04602273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5963408|NCT04602273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5963409|NCT04602247|Fesoterodine|fesoterodine|mesh-list
5963410|NCT04602247|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5963411|NCT04602247|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5963412|NCT04602247|Cholinergic Agents|cholinergic agents|mesh-ancestor
5963413|NCT04602247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5963414|NCT04602247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963415|NCT04602247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963416|NCT04602247|Urological Agents|urological agents|mesh-ancestor
5963417|NCT04602026|Coal Tar|coal tar|mesh-list
5963418|NCT04602026|Keratolytic Agents|keratolytic agents|mesh-ancestor
5963419|NCT04602026|Dermatologic Agents|dermatologic agents|mesh-ancestor
5963420|NCT04602143|Testosterone|testosterone|mesh-list
5963421|NCT04602143|Androgens|androgens|mesh-ancestor
5699788|NCT03359018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5699789|NCT03359018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5699790|NCT03359018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5699791|NCT03359018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699792|NCT03359005|Vincristine|vincristine|mesh-list
5699793|NCT03359005|Temozolomide|temozolomide|mesh-list
5699794|NCT03359005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5699795|NCT03359005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5699796|NCT03359005|Tubulin Modulators|tubulin modulators|mesh-ancestor
5699797|NCT03359005|Antimitotic Agents|antimitotic agents|mesh-ancestor
5699798|NCT03359005|Mitosis Modulators|mitosis modulators|mesh-ancestor
5699799|NCT03359005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699800|NCT03359005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5699801|NCT03359005|Alkylating Agents|alkylating agents|mesh-ancestor
5963422|NCT04602143|Hormones|hormones|mesh-ancestor
5963423|NCT04602143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5963424|NCT04602143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963425|NCT04601961|Propofol|propofol|mesh-list
5963426|NCT04601961|Sevoflurane|sevoflurane|mesh-list
5963427|NCT04601961|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5963428|NCT04601961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5963429|NCT04601961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963430|NCT04601961|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5963431|NCT04601961|Anesthetics, General|anesthetics, general|mesh-ancestor
5963432|NCT04601961|Anesthetics|anesthetics|mesh-ancestor
5963433|NCT04601961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5963434|NCT04601961|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5963435|NCT04602078|Gemcitabine|gemcitabine|mesh-list
5963436|NCT04602078|Atezolizumab|atezolizumab|mesh-list
5963437|NCT04602078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5963438|NCT04602078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5914640|NCT05031481|Butoconazole|butoconazole|mesh-list
5914641|NCT05031481|Antifungal Agents|antifungal agents|mesh-ancestor
5914642|NCT05031481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5914643|NCT05031520|Metoprolol|metoprolol|mesh-list
5914644|NCT05031520|Nitroglycerin|nitroglycerin|mesh-list
5914645|NCT05031520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5699802|NCT03358953|Nicotine|nicotine|mesh-list
5699803|NCT03358953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5699804|NCT03358953|Autonomic Agents|autonomic agents|mesh-ancestor
5699805|NCT03358953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5699806|NCT03358953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699807|NCT03358953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5699808|NCT03358953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5699809|NCT03358953|Cholinergic Agents|cholinergic agents|mesh-ancestor
5699810|NCT03358953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5699811|NCT03358953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699812|NCT03358888|Analgesics, Opioid|analgesics, opioid|mesh-list
5699813|NCT03358888|Narcotics|narcotics|mesh-ancestor
5699814|NCT03358888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5699815|NCT03358888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699816|NCT03358888|Analgesics|analgesics|mesh-ancestor
5699817|NCT03358888|Sensory System Agents|sensory system agents|mesh-ancestor
5699818|NCT03358888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5699819|NCT03358875|Docetaxel|docetaxel|mesh-list
5699820|NCT03358875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5699821|NCT03358875|Tubulin Modulators|tubulin modulators|mesh-ancestor
5699822|NCT03358875|Antimitotic Agents|antimitotic agents|mesh-ancestor
5914646|NCT05031520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5914647|NCT05031520|Sympatholytics|sympatholytics|mesh-ancestor
5914648|NCT05031520|Autonomic Agents|autonomic agents|mesh-ancestor
5914649|NCT05031520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5914650|NCT05031520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914651|NCT05031520|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5914652|NCT05031520|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5914653|NCT05031520|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5914654|NCT05031520|Adrenergic Agents|adrenergic agents|mesh-ancestor
5914655|NCT05031520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5914656|NCT05031520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914657|NCT05031520|Vasodilator Agents|vasodilator agents|mesh-ancestor
5914658|NCT05031234|Morphine|morphine|mesh-list
5914659|NCT05031234|Anesthetics|anesthetics|mesh-list
5914660|NCT05031234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5914661|NCT05031234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914662|NCT05031234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6675824|NCT01578057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6675825|NCT01578057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6675826|NCT01578057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675827|NCT01578070|Salicylic Acid|salicylic acid|mesh-list
6675828|NCT01578070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6675829|NCT01578070|Antifungal Agents|antifungal agents|mesh-ancestor
6675830|NCT01578070|Keratolytic Agents|keratolytic agents|mesh-ancestor
6675831|NCT01578070|Dermatologic Agents|dermatologic agents|mesh-ancestor
6675832|NCT01578109|Sorafenib|sorafenib|mesh-list
6675833|NCT01578109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6675834|NCT01578109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6675835|NCT01578109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6675836|NCT01578109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675837|NCT01578161|Dexmedetomidine|dexmedetomidine|mesh-list
6675838|NCT01578161|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6675839|NCT01578161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6675840|NCT01578161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675841|NCT01578161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6675842|NCT01578161|Analgesics|analgesics|mesh-ancestor
6675843|NCT01578161|Sensory System Agents|sensory system agents|mesh-ancestor
6675844|NCT01578161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6675845|NCT01578161|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5699823|NCT03358875|Mitosis Modulators|mitosis modulators|mesh-ancestor
5914663|NCT05031234|Narcotics|narcotics|mesh-ancestor
5699824|NCT03358875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5720825|NCT03210480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720826|NCT03210493|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5720827|NCT03210493|Antiviral Agents|antiviral agents|mesh-ancestor
5720828|NCT03210493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5722269|NCT03200236|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5722270|NCT03200236|Autonomic Agents|autonomic agents|mesh-ancestor
5722271|NCT03200236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5914664|NCT05031234|Analgesics|analgesics|mesh-ancestor
5914665|NCT05031234|Sensory System Agents|sensory system agents|mesh-ancestor
5914666|NCT05031234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5914667|NCT05031143|Triamcinolone|triamcinolone|mesh-list
5914668|NCT05031143|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5914669|NCT05031143|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5914670|NCT05031143|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5914671|NCT05031143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5914672|NCT05031143|Glucocorticoids|glucocorticoids|mesh-ancestor
5914673|NCT05031143|Hormones|hormones|mesh-ancestor
5914674|NCT05031143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5914675|NCT05031143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914676|NCT05031143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5914677|NCT05031143|Immunologic Factors|immunologic factors|mesh-ancestor
5914678|NCT05031143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5914679|NCT05031143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914680|NCT05030818|Aspirin|aspirin|mesh-list
5914681|NCT05030818|Ramipril|ramipril|mesh-list
5914682|NCT05030818|Atorvastatin|atorvastatin|mesh-list
5914683|NCT05030818|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5914684|NCT05030818|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5914685|NCT05030818|Antimetabolites|antimetabolites|mesh-ancestor
5914686|NCT05030818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914687|NCT05030818|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5914688|NCT05030818|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5914689|NCT05030818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5914690|NCT05030818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5914691|NCT05030818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5914692|NCT05030818|Analgesics|analgesics|mesh-ancestor
5914693|NCT05030818|Sensory System Agents|sensory system agents|mesh-ancestor
5914694|NCT05030818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5914695|NCT05030818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914696|NCT05030818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5914697|NCT05030818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5914698|NCT05030818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5914699|NCT05030818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5914700|NCT05030818|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5914701|NCT05030818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5914702|NCT05030818|Antipyretics|antipyretics|mesh-ancestor
5914703|NCT05030818|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5914704|NCT05030818|Protease Inhibitors|protease inhibitors|mesh-ancestor
5914705|NCT05030818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5914706|NCT05030623|Tadalafil|tadalafil|mesh-list
5914707|NCT05030623|Vasodilator Agents|vasodilator agents|mesh-ancestor
5914708|NCT05030623|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5914709|NCT05030623|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5914710|NCT05030623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5914711|NCT05030623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914712|NCT05030623|Urological Agents|urological agents|mesh-ancestor
5914713|NCT05030545|Eplerenone|eplerenone|mesh-list
5914714|NCT05030545|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
5914715|NCT05030545|Mineralocorticoids|mineralocorticoids|mesh-list
5914716|NCT05030545|Hormone Antagonists|hormone antagonists|mesh-ancestor
5914717|NCT05030545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5914718|NCT05030545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914719|NCT05030545|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5914720|NCT05030545|Diuretics|diuretics|mesh-ancestor
5914721|NCT05030545|Natriuretic Agents|natriuretic agents|mesh-ancestor
5914722|NCT05030545|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5914723|NCT05030545|Hormones|hormones|mesh-ancestor
5914724|NCT05030415|Ixekizumab|ixekizumab|mesh-list
5914725|NCT05030415|Dermatologic Agents|dermatologic agents|mesh-ancestor
5914726|NCT05030194|Nicotine|nicotine|mesh-list
5914727|NCT05030194|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5914728|NCT05030194|Autonomic Agents|autonomic agents|mesh-ancestor
5914729|NCT05030194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5914730|NCT05030194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914731|NCT05030194|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5914732|NCT05030194|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5914733|NCT05030194|Cholinergic Agents|cholinergic agents|mesh-ancestor
5914734|NCT05030194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5914735|NCT05030194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914736|NCT05030493|Bevacizumab|bevacizumab|mesh-list
5914737|NCT05030493|Panitumumab|panitumumab|mesh-list
5914738|NCT05030493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5914739|NCT05030493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5914740|NCT05030493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5914741|NCT05030493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5914742|NCT05030493|Growth Substances|growth substances|mesh-ancestor
5914743|NCT05030493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914744|NCT05030493|Growth Inhibitors|growth inhibitors|mesh-ancestor
5914745|NCT05030116|Domperidone|domperidone|mesh-list
5914746|NCT05030116|Antiemetics|antiemetics|mesh-ancestor
5914747|NCT05030116|Autonomic Agents|autonomic agents|mesh-ancestor
5914748|NCT05030116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5914749|NCT05030116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914750|NCT05030116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5914751|NCT05030116|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5914752|NCT05030116|Dopamine Agents|dopamine agents|mesh-ancestor
5914753|NCT05030116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5914754|NCT05030116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914755|NCT05030155|Cyclophosphamide|cyclophosphamide|mesh-list
5914756|NCT05030155|Azathioprine|azathioprine|mesh-list
5914757|NCT05030155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5914758|NCT05030155|Immunologic Factors|immunologic factors|mesh-ancestor
5914759|NCT05030155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914760|NCT05030155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5914761|NCT05030155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5914762|NCT05030155|Alkylating Agents|alkylating agents|mesh-ancestor
5699825|NCT03358719|Poly I-C|poly i-c|mesh-list
5699826|NCT03358719|Nivolumab|nivolumab|mesh-list
5699827|NCT03358719|Decitabine|decitabine|mesh-list
5699828|NCT03358719|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
5699829|NCT03358719|Poly ICLC|poly iclc|mesh-list
5699830|NCT03358719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5699831|NCT03358719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5699832|NCT03358719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5699833|NCT03358719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699834|NCT03358719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5699835|NCT03358719|Antimetabolites|antimetabolites|mesh-ancestor
5699836|NCT03358719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5699837|NCT03358719|Interferon Inducers|interferon inducers|mesh-ancestor
5914763|NCT05030155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914764|NCT05030155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5914765|NCT05030155|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5914766|NCT05030155|Antimetabolites|antimetabolites|mesh-ancestor
5914767|NCT05030155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5914768|NCT05029726|Clonidine|clonidine|mesh-list
5914769|NCT05029726|Epinephrine|epinephrine|mesh-list
5914770|NCT05029726|Bupivacaine|bupivacaine|mesh-list
5914771|NCT05029726|Anesthetics, Local|anesthetics, local|mesh-ancestor
5914772|NCT05029726|Anesthetics|anesthetics|mesh-ancestor
5914773|NCT05029726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5914774|NCT05029726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914775|NCT05029726|Sensory System Agents|sensory system agents|mesh-ancestor
5914776|NCT05029726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5914777|NCT05029726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5914778|NCT05029726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5914779|NCT05029726|Adrenergic Agents|adrenergic agents|mesh-ancestor
5914780|NCT05029726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5914781|NCT05029726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914782|NCT05029726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5914783|NCT05029726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5914784|NCT05029726|Autonomic Agents|autonomic agents|mesh-ancestor
5914785|NCT05029726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5914786|NCT05029726|Respiratory System Agents|respiratory system agents|mesh-ancestor
5914787|NCT05029726|Mydriatics|mydriatics|mesh-ancestor
5914788|NCT05029726|Sympathomimetics|sympathomimetics|mesh-ancestor
5914789|NCT05029726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5914790|NCT05029726|Analgesics|analgesics|mesh-ancestor
5914791|NCT05029726|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5914792|NCT05029726|Sympatholytics|sympatholytics|mesh-ancestor
5914793|NCT05029726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5914794|NCT05030025|Lamivudine|lamivudine|mesh-list
5914795|NCT05030025|Abacavir|abacavir|mesh-list
5914796|NCT05030025|Dideoxynucleosides|dideoxynucleosides|mesh-list
5914797|NCT05030025|Dolutegravir|dolutegravir|mesh-list
5699838|NCT03358719|Immunologic Factors|immunologic factors|mesh-ancestor
5699839|NCT03358719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699840|NCT03358719|Laxatives|laxatives|mesh-ancestor
5699841|NCT03358719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5699842|NCT03358719|Antiviral Agents|antiviral agents|mesh-ancestor
5914798|NCT05030025|Triumeq|triumeq|mesh-list
5914799|NCT05030025|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5914800|NCT05030025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5914801|NCT05030025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5914802|NCT05030025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914803|NCT05030025|Antiviral Agents|antiviral agents|mesh-ancestor
5914804|NCT05030025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5914805|NCT05030025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5914806|NCT05030025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5914807|NCT05030025|Antimetabolites|antimetabolites|mesh-ancestor
5914808|NCT05030025|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5914809|NCT05030025|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5914810|NCT05030129|Vitamin B 6|vitamin b 6|mesh-list
5914811|NCT05030129|Pyridoxal|pyridoxal|mesh-list
5914812|NCT05030129|Pyridoxine|pyridoxine|mesh-list
5914813|NCT05030129|Ergoloid Mesylates|ergoloid mesylates|mesh-list
5914814|NCT05030129|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
5914815|NCT05030129|Dihydroergotoxine|dihydroergotoxine|mesh-list
5914816|NCT05030129|Vitamins|vitamins|mesh-ancestor
5914817|NCT05030129|Micronutrients|micronutrients|mesh-ancestor
5914818|NCT05030129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914819|NCT05030129|Vitamin B Complex|vitamin b complex|mesh-ancestor
5914820|NCT05030129|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5914821|NCT05030129|Antidepressive Agents|antidepressive agents|mesh-ancestor
5914822|NCT05030129|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5914823|NCT05030129|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5914824|NCT05030129|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5914825|NCT05030129|Adrenergic Agents|adrenergic agents|mesh-ancestor
5914826|NCT05030129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5914827|NCT05030129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914828|NCT05030129|Vasodilator Agents|vasodilator agents|mesh-ancestor
5699843|NCT03358719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5699844|NCT03358693|Infliximab|infliximab|mesh-list
5699845|NCT03358693|Upadacitinib|upadacitinib|mesh-list
5699846|NCT03358693|Ustekinumab|ustekinumab|mesh-list
5699847|NCT03358693|Ixekizumab|ixekizumab|mesh-list
5699848|NCT03358693|Brodalumab|brodalumab|mesh-list
5699849|NCT03358693|Abrocitinib|abrocitinib|mesh-list
5699850|NCT03358693|Dermatologic Agents|dermatologic agents|mesh-ancestor
5699851|NCT03358693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5699852|NCT03358693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5699853|NCT03358693|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
5699854|NCT03358693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5699855|NCT03358693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5699856|NCT03358693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699857|NCT03358524|Vitamins|vitamins|mesh-list
5699858|NCT03358524|Vitamin E|vitamin e|mesh-list
5699859|NCT03358524|Tocopherols|tocopherols|mesh-list
5699860|NCT03358524|Tocotrienols|tocotrienols|mesh-list
5699861|NCT03358524|alpha-Tocopherol|alpha-tocopherol|mesh-list
5699862|NCT03358524|Micronutrients|micronutrients|mesh-ancestor
6496755|NCT00629278|Hormones|hormones|mesh-list
6496756|NCT00629278|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5699863|NCT03358524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699864|NCT03358524|Antioxidants|antioxidants|mesh-ancestor
5699865|NCT03358524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699866|NCT03358524|Protective Agents|protective agents|mesh-ancestor
5699867|NCT03358433|Antidepressive Agents|antidepressive agents|mesh-list
5699868|NCT03358433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5699869|NCT03358277|Methylphenidate|methylphenidate|mesh-list
5699870|NCT03358277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699871|NCT03358277|Dopamine Agents|dopamine agents|mesh-ancestor
5699872|NCT03358277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5699873|NCT03358277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699874|NCT03358277|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6496757|NCT00629278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6496758|NCT00629278|Tubulin Modulators|tubulin modulators|mesh-ancestor
5699875|NCT03358277|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5699876|NCT03358277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5914829|NCT05030129|Nootropic Agents|nootropic agents|mesh-ancestor
6496759|NCT00629278|Antimitotic Agents|antimitotic agents|mesh-ancestor
6496760|NCT00629278|Mitosis Modulators|mitosis modulators|mesh-ancestor
6496761|NCT00629278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496762|NCT00629278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6496763|NCT00629278|Immunologic Factors|immunologic factors|mesh-ancestor
6496764|NCT00629278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496765|NCT00629278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6496766|NCT00629278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6496767|NCT00629278|Alkylating Agents|alkylating agents|mesh-ancestor
6496768|NCT00629278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6496769|NCT00629278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6496770|NCT00629278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6496771|NCT00629278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6496772|NCT00629278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6496773|NCT00629278|Antimetabolites|antimetabolites|mesh-ancestor
6496774|NCT00629278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6496775|NCT00629278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6496776|NCT00629278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6496777|NCT00629278|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6496778|NCT00629278|Hormone Antagonists|hormone antagonists|mesh-ancestor
6496779|NCT00629278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6496780|NCT00629278|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6496781|NCT00629278|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6496782|NCT00629278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6496783|NCT00629278|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6496784|NCT00629304|Antithrombin III|antithrombin iii|mesh-list
5914830|NCT05030129|Dopamine Agonists|dopamine agonists|mesh-ancestor
5914831|NCT05030129|Dopamine Agents|dopamine agents|mesh-ancestor
5914832|NCT05030077|Gemcitabine|gemcitabine|mesh-list
5914833|NCT05030077|Carboplatin|carboplatin|mesh-list
5914834|NCT05030077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5914835|NCT05030077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5914836|NCT05030077|Antimetabolites|antimetabolites|mesh-ancestor
5914837|NCT05030077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914838|NCT05030077|Antiviral Agents|antiviral agents|mesh-ancestor
5914839|NCT05030077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5914840|NCT05030077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5914841|NCT05030077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5914842|NCT05030077|Immunologic Factors|immunologic factors|mesh-ancestor
5914843|NCT05030077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963439|NCT04602078|Antimetabolites|antimetabolites|mesh-ancestor
5963440|NCT04602078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963441|NCT04602078|Antiviral Agents|antiviral agents|mesh-ancestor
5963442|NCT04602078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5963443|NCT04602078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5963444|NCT04602078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5963445|NCT04602078|Immunologic Factors|immunologic factors|mesh-ancestor
5963446|NCT04602078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963447|NCT04602065|Antibodies|antibodies|mesh-list
5963448|NCT04602065|Antibodies, Bispecific|antibodies, bispecific|mesh-list
5963449|NCT04602065|Immunologic Factors|immunologic factors|mesh-ancestor
5963450|NCT04602065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963451|NCT04602013|Paclitaxel|paclitaxel|mesh-list
5963452|NCT04602013|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5963453|NCT04602013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5963454|NCT04602013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5963455|NCT04602013|Tubulin Modulators|tubulin modulators|mesh-ancestor
5963456|NCT04602013|Antimitotic Agents|antimitotic agents|mesh-ancestor
5963457|NCT04602013|Mitosis Modulators|mitosis modulators|mesh-ancestor
5963458|NCT04602013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970511|NCT04534023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970512|NCT04534023|Protective Agents|protective agents|mesh-ancestor
5970513|NCT04534023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970514|NCT04534231|Nicotine|nicotine|mesh-list
5970515|NCT04534231|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5970516|NCT04534231|Autonomic Agents|autonomic agents|mesh-ancestor
5970517|NCT04534231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5970518|NCT04534231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970519|NCT04534231|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5970520|NCT04534231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5970521|NCT04534231|Cholinergic Agents|cholinergic agents|mesh-ancestor
5970522|NCT04534231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5970523|NCT04534231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970524|NCT04534153|Fexofenadine|fexofenadine|mesh-list
5699877|NCT03358277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5699878|NCT03358212|Denosumab|denosumab|mesh-list
5699879|NCT03358212|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5699880|NCT03358212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699881|NCT03358082|Hydrocortisone|hydrocortisone|mesh-list
5699882|NCT03358082|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
5699883|NCT03358082|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
5699884|NCT03358082|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
5699885|NCT03358082|Tacrolimus|tacrolimus|mesh-list
5699886|NCT03358082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5699887|NCT03358082|Immunologic Factors|immunologic factors|mesh-ancestor
5699888|NCT03358082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699889|NCT03358082|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5699890|NCT03358082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5699891|NCT03358082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699892|NCT03358082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5699893|NCT03358017|Zoledronic Acid|zoledronic acid|mesh-list
5699894|NCT03358017|Atorvastatin|atorvastatin|mesh-list
5699895|NCT03358017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5699896|NCT03358017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5699897|NCT03358017|Antimetabolites|antimetabolites|mesh-ancestor
5699898|NCT03358017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699899|NCT03358017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5699900|NCT03358017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5699901|NCT03358017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5914844|NCT05029453|Apatinib|apatinib|mesh-list
5914845|NCT05029453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5914846|NCT05029453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5914847|NCT05029453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5914848|NCT05029453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914849|NCT05029596|Heparin|heparin|mesh-list
5914850|NCT05029596|Calcium heparin|calcium heparin|mesh-list
5914851|NCT05029596|Anticoagulants|anticoagulants|mesh-ancestor
5914852|NCT05029596|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5914853|NCT05029596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5699902|NCT03358017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5699903|NCT03358017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699904|NCT03358004|Capecitabine|capecitabine|mesh-list
5699905|NCT03358004|Vinorelbine|vinorelbine|mesh-list
5699906|NCT03358004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5699907|NCT03358004|Antimetabolites|antimetabolites|mesh-ancestor
5699908|NCT03358004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699909|NCT03358004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5699910|NCT03358004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5699911|NCT03358004|Tubulin Modulators|tubulin modulators|mesh-ancestor
5699912|NCT03358004|Antimitotic Agents|antimitotic agents|mesh-ancestor
5699913|NCT03358004|Mitosis Modulators|mitosis modulators|mesh-ancestor
5699914|NCT03357939|Adalimumab|adalimumab|mesh-list
5914854|NCT05029596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914855|NCT05029115|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
5914856|NCT05029115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914857|NCT05029115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5914858|NCT05029115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914859|NCT05029076|Liraglutide|liraglutide|mesh-list
5914860|NCT05029076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5914861|NCT05029076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914862|NCT05029076|Incretins|incretins|mesh-ancestor
5914863|NCT05029076|Hormones|hormones|mesh-ancestor
5914864|NCT05029076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5914865|NCT05029401|Ibogaine|ibogaine|mesh-list
5914866|NCT05029401|Hallucinogens|hallucinogens|mesh-ancestor
5914867|NCT05029401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914868|NCT05029401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5914869|NCT05029401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5914870|NCT05029401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5699915|NCT03357939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5699916|NCT03357939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5914871|NCT05029401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5914872|NCT05029401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914873|NCT05028946|Muromonab-CD3|muromonab-cd3|mesh-list
5914874|NCT05028946|Immunologic Factors|immunologic factors|mesh-ancestor
5914875|NCT05028946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914876|NCT05028946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5914877|NCT05029297|Capsaicin|capsaicin|mesh-list
5914878|NCT05029297|Antipruritics|antipruritics|mesh-ancestor
5914879|NCT05029297|Dermatologic Agents|dermatologic agents|mesh-ancestor
5914880|NCT05029297|Sensory System Agents|sensory system agents|mesh-ancestor
5914881|NCT05029297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5914882|NCT05029297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914883|NCT05029037|Ascorbic Acid|ascorbic acid|mesh-list
5914884|NCT05029037|Vitamins|vitamins|mesh-ancestor
5914885|NCT05029037|Micronutrients|micronutrients|mesh-ancestor
5914886|NCT05029037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914887|NCT05029037|Antioxidants|antioxidants|mesh-ancestor
5699917|NCT03357900|Remifentanil|remifentanil|mesh-list
5699918|NCT03357900|Propofol|propofol|mesh-list
5699919|NCT03357900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5914888|NCT05029037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914889|NCT05029037|Protective Agents|protective agents|mesh-ancestor
5914890|NCT05029063|Rivaroxaban|rivaroxaban|mesh-list
5914891|NCT05029063|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5914892|NCT05029063|Antithrombins|antithrombins|mesh-ancestor
5914893|NCT05029063|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5914894|NCT05029063|Protease Inhibitors|protease inhibitors|mesh-ancestor
5914895|NCT05029063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5914896|NCT05029063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914897|NCT05029063|Anticoagulants|anticoagulants|mesh-ancestor
5914898|NCT05028907|Tocopherols|tocopherols|mesh-list
5914899|NCT05028907|Vitamin E|vitamin e|mesh-list
5914900|NCT05028907|alpha-Tocopherol|alpha-tocopherol|mesh-list
5914901|NCT05028907|Chloramphenicol|chloramphenicol|mesh-list
5914902|NCT05028907|Dexamethasone|dexamethasone|mesh-list
5914903|NCT05028907|Dexamethasone acetate|dexamethasone acetate|mesh-list
5914904|NCT05028907|Tetrahydrozoline|tetrahydrozoline|mesh-list
5914905|NCT05028907|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
5914906|NCT05028907|Hyaluronic Acid|hyaluronic acid|mesh-list
5914907|NCT05028907|BB 1101|bb 1101|mesh-list
5914908|NCT05028907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5914909|NCT05028907|Antiemetics|antiemetics|mesh-ancestor
5914910|NCT05028907|Autonomic Agents|autonomic agents|mesh-ancestor
5914911|NCT05028907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5914912|NCT05028907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914913|NCT05028907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5914914|NCT05028907|Glucocorticoids|glucocorticoids|mesh-ancestor
5914915|NCT05028907|Hormones|hormones|mesh-ancestor
5914916|NCT05028907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5914917|NCT05028907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5914918|NCT05028907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5914919|NCT05028907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5914920|NCT05028907|Immunologic Factors|immunologic factors|mesh-ancestor
5914921|NCT05028907|Viscosupplements|viscosupplements|mesh-ancestor
5914922|NCT05028907|Protective Agents|protective agents|mesh-ancestor
5914923|NCT05028907|Antioxidants|antioxidants|mesh-ancestor
5914924|NCT05028907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914925|NCT05028907|Vitamins|vitamins|mesh-ancestor
5914926|NCT05028907|Micronutrients|micronutrients|mesh-ancestor
5914927|NCT05028907|Protease Inhibitors|protease inhibitors|mesh-ancestor
5914928|NCT05028907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5914929|NCT05028907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5914930|NCT05028907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5914931|NCT05028907|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5914932|NCT05028907|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5914933|NCT05028907|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5914934|NCT05028907|Sympathomimetics|sympathomimetics|mesh-ancestor
5914935|NCT05028907|Nasal Decongestants|nasal decongestants|mesh-ancestor
5914936|NCT05028907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5914937|NCT05028907|Respiratory System Agents|respiratory system agents|mesh-ancestor
5914938|NCT05028803|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
5914939|NCT05028803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5914940|NCT05028335|Carbamide Peroxide|carbamide peroxide|mesh-list
5914941|NCT05028335|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5914942|NCT05028335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5914943|NCT05028322|Imiquimod|imiquimod|mesh-list
5914944|NCT05028322|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5914945|NCT05028322|Immunologic Factors|immunologic factors|mesh-ancestor
5914946|NCT05028322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496785|NCT00629304|Antithrombins|antithrombins|mesh-list
5699920|NCT03357900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5699921|NCT03357900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699922|NCT03357900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5699923|NCT03357900|Anesthetics, General|anesthetics, general|mesh-ancestor
5699924|NCT03357900|Anesthetics|anesthetics|mesh-ancestor
5699925|NCT03357900|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5914947|NCT05028322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5914948|NCT05028322|Interferon Inducers|interferon inducers|mesh-ancestor
5914949|NCT05028348|Dexamethasone|dexamethasone|mesh-list
5914950|NCT05028348|Pomalidomide|pomalidomide|mesh-list
5914951|NCT05028348|Elotuzumab|elotuzumab|mesh-list
5914952|NCT05028348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5914953|NCT05028348|Antiemetics|antiemetics|mesh-ancestor
5914954|NCT05028348|Autonomic Agents|autonomic agents|mesh-ancestor
5914955|NCT05028348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5914956|NCT05028348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914957|NCT05028348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5914958|NCT05028348|Glucocorticoids|glucocorticoids|mesh-ancestor
5914959|NCT05028348|Hormones|hormones|mesh-ancestor
5914960|NCT05028348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5914961|NCT05028348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5914962|NCT05028348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5914963|NCT05028348|Immunologic Factors|immunologic factors|mesh-ancestor
5914964|NCT05028348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5914965|NCT05028348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5914966|NCT05028348|Growth Substances|growth substances|mesh-ancestor
5914967|NCT05028348|Growth Inhibitors|growth inhibitors|mesh-ancestor
5914968|NCT05028049|Sufentanil|sufentanil|mesh-list
5914969|NCT05028049|Remifentanil|remifentanil|mesh-list
5914970|NCT05028049|Dsuvia|dsuvia|mesh-list
5914971|NCT05028049|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5914972|NCT05028049|Narcotics|narcotics|mesh-ancestor
5914973|NCT05028049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5914974|NCT05028049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914975|NCT05028049|Analgesics|analgesics|mesh-ancestor
5914976|NCT05028049|Sensory System Agents|sensory system agents|mesh-ancestor
5914977|NCT05028049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5914978|NCT05028049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5914979|NCT05028049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5914980|NCT05028049|Anesthetics, General|anesthetics, general|mesh-ancestor
5914981|NCT05028049|Anesthetics|anesthetics|mesh-ancestor
5914982|NCT05027893|Moxifloxacin|moxifloxacin|mesh-list
5914983|NCT05027893|Cefixime|cefixime|mesh-list
5914984|NCT05027893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5914985|NCT05027893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5914986|NCT05027893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5914987|NCT05027893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5914988|NCT05027893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5914989|NCT05027893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5914990|NCT05027893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5914991|NCT05028153|Azithromycin|azithromycin|mesh-list
5914992|NCT05028153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5914993|NCT05028153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5914994|NCT05028140|Pioglitazone|pioglitazone|mesh-list
5914995|NCT05028140|Empagliflozin|empagliflozin|mesh-list
5914996|NCT05028140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5914997|NCT05028140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5914998|NCT05028140|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5914999|NCT05028140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5915000|NCT05027594|Dexamethasone|dexamethasone|mesh-list
5915001|NCT05027594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5915002|NCT05027594|Antiemetics|antiemetics|mesh-ancestor
5915003|NCT05027594|Autonomic Agents|autonomic agents|mesh-ancestor
5915004|NCT05027594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5915005|NCT05027594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915006|NCT05027594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5915007|NCT05027594|Glucocorticoids|glucocorticoids|mesh-ancestor
5915008|NCT05027594|Hormones|hormones|mesh-ancestor
5915009|NCT05027594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5915010|NCT05027594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5915011|NCT05027594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5915012|NCT05027646|Granisetron|granisetron|mesh-list
5915013|NCT05027646|Antiemetics|antiemetics|mesh-ancestor
5915014|NCT05027646|Autonomic Agents|autonomic agents|mesh-ancestor
5915015|NCT05027646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5915016|NCT05027646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915017|NCT05027646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5915018|NCT05027646|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5915019|NCT05027646|Serotonin Agents|serotonin agents|mesh-ancestor
5915020|NCT05027646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5915021|NCT05027646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5915022|NCT05027516|Azithromycin|azithromycin|mesh-list
5915023|NCT05027516|Ceftriaxone|ceftriaxone|mesh-list
5915024|NCT05027516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5915025|NCT05027516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5963459|NCT04601688|Dexamethasone|dexamethasone|mesh-list
5963460|NCT04601688|Bevacizumab|bevacizumab|mesh-list
5963461|NCT04601688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5963462|NCT04601688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5963463|NCT04601688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5963464|NCT04601688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5963465|NCT04601688|Growth Substances|growth substances|mesh-ancestor
5963466|NCT04601688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963467|NCT04601688|Growth Inhibitors|growth inhibitors|mesh-ancestor
5963468|NCT04601688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5963469|NCT04601688|Antiemetics|antiemetics|mesh-ancestor
5963470|NCT04601688|Autonomic Agents|autonomic agents|mesh-ancestor
5963471|NCT04601688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5963472|NCT04601688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5963473|NCT04601688|Glucocorticoids|glucocorticoids|mesh-ancestor
5963474|NCT04601688|Hormones|hormones|mesh-ancestor
5963475|NCT04601688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5963476|NCT04601688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5963477|NCT04601532|Sulfadiazine|sulfadiazine|mesh-list
5963478|NCT04601532|Silver Sulfadiazine|silver sulfadiazine|mesh-list
5963479|NCT04601532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5963480|NCT04601532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5963481|NCT04601532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5963482|NCT04601532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5963483|NCT04601532|Coccidiostats|coccidiostats|mesh-ancestor
5963484|NCT04601532|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5963485|NCT04601701|Dexamethasone|dexamethasone|mesh-list
5963486|NCT04601701|Bevacizumab|bevacizumab|mesh-list
5963487|NCT04601701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5963488|NCT04601701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5963489|NCT04601701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5963490|NCT04601701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5963491|NCT04601701|Growth Substances|growth substances|mesh-ancestor
5963492|NCT04601701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963493|NCT04601701|Growth Inhibitors|growth inhibitors|mesh-ancestor
5963494|NCT04601701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5963495|NCT04601701|Antiemetics|antiemetics|mesh-ancestor
5963496|NCT04601701|Autonomic Agents|autonomic agents|mesh-ancestor
5963497|NCT04601701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5963498|NCT04601701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5963499|NCT04601701|Glucocorticoids|glucocorticoids|mesh-ancestor
5963500|NCT04601701|Hormones|hormones|mesh-ancestor
5963501|NCT04601701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5963502|NCT04601701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5963503|NCT04601675|Dexamethasone|dexamethasone|mesh-list
5963504|NCT04601675|Ranibizumab|ranibizumab|mesh-list
5963505|NCT04601675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5963506|NCT04601675|Antiemetics|antiemetics|mesh-ancestor
5963507|NCT04601675|Autonomic Agents|autonomic agents|mesh-ancestor
5963508|NCT04601675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5963509|NCT04601675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963510|NCT04601675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5963511|NCT04601675|Glucocorticoids|glucocorticoids|mesh-ancestor
5963512|NCT04601675|Hormones|hormones|mesh-ancestor
5963513|NCT04601675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5963514|NCT04601675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5963515|NCT04601675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5963516|NCT04601675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5963517|NCT04601675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5963518|NCT04601675|Growth Substances|growth substances|mesh-ancestor
5963519|NCT04601675|Growth Inhibitors|growth inhibitors|mesh-ancestor
5963520|NCT04601402|Avelumab|avelumab|mesh-list
5963521|NCT04601402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5963522|NCT04601402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5963523|NCT04601324|Fluticasone|fluticasone|mesh-list
5963524|NCT04601324|Xhance|xhance|mesh-list
5963525|NCT04601324|Azelastine|azelastine|mesh-list
5963526|NCT04601324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5963527|NCT04601324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5963528|NCT04601324|Autonomic Agents|autonomic agents|mesh-ancestor
5963529|NCT04601324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5963530|NCT04601324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963531|NCT04601324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5963532|NCT04601324|Respiratory System Agents|respiratory system agents|mesh-ancestor
5963533|NCT04601324|Dermatologic Agents|dermatologic agents|mesh-ancestor
5915026|NCT05027581|Hyaluronic Acid|hyaluronic acid|mesh-list
5915027|NCT05027581|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5915028|NCT05027581|Immunologic Factors|immunologic factors|mesh-ancestor
5915029|NCT05027581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915030|NCT05027581|Viscosupplements|viscosupplements|mesh-ancestor
5915031|NCT05027581|Protective Agents|protective agents|mesh-ancestor
5915032|NCT05027295|Riboflavin|riboflavin|mesh-list
5915033|NCT05027295|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5915034|NCT05027295|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5915035|NCT05027295|Vitamin B Complex|vitamin b complex|mesh-ancestor
5915036|NCT05027295|Vitamins|vitamins|mesh-ancestor
5915037|NCT05027295|Micronutrients|micronutrients|mesh-ancestor
5915038|NCT05027295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915039|NCT05027295|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5915040|NCT05027295|Dermatologic Agents|dermatologic agents|mesh-ancestor
5915041|NCT05027126|Folic Acid|folic acid|mesh-list
5915042|NCT05027126|Vitamin B Complex|vitamin b complex|mesh-list
5915043|NCT05027126|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
5915044|NCT05027126|Vitamins|vitamins|mesh-ancestor
5915045|NCT05027126|Micronutrients|micronutrients|mesh-ancestor
5915046|NCT05027126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915047|NCT05027126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5915048|NCT05027126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5915049|NCT05027126|Analgesics|analgesics|mesh-ancestor
5915050|NCT05027126|Sensory System Agents|sensory system agents|mesh-ancestor
5915051|NCT05027126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5915052|NCT05027126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5915053|NCT05027126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5915054|NCT05027126|Hematinics|hematinics|mesh-ancestor
5915055|NCT05027386|Irinotecan|irinotecan|mesh-list
5915056|NCT05027386|Temozolomide|temozolomide|mesh-list
5915057|NCT05027386|Apatinib|apatinib|mesh-list
5915058|NCT05027386|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5915059|NCT05027386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5915060|NCT05027386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5915061|NCT05027386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5915062|NCT05027386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5915063|NCT05027386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5915064|NCT05027386|Alkylating Agents|alkylating agents|mesh-ancestor
5915065|NCT05027386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5915066|NCT05027191|Sevoflurane|sevoflurane|mesh-list
5699926|NCT03357900|Narcotics|narcotics|mesh-ancestor
5699927|NCT03357900|Analgesics|analgesics|mesh-ancestor
5699928|NCT03357900|Sensory System Agents|sensory system agents|mesh-ancestor
5699929|NCT03357900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5699930|NCT03357874|Clopidogrel|clopidogrel|mesh-list
5699931|NCT03357874|Ticagrelor|ticagrelor|mesh-list
5699932|NCT03357874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5699933|NCT03357874|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5915067|NCT05027191|Desflurane|desflurane|mesh-list
5915068|NCT05027191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5915069|NCT05027191|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5915070|NCT05027191|Anesthetics, General|anesthetics, general|mesh-ancestor
5915071|NCT05027191|Anesthetics|anesthetics|mesh-ancestor
5915072|NCT05027191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5915073|NCT05027191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699934|NCT03357874|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5699935|NCT03357874|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5915074|NCT05027243|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
5915075|NCT05027243|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5915076|NCT05027243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5915077|NCT05027243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915078|NCT05027243|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5915079|NCT05027243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5915080|NCT05027243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5915081|NCT05027243|Cholinergic Agents|cholinergic agents|mesh-ancestor
5915082|NCT05027243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5915083|NCT05026398|Fenfluramine|fenfluramine|mesh-list
5915084|NCT05026398|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5915085|NCT05026398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5915086|NCT05026398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5915087|NCT05026398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5915088|NCT05026398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5915089|NCT05026398|Serotonin Agents|serotonin agents|mesh-ancestor
5915090|NCT05026398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915091|NCT05026593|Carboplatin|carboplatin|mesh-list
5915092|NCT05026593|Etoposide|etoposide|mesh-list
5915093|NCT05026593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5699936|NCT03357874|Purinergic Agents|purinergic agents|mesh-ancestor
5699937|NCT03357874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5699938|NCT03357874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699939|NCT03357874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699940|NCT03357822|Interferons|interferons|mesh-list
5699941|NCT03357822|Tenofovir|tenofovir|mesh-list
5699942|NCT03357822|Entecavir|entecavir|mesh-list
5699943|NCT03357822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5699944|NCT03357822|Antiviral Agents|antiviral agents|mesh-ancestor
5699945|NCT03357822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5699946|NCT03357822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5699947|NCT03357822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5699948|NCT03357822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5699949|NCT03357822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699950|NCT03357822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5699951|NCT03357822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5699952|NCT03357796|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
5699953|NCT03357796|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5699954|NCT03357796|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5699955|NCT03357796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5699956|NCT03357796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699957|NCT03357796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5699958|NCT03357796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915094|NCT05026593|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5915095|NCT05026593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5915096|NCT05026593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5915097|NCT05026593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5915098|NCT05026593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5915099|NCT05026567|Midazolam|midazolam|mesh-list
5915100|NCT05026567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5915101|NCT05026567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5915102|NCT05026567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5915103|NCT05026567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915104|NCT05026567|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5915105|NCT05026567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5915106|NCT05026567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5915107|NCT05026567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5915108|NCT05026567|Anesthetics, General|anesthetics, general|mesh-ancestor
5915109|NCT05026567|Anesthetics|anesthetics|mesh-ancestor
5915110|NCT05026567|GABA Modulators|gaba modulators|mesh-ancestor
5915111|NCT05026567|GABA Agents|gaba agents|mesh-ancestor
5915112|NCT05026567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5915113|NCT05026567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5915114|NCT05026125|Remifentanil|remifentanil|mesh-list
5915115|NCT05026125|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5915116|NCT05026125|Narcotics|narcotics|mesh-ancestor
5915117|NCT05026125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5915118|NCT05026125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915119|NCT05026125|Analgesics|analgesics|mesh-ancestor
5915120|NCT05026125|Sensory System Agents|sensory system agents|mesh-ancestor
5915121|NCT05026125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5915122|NCT05026229|Cytarabine|cytarabine|mesh-list
5915123|NCT05026229|Prednisone|prednisone|mesh-list
5915124|NCT05026229|Methotrexate|methotrexate|mesh-list
5915125|NCT05026229|Vincristine|vincristine|mesh-list
5915126|NCT05026229|Dasatinib|dasatinib|mesh-list
5915127|NCT05026229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5915128|NCT05026229|Glucocorticoids|glucocorticoids|mesh-ancestor
5915129|NCT05026229|Hormones|hormones|mesh-ancestor
5915130|NCT05026229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5915131|NCT05026229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915132|NCT05026229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5915133|NCT05026229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5915134|NCT05026229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5915135|NCT05026229|Abortifacient Agents|abortifacient agents|mesh-ancestor
5915136|NCT05026229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5915137|NCT05026229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5915138|NCT05026229|Antimetabolites|antimetabolites|mesh-ancestor
5915139|NCT05026229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5915140|NCT05026229|Dermatologic Agents|dermatologic agents|mesh-ancestor
5915141|NCT05026229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5915142|NCT05026229|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5915143|NCT05026229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5915144|NCT05026229|Immunologic Factors|immunologic factors|mesh-ancestor
5915145|NCT05026229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5915146|NCT05026229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5915147|NCT05026229|Antiviral Agents|antiviral agents|mesh-ancestor
5915148|NCT05026229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5915149|NCT05026229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5915150|NCT05026229|Tubulin Modulators|tubulin modulators|mesh-ancestor
5915151|NCT05026229|Antimitotic Agents|antimitotic agents|mesh-ancestor
5915152|NCT05026229|Mitosis Modulators|mitosis modulators|mesh-ancestor
5915153|NCT05026229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5915154|NCT05026203|Midazolam|midazolam|mesh-list
5915155|NCT05026203|Ketamine|ketamine|mesh-list
5915156|NCT05026203|Analgesics|analgesics|mesh-ancestor
5915157|NCT05026203|Sensory System Agents|sensory system agents|mesh-ancestor
5915158|NCT05026203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5915159|NCT05026203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915160|NCT05026203|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5915161|NCT05026203|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5915162|NCT05026203|Anesthetics, General|anesthetics, general|mesh-ancestor
5915163|NCT05026203|Anesthetics|anesthetics|mesh-ancestor
5915164|NCT05026203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5915165|NCT05026203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5915166|NCT05026203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5915167|NCT05026203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5915168|NCT05026203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5915169|NCT05026203|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5915170|NCT05026203|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5915171|NCT05026203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5915172|NCT05026203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5915173|NCT05026203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5915174|NCT05026203|GABA Modulators|gaba modulators|mesh-ancestor
5915175|NCT05026203|GABA Agents|gaba agents|mesh-ancestor
5915176|NCT05025813|Pembrolizumab|pembrolizumab|mesh-list
5915177|NCT05025813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5915178|NCT05025813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5915179|NCT05025644|Dobutamine|dobutamine|mesh-list
5915180|NCT05025644|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5915181|NCT05025644|Sympathomimetics|sympathomimetics|mesh-ancestor
5915182|NCT05025644|Autonomic Agents|autonomic agents|mesh-ancestor
5915183|NCT05025644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5915184|NCT05025644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915185|NCT05025644|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5915186|NCT05025644|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5915187|NCT05025644|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5915188|NCT05025644|Adrenergic Agents|adrenergic agents|mesh-ancestor
5915189|NCT05025644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5915190|NCT05025644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5915191|NCT05025644|Protective Agents|protective agents|mesh-ancestor
5963534|NCT04601324|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5963535|NCT04601324|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
5963536|NCT04601324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5963537|NCT04601324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963538|NCT04601324|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5963539|NCT04601324|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5963540|NCT04601324|Histamine Antagonists|histamine antagonists|mesh-ancestor
5963541|NCT04601324|Histamine Agents|histamine agents|mesh-ancestor
5963542|NCT04601324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5963543|NCT04600999|Favipiravir|favipiravir|mesh-list
5963544|NCT04600999|Antiviral Agents|antiviral agents|mesh-ancestor
5963545|NCT04600999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5963546|NCT04601142|Methylprednisolone|methylprednisolone|mesh-list
5963547|NCT04601142|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5963548|NCT04601142|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5963549|NCT04601142|Prednisolone|prednisolone|mesh-list
5963550|NCT04601142|Prednisolone acetate|prednisolone acetate|mesh-list
5963551|NCT04601142|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5963552|NCT04601142|Prednisolone phosphate|prednisolone phosphate|mesh-list
5963553|NCT04601142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5963554|NCT04601142|Antiemetics|antiemetics|mesh-ancestor
5963555|NCT04601142|Autonomic Agents|autonomic agents|mesh-ancestor
5963556|NCT04601142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5963557|NCT04601142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963558|NCT04601142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5963559|NCT04601142|Glucocorticoids|glucocorticoids|mesh-ancestor
5963560|NCT04601142|Hormones|hormones|mesh-ancestor
5963561|NCT04601142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5915192|NCT05025488|Poly ICLC|poly iclc|mesh-list
5915193|NCT05025488|Interferon Inducers|interferon inducers|mesh-ancestor
5915194|NCT05025488|Immunologic Factors|immunologic factors|mesh-ancestor
5915195|NCT05025488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915196|NCT05025228|Acetaminophen|acetaminophen|mesh-list
5915197|NCT05025228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5915198|NCT05025228|Analgesics|analgesics|mesh-ancestor
5915199|NCT05025228|Sensory System Agents|sensory system agents|mesh-ancestor
5915200|NCT05025228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5915201|NCT05025228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915202|NCT05025228|Antipyretics|antipyretics|mesh-ancestor
5915203|NCT05025072|Hydroxyurea|hydroxyurea|mesh-list
5915204|NCT05025072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5915205|NCT05025072|Antisickling Agents|antisickling agents|mesh-ancestor
5915206|NCT05025072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5915207|NCT05025072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5915208|NCT05025072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5915209|NCT05025033|Paclitaxel|paclitaxel|mesh-list
5915210|NCT05025033|Irinotecan|irinotecan|mesh-list
5915211|NCT05025033|Apatinib|apatinib|mesh-list
5915212|NCT05025033|Antibodies|antibodies|mesh-list
6675846|NCT01578161|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6675847|NCT01578161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6675848|NCT01578161|Adrenergic Agents|adrenergic agents|mesh-ancestor
6675849|NCT01578161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6212671|NCT02192814|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6212672|NCT02192814|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6212673|NCT02192814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6212674|NCT02192814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212675|NCT02192970|Bevacizumab|bevacizumab|mesh-list
6212676|NCT02192970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6212677|NCT02192970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6675850|NCT01578161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675851|NCT01578174|Dexmedetomidine|dexmedetomidine|mesh-list
6675852|NCT01578174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6675853|NCT01578174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6675854|NCT01578174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675855|NCT01578174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6675856|NCT01578174|Analgesics|analgesics|mesh-ancestor
6675857|NCT01578174|Sensory System Agents|sensory system agents|mesh-ancestor
6675858|NCT01578174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6675859|NCT01578174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6675860|NCT01578174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6675861|NCT01578174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6675862|NCT01578174|Adrenergic Agents|adrenergic agents|mesh-ancestor
6675863|NCT01578174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6675864|NCT01578174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675865|NCT01578200|Calcium Carbonate|calcium carbonate|mesh-list
6675866|NCT01578200|Calcium|calcium|mesh-list
6675867|NCT01578200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6675868|NCT01578200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675869|NCT01578200|Antacids|antacids|mesh-ancestor
6675870|NCT01578200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675871|NCT01578200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6675872|NCT01578213|Imatinib Mesylate|imatinib mesylate|mesh-list
6675873|NCT01578213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6675874|NCT01578213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6675875|NCT01578213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6675876|NCT01578213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5915213|NCT05025033|Immunoglobulins|immunoglobulins|mesh-list
5915214|NCT05025033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5915215|NCT05025033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5915216|NCT05025033|Tubulin Modulators|tubulin modulators|mesh-ancestor
5915217|NCT05025033|Antimitotic Agents|antimitotic agents|mesh-ancestor
5915218|NCT05025033|Mitosis Modulators|mitosis modulators|mesh-ancestor
5915219|NCT05025033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5915220|NCT05025033|Immunologic Factors|immunologic factors|mesh-ancestor
5915221|NCT05025033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915222|NCT05025033|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5915223|NCT05025033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5915224|NCT05025033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5915225|NCT05025033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5915226|NCT05025098|Azacitidine|azacitidine|mesh-list
5915227|NCT05025098|Venetoclax|venetoclax|mesh-list
5915228|NCT05025098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5915229|NCT05025098|Antimetabolites|antimetabolites|mesh-ancestor
5915230|NCT05025098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5915231|NCT05025098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5915232|NCT05025098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5915233|NCT05024799|Fentanyl|fentanyl|mesh-list
5915234|NCT05024799|Butorphanol|butorphanol|mesh-list
5915235|NCT05024799|Propofol|propofol|mesh-list
5915236|NCT05024799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5915237|NCT05024799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5915238|NCT05024799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915239|NCT05024799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5915240|NCT05024799|Anesthetics, General|anesthetics, general|mesh-ancestor
5915241|NCT05024799|Anesthetics|anesthetics|mesh-ancestor
5915242|NCT05024799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5915243|NCT05024799|Narcotics|narcotics|mesh-ancestor
5915244|NCT05024799|Analgesics|analgesics|mesh-ancestor
5915245|NCT05024799|Sensory System Agents|sensory system agents|mesh-ancestor
5915246|NCT05024799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5915247|NCT05024799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5915248|NCT05024799|Antitussive Agents|antitussive agents|mesh-ancestor
5915249|NCT05024799|Respiratory System Agents|respiratory system agents|mesh-ancestor
5915250|NCT05024799|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5915251|NCT05024825|Acetaminophen|acetaminophen|mesh-list
5915252|NCT05024825|Ibuprofen|ibuprofen|mesh-list
5915253|NCT05024825|Gabapentin|gabapentin|mesh-list
5915254|NCT05024825|Hydrocodone|hydrocodone|mesh-list
5915255|NCT05024825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5915256|NCT05024825|Analgesics|analgesics|mesh-ancestor
5915257|NCT05024825|Sensory System Agents|sensory system agents|mesh-ancestor
5915258|NCT05024825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5915259|NCT05024825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915260|NCT05024825|Antipyretics|antipyretics|mesh-ancestor
5915261|NCT05024825|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5915262|NCT05024825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5915263|NCT05024825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5915264|NCT05024825|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5915265|NCT05024825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5915266|NCT05024825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5915267|NCT05024825|Anticonvulsants|anticonvulsants|mesh-ancestor
5915268|NCT05024825|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5915269|NCT05024825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5915270|NCT05024825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5915271|NCT05024825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5915272|NCT05024825|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5915273|NCT05024825|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5915274|NCT05024825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5915275|NCT05024825|Antimanic Agents|antimanic agents|mesh-ancestor
5915276|NCT05024825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5699959|NCT03357796|Antidepressive Agents|antidepressive agents|mesh-ancestor
5699960|NCT03357796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5915277|NCT05024825|Narcotics|narcotics|mesh-ancestor
5915278|NCT05024825|Antitussive Agents|antitussive agents|mesh-ancestor
5915279|NCT05024825|Respiratory System Agents|respiratory system agents|mesh-ancestor
5915280|NCT05024734|Gemcitabine|gemcitabine|mesh-list
5915281|NCT05024734|Docetaxel|docetaxel|mesh-list
5915282|NCT05024734|Epirubicin|epirubicin|mesh-list
5915283|NCT05024734|Mitomycins|mitomycins|mesh-list
5915284|NCT05024734|Mitomycin|mitomycin|mesh-list
5915285|NCT05024734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5915286|NCT05024734|Antimetabolites|antimetabolites|mesh-ancestor
5915287|NCT05024734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5915288|NCT05024734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5915289|NCT05024734|Antiviral Agents|antiviral agents|mesh-ancestor
5699961|NCT03357757|Avelumab|avelumab|mesh-list
5699962|NCT03357757|Valproic Acid|valproic acid|mesh-list
5699963|NCT03357757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5699964|NCT03357757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5699965|NCT03357757|Anticonvulsants|anticonvulsants|mesh-ancestor
5699966|NCT03357757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5699967|NCT03357757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699968|NCT03357757|GABA Agents|gaba agents|mesh-ancestor
5699969|NCT03357757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5699970|NCT03357757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699971|NCT03357757|Antimanic Agents|antimanic agents|mesh-ancestor
5699972|NCT03357757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5699973|NCT03357757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5699974|NCT03357757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5699975|NCT03357718|Midazolam|midazolam|mesh-list
5699976|NCT03357718|Dexmedetomidine|dexmedetomidine|mesh-list
5699977|NCT03357718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5699978|NCT03357718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5699979|NCT03357718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5699980|NCT03357718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5699981|NCT03357718|Analgesics|analgesics|mesh-ancestor
5699982|NCT03357718|Sensory System Agents|sensory system agents|mesh-ancestor
5699983|NCT03357718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5699984|NCT03357718|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5699985|NCT03357718|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5699986|NCT03357718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5699987|NCT03357718|Adrenergic Agents|adrenergic agents|mesh-ancestor
5699988|NCT03357718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5699989|NCT03357718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5699990|NCT03357718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5699991|NCT03357718|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5699992|NCT03357718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5699993|NCT03357718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5699994|NCT03357718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5699995|NCT03357718|Anesthetics, General|anesthetics, general|mesh-ancestor
5699996|NCT03357718|Anesthetics|anesthetics|mesh-ancestor
5699997|NCT03357718|GABA Modulators|gaba modulators|mesh-ancestor
5699998|NCT03357718|GABA Agents|gaba agents|mesh-ancestor
5699999|NCT03357653|Losartan|losartan|mesh-list
5700000|NCT03357653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5700001|NCT03357653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5915290|NCT05024734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5915291|NCT05024734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5915292|NCT05024734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5915293|NCT05024734|Immunologic Factors|immunologic factors|mesh-ancestor
5915294|NCT05024734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915295|NCT05024734|Tubulin Modulators|tubulin modulators|mesh-ancestor
5915296|NCT05024734|Antimitotic Agents|antimitotic agents|mesh-ancestor
5915297|NCT05024734|Mitosis Modulators|mitosis modulators|mesh-ancestor
5915298|NCT05024734|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5915299|NCT05024734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5915300|NCT05024734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5915301|NCT05024734|Alkylating Agents|alkylating agents|mesh-ancestor
5915302|NCT05024734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5915303|NCT05024604|Progesterone|progesterone|mesh-list
5915304|NCT05024604|Progestins|progestins|mesh-ancestor
5915305|NCT05024604|Hormones|hormones|mesh-ancestor
5915306|NCT05024604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5915307|NCT05024604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915308|NCT05024435|Pulmonary Surfactants|pulmonary surfactants|mesh-list
5915309|NCT05024435|Respiratory System Agents|respiratory system agents|mesh-ancestor
5915310|NCT05024760|Chlorhexidine|chlorhexidine|mesh-list
5915311|NCT05024760|Hydrogen Peroxide|hydrogen peroxide|mesh-list
5915312|NCT05024760|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5915313|NCT05024760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5915314|NCT05024760|Disinfectants|disinfectants|mesh-ancestor
6212678|NCT02192970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6212679|NCT02192970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6212680|NCT02192970|Growth Substances|growth substances|mesh-ancestor
6212681|NCT02192970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212682|NCT02192970|Growth Inhibitors|growth inhibitors|mesh-ancestor
6212683|NCT02193165|Triclosan|triclosan|mesh-list
6212684|NCT02193165|Cetylpyridinium|cetylpyridinium|mesh-list
6212685|NCT02193165|Fluorides|fluorides|mesh-list
6212686|NCT02193165|Tin Fluorides|tin fluorides|mesh-list
6212687|NCT02193165|Cariostatic Agents|cariostatic agents|mesh-ancestor
6212688|NCT02193165|Protective Agents|protective agents|mesh-ancestor
6212689|NCT02193165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212690|NCT02193165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6212691|NCT02193165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6212692|NCT02193165|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6212693|NCT02193165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6212694|NCT02193165|Antimetabolites|antimetabolites|mesh-ancestor
6212695|NCT02193165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212696|NCT02193165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6212697|NCT02193347|Temozolomide|temozolomide|mesh-list
6212698|NCT02193347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6212699|NCT02193347|Alkylating Agents|alkylating agents|mesh-ancestor
6212700|NCT02193347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675877|NCT01578252|Ondansetron|ondansetron|mesh-list
5915315|NCT05024448|Prednisone|prednisone|mesh-list
5915316|NCT05024448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5915317|NCT05024448|Glucocorticoids|glucocorticoids|mesh-ancestor
5915318|NCT05024448|Hormones|hormones|mesh-ancestor
5915319|NCT05024448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5915320|NCT05024448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915321|NCT05024448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5915322|NCT05024448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5915323|NCT05024877|Stanozolol|stanozolol|mesh-list
5915324|NCT05024877|Androgens|androgens|mesh-ancestor
5915325|NCT05024877|Hormones|hormones|mesh-ancestor
5915326|NCT05024877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5915327|NCT05024877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915328|NCT05024877|Anabolic Agents|anabolic agents|mesh-ancestor
5915329|NCT05024526|Edaravone|edaravone|mesh-list
5915330|NCT05024526|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5915331|NCT05024526|Antioxidants|antioxidants|mesh-ancestor
5915332|NCT05024526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5915333|NCT05024526|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5915334|NCT05024526|Protective Agents|protective agents|mesh-ancestor
5915335|NCT05024526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915336|NCT05024565|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5915337|NCT05024565|Lactams|lactams|mesh-list
5915338|NCT05024565|beta-Lactams|beta-lactams|mesh-list
5915339|NCT05024565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5915340|NCT05024422|Pyridoxine|pyridoxine|mesh-list
5915341|NCT05024422|Vitamin B 6|vitamin b 6|mesh-list
5915342|NCT05024422|Cabergoline|cabergoline|mesh-list
5915343|NCT05024422|Vitamins|vitamins|mesh-ancestor
5915344|NCT05024422|Micronutrients|micronutrients|mesh-ancestor
5915345|NCT05024422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915346|NCT05024422|Vitamin B Complex|vitamin b complex|mesh-ancestor
5915347|NCT05024422|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5915348|NCT05024422|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5915349|NCT05024422|Dopamine Agonists|dopamine agonists|mesh-ancestor
5915350|NCT05024422|Dopamine Agents|dopamine agents|mesh-ancestor
5915351|NCT05024422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5915352|NCT05024422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5915353|NCT05024357|Dasatinib|dasatinib|mesh-list
5915354|NCT05024357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5915355|NCT05024357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5915356|NCT05024357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5915357|NCT05024357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5915358|NCT05024344|Dexamethasone|dexamethasone|mesh-list
5915359|NCT05024344|Ropivacaine|ropivacaine|mesh-list
5915360|NCT05024344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5915361|NCT05024344|Antiemetics|antiemetics|mesh-ancestor
5915362|NCT05024344|Autonomic Agents|autonomic agents|mesh-ancestor
5915363|NCT05024344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5915364|NCT05024344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915365|NCT05024344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5915366|NCT05024344|Glucocorticoids|glucocorticoids|mesh-ancestor
5915367|NCT05024344|Hormones|hormones|mesh-ancestor
5915368|NCT05024344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5915369|NCT05024344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5915370|NCT05024344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5915371|NCT05024344|Anesthetics, Local|anesthetics, local|mesh-ancestor
5915372|NCT05024344|Anesthetics|anesthetics|mesh-ancestor
5915373|NCT05024344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5915374|NCT05024344|Sensory System Agents|sensory system agents|mesh-ancestor
5915375|NCT05024318|Pembrolizumab|pembrolizumab|mesh-list
5915376|NCT05024318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5915377|NCT05024318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5915378|NCT05023915|Dexamethasone|dexamethasone|mesh-list
5915379|NCT05023915|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
5700002|NCT03357653|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5700003|NCT03357653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5700004|NCT03357653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700005|NCT03357640|Contraceptive Agents|contraceptive agents|mesh-list
5700006|NCT03357640|Contraceptives, Oral|contraceptives, oral|mesh-list
5700007|NCT03357640|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
5700008|NCT03357640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5720829|NCT03210064|Fluorouracil|fluorouracil|mesh-list
5915380|NCT05023915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5915381|NCT05023915|Antiemetics|antiemetics|mesh-ancestor
5915382|NCT05023915|Autonomic Agents|autonomic agents|mesh-ancestor
5915383|NCT05023915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5915384|NCT05023915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915385|NCT05023915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5915386|NCT05023915|Glucocorticoids|glucocorticoids|mesh-ancestor
5915387|NCT05023915|Hormones|hormones|mesh-ancestor
5915388|NCT05023915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5915389|NCT05023915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5915390|NCT05023915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5915391|NCT05024006|Interferons|interferons|mesh-list
5915392|NCT05024006|Ritonavir|ritonavir|mesh-list
5915393|NCT05024006|Lopinavir|lopinavir|mesh-list
5915394|NCT05024006|Interferon-beta|interferon-beta|mesh-list
5915395|NCT05024006|Interferon beta-1a|interferon beta-1a|mesh-list
5915396|NCT05024006|Remdesivir|remdesivir|mesh-list
5915397|NCT05024006|Hydroxychloroquine|hydroxychloroquine|mesh-list
5915398|NCT05024006|Acalabrutinib|acalabrutinib|mesh-list
5915399|NCT05024006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5915400|NCT05024006|Antiviral Agents|antiviral agents|mesh-ancestor
5915401|NCT05024006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5915402|NCT05024006|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5915403|NCT05024006|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5915404|NCT05024006|Protease Inhibitors|protease inhibitors|mesh-ancestor
5915405|NCT05024006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5915406|NCT05024006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5915407|NCT05024006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5915408|NCT05024006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5915409|NCT05024006|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5915410|NCT05024006|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5915411|NCT05024006|Antimalarials|antimalarials|mesh-ancestor
5915412|NCT05024006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5915413|NCT05024006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5915414|NCT05024006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5915415|NCT05024006|Immunologic Factors|immunologic factors|mesh-ancestor
5915416|NCT05024006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915417|NCT05024006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5915418|NCT05024006|Antimetabolites|antimetabolites|mesh-ancestor
5915419|NCT05023941|Acetazolamide|acetazolamide|mesh-list
5915420|NCT05023941|Anticonvulsants|anticonvulsants|mesh-ancestor
5915421|NCT05023941|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5915422|NCT05023941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5915423|NCT05023941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5915424|NCT05023941|Diuretics|diuretics|mesh-ancestor
5915425|NCT05023941|Natriuretic Agents|natriuretic agents|mesh-ancestor
5915426|NCT05023941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915427|NCT05024266|Paclitaxel|paclitaxel|mesh-list
5915428|NCT05024266|Carboplatin|carboplatin|mesh-list
5915429|NCT05024266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5915430|NCT05024266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5915431|NCT05024266|Tubulin Modulators|tubulin modulators|mesh-ancestor
5915432|NCT05024266|Antimitotic Agents|antimitotic agents|mesh-ancestor
5915433|NCT05024266|Mitosis Modulators|mitosis modulators|mesh-ancestor
5915434|NCT05024266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5915435|NCT05024084|Anesthetics|anesthetics|mesh-list
5915436|NCT05024084|Sevoflurane|sevoflurane|mesh-list
5915437|NCT05024084|Desflurane|desflurane|mesh-list
5915438|NCT05024084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5915439|NCT05024084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915440|NCT05024084|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5915441|NCT05024084|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5915442|NCT05024084|Anesthetics, General|anesthetics, general|mesh-ancestor
5700009|NCT03357640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700010|NCT03357640|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5700011|NCT03357627|Venetoclax|venetoclax|mesh-list
5700012|NCT03357627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5700013|NCT03357575|Hyaluronic Acid|hyaluronic acid|mesh-list
5700014|NCT03357575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5700015|NCT03357575|Immunologic Factors|immunologic factors|mesh-ancestor
5700016|NCT03357575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700017|NCT03357575|Viscosupplements|viscosupplements|mesh-ancestor
5700018|NCT03357575|Protective Agents|protective agents|mesh-ancestor
5700019|NCT03357419|Clindamycin|clindamycin|mesh-list
5700020|NCT03357419|Clindamycin palmitate|clindamycin palmitate|mesh-list
5700021|NCT03357419|Clindamycin phosphate|clindamycin phosphate|mesh-list
5700022|NCT03357419|Cephalexin|cephalexin|mesh-list
5700023|NCT03357419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5700024|NCT03357419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5700025|NCT03357419|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5700026|NCT03357419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5915443|NCT05024019|Nimotuzumab|nimotuzumab|mesh-list
5915444|NCT05024019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5915445|NCT05024019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5915446|NCT05023824|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
5915447|NCT05023824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5915448|NCT05023824|Adrenergic Agents|adrenergic agents|mesh-ancestor
5915449|NCT05023824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5915450|NCT05023824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5915451|NCT05023824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915452|NCT05023863|Thioctic Acid|thioctic acid|mesh-list
5915453|NCT05023863|Antioxidants|antioxidants|mesh-ancestor
5915454|NCT05023863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5915455|NCT05023863|Protective Agents|protective agents|mesh-ancestor
5915456|NCT05023863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915457|NCT05023863|Vitamin B Complex|vitamin b complex|mesh-ancestor
5915458|NCT05023863|Vitamins|vitamins|mesh-ancestor
5915459|NCT05023863|Micronutrients|micronutrients|mesh-ancestor
5915460|NCT05023382|Teduglutide|teduglutide|mesh-list
5915461|NCT05023382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5915462|NCT05023382|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5915463|NCT05023382|Protective Agents|protective agents|mesh-ancestor
5915464|NCT05023382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915465|NCT05023473|Morphine|morphine|mesh-list
5915466|NCT05023473|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5915467|NCT05023473|Narcotics|narcotics|mesh-ancestor
5915468|NCT05023473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5915469|NCT05023473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915470|NCT05023473|Analgesics|analgesics|mesh-ancestor
5915471|NCT05023473|Sensory System Agents|sensory system agents|mesh-ancestor
5915472|NCT05023473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5915473|NCT05023408|Bleomycin|bleomycin|mesh-list
5915474|NCT05023408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5915475|NCT05023408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5915476|NCT05023304|Prednisolone|prednisolone|mesh-list
5915477|NCT05023304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5915478|NCT05023304|Glucocorticoids|glucocorticoids|mesh-ancestor
5915479|NCT05023304|Hormones|hormones|mesh-ancestor
5915480|NCT05023304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5915481|NCT05023304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915482|NCT05023304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5915483|NCT05023304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5915484|NCT05023759|Cannabidiol|cannabidiol|mesh-list
5915485|NCT05023759|Anticonvulsants|anticonvulsants|mesh-ancestor
5963562|NCT04601142|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5963563|NCT04601142|Protective Agents|protective agents|mesh-ancestor
5963564|NCT04601142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5963565|NCT04601142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5963566|NCT04601259|Salicylic Acid|salicylic acid|mesh-list
5963567|NCT04601259|Salicylates|salicylates|mesh-list
5963568|NCT04601259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5963569|NCT04601259|Antifungal Agents|antifungal agents|mesh-ancestor
5963570|NCT04601259|Keratolytic Agents|keratolytic agents|mesh-ancestor
5963571|NCT04601259|Dermatologic Agents|dermatologic agents|mesh-ancestor
5963572|NCT04601259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5963573|NCT04601259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5963574|NCT04601259|Analgesics|analgesics|mesh-ancestor
5963575|NCT04601259|Sensory System Agents|sensory system agents|mesh-ancestor
5963576|NCT04601259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5963577|NCT04601259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963578|NCT04601259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5963579|NCT04601259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5963580|NCT04601259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5963581|NCT04601259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5700027|NCT03357419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700028|NCT03357224|Atezolizumab|atezolizumab|mesh-list
5700029|NCT03357224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5700030|NCT03357159|Cyclophosphamide|cyclophosphamide|mesh-list
5700031|NCT03357159|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5700032|NCT03357159|Immunoglobulins|immunoglobulins|mesh-list
5700033|NCT03357159|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5700034|NCT03357159|Antibodies|antibodies|mesh-list
5700035|NCT03357159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5700036|NCT03357159|Immunologic Factors|immunologic factors|mesh-ancestor
5700037|NCT03357159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963582|NCT04601259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963583|NCT04601389|Omalizumab|omalizumab|mesh-list
5915486|NCT05023577|Metronidazole|metronidazole|mesh-list
5915487|NCT05023577|Clarithromycin|clarithromycin|mesh-list
5915488|NCT05023577|Levofloxacin|levofloxacin|mesh-list
5915489|NCT05023577|Ofloxacin|ofloxacin|mesh-list
5915490|NCT05023577|Potassium Citrate|potassium citrate|mesh-list
5915491|NCT05023577|Rabeprazole|rabeprazole|mesh-list
5915492|NCT05023577|Bismuth|bismuth|mesh-list
5915493|NCT05023577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5915494|NCT05023577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5915495|NCT05023577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5915496|NCT05023577|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5915497|NCT05023577|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5915498|NCT05023577|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5915499|NCT05023577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5915500|NCT05023577|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5915501|NCT05023577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5915502|NCT05023577|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5915503|NCT05023577|Renal Agents|renal agents|mesh-ancestor
5915504|NCT05023577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5915505|NCT05023577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5915506|NCT05023577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5915507|NCT05023577|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5915508|NCT05023577|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5915509|NCT05023577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5915510|NCT05023577|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5915511|NCT05023577|Antacids|antacids|mesh-ancestor
5915512|NCT05023577|Diuretics|diuretics|mesh-ancestor
5915513|NCT05023577|Natriuretic Agents|natriuretic agents|mesh-ancestor
5915514|NCT05023577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915515|NCT05023577|Expectorants|expectorants|mesh-ancestor
5915516|NCT05023577|Respiratory System Agents|respiratory system agents|mesh-ancestor
5915517|NCT05023278|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
5915518|NCT05023278|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5915519|NCT05023278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5915520|NCT05023278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5915521|NCT05023278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5915522|NCT05023278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5915523|NCT05023278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915524|NCT05023278|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5915525|NCT05023278|Antidepressive Agents|antidepressive agents|mesh-ancestor
5915526|NCT05023278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6675878|NCT01578252|Antiemetics|antiemetics|mesh-ancestor
5700038|NCT03357159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5700039|NCT03357159|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5700040|NCT03357159|Alkylating Agents|alkylating agents|mesh-ancestor
5700041|NCT03357159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700042|NCT03357159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5700043|NCT03357159|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5720830|NCT03210064|Apatinib|apatinib|mesh-list
5720831|NCT03210064|Antimetabolites|antimetabolites|mesh-ancestor
5720832|NCT03210064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5720833|NCT03210064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5720834|NCT03210064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5720835|NCT03210064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5720836|NCT03210064|Immunologic Factors|immunologic factors|mesh-ancestor
5720837|NCT03210064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720838|NCT03210064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5720839|NCT03210064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5720840|NCT03210025|Methyldopa|methyldopa|mesh-list
5720841|NCT03210025|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5720842|NCT03210025|Sympatholytics|sympatholytics|mesh-ancestor
5720843|NCT03210025|Autonomic Agents|autonomic agents|mesh-ancestor
5720844|NCT03210025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5720845|NCT03210025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720846|NCT03210025|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5720847|NCT03210025|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5720848|NCT03210025|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5720849|NCT03210025|Adrenergic Agents|adrenergic agents|mesh-ancestor
5720850|NCT03210025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5720851|NCT03210025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5720852|NCT03210038|Lidocaine|lidocaine|mesh-list
5720853|NCT03210038|Anesthetics, Local|anesthetics, local|mesh-ancestor
5720854|NCT03210038|Anesthetics|anesthetics|mesh-ancestor
5915527|NCT05023122|Vitamin D|vitamin d|mesh-list
5915528|NCT05023122|Cholecalciferol|cholecalciferol|mesh-list
5915529|NCT05023122|Calcium|calcium|mesh-list
5915530|NCT05023122|Vitamins|vitamins|mesh-ancestor
5915531|NCT05023122|Micronutrients|micronutrients|mesh-ancestor
5915532|NCT05023122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915533|NCT05023122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5915534|NCT05023122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5915535|NCT05022901|Melphalan|melphalan|mesh-list
5915536|NCT05022901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5915537|NCT05022901|Alkylating Agents|alkylating agents|mesh-ancestor
5915538|NCT05022901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700044|NCT03357133|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5700045|NCT03357133|Tirofiban|tirofiban|mesh-list
5700046|NCT03357133|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5915539|NCT05022901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5915540|NCT05022901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5915541|NCT05022901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5915542|NCT05022901|Immunologic Factors|immunologic factors|mesh-ancestor
5915543|NCT05022901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915544|NCT05022524|Acetic Acid|acetic acid|mesh-list
5915545|NCT05022524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5915546|NCT05022524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5915547|NCT05022394|Nivolumab|nivolumab|mesh-list
5915548|NCT05022394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5915549|NCT05022394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5915550|NCT05022394|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5915551|NCT05022394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5915552|NCT05022030|Cetuximab|cetuximab|mesh-list
5915553|NCT05022030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5915554|NCT05022030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5915555|NCT05021887|Fluticasone|fluticasone|mesh-list
5915556|NCT05021887|Xhance|xhance|mesh-list
5915557|NCT05021887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5915558|NCT05021887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5915559|NCT05021887|Autonomic Agents|autonomic agents|mesh-ancestor
5915560|NCT05021887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5915561|NCT05021887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915562|NCT05021887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5915563|NCT05021887|Respiratory System Agents|respiratory system agents|mesh-ancestor
5915564|NCT05021887|Dermatologic Agents|dermatologic agents|mesh-ancestor
5915565|NCT05021887|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5915566|NCT05022186|Cannabidiol|cannabidiol|mesh-list
5915567|NCT05022186|Tramiprosate|tramiprosate|mesh-list
5915568|NCT05022186|Anticonvulsants|anticonvulsants|mesh-ancestor
5915569|NCT05022186|GABA Agonists|gaba agonists|mesh-ancestor
5915570|NCT05022186|GABA Agents|gaba agents|mesh-ancestor
5915571|NCT05022186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5915572|NCT05022186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5915573|NCT05022186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915574|NCT05021770|Thiotepa|thiotepa|mesh-list
5915575|NCT05021770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5915576|NCT05021770|Alkylating Agents|alkylating agents|mesh-ancestor
5915577|NCT05021770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5915578|NCT05021770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5915579|NCT05021770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5915580|NCT05021770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5915581|NCT05021770|Immunologic Factors|immunologic factors|mesh-ancestor
5915582|NCT05021770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915583|NCT05021809|Calcium|calcium|mesh-list
5915584|NCT05021809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5915585|NCT05021809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915586|NCT05021588|Anticoagulants|anticoagulants|mesh-list
5915587|NCT05021406|Carvedilol|carvedilol|mesh-list
5915588|NCT05021406|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5700047|NCT03357133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5700048|NCT03357133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700049|NCT03357133|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5700050|NCT03357055|Ketamine|ketamine|mesh-list
5700051|NCT03357055|Analgesics|analgesics|mesh-ancestor
5700052|NCT03357055|Sensory System Agents|sensory system agents|mesh-ancestor
5915589|NCT05021406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5915590|NCT05021406|Adrenergic Agents|adrenergic agents|mesh-ancestor
5915591|NCT05021406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5915592|NCT05021406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5915593|NCT05021406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915594|NCT05021406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5915595|NCT05021406|Antioxidants|antioxidants|mesh-ancestor
5700053|NCT03357055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5700054|NCT03357055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700055|NCT03357055|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5700056|NCT03357055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5700057|NCT03357055|Anesthetics, General|anesthetics, general|mesh-ancestor
5700058|NCT03357055|Anesthetics|anesthetics|mesh-ancestor
5915596|NCT05021406|Protective Agents|protective agents|mesh-ancestor
5915597|NCT05021406|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5915598|NCT05021406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5915599|NCT05021406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5915600|NCT05021406|Vasodilator Agents|vasodilator agents|mesh-ancestor
5915601|NCT05021406|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5915602|NCT05021406|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5915603|NCT05021484|Felzartamab|felzartamab|mesh-list
5915604|NCT05021484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5915605|NCT05021484|Immunologic Factors|immunologic factors|mesh-ancestor
5915606|NCT05021484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915607|NCT05021731|Rifampin|rifampin|mesh-list
5915608|NCT05021731|Rifapentine|rifapentine|mesh-list
5915609|NCT05021731|Isoniazid|isoniazid|mesh-list
5915610|NCT05021731|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5915611|NCT05021731|Antitubercular Agents|antitubercular agents|mesh-ancestor
5915612|NCT05021731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5915613|NCT05021731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5915614|NCT05021731|Leprostatic Agents|leprostatic agents|mesh-ancestor
5915615|NCT05021731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5915616|NCT05021731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5915617|NCT05021731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5915618|NCT05021731|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5915619|NCT05021731|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5915620|NCT05021731|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5915621|NCT05021731|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5915622|NCT05021731|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5915623|NCT05021731|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5915624|NCT05021731|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5915625|NCT05021731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5915626|NCT05021731|Antimetabolites|antimetabolites|mesh-ancestor
5915627|NCT05021731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5915628|NCT05021094|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5915629|NCT05021094|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5915630|NCT05021094|Estradiol|estradiol|mesh-list
5915631|NCT05021094|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5915632|NCT05021094|Dydrogesterone|dydrogesterone|mesh-list
5915633|NCT05021094|Estrogens|estrogens|mesh-ancestor
5915634|NCT05021094|Hormones|hormones|mesh-ancestor
5963584|NCT04601389|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5700059|NCT03357055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5700060|NCT03357055|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5700061|NCT03357055|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5700062|NCT03357055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5700063|NCT03357055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700064|NCT03356964|Hormones|hormones|mesh-list
5700065|NCT03356964|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5700066|NCT03356964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5700067|NCT03356964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700068|NCT03356912|Prednisone|prednisone|mesh-list
5700069|NCT03356912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5700070|NCT03356912|Glucocorticoids|glucocorticoids|mesh-ancestor
5700071|NCT03356912|Hormones|hormones|mesh-ancestor
5700072|NCT03356912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5700073|NCT03356912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700074|NCT03356912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5700075|NCT03356912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5700076|NCT03356899|Bupivacaine|bupivacaine|mesh-list
5700077|NCT03356899|Anesthetics|anesthetics|mesh-list
5700078|NCT03356899|Anesthetics, Local|anesthetics, local|mesh-ancestor
5700079|NCT03356899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5700080|NCT03356899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700081|NCT03356899|Sensory System Agents|sensory system agents|mesh-ancestor
5700082|NCT03356899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5700083|NCT03356873|Vitamin D|vitamin d|mesh-list
5700084|NCT03356873|Ergocalciferols|ergocalciferols|mesh-list
5915635|NCT05021094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5915636|NCT05021094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915637|NCT05021094|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5915638|NCT05021094|Contraceptive Agents|contraceptive agents|mesh-ancestor
5915639|NCT05021094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5915640|NCT05021094|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5915641|NCT05021094|Progestins|progestins|mesh-ancestor
5963585|NCT04601389|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5963586|NCT04601389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5963587|NCT04601389|Respiratory System Agents|respiratory system agents|mesh-ancestor
5963588|NCT04601389|Immunologic Factors|immunologic factors|mesh-ancestor
5963589|NCT04601389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963590|NCT04601077|Nitric Oxide|nitric oxide|mesh-list
5963591|NCT04601077|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5963592|NCT04601077|Autonomic Agents|autonomic agents|mesh-ancestor
5963593|NCT04601077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5963594|NCT04601077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963595|NCT04601077|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5963596|NCT04601077|Respiratory System Agents|respiratory system agents|mesh-ancestor
5963597|NCT04601077|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5963598|NCT04601077|Antioxidants|antioxidants|mesh-ancestor
5963599|NCT04601077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963600|NCT04601077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5963601|NCT04601077|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5963602|NCT04601077|Vasodilator Agents|vasodilator agents|mesh-ancestor
5963603|NCT04601077|Gasotransmitters|gasotransmitters|mesh-ancestor
5963604|NCT04601077|Protective Agents|protective agents|mesh-ancestor
5963605|NCT04600752|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5963606|NCT04600752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5963607|NCT04600752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5963608|NCT04600752|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5963609|NCT04600752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5963610|NCT04600752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963611|NCT04601116|Atorvastatin|atorvastatin|mesh-list
5963612|NCT04601116|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5963613|NCT04601116|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5963614|NCT04601116|Antimetabolites|antimetabolites|mesh-ancestor
5963615|NCT04601116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963616|NCT04601116|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5963617|NCT04601116|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5963618|NCT04601116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5963619|NCT04600648|Insulin|insulin|mesh-list
5700085|NCT03356873|Vitamins|vitamins|mesh-list
5700086|NCT03356873|Micronutrients|micronutrients|mesh-ancestor
5700087|NCT03356873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700088|NCT03356873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5700089|NCT03356873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5700090|NCT03356860|Paclitaxel|paclitaxel|mesh-list
5700091|NCT03356860|Cyclophosphamide|cyclophosphamide|mesh-list
5700092|NCT03356860|Durvalumab|durvalumab|mesh-list
5700093|NCT03356860|Epirubicin|epirubicin|mesh-list
5700094|NCT03356860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5700095|NCT03356860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5700096|NCT03356860|Tubulin Modulators|tubulin modulators|mesh-ancestor
5700097|NCT03356860|Antimitotic Agents|antimitotic agents|mesh-ancestor
5700098|NCT03356860|Mitosis Modulators|mitosis modulators|mesh-ancestor
5700099|NCT03356860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700100|NCT03356860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5700101|NCT03356860|Immunologic Factors|immunologic factors|mesh-ancestor
5963620|NCT04600648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5963621|NCT04600648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963622|NCT04600167|Isoniazid|isoniazid|mesh-list
5963623|NCT04600167|Rifapentine|rifapentine|mesh-list
5963624|NCT04600167|Antitubercular Agents|antitubercular agents|mesh-ancestor
5963625|NCT04600167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5963626|NCT04600167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5963627|NCT04600167|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5963628|NCT04600167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5963629|NCT04600167|Antimetabolites|antimetabolites|mesh-ancestor
5963630|NCT04600167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963631|NCT04600167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5963632|NCT04600167|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5700102|NCT03356860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700103|NCT03356860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5915642|NCT05021263|GABA Agonists|gaba agonists|mesh-list
5915643|NCT05021263|GABA Agents|gaba agents|mesh-ancestor
5915644|NCT05021263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5915645|NCT05021263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5915646|NCT05021263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915647|NCT05021276|Basiliximab|basiliximab|mesh-list
5915648|NCT05021276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5915649|NCT05021276|Immunologic Factors|immunologic factors|mesh-ancestor
5915650|NCT05021276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915651|NCT05021250|Ethiodized Oil|ethiodized oil|mesh-list
5915652|NCT05021250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5915653|NCT05021315|Povidone-Iodine|povidone-iodine|mesh-list
5915654|NCT05021315|Povidone|povidone|mesh-list
5915655|NCT05021315|Plasma Substitutes|plasma substitutes|mesh-ancestor
5915656|NCT05021315|Blood Substitutes|blood substitutes|mesh-ancestor
5915657|NCT05021315|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5915658|NCT05021315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5915659|NCT05020964|Trastuzumab|trastuzumab|mesh-list
5915660|NCT05020964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5915661|NCT05020964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5915662|NCT05020860|Paclitaxel|paclitaxel|mesh-list
5915663|NCT05020860|Cyclophosphamide|cyclophosphamide|mesh-list
5915664|NCT05020860|Carboplatin|carboplatin|mesh-list
5915665|NCT05020860|Doxorubicin|doxorubicin|mesh-list
5915666|NCT05020860|Trastuzumab|trastuzumab|mesh-list
5915667|NCT05020860|Pertuzumab|pertuzumab|mesh-list
5915668|NCT05020860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5915669|NCT05020860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5915670|NCT05020860|Tubulin Modulators|tubulin modulators|mesh-ancestor
5915671|NCT05020860|Antimitotic Agents|antimitotic agents|mesh-ancestor
5915672|NCT05020860|Mitosis Modulators|mitosis modulators|mesh-ancestor
5915673|NCT05020860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5915674|NCT05020860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5915675|NCT05020860|Immunologic Factors|immunologic factors|mesh-ancestor
5915676|NCT05020860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915677|NCT05020860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5700104|NCT03356860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5700105|NCT03356860|Alkylating Agents|alkylating agents|mesh-ancestor
5700106|NCT03356860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5700107|NCT03356860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5700108|NCT03356860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5700109|NCT03356860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5700110|NCT03356860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5700111|NCT03356860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5700112|NCT03356834|Tenofovir|tenofovir|mesh-list
5700113|NCT03356834|Antiviral Agents|antiviral agents|mesh-ancestor
5700114|NCT03356834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5700115|NCT03356834|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5915678|NCT05020860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5915679|NCT05020860|Alkylating Agents|alkylating agents|mesh-ancestor
5915680|NCT05020860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5915681|NCT05020860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5915682|NCT05020860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5915683|NCT05020860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5915684|NCT05020860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5915685|NCT05020860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5915686|NCT05020821|Dexmedetomidine|dexmedetomidine|mesh-list
5915687|NCT05020821|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5915688|NCT05020821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5915689|NCT05020821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915690|NCT05020821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5915691|NCT05020821|Analgesics|analgesics|mesh-ancestor
5915692|NCT05020821|Sensory System Agents|sensory system agents|mesh-ancestor
5915693|NCT05020821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5700116|NCT03356834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5700117|NCT03356834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5700118|NCT03356834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700119|NCT03356834|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5700120|NCT03356834|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5700121|NCT03356769|Aspirin|aspirin|mesh-list
5700122|NCT03356769|Anticonvulsants|anticonvulsants|mesh-list
5700123|NCT03356769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5700124|NCT03356769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5915694|NCT05020821|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5915695|NCT05020821|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5700125|NCT03356769|Analgesics|analgesics|mesh-ancestor
5915696|NCT05020821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5915697|NCT05020821|Adrenergic Agents|adrenergic agents|mesh-ancestor
5915698|NCT05020821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5915699|NCT05020821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700126|NCT03356769|Sensory System Agents|sensory system agents|mesh-ancestor
5700127|NCT03356769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5700128|NCT03356769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700129|NCT03356769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5700130|NCT03356769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5700131|NCT03356769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5700132|NCT03356769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5700133|NCT03356769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700134|NCT03356769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5700135|NCT03356769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5700136|NCT03356769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5700137|NCT03356769|Antipyretics|antipyretics|mesh-ancestor
5700138|NCT03356756|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5700139|NCT03356756|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5700140|NCT03356756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700141|NCT03356730|Vitamin D|vitamin d|mesh-list
5700142|NCT03356730|Vitamins|vitamins|mesh-ancestor
5700143|NCT03356730|Micronutrients|micronutrients|mesh-ancestor
5915700|NCT05020704|Empagliflozin|empagliflozin|mesh-list
5915701|NCT05020704|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5915702|NCT05020704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5915703|NCT05020704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5915704|NCT05020704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915705|NCT05020483|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
5915706|NCT05020483|Coagulants|coagulants|mesh-ancestor
5915707|NCT05020782|Belimumab|belimumab|mesh-list
5915708|NCT05020782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5915709|NCT05020782|Immunologic Factors|immunologic factors|mesh-ancestor
5915710|NCT05020782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915711|NCT05020600|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5915712|NCT05020600|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5915713|NCT05020600|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5915714|NCT05020600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5915715|NCT05020600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5915716|NCT05020600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5915717|NCT05020600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915718|NCT05020600|Analgesics|analgesics|mesh-ancestor
5915719|NCT05020600|Sensory System Agents|sensory system agents|mesh-ancestor
5915720|NCT05020600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5915721|NCT05020600|Antidepressive Agents|antidepressive agents|mesh-ancestor
5915722|NCT05020600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5915723|NCT05020600|Dopamine Agents|dopamine agents|mesh-ancestor
5915724|NCT05020522|Phenobarbital|phenobarbital|mesh-list
5915725|NCT05020522|Anticonvulsants|anticonvulsants|mesh-ancestor
5915726|NCT05020522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5915727|NCT05020522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5915728|NCT05020522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915729|NCT05020522|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5915730|NCT05020522|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5915731|NCT05020522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5915732|NCT05020522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5915733|NCT05020522|GABA Modulators|gaba modulators|mesh-ancestor
5700144|NCT03356730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700145|NCT03356730|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5700146|NCT03356600|Apatinib|apatinib|mesh-list
5700147|NCT03356600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5700148|NCT03356600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5700149|NCT03356600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5700150|NCT03356600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700151|NCT03356444|Docetaxel|docetaxel|mesh-list
5700152|NCT03356444|Abiraterone Acetate|abiraterone acetate|mesh-list
5700153|NCT03356444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5700154|NCT03356444|Tubulin Modulators|tubulin modulators|mesh-ancestor
5700155|NCT03356444|Antimitotic Agents|antimitotic agents|mesh-ancestor
5700156|NCT03356444|Mitosis Modulators|mitosis modulators|mesh-ancestor
5700157|NCT03356444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700158|NCT03356444|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5700159|NCT03356444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5915734|NCT05020522|GABA Agents|gaba agents|mesh-ancestor
5700160|NCT03356444|Hormone Antagonists|hormone antagonists|mesh-ancestor
5700161|NCT03356444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5700162|NCT03356444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700163|NCT03356444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5700164|NCT03356353|Sildenafil Citrate|sildenafil citrate|mesh-list
5700165|NCT03356353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700166|NCT03356353|Vasodilator Agents|vasodilator agents|mesh-ancestor
5915735|NCT05020522|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5915736|NCT05020522|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5915737|NCT05020522|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5915738|NCT05020028|Cannabidiol|cannabidiol|mesh-list
5915739|NCT05020028|Anticonvulsants|anticonvulsants|mesh-ancestor
5915740|NCT05020184|Cimetidine|cimetidine|mesh-list
5915741|NCT05020184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5915742|NCT05020184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5915743|NCT05020184|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5915744|NCT05020184|Histamine Antagonists|histamine antagonists|mesh-ancestor
5915745|NCT05020184|Histamine Agents|histamine agents|mesh-ancestor
5915746|NCT05020184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5915747|NCT05020184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5915748|NCT05020184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915749|NCT05020184|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5915750|NCT05020184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5915751|NCT05020184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5915752|NCT05020210|Sivelestat|sivelestat|mesh-list
5915753|NCT05020210|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5915754|NCT05020210|Protease Inhibitors|protease inhibitors|mesh-ancestor
5915755|NCT05020210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5915756|NCT05020210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5915757|NCT05019755|Varespladib methyl|varespladib methyl|mesh-list
5915758|NCT05019755|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
5915759|NCT05019755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5915760|NCT05019755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5915761|NCT05019794|Infigratinib|infigratinib|mesh-list
5915762|NCT05019794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5915763|NCT05019534|Cetuximab|cetuximab|mesh-list
5915764|NCT05019534|Vemurafenib|vemurafenib|mesh-list
5915765|NCT05019534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5915766|NCT05019534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5915767|NCT05019534|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5915768|NCT05019534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5915769|NCT05019534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5915770|NCT05019586|Amoxicillin|amoxicillin|mesh-list
5915771|NCT05019586|Clarithromycin|clarithromycin|mesh-list
5915772|NCT05019586|Levofloxacin|levofloxacin|mesh-list
5915773|NCT05019586|Ofloxacin|ofloxacin|mesh-list
5915774|NCT05019586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5915775|NCT05019586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5915776|NCT05019586|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5915777|NCT05019586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5915778|NCT05019586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5915779|NCT05019586|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5915780|NCT05019586|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5915781|NCT05019586|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5915782|NCT05019586|Renal Agents|renal agents|mesh-ancestor
5915783|NCT05019586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5915784|NCT05019586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5915785|NCT05019586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5915786|NCT05019586|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5915787|NCT05019638|Ketorolac|ketorolac|mesh-list
5915788|NCT05019638|Epinephrine|epinephrine|mesh-list
5915789|NCT05019638|Racepinephrine|racepinephrine|mesh-list
5915790|NCT05019638|Morphine|morphine|mesh-list
5915791|NCT05019638|Bupivacaine|bupivacaine|mesh-list
5915792|NCT05019638|Epinephryl borate|epinephryl borate|mesh-list
5915793|NCT05019638|Anesthetics, Local|anesthetics, local|mesh-ancestor
5915794|NCT05019638|Anesthetics|anesthetics|mesh-ancestor
5915795|NCT05019638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5915796|NCT05019638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915797|NCT05019638|Sensory System Agents|sensory system agents|mesh-ancestor
5915798|NCT05019638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5915799|NCT05019638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5915800|NCT05019638|Narcotics|narcotics|mesh-ancestor
5915801|NCT05019638|Analgesics|analgesics|mesh-ancestor
5915802|NCT05019638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5915803|NCT05019638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5915804|NCT05019638|Adrenergic Agents|adrenergic agents|mesh-ancestor
5915805|NCT05019638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5915806|NCT05019638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5915807|NCT05019638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5915808|NCT05019638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5915809|NCT05019638|Autonomic Agents|autonomic agents|mesh-ancestor
5915810|NCT05019638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5915811|NCT05019638|Respiratory System Agents|respiratory system agents|mesh-ancestor
5915812|NCT05019638|Mydriatics|mydriatics|mesh-ancestor
5915813|NCT05019638|Sympathomimetics|sympathomimetics|mesh-ancestor
5915814|NCT05019638|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5915815|NCT05019638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5915816|NCT05019638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5915817|NCT05019638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5915818|NCT05019638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5915819|NCT05019638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5915820|NCT05019638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5915821|NCT05019690|Paclitaxel|paclitaxel|mesh-list
5915822|NCT05019690|Apatinib|apatinib|mesh-list
5915823|NCT05019690|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5915824|NCT05019690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5915825|NCT05019690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5915826|NCT05019690|Tubulin Modulators|tubulin modulators|mesh-ancestor
5915827|NCT05019690|Antimitotic Agents|antimitotic agents|mesh-ancestor
5915828|NCT05019690|Mitosis Modulators|mitosis modulators|mesh-ancestor
5700167|NCT03356353|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5700168|NCT03356353|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5700169|NCT03356353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5700170|NCT03356353|Urological Agents|urological agents|mesh-ancestor
5700171|NCT03356158|Cetuximab|cetuximab|mesh-list
5700172|NCT03356158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5700173|NCT03356158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5700174|NCT03356080|Cytarabine|cytarabine|mesh-list
5915829|NCT05019690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5915830|NCT05019690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5915831|NCT05019690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5915832|NCT05019703|Atezolizumab|atezolizumab|mesh-list
5915833|NCT05019703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5915834|NCT05019703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5915835|NCT05019703|Immunologic Factors|immunologic factors|mesh-ancestor
5915836|NCT05019703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915837|NCT05019716|Cisplatin|cisplatin|mesh-list
5915838|NCT05019716|Etoposide|etoposide|mesh-list
5915839|NCT05019716|Etoposide phosphate|etoposide phosphate|mesh-list
5915840|NCT05019716|Podophyllotoxin|podophyllotoxin|mesh-list
5915841|NCT05019716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5915842|NCT05019716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5915843|NCT05019716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5915844|NCT05019716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5915845|NCT05019716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5915846|NCT05019716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5915847|NCT05019716|Keratolytic Agents|keratolytic agents|mesh-ancestor
5915848|NCT05019716|Dermatologic Agents|dermatologic agents|mesh-ancestor
5915849|NCT05019716|Tubulin Modulators|tubulin modulators|mesh-ancestor
5915850|NCT05019716|Antimitotic Agents|antimitotic agents|mesh-ancestor
5915851|NCT05019716|Mitosis Modulators|mitosis modulators|mesh-ancestor
5915852|NCT05019222|Anesthetics|anesthetics|mesh-list
5915853|NCT05019222|Sevoflurane|sevoflurane|mesh-list
5915854|NCT05019222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5915855|NCT05019222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915856|NCT05019222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5915857|NCT05019222|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5915858|NCT05019222|Anesthetics, General|anesthetics, general|mesh-ancestor
5963633|NCT04600167|Leprostatic Agents|leprostatic agents|mesh-ancestor
5963634|NCT04600362|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5963635|NCT04600362|Immunologic Factors|immunologic factors|mesh-ancestor
5963636|NCT04600362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963637|NCT04600427|Anesthetics|anesthetics|mesh-list
5963638|NCT04600427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5963639|NCT04600427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963640|NCT04600271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
5963641|NCT04600271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
5963642|NCT04600271|Norepinephrine|norepinephrine|mesh-list
5963643|NCT04600271|Analgesics|analgesics|mesh-list
5963644|NCT04600271|Diuretics|diuretics|mesh-list
5963645|NCT04600271|Sensory System Agents|sensory system agents|mesh-ancestor
5915859|NCT05019417|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
5915860|NCT05019417|Glycerol|glycerol|mesh-list
5915861|NCT05019417|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
5700175|NCT03356080|Decitabine|decitabine|mesh-list
5700176|NCT03356080|Tretinoin|tretinoin|mesh-list
5700177|NCT03356080|Immunologic Factors|immunologic factors|mesh-ancestor
5915862|NCT05019417|Protective Agents|protective agents|mesh-ancestor
5915863|NCT05019417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915864|NCT05019417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5915865|NCT05018923|Metronidazole|metronidazole|mesh-list
5915866|NCT05018923|Doxycycline|doxycycline|mesh-list
5915867|NCT05018923|Tetracycline|tetracycline|mesh-list
5915868|NCT05018923|Potassium Citrate|potassium citrate|mesh-list
5915869|NCT05018923|Rabeprazole|rabeprazole|mesh-list
5915870|NCT05018923|Bismuth|bismuth|mesh-list
5915871|NCT05018923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5915872|NCT05018923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5915873|NCT05018923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5915874|NCT05018923|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5915875|NCT05018923|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5915876|NCT05018923|Antimalarials|antimalarials|mesh-ancestor
5915877|NCT05018923|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5915878|NCT05018923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5915879|NCT05018923|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5915880|NCT05018923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5915881|NCT05018923|Antacids|antacids|mesh-ancestor
5915882|NCT05018923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5915883|NCT05018923|Diuretics|diuretics|mesh-ancestor
5915884|NCT05018923|Natriuretic Agents|natriuretic agents|mesh-ancestor
5915885|NCT05018923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915886|NCT05018923|Expectorants|expectorants|mesh-ancestor
5915887|NCT05018923|Respiratory System Agents|respiratory system agents|mesh-ancestor
5915888|NCT05019326|Andrographolide|andrographolide|mesh-list
5915889|NCT05019326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5915890|NCT05019326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5915891|NCT05019326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5915892|NCT05019326|Analgesics|analgesics|mesh-ancestor
5915893|NCT05019326|Sensory System Agents|sensory system agents|mesh-ancestor
5915894|NCT05019326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5915895|NCT05019326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915896|NCT05019326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5915897|NCT05019326|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5915898|NCT05019326|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5915899|NCT05019326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5915900|NCT05019326|Antiviral Agents|antiviral agents|mesh-ancestor
5915901|NCT05019326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5700178|NCT03356080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700179|NCT03356080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5700180|NCT03356080|Antimetabolites|antimetabolites|mesh-ancestor
5700181|NCT03356080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700182|NCT03356080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5700183|NCT03356080|Antiviral Agents|antiviral agents|mesh-ancestor
5700184|NCT03356080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5915902|NCT05018988|Vitamin D|vitamin d|mesh-list
5915903|NCT05018988|Ergocalciferols|ergocalciferols|mesh-list
5915904|NCT05018988|Vitamins|vitamins|mesh-list
5915905|NCT05018988|Micronutrients|micronutrients|mesh-ancestor
5915906|NCT05018988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915907|NCT05018988|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5915908|NCT05018988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5915909|NCT05018962|Paclitaxel|paclitaxel|mesh-list
5915910|NCT05018962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5915911|NCT05018962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5915912|NCT05018962|Tubulin Modulators|tubulin modulators|mesh-ancestor
5915913|NCT05018962|Antimitotic Agents|antimitotic agents|mesh-ancestor
5915914|NCT05018962|Mitosis Modulators|mitosis modulators|mesh-ancestor
5915915|NCT05018962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5915916|NCT05018520|Prednisone|prednisone|mesh-list
5915917|NCT05018520|Rituximab|rituximab|mesh-list
5915918|NCT05018520|Cyclophosphamide|cyclophosphamide|mesh-list
5700185|NCT03356080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5915919|NCT05018520|Vincristine|vincristine|mesh-list
5915920|NCT05018520|Doxorubicin|doxorubicin|mesh-list
5915921|NCT05018520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5915922|NCT05018520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5915923|NCT05018520|Immunologic Factors|immunologic factors|mesh-ancestor
5915924|NCT05018520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915925|NCT05018520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5915926|NCT05018520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5915927|NCT05018520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5915928|NCT05018520|Alkylating Agents|alkylating agents|mesh-ancestor
5700186|NCT03356080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5700187|NCT03356080|Keratolytic Agents|keratolytic agents|mesh-ancestor
5700188|NCT03356080|Dermatologic Agents|dermatologic agents|mesh-ancestor
5700189|NCT03356054|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5700190|NCT03356054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5700191|NCT03356054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5700192|NCT03355976|Nivolumab|nivolumab|mesh-list
5700193|NCT03355976|Ipilimumab|ipilimumab|mesh-list
5700194|NCT03355976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5700195|NCT03355976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5700196|NCT03355976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5700197|NCT03355976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700198|NCT03355963|Botulinum Toxins|botulinum toxins|mesh-list
5700199|NCT03355963|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5915929|NCT05018520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5915930|NCT05018520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5915931|NCT05018520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5700200|NCT03355963|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5700201|NCT03355963|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5700202|NCT03355963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5700203|NCT03355963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700204|NCT03355963|Cholinergic Agents|cholinergic agents|mesh-ancestor
5700205|NCT03355963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5700206|NCT03355963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700207|NCT03355963|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5700208|NCT03355963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5700209|NCT03355794|Everolimus|everolimus|mesh-list
5700210|NCT03355794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5700211|NCT03355794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5700212|NCT03355794|Immunologic Factors|immunologic factors|mesh-ancestor
5700213|NCT03355794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700214|NCT03355768|Romidepsin|romidepsin|mesh-list
5700215|NCT03355768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5700216|NCT03355768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5700217|NCT03355716|Fentanyl|fentanyl|mesh-list
5915932|NCT05018520|Glucocorticoids|glucocorticoids|mesh-ancestor
5915933|NCT05018520|Hormones|hormones|mesh-ancestor
5915934|NCT05018520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5915935|NCT05018520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5915936|NCT05018520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5915937|NCT05018520|Tubulin Modulators|tubulin modulators|mesh-ancestor
5915938|NCT05018520|Antimitotic Agents|antimitotic agents|mesh-ancestor
5915939|NCT05018520|Mitosis Modulators|mitosis modulators|mesh-ancestor
5915940|NCT05018520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5915941|NCT05018520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5915942|NCT05018520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5915943|NCT05018520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5915944|NCT05018637|Teriparatide|teriparatide|mesh-list
5915945|NCT05018637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5915946|NCT05018637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915947|NCT05018637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5915948|NCT05018585|Cholecalciferol|cholecalciferol|mesh-list
5915949|NCT05018585|Aluminum Hydroxide|aluminum hydroxide|mesh-list
5915950|NCT05018585|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5915951|NCT05018585|Immunologic Factors|immunologic factors|mesh-ancestor
5915952|NCT05018585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915953|NCT05018585|Antacids|antacids|mesh-ancestor
5915954|NCT05018585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5915955|NCT05018585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5915956|NCT05018585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5915957|NCT05018585|Vitamins|vitamins|mesh-ancestor
5915958|NCT05018585|Micronutrients|micronutrients|mesh-ancestor
5915959|NCT05018585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5915960|NCT05018364|Epoetin Alfa|epoetin alfa|mesh-list
5915961|NCT05018364|Hematinics|hematinics|mesh-ancestor
5915962|NCT05018182|Leucovorin|leucovorin|mesh-list
5915963|NCT05018182|Folic Acid|folic acid|mesh-list
5915964|NCT05018182|Fluorouracil|fluorouracil|mesh-list
5915965|NCT05018182|Capecitabine|capecitabine|mesh-list
5915966|NCT05018182|Oxaliplatin|oxaliplatin|mesh-list
5700218|NCT03355716|Morphine|morphine|mesh-list
5700219|NCT03355716|Ketamine|ketamine|mesh-list
5915967|NCT05018182|Irinotecan|irinotecan|mesh-list
5915968|NCT05018182|Levoleucovorin|levoleucovorin|mesh-list
5915969|NCT05018182|Antimetabolites|antimetabolites|mesh-ancestor
5915970|NCT05018182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5915971|NCT05018182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5915972|NCT05018182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5915973|NCT05018182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5915974|NCT05018182|Immunologic Factors|immunologic factors|mesh-ancestor
5915975|NCT05018182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5915976|NCT05018182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5915977|NCT05018182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5915978|NCT05018182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5915979|NCT05018182|Antidotes|antidotes|mesh-ancestor
5915980|NCT05018182|Protective Agents|protective agents|mesh-ancestor
5915981|NCT05018182|Vitamin B Complex|vitamin b complex|mesh-ancestor
5915982|NCT05018182|Vitamins|vitamins|mesh-ancestor
5700220|NCT03355716|Bupivacaine|bupivacaine|mesh-list
5700221|NCT03355716|Anesthetics, Local|anesthetics, local|mesh-ancestor
5700222|NCT03355716|Anesthetics|anesthetics|mesh-ancestor
5700223|NCT03355716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5700224|NCT03355716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700225|NCT03355716|Sensory System Agents|sensory system agents|mesh-ancestor
5700226|NCT03355716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5700227|NCT03355716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5700228|NCT03355716|Narcotics|narcotics|mesh-ancestor
5700229|NCT03355716|Analgesics|analgesics|mesh-ancestor
5700230|NCT03355716|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5700231|NCT03355716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5700232|NCT03355716|Anesthetics, General|anesthetics, general|mesh-ancestor
5700233|NCT03355716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5700234|NCT03355716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5700235|NCT03355716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5700236|NCT03355716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700237|NCT03355716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5720855|NCT03210038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5915983|NCT05018182|Micronutrients|micronutrients|mesh-ancestor
5915984|NCT05018182|Hematinics|hematinics|mesh-ancestor
5915985|NCT05017987|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
5915986|NCT05017987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5915987|NCT05017987|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5915988|NCT05017987|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5915989|NCT05017987|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5915990|NCT05017766|Anti-Infective Agents|anti-infective agents|mesh-list
5915991|NCT05017766|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5915992|NCT05017454|Mometasone Furoate|mometasone furoate|mesh-list
5915993|NCT05017454|Valproic Acid|valproic acid|mesh-list
5915994|NCT05017454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5915995|NCT05017454|Dermatologic Agents|dermatologic agents|mesh-ancestor
5915996|NCT05017454|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5915997|NCT05017454|Anticonvulsants|anticonvulsants|mesh-ancestor
5915998|NCT05017454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5915999|NCT05017454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916000|NCT05017454|GABA Agents|gaba agents|mesh-ancestor
5916001|NCT05017454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5916002|NCT05017454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916003|NCT05017454|Antimanic Agents|antimanic agents|mesh-ancestor
5916004|NCT05017454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5916005|NCT05017454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5916006|NCT05017454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5916007|NCT05017311|Citalopram|citalopram|mesh-list
5720856|NCT03210038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720857|NCT03210038|Sensory System Agents|sensory system agents|mesh-ancestor
5720858|NCT03210038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5720859|NCT03210038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5720860|NCT03210038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5720861|NCT03210038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5720862|NCT03210038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5720863|NCT03210038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5720864|NCT03209908|Tenofovir|tenofovir|mesh-list
5720865|NCT03209908|Antiviral Agents|antiviral agents|mesh-ancestor
5720866|NCT03209908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5720867|NCT03209908|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5720868|NCT03209908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5916008|NCT05017311|Brexpiprazole|brexpiprazole|mesh-list
5916009|NCT05017311|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5916010|NCT05017311|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5916011|NCT05017311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5916012|NCT05017311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916013|NCT05017311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5916014|NCT05017311|Serotonin Agents|serotonin agents|mesh-ancestor
5916015|NCT05017311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916016|NCT05017311|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5916017|NCT05017311|Antidepressive Agents|antidepressive agents|mesh-ancestor
5916018|NCT05017311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5916019|NCT05017311|Dopamine Agonists|dopamine agonists|mesh-ancestor
5916020|NCT05017311|Dopamine Agents|dopamine agents|mesh-ancestor
5963646|NCT04600271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5963647|NCT04600271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963648|NCT04600271|Natriuretic Agents|natriuretic agents|mesh-ancestor
5963649|NCT04600271|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5963650|NCT04600271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5963651|NCT04600271|Adrenergic Agents|adrenergic agents|mesh-ancestor
5963652|NCT04600271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5963653|NCT04600271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963654|NCT04600271|Sympathomimetics|sympathomimetics|mesh-ancestor
5963655|NCT04600271|Autonomic Agents|autonomic agents|mesh-ancestor
5963656|NCT04600271|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5963657|NCT04600271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5963658|NCT04600271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5963659|NCT04600141|Heparin|heparin|mesh-list
5963660|NCT04600141|Calcium heparin|calcium heparin|mesh-list
5963661|NCT04600141|Anticoagulants|anticoagulants|mesh-ancestor
5963662|NCT04600141|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5963663|NCT04600141|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5963664|NCT04600141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963665|NCT04600089|Ketamine|ketamine|mesh-list
5963666|NCT04600089|Analgesics|analgesics|mesh-ancestor
5963667|NCT04600089|Sensory System Agents|sensory system agents|mesh-ancestor
5963668|NCT04600089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5963669|NCT04600089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963670|NCT04600089|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5963671|NCT04600089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5963672|NCT04600089|Anesthetics, General|anesthetics, general|mesh-ancestor
5963673|NCT04600089|Anesthetics|anesthetics|mesh-ancestor
5963674|NCT04600089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5963675|NCT04600089|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5963676|NCT04600089|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5963677|NCT04600089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5963678|NCT04600089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963679|NCT04600414|Analgesics, Opioid|analgesics, opioid|mesh-list
5963680|NCT04600414|Narcotics|narcotics|mesh-ancestor
5963681|NCT04600414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5963682|NCT04600414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963683|NCT04600414|Analgesics|analgesics|mesh-ancestor
5963684|NCT04600414|Sensory System Agents|sensory system agents|mesh-ancestor
5963685|NCT04600414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5963686|NCT04599959|Hydrocortisone|hydrocortisone|mesh-list
5963687|NCT04599959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5970525|NCT04534153|Terfenadine|terfenadine|mesh-list
5970526|NCT04534153|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5970527|NCT04534153|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5970528|NCT04534153|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5970529|NCT04534153|Histamine Antagonists|histamine antagonists|mesh-ancestor
5970530|NCT04534153|Histamine Agents|histamine agents|mesh-ancestor
5970531|NCT04534153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5970532|NCT04534153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970533|NCT04534153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970534|NCT04534257|Sirolimus|sirolimus|mesh-list
5970535|NCT04534257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5970536|NCT04534257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5970537|NCT04534257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5970538|NCT04534257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5700238|NCT03355638|Pyranoprofen|pyranoprofen|mesh-list
5700239|NCT03355638|Aflibercept|aflibercept|mesh-list
5700240|NCT03355638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5700241|NCT03355638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5700242|NCT03355638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5700243|NCT03355638|Growth Substances|growth substances|mesh-ancestor
5700244|NCT03355638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700245|NCT03355638|Growth Inhibitors|growth inhibitors|mesh-ancestor
5700246|NCT03355638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5916021|NCT05017428|Niacinamide|niacinamide|mesh-list
5916022|NCT05017428|Niacin|niacin|mesh-list
5916023|NCT05017428|Nicotinic Acids|nicotinic acids|mesh-list
5916024|NCT05017428|Vitamin B Complex|vitamin b complex|mesh-ancestor
5916025|NCT05017428|Vitamins|vitamins|mesh-ancestor
5916026|NCT05017428|Micronutrients|micronutrients|mesh-ancestor
5916027|NCT05017428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916028|NCT05017428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5916029|NCT05017428|Antimetabolites|antimetabolites|mesh-ancestor
5916030|NCT05017428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916031|NCT05017428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5916032|NCT05017428|Vasodilator Agents|vasodilator agents|mesh-ancestor
5916033|NCT05017272|Analgesics, Opioid|analgesics, opioid|mesh-list
5916034|NCT05017272|Narcotics|narcotics|mesh-ancestor
5916035|NCT05017272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5916036|NCT05017272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916037|NCT05017272|Analgesics|analgesics|mesh-ancestor
5916038|NCT05017272|Sensory System Agents|sensory system agents|mesh-ancestor
5916039|NCT05017272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5916040|NCT05017103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5916041|NCT05017103|Antibodies|antibodies|mesh-list
5916042|NCT05017103|Immunoglobulins|immunoglobulins|mesh-list
5916043|NCT05017103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5916044|NCT05017103|Immunologic Factors|immunologic factors|mesh-ancestor
5916045|NCT05017103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916046|NCT05017103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5916047|NCT05017155|Mexiletine|mexiletine|mesh-list
5700247|NCT03355638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5700248|NCT03355638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5700249|NCT03355638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5700250|NCT03355638|Analgesics|analgesics|mesh-ancestor
5700251|NCT03355638|Sensory System Agents|sensory system agents|mesh-ancestor
5700252|NCT03355638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5700253|NCT03355638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5700254|NCT03355638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5700255|NCT03355638|Gout Suppressants|gout suppressants|mesh-ancestor
5700256|NCT03355612|Capecitabine|capecitabine|mesh-list
5700257|NCT03355612|Oxaliplatin|oxaliplatin|mesh-list
5700258|NCT03355612|Apatinib|apatinib|mesh-list
5700259|NCT03355612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5700260|NCT03355612|Antimetabolites|antimetabolites|mesh-ancestor
5916048|NCT05017155|Lamotrigine|lamotrigine|mesh-list
5916049|NCT05017155|Anticonvulsants|anticonvulsants|mesh-ancestor
5916050|NCT05017155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5916051|NCT05017155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5916052|NCT05017155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916053|NCT05017155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5916054|NCT05017155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916055|NCT05017155|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5916056|NCT05017155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5916057|NCT05017155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5916058|NCT05017155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5916059|NCT05017155|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5916060|NCT05017155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5916061|NCT05017155|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5916062|NCT05017116|Entecavir|entecavir|mesh-list
5916063|NCT05017116|Antiviral Agents|antiviral agents|mesh-ancestor
5916064|NCT05017116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5700261|NCT03355612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700262|NCT03355612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5700263|NCT03355612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5700264|NCT03355612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5700265|NCT03355560|Nivolumab|nivolumab|mesh-list
5700266|NCT03355560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5700267|NCT03355560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5700268|NCT03355560|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5700269|NCT03355560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700270|NCT03355534|Dexmedetomidine|dexmedetomidine|mesh-list
5700271|NCT03355534|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5700272|NCT03355534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5700273|NCT03355534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916065|NCT05017194|Emodepside|emodepside|mesh-list
5916066|NCT05017194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5916067|NCT05017194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5916068|NCT05016609|Sofosbuvir|sofosbuvir|mesh-list
5916069|NCT05016609|Velpatasvir|velpatasvir|mesh-list
5916070|NCT05016609|Antibodies|antibodies|mesh-list
5916071|NCT05016609|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
5916072|NCT05016609|Immunologic Factors|immunologic factors|mesh-ancestor
5916073|NCT05016609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916074|NCT05016609|Antiviral Agents|antiviral agents|mesh-ancestor
5916075|NCT05016609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5916076|NCT05016869|Capecitabine|capecitabine|mesh-list
5916077|NCT05016869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5916078|NCT05016869|Antimetabolites|antimetabolites|mesh-ancestor
5916079|NCT05016869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916080|NCT05016869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5916081|NCT05016713|Chlorhexidine|chlorhexidine|mesh-list
5916082|NCT05016713|Fluorides|fluorides|mesh-list
5916083|NCT05016713|Cariostatic Agents|cariostatic agents|mesh-ancestor
5916084|NCT05016713|Protective Agents|protective agents|mesh-ancestor
5700274|NCT03355534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5700275|NCT03355534|Analgesics|analgesics|mesh-ancestor
5916085|NCT05016713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916086|NCT05016713|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5916087|NCT05016713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5916088|NCT05016713|Disinfectants|disinfectants|mesh-ancestor
5916089|NCT05016128|Ketamine|ketamine|mesh-list
5916090|NCT05016128|Esketamine|esketamine|mesh-list
5916091|NCT05016128|Analgesics|analgesics|mesh-ancestor
5916092|NCT05016128|Sensory System Agents|sensory system agents|mesh-ancestor
5916093|NCT05016128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5916094|NCT05016128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916095|NCT05016128|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5916096|NCT05016128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5916097|NCT05016128|Anesthetics, General|anesthetics, general|mesh-ancestor
5916098|NCT05016128|Anesthetics|anesthetics|mesh-ancestor
5916099|NCT05016128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5916100|NCT05016128|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5916101|NCT05016128|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5916102|NCT05016128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5916103|NCT05016128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916104|NCT05016128|Antidepressive Agents|antidepressive agents|mesh-ancestor
5916105|NCT05016128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5916106|NCT05016206|Moxifloxacin|moxifloxacin|mesh-list
5916107|NCT05016206|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
5916108|NCT05016206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5916109|NCT05016206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5916110|NCT05016206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5916111|NCT05016206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5916112|NCT05016206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5916113|NCT05016206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916114|NCT05016206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5916115|NCT05016206|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5916116|NCT05016206|Contraceptive Agents|contraceptive agents|mesh-ancestor
5916117|NCT05016206|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5916118|NCT05016206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916119|NCT05016206|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5916120|NCT05016206|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5916121|NCT05016206|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5916122|NCT05016297|Hydroxychloroquine|hydroxychloroquine|mesh-list
5916123|NCT05016297|Antimalarials|antimalarials|mesh-ancestor
5916124|NCT05016297|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5916125|NCT05016297|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5916126|NCT05016297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5916127|NCT05016297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5700276|NCT03355534|Sensory System Agents|sensory system agents|mesh-ancestor
5700277|NCT03355534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5700278|NCT03355534|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5700279|NCT03355534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5700280|NCT03355534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5700281|NCT03355534|Adrenergic Agents|adrenergic agents|mesh-ancestor
5700282|NCT03355534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5700283|NCT03355534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700284|NCT03355482|Methylprednisolone|methylprednisolone|mesh-list
5700285|NCT03355482|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5700286|NCT03355482|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5700287|NCT03355482|Prednisolone|prednisolone|mesh-list
5700288|NCT03355482|Prednisolone acetate|prednisolone acetate|mesh-list
5700289|NCT03355482|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5700290|NCT03355482|Prednisolone phosphate|prednisolone phosphate|mesh-list
5916128|NCT05016297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916129|NCT05016297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5916130|NCT05016440|Lisinopril|lisinopril|mesh-list
5916131|NCT05016440|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5916132|NCT05016440|Protease Inhibitors|protease inhibitors|mesh-ancestor
5916133|NCT05016440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5916134|NCT05016440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916135|NCT05016440|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5700291|NCT03355482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5700292|NCT03355482|Antiemetics|antiemetics|mesh-ancestor
5700293|NCT03355482|Autonomic Agents|autonomic agents|mesh-ancestor
5700294|NCT03355482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5700295|NCT03355482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700296|NCT03355482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5700297|NCT03355482|Glucocorticoids|glucocorticoids|mesh-ancestor
5700298|NCT03355482|Hormones|hormones|mesh-ancestor
5700299|NCT03355482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5700300|NCT03355482|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5700301|NCT03355482|Protective Agents|protective agents|mesh-ancestor
5700302|NCT03355482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5700303|NCT03355482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5916136|NCT05016440|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5916137|NCT05016440|Protective Agents|protective agents|mesh-ancestor
5916138|NCT05016440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916139|NCT05016349|Tamoxifen|tamoxifen|mesh-list
5916140|NCT05016349|Tocopherols|tocopherols|mesh-list
5916141|NCT05016349|Tretinoin|tretinoin|mesh-list
5916142|NCT05016349|Alitretinoin|alitretinoin|mesh-list
5916143|NCT05016349|Cannabidiol|cannabidiol|mesh-list
5916144|NCT05016349|Isotretinoin|isotretinoin|mesh-list
5916145|NCT05016349|Mifepristone|mifepristone|mesh-list
5916146|NCT05016349|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5916147|NCT05016349|Hormone Antagonists|hormone antagonists|mesh-ancestor
5916148|NCT05016349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5916149|NCT05016349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916150|NCT05016349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5916151|NCT05016349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5916152|NCT05016349|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5916153|NCT05016349|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5916154|NCT05016349|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5916155|NCT05016349|Anticonvulsants|anticonvulsants|mesh-ancestor
5916156|NCT05016349|Keratolytic Agents|keratolytic agents|mesh-ancestor
5916157|NCT05016349|Dermatologic Agents|dermatologic agents|mesh-ancestor
5916158|NCT05016349|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5916159|NCT05016349|Abortifacient Agents|abortifacient agents|mesh-ancestor
5916160|NCT05016349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5916161|NCT05016349|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5916162|NCT05016349|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5916163|NCT05016349|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5916164|NCT05016349|Contraceptive Agents|contraceptive agents|mesh-ancestor
5916165|NCT05016349|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5916166|NCT05016349|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5916167|NCT05016349|Luteolytic Agents|luteolytic agents|mesh-ancestor
5916168|NCT05016349|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5916169|NCT05016349|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5916170|NCT05016349|Antioxidants|antioxidants|mesh-ancestor
5916171|NCT05016349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916172|NCT05016349|Protective Agents|protective agents|mesh-ancestor
5916173|NCT05016349|Vitamins|vitamins|mesh-ancestor
5916174|NCT05016349|Micronutrients|micronutrients|mesh-ancestor
5916175|NCT05016180|Ropivacaine|ropivacaine|mesh-list
5916176|NCT05016180|Anesthetics, Local|anesthetics, local|mesh-ancestor
5916177|NCT05016180|Anesthetics|anesthetics|mesh-ancestor
5916178|NCT05016180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5916179|NCT05016180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916180|NCT05016180|Sensory System Agents|sensory system agents|mesh-ancestor
5916181|NCT05016180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5916182|NCT05016063|Fludarabine|fludarabine|mesh-list
5916183|NCT05016063|Cyclophosphamide|cyclophosphamide|mesh-list
5916184|NCT05016063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5916185|NCT05016063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916186|NCT05016063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5916187|NCT05016063|Immunologic Factors|immunologic factors|mesh-ancestor
5916188|NCT05016063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700304|NCT03355469|Metformin|metformin|mesh-list
5916189|NCT05016063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5916190|NCT05016063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5916191|NCT05016063|Alkylating Agents|alkylating agents|mesh-ancestor
5916192|NCT05016063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5916193|NCT05016076|Dexamethasone|dexamethasone|mesh-list
5916194|NCT05016076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5916195|NCT05016076|Antiemetics|antiemetics|mesh-ancestor
5916196|NCT05016076|Autonomic Agents|autonomic agents|mesh-ancestor
5916197|NCT05016076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5916198|NCT05016076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916199|NCT05016076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5916200|NCT05016076|Glucocorticoids|glucocorticoids|mesh-ancestor
5916201|NCT05016076|Hormones|hormones|mesh-ancestor
5916202|NCT05016076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5916203|NCT05016076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5916204|NCT05016076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5916205|NCT05016518|Propofol|propofol|mesh-list
5916206|NCT05016518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5916207|NCT05016518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5916208|NCT05016518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916209|NCT05016518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5916210|NCT05016518|Anesthetics, General|anesthetics, general|mesh-ancestor
5916211|NCT05016518|Anesthetics|anesthetics|mesh-ancestor
5916212|NCT05015907|Ropivacaine|ropivacaine|mesh-list
5916213|NCT05015907|Anesthetics, Local|anesthetics, local|mesh-ancestor
5916214|NCT05015907|Anesthetics|anesthetics|mesh-ancestor
5916215|NCT05015907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5916216|NCT05015907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916217|NCT05015907|Sensory System Agents|sensory system agents|mesh-ancestor
5916218|NCT05015907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5916219|NCT05015595|Memantine|memantine|mesh-list
5916220|NCT05015595|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5916221|NCT05015595|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5700305|NCT03355469|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5700306|NCT03355469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700307|NCT03355352|Sufentanil|sufentanil|mesh-list
5700308|NCT03355352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5700309|NCT03355352|Narcotics|narcotics|mesh-ancestor
5700310|NCT03355352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5700311|NCT03355352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700312|NCT03355352|Analgesics|analgesics|mesh-ancestor
5700313|NCT03355352|Sensory System Agents|sensory system agents|mesh-ancestor
5700314|NCT03355352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5700315|NCT03355352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5700316|NCT03355352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5700317|NCT03355352|Anesthetics, General|anesthetics, general|mesh-ancestor
5700318|NCT03355352|Anesthetics|anesthetics|mesh-ancestor
5700319|NCT03355300|Cannabidiol|cannabidiol|mesh-list
5700320|NCT03355300|Anticonvulsants|anticonvulsants|mesh-ancestor
5916222|NCT05015595|Dopamine Agents|dopamine agents|mesh-ancestor
5916223|NCT05015595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5916224|NCT05015595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916225|NCT05015595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916226|NCT05015595|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5916227|NCT05015595|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5916228|NCT05015621|Leucovorin|leucovorin|mesh-list
5916229|NCT05015621|Fluorouracil|fluorouracil|mesh-list
5700321|NCT03355248|Acetaminophen|acetaminophen|mesh-list
5700322|NCT03355248|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
5700323|NCT03355248|Oxycodone|oxycodone|mesh-list
5700324|NCT03355248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5700325|NCT03355248|Analgesics|analgesics|mesh-ancestor
5916230|NCT05015621|Irinotecan|irinotecan|mesh-list
5916231|NCT05015621|Calcium|calcium|mesh-list
5916232|NCT05015621|Levoleucovorin|levoleucovorin|mesh-list
5916233|NCT05015621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5916234|NCT05015621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916235|NCT05015621|Antimetabolites|antimetabolites|mesh-ancestor
5916236|NCT05015621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916237|NCT05015621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5916238|NCT05015621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5916239|NCT05015621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5916240|NCT05015621|Immunologic Factors|immunologic factors|mesh-ancestor
5916241|NCT05015621|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5700326|NCT03355248|Sensory System Agents|sensory system agents|mesh-ancestor
5916242|NCT05015621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5916243|NCT05015621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5700327|NCT03355248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5916244|NCT05015621|Antidotes|antidotes|mesh-ancestor
5916245|NCT05015621|Protective Agents|protective agents|mesh-ancestor
5916246|NCT05015621|Vitamin B Complex|vitamin b complex|mesh-ancestor
5916247|NCT05015621|Vitamins|vitamins|mesh-ancestor
5916248|NCT05015621|Micronutrients|micronutrients|mesh-ancestor
5916249|NCT05015829|Dobutamine|dobutamine|mesh-list
5916250|NCT05015829|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5916251|NCT05015829|Sympathomimetics|sympathomimetics|mesh-ancestor
5916252|NCT05015829|Autonomic Agents|autonomic agents|mesh-ancestor
5916253|NCT05015829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5916254|NCT05015829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916255|NCT05015829|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5916256|NCT05015829|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5916257|NCT05015829|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5916258|NCT05015829|Adrenergic Agents|adrenergic agents|mesh-ancestor
5916259|NCT05015829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5916260|NCT05015829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916261|NCT05015829|Protective Agents|protective agents|mesh-ancestor
5963688|NCT04600115|Adenosine|adenosine|mesh-list
5700328|NCT03355248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700329|NCT03355248|Antipyretics|antipyretics|mesh-ancestor
5700330|NCT03355248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5700331|NCT03355248|Narcotics|narcotics|mesh-ancestor
5700332|NCT03355248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5700333|NCT03355248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5700334|NCT03355248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5700335|NCT03355248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5700336|NCT03355170|Domperidone|domperidone|mesh-list
5700337|NCT03355170|Lansoprazole|lansoprazole|mesh-list
5700338|NCT03355170|Dexlansoprazole|dexlansoprazole|mesh-list
5963689|NCT04600115|Regadenoson|regadenoson|mesh-list
5963690|NCT04600115|Analgesics|analgesics|mesh-ancestor
5963691|NCT04600115|Sensory System Agents|sensory system agents|mesh-ancestor
5963692|NCT04600115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5963693|NCT04600115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963694|NCT04600115|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5963695|NCT04600115|Vasodilator Agents|vasodilator agents|mesh-ancestor
5963696|NCT04600115|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5963697|NCT04600115|Purinergic Agonists|purinergic agonists|mesh-ancestor
5963698|NCT04600115|Purinergic Agents|purinergic agents|mesh-ancestor
5963699|NCT04600115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5963700|NCT04600115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963701|NCT04600115|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
5963702|NCT04600492|Riociguat|riociguat|mesh-list
5963703|NCT04600492|Enzyme Activators|enzyme activators|mesh-ancestor
5963704|NCT04600492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963705|NCT04600037|Pregabalin|pregabalin|mesh-list
5963706|NCT04600037|Analgesics|analgesics|mesh-ancestor
5963707|NCT04600037|Sensory System Agents|sensory system agents|mesh-ancestor
5963708|NCT04600037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5963709|NCT04600037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963710|NCT04600037|Anticonvulsants|anticonvulsants|mesh-ancestor
5963711|NCT04600037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5963712|NCT04600037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5963713|NCT04600037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963714|NCT04600037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5963715|NCT04600037|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5963716|NCT04600037|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5963717|NCT04600037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5963718|NCT04600037|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5963719|NCT04599894|Pregabalin|pregabalin|mesh-list
5963720|NCT04599894|Analgesics|analgesics|mesh-ancestor
5963721|NCT04599894|Sensory System Agents|sensory system agents|mesh-ancestor
5963722|NCT04599894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5963723|NCT04599894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963724|NCT04599894|Anticonvulsants|anticonvulsants|mesh-ancestor
5700339|NCT03355170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5700340|NCT03355170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5700341|NCT03355170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5700342|NCT03355170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5700343|NCT03355170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700344|NCT03355170|Antiemetics|antiemetics|mesh-ancestor
5700345|NCT03355170|Autonomic Agents|autonomic agents|mesh-ancestor
5963725|NCT04599894|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5963726|NCT04599894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5916262|NCT05015361|Propofol|propofol|mesh-list
5916263|NCT05015361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5916264|NCT05015361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5916265|NCT05015361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700346|NCT03355170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5700347|NCT03355170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700348|NCT03355170|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5700349|NCT03355170|Dopamine Agents|dopamine agents|mesh-ancestor
5916266|NCT05015361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5916267|NCT05015361|Anesthetics, General|anesthetics, general|mesh-ancestor
5916268|NCT05015361|Anesthetics|anesthetics|mesh-ancestor
5916269|NCT05015322|Methylprednisolone|methylprednisolone|mesh-list
5916270|NCT05015322|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5916271|NCT05015322|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5916272|NCT05015322|Prednisolone|prednisolone|mesh-list
5916273|NCT05015322|Prednisolone acetate|prednisolone acetate|mesh-list
5916274|NCT05015322|Bupivacaine|bupivacaine|mesh-list
5916275|NCT05015322|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5916276|NCT05015322|Prednisolone phosphate|prednisolone phosphate|mesh-list
5916277|NCT05015322|Anesthetics, Local|anesthetics, local|mesh-ancestor
5916278|NCT05015322|Anesthetics|anesthetics|mesh-ancestor
5916279|NCT05015322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5916280|NCT05015322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916281|NCT05015322|Sensory System Agents|sensory system agents|mesh-ancestor
5916282|NCT05015322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5916283|NCT05015322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5700350|NCT03355170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5700351|NCT03355118|Anesthetics|anesthetics|mesh-list
5700352|NCT03355118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5700353|NCT03355118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700354|NCT03355053|Dexmedetomidine|dexmedetomidine|mesh-list
5700355|NCT03355053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5700356|NCT03355053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5700357|NCT03355053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700358|NCT03355053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5700359|NCT03355053|Analgesics|analgesics|mesh-ancestor
5700360|NCT03355053|Sensory System Agents|sensory system agents|mesh-ancestor
5700361|NCT03355053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5916284|NCT05015322|Antiemetics|antiemetics|mesh-ancestor
5916285|NCT05015322|Autonomic Agents|autonomic agents|mesh-ancestor
5916286|NCT05015322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5916287|NCT05015322|Glucocorticoids|glucocorticoids|mesh-ancestor
5916288|NCT05015322|Hormones|hormones|mesh-ancestor
5916289|NCT05015322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5916290|NCT05015322|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5916291|NCT05015322|Protective Agents|protective agents|mesh-ancestor
5916292|NCT05015322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5916293|NCT05015322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5916294|NCT05014711|Fentanyl|fentanyl|mesh-list
5916295|NCT05014711|Remifentanil|remifentanil|mesh-list
5916296|NCT05014711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5916297|NCT05014711|Narcotics|narcotics|mesh-ancestor
5916298|NCT05014711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5916299|NCT05014711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916300|NCT05014711|Analgesics|analgesics|mesh-ancestor
5916301|NCT05014711|Sensory System Agents|sensory system agents|mesh-ancestor
5916302|NCT05014711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5916303|NCT05014711|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5916304|NCT05014711|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5916305|NCT05014711|Anesthetics, General|anesthetics, general|mesh-ancestor
5916306|NCT05014711|Anesthetics|anesthetics|mesh-ancestor
5916307|NCT05014685|Amoxicillin|amoxicillin|mesh-list
5916308|NCT05014685|Metronidazole|metronidazole|mesh-list
5916309|NCT05014685|Potassium Citrate|potassium citrate|mesh-list
5916310|NCT05014685|Rabeprazole|rabeprazole|mesh-list
5916311|NCT05014685|Bismuth|bismuth|mesh-list
5916312|NCT05014685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916313|NCT05014685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5916314|NCT05014685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5916315|NCT05014685|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5916316|NCT05014685|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5916317|NCT05014685|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5916318|NCT05014685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5916319|NCT05014685|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5916320|NCT05014685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5916321|NCT05014685|Antacids|antacids|mesh-ancestor
5916322|NCT05014685|Diuretics|diuretics|mesh-ancestor
5916323|NCT05014685|Natriuretic Agents|natriuretic agents|mesh-ancestor
5916324|NCT05014685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916325|NCT05014685|Expectorants|expectorants|mesh-ancestor
5916326|NCT05014685|Respiratory System Agents|respiratory system agents|mesh-ancestor
5916327|NCT05014906|Minocycline|minocycline|mesh-list
5916328|NCT05014906|Azelaic acid|azelaic acid|mesh-list
5916329|NCT05014906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5916330|NCT05014906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5916331|NCT05014906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5916332|NCT05014906|Dermatologic Agents|dermatologic agents|mesh-ancestor
5916333|NCT05014724|Rozanolixizumab|rozanolixizumab|mesh-list
5916334|NCT05014724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5916335|NCT05014724|Immunologic Factors|immunologic factors|mesh-ancestor
5916336|NCT05014724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916337|NCT05014828|Lenvatinib|lenvatinib|mesh-list
5916338|NCT05014828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5916339|NCT05014828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5916340|NCT05014828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5700362|NCT03355053|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5700363|NCT03355053|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5700364|NCT03355053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5700365|NCT03355053|Adrenergic Agents|adrenergic agents|mesh-ancestor
5700366|NCT03355053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5700367|NCT03355053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700368|NCT03355027|Atorvastatin|atorvastatin|mesh-list
5700369|NCT03355027|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5700370|NCT03355027|Simvastatin|simvastatin|mesh-list
5700371|NCT03355027|Ezetimibe|ezetimibe|mesh-list
5700372|NCT03355027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5700373|NCT03355027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5916341|NCT05014828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916342|NCT05015387|Proanthocyanidin|proanthocyanidin|mesh-list
5916343|NCT05015387|Procyanidin|procyanidin|mesh-list
5916344|NCT05015387|Antioxidants|antioxidants|mesh-ancestor
5916345|NCT05015387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916346|NCT05015387|Protective Agents|protective agents|mesh-ancestor
5916347|NCT05015387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916348|NCT05015387|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5916349|NCT05015387|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5916350|NCT05015387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5916351|NCT05014464|Crizotinib|crizotinib|mesh-list
5916352|NCT05014464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5916353|NCT05014464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5916354|NCT05014464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5916355|NCT05014464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916356|NCT05014490|Etoricoxib|etoricoxib|mesh-list
5700374|NCT03355027|Antimetabolites|antimetabolites|mesh-ancestor
5700375|NCT03355027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700376|NCT03355027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5700377|NCT03355027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5700378|NCT03355027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5700379|NCT03355014|Metformin|metformin|mesh-list
5700380|NCT03355014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5700381|NCT03355014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700382|NCT03354962|Nivolumab|nivolumab|mesh-list
5700383|NCT03354962|Ipilimumab|ipilimumab|mesh-list
5700384|NCT03354962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5700385|NCT03354962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5700386|NCT03354962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5700387|NCT03354962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700388|NCT03354897|Torsemide|torsemide|mesh-list
5700389|NCT03354897|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5700390|NCT03354897|Diuretics|diuretics|mesh-ancestor
5700391|NCT03354897|Natriuretic Agents|natriuretic agents|mesh-ancestor
5700392|NCT03354897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700393|NCT03354897|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5700394|NCT03354897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5700395|NCT03354897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700396|NCT03354806|Analgesics|analgesics|mesh-list
5700397|NCT03354806|Sensory System Agents|sensory system agents|mesh-ancestor
5700398|NCT03354806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5700399|NCT03354806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700400|NCT03354624|Mitogens|mitogens|mesh-list
5700401|NCT03354624|Mitosis Modulators|mitosis modulators|mesh-ancestor
5916357|NCT05014490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5700402|NCT03354624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700403|NCT03354572|Acetylcysteine|acetylcysteine|mesh-list
5700404|NCT03354572|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5700405|NCT03354572|Antiviral Agents|antiviral agents|mesh-ancestor
5700406|NCT03354572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5700407|NCT03354572|Expectorants|expectorants|mesh-ancestor
5700408|NCT03354572|Respiratory System Agents|respiratory system agents|mesh-ancestor
5700409|NCT03354572|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5700410|NCT03354572|Antioxidants|antioxidants|mesh-ancestor
5700411|NCT03354572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700412|NCT03354572|Protective Agents|protective agents|mesh-ancestor
5700413|NCT03354572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700414|NCT03354572|Antidotes|antidotes|mesh-ancestor
5700415|NCT03354494|Desogestrel|desogestrel|mesh-list
5700416|NCT03354494|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5700417|NCT03354494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5700418|NCT03354494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5700419|NCT03354494|Contraceptive Agents|contraceptive agents|mesh-ancestor
5700420|NCT03354494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5916358|NCT05014490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5916359|NCT05014490|Analgesics|analgesics|mesh-ancestor
5916360|NCT05014490|Sensory System Agents|sensory system agents|mesh-ancestor
5916361|NCT05014490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5916362|NCT05014490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916363|NCT05014490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5916364|NCT05014490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5916365|NCT05014490|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5916366|NCT05014490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5916367|NCT05014490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5916368|NCT05014490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916369|NCT05014516|Xenon|xenon|mesh-list
5916370|NCT05014516|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5916371|NCT05014516|Anesthetics, General|anesthetics, general|mesh-ancestor
5916372|NCT05014516|Anesthetics|anesthetics|mesh-ancestor
5916373|NCT05014516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5916374|NCT05014516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916375|NCT05014581|Norepinephrine|norepinephrine|mesh-list
5916376|NCT05014581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5916377|NCT05014581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5916378|NCT05014581|Adrenergic Agents|adrenergic agents|mesh-ancestor
5916379|NCT05014581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5916380|NCT05014581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916381|NCT05014581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916382|NCT05014581|Sympathomimetics|sympathomimetics|mesh-ancestor
5916383|NCT05014581|Autonomic Agents|autonomic agents|mesh-ancestor
5916384|NCT05014581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5916385|NCT05014581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5916386|NCT05014594|Dapagliflozin|dapagliflozin|mesh-list
5916387|NCT05014594|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5916388|NCT05014594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916389|NCT05014594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5916390|NCT05014594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916391|NCT05014373|Favipiravir|favipiravir|mesh-list
5916392|NCT05014373|Antiviral Agents|antiviral agents|mesh-ancestor
5916393|NCT05014373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5916394|NCT05014100|Lenalidomide|lenalidomide|mesh-list
5916395|NCT05014100|Immunologic Factors|immunologic factors|mesh-ancestor
5916396|NCT05014100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916397|NCT05014100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5916398|NCT05014100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5916399|NCT05014100|Growth Substances|growth substances|mesh-ancestor
5720869|NCT03209908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5916400|NCT05014100|Growth Inhibitors|growth inhibitors|mesh-ancestor
5916401|NCT05014100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5916402|NCT05014048|Vitamin D|vitamin d|mesh-list
5916403|NCT05014048|Cholecalciferol|cholecalciferol|mesh-list
5916404|NCT05014048|Vitamins|vitamins|mesh-ancestor
5916405|NCT05014048|Micronutrients|micronutrients|mesh-ancestor
5916406|NCT05014048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916407|NCT05014048|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5916408|NCT05014048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5916409|NCT05013892|Memantine|memantine|mesh-list
5916410|NCT05013892|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5916411|NCT05013892|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5916412|NCT05013892|Dopamine Agents|dopamine agents|mesh-ancestor
5916413|NCT05013892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5916414|NCT05013892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916415|NCT05013892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916416|NCT05013892|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5916417|NCT05013892|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5916418|NCT05013697|Paclitaxel|paclitaxel|mesh-list
5916419|NCT05013697|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5916420|NCT05013697|Cisplatin|cisplatin|mesh-list
5916421|NCT05013697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5916422|NCT05013697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5916423|NCT05013697|Tubulin Modulators|tubulin modulators|mesh-ancestor
5916424|NCT05013697|Antimitotic Agents|antimitotic agents|mesh-ancestor
5916425|NCT05013697|Mitosis Modulators|mitosis modulators|mesh-ancestor
5916426|NCT05013697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916427|NCT05013567|Ibuprofen|ibuprofen|mesh-list
5916428|NCT05013567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5916429|NCT05013567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5916430|NCT05013567|Analgesics|analgesics|mesh-ancestor
5916431|NCT05013567|Sensory System Agents|sensory system agents|mesh-ancestor
5916432|NCT05013567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5916433|NCT05013567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916434|NCT05013567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5916435|NCT05013567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5916436|NCT05013567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5916437|NCT05013567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5916438|NCT05013567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963727|NCT04599894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963728|NCT04599894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5963729|NCT04599894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5963730|NCT04599894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5963731|NCT04599894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5963732|NCT04599894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5963733|NCT04599478|Naltrexone|naltrexone|mesh-list
5963734|NCT04599478|Bupropion|bupropion|mesh-list
5963735|NCT04599478|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5963736|NCT04599478|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5963737|NCT04599478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963738|NCT04599478|Sensory System Agents|sensory system agents|mesh-ancestor
5963739|NCT04599478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5963740|NCT04599478|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5963741|NCT04599478|Antidepressive Agents|antidepressive agents|mesh-ancestor
5963742|NCT04599478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5963743|NCT04599478|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5963744|NCT04599478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5963745|NCT04599478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5963746|NCT04599478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700421|NCT03354494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700422|NCT03354494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5700423|NCT03354494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5700424|NCT03354494|Progestins|progestins|mesh-ancestor
5700425|NCT03354494|Hormones|hormones|mesh-ancestor
5700426|NCT03354494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5700427|NCT03354338|Amoxicillin|amoxicillin|mesh-list
5700428|NCT03354338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5700429|NCT03354338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5700430|NCT03354312|Lidocaine|lidocaine|mesh-list
5700431|NCT03354312|Epinephrine|epinephrine|mesh-list
5700432|NCT03354312|Racepinephrine|racepinephrine|mesh-list
5700433|NCT03354312|Carticaine|carticaine|mesh-list
5916439|NCT05013463|Hydroxychloroquine|hydroxychloroquine|mesh-list
5916440|NCT05013463|Indapamide|indapamide|mesh-list
5916441|NCT05013463|Antimalarials|antimalarials|mesh-ancestor
5916442|NCT05013463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5916443|NCT05013463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5700434|NCT03354312|Epinephryl borate|epinephryl borate|mesh-list
5700435|NCT03354312|Anesthetics, Local|anesthetics, local|mesh-ancestor
5700436|NCT03354312|Anesthetics|anesthetics|mesh-ancestor
5700437|NCT03354312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5700438|NCT03354312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700439|NCT03354312|Sensory System Agents|sensory system agents|mesh-ancestor
5700440|NCT03354312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5700441|NCT03354312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5700442|NCT03354312|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5700443|NCT03354312|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5700444|NCT03354312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5700445|NCT03354312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700446|NCT03354312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5700447|NCT03354312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5700448|NCT03354312|Adrenergic Agents|adrenergic agents|mesh-ancestor
5700449|NCT03354312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5700450|NCT03354312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5700451|NCT03354312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5700452|NCT03354312|Autonomic Agents|autonomic agents|mesh-ancestor
5700453|NCT03354312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5700454|NCT03354312|Respiratory System Agents|respiratory system agents|mesh-ancestor
5916444|NCT05013463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5916445|NCT05013463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5916446|NCT05013463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916447|NCT05013463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5916448|NCT05013463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5916449|NCT05013463|Diuretics|diuretics|mesh-ancestor
5916450|NCT05013463|Natriuretic Agents|natriuretic agents|mesh-ancestor
5916451|NCT05013463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916452|NCT05013463|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5916453|NCT05013463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5916454|NCT05013060|Butyric Acid|butyric acid|mesh-list
5916455|NCT05013060|Histamine Antagonists|histamine antagonists|mesh-ancestor
5916456|NCT05013060|Histamine Agents|histamine agents|mesh-ancestor
5916457|NCT05013060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5916458|NCT05013060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916459|NCT05013060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916460|NCT05013112|Metformin|metformin|mesh-list
5916461|NCT05013112|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
5916462|NCT05013112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5916463|NCT05013112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916464|NCT05013112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916465|NCT05013164|Leucovorin|leucovorin|mesh-list
5916466|NCT05013164|Folic Acid|folic acid|mesh-list
5916467|NCT05013164|Levoleucovorin|levoleucovorin|mesh-list
5916468|NCT05013164|Antidotes|antidotes|mesh-ancestor
5916469|NCT05013164|Protective Agents|protective agents|mesh-ancestor
5916470|NCT05013164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916471|NCT05013164|Vitamin B Complex|vitamin b complex|mesh-ancestor
5916472|NCT05013164|Vitamins|vitamins|mesh-ancestor
5916473|NCT05013164|Micronutrients|micronutrients|mesh-ancestor
5916474|NCT05013164|Hematinics|hematinics|mesh-ancestor
5916475|NCT05013034|Basiliximab|basiliximab|mesh-list
5916476|NCT05013034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5916477|NCT05013034|Immunologic Factors|immunologic factors|mesh-ancestor
5916478|NCT05013034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916479|NCT05013151|Castor Oil|castor oil|mesh-list
5916480|NCT05013151|Cathartics|cathartics|mesh-ancestor
5916481|NCT05013151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5916482|NCT05013268|Paclitaxel|paclitaxel|mesh-list
5916483|NCT05013268|Docetaxel|docetaxel|mesh-list
5916484|NCT05013268|Carboplatin|carboplatin|mesh-list
5916485|NCT05013268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5916486|NCT05013268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5916487|NCT05013268|Tubulin Modulators|tubulin modulators|mesh-ancestor
5916488|NCT05013268|Antimitotic Agents|antimitotic agents|mesh-ancestor
5916489|NCT05013268|Mitosis Modulators|mitosis modulators|mesh-ancestor
5916490|NCT05013268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916491|NCT05013320|Glycopyrrolate|glycopyrrolate|mesh-list
5916492|NCT05013320|Dexmedetomidine|dexmedetomidine|mesh-list
5916493|NCT05013320|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5916494|NCT05013320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5916495|NCT05013320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916496|NCT05013320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5700455|NCT03354312|Mydriatics|mydriatics|mesh-ancestor
5700456|NCT03354312|Sympathomimetics|sympathomimetics|mesh-ancestor
5700457|NCT03354312|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5720870|NCT03209908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5720871|NCT03209908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5720872|NCT03209908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5720873|NCT03209856|Vitamin D|vitamin d|mesh-list
5720874|NCT03209856|Calcitriol|calcitriol|mesh-list
5720875|NCT03209856|Vitamins|vitamins|mesh-ancestor
5720876|NCT03209856|Micronutrients|micronutrients|mesh-ancestor
5720877|NCT03209856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720878|NCT03209856|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5720879|NCT03209856|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5720880|NCT03209856|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
5720881|NCT03209856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5720882|NCT03209856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5720883|NCT03209856|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5720884|NCT03209622|Nicotine|nicotine|mesh-list
5720885|NCT03209622|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5720886|NCT03209622|Autonomic Agents|autonomic agents|mesh-ancestor
5720887|NCT03209622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5720888|NCT03209622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720889|NCT03209622|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5720890|NCT03209622|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5720891|NCT03209622|Cholinergic Agents|cholinergic agents|mesh-ancestor
5720892|NCT03209622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5720893|NCT03209622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5720894|NCT03209466|Chlorhexidine|chlorhexidine|mesh-list
5720895|NCT03209466|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5720896|NCT03209466|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5720897|NCT03209466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5720898|NCT03209466|Disinfectants|disinfectants|mesh-ancestor
5720899|NCT03209466|Dermatologic Agents|dermatologic agents|mesh-ancestor
5720900|NCT03209427|Morphine|morphine|mesh-list
5720901|NCT03209427|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5720902|NCT03209427|Narcotics|narcotics|mesh-ancestor
5720903|NCT03209427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5720904|NCT03209427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720905|NCT03209427|Analgesics|analgesics|mesh-ancestor
5720906|NCT03209427|Sensory System Agents|sensory system agents|mesh-ancestor
5720907|NCT03209427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5720908|NCT03209661|Menthol|menthol|mesh-list
5720909|NCT03209661|Nicotine|nicotine|mesh-list
5720910|NCT03209661|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5720911|NCT03209661|Autonomic Agents|autonomic agents|mesh-ancestor
5720912|NCT03209661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5720913|NCT03209661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720914|NCT03209661|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5916497|NCT05013320|Analgesics|analgesics|mesh-ancestor
5916498|NCT05013320|Sensory System Agents|sensory system agents|mesh-ancestor
5916499|NCT05013320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5916500|NCT05013320|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5916501|NCT05013320|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5916502|NCT05013320|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5916503|NCT05013320|Adrenergic Agents|adrenergic agents|mesh-ancestor
5916504|NCT05013320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5916505|NCT05013320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5720915|NCT03209661|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5720916|NCT03209661|Cholinergic Agents|cholinergic agents|mesh-ancestor
5720917|NCT03209661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5720918|NCT03209661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916506|NCT05013320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5916507|NCT05013320|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5916508|NCT05013320|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5916509|NCT05013320|Cholinergic Agents|cholinergic agents|mesh-ancestor
5916510|NCT05012566|Botulinum Toxins|botulinum toxins|mesh-list
5916511|NCT05012566|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5916512|NCT05012566|Hyaluronic Acid|hyaluronic acid|mesh-list
5916513|NCT05012566|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5916514|NCT05012566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5916515|NCT05012566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916516|NCT05012566|Cholinergic Agents|cholinergic agents|mesh-ancestor
5916517|NCT05012566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5916518|NCT05012566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916519|NCT05012566|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5916520|NCT05012566|Immunologic Factors|immunologic factors|mesh-ancestor
5916521|NCT05012566|Viscosupplements|viscosupplements|mesh-ancestor
5916522|NCT05012566|Protective Agents|protective agents|mesh-ancestor
5916523|NCT05012566|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5916524|NCT05012566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5916525|NCT05012787|Vaccines|vaccines|mesh-list
5916526|NCT05012787|1018 oligonucleotide|1018 oligonucleotide|mesh-list
5916527|NCT05012787|Immunologic Factors|immunologic factors|mesh-ancestor
5916528|NCT05012787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916529|NCT05012787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5916530|NCT05012137|Ropivacaine|ropivacaine|mesh-list
5916531|NCT05012137|Anesthetics, Local|anesthetics, local|mesh-ancestor
5916532|NCT05012137|Anesthetics|anesthetics|mesh-ancestor
5916533|NCT05012137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5916534|NCT05012137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916535|NCT05012137|Sensory System Agents|sensory system agents|mesh-ancestor
5916536|NCT05012137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5916537|NCT05012033|Prednisolone|prednisolone|mesh-list
5916538|NCT05012033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5916539|NCT05012033|Glucocorticoids|glucocorticoids|mesh-ancestor
5916540|NCT05012033|Hormones|hormones|mesh-ancestor
5916541|NCT05012033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5916542|NCT05012033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916543|NCT05012033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5916544|NCT05012033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5916545|NCT05012189|Oseltamivir|oseltamivir|mesh-list
5916546|NCT05012189|Baloxavir|baloxavir|mesh-list
5916547|NCT05012189|Antiviral Agents|antiviral agents|mesh-ancestor
5916548|NCT05012189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5916549|NCT05012189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5916550|NCT05012189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916551|NCT05011916|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5916552|NCT05011916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5916553|NCT05011760|Amphetamine|amphetamine|mesh-list
5916554|NCT05011760|Dextroamphetamine|dextroamphetamine|mesh-list
5916555|NCT05011760|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5916556|NCT05011760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916557|NCT05011760|Sympathomimetics|sympathomimetics|mesh-ancestor
6212701|NCT02193347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6212702|NCT02193776|Moxifloxacin|moxifloxacin|mesh-list
6212703|NCT02193776|Rifampin|rifampin|mesh-list
6212704|NCT02193776|Isoniazid|isoniazid|mesh-list
6212705|NCT02193776|Pyrazinamide|pyrazinamide|mesh-list
6212706|NCT02193776|Ethambutol|ethambutol|mesh-list
6212707|NCT02193776|Bedaquiline|bedaquiline|mesh-list
5916558|NCT05011760|Autonomic Agents|autonomic agents|mesh-ancestor
5916559|NCT05011760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5916560|NCT05011760|Dopamine Agents|dopamine agents|mesh-ancestor
5916561|NCT05011760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5916562|NCT05011760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916563|NCT05011760|Adrenergic Agents|adrenergic agents|mesh-ancestor
5916564|NCT05011760|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5916565|NCT05011760|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5916566|NCT05011760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5916567|NCT05011760|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5916568|NCT05011487|Pemetrexed|pemetrexed|mesh-list
5916569|NCT05011487|Osimertinib|osimertinib|mesh-list
5916570|NCT05011487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5916571|NCT05011487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5916572|NCT05011487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916573|NCT05011487|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6212708|NCT02193776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6675879|NCT01578252|Autonomic Agents|autonomic agents|mesh-ancestor
5700458|NCT03354117|Meloxicam|meloxicam|mesh-list
5700459|NCT03354117|Ulipristal acetate|ulipristal acetate|mesh-list
5700460|NCT03354117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5700461|NCT03354117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5700462|NCT03354117|Analgesics|analgesics|mesh-ancestor
5700463|NCT03354117|Sensory System Agents|sensory system agents|mesh-ancestor
5700464|NCT03354117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5700465|NCT03354117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700466|NCT03354117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5700467|NCT03354117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5700468|NCT03354117|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5700469|NCT03354117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5700470|NCT03354117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5700471|NCT03354117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916574|NCT05011487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5916575|NCT05011487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5916576|NCT05011617|Anesthetics|anesthetics|mesh-list
5916577|NCT05011617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5916578|NCT05011617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916579|NCT05011669|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
5916580|NCT05011669|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5916581|NCT05011669|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5916582|NCT05011669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5916583|NCT05011669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916584|NCT05011669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5916585|NCT05011669|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5916586|NCT05011669|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5916587|NCT05011669|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5916588|NCT05011669|Adrenergic Agents|adrenergic agents|mesh-ancestor
5916589|NCT05011669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5916590|NCT05011669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916591|NCT05011669|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5916592|NCT05011669|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5916593|NCT05011669|Serotonin Agents|serotonin agents|mesh-ancestor
5916594|NCT05011669|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5916595|NCT05011669|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5916596|NCT05011669|Dopamine Agents|dopamine agents|mesh-ancestor
5963747|NCT04599478|Dopamine Agents|dopamine agents|mesh-ancestor
5963748|NCT04599478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5963749|NCT04599478|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5963750|NCT04599478|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5963751|NCT04599478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5963752|NCT04599712|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
5963753|NCT04599712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5963754|NCT04599712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5963755|NCT04599621|Uric Acid|uric acid|mesh-list
5963756|NCT04599621|Antioxidants|antioxidants|mesh-ancestor
5963757|NCT04599621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963758|NCT04599621|Protective Agents|protective agents|mesh-ancestor
5963759|NCT04599621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963760|NCT04599699|Androgens|androgens|mesh-list
5963761|NCT04599699|Hormones|hormones|mesh-ancestor
5963762|NCT04599699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5963763|NCT04599699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496786|NCT00629304|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6496787|NCT00629304|Protease Inhibitors|protease inhibitors|mesh-ancestor
6496788|NCT00629304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6496789|NCT00629304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496790|NCT00629304|Anticoagulants|anticoagulants|mesh-ancestor
6496791|NCT00629317|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6496792|NCT00629317|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
6496793|NCT00629317|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6496794|NCT00629317|Dermatologic Agents|dermatologic agents|mesh-ancestor
6496795|NCT00629343|Temozolomide|temozolomide|mesh-list
6496796|NCT00629343|Azacitidine|azacitidine|mesh-list
6496797|NCT00629343|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6496798|NCT00629343|Alkylating Agents|alkylating agents|mesh-ancestor
6496799|NCT00629343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496800|NCT00629343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6496801|NCT00629343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6496802|NCT00629343|Antimetabolites|antimetabolites|mesh-ancestor
5963764|NCT04599075|Insulin|insulin|mesh-list
5963765|NCT04599075|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5700472|NCT03354117|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5700473|NCT03354117|Contraceptive Agents|contraceptive agents|mesh-ancestor
5700474|NCT03354117|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5700475|NCT03354117|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5700476|NCT03354039|Tamoxifen|tamoxifen|mesh-list
5700477|NCT03354039|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5700478|NCT03354039|Hormone Antagonists|hormone antagonists|mesh-ancestor
5700479|NCT03354039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5700480|NCT03354039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700481|NCT03354039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5700482|NCT03354039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5700483|NCT03354039|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5700484|NCT03354039|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5700485|NCT03354039|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5700486|NCT03354013|Calcium|calcium|mesh-list
5700487|NCT03354013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5700488|NCT03354013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700489|NCT03353948|Metformin|metformin|mesh-list
5700490|NCT03353948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5700491|NCT03353948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700492|NCT03353909|Hyaluronic Acid|hyaluronic acid|mesh-list
5700493|NCT03353909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5700494|NCT03353909|Immunologic Factors|immunologic factors|mesh-ancestor
5700495|NCT03353909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700496|NCT03353909|Viscosupplements|viscosupplements|mesh-ancestor
5700497|NCT03353909|Protective Agents|protective agents|mesh-ancestor
5700498|NCT03353883|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5700499|NCT03353883|Luteolytic Agents|luteolytic agents|mesh-ancestor
6496803|NCT00629343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6496804|NCT00629382|Polymyxins|polymyxins|mesh-list
6496805|NCT00629382|Polymyxin B|polymyxin b|mesh-list
6496806|NCT00629382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6496807|NCT00629382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6496808|NCT00629447|Tinzaparin|tinzaparin|mesh-list
6496809|NCT00629447|Anticoagulants|anticoagulants|mesh-ancestor
6496810|NCT00629447|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6496811|NCT00629447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6496812|NCT00629447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496813|NCT00629473|Dexamethasone|dexamethasone|mesh-list
6496814|NCT00629473|Proteasome Inhibitors|proteasome inhibitors|mesh-list
6496815|NCT00629473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5916597|NCT05011383|Testosterone|testosterone|mesh-list
5916598|NCT05011383|Androgens|androgens|mesh-list
5916599|NCT05011383|Hormones|hormones|mesh-ancestor
5916600|NCT05011383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5916601|NCT05011383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916602|NCT05011214|Ketamine|ketamine|mesh-list
5916603|NCT05011214|Sevoflurane|sevoflurane|mesh-list
5916604|NCT05011214|Esketamine|esketamine|mesh-list
5916605|NCT05011214|Analgesics|analgesics|mesh-ancestor
5700500|NCT03353883|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5700501|NCT03353883|Contraceptive Agents|contraceptive agents|mesh-ancestor
5700502|NCT03353883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5700503|NCT03353883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700504|NCT03353883|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5700505|NCT03353883|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5700506|NCT03353883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5700507|NCT03353857|Rifampin|rifampin|mesh-list
5700508|NCT03353857|Dienogest|dienogest|mesh-list
5916606|NCT05011214|Sensory System Agents|sensory system agents|mesh-ancestor
5916607|NCT05011214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5916608|NCT05011214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916609|NCT05011214|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5916610|NCT05011214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5916611|NCT05011214|Anesthetics, General|anesthetics, general|mesh-ancestor
5916612|NCT05011214|Anesthetics|anesthetics|mesh-ancestor
5916613|NCT05011214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5916614|NCT05011214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5916615|NCT05011214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5916616|NCT05011214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5916617|NCT05011214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916618|NCT05011214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5916619|NCT05011214|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6496816|NCT00629473|Antiemetics|antiemetics|mesh-ancestor
5916620|NCT05011214|Antidepressive Agents|antidepressive agents|mesh-ancestor
6496817|NCT00629473|Autonomic Agents|autonomic agents|mesh-ancestor
5700509|NCT03353857|Drospirenone|drospirenone|mesh-list
5700510|NCT03353857|Midazolam|midazolam|mesh-list
5916621|NCT05011214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5916622|NCT05010954|Lansoprazole|lansoprazole|mesh-list
5916623|NCT05010954|Dexlansoprazole|dexlansoprazole|mesh-list
5916624|NCT05010954|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5916625|NCT05010954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5916626|NCT05010954|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5916627|NCT05010954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5916628|NCT05010954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916629|NCT05010876|Icatibant|icatibant|mesh-list
5916630|NCT05010876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5916631|NCT05010876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5916632|NCT05010876|Analgesics|analgesics|mesh-ancestor
5916633|NCT05010876|Sensory System Agents|sensory system agents|mesh-ancestor
5916634|NCT05010876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5916635|NCT05010876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916636|NCT05010876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5916637|NCT05010876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5916638|NCT05010876|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
5916639|NCT05010876|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
5700511|NCT03353857|Levonorgestrel|levonorgestrel|mesh-list
5700512|NCT03353857|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5700513|NCT03353857|Norethindrone|norethindrone|mesh-list
5700514|NCT03353857|Norethindrone Acetate|norethindrone acetate|mesh-list
5700515|NCT03353857|Desogestrel|desogestrel|mesh-list
5700516|NCT03353857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5700517|NCT03353857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5700518|NCT03353857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5700519|NCT03353857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700520|NCT03353857|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5700521|NCT03353857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5700522|NCT03353857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5700523|NCT03353857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5700524|NCT03353857|Anesthetics, General|anesthetics, general|mesh-ancestor
5700525|NCT03353857|Anesthetics|anesthetics|mesh-ancestor
5916640|NCT05010876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916641|NCT05010876|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5916642|NCT05010876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5916643|NCT05010876|Immunologic Factors|immunologic factors|mesh-ancestor
5916644|NCT05010707|Spironolactone|spironolactone|mesh-list
5916645|NCT05010707|Hormones|hormones|mesh-list
5916646|NCT05010707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5916647|NCT05010707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700526|NCT03353857|GABA Modulators|gaba modulators|mesh-ancestor
5700527|NCT03353857|GABA Agents|gaba agents|mesh-ancestor
5700528|NCT03353857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5700529|NCT03353857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700530|NCT03353857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5700531|NCT03353857|Contraceptive Agents|contraceptive agents|mesh-ancestor
5700532|NCT03353857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5700533|NCT03353857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5700534|NCT03353857|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5700535|NCT03353857|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5700536|NCT03353857|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5700537|NCT03353857|Antitubercular Agents|antitubercular agents|mesh-ancestor
5700538|NCT03353857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5700539|NCT03353857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5916648|NCT05010707|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5916649|NCT05010707|Hormone Antagonists|hormone antagonists|mesh-ancestor
5916650|NCT05010707|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5916651|NCT05010707|Diuretics|diuretics|mesh-ancestor
5916652|NCT05010707|Natriuretic Agents|natriuretic agents|mesh-ancestor
5916653|NCT05010668|Lenvatinib|lenvatinib|mesh-list
5700540|NCT03353857|Leprostatic Agents|leprostatic agents|mesh-ancestor
5700541|NCT03353857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5700542|NCT03353857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5700543|NCT03353857|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5700544|NCT03353857|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5700545|NCT03353857|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5700546|NCT03353857|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5700547|NCT03353857|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5916654|NCT05010668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5916655|NCT05010668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5916656|NCT05010668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5700548|NCT03353857|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5700549|NCT03353857|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5700550|NCT03353857|Estrogens|estrogens|mesh-ancestor
5916657|NCT05010668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916658|NCT05010681|Lenvatinib|lenvatinib|mesh-list
5916659|NCT05010681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5916660|NCT05010681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5916661|NCT05010681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5916662|NCT05010681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916663|NCT05010538|Sarecycline|sarecycline|mesh-list
5916664|NCT05010538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5916665|NCT05010538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5916666|NCT05010538|Dermatologic Agents|dermatologic agents|mesh-ancestor
5916667|NCT05010499|Bupivacaine|bupivacaine|mesh-list
5916668|NCT05010499|Levobupivacaine|levobupivacaine|mesh-list
5916669|NCT05010499|Anesthetics, Local|anesthetics, local|mesh-ancestor
5916670|NCT05010499|Anesthetics|anesthetics|mesh-ancestor
5916671|NCT05010499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5916672|NCT05010499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916673|NCT05010499|Sensory System Agents|sensory system agents|mesh-ancestor
5916674|NCT05010499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5916675|NCT05010434|Bevacizumab|bevacizumab|mesh-list
5916676|NCT05010434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5916677|NCT05010434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5916678|NCT05010434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5916679|NCT05010434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5916680|NCT05010434|Growth Substances|growth substances|mesh-ancestor
5916681|NCT05010434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916682|NCT05010434|Growth Inhibitors|growth inhibitors|mesh-ancestor
5916683|NCT05010356|Insulin|insulin|mesh-list
5916684|NCT05010356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5916685|NCT05010356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916686|NCT05010590|Denosumab|denosumab|mesh-list
5916687|NCT05010590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5916688|NCT05010590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916689|NCT05010200|Poly ICLC|poly iclc|mesh-list
5916690|NCT05010200|Interferon Inducers|interferon inducers|mesh-ancestor
5916691|NCT05010200|Immunologic Factors|immunologic factors|mesh-ancestor
5916692|NCT05010200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916693|NCT05010148|Lidocaine|lidocaine|mesh-list
5916694|NCT05010148|Anesthetics, Local|anesthetics, local|mesh-ancestor
5916695|NCT05010148|Anesthetics|anesthetics|mesh-ancestor
5916696|NCT05010148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5916697|NCT05010148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916698|NCT05010148|Sensory System Agents|sensory system agents|mesh-ancestor
5916699|NCT05010148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5916700|NCT05010148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5916701|NCT05010148|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5916702|NCT05010148|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5916703|NCT05010148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5700551|NCT03353857|Hormones|hormones|mesh-ancestor
5700552|NCT03353857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5700553|NCT03353857|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5700554|NCT03353857|Hormone Antagonists|hormone antagonists|mesh-ancestor
5700555|NCT03353857|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5700556|NCT03353857|Diuretics|diuretics|mesh-ancestor
5700557|NCT03353857|Natriuretic Agents|natriuretic agents|mesh-ancestor
5720919|NCT03209661|Antipruritics|antipruritics|mesh-ancestor
5916704|NCT05010148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916705|NCT05009901|Thioctic Acid|thioctic acid|mesh-list
5916706|NCT05009901|Antioxidants|antioxidants|mesh-ancestor
5916707|NCT05009901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916708|NCT05009901|Protective Agents|protective agents|mesh-ancestor
5916709|NCT05009901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916710|NCT05009901|Vitamin B Complex|vitamin b complex|mesh-ancestor
5916711|NCT05009901|Vitamins|vitamins|mesh-ancestor
5916712|NCT05009901|Micronutrients|micronutrients|mesh-ancestor
5916713|NCT05009953|Leucovorin|leucovorin|mesh-list
5916714|NCT05009953|Fluorouracil|fluorouracil|mesh-list
5916715|NCT05009953|Irinotecan|irinotecan|mesh-list
5916716|NCT05009953|Antimetabolites|antimetabolites|mesh-ancestor
5916717|NCT05009953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916718|NCT05009953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5916719|NCT05009953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5916720|NCT05009953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5700558|NCT03353857|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5700559|NCT03353857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5700560|NCT03353857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5700561|NCT03353857|Progestins|progestins|mesh-ancestor
5700562|NCT03353831|Bevacizumab|bevacizumab|mesh-list
5700563|NCT03353831|Atezolizumab|atezolizumab|mesh-list
5700564|NCT03353831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5916721|NCT05009953|Immunologic Factors|immunologic factors|mesh-ancestor
5916722|NCT05009953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916723|NCT05009953|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5916724|NCT05009953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5916725|NCT05009953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5916726|NCT05009953|Antidotes|antidotes|mesh-ancestor
5916727|NCT05009953|Protective Agents|protective agents|mesh-ancestor
5916728|NCT05009953|Vitamin B Complex|vitamin b complex|mesh-ancestor
5916729|NCT05009953|Vitamins|vitamins|mesh-ancestor
5916730|NCT05009953|Micronutrients|micronutrients|mesh-ancestor
5916731|NCT05009927|Imatinib Mesylate|imatinib mesylate|mesh-list
5916732|NCT05009927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5916733|NCT05009927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5916734|NCT05009927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5916735|NCT05009927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963766|NCT04599075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5963767|NCT04599075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963768|NCT04599205|Tranexamic Acid|tranexamic acid|mesh-list
5963769|NCT04599205|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5963770|NCT04599205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5963771|NCT04599205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963772|NCT04599205|Hemostatics|hemostatics|mesh-ancestor
5963773|NCT04599205|Coagulants|coagulants|mesh-ancestor
5963774|NCT04599140|Nivolumab|nivolumab|mesh-list
5963775|NCT04599140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5963776|NCT04599140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5700565|NCT03353831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5700566|NCT03353831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5700567|NCT03353831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5700568|NCT03353831|Growth Substances|growth substances|mesh-ancestor
5700569|NCT03353831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700570|NCT03353831|Growth Inhibitors|growth inhibitors|mesh-ancestor
5963777|NCT04599140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5963778|NCT04599140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963779|NCT04598880|Picosulfate sodium|picosulfate sodium|mesh-list
5963780|NCT04598880|Magnesium citrate|magnesium citrate|mesh-list
5963781|NCT04598880|Cathartics|cathartics|mesh-ancestor
5963782|NCT04598880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5963783|NCT04598737|Lithium Carbonate|lithium carbonate|mesh-list
5963784|NCT04598737|Antidepressive Agents|antidepressive agents|mesh-ancestor
5963785|NCT04598737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5963786|NCT04598737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5963787|NCT04598737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963788|NCT04598737|Antimanic Agents|antimanic agents|mesh-ancestor
5963789|NCT04598737|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5963790|NCT04598737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5963791|NCT04598737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963792|NCT04599062|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
5963793|NCT04599062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5963794|NCT04599062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5963795|NCT04598542|Triamcinolone|triamcinolone|mesh-list
5963796|NCT04598542|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5963797|NCT04598542|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5963798|NCT04598542|Lorecivivint|lorecivivint|mesh-list
5963799|NCT04598542|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5963800|NCT04598542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5963801|NCT04598542|Glucocorticoids|glucocorticoids|mesh-ancestor
5963802|NCT04598542|Hormones|hormones|mesh-ancestor
5963803|NCT04598542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5963804|NCT04598542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963805|NCT04598542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5963806|NCT04598542|Immunologic Factors|immunologic factors|mesh-ancestor
5963807|NCT04598542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5963808|NCT04598542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963809|NCT04598594|Nicotine|nicotine|mesh-list
5963810|NCT04598594|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5963811|NCT04598594|Autonomic Agents|autonomic agents|mesh-ancestor
5963812|NCT04598594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5700571|NCT03353480|Azithromycin|azithromycin|mesh-list
5916736|NCT05009342|Calpastatin|calpastatin|mesh-list
5916737|NCT05009342|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
5916738|NCT05009342|Protease Inhibitors|protease inhibitors|mesh-ancestor
5916739|NCT05009342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5916740|NCT05009342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916741|NCT05009498|Vitamin D|vitamin d|mesh-list
5916742|NCT05009498|Cholecalciferol|cholecalciferol|mesh-list
5916743|NCT05009498|Vitamins|vitamins|mesh-ancestor
5916744|NCT05009498|Micronutrients|micronutrients|mesh-ancestor
5916745|NCT05009498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916746|NCT05009498|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5916747|NCT05009498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5916748|NCT05009355|Ascorbic Acid|ascorbic acid|mesh-list
5916749|NCT05009355|Vitamins|vitamins|mesh-ancestor
5916750|NCT05009355|Micronutrients|micronutrients|mesh-ancestor
5700572|NCT03353480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5700573|NCT03353480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5700574|NCT03353441|Glycine|glycine|mesh-list
5700575|NCT03353441|Glycine Agents|glycine agents|mesh-ancestor
5700576|NCT03353441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5700577|NCT03353441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700578|NCT03353441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700579|NCT03353363|Bupivacaine|bupivacaine|mesh-list
5916751|NCT05009355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916752|NCT05009355|Antioxidants|antioxidants|mesh-ancestor
5916753|NCT05009355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916754|NCT05009355|Protective Agents|protective agents|mesh-ancestor
5916755|NCT05008887|Fluorouracil|fluorouracil|mesh-list
5916756|NCT05008887|Methotrexate|methotrexate|mesh-list
5916757|NCT05008887|Antimetabolites|antimetabolites|mesh-ancestor
5916758|NCT05008887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916759|NCT05008887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5916760|NCT05008887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5916761|NCT05008887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5916762|NCT05008887|Immunologic Factors|immunologic factors|mesh-ancestor
5916763|NCT05008887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916764|NCT05008887|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5916765|NCT05008887|Abortifacient Agents|abortifacient agents|mesh-ancestor
5916766|NCT05008887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5700580|NCT03353363|Anesthetics, Local|anesthetics, local|mesh-ancestor
5700581|NCT03353363|Anesthetics|anesthetics|mesh-ancestor
5700582|NCT03353363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5700583|NCT03353363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700584|NCT03353363|Sensory System Agents|sensory system agents|mesh-ancestor
5700585|NCT03353363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5700586|NCT03353324|Bevacizumab|bevacizumab|mesh-list
5700587|NCT03353324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5700588|NCT03353324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5700589|NCT03353324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5700590|NCT03353324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5700591|NCT03353324|Growth Substances|growth substances|mesh-ancestor
5700592|NCT03353324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700593|NCT03353324|Growth Inhibitors|growth inhibitors|mesh-ancestor
5700594|NCT03353298|Allopurinol|allopurinol|mesh-list
5700595|NCT03353298|Antimetabolites|antimetabolites|mesh-ancestor
5700596|NCT03353298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700597|NCT03353298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5700598|NCT03353298|Gout Suppressants|gout suppressants|mesh-ancestor
5916767|NCT05008887|Dermatologic Agents|dermatologic agents|mesh-ancestor
5916768|NCT05008887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5916769|NCT05008887|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5916770|NCT05008887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5916771|NCT05008887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5916772|NCT05009017|Bevacizumab|bevacizumab|mesh-list
5916773|NCT05009017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5916774|NCT05009017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5916775|NCT05009017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5916776|NCT05009017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5916777|NCT05009017|Growth Substances|growth substances|mesh-ancestor
5916778|NCT05009017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916779|NCT05009017|Growth Inhibitors|growth inhibitors|mesh-ancestor
5700599|NCT03353298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5916780|NCT05009082|Paclitaxel|paclitaxel|mesh-list
5916781|NCT05009082|Bevacizumab|bevacizumab|mesh-list
5916782|NCT05009082|Carboplatin|carboplatin|mesh-list
5916783|NCT05009082|Niraparib|niraparib|mesh-list
5916784|NCT05009082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5916785|NCT05009082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5916786|NCT05009082|Tubulin Modulators|tubulin modulators|mesh-ancestor
5916787|NCT05009082|Antimitotic Agents|antimitotic agents|mesh-ancestor
5916788|NCT05009082|Mitosis Modulators|mitosis modulators|mesh-ancestor
5916789|NCT05009082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700600|NCT03353298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5700601|NCT03353298|Antioxidants|antioxidants|mesh-ancestor
5700602|NCT03353298|Protective Agents|protective agents|mesh-ancestor
5700603|NCT03353298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700604|NCT03353103|Listerine|listerine|mesh-list
5700605|NCT03353103|Fluorides|fluorides|mesh-list
5700606|NCT03353103|Sodium Fluoride|sodium fluoride|mesh-list
5700607|NCT03353103|Cariostatic Agents|cariostatic agents|mesh-ancestor
5700608|NCT03353103|Protective Agents|protective agents|mesh-ancestor
5700609|NCT03353103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700610|NCT03353103|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5700611|NCT03353103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5700612|NCT03353025|Dopamine|dopamine|mesh-list
5916790|NCT05009082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5916791|NCT05009082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5916792|NCT05009082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5916793|NCT05009082|Growth Substances|growth substances|mesh-ancestor
6212709|NCT02193776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6212710|NCT02193776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6212711|NCT02193776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6212712|NCT02193776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6212713|NCT02193776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916794|NCT05009082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916795|NCT05009082|Growth Inhibitors|growth inhibitors|mesh-ancestor
5916796|NCT05009082|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5916797|NCT05009082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5916798|NCT05008939|Sevoflurane|sevoflurane|mesh-list
5916799|NCT05008939|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5916800|NCT05008939|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5916801|NCT05008939|Anesthetics, General|anesthetics, general|mesh-ancestor
5916802|NCT05008939|Anesthetics|anesthetics|mesh-ancestor
5916803|NCT05008939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5916804|NCT05008939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916805|NCT05008861|Pembrolizumab|pembrolizumab|mesh-list
5916806|NCT05008861|Nivolumab|nivolumab|mesh-list
5916807|NCT05008861|Durvalumab|durvalumab|mesh-list
5916808|NCT05008861|Antibodies|antibodies|mesh-list
5916809|NCT05008861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5916810|NCT05008861|Immunologic Factors|immunologic factors|mesh-ancestor
5916811|NCT05008861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916812|NCT05008861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5916813|NCT05008861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5916814|NCT05008861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5916815|NCT05008861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916816|NCT05008523|Analgesics, Opioid|analgesics, opioid|mesh-list
5916817|NCT05008523|Narcotics|narcotics|mesh-ancestor
5916818|NCT05008523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5916819|NCT05008523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916820|NCT05008523|Analgesics|analgesics|mesh-ancestor
5916821|NCT05008523|Sensory System Agents|sensory system agents|mesh-ancestor
5916822|NCT05008523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5916823|NCT05008679|Oseltamivir|oseltamivir|mesh-list
5916824|NCT05008679|Antiviral Agents|antiviral agents|mesh-ancestor
5916825|NCT05008679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5916826|NCT05008679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5916827|NCT05008679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916828|NCT05008666|Azacitidine|azacitidine|mesh-list
5916829|NCT05008666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5916830|NCT05008666|Antimetabolites|antimetabolites|mesh-ancestor
5916831|NCT05008666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916832|NCT05008666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5916833|NCT05008666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5916834|NCT05008458|Arginine Vasopressin|arginine vasopressin|mesh-list
5916835|NCT05008458|Hemostatics|hemostatics|mesh-ancestor
5916836|NCT05008458|Coagulants|coagulants|mesh-ancestor
5700613|NCT03353025|Dopamine Agonists|dopamine agonists|mesh-list
5916837|NCT05008458|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5700614|NCT03353025|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5700615|NCT03353025|Sympathomimetics|sympathomimetics|mesh-ancestor
5916838|NCT05008458|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5916839|NCT05008458|Natriuretic Agents|natriuretic agents|mesh-ancestor
5916840|NCT05008458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916841|NCT05008731|Botulinum Toxins|botulinum toxins|mesh-list
5916842|NCT05008731|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5916843|NCT05008731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5916844|NCT05008731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916845|NCT05008731|Cholinergic Agents|cholinergic agents|mesh-ancestor
5916846|NCT05008731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5916847|NCT05008731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916848|NCT05008367|Dexamethasone|dexamethasone|mesh-list
5916849|NCT05008367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5916850|NCT05008367|Antiemetics|antiemetics|mesh-ancestor
5916851|NCT05008367|Autonomic Agents|autonomic agents|mesh-ancestor
5916852|NCT05008367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5916853|NCT05008367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700616|NCT03353025|Autonomic Agents|autonomic agents|mesh-ancestor
5700617|NCT03353025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5700618|NCT03353025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700619|NCT03353025|Dopamine Agents|dopamine agents|mesh-ancestor
6496818|NCT00629473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6496819|NCT00629473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496820|NCT00629473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5700620|NCT03353025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5700621|NCT03353025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700622|NCT03353025|Protective Agents|protective agents|mesh-ancestor
5700623|NCT03353012|Levonorgestrel|levonorgestrel|mesh-list
5700624|NCT03353012|Etonogestrel|etonogestrel|mesh-list
5700625|NCT03353012|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5700626|NCT03353012|Contraceptive Agents|contraceptive agents|mesh-ancestor
5700627|NCT03353012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5700628|NCT03353012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700629|NCT03353012|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5700630|NCT03353012|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5700631|NCT03353012|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5916854|NCT05008367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5916855|NCT05008367|Glucocorticoids|glucocorticoids|mesh-ancestor
5916856|NCT05008367|Hormones|hormones|mesh-ancestor
5916857|NCT05008367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5916858|NCT05008367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5916859|NCT05008367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5916860|NCT05008029|Anesthetics|anesthetics|mesh-list
5916861|NCT05008029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5916862|NCT05008029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916863|NCT05008068|Simvastatin|simvastatin|mesh-list
5916864|NCT05008068|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5916865|NCT05008068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5700632|NCT03352947|Trametinib|trametinib|mesh-list
5700633|NCT03352947|Dabrafenib|dabrafenib|mesh-list
5700634|NCT03352947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5700635|NCT03352947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5700636|NCT03352947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5700637|NCT03352947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212714|NCT02193776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6212715|NCT02193776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6212716|NCT02193776|Antitubercular Agents|antitubercular agents|mesh-ancestor
5700641|NCT03352895|Grape Seed Extract|grape seed extract|mesh-list
5700642|NCT03352895|Resveratrol|resveratrol|mesh-list
5700643|NCT03352895|Antioxidants|antioxidants|mesh-ancestor
5700644|NCT03352895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700645|NCT03352895|Protective Agents|protective agents|mesh-ancestor
5700646|NCT03352895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700647|NCT03352895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5700648|NCT03352895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5916866|NCT05008068|Antimetabolites|antimetabolites|mesh-ancestor
5916867|NCT05008068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916868|NCT05008068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5916869|NCT05008068|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5916870|NCT05008068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5916871|NCT05008263|Liver Extracts|liver extracts|mesh-list
5916872|NCT05008263|Technetium Tc 99m mebrofenin|technetium tc 99m mebrofenin|mesh-list
5916873|NCT05008263|Hematinics|hematinics|mesh-ancestor
5916874|NCT05008263|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5916875|NCT05008263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916876|NCT05008237|Docetaxel|docetaxel|mesh-list
5916877|NCT05008237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5916878|NCT05008237|Tubulin Modulators|tubulin modulators|mesh-ancestor
5916879|NCT05008237|Antimitotic Agents|antimitotic agents|mesh-ancestor
5916880|NCT05008237|Mitosis Modulators|mitosis modulators|mesh-ancestor
5916881|NCT05008237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916882|NCT05008146|Hydrocortisone|hydrocortisone|mesh-list
5916883|NCT05008146|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
5916884|NCT05008146|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
5916885|NCT05008146|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
5916886|NCT05008146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5916887|NCT05008354|Pyridoxine|pyridoxine|mesh-list
5916888|NCT05008354|Vitamin B Complex|vitamin b complex|mesh-ancestor
5916889|NCT05008354|Vitamins|vitamins|mesh-ancestor
5916890|NCT05008354|Micronutrients|micronutrients|mesh-ancestor
5916891|NCT05008354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916892|NCT05008250|Metoprolol|metoprolol|mesh-list
5916893|NCT05008250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5916894|NCT05008250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5916895|NCT05008250|Sympatholytics|sympatholytics|mesh-ancestor
5916896|NCT05008250|Autonomic Agents|autonomic agents|mesh-ancestor
5916897|NCT05008250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5916898|NCT05008250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916899|NCT05008250|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5916900|NCT05008250|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5700649|NCT03352895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5700650|NCT03352895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5700651|NCT03352869|Metformin|metformin|mesh-list
5700652|NCT03352869|Exenatide|exenatide|mesh-list
5700653|NCT03352869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5700654|NCT03352869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700655|NCT03352869|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5700656|NCT03352869|Incretins|incretins|mesh-ancestor
5700657|NCT03352869|Hormones|hormones|mesh-ancestor
5700658|NCT03352869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5916901|NCT05008250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5916902|NCT05008250|Adrenergic Agents|adrenergic agents|mesh-ancestor
5916903|NCT05008250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5916904|NCT05008250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916905|NCT05007691|Salicylic Acid|salicylic acid|mesh-list
5916906|NCT05007691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5916907|NCT05007691|Antifungal Agents|antifungal agents|mesh-ancestor
5916908|NCT05007691|Keratolytic Agents|keratolytic agents|mesh-ancestor
5916909|NCT05007691|Dermatologic Agents|dermatologic agents|mesh-ancestor
5916910|NCT05007678|Leflunomide|leflunomide|mesh-list
5916911|NCT05007678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5916912|NCT05007678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916913|NCT05007678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5916914|NCT05007678|Immunologic Factors|immunologic factors|mesh-ancestor
5916915|NCT05007678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916916|NCT05007587|Leucovorin|leucovorin|mesh-list
5916917|NCT05007587|Fluorouracil|fluorouracil|mesh-list
5916918|NCT05007587|Raltitrexed|raltitrexed|mesh-list
5916919|NCT05007587|Oxaliplatin|oxaliplatin|mesh-list
5916920|NCT05007587|Lenvatinib|lenvatinib|mesh-list
5916921|NCT05007587|Antimetabolites|antimetabolites|mesh-ancestor
5916922|NCT05007587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916923|NCT05007587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5916924|NCT05007587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5916925|NCT05007587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5916926|NCT05007587|Immunologic Factors|immunologic factors|mesh-ancestor
5916927|NCT05007587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916928|NCT05007587|Antidotes|antidotes|mesh-ancestor
5916929|NCT05007587|Protective Agents|protective agents|mesh-ancestor
5916930|NCT05007587|Vitamin B Complex|vitamin b complex|mesh-ancestor
5916931|NCT05007587|Vitamins|vitamins|mesh-ancestor
5916932|NCT05007587|Micronutrients|micronutrients|mesh-ancestor
5916933|NCT05007587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5916934|NCT05007587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5916935|NCT05007587|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5916936|NCT05007860|Vaccines|vaccines|mesh-list
5916937|NCT05007860|Immunologic Factors|immunologic factors|mesh-ancestor
5916938|NCT05007860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916939|NCT05007561|Naltrexone|naltrexone|mesh-list
5916940|NCT05007561|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5916941|NCT05007561|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5916942|NCT05007561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916943|NCT05007561|Sensory System Agents|sensory system agents|mesh-ancestor
5700659|NCT03352843|Primaquine|primaquine|mesh-list
5700660|NCT03352843|Antimalarials|antimalarials|mesh-ancestor
5700661|NCT03352843|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5700662|NCT03352843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5700663|NCT03352843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5720920|NCT03209661|Dermatologic Agents|dermatologic agents|mesh-ancestor
5720921|NCT03209648|Itraconazole|itraconazole|mesh-list
5916944|NCT05007561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5963813|NCT04598594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963814|NCT04598594|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5963815|NCT04598594|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5963816|NCT04598594|Cholinergic Agents|cholinergic agents|mesh-ancestor
5963817|NCT04598594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5963818|NCT04598594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963819|NCT04598191|Iloprost|iloprost|mesh-list
5963820|NCT04598191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5963821|NCT04598191|Vasodilator Agents|vasodilator agents|mesh-ancestor
5970539|NCT04534257|Antifungal Agents|antifungal agents|mesh-ancestor
5970540|NCT04534257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5970541|NCT04534257|Immunologic Factors|immunologic factors|mesh-ancestor
5970542|NCT04534257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970543|NCT04534452|Phenylephrine|phenylephrine|mesh-list
5970544|NCT04534452|Oxymetazoline|oxymetazoline|mesh-list
5970545|NCT04534452|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5970546|NCT04534452|Mydriatics|mydriatics|mesh-ancestor
5970547|NCT04534452|Autonomic Agents|autonomic agents|mesh-ancestor
5970548|NCT04534452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5970549|NCT04534452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970550|NCT04534452|Sympathomimetics|sympathomimetics|mesh-ancestor
5970551|NCT04534452|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5970552|NCT04534452|Nasal Decongestants|nasal decongestants|mesh-ancestor
5970553|NCT04534452|Respiratory System Agents|respiratory system agents|mesh-ancestor
5970554|NCT04534452|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5970555|NCT04534452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5970556|NCT04534452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5970557|NCT04534452|Adrenergic Agents|adrenergic agents|mesh-ancestor
5970558|NCT04534452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5970559|NCT04534452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970560|NCT04534452|Protective Agents|protective agents|mesh-ancestor
5970561|NCT04534322|Dexamethasone|dexamethasone|mesh-list
5970562|NCT04534322|Melphalan|melphalan|mesh-list
5970563|NCT04534322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5970564|NCT04534322|Antiemetics|antiemetics|mesh-ancestor
5970565|NCT04534322|Autonomic Agents|autonomic agents|mesh-ancestor
5970566|NCT04534322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5970567|NCT04534322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970568|NCT04534322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5970569|NCT04534322|Glucocorticoids|glucocorticoids|mesh-ancestor
5970570|NCT04534322|Hormones|hormones|mesh-ancestor
5970571|NCT04534322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5970572|NCT04534322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5970573|NCT04534322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5970574|NCT04534322|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5970575|NCT04534322|Alkylating Agents|alkylating agents|mesh-ancestor
5970576|NCT04534322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970577|NCT04534322|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5970578|NCT04534322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5970579|NCT04534322|Immunologic Factors|immunologic factors|mesh-ancestor
5970580|NCT04533997|Furosemide|furosemide|mesh-list
5970581|NCT04533997|Diuretics|diuretics|mesh-ancestor
5970582|NCT04533997|Natriuretic Agents|natriuretic agents|mesh-ancestor
5970583|NCT04533997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970584|NCT04533997|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5970585|NCT04533997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5720922|NCT03209648|Antifungal Agents|antifungal agents|mesh-ancestor
5720923|NCT03209648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5720924|NCT03209648|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5720925|NCT03209648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5720926|NCT03209648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5720927|NCT03209648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5720928|NCT03209648|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5720929|NCT03209648|Hormone Antagonists|hormone antagonists|mesh-ancestor
5720930|NCT03209648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5720931|NCT03209648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700664|NCT03352700|Dyclonine|dyclonine|mesh-list
5700665|NCT03352700|Anesthetics, Local|anesthetics, local|mesh-ancestor
5700666|NCT03352700|Anesthetics|anesthetics|mesh-ancestor
5700667|NCT03352700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5700668|NCT03352700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700669|NCT03352700|Sensory System Agents|sensory system agents|mesh-ancestor
5700670|NCT03352700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5700671|NCT03352674|Insulin|insulin|mesh-list
5700672|NCT03352674|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5700673|NCT03352674|Insulin Glargine|insulin glargine|mesh-list
5700674|NCT03352674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5700675|NCT03352674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700676|NCT03352479|Analgesics, Opioid|analgesics, opioid|mesh-list
5916945|NCT05007652|Plerixafor|plerixafor|mesh-list
5916946|NCT05007652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5916947|NCT05007652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5916948|NCT05007652|Antiviral Agents|antiviral agents|mesh-ancestor
5916949|NCT05007652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5916950|NCT05007613|Atezolizumab|atezolizumab|mesh-list
5916951|NCT05007613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5916952|NCT05006911|Bromfenac|bromfenac|mesh-list
5916953|NCT05006911|Brimonidine Tartrate|brimonidine tartrate|mesh-list
5916954|NCT05006911|Phenylephrine|phenylephrine|mesh-list
5916955|NCT05006911|Oxymetazoline|oxymetazoline|mesh-list
5916956|NCT05006911|Hyaluronic Acid|hyaluronic acid|mesh-list
5916957|NCT05006911|Pilocarpine|pilocarpine|mesh-list
5916958|NCT05006911|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5916959|NCT05006911|Immunologic Factors|immunologic factors|mesh-ancestor
5916960|NCT05006911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5916961|NCT05006911|Viscosupplements|viscosupplements|mesh-ancestor
5916962|NCT05006911|Protective Agents|protective agents|mesh-ancestor
5916963|NCT05006911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5916964|NCT05006911|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5916965|NCT05006911|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5916966|NCT05006911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5916967|NCT05006911|Adrenergic Agents|adrenergic agents|mesh-ancestor
5916968|NCT05006911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5916969|NCT05006911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5916970|NCT05006911|Sympathomimetics|sympathomimetics|mesh-ancestor
5916971|NCT05006911|Autonomic Agents|autonomic agents|mesh-ancestor
5916972|NCT05006911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5700677|NCT03352479|Narcotics|narcotics|mesh-ancestor
5700678|NCT03352479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5700679|NCT03352479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700680|NCT03352479|Analgesics|analgesics|mesh-ancestor
5700681|NCT03352479|Sensory System Agents|sensory system agents|mesh-ancestor
5700682|NCT03352479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5916973|NCT05006911|Nasal Decongestants|nasal decongestants|mesh-ancestor
5916974|NCT05006911|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5916975|NCT05006911|Respiratory System Agents|respiratory system agents|mesh-ancestor
5916976|NCT05006911|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5916977|NCT05006911|Mydriatics|mydriatics|mesh-ancestor
5916978|NCT05006911|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5916979|NCT05006911|Miotics|miotics|mesh-ancestor
5916980|NCT05006911|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
5916981|NCT05006911|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5916982|NCT05006911|Cholinergic Agents|cholinergic agents|mesh-ancestor
5916983|NCT05006911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5916984|NCT05006911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5916985|NCT05006911|Analgesics|analgesics|mesh-ancestor
5916986|NCT05006911|Sensory System Agents|sensory system agents|mesh-ancestor
5916987|NCT05006911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5916988|NCT05006911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5916989|NCT05006898|Brimonidine Tartrate|brimonidine tartrate|mesh-list
5916990|NCT05006898|Oxymetazoline|oxymetazoline|mesh-list
5916991|NCT05006898|Pilocarpine|pilocarpine|mesh-list
5916992|NCT05006898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5916993|NCT05006898|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5916994|NCT05006898|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5916995|NCT05006898|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5916996|NCT05006898|Adrenergic Agents|adrenergic agents|mesh-ancestor
5916997|NCT05006898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5916998|NCT05006898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700683|NCT03352362|Acetaminophen|acetaminophen|mesh-list
5700684|NCT03352362|Ibuprofen|ibuprofen|mesh-list
5916999|NCT05006898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917000|NCT05006898|Sympathomimetics|sympathomimetics|mesh-ancestor
5917001|NCT05006898|Autonomic Agents|autonomic agents|mesh-ancestor
5963822|NCT04598074|Analgesics, Opioid|analgesics, opioid|mesh-list
5700685|NCT03352362|Propacetamol|propacetamol|mesh-list
5917002|NCT05006898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5917003|NCT05006898|Nasal Decongestants|nasal decongestants|mesh-ancestor
5917004|NCT05006898|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5917005|NCT05006898|Respiratory System Agents|respiratory system agents|mesh-ancestor
5917006|NCT05006898|Miotics|miotics|mesh-ancestor
5917007|NCT05006898|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
5917008|NCT05006898|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5917009|NCT05006898|Cholinergic Agents|cholinergic agents|mesh-ancestor
5917010|NCT05007262|Calcium Dobesilate|calcium dobesilate|mesh-list
5917011|NCT05007262|Calcium|calcium|mesh-list
5917012|NCT05007262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5917013|NCT05007262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917014|NCT05007262|Hemostatics|hemostatics|mesh-ancestor
5917015|NCT05007262|Coagulants|coagulants|mesh-ancestor
5917016|NCT05007041|Vaccines|vaccines|mesh-list
5917017|NCT05007041|Immunologic Factors|immunologic factors|mesh-ancestor
5917018|NCT05007041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917019|NCT05006846|Analgesics, Opioid|analgesics, opioid|mesh-list
5917020|NCT05006846|Narcotics|narcotics|mesh-ancestor
5917021|NCT05006846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5917022|NCT05006846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917023|NCT05006846|Analgesics|analgesics|mesh-ancestor
5917024|NCT05006846|Sensory System Agents|sensory system agents|mesh-ancestor
5917025|NCT05006846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5917026|NCT05007223|Doxycycline|doxycycline|mesh-list
5917027|NCT05007223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5917028|NCT05007223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5917029|NCT05007223|Antimalarials|antimalarials|mesh-ancestor
5917030|NCT05007223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5917031|NCT05007223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5917032|NCT05007132|Trifluridine|trifluridine|mesh-list
5917033|NCT05007132|Bevacizumab|bevacizumab|mesh-list
5917034|NCT05007132|Panitumumab|panitumumab|mesh-list
5917035|NCT05007132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5917036|NCT05007132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5917037|NCT05007132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5917038|NCT05007132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5917039|NCT05007132|Growth Substances|growth substances|mesh-ancestor
5917040|NCT05007132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917041|NCT05007132|Growth Inhibitors|growth inhibitors|mesh-ancestor
5917042|NCT05007132|Antimetabolites|antimetabolites|mesh-ancestor
5917043|NCT05007132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5917044|NCT05007132|Antiviral Agents|antiviral agents|mesh-ancestor
5917045|NCT05007132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5917046|NCT05006469|Dexamethasone|dexamethasone|mesh-list
5917047|NCT05006469|Doxorubicin|doxorubicin|mesh-list
5700686|NCT03352362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5700687|NCT03352362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5700688|NCT03352362|Analgesics|analgesics|mesh-ancestor
5700689|NCT03352362|Sensory System Agents|sensory system agents|mesh-ancestor
5700690|NCT03352362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5700691|NCT03352362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700692|NCT03352362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5700693|NCT03352362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5700694|NCT03352362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5917048|NCT05006469|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5917049|NCT05006469|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5917050|NCT05006469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5917051|NCT05006469|Antiemetics|antiemetics|mesh-ancestor
5917052|NCT05006469|Autonomic Agents|autonomic agents|mesh-ancestor
5917053|NCT05006469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5917054|NCT05006469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917055|NCT05006469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5917056|NCT05006469|Glucocorticoids|glucocorticoids|mesh-ancestor
5917057|NCT05006469|Hormones|hormones|mesh-ancestor
5917058|NCT05006469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5917059|NCT05006469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5917060|NCT05006469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5917061|NCT05006469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5917062|NCT05006469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5917063|NCT05006469|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5917064|NCT05006469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5917065|NCT05006469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5917066|NCT05006469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5917067|NCT05006469|Alkylating Agents|alkylating agents|mesh-ancestor
5917068|NCT05006664|Prednisone|prednisone|mesh-list
5917069|NCT05006664|Cyclophosphamide|cyclophosphamide|mesh-list
5917070|NCT05006664|Doxorubicin|doxorubicin|mesh-list
5917071|NCT05006664|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5917072|NCT05006664|Etoposide|etoposide|mesh-list
5917073|NCT05006664|Etoposide phosphate|etoposide phosphate|mesh-list
5917074|NCT05006664|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5917075|NCT05006664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5917076|NCT05006664|Immunologic Factors|immunologic factors|mesh-ancestor
5917077|NCT05006664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917078|NCT05006664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5917079|NCT05006664|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5917080|NCT05006664|Alkylating Agents|alkylating agents|mesh-ancestor
5917081|NCT05006664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5917082|NCT05006664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5917083|NCT05006664|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5917084|NCT05006664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5917085|NCT05006664|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5917086|NCT05006664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5917087|NCT05006664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5917088|NCT05006664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5917089|NCT05006664|Glucocorticoids|glucocorticoids|mesh-ancestor
5917090|NCT05006664|Hormones|hormones|mesh-ancestor
5700695|NCT03352362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5700696|NCT03352362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700697|NCT03352362|Antipyretics|antipyretics|mesh-ancestor
5700698|NCT03352349|Terlipressin|terlipressin|mesh-list
5700699|NCT03352349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5700700|NCT03352349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5700701|NCT03352128|Calcium|calcium|mesh-list
5700702|NCT03352128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5700703|NCT03352128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700704|NCT03352115|Prednisolone|prednisolone|mesh-list
5917091|NCT05006664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5917092|NCT05006664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5917093|NCT05006664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5917094|NCT05006664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5917095|NCT05006677|Vitamin K|vitamin k|mesh-list
5917096|NCT05006677|Anticoagulants|anticoagulants|mesh-list
5917097|NCT05006677|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
5917098|NCT05006677|Vitamins|vitamins|mesh-ancestor
5917099|NCT05006677|Micronutrients|micronutrients|mesh-ancestor
5917100|NCT05006677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917101|NCT05006677|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5917102|NCT05006677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5917103|NCT05006677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5917104|NCT05006677|Hemostatics|hemostatics|mesh-ancestor
5917105|NCT05006677|Coagulants|coagulants|mesh-ancestor
5917106|NCT05006287|Warfarin|warfarin|mesh-list
5917107|NCT05006287|Rivaroxaban|rivaroxaban|mesh-list
5917108|NCT05006287|Dabigatran|dabigatran|mesh-list
5917109|NCT05006287|Apixaban|apixaban|mesh-list
5917110|NCT05006287|Edoxaban|edoxaban|mesh-list
5917111|NCT05006287|Anticoagulants|anticoagulants|mesh-list
5917112|NCT05006287|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5917113|NCT05006287|Antithrombins|antithrombins|mesh-ancestor
5917114|NCT05006287|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5917115|NCT05006287|Protease Inhibitors|protease inhibitors|mesh-ancestor
5917116|NCT05006287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5917117|NCT05006287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5917118|NCT05006638|Atropine|atropine|mesh-list
5917119|NCT05006638|Ondansetron|ondansetron|mesh-list
5917120|NCT05006638|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
5917121|NCT05006638|Obidoxime Chloride|obidoxime chloride|mesh-list
5917122|NCT05006638|Antiemetics|antiemetics|mesh-ancestor
5917123|NCT05006638|Autonomic Agents|autonomic agents|mesh-ancestor
5917124|NCT05006638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5917125|NCT05006638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917126|NCT05006638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5917127|NCT05006638|Antipruritics|antipruritics|mesh-ancestor
5917128|NCT05006638|Dermatologic Agents|dermatologic agents|mesh-ancestor
5917129|NCT05006638|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5917130|NCT05006638|Serotonin Agents|serotonin agents|mesh-ancestor
5917131|NCT05006638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5917132|NCT05006638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5917133|NCT05006638|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5917134|NCT05006638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5917135|NCT05006638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5917136|NCT05006638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5700705|NCT03352115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5700706|NCT03352115|Glucocorticoids|glucocorticoids|mesh-ancestor
5700707|NCT03352115|Hormones|hormones|mesh-ancestor
5700708|NCT03352115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5700709|NCT03352115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700710|NCT03352115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5700711|NCT03352115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5700712|NCT03352076|Danazol|danazol|mesh-list
5700713|NCT03352076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5700714|NCT03352076|Hormone Antagonists|hormone antagonists|mesh-ancestor
5700715|NCT03352076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5700716|NCT03352076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700717|NCT03351998|Atorvastatin|atorvastatin|mesh-list
5700718|NCT03351998|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5700719|NCT03351998|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5917137|NCT05006638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5917138|NCT05006638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5917139|NCT05006638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5917140|NCT05006638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5917141|NCT05006638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5917142|NCT05006638|Respiratory System Agents|respiratory system agents|mesh-ancestor
5917143|NCT05006638|Mydriatics|mydriatics|mesh-ancestor
5917144|NCT05006638|Parasympatholytics|parasympatholytics|mesh-ancestor
6212717|NCT02193776|Leprostatic Agents|leprostatic agents|mesh-ancestor
6212718|NCT02193776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6212719|NCT02193776|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6212720|NCT02193776|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6212721|NCT02193776|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6212722|NCT02193776|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6212723|NCT02193776|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6212724|NCT02193776|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5917145|NCT05006638|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5917146|NCT05006638|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5917147|NCT05006638|Cholinergic Agents|cholinergic agents|mesh-ancestor
5917148|NCT05006638|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5917149|NCT05006638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5917150|NCT05006638|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
5917151|NCT05006638|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
5917152|NCT05006001|Colchicine|colchicine|mesh-list
5917153|NCT05006001|Gout Suppressants|gout suppressants|mesh-ancestor
5917154|NCT05006001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5917155|NCT05006001|Tubulin Modulators|tubulin modulators|mesh-ancestor
5917156|NCT05006001|Antimitotic Agents|antimitotic agents|mesh-ancestor
5917157|NCT05006001|Mitosis Modulators|mitosis modulators|mesh-ancestor
5917158|NCT05006001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5917159|NCT05006001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5917160|NCT05006209|Calcium|calcium|mesh-list
5917161|NCT05006209|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5917162|NCT05006209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917163|NCT05006235|Epinephrine|epinephrine|mesh-list
5917164|NCT05006235|Albuterol|albuterol|mesh-list
5917165|NCT05006235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5917166|NCT05006235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5917167|NCT05006235|Adrenergic Agents|adrenergic agents|mesh-ancestor
5917168|NCT05006235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5917169|NCT05006235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5917170|NCT05006235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917171|NCT05006235|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5917172|NCT05006235|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5917173|NCT05006235|Autonomic Agents|autonomic agents|mesh-ancestor
5917174|NCT05006235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5917175|NCT05006235|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5917176|NCT05006235|Respiratory System Agents|respiratory system agents|mesh-ancestor
5917177|NCT05006235|Mydriatics|mydriatics|mesh-ancestor
5917178|NCT05006235|Sympathomimetics|sympathomimetics|mesh-ancestor
5917179|NCT05006235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5700720|NCT03351998|Antimetabolites|antimetabolites|mesh-ancestor
5700721|NCT03351998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700722|NCT03351998|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5917180|NCT05006235|Tocolytic Agents|tocolytic agents|mesh-ancestor
5917181|NCT05006235|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5917182|NCT05006235|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5917183|NCT05005689|Fluorides|fluorides|mesh-list
5917184|NCT05005689|Sodium Fluoride|sodium fluoride|mesh-list
5917185|NCT05005689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917186|NCT05005689|Cariostatic Agents|cariostatic agents|mesh-ancestor
5917187|NCT05005689|Protective Agents|protective agents|mesh-ancestor
5917188|NCT05005494|Magnesium Sulfate|magnesium sulfate|mesh-list
5917189|NCT05005494|Analgesics|analgesics|mesh-ancestor
5917190|NCT05005494|Sensory System Agents|sensory system agents|mesh-ancestor
5917191|NCT05005494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5917192|NCT05005494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917193|NCT05005494|Anesthetics|anesthetics|mesh-ancestor
5917194|NCT05005494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5917195|NCT05005494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5917196|NCT05005494|Anticonvulsants|anticonvulsants|mesh-ancestor
5917197|NCT05005494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5917198|NCT05005494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5917199|NCT05005494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5917200|NCT05005494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5917201|NCT05005494|Tocolytic Agents|tocolytic agents|mesh-ancestor
5917202|NCT05005494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5917203|NCT05005715|Dexmedetomidine|dexmedetomidine|mesh-list
5917204|NCT05005715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5917205|NCT05005715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5917206|NCT05005715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917207|NCT05005715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5917208|NCT05005715|Analgesics|analgesics|mesh-ancestor
5917209|NCT05005715|Sensory System Agents|sensory system agents|mesh-ancestor
5917210|NCT05005715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5917211|NCT05005715|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5917212|NCT05005715|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5917213|NCT05005715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5917214|NCT05005715|Adrenergic Agents|adrenergic agents|mesh-ancestor
5917215|NCT05005715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5917216|NCT05005715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5917217|NCT05005637|Antitubercular Agents|antitubercular agents|mesh-list
5917218|NCT05005637|Prednisone|prednisone|mesh-list
5917219|NCT05005637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5917220|NCT05005637|Glucocorticoids|glucocorticoids|mesh-ancestor
5917221|NCT05005637|Hormones|hormones|mesh-ancestor
5917222|NCT05005637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5917223|NCT05005637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917224|NCT05005637|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5917225|NCT05005637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5917226|NCT05005637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5917227|NCT05005637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5917228|NCT05005455|Bevacizumab|bevacizumab|mesh-list
5917229|NCT05005455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5917230|NCT05005455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5917231|NCT05005455|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5917232|NCT05005455|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5917233|NCT05005455|Growth Substances|growth substances|mesh-ancestor
5917234|NCT05005455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917235|NCT05005455|Growth Inhibitors|growth inhibitors|mesh-ancestor
5917236|NCT05005741|Dulaglutide|dulaglutide|mesh-list
5917237|NCT05005741|Glucagon|glucagon|mesh-list
5917238|NCT05005741|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5917239|NCT05005741|Incretins|incretins|mesh-ancestor
5917240|NCT05005741|Hormones|hormones|mesh-ancestor
5917241|NCT05005741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5917242|NCT05005741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917243|NCT05005741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5700723|NCT03351998|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5700724|NCT03351998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5700725|NCT03351842|Cisplatin|cisplatin|mesh-list
5700726|NCT03351842|Carboplatin|carboplatin|mesh-list
5700727|NCT03351842|Pemetrexed|pemetrexed|mesh-list
5700728|NCT03351842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5700729|NCT03351842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5700730|NCT03351842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700731|NCT03351842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5700732|NCT03351842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5700733|NCT03351751|PF-06372865|pf-06372865|mesh-list
5917244|NCT05005741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5963823|NCT04598074|Narcotics|narcotics|mesh-ancestor
5963824|NCT04598074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5963825|NCT04598074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963826|NCT04598074|Analgesics|analgesics|mesh-ancestor
5963827|NCT04598074|Sensory System Agents|sensory system agents|mesh-ancestor
5963828|NCT04598074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5963829|NCT04598321|Talazoparib|talazoparib|mesh-list
5963830|NCT04598321|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5963831|NCT04598321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5963832|NCT04598321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963833|NCT04598321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5963834|NCT04598061|Dexmedetomidine|dexmedetomidine|mesh-list
5963835|NCT04598061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5963836|NCT04598061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5963837|NCT04598061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963838|NCT04598061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5963839|NCT04598061|Analgesics|analgesics|mesh-ancestor
5963840|NCT04598061|Sensory System Agents|sensory system agents|mesh-ancestor
5963841|NCT04598061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5963842|NCT04598061|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5963843|NCT04598061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5963844|NCT04598061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5963845|NCT04598061|Adrenergic Agents|adrenergic agents|mesh-ancestor
5963846|NCT04598061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5963847|NCT04598061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963848|NCT04597762|Cyclosporine|cyclosporine|mesh-list
5963849|NCT04597762|Hydrocortisone|hydrocortisone|mesh-list
5963850|NCT04597762|Cyclosporins|cyclosporins|mesh-list
5963851|NCT04597762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5963852|NCT04597762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963853|NCT04597762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5963854|NCT04597762|Immunologic Factors|immunologic factors|mesh-ancestor
5963855|NCT04597762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963856|NCT04597762|Antifungal Agents|antifungal agents|mesh-ancestor
5963857|NCT04597762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5700734|NCT03351751|GABA Modulators|gaba modulators|mesh-ancestor
5700735|NCT03351751|GABA Agents|gaba agents|mesh-ancestor
5700736|NCT03351751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5700737|NCT03351751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700738|NCT03351751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700739|NCT03351686|Tranexamic Acid|tranexamic acid|mesh-list
5700740|NCT03351686|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5700741|NCT03351686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5700742|NCT03351686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700743|NCT03351686|Hemostatics|hemostatics|mesh-ancestor
5700744|NCT03351686|Coagulants|coagulants|mesh-ancestor
5700745|NCT03351647|Ustekinumab|ustekinumab|mesh-list
5700746|NCT03351647|Dermatologic Agents|dermatologic agents|mesh-ancestor
5700747|NCT03351569|Immunoglobulins|immunoglobulins|mesh-list
5700748|NCT03351569|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5700749|NCT03351569|Antibodies|antibodies|mesh-list
5700750|NCT03351569|gamma-Globulins|gamma-globulins|mesh-list
5700751|NCT03351569|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5700752|NCT03351569|Immunologic Factors|immunologic factors|mesh-ancestor
5963858|NCT04597762|Dermatologic Agents|dermatologic agents|mesh-ancestor
5963859|NCT04597762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5963860|NCT04597762|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5963861|NCT04597762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5963862|NCT04597619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
5963863|NCT04597619|Analgesics|analgesics|mesh-ancestor
5700753|NCT03351569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700754|NCT03351517|Tapentadol|tapentadol|mesh-list
5917245|NCT05005299|Cyclophosphamide|cyclophosphamide|mesh-list
5917246|NCT05005299|Fludarabine|fludarabine|mesh-list
5917247|NCT05005299|Venetoclax|venetoclax|mesh-list
5917248|NCT05005299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5917249|NCT05005299|Immunologic Factors|immunologic factors|mesh-ancestor
5917250|NCT05005299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917251|NCT05005299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5917252|NCT05005299|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5917253|NCT05005299|Alkylating Agents|alkylating agents|mesh-ancestor
5917254|NCT05005299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5917255|NCT05005299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5917256|NCT05005299|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5917257|NCT05004909|Tretinoin|tretinoin|mesh-list
5917258|NCT05004909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5917259|NCT05004909|Keratolytic Agents|keratolytic agents|mesh-ancestor
5917260|NCT05004909|Dermatologic Agents|dermatologic agents|mesh-ancestor
5917261|NCT05005000|Triamcinolone|triamcinolone|mesh-list
5917262|NCT05005000|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5917263|NCT05005000|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5917264|NCT05005000|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5917265|NCT05005000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5917266|NCT05005000|Glucocorticoids|glucocorticoids|mesh-ancestor
5917267|NCT05005000|Hormones|hormones|mesh-ancestor
5917268|NCT05005000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5917269|NCT05005000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917270|NCT05005000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5917271|NCT05005000|Immunologic Factors|immunologic factors|mesh-ancestor
5917272|NCT05005000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5917273|NCT05005000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5917274|NCT05004753|Artemisinins|artemisinins|mesh-list
5917275|NCT05004753|Artemisinin|artemisinin|mesh-list
5917276|NCT05004753|Dexamethasone|dexamethasone|mesh-list
5917277|NCT05004753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5917278|NCT05004753|Antiemetics|antiemetics|mesh-ancestor
5917279|NCT05004753|Autonomic Agents|autonomic agents|mesh-ancestor
5917280|NCT05004753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5917281|NCT05004753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917282|NCT05004753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5917283|NCT05004753|Glucocorticoids|glucocorticoids|mesh-ancestor
5917284|NCT05004753|Hormones|hormones|mesh-ancestor
5917285|NCT05004753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5917286|NCT05004753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5917287|NCT05004753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5917288|NCT05004753|Antimalarials|antimalarials|mesh-ancestor
5917289|NCT05004753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5917290|NCT05004753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5917291|NCT05004753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5917292|NCT05004519|Dexmedetomidine|dexmedetomidine|mesh-list
5917293|NCT05004519|Remifentanil|remifentanil|mesh-list
5917294|NCT05004519|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5917295|NCT05004519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5917296|NCT05004519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917297|NCT05004519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5917298|NCT05004519|Analgesics|analgesics|mesh-ancestor
5917299|NCT05004519|Sensory System Agents|sensory system agents|mesh-ancestor
5917300|NCT05004519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5917301|NCT05004519|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5917302|NCT05004519|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5917303|NCT05004519|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5917304|NCT05004519|Adrenergic Agents|adrenergic agents|mesh-ancestor
5917305|NCT05004519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5917306|NCT05004519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5917307|NCT05004519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5917308|NCT05004519|Narcotics|narcotics|mesh-ancestor
5917309|NCT05004545|Propofol|propofol|mesh-list
5917310|NCT05004545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5917311|NCT05004545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5917312|NCT05004545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917313|NCT05004545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5917314|NCT05004545|Anesthetics, General|anesthetics, general|mesh-ancestor
5917315|NCT05004545|Anesthetics|anesthetics|mesh-ancestor
5917316|NCT05004064|Rituximab|rituximab|mesh-list
5917317|NCT05004064|Acalabrutinib|acalabrutinib|mesh-list
5917318|NCT05004064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5917319|NCT05004064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5917320|NCT05004064|Immunologic Factors|immunologic factors|mesh-ancestor
5700755|NCT03351517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5700756|NCT03351517|Narcotics|narcotics|mesh-ancestor
5700757|NCT03351517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5700758|NCT03351517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917321|NCT05004064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917322|NCT05004064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5917323|NCT05004207|Lactulose|lactulose|mesh-list
5917324|NCT05004207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5917325|NCT05004142|Letrozole|letrozole|mesh-list
5917326|NCT05004142|Fulvestrant|fulvestrant|mesh-list
5917327|NCT05004142|Goserelin|goserelin|mesh-list
5917328|NCT05004142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5917329|NCT05004142|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5917330|NCT05004142|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5917331|NCT05004142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5917332|NCT05004142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5917333|NCT05004142|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5917334|NCT05004142|Hormone Antagonists|hormone antagonists|mesh-ancestor
5917335|NCT05004142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5917336|NCT05004142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917337|NCT05004142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5917338|NCT05004142|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5917339|NCT05003765|Magnesium Sulfate|magnesium sulfate|mesh-list
5917340|NCT05003765|Buprenorphine|buprenorphine|mesh-list
5917341|NCT05003765|Bupivacaine|bupivacaine|mesh-list
5917342|NCT05003765|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5917343|NCT05003765|Anesthetics, Local|anesthetics, local|mesh-ancestor
5917344|NCT05003765|Anesthetics|anesthetics|mesh-ancestor
5917345|NCT05003765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5917346|NCT05003765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917347|NCT05003765|Sensory System Agents|sensory system agents|mesh-ancestor
5917348|NCT05003765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5917349|NCT05003765|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5917350|NCT05003765|Narcotics|narcotics|mesh-ancestor
5917351|NCT05003765|Analgesics|analgesics|mesh-ancestor
5917352|NCT05003765|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5917353|NCT05003765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5917354|NCT05003765|Anticonvulsants|anticonvulsants|mesh-ancestor
5917355|NCT05003765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5917356|NCT05003765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5917357|NCT05003765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5917358|NCT05003765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5917359|NCT05003765|Tocolytic Agents|tocolytic agents|mesh-ancestor
5917360|NCT05003765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5917361|NCT05003570|Fentanyl|fentanyl|mesh-list
5917362|NCT05003570|Remifentanil|remifentanil|mesh-list
5917363|NCT05003570|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5917364|NCT05003570|Narcotics|narcotics|mesh-ancestor
5917365|NCT05003570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5917366|NCT05003570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917367|NCT05003570|Analgesics|analgesics|mesh-ancestor
5917368|NCT05003570|Sensory System Agents|sensory system agents|mesh-ancestor
5917369|NCT05003570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5917370|NCT05003570|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5917371|NCT05003570|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5917372|NCT05003570|Anesthetics, General|anesthetics, general|mesh-ancestor
5917373|NCT05003570|Anesthetics|anesthetics|mesh-ancestor
5917374|NCT05003713|Prednisone|prednisone|mesh-list
5917375|NCT05003713|Cortisone|cortisone|mesh-list
5917376|NCT05003713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5917377|NCT05003713|Glucocorticoids|glucocorticoids|mesh-ancestor
5917378|NCT05003713|Hormones|hormones|mesh-ancestor
5917379|NCT05003713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5917380|NCT05003713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917381|NCT05003713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5917382|NCT05003713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5917383|NCT05003752|Goserelin|goserelin|mesh-list
5917384|NCT05003752|Androgens|androgens|mesh-list
5700759|NCT03351517|Analgesics|analgesics|mesh-ancestor
5700760|NCT03351517|Sensory System Agents|sensory system agents|mesh-ancestor
5700761|NCT03351517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5700762|NCT03351517|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5917385|NCT05003752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5917386|NCT05003752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5917387|NCT05003752|Hormones|hormones|mesh-ancestor
5917388|NCT05003752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5700763|NCT03351517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5700764|NCT03351517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5700765|NCT03351517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700766|NCT03351517|Adrenergic Agents|adrenergic agents|mesh-ancestor
5917389|NCT05003752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917390|NCT05003648|Pramipexole|pramipexole|mesh-list
5917391|NCT05003648|Antioxidants|antioxidants|mesh-ancestor
5917392|NCT05003648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5917393|NCT05003648|Protective Agents|protective agents|mesh-ancestor
5917394|NCT05003648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917395|NCT05003648|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5917396|NCT05003648|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5917397|NCT05003648|Dopamine Agonists|dopamine agonists|mesh-ancestor
5917398|NCT05003648|Dopamine Agents|dopamine agents|mesh-ancestor
5917399|NCT05003648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5917400|NCT05003258|Dexamethasone|dexamethasone|mesh-list
5917401|NCT05003258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5917402|NCT05003258|Antiemetics|antiemetics|mesh-ancestor
5917403|NCT05003258|Autonomic Agents|autonomic agents|mesh-ancestor
5917404|NCT05003258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5917405|NCT05003258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917406|NCT05003258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5917407|NCT05003258|Glucocorticoids|glucocorticoids|mesh-ancestor
5917408|NCT05003258|Hormones|hormones|mesh-ancestor
5917409|NCT05003258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5917410|NCT05003258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5917411|NCT05003258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5917412|NCT05003596|Methylprednisolone|methylprednisolone|mesh-list
5917413|NCT05003596|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5917414|NCT05003596|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5917415|NCT05003596|Prednisolone|prednisolone|mesh-list
5917416|NCT05003596|Prednisolone acetate|prednisolone acetate|mesh-list
5917417|NCT05003596|Narcotics|narcotics|mesh-list
5917418|NCT05003596|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5917419|NCT05003596|Prednisolone phosphate|prednisolone phosphate|mesh-list
5917420|NCT05003596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5917421|NCT05003596|Antiemetics|antiemetics|mesh-ancestor
5917422|NCT05003596|Autonomic Agents|autonomic agents|mesh-ancestor
5917423|NCT05003596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5917424|NCT05003596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917425|NCT05003596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5917426|NCT05003596|Glucocorticoids|glucocorticoids|mesh-ancestor
5917427|NCT05003596|Hormones|hormones|mesh-ancestor
5917428|NCT05003596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5917429|NCT05003596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5917430|NCT05003596|Protective Agents|protective agents|mesh-ancestor
5700767|NCT03351517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5700768|NCT03351361|Nivolumab|nivolumab|mesh-list
5700769|NCT03351361|Ipilimumab|ipilimumab|mesh-list
5917431|NCT05003596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5917432|NCT05003596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5917433|NCT05003596|Analgesics|analgesics|mesh-ancestor
5917434|NCT05003596|Sensory System Agents|sensory system agents|mesh-ancestor
5917435|NCT05003596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5917436|NCT05003700|Lenvatinib|lenvatinib|mesh-list
5917437|NCT05003700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5917438|NCT05003700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5917439|NCT05003700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5917440|NCT05003700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5917441|NCT05002933|Insulin Glargine|insulin glargine|mesh-list
5917442|NCT05002933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5917443|NCT05002933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963864|NCT04597619|Sensory System Agents|sensory system agents|mesh-ancestor
5963865|NCT04597619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5963866|NCT04597619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963867|NCT04597931|Zoledronic Acid|zoledronic acid|mesh-list
5963868|NCT04597931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5917444|NCT05002725|Lidocaine|lidocaine|mesh-list
5917445|NCT05002725|Anesthetics, Local|anesthetics, local|mesh-ancestor
5700770|NCT03351361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5700771|NCT03351361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5700772|NCT03351361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5700773|NCT03351361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700774|NCT03351322|Minoxidil|minoxidil|mesh-list
5700775|NCT03351322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5700776|NCT03351322|Vasodilator Agents|vasodilator agents|mesh-ancestor
5700777|NCT03351296|Bevacizumab|bevacizumab|mesh-list
5700778|NCT03351296|Capecitabine|capecitabine|mesh-list
5700779|NCT03351296|Temozolomide|temozolomide|mesh-list
5700780|NCT03351296|Streptozocin|streptozocin|mesh-list
5700781|NCT03351296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5700782|NCT03351296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5700783|NCT03351296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5700784|NCT03351296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5700785|NCT03351296|Growth Substances|growth substances|mesh-ancestor
5700786|NCT03351296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700787|NCT03351296|Growth Inhibitors|growth inhibitors|mesh-ancestor
5700788|NCT03351296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5700789|NCT03351296|Antimetabolites|antimetabolites|mesh-ancestor
5700790|NCT03351296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5917446|NCT05002725|Anesthetics|anesthetics|mesh-ancestor
5917447|NCT05002725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5917448|NCT05002725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917449|NCT05002725|Sensory System Agents|sensory system agents|mesh-ancestor
5917450|NCT05002725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5917451|NCT05002725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5917452|NCT05002725|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5700791|NCT03351296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5700792|NCT03351296|Alkylating Agents|alkylating agents|mesh-ancestor
5700793|NCT03351296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5700794|NCT03351244|BI 409306|bi 409306|mesh-list
5700795|NCT03351244|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5700796|NCT03351244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5700797|NCT03351244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700798|NCT03351205|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5700799|NCT03351205|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5700800|NCT03351205|Estradiol|estradiol|mesh-list
5700801|NCT03351205|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5700802|NCT03351205|Dydrogesterone|dydrogesterone|mesh-list
5700803|NCT03351205|Estrogens|estrogens|mesh-ancestor
5700804|NCT03351205|Hormones|hormones|mesh-ancestor
5700805|NCT03351205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5700806|NCT03351205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700807|NCT03351205|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5700808|NCT03351205|Contraceptive Agents|contraceptive agents|mesh-ancestor
5700809|NCT03351205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5917453|NCT05002725|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5917454|NCT05002725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5917455|NCT05002725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5917456|NCT05002465|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5917457|NCT05002465|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5917458|NCT05002465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5917459|NCT05002673|Anesthetics|anesthetics|mesh-list
5917460|NCT05002673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5917461|NCT05002673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917467|NCT05002517|Methylprednisolone|methylprednisolone|mesh-list
5917468|NCT05002517|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5917469|NCT05002517|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5917470|NCT05002517|Prednisolone|prednisolone|mesh-list
5917471|NCT05002517|Prednisolone acetate|prednisolone acetate|mesh-list
5917472|NCT05002517|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5917473|NCT05002517|Prednisolone phosphate|prednisolone phosphate|mesh-list
5917474|NCT05002517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5917475|NCT05002517|Antiemetics|antiemetics|mesh-ancestor
5917476|NCT05002517|Autonomic Agents|autonomic agents|mesh-ancestor
6496821|NCT00629473|Glucocorticoids|glucocorticoids|mesh-ancestor
5917477|NCT05002517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5917478|NCT05002517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917479|NCT05002517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5917480|NCT05002517|Glucocorticoids|glucocorticoids|mesh-ancestor
5917481|NCT05002517|Hormones|hormones|mesh-ancestor
5917482|NCT05002517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5917483|NCT05002517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5917484|NCT05002517|Protective Agents|protective agents|mesh-ancestor
5917485|NCT05002517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5917486|NCT05002517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5700810|NCT03351205|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5700811|NCT03351205|Progestins|progestins|mesh-ancestor
5720932|NCT03209648|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5720933|NCT03209687|Menotropins|menotropins|mesh-list
5720934|NCT03209687|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5720935|NCT03209687|Fertility Agents|fertility agents|mesh-ancestor
5720936|NCT03209687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5720937|NCT03209687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720938|NCT03209401|Carboplatin|carboplatin|mesh-list
5720939|NCT03209401|Niraparib|niraparib|mesh-list
5720940|NCT03209401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5917487|NCT05002309|Antidepressive Agents|antidepressive agents|mesh-list
5917488|NCT05002309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5917489|NCT05002270|Cetuximab|cetuximab|mesh-list
5917490|NCT05002270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5917491|NCT05002270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5917492|NCT05002361|Dexamethasone|dexamethasone|mesh-list
5917493|NCT05002361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5917494|NCT05002361|Antiemetics|antiemetics|mesh-ancestor
5917495|NCT05002361|Autonomic Agents|autonomic agents|mesh-ancestor
5917496|NCT05002361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5917497|NCT05002361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917498|NCT05002361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5917499|NCT05002361|Glucocorticoids|glucocorticoids|mesh-ancestor
5917500|NCT05002361|Hormones|hormones|mesh-ancestor
5917501|NCT05002361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5917502|NCT05002361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5917503|NCT05002361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5917504|NCT05002686|Paclitaxel|paclitaxel|mesh-list
5917505|NCT05002686|Capecitabine|capecitabine|mesh-list
5917506|NCT05002686|Oxaliplatin|oxaliplatin|mesh-list
5917507|NCT05002686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5917508|NCT05002686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5917509|NCT05002686|Tubulin Modulators|tubulin modulators|mesh-ancestor
5917510|NCT05002686|Antimitotic Agents|antimitotic agents|mesh-ancestor
5917511|NCT05002686|Mitosis Modulators|mitosis modulators|mesh-ancestor
5917512|NCT05002686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5917513|NCT05002686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5917514|NCT05002686|Antimetabolites|antimetabolites|mesh-ancestor
5917515|NCT05002036|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5917516|NCT05002036|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5917517|NCT05002413|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5917518|NCT05002413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5917519|NCT05002101|Zinc|zinc|mesh-list
5917520|NCT05002101|Zinc Sulfate|zinc sulfate|mesh-list
5917521|NCT05002101|Trace Elements|trace elements|mesh-ancestor
5720941|NCT03209401|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5720942|NCT03209401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5720943|NCT03209401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5720944|NCT03209037|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5720945|NCT03209037|Antiviral Agents|antiviral agents|mesh-ancestor
5720946|NCT03209037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5720947|NCT03209180|Carvedilol|carvedilol|mesh-list
5720948|NCT03209180|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5720949|NCT03209180|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5720950|NCT03209180|Adrenergic Agents|adrenergic agents|mesh-ancestor
5720951|NCT03209180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5917522|NCT05002101|Micronutrients|micronutrients|mesh-ancestor
5917523|NCT05002101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917524|NCT05002101|Astringents|astringents|mesh-ancestor
5917525|NCT05002101|Dermatologic Agents|dermatologic agents|mesh-ancestor
5917526|NCT05001919|Mitogens|mitogens|mesh-list
5917527|NCT05001919|Mitosis Modulators|mitosis modulators|mesh-ancestor
5720952|NCT03209180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5917528|NCT05001919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5917529|NCT05001763|Prucalopride|prucalopride|mesh-list
5917530|NCT05001763|Laxatives|laxatives|mesh-ancestor
5917531|NCT05001763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5917532|NCT05001763|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
5917533|NCT05001763|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5917534|NCT05001763|Serotonin Agents|serotonin agents|mesh-ancestor
5917535|NCT05001763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5917536|NCT05001763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5917537|NCT05001763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917538|NCT05002114|Cannabidiol|cannabidiol|mesh-list
5917539|NCT05002114|Anticonvulsants|anticonvulsants|mesh-ancestor
5917540|NCT05001724|Docetaxel|docetaxel|mesh-list
5917541|NCT05001724|Lenvatinib|lenvatinib|mesh-list
5700812|NCT03351062|Tamoxifen|tamoxifen|mesh-list
5700813|NCT03351062|Toremifene|toremifene|mesh-list
5700814|NCT03351062|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5700815|NCT03351062|Hormone Antagonists|hormone antagonists|mesh-ancestor
5700816|NCT03351062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5700817|NCT03351062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700818|NCT03351062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5700819|NCT03351062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5917542|NCT05001724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5917543|NCT05001724|Tubulin Modulators|tubulin modulators|mesh-ancestor
5917544|NCT05001724|Antimitotic Agents|antimitotic agents|mesh-ancestor
5917545|NCT05001724|Mitosis Modulators|mitosis modulators|mesh-ancestor
5917546|NCT05001724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5917547|NCT05001724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5917548|NCT05001724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5917549|NCT05001750|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5917550|NCT05001750|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5917551|NCT05001750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5917552|NCT05001750|Antitubercular Agents|antitubercular agents|mesh-ancestor
5917553|NCT05001854|Fludrocortisone|fludrocortisone|mesh-list
5917554|NCT05001854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5700820|NCT03351062|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5700821|NCT03351062|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5700822|NCT03351062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5700823|NCT03350737|Heparin|heparin|mesh-list
5700824|NCT03350737|Anticoagulants|anticoagulants|mesh-ancestor
5700825|NCT03350737|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5700826|NCT03350737|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5700827|NCT03350737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700828|NCT03350659|Midodrine|midodrine|mesh-list
5700829|NCT03350659|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
5700830|NCT03350659|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5700831|NCT03350659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5700832|NCT03350659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5700833|NCT03350659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700834|NCT03350659|Adrenergic Agents|adrenergic agents|mesh-ancestor
5700835|NCT03350659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5700836|NCT03350659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700837|NCT03350659|Sympathomimetics|sympathomimetics|mesh-ancestor
5700838|NCT03350659|Autonomic Agents|autonomic agents|mesh-ancestor
5700839|NCT03350659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5700840|NCT03350659|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5700841|NCT03350659|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5917555|NCT05001828|Azacitidine|azacitidine|mesh-list
5917556|NCT05001828|Venetoclax|venetoclax|mesh-list
5917557|NCT05001828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5917558|NCT05001828|Antimetabolites|antimetabolites|mesh-ancestor
5917559|NCT05001828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5917560|NCT05001828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5917561|NCT05001828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5917562|NCT05001672|Tenofovir|tenofovir|mesh-list
5700842|NCT03350659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5700843|NCT03350659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5700844|NCT03350633|Azathioprine|azathioprine|mesh-list
5700845|NCT03350633|Antimetabolites|antimetabolites|mesh-ancestor
5700846|NCT03350633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700847|NCT03350633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5700848|NCT03350633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5917563|NCT05001672|Antiviral Agents|antiviral agents|mesh-ancestor
5917564|NCT05001672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5917565|NCT05001672|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5700849|NCT03350633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5917566|NCT05001672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5917567|NCT05001672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5917568|NCT05001672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5917569|NCT05001672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5917570|NCT05001672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5917571|NCT05001412|Carboplatin|carboplatin|mesh-list
5917572|NCT05001412|Etoposide|etoposide|mesh-list
5917573|NCT05001412|Apatinib|apatinib|mesh-list
5917574|NCT05001412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5917575|NCT05001412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5917576|NCT05001412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5917577|NCT05001412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5917578|NCT05001412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5917579|NCT05001412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5917580|NCT05001412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5917581|NCT05001776|PENTA|penta|mesh-list
5917582|NCT05001776|Fondaparinux|fondaparinux|mesh-list
5917583|NCT05001776|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5917584|NCT05001776|Antithrombins|antithrombins|mesh-ancestor
5917585|NCT05001776|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5917586|NCT05001776|Protease Inhibitors|protease inhibitors|mesh-ancestor
5917587|NCT05001776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5917588|NCT05001776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5917589|NCT05001776|Anticoagulants|anticoagulants|mesh-ancestor
5917590|NCT05001776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5917591|NCT05001776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5917592|NCT05001529|Antibodies|antibodies|mesh-list
5917593|NCT05001529|Immunologic Factors|immunologic factors|mesh-ancestor
5917594|NCT05001529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917595|NCT05001243|Bromfenac|bromfenac|mesh-list
5917596|NCT05001243|Brimonidine Tartrate|brimonidine tartrate|mesh-list
5917597|NCT05001243|Phenylephrine|phenylephrine|mesh-list
5917598|NCT05001243|Oxymetazoline|oxymetazoline|mesh-list
5917599|NCT05001243|Hyaluronic Acid|hyaluronic acid|mesh-list
5917600|NCT05001243|Pilocarpine|pilocarpine|mesh-list
5917601|NCT05001243|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5917602|NCT05001243|Immunologic Factors|immunologic factors|mesh-ancestor
5917603|NCT05001243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917604|NCT05001243|Viscosupplements|viscosupplements|mesh-ancestor
5917605|NCT05001243|Protective Agents|protective agents|mesh-ancestor
5917606|NCT05001243|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5917607|NCT05001243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5917608|NCT05001243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5917609|NCT05001243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5917610|NCT05001243|Adrenergic Agents|adrenergic agents|mesh-ancestor
5917611|NCT05001243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5917612|NCT05001243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5917613|NCT05001243|Sympathomimetics|sympathomimetics|mesh-ancestor
5917614|NCT05001243|Autonomic Agents|autonomic agents|mesh-ancestor
5917615|NCT05001243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5917616|NCT05001243|Nasal Decongestants|nasal decongestants|mesh-ancestor
5917617|NCT05001243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5917618|NCT05001243|Respiratory System Agents|respiratory system agents|mesh-ancestor
5917619|NCT05001243|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5917620|NCT05001243|Mydriatics|mydriatics|mesh-ancestor
5917621|NCT05001243|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5917622|NCT05001243|Miotics|miotics|mesh-ancestor
5917623|NCT05001243|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
5917624|NCT05001243|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5917625|NCT05001243|Cholinergic Agents|cholinergic agents|mesh-ancestor
5917626|NCT05001243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5917627|NCT05001243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5917628|NCT05001243|Analgesics|analgesics|mesh-ancestor
5917629|NCT05001243|Sensory System Agents|sensory system agents|mesh-ancestor
5917630|NCT05001243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5917631|NCT05001243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5917632|NCT05001061|Misoprostol|misoprostol|mesh-list
5917633|NCT05001061|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5917634|NCT05001061|Abortifacient Agents|abortifacient agents|mesh-ancestor
5917635|NCT05001061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5917636|NCT05001061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917637|NCT05001061|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5917638|NCT05001061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5917639|NCT05001061|Oxytocics|oxytocics|mesh-ancestor
5917640|NCT05001204|68Ga-NOTA-RM26|68ga-nota-rm26|mesh-list
5917641|NCT05001204|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5917642|NCT05001204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5917643|NCT05001152|Ozanimod|ozanimod|mesh-list
6496822|NCT00629473|Hormones|hormones|mesh-ancestor
5917644|NCT05001152|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5917645|NCT05001152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5917646|NCT05001152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5917647|NCT05001152|Immunologic Factors|immunologic factors|mesh-ancestor
5917648|NCT05001152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963869|NCT04597931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963870|NCT04597775|Hydroxychloroquine|hydroxychloroquine|mesh-list
5963871|NCT04597775|Antimalarials|antimalarials|mesh-ancestor
5963872|NCT04597775|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5963873|NCT04597775|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5963874|NCT04597775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5963875|NCT04597775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5963876|NCT04597775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963877|NCT04597775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5963878|NCT04597437|Zanamivir|zanamivir|mesh-list
5963879|NCT04597437|Antiviral Agents|antiviral agents|mesh-ancestor
5963880|NCT04597437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5963881|NCT04597437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5963882|NCT04597437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963883|NCT04597424|Doxycycline|doxycycline|mesh-list
5963884|NCT04597424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5963885|NCT04597424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5963886|NCT04597424|Antimalarials|antimalarials|mesh-ancestor
5963887|NCT04597424|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5963888|NCT04597424|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5963889|NCT04597333|Dinoprostone|dinoprostone|mesh-list
5963890|NCT04597333|Oxytocics|oxytocics|mesh-ancestor
5963891|NCT04597333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5963892|NCT04597333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700850|NCT03350633|Immunologic Factors|immunologic factors|mesh-ancestor
5700851|NCT03350633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700852|NCT03350633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5700853|NCT03350516|Calcium, Dietary|calcium, dietary|mesh-list
5700854|NCT03350516|Calcium Carbonate|calcium carbonate|mesh-list
5700855|NCT03350516|Calcium|calcium|mesh-list
5700856|NCT03350516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5700857|NCT03350516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700858|NCT03350516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5700859|NCT03350516|Antacids|antacids|mesh-ancestor
5700860|NCT03350516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700861|NCT03350516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5700862|NCT03350399|Mitogens|mitogens|mesh-list
5700863|NCT03350399|Mitosis Modulators|mitosis modulators|mesh-ancestor
5700864|NCT03350399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700865|NCT03350386|Oxaprozin|oxaprozin|mesh-list
5700866|NCT03350386|Dotinurad|dotinurad|mesh-list
5700867|NCT03350386|Uricosuric Agents|uricosuric agents|mesh-ancestor
5700868|NCT03350386|Gout Suppressants|gout suppressants|mesh-ancestor
5963893|NCT04597320|Fentanyl|fentanyl|mesh-list
5963894|NCT04597320|Midazolam|midazolam|mesh-list
5963895|NCT04597320|Esketamine|esketamine|mesh-list
5963896|NCT04597320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5963897|NCT04597320|Narcotics|narcotics|mesh-ancestor
5963898|NCT04597320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5963899|NCT04597320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963900|NCT04597320|Analgesics|analgesics|mesh-ancestor
5963901|NCT04597320|Sensory System Agents|sensory system agents|mesh-ancestor
5963902|NCT04597320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5963903|NCT04597320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5963904|NCT04597320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5963905|NCT04597320|Anesthetics, General|anesthetics, general|mesh-ancestor
5963906|NCT04597320|Anesthetics|anesthetics|mesh-ancestor
5963907|NCT04597320|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5963908|NCT04597320|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5963909|NCT04597320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5963910|NCT04597320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5963911|NCT04597320|GABA Modulators|gaba modulators|mesh-ancestor
5963912|NCT04597320|GABA Agents|gaba agents|mesh-ancestor
5963913|NCT04597320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5963914|NCT04597320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700869|NCT03350386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5700870|NCT03350386|Renal Agents|renal agents|mesh-ancestor
5700871|NCT03350386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5700872|NCT03350386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5700873|NCT03350386|Analgesics|analgesics|mesh-ancestor
5700874|NCT03350386|Sensory System Agents|sensory system agents|mesh-ancestor
5963915|NCT04597320|Antidepressive Agents|antidepressive agents|mesh-ancestor
5700875|NCT03350386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5700876|NCT03350386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700877|NCT03350386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5700878|NCT03350386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5700879|NCT03350386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5700880|NCT03350386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700881|NCT03350373|Dotinurad|dotinurad|mesh-list
5700882|NCT03350373|Uricosuric Agents|uricosuric agents|mesh-ancestor
5700883|NCT03350373|Gout Suppressants|gout suppressants|mesh-ancestor
5700884|NCT03350373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5700885|NCT03350373|Renal Agents|renal agents|mesh-ancestor
5700886|NCT03350347|Darbepoetin alfa|darbepoetin alfa|mesh-list
5917649|NCT05001074|Tacrolimus|tacrolimus|mesh-list
5917650|NCT05001074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5917651|NCT05001074|Immunologic Factors|immunologic factors|mesh-ancestor
5917652|NCT05001074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917653|NCT05001074|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5917654|NCT05001074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5917655|NCT05001074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5917656|NCT05001048|Phenylephrine|phenylephrine|mesh-list
5917657|NCT05001048|Oxymetazoline|oxymetazoline|mesh-list
5917658|NCT05001048|Synephrine|synephrine|mesh-list
5917659|NCT05001048|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5917660|NCT05001048|Mydriatics|mydriatics|mesh-ancestor
5917661|NCT05001048|Autonomic Agents|autonomic agents|mesh-ancestor
5917662|NCT05001048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5917663|NCT05001048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917664|NCT05001048|Sympathomimetics|sympathomimetics|mesh-ancestor
5917665|NCT05001048|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5917666|NCT05001048|Nasal Decongestants|nasal decongestants|mesh-ancestor
5917667|NCT05001048|Respiratory System Agents|respiratory system agents|mesh-ancestor
5917668|NCT05001048|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5917669|NCT05001048|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5917670|NCT05001048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5917671|NCT05001048|Adrenergic Agents|adrenergic agents|mesh-ancestor
5917672|NCT05001048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5917673|NCT05001048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5917674|NCT05001048|Protective Agents|protective agents|mesh-ancestor
5917675|NCT05000892|Paclitaxel|paclitaxel|mesh-list
5917676|NCT05000892|Carboplatin|carboplatin|mesh-list
5917677|NCT05000892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5917678|NCT05000892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6496823|NCT00629473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6496824|NCT00629473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6496825|NCT00629473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6675880|NCT01578252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6675881|NCT01578252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675882|NCT01578252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6675883|NCT01578252|Antipruritics|antipruritics|mesh-ancestor
6675884|NCT01578252|Dermatologic Agents|dermatologic agents|mesh-ancestor
6675885|NCT01578252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6675886|NCT01578252|Serotonin Agents|serotonin agents|mesh-ancestor
5700887|NCT03350347|Hematinics|hematinics|mesh-ancestor
5700888|NCT03350334|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5917679|NCT05000892|Tubulin Modulators|tubulin modulators|mesh-ancestor
5917680|NCT05000892|Antimitotic Agents|antimitotic agents|mesh-ancestor
5917681|NCT05000892|Mitosis Modulators|mitosis modulators|mesh-ancestor
5917682|NCT05000892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5917683|NCT05000658|Dexamethasone|dexamethasone|mesh-list
5917684|NCT05000658|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
5917685|NCT05000658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5917686|NCT05000658|Antiemetics|antiemetics|mesh-ancestor
5917687|NCT05000658|Autonomic Agents|autonomic agents|mesh-ancestor
5917688|NCT05000658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5917689|NCT05000658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917690|NCT05000658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5917691|NCT05000658|Glucocorticoids|glucocorticoids|mesh-ancestor
5917692|NCT05000658|Hormones|hormones|mesh-ancestor
5917693|NCT05000658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5917694|NCT05000658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5700889|NCT03350334|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5700890|NCT03350334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5917695|NCT05000658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5917696|NCT05000736|Fulvestrant|fulvestrant|mesh-list
5917697|NCT05000736|Palbociclib|palbociclib|mesh-list
5700891|NCT03350334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5700892|NCT03350334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700893|NCT03350334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5700894|NCT03350334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700895|NCT03350334|Analgesics|analgesics|mesh-ancestor
5700896|NCT03350334|Sensory System Agents|sensory system agents|mesh-ancestor
5700897|NCT03350334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5700898|NCT03350334|Antidepressive Agents|antidepressive agents|mesh-ancestor
5700899|NCT03350334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5700900|NCT03350334|Dopamine Agents|dopamine agents|mesh-ancestor
5700901|NCT03350321|Darbepoetin alfa|darbepoetin alfa|mesh-list
5700902|NCT03350321|Hematinics|hematinics|mesh-ancestor
5700903|NCT03350295|Nifurtimox|nifurtimox|mesh-list
5700904|NCT03350295|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5700905|NCT03350295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5917698|NCT05000736|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5917699|NCT05000736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5917700|NCT05000736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5917701|NCT05000736|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5917702|NCT05000736|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5917703|NCT05000736|Hormone Antagonists|hormone antagonists|mesh-ancestor
5917704|NCT05000736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5917705|NCT05000736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917706|NCT05000736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5917707|NCT05000736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5917708|NCT05000736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5917709|NCT05000736|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5917710|NCT05000697|Oxaliplatin|oxaliplatin|mesh-list
5917711|NCT05000697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5917712|NCT05000086|Diphosphonates|diphosphonates|mesh-list
6675887|NCT01578252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6675888|NCT01578252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675889|NCT01578252|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5917713|NCT05000086|Methylene diphosphonate|methylene diphosphonate|mesh-list
5917714|NCT05000086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5917715|NCT05000086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917716|NCT05000281|Ibuprofen|ibuprofen|mesh-list
5917717|NCT05000281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5917718|NCT05000281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5917719|NCT05000281|Analgesics|analgesics|mesh-ancestor
5917720|NCT05000281|Sensory System Agents|sensory system agents|mesh-ancestor
5917721|NCT05000281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5917722|NCT05000281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917723|NCT05000281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5917724|NCT05000281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5917725|NCT05000281|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5917726|NCT05000281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5917727|NCT05000281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5917728|NCT05000047|Silicon|silicon|mesh-list
5917729|NCT05000047|Trace Elements|trace elements|mesh-ancestor
5917730|NCT05000047|Micronutrients|micronutrients|mesh-ancestor
5917731|NCT05000047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917732|NCT04999592|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5917733|NCT04999592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5917734|NCT04999800|Pembrolizumab|pembrolizumab|mesh-list
5917735|NCT04999800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5917736|NCT04999800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5917737|NCT04999878|Gemcitabine|gemcitabine|mesh-list
6496826|NCT00629473|Protease Inhibitors|protease inhibitors|mesh-ancestor
6496827|NCT00629473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6496828|NCT00629473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496829|NCT00629512|Esomeprazole|esomeprazole|mesh-list
6496830|NCT00629512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6496831|NCT00629512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6496832|NCT00629512|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6496833|NCT00629512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6496834|NCT00629512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496835|NCT00629564|Esomeprazole|esomeprazole|mesh-list
6496836|NCT00629564|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6496837|NCT00629564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6496838|NCT00629564|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6496839|NCT00629564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6496840|NCT00629564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700906|NCT03350295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5700907|NCT03350295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5700908|NCT03350191|Exenatide|exenatide|mesh-list
5700909|NCT03350191|Glucagon|glucagon|mesh-list
5700910|NCT03350191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5917738|NCT04999878|Dexamethasone|dexamethasone|mesh-list
5917739|NCT04999878|Etoposide|etoposide|mesh-list
5917740|NCT04999878|Cisplatin|cisplatin|mesh-list
5917741|NCT04999878|Pegaspargase|pegaspargase|mesh-list
5917742|NCT04999878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5917743|NCT04999878|Antiemetics|antiemetics|mesh-ancestor
5917744|NCT04999878|Autonomic Agents|autonomic agents|mesh-ancestor
5917745|NCT04999878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5917746|NCT04999878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917747|NCT04999878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5917748|NCT04999878|Glucocorticoids|glucocorticoids|mesh-ancestor
5700911|NCT03350191|Hormones|hormones|mesh-ancestor
5700912|NCT03350191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5700913|NCT03350191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700914|NCT03350191|Incretins|incretins|mesh-ancestor
5700915|NCT03350191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5700916|NCT03350191|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5700917|NCT03350126|Nivolumab|nivolumab|mesh-list
5700918|NCT03350126|Ipilimumab|ipilimumab|mesh-list
5700919|NCT03350126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5700920|NCT03350126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5700921|NCT03350126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5700922|NCT03350126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700923|NCT03349957|Idarubicin|idarubicin|mesh-list
5700924|NCT03349957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5700925|NCT03349957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5700926|NCT03349957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5917749|NCT04999878|Hormones|hormones|mesh-ancestor
5917750|NCT04999878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5917751|NCT04999878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5700927|NCT03349957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5700928|NCT03349957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5700929|NCT03349957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700930|NCT03349866|Capecitabine|capecitabine|mesh-list
5700931|NCT03349866|Oxaliplatin|oxaliplatin|mesh-list
5700932|NCT03349866|Apatinib|apatinib|mesh-list
5700933|NCT03349866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5700934|NCT03349866|Antimetabolites|antimetabolites|mesh-ancestor
5700935|NCT03349866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700936|NCT03349866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5700937|NCT03349866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5700938|NCT03349866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5700939|NCT03349840|Insulin|insulin|mesh-list
5700940|NCT03349840|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5917752|NCT04999878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5917753|NCT04999878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5917754|NCT04999878|Antimetabolites|antimetabolites|mesh-ancestor
5917755|NCT04999878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5917756|NCT04999878|Antiviral Agents|antiviral agents|mesh-ancestor
5917757|NCT04999878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5917758|NCT04999878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5917759|NCT04999878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5917760|NCT04999878|Immunologic Factors|immunologic factors|mesh-ancestor
5917761|NCT04999878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5917762|NCT04999878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5917763|NCT04999878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5917764|NCT04999930|Tiotropium Bromide|tiotropium bromide|mesh-list
5917765|NCT04999930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5917766|NCT04999930|Autonomic Agents|autonomic agents|mesh-ancestor
5917767|NCT04999930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5917768|NCT04999930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917769|NCT04999930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5917770|NCT04999930|Respiratory System Agents|respiratory system agents|mesh-ancestor
5917771|NCT04999930|Parasympatholytics|parasympatholytics|mesh-ancestor
5917772|NCT04999930|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5917773|NCT04999930|Cholinergic Agents|cholinergic agents|mesh-ancestor
5917774|NCT04999930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5917775|NCT04999930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5917776|NCT04999540|Fulvestrant|fulvestrant|mesh-list
5917777|NCT04999540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5700941|NCT03349840|Insulin Glargine|insulin glargine|mesh-list
5700942|NCT03349840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5700943|NCT03349840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700944|NCT03349827|Apatinib|apatinib|mesh-list
5917778|NCT04999540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5917779|NCT04999540|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5917780|NCT04999540|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5917781|NCT04999540|Hormone Antagonists|hormone antagonists|mesh-ancestor
5917782|NCT04999540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5917783|NCT04999540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917784|NCT04999293|Clopidogrel|clopidogrel|mesh-list
5917785|NCT04999293|Ticagrelor|ticagrelor|mesh-list
5917786|NCT04999293|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5917787|NCT04999293|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5917788|NCT04999293|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5917789|NCT04999293|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5917790|NCT04999293|Purinergic Agents|purinergic agents|mesh-ancestor
5917791|NCT04999293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5917792|NCT04999293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5917793|NCT04999293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917794|NCT04999332|Leucovorin|leucovorin|mesh-list
5917795|NCT04999332|Docetaxel|docetaxel|mesh-list
5917796|NCT04999332|Oxaliplatin|oxaliplatin|mesh-list
5917797|NCT04999332|Levoleucovorin|levoleucovorin|mesh-list
5917798|NCT04999332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5917799|NCT04999332|Tubulin Modulators|tubulin modulators|mesh-ancestor
5917800|NCT04999332|Antimitotic Agents|antimitotic agents|mesh-ancestor
5917801|NCT04999332|Mitosis Modulators|mitosis modulators|mesh-ancestor
5917802|NCT04999332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5917803|NCT04999332|Antidotes|antidotes|mesh-ancestor
5917804|NCT04999332|Protective Agents|protective agents|mesh-ancestor
5917805|NCT04999332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917806|NCT04999332|Vitamin B Complex|vitamin b complex|mesh-ancestor
5917807|NCT04999332|Vitamins|vitamins|mesh-ancestor
5917808|NCT04999332|Micronutrients|micronutrients|mesh-ancestor
5700945|NCT03349827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5700946|NCT03349827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5700947|NCT03349827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5700948|NCT03349827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700949|NCT03349684|Metformin|metformin|mesh-list
5700950|NCT03349684|Acarbose|acarbose|mesh-list
5700951|NCT03349684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5700952|NCT03349684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700953|NCT03349684|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
5700954|NCT03349684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5700955|NCT03349684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700956|NCT03349658|Anesthetics|anesthetics|mesh-list
5700957|NCT03349658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5700958|NCT03349658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700959|NCT03349619|Resveratrol|resveratrol|mesh-list
5700960|NCT03349619|Antioxidants|antioxidants|mesh-ancestor
5917809|NCT04999449|Scopolamine|scopolamine|mesh-list
5917810|NCT04999449|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
5917811|NCT04999449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5917812|NCT04999449|Antiemetics|antiemetics|mesh-ancestor
5917813|NCT04999449|Autonomic Agents|autonomic agents|mesh-ancestor
5917814|NCT04999449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5917815|NCT04999449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917816|NCT04999449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5917817|NCT04999449|Mydriatics|mydriatics|mesh-ancestor
5917818|NCT04999449|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5917819|NCT04999449|Cholinergic Agents|cholinergic agents|mesh-ancestor
5917820|NCT04999449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5917821|NCT04999449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5917822|NCT04999449|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5917823|NCT04999449|Parasympatholytics|parasympatholytics|mesh-ancestor
5917824|NCT04999176|Enoxaparin|enoxaparin|mesh-list
5917825|NCT04999176|Rivaroxaban|rivaroxaban|mesh-list
5917826|NCT04999176|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5917827|NCT04999176|Antithrombins|antithrombins|mesh-ancestor
5917828|NCT04999176|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5917829|NCT04999176|Protease Inhibitors|protease inhibitors|mesh-ancestor
5917830|NCT04999176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5917831|NCT04999176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700961|NCT03349619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5917832|NCT04999176|Anticoagulants|anticoagulants|mesh-ancestor
5917833|NCT04999176|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5917834|NCT04999176|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5963916|NCT04597476|Fucoidan|fucoidan|mesh-list
5963917|NCT04597476|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5963918|NCT04597476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5963919|NCT04597476|Anticoagulants|anticoagulants|mesh-ancestor
5963920|NCT04597476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5963921|NCT04597203|Hydroquinone|hydroquinone|mesh-list
6675890|NCT01578252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6675891|NCT01578252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5963922|NCT04597203|Antioxidants|antioxidants|mesh-ancestor
5963923|NCT04597203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963924|NCT04597203|Protective Agents|protective agents|mesh-ancestor
5963925|NCT04597203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963926|NCT04597203|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5963927|NCT04597190|Norepinephrine|norepinephrine|mesh-list
5963928|NCT04597190|Serotonin|serotonin|mesh-list
5963929|NCT04597190|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
5963930|NCT04597190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5963931|NCT04597190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5963932|NCT04597190|Adrenergic Agents|adrenergic agents|mesh-ancestor
5963933|NCT04597190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5963934|NCT04597190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963935|NCT04597190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963936|NCT04597190|Sympathomimetics|sympathomimetics|mesh-ancestor
5963937|NCT04597190|Autonomic Agents|autonomic agents|mesh-ancestor
5963938|NCT04597190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5963939|NCT04597190|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5963940|NCT04597190|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5963941|NCT04597190|Serotonin Agents|serotonin agents|mesh-ancestor
6675892|NCT01578252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6675893|NCT01578252|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6675894|NCT01578265|Ondansetron|ondansetron|mesh-list
6675895|NCT01578265|Antiemetics|antiemetics|mesh-ancestor
6675896|NCT01578265|Autonomic Agents|autonomic agents|mesh-ancestor
6675897|NCT01578265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5963942|NCT04597190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5963943|NCT04597190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5963944|NCT04596826|Dronabinol|dronabinol|mesh-list
5963945|NCT04596826|Hallucinogens|hallucinogens|mesh-ancestor
5963946|NCT04596826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963947|NCT04596826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5963948|NCT04596826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5963949|NCT04596826|Analgesics|analgesics|mesh-ancestor
5963950|NCT04596826|Sensory System Agents|sensory system agents|mesh-ancestor
5963951|NCT04596826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5963952|NCT04596826|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5963953|NCT04596826|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5963954|NCT04596826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5963955|NCT04596826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963956|NCT04596826|Hormones|hormones|mesh-ancestor
5963957|NCT04596826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5963958|NCT04596839|Remdesivir|remdesivir|mesh-list
5963959|NCT04596839|Antimetabolites|antimetabolites|mesh-ancestor
5963960|NCT04596839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963961|NCT04596839|Antiviral Agents|antiviral agents|mesh-ancestor
5963962|NCT04596839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5963963|NCT04597099|Flutamide|flutamide|mesh-list
5963964|NCT04597099|Estradiol|estradiol|mesh-list
5963965|NCT04597099|Progesterone|progesterone|mesh-list
5963966|NCT04597099|Estrogens|estrogens|mesh-ancestor
5963967|NCT04597099|Hormones|hormones|mesh-ancestor
5963968|NCT04597099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5963969|NCT04597099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963970|NCT04597099|Progestins|progestins|mesh-ancestor
5963971|NCT04597099|Androgen Antagonists|androgen antagonists|mesh-ancestor
5963972|NCT04597099|Hormone Antagonists|hormone antagonists|mesh-ancestor
5963973|NCT04597099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5963974|NCT04597099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5970586|NCT04533997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970587|NCT04534582|Denosumab|denosumab|mesh-list
5970588|NCT04534582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5970589|NCT04534582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971359|NCT04528797|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5971360|NCT04528797|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5971361|NCT04528797|Prednisolone|prednisolone|mesh-list
6675898|NCT01578265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917835|NCT04999137|Vitamins|vitamins|mesh-list
5917836|NCT04999137|Ascorbic Acid|ascorbic acid|mesh-list
5917837|NCT04999137|Thiamine|thiamine|mesh-list
5917838|NCT04999137|Micronutrients|micronutrients|mesh-ancestor
5917839|NCT04999137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917840|NCT04999137|Antioxidants|antioxidants|mesh-ancestor
5917841|NCT04999137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5917842|NCT04999137|Protective Agents|protective agents|mesh-ancestor
5917843|NCT04999137|Vitamin B Complex|vitamin b complex|mesh-ancestor
5917844|NCT04998279|Lenograstim|lenograstim|mesh-list
5917845|NCT04998279|Sargramostim|sargramostim|mesh-list
5917846|NCT04998279|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5917847|NCT04998279|Immunologic Factors|immunologic factors|mesh-ancestor
5917848|NCT04998279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917849|NCT04998838|Tenofovir|tenofovir|mesh-list
5917850|NCT04998838|Immunoglobulins|immunoglobulins|mesh-list
5917851|NCT04998838|Antibodies|antibodies|mesh-list
5917852|NCT04998838|gamma-Globulins|gamma-globulins|mesh-list
5917853|NCT04998838|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5917854|NCT04998838|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5917855|NCT04998838|Antiviral Agents|antiviral agents|mesh-ancestor
5917856|NCT04998838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5917857|NCT04998838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5917858|NCT04998838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5917859|NCT04998838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5917860|NCT04998838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5917861|NCT04998838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5917862|NCT04998838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5700962|NCT03349619|Protective Agents|protective agents|mesh-ancestor
5700963|NCT03349619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700964|NCT03349619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5700965|NCT03349619|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5700966|NCT03349606|Amphetamine|amphetamine|mesh-list
5700967|NCT03349606|Dextroamphetamine|dextroamphetamine|mesh-list
5700968|NCT03349606|FLB 457|flb 457|mesh-list
5700969|NCT03349606|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5700970|NCT03349606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700971|NCT03349606|Sympathomimetics|sympathomimetics|mesh-ancestor
5700972|NCT03349606|Autonomic Agents|autonomic agents|mesh-ancestor
5700973|NCT03349606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5700974|NCT03349606|Dopamine Agents|dopamine agents|mesh-ancestor
5700975|NCT03349606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5700976|NCT03349606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700977|NCT03349606|Adrenergic Agents|adrenergic agents|mesh-ancestor
5700978|NCT03349606|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5700979|NCT03349606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5700980|NCT03349606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5700981|NCT03349606|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5700982|NCT03349606|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5720953|NCT03209180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720954|NCT03209180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5720955|NCT03209180|Antioxidants|antioxidants|mesh-ancestor
5720956|NCT03209180|Protective Agents|protective agents|mesh-ancestor
5720957|NCT03209180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5720958|NCT03209180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5720959|NCT03209180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5720960|NCT03209180|Vasodilator Agents|vasodilator agents|mesh-ancestor
5720961|NCT03209180|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5720962|NCT03209180|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5720963|NCT03209297|Salicylic Acid|salicylic acid|mesh-list
5720964|NCT03209297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5720965|NCT03209297|Antifungal Agents|antifungal agents|mesh-ancestor
5720966|NCT03209297|Keratolytic Agents|keratolytic agents|mesh-ancestor
5720967|NCT03209297|Dermatologic Agents|dermatologic agents|mesh-ancestor
5720968|NCT03209115|Calcium, Dietary|calcium, dietary|mesh-list
5720969|NCT03209115|Chlorhexidine|chlorhexidine|mesh-list
5720970|NCT03209115|Calcium|calcium|mesh-list
5720971|NCT03209115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5720972|NCT03209115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720973|NCT03209115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5720974|NCT03209115|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5720975|NCT03209115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5720976|NCT03209115|Disinfectants|disinfectants|mesh-ancestor
5720977|NCT03209193|Sevoflurane|sevoflurane|mesh-list
5917863|NCT04998838|Immunologic Factors|immunologic factors|mesh-ancestor
5917864|NCT04998838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917865|NCT04998071|Bupivacaine|bupivacaine|mesh-list
5917866|NCT04998071|Anesthetics, Local|anesthetics, local|mesh-ancestor
5917867|NCT04998071|Anesthetics|anesthetics|mesh-ancestor
5917868|NCT04998071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5917869|NCT04998071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917870|NCT04998071|Sensory System Agents|sensory system agents|mesh-ancestor
5917871|NCT04998071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5917872|NCT04998344|Vaccines|vaccines|mesh-list
5917873|NCT04998344|Immunologic Factors|immunologic factors|mesh-ancestor
5917874|NCT04998344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917875|NCT04998253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
5917876|NCT04998253|Propofol|propofol|mesh-list
5917877|NCT04998253|Sevoflurane|sevoflurane|mesh-list
5917878|NCT04998253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5917879|NCT04998253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5917880|NCT04998253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917881|NCT04998253|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5917882|NCT04998253|Anesthetics, General|anesthetics, general|mesh-ancestor
5917883|NCT04998253|Anesthetics|anesthetics|mesh-ancestor
5917884|NCT04998253|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5917885|NCT04998253|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5917886|NCT04998500|Hormones|hormones|mesh-list
5917887|NCT04998500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5917888|NCT04998500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917889|NCT04998240|Myeloma Proteins|myeloma proteins|mesh-list
5917890|NCT04998240|Paraproteins|paraproteins|mesh-list
5917891|NCT04998240|Immunologic Factors|immunologic factors|mesh-ancestor
5917892|NCT04998240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917893|NCT04998214|Thrombin|thrombin|mesh-list
5700983|NCT03349489|Insulin|insulin|mesh-list
5700984|NCT03349489|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5700985|NCT03349489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5700986|NCT03349489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700987|NCT03349450|Cyclophosphamide|cyclophosphamide|mesh-list
5700988|NCT03349450|Pembrolizumab|pembrolizumab|mesh-list
5700989|NCT03349450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5700990|NCT03349450|Immunologic Factors|immunologic factors|mesh-ancestor
5700991|NCT03349450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5700992|NCT03349450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5700993|NCT03349450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5700994|NCT03349450|Alkylating Agents|alkylating agents|mesh-ancestor
5700995|NCT03349450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5700996|NCT03349450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5700997|NCT03349450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5700998|NCT03349450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5700999|NCT03349424|Somatostatin|somatostatin|mesh-list
5701000|NCT03349424|Hormones|hormones|mesh-ancestor
5701001|NCT03349424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5701002|NCT03349424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701003|NCT03349359|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
5701004|NCT03349359|Antiviral Agents|antiviral agents|mesh-ancestor
5701005|NCT03349359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5701006|NCT03349346|Rituximab|rituximab|mesh-list
5917894|NCT04998214|Hemostatics|hemostatics|mesh-ancestor
5917895|NCT04998214|Coagulants|coagulants|mesh-ancestor
5917896|NCT04998006|Ethanol|ethanol|mesh-list
5917897|NCT04998006|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5917898|NCT04998006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5917899|NCT04998006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5917900|NCT04998006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917901|NCT04997967|Ketamine|ketamine|mesh-list
5917902|NCT04997967|Propofol|propofol|mesh-list
5917903|NCT04997967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5917904|NCT04997967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5917905|NCT04997967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917906|NCT04997967|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5917907|NCT04997967|Anesthetics, General|anesthetics, general|mesh-ancestor
5917908|NCT04997967|Anesthetics|anesthetics|mesh-ancestor
5917909|NCT04997967|Analgesics|analgesics|mesh-ancestor
5917910|NCT04997967|Sensory System Agents|sensory system agents|mesh-ancestor
5917911|NCT04997967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5917912|NCT04997967|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5917913|NCT04997967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5917914|NCT04997967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5701007|NCT03349346|Carboplatin|carboplatin|mesh-list
5917915|NCT04997967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5917916|NCT04997967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5917917|NCT04997980|Amiodarone|amiodarone|mesh-list
5917918|NCT04997980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5917919|NCT04997980|Vasodilator Agents|vasodilator agents|mesh-ancestor
5917920|NCT04997980|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5917921|NCT04997980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5917922|NCT04997980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5917923|NCT04997980|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5917924|NCT04997980|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5917925|NCT04997980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5917926|NCT04997980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5917927|NCT04997980|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5917928|NCT04997980|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5917929|NCT04997980|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5701008|NCT03349346|Etoposide|etoposide|mesh-list
5701009|NCT03349346|Ifosfamide|ifosfamide|mesh-list
5701010|NCT03349346|Idelalisib|idelalisib|mesh-list
5917930|NCT04997837|Capecitabine|capecitabine|mesh-list
5701011|NCT03349346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5701012|NCT03349346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5701013|NCT03349346|Immunologic Factors|immunologic factors|mesh-ancestor
5701014|NCT03349346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701015|NCT03349346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5701016|NCT03349346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5701017|NCT03349346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5701018|NCT03349346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5701019|NCT03349346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5701020|NCT03349346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5917931|NCT04997837|Tegafur|tegafur|mesh-list
5917932|NCT04997837|Oxaliplatin|oxaliplatin|mesh-list
5917933|NCT04997837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5917934|NCT04997837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5917935|NCT04997837|Antimetabolites|antimetabolites|mesh-ancestor
5917936|NCT04997837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5917937|NCT04997837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5917938|NCT04997850|Lenvatinib|lenvatinib|mesh-list
5917939|NCT04997850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5917940|NCT04997850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5917941|NCT04997850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5917942|NCT04997850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5917943|NCT04997759|Neostigmine|neostigmine|mesh-list
5917944|NCT04997759|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5917945|NCT04997759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5917946|NCT04997759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5917947|NCT04997759|Cholinergic Agents|cholinergic agents|mesh-ancestor
5917948|NCT04997759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5917949|NCT04997759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917950|NCT04997759|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5917951|NCT04997759|Autonomic Agents|autonomic agents|mesh-ancestor
5917952|NCT04997759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5917953|NCT04997707|Propofol|propofol|mesh-list
5917954|NCT04997707|Sevoflurane|sevoflurane|mesh-list
5917955|NCT04997707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5917956|NCT04997707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5917957|NCT04997707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917958|NCT04997707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5917959|NCT04997707|Anesthetics, General|anesthetics, general|mesh-ancestor
5917960|NCT04997707|Anesthetics|anesthetics|mesh-ancestor
5917961|NCT04997707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5917962|NCT04997707|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5917963|NCT04997798|Trastuzumab|trastuzumab|mesh-list
5917964|NCT04997798|Letrozole|letrozole|mesh-list
5917965|NCT04997798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5917966|NCT04997798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5917967|NCT04997798|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5917968|NCT04997798|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5917969|NCT04997798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5917970|NCT04997798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5917971|NCT04997798|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5917972|NCT04997798|Hormone Antagonists|hormone antagonists|mesh-ancestor
5917973|NCT04997798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5917974|NCT04997798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917975|NCT04997564|Tenofovir|tenofovir|mesh-list
5917976|NCT04997564|Sofosbuvir|sofosbuvir|mesh-list
5917977|NCT04997564|Velpatasvir|velpatasvir|mesh-list
5917978|NCT04997564|Antiviral Agents|antiviral agents|mesh-ancestor
5917979|NCT04997564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5917980|NCT04997564|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5917981|NCT04997564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5917982|NCT04997564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5917983|NCT04997564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5917984|NCT04997564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5917985|NCT04997564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5917986|NCT04997525|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5917987|NCT04997525|Estradiol|estradiol|mesh-list
5917988|NCT04997525|Progesterone|progesterone|mesh-list
5917989|NCT04997525|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5917990|NCT04997525|Estrogens|estrogens|mesh-ancestor
5917991|NCT04997525|Hormones|hormones|mesh-ancestor
5917992|NCT04997525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5917993|NCT04997525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5917994|NCT04997525|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5917995|NCT04997525|Progestins|progestins|mesh-ancestor
5917996|NCT04997317|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
5917997|NCT04997317|Chelating Agents|chelating agents|mesh-ancestor
5917998|NCT04997317|Sequestering Agents|sequestering agents|mesh-ancestor
5917999|NCT04997317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963975|NCT04596488|Efavirenz|efavirenz|mesh-list
5963976|NCT04596488|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5963977|NCT04596488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5963978|NCT04596488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5963979|NCT04596488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5963980|NCT04596488|Antiviral Agents|antiviral agents|mesh-ancestor
5963981|NCT04596488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5963982|NCT04596488|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5963983|NCT04596488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5963984|NCT04596488|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5963985|NCT04596488|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5963986|NCT04596488|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5963987|NCT04596488|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5963988|NCT04596189|Mometasone Furoate|mometasone furoate|mesh-list
5963989|NCT04596189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5963990|NCT04596189|Dermatologic Agents|dermatologic agents|mesh-ancestor
5963991|NCT04596189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5963992|NCT04595942|Fludrocortisone|fludrocortisone|mesh-list
5963993|NCT04595942|Midodrine|midodrine|mesh-list
5701021|NCT03349346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5701022|NCT03349346|Alkylating Agents|alkylating agents|mesh-ancestor
5701023|NCT03349216|Anesthetics|anesthetics|mesh-list
5701024|NCT03349216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5963994|NCT04595942|Sympathomimetics|sympathomimetics|mesh-ancestor
5963995|NCT04595942|Autonomic Agents|autonomic agents|mesh-ancestor
5963996|NCT04595942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5963997|NCT04595942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5963998|NCT04595942|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5963999|NCT04595942|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5964000|NCT04595942|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5701025|NCT03349216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701026|NCT03349190|Ulipristal acetate|ulipristal acetate|mesh-list
5701027|NCT03349190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5701028|NCT03349190|Contraceptive Agents|contraceptive agents|mesh-ancestor
5701029|NCT03349190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5701030|NCT03349190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701031|NCT03349190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5701032|NCT03349177|Cyclophosphamide|cyclophosphamide|mesh-list
5701033|NCT03349177|Docetaxel|docetaxel|mesh-list
5701034|NCT03349177|Fluorouracil|fluorouracil|mesh-list
5701035|NCT03349177|Epirubicin|epirubicin|mesh-list
5701036|NCT03349177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5701037|NCT03349177|Immunologic Factors|immunologic factors|mesh-ancestor
5701038|NCT03349177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701039|NCT03349177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5701040|NCT03349177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5701041|NCT03349177|Alkylating Agents|alkylating agents|mesh-ancestor
5701042|NCT03349177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701043|NCT03349177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5701044|NCT03349177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5701045|NCT03349177|Tubulin Modulators|tubulin modulators|mesh-ancestor
5918000|NCT04996979|Ropivacaine|ropivacaine|mesh-list
5918001|NCT04996979|Anesthetics, Local|anesthetics, local|mesh-ancestor
5918002|NCT04996979|Anesthetics|anesthetics|mesh-ancestor
5918003|NCT04996979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5918004|NCT04996979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918005|NCT04996979|Sensory System Agents|sensory system agents|mesh-ancestor
5918006|NCT04996979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5918007|NCT04997291|Dexrazoxane|dexrazoxane|mesh-list
5918008|NCT04997291|Razoxane|razoxane|mesh-list
5701046|NCT03349177|Antimitotic Agents|antimitotic agents|mesh-ancestor
5701047|NCT03349177|Mitosis Modulators|mitosis modulators|mesh-ancestor
5701048|NCT03349177|Antimetabolites|antimetabolites|mesh-ancestor
5701049|NCT03349177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5701050|NCT03349177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5701051|NCT03349177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5701052|NCT03349177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5701053|NCT03349177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5701054|NCT03349112|Lidocaine|lidocaine|mesh-list
5701055|NCT03349112|Anesthetics, Local|anesthetics, local|mesh-ancestor
5701056|NCT03349112|Anesthetics|anesthetics|mesh-ancestor
5701057|NCT03349112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5701058|NCT03349112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701059|NCT03349112|Sensory System Agents|sensory system agents|mesh-ancestor
5701060|NCT03349112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5701061|NCT03349112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5701062|NCT03349112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5701063|NCT03349112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5701064|NCT03349112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5701065|NCT03349112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701066|NCT03349008|Entecavir|entecavir|mesh-list
5701067|NCT03349008|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
5701068|NCT03349008|Antiviral Agents|antiviral agents|mesh-ancestor
5701069|NCT03349008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5701070|NCT03349008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5701071|NCT03348969|Mitomycins|mitomycins|mesh-list
5701072|NCT03348969|Mitomycin|mitomycin|mesh-list
5701073|NCT03348969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5701074|NCT03348969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5918009|NCT04997291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5918010|NCT04997291|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5918011|NCT04997291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5918012|NCT04997291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5918013|NCT04997291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5918014|NCT04997291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918015|NCT04997291|Protective Agents|protective agents|mesh-ancestor
5918016|NCT04997291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918017|NCT04997291|Antimitotic Agents|antimitotic agents|mesh-ancestor
5918018|NCT04997291|Mitosis Modulators|mitosis modulators|mesh-ancestor
5918019|NCT04997304|Albuterol|albuterol|mesh-list
5918020|NCT04997304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5918021|NCT04997304|Autonomic Agents|autonomic agents|mesh-ancestor
5918022|NCT04997304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5918023|NCT04997304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918024|NCT04997304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5918025|NCT04997304|Respiratory System Agents|respiratory system agents|mesh-ancestor
5918026|NCT04997304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5918027|NCT04997304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5918028|NCT04997304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5918029|NCT04997304|Adrenergic Agents|adrenergic agents|mesh-ancestor
5918030|NCT04997304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5918031|NCT04997304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918032|NCT04997304|Tocolytic Agents|tocolytic agents|mesh-ancestor
5918033|NCT04997304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5918034|NCT04996550|Metoprolol|metoprolol|mesh-list
5918035|NCT04996550|Carvedilol|carvedilol|mesh-list
5918036|NCT04996550|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5918037|NCT04996550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5918038|NCT04996550|Sympatholytics|sympatholytics|mesh-ancestor
5918039|NCT04996550|Autonomic Agents|autonomic agents|mesh-ancestor
5918040|NCT04996550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5918041|NCT04996550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918042|NCT04996550|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5918043|NCT04996550|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5918044|NCT04996550|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5701075|NCT03348969|Alkylating Agents|alkylating agents|mesh-ancestor
5918045|NCT04996550|Adrenergic Agents|adrenergic agents|mesh-ancestor
5918046|NCT04996550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5918047|NCT04996550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918048|NCT04996550|Antioxidants|antioxidants|mesh-ancestor
5918049|NCT04996550|Protective Agents|protective agents|mesh-ancestor
5918050|NCT04996550|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5918051|NCT04996550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5918052|NCT04996550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5918053|NCT04996550|Vasodilator Agents|vasodilator agents|mesh-ancestor
5918054|NCT04996550|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5918055|NCT04996550|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5918056|NCT04996667|Nitric Oxide|nitric oxide|mesh-list
5918057|NCT04996667|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5918058|NCT04996667|Autonomic Agents|autonomic agents|mesh-ancestor
5918059|NCT04996667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5918060|NCT04996667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918061|NCT04996667|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5918062|NCT04996667|Respiratory System Agents|respiratory system agents|mesh-ancestor
5918063|NCT04996667|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5918064|NCT04996667|Antioxidants|antioxidants|mesh-ancestor
5918065|NCT04996667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918066|NCT04996667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5918067|NCT04996667|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5918068|NCT04996667|Vasodilator Agents|vasodilator agents|mesh-ancestor
5918069|NCT04996667|Gasotransmitters|gasotransmitters|mesh-ancestor
5918070|NCT04996667|Protective Agents|protective agents|mesh-ancestor
5918071|NCT04996602|177Lu-PSMA-617|177lu-psma-617|mesh-list
5918072|NCT04996602|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
5918073|NCT04996602|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5918074|NCT04996602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918075|NCT04996485|Ustekinumab|ustekinumab|mesh-list
5701076|NCT03348969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701077|NCT03348969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5701078|NCT03348969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5701079|NCT03348930|Tolcapone|tolcapone|mesh-list
5918076|NCT04996485|Dermatologic Agents|dermatologic agents|mesh-ancestor
5918077|NCT04996433|Antidepressive Agents|antidepressive agents|mesh-list
5918078|NCT04996433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5918079|NCT04996290|Ropivacaine|ropivacaine|mesh-list
5918080|NCT04996290|Anesthetics, Local|anesthetics, local|mesh-ancestor
5918081|NCT04996290|Anesthetics|anesthetics|mesh-ancestor
5918082|NCT04996290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5918083|NCT04996290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918084|NCT04996290|Sensory System Agents|sensory system agents|mesh-ancestor
5918085|NCT04996290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5918086|NCT04996134|Domperidone|domperidone|mesh-list
5918087|NCT04996134|Antiemetics|antiemetics|mesh-ancestor
5918088|NCT04996134|Autonomic Agents|autonomic agents|mesh-ancestor
5918089|NCT04996134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5918090|NCT04996134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918091|NCT04996134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5701080|NCT03348930|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5701081|NCT03348930|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5701082|NCT03348930|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
5701083|NCT03348930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5918092|NCT04996134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5918093|NCT04996134|Dopamine Agents|dopamine agents|mesh-ancestor
5918094|NCT04996134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5918095|NCT04996134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918096|NCT04996251|Bupivacaine|bupivacaine|mesh-list
5918097|NCT04996251|Anesthetics, Local|anesthetics, local|mesh-ancestor
5918098|NCT04996251|Anesthetics|anesthetics|mesh-ancestor
6496841|NCT00629616|Fulvestrant|fulvestrant|mesh-list
6496842|NCT00629616|Anastrozole|anastrozole|mesh-list
6496843|NCT00629616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5701084|NCT03348930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701085|NCT03348917|Chlorhexidine|chlorhexidine|mesh-list
5701086|NCT03348917|Povidone-Iodine|povidone-iodine|mesh-list
5701087|NCT03348917|Povidone|povidone|mesh-list
5701088|NCT03348917|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5701089|NCT03348917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5701090|NCT03348917|Disinfectants|disinfectants|mesh-ancestor
5701091|NCT03348917|Plasma Substitutes|plasma substitutes|mesh-ancestor
5701092|NCT03348917|Blood Substitutes|blood substitutes|mesh-ancestor
5918099|NCT04996251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6496844|NCT00629616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6496845|NCT00629616|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6496846|NCT00629616|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6496847|NCT00629616|Hormone Antagonists|hormone antagonists|mesh-ancestor
6496848|NCT00629616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6496849|NCT00629616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496850|NCT00629616|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6675899|NCT01578265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6675900|NCT01578265|Antipruritics|antipruritics|mesh-ancestor
5918100|NCT04996251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918101|NCT04996251|Sensory System Agents|sensory system agents|mesh-ancestor
5918102|NCT04996251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5918103|NCT04996498|Oxytocin|oxytocin|mesh-list
5918104|NCT04996498|Oxytocics|oxytocics|mesh-ancestor
5918105|NCT04996498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5918106|NCT04996498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675901|NCT01578265|Dermatologic Agents|dermatologic agents|mesh-ancestor
6675902|NCT01578265|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6675903|NCT01578265|Serotonin Agents|serotonin agents|mesh-ancestor
6675904|NCT01578265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6675905|NCT01578265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675906|NCT01578265|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5918107|NCT04996238|Vaccines|vaccines|mesh-list
5918108|NCT04996238|Immunologic Factors|immunologic factors|mesh-ancestor
5918109|NCT04996238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918110|NCT04996160|Dexamethasone|dexamethasone|mesh-list
5918111|NCT04996160|Dexamethasone acetate|dexamethasone acetate|mesh-list
5918112|NCT04996160|Doxorubicin|doxorubicin|mesh-list
5918113|NCT04996160|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5918114|NCT04996160|Bortezomib|bortezomib|mesh-list
5918115|NCT04996160|Palbociclib|palbociclib|mesh-list
5918116|NCT04996160|BB 1101|bb 1101|mesh-list
5918117|NCT04996160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5918118|NCT04996160|Antiemetics|antiemetics|mesh-ancestor
5918119|NCT04996160|Autonomic Agents|autonomic agents|mesh-ancestor
5918120|NCT04996160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5918121|NCT04996160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918122|NCT04996160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5918123|NCT04996160|Glucocorticoids|glucocorticoids|mesh-ancestor
5918124|NCT04996160|Hormones|hormones|mesh-ancestor
5918125|NCT04996160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5918126|NCT04996160|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5918127|NCT04996160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5918128|NCT04996160|Protease Inhibitors|protease inhibitors|mesh-ancestor
5918129|NCT04996160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5918130|NCT04996160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918131|NCT04996160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5918132|NCT04996160|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5918133|NCT04996160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5918134|NCT04996160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5918135|NCT04996017|Atezolizumab|atezolizumab|mesh-list
5918136|NCT04996017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5918137|NCT04995653|Vancomycin|vancomycin|mesh-list
5918138|NCT04995653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5918139|NCT04995653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5918140|NCT04995354|Mitogens|mitogens|mesh-list
5918141|NCT04995354|Mitosis Modulators|mitosis modulators|mesh-ancestor
5918142|NCT04995354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918143|NCT04995263|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
5918144|NCT04995263|Caffeine|caffeine|mesh-list
5918145|NCT04995263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5918146|NCT04995263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918147|NCT04995263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5918148|NCT04995263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5918149|NCT04995263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918150|NCT04995263|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5918151|NCT04995263|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5918152|NCT04995263|Purinergic Agents|purinergic agents|mesh-ancestor
5918153|NCT04995263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5918154|NCT04995263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5964001|NCT04595942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5964002|NCT04595942|Adrenergic Agents|adrenergic agents|mesh-ancestor
6496851|NCT00629616|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5964003|NCT04595942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5964004|NCT04595942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918155|NCT04995497|Lidocaine|lidocaine|mesh-list
5918156|NCT04995497|Anesthetics, Local|anesthetics, local|mesh-ancestor
5918157|NCT04995497|Anesthetics|anesthetics|mesh-ancestor
5918158|NCT04995497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5918159|NCT04995497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918160|NCT04995497|Sensory System Agents|sensory system agents|mesh-ancestor
5918161|NCT04995497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5918162|NCT04995497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5918163|NCT04995497|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5918164|NCT04995497|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5918165|NCT04995497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5918166|NCT04995497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918167|NCT04995133|Colistin|colistin|mesh-list
5918168|NCT04995133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5918169|NCT04995133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5918170|NCT04994990|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5918171|NCT04994990|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5918172|NCT04994990|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5918173|NCT04994990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5918174|NCT04994990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918175|NCT04994990|Cholinergic Agents|cholinergic agents|mesh-ancestor
5701093|NCT03348826|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5701094|NCT03348826|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5701095|NCT03348826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5701096|NCT03348826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5701097|NCT03348826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701098|NCT03348800|Anesthetics|anesthetics|mesh-list
5701099|NCT03348800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5701100|NCT03348800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701101|NCT03348735|Lidocaine|lidocaine|mesh-list
5701102|NCT03348735|Pregabalin|pregabalin|mesh-list
5701103|NCT03348735|Capsaicin|capsaicin|mesh-list
5701104|NCT03348735|Anesthetics, Local|anesthetics, local|mesh-ancestor
5701105|NCT03348735|Anesthetics|anesthetics|mesh-ancestor
5701106|NCT03348735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5701107|NCT03348735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701108|NCT03348735|Sensory System Agents|sensory system agents|mesh-ancestor
5701109|NCT03348735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5701110|NCT03348735|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5701111|NCT03348735|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5701112|NCT03348735|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5701113|NCT03348735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5701114|NCT03348735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701115|NCT03348735|Analgesics|analgesics|mesh-ancestor
5701116|NCT03348735|Anticonvulsants|anticonvulsants|mesh-ancestor
5701117|NCT03348735|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5701118|NCT03348735|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5701119|NCT03348735|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5701120|NCT03348735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5701121|NCT03348735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5701122|NCT03348735|Antipruritics|antipruritics|mesh-ancestor
5701123|NCT03348735|Dermatologic Agents|dermatologic agents|mesh-ancestor
5701124|NCT03348696|Dexamethasone|dexamethasone|mesh-list
5701125|NCT03348696|Dexamethasone acetate|dexamethasone acetate|mesh-list
5701126|NCT03348696|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
5701127|NCT03348696|BB 1101|bb 1101|mesh-list
5701128|NCT03348696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5701129|NCT03348696|Antiemetics|antiemetics|mesh-ancestor
5701130|NCT03348696|Autonomic Agents|autonomic agents|mesh-ancestor
5701131|NCT03348696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5701132|NCT03348696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701133|NCT03348696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5701134|NCT03348696|Glucocorticoids|glucocorticoids|mesh-ancestor
5701135|NCT03348696|Hormones|hormones|mesh-ancestor
5701136|NCT03348696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5701137|NCT03348696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5701138|NCT03348696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5701139|NCT03348696|Protease Inhibitors|protease inhibitors|mesh-ancestor
5701140|NCT03348696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5701141|NCT03348696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701142|NCT03348527|Hydroxyflutamide|hydroxyflutamide|mesh-list
5701143|NCT03348527|Androgen Antagonists|androgen antagonists|mesh-ancestor
5701144|NCT03348527|Hormone Antagonists|hormone antagonists|mesh-ancestor
5720978|NCT03209193|Desflurane|desflurane|mesh-list
5918176|NCT04994990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5918177|NCT04994990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918178|NCT04994990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5918179|NCT04994990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5918180|NCT04994951|Triamcinolone|triamcinolone|mesh-list
5918181|NCT04994951|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5918182|NCT04994951|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5918183|NCT04994951|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5918184|NCT04994951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5918185|NCT04994951|Glucocorticoids|glucocorticoids|mesh-ancestor
5918186|NCT04994951|Hormones|hormones|mesh-ancestor
5918187|NCT04994951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5918188|NCT04994951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918189|NCT04994951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5918190|NCT04994951|Immunologic Factors|immunologic factors|mesh-ancestor
5918191|NCT04994951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5918192|NCT04994951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918193|NCT04995016|Pembrolizumab|pembrolizumab|mesh-list
5918194|NCT04995016|Axitinib|axitinib|mesh-list
5918195|NCT04995016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5918196|NCT04995016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5918197|NCT04995016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5918198|NCT04995016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5918199|NCT04995016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918200|NCT04994860|Sildenafil Citrate|sildenafil citrate|mesh-list
5918201|NCT04994860|Zamicastat|zamicastat|mesh-list
5918202|NCT04994860|Vasodilator Agents|vasodilator agents|mesh-ancestor
5918203|NCT04994860|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5918204|NCT04994860|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5918205|NCT04994860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5918206|NCT04994860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918207|NCT04994860|Urological Agents|urological agents|mesh-ancestor
5918208|NCT04994626|Rituximab|rituximab|mesh-list
5918209|NCT04994626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5918210|NCT04994626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5918211|NCT04994626|Immunologic Factors|immunologic factors|mesh-ancestor
5918212|NCT04994626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918213|NCT04994626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5918214|NCT04994743|Cortisone|cortisone|mesh-list
5918215|NCT04994743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5918216|NCT04994353|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5918217|NCT04994444|Nicotine|nicotine|mesh-list
5701145|NCT03348527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5701146|NCT03348527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701147|NCT03348462|Anthralin|anthralin|mesh-list
5701148|NCT03348462|Dermatologic Agents|dermatologic agents|mesh-ancestor
5701149|NCT03348423|Fentanyl|fentanyl|mesh-list
5701150|NCT03348423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5701151|NCT03348423|Narcotics|narcotics|mesh-ancestor
5701152|NCT03348423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5701153|NCT03348423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701154|NCT03348423|Analgesics|analgesics|mesh-ancestor
5701155|NCT03348423|Sensory System Agents|sensory system agents|mesh-ancestor
5701156|NCT03348423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5701157|NCT03348423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5701158|NCT03348423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5701159|NCT03348423|Anesthetics, General|anesthetics, general|mesh-ancestor
5701160|NCT03348423|Anesthetics|anesthetics|mesh-ancestor
5701161|NCT03348371|Ethanol|ethanol|mesh-list
5701162|NCT03348371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5701163|NCT03348371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5701164|NCT03348371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5918218|NCT04994444|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5918219|NCT04994444|Autonomic Agents|autonomic agents|mesh-ancestor
5918220|NCT04994444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5918221|NCT04994444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918222|NCT04994444|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5918223|NCT04994444|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5918224|NCT04994444|Cholinergic Agents|cholinergic agents|mesh-ancestor
5918225|NCT04994444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5918226|NCT04994444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918227|NCT04994314|Fluorides|fluorides|mesh-list
5918228|NCT04994314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918229|NCT04994314|Cariostatic Agents|cariostatic agents|mesh-ancestor
5701165|NCT03348371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701166|NCT03348267|Caseins|caseins|mesh-list
5701167|NCT03348267|Chelating Agents|chelating agents|mesh-ancestor
5918230|NCT04994314|Protective Agents|protective agents|mesh-ancestor
5918231|NCT04994262|Menthol|menthol|mesh-list
5918232|NCT04994262|Antipruritics|antipruritics|mesh-ancestor
5918233|NCT04994262|Dermatologic Agents|dermatologic agents|mesh-ancestor
5918234|NCT04994574|Tiotropium Bromide|tiotropium bromide|mesh-list
5918235|NCT04994574|Olodaterol|olodaterol|mesh-list
5918236|NCT04994574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5918237|NCT04994574|Autonomic Agents|autonomic agents|mesh-ancestor
5918238|NCT04994574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5918239|NCT04994574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918240|NCT04994574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5918241|NCT04994574|Respiratory System Agents|respiratory system agents|mesh-ancestor
5918242|NCT04994574|Parasympatholytics|parasympatholytics|mesh-ancestor
5918243|NCT04994574|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5918244|NCT04994574|Cholinergic Agents|cholinergic agents|mesh-ancestor
5918245|NCT04994574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5918246|NCT04994574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918247|NCT04994236|Leucovorin|leucovorin|mesh-list
5918248|NCT04994236|Fluorouracil|fluorouracil|mesh-list
5918249|NCT04994236|Oxaliplatin|oxaliplatin|mesh-list
5918250|NCT04994236|Antimetabolites|antimetabolites|mesh-ancestor
5918251|NCT04994236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918252|NCT04994236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5918253|NCT04994236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5918254|NCT04994236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5918255|NCT04994236|Immunologic Factors|immunologic factors|mesh-ancestor
5918256|NCT04994236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918257|NCT04994236|Antidotes|antidotes|mesh-ancestor
5918258|NCT04994236|Protective Agents|protective agents|mesh-ancestor
5918259|NCT04994236|Vitamin B Complex|vitamin b complex|mesh-ancestor
5918260|NCT04994236|Vitamins|vitamins|mesh-ancestor
5918261|NCT04994236|Micronutrients|micronutrients|mesh-ancestor
5918262|NCT04994223|Rivaroxaban|rivaroxaban|mesh-list
5918263|NCT04994223|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5918264|NCT04994223|Antithrombins|antithrombins|mesh-ancestor
5918265|NCT04994223|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5918266|NCT04994223|Protease Inhibitors|protease inhibitors|mesh-ancestor
5918267|NCT04994223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5918268|NCT04994223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918269|NCT04994223|Anticoagulants|anticoagulants|mesh-ancestor
5918270|NCT04994119|Warfarin|warfarin|mesh-list
5918271|NCT04994119|Zamicastat|zamicastat|mesh-list
5918272|NCT04994119|Anticoagulants|anticoagulants|mesh-ancestor
5701168|NCT03348267|Sequestering Agents|sequestering agents|mesh-ancestor
5701169|NCT03348267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701170|NCT03348254|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5701171|NCT03348254|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5701172|NCT03348254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5701173|NCT03348254|Antitubercular Agents|antitubercular agents|mesh-ancestor
5701174|NCT03348098|Paclitaxel|paclitaxel|mesh-list
5701175|NCT03348098|Apatinib|apatinib|mesh-list
5701176|NCT03348098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5701177|NCT03348098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5701178|NCT03348098|Tubulin Modulators|tubulin modulators|mesh-ancestor
5701179|NCT03348098|Antimitotic Agents|antimitotic agents|mesh-ancestor
5701180|NCT03348098|Mitosis Modulators|mitosis modulators|mesh-ancestor
5701181|NCT03348098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701182|NCT03348098|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5701183|NCT03348098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5701184|NCT03348059|Antiviral Agents|antiviral agents|mesh-list
5918273|NCT04994119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5918274|NCT04994119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964005|NCT04595942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5964006|NCT04595916|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
5964007|NCT04595916|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5964008|NCT04595916|Antimetabolites|antimetabolites|mesh-ancestor
5964009|NCT04595916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964010|NCT04595916|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5964011|NCT04595929|Leucovorin|leucovorin|mesh-list
5964012|NCT04595929|Docetaxel|docetaxel|mesh-list
5964013|NCT04595929|Fluorouracil|fluorouracil|mesh-list
5964014|NCT04595929|Oxaliplatin|oxaliplatin|mesh-list
5964015|NCT04595929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5701185|NCT03348059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5964016|NCT04595929|Tubulin Modulators|tubulin modulators|mesh-ancestor
5964017|NCT04595929|Antimitotic Agents|antimitotic agents|mesh-ancestor
5964018|NCT04595929|Mitosis Modulators|mitosis modulators|mesh-ancestor
5918275|NCT04993209|Vaccines|vaccines|mesh-list
5918276|NCT04993209|Immunologic Factors|immunologic factors|mesh-ancestor
5918277|NCT04993209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918278|NCT04993365|Vaccines|vaccines|mesh-list
5918279|NCT04993365|Immunologic Factors|immunologic factors|mesh-ancestor
5918280|NCT04993365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675907|NCT01578265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6675908|NCT01578265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6675909|NCT01578265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5701186|NCT03348046|Infliximab|infliximab|mesh-list
5701187|NCT03348046|Dermatologic Agents|dermatologic agents|mesh-ancestor
5701188|NCT03348046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5701189|NCT03348046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5701190|NCT03347994|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
5701191|NCT03347994|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5701192|NCT03347994|Alkylating Agents|alkylating agents|mesh-ancestor
5701193|NCT03347994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701194|NCT03347994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5701195|NCT03347968|Warfarin|warfarin|mesh-list
5701196|NCT03347968|Esmolol|esmolol|mesh-list
5701197|NCT03347968|Anticoagulants|anticoagulants|mesh-ancestor
6675910|NCT01578265|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6675911|NCT01578304|Fesoterodine|fesoterodine|mesh-list
6675912|NCT01578304|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6675913|NCT01578304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6675914|NCT01578304|Cholinergic Agents|cholinergic agents|mesh-ancestor
6675915|NCT01578304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6675916|NCT01578304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675917|NCT01578304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675918|NCT01578304|Urological Agents|urological agents|mesh-ancestor
6779645|NCT02180321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779646|NCT02180321|Hemostatics|hemostatics|mesh-ancestor
6779647|NCT02180321|Coagulants|coagulants|mesh-ancestor
6779648|NCT02180334|Acetaminophen|acetaminophen|mesh-list
6779649|NCT02180334|Linagliptin|linagliptin|mesh-list
5918281|NCT04993222|Amphotericin B|amphotericin b|mesh-list
5918282|NCT04993222|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
5918283|NCT04993222|Amebicides|amebicides|mesh-ancestor
5918284|NCT04993222|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5918285|NCT04993222|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5918286|NCT04993222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5918287|NCT04993222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5918288|NCT04993222|Antifungal Agents|antifungal agents|mesh-ancestor
5918289|NCT04993014|Trastuzumab|trastuzumab|mesh-list
5918290|NCT04993014|Pertuzumab|pertuzumab|mesh-list
5918291|NCT04993014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5918292|NCT04993014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5918293|NCT04993040|Paclitaxel|paclitaxel|mesh-list
5918294|NCT04993040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5918295|NCT04993040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5918296|NCT04993040|Tubulin Modulators|tubulin modulators|mesh-ancestor
5918297|NCT04993040|Antimitotic Agents|antimitotic agents|mesh-ancestor
5918298|NCT04993040|Mitosis Modulators|mitosis modulators|mesh-ancestor
5918299|NCT04993040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918300|NCT04993027|Vancomycin|vancomycin|mesh-list
5918301|NCT04993027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5918302|NCT04993027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5918303|NCT04992507|Anesthetics|anesthetics|mesh-list
5918304|NCT04992507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5918305|NCT04992507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918306|NCT04992468|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
5918307|NCT04992468|Hormones|hormones|mesh-ancestor
5918308|NCT04992468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5918309|NCT04992468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918310|NCT04992533|Oxymetazoline|oxymetazoline|mesh-list
5918311|NCT04992533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5918312|NCT04992533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5918313|NCT04992533|Adrenergic Agents|adrenergic agents|mesh-ancestor
5918314|NCT04992533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5918315|NCT04992533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918316|NCT04992533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918317|NCT04992533|Sympathomimetics|sympathomimetics|mesh-ancestor
5918318|NCT04992533|Autonomic Agents|autonomic agents|mesh-ancestor
5918319|NCT04992533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5918320|NCT04992533|Nasal Decongestants|nasal decongestants|mesh-ancestor
6779650|NCT02180334|Mosapride|mosapride|mesh-list
5918321|NCT04992533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5918322|NCT04992533|Respiratory System Agents|respiratory system agents|mesh-ancestor
5918323|NCT04992481|Fluorides|fluorides|mesh-list
5918324|NCT04992481|Fluorides, Topical|fluorides, topical|mesh-list
5918325|NCT04992481|Cariostatic Agents|cariostatic agents|mesh-ancestor
5918326|NCT04992481|Protective Agents|protective agents|mesh-ancestor
5918327|NCT04992481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918328|NCT04992572|Lidocaine|lidocaine|mesh-list
5918329|NCT04992572|Propofol|propofol|mesh-list
6212725|NCT02193776|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6212726|NCT02193776|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6212727|NCT02193776|Antimetabolites|antimetabolites|mesh-ancestor
6212728|NCT02193776|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6212729|NCT02193815|Calcitriol|calcitriol|mesh-list
6212730|NCT02193815|Calcipotriene|calcipotriene|mesh-list
6212731|NCT02193815|Tofacitinib|tofacitinib|mesh-list
6212732|NCT02193815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6212733|NCT02193815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6212734|NCT02193815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212735|NCT02193815|Dermatologic Agents|dermatologic agents|mesh-ancestor
6212736|NCT02193815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6212737|NCT02193815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212738|NCT02193815|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6212739|NCT02193815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6212740|NCT02193815|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6212741|NCT02193815|Vitamins|vitamins|mesh-ancestor
6212742|NCT02193815|Micronutrients|micronutrients|mesh-ancestor
6212743|NCT02193815|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6212744|NCT02193880|Cyclophosphamide|cyclophosphamide|mesh-list
6212745|NCT02193880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6212746|NCT02193880|Immunologic Factors|immunologic factors|mesh-ancestor
6212747|NCT02193880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212748|NCT02193880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6212749|NCT02193880|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6212750|NCT02193880|Alkylating Agents|alkylating agents|mesh-ancestor
6212751|NCT02193880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212752|NCT02193880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6212753|NCT02193880|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6212754|NCT02194062|Fluticasone|fluticasone|mesh-list
6212755|NCT02194062|Xhance|xhance|mesh-list
6496852|NCT00629616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6496853|NCT00629616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496854|NCT00629642|Solifenacin Succinate|solifenacin succinate|mesh-list
6496855|NCT00629642|Oxybutynin|oxybutynin|mesh-list
6496856|NCT00629642|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6496857|NCT00629642|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6496858|NCT00629642|Cholinergic Agents|cholinergic agents|mesh-ancestor
6496859|NCT00629642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6496860|NCT00629642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496861|NCT00629642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496862|NCT00629642|Urological Agents|urological agents|mesh-ancestor
6496863|NCT00629642|Parasympatholytics|parasympatholytics|mesh-ancestor
6496864|NCT00629642|Autonomic Agents|autonomic agents|mesh-ancestor
6496865|NCT00629642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6496866|NCT00629681|Pregabalin|pregabalin|mesh-list
6496867|NCT00629681|Analgesics|analgesics|mesh-ancestor
6496868|NCT00629681|Sensory System Agents|sensory system agents|mesh-ancestor
5701198|NCT03347968|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5701199|NCT03347968|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5701200|NCT03347968|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5701201|NCT03347968|Adrenergic Agents|adrenergic agents|mesh-ancestor
5701202|NCT03347968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5701203|NCT03347968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701204|NCT03347968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496869|NCT00629681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6496870|NCT00629681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496871|NCT00629681|Anticonvulsants|anticonvulsants|mesh-ancestor
6496872|NCT00629681|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6496873|NCT00629681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6496874|NCT00629681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496875|NCT00629681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5701205|NCT03347916|Gabapentin|gabapentin|mesh-list
5701206|NCT03347916|Analgesics|analgesics|mesh-ancestor
5701207|NCT03347916|Sensory System Agents|sensory system agents|mesh-ancestor
5701208|NCT03347916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5918330|NCT04992572|Anesthetics, Local|anesthetics, local|mesh-ancestor
5918331|NCT04992572|Anesthetics|anesthetics|mesh-ancestor
5918332|NCT04992572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5918333|NCT04992572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918334|NCT04992572|Sensory System Agents|sensory system agents|mesh-ancestor
5918335|NCT04992572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5918336|NCT04992572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5918337|NCT04992572|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6212756|NCT02194062|Budesonide|budesonide|mesh-list
6212757|NCT02194062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6212758|NCT02194062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6212759|NCT02194062|Autonomic Agents|autonomic agents|mesh-ancestor
6212760|NCT02194062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6212761|NCT02194062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212762|NCT02194062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6212763|NCT02194062|Respiratory System Agents|respiratory system agents|mesh-ancestor
6212764|NCT02194062|Dermatologic Agents|dermatologic agents|mesh-ancestor
6212765|NCT02194062|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6212766|NCT02194062|Glucocorticoids|glucocorticoids|mesh-ancestor
6212767|NCT02194062|Hormones|hormones|mesh-ancestor
6212768|NCT02194062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6212769|NCT02194088|Diclofenac|diclofenac|mesh-list
6212770|NCT02194088|Atropine|atropine|mesh-list
6212771|NCT02194088|Analgesics|analgesics|mesh-list
6212772|NCT02194088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6212773|NCT02194088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6212774|NCT02194088|Sensory System Agents|sensory system agents|mesh-ancestor
6212775|NCT02194088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6212776|NCT02194088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212777|NCT02194088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6212778|NCT02194088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6212779|NCT02194088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6212780|NCT02194088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6212781|NCT02194088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212782|NCT02194088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6212783|NCT02194088|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5701209|NCT03347916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701210|NCT03347916|Anticonvulsants|anticonvulsants|mesh-ancestor
5701211|NCT03347916|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5701212|NCT03347916|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5701213|NCT03347916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5701214|NCT03347916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5701215|NCT03347916|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5701216|NCT03347916|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5701217|NCT03347916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5701218|NCT03347916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701219|NCT03347916|Antimanic Agents|antimanic agents|mesh-ancestor
5720979|NCT03209193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5720980|NCT03209193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5720981|NCT03209193|Anesthetics, General|anesthetics, general|mesh-ancestor
5720982|NCT03209193|Anesthetics|anesthetics|mesh-ancestor
5720983|NCT03209193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5720984|NCT03209193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720985|NCT03209219|Interferons|interferons|mesh-list
5720986|NCT03209219|Interferon-alpha|interferon-alpha|mesh-list
5720987|NCT03209219|Interferon alpha-2|interferon alpha-2|mesh-list
5720988|NCT03209219|Cyclosporine|cyclosporine|mesh-list
5720989|NCT03209219|Cyclosporins|cyclosporins|mesh-list
5720990|NCT03209219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5720991|NCT03209219|Antiviral Agents|antiviral agents|mesh-ancestor
5720992|NCT03209219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5720993|NCT03209219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5720994|NCT03209219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5720995|NCT03209219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5720996|NCT03209219|Immunologic Factors|immunologic factors|mesh-ancestor
5720997|NCT03209219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720998|NCT03209219|Antifungal Agents|antifungal agents|mesh-ancestor
5720999|NCT03209219|Dermatologic Agents|dermatologic agents|mesh-ancestor
5721000|NCT03209219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6212784|NCT02194088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6212785|NCT02194088|Autonomic Agents|autonomic agents|mesh-ancestor
6212786|NCT02194088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6212787|NCT02194088|Respiratory System Agents|respiratory system agents|mesh-ancestor
5721001|NCT03209219|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5721002|NCT03209102|Hydrocortisone|hydrocortisone|mesh-list
5918338|NCT04992572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5918339|NCT04992572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5918340|NCT04992572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918341|NCT04992572|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5918342|NCT04992572|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5918343|NCT04992572|Anesthetics, General|anesthetics, general|mesh-ancestor
5918344|NCT04992156|Palbociclib|palbociclib|mesh-list
5918345|NCT04992156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6212788|NCT02194088|Mydriatics|mydriatics|mesh-ancestor
6212789|NCT02194088|Parasympatholytics|parasympatholytics|mesh-ancestor
6212790|NCT02194088|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6212791|NCT02194088|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6212792|NCT02194088|Cholinergic Agents|cholinergic agents|mesh-ancestor
6675919|NCT01578343|Vidarabine|vidarabine|mesh-list
6675920|NCT01578343|Dexamethasone|dexamethasone|mesh-list
6675921|NCT01578343|Dexamethasone acetate|dexamethasone acetate|mesh-list
6675922|NCT01578343|Fludarabine|fludarabine|mesh-list
6675923|NCT01578343|Fludarabine phosphate|fludarabine phosphate|mesh-list
6675924|NCT01578343|Mitoxantrone|mitoxantrone|mesh-list
5701220|NCT03347890|Liraglutide|liraglutide|mesh-list
5701221|NCT03347890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5701222|NCT03347890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701223|NCT03347890|Incretins|incretins|mesh-ancestor
5701224|NCT03347890|Hormones|hormones|mesh-ancestor
5701225|NCT03347890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5701226|NCT03347864|68Ga-NOTA-RM26|68ga-nota-rm26|mesh-list
5701227|NCT03347864|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5701228|NCT03347864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701229|NCT03347786|Verapamil|verapamil|mesh-list
5701230|NCT03347786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5701231|NCT03347786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5701232|NCT03347786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5701233|NCT03347786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701234|NCT03347786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5701235|NCT03347786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701236|NCT03347786|Vasodilator Agents|vasodilator agents|mesh-ancestor
5701237|NCT03347760|Octreotide|octreotide|mesh-list
5701238|NCT03347760|Edotreotide|edotreotide|mesh-list
5701239|NCT03347760|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5701240|NCT03347760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701241|NCT03347760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5701242|NCT03347760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6675925|NCT01578343|Vorinostat|vorinostat|mesh-list
6675926|NCT01578343|BB 1101|bb 1101|mesh-list
6212793|NCT02194088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6212794|NCT02194465|Spironolactone|spironolactone|mesh-list
6212795|NCT02194465|Tadalafil|tadalafil|mesh-list
6212796|NCT02194465|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
6212797|NCT02194465|Mineralocorticoids|mineralocorticoids|mesh-list
6212798|NCT02194465|Vasodilator Agents|vasodilator agents|mesh-ancestor
6212799|NCT02194465|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6212800|NCT02194465|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6212801|NCT02194465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6212802|NCT02194465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212803|NCT02194465|Urological Agents|urological agents|mesh-ancestor
6212804|NCT02194465|Hormone Antagonists|hormone antagonists|mesh-ancestor
6212805|NCT02194465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6212806|NCT02194465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212807|NCT02194465|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6212808|NCT02194465|Diuretics|diuretics|mesh-ancestor
6212809|NCT02194465|Natriuretic Agents|natriuretic agents|mesh-ancestor
6212810|NCT02194465|Hormones|hormones|mesh-ancestor
6212811|NCT02194933|Brexpiprazole|brexpiprazole|mesh-list
6212812|NCT02194933|Serotonin Agents|serotonin agents|mesh-ancestor
6212813|NCT02194933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6212814|NCT02194933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212815|NCT02194933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212816|NCT02194933|Dopamine Agonists|dopamine agonists|mesh-ancestor
6212817|NCT02194933|Dopamine Agents|dopamine agents|mesh-ancestor
6212818|NCT02194998|Ritonavir|ritonavir|mesh-list
6212819|NCT02194998|Ribavirin|ribavirin|mesh-list
6212820|NCT02194998|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6212821|NCT02194998|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6212822|NCT02194998|Protease Inhibitors|protease inhibitors|mesh-ancestor
6212823|NCT02194998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6675927|NCT01578343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6675928|NCT01578343|Antiemetics|antiemetics|mesh-ancestor
6212824|NCT02194998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212825|NCT02194998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6212826|NCT02194998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6212827|NCT02194998|Antiviral Agents|antiviral agents|mesh-ancestor
6212828|NCT02194998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6212829|NCT02194998|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6212830|NCT02194998|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6212831|NCT02194998|Antimetabolites|antimetabolites|mesh-ancestor
6212832|NCT02195232|Quercetin|quercetin|mesh-list
6212833|NCT02195232|Antioxidants|antioxidants|mesh-ancestor
6212834|NCT02195232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212835|NCT02195232|Protective Agents|protective agents|mesh-ancestor
6212836|NCT02195232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212837|NCT02195518|Tenofovir|tenofovir|mesh-list
6212838|NCT02195518|Antiviral Agents|antiviral agents|mesh-ancestor
6212839|NCT02195518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6212840|NCT02195518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6496876|NCT00629681|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6496877|NCT00629681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6496878|NCT00629681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6496879|NCT00629681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6496880|NCT00629720|Alfuzosin|alfuzosin|mesh-list
6496881|NCT00629720|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6496882|NCT00629720|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6496883|NCT00629720|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6496884|NCT00629720|Adrenergic Agents|adrenergic agents|mesh-ancestor
6496885|NCT00629720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6496886|NCT00629720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496887|NCT00629720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496888|NCT00629720|Urological Agents|urological agents|mesh-ancestor
6496889|NCT00629811|Mitogens|mitogens|mesh-list
6496890|NCT00629811|Mitosis Modulators|mitosis modulators|mesh-ancestor
6496891|NCT00629811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496892|NCT00629824|Interferons|interferons|mesh-list
6496893|NCT00629824|Ribavirin|ribavirin|mesh-list
6496894|NCT00629824|Interferon-alpha|interferon-alpha|mesh-list
6496895|NCT00629824|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6496896|NCT00629824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6496897|NCT00629824|Antiviral Agents|antiviral agents|mesh-ancestor
6496898|NCT00629824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6496899|NCT00629824|Antimetabolites|antimetabolites|mesh-ancestor
6496900|NCT00629824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496901|NCT00629824|Immunologic Factors|immunologic factors|mesh-ancestor
6496902|NCT00629824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496903|NCT00629837|Factor VIII|factor viii|mesh-list
6496904|NCT00629837|Coagulants|coagulants|mesh-ancestor
6496905|NCT00629863|Fluorouracil|fluorouracil|mesh-list
6496906|NCT00629863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6496907|NCT00629863|Antimetabolites|antimetabolites|mesh-ancestor
6496908|NCT00629863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496909|NCT00629863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6496910|NCT00629863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6496911|NCT00629863|Immunologic Factors|immunologic factors|mesh-ancestor
6496912|NCT00629863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524402|NCT00757978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701243|NCT03347760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5701244|NCT03347721|Lidocaine|lidocaine|mesh-list
5701245|NCT03347721|Anesthetics, Local|anesthetics, local|mesh-ancestor
5701246|NCT03347721|Anesthetics|anesthetics|mesh-ancestor
5701247|NCT03347721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5701248|NCT03347721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701249|NCT03347721|Sensory System Agents|sensory system agents|mesh-ancestor
5970590|NCT04533646|Insulin|insulin|mesh-list
6524403|NCT00757978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524404|NCT00757978|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6524405|NCT00757978|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5970591|NCT04533646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5970592|NCT04533646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970593|NCT04533841|Propranolol|propranolol|mesh-list
5970594|NCT04533841|Misoprostol|misoprostol|mesh-list
5970595|NCT04533841|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5970596|NCT04533841|Abortifacient Agents|abortifacient agents|mesh-ancestor
5970597|NCT04533841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5970598|NCT04533841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212841|NCT02195518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6212842|NCT02195518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6212843|NCT02195518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212844|NCT02195518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6212845|NCT02195518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6212846|NCT02195583|Zinc|zinc|mesh-list
6212847|NCT02195583|Listerine|listerine|mesh-list
6212848|NCT02195583|Fluorides|fluorides|mesh-list
6212849|NCT02195583|Sodium Fluoride|sodium fluoride|mesh-list
6212850|NCT02195583|Cariostatic Agents|cariostatic agents|mesh-ancestor
6212851|NCT02195583|Protective Agents|protective agents|mesh-ancestor
6212852|NCT02195583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212853|NCT02195583|Trace Elements|trace elements|mesh-ancestor
6212854|NCT02195583|Micronutrients|micronutrients|mesh-ancestor
6212855|NCT02195583|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6212856|NCT02195583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6212857|NCT02195687|Botulinum Toxins|botulinum toxins|mesh-list
6212858|NCT02195687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6212859|NCT02195687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6212860|NCT02195687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6212861|NCT02195687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6212862|NCT02195687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212863|NCT02195687|Cholinergic Agents|cholinergic agents|mesh-ancestor
6212864|NCT02195687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6212865|NCT02195687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212866|NCT02195687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6212867|NCT02195687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6212868|NCT02195895|Calcium, Dietary|calcium, dietary|mesh-list
6212869|NCT02195895|Vitamin D|vitamin d|mesh-list
6212870|NCT02195895|Ergocalciferols|ergocalciferols|mesh-list
6212871|NCT02195895|Cholecalciferol|cholecalciferol|mesh-list
6212872|NCT02195895|Alendronate|alendronate|mesh-list
6212873|NCT02195895|Vitamins|vitamins|mesh-list
6212874|NCT02195895|Calcium Carbonate|calcium carbonate|mesh-list
6212875|NCT02195895|Antacids|antacids|mesh-list
6212876|NCT02195895|Calcium|calcium|mesh-list
6212877|NCT02195895|Micronutrients|micronutrients|mesh-ancestor
6212878|NCT02195895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212879|NCT02195895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6212880|NCT02195895|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6212881|NCT02195895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212882|NCT02195895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6212883|NCT02195921|Antiemetics|antiemetics|mesh-list
6212884|NCT02195921|Autonomic Agents|autonomic agents|mesh-ancestor
6212885|NCT02195921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6212886|NCT02195921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212887|NCT02195921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6212888|NCT02195986|Estradiol|estradiol|mesh-list
6212889|NCT02195986|Estrogens|estrogens|mesh-ancestor
6212890|NCT02195986|Hormones|hormones|mesh-ancestor
6212891|NCT02195986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6212892|NCT02195986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212893|NCT02196168|Cisplatin|cisplatin|mesh-list
5701250|NCT03347721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5701251|NCT03347721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5701252|NCT03347721|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5701253|NCT03347721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5701254|NCT03347721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5701255|NCT03347721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701256|NCT03347708|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5701257|NCT03347708|Hyaluronic Acid|hyaluronic acid|mesh-list
5701258|NCT03347708|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5701259|NCT03347708|Immunologic Factors|immunologic factors|mesh-ancestor
5701260|NCT03347708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701261|NCT03347708|Viscosupplements|viscosupplements|mesh-ancestor
5701262|NCT03347708|Protective Agents|protective agents|mesh-ancestor
5701263|NCT03347591|polysaccharide-K|polysaccharide-k|mesh-list
5701264|NCT03347591|Hemostatics|hemostatics|mesh-list
5701265|NCT03347591|Coagulants|coagulants|mesh-ancestor
6212894|NCT02196168|Adavosertib|adavosertib|mesh-list
6212895|NCT02196168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6212896|NCT02196168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6212897|NCT02196168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212898|NCT02196259|Ketamine|ketamine|mesh-list
6212899|NCT02196259|Anesthetics, Dissociative|anesthetics, dissociative|mesh-list
6212900|NCT02196259|Anesthetics|anesthetics|mesh-list
6212901|NCT02196259|Analgesics|analgesics|mesh-ancestor
6212902|NCT02196259|Sensory System Agents|sensory system agents|mesh-ancestor
6212903|NCT02196259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6212904|NCT02196259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212905|NCT02196259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6212906|NCT02196259|Anesthetics, General|anesthetics, general|mesh-ancestor
6212907|NCT02196259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6212908|NCT02196259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6212909|NCT02196259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6212910|NCT02196259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6212911|NCT02196259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212912|NCT02196324|Serlopitant|serlopitant|mesh-list
6212913|NCT02196324|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6212914|NCT02196324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6212915|NCT02196324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212916|NCT02196324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212917|NCT02196506|Brexpiprazole|brexpiprazole|mesh-list
6212918|NCT02196506|Serotonin Agents|serotonin agents|mesh-ancestor
6212919|NCT02196506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6212920|NCT02196506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212921|NCT02196506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212922|NCT02196506|Dopamine Agonists|dopamine agonists|mesh-ancestor
6212923|NCT02196506|Dopamine Agents|dopamine agents|mesh-ancestor
6212924|NCT02196558|Quetmolimab|quetmolimab|mesh-list
6212925|NCT02196558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6242826|NCT02657031|Sensory System Agents|sensory system agents|mesh-ancestor
6242827|NCT02657031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5701266|NCT03347591|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5701267|NCT03347591|Immunologic Factors|immunologic factors|mesh-ancestor
5701268|NCT03347591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701269|NCT03347591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5701270|NCT03347591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5701271|NCT03347591|Antiviral Agents|antiviral agents|mesh-ancestor
5701272|NCT03347591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5701273|NCT03347591|Interferon Inducers|interferon inducers|mesh-ancestor
5701274|NCT03347591|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5701275|NCT03347591|Protective Agents|protective agents|mesh-ancestor
5701276|NCT03347526|Vigabatrin|vigabatrin|mesh-list
5701277|NCT03347526|Cosyntropin|cosyntropin|mesh-list
5701278|NCT03347526|Anticonvulsants|anticonvulsants|mesh-ancestor
5701279|NCT03347526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5701280|NCT03347526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701281|NCT03347526|GABA Agents|gaba agents|mesh-ancestor
5701282|NCT03347526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5701283|NCT03347526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701284|NCT03347526|Hormones|hormones|mesh-ancestor
5701285|NCT03347526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5701286|NCT03347513|Glycine|glycine|mesh-list
5701287|NCT03347513|Glycine Agents|glycine agents|mesh-ancestor
5701288|NCT03347513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5701289|NCT03347513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970599|NCT04533841|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5970600|NCT04533841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5970601|NCT04533841|Oxytocics|oxytocics|mesh-ancestor
5970602|NCT04533841|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5970603|NCT04533841|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5970604|NCT04533841|Adrenergic Agents|adrenergic agents|mesh-ancestor
5970605|NCT04533841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5970606|NCT04533841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970607|NCT04533841|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5970608|NCT04533841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5970609|NCT04533841|Vasodilator Agents|vasodilator agents|mesh-ancestor
5970610|NCT04533984|Teriparatide|teriparatide|mesh-list
5970611|NCT04533984|Calcium|calcium|mesh-list
5970612|NCT04533984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5970613|NCT04533984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970614|NCT04533984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5970615|NCT04533724|Amisulpride|amisulpride|mesh-list
5970616|NCT04533724|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5970617|NCT04533724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5970618|NCT04533724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5970619|NCT04533724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970620|NCT04533724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5970621|NCT04533724|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6212926|NCT02196701|Adalimumab|adalimumab|mesh-list
6212927|NCT02196701|Methotrexate|methotrexate|mesh-list
6212928|NCT02196701|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6212929|NCT02196701|Abortifacient Agents|abortifacient agents|mesh-ancestor
6212930|NCT02196701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6212931|NCT02196701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212932|NCT02196701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6212933|NCT02196701|Antimetabolites|antimetabolites|mesh-ancestor
6212934|NCT02196701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212935|NCT02196701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6212936|NCT02196701|Dermatologic Agents|dermatologic agents|mesh-ancestor
6212937|NCT02196701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6212938|NCT02196701|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6212939|NCT02196701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6212940|NCT02196701|Immunologic Factors|immunologic factors|mesh-ancestor
6212941|NCT02196701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6212942|NCT02196701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6212943|NCT02196701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6212944|NCT02196714|Glycopyrrolate|glycopyrrolate|mesh-list
6212945|NCT02196714|Formoterol Fumarate|formoterol fumarate|mesh-list
6212946|NCT02196714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6212947|NCT02196714|Autonomic Agents|autonomic agents|mesh-ancestor
6212948|NCT02196714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6212949|NCT02196714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212950|NCT02196714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6212951|NCT02196714|Respiratory System Agents|respiratory system agents|mesh-ancestor
6212952|NCT02196714|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6212953|NCT02196714|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6212954|NCT02196714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6212955|NCT02196714|Adrenergic Agents|adrenergic agents|mesh-ancestor
6212956|NCT02196714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6212957|NCT02196714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212958|NCT02196714|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6212959|NCT02196714|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6212960|NCT02196714|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6212961|NCT02196714|Cholinergic Agents|cholinergic agents|mesh-ancestor
6212962|NCT02196831|Tesamorelin|tesamorelin|mesh-list
5701290|NCT03347513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701291|NCT03347461|Ciprofloxacin|ciprofloxacin|mesh-list
5701292|NCT03347461|Dexamethasone|dexamethasone|mesh-list
5701293|NCT03347461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5701294|NCT03347461|Antiemetics|antiemetics|mesh-ancestor
5701295|NCT03347461|Autonomic Agents|autonomic agents|mesh-ancestor
5701296|NCT03347461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5701297|NCT03347461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701298|NCT03347461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5701299|NCT03347461|Glucocorticoids|glucocorticoids|mesh-ancestor
5701300|NCT03347461|Hormones|hormones|mesh-ancestor
5701301|NCT03347461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5701302|NCT03347461|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5701303|NCT03347461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5701304|NCT03347461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5701305|NCT03347461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701306|NCT03347461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5701307|NCT03347461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5701308|NCT03347461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5701309|NCT03347461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5701310|NCT03347461|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5701311|NCT03347461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5701312|NCT03347370|Interferons|interferons|mesh-list
5701313|NCT03347370|Interferon-beta|interferon-beta|mesh-list
5701314|NCT03347370|Interferon beta-1a|interferon beta-1a|mesh-list
5701315|NCT03347370|Interferon beta-1b|interferon beta-1b|mesh-list
5701316|NCT03347370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5701317|NCT03347370|Antiviral Agents|antiviral agents|mesh-ancestor
5701318|NCT03347370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5701319|NCT03347370|Immunologic Factors|immunologic factors|mesh-ancestor
5701320|NCT03347370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701321|NCT03347370|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5701322|NCT03347357|Tacrolimus|tacrolimus|mesh-list
5701323|NCT03347357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5701324|NCT03347357|Immunologic Factors|immunologic factors|mesh-ancestor
5701325|NCT03347357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701326|NCT03347357|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5701327|NCT03347357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6212963|NCT02196831|Growth Substances|growth substances|mesh-ancestor
6212964|NCT02196831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6212965|NCT02196857|Sorafenib|sorafenib|mesh-list
6212966|NCT02196857|Azacitidine|azacitidine|mesh-list
6212967|NCT02196857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6212968|NCT02196857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6496913|NCT00629889|Pregabalin|pregabalin|mesh-list
6496914|NCT00629889|Levetiracetam|levetiracetam|mesh-list
6496915|NCT00629889|Analgesics|analgesics|mesh-ancestor
6496916|NCT00629889|Sensory System Agents|sensory system agents|mesh-ancestor
6496917|NCT00629889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6496918|NCT00629889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496919|NCT00629889|Anticonvulsants|anticonvulsants|mesh-ancestor
6496920|NCT00629889|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6496921|NCT00629889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6496922|NCT00629889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496923|NCT00629889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6496924|NCT00629889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6496925|NCT00629889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6496926|NCT00629889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6496927|NCT00629889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6496928|NCT00629889|Nootropic Agents|nootropic agents|mesh-ancestor
6496929|NCT00629928|Esomeprazole|esomeprazole|mesh-list
6496930|NCT00629928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6496931|NCT00629928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6496932|NCT00629928|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6496933|NCT00629928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6496934|NCT00629928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496935|NCT00629967|Interferons|interferons|mesh-list
6496936|NCT00629967|Ribavirin|ribavirin|mesh-list
6496937|NCT00629967|Interferon-alpha|interferon-alpha|mesh-list
6496938|NCT00629967|Interferon alpha-2|interferon alpha-2|mesh-list
6496939|NCT00629967|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6496940|NCT00629967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6496941|NCT00629967|Antiviral Agents|antiviral agents|mesh-ancestor
6496942|NCT00629967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6496943|NCT00629967|Antimetabolites|antimetabolites|mesh-ancestor
6496944|NCT00629967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496945|NCT00629967|Immunologic Factors|immunologic factors|mesh-ancestor
6496946|NCT00629967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701328|NCT03347357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701329|NCT03347344|Riluzole|riluzole|mesh-list
5701330|NCT03347344|Anticonvulsants|anticonvulsants|mesh-ancestor
5701331|NCT03347344|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5701332|NCT03347344|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5701333|NCT03347344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6496947|NCT00630019|Moxifloxacin|moxifloxacin|mesh-list
6496948|NCT00630019|Levofloxacin|levofloxacin|mesh-list
6496949|NCT00630019|Ofloxacin|ofloxacin|mesh-list
6496950|NCT00630019|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6496951|NCT00630019|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6496952|NCT00630019|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6496953|NCT00630019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6496954|NCT00630019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6496955|NCT00630019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6496956|NCT00630019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6496957|NCT00630019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6496958|NCT00630019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496959|NCT00630019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6496960|NCT00630019|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6496961|NCT00630019|Contraceptive Agents|contraceptive agents|mesh-ancestor
6496962|NCT00630019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6496963|NCT00630019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496964|NCT00630019|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6496965|NCT00630019|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6496966|NCT00630019|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6496967|NCT00630019|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6496968|NCT00630019|Renal Agents|renal agents|mesh-ancestor
6496969|NCT00630019|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6496970|NCT00630019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6496971|NCT00630045|Capecitabine|capecitabine|mesh-list
6496972|NCT00630045|Oxaliplatin|oxaliplatin|mesh-list
6496973|NCT00630045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6496974|NCT00630045|Antimetabolites|antimetabolites|mesh-ancestor
5721003|NCT03209102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6212969|NCT02196857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6212970|NCT02196857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212971|NCT02196857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6212972|NCT02196857|Antimetabolites|antimetabolites|mesh-ancestor
6212973|NCT02197065|Atorvastatin|atorvastatin|mesh-list
6212974|NCT02197065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6212975|NCT02197065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6212976|NCT02197065|Antimetabolites|antimetabolites|mesh-ancestor
6212977|NCT02197065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212978|NCT02197065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6212979|NCT02197065|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6212980|NCT02197065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6212981|NCT02197247|Rifampin|rifampin|mesh-list
6212982|NCT02197247|Osimertinib|osimertinib|mesh-list
6212983|NCT02197247|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6212984|NCT02197247|Antitubercular Agents|antitubercular agents|mesh-ancestor
6212985|NCT02197247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6212986|NCT02197247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6212987|NCT02197247|Leprostatic Agents|leprostatic agents|mesh-ancestor
6212988|NCT02197247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6212989|NCT02197247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6212990|NCT02197247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6212991|NCT02197247|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6212992|NCT02197247|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6212993|NCT02197247|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6212994|NCT02197247|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6212995|NCT02197247|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6212996|NCT02197247|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6212997|NCT02197247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6212998|NCT02197247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6212999|NCT02197273|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6213000|NCT02197273|Epinephrine|epinephrine|mesh-list
6213001|NCT02197273|Fentanyl|fentanyl|mesh-list
6213002|NCT02197273|Morphine|morphine|mesh-list
6213003|NCT02197273|Bupivacaine|bupivacaine|mesh-list
6213004|NCT02197273|Ropivacaine|ropivacaine|mesh-list
6213005|NCT02197273|Anesthetics, Local|anesthetics, local|mesh-ancestor
6213006|NCT02197273|Anesthetics|anesthetics|mesh-ancestor
6213007|NCT02197273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6213008|NCT02197273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213009|NCT02197273|Sensory System Agents|sensory system agents|mesh-ancestor
6213010|NCT02197273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6213011|NCT02197273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6213012|NCT02197273|Narcotics|narcotics|mesh-ancestor
6213013|NCT02197273|Analgesics|analgesics|mesh-ancestor
6213014|NCT02197273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6213015|NCT02197273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6213016|NCT02197273|Anesthetics, General|anesthetics, general|mesh-ancestor
6213017|NCT02197273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6213018|NCT02197273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6213019|NCT02197273|Adrenergic Agents|adrenergic agents|mesh-ancestor
6213020|NCT02197273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6213021|NCT02197273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6213022|NCT02197273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6213023|NCT02197273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6213024|NCT02197273|Autonomic Agents|autonomic agents|mesh-ancestor
6213025|NCT02197273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6213026|NCT02197273|Respiratory System Agents|respiratory system agents|mesh-ancestor
6213027|NCT02197273|Mydriatics|mydriatics|mesh-ancestor
6213028|NCT02197273|Sympathomimetics|sympathomimetics|mesh-ancestor
6213029|NCT02197273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6213030|NCT02197273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6213031|NCT02197273|Glucocorticoids|glucocorticoids|mesh-ancestor
6213032|NCT02197273|Hormones|hormones|mesh-ancestor
6213033|NCT02197273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6213034|NCT02197273|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6213035|NCT02197273|Protective Agents|protective agents|mesh-ancestor
6213036|NCT02197273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6213037|NCT02197273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6213038|NCT02197377|Chlorhexidine|chlorhexidine|mesh-list
6213039|NCT02197377|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6213040|NCT02197377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6213041|NCT02197377|Disinfectants|disinfectants|mesh-ancestor
6213042|NCT02197416|Dabigatran|dabigatran|mesh-list
6213043|NCT02197416|Antithrombins|antithrombins|mesh-ancestor
5701334|NCT03347344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701335|NCT03347344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701336|NCT03347344|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5701337|NCT03347344|Protective Agents|protective agents|mesh-ancestor
5701338|NCT03347331|Befiradol|befiradol|mesh-list
5701339|NCT03347331|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5701340|NCT03347331|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5701341|NCT03347331|Serotonin Agents|serotonin agents|mesh-ancestor
5701342|NCT03347331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5701343|NCT03347331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6213044|NCT02197416|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6213045|NCT02197416|Protease Inhibitors|protease inhibitors|mesh-ancestor
6213046|NCT02197416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6213047|NCT02197416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6213048|NCT02197416|Anticoagulants|anticoagulants|mesh-ancestor
5701344|NCT03347331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701345|NCT03347240|Baclofen|baclofen|mesh-list
5701346|NCT03347240|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5701347|NCT03347240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701348|NCT03347240|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5701349|NCT03347240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5701350|NCT03347240|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
5701351|NCT03347240|GABA Agonists|gaba agonists|mesh-ancestor
5701352|NCT03347240|GABA Agents|gaba agents|mesh-ancestor
5701353|NCT03347240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5701354|NCT03347240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6213049|NCT02197455|Tofacitinib|tofacitinib|mesh-list
6213050|NCT02197455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6213051|NCT02197455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6213052|NCT02197455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6213053|NCT02197520|Insulin|insulin|mesh-list
6213054|NCT02197520|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6213055|NCT02197520|Insulin Glargine|insulin glargine|mesh-list
6213056|NCT02197520|Insulin Lispro|insulin lispro|mesh-list
6213057|NCT02197520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6213058|NCT02197520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213059|NCT02197767|Rituximab|rituximab|mesh-list
6213060|NCT02197767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6213061|NCT02197767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6213062|NCT02197767|Immunologic Factors|immunologic factors|mesh-ancestor
6213063|NCT02197767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213064|NCT02197767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6496975|NCT00630045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496976|NCT00630045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6496977|NCT00630084|Interferons|interferons|mesh-list
6496978|NCT00630084|Ribavirin|ribavirin|mesh-list
6496979|NCT00630084|Interferon-alpha|interferon-alpha|mesh-list
6496980|NCT00630084|Interferon alpha-2|interferon alpha-2|mesh-list
6213065|NCT02197897|Tamoxifen|tamoxifen|mesh-list
6213066|NCT02197897|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6213067|NCT02197897|Hormone Antagonists|hormone antagonists|mesh-ancestor
6213068|NCT02197897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6213069|NCT02197897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213070|NCT02197897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6213071|NCT02197897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6213072|NCT02197897|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6213073|NCT02197897|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6213074|NCT02197897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6213075|NCT02198235|Dexamethasone|dexamethasone|mesh-list
6213076|NCT02198235|Buprenorphine|buprenorphine|mesh-list
6213077|NCT02198235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6213078|NCT02198235|Antiemetics|antiemetics|mesh-ancestor
6213079|NCT02198235|Autonomic Agents|autonomic agents|mesh-ancestor
6213080|NCT02198235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6213081|NCT02198235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213082|NCT02198235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6213083|NCT02198235|Glucocorticoids|glucocorticoids|mesh-ancestor
6213084|NCT02198235|Hormones|hormones|mesh-ancestor
6213085|NCT02198235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6213086|NCT02198235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6213087|NCT02198235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6213088|NCT02198235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6213089|NCT02198235|Narcotics|narcotics|mesh-ancestor
6496981|NCT00630084|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6213090|NCT02198235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6213091|NCT02198235|Analgesics|analgesics|mesh-ancestor
6213092|NCT02198235|Sensory System Agents|sensory system agents|mesh-ancestor
6213093|NCT02198235|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6213094|NCT02198651|Adalimumab|adalimumab|mesh-list
6213095|NCT02198651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6213096|NCT02198651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6213097|NCT02199041|Mycophenolic Acid|mycophenolic acid|mesh-list
6213098|NCT02199041|Methylprednisolone|methylprednisolone|mesh-list
6213099|NCT02199041|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6213100|NCT02199041|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6213101|NCT02199041|Prednisolone|prednisolone|mesh-list
6213102|NCT02199041|Prednisolone acetate|prednisolone acetate|mesh-list
6213103|NCT02199041|Cyclophosphamide|cyclophosphamide|mesh-list
6213104|NCT02199041|Melphalan|melphalan|mesh-list
6213105|NCT02199041|Mechlorethamine|mechlorethamine|mesh-list
6213106|NCT02199041|Thiotepa|thiotepa|mesh-list
6213107|NCT02199041|Fludarabine|fludarabine|mesh-list
6213108|NCT02199041|Tacrolimus|tacrolimus|mesh-list
6213109|NCT02199041|Lenograstim|lenograstim|mesh-list
6213110|NCT02199041|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6213111|NCT02199041|Prednisolone phosphate|prednisolone phosphate|mesh-list
6213112|NCT02199041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6213113|NCT02199041|Immunologic Factors|immunologic factors|mesh-ancestor
6213114|NCT02199041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213115|NCT02199041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6213116|NCT02199041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6213117|NCT02199041|Alkylating Agents|alkylating agents|mesh-ancestor
6213118|NCT02199041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6213119|NCT02199041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6213120|NCT02199041|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6213121|NCT02199041|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6213122|NCT02199041|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6213123|NCT02199041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6213124|NCT02199041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6213125|NCT02199041|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6213126|NCT02199041|Antitubercular Agents|antitubercular agents|mesh-ancestor
6213127|NCT02199041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6213128|NCT02199041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6213129|NCT02199041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6213130|NCT02199041|Antiemetics|antiemetics|mesh-ancestor
6213131|NCT02199041|Autonomic Agents|autonomic agents|mesh-ancestor
6213132|NCT02199041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6213133|NCT02199041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6213134|NCT02199041|Glucocorticoids|glucocorticoids|mesh-ancestor
6213135|NCT02199041|Hormones|hormones|mesh-ancestor
6213136|NCT02199041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6213137|NCT02199041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6213138|NCT02199041|Protective Agents|protective agents|mesh-ancestor
6213139|NCT02199041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6213140|NCT02199080|Fibrin fragment D|fibrin fragment d|mesh-list
6213141|NCT02199080|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6213142|NCT02199080|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6213143|NCT02199080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6213144|NCT02199080|Hemostatics|hemostatics|mesh-ancestor
6213145|NCT02199080|Coagulants|coagulants|mesh-ancestor
6213146|NCT02199197|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
5701361|NCT03346993|Bupivacaine|bupivacaine|mesh-list
6213147|NCT02199197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6213148|NCT02199314|Desflurane|desflurane|mesh-list
6213149|NCT02199314|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6213150|NCT02199314|Anesthetics, General|anesthetics, general|mesh-ancestor
6213151|NCT02199314|Anesthetics|anesthetics|mesh-ancestor
6213152|NCT02199314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6213153|NCT02199314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213154|NCT02199496|Ustekinumab|ustekinumab|mesh-list
6213155|NCT02199496|Dermatologic Agents|dermatologic agents|mesh-ancestor
6213156|NCT02199509|Levetiracetam|levetiracetam|mesh-list
6213157|NCT02199509|Anticonvulsants|anticonvulsants|mesh-ancestor
6213158|NCT02199509|Nootropic Agents|nootropic agents|mesh-ancestor
6213159|NCT02199574|Bupivacaine|bupivacaine|mesh-list
6213160|NCT02199574|Anesthetics, Local|anesthetics, local|mesh-ancestor
6213161|NCT02199574|Anesthetics|anesthetics|mesh-ancestor
6213162|NCT02199574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6213163|NCT02199574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213164|NCT02199574|Sensory System Agents|sensory system agents|mesh-ancestor
6213165|NCT02199574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6213166|NCT02199652|Prazosin|prazosin|mesh-list
6213167|NCT02199652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6213168|NCT02199652|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6213169|NCT02199652|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6213170|NCT02199652|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6213171|NCT02199652|Adrenergic Agents|adrenergic agents|mesh-ancestor
6213172|NCT02199652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6213173|NCT02199652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6213174|NCT02199652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213175|NCT02199691|Vaccines|vaccines|mesh-list
6213176|NCT02199691|Immunologic Factors|immunologic factors|mesh-ancestor
6213177|NCT02199691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213178|NCT02199743|Haloperidol|haloperidol|mesh-list
6213179|NCT02199743|Haloperidol decanoate|haloperidol decanoate|mesh-list
6496982|NCT00630084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6496983|NCT00630084|Antiviral Agents|antiviral agents|mesh-ancestor
6496984|NCT00630084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6496985|NCT00630084|Antimetabolites|antimetabolites|mesh-ancestor
6496986|NCT00630084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496987|NCT00630084|Immunologic Factors|immunologic factors|mesh-ancestor
6496988|NCT00630084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496989|NCT00630097|Modafinil|modafinil|mesh-list
6496990|NCT00630097|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6496991|NCT00630097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6496992|NCT00630097|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6496993|NCT00630097|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6496994|NCT00630097|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6496995|NCT00630097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6496996|NCT00630110|Docetaxel|docetaxel|mesh-list
6496997|NCT00630110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6496998|NCT00630110|Tubulin Modulators|tubulin modulators|mesh-ancestor
6496999|NCT00630110|Antimitotic Agents|antimitotic agents|mesh-ancestor
6497000|NCT00630110|Mitosis Modulators|mitosis modulators|mesh-ancestor
6497001|NCT00630110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497002|NCT00630149|Pemetrexed|pemetrexed|mesh-list
6497003|NCT00630149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6497004|NCT00630149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6497005|NCT00630149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497006|NCT00630149|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6497007|NCT00630149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6497008|NCT00630175|Zolpidem|zolpidem|mesh-list
6497009|NCT00630175|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6497010|NCT00630175|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6497011|NCT00630175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6497012|NCT00630175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497013|NCT00630175|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6497014|NCT00630175|GABA Agonists|gaba agonists|mesh-ancestor
6497015|NCT00630175|GABA Agents|gaba agents|mesh-ancestor
6497016|NCT00630175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6497017|NCT00630175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497018|NCT00630214|Calcium, Dietary|calcium, dietary|mesh-list
6497019|NCT00630214|Vitamin D|vitamin d|mesh-list
6497020|NCT00630214|Ergocalciferols|ergocalciferols|mesh-list
6497021|NCT00630214|Vitamins|vitamins|mesh-list
6497022|NCT00630214|Calcium Carbonate|calcium carbonate|mesh-list
6497023|NCT00630214|Calcium|calcium|mesh-list
6497024|NCT00630214|Micronutrients|micronutrients|mesh-ancestor
6497025|NCT00630214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497026|NCT00630214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6497027|NCT00630214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6497028|NCT00630214|Antacids|antacids|mesh-ancestor
6497029|NCT00630214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497030|NCT00630214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6497031|NCT00630357|Levetiracetam|levetiracetam|mesh-list
6497032|NCT00630357|Anticonvulsants|anticonvulsants|mesh-ancestor
6497033|NCT00630357|Nootropic Agents|nootropic agents|mesh-ancestor
6497034|NCT00630370|ATI 7505|ati 7505|mesh-list
6497035|NCT00630370|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
6497036|NCT00630370|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6497037|NCT00630370|Serotonin Agents|serotonin agents|mesh-ancestor
6213180|NCT02199743|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
6213181|NCT02199743|Perphenazine|perphenazine|mesh-list
6213182|NCT02199743|Antiemetics|antiemetics|mesh-ancestor
6213183|NCT02199743|Autonomic Agents|autonomic agents|mesh-ancestor
6213184|NCT02199743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6213185|NCT02199743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213186|NCT02199743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6213187|NCT02199743|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6213188|NCT02199743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6213189|NCT02199743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6213190|NCT02199743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6213191|NCT02199743|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6213192|NCT02199743|Dopamine Agents|dopamine agents|mesh-ancestor
6213193|NCT02199743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6213194|NCT02199743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6213195|NCT02199743|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6213196|NCT02199743|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6213197|NCT02199743|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6213198|NCT02199743|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6213199|NCT02199743|Adrenergic Agents|adrenergic agents|mesh-ancestor
6213200|NCT02199743|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5918346|NCT04992156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5918347|NCT04992156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5918348|NCT04992156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918349|NCT04992182|Vaccines|vaccines|mesh-list
5918350|NCT04992182|Immunologic Factors|immunologic factors|mesh-ancestor
5918351|NCT04992182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918352|NCT04992052|Bone wax|bone wax|mesh-list
5918353|NCT04992052|Hemostatics|hemostatics|mesh-ancestor
6213201|NCT02199743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6213202|NCT02199743|Serotonin Agents|serotonin agents|mesh-ancestor
6213203|NCT02199743|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6213204|NCT02199964|Cyclosporine|cyclosporine|mesh-list
6213205|NCT02199964|Lubricant Eye Drops|lubricant eye drops|mesh-list
6213206|NCT02199964|Cyclosporins|cyclosporins|mesh-list
6213207|NCT02199964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6213208|NCT02199964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6213209|NCT02199964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6213210|NCT02199964|Immunologic Factors|immunologic factors|mesh-ancestor
6213211|NCT02199964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213212|NCT02199964|Antifungal Agents|antifungal agents|mesh-ancestor
6213213|NCT02199964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6213214|NCT02199964|Dermatologic Agents|dermatologic agents|mesh-ancestor
6213215|NCT02199964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6213216|NCT02199964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6213217|NCT02199964|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6213218|NCT02199964|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6213219|NCT02200445|Aldesleukin|aldesleukin|mesh-list
6213220|NCT02200445|Interleukin-2|interleukin-2|mesh-list
6213221|NCT02200445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6213222|NCT02200445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6213223|NCT02200445|Analgesics|analgesics|mesh-ancestor
6213224|NCT02200445|Sensory System Agents|sensory system agents|mesh-ancestor
6213225|NCT02200445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6213226|NCT02200445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213227|NCT02200445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6213228|NCT02200445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6213229|NCT02200445|Antiviral Agents|antiviral agents|mesh-ancestor
6213230|NCT02200445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6213231|NCT02201108|Teriflunomide|teriflunomide|mesh-list
6213232|NCT02201108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6213233|NCT02201108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6213234|NCT02201108|Analgesics|analgesics|mesh-ancestor
6213235|NCT02201108|Sensory System Agents|sensory system agents|mesh-ancestor
6213236|NCT02201108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6213237|NCT02201108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213238|NCT02201108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6213239|NCT02201108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6213240|NCT02201108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6213241|NCT02201108|Immunologic Factors|immunologic factors|mesh-ancestor
6213242|NCT02201212|Everolimus|everolimus|mesh-list
6213243|NCT02201212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6213244|NCT02201212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6213245|NCT02201212|Immunologic Factors|immunologic factors|mesh-ancestor
6213246|NCT02201212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213247|NCT02201251|Topiramate|topiramate|mesh-list
6213248|NCT02201251|Levetiracetam|levetiracetam|mesh-list
6213249|NCT02201251|Anticonvulsants|anticonvulsants|mesh-ancestor
6213250|NCT02201251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6213251|NCT02201251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213252|NCT02201251|Nootropic Agents|nootropic agents|mesh-ancestor
6213253|NCT02201329|Azacitidine|azacitidine|mesh-list
6213254|NCT02201329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6213255|NCT02201329|Antimetabolites|antimetabolites|mesh-ancestor
6213256|NCT02201329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6213257|NCT02201329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6213258|NCT02201329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6213259|NCT02201394|Aspirin|aspirin|mesh-list
6213260|NCT02201394|Ticagrelor|ticagrelor|mesh-list
6213261|NCT02201394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6213262|NCT02201394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6213263|NCT02201394|Analgesics|analgesics|mesh-ancestor
6213264|NCT02201394|Sensory System Agents|sensory system agents|mesh-ancestor
6213265|NCT02201394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6213266|NCT02201394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213267|NCT02201394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6213268|NCT02201394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6213269|NCT02201394|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6213270|NCT02201394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6213271|NCT02201394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6213272|NCT02201394|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6213273|NCT02201394|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6213274|NCT02201394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6213275|NCT02201394|Antipyretics|antipyretics|mesh-ancestor
6213276|NCT02201394|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6213277|NCT02201394|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6213278|NCT02201394|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6213279|NCT02201394|Purinergic Agents|purinergic agents|mesh-ancestor
6213280|NCT02201394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6213281|NCT02201524|Abrocitinib|abrocitinib|mesh-list
6213282|NCT02201524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6213283|NCT02201524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6213284|NCT02201524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6213285|NCT02201771|Aspirin|aspirin|mesh-list
6213286|NCT02201771|Ticagrelor|ticagrelor|mesh-list
6213287|NCT02201771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6213288|NCT02201771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6213289|NCT02201771|Analgesics|analgesics|mesh-ancestor
6213290|NCT02201771|Sensory System Agents|sensory system agents|mesh-ancestor
6213291|NCT02201771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6213292|NCT02201771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213293|NCT02201771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5918354|NCT04992052|Coagulants|coagulants|mesh-ancestor
5918355|NCT04992143|Sorafenib|sorafenib|mesh-list
5918356|NCT04992143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6213294|NCT02201771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6213295|NCT02201771|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6213296|NCT02201771|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6213297|NCT02201771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701362|NCT03346993|Anesthetics, Local|anesthetics, local|mesh-ancestor
5701363|NCT03346993|Anesthetics|anesthetics|mesh-ancestor
5701364|NCT03346993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5701365|NCT03346993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701366|NCT03346993|Sensory System Agents|sensory system agents|mesh-ancestor
5701367|NCT03346993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5701368|NCT03346837|Itraconazole|itraconazole|mesh-list
5701369|NCT03346837|Rifampin|rifampin|mesh-list
5701370|NCT03346837|Linrodostat|linrodostat|mesh-list
5918357|NCT04992143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5918358|NCT04992143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5918359|NCT04992143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918360|NCT04992026|Prednisone|prednisone|mesh-list
5918361|NCT04992026|Abiraterone Acetate|abiraterone acetate|mesh-list
5918362|NCT04992026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5918363|NCT04992026|Glucocorticoids|glucocorticoids|mesh-ancestor
5918364|NCT04992026|Hormones|hormones|mesh-ancestor
5918365|NCT04992026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5918366|NCT04992026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918367|NCT04992026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5918368|NCT04992026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5918369|NCT04992026|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5918370|NCT04992026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6213298|NCT02201771|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6213299|NCT02201771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6213300|NCT02201771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5701371|NCT03346837|Antifungal Agents|antifungal agents|mesh-ancestor
5701372|NCT03346837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5701373|NCT03346837|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5701374|NCT03346837|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5701375|NCT03346837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5701376|NCT03346837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701377|NCT03346837|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5701378|NCT03346837|Hormone Antagonists|hormone antagonists|mesh-ancestor
5701379|NCT03346837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5701380|NCT03346837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701381|NCT03346837|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5701382|NCT03346837|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5701383|NCT03346837|Antitubercular Agents|antitubercular agents|mesh-ancestor
5701384|NCT03346837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5701385|NCT03346837|Leprostatic Agents|leprostatic agents|mesh-ancestor
6213301|NCT02201771|Antipyretics|antipyretics|mesh-ancestor
6213302|NCT02201771|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6213303|NCT02201771|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6213304|NCT02201771|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6213305|NCT02201771|Purinergic Agents|purinergic agents|mesh-ancestor
6213306|NCT02201771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6213307|NCT02201784|Ropivacaine|ropivacaine|mesh-list
6213308|NCT02201784|Levobupivacaine|levobupivacaine|mesh-list
6213309|NCT02201784|Anesthetics, Local|anesthetics, local|mesh-ancestor
6213310|NCT02201784|Anesthetics|anesthetics|mesh-ancestor
6213311|NCT02201784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6213312|NCT02201784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213313|NCT02201784|Sensory System Agents|sensory system agents|mesh-ancestor
6213314|NCT02201784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6213315|NCT02201901|Sofosbuvir|sofosbuvir|mesh-list
6213316|NCT02201901|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
6213317|NCT02201901|Velpatasvir|velpatasvir|mesh-list
6213318|NCT02201901|Antiviral Agents|antiviral agents|mesh-ancestor
6213319|NCT02201901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6213320|NCT02201940|Sofosbuvir|sofosbuvir|mesh-list
6213321|NCT02201940|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
6213322|NCT02201940|Velpatasvir|velpatasvir|mesh-list
6213323|NCT02201940|Antiviral Agents|antiviral agents|mesh-ancestor
6213324|NCT02201940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6213325|NCT02201953|Sofosbuvir|sofosbuvir|mesh-list
6213326|NCT02201953|Antiviral Agents|antiviral agents|mesh-ancestor
6213327|NCT02201953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6213328|NCT02202135|Vancomycin|vancomycin|mesh-list
6213329|NCT02202135|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
6213330|NCT02202135|Aztreonam|aztreonam|mesh-list
6213331|NCT02202135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6213332|NCT02202135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6213333|NCT02202161|Metformin|metformin|mesh-list
6213334|NCT02202161|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6213335|NCT02202161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6213336|NCT02202161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213337|NCT02202161|Incretins|incretins|mesh-ancestor
6213338|NCT02202161|Hormones|hormones|mesh-ancestor
6213339|NCT02202161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6213340|NCT02202161|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6213341|NCT02202161|Protease Inhibitors|protease inhibitors|mesh-ancestor
6213342|NCT02202161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5701386|NCT03346837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5701387|NCT03346837|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5701388|NCT03346837|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5701389|NCT03346837|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5701390|NCT03346837|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5701391|NCT03346837|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5701392|NCT03346837|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5701393|NCT03346772|Vaccines|vaccines|mesh-list
5701394|NCT03346772|Immunologic Factors|immunologic factors|mesh-ancestor
5701395|NCT03346772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701396|NCT03346733|Psyllium|psyllium|mesh-list
5701397|NCT03346733|Cathartics|cathartics|mesh-ancestor
6213343|NCT02202161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6213344|NCT02202499|Varenicline|varenicline|mesh-list
6675929|NCT01578343|Autonomic Agents|autonomic agents|mesh-ancestor
6213345|NCT02202499|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6213346|NCT02202499|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6213347|NCT02202499|Cholinergic Agents|cholinergic agents|mesh-ancestor
6213348|NCT02202499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6213349|NCT02202499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6213350|NCT02202499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213351|NCT02202551|Amantadine|amantadine|mesh-list
6213352|NCT02202551|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6213353|NCT02202551|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6213354|NCT02202551|Antiviral Agents|antiviral agents|mesh-ancestor
6213355|NCT02202551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6213356|NCT02202551|Dopamine Agents|dopamine agents|mesh-ancestor
6213357|NCT02202551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6213358|NCT02202551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6213359|NCT02202551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213360|NCT02202551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6213361|NCT02202551|Analgesics|analgesics|mesh-ancestor
6213362|NCT02202551|Sensory System Agents|sensory system agents|mesh-ancestor
6213363|NCT02202551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6213364|NCT02202616|Glycopyrrolate|glycopyrrolate|mesh-list
6213365|NCT02202616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6213366|NCT02202616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6213367|NCT02202616|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6213368|NCT02202616|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6213369|NCT02202616|Cholinergic Agents|cholinergic agents|mesh-ancestor
6213370|NCT02202616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6213371|NCT02202616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213372|NCT02202837|Etanercept|etanercept|mesh-list
6213373|NCT02202837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6497038|NCT00630370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5701398|NCT03346733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5701399|NCT03346681|Acetylcysteine|acetylcysteine|mesh-list
5701400|NCT03346681|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5701401|NCT03346681|Antiviral Agents|antiviral agents|mesh-ancestor
5701402|NCT03346681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5701403|NCT03346681|Expectorants|expectorants|mesh-ancestor
5701404|NCT03346681|Respiratory System Agents|respiratory system agents|mesh-ancestor
5701405|NCT03346681|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5701406|NCT03346681|Antioxidants|antioxidants|mesh-ancestor
5701407|NCT03346681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701408|NCT03346681|Protective Agents|protective agents|mesh-ancestor
5701409|NCT03346681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701410|NCT03346681|Antidotes|antidotes|mesh-ancestor
5701411|NCT03346642|Decitabine|decitabine|mesh-list
6497039|NCT00630370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497040|NCT00630370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497041|NCT00630383|Histamine|histamine|mesh-list
6497042|NCT00630383|Histamine Agonists|histamine agonists|mesh-ancestor
6497043|NCT00630383|Histamine Agents|histamine agents|mesh-ancestor
5918371|NCT04992026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918372|NCT04992026|Hormone Antagonists|hormone antagonists|mesh-ancestor
6497044|NCT00630383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6524406|NCT00758004|Atorvastatin|atorvastatin|mesh-list
5701412|NCT03346642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5918373|NCT04992026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5918374|NCT04991961|Antihypertensive Agents|antihypertensive agents|mesh-list
5918375|NCT04991948|Pembrolizumab|pembrolizumab|mesh-list
5918376|NCT04991948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5918377|NCT04991948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5918378|NCT04991597|Lidocaine|lidocaine|mesh-list
5918379|NCT04991597|Epinephrine|epinephrine|mesh-list
5918380|NCT04991597|Racepinephrine|racepinephrine|mesh-list
5918381|NCT04991597|Epinephryl borate|epinephryl borate|mesh-list
5918382|NCT04991597|Anesthetics, Local|anesthetics, local|mesh-ancestor
5918383|NCT04991597|Anesthetics|anesthetics|mesh-ancestor
5918384|NCT04991597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5918385|NCT04991597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918386|NCT04991597|Sensory System Agents|sensory system agents|mesh-ancestor
5918387|NCT04991597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5918388|NCT04991597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5918389|NCT04991597|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5918390|NCT04991597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5918391|NCT04991597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5918392|NCT04991597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701413|NCT03346642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5701414|NCT03346642|Antimetabolites|antimetabolites|mesh-ancestor
5701415|NCT03346642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701416|NCT03346642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5701417|NCT03346642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5701418|NCT03346629|Misoprostol|misoprostol|mesh-list
5701419|NCT03346629|Mifepristone|mifepristone|mesh-list
5701420|NCT03346629|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5701421|NCT03346629|Abortifacient Agents|abortifacient agents|mesh-ancestor
5701422|NCT03346629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6213374|NCT02202837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6213375|NCT02202837|Analgesics|analgesics|mesh-ancestor
6213376|NCT02202837|Sensory System Agents|sensory system agents|mesh-ancestor
6213377|NCT02202837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6213378|NCT02202837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213379|NCT02202837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6213380|NCT02202837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6213381|NCT02202837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6213382|NCT02202837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6213383|NCT02202837|Immunologic Factors|immunologic factors|mesh-ancestor
6213384|NCT02202850|Etanercept|etanercept|mesh-list
6213385|NCT02202850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6213386|NCT02202850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6213387|NCT02202850|Analgesics|analgesics|mesh-ancestor
6213388|NCT02202850|Sensory System Agents|sensory system agents|mesh-ancestor
6213389|NCT02202850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6213390|NCT02202850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213391|NCT02202850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6213392|NCT02202850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6213393|NCT02202850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6213394|NCT02202850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6213395|NCT02202850|Immunologic Factors|immunologic factors|mesh-ancestor
6213396|NCT02202980|Sofosbuvir|sofosbuvir|mesh-list
6213397|NCT02202980|Antiviral Agents|antiviral agents|mesh-ancestor
6213398|NCT02202980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6213399|NCT02203019|Fentanyl|fentanyl|mesh-list
6213400|NCT02203019|Dexmedetomidine|dexmedetomidine|mesh-list
6213401|NCT02203019|Propofol|propofol|mesh-list
6213402|NCT02203019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6213403|NCT02203019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6213404|NCT02203019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213405|NCT02203019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6213406|NCT02203019|Anesthetics, General|anesthetics, general|mesh-ancestor
6213407|NCT02203019|Anesthetics|anesthetics|mesh-ancestor
6213408|NCT02203019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6213409|NCT02203019|Analgesics|analgesics|mesh-ancestor
6213410|NCT02203019|Sensory System Agents|sensory system agents|mesh-ancestor
6213411|NCT02203019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6213412|NCT02203019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6213413|NCT02203019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6213414|NCT02203019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6213415|NCT02203019|Adrenergic Agents|adrenergic agents|mesh-ancestor
6213416|NCT02203019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6213417|NCT02203019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6213418|NCT02203019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6213419|NCT02203019|Narcotics|narcotics|mesh-ancestor
6213420|NCT02203019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6213421|NCT02203032|Ustekinumab|ustekinumab|mesh-list
6213422|NCT02203032|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6213423|NCT02203032|Dermatologic Agents|dermatologic agents|mesh-ancestor
6213424|NCT02203032|Immunologic Factors|immunologic factors|mesh-ancestor
6213425|NCT02203032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213426|NCT02203149|Grazoprevir|grazoprevir|mesh-list
6213427|NCT02203149|Antiviral Agents|antiviral agents|mesh-ancestor
6213428|NCT02203149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6213429|NCT02203331|Anastrozole|anastrozole|mesh-list
6213430|NCT02203331|Leuprolide|leuprolide|mesh-list
6213431|NCT02203331|Levonorgestrel|levonorgestrel|mesh-list
6213432|NCT02203331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6213433|NCT02203331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6213434|NCT02203331|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6213435|NCT02203331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6213436|NCT02203331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6213437|NCT02203331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6213438|NCT02203331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6213439|NCT02203331|Hormone Antagonists|hormone antagonists|mesh-ancestor
5721004|NCT03209011|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6213440|NCT02203331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6213441|NCT02203331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213442|NCT02203331|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6213443|NCT02203331|Fertility Agents|fertility agents|mesh-ancestor
6213444|NCT02203331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6213445|NCT02203331|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6213446|NCT02203331|Contraceptive Agents|contraceptive agents|mesh-ancestor
6213447|NCT02203331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6213448|NCT02203331|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6213449|NCT02203331|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6213450|NCT02203565|Sodium Hypochlorite|sodium hypochlorite|mesh-list
6213451|NCT02203565|Eusol|eusol|mesh-list
6213452|NCT02203565|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6213453|NCT02203565|Disinfectants|disinfectants|mesh-ancestor
6213454|NCT02203565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6213455|NCT02203578|Romidepsin|romidepsin|mesh-list
6213456|NCT02203578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5701423|NCT03346629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701424|NCT03346629|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5701425|NCT03346629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5701426|NCT03346629|Oxytocics|oxytocics|mesh-ancestor
5701427|NCT03346629|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5701428|NCT03346629|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5701429|NCT03346629|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5701430|NCT03346629|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5701431|NCT03346629|Contraceptive Agents|contraceptive agents|mesh-ancestor
5701432|NCT03346629|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5701433|NCT03346629|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5701434|NCT03346629|Hormone Antagonists|hormone antagonists|mesh-ancestor
5701435|NCT03346629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5701436|NCT03346629|Luteolytic Agents|luteolytic agents|mesh-ancestor
5701437|NCT03346629|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6213457|NCT02203578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6213458|NCT02203591|Ethanol|ethanol|mesh-list
6213459|NCT02203591|Chlorhexidine|chlorhexidine|mesh-list
6213460|NCT02203591|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6213461|NCT02203591|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6213462|NCT02203591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6213463|NCT02203591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6213464|NCT02203591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213465|NCT02203591|Disinfectants|disinfectants|mesh-ancestor
6213466|NCT02203591|Dermatologic Agents|dermatologic agents|mesh-ancestor
6213467|NCT02203630|Phenylephrine|phenylephrine|mesh-list
6213468|NCT02203630|Oxymetazoline|oxymetazoline|mesh-list
6213469|NCT02203630|Norepinephrine|norepinephrine|mesh-list
6213470|NCT02203630|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6213471|NCT02203630|Mydriatics|mydriatics|mesh-ancestor
6213472|NCT02203630|Autonomic Agents|autonomic agents|mesh-ancestor
6213473|NCT02203630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6213474|NCT02203630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213475|NCT02203630|Sympathomimetics|sympathomimetics|mesh-ancestor
6213476|NCT02203630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6213477|NCT02203630|Nasal Decongestants|nasal decongestants|mesh-ancestor
6213478|NCT02203630|Respiratory System Agents|respiratory system agents|mesh-ancestor
6213479|NCT02203630|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6213480|NCT02203630|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6213481|NCT02203630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6213482|NCT02203630|Adrenergic Agents|adrenergic agents|mesh-ancestor
6213483|NCT02203630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6213484|NCT02203630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6213485|NCT02203630|Protective Agents|protective agents|mesh-ancestor
6213486|NCT02203786|Haloperidol|haloperidol|mesh-list
6213487|NCT02203786|Haloperidol decanoate|haloperidol decanoate|mesh-list
6213488|NCT02203786|Fluphenazine|fluphenazine|mesh-list
6213489|NCT02203786|Fluphenazine depot|fluphenazine depot|mesh-list
6213490|NCT02203786|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
5701438|NCT03346629|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5701439|NCT03346538|Edaravone|edaravone|mesh-list
5701440|NCT03346538|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5701441|NCT03346538|Antioxidants|antioxidants|mesh-ancestor
5701442|NCT03346538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701443|NCT03346538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5701444|NCT03346538|Protective Agents|protective agents|mesh-ancestor
6213491|NCT02203786|Amphetamine|amphetamine|mesh-list
6213492|NCT02203786|Dextroamphetamine|dextroamphetamine|mesh-list
6213493|NCT02203786|Antiemetics|antiemetics|mesh-ancestor
5701445|NCT03346538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701446|NCT03346525|Penicillins|penicillins|mesh-list
5701447|NCT03346525|Penicillin G|penicillin g|mesh-list
5701448|NCT03346525|Penicillin G Benzathine|penicillin g benzathine|mesh-list
5701449|NCT03346525|Penicillin G Procaine|penicillin g procaine|mesh-list
5701450|NCT03346525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5701451|NCT03346525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5721005|NCT03209011|Antiviral Agents|antiviral agents|mesh-ancestor
5721006|NCT03209011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5721007|NCT03209206|Docetaxel|docetaxel|mesh-list
5721008|NCT03209206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5721009|NCT03209206|Tubulin Modulators|tubulin modulators|mesh-ancestor
5721010|NCT03209206|Antimitotic Agents|antimitotic agents|mesh-ancestor
5721011|NCT03209206|Mitosis Modulators|mitosis modulators|mesh-ancestor
5721012|NCT03209206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721013|NCT03209232|Infliximab|infliximab|mesh-list
5721014|NCT03209232|Dermatologic Agents|dermatologic agents|mesh-ancestor
5721015|NCT03209232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5721016|NCT03209232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5721017|NCT03208972|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5721018|NCT03208972|Menotropins|menotropins|mesh-list
5721019|NCT03208972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5721020|NCT03208972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721021|NCT03208972|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5721022|NCT03208972|Fertility Agents|fertility agents|mesh-ancestor
5721023|NCT03208764|Nitric Oxide|nitric oxide|mesh-list
5721024|NCT03208764|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5721025|NCT03208764|Autonomic Agents|autonomic agents|mesh-ancestor
6213494|NCT02203786|Autonomic Agents|autonomic agents|mesh-ancestor
6213495|NCT02203786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6213496|NCT02203786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213497|NCT02203786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6213498|NCT02203786|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6213499|NCT02203786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6213500|NCT02203786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6213501|NCT02203786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6213502|NCT02203786|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6213503|NCT02203786|Dopamine Agents|dopamine agents|mesh-ancestor
6213504|NCT02203786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6213505|NCT02203786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6213506|NCT02203786|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6213507|NCT02203786|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6213508|NCT02203786|Sympathomimetics|sympathomimetics|mesh-ancestor
6213509|NCT02203786|Adrenergic Agents|adrenergic agents|mesh-ancestor
6213510|NCT02203786|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6213511|NCT02203786|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6213512|NCT02203786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6213513|NCT02203786|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6213514|NCT02203838|Risperidone|risperidone|mesh-list
6213515|NCT02203838|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6213516|NCT02203838|Serotonin Agents|serotonin agents|mesh-ancestor
6213517|NCT02203838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6213518|NCT02203838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6213519|NCT02203838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213520|NCT02203838|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6213521|NCT02203838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6213522|NCT02203838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6213523|NCT02203838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6213524|NCT02203838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6213525|NCT02203838|Dopamine Agents|dopamine agents|mesh-ancestor
6213526|NCT02203916|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
6213527|NCT02203916|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6213528|NCT02203916|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6213529|NCT02203916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242828|NCT02657031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721026|NCT03208764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5721027|NCT03208764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721028|NCT03208764|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5721029|NCT03208764|Respiratory System Agents|respiratory system agents|mesh-ancestor
5721030|NCT03208764|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5721031|NCT03208764|Antioxidants|antioxidants|mesh-ancestor
5721032|NCT03208764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721033|NCT03208764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5721034|NCT03208764|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5701452|NCT03346317|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5701453|NCT03346317|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5701454|NCT03346317|Estradiol|estradiol|mesh-list
5701455|NCT03346317|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5701456|NCT03346317|Dydrogesterone|dydrogesterone|mesh-list
5701457|NCT03346317|Estrogens|estrogens|mesh-ancestor
5701458|NCT03346317|Hormones|hormones|mesh-ancestor
6213530|NCT02204410|Methylphenidate|methylphenidate|mesh-list
6213531|NCT02204410|Amphetamine|amphetamine|mesh-list
6213532|NCT02204410|Adderall|adderall|mesh-list
6213533|NCT02204410|Dextroamphetamine|dextroamphetamine|mesh-list
6213534|NCT02204410|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6213535|NCT02204410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213536|NCT02204410|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6213537|NCT02204410|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6213538|NCT02204410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6213539|NCT02204410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6213540|NCT02204410|Dopamine Agents|dopamine agents|mesh-ancestor
6213541|NCT02204410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6213542|NCT02204410|Sympathomimetics|sympathomimetics|mesh-ancestor
6213543|NCT02204410|Autonomic Agents|autonomic agents|mesh-ancestor
6213544|NCT02204410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6213545|NCT02204410|Adrenergic Agents|adrenergic agents|mesh-ancestor
6213546|NCT02204410|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6213547|NCT02204982|Rituximab|rituximab|mesh-list
6213548|NCT02204982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6213549|NCT02204982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6213550|NCT02204982|Immunologic Factors|immunologic factors|mesh-ancestor
6213551|NCT02204982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213552|NCT02204982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6213553|NCT02205333|Rituximab|rituximab|mesh-list
6213554|NCT02205333|Durvalumab|durvalumab|mesh-list
6213555|NCT02205333|Tremelimumab|tremelimumab|mesh-list
6213556|NCT02205333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6213557|NCT02205333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6213558|NCT02205333|Immunologic Factors|immunologic factors|mesh-ancestor
6213559|NCT02205333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213560|NCT02205333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5701459|NCT03346317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5701460|NCT03346317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701461|NCT03346317|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5701462|NCT03346317|Contraceptive Agents|contraceptive agents|mesh-ancestor
5701463|NCT03346317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5701464|NCT03346317|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5701465|NCT03346317|Progestins|progestins|mesh-ancestor
5701466|NCT03346252|Botulinum Toxins|botulinum toxins|mesh-list
5701467|NCT03346252|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5701468|NCT03346252|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5701469|NCT03346252|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5701470|NCT03346252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6213561|NCT02205801|Bupivacaine|bupivacaine|mesh-list
6213562|NCT02205801|Anesthetics, Local|anesthetics, local|mesh-ancestor
6213563|NCT02205801|Anesthetics|anesthetics|mesh-ancestor
6213564|NCT02205801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6213565|NCT02205801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213566|NCT02205801|Sensory System Agents|sensory system agents|mesh-ancestor
6213567|NCT02205801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5701471|NCT03346252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6213568|NCT02205814|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2H-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2h-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|mesh-list
6213569|NCT02205814|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
6213570|NCT02205814|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
6213571|NCT02205814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6213572|NCT02205814|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6213573|NCT02205814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6213574|NCT02205814|Immunologic Factors|immunologic factors|mesh-ancestor
6213575|NCT02205814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213576|NCT02205983|Acetaminophen|acetaminophen|mesh-list
6213577|NCT02205983|Hydromorphone|hydromorphone|mesh-list
6213578|NCT02205983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6213579|NCT02205983|Analgesics|analgesics|mesh-ancestor
6213580|NCT02205983|Sensory System Agents|sensory system agents|mesh-ancestor
6213581|NCT02205983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5701472|NCT03346252|Cholinergic Agents|cholinergic agents|mesh-ancestor
5701473|NCT03346252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5701474|NCT03346252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701475|NCT03346252|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5701476|NCT03346252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5701477|NCT03346226|Dexmedetomidine|dexmedetomidine|mesh-list
5701478|NCT03346226|Propofol|propofol|mesh-list
5701479|NCT03346226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5701480|NCT03346226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5701481|NCT03346226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701482|NCT03346226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5701483|NCT03346226|Anesthetics, General|anesthetics, general|mesh-ancestor
5701484|NCT03346226|Anesthetics|anesthetics|mesh-ancestor
5701485|NCT03346226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5701486|NCT03346226|Analgesics|analgesics|mesh-ancestor
5701487|NCT03346226|Sensory System Agents|sensory system agents|mesh-ancestor
5701488|NCT03346226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5701489|NCT03346226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5701490|NCT03346226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5701491|NCT03346226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5701492|NCT03346226|Adrenergic Agents|adrenergic agents|mesh-ancestor
5701493|NCT03346226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5701494|NCT03346226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701495|NCT03346200|Tamoxifen|tamoxifen|mesh-list
5701496|NCT03346200|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5701497|NCT03346200|Hormone Antagonists|hormone antagonists|mesh-ancestor
5701498|NCT03346200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5701499|NCT03346200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701500|NCT03346200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5701501|NCT03346200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5701502|NCT03346200|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5701503|NCT03346200|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5701504|NCT03346200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5701505|NCT03346187|Atorvastatin|atorvastatin|mesh-list
5701506|NCT03346187|Fenofibrate|fenofibrate|mesh-list
5701507|NCT03346187|Calcium|calcium|mesh-list
5701508|NCT03346187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5701509|NCT03346187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701510|NCT03346187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6213582|NCT02205983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213583|NCT02205983|Antipyretics|antipyretics|mesh-ancestor
6213584|NCT02205983|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6213585|NCT02205983|Narcotics|narcotics|mesh-ancestor
6213586|NCT02205983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6213587|NCT02206152|Acetylcysteine|acetylcysteine|mesh-list
6213588|NCT02206152|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6213589|NCT02206152|Antiviral Agents|antiviral agents|mesh-ancestor
6213590|NCT02206152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6213591|NCT02206152|Expectorants|expectorants|mesh-ancestor
6213592|NCT02206152|Respiratory System Agents|respiratory system agents|mesh-ancestor
6213593|NCT02206152|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6213594|NCT02206152|Antioxidants|antioxidants|mesh-ancestor
6213595|NCT02206152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6213596|NCT02206152|Protective Agents|protective agents|mesh-ancestor
6213597|NCT02206152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213598|NCT02206152|Antidotes|antidotes|mesh-ancestor
6213599|NCT02206620|Donepezil|donepezil|mesh-list
5701511|NCT03346187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5701512|NCT03346187|Antimetabolites|antimetabolites|mesh-ancestor
5701513|NCT03346187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701514|NCT03346187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5701515|NCT03346187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5918393|NCT04991597|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5918394|NCT04991597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5918395|NCT04991597|Adrenergic Agents|adrenergic agents|mesh-ancestor
5918396|NCT04991597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5918397|NCT04991597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5918398|NCT04991597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5918399|NCT04991597|Autonomic Agents|autonomic agents|mesh-ancestor
5918400|NCT04991597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5918401|NCT04991597|Respiratory System Agents|respiratory system agents|mesh-ancestor
5918402|NCT04991597|Mydriatics|mydriatics|mesh-ancestor
6213600|NCT02206620|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5918403|NCT04991597|Sympathomimetics|sympathomimetics|mesh-ancestor
6213601|NCT02206620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6213602|NCT02206620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6213603|NCT02206620|Cholinergic Agents|cholinergic agents|mesh-ancestor
6213604|NCT02206620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6213605|NCT02206620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213606|NCT02206620|Nootropic Agents|nootropic agents|mesh-ancestor
6213607|NCT02206685|Methadone|methadone|mesh-list
6213608|NCT02206685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6213609|NCT02206685|Narcotics|narcotics|mesh-ancestor
6213610|NCT02206685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6213611|NCT02206685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213612|NCT02206685|Analgesics|analgesics|mesh-ancestor
6213613|NCT02206685|Sensory System Agents|sensory system agents|mesh-ancestor
6213614|NCT02206685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6213615|NCT02206685|Antitussive Agents|antitussive agents|mesh-ancestor
6213616|NCT02206685|Respiratory System Agents|respiratory system agents|mesh-ancestor
6213617|NCT02206776|Midazolam|midazolam|mesh-list
6213618|NCT02206776|Ketamine|ketamine|mesh-list
6213619|NCT02206776|Analgesics|analgesics|mesh-ancestor
6213620|NCT02206776|Sensory System Agents|sensory system agents|mesh-ancestor
6213621|NCT02206776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6213622|NCT02206776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213623|NCT02206776|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6213624|NCT02206776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6213625|NCT02206776|Anesthetics, General|anesthetics, general|mesh-ancestor
6213626|NCT02206776|Anesthetics|anesthetics|mesh-ancestor
6497045|NCT00630383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497046|NCT00630383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497047|NCT00630435|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6497048|NCT00630435|Estrogens|estrogens|mesh-ancestor
6497049|NCT00630435|Hormones|hormones|mesh-ancestor
6497050|NCT00630435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6497051|NCT00630435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497052|NCT00630474|Xylometazoline|xylometazoline|mesh-list
6497053|NCT00630474|Nasal Decongestants|nasal decongestants|mesh-ancestor
6497054|NCT00630474|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6497055|NCT00630474|Respiratory System Agents|respiratory system agents|mesh-ancestor
6497056|NCT00630500|Memantine|memantine|mesh-list
6497057|NCT00630500|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6497058|NCT00630500|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6497059|NCT00630500|Dopamine Agents|dopamine agents|mesh-ancestor
6497060|NCT00630500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5701516|NCT03346187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5701517|NCT03346096|Thiotepa|thiotepa|mesh-list
5701518|NCT03346096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5701519|NCT03346096|Alkylating Agents|alkylating agents|mesh-ancestor
5701520|NCT03346096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701521|NCT03346096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5701522|NCT03346096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5701523|NCT03346096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5701524|NCT03346096|Immunologic Factors|immunologic factors|mesh-ancestor
5701525|NCT03346096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701526|NCT03346083|Betrixaban|betrixaban|mesh-list
5701527|NCT03346083|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5701528|NCT03346083|Antithrombins|antithrombins|mesh-ancestor
5701529|NCT03346083|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5701530|NCT03346083|Protease Inhibitors|protease inhibitors|mesh-ancestor
5701531|NCT03346083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5918404|NCT04991597|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5964019|NCT04595929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964020|NCT04595929|Antimetabolites|antimetabolites|mesh-ancestor
5964021|NCT04595929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5964022|NCT04595929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5964023|NCT04595929|Immunologic Factors|immunologic factors|mesh-ancestor
5964024|NCT04595929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964025|NCT04595929|Antidotes|antidotes|mesh-ancestor
5964026|NCT04595929|Protective Agents|protective agents|mesh-ancestor
5964027|NCT04595929|Vitamin B Complex|vitamin b complex|mesh-ancestor
5964028|NCT04595929|Vitamins|vitamins|mesh-ancestor
5964029|NCT04595929|Micronutrients|micronutrients|mesh-ancestor
5964030|NCT04595812|Misoprostol|misoprostol|mesh-list
5964031|NCT04595812|Hemostatics|hemostatics|mesh-list
5964032|NCT04595812|Oxytocin|oxytocin|mesh-list
5964033|NCT04595812|Carbetocin|carbetocin|mesh-list
5964034|NCT04595812|Oxytocics|oxytocics|mesh-ancestor
6213627|NCT02206776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6213628|NCT02206776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6213629|NCT02206776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6213630|NCT02206776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6213631|NCT02206776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6213632|NCT02206776|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6213633|NCT02206776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6213634|NCT02206776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6213635|NCT02206776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6213636|NCT02206776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6213637|NCT02206776|GABA Modulators|gaba modulators|mesh-ancestor
6213638|NCT02206776|GABA Agents|gaba agents|mesh-ancestor
6213639|NCT02207088|Ritonavir|ritonavir|mesh-list
6213640|NCT02207088|Ribavirin|ribavirin|mesh-list
6213641|NCT02207088|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6213642|NCT02207088|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6213643|NCT02207088|Protease Inhibitors|protease inhibitors|mesh-ancestor
6213644|NCT02207088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6213645|NCT02207088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6213646|NCT02207088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6213647|NCT02207088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6213648|NCT02207088|Antiviral Agents|antiviral agents|mesh-ancestor
6213649|NCT02207088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6213650|NCT02207088|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6213651|NCT02207088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6213652|NCT02207088|Antimetabolites|antimetabolites|mesh-ancestor
6213653|NCT02207231|Adalimumab|adalimumab|mesh-list
6213654|NCT02207231|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6213655|NCT02207231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6213656|NCT02207231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6213657|NCT02207231|Immunologic Factors|immunologic factors|mesh-ancestor
6213658|NCT02207231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213659|NCT02207244|Adalimumab|adalimumab|mesh-list
6213660|NCT02207244|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6213661|NCT02207244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6213662|NCT02207244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5701532|NCT03346083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701533|NCT03346083|Anticoagulants|anticoagulants|mesh-ancestor
5701534|NCT03345992|Clarithromycin|clarithromycin|mesh-list
5701535|NCT03345992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5701536|NCT03345992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5701537|NCT03345992|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5701538|NCT03345992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5701539|NCT03345992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918405|NCT04991584|Amoxicillin|amoxicillin|mesh-list
5918406|NCT04991584|Levofloxacin|levofloxacin|mesh-list
6213663|NCT02207244|Immunologic Factors|immunologic factors|mesh-ancestor
6213664|NCT02207244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213665|NCT02207374|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
6213666|NCT02207374|Protease Inhibitors|protease inhibitors|mesh-ancestor
6213667|NCT02207374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6213668|NCT02207374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6213669|NCT02207374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6213670|NCT02207374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213671|NCT02207400|Listerine|listerine|mesh-list
6213672|NCT02207400|Fluorides|fluorides|mesh-list
6213673|NCT02207400|Sodium Fluoride|sodium fluoride|mesh-list
6213674|NCT02207400|Cariostatic Agents|cariostatic agents|mesh-ancestor
6213675|NCT02207400|Protective Agents|protective agents|mesh-ancestor
6213676|NCT02207400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213677|NCT02207400|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6213678|NCT02207400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6213679|NCT02207413|Vaccines|vaccines|mesh-list
6213680|NCT02207413|Immunologic Factors|immunologic factors|mesh-ancestor
6213681|NCT02207413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213682|NCT02207491|Timolol|timolol|mesh-list
6213683|NCT02207491|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5701540|NCT03345992|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5721035|NCT03208764|Vasodilator Agents|vasodilator agents|mesh-ancestor
5918407|NCT04991584|Ofloxacin|ofloxacin|mesh-list
5918408|NCT04991584|Tetracycline|tetracycline|mesh-list
5918409|NCT04991584|Furazolidone|furazolidone|mesh-list
5918410|NCT04991584|Esomeprazole|esomeprazole|mesh-list
5918411|NCT04991584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5918412|NCT04991584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5918413|NCT04991584|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5918414|NCT04991584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5918415|NCT04991584|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6213684|NCT02207491|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6213685|NCT02207491|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6213686|NCT02207491|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6213687|NCT02207491|Adrenergic Agents|adrenergic agents|mesh-ancestor
6213688|NCT02207491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6213689|NCT02207491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6213690|NCT02207491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213691|NCT02207491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6213692|NCT02207491|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6213693|NCT02207530|Durvalumab|durvalumab|mesh-list
6213694|NCT02207530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6213695|NCT02207530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6213696|NCT02207556|Doxycycline|doxycycline|mesh-list
6213697|NCT02207556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6213698|NCT02207556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6213699|NCT02207556|Antimalarials|antimalarials|mesh-ancestor
6213700|NCT02207556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6213701|NCT02207556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6213702|NCT02207608|Hyaluronic Acid|hyaluronic acid|mesh-list
6213703|NCT02207608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6213704|NCT02207608|Immunologic Factors|immunologic factors|mesh-ancestor
6213705|NCT02207608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213706|NCT02207608|Viscosupplements|viscosupplements|mesh-ancestor
6213707|NCT02207608|Protective Agents|protective agents|mesh-ancestor
6213708|NCT02207621|Timolol|timolol|mesh-list
6213709|NCT02207621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6213710|NCT02207621|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6213711|NCT02207621|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6213712|NCT02207621|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6213713|NCT02207621|Adrenergic Agents|adrenergic agents|mesh-ancestor
6213714|NCT02207621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5701541|NCT03345992|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5701542|NCT03345966|Antibodies|antibodies|mesh-list
5701543|NCT03345966|Immunologic Factors|immunologic factors|mesh-ancestor
5701544|NCT03345966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701545|NCT03345940|Dimethyl Fumarate|dimethyl fumarate|mesh-list
5701546|NCT03345940|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
5701547|NCT03345940|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5701548|NCT03345940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701549|NCT03345940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5701550|NCT03345940|Immunologic Factors|immunologic factors|mesh-ancestor
5701551|NCT03345940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701552|NCT03345940|Dermatologic Agents|dermatologic agents|mesh-ancestor
5701553|NCT03345836|Upadacitinib|upadacitinib|mesh-list
5701554|NCT03345836|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
5701555|NCT03345836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5701556|NCT03345836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5701557|NCT03345836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701558|NCT03345836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6213715|NCT02207621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6213716|NCT02207621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213717|NCT02207621|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6213718|NCT02207621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6213719|NCT02207634|Evolocumab|evolocumab|mesh-list
6213720|NCT02207634|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6213721|NCT02207634|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6213722|NCT02207634|Antimetabolites|antimetabolites|mesh-ancestor
6213723|NCT02207634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6213724|NCT02207634|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5701559|NCT03345810|Gemcitabine|gemcitabine|mesh-list
5701560|NCT03345810|Paclitaxel|paclitaxel|mesh-list
5701561|NCT03345810|Vinorelbine|vinorelbine|mesh-list
5701562|NCT03345810|Carboplatin|carboplatin|mesh-list
5701563|NCT03345810|Durvalumab|durvalumab|mesh-list
5701564|NCT03345810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5701565|NCT03345810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5701566|NCT03345810|Tubulin Modulators|tubulin modulators|mesh-ancestor
5701567|NCT03345810|Antimitotic Agents|antimitotic agents|mesh-ancestor
5701568|NCT03345810|Mitosis Modulators|mitosis modulators|mesh-ancestor
5701569|NCT03345810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701570|NCT03345810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5701571|NCT03345810|Antimetabolites|antimetabolites|mesh-ancestor
5701572|NCT03345810|Antiviral Agents|antiviral agents|mesh-ancestor
6213725|NCT02207816|Vaccines|vaccines|mesh-list
5701573|NCT03345810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6213726|NCT02207816|Immunologic Factors|immunologic factors|mesh-ancestor
6213727|NCT02207816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213728|NCT02207829|Tiotropium Bromide|tiotropium bromide|mesh-list
6213729|NCT02207829|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6213730|NCT02207829|Autonomic Agents|autonomic agents|mesh-ancestor
6213731|NCT02207829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6213732|NCT02207829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213733|NCT02207829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6213734|NCT02207829|Respiratory System Agents|respiratory system agents|mesh-ancestor
6213735|NCT02207829|Parasympatholytics|parasympatholytics|mesh-ancestor
6213736|NCT02207829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6213737|NCT02207829|Cholinergic Agents|cholinergic agents|mesh-ancestor
6213738|NCT02207829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6213739|NCT02207829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6213740|NCT02207907|Listerine|listerine|mesh-list
6213741|NCT02207907|Fluorides|fluorides|mesh-list
6213742|NCT02207907|Sodium Fluoride|sodium fluoride|mesh-list
6213743|NCT02207907|Cariostatic Agents|cariostatic agents|mesh-ancestor
5701574|NCT03345810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5701575|NCT03345810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5701576|NCT03345810|Immunologic Factors|immunologic factors|mesh-ancestor
5701577|NCT03345810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701578|NCT03345810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5701579|NCT03345797|Testosterone|testosterone|mesh-list
5701580|NCT03345797|Androgens|androgens|mesh-ancestor
5701581|NCT03345797|Hormones|hormones|mesh-ancestor
5701582|NCT03345797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5701583|NCT03345797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701584|NCT03345667|Ranibizumab|ranibizumab|mesh-list
5701585|NCT03345667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5701586|NCT03345667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5701587|NCT03345667|Growth Substances|growth substances|mesh-ancestor
5701588|NCT03345667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701589|NCT03345667|Growth Inhibitors|growth inhibitors|mesh-ancestor
5701590|NCT03345667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6213744|NCT02207907|Protective Agents|protective agents|mesh-ancestor
6213745|NCT02207907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213746|NCT02207907|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6213747|NCT02207907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6213748|NCT02207946|Botulinum Toxins|botulinum toxins|mesh-list
6213749|NCT02207946|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6213750|NCT02207946|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6213751|NCT02207946|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
6213752|NCT02207946|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6213753|NCT02207946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6213754|NCT02207946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6213755|NCT02207946|Cholinergic Agents|cholinergic agents|mesh-ancestor
6213756|NCT02207946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6213757|NCT02207946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213758|NCT02207946|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6213759|NCT02207946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6213760|NCT02208037|Mycophenolic Acid|mycophenolic acid|mesh-list
6213761|NCT02208037|Maraviroc|maraviroc|mesh-list
6213762|NCT02208037|Cyclophosphamide|cyclophosphamide|mesh-list
6213763|NCT02208037|Methotrexate|methotrexate|mesh-list
6213764|NCT02208037|Bortezomib|bortezomib|mesh-list
5701591|NCT03345628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
5701592|NCT03345628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5701593|NCT03345628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701594|NCT03345576|Methyltestosterone|methyltestosterone|mesh-list
5701595|NCT03345576|Testosterone|testosterone|mesh-list
5701596|NCT03345576|Testosterone undecanoate|testosterone undecanoate|mesh-list
5701597|NCT03345576|Testosterone enanthate|testosterone enanthate|mesh-list
5701598|NCT03345576|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6213765|NCT02208037|Tacrolimus|tacrolimus|mesh-list
6213766|NCT02208037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6213767|NCT02208037|Immunologic Factors|immunologic factors|mesh-ancestor
6213768|NCT02208037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213769|NCT02208037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6213770|NCT02208037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6213771|NCT02208037|Alkylating Agents|alkylating agents|mesh-ancestor
5701599|NCT03345576|Androgens|androgens|mesh-ancestor
5701600|NCT03345576|Hormones|hormones|mesh-ancestor
5701601|NCT03345576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5701602|NCT03345576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701603|NCT03345576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6213772|NCT02208037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6213773|NCT02208037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6213774|NCT02208037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6213775|NCT02208037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6213776|NCT02208037|Abortifacient Agents|abortifacient agents|mesh-ancestor
6213777|NCT02208037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6213778|NCT02208037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6497061|NCT00630500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497062|NCT00630500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497063|NCT00630500|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6213779|NCT02208037|Antimetabolites|antimetabolites|mesh-ancestor
6213780|NCT02208037|Dermatologic Agents|dermatologic agents|mesh-ancestor
6213781|NCT02208037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6213782|NCT02208037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6213783|NCT02208037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6213784|NCT02208037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6213785|NCT02208037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6213786|NCT02208037|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6213787|NCT02208037|Antitubercular Agents|antitubercular agents|mesh-ancestor
6213788|NCT02208037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6213789|NCT02208037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6213790|NCT02208037|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6213791|NCT02208037|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6213792|NCT02208037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6213793|NCT02208037|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6213794|NCT02208037|Antiviral Agents|antiviral agents|mesh-ancestor
6213795|NCT02208037|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6213796|NCT02208050|4-Aminopyridine|4-aminopyridine|mesh-list
6213797|NCT02208050|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6213798|NCT02208050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6213799|NCT02208050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6213800|NCT02208063|Vancomycin|vancomycin|mesh-list
6213801|NCT02208063|Cefazolin|cefazolin|mesh-list
6213802|NCT02208063|Daptomycin|daptomycin|mesh-list
6213803|NCT02208063|Penicillins|penicillins|mesh-list
6213804|NCT02208063|Cloxacillin|cloxacillin|mesh-list
6213805|NCT02208063|Oxacillin|oxacillin|mesh-list
6213806|NCT02208063|Telavancin|telavancin|mesh-list
6213807|NCT02208063|Nafcillin|nafcillin|mesh-list
6213808|NCT02208063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6213809|NCT02208063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6213810|NCT02208297|Loteprednol Etabonate|loteprednol etabonate|mesh-list
6213811|NCT02208297|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6213812|NCT02208310|Vitamin D|vitamin d|mesh-list
6213813|NCT02208310|Ergocalciferols|ergocalciferols|mesh-list
6213814|NCT02208310|Cholecalciferol|cholecalciferol|mesh-list
6213815|NCT02208310|Vitamins|vitamins|mesh-list
6213816|NCT02208310|Micronutrients|micronutrients|mesh-ancestor
6213817|NCT02208310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213818|NCT02208310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6213819|NCT02208310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6213820|NCT02208466|Fluoxetine|fluoxetine|mesh-list
6213821|NCT02208466|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6213822|NCT02208466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6213823|NCT02208466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6213824|NCT02208466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6213825|NCT02208466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6213826|NCT02208466|Serotonin Agents|serotonin agents|mesh-ancestor
6213827|NCT02208466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213828|NCT02208466|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6213829|NCT02208466|Antidepressive Agents|antidepressive agents|mesh-ancestor
6213830|NCT02208466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6213831|NCT02208466|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6213832|NCT02208466|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6213833|NCT02208466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6213834|NCT02208843|Afatinib|afatinib|mesh-list
6213835|NCT02208843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6213836|NCT02208843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6213837|NCT02208843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6213838|NCT02208843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6213839|NCT02209181|Acetaminophen|acetaminophen|mesh-list
6213840|NCT02209181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6213841|NCT02209181|Analgesics|analgesics|mesh-ancestor
6497064|NCT00630500|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6497065|NCT00630513|Ampicillin|ampicillin|mesh-list
6213842|NCT02209181|Sensory System Agents|sensory system agents|mesh-ancestor
6213843|NCT02209181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6213844|NCT02209181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213845|NCT02209181|Antipyretics|antipyretics|mesh-ancestor
6213846|NCT02209272|Lidocaine|lidocaine|mesh-list
6213847|NCT02209272|Benzyl Alcohol|benzyl alcohol|mesh-list
6213848|NCT02209272|Anesthetics, Local|anesthetics, local|mesh-ancestor
6213849|NCT02209272|Anesthetics|anesthetics|mesh-ancestor
6213850|NCT02209272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6213851|NCT02209272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213852|NCT02209272|Sensory System Agents|sensory system agents|mesh-ancestor
5701604|NCT03345576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5701605|NCT03345576|Anabolic Agents|anabolic agents|mesh-ancestor
5701606|NCT03345498|Entecavir|entecavir|mesh-list
5701607|NCT03345498|Antiviral Agents|antiviral agents|mesh-ancestor
5701608|NCT03345498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5701609|NCT03345303|Bortezomib|bortezomib|mesh-list
5701610|NCT03345303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5701611|NCT03345173|Ketamine|ketamine|mesh-list
5701612|NCT03345173|Analgesics|analgesics|mesh-ancestor
5701613|NCT03345173|Sensory System Agents|sensory system agents|mesh-ancestor
5701614|NCT03345173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5701615|NCT03345173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701616|NCT03345173|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6213853|NCT02209272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6213854|NCT02209272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6213855|NCT02209272|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6213856|NCT02209272|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6213857|NCT02209272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6213858|NCT02209272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6213859|NCT02209454|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
6213860|NCT02209454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6213861|NCT02209454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6213862|NCT02209454|Analgesics|analgesics|mesh-ancestor
6213863|NCT02209454|Sensory System Agents|sensory system agents|mesh-ancestor
6213864|NCT02209454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6213865|NCT02209454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213866|NCT02209454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6213867|NCT02209454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6213868|NCT02209519|Metronidazole|metronidazole|mesh-list
6213869|NCT02209519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6213870|NCT02209519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6213871|NCT02209519|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6213872|NCT02209519|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6213873|NCT02209597|Bupropion|bupropion|mesh-list
6213874|NCT02209597|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6213875|NCT02209597|Antidepressive Agents|antidepressive agents|mesh-ancestor
6213876|NCT02209597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5701617|NCT03345173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5701618|NCT03345173|Anesthetics, General|anesthetics, general|mesh-ancestor
5701619|NCT03345173|Anesthetics|anesthetics|mesh-ancestor
5701620|NCT03345173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5701621|NCT03345173|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5701622|NCT03345173|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5701623|NCT03345173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5701624|NCT03345173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701625|NCT03345147|Vitamins|vitamins|mesh-list
5701626|NCT03345147|Vitamin A|vitamin a|mesh-list
5701627|NCT03345147|Retinol palmitate|retinol palmitate|mesh-list
5701628|NCT03345147|Micronutrients|micronutrients|mesh-ancestor
5701629|NCT03345147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701630|NCT03345147|Antioxidants|antioxidants|mesh-ancestor
5701631|NCT03345147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701632|NCT03345147|Protective Agents|protective agents|mesh-ancestor
5701633|NCT03345147|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5701634|NCT03345147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5701635|NCT03345134|Pembrolizumab|pembrolizumab|mesh-list
5701636|NCT03345134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6213877|NCT02209597|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6213878|NCT02209597|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6213879|NCT02209597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5701637|NCT03345134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5701638|NCT03345095|Temozolomide|temozolomide|mesh-list
5701639|NCT03345095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5701640|NCT03345095|Alkylating Agents|alkylating agents|mesh-ancestor
6675930|NCT01578343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6675931|NCT01578343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675932|NCT01578343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6675933|NCT01578343|Glucocorticoids|glucocorticoids|mesh-ancestor
6675934|NCT01578343|Hormones|hormones|mesh-ancestor
6675935|NCT01578343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6675936|NCT01578343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6675937|NCT01578343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6675938|NCT01578343|Protease Inhibitors|protease inhibitors|mesh-ancestor
6675939|NCT01578343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6675940|NCT01578343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701641|NCT03345095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701642|NCT03345095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5701643|NCT03345004|Vitamin D|vitamin d|mesh-list
5701644|NCT03345004|Ergocalciferols|ergocalciferols|mesh-list
5701645|NCT03345004|Vitamins|vitamins|mesh-list
5701646|NCT03345004|Aluminum sulfate|aluminum sulfate|mesh-list
5701647|NCT03345004|Micronutrients|micronutrients|mesh-ancestor
5701648|NCT03345004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701649|NCT03345004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5701650|NCT03345004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5701651|NCT03345004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5701652|NCT03345004|Immunologic Factors|immunologic factors|mesh-ancestor
6213880|NCT02209597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6213881|NCT02209597|Dopamine Agents|dopamine agents|mesh-ancestor
6213882|NCT02209597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6213883|NCT02209597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213884|NCT02209597|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6213885|NCT02209597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6213886|NCT02209597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6213887|NCT02209610|Fentanyl|fentanyl|mesh-list
6213888|NCT02209610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6213889|NCT02209610|Narcotics|narcotics|mesh-ancestor
6213890|NCT02209610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5701653|NCT03344965|Olaparib|olaparib|mesh-list
5701654|NCT03344965|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5701655|NCT03344965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5701656|NCT03344965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701657|NCT03344965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5701658|NCT03344952|Botulinum Toxins|botulinum toxins|mesh-list
5701659|NCT03344952|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5701660|NCT03344952|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5701661|NCT03344952|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5701662|NCT03344952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5701663|NCT03344952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701664|NCT03344952|Cholinergic Agents|cholinergic agents|mesh-ancestor
5701665|NCT03344952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5701666|NCT03344952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701667|NCT03344952|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5701668|NCT03344952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5701669|NCT03344822|Choline|choline|mesh-list
5701670|NCT03344822|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
6213891|NCT02209610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213892|NCT02209610|Analgesics|analgesics|mesh-ancestor
6213893|NCT02209610|Sensory System Agents|sensory system agents|mesh-ancestor
6213894|NCT02209610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6213895|NCT02209610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6213896|NCT02209610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6213897|NCT02209610|Anesthetics, General|anesthetics, general|mesh-ancestor
6675941|NCT01578343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5701671|NCT03344822|Lipotropic Agents|lipotropic agents|mesh-ancestor
5701672|NCT03344822|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5701673|NCT03344822|Antimetabolites|antimetabolites|mesh-ancestor
5701674|NCT03344822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721036|NCT03208764|Gasotransmitters|gasotransmitters|mesh-ancestor
5918416|NCT04991584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5918417|NCT04991584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6213898|NCT02209610|Anesthetics|anesthetics|mesh-ancestor
6213899|NCT02209948|Temozolomide|temozolomide|mesh-list
6213900|NCT02209948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5918418|NCT04991584|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5918419|NCT04991584|Renal Agents|renal agents|mesh-ancestor
5918420|NCT04991584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5701675|NCT03344822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5701676|NCT03344822|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5701677|NCT03344822|Nootropic Agents|nootropic agents|mesh-ancestor
5701678|NCT03344822|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5721037|NCT03208764|Protective Agents|protective agents|mesh-ancestor
5721038|NCT03208894|Furosemide|furosemide|mesh-list
5721039|NCT03208894|Diuretics|diuretics|mesh-ancestor
5721040|NCT03208894|Natriuretic Agents|natriuretic agents|mesh-ancestor
5721041|NCT03208894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721042|NCT03208894|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6213901|NCT02209948|Alkylating Agents|alkylating agents|mesh-ancestor
6213902|NCT02209948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6213903|NCT02209948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6213904|NCT02210091|Factor VIII|factor viii|mesh-list
6213905|NCT02210091|BAX 855|bax 855|mesh-list
6213906|NCT02210091|Coagulants|coagulants|mesh-ancestor
6213907|NCT02210195|Aprepitant|aprepitant|mesh-list
6213908|NCT02210195|Antiemetics|antiemetics|mesh-ancestor
6497066|NCT00630513|Ertapenem|ertapenem|mesh-list
6497067|NCT00630513|Sulbactam|sulbactam|mesh-list
6497068|NCT00630513|Sultamicillin|sultamicillin|mesh-list
6497069|NCT00630513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6497070|NCT00630513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6497071|NCT00630513|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6497072|NCT00630513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6497073|NCT00630513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497074|NCT00630565|Dexamethasone|dexamethasone|mesh-list
5721043|NCT03208894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5721044|NCT03208894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721045|NCT03208712|Atezolizumab|atezolizumab|mesh-list
5721046|NCT03208712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5721047|NCT03208998|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5721048|NCT03208998|Antiviral Agents|antiviral agents|mesh-ancestor
5721049|NCT03208998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5721050|NCT03208556|Cyclophosphamide|cyclophosphamide|mesh-list
5721051|NCT03208556|Fludarabine|fludarabine|mesh-list
5721052|NCT03208556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5721053|NCT03208556|Immunologic Factors|immunologic factors|mesh-ancestor
5721054|NCT03208556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721055|NCT03208556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5721056|NCT03208556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5721057|NCT03208556|Alkylating Agents|alkylating agents|mesh-ancestor
5721058|NCT03208556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721059|NCT03208556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5721060|NCT03208556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6497075|NCT00630565|Cyclophosphamide|cyclophosphamide|mesh-list
6497076|NCT00630565|Busulfan|busulfan|mesh-list
6497077|NCT00630565|Etoposide|etoposide|mesh-list
6497078|NCT00630565|Sargramostim|sargramostim|mesh-list
6497079|NCT00630565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5722272|NCT03200236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722273|NCT03200236|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5722274|NCT03200236|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5722275|NCT03200236|Cholinergic Agents|cholinergic agents|mesh-ancestor
5722276|NCT03200236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5722277|NCT03200236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722278|NCT03200015|Metformin|metformin|mesh-list
5722279|NCT03200015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5722280|NCT03200015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722281|NCT03200184|Sofosbuvir|sofosbuvir|mesh-list
5722282|NCT03200184|Antiviral Agents|antiviral agents|mesh-ancestor
5722283|NCT03200184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5722284|NCT03199989|Capecitabine|capecitabine|mesh-list
5722285|NCT03199989|Oxaliplatin|oxaliplatin|mesh-list
5722286|NCT03199989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5722287|NCT03199989|Antimetabolites|antimetabolites|mesh-ancestor
5722288|NCT03199989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722289|NCT03199989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6497080|NCT00630565|Immunologic Factors|immunologic factors|mesh-ancestor
6497081|NCT00630565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497082|NCT00630565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5722290|NCT03200002|Mycophenolic Acid|mycophenolic acid|mesh-list
5722291|NCT03200002|Cyclophosphamide|cyclophosphamide|mesh-list
5722292|NCT03200002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6213909|NCT02210195|Autonomic Agents|autonomic agents|mesh-ancestor
6213910|NCT02210195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6497083|NCT00630565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6497084|NCT00630565|Alkylating Agents|alkylating agents|mesh-ancestor
6213911|NCT02210195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213912|NCT02210195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6213913|NCT02210195|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6213914|NCT02210195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6213915|NCT02210195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6213916|NCT02210247|Bupivacaine|bupivacaine|mesh-list
6213917|NCT02210247|Anesthetics, Local|anesthetics, local|mesh-ancestor
6213918|NCT02210247|Anesthetics|anesthetics|mesh-ancestor
6213919|NCT02210247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6213920|NCT02210247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213921|NCT02210247|Sensory System Agents|sensory system agents|mesh-ancestor
6213922|NCT02210247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6213923|NCT02210689|Clindamycin|clindamycin|mesh-list
6213924|NCT02210689|Clindamycin palmitate|clindamycin palmitate|mesh-list
6213925|NCT02210689|Clindamycin phosphate|clindamycin phosphate|mesh-list
6213926|NCT02210689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6213927|NCT02210689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6213928|NCT02210689|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6213929|NCT02210689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6213930|NCT02210689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6213931|NCT02211014|Acalabrutinib|acalabrutinib|mesh-list
6213932|NCT02211014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6213933|NCT02211638|Candesartan|candesartan|mesh-list
6213934|NCT02211638|Candesartan cilexetil|candesartan cilexetil|mesh-list
6213935|NCT02211638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6213936|NCT02211638|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6213937|NCT02211638|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6213938|NCT02211638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6213939|NCT02212028|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6213940|NCT02212028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6213941|NCT02212106|Vaccines|vaccines|mesh-list
6213942|NCT02212106|Immunologic Factors|immunologic factors|mesh-ancestor
6213943|NCT02212106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213944|NCT02212197|Leuprolide|leuprolide|mesh-list
6213945|NCT02212197|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5701679|NCT03344705|Cyclophosphamide|cyclophosphamide|mesh-list
5701680|NCT03344705|Fludarabine|fludarabine|mesh-list
5701681|NCT03344705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5701682|NCT03344705|Immunologic Factors|immunologic factors|mesh-ancestor
5701683|NCT03344705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701684|NCT03344705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5701685|NCT03344705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5701686|NCT03344705|Alkylating Agents|alkylating agents|mesh-ancestor
6213946|NCT02212197|Fertility Agents|fertility agents|mesh-ancestor
6213947|NCT02212197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6213948|NCT02212197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213949|NCT02212197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6213950|NCT02212197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6213951|NCT02212379|Raltegravir Potassium|raltegravir potassium|mesh-list
6213952|NCT02212379|Etravirine|etravirine|mesh-list
6213953|NCT02212379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6213954|NCT02212379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6213955|NCT02212379|Antiviral Agents|antiviral agents|mesh-ancestor
6213956|NCT02212379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6213957|NCT02212379|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6213958|NCT02212379|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6213959|NCT02212379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6213960|NCT02212379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6213961|NCT02212379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6213962|NCT02212379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6213963|NCT02212678|Acetylcysteine|acetylcysteine|mesh-list
6213964|NCT02212678|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6213965|NCT02212678|Antiviral Agents|antiviral agents|mesh-ancestor
5701687|NCT03344705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701688|NCT03344705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5701689|NCT03344705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5701690|NCT03344679|Magnesium Sulfate|magnesium sulfate|mesh-list
5701691|NCT03344679|Adenosine|adenosine|mesh-list
5701692|NCT03344679|Bupivacaine|bupivacaine|mesh-list
5701693|NCT03344679|Anesthetics, Local|anesthetics, local|mesh-ancestor
5701694|NCT03344679|Anesthetics|anesthetics|mesh-ancestor
5701695|NCT03344679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6213966|NCT02212678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6213967|NCT02212678|Expectorants|expectorants|mesh-ancestor
6497085|NCT00630565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6213968|NCT02212678|Respiratory System Agents|respiratory system agents|mesh-ancestor
6213969|NCT02212678|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6213970|NCT02212678|Antioxidants|antioxidants|mesh-ancestor
6213971|NCT02212678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6213972|NCT02212678|Protective Agents|protective agents|mesh-ancestor
6213973|NCT02212678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701696|NCT03344679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701697|NCT03344679|Sensory System Agents|sensory system agents|mesh-ancestor
5701698|NCT03344679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5701699|NCT03344679|Analgesics|analgesics|mesh-ancestor
5701700|NCT03344679|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5701701|NCT03344679|Anticonvulsants|anticonvulsants|mesh-ancestor
5701702|NCT03344679|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5701703|NCT03344679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5701704|NCT03344679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701705|NCT03344679|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5701706|NCT03344679|Tocolytic Agents|tocolytic agents|mesh-ancestor
5701707|NCT03344679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5701708|NCT03344679|Vasodilator Agents|vasodilator agents|mesh-ancestor
5701709|NCT03344679|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6213974|NCT02212678|Antidotes|antidotes|mesh-ancestor
6213975|NCT02212730|Pembrolizumab|pembrolizumab|mesh-list
6213976|NCT02212730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6213977|NCT02212730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6242829|NCT02657031|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6242830|NCT02657031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6242831|NCT02657031|Anesthetics, General|anesthetics, general|mesh-ancestor
6242832|NCT02657031|Anesthetics|anesthetics|mesh-ancestor
6242833|NCT02657031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6242834|NCT02657031|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6242835|NCT02657031|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6242836|NCT02657031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6242837|NCT02657031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242838|NCT02657031|Antiemetics|antiemetics|mesh-ancestor
6242839|NCT02657031|Autonomic Agents|autonomic agents|mesh-ancestor
6242840|NCT02657031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6242841|NCT02657031|Antipruritics|antipruritics|mesh-ancestor
6242842|NCT02657031|Dermatologic Agents|dermatologic agents|mesh-ancestor
6242843|NCT02657031|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6242844|NCT02657031|Serotonin Agents|serotonin agents|mesh-ancestor
6242845|NCT02657031|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6242846|NCT02657031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6242847|NCT02657031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6242848|NCT02657031|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6242849|NCT02657031|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6242850|NCT02657031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6242851|NCT02657031|Anesthetics, Local|anesthetics, local|mesh-ancestor
6242852|NCT02657031|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6242853|NCT02657031|Histamine Antagonists|histamine antagonists|mesh-ancestor
6242854|NCT02657031|Histamine Agents|histamine agents|mesh-ancestor
6242855|NCT02657031|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6242856|NCT02657031|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6242857|NCT02657031|Dopamine Agents|dopamine agents|mesh-ancestor
6242858|NCT02657252|Polidocanol|polidocanol|mesh-list
6242859|NCT02657252|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
6242860|NCT02657252|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6242861|NCT02657369|Lenvatinib|lenvatinib|mesh-list
6242862|NCT02657369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6242863|NCT02657369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6242864|NCT02657369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6242865|NCT02657369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242866|NCT02657889|Pembrolizumab|pembrolizumab|mesh-list
6242867|NCT02657889|Niraparib|niraparib|mesh-list
6242868|NCT02657889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6242869|NCT02657889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6242870|NCT02657889|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6242871|NCT02657889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6242872|NCT02657889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242873|NCT02657928|Letrozole|letrozole|mesh-list
6242874|NCT02657928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6242875|NCT02657928|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6242876|NCT02657928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6242877|NCT02657928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6242878|NCT02657928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242879|NCT02657928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6213978|NCT02213042|Trastuzumab|trastuzumab|mesh-list
6213979|NCT02213042|Lapatinib|lapatinib|mesh-list
6213980|NCT02213042|Aromatase Inhibitors|aromatase inhibitors|mesh-list
6213981|NCT02213042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6213982|NCT02213042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6213983|NCT02213042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6213984|NCT02213042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6213985|NCT02213042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6213986|NCT02213042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6213987|NCT02213042|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6213988|NCT02213042|Hormone Antagonists|hormone antagonists|mesh-ancestor
6213989|NCT02213042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6213990|NCT02213042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213991|NCT02213055|Permethrin|permethrin|mesh-list
6213992|NCT02213055|Malathion|malathion|mesh-list
6213993|NCT02213055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6213994|NCT02213055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701710|NCT03344679|Purinergic Agonists|purinergic agonists|mesh-ancestor
5701711|NCT03344679|Purinergic Agents|purinergic agents|mesh-ancestor
5701712|NCT03344679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5701713|NCT03344627|Meropenem|meropenem|mesh-list
5701714|NCT03344627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5701715|NCT03344627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5701716|NCT03344614|Apatinib|apatinib|mesh-list
5701717|NCT03344614|Raltitrexed|raltitrexed|mesh-list
5701718|NCT03344614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5701719|NCT03344614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5701720|NCT03344614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5701721|NCT03344614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701722|NCT03344614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5701723|NCT03344614|Antimetabolites|antimetabolites|mesh-ancestor
5701724|NCT03344614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5701725|NCT03344536|Fulvestrant|fulvestrant|mesh-list
5701726|NCT03344536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5701727|NCT03344536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5701728|NCT03344536|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5701729|NCT03344536|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5701730|NCT03344536|Hormone Antagonists|hormone antagonists|mesh-ancestor
6213995|NCT02213055|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6213996|NCT02213055|Cholinergic Agents|cholinergic agents|mesh-ancestor
6213997|NCT02213055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6213998|NCT02213055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6213999|NCT02213068|Mycophenolic Acid|mycophenolic acid|mesh-list
6214000|NCT02213068|Abatacept|abatacept|mesh-list
6214001|NCT02213068|Tacrolimus|tacrolimus|mesh-list
6214002|NCT02213068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6214003|NCT02213068|Immunologic Factors|immunologic factors|mesh-ancestor
6214004|NCT02213068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214005|NCT02213068|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6214006|NCT02213068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6214007|NCT02213068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214008|NCT02213068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6214009|NCT02213068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6214010|NCT02213068|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6214011|NCT02213068|Antitubercular Agents|antitubercular agents|mesh-ancestor
6214012|NCT02213068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6214013|NCT02213068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6214014|NCT02213068|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6214015|NCT02213068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6214016|NCT02213094|Vitamins|vitamins|mesh-list
6214017|NCT02213094|Niacinamide|niacinamide|mesh-list
6214018|NCT02213094|Niacin|niacin|mesh-list
6214019|NCT02213094|Nicotinic Acids|nicotinic acids|mesh-list
6214020|NCT02213094|Vitamin B Complex|vitamin b complex|mesh-list
6214021|NCT02213094|Micronutrients|micronutrients|mesh-ancestor
6214022|NCT02213094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214023|NCT02213094|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6214024|NCT02213094|Antimetabolites|antimetabolites|mesh-ancestor
6214025|NCT02213094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214026|NCT02213094|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6214027|NCT02213094|Vasodilator Agents|vasodilator agents|mesh-ancestor
6214028|NCT02213263|Rituximab|rituximab|mesh-list
5701731|NCT03344536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6214029|NCT02213263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6214030|NCT02213263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6214031|NCT02213263|Immunologic Factors|immunologic factors|mesh-ancestor
5701732|NCT03344536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701733|NCT03344523|Iron protein succinylate|iron protein succinylate|mesh-list
5701734|NCT03344523|Hematinics|hematinics|mesh-ancestor
5701735|NCT03344445|Anesthetics|anesthetics|mesh-list
5701736|NCT03344445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5701737|NCT03344445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701738|NCT03344419|Ketamine|ketamine|mesh-list
5701739|NCT03344419|Analgesics|analgesics|mesh-ancestor
5701740|NCT03344419|Sensory System Agents|sensory system agents|mesh-ancestor
5701741|NCT03344419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5701742|NCT03344419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214032|NCT02213263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214033|NCT02213263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6214034|NCT02213289|Nivolumab|nivolumab|mesh-list
6214035|NCT02213289|Trastuzumab|trastuzumab|mesh-list
6214036|NCT02213289|Bemarituzumab|bemarituzumab|mesh-list
5701743|NCT03344419|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5701744|NCT03344419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5701745|NCT03344419|Anesthetics, General|anesthetics, general|mesh-ancestor
5701746|NCT03344419|Anesthetics|anesthetics|mesh-ancestor
5701747|NCT03344419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5701748|NCT03344419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5701749|NCT03344419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5701750|NCT03344419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5701751|NCT03344419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214037|NCT02213289|Ramucirumab|ramucirumab|mesh-list
6214038|NCT02213289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6214039|NCT02213289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6214040|NCT02213289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6214041|NCT02213289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214042|NCT02213380|Anesthetics|anesthetics|mesh-list
6214043|NCT02213380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6214044|NCT02213380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214045|NCT02213900|Haloperidol|haloperidol|mesh-list
6214046|NCT02213900|Haloperidol decanoate|haloperidol decanoate|mesh-list
6214047|NCT02213900|Antiemetics|antiemetics|mesh-ancestor
6214048|NCT02213900|Autonomic Agents|autonomic agents|mesh-ancestor
5701752|NCT03344393|Ketamine|ketamine|mesh-list
5701753|NCT03344393|Analgesics|analgesics|mesh-ancestor
5701754|NCT03344393|Sensory System Agents|sensory system agents|mesh-ancestor
5701755|NCT03344393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5701756|NCT03344393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701757|NCT03344393|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5701758|NCT03344393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5701759|NCT03344393|Anesthetics, General|anesthetics, general|mesh-ancestor
5701760|NCT03344393|Anesthetics|anesthetics|mesh-ancestor
5701761|NCT03344393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5701762|NCT03344393|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5701763|NCT03344393|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5701764|NCT03344393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5701765|NCT03344393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701766|NCT03344328|Bortezomib|bortezomib|mesh-list
5701767|NCT03344328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5701768|NCT03344302|Oxytocin|oxytocin|mesh-list
5701769|NCT03344302|Oxytocics|oxytocics|mesh-ancestor
5701770|NCT03344302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5701771|NCT03344302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701772|NCT03344211|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
5701773|NCT03344211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5701774|NCT03344094|Interferons|interferons|mesh-list
5701775|NCT03344094|Interferon-beta|interferon-beta|mesh-list
6214049|NCT02213900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6214050|NCT02213900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214051|NCT02213900|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6214052|NCT02213900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6214053|NCT02213900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6214054|NCT02213900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6214055|NCT02213900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6214056|NCT02213900|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6214057|NCT02213900|Dopamine Agents|dopamine agents|mesh-ancestor
6214058|NCT02213900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6214059|NCT02213900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214060|NCT02213900|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6214061|NCT02214121|Ticagrelor|ticagrelor|mesh-list
5701776|NCT03344094|Ocrelizumab|ocrelizumab|mesh-list
6242880|NCT02657928|Hormone Antagonists|hormone antagonists|mesh-ancestor
6214062|NCT02214121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6214063|NCT02214121|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6214064|NCT02214121|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6214065|NCT02214121|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6214066|NCT02214121|Purinergic Agents|purinergic agents|mesh-ancestor
6214067|NCT02214121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6214068|NCT02214121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214069|NCT02214121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214070|NCT02214225|Vaccines|vaccines|mesh-list
6214071|NCT02214225|Immunologic Factors|immunologic factors|mesh-ancestor
6214072|NCT02214225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497086|NCT00630565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6497087|NCT00630565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6497088|NCT00630565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6497089|NCT00630565|Antiemetics|antiemetics|mesh-ancestor
6497090|NCT00630565|Autonomic Agents|autonomic agents|mesh-ancestor
6497091|NCT00630565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6497092|NCT00630565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6497093|NCT00630565|Glucocorticoids|glucocorticoids|mesh-ancestor
6497094|NCT00630565|Hormones|hormones|mesh-ancestor
6497095|NCT00630565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6497096|NCT00630565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6497097|NCT00630565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6497098|NCT00630565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6497099|NCT00630565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6497100|NCT00630565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5701777|NCT03344094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5701778|NCT03344094|Antiviral Agents|antiviral agents|mesh-ancestor
5701779|NCT03344094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6497101|NCT00630630|Levetiracetam|levetiracetam|mesh-list
6497102|NCT00630630|Anticonvulsants|anticonvulsants|mesh-ancestor
6497103|NCT00630630|Nootropic Agents|nootropic agents|mesh-ancestor
6497104|NCT00630643|Muromonab-CD3|muromonab-cd3|mesh-list
6497105|NCT00630643|Immunologic Factors|immunologic factors|mesh-ancestor
6497106|NCT00630643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497107|NCT00630643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6497108|NCT00630682|Dextroamphetamine|dextroamphetamine|mesh-list
6497109|NCT00630682|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6497110|NCT00630682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497111|NCT00630682|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6497112|NCT00630682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6497113|NCT00630682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5701780|NCT03344094|Immunologic Factors|immunologic factors|mesh-ancestor
5701781|NCT03344094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701782|NCT03344042|Fentanyl|fentanyl|mesh-list
5701783|NCT03344042|Sufentanil|sufentanil|mesh-list
5701784|NCT03344042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5701785|NCT03344042|Narcotics|narcotics|mesh-ancestor
5701786|NCT03344042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5701787|NCT03344042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701788|NCT03344042|Analgesics|analgesics|mesh-ancestor
5701789|NCT03344042|Sensory System Agents|sensory system agents|mesh-ancestor
5701790|NCT03344042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5701791|NCT03344042|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5701792|NCT03344042|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5701793|NCT03344042|Anesthetics, General|anesthetics, general|mesh-ancestor
5701794|NCT03344042|Anesthetics|anesthetics|mesh-ancestor
5701795|NCT03344029|Vaccines|vaccines|mesh-list
5701796|NCT03344029|Immunologic Factors|immunologic factors|mesh-ancestor
5701797|NCT03344029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701798|NCT03344003|Factor VIII|factor viii|mesh-list
5701799|NCT03344003|Coagulants|coagulants|mesh-ancestor
5701800|NCT03343977|Docetaxel|docetaxel|mesh-list
5701801|NCT03343977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5701802|NCT03343977|Tubulin Modulators|tubulin modulators|mesh-ancestor
5701803|NCT03343977|Antimitotic Agents|antimitotic agents|mesh-ancestor
5701804|NCT03343977|Mitosis Modulators|mitosis modulators|mesh-ancestor
5701805|NCT03343977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701806|NCT03343873|Midazolam|midazolam|mesh-list
5701807|NCT03343873|Dexmedetomidine|dexmedetomidine|mesh-list
5701808|NCT03343873|Propofol|propofol|mesh-list
5701809|NCT03343873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5701810|NCT03343873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5701811|NCT03343873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701812|NCT03343873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5701813|NCT03343873|Anesthetics, General|anesthetics, general|mesh-ancestor
5701814|NCT03343873|Anesthetics|anesthetics|mesh-ancestor
5701815|NCT03343873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5701816|NCT03343873|Analgesics|analgesics|mesh-ancestor
5701817|NCT03343873|Sensory System Agents|sensory system agents|mesh-ancestor
5701818|NCT03343873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5701819|NCT03343873|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5701820|NCT03343873|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5701821|NCT03343873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5701822|NCT03343873|Adrenergic Agents|adrenergic agents|mesh-ancestor
5701823|NCT03343873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5701824|NCT03343873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701825|NCT03343873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6214073|NCT02214290|Caffeine|caffeine|mesh-list
6214074|NCT02214290|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6214075|NCT02214290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214076|NCT02214290|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6214077|NCT02214290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6214078|NCT02214290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214079|NCT02214290|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6214080|NCT02214290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6214081|NCT02214290|Purinergic Agents|purinergic agents|mesh-ancestor
6214082|NCT02214290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6214083|NCT02214420|Ribavirin|ribavirin|mesh-list
6214084|NCT02214420|Sofosbuvir|sofosbuvir|mesh-list
6214085|NCT02214420|Simeprevir|simeprevir|mesh-list
6214086|NCT02214420|Antimetabolites|antimetabolites|mesh-ancestor
6214087|NCT02214420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214088|NCT02214420|Antiviral Agents|antiviral agents|mesh-ancestor
6214089|NCT02214420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6214090|NCT02214420|Protease Inhibitors|protease inhibitors|mesh-ancestor
6214091|NCT02214420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6214092|NCT02214615|Carbamazepine|carbamazepine|mesh-list
6214093|NCT02214615|Anticonvulsants|anticonvulsants|mesh-ancestor
6214094|NCT02214615|Antimanic Agents|antimanic agents|mesh-ancestor
6214095|NCT02214615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6214096|NCT02214615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6214097|NCT02214615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214098|NCT02214615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6214099|NCT02214615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6214100|NCT02214615|Analgesics|analgesics|mesh-ancestor
6214101|NCT02214615|Sensory System Agents|sensory system agents|mesh-ancestor
6214102|NCT02214615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6214103|NCT02214615|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6214104|NCT02214615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6214105|NCT02214615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214106|NCT02214615|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6214107|NCT02214615|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6214108|NCT02214628|Bevacizumab|bevacizumab|mesh-list
6214109|NCT02214628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6214110|NCT02214628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5701826|NCT03343873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5701827|NCT03343873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5701828|NCT03343873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5701829|NCT03343873|GABA Modulators|gaba modulators|mesh-ancestor
5701830|NCT03343873|GABA Agents|gaba agents|mesh-ancestor
5701831|NCT03343795|Progesterone|progesterone|mesh-list
5701832|NCT03343795|Progestins|progestins|mesh-ancestor
5701833|NCT03343795|Hormones|hormones|mesh-ancestor
5701834|NCT03343795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5701835|NCT03343795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701836|NCT03343678|Venetoclax|venetoclax|mesh-list
6214111|NCT02214628|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6214112|NCT02214628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6214113|NCT02214628|Growth Substances|growth substances|mesh-ancestor
6214114|NCT02214628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214115|NCT02214628|Growth Inhibitors|growth inhibitors|mesh-ancestor
6214116|NCT02215070|Pasireotide|pasireotide|mesh-list
6214117|NCT02215070|Hormones|hormones|mesh-ancestor
6214118|NCT02215070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6214119|NCT02215070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214120|NCT02215200|Sargramostim|sargramostim|mesh-list
6214121|NCT02215200|Lenograstim|lenograstim|mesh-list
6214122|NCT02215200|Thymoglobulin|thymoglobulin|mesh-list
5701837|NCT03343678|BI 836826|bi 836826|mesh-list
5701838|NCT03343678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6214123|NCT02215200|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5701839|NCT03343678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5701840|NCT03343665|Nivolumab|nivolumab|mesh-list
5701841|NCT03343665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5701842|NCT03343665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5701843|NCT03343665|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5701844|NCT03343665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701845|NCT03343652|Nivolumab|nivolumab|mesh-list
5701846|NCT03343652|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5701847|NCT03343652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5701848|NCT03343652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5701849|NCT03343652|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5701850|NCT03343652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701851|NCT03343652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5701852|NCT03343652|Alkylating Agents|alkylating agents|mesh-ancestor
5701853|NCT03343600|Imatinib Mesylate|imatinib mesylate|mesh-list
5701854|NCT03343600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5701855|NCT03343600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5701856|NCT03343600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5721061|NCT03208582|Risedronic Acid|risedronic acid|mesh-list
6214124|NCT02215200|Immunologic Factors|immunologic factors|mesh-ancestor
6214125|NCT02215200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214126|NCT02215200|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6214127|NCT02215200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6214128|NCT02215252|Pregabalin|pregabalin|mesh-list
6214129|NCT02215252|Analgesics|analgesics|mesh-ancestor
6214130|NCT02215252|Sensory System Agents|sensory system agents|mesh-ancestor
6214131|NCT02215252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6214132|NCT02215252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214133|NCT02215252|Anticonvulsants|anticonvulsants|mesh-ancestor
6214134|NCT02215252|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6214135|NCT02215252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6214136|NCT02215252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214137|NCT02215252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6214138|NCT02215252|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6214139|NCT02215252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6214140|NCT02215252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6214141|NCT02215252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6214142|NCT02215967|Cyclophosphamide|cyclophosphamide|mesh-list
6214143|NCT02215967|Fludarabine|fludarabine|mesh-list
6214144|NCT02215967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6214145|NCT02215967|Immunologic Factors|immunologic factors|mesh-ancestor
6214146|NCT02215967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214147|NCT02215967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6214148|NCT02215967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6214149|NCT02215967|Alkylating Agents|alkylating agents|mesh-ancestor
6214150|NCT02215967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214151|NCT02215967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6214152|NCT02215967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6214153|NCT02216071|Ciprofloxacin|ciprofloxacin|mesh-list
6214154|NCT02216071|Dexamethasone|dexamethasone|mesh-list
6214155|NCT02216071|Dexamethasone acetate|dexamethasone acetate|mesh-list
6214156|NCT02216071|BB 1101|bb 1101|mesh-list
6214157|NCT02216071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6214158|NCT02216071|Antiemetics|antiemetics|mesh-ancestor
6214159|NCT02216071|Autonomic Agents|autonomic agents|mesh-ancestor
6214160|NCT02216071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6214161|NCT02216071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214162|NCT02216071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6214163|NCT02216071|Glucocorticoids|glucocorticoids|mesh-ancestor
6214164|NCT02216071|Hormones|hormones|mesh-ancestor
6214165|NCT02216071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6214166|NCT02216071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6214167|NCT02216071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6214168|NCT02216071|Protease Inhibitors|protease inhibitors|mesh-ancestor
6214169|NCT02216071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6214170|NCT02216071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214171|NCT02216071|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6214172|NCT02216071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6214173|NCT02216071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6214174|NCT02216071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6214175|NCT02216071|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6214176|NCT02216071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6214177|NCT02216123|Chloroquine|chloroquine|mesh-list
5701857|NCT03343600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701858|NCT03343548|Magnesium Sulfate|magnesium sulfate|mesh-list
5701859|NCT03343548|Analgesics|analgesics|mesh-ancestor
5701860|NCT03343548|Sensory System Agents|sensory system agents|mesh-ancestor
5701861|NCT03343548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5701862|NCT03343548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701863|NCT03343548|Anesthetics|anesthetics|mesh-ancestor
5701864|NCT03343548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5701865|NCT03343548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5701866|NCT03343548|Anticonvulsants|anticonvulsants|mesh-ancestor
5701867|NCT03343548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5701868|NCT03343548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5701869|NCT03343548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701870|NCT03343548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5701871|NCT03343548|Tocolytic Agents|tocolytic agents|mesh-ancestor
5701872|NCT03343548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5701873|NCT03343509|Metronidazole|metronidazole|mesh-list
5701874|NCT03343509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6214178|NCT02216123|Primaquine|primaquine|mesh-list
6214179|NCT02216123|Tafenoquine|tafenoquine|mesh-list
6214180|NCT02216123|Amebicides|amebicides|mesh-ancestor
6214181|NCT02216123|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6214182|NCT02216123|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6214183|NCT02216123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6214184|NCT02216123|Antimalarials|antimalarials|mesh-ancestor
6214185|NCT02216123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6214186|NCT02216214|Mirabegron|mirabegron|mesh-list
6214187|NCT02216214|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6214188|NCT02216214|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6214189|NCT02216214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6214190|NCT02216214|Adrenergic Agents|adrenergic agents|mesh-ancestor
6214191|NCT02216214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6214192|NCT02216214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214193|NCT02216214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214194|NCT02216214|Urological Agents|urological agents|mesh-ancestor
6214195|NCT02216357|Ifetroban|ifetroban|mesh-list
6214196|NCT02216357|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6214197|NCT02216422|Ritonavir|ritonavir|mesh-list
6214198|NCT02216422|Ribavirin|ribavirin|mesh-list
6214199|NCT02216422|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6214200|NCT02216422|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5701875|NCT03343509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5701876|NCT03343509|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5701877|NCT03343509|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5701878|NCT03343444|Sofosbuvir|sofosbuvir|mesh-list
5701879|NCT03343444|Ledipasvir|ledipasvir|mesh-list
5701880|NCT03343444|Antiviral Agents|antiviral agents|mesh-ancestor
5701881|NCT03343444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5701882|NCT03343431|Tenofovir|tenofovir|mesh-list
6214201|NCT02216422|Protease Inhibitors|protease inhibitors|mesh-ancestor
6214202|NCT02216422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6214203|NCT02216422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214204|NCT02216422|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6214205|NCT02216422|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6214206|NCT02216422|Antiviral Agents|antiviral agents|mesh-ancestor
6214207|NCT02216422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6214208|NCT02216422|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6214209|NCT02216422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6214210|NCT02216422|Antimetabolites|antimetabolites|mesh-ancestor
6214211|NCT02216812|Ascorbic Acid|ascorbic acid|mesh-list
6214212|NCT02216812|Vitamins|vitamins|mesh-ancestor
6214213|NCT02216812|Micronutrients|micronutrients|mesh-ancestor
6214214|NCT02216812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214215|NCT02216812|Antioxidants|antioxidants|mesh-ancestor
6214216|NCT02216812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497114|NCT00630682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497115|NCT00630682|Dopamine Agents|dopamine agents|mesh-ancestor
6497116|NCT00630682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6497117|NCT00630695|Lanreotide|lanreotide|mesh-list
6497118|NCT00630695|Somatostatin|somatostatin|mesh-list
6497119|NCT00630695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6497120|NCT00630695|Hormones|hormones|mesh-ancestor
6497121|NCT00630695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6497122|NCT00630695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497123|NCT00630708|Losartan|losartan|mesh-list
6497124|NCT00630708|Benazepril|benazepril|mesh-list
6214217|NCT02216812|Protective Agents|protective agents|mesh-ancestor
6214218|NCT02217332|Pramipexole|pramipexole|mesh-list
6214219|NCT02217332|Antioxidants|antioxidants|mesh-ancestor
6214220|NCT02217332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214221|NCT02217332|Protective Agents|protective agents|mesh-ancestor
6214222|NCT02217332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214223|NCT02217332|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6214224|NCT02217332|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6214225|NCT02217332|Dopamine Agonists|dopamine agonists|mesh-ancestor
6214226|NCT02217332|Dopamine Agents|dopamine agents|mesh-ancestor
6214227|NCT02217332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6214228|NCT02217410|Mycophenolic Acid|mycophenolic acid|mesh-list
6214229|NCT02217410|Tacrolimus|tacrolimus|mesh-list
6214230|NCT02217410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6214231|NCT02217410|Immunologic Factors|immunologic factors|mesh-ancestor
6214232|NCT02217410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214233|NCT02217410|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6214234|NCT02217410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6214235|NCT02217410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214236|NCT02217410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6214237|NCT02217410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6214238|NCT02217410|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6214239|NCT02217410|Antitubercular Agents|antitubercular agents|mesh-ancestor
6214240|NCT02217410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6214241|NCT02217410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6214242|NCT02217475|Cenicriviroc|cenicriviroc|mesh-list
6214243|NCT02217475|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6214244|NCT02217475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214245|NCT02217475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6214246|NCT02217475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5701883|NCT03343431|Antiviral Agents|antiviral agents|mesh-list
5701884|NCT03343431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5701885|NCT03343431|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5701886|NCT03343431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5701887|NCT03343431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5701888|NCT03343431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701889|NCT03343431|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5701890|NCT03343431|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5701891|NCT03343418|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
5701892|NCT03343418|Hemostatics|hemostatics|mesh-ancestor
5701893|NCT03343418|Coagulants|coagulants|mesh-ancestor
5701894|NCT03343418|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5701895|NCT03343418|Natriuretic Agents|natriuretic agents|mesh-ancestor
5701896|NCT03343418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214247|NCT02217475|Antiviral Agents|antiviral agents|mesh-ancestor
6214248|NCT02217475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6214249|NCT02217501|Aspirin|aspirin|mesh-list
6214250|NCT02217501|Clopidogrel|clopidogrel|mesh-list
6214251|NCT02217501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6214252|NCT02217501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6214253|NCT02217501|Analgesics|analgesics|mesh-ancestor
6214254|NCT02217501|Sensory System Agents|sensory system agents|mesh-ancestor
6214255|NCT02217501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6214256|NCT02217501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214257|NCT02217501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6214258|NCT02217501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6214259|NCT02217501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6214260|NCT02217501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6214261|NCT02217501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214262|NCT02217501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6214263|NCT02217501|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6214264|NCT02217501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6214265|NCT02217501|Antipyretics|antipyretics|mesh-ancestor
6214266|NCT02217501|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6214267|NCT02217501|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6214268|NCT02217501|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6214269|NCT02217501|Purinergic Agents|purinergic agents|mesh-ancestor
6214270|NCT02217501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6214271|NCT02217566|Prednisone|prednisone|mesh-list
6214272|NCT02217566|Abiraterone Acetate|abiraterone acetate|mesh-list
6214273|NCT02217566|Androgens|androgens|mesh-list
6214274|NCT02217566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6214275|NCT02217566|Glucocorticoids|glucocorticoids|mesh-ancestor
6214276|NCT02217566|Hormones|hormones|mesh-ancestor
6214277|NCT02217566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6214278|NCT02217566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214279|NCT02217566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6214280|NCT02217566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6214281|NCT02217566|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6214282|NCT02217566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6214283|NCT02217566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214284|NCT02217566|Hormone Antagonists|hormone antagonists|mesh-ancestor
6214285|NCT02217566|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6214286|NCT02217800|Octreotide|octreotide|mesh-list
6214287|NCT02217800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6214288|NCT02217800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6214289|NCT02217800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6214290|NCT02217878|Morphine|morphine|mesh-list
6214291|NCT02217878|Ticagrelor|ticagrelor|mesh-list
6214292|NCT02217878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6214293|NCT02217878|Narcotics|narcotics|mesh-ancestor
6214294|NCT02217878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6214295|NCT02217878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214296|NCT02217878|Analgesics|analgesics|mesh-ancestor
6214297|NCT02217878|Sensory System Agents|sensory system agents|mesh-ancestor
6214298|NCT02217878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6214299|NCT02217878|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6214300|NCT02217878|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6214301|NCT02217878|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6214302|NCT02217878|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6214303|NCT02217878|Purinergic Agents|purinergic agents|mesh-ancestor
6214304|NCT02217878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6214305|NCT02217878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214306|NCT02217904|Islatravir|islatravir|mesh-list
6214307|NCT02217904|Antiviral Agents|antiviral agents|mesh-ancestor
5701897|NCT03343366|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5701898|NCT03343366|Metronidazole|metronidazole|mesh-list
5701899|NCT03343366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5701900|NCT03343366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5701901|NCT03343366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5721062|NCT03208582|Diphosphonates|diphosphonates|mesh-list
5721063|NCT03208582|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5721064|NCT03208582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5721065|NCT03208582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214308|NCT02217904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6214309|NCT02217904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6214310|NCT02217904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214311|NCT02217904|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6214312|NCT02217904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6214313|NCT02217904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6214314|NCT02217982|Simethicone|simethicone|mesh-list
6214315|NCT02217982|Loperamide|loperamide|mesh-list
6214316|NCT02217982|Antidiarrheals|antidiarrheals|mesh-list
6214317|NCT02217982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6214318|NCT02217982|Antifoaming Agents|antifoaming agents|mesh-ancestor
6214319|NCT02217982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214320|NCT02217982|Emollients|emollients|mesh-ancestor
6214321|NCT02217982|Dermatologic Agents|dermatologic agents|mesh-ancestor
6214322|NCT02218164|Interferons|interferons|mesh-list
6214323|NCT02218164|Interferon-alpha|interferon-alpha|mesh-list
6214324|NCT02218164|Interferon alpha-2|interferon alpha-2|mesh-list
6214325|NCT02218164|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6214326|NCT02218164|Fluorouracil|fluorouracil|mesh-list
6214327|NCT02218164|Capecitabine|capecitabine|mesh-list
6214328|NCT02218164|Antimetabolites|antimetabolites|mesh-ancestor
6214329|NCT02218164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214330|NCT02218164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6214331|NCT02218164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6214332|NCT02218164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6214333|NCT02218164|Immunologic Factors|immunologic factors|mesh-ancestor
6214334|NCT02218164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214335|NCT02218164|Antiviral Agents|antiviral agents|mesh-ancestor
6214336|NCT02218164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6214337|NCT02218190|Alvimopan|alvimopan|mesh-list
6214338|NCT02218190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6214339|NCT02218203|Lidocaine|lidocaine|mesh-list
6214340|NCT02218203|Dextromethorphan|dextromethorphan|mesh-list
6214341|NCT02218203|Anesthetics, Local|anesthetics, local|mesh-ancestor
6214342|NCT02218203|Anesthetics|anesthetics|mesh-ancestor
6214343|NCT02218203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6214344|NCT02218203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214345|NCT02218203|Sensory System Agents|sensory system agents|mesh-ancestor
6214346|NCT02218203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5701902|NCT03343054|Talazoparib|talazoparib|mesh-list
5701903|NCT03343054|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5701904|NCT03343054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5701905|NCT03343054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701906|NCT03343054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5701907|NCT03343002|Fentanyl|fentanyl|mesh-list
5701908|NCT03343002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5701909|NCT03343002|Narcotics|narcotics|mesh-ancestor
5701910|NCT03343002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5701911|NCT03343002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701912|NCT03343002|Analgesics|analgesics|mesh-ancestor
5701913|NCT03343002|Sensory System Agents|sensory system agents|mesh-ancestor
5701914|NCT03343002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6214347|NCT02218203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6214348|NCT02218203|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6214349|NCT02218203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6214350|NCT02218203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6214351|NCT02218203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214352|NCT02218203|Antitussive Agents|antitussive agents|mesh-ancestor
6214353|NCT02218203|Respiratory System Agents|respiratory system agents|mesh-ancestor
6214354|NCT02218203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6214355|NCT02218203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6214356|NCT02218203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6214357|NCT02218307|Mupirocin|mupirocin|mesh-list
6214358|NCT02218307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6214359|NCT02218307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6214360|NCT02218307|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6214361|NCT02218307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6214362|NCT02218307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214363|NCT02218320|Raltegravir Potassium|raltegravir potassium|mesh-list
6214364|NCT02218320|Dolutegravir|dolutegravir|mesh-list
6214365|NCT02218320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6214366|NCT02218320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6214367|NCT02218320|Antiviral Agents|antiviral agents|mesh-ancestor
6214368|NCT02218320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6214369|NCT02218320|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6214370|NCT02218320|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6214371|NCT02218320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6214372|NCT02218320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214373|NCT02218372|Vancomycin|vancomycin|mesh-list
6214374|NCT02218372|Fidaxomicin|fidaxomicin|mesh-list
6214375|NCT02218372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6214376|NCT02218372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6214377|NCT02218463|Estradiol|estradiol|mesh-list
6214378|NCT02218463|Estrogens|estrogens|mesh-ancestor
6214379|NCT02218463|Hormones|hormones|mesh-ancestor
6214380|NCT02218463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6214381|NCT02218463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214382|NCT02218489|Loteprednol Etabonate|loteprednol etabonate|mesh-list
6214383|NCT02218489|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6214384|NCT02218736|Aticaprant|aticaprant|mesh-list
6214385|NCT02218736|Narcotic Antagonists|narcotic antagonists|mesh-list
6214386|NCT02218736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214387|NCT02218736|Sensory System Agents|sensory system agents|mesh-ancestor
6214388|NCT02218736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6214389|NCT02219009|Aripiprazole|aripiprazole|mesh-list
6214390|NCT02219009|Antidepressive Agents|antidepressive agents|mesh-ancestor
6214391|NCT02219009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6214392|NCT02219009|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6214393|NCT02219009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6214394|NCT02219009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6214395|NCT02219009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214396|NCT02219009|Dopamine Agonists|dopamine agonists|mesh-ancestor
6214397|NCT02219009|Dopamine Agents|dopamine agents|mesh-ancestor
6214398|NCT02219009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6214399|NCT02219009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214400|NCT02219009|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6675942|NCT01578343|Antimetabolites|antimetabolites|mesh-ancestor
5701915|NCT03343002|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5701916|NCT03343002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5701917|NCT03343002|Anesthetics, General|anesthetics, general|mesh-ancestor
5701918|NCT03343002|Anesthetics|anesthetics|mesh-ancestor
5701919|NCT03342911|Paclitaxel|paclitaxel|mesh-list
5701920|NCT03342911|Carboplatin|carboplatin|mesh-list
5701921|NCT03342911|Nivolumab|nivolumab|mesh-list
5722293|NCT03200002|Immunologic Factors|immunologic factors|mesh-ancestor
6214401|NCT02219009|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6214402|NCT02219009|Serotonin Agents|serotonin agents|mesh-ancestor
6214403|NCT02219009|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6214404|NCT02219009|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6214405|NCT02219009|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6214406|NCT02219009|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6214407|NCT02219087|Bupivacaine|bupivacaine|mesh-list
6214408|NCT02219087|Anesthetics, Local|anesthetics, local|mesh-ancestor
6214409|NCT02219087|Anesthetics|anesthetics|mesh-ancestor
6214410|NCT02219087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5701922|NCT03342911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5701923|NCT03342911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5701924|NCT03342911|Tubulin Modulators|tubulin modulators|mesh-ancestor
5701925|NCT03342911|Antimitotic Agents|antimitotic agents|mesh-ancestor
5701926|NCT03342911|Mitosis Modulators|mitosis modulators|mesh-ancestor
5701927|NCT03342911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701928|NCT03342911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5701929|NCT03342911|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6214411|NCT02219087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214412|NCT02219087|Sensory System Agents|sensory system agents|mesh-ancestor
6497125|NCT00630708|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6497126|NCT00630708|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6497127|NCT00630708|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6497128|NCT00630708|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6497129|NCT00630708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497130|NCT00630708|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6497131|NCT00630708|Protease Inhibitors|protease inhibitors|mesh-ancestor
6497132|NCT00630708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6497133|NCT00630851|Donepezil|donepezil|mesh-list
6497134|NCT00630851|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6497135|NCT00630851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6497136|NCT00630851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497137|NCT00630851|Cholinergic Agents|cholinergic agents|mesh-ancestor
6497138|NCT00630851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6497139|NCT00630851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497140|NCT00630851|Nootropic Agents|nootropic agents|mesh-ancestor
6497141|NCT00630890|Capecitabine|capecitabine|mesh-list
6497142|NCT00630890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5701930|NCT03342859|Ulipristal acetate|ulipristal acetate|mesh-list
5701931|NCT03342859|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5701932|NCT03342859|Contraceptive Agents|contraceptive agents|mesh-ancestor
5701933|NCT03342859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5701934|NCT03342859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497143|NCT00630890|Antimetabolites|antimetabolites|mesh-ancestor
6497144|NCT00630890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497145|NCT00630890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6497146|NCT00630903|Methoxsalen|methoxsalen|mesh-list
6497147|NCT00630903|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6497148|NCT00630903|Dermatologic Agents|dermatologic agents|mesh-ancestor
6497149|NCT00630929|Ibuprofen|ibuprofen|mesh-list
6497150|NCT00630929|Celecoxib|celecoxib|mesh-list
6497151|NCT00630929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6497152|NCT00630929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6497153|NCT00630929|Analgesics|analgesics|mesh-ancestor
6497154|NCT00630929|Sensory System Agents|sensory system agents|mesh-ancestor
6497155|NCT00630929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6497156|NCT00630929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497157|NCT00630929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6675943|NCT01578343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6675944|NCT01578343|Immunologic Factors|immunologic factors|mesh-ancestor
6675945|NCT01578343|Antiviral Agents|antiviral agents|mesh-ancestor
5701935|NCT03342859|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5701936|NCT03342807|Insulin|insulin|mesh-list
5701937|NCT03342807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5701938|NCT03342807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701939|NCT03342651|Vitamin D|vitamin d|mesh-list
5701940|NCT03342651|Vitamins|vitamins|mesh-ancestor
5701941|NCT03342651|Micronutrients|micronutrients|mesh-ancestor
5701942|NCT03342651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675946|NCT01578343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6675947|NCT01578343|Analgesics|analgesics|mesh-ancestor
6675948|NCT01578343|Sensory System Agents|sensory system agents|mesh-ancestor
6675949|NCT01578343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6675950|NCT01578343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6214413|NCT02219087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6214414|NCT02219321|Lidocaine|lidocaine|mesh-list
6214415|NCT02219321|Anesthetics, Local|anesthetics, local|mesh-ancestor
6214416|NCT02219321|Anesthetics|anesthetics|mesh-ancestor
6214417|NCT02219321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6214418|NCT02219321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214419|NCT02219321|Sensory System Agents|sensory system agents|mesh-ancestor
6214420|NCT02219321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6214421|NCT02219321|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6214422|NCT02219321|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6214423|NCT02219321|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6214424|NCT02219321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6214425|NCT02219321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214426|NCT02219477|Ritonavir|ritonavir|mesh-list
6214427|NCT02219477|Ribavirin|ribavirin|mesh-list
6214428|NCT02219477|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6214429|NCT02219477|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6214430|NCT02219477|Protease Inhibitors|protease inhibitors|mesh-ancestor
6214431|NCT02219477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6214432|NCT02219477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214433|NCT02219477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6214434|NCT02219477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6214435|NCT02219477|Antiviral Agents|antiviral agents|mesh-ancestor
6214436|NCT02219477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6214437|NCT02219477|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6214438|NCT02219477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6214439|NCT02219477|Antimetabolites|antimetabolites|mesh-ancestor
6214440|NCT02219503|Ritonavir|ritonavir|mesh-list
6214441|NCT02219503|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6214442|NCT02219503|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5701943|NCT03342651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5701944|NCT03342599|Thioctic Acid|thioctic acid|mesh-list
5701945|NCT03342599|Antioxidants|antioxidants|mesh-ancestor
5701946|NCT03342599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701947|NCT03342599|Protective Agents|protective agents|mesh-ancestor
5701948|NCT03342599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701949|NCT03342599|Vitamin B Complex|vitamin b complex|mesh-ancestor
5701950|NCT03342599|Vitamins|vitamins|mesh-ancestor
5701951|NCT03342599|Micronutrients|micronutrients|mesh-ancestor
5701952|NCT03342443|Memantine|memantine|mesh-list
5701953|NCT03342443|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5701954|NCT03342443|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5701955|NCT03342443|Dopamine Agents|dopamine agents|mesh-ancestor
5701956|NCT03342443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5918421|NCT04991584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5918422|NCT04991584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5918423|NCT04991584|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5918424|NCT04991584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5918425|NCT04991584|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5918426|NCT04991584|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5701957|NCT03342443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701958|NCT03342443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701959|NCT03342443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5701960|NCT03342443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5701961|NCT03342352|Carboplatin|carboplatin|mesh-list
5701962|NCT03342352|Fluorouracil|fluorouracil|mesh-list
5701963|NCT03342352|Nivolumab|nivolumab|mesh-list
5701964|NCT03342352|Cetuximab|cetuximab|mesh-list
5701965|NCT03342352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5701966|NCT03342352|Antimetabolites|antimetabolites|mesh-ancestor
5701967|NCT03342352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701968|NCT03342352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5701969|NCT03342352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5701970|NCT03342352|Immunologic Factors|immunologic factors|mesh-ancestor
5701971|NCT03342352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918427|NCT04991584|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
5918428|NCT04991584|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6214443|NCT02219503|Protease Inhibitors|protease inhibitors|mesh-ancestor
6214444|NCT02219503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6214445|NCT02219503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214446|NCT02219503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6214447|NCT02219503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5918429|NCT04991584|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5918430|NCT04991584|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6214448|NCT02219503|Antiviral Agents|antiviral agents|mesh-ancestor
6214449|NCT02219503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6214450|NCT02219503|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6214451|NCT02219503|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6214452|NCT02219516|Verinurad|verinurad|mesh-list
6214453|NCT02219516|Gout Suppressants|gout suppressants|mesh-ancestor
6214454|NCT02219516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6214455|NCT02219685|Sofosbuvir|sofosbuvir|mesh-list
6214456|NCT02219685|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
6214457|NCT02219685|Ledipasvir|ledipasvir|mesh-list
6214458|NCT02219685|Antiviral Agents|antiviral agents|mesh-ancestor
6214459|NCT02219685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6214460|NCT02219932|4-Aminopyridine|4-aminopyridine|mesh-list
6214461|NCT02219932|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6214462|NCT02219932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6214463|NCT02219932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214464|NCT02219997|Methamphetamine|methamphetamine|mesh-list
6214465|NCT02219997|beta-Endorphin|beta-endorphin|mesh-list
6214466|NCT02219997|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6214467|NCT02219997|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
6214468|NCT02219997|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6214469|NCT02219997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214470|NCT02219997|Sympathomimetics|sympathomimetics|mesh-ancestor
6214471|NCT02219997|Autonomic Agents|autonomic agents|mesh-ancestor
6214472|NCT02219997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6214473|NCT02219997|Dopamine Agents|dopamine agents|mesh-ancestor
6214474|NCT02219997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6214475|NCT02219997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214476|NCT02219997|Adrenergic Agents|adrenergic agents|mesh-ancestor
6214477|NCT02219997|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6214478|NCT02219997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6214479|NCT02219997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6214480|NCT02219997|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6214481|NCT02219997|Hormones|hormones|mesh-ancestor
6214482|NCT02219997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6214483|NCT02220712|Aripiprazole|aripiprazole|mesh-list
6214484|NCT02220712|Antidepressive Agents|antidepressive agents|mesh-ancestor
6214485|NCT02220712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6214486|NCT02220712|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6214487|NCT02220712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6214488|NCT02220712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5701972|NCT03342352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5701973|NCT03342352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5701974|NCT03342300|Doxorubicin|doxorubicin|mesh-list
5701975|NCT03342300|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6214489|NCT02220712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214490|NCT02220712|Dopamine Agonists|dopamine agonists|mesh-ancestor
6214491|NCT02220712|Dopamine Agents|dopamine agents|mesh-ancestor
6214492|NCT02220712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6214493|NCT02220712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214494|NCT02220712|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6214495|NCT02220712|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6214496|NCT02220712|Serotonin Agents|serotonin agents|mesh-ancestor
6214497|NCT02220712|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6214498|NCT02220712|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6214499|NCT02220712|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6214500|NCT02220712|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6214501|NCT02220907|Canagliflozin|canagliflozin|mesh-list
6214502|NCT02220907|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6214503|NCT02220907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214504|NCT02220907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6214505|NCT02220907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6242881|NCT02657928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6242882|NCT02657928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6242883|NCT02658019|Pembrolizumab|pembrolizumab|mesh-list
6242884|NCT02658019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6242885|NCT02658019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6242886|NCT02658084|Trastuzumab|trastuzumab|mesh-list
6242887|NCT02658084|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
6242888|NCT02658084|Vinorelbine|vinorelbine|mesh-list
6242889|NCT02658084|Maytansine|maytansine|mesh-list
6242890|NCT02658084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6242891|NCT02658084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6214506|NCT02220920|Canagliflozin|canagliflozin|mesh-list
6214507|NCT02220920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6214508|NCT02220920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214509|NCT02220920|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6214510|NCT02220920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214511|NCT02220998|Sofosbuvir|sofosbuvir|mesh-list
6214512|NCT02220998|Antiviral Agents|antiviral agents|mesh-ancestor
6214513|NCT02220998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6214514|NCT02221219|Indomethacin|indomethacin|mesh-list
6214515|NCT02221219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6214516|NCT02221219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6214517|NCT02221219|Analgesics|analgesics|mesh-ancestor
6214518|NCT02221219|Sensory System Agents|sensory system agents|mesh-ancestor
6214519|NCT02221219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6214520|NCT02221219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214521|NCT02221219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6214522|NCT02221219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6214523|NCT02221219|Gout Suppressants|gout suppressants|mesh-ancestor
6214524|NCT02221219|Tocolytic Agents|tocolytic agents|mesh-ancestor
6214525|NCT02221219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6214526|NCT02221219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6214527|NCT02221219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6214528|NCT02221219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214529|NCT02221284|Alogliptin|alogliptin|mesh-list
6214530|NCT02221284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6214531|NCT02221284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214532|NCT02221284|Incretins|incretins|mesh-ancestor
6214533|NCT02221284|Hormones|hormones|mesh-ancestor
6214534|NCT02221284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6214535|NCT02221284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6214536|NCT02221284|Protease Inhibitors|protease inhibitors|mesh-ancestor
6214537|NCT02221284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6214538|NCT02221284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214539|NCT02221349|Listerine|listerine|mesh-list
6214540|NCT02221349|Fluorides|fluorides|mesh-list
6214541|NCT02221349|Sodium Fluoride|sodium fluoride|mesh-list
6214542|NCT02221349|Tin Fluorides|tin fluorides|mesh-list
6214543|NCT02221349|Cariostatic Agents|cariostatic agents|mesh-ancestor
6214544|NCT02221349|Protective Agents|protective agents|mesh-ancestor
6214545|NCT02221349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214546|NCT02221349|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6214547|NCT02221349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6214548|NCT02221648|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6214549|NCT02221648|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6214550|NCT02221648|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6214551|NCT02221648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6214552|NCT02221648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214553|NCT02221648|Cholinergic Agents|cholinergic agents|mesh-ancestor
6214554|NCT02221648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6214555|NCT02221648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214556|NCT02221648|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6214557|NCT02221648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6214558|NCT02221674|Tapentadol|tapentadol|mesh-list
6214559|NCT02221674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6214560|NCT02221674|Narcotics|narcotics|mesh-ancestor
6214561|NCT02221674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6214562|NCT02221674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214563|NCT02221674|Analgesics|analgesics|mesh-ancestor
6214564|NCT02221674|Sensory System Agents|sensory system agents|mesh-ancestor
6214565|NCT02221674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6214566|NCT02221674|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6214567|NCT02221674|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6214568|NCT02221674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5701976|NCT03342300|Pirarubicin|pirarubicin|mesh-list
5701977|NCT03342300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5701978|NCT03342300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5701979|NCT03342300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5701980|NCT03342300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5701981|NCT03342300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5701982|NCT03342300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5701983|NCT03342261|Antiviral Agents|antiviral agents|mesh-list
5701984|NCT03342261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5701985|NCT03342170|Thrombin|thrombin|mesh-list
5701986|NCT03342170|Hemostatics|hemostatics|mesh-ancestor
5701987|NCT03342170|Coagulants|coagulants|mesh-ancestor
6214569|NCT02221674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214570|NCT02221674|Adrenergic Agents|adrenergic agents|mesh-ancestor
6214571|NCT02221674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6214572|NCT02221739|Ipilimumab|ipilimumab|mesh-list
6214573|NCT02221739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6214574|NCT02221739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6214575|NCT02221739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6214576|NCT02221739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214577|NCT02221947|Bryostatin 1|bryostatin 1|mesh-list
6214578|NCT02221947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6214579|NCT02221947|Immunologic Factors|immunologic factors|mesh-ancestor
6214580|NCT02221947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214581|NCT02221947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6214582|NCT02222129|Bupivacaine|bupivacaine|mesh-list
6214583|NCT02222129|Anesthetics, Local|anesthetics, local|mesh-ancestor
6214584|NCT02222129|Anesthetics|anesthetics|mesh-ancestor
6214585|NCT02222129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6214586|NCT02222129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214587|NCT02222129|Sensory System Agents|sensory system agents|mesh-ancestor
6214588|NCT02222129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6214589|NCT02222207|Ranibizumab|ranibizumab|mesh-list
6214590|NCT02222207|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6214591|NCT02222207|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6214592|NCT02222207|Growth Substances|growth substances|mesh-ancestor
6214593|NCT02222207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214594|NCT02222207|Growth Inhibitors|growth inhibitors|mesh-ancestor
6214595|NCT02222207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6214596|NCT02222246|Morphine|morphine|mesh-list
6214597|NCT02222246|Hydromorphone|hydromorphone|mesh-list
6214598|NCT02222246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6214599|NCT02222246|Narcotics|narcotics|mesh-ancestor
6214600|NCT02222246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6214601|NCT02222246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214602|NCT02222246|Analgesics|analgesics|mesh-ancestor
6214603|NCT02222246|Sensory System Agents|sensory system agents|mesh-ancestor
6214604|NCT02222246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6214605|NCT02222493|Infliximab|infliximab|mesh-list
6214606|NCT02222493|Dermatologic Agents|dermatologic agents|mesh-ancestor
6214607|NCT02222493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6214608|NCT02222493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6214609|NCT02222558|Testosterone|testosterone|mesh-list
6214610|NCT02222558|Androgens|androgens|mesh-ancestor
6214611|NCT02222558|Hormones|hormones|mesh-ancestor
6214612|NCT02222558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6214613|NCT02222558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214614|NCT02222610|Ranibizumab|ranibizumab|mesh-list
6214615|NCT02222610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6214616|NCT02222610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6214617|NCT02222610|Growth Substances|growth substances|mesh-ancestor
6214618|NCT02222610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214619|NCT02222610|Growth Inhibitors|growth inhibitors|mesh-ancestor
6214620|NCT02222610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6214621|NCT02222714|Protein C|protein c|mesh-list
6214622|NCT02222714|Anticoagulants|anticoagulants|mesh-ancestor
6214623|NCT02222714|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6214624|NCT02222714|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6214625|NCT02222714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214626|NCT02222870|Vaccines|vaccines|mesh-list
6214627|NCT02222870|Immunologic Factors|immunologic factors|mesh-ancestor
6214628|NCT02222870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497158|NCT00630929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6497159|NCT00630929|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6497160|NCT00630929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6497161|NCT00630929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497162|NCT00630929|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6497163|NCT00630942|Minocycline|minocycline|mesh-list
6497164|NCT00630942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6497165|NCT00630942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6497166|NCT00630968|Levetiracetam|levetiracetam|mesh-list
6497167|NCT00630968|Anticonvulsants|anticonvulsants|mesh-ancestor
6497168|NCT00630968|Nootropic Agents|nootropic agents|mesh-ancestor
6497169|NCT00630981|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6497170|NCT00630981|Citalopram|citalopram|mesh-list
6497171|NCT00630981|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6497172|NCT00630981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6497173|NCT00630981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6214629|NCT02222896|Chlorhexidine|chlorhexidine|mesh-list
6214630|NCT02222896|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6214631|NCT02222896|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6214632|NCT02222896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6214633|NCT02222896|Disinfectants|disinfectants|mesh-ancestor
6214634|NCT02222896|Dermatologic Agents|dermatologic agents|mesh-ancestor
6214635|NCT02222922|Fluconazole|fluconazole|mesh-list
6214636|NCT02222922|Avelumab|avelumab|mesh-list
6214637|NCT02222922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6214638|NCT02222922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6214639|NCT02222922|Antifungal Agents|antifungal agents|mesh-ancestor
6214640|NCT02222922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6214641|NCT02222922|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6214642|NCT02222922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6214643|NCT02222922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6214644|NCT02222922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214645|NCT02222922|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6214646|NCT02222922|Hormone Antagonists|hormone antagonists|mesh-ancestor
6214647|NCT02222922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6214648|NCT02222922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214649|NCT02222922|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6214650|NCT02222922|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6214651|NCT02223065|Dapagliflozin|dapagliflozin|mesh-list
6214652|NCT02223065|Saxagliptin|saxagliptin|mesh-list
6214653|NCT02223065|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6214654|NCT02223065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214655|NCT02223065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6214656|NCT02223065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214657|NCT02223065|Incretins|incretins|mesh-ancestor
6214658|NCT02223065|Hormones|hormones|mesh-ancestor
6214659|NCT02223065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6214660|NCT02223065|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6214661|NCT02223065|Protease Inhibitors|protease inhibitors|mesh-ancestor
6214662|NCT02223065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6214663|NCT02223260|Dabigatran|dabigatran|mesh-list
6214664|NCT02223260|Antithrombins|antithrombins|mesh-ancestor
6214665|NCT02223260|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6214666|NCT02223260|Protease Inhibitors|protease inhibitors|mesh-ancestor
6214667|NCT02223260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6214668|NCT02223260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214669|NCT02223260|Anticoagulants|anticoagulants|mesh-ancestor
6214670|NCT02223338|Ciprofloxacin|ciprofloxacin|mesh-list
6214671|NCT02223338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6214672|NCT02223338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6214673|NCT02223338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6214674|NCT02223338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6214675|NCT02223338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6214676|NCT02223338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214677|NCT02223338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6214678|NCT02223338|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6214679|NCT02223338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6214680|NCT02223351|Ritonavir|ritonavir|mesh-list
6214681|NCT02223351|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6214682|NCT02223351|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6214683|NCT02223351|Protease Inhibitors|protease inhibitors|mesh-ancestor
6214684|NCT02223351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6214685|NCT02223351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214686|NCT02223351|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6214687|NCT02223351|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6214688|NCT02223351|Antiviral Agents|antiviral agents|mesh-ancestor
6214689|NCT02223351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6214690|NCT02223351|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6214691|NCT02223351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6214692|NCT02223364|Bupivacaine|bupivacaine|mesh-list
6214693|NCT02223364|Ropivacaine|ropivacaine|mesh-list
6214694|NCT02223364|Anesthetics, Local|anesthetics, local|mesh-ancestor
6214695|NCT02223364|Anesthetics|anesthetics|mesh-ancestor
6214696|NCT02223364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6214697|NCT02223364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214698|NCT02223364|Sensory System Agents|sensory system agents|mesh-ancestor
6214699|NCT02223364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6214700|NCT02223429|Vasopressins|vasopressins|mesh-list
6214701|NCT02223429|Arginine Vasopressin|arginine vasopressin|mesh-list
6214702|NCT02223429|Oxytocin|oxytocin|mesh-list
6214703|NCT02223429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214704|NCT02223429|Oxytocics|oxytocics|mesh-ancestor
6214705|NCT02223429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5701988|NCT03342079|Nitrous Oxide|nitrous oxide|mesh-list
5701989|NCT03342079|Anesthetics|anesthetics|mesh-list
5701990|NCT03342079|Anesthetics, Local|anesthetics, local|mesh-list
6214706|NCT02223429|Hemostatics|hemostatics|mesh-ancestor
6214707|NCT02223429|Coagulants|coagulants|mesh-ancestor
6214708|NCT02223429|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6214709|NCT02223429|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6214710|NCT02223429|Natriuretic Agents|natriuretic agents|mesh-ancestor
6214711|NCT02223702|Amoxicillin|amoxicillin|mesh-list
6214712|NCT02223702|Moxifloxacin|moxifloxacin|mesh-list
6214713|NCT02223702|Metronidazole|metronidazole|mesh-list
6214714|NCT02223702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6214715|NCT02223702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6214716|NCT02223702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6214717|NCT02223702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6214718|NCT02223702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6214719|NCT02223702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214720|NCT02223702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6214721|NCT02223702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6214722|NCT02223702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6214723|NCT02223871|Lumefantrine|lumefantrine|mesh-list
6214724|NCT02223871|Artemether|artemether|mesh-list
6214725|NCT02223871|Primaquine|primaquine|mesh-list
6214726|NCT02223871|Antimalarials|antimalarials|mesh-ancestor
6214727|NCT02223871|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6214728|NCT02223871|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6214729|NCT02223871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6214730|NCT02224053|Osimertinib|osimertinib|mesh-list
6214731|NCT02224053|Omeprazole|omeprazole|mesh-list
6214732|NCT02224053|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6214733|NCT02224053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6214734|NCT02224053|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6214735|NCT02224053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6214736|NCT02224053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214737|NCT02224053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6214738|NCT02224053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6214739|NCT02224157|Budesonide|budesonide|mesh-list
6214740|NCT02224157|Terbutaline|terbutaline|mesh-list
6214741|NCT02224157|Formoterol Fumarate|formoterol fumarate|mesh-list
6214742|NCT02224157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6214743|NCT02224157|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6214744|NCT02224157|Autonomic Agents|autonomic agents|mesh-ancestor
6214745|NCT02224157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6214746|NCT02224157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214747|NCT02224157|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6214748|NCT02224157|Respiratory System Agents|respiratory system agents|mesh-ancestor
6214749|NCT02224157|Glucocorticoids|glucocorticoids|mesh-ancestor
6214750|NCT02224157|Hormones|hormones|mesh-ancestor
6214751|NCT02224157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6214752|NCT02224157|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6214753|NCT02224157|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6214754|NCT02224157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6214755|NCT02224157|Adrenergic Agents|adrenergic agents|mesh-ancestor
6214756|NCT02224157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6214757|NCT02224157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214758|NCT02224157|Sympathomimetics|sympathomimetics|mesh-ancestor
6214759|NCT02224157|Tocolytic Agents|tocolytic agents|mesh-ancestor
6214760|NCT02224157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6214761|NCT02224274|Clopidogrel|clopidogrel|mesh-list
6214762|NCT02224274|Ticagrelor|ticagrelor|mesh-list
6214763|NCT02224274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6214764|NCT02224274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6214765|NCT02224274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6497174|NCT00630981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497175|NCT00630981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6497176|NCT00630981|Serotonin Agents|serotonin agents|mesh-ancestor
6497177|NCT00630981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497178|NCT00630981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6497179|NCT00630981|Antidepressive Agents|antidepressive agents|mesh-ancestor
6497180|NCT00630981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5918431|NCT04991896|Metoprolol|metoprolol|mesh-list
6214766|NCT02224274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6214767|NCT02224274|Purinergic Agents|purinergic agents|mesh-ancestor
6214768|NCT02224274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6214769|NCT02224274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214770|NCT02224274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214771|NCT02224313|Estradiol|estradiol|mesh-list
6214772|NCT02224313|Progesterone|progesterone|mesh-list
6214773|NCT02224313|Estrogens|estrogens|mesh-ancestor
6214774|NCT02224313|Hormones|hormones|mesh-ancestor
5701991|NCT03342079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5701992|NCT03342079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5701993|NCT03342079|Sensory System Agents|sensory system agents|mesh-ancestor
5701994|NCT03342079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5701995|NCT03342079|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5701996|NCT03342079|Anesthetics, General|anesthetics, general|mesh-ancestor
5701997|NCT03342079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5701998|NCT03342079|Analgesics|analgesics|mesh-ancestor
5701999|NCT03342040|Bupivacaine|bupivacaine|mesh-list
5702000|NCT03342040|Ropivacaine|ropivacaine|mesh-list
5702001|NCT03342040|Anesthetics, Local|anesthetics, local|mesh-ancestor
5702002|NCT03342040|Anesthetics|anesthetics|mesh-ancestor
5702003|NCT03342040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5702004|NCT03342040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702005|NCT03342040|Sensory System Agents|sensory system agents|mesh-ancestor
5702006|NCT03342040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5702007|NCT03341988|Ritonavir|ritonavir|mesh-list
5702008|NCT03341988|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5702009|NCT03341988|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5702010|NCT03341988|Protease Inhibitors|protease inhibitors|mesh-ancestor
5702011|NCT03341988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5702012|NCT03341988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5702013|NCT03341988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5702014|NCT03341988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5702015|NCT03341988|Antiviral Agents|antiviral agents|mesh-ancestor
5918432|NCT04991896|Sotalol|sotalol|mesh-list
5918433|NCT04991896|Flecainide|flecainide|mesh-list
6214775|NCT02224313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6214776|NCT02224313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214777|NCT02224313|Progestins|progestins|mesh-ancestor
6214778|NCT02224560|Cannabidiol|cannabidiol|mesh-list
6214779|NCT02224560|Anticonvulsants|anticonvulsants|mesh-ancestor
6214780|NCT02224625|Chlorhexidine|chlorhexidine|mesh-list
6214781|NCT02224625|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6214782|NCT02224625|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6214783|NCT02224625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6214784|NCT02224625|Disinfectants|disinfectants|mesh-ancestor
6214785|NCT02224625|Dermatologic Agents|dermatologic agents|mesh-ancestor
6214786|NCT02224690|Cannabidiol|cannabidiol|mesh-list
6214787|NCT02224690|Anticonvulsants|anticonvulsants|mesh-ancestor
6214788|NCT02224703|Cannabidiol|cannabidiol|mesh-list
6214789|NCT02224703|Anticonvulsants|anticonvulsants|mesh-ancestor
6214790|NCT02224729|Dexamethasone|dexamethasone|mesh-list
6214791|NCT02224729|Bortezomib|bortezomib|mesh-list
6214792|NCT02224729|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6214793|NCT02224729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6214794|NCT02224729|Antiemetics|antiemetics|mesh-ancestor
6214795|NCT02224729|Autonomic Agents|autonomic agents|mesh-ancestor
6497181|NCT00630981|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5702016|NCT03341988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5918434|NCT04991896|Bisoprolol|bisoprolol|mesh-list
5918435|NCT04991896|Betaxolol|betaxolol|mesh-list
5918436|NCT04991896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5918437|NCT04991896|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5918438|NCT04991896|Sympatholytics|sympatholytics|mesh-ancestor
5918439|NCT04991896|Autonomic Agents|autonomic agents|mesh-ancestor
5918440|NCT04991896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5918441|NCT04991896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918442|NCT04991896|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5918443|NCT04991896|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5918444|NCT04991896|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5918445|NCT04991896|Adrenergic Agents|adrenergic agents|mesh-ancestor
5918446|NCT04991896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5970622|NCT04533724|Dopamine Agents|dopamine agents|mesh-ancestor
5970623|NCT04533724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5970624|NCT04533724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970625|NCT04533724|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5970626|NCT04533724|Antidepressive Agents|antidepressive agents|mesh-ancestor
5970627|NCT04533867|Ondansetron|ondansetron|mesh-list
5970628|NCT04533867|Palonosetron|palonosetron|mesh-list
5970629|NCT04533867|Antiemetics|antiemetics|mesh-ancestor
5970630|NCT04533867|Autonomic Agents|autonomic agents|mesh-ancestor
6214796|NCT02224729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5702017|NCT03341988|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5702018|NCT03341988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5702019|NCT03341936|Nivolumab|nivolumab|mesh-list
5702020|NCT03341936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5702021|NCT03341936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5702022|NCT03341936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5702023|NCT03341936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5702024|NCT03341845|Avelumab|avelumab|mesh-list
5702025|NCT03341845|Axitinib|axitinib|mesh-list
5702026|NCT03341845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5702027|NCT03341845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5702028|NCT03341845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6214797|NCT02224729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214798|NCT02224729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6214799|NCT02224729|Glucocorticoids|glucocorticoids|mesh-ancestor
6214800|NCT02224729|Hormones|hormones|mesh-ancestor
6214801|NCT02224729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6214802|NCT02224729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6214803|NCT02224729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6214804|NCT02224729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6214805|NCT02224729|Alkylating Agents|alkylating agents|mesh-ancestor
6214806|NCT02224729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214807|NCT02224846|Tadalafil|tadalafil|mesh-list
6214808|NCT02224846|Vasodilator Agents|vasodilator agents|mesh-ancestor
6214809|NCT02224846|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6214810|NCT02224846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6214811|NCT02224846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6214812|NCT02224846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214813|NCT02224846|Urological Agents|urological agents|mesh-ancestor
6214814|NCT02225106|Methylphenidate|methylphenidate|mesh-list
6214815|NCT02225106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5702029|NCT03341845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5702030|NCT03341845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5702031|NCT03341767|Clofazimine|clofazimine|mesh-list
5702032|NCT03341767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5702033|NCT03341767|Leprostatic Agents|leprostatic agents|mesh-ancestor
5702034|NCT03341767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5702035|NCT03341767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5702036|NCT03341741|Tobramycin|tobramycin|mesh-list
5702037|NCT03341741|Colistin|colistin|mesh-list
5702038|NCT03341741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5702039|NCT03341741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6214816|NCT02225106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214817|NCT02225106|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6214818|NCT02225106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6214819|NCT02225106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5702044|NCT03341676|Dexamethasone|dexamethasone|mesh-list
5702045|NCT03341676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5702046|NCT03341676|Antiemetics|antiemetics|mesh-ancestor
5702047|NCT03341676|Autonomic Agents|autonomic agents|mesh-ancestor
5702048|NCT03341676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5702049|NCT03341676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702050|NCT03341676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5702051|NCT03341676|Glucocorticoids|glucocorticoids|mesh-ancestor
6214820|NCT02225106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214821|NCT02225106|Dopamine Agents|dopamine agents|mesh-ancestor
6214822|NCT02225106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6214823|NCT02225132|Hydroxyurea|hydroxyurea|mesh-list
6214824|NCT02225132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6214825|NCT02225132|Antisickling Agents|antisickling agents|mesh-ancestor
6214826|NCT02225132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6214827|NCT02225132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214828|NCT02225132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6214829|NCT02225353|Progesterone|progesterone|mesh-list
6214830|NCT02225353|Progestins|progestins|mesh-ancestor
6214831|NCT02225353|Hormones|hormones|mesh-ancestor
6214832|NCT02225353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6214833|NCT02225353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214834|NCT02225587|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6214835|NCT02225587|Immunologic Factors|immunologic factors|mesh-ancestor
6214836|NCT02225587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702052|NCT03341676|Hormones|hormones|mesh-ancestor
6214837|NCT02225665|Cyclophosphamide|cyclophosphamide|mesh-list
6214838|NCT02225665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6214839|NCT02225665|Immunologic Factors|immunologic factors|mesh-ancestor
6214840|NCT02225665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214841|NCT02225665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6214842|NCT02225665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6214843|NCT02225665|Alkylating Agents|alkylating agents|mesh-ancestor
6214844|NCT02225665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214845|NCT02225665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6214846|NCT02225665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6214847|NCT02226003|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6214848|NCT02226003|Glimepiride|glimepiride|mesh-list
6214849|NCT02226003|Ertugliflozin|ertugliflozin|mesh-list
6214850|NCT02226003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6214851|NCT02226003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214852|NCT02226003|Incretins|incretins|mesh-ancestor
6214853|NCT02226003|Hormones|hormones|mesh-ancestor
6214854|NCT02226003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6214855|NCT02226003|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6214856|NCT02226003|Protease Inhibitors|protease inhibitors|mesh-ancestor
6214857|NCT02226003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6214858|NCT02226003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214859|NCT02226003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6214860|NCT02226003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6214861|NCT02226003|Immunologic Factors|immunologic factors|mesh-ancestor
6214862|NCT02226003|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6214863|NCT02226120|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
6214864|NCT02226120|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6214865|NCT02226120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214866|NCT02226159|Dexamethasone|dexamethasone|mesh-list
6214867|NCT02226159|Dexamethasone acetate|dexamethasone acetate|mesh-list
6214868|NCT02226159|Lidocaine|lidocaine|mesh-list
5702053|NCT03341676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5702054|NCT03341676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5702055|NCT03341676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5702056|NCT03341520|Obinutuzumab|obinutuzumab|mesh-list
5702057|NCT03341520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5702058|NCT03341520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5702059|NCT03341494|Thalidomide|thalidomide|mesh-list
5702060|NCT03341494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5702061|NCT03341494|Immunologic Factors|immunologic factors|mesh-ancestor
5702062|NCT03341494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702063|NCT03341494|Leprostatic Agents|leprostatic agents|mesh-ancestor
5702064|NCT03341494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5702065|NCT03341494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5702066|NCT03341494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5702067|NCT03341494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5702068|NCT03341494|Growth Substances|growth substances|mesh-ancestor
5702069|NCT03341494|Growth Inhibitors|growth inhibitors|mesh-ancestor
5702070|NCT03341494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5721066|NCT03208582|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5721067|NCT03208582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721068|NCT03208582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5721069|NCT03208452|Magnesium Sulfate|magnesium sulfate|mesh-list
5721070|NCT03208452|Analgesics|analgesics|mesh-ancestor
5721071|NCT03208452|Sensory System Agents|sensory system agents|mesh-ancestor
5721072|NCT03208452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5721073|NCT03208452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721074|NCT03208452|Anesthetics|anesthetics|mesh-ancestor
5964035|NCT04595812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5964036|NCT04595812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964037|NCT04595812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5964038|NCT04595812|Abortifacient Agents|abortifacient agents|mesh-ancestor
5964039|NCT04595812|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5964040|NCT04595812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5964041|NCT04595812|Coagulants|coagulants|mesh-ancestor
5964042|NCT04595981|Cisplatin|cisplatin|mesh-list
5964043|NCT04595981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5964044|NCT04595877|Dipyrone|dipyrone|mesh-list
5964045|NCT04595877|Endorphins|endorphins|mesh-list
5964046|NCT04595877|beta-Endorphin|beta-endorphin|mesh-list
5964047|NCT04595877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5964048|NCT04595877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6214869|NCT02226159|BB 1101|bb 1101|mesh-list
6214870|NCT02226159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6214871|NCT02226159|Antiemetics|antiemetics|mesh-ancestor
6214872|NCT02226159|Autonomic Agents|autonomic agents|mesh-ancestor
6214873|NCT02226159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6214874|NCT02226159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214875|NCT02226159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6214876|NCT02226159|Glucocorticoids|glucocorticoids|mesh-ancestor
6214877|NCT02226159|Hormones|hormones|mesh-ancestor
6214878|NCT02226159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6214879|NCT02226159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6214880|NCT02226159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6214881|NCT02226159|Protease Inhibitors|protease inhibitors|mesh-ancestor
6214882|NCT02226159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6214883|NCT02226159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214884|NCT02226159|Anesthetics, Local|anesthetics, local|mesh-ancestor
6214885|NCT02226159|Anesthetics|anesthetics|mesh-ancestor
6214886|NCT02226159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6214887|NCT02226159|Sensory System Agents|sensory system agents|mesh-ancestor
6214888|NCT02226159|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6214889|NCT02226159|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6214890|NCT02226159|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6214891|NCT02226159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6214892|NCT02226198|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6214893|NCT02226198|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6214894|NCT02226198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6214895|NCT02226198|Antimetabolites|antimetabolites|mesh-ancestor
6214896|NCT02226198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214897|NCT02226198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6214898|NCT02226198|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6214899|NCT02226198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6214900|NCT02226549|Sofosbuvir|sofosbuvir|mesh-list
6214901|NCT02226549|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
6214902|NCT02226549|Ledipasvir|ledipasvir|mesh-list
6214903|NCT02226549|Antiviral Agents|antiviral agents|mesh-ancestor
6214904|NCT02226549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6214905|NCT02226562|Listerine|listerine|mesh-list
6214906|NCT02226562|Fluorides|fluorides|mesh-list
6214907|NCT02226562|Sodium Fluoride|sodium fluoride|mesh-list
6214908|NCT02226562|Cariostatic Agents|cariostatic agents|mesh-ancestor
6214909|NCT02226562|Protective Agents|protective agents|mesh-ancestor
6214910|NCT02226562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214911|NCT02226562|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6214912|NCT02226562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6214913|NCT02226653|Evacetrapib|evacetrapib|mesh-list
6214914|NCT02226653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6214915|NCT02226653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6214916|NCT02226653|Antimetabolites|antimetabolites|mesh-ancestor
6214917|NCT02226653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214918|NCT02226653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6214919|NCT02227108|Immunotoxin HA22|immunotoxin ha22|mesh-list
6214920|NCT02227108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6214921|NCT02227316|Acetaminophen|acetaminophen|mesh-list
6214922|NCT02227316|Ibuprofen|ibuprofen|mesh-list
6214923|NCT02227316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6214924|NCT02227316|Analgesics|analgesics|mesh-ancestor
6214925|NCT02227316|Sensory System Agents|sensory system agents|mesh-ancestor
6214926|NCT02227316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6214927|NCT02227316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214928|NCT02227316|Antipyretics|antipyretics|mesh-ancestor
6214929|NCT02227316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6214930|NCT02227316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6214931|NCT02227316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6214932|NCT02227316|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6214933|NCT02227316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6497182|NCT00630981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6497183|NCT00630981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6497184|NCT00631033|Metformin|metformin|mesh-list
6497185|NCT00631033|Diazoxide|diazoxide|mesh-list
6497186|NCT00631033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6497187|NCT00631033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497188|NCT00631033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6497189|NCT00631033|Vasodilator Agents|vasodilator agents|mesh-ancestor
6497190|NCT00631085|Tocopherols|tocopherols|mesh-list
6242892|NCT02658084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6497191|NCT00631085|Vitamin E|vitamin e|mesh-list
6497192|NCT00631085|Tocotrienols|tocotrienols|mesh-list
6214934|NCT02227316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214935|NCT02227329|Ethanol|ethanol|mesh-list
6214936|NCT02227329|Heparin|heparin|mesh-list
6214937|NCT02227329|Calcium heparin|calcium heparin|mesh-list
6214938|NCT02227329|Anticoagulants|anticoagulants|mesh-ancestor
6214939|NCT02227329|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6214940|NCT02227329|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6214941|NCT02227329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214942|NCT02227329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6214943|NCT02227329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6214944|NCT02227329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6214945|NCT02227329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214946|NCT02227368|Aspirin|aspirin|mesh-list
6214947|NCT02227368|Ticagrelor|ticagrelor|mesh-list
6214948|NCT02227368|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6214949|NCT02227368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6214950|NCT02227368|Analgesics|analgesics|mesh-ancestor
6214951|NCT02227368|Sensory System Agents|sensory system agents|mesh-ancestor
5702071|NCT03341429|Liraglutide|liraglutide|mesh-list
5702072|NCT03341429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5702073|NCT03341429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702074|NCT03341429|Incretins|incretins|mesh-ancestor
5702075|NCT03341429|Hormones|hormones|mesh-ancestor
5702076|NCT03341429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5702077|NCT03341390|Aspirin|aspirin|mesh-list
5702078|NCT03341390|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5702079|NCT03341390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5702080|NCT03341390|Analgesics|analgesics|mesh-ancestor
5702081|NCT03341390|Sensory System Agents|sensory system agents|mesh-ancestor
5702082|NCT03341390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5702083|NCT03341390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702084|NCT03341390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5702085|NCT03341390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5702086|NCT03341390|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5702087|NCT03341390|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5702088|NCT03341390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5702089|NCT03341390|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5702090|NCT03341390|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5702091|NCT03341390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5702092|NCT03341390|Antipyretics|antipyretics|mesh-ancestor
5702093|NCT03341260|Diclofenac|diclofenac|mesh-list
5702094|NCT03341260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5702095|NCT03341260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5702096|NCT03341260|Analgesics|analgesics|mesh-ancestor
5702097|NCT03341260|Sensory System Agents|sensory system agents|mesh-ancestor
5702098|NCT03341260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5702099|NCT03341260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702100|NCT03341260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5702101|NCT03341260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5702102|NCT03341260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5702103|NCT03341260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5702104|NCT03341260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5702105|NCT03341234|Bupivacaine|bupivacaine|mesh-list
5702106|NCT03341234|Anesthetics, Local|anesthetics, local|mesh-ancestor
5702107|NCT03341234|Anesthetics|anesthetics|mesh-ancestor
5702108|NCT03341234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5702109|NCT03341234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702110|NCT03341234|Sensory System Agents|sensory system agents|mesh-ancestor
5702111|NCT03341234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5702112|NCT03341117|Aspirin|aspirin|mesh-list
5702113|NCT03341117|Magnesium Oxide|magnesium oxide|mesh-list
5702114|NCT03341117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5702115|NCT03341117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5702116|NCT03341117|Analgesics|analgesics|mesh-ancestor
5702117|NCT03341117|Sensory System Agents|sensory system agents|mesh-ancestor
5702118|NCT03341117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5702119|NCT03341117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702120|NCT03341117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6214952|NCT02227368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6214953|NCT02227368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214954|NCT02227368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6214955|NCT02227368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6214956|NCT02227368|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6214957|NCT02227368|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6242893|NCT02658084|Tubulin Modulators|tubulin modulators|mesh-ancestor
6214958|NCT02227368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214959|NCT02227368|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6214960|NCT02227368|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6214961|NCT02227368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6214962|NCT02227368|Antipyretics|antipyretics|mesh-ancestor
6214963|NCT02227368|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6214964|NCT02227368|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6214965|NCT02227368|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6214966|NCT02227368|Purinergic Agents|purinergic agents|mesh-ancestor
6214967|NCT02227368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6214968|NCT02227446|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6214969|NCT02227446|Vancomycin|vancomycin|mesh-list
6214970|NCT02227446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6214971|NCT02227485|Chlorhexidine|chlorhexidine|mesh-list
6214972|NCT02227485|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6214973|NCT02227485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6214974|NCT02227485|Disinfectants|disinfectants|mesh-ancestor
6214975|NCT02227667|Durvalumab|durvalumab|mesh-list
6214976|NCT02227667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6214977|NCT02227667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6214978|NCT02227706|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6214979|NCT02227706|Hemostatics|hemostatics|mesh-ancestor
6214980|NCT02227706|Coagulants|coagulants|mesh-ancestor
6214981|NCT02227784|Atorvastatin|atorvastatin|mesh-list
6214982|NCT02227784|Ezetimibe|ezetimibe|mesh-list
6214983|NCT02227784|Evacetrapib|evacetrapib|mesh-list
6214984|NCT02227784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6214985|NCT02227784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6214986|NCT02227784|Antimetabolites|antimetabolites|mesh-ancestor
6214987|NCT02227784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214988|NCT02227784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6214989|NCT02227784|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6214990|NCT02227784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6214991|NCT02227849|Canagliflozin|canagliflozin|mesh-list
6214992|NCT02227849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6214993|NCT02227849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6214994|NCT02227849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6214995|NCT02227849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214996|NCT02227862|Insulin Glargine|insulin glargine|mesh-list
6214997|NCT02227862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6214998|NCT02227862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6214999|NCT02227875|Insulin Glargine|insulin glargine|mesh-list
6215000|NCT02227875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6215001|NCT02227875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6242894|NCT02658084|Antimitotic Agents|antimitotic agents|mesh-ancestor
6242895|NCT02658084|Mitosis Modulators|mitosis modulators|mesh-ancestor
6242896|NCT02658084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242897|NCT02658149|Ketorolac|ketorolac|mesh-list
6242898|NCT02658149|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6242899|NCT02658149|Epinephrine|epinephrine|mesh-list
6242900|NCT02658149|Morphine|morphine|mesh-list
6242901|NCT02658149|Ropivacaine|ropivacaine|mesh-list
6242902|NCT02658149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6242903|NCT02658149|Narcotics|narcotics|mesh-ancestor
6242904|NCT02658149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6242905|NCT02658149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6242906|NCT02658149|Analgesics|analgesics|mesh-ancestor
6242907|NCT02658149|Sensory System Agents|sensory system agents|mesh-ancestor
6242908|NCT02658149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6242909|NCT02658149|Anesthetics, Local|anesthetics, local|mesh-ancestor
6242910|NCT02658149|Anesthetics|anesthetics|mesh-ancestor
6242911|NCT02658149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6242912|NCT02658149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6242913|NCT02658149|Adrenergic Agents|adrenergic agents|mesh-ancestor
6242914|NCT02658149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6242915|NCT02658149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242916|NCT02658149|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6242917|NCT02658149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6242918|NCT02658149|Autonomic Agents|autonomic agents|mesh-ancestor
6242919|NCT02658149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6242920|NCT02658149|Respiratory System Agents|respiratory system agents|mesh-ancestor
6242921|NCT02658149|Mydriatics|mydriatics|mesh-ancestor
6242922|NCT02658149|Sympathomimetics|sympathomimetics|mesh-ancestor
6242923|NCT02658149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6242924|NCT02658149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6242925|NCT02658149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5918447|NCT04991896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918448|NCT04991896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6215002|NCT02228408|Hydralazine|hydralazine|mesh-list
6497193|NCT00631085|alpha-Tocopherol|alpha-tocopherol|mesh-list
6215003|NCT02228408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6215004|NCT02228408|Vasodilator Agents|vasodilator agents|mesh-ancestor
6215005|NCT02228590|Apomorphine|apomorphine|mesh-list
6215006|NCT02228590|Emetics|emetics|mesh-ancestor
6215007|NCT02228590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215008|NCT02228590|Autonomic Agents|autonomic agents|mesh-ancestor
6215009|NCT02228590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6215010|NCT02228590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6215011|NCT02228590|Dopamine Agonists|dopamine agonists|mesh-ancestor
6215012|NCT02228590|Dopamine Agents|dopamine agents|mesh-ancestor
6215013|NCT02228590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6215014|NCT02228590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215015|NCT02228681|Tamoxifen|tamoxifen|mesh-list
6215016|NCT02228681|Everolimus|everolimus|mesh-list
6215017|NCT02228681|Letrozole|letrozole|mesh-list
6215018|NCT02228681|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6215019|NCT02228681|Medroxyprogesterone|medroxyprogesterone|mesh-list
6215020|NCT02228681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6215021|NCT02228681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6215022|NCT02228681|Immunologic Factors|immunologic factors|mesh-ancestor
6215023|NCT02228681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215024|NCT02228681|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6215025|NCT02228681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6215026|NCT02228681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6215027|NCT02228681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215028|NCT02228681|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6215029|NCT02228681|Hormone Antagonists|hormone antagonists|mesh-ancestor
6215030|NCT02228681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6215031|NCT02228681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6215032|NCT02228681|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6215033|NCT02228681|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6215034|NCT02228681|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6215035|NCT02228681|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5702121|NCT03341117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5702122|NCT03341117|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5702123|NCT03341117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5702124|NCT03341117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5702125|NCT03341117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5702126|NCT03341117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5702127|NCT03341117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5702128|NCT03341117|Antipyretics|antipyretics|mesh-ancestor
5702129|NCT03341117|Antacids|antacids|mesh-ancestor
5702130|NCT03341117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5702131|NCT03341104|Bupivacaine|bupivacaine|mesh-list
6215036|NCT02228681|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6215037|NCT02228681|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6215038|NCT02228681|Contraceptive Agents|contraceptive agents|mesh-ancestor
6215039|NCT02228681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6215040|NCT02228681|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6215041|NCT02228681|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6215042|NCT02228681|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6215043|NCT02228720|Mometasone Furoate|mometasone furoate|mesh-list
6215044|NCT02228720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6215045|NCT02228720|Dermatologic Agents|dermatologic agents|mesh-ancestor
6215046|NCT02228720|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6215047|NCT02228824|Nicotine|nicotine|mesh-list
6215048|NCT02228824|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6215049|NCT02228824|Autonomic Agents|autonomic agents|mesh-ancestor
6215050|NCT02228824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6215051|NCT02228824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215052|NCT02228824|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6215053|NCT02228824|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6215054|NCT02228824|Cholinergic Agents|cholinergic agents|mesh-ancestor
6215055|NCT02228824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6497194|NCT00631085|gamma-Tocopherol|gamma-tocopherol|mesh-list
6497195|NCT00631085|Antioxidants|antioxidants|mesh-ancestor
6497196|NCT00631085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497197|NCT00631085|Protective Agents|protective agents|mesh-ancestor
6497198|NCT00631085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497199|NCT00631085|Vitamins|vitamins|mesh-ancestor
6497200|NCT00631085|Micronutrients|micronutrients|mesh-ancestor
5702132|NCT03341104|Anesthetics, Local|anesthetics, local|mesh-ancestor
5702133|NCT03341104|Anesthetics|anesthetics|mesh-ancestor
5702134|NCT03341104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5702135|NCT03341104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702136|NCT03341104|Sensory System Agents|sensory system agents|mesh-ancestor
5702137|NCT03341104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5702138|NCT03340922|Long-Acting Thyroid Stimulator|long-acting thyroid stimulator|mesh-list
5702139|NCT03340922|Immunologic Factors|immunologic factors|mesh-ancestor
5702140|NCT03340922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702141|NCT03340909|Prednisolone|prednisolone|mesh-list
5702142|NCT03340909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5702143|NCT03340909|Glucocorticoids|glucocorticoids|mesh-ancestor
5702144|NCT03340909|Hormones|hormones|mesh-ancestor
6215056|NCT02228824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215057|NCT02228980|Vaccines|vaccines|mesh-list
6215058|NCT02228980|Immunologic Factors|immunologic factors|mesh-ancestor
6215059|NCT02228980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215060|NCT02229214|Topiramate|topiramate|mesh-list
6215061|NCT02229214|Phentermine|phentermine|mesh-list
6215062|NCT02229214|Anticonvulsants|anticonvulsants|mesh-ancestor
6215063|NCT02229214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6215064|NCT02229214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702145|NCT03340909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5702146|NCT03340909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702147|NCT03340909|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5702148|NCT03340909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5702149|NCT03340896|Docetaxel|docetaxel|mesh-list
5702150|NCT03340896|Fluorouracil|fluorouracil|mesh-list
5702151|NCT03340896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5702152|NCT03340896|Tubulin Modulators|tubulin modulators|mesh-ancestor
5702153|NCT03340896|Antimitotic Agents|antimitotic agents|mesh-ancestor
5702154|NCT03340896|Mitosis Modulators|mitosis modulators|mesh-ancestor
5702155|NCT03340896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5702156|NCT03340896|Antimetabolites|antimetabolites|mesh-ancestor
5702157|NCT03340896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5702158|NCT03340896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5702159|NCT03340896|Immunologic Factors|immunologic factors|mesh-ancestor
5702160|NCT03340896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215065|NCT02229214|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6215066|NCT02229214|Appetite Depressants|appetite depressants|mesh-ancestor
6215067|NCT02229214|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6215068|NCT02229214|Sympathomimetics|sympathomimetics|mesh-ancestor
6215069|NCT02229214|Autonomic Agents|autonomic agents|mesh-ancestor
6215070|NCT02229214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6215071|NCT02229214|Adrenergic Agents|adrenergic agents|mesh-ancestor
6215072|NCT02229214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6215073|NCT02229214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215074|NCT02229227|Insulin|insulin|mesh-list
6215075|NCT02229227|Insulin Glargine|insulin glargine|mesh-list
6215076|NCT02229227|Insulin Lispro|insulin lispro|mesh-list
6215077|NCT02229227|rGLP-1 protein|rglp-1 protein|mesh-list
6215078|NCT02229227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6215079|NCT02229227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215080|NCT02229227|Incretins|incretins|mesh-ancestor
6215081|NCT02229227|Hormones|hormones|mesh-ancestor
6215082|NCT02229227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6215083|NCT02229383|Exenatide|exenatide|mesh-list
6215084|NCT02229383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6215085|NCT02229383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215086|NCT02229383|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6215087|NCT02229383|Incretins|incretins|mesh-ancestor
6215088|NCT02229383|Hormones|hormones|mesh-ancestor
6215089|NCT02229383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6215090|NCT02229396|Dapagliflozin|dapagliflozin|mesh-list
6215091|NCT02229396|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6215092|NCT02229396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215093|NCT02229396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6215094|NCT02229396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215095|NCT02229461|Aspirin|aspirin|mesh-list
6215096|NCT02229461|Naproxen|naproxen|mesh-list
6215097|NCT02229461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6215098|NCT02229461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6215099|NCT02229461|Analgesics|analgesics|mesh-ancestor
6215100|NCT02229461|Sensory System Agents|sensory system agents|mesh-ancestor
5702161|NCT03340779|Dobutamine|dobutamine|mesh-list
5702162|NCT03340779|Norepinephrine|norepinephrine|mesh-list
6215101|NCT02229461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6215102|NCT02229461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215103|NCT02229461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6215104|NCT02229461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6675951|NCT01578343|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6675952|NCT01578434|Calcium, Dietary|calcium, dietary|mesh-list
6675953|NCT01578434|Vitamin D|vitamin d|mesh-list
6675954|NCT01578434|Ergocalciferols|ergocalciferols|mesh-list
6675955|NCT01578434|Vitamins|vitamins|mesh-list
6675956|NCT01578434|Calcium Carbonate|calcium carbonate|mesh-list
6675957|NCT01578434|Calcium|calcium|mesh-list
6675958|NCT01578434|Micronutrients|micronutrients|mesh-ancestor
6675959|NCT01578434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675960|NCT01578434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6675961|NCT01578434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5702163|NCT03340779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6215105|NCT02229461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6215106|NCT02229461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6215107|NCT02229461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215108|NCT02229461|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6215109|NCT02229461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6497201|NCT00631124|Drospirenone|drospirenone|mesh-list
6497202|NCT00631124|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6497203|NCT00631124|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6497204|NCT00631124|Estradiol|estradiol|mesh-list
6497205|NCT00631124|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6497206|NCT00631124|Estrogens|estrogens|mesh-ancestor
6497207|NCT00631124|Hormones|hormones|mesh-ancestor
6497208|NCT00631124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6497209|NCT00631124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497210|NCT00631124|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6497211|NCT00631124|Contraceptive Agents|contraceptive agents|mesh-ancestor
6497212|NCT00631124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6497213|NCT00631124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6497214|NCT00631124|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6497215|NCT00631124|Hormone Antagonists|hormone antagonists|mesh-ancestor
6497216|NCT00631124|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6497217|NCT00631124|Diuretics|diuretics|mesh-ancestor
6497218|NCT00631124|Natriuretic Agents|natriuretic agents|mesh-ancestor
6497219|NCT00631150|Levetiracetam|levetiracetam|mesh-list
6497220|NCT00631150|Anticonvulsants|anticonvulsants|mesh-ancestor
6497221|NCT00631150|Nootropic Agents|nootropic agents|mesh-ancestor
6497222|NCT00631202|Epoetin Alfa|epoetin alfa|mesh-list
6497223|NCT00631202|Hematinics|hematinics|mesh-ancestor
6497224|NCT00631228|Everolimus|everolimus|mesh-list
6497225|NCT00631228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6497226|NCT00631228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6497227|NCT00631228|Immunologic Factors|immunologic factors|mesh-ancestor
6497228|NCT00631228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497229|NCT00631501|Doxycycline|doxycycline|mesh-list
6497230|NCT00631501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6497231|NCT00631501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6497232|NCT00631501|Antimalarials|antimalarials|mesh-ancestor
6497233|NCT00631501|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6497234|NCT00631501|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6497235|NCT00631514|Acetaminophen|acetaminophen|mesh-list
6497236|NCT00631514|Ibuprofen|ibuprofen|mesh-list
6497237|NCT00631514|Piroxicam|piroxicam|mesh-list
6497238|NCT00631514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6497239|NCT00631514|Analgesics|analgesics|mesh-ancestor
6497240|NCT00631514|Sensory System Agents|sensory system agents|mesh-ancestor
6497241|NCT00631514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6497242|NCT00631514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497243|NCT00631514|Antipyretics|antipyretics|mesh-ancestor
6497244|NCT00631514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6497245|NCT00631514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6497246|NCT00631514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6497247|NCT00631514|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6497248|NCT00631514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6497249|NCT00631514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497250|NCT00631527|Sunitinib|sunitinib|mesh-list
6497251|NCT00631527|Leuprolide|leuprolide|mesh-list
6497252|NCT00631527|Goserelin|goserelin|mesh-list
6497253|NCT00631527|Bicalutamide|bicalutamide|mesh-list
6497254|NCT00631527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6675962|NCT01578434|Antacids|antacids|mesh-ancestor
6497255|NCT00631527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6675963|NCT01578434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5702164|NCT03340779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5702165|NCT03340779|Adrenergic Agents|adrenergic agents|mesh-ancestor
5702166|NCT03340779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5702167|NCT03340779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5702168|NCT03340779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702169|NCT03340779|Sympathomimetics|sympathomimetics|mesh-ancestor
5702170|NCT03340779|Autonomic Agents|autonomic agents|mesh-ancestor
5702171|NCT03340779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5702172|NCT03340779|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5702173|NCT03340779|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5702174|NCT03340779|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5702175|NCT03340779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5702176|NCT03340779|Protective Agents|protective agents|mesh-ancestor
6215110|NCT02229461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6215111|NCT02229461|Antipyretics|antipyretics|mesh-ancestor
6215112|NCT02229461|Gout Suppressants|gout suppressants|mesh-ancestor
6215113|NCT02229539|Diphenhydramine|diphenhydramine|mesh-list
6215114|NCT02229539|Promethazine|promethazine|mesh-list
6215115|NCT02229539|Lidocaine|lidocaine|mesh-list
6215116|NCT02229539|Doxepin|doxepin|mesh-list
6215117|NCT02229539|Antacids|antacids|mesh-list
6215118|NCT02229539|Anesthetics, Local|anesthetics, local|mesh-ancestor
6215119|NCT02229539|Anesthetics|anesthetics|mesh-ancestor
6215120|NCT02229539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6215121|NCT02229539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215122|NCT02229539|Sensory System Agents|sensory system agents|mesh-ancestor
6215123|NCT02229539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6215124|NCT02229539|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6215125|NCT02229539|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6215126|NCT02229539|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6215127|NCT02229539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6215128|NCT02229539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215129|NCT02229539|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6215130|NCT02229539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6215131|NCT02229539|Antiemetics|antiemetics|mesh-ancestor
6215132|NCT02229539|Autonomic Agents|autonomic agents|mesh-ancestor
6215133|NCT02229539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6215134|NCT02229539|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6215135|NCT02229539|Histamine Antagonists|histamine antagonists|mesh-ancestor
6215136|NCT02229539|Histamine Agents|histamine agents|mesh-ancestor
6215137|NCT02229539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5702181|NCT03340753|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
5702182|NCT03340753|Mineralocorticoids|mineralocorticoids|mesh-list
5702183|NCT03340753|Hormone Antagonists|hormone antagonists|mesh-ancestor
5702184|NCT03340753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5702185|NCT03340753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702186|NCT03340753|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5702187|NCT03340753|Diuretics|diuretics|mesh-ancestor
5702188|NCT03340753|Natriuretic Agents|natriuretic agents|mesh-ancestor
5702189|NCT03340753|Hormones|hormones|mesh-ancestor
5702190|NCT03340740|Cetirizine|cetirizine|mesh-list
5702191|NCT03340740|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5702192|NCT03340740|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6215138|NCT02229539|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6215139|NCT02229539|Antipruritics|antipruritics|mesh-ancestor
6215140|NCT02229539|Dermatologic Agents|dermatologic agents|mesh-ancestor
6215141|NCT02229539|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6215142|NCT02229539|Antidepressive Agents|antidepressive agents|mesh-ancestor
6215143|NCT02229539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6215144|NCT02230306|Vemurafenib|vemurafenib|mesh-list
6215145|NCT02230306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6215146|NCT02230306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6215147|NCT02230306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6215148|NCT02230306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215149|NCT02230332|Alendronate|alendronate|mesh-list
6215150|NCT02230332|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6215151|NCT02230332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215152|NCT02230527|Clopidogrel|clopidogrel|mesh-list
6215153|NCT02230527|Ticagrelor|ticagrelor|mesh-list
6215154|NCT02230527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6215155|NCT02230527|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6215156|NCT02230527|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6215157|NCT02230527|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6215158|NCT02230527|Purinergic Agents|purinergic agents|mesh-ancestor
6215159|NCT02230527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5702193|NCT03340740|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5702194|NCT03340740|Histamine Antagonists|histamine antagonists|mesh-ancestor
6215160|NCT02230527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215161|NCT02230527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215162|NCT02230696|Fluticasone|fluticasone|mesh-list
6215163|NCT02230696|Xhance|xhance|mesh-list
6215164|NCT02230696|Azelastine|azelastine|mesh-list
6215165|NCT02230696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6215166|NCT02230696|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6215167|NCT02230696|Autonomic Agents|autonomic agents|mesh-ancestor
6215168|NCT02230696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6215169|NCT02230696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215170|NCT02230696|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6215171|NCT02230696|Respiratory System Agents|respiratory system agents|mesh-ancestor
6215172|NCT02230696|Dermatologic Agents|dermatologic agents|mesh-ancestor
6215173|NCT02230696|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6497256|NCT00631527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6497257|NCT00631527|Growth Substances|growth substances|mesh-ancestor
6497258|NCT00631527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497259|NCT00631527|Growth Inhibitors|growth inhibitors|mesh-ancestor
6497260|NCT00631527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6497261|NCT00631527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6497262|NCT00631527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918449|NCT04991896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6215174|NCT02230696|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6215175|NCT02230696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6215176|NCT02230696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215177|NCT02230696|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6215178|NCT02230696|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6215179|NCT02230696|Histamine Antagonists|histamine antagonists|mesh-ancestor
6215180|NCT02230696|Histamine Agents|histamine agents|mesh-ancestor
6215181|NCT02230696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6215182|NCT02230904|Rotigotine|rotigotine|mesh-list
6215183|NCT02230904|Dopamine Agonists|dopamine agonists|mesh-ancestor
6215184|NCT02230904|Dopamine Agents|dopamine agents|mesh-ancestor
6215185|NCT02230904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6215186|NCT02230904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215187|NCT02230904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215188|NCT02230956|Botulinum Toxins|botulinum toxins|mesh-list
6215189|NCT02230956|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6215190|NCT02230956|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6215191|NCT02230956|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6215192|NCT02230956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6215193|NCT02230956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215194|NCT02230956|Cholinergic Agents|cholinergic agents|mesh-ancestor
6215195|NCT02230956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6215196|NCT02230956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215197|NCT02230956|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6215198|NCT02230956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6215199|NCT02230995|Metformin|metformin|mesh-list
6215200|NCT02230995|Empagliflozin|empagliflozin|mesh-list
6215201|NCT02230995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6215202|NCT02230995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215203|NCT02230995|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6215204|NCT02230995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215205|NCT02231086|Leucovorin|leucovorin|mesh-list
6215206|NCT02231086|Fluorouracil|fluorouracil|mesh-list
6215207|NCT02231086|Capecitabine|capecitabine|mesh-list
6215208|NCT02231086|Oxaliplatin|oxaliplatin|mesh-list
6215209|NCT02231086|Antimetabolites|antimetabolites|mesh-ancestor
6215210|NCT02231086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215211|NCT02231086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6215212|NCT02231086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6215213|NCT02231086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5702195|NCT03340740|Histamine Agents|histamine agents|mesh-ancestor
5702196|NCT03340740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5702197|NCT03340740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5702198|NCT03340740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702199|NCT03340701|Progesterone|progesterone|mesh-list
5702200|NCT03340701|Progestins|progestins|mesh-ancestor
5702201|NCT03340701|Hormones|hormones|mesh-ancestor
5702202|NCT03340701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5702203|NCT03340701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215214|NCT02231086|Immunologic Factors|immunologic factors|mesh-ancestor
6215215|NCT02231086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215216|NCT02231086|Antidotes|antidotes|mesh-ancestor
6215217|NCT02231086|Protective Agents|protective agents|mesh-ancestor
6215218|NCT02231086|Vitamin B Complex|vitamin b complex|mesh-ancestor
6215219|NCT02231086|Vitamins|vitamins|mesh-ancestor
6215220|NCT02231086|Micronutrients|micronutrients|mesh-ancestor
6215221|NCT02231164|Docetaxel|docetaxel|mesh-list
6215222|NCT02231164|Nintedanib|nintedanib|mesh-list
6215223|NCT02231164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6215224|NCT02231164|Tubulin Modulators|tubulin modulators|mesh-ancestor
6215225|NCT02231164|Antimitotic Agents|antimitotic agents|mesh-ancestor
6215226|NCT02231164|Mitosis Modulators|mitosis modulators|mesh-ancestor
6215227|NCT02231164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215228|NCT02231164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6215229|NCT02231164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6215230|NCT02231177|Tiotropium Bromide|tiotropium bromide|mesh-list
6215231|NCT02231177|Olodaterol|olodaterol|mesh-list
6215232|NCT02231177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6215233|NCT02231177|Autonomic Agents|autonomic agents|mesh-ancestor
6215234|NCT02231177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6215235|NCT02231177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215236|NCT02231177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6215237|NCT02231177|Respiratory System Agents|respiratory system agents|mesh-ancestor
6215238|NCT02231177|Parasympatholytics|parasympatholytics|mesh-ancestor
6215239|NCT02231177|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6215240|NCT02231177|Cholinergic Agents|cholinergic agents|mesh-ancestor
6215241|NCT02231177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6215242|NCT02231177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215243|NCT02231749|Nivolumab|nivolumab|mesh-list
6215244|NCT02231749|Ipilimumab|ipilimumab|mesh-list
6215245|NCT02231749|Sunitinib|sunitinib|mesh-list
6215246|NCT02231749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6215247|NCT02231749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6215248|NCT02231749|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6215249|NCT02231749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215250|NCT02231749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6215251|NCT02231749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6215252|NCT02231749|Growth Substances|growth substances|mesh-ancestor
6215253|NCT02231749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215254|NCT02231749|Growth Inhibitors|growth inhibitors|mesh-ancestor
6215255|NCT02231749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6215256|NCT02231749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6497263|NCT00631527|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5702204|NCT03340675|Ifetroban|ifetroban|mesh-list
5702205|NCT03340675|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5702206|NCT03340662|Itraconazole|itraconazole|mesh-list
5702207|NCT03340662|Rifampin|rifampin|mesh-list
5702208|NCT03340662|Fluvoxamine|fluvoxamine|mesh-list
5702209|NCT03340662|Antifungal Agents|antifungal agents|mesh-ancestor
5702210|NCT03340662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5702211|NCT03340662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5702212|NCT03340662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5702213|NCT03340662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5702214|NCT03340662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5702215|NCT03340662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5702216|NCT03340662|Hormone Antagonists|hormone antagonists|mesh-ancestor
5702217|NCT03340662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5702218|NCT03340662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702219|NCT03340662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5918450|NCT04991896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5918451|NCT04991181|Zamicastat|zamicastat|mesh-list
5918452|NCT04991181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5918453|NCT04991181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918454|NCT04991324|Vitamin D|vitamin d|mesh-list
5918455|NCT04991324|Cholecalciferol|cholecalciferol|mesh-list
5918456|NCT04991324|Vitamins|vitamins|mesh-ancestor
5918457|NCT04991324|Micronutrients|micronutrients|mesh-ancestor
5918458|NCT04991324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918459|NCT04991324|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5918460|NCT04991324|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5918461|NCT04991402|Dolutegravir|dolutegravir|mesh-list
5918462|NCT04991402|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6215257|NCT02231918|Pramipexole|pramipexole|mesh-list
6215258|NCT02231918|Antioxidants|antioxidants|mesh-ancestor
6242926|NCT02658149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6215259|NCT02231918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215260|NCT02231918|Protective Agents|protective agents|mesh-ancestor
6215261|NCT02231918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215262|NCT02231918|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6215263|NCT02231918|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6215264|NCT02231918|Dopamine Agonists|dopamine agonists|mesh-ancestor
6215265|NCT02231918|Dopamine Agents|dopamine agents|mesh-ancestor
6215266|NCT02231918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6215267|NCT02232061|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6215268|NCT02232061|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5702220|NCT03340662|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6215269|NCT02232061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215270|NCT02232061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6215271|NCT02232061|Immunologic Factors|immunologic factors|mesh-ancestor
6215272|NCT02232061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215273|NCT02232087|Fluticasone|fluticasone|mesh-list
6215274|NCT02232087|Xhance|xhance|mesh-list
6215275|NCT02232087|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6215276|NCT02232087|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6215277|NCT02232087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6215278|NCT02232087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6215279|NCT02232087|Autonomic Agents|autonomic agents|mesh-ancestor
6215280|NCT02232087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6215281|NCT02232087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215282|NCT02232087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6215283|NCT02232087|Respiratory System Agents|respiratory system agents|mesh-ancestor
6215284|NCT02232087|Dermatologic Agents|dermatologic agents|mesh-ancestor
6215285|NCT02232087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6215286|NCT02232087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6215287|NCT02232087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6215288|NCT02232087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6215289|NCT02232087|Adrenergic Agents|adrenergic agents|mesh-ancestor
6215290|NCT02232087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6215291|NCT02232087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215292|NCT02232087|Glucocorticoids|glucocorticoids|mesh-ancestor
6215293|NCT02232087|Hormones|hormones|mesh-ancestor
6215294|NCT02232087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6215295|NCT02232087|Sympathomimetics|sympathomimetics|mesh-ancestor
6215296|NCT02232178|Bupivacaine|bupivacaine|mesh-list
6215297|NCT02232178|Anesthetics, Local|anesthetics, local|mesh-ancestor
6215298|NCT02232178|Anesthetics|anesthetics|mesh-ancestor
6215299|NCT02232178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6215300|NCT02232178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215301|NCT02232178|Sensory System Agents|sensory system agents|mesh-ancestor
6215302|NCT02232178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6215303|NCT02232243|Hydroxychloroquine|hydroxychloroquine|mesh-list
6215304|NCT02232243|Antimalarials|antimalarials|mesh-ancestor
6215305|NCT02232243|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6215306|NCT02232243|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6215307|NCT02232243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6215308|NCT02232243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6215309|NCT02232243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215310|NCT02232243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6215311|NCT02232802|Enoxaparin|enoxaparin|mesh-list
6215312|NCT02232802|Enoxaparin sodium|enoxaparin sodium|mesh-list
6215313|NCT02232802|Anticoagulants|anticoagulants|mesh-ancestor
6215314|NCT02232802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6215315|NCT02232802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6215316|NCT02232802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215317|NCT02233101|Tranexamic Acid|tranexamic acid|mesh-list
6215318|NCT02233101|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6215319|NCT02233101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6215320|NCT02233101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215321|NCT02233101|Hemostatics|hemostatics|mesh-ancestor
6215322|NCT02233101|Coagulants|coagulants|mesh-ancestor
6215323|NCT02233296|Lasmiditan|lasmiditan|mesh-list
6497264|NCT00631527|Fertility Agents|fertility agents|mesh-ancestor
6497265|NCT00631527|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6497266|NCT00631527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6497267|NCT00631527|Androgen Antagonists|androgen antagonists|mesh-ancestor
6497268|NCT00631527|Hormone Antagonists|hormone antagonists|mesh-ancestor
5702221|NCT03340662|Antitubercular Agents|antitubercular agents|mesh-ancestor
6215324|NCT02233296|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6215325|NCT02233296|Serotonin Agents|serotonin agents|mesh-ancestor
6242927|NCT02658149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5702222|NCT03340662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5702223|NCT03340662|Leprostatic Agents|leprostatic agents|mesh-ancestor
5702224|NCT03340662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5702225|NCT03340662|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5702226|NCT03340662|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5702227|NCT03340662|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5702228|NCT03340662|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5702229|NCT03340662|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5702230|NCT03340662|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5702231|NCT03340662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5702232|NCT03340662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6215326|NCT02233296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6215327|NCT02233296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215328|NCT02233296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215329|NCT02233309|Anesthetics|anesthetics|mesh-list
6215330|NCT02233309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6215331|NCT02233309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215332|NCT02233543|Glycopyrrolate|glycopyrrolate|mesh-list
6215333|NCT02233543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6215334|NCT02233543|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6215335|NCT02233543|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6215336|NCT02233543|Cholinergic Agents|cholinergic agents|mesh-ancestor
6215337|NCT02233543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6215338|NCT02233543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215339|NCT02233543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215340|NCT02233647|Cocaine|cocaine|mesh-list
6215341|NCT02233647|Anesthetics, Local|anesthetics, local|mesh-ancestor
6215342|NCT02233647|Anesthetics|anesthetics|mesh-ancestor
6215343|NCT02233647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6215344|NCT02233647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215345|NCT02233647|Sensory System Agents|sensory system agents|mesh-ancestor
6215346|NCT02233647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6215347|NCT02233647|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6215348|NCT02233647|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6215349|NCT02233647|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6215350|NCT02233647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6215351|NCT02233647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215352|NCT02233647|Dopamine Agents|dopamine agents|mesh-ancestor
6215353|NCT02233647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6215354|NCT02233751|Methyltestosterone|methyltestosterone|mesh-list
6215355|NCT02233751|Testosterone|testosterone|mesh-list
6215356|NCT02233751|Testosterone undecanoate|testosterone undecanoate|mesh-list
6215357|NCT02233751|Testosterone enanthate|testosterone enanthate|mesh-list
6215358|NCT02233751|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6215359|NCT02233751|Androgens|androgens|mesh-ancestor
6215360|NCT02233751|Hormones|hormones|mesh-ancestor
6215361|NCT02233751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6215362|NCT02233751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215363|NCT02233751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6215364|NCT02233751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6215365|NCT02233751|Anabolic Agents|anabolic agents|mesh-ancestor
6215366|NCT02233803|Budesonide|budesonide|mesh-list
6215367|NCT02233803|Albuterol|albuterol|mesh-list
6215368|NCT02233803|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6215369|NCT02233803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6215370|NCT02233803|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6215371|NCT02233803|Autonomic Agents|autonomic agents|mesh-ancestor
6215372|NCT02233803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5964049|NCT04595877|Analgesics|analgesics|mesh-ancestor
5964050|NCT04595877|Sensory System Agents|sensory system agents|mesh-ancestor
5964051|NCT04595877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5964052|NCT04595877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964053|NCT04595877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5964054|NCT04595877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5964055|NCT04595877|Antipyretics|antipyretics|mesh-ancestor
5964056|NCT04595877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5964057|NCT04595877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964058|NCT04595617|Antibodies|antibodies|mesh-list
5964059|NCT04595617|Immunologic Factors|immunologic factors|mesh-ancestor
5964060|NCT04595617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964061|NCT04595318|Varenicline|varenicline|mesh-list
5964062|NCT04595318|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5702233|NCT03340662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5702234|NCT03340662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5702235|NCT03340662|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5702236|NCT03340662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5702237|NCT03340662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5702238|NCT03340662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5702239|NCT03340662|Serotonin Agents|serotonin agents|mesh-ancestor
5702240|NCT03340662|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5702241|NCT03340662|Antidepressive Agents|antidepressive agents|mesh-ancestor
5702242|NCT03340662|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5702243|NCT03340662|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5702244|NCT03340597|Olorofim|olorofim|mesh-list
5702245|NCT03340597|Antifungal Agents|antifungal agents|mesh-ancestor
6215373|NCT02233803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215374|NCT02233803|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6215375|NCT02233803|Respiratory System Agents|respiratory system agents|mesh-ancestor
6215376|NCT02233803|Glucocorticoids|glucocorticoids|mesh-ancestor
6215377|NCT02233803|Hormones|hormones|mesh-ancestor
6215378|NCT02233803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6215379|NCT02233803|Tocolytic Agents|tocolytic agents|mesh-ancestor
6215380|NCT02233803|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6215381|NCT02233803|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6215382|NCT02233803|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5702246|NCT03340597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5702247|NCT03340558|Atezolizumab|atezolizumab|mesh-list
5702248|NCT03340558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5702249|NCT03340493|Tenecteplase|tenecteplase|mesh-list
5702250|NCT03340493|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5702251|NCT03340493|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5702252|NCT03340493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5702253|NCT03340376|Doxorubicin|doxorubicin|mesh-list
5702254|NCT03340376|Atezolizumab|atezolizumab|mesh-list
5702255|NCT03340376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5702256|NCT03340376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5702257|NCT03340376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5702258|NCT03340376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5702259|NCT03340376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5702260|NCT03340376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5702261|NCT03340168|Bisphenol A|bisphenol a|mesh-list
5702262|NCT03340168|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
5702263|NCT03340168|Estrogens|estrogens|mesh-ancestor
5702264|NCT03340168|Hormones|hormones|mesh-ancestor
5702265|NCT03340168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5702266|NCT03340168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702267|NCT03340168|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5702268|NCT03340168|Antioxidants|antioxidants|mesh-ancestor
5702269|NCT03340168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5702270|NCT03340168|Protective Agents|protective agents|mesh-ancestor
5702271|NCT03340129|Nivolumab|nivolumab|mesh-list
5702272|NCT03340129|Ipilimumab|ipilimumab|mesh-list
5702273|NCT03340129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5702274|NCT03340129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5702275|NCT03340129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6215383|NCT02233803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6215384|NCT02233803|Adrenergic Agents|adrenergic agents|mesh-ancestor
6215385|NCT02233803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6215386|NCT02233803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5702276|NCT03340129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5702277|NCT03339921|Botulinum Toxins|botulinum toxins|mesh-list
5702278|NCT03339921|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5702279|NCT03339921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5702280|NCT03339921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5702281|NCT03339921|Cholinergic Agents|cholinergic agents|mesh-ancestor
6215387|NCT02233998|Listerine|listerine|mesh-list
6215388|NCT02233998|Sodium Fluoride|sodium fluoride|mesh-list
6215389|NCT02233998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6215390|NCT02233998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6215391|NCT02233998|Cariostatic Agents|cariostatic agents|mesh-ancestor
6215392|NCT02233998|Protective Agents|protective agents|mesh-ancestor
6215393|NCT02233998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215394|NCT02234115|Leuprolide|leuprolide|mesh-list
6215395|NCT02234115|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6215396|NCT02234115|Fertility Agents|fertility agents|mesh-ancestor
5702282|NCT03339921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5702283|NCT03339921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702284|NCT03339804|Cyclophosphamide|cyclophosphamide|mesh-list
5702285|NCT03339804|Doxorubicin|doxorubicin|mesh-list
5702286|NCT03339804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5702287|NCT03339804|Immunologic Factors|immunologic factors|mesh-ancestor
6215397|NCT02234115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6215398|NCT02234115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215399|NCT02234115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6215400|NCT02234115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6215401|NCT02234141|Selonsertib|selonsertib|mesh-list
6215402|NCT02234141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6215403|NCT02234141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6215404|NCT02234141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215405|NCT02234323|Factor VIII|factor viii|mesh-list
6215406|NCT02234323|Coagulants|coagulants|mesh-ancestor
6215407|NCT02234362|Vortioxetine|vortioxetine|mesh-list
6215408|NCT02234362|Antidepressive Agents|antidepressive agents|mesh-ancestor
6215409|NCT02234362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6215410|NCT02234362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6215411|NCT02234362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6215412|NCT02234362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6215413|NCT02234362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215414|NCT02234362|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6215415|NCT02234362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6215416|NCT02234362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6215417|NCT02234362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215418|NCT02234362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6215419|NCT02234362|Serotonin Agents|serotonin agents|mesh-ancestor
6215420|NCT02234362|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6215421|NCT02234362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6215422|NCT02234362|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6215423|NCT02234362|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6215424|NCT02234427|Aspirin|aspirin|mesh-list
6215425|NCT02234427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6215426|NCT02234427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6215427|NCT02234427|Analgesics|analgesics|mesh-ancestor
6215428|NCT02234427|Sensory System Agents|sensory system agents|mesh-ancestor
6215429|NCT02234427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6215430|NCT02234427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215431|NCT02234427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6215432|NCT02234427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6215433|NCT02234427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6215434|NCT02234427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6215435|NCT02234427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215436|NCT02234427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6215437|NCT02234427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6215438|NCT02234427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6215439|NCT02234427|Antipyretics|antipyretics|mesh-ancestor
6215440|NCT02234570|Oxfendazole|oxfendazole|mesh-list
6215441|NCT02234570|Anthelmintics|anthelmintics|mesh-ancestor
6215442|NCT02234570|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6215443|NCT02234570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6215444|NCT02234570|Antinematodal Agents|antinematodal agents|mesh-ancestor
6215445|NCT02234596|Nintedanib|nintedanib|mesh-list
6215446|NCT02234596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6215447|NCT02234596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6215448|NCT02234596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6215449|NCT02234596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215450|NCT02234752|Memantine|memantine|mesh-list
6215451|NCT02234752|Galantamine|galantamine|mesh-list
6215452|NCT02234752|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6215453|NCT02234752|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6215454|NCT02234752|Dopamine Agents|dopamine agents|mesh-ancestor
6215455|NCT02234752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6215456|NCT02234752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215457|NCT02234752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215458|NCT02234752|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6215459|NCT02234752|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6215460|NCT02234752|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6215461|NCT02234752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6215462|NCT02234752|Cholinergic Agents|cholinergic agents|mesh-ancestor
6215463|NCT02234752|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5702288|NCT03339804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215464|NCT02234752|Autonomic Agents|autonomic agents|mesh-ancestor
6215465|NCT02234752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6215466|NCT02234752|Nootropic Agents|nootropic agents|mesh-ancestor
6215467|NCT02235064|Sertraline|sertraline|mesh-list
6215468|NCT02235064|Antidepressive Agents|antidepressive agents|mesh-ancestor
6215469|NCT02235064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6215470|NCT02235064|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6215471|NCT02235064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6215472|NCT02235064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6215473|NCT02235064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215474|NCT02235064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6215475|NCT02235064|Serotonin Agents|serotonin agents|mesh-ancestor
6215476|NCT02235064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215477|NCT02235077|Spironolactone|spironolactone|mesh-list
6215478|NCT02235077|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6215479|NCT02235077|Hormone Antagonists|hormone antagonists|mesh-ancestor
6215480|NCT02235077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6215481|NCT02235077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215482|NCT02235077|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6497269|NCT00631527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6497270|NCT00631579|Rasburicase|rasburicase|mesh-list
6497271|NCT00631579|Gout Suppressants|gout suppressants|mesh-ancestor
6497272|NCT00631579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6497273|NCT00631592|Dolutegravir|dolutegravir|mesh-list
6497274|NCT00631592|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6497275|NCT00631592|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6497276|NCT00631592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6497277|NCT00631592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497278|NCT00631592|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6497279|NCT00631592|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6497280|NCT00631592|Antiviral Agents|antiviral agents|mesh-ancestor
6497281|NCT00631592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6497282|NCT00631618|Sunitinib|sunitinib|mesh-list
6497283|NCT00631618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6497284|NCT00631618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6497285|NCT00631618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6497286|NCT00631618|Growth Substances|growth substances|mesh-ancestor
6497287|NCT00631618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497288|NCT00631618|Growth Inhibitors|growth inhibitors|mesh-ancestor
6497289|NCT00631618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6497290|NCT00631618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6497291|NCT00631618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497292|NCT00631631|Mifamurtide|mifamurtide|mesh-list
6497293|NCT00631631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6497294|NCT00631631|Immunologic Factors|immunologic factors|mesh-ancestor
6497295|NCT00631631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497296|NCT00631722|Haloperidol|haloperidol|mesh-list
6497297|NCT00631722|Haloperidol decanoate|haloperidol decanoate|mesh-list
6497298|NCT00631722|Antiemetics|antiemetics|mesh-ancestor
6497299|NCT00631722|Autonomic Agents|autonomic agents|mesh-ancestor
6497300|NCT00631722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6497301|NCT00631722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497302|NCT00631722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6497303|NCT00631722|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6497304|NCT00631722|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6497305|NCT00631722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6497306|NCT00631722|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6497307|NCT00631722|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6497308|NCT00631722|Dopamine Agents|dopamine agents|mesh-ancestor
6497309|NCT00631722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6497310|NCT00631722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497311|NCT00631722|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6524407|NCT00758004|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6524408|NCT00758004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6524409|NCT00758004|Antimetabolites|antimetabolites|mesh-ancestor
6524410|NCT00758004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524411|NCT00758004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6524412|NCT00758004|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6524413|NCT00758004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6524414|NCT00758030|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6524415|NCT00758030|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6524416|NCT00758030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6524417|NCT00758030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5702289|NCT03339804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5702290|NCT03339804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5702291|NCT03339804|Alkylating Agents|alkylating agents|mesh-ancestor
5702292|NCT03339804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5702293|NCT03339804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5702294|NCT03339804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5702295|NCT03339804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5702296|NCT03339804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5702297|NCT03339804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5702298|NCT03339804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5721075|NCT03208452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5721076|NCT03208452|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5721077|NCT03208452|Anticonvulsants|anticonvulsants|mesh-ancestor
5721078|NCT03208452|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5721079|NCT03208452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5721080|NCT03208452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721081|NCT03208452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5721082|NCT03208452|Tocolytic Agents|tocolytic agents|mesh-ancestor
5721083|NCT03208452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5721084|NCT03208465|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5721085|NCT03208465|Empagliflozin|empagliflozin|mesh-list
5721086|NCT03208465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5721087|NCT03208465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721088|NCT03208465|Incretins|incretins|mesh-ancestor
5721089|NCT03208465|Hormones|hormones|mesh-ancestor
5721090|NCT03208465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5721091|NCT03208465|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6215483|NCT02235077|Diuretics|diuretics|mesh-ancestor
6215484|NCT02235077|Natriuretic Agents|natriuretic agents|mesh-ancestor
6215485|NCT02235298|Metformin|metformin|mesh-list
6215486|NCT02235298|Dapagliflozin|dapagliflozin|mesh-list
6215487|NCT02235298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6215488|NCT02235298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215489|NCT02235298|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6215490|NCT02235298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215491|NCT02235311|Pantoprazole|pantoprazole|mesh-list
6215492|NCT02235311|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6215493|NCT02235311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6215494|NCT02235311|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6215495|NCT02235311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6215496|NCT02235311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242928|NCT02658149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6242929|NCT02658149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6242930|NCT02658240|Epinephrine|epinephrine|mesh-list
6242931|NCT02658240|Ropivacaine|ropivacaine|mesh-list
6242932|NCT02658240|Anesthetics, Local|anesthetics, local|mesh-ancestor
6242933|NCT02658240|Anesthetics|anesthetics|mesh-ancestor
6242934|NCT02658240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6242935|NCT02658240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6242936|NCT02658240|Sensory System Agents|sensory system agents|mesh-ancestor
6242937|NCT02658240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6242938|NCT02658240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6242939|NCT02658240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6242940|NCT02658240|Adrenergic Agents|adrenergic agents|mesh-ancestor
6242941|NCT02658240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6242942|NCT02658240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242943|NCT02658240|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6242944|NCT02658240|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6242945|NCT02658240|Autonomic Agents|autonomic agents|mesh-ancestor
6242946|NCT02658240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6242947|NCT02658240|Respiratory System Agents|respiratory system agents|mesh-ancestor
6242948|NCT02658240|Mydriatics|mydriatics|mesh-ancestor
6242949|NCT02658240|Sympathomimetics|sympathomimetics|mesh-ancestor
6242950|NCT02658240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6242951|NCT02658461|Trastuzumab|trastuzumab|mesh-list
6242952|NCT02658461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6242953|NCT02658461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6242954|NCT02658487|Cytarabine|cytarabine|mesh-list
6242955|NCT02658487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6242956|NCT02658487|Antimetabolites|antimetabolites|mesh-ancestor
6242957|NCT02658487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242958|NCT02658487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6242959|NCT02658487|Antiviral Agents|antiviral agents|mesh-ancestor
6242960|NCT02658487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6215497|NCT02235987|Octreotide|octreotide|mesh-list
6215498|NCT02235987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6215499|NCT02235987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6215500|NCT02235987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6215501|NCT02236130|Acetaminophen|acetaminophen|mesh-list
6215502|NCT02236130|Morphine|morphine|mesh-list
6215503|NCT02236130|Hydrocodone|hydrocodone|mesh-list
6215504|NCT02236130|Analgesics|analgesics|mesh-list
6215505|NCT02236130|Anesthetics|anesthetics|mesh-list
6215506|NCT02236130|Ropivacaine|ropivacaine|mesh-list
6215507|NCT02236130|Anesthetics, Local|anesthetics, local|mesh-list
6215508|NCT02236130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6215509|NCT02236130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215510|NCT02236130|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6215511|NCT02236130|Narcotics|narcotics|mesh-ancestor
6215512|NCT02236130|Sensory System Agents|sensory system agents|mesh-ancestor
6215513|NCT02236130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6215514|NCT02236130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5702299|NCT03339752|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5702300|NCT03339752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5702301|NCT03339752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5702302|NCT03339752|Antimetabolites|antimetabolites|mesh-ancestor
5702303|NCT03339752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5702304|NCT03339752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5702305|NCT03339752|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5702306|NCT03339752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6215515|NCT02236130|Antipyretics|antipyretics|mesh-ancestor
6215516|NCT02236130|Antitussive Agents|antitussive agents|mesh-ancestor
6215517|NCT02236130|Respiratory System Agents|respiratory system agents|mesh-ancestor
6215518|NCT02236520|Chlorthalidone|chlorthalidone|mesh-list
6215519|NCT02236520|Spironolactone|spironolactone|mesh-list
6215520|NCT02236520|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6215521|NCT02236520|Hormone Antagonists|hormone antagonists|mesh-ancestor
6215522|NCT02236520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6215523|NCT02236520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702307|NCT03339700|Gemcitabine|gemcitabine|mesh-list
5702308|NCT03339700|Cyclophosphamide|cyclophosphamide|mesh-list
5702309|NCT03339700|Busulfan|busulfan|mesh-list
5702310|NCT03339700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5702311|NCT03339700|Immunologic Factors|immunologic factors|mesh-ancestor
6215524|NCT02236520|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6215525|NCT02236520|Diuretics|diuretics|mesh-ancestor
6215526|NCT02236520|Natriuretic Agents|natriuretic agents|mesh-ancestor
6215527|NCT02236520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6215528|NCT02236520|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6215529|NCT02236520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6215530|NCT02236520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215531|NCT02236611|Glycopyrrolate|glycopyrrolate|mesh-list
6215532|NCT02236611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6215533|NCT02236611|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6215534|NCT02236611|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6215535|NCT02236611|Cholinergic Agents|cholinergic agents|mesh-ancestor
6215536|NCT02236611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6215537|NCT02236611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215538|NCT02236611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215539|NCT02236988|Thalidomide|thalidomide|mesh-list
6215540|NCT02236988|Apremilast|apremilast|mesh-list
6215541|NCT02236988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6215542|NCT02236988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6215543|NCT02236988|Analgesics|analgesics|mesh-ancestor
6215544|NCT02236988|Sensory System Agents|sensory system agents|mesh-ancestor
6215545|NCT02236988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6215546|NCT02236988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215547|NCT02236988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6215548|NCT02236988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6215549|NCT02236988|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6215550|NCT02236988|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6215551|NCT02236988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6215552|NCT02236988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215553|NCT02236988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6215554|NCT02236988|Immunologic Factors|immunologic factors|mesh-ancestor
6215555|NCT02236988|Leprostatic Agents|leprostatic agents|mesh-ancestor
6215556|NCT02236988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6215557|NCT02236988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6215558|NCT02236988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6497312|NCT00631813|Prucalopride|prucalopride|mesh-list
5702312|NCT03339700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702313|NCT03339700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5702314|NCT03339700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5702315|NCT03339700|Alkylating Agents|alkylating agents|mesh-ancestor
5702316|NCT03339700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5702317|NCT03339700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6215559|NCT02236988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6215560|NCT02236988|Growth Substances|growth substances|mesh-ancestor
6215561|NCT02236988|Growth Inhibitors|growth inhibitors|mesh-ancestor
6215562|NCT02236988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6215563|NCT02237157|Gemcitabine|gemcitabine|mesh-list
6215564|NCT02237157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6215565|NCT02237157|Antimetabolites|antimetabolites|mesh-ancestor
6215566|NCT02237157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215567|NCT02237157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6215568|NCT02237157|Antiviral Agents|antiviral agents|mesh-ancestor
6215569|NCT02237157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6215570|NCT02237157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6215571|NCT02237157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6215572|NCT02237157|Immunologic Factors|immunologic factors|mesh-ancestor
6215573|NCT02237157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215574|NCT02237196|Immunologic Factors|immunologic factors|mesh-list
6215575|NCT02237196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215576|NCT02237417|Aripiprazole|aripiprazole|mesh-list
6215577|NCT02237417|Antipsychotic Agents|antipsychotic agents|mesh-list
6215578|NCT02237417|Antidepressive Agents|antidepressive agents|mesh-ancestor
6215579|NCT02237417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6215580|NCT02237417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6215581|NCT02237417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6215582|NCT02237417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215583|NCT02237417|Dopamine Agonists|dopamine agonists|mesh-ancestor
6215584|NCT02237417|Dopamine Agents|dopamine agents|mesh-ancestor
6215585|NCT02237417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6215586|NCT02237417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215587|NCT02237417|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6215588|NCT02237417|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6215589|NCT02237417|Serotonin Agents|serotonin agents|mesh-ancestor
6215590|NCT02237417|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6215591|NCT02237417|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6215592|NCT02237417|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6215593|NCT02237417|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6215594|NCT02237898|Carbon Monoxide|carbon monoxide|mesh-list
6215595|NCT02237898|Antimetabolites|antimetabolites|mesh-ancestor
6215596|NCT02237898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215597|NCT02237898|Gasotransmitters|gasotransmitters|mesh-ancestor
6215598|NCT02237898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6215599|NCT02237898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215600|NCT02237950|Metronidazole|metronidazole|mesh-list
6215601|NCT02237950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6215602|NCT02237950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6215603|NCT02237950|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6675964|NCT01578434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6675965|NCT01578447|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6675966|NCT01578447|Medroxyprogesterone|medroxyprogesterone|mesh-list
6675967|NCT01578447|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6675968|NCT01578447|Contraceptive Agents|contraceptive agents|mesh-ancestor
6675969|NCT01578447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6675970|NCT01578447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6675971|NCT01578447|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6675972|NCT01578447|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6215604|NCT02237950|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6215605|NCT02237989|Acetaminophen|acetaminophen|mesh-list
6215606|NCT02237989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6215607|NCT02237989|Analgesics|analgesics|mesh-ancestor
6215608|NCT02237989|Sensory System Agents|sensory system agents|mesh-ancestor
6215609|NCT02237989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6215610|NCT02237989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215611|NCT02237989|Antipyretics|antipyretics|mesh-ancestor
6215612|NCT02238080|Epoetin Alfa|epoetin alfa|mesh-list
6215613|NCT02238080|Hematinics|hematinics|mesh-ancestor
6215614|NCT02238379|Oxytocin|oxytocin|mesh-list
6215615|NCT02238379|Oxytocics|oxytocics|mesh-ancestor
6215616|NCT02238379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6215617|NCT02238379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215618|NCT02238483|AZD7624|azd7624|mesh-list
6215619|NCT02238483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6215620|NCT02238483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6215621|NCT02238483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215622|NCT02238626|Ibudilast|ibudilast|mesh-list
6215623|NCT02238626|Riluzole|riluzole|mesh-list
6215624|NCT02238626|Anticonvulsants|anticonvulsants|mesh-ancestor
6215625|NCT02238626|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6215626|NCT02238626|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6215627|NCT02238626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6215628|NCT02238626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215629|NCT02238626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215630|NCT02238626|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6215631|NCT02238626|Protective Agents|protective agents|mesh-ancestor
6215632|NCT02238626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6215633|NCT02238626|Autonomic Agents|autonomic agents|mesh-ancestor
6215634|NCT02238626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6675973|NCT01578447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6675974|NCT01578447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6675975|NCT01578447|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6675976|NCT01578447|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6675977|NCT01578447|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6675978|NCT01578473|Vitamin D|vitamin d|mesh-list
6675979|NCT01578473|Ergocalciferols|ergocalciferols|mesh-list
6675980|NCT01578473|Vitamins|vitamins|mesh-list
6675981|NCT01578473|Vitamin E|vitamin e|mesh-list
6675982|NCT01578473|Methyltestosterone|methyltestosterone|mesh-list
6675983|NCT01578473|Testosterone|testosterone|mesh-list
6215635|NCT02238626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6215636|NCT02238626|Respiratory System Agents|respiratory system agents|mesh-ancestor
6215637|NCT02238626|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6215638|NCT02238626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6215639|NCT02238626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6215640|NCT02238626|Vasodilator Agents|vasodilator agents|mesh-ancestor
6215641|NCT02238977|Bupropion|bupropion|mesh-list
6215642|NCT02238977|Fluoxetine|fluoxetine|mesh-list
6215643|NCT02238977|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6215644|NCT02238977|Antidepressive Agents|antidepressive agents|mesh-ancestor
6215645|NCT02238977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6675984|NCT01578473|Testosterone undecanoate|testosterone undecanoate|mesh-list
6675985|NCT01578473|Testosterone enanthate|testosterone enanthate|mesh-list
6675986|NCT01578473|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6215646|NCT02238977|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6215647|NCT02238977|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6215648|NCT02238977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6215649|NCT02238977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215650|NCT02238977|Dopamine Agents|dopamine agents|mesh-ancestor
6215651|NCT02238977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6215652|NCT02238977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215653|NCT02238977|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6215654|NCT02238977|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6215655|NCT02238977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6215656|NCT02238977|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6215657|NCT02238977|Serotonin Agents|serotonin agents|mesh-ancestor
6215658|NCT02239094|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
6215659|NCT02239094|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6215660|NCT02239094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6215661|NCT02239094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6215662|NCT02239094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215663|NCT02239094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6215664|NCT02239094|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6215665|NCT02239094|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6215666|NCT02239094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6215667|NCT02239094|Adrenergic Agents|adrenergic agents|mesh-ancestor
6215668|NCT02239094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6215669|NCT02239094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215670|NCT02239094|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6215671|NCT02239094|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6215672|NCT02239094|Serotonin Agents|serotonin agents|mesh-ancestor
6215673|NCT02239094|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6675987|NCT01578473|Micronutrients|micronutrients|mesh-ancestor
6675988|NCT01578473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702318|NCT03339700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5702319|NCT03339700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6215674|NCT02239094|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6215675|NCT02239094|Dopamine Agents|dopamine agents|mesh-ancestor
6215676|NCT02239120|Dabigatran|dabigatran|mesh-list
6215677|NCT02239120|Antithrombins|antithrombins|mesh-ancestor
6215678|NCT02239120|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6215679|NCT02239120|Protease Inhibitors|protease inhibitors|mesh-ancestor
6215680|NCT02239120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6215681|NCT02239120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215682|NCT02239120|Anticoagulants|anticoagulants|mesh-ancestor
6215683|NCT02239380|Lorazepam|lorazepam|mesh-list
6215684|NCT02239380|Anticonvulsants|anticonvulsants|mesh-ancestor
6215685|NCT02239380|Antiemetics|antiemetics|mesh-ancestor
6215686|NCT02239380|Autonomic Agents|autonomic agents|mesh-ancestor
6215687|NCT02239380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6215688|NCT02239380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215689|NCT02239380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5702320|NCT03339700|Antimetabolites|antimetabolites|mesh-ancestor
5702321|NCT03339700|Antiviral Agents|antiviral agents|mesh-ancestor
5702322|NCT03339700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5702323|NCT03339700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6215690|NCT02239380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6215691|NCT02239380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6215692|NCT02239380|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6215693|NCT02239380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6215694|NCT02239380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6215695|NCT02239380|GABA Modulators|gaba modulators|mesh-ancestor
6497313|NCT00631813|Laxatives|laxatives|mesh-ancestor
6497314|NCT00631813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6497315|NCT00631813|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
6497316|NCT00631813|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6497317|NCT00631813|Serotonin Agents|serotonin agents|mesh-ancestor
6497318|NCT00631813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6497319|NCT00631813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497320|NCT00631813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497321|NCT00631943|Pregabalin|pregabalin|mesh-list
6497322|NCT00631943|Analgesics|analgesics|mesh-ancestor
6497323|NCT00631943|Sensory System Agents|sensory system agents|mesh-ancestor
6497324|NCT00631943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6497325|NCT00631943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497326|NCT00631943|Anticonvulsants|anticonvulsants|mesh-ancestor
6497327|NCT00631943|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6497328|NCT00631943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6497329|NCT00631943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497330|NCT00631943|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6497331|NCT00631943|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6497332|NCT00631943|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6497333|NCT00631943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6497334|NCT00631943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6497335|NCT00631995|Vaccines|vaccines|mesh-list
6497336|NCT00631995|Immunologic Factors|immunologic factors|mesh-ancestor
6497337|NCT00631995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497338|NCT00632073|Maleic acid|maleic acid|mesh-list
6497339|NCT00632073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6497340|NCT00632073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497341|NCT00632086|Aspirin|aspirin|mesh-list
6497342|NCT00632086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6497343|NCT00632086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6497344|NCT00632086|Analgesics|analgesics|mesh-ancestor
6497345|NCT00632086|Sensory System Agents|sensory system agents|mesh-ancestor
6497346|NCT00632086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6497347|NCT00632086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497348|NCT00632086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6497349|NCT00632086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6497350|NCT00632086|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6497351|NCT00632086|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6497352|NCT00632086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497353|NCT00632086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6497354|NCT00632086|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6497355|NCT00632086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6497356|NCT00632086|Antipyretics|antipyretics|mesh-ancestor
6497357|NCT00632216|Risedronic Acid|risedronic acid|mesh-list
6497358|NCT00632216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6497359|NCT00632216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5702324|NCT03339635|Methyltestosterone|methyltestosterone|mesh-list
5702325|NCT03339635|Testosterone|testosterone|mesh-list
6215696|NCT02239380|GABA Agents|gaba agents|mesh-ancestor
5702326|NCT03339635|Testosterone undecanoate|testosterone undecanoate|mesh-list
5702327|NCT03339635|Testosterone enanthate|testosterone enanthate|mesh-list
5702328|NCT03339635|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5702329|NCT03339635|Androgens|androgens|mesh-ancestor
5702330|NCT03339635|Hormones|hormones|mesh-ancestor
5702331|NCT03339635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5702332|NCT03339635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702333|NCT03339635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5702334|NCT03339635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5702335|NCT03339635|Anabolic Agents|anabolic agents|mesh-ancestor
5702336|NCT03339596|Epoetin Alfa|epoetin alfa|mesh-list
6215697|NCT02239380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6215698|NCT02239380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215699|NCT02239510|Linaclotide|linaclotide|mesh-list
6215700|NCT02239510|Sennosides|sennosides|mesh-list
6215701|NCT02239510|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
6215702|NCT02239510|Enzyme Activators|enzyme activators|mesh-ancestor
6215703|NCT02239510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215704|NCT02239510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6215705|NCT02239510|Laxatives|laxatives|mesh-ancestor
6215706|NCT02239679|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6675989|NCT01578473|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6675990|NCT01578473|Androgens|androgens|mesh-ancestor
6675991|NCT01578473|Hormones|hormones|mesh-ancestor
6675992|NCT01578473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6675993|NCT01578473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6675994|NCT01578473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6675995|NCT01578473|Anabolic Agents|anabolic agents|mesh-ancestor
6675996|NCT01578473|Antioxidants|antioxidants|mesh-ancestor
6675997|NCT01578473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6675998|NCT01578473|Protective Agents|protective agents|mesh-ancestor
6675999|NCT01578473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6676000|NCT01578564|SOR-C13|sor-c13|mesh-list
6676001|NCT01578564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6497360|NCT00632216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497361|NCT00632216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6676002|NCT01578564|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6676003|NCT01578564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6676004|NCT01578564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676005|NCT01578564|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6676006|NCT01578564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676007|NCT01578603|Calcium|calcium|mesh-list
6676008|NCT01578603|Caseins|caseins|mesh-list
5702337|NCT03339596|Hematinics|hematinics|mesh-ancestor
5702338|NCT03339544|Celecoxib|celecoxib|mesh-list
5702339|NCT03339544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5702340|NCT03339544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6215707|NCT02239679|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6215708|NCT02239679|Dermatologic Agents|dermatologic agents|mesh-ancestor
6215709|NCT02239692|Picosulfate sodium|picosulfate sodium|mesh-list
6215710|NCT02239692|Cathartics|cathartics|mesh-ancestor
6215711|NCT02239692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6215712|NCT02239770|Nicotine|nicotine|mesh-list
6215713|NCT02239770|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6215714|NCT02239770|Autonomic Agents|autonomic agents|mesh-ancestor
6215715|NCT02239770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6215716|NCT02239770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215717|NCT02239770|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6215718|NCT02239770|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6215719|NCT02239770|Cholinergic Agents|cholinergic agents|mesh-ancestor
6215720|NCT02239770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6215721|NCT02239770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215722|NCT02240030|Levodopa|levodopa|mesh-list
6215723|NCT02240030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6215724|NCT02240030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6215725|NCT02240030|Dopamine Agents|dopamine agents|mesh-ancestor
6215726|NCT02240030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6497362|NCT00632216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497363|NCT00632216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6497364|NCT00632255|Imatinib Mesylate|imatinib mesylate|mesh-list
6497365|NCT00632255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6497366|NCT00632255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6497367|NCT00632255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6215727|NCT02240030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215728|NCT02240030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215729|NCT02240108|Rifaximin|rifaximin|mesh-list
6215730|NCT02240108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6215731|NCT02240108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6215732|NCT02240108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6215733|NCT02240121|Rifaximin|rifaximin|mesh-list
6215734|NCT02240121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6215735|NCT02240121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6215736|NCT02240121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6215737|NCT02240329|Capsaicin|capsaicin|mesh-list
6215738|NCT02240329|Antipruritics|antipruritics|mesh-ancestor
6215739|NCT02240329|Dermatologic Agents|dermatologic agents|mesh-ancestor
6215740|NCT02240329|Sensory System Agents|sensory system agents|mesh-ancestor
6215741|NCT02240329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6215742|NCT02240329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215743|NCT02240589|Memantine|memantine|mesh-list
6215744|NCT02240589|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6215745|NCT02240589|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6215746|NCT02240589|Dopamine Agents|dopamine agents|mesh-ancestor
6215747|NCT02240589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6215748|NCT02240589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215749|NCT02240589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215750|NCT02240589|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6215751|NCT02240589|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6215752|NCT02240628|Lidocaine|lidocaine|mesh-list
6215753|NCT02240628|Tetracaine|tetracaine|mesh-list
6215754|NCT02240628|Anesthetics, Local|anesthetics, local|mesh-ancestor
6215755|NCT02240628|Anesthetics|anesthetics|mesh-ancestor
6215756|NCT02240628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6215757|NCT02240628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215758|NCT02240628|Sensory System Agents|sensory system agents|mesh-ancestor
6215759|NCT02240628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6215760|NCT02240628|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6215761|NCT02240628|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6215762|NCT02240628|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6215763|NCT02240628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6215764|NCT02240628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215765|NCT02240667|Vitamin K|vitamin k|mesh-list
6215766|NCT02240667|Dabigatran|dabigatran|mesh-list
6215767|NCT02240667|Phenprocoumon|phenprocoumon|mesh-list
6215768|NCT02240667|Vitamins|vitamins|mesh-ancestor
6215769|NCT02240667|Micronutrients|micronutrients|mesh-ancestor
6215770|NCT02240667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215771|NCT02240667|Antithrombins|antithrombins|mesh-ancestor
6215772|NCT02240667|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6215773|NCT02240667|Protease Inhibitors|protease inhibitors|mesh-ancestor
6215774|NCT02240667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6215775|NCT02240667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215776|NCT02240667|Anticoagulants|anticoagulants|mesh-ancestor
6215777|NCT02240667|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6215778|NCT02240667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6215779|NCT02240667|Hemostatics|hemostatics|mesh-ancestor
6215780|NCT02240667|Coagulants|coagulants|mesh-ancestor
6215781|NCT02240680|Linagliptin|linagliptin|mesh-list
6215782|NCT02240680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6215783|NCT02240680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215784|NCT02240680|Incretins|incretins|mesh-ancestor
6215785|NCT02240680|Hormones|hormones|mesh-ancestor
6215786|NCT02240680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6215787|NCT02240680|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6215788|NCT02240680|Protease Inhibitors|protease inhibitors|mesh-ancestor
6215789|NCT02240680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6215790|NCT02240680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215791|NCT02240693|BI 409306|bi 409306|mesh-list
6215792|NCT02240693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6215793|NCT02240693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6215794|NCT02240693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215795|NCT02241486|Fentanyl|fentanyl|mesh-list
6215796|NCT02241486|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6215797|NCT02241486|Narcotics|narcotics|mesh-ancestor
6215798|NCT02241486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6215799|NCT02241486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215800|NCT02241486|Analgesics|analgesics|mesh-ancestor
6215801|NCT02241486|Sensory System Agents|sensory system agents|mesh-ancestor
6215802|NCT02241486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6215803|NCT02241486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6215804|NCT02241486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6215805|NCT02241486|Anesthetics, General|anesthetics, general|mesh-ancestor
6215806|NCT02241486|Anesthetics|anesthetics|mesh-ancestor
6215807|NCT02241512|Ibuprofen|ibuprofen|mesh-list
6215808|NCT02241512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6215809|NCT02241512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6215810|NCT02241512|Analgesics|analgesics|mesh-ancestor
6215811|NCT02241512|Sensory System Agents|sensory system agents|mesh-ancestor
6215812|NCT02241512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6215813|NCT02241512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215814|NCT02241512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6215815|NCT02241512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6215816|NCT02241512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6215817|NCT02241512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6215818|NCT02241512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215819|NCT02241655|Anesthetics|anesthetics|mesh-list
6215820|NCT02241655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6215821|NCT02241655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215822|NCT02241785|Natalizumab|natalizumab|mesh-list
6215823|NCT02241785|Immunologic Factors|immunologic factors|mesh-ancestor
6215824|NCT02241785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215825|NCT02241889|Pancrelipase|pancrelipase|mesh-list
6215826|NCT02241889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6215827|NCT02242045|Idelalisib|idelalisib|mesh-list
6215828|NCT02242045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6215829|NCT02242045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6215830|NCT02242045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215831|NCT02242201|Ketorolac|ketorolac|mesh-list
6215832|NCT02242201|Epinephrine|epinephrine|mesh-list
6215833|NCT02242201|Bupivacaine|bupivacaine|mesh-list
6215834|NCT02242201|Ropivacaine|ropivacaine|mesh-list
6215835|NCT02242201|Anesthetics, Local|anesthetics, local|mesh-ancestor
6215836|NCT02242201|Anesthetics|anesthetics|mesh-ancestor
6215837|NCT02242201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6215838|NCT02242201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215839|NCT02242201|Sensory System Agents|sensory system agents|mesh-ancestor
6215840|NCT02242201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6215841|NCT02242201|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6215842|NCT02242201|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6215843|NCT02242201|Adrenergic Agents|adrenergic agents|mesh-ancestor
6215844|NCT02242201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6215845|NCT02242201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215846|NCT02242201|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6215847|NCT02242201|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6215848|NCT02242201|Autonomic Agents|autonomic agents|mesh-ancestor
6215849|NCT02242201|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6215850|NCT02242201|Respiratory System Agents|respiratory system agents|mesh-ancestor
6215851|NCT02242201|Mydriatics|mydriatics|mesh-ancestor
6215852|NCT02242201|Sympathomimetics|sympathomimetics|mesh-ancestor
6215853|NCT02242201|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5702341|NCT03339544|Analgesics|analgesics|mesh-ancestor
5702342|NCT03339544|Sensory System Agents|sensory system agents|mesh-ancestor
5702343|NCT03339544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5702344|NCT03339544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702345|NCT03339544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5702346|NCT03339544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5702347|NCT03339544|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5702348|NCT03339544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5702349|NCT03339544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5702350|NCT03339544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5702351|NCT03339427|Vitamin D|vitamin d|mesh-list
5702352|NCT03339427|Vitamins|vitamins|mesh-ancestor
5702353|NCT03339427|Micronutrients|micronutrients|mesh-ancestor
5702354|NCT03339427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676009|NCT01578603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6215854|NCT02242201|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6215855|NCT02242201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6676010|NCT01578603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676011|NCT01578603|Chelating Agents|chelating agents|mesh-ancestor
6676012|NCT01578603|Sequestering Agents|sequestering agents|mesh-ancestor
6676013|NCT01578603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676014|NCT01578629|Aspirin|aspirin|mesh-list
6676015|NCT01578629|Vitamin E|vitamin e|mesh-list
6676016|NCT01578629|Tocopherols|tocopherols|mesh-list
6676017|NCT01578629|Tocotrienols|tocotrienols|mesh-list
6215856|NCT02242201|Analgesics|analgesics|mesh-ancestor
6215857|NCT02242201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6215858|NCT02242201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6215859|NCT02242201|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6215860|NCT02242201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6215861|NCT02242305|Scopolamine|scopolamine|mesh-list
6215862|NCT02242305|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
6215863|NCT02242305|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6215864|NCT02242305|Antiemetics|antiemetics|mesh-ancestor
6215865|NCT02242305|Autonomic Agents|autonomic agents|mesh-ancestor
6215866|NCT02242305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6215867|NCT02242305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215868|NCT02242305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6215869|NCT02242305|Mydriatics|mydriatics|mesh-ancestor
6215870|NCT02242305|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6215871|NCT02242305|Cholinergic Agents|cholinergic agents|mesh-ancestor
6215872|NCT02242305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6215873|NCT02242305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215874|NCT02242305|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6215875|NCT02242305|Parasympatholytics|parasympatholytics|mesh-ancestor
6215876|NCT02242487|Levodopa|levodopa|mesh-list
6215877|NCT02242487|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6215878|NCT02242487|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6215879|NCT02242487|Dopamine Agents|dopamine agents|mesh-ancestor
6215880|NCT02242487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6215881|NCT02242487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215882|NCT02242487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215883|NCT02242630|Methylprednisolone|methylprednisolone|mesh-list
6215884|NCT02242630|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6215885|NCT02242630|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6215886|NCT02242630|Prednisolone|prednisolone|mesh-list
6215887|NCT02242630|Prednisolone acetate|prednisolone acetate|mesh-list
6215888|NCT02242630|Triamcinolone|triamcinolone|mesh-list
6215889|NCT02242630|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6215890|NCT02242630|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6215891|NCT02242630|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6215892|NCT02242630|Prednisolone phosphate|prednisolone phosphate|mesh-list
6215893|NCT02242630|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6215894|NCT02242630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6215895|NCT02242630|Antiemetics|antiemetics|mesh-ancestor
6215896|NCT02242630|Autonomic Agents|autonomic agents|mesh-ancestor
6215897|NCT02242630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6215898|NCT02242630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215899|NCT02242630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6215900|NCT02242630|Glucocorticoids|glucocorticoids|mesh-ancestor
6215901|NCT02242630|Hormones|hormones|mesh-ancestor
6215902|NCT02242630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6215903|NCT02242630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6215904|NCT02242630|Protective Agents|protective agents|mesh-ancestor
6497368|NCT00632255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497369|NCT00632268|Leucovorin|leucovorin|mesh-list
6497370|NCT00632268|Everolimus|everolimus|mesh-list
6497371|NCT00632268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6497372|NCT00632268|Antidotes|antidotes|mesh-ancestor
6497373|NCT00632268|Protective Agents|protective agents|mesh-ancestor
6497374|NCT00632268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497375|NCT00632268|Vitamin B Complex|vitamin b complex|mesh-ancestor
6497376|NCT00632268|Vitamins|vitamins|mesh-ancestor
6497377|NCT00632268|Micronutrients|micronutrients|mesh-ancestor
6497378|NCT00632268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6497379|NCT00632268|Immunologic Factors|immunologic factors|mesh-ancestor
6497380|NCT00632333|Fluorouracil|fluorouracil|mesh-list
6497381|NCT00632333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6497382|NCT00632333|Antimetabolites|antimetabolites|mesh-ancestor
6497383|NCT00632333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497384|NCT00632333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6497385|NCT00632333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6497386|NCT00632333|Immunologic Factors|immunologic factors|mesh-ancestor
6497387|NCT00632333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497388|NCT00632385|Eletriptan|eletriptan|mesh-list
6497389|NCT00632385|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6497390|NCT00632385|Serotonin Agents|serotonin agents|mesh-ancestor
6497391|NCT00632385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6497392|NCT00632385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215905|NCT02242630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6497393|NCT00632385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497394|NCT00632476|Ascorbic Acid|ascorbic acid|mesh-list
6215906|NCT02242630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6215907|NCT02242630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6215908|NCT02242630|Immunologic Factors|immunologic factors|mesh-ancestor
6215909|NCT02242630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6215910|NCT02242630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215911|NCT02242942|Venetoclax|venetoclax|mesh-list
6215912|NCT02242942|Obinutuzumab|obinutuzumab|mesh-list
6215913|NCT02242942|Chlorambucil|chlorambucil|mesh-list
6215914|NCT02242942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6215915|NCT02242942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6215916|NCT02242942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6215917|NCT02242942|Alkylating Agents|alkylating agents|mesh-ancestor
6215918|NCT02242942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215919|NCT02243007|Gemcitabine|gemcitabine|mesh-list
6215920|NCT02243007|Paclitaxel|paclitaxel|mesh-list
6215921|NCT02243007|Capecitabine|capecitabine|mesh-list
6215922|NCT02243007|Folfirinox|folfirinox|mesh-list
6215923|NCT02243007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6215924|NCT02243007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6215925|NCT02243007|Tubulin Modulators|tubulin modulators|mesh-ancestor
6215926|NCT02243007|Antimitotic Agents|antimitotic agents|mesh-ancestor
6215927|NCT02243007|Mitosis Modulators|mitosis modulators|mesh-ancestor
6215928|NCT02243007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215929|NCT02243007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6215930|NCT02243007|Antimetabolites|antimetabolites|mesh-ancestor
6215931|NCT02243007|Antiviral Agents|antiviral agents|mesh-ancestor
6215932|NCT02243007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5702355|NCT03339427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5702356|NCT03339362|Methylprednisolone|methylprednisolone|mesh-list
5702357|NCT03339362|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5702358|NCT03339362|Bupivacaine|bupivacaine|mesh-list
5702359|NCT03339362|Anesthetics, Local|anesthetics, local|mesh-ancestor
5702360|NCT03339362|Anesthetics|anesthetics|mesh-ancestor
5702361|NCT03339362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6215933|NCT02243007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6215934|NCT02243007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6215935|NCT02243007|Immunologic Factors|immunologic factors|mesh-ancestor
6215936|NCT02243007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215937|NCT02243176|Saxagliptin|saxagliptin|mesh-list
6215938|NCT02243176|Acarbose|acarbose|mesh-list
6215939|NCT02243176|Incretins|incretins|mesh-ancestor
6215940|NCT02243176|Hormones|hormones|mesh-ancestor
6215941|NCT02243176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6497395|NCT00632476|Vitamins|vitamins|mesh-ancestor
6497396|NCT00632476|Micronutrients|micronutrients|mesh-ancestor
6497397|NCT00632476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497398|NCT00632476|Antioxidants|antioxidants|mesh-ancestor
6497399|NCT00632476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497400|NCT00632476|Protective Agents|protective agents|mesh-ancestor
6497401|NCT00632554|Prednisolone|prednisolone|mesh-list
6497402|NCT00632554|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6497403|NCT00632554|Methylprednisolone|methylprednisolone|mesh-list
6497404|NCT00632554|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6497405|NCT00632554|Prednisolone acetate|prednisolone acetate|mesh-list
6497406|NCT00632554|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6497407|NCT00632554|Prednisolone phosphate|prednisolone phosphate|mesh-list
6497408|NCT00632554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5702362|NCT03339362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702363|NCT03339362|Sensory System Agents|sensory system agents|mesh-ancestor
5702364|NCT03339362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5702365|NCT03339362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5702366|NCT03339362|Antiemetics|antiemetics|mesh-ancestor
5702367|NCT03339362|Autonomic Agents|autonomic agents|mesh-ancestor
5702368|NCT03339362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5702369|NCT03339362|Glucocorticoids|glucocorticoids|mesh-ancestor
5702370|NCT03339362|Hormones|hormones|mesh-ancestor
5702371|NCT03339362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5702372|NCT03339362|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5702373|NCT03339362|Protective Agents|protective agents|mesh-ancestor
5702374|NCT03339349|Enoxaparin|enoxaparin|mesh-list
5702375|NCT03339349|Anticoagulants|anticoagulants|mesh-ancestor
5702376|NCT03339349|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5702377|NCT03339349|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5702378|NCT03339349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5702379|NCT03339258|Doxazosin|doxazosin|mesh-list
6215942|NCT02243176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497409|NCT00632554|Glucocorticoids|glucocorticoids|mesh-ancestor
6215943|NCT02243176|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6215944|NCT02243176|Protease Inhibitors|protease inhibitors|mesh-ancestor
6215945|NCT02243176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6215946|NCT02243176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215947|NCT02243176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6215948|NCT02243176|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6215949|NCT02243202|Canagliflozin|canagliflozin|mesh-list
6215950|NCT02243202|Phentermine|phentermine|mesh-list
6215951|NCT02243202|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6215952|NCT02243202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215953|NCT02243202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5702380|NCT03339258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5702381|NCT03339258|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5702382|NCT03339258|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6215954|NCT02243202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215955|NCT02243202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6215956|NCT02243202|Appetite Depressants|appetite depressants|mesh-ancestor
6215957|NCT02243202|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6215958|NCT02243202|Sympathomimetics|sympathomimetics|mesh-ancestor
6215959|NCT02243202|Autonomic Agents|autonomic agents|mesh-ancestor
6215960|NCT02243202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6215961|NCT02243202|Adrenergic Agents|adrenergic agents|mesh-ancestor
6215962|NCT02243202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6215963|NCT02243293|Ribavirin|ribavirin|mesh-list
6215964|NCT02243293|Antimetabolites|antimetabolites|mesh-ancestor
6215965|NCT02243293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215966|NCT02243293|Antiviral Agents|antiviral agents|mesh-ancestor
6215967|NCT02243293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6215968|NCT02243371|Cyclophosphamide|cyclophosphamide|mesh-list
6215969|NCT02243371|Nivolumab|nivolumab|mesh-list
6215970|NCT02243371|Immunologic Factors|immunologic factors|mesh-ancestor
6215971|NCT02243371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215972|NCT02243371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6215973|NCT02243371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6215974|NCT02243371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6215975|NCT02243371|Alkylating Agents|alkylating agents|mesh-ancestor
6215976|NCT02243371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215977|NCT02243371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5702383|NCT03339258|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5702384|NCT03339258|Adrenergic Agents|adrenergic agents|mesh-ancestor
5702385|NCT03339258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5702386|NCT03339258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5702387|NCT03339258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702388|NCT03339024|Oxytocin|oxytocin|mesh-list
5702389|NCT03339024|Oxytocics|oxytocics|mesh-ancestor
5702390|NCT03339024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5702391|NCT03339024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702392|NCT03338972|Cyclophosphamide|cyclophosphamide|mesh-list
5702393|NCT03338972|Fludarabine|fludarabine|mesh-list
6215978|NCT02243371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6215979|NCT02243371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6215980|NCT02243371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6215981|NCT02243579|Pembrolizumab|pembrolizumab|mesh-list
6215982|NCT02243579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6215983|NCT02243579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6215984|NCT02243943|Neostigmine|neostigmine|mesh-list
6215985|NCT02243943|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6215986|NCT02243943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6215987|NCT02243943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6215988|NCT02243943|Cholinergic Agents|cholinergic agents|mesh-ancestor
6215989|NCT02243943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6215990|NCT02243943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6215991|NCT02243943|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6215992|NCT02243943|Autonomic Agents|autonomic agents|mesh-ancestor
6215993|NCT02243943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6215994|NCT02244619|Acetaminophen|acetaminophen|mesh-list
6215995|NCT02244619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6215996|NCT02244619|Analgesics|analgesics|mesh-ancestor
6215997|NCT02244619|Sensory System Agents|sensory system agents|mesh-ancestor
6215998|NCT02244619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6215999|NCT02244619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497410|NCT00632554|Hormones|hormones|mesh-ancestor
5702394|NCT03338972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5702395|NCT03338972|Immunologic Factors|immunologic factors|mesh-ancestor
6216000|NCT02244619|Antipyretics|antipyretics|mesh-ancestor
6242961|NCT02658487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6242962|NCT02658487|Immunologic Factors|immunologic factors|mesh-ancestor
6242963|NCT02658487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6242964|NCT02658734|Trastuzumab|trastuzumab|mesh-list
6242965|NCT02658734|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
6242966|NCT02658734|Maytansine|maytansine|mesh-list
6242967|NCT02658734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6242968|NCT02658734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6242969|NCT02658734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6242970|NCT02658734|Tubulin Modulators|tubulin modulators|mesh-ancestor
6242971|NCT02658734|Antimitotic Agents|antimitotic agents|mesh-ancestor
5702396|NCT03338972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702397|NCT03338972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5702398|NCT03338972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5702399|NCT03338972|Alkylating Agents|alkylating agents|mesh-ancestor
5702400|NCT03338972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5702401|NCT03338972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5702402|NCT03338972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5702403|NCT03338621|Moxifloxacin|moxifloxacin|mesh-list
5702404|NCT03338621|Rifampin|rifampin|mesh-list
5702405|NCT03338621|Isoniazid|isoniazid|mesh-list
5702406|NCT03338621|Pyrazinamide|pyrazinamide|mesh-list
5702407|NCT03338621|Ethambutol|ethambutol|mesh-list
5702408|NCT03338621|Bedaquiline|bedaquiline|mesh-list
5702409|NCT03338621|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5702410|NCT03338621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5702411|NCT03338621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5702412|NCT03338621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5702413|NCT03338621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5702414|NCT03338621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5702415|NCT03338621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5702416|NCT03338621|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5702417|NCT03338621|Antitubercular Agents|antitubercular agents|mesh-ancestor
6497411|NCT00632554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6497412|NCT00632554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497413|NCT00632554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6497414|NCT00632554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6497415|NCT00632554|Antiemetics|antiemetics|mesh-ancestor
5702418|NCT03338621|Leprostatic Agents|leprostatic agents|mesh-ancestor
5702419|NCT03338621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5702420|NCT03338621|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5702421|NCT03338621|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5702422|NCT03338621|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5702423|NCT03338621|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5702424|NCT03338621|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5702425|NCT03338621|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5702426|NCT03338621|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5702427|NCT03338621|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5702428|NCT03338621|Antimetabolites|antimetabolites|mesh-ancestor
5702429|NCT03338621|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6497416|NCT00632554|Autonomic Agents|autonomic agents|mesh-ancestor
6676018|NCT01578629|Vitamins|vitamins|mesh-ancestor
6676019|NCT01578629|Micronutrients|micronutrients|mesh-ancestor
6676020|NCT01578629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676021|NCT01578629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6676022|NCT01578629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6676023|NCT01578629|Analgesics|analgesics|mesh-ancestor
6676024|NCT01578629|Sensory System Agents|sensory system agents|mesh-ancestor
5702430|NCT03338426|Atorvastatin|atorvastatin|mesh-list
5702431|NCT03338426|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5702432|NCT03338426|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5702433|NCT03338426|Antimetabolites|antimetabolites|mesh-ancestor
5702434|NCT03338426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5702435|NCT03338426|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5702436|NCT03338426|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5702437|NCT03338426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5702438|NCT03338387|Acipimox|acipimox|mesh-list
6242972|NCT02658734|Mitosis Modulators|mitosis modulators|mesh-ancestor
6497417|NCT00632554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6497418|NCT00632554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6497419|NCT00632554|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6497420|NCT00632554|Protective Agents|protective agents|mesh-ancestor
6497421|NCT00632580|Ropivacaine|ropivacaine|mesh-list
6497422|NCT00632580|Anesthetics, Local|anesthetics, local|mesh-ancestor
6497423|NCT00632580|Anesthetics|anesthetics|mesh-ancestor
6497424|NCT00632580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6497425|NCT00632580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497426|NCT00632580|Sensory System Agents|sensory system agents|mesh-ancestor
6497427|NCT00632580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6497428|NCT00632606|Magnesium Sulfate|magnesium sulfate|mesh-list
6676025|NCT01578629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5702439|NCT03338387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5702440|NCT03338387|Antimetabolites|antimetabolites|mesh-ancestor
5702441|NCT03338387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5702442|NCT03338387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5702443|NCT03338348|Azacitidine|azacitidine|mesh-list
5702444|NCT03338348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5702445|NCT03338348|Antimetabolites|antimetabolites|mesh-ancestor
5702446|NCT03338348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216001|NCT02244918|Nicotine|nicotine|mesh-list
6216002|NCT02244918|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6216003|NCT02244918|Autonomic Agents|autonomic agents|mesh-ancestor
6216004|NCT02244918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6216005|NCT02244918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216006|NCT02244918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6216007|NCT02244918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6216008|NCT02244918|Cholinergic Agents|cholinergic agents|mesh-ancestor
6216009|NCT02244918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6216010|NCT02244918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216011|NCT02245516|Loteprednol Etabonate|loteprednol etabonate|mesh-list
6216012|NCT02245516|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6216013|NCT02246218|Glycerol|glycerol|mesh-list
6216014|NCT02246218|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6216015|NCT02246218|Protective Agents|protective agents|mesh-ancestor
6216016|NCT02246218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216017|NCT02246582|Insulin|insulin|mesh-list
6216018|NCT02246582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6216019|NCT02246582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216020|NCT02246647|Mannitol|mannitol|mesh-list
6216021|NCT02246647|Lactulose|lactulose|mesh-list
6216022|NCT02246647|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5702447|NCT03338348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5702448|NCT03338348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5702449|NCT03338244|Azithromycin|azithromycin|mesh-list
5702450|NCT03338244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6216023|NCT02246647|Diuretics|diuretics|mesh-ancestor
6216024|NCT02246647|Natriuretic Agents|natriuretic agents|mesh-ancestor
6216025|NCT02246647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216026|NCT02246647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6216027|NCT02246660|Resveratrol|resveratrol|mesh-list
6216028|NCT02246660|Antioxidants|antioxidants|mesh-ancestor
6216029|NCT02246660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216030|NCT02246660|Protective Agents|protective agents|mesh-ancestor
6216031|NCT02246660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216032|NCT02246660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6216033|NCT02246660|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6216034|NCT02246673|Febuxostat|febuxostat|mesh-list
6216035|NCT02246673|Verinurad|verinurad|mesh-list
6216036|NCT02246673|Gout Suppressants|gout suppressants|mesh-ancestor
6216037|NCT02246673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6216038|NCT02246764|Timolol|timolol|mesh-list
6216039|NCT02246764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6216040|NCT02246764|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6216041|NCT02246764|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6216042|NCT02246764|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6216043|NCT02246764|Adrenergic Agents|adrenergic agents|mesh-ancestor
6216044|NCT02246764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6216045|NCT02246764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216046|NCT02246764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216047|NCT02246764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6216048|NCT02246764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6216049|NCT02246998|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6216050|NCT02246998|Antiviral Agents|antiviral agents|mesh-ancestor
6216051|NCT02246998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6216052|NCT02246998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6216053|NCT02246998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6497429|NCT00632606|Metoclopramide|metoclopramide|mesh-list
6497430|NCT00632606|Analgesics|analgesics|mesh-ancestor
6497431|NCT00632606|Sensory System Agents|sensory system agents|mesh-ancestor
6216054|NCT02247193|Botulinum Toxins|botulinum toxins|mesh-list
6216055|NCT02247193|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6216056|NCT02247193|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6216057|NCT02247193|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6216058|NCT02247193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6216059|NCT02247193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497432|NCT00632606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6497433|NCT00632606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497434|NCT00632606|Anesthetics|anesthetics|mesh-ancestor
6497435|NCT00632606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6497436|NCT00632606|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6497437|NCT00632606|Anticonvulsants|anticonvulsants|mesh-ancestor
6497438|NCT00632606|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6497439|NCT00632606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6497440|NCT00632606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497441|NCT00632606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6497442|NCT00632606|Tocolytic Agents|tocolytic agents|mesh-ancestor
6497443|NCT00632606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6497444|NCT00632606|Antiemetics|antiemetics|mesh-ancestor
6497445|NCT00632606|Autonomic Agents|autonomic agents|mesh-ancestor
6497446|NCT00632606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6497447|NCT00632606|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6497448|NCT00632606|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6497449|NCT00632606|Dopamine Agents|dopamine agents|mesh-ancestor
6497450|NCT00632606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6497451|NCT00632645|Olanzapine|olanzapine|mesh-list
6497452|NCT00632645|Tiapride Hydrochloride|tiapride hydrochloride|mesh-list
6497453|NCT00632645|Tetrabenazine|tetrabenazine|mesh-list
6497454|NCT00632645|Antiemetics|antiemetics|mesh-ancestor
6497455|NCT00632645|Autonomic Agents|autonomic agents|mesh-ancestor
6497456|NCT00632645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6497457|NCT00632645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497458|NCT00632645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6497459|NCT00632645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6497460|NCT00632645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6497461|NCT00632645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5702451|NCT03338244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5702452|NCT03338205|Ketamine|ketamine|mesh-list
5702453|NCT03338205|Analgesics|analgesics|mesh-ancestor
5702454|NCT03338205|Sensory System Agents|sensory system agents|mesh-ancestor
5702455|NCT03338205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6497462|NCT00632645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6497463|NCT00632645|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6497464|NCT00632645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6497465|NCT00632645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6497466|NCT00632645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497467|NCT00632645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6497468|NCT00632645|Serotonin Agents|serotonin agents|mesh-ancestor
6497469|NCT00632645|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6497470|NCT00632645|Adrenergic Agents|adrenergic agents|mesh-ancestor
6497471|NCT00632645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6497472|NCT00632645|Dopamine Agents|dopamine agents|mesh-ancestor
6497473|NCT00632697|Pentoxifylline|pentoxifylline|mesh-list
6497474|NCT00632697|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6497475|NCT00632697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6497476|NCT00632697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497477|NCT00632697|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6497478|NCT00632697|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6497479|NCT00632697|Protective Agents|protective agents|mesh-ancestor
6497480|NCT00632697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497481|NCT00632697|Vasodilator Agents|vasodilator agents|mesh-ancestor
6497482|NCT00632697|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6497483|NCT00632697|Antioxidants|antioxidants|mesh-ancestor
6497484|NCT00632723|Gefitinib|gefitinib|mesh-list
6497485|NCT00632723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6497486|NCT00632723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6497487|NCT00632723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6497488|NCT00632723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497489|NCT00632762|Amantadine|amantadine|mesh-list
6497490|NCT00632762|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6497491|NCT00632762|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6497492|NCT00632762|Antiviral Agents|antiviral agents|mesh-ancestor
6497493|NCT00632762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6497494|NCT00632762|Dopamine Agents|dopamine agents|mesh-ancestor
6497495|NCT00632762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6216060|NCT02247193|Cholinergic Agents|cholinergic agents|mesh-ancestor
6216061|NCT02247193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6216062|NCT02247193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216063|NCT02247193|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6216064|NCT02247193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6216065|NCT02247440|Interferons|interferons|mesh-list
6216066|NCT02247440|Ribavirin|ribavirin|mesh-list
6216067|NCT02247440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6216068|NCT02247440|Antiviral Agents|antiviral agents|mesh-ancestor
6216069|NCT02247440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6216070|NCT02247440|Antimetabolites|antimetabolites|mesh-ancestor
6216071|NCT02247440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216072|NCT02247466|Rocuronium|rocuronium|mesh-list
6216073|NCT02247466|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6216074|NCT02247466|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6216075|NCT02247466|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6216076|NCT02247466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6216077|NCT02247466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216078|NCT02247739|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
6216079|NCT02247739|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6216080|NCT02247739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6216081|NCT02247739|Immunologic Factors|immunologic factors|mesh-ancestor
6216082|NCT02247739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216083|NCT02247804|Timolol|timolol|mesh-list
6216084|NCT02247804|Bimatoprost|bimatoprost|mesh-list
6216085|NCT02247804|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6216086|NCT02247804|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6216087|NCT02247804|Adrenergic Agents|adrenergic agents|mesh-ancestor
6216088|NCT02247804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6216089|NCT02247804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216090|NCT02247804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216091|NCT02247804|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6216092|NCT02247804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6216093|NCT02247960|Ciprofloxacin|ciprofloxacin|mesh-list
6216094|NCT02247960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6216095|NCT02247960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6216096|NCT02247960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6216097|NCT02247960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6216098|NCT02247960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6216099|NCT02247960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216100|NCT02247960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6216101|NCT02247960|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6216102|NCT02247960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6216103|NCT02248480|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6216104|NCT02248480|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6216105|NCT02248480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6216106|NCT02248480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6216107|NCT02248480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216108|NCT02248480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6216109|NCT02248480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216110|NCT02248480|Analgesics|analgesics|mesh-ancestor
6216111|NCT02248480|Sensory System Agents|sensory system agents|mesh-ancestor
6216112|NCT02248480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6216113|NCT02248480|Antidepressive Agents|antidepressive agents|mesh-ancestor
6216114|NCT02248480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6216115|NCT02248480|Dopamine Agents|dopamine agents|mesh-ancestor
6216116|NCT02248636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
6216117|NCT02248636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6216118|NCT02248636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216119|NCT02248636|Cholinergic Agents|cholinergic agents|mesh-ancestor
6216120|NCT02248636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5702456|NCT03338205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702457|NCT03338205|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5702458|NCT03338205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5702459|NCT03338205|Anesthetics, General|anesthetics, general|mesh-ancestor
5702460|NCT03338205|Anesthetics|anesthetics|mesh-ancestor
5702461|NCT03338205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5702462|NCT03338205|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5702463|NCT03338205|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5702464|NCT03338205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5702465|NCT03338205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216121|NCT02248636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216122|NCT02248961|Losartan|losartan|mesh-list
6216123|NCT02248961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6216124|NCT02248961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6216125|NCT02248961|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6216126|NCT02248961|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6216127|NCT02248961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216128|NCT02249065|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6216129|NCT02249065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6216130|NCT02249065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6216131|NCT02249065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6216132|NCT02249065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6216133|NCT02249065|Adrenergic Agents|adrenergic agents|mesh-ancestor
6216134|NCT02249065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6216135|NCT02249065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216136|NCT02249065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216137|NCT02249091|Cytarabine|cytarabine|mesh-list
6216138|NCT02249091|Idarubicin|idarubicin|mesh-list
6216139|NCT02249091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6216140|NCT02249091|Antimetabolites|antimetabolites|mesh-ancestor
6216141|NCT02249091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216142|NCT02249091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6216143|NCT02249091|Antiviral Agents|antiviral agents|mesh-ancestor
6216144|NCT02249091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6216145|NCT02249091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6216146|NCT02249091|Immunologic Factors|immunologic factors|mesh-ancestor
6216147|NCT02249091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216148|NCT02249091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6216149|NCT02249091|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6216150|NCT02249091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6216151|NCT02249091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6216152|NCT02249104|Adapalene|adapalene|mesh-list
6216153|NCT02249104|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
6216154|NCT02249104|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6216155|NCT02249104|Dermatologic Agents|dermatologic agents|mesh-ancestor
6216156|NCT02249104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6216157|NCT02249104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6216158|NCT02249104|Analgesics|analgesics|mesh-ancestor
6497496|NCT00632762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497497|NCT00632762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497498|NCT00632762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6497499|NCT00632762|Analgesics|analgesics|mesh-ancestor
6497500|NCT00632762|Sensory System Agents|sensory system agents|mesh-ancestor
6497501|NCT00632762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6497502|NCT00632840|Atorvastatin|atorvastatin|mesh-list
6497503|NCT00632840|Fenofibrate|fenofibrate|mesh-list
6497504|NCT00632840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5702466|NCT03337932|Doxycycline|doxycycline|mesh-list
5702467|NCT03337932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5702468|NCT03337932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5702469|NCT03337932|Antimalarials|antimalarials|mesh-ancestor
6497505|NCT00632840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6497506|NCT00632840|Antimetabolites|antimetabolites|mesh-ancestor
6497507|NCT00632840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497508|NCT00632840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6497509|NCT00632840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6497510|NCT00632840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6497511|NCT00632853|Carboplatin|carboplatin|mesh-list
6497512|NCT00632853|Etoposide|etoposide|mesh-list
6497513|NCT00632853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6497514|NCT00632853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6497515|NCT00632853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6497516|NCT00632853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6497517|NCT00632853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6497518|NCT00632853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497519|NCT00632866|Hydroxychloroquine|hydroxychloroquine|mesh-list
6497520|NCT00632866|Antimalarials|antimalarials|mesh-ancestor
6497521|NCT00632866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6497522|NCT00632866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6497523|NCT00632866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6497524|NCT00632866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6497525|NCT00632866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5702470|NCT03337932|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5702471|NCT03337932|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6216159|NCT02249104|Sensory System Agents|sensory system agents|mesh-ancestor
6216160|NCT02249104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6216161|NCT02249104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497526|NCT00632866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6497527|NCT00633035|Esomeprazole|esomeprazole|mesh-list
6216162|NCT02249104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6216163|NCT02249104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6216164|NCT02249182|Ribavirin|ribavirin|mesh-list
6216165|NCT02249182|Sofosbuvir|sofosbuvir|mesh-list
6216166|NCT02249182|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
6497528|NCT00633035|Famotidine|famotidine|mesh-list
6497529|NCT00633035|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6497530|NCT00633035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6497531|NCT00633035|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6497532|NCT00633035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6497533|NCT00633035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497534|NCT00633035|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6497535|NCT00633035|Histamine Antagonists|histamine antagonists|mesh-ancestor
6497536|NCT00633035|Histamine Agents|histamine agents|mesh-ancestor
6497537|NCT00633035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6497538|NCT00633035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497539|NCT00633269|Olaparib|olaparib|mesh-list
5702472|NCT03337919|Nivolumab|nivolumab|mesh-list
5702473|NCT03337919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5702474|NCT03337919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5702475|NCT03337919|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5702476|NCT03337919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5702477|NCT03337841|Pembrolizumab|pembrolizumab|mesh-list
5702478|NCT03337841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5702479|NCT03337841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5702480|NCT03337828|Ethanol|ethanol|mesh-list
5702481|NCT03337828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5702482|NCT03337828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5702483|NCT03337828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6497540|NCT00633269|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6497541|NCT00633269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5702484|NCT03337828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702485|NCT03337672|Midazolam|midazolam|mesh-list
5702486|NCT03337672|Dexmedetomidine|dexmedetomidine|mesh-list
5702487|NCT03337672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5702488|NCT03337672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5702489|NCT03337672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702490|NCT03337672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5702491|NCT03337672|Analgesics|analgesics|mesh-ancestor
5702492|NCT03337672|Sensory System Agents|sensory system agents|mesh-ancestor
5702493|NCT03337672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5702494|NCT03337672|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5702495|NCT03337672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6676026|NCT01578629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6676027|NCT01578629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5918463|NCT04991402|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5918464|NCT04991402|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5918465|NCT04991402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5918466|NCT04991402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918467|NCT04991402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5918468|NCT04991402|Antiviral Agents|antiviral agents|mesh-ancestor
5918469|NCT04991402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5918470|NCT04991207|Bosentan|bosentan|mesh-list
5918471|NCT04991207|Zamicastat|zamicastat|mesh-list
5918472|NCT04991207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5918473|NCT04991207|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5918474|NCT04991207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918475|NCT04991207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5918476|NCT04991064|Titanium dioxide|titanium dioxide|mesh-list
5702496|NCT03337672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6216167|NCT02249182|Ledipasvir|ledipasvir|mesh-list
6676028|NCT01578629|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5702497|NCT03337672|Adrenergic Agents|adrenergic agents|mesh-ancestor
5702498|NCT03337672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5702499|NCT03337672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5702500|NCT03337672|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5702501|NCT03337672|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5702502|NCT03337672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5702503|NCT03337672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5702504|NCT03337672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5702505|NCT03337672|Anesthetics, General|anesthetics, general|mesh-ancestor
5702506|NCT03337672|Anesthetics|anesthetics|mesh-ancestor
5702507|NCT03337672|GABA Modulators|gaba modulators|mesh-ancestor
6216168|NCT02249182|Antimetabolites|antimetabolites|mesh-ancestor
6216169|NCT02249182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216170|NCT02249182|Antiviral Agents|antiviral agents|mesh-ancestor
6216171|NCT02249182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6216172|NCT02249585|Iodine|iodine|mesh-list
6216173|NCT02249585|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6216174|NCT02249585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6216175|NCT02249585|Trace Elements|trace elements|mesh-ancestor
6216176|NCT02249585|Micronutrients|micronutrients|mesh-ancestor
6216177|NCT02249585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216178|NCT02249767|Tretinoin|tretinoin|mesh-list
6216179|NCT02249767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6216180|NCT02249767|Keratolytic Agents|keratolytic agents|mesh-ancestor
6216181|NCT02249767|Dermatologic Agents|dermatologic agents|mesh-ancestor
6216182|NCT02249949|Efatutazone|efatutazone|mesh-list
6216183|NCT02249949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6216184|NCT02250612|Timolol|timolol|mesh-list
6216185|NCT02250612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6216186|NCT02250612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6216187|NCT02250612|Adrenergic Agents|adrenergic agents|mesh-ancestor
6216188|NCT02250612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6216189|NCT02250612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216190|NCT02250612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216191|NCT02250612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6216192|NCT02250612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6216193|NCT02250651|Timolol|timolol|mesh-list
6216194|NCT02250651|Bimatoprost|bimatoprost|mesh-list
6216195|NCT02250651|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6216196|NCT02250651|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6216197|NCT02250651|Adrenergic Agents|adrenergic agents|mesh-ancestor
6216198|NCT02250651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6216199|NCT02250651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216200|NCT02250651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216201|NCT02250651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6216202|NCT02250651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6216203|NCT02250703|Midazolam|midazolam|mesh-list
6216204|NCT02250703|Dexmedetomidine|dexmedetomidine|mesh-list
6216205|NCT02250703|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6216206|NCT02250703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6216207|NCT02250703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216208|NCT02250703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6216209|NCT02250703|Analgesics|analgesics|mesh-ancestor
6216210|NCT02250703|Sensory System Agents|sensory system agents|mesh-ancestor
6216211|NCT02250703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6216212|NCT02250703|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6216213|NCT02250703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6216214|NCT02250703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6216215|NCT02250703|Adrenergic Agents|adrenergic agents|mesh-ancestor
6216216|NCT02250703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6216217|NCT02250703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216218|NCT02250703|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6216219|NCT02250703|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6676029|NCT01578629|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6676030|NCT01578629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676031|NCT01578629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6676032|NCT01578629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6676033|NCT01578629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6676034|NCT01578629|Antipyretics|antipyretics|mesh-ancestor
6676035|NCT01578629|Antioxidants|antioxidants|mesh-ancestor
6676036|NCT01578629|Protective Agents|protective agents|mesh-ancestor
6676037|NCT01578668|Pemetrexed|pemetrexed|mesh-list
6676038|NCT01578668|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6676039|NCT01578668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6676040|NCT01578668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6216220|NCT02250703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6216221|NCT02250703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6216222|NCT02250703|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6216223|NCT02250703|Anesthetics, General|anesthetics, general|mesh-ancestor
6216224|NCT02250703|Anesthetics|anesthetics|mesh-ancestor
5702508|NCT03337672|GABA Agents|gaba agents|mesh-ancestor
5702509|NCT03337646|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
5702510|NCT03337646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5702511|NCT03337646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702512|NCT03337646|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6216225|NCT02250703|GABA Modulators|gaba modulators|mesh-ancestor
6216226|NCT02250703|GABA Agents|gaba agents|mesh-ancestor
6216227|NCT02250807|Sofosbuvir|sofosbuvir|mesh-list
6216228|NCT02250807|Simeprevir|simeprevir|mesh-list
6216229|NCT02250807|Antiviral Agents|antiviral agents|mesh-ancestor
6216230|NCT02250807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6216231|NCT02250807|Protease Inhibitors|protease inhibitors|mesh-ancestor
6216232|NCT02250807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6216233|NCT02250807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216234|NCT02251236|Tenofovir|tenofovir|mesh-list
6216235|NCT02251236|Emtricitabine|emtricitabine|mesh-list
6216236|NCT02251236|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6216237|NCT02251236|Cobicistat|cobicistat|mesh-list
6216238|NCT02251236|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
6216239|NCT02251236|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6216240|NCT02251236|Elvitegravir|elvitegravir|mesh-list
6216241|NCT02251236|Antiviral Agents|antiviral agents|mesh-ancestor
6216242|NCT02251236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6216243|NCT02251236|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6216244|NCT02251236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6216245|NCT02251236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6216246|NCT02251236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216247|NCT02251236|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5702513|NCT03337646|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5702514|NCT03337646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5702515|NCT03337646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5702516|NCT03337646|Dopamine Agents|dopamine agents|mesh-ancestor
5702517|NCT03337646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5702518|NCT03337607|Celecoxib|celecoxib|mesh-list
5702519|NCT03337607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
5702520|NCT03337607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
5702521|NCT03337607|Eperisone|eperisone|mesh-list
5702522|NCT03337607|Parasympatholytics|parasympatholytics|mesh-list
5702523|NCT03337607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5702524|NCT03337607|Analgesics|analgesics|mesh-ancestor
5702525|NCT03337607|Sensory System Agents|sensory system agents|mesh-ancestor
5702526|NCT03337607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5702527|NCT03337607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702528|NCT03337607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6216248|NCT02251236|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6216249|NCT02251236|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6216250|NCT02251236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6216251|NCT02251236|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6216252|NCT02251275|Tolvaptan|tolvaptan|mesh-list
6216253|NCT02251275|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6216254|NCT02251275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216255|NCT02251275|Natriuretic Agents|natriuretic agents|mesh-ancestor
6216256|NCT02251275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216257|NCT02251379|Fluticasone|fluticasone|mesh-list
6216258|NCT02251379|Xhance|xhance|mesh-list
6216259|NCT02251379|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6216260|NCT02251379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6216261|NCT02251379|Autonomic Agents|autonomic agents|mesh-ancestor
6216262|NCT02251379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6216263|NCT02251379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216264|NCT02251379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6216265|NCT02251379|Respiratory System Agents|respiratory system agents|mesh-ancestor
6216266|NCT02251379|Glucocorticoids|glucocorticoids|mesh-ancestor
6216267|NCT02251379|Hormones|hormones|mesh-ancestor
6216268|NCT02251379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6216269|NCT02251379|Sympathomimetics|sympathomimetics|mesh-ancestor
6216270|NCT02251379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6216271|NCT02251379|Dermatologic Agents|dermatologic agents|mesh-ancestor
6216272|NCT02251379|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6216273|NCT02251548|Cyclophosphamide|cyclophosphamide|mesh-list
6216274|NCT02251548|Rituximab|rituximab|mesh-list
6216275|NCT02251548|Fludarabine|fludarabine|mesh-list
6216276|NCT02251548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6216277|NCT02251548|Immunologic Factors|immunologic factors|mesh-ancestor
6216278|NCT02251548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216279|NCT02251548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6216280|NCT02251548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6216281|NCT02251548|Alkylating Agents|alkylating agents|mesh-ancestor
6216282|NCT02251548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216283|NCT02251548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6216284|NCT02251548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6216285|NCT02251548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6216286|NCT02251613|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
6216287|NCT02251613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6216288|NCT02251613|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6216289|NCT02251613|Epinastine|epinastine|mesh-list
6216290|NCT02251613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6216291|NCT02251613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6216292|NCT02251613|Analgesics|analgesics|mesh-ancestor
6216293|NCT02251613|Sensory System Agents|sensory system agents|mesh-ancestor
6216294|NCT02251613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6216295|NCT02251613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216296|NCT02251613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6497542|NCT00633269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497543|NCT00633269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6497544|NCT00633282|Pioglitazone|pioglitazone|mesh-list
6216297|NCT02251613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6216298|NCT02251613|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6216299|NCT02251613|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6216300|NCT02251613|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6216301|NCT02251613|Histamine Antagonists|histamine antagonists|mesh-ancestor
6216302|NCT02251613|Histamine Agents|histamine agents|mesh-ancestor
6216303|NCT02251613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6216304|NCT02251613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216305|NCT02251717|Sofosbuvir|sofosbuvir|mesh-list
6216306|NCT02251717|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
6216307|NCT02251717|Ledipasvir|ledipasvir|mesh-list
6216308|NCT02251717|Antiviral Agents|antiviral agents|mesh-ancestor
6216309|NCT02251717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6216310|NCT02251912|Oxytocin|oxytocin|mesh-list
6216311|NCT02251912|Oxytocics|oxytocics|mesh-ancestor
6216312|NCT02251912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6216313|NCT02251912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216314|NCT02251938|Sirolimus|sirolimus|mesh-list
6216315|NCT02251938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6216316|NCT02251938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6216317|NCT02251938|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6216318|NCT02251938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6216319|NCT02251938|Antifungal Agents|antifungal agents|mesh-ancestor
6216320|NCT02251938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6216321|NCT02251938|Immunologic Factors|immunologic factors|mesh-ancestor
6216322|NCT02251938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216323|NCT02251990|Grazoprevir|grazoprevir|mesh-list
6216324|NCT02251990|Antiviral Agents|antiviral agents|mesh-ancestor
6216325|NCT02251990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6216326|NCT02252016|Grazoprevir|grazoprevir|mesh-list
6216327|NCT02252016|Antiviral Agents|antiviral agents|mesh-ancestor
6216328|NCT02252016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6216329|NCT02252042|Docetaxel|docetaxel|mesh-list
6216330|NCT02252042|Pembrolizumab|pembrolizumab|mesh-list
6216331|NCT02252042|Methotrexate|methotrexate|mesh-list
6216332|NCT02252042|Cetuximab|cetuximab|mesh-list
6216333|NCT02252042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6216334|NCT02252042|Tubulin Modulators|tubulin modulators|mesh-ancestor
6216335|NCT02252042|Antimitotic Agents|antimitotic agents|mesh-ancestor
6216336|NCT02252042|Mitosis Modulators|mitosis modulators|mesh-ancestor
6216337|NCT02252042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216338|NCT02252042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6216339|NCT02252042|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6216340|NCT02252042|Abortifacient Agents|abortifacient agents|mesh-ancestor
6216341|NCT02252042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6216342|NCT02252042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216343|NCT02252042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6216344|NCT02252042|Antimetabolites|antimetabolites|mesh-ancestor
6497545|NCT00633282|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
6216345|NCT02252042|Dermatologic Agents|dermatologic agents|mesh-ancestor
6216346|NCT02252042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6216347|NCT02252042|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6216348|NCT02252042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6216349|NCT02252042|Immunologic Factors|immunologic factors|mesh-ancestor
6216350|NCT02252042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6216351|NCT02252042|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6216352|NCT02252081|Metformin|metformin|mesh-list
6216353|NCT02252081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6216354|NCT02252081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6242973|NCT02658734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242974|NCT02659020|Gemcitabine|gemcitabine|mesh-list
6242975|NCT02659020|Docetaxel|docetaxel|mesh-list
6242976|NCT02659020|Olaratumab|olaratumab|mesh-list
6242977|NCT02659020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6242978|NCT02659020|Antimetabolites|antimetabolites|mesh-ancestor
6242979|NCT02659020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242980|NCT02659020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6242981|NCT02659020|Antiviral Agents|antiviral agents|mesh-ancestor
6242982|NCT02659020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6242983|NCT02659020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6242984|NCT02659020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6242985|NCT02659020|Immunologic Factors|immunologic factors|mesh-ancestor
5702529|NCT03337607|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5702530|NCT03337607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5702531|NCT03337607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5702532|NCT03337607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5702533|NCT03337607|Anticonvulsants|anticonvulsants|mesh-ancestor
5702534|NCT03337607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5702535|NCT03337607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5702536|NCT03337607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5702537|NCT03337607|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5702538|NCT03337607|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5702539|NCT03337607|Autonomic Agents|autonomic agents|mesh-ancestor
5702540|NCT03337607|Vasodilator Agents|vasodilator agents|mesh-ancestor
6242986|NCT02659020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6242987|NCT02659020|Tubulin Modulators|tubulin modulators|mesh-ancestor
6242988|NCT02659020|Antimitotic Agents|antimitotic agents|mesh-ancestor
6242989|NCT02659020|Mitosis Modulators|mitosis modulators|mesh-ancestor
6242990|NCT02659059|Paclitaxel|paclitaxel|mesh-list
6242991|NCT02659059|Cisplatin|cisplatin|mesh-list
6242992|NCT02659059|Carboplatin|carboplatin|mesh-list
6242993|NCT02659059|Nivolumab|nivolumab|mesh-list
6242994|NCT02659059|Pemetrexed|pemetrexed|mesh-list
6242995|NCT02659059|Ipilimumab|ipilimumab|mesh-list
6242996|NCT02659059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6242997|NCT02659059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6242998|NCT02659059|Tubulin Modulators|tubulin modulators|mesh-ancestor
6242999|NCT02659059|Antimitotic Agents|antimitotic agents|mesh-ancestor
6243000|NCT02659059|Mitosis Modulators|mitosis modulators|mesh-ancestor
6243001|NCT02659059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243002|NCT02659059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6243003|NCT02659059|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6243004|NCT02659059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6243005|NCT02659059|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6243006|NCT02659059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6243007|NCT02659501|Acetaminophen|acetaminophen|mesh-list
6243008|NCT02659501|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
6243009|NCT02659501|Epinephrine|epinephrine|mesh-list
6243010|NCT02659501|Diazepam|diazepam|mesh-list
6243011|NCT02659501|Morphine|morphine|mesh-list
6243012|NCT02659501|Hydrocodone|hydrocodone|mesh-list
6243013|NCT02659501|Bupivacaine|bupivacaine|mesh-list
6243014|NCT02659501|Anesthetics, Local|anesthetics, local|mesh-ancestor
6243015|NCT02659501|Anesthetics|anesthetics|mesh-ancestor
6243016|NCT02659501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6243017|NCT02659501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243018|NCT02659501|Sensory System Agents|sensory system agents|mesh-ancestor
6243019|NCT02659501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6243020|NCT02659501|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6243021|NCT02659501|Narcotics|narcotics|mesh-ancestor
6243022|NCT02659501|Analgesics|analgesics|mesh-ancestor
6243023|NCT02659501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6243024|NCT02659501|Antipyretics|antipyretics|mesh-ancestor
6243025|NCT02659501|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6243026|NCT02659501|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6243027|NCT02659501|Adrenergic Agents|adrenergic agents|mesh-ancestor
6243028|NCT02659501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6216355|NCT02252354|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6216356|NCT02252354|Relugolix|relugolix|mesh-list
6216357|NCT02252354|Androgen Antagonists|androgen antagonists|mesh-ancestor
6216358|NCT02252354|Hormone Antagonists|hormone antagonists|mesh-ancestor
6216359|NCT02252354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6216360|NCT02252354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216361|NCT02252406|Ranolazine|ranolazine|mesh-list
6216362|NCT02252406|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6216363|NCT02252406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6216364|NCT02252406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216365|NCT02252445|Propofol|propofol|mesh-list
6216366|NCT02252445|Sevoflurane|sevoflurane|mesh-list
6216367|NCT02252445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6216368|NCT02252445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6216369|NCT02252445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216370|NCT02252445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6216371|NCT02252445|Anesthetics, General|anesthetics, general|mesh-ancestor
6216372|NCT02252445|Anesthetics|anesthetics|mesh-ancestor
6216373|NCT02252445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6216374|NCT02252445|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6216375|NCT02252536|Gabapentin|gabapentin|mesh-list
6216376|NCT02252536|Analgesics|analgesics|mesh-ancestor
6216377|NCT02252536|Sensory System Agents|sensory system agents|mesh-ancestor
6216378|NCT02252536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6216379|NCT02252536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216380|NCT02252536|Anticonvulsants|anticonvulsants|mesh-ancestor
6216381|NCT02252536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6216382|NCT02252536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6216383|NCT02252536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6216384|NCT02252536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6216385|NCT02252536|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6216386|NCT02252536|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6216387|NCT02252536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6216388|NCT02252536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216389|NCT02252536|Antimanic Agents|antimanic agents|mesh-ancestor
6216390|NCT02252588|Chlorhexidine|chlorhexidine|mesh-list
6216391|NCT02252588|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6216392|NCT02252588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6216393|NCT02252588|Disinfectants|disinfectants|mesh-ancestor
6216394|NCT02252965|Metformin|metformin|mesh-list
6497546|NCT00633282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6497547|NCT00633282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497548|NCT00633347|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6497549|NCT00633347|Cetrorelix|cetrorelix|mesh-list
6497550|NCT00633347|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
6497551|NCT00633347|Hormones|hormones|mesh-ancestor
6497552|NCT00633347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6497553|NCT00633347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497554|NCT00633347|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6497555|NCT00633347|Fertility Agents|fertility agents|mesh-ancestor
6497556|NCT00633347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5702541|NCT03337581|Dexmedetomidine|dexmedetomidine|mesh-list
5702542|NCT03337581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5702543|NCT03337581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5702544|NCT03337581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702545|NCT03337581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5702546|NCT03337581|Analgesics|analgesics|mesh-ancestor
5702547|NCT03337581|Sensory System Agents|sensory system agents|mesh-ancestor
5702548|NCT03337581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5702549|NCT03337581|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5702550|NCT03337581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5702551|NCT03337581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5702552|NCT03337581|Adrenergic Agents|adrenergic agents|mesh-ancestor
5702553|NCT03337581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5702554|NCT03337581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5702555|NCT03337529|Ascorbic Acid|ascorbic acid|mesh-list
5702556|NCT03337529|Vitamins|vitamins|mesh-ancestor
5702557|NCT03337529|Micronutrients|micronutrients|mesh-ancestor
5702558|NCT03337529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702559|NCT03337529|Antioxidants|antioxidants|mesh-ancestor
5721092|NCT03208465|Protease Inhibitors|protease inhibitors|mesh-ancestor
6497557|NCT00633347|Hormone Antagonists|hormone antagonists|mesh-ancestor
6497558|NCT00633347|Luteolytic Agents|luteolytic agents|mesh-ancestor
6497559|NCT00633347|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6497560|NCT00633347|Contraceptive Agents|contraceptive agents|mesh-ancestor
5702560|NCT03337529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5702561|NCT03337529|Protective Agents|protective agents|mesh-ancestor
5702562|NCT03337503|Dronabinol|dronabinol|mesh-list
5702563|NCT03337503|Hallucinogens|hallucinogens|mesh-ancestor
5702564|NCT03337503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702565|NCT03337503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5702566|NCT03337503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6216395|NCT02252965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6216396|NCT02252965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216397|NCT02253160|Sargramostim|sargramostim|mesh-list
6216398|NCT02253160|Lenograstim|lenograstim|mesh-list
6216399|NCT02253160|Immunologic Factors|immunologic factors|mesh-ancestor
6216400|NCT02253160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216401|NCT02253160|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6216402|NCT02253173|Estradiol|estradiol|mesh-list
6216403|NCT02253173|Estrogens|estrogens|mesh-ancestor
6216404|NCT02253173|Hormones|hormones|mesh-ancestor
6216405|NCT02253173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6216406|NCT02253173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216407|NCT02253654|Epoetin Alfa|epoetin alfa|mesh-list
6216408|NCT02253654|Hematinics|hematinics|mesh-ancestor
6216409|NCT02253992|Nivolumab|nivolumab|mesh-list
6216410|NCT02253992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6216411|NCT02253992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6216412|NCT02253992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6216413|NCT02253992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216414|NCT02254252|Nicorandil|nicorandil|mesh-list
6216415|NCT02254252|Nitroglycerin|nitroglycerin|mesh-list
6216416|NCT02254252|Vasodilator Agents|vasodilator agents|mesh-ancestor
6216417|NCT02254252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6216418|NCT02254252|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6216419|NCT02254252|Vitamin B Complex|vitamin b complex|mesh-ancestor
6216420|NCT02254252|Vitamins|vitamins|mesh-ancestor
6216421|NCT02254252|Micronutrients|micronutrients|mesh-ancestor
6216422|NCT02254252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216423|NCT02254278|Cisplatin|cisplatin|mesh-list
6216424|NCT02254278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6216425|NCT02254291|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6216426|NCT02254291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6216427|NCT02254291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216428|NCT02254291|Incretins|incretins|mesh-ancestor
6216429|NCT02254291|Hormones|hormones|mesh-ancestor
6216430|NCT02254291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6216431|NCT02254291|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6216432|NCT02254291|Protease Inhibitors|protease inhibitors|mesh-ancestor
6216433|NCT02254291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6216434|NCT02254291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216435|NCT02254304|Interferons|interferons|mesh-list
6216436|NCT02254304|Interferon-beta|interferon-beta|mesh-list
6216437|NCT02254304|Interferon beta-1a|interferon beta-1a|mesh-list
6216438|NCT02254304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6216439|NCT02254304|Antiviral Agents|antiviral agents|mesh-ancestor
6216440|NCT02254304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6216441|NCT02254304|Immunologic Factors|immunologic factors|mesh-ancestor
6216442|NCT02254304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216443|NCT02254304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6216444|NCT02254551|Bortezomib|bortezomib|mesh-list
6216445|NCT02254551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6216446|NCT02254681|Gemcitabine|gemcitabine|mesh-list
6216447|NCT02254681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6216448|NCT02254681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6216449|NCT02254681|Antimetabolites|antimetabolites|mesh-ancestor
6216450|NCT02254681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216451|NCT02254681|Antiviral Agents|antiviral agents|mesh-ancestor
6216452|NCT02254681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6216453|NCT02254681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6676041|NCT01578668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5702567|NCT03337503|Analgesics|analgesics|mesh-ancestor
5702568|NCT03337503|Sensory System Agents|sensory system agents|mesh-ancestor
5702569|NCT03337503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5702570|NCT03337503|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5702571|NCT03337503|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5702572|NCT03337503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5702573|NCT03337503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216454|NCT02254681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6216455|NCT02254681|Immunologic Factors|immunologic factors|mesh-ancestor
6216456|NCT02254681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216457|NCT02254772|Ipilimumab|ipilimumab|mesh-list
6216458|NCT02254772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6216459|NCT02254772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6216460|NCT02254772|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6216461|NCT02254772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216462|NCT02255097|Pembrolizumab|pembrolizumab|mesh-list
6216463|NCT02255097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6216464|NCT02255097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6216465|NCT02255110|Doxorubicin|doxorubicin|mesh-list
6216466|NCT02255110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6216467|NCT02255110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6216468|NCT02255110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6216469|NCT02255110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6216470|NCT02255110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6216471|NCT02255110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216472|NCT02255175|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6216473|NCT02255175|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6216474|NCT02255175|Estradiol|estradiol|mesh-list
6216475|NCT02255175|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6216476|NCT02255175|Progesterone|progesterone|mesh-list
6216477|NCT02255175|Estrogens|estrogens|mesh-ancestor
6216478|NCT02255175|Hormones|hormones|mesh-ancestor
6216479|NCT02255175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6216480|NCT02255175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216481|NCT02255175|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6216482|NCT02255175|Contraceptive Agents|contraceptive agents|mesh-ancestor
6216483|NCT02255175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6216484|NCT02255175|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6216485|NCT02255175|Progestins|progestins|mesh-ancestor
6216486|NCT02255279|Vaccines|vaccines|mesh-list
6216487|NCT02255279|Immunologic Factors|immunologic factors|mesh-ancestor
6216488|NCT02255279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216489|NCT02255357|Oxytocin|oxytocin|mesh-list
6216490|NCT02255357|Oxytocics|oxytocics|mesh-ancestor
6216491|NCT02255357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6216492|NCT02255357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216493|NCT02255461|Palbociclib|palbociclib|mesh-list
6216494|NCT02255461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6216495|NCT02255461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6216496|NCT02255461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6216497|NCT02255461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216498|NCT02255500|Bupivacaine|bupivacaine|mesh-list
6216499|NCT02255500|Anesthetics, Local|anesthetics, local|mesh-ancestor
6216500|NCT02255500|Anesthetics|anesthetics|mesh-ancestor
6216501|NCT02255500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6216502|NCT02255500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216503|NCT02255500|Sensory System Agents|sensory system agents|mesh-ancestor
6216504|NCT02255500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6216505|NCT02255513|Methylphenidate|methylphenidate|mesh-list
6216506|NCT02255513|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6216507|NCT02255513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216508|NCT02255513|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6216509|NCT02255513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6216510|NCT02255513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6216511|NCT02255513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216512|NCT02255513|Dopamine Agents|dopamine agents|mesh-ancestor
6216513|NCT02255513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6216514|NCT02255565|Methylphenidate|methylphenidate|mesh-list
6216515|NCT02255565|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6216516|NCT02255565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216517|NCT02255565|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6216518|NCT02255565|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6216519|NCT02255565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6216520|NCT02255565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216521|NCT02255565|Dopamine Agents|dopamine agents|mesh-ancestor
6216522|NCT02255565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6216523|NCT02255656|Alemtuzumab|alemtuzumab|mesh-list
6216524|NCT02255656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6216525|NCT02255656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6216526|NCT02255760|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6216527|NCT02255760|Immunologic Factors|immunologic factors|mesh-ancestor
6216528|NCT02255760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216529|NCT02256111|Androgens|androgens|mesh-list
6216530|NCT02256111|Hormones|hormones|mesh-ancestor
6216531|NCT02256111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6216532|NCT02256111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216533|NCT02256189|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6216534|NCT02256189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6216535|NCT02256189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216536|NCT02256189|Incretins|incretins|mesh-ancestor
6216537|NCT02256189|Hormones|hormones|mesh-ancestor
6216538|NCT02256189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6216539|NCT02256189|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6216540|NCT02256189|Protease Inhibitors|protease inhibitors|mesh-ancestor
6216541|NCT02256189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6216542|NCT02256189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216543|NCT02256267|Rifampin|rifampin|mesh-list
6216544|NCT02256267|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6216545|NCT02256267|Antitubercular Agents|antitubercular agents|mesh-ancestor
6216546|NCT02256267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6216547|NCT02256267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6216548|NCT02256267|Leprostatic Agents|leprostatic agents|mesh-ancestor
6216549|NCT02256267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6216550|NCT02256267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6216551|NCT02256267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216552|NCT02256267|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6216553|NCT02256267|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6216554|NCT02256267|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6216555|NCT02256267|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6216556|NCT02256267|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6216557|NCT02256267|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6216558|NCT02256358|Midazolam|midazolam|mesh-list
6216559|NCT02256358|Ketamine|ketamine|mesh-list
6216560|NCT02256358|Analgesics|analgesics|mesh-ancestor
6216561|NCT02256358|Sensory System Agents|sensory system agents|mesh-ancestor
6216562|NCT02256358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6497561|NCT00633347|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6497562|NCT00633347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6216563|NCT02256358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216564|NCT02256358|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6216565|NCT02256358|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6216566|NCT02256358|Anesthetics, General|anesthetics, general|mesh-ancestor
5702574|NCT03337503|Hormones|hormones|mesh-ancestor
5702575|NCT03337503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5702576|NCT03337373|Cisatracurium|cisatracurium|mesh-list
5702577|NCT03337373|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5702578|NCT03337373|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5702579|NCT03337373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5702580|NCT03337373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702581|NCT03337282|Anesthetics|anesthetics|mesh-list
5702582|NCT03337282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5702583|NCT03337282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702584|NCT03337191|Morphine|morphine|mesh-list
5702585|NCT03337191|Levobupivacaine|levobupivacaine|mesh-list
6216567|NCT02256358|Anesthetics|anesthetics|mesh-ancestor
6216568|NCT02256358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6216569|NCT02256358|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6216570|NCT02256358|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5702586|NCT03337191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5702587|NCT03337191|Narcotics|narcotics|mesh-ancestor
5702588|NCT03337191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5702589|NCT03337191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702590|NCT03337191|Analgesics|analgesics|mesh-ancestor
5702591|NCT03337191|Sensory System Agents|sensory system agents|mesh-ancestor
5702592|NCT03337191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5702593|NCT03337191|Anesthetics, Local|anesthetics, local|mesh-ancestor
6216571|NCT02256358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6216572|NCT02256358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216573|NCT02256358|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6216574|NCT02256358|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6216575|NCT02256358|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6216576|NCT02256358|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5702594|NCT03337191|Anesthetics|anesthetics|mesh-ancestor
5702595|NCT03337126|Metronidazole|metronidazole|mesh-list
5721093|NCT03208465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5702596|NCT03337126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5702597|NCT03337126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5702598|NCT03337126|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5702599|NCT03337126|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5702600|NCT03337035|Oxytocin|oxytocin|mesh-list
6216577|NCT02256358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6216578|NCT02256358|GABA Modulators|gaba modulators|mesh-ancestor
6216579|NCT02256358|GABA Agents|gaba agents|mesh-ancestor
6216580|NCT02256436|Paclitaxel|paclitaxel|mesh-list
6216581|NCT02256436|Docetaxel|docetaxel|mesh-list
6216582|NCT02256436|Pembrolizumab|pembrolizumab|mesh-list
6216583|NCT02256436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6216584|NCT02256436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6216585|NCT02256436|Tubulin Modulators|tubulin modulators|mesh-ancestor
6216586|NCT02256436|Antimitotic Agents|antimitotic agents|mesh-ancestor
6216587|NCT02256436|Mitosis Modulators|mitosis modulators|mesh-ancestor
6216588|NCT02256436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216589|NCT02256436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6216590|NCT02256540|Resveratrol|resveratrol|mesh-list
6216591|NCT02256540|Estradiol|estradiol|mesh-list
6216592|NCT02256540|Estrogens|estrogens|mesh-ancestor
6216593|NCT02256540|Hormones|hormones|mesh-ancestor
6216594|NCT02256540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6216595|NCT02256540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216596|NCT02256540|Antioxidants|antioxidants|mesh-ancestor
6216597|NCT02256540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216598|NCT02256540|Protective Agents|protective agents|mesh-ancestor
6216599|NCT02256540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6216600|NCT02256540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6216601|NCT02256969|Sulfacetamide|sulfacetamide|mesh-list
6216602|NCT02256969|Prednisolone|prednisolone|mesh-list
6216603|NCT02256969|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6216604|NCT02256969|Methylprednisolone|methylprednisolone|mesh-list
6216605|NCT02256969|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6216606|NCT02256969|Prednisolone acetate|prednisolone acetate|mesh-list
6216607|NCT02256969|Mineral Oil|mineral oil|mesh-list
6216608|NCT02256969|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6216609|NCT02256969|Prednisolone phosphate|prednisolone phosphate|mesh-list
6216610|NCT02256969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6216611|NCT02256969|Glucocorticoids|glucocorticoids|mesh-ancestor
6216612|NCT02256969|Hormones|hormones|mesh-ancestor
6216613|NCT02256969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6216614|NCT02256969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216615|NCT02256969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6216616|NCT02256969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6216617|NCT02256969|Antiemetics|antiemetics|mesh-ancestor
6216618|NCT02256969|Autonomic Agents|autonomic agents|mesh-ancestor
6216619|NCT02256969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6216620|NCT02256969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6216621|NCT02256969|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6216622|NCT02256969|Protective Agents|protective agents|mesh-ancestor
6216623|NCT02256969|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6216624|NCT02256969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6216625|NCT02256969|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6216626|NCT02256969|Renal Agents|renal agents|mesh-ancestor
5702601|NCT03337035|Oxytocics|oxytocics|mesh-ancestor
5702602|NCT03337035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5702603|NCT03337035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702604|NCT03337009|Naloxone|naloxone|mesh-list
5702605|NCT03337009|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6676042|NCT01578668|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6216627|NCT02256969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6216628|NCT02256969|Emollients|emollients|mesh-ancestor
6216629|NCT02256969|Dermatologic Agents|dermatologic agents|mesh-ancestor
6216630|NCT02256982|Gemcitabine|gemcitabine|mesh-list
6216631|NCT02256982|Cisplatin|cisplatin|mesh-list
6676043|NCT01578668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6676044|NCT01578668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6676045|NCT01578720|Aflibercept|aflibercept|mesh-list
6676046|NCT01578720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6676047|NCT01578720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6676048|NCT01578720|Growth Substances|growth substances|mesh-ancestor
6676049|NCT01578720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702606|NCT03337009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216632|NCT02256982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6216633|NCT02256982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6216634|NCT02256982|Antimetabolites|antimetabolites|mesh-ancestor
6216635|NCT02256982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216636|NCT02256982|Antiviral Agents|antiviral agents|mesh-ancestor
6216637|NCT02256982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6216638|NCT02256982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6216639|NCT02256982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6216640|NCT02256982|Immunologic Factors|immunologic factors|mesh-ancestor
6216641|NCT02256982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216642|NCT02257372|Albuterol|albuterol|mesh-list
6216643|NCT02257372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6216644|NCT02257372|Autonomic Agents|autonomic agents|mesh-ancestor
6216645|NCT02257372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6216646|NCT02257372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216647|NCT02257372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6216648|NCT02257372|Respiratory System Agents|respiratory system agents|mesh-ancestor
6216649|NCT02257372|Tocolytic Agents|tocolytic agents|mesh-ancestor
5702607|NCT03337009|Sensory System Agents|sensory system agents|mesh-ancestor
5702608|NCT03337009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5702609|NCT03336983|Zoledronic Acid|zoledronic acid|mesh-list
5702610|NCT03336983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5702611|NCT03336983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702612|NCT03336970|Calcium|calcium|mesh-list
6216650|NCT02257372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6216651|NCT02257372|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6216652|NCT02257372|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6216653|NCT02257372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6216654|NCT02257372|Adrenergic Agents|adrenergic agents|mesh-ancestor
6497563|NCT00633347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6497564|NCT00633373|Cyclosporine|cyclosporine|mesh-list
6497565|NCT00633373|Cyclosporins|cyclosporins|mesh-list
6497566|NCT00633373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6497567|NCT00633373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497568|NCT00633373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6497569|NCT00633373|Immunologic Factors|immunologic factors|mesh-ancestor
6497570|NCT00633373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497571|NCT00633373|Antifungal Agents|antifungal agents|mesh-ancestor
6497572|NCT00633373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6497573|NCT00633373|Dermatologic Agents|dermatologic agents|mesh-ancestor
6497574|NCT00633373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6497575|NCT00633373|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6497576|NCT00633386|Celecoxib|celecoxib|mesh-list
6497577|NCT00633386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6497578|NCT00633386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6497579|NCT00633386|Analgesics|analgesics|mesh-ancestor
6497580|NCT00633386|Sensory System Agents|sensory system agents|mesh-ancestor
6497581|NCT00633386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6497582|NCT00633386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497583|NCT00633386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6497584|NCT00633386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6497585|NCT00633386|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6497586|NCT00633386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6497587|NCT00633386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6497588|NCT00633386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497589|NCT00633412|Esomeprazole|esomeprazole|mesh-list
6497590|NCT00633412|Ranitidine|ranitidine|mesh-list
6497591|NCT00633412|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
6497592|NCT00633412|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6497593|NCT00633412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6497594|NCT00633412|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6497595|NCT00633412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6497596|NCT00633412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497597|NCT00633412|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6497598|NCT00633412|Histamine Antagonists|histamine antagonists|mesh-ancestor
6497599|NCT00633412|Histamine Agents|histamine agents|mesh-ancestor
6497600|NCT00633412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6497601|NCT00633412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497602|NCT00633425|Glimepiride|glimepiride|mesh-list
6497603|NCT00633425|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6497604|NCT00633425|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6497605|NCT00633425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497606|NCT00633425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6497607|NCT00633425|Immunologic Factors|immunologic factors|mesh-ancestor
6497608|NCT00633438|Celecoxib|celecoxib|mesh-list
5702613|NCT03336970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6216655|NCT02257372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6497609|NCT00633438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6216656|NCT02257372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216657|NCT02257385|Albuterol|albuterol|mesh-list
6216658|NCT02257385|Tiotropium Bromide|tiotropium bromide|mesh-list
6216659|NCT02257385|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6216660|NCT02257385|Autonomic Agents|autonomic agents|mesh-ancestor
6216661|NCT02257385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6216662|NCT02257385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216663|NCT02257385|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6216664|NCT02257385|Respiratory System Agents|respiratory system agents|mesh-ancestor
6216665|NCT02257385|Parasympatholytics|parasympatholytics|mesh-ancestor
6216666|NCT02257385|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6216667|NCT02257385|Cholinergic Agents|cholinergic agents|mesh-ancestor
6216668|NCT02257385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6216669|NCT02257385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216670|NCT02257385|Tocolytic Agents|tocolytic agents|mesh-ancestor
6216671|NCT02257385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6216672|NCT02257385|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6216673|NCT02257385|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6216674|NCT02257385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6216675|NCT02257385|Adrenergic Agents|adrenergic agents|mesh-ancestor
6216676|NCT02257541|Imatinib Mesylate|imatinib mesylate|mesh-list
6216677|NCT02257541|Infigratinib|infigratinib|mesh-list
6216678|NCT02257541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6216679|NCT02257541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5702614|NCT03336970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702615|NCT03336918|Lithium Carbonate|lithium carbonate|mesh-list
5702616|NCT03336918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5702617|NCT03336918|Antidepressive Agents|antidepressive agents|mesh-ancestor
5702618|NCT03336918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5702619|NCT03336918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5702620|NCT03336918|Antimanic Agents|antimanic agents|mesh-ancestor
5702621|NCT03336918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5702622|NCT03336918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5702623|NCT03336918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702624|NCT03336840|Metformin|metformin|mesh-list
5702625|NCT03336840|Promethazine|promethazine|mesh-list
6216680|NCT02257541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6216681|NCT02257541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216682|NCT02257632|Ranibizumab|ranibizumab|mesh-list
6216683|NCT02257632|Aflibercept|aflibercept|mesh-list
6216684|NCT02257632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6216685|NCT02257632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6216686|NCT02257632|Growth Substances|growth substances|mesh-ancestor
6216687|NCT02257632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216688|NCT02257632|Growth Inhibitors|growth inhibitors|mesh-ancestor
6216689|NCT02257632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6216690|NCT02257957|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6216691|NCT02257957|Hyaluronic Acid|hyaluronic acid|mesh-list
6216692|NCT02257957|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6216693|NCT02257957|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6216694|NCT02257957|Immunologic Factors|immunologic factors|mesh-ancestor
6216695|NCT02257957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216696|NCT02257957|Viscosupplements|viscosupplements|mesh-ancestor
6216697|NCT02257957|Protective Agents|protective agents|mesh-ancestor
6216698|NCT02257970|Ketoprofen|ketoprofen|mesh-list
6216699|NCT02257970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6216700|NCT02257970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6216701|NCT02257970|Analgesics|analgesics|mesh-ancestor
6216702|NCT02257970|Sensory System Agents|sensory system agents|mesh-ancestor
6216703|NCT02257970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6216704|NCT02257970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216705|NCT02257970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6216706|NCT02257970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6216707|NCT02257970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6216708|NCT02257970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6216709|NCT02257970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216710|NCT02258074|Niacinamide|niacinamide|mesh-list
6216711|NCT02258074|Niacin|niacin|mesh-list
6216712|NCT02258074|Nicotinic Acids|nicotinic acids|mesh-list
6216713|NCT02258074|Vitamin B Complex|vitamin b complex|mesh-ancestor
6216714|NCT02258074|Vitamins|vitamins|mesh-ancestor
6216715|NCT02258074|Micronutrients|micronutrients|mesh-ancestor
6216716|NCT02258074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216717|NCT02258074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6216718|NCT02258074|Antimetabolites|antimetabolites|mesh-ancestor
6216719|NCT02258074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216720|NCT02258074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6216721|NCT02258074|Vasodilator Agents|vasodilator agents|mesh-ancestor
6216722|NCT02258217|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6216723|NCT02258217|Hormones|hormones|mesh-ancestor
6216724|NCT02258217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6216725|NCT02258217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216726|NCT02258334|Vaccines|vaccines|mesh-list
6216727|NCT02258334|Immunologic Factors|immunologic factors|mesh-ancestor
6216728|NCT02258334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216729|NCT02258412|Ethanol|ethanol|mesh-list
6216730|NCT02258412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
6216731|NCT02258412|Hand Sanitizers|hand sanitizers|mesh-list
6216732|NCT02258412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6216733|NCT02258412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6216734|NCT02258412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216735|NCT02258412|Disinfectants|disinfectants|mesh-ancestor
6216736|NCT02258464|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
6216737|NCT02258464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6216738|NCT02258529|Rituximab|rituximab|mesh-list
6216739|NCT02258529|Idelalisib|idelalisib|mesh-list
6216740|NCT02258529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6216741|NCT02258529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6216742|NCT02258529|Immunologic Factors|immunologic factors|mesh-ancestor
6216743|NCT02258529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216744|NCT02258529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6216745|NCT02258529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6216746|NCT02258529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216747|NCT02259010|Itraconazole|itraconazole|mesh-list
6216748|NCT02259010|Antifungal Agents|antifungal agents|mesh-ancestor
6216749|NCT02259010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6216750|NCT02259010|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6216751|NCT02259010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6216752|NCT02259010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6216753|NCT02259010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216754|NCT02259010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6216755|NCT02259010|Hormone Antagonists|hormone antagonists|mesh-ancestor
6216756|NCT02259010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6216757|NCT02259010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216758|NCT02259010|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6216759|NCT02259088|Ranibizumab|ranibizumab|mesh-list
6216760|NCT02259088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6216761|NCT02259088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6216762|NCT02259088|Growth Substances|growth substances|mesh-ancestor
6216763|NCT02259088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216764|NCT02259088|Growth Inhibitors|growth inhibitors|mesh-ancestor
6216765|NCT02259088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6216766|NCT02259231|Nivolumab|nivolumab|mesh-list
6216767|NCT02259231|Ipilimumab|ipilimumab|mesh-list
6216768|NCT02259231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6216769|NCT02259231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6216770|NCT02259231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6216771|NCT02259231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216772|NCT02259348|Aldesleukin|aldesleukin|mesh-list
6216773|NCT02259348|Cyclophosphamide|cyclophosphamide|mesh-list
6216774|NCT02259348|Melphalan|melphalan|mesh-list
6216775|NCT02259348|Mechlorethamine|mechlorethamine|mesh-list
6216776|NCT02259348|Thiotepa|thiotepa|mesh-list
6216777|NCT02259348|Rituximab|rituximab|mesh-list
6216778|NCT02259348|Fludarabine|fludarabine|mesh-list
6216779|NCT02259348|Fludarabine phosphate|fludarabine phosphate|mesh-list
6216780|NCT02259348|Interleukin-2|interleukin-2|mesh-list
6216781|NCT02259348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6216782|NCT02259348|Immunologic Factors|immunologic factors|mesh-ancestor
6216783|NCT02259348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216784|NCT02259348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6216785|NCT02259348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6216786|NCT02259348|Alkylating Agents|alkylating agents|mesh-ancestor
6216787|NCT02259348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216788|NCT02259348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6216789|NCT02259348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6216790|NCT02259348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6216791|NCT02259348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6216792|NCT02259348|Antimetabolites|antimetabolites|mesh-ancestor
6216793|NCT02259348|Antiviral Agents|antiviral agents|mesh-ancestor
6676050|NCT01578720|Growth Inhibitors|growth inhibitors|mesh-ancestor
6216794|NCT02259348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6216795|NCT02259348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6216796|NCT02259348|Analgesics|analgesics|mesh-ancestor
6216797|NCT02259348|Sensory System Agents|sensory system agents|mesh-ancestor
6216798|NCT02259348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6216799|NCT02259348|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6216800|NCT02259348|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6216801|NCT02259582|Carboplatin|carboplatin|mesh-list
6216802|NCT02259582|Pemetrexed|pemetrexed|mesh-list
6216803|NCT02259582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6216804|NCT02259582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6676051|NCT01578720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6676052|NCT01578824|Methacholine Chloride|methacholine chloride|mesh-list
6216805|NCT02259582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216806|NCT02259582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6216807|NCT02259582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6216808|NCT02259608|BCG Vaccine|bcg vaccine|mesh-list
6216809|NCT02259608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6216810|NCT02259608|Immunologic Factors|immunologic factors|mesh-ancestor
6216811|NCT02259608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216812|NCT02260154|Mebeverine|mebeverine|mesh-list
6216813|NCT02260154|Alverine|alverine|mesh-list
6216814|NCT02260154|Anticonvulsants|anticonvulsants|mesh-ancestor
6216815|NCT02260154|Parasympatholytics|parasympatholytics|mesh-ancestor
6216816|NCT02260154|Autonomic Agents|autonomic agents|mesh-ancestor
6216817|NCT02260154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6216818|NCT02260154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243029|NCT02659501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243030|NCT02659501|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6243031|NCT02659501|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6243032|NCT02659501|Autonomic Agents|autonomic agents|mesh-ancestor
6243033|NCT02659501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6243034|NCT02659501|Respiratory System Agents|respiratory system agents|mesh-ancestor
6243035|NCT02659501|Mydriatics|mydriatics|mesh-ancestor
6243036|NCT02659501|Sympathomimetics|sympathomimetics|mesh-ancestor
6243037|NCT02659501|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6243038|NCT02659501|Antitussive Agents|antitussive agents|mesh-ancestor
6243039|NCT02659501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6243040|NCT02659501|Anticonvulsants|anticonvulsants|mesh-ancestor
6243041|NCT02659501|Antiemetics|antiemetics|mesh-ancestor
6243042|NCT02659501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6243043|NCT02659501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6243044|NCT02659501|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6243045|NCT02659501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6243046|NCT02659501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6243047|NCT02659501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6243048|NCT02659501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6243049|NCT02659501|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6243050|NCT02659501|Anesthetics, General|anesthetics, general|mesh-ancestor
6243051|NCT02659501|GABA Modulators|gaba modulators|mesh-ancestor
6243052|NCT02659501|GABA Agents|gaba agents|mesh-ancestor
6497610|NCT00633438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6497611|NCT00633438|Analgesics|analgesics|mesh-ancestor
6497612|NCT00633438|Sensory System Agents|sensory system agents|mesh-ancestor
6497613|NCT00633438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6497614|NCT00633438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497615|NCT00633438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6497616|NCT00633438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6497617|NCT00633438|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6497618|NCT00633438|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6497619|NCT00633438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6497620|NCT00633438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497621|NCT00633490|Apatinib|apatinib|mesh-list
6497622|NCT00633490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6497623|NCT00633490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6497624|NCT00633490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6497625|NCT00633490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497626|NCT00633542|Interferons|interferons|mesh-list
6497627|NCT00633542|Interferon-alpha|interferon-alpha|mesh-list
6497628|NCT00633542|Thalidomide|thalidomide|mesh-list
6497629|NCT00633542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6497630|NCT00633542|Antiviral Agents|antiviral agents|mesh-ancestor
6497631|NCT00633542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6497632|NCT00633542|Immunologic Factors|immunologic factors|mesh-ancestor
6497633|NCT00633542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243053|NCT02659501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6243054|NCT02659501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6216819|NCT02260258|Rocuronium|rocuronium|mesh-list
6216820|NCT02260258|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6216821|NCT02260258|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6216822|NCT02260258|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6216823|NCT02260258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6216824|NCT02260258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216825|NCT02260388|Mexiletine|mexiletine|mesh-list
6216826|NCT02260388|Pregabalin|pregabalin|mesh-list
6216827|NCT02260388|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6216828|NCT02260388|Nortriptyline|nortriptyline|mesh-list
6216829|NCT02260388|Analgesics|analgesics|mesh-ancestor
6216830|NCT02260388|Sensory System Agents|sensory system agents|mesh-ancestor
6216831|NCT02260388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6216832|NCT02260388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216833|NCT02260388|Anticonvulsants|anticonvulsants|mesh-ancestor
6216834|NCT02260388|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6216835|NCT02260388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6216836|NCT02260388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216837|NCT02260388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6216838|NCT02260388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6216839|NCT02260388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6216840|NCT02260388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6216841|NCT02260388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6216842|NCT02260388|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6216843|NCT02260388|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6216844|NCT02260388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6216845|NCT02260388|Antidepressive Agents|antidepressive agents|mesh-ancestor
6216846|NCT02260388|Dopamine Agents|dopamine agents|mesh-ancestor
6216847|NCT02260388|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6216848|NCT02260388|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6216849|NCT02260388|Adrenergic Agents|adrenergic agents|mesh-ancestor
6216850|NCT02260388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6216851|NCT02260388|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6216852|NCT02260388|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6216853|NCT02260440|Pembrolizumab|pembrolizumab|mesh-list
6216854|NCT02260440|Azacitidine|azacitidine|mesh-list
6216855|NCT02260440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6216856|NCT02260440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6216857|NCT02260440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6216858|NCT02260440|Antimetabolites|antimetabolites|mesh-ancestor
6216859|NCT02260440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216860|NCT02260440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6216861|NCT02260492|Fluticasone|fluticasone|mesh-list
6216862|NCT02260492|Xhance|xhance|mesh-list
6216863|NCT02260492|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6216864|NCT02260492|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6216865|NCT02260492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6216866|NCT02260492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6216867|NCT02260492|Autonomic Agents|autonomic agents|mesh-ancestor
6216868|NCT02260492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6216869|NCT02260492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216870|NCT02260492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6216871|NCT02260492|Respiratory System Agents|respiratory system agents|mesh-ancestor
6216872|NCT02260492|Dermatologic Agents|dermatologic agents|mesh-ancestor
6216873|NCT02260492|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6216874|NCT02260492|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6216875|NCT02260492|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6216876|NCT02260492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6216877|NCT02260492|Adrenergic Agents|adrenergic agents|mesh-ancestor
6216878|NCT02260492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6216879|NCT02260492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216880|NCT02260492|Glucocorticoids|glucocorticoids|mesh-ancestor
6216881|NCT02260492|Hormones|hormones|mesh-ancestor
6216882|NCT02260492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6216883|NCT02260492|Sympathomimetics|sympathomimetics|mesh-ancestor
6216884|NCT02260531|Trastuzumab|trastuzumab|mesh-list
6216885|NCT02260531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6216886|NCT02260531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6216887|NCT02260622|Aspirin|aspirin|mesh-list
6216888|NCT02260622|Rivaroxaban|rivaroxaban|mesh-list
6216889|NCT02260622|Clopidogrel|clopidogrel|mesh-list
6216890|NCT02260622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6216891|NCT02260622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6216892|NCT02260622|Analgesics|analgesics|mesh-ancestor
6216893|NCT02260622|Sensory System Agents|sensory system agents|mesh-ancestor
6216894|NCT02260622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6216895|NCT02260622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216896|NCT02260622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6216897|NCT02260622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6216898|NCT02260622|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6216899|NCT02260622|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6216900|NCT02260622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216901|NCT02260622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6216902|NCT02260622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6216903|NCT02260622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6216904|NCT02260622|Antipyretics|antipyretics|mesh-ancestor
6216905|NCT02260622|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6216906|NCT02260622|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6216907|NCT02260622|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6216908|NCT02260622|Purinergic Agents|purinergic agents|mesh-ancestor
6216909|NCT02260622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6216910|NCT02260622|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6216911|NCT02260622|Antithrombins|antithrombins|mesh-ancestor
6216912|NCT02260622|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6216913|NCT02260622|Protease Inhibitors|protease inhibitors|mesh-ancestor
6216914|NCT02260622|Anticoagulants|anticoagulants|mesh-ancestor
6216915|NCT02260635|Evacetrapib|evacetrapib|mesh-list
6216916|NCT02260635|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6216917|NCT02260635|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6216918|NCT02260635|Antimetabolites|antimetabolites|mesh-ancestor
6216919|NCT02260635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216920|NCT02260635|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6216921|NCT02260648|Atorvastatin|atorvastatin|mesh-list
6216922|NCT02260648|Ezetimibe|ezetimibe|mesh-list
6216923|NCT02260648|Evacetrapib|evacetrapib|mesh-list
6216924|NCT02260648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6216925|NCT02260648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6216926|NCT02260648|Antimetabolites|antimetabolites|mesh-ancestor
6216927|NCT02260648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216928|NCT02260648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6216929|NCT02260648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6216930|NCT02260648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6216931|NCT02260791|Adalimumab|adalimumab|mesh-list
6216932|NCT02260791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6216933|NCT02260791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6216934|NCT02260804|Rituximab|rituximab|mesh-list
6216935|NCT02260804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6216936|NCT02260804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6216937|NCT02260804|Immunologic Factors|immunologic factors|mesh-ancestor
6216938|NCT02260804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216939|NCT02260804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6216940|NCT02260817|Choline|choline|mesh-list
6216941|NCT02260817|Lipotropic Agents|lipotropic agents|mesh-ancestor
6216942|NCT02260817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6216943|NCT02260817|Antimetabolites|antimetabolites|mesh-ancestor
6216944|NCT02260817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216945|NCT02260817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6216946|NCT02260817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6216947|NCT02260817|Nootropic Agents|nootropic agents|mesh-ancestor
6216948|NCT02260882|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6216949|NCT02260882|Immunologic Factors|immunologic factors|mesh-ancestor
6216950|NCT02260882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216951|NCT02260934|Acetaminophen|acetaminophen|mesh-list
6216952|NCT02260934|Diphenhydramine|diphenhydramine|mesh-list
6216953|NCT02260934|Promethazine|promethazine|mesh-list
6216954|NCT02260934|Prednisone|prednisone|mesh-list
6216955|NCT02260934|Methylprednisolone|methylprednisolone|mesh-list
6216956|NCT02260934|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6216957|NCT02260934|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6216958|NCT02260934|Prednisolone|prednisolone|mesh-list
6216959|NCT02260934|Prednisolone acetate|prednisolone acetate|mesh-list
6216960|NCT02260934|Cyclophosphamide|cyclophosphamide|mesh-list
6216961|NCT02260934|Rituximab|rituximab|mesh-list
6216962|NCT02260934|Belimumab|belimumab|mesh-list
6216963|NCT02260934|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6216964|NCT02260934|Prednisolone phosphate|prednisolone phosphate|mesh-list
6216965|NCT02260934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6216966|NCT02260934|Immunologic Factors|immunologic factors|mesh-ancestor
6216967|NCT02260934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6216968|NCT02260934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6216969|NCT02260934|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6216970|NCT02260934|Alkylating Agents|alkylating agents|mesh-ancestor
6216971|NCT02260934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6216972|NCT02260934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6216973|NCT02260934|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6216974|NCT02260934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6216975|NCT02260934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6216976|NCT02260934|Glucocorticoids|glucocorticoids|mesh-ancestor
6216977|NCT02260934|Hormones|hormones|mesh-ancestor
6216978|NCT02260934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6216979|NCT02260934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6216980|NCT02260934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6216981|NCT02260934|Analgesics|analgesics|mesh-ancestor
6216982|NCT02260934|Sensory System Agents|sensory system agents|mesh-ancestor
6216983|NCT02260934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6216984|NCT02260934|Antipyretics|antipyretics|mesh-ancestor
6216985|NCT02260934|Antiemetics|antiemetics|mesh-ancestor
6216986|NCT02260934|Autonomic Agents|autonomic agents|mesh-ancestor
5702626|NCT03336840|Diphenhydramine|diphenhydramine|mesh-list
5702627|NCT03336840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5702628|NCT03336840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702629|NCT03336840|Antipruritics|antipruritics|mesh-ancestor
5702630|NCT03336840|Dermatologic Agents|dermatologic agents|mesh-ancestor
5702631|NCT03336840|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5702632|NCT03336840|Histamine Antagonists|histamine antagonists|mesh-ancestor
5702633|NCT03336840|Histamine Agents|histamine agents|mesh-ancestor
5702634|NCT03336840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5702635|NCT03336840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5702636|NCT03336840|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5702637|NCT03336840|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5702638|NCT03336840|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5702639|NCT03336840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5702640|NCT03336840|Anesthetics, Local|anesthetics, local|mesh-ancestor
5702641|NCT03336840|Anesthetics|anesthetics|mesh-ancestor
5702642|NCT03336840|Sensory System Agents|sensory system agents|mesh-ancestor
5702643|NCT03336840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5702644|NCT03336840|Antiemetics|antiemetics|mesh-ancestor
5702645|NCT03336840|Autonomic Agents|autonomic agents|mesh-ancestor
5702646|NCT03336840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5702647|NCT03336814|Terlipressin|terlipressin|mesh-list
5702648|NCT03336814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5702649|NCT03336814|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5702650|NCT03336801|Propofol|propofol|mesh-list
5702651|NCT03336801|Sevoflurane|sevoflurane|mesh-list
5702652|NCT03336801|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5702653|NCT03336801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5702654|NCT03336801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702655|NCT03336801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5702656|NCT03336801|Anesthetics, General|anesthetics, general|mesh-ancestor
6216987|NCT02260934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6216988|NCT02260934|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6216989|NCT02260934|Protective Agents|protective agents|mesh-ancestor
6216990|NCT02260934|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6216991|NCT02260934|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6216992|NCT02260934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6216993|NCT02260934|Anesthetics, Local|anesthetics, local|mesh-ancestor
6216994|NCT02260934|Anesthetics|anesthetics|mesh-ancestor
6216995|NCT02260934|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6216996|NCT02260934|Histamine Antagonists|histamine antagonists|mesh-ancestor
6216997|NCT02260934|Histamine Agents|histamine agents|mesh-ancestor
6216998|NCT02260934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6216999|NCT02260934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6217000|NCT02260934|Antipruritics|antipruritics|mesh-ancestor
6217001|NCT02260934|Dermatologic Agents|dermatologic agents|mesh-ancestor
6217002|NCT02260986|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6217003|NCT02260986|Immunologic Factors|immunologic factors|mesh-ancestor
5702657|NCT03336801|Anesthetics|anesthetics|mesh-ancestor
5702658|NCT03336801|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5702659|NCT03336801|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5702660|NCT03336632|Cyclosporine|cyclosporine|mesh-list
5702661|NCT03336632|Cyclophosphamide|cyclophosphamide|mesh-list
5702662|NCT03336632|Cyclosporins|cyclosporins|mesh-list
5702663|NCT03336632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6217004|NCT02260986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702664|NCT03336632|Immunologic Factors|immunologic factors|mesh-ancestor
5702665|NCT03336632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217005|NCT02261467|Botulinum Toxins|botulinum toxins|mesh-list
6217006|NCT02261467|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6217007|NCT02261467|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6217008|NCT02261467|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6217009|NCT02261467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6217010|NCT02261467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217011|NCT02261467|Cholinergic Agents|cholinergic agents|mesh-ancestor
6217012|NCT02261467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6217013|NCT02261467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217014|NCT02261467|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6217015|NCT02261467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5702666|NCT03336632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5702667|NCT03336632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5702668|NCT03336632|Alkylating Agents|alkylating agents|mesh-ancestor
6217016|NCT02261493|Botulinum Toxins|botulinum toxins|mesh-list
6217017|NCT02261493|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6217018|NCT02261493|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6217019|NCT02261493|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6217020|NCT02261493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6217021|NCT02261493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217022|NCT02261493|Cholinergic Agents|cholinergic agents|mesh-ancestor
6217023|NCT02261493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6217024|NCT02261493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217025|NCT02261493|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6217026|NCT02261493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6217027|NCT02261727|Prednisone|prednisone|mesh-list
6217028|NCT02261727|Cortisone|cortisone|mesh-list
6217029|NCT02261727|Theophylline|theophylline|mesh-list
6217030|NCT02261727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6217031|NCT02261727|Glucocorticoids|glucocorticoids|mesh-ancestor
6217032|NCT02261727|Hormones|hormones|mesh-ancestor
6217033|NCT02261727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6217034|NCT02261727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217035|NCT02261727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6217036|NCT02261727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6217037|NCT02261727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6217038|NCT02261727|Autonomic Agents|autonomic agents|mesh-ancestor
6217039|NCT02261727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6217040|NCT02261727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6217041|NCT02261727|Respiratory System Agents|respiratory system agents|mesh-ancestor
6217042|NCT02261727|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6217043|NCT02261727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6217044|NCT02261727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217045|NCT02261727|Vasodilator Agents|vasodilator agents|mesh-ancestor
6217046|NCT02261727|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6217047|NCT02261727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6497634|NCT00633542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6497635|NCT00633542|Leprostatic Agents|leprostatic agents|mesh-ancestor
6497636|NCT00633542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6497637|NCT00633542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6497638|NCT00633542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6497639|NCT00633542|Growth Substances|growth substances|mesh-ancestor
6497640|NCT00633542|Growth Inhibitors|growth inhibitors|mesh-ancestor
6497641|NCT00633568|Cisplatin|cisplatin|mesh-list
6497642|NCT00633568|Docetaxel|docetaxel|mesh-list
6497643|NCT00633568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6497644|NCT00633568|Tubulin Modulators|tubulin modulators|mesh-ancestor
6497645|NCT00633568|Antimitotic Agents|antimitotic agents|mesh-ancestor
6497646|NCT00633568|Mitosis Modulators|mitosis modulators|mesh-ancestor
6217048|NCT02261727|Purinergic Agents|purinergic agents|mesh-ancestor
6217049|NCT02261727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6217050|NCT02261805|Doxorubicin|doxorubicin|mesh-list
6217051|NCT02261805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6217052|NCT02261805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6497647|NCT00633568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497648|NCT00633581|Ascorbic Acid|ascorbic acid|mesh-list
6497649|NCT00633581|Vitamins|vitamins|mesh-ancestor
6497650|NCT00633581|Micronutrients|micronutrients|mesh-ancestor
6497651|NCT00633581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497652|NCT00633581|Antioxidants|antioxidants|mesh-ancestor
6497653|NCT00633581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497654|NCT00633581|Protective Agents|protective agents|mesh-ancestor
6497655|NCT00633659|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
6497656|NCT00633659|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6497657|NCT00633659|Plasma Substitutes|plasma substitutes|mesh-ancestor
6497658|NCT00633659|Blood Substitutes|blood substitutes|mesh-ancestor
6497659|NCT00633672|Esomeprazole|esomeprazole|mesh-list
5702669|NCT03336632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5702670|NCT03336632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5702671|NCT03336632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5702672|NCT03336632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6217053|NCT02261805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6217054|NCT02261805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6217055|NCT02261805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6217056|NCT02261805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217057|NCT02261948|Simendan|simendan|mesh-list
6217058|NCT02261948|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6217059|NCT02261948|Vasodilator Agents|vasodilator agents|mesh-ancestor
6217060|NCT02261948|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6217061|NCT02261948|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6217062|NCT02261948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6217063|NCT02261948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217064|NCT02261948|Protective Agents|protective agents|mesh-ancestor
6217065|NCT02261948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217066|NCT02261961|Vaccines|vaccines|mesh-list
6217067|NCT02261961|Immunologic Factors|immunologic factors|mesh-ancestor
6217068|NCT02261961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217069|NCT02262130|Omalizumab|omalizumab|mesh-list
6217070|NCT02262130|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6217071|NCT02262130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6217072|NCT02262130|Respiratory System Agents|respiratory system agents|mesh-ancestor
6217073|NCT02262728|Sofosbuvir|sofosbuvir|mesh-list
6217074|NCT02262728|Simeprevir|simeprevir|mesh-list
6217075|NCT02262728|Antiviral Agents|antiviral agents|mesh-ancestor
6217076|NCT02262728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5702673|NCT03336632|Antifungal Agents|antifungal agents|mesh-ancestor
5702674|NCT03336632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5702675|NCT03336632|Dermatologic Agents|dermatologic agents|mesh-ancestor
5702676|NCT03336632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5702677|NCT03336593|Vaccines|vaccines|mesh-list
5702678|NCT03336593|Immunologic Factors|immunologic factors|mesh-ancestor
6217077|NCT02262728|Protease Inhibitors|protease inhibitors|mesh-ancestor
6217078|NCT02262728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6217079|NCT02262728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217080|NCT02262754|Naproxen|naproxen|mesh-list
6217081|NCT02262754|PF-06372865|pf-06372865|mesh-list
6217082|NCT02262754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6217083|NCT02262754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6217084|NCT02262754|Analgesics|analgesics|mesh-ancestor
6217085|NCT02262754|Sensory System Agents|sensory system agents|mesh-ancestor
6217086|NCT02262754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6217087|NCT02262754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217088|NCT02262754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6217089|NCT02262754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6217090|NCT02262754|Gout Suppressants|gout suppressants|mesh-ancestor
6217091|NCT02262754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6217092|NCT02262754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6217093|NCT02262754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217094|NCT02262754|GABA Modulators|gaba modulators|mesh-ancestor
6217095|NCT02262754|GABA Agents|gaba agents|mesh-ancestor
6217096|NCT02262754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6217097|NCT02263079|Interferons|interferons|mesh-list
5702679|NCT03336593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702680|NCT03336528|Insulin Glargine|insulin glargine|mesh-list
5702681|NCT03336528|Insulin, Long-Acting|insulin, long-acting|mesh-list
5702682|NCT03336528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5702683|NCT03336528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702684|NCT03336437|Estradiol|estradiol|mesh-list
5702685|NCT03336437|Estrogens|estrogens|mesh-ancestor
5702686|NCT03336437|Hormones|hormones|mesh-ancestor
5702687|NCT03336437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5702688|NCT03336437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702689|NCT03336398|Ketamine|ketamine|mesh-list
5702690|NCT03336398|Analgesics|analgesics|mesh-ancestor
5702691|NCT03336398|Sensory System Agents|sensory system agents|mesh-ancestor
5702692|NCT03336398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6217098|NCT02263079|Interferon-alpha|interferon-alpha|mesh-list
6217099|NCT02263079|Lamivudine|lamivudine|mesh-list
6217100|NCT02263079|Interferon alpha-2|interferon alpha-2|mesh-list
6217101|NCT02263079|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5702693|NCT03336398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217102|NCT02263079|Entecavir|entecavir|mesh-list
6217103|NCT02263079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6217104|NCT02263079|Antiviral Agents|antiviral agents|mesh-ancestor
6243055|NCT02659501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6217105|NCT02263079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6217106|NCT02263079|Immunologic Factors|immunologic factors|mesh-ancestor
6217107|NCT02263079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217108|NCT02263079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6217109|NCT02263079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6217110|NCT02263079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6217111|NCT02263079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217112|NCT02263079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6217113|NCT02263079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6217114|NCT02263326|Lamivudine|lamivudine|mesh-list
5702694|NCT03336398|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5702695|NCT03336398|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5702696|NCT03336398|Anesthetics, General|anesthetics, general|mesh-ancestor
5702697|NCT03336398|Anesthetics|anesthetics|mesh-ancestor
5702698|NCT03336398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5702699|NCT03336398|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5702700|NCT03336398|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5702701|NCT03336398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5702702|NCT03336398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721094|NCT03208465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721095|NCT03208465|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6217115|NCT02263326|Dolutegravir|dolutegravir|mesh-list
6217116|NCT02263326|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6217117|NCT02263326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6217118|NCT02263326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6217119|NCT02263326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6217120|NCT02263326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217121|NCT02263326|Antiviral Agents|antiviral agents|mesh-ancestor
6217122|NCT02263326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6217123|NCT02263326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6217124|NCT02263326|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6217125|NCT02263326|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6217126|NCT02263547|Teriflunomide|teriflunomide|mesh-list
6217127|NCT02263547|Colestipol|colestipol|mesh-list
6217128|NCT02263547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6217129|NCT02263547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6217130|NCT02263547|Analgesics|analgesics|mesh-ancestor
6217131|NCT02263547|Sensory System Agents|sensory system agents|mesh-ancestor
6217132|NCT02263547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6217133|NCT02263547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217134|NCT02263547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6217135|NCT02263547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6217136|NCT02263547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6217137|NCT02263547|Immunologic Factors|immunologic factors|mesh-ancestor
6217138|NCT02263547|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6217139|NCT02263547|Antimetabolites|antimetabolites|mesh-ancestor
6217140|NCT02263547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217141|NCT02263547|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6217142|NCT02263547|Sequestering Agents|sequestering agents|mesh-ancestor
6217143|NCT02264353|Donepezil|donepezil|mesh-list
6217144|NCT02264353|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6217145|NCT02264353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6217146|NCT02264353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217147|NCT02264353|Cholinergic Agents|cholinergic agents|mesh-ancestor
6217148|NCT02264353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6217149|NCT02264353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217150|NCT02264353|Nootropic Agents|nootropic agents|mesh-ancestor
6217151|NCT02264574|Obinutuzumab|obinutuzumab|mesh-list
6217152|NCT02264574|Chlorambucil|chlorambucil|mesh-list
6217153|NCT02264574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6217154|NCT02264574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6217155|NCT02264574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6217156|NCT02264574|Alkylating Agents|alkylating agents|mesh-ancestor
6217157|NCT02264574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217158|NCT02264821|Morphine|morphine|mesh-list
6497660|NCT00633672|Ranitidine|ranitidine|mesh-list
5702703|NCT03336346|Efavirenz|efavirenz|mesh-list
5702704|NCT03336346|Dolutegravir|dolutegravir|mesh-list
5702705|NCT03336346|Etonogestrel|etonogestrel|mesh-list
5702706|NCT03336346|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5702707|NCT03336346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5702708|NCT03336346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5702709|NCT03336346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217159|NCT02264821|Ropivacaine|ropivacaine|mesh-list
6217160|NCT02264821|Anesthetics, Local|anesthetics, local|mesh-list
6217161|NCT02264821|Anesthetics|anesthetics|mesh-list
6217162|NCT02264821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6217163|NCT02264821|Narcotics|narcotics|mesh-ancestor
6217164|NCT02264821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6217165|NCT02264821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217166|NCT02264821|Analgesics|analgesics|mesh-ancestor
6217167|NCT02264821|Sensory System Agents|sensory system agents|mesh-ancestor
6217168|NCT02264821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6217169|NCT02264990|Paclitaxel|paclitaxel|mesh-list
6217170|NCT02264990|Carboplatin|carboplatin|mesh-list
6217171|NCT02264990|Pemetrexed|pemetrexed|mesh-list
6217172|NCT02264990|Veliparib|veliparib|mesh-list
6217173|NCT02264990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6217174|NCT02264990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6217175|NCT02264990|Tubulin Modulators|tubulin modulators|mesh-ancestor
6217176|NCT02264990|Antimitotic Agents|antimitotic agents|mesh-ancestor
6217177|NCT02264990|Mitosis Modulators|mitosis modulators|mesh-ancestor
6217178|NCT02264990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217179|NCT02264990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6217180|NCT02264990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6217181|NCT02264990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6217182|NCT02264990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6217183|NCT02265224|Acetylcysteine|acetylcysteine|mesh-list
6217184|NCT02265224|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6217185|NCT02265224|Antiviral Agents|antiviral agents|mesh-ancestor
6217186|NCT02265224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6217187|NCT02265224|Expectorants|expectorants|mesh-ancestor
6217188|NCT02265224|Respiratory System Agents|respiratory system agents|mesh-ancestor
6217189|NCT02265224|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6217190|NCT02265224|Antioxidants|antioxidants|mesh-ancestor
6217191|NCT02265224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217192|NCT02265224|Protective Agents|protective agents|mesh-ancestor
6217193|NCT02265224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217194|NCT02265224|Antidotes|antidotes|mesh-ancestor
6217195|NCT02265237|Ritonavir|ritonavir|mesh-list
6217196|NCT02265237|Ribavirin|ribavirin|mesh-list
6217197|NCT02265237|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6217198|NCT02265237|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6217199|NCT02265237|Protease Inhibitors|protease inhibitors|mesh-ancestor
6217200|NCT02265237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6217201|NCT02265237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217202|NCT02265237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6217203|NCT02265237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6217204|NCT02265237|Antiviral Agents|antiviral agents|mesh-ancestor
6217205|NCT02265237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6217206|NCT02265237|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6217207|NCT02265237|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6217208|NCT02265237|Antimetabolites|antimetabolites|mesh-ancestor
6217209|NCT02265341|Ponatinib|ponatinib|mesh-list
6217210|NCT02265341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6217211|NCT02265341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6217212|NCT02265341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6217213|NCT02265341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217214|NCT02265510|Gemcitabine|gemcitabine|mesh-list
6217215|NCT02265510|Dexamethasone|dexamethasone|mesh-list
6217216|NCT02265510|Paclitaxel|paclitaxel|mesh-list
6217217|NCT02265510|Lenalidomide|lenalidomide|mesh-list
6217218|NCT02265510|Bortezomib|bortezomib|mesh-list
6217219|NCT02265510|Azacitidine|azacitidine|mesh-list
6217220|NCT02265510|Pomalidomide|pomalidomide|mesh-list
6217221|NCT02265510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6217222|NCT02265510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6217223|NCT02265510|Tubulin Modulators|tubulin modulators|mesh-ancestor
6217224|NCT02265510|Antimitotic Agents|antimitotic agents|mesh-ancestor
6217225|NCT02265510|Mitosis Modulators|mitosis modulators|mesh-ancestor
6217226|NCT02265510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217227|NCT02265510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6217228|NCT02265510|Antiemetics|antiemetics|mesh-ancestor
6217229|NCT02265510|Autonomic Agents|autonomic agents|mesh-ancestor
5702710|NCT03336346|Antiviral Agents|antiviral agents|mesh-ancestor
5702711|NCT03336346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5702712|NCT03336346|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5702713|NCT03336346|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5702714|NCT03336346|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5702715|NCT03336346|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5702716|NCT03336346|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5702717|NCT03336346|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6217230|NCT02265510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6217231|NCT02265510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217232|NCT02265510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6217233|NCT02265510|Glucocorticoids|glucocorticoids|mesh-ancestor
6217234|NCT02265510|Hormones|hormones|mesh-ancestor
6217235|NCT02265510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6217236|NCT02265510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6243056|NCT02659540|Nivolumab|nivolumab|mesh-list
6497661|NCT00633672|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
6497662|NCT00633672|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6497663|NCT00633672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6497664|NCT00633672|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6497665|NCT00633672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6497666|NCT00633672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497667|NCT00633672|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6497668|NCT00633672|Histamine Antagonists|histamine antagonists|mesh-ancestor
6497669|NCT00633672|Histamine Agents|histamine agents|mesh-ancestor
6497670|NCT00633672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6497671|NCT00633672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524418|NCT00758030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524419|NCT00758030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6524420|NCT00758030|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6524421|NCT00758030|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6524422|NCT00758030|Serotonin Agents|serotonin agents|mesh-ancestor
6524423|NCT00758030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6524424|NCT00758030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524425|NCT00758030|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6524426|NCT00758030|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6524427|NCT00758030|Dopamine Agents|dopamine agents|mesh-ancestor
6524428|NCT00758134|Trastuzumab|trastuzumab|mesh-list
6524429|NCT00758134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6524430|NCT00758134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6524431|NCT00758199|Moxifloxacin|moxifloxacin|mesh-list
6524432|NCT00758199|Prednisolone|prednisolone|mesh-list
6524433|NCT00758199|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6524434|NCT00758199|Methylprednisolone|methylprednisolone|mesh-list
6524435|NCT00758199|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6524436|NCT00758199|Prednisolone acetate|prednisolone acetate|mesh-list
6524437|NCT00758199|Bromfenac|bromfenac|mesh-list
6524438|NCT00758199|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6524439|NCT00758199|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6524440|NCT00758199|Prednisolone phosphate|prednisolone phosphate|mesh-list
6524441|NCT00758199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6524442|NCT00758199|Glucocorticoids|glucocorticoids|mesh-ancestor
6524443|NCT00758199|Hormones|hormones|mesh-ancestor
6524444|NCT00758199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6524445|NCT00758199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524446|NCT00758199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6524447|NCT00758199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6524448|NCT00758199|Antiemetics|antiemetics|mesh-ancestor
6524449|NCT00758199|Autonomic Agents|autonomic agents|mesh-ancestor
6524450|NCT00758199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6524451|NCT00758199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6524452|NCT00758199|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6524453|NCT00758199|Protective Agents|protective agents|mesh-ancestor
6524454|NCT00758199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6524455|NCT00758199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6524456|NCT00758199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6524457|NCT00758199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6524458|NCT00758199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6524459|NCT00758199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524460|NCT00758199|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6524461|NCT00758199|Contraceptive Agents|contraceptive agents|mesh-ancestor
5702718|NCT03336346|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6524462|NCT00758199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6217237|NCT02265510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6217238|NCT02265510|Antimetabolites|antimetabolites|mesh-ancestor
6217239|NCT02265510|Antiviral Agents|antiviral agents|mesh-ancestor
6217240|NCT02265510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6217241|NCT02265510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6217242|NCT02265510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6217243|NCT02265510|Immunologic Factors|immunologic factors|mesh-ancestor
6217244|NCT02265510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6217245|NCT02265510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6217246|NCT02265510|Growth Substances|growth substances|mesh-ancestor
6217247|NCT02265510|Growth Inhibitors|growth inhibitors|mesh-ancestor
6217248|NCT02265744|Antibodies|antibodies|mesh-list
6217249|NCT02265744|Immunologic Factors|immunologic factors|mesh-ancestor
6217250|NCT02265744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217251|NCT02265796|Ranolazine|ranolazine|mesh-list
5702719|NCT03336346|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5702720|NCT03336346|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5702721|NCT03336346|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5702722|NCT03336346|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6217252|NCT02265796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6217253|NCT02265796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6217254|NCT02265796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217255|NCT02265913|Acyclovir|acyclovir|mesh-list
6217256|NCT02265913|Antiviral Agents|antiviral agents|mesh-ancestor
6217257|NCT02265913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6217258|NCT02265965|Nitroglycerin|nitroglycerin|mesh-list
6217259|NCT02265965|Vasodilator Agents|vasodilator agents|mesh-ancestor
6217260|NCT02266433|Dexamethasone|dexamethasone|mesh-list
6217261|NCT02266433|Ketorolac|ketorolac|mesh-list
6217262|NCT02266433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6217263|NCT02266433|Antiemetics|antiemetics|mesh-ancestor
6217264|NCT02266433|Autonomic Agents|autonomic agents|mesh-ancestor
6217265|NCT02266433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6217266|NCT02266433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702723|NCT03336346|Contraceptive Agents|contraceptive agents|mesh-ancestor
5702724|NCT03336346|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5702725|NCT03336346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702726|NCT03336346|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5702727|NCT03336281|Ustekinumab|ustekinumab|mesh-list
5702728|NCT03336281|Dermatologic Agents|dermatologic agents|mesh-ancestor
5702729|NCT03336242|Cannabidiol|cannabidiol|mesh-list
5702730|NCT03336242|Anticonvulsants|anticonvulsants|mesh-ancestor
5702731|NCT03336125|Vitamin D|vitamin d|mesh-list
5702732|NCT03336125|Vitamins|vitamins|mesh-ancestor
5702733|NCT03336125|Micronutrients|micronutrients|mesh-ancestor
5702734|NCT03336125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702735|NCT03336125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5702736|NCT03336073|Dexamethasone|dexamethasone|mesh-list
5702737|NCT03336073|Cyclophosphamide|cyclophosphamide|mesh-list
5702738|NCT03336073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6217267|NCT02266433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6217268|NCT02266433|Glucocorticoids|glucocorticoids|mesh-ancestor
6217269|NCT02266433|Hormones|hormones|mesh-ancestor
6217270|NCT02266433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6217271|NCT02266433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6217272|NCT02266433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6217273|NCT02266433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6217274|NCT02266433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6217275|NCT02266433|Analgesics|analgesics|mesh-ancestor
6217276|NCT02266433|Sensory System Agents|sensory system agents|mesh-ancestor
6217277|NCT02266433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6217278|NCT02266433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6217279|NCT02266433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6217280|NCT02266433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217281|NCT02266472|Metformin|metformin|mesh-list
6217282|NCT02266472|Empagliflozin|empagliflozin|mesh-list
6217283|NCT02266472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6217284|NCT02266472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217285|NCT02266472|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6217286|NCT02266472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217287|NCT02266706|Tazobactam|tazobactam|mesh-list
6217288|NCT02266706|Ceftolozane|ceftolozane|mesh-list
6217289|NCT02266706|Cephalosporins|cephalosporins|mesh-list
6217290|NCT02266706|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
6217291|NCT02266706|Penicillanic Acid|penicillanic acid|mesh-list
5702739|NCT03336073|Immunologic Factors|immunologic factors|mesh-ancestor
5702740|NCT03336073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702741|NCT03336073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6217292|NCT02266706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6217293|NCT02266706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6217294|NCT02266706|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6217295|NCT02266706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6217296|NCT02266706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217297|NCT02266706|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6217298|NCT02266706|Renal Agents|renal agents|mesh-ancestor
6217299|NCT02266810|Mometasone Furoate|mometasone furoate|mesh-list
6217300|NCT02266810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6217301|NCT02266810|Dermatologic Agents|dermatologic agents|mesh-ancestor
6217302|NCT02266810|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6217303|NCT02266888|Rituximab|rituximab|mesh-list
6217304|NCT02266888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6217305|NCT02266888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6217306|NCT02266888|Immunologic Factors|immunologic factors|mesh-ancestor
6217307|NCT02266888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217308|NCT02266888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6217309|NCT02267083|Doxorubicin|doxorubicin|mesh-list
6217310|NCT02267083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6217311|NCT02267083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6217312|NCT02267083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6217313|NCT02267083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6217314|NCT02267083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6217315|NCT02267083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217316|NCT02267187|Anesthetics|anesthetics|mesh-list
6217317|NCT02267187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6217318|NCT02267187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217319|NCT02267538|Dexmedetomidine|dexmedetomidine|mesh-list
6217320|NCT02267538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6217321|NCT02267538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6217322|NCT02267538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217323|NCT02267538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6217324|NCT02267538|Analgesics|analgesics|mesh-ancestor
6217325|NCT02267538|Sensory System Agents|sensory system agents|mesh-ancestor
6217326|NCT02267538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6217327|NCT02267538|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6217328|NCT02267538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6217329|NCT02267538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6217330|NCT02267538|Adrenergic Agents|adrenergic agents|mesh-ancestor
6217331|NCT02267538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6217332|NCT02267538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217333|NCT02267603|Pembrolizumab|pembrolizumab|mesh-list
6217334|NCT02267603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6217335|NCT02267603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6217336|NCT02267746|Nicotinic Acids|nicotinic acids|mesh-list
6217337|NCT02267746|Tazarotene|tazarotene|mesh-list
6217338|NCT02267746|Dermatologic Agents|dermatologic agents|mesh-ancestor
6217339|NCT02267746|Keratolytic Agents|keratolytic agents|mesh-ancestor
6217340|NCT02267746|Vitamin B Complex|vitamin b complex|mesh-ancestor
6217341|NCT02267746|Vitamins|vitamins|mesh-ancestor
5702742|NCT03336073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5702743|NCT03336073|Alkylating Agents|alkylating agents|mesh-ancestor
5702744|NCT03336073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5702745|NCT03336073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5702746|NCT03336073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5702747|NCT03336073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5702748|NCT03336073|Antiemetics|antiemetics|mesh-ancestor
5702749|NCT03336073|Autonomic Agents|autonomic agents|mesh-ancestor
5702750|NCT03336073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5702751|NCT03336073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5702752|NCT03336073|Glucocorticoids|glucocorticoids|mesh-ancestor
5702753|NCT03336073|Hormones|hormones|mesh-ancestor
5702754|NCT03336073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5702755|NCT03336073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5702756|NCT03335956|Pioglitazone|pioglitazone|mesh-list
5702757|NCT03335956|Prednisone|prednisone|mesh-list
5702758|NCT03335956|Cortisone|cortisone|mesh-list
5702759|NCT03335956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6217342|NCT02267746|Micronutrients|micronutrients|mesh-ancestor
6217343|NCT02267746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217344|NCT02267772|Acetaminophen|acetaminophen|mesh-list
6217345|NCT02267772|Morphine|morphine|mesh-list
6217346|NCT02267772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6217347|NCT02267772|Narcotics|narcotics|mesh-ancestor
6217348|NCT02267772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6243057|NCT02659540|Ipilimumab|ipilimumab|mesh-list
6217349|NCT02267772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217350|NCT02267772|Analgesics|analgesics|mesh-ancestor
6217351|NCT02267772|Sensory System Agents|sensory system agents|mesh-ancestor
6217352|NCT02267772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6217353|NCT02267772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6217354|NCT02267772|Antipyretics|antipyretics|mesh-ancestor
6217355|NCT02268045|Rituximab|rituximab|mesh-list
6217356|NCT02268045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6217357|NCT02268045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6217358|NCT02268045|Immunologic Factors|immunologic factors|mesh-ancestor
6217359|NCT02268045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217360|NCT02268045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6217361|NCT02268058|Acetaminophen|acetaminophen|mesh-list
6217362|NCT02268058|Ibuprofen|ibuprofen|mesh-list
6217363|NCT02268058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6217364|NCT02268058|Analgesics|analgesics|mesh-ancestor
6217365|NCT02268058|Sensory System Agents|sensory system agents|mesh-ancestor
6217366|NCT02268058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6217367|NCT02268058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217368|NCT02268058|Antipyretics|antipyretics|mesh-ancestor
6217369|NCT02268058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6217370|NCT02268058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6217371|NCT02268058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6217372|NCT02268058|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6217373|NCT02268058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6217374|NCT02268058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217375|NCT02268175|Prednisone|prednisone|mesh-list
6217376|NCT02268175|Leuprolide|leuprolide|mesh-list
6217377|NCT02268175|Abiraterone Acetate|abiraterone acetate|mesh-list
6217378|NCT02268175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6217379|NCT02268175|Glucocorticoids|glucocorticoids|mesh-ancestor
6217380|NCT02268175|Hormones|hormones|mesh-ancestor
6217381|NCT02268175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6217382|NCT02268175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217383|NCT02268175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6217384|NCT02268175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6217385|NCT02268175|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6217386|NCT02268175|Fertility Agents|fertility agents|mesh-ancestor
6217387|NCT02268175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6217388|NCT02268175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6217389|NCT02268175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6217390|NCT02268175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217391|NCT02268175|Hormone Antagonists|hormone antagonists|mesh-ancestor
6217392|NCT02268175|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6217393|NCT02268214|Dapagliflozin|dapagliflozin|mesh-list
6217394|NCT02268214|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6497672|NCT00633685|Fluoxetine|fluoxetine|mesh-list
6497673|NCT00633685|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6497674|NCT00633685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6217395|NCT02268214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217396|NCT02268214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6217397|NCT02268214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243058|NCT02659540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5702760|NCT03335956|Glucocorticoids|glucocorticoids|mesh-ancestor
5702761|NCT03335956|Hormones|hormones|mesh-ancestor
5702762|NCT03335956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5702763|NCT03335956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702764|NCT03335956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6243059|NCT02659540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6243060|NCT02659540|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6243061|NCT02659540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243062|NCT02659787|Buprenorphine|buprenorphine|mesh-list
6243063|NCT02659787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6243064|NCT02659787|Narcotics|narcotics|mesh-ancestor
6243065|NCT02659787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6243066|NCT02659787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243067|NCT02659787|Analgesics|analgesics|mesh-ancestor
6243068|NCT02659787|Sensory System Agents|sensory system agents|mesh-ancestor
6243069|NCT02659787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6243070|NCT02659787|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6243071|NCT02659943|Cyclophosphamide|cyclophosphamide|mesh-list
6243072|NCT02659943|Fludarabine|fludarabine|mesh-list
6243073|NCT02659943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6497675|NCT00633685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6217398|NCT02268396|Glycopyrrolate|glycopyrrolate|mesh-list
6217399|NCT02268396|Formoterol Fumarate|formoterol fumarate|mesh-list
6217400|NCT02268396|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6217401|NCT02268396|Autonomic Agents|autonomic agents|mesh-ancestor
6217402|NCT02268396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6217403|NCT02268396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702765|NCT03335956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5702766|NCT03335956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5702767|NCT03335904|Losartan|losartan|mesh-list
5702768|NCT03335904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5702769|NCT03335904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5702770|NCT03335904|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5702771|NCT03335904|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5702772|NCT03335904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5702773|NCT03335839|Plasminogen|plasminogen|mesh-list
5702774|NCT03335839|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5702775|NCT03335839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5702776|NCT03335839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5702777|NCT03335839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5702778|NCT03335826|Anesthetics|anesthetics|mesh-list
5702779|NCT03335826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5702780|NCT03335826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702781|NCT03335774|Hydrocortisone|hydrocortisone|mesh-list
5702782|NCT03335774|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
5702783|NCT03335774|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
5702784|NCT03335774|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
5702785|NCT03335774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5702786|NCT03335579|Sufentanil|sufentanil|mesh-list
5702787|NCT03335579|Remifentanil|remifentanil|mesh-list
6217404|NCT02268396|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6217405|NCT02268396|Respiratory System Agents|respiratory system agents|mesh-ancestor
6217406|NCT02268396|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6217407|NCT02268396|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6217408|NCT02268396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6217409|NCT02268396|Adrenergic Agents|adrenergic agents|mesh-ancestor
6217410|NCT02268396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6217411|NCT02268396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217412|NCT02268396|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6217413|NCT02268396|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6217414|NCT02268396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6217415|NCT02268396|Cholinergic Agents|cholinergic agents|mesh-ancestor
6217416|NCT02268864|Simeprevir|simeprevir|mesh-list
6217417|NCT02268864|Antiviral Agents|antiviral agents|mesh-ancestor
6217418|NCT02268864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6217419|NCT02268864|Protease Inhibitors|protease inhibitors|mesh-ancestor
6217420|NCT02268864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6217421|NCT02268864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217422|NCT02268955|Ibuprofen|ibuprofen|mesh-list
6217423|NCT02268955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6217424|NCT02268955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6217425|NCT02268955|Analgesics|analgesics|mesh-ancestor
6217426|NCT02268955|Sensory System Agents|sensory system agents|mesh-ancestor
6217427|NCT02268955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6217428|NCT02268955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217429|NCT02268955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6217430|NCT02268955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6217431|NCT02268955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6217432|NCT02268955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6217433|NCT02268955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217434|NCT02269163|Immunoglobulins|immunoglobulins|mesh-list
6217435|NCT02269163|Antibodies|antibodies|mesh-list
6217436|NCT02269163|gamma-Globulins|gamma-globulins|mesh-list
6217437|NCT02269163|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6217438|NCT02269163|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6217439|NCT02269163|Immunoglobulin G|immunoglobulin g|mesh-list
6217440|NCT02269163|Immunologic Factors|immunologic factors|mesh-ancestor
6217441|NCT02269163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217442|NCT02269241|Drospirenone|drospirenone|mesh-list
6217443|NCT02269241|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6217444|NCT02269241|Hormone Antagonists|hormone antagonists|mesh-ancestor
6217445|NCT02269241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6217446|NCT02269241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217447|NCT02269241|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6217448|NCT02269241|Diuretics|diuretics|mesh-ancestor
5702788|NCT03335579|Propofol|propofol|mesh-list
5702789|NCT03335579|Anesthetics|anesthetics|mesh-ancestor
5702790|NCT03335579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5702791|NCT03335579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702792|NCT03335579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5702793|NCT03335579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5702794|NCT03335579|Anesthetics, General|anesthetics, general|mesh-ancestor
5702795|NCT03335579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5702796|NCT03335579|Narcotics|narcotics|mesh-ancestor
5702797|NCT03335579|Analgesics|analgesics|mesh-ancestor
5702798|NCT03335579|Sensory System Agents|sensory system agents|mesh-ancestor
5702799|NCT03335579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5702800|NCT03335579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5702801|NCT03335527|Dexmedetomidine|dexmedetomidine|mesh-list
5702802|NCT03335527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5702803|NCT03335527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5702804|NCT03335527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702805|NCT03335527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5702806|NCT03335527|Analgesics|analgesics|mesh-ancestor
5702807|NCT03335527|Sensory System Agents|sensory system agents|mesh-ancestor
5702808|NCT03335527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5702809|NCT03335527|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5702810|NCT03335527|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5702811|NCT03335527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5702812|NCT03335527|Adrenergic Agents|adrenergic agents|mesh-ancestor
5702813|NCT03335527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5702814|NCT03335527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5702815|NCT03335501|Pancrelipase|pancrelipase|mesh-list
5702816|NCT03335501|Hormones|hormones|mesh-list
5702817|NCT03335501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702818|NCT03335501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5702819|NCT03335501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5702820|NCT03335436|Gabapentin|gabapentin|mesh-list
6217449|NCT02269241|Natriuretic Agents|natriuretic agents|mesh-ancestor
6217450|NCT02269943|Azacitidine|azacitidine|mesh-list
6217451|NCT02269943|Cc-486|cc-486|mesh-list
6217452|NCT02269943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6217453|NCT02269943|Antimetabolites|antimetabolites|mesh-ancestor
6217454|NCT02269943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217455|NCT02269943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6217456|NCT02269943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6217457|NCT02270242|Aspirin|aspirin|mesh-list
6217458|NCT02270242|Ticagrelor|ticagrelor|mesh-list
6217459|NCT02270242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6217460|NCT02270242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6217461|NCT02270242|Analgesics|analgesics|mesh-ancestor
6217462|NCT02270242|Sensory System Agents|sensory system agents|mesh-ancestor
6217463|NCT02270242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6217464|NCT02270242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217465|NCT02270242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6217466|NCT02270242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6217467|NCT02270242|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6217468|NCT02270242|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6217469|NCT02270242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217470|NCT02270242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6217471|NCT02270242|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6217472|NCT02270242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6217473|NCT02270242|Antipyretics|antipyretics|mesh-ancestor
6217474|NCT02270242|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6217475|NCT02270242|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6217476|NCT02270242|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6217477|NCT02270242|Purinergic Agents|purinergic agents|mesh-ancestor
6217478|NCT02270242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6217479|NCT02270255|Lidocaine|lidocaine|mesh-list
6217480|NCT02270255|Ropivacaine|ropivacaine|mesh-list
6217481|NCT02270255|Anesthetics, Local|anesthetics, local|mesh-ancestor
6217482|NCT02270255|Anesthetics|anesthetics|mesh-ancestor
6217483|NCT02270255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6217484|NCT02270255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217485|NCT02270255|Sensory System Agents|sensory system agents|mesh-ancestor
6217486|NCT02270255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6217487|NCT02270255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6217488|NCT02270255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6217489|NCT02270255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6217490|NCT02270255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6497676|NCT00633685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497677|NCT00633685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6497678|NCT00633685|Serotonin Agents|serotonin agents|mesh-ancestor
6497679|NCT00633685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497680|NCT00633685|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6497681|NCT00633685|Antidepressive Agents|antidepressive agents|mesh-ancestor
6497682|NCT00633685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6497683|NCT00633685|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6497684|NCT00633685|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6497685|NCT00633685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6497686|NCT00633698|Niacin|niacin|mesh-list
6497687|NCT00633698|Nicotinic Acids|nicotinic acids|mesh-list
6497688|NCT00633698|Niacinamide|niacinamide|mesh-list
6497689|NCT00633698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6497690|NCT00633698|Antimetabolites|antimetabolites|mesh-ancestor
6497691|NCT00633698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497692|NCT00633698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6497693|NCT00633698|Vasodilator Agents|vasodilator agents|mesh-ancestor
6497694|NCT00633698|Vitamin B Complex|vitamin b complex|mesh-ancestor
5702821|NCT03335436|Analgesics|analgesics|mesh-ancestor
5702822|NCT03335436|Sensory System Agents|sensory system agents|mesh-ancestor
5702823|NCT03335436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5702824|NCT03335436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702825|NCT03335436|Anticonvulsants|anticonvulsants|mesh-ancestor
6497695|NCT00633698|Vitamins|vitamins|mesh-ancestor
6497696|NCT00633698|Micronutrients|micronutrients|mesh-ancestor
6497697|NCT00633698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497698|NCT00633763|Fallypride|fallypride|mesh-list
6497699|NCT00633763|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6497700|NCT00633763|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6497701|NCT00633763|Dopamine Agents|dopamine agents|mesh-ancestor
6497702|NCT00633763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6497703|NCT00633763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497704|NCT00633763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497705|NCT00633776|Formoterol Fumarate|formoterol fumarate|mesh-list
6497706|NCT00633776|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6497707|NCT00633776|Autonomic Agents|autonomic agents|mesh-ancestor
6497708|NCT00633776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6497709|NCT00633776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497710|NCT00633776|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6497711|NCT00633776|Respiratory System Agents|respiratory system agents|mesh-ancestor
6497712|NCT00633776|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6497713|NCT00633776|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6497714|NCT00633776|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6497715|NCT00633776|Adrenergic Agents|adrenergic agents|mesh-ancestor
6497716|NCT00633776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6497717|NCT00633776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497718|NCT00633802|Risperidone|risperidone|mesh-list
6497719|NCT00633802|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6497720|NCT00633802|Serotonin Agents|serotonin agents|mesh-ancestor
6497721|NCT00633802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6497722|NCT00633802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497723|NCT00633802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497724|NCT00633802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6497725|NCT00633802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6497726|NCT00633802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6497727|NCT00633802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6497728|NCT00633802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6497729|NCT00633802|Dopamine Agents|dopamine agents|mesh-ancestor
6497730|NCT00633958|Alovudine|alovudine|mesh-list
6497731|NCT00633958|Antiviral Agents|antiviral agents|mesh-ancestor
6497732|NCT00633958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6497733|NCT00634062|Lamotrigine|lamotrigine|mesh-list
6497734|NCT00634062|Anticonvulsants|anticonvulsants|mesh-ancestor
6497735|NCT00634062|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6497736|NCT00634062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6497737|NCT00634062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497738|NCT00634062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6497739|NCT00634062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497740|NCT00634062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6497741|NCT00634062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6497742|NCT00634062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5702826|NCT03335436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5702827|NCT03335436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5702828|NCT03335436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5702829|NCT03335436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5702830|NCT03335436|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5702831|NCT03335436|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5702832|NCT03335436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6217491|NCT02270255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217492|NCT02270736|Botulinum Toxins|botulinum toxins|mesh-list
6217493|NCT02270736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6217494|NCT02270736|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6217495|NCT02270736|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
6217496|NCT02270736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6217497|NCT02270736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6217498|NCT02270736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217499|NCT02270736|Cholinergic Agents|cholinergic agents|mesh-ancestor
6217500|NCT02270736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6217501|NCT02270736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217502|NCT02270736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6217503|NCT02270736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6217504|NCT02270944|Vaccines|vaccines|mesh-list
6217505|NCT02270944|Immunologic Factors|immunologic factors|mesh-ancestor
6217506|NCT02270944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217507|NCT02270983|Linaclotide|linaclotide|mesh-list
6217508|NCT02270983|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
6217509|NCT02270983|Enzyme Activators|enzyme activators|mesh-ancestor
6217510|NCT02270983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217511|NCT02270983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6217512|NCT02271217|4-Aminopyridine|4-aminopyridine|mesh-list
6217513|NCT02271217|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6217514|NCT02271217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6217515|NCT02271217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217516|NCT02271425|Evacetrapib|evacetrapib|mesh-list
6217517|NCT02271425|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6217518|NCT02271425|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6217519|NCT02271425|Antimetabolites|antimetabolites|mesh-ancestor
6217520|NCT02271425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217521|NCT02271425|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6217522|NCT02271698|Dexamethasone|dexamethasone|mesh-list
6217523|NCT02271698|Dexamethasone acetate|dexamethasone acetate|mesh-list
6217524|NCT02271698|BB 1101|bb 1101|mesh-list
6217525|NCT02271698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6217526|NCT02271698|Antiemetics|antiemetics|mesh-ancestor
5702833|NCT03335436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5702834|NCT03335436|Antimanic Agents|antimanic agents|mesh-ancestor
5702835|NCT03335423|Metformin|metformin|mesh-list
5702836|NCT03335423|Codeine|codeine|mesh-list
5702837|NCT03335423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5702838|NCT03335423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702839|NCT03335423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5702840|NCT03335423|Narcotics|narcotics|mesh-ancestor
6676053|NCT01578824|Miotics|miotics|mesh-ancestor
6676054|NCT01578824|Autonomic Agents|autonomic agents|mesh-ancestor
6676055|NCT01578824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6676056|NCT01578824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676057|NCT01578824|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6676058|NCT01578824|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
6676059|NCT01578824|Respiratory System Agents|respiratory system agents|mesh-ancestor
6676060|NCT01578824|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6676061|NCT01578824|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6676062|NCT01578824|Cholinergic Agents|cholinergic agents|mesh-ancestor
5918477|NCT04991064|Sunscreening Agents|sunscreening agents|mesh-ancestor
5918478|NCT04991064|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5918479|NCT04991064|Protective Agents|protective agents|mesh-ancestor
5918480|NCT04991064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918481|NCT04991064|Dermatologic Agents|dermatologic agents|mesh-ancestor
5918482|NCT04991064|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5918483|NCT04991155|Zamicastat|zamicastat|mesh-list
5918484|NCT04991155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5918485|NCT04991155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918486|NCT04991298|Fentanyl|fentanyl|mesh-list
5918487|NCT04991298|Midazolam|midazolam|mesh-list
5918488|NCT04991298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5918489|NCT04991298|Narcotics|narcotics|mesh-ancestor
5964063|NCT04595318|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6676063|NCT01578824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6217527|NCT02271698|Autonomic Agents|autonomic agents|mesh-ancestor
6217528|NCT02271698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6217529|NCT02271698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217530|NCT02271698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6217531|NCT02271698|Glucocorticoids|glucocorticoids|mesh-ancestor
6217532|NCT02271698|Hormones|hormones|mesh-ancestor
6217533|NCT02271698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6217534|NCT02271698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6217535|NCT02271698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6217536|NCT02271698|Protease Inhibitors|protease inhibitors|mesh-ancestor
6217537|NCT02271698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5702841|NCT03335423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5702842|NCT03335423|Analgesics|analgesics|mesh-ancestor
5702843|NCT03335423|Sensory System Agents|sensory system agents|mesh-ancestor
5702844|NCT03335423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5702845|NCT03335423|Antitussive Agents|antitussive agents|mesh-ancestor
5702846|NCT03335423|Respiratory System Agents|respiratory system agents|mesh-ancestor
6217538|NCT02271698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217539|NCT02271854|Diclofenac|diclofenac|mesh-list
6217540|NCT02271854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6217541|NCT02271854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6217542|NCT02271854|Analgesics|analgesics|mesh-ancestor
6217543|NCT02271854|Sensory System Agents|sensory system agents|mesh-ancestor
6217544|NCT02271854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6217545|NCT02271854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217546|NCT02271854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6217547|NCT02271854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6217548|NCT02271854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6217549|NCT02271854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6217550|NCT02271854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217551|NCT02271906|Afatinib|afatinib|mesh-list
6217552|NCT02271906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6217553|NCT02271906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6217554|NCT02271906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6217555|NCT02271906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217556|NCT02271984|Praziquantel|praziquantel|mesh-list
6217557|NCT02271984|Anthelmintics|anthelmintics|mesh-ancestor
6217558|NCT02271984|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6217559|NCT02271984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6217560|NCT02272413|Bevacizumab|bevacizumab|mesh-list
6217561|NCT02272413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6217562|NCT02272413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6217563|NCT02272413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5702847|NCT03335293|Epinephrine|epinephrine|mesh-list
5702848|NCT03335293|Racepinephrine|racepinephrine|mesh-list
5702849|NCT03335293|Epinephryl borate|epinephryl borate|mesh-list
5702850|NCT03335293|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5702851|NCT03335293|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5702852|NCT03335293|Adrenergic Agents|adrenergic agents|mesh-ancestor
5702853|NCT03335293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5721096|NCT03208218|Lenalidomide|lenalidomide|mesh-list
6217564|NCT02272413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6217565|NCT02272413|Growth Substances|growth substances|mesh-ancestor
6217566|NCT02272413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217567|NCT02272413|Growth Inhibitors|growth inhibitors|mesh-ancestor
6217568|NCT02272725|Ibuprofen|ibuprofen|mesh-list
6217569|NCT02272725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6217570|NCT02272725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6217571|NCT02272725|Analgesics|analgesics|mesh-ancestor
6217572|NCT02272725|Sensory System Agents|sensory system agents|mesh-ancestor
6217573|NCT02272725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6217574|NCT02272725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217575|NCT02272725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6217576|NCT02272725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6217577|NCT02272725|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6217578|NCT02272725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6217579|NCT02272725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217580|NCT02272777|Imatinib Mesylate|imatinib mesylate|mesh-list
6217581|NCT02272777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6217582|NCT02272777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6217583|NCT02272777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6217584|NCT02272777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217585|NCT02272790|Gemcitabine|gemcitabine|mesh-list
6217586|NCT02272790|Paclitaxel|paclitaxel|mesh-list
6217587|NCT02272790|Carboplatin|carboplatin|mesh-list
6217588|NCT02272790|Adavosertib|adavosertib|mesh-list
6217589|NCT02272790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6217590|NCT02272790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6217591|NCT02272790|Tubulin Modulators|tubulin modulators|mesh-ancestor
6217592|NCT02272790|Antimitotic Agents|antimitotic agents|mesh-ancestor
6217593|NCT02272790|Mitosis Modulators|mitosis modulators|mesh-ancestor
6217594|NCT02272790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217595|NCT02272790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6217596|NCT02272790|Antimetabolites|antimetabolites|mesh-ancestor
6217597|NCT02272790|Antiviral Agents|antiviral agents|mesh-ancestor
6217598|NCT02272790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6217599|NCT02272790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6217600|NCT02272790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6217601|NCT02272790|Immunologic Factors|immunologic factors|mesh-ancestor
6217602|NCT02272790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217603|NCT02272816|Carboplatin|carboplatin|mesh-list
6217604|NCT02272816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6217605|NCT02272842|Vitamin B 12|vitamin b 12|mesh-list
6217606|NCT02272842|Hydroxocobalamin|hydroxocobalamin|mesh-list
6217607|NCT02272842|Vitamins|vitamins|mesh-ancestor
6217608|NCT02272842|Micronutrients|micronutrients|mesh-ancestor
6217609|NCT02272842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217610|NCT02272842|Vitamin B Complex|vitamin b complex|mesh-ancestor
6217611|NCT02272842|Hematinics|hematinics|mesh-ancestor
6217612|NCT02273050|Metformin|metformin|mesh-list
6217613|NCT02273050|Saxagliptin|saxagliptin|mesh-list
6217614|NCT02273050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6217615|NCT02273050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217616|NCT02273050|Incretins|incretins|mesh-ancestor
6217617|NCT02273050|Hormones|hormones|mesh-ancestor
6217618|NCT02273050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6217619|NCT02273050|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6217620|NCT02273050|Protease Inhibitors|protease inhibitors|mesh-ancestor
6217621|NCT02273050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6217622|NCT02273050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217623|NCT02273115|Oxytocin|oxytocin|mesh-list
6497743|NCT00634062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6497744|NCT00634062|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6497745|NCT00634140|Ezetimibe|ezetimibe|mesh-list
6497746|NCT00634140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6497747|NCT00634140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6497748|NCT00634140|Antimetabolites|antimetabolites|mesh-ancestor
6497749|NCT00634140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497750|NCT00634140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6497751|NCT00634192|Tobramycin|tobramycin|mesh-list
6497752|NCT00634192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6497753|NCT00634192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6497754|NCT00634205|Doxorubicin|doxorubicin|mesh-list
6497755|NCT00634205|Valproic Acid|valproic acid|mesh-list
6497756|NCT00634205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6497757|NCT00634205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6497758|NCT00634205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6497759|NCT00634205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6497760|NCT00634205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6497761|NCT00634205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497762|NCT00634205|Anticonvulsants|anticonvulsants|mesh-ancestor
6497763|NCT00634205|GABA Agents|gaba agents|mesh-ancestor
6497764|NCT00634205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6497765|NCT00634205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497766|NCT00634205|Antimanic Agents|antimanic agents|mesh-ancestor
6497767|NCT00634205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6497768|NCT00634205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6497769|NCT00634205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6497770|NCT00634231|Valacyclovir|valacyclovir|mesh-list
6497771|NCT00634231|Antiviral Agents|antiviral agents|mesh-ancestor
6497772|NCT00634231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6497773|NCT00634309|Candesartan|candesartan|mesh-list
6497774|NCT00634309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6497775|NCT00634309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6497776|NCT00634309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6497777|NCT00634309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497778|NCT00634348|Aripiprazole|aripiprazole|mesh-list
6497779|NCT00634348|Ziprasidone|ziprasidone|mesh-list
5721097|NCT03208218|Immunologic Factors|immunologic factors|mesh-ancestor
6217624|NCT02273115|Oxytocics|oxytocics|mesh-ancestor
6217625|NCT02273115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6497780|NCT00634348|Antidepressive Agents|antidepressive agents|mesh-ancestor
6497781|NCT00634348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5702854|NCT03335293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5702855|NCT03335293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702856|NCT03335293|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5702857|NCT03335293|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5702858|NCT03335293|Autonomic Agents|autonomic agents|mesh-ancestor
6217626|NCT02273115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217627|NCT02273180|Insulin|insulin|mesh-list
6217628|NCT02273180|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6217629|NCT02273180|Insulin Glargine|insulin glargine|mesh-list
6217630|NCT02273180|Insulin Lispro|insulin lispro|mesh-list
6217631|NCT02273180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6217632|NCT02273180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217633|NCT02273726|Epoetin Alfa|epoetin alfa|mesh-list
6217634|NCT02273726|Hematinics|hematinics|mesh-ancestor
6217635|NCT02273973|Letrozole|letrozole|mesh-list
6217636|NCT02273973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6217637|NCT02273973|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6217638|NCT02273973|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6217639|NCT02273973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6217640|NCT02273973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217641|NCT02273973|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6217642|NCT02273973|Hormone Antagonists|hormone antagonists|mesh-ancestor
6217643|NCT02273973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6217644|NCT02273973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217645|NCT02274038|Pemetrexed|pemetrexed|mesh-list
6217646|NCT02274038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6217647|NCT02274038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6217648|NCT02274038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217649|NCT02274038|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6217650|NCT02274038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6217651|NCT02274311|Clomiphene|clomiphene|mesh-list
6217652|NCT02274311|Enclomiphene|enclomiphene|mesh-list
6217653|NCT02274311|Zuclomiphene|zuclomiphene|mesh-list
6217654|NCT02274311|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6217655|NCT02274311|Hormone Antagonists|hormone antagonists|mesh-ancestor
6217656|NCT02274311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6217657|NCT02274311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217658|NCT02274311|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6217659|NCT02274311|Fertility Agents|fertility agents|mesh-ancestor
6217660|NCT02274311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6217661|NCT02274311|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6217662|NCT02274311|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6217663|NCT02274766|Amantadine|amantadine|mesh-list
6217664|NCT02274766|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6217665|NCT02274766|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6217666|NCT02274766|Antiviral Agents|antiviral agents|mesh-ancestor
6497782|NCT00634348|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6497783|NCT00634348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6497784|NCT00634348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6497785|NCT00634348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497786|NCT00634348|Dopamine Agonists|dopamine agonists|mesh-ancestor
6497787|NCT00634348|Dopamine Agents|dopamine agents|mesh-ancestor
6497788|NCT00634348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6497789|NCT00634348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5702859|NCT03335293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5702860|NCT03335293|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6217667|NCT02274766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6217668|NCT02274766|Dopamine Agents|dopamine agents|mesh-ancestor
6217669|NCT02274766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6217670|NCT02274766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217671|NCT02274766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217672|NCT02274766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6217673|NCT02274766|Analgesics|analgesics|mesh-ancestor
6217674|NCT02274766|Sensory System Agents|sensory system agents|mesh-ancestor
6217675|NCT02274766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6217676|NCT02274792|Etanercept|etanercept|mesh-list
6217677|NCT02274792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6217678|NCT02274792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6217679|NCT02274792|Analgesics|analgesics|mesh-ancestor
6217680|NCT02274792|Sensory System Agents|sensory system agents|mesh-ancestor
5702861|NCT03335293|Respiratory System Agents|respiratory system agents|mesh-ancestor
5702862|NCT03335293|Mydriatics|mydriatics|mesh-ancestor
6217681|NCT02274792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6243074|NCT02659943|Immunologic Factors|immunologic factors|mesh-ancestor
6217682|NCT02274792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217683|NCT02274792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6217684|NCT02274792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6217685|NCT02274792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6217686|NCT02274792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6217687|NCT02274792|Immunologic Factors|immunologic factors|mesh-ancestor
6217688|NCT02274870|Bupivacaine|bupivacaine|mesh-list
6217689|NCT02274870|Anesthetics, Local|anesthetics, local|mesh-ancestor
6217690|NCT02274870|Anesthetics|anesthetics|mesh-ancestor
6217691|NCT02274870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6217692|NCT02274870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217693|NCT02274870|Sensory System Agents|sensory system agents|mesh-ancestor
6217694|NCT02274870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6217695|NCT02274948|Metformin|metformin|mesh-list
6217696|NCT02274948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6217697|NCT02274948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217698|NCT02275052|Albuterol|albuterol|mesh-list
6217699|NCT02275052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6217700|NCT02275052|Autonomic Agents|autonomic agents|mesh-ancestor
6217701|NCT02275052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6217702|NCT02275052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217703|NCT02275052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6217704|NCT02275052|Respiratory System Agents|respiratory system agents|mesh-ancestor
6217705|NCT02275052|Tocolytic Agents|tocolytic agents|mesh-ancestor
6217706|NCT02275052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6217707|NCT02275052|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6217708|NCT02275052|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6217709|NCT02275052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6217710|NCT02275052|Adrenergic Agents|adrenergic agents|mesh-ancestor
6217711|NCT02275052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6217712|NCT02275052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217713|NCT02275156|Evolocumab|evolocumab|mesh-list
6217714|NCT02275156|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6217715|NCT02275156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6217716|NCT02275156|Antimetabolites|antimetabolites|mesh-ancestor
6217717|NCT02275156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217718|NCT02275156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6217719|NCT02275338|Lanreotide|lanreotide|mesh-list
6217720|NCT02275338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6217721|NCT02275611|Oxytocin|oxytocin|mesh-list
6217722|NCT02275611|Oxytocics|oxytocics|mesh-ancestor
6217723|NCT02275611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6217724|NCT02275611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217725|NCT02275780|Ritonavir|ritonavir|mesh-list
6217726|NCT02275780|Darunavir|darunavir|mesh-list
6217727|NCT02275780|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6217728|NCT02275780|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6217729|NCT02275780|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6217730|NCT02275780|Protease Inhibitors|protease inhibitors|mesh-ancestor
6217731|NCT02275780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6217732|NCT02275780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217733|NCT02275780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6217734|NCT02275780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6217735|NCT02275780|Antiviral Agents|antiviral agents|mesh-ancestor
6217736|NCT02275780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6217737|NCT02275780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6217738|NCT02275780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6217739|NCT02275780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6217740|NCT02275780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6217741|NCT02276027|Ceritinib|ceritinib|mesh-list
6217742|NCT02276027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6217743|NCT02276027|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6217744|NCT02276027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6217745|NCT02276027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217746|NCT02276040|Bupivacaine|bupivacaine|mesh-list
6217747|NCT02276040|Anesthetics, Local|anesthetics, local|mesh-ancestor
6217748|NCT02276040|Anesthetics|anesthetics|mesh-ancestor
6217749|NCT02276040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6217750|NCT02276040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217751|NCT02276040|Sensory System Agents|sensory system agents|mesh-ancestor
6217752|NCT02276040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6217753|NCT02276222|Glycopyrrolate|glycopyrrolate|mesh-list
6217754|NCT02276222|Tiotropium Bromide|tiotropium bromide|mesh-list
6217755|NCT02276222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6217756|NCT02276222|Autonomic Agents|autonomic agents|mesh-ancestor
5702863|NCT03335293|Sympathomimetics|sympathomimetics|mesh-ancestor
5702864|NCT03335293|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6217757|NCT02276222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6217758|NCT02276222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217759|NCT02276222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6217760|NCT02276222|Respiratory System Agents|respiratory system agents|mesh-ancestor
6217761|NCT02276222|Parasympatholytics|parasympatholytics|mesh-ancestor
6217762|NCT02276222|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6217763|NCT02276222|Cholinergic Agents|cholinergic agents|mesh-ancestor
6217764|NCT02276222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6217765|NCT02276222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217766|NCT02276222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6217767|NCT02276222|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6217768|NCT02276274|Alogliptin|alogliptin|mesh-list
6217769|NCT02276274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6217770|NCT02276274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217771|NCT02276274|Incretins|incretins|mesh-ancestor
6217772|NCT02276274|Hormones|hormones|mesh-ancestor
6217773|NCT02276274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6497790|NCT00634348|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6497791|NCT00634348|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6497792|NCT00634348|Serotonin Agents|serotonin agents|mesh-ancestor
6497793|NCT00634348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6497794|NCT00634348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6497795|NCT00634348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6497796|NCT00634348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6497797|NCT00634361|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
6497798|NCT00634361|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6497799|NCT00634361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6497800|NCT00634400|Candesartan|candesartan|mesh-list
6676064|NCT01578824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676065|NCT01578889|Vaccines|vaccines|mesh-list
6676066|NCT01578889|Immunologic Factors|immunologic factors|mesh-ancestor
6676067|NCT01578889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676068|NCT01578928|Pasireotide|pasireotide|mesh-list
6676069|NCT01578928|Hormones|hormones|mesh-ancestor
6676070|NCT01578928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6676071|NCT01578928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676072|NCT01579019|Ritonavir|ritonavir|mesh-list
6676073|NCT01579019|Ribavirin|ribavirin|mesh-list
6676074|NCT01579019|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6676075|NCT01579019|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6676076|NCT01579019|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6676077|NCT01579019|Protease Inhibitors|protease inhibitors|mesh-ancestor
6676078|NCT01579019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6676079|NCT01579019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676080|NCT01579019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6676081|NCT01579019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6676082|NCT01579019|Antiviral Agents|antiviral agents|mesh-ancestor
6676083|NCT01579019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6676084|NCT01579019|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6676085|NCT01579019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6676086|NCT01579019|Antimetabolites|antimetabolites|mesh-ancestor
6676087|NCT01579058|Bisoprolol|bisoprolol|mesh-list
6676088|NCT01579058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6676089|NCT01579058|Sympatholytics|sympatholytics|mesh-ancestor
6676090|NCT01579058|Autonomic Agents|autonomic agents|mesh-ancestor
5702865|NCT03335241|Doxorubicin|doxorubicin|mesh-list
5702866|NCT03335241|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5702867|NCT03335241|Fludarabine|fludarabine|mesh-list
5702868|NCT03335241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5702869|NCT03335241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5702870|NCT03335241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5702871|NCT03335241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5702872|NCT03335241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5702873|NCT03335241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5702874|NCT03335163|Topiramate|topiramate|mesh-list
5702875|NCT03335163|Anticonvulsants|anticonvulsants|mesh-ancestor
5702876|NCT03335163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6676091|NCT01579058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6676092|NCT01579058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676093|NCT01579058|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6676094|NCT01579058|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5702877|NCT03335163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702878|NCT03335124|Vitamins|vitamins|mesh-list
6217774|NCT02276274|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6217775|NCT02276274|Protease Inhibitors|protease inhibitors|mesh-ancestor
6217776|NCT02276274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6217777|NCT02276274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243075|NCT02659943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243076|NCT02659943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6243077|NCT02659943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6243078|NCT02659943|Alkylating Agents|alkylating agents|mesh-ancestor
6243079|NCT02659943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243080|NCT02659943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6243081|NCT02659943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6243082|NCT02660138|Botulinum Toxins|botulinum toxins|mesh-list
6243083|NCT02660138|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6243084|NCT02660138|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6243085|NCT02660138|Hemagglutinins|hemagglutinins|mesh-list
6243086|NCT02660138|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6243087|NCT02660138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6243088|NCT02660138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243089|NCT02660138|Cholinergic Agents|cholinergic agents|mesh-ancestor
6243090|NCT02660138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6243091|NCT02660138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243092|NCT02660138|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6243093|NCT02660138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6243094|NCT02660138|Agglutinins|agglutinins|mesh-ancestor
6243095|NCT02660138|Immunologic Factors|immunologic factors|mesh-ancestor
6243096|NCT02660229|Morphine|morphine|mesh-list
6243097|NCT02660229|Oxycodone|oxycodone|mesh-list
6243098|NCT02660229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6243099|NCT02660229|Narcotics|narcotics|mesh-ancestor
6243100|NCT02660229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6243101|NCT02660229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243102|NCT02660229|Analgesics|analgesics|mesh-ancestor
6243103|NCT02660229|Sensory System Agents|sensory system agents|mesh-ancestor
6243104|NCT02660229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6243105|NCT02660242|Glucagon|glucagon|mesh-list
6243106|NCT02660242|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6243107|NCT02660242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243108|NCT02660242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6243109|NCT02660242|Hormones|hormones|mesh-ancestor
6243110|NCT02660242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6243111|NCT02660242|Incretins|incretins|mesh-ancestor
6243112|NCT02660359|Botulinum Toxins|botulinum toxins|mesh-list
6243113|NCT02660359|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6243114|NCT02660359|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6243115|NCT02660359|Hemagglutinins|hemagglutinins|mesh-list
6243116|NCT02660359|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6243117|NCT02660359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6243118|NCT02660359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243119|NCT02660359|Cholinergic Agents|cholinergic agents|mesh-ancestor
6243120|NCT02660359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6243121|NCT02660359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243122|NCT02660359|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6243123|NCT02660359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6243124|NCT02660359|Agglutinins|agglutinins|mesh-ancestor
6243125|NCT02660359|Immunologic Factors|immunologic factors|mesh-ancestor
6243126|NCT02660580|Adalimumab|adalimumab|mesh-list
6243127|NCT02660580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6243128|NCT02660580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6243129|NCT02660918|Bupivacaine|bupivacaine|mesh-list
6243130|NCT02660918|Anesthetics, Local|anesthetics, local|mesh-ancestor
6243131|NCT02660918|Anesthetics|anesthetics|mesh-ancestor
6243132|NCT02660918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6243133|NCT02660918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243134|NCT02660918|Sensory System Agents|sensory system agents|mesh-ancestor
6243135|NCT02660918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6243136|NCT02660983|Donepezil|donepezil|mesh-list
6243137|NCT02660983|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6243138|NCT02660983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6243139|NCT02660983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243140|NCT02660983|Cholinergic Agents|cholinergic agents|mesh-ancestor
6243141|NCT02660983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6243142|NCT02660983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243143|NCT02660983|Nootropic Agents|nootropic agents|mesh-ancestor
6243144|NCT02661061|Midazolam|midazolam|mesh-list
6243145|NCT02661061|Ketamine|ketamine|mesh-list
5702879|NCT03335124|Ascorbic Acid|ascorbic acid|mesh-list
6217778|NCT02276482|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6217779|NCT02276482|Metronidazole|metronidazole|mesh-list
6217780|NCT02276482|Vancomycin|vancomycin|mesh-list
6217781|NCT02276482|Clindamycin|clindamycin|mesh-list
6217782|NCT02276482|Cefazolin|cefazolin|mesh-list
6217783|NCT02276482|Linezolid|linezolid|mesh-list
6217784|NCT02276482|Cephalexin|cephalexin|mesh-list
6217785|NCT02276482|Aztreonam|aztreonam|mesh-list
6217786|NCT02276482|Tedizolid|tedizolid|mesh-list
6217787|NCT02276482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6217788|NCT02276482|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6217789|NCT02276482|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6217790|NCT02276482|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5918490|NCT04991298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5918491|NCT04991298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918492|NCT04991298|Analgesics|analgesics|mesh-ancestor
5918493|NCT04991298|Sensory System Agents|sensory system agents|mesh-ancestor
6217791|NCT02276482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6217792|NCT02276482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217793|NCT02276612|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6217794|NCT02276612|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6217795|NCT02276612|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6217796|NCT02276612|Antiviral Agents|antiviral agents|mesh-ancestor
6217797|NCT02276612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6217798|NCT02276872|Treprostinil|treprostinil|mesh-list
6217799|NCT02276872|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6217800|NCT02277249|Digoxin|digoxin|mesh-list
6217801|NCT02277249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6217802|NCT02277249|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6217803|NCT02277249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6217804|NCT02277249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217805|NCT02277249|Protective Agents|protective agents|mesh-ancestor
6217806|NCT02277249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217807|NCT02277548|Pregabalin|pregabalin|mesh-list
6217808|NCT02277548|Analgesics|analgesics|mesh-ancestor
6217809|NCT02277548|Sensory System Agents|sensory system agents|mesh-ancestor
6217810|NCT02277548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6217811|NCT02277548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217812|NCT02277548|Anticonvulsants|anticonvulsants|mesh-ancestor
6217813|NCT02277548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6217814|NCT02277548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6217815|NCT02277548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217816|NCT02277548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6217817|NCT02277548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6217818|NCT02277548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6217819|NCT02277548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6217820|NCT02277548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6217821|NCT02277691|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
6217822|NCT02277691|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6217823|NCT02277691|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6217824|NCT02277691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217825|NCT02277743|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6217826|NCT02277743|Immunologic Factors|immunologic factors|mesh-ancestor
6217827|NCT02277743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217828|NCT02277769|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6217829|NCT02277769|Immunologic Factors|immunologic factors|mesh-ancestor
6217830|NCT02277769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217831|NCT02277990|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6217832|NCT02277990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6217833|NCT02278003|Propofol|propofol|mesh-list
6217834|NCT02278003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6217835|NCT02278003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6497801|NCT00634400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6497802|NCT00634400|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5918494|NCT04991298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5918495|NCT04991298|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5918496|NCT04991298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5918497|NCT04991298|Anesthetics, General|anesthetics, general|mesh-ancestor
5918498|NCT04991298|Anesthetics|anesthetics|mesh-ancestor
5918499|NCT04991298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5918500|NCT04991298|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5918501|NCT04991298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5918502|NCT04991298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5918503|NCT04991298|GABA Modulators|gaba modulators|mesh-ancestor
5918504|NCT04991298|GABA Agents|gaba agents|mesh-ancestor
6217836|NCT02278003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217837|NCT02278003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6217838|NCT02278003|Anesthetics, General|anesthetics, general|mesh-ancestor
6217839|NCT02278003|Anesthetics|anesthetics|mesh-ancestor
6217840|NCT02278263|Tranexamic Acid|tranexamic acid|mesh-list
6217841|NCT02278263|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6217842|NCT02278263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6217843|NCT02278263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217844|NCT02278263|Hemostatics|hemostatics|mesh-ancestor
6217845|NCT02278263|Coagulants|coagulants|mesh-ancestor
6217846|NCT02278341|Epoetin Alfa|epoetin alfa|mesh-list
6217847|NCT02278341|Darbepoetin alfa|darbepoetin alfa|mesh-list
6217848|NCT02278341|Hematinics|hematinics|mesh-ancestor
6217849|NCT02278471|Losartan|losartan|mesh-list
6217850|NCT02278471|Amlodipine|amlodipine|mesh-list
6217851|NCT02278471|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6217852|NCT02278471|Atorvastatin|atorvastatin|mesh-list
6217853|NCT02278471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6217854|NCT02278471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6217855|NCT02278471|Antimetabolites|antimetabolites|mesh-ancestor
6217856|NCT02278471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217857|NCT02278471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6217858|NCT02278471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6217859|NCT02278471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6217860|NCT02278471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6217861|NCT02278471|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6217862|NCT02278471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6217863|NCT02278471|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6217864|NCT02278471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217865|NCT02278471|Vasodilator Agents|vasodilator agents|mesh-ancestor
6217866|NCT02278471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6217867|NCT02278471|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6217868|NCT02278471|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6217869|NCT02278471|Diuretics|diuretics|mesh-ancestor
6217870|NCT02278471|Natriuretic Agents|natriuretic agents|mesh-ancestor
6217871|NCT02278471|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6217872|NCT02278562|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6217873|NCT02278562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6217874|NCT02278614|Timolol|timolol|mesh-list
6217875|NCT02278614|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6217876|NCT02278614|Latanoprost|latanoprost|mesh-list
6217877|NCT02278614|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6217878|NCT02278614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6217879|NCT02278614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6217880|NCT02278614|Adrenergic Agents|adrenergic agents|mesh-ancestor
6217881|NCT02278614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6217882|NCT02278614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217883|NCT02278614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217884|NCT02278614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6217885|NCT02278614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6217886|NCT02279407|Dapagliflozin|dapagliflozin|mesh-list
6217887|NCT02279407|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6217888|NCT02279407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217889|NCT02279407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6217890|NCT02279407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217891|NCT02279641|Allopurinol|allopurinol|mesh-list
6217892|NCT02279641|Verinurad|verinurad|mesh-list
6217893|NCT02279641|Antimetabolites|antimetabolites|mesh-ancestor
6217894|NCT02279641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217895|NCT02279641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6217896|NCT02279641|Gout Suppressants|gout suppressants|mesh-ancestor
6217897|NCT02279641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6217898|NCT02279641|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6217899|NCT02279641|Antioxidants|antioxidants|mesh-ancestor
6217900|NCT02279641|Protective Agents|protective agents|mesh-ancestor
6217901|NCT02279641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217902|NCT02279667|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
6217903|NCT02279667|Anticonvulsants|anticonvulsants|mesh-ancestor
6217904|NCT02279667|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6676095|NCT01579058|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6676096|NCT01579058|Adrenergic Agents|adrenergic agents|mesh-ancestor
6676097|NCT01579058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6676098|NCT01579058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676099|NCT01579110|Levamisole|levamisole|mesh-list
6217905|NCT02279667|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5702880|NCT03335124|Thiamine|thiamine|mesh-list
5702881|NCT03335124|Hydrocortisone|hydrocortisone|mesh-list
5702882|NCT03335124|Micronutrients|micronutrients|mesh-ancestor
5702883|NCT03335124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702884|NCT03335124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5702885|NCT03335124|Antioxidants|antioxidants|mesh-ancestor
5702886|NCT03335124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5702887|NCT03335124|Protective Agents|protective agents|mesh-ancestor
5702888|NCT03335124|Vitamin B Complex|vitamin b complex|mesh-ancestor
5702889|NCT03335098|Thalidomide|thalidomide|mesh-list
5702890|NCT03335098|Dexamethasone|dexamethasone|mesh-list
5702891|NCT03335098|Bortezomib|bortezomib|mesh-list
5702892|NCT03335098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5702893|NCT03335098|Antiemetics|antiemetics|mesh-ancestor
6217906|NCT02279667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6217907|NCT02279667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217908|NCT02279719|Sorafenib|sorafenib|mesh-list
6217909|NCT02279719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6217910|NCT02279719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6217911|NCT02279719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6217912|NCT02279719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217913|NCT02279732|Paclitaxel|paclitaxel|mesh-list
5702894|NCT03335098|Autonomic Agents|autonomic agents|mesh-ancestor
5702895|NCT03335098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5702896|NCT03335098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702897|NCT03335098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5702898|NCT03335098|Glucocorticoids|glucocorticoids|mesh-ancestor
5702899|NCT03335098|Hormones|hormones|mesh-ancestor
5702900|NCT03335098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5702901|NCT03335098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5702902|NCT03335098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5702903|NCT03335098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5702904|NCT03335098|Immunologic Factors|immunologic factors|mesh-ancestor
5702905|NCT03335098|Leprostatic Agents|leprostatic agents|mesh-ancestor
5702906|NCT03335098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5702907|NCT03335098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5702908|NCT03335098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5964064|NCT04595318|Cholinergic Agents|cholinergic agents|mesh-ancestor
6217914|NCT02279732|Carboplatin|carboplatin|mesh-list
6217915|NCT02279732|Ipilimumab|ipilimumab|mesh-list
6217916|NCT02279732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6217917|NCT02279732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6217918|NCT02279732|Tubulin Modulators|tubulin modulators|mesh-ancestor
6217919|NCT02279732|Antimitotic Agents|antimitotic agents|mesh-ancestor
6217920|NCT02279732|Mitosis Modulators|mitosis modulators|mesh-ancestor
6217921|NCT02279732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217922|NCT02279732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6217923|NCT02279732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6217924|NCT02279862|Ipilimumab|ipilimumab|mesh-list
6217925|NCT02279862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6217926|NCT02279862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6497803|NCT00634400|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6497804|NCT00634400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497805|NCT00634413|Budesonide|budesonide|mesh-list
6497806|NCT00634413|Theophylline|theophylline|mesh-list
6497807|NCT00634413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6497808|NCT00634413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6497809|NCT00634413|Autonomic Agents|autonomic agents|mesh-ancestor
6497810|NCT00634413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6497811|NCT00634413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497812|NCT00634413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6497813|NCT00634413|Respiratory System Agents|respiratory system agents|mesh-ancestor
6497814|NCT00634413|Glucocorticoids|glucocorticoids|mesh-ancestor
6497815|NCT00634413|Hormones|hormones|mesh-ancestor
6524463|NCT00758199|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6524464|NCT00758199|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6524465|NCT00758199|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6524466|NCT00758199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6524467|NCT00758199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6524468|NCT00758199|Analgesics|analgesics|mesh-ancestor
6524469|NCT00758199|Sensory System Agents|sensory system agents|mesh-ancestor
6524470|NCT00758199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6524471|NCT00758212|Vaccines|vaccines|mesh-list
6524472|NCT00758212|Immunologic Factors|immunologic factors|mesh-ancestor
6524473|NCT00758212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524474|NCT00758225|Idebenone|idebenone|mesh-list
6217927|NCT02279862|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6217928|NCT02279862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217929|NCT02280044|Rifaximin|rifaximin|mesh-list
6217930|NCT02280044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6217931|NCT02280044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6217932|NCT02280044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6217933|NCT02280096|4-Aminopyridine|4-aminopyridine|mesh-list
6217934|NCT02280096|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6217935|NCT02280096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6217936|NCT02280096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217937|NCT02280421|Cyclosporine|cyclosporine|mesh-list
6217938|NCT02280421|Cyclosporins|cyclosporins|mesh-list
6217939|NCT02280421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6217940|NCT02280421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217941|NCT02280421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6217942|NCT02280421|Immunologic Factors|immunologic factors|mesh-ancestor
6217943|NCT02280421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217944|NCT02280421|Antifungal Agents|antifungal agents|mesh-ancestor
6217945|NCT02280421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6217946|NCT02280421|Dermatologic Agents|dermatologic agents|mesh-ancestor
6217947|NCT02280421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6217948|NCT02280421|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6217949|NCT02280473|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6217950|NCT02280473|Laxatives|laxatives|mesh-ancestor
6217951|NCT02280473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6217952|NCT02280811|Aldesleukin|aldesleukin|mesh-list
6217953|NCT02280811|Cyclophosphamide|cyclophosphamide|mesh-list
6217954|NCT02280811|Fludarabine|fludarabine|mesh-list
6217955|NCT02280811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5702909|NCT03335098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5702910|NCT03335098|Growth Substances|growth substances|mesh-ancestor
5702911|NCT03335098|Growth Inhibitors|growth inhibitors|mesh-ancestor
5702912|NCT03335085|Oxytocin|oxytocin|mesh-list
5702913|NCT03335085|Oxytocics|oxytocics|mesh-ancestor
5702914|NCT03335085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6217956|NCT02280811|Immunologic Factors|immunologic factors|mesh-ancestor
6217957|NCT02280811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6217958|NCT02280811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6217959|NCT02280811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6217960|NCT02280811|Alkylating Agents|alkylating agents|mesh-ancestor
6217961|NCT02280811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217962|NCT02280811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6217963|NCT02280811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6217964|NCT02280811|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6217965|NCT02280811|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6217966|NCT02280811|Antiviral Agents|antiviral agents|mesh-ancestor
6217967|NCT02280811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6217968|NCT02281136|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6217969|NCT02281136|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6217970|NCT02281136|Dermatologic Agents|dermatologic agents|mesh-ancestor
6217971|NCT02281409|Mogamulizumab|mogamulizumab|mesh-list
6217972|NCT02281409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6217973|NCT02281422|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
6217974|NCT02281422|Anticonvulsants|anticonvulsants|mesh-ancestor
6217975|NCT02281422|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6217976|NCT02281422|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6217977|NCT02281422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6217978|NCT02281422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217979|NCT02281448|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
6217980|NCT02281448|Contraceptive Agents|contraceptive agents|mesh-list
6217981|NCT02281448|Contraceptives, Oral|contraceptives, oral|mesh-list
6217982|NCT02281448|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
6217983|NCT02281448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6217984|NCT02281448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971362|NCT04528797|Prednisolone acetate|prednisolone acetate|mesh-list
5971363|NCT04528797|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5971364|NCT04528797|Prednisolone phosphate|prednisolone phosphate|mesh-list
5971365|NCT04528797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5971366|NCT04528797|Antiemetics|antiemetics|mesh-ancestor
5971367|NCT04528797|Autonomic Agents|autonomic agents|mesh-ancestor
5971368|NCT04528797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5971369|NCT04528797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971370|NCT04528797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5971371|NCT04528797|Glucocorticoids|glucocorticoids|mesh-ancestor
5971372|NCT04528797|Hormones|hormones|mesh-ancestor
6217985|NCT02281448|Anticonvulsants|anticonvulsants|mesh-ancestor
6217986|NCT02281448|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6217987|NCT02281448|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6217988|NCT02281448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6217989|NCT02281448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217990|NCT02281448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6217991|NCT02281526|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
6217992|NCT02281526|Anticonvulsants|anticonvulsants|mesh-ancestor
6217993|NCT02281526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6217994|NCT02281526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6217995|NCT02281526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6217996|NCT02281526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6217997|NCT02281552|Tofacitinib|tofacitinib|mesh-list
6217998|NCT02281552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6217999|NCT02281552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6218000|NCT02281552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218001|NCT02281591|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
6218002|NCT02281591|Anticonvulsants|anticonvulsants|mesh-ancestor
6218003|NCT02281591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6218004|NCT02281591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6218005|NCT02281591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6218006|NCT02281591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218007|NCT02281760|Trametinib|trametinib|mesh-list
6218008|NCT02281760|Dabrafenib|dabrafenib|mesh-list
6218009|NCT02281760|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
6218010|NCT02281760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6218011|NCT02281760|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6218012|NCT02281760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6218013|NCT02281760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218014|NCT02281760|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6218015|NCT02281760|Protective Agents|protective agents|mesh-ancestor
6218016|NCT02281760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218017|NCT02281760|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6218018|NCT02281760|Antioxidants|antioxidants|mesh-ancestor
6218019|NCT02281773|BI 409306|bi 409306|mesh-list
6218020|NCT02281773|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6218021|NCT02281773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6218022|NCT02281773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218023|NCT02282293|Piperaquine|piperaquine|mesh-list
6218024|NCT02282293|Trimethoprim|trimethoprim|mesh-list
6218025|NCT02282293|Artenimol|artenimol|mesh-list
6497816|NCT00634413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6497817|NCT00634413|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6497818|NCT00634413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6524475|NCT00758225|Antioxidants|antioxidants|mesh-ancestor
6218026|NCT02282293|Sulfamethoxazole|sulfamethoxazole|mesh-list
6218027|NCT02282293|Antimalarials|antimalarials|mesh-ancestor
6218028|NCT02282293|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6218029|NCT02282293|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6218030|NCT02282293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6218031|NCT02282293|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6218032|NCT02282293|Renal Agents|renal agents|mesh-ancestor
6218033|NCT02282293|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6218034|NCT02282293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6218035|NCT02282293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218036|NCT02282293|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6218037|NCT02282293|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6218038|NCT02282293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6218039|NCT02282514|Methylprednisolone|methylprednisolone|mesh-list
6218040|NCT02282514|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6218041|NCT02282514|Cyclophosphamide|cyclophosphamide|mesh-list
6218042|NCT02282514|Rituximab|rituximab|mesh-list
6218043|NCT02282514|Thymoglobulin|thymoglobulin|mesh-list
6218044|NCT02282514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6218045|NCT02282514|Immunologic Factors|immunologic factors|mesh-ancestor
5702915|NCT03335085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702916|NCT03335072|Azithromycin|azithromycin|mesh-list
5702917|NCT03335072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5702918|NCT03335072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5702919|NCT03335059|Mitomycins|mitomycins|mesh-list
5702920|NCT03335059|Mitomycin|mitomycin|mesh-list
5702921|NCT03335059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5702922|NCT03335059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6218046|NCT02282514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218047|NCT02282514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6218048|NCT02282514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6218049|NCT02282514|Alkylating Agents|alkylating agents|mesh-ancestor
6218050|NCT02282514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218051|NCT02282514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6218052|NCT02282514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6218053|NCT02282514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6218054|NCT02282514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6218055|NCT02282514|Antiemetics|antiemetics|mesh-ancestor
6218056|NCT02282514|Autonomic Agents|autonomic agents|mesh-ancestor
6218057|NCT02282514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6218058|NCT02282514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6218059|NCT02282514|Glucocorticoids|glucocorticoids|mesh-ancestor
6218060|NCT02282514|Hormones|hormones|mesh-ancestor
6218061|NCT02282514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5702923|NCT03335059|Alkylating Agents|alkylating agents|mesh-ancestor
5702924|NCT03335059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5702925|NCT03335059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5702926|NCT03335059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6218062|NCT02282514|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6218063|NCT02282514|Protective Agents|protective agents|mesh-ancestor
6218064|NCT02282514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6497819|NCT00634413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497820|NCT00634413|Vasodilator Agents|vasodilator agents|mesh-ancestor
6497821|NCT00634413|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6497822|NCT00634413|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6497823|NCT00634413|Purinergic Agents|purinergic agents|mesh-ancestor
6497824|NCT00634413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6497825|NCT00634439|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6497826|NCT00634439|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6497827|NCT00634439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6497828|NCT00634439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6497829|NCT00634439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497830|NCT00634439|Adrenergic Agents|adrenergic agents|mesh-ancestor
6497831|NCT00634439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6497832|NCT00634439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497833|NCT00634491|Acetazolamide|acetazolamide|mesh-list
6497834|NCT00634491|Anticonvulsants|anticonvulsants|mesh-ancestor
6218065|NCT02282527|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
6218066|NCT02282527|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6218067|NCT02282527|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6218068|NCT02282527|Protease Inhibitors|protease inhibitors|mesh-ancestor
6218069|NCT02282527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6218070|NCT02282527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218071|NCT02282605|Chlorhexidine|chlorhexidine|mesh-list
6218072|NCT02282605|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6218073|NCT02282605|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6218074|NCT02282605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6218075|NCT02282605|Disinfectants|disinfectants|mesh-ancestor
6218076|NCT02282605|Dermatologic Agents|dermatologic agents|mesh-ancestor
6218077|NCT02282813|Calcitriol|calcitriol|mesh-list
6218078|NCT02282813|Calcifediol|calcifediol|mesh-list
6218079|NCT02282813|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
6218080|NCT02282813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6218081|NCT02282813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218082|NCT02282813|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6218083|NCT02282813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6218084|NCT02282813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218085|NCT02282813|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6218086|NCT02282813|Vitamins|vitamins|mesh-ancestor
6218087|NCT02282813|Micronutrients|micronutrients|mesh-ancestor
6218088|NCT02282813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6218089|NCT02282904|Sirolimus|sirolimus|mesh-list
6218090|NCT02282904|Cyclophosphamide|cyclophosphamide|mesh-list
6218091|NCT02282904|Busulfan|busulfan|mesh-list
6218092|NCT02282904|Fludarabine|fludarabine|mesh-list
6218093|NCT02282904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6218094|NCT02282904|Immunologic Factors|immunologic factors|mesh-ancestor
6218095|NCT02282904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218096|NCT02282904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6218097|NCT02282904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6218098|NCT02282904|Alkylating Agents|alkylating agents|mesh-ancestor
6218099|NCT02282904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218100|NCT02282904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6218101|NCT02282904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6218102|NCT02282904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6218103|NCT02282904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6218104|NCT02282904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6218105|NCT02282904|Antifungal Agents|antifungal agents|mesh-ancestor
6218106|NCT02283294|Warfarin|warfarin|mesh-list
6218107|NCT02283294|Apixaban|apixaban|mesh-list
6218108|NCT02283294|Anticoagulants|anticoagulants|mesh-ancestor
6218109|NCT02283294|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6218110|NCT02283294|Antithrombins|antithrombins|mesh-ancestor
6218111|NCT02283294|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6218112|NCT02283294|Protease Inhibitors|protease inhibitors|mesh-ancestor
6218113|NCT02283294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6497835|NCT00634491|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6497836|NCT00634491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6497837|NCT00634491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497838|NCT00634491|Diuretics|diuretics|mesh-ancestor
6497839|NCT00634491|Natriuretic Agents|natriuretic agents|mesh-ancestor
6497840|NCT00634491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497841|NCT00634556|Levodopa|levodopa|mesh-list
6497842|NCT00634556|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
6497843|NCT00634556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6497844|NCT00634556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6497845|NCT00634556|Dopamine Agents|dopamine agents|mesh-ancestor
6497846|NCT00634556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6497847|NCT00634556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497848|NCT00634556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497849|NCT00634595|Paclitaxel|paclitaxel|mesh-list
6497850|NCT00634595|Cisplatin|cisplatin|mesh-list
6497851|NCT00634595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6497852|NCT00634595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6497853|NCT00634595|Tubulin Modulators|tubulin modulators|mesh-ancestor
6497854|NCT00634595|Antimitotic Agents|antimitotic agents|mesh-ancestor
6497855|NCT00634595|Mitosis Modulators|mitosis modulators|mesh-ancestor
6497856|NCT00634595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497857|NCT00634634|Sorafenib|sorafenib|mesh-list
6497858|NCT00634634|Letrozole|letrozole|mesh-list
6497859|NCT00634634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6497860|NCT00634634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6497861|NCT00634634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6497862|NCT00634634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497863|NCT00634634|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6497864|NCT00634634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6497865|NCT00634634|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6497866|NCT00634634|Hormone Antagonists|hormone antagonists|mesh-ancestor
6497867|NCT00634634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5702927|NCT03335007|Aceclofenac|aceclofenac|mesh-list
5702928|NCT03335007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5702929|NCT03335007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5702930|NCT03335007|Analgesics|analgesics|mesh-ancestor
5702931|NCT03335007|Sensory System Agents|sensory system agents|mesh-ancestor
5702932|NCT03335007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5702933|NCT03335007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702934|NCT03335007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5702935|NCT03335007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5702936|NCT03334981|Buprenorphine|buprenorphine|mesh-list
5702937|NCT03334981|Methadone|methadone|mesh-list
5702938|NCT03334981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5702939|NCT03334981|Narcotics|narcotics|mesh-ancestor
5702940|NCT03334981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5702941|NCT03334981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702942|NCT03334981|Analgesics|analgesics|mesh-ancestor
5702943|NCT03334981|Sensory System Agents|sensory system agents|mesh-ancestor
5702944|NCT03334981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5702945|NCT03334981|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5702946|NCT03334981|Antitussive Agents|antitussive agents|mesh-ancestor
6497868|NCT00634634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497869|NCT00634686|Vitamin D|vitamin d|mesh-list
6497870|NCT00634686|Calcium|calcium|mesh-list
6497871|NCT00634686|Vitamins|vitamins|mesh-ancestor
5702947|NCT03334981|Respiratory System Agents|respiratory system agents|mesh-ancestor
6497872|NCT00634686|Micronutrients|micronutrients|mesh-ancestor
5702948|NCT03334877|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5702949|NCT03334877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6218114|NCT02283294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676100|NCT01579110|Prednisone|prednisone|mesh-list
6218115|NCT02283658|Everolimus|everolimus|mesh-list
6218116|NCT02283658|Letrozole|letrozole|mesh-list
6218117|NCT02283658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6218118|NCT02283658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6218119|NCT02283658|Immunologic Factors|immunologic factors|mesh-ancestor
6218120|NCT02283658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218121|NCT02283658|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6218122|NCT02283658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6218123|NCT02283658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6218124|NCT02283658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218125|NCT02283658|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6218126|NCT02283658|Hormone Antagonists|hormone antagonists|mesh-ancestor
6218127|NCT02283658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6218128|NCT02283749|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
6218129|NCT02283749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6218130|NCT02283762|Riociguat|riociguat|mesh-list
6218131|NCT02283762|Enzyme Activators|enzyme activators|mesh-ancestor
6218132|NCT02283762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218133|NCT02283788|Moxifloxacin|moxifloxacin|mesh-list
6218134|NCT02283788|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
6218135|NCT02283788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6218136|NCT02283788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6218137|NCT02283788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6218138|NCT02283788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6218139|NCT02283788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6218140|NCT02283788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218141|NCT02283788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6218142|NCT02283788|Anticonvulsants|anticonvulsants|mesh-ancestor
6218143|NCT02283788|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6218144|NCT02283788|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6218145|NCT02283788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6243146|NCT02661061|Analgesics|analgesics|mesh-ancestor
6243147|NCT02661061|Sensory System Agents|sensory system agents|mesh-ancestor
6243148|NCT02661061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6243149|NCT02661061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243150|NCT02661061|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6243151|NCT02661061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6243152|NCT02661061|Anesthetics, General|anesthetics, general|mesh-ancestor
6243153|NCT02661061|Anesthetics|anesthetics|mesh-ancestor
6243154|NCT02661061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6243155|NCT02661061|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6243156|NCT02661061|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6243157|NCT02661061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6243158|NCT02661061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243159|NCT02661061|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6243160|NCT02661061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6243161|NCT02661061|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6243162|NCT02661061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6243163|NCT02661061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6243164|NCT02661061|GABA Modulators|gaba modulators|mesh-ancestor
6243165|NCT02661061|GABA Agents|gaba agents|mesh-ancestor
6497873|NCT00634686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497874|NCT00634686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6497875|NCT00634686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6497876|NCT00634712|Candesartan|candesartan|mesh-list
6497877|NCT00634712|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6497878|NCT00634712|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6676101|NCT01579110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6676102|NCT01579110|Glucocorticoids|glucocorticoids|mesh-ancestor
6243166|NCT02661126|Uprifosbuvir|uprifosbuvir|mesh-list
6497879|NCT00634712|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6497880|NCT00634712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497881|NCT00634725|Gemcitabine|gemcitabine|mesh-list
6497882|NCT00634725|Capecitabine|capecitabine|mesh-list
6497883|NCT00634725|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6676103|NCT01579110|Hormones|hormones|mesh-ancestor
6218146|NCT02283814|Topiramate|topiramate|mesh-list
6218147|NCT02283814|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
6218148|NCT02283814|Anticonvulsants|anticonvulsants|mesh-ancestor
6218149|NCT02283814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6218150|NCT02283814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218151|NCT02283814|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6218152|NCT02283814|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6218153|NCT02283814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6218154|NCT02283814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218155|NCT02283827|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
6218156|NCT02283827|Phenytoin|phenytoin|mesh-list
6218157|NCT02283827|Anticonvulsants|anticonvulsants|mesh-ancestor
6218158|NCT02283827|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6218159|NCT02283827|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6218160|NCT02283827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6218161|NCT02283827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218162|NCT02283827|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6218163|NCT02283827|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6218164|NCT02283840|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
6218165|NCT02283840|Anticonvulsants|anticonvulsants|mesh-ancestor
6218166|NCT02283840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6218167|NCT02283840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6218168|NCT02283840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6218169|NCT02283840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5702950|NCT03334877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702951|NCT03334838|Nifurtimox|nifurtimox|mesh-list
5702952|NCT03334838|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6218170|NCT02284009|rGLP-1 protein|rglp-1 protein|mesh-list
6218171|NCT02284009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218172|NCT02284009|Incretins|incretins|mesh-ancestor
6218173|NCT02284009|Hormones|hormones|mesh-ancestor
6218174|NCT02284009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6218175|NCT02284126|Vancomycin|vancomycin|mesh-list
6218176|NCT02284126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6218177|NCT02284126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6218178|NCT02284243|Dexmedetomidine|dexmedetomidine|mesh-list
6218179|NCT02284243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6218180|NCT02284243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6218181|NCT02284243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218182|NCT02284243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5702953|NCT03334838|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5702954|NCT03334838|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5702955|NCT03334838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5721098|NCT03208218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721099|NCT03208218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5721100|NCT03208218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5721101|NCT03208218|Growth Substances|growth substances|mesh-ancestor
5721102|NCT03208218|Growth Inhibitors|growth inhibitors|mesh-ancestor
5721103|NCT03208218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5721104|NCT03208413|Thalidomide|thalidomide|mesh-list
5721105|NCT03208413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5721106|NCT03208413|Immunologic Factors|immunologic factors|mesh-ancestor
5721107|NCT03208413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721108|NCT03208413|Leprostatic Agents|leprostatic agents|mesh-ancestor
5721109|NCT03208413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5721110|NCT03208413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5721111|NCT03208413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6218183|NCT02284243|Analgesics|analgesics|mesh-ancestor
6218184|NCT02284243|Sensory System Agents|sensory system agents|mesh-ancestor
6218185|NCT02284243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6218186|NCT02284243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6218187|NCT02284243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6218188|NCT02284243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6218189|NCT02284243|Adrenergic Agents|adrenergic agents|mesh-ancestor
6218190|NCT02284243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6218191|NCT02284243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218192|NCT02284386|Bupivacaine|bupivacaine|mesh-list
6218193|NCT02284386|Anesthetics, Local|anesthetics, local|mesh-ancestor
6218194|NCT02284386|Anesthetics|anesthetics|mesh-ancestor
6218195|NCT02284386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6218196|NCT02284386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721112|NCT03208413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5721113|NCT03208413|Growth Substances|growth substances|mesh-ancestor
6218197|NCT02284386|Sensory System Agents|sensory system agents|mesh-ancestor
6218198|NCT02284386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6218199|NCT02284464|Prednisone|prednisone|mesh-list
6218200|NCT02284464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6218201|NCT02284464|Glucocorticoids|glucocorticoids|mesh-ancestor
6218202|NCT02284464|Hormones|hormones|mesh-ancestor
6218203|NCT02284464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6218204|NCT02284464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218205|NCT02284464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6218206|NCT02284464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6218207|NCT02284516|Lifitegrast|lifitegrast|mesh-list
6218208|NCT02284516|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6218209|NCT02284516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6218210|NCT02284555|Mupirocin|mupirocin|mesh-list
6218211|NCT02284555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6218212|NCT02284555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6218213|NCT02284555|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6218214|NCT02284555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6218215|NCT02284555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218216|NCT02284828|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
6218217|NCT02284828|Anticonvulsants|anticonvulsants|mesh-ancestor
6218218|NCT02284828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6218219|NCT02284828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6218220|NCT02284828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6218221|NCT02284828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218222|NCT02284854|Carbamazepine|carbamazepine|mesh-list
6218223|NCT02284854|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
5702956|NCT03334682|Doxycycline|doxycycline|mesh-list
5702957|NCT03334682|Spironolactone|spironolactone|mesh-list
6218224|NCT02284854|Anticonvulsants|anticonvulsants|mesh-ancestor
6218225|NCT02284854|Antimanic Agents|antimanic agents|mesh-ancestor
6218226|NCT02284854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6218227|NCT02284854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6218228|NCT02284854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218229|NCT02284854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6218230|NCT02284854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6218231|NCT02284854|Analgesics|analgesics|mesh-ancestor
6218232|NCT02284854|Sensory System Agents|sensory system agents|mesh-ancestor
6218233|NCT02284854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6218234|NCT02284854|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6218235|NCT02284854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6218236|NCT02284854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218237|NCT02284854|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6218238|NCT02284854|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6218239|NCT02284854|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6218240|NCT02284880|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
6218241|NCT02284880|Anticonvulsants|anticonvulsants|mesh-ancestor
6218242|NCT02284880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6218243|NCT02284880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6218244|NCT02284880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6218245|NCT02284880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218246|NCT02284893|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6218247|NCT02284893|Dapagliflozin|dapagliflozin|mesh-list
6218248|NCT02284893|Saxagliptin|saxagliptin|mesh-list
6218249|NCT02284893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6218250|NCT02284893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218251|NCT02284893|Incretins|incretins|mesh-ancestor
6218252|NCT02284893|Hormones|hormones|mesh-ancestor
6218253|NCT02284893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6218254|NCT02284893|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6218255|NCT02284893|Protease Inhibitors|protease inhibitors|mesh-ancestor
6218256|NCT02284893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6218257|NCT02284893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218258|NCT02284893|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6218259|NCT02285010|Pregabalin|pregabalin|mesh-list
6218260|NCT02285010|Analgesics|analgesics|mesh-ancestor
6218261|NCT02285010|Sensory System Agents|sensory system agents|mesh-ancestor
6218262|NCT02285010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6218263|NCT02285010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218264|NCT02285010|Anticonvulsants|anticonvulsants|mesh-ancestor
6218265|NCT02285010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6218266|NCT02285010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5702958|NCT03334682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5702959|NCT03334682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5702960|NCT03334682|Antimalarials|antimalarials|mesh-ancestor
5702961|NCT03334682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5702962|NCT03334682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5702963|NCT03334682|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5702964|NCT03334682|Hormone Antagonists|hormone antagonists|mesh-ancestor
5702965|NCT03334682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5702966|NCT03334682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702967|NCT03334682|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5702968|NCT03334682|Diuretics|diuretics|mesh-ancestor
5702969|NCT03334682|Natriuretic Agents|natriuretic agents|mesh-ancestor
6218267|NCT02285010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218268|NCT02285010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6218269|NCT02285010|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6218270|NCT02285010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6218271|NCT02285010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6218272|NCT02285010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6218273|NCT02285153|Aspirin|aspirin|mesh-list
6218274|NCT02285153|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
6218275|NCT02285153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6218276|NCT02285153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6218277|NCT02285153|Analgesics|analgesics|mesh-ancestor
6218278|NCT02285153|Sensory System Agents|sensory system agents|mesh-ancestor
6218279|NCT02285153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6218280|NCT02285153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218281|NCT02285153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6218282|NCT02285153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6218283|NCT02285153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6218284|NCT02285153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6218285|NCT02285153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218286|NCT02285153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6218287|NCT02285153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6218288|NCT02285153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6218289|NCT02285153|Antipyretics|antipyretics|mesh-ancestor
6218290|NCT02285283|Itraconazole|itraconazole|mesh-list
6218291|NCT02285283|Antifungal Agents|antifungal agents|mesh-ancestor
6218292|NCT02285283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6218293|NCT02285283|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6218294|NCT02285283|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6218295|NCT02285283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6218296|NCT02285283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218297|NCT02285283|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6218298|NCT02285283|Hormone Antagonists|hormone antagonists|mesh-ancestor
6218299|NCT02285283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6218300|NCT02285283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218301|NCT02285283|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6218302|NCT02285634|Lidocaine|lidocaine|mesh-list
6218303|NCT02285634|Phenylephrine|phenylephrine|mesh-list
6218304|NCT02285634|Epinephrine|epinephrine|mesh-list
6218305|NCT02285634|Oxymetazoline|oxymetazoline|mesh-list
6218306|NCT02285634|Anesthetics, Local|anesthetics, local|mesh-ancestor
6218307|NCT02285634|Anesthetics|anesthetics|mesh-ancestor
6218308|NCT02285634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6218309|NCT02285634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218310|NCT02285634|Sensory System Agents|sensory system agents|mesh-ancestor
5702970|NCT03334591|Apatinib|apatinib|mesh-list
5721114|NCT03208413|Growth Inhibitors|growth inhibitors|mesh-ancestor
6218311|NCT02285634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6218312|NCT02285634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6218313|NCT02285634|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6218314|NCT02285634|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6218315|NCT02285634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6218316|NCT02285634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218317|NCT02285634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6218318|NCT02285634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6218319|NCT02285634|Adrenergic Agents|adrenergic agents|mesh-ancestor
6218320|NCT02285634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6218321|NCT02285634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6218322|NCT02285634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6218323|NCT02285634|Autonomic Agents|autonomic agents|mesh-ancestor
6218324|NCT02285634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6218325|NCT02285634|Respiratory System Agents|respiratory system agents|mesh-ancestor
6218326|NCT02285634|Mydriatics|mydriatics|mesh-ancestor
6218327|NCT02285634|Sympathomimetics|sympathomimetics|mesh-ancestor
6218328|NCT02285634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6218329|NCT02285634|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6218330|NCT02285634|Nasal Decongestants|nasal decongestants|mesh-ancestor
6218331|NCT02285634|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6218332|NCT02285634|Protective Agents|protective agents|mesh-ancestor
6218333|NCT02285855|Metformin|metformin|mesh-list
6218334|NCT02285855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6218335|NCT02285855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218336|NCT02285920|Spironolactone|spironolactone|mesh-list
6218337|NCT02285920|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6218338|NCT02285920|Hormone Antagonists|hormone antagonists|mesh-ancestor
6218339|NCT02285920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6218340|NCT02285920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218341|NCT02285920|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6218342|NCT02285920|Diuretics|diuretics|mesh-ancestor
6218343|NCT02285920|Natriuretic Agents|natriuretic agents|mesh-ancestor
6218344|NCT02285998|Vaccines|vaccines|mesh-list
6218345|NCT02285998|Immunologic Factors|immunologic factors|mesh-ancestor
6218346|NCT02285998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218347|NCT02286726|Cytarabine|cytarabine|mesh-list
6497884|NCT00634725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6497885|NCT00634725|Antimetabolites|antimetabolites|mesh-ancestor
6497886|NCT00634725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497887|NCT00634725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6497888|NCT00634725|Antiviral Agents|antiviral agents|mesh-ancestor
6497889|NCT00634725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6497890|NCT00634725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6497891|NCT00634725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6497892|NCT00634725|Immunologic Factors|immunologic factors|mesh-ancestor
6497893|NCT00634725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702971|NCT03334591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5702972|NCT03334591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5702973|NCT03334591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5702974|NCT03334591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5702975|NCT03334513|Bevacizumab|bevacizumab|mesh-list
6497894|NCT00634725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6497895|NCT00634790|Alprazolam|alprazolam|mesh-list
6497896|NCT00634790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6497897|NCT00634790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6497898|NCT00634790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497899|NCT00634790|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6497900|NCT00634790|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6497901|NCT00634790|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6497902|NCT00634790|GABA Modulators|gaba modulators|mesh-ancestor
6497903|NCT00634790|GABA Agents|gaba agents|mesh-ancestor
6497904|NCT00634790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6497905|NCT00634790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497906|NCT00634881|Alemtuzumab|alemtuzumab|mesh-list
6497907|NCT00634881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5702976|NCT03334513|Ranibizumab|ranibizumab|mesh-list
5702977|NCT03334513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5702978|NCT03334513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5702979|NCT03334513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5702980|NCT03334513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5702981|NCT03334513|Growth Substances|growth substances|mesh-ancestor
5702982|NCT03334513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702983|NCT03334513|Growth Inhibitors|growth inhibitors|mesh-ancestor
5702984|NCT03334487|Dexamethasone|dexamethasone|mesh-list
5702985|NCT03334487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5702986|NCT03334487|Antiemetics|antiemetics|mesh-ancestor
5702987|NCT03334487|Autonomic Agents|autonomic agents|mesh-ancestor
5702988|NCT03334487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5702989|NCT03334487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5702990|NCT03334487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5702991|NCT03334487|Glucocorticoids|glucocorticoids|mesh-ancestor
5702992|NCT03334487|Hormones|hormones|mesh-ancestor
5702993|NCT03334487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6497908|NCT00634881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6497909|NCT00634894|Letrozole|letrozole|mesh-list
6497910|NCT00634894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6497911|NCT00634894|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6497912|NCT00634894|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6497913|NCT00634894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6497914|NCT00634894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218348|NCT02286726|Daunorubicin|daunorubicin|mesh-list
6218349|NCT02286726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6218350|NCT02286726|Antimetabolites|antimetabolites|mesh-ancestor
6218351|NCT02286726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218352|NCT02286726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6218353|NCT02286726|Antiviral Agents|antiviral agents|mesh-ancestor
6218354|NCT02286726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6218355|NCT02286726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6218356|NCT02286726|Immunologic Factors|immunologic factors|mesh-ancestor
6218357|NCT02286726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218358|NCT02286726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6218359|NCT02286726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6218360|NCT02286726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6218361|NCT02286726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6218362|NCT02286843|Trastuzumab|trastuzumab|mesh-list
6218363|NCT02286843|Pertuzumab|pertuzumab|mesh-list
6218364|NCT02286843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6218365|NCT02286843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6218366|NCT02286895|Vaccines|vaccines|mesh-list
6218367|NCT02286895|Immunologic Factors|immunologic factors|mesh-ancestor
6218368|NCT02286895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218369|NCT02286921|Methyltestosterone|methyltestosterone|mesh-list
6218370|NCT02286921|Testosterone|testosterone|mesh-list
6218371|NCT02286921|Testosterone undecanoate|testosterone undecanoate|mesh-list
6218372|NCT02286921|Testosterone enanthate|testosterone enanthate|mesh-list
5702994|NCT03334487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5702995|NCT03334487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5702996|NCT03334461|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
5702997|NCT03334461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5702998|NCT03334409|Vitamins|vitamins|mesh-list
6218373|NCT02286921|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6218374|NCT02286921|Androgens|androgens|mesh-ancestor
6218375|NCT02286921|Hormones|hormones|mesh-ancestor
6218376|NCT02286921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6218377|NCT02286921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218378|NCT02286921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6218379|NCT02286921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5702999|NCT03334409|Ascorbic Acid|ascorbic acid|mesh-list
5703000|NCT03334409|Micronutrients|micronutrients|mesh-ancestor
5703001|NCT03334409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703002|NCT03334409|Antioxidants|antioxidants|mesh-ancestor
5703003|NCT03334409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703004|NCT03334409|Protective Agents|protective agents|mesh-ancestor
5703005|NCT03334318|Allopurinol|allopurinol|mesh-list
5703006|NCT03334318|Antimetabolites|antimetabolites|mesh-ancestor
5703007|NCT03334318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703008|NCT03334318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5703009|NCT03334318|Gout Suppressants|gout suppressants|mesh-ancestor
5703010|NCT03334318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5703011|NCT03334318|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5703012|NCT03334318|Antioxidants|antioxidants|mesh-ancestor
5703013|NCT03334318|Protective Agents|protective agents|mesh-ancestor
5703014|NCT03334318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703015|NCT03334136|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
5703016|NCT03334136|Calcifediol|calcifediol|mesh-list
5703017|NCT03334136|Vitamins|vitamins|mesh-ancestor
5703018|NCT03334136|Micronutrients|micronutrients|mesh-ancestor
5703019|NCT03334136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703020|NCT03334136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5703021|NCT03333824|Midazolam|midazolam|mesh-list
5703022|NCT03333824|Granisetron|granisetron|mesh-list
6218380|NCT02286921|Anabolic Agents|anabolic agents|mesh-ancestor
6218381|NCT02287038|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6218382|NCT02287038|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6218383|NCT02287038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6218384|NCT02287038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6218385|NCT02287038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218386|NCT02287038|Adrenergic Agents|adrenergic agents|mesh-ancestor
6218387|NCT02287038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6218388|NCT02287038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218389|NCT02287350|Diclofenac|diclofenac|mesh-list
6218390|NCT02287350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6218391|NCT02287350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6218392|NCT02287350|Analgesics|analgesics|mesh-ancestor
5703023|NCT03333824|Caffeine|caffeine|mesh-list
6218393|NCT02287350|Sensory System Agents|sensory system agents|mesh-ancestor
6243167|NCT02661126|Antiviral Agents|antiviral agents|mesh-ancestor
6218394|NCT02287350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6218395|NCT02287350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218396|NCT02287350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6218397|NCT02287350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6218398|NCT02287350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6218399|NCT02287350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6218400|NCT02287350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218401|NCT02287376|Diclofenac|diclofenac|mesh-list
6218402|NCT02287376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6218403|NCT02287376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6218404|NCT02287376|Analgesics|analgesics|mesh-ancestor
6218405|NCT02287376|Sensory System Agents|sensory system agents|mesh-ancestor
6218406|NCT02287376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6218407|NCT02287376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218408|NCT02287376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6218409|NCT02287376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6218410|NCT02287376|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6218411|NCT02287376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6218412|NCT02287376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218413|NCT02287402|Voglibose|voglibose|mesh-list
6218414|NCT02287402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6218415|NCT02287402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218416|NCT02287402|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6218417|NCT02287402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6218418|NCT02287402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703024|NCT03333824|Omeprazole|omeprazole|mesh-list
5703025|NCT03333824|Adavosertib|adavosertib|mesh-list
5703026|NCT03333824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5703027|NCT03333824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5703028|NCT03333824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5703029|NCT03333824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703030|NCT03333824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5703031|NCT03333824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5703032|NCT03333824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6218419|NCT02287415|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
6218420|NCT02287415|Warfarin|warfarin|mesh-list
6218421|NCT02287415|Anticoagulants|anticoagulants|mesh-ancestor
6218422|NCT02287415|Anticonvulsants|anticonvulsants|mesh-ancestor
6218423|NCT02287415|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6218424|NCT02287415|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6218425|NCT02287415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6218426|NCT02287415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218427|NCT02287467|Immunoglobulins|immunoglobulins|mesh-list
6218428|NCT02287467|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6218429|NCT02287467|Antibodies|antibodies|mesh-list
6218430|NCT02287467|gamma-Globulins|gamma-globulins|mesh-list
6218431|NCT02287467|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6218432|NCT02287467|Immunologic Factors|immunologic factors|mesh-ancestor
6218433|NCT02287467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218434|NCT02287610|Prednisone|prednisone|mesh-list
6218435|NCT02287610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6218436|NCT02287610|Glucocorticoids|glucocorticoids|mesh-ancestor
6218437|NCT02287610|Hormones|hormones|mesh-ancestor
6218438|NCT02287610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6218439|NCT02287610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218440|NCT02287610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6218441|NCT02287610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6218442|NCT02287623|Bupivacaine|bupivacaine|mesh-list
6218443|NCT02287623|Anesthetics, Local|anesthetics, local|mesh-ancestor
6218444|NCT02287623|Anesthetics|anesthetics|mesh-ancestor
6218445|NCT02287623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6218446|NCT02287623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218447|NCT02287623|Sensory System Agents|sensory system agents|mesh-ancestor
6218448|NCT02287623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6218449|NCT02287779|Volixibat|volixibat|mesh-list
6218450|NCT02287779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6218451|NCT02287818|Febuxostat|febuxostat|mesh-list
6218452|NCT02287818|Gout Suppressants|gout suppressants|mesh-ancestor
6218453|NCT02287818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6218454|NCT02287909|Clopidogrel|clopidogrel|mesh-list
6218455|NCT02287909|Ticagrelor|ticagrelor|mesh-list
6218456|NCT02287909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6218457|NCT02287909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6218458|NCT02287909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6497915|NCT00634894|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6218459|NCT02287909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6218460|NCT02287909|Purinergic Agents|purinergic agents|mesh-ancestor
6218461|NCT02287909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6218462|NCT02287909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218463|NCT02287909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218464|NCT02288156|Capsaicin|capsaicin|mesh-list
6218465|NCT02288156|Antipruritics|antipruritics|mesh-ancestor
6218466|NCT02288156|Dermatologic Agents|dermatologic agents|mesh-ancestor
6218467|NCT02288156|Sensory System Agents|sensory system agents|mesh-ancestor
6218468|NCT02288156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6218469|NCT02288156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218470|NCT02288273|Exenatide|exenatide|mesh-list
6218471|NCT02288273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6218472|NCT02288273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218473|NCT02288273|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6218474|NCT02288273|Incretins|incretins|mesh-ancestor
6218475|NCT02288273|Hormones|hormones|mesh-ancestor
6218476|NCT02288273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6218477|NCT02288312|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
6218478|NCT02288312|Anticonvulsants|anticonvulsants|mesh-ancestor
6218479|NCT02288312|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6218480|NCT02288312|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6218481|NCT02288312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6218482|NCT02288312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218483|NCT02288325|Milnacipran|milnacipran|mesh-list
6218484|NCT02288325|Levomilnacipran|levomilnacipran|mesh-list
6218485|NCT02288325|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6218486|NCT02288325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6218487|NCT02288325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6218488|NCT02288325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218489|NCT02288325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6218490|NCT02288325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218491|NCT02288325|Antidepressive Agents|antidepressive agents|mesh-ancestor
6218492|NCT02288325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6218493|NCT02288325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6218494|NCT02288325|Analgesics|analgesics|mesh-ancestor
6218495|NCT02288325|Sensory System Agents|sensory system agents|mesh-ancestor
6218496|NCT02288325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6218497|NCT02288364|Lidocaine|lidocaine|mesh-list
6218498|NCT02288364|Anesthetics, Local|anesthetics, local|mesh-ancestor
6218499|NCT02288364|Anesthetics|anesthetics|mesh-ancestor
6218500|NCT02288364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6218501|NCT02288364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218502|NCT02288364|Sensory System Agents|sensory system agents|mesh-ancestor
6218503|NCT02288364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6218504|NCT02288364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5703033|NCT03333824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5703034|NCT03333824|Anesthetics, General|anesthetics, general|mesh-ancestor
5703035|NCT03333824|Anesthetics|anesthetics|mesh-ancestor
5703036|NCT03333824|GABA Modulators|gaba modulators|mesh-ancestor
5703037|NCT03333824|GABA Agents|gaba agents|mesh-ancestor
5703038|NCT03333824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5703039|NCT03333824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703040|NCT03333824|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5703041|NCT03333824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6218505|NCT02288364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6218506|NCT02288364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6218507|NCT02288364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6218508|NCT02288364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218509|NCT02288377|Lanreotide|lanreotide|mesh-list
6218510|NCT02288377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6218511|NCT02288819|Diuretics|diuretics|mesh-list
6218512|NCT02288819|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
6218513|NCT02288819|Natriuretic Agents|natriuretic agents|mesh-ancestor
6218514|NCT02288819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218515|NCT02288819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6218516|NCT02288819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218517|NCT02289079|Bupivacaine|bupivacaine|mesh-list
6218518|NCT02289079|Anesthetics, Local|anesthetics, local|mesh-ancestor
6218519|NCT02289079|Anesthetics|anesthetics|mesh-ancestor
6218520|NCT02289079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6218521|NCT02289079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218522|NCT02289079|Sensory System Agents|sensory system agents|mesh-ancestor
6218523|NCT02289079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6218524|NCT02289222|Dexamethasone|dexamethasone|mesh-list
5703042|NCT03333824|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5703043|NCT03333824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5703044|NCT03333824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5918505|NCT04991298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5918506|NCT04991298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918507|NCT04991194|Zamicastat|zamicastat|mesh-list
5918508|NCT04991194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5918509|NCT04991194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918510|NCT04991012|Triamcinolone|triamcinolone|mesh-list
5918511|NCT04991012|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5918512|NCT04991012|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6218525|NCT02289222|Pembrolizumab|pembrolizumab|mesh-list
6218526|NCT02289222|Pomalidomide|pomalidomide|mesh-list
6218527|NCT02289222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6218528|NCT02289222|Antiemetics|antiemetics|mesh-ancestor
6218529|NCT02289222|Autonomic Agents|autonomic agents|mesh-ancestor
6218530|NCT02289222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6218531|NCT02289222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218532|NCT02289222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6218533|NCT02289222|Glucocorticoids|glucocorticoids|mesh-ancestor
6218534|NCT02289222|Hormones|hormones|mesh-ancestor
6218535|NCT02289222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6218536|NCT02289222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6218537|NCT02289222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6218538|NCT02289222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6218539|NCT02289222|Immunologic Factors|immunologic factors|mesh-ancestor
6218540|NCT02289222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6218541|NCT02289222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6218542|NCT02289222|Growth Substances|growth substances|mesh-ancestor
6218543|NCT02289222|Growth Inhibitors|growth inhibitors|mesh-ancestor
6218544|NCT02289352|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6218545|NCT02289352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6218546|NCT02289352|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6218547|NCT02289352|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6218548|NCT02289352|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6218549|NCT02289352|Adrenergic Agents|adrenergic agents|mesh-ancestor
6218550|NCT02289352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6218551|NCT02289352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218552|NCT02289352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218553|NCT02289417|Apremilast|apremilast|mesh-list
6218554|NCT02289417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6218555|NCT02289417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6218556|NCT02289417|Analgesics|analgesics|mesh-ancestor
6218557|NCT02289417|Sensory System Agents|sensory system agents|mesh-ancestor
5703045|NCT03333824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5703046|NCT03333824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5703047|NCT03333824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5703048|NCT03333824|Purinergic Agents|purinergic agents|mesh-ancestor
5703049|NCT03333824|Antiemetics|antiemetics|mesh-ancestor
5703050|NCT03333824|Autonomic Agents|autonomic agents|mesh-ancestor
5703051|NCT03333824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5703052|NCT03333824|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5703053|NCT03333824|Serotonin Agents|serotonin agents|mesh-ancestor
5703054|NCT03333668|Guanfacine|guanfacine|mesh-list
6218558|NCT02289417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6218559|NCT02289417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218560|NCT02289417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6218561|NCT02289417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6218562|NCT02289417|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6218563|NCT02289417|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6218564|NCT02289417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6218565|NCT02289417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218566|NCT02289456|Paclitaxel|paclitaxel|mesh-list
6218567|NCT02289456|Carboplatin|carboplatin|mesh-list
6218568|NCT02289456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6218569|NCT02289456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6218570|NCT02289456|Tubulin Modulators|tubulin modulators|mesh-ancestor
6218571|NCT02289456|Antimitotic Agents|antimitotic agents|mesh-ancestor
6218572|NCT02289456|Mitosis Modulators|mitosis modulators|mesh-ancestor
6497916|NCT00634894|Hormone Antagonists|hormone antagonists|mesh-ancestor
5703055|NCT03333668|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6218573|NCT02289456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218574|NCT02289690|Carboplatin|carboplatin|mesh-list
6218575|NCT02289690|Etoposide|etoposide|mesh-list
6218576|NCT02289690|Veliparib|veliparib|mesh-list
6218577|NCT02289690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6218578|NCT02289690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6218579|NCT02289690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6218580|NCT02289690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6218581|NCT02289690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6218582|NCT02289690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218583|NCT02289690|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6218584|NCT02289833|Trastuzumab|trastuzumab|mesh-list
6218585|NCT02289833|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
6218586|NCT02289833|Maytansine|maytansine|mesh-list
6218587|NCT02289833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6218588|NCT02289833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6218589|NCT02289833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6218590|NCT02289833|Tubulin Modulators|tubulin modulators|mesh-ancestor
6218591|NCT02289833|Antimitotic Agents|antimitotic agents|mesh-ancestor
6218592|NCT02289833|Mitosis Modulators|mitosis modulators|mesh-ancestor
6218593|NCT02289833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703056|NCT03333668|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5703057|NCT03333668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703058|NCT03333668|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5703059|NCT03333668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5703060|NCT03333668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5918513|NCT04991012|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5918514|NCT04991012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6218594|NCT02289898|Gemcitabine|gemcitabine|mesh-list
6218595|NCT02289898|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6218596|NCT02289898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6218597|NCT02289898|Antimetabolites|antimetabolites|mesh-ancestor
6218598|NCT02289898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676104|NCT01579110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6676105|NCT01579110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676106|NCT01579110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6676107|NCT01579110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6676108|NCT01579110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6676109|NCT01579110|Immunologic Factors|immunologic factors|mesh-ancestor
6676110|NCT01579110|Antinematodal Agents|antinematodal agents|mesh-ancestor
6676111|NCT01579110|Anthelmintics|anthelmintics|mesh-ancestor
6218599|NCT02289898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6218600|NCT02289898|Antiviral Agents|antiviral agents|mesh-ancestor
6218601|NCT02289898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6218602|NCT02289898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6218603|NCT02289898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6218604|NCT02289898|Immunologic Factors|immunologic factors|mesh-ancestor
6218605|NCT02289898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218606|NCT02289950|Farletuzumab|farletuzumab|mesh-list
6218607|NCT02289950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6218608|NCT02289963|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6497917|NCT00634894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6497918|NCT00634894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497919|NCT00634959|Maraviroc|maraviroc|mesh-list
6497920|NCT00634959|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6497921|NCT00634959|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6497922|NCT00634959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497923|NCT00634959|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6497924|NCT00634959|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6497925|NCT00634959|Antiviral Agents|antiviral agents|mesh-ancestor
6497926|NCT00634959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6497927|NCT00634959|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
5918515|NCT04991012|Glucocorticoids|glucocorticoids|mesh-ancestor
5918516|NCT04991012|Hormones|hormones|mesh-ancestor
5918517|NCT04991012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5918518|NCT04991012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918519|NCT04991012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5918520|NCT04991012|Immunologic Factors|immunologic factors|mesh-ancestor
5918521|NCT04991012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5918522|NCT04991012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918523|NCT04990830|Heparin|heparin|mesh-list
6218609|NCT02289963|Immunologic Factors|immunologic factors|mesh-ancestor
6218610|NCT02289963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218611|NCT02289989|Hydrocortisone|hydrocortisone|mesh-list
6218612|NCT02289989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6218613|NCT02290106|Pitavastatin|pitavastatin|mesh-list
6218614|NCT02290106|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6218615|NCT02290106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6218616|NCT02290106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6497928|NCT00634985|Eletriptan|eletriptan|mesh-list
6497929|NCT00634985|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6497930|NCT00634985|Serotonin Agents|serotonin agents|mesh-ancestor
6497931|NCT00634985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6497932|NCT00634985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497933|NCT00634985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497934|NCT00634998|Ascorbic Acid|ascorbic acid|mesh-list
6497935|NCT00634998|Vitamins|vitamins|mesh-ancestor
6497936|NCT00634998|Micronutrients|micronutrients|mesh-ancestor
6497937|NCT00634998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497938|NCT00634998|Antioxidants|antioxidants|mesh-ancestor
6497939|NCT00634998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497940|NCT00634998|Protective Agents|protective agents|mesh-ancestor
6497941|NCT00635037|Bupivacaine|bupivacaine|mesh-list
6497942|NCT00635037|Anesthetics, Local|anesthetics, local|mesh-ancestor
6497943|NCT00635037|Anesthetics|anesthetics|mesh-ancestor
6497944|NCT00635037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6497945|NCT00635037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497946|NCT00635037|Sensory System Agents|sensory system agents|mesh-ancestor
6497947|NCT00635037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6497948|NCT00635076|Alprazolam|alprazolam|mesh-list
6497949|NCT00635076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6497950|NCT00635076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6497951|NCT00635076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497952|NCT00635076|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6497953|NCT00635076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6497954|NCT00635076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6497955|NCT00635076|GABA Modulators|gaba modulators|mesh-ancestor
6497956|NCT00635076|GABA Agents|gaba agents|mesh-ancestor
6497957|NCT00635076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6497958|NCT00635076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497959|NCT00635258|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6497960|NCT00635258|Ganirelix|ganirelix|mesh-list
6497961|NCT00635258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6497962|NCT00635258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497963|NCT00635258|Luteolytic Agents|luteolytic agents|mesh-ancestor
6497964|NCT00635258|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6497965|NCT00635258|Contraceptive Agents|contraceptive agents|mesh-ancestor
6497966|NCT00635258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6497967|NCT00635258|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6497968|NCT00635258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6497969|NCT00635258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6497970|NCT00635258|Hormone Antagonists|hormone antagonists|mesh-ancestor
6497971|NCT00635284|Sirolimus|sirolimus|mesh-list
6497972|NCT00635284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6497973|NCT00635284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6497974|NCT00635284|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6497975|NCT00635284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6497976|NCT00635284|Antifungal Agents|antifungal agents|mesh-ancestor
6497977|NCT00635284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6497978|NCT00635284|Immunologic Factors|immunologic factors|mesh-ancestor
6497979|NCT00635284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497980|NCT00635310|Liver Extracts|liver extracts|mesh-list
6497981|NCT00635310|Hematinics|hematinics|mesh-ancestor
6497982|NCT00635323|Capecitabine|capecitabine|mesh-list
6497983|NCT00635323|Irinotecan|irinotecan|mesh-list
6497984|NCT00635323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6497985|NCT00635323|Antimetabolites|antimetabolites|mesh-ancestor
6497986|NCT00635323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497987|NCT00635323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6497988|NCT00635323|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6497989|NCT00635323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6497990|NCT00635323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6497991|NCT00635401|Varenicline|varenicline|mesh-list
6676112|NCT01579110|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6218617|NCT02290106|Antimetabolites|antimetabolites|mesh-ancestor
6497992|NCT00635401|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6497993|NCT00635401|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6218618|NCT02290106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218619|NCT02290106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6218620|NCT02290106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6218621|NCT02290444|Hormones|hormones|mesh-list
6218622|NCT02290444|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6218623|NCT02290444|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
6218624|NCT02290444|beta-Endorphin|beta-endorphin|mesh-list
6218625|NCT02290444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6218626|NCT02290444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218627|NCT02290444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6218628|NCT02290444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218629|NCT02290613|Ambrisentan|ambrisentan|mesh-list
6218630|NCT02290613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6243168|NCT02661126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6243169|NCT02661178|Emodepside|emodepside|mesh-list
6243170|NCT02661178|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6243171|NCT02661178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6243172|NCT02661217|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
6243173|NCT02661217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6243174|NCT02661217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243175|NCT02661490|Vaccines|vaccines|mesh-list
6243176|NCT02661490|Immunologic Factors|immunologic factors|mesh-ancestor
6243177|NCT02661490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243178|NCT02661594|Moxifloxacin|moxifloxacin|mesh-list
6243179|NCT02661594|Amisulpride|amisulpride|mesh-list
6243180|NCT02661594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6243181|NCT02661594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6243182|NCT02661594|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6243183|NCT02661594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6243184|NCT02661594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6243185|NCT02661594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243186|NCT02661594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6243187|NCT02661594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243188|NCT02661594|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6243189|NCT02661594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6243190|NCT02661594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6243191|NCT02661594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6243192|NCT02661594|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6243193|NCT02661594|Dopamine Agents|dopamine agents|mesh-ancestor
6243194|NCT02661594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6243195|NCT02661594|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6243196|NCT02661594|Antidepressive Agents|antidepressive agents|mesh-ancestor
6243197|NCT02661815|Paclitaxel|paclitaxel|mesh-list
6243198|NCT02661815|Bevacizumab|bevacizumab|mesh-list
6243199|NCT02661815|Ricolinostat|ricolinostat|mesh-list
6243200|NCT02661815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6243201|NCT02661815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6243202|NCT02661815|Tubulin Modulators|tubulin modulators|mesh-ancestor
6243203|NCT02661815|Antimitotic Agents|antimitotic agents|mesh-ancestor
6243204|NCT02661815|Mitosis Modulators|mitosis modulators|mesh-ancestor
6243205|NCT02661815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243206|NCT02661815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6243207|NCT02661815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6243208|NCT02661815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6243209|NCT02661815|Growth Substances|growth substances|mesh-ancestor
6243210|NCT02661815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243211|NCT02661815|Growth Inhibitors|growth inhibitors|mesh-ancestor
6243212|NCT02661815|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6243213|NCT02661815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6243214|NCT02661828|Antidepressive Agents|antidepressive agents|mesh-list
6243215|NCT02661828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6243216|NCT02662036|Bupivacaine|bupivacaine|mesh-list
6243217|NCT02662036|Anesthetics, Local|anesthetics, local|mesh-ancestor
6243218|NCT02662036|Anesthetics|anesthetics|mesh-ancestor
5703061|NCT03333668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703062|NCT03333668|Dopamine Agents|dopamine agents|mesh-ancestor
5703063|NCT03333668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5703064|NCT03333668|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5703065|NCT03333668|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5703066|NCT03333668|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5703067|NCT03333668|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5703068|NCT03333668|Adrenergic Agents|adrenergic agents|mesh-ancestor
5703069|NCT03333616|Nivolumab|nivolumab|mesh-list
5703070|NCT03333616|Ipilimumab|ipilimumab|mesh-list
6218631|NCT02290873|Midazolam|midazolam|mesh-list
6218632|NCT02290873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6218633|NCT02290873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6218634|NCT02290873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6218635|NCT02290873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218636|NCT02290873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6218637|NCT02290873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6218638|NCT02290873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6218639|NCT02290873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6218640|NCT02290873|Anesthetics, General|anesthetics, general|mesh-ancestor
6218641|NCT02290873|Anesthetics|anesthetics|mesh-ancestor
6218642|NCT02290873|GABA Modulators|gaba modulators|mesh-ancestor
6218643|NCT02290873|GABA Agents|gaba agents|mesh-ancestor
6218644|NCT02290873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6218645|NCT02290873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218646|NCT02291016|Formoterol Fumarate|formoterol fumarate|mesh-list
6218647|NCT02291016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6218648|NCT02291016|Autonomic Agents|autonomic agents|mesh-ancestor
6218649|NCT02291016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6218650|NCT02291016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218651|NCT02291016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6218652|NCT02291016|Respiratory System Agents|respiratory system agents|mesh-ancestor
6218653|NCT02291016|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6218654|NCT02291016|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6218655|NCT02291016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6218656|NCT02291016|Adrenergic Agents|adrenergic agents|mesh-ancestor
6218657|NCT02291016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6218658|NCT02291016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218659|NCT02291029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6218660|NCT02291029|Immunologic Factors|immunologic factors|mesh-ancestor
6218661|NCT02291029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218662|NCT02291133|Bleomycin|bleomycin|mesh-list
6218663|NCT02291133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5703071|NCT03333616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5703072|NCT03333616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5703073|NCT03333616|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6218664|NCT02291133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6218665|NCT02291289|Bevacizumab|bevacizumab|mesh-list
6218666|NCT02291289|Trastuzumab|trastuzumab|mesh-list
6218667|NCT02291289|Cetuximab|cetuximab|mesh-list
6218668|NCT02291289|Pertuzumab|pertuzumab|mesh-list
6218669|NCT02291289|Capecitabine|capecitabine|mesh-list
6218670|NCT02291289|Fluorouracil|fluorouracil|mesh-list
6218671|NCT02291289|Atezolizumab|atezolizumab|mesh-list
6218672|NCT02291289|Vemurafenib|vemurafenib|mesh-list
6218673|NCT02291289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6218674|NCT02291289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6218675|NCT02291289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6218676|NCT02291289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6218677|NCT02291289|Growth Substances|growth substances|mesh-ancestor
6218678|NCT02291289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218679|NCT02291289|Growth Inhibitors|growth inhibitors|mesh-ancestor
6218680|NCT02291289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6218681|NCT02291289|Antimetabolites|antimetabolites|mesh-ancestor
6218682|NCT02291289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218683|NCT02291289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6218684|NCT02291289|Immunologic Factors|immunologic factors|mesh-ancestor
6218685|NCT02291289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6218686|NCT02291289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6218687|NCT02291419|Aspirin|aspirin|mesh-list
6218688|NCT02291419|Ticagrelor|ticagrelor|mesh-list
6218689|NCT02291419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5703074|NCT03333616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703075|NCT03333603|Esomeprazole|esomeprazole|mesh-list
6218690|NCT02291419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6218691|NCT02291419|Analgesics|analgesics|mesh-ancestor
6218692|NCT02291419|Sensory System Agents|sensory system agents|mesh-ancestor
6218693|NCT02291419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6218694|NCT02291419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218695|NCT02291419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6218696|NCT02291419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6218697|NCT02291419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6218698|NCT02291419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5703076|NCT03333603|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6218699|NCT02291419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218700|NCT02291419|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5703077|NCT03333603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5703078|NCT03333603|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5703079|NCT03333603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5703080|NCT03333603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703081|NCT03333525|Insulin|insulin|mesh-list
5703082|NCT03333525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5703083|NCT03333525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703084|NCT03333499|Trimetazidine|trimetazidine|mesh-list
5703085|NCT03333499|Vasodilator Agents|vasodilator agents|mesh-ancestor
5703086|NCT03333408|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5703087|NCT03333408|Clindamycin|clindamycin|mesh-list
5703088|NCT03333408|Clindamycin palmitate|clindamycin palmitate|mesh-list
5703089|NCT03333408|Clindamycin phosphate|clindamycin phosphate|mesh-list
5703090|NCT03333408|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5703091|NCT03333408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5703092|NCT03333408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5703093|NCT03333408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5703094|NCT03333408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703095|NCT03333408|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5703096|NCT03333395|Heparin|heparin|mesh-list
5703097|NCT03333395|Albuterol|albuterol|mesh-list
5703098|NCT03333395|Anticoagulants|anticoagulants|mesh-ancestor
5703099|NCT03333395|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5703100|NCT03333395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5703101|NCT03333395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703102|NCT03333395|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5703103|NCT03333395|Autonomic Agents|autonomic agents|mesh-ancestor
5703104|NCT03333395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5703105|NCT03333395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218701|NCT02291419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6218702|NCT02291419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6218703|NCT02291419|Antipyretics|antipyretics|mesh-ancestor
6218704|NCT02291419|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6218705|NCT02291419|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6218706|NCT02291419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6218707|NCT02291419|Purinergic Agents|purinergic agents|mesh-ancestor
6218708|NCT02291419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6218709|NCT02291549|Mometasone Furoate|mometasone furoate|mesh-list
5703106|NCT03333395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5703107|NCT03333395|Respiratory System Agents|respiratory system agents|mesh-ancestor
5703108|NCT03333395|Tocolytic Agents|tocolytic agents|mesh-ancestor
5703109|NCT03333395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5703110|NCT03333395|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5703111|NCT03333395|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5703112|NCT03333395|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6218710|NCT02291549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6218711|NCT02291549|Dermatologic Agents|dermatologic agents|mesh-ancestor
6218712|NCT02291549|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6218713|NCT02291601|Chlorhexidine|chlorhexidine|mesh-list
6218714|NCT02291601|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6218715|NCT02291601|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6218716|NCT02291601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6218717|NCT02291601|Disinfectants|disinfectants|mesh-ancestor
6218718|NCT02291601|Dermatologic Agents|dermatologic agents|mesh-ancestor
6218719|NCT02291679|Linaclotide|linaclotide|mesh-list
6218720|NCT02291679|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
6218721|NCT02291679|Enzyme Activators|enzyme activators|mesh-ancestor
6218722|NCT02291679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218723|NCT02291679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6218724|NCT02291913|Tamoxifen|tamoxifen|mesh-list
6218725|NCT02291913|Everolimus|everolimus|mesh-list
6218726|NCT02291913|Letrozole|letrozole|mesh-list
5703113|NCT03333395|Adrenergic Agents|adrenergic agents|mesh-ancestor
5703114|NCT03333395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6218727|NCT02291913|Fulvestrant|fulvestrant|mesh-list
6218728|NCT02291913|Anastrozole|anastrozole|mesh-list
6218729|NCT02291913|Exemestane|exemestane|mesh-list
6218730|NCT02291913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6218731|NCT02291913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6218732|NCT02291913|Immunologic Factors|immunologic factors|mesh-ancestor
6218733|NCT02291913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218734|NCT02291913|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6218735|NCT02291913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6218736|NCT02291913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6218737|NCT02291913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218738|NCT02291913|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6218739|NCT02291913|Hormone Antagonists|hormone antagonists|mesh-ancestor
6218740|NCT02291913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6218741|NCT02291913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6218742|NCT02291913|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6218743|NCT02291913|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6218744|NCT02291913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6218745|NCT02291913|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6218746|NCT02292082|Cefazolin|cefazolin|mesh-list
6218747|NCT02292082|Dexamethasone|dexamethasone|mesh-list
6218748|NCT02292082|Methylprednisolone|methylprednisolone|mesh-list
6218749|NCT02292082|Midazolam|midazolam|mesh-list
6218750|NCT02292082|Morphine|morphine|mesh-list
6218751|NCT02292082|Bupivacaine|bupivacaine|mesh-list
6218752|NCT02292082|Propofol|propofol|mesh-list
6218753|NCT02292082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6218754|NCT02292082|Antiemetics|antiemetics|mesh-ancestor
6218755|NCT02292082|Autonomic Agents|autonomic agents|mesh-ancestor
6218756|NCT02292082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6218757|NCT02292082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218758|NCT02292082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6218759|NCT02292082|Glucocorticoids|glucocorticoids|mesh-ancestor
6218760|NCT02292082|Hormones|hormones|mesh-ancestor
6218761|NCT02292082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6218762|NCT02292082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6218763|NCT02292082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6218764|NCT02292082|Anesthetics, Local|anesthetics, local|mesh-ancestor
6218765|NCT02292082|Anesthetics|anesthetics|mesh-ancestor
6218766|NCT02292082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6218767|NCT02292082|Sensory System Agents|sensory system agents|mesh-ancestor
6218768|NCT02292082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6218769|NCT02292082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6218770|NCT02292082|Anesthetics, General|anesthetics, general|mesh-ancestor
6218771|NCT02292082|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6218772|NCT02292082|Narcotics|narcotics|mesh-ancestor
6218773|NCT02292082|Analgesics|analgesics|mesh-ancestor
6218774|NCT02292082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6218775|NCT02292082|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6218776|NCT02292082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6218777|NCT02292082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6218778|NCT02292082|GABA Modulators|gaba modulators|mesh-ancestor
6218779|NCT02292082|GABA Agents|gaba agents|mesh-ancestor
6218780|NCT02292082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6218781|NCT02292082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218782|NCT02292082|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6218783|NCT02292082|Protective Agents|protective agents|mesh-ancestor
6218784|NCT02292082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6218785|NCT02292082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6218786|NCT02292719|Ritonavir|ritonavir|mesh-list
6218787|NCT02292719|Ribavirin|ribavirin|mesh-list
6218788|NCT02292719|Sofosbuvir|sofosbuvir|mesh-list
6218789|NCT02292719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6218790|NCT02292719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6218791|NCT02292719|Protease Inhibitors|protease inhibitors|mesh-ancestor
6218792|NCT02292719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5703115|NCT03333369|Levodopa|levodopa|mesh-list
5703116|NCT03333369|Benserazide|benserazide|mesh-list
5703117|NCT03333369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5703118|NCT03333369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5703119|NCT03333369|Dopamine Agents|dopamine agents|mesh-ancestor
5703120|NCT03333369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5703121|NCT03333369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703122|NCT03333369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218793|NCT02292719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218794|NCT02292719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6218795|NCT02292719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6218796|NCT02292719|Antiviral Agents|antiviral agents|mesh-ancestor
6218797|NCT02292719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6218798|NCT02292719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6218799|NCT02292719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6218800|NCT02292719|Antimetabolites|antimetabolites|mesh-ancestor
6218801|NCT02292771|Vasotocin|vasotocin|mesh-list
6218802|NCT02292771|Atosiban|atosiban|mesh-list
6218803|NCT02292771|Hormone Antagonists|hormone antagonists|mesh-ancestor
6218804|NCT02292771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6218805|NCT02292771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218806|NCT02292771|Tocolytic Agents|tocolytic agents|mesh-ancestor
6218807|NCT02292771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6218808|NCT02292771|Oxytocics|oxytocics|mesh-ancestor
6218809|NCT02292771|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6218810|NCT02292784|Atosiban|atosiban|mesh-list
6218811|NCT02292784|Hormone Antagonists|hormone antagonists|mesh-ancestor
6218812|NCT02292784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6218813|NCT02292784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218814|NCT02292784|Tocolytic Agents|tocolytic agents|mesh-ancestor
6218815|NCT02292784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6218816|NCT02293096|Metoprolol|metoprolol|mesh-list
6218817|NCT02293096|Dextromethorphan|dextromethorphan|mesh-list
6218818|NCT02293096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6218819|NCT02293096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6218820|NCT02293096|Sympatholytics|sympatholytics|mesh-ancestor
6218821|NCT02293096|Autonomic Agents|autonomic agents|mesh-ancestor
6218822|NCT02293096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6218823|NCT02293096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218824|NCT02293096|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6218825|NCT02293096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6218826|NCT02293096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6218827|NCT02293096|Adrenergic Agents|adrenergic agents|mesh-ancestor
6218828|NCT02293096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6218829|NCT02293096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218830|NCT02293096|Antitussive Agents|antitussive agents|mesh-ancestor
6497994|NCT00635401|Cholinergic Agents|cholinergic agents|mesh-ancestor
6497995|NCT00635401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6497996|NCT00635401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6497997|NCT00635401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6497998|NCT00635414|Esomeprazole|esomeprazole|mesh-list
6497999|NCT00635414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6498000|NCT00635414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5703123|NCT03333369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5703124|NCT03333343|Gefitinib|gefitinib|mesh-list
5703125|NCT03333343|Trametinib|trametinib|mesh-list
5703126|NCT03333343|Nazartinib|nazartinib|mesh-list
5703127|NCT03333343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5703128|NCT03333343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5703129|NCT03333343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5703130|NCT03333343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703131|NCT03333278|Vitamins|vitamins|mesh-list
5703132|NCT03333278|Ascorbic Acid|ascorbic acid|mesh-list
6498001|NCT00635414|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6498002|NCT00635414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6498003|NCT00635414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498004|NCT00635531|Alprazolam|alprazolam|mesh-list
6498005|NCT00635531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6498006|NCT00635531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6498007|NCT00635531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498008|NCT00635531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6498009|NCT00635531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6498010|NCT00635531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6498011|NCT00635531|GABA Modulators|gaba modulators|mesh-ancestor
6498012|NCT00635531|GABA Agents|gaba agents|mesh-ancestor
6498013|NCT00635531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6498014|NCT00635531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498015|NCT00635557|Carboplatin|carboplatin|mesh-list
6498016|NCT00635557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6498017|NCT00635713|Fulvestrant|fulvestrant|mesh-list
6498018|NCT00635713|Anastrozole|anastrozole|mesh-list
6498019|NCT00635713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6498020|NCT00635713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6498021|NCT00635713|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6498022|NCT00635713|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6498023|NCT00635713|Hormone Antagonists|hormone antagonists|mesh-ancestor
6498024|NCT00635713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6498025|NCT00635713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498026|NCT00635713|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6498027|NCT00635713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6498028|NCT00635713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6498029|NCT00635713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498030|NCT00635726|Gemcitabine|gemcitabine|mesh-list
6498031|NCT00635726|Cisplatin|cisplatin|mesh-list
6498032|NCT00635726|Doxorubicin|doxorubicin|mesh-list
6498033|NCT00635726|Methotrexate|methotrexate|mesh-list
5703133|NCT03333278|Thiamine|thiamine|mesh-list
5703134|NCT03333278|Hydrocortisone|hydrocortisone|mesh-list
5703135|NCT03333278|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6498034|NCT00635726|Vinblastine|vinblastine|mesh-list
6218831|NCT02293096|Respiratory System Agents|respiratory system agents|mesh-ancestor
6218832|NCT02293096|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6218833|NCT02293096|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6218834|NCT02293395|Aspirin|aspirin|mesh-list
6218835|NCT02293395|Rivaroxaban|rivaroxaban|mesh-list
6218836|NCT02293395|Clopidogrel|clopidogrel|mesh-list
6218837|NCT02293395|Ticagrelor|ticagrelor|mesh-list
6218838|NCT02293395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6218839|NCT02293395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6218840|NCT02293395|Analgesics|analgesics|mesh-ancestor
5703136|NCT03333278|Micronutrients|micronutrients|mesh-ancestor
5703137|NCT03333278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703138|NCT03333278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5703139|NCT03333278|Antioxidants|antioxidants|mesh-ancestor
5703140|NCT03333278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218841|NCT02293395|Sensory System Agents|sensory system agents|mesh-ancestor
6218842|NCT02293395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6218843|NCT02293395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218844|NCT02293395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6218845|NCT02293395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6218846|NCT02293395|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6218847|NCT02293395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6218848|NCT02293395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218849|NCT02293395|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6218850|NCT02293395|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6218851|NCT02293395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6218852|NCT02293395|Antipyretics|antipyretics|mesh-ancestor
6218853|NCT02293395|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6218854|NCT02293395|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6218855|NCT02293395|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6218856|NCT02293395|Purinergic Agents|purinergic agents|mesh-ancestor
6218857|NCT02293395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6218858|NCT02293395|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6218859|NCT02293395|Antithrombins|antithrombins|mesh-ancestor
6218860|NCT02293395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6218861|NCT02293395|Protease Inhibitors|protease inhibitors|mesh-ancestor
6218862|NCT02293395|Anticoagulants|anticoagulants|mesh-ancestor
6218863|NCT02293538|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6218864|NCT02293538|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6218865|NCT02293863|Oseltamivir|oseltamivir|mesh-list
6218866|NCT02293863|Antiviral Agents|antiviral agents|mesh-ancestor
6218867|NCT02293863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6218868|NCT02293863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6218869|NCT02293863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218870|NCT02293902|Folic Acid|folic acid|mesh-list
6218871|NCT02293902|Methotrexate|methotrexate|mesh-list
6218872|NCT02293902|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6218873|NCT02293902|Abortifacient Agents|abortifacient agents|mesh-ancestor
6218874|NCT02293902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6218875|NCT02293902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218876|NCT02293902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6218877|NCT02293902|Antimetabolites|antimetabolites|mesh-ancestor
6218878|NCT02293902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218879|NCT02293902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6218880|NCT02293902|Dermatologic Agents|dermatologic agents|mesh-ancestor
6218881|NCT02293902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6218882|NCT02293902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6218883|NCT02293902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6218884|NCT02293902|Immunologic Factors|immunologic factors|mesh-ancestor
6218885|NCT02293902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6218886|NCT02293902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6218887|NCT02293902|Hematinics|hematinics|mesh-ancestor
6218888|NCT02293902|Vitamin B Complex|vitamin b complex|mesh-ancestor
6218889|NCT02293902|Vitamins|vitamins|mesh-ancestor
6218890|NCT02293902|Micronutrients|micronutrients|mesh-ancestor
6218891|NCT02293993|Guadecitabine|guadecitabine|mesh-list
6218892|NCT02293993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6218893|NCT02294019|Ibuprofen|ibuprofen|mesh-list
6218894|NCT02294019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6218895|NCT02294019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5703141|NCT03333278|Protective Agents|protective agents|mesh-ancestor
5703142|NCT03333278|Vitamin B Complex|vitamin b complex|mesh-ancestor
5721115|NCT03208413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5721116|NCT03208257|Esmolol|esmolol|mesh-list
6218896|NCT02294019|Analgesics|analgesics|mesh-ancestor
6218897|NCT02294019|Sensory System Agents|sensory system agents|mesh-ancestor
5703143|NCT03333083|Lamivudine|lamivudine|mesh-list
5703144|NCT03333083|Raltegravir Potassium|raltegravir potassium|mesh-list
6218898|NCT02294019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6218899|NCT02294019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218900|NCT02294019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6218901|NCT02294019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6218902|NCT02294019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6218903|NCT02294019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6218904|NCT02294019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218905|NCT02294058|Interferons|interferons|mesh-list
6218906|NCT02294058|Interferon-beta|interferon-beta|mesh-list
6218907|NCT02294058|Interferon beta-1a|interferon beta-1a|mesh-list
6218908|NCT02294058|Ozanimod|ozanimod|mesh-list
6218909|NCT02294058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6218910|NCT02294058|Antiviral Agents|antiviral agents|mesh-ancestor
6218911|NCT02294058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6218912|NCT02294058|Immunologic Factors|immunologic factors|mesh-ancestor
6218913|NCT02294058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218914|NCT02294058|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6218915|NCT02294058|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6218916|NCT02294058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218917|NCT02294058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6218918|NCT02294253|Buprenorphine|buprenorphine|mesh-list
6218919|NCT02294253|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6218920|NCT02294253|Naloxone|naloxone|mesh-list
6218921|NCT02294253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6218922|NCT02294253|Narcotics|narcotics|mesh-ancestor
6218923|NCT02294253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6218924|NCT02294253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218925|NCT02294253|Analgesics|analgesics|mesh-ancestor
6218926|NCT02294253|Sensory System Agents|sensory system agents|mesh-ancestor
6218927|NCT02294253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6218928|NCT02294253|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6218929|NCT02294396|Solifenacin Succinate|solifenacin succinate|mesh-list
6218930|NCT02294396|Mirabegron|mirabegron|mesh-list
6218931|NCT02294396|Tolterodine Tartrate|tolterodine tartrate|mesh-list
5703145|NCT03333083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5703146|NCT03333083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5703147|NCT03333083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5703148|NCT03333083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703149|NCT03333083|Antiviral Agents|antiviral agents|mesh-ancestor
5703150|NCT03333083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5703151|NCT03333083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5703152|NCT03333083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5703153|NCT03333083|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6218932|NCT02294396|Propiverine|propiverine|mesh-list
6218933|NCT02294396|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6218934|NCT02294396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6218935|NCT02294396|Cholinergic Agents|cholinergic agents|mesh-ancestor
6218936|NCT02294396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6218937|NCT02294396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218938|NCT02294396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218939|NCT02294396|Urological Agents|urological agents|mesh-ancestor
6218940|NCT02294396|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6218941|NCT02294396|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6218942|NCT02294396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6218943|NCT02294396|Adrenergic Agents|adrenergic agents|mesh-ancestor
6218944|NCT02294396|Parasympatholytics|parasympatholytics|mesh-ancestor
6218945|NCT02294396|Autonomic Agents|autonomic agents|mesh-ancestor
6218946|NCT02294396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6218947|NCT02294474|Insulin|insulin|mesh-list
6218948|NCT02294474|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6218949|NCT02294474|Insulin Glargine|insulin glargine|mesh-list
6218950|NCT02294474|Insulin Lispro|insulin lispro|mesh-list
6218951|NCT02294474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6218952|NCT02294474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218953|NCT02294604|Chlorhexidine|chlorhexidine|mesh-list
6218954|NCT02294604|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6218955|NCT02294604|Povidone-Iodine|povidone-iodine|mesh-list
6218956|NCT02294604|Povidone|povidone|mesh-list
6218957|NCT02294604|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6218958|NCT02294604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6218959|NCT02294604|Disinfectants|disinfectants|mesh-ancestor
6218960|NCT02294604|Dermatologic Agents|dermatologic agents|mesh-ancestor
6218961|NCT02294604|Plasma Substitutes|plasma substitutes|mesh-ancestor
6218962|NCT02294604|Blood Substitutes|blood substitutes|mesh-ancestor
6218963|NCT02294630|Pulmonary Surfactants|pulmonary surfactants|mesh-list
6218964|NCT02294630|Respiratory System Agents|respiratory system agents|mesh-ancestor
6218965|NCT02294734|Nemiralisib|nemiralisib|mesh-list
6218966|NCT02294734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6218967|NCT02294734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6218968|NCT02294734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218969|NCT02294773|Letrozole|letrozole|mesh-list
6218970|NCT02294773|Clomiphene|clomiphene|mesh-list
6218971|NCT02294773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6218972|NCT02294773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6218973|NCT02294773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6218974|NCT02294773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6218975|NCT02294773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218976|NCT02294773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6218977|NCT02294773|Hormone Antagonists|hormone antagonists|mesh-ancestor
6218978|NCT02294773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6218979|NCT02294773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6218980|NCT02294773|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6218981|NCT02294773|Fertility Agents|fertility agents|mesh-ancestor
6218982|NCT02294773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6218983|NCT02294773|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6218984|NCT02294773|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6218985|NCT02294786|Capecitabine|capecitabine|mesh-list
6218986|NCT02294786|Lapatinib|lapatinib|mesh-list
6218987|NCT02294786|Octreotide|octreotide|mesh-list
6218988|NCT02294786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6218989|NCT02294786|Antimetabolites|antimetabolites|mesh-ancestor
6218990|NCT02294786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6218991|NCT02294786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6218992|NCT02294786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6218993|NCT02294786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6218994|NCT02294786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6218995|NCT02294786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6218996|NCT02295280|Diphenhydramine|diphenhydramine|mesh-list
6218997|NCT02295280|Promethazine|promethazine|mesh-list
6218998|NCT02295280|Codeine|codeine|mesh-list
6218999|NCT02295280|Metoclopramide|metoclopramide|mesh-list
6498035|NCT00635726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6498036|NCT00635726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6498037|NCT00635726|Antimetabolites|antimetabolites|mesh-ancestor
6498038|NCT00635726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498039|NCT00635726|Antiviral Agents|antiviral agents|mesh-ancestor
6498040|NCT00635726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6498041|NCT00635726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6498042|NCT00635726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6498043|NCT00635726|Immunologic Factors|immunologic factors|mesh-ancestor
6498044|NCT00635726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498045|NCT00635726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6498046|NCT00635726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6498047|NCT00635726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6498048|NCT00635726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6498049|NCT00635726|Abortifacient Agents|abortifacient agents|mesh-ancestor
6498050|NCT00635726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6498051|NCT00635726|Dermatologic Agents|dermatologic agents|mesh-ancestor
6498052|NCT00635726|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6498053|NCT00635726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6498054|NCT00635726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6498055|NCT00635726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6498056|NCT00635726|Tubulin Modulators|tubulin modulators|mesh-ancestor
6498057|NCT00635726|Antimitotic Agents|antimitotic agents|mesh-ancestor
6219000|NCT02295280|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5703154|NCT03333083|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5703155|NCT03333018|Bromides|bromides|mesh-list
5703156|NCT03333018|Formoterol Fumarate|formoterol fumarate|mesh-list
5703157|NCT03333018|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5703158|NCT03333018|Autonomic Agents|autonomic agents|mesh-ancestor
5703159|NCT03333018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5703160|NCT03333018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703161|NCT03333018|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5703162|NCT03333018|Respiratory System Agents|respiratory system agents|mesh-ancestor
5703163|NCT03333018|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5703164|NCT03333018|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5703165|NCT03333018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5703166|NCT03333018|Adrenergic Agents|adrenergic agents|mesh-ancestor
5703167|NCT03333018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5703168|NCT03333018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703169|NCT03333018|Anticonvulsants|anticonvulsants|mesh-ancestor
5703170|NCT03333005|Antifungal Agents|antifungal agents|mesh-list
5703171|NCT03333005|Clotrimazole|clotrimazole|mesh-list
5703172|NCT03333005|Miconazole|miconazole|mesh-list
6219001|NCT02295280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6219002|NCT02295280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6219003|NCT02295280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219004|NCT02295280|Anesthetics, Local|anesthetics, local|mesh-ancestor
6219005|NCT02295280|Anesthetics|anesthetics|mesh-ancestor
6219006|NCT02295280|Sensory System Agents|sensory system agents|mesh-ancestor
6219007|NCT02295280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6219008|NCT02295280|Antiemetics|antiemetics|mesh-ancestor
6219009|NCT02295280|Autonomic Agents|autonomic agents|mesh-ancestor
6219010|NCT02295280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6219011|NCT02295280|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6219012|NCT02295280|Histamine Antagonists|histamine antagonists|mesh-ancestor
6219013|NCT02295280|Histamine Agents|histamine agents|mesh-ancestor
6219014|NCT02295280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6219015|NCT02295280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219016|NCT02295280|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6219017|NCT02295280|Antipruritics|antipruritics|mesh-ancestor
6219018|NCT02295280|Dermatologic Agents|dermatologic agents|mesh-ancestor
6219019|NCT02295280|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6219020|NCT02295280|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6219021|NCT02295280|Dopamine Agents|dopamine agents|mesh-ancestor
6219022|NCT02295280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6219023|NCT02295280|Narcotics|narcotics|mesh-ancestor
6219024|NCT02295280|Analgesics|analgesics|mesh-ancestor
6219025|NCT02295280|Antitussive Agents|antitussive agents|mesh-ancestor
6219026|NCT02295280|Respiratory System Agents|respiratory system agents|mesh-ancestor
6219027|NCT02295553|Ketamine|ketamine|mesh-list
6219028|NCT02295553|Propofol|propofol|mesh-list
6219029|NCT02295553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6219030|NCT02295553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6219031|NCT02295553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219032|NCT02295553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6219033|NCT02295553|Anesthetics, General|anesthetics, general|mesh-ancestor
6219034|NCT02295553|Anesthetics|anesthetics|mesh-ancestor
6219035|NCT02295553|Analgesics|analgesics|mesh-ancestor
6219036|NCT02295553|Sensory System Agents|sensory system agents|mesh-ancestor
6219037|NCT02295553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6219038|NCT02295553|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6219039|NCT02295553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6219040|NCT02295553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6219041|NCT02295553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6219042|NCT02295553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219043|NCT02295774|Methylene Blue|methylene blue|mesh-list
6219044|NCT02295774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6219045|NCT02295774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219046|NCT02296099|Bupivacaine|bupivacaine|mesh-list
6219047|NCT02296099|Anesthetics, Local|anesthetics, local|mesh-ancestor
6219048|NCT02296099|Anesthetics|anesthetics|mesh-ancestor
6219049|NCT02296099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6219050|NCT02296099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219051|NCT02296099|Sensory System Agents|sensory system agents|mesh-ancestor
6219052|NCT02296099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6219053|NCT02296112|Trametinib|trametinib|mesh-list
6219054|NCT02296112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6219055|NCT02296112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6219056|NCT02296112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5703173|NCT03333005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6219057|NCT02296112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219058|NCT02296125|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6219059|NCT02296125|Gefitinib|gefitinib|mesh-list
6219060|NCT02296125|Osimertinib|osimertinib|mesh-list
5703174|NCT03333005|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5703175|NCT03333005|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5703176|NCT03333005|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5703177|NCT03333005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5703178|NCT03333005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703179|NCT03333005|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5703180|NCT03333005|Hormone Antagonists|hormone antagonists|mesh-ancestor
5703181|NCT03333005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5703182|NCT03333005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703183|NCT03333005|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5703184|NCT03333005|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5703185|NCT03332953|Nicotine|nicotine|mesh-list
5703186|NCT03332953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6219061|NCT02296125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6219062|NCT02296125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6219063|NCT02296125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6219064|NCT02296125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219065|NCT02296138|Tiotropium Bromide|tiotropium bromide|mesh-list
6219066|NCT02296138|Olodaterol|olodaterol|mesh-list
6219067|NCT02296138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6219068|NCT02296138|Autonomic Agents|autonomic agents|mesh-ancestor
6219069|NCT02296138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6219070|NCT02296138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219071|NCT02296138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6219072|NCT02296138|Respiratory System Agents|respiratory system agents|mesh-ancestor
6219073|NCT02296138|Parasympatholytics|parasympatholytics|mesh-ancestor
6219074|NCT02296138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6219075|NCT02296138|Cholinergic Agents|cholinergic agents|mesh-ancestor
6219076|NCT02296138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6219077|NCT02296138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219078|NCT02296164|Mechlorethamine|mechlorethamine|mesh-list
6498058|NCT00635726|Mitosis Modulators|mitosis modulators|mesh-ancestor
6524476|NCT00758225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524477|NCT00758225|Protective Agents|protective agents|mesh-ancestor
6524478|NCT00758225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524479|NCT00758277|Levetiracetam|levetiracetam|mesh-list
6524480|NCT00758277|Anticonvulsants|anticonvulsants|mesh-ancestor
6524481|NCT00758277|Nootropic Agents|nootropic agents|mesh-ancestor
6524482|NCT00758368|Apomorphine|apomorphine|mesh-list
6524483|NCT00758368|Emetics|emetics|mesh-ancestor
6524484|NCT00758368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524485|NCT00758368|Autonomic Agents|autonomic agents|mesh-ancestor
6524486|NCT00758368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6524487|NCT00758368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6524488|NCT00758368|Dopamine Agonists|dopamine agonists|mesh-ancestor
6524489|NCT00758368|Dopamine Agents|dopamine agents|mesh-ancestor
6524490|NCT00758368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6524491|NCT00758368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524492|NCT00758381|Sorafenib|sorafenib|mesh-list
6524493|NCT00758381|Cisplatin|cisplatin|mesh-list
6524494|NCT00758381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6524495|NCT00758381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6524496|NCT00758381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6524497|NCT00758381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703187|NCT03332953|Autonomic Agents|autonomic agents|mesh-ancestor
5703188|NCT03332953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5703189|NCT03332953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703190|NCT03332953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5703191|NCT03332953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5703192|NCT03332953|Cholinergic Agents|cholinergic agents|mesh-ancestor
6524498|NCT00758407|Methylphenidate|methylphenidate|mesh-list
6524499|NCT00758407|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6524500|NCT00758407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524501|NCT00758407|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6524502|NCT00758407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6524503|NCT00758407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6524504|NCT00758407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524505|NCT00758407|Dopamine Agents|dopamine agents|mesh-ancestor
6219079|NCT02296164|Alkylating Agents|alkylating agents|mesh-ancestor
6219080|NCT02296164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219081|NCT02296164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6219082|NCT02296164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6219083|NCT02296190|Etripamil|etripamil|mesh-list
6219084|NCT02296190|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6219085|NCT02296190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6219086|NCT02296190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219087|NCT02296190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6219088|NCT02296190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219089|NCT02296346|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6219090|NCT02296346|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6219091|NCT02296346|Methylprednisolone|methylprednisolone|mesh-list
6219092|NCT02296346|Prednisolone|prednisolone|mesh-list
6219093|NCT02296346|Prednisolone acetate|prednisolone acetate|mesh-list
6219094|NCT02296346|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6219095|NCT02296346|Prednisolone phosphate|prednisolone phosphate|mesh-list
6219096|NCT02296346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6219097|NCT02296346|Glucocorticoids|glucocorticoids|mesh-ancestor
6219098|NCT02296346|Hormones|hormones|mesh-ancestor
6219099|NCT02296346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6219100|NCT02296346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219101|NCT02296346|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6219102|NCT02296346|Protective Agents|protective agents|mesh-ancestor
6219103|NCT02296346|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6219104|NCT02296346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6219105|NCT02296346|Antiemetics|antiemetics|mesh-ancestor
6219106|NCT02296346|Autonomic Agents|autonomic agents|mesh-ancestor
6219107|NCT02296346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6219108|NCT02296346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6219109|NCT02296424|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6219110|NCT02296424|Immunologic Factors|immunologic factors|mesh-ancestor
6219111|NCT02296424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219112|NCT02296775|Rituximab|rituximab|mesh-list
6219113|NCT02296775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6219114|NCT02296775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6219115|NCT02296775|Immunologic Factors|immunologic factors|mesh-ancestor
6219116|NCT02296775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219117|NCT02296775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6219118|NCT02296840|Acetaminophen|acetaminophen|mesh-list
6219119|NCT02296840|Ibuprofen|ibuprofen|mesh-list
6219120|NCT02296840|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
6219121|NCT02296840|Hydrocodone|hydrocodone|mesh-list
6219122|NCT02296840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6219123|NCT02296840|Analgesics|analgesics|mesh-ancestor
6219124|NCT02296840|Sensory System Agents|sensory system agents|mesh-ancestor
6219125|NCT02296840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6219126|NCT02296840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219127|NCT02296840|Antipyretics|antipyretics|mesh-ancestor
6219128|NCT02296840|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6219129|NCT02296840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6219130|NCT02296840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6219131|NCT02296840|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6219132|NCT02296840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6219133|NCT02296840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219134|NCT02296840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6219135|NCT02296840|Narcotics|narcotics|mesh-ancestor
6219136|NCT02296840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6219137|NCT02296840|Antitussive Agents|antitussive agents|mesh-ancestor
6219138|NCT02296840|Respiratory System Agents|respiratory system agents|mesh-ancestor
6219139|NCT02296892|Midazolam|midazolam|mesh-list
6219140|NCT02296892|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6219141|NCT02296892|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6219142|NCT02296892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6219143|NCT02296892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219144|NCT02296892|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6219145|NCT02296892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6219146|NCT02296892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6219147|NCT02296892|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6219148|NCT02296892|Anesthetics, General|anesthetics, general|mesh-ancestor
6219149|NCT02296892|Anesthetics|anesthetics|mesh-ancestor
6219150|NCT02296892|GABA Modulators|gaba modulators|mesh-ancestor
6219151|NCT02296892|GABA Agents|gaba agents|mesh-ancestor
6219152|NCT02296892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6219153|NCT02296892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219154|NCT02296931|Magnesium Sulfate|magnesium sulfate|mesh-list
6219155|NCT02296931|Analgesics|analgesics|mesh-ancestor
6219156|NCT02296931|Sensory System Agents|sensory system agents|mesh-ancestor
6219157|NCT02296931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6219158|NCT02296931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219159|NCT02296931|Anesthetics|anesthetics|mesh-ancestor
6219160|NCT02296931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6219161|NCT02296931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6219162|NCT02296931|Anticonvulsants|anticonvulsants|mesh-ancestor
6219163|NCT02296931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6219164|NCT02296931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6219165|NCT02296931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219166|NCT02296931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6219167|NCT02296931|Tocolytic Agents|tocolytic agents|mesh-ancestor
6219168|NCT02296931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6219169|NCT02297100|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6219170|NCT02297100|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6219171|NCT02297100|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6219172|NCT02297100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6219173|NCT02297100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219174|NCT02297100|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6219175|NCT02297100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6219176|NCT02297100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219177|NCT02297100|Cholinergic Agents|cholinergic agents|mesh-ancestor
6219178|NCT02297100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6219179|NCT02297503|Botulinum Toxins|botulinum toxins|mesh-list
6219180|NCT02297503|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6219181|NCT02297503|Hyaluronic Acid|hyaluronic acid|mesh-list
6219182|NCT02297503|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6219183|NCT02297503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6219184|NCT02297503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219185|NCT02297503|Cholinergic Agents|cholinergic agents|mesh-ancestor
6219186|NCT02297503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6219187|NCT02297503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219188|NCT02297503|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6219189|NCT02297503|Immunologic Factors|immunologic factors|mesh-ancestor
6219190|NCT02297503|Viscosupplements|viscosupplements|mesh-ancestor
6219191|NCT02297503|Protective Agents|protective agents|mesh-ancestor
6219192|NCT02297516|Botulinum Toxins|botulinum toxins|mesh-list
6219193|NCT02297516|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6219194|NCT02297516|Hyaluronic Acid|hyaluronic acid|mesh-list
6219195|NCT02297516|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6219196|NCT02297516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6219197|NCT02297516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219198|NCT02297516|Cholinergic Agents|cholinergic agents|mesh-ancestor
6219199|NCT02297516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6498059|NCT00635791|Sorafenib|sorafenib|mesh-list
6219200|NCT02297516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219201|NCT02297516|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6219202|NCT02297516|Immunologic Factors|immunologic factors|mesh-ancestor
6219203|NCT02297516|Viscosupplements|viscosupplements|mesh-ancestor
6219204|NCT02297516|Protective Agents|protective agents|mesh-ancestor
6219205|NCT02297815|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6219206|NCT02297815|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6219207|NCT02297815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6219208|NCT02297815|Antitubercular Agents|antitubercular agents|mesh-ancestor
6219209|NCT02298023|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6219210|NCT02298023|Hemostatics|hemostatics|mesh-ancestor
6219211|NCT02298023|Coagulants|coagulants|mesh-ancestor
6219212|NCT02298179|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6219213|NCT02298179|MF59 oil emulsion|mf59 oil emulsion|mesh-list
6219214|NCT02298179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6219215|NCT02298179|Immunologic Factors|immunologic factors|mesh-ancestor
6219216|NCT02298179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219217|NCT02298179|Antacids|antacids|mesh-ancestor
6219218|NCT02298179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219219|NCT02298179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6219220|NCT02298192|Liraglutide|liraglutide|mesh-list
6219221|NCT02298192|Xultophy|xultophy|mesh-list
6219222|NCT02298192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6219223|NCT02298192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219224|NCT02298192|Incretins|incretins|mesh-ancestor
6219225|NCT02298192|Hormones|hormones|mesh-ancestor
6219226|NCT02298192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6219227|NCT02298868|Baclofen|baclofen|mesh-list
6219228|NCT02298868|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6219229|NCT02298868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219230|NCT02298868|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6219231|NCT02298868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6219232|NCT02298868|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6219233|NCT02298868|GABA Agonists|gaba agonists|mesh-ancestor
6219234|NCT02298868|GABA Agents|gaba agents|mesh-ancestor
6219235|NCT02298868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6219236|NCT02298868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219237|NCT02298933|Eculizumab|eculizumab|mesh-list
6219238|NCT02298933|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6219239|NCT02298933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6219240|NCT02298933|Immunologic Factors|immunologic factors|mesh-ancestor
6219241|NCT02298933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219242|NCT02298946|Cyclophosphamide|cyclophosphamide|mesh-list
6219243|NCT02298946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6219244|NCT02298946|Immunologic Factors|immunologic factors|mesh-ancestor
6219245|NCT02298946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219246|NCT02298946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6219247|NCT02298946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6219248|NCT02298946|Alkylating Agents|alkylating agents|mesh-ancestor
6219249|NCT02298946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219250|NCT02298946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6219251|NCT02298946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6219252|NCT02299050|Bromocriptine|bromocriptine|mesh-list
5703193|NCT03332953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5703194|NCT03332953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703195|NCT03332940|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
5703196|NCT03332940|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5703197|NCT03332940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703198|NCT03332888|Rituximab|rituximab|mesh-list
5703199|NCT03332888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5703200|NCT03332888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5703201|NCT03332888|Immunologic Factors|immunologic factors|mesh-ancestor
5703202|NCT03332888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703203|NCT03332888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5703204|NCT03332732|Metronidazole|metronidazole|mesh-list
5703205|NCT03332732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5703206|NCT03332732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5703207|NCT03332732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5703208|NCT03332732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5703209|NCT03332719|Etanercept|etanercept|mesh-list
5703210|NCT03332719|Methotrexate|methotrexate|mesh-list
5703211|NCT03332719|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6219253|NCT02299050|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6219254|NCT02299050|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6219255|NCT02299050|Hormone Antagonists|hormone antagonists|mesh-ancestor
6498060|NCT00635791|Vorinostat|vorinostat|mesh-list
6219256|NCT02299050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6219257|NCT02299050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219258|NCT02299050|Dopamine Agonists|dopamine agonists|mesh-ancestor
6219259|NCT02299050|Dopamine Agents|dopamine agents|mesh-ancestor
6219260|NCT02299050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6219261|NCT02299050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243219|NCT02662036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6243220|NCT02662036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243221|NCT02662036|Sensory System Agents|sensory system agents|mesh-ancestor
6243222|NCT02662036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6243223|NCT02662556|Sufentanil|sufentanil|mesh-list
6243224|NCT02662556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6498061|NCT00635791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6498062|NCT00635791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6498063|NCT00635791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6498064|NCT00635791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498065|NCT00635791|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6498066|NCT00635856|Gefitinib|gefitinib|mesh-list
6498067|NCT00635856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6498068|NCT00635856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6498069|NCT00635856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6498070|NCT00635856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498071|NCT00635921|Ziprasidone|ziprasidone|mesh-list
6498072|NCT00635921|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6498073|NCT00635921|Serotonin Agents|serotonin agents|mesh-ancestor
6498074|NCT00635921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6498075|NCT00635921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703212|NCT03332719|Abortifacient Agents|abortifacient agents|mesh-ancestor
5703213|NCT03332719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5703214|NCT03332719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703215|NCT03332719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5703216|NCT03332719|Antimetabolites|antimetabolites|mesh-ancestor
5703217|NCT03332719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703218|NCT03332719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5703219|NCT03332719|Dermatologic Agents|dermatologic agents|mesh-ancestor
5703220|NCT03332719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5703221|NCT03332719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6498076|NCT00635921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498077|NCT00635921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6498078|NCT00635921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6498079|NCT00635921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6498080|NCT00635921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6498081|NCT00635921|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6498082|NCT00635921|Dopamine Agents|dopamine agents|mesh-ancestor
6498083|NCT00635960|Hormones|hormones|mesh-list
6498084|NCT00635960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6498085|NCT00635960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498086|NCT00635973|Gefitinib|gefitinib|mesh-list
6498087|NCT00635973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6498088|NCT00635973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6498089|NCT00635973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6498090|NCT00635973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498091|NCT00635986|Fentanyl|fentanyl|mesh-list
6498092|NCT00635986|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6498093|NCT00635986|Narcotics|narcotics|mesh-ancestor
6498094|NCT00635986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6498095|NCT00635986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498096|NCT00635986|Analgesics|analgesics|mesh-ancestor
6498097|NCT00635986|Sensory System Agents|sensory system agents|mesh-ancestor
6498098|NCT00635986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6498099|NCT00635986|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6498100|NCT00635986|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6498101|NCT00635986|Anesthetics, General|anesthetics, general|mesh-ancestor
6498102|NCT00635986|Anesthetics|anesthetics|mesh-ancestor
6498103|NCT00636038|Beta Carotene|beta carotene|mesh-list
6498104|NCT00636038|Carotenoids|carotenoids|mesh-list
6498105|NCT00636038|Antioxidants|antioxidants|mesh-ancestor
6498106|NCT00636038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498107|NCT00636038|Protective Agents|protective agents|mesh-ancestor
6498108|NCT00636038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498109|NCT00636038|Provitamins|provitamins|mesh-ancestor
6498110|NCT00636038|Vitamins|vitamins|mesh-ancestor
5703222|NCT03332719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6219262|NCT02299089|Octreotide|octreotide|mesh-list
6219263|NCT02299089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6219264|NCT02299089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6219265|NCT02299089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6219266|NCT02299141|Nintedanib|nintedanib|mesh-list
6219267|NCT02299141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6219268|NCT02299141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6219269|NCT02299141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6219270|NCT02299141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219271|NCT02299297|Tofacitinib|tofacitinib|mesh-list
6219272|NCT02299297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6219273|NCT02299297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6219274|NCT02299297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219275|NCT02299336|Aflibercept|aflibercept|mesh-list
6219276|NCT02299336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6219277|NCT02299336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6676113|NCT01579110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6676114|NCT01579110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6676115|NCT01579149|Plerixafor|plerixafor|mesh-list
6676116|NCT01579149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6219278|NCT02299336|Growth Substances|growth substances|mesh-ancestor
6219279|NCT02299336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219280|NCT02299336|Growth Inhibitors|growth inhibitors|mesh-ancestor
6219281|NCT02299336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6219282|NCT02299349|Epinephrine|epinephrine|mesh-list
6219283|NCT02299349|Racepinephrine|racepinephrine|mesh-list
6219284|NCT02299349|Morphine|morphine|mesh-list
6219285|NCT02299349|Bupivacaine|bupivacaine|mesh-list
6219286|NCT02299349|Epinephryl borate|epinephryl borate|mesh-list
6219287|NCT02299349|Anesthetics, Local|anesthetics, local|mesh-ancestor
6219288|NCT02299349|Anesthetics|anesthetics|mesh-ancestor
6219289|NCT02299349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6219290|NCT02299349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219291|NCT02299349|Sensory System Agents|sensory system agents|mesh-ancestor
6219292|NCT02299349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6219293|NCT02299349|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6219294|NCT02299349|Narcotics|narcotics|mesh-ancestor
6219295|NCT02299349|Analgesics|analgesics|mesh-ancestor
6219296|NCT02299349|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6219297|NCT02299349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6219298|NCT02299349|Adrenergic Agents|adrenergic agents|mesh-ancestor
6219299|NCT02299349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6219300|NCT02299349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219301|NCT02299349|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6219302|NCT02299349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6219303|NCT02299349|Autonomic Agents|autonomic agents|mesh-ancestor
5703223|NCT03332719|Immunologic Factors|immunologic factors|mesh-ancestor
5703224|NCT03332719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5703225|NCT03332719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5703226|NCT03332719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5703227|NCT03332719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6219304|NCT02299349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6219305|NCT02299349|Respiratory System Agents|respiratory system agents|mesh-ancestor
6219306|NCT02299349|Mydriatics|mydriatics|mesh-ancestor
6219307|NCT02299349|Sympathomimetics|sympathomimetics|mesh-ancestor
6219308|NCT02299349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6219309|NCT02299375|Albuterol|albuterol|mesh-list
6219310|NCT02299375|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6219311|NCT02299375|Autonomic Agents|autonomic agents|mesh-ancestor
6219312|NCT02299375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6219313|NCT02299375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219314|NCT02299375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6219315|NCT02299375|Respiratory System Agents|respiratory system agents|mesh-ancestor
6219316|NCT02299375|Tocolytic Agents|tocolytic agents|mesh-ancestor
6219317|NCT02299375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6219318|NCT02299375|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5703228|NCT03332719|Analgesics|analgesics|mesh-ancestor
5703229|NCT03332719|Sensory System Agents|sensory system agents|mesh-ancestor
5703230|NCT03332719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5703231|NCT03332719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5703232|NCT03332719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5703233|NCT03332602|Vitamins|vitamins|mesh-list
6219319|NCT02299375|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6219320|NCT02299375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5703234|NCT03332602|Folic Acid|folic acid|mesh-list
6219321|NCT02299375|Adrenergic Agents|adrenergic agents|mesh-ancestor
6219322|NCT02299375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6219323|NCT02299375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219324|NCT02299388|Liraglutide|liraglutide|mesh-list
6498111|NCT00636038|Micronutrients|micronutrients|mesh-ancestor
6498112|NCT00636064|Parecoxib|parecoxib|mesh-list
6498113|NCT00636064|Valdecoxib|valdecoxib|mesh-list
6498114|NCT00636064|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6498115|NCT00636064|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6498116|NCT00636064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6498117|NCT00636064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498118|NCT00636064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6498119|NCT00636064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6498120|NCT00636064|Analgesics|analgesics|mesh-ancestor
6498121|NCT00636064|Sensory System Agents|sensory system agents|mesh-ancestor
6498122|NCT00636064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6498123|NCT00636064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676117|NCT01579149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6676118|NCT01579149|Antiviral Agents|antiviral agents|mesh-ancestor
5703235|NCT03332602|Vitamin A|vitamin a|mesh-list
6219325|NCT02299388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6219326|NCT02299388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219327|NCT02299388|Incretins|incretins|mesh-ancestor
6219328|NCT02299388|Hormones|hormones|mesh-ancestor
6219329|NCT02299388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6219330|NCT02300077|Fentanyl|fentanyl|mesh-list
6219331|NCT02300077|Morphine|morphine|mesh-list
6219332|NCT02300077|Methadone|methadone|mesh-list
6219333|NCT02300077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6219334|NCT02300077|Narcotics|narcotics|mesh-ancestor
6219335|NCT02300077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6219336|NCT02300077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219337|NCT02300077|Analgesics|analgesics|mesh-ancestor
6219338|NCT02300077|Sensory System Agents|sensory system agents|mesh-ancestor
6219339|NCT02300077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6219340|NCT02300077|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6219341|NCT02300077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6219342|NCT02300077|Anesthetics, General|anesthetics, general|mesh-ancestor
6219343|NCT02300077|Anesthetics|anesthetics|mesh-ancestor
6219344|NCT02300077|Antitussive Agents|antitussive agents|mesh-ancestor
6219345|NCT02300077|Respiratory System Agents|respiratory system agents|mesh-ancestor
6219346|NCT02300103|Sofosbuvir|sofosbuvir|mesh-list
5703236|NCT03332602|Retinol palmitate|retinol palmitate|mesh-list
5703237|NCT03332602|Fesoterodine|fesoterodine|mesh-list
5703238|NCT03332602|Hyaluronic Acid|hyaluronic acid|mesh-list
5703239|NCT03332602|Micronutrients|micronutrients|mesh-ancestor
5703240|NCT03332602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219347|NCT02300103|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
6219348|NCT02300103|Velpatasvir|velpatasvir|mesh-list
6219349|NCT02300103|Antiviral Agents|antiviral agents|mesh-ancestor
6219350|NCT02300103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6219351|NCT02300220|Ciprofloxacin|ciprofloxacin|mesh-list
6219352|NCT02300220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6219353|NCT02300220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6219354|NCT02300220|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6219355|NCT02300220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6219356|NCT02300220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6219357|NCT02300220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219358|NCT02300220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6219359|NCT02300220|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6219360|NCT02300220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6219361|NCT02300259|Itraconazole|itraconazole|mesh-list
6219362|NCT02300259|Diltiazem|diltiazem|mesh-list
6219363|NCT02300259|Tadalafil|tadalafil|mesh-list
6219364|NCT02300259|Simvastatin|simvastatin|mesh-list
6219365|NCT02300259|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6219366|NCT02300259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6219367|NCT02300259|Antimetabolites|antimetabolites|mesh-ancestor
6219368|NCT02300259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219369|NCT02300259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6219370|NCT02300259|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6219371|NCT02300259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6219372|NCT02300259|Antifungal Agents|antifungal agents|mesh-ancestor
6219373|NCT02300259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6219374|NCT02300259|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6219375|NCT02300259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6498124|NCT00636064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6498125|NCT00636064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5703241|NCT03332602|Hematinics|hematinics|mesh-ancestor
6219376|NCT02300259|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6219377|NCT02300259|Hormone Antagonists|hormone antagonists|mesh-ancestor
6219378|NCT02300259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6219379|NCT02300259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219380|NCT02300259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6219381|NCT02300259|Vasodilator Agents|vasodilator agents|mesh-ancestor
6219382|NCT02300259|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6219383|NCT02300259|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6219384|NCT02300259|Urological Agents|urological agents|mesh-ancestor
6219385|NCT02300259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6219386|NCT02300259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6219387|NCT02300259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6219388|NCT02300259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6219389|NCT02300298|Docetaxel|docetaxel|mesh-list
6219390|NCT02300298|Nintedanib|nintedanib|mesh-list
6219391|NCT02300298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6219392|NCT02300298|Tubulin Modulators|tubulin modulators|mesh-ancestor
6219393|NCT02300298|Antimitotic Agents|antimitotic agents|mesh-ancestor
6219394|NCT02300298|Mitosis Modulators|mitosis modulators|mesh-ancestor
6219395|NCT02300298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219396|NCT02300298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6219397|NCT02300298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6219398|NCT02300311|Nicotinic Acids|nicotinic acids|mesh-list
6219399|NCT02300311|Capsaicin|capsaicin|mesh-list
6219400|NCT02300311|Nonivamide|nonivamide|mesh-list
6219401|NCT02300311|Vitamin B Complex|vitamin b complex|mesh-ancestor
6219402|NCT02300311|Vitamins|vitamins|mesh-ancestor
6219403|NCT02300311|Micronutrients|micronutrients|mesh-ancestor
6219404|NCT02300311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219405|NCT02300311|Sensory System Agents|sensory system agents|mesh-ancestor
6219406|NCT02300311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6219407|NCT02300311|Antipruritics|antipruritics|mesh-ancestor
6219408|NCT02300311|Dermatologic Agents|dermatologic agents|mesh-ancestor
6219409|NCT02300610|Gemcitabine|gemcitabine|mesh-list
6219410|NCT02300610|Cisplatin|cisplatin|mesh-list
6219411|NCT02300610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6219412|NCT02300610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6219413|NCT02300610|Antimetabolites|antimetabolites|mesh-ancestor
6219414|NCT02300610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219415|NCT02300610|Antiviral Agents|antiviral agents|mesh-ancestor
6219416|NCT02300610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6219417|NCT02300610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6219418|NCT02300610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6498126|NCT00636116|Antivenins|antivenins|mesh-list
6498127|NCT00636116|Immunologic Factors|immunologic factors|mesh-ancestor
6498128|NCT00636116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498129|NCT00636142|Infliximab|infliximab|mesh-list
6498130|NCT00636142|Dermatologic Agents|dermatologic agents|mesh-ancestor
6498131|NCT00636142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6498132|NCT00636142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6498133|NCT00636246|Sertraline|sertraline|mesh-list
6498134|NCT00636246|Reboxetine|reboxetine|mesh-list
6498135|NCT00636246|Antidepressive Agents|antidepressive agents|mesh-ancestor
6498136|NCT00636246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6498137|NCT00636246|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6498138|NCT00636246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6498139|NCT00636246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6498140|NCT00636246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498141|NCT00636246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6498142|NCT00636246|Serotonin Agents|serotonin agents|mesh-ancestor
6498143|NCT00636246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498144|NCT00636246|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6498145|NCT00636246|Adrenergic Agents|adrenergic agents|mesh-ancestor
6498146|NCT00636259|Bicalutamide|bicalutamide|mesh-list
6498147|NCT00636259|Androgen Antagonists|androgen antagonists|mesh-ancestor
6498148|NCT00636259|Hormone Antagonists|hormone antagonists|mesh-ancestor
6498149|NCT00636259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6498150|NCT00636259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498151|NCT00636259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6498152|NCT00636285|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6498153|NCT00636285|Immunologic Factors|immunologic factors|mesh-ancestor
6498154|NCT00636285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498155|NCT00636298|Bevacizumab|bevacizumab|mesh-list
6498156|NCT00636298|Cetuximab|cetuximab|mesh-list
6498157|NCT00636298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6498158|NCT00636298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6219419|NCT02300610|Immunologic Factors|immunologic factors|mesh-ancestor
6219420|NCT02300610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219421|NCT02300727|Curcumin|curcumin|mesh-list
6219422|NCT02300727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6219423|NCT02300727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6219424|NCT02300727|Analgesics|analgesics|mesh-ancestor
6219425|NCT02300727|Sensory System Agents|sensory system agents|mesh-ancestor
6219426|NCT02300727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6219427|NCT02300727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219428|NCT02300727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6219429|NCT02300727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6219430|NCT02300727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6219431|NCT02300727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6219432|NCT02300727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219433|NCT02301039|Pembrolizumab|pembrolizumab|mesh-list
6219434|NCT02301039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6219435|NCT02301039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6219436|NCT02301143|Gemcitabine|gemcitabine|mesh-list
6219437|NCT02301143|Paclitaxel|paclitaxel|mesh-list
6219438|NCT02301143|Capecitabine|capecitabine|mesh-list
6219439|NCT02301143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6219440|NCT02301143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6219441|NCT02301143|Tubulin Modulators|tubulin modulators|mesh-ancestor
6219442|NCT02301143|Antimitotic Agents|antimitotic agents|mesh-ancestor
6219443|NCT02301143|Mitosis Modulators|mitosis modulators|mesh-ancestor
6219444|NCT02301143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219445|NCT02301143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6219446|NCT02301143|Antimetabolites|antimetabolites|mesh-ancestor
6219447|NCT02301143|Antiviral Agents|antiviral agents|mesh-ancestor
6219448|NCT02301143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6219449|NCT02301143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6219450|NCT02301143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6219451|NCT02301143|Immunologic Factors|immunologic factors|mesh-ancestor
6219452|NCT02301143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219453|NCT02301390|Amiodarone|amiodarone|mesh-list
6219454|NCT02301390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6219455|NCT02301390|Vasodilator Agents|vasodilator agents|mesh-ancestor
6219456|NCT02301390|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6219457|NCT02301390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6219458|NCT02301390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219459|NCT02301390|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6219460|NCT02301390|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6219461|NCT02301390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6219462|NCT02301390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6219463|NCT02301390|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6219464|NCT02301390|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6219465|NCT02301390|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5703242|NCT03332602|Vitamin B Complex|vitamin b complex|mesh-ancestor
5703243|NCT03332602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5703244|NCT03332602|Immunologic Factors|immunologic factors|mesh-ancestor
5703245|NCT03332602|Viscosupplements|viscosupplements|mesh-ancestor
5703246|NCT03332602|Protective Agents|protective agents|mesh-ancestor
5703247|NCT03332602|Antioxidants|antioxidants|mesh-ancestor
5703248|NCT03332602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703249|NCT03332602|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5918524|NCT04990830|Enoxaparin|enoxaparin|mesh-list
5918525|NCT04990830|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5918526|NCT04990830|Tinzaparin|tinzaparin|mesh-list
5918527|NCT04990830|Dalteparin|dalteparin|mesh-list
5918528|NCT04990830|Enoxaparin sodium|enoxaparin sodium|mesh-list
5918529|NCT04990830|Anticoagulants|anticoagulants|mesh-ancestor
5918530|NCT04990830|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5918531|NCT04990830|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5918532|NCT04990830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918533|NCT04990869|Niacinamide|niacinamide|mesh-list
5918534|NCT04990869|Niacin|niacin|mesh-list
5918535|NCT04990869|Nicotinic Acids|nicotinic acids|mesh-list
5918536|NCT04990869|Vitamin B Complex|vitamin b complex|mesh-ancestor
5918537|NCT04990869|Vitamins|vitamins|mesh-ancestor
5918538|NCT04990869|Micronutrients|micronutrients|mesh-ancestor
5918539|NCT04990869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918540|NCT04990869|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5918541|NCT04990869|Antimetabolites|antimetabolites|mesh-ancestor
5918542|NCT04990869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918543|NCT04990869|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6219466|NCT02301403|Nicotine|nicotine|mesh-list
6219467|NCT02301403|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6219468|NCT02301403|Autonomic Agents|autonomic agents|mesh-ancestor
6219469|NCT02301403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6219470|NCT02301403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219471|NCT02301403|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6219472|NCT02301403|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6219473|NCT02301403|Cholinergic Agents|cholinergic agents|mesh-ancestor
6219474|NCT02301403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6219475|NCT02301403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219476|NCT02301416|Topiramate|topiramate|mesh-list
6219477|NCT02301416|Phentermine|phentermine|mesh-list
6219478|NCT02301416|Anticonvulsants|anticonvulsants|mesh-ancestor
5703250|NCT03332602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5703251|NCT03332602|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5703252|NCT03332602|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5703253|NCT03332602|Cholinergic Agents|cholinergic agents|mesh-ancestor
5703254|NCT03332602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5703255|NCT03332602|Urological Agents|urological agents|mesh-ancestor
5703256|NCT03332589|Dabrafenib|dabrafenib|mesh-list
5703257|NCT03332589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5703258|NCT03332589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5703259|NCT03332589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5703260|NCT03332589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703261|NCT03332576|Cyclophosphamide|cyclophosphamide|mesh-list
5703262|NCT03332576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5703263|NCT03332576|Immunologic Factors|immunologic factors|mesh-ancestor
5703264|NCT03332576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703265|NCT03332576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5703266|NCT03332576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5703267|NCT03332576|Alkylating Agents|alkylating agents|mesh-ancestor
5703268|NCT03332576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703269|NCT03332576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5703270|NCT03332576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5703271|NCT03332524|Chlorpheniramine|chlorpheniramine|mesh-list
5703272|NCT03332524|Ibuprofen|ibuprofen|mesh-list
6219479|NCT02301416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6219480|NCT02301416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219481|NCT02301416|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6219482|NCT02301416|Appetite Depressants|appetite depressants|mesh-ancestor
6219483|NCT02301416|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6219484|NCT02301416|Sympathomimetics|sympathomimetics|mesh-ancestor
6219485|NCT02301416|Autonomic Agents|autonomic agents|mesh-ancestor
6219486|NCT02301416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6219487|NCT02301416|Adrenergic Agents|adrenergic agents|mesh-ancestor
6219488|NCT02301416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6219489|NCT02301416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219490|NCT02301624|Eculizumab|eculizumab|mesh-list
6219491|NCT02301624|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6219492|NCT02301624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6219493|NCT02301624|Immunologic Factors|immunologic factors|mesh-ancestor
6219494|NCT02301624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219495|NCT02301936|Sofosbuvir|sofosbuvir|mesh-list
6219496|NCT02301936|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
6219497|NCT02301936|Ledipasvir|ledipasvir|mesh-list
6219498|NCT02301936|Antiviral Agents|antiviral agents|mesh-ancestor
6219499|NCT02301936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6219500|NCT02301975|Fluticasone|fluticasone|mesh-list
6219501|NCT02301975|Xhance|xhance|mesh-list
6219502|NCT02301975|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6219503|NCT02301975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5703273|NCT03332524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5703274|NCT03332524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5703275|NCT03332524|Analgesics|analgesics|mesh-ancestor
5703276|NCT03332524|Sensory System Agents|sensory system agents|mesh-ancestor
5703277|NCT03332524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5703278|NCT03332524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703279|NCT03332524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5703280|NCT03332524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5703281|NCT03332524|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5703282|NCT03332524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5703283|NCT03332524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219504|NCT02301975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6219505|NCT02301975|Autonomic Agents|autonomic agents|mesh-ancestor
6219506|NCT02301975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6219507|NCT02301975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219508|NCT02301975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6219509|NCT02301975|Respiratory System Agents|respiratory system agents|mesh-ancestor
6219510|NCT02301975|Dermatologic Agents|dermatologic agents|mesh-ancestor
6219511|NCT02301975|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6219512|NCT02301975|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6219513|NCT02301975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6219514|NCT02301975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6219515|NCT02301975|Adrenergic Agents|adrenergic agents|mesh-ancestor
6219516|NCT02301975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6219517|NCT02301975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219518|NCT02301988|Paclitaxel|paclitaxel|mesh-list
6219519|NCT02301988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6219520|NCT02301988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5703284|NCT03332524|Antipruritics|antipruritics|mesh-ancestor
5703285|NCT03332524|Dermatologic Agents|dermatologic agents|mesh-ancestor
5703286|NCT03332524|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5703287|NCT03332524|Histamine Antagonists|histamine antagonists|mesh-ancestor
5703288|NCT03332524|Histamine Agents|histamine agents|mesh-ancestor
6219521|NCT02301988|Tubulin Modulators|tubulin modulators|mesh-ancestor
6219522|NCT02301988|Antimitotic Agents|antimitotic agents|mesh-ancestor
6219523|NCT02301988|Mitosis Modulators|mitosis modulators|mesh-ancestor
6219524|NCT02301988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219525|NCT02302092|Cefepime|cefepime|mesh-list
6219526|NCT02302092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6219527|NCT02302092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6219528|NCT02302339|Pembrolizumab|pembrolizumab|mesh-list
6219529|NCT02302339|Nivolumab|nivolumab|mesh-list
6219530|NCT02302339|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
6219531|NCT02302339|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6219532|NCT02302339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6219533|NCT02302339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6219534|NCT02302339|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6219535|NCT02302339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219536|NCT02302339|Immunologic Factors|immunologic factors|mesh-ancestor
6219537|NCT02302339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219538|NCT02302716|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6219539|NCT02302716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219540|NCT02302807|Paclitaxel|paclitaxel|mesh-list
6219541|NCT02302807|Docetaxel|docetaxel|mesh-list
6219542|NCT02302807|Atezolizumab|atezolizumab|mesh-list
6219543|NCT02302807|Antibodies|antibodies|mesh-list
6219544|NCT02302807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6219545|NCT02302807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6219546|NCT02302807|Tubulin Modulators|tubulin modulators|mesh-ancestor
6219547|NCT02302807|Antimitotic Agents|antimitotic agents|mesh-ancestor
6219548|NCT02302807|Mitosis Modulators|mitosis modulators|mesh-ancestor
6219549|NCT02302807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219550|NCT02302807|Immunologic Factors|immunologic factors|mesh-ancestor
6219551|NCT02302807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219552|NCT02302846|Ixazomib|ixazomib|mesh-list
6219553|NCT02302846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6219554|NCT02302846|Protease Inhibitors|protease inhibitors|mesh-ancestor
6219555|NCT02302846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6219556|NCT02302846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219557|NCT02303093|gamma-Globulins|gamma-globulins|mesh-list
6219558|NCT02303093|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6219559|NCT02303093|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6219560|NCT02303093|Immunologic Factors|immunologic factors|mesh-ancestor
6219561|NCT02303093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219562|NCT02303184|Aflibercept|aflibercept|mesh-list
6219563|NCT02303184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6219564|NCT02303184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6219565|NCT02303184|Growth Substances|growth substances|mesh-ancestor
6219566|NCT02303184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219567|NCT02303184|Growth Inhibitors|growth inhibitors|mesh-ancestor
6219568|NCT02303184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6219569|NCT02303262|Gemcitabine|gemcitabine|mesh-list
6219570|NCT02303262|Mocetinostat|mocetinostat|mesh-list
6219571|NCT02303262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6219572|NCT02303262|Antimetabolites|antimetabolites|mesh-ancestor
6219573|NCT02303262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219574|NCT02303262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5703289|NCT03332524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6219575|NCT02303262|Antiviral Agents|antiviral agents|mesh-ancestor
6219576|NCT02303262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6219577|NCT02303262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6219578|NCT02303262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6219579|NCT02303262|Immunologic Factors|immunologic factors|mesh-ancestor
6219580|NCT02303262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219581|NCT02303262|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6219582|NCT02303574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6219583|NCT02303977|Gemcitabine|gemcitabine|mesh-list
6219584|NCT02303977|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5703290|NCT03332524|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5703291|NCT03332329|Entecavir|entecavir|mesh-list
5703292|NCT03332329|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6219585|NCT02303977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6219586|NCT02303977|Antimetabolites|antimetabolites|mesh-ancestor
6219587|NCT02303977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219588|NCT02303977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6219589|NCT02303977|Antiviral Agents|antiviral agents|mesh-ancestor
6219590|NCT02303977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6219591|NCT02303977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6219592|NCT02303977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6219593|NCT02303977|Immunologic Factors|immunologic factors|mesh-ancestor
6219594|NCT02303977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219595|NCT02303990|Pembrolizumab|pembrolizumab|mesh-list
6219596|NCT02303990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6219597|NCT02303990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6219598|NCT02304159|Ribavirin|ribavirin|mesh-list
6219599|NCT02304159|Sofosbuvir|sofosbuvir|mesh-list
6219600|NCT02304159|Antimetabolites|antimetabolites|mesh-ancestor
6219601|NCT02304159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219602|NCT02304159|Antiviral Agents|antiviral agents|mesh-ancestor
6219603|NCT02304159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6219604|NCT02304432|Cycloserine|cycloserine|mesh-list
6219605|NCT02304432|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6219606|NCT02304432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6219607|NCT02304432|Renal Agents|renal agents|mesh-ancestor
6219608|NCT02304432|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6219609|NCT02304432|Antitubercular Agents|antitubercular agents|mesh-ancestor
6219610|NCT02304432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6219611|NCT02304432|Antimetabolites|antimetabolites|mesh-ancestor
6219612|NCT02304432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219613|NCT02304484|Evolocumab|evolocumab|mesh-list
6219614|NCT02304484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6219615|NCT02304484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6219616|NCT02304484|Antimetabolites|antimetabolites|mesh-ancestor
6219617|NCT02304484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219618|NCT02304484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6219619|NCT02304705|Sildenafil Citrate|sildenafil citrate|mesh-list
6219620|NCT02304705|Vasodilator Agents|vasodilator agents|mesh-ancestor
6219621|NCT02304705|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6219622|NCT02304705|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6219623|NCT02304705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6219624|NCT02304705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219625|NCT02304705|Urological Agents|urological agents|mesh-ancestor
6219626|NCT02304757|Alendronate|alendronate|mesh-list
6219627|NCT02304757|Methylene diphosphonate|methylene diphosphonate|mesh-list
6219628|NCT02304757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6219629|NCT02304757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219630|NCT02304926|Simvastatin|simvastatin|mesh-list
6219631|NCT02304926|Ezetimibe|ezetimibe|mesh-list
6219632|NCT02304926|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
6219633|NCT02304926|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6219634|NCT02304926|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6219635|NCT02304926|Antimetabolites|antimetabolites|mesh-ancestor
6219636|NCT02304926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219637|NCT02304926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6219638|NCT02304926|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6498159|NCT00636298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6498160|NCT00636298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6498161|NCT00636298|Growth Substances|growth substances|mesh-ancestor
6498162|NCT00636298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498163|NCT00636298|Growth Inhibitors|growth inhibitors|mesh-ancestor
6498164|NCT00636311|Gemcitabine|gemcitabine|mesh-list
6498165|NCT00636311|Bortezomib|bortezomib|mesh-list
6498166|NCT00636311|Vinorelbine|vinorelbine|mesh-list
5703293|NCT03332329|Molgramostim|molgramostim|mesh-list
6498167|NCT00636311|Ifosfamide|ifosfamide|mesh-list
6498168|NCT00636311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6498169|NCT00636311|Antimetabolites|antimetabolites|mesh-ancestor
6219639|NCT02304926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6219640|NCT02305017|Acetaminophen|acetaminophen|mesh-list
6219641|NCT02305017|Opicapone|opicapone|mesh-list
6219642|NCT02305017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6219643|NCT02305017|Analgesics|analgesics|mesh-ancestor
6219644|NCT02305017|Sensory System Agents|sensory system agents|mesh-ancestor
6219645|NCT02305017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6219646|NCT02305017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219647|NCT02305017|Antipyretics|antipyretics|mesh-ancestor
6219648|NCT02305017|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6219649|NCT02305017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6219650|NCT02305017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219651|NCT02305017|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6219652|NCT02305017|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6219653|NCT02305238|Aflibercept|aflibercept|mesh-list
6219654|NCT02305238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6219655|NCT02305238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6219656|NCT02305238|Growth Substances|growth substances|mesh-ancestor
6219657|NCT02305238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219658|NCT02305238|Growth Inhibitors|growth inhibitors|mesh-ancestor
6219659|NCT02305238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6219660|NCT02305277|Opicapone|opicapone|mesh-list
6219661|NCT02305277|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6219662|NCT02305277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6219663|NCT02305277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219664|NCT02305277|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6219665|NCT02305277|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6219666|NCT02305316|Opicapone|opicapone|mesh-list
6219667|NCT02305316|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6219668|NCT02305316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6219669|NCT02305316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219670|NCT02305316|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6219671|NCT02305316|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6219672|NCT02305329|Opicapone|opicapone|mesh-list
6219673|NCT02305329|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6219674|NCT02305329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6219675|NCT02305329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219676|NCT02305329|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6219677|NCT02305329|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6219678|NCT02305563|Cytarabine|cytarabine|mesh-list
6219679|NCT02305563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6219680|NCT02305563|Antimetabolites|antimetabolites|mesh-ancestor
6219681|NCT02305563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219682|NCT02305563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6219683|NCT02305563|Antiviral Agents|antiviral agents|mesh-ancestor
6219684|NCT02305563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6219685|NCT02305563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6219686|NCT02305563|Immunologic Factors|immunologic factors|mesh-ancestor
6243225|NCT02662556|Narcotics|narcotics|mesh-ancestor
5703294|NCT03332329|Vaccines|vaccines|mesh-list
5703295|NCT03332329|Sargramostim|sargramostim|mesh-list
5703296|NCT03332329|Immunologic Factors|immunologic factors|mesh-ancestor
5703297|NCT03332329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703298|NCT03332329|Antiviral Agents|antiviral agents|mesh-ancestor
5703299|NCT03332329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5703300|NCT03332329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5703301|NCT03332316|Dexamethasone|dexamethasone|mesh-list
5703302|NCT03332316|Dexamethasone acetate|dexamethasone acetate|mesh-list
5703303|NCT03332316|Ropivacaine|ropivacaine|mesh-list
5703304|NCT03332316|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
5703305|NCT03332316|BB 1101|bb 1101|mesh-list
5703306|NCT03332316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5703307|NCT03332316|Antiemetics|antiemetics|mesh-ancestor
5703308|NCT03332316|Autonomic Agents|autonomic agents|mesh-ancestor
5918544|NCT04990869|Vasodilator Agents|vasodilator agents|mesh-ancestor
5918545|NCT04990713|Ropivacaine|ropivacaine|mesh-list
5918546|NCT04990713|Anesthetics, Local|anesthetics, local|mesh-list
5918547|NCT04990713|Anesthetics|anesthetics|mesh-list
5918548|NCT04990713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5918549|NCT04990713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918550|NCT04990713|Sensory System Agents|sensory system agents|mesh-ancestor
5918551|NCT04990713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5918552|NCT04990791|Aspirin|aspirin|mesh-list
5918553|NCT04990791|Rivaroxaban|rivaroxaban|mesh-list
5918554|NCT04990791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5918555|NCT04990791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5918556|NCT04990791|Analgesics|analgesics|mesh-ancestor
6219687|NCT02305563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219688|NCT02305758|Bevacizumab|bevacizumab|mesh-list
6219689|NCT02305758|Fluorouracil|fluorouracil|mesh-list
6219690|NCT02305758|Veliparib|veliparib|mesh-list
6219691|NCT02305758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6219692|NCT02305758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6219693|NCT02305758|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6219694|NCT02305758|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6219695|NCT02305758|Growth Substances|growth substances|mesh-ancestor
6219696|NCT02305758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219697|NCT02305758|Growth Inhibitors|growth inhibitors|mesh-ancestor
6219698|NCT02305758|Antimetabolites|antimetabolites|mesh-ancestor
6219699|NCT02305758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219700|NCT02305758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6219701|NCT02305758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6219702|NCT02305758|Immunologic Factors|immunologic factors|mesh-ancestor
6219703|NCT02305758|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6219704|NCT02305758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6219705|NCT02305797|Lorazepam|lorazepam|mesh-list
6219706|NCT02305797|Anticonvulsants|anticonvulsants|mesh-ancestor
6219707|NCT02305797|Antiemetics|antiemetics|mesh-ancestor
6219708|NCT02305797|Autonomic Agents|autonomic agents|mesh-ancestor
6219709|NCT02305797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6219710|NCT02305797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219711|NCT02305797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6219712|NCT02305797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6219713|NCT02305797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6219714|NCT02305797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6219715|NCT02305797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6219716|NCT02305797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6219717|NCT02305797|GABA Modulators|gaba modulators|mesh-ancestor
6219718|NCT02305797|GABA Agents|gaba agents|mesh-ancestor
6219719|NCT02305797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6219720|NCT02305797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219721|NCT02305849|Methotrexate|methotrexate|mesh-list
6219722|NCT02305849|Peficitinib|peficitinib|mesh-list
6219723|NCT02305849|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6219724|NCT02305849|Abortifacient Agents|abortifacient agents|mesh-ancestor
6219725|NCT02305849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6219726|NCT02305849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219727|NCT02305849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6219728|NCT02305849|Antimetabolites|antimetabolites|mesh-ancestor
6219729|NCT02305849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219730|NCT02305849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6219731|NCT02305849|Dermatologic Agents|dermatologic agents|mesh-ancestor
6219732|NCT02305849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6219733|NCT02305849|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6219734|NCT02305849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6219735|NCT02305849|Immunologic Factors|immunologic factors|mesh-ancestor
6219736|NCT02305849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6219737|NCT02305849|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6219738|NCT02306694|Factor VIII|factor viii|mesh-list
6219739|NCT02306694|Coagulants|coagulants|mesh-ancestor
6219740|NCT02306759|Ketamine|ketamine|mesh-list
6219741|NCT02306759|Analgesics|analgesics|mesh-ancestor
6219742|NCT02306759|Sensory System Agents|sensory system agents|mesh-ancestor
6219743|NCT02306759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6219744|NCT02306759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703309|NCT03332316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6219745|NCT02306759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6219746|NCT02306759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6219747|NCT02306759|Anesthetics, General|anesthetics, general|mesh-ancestor
6219748|NCT02306759|Anesthetics|anesthetics|mesh-ancestor
6219749|NCT02306759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6219750|NCT02306759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6219751|NCT02306759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6219752|NCT02306759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6219753|NCT02306759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219754|NCT02306850|Pembrolizumab|pembrolizumab|mesh-list
6219755|NCT02306850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6219756|NCT02306850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6219757|NCT02307318|Hemostatics|hemostatics|mesh-list
6219758|NCT02307318|Coagulants|coagulants|mesh-ancestor
6219759|NCT02307513|Apremilast|apremilast|mesh-list
6219760|NCT02307513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5703310|NCT03332316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703311|NCT03332316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5703312|NCT03332316|Glucocorticoids|glucocorticoids|mesh-ancestor
5703313|NCT03332316|Hormones|hormones|mesh-ancestor
5703314|NCT03332316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5703315|NCT03332316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5703316|NCT03332316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5703317|NCT03332316|Anesthetics, Local|anesthetics, local|mesh-ancestor
5703318|NCT03332316|Anesthetics|anesthetics|mesh-ancestor
5703319|NCT03332316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5703320|NCT03332316|Sensory System Agents|sensory system agents|mesh-ancestor
6219761|NCT02307513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6219762|NCT02307513|Analgesics|analgesics|mesh-ancestor
6219763|NCT02307513|Sensory System Agents|sensory system agents|mesh-ancestor
6219764|NCT02307513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6219765|NCT02307513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219766|NCT02307513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6219767|NCT02307513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6219768|NCT02307513|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6219769|NCT02307513|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6219770|NCT02307513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6219771|NCT02307513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703321|NCT03332316|Protease Inhibitors|protease inhibitors|mesh-ancestor
5703322|NCT03332316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5703323|NCT03332316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703324|NCT03332225|Interferons|interferons|mesh-list
5703325|NCT03332225|Interferon-gamma|interferon-gamma|mesh-list
5703326|NCT03332225|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5703327|NCT03332225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5703328|NCT03332225|Antiviral Agents|antiviral agents|mesh-ancestor
5703329|NCT03332225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5703330|NCT03332225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5703331|NCT03332173|Zanubrutinib|zanubrutinib|mesh-list
5703332|NCT03332173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5703333|NCT03332173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5703334|NCT03332173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5703335|NCT03332173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703336|NCT03332069|Cisplatin|cisplatin|mesh-list
6219772|NCT02307526|Bromides|bromides|mesh-list
6219773|NCT02307526|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
6219774|NCT02307526|Anticonvulsants|anticonvulsants|mesh-ancestor
6219775|NCT02307526|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6219776|NCT02307526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6219777|NCT02307526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219778|NCT02307526|Cholinergic Agents|cholinergic agents|mesh-ancestor
6219779|NCT02307526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6219780|NCT02307526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219781|NCT02307682|Aflibercept|aflibercept|mesh-list
6219782|NCT02307682|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6219783|NCT02307682|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6219784|NCT02307682|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6219785|NCT02307682|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6219786|NCT02307682|Growth Substances|growth substances|mesh-ancestor
6219787|NCT02307682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219788|NCT02307682|Growth Inhibitors|growth inhibitors|mesh-ancestor
6219789|NCT02307682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6243226|NCT02662556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6243227|NCT02662556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243228|NCT02662556|Analgesics|analgesics|mesh-ancestor
6243229|NCT02662556|Sensory System Agents|sensory system agents|mesh-ancestor
6243230|NCT02662556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6243231|NCT02662556|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6243232|NCT02662556|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6243233|NCT02662556|Anesthetics, General|anesthetics, general|mesh-ancestor
6243234|NCT02662556|Anesthetics|anesthetics|mesh-ancestor
6243235|NCT02662569|Atorvastatin|atorvastatin|mesh-list
6243236|NCT02662569|Evolocumab|evolocumab|mesh-list
6243237|NCT02662569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6243238|NCT02662569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6243239|NCT02662569|Antimetabolites|antimetabolites|mesh-ancestor
6243240|NCT02662569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243241|NCT02662569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6244254|NCT02691494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5703337|NCT03332069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5703338|NCT03332017|Obinutuzumab|obinutuzumab|mesh-list
5703339|NCT03332017|Zanubrutinib|zanubrutinib|mesh-list
5703340|NCT03332017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5703341|NCT03332017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5703342|NCT03332017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5703343|NCT03332017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5703344|NCT03332017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219790|NCT02307916|Mitogens|mitogens|mesh-list
6219791|NCT02307916|Mitosis Modulators|mitosis modulators|mesh-ancestor
6219792|NCT02307916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219793|NCT02308007|Metronidazole|metronidazole|mesh-list
6219794|NCT02308007|Terconazole|terconazole|mesh-list
6219795|NCT02308007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6219796|NCT02308007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6219797|NCT02308007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6219798|NCT02308007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6219799|NCT02308007|Antifungal Agents|antifungal agents|mesh-ancestor
6219800|NCT02308033|Metronidazole|metronidazole|mesh-list
6219801|NCT02308033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6219802|NCT02308033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6219803|NCT02308033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6219804|NCT02308033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6219805|NCT02308046|Terconazole|terconazole|mesh-list
6219806|NCT02308046|Antifungal Agents|antifungal agents|mesh-ancestor
6219807|NCT02308046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6219808|NCT02308124|Midodrine|midodrine|mesh-list
6219809|NCT02308124|Bromides|bromides|mesh-list
6219810|NCT02308124|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
6219811|NCT02308124|Anticonvulsants|anticonvulsants|mesh-ancestor
6219812|NCT02308124|Sympathomimetics|sympathomimetics|mesh-ancestor
6219813|NCT02308124|Autonomic Agents|autonomic agents|mesh-ancestor
6219814|NCT02308124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6219815|NCT02308124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219816|NCT02308124|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6219817|NCT02308124|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6219818|NCT02308124|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6219819|NCT02308124|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6219820|NCT02308124|Adrenergic Agents|adrenergic agents|mesh-ancestor
6219821|NCT02308124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6219822|NCT02308124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219823|NCT02308124|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6219824|NCT02308124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6219825|NCT02308124|Cholinergic Agents|cholinergic agents|mesh-ancestor
6219826|NCT02308163|Etanercept|etanercept|mesh-list
6219827|NCT02308163|Peficitinib|peficitinib|mesh-list
6219828|NCT02308163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6219829|NCT02308163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6219830|NCT02308163|Analgesics|analgesics|mesh-ancestor
6219831|NCT02308163|Sensory System Agents|sensory system agents|mesh-ancestor
6219832|NCT02308163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6219833|NCT02308163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219834|NCT02308163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6219835|NCT02308163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6219836|NCT02308163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6219837|NCT02308163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6219838|NCT02308163|Immunologic Factors|immunologic factors|mesh-ancestor
6219839|NCT02308163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6219840|NCT02308163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219841|NCT02308228|Metformin|metformin|mesh-list
6219842|NCT02308228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6219843|NCT02308228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219844|NCT02308501|Alcaftadine|alcaftadine|mesh-list
6219845|NCT02308501|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6219846|NCT02308501|Histamine Antagonists|histamine antagonists|mesh-ancestor
5703345|NCT03331913|Botulinum Toxins|botulinum toxins|mesh-list
5703346|NCT03331913|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5703347|NCT03331913|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5703348|NCT03331913|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5703349|NCT03331913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5703350|NCT03331913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703351|NCT03331913|Cholinergic Agents|cholinergic agents|mesh-ancestor
5703352|NCT03331913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5703353|NCT03331913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219847|NCT02308501|Histamine Agents|histamine agents|mesh-ancestor
6219848|NCT02308501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6219849|NCT02308501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219850|NCT02308501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219851|NCT02308540|Vaccines|vaccines|mesh-list
6219852|NCT02308540|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6219853|NCT02308540|Immunologic Factors|immunologic factors|mesh-ancestor
6219854|NCT02308540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219855|NCT02308748|Moxifloxacin|moxifloxacin|mesh-list
6219856|NCT02308748|Lidocaine|lidocaine|mesh-list
6219857|NCT02308748|Mexiletine|mexiletine|mesh-list
6219858|NCT02308748|Dofetilide|dofetilide|mesh-list
6219859|NCT02308748|Diltiazem|diltiazem|mesh-list
6219860|NCT02308748|Anesthetics, Local|anesthetics, local|mesh-ancestor
6219861|NCT02308748|Anesthetics|anesthetics|mesh-ancestor
6219862|NCT02308748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6219863|NCT02308748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219864|NCT02308748|Sensory System Agents|sensory system agents|mesh-ancestor
6219865|NCT02308748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6219866|NCT02308748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6219867|NCT02308748|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6219868|NCT02308748|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6219869|NCT02308748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6219870|NCT02308748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219871|NCT02308748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6219872|NCT02308748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6498170|NCT00636311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498171|NCT00636311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6498172|NCT00636311|Antiviral Agents|antiviral agents|mesh-ancestor
6498173|NCT00636311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6498174|NCT00636311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6498175|NCT00636311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6498176|NCT00636311|Immunologic Factors|immunologic factors|mesh-ancestor
6498177|NCT00636311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703354|NCT03331913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5703355|NCT03331913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5703356|NCT03331861|Metformin|metformin|mesh-list
5703357|NCT03331861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5703358|NCT03331861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703359|NCT03331770|Latanoprost|latanoprost|mesh-list
5703360|NCT03331770|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5703361|NCT03331770|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5703362|NCT03331692|Anesthetics|anesthetics|mesh-list
5703363|NCT03331692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5703364|NCT03331692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498178|NCT00636311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6676119|NCT01579149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6676120|NCT01579201|Carbetocin|carbetocin|mesh-list
6676121|NCT01579201|Oxytocics|oxytocics|mesh-ancestor
6676122|NCT01579201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6676123|NCT01579201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676124|NCT01579227|Tamoxifen|tamoxifen|mesh-list
6676125|NCT01579227|Tocotrienols|tocotrienols|mesh-list
6676126|NCT01579227|Vitamin E|vitamin e|mesh-list
6676127|NCT01579227|Tocopherols|tocopherols|mesh-list
6676128|NCT01579227|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6676129|NCT01579227|Hormone Antagonists|hormone antagonists|mesh-ancestor
6676130|NCT01579227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6676131|NCT01579227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676132|NCT01579227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6676133|NCT01579227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6676134|NCT01579227|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6676135|NCT01579227|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6676136|NCT01579227|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6676137|NCT01579227|Antioxidants|antioxidants|mesh-ancestor
6676138|NCT01579227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676139|NCT01579227|Protective Agents|protective agents|mesh-ancestor
5703365|NCT03331562|Ergocalciferols|ergocalciferols|mesh-list
5703366|NCT03331562|Pembrolizumab|pembrolizumab|mesh-list
5703367|NCT03331562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5703368|NCT03331562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5703369|NCT03331562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5703370|NCT03331562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703371|NCT03331562|Vitamins|vitamins|mesh-ancestor
5703372|NCT03331562|Micronutrients|micronutrients|mesh-ancestor
5703373|NCT03331562|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5703374|NCT03331523|Betamethasone|betamethasone|mesh-list
6219873|NCT02308748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6676140|NCT01579227|Vitamins|vitamins|mesh-ancestor
6676141|NCT01579227|Micronutrients|micronutrients|mesh-ancestor
6219874|NCT02308748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6219875|NCT02308748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6219876|NCT02308748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6219877|NCT02308748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6219878|NCT02308748|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6219879|NCT02308748|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6219880|NCT02308748|Vasodilator Agents|vasodilator agents|mesh-ancestor
6219881|NCT02308748|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6219882|NCT02309359|Methotrexate|methotrexate|mesh-list
6219883|NCT02309359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6219884|NCT02309359|Abortifacient Agents|abortifacient agents|mesh-ancestor
6219885|NCT02309359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6219886|NCT02309359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219887|NCT02309359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6219888|NCT02309359|Antimetabolites|antimetabolites|mesh-ancestor
6219889|NCT02309359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219890|NCT02309359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6219891|NCT02309359|Dermatologic Agents|dermatologic agents|mesh-ancestor
6219892|NCT02309359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6219893|NCT02309359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6219894|NCT02309359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6219895|NCT02309359|Immunologic Factors|immunologic factors|mesh-ancestor
6219896|NCT02309359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6219897|NCT02309359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6219898|NCT02309411|Rivaroxaban|rivaroxaban|mesh-list
6219899|NCT02309411|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6219900|NCT02309411|Antithrombins|antithrombins|mesh-ancestor
6219901|NCT02309411|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6219902|NCT02309411|Protease Inhibitors|protease inhibitors|mesh-ancestor
6219903|NCT02309411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6219904|NCT02309411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219905|NCT02309411|Anticoagulants|anticoagulants|mesh-ancestor
6219906|NCT02309515|Lenalidomide|lenalidomide|mesh-list
6219907|NCT02309515|Vaccines|vaccines|mesh-list
6219908|NCT02309515|Immunologic Factors|immunologic factors|mesh-ancestor
6219909|NCT02309515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219910|NCT02309515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6219911|NCT02309515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6219912|NCT02309515|Growth Substances|growth substances|mesh-ancestor
6219913|NCT02309515|Growth Inhibitors|growth inhibitors|mesh-ancestor
6219914|NCT02309515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6219915|NCT02310568|PF-06372865|pf-06372865|mesh-list
6219916|NCT02310568|GABA Modulators|gaba modulators|mesh-ancestor
6219917|NCT02310568|GABA Agents|gaba agents|mesh-ancestor
6219918|NCT02310568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6219919|NCT02310568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219920|NCT02310568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219921|NCT02310581|Buprenorphine|buprenorphine|mesh-list
6219922|NCT02310581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6219923|NCT02310581|Narcotics|narcotics|mesh-ancestor
6219924|NCT02310581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6219925|NCT02310581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219926|NCT02310581|Analgesics|analgesics|mesh-ancestor
6219927|NCT02310581|Sensory System Agents|sensory system agents|mesh-ancestor
6219928|NCT02310581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6219929|NCT02310581|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6219930|NCT02310672|Macitentan|macitentan|mesh-list
6219931|NCT02310672|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
6219932|NCT02310672|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6219933|NCT02310672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219934|NCT02310672|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
6219935|NCT02310750|PF-06700841|pf-06700841|mesh-list
6219936|NCT02310750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6219937|NCT02310750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6219938|NCT02310750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219939|NCT02310789|Ivacaftor|ivacaftor|mesh-list
6219940|NCT02310789|Pilocarpine|pilocarpine|mesh-list
6219941|NCT02310789|Adrenergic Agents|adrenergic agents|mesh-list
6219942|NCT02310789|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6219943|NCT02310789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6219944|NCT02310789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219945|NCT02310789|Miotics|miotics|mesh-ancestor
6219946|NCT02310789|Autonomic Agents|autonomic agents|mesh-ancestor
6219947|NCT02310789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6244255|NCT02691507|Decanoic acid|decanoic acid|mesh-list
6219948|NCT02310789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219949|NCT02310789|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6219950|NCT02310789|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6219951|NCT02310789|Cholinergic Agents|cholinergic agents|mesh-ancestor
6219952|NCT02310789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6219953|NCT02311361|Durvalumab|durvalumab|mesh-list
6219954|NCT02311361|Tremelimumab|tremelimumab|mesh-list
6219955|NCT02311361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6219956|NCT02311361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6219957|NCT02311478|Copper|copper|mesh-list
6219958|NCT02311478|Contraceptive Agents|contraceptive agents|mesh-list
6219959|NCT02311478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6219960|NCT02311478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219961|NCT02311478|Trace Elements|trace elements|mesh-ancestor
6219962|NCT02311478|Micronutrients|micronutrients|mesh-ancestor
6219963|NCT02311881|Acetaminophen|acetaminophen|mesh-list
6219964|NCT02311881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6219965|NCT02311881|Analgesics|analgesics|mesh-ancestor
6219966|NCT02311881|Sensory System Agents|sensory system agents|mesh-ancestor
6219967|NCT02311881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6219968|NCT02311881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219969|NCT02311881|Antipyretics|antipyretics|mesh-ancestor
6219970|NCT02311907|Paclitaxel|paclitaxel|mesh-list
6219971|NCT02311907|Carboplatin|carboplatin|mesh-list
6219972|NCT02311907|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6219973|NCT02311907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6219974|NCT02311907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6219975|NCT02311907|Tubulin Modulators|tubulin modulators|mesh-ancestor
6219976|NCT02311907|Antimitotic Agents|antimitotic agents|mesh-ancestor
6219977|NCT02311907|Mitosis Modulators|mitosis modulators|mesh-ancestor
6219978|NCT02311907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6219979|NCT02311933|Tamoxifen|tamoxifen|mesh-list
6219980|NCT02311933|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6219981|NCT02311933|Hormone Antagonists|hormone antagonists|mesh-ancestor
6219982|NCT02311933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6219983|NCT02311933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219984|NCT02311933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6219985|NCT02311933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6219986|NCT02311933|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6219987|NCT02311933|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6219988|NCT02311933|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6219989|NCT02312063|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6219990|NCT02312063|Glimepiride|glimepiride|mesh-list
6219991|NCT02312063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6219992|NCT02312063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6219993|NCT02312063|Incretins|incretins|mesh-ancestor
6219994|NCT02312063|Hormones|hormones|mesh-ancestor
6219995|NCT02312063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6219996|NCT02312063|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6219997|NCT02312063|Protease Inhibitors|protease inhibitors|mesh-ancestor
6219998|NCT02312063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6219999|NCT02312063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220000|NCT02312063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6220001|NCT02312063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6220002|NCT02312063|Immunologic Factors|immunologic factors|mesh-ancestor
6220003|NCT02312219|Folic Acid|folic acid|mesh-list
6220004|NCT02312219|Methotrexate|methotrexate|mesh-list
6220005|NCT02312219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6220006|NCT02312219|Abortifacient Agents|abortifacient agents|mesh-ancestor
6220007|NCT02312219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6220008|NCT02312219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220009|NCT02312219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6220010|NCT02312219|Antimetabolites|antimetabolites|mesh-ancestor
6220011|NCT02312219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220012|NCT02312219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6220013|NCT02312219|Dermatologic Agents|dermatologic agents|mesh-ancestor
6220014|NCT02312219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6220015|NCT02312219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6220016|NCT02312219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6220017|NCT02312219|Immunologic Factors|immunologic factors|mesh-ancestor
6220018|NCT02312219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6220019|NCT02312219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6220020|NCT02312219|Hematinics|hematinics|mesh-ancestor
6220021|NCT02312219|Vitamin B Complex|vitamin b complex|mesh-ancestor
6220022|NCT02312219|Vitamins|vitamins|mesh-ancestor
6220023|NCT02312219|Micronutrients|micronutrients|mesh-ancestor
6220024|NCT02312622|Irinotecan|irinotecan|mesh-list
6220025|NCT02312622|Etirinotecan pegol|etirinotecan pegol|mesh-list
6220026|NCT02312622|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6220027|NCT02312622|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6220028|NCT02312622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6220029|NCT02312622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220030|NCT02312622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6220031|NCT02312622|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6220032|NCT02312739|Ketorolac|ketorolac|mesh-list
6220033|NCT02312739|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6220034|NCT02312739|Nitrous Oxide|nitrous oxide|mesh-list
6220035|NCT02312739|Analgesics|analgesics|mesh-list
6220036|NCT02312739|Lorazepam|lorazepam|mesh-list
6220037|NCT02312739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6220038|NCT02312739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6220039|NCT02312739|Sensory System Agents|sensory system agents|mesh-ancestor
6220040|NCT02312739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6220041|NCT02312739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220042|NCT02312739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6220043|NCT02312739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6220044|NCT02312739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6220045|NCT02312739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6220046|NCT02312739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220047|NCT02312739|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6220048|NCT02312739|Anesthetics, General|anesthetics, general|mesh-ancestor
6220049|NCT02312739|Anesthetics|anesthetics|mesh-ancestor
6220050|NCT02312739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6220051|NCT02312739|Anticonvulsants|anticonvulsants|mesh-ancestor
6220052|NCT02312739|Antiemetics|antiemetics|mesh-ancestor
6220053|NCT02312739|Autonomic Agents|autonomic agents|mesh-ancestor
6220054|NCT02312739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6220055|NCT02312739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6220056|NCT02312739|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6220057|NCT02312739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6498179|NCT00636311|Tubulin Modulators|tubulin modulators|mesh-ancestor
6498180|NCT00636311|Antimitotic Agents|antimitotic agents|mesh-ancestor
6498181|NCT00636311|Mitosis Modulators|mitosis modulators|mesh-ancestor
6498182|NCT00636311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6498183|NCT00636311|Alkylating Agents|alkylating agents|mesh-ancestor
6498184|NCT00636415|Morphine|morphine|mesh-list
6498185|NCT00636415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6498186|NCT00636415|Narcotics|narcotics|mesh-ancestor
6498187|NCT00636415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6498188|NCT00636415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498189|NCT00636415|Analgesics|analgesics|mesh-ancestor
6498190|NCT00636415|Sensory System Agents|sensory system agents|mesh-ancestor
6498191|NCT00636415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6498192|NCT00636428|Midazolam|midazolam|mesh-list
6498193|NCT00636428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6498194|NCT00636428|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6498195|NCT00636428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6498196|NCT00636428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703375|NCT03331523|Betamethasone Valerate|betamethasone valerate|mesh-list
5703376|NCT03331523|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5703377|NCT03331523|Betamethasone benzoate|betamethasone benzoate|mesh-list
6498197|NCT00636428|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6498198|NCT00636428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6498199|NCT00636428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6498200|NCT00636428|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6498201|NCT00636428|Anesthetics, General|anesthetics, general|mesh-ancestor
6498202|NCT00636428|Anesthetics|anesthetics|mesh-ancestor
6498203|NCT00636428|GABA Modulators|gaba modulators|mesh-ancestor
6498204|NCT00636428|GABA Agents|gaba agents|mesh-ancestor
6498205|NCT00636428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6498206|NCT00636428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498207|NCT00636493|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
6498208|NCT00636493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6498209|NCT00636493|Glucocorticoids|glucocorticoids|mesh-ancestor
6498210|NCT00636493|Hormones|hormones|mesh-ancestor
6498211|NCT00636493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6498212|NCT00636493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498213|NCT00636519|Antitoxins|antitoxins|mesh-list
5703378|NCT03331523|Calcipotriene|calcipotriene|mesh-list
6220058|NCT02312739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6220059|NCT02312739|GABA Modulators|gaba modulators|mesh-ancestor
6498214|NCT00636519|Botulinum Antitoxin|botulinum antitoxin|mesh-list
6498215|NCT00636519|Immunologic Factors|immunologic factors|mesh-ancestor
6220060|NCT02312739|GABA Agents|gaba agents|mesh-ancestor
6220061|NCT02312739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6220062|NCT02312882|Tofacitinib|tofacitinib|mesh-list
6220063|NCT02312882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6220064|NCT02312882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6220065|NCT02312882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220066|NCT02312934|Nicotine|nicotine|mesh-list
6220067|NCT02312934|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6220068|NCT02312934|Autonomic Agents|autonomic agents|mesh-ancestor
6220069|NCT02312934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6220070|NCT02312934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220071|NCT02312934|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6220072|NCT02312934|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6220073|NCT02312934|Cholinergic Agents|cholinergic agents|mesh-ancestor
6220074|NCT02312934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6220075|NCT02312934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703379|NCT03331523|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
5703380|NCT03331523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5703381|NCT03331523|Glucocorticoids|glucocorticoids|mesh-ancestor
5703382|NCT03331523|Hormones|hormones|mesh-ancestor
5703383|NCT03331523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5703384|NCT03331523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703385|NCT03331523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5703386|NCT03331523|Respiratory System Agents|respiratory system agents|mesh-ancestor
5703387|NCT03331523|Dermatologic Agents|dermatologic agents|mesh-ancestor
5703388|NCT03331484|Rivaroxaban|rivaroxaban|mesh-list
6220076|NCT02313675|Acetaminophen|acetaminophen|mesh-list
6220077|NCT02313675|Ketorolac|ketorolac|mesh-list
6220078|NCT02313675|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6220079|NCT02313675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6220080|NCT02313675|Analgesics|analgesics|mesh-ancestor
6220081|NCT02313675|Sensory System Agents|sensory system agents|mesh-ancestor
6220082|NCT02313675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6220083|NCT02313675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220084|NCT02313675|Antipyretics|antipyretics|mesh-ancestor
6220085|NCT02313675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6220086|NCT02313675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6220087|NCT02313675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6220088|NCT02313675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6220089|NCT02313675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6220090|NCT02313675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220091|NCT02313909|Aspirin|aspirin|mesh-list
6220092|NCT02313909|Rivaroxaban|rivaroxaban|mesh-list
6220093|NCT02313909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6220094|NCT02313909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6220095|NCT02313909|Analgesics|analgesics|mesh-ancestor
6220096|NCT02313909|Sensory System Agents|sensory system agents|mesh-ancestor
6220097|NCT02313909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5703389|NCT03331484|Ticagrelor|ticagrelor|mesh-list
5703390|NCT03331484|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5703391|NCT03331484|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5703392|NCT03331484|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5703393|NCT03331484|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5703394|NCT03331484|Purinergic Agents|purinergic agents|mesh-ancestor
5703395|NCT03331484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5703396|NCT03331484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703397|NCT03331484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703398|NCT03331484|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6220098|NCT02313909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220099|NCT02313909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6220100|NCT02313909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6220101|NCT02313909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6220102|NCT02313909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6220103|NCT02313909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220104|NCT02313909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6220105|NCT02313909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6220106|NCT02313909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6220107|NCT02313909|Antipyretics|antipyretics|mesh-ancestor
6220108|NCT02313909|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6220109|NCT02313909|Antithrombins|antithrombins|mesh-ancestor
6220110|NCT02313909|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6220111|NCT02313909|Protease Inhibitors|protease inhibitors|mesh-ancestor
6220112|NCT02313909|Anticoagulants|anticoagulants|mesh-ancestor
6220113|NCT02314104|Ropivacaine|ropivacaine|mesh-list
6220114|NCT02314104|Anesthetics, Local|anesthetics, local|mesh-ancestor
6220115|NCT02314104|Anesthetics|anesthetics|mesh-ancestor
6220116|NCT02314104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6220117|NCT02314104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220118|NCT02314104|Sensory System Agents|sensory system agents|mesh-ancestor
6220119|NCT02314104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6220120|NCT02314117|Fluorouracil|fluorouracil|mesh-list
6220121|NCT02314117|Capecitabine|capecitabine|mesh-list
6220122|NCT02314117|Ramucirumab|ramucirumab|mesh-list
6220123|NCT02314117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6220124|NCT02314117|Antimetabolites|antimetabolites|mesh-ancestor
6220125|NCT02314117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220126|NCT02314117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6220127|NCT02314117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6220128|NCT02314117|Immunologic Factors|immunologic factors|mesh-ancestor
6220129|NCT02314117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220130|NCT02314143|Trametinib|trametinib|mesh-list
6220131|NCT02314143|Dabrafenib|dabrafenib|mesh-list
6220132|NCT02314143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6220133|NCT02314143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6220134|NCT02314143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6220135|NCT02314143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220136|NCT02314403|Rituximab|rituximab|mesh-list
6220137|NCT02314403|Abatacept|abatacept|mesh-list
6220138|NCT02314403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6220139|NCT02314403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6220140|NCT02314403|Immunologic Factors|immunologic factors|mesh-ancestor
6220141|NCT02314403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703399|NCT03331484|Antithrombins|antithrombins|mesh-ancestor
5703400|NCT03331484|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5703401|NCT03331484|Protease Inhibitors|protease inhibitors|mesh-ancestor
5703402|NCT03331484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5703403|NCT03331484|Anticoagulants|anticoagulants|mesh-ancestor
6220142|NCT02314403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6220143|NCT02314403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6220144|NCT02314403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220145|NCT02314403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6220146|NCT02314546|Lidocaine|lidocaine|mesh-list
6220147|NCT02314546|Midazolam|midazolam|mesh-list
6220148|NCT02314546|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6220149|NCT02314546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6220150|NCT02314546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6220151|NCT02314546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220152|NCT02314546|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6220153|NCT02314546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6220154|NCT02314546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6220155|NCT02314546|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6220156|NCT02314546|Anesthetics, General|anesthetics, general|mesh-ancestor
6220157|NCT02314546|Anesthetics|anesthetics|mesh-ancestor
6220158|NCT02314546|GABA Modulators|gaba modulators|mesh-ancestor
6220159|NCT02314546|GABA Agents|gaba agents|mesh-ancestor
6220160|NCT02314546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6220161|NCT02314546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220162|NCT02314546|Anesthetics, Local|anesthetics, local|mesh-ancestor
6220163|NCT02314546|Sensory System Agents|sensory system agents|mesh-ancestor
6220164|NCT02314546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6220165|NCT02314546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6220166|NCT02314546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6220167|NCT02314546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6220168|NCT02314546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6220169|NCT02314728|Misoprostol|misoprostol|mesh-list
6220170|NCT02314728|Oxytocin|oxytocin|mesh-list
6220171|NCT02314728|Oxytocics|oxytocics|mesh-ancestor
6220172|NCT02314728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6220173|NCT02314728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220174|NCT02314728|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6220175|NCT02314728|Abortifacient Agents|abortifacient agents|mesh-ancestor
6220176|NCT02314728|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6220177|NCT02314728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6220178|NCT02315534|Temozolomide|temozolomide|mesh-list
6220179|NCT02315534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6220180|NCT02315534|Alkylating Agents|alkylating agents|mesh-ancestor
6220181|NCT02315534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220182|NCT02315534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6220183|NCT02315625|Everolimus|everolimus|mesh-list
6220184|NCT02315625|Sunitinib|sunitinib|mesh-list
6220185|NCT02315625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6220186|NCT02315625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6220187|NCT02315625|Immunologic Factors|immunologic factors|mesh-ancestor
6220188|NCT02315625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220189|NCT02315625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6220190|NCT02315625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6220191|NCT02315625|Growth Substances|growth substances|mesh-ancestor
6220192|NCT02315625|Growth Inhibitors|growth inhibitors|mesh-ancestor
6220193|NCT02315625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6220194|NCT02315625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6220195|NCT02315625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220196|NCT02315872|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6220197|NCT02315872|Hormones|hormones|mesh-ancestor
6220198|NCT02315872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6220199|NCT02315872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243242|NCT02662569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6243243|NCT02662569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6243244|NCT02662764|Sufentanil|sufentanil|mesh-list
6243245|NCT02662764|Dsuvia|dsuvia|mesh-list
6243246|NCT02662764|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6243247|NCT02662764|Narcotics|narcotics|mesh-ancestor
6243248|NCT02662764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6243249|NCT02662764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243250|NCT02662764|Analgesics|analgesics|mesh-ancestor
6243251|NCT02662764|Sensory System Agents|sensory system agents|mesh-ancestor
6243252|NCT02662764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6243253|NCT02662764|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6243254|NCT02662764|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6243255|NCT02662764|Anesthetics, General|anesthetics, general|mesh-ancestor
6243256|NCT02662764|Anesthetics|anesthetics|mesh-ancestor
6243257|NCT02663453|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6243258|NCT02663453|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6243259|NCT02663453|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6243260|NCT02663453|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6243261|NCT02663674|Fluconazole|fluconazole|mesh-list
6243262|NCT02663674|Antifungal Agents|antifungal agents|mesh-ancestor
6243263|NCT02663674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6243264|NCT02663674|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6243265|NCT02663674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6243266|NCT02663674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6498216|NCT00636519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498217|NCT00636545|Oblimersen|oblimersen|mesh-list
6498218|NCT00636545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6498219|NCT00636584|Nitroprusside|nitroprusside|mesh-list
6498220|NCT00636584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6498221|NCT00636584|Vasodilator Agents|vasodilator agents|mesh-ancestor
6498222|NCT00636584|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6498223|NCT00636584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498224|NCT00636740|Zoledronic Acid|zoledronic acid|mesh-list
6498225|NCT00636740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6498226|NCT00636740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498227|NCT00636766|Metformin|metformin|mesh-list
6498228|NCT00636766|Rosiglitazone|rosiglitazone|mesh-list
6498229|NCT00636766|Rimonabant|rimonabant|mesh-list
6498230|NCT00636766|Atorvastatin|atorvastatin|mesh-list
6498231|NCT00636766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6498232|NCT00636766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498233|NCT00636766|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6498234|NCT00636766|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6498235|NCT00636766|Antimetabolites|antimetabolites|mesh-ancestor
6498236|NCT00636766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498237|NCT00636766|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6498238|NCT00636766|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6498239|NCT00636766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6498240|NCT00636766|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6498241|NCT00636766|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
6498242|NCT00636766|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6498243|NCT00636766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6498244|NCT00636766|Hormones|hormones|mesh-ancestor
6498245|NCT00636766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6498246|NCT00636831|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6498247|NCT00636831|Cefazolin|cefazolin|mesh-list
6498248|NCT00636831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6498249|NCT00636870|Fexofenadine|fexofenadine|mesh-list
6498250|NCT00636870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6524506|NCT00758407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6220200|NCT02316002|Pembrolizumab|pembrolizumab|mesh-list
6220201|NCT02316002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6220202|NCT02316002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6220203|NCT02316171|Mitomycins|mitomycins|mesh-list
6220204|NCT02316171|Mitomycin|mitomycin|mesh-list
6220205|NCT02316171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6220206|NCT02316171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6220207|NCT02316171|Alkylating Agents|alkylating agents|mesh-ancestor
6220208|NCT02316171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220209|NCT02316171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6220210|NCT02316171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6220211|NCT02316353|Complement C1s|complement c1s|mesh-list
6220212|NCT02316353|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
6220213|NCT02316353|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
6220214|NCT02316353|Immunologic Factors|immunologic factors|mesh-ancestor
6220215|NCT02316353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220216|NCT02316353|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6220217|NCT02316353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6220218|NCT02316613|Rituximab|rituximab|mesh-list
6220219|NCT02316613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6220220|NCT02316613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6220221|NCT02316613|Immunologic Factors|immunologic factors|mesh-ancestor
6220222|NCT02316613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220223|NCT02316613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6220224|NCT02316847|Diazepam|diazepam|mesh-list
6220225|NCT02316847|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6220226|NCT02316847|Anticonvulsants|anticonvulsants|mesh-ancestor
6220227|NCT02316847|Antiemetics|antiemetics|mesh-ancestor
6220228|NCT02316847|Autonomic Agents|autonomic agents|mesh-ancestor
6220229|NCT02316847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6220230|NCT02316847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220231|NCT02316847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6220232|NCT02316847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6220233|NCT02316847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6220234|NCT02316847|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6220235|NCT02316847|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6220236|NCT02316847|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6220237|NCT02316847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6220238|NCT02316847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6220239|NCT02316847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6220240|NCT02316847|Anesthetics, General|anesthetics, general|mesh-ancestor
6220241|NCT02316847|Anesthetics|anesthetics|mesh-ancestor
6220242|NCT02316847|GABA Modulators|gaba modulators|mesh-ancestor
6220243|NCT02316847|GABA Agents|gaba agents|mesh-ancestor
6220244|NCT02316847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6220245|NCT02316847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220246|NCT02317016|Osimertinib|osimertinib|mesh-list
6220247|NCT02317016|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6220248|NCT02317016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6220249|NCT02317016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6220250|NCT02317016|Antimetabolites|antimetabolites|mesh-ancestor
6220251|NCT02317016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220252|NCT02317016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6220253|NCT02317016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6220254|NCT02317016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6220255|NCT02317016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6220256|NCT02317016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6220257|NCT02317510|Anesthetics|anesthetics|mesh-list
6220258|NCT02317510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6220259|NCT02317510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220260|NCT02317549|Tranexamic Acid|tranexamic acid|mesh-list
6220261|NCT02317549|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6220262|NCT02317549|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6220263|NCT02317549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220264|NCT02317549|Hemostatics|hemostatics|mesh-ancestor
6220265|NCT02317549|Coagulants|coagulants|mesh-ancestor
6220266|NCT02317575|Insulin Lispro|insulin lispro|mesh-list
6220267|NCT02317575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6220268|NCT02317575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220269|NCT02317744|Naltrexone|naltrexone|mesh-list
6220270|NCT02317744|Bupropion|bupropion|mesh-list
6220271|NCT02317744|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6220272|NCT02317744|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6220273|NCT02317744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220274|NCT02317744|Sensory System Agents|sensory system agents|mesh-ancestor
6220275|NCT02317744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5703404|NCT03331445|Nitric Oxide|nitric oxide|mesh-list
5703405|NCT03331445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5703406|NCT03331445|Autonomic Agents|autonomic agents|mesh-ancestor
5703407|NCT03331445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5703408|NCT03331445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703409|NCT03331445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5703410|NCT03331445|Respiratory System Agents|respiratory system agents|mesh-ancestor
5703411|NCT03331445|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5703412|NCT03331445|Antioxidants|antioxidants|mesh-ancestor
5703413|NCT03331445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703414|NCT03331445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5703415|NCT03331445|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5703416|NCT03331445|Vasodilator Agents|vasodilator agents|mesh-ancestor
5703417|NCT03331445|Gasotransmitters|gasotransmitters|mesh-ancestor
5703418|NCT03331445|Protective Agents|protective agents|mesh-ancestor
5703419|NCT03331432|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
5703420|NCT03331432|Antiviral Agents|antiviral agents|mesh-ancestor
5703421|NCT03331432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5703422|NCT03331432|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5703423|NCT03331432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6220276|NCT02317744|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6220277|NCT02317744|Antidepressive Agents|antidepressive agents|mesh-ancestor
6220278|NCT02317744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6220279|NCT02317744|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6220280|NCT02317744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6220281|NCT02317744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6220282|NCT02317744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220283|NCT02317744|Dopamine Agents|dopamine agents|mesh-ancestor
6220284|NCT02317744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6220285|NCT02317744|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6220286|NCT02317744|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6220287|NCT02317744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6220288|NCT02317809|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6220289|NCT02317809|Hormones|hormones|mesh-ancestor
6220290|NCT02317809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6220291|NCT02317809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220292|NCT02318095|Gemcitabine|gemcitabine|mesh-list
6220293|NCT02318095|Paclitaxel|paclitaxel|mesh-list
6220294|NCT02318095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6220295|NCT02318095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6220296|NCT02318095|Tubulin Modulators|tubulin modulators|mesh-ancestor
6220297|NCT02318095|Antimitotic Agents|antimitotic agents|mesh-ancestor
6220298|NCT02318095|Mitosis Modulators|mitosis modulators|mesh-ancestor
6220299|NCT02318095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220300|NCT02318095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6220301|NCT02318095|Antimetabolites|antimetabolites|mesh-ancestor
6220302|NCT02318095|Antiviral Agents|antiviral agents|mesh-ancestor
6220303|NCT02318095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6220304|NCT02318095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6220305|NCT02318095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6220306|NCT02318095|Immunologic Factors|immunologic factors|mesh-ancestor
6220307|NCT02318095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220308|NCT02318303|Mometasone Furoate|mometasone furoate|mesh-list
6220309|NCT02318303|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
6220310|NCT02318303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6220311|NCT02318303|Dermatologic Agents|dermatologic agents|mesh-ancestor
6220312|NCT02318303|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6220313|NCT02318303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6220314|NCT02318303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6220315|NCT02318303|Analgesics|analgesics|mesh-ancestor
6220316|NCT02318303|Sensory System Agents|sensory system agents|mesh-ancestor
6220317|NCT02318303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6220318|NCT02318303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220319|NCT02318303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6220320|NCT02318303|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6220321|NCT02318303|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6220322|NCT02318303|Histamine Antagonists|histamine antagonists|mesh-ancestor
6220323|NCT02318303|Histamine Agents|histamine agents|mesh-ancestor
6220324|NCT02318303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6220325|NCT02318303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220326|NCT02318368|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5703424|NCT03331302|Xenon|xenon|mesh-list
5703425|NCT03331302|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6220327|NCT02318368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6220328|NCT02318368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6220329|NCT02318368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6220330|NCT02318368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220331|NCT02318602|Cannabidiol|cannabidiol|mesh-list
6220332|NCT02318602|Anticonvulsants|anticonvulsants|mesh-ancestor
6220333|NCT02318667|Golimumab|golimumab|mesh-list
6220334|NCT02318667|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6220335|NCT02318667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6220336|NCT02318667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6220337|NCT02318667|Immunologic Factors|immunologic factors|mesh-ancestor
6220338|NCT02318667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220339|NCT02318693|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6220340|NCT02318693|Glyburide|glyburide|mesh-list
6220341|NCT02318693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6220342|NCT02318693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220343|NCT02318693|Incretins|incretins|mesh-ancestor
6220344|NCT02318693|Hormones|hormones|mesh-ancestor
6220345|NCT02318693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6220346|NCT02318693|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6220347|NCT02318693|Protease Inhibitors|protease inhibitors|mesh-ancestor
6220348|NCT02318693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6220349|NCT02318693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220350|NCT02319031|Ribavirin|ribavirin|mesh-list
6220351|NCT02319031|Sofosbuvir|sofosbuvir|mesh-list
6220352|NCT02319031|Antimetabolites|antimetabolites|mesh-ancestor
6220353|NCT02319031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220354|NCT02319031|Antiviral Agents|antiviral agents|mesh-ancestor
6220355|NCT02319031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6498251|NCT00636870|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6498252|NCT00636870|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6498253|NCT00636870|Histamine Antagonists|histamine antagonists|mesh-ancestor
6498254|NCT00636870|Histamine Agents|histamine agents|mesh-ancestor
6498255|NCT00636870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6498256|NCT00636870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498257|NCT00636870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498258|NCT00636883|Gemcitabine|gemcitabine|mesh-list
6498259|NCT00636883|Oxaliplatin|oxaliplatin|mesh-list
6498260|NCT00636883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6498261|NCT00636883|Antimetabolites|antimetabolites|mesh-ancestor
6498262|NCT00636883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498263|NCT00636883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6498264|NCT00636883|Antiviral Agents|antiviral agents|mesh-ancestor
6498265|NCT00636883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6498266|NCT00636883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6498267|NCT00636883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6498268|NCT00636883|Immunologic Factors|immunologic factors|mesh-ancestor
6498269|NCT00636883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498270|NCT00636896|Olanzapine|olanzapine|mesh-list
6498271|NCT00636896|Modafinil|modafinil|mesh-list
6498272|NCT00636896|Antiemetics|antiemetics|mesh-ancestor
6498273|NCT00636896|Autonomic Agents|autonomic agents|mesh-ancestor
6498274|NCT00636896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6498275|NCT00636896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498276|NCT00636896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6498277|NCT00636896|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6498278|NCT00636896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6498279|NCT00636896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6498280|NCT00636896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6498281|NCT00636896|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6498282|NCT00636896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6498283|NCT00636896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6498284|NCT00636896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498285|NCT00636896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6498286|NCT00636896|Serotonin Agents|serotonin agents|mesh-ancestor
6498287|NCT00636896|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6498288|NCT00636896|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6498289|NCT00636896|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6498290|NCT00636896|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6498291|NCT00636909|Cyclosporine|cyclosporine|mesh-list
6498292|NCT00636909|Cyclophosphamide|cyclophosphamide|mesh-list
6498293|NCT00636909|Methotrexate|methotrexate|mesh-list
6498294|NCT00636909|Fludarabine|fludarabine|mesh-list
6498295|NCT00636909|Cyclosporins|cyclosporins|mesh-list
6220356|NCT02319044|Durvalumab|durvalumab|mesh-list
6220357|NCT02319044|Tremelimumab|tremelimumab|mesh-list
5703426|NCT03331302|Anesthetics, General|anesthetics, general|mesh-ancestor
5703427|NCT03331302|Anesthetics|anesthetics|mesh-ancestor
5703428|NCT03331302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5703429|NCT03331302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703430|NCT03331263|Chlorhexidine|chlorhexidine|mesh-list
5703431|NCT03331263|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5703432|NCT03331263|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5703433|NCT03331263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5703434|NCT03331263|Disinfectants|disinfectants|mesh-ancestor
5703435|NCT03331263|Dermatologic Agents|dermatologic agents|mesh-ancestor
5703436|NCT03331211|Dasatinib|dasatinib|mesh-list
5703437|NCT03331211|Ponatinib|ponatinib|mesh-list
5703438|NCT03331211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5703439|NCT03331211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5703440|NCT03331211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5703441|NCT03331211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703442|NCT03330990|Midazolam|midazolam|mesh-list
5703443|NCT03330990|Entrectinib|entrectinib|mesh-list
6220358|NCT02319044|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6220359|NCT02319044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6220360|NCT02319044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6220361|NCT02319044|Immunologic Factors|immunologic factors|mesh-ancestor
6220362|NCT02319044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220363|NCT02319148|Itraconazole|itraconazole|mesh-list
6220364|NCT02319148|Verapamil|verapamil|mesh-list
6220365|NCT02319148|Diltiazem|diltiazem|mesh-list
6220366|NCT02319148|Antifungal Agents|antifungal agents|mesh-ancestor
6220367|NCT02319148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6220368|NCT02319148|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6220369|NCT02319148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6220370|NCT02319148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6220371|NCT02319148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220372|NCT02319148|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6220373|NCT02319148|Hormone Antagonists|hormone antagonists|mesh-ancestor
6220374|NCT02319148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6220375|NCT02319148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220376|NCT02319148|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6220377|NCT02319148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6220378|NCT02319148|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6220379|NCT02319148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6220380|NCT02319148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6220381|NCT02319148|Vasodilator Agents|vasodilator agents|mesh-ancestor
6220382|NCT02319148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6220383|NCT02319304|Leucovorin|leucovorin|mesh-list
6220384|NCT02319304|Fluorouracil|fluorouracil|mesh-list
6220385|NCT02319304|Oxaliplatin|oxaliplatin|mesh-list
6220386|NCT02319304|Antimetabolites|antimetabolites|mesh-ancestor
6220387|NCT02319304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220388|NCT02319304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6220389|NCT02319304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6220390|NCT02319304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6220391|NCT02319304|Immunologic Factors|immunologic factors|mesh-ancestor
6220392|NCT02319304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220393|NCT02319304|Antidotes|antidotes|mesh-ancestor
6220394|NCT02319304|Protective Agents|protective agents|mesh-ancestor
6220395|NCT02319304|Vitamin B Complex|vitamin b complex|mesh-ancestor
6220396|NCT02319304|Vitamins|vitamins|mesh-ancestor
6220397|NCT02319304|Micronutrients|micronutrients|mesh-ancestor
6220398|NCT02319369|Azacitidine|azacitidine|mesh-list
6220399|NCT02319369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6220400|NCT02319369|Antimetabolites|antimetabolites|mesh-ancestor
6220401|NCT02319369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220402|NCT02319369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6220403|NCT02319369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6220404|NCT02319486|Carboplatin|carboplatin|mesh-list
6220405|NCT02319486|Etoposide|etoposide|mesh-list
6220406|NCT02319486|Vincristine|vincristine|mesh-list
6220407|NCT02319486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6220408|NCT02319486|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6220409|NCT02319486|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6220410|NCT02319486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6220411|NCT02319486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5703444|NCT03330990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5703445|NCT03330990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6244256|NCT02691507|Antifungal Agents|antifungal agents|mesh-ancestor
5703446|NCT03330990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6220412|NCT02319486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703447|NCT03330990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703448|NCT03330990|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5703449|NCT03330990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5703450|NCT03330990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5703451|NCT03330990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5703452|NCT03330990|Anesthetics, General|anesthetics, general|mesh-ancestor
5703453|NCT03330990|Anesthetics|anesthetics|mesh-ancestor
5703454|NCT03330990|GABA Modulators|gaba modulators|mesh-ancestor
5703455|NCT03330990|GABA Agents|gaba agents|mesh-ancestor
5703456|NCT03330990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5703457|NCT03330990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703458|NCT03330990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5703459|NCT03330990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5703460|NCT03330886|Atezolizumab|atezolizumab|mesh-list
6220413|NCT02319486|Tubulin Modulators|tubulin modulators|mesh-ancestor
6220414|NCT02319486|Antimitotic Agents|antimitotic agents|mesh-ancestor
6220415|NCT02319486|Mitosis Modulators|mitosis modulators|mesh-ancestor
6220416|NCT02319642|Certolizumab Pegol|certolizumab pegol|mesh-list
6220417|NCT02319642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6220418|NCT02319642|Immunologic Factors|immunologic factors|mesh-ancestor
6220419|NCT02319642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220420|NCT02319642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6220421|NCT02319668|Chlorhexidine|chlorhexidine|mesh-list
6220422|NCT02319668|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6220423|NCT02319668|Listerine|listerine|mesh-list
6220424|NCT02319668|Fluorides|fluorides|mesh-list
6220425|NCT02319668|Sodium Fluoride|sodium fluoride|mesh-list
6220426|NCT02319668|Cariostatic Agents|cariostatic agents|mesh-ancestor
6220427|NCT02319668|Protective Agents|protective agents|mesh-ancestor
6220428|NCT02319668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220429|NCT02319668|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6220430|NCT02319668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6220431|NCT02319668|Disinfectants|disinfectants|mesh-ancestor
6220432|NCT02319668|Dermatologic Agents|dermatologic agents|mesh-ancestor
6220433|NCT02319759|Ustekinumab|ustekinumab|mesh-list
6220434|NCT02319759|Dermatologic Agents|dermatologic agents|mesh-ancestor
6220435|NCT02320058|Nivolumab|nivolumab|mesh-list
6220436|NCT02320058|Ipilimumab|ipilimumab|mesh-list
6220437|NCT02320058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6220438|NCT02320058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6220439|NCT02320058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6220440|NCT02320058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220441|NCT02320149|Sarecycline|sarecycline|mesh-list
6220442|NCT02320149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6220443|NCT02320149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6220444|NCT02320149|Dermatologic Agents|dermatologic agents|mesh-ancestor
6220445|NCT02320487|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6220446|NCT02320487|Obinutuzumab|obinutuzumab|mesh-list
6220447|NCT02320487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6220448|NCT02320487|Alkylating Agents|alkylating agents|mesh-ancestor
6220449|NCT02320487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220450|NCT02320487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6220451|NCT02320487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6220452|NCT02320695|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6220453|NCT02320695|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
6220454|NCT02320695|Bacitracin|bacitracin|mesh-list
6220455|NCT02320695|Neomycin|neomycin|mesh-list
6220456|NCT02320695|Polymyxin B|polymyxin b|mesh-list
6220457|NCT02320695|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6220458|NCT02320695|Ethanol|ethanol|mesh-list
6220459|NCT02320695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6220460|NCT02320695|Antitubercular Agents|antitubercular agents|mesh-ancestor
6220461|NCT02320695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6220462|NCT02320695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6220463|NCT02320695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220464|NCT02320695|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6220465|NCT02320695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6220466|NCT02320695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220467|NCT02320721|Insulin|insulin|mesh-list
6220468|NCT02320721|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6220469|NCT02320721|Insulin Glargine|insulin glargine|mesh-list
6220470|NCT02320721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6220471|NCT02320721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220472|NCT02321098|Amorolfine|amorolfine|mesh-list
5703461|NCT03330886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6220473|NCT02321098|Antifungal Agents|antifungal agents|mesh-ancestor
6220474|NCT02321098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6220475|NCT02321319|Hydromorphone|hydromorphone|mesh-list
6220476|NCT02321319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6220477|NCT02321319|Narcotics|narcotics|mesh-ancestor
6220478|NCT02321319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6220479|NCT02321319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220480|NCT02321319|Analgesics|analgesics|mesh-ancestor
6220481|NCT02321319|Sensory System Agents|sensory system agents|mesh-ancestor
6220482|NCT02321319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6220483|NCT02321436|Botulinum Toxins|botulinum toxins|mesh-list
6220484|NCT02321436|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6220485|NCT02321436|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6220486|NCT02321436|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6220487|NCT02321436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6220488|NCT02321436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220489|NCT02321436|Cholinergic Agents|cholinergic agents|mesh-ancestor
6220490|NCT02321436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6220491|NCT02321436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220492|NCT02321436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6220493|NCT02321436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6220494|NCT02321748|Montelukast|montelukast|mesh-list
6220495|NCT02321748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6220496|NCT02321748|Respiratory System Agents|respiratory system agents|mesh-ancestor
6220497|NCT02321748|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6220498|NCT02321748|Hormone Antagonists|hormone antagonists|mesh-ancestor
6220499|NCT02321748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6220500|NCT02321748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220501|NCT02321748|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6220502|NCT02321748|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6220503|NCT02321748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220504|NCT02321800|Imipenem|imipenem|mesh-list
6220505|NCT02321800|Cilastatin|cilastatin|mesh-list
6220506|NCT02321800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6220507|NCT02321800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6220508|NCT02321800|Protease Inhibitors|protease inhibitors|mesh-ancestor
6220509|NCT02321800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6220510|NCT02321800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220511|NCT02321930|Tofacitinib|tofacitinib|mesh-list
6220512|NCT02321930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6220513|NCT02321930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6220514|NCT02321930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220515|NCT02322047|Prazosin|prazosin|mesh-list
6220516|NCT02322047|Naltrexone|naltrexone|mesh-list
6220517|NCT02322047|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6220518|NCT02322047|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6220519|NCT02322047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220520|NCT02322047|Sensory System Agents|sensory system agents|mesh-ancestor
6220521|NCT02322047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6220522|NCT02322047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6220523|NCT02322047|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6220524|NCT02322047|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6220525|NCT02322047|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6220526|NCT02322047|Adrenergic Agents|adrenergic agents|mesh-ancestor
6220527|NCT02322047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6220528|NCT02322047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220529|NCT02322190|Methoxsalen|methoxsalen|mesh-list
6220530|NCT02322190|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6220531|NCT02322190|Dermatologic Agents|dermatologic agents|mesh-ancestor
6220532|NCT02322216|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
6220533|NCT02322216|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6220534|NCT02322216|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6220535|NCT02322216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6220536|NCT02322216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6220537|NCT02322216|Analgesics|analgesics|mesh-ancestor
6220538|NCT02322216|Sensory System Agents|sensory system agents|mesh-ancestor
6220539|NCT02322216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6220540|NCT02322216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220541|NCT02322216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6220542|NCT02322216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6220543|NCT02322216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6220544|NCT02322216|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6220545|NCT02322216|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6220546|NCT02322216|Histamine Antagonists|histamine antagonists|mesh-ancestor
6220547|NCT02322216|Histamine Agents|histamine agents|mesh-ancestor
6220548|NCT02322216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6220549|NCT02322216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220550|NCT02322242|Dexamethasone|dexamethasone|mesh-list
6220551|NCT02322242|Dexamethasone acetate|dexamethasone acetate|mesh-list
6220552|NCT02322242|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
6220553|NCT02322242|BB 1101|bb 1101|mesh-list
6220554|NCT02322242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6220555|NCT02322242|Antiemetics|antiemetics|mesh-ancestor
6220556|NCT02322242|Autonomic Agents|autonomic agents|mesh-ancestor
6220557|NCT02322242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6220558|NCT02322242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220559|NCT02322242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6220560|NCT02322242|Glucocorticoids|glucocorticoids|mesh-ancestor
6220561|NCT02322242|Hormones|hormones|mesh-ancestor
6220562|NCT02322242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6220563|NCT02322242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6220564|NCT02322242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6220565|NCT02322242|Protease Inhibitors|protease inhibitors|mesh-ancestor
6676142|NCT01579279|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6676143|NCT01579279|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6220566|NCT02322242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6220567|NCT02322242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220568|NCT02322281|Gemcitabine|gemcitabine|mesh-list
6220569|NCT02322281|Paclitaxel|paclitaxel|mesh-list
6220570|NCT02322281|Docetaxel|docetaxel|mesh-list
6220571|NCT02322281|Pemetrexed|pemetrexed|mesh-list
6220572|NCT02322281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6220573|NCT02322281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6220574|NCT02322281|Tubulin Modulators|tubulin modulators|mesh-ancestor
6220575|NCT02322281|Antimitotic Agents|antimitotic agents|mesh-ancestor
6220576|NCT02322281|Mitosis Modulators|mitosis modulators|mesh-ancestor
6220577|NCT02322281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220578|NCT02322281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6220579|NCT02322281|Antimetabolites|antimetabolites|mesh-ancestor
6220580|NCT02322281|Antiviral Agents|antiviral agents|mesh-ancestor
6220581|NCT02322281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6220582|NCT02322281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6220583|NCT02322281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6498296|NCT00636909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6498297|NCT00636909|Immunologic Factors|immunologic factors|mesh-ancestor
6498298|NCT00636909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498299|NCT00636909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6498300|NCT00636909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6498301|NCT00636909|Alkylating Agents|alkylating agents|mesh-ancestor
6498302|NCT00636909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498303|NCT00636909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6498304|NCT00636909|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6498305|NCT00636909|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6498306|NCT00636909|Abortifacient Agents|abortifacient agents|mesh-ancestor
6498307|NCT00636909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6498308|NCT00636909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6498309|NCT00636909|Antimetabolites|antimetabolites|mesh-ancestor
6498310|NCT00636909|Dermatologic Agents|dermatologic agents|mesh-ancestor
6498311|NCT00636909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6498312|NCT00636909|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6498313|NCT00636909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6498314|NCT00636909|Antifungal Agents|antifungal agents|mesh-ancestor
6498315|NCT00636909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6498316|NCT00636909|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6498317|NCT00636922|Everolimus|everolimus|mesh-list
6498318|NCT00636922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6498319|NCT00636922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6498320|NCT00636922|Immunologic Factors|immunologic factors|mesh-ancestor
6498321|NCT00636922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498322|NCT00636935|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6498323|NCT00636935|Clindamycin|clindamycin|mesh-list
6498324|NCT00636935|Clindamycin palmitate|clindamycin palmitate|mesh-list
6498325|NCT00636935|Clindamycin phosphate|clindamycin phosphate|mesh-list
6498326|NCT00636935|Dapsone|dapsone|mesh-list
6498327|NCT00636935|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6498328|NCT00636935|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6498329|NCT00636935|Primaquine|primaquine|mesh-list
6220584|NCT02322281|Immunologic Factors|immunologic factors|mesh-ancestor
6498330|NCT00636935|Trimethoprim|trimethoprim|mesh-list
6220585|NCT02322281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220586|NCT02322281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6220587|NCT02322281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6220588|NCT02322320|Lenalidomide|lenalidomide|mesh-list
6220589|NCT02322320|Immunologic Factors|immunologic factors|mesh-ancestor
6220590|NCT02322320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220591|NCT02322320|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6220592|NCT02322320|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6220593|NCT02322320|Growth Substances|growth substances|mesh-ancestor
6220594|NCT02322320|Growth Inhibitors|growth inhibitors|mesh-ancestor
6220595|NCT02322320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6220596|NCT02322528|Loteprednol Etabonate|loteprednol etabonate|mesh-list
6220597|NCT02322528|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6220598|NCT02322710|Petrolatum|petrolatum|mesh-list
6220599|NCT02322710|Emollients|emollients|mesh-ancestor
6220600|NCT02322710|Dermatologic Agents|dermatologic agents|mesh-ancestor
6220601|NCT02322775|Benralizumab|benralizumab|mesh-list
6220602|NCT02322775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6220603|NCT02322775|Respiratory System Agents|respiratory system agents|mesh-ancestor
6220604|NCT02322788|Terbutaline|terbutaline|mesh-list
6220605|NCT02322788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5703462|NCT03330860|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
5703463|NCT03330860|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
5703464|NCT03330860|beta-Endorphin|beta-endorphin|mesh-list
5703465|NCT03330860|Hormones|hormones|mesh-ancestor
5703466|NCT03330860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5703467|NCT03330860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703468|NCT03330860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5703469|NCT03330860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703470|NCT03330808|Anesthetics|anesthetics|mesh-list
5703471|NCT03330808|Ropivacaine|ropivacaine|mesh-list
5703472|NCT03330808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5703473|NCT03330808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703474|NCT03330808|Anesthetics, Local|anesthetics, local|mesh-ancestor
5703475|NCT03330808|Sensory System Agents|sensory system agents|mesh-ancestor
5703476|NCT03330808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5703477|NCT03330782|Remifentanil|remifentanil|mesh-list
5703478|NCT03330782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5703479|NCT03330782|Narcotics|narcotics|mesh-ancestor
5703480|NCT03330782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5703481|NCT03330782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703482|NCT03330782|Analgesics|analgesics|mesh-ancestor
5703483|NCT03330782|Sensory System Agents|sensory system agents|mesh-ancestor
5703484|NCT03330782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5703485|NCT03330769|Antirheumatic Agents|antirheumatic agents|mesh-list
5703486|NCT03330717|Anesthetics|anesthetics|mesh-list
5703487|NCT03330717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5703488|NCT03330717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703489|NCT03330639|Capsaicin|capsaicin|mesh-list
5703490|NCT03330639|Antipruritics|antipruritics|mesh-ancestor
5703491|NCT03330639|Dermatologic Agents|dermatologic agents|mesh-ancestor
5703492|NCT03330639|Sensory System Agents|sensory system agents|mesh-ancestor
5703493|NCT03330639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5703494|NCT03330639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703495|NCT03330613|Anesthetics|anesthetics|mesh-list
5703496|NCT03330613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5703497|NCT03330613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703498|NCT03330249|Cisplatin|cisplatin|mesh-list
5703499|NCT03330249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5703500|NCT03330223|Clopidogrel|clopidogrel|mesh-list
5703501|NCT03330223|Ticagrelor|ticagrelor|mesh-list
5703502|NCT03330223|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6220606|NCT02322788|Autonomic Agents|autonomic agents|mesh-ancestor
6220607|NCT02322788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6220608|NCT02322788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220609|NCT02322788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6220610|NCT02322788|Respiratory System Agents|respiratory system agents|mesh-ancestor
6220611|NCT02322788|Sympathomimetics|sympathomimetics|mesh-ancestor
6220612|NCT02322788|Tocolytic Agents|tocolytic agents|mesh-ancestor
6220613|NCT02322788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6220614|NCT02322788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6220615|NCT02322788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6220616|NCT02322788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6220617|NCT02322788|Adrenergic Agents|adrenergic agents|mesh-ancestor
6220618|NCT02322788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6244257|NCT02691507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6220619|NCT02322788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220620|NCT02322814|Paclitaxel|paclitaxel|mesh-list
6220621|NCT02322814|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6220622|NCT02322814|Atezolizumab|atezolizumab|mesh-list
6220623|NCT02322814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6220624|NCT02322814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6220625|NCT02322814|Tubulin Modulators|tubulin modulators|mesh-ancestor
6220626|NCT02322814|Antimitotic Agents|antimitotic agents|mesh-ancestor
6220627|NCT02322814|Mitosis Modulators|mitosis modulators|mesh-ancestor
6220628|NCT02322814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220629|NCT02322866|Sarecycline|sarecycline|mesh-list
6220630|NCT02322866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6220631|NCT02322866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6220632|NCT02322866|Dermatologic Agents|dermatologic agents|mesh-ancestor
6220633|NCT02322892|Thiamine|thiamine|mesh-list
6220634|NCT02322892|Vitamins|vitamins|mesh-ancestor
6220635|NCT02322892|Micronutrients|micronutrients|mesh-ancestor
6220636|NCT02322892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220637|NCT02322892|Vitamin B Complex|vitamin b complex|mesh-ancestor
6220638|NCT02323048|Methamphetamine|methamphetamine|mesh-list
6220639|NCT02323048|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6220640|NCT02323048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220641|NCT02323048|Sympathomimetics|sympathomimetics|mesh-ancestor
6220642|NCT02323048|Autonomic Agents|autonomic agents|mesh-ancestor
6220643|NCT02323048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6220644|NCT02323048|Dopamine Agents|dopamine agents|mesh-ancestor
6220645|NCT02323048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6220646|NCT02323048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220647|NCT02323048|Adrenergic Agents|adrenergic agents|mesh-ancestor
6220648|NCT02323048|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6220649|NCT02323048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6220650|NCT02323048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6220651|NCT02323048|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6220658|NCT02323217|Isocarboxazid|isocarboxazid|mesh-list
6220659|NCT02323217|Idazoxan|idazoxan|mesh-list
6220660|NCT02323217|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6220661|NCT02323217|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6220662|NCT02323217|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6220663|NCT02323217|Adrenergic Agents|adrenergic agents|mesh-ancestor
6220664|NCT02323217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6220665|NCT02323217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220666|NCT02323217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220667|NCT02323217|Antidepressive Agents|antidepressive agents|mesh-ancestor
6220668|NCT02323217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6220669|NCT02323217|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6220670|NCT02323217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6220671|NCT02323334|Itraconazole|itraconazole|mesh-list
6220672|NCT02323334|Antifungal Agents|antifungal agents|mesh-ancestor
6220673|NCT02323334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6220674|NCT02323334|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6220675|NCT02323334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6220676|NCT02323334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6220677|NCT02323334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220678|NCT02323334|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6220679|NCT02323334|Hormone Antagonists|hormone antagonists|mesh-ancestor
6220680|NCT02323334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6220681|NCT02323334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220682|NCT02323334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6243267|NCT02663674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243268|NCT02663674|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6243269|NCT02663674|Hormone Antagonists|hormone antagonists|mesh-ancestor
6243270|NCT02663674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6243271|NCT02663674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243272|NCT02663674|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6243273|NCT02663674|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6220683|NCT02324153|Riboflavin|riboflavin|mesh-list
6220684|NCT02324153|Vitamin B Complex|vitamin b complex|mesh-ancestor
6220685|NCT02324153|Vitamins|vitamins|mesh-ancestor
6220686|NCT02324153|Micronutrients|micronutrients|mesh-ancestor
6220687|NCT02324153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220688|NCT02324153|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6220689|NCT02324153|Dermatologic Agents|dermatologic agents|mesh-ancestor
6220690|NCT02324270|Diclofenac|diclofenac|mesh-list
6220691|NCT02324270|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
6220692|NCT02324270|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6220693|NCT02324270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6220694|NCT02324270|Analgesics|analgesics|mesh-ancestor
6220695|NCT02324270|Sensory System Agents|sensory system agents|mesh-ancestor
6220696|NCT02324270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6220697|NCT02324270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220698|NCT02324270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6220699|NCT02324270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5703503|NCT03330223|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5703504|NCT03330223|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5703505|NCT03330223|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5703506|NCT03330223|Purinergic Agents|purinergic agents|mesh-ancestor
5703507|NCT03330223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5722294|NCT03200002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220700|NCT02324270|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6220701|NCT02324270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6220702|NCT02324270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220703|NCT02324543|Gemcitabine|gemcitabine|mesh-list
6220704|NCT02324543|Docetaxel|docetaxel|mesh-list
6220705|NCT02324543|Capecitabine|capecitabine|mesh-list
6220706|NCT02324543|Irinotecan|irinotecan|mesh-list
6220707|NCT02324543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6220708|NCT02324543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6220709|NCT02324543|Antimetabolites|antimetabolites|mesh-ancestor
6220710|NCT02324543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220711|NCT02324543|Antiviral Agents|antiviral agents|mesh-ancestor
6220712|NCT02324543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6220713|NCT02324543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6220714|NCT02324543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6220715|NCT02324543|Immunologic Factors|immunologic factors|mesh-ancestor
6220716|NCT02324543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220717|NCT02324543|Tubulin Modulators|tubulin modulators|mesh-ancestor
6220718|NCT02324543|Antimitotic Agents|antimitotic agents|mesh-ancestor
6220719|NCT02324543|Mitosis Modulators|mitosis modulators|mesh-ancestor
6220720|NCT02324543|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6220721|NCT02324543|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6220722|NCT02324673|Cannabidiol|cannabidiol|mesh-list
6220723|NCT02324673|Anticonvulsants|anticonvulsants|mesh-ancestor
6220724|NCT02324699|Prednisone|prednisone|mesh-list
6220725|NCT02324699|Vedolizumab|vedolizumab|mesh-list
6220726|NCT02324699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6220727|NCT02324699|Glucocorticoids|glucocorticoids|mesh-ancestor
6220728|NCT02324699|Hormones|hormones|mesh-ancestor
6220729|NCT02324699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6220730|NCT02324699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220731|NCT02324699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6220732|NCT02324699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6220733|NCT02324699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6220734|NCT02324842|Liraglutide|liraglutide|mesh-list
6220735|NCT02324842|Canagliflozin|canagliflozin|mesh-list
6220736|NCT02324842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6220737|NCT02324842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220738|NCT02324842|Incretins|incretins|mesh-ancestor
6220739|NCT02324842|Hormones|hormones|mesh-ancestor
6220740|NCT02324842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6220741|NCT02324842|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6220742|NCT02324842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220743|NCT02325219|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6220744|NCT02325219|Immunologic Factors|immunologic factors|mesh-ancestor
6220745|NCT02325219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220746|NCT02325401|Metformin|metformin|mesh-list
6220747|NCT02325401|Cisplatin|cisplatin|mesh-list
6220748|NCT02325401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6220749|NCT02325401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6220750|NCT02325401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220751|NCT02325414|Zoledronic Acid|zoledronic acid|mesh-list
6220752|NCT02325414|Diphosphonates|diphosphonates|mesh-list
6243274|NCT02663687|Complement C1s|complement c1s|mesh-list
6220753|NCT02325414|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6220754|NCT02325414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220755|NCT02325518|Timolol|timolol|mesh-list
6220756|NCT02325518|Dorzolamide|dorzolamide|mesh-list
6220757|NCT02325518|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6220758|NCT02325518|Maleic acid|maleic acid|mesh-list
6220759|NCT02325518|Brinzolamide|brinzolamide|mesh-list
6220760|NCT02325518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6220761|NCT02325518|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6220762|NCT02325518|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6220763|NCT02325518|Adrenergic Agents|adrenergic agents|mesh-ancestor
6220764|NCT02325518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6220765|NCT02325518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220766|NCT02325518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220767|NCT02325518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6220768|NCT02325518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6220769|NCT02325518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6220770|NCT02325518|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6220771|NCT02325713|Praziquantel|praziquantel|mesh-list
6220772|NCT02325713|Anthelmintics|anthelmintics|mesh-ancestor
6220773|NCT02325713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6220774|NCT02325713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6220775|NCT02325739|Spartalizumab|spartalizumab|mesh-list
6220776|NCT02325739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6220777|NCT02325739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220778|NCT02325739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6220779|NCT02326025|Doxorubicin|doxorubicin|mesh-list
6220780|NCT02326025|Olaratumab|olaratumab|mesh-list
6220781|NCT02326025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6220782|NCT02326025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6220783|NCT02326025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6220784|NCT02326025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6220785|NCT02326025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6220786|NCT02326025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220787|NCT02326272|Certolizumab Pegol|certolizumab pegol|mesh-list
6220788|NCT02326272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6220789|NCT02326272|Immunologic Factors|immunologic factors|mesh-ancestor
6220790|NCT02326272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220791|NCT02326272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6220792|NCT02326298|Certolizumab Pegol|certolizumab pegol|mesh-list
6220793|NCT02326298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6220794|NCT02326298|Immunologic Factors|immunologic factors|mesh-ancestor
6220795|NCT02326298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220796|NCT02326298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6220797|NCT02326467|Chlorhexidine|chlorhexidine|mesh-list
6220798|NCT02326467|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6220799|NCT02326467|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6220800|NCT02326467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6220801|NCT02326467|Disinfectants|disinfectants|mesh-ancestor
6220802|NCT02326467|Dermatologic Agents|dermatologic agents|mesh-ancestor
6220803|NCT02326805|Metronidazole|metronidazole|mesh-list
6220804|NCT02326805|Vaccines|vaccines|mesh-list
6220805|NCT02326805|Immunologic Factors|immunologic factors|mesh-ancestor
6220806|NCT02326805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220807|NCT02326805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6220808|NCT02326805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6220809|NCT02326805|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6498331|NCT00636935|Atovaquone|atovaquone|mesh-list
6498332|NCT00636935|Pentamidine|pentamidine|mesh-list
6498333|NCT00636935|Prednisone|prednisone|mesh-list
6498334|NCT00636935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6498335|NCT00636935|Glucocorticoids|glucocorticoids|mesh-ancestor
6498336|NCT00636935|Hormones|hormones|mesh-ancestor
6498337|NCT00636935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6498338|NCT00636935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498339|NCT00636935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6498340|NCT00636935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6498341|NCT00636935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6498342|NCT00636935|Antitubercular Agents|antitubercular agents|mesh-ancestor
6498343|NCT00636935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6498344|NCT00636935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6524507|NCT00758433|Capsaicin|capsaicin|mesh-list
5722295|NCT03200002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6220810|NCT02326805|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6220811|NCT02326844|Talazoparib|talazoparib|mesh-list
6524508|NCT00758433|Antipruritics|antipruritics|mesh-ancestor
6524509|NCT00758433|Dermatologic Agents|dermatologic agents|mesh-ancestor
6524510|NCT00758433|Sensory System Agents|sensory system agents|mesh-ancestor
6220812|NCT02326844|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6220813|NCT02326844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6220814|NCT02326844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220815|NCT02326844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6220816|NCT02326974|Pertuzumab|pertuzumab|mesh-list
6220817|NCT02326974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6220818|NCT02326974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6220819|NCT02327013|Vortioxetine|vortioxetine|mesh-list
6220820|NCT02327013|Antidepressive Agents|antidepressive agents|mesh-ancestor
6220821|NCT02327013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6220822|NCT02327013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6220823|NCT02327013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6220824|NCT02327013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6220825|NCT02327013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220826|NCT02327013|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6220827|NCT02327013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6220828|NCT02327013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6220829|NCT02327013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220830|NCT02327013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6220831|NCT02327013|Serotonin Agents|serotonin agents|mesh-ancestor
6220832|NCT02327013|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6220833|NCT02327013|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6220834|NCT02327013|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6220835|NCT02327013|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6220836|NCT02327117|Tranexamic Acid|tranexamic acid|mesh-list
6220837|NCT02327117|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6220838|NCT02327117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6220839|NCT02327117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220840|NCT02327117|Hemostatics|hemostatics|mesh-ancestor
6220841|NCT02327117|Coagulants|coagulants|mesh-ancestor
6220842|NCT02327169|Paclitaxel|paclitaxel|mesh-list
6220843|NCT02327169|Irinotecan|irinotecan|mesh-list
6220844|NCT02327169|Cetuximab|cetuximab|mesh-list
6220845|NCT02327169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6220846|NCT02327169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6220847|NCT02327169|Tubulin Modulators|tubulin modulators|mesh-ancestor
6220848|NCT02327169|Antimitotic Agents|antimitotic agents|mesh-ancestor
6220849|NCT02327169|Mitosis Modulators|mitosis modulators|mesh-ancestor
6220850|NCT02327169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220851|NCT02327169|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6220852|NCT02327169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6220853|NCT02327169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6220854|NCT02327169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6220855|NCT02327741|Clopidogrel|clopidogrel|mesh-list
6220856|NCT02327741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6220857|NCT02327741|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6220858|NCT02327741|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6220859|NCT02327741|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6220860|NCT02327741|Purinergic Agents|purinergic agents|mesh-ancestor
6220861|NCT02327741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6220862|NCT02327741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220863|NCT02327741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220864|NCT02328040|Insulin|insulin|mesh-list
6220865|NCT02328040|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6220866|NCT02328040|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6220867|NCT02328040|Insulin Aspart|insulin aspart|mesh-list
6220868|NCT02328040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6220869|NCT02328040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220870|NCT02328040|Incretins|incretins|mesh-ancestor
6220871|NCT02328040|Hormones|hormones|mesh-ancestor
6220872|NCT02328040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6220873|NCT02328040|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6220874|NCT02328040|Protease Inhibitors|protease inhibitors|mesh-ancestor
6220875|NCT02328040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6220876|NCT02328040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220877|NCT02328105|Paclitaxel|paclitaxel|mesh-list
6220878|NCT02328105|Carboplatin|carboplatin|mesh-list
6220879|NCT02328105|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6220880|NCT02328105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6220881|NCT02328105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6220882|NCT02328105|Tubulin Modulators|tubulin modulators|mesh-ancestor
6220883|NCT02328105|Antimitotic Agents|antimitotic agents|mesh-ancestor
6220884|NCT02328105|Mitosis Modulators|mitosis modulators|mesh-ancestor
6220885|NCT02328105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220886|NCT02328404|Vitamin D|vitamin d|mesh-list
6220887|NCT02328404|Cholecalciferol|cholecalciferol|mesh-list
6220888|NCT02328404|Vitamins|vitamins|mesh-ancestor
6220889|NCT02328404|Micronutrients|micronutrients|mesh-ancestor
6220890|NCT02328404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220891|NCT02328404|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6220892|NCT02328404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6220893|NCT02328755|Methotrexate|methotrexate|mesh-list
6220894|NCT02328755|Tacrolimus|tacrolimus|mesh-list
6220895|NCT02328755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6220896|NCT02328755|Abortifacient Agents|abortifacient agents|mesh-ancestor
6220897|NCT02328755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6220898|NCT02328755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220899|NCT02328755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6220900|NCT02328755|Antimetabolites|antimetabolites|mesh-ancestor
6220901|NCT02328755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220902|NCT02328755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6220903|NCT02328755|Dermatologic Agents|dermatologic agents|mesh-ancestor
6220904|NCT02328755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6220905|NCT02328755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6220906|NCT02328755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6220907|NCT02328755|Immunologic Factors|immunologic factors|mesh-ancestor
6498345|NCT00636935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498346|NCT00636935|Antimalarials|antimalarials|mesh-ancestor
5703508|NCT03330223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703509|NCT03330223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498347|NCT00636935|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6498348|NCT00636935|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6498349|NCT00636935|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6498350|NCT00636935|Renal Agents|renal agents|mesh-ancestor
5703510|NCT03330171|Vaccines|vaccines|mesh-list
5703511|NCT03330171|Immunologic Factors|immunologic factors|mesh-ancestor
6498351|NCT00636935|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6498352|NCT00636935|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6498353|NCT00636935|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6498354|NCT00636935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6498355|NCT00636935|Leprostatic Agents|leprostatic agents|mesh-ancestor
6498356|NCT00636935|Antifungal Agents|antifungal agents|mesh-ancestor
6498357|NCT00636935|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6498358|NCT00636974|Anesthetics|anesthetics|mesh-list
6498359|NCT00636974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6498360|NCT00636974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498361|NCT00637026|Gefitinib|gefitinib|mesh-list
6498362|NCT00637026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6676144|NCT01579279|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6676145|NCT01579279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6498363|NCT00637026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6498364|NCT00637026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6498365|NCT00637026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498366|NCT00637065|Bosentan|bosentan|mesh-list
6498367|NCT00637065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6498368|NCT00637065|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6498369|NCT00637065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498370|NCT00637078|Amlodipine|amlodipine|mesh-list
6498371|NCT00637078|Spironolactone|spironolactone|mesh-list
6498372|NCT00637078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6498373|NCT00637078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6498374|NCT00637078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6498375|NCT00637078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498376|NCT00637078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6498377|NCT00637078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498378|NCT00637078|Vasodilator Agents|vasodilator agents|mesh-ancestor
6498379|NCT00637078|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6498380|NCT00637078|Hormone Antagonists|hormone antagonists|mesh-ancestor
6498381|NCT00637078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6498382|NCT00637078|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6498383|NCT00637078|Diuretics|diuretics|mesh-ancestor
6498384|NCT00637078|Natriuretic Agents|natriuretic agents|mesh-ancestor
6498385|NCT00637091|Irinotecan|irinotecan|mesh-list
6498386|NCT00637091|Cetuximab|cetuximab|mesh-list
6498387|NCT00637091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6498388|NCT00637091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6220908|NCT02328755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6220909|NCT02328755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6220910|NCT02328755|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6220911|NCT02329223|Omalizumab|omalizumab|mesh-list
6220912|NCT02329223|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6220913|NCT02329223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6220914|NCT02329223|Respiratory System Agents|respiratory system agents|mesh-ancestor
6220915|NCT02329600|Triamcinolone|triamcinolone|mesh-list
6220916|NCT02329600|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6220917|NCT02329600|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6220918|NCT02329600|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6220919|NCT02329600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6220920|NCT02329600|Glucocorticoids|glucocorticoids|mesh-ancestor
6220921|NCT02329600|Hormones|hormones|mesh-ancestor
6220922|NCT02329600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6220923|NCT02329600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220924|NCT02329600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6220925|NCT02329600|Immunologic Factors|immunologic factors|mesh-ancestor
6220926|NCT02329600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6220927|NCT02329600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220928|NCT02329964|Neostigmine|neostigmine|mesh-list
6220929|NCT02329964|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
6220930|NCT02329964|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6220931|NCT02329964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6220932|NCT02329964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220933|NCT02329964|Cholinergic Agents|cholinergic agents|mesh-ancestor
6220934|NCT02329964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6220935|NCT02329964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220936|NCT02329964|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6220937|NCT02329964|Autonomic Agents|autonomic agents|mesh-ancestor
6220938|NCT02329964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6220939|NCT02330094|Gabapentin|gabapentin|mesh-list
6220940|NCT02330094|Analgesics|analgesics|mesh-ancestor
6220941|NCT02330094|Sensory System Agents|sensory system agents|mesh-ancestor
6220942|NCT02330094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6220943|NCT02330094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220944|NCT02330094|Anticonvulsants|anticonvulsants|mesh-ancestor
6220945|NCT02330094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6220946|NCT02330094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6220947|NCT02330094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6220948|NCT02330094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6220949|NCT02330094|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5703512|NCT03330171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703513|NCT03330132|Vaccines|vaccines|mesh-list
5703514|NCT03330132|Hemagglutinins|hemagglutinins|mesh-list
5703515|NCT03330132|Immunologic Factors|immunologic factors|mesh-ancestor
5703516|NCT03330132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703517|NCT03330132|Agglutinins|agglutinins|mesh-ancestor
5703518|NCT03330106|Paclitaxel|paclitaxel|mesh-list
5703519|NCT03330106|Docetaxel|docetaxel|mesh-list
5703520|NCT03330106|Carboplatin|carboplatin|mesh-list
5703521|NCT03330106|Pevonedistat|pevonedistat|mesh-list
5703522|NCT03330106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5703523|NCT03330106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5703524|NCT03330106|Tubulin Modulators|tubulin modulators|mesh-ancestor
5703525|NCT03330106|Antimitotic Agents|antimitotic agents|mesh-ancestor
5703526|NCT03330106|Mitosis Modulators|mitosis modulators|mesh-ancestor
5703527|NCT03330106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703528|NCT03330106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6220950|NCT02330094|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6220951|NCT02330094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6220952|NCT02330094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220953|NCT02330094|Antimanic Agents|antimanic agents|mesh-ancestor
6220954|NCT02330172|Neostigmine|neostigmine|mesh-list
6220955|NCT02330172|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6220956|NCT02330172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6220957|NCT02330172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220958|NCT02330172|Cholinergic Agents|cholinergic agents|mesh-ancestor
6220959|NCT02330172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6220960|NCT02330172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220961|NCT02330172|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6220962|NCT02330172|Autonomic Agents|autonomic agents|mesh-ancestor
6220963|NCT02330172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6220964|NCT02330549|Cenicriviroc|cenicriviroc|mesh-list
6220965|NCT02330549|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6220966|NCT02330549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220967|NCT02330549|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6220968|NCT02330549|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6220969|NCT02330549|Antiviral Agents|antiviral agents|mesh-ancestor
6220970|NCT02330549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6220971|NCT02331095|Warfarin|warfarin|mesh-list
6220972|NCT02331095|Rivaroxaban|rivaroxaban|mesh-list
6220973|NCT02331095|Atorvastatin|atorvastatin|mesh-list
6220974|NCT02331095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6220975|NCT02331095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6220976|NCT02331095|Antimetabolites|antimetabolites|mesh-ancestor
6220977|NCT02331095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6220978|NCT02331095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6220979|NCT02331095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6220980|NCT02331095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6220981|NCT02331095|Anticoagulants|anticoagulants|mesh-ancestor
6220982|NCT02331095|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6220983|NCT02331095|Antithrombins|antithrombins|mesh-ancestor
6220984|NCT02331095|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6220985|NCT02331095|Protease Inhibitors|protease inhibitors|mesh-ancestor
6220986|NCT02331108|Anesthetics|anesthetics|mesh-list
6220987|NCT02331108|Propofol|propofol|mesh-list
6220988|NCT02331108|Sevoflurane|sevoflurane|mesh-list
6220989|NCT02331108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6220990|NCT02331108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6220991|NCT02331108|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6220992|NCT02331108|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6220993|NCT02331108|Anesthetics, General|anesthetics, general|mesh-ancestor
6220994|NCT02331108|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6220995|NCT02331108|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6220996|NCT02331368|Pembrolizumab|pembrolizumab|mesh-list
6220997|NCT02331368|Lenalidomide|lenalidomide|mesh-list
6220998|NCT02331368|Melphalan|melphalan|mesh-list
6220999|NCT02331368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6221000|NCT02331368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6221001|NCT02331368|Immunologic Factors|immunologic factors|mesh-ancestor
6221002|NCT02331368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221003|NCT02331368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6221004|NCT02331368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6221005|NCT02331368|Growth Substances|growth substances|mesh-ancestor
6221006|NCT02331368|Growth Inhibitors|growth inhibitors|mesh-ancestor
6221007|NCT02331368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6221008|NCT02331368|Alkylating Agents|alkylating agents|mesh-ancestor
6221009|NCT02331368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221010|NCT02331368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6221011|NCT02331368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6221012|NCT02331680|Tolvaptan|tolvaptan|mesh-list
6221013|NCT02331680|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6221014|NCT02331680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221015|NCT02331680|Natriuretic Agents|natriuretic agents|mesh-ancestor
6221016|NCT02331680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221017|NCT02331940|Tiotropium Bromide|tiotropium bromide|mesh-list
6221018|NCT02331940|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6221019|NCT02331940|Autonomic Agents|autonomic agents|mesh-ancestor
6221020|NCT02331940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6221021|NCT02331940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221022|NCT02331940|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6221023|NCT02331940|Respiratory System Agents|respiratory system agents|mesh-ancestor
6221024|NCT02331940|Parasympatholytics|parasympatholytics|mesh-ancestor
6221025|NCT02331940|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6221026|NCT02331940|Cholinergic Agents|cholinergic agents|mesh-ancestor
6221027|NCT02331940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6221028|NCT02331940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221029|NCT02332291|Citalopram|citalopram|mesh-list
6221030|NCT02332291|Bupropion|bupropion|mesh-list
6221031|NCT02332291|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6221032|NCT02332291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6221033|NCT02332291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6221034|NCT02332291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221035|NCT02332291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6221036|NCT02332291|Serotonin Agents|serotonin agents|mesh-ancestor
6221037|NCT02332291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221038|NCT02332291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6221039|NCT02332291|Antidepressive Agents|antidepressive agents|mesh-ancestor
6221040|NCT02332291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6221041|NCT02332291|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6221042|NCT02332291|Dopamine Agents|dopamine agents|mesh-ancestor
6221043|NCT02332291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6221044|NCT02332291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6221045|NCT02332291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6221046|NCT02332707|Ribavirin|ribavirin|mesh-list
6221047|NCT02332707|Grazoprevir|grazoprevir|mesh-list
6221048|NCT02332707|Uprifosbuvir|uprifosbuvir|mesh-list
6221049|NCT02332707|Ruzasvir|ruzasvir|mesh-list
6221050|NCT02332707|Antimetabolites|antimetabolites|mesh-ancestor
5703572|NCT03329950|Pembrolizumab|pembrolizumab|mesh-list
5703573|NCT03329950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5703574|NCT03329950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5703575|NCT03329898|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5703576|NCT03329898|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5703577|NCT03329898|Estradiol|estradiol|mesh-list
6221051|NCT02332707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221052|NCT02332707|Antiviral Agents|antiviral agents|mesh-ancestor
6221053|NCT02332707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6221054|NCT02332720|Ribavirin|ribavirin|mesh-list
6221055|NCT02332720|Grazoprevir|grazoprevir|mesh-list
6221056|NCT02332720|Uprifosbuvir|uprifosbuvir|mesh-list
6221057|NCT02332720|Ruzasvir|ruzasvir|mesh-list
6221058|NCT02332720|Antimetabolites|antimetabolites|mesh-ancestor
6221059|NCT02332720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221060|NCT02332720|Antiviral Agents|antiviral agents|mesh-ancestor
6221061|NCT02332720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6221062|NCT02332824|Candesartan|candesartan|mesh-list
6221063|NCT02332824|Candesartan cilexetil|candesartan cilexetil|mesh-list
6221064|NCT02332824|Imarikiren hydrochloride|imarikiren hydrochloride|mesh-list
6221065|NCT02332824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6221066|NCT02332824|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6221067|NCT02332824|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6221068|NCT02332824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221069|NCT02332824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5703578|NCT03329898|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5703579|NCT03329898|Dydrogesterone|dydrogesterone|mesh-list
5703580|NCT03329898|Estrogens|estrogens|mesh-ancestor
5703581|NCT03329898|Hormones|hormones|mesh-ancestor
5703582|NCT03329898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5703583|NCT03329898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703584|NCT03329898|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5703585|NCT03329898|Contraceptive Agents|contraceptive agents|mesh-ancestor
5703586|NCT03329898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5703587|NCT03329898|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5703588|NCT03329898|Progestins|progestins|mesh-ancestor
6221070|NCT02332889|Decitabine|decitabine|mesh-list
6221071|NCT02332889|Poly ICLC|poly iclc|mesh-list
6221072|NCT02332889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6221073|NCT02332889|Antimetabolites|antimetabolites|mesh-ancestor
6221074|NCT02332889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221075|NCT02332889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6221076|NCT02332889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6221077|NCT02332889|Interferon Inducers|interferon inducers|mesh-ancestor
6221078|NCT02332889|Immunologic Factors|immunologic factors|mesh-ancestor
6221079|NCT02332889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221080|NCT02332902|Everolimus|everolimus|mesh-list
6221081|NCT02332902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6221082|NCT02332902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6221083|NCT02332902|Immunologic Factors|immunologic factors|mesh-ancestor
6221084|NCT02332902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243275|NCT02663687|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
6243276|NCT02663687|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
6243277|NCT02663687|Immunologic Factors|immunologic factors|mesh-ancestor
6243278|NCT02663687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243279|NCT02663687|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6243280|NCT02663687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6243281|NCT02663895|Treprostinil|treprostinil|mesh-list
6243282|NCT02663895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6243283|NCT02664220|Povidone-Iodine|povidone-iodine|mesh-list
6243284|NCT02664220|Povidone|povidone|mesh-list
6243285|NCT02664220|Plasma Substitutes|plasma substitutes|mesh-ancestor
6243286|NCT02664220|Blood Substitutes|blood substitutes|mesh-ancestor
6243287|NCT02664220|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6243288|NCT02664220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6244258|NCT02691572|Acetaminophen|acetaminophen|mesh-list
6244259|NCT02691572|Ketorolac|ketorolac|mesh-list
6244260|NCT02691572|Fentanyl|fentanyl|mesh-list
6244261|NCT02691572|Bupivacaine|bupivacaine|mesh-list
6244262|NCT02691572|Anesthetics, Local|anesthetics, local|mesh-ancestor
6244263|NCT02691572|Anesthetics|anesthetics|mesh-ancestor
6244264|NCT02691572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6244265|NCT02691572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244266|NCT02691572|Sensory System Agents|sensory system agents|mesh-ancestor
6244267|NCT02691572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6244268|NCT02691572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6244269|NCT02691572|Narcotics|narcotics|mesh-ancestor
6244270|NCT02691572|Analgesics|analgesics|mesh-ancestor
6244271|NCT02691572|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5703589|NCT03329781|Curcumin|curcumin|mesh-list
6244272|NCT02691572|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6244273|NCT02691572|Anesthetics, General|anesthetics, general|mesh-ancestor
6244274|NCT02691572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6244275|NCT02691572|Antipyretics|antipyretics|mesh-ancestor
6221085|NCT02333045|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6221086|NCT02333045|Maraviroc|maraviroc|mesh-list
6498389|NCT00637091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6498390|NCT00637091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498391|NCT00637091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6498392|NCT00637091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6498393|NCT00637104|Chromium|chromium|mesh-list
6498394|NCT00637104|Trace Elements|trace elements|mesh-ancestor
6498395|NCT00637104|Micronutrients|micronutrients|mesh-ancestor
6498396|NCT00637104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498397|NCT00637117|Interferons|interferons|mesh-list
6498398|NCT00637117|Interferon-alpha|interferon-alpha|mesh-list
6498399|NCT00637117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6498400|NCT00637117|Antiviral Agents|antiviral agents|mesh-ancestor
6498401|NCT00637117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6498402|NCT00637117|Immunologic Factors|immunologic factors|mesh-ancestor
6498403|NCT00637117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498404|NCT00637143|Cyclosporine|cyclosporine|mesh-list
6498405|NCT00637143|Tacrolimus|tacrolimus|mesh-list
6498406|NCT00637143|Cyclosporins|cyclosporins|mesh-list
6498407|NCT00637143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6498408|NCT00637143|Immunologic Factors|immunologic factors|mesh-ancestor
6498409|NCT00637143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498410|NCT00637143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6498411|NCT00637143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6498412|NCT00637143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498413|NCT00637143|Antifungal Agents|antifungal agents|mesh-ancestor
6498414|NCT00637143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6498415|NCT00637143|Dermatologic Agents|dermatologic agents|mesh-ancestor
6498416|NCT00637143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6498417|NCT00637182|Anastrozole|anastrozole|mesh-list
6498418|NCT00637182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6498419|NCT00637182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6498420|NCT00637182|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6498421|NCT00637182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6498422|NCT00637182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6498423|NCT00637182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498424|NCT00637182|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6498425|NCT00637182|Hormone Antagonists|hormone antagonists|mesh-ancestor
6498426|NCT00637182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6498427|NCT00637182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498428|NCT00637234|Oxcarbazepine|oxcarbazepine|mesh-list
6498429|NCT00637234|Anticonvulsants|anticonvulsants|mesh-ancestor
6498430|NCT00637234|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6498431|NCT00637234|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6498432|NCT00637234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6498433|NCT00637234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498434|NCT00637234|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6498435|NCT00637234|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6498436|NCT00637286|Zolmitriptan|zolmitriptan|mesh-list
6498437|NCT00637286|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6498438|NCT00637286|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6498439|NCT00637286|Serotonin Agents|serotonin agents|mesh-ancestor
6498440|NCT00637286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6498441|NCT00637286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498442|NCT00637286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498443|NCT00637325|Trastuzumab|trastuzumab|mesh-list
6498444|NCT00637325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6498445|NCT00637325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6498446|NCT00637390|Alemtuzumab|alemtuzumab|mesh-list
6498447|NCT00637390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6498448|NCT00637390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6498449|NCT00637403|Megestrol|megestrol|mesh-list
6498450|NCT00637403|Megestrol Acetate|megestrol acetate|mesh-list
6498451|NCT00637403|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5703590|NCT03329781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5703591|NCT03329781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5703592|NCT03329781|Analgesics|analgesics|mesh-ancestor
5703593|NCT03329781|Sensory System Agents|sensory system agents|mesh-ancestor
5703594|NCT03329781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5703595|NCT03329781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703596|NCT03329781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5703597|NCT03329781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6221087|NCT02333045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6221088|NCT02333045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6221089|NCT02333045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6221090|NCT02333045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221091|NCT02333045|Antiviral Agents|antiviral agents|mesh-ancestor
6221092|NCT02333045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6221093|NCT02333045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6221094|NCT02333045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6221095|NCT02333045|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6221096|NCT02333045|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6221097|NCT02333045|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6221098|NCT02333383|Adalimumab|adalimumab|mesh-list
6221099|NCT02333383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6221100|NCT02333383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6221101|NCT02334059|Ketamine|ketamine|mesh-list
6221102|NCT02334059|Analgesics|analgesics|mesh-ancestor
6221103|NCT02334059|Sensory System Agents|sensory system agents|mesh-ancestor
6221104|NCT02334059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6221105|NCT02334059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221106|NCT02334059|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6221107|NCT02334059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6221108|NCT02334059|Anesthetics, General|anesthetics, general|mesh-ancestor
6221109|NCT02334059|Anesthetics|anesthetics|mesh-ancestor
6221110|NCT02334059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6221111|NCT02334059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6221112|NCT02334059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6221113|NCT02334059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6221114|NCT02334059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221115|NCT02334215|Methadone|methadone|mesh-list
6221116|NCT02334215|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6221117|NCT02334215|Narcotics|narcotics|mesh-ancestor
6221118|NCT02334215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6221119|NCT02334215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221120|NCT02334215|Analgesics|analgesics|mesh-ancestor
6221121|NCT02334215|Sensory System Agents|sensory system agents|mesh-ancestor
6221122|NCT02334215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6221123|NCT02334215|Antitussive Agents|antitussive agents|mesh-ancestor
6221124|NCT02334215|Respiratory System Agents|respiratory system agents|mesh-ancestor
6221125|NCT02334384|Anti-Infective Agents|anti-infective agents|mesh-list
6221126|NCT02334384|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6221127|NCT02334423|Botulinum Toxins|botulinum toxins|mesh-list
6221128|NCT02334423|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6221129|NCT02334423|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6221130|NCT02334423|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6221131|NCT02334423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6221132|NCT02334423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221133|NCT02334423|Cholinergic Agents|cholinergic agents|mesh-ancestor
6221134|NCT02334423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6221135|NCT02334423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221136|NCT02334423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6221137|NCT02334423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6221138|NCT02334436|Botulinum Toxins|botulinum toxins|mesh-list
6221139|NCT02334436|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6221140|NCT02334436|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6221141|NCT02334436|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6221142|NCT02334436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6221143|NCT02334436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221144|NCT02334436|Cholinergic Agents|cholinergic agents|mesh-ancestor
6221145|NCT02334436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6221146|NCT02334436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221147|NCT02334436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6221148|NCT02334436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6221149|NCT02334527|Palbociclib|palbociclib|mesh-list
6221150|NCT02334527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6221151|NCT02334527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6221152|NCT02334527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6221153|NCT02334527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221154|NCT02334800|Palbociclib|palbociclib|mesh-list
6221155|NCT02334800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5703598|NCT03329781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5703599|NCT03329781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5703600|NCT03329781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703601|NCT03329729|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5703602|NCT03329729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6221156|NCT02334800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6221157|NCT02334800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6221158|NCT02334800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221159|NCT02334813|Dexamethasone|dexamethasone|mesh-list
6221160|NCT02334813|Prednisone|prednisone|mesh-list
6221161|NCT02334813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6221162|NCT02334813|Antiemetics|antiemetics|mesh-ancestor
6221163|NCT02334813|Autonomic Agents|autonomic agents|mesh-ancestor
6221164|NCT02334813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6221165|NCT02334813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221166|NCT02334813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6221167|NCT02334813|Glucocorticoids|glucocorticoids|mesh-ancestor
6221168|NCT02334813|Hormones|hormones|mesh-ancestor
6221169|NCT02334813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6221170|NCT02334813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6221171|NCT02334813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6221172|NCT02335125|Psychotropic Drugs|psychotropic drugs|mesh-list
6221173|NCT02335294|Morphine|morphine|mesh-list
6221174|NCT02335294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6221175|NCT02335294|Narcotics|narcotics|mesh-ancestor
6221176|NCT02335294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6221177|NCT02335294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221178|NCT02335294|Analgesics|analgesics|mesh-ancestor
6221179|NCT02335294|Sensory System Agents|sensory system agents|mesh-ancestor
6221180|NCT02335294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6221181|NCT02335346|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6221182|NCT02335346|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6221183|NCT02335346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6221184|NCT02335346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6221185|NCT02335346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221186|NCT02335346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6221187|NCT02335346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221188|NCT02335346|Analgesics|analgesics|mesh-ancestor
6221189|NCT02335346|Sensory System Agents|sensory system agents|mesh-ancestor
5703603|NCT03329729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5703604|NCT03329729|Antimetabolites|antimetabolites|mesh-ancestor
5703605|NCT03329729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221190|NCT02335346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6221191|NCT02335346|Antidepressive Agents|antidepressive agents|mesh-ancestor
6221192|NCT02335346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6221193|NCT02335346|Dopamine Agents|dopamine agents|mesh-ancestor
6221194|NCT02335905|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
6221195|NCT02335905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6221196|NCT02335905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6221197|NCT02335983|Dexamethasone|dexamethasone|mesh-list
6221198|NCT02335983|Lenalidomide|lenalidomide|mesh-list
6221199|NCT02335983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6221200|NCT02335983|Antiemetics|antiemetics|mesh-ancestor
6221201|NCT02335983|Autonomic Agents|autonomic agents|mesh-ancestor
6221202|NCT02335983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6221203|NCT02335983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221204|NCT02335983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6221205|NCT02335983|Glucocorticoids|glucocorticoids|mesh-ancestor
6221206|NCT02335983|Hormones|hormones|mesh-ancestor
6221207|NCT02335983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6221208|NCT02335983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6221209|NCT02335983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6221210|NCT02335983|Immunologic Factors|immunologic factors|mesh-ancestor
6221211|NCT02335983|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6221212|NCT02335983|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6221213|NCT02335983|Growth Substances|growth substances|mesh-ancestor
6221214|NCT02335983|Growth Inhibitors|growth inhibitors|mesh-ancestor
6221215|NCT02336074|Raltegravir Potassium|raltegravir potassium|mesh-list
6221216|NCT02336074|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6221217|NCT02336074|Vorinostat|vorinostat|mesh-list
6221218|NCT02336074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6221219|NCT02336074|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6221220|NCT02336074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6221221|NCT02336074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221222|NCT02336074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6221223|NCT02336074|Antiviral Agents|antiviral agents|mesh-ancestor
6221224|NCT02336074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6221225|NCT02336074|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6221226|NCT02336074|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6221227|NCT02336165|Bevacizumab|bevacizumab|mesh-list
6221228|NCT02336165|Durvalumab|durvalumab|mesh-list
6221229|NCT02336165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6221230|NCT02336165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6221231|NCT02336165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6221232|NCT02336165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6221233|NCT02336165|Growth Substances|growth substances|mesh-ancestor
6221234|NCT02336165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221235|NCT02336165|Growth Inhibitors|growth inhibitors|mesh-ancestor
6221236|NCT02336373|Hydroxyurea|hydroxyurea|mesh-list
6221237|NCT02336373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6221238|NCT02336373|Antisickling Agents|antisickling agents|mesh-ancestor
6221239|NCT02336373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6221240|NCT02336373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221241|NCT02336373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6221242|NCT02336438|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
6221243|NCT02336438|Cathartics|cathartics|mesh-ancestor
6221244|NCT02336438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6221245|NCT02336451|Ceritinib|ceritinib|mesh-list
6221246|NCT02336451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6221247|NCT02336451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6221248|NCT02336451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6221249|NCT02336451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221250|NCT02336594|Verinurad|verinurad|mesh-list
6221251|NCT02336594|Gout Suppressants|gout suppressants|mesh-ancestor
6221252|NCT02336594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6221253|NCT02336607|Metoprolol|metoprolol|mesh-list
6221254|NCT02336607|Felodipine|felodipine|mesh-list
6221255|NCT02336607|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6221256|NCT02336607|Lisinopril|lisinopril|mesh-list
6221257|NCT02336607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6221258|NCT02336607|Diuretics|diuretics|mesh-ancestor
6221259|NCT02336607|Natriuretic Agents|natriuretic agents|mesh-ancestor
6221260|NCT02336607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221261|NCT02336607|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6221262|NCT02336607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6221263|NCT02336607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221264|NCT02336607|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6221265|NCT02336607|Sympatholytics|sympatholytics|mesh-ancestor
6221266|NCT02336607|Autonomic Agents|autonomic agents|mesh-ancestor
6221267|NCT02336607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6221268|NCT02336607|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6221269|NCT02336607|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6221270|NCT02336607|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6221271|NCT02336607|Adrenergic Agents|adrenergic agents|mesh-ancestor
6221272|NCT02336607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6221273|NCT02336607|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6221274|NCT02336607|Protease Inhibitors|protease inhibitors|mesh-ancestor
6221275|NCT02336607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6221276|NCT02336607|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6221277|NCT02336607|Protective Agents|protective agents|mesh-ancestor
6221278|NCT02336607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6221279|NCT02336607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6221280|NCT02336607|Vasodilator Agents|vasodilator agents|mesh-ancestor
6221281|NCT02336737|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
6221282|NCT02336737|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6221283|NCT02336737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221284|NCT02336815|Dexamethasone|dexamethasone|mesh-list
6221285|NCT02336815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6221286|NCT02336815|Antiemetics|antiemetics|mesh-ancestor
6221287|NCT02336815|Autonomic Agents|autonomic agents|mesh-ancestor
6221288|NCT02336815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6221289|NCT02336815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221290|NCT02336815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6221291|NCT02336815|Glucocorticoids|glucocorticoids|mesh-ancestor
6221292|NCT02336815|Hormones|hormones|mesh-ancestor
6221293|NCT02336815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5703606|NCT03329729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5703607|NCT03329729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5703608|NCT03329729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5721117|NCT03208257|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5721118|NCT03208257|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5721119|NCT03208257|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6221294|NCT02336815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6221295|NCT02336815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6221296|NCT02336958|Ropivacaine|ropivacaine|mesh-list
6221297|NCT02336958|Prilocaine|prilocaine|mesh-list
6221298|NCT02336958|Anesthetics, Local|anesthetics, local|mesh-ancestor
6221299|NCT02336958|Anesthetics|anesthetics|mesh-ancestor
6221300|NCT02336958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6221301|NCT02336958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221302|NCT02336958|Sensory System Agents|sensory system agents|mesh-ancestor
6221303|NCT02336958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6221304|NCT02337478|Vincristine|vincristine|mesh-list
6221305|NCT02337478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6221306|NCT02337478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6221307|NCT02337478|Tubulin Modulators|tubulin modulators|mesh-ancestor
6221308|NCT02337478|Antimitotic Agents|antimitotic agents|mesh-ancestor
6221309|NCT02337478|Mitosis Modulators|mitosis modulators|mesh-ancestor
6221310|NCT02337478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221311|NCT02337491|Bevacizumab|bevacizumab|mesh-list
6221312|NCT02337491|Pembrolizumab|pembrolizumab|mesh-list
6221313|NCT02337491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6221314|NCT02337491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6221315|NCT02337491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6221316|NCT02337491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6221317|NCT02337491|Growth Substances|growth substances|mesh-ancestor
6221318|NCT02337491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221319|NCT02337491|Growth Inhibitors|growth inhibitors|mesh-ancestor
6221320|NCT02337530|Carboplatin|carboplatin|mesh-list
6221321|NCT02337530|Pemetrexed|pemetrexed|mesh-list
6221322|NCT02337530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6221323|NCT02337530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6221324|NCT02337530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221325|NCT02337530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6221326|NCT02337530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6221327|NCT02337907|Donepezil|donepezil|mesh-list
6221328|NCT02337907|BI 409306|bi 409306|mesh-list
6221329|NCT02337907|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6221330|NCT02337907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6221331|NCT02337907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221332|NCT02337907|Cholinergic Agents|cholinergic agents|mesh-ancestor
6221333|NCT02337907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6221334|NCT02337907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221335|NCT02337907|Nootropic Agents|nootropic agents|mesh-ancestor
6221336|NCT02337907|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6498452|NCT00637403|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6498453|NCT00637403|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6498454|NCT00637403|Contraceptive Agents|contraceptive agents|mesh-ancestor
6498455|NCT00637403|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6498456|NCT00637403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498457|NCT00637403|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6498458|NCT00637403|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6498459|NCT00637403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6498460|NCT00637403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6498461|NCT00637403|Appetite Stimulants|appetite stimulants|mesh-ancestor
5703609|NCT03329651|Metformin|metformin|mesh-list
5703610|NCT03329651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5703611|NCT03329651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703612|NCT03329638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6498462|NCT00637403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6498463|NCT00637442|Galantamine|galantamine|mesh-list
6498464|NCT00637442|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6498465|NCT00637442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6498466|NCT00637442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498467|NCT00637442|Cholinergic Agents|cholinergic agents|mesh-ancestor
6498468|NCT00637442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6498469|NCT00637442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498470|NCT00637442|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6498471|NCT00637442|Autonomic Agents|autonomic agents|mesh-ancestor
6498472|NCT00637442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6498473|NCT00637442|Nootropic Agents|nootropic agents|mesh-ancestor
5703613|NCT03329638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5703614|NCT03329547|Cefixime|cefixime|mesh-list
5703615|NCT03329547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5703616|NCT03329547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5703617|NCT03329508|Pramipexole|pramipexole|mesh-list
5703618|NCT03329508|Rasagiline|rasagiline|mesh-list
6221337|NCT02337933|Ursolic acid|ursolic acid|mesh-list
6221338|NCT02337933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221339|NCT02337933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6221340|NCT02337933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6221341|NCT02337933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6221342|NCT02337933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6221343|NCT02337933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6221344|NCT02337933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6221345|NCT02337933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6221346|NCT02337933|Analgesics|analgesics|mesh-ancestor
6221347|NCT02337933|Sensory System Agents|sensory system agents|mesh-ancestor
6221348|NCT02337933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6221349|NCT02337933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221350|NCT02337933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6221351|NCT02337933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6221352|NCT02337946|Calcium, Dietary|calcium, dietary|mesh-list
6221353|NCT02337946|Leucovorin|leucovorin|mesh-list
6221354|NCT02337946|Oxaliplatin|oxaliplatin|mesh-list
6221355|NCT02337946|Fluorouracil|fluorouracil|mesh-list
6221356|NCT02337946|Panitumumab|panitumumab|mesh-list
6221357|NCT02337946|Calcium|calcium|mesh-list
6221358|NCT02337946|Levoleucovorin|levoleucovorin|mesh-list
6221359|NCT02337946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6221360|NCT02337946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221361|NCT02337946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6221362|NCT02337946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5703619|NCT03329508|Antioxidants|antioxidants|mesh-ancestor
5703620|NCT03329508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703621|NCT03329508|Protective Agents|protective agents|mesh-ancestor
5703622|NCT03329508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703623|NCT03329508|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5703624|NCT03329508|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5703625|NCT03329508|Dopamine Agonists|dopamine agonists|mesh-ancestor
5703626|NCT03329508|Dopamine Agents|dopamine agents|mesh-ancestor
5703627|NCT03329508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5703628|NCT03329508|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
5703629|NCT03329508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5703630|NCT03329508|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5703631|NCT03329456|Ropivacaine|ropivacaine|mesh-list
5703632|NCT03329456|Anesthetics, Local|anesthetics, local|mesh-ancestor
5703633|NCT03329456|Anesthetics|anesthetics|mesh-ancestor
5703634|NCT03329456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5703635|NCT03329456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703636|NCT03329456|Sensory System Agents|sensory system agents|mesh-ancestor
5703637|NCT03329456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6221363|NCT02337946|Antimetabolites|antimetabolites|mesh-ancestor
6221364|NCT02337946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221365|NCT02337946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6221366|NCT02337946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6221367|NCT02337946|Immunologic Factors|immunologic factors|mesh-ancestor
6221368|NCT02337946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6221369|NCT02337946|Antidotes|antidotes|mesh-ancestor
6221370|NCT02337946|Protective Agents|protective agents|mesh-ancestor
6221371|NCT02337946|Vitamin B Complex|vitamin b complex|mesh-ancestor
6221372|NCT02337946|Vitamins|vitamins|mesh-ancestor
6221373|NCT02337946|Micronutrients|micronutrients|mesh-ancestor
6221374|NCT02338076|Petrolatum|petrolatum|mesh-list
6221375|NCT02338076|Emollients|emollients|mesh-ancestor
6221376|NCT02338076|Dermatologic Agents|dermatologic agents|mesh-ancestor
6221377|NCT02338193|Metformin|metformin|mesh-list
6221378|NCT02338193|Dapagliflozin|dapagliflozin|mesh-list
6221379|NCT02338193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6221380|NCT02338193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221381|NCT02338193|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6221382|NCT02338193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221383|NCT02338362|Fluticasone|fluticasone|mesh-list
6221384|NCT02338362|Xhance|xhance|mesh-list
6221385|NCT02338362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6221386|NCT02338362|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6221387|NCT02338362|Autonomic Agents|autonomic agents|mesh-ancestor
6221388|NCT02338362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6221389|NCT02338362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221390|NCT02338362|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6221391|NCT02338362|Respiratory System Agents|respiratory system agents|mesh-ancestor
6221392|NCT02338362|Dermatologic Agents|dermatologic agents|mesh-ancestor
5703638|NCT03329443|Spironolactone|spironolactone|mesh-list
5703639|NCT03329443|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6221393|NCT02338362|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6221394|NCT02338713|Calcium Carbonate|calcium carbonate|mesh-list
5703640|NCT03329443|Hormone Antagonists|hormone antagonists|mesh-ancestor
5703641|NCT03329443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5703642|NCT03329443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703643|NCT03329443|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5703644|NCT03329443|Diuretics|diuretics|mesh-ancestor
5703645|NCT03329443|Natriuretic Agents|natriuretic agents|mesh-ancestor
5703646|NCT03329339|Ascorbic Acid|ascorbic acid|mesh-list
5703647|NCT03329339|Antioxidants|antioxidants|mesh-ancestor
5703648|NCT03329339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703649|NCT03329339|Protective Agents|protective agents|mesh-ancestor
5703650|NCT03329339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703651|NCT03329339|Vitamins|vitamins|mesh-ancestor
5703652|NCT03329339|Micronutrients|micronutrients|mesh-ancestor
5703653|NCT03329261|Clopidogrel|clopidogrel|mesh-list
5703654|NCT03329261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5703655|NCT03329261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5703656|NCT03329261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5703657|NCT03329261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5703658|NCT03329261|Purinergic Agents|purinergic agents|mesh-ancestor
5703659|NCT03329261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5703660|NCT03329261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703661|NCT03329261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703662|NCT03329248|Leucovorin|leucovorin|mesh-list
5703663|NCT03329248|Paclitaxel|paclitaxel|mesh-list
5703664|NCT03329248|Cyclophosphamide|cyclophosphamide|mesh-list
5703665|NCT03329248|Bevacizumab|bevacizumab|mesh-list
5703666|NCT03329248|Fluorouracil|fluorouracil|mesh-list
6221395|NCT02338713|Antacids|antacids|mesh-ancestor
6221396|NCT02338713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221397|NCT02338713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6221398|NCT02338843|Angiotensin II|angiotensin ii|mesh-list
6221399|NCT02338843|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6221400|NCT02338973|Interferons|interferons|mesh-list
6221401|NCT02338973|Interferon-gamma|interferon-gamma|mesh-list
6221402|NCT02338973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6221403|NCT02338973|Antiviral Agents|antiviral agents|mesh-ancestor
6221404|NCT02338973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6221405|NCT02338999|Pioglitazone|pioglitazone|mesh-list
6221406|NCT02338999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6221407|NCT02338999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221408|NCT02339038|Sofosbuvir|sofosbuvir|mesh-list
6221409|NCT02339038|Ledipasvir|ledipasvir|mesh-list
6221410|NCT02339038|Antiviral Agents|antiviral agents|mesh-ancestor
6221411|NCT02339038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6221412|NCT02339155|Diphenhydramine|diphenhydramine|mesh-list
6221413|NCT02339155|Promethazine|promethazine|mesh-list
6221414|NCT02339155|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6221415|NCT02339155|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6221416|NCT02339155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6221417|NCT02339155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221418|NCT02339155|Anesthetics, Local|anesthetics, local|mesh-ancestor
6221419|NCT02339155|Anesthetics|anesthetics|mesh-ancestor
6221420|NCT02339155|Sensory System Agents|sensory system agents|mesh-ancestor
6221421|NCT02339155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6221422|NCT02339155|Antiemetics|antiemetics|mesh-ancestor
6221423|NCT02339155|Autonomic Agents|autonomic agents|mesh-ancestor
6221424|NCT02339155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6221425|NCT02339155|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6221426|NCT02339155|Histamine Antagonists|histamine antagonists|mesh-ancestor
6221427|NCT02339155|Histamine Agents|histamine agents|mesh-ancestor
6221428|NCT02339155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6221429|NCT02339155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221430|NCT02339155|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6221431|NCT02339155|Antipruritics|antipruritics|mesh-ancestor
6221432|NCT02339155|Dermatologic Agents|dermatologic agents|mesh-ancestor
6221433|NCT02339246|Tacrolimus|tacrolimus|mesh-list
6221434|NCT02339246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6221435|NCT02339246|Immunologic Factors|immunologic factors|mesh-ancestor
6221436|NCT02339246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221437|NCT02339246|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6221438|NCT02339246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6221439|NCT02339246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703667|NCT03329248|Capecitabine|capecitabine|mesh-list
5703668|NCT03329248|Oxaliplatin|oxaliplatin|mesh-list
6221440|NCT02339415|Edoxaban|edoxaban|mesh-list
6221441|NCT02339415|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6221442|NCT02339415|Antithrombins|antithrombins|mesh-ancestor
6221443|NCT02339415|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6221444|NCT02339415|Protease Inhibitors|protease inhibitors|mesh-ancestor
6221445|NCT02339415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6221446|NCT02339415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221447|NCT02339415|Anticoagulants|anticoagulants|mesh-ancestor
6221448|NCT02339506|Cosyntropin|cosyntropin|mesh-list
6221449|NCT02339506|Hormones|hormones|mesh-ancestor
6221450|NCT02339506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6221451|NCT02339506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221452|NCT02339558|Nivolumab|nivolumab|mesh-list
6221453|NCT02339558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6221454|NCT02339558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6221455|NCT02339558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6221456|NCT02339558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221457|NCT02339584|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6221458|NCT02339584|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6221459|NCT02339584|Brinzolamide|brinzolamide|mesh-list
6221460|NCT02339584|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6221461|NCT02339584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6221462|NCT02339584|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6221463|NCT02339584|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6221464|NCT02339584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6221465|NCT02339584|Adrenergic Agents|adrenergic agents|mesh-ancestor
6221466|NCT02339584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6221467|NCT02339584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221468|NCT02339584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221469|NCT02339584|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6221470|NCT02339584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6221471|NCT02340000|Amoxicillin|amoxicillin|mesh-list
6221472|NCT02340000|Clavulanic Acid|clavulanic acid|mesh-list
6221473|NCT02340000|Clavulanic Acids|clavulanic acids|mesh-list
6221474|NCT02340000|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6221475|NCT02340000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6221476|NCT02340000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6221477|NCT02340000|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6221478|NCT02340000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6221479|NCT02340000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221480|NCT02340156|Temozolomide|temozolomide|mesh-list
6221481|NCT02340156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6221482|NCT02340156|Alkylating Agents|alkylating agents|mesh-ancestor
6221483|NCT02340156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221484|NCT02340156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6221485|NCT02340520|Theophylline|theophylline|mesh-list
6221486|NCT02340520|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6221487|NCT02340520|Autonomic Agents|autonomic agents|mesh-ancestor
6221488|NCT02340520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6221489|NCT02340520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221490|NCT02340520|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6221491|NCT02340520|Respiratory System Agents|respiratory system agents|mesh-ancestor
6221492|NCT02340520|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6221493|NCT02340520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6221494|NCT02340520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221495|NCT02340520|Vasodilator Agents|vasodilator agents|mesh-ancestor
6221496|NCT02340520|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6221497|NCT02340520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6221498|NCT02340520|Purinergic Agents|purinergic agents|mesh-ancestor
6221499|NCT02340520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6243289|NCT02664909|Tranexamic Acid|tranexamic acid|mesh-list
6243290|NCT02664909|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6243291|NCT02664909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6243292|NCT02664909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243293|NCT02664909|Hemostatics|hemostatics|mesh-ancestor
6243294|NCT02664909|Coagulants|coagulants|mesh-ancestor
6243295|NCT02664922|Ketamine|ketamine|mesh-list
6243296|NCT02664922|Remifentanil|remifentanil|mesh-list
6243297|NCT02664922|Propofol|propofol|mesh-list
6243298|NCT02664922|Sevoflurane|sevoflurane|mesh-list
6243299|NCT02664922|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6243300|NCT02664922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6243301|NCT02664922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243302|NCT02664922|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6243303|NCT02664922|Anesthetics, General|anesthetics, general|mesh-ancestor
6498474|NCT00637455|Fexofenadine|fexofenadine|mesh-list
6221500|NCT02340819|Teduglutide|teduglutide|mesh-list
6221501|NCT02340819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6221502|NCT02340819|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6221503|NCT02340819|Protective Agents|protective agents|mesh-ancestor
6221504|NCT02340819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221505|NCT02340949|Leucovorin|leucovorin|mesh-list
6221506|NCT02340949|Oxaliplatin|oxaliplatin|mesh-list
6221507|NCT02340949|Aflibercept|aflibercept|mesh-list
6221508|NCT02340949|Fluorouracil|fluorouracil|mesh-list
6221509|NCT02340949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6221510|NCT02340949|Antidotes|antidotes|mesh-ancestor
6221511|NCT02340949|Protective Agents|protective agents|mesh-ancestor
6498475|NCT00637455|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5918557|NCT04990791|Sensory System Agents|sensory system agents|mesh-ancestor
5918558|NCT04990791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5918559|NCT04990791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918560|NCT04990791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5918561|NCT04990791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6498476|NCT00637455|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5703669|NCT03329248|Avelumab|avelumab|mesh-list
5703670|NCT03329248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5703671|NCT03329248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5703672|NCT03329248|Tubulin Modulators|tubulin modulators|mesh-ancestor
5703673|NCT03329248|Antimitotic Agents|antimitotic agents|mesh-ancestor
5703674|NCT03329248|Mitosis Modulators|mitosis modulators|mesh-ancestor
5703675|NCT03329248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703676|NCT03329248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5703677|NCT03329248|Immunologic Factors|immunologic factors|mesh-ancestor
5703678|NCT03329248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703679|NCT03329248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5703680|NCT03329248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5703681|NCT03329248|Alkylating Agents|alkylating agents|mesh-ancestor
5703682|NCT03329248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6498477|NCT00637455|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6498478|NCT00637455|Histamine Antagonists|histamine antagonists|mesh-ancestor
6498479|NCT00637455|Histamine Agents|histamine agents|mesh-ancestor
6498480|NCT00637455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6498481|NCT00637455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498482|NCT00637455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498483|NCT00637468|Aspirin|aspirin|mesh-list
6498484|NCT00637468|Heparin|heparin|mesh-list
6498485|NCT00637468|Acetazolamide|acetazolamide|mesh-list
6498486|NCT00637468|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
6498487|NCT00637468|Anticoagulants|anticoagulants|mesh-ancestor
6498488|NCT00637468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6498489|NCT00637468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6498490|NCT00637468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498491|NCT00637468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6498492|NCT00637468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6498493|NCT00637468|Analgesics|analgesics|mesh-ancestor
6498494|NCT00637468|Sensory System Agents|sensory system agents|mesh-ancestor
6498495|NCT00637468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6498496|NCT00637468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498497|NCT00637468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6498498|NCT00637468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6498499|NCT00637468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6498500|NCT00637468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6498501|NCT00637468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6498502|NCT00637468|Antipyretics|antipyretics|mesh-ancestor
6498503|NCT00637468|Anticonvulsants|anticonvulsants|mesh-ancestor
6498504|NCT00637468|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6498505|NCT00637468|Diuretics|diuretics|mesh-ancestor
6498506|NCT00637468|Natriuretic Agents|natriuretic agents|mesh-ancestor
6498507|NCT00637468|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6498508|NCT00637468|Adrenergic Agents|adrenergic agents|mesh-ancestor
6498509|NCT00637468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6498510|NCT00637481|Atorvastatin|atorvastatin|mesh-list
6498511|NCT00637481|Calcium|calcium|mesh-list
6498512|NCT00637481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6498513|NCT00637481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498514|NCT00637481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6498515|NCT00637481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6498516|NCT00637481|Antimetabolites|antimetabolites|mesh-ancestor
5918562|NCT04990791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6221512|NCT02340949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221513|NCT02340949|Vitamin B Complex|vitamin b complex|mesh-ancestor
6221514|NCT02340949|Vitamins|vitamins|mesh-ancestor
5703683|NCT03329248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5703684|NCT03329248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5703685|NCT03329248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5703686|NCT03329248|Growth Substances|growth substances|mesh-ancestor
5703687|NCT03329248|Growth Inhibitors|growth inhibitors|mesh-ancestor
5703688|NCT03329248|Antimetabolites|antimetabolites|mesh-ancestor
5703689|NCT03329248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6221515|NCT02340949|Micronutrients|micronutrients|mesh-ancestor
6221516|NCT02340949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6221517|NCT02340949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6221518|NCT02340949|Growth Substances|growth substances|mesh-ancestor
6221519|NCT02340949|Growth Inhibitors|growth inhibitors|mesh-ancestor
6221520|NCT02340949|Antimetabolites|antimetabolites|mesh-ancestor
6221521|NCT02340949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221522|NCT02340949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6221523|NCT02340949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5703690|NCT03329248|Antidotes|antidotes|mesh-ancestor
5703691|NCT03329248|Protective Agents|protective agents|mesh-ancestor
5703692|NCT03329248|Vitamin B Complex|vitamin b complex|mesh-ancestor
5703693|NCT03329248|Vitamins|vitamins|mesh-ancestor
5703694|NCT03329248|Micronutrients|micronutrients|mesh-ancestor
5703695|NCT03329183|Irinotecan|irinotecan|mesh-list
5703696|NCT03329183|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5703697|NCT03329183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5703698|NCT03329183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5703699|NCT03329183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703700|NCT03329183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5703701|NCT03329118|Simvastatin|simvastatin|mesh-list
5703702|NCT03329118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5703703|NCT03329118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5703704|NCT03329118|Antimetabolites|antimetabolites|mesh-ancestor
5703705|NCT03329118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703706|NCT03329118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5703707|NCT03329118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5703708|NCT03329118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5703709|NCT03328975|Dexamethasone|dexamethasone|mesh-list
5703710|NCT03328975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5703711|NCT03328975|Antiemetics|antiemetics|mesh-ancestor
5703712|NCT03328975|Autonomic Agents|autonomic agents|mesh-ancestor
5703713|NCT03328975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5703714|NCT03328975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703715|NCT03328975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6221524|NCT02340949|Immunologic Factors|immunologic factors|mesh-ancestor
6221525|NCT02340962|Interferons|interferons|mesh-list
6221526|NCT02340962|Ribavirin|ribavirin|mesh-list
6221527|NCT02340962|Interferon-alpha|interferon-alpha|mesh-list
6221528|NCT02340962|Interferon alpha-2|interferon alpha-2|mesh-list
6221529|NCT02340962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6221530|NCT02340962|Antiviral Agents|antiviral agents|mesh-ancestor
6221531|NCT02340962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6221532|NCT02340962|Antimetabolites|antimetabolites|mesh-ancestor
6221533|NCT02340962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221534|NCT02340962|Immunologic Factors|immunologic factors|mesh-ancestor
6221535|NCT02340962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221536|NCT02340975|Durvalumab|durvalumab|mesh-list
5703716|NCT03328975|Glucocorticoids|glucocorticoids|mesh-ancestor
5703717|NCT03328975|Hormones|hormones|mesh-ancestor
5703718|NCT03328975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5703719|NCT03328975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5703720|NCT03328975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6221537|NCT02340975|Tremelimumab|tremelimumab|mesh-list
6221538|NCT02340975|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6221539|NCT02340975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6221540|NCT02340975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6221541|NCT02340975|Immunologic Factors|immunologic factors|mesh-ancestor
6221542|NCT02340975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221543|NCT02341144|Ropivacaine|ropivacaine|mesh-list
6221544|NCT02341144|Anesthetics, Local|anesthetics, local|mesh-ancestor
6221545|NCT02341144|Anesthetics|anesthetics|mesh-ancestor
6221546|NCT02341144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6221547|NCT02341144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221548|NCT02341144|Sensory System Agents|sensory system agents|mesh-ancestor
6221549|NCT02341144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6221550|NCT02341417|Cinacalcet|cinacalcet|mesh-list
6221551|NCT02341417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6221552|NCT02341417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221553|NCT02341417|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6221554|NCT02341417|Hormone Antagonists|hormone antagonists|mesh-ancestor
6221555|NCT02341417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6221556|NCT02341456|Paclitaxel|paclitaxel|mesh-list
6221557|NCT02341456|Carboplatin|carboplatin|mesh-list
6221558|NCT02341456|Adavosertib|adavosertib|mesh-list
6221559|NCT02341456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6221560|NCT02341456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5703721|NCT03328936|Melphalan|melphalan|mesh-list
5703722|NCT03328936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5703723|NCT03328936|Alkylating Agents|alkylating agents|mesh-ancestor
5703724|NCT03328936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703725|NCT03328936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5703726|NCT03328936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5703727|NCT03328936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5703728|NCT03328936|Immunologic Factors|immunologic factors|mesh-ancestor
5703729|NCT03328936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703730|NCT03328884|Irinotecan|irinotecan|mesh-list
5703731|NCT03328884|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5703732|NCT03328884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5703733|NCT03328884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6221561|NCT02341456|Tubulin Modulators|tubulin modulators|mesh-ancestor
6221562|NCT02341456|Antimitotic Agents|antimitotic agents|mesh-ancestor
6221563|NCT02341456|Mitosis Modulators|mitosis modulators|mesh-ancestor
6221564|NCT02341456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221565|NCT02341456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6221566|NCT02341482|Itraconazole|itraconazole|mesh-list
6221567|NCT02341482|Antifungal Agents|antifungal agents|mesh-ancestor
6221568|NCT02341482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6221569|NCT02341482|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6221570|NCT02341482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6221571|NCT02341482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6221572|NCT02341482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221573|NCT02341482|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5703734|NCT03328884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703735|NCT03328884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5703736|NCT03328728|Hylan|hylan|mesh-list
5703737|NCT03328728|Viscosupplements|viscosupplements|mesh-ancestor
5703738|NCT03328728|Protective Agents|protective agents|mesh-ancestor
5918563|NCT04990791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6221574|NCT02341482|Hormone Antagonists|hormone antagonists|mesh-ancestor
6221575|NCT02341482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6221576|NCT02341482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221577|NCT02341482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6221578|NCT02342015|Atorvastatin|atorvastatin|mesh-list
6221579|NCT02342015|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6221580|NCT02342015|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6221581|NCT02342015|Antimetabolites|antimetabolites|mesh-ancestor
6221582|NCT02342015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221583|NCT02342015|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6221584|NCT02342015|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5721120|NCT03208257|Adrenergic Agents|adrenergic agents|mesh-ancestor
5918564|NCT04990791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918565|NCT04990791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5918566|NCT04990791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5918567|NCT04990791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5918568|NCT04990791|Antipyretics|antipyretics|mesh-ancestor
5918569|NCT04990791|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5918570|NCT04990791|Antithrombins|antithrombins|mesh-ancestor
5918571|NCT04990791|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5918572|NCT04990791|Protease Inhibitors|protease inhibitors|mesh-ancestor
5918573|NCT04990791|Anticoagulants|anticoagulants|mesh-ancestor
5918581|NCT04990778|Venetoclax|venetoclax|mesh-list
5918582|NCT04990778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5918583|NCT04990752|Urinastatin|urinastatin|mesh-list
5918584|NCT04990752|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6221585|NCT02342015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6221586|NCT02342197|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6221587|NCT02342197|Luteolytic Agents|luteolytic agents|mesh-ancestor
6221588|NCT02342197|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6221589|NCT02342197|Contraceptive Agents|contraceptive agents|mesh-ancestor
6221590|NCT02342197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6221591|NCT02342197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221592|NCT02342197|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6221593|NCT02342197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6221594|NCT02342197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6221595|NCT02342223|Hyaluronic Acid|hyaluronic acid|mesh-list
6221596|NCT02342223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6221597|NCT02342223|Immunologic Factors|immunologic factors|mesh-ancestor
6221598|NCT02342223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221599|NCT02342223|Viscosupplements|viscosupplements|mesh-ancestor
6221600|NCT02342223|Protective Agents|protective agents|mesh-ancestor
6221601|NCT02342327|Menthol|menthol|mesh-list
6221602|NCT02342327|Antipruritics|antipruritics|mesh-ancestor
6221603|NCT02342327|Dermatologic Agents|dermatologic agents|mesh-ancestor
6221604|NCT02342379|Bevacizumab|bevacizumab|mesh-list
6221605|NCT02342379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6221606|NCT02342379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6221607|NCT02342379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6221608|NCT02342379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6221609|NCT02342379|Growth Substances|growth substances|mesh-ancestor
6221610|NCT02342379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221611|NCT02342379|Growth Inhibitors|growth inhibitors|mesh-ancestor
6221612|NCT02342418|Tedizolid|tedizolid|mesh-list
5703739|NCT03328728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703740|NCT03328676|Chlorophyllin|chlorophyllin|mesh-list
5703741|NCT03328676|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
5703742|NCT03328676|Protective Agents|protective agents|mesh-ancestor
5703743|NCT03328676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703744|NCT03328533|Phenylephrine|phenylephrine|mesh-list
5703745|NCT03328533|Oxymetazoline|oxymetazoline|mesh-list
5703746|NCT03328533|Norepinephrine|norepinephrine|mesh-list
6221613|NCT02342418|Tedizolid phosphate|tedizolid phosphate|mesh-list
6221614|NCT02342418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6221615|NCT02342418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6221616|NCT02342561|Anti-Infective Agents|anti-infective agents|mesh-list
6221617|NCT02342561|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6221618|NCT02342639|Rifaximin|rifaximin|mesh-list
6221619|NCT02342639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6221620|NCT02342639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6221621|NCT02342639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6221622|NCT02342704|Natalizumab|natalizumab|mesh-list
6221623|NCT02342704|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6221624|NCT02342704|Immunologic Factors|immunologic factors|mesh-ancestor
6221625|NCT02342704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221626|NCT02342704|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6221627|NCT02342704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221628|NCT02342704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6221629|NCT02342886|Moxifloxacin|moxifloxacin|mesh-list
6221630|NCT02342886|Rifampin|rifampin|mesh-list
6221631|NCT02342886|Isoniazid|isoniazid|mesh-list
6221632|NCT02342886|Pyrazinamide|pyrazinamide|mesh-list
6221633|NCT02342886|Ethambutol|ethambutol|mesh-list
6221634|NCT02342886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6221635|NCT02342886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6221636|NCT02342886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6221637|NCT02342886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6221638|NCT02342886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6221639|NCT02342886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221640|NCT02342886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6221641|NCT02342886|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6221642|NCT02342886|Antitubercular Agents|antitubercular agents|mesh-ancestor
6221643|NCT02342886|Leprostatic Agents|leprostatic agents|mesh-ancestor
6221644|NCT02342886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6221645|NCT02342886|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6221646|NCT02342886|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6221647|NCT02342886|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6221648|NCT02342886|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6221649|NCT02342886|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5703747|NCT03328533|Bupivacaine|bupivacaine|mesh-list
5703748|NCT03328533|Anesthetics, Local|anesthetics, local|mesh-ancestor
6221650|NCT02342886|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6221651|NCT02342886|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6676146|NCT01579279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676147|NCT01579279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6676148|NCT01579279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676149|NCT01579279|Analgesics|analgesics|mesh-ancestor
6676150|NCT01579279|Sensory System Agents|sensory system agents|mesh-ancestor
6676151|NCT01579279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5703749|NCT03328533|Anesthetics|anesthetics|mesh-ancestor
6221652|NCT02342886|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6221653|NCT02342886|Antimetabolites|antimetabolites|mesh-ancestor
6221654|NCT02342886|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6221655|NCT02343081|Temozolomide|temozolomide|mesh-list
6221656|NCT02343081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6221657|NCT02343081|Alkylating Agents|alkylating agents|mesh-ancestor
6221658|NCT02343081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703750|NCT03328533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5703751|NCT03328533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703752|NCT03328533|Sensory System Agents|sensory system agents|mesh-ancestor
5703753|NCT03328533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5703754|NCT03328533|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5703755|NCT03328533|Mydriatics|mydriatics|mesh-ancestor
5703756|NCT03328533|Autonomic Agents|autonomic agents|mesh-ancestor
5703757|NCT03328533|Sympathomimetics|sympathomimetics|mesh-ancestor
5703758|NCT03328533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6221659|NCT02343081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6221660|NCT02343276|Nitroglycerin|nitroglycerin|mesh-list
6221661|NCT02343276|Vasodilator Agents|vasodilator agents|mesh-ancestor
6221662|NCT02343406|Temozolomide|temozolomide|mesh-list
6221663|NCT02343406|Lomustine|lomustine|mesh-list
6221664|NCT02343406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6221665|NCT02343406|Alkylating Agents|alkylating agents|mesh-ancestor
6221666|NCT02343406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221667|NCT02343406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6221668|NCT02343458|Glycopyrrolate|glycopyrrolate|mesh-list
6221669|NCT02343458|Formoterol Fumarate|formoterol fumarate|mesh-list
6221670|NCT02343458|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6221671|NCT02343458|Autonomic Agents|autonomic agents|mesh-ancestor
6221672|NCT02343458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6221673|NCT02343458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221674|NCT02343458|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6221675|NCT02343458|Respiratory System Agents|respiratory system agents|mesh-ancestor
6221676|NCT02343458|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6221677|NCT02343458|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6221678|NCT02343458|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6221679|NCT02343458|Adrenergic Agents|adrenergic agents|mesh-ancestor
6221680|NCT02343458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6221681|NCT02343458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221682|NCT02343458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6221683|NCT02343458|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6221684|NCT02343458|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6221685|NCT02343458|Cholinergic Agents|cholinergic agents|mesh-ancestor
6221686|NCT02343549|Bevacizumab|bevacizumab|mesh-list
6221687|NCT02343549|Temozolomide|temozolomide|mesh-list
6221688|NCT02343549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6221689|NCT02343549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6221690|NCT02343549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6221691|NCT02343549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6221692|NCT02343549|Growth Substances|growth substances|mesh-ancestor
6221693|NCT02343549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221694|NCT02343549|Growth Inhibitors|growth inhibitors|mesh-ancestor
6221695|NCT02343549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6221696|NCT02343549|Alkylating Agents|alkylating agents|mesh-ancestor
6221697|NCT02343549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221698|NCT02343575|Valproic Acid|valproic acid|mesh-list
6221699|NCT02343575|Haloperidol|haloperidol|mesh-list
6221700|NCT02343575|Haloperidol decanoate|haloperidol decanoate|mesh-list
6221701|NCT02343575|Antiemetics|antiemetics|mesh-ancestor
6221702|NCT02343575|Autonomic Agents|autonomic agents|mesh-ancestor
6221703|NCT02343575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6221704|NCT02343575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221705|NCT02343575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6221706|NCT02343575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6221707|NCT02343575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6221708|NCT02343575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6221709|NCT02343575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6221710|NCT02343575|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6221711|NCT02343575|Dopamine Agents|dopamine agents|mesh-ancestor
6221712|NCT02343575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6221713|NCT02343575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221714|NCT02343575|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6221715|NCT02343575|Anticonvulsants|anticonvulsants|mesh-ancestor
6221716|NCT02343575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6221717|NCT02343575|GABA Agents|gaba agents|mesh-ancestor
6221718|NCT02343575|Antimanic Agents|antimanic agents|mesh-ancestor
6221719|NCT02343939|Cytarabine|cytarabine|mesh-list
6221720|NCT02343939|Azacitidine|azacitidine|mesh-list
6221721|NCT02343939|Decitabine|decitabine|mesh-list
6221722|NCT02343939|Daunorubicin|daunorubicin|mesh-list
6221723|NCT02343939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6221724|NCT02343939|Antimetabolites|antimetabolites|mesh-ancestor
6221725|NCT02343939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221726|NCT02343939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6221727|NCT02343939|Antiviral Agents|antiviral agents|mesh-ancestor
6221728|NCT02343939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6221729|NCT02343939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6221730|NCT02343939|Immunologic Factors|immunologic factors|mesh-ancestor
6221731|NCT02343939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221732|NCT02343939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6221733|NCT02343939|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6221734|NCT02343939|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6221735|NCT02343939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6221736|NCT02344004|Amikacin|amikacin|mesh-list
6221737|NCT02344004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5703759|NCT03328533|Nasal Decongestants|nasal decongestants|mesh-ancestor
5703760|NCT03328533|Respiratory System Agents|respiratory system agents|mesh-ancestor
5703761|NCT03328533|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5703762|NCT03328533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5703763|NCT03328533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5703764|NCT03328533|Adrenergic Agents|adrenergic agents|mesh-ancestor
5703765|NCT03328533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5703766|NCT03328533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703767|NCT03328533|Protective Agents|protective agents|mesh-ancestor
5703768|NCT03328494|Paclitaxel|paclitaxel|mesh-list
5703769|NCT03328494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5703770|NCT03328494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5703771|NCT03328494|Tubulin Modulators|tubulin modulators|mesh-ancestor
5703772|NCT03328494|Antimitotic Agents|antimitotic agents|mesh-ancestor
5703773|NCT03328494|Mitosis Modulators|mitosis modulators|mesh-ancestor
5703774|NCT03328494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703775|NCT03328481|Anesthetics|anesthetics|mesh-list
5703776|NCT03328481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5703777|NCT03328481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703778|NCT03328364|Docetaxel|docetaxel|mesh-list
5703779|NCT03328364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5703780|NCT03328364|Tubulin Modulators|tubulin modulators|mesh-ancestor
6221738|NCT02344004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6221739|NCT02344225|Ibuprofen|ibuprofen|mesh-list
6221740|NCT02344225|Ketorolac|ketorolac|mesh-list
6221741|NCT02344225|Caffeine|caffeine|mesh-list
6221742|NCT02344225|Caffeine citrate|caffeine citrate|mesh-list
6221743|NCT02344225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221744|NCT02344225|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6221745|NCT02344225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6221746|NCT02344225|Analgesics|analgesics|mesh-ancestor
6221747|NCT02344225|Sensory System Agents|sensory system agents|mesh-ancestor
6221748|NCT02344225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6221749|NCT02344225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221750|NCT02344225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6221751|NCT02344225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6221752|NCT02344225|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6221753|NCT02344225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6221754|NCT02344225|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6221755|NCT02344225|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6221756|NCT02344225|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6221757|NCT02344225|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6221758|NCT02344225|Purinergic Agents|purinergic agents|mesh-ancestor
6221759|NCT02344225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6221760|NCT02344238|Riboflavin|riboflavin|mesh-list
6221761|NCT02344238|Vitamin B Complex|vitamin b complex|mesh-ancestor
6221762|NCT02344238|Vitamins|vitamins|mesh-ancestor
5703781|NCT03328364|Antimitotic Agents|antimitotic agents|mesh-ancestor
6221763|NCT02344238|Micronutrients|micronutrients|mesh-ancestor
6221764|NCT02344238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703782|NCT03328364|Mitosis Modulators|mitosis modulators|mesh-ancestor
5703783|NCT03328364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703784|NCT03328312|Atropine|atropine|mesh-list
5703785|NCT03328312|Neostigmine|neostigmine|mesh-list
5703786|NCT03328312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5703787|NCT03328312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5703788|NCT03328312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5703789|NCT03328312|Autonomic Agents|autonomic agents|mesh-ancestor
5703790|NCT03328312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5703791|NCT03328312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703792|NCT03328312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5703793|NCT03328312|Respiratory System Agents|respiratory system agents|mesh-ancestor
5703794|NCT03328312|Mydriatics|mydriatics|mesh-ancestor
5703795|NCT03328312|Parasympatholytics|parasympatholytics|mesh-ancestor
5703796|NCT03328312|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5703797|NCT03328312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5703798|NCT03328312|Cholinergic Agents|cholinergic agents|mesh-ancestor
5703799|NCT03328312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5703800|NCT03328312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703801|NCT03328312|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5703802|NCT03328312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5703803|NCT03328312|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6221765|NCT02344238|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6221766|NCT02344238|Dermatologic Agents|dermatologic agents|mesh-ancestor
6498517|NCT00637481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498518|NCT00637481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6498519|NCT00637481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6498520|NCT00637481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6498521|NCT00637533|Botulinum Toxins|botulinum toxins|mesh-list
6498522|NCT00637533|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6498523|NCT00637533|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6498524|NCT00637533|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6498525|NCT00637533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6498526|NCT00637533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498527|NCT00637533|Cholinergic Agents|cholinergic agents|mesh-ancestor
6498528|NCT00637533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6498529|NCT00637533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498530|NCT00637533|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6498531|NCT00637533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6498532|NCT00637559|Esomeprazole|esomeprazole|mesh-list
6498533|NCT00637559|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6498534|NCT00637559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6498535|NCT00637559|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6498536|NCT00637559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6498537|NCT00637559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498538|NCT00637585|Fexofenadine|fexofenadine|mesh-list
6498539|NCT00637585|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6498540|NCT00637585|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6498541|NCT00637585|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6498542|NCT00637585|Histamine Antagonists|histamine antagonists|mesh-ancestor
6498543|NCT00637585|Histamine Agents|histamine agents|mesh-ancestor
6498544|NCT00637585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6498545|NCT00637585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498546|NCT00637585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498547|NCT00637611|Fexofenadine|fexofenadine|mesh-list
6498548|NCT00637611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6498549|NCT00637611|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6498550|NCT00637611|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6498551|NCT00637611|Histamine Antagonists|histamine antagonists|mesh-ancestor
6498552|NCT00637611|Histamine Agents|histamine agents|mesh-ancestor
6498553|NCT00637611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6498554|NCT00637611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498555|NCT00637611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498556|NCT00637624|Acetylcysteine|acetylcysteine|mesh-list
6498557|NCT00637624|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6498558|NCT00637624|Antiviral Agents|antiviral agents|mesh-ancestor
6498559|NCT00637624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6498560|NCT00637624|Expectorants|expectorants|mesh-ancestor
6498561|NCT00637624|Respiratory System Agents|respiratory system agents|mesh-ancestor
6498562|NCT00637624|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6498563|NCT00637624|Antioxidants|antioxidants|mesh-ancestor
6221767|NCT02344316|Melatonin|melatonin|mesh-list
6221768|NCT02344316|Antioxidants|antioxidants|mesh-ancestor
6221769|NCT02344316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221770|NCT02344316|Protective Agents|protective agents|mesh-ancestor
6221771|NCT02344316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221772|NCT02344316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6221773|NCT02344342|Diuretics|diuretics|mesh-list
6221774|NCT02344342|Natriuretic Agents|natriuretic agents|mesh-ancestor
5703804|NCT03328299|Dexmedetomidine|dexmedetomidine|mesh-list
5703805|NCT03328299|Bupivacaine|bupivacaine|mesh-list
5703806|NCT03328299|Anesthetics, Local|anesthetics, local|mesh-ancestor
5703807|NCT03328299|Anesthetics|anesthetics|mesh-ancestor
5703808|NCT03328299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5703809|NCT03328299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703810|NCT03328299|Sensory System Agents|sensory system agents|mesh-ancestor
5703811|NCT03328299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5703812|NCT03328299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5703813|NCT03328299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5703814|NCT03328299|Analgesics|analgesics|mesh-ancestor
5703815|NCT03328299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5703816|NCT03328299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5703817|NCT03328299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5703818|NCT03328299|Adrenergic Agents|adrenergic agents|mesh-ancestor
5703819|NCT03328299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5703820|NCT03328299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703821|NCT03328234|Paclitaxel|paclitaxel|mesh-list
5703822|NCT03328234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5703823|NCT03328234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6221775|NCT02344342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221776|NCT02344628|Azithromycin|azithromycin|mesh-list
6221777|NCT02344628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6221778|NCT02344628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6221779|NCT02345161|Budesonide|budesonide|mesh-list
6221780|NCT02345161|Albuterol|albuterol|mesh-list
6221781|NCT02345161|Formoterol Fumarate|formoterol fumarate|mesh-list
6221782|NCT02345161|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6221783|NCT02345161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6221784|NCT02345161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6221785|NCT02345161|Autonomic Agents|autonomic agents|mesh-ancestor
6221786|NCT02345161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6221787|NCT02345161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221788|NCT02345161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6221789|NCT02345161|Respiratory System Agents|respiratory system agents|mesh-ancestor
6221790|NCT02345161|Glucocorticoids|glucocorticoids|mesh-ancestor
6221791|NCT02345161|Hormones|hormones|mesh-ancestor
6221792|NCT02345161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6221793|NCT02345161|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6221794|NCT02345161|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6221795|NCT02345161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6221796|NCT02345161|Adrenergic Agents|adrenergic agents|mesh-ancestor
6221797|NCT02345161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6221798|NCT02345161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221799|NCT02345161|Tocolytic Agents|tocolytic agents|mesh-ancestor
6221800|NCT02345161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5703824|NCT03328234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5703825|NCT03328234|Tubulin Modulators|tubulin modulators|mesh-ancestor
5703826|NCT03328234|Antimitotic Agents|antimitotic agents|mesh-ancestor
5703827|NCT03328234|Mitosis Modulators|mitosis modulators|mesh-ancestor
5721121|NCT03208257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6221801|NCT02345226|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6221802|NCT02345226|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6221803|NCT02345226|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6221804|NCT02345226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6221805|NCT02345226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6221806|NCT02345226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221807|NCT02345226|Antiviral Agents|antiviral agents|mesh-ancestor
6221808|NCT02345226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6221809|NCT02345226|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6221810|NCT02345226|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6221811|NCT02345252|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
6221812|NCT02345252|Antiviral Agents|antiviral agents|mesh-ancestor
6221813|NCT02345252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6221814|NCT02345252|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6221815|NCT02345252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6221816|NCT02345252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6221817|NCT02345252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221818|NCT02345252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6221819|NCT02345252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6221820|NCT02345330|Interleukin-12|interleukin-12|mesh-list
6221821|NCT02345330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6221822|NCT02345330|Immunologic Factors|immunologic factors|mesh-ancestor
6221823|NCT02345330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221824|NCT02345330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6221825|NCT02345330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6221826|NCT02345330|Growth Substances|growth substances|mesh-ancestor
6221827|NCT02345330|Growth Inhibitors|growth inhibitors|mesh-ancestor
6221828|NCT02345330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6221829|NCT02345486|Plasma-lyte 148|plasma-lyte 148|mesh-list
6221830|NCT02345486|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6221831|NCT02345486|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6221832|NCT02346240|Etanercept|etanercept|mesh-list
6221833|NCT02346240|Certolizumab Pegol|certolizumab pegol|mesh-list
6221834|NCT02346240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6221835|NCT02346240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6221836|NCT02346240|Analgesics|analgesics|mesh-ancestor
6221837|NCT02346240|Sensory System Agents|sensory system agents|mesh-ancestor
5703828|NCT03328234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703829|NCT03328117|Imatinib Mesylate|imatinib mesylate|mesh-list
6221838|NCT02346240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6221839|NCT02346240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498564|NCT00637624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498565|NCT00637624|Protective Agents|protective agents|mesh-ancestor
6498566|NCT00637624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498567|NCT00637624|Antidotes|antidotes|mesh-ancestor
6498568|NCT00637637|Ritonavir|ritonavir|mesh-list
6498569|NCT00637637|Indinavir|indinavir|mesh-list
6498570|NCT00637637|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6498571|NCT00637637|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6498572|NCT00637637|Protease Inhibitors|protease inhibitors|mesh-ancestor
6676152|NCT01579279|Antidepressive Agents|antidepressive agents|mesh-ancestor
6676153|NCT01579279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6676154|NCT01579279|Dopamine Agents|dopamine agents|mesh-ancestor
6676155|NCT01579383|Sumatriptan|sumatriptan|mesh-list
6676156|NCT01579383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6676157|NCT01579383|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6676158|NCT01579383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6676159|NCT01579383|Serotonin Agents|serotonin agents|mesh-ancestor
6676160|NCT01579383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6676161|NCT01579383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676162|NCT01579383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676163|NCT01579448|Vaccines|vaccines|mesh-list
6676164|NCT01579448|Immunologic Factors|immunologic factors|mesh-ancestor
5703830|NCT03328117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5703831|NCT03328117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5703832|NCT03328117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5703833|NCT03328117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703834|NCT03328104|Cyclophosphamide|cyclophosphamide|mesh-list
5703835|NCT03328104|Etoposide|etoposide|mesh-list
5703836|NCT03328104|Everolimus|everolimus|mesh-list
6221840|NCT02346240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6498573|NCT00637637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6498574|NCT00637637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498575|NCT00637637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6676165|NCT01579448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676166|NCT01579461|Mirabegron|mirabegron|mesh-list
6221841|NCT02346240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6221842|NCT02346240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6221843|NCT02346240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6221844|NCT02346240|Immunologic Factors|immunologic factors|mesh-ancestor
6221845|NCT02346370|Docetaxel|docetaxel|mesh-list
6221846|NCT02346370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6221847|NCT02346370|Tubulin Modulators|tubulin modulators|mesh-ancestor
6221848|NCT02346370|Antimitotic Agents|antimitotic agents|mesh-ancestor
6221849|NCT02346370|Mitosis Modulators|mitosis modulators|mesh-ancestor
6221850|NCT02346370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221851|NCT02346721|Sofosbuvir|sofosbuvir|mesh-list
6243304|NCT02664922|Anesthetics|anesthetics|mesh-ancestor
6676167|NCT01579461|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6221852|NCT02346721|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
6221853|NCT02346721|Velpatasvir|velpatasvir|mesh-list
6221854|NCT02346721|Antiviral Agents|antiviral agents|mesh-ancestor
6221855|NCT02346721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6221856|NCT02346903|Capsaicin|capsaicin|mesh-list
6221857|NCT02346903|Antipruritics|antipruritics|mesh-ancestor
6221858|NCT02346903|Dermatologic Agents|dermatologic agents|mesh-ancestor
6221859|NCT02346903|Sensory System Agents|sensory system agents|mesh-ancestor
6221860|NCT02346903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6221861|NCT02346903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221862|NCT02346916|Capsaicin|capsaicin|mesh-list
6221863|NCT02346916|Antipruritics|antipruritics|mesh-ancestor
5918585|NCT04990752|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5918586|NCT04990752|Protease Inhibitors|protease inhibitors|mesh-ancestor
5918587|NCT04990752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5918588|NCT04990752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918589|NCT04990232|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5918590|NCT04990232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5918591|NCT04989985|Oxaliplatin|oxaliplatin|mesh-list
5918592|NCT04989985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6221864|NCT02346916|Dermatologic Agents|dermatologic agents|mesh-ancestor
6221865|NCT02346916|Sensory System Agents|sensory system agents|mesh-ancestor
6498576|NCT00637637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6498577|NCT00637637|Antiviral Agents|antiviral agents|mesh-ancestor
6498578|NCT00637637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6498579|NCT00637637|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6221866|NCT02346916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6221867|NCT02346916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221868|NCT02347072|Glycopyrrolate|glycopyrrolate|mesh-list
6221869|NCT02347072|Bromides|bromides|mesh-list
6221870|NCT02347072|Formoterol Fumarate|formoterol fumarate|mesh-list
6221871|NCT02347072|Tiotropium Bromide|tiotropium bromide|mesh-list
6221872|NCT02347072|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6221873|NCT02347072|Autonomic Agents|autonomic agents|mesh-ancestor
6221874|NCT02347072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6221875|NCT02347072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221876|NCT02347072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6221877|NCT02347072|Respiratory System Agents|respiratory system agents|mesh-ancestor
6221878|NCT02347072|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6221879|NCT02347072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6221880|NCT02347072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6221881|NCT02347072|Adrenergic Agents|adrenergic agents|mesh-ancestor
6221882|NCT02347072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6221883|NCT02347072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221884|NCT02347072|Parasympatholytics|parasympatholytics|mesh-ancestor
6221885|NCT02347072|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6221886|NCT02347072|Cholinergic Agents|cholinergic agents|mesh-ancestor
6221887|NCT02347072|Anticonvulsants|anticonvulsants|mesh-ancestor
6221888|NCT02347072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6221889|NCT02347072|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6498580|NCT00637637|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5703837|NCT03328104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5703838|NCT03328104|Immunologic Factors|immunologic factors|mesh-ancestor
5703839|NCT03328104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918593|NCT04990037|Folfirinox|folfirinox|mesh-list
5918594|NCT04990037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5918595|NCT04990258|Infliximab|infliximab|mesh-list
5918596|NCT04990258|Dermatologic Agents|dermatologic agents|mesh-ancestor
5918597|NCT04990258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5918598|NCT04990258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5918599|NCT04990167|Bromides|bromides|mesh-list
5918600|NCT04990167|Tiotropium Bromide|tiotropium bromide|mesh-list
5918601|NCT04990167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5918602|NCT04990167|Autonomic Agents|autonomic agents|mesh-ancestor
5918603|NCT04990167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5703840|NCT03328104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5703841|NCT03328104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5703842|NCT03328104|Alkylating Agents|alkylating agents|mesh-ancestor
5703843|NCT03328104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918604|NCT04990167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918605|NCT04990167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5918606|NCT04990167|Respiratory System Agents|respiratory system agents|mesh-ancestor
5918607|NCT04990167|Parasympatholytics|parasympatholytics|mesh-ancestor
5918608|NCT04990167|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5918609|NCT04990167|Cholinergic Agents|cholinergic agents|mesh-ancestor
6221890|NCT02347085|Glycopyrrolate|glycopyrrolate|mesh-list
6221891|NCT02347085|Formoterol Fumarate|formoterol fumarate|mesh-list
6221892|NCT02347085|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6221893|NCT02347085|Autonomic Agents|autonomic agents|mesh-ancestor
6221894|NCT02347085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6221895|NCT02347085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221896|NCT02347085|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6221897|NCT02347085|Respiratory System Agents|respiratory system agents|mesh-ancestor
6221898|NCT02347085|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6221899|NCT02347085|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6221900|NCT02347085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6221901|NCT02347085|Adrenergic Agents|adrenergic agents|mesh-ancestor
6221902|NCT02347085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6221903|NCT02347085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221904|NCT02347085|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6221905|NCT02347085|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6221906|NCT02347085|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6221907|NCT02347085|Cholinergic Agents|cholinergic agents|mesh-ancestor
6221908|NCT02347098|Atorvastatin|atorvastatin|mesh-list
6221909|NCT02347098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
6221910|NCT02347098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6221911|NCT02347098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6221912|NCT02347098|Antimetabolites|antimetabolites|mesh-ancestor
6221913|NCT02347098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221914|NCT02347098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6221915|NCT02347098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6221916|NCT02347176|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6221917|NCT02347176|Immunologic Factors|immunologic factors|mesh-ancestor
6221918|NCT02347176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221919|NCT02347332|Methotrexate|methotrexate|mesh-list
6221920|NCT02347332|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6221921|NCT02347332|Abortifacient Agents|abortifacient agents|mesh-ancestor
6221922|NCT02347332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6221923|NCT02347332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221924|NCT02347332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6221925|NCT02347332|Antimetabolites|antimetabolites|mesh-ancestor
6221926|NCT02347332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221927|NCT02347332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6221928|NCT02347332|Dermatologic Agents|dermatologic agents|mesh-ancestor
6498581|NCT00637663|Lamivudine|lamivudine|mesh-list
6498582|NCT00637663|Entecavir|entecavir|mesh-list
6498583|NCT00637663|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6498584|NCT00637663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6498585|NCT00637663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6498586|NCT00637663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498587|NCT00637663|Antiviral Agents|antiviral agents|mesh-ancestor
6498588|NCT00637663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6498589|NCT00637663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6498590|NCT00637663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6498591|NCT00637715|Alfuzosin|alfuzosin|mesh-list
6498592|NCT00637715|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6498593|NCT00637715|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6498594|NCT00637715|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6498595|NCT00637715|Adrenergic Agents|adrenergic agents|mesh-ancestor
6498596|NCT00637715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6498597|NCT00637715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498598|NCT00637715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498599|NCT00637715|Urological Agents|urological agents|mesh-ancestor
6498600|NCT00637767|Melphalan|melphalan|mesh-list
6498601|NCT00637767|Antibodies|antibodies|mesh-list
6498602|NCT00637767|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6498603|NCT00637767|Immunologic Factors|immunologic factors|mesh-ancestor
6498604|NCT00637767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498605|NCT00637767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6498606|NCT00637767|Alkylating Agents|alkylating agents|mesh-ancestor
6498607|NCT00637767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498608|NCT00637767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6498609|NCT00637767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6498610|NCT00637767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6498611|NCT00637793|(S)-2-ethyl-8-methyl-1-thia-4,8-diazaspiro(4.5)decan-3-one|(s)-2-ethyl-8-methyl-1-thia-4,8-diazaspiro(4.5)decan-3-one|mesh-list
6498612|NCT00637793|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6221929|NCT02347332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6221930|NCT02347332|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6221931|NCT02347332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6221932|NCT02347332|Immunologic Factors|immunologic factors|mesh-ancestor
6221933|NCT02347332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6221934|NCT02347332|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6221935|NCT02347345|Sofosbuvir|sofosbuvir|mesh-list
6221936|NCT02347345|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
6221937|NCT02347345|Ledipasvir|ledipasvir|mesh-list
6221938|NCT02347345|Antiviral Agents|antiviral agents|mesh-ancestor
6221939|NCT02347345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6221940|NCT02347605|Nicotine|nicotine|mesh-list
6221941|NCT02347605|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6221942|NCT02347605|Autonomic Agents|autonomic agents|mesh-ancestor
6221943|NCT02347605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6221944|NCT02347605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221945|NCT02347605|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6221946|NCT02347605|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6221947|NCT02347605|Cholinergic Agents|cholinergic agents|mesh-ancestor
6221948|NCT02347605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6221949|NCT02347605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221950|NCT02347631|Dipivefrin|dipivefrin|mesh-list
6221951|NCT02347631|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6221952|NCT02347631|Adrenergic Agents|adrenergic agents|mesh-ancestor
6221953|NCT02347631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6221954|NCT02347631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221955|NCT02347631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221956|NCT02347657|Ivacaftor|ivacaftor|mesh-list
6221957|NCT02347657|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6221958|NCT02347657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6221959|NCT02347657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221960|NCT02347813|Pioglitazone|pioglitazone|mesh-list
6221961|NCT02347813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6221962|NCT02347813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221963|NCT02347917|Pemetrexed|pemetrexed|mesh-list
6221964|NCT02347917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6221965|NCT02347917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6221966|NCT02347917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221967|NCT02347917|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6221968|NCT02347917|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6221969|NCT02348008|Bevacizumab|bevacizumab|mesh-list
6221970|NCT02348008|Pembrolizumab|pembrolizumab|mesh-list
6221971|NCT02348008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6221972|NCT02348008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6221973|NCT02348008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6221974|NCT02348008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6221975|NCT02348008|Growth Substances|growth substances|mesh-ancestor
6221976|NCT02348008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221977|NCT02348008|Growth Inhibitors|growth inhibitors|mesh-ancestor
6221978|NCT02348203|Aspirin|aspirin|mesh-list
6221979|NCT02348203|Zileuton|zileuton|mesh-list
6221980|NCT02348203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6221981|NCT02348203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6221982|NCT02348203|Analgesics|analgesics|mesh-ancestor
6221983|NCT02348203|Sensory System Agents|sensory system agents|mesh-ancestor
6221984|NCT02348203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6221985|NCT02348203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6221986|NCT02348203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6221987|NCT02348203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6221988|NCT02348203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6221989|NCT02348203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6221990|NCT02348203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6221991|NCT02348203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6221992|NCT02348203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6221993|NCT02348203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6221994|NCT02348203|Antipyretics|antipyretics|mesh-ancestor
6221995|NCT02348203|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6221996|NCT02348203|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6221997|NCT02348203|Hormone Antagonists|hormone antagonists|mesh-ancestor
6221998|NCT02348203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6221999|NCT02348216|Cyclophosphamide|cyclophosphamide|mesh-list
6222000|NCT02348216|Fludarabine|fludarabine|mesh-list
6222001|NCT02348216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6222002|NCT02348216|Immunologic Factors|immunologic factors|mesh-ancestor
6222003|NCT02348216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222004|NCT02348216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6243305|NCT02664922|Analgesics|analgesics|mesh-ancestor
6222005|NCT02348216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6222006|NCT02348216|Alkylating Agents|alkylating agents|mesh-ancestor
6222007|NCT02348216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222008|NCT02348216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6222009|NCT02348216|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6222010|NCT02348385|Amphetamine|amphetamine|mesh-list
6222011|NCT02348385|Dextroamphetamine|dextroamphetamine|mesh-list
6222012|NCT02348385|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6222013|NCT02348385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222014|NCT02348385|Sympathomimetics|sympathomimetics|mesh-ancestor
6222015|NCT02348385|Autonomic Agents|autonomic agents|mesh-ancestor
6222016|NCT02348385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6222017|NCT02348385|Dopamine Agents|dopamine agents|mesh-ancestor
6222018|NCT02348385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6222019|NCT02348385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222020|NCT02348385|Adrenergic Agents|adrenergic agents|mesh-ancestor
6222021|NCT02348385|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6222022|NCT02348385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6222023|NCT02348385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6222024|NCT02348385|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6222025|NCT02348489|Guadecitabine|guadecitabine|mesh-list
6222026|NCT02348489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6243306|NCT02664922|Sensory System Agents|sensory system agents|mesh-ancestor
6243307|NCT02664922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6243308|NCT02664922|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6243309|NCT02664922|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5703844|NCT03328104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5703845|NCT03328104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5703846|NCT03328104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5703847|NCT03328104|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5703848|NCT03328104|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5703849|NCT03328104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5703850|NCT03328052|Antidepressive Agents|antidepressive agents|mesh-list
5703851|NCT03328052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5703852|NCT03327987|Vaccines|vaccines|mesh-list
5703853|NCT03327987|Immunologic Factors|immunologic factors|mesh-ancestor
5703854|NCT03327987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721122|NCT03208257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721123|NCT03208257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721124|NCT03208270|Antithrombins|antithrombins|mesh-list
6243310|NCT02664922|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6243311|NCT02664922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6243312|NCT02664922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243313|NCT02664922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6243314|NCT02664922|Narcotics|narcotics|mesh-ancestor
6243315|NCT02664922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6243316|NCT02664922|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6243317|NCT02664961|Bevacizumab|bevacizumab|mesh-list
6243318|NCT02664961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6243319|NCT02664961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6243320|NCT02664961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6243321|NCT02664961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6243322|NCT02664961|Growth Substances|growth substances|mesh-ancestor
6243323|NCT02664961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243324|NCT02664961|Growth Inhibitors|growth inhibitors|mesh-ancestor
6243325|NCT02665260|Cantharidin|cantharidin|mesh-list
6243326|NCT02665260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6243327|NCT02665260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243328|NCT02665273|Bupivacaine|bupivacaine|mesh-list
6243329|NCT02665273|Anesthetics, Local|anesthetics, local|mesh-ancestor
6243330|NCT02665273|Anesthetics|anesthetics|mesh-ancestor
6243331|NCT02665273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6243332|NCT02665273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243333|NCT02665273|Sensory System Agents|sensory system agents|mesh-ancestor
6243334|NCT02665273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6243335|NCT02665286|Naproxen|naproxen|mesh-list
6243336|NCT02665286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
6243337|NCT02665286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
6243338|NCT02665286|Orphenadrine|orphenadrine|mesh-list
6243339|NCT02665286|Methocarbamol|methocarbamol|mesh-list
6243340|NCT02665286|Cholinergic Antagonists|cholinergic antagonists|mesh-list
6243341|NCT02665286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6243342|NCT02665286|Analgesics|analgesics|mesh-ancestor
5703855|NCT03327831|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5703856|NCT03327831|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5703857|NCT03327831|Dermatologic Agents|dermatologic agents|mesh-ancestor
5703858|NCT03327766|Calcifediol|calcifediol|mesh-list
5703859|NCT03327766|Vitamins|vitamins|mesh-ancestor
5703860|NCT03327766|Micronutrients|micronutrients|mesh-ancestor
5703861|NCT03327766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703862|NCT03327766|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5703863|NCT03327727|Voriconazole|voriconazole|mesh-list
5703864|NCT03327727|Amphotericin B|amphotericin b|mesh-list
6222027|NCT02348658|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
6222028|NCT02348658|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6222029|NCT02348658|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6222030|NCT02348658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222031|NCT02348723|Warfarin|warfarin|mesh-list
6222032|NCT02348723|Dabigatran|dabigatran|mesh-list
6222033|NCT02348723|Anticoagulants|anticoagulants|mesh-ancestor
6222034|NCT02348723|Antithrombins|antithrombins|mesh-ancestor
6222035|NCT02348723|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6222036|NCT02348723|Protease Inhibitors|protease inhibitors|mesh-ancestor
6222037|NCT02348723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6222038|NCT02348723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222039|NCT02348775|Acetylcysteine|acetylcysteine|mesh-list
6222040|NCT02348775|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6222041|NCT02348775|Glycine|glycine|mesh-list
6222042|NCT02348775|Antiviral Agents|antiviral agents|mesh-ancestor
6222043|NCT02348775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6222044|NCT02348775|Expectorants|expectorants|mesh-ancestor
6222045|NCT02348775|Respiratory System Agents|respiratory system agents|mesh-ancestor
6222046|NCT02348775|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6222047|NCT02348775|Antioxidants|antioxidants|mesh-ancestor
6222048|NCT02348775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222049|NCT02348775|Protective Agents|protective agents|mesh-ancestor
6222050|NCT02348775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703865|NCT03327727|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
5703866|NCT03327727|Isavuconazole|isavuconazole|mesh-list
5703867|NCT03327727|VL-2397|vl-2397|mesh-list
6498613|NCT00637793|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6498614|NCT00637793|Cholinergic Agents|cholinergic agents|mesh-ancestor
6498615|NCT00637793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6498616|NCT00637793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498617|NCT00637793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498618|NCT00637819|Leflunomide|leflunomide|mesh-list
6498619|NCT00637819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6498620|NCT00637819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498621|NCT00637819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6498622|NCT00637819|Immunologic Factors|immunologic factors|mesh-ancestor
6222051|NCT02348775|Antidotes|antidotes|mesh-ancestor
6222052|NCT02348775|Glycine Agents|glycine agents|mesh-ancestor
5703868|NCT03327727|Antifungal Agents|antifungal agents|mesh-ancestor
5703869|NCT03327727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5703870|NCT03327727|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6222053|NCT02348775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6222054|NCT02348918|Bevacizumab|bevacizumab|mesh-list
6222055|NCT02348918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6222056|NCT02348918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6222057|NCT02348918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6222058|NCT02348918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6222059|NCT02348918|Growth Substances|growth substances|mesh-ancestor
6222060|NCT02348918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222061|NCT02348918|Growth Inhibitors|growth inhibitors|mesh-ancestor
6222062|NCT02349048|Sofosbuvir|sofosbuvir|mesh-list
6222063|NCT02349048|Simeprevir|simeprevir|mesh-list
6222064|NCT02349048|Antiviral Agents|antiviral agents|mesh-ancestor
6222065|NCT02349048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5703871|NCT03327727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5918610|NCT04990167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5918611|NCT04990167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918612|NCT04990167|Anticonvulsants|anticonvulsants|mesh-ancestor
5964065|NCT04595318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5964066|NCT04595318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964067|NCT04595318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964068|NCT04595591|Remifentanil|remifentanil|mesh-list
5964069|NCT04595591|Rocuronium|rocuronium|mesh-list
5964070|NCT04595591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6222066|NCT02349048|Protease Inhibitors|protease inhibitors|mesh-ancestor
6222067|NCT02349048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6222068|NCT02349048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222069|NCT02349061|Ustekinumab|ustekinumab|mesh-list
6222070|NCT02349061|Dermatologic Agents|dermatologic agents|mesh-ancestor
6222071|NCT02349152|Fentanyl|fentanyl|mesh-list
6222072|NCT02349152|Remifentanil|remifentanil|mesh-list
6222073|NCT02349152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6222074|NCT02349152|Narcotics|narcotics|mesh-ancestor
6222075|NCT02349152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6222076|NCT02349152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222077|NCT02349152|Analgesics|analgesics|mesh-ancestor
6222078|NCT02349152|Sensory System Agents|sensory system agents|mesh-ancestor
6222079|NCT02349152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6222080|NCT02349152|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6222081|NCT02349152|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6222082|NCT02349152|Anesthetics, General|anesthetics, general|mesh-ancestor
6222083|NCT02349152|Anesthetics|anesthetics|mesh-ancestor
5918613|NCT04989660|Phenol|phenol|mesh-list
5918614|NCT04989660|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5918615|NCT04989660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5918616|NCT04989660|Disinfectants|disinfectants|mesh-ancestor
5918617|NCT04989660|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
5918618|NCT04989660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6222084|NCT02349178|Cyclophosphamide|cyclophosphamide|mesh-list
6222085|NCT02349178|Etoposide|etoposide|mesh-list
6222086|NCT02349178|Clofarabine|clofarabine|mesh-list
6222087|NCT02349178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6222088|NCT02349178|Immunologic Factors|immunologic factors|mesh-ancestor
6222089|NCT02349178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222090|NCT02349178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6222091|NCT02349178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6222092|NCT02349178|Alkylating Agents|alkylating agents|mesh-ancestor
6222093|NCT02349178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222094|NCT02349178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6222095|NCT02349178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6222096|NCT02349178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6222097|NCT02349178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6222098|NCT02349178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6222099|NCT02349178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6222100|NCT02349178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6222101|NCT02349178|Antimetabolites|antimetabolites|mesh-ancestor
6222102|NCT02349295|Ixekizumab|ixekizumab|mesh-list
6222103|NCT02349295|Dermatologic Agents|dermatologic agents|mesh-ancestor
6222104|NCT02349451|Adalimumab|adalimumab|mesh-list
6222105|NCT02349451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6222106|NCT02349451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6498623|NCT00637819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498624|NCT00637845|Esomeprazole|esomeprazole|mesh-list
6498625|NCT00637845|Lansoprazole|lansoprazole|mesh-list
6498626|NCT00637845|Dexlansoprazole|dexlansoprazole|mesh-list
6498627|NCT00637845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6498628|NCT00637845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6498629|NCT00637845|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6498630|NCT00637845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6498631|NCT00637845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498632|NCT00637858|Lycopene|lycopene|mesh-list
6498633|NCT00637858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6498634|NCT00637858|Antioxidants|antioxidants|mesh-ancestor
6498635|NCT00637858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498636|NCT00637858|Protective Agents|protective agents|mesh-ancestor
6498637|NCT00637858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498638|NCT00637858|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6498639|NCT00637858|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6498640|NCT00637858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6498641|NCT00637871|Tamoxifen|tamoxifen|mesh-list
6498642|NCT00637871|Bicalutamide|bicalutamide|mesh-list
6498643|NCT00637871|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6498644|NCT00637871|Hormone Antagonists|hormone antagonists|mesh-ancestor
6498645|NCT00637871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6498646|NCT00637871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498647|NCT00637871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6498648|NCT00637871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6498649|NCT00637871|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6498650|NCT00637871|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5918619|NCT04989621|Rituximab|rituximab|mesh-list
6222107|NCT02349477|Gabapentin|gabapentin|mesh-list
6222108|NCT02349477|Analgesics|analgesics|mesh-ancestor
6222109|NCT02349477|Sensory System Agents|sensory system agents|mesh-ancestor
6222110|NCT02349477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6222111|NCT02349477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222112|NCT02349477|Anticonvulsants|anticonvulsants|mesh-ancestor
6222113|NCT02349477|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6222114|NCT02349477|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6222115|NCT02349477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6222116|NCT02349477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6222117|NCT02349477|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5703872|NCT03327727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5703873|NCT03327727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703874|NCT03327727|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5703875|NCT03327727|Hormone Antagonists|hormone antagonists|mesh-ancestor
5703876|NCT03327727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5703877|NCT03327727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703878|NCT03327727|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6222118|NCT02349477|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6222119|NCT02349477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6222120|NCT02349477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222121|NCT02349477|Antimanic Agents|antimanic agents|mesh-ancestor
6222122|NCT02349542|Bupivacaine|bupivacaine|mesh-list
6222123|NCT02349542|Anesthetics, Local|anesthetics, local|mesh-ancestor
6222124|NCT02349542|Anesthetics|anesthetics|mesh-ancestor
6222125|NCT02349542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6222126|NCT02349542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222127|NCT02349542|Sensory System Agents|sensory system agents|mesh-ancestor
6222128|NCT02349542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6222129|NCT02349633|Palbociclib|palbociclib|mesh-list
6222130|NCT02349633|Avelumab|avelumab|mesh-list
6222131|NCT02349633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6222132|NCT02349633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6222133|NCT02349633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6222134|NCT02349633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222135|NCT02349633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6222136|NCT02349685|Anti-Infective Agents|anti-infective agents|mesh-list
6222137|NCT02349685|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6222138|NCT02350309|Lemborexant|lemborexant|mesh-list
6222139|NCT02350309|Flurazepam|flurazepam|mesh-list
6222140|NCT02350309|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
6222141|NCT02350309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6222142|NCT02350309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222143|NCT02350309|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6222144|NCT02350309|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6222145|NCT02350309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6222146|NCT02350309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222147|NCT02350309|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6222148|NCT02350309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6222149|NCT02350309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6222150|NCT02350309|GABA Modulators|gaba modulators|mesh-ancestor
6222151|NCT02350309|GABA Agents|gaba agents|mesh-ancestor
6222152|NCT02350478|Linagliptin|linagliptin|mesh-list
6222153|NCT02350478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6222154|NCT02350478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222155|NCT02350478|Incretins|incretins|mesh-ancestor
6222156|NCT02350478|Hormones|hormones|mesh-ancestor
6222157|NCT02350478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6222158|NCT02350478|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6222159|NCT02350478|Protease Inhibitors|protease inhibitors|mesh-ancestor
6222160|NCT02350478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6222161|NCT02350478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222162|NCT02350569|Sofosbuvir|sofosbuvir|mesh-list
6222163|NCT02350569|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
6222164|NCT02350569|Ledipasvir|ledipasvir|mesh-list
6222165|NCT02350569|Antiviral Agents|antiviral agents|mesh-ancestor
6222166|NCT02350569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6222167|NCT02351037|Azacitidine|azacitidine|mesh-list
6222168|NCT02351037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6222169|NCT02351037|Antimetabolites|antimetabolites|mesh-ancestor
6222170|NCT02351037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222171|NCT02351037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6222172|NCT02351037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6222173|NCT02351115|Alprazolam|alprazolam|mesh-list
6222174|NCT02351115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6222175|NCT02351115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6222176|NCT02351115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222177|NCT02351115|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6222178|NCT02351115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6222179|NCT02351115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6222180|NCT02351115|GABA Modulators|gaba modulators|mesh-ancestor
6222181|NCT02351115|GABA Agents|gaba agents|mesh-ancestor
5703879|NCT03327727|Amebicides|amebicides|mesh-ancestor
5703880|NCT03327727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5703881|NCT03327727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5703882|NCT03327727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5703883|NCT03327701|Benralizumab|benralizumab|mesh-list
5703884|NCT03327701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5703885|NCT03327701|Respiratory System Agents|respiratory system agents|mesh-ancestor
5703886|NCT03327675|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5703887|NCT03327675|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5703888|NCT03327675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703889|NCT03327558|Mesalamine|mesalamine|mesh-list
5703890|NCT03327558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5703891|NCT03327558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5703892|NCT03327558|Analgesics|analgesics|mesh-ancestor
5703893|NCT03327558|Sensory System Agents|sensory system agents|mesh-ancestor
5703894|NCT03327558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5703895|NCT03327558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703896|NCT03327558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5703897|NCT03327558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5703898|NCT03327506|Alprazolam|alprazolam|mesh-list
5703899|NCT03327506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5703900|NCT03327506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5703901|NCT03327506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703902|NCT03327506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5703903|NCT03327506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6222182|NCT02351115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6222183|NCT02351115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222184|NCT02351167|Nicotine|nicotine|mesh-list
6222185|NCT02351167|Varenicline|varenicline|mesh-list
6222186|NCT02351167|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6222187|NCT02351167|Autonomic Agents|autonomic agents|mesh-ancestor
5703904|NCT03327506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5703905|NCT03327506|GABA Modulators|gaba modulators|mesh-ancestor
5703906|NCT03327506|GABA Agents|gaba agents|mesh-ancestor
5703907|NCT03327506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5703908|NCT03327506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222188|NCT02351167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6222189|NCT02351167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222190|NCT02351167|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6222191|NCT02351167|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6222192|NCT02351167|Cholinergic Agents|cholinergic agents|mesh-ancestor
6222193|NCT02351167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6222194|NCT02351167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222195|NCT02351700|Ibuprofen|ibuprofen|mesh-list
6222196|NCT02351700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6222197|NCT02351700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6222198|NCT02351700|Analgesics|analgesics|mesh-ancestor
6222199|NCT02351700|Sensory System Agents|sensory system agents|mesh-ancestor
6222200|NCT02351700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6222201|NCT02351700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222202|NCT02351700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6222203|NCT02351700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6222204|NCT02351700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6222205|NCT02351700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6222206|NCT02351700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222207|NCT02351739|Pembrolizumab|pembrolizumab|mesh-list
6222208|NCT02351739|Acalabrutinib|acalabrutinib|mesh-list
6222209|NCT02351739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6222210|NCT02351739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6222211|NCT02351934|Celecoxib|celecoxib|mesh-list
6222212|NCT02351934|Furosemide|furosemide|mesh-list
6222213|NCT02351934|Gabapentin|gabapentin|mesh-list
6222214|NCT02351934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6222215|NCT02351934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6222216|NCT02351934|Analgesics|analgesics|mesh-ancestor
6222217|NCT02351934|Sensory System Agents|sensory system agents|mesh-ancestor
6222218|NCT02351934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6222219|NCT02351934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703909|NCT03327454|Etanercept|etanercept|mesh-list
6222220|NCT02351934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6222221|NCT02351934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6222222|NCT02351934|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6222223|NCT02351934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6222224|NCT02351934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6222225|NCT02351934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222226|NCT02351934|Anticonvulsants|anticonvulsants|mesh-ancestor
6222227|NCT02351934|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6222228|NCT02351934|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6222229|NCT02351934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6222230|NCT02351934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6222231|NCT02351934|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6222232|NCT02351934|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6222233|NCT02351934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6222234|NCT02351934|Antimanic Agents|antimanic agents|mesh-ancestor
6222235|NCT02351934|Diuretics|diuretics|mesh-ancestor
6222236|NCT02351934|Natriuretic Agents|natriuretic agents|mesh-ancestor
6222237|NCT02351934|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6222238|NCT02351934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6222239|NCT02351960|Dexlansoprazole|dexlansoprazole|mesh-list
6222240|NCT02351960|Lansoprazole|lansoprazole|mesh-list
6222241|NCT02351960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6222242|NCT02351960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6222243|NCT02351960|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6222244|NCT02351960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6222245|NCT02351960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222246|NCT02352090|Dienogest|dienogest|mesh-list
6222247|NCT02352090|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6222248|NCT02352090|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6222249|NCT02352090|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6222250|NCT02352090|Estradiol|estradiol|mesh-list
6222251|NCT02352090|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6222252|NCT02352090|Nandrolone|nandrolone|mesh-list
6222253|NCT02352090|Estrogens|estrogens|mesh-ancestor
6222254|NCT02352090|Hormones|hormones|mesh-ancestor
6222255|NCT02352090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6222256|NCT02352090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222257|NCT02352090|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6222258|NCT02352090|Contraceptive Agents|contraceptive agents|mesh-ancestor
6222259|NCT02352090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6222260|NCT02352090|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5703910|NCT03327454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5703911|NCT03327454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5703912|NCT03327454|Analgesics|analgesics|mesh-ancestor
5703913|NCT03327454|Sensory System Agents|sensory system agents|mesh-ancestor
5703914|NCT03327454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5703915|NCT03327454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703916|NCT03327454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5703917|NCT03327454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5703918|NCT03327454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5703919|NCT03327454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5703920|NCT03327454|Immunologic Factors|immunologic factors|mesh-ancestor
5703921|NCT03327389|Dexmedetomidine|dexmedetomidine|mesh-list
6222261|NCT02352090|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6222262|NCT02352090|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6222263|NCT02352090|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6222264|NCT02352090|Hormone Antagonists|hormone antagonists|mesh-ancestor
6222265|NCT02352090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6222266|NCT02352090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6222267|NCT02352090|Androgens|androgens|mesh-ancestor
6222268|NCT02352090|Anabolic Agents|anabolic agents|mesh-ancestor
6222269|NCT02352259|Bleomycin|bleomycin|mesh-list
6222270|NCT02352259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6222271|NCT02352259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6222272|NCT02352363|Levodopa|levodopa|mesh-list
6222273|NCT02352363|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6222274|NCT02352363|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6222275|NCT02352363|Dopamine Agents|dopamine agents|mesh-ancestor
6222276|NCT02352363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6222277|NCT02352363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222278|NCT02352363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222279|NCT02352831|Capecitabine|capecitabine|mesh-list
6222280|NCT02352831|Tosedostat|tosedostat|mesh-list
6222281|NCT02352831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6222282|NCT02352831|Antimetabolites|antimetabolites|mesh-ancestor
5703922|NCT03327389|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5703923|NCT03327389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5703924|NCT03327389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703925|NCT03327389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5703926|NCT03327389|Analgesics|analgesics|mesh-ancestor
5703927|NCT03327389|Sensory System Agents|sensory system agents|mesh-ancestor
5703928|NCT03327389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5703929|NCT03327389|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5703930|NCT03327389|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5703931|NCT03327389|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6222283|NCT02352831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222284|NCT02352831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6222285|NCT02352831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6222286|NCT02352844|Everolimus|everolimus|mesh-list
6222287|NCT02352844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6222288|NCT02352844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6222289|NCT02352844|Immunologic Factors|immunologic factors|mesh-ancestor
6222290|NCT02352844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222291|NCT02352922|Bupivacaine|bupivacaine|mesh-list
6222292|NCT02352922|Anesthetics, Local|anesthetics, local|mesh-ancestor
6222293|NCT02352922|Anesthetics|anesthetics|mesh-ancestor
6222294|NCT02352922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6222295|NCT02352922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222296|NCT02352922|Sensory System Agents|sensory system agents|mesh-ancestor
6222297|NCT02352922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6222298|NCT02352974|Vitamin D|vitamin d|mesh-list
6222299|NCT02352974|Vitamins|vitamins|mesh-ancestor
6222300|NCT02352974|Micronutrients|micronutrients|mesh-ancestor
5703932|NCT03327389|Adrenergic Agents|adrenergic agents|mesh-ancestor
5703933|NCT03327389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5703934|NCT03327389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703935|NCT03327350|Anticoagulants|anticoagulants|mesh-list
5703936|NCT03327272|Methylprednisolone|methylprednisolone|mesh-list
5703937|NCT03327272|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5703938|NCT03327272|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5703939|NCT03327272|Prednisolone|prednisolone|mesh-list
5703940|NCT03327272|Prednisolone acetate|prednisolone acetate|mesh-list
5703941|NCT03327272|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5703942|NCT03327272|Prednisolone phosphate|prednisolone phosphate|mesh-list
5703943|NCT03327272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5703944|NCT03327272|Antiemetics|antiemetics|mesh-ancestor
5703945|NCT03327272|Autonomic Agents|autonomic agents|mesh-ancestor
5703946|NCT03327272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5703947|NCT03327272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703948|NCT03327272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5703949|NCT03327272|Glucocorticoids|glucocorticoids|mesh-ancestor
5703950|NCT03327272|Hormones|hormones|mesh-ancestor
5703951|NCT03327272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5703952|NCT03327272|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5703953|NCT03327272|Protective Agents|protective agents|mesh-ancestor
5703954|NCT03327272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5703955|NCT03327272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5703956|NCT03327168|Adenosine|adenosine|mesh-list
5703957|NCT03327168|Analgesics|analgesics|mesh-ancestor
5703958|NCT03327168|Sensory System Agents|sensory system agents|mesh-ancestor
6498651|NCT00637871|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6498652|NCT00637871|Androgen Antagonists|androgen antagonists|mesh-ancestor
6498653|NCT00637884|Fexofenadine|fexofenadine|mesh-list
6498654|NCT00637884|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6498655|NCT00637884|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6498656|NCT00637884|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6498657|NCT00637884|Histamine Antagonists|histamine antagonists|mesh-ancestor
6498658|NCT00637884|Histamine Agents|histamine agents|mesh-ancestor
6498659|NCT00637884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6498660|NCT00637884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498661|NCT00637884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498662|NCT00637897|Paclitaxel|paclitaxel|mesh-list
6498663|NCT00637897|Docetaxel|docetaxel|mesh-list
6498664|NCT00637897|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6498665|NCT00637897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6498666|NCT00637897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6498667|NCT00637897|Tubulin Modulators|tubulin modulators|mesh-ancestor
6498668|NCT00637897|Antimitotic Agents|antimitotic agents|mesh-ancestor
6498669|NCT00637897|Mitosis Modulators|mitosis modulators|mesh-ancestor
6498670|NCT00637897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222301|NCT02352974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222302|NCT02352974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6222303|NCT02353169|Dexmedetomidine|dexmedetomidine|mesh-list
6222304|NCT02353169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6222305|NCT02353169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6222306|NCT02353169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222307|NCT02353169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6222308|NCT02353169|Analgesics|analgesics|mesh-ancestor
6222309|NCT02353169|Sensory System Agents|sensory system agents|mesh-ancestor
6222310|NCT02353169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6222311|NCT02353169|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6222312|NCT02353169|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6222313|NCT02353169|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6222314|NCT02353169|Adrenergic Agents|adrenergic agents|mesh-ancestor
6222315|NCT02353169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6222316|NCT02353169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222317|NCT02353299|Zolpidem|zolpidem|mesh-list
6222318|NCT02353299|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6222319|NCT02353299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6222320|NCT02353299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6222321|NCT02353299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222322|NCT02353299|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6222323|NCT02353299|GABA Agonists|gaba agonists|mesh-ancestor
6222324|NCT02353299|GABA Agents|gaba agents|mesh-ancestor
6222325|NCT02353299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6222326|NCT02353299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222327|NCT02353754|Morphine|morphine|mesh-list
6222328|NCT02353754|Bupivacaine|bupivacaine|mesh-list
6222329|NCT02353754|Anesthetics, Local|anesthetics, local|mesh-ancestor
6222330|NCT02353754|Anesthetics|anesthetics|mesh-ancestor
6222331|NCT02353754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6222332|NCT02353754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222333|NCT02353754|Sensory System Agents|sensory system agents|mesh-ancestor
6222334|NCT02353754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6222335|NCT02353754|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6222336|NCT02353754|Narcotics|narcotics|mesh-ancestor
6222337|NCT02353754|Analgesics|analgesics|mesh-ancestor
6222338|NCT02353780|Etanercept|etanercept|mesh-list
6222339|NCT02353780|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
6222340|NCT02353780|Abatacept|abatacept|mesh-list
6222341|NCT02353780|Infliximab|infliximab|mesh-list
6222342|NCT02353780|Certolizumab Pegol|certolizumab pegol|mesh-list
6222343|NCT02353780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6222344|NCT02353780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6222345|NCT02353780|Analgesics|analgesics|mesh-ancestor
6222346|NCT02353780|Sensory System Agents|sensory system agents|mesh-ancestor
6222347|NCT02353780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6222348|NCT02353780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222349|NCT02353780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6222350|NCT02353780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6222351|NCT02353780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5703959|NCT03327168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5703960|NCT03327168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703961|NCT03327168|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5703962|NCT03327168|Vasodilator Agents|vasodilator agents|mesh-ancestor
5703963|NCT03327168|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5703964|NCT03327168|Purinergic Agonists|purinergic agonists|mesh-ancestor
5703965|NCT03327168|Purinergic Agents|purinergic agents|mesh-ancestor
5703966|NCT03327168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5703967|NCT03327168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703968|NCT03327155|Tenofovir|tenofovir|mesh-list
6676168|NCT01579461|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6676169|NCT01579461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6222352|NCT02353780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6222353|NCT02353780|Immunologic Factors|immunologic factors|mesh-ancestor
6676170|NCT01579461|Adrenergic Agents|adrenergic agents|mesh-ancestor
6676171|NCT01579461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6676172|NCT01579461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676173|NCT01579461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676174|NCT01579461|Urological Agents|urological agents|mesh-ancestor
6676175|NCT01579500|Botulinum Toxins|botulinum toxins|mesh-list
6676176|NCT01579500|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6676177|NCT01579500|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5703969|NCT03327155|Emtricitabine|emtricitabine|mesh-list
6222354|NCT02353780|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6676178|NCT01579500|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6222355|NCT02353780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222356|NCT02353780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6222357|NCT02353780|Dermatologic Agents|dermatologic agents|mesh-ancestor
6222358|NCT02353806|Amlodipine|amlodipine|mesh-list
6222359|NCT02353806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6222360|NCT02353806|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6222361|NCT02353806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6222362|NCT02353806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222363|NCT02353806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6222364|NCT02353806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222365|NCT02353806|Vasodilator Agents|vasodilator agents|mesh-ancestor
6222366|NCT02353871|Botulinum Toxins|botulinum toxins|mesh-list
6222367|NCT02353871|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6222368|NCT02353871|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6222369|NCT02353871|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6222370|NCT02353871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6222371|NCT02353871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222372|NCT02353871|Cholinergic Agents|cholinergic agents|mesh-ancestor
6222373|NCT02353871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6222374|NCT02353871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222375|NCT02353871|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6222376|NCT02353871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6222377|NCT02354092|Anesthetics|anesthetics|mesh-list
6222378|NCT02354092|Anesthetics, Local|anesthetics, local|mesh-list
6222379|NCT02354092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6222380|NCT02354092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222381|NCT02354092|Sensory System Agents|sensory system agents|mesh-ancestor
6222382|NCT02354092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6222383|NCT02354222|Canagliflozin|canagliflozin|mesh-list
6222384|NCT02354222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6222385|NCT02354222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222386|NCT02354222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6222387|NCT02354222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222388|NCT02354235|Canagliflozin|canagliflozin|mesh-list
6222389|NCT02354235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6222390|NCT02354235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222391|NCT02354235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6222392|NCT02354235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222393|NCT02354339|Magnesium Oxide|magnesium oxide|mesh-list
6222394|NCT02354339|Antacids|antacids|mesh-ancestor
6222395|NCT02354339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222396|NCT02354339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6222397|NCT02354352|Eplerenone|eplerenone|mesh-list
6222398|NCT02354352|Spironolactone|spironolactone|mesh-list
6222399|NCT02354352|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6222400|NCT02354352|Hormone Antagonists|hormone antagonists|mesh-ancestor
6222401|NCT02354352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5703970|NCT03327155|Antiviral Agents|antiviral agents|mesh-ancestor
5703971|NCT03327155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5703972|NCT03327155|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5703973|NCT03327155|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6222402|NCT02354352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222403|NCT02354352|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6222404|NCT02354352|Diuretics|diuretics|mesh-ancestor
6222405|NCT02354352|Natriuretic Agents|natriuretic agents|mesh-ancestor
6222406|NCT02354352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6222407|NCT02354378|Dexmedetomidine|dexmedetomidine|mesh-list
6222408|NCT02354378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6222409|NCT02354378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6222410|NCT02354378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222411|NCT02354378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6222412|NCT02354378|Analgesics|analgesics|mesh-ancestor
6222413|NCT02354378|Sensory System Agents|sensory system agents|mesh-ancestor
6222414|NCT02354378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6222415|NCT02354378|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6222416|NCT02354378|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6222417|NCT02354378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6222418|NCT02354378|Adrenergic Agents|adrenergic agents|mesh-ancestor
6222419|NCT02354378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5703974|NCT03327155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5703975|NCT03327155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703976|NCT03327155|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5703977|NCT03327155|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5703978|NCT03327116|Methotrexate|methotrexate|mesh-list
5703979|NCT03327116|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5703980|NCT03327116|Abortifacient Agents|abortifacient agents|mesh-ancestor
5703981|NCT03327116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5703982|NCT03327116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5703983|NCT03327116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5703984|NCT03327116|Antimetabolites|antimetabolites|mesh-ancestor
6222420|NCT02354378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222421|NCT02354508|Pasireotide|pasireotide|mesh-list
6222422|NCT02354508|Hormones|hormones|mesh-ancestor
6222423|NCT02354508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6222424|NCT02354508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222425|NCT02354534|Artesunate|artesunate|mesh-list
6222426|NCT02354534|Antimalarials|antimalarials|mesh-ancestor
6222427|NCT02354534|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6222428|NCT02354534|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6222429|NCT02354534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6222430|NCT02354534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6222431|NCT02354534|Antiviral Agents|antiviral agents|mesh-ancestor
6222432|NCT02354534|Schistosomicides|schistosomicides|mesh-ancestor
6222433|NCT02354534|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6222434|NCT02354534|Anthelmintics|anthelmintics|mesh-ancestor
6222435|NCT02354586|Niraparib|niraparib|mesh-list
6222436|NCT02354586|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6222437|NCT02354586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6222438|NCT02354586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222439|NCT02354586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6222440|NCT02354599|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6222441|NCT02354599|Immunologic Factors|immunologic factors|mesh-ancestor
6222442|NCT02354599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222443|NCT02354690|Cyclophosphamide|cyclophosphamide|mesh-list
6222444|NCT02354690|Fludarabine|fludarabine|mesh-list
6222445|NCT02354690|Interleukin-2|interleukin-2|mesh-list
6222446|NCT02354690|Vemurafenib|vemurafenib|mesh-list
6222447|NCT02354690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6222448|NCT02354690|Immunologic Factors|immunologic factors|mesh-ancestor
6222449|NCT02354690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222450|NCT02354690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6222451|NCT02354690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6222452|NCT02354690|Alkylating Agents|alkylating agents|mesh-ancestor
6222453|NCT02354690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222454|NCT02354690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6222455|NCT02354690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6222456|NCT02354690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6222457|NCT02354690|Analgesics|analgesics|mesh-ancestor
6222458|NCT02354690|Sensory System Agents|sensory system agents|mesh-ancestor
6222459|NCT02354690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6222460|NCT02354690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6222461|NCT02354690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6222462|NCT02354833|Phenylephrine|phenylephrine|mesh-list
6222463|NCT02354833|Oxymetazoline|oxymetazoline|mesh-list
5703985|NCT03327116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5703986|NCT03327116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5703987|NCT03327116|Dermatologic Agents|dermatologic agents|mesh-ancestor
5703988|NCT03327116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5703989|NCT03327116|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5703990|NCT03327116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5703991|NCT03327116|Immunologic Factors|immunologic factors|mesh-ancestor
5703992|NCT03327116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5703993|NCT03327116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5703994|NCT03326960|Propofol|propofol|mesh-list
5703995|NCT03326960|Sevoflurane|sevoflurane|mesh-list
5703996|NCT03326960|Desflurane|desflurane|mesh-list
6222464|NCT02354833|Norepinephrine|norepinephrine|mesh-list
6222465|NCT02354833|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6222466|NCT02354833|Mydriatics|mydriatics|mesh-ancestor
6222467|NCT02354833|Autonomic Agents|autonomic agents|mesh-ancestor
6222468|NCT02354833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6222469|NCT02354833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222470|NCT02354833|Sympathomimetics|sympathomimetics|mesh-ancestor
6222471|NCT02354833|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6222472|NCT02354833|Nasal Decongestants|nasal decongestants|mesh-ancestor
6222473|NCT02354833|Respiratory System Agents|respiratory system agents|mesh-ancestor
6222474|NCT02354833|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6222475|NCT02354833|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6222476|NCT02354833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6222477|NCT02354833|Adrenergic Agents|adrenergic agents|mesh-ancestor
6222478|NCT02354833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6222479|NCT02354833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222480|NCT02354833|Protective Agents|protective agents|mesh-ancestor
6222481|NCT02354859|Gallium nitrate|gallium nitrate|mesh-list
6222482|NCT02354859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6222483|NCT02354859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222484|NCT02354859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6222485|NCT02354976|Fenofibrate|fenofibrate|mesh-list
6222486|NCT02354976|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6222487|NCT02354976|Antimetabolites|antimetabolites|mesh-ancestor
6222488|NCT02354976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222489|NCT02354976|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6222490|NCT02355028|Ranibizumab|ranibizumab|mesh-list
6222491|NCT02355028|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6222492|NCT02355028|Acrizanib|acrizanib|mesh-list
6222493|NCT02355028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6222494|NCT02355028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6222495|NCT02355028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6222496|NCT02355028|Growth Substances|growth substances|mesh-ancestor
6498671|NCT00637910|Docetaxel|docetaxel|mesh-list
6498672|NCT00637910|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6498673|NCT00637910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6498674|NCT00637910|Tubulin Modulators|tubulin modulators|mesh-ancestor
6498675|NCT00637910|Antimitotic Agents|antimitotic agents|mesh-ancestor
6498676|NCT00637910|Mitosis Modulators|mitosis modulators|mesh-ancestor
6498677|NCT00637910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498678|NCT00637910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6498679|NCT00637910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5703997|NCT03326960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5703998|NCT03326960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5703999|NCT03326960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704000|NCT03326960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6498680|NCT00637949|Rofecoxib|rofecoxib|mesh-list
6498681|NCT00637949|Lumiracoxib|lumiracoxib|mesh-list
6498682|NCT00637949|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6498683|NCT00637949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6498684|NCT00637949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6498685|NCT00637949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498686|NCT00637949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6498687|NCT00637949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6498688|NCT00637949|Analgesics|analgesics|mesh-ancestor
6498689|NCT00637949|Sensory System Agents|sensory system agents|mesh-ancestor
6498690|NCT00637949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6498691|NCT00637949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498692|NCT00637949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6498693|NCT00637949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6498694|NCT00637962|polysaccharide-K|polysaccharide-k|mesh-list
6498695|NCT00637962|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6498696|NCT00637962|Immunologic Factors|immunologic factors|mesh-ancestor
6498697|NCT00637962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498698|NCT00637962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6498699|NCT00637962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6498700|NCT00637962|Antiviral Agents|antiviral agents|mesh-ancestor
6498701|NCT00637962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6498702|NCT00637962|Interferon Inducers|interferon inducers|mesh-ancestor
6498703|NCT00637962|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6498704|NCT00637962|Protective Agents|protective agents|mesh-ancestor
6498705|NCT00637975|Pregabalin|pregabalin|mesh-list
6498706|NCT00637975|Oxycodone|oxycodone|mesh-list
6498707|NCT00637975|Analgesics|analgesics|mesh-ancestor
5704001|NCT03326960|Anesthetics, General|anesthetics, general|mesh-ancestor
6498708|NCT00637975|Sensory System Agents|sensory system agents|mesh-ancestor
6676179|NCT01579500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6222497|NCT02355028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222498|NCT02355028|Growth Inhibitors|growth inhibitors|mesh-ancestor
6222499|NCT02355028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6222500|NCT02355028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6222501|NCT02355028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6222502|NCT02355028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222503|NCT02355158|Clonidine|clonidine|mesh-list
6222504|NCT02355158|Analgesics|analgesics|mesh-ancestor
6222505|NCT02355158|Sensory System Agents|sensory system agents|mesh-ancestor
6222506|NCT02355158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6222507|NCT02355158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222508|NCT02355158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6222509|NCT02355158|Sympatholytics|sympatholytics|mesh-ancestor
6222510|NCT02355158|Autonomic Agents|autonomic agents|mesh-ancestor
6222511|NCT02355158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6222512|NCT02355158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6222513|NCT02355158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5704002|NCT03326960|Anesthetics|anesthetics|mesh-ancestor
5704003|NCT03326960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5704004|NCT03326960|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5704005|NCT03326947|Docetaxel|docetaxel|mesh-list
5704006|NCT03326947|Fluorouracil|fluorouracil|mesh-list
5704007|NCT03326947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5704008|NCT03326947|Tubulin Modulators|tubulin modulators|mesh-ancestor
6222514|NCT02355158|Adrenergic Agents|adrenergic agents|mesh-ancestor
6222515|NCT02355158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6222516|NCT02355158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222517|NCT02355210|DEFB1 protein, human|defb1 protein, human|mesh-list
6222518|NCT02355210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6222519|NCT02355665|Nicotine|nicotine|mesh-list
6222520|NCT02355665|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6222521|NCT02355665|Autonomic Agents|autonomic agents|mesh-ancestor
6222522|NCT02355665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6222523|NCT02355665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222524|NCT02355665|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6222525|NCT02355665|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6222526|NCT02355665|Cholinergic Agents|cholinergic agents|mesh-ancestor
6222527|NCT02355665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6222528|NCT02355665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222529|NCT02355821|Bisoprolol|bisoprolol|mesh-list
6222530|NCT02355821|Moxonidine|moxonidine|mesh-list
6676180|NCT01579500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676181|NCT01579500|Cholinergic Agents|cholinergic agents|mesh-ancestor
6676182|NCT01579500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5704009|NCT03326947|Antimitotic Agents|antimitotic agents|mesh-ancestor
5704010|NCT03326947|Mitosis Modulators|mitosis modulators|mesh-ancestor
5704011|NCT03326947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704012|NCT03326947|Antimetabolites|antimetabolites|mesh-ancestor
5918620|NCT04989621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5918621|NCT04989621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5918622|NCT04989621|Immunologic Factors|immunologic factors|mesh-ancestor
5918623|NCT04989621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918624|NCT04989621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5918625|NCT04989413|Dronabinol|dronabinol|mesh-list
5918626|NCT04989413|Cannabidiol|cannabidiol|mesh-list
5918627|NCT04989413|Anticonvulsants|anticonvulsants|mesh-ancestor
5918628|NCT04989413|Hallucinogens|hallucinogens|mesh-ancestor
5918629|NCT04989413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918630|NCT04989413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5918631|NCT04989413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5918632|NCT04989413|Analgesics|analgesics|mesh-ancestor
5918633|NCT04989413|Sensory System Agents|sensory system agents|mesh-ancestor
5918634|NCT04989413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5918635|NCT04989413|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5918636|NCT04989413|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6222531|NCT02355821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6222532|NCT02355821|Sympatholytics|sympatholytics|mesh-ancestor
6222533|NCT02355821|Autonomic Agents|autonomic agents|mesh-ancestor
6222534|NCT02355821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6222535|NCT02355821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222536|NCT02355821|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6222537|NCT02355821|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6222538|NCT02355821|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6222539|NCT02355821|Adrenergic Agents|adrenergic agents|mesh-ancestor
6222540|NCT02355821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6222541|NCT02355821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222542|NCT02355886|Gabapentin|gabapentin|mesh-list
6222543|NCT02355886|Analgesics|analgesics|mesh-ancestor
6222544|NCT02355886|Sensory System Agents|sensory system agents|mesh-ancestor
6222545|NCT02355886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6222546|NCT02355886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222547|NCT02355886|Anticonvulsants|anticonvulsants|mesh-ancestor
6222548|NCT02355886|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6222549|NCT02355886|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6222550|NCT02355886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6222551|NCT02355886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6222552|NCT02355886|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6222553|NCT02355886|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6222554|NCT02355886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6222555|NCT02355886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222556|NCT02355886|Antimanic Agents|antimanic agents|mesh-ancestor
6222557|NCT02355977|Minocycline|minocycline|mesh-list
6222558|NCT02355977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6222559|NCT02355977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6222560|NCT02356107|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
6222561|NCT02356107|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6222562|NCT02356107|Antidepressive Agents|antidepressive agents|mesh-ancestor
6222563|NCT02356107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6222564|NCT02356198|Hydromorphone|hydromorphone|mesh-list
6222565|NCT02356198|Bupivacaine|bupivacaine|mesh-list
6222566|NCT02356198|Anesthetics, Local|anesthetics, local|mesh-ancestor
6222567|NCT02356198|Anesthetics|anesthetics|mesh-ancestor
6222568|NCT02356198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6222569|NCT02356198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222570|NCT02356198|Sensory System Agents|sensory system agents|mesh-ancestor
6222571|NCT02356198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6222572|NCT02356198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6222573|NCT02356198|Narcotics|narcotics|mesh-ancestor
6222574|NCT02356198|Analgesics|analgesics|mesh-ancestor
6243343|NCT02665286|Sensory System Agents|sensory system agents|mesh-ancestor
6243344|NCT02665286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6243345|NCT02665286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243346|NCT02665286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6243347|NCT02665286|Gout Suppressants|gout suppressants|mesh-ancestor
6243348|NCT02665286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6243349|NCT02665286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6243350|NCT02665286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243351|NCT02665286|Cholinergic Agents|cholinergic agents|mesh-ancestor
6243352|NCT02665286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6243353|NCT02665286|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6243354|NCT02665286|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6243355|NCT02665286|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6243356|NCT02665286|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6243357|NCT02665286|Parasympatholytics|parasympatholytics|mesh-ancestor
6243358|NCT02665286|Autonomic Agents|autonomic agents|mesh-ancestor
6243359|NCT02665286|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6243360|NCT02665286|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
6243361|NCT02665286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6243362|NCT02665689|Ranibizumab|ranibizumab|mesh-list
6243363|NCT02665689|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6243364|NCT02665689|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6243365|NCT02665689|Growth Substances|growth substances|mesh-ancestor
6243366|NCT02665689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243367|NCT02665689|Growth Inhibitors|growth inhibitors|mesh-ancestor
6243368|NCT02665689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6243369|NCT02665728|Laxatives|laxatives|mesh-list
6243370|NCT02665728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6243371|NCT02666352|Uprifosbuvir|uprifosbuvir|mesh-list
6243372|NCT02666352|Ruzasvir|ruzasvir|mesh-list
6243373|NCT02666352|Antiviral Agents|antiviral agents|mesh-ancestor
5704013|NCT03326947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5704014|NCT03326947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5704015|NCT03326947|Immunologic Factors|immunologic factors|mesh-ancestor
5704016|NCT03326947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704017|NCT03326921|Vidarabine|vidarabine|mesh-list
6222575|NCT02356562|Ritonavir|ritonavir|mesh-list
6222576|NCT02356562|Ribavirin|ribavirin|mesh-list
6222577|NCT02356562|Sofosbuvir|sofosbuvir|mesh-list
5704018|NCT03326921|Fludarabine|fludarabine|mesh-list
5704019|NCT03326921|Fludarabine phosphate|fludarabine phosphate|mesh-list
5704020|NCT03326921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5704021|NCT03326921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5704022|NCT03326921|Antimetabolites|antimetabolites|mesh-ancestor
5704023|NCT03326921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704024|NCT03326921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6222578|NCT02356562|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6222579|NCT02356562|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6222580|NCT02356562|Protease Inhibitors|protease inhibitors|mesh-ancestor
6222581|NCT02356562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6222582|NCT02356562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222583|NCT02356562|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6222584|NCT02356562|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6222585|NCT02356562|Antiviral Agents|antiviral agents|mesh-ancestor
6222586|NCT02356562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6222587|NCT02356562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6222588|NCT02356562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6222589|NCT02356562|Antimetabolites|antimetabolites|mesh-ancestor
6222590|NCT02356588|Sufentanil|sufentanil|mesh-list
6222591|NCT02356588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6222592|NCT02356588|Narcotics|narcotics|mesh-ancestor
6222593|NCT02356588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6222594|NCT02356588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222595|NCT02356588|Analgesics|analgesics|mesh-ancestor
6222596|NCT02356588|Sensory System Agents|sensory system agents|mesh-ancestor
6222597|NCT02356588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6222598|NCT02356588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6222599|NCT02356588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6222600|NCT02356588|Anesthetics, General|anesthetics, general|mesh-ancestor
6222601|NCT02356588|Anesthetics|anesthetics|mesh-ancestor
6222602|NCT02356705|Lidocaine|lidocaine|mesh-list
6222603|NCT02356705|Midazolam|midazolam|mesh-list
6222604|NCT02356705|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6222605|NCT02356705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6222606|NCT02356705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6222607|NCT02356705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222608|NCT02356705|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6222609|NCT02356705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6222610|NCT02356705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6222611|NCT02356705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6222612|NCT02356705|Anesthetics, General|anesthetics, general|mesh-ancestor
6222613|NCT02356705|Anesthetics|anesthetics|mesh-ancestor
6222614|NCT02356705|GABA Modulators|gaba modulators|mesh-ancestor
6222615|NCT02356705|GABA Agents|gaba agents|mesh-ancestor
6222616|NCT02356705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6222617|NCT02356705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222618|NCT02356705|Anesthetics, Local|anesthetics, local|mesh-ancestor
6222619|NCT02356705|Sensory System Agents|sensory system agents|mesh-ancestor
6222620|NCT02356705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6222621|NCT02356705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6222622|NCT02356705|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6222623|NCT02356705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6222624|NCT02356705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6222625|NCT02357147|Pemetrexed|pemetrexed|mesh-list
6222626|NCT02357147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6222627|NCT02357147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6222628|NCT02357147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222629|NCT02357147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5704025|NCT03326921|Immunologic Factors|immunologic factors|mesh-ancestor
5704026|NCT03326921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704027|NCT03326921|Antiviral Agents|antiviral agents|mesh-ancestor
5704028|NCT03326921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5704029|NCT03326791|Aspirin|aspirin|mesh-list
5704030|NCT03326791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5704031|NCT03326791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5704032|NCT03326791|Analgesics|analgesics|mesh-ancestor
5704033|NCT03326791|Sensory System Agents|sensory system agents|mesh-ancestor
6498709|NCT00637975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6498710|NCT00637975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498711|NCT00637975|Anticonvulsants|anticonvulsants|mesh-ancestor
6498712|NCT00637975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5704034|NCT03326791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6222630|NCT02357147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6222631|NCT02357290|Acetylcysteine|acetylcysteine|mesh-list
6222632|NCT02357290|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6222633|NCT02357290|Antiviral Agents|antiviral agents|mesh-ancestor
6222634|NCT02357290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6222635|NCT02357290|Expectorants|expectorants|mesh-ancestor
6222636|NCT02357290|Respiratory System Agents|respiratory system agents|mesh-ancestor
6222637|NCT02357290|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6222638|NCT02357290|Antioxidants|antioxidants|mesh-ancestor
6222639|NCT02357290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222640|NCT02357290|Protective Agents|protective agents|mesh-ancestor
6222641|NCT02357290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222642|NCT02357290|Antidotes|antidotes|mesh-ancestor
6222643|NCT02357342|Sirolimus|sirolimus|mesh-list
6222644|NCT02357342|Aflibercept|aflibercept|mesh-list
6222645|NCT02357342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6222646|NCT02357342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6222647|NCT02357342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6222648|NCT02357342|Growth Substances|growth substances|mesh-ancestor
6222649|NCT02357342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222650|NCT02357342|Growth Inhibitors|growth inhibitors|mesh-ancestor
6222651|NCT02357342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6222652|NCT02357342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6222653|NCT02357342|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6222654|NCT02357342|Antifungal Agents|antifungal agents|mesh-ancestor
6222655|NCT02357342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6222656|NCT02357342|Immunologic Factors|immunologic factors|mesh-ancestor
6222657|NCT02357368|Copper|copper|mesh-list
6222658|NCT02357368|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6222659|NCT02357368|Contraceptive Agents|contraceptive agents|mesh-list
6222660|NCT02357368|Levonorgestrel|levonorgestrel|mesh-list
6222661|NCT02357368|Medroxyprogesterone|medroxyprogesterone|mesh-list
6222662|NCT02357368|Etonogestrel|etonogestrel|mesh-list
6222663|NCT02357368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5704035|NCT03326791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704036|NCT03326791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5704037|NCT03326791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5704038|NCT03326791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5704039|NCT03326791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5704040|NCT03326791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704041|NCT03326791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5704042|NCT03326791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5704043|NCT03326791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5704044|NCT03326791|Antipyretics|antipyretics|mesh-ancestor
5704045|NCT03326752|Nivolumab|nivolumab|mesh-list
5704046|NCT03326752|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5704047|NCT03326752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5704048|NCT03326752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6222664|NCT02357368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222665|NCT02357368|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6222666|NCT02357368|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6222667|NCT02357368|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6222668|NCT02357368|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6222669|NCT02357368|Trace Elements|trace elements|mesh-ancestor
6222670|NCT02357368|Micronutrients|micronutrients|mesh-ancestor
6222671|NCT02357368|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5704049|NCT03326752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704050|NCT03326674|Capecitabine|capecitabine|mesh-list
5704051|NCT03326674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6222672|NCT02357368|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6498713|NCT00637975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6222673|NCT02357368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6222674|NCT02357368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6222675|NCT02357459|Triamcinolone|triamcinolone|mesh-list
6222676|NCT02357459|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6222677|NCT02357459|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6222678|NCT02357459|FX006|fx006|mesh-list
6222679|NCT02357459|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6222680|NCT02357459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6222681|NCT02357459|Glucocorticoids|glucocorticoids|mesh-ancestor
6222682|NCT02357459|Hormones|hormones|mesh-ancestor
6222683|NCT02357459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6222684|NCT02357459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704052|NCT03326674|Antimetabolites|antimetabolites|mesh-ancestor
5704053|NCT03326674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704054|NCT03326674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5704055|NCT03326661|Clindamycin|clindamycin|mesh-list
5704056|NCT03326661|Clindamycin palmitate|clindamycin palmitate|mesh-list
5704057|NCT03326661|Clindamycin phosphate|clindamycin phosphate|mesh-list
5704058|NCT03326661|Penicillins|penicillins|mesh-list
5704059|NCT03326661|Metronidazole|metronidazole|mesh-list
6222685|NCT02357459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6222686|NCT02357459|Immunologic Factors|immunologic factors|mesh-ancestor
6222687|NCT02357459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6222688|NCT02357459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222689|NCT02357576|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6222690|NCT02357576|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6222691|NCT02357576|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6222692|NCT02357576|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6222693|NCT02357706|Acetaminophen|acetaminophen|mesh-list
6222694|NCT02357706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6222695|NCT02357706|Analgesics|analgesics|mesh-ancestor
6222696|NCT02357706|Sensory System Agents|sensory system agents|mesh-ancestor
6222697|NCT02357706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6222698|NCT02357706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222699|NCT02357706|Antipyretics|antipyretics|mesh-ancestor
6222700|NCT02357758|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6222701|NCT02357758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6222702|NCT02357810|Topotecan|topotecan|mesh-list
6222703|NCT02357810|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6222704|NCT02357810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6222705|NCT02357810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6222706|NCT02357810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222707|NCT02357810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6222708|NCT02357836|Itraconazole|itraconazole|mesh-list
6222709|NCT02357836|Antifungal Agents|antifungal agents|mesh-ancestor
6222710|NCT02357836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6222711|NCT02357836|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6222712|NCT02357836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6222713|NCT02357836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6222714|NCT02357836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498714|NCT00637975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498715|NCT00637975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6498716|NCT00637975|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6498717|NCT00637975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6222715|NCT02357836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6222716|NCT02357836|Hormone Antagonists|hormone antagonists|mesh-ancestor
6222717|NCT02357836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6222718|NCT02357836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222719|NCT02357836|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6222720|NCT02357901|Buprenorphine|buprenorphine|mesh-list
6222721|NCT02357901|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6222722|NCT02357901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6222723|NCT02357901|Narcotics|narcotics|mesh-ancestor
6222724|NCT02357901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6222725|NCT02357901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222726|NCT02357901|Analgesics|analgesics|mesh-ancestor
6222727|NCT02357901|Sensory System Agents|sensory system agents|mesh-ancestor
6222728|NCT02357901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6222729|NCT02357901|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6222730|NCT02357979|Fluorides|fluorides|mesh-list
6222731|NCT02357979|Cariostatic Agents|cariostatic agents|mesh-ancestor
6222732|NCT02357979|Protective Agents|protective agents|mesh-ancestor
6498718|NCT00637975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5704060|NCT03326661|Penicillin V|penicillin v|mesh-list
5704061|NCT03326661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5704062|NCT03326661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5704063|NCT03326661|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5704064|NCT03326661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5704065|NCT03326661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704066|NCT03326661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5704067|NCT03326661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5704068|NCT03326609|Ropivacaine|ropivacaine|mesh-list
6222733|NCT02357979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222734|NCT02358031|Carboplatin|carboplatin|mesh-list
6222735|NCT02358031|Pembrolizumab|pembrolizumab|mesh-list
6222736|NCT02358031|Cetuximab|cetuximab|mesh-list
6222737|NCT02358031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6222738|NCT02358031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6222739|NCT02358044|Ribavirin|ribavirin|mesh-list
6222740|NCT02358044|Sofosbuvir|sofosbuvir|mesh-list
6222741|NCT02358044|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6222742|NCT02358044|Grazoprevir|grazoprevir|mesh-list
6222743|NCT02358044|Antimetabolites|antimetabolites|mesh-ancestor
6222744|NCT02358044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222745|NCT02358044|Antiviral Agents|antiviral agents|mesh-ancestor
6498719|NCT00637975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6498720|NCT00637975|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6498721|NCT00637975|Narcotics|narcotics|mesh-ancestor
6498722|NCT00637988|Aspirin|aspirin|mesh-list
6498723|NCT00637988|Rofecoxib|rofecoxib|mesh-list
6498724|NCT00637988|Esomeprazole|esomeprazole|mesh-list
6498725|NCT00637988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6498726|NCT00637988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6498727|NCT00637988|Analgesics|analgesics|mesh-ancestor
6498728|NCT00637988|Sensory System Agents|sensory system agents|mesh-ancestor
6498729|NCT00637988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6498730|NCT00637988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498731|NCT00637988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6498732|NCT00637988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6498733|NCT00637988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6498734|NCT00637988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6498735|NCT00637988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704069|NCT03326609|Anesthetics, Local|anesthetics, local|mesh-ancestor
5704070|NCT03326609|Anesthetics|anesthetics|mesh-ancestor
5704071|NCT03326609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5704072|NCT03326609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704073|NCT03326609|Sensory System Agents|sensory system agents|mesh-ancestor
6222746|NCT02358044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6498736|NCT00637988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6498737|NCT00637988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6498738|NCT00637988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6498739|NCT00637988|Antipyretics|antipyretics|mesh-ancestor
6498740|NCT00637988|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6498741|NCT00637988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6498742|NCT00637988|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6498743|NCT00637988|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6498744|NCT00638066|Botulinum Toxins|botulinum toxins|mesh-list
6498745|NCT00638066|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6498746|NCT00638066|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6498747|NCT00638066|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6498748|NCT00638066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6498749|NCT00638066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498750|NCT00638066|Cholinergic Agents|cholinergic agents|mesh-ancestor
6498751|NCT00638066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6498752|NCT00638066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498753|NCT00638066|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6498754|NCT00638066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6498755|NCT00638079|Megestrol|megestrol|mesh-list
6498756|NCT00638079|Megestrol Acetate|megestrol acetate|mesh-list
6498757|NCT00638079|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6498758|NCT00638079|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6498759|NCT00638079|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6498760|NCT00638079|Contraceptive Agents|contraceptive agents|mesh-ancestor
6498761|NCT00638079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6498762|NCT00638079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498763|NCT00638079|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6498764|NCT00638079|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6498765|NCT00638079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6498766|NCT00638079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6222747|NCT02358343|Sertraline|sertraline|mesh-list
6222748|NCT02358343|Antidepressive Agents|antidepressive agents|mesh-list
6222749|NCT02358343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6222750|NCT02358343|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6222751|NCT02358343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6222752|NCT02358343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6222753|NCT02358343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222754|NCT02358343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6222755|NCT02358343|Serotonin Agents|serotonin agents|mesh-ancestor
6222756|NCT02358343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222757|NCT02358369|Timolol|timolol|mesh-list
6222758|NCT02358369|Bimatoprost|bimatoprost|mesh-list
6222759|NCT02358369|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6222760|NCT02358369|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6222761|NCT02358369|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6222762|NCT02358369|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6222763|NCT02358369|Adrenergic Agents|adrenergic agents|mesh-ancestor
6222764|NCT02358369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6222765|NCT02358369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222766|NCT02358369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222767|NCT02358369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6222768|NCT02358369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6222769|NCT02358473|Docetaxel|docetaxel|mesh-list
6222770|NCT02358473|Mogamulizumab|mogamulizumab|mesh-list
6222771|NCT02358473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6222772|NCT02358473|Tubulin Modulators|tubulin modulators|mesh-ancestor
6222773|NCT02358473|Antimitotic Agents|antimitotic agents|mesh-ancestor
6222774|NCT02358473|Mitosis Modulators|mitosis modulators|mesh-ancestor
6222775|NCT02358473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222776|NCT02358668|PAZ320|paz320|mesh-list
6222777|NCT02358668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6222778|NCT02358668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222779|NCT02358863|Leucovorin|leucovorin|mesh-list
6222780|NCT02358863|Cisplatin|cisplatin|mesh-list
6222781|NCT02358863|Docetaxel|docetaxel|mesh-list
6222782|NCT02358863|Capecitabine|capecitabine|mesh-list
6222783|NCT02358863|Oxaliplatin|oxaliplatin|mesh-list
6222784|NCT02358863|Irinotecan|irinotecan|mesh-list
6222785|NCT02358863|Epirubicin|epirubicin|mesh-list
6222786|NCT02358863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6222787|NCT02358863|Tubulin Modulators|tubulin modulators|mesh-ancestor
6222788|NCT02358863|Antimitotic Agents|antimitotic agents|mesh-ancestor
6222789|NCT02358863|Mitosis Modulators|mitosis modulators|mesh-ancestor
6222790|NCT02358863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222791|NCT02358863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6222792|NCT02358863|Antimetabolites|antimetabolites|mesh-ancestor
6222793|NCT02358863|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6222794|NCT02358863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6676183|NCT01579500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676184|NCT01579500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6676185|NCT01579500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6676186|NCT01579539|Methylprednisolone|methylprednisolone|mesh-list
6676187|NCT01579539|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6676188|NCT01579539|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6676189|NCT01579539|Prednisolone|prednisolone|mesh-list
6676190|NCT01579539|Prednisolone acetate|prednisolone acetate|mesh-list
6676191|NCT01579539|Esomeprazole|esomeprazole|mesh-list
5704074|NCT03326609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5704075|NCT03326596|Tranexamic Acid|tranexamic acid|mesh-list
5704076|NCT03326596|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5704077|NCT03326596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5704078|NCT03326596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704079|NCT03326596|Hemostatics|hemostatics|mesh-ancestor
5704080|NCT03326596|Coagulants|coagulants|mesh-ancestor
5721125|NCT03208270|Antithrombin III|antithrombin iii|mesh-list
5721126|NCT03208270|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5918637|NCT04989413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5918638|NCT04989413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918639|NCT04989413|Hormones|hormones|mesh-ancestor
5918640|NCT04989413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5918641|NCT04989335|Fludarabine|fludarabine|mesh-list
5918642|NCT04989335|Clofarabine|clofarabine|mesh-list
5918643|NCT04989335|Bisantrene|bisantrene|mesh-list
5918644|NCT04989335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5918645|NCT04989335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6222795|NCT02358863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6222796|NCT02358863|Antidotes|antidotes|mesh-ancestor
6222797|NCT02358863|Protective Agents|protective agents|mesh-ancestor
6222798|NCT02358863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222799|NCT02358863|Vitamin B Complex|vitamin b complex|mesh-ancestor
6222800|NCT02358863|Vitamins|vitamins|mesh-ancestor
6222801|NCT02358863|Micronutrients|micronutrients|mesh-ancestor
6222802|NCT02358863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6222803|NCT02358863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6222804|NCT02358889|Ranibizumab|ranibizumab|mesh-list
6222805|NCT02358889|Immunoconjugates|immunoconjugates|mesh-list
6222806|NCT02358889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6222807|NCT02358889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6222808|NCT02358889|Growth Substances|growth substances|mesh-ancestor
6222809|NCT02358889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222810|NCT02358889|Growth Inhibitors|growth inhibitors|mesh-ancestor
6222811|NCT02358889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6222812|NCT02358889|Immunologic Factors|immunologic factors|mesh-ancestor
6222813|NCT02359006|Minocycline|minocycline|mesh-list
6222814|NCT02359006|Tetracycline|tetracycline|mesh-list
6222815|NCT02359006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6222816|NCT02359006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6222817|NCT02359006|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6222818|NCT02359006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6222819|NCT02359006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222820|NCT02359019|Pembrolizumab|pembrolizumab|mesh-list
6222821|NCT02359019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6222822|NCT02359019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6222823|NCT02359058|Capecitabine|capecitabine|mesh-list
6222824|NCT02359058|Oxaliplatin|oxaliplatin|mesh-list
6222825|NCT02359058|Ramucirumab|ramucirumab|mesh-list
6222826|NCT02359058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6222827|NCT02359058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6222828|NCT02359058|Antimetabolites|antimetabolites|mesh-ancestor
6498767|NCT00638079|Appetite Stimulants|appetite stimulants|mesh-ancestor
5704081|NCT03326310|Azacitidine|azacitidine|mesh-list
5704082|NCT03326310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5704083|NCT03326310|Antimetabolites|antimetabolites|mesh-ancestor
5704084|NCT03326310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704085|NCT03326310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5704086|NCT03326310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5704087|NCT03326258|Nivolumab|nivolumab|mesh-list
5704088|NCT03326258|Ipilimumab|ipilimumab|mesh-list
5704089|NCT03326258|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
5704090|NCT03326258|Antibodies|antibodies|mesh-list
5704091|NCT03326258|Immunoglobulins|immunoglobulins|mesh-list
5704092|NCT03326258|Immunoconjugates|immunoconjugates|mesh-list
5704093|NCT03326258|Immunotoxins|immunotoxins|mesh-list
5704094|NCT03326258|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5704095|NCT03326258|Immunologic Factors|immunologic factors|mesh-ancestor
5918646|NCT04989335|Antimetabolites|antimetabolites|mesh-ancestor
5918647|NCT04989335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918648|NCT04989335|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5918649|NCT04989361|Hyaluronic Acid|hyaluronic acid|mesh-list
5918650|NCT04989361|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5918651|NCT04989361|Immunologic Factors|immunologic factors|mesh-ancestor
5918652|NCT04989361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918653|NCT04989361|Viscosupplements|viscosupplements|mesh-ancestor
5918654|NCT04989361|Protective Agents|protective agents|mesh-ancestor
5918655|NCT04989400|Misoprostol|misoprostol|mesh-list
5918656|NCT04989400|Ulipristal acetate|ulipristal acetate|mesh-list
5918657|NCT04989400|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5918658|NCT04989400|Abortifacient Agents|abortifacient agents|mesh-ancestor
5918659|NCT04989400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5918660|NCT04989400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918661|NCT04989400|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5918662|NCT04989400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5918663|NCT04989400|Oxytocics|oxytocics|mesh-ancestor
5918664|NCT04989400|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5918665|NCT04989400|Contraceptive Agents|contraceptive agents|mesh-ancestor
5918666|NCT04989400|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5918667|NCT04989127|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5918668|NCT04989127|Penicillins|penicillins|mesh-list
6222829|NCT02359058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222830|NCT02359110|Gabapentin|gabapentin|mesh-list
6222831|NCT02359110|Analgesics|analgesics|mesh-ancestor
6222832|NCT02359110|Sensory System Agents|sensory system agents|mesh-ancestor
6498768|NCT00638079|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6498769|NCT00638118|Fexofenadine|fexofenadine|mesh-list
6498770|NCT00638118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5704096|NCT03326258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704097|NCT03326258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5704098|NCT03326258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5704099|NCT03326258|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5704100|NCT03326258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704101|NCT03326180|Bupivacaine|bupivacaine|mesh-list
5704102|NCT03326180|Anesthetics, Local|anesthetics, local|mesh-ancestor
5704103|NCT03326180|Anesthetics|anesthetics|mesh-ancestor
5704104|NCT03326180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5704105|NCT03326180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704106|NCT03326180|Sensory System Agents|sensory system agents|mesh-ancestor
5704107|NCT03326180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5704108|NCT03326128|Bupropion|bupropion|mesh-list
5704109|NCT03326128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5704110|NCT03326128|Antidepressive Agents|antidepressive agents|mesh-ancestor
5704111|NCT03326128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6222833|NCT02359110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6222834|NCT02359110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222835|NCT02359110|Anticonvulsants|anticonvulsants|mesh-ancestor
6222836|NCT02359110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6222837|NCT02359110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6222838|NCT02359110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6222839|NCT02359110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6222840|NCT02359110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6222841|NCT02359110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6222842|NCT02359110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6222843|NCT02359110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222844|NCT02359110|Antimanic Agents|antimanic agents|mesh-ancestor
6222845|NCT02359305|Acetaminophen|acetaminophen|mesh-list
6222846|NCT02359305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6222847|NCT02359305|Analgesics|analgesics|mesh-ancestor
6222848|NCT02359305|Sensory System Agents|sensory system agents|mesh-ancestor
6222849|NCT02359305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6222850|NCT02359305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222851|NCT02359305|Antipyretics|antipyretics|mesh-ancestor
6222852|NCT02359435|Amoxicillin|amoxicillin|mesh-list
6222853|NCT02359435|Metronidazole|metronidazole|mesh-list
6222854|NCT02359435|Clarithromycin|clarithromycin|mesh-list
6222855|NCT02359435|Pantoprazole|pantoprazole|mesh-list
6222856|NCT02359435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6222857|NCT02359435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6222858|NCT02359435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6222859|NCT02359435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6222860|NCT02359435|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6222861|NCT02359435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6222862|NCT02359435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222863|NCT02359435|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6222864|NCT02359435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6222865|NCT02359435|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6222866|NCT02359435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6222867|NCT02359435|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6222868|NCT02359552|Rasagiline|rasagiline|mesh-list
6222869|NCT02359552|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6222870|NCT02359552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6222871|NCT02359552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222872|NCT02359552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6222873|NCT02359552|Protective Agents|protective agents|mesh-ancestor
6222874|NCT02359552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222875|NCT02359851|Pembrolizumab|pembrolizumab|mesh-list
6222876|NCT02359851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6222877|NCT02359851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6222878|NCT02359877|Interferons|interferons|mesh-list
6222879|NCT02359877|Interferon-beta|interferon-beta|mesh-list
6222880|NCT02359877|Interferon beta-1a|interferon beta-1a|mesh-list
6222881|NCT02359877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6222882|NCT02359877|Antiviral Agents|antiviral agents|mesh-ancestor
6222883|NCT02359877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6222884|NCT02359877|Immunologic Factors|immunologic factors|mesh-ancestor
6222885|NCT02359877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222886|NCT02359877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6222887|NCT02359903|Infliximab|infliximab|mesh-list
6222888|NCT02359903|Dermatologic Agents|dermatologic agents|mesh-ancestor
6222889|NCT02359903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6222890|NCT02359903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6222891|NCT02360098|Anesthetics|anesthetics|mesh-list
6222892|NCT02360098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6222893|NCT02360098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222894|NCT02360124|Fluorides|fluorides|mesh-list
6222895|NCT02360124|Cariostatic Agents|cariostatic agents|mesh-ancestor
6222896|NCT02360124|Protective Agents|protective agents|mesh-ancestor
6222897|NCT02360124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222898|NCT02360215|Memantine|memantine|mesh-list
6222899|NCT02360215|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6222900|NCT02360215|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6222901|NCT02360215|Dopamine Agents|dopamine agents|mesh-ancestor
5704112|NCT03326128|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5704113|NCT03326128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5704114|NCT03326128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5704115|NCT03326128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704116|NCT03326128|Dopamine Agents|dopamine agents|mesh-ancestor
5704117|NCT03326128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5704118|NCT03326128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704119|NCT03326128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5704120|NCT03326128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5704121|NCT03326128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5704122|NCT03326102|Paclitaxel|paclitaxel|mesh-list
5918669|NCT04989127|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6222902|NCT02360215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6222903|NCT02360215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222904|NCT02360215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222905|NCT02360215|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6222906|NCT02360215|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6222907|NCT02360280|Midazolam|midazolam|mesh-list
6222908|NCT02360280|Ketamine|ketamine|mesh-list
6222909|NCT02360280|Analgesics|analgesics|mesh-ancestor
6222910|NCT02360280|Sensory System Agents|sensory system agents|mesh-ancestor
6222911|NCT02360280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6222912|NCT02360280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222913|NCT02360280|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6222914|NCT02360280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6222915|NCT02360280|Anesthetics, General|anesthetics, general|mesh-ancestor
6222916|NCT02360280|Anesthetics|anesthetics|mesh-ancestor
6222917|NCT02360280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6222918|NCT02360280|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6222919|NCT02360280|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6222920|NCT02360280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6222921|NCT02360280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222922|NCT02360280|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6222923|NCT02360280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6222924|NCT02360280|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6222925|NCT02360280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6222926|NCT02360280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6222927|NCT02360280|GABA Modulators|gaba modulators|mesh-ancestor
6222928|NCT02360280|GABA Agents|gaba agents|mesh-ancestor
6222929|NCT02360319|Aripiprazole|aripiprazole|mesh-list
6222930|NCT02360319|Antipsychotic Agents|antipsychotic agents|mesh-list
6222931|NCT02360319|Antidepressive Agents|antidepressive agents|mesh-ancestor
6222932|NCT02360319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6222933|NCT02360319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6222934|NCT02360319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6222935|NCT02360319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222936|NCT02360319|Dopamine Agonists|dopamine agonists|mesh-ancestor
6222937|NCT02360319|Dopamine Agents|dopamine agents|mesh-ancestor
6222938|NCT02360319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6222939|NCT02360319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222940|NCT02360319|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6222941|NCT02360319|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6222942|NCT02360319|Serotonin Agents|serotonin agents|mesh-ancestor
6222943|NCT02360319|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6222944|NCT02360319|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5918670|NCT04989127|Analgesics|analgesics|mesh-list
5918671|NCT04989127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5918672|NCT04989127|Antitubercular Agents|antitubercular agents|mesh-ancestor
5918673|NCT04989127|Sensory System Agents|sensory system agents|mesh-ancestor
5918674|NCT04989127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5918675|NCT04989127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918676|NCT04989166|Curcumin|curcumin|mesh-list
5964071|NCT04595591|Narcotics|narcotics|mesh-ancestor
6222945|NCT02360319|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6222946|NCT02360319|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6222947|NCT02360397|Ranolazine|ranolazine|mesh-list
6222948|NCT02360397|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6222949|NCT02360397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6222950|NCT02360397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222951|NCT02360475|Vaccines|vaccines|mesh-list
6222952|NCT02360475|Immunologic Factors|immunologic factors|mesh-ancestor
6222953|NCT02360475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222954|NCT02360631|Varenicline|varenicline|mesh-list
6222955|NCT02360631|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6222956|NCT02360631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6222957|NCT02360631|Cholinergic Agents|cholinergic agents|mesh-ancestor
6222958|NCT02360631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6222959|NCT02360631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222960|NCT02360631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222961|NCT02360774|Canagliflozin|canagliflozin|mesh-list
6222962|NCT02360774|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6222963|NCT02360774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222964|NCT02360774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6222965|NCT02360774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222966|NCT02360995|Triclosan|triclosan|mesh-list
6222967|NCT02360995|Cetylpyridinium|cetylpyridinium|mesh-list
6222968|NCT02360995|Fluorides|fluorides|mesh-list
6222969|NCT02360995|Tin Fluorides|tin fluorides|mesh-list
6222970|NCT02360995|Cariostatic Agents|cariostatic agents|mesh-ancestor
6222971|NCT02360995|Protective Agents|protective agents|mesh-ancestor
6222972|NCT02360995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222973|NCT02360995|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6222974|NCT02360995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6222975|NCT02360995|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6222976|NCT02360995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6222977|NCT02360995|Antimetabolites|antimetabolites|mesh-ancestor
6222978|NCT02360995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222979|NCT02360995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6222980|NCT02361476|Clonidine|clonidine|mesh-list
6222981|NCT02361476|Analgesics|analgesics|mesh-ancestor
6222982|NCT02361476|Sensory System Agents|sensory system agents|mesh-ancestor
6222983|NCT02361476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6222984|NCT02361476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6222985|NCT02361476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6222986|NCT02361476|Sympatholytics|sympatholytics|mesh-ancestor
6222987|NCT02361476|Autonomic Agents|autonomic agents|mesh-ancestor
6222988|NCT02361476|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6222989|NCT02361476|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6222990|NCT02361476|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6222991|NCT02361476|Adrenergic Agents|adrenergic agents|mesh-ancestor
6222992|NCT02361476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6498771|NCT00638118|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6498772|NCT00638118|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6498773|NCT00638118|Histamine Antagonists|histamine antagonists|mesh-ancestor
6498774|NCT00638118|Histamine Agents|histamine agents|mesh-ancestor
6498775|NCT00638118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6498776|NCT00638118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498777|NCT00638118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498778|NCT00638131|Bosentan|bosentan|mesh-list
6498779|NCT00638131|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6498780|NCT00638131|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6498781|NCT00638131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498782|NCT00638209|Insulin|insulin|mesh-list
6498783|NCT00638209|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6498784|NCT00638209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6498785|NCT00638209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498786|NCT00638248|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
6498787|NCT00638248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6498788|NCT00638248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6498789|NCT00638248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498790|NCT00638300|Dialysis Solutions|dialysis solutions|mesh-list
6498791|NCT00638300|Calcium|calcium|mesh-list
6498792|NCT00638300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6498793|NCT00638300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498794|NCT00638300|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6498795|NCT00638326|Clopidogrel|clopidogrel|mesh-list
6222993|NCT02361476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6222994|NCT02362048|Pembrolizumab|pembrolizumab|mesh-list
6222995|NCT02362048|Acalabrutinib|acalabrutinib|mesh-list
6222996|NCT02362048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6222997|NCT02362048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6222998|NCT02362269|Vitamin D|vitamin d|mesh-list
6222999|NCT02362269|Vitamins|vitamins|mesh-ancestor
5704123|NCT03326102|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5704124|NCT03326102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5704125|NCT03326102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5704126|NCT03326102|Tubulin Modulators|tubulin modulators|mesh-ancestor
5704127|NCT03326102|Antimitotic Agents|antimitotic agents|mesh-ancestor
5704128|NCT03326102|Mitosis Modulators|mitosis modulators|mesh-ancestor
5704129|NCT03326102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704130|NCT03326063|Ifetroban|ifetroban|mesh-list
5704131|NCT03326063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6223000|NCT02362269|Micronutrients|micronutrients|mesh-ancestor
6223001|NCT02362269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223002|NCT02362269|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6223003|NCT02362321|Dexamethasone|dexamethasone|mesh-list
6223004|NCT02362321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6223005|NCT02362321|Antiemetics|antiemetics|mesh-ancestor
6223006|NCT02362321|Autonomic Agents|autonomic agents|mesh-ancestor
6498796|NCT00638326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6498797|NCT00638326|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6498798|NCT00638326|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6498799|NCT00638326|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6223007|NCT02362321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6223008|NCT02362321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223009|NCT02362321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6223010|NCT02362321|Glucocorticoids|glucocorticoids|mesh-ancestor
6223011|NCT02362321|Hormones|hormones|mesh-ancestor
6223012|NCT02362321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6223013|NCT02362321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6223014|NCT02362321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6223015|NCT02362373|Levonorgestrel|levonorgestrel|mesh-list
6223016|NCT02362373|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6223017|NCT02362373|Contraceptive Agents|contraceptive agents|mesh-ancestor
6223018|NCT02362373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6223019|NCT02362373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223020|NCT02362373|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6223021|NCT02362373|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6223022|NCT02362373|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6223023|NCT02362412|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6223024|NCT02362412|Antidepressive Agents|antidepressive agents|mesh-ancestor
6223025|NCT02362412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6223026|NCT02362412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6223027|NCT02362412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6223028|NCT02362412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6223029|NCT02362412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223030|NCT02362425|Acetylcysteine|acetylcysteine|mesh-list
6223031|NCT02362425|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6223032|NCT02362425|Antiviral Agents|antiviral agents|mesh-ancestor
6223033|NCT02362425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6223034|NCT02362425|Expectorants|expectorants|mesh-ancestor
6223035|NCT02362425|Respiratory System Agents|respiratory system agents|mesh-ancestor
6223036|NCT02362425|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6223037|NCT02362425|Antioxidants|antioxidants|mesh-ancestor
6223038|NCT02362425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223039|NCT02362425|Protective Agents|protective agents|mesh-ancestor
6223040|NCT02362425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223041|NCT02362425|Antidotes|antidotes|mesh-ancestor
6223042|NCT02362503|Fostemsavir|fostemsavir|mesh-list
6223043|NCT02362503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6223044|NCT02362503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6223045|NCT02362503|Antiviral Agents|antiviral agents|mesh-ancestor
6223046|NCT02362503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6223047|NCT02362503|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6223048|NCT02362503|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6223049|NCT02362503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223050|NCT02362594|Pembrolizumab|pembrolizumab|mesh-list
6223051|NCT02362594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6498800|NCT00638326|Purinergic Agents|purinergic agents|mesh-ancestor
6498801|NCT00638326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6223052|NCT02362594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6223053|NCT02363270|Ketamine|ketamine|mesh-list
6223054|NCT02363270|Analgesics|analgesics|mesh-ancestor
6223055|NCT02363270|Sensory System Agents|sensory system agents|mesh-ancestor
6223056|NCT02363270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6223057|NCT02363270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223058|NCT02363270|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6223059|NCT02363270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6223060|NCT02363270|Anesthetics, General|anesthetics, general|mesh-ancestor
6223061|NCT02363270|Anesthetics|anesthetics|mesh-ancestor
6223062|NCT02363270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6223063|NCT02363270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6223064|NCT02363270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6223065|NCT02363270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6223066|NCT02363270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223067|NCT02363283|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
6223068|NCT02363283|Immunoconjugates|immunoconjugates|mesh-list
6223069|NCT02363283|Immunotoxins|immunotoxins|mesh-list
6223070|NCT02363283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6223071|NCT02363283|Immunologic Factors|immunologic factors|mesh-ancestor
6223072|NCT02363283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223073|NCT02363283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6223074|NCT02363283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6223075|NCT02363478|Buspirone|buspirone|mesh-list
6223076|NCT02363478|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6223077|NCT02363478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6223078|NCT02363478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6223079|NCT02363478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223080|NCT02363478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5704132|NCT03326050|Ciprofloxacin|ciprofloxacin|mesh-list
5704133|NCT03326050|Rifampin|rifampin|mesh-list
5704134|NCT03326050|Gemifloxacin|gemifloxacin|mesh-list
6223081|NCT02363478|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6223082|NCT02363478|Serotonin Agents|serotonin agents|mesh-ancestor
6223083|NCT02363478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6223084|NCT02363478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223085|NCT02363621|Ranibizumab|ranibizumab|mesh-list
6223086|NCT02363621|Aflibercept|aflibercept|mesh-list
6223087|NCT02363621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6223088|NCT02363621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6223089|NCT02363621|Growth Substances|growth substances|mesh-ancestor
6223090|NCT02363621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223091|NCT02363621|Growth Inhibitors|growth inhibitors|mesh-ancestor
6223092|NCT02363621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6223093|NCT02363738|Infliximab|infliximab|mesh-list
6223094|NCT02363738|Dermatologic Agents|dermatologic agents|mesh-ancestor
6223095|NCT02363738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6223096|NCT02363738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6223097|NCT02363803|Lidocaine|lidocaine|mesh-list
6223098|NCT02363803|Anesthetics, Local|anesthetics, local|mesh-ancestor
6223099|NCT02363803|Anesthetics|anesthetics|mesh-ancestor
6223100|NCT02363803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6223101|NCT02363803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223102|NCT02363803|Sensory System Agents|sensory system agents|mesh-ancestor
6223103|NCT02363803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6223104|NCT02363803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6223105|NCT02363803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6223106|NCT02363803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6223107|NCT02363803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6223108|NCT02363803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243374|NCT02666352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6498802|NCT00638326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704135|NCT03326050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5704136|NCT03326050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5704137|NCT03326050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5704138|NCT03326050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5704139|NCT03326050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5704140|NCT03326050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704141|NCT03326050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5704142|NCT03326050|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5704143|NCT03326050|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5704144|NCT03326050|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5721127|NCT03208270|Protease Inhibitors|protease inhibitors|mesh-ancestor
6243375|NCT02666430|Insulin Glargine|insulin glargine|mesh-list
6223109|NCT02363946|Diphenhydramine|diphenhydramine|mesh-list
6223110|NCT02363946|Promethazine|promethazine|mesh-list
6223111|NCT02363946|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6223112|NCT02363946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6223113|NCT02363946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6223114|NCT02363946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223115|NCT02363946|Anesthetics, Local|anesthetics, local|mesh-ancestor
6223116|NCT02363946|Anesthetics|anesthetics|mesh-ancestor
6223117|NCT02363946|Sensory System Agents|sensory system agents|mesh-ancestor
6223118|NCT02363946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6223119|NCT02363946|Antiemetics|antiemetics|mesh-ancestor
6223120|NCT02363946|Autonomic Agents|autonomic agents|mesh-ancestor
6223121|NCT02363946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6223122|NCT02363946|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6223123|NCT02363946|Histamine Antagonists|histamine antagonists|mesh-ancestor
6223124|NCT02363946|Histamine Agents|histamine agents|mesh-ancestor
6223125|NCT02363946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6223126|NCT02363946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223127|NCT02363946|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6223128|NCT02363946|Antipruritics|antipruritics|mesh-ancestor
6223129|NCT02363946|Dermatologic Agents|dermatologic agents|mesh-ancestor
6223130|NCT02363998|Lofexidine|lofexidine|mesh-list
6223131|NCT02363998|Clonidine|clonidine|mesh-list
6223132|NCT02363998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6223133|NCT02363998|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6223134|NCT02363998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223135|NCT02363998|Sensory System Agents|sensory system agents|mesh-ancestor
6223136|NCT02363998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6223137|NCT02363998|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6223138|NCT02363998|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6223139|NCT02363998|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6223140|NCT02363998|Adrenergic Agents|adrenergic agents|mesh-ancestor
6223141|NCT02363998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6223142|NCT02363998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223143|NCT02363998|Analgesics|analgesics|mesh-ancestor
6223144|NCT02363998|Sympatholytics|sympatholytics|mesh-ancestor
6223145|NCT02363998|Autonomic Agents|autonomic agents|mesh-ancestor
6223146|NCT02364037|Contraceptive Agents|contraceptive agents|mesh-list
6223147|NCT02364037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6223148|NCT02364037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223149|NCT02364076|Pembrolizumab|pembrolizumab|mesh-list
6223150|NCT02364076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6223151|NCT02364076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6223152|NCT02364336|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5704145|NCT03326050|Antitubercular Agents|antitubercular agents|mesh-ancestor
5704146|NCT03326050|Leprostatic Agents|leprostatic agents|mesh-ancestor
5704147|NCT03326050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5704148|NCT03326050|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5704149|NCT03326050|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5704150|NCT03326050|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5704151|NCT03326050|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5704152|NCT03326050|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5704153|NCT03326050|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5704154|NCT03325972|Dexmedetomidine|dexmedetomidine|mesh-list
5704155|NCT03325972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5704156|NCT03325972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5704157|NCT03325972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704158|NCT03325972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5704159|NCT03325972|Analgesics|analgesics|mesh-ancestor
5704160|NCT03325972|Sensory System Agents|sensory system agents|mesh-ancestor
5704161|NCT03325972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6223153|NCT02364336|Antiviral Agents|antiviral agents|mesh-ancestor
6223154|NCT02364336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6223155|NCT02364947|Nalmefene|nalmefene|mesh-list
6223156|NCT02364947|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6223157|NCT02364947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223158|NCT02364947|Sensory System Agents|sensory system agents|mesh-ancestor
6223159|NCT02364947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6223160|NCT02364999|Paclitaxel|paclitaxel|mesh-list
6223161|NCT02364999|Bevacizumab|bevacizumab|mesh-list
6223162|NCT02364999|Carboplatin|carboplatin|mesh-list
6223163|NCT02364999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6223164|NCT02364999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6223165|NCT02364999|Tubulin Modulators|tubulin modulators|mesh-ancestor
6223166|NCT02364999|Antimitotic Agents|antimitotic agents|mesh-ancestor
6223167|NCT02364999|Mitosis Modulators|mitosis modulators|mesh-ancestor
6223168|NCT02364999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223169|NCT02364999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6223170|NCT02364999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6223171|NCT02364999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6223172|NCT02364999|Growth Substances|growth substances|mesh-ancestor
6223173|NCT02364999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223174|NCT02364999|Growth Inhibitors|growth inhibitors|mesh-ancestor
6223175|NCT02365285|Heparin|heparin|mesh-list
6223176|NCT02365285|Galantamine|galantamine|mesh-list
6223177|NCT02365285|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6223178|NCT02365285|Anticoagulants|anticoagulants|mesh-ancestor
6223179|NCT02365285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6223180|NCT02365285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6223181|NCT02365285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223182|NCT02365285|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6223183|NCT02365285|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5704162|NCT03325972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5704163|NCT03325972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5704164|NCT03325972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5704165|NCT03325972|Adrenergic Agents|adrenergic agents|mesh-ancestor
5704166|NCT03325972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5704167|NCT03325972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704168|NCT03325959|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5704169|NCT03325959|Analgesics|analgesics|mesh-ancestor
5704170|NCT03325959|Sensory System Agents|sensory system agents|mesh-ancestor
5704171|NCT03325959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5704172|NCT03325959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704173|NCT03325959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6223184|NCT02365285|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6223185|NCT02365285|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6223186|NCT02365285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6223187|NCT02365285|Cholinergic Agents|cholinergic agents|mesh-ancestor
6223188|NCT02365285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6223189|NCT02365285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223190|NCT02365285|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6223191|NCT02365285|Autonomic Agents|autonomic agents|mesh-ancestor
6223192|NCT02365285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6223193|NCT02365285|Nootropic Agents|nootropic agents|mesh-ancestor
6223194|NCT02365519|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6223195|NCT02365519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6223196|NCT02365558|Omeprazole|omeprazole|mesh-list
6223197|NCT02365558|Evacetrapib|evacetrapib|mesh-list
6223198|NCT02365558|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6223199|NCT02365558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6223200|NCT02365558|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5704174|NCT03325959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704175|NCT03325959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5704176|NCT03325959|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5704177|NCT03325959|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5704178|NCT03325959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5704179|NCT03325959|Antidepressive Agents|antidepressive agents|mesh-ancestor
5704180|NCT03325959|Dopamine Agents|dopamine agents|mesh-ancestor
5704181|NCT03325868|Ulipristal acetate|ulipristal acetate|mesh-list
5704182|NCT03325868|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5704183|NCT03325868|Contraceptive Agents|contraceptive agents|mesh-ancestor
5704184|NCT03325868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5704185|NCT03325868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918677|NCT04989166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5918678|NCT04989166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5918679|NCT04989166|Analgesics|analgesics|mesh-ancestor
6223201|NCT02365558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6223202|NCT02365558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223203|NCT02365558|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6223204|NCT02365558|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6223205|NCT02365558|Antimetabolites|antimetabolites|mesh-ancestor
6223206|NCT02365558|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6223207|NCT02365584|Lanreotide|lanreotide|mesh-list
6223208|NCT02365584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5918680|NCT04989166|Sensory System Agents|sensory system agents|mesh-ancestor
5918681|NCT04989166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5918682|NCT04989166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918683|NCT04989166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5918684|NCT04989166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6223209|NCT02365870|Rotigotine|rotigotine|mesh-list
6223210|NCT02365870|Dopamine Agonists|dopamine agonists|mesh-ancestor
6223211|NCT02365870|Dopamine Agents|dopamine agents|mesh-ancestor
6223212|NCT02365870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6223213|NCT02365870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223214|NCT02365870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223215|NCT02365961|Clonidine|clonidine|mesh-list
6223216|NCT02365961|Epinephrine|epinephrine|mesh-list
6223217|NCT02365961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6223218|NCT02365961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6223219|NCT02365961|Adrenergic Agents|adrenergic agents|mesh-ancestor
5704186|NCT03325868|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5704187|NCT03325803|Lidocaine|lidocaine|mesh-list
5704188|NCT03325803|Prilocaine|prilocaine|mesh-list
5704189|NCT03325803|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
5704190|NCT03325803|Anesthetics, Local|anesthetics, local|mesh-ancestor
5704191|NCT03325803|Anesthetics|anesthetics|mesh-ancestor
5704192|NCT03325803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5704193|NCT03325803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704194|NCT03325803|Sensory System Agents|sensory system agents|mesh-ancestor
5704195|NCT03325803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5704196|NCT03325803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5704197|NCT03325803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6223220|NCT02365961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6223221|NCT02365961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223222|NCT02365961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223223|NCT02365961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6223224|NCT02365961|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6223225|NCT02365961|Autonomic Agents|autonomic agents|mesh-ancestor
6223226|NCT02365961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6223227|NCT02365961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6223228|NCT02365961|Respiratory System Agents|respiratory system agents|mesh-ancestor
6223229|NCT02365961|Mydriatics|mydriatics|mesh-ancestor
6223230|NCT02365961|Sympathomimetics|sympathomimetics|mesh-ancestor
6223231|NCT02365961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6223232|NCT02365961|Analgesics|analgesics|mesh-ancestor
6223233|NCT02365961|Sensory System Agents|sensory system agents|mesh-ancestor
5704198|NCT03325803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5704199|NCT03325803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5704200|NCT03325803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704201|NCT03325803|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
5704202|NCT03325790|Ebselen|ebselen|mesh-list
5704203|NCT03325790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5704204|NCT03325790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5704205|NCT03325790|Analgesics|analgesics|mesh-ancestor
5704206|NCT03325790|Sensory System Agents|sensory system agents|mesh-ancestor
5704207|NCT03325790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5704208|NCT03325790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704209|NCT03325790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5704210|NCT03325790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5704211|NCT03325790|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6223234|NCT02365961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6223235|NCT02365961|Sympatholytics|sympatholytics|mesh-ancestor
6223236|NCT02365961|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6223237|NCT02366091|Methotrexate|methotrexate|mesh-list
6223238|NCT02366091|Colchicine|colchicine|mesh-list
6223239|NCT02366091|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6223240|NCT02366091|Abortifacient Agents|abortifacient agents|mesh-ancestor
6223241|NCT02366091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6223242|NCT02366091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223243|NCT02366091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6223244|NCT02366091|Antimetabolites|antimetabolites|mesh-ancestor
6223245|NCT02366091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223246|NCT02366091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6223247|NCT02366091|Dermatologic Agents|dermatologic agents|mesh-ancestor
6223248|NCT02366091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6223249|NCT02366091|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6223250|NCT02366091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6223251|NCT02366091|Immunologic Factors|immunologic factors|mesh-ancestor
6498803|NCT00638326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498804|NCT00638391|Anastrozole|anastrozole|mesh-list
6498805|NCT00638391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6498806|NCT00638391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6498807|NCT00638391|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6498808|NCT00638391|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6223252|NCT02366091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6223253|NCT02366091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6223254|NCT02366091|Gout Suppressants|gout suppressants|mesh-ancestor
6223255|NCT02366091|Tubulin Modulators|tubulin modulators|mesh-ancestor
6223256|NCT02366091|Antimitotic Agents|antimitotic agents|mesh-ancestor
6223257|NCT02366091|Mitosis Modulators|mitosis modulators|mesh-ancestor
6223258|NCT02366130|Denosumab|denosumab|mesh-list
6223259|NCT02366130|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
6223260|NCT02366130|Hormones|hormones|mesh-list
6223261|NCT02366130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6223262|NCT02366130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223263|NCT02366130|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6223264|NCT02366130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6223265|NCT02366143|Paclitaxel|paclitaxel|mesh-list
6223266|NCT02366143|Bevacizumab|bevacizumab|mesh-list
6223267|NCT02366143|Carboplatin|carboplatin|mesh-list
6223268|NCT02366143|Atezolizumab|atezolizumab|mesh-list
6223269|NCT02366143|Antibodies|antibodies|mesh-list
6223270|NCT02366143|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6223271|NCT02366143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6223272|NCT02366143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6223273|NCT02366143|Tubulin Modulators|tubulin modulators|mesh-ancestor
6223274|NCT02366143|Antimitotic Agents|antimitotic agents|mesh-ancestor
6223275|NCT02366143|Mitosis Modulators|mitosis modulators|mesh-ancestor
6223276|NCT02366143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223277|NCT02366143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6223278|NCT02366143|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6223279|NCT02366143|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6223280|NCT02366143|Growth Substances|growth substances|mesh-ancestor
6223281|NCT02366143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223282|NCT02366143|Growth Inhibitors|growth inhibitors|mesh-ancestor
6223283|NCT02366143|Immunologic Factors|immunologic factors|mesh-ancestor
6223284|NCT02366195|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
6223285|NCT02366195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6223286|NCT02366195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6223287|NCT02366468|Ranibizumab|ranibizumab|mesh-list
6223288|NCT02366468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6223289|NCT02366468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6223290|NCT02366468|Growth Substances|growth substances|mesh-ancestor
6223291|NCT02366468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223292|NCT02366468|Growth Inhibitors|growth inhibitors|mesh-ancestor
6223293|NCT02366468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6223294|NCT02366663|Cytarabine|cytarabine|mesh-list
6223295|NCT02366663|Rituximab|rituximab|mesh-list
6223296|NCT02366663|Etoposide|etoposide|mesh-list
6223297|NCT02366663|Melphalan|melphalan|mesh-list
6223298|NCT02366663|Carmustine|carmustine|mesh-list
6223299|NCT02366663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6223300|NCT02366663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6223301|NCT02366663|Immunologic Factors|immunologic factors|mesh-ancestor
6223302|NCT02366663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223303|NCT02366663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6223304|NCT02366663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6223305|NCT02366663|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6223306|NCT02366663|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6223307|NCT02366663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6223308|NCT02366663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223309|NCT02366663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6223310|NCT02366663|Antimetabolites|antimetabolites|mesh-ancestor
6223311|NCT02366663|Antiviral Agents|antiviral agents|mesh-ancestor
6223312|NCT02366663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6223313|NCT02366663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6223314|NCT02366663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6223315|NCT02366663|Alkylating Agents|alkylating agents|mesh-ancestor
6223316|NCT02366663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6223317|NCT02366689|Triclosan|triclosan|mesh-list
6223318|NCT02366689|Cetylpyridinium|cetylpyridinium|mesh-list
6223319|NCT02366689|Fluorides|fluorides|mesh-list
6223320|NCT02366689|Tin Fluorides|tin fluorides|mesh-list
6223321|NCT02366689|Cariostatic Agents|cariostatic agents|mesh-ancestor
6223322|NCT02366689|Protective Agents|protective agents|mesh-ancestor
6223323|NCT02366689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223324|NCT02366689|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6223325|NCT02366689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6223326|NCT02366689|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6223327|NCT02366689|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6223328|NCT02366689|Antimetabolites|antimetabolites|mesh-ancestor
6223329|NCT02366689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223330|NCT02366689|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6223331|NCT02366767|Insulin|insulin|mesh-list
6223332|NCT02366767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6223333|NCT02366767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223334|NCT02366871|Enoxaparin|enoxaparin|mesh-list
6223335|NCT02366871|Apixaban|apixaban|mesh-list
6223336|NCT02366871|Anticoagulants|anticoagulants|mesh-ancestor
6223337|NCT02366871|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6223338|NCT02366871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6223339|NCT02366871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223340|NCT02366871|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6223341|NCT02366871|Antithrombins|antithrombins|mesh-ancestor
6223342|NCT02366871|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6223343|NCT02366871|Protease Inhibitors|protease inhibitors|mesh-ancestor
6223344|NCT02366871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6223345|NCT02367131|Empagliflozin|empagliflozin|mesh-list
6223346|NCT02367131|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6223347|NCT02367131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223348|NCT02367131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5704212|NCT03325790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5704213|NCT03325790|Antioxidants|antioxidants|mesh-ancestor
5704214|NCT03325790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704215|NCT03325790|Protective Agents|protective agents|mesh-ancestor
5704216|NCT03325790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5704217|NCT03325790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6223349|NCT02367131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223350|NCT02367352|Paclitaxel|paclitaxel|mesh-list
6223351|NCT02367352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6223352|NCT02367352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6223353|NCT02367352|Tubulin Modulators|tubulin modulators|mesh-ancestor
6223354|NCT02367352|Antimitotic Agents|antimitotic agents|mesh-ancestor
6223355|NCT02367352|Mitosis Modulators|mitosis modulators|mesh-ancestor
6223356|NCT02367352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223357|NCT02367599|Vitamin D|vitamin d|mesh-list
6223358|NCT02367599|Vitamins|vitamins|mesh-ancestor
6223359|NCT02367599|Micronutrients|micronutrients|mesh-ancestor
6223360|NCT02367599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223361|NCT02367599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6223362|NCT02367781|Paclitaxel|paclitaxel|mesh-list
6223363|NCT02367781|Carboplatin|carboplatin|mesh-list
6223364|NCT02367781|Pemetrexed|pemetrexed|mesh-list
6223365|NCT02367781|Atezolizumab|atezolizumab|mesh-list
6223366|NCT02367781|Antibodies|antibodies|mesh-list
6223367|NCT02367781|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6223368|NCT02367781|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6223369|NCT02367781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6223370|NCT02367781|Tubulin Modulators|tubulin modulators|mesh-ancestor
6223371|NCT02367781|Antimitotic Agents|antimitotic agents|mesh-ancestor
6223372|NCT02367781|Mitosis Modulators|mitosis modulators|mesh-ancestor
6223373|NCT02367781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223374|NCT02367781|Immunologic Factors|immunologic factors|mesh-ancestor
6223375|NCT02367781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223376|NCT02367781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6223377|NCT02367781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6223378|NCT02367781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6223379|NCT02367794|Paclitaxel|paclitaxel|mesh-list
6223380|NCT02367794|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6223381|NCT02367794|Carboplatin|carboplatin|mesh-list
6223382|NCT02367794|Atezolizumab|atezolizumab|mesh-list
6223383|NCT02367794|Antibodies|antibodies|mesh-list
6223384|NCT02367794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6223385|NCT02367794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6223386|NCT02367794|Tubulin Modulators|tubulin modulators|mesh-ancestor
6223387|NCT02367794|Antimitotic Agents|antimitotic agents|mesh-ancestor
6223388|NCT02367794|Mitosis Modulators|mitosis modulators|mesh-ancestor
6223389|NCT02367794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223390|NCT02367794|Immunologic Factors|immunologic factors|mesh-ancestor
6223391|NCT02367794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223392|NCT02367833|Contraceptive Agents|contraceptive agents|mesh-list
6223393|NCT02367833|NuvaRing|nuvaring|mesh-list
6223394|NCT02367833|Contraceptives, Oral|contraceptives, oral|mesh-list
5704218|NCT03325790|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6223395|NCT02367833|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
5704219|NCT03325686|Vitamin D|vitamin d|mesh-list
6223396|NCT02367833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6223397|NCT02367833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223398|NCT02367833|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5918685|NCT04989166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5918686|NCT04989166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5918687|NCT04989166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918688|NCT04989140|Dexamethasone|dexamethasone|mesh-list
5918689|NCT04989140|Pomalidomide|pomalidomide|mesh-list
5918690|NCT04989140|Ixazomib|ixazomib|mesh-list
6223399|NCT02367833|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6223400|NCT02367859|Trametinib|trametinib|mesh-list
6223401|NCT02367859|Dabrafenib|dabrafenib|mesh-list
6223402|NCT02367859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6223403|NCT02367859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6223404|NCT02367859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6223405|NCT02367859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223406|NCT02367872|Imarikiren hydrochloride|imarikiren hydrochloride|mesh-list
6223407|NCT02367872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6223408|NCT02367872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223409|NCT02368093|Dextromethorphan|dextromethorphan|mesh-list
6223410|NCT02368093|Antitussive Agents|antitussive agents|mesh-ancestor
6223411|NCT02368093|Respiratory System Agents|respiratory system agents|mesh-ancestor
6223412|NCT02368093|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6223413|NCT02368093|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6223414|NCT02368093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6223415|NCT02368093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223416|NCT02368093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223417|NCT02368314|Enoxaparin|enoxaparin|mesh-list
6223418|NCT02368314|Enoxaparin sodium|enoxaparin sodium|mesh-list
6223419|NCT02368314|Anticoagulants|anticoagulants|mesh-ancestor
6223420|NCT02368314|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6223421|NCT02368314|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6223422|NCT02368314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223423|NCT02368431|Zonisamide|zonisamide|mesh-list
6223424|NCT02368431|Anticonvulsants|anticonvulsants|mesh-ancestor
6223425|NCT02368431|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6223426|NCT02368431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6223427|NCT02368431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223428|NCT02368431|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6223429|NCT02368431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223430|NCT02368457|Tocopherols|tocopherols|mesh-list
6223431|NCT02368457|Vitamin E|vitamin e|mesh-list
6223432|NCT02368457|Tocotrienols|tocotrienols|mesh-list
6223433|NCT02368457|alpha-Tocopherol|alpha-tocopherol|mesh-list
6223434|NCT02368457|Pentoxifylline|pentoxifylline|mesh-list
6223435|NCT02368457|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6223436|NCT02368457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6223437|NCT02368457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223438|NCT02368457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6223439|NCT02368457|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6223440|NCT02368457|Protective Agents|protective agents|mesh-ancestor
6223441|NCT02368457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223442|NCT02368457|Vasodilator Agents|vasodilator agents|mesh-ancestor
6223443|NCT02368457|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6223444|NCT02368457|Antioxidants|antioxidants|mesh-ancestor
6223445|NCT02368457|Vitamins|vitamins|mesh-ancestor
6223446|NCT02368457|Micronutrients|micronutrients|mesh-ancestor
6498809|NCT00638391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6498810|NCT00638391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498811|NCT00638391|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6498812|NCT00638391|Hormone Antagonists|hormone antagonists|mesh-ancestor
6498813|NCT00638391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6498814|NCT00638391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498815|NCT00638482|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6498816|NCT00638482|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6498817|NCT00638482|Diuretics|diuretics|mesh-ancestor
6498818|NCT00638482|Natriuretic Agents|natriuretic agents|mesh-ancestor
6498819|NCT00638482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498820|NCT00638482|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6498821|NCT00638482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6524511|NCT00758433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6524512|NCT00758433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524513|NCT00758693|Rituximab|rituximab|mesh-list
6524514|NCT00758693|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6524515|NCT00758693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5704220|NCT03325686|Vitamins|vitamins|mesh-ancestor
5704221|NCT03325686|Micronutrients|micronutrients|mesh-ancestor
6676192|NCT01579539|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6676193|NCT01579539|Prednisolone phosphate|prednisolone phosphate|mesh-list
6676194|NCT01579539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6676195|NCT01579539|Antiemetics|antiemetics|mesh-ancestor
6676196|NCT01579539|Autonomic Agents|autonomic agents|mesh-ancestor
6676197|NCT01579539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6676198|NCT01579539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676199|NCT01579539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5704222|NCT03325686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704223|NCT03325686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5704224|NCT03325647|Methyltestosterone|methyltestosterone|mesh-list
5704225|NCT03325647|Testosterone|testosterone|mesh-list
5704226|NCT03325647|Testosterone undecanoate|testosterone undecanoate|mesh-list
5704227|NCT03325647|Testosterone enanthate|testosterone enanthate|mesh-list
5704228|NCT03325647|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5704229|NCT03325647|Androgens|androgens|mesh-ancestor
5704230|NCT03325647|Hormones|hormones|mesh-ancestor
5704231|NCT03325647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5704232|NCT03325647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704233|NCT03325647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6676200|NCT01579539|Glucocorticoids|glucocorticoids|mesh-ancestor
6676201|NCT01579539|Hormones|hormones|mesh-ancestor
6676202|NCT01579539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6223447|NCT02369068|Triamcinolone|triamcinolone|mesh-list
6223448|NCT02369068|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6223449|NCT02369068|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6223450|NCT02369068|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6223451|NCT02369068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6223452|NCT02369068|Glucocorticoids|glucocorticoids|mesh-ancestor
6223453|NCT02369068|Hormones|hormones|mesh-ancestor
6223454|NCT02369068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6223455|NCT02369068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223456|NCT02369068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6223457|NCT02369068|Immunologic Factors|immunologic factors|mesh-ancestor
5704234|NCT03325647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5704235|NCT03325647|Anabolic Agents|anabolic agents|mesh-ancestor
5704236|NCT03325491|Acipimox|acipimox|mesh-list
5704237|NCT03325491|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5704238|NCT03325491|Antimetabolites|antimetabolites|mesh-ancestor
5704239|NCT03325491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704240|NCT03325491|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5704241|NCT03325465|Pembrolizumab|pembrolizumab|mesh-list
5704242|NCT03325465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5704243|NCT03325465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5704244|NCT03325413|Anesthetics|anesthetics|mesh-list
5704245|NCT03325413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5704246|NCT03325413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704247|NCT03325400|Fluorides|fluorides|mesh-list
5704248|NCT03325400|Cariostatic Agents|cariostatic agents|mesh-ancestor
5704249|NCT03325400|Protective Agents|protective agents|mesh-ancestor
5704250|NCT03325400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704251|NCT03325348|Labetalol|labetalol|mesh-list
5704252|NCT03325348|Nifedipine|nifedipine|mesh-list
5704253|NCT03325348|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6223458|NCT02369068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223459|NCT02369068|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6223460|NCT02369068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6223461|NCT02369068|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6223462|NCT02369068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6223463|NCT02369068|Cholinergic Agents|cholinergic agents|mesh-ancestor
6223464|NCT02369068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6223465|NCT02369159|Oseltamivir|oseltamivir|mesh-list
6223466|NCT02369159|Peramivir|peramivir|mesh-list
6223467|NCT02369159|Antiviral Agents|antiviral agents|mesh-ancestor
6223468|NCT02369159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6223469|NCT02369159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6223470|NCT02369159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223471|NCT02369172|Bupropion|bupropion|mesh-list
6223472|NCT02369172|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6223473|NCT02369172|Antidepressive Agents|antidepressive agents|mesh-ancestor
6223474|NCT02369172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5704254|NCT03325348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5704255|NCT03325348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223475|NCT02369172|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6223476|NCT02369172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6223477|NCT02369172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6223478|NCT02369172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223479|NCT02369172|Dopamine Agents|dopamine agents|mesh-ancestor
6223480|NCT02369172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6223481|NCT02369172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498822|NCT00638482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498823|NCT00638534|Telithromycin|telithromycin|mesh-list
6498824|NCT00638534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6498825|NCT00638534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6498826|NCT00638560|Vitamins|vitamins|mesh-list
6498827|NCT00638560|Ascorbic Acid|ascorbic acid|mesh-list
6498828|NCT00638560|Vitamin E|vitamin e|mesh-list
6498829|NCT00638560|Antioxidants|antioxidants|mesh-list
6498830|NCT00638560|Micronutrients|micronutrients|mesh-ancestor
6498831|NCT00638560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498832|NCT00638560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498833|NCT00638560|Protective Agents|protective agents|mesh-ancestor
6498834|NCT00638612|Valacyclovir|valacyclovir|mesh-list
6498835|NCT00638612|Antiviral Agents|antiviral agents|mesh-ancestor
6498836|NCT00638612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6498837|NCT00638638|Abciximab|abciximab|mesh-list
6498838|NCT00638638|Anticoagulants|anticoagulants|mesh-ancestor
6498839|NCT00638638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6498840|NCT00638677|Sorbitol|sorbitol|mesh-list
6498841|NCT00638677|Cathartics|cathartics|mesh-ancestor
6498842|NCT00638677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6498843|NCT00638729|Clonidine|clonidine|mesh-list
6498844|NCT00638729|Midazolam|midazolam|mesh-list
6498845|NCT00638729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6498846|NCT00638729|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6498847|NCT00638729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6498848|NCT00638729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498849|NCT00638729|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6498850|NCT00638729|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6498851|NCT00638729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6498852|NCT00638729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6498853|NCT00638729|Anesthetics, General|anesthetics, general|mesh-ancestor
6498854|NCT00638729|Anesthetics|anesthetics|mesh-ancestor
6498855|NCT00638729|GABA Modulators|gaba modulators|mesh-ancestor
6498856|NCT00638729|GABA Agents|gaba agents|mesh-ancestor
6498857|NCT00638729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6498858|NCT00638729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498859|NCT00638729|Analgesics|analgesics|mesh-ancestor
6498860|NCT00638729|Sensory System Agents|sensory system agents|mesh-ancestor
6498861|NCT00638729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6498862|NCT00638729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6498863|NCT00638729|Sympatholytics|sympatholytics|mesh-ancestor
6498864|NCT00638729|Autonomic Agents|autonomic agents|mesh-ancestor
6498865|NCT00638729|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6498866|NCT00638729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6498867|NCT00638729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6498868|NCT00638729|Adrenergic Agents|adrenergic agents|mesh-ancestor
6498869|NCT00638742|Latanoprost|latanoprost|mesh-list
6498870|NCT00638742|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6498871|NCT00638742|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6498872|NCT00638781|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
6498873|NCT00638781|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6498874|NCT00638781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6498875|NCT00638781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498876|NCT00638807|Celecoxib|celecoxib|mesh-list
6498877|NCT00638807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6498878|NCT00638807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6498879|NCT00638807|Analgesics|analgesics|mesh-ancestor
6498880|NCT00638807|Sensory System Agents|sensory system agents|mesh-ancestor
6498881|NCT00638807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6498882|NCT00638807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498883|NCT00638807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6498884|NCT00638807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6498885|NCT00638807|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6498886|NCT00638807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6498887|NCT00638807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6498888|NCT00638807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498889|NCT00638833|Memantine|memantine|mesh-list
6498890|NCT00638833|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6223482|NCT02369172|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6223483|NCT02369172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6223484|NCT02369172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6223485|NCT02369211|Acetaminophen|acetaminophen|mesh-list
6223486|NCT02369211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6223487|NCT02369211|Analgesics|analgesics|mesh-ancestor
6223488|NCT02369211|Sensory System Agents|sensory system agents|mesh-ancestor
6223489|NCT02369211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6223490|NCT02369211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223491|NCT02369211|Antipyretics|antipyretics|mesh-ancestor
6223492|NCT02369341|Vaccines|vaccines|mesh-list
6223493|NCT02369341|Immunologic Factors|immunologic factors|mesh-ancestor
6223494|NCT02369341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223495|NCT02369484|Afatinib|afatinib|mesh-list
6223496|NCT02369484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6223497|NCT02369484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5704256|NCT03325348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5704257|NCT03325348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704258|NCT03325348|Vasodilator Agents|vasodilator agents|mesh-ancestor
5704259|NCT03325348|Tocolytic Agents|tocolytic agents|mesh-ancestor
5704260|NCT03325348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5721128|NCT03208270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6223498|NCT02369484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6223499|NCT02369484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223500|NCT02369510|Epinephrine|epinephrine|mesh-list
6223501|NCT02369510|Racepinephrine|racepinephrine|mesh-list
6223502|NCT02369510|Epinephryl borate|epinephryl borate|mesh-list
6223503|NCT02369510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6223504|NCT02369510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6223505|NCT02369510|Adrenergic Agents|adrenergic agents|mesh-ancestor
6223506|NCT02369510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6223507|NCT02369510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223508|NCT02369510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223509|NCT02369510|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6223510|NCT02369510|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6223511|NCT02369510|Autonomic Agents|autonomic agents|mesh-ancestor
6223512|NCT02369510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6223513|NCT02369510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6223514|NCT02369510|Respiratory System Agents|respiratory system agents|mesh-ancestor
6223515|NCT02369510|Mydriatics|mydriatics|mesh-ancestor
6223516|NCT02369510|Sympathomimetics|sympathomimetics|mesh-ancestor
6223517|NCT02369510|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6223518|NCT02369835|Sodium Hypochlorite|sodium hypochlorite|mesh-list
6223519|NCT02369835|Eusol|eusol|mesh-list
6223520|NCT02369835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6223521|NCT02369835|Disinfectants|disinfectants|mesh-ancestor
6223522|NCT02369835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6223523|NCT02369874|Durvalumab|durvalumab|mesh-list
6223524|NCT02369874|Tremelimumab|tremelimumab|mesh-list
6223525|NCT02369874|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6223526|NCT02369874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6223527|NCT02369874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6223528|NCT02369874|Immunologic Factors|immunologic factors|mesh-ancestor
6223529|NCT02369874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223530|NCT02369900|Esmolol|esmolol|mesh-list
6223531|NCT02369900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6223532|NCT02369900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6223533|NCT02369900|Adrenergic Agents|adrenergic agents|mesh-ancestor
6223534|NCT02369900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6223535|NCT02369900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223536|NCT02369900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223537|NCT02369900|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6223538|NCT02370095|Treprostinil|treprostinil|mesh-list
6223539|NCT02370095|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6223540|NCT02370095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6223541|NCT02370238|Paclitaxel|paclitaxel|mesh-list
6223542|NCT02370238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6223543|NCT02370238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6223544|NCT02370238|Tubulin Modulators|tubulin modulators|mesh-ancestor
6223545|NCT02370238|Antimitotic Agents|antimitotic agents|mesh-ancestor
6223546|NCT02370238|Mitosis Modulators|mitosis modulators|mesh-ancestor
6223547|NCT02370238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223548|NCT02370498|Paclitaxel|paclitaxel|mesh-list
6223549|NCT02370498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6223550|NCT02370498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6223551|NCT02370498|Tubulin Modulators|tubulin modulators|mesh-ancestor
6223552|NCT02370498|Antimitotic Agents|antimitotic agents|mesh-ancestor
6223553|NCT02370498|Mitosis Modulators|mitosis modulators|mesh-ancestor
6223554|NCT02370498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223555|NCT02370615|Itraconazole|itraconazole|mesh-list
6223556|NCT02370615|Digoxin|digoxin|mesh-list
6223557|NCT02370615|Midazolam|midazolam|mesh-list
6223558|NCT02370615|Imarikiren hydrochloride|imarikiren hydrochloride|mesh-list
6223559|NCT02370615|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6223560|NCT02370615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6223561|NCT02370615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6223562|NCT02370615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223563|NCT02370615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6223564|NCT02370615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6223565|NCT02370615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6223566|NCT02370615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6223567|NCT02370615|Anesthetics, General|anesthetics, general|mesh-ancestor
6223568|NCT02370615|Anesthetics|anesthetics|mesh-ancestor
6223569|NCT02370615|GABA Modulators|gaba modulators|mesh-ancestor
6223570|NCT02370615|GABA Agents|gaba agents|mesh-ancestor
6223571|NCT02370615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6223572|NCT02370615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223573|NCT02370615|Antifungal Agents|antifungal agents|mesh-ancestor
6676203|NCT01579539|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5704261|NCT03325348|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5704262|NCT03325348|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5704263|NCT03325348|Adrenergic Agents|adrenergic agents|mesh-ancestor
5704264|NCT03325348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5704265|NCT03325348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5704266|NCT03325348|Sympathomimetics|sympathomimetics|mesh-ancestor
5704267|NCT03325348|Autonomic Agents|autonomic agents|mesh-ancestor
5704268|NCT03325348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5704269|NCT03325348|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5704270|NCT03325348|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5704271|NCT03325335|Midazolam|midazolam|mesh-list
5704272|NCT03325335|Remifentanil|remifentanil|mesh-list
5704273|NCT03325335|Propofol|propofol|mesh-list
5704274|NCT03325335|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5704275|NCT03325335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5704276|NCT03325335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704277|NCT03325335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5704278|NCT03325335|Anesthetics, General|anesthetics, general|mesh-ancestor
5704279|NCT03325335|Anesthetics|anesthetics|mesh-ancestor
5704280|NCT03325335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5704281|NCT03325335|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5704282|NCT03325335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5704283|NCT03325335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5704284|NCT03325335|GABA Modulators|gaba modulators|mesh-ancestor
5704285|NCT03325335|GABA Agents|gaba agents|mesh-ancestor
5704286|NCT03325335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5704287|NCT03325335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704288|NCT03325335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5704289|NCT03325335|Narcotics|narcotics|mesh-ancestor
5704290|NCT03325335|Analgesics|analgesics|mesh-ancestor
5704291|NCT03325335|Sensory System Agents|sensory system agents|mesh-ancestor
5704292|NCT03325335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5704293|NCT03325270|Ferrous fumarate|ferrous fumarate|mesh-list
5704294|NCT03325270|Trace Elements|trace elements|mesh-ancestor
6676204|NCT01579539|Protective Agents|protective agents|mesh-ancestor
6676205|NCT01579539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6676206|NCT01579539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6676207|NCT01579539|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6676208|NCT01579539|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6676209|NCT01579539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6676210|NCT01579539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676211|NCT01579630|Pemetrexed|pemetrexed|mesh-list
6676212|NCT01579630|Gefitinib|gefitinib|mesh-list
6676213|NCT01579630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6676214|NCT01579630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6676215|NCT01579630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676216|NCT01579630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6676217|NCT01579630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6676218|NCT01579630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6676219|NCT01579695|Tesamorelin|tesamorelin|mesh-list
5704295|NCT03325270|Micronutrients|micronutrients|mesh-ancestor
5704296|NCT03325270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704297|NCT03325166|Pembrolizumab|pembrolizumab|mesh-list
5704298|NCT03325166|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
6223574|NCT02370615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6223575|NCT02370615|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6223576|NCT02370615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6223577|NCT02370615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6223578|NCT02370615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6223579|NCT02370615|Hormone Antagonists|hormone antagonists|mesh-ancestor
6223580|NCT02370615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6223581|NCT02370615|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5704299|NCT03325166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5704300|NCT03325166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5704301|NCT03325166|Hematinics|hematinics|mesh-ancestor
5704302|NCT03325166|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5704303|NCT03325166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5704304|NCT03325127|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
5704305|NCT03325127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5704306|NCT03324984|Bupivacaine|bupivacaine|mesh-list
5704307|NCT03324984|Chloroprocaine|chloroprocaine|mesh-list
5704308|NCT03324984|Anesthetics, Local|anesthetics, local|mesh-ancestor
5704309|NCT03324984|Anesthetics|anesthetics|mesh-ancestor
6223582|NCT02370615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6223583|NCT02370615|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6223584|NCT02370615|Protective Agents|protective agents|mesh-ancestor
6243376|NCT02666430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6243377|NCT02666430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243378|NCT02666664|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
6243379|NCT02666664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6243380|NCT02666664|Antimetabolites|antimetabolites|mesh-ancestor
6243381|NCT02666664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243382|NCT02666664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6243383|NCT02666664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6243384|NCT02666664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6243385|NCT02666664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243386|NCT02666742|Aspirin|aspirin|mesh-list
6676220|NCT01579695|Growth Substances|growth substances|mesh-ancestor
6676221|NCT01579695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676222|NCT01579734|Tamoxifen|tamoxifen|mesh-list
6676223|NCT01579734|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6676224|NCT01579734|Hormone Antagonists|hormone antagonists|mesh-ancestor
6676225|NCT01579734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6676226|NCT01579734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676227|NCT01579734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6676228|NCT01579734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6676229|NCT01579734|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6676230|NCT01579734|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6676231|NCT01579734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6676232|NCT01579760|Aflibercept|aflibercept|mesh-list
6676233|NCT01579760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6676234|NCT01579760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6676235|NCT01579760|Growth Substances|growth substances|mesh-ancestor
6676236|NCT01579760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676237|NCT01579760|Growth Inhibitors|growth inhibitors|mesh-ancestor
6676238|NCT01579760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6243387|NCT02666742|Rivaroxaban|rivaroxaban|mesh-list
6243388|NCT02666742|Edoxaban|edoxaban|mesh-list
6243389|NCT02666742|Dabigatran|dabigatran|mesh-list
6243390|NCT02666742|Anticoagulants|anticoagulants|mesh-list
6243391|NCT02666742|Coagulants|coagulants|mesh-list
6243392|NCT02666742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6243393|NCT02666742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6676239|NCT01579786|Acetaminophen|acetaminophen|mesh-list
6676240|NCT01579786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6676241|NCT01579786|Analgesics|analgesics|mesh-ancestor
6676242|NCT01579786|Sensory System Agents|sensory system agents|mesh-ancestor
6676243|NCT01579786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6676244|NCT01579786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676245|NCT01579786|Antipyretics|antipyretics|mesh-ancestor
6676246|NCT01579838|Eculizumab|eculizumab|mesh-list
6676247|NCT01579838|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6676248|NCT01579838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6676249|NCT01579838|Immunologic Factors|immunologic factors|mesh-ancestor
6676250|NCT01579838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676251|NCT01579864|Rocuronium|rocuronium|mesh-list
5704310|NCT03324984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6243394|NCT02666742|Analgesics|analgesics|mesh-ancestor
6676252|NCT01579864|Succinylcholine|succinylcholine|mesh-list
6676253|NCT01579864|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6676254|NCT01579864|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6676255|NCT01579864|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6676256|NCT01579864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6676257|NCT01579864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223585|NCT02370693|Mycophenolic Acid|mycophenolic acid|mesh-list
6223586|NCT02370693|Bortezomib|bortezomib|mesh-list
6223587|NCT02370693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6223588|NCT02370693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6223589|NCT02370693|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6223590|NCT02370693|Antitubercular Agents|antitubercular agents|mesh-ancestor
6223591|NCT02370693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6223592|NCT02370693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6223593|NCT02370693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6223594|NCT02370693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223595|NCT02370784|Atorvastatin|atorvastatin|mesh-list
6223596|NCT02370784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6223597|NCT02370784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6223598|NCT02370784|Antimetabolites|antimetabolites|mesh-ancestor
6223599|NCT02370784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223600|NCT02370784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6223601|NCT02370784|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6223602|NCT02370784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6223603|NCT02371187|Dapagliflozin|dapagliflozin|mesh-list
6223604|NCT02371187|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6223605|NCT02371187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223606|NCT02371187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6498891|NCT00638833|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6498892|NCT00638833|Dopamine Agents|dopamine agents|mesh-ancestor
6498893|NCT00638833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6498894|NCT00638833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498895|NCT00638833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498896|NCT00638833|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6498897|NCT00638833|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6498898|NCT00638859|Telithromycin|telithromycin|mesh-list
6498899|NCT00638859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6498900|NCT00638859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6498901|NCT00638898|Melphalan|melphalan|mesh-list
6498902|NCT00638898|Busulfan|busulfan|mesh-list
6498903|NCT00638898|Topotecan|topotecan|mesh-list
6498904|NCT00638898|Lenograstim|lenograstim|mesh-list
6498905|NCT00638898|Sargramostim|sargramostim|mesh-list
6498906|NCT00638898|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6498907|NCT00638898|Immunologic Factors|immunologic factors|mesh-ancestor
6498908|NCT00638898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498909|NCT00638898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6498910|NCT00638898|Alkylating Agents|alkylating agents|mesh-ancestor
6498911|NCT00638898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498912|NCT00638898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6498913|NCT00638898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6498914|NCT00638898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6498915|NCT00638898|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6498916|NCT00638898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6498917|NCT00638898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6498918|NCT00638976|Eptifibatide|eptifibatide|mesh-list
6498919|NCT00638976|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6498920|NCT00639015|Phenylephrine|phenylephrine|mesh-list
6498921|NCT00639015|Oxymetazoline|oxymetazoline|mesh-list
6498922|NCT00639015|Norepinephrine|norepinephrine|mesh-list
6498923|NCT00639015|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6498924|NCT00639015|Mydriatics|mydriatics|mesh-ancestor
6498925|NCT00639015|Autonomic Agents|autonomic agents|mesh-ancestor
6498926|NCT00639015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6498927|NCT00639015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498928|NCT00639015|Sympathomimetics|sympathomimetics|mesh-ancestor
6498929|NCT00639015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5704311|NCT03324984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704312|NCT03324984|Sensory System Agents|sensory system agents|mesh-ancestor
5704313|NCT03324984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5704314|NCT03324932|Denosumab|denosumab|mesh-list
5704315|NCT03324932|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5704316|NCT03324932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704317|NCT03324867|Insulin|insulin|mesh-list
6498930|NCT00639015|Nasal Decongestants|nasal decongestants|mesh-ancestor
5704318|NCT03324867|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5704319|NCT03324867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6223607|NCT02371187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223608|NCT02371252|Alendronate|alendronate|mesh-list
6223609|NCT02371252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6223610|NCT02371252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223611|NCT02371616|Listerine|listerine|mesh-list
6223612|NCT02371616|Calcium|calcium|mesh-list
6223613|NCT02371616|Fluorides|fluorides|mesh-list
6223614|NCT02371616|Sodium Fluoride|sodium fluoride|mesh-list
6223615|NCT02371616|Fluorophosphate|fluorophosphate|mesh-list
6223616|NCT02371616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6223617|NCT02371616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223618|NCT02371616|Cariostatic Agents|cariostatic agents|mesh-ancestor
6223619|NCT02371616|Protective Agents|protective agents|mesh-ancestor
6223620|NCT02371616|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6223621|NCT02371616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6223622|NCT02371629|Glycopyrrolate|glycopyrrolate|mesh-list
6223623|NCT02371629|Bromides|bromides|mesh-list
6223624|NCT02371629|Albuterol|albuterol|mesh-list
6223625|NCT02371629|Anticonvulsants|anticonvulsants|mesh-ancestor
6223626|NCT02371629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6223627|NCT02371629|Autonomic Agents|autonomic agents|mesh-ancestor
6223628|NCT02371629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6223629|NCT02371629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223630|NCT02371629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6223631|NCT02371629|Respiratory System Agents|respiratory system agents|mesh-ancestor
6223632|NCT02371629|Tocolytic Agents|tocolytic agents|mesh-ancestor
6223633|NCT02371629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6223634|NCT02371629|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6223635|NCT02371629|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6223636|NCT02371629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6223637|NCT02371629|Adrenergic Agents|adrenergic agents|mesh-ancestor
6223638|NCT02371629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6223639|NCT02371629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223640|NCT02371629|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6223641|NCT02371629|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6223642|NCT02371629|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6223643|NCT02371629|Cholinergic Agents|cholinergic agents|mesh-ancestor
6223644|NCT02371746|Travoprost|travoprost|mesh-list
6223645|NCT02371746|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6223646|NCT02371759|Anesthetics|anesthetics|mesh-list
6223647|NCT02371759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6223648|NCT02371759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223649|NCT02371850|Nicotine|nicotine|mesh-list
6223650|NCT02371850|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6223651|NCT02371850|Autonomic Agents|autonomic agents|mesh-ancestor
6223652|NCT02371850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6223653|NCT02371850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704320|NCT03324867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721129|NCT03208270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721130|NCT03208270|Anticoagulants|anticoagulants|mesh-ancestor
5721131|NCT03208127|Antiviral Agents|antiviral agents|mesh-list
5721132|NCT03208127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5721133|NCT03208309|Diacetylrhein|diacetylrhein|mesh-list
5721134|NCT03208309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5721135|NCT03208244|Antiviral Agents|antiviral agents|mesh-list
5721136|NCT03208244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5721137|NCT03208426|Amoxicillin|amoxicillin|mesh-list
5721138|NCT03208426|Metronidazole|metronidazole|mesh-list
5721139|NCT03208426|Clarithromycin|clarithromycin|mesh-list
5721140|NCT03208426|Tetracycline|tetracycline|mesh-list
5721141|NCT03208426|Esomeprazole|esomeprazole|mesh-list
5721142|NCT03208426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5721143|NCT03208426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5721144|NCT03208426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5721145|NCT03208426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5721146|NCT03208426|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5721147|NCT03208426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5721148|NCT03208426|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5721149|NCT03208426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5721150|NCT03208426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721151|NCT03208426|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6223654|NCT02371850|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6223655|NCT02371850|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6223656|NCT02371850|Cholinergic Agents|cholinergic agents|mesh-ancestor
6223657|NCT02371850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6243395|NCT02666742|Sensory System Agents|sensory system agents|mesh-ancestor
6223658|NCT02371850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223659|NCT02371980|Vortioxetine|vortioxetine|mesh-list
6223660|NCT02371980|Antidepressive Agents|antidepressive agents|mesh-ancestor
6223661|NCT02371980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6223662|NCT02371980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6223663|NCT02371980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6223664|NCT02371980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6223665|NCT02371980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223666|NCT02371980|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6223667|NCT02371980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6223668|NCT02371980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6223669|NCT02371980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223670|NCT02371980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6223671|NCT02371980|Serotonin Agents|serotonin agents|mesh-ancestor
6223672|NCT02371980|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6223673|NCT02371980|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6223674|NCT02371980|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6223675|NCT02371980|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6223676|NCT02372006|Afatinib|afatinib|mesh-list
6223677|NCT02372006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6223678|NCT02372006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6223679|NCT02372006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6223680|NCT02372006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223681|NCT02372253|Verapamil|verapamil|mesh-list
6223682|NCT02372253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6223683|NCT02372253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6223684|NCT02372253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6223685|NCT02372253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223686|NCT02372253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6223687|NCT02372253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223688|NCT02372253|Vasodilator Agents|vasodilator agents|mesh-ancestor
6223689|NCT02372383|Azithromycin|azithromycin|mesh-list
6223690|NCT02372383|Rifampin|rifampin|mesh-list
6223691|NCT02372383|Ethambutol|ethambutol|mesh-list
6223692|NCT02372383|Pancrelipase|pancrelipase|mesh-list
6223693|NCT02372383|Pancreatin|pancreatin|mesh-list
6223694|NCT02372383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6223695|NCT02372383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6223696|NCT02372383|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6223697|NCT02372383|Antitubercular Agents|antitubercular agents|mesh-ancestor
6223698|NCT02372383|Leprostatic Agents|leprostatic agents|mesh-ancestor
6223699|NCT02372383|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6223700|NCT02372383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6223701|NCT02372383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223702|NCT02372383|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6223703|NCT02372383|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6223704|NCT02372383|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6223705|NCT02372383|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6223706|NCT02372383|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6223707|NCT02372383|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6223708|NCT02372383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6223709|NCT02372799|Fluoxetine|fluoxetine|mesh-list
6223710|NCT02372799|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
6223711|NCT02372799|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6223712|NCT02372799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6223713|NCT02372799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6223714|NCT02372799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223715|NCT02372799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6223716|NCT02372799|Serotonin Agents|serotonin agents|mesh-ancestor
6223717|NCT02372799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223718|NCT02372799|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6223719|NCT02372799|Antidepressive Agents|antidepressive agents|mesh-ancestor
6223720|NCT02372799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6223721|NCT02372799|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6223722|NCT02372799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6223723|NCT02372799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6223724|NCT02372799|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6223725|NCT02372799|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6223726|NCT02373098|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6223727|NCT02373098|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6223728|NCT02373098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223729|NCT02373098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6223730|NCT02373098|Immunologic Factors|immunologic factors|mesh-ancestor
6223731|NCT02373098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223732|NCT02373124|N-Methylaspartate|n-methylaspartate|mesh-list
6223733|NCT02373124|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
6223734|NCT02373124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6223735|NCT02373124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6223736|NCT02373124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223737|NCT02373124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223738|NCT02373137|Ofloxacin|ofloxacin|mesh-list
6223739|NCT02373137|Prednisolone|prednisolone|mesh-list
6223740|NCT02373137|Phenylephrine|phenylephrine|mesh-list
6223741|NCT02373137|Oxymetazoline|oxymetazoline|mesh-list
6223742|NCT02373137|Tropicamide|tropicamide|mesh-list
6223743|NCT02373137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6223744|NCT02373137|Glucocorticoids|glucocorticoids|mesh-ancestor
6223745|NCT02373137|Hormones|hormones|mesh-ancestor
6223746|NCT02373137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5704321|NCT03324828|Hydroxyzine|hydroxyzine|mesh-list
5704322|NCT03324828|Antipruritics|antipruritics|mesh-ancestor
5704323|NCT03324828|Dermatologic Agents|dermatologic agents|mesh-ancestor
5704324|NCT03324828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5704325|NCT03324828|Histamine Antagonists|histamine antagonists|mesh-ancestor
5704326|NCT03324828|Histamine Agents|histamine agents|mesh-ancestor
5704327|NCT03324828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5704328|NCT03324828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704329|NCT03324828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704330|NCT03324815|Morphine|morphine|mesh-list
5704331|NCT03324815|Methadone|methadone|mesh-list
5704332|NCT03324815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5704333|NCT03324815|Narcotics|narcotics|mesh-ancestor
5704334|NCT03324815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5704335|NCT03324815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704336|NCT03324815|Analgesics|analgesics|mesh-ancestor
5704337|NCT03324815|Sensory System Agents|sensory system agents|mesh-ancestor
5704338|NCT03324815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5704339|NCT03324815|Antitussive Agents|antitussive agents|mesh-ancestor
5704340|NCT03324815|Respiratory System Agents|respiratory system agents|mesh-ancestor
5704341|NCT03324776|Insulin|insulin|mesh-list
5704342|NCT03324776|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5704343|NCT03324776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5704344|NCT03324776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223747|NCT02373137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223748|NCT02373137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6223749|NCT02373137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6223750|NCT02373137|Autonomic Agents|autonomic agents|mesh-ancestor
6223751|NCT02373137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6223752|NCT02373137|Protective Agents|protective agents|mesh-ancestor
6223753|NCT02373137|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6223754|NCT02373137|Mydriatics|mydriatics|mesh-ancestor
6223755|NCT02373137|Sympathomimetics|sympathomimetics|mesh-ancestor
6498931|NCT00639015|Respiratory System Agents|respiratory system agents|mesh-ancestor
6498932|NCT00639015|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6498933|NCT00639015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6223756|NCT02373137|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6223757|NCT02373137|Nasal Decongestants|nasal decongestants|mesh-ancestor
6223758|NCT02373137|Respiratory System Agents|respiratory system agents|mesh-ancestor
6223759|NCT02373137|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6223760|NCT02373137|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6223761|NCT02373137|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6223762|NCT02373137|Adrenergic Agents|adrenergic agents|mesh-ancestor
6223763|NCT02373137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6223764|NCT02373137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223765|NCT02373137|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6223766|NCT02373137|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6223767|NCT02373137|Cholinergic Agents|cholinergic agents|mesh-ancestor
6223768|NCT02373137|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6223769|NCT02373137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6223770|NCT02373137|Renal Agents|renal agents|mesh-ancestor
6223771|NCT02373137|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6223772|NCT02373137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5704345|NCT03324685|Levonorgestrel|levonorgestrel|mesh-list
5704346|NCT03324685|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5704347|NCT03324685|Estradiol|estradiol|mesh-list
5704348|NCT03324685|Estrogens|estrogens|mesh-ancestor
6223773|NCT02373137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6223774|NCT02373137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6223775|NCT02373137|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6498934|NCT00639015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6498935|NCT00639015|Adrenergic Agents|adrenergic agents|mesh-ancestor
6498936|NCT00639015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6498937|NCT00639015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498938|NCT00639015|Protective Agents|protective agents|mesh-ancestor
6498939|NCT00639119|Ropinirole|ropinirole|mesh-list
6498940|NCT00639119|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6498941|NCT00639119|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6498942|NCT00639119|Dopamine Agonists|dopamine agonists|mesh-ancestor
6498943|NCT00639119|Dopamine Agents|dopamine agents|mesh-ancestor
6498944|NCT00639119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6498945|NCT00639119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498946|NCT00639119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498947|NCT00639249|SA 4503|sa 4503|mesh-list
6498948|NCT00639249|Nootropic Agents|nootropic agents|mesh-ancestor
6498949|NCT00639262|Temozolomide|temozolomide|mesh-list
6498950|NCT00639262|Sorafenib|sorafenib|mesh-list
6498951|NCT00639262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6498952|NCT00639262|Alkylating Agents|alkylating agents|mesh-ancestor
5704349|NCT03324685|Hormones|hormones|mesh-ancestor
5704350|NCT03324685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5704351|NCT03324685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704352|NCT03324685|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5704353|NCT03324685|Contraceptive Agents|contraceptive agents|mesh-ancestor
5704354|NCT03324685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5704355|NCT03324685|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5704356|NCT03324685|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5704357|NCT03324685|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5704358|NCT03324685|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5704359|NCT03324542|Ranibizumab|ranibizumab|mesh-list
5704360|NCT03324542|Aflibercept|aflibercept|mesh-list
6498953|NCT00639262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498954|NCT00639262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6498955|NCT00639262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6498956|NCT00639262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6498957|NCT00639327|Irinotecan|irinotecan|mesh-list
6498958|NCT00639327|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6498959|NCT00639327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6498960|NCT00639327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6498961|NCT00639327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498962|NCT00639327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6498963|NCT00639366|Trastuzumab|trastuzumab|mesh-list
6498964|NCT00639366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6498965|NCT00639366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6498966|NCT00639392|Zoledronic Acid|zoledronic acid|mesh-list
6498967|NCT00639392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6498968|NCT00639392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524516|NCT00758693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6524517|NCT00758693|Immunologic Factors|immunologic factors|mesh-ancestor
6524518|NCT00758693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524519|NCT00758693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6524520|NCT00758693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6524521|NCT00758693|Alkylating Agents|alkylating agents|mesh-ancestor
6524522|NCT00758693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524523|NCT00758732|Carboplatin|carboplatin|mesh-list
6524524|NCT00758732|Docetaxel|docetaxel|mesh-list
6524525|NCT00758732|Doxorubicin|doxorubicin|mesh-list
6524526|NCT00758732|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6524527|NCT00758732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6524528|NCT00758732|Tubulin Modulators|tubulin modulators|mesh-ancestor
6524529|NCT00758732|Antimitotic Agents|antimitotic agents|mesh-ancestor
6524530|NCT00758732|Mitosis Modulators|mitosis modulators|mesh-ancestor
6524531|NCT00758732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524532|NCT00758732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6524533|NCT00758732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6524534|NCT00758732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6524535|NCT00758732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6524536|NCT00758914|Vitamin E|vitamin e|mesh-list
6524537|NCT00758914|Vitamins|vitamins|mesh-ancestor
6524538|NCT00758914|Micronutrients|micronutrients|mesh-ancestor
5704361|NCT03324542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6524539|NCT00758914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223776|NCT02373137|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6223777|NCT02373202|Sulfasalazine|sulfasalazine|mesh-list
6223778|NCT02373202|Mizoribine|mizoribine|mesh-list
6223779|NCT02373202|Bucillamine|bucillamine|mesh-list
6223780|NCT02373202|Tacrolimus|tacrolimus|mesh-list
6223781|NCT02373202|Leflunomide|leflunomide|mesh-list
6223782|NCT02373202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6223783|NCT02373202|Immunologic Factors|immunologic factors|mesh-ancestor
6223784|NCT02373202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223785|NCT02373202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6223786|NCT02373202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6223787|NCT02373202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223788|NCT02373202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6223789|NCT02373202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6223790|NCT02373202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6223791|NCT02373202|Analgesics|analgesics|mesh-ancestor
6223792|NCT02373202|Sensory System Agents|sensory system agents|mesh-ancestor
6223793|NCT02373202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6223794|NCT02373202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6223795|NCT02373202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6498969|NCT00639483|Celecoxib|celecoxib|mesh-list
6498970|NCT00639483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6498971|NCT00639483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6498972|NCT00639483|Analgesics|analgesics|mesh-ancestor
6498973|NCT00639483|Sensory System Agents|sensory system agents|mesh-ancestor
6498974|NCT00639483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6498975|NCT00639483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498976|NCT00639483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6498977|NCT00639483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6676258|NCT01579864|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
6676259|NCT01579890|Diclofenac|diclofenac|mesh-list
6676260|NCT01579890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6676261|NCT01579890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6676262|NCT01579890|Analgesics|analgesics|mesh-ancestor
6676263|NCT01579890|Sensory System Agents|sensory system agents|mesh-ancestor
6676264|NCT01579890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6676265|NCT01579890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676266|NCT01579890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6676267|NCT01579890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6676268|NCT01579890|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6676269|NCT01579890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6676270|NCT01579890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676271|NCT01579903|Factor VIII|factor viii|mesh-list
6676272|NCT01579903|Coagulants|coagulants|mesh-ancestor
6676273|NCT01579929|Etoposide|etoposide|mesh-list
6676274|NCT01579929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6676275|NCT01579929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6676276|NCT01579929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6676277|NCT01579929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6676278|NCT01579929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6676279|NCT01579929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704362|NCT03324542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6223796|NCT02373202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6223797|NCT02373202|Antioxidants|antioxidants|mesh-ancestor
6223798|NCT02373202|Protective Agents|protective agents|mesh-ancestor
5704363|NCT03324542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5704364|NCT03324542|Growth Substances|growth substances|mesh-ancestor
5704365|NCT03324542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704366|NCT03324542|Growth Inhibitors|growth inhibitors|mesh-ancestor
5704367|NCT03324503|Prednisone|prednisone|mesh-list
5704368|NCT03324503|Prednisolone|prednisolone|mesh-list
5704369|NCT03324503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5704370|NCT03324503|Methylprednisolone|methylprednisolone|mesh-list
5704371|NCT03324503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5704372|NCT03324503|Prednisolone acetate|prednisolone acetate|mesh-list
5704373|NCT03324503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5704374|NCT03324503|Prednisolone phosphate|prednisolone phosphate|mesh-list
5704375|NCT03324503|Glucocorticoids|glucocorticoids|mesh-list
5704376|NCT03324503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5704377|NCT03324503|Hormones|hormones|mesh-ancestor
5704378|NCT03324503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5704379|NCT03324503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223799|NCT02373202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6223800|NCT02373202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6498978|NCT00639483|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6676280|NCT01579994|Crizotinib|crizotinib|mesh-list
6223801|NCT02373202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6223802|NCT02373202|Antimalarials|antimalarials|mesh-ancestor
6223803|NCT02373202|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6223804|NCT02373202|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6223805|NCT02373371|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
6223806|NCT02373371|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6223807|NCT02373371|Dermatologic Agents|dermatologic agents|mesh-ancestor
6223808|NCT02373813|Folic Acid|folic acid|mesh-list
6223809|NCT02373813|Etanercept|etanercept|mesh-list
6223810|NCT02373813|Methotrexate|methotrexate|mesh-list
6223811|NCT02373813|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6223812|NCT02373813|Abortifacient Agents|abortifacient agents|mesh-ancestor
6223813|NCT02373813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6223814|NCT02373813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223815|NCT02373813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6223816|NCT02373813|Antimetabolites|antimetabolites|mesh-ancestor
6223817|NCT02373813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223818|NCT02373813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6223819|NCT02373813|Dermatologic Agents|dermatologic agents|mesh-ancestor
6223820|NCT02373813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6223821|NCT02373813|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6223822|NCT02373813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6223823|NCT02373813|Immunologic Factors|immunologic factors|mesh-ancestor
6223824|NCT02373813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6223825|NCT02373813|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6223826|NCT02373813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6223827|NCT02373813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6223828|NCT02373813|Analgesics|analgesics|mesh-ancestor
6223829|NCT02373813|Sensory System Agents|sensory system agents|mesh-ancestor
6223830|NCT02373813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6223831|NCT02373813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6223832|NCT02373813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6223833|NCT02373813|Hematinics|hematinics|mesh-ancestor
6223834|NCT02373813|Vitamin B Complex|vitamin b complex|mesh-ancestor
6223835|NCT02373813|Vitamins|vitamins|mesh-ancestor
6223836|NCT02373813|Micronutrients|micronutrients|mesh-ancestor
6223837|NCT02374060|Dexamethasone|dexamethasone|mesh-list
6223838|NCT02374060|Triamcinolone|triamcinolone|mesh-list
6223839|NCT02374060|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6223840|NCT02374060|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6223841|NCT02374060|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6223842|NCT02374060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6223843|NCT02374060|Antiemetics|antiemetics|mesh-ancestor
6223844|NCT02374060|Autonomic Agents|autonomic agents|mesh-ancestor
6223845|NCT02374060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6223846|NCT02374060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223847|NCT02374060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6223848|NCT02374060|Glucocorticoids|glucocorticoids|mesh-ancestor
6223849|NCT02374060|Hormones|hormones|mesh-ancestor
6223850|NCT02374060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6223851|NCT02374060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6223852|NCT02374060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6223853|NCT02374060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6223854|NCT02374060|Immunologic Factors|immunologic factors|mesh-ancestor
6223855|NCT02374060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6223856|NCT02374060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223857|NCT02374099|Azacitidine|azacitidine|mesh-list
6223858|NCT02374099|Fulvestrant|fulvestrant|mesh-list
6223859|NCT02374099|Cc-486|cc-486|mesh-list
6223860|NCT02374099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6223861|NCT02374099|Antimetabolites|antimetabolites|mesh-ancestor
6223862|NCT02374099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223863|NCT02374099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6223864|NCT02374099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6223865|NCT02374099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6223866|NCT02374099|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6223867|NCT02374099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6223868|NCT02374099|Hormone Antagonists|hormone antagonists|mesh-ancestor
6223869|NCT02374099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6223870|NCT02374099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223871|NCT02374164|Febuxostat|febuxostat|mesh-list
6223872|NCT02374164|Gout Suppressants|gout suppressants|mesh-ancestor
6223873|NCT02374164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6223874|NCT02374398|Tranexamic Acid|tranexamic acid|mesh-list
6223875|NCT02374398|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6223876|NCT02374398|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6223877|NCT02374398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223878|NCT02374398|Hemostatics|hemostatics|mesh-ancestor
6223879|NCT02374398|Coagulants|coagulants|mesh-ancestor
6223880|NCT02374957|Cilostazol|cilostazol|mesh-list
6223881|NCT02374957|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6223882|NCT02374957|Autonomic Agents|autonomic agents|mesh-ancestor
6223883|NCT02374957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6223884|NCT02374957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223885|NCT02374957|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6223886|NCT02374957|Respiratory System Agents|respiratory system agents|mesh-ancestor
6223887|NCT02374957|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6223888|NCT02374957|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6223889|NCT02374957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223890|NCT02374957|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6223891|NCT02374957|Vasodilator Agents|vasodilator agents|mesh-ancestor
6223892|NCT02374957|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6223893|NCT02374957|Protective Agents|protective agents|mesh-ancestor
6223894|NCT02374957|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6223895|NCT02374957|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6223896|NCT02374957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6223897|NCT02375724|Bromides|bromides|mesh-list
6223898|NCT02375724|Anticonvulsants|anticonvulsants|mesh-ancestor
6223899|NCT02375971|Ranibizumab|ranibizumab|mesh-list
6223900|NCT02375971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6223901|NCT02375971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6223902|NCT02375971|Growth Substances|growth substances|mesh-ancestor
6223903|NCT02375971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223904|NCT02375971|Growth Inhibitors|growth inhibitors|mesh-ancestor
6223905|NCT02375971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6223906|NCT02376010|Warfarin|warfarin|mesh-list
6223907|NCT02376010|Rivaroxaban|rivaroxaban|mesh-list
6223908|NCT02376010|Anticoagulants|anticoagulants|mesh-ancestor
6223909|NCT02376010|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6223910|NCT02376010|Antithrombins|antithrombins|mesh-ancestor
6223911|NCT02376010|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6223912|NCT02376010|Protease Inhibitors|protease inhibitors|mesh-ancestor
6223913|NCT02376010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6223914|NCT02376010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223915|NCT02376166|Metformin|metformin|mesh-list
6223916|NCT02376166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6223917|NCT02376166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223918|NCT02376257|Cycloserine|cycloserine|mesh-list
6223919|NCT02376257|Modafinil|modafinil|mesh-list
6223920|NCT02376257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6223921|NCT02376257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223922|NCT02376257|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6223923|NCT02376257|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6223924|NCT02376257|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6223925|NCT02376257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223926|NCT02376257|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6223927|NCT02376257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6223928|NCT02376257|Renal Agents|renal agents|mesh-ancestor
6223929|NCT02376257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6223930|NCT02376257|Antitubercular Agents|antitubercular agents|mesh-ancestor
6223931|NCT02376257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6223932|NCT02376257|Antimetabolites|antimetabolites|mesh-ancestor
6223933|NCT02376283|Clopidogrel|clopidogrel|mesh-list
6223934|NCT02376283|Ticagrelor|ticagrelor|mesh-list
6223935|NCT02376283|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6223936|NCT02376283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6223937|NCT02376283|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6223938|NCT02376283|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6223939|NCT02376283|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6223940|NCT02376283|Purinergic Agents|purinergic agents|mesh-ancestor
6223941|NCT02376283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6223942|NCT02376283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223943|NCT02376283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223944|NCT02376790|Etanercept|etanercept|mesh-list
6223945|NCT02376790|Methotrexate|methotrexate|mesh-list
6223946|NCT02376790|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6223947|NCT02376790|Abortifacient Agents|abortifacient agents|mesh-ancestor
6223948|NCT02376790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6223949|NCT02376790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6223950|NCT02376790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5704380|NCT03324503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6223951|NCT02376790|Antimetabolites|antimetabolites|mesh-ancestor
6223952|NCT02376790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223953|NCT02376790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6223954|NCT02376790|Dermatologic Agents|dermatologic agents|mesh-ancestor
6223955|NCT02376790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6223956|NCT02376790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6223957|NCT02376790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6223958|NCT02376790|Immunologic Factors|immunologic factors|mesh-ancestor
6223959|NCT02376790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6223960|NCT02376790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6223961|NCT02376790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6223962|NCT02376790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6223963|NCT02376790|Analgesics|analgesics|mesh-ancestor
6223964|NCT02376790|Sensory System Agents|sensory system agents|mesh-ancestor
6223965|NCT02376790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6223966|NCT02376790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6223967|NCT02376790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6223968|NCT02377752|Doxorubicin|doxorubicin|mesh-list
6223969|NCT02377752|Olaratumab|olaratumab|mesh-list
6223970|NCT02377752|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6223971|NCT02377752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6223972|NCT02377752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6223973|NCT02377752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6223974|NCT02377752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6223975|NCT02377752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223976|NCT02378480|Linezolid|linezolid|mesh-list
6223977|NCT02378480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6223978|NCT02378480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6223979|NCT02378480|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6223980|NCT02378480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6223981|NCT02378480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6223982|NCT02378506|Etanercept|etanercept|mesh-list
6223983|NCT02378506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6223984|NCT02378506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6223985|NCT02378506|Analgesics|analgesics|mesh-ancestor
6223986|NCT02378506|Sensory System Agents|sensory system agents|mesh-ancestor
6223987|NCT02378506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6223988|NCT02378506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498979|NCT00639483|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6498980|NCT00639483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6498981|NCT00639483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498982|NCT00639496|Acetylcysteine|acetylcysteine|mesh-list
6498983|NCT00639496|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6498984|NCT00639496|Antiviral Agents|antiviral agents|mesh-ancestor
6498985|NCT00639496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6676281|NCT01579994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6676282|NCT01579994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5704381|NCT03324503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5704382|NCT03324503|Antiemetics|antiemetics|mesh-ancestor
5704383|NCT03324503|Autonomic Agents|autonomic agents|mesh-ancestor
6223989|NCT02378506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6223990|NCT02378506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6223991|NCT02378506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5704384|NCT03324503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5704385|NCT03324503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5704386|NCT03324503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5704387|NCT03324503|Protective Agents|protective agents|mesh-ancestor
5704388|NCT03324490|Fentanyl|fentanyl|mesh-list
5704389|NCT03324490|Dexmedetomidine|dexmedetomidine|mesh-list
5704390|NCT03324490|Bupivacaine|bupivacaine|mesh-list
5704391|NCT03324490|Anesthetics|anesthetics|mesh-list
5704392|NCT03324490|Anesthetics, Local|anesthetics, local|mesh-ancestor
5704393|NCT03324490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5704394|NCT03324490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704395|NCT03324490|Sensory System Agents|sensory system agents|mesh-ancestor
5704396|NCT03324490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5704397|NCT03324490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6223992|NCT02378506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6223993|NCT02378506|Immunologic Factors|immunologic factors|mesh-ancestor
6223994|NCT02378714|Varenicline|varenicline|mesh-list
6223995|NCT02378714|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6223996|NCT02378714|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6223997|NCT02378714|Cholinergic Agents|cholinergic agents|mesh-ancestor
6498986|NCT00639496|Expectorants|expectorants|mesh-ancestor
6498987|NCT00639496|Respiratory System Agents|respiratory system agents|mesh-ancestor
6223998|NCT02378714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6223999|NCT02378714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224000|NCT02378714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224001|NCT02378935|Sofosbuvir|sofosbuvir|mesh-list
6224002|NCT02378935|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
6224003|NCT02378935|Velpatasvir|velpatasvir|mesh-list
6224004|NCT02378935|Antiviral Agents|antiviral agents|mesh-ancestor
6224005|NCT02378935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6224006|NCT02378961|Sofosbuvir|sofosbuvir|mesh-list
6224007|NCT02378961|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
6224008|NCT02378961|Velpatasvir|velpatasvir|mesh-list
6224009|NCT02378961|Antiviral Agents|antiviral agents|mesh-ancestor
6224010|NCT02378961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6224011|NCT02379091|Leucovorin|leucovorin|mesh-list
6224012|NCT02379091|Folic Acid|folic acid|mesh-list
6224013|NCT02379091|Methotrexate|methotrexate|mesh-list
6224014|NCT02379091|Levoleucovorin|levoleucovorin|mesh-list
6224015|NCT02379091|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6224016|NCT02379091|Abortifacient Agents|abortifacient agents|mesh-ancestor
6224017|NCT02379091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6224018|NCT02379091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704398|NCT03324490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5704399|NCT03324490|Analgesics|analgesics|mesh-ancestor
5704400|NCT03324490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5704401|NCT03324490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5704402|NCT03324490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5704403|NCT03324490|Adrenergic Agents|adrenergic agents|mesh-ancestor
5704404|NCT03324490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5704405|NCT03324490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704406|NCT03324490|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5704407|NCT03324490|Narcotics|narcotics|mesh-ancestor
5704408|NCT03324490|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5704409|NCT03324490|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6224019|NCT02379091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6224020|NCT02379091|Antimetabolites|antimetabolites|mesh-ancestor
6224021|NCT02379091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224022|NCT02379091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6224023|NCT02379091|Dermatologic Agents|dermatologic agents|mesh-ancestor
6498988|NCT00639496|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6498989|NCT00639496|Antioxidants|antioxidants|mesh-ancestor
6498990|NCT00639496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6498991|NCT00639496|Protective Agents|protective agents|mesh-ancestor
6498992|NCT00639496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6498993|NCT00639496|Antidotes|antidotes|mesh-ancestor
6498994|NCT00639522|Paclitaxel|paclitaxel|mesh-list
5704410|NCT03324490|Anesthetics, General|anesthetics, general|mesh-ancestor
5704411|NCT03324425|Simvastatin|simvastatin|mesh-list
5704412|NCT03324425|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5704413|NCT03324425|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6498995|NCT00639522|Capecitabine|capecitabine|mesh-list
6498996|NCT00639522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6498997|NCT00639522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6498998|NCT00639522|Tubulin Modulators|tubulin modulators|mesh-ancestor
6498999|NCT00639522|Antimitotic Agents|antimitotic agents|mesh-ancestor
6499000|NCT00639522|Mitosis Modulators|mitosis modulators|mesh-ancestor
6499001|NCT00639522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499002|NCT00639522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6499003|NCT00639522|Antimetabolites|antimetabolites|mesh-ancestor
6499004|NCT00639574|Nefopam|nefopam|mesh-list
6499005|NCT00639574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5704414|NCT03324425|Antimetabolites|antimetabolites|mesh-ancestor
5704415|NCT03324425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704416|NCT03324425|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5704417|NCT03324425|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5704418|NCT03324425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5704419|NCT03324334|Antibodies|antibodies|mesh-list
5704420|NCT03324334|Immunologic Factors|immunologic factors|mesh-ancestor
5704421|NCT03324334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704422|NCT03324282|Avelumab|avelumab|mesh-list
5704423|NCT03324282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5704424|NCT03324282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5704425|NCT03324243|Cytarabine|cytarabine|mesh-list
5704426|NCT03324243|Fludarabine|fludarabine|mesh-list
6499006|NCT00639574|Analgesics|analgesics|mesh-ancestor
5704427|NCT03324243|Crenolanib|crenolanib|mesh-list
5704428|NCT03324243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6224024|NCT02379091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6224025|NCT02379091|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6224026|NCT02379091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6224027|NCT02379091|Immunologic Factors|immunologic factors|mesh-ancestor
6224028|NCT02379091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6224029|NCT02379091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6224030|NCT02379091|Antidotes|antidotes|mesh-ancestor
6224031|NCT02379091|Protective Agents|protective agents|mesh-ancestor
6224032|NCT02379091|Vitamin B Complex|vitamin b complex|mesh-ancestor
6224033|NCT02379091|Vitamins|vitamins|mesh-ancestor
6224034|NCT02379091|Micronutrients|micronutrients|mesh-ancestor
6224035|NCT02379091|Hematinics|hematinics|mesh-ancestor
6224036|NCT02379195|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6224037|NCT02379195|Cyclophosphamide|cyclophosphamide|mesh-list
6224038|NCT02379195|Fludarabine|fludarabine|mesh-list
6224039|NCT02379195|Interleukin-2|interleukin-2|mesh-list
6224040|NCT02379195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6224041|NCT02379195|Immunologic Factors|immunologic factors|mesh-ancestor
6224042|NCT02379195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224043|NCT02379195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6224044|NCT02379195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6224045|NCT02379195|Alkylating Agents|alkylating agents|mesh-ancestor
6224046|NCT02379195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224047|NCT02379195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6224048|NCT02379195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6224049|NCT02379195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6224050|NCT02379195|Analgesics|analgesics|mesh-ancestor
6224051|NCT02379195|Sensory System Agents|sensory system agents|mesh-ancestor
6224052|NCT02379195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6224053|NCT02379195|Antiviral Agents|antiviral agents|mesh-ancestor
6224054|NCT02379195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6224055|NCT02379221|Lidocaine|lidocaine|mesh-list
6224056|NCT02379221|Epinephrine|epinephrine|mesh-list
6224057|NCT02379221|Benzocaine|benzocaine|mesh-list
6224058|NCT02379221|Anesthetics, Local|anesthetics, local|mesh-ancestor
6224059|NCT02379221|Anesthetics|anesthetics|mesh-ancestor
6224060|NCT02379221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6224061|NCT02379221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224062|NCT02379221|Sensory System Agents|sensory system agents|mesh-ancestor
6224063|NCT02379221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6224064|NCT02379221|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6224065|NCT02379221|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6224066|NCT02379221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5704429|NCT03324243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5704430|NCT03324243|Antimetabolites|antimetabolites|mesh-ancestor
5704431|NCT03324243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704432|NCT03324243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5704433|NCT03324243|Immunologic Factors|immunologic factors|mesh-ancestor
5704434|NCT03324243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704435|NCT03324243|Antiviral Agents|antiviral agents|mesh-ancestor
5704436|NCT03324243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5704437|NCT03324139|Heparin|heparin|mesh-list
6224067|NCT02379221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6224068|NCT02379221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224069|NCT02379221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6224070|NCT02379221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5704438|NCT03324139|Calcium heparin|calcium heparin|mesh-list
5704439|NCT03324139|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5704440|NCT03324139|Tinzaparin|tinzaparin|mesh-list
5704441|NCT03324139|Dalteparin|dalteparin|mesh-list
5704442|NCT03324139|Anticoagulants|anticoagulants|mesh-ancestor
6224071|NCT02379221|Adrenergic Agents|adrenergic agents|mesh-ancestor
6224072|NCT02379221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6224073|NCT02379221|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6224074|NCT02379221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6224075|NCT02379221|Autonomic Agents|autonomic agents|mesh-ancestor
6224076|NCT02379221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6224077|NCT02379221|Respiratory System Agents|respiratory system agents|mesh-ancestor
6224078|NCT02379221|Mydriatics|mydriatics|mesh-ancestor
6224079|NCT02379221|Sympathomimetics|sympathomimetics|mesh-ancestor
6224080|NCT02379221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6224081|NCT02379247|Paclitaxel|paclitaxel|mesh-list
6224082|NCT02379247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6224083|NCT02379247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5704443|NCT03324139|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5704444|NCT03324139|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6224084|NCT02379247|Tubulin Modulators|tubulin modulators|mesh-ancestor
6499007|NCT00639574|Sensory System Agents|sensory system agents|mesh-ancestor
6524540|NCT00758914|Antioxidants|antioxidants|mesh-ancestor
6224085|NCT02379247|Antimitotic Agents|antimitotic agents|mesh-ancestor
6224086|NCT02379247|Mitosis Modulators|mitosis modulators|mesh-ancestor
6224087|NCT02379247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243396|NCT02666742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6243397|NCT02666742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243398|NCT02666742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6243399|NCT02666742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6243400|NCT02666742|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6243401|NCT02666742|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6243402|NCT02666742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243403|NCT02666742|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6243404|NCT02666742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6243405|NCT02666742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6243406|NCT02666742|Antipyretics|antipyretics|mesh-ancestor
6243407|NCT02666742|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6243408|NCT02666742|Antithrombins|antithrombins|mesh-ancestor
6243409|NCT02666742|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6243410|NCT02666742|Protease Inhibitors|protease inhibitors|mesh-ancestor
6243411|NCT02666846|Ibuprofen|ibuprofen|mesh-list
6243412|NCT02666846|Diclofenac|diclofenac|mesh-list
6243413|NCT02666846|Salicylates|salicylates|mesh-list
6243414|NCT02666846|Methyl salicylate|methyl salicylate|mesh-list
6243415|NCT02666846|Menthol|menthol|mesh-list
6243416|NCT02666846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6243417|NCT02666846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6243418|NCT02666846|Analgesics|analgesics|mesh-ancestor
6243419|NCT02666846|Sensory System Agents|sensory system agents|mesh-ancestor
6243420|NCT02666846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6676283|NCT01579994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6676284|NCT01579994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676285|NCT01580007|Cholecalciferol|cholecalciferol|mesh-list
6676286|NCT01580007|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
6676287|NCT01580007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6676288|NCT01580007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676289|NCT01580007|Vitamins|vitamins|mesh-ancestor
6676290|NCT01580007|Micronutrients|micronutrients|mesh-ancestor
6676291|NCT01580007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6676292|NCT01580007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6779651|NCT02180334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6779652|NCT02180334|Analgesics|analgesics|mesh-ancestor
6779653|NCT02180334|Sensory System Agents|sensory system agents|mesh-ancestor
6779654|NCT02180334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5918691|NCT04989140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6243421|NCT02666846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243422|NCT02666846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6243423|NCT02666846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6243424|NCT02666846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6243425|NCT02666846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6243426|NCT02666846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243427|NCT02666846|Antipruritics|antipruritics|mesh-ancestor
6243428|NCT02666846|Dermatologic Agents|dermatologic agents|mesh-ancestor
6243429|NCT02666950|Cytarabine|cytarabine|mesh-list
6243430|NCT02666950|Adavosertib|adavosertib|mesh-list
6243431|NCT02666950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6243432|NCT02666950|Antimetabolites|antimetabolites|mesh-ancestor
6243433|NCT02666950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243434|NCT02666950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6243435|NCT02666950|Antiviral Agents|antiviral agents|mesh-ancestor
6243436|NCT02666950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6243437|NCT02666950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6243438|NCT02666950|Immunologic Factors|immunologic factors|mesh-ancestor
6243439|NCT02666950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243440|NCT02666950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6243441|NCT02667236|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6243442|NCT02667275|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6243443|NCT02667704|Nintedanib|nintedanib|mesh-list
6243444|NCT02667704|Bosentan|bosentan|mesh-list
6243445|NCT02667704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6243446|NCT02667704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6243447|NCT02667704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6243448|NCT02667704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243449|NCT02667704|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6243450|NCT02667704|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6243451|NCT02668393|Docetaxel|docetaxel|mesh-list
6243452|NCT02668393|Nintedanib|nintedanib|mesh-list
6779655|NCT02180334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224088|NCT02379637|Acetylcysteine|acetylcysteine|mesh-list
6224089|NCT02379637|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6224090|NCT02379637|Antiviral Agents|antiviral agents|mesh-ancestor
6224091|NCT02379637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6224092|NCT02379637|Expectorants|expectorants|mesh-ancestor
6224093|NCT02379637|Respiratory System Agents|respiratory system agents|mesh-ancestor
6224094|NCT02379637|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6224095|NCT02379637|Antioxidants|antioxidants|mesh-ancestor
6224096|NCT02379637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224097|NCT02379637|Protective Agents|protective agents|mesh-ancestor
6224098|NCT02379637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224099|NCT02379637|Antidotes|antidotes|mesh-ancestor
6224100|NCT02379858|Alvimopan|alvimopan|mesh-list
6224101|NCT02379858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6224102|NCT02380248|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6224103|NCT02380248|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6224104|NCT02380287|Antibodies|antibodies|mesh-list
6224105|NCT02380287|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6224106|NCT02380287|Immunologic Factors|immunologic factors|mesh-ancestor
6224107|NCT02380287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224108|NCT02380742|Lidocaine|lidocaine|mesh-list
6224109|NCT02380742|Prilocaine|prilocaine|mesh-list
6224110|NCT02380742|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
6224111|NCT02380742|Anesthetics, Local|anesthetics, local|mesh-ancestor
6224112|NCT02380742|Anesthetics|anesthetics|mesh-ancestor
5704445|NCT03324139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704446|NCT03324113|Diphenhydramine|diphenhydramine|mesh-list
5704447|NCT03324113|Promethazine|promethazine|mesh-list
5704448|NCT03324113|Dexamethasone|dexamethasone|mesh-list
5704449|NCT03324113|Naphazoline|naphazoline|mesh-list
5704450|NCT03324113|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6224113|NCT02380742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6224114|NCT02380742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224115|NCT02380742|Sensory System Agents|sensory system agents|mesh-ancestor
6224116|NCT02380742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6224117|NCT02380742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6224118|NCT02380742|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6224119|NCT02380742|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6224120|NCT02380742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6224121|NCT02380742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224122|NCT02380742|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
6224123|NCT02381652|Triamcinolone|triamcinolone|mesh-list
6224124|NCT02381652|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6224125|NCT02381652|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6224126|NCT02381652|Hyaluronic Acid|hyaluronic acid|mesh-list
6224127|NCT02381652|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6224128|NCT02381652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6224129|NCT02381652|Glucocorticoids|glucocorticoids|mesh-ancestor
6224130|NCT02381652|Hormones|hormones|mesh-ancestor
6224131|NCT02381652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6224132|NCT02381652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704451|NCT03324113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5704452|NCT03324113|Antiemetics|antiemetics|mesh-ancestor
5704453|NCT03324113|Autonomic Agents|autonomic agents|mesh-ancestor
5704454|NCT03324113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5704455|NCT03324113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676293|NCT01580033|Vaccines|vaccines|mesh-list
6676294|NCT01580033|Immunologic Factors|immunologic factors|mesh-ancestor
6676295|NCT01580033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676296|NCT01580163|Methadone|methadone|mesh-list
6676297|NCT01580163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6676298|NCT01580163|Narcotics|narcotics|mesh-ancestor
6676299|NCT01580163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6676300|NCT01580163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676301|NCT01580163|Analgesics|analgesics|mesh-ancestor
6224133|NCT02381652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6224134|NCT02381652|Immunologic Factors|immunologic factors|mesh-ancestor
6224135|NCT02381652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6676302|NCT01580163|Sensory System Agents|sensory system agents|mesh-ancestor
6676303|NCT01580163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6676304|NCT01580163|Antitussive Agents|antitussive agents|mesh-ancestor
6676305|NCT01580163|Respiratory System Agents|respiratory system agents|mesh-ancestor
6676306|NCT01580202|Lamivudine|lamivudine|mesh-list
6676307|NCT01580202|Entecavir|entecavir|mesh-list
6224136|NCT02381652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224137|NCT02381652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6676308|NCT01580202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6676309|NCT01580202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6676310|NCT01580202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6676311|NCT01580202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676312|NCT01580202|Antiviral Agents|antiviral agents|mesh-ancestor
6676313|NCT01580202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6676314|NCT01580202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6676315|NCT01580202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6676316|NCT01580228|Ofatumumab|ofatumumab|mesh-list
6676317|NCT01580228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6676318|NCT01580254|Latanoprost|latanoprost|mesh-list
6676319|NCT01580254|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6676320|NCT01580254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6676321|NCT01580371|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
6676322|NCT01580371|CKD-581|ckd-581|mesh-list
6676323|NCT01580371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6676324|NCT01580371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676325|NCT01580501|Sildenafil Citrate|sildenafil citrate|mesh-list
6499008|NCT00639574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6499009|NCT00639574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499010|NCT00639587|Cetirizine|cetirizine|mesh-list
6499011|NCT00639587|Ketotifen|ketotifen|mesh-list
6499012|NCT00639587|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6499013|NCT00639587|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6499014|NCT00639587|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6676326|NCT01580501|Tadalafil|tadalafil|mesh-list
6676327|NCT01580501|Vasodilator Agents|vasodilator agents|mesh-ancestor
6224138|NCT02381652|Viscosupplements|viscosupplements|mesh-ancestor
6224139|NCT02381652|Protective Agents|protective agents|mesh-ancestor
6224140|NCT02382016|Macitentan|macitentan|mesh-list
6224141|NCT02382016|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
6224142|NCT02382016|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6224143|NCT02382016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224144|NCT02382016|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
6224145|NCT02382276|Nalmefene|nalmefene|mesh-list
6224146|NCT02382276|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6224147|NCT02382276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224148|NCT02382276|Sensory System Agents|sensory system agents|mesh-ancestor
6224149|NCT02382276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6224150|NCT02382640|Febuxostat|febuxostat|mesh-list
6224151|NCT02382640|Gout Suppressants|gout suppressants|mesh-ancestor
6224152|NCT02382640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6224153|NCT02382848|Prazosin|prazosin|mesh-list
6224154|NCT02382848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6224155|NCT02382848|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6224156|NCT02382848|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6224157|NCT02382848|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6224158|NCT02382848|Adrenergic Agents|adrenergic agents|mesh-ancestor
6224159|NCT02382848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6224160|NCT02382848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224161|NCT02382848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224162|NCT02383043|Cocaine|cocaine|mesh-list
6224163|NCT02383043|Amphetamine|amphetamine|mesh-list
6224164|NCT02383043|Dextroamphetamine|dextroamphetamine|mesh-list
6224165|NCT02383043|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6224166|NCT02383043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224167|NCT02383043|Sympathomimetics|sympathomimetics|mesh-ancestor
6224168|NCT02383043|Autonomic Agents|autonomic agents|mesh-ancestor
6224169|NCT02383043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6224170|NCT02383043|Dopamine Agents|dopamine agents|mesh-ancestor
6224171|NCT02383043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6224172|NCT02383043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224173|NCT02383043|Adrenergic Agents|adrenergic agents|mesh-ancestor
6224174|NCT02383043|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6224175|NCT02383043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6224176|NCT02383043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6224177|NCT02383043|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6224178|NCT02383043|Anesthetics, Local|anesthetics, local|mesh-ancestor
6224179|NCT02383043|Anesthetics|anesthetics|mesh-ancestor
6499015|NCT00639587|Histamine Antagonists|histamine antagonists|mesh-ancestor
6499016|NCT00639587|Histamine Agents|histamine agents|mesh-ancestor
6499017|NCT00639587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6499018|NCT00639587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499019|NCT00639587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499020|NCT00639587|Antipruritics|antipruritics|mesh-ancestor
6676328|NCT01580501|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6224180|NCT02383043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6224181|NCT02383043|Sensory System Agents|sensory system agents|mesh-ancestor
6224182|NCT02383043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6224183|NCT02383355|Raltegravir Potassium|raltegravir potassium|mesh-list
6224184|NCT02383355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6224185|NCT02383355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6224186|NCT02383355|Antiviral Agents|antiviral agents|mesh-ancestor
6224187|NCT02383355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6224188|NCT02383355|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6224189|NCT02383355|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6224190|NCT02383355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6224191|NCT02383355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224192|NCT02383589|Mycophenolic Acid|mycophenolic acid|mesh-list
5704456|NCT03324113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5704457|NCT03324113|Glucocorticoids|glucocorticoids|mesh-ancestor
5704458|NCT03324113|Hormones|hormones|mesh-ancestor
5704459|NCT03324113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5704460|NCT03324113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5704461|NCT03324113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6224193|NCT02383589|Rituximab|rituximab|mesh-list
6224194|NCT02383589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6224195|NCT02383589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6224196|NCT02383589|Immunologic Factors|immunologic factors|mesh-ancestor
5704462|NCT03324113|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5704463|NCT03324113|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5704464|NCT03324113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5704465|NCT03324113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6224197|NCT02383589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224198|NCT02383589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6224199|NCT02383589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6224200|NCT02383589|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6224201|NCT02383589|Antitubercular Agents|antitubercular agents|mesh-ancestor
6224202|NCT02383589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6224203|NCT02383589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6224204|NCT02383589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6224205|NCT02383589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224206|NCT02383758|Bisacodyl|bisacodyl|mesh-list
6224207|NCT02383758|Glycerol|glycerol|mesh-list
6224208|NCT02383758|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6224209|NCT02383758|Protective Agents|protective agents|mesh-ancestor
6224210|NCT02383758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224211|NCT02383758|Cathartics|cathartics|mesh-ancestor
6224212|NCT02383758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6224213|NCT02383758|Laxatives|laxatives|mesh-ancestor
6224214|NCT02383940|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
6224215|NCT02383940|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6224216|NCT02383940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224217|NCT02383940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6224218|NCT02383940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224219|NCT02383966|Carboplatin|carboplatin|mesh-list
6224220|NCT02383966|Fluorouracil|fluorouracil|mesh-list
6224221|NCT02383966|Cetuximab|cetuximab|mesh-list
6224222|NCT02383966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6224223|NCT02383966|Antimetabolites|antimetabolites|mesh-ancestor
6224224|NCT02383966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224225|NCT02383966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6224226|NCT02383966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6224227|NCT02383966|Immunologic Factors|immunologic factors|mesh-ancestor
6224228|NCT02383966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224229|NCT02383966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6224230|NCT02384044|Listerine|listerine|mesh-list
6224231|NCT02384044|Sodium Fluoride|sodium fluoride|mesh-list
6224232|NCT02384044|Cariostatic Agents|cariostatic agents|mesh-ancestor
6224233|NCT02384044|Protective Agents|protective agents|mesh-ancestor
6224234|NCT02384044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224235|NCT02384044|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6224236|NCT02384044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6224237|NCT02384070|Aspirin|aspirin|mesh-list
6224238|NCT02384070|Bivalirudin|bivalirudin|mesh-list
6224239|NCT02384070|Clopidogrel|clopidogrel|mesh-list
6224240|NCT02384070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6224241|NCT02384070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6224242|NCT02384070|Analgesics|analgesics|mesh-ancestor
6224243|NCT02384070|Sensory System Agents|sensory system agents|mesh-ancestor
5704466|NCT03324113|Anesthetics, Local|anesthetics, local|mesh-ancestor
5704467|NCT03324113|Anesthetics|anesthetics|mesh-ancestor
5704468|NCT03324113|Sensory System Agents|sensory system agents|mesh-ancestor
5704469|NCT03324113|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5704470|NCT03324113|Histamine Antagonists|histamine antagonists|mesh-ancestor
5704471|NCT03324113|Histamine Agents|histamine agents|mesh-ancestor
5704472|NCT03324113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5704473|NCT03324113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704474|NCT03324113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5704475|NCT03324113|Antipruritics|antipruritics|mesh-ancestor
5704476|NCT03324113|Dermatologic Agents|dermatologic agents|mesh-ancestor
5704477|NCT03324113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6224244|NCT02384070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6224245|NCT02384070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224246|NCT02384070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6224247|NCT02384070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6224248|NCT02384070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6224249|NCT02384070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6224250|NCT02384070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224251|NCT02384070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6224252|NCT02384070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6224253|NCT02384070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6224254|NCT02384070|Antipyretics|antipyretics|mesh-ancestor
6224255|NCT02384070|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6224256|NCT02384070|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6224257|NCT02384070|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6224258|NCT02384070|Purinergic Agents|purinergic agents|mesh-ancestor
6224259|NCT02384070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6224260|NCT02384070|Antithrombins|antithrombins|mesh-ancestor
6224261|NCT02384070|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6224262|NCT02384070|Protease Inhibitors|protease inhibitors|mesh-ancestor
6224263|NCT02384070|Anticoagulants|anticoagulants|mesh-ancestor
6224264|NCT02384200|Vancomycin|vancomycin|mesh-list
6224265|NCT02384200|Gentamicins|gentamicins|mesh-list
6224266|NCT02384200|Ceftriaxone|ceftriaxone|mesh-list
6224267|NCT02384200|Ampicillin|ampicillin|mesh-list
6224268|NCT02384200|Nitrofurantoin|nitrofurantoin|mesh-list
6224269|NCT02384200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6224270|NCT02384200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6224271|NCT02384200|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6224272|NCT02384200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6224273|NCT02384200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224274|NCT02384200|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6224275|NCT02384200|Renal Agents|renal agents|mesh-ancestor
6224276|NCT02384395|Lamivudine|lamivudine|mesh-list
6224277|NCT02384395|Abacavir|abacavir|mesh-list
6224278|NCT02384395|Dolutegravir|dolutegravir|mesh-list
6224279|NCT02384395|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6224280|NCT02384395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6224281|NCT02384395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6224282|NCT02384395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224283|NCT02384395|Antiviral Agents|antiviral agents|mesh-ancestor
6224284|NCT02384395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6224285|NCT02384395|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6224286|NCT02384395|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6224287|NCT02384395|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6224288|NCT02384395|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6224289|NCT02384941|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
6224290|NCT02384941|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6224291|NCT02384941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704478|NCT03324113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5704479|NCT03324113|Adrenergic Agents|adrenergic agents|mesh-ancestor
5704480|NCT03324113|Nasal Decongestants|nasal decongestants|mesh-ancestor
5704481|NCT03324113|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5704482|NCT03324113|Respiratory System Agents|respiratory system agents|mesh-ancestor
5704483|NCT03324061|Fulvestrant|fulvestrant|mesh-list
5704484|NCT03324061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6224292|NCT02384941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6224293|NCT02384941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224294|NCT02385097|Ropivacaine|ropivacaine|mesh-list
6224295|NCT02385097|Chloroprocaine|chloroprocaine|mesh-list
5704485|NCT03324061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5704486|NCT03324061|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5704487|NCT03324061|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5704488|NCT03324061|Hormone Antagonists|hormone antagonists|mesh-ancestor
5721152|NCT03208426|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6224296|NCT02385097|Anesthetics, Local|anesthetics, local|mesh-ancestor
6224297|NCT02385097|Anesthetics|anesthetics|mesh-ancestor
6224298|NCT02385097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6224299|NCT02385097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224300|NCT02385097|Sensory System Agents|sensory system agents|mesh-ancestor
6224301|NCT02385097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6224302|NCT02385240|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6224303|NCT02385240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6224304|NCT02385240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6224305|NCT02385240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6224306|NCT02385240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6224307|NCT02385240|Adrenergic Agents|adrenergic agents|mesh-ancestor
6224308|NCT02385240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6224309|NCT02385240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224310|NCT02385240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224311|NCT02385669|Ipilimumab|ipilimumab|mesh-list
6224312|NCT02385669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6224313|NCT02385669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6224314|NCT02385669|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6224315|NCT02385669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224316|NCT02385708|Chlorhexidine|chlorhexidine|mesh-list
6224317|NCT02385708|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6224318|NCT02385708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6224319|NCT02385708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6224320|NCT02385708|Disinfectants|disinfectants|mesh-ancestor
6224321|NCT02385708|Dermatologic Agents|dermatologic agents|mesh-ancestor
6224322|NCT02385799|Sertraline|sertraline|mesh-list
6224323|NCT02385799|Antidepressive Agents|antidepressive agents|mesh-ancestor
6224324|NCT02385799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6224325|NCT02385799|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6224326|NCT02385799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6224327|NCT02385799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6224328|NCT02385799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224329|NCT02385799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6224330|NCT02385799|Serotonin Agents|serotonin agents|mesh-ancestor
6224331|NCT02385799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224332|NCT02386098|Ritonavir|ritonavir|mesh-list
6224333|NCT02386098|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6224334|NCT02386098|Tenofovir|tenofovir|mesh-list
6224335|NCT02386098|Dolutegravir|dolutegravir|mesh-list
6224336|NCT02386098|BMS-955176|bms-955176|mesh-list
6224337|NCT02386098|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6224338|NCT02386098|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6224339|NCT02386098|Protease Inhibitors|protease inhibitors|mesh-ancestor
6224340|NCT02386098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6224341|NCT02386098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224342|NCT02386098|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6224343|NCT02386098|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6224344|NCT02386098|Antiviral Agents|antiviral agents|mesh-ancestor
6224345|NCT02386098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6224346|NCT02386098|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6224347|NCT02386098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6224348|NCT02386098|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6499021|NCT00639587|Dermatologic Agents|dermatologic agents|mesh-ancestor
6499022|NCT00639691|Omalizumab|omalizumab|mesh-list
6499023|NCT00639691|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6499024|NCT00639691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6499025|NCT00639691|Respiratory System Agents|respiratory system agents|mesh-ancestor
6499026|NCT00639743|Tenecteplase|tenecteplase|mesh-list
6499027|NCT00639743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6499028|NCT00639743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6499029|NCT00639743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499030|NCT00639756|Allopurinol|allopurinol|mesh-list
6499031|NCT00639756|Antimetabolites|antimetabolites|mesh-ancestor
6499032|NCT00639756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499033|NCT00639756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6499034|NCT00639756|Gout Suppressants|gout suppressants|mesh-ancestor
6499035|NCT00639756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6499036|NCT00639756|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6499037|NCT00639756|Antioxidants|antioxidants|mesh-ancestor
6499038|NCT00639756|Protective Agents|protective agents|mesh-ancestor
6779656|NCT02180334|Antipyretics|antipyretics|mesh-ancestor
6499039|NCT00639756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704489|NCT03324061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5704490|NCT03324061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704491|NCT03323866|Mometasone Furoate|mometasone furoate|mesh-list
6224349|NCT02386098|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6224350|NCT02386098|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6224351|NCT02386098|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6224352|NCT02386319|Melatonin|melatonin|mesh-list
6224353|NCT02386319|Antioxidants|antioxidants|mesh-ancestor
6224354|NCT02386319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224355|NCT02386319|Protective Agents|protective agents|mesh-ancestor
6499040|NCT00639873|Doxycycline|doxycycline|mesh-list
6499041|NCT00639873|Artesunate|artesunate|mesh-list
6499042|NCT00639873|Quinine|quinine|mesh-list
6499043|NCT00639873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6499044|NCT00639873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6499045|NCT00639873|Antimalarials|antimalarials|mesh-ancestor
6499046|NCT00639873|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6499047|NCT00639873|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6499048|NCT00639873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6499049|NCT00639873|Antiviral Agents|antiviral agents|mesh-ancestor
6499050|NCT00639873|Schistosomicides|schistosomicides|mesh-ancestor
6499051|NCT00639873|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6499052|NCT00639873|Anthelmintics|anthelmintics|mesh-ancestor
6499053|NCT00639873|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6499054|NCT00639873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499055|NCT00639873|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6499056|NCT00639873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6499057|NCT00639873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6499058|NCT00639873|Analgesics|analgesics|mesh-ancestor
6499059|NCT00639873|Sensory System Agents|sensory system agents|mesh-ancestor
6499060|NCT00639925|Gemcitabine|gemcitabine|mesh-list
6499061|NCT00639925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6499062|NCT00639925|Antimetabolites|antimetabolites|mesh-ancestor
6499063|NCT00639925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499064|NCT00639925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6499065|NCT00639925|Antiviral Agents|antiviral agents|mesh-ancestor
6499066|NCT00639925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6499067|NCT00639925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6499068|NCT00639925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6499069|NCT00639925|Immunologic Factors|immunologic factors|mesh-ancestor
6499070|NCT00639925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499071|NCT00639938|Nevirapine|nevirapine|mesh-list
6499072|NCT00639938|Immunoglobulins|immunoglobulins|mesh-list
6499073|NCT00639938|Antibodies|antibodies|mesh-list
6499074|NCT00639938|gamma-Globulins|gamma-globulins|mesh-list
6499075|NCT00639938|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6499076|NCT00639938|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6499077|NCT00639938|Immunologic Factors|immunologic factors|mesh-ancestor
6499078|NCT00639938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499079|NCT00639938|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6499080|NCT00639938|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6499081|NCT00639938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6499082|NCT00639938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499083|NCT00639938|Antiviral Agents|antiviral agents|mesh-ancestor
6499084|NCT00639938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6499085|NCT00639938|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6499086|NCT00639938|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6499087|NCT00639938|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5704492|NCT03323866|Budesonide|budesonide|mesh-list
5704493|NCT03323866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5704494|NCT03323866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5704495|NCT03323866|Autonomic Agents|autonomic agents|mesh-ancestor
5704496|NCT03323866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5704497|NCT03323866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704498|NCT03323866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5704499|NCT03323866|Respiratory System Agents|respiratory system agents|mesh-ancestor
5704500|NCT03323866|Glucocorticoids|glucocorticoids|mesh-ancestor
5704501|NCT03323866|Hormones|hormones|mesh-ancestor
5721153|NCT03208426|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6499088|NCT00639938|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6499089|NCT00640003|Baclofen|baclofen|mesh-list
6499090|NCT00640003|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6499091|NCT00640003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499092|NCT00640003|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6499093|NCT00640003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6499094|NCT00640003|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
5704502|NCT03323866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5704503|NCT03323866|Dermatologic Agents|dermatologic agents|mesh-ancestor
5704504|NCT03323866|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6224356|NCT02386319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224357|NCT02386319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6224358|NCT02387164|Vitamin D|vitamin d|mesh-list
6224359|NCT02387164|Cholecalciferol|cholecalciferol|mesh-list
6224360|NCT02387164|Vitamins|vitamins|mesh-ancestor
6224361|NCT02387164|Micronutrients|micronutrients|mesh-ancestor
6224362|NCT02387164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224363|NCT02387164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6224364|NCT02387164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6224365|NCT02387216|Docetaxel|docetaxel|mesh-list
6224366|NCT02387216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6224367|NCT02387216|Tubulin Modulators|tubulin modulators|mesh-ancestor
6224368|NCT02387216|Antimitotic Agents|antimitotic agents|mesh-ancestor
6224369|NCT02387216|Mitosis Modulators|mitosis modulators|mesh-ancestor
6224370|NCT02387216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224371|NCT02387294|Vaccines|vaccines|mesh-list
6224372|NCT02387294|Immunologic Factors|immunologic factors|mesh-ancestor
6224373|NCT02387294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499095|NCT00640003|GABA Agonists|gaba agonists|mesh-ancestor
6499096|NCT00640003|GABA Agents|gaba agents|mesh-ancestor
6499097|NCT00640003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6499098|NCT00640003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499099|NCT00640029|Meloxicam|meloxicam|mesh-list
6499100|NCT00640029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6499101|NCT00640029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6499102|NCT00640029|Analgesics|analgesics|mesh-ancestor
6499103|NCT00640029|Sensory System Agents|sensory system agents|mesh-ancestor
6499104|NCT00640029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6499105|NCT00640029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499106|NCT00640029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6499107|NCT00640029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6499108|NCT00640029|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6499109|NCT00640029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6499110|NCT00640029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6499111|NCT00640029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499112|NCT00640081|Leucovorin|leucovorin|mesh-list
6499113|NCT00640081|Fluorouracil|fluorouracil|mesh-list
6499114|NCT00640081|Capecitabine|capecitabine|mesh-list
6499115|NCT00640081|Oxaliplatin|oxaliplatin|mesh-list
6499116|NCT00640081|Cetuximab|cetuximab|mesh-list
6499117|NCT00640081|Calcium|calcium|mesh-list
6499118|NCT00640081|Levoleucovorin|levoleucovorin|mesh-list
6499119|NCT00640081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6499120|NCT00640081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499121|NCT00640081|Antimetabolites|antimetabolites|mesh-ancestor
6499122|NCT00640081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499123|NCT00640081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6499124|NCT00640081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6499125|NCT00640081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6499126|NCT00640081|Immunologic Factors|immunologic factors|mesh-ancestor
6499127|NCT00640081|Antidotes|antidotes|mesh-ancestor
6499128|NCT00640081|Protective Agents|protective agents|mesh-ancestor
6499129|NCT00640081|Vitamin B Complex|vitamin b complex|mesh-ancestor
6499130|NCT00640081|Vitamins|vitamins|mesh-ancestor
6499131|NCT00640081|Micronutrients|micronutrients|mesh-ancestor
6499132|NCT00640081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6499133|NCT00640094|Melatonin|melatonin|mesh-list
6499134|NCT00640094|Antioxidants|antioxidants|mesh-ancestor
6499135|NCT00640094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499136|NCT00640094|Protective Agents|protective agents|mesh-ancestor
6499137|NCT00640094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499138|NCT00640094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6499139|NCT00640159|Selegiline|selegiline|mesh-list
6499140|NCT00640159|Antidepressive Agents|antidepressive agents|mesh-ancestor
6499141|NCT00640159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6499142|NCT00640159|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6499143|NCT00640159|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6499144|NCT00640159|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6499145|NCT00640159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6499146|NCT00640159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676329|NCT01580501|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6499147|NCT00640159|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6676330|NCT01580501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6224374|NCT02387359|Plecanatide|plecanatide|mesh-list
6224375|NCT02387359|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
6224376|NCT02387359|Enzyme Activators|enzyme activators|mesh-ancestor
6224377|NCT02387359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224378|NCT02387359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6224379|NCT02387372|Tazobactam|tazobactam|mesh-list
6224380|NCT02387372|Ceftolozane|ceftolozane|mesh-list
6224381|NCT02387372|Cephalosporins|cephalosporins|mesh-list
6224382|NCT02387372|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
6224383|NCT02387372|Penicillanic Acid|penicillanic acid|mesh-list
6224384|NCT02387372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6224385|NCT02387372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6224386|NCT02387372|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6224387|NCT02387372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6499148|NCT00640159|Protective Agents|protective agents|mesh-ancestor
6499149|NCT00640159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499150|NCT00640198|Memantine|memantine|mesh-list
6499151|NCT00640198|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6499152|NCT00640198|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6499153|NCT00640198|Dopamine Agents|dopamine agents|mesh-ancestor
6499154|NCT00640198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6499155|NCT00640198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499156|NCT00640198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499157|NCT00640198|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6499158|NCT00640198|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6499159|NCT00640237|Calcifediol|calcifediol|mesh-list
6499160|NCT00640237|Vitamins|vitamins|mesh-ancestor
6499161|NCT00640237|Micronutrients|micronutrients|mesh-ancestor
6499162|NCT00640237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499163|NCT00640237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6499164|NCT00640263|Ritonavir|ritonavir|mesh-list
6499165|NCT00640263|Lopinavir|lopinavir|mesh-list
6499166|NCT00640263|Lamivudine|lamivudine|mesh-list
6499167|NCT00640263|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6499168|NCT00640263|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6499169|NCT00640263|Protease Inhibitors|protease inhibitors|mesh-ancestor
6499170|NCT00640263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6499171|NCT00640263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499172|NCT00640263|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6499173|NCT00640263|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6499174|NCT00640263|Antiviral Agents|antiviral agents|mesh-ancestor
6499175|NCT00640263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6499176|NCT00640263|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6499177|NCT00640263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6499178|NCT00640263|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6499179|NCT00640263|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6499180|NCT00640276|Pitavastatin|pitavastatin|mesh-list
6499181|NCT00640276|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6499182|NCT00640276|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6499183|NCT00640276|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6499184|NCT00640276|Antimetabolites|antimetabolites|mesh-ancestor
6499185|NCT00640276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499186|NCT00640276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6499187|NCT00640276|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6499188|NCT00640367|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6499189|NCT00640367|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6499190|NCT00640367|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6499191|NCT00640367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499192|NCT00640432|Celecoxib|celecoxib|mesh-list
6499193|NCT00640432|Diclofenac|diclofenac|mesh-list
6499194|NCT00640432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6499195|NCT00640432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6499196|NCT00640432|Analgesics|analgesics|mesh-ancestor
6499197|NCT00640432|Sensory System Agents|sensory system agents|mesh-ancestor
6499198|NCT00640432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6499199|NCT00640432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499200|NCT00640432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5704505|NCT03323710|Sunitinib|sunitinib|mesh-list
5704506|NCT03323710|Propranolol|propranolol|mesh-list
5704507|NCT03323710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5704508|NCT03323710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5704509|NCT03323710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5704510|NCT03323710|Growth Substances|growth substances|mesh-ancestor
5704511|NCT03323710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499201|NCT00640432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6224388|NCT02387372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224389|NCT02387372|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6224390|NCT02387372|Renal Agents|renal agents|mesh-ancestor
6224391|NCT02387554|Losartan|losartan|mesh-list
6224392|NCT02387554|Amlodipine|amlodipine|mesh-list
6224393|NCT02387554|Chlorthalidone|chlorthalidone|mesh-list
6224394|NCT02387554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6224395|NCT02387554|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6224396|NCT02387554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6224397|NCT02387554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224398|NCT02387554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6224399|NCT02387554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224400|NCT02387554|Vasodilator Agents|vasodilator agents|mesh-ancestor
6224401|NCT02387554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6224402|NCT02387554|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6224403|NCT02387554|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6224404|NCT02387554|Diuretics|diuretics|mesh-ancestor
6224405|NCT02387554|Natriuretic Agents|natriuretic agents|mesh-ancestor
6499202|NCT00640432|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6499203|NCT00640432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6499204|NCT00640432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6499205|NCT00640432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499206|NCT00640458|Sildenafil Citrate|sildenafil citrate|mesh-list
5704512|NCT03323710|Growth Inhibitors|growth inhibitors|mesh-ancestor
5704513|NCT03323710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5704514|NCT03323710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5704515|NCT03323710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704516|NCT03323710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5704517|NCT03323710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5704518|NCT03323710|Adrenergic Agents|adrenergic agents|mesh-ancestor
5704519|NCT03323710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5704520|NCT03323710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5704521|NCT03323710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5704522|NCT03323710|Vasodilator Agents|vasodilator agents|mesh-ancestor
5704523|NCT03323697|Citalopram|citalopram|mesh-list
5704524|NCT03323697|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5704525|NCT03323697|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5704526|NCT03323697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5704527|NCT03323697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704528|NCT03323697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5704529|NCT03323697|Serotonin Agents|serotonin agents|mesh-ancestor
5704530|NCT03323697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721154|NCT03208101|Vaccines|vaccines|mesh-list
6499207|NCT00640458|Vasodilator Agents|vasodilator agents|mesh-ancestor
6499208|NCT00640458|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6499209|NCT00640458|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6499210|NCT00640458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6499211|NCT00640458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499212|NCT00640458|Urological Agents|urological agents|mesh-ancestor
6499213|NCT00640471|Cetuximab|cetuximab|mesh-list
6499214|NCT00640471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6499215|NCT00640471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6499216|NCT00640549|Atorvastatin|atorvastatin|mesh-list
6499217|NCT00640549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6499218|NCT00640549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6499219|NCT00640549|Antimetabolites|antimetabolites|mesh-ancestor
6499220|NCT00640549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499221|NCT00640549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6499222|NCT00640549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6499223|NCT00640549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6499224|NCT00640575|Triamcinolone|triamcinolone|mesh-list
6499225|NCT00640575|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6499226|NCT00640575|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6499227|NCT00640575|Lidocaine|lidocaine|mesh-list
6499228|NCT00640575|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6499229|NCT00640575|Anesthetics, Local|anesthetics, local|mesh-ancestor
6499230|NCT00640575|Anesthetics|anesthetics|mesh-ancestor
6499231|NCT00640575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6499232|NCT00640575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499233|NCT00640575|Sensory System Agents|sensory system agents|mesh-ancestor
6499234|NCT00640575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6499235|NCT00640575|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6499236|NCT00640575|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6224406|NCT02387554|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6224407|NCT02387580|Artefenomel|artefenomel|mesh-list
6224408|NCT02387580|Antimalarials|antimalarials|mesh-ancestor
6224409|NCT02387580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6224410|NCT02387580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6224411|NCT02387580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6224412|NCT02387710|Tiagabine|tiagabine|mesh-list
6499237|NCT00640575|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6499238|NCT00640575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6499239|NCT00640575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499240|NCT00640575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6499241|NCT00640575|Glucocorticoids|glucocorticoids|mesh-ancestor
6499242|NCT00640575|Hormones|hormones|mesh-ancestor
6499243|NCT00640575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6499244|NCT00640575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6499245|NCT00640575|Immunologic Factors|immunologic factors|mesh-ancestor
6499246|NCT00640575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6499247|NCT00640588|Adefovir|adefovir|mesh-list
6499248|NCT00640588|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6499249|NCT00640588|Telbivudine|telbivudine|mesh-list
6499250|NCT00640588|Antiviral Agents|antiviral agents|mesh-ancestor
6499251|NCT00640588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6499252|NCT00640588|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6499253|NCT00640588|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6499254|NCT00640588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6499255|NCT00640588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499256|NCT00640627|Celecoxib|celecoxib|mesh-list
6499257|NCT00640627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6499258|NCT00640627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6499259|NCT00640627|Analgesics|analgesics|mesh-ancestor
6499260|NCT00640627|Sensory System Agents|sensory system agents|mesh-ancestor
6499261|NCT00640627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6499262|NCT00640627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499263|NCT00640627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6499264|NCT00640627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6499265|NCT00640627|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6499266|NCT00640627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6499267|NCT00640627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6499268|NCT00640627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499269|NCT00640640|Bevacizumab|bevacizumab|mesh-list
6499270|NCT00640640|Ranibizumab|ranibizumab|mesh-list
6499271|NCT00640640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6499272|NCT00640640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6499273|NCT00640640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6499274|NCT00640640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6499275|NCT00640640|Growth Substances|growth substances|mesh-ancestor
6499276|NCT00640640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499277|NCT00640640|Growth Inhibitors|growth inhibitors|mesh-ancestor
6499278|NCT00640679|Clopidogrel|clopidogrel|mesh-list
6499279|NCT00640679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6499280|NCT00640679|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6499281|NCT00640679|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6499282|NCT00640679|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6499283|NCT00640679|Purinergic Agents|purinergic agents|mesh-ancestor
6499284|NCT00640679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6499285|NCT00640679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499286|NCT00640679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499287|NCT00640705|Diclofenac|diclofenac|mesh-list
6499288|NCT00640705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6499289|NCT00640705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6499290|NCT00640705|Analgesics|analgesics|mesh-ancestor
6499291|NCT00640705|Sensory System Agents|sensory system agents|mesh-ancestor
6499292|NCT00640705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6499293|NCT00640705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499294|NCT00640705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6499295|NCT00640705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6499296|NCT00640705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6499297|NCT00640705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6499298|NCT00640705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499299|NCT00640744|Atorvastatin|atorvastatin|mesh-list
6499300|NCT00640744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6499301|NCT00640744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6499302|NCT00640744|Antimetabolites|antimetabolites|mesh-ancestor
6224413|NCT02387710|Anticonvulsants|anticonvulsants|mesh-ancestor
6224414|NCT02387710|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
6224415|NCT02387710|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6224416|NCT02387710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6224417|NCT02387710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224418|NCT02387710|GABA Agents|gaba agents|mesh-ancestor
6224419|NCT02387710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6224420|NCT02387710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224421|NCT02387762|Methotrexate|methotrexate|mesh-list
6224422|NCT02387762|Acalabrutinib|acalabrutinib|mesh-list
6224423|NCT02387762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6224424|NCT02387762|Abortifacient Agents|abortifacient agents|mesh-ancestor
6224425|NCT02387762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6224426|NCT02387762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224427|NCT02387762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6224428|NCT02387762|Antimetabolites|antimetabolites|mesh-ancestor
6224429|NCT02387762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224430|NCT02387762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6224431|NCT02387762|Dermatologic Agents|dermatologic agents|mesh-ancestor
6224432|NCT02387762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6224433|NCT02387762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6224434|NCT02387762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6224435|NCT02387762|Immunologic Factors|immunologic factors|mesh-ancestor
6224436|NCT02387762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6224437|NCT02387762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6224438|NCT02387801|Ixekizumab|ixekizumab|mesh-list
6224439|NCT02387801|Dermatologic Agents|dermatologic agents|mesh-ancestor
6499303|NCT00640744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499304|NCT00640744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6499305|NCT00640744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6499306|NCT00640744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6676331|NCT01580501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499307|NCT00640796|Aldesleukin|aldesleukin|mesh-list
6499308|NCT00640796|Cyclophosphamide|cyclophosphamide|mesh-list
6499309|NCT00640796|Fludarabine|fludarabine|mesh-list
6499310|NCT00640796|Interleukin-2|interleukin-2|mesh-list
6499311|NCT00640796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6499312|NCT00640796|Immunologic Factors|immunologic factors|mesh-ancestor
6499313|NCT00640796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499314|NCT00640796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6499315|NCT00640796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6499316|NCT00640796|Alkylating Agents|alkylating agents|mesh-ancestor
6499317|NCT00640796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499318|NCT00640796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6499319|NCT00640796|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6499320|NCT00640796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6499321|NCT00640796|Analgesics|analgesics|mesh-ancestor
6499322|NCT00640796|Sensory System Agents|sensory system agents|mesh-ancestor
6499323|NCT00640796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6499324|NCT00640796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6499325|NCT00640796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6499326|NCT00640796|Antiviral Agents|antiviral agents|mesh-ancestor
6499327|NCT00640796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6499328|NCT00640809|Ibuprofen|ibuprofen|mesh-list
6499329|NCT00640809|Celecoxib|celecoxib|mesh-list
6499330|NCT00640809|Omeprazole|omeprazole|mesh-list
6499331|NCT00640809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6499332|NCT00640809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6499333|NCT00640809|Analgesics|analgesics|mesh-ancestor
6499334|NCT00640809|Sensory System Agents|sensory system agents|mesh-ancestor
6499335|NCT00640809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6499336|NCT00640809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499337|NCT00640809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6499338|NCT00640809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6499339|NCT00640809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6499340|NCT00640809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6499341|NCT00640809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499342|NCT00640809|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6499343|NCT00640809|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6499344|NCT00640809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6499345|NCT00640809|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6499346|NCT00640861|Vaccines|vaccines|mesh-list
6499347|NCT00640861|Sargramostim|sargramostim|mesh-list
6499348|NCT00640861|Freund's Adjuvant|freund's adjuvant|mesh-list
5721155|NCT03208101|Immunologic Factors|immunologic factors|mesh-ancestor
6224440|NCT02387957|Bevacizumab|bevacizumab|mesh-list
6224441|NCT02387957|Ranibizumab|ranibizumab|mesh-list
6224442|NCT02387957|Aflibercept|aflibercept|mesh-list
6224443|NCT02387957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6224444|NCT02387957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6224445|NCT02387957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6224446|NCT02387957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6224447|NCT02387957|Growth Substances|growth substances|mesh-ancestor
6224448|NCT02387957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224449|NCT02387957|Growth Inhibitors|growth inhibitors|mesh-ancestor
6224450|NCT02387983|Posaconazole|posaconazole|mesh-list
6499349|NCT00640861|Immunologic Factors|immunologic factors|mesh-ancestor
6499350|NCT00640861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499351|NCT00640861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6499352|NCT00640887|Ritonavir|ritonavir|mesh-list
6499353|NCT00640887|Lopinavir|lopinavir|mesh-list
6499354|NCT00640887|Nevirapine|nevirapine|mesh-list
6499355|NCT00640887|Efavirenz|efavirenz|mesh-list
6499356|NCT00640887|Rifabutin|rifabutin|mesh-list
6499357|NCT00640887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6499358|NCT00640887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6499359|NCT00640887|Protease Inhibitors|protease inhibitors|mesh-ancestor
6499360|NCT00640887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6499361|NCT00640887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704531|NCT03323697|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5704532|NCT03323697|Antidepressive Agents|antidepressive agents|mesh-ancestor
5704533|NCT03323697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5704534|NCT03323684|Acetaminophen|acetaminophen|mesh-list
5704535|NCT03323684|Ketorolac|ketorolac|mesh-list
5704536|NCT03323684|Fentanyl|fentanyl|mesh-list
5704537|NCT03323684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5704538|NCT03323684|Narcotics|narcotics|mesh-ancestor
5704539|NCT03323684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5704540|NCT03323684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704541|NCT03323684|Analgesics|analgesics|mesh-ancestor
5704542|NCT03323684|Sensory System Agents|sensory system agents|mesh-ancestor
5704543|NCT03323684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5704544|NCT03323684|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6499362|NCT00640887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6499363|NCT00640887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6499364|NCT00640887|Antiviral Agents|antiviral agents|mesh-ancestor
6499365|NCT00640887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6499366|NCT00640887|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6499367|NCT00640887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6499368|NCT00640887|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6499369|NCT00640887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6499370|NCT00640887|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6499371|NCT00640887|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6499372|NCT00640887|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6499373|NCT00640887|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6499374|NCT00640887|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6499375|NCT00640887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6499376|NCT00640887|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6499377|NCT00640887|Antitubercular Agents|antitubercular agents|mesh-ancestor
6499378|NCT00640939|Diclofenac|diclofenac|mesh-list
6499379|NCT00640939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6499380|NCT00640939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6499381|NCT00640939|Analgesics|analgesics|mesh-ancestor
5704545|NCT03323684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5704546|NCT03323684|Anesthetics, General|anesthetics, general|mesh-ancestor
5704547|NCT03323684|Anesthetics|anesthetics|mesh-ancestor
5704548|NCT03323684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5704549|NCT03323684|Antipyretics|antipyretics|mesh-ancestor
5704550|NCT03323684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5704551|NCT03323684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5704552|NCT03323684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5704553|NCT03323684|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6499382|NCT00640939|Sensory System Agents|sensory system agents|mesh-ancestor
6499383|NCT00640939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6499384|NCT00640939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499385|NCT00640939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6499386|NCT00640939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6499387|NCT00640939|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5704554|NCT03323684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5721156|NCT03208101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499388|NCT00640939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6224451|NCT02387983|Antifungal Agents|antifungal agents|mesh-ancestor
6224452|NCT02387983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6224453|NCT02387983|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6224454|NCT02387983|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6224455|NCT02387983|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6224456|NCT02387983|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6224457|NCT02387983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6224458|NCT02387983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6224459|NCT02387983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224460|NCT02387983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6224461|NCT02387983|Hormone Antagonists|hormone antagonists|mesh-ancestor
6224462|NCT02387983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6224463|NCT02387983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224464|NCT02387996|Nivolumab|nivolumab|mesh-list
6224465|NCT02387996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6224466|NCT02387996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6224467|NCT02387996|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6224468|NCT02387996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224469|NCT02388165|Vaccines|vaccines|mesh-list
6224470|NCT02388165|Immunologic Factors|immunologic factors|mesh-ancestor
6224471|NCT02388165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224472|NCT02388191|Naproxen|naproxen|mesh-list
6224473|NCT02388191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6224474|NCT02388191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6224475|NCT02388191|Analgesics|analgesics|mesh-ancestor
6224476|NCT02388191|Sensory System Agents|sensory system agents|mesh-ancestor
6224477|NCT02388191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6224478|NCT02388191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499389|NCT00640939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499390|NCT00640952|Acamprosate|acamprosate|mesh-list
6499391|NCT00640952|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6499392|NCT00640991|Insulin|insulin|mesh-list
6499393|NCT00640991|Insulin Glargine|insulin glargine|mesh-list
6499394|NCT00640991|Insulin glulisine|insulin glulisine|mesh-list
6499395|NCT00640991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6499396|NCT00640991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499397|NCT00641004|Esomeprazole|esomeprazole|mesh-list
6499398|NCT00641004|Rebamipide|rebamipide|mesh-list
6499399|NCT00641004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6499400|NCT00641004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6499401|NCT00641004|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6499402|NCT00641004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6499403|NCT00641004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499404|NCT00641004|Antioxidants|antioxidants|mesh-ancestor
6499405|NCT00641004|Protective Agents|protective agents|mesh-ancestor
6499406|NCT00641004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499407|NCT00641030|Melphalan|melphalan|mesh-list
6499408|NCT00641030|Clofarabine|clofarabine|mesh-list
6499409|NCT00641030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6499410|NCT00641030|Alkylating Agents|alkylating agents|mesh-ancestor
6499411|NCT00641030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499412|NCT00641030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6499413|NCT00641030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6499414|NCT00641030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6499415|NCT00641030|Immunologic Factors|immunologic factors|mesh-ancestor
6499416|NCT00641030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499417|NCT00641030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6499418|NCT00641030|Antimetabolites|antimetabolites|mesh-ancestor
6499419|NCT00641082|Adefovir|adefovir|mesh-list
6499420|NCT00641082|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6499421|NCT00641082|Clevudine|clevudine|mesh-list
6499422|NCT00641082|Antiviral Agents|antiviral agents|mesh-ancestor
6499423|NCT00641082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6499424|NCT00641082|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6499425|NCT00641082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6499426|NCT00641082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6499427|NCT00641082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499428|NCT00641095|Cyclophosphamide|cyclophosphamide|mesh-list
6499429|NCT00641095|Rituximab|rituximab|mesh-list
6499430|NCT00641095|Fludarabine|fludarabine|mesh-list
6499431|NCT00641095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6499432|NCT00641095|Immunologic Factors|immunologic factors|mesh-ancestor
6499433|NCT00641095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499434|NCT00641095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6499435|NCT00641095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6224479|NCT02388191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6224480|NCT02388191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6224481|NCT02388191|Gout Suppressants|gout suppressants|mesh-ancestor
6224482|NCT02388191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6224483|NCT02388191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6224484|NCT02388191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224485|NCT02388321|Fentanyl|fentanyl|mesh-list
6224486|NCT02388321|Ketamine|ketamine|mesh-list
6224487|NCT02388321|Analgesics|analgesics|mesh-ancestor
6224488|NCT02388321|Sensory System Agents|sensory system agents|mesh-ancestor
6224489|NCT02388321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6224490|NCT02388321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224491|NCT02388321|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6224492|NCT02388321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6224493|NCT02388321|Anesthetics, General|anesthetics, general|mesh-ancestor
6224494|NCT02388321|Anesthetics|anesthetics|mesh-ancestor
6224495|NCT02388321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6224496|NCT02388321|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6224497|NCT02388321|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6224498|NCT02388321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6224499|NCT02388321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224500|NCT02388321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6224501|NCT02388321|Narcotics|narcotics|mesh-ancestor
6224502|NCT02388321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6243453|NCT02668393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6243454|NCT02668393|Tubulin Modulators|tubulin modulators|mesh-ancestor
6243455|NCT02668393|Antimitotic Agents|antimitotic agents|mesh-ancestor
6243456|NCT02668393|Mitosis Modulators|mitosis modulators|mesh-ancestor
6243457|NCT02668393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704555|NCT03323684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704556|NCT03323671|Mefenamic Acid|mefenamic acid|mesh-list
5704557|NCT03323671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5704558|NCT03323671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5704559|NCT03323671|Analgesics|analgesics|mesh-ancestor
5704560|NCT03323671|Sensory System Agents|sensory system agents|mesh-ancestor
5704561|NCT03323671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5704562|NCT03323671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704563|NCT03323671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5704564|NCT03323671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5704565|NCT03323671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5704566|NCT03323671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5704567|NCT03323671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704568|NCT03323658|Bexarotene|bexarotene|mesh-list
5704569|NCT03323658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5704570|NCT03323619|Anesthetics|anesthetics|mesh-list
5704571|NCT03323619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5704572|NCT03323619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704573|NCT03323593|Dexmedetomidine|dexmedetomidine|mesh-list
5704574|NCT03323593|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5704575|NCT03323593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5704576|NCT03323593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704577|NCT03323593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5704578|NCT03323593|Analgesics|analgesics|mesh-ancestor
5704579|NCT03323593|Sensory System Agents|sensory system agents|mesh-ancestor
5704580|NCT03323593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5704581|NCT03323593|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5704582|NCT03323593|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5704583|NCT03323593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5704584|NCT03323593|Adrenergic Agents|adrenergic agents|mesh-ancestor
5704585|NCT03323593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5704586|NCT03323593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704587|NCT03323567|Lidocaine|lidocaine|mesh-list
5704588|NCT03323567|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5704589|NCT03323567|Anesthetics, Local|anesthetics, local|mesh-ancestor
5704590|NCT03323567|Anesthetics|anesthetics|mesh-ancestor
5704591|NCT03323567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5704592|NCT03323567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704593|NCT03323567|Sensory System Agents|sensory system agents|mesh-ancestor
5704594|NCT03323567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5704595|NCT03323567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5704596|NCT03323567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5704597|NCT03323567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5704598|NCT03323567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5704599|NCT03323567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704600|NCT03323541|Lenograstim|lenograstim|mesh-list
5704601|NCT03323541|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5704602|NCT03323541|Immunologic Factors|immunologic factors|mesh-ancestor
5704603|NCT03323541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704604|NCT03323528|Benzalkonium Compounds|benzalkonium compounds|mesh-list
5704605|NCT03323528|Benzocaine|benzocaine|mesh-list
5704606|NCT03323528|Anesthetics, Local|anesthetics, local|mesh-ancestor
5704607|NCT03323528|Anesthetics|anesthetics|mesh-ancestor
5704608|NCT03323528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5704609|NCT03323528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704610|NCT03323528|Sensory System Agents|sensory system agents|mesh-ancestor
5704611|NCT03323528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5704612|NCT03323528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5704613|NCT03323528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5704614|NCT03323476|Mycophenolic Acid|mycophenolic acid|mesh-list
5704615|NCT03323476|Prednisone|prednisone|mesh-list
5704616|NCT03323476|Rituximab|rituximab|mesh-list
5704617|NCT03323476|Immunosuppressive Agents|immunosuppressive agents|mesh-list
5704618|NCT03323476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5704619|NCT03323476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5704620|NCT03323476|Immunologic Factors|immunologic factors|mesh-ancestor
5704621|NCT03323476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704622|NCT03323476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5704623|NCT03323476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5704624|NCT03323476|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5704625|NCT03323476|Antitubercular Agents|antitubercular agents|mesh-ancestor
6224503|NCT02388724|Lansoprazole|lansoprazole|mesh-list
6224504|NCT02388724|Dexlansoprazole|dexlansoprazole|mesh-list
6224505|NCT02388724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6224506|NCT02388724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6224507|NCT02388724|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6224508|NCT02388724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6224509|NCT02388724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224510|NCT02388737|Lansoprazole|lansoprazole|mesh-list
6224511|NCT02388737|Dexlansoprazole|dexlansoprazole|mesh-list
6224512|NCT02388737|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6224513|NCT02388737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6224514|NCT02388737|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6224515|NCT02388737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6499436|NCT00641095|Alkylating Agents|alkylating agents|mesh-ancestor
6499437|NCT00641095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499438|NCT00641095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6499439|NCT00641095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6499440|NCT00641095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6499441|NCT00641160|Vinorelbine|vinorelbine|mesh-list
6499442|NCT00641160|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6499443|NCT00641160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6499444|NCT00641160|Tubulin Modulators|tubulin modulators|mesh-ancestor
6499445|NCT00641160|Antimitotic Agents|antimitotic agents|mesh-ancestor
6499446|NCT00641160|Mitosis Modulators|mitosis modulators|mesh-ancestor
6499447|NCT00641160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499448|NCT00641173|Paroxetine|paroxetine|mesh-list
6499449|NCT00641173|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6499450|NCT00641173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6499451|NCT00641173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6499452|NCT00641173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499453|NCT00641173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6499454|NCT00641173|Serotonin Agents|serotonin agents|mesh-ancestor
6499455|NCT00641173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499456|NCT00641173|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6499457|NCT00641173|Antidepressive Agents|antidepressive agents|mesh-ancestor
6499458|NCT00641173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6499459|NCT00641173|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6499460|NCT00641173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6499461|NCT00641173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6499462|NCT00641186|Sodium Oxybate|sodium oxybate|mesh-list
6499463|NCT00641186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6499464|NCT00641186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6499465|NCT00641186|Anesthetics, General|anesthetics, general|mesh-ancestor
6499466|NCT00641186|Anesthetics|anesthetics|mesh-ancestor
6499467|NCT00641186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6676332|NCT01580501|Urological Agents|urological agents|mesh-ancestor
6224516|NCT02388737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224517|NCT02388906|Nivolumab|nivolumab|mesh-list
6224518|NCT02388906|Ipilimumab|ipilimumab|mesh-list
6224519|NCT02388906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6224520|NCT02388906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6499468|NCT00641186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524541|NCT00758914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524542|NCT00758914|Protective Agents|protective agents|mesh-ancestor
6524543|NCT00759005|Hydrocortisone|hydrocortisone|mesh-list
6524544|NCT00759005|Propranolol|propranolol|mesh-list
6524545|NCT00759005|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6524546|NCT00759005|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6524547|NCT00759005|Adrenergic Agents|adrenergic agents|mesh-ancestor
6524548|NCT00759005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6524549|NCT00759005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524550|NCT00759005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524551|NCT00759005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6524552|NCT00759005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6524553|NCT00759005|Vasodilator Agents|vasodilator agents|mesh-ancestor
6524554|NCT00759005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6524555|NCT00759018|Remestemcel-l|remestemcel-l|mesh-list
6524556|NCT00759018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6524557|NCT00759018|Antiviral Agents|antiviral agents|mesh-ancestor
6524558|NCT00759018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6676333|NCT01580514|Exenatide|exenatide|mesh-list
6676334|NCT01580514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6676335|NCT01580514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676336|NCT01580514|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6676337|NCT01580514|Incretins|incretins|mesh-ancestor
6676338|NCT01580514|Hormones|hormones|mesh-ancestor
6676339|NCT01580514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6676340|NCT01580683|Ascorbic Acid|ascorbic acid|mesh-list
6676341|NCT01580683|Vitamins|vitamins|mesh-ancestor
6676342|NCT01580683|Micronutrients|micronutrients|mesh-ancestor
6676343|NCT01580683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676344|NCT01580683|Antioxidants|antioxidants|mesh-ancestor
6676345|NCT01580683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676346|NCT01580683|Protective Agents|protective agents|mesh-ancestor
6676347|NCT01580813|Acipimox|acipimox|mesh-list
6676348|NCT01580813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6676349|NCT01580813|Antimetabolites|antimetabolites|mesh-ancestor
6676350|NCT01580813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676351|NCT01580813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6676352|NCT01580839|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6676353|NCT01580839|Plasminogen|plasminogen|mesh-list
6676354|NCT01580839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6676355|NCT01580839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6676356|NCT01580839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676357|NCT01580865|Mycophenolic Acid|mycophenolic acid|mesh-list
6676358|NCT01580865|Tacrolimus|tacrolimus|mesh-list
6676359|NCT01580865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6676360|NCT01580865|Immunologic Factors|immunologic factors|mesh-ancestor
6676361|NCT01580865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676362|NCT01580865|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6676363|NCT01580865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6676364|NCT01580865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676365|NCT01580865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6676366|NCT01580865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6676367|NCT01580865|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6676368|NCT01580865|Antitubercular Agents|antitubercular agents|mesh-ancestor
6676369|NCT01580865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6676370|NCT01580865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6676371|NCT01580878|Butenafine|butenafine|mesh-list
6676372|NCT01580878|Clotrimazole|clotrimazole|mesh-list
6676373|NCT01580878|Antifungal Agents|antifungal agents|mesh-ancestor
6676374|NCT01580878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6676375|NCT01580878|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6676376|NCT01580878|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6676377|NCT01580878|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6676378|NCT01580878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6676379|NCT01580878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676380|NCT01580878|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6676381|NCT01580878|Hormone Antagonists|hormone antagonists|mesh-ancestor
6676382|NCT01580878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6676383|NCT01580878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676384|NCT01580891|Naftifine|naftifine|mesh-list
5704626|NCT03323476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6224521|NCT02388906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6224522|NCT02388906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224523|NCT02388997|Omalizumab|omalizumab|mesh-list
6224524|NCT02388997|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6224525|NCT02388997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6224526|NCT02388997|Respiratory System Agents|respiratory system agents|mesh-ancestor
6224527|NCT02389088|Letrozole|letrozole|mesh-list
6224528|NCT02389088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6224529|NCT02389088|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6224530|NCT02389088|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6224531|NCT02389088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6224532|NCT02389088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224533|NCT02389088|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6224534|NCT02389088|Hormone Antagonists|hormone antagonists|mesh-ancestor
6224535|NCT02389088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6224536|NCT02389088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224537|NCT02389361|Acetaminophen|acetaminophen|mesh-list
6224538|NCT02389361|Tramadol|tramadol|mesh-list
6224539|NCT02389361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6224540|NCT02389361|Analgesics|analgesics|mesh-ancestor
6224541|NCT02389361|Sensory System Agents|sensory system agents|mesh-ancestor
6224542|NCT02389361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6224543|NCT02389361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224544|NCT02389361|Antipyretics|antipyretics|mesh-ancestor
6224545|NCT02389361|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6224546|NCT02389361|Narcotics|narcotics|mesh-ancestor
6224547|NCT02389361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6224548|NCT02389374|Chloroquine|chloroquine|mesh-list
6224549|NCT02389374|Lumefantrine|lumefantrine|mesh-list
6224550|NCT02389374|Artemether|artemether|mesh-list
6224551|NCT02389374|Primaquine|primaquine|mesh-list
6224552|NCT02389374|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6224553|NCT02389374|Amebicides|amebicides|mesh-ancestor
6224554|NCT02389374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6224555|NCT02389374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6224556|NCT02389374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6224557|NCT02389374|Antimalarials|antimalarials|mesh-ancestor
6224558|NCT02389374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6224559|NCT02389452|Hylan|hylan|mesh-list
6224560|NCT02389452|Viscosupplements|viscosupplements|mesh-ancestor
6224561|NCT02389452|Protective Agents|protective agents|mesh-ancestor
6224562|NCT02389452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224563|NCT02389738|Temozolomide|temozolomide|mesh-list
6224564|NCT02389738|Regadenoson|regadenoson|mesh-list
6224565|NCT02389738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6224566|NCT02389738|Alkylating Agents|alkylating agents|mesh-ancestor
6224567|NCT02389738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224568|NCT02389738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5704627|NCT03323476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5704628|NCT03323476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5704629|NCT03323476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704630|NCT03323476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5704631|NCT03323476|Glucocorticoids|glucocorticoids|mesh-ancestor
5704632|NCT03323476|Hormones|hormones|mesh-ancestor
5704633|NCT03323476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5704634|NCT03323476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5704635|NCT03323437|Risperidone|risperidone|mesh-list
5704636|NCT03323437|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5704637|NCT03323437|Serotonin Agents|serotonin agents|mesh-ancestor
5704638|NCT03323437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5704639|NCT03323437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704640|NCT03323437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704641|NCT03323437|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5704642|NCT03323437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6224569|NCT02389738|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
6224570|NCT02389738|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5704643|NCT03323437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5704644|NCT03323437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5704645|NCT03323437|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6224571|NCT02389738|Purinergic Agonists|purinergic agonists|mesh-ancestor
6224572|NCT02389738|Purinergic Agents|purinergic agents|mesh-ancestor
6224573|NCT02389738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6224574|NCT02389738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224575|NCT02389764|Nintedanib|nintedanib|mesh-list
6224576|NCT02389764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6224577|NCT02389764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6224578|NCT02389764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6224579|NCT02389764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224580|NCT02389816|Vortioxetine|vortioxetine|mesh-list
6224581|NCT02389816|Antidepressive Agents|antidepressive agents|mesh-ancestor
6224582|NCT02389816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6224583|NCT02389816|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6224584|NCT02389816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6224585|NCT02389816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6224586|NCT02389816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224587|NCT02389816|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6224588|NCT02389816|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6224589|NCT02389816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6224590|NCT02389816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224591|NCT02389816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6224592|NCT02389816|Serotonin Agents|serotonin agents|mesh-ancestor
6224593|NCT02389816|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6224594|NCT02389816|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6224595|NCT02389816|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6224596|NCT02389816|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6224597|NCT02389829|Diphenhydramine|diphenhydramine|mesh-list
6499469|NCT00641212|Budesonide|budesonide|mesh-list
6499470|NCT00641212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6499471|NCT00641212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6499472|NCT00641212|Autonomic Agents|autonomic agents|mesh-ancestor
6499473|NCT00641212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6499474|NCT00641212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499475|NCT00641212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6499476|NCT00641212|Respiratory System Agents|respiratory system agents|mesh-ancestor
6499477|NCT00641212|Glucocorticoids|glucocorticoids|mesh-ancestor
6499478|NCT00641212|Hormones|hormones|mesh-ancestor
6499479|NCT00641212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6499480|NCT00641264|Omeprazole|omeprazole|mesh-list
6499481|NCT00641264|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6676385|NCT01580891|Antifungal Agents|antifungal agents|mesh-ancestor
6676386|NCT01580891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6676387|NCT01580943|Chlorhexidine|chlorhexidine|mesh-list
6676388|NCT01580943|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6676389|NCT01580943|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6676390|NCT01580943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6676391|NCT01580943|Disinfectants|disinfectants|mesh-ancestor
6676392|NCT01580943|Dermatologic Agents|dermatologic agents|mesh-ancestor
6676393|NCT01581073|Darbepoetin alfa|darbepoetin alfa|mesh-list
6676394|NCT01581073|Hematinics|hematinics|mesh-ancestor
6676395|NCT01581151|Dexamethasone|dexamethasone|mesh-list
6676396|NCT01581151|Ranibizumab|ranibizumab|mesh-list
6676397|NCT01581151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6676398|NCT01581151|Antiemetics|antiemetics|mesh-ancestor
6676399|NCT01581151|Autonomic Agents|autonomic agents|mesh-ancestor
6676400|NCT01581151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6676401|NCT01581151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676402|NCT01581151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6676403|NCT01581151|Glucocorticoids|glucocorticoids|mesh-ancestor
6676404|NCT01581151|Hormones|hormones|mesh-ancestor
6676405|NCT01581151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6676406|NCT01581151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6676407|NCT01581151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6676408|NCT01581151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6676409|NCT01581151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5704646|NCT03323437|Dopamine Agents|dopamine agents|mesh-ancestor
5704647|NCT03323385|Meloxicam|meloxicam|mesh-list
5704648|NCT03323385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5704649|NCT03323385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5704650|NCT03323385|Analgesics|analgesics|mesh-ancestor
5704651|NCT03323385|Sensory System Agents|sensory system agents|mesh-ancestor
5704652|NCT03323385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5704653|NCT03323385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704654|NCT03323385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5704655|NCT03323385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5704656|NCT03323385|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5704657|NCT03323385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5704658|NCT03323385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5704659|NCT03323385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704660|NCT03323372|Listerine|listerine|mesh-list
5704661|NCT03323372|Fluorides|fluorides|mesh-list
6224598|NCT02389829|Promethazine|promethazine|mesh-list
6224599|NCT02389829|Hydromorphone|hydromorphone|mesh-list
6224600|NCT02389829|Prochlorperazine|prochlorperazine|mesh-list
6224601|NCT02389829|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6224602|NCT02389829|Narcotics|narcotics|mesh-ancestor
6224603|NCT02389829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6224604|NCT02389829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704662|NCT03323372|Sodium Fluoride|sodium fluoride|mesh-list
5704663|NCT03323372|Cariostatic Agents|cariostatic agents|mesh-ancestor
5704664|NCT03323372|Protective Agents|protective agents|mesh-ancestor
5704665|NCT03323372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704666|NCT03323372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5704667|NCT03323372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5721157|NCT03208361|Amoxicillin|amoxicillin|mesh-list
5721158|NCT03208361|Penicillins|penicillins|mesh-list
5721159|NCT03208361|Penicillin V|penicillin v|mesh-list
5721160|NCT03208361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5721161|NCT03208361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5721162|NCT03208335|Endostatins|endostatins|mesh-list
5721163|NCT03208335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5721164|NCT03208335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5721165|NCT03208335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5721166|NCT03208335|Growth Substances|growth substances|mesh-ancestor
5721167|NCT03208335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721168|NCT03208335|Growth Inhibitors|growth inhibitors|mesh-ancestor
5721169|NCT03208179|Azithromycin|azithromycin|mesh-list
5721170|NCT03208179|Pyrimethamine|pyrimethamine|mesh-list
5721171|NCT03208179|Piperaquine|piperaquine|mesh-list
5721172|NCT03208179|Sulfadoxine|sulfadoxine|mesh-list
5721173|NCT03208179|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
5721174|NCT03208179|Artenimol|artenimol|mesh-list
5721175|NCT03208179|Artemisinins|artemisinins|mesh-list
5721176|NCT03208179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5721177|NCT03208179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5721178|NCT03208179|Antimalarials|antimalarials|mesh-ancestor
5721179|NCT03208179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5721180|NCT03208179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5721181|NCT03208179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5721182|NCT03208179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5721183|NCT03208179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721184|NCT03208179|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5721185|NCT03208179|Renal Agents|renal agents|mesh-ancestor
5721186|NCT03207698|Metformin|metformin|mesh-list
5721187|NCT03207698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5721188|NCT03207698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721189|NCT03207308|Vitamin A|vitamin a|mesh-list
5721190|NCT03207308|Vitamins|vitamins|mesh-ancestor
5721191|NCT03207308|Micronutrients|micronutrients|mesh-ancestor
5721192|NCT03207308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721193|NCT03207529|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
5721194|NCT03207529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5721195|NCT03207529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721196|NCT03207295|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
5721197|NCT03207295|Natriuretic Agents|natriuretic agents|mesh-ancestor
5721198|NCT03207295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721199|NCT03207451|Aspirin|aspirin|mesh-list
5721200|NCT03207451|Clopidogrel|clopidogrel|mesh-list
6224605|NCT02389829|Analgesics|analgesics|mesh-ancestor
6224606|NCT02389829|Sensory System Agents|sensory system agents|mesh-ancestor
6224607|NCT02389829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6224608|NCT02389829|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6224609|NCT02389829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6224610|NCT02389829|Anesthetics, Local|anesthetics, local|mesh-ancestor
6224611|NCT02389829|Anesthetics|anesthetics|mesh-ancestor
6224612|NCT02389829|Antiemetics|antiemetics|mesh-ancestor
6224613|NCT02389829|Autonomic Agents|autonomic agents|mesh-ancestor
6224614|NCT02389829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6224615|NCT02389829|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6224616|NCT02389829|Histamine Antagonists|histamine antagonists|mesh-ancestor
6224617|NCT02389829|Histamine Agents|histamine agents|mesh-ancestor
6224618|NCT02389829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6224619|NCT02389829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224620|NCT02389829|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6224621|NCT02389829|Antipruritics|antipruritics|mesh-ancestor
6224622|NCT02389829|Dermatologic Agents|dermatologic agents|mesh-ancestor
5721201|NCT03207451|Vorapaxar|vorapaxar|mesh-list
5721202|NCT03207451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5721203|NCT03207451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6224623|NCT02389829|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6224624|NCT02389829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6224625|NCT02389829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6499482|NCT00641264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6499483|NCT00641264|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6499484|NCT00641264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6499485|NCT00641264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499486|NCT00641329|Clonidine|clonidine|mesh-list
6499487|NCT00641329|Analgesics|analgesics|mesh-ancestor
6499488|NCT00641329|Sensory System Agents|sensory system agents|mesh-ancestor
6499489|NCT00641329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6499490|NCT00641329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499491|NCT00641329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6499492|NCT00641329|Sympatholytics|sympatholytics|mesh-ancestor
6499493|NCT00641329|Autonomic Agents|autonomic agents|mesh-ancestor
6499494|NCT00641329|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6499495|NCT00641329|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6499496|NCT00641329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6499497|NCT00641329|Adrenergic Agents|adrenergic agents|mesh-ancestor
6499498|NCT00641329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6499499|NCT00641329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499500|NCT00641407|Insulin|insulin|mesh-list
6499501|NCT00641407|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6499502|NCT00641407|Insulin Glargine|insulin glargine|mesh-list
6499503|NCT00641407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5704668|NCT03323346|Disulfiram|disulfiram|mesh-list
5704669|NCT03323346|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5704670|NCT03323346|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
5704671|NCT03323346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5704672|NCT03323346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704673|NCT03323047|Acetaminophen|acetaminophen|mesh-list
5704674|NCT03323047|Dexamethasone|dexamethasone|mesh-list
5704675|NCT03323047|Dexamethasone acetate|dexamethasone acetate|mesh-list
6499504|NCT00641407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499505|NCT00641433|Sulfadiazine|sulfadiazine|mesh-list
6499506|NCT00641433|Silver Sulfadiazine|silver sulfadiazine|mesh-list
6499507|NCT00641433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6499508|NCT00641433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6499509|NCT00641433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6499510|NCT00641433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6499511|NCT00641433|Coccidiostats|coccidiostats|mesh-ancestor
5704676|NCT03323047|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
5704677|NCT03323047|BB 1101|bb 1101|mesh-list
5704678|NCT03323047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5704679|NCT03323047|Antiemetics|antiemetics|mesh-ancestor
5704680|NCT03323047|Autonomic Agents|autonomic agents|mesh-ancestor
5704681|NCT03323047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5704682|NCT03323047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704683|NCT03323047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5704684|NCT03323047|Glucocorticoids|glucocorticoids|mesh-ancestor
5704685|NCT03323047|Hormones|hormones|mesh-ancestor
5704686|NCT03323047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5704687|NCT03323047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5704688|NCT03323047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5704689|NCT03323047|Protease Inhibitors|protease inhibitors|mesh-ancestor
5704690|NCT03323047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5704691|NCT03323047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704692|NCT03323047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5704693|NCT03323047|Analgesics|analgesics|mesh-ancestor
5704694|NCT03323047|Sensory System Agents|sensory system agents|mesh-ancestor
5704695|NCT03323047|Antipyretics|antipyretics|mesh-ancestor
5704696|NCT03323034|Irinotecan|irinotecan|mesh-list
5704697|NCT03323034|Temozolomide|temozolomide|mesh-list
5704698|NCT03323034|Enzyme Inhibitors|enzyme inhibitors|mesh-list
5704699|NCT03323034|Pevonedistat|pevonedistat|mesh-list
5704700|NCT03323034|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5704701|NCT03323034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5704702|NCT03323034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704703|NCT03323034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5704704|NCT03323034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5704705|NCT03323034|Alkylating Agents|alkylating agents|mesh-ancestor
5704706|NCT03322995|Fluorouracil|fluorouracil|mesh-list
5704707|NCT03322995|Antimetabolites|antimetabolites|mesh-ancestor
5704708|NCT03322995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704709|NCT03322995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6224626|NCT02389829|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6499512|NCT00641433|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6499513|NCT00641446|Budesonide|budesonide|mesh-list
6224627|NCT02389829|Dopamine Agents|dopamine agents|mesh-ancestor
6224628|NCT02389946|Sirolimus|sirolimus|mesh-list
6224629|NCT02389946|Everolimus|everolimus|mesh-list
6224630|NCT02389946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6224631|NCT02389946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6224632|NCT02389946|Immunologic Factors|immunologic factors|mesh-ancestor
6224633|NCT02389946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224634|NCT02389946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6224635|NCT02389946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6224636|NCT02389946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6224637|NCT02389946|Antifungal Agents|antifungal agents|mesh-ancestor
6224638|NCT02389959|Bevacizumab|bevacizumab|mesh-list
6224639|NCT02389959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6224640|NCT02389959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6224641|NCT02389959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6224642|NCT02389959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6224643|NCT02389959|Growth Substances|growth substances|mesh-ancestor
6224644|NCT02389959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224645|NCT02389959|Growth Inhibitors|growth inhibitors|mesh-ancestor
6224646|NCT02389998|Hyoscyamine|hyoscyamine|mesh-list
6224647|NCT02389998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6224648|NCT02389998|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6224649|NCT02389998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6224650|NCT02389998|Autonomic Agents|autonomic agents|mesh-ancestor
6224651|NCT02389998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6224652|NCT02389998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499514|NCT00641446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6499515|NCT00641446|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5704710|NCT03322995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5704711|NCT03322995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6499516|NCT00641446|Autonomic Agents|autonomic agents|mesh-ancestor
6499517|NCT00641446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6499518|NCT00641446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499519|NCT00641446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6499520|NCT00641446|Respiratory System Agents|respiratory system agents|mesh-ancestor
6499521|NCT00641446|Glucocorticoids|glucocorticoids|mesh-ancestor
6499522|NCT00641446|Hormones|hormones|mesh-ancestor
6499523|NCT00641446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6499524|NCT00641472|Budesonide|budesonide|mesh-list
6499525|NCT00641472|Montelukast|montelukast|mesh-list
6499526|NCT00641472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6499527|NCT00641472|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6499528|NCT00641472|Autonomic Agents|autonomic agents|mesh-ancestor
6499529|NCT00641472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6499530|NCT00641472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499531|NCT00641472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6499532|NCT00641472|Respiratory System Agents|respiratory system agents|mesh-ancestor
6499533|NCT00641472|Glucocorticoids|glucocorticoids|mesh-ancestor
6499534|NCT00641472|Hormones|hormones|mesh-ancestor
6499535|NCT00641472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6499536|NCT00641472|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6499537|NCT00641472|Hormone Antagonists|hormone antagonists|mesh-ancestor
6499538|NCT00641472|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6499539|NCT00641472|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6499540|NCT00641472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499541|NCT00641537|Cladribine|cladribine|mesh-list
6499542|NCT00641537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6499543|NCT00641537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6499544|NCT00641537|Immunologic Factors|immunologic factors|mesh-ancestor
6499545|NCT00641537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499546|NCT00641589|Epoetin Alfa|epoetin alfa|mesh-list
6499547|NCT00641589|Hematinics|hematinics|mesh-ancestor
6499548|NCT00641602|Esomeprazole|esomeprazole|mesh-list
6499549|NCT00641602|Lansoprazole|lansoprazole|mesh-list
6499550|NCT00641602|Dexlansoprazole|dexlansoprazole|mesh-list
6499551|NCT00641602|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6499552|NCT00641602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6499553|NCT00641602|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6499554|NCT00641602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6499555|NCT00641602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499556|NCT00641654|Interferons|interferons|mesh-list
6499557|NCT00641654|Ribavirin|ribavirin|mesh-list
6499558|NCT00641654|Interferon-alpha|interferon-alpha|mesh-list
6499559|NCT00641654|Interferon alpha-2|interferon alpha-2|mesh-list
6499560|NCT00641654|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5704712|NCT03322995|Immunologic Factors|immunologic factors|mesh-ancestor
5704713|NCT03322995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704714|NCT03322969|Paclitaxel|paclitaxel|mesh-list
5704715|NCT03322969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5704716|NCT03322969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5704717|NCT03322969|Tubulin Modulators|tubulin modulators|mesh-ancestor
5704718|NCT03322969|Antimitotic Agents|antimitotic agents|mesh-ancestor
5704719|NCT03322969|Mitosis Modulators|mitosis modulators|mesh-ancestor
5704720|NCT03322969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704721|NCT03322878|Magnesium Sulfate|magnesium sulfate|mesh-list
5704722|NCT03322878|Anesthetics|anesthetics|mesh-ancestor
5704723|NCT03322878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5704724|NCT03322878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704725|NCT03322878|Analgesics|analgesics|mesh-ancestor
5704726|NCT03322878|Sensory System Agents|sensory system agents|mesh-ancestor
5704727|NCT03322878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5704728|NCT03322878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5704729|NCT03322878|Anticonvulsants|anticonvulsants|mesh-ancestor
5704730|NCT03322878|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5704731|NCT03322878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5704732|NCT03322878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704733|NCT03322878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5704734|NCT03322878|Tocolytic Agents|tocolytic agents|mesh-ancestor
5704735|NCT03322878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5704736|NCT03322865|Obinutuzumab|obinutuzumab|mesh-list
5704737|NCT03322865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5704738|NCT03322865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5704739|NCT03322800|Ziresovir|ziresovir|mesh-list
5704740|NCT03322800|Antiviral Agents|antiviral agents|mesh-ancestor
5704741|NCT03322800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5704742|NCT03322735|Cyclophosphamide|cyclophosphamide|mesh-list
5704743|NCT03322735|Fludarabine|fludarabine|mesh-list
5704744|NCT03322735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5704745|NCT03322735|Immunologic Factors|immunologic factors|mesh-ancestor
5704746|NCT03322735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704747|NCT03322735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5704748|NCT03322735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5704749|NCT03322735|Alkylating Agents|alkylating agents|mesh-ancestor
5704750|NCT03322735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704751|NCT03322735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5704752|NCT03322735|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5704753|NCT03322631|Tirzepatide|tirzepatide|mesh-list
5704754|NCT03322631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5704755|NCT03322631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704756|NCT03322631|Incretins|incretins|mesh-ancestor
5704757|NCT03322631|Hormones|hormones|mesh-ancestor
5704758|NCT03322631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5704759|NCT03322488|Metronidazole|metronidazole|mesh-list
5704760|NCT03322488|Doxycycline|doxycycline|mesh-list
5704761|NCT03322488|Ciprofloxacin|ciprofloxacin|mesh-list
5704762|NCT03322488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5704763|NCT03322488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5704764|NCT03322488|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5704765|NCT03322488|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5704766|NCT03322488|Antimalarials|antimalarials|mesh-ancestor
5704767|NCT03322488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5704768|NCT03322488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5704769|NCT03322488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5704770|NCT03322488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704771|NCT03322488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5704772|NCT03322488|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5918692|NCT04989140|Antiemetics|antiemetics|mesh-ancestor
5918693|NCT04989140|Autonomic Agents|autonomic agents|mesh-ancestor
5918694|NCT04989140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5918695|NCT04989140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918696|NCT04989140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5918697|NCT04989140|Glucocorticoids|glucocorticoids|mesh-ancestor
5918698|NCT04989140|Hormones|hormones|mesh-ancestor
5918699|NCT04989140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5918700|NCT04989140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5918701|NCT04989140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5918702|NCT04989140|Immunologic Factors|immunologic factors|mesh-ancestor
5918703|NCT04989140|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5918704|NCT04989140|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5918705|NCT04989140|Growth Substances|growth substances|mesh-ancestor
5918706|NCT04989140|Growth Inhibitors|growth inhibitors|mesh-ancestor
6224653|NCT02389998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6224654|NCT02389998|Respiratory System Agents|respiratory system agents|mesh-ancestor
6224655|NCT02389998|Mydriatics|mydriatics|mesh-ancestor
6224656|NCT02389998|Parasympatholytics|parasympatholytics|mesh-ancestor
6224657|NCT02389998|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6224658|NCT02389998|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6224659|NCT02389998|Cholinergic Agents|cholinergic agents|mesh-ancestor
6224660|NCT02389998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6224661|NCT02389998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224662|NCT02390050|Bexagliflozin|bexagliflozin|mesh-list
6224663|NCT02390050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6224664|NCT02390050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224665|NCT02390219|Ivacaftor|ivacaftor|mesh-list
6224666|NCT02390219|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6224667|NCT02390219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6224668|NCT02390219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224669|NCT02391337|Digoxin|digoxin|mesh-list
6224670|NCT02391337|Bisoprolol|bisoprolol|mesh-list
6224671|NCT02391337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6499561|NCT00641654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6499562|NCT00641654|Antiviral Agents|antiviral agents|mesh-ancestor
6499563|NCT00641654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6499564|NCT00641654|Antimetabolites|antimetabolites|mesh-ancestor
6499565|NCT00641654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499566|NCT00641654|Immunologic Factors|immunologic factors|mesh-ancestor
6499567|NCT00641654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499568|NCT00641680|Fluticasone|fluticasone|mesh-list
6499569|NCT00641680|Xhance|xhance|mesh-list
6499570|NCT00641680|Budesonide|budesonide|mesh-list
6499571|NCT00641680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6499572|NCT00641680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6499573|NCT00641680|Autonomic Agents|autonomic agents|mesh-ancestor
6499574|NCT00641680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6499575|NCT00641680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499576|NCT00641680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6499577|NCT00641680|Respiratory System Agents|respiratory system agents|mesh-ancestor
6499578|NCT00641680|Dermatologic Agents|dermatologic agents|mesh-ancestor
6499579|NCT00641680|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6499580|NCT00641680|Glucocorticoids|glucocorticoids|mesh-ancestor
6499581|NCT00641680|Hormones|hormones|mesh-ancestor
6499582|NCT00641680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6499583|NCT00641693|Budesonide|budesonide|mesh-list
5704773|NCT03322488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5704774|NCT03322358|Diphenhydramine|diphenhydramine|mesh-list
5704775|NCT03322358|Promethazine|promethazine|mesh-list
5704776|NCT03322358|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5704777|NCT03322358|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5704778|NCT03322358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5704779|NCT03322358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499584|NCT00641693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6499585|NCT00641693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6499586|NCT00641693|Autonomic Agents|autonomic agents|mesh-ancestor
6499587|NCT00641693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6499588|NCT00641693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499589|NCT00641693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6499590|NCT00641693|Respiratory System Agents|respiratory system agents|mesh-ancestor
6499591|NCT00641693|Glucocorticoids|glucocorticoids|mesh-ancestor
6499592|NCT00641693|Hormones|hormones|mesh-ancestor
6499593|NCT00641693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5704780|NCT03322358|Anesthetics, Local|anesthetics, local|mesh-ancestor
5704781|NCT03322358|Anesthetics|anesthetics|mesh-ancestor
5704782|NCT03322358|Sensory System Agents|sensory system agents|mesh-ancestor
5704783|NCT03322358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5704784|NCT03322358|Antiemetics|antiemetics|mesh-ancestor
6499594|NCT00641758|Pycnogenols|pycnogenols|mesh-list
6499595|NCT00641758|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6499596|NCT00641758|Immunologic Factors|immunologic factors|mesh-ancestor
6499597|NCT00641758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704785|NCT03322358|Autonomic Agents|autonomic agents|mesh-ancestor
5704786|NCT03322358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5704787|NCT03322358|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5704788|NCT03322358|Histamine Antagonists|histamine antagonists|mesh-ancestor
5704789|NCT03322358|Histamine Agents|histamine agents|mesh-ancestor
6499598|NCT00641758|Antioxidants|antioxidants|mesh-ancestor
5704790|NCT03322358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6224672|NCT02391337|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6676410|NCT01581151|Growth Substances|growth substances|mesh-ancestor
6224673|NCT02391337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6224674|NCT02391337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224675|NCT02391337|Protective Agents|protective agents|mesh-ancestor
6224676|NCT02391337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224677|NCT02391337|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6224678|NCT02391337|Sympatholytics|sympatholytics|mesh-ancestor
6224679|NCT02391337|Autonomic Agents|autonomic agents|mesh-ancestor
6224680|NCT02391337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6224681|NCT02391337|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6224682|NCT02391337|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6224683|NCT02391337|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6224684|NCT02391337|Adrenergic Agents|adrenergic agents|mesh-ancestor
6499599|NCT00641758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499600|NCT00641758|Protective Agents|protective agents|mesh-ancestor
6499601|NCT00641758|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6499602|NCT00641810|Caffeine|caffeine|mesh-list
6499603|NCT00641810|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6499604|NCT00641810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499605|NCT00641810|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6499606|NCT00641810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6499607|NCT00641810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499608|NCT00641810|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6499609|NCT00641810|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6499610|NCT00641810|Purinergic Agents|purinergic agents|mesh-ancestor
6499611|NCT00641810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6499612|NCT00641914|Budesonide|budesonide|mesh-list
6499613|NCT00641914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6499614|NCT00641914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6499615|NCT00641914|Autonomic Agents|autonomic agents|mesh-ancestor
6499616|NCT00641914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6499617|NCT00641914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499618|NCT00641914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6499619|NCT00641914|Respiratory System Agents|respiratory system agents|mesh-ancestor
6499620|NCT00641914|Glucocorticoids|glucocorticoids|mesh-ancestor
6499621|NCT00641914|Hormones|hormones|mesh-ancestor
6499622|NCT00641914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6499623|NCT00641927|Lithium Carbonate|lithium carbonate|mesh-list
6499624|NCT00641927|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6499625|NCT00641927|Antidepressive Agents|antidepressive agents|mesh-ancestor
6499626|NCT00641927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6499627|NCT00641927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6499628|NCT00641927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499629|NCT00641927|Antimanic Agents|antimanic agents|mesh-ancestor
6499630|NCT00641927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6499631|NCT00641927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6499632|NCT00641927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499633|NCT00641927|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6499634|NCT00641927|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6499635|NCT00641927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6499636|NCT00641927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6499637|NCT00641927|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5704791|NCT03322358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704792|NCT03322358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6499638|NCT00641979|Budesonide|budesonide|mesh-list
6499639|NCT00641979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6499640|NCT00641979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6499641|NCT00641979|Autonomic Agents|autonomic agents|mesh-ancestor
6499642|NCT00641979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6499643|NCT00641979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499644|NCT00641979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6499645|NCT00641979|Respiratory System Agents|respiratory system agents|mesh-ancestor
6499646|NCT00641979|Glucocorticoids|glucocorticoids|mesh-ancestor
6499647|NCT00641979|Hormones|hormones|mesh-ancestor
6499648|NCT00641979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6499649|NCT00642057|Tetrabenazine|tetrabenazine|mesh-list
6499650|NCT00642057|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6676411|NCT01581151|Growth Inhibitors|growth inhibitors|mesh-ancestor
5704793|NCT03322358|Antipruritics|antipruritics|mesh-ancestor
5704794|NCT03322358|Dermatologic Agents|dermatologic agents|mesh-ancestor
5704795|NCT03322267|Cisplatin|cisplatin|mesh-list
5704796|NCT03322267|Pembrolizumab|pembrolizumab|mesh-list
5704797|NCT03322267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6224685|NCT02391337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6224686|NCT02391545|Rituximab|rituximab|mesh-list
6224687|NCT02391545|Obinutuzumab|obinutuzumab|mesh-list
6224688|NCT02391545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6224689|NCT02391545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6224690|NCT02391545|Immunologic Factors|immunologic factors|mesh-ancestor
6224691|NCT02391545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224692|NCT02391545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6224693|NCT02391714|Chlorhexidine|chlorhexidine|mesh-list
6224694|NCT02391714|Povidone-Iodine|povidone-iodine|mesh-list
6224695|NCT02391714|Nitrous Oxide|nitrous oxide|mesh-list
6224696|NCT02391714|Povidone|povidone|mesh-list
6224697|NCT02391714|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6224698|NCT02391714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6224699|NCT02391714|Disinfectants|disinfectants|mesh-ancestor
6224700|NCT02391714|Plasma Substitutes|plasma substitutes|mesh-ancestor
6224701|NCT02391714|Blood Substitutes|blood substitutes|mesh-ancestor
6224702|NCT02391714|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6224703|NCT02391714|Anesthetics, General|anesthetics, general|mesh-ancestor
6224704|NCT02391714|Anesthetics|anesthetics|mesh-ancestor
6224705|NCT02391714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6224706|NCT02391714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224707|NCT02391714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6224708|NCT02391714|Analgesics|analgesics|mesh-ancestor
6224709|NCT02391714|Sensory System Agents|sensory system agents|mesh-ancestor
6224710|NCT02391714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6224711|NCT02391961|4-Aminopyridine|4-aminopyridine|mesh-list
6224712|NCT02391961|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6224713|NCT02391961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6224714|NCT02391961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224715|NCT02392104|Warfarin|warfarin|mesh-list
6224716|NCT02392104|Anticoagulants|anticoagulants|mesh-ancestor
6224717|NCT02392208|Telavancin|telavancin|mesh-list
6224718|NCT02392208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6224719|NCT02392208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6224720|NCT02392234|Ivacaftor|ivacaftor|mesh-list
6224721|NCT02392234|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6224722|NCT02392234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6224723|NCT02392234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224724|NCT02392286|Prednisone|prednisone|mesh-list
6224725|NCT02392286|Methylprednisolone|methylprednisolone|mesh-list
6224726|NCT02392286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6224727|NCT02392286|Glucocorticoids|glucocorticoids|mesh-ancestor
6224728|NCT02392286|Hormones|hormones|mesh-ancestor
6224729|NCT02392286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6224730|NCT02392286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224731|NCT02392286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6676412|NCT01581164|Vaccines|vaccines|mesh-list
6676413|NCT01581164|Immunologic Factors|immunologic factors|mesh-ancestor
6676414|NCT01581164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676415|NCT01581242|Adefovir|adefovir|mesh-list
6676416|NCT01581242|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6676417|NCT01581242|Clevudine|clevudine|mesh-list
6676418|NCT01581242|Antiviral Agents|antiviral agents|mesh-ancestor
6224732|NCT02392286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6224733|NCT02392286|Antiemetics|antiemetics|mesh-ancestor
6224734|NCT02392286|Autonomic Agents|autonomic agents|mesh-ancestor
6224735|NCT02392286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6224736|NCT02392286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6224737|NCT02392286|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6224738|NCT02392286|Protective Agents|protective agents|mesh-ancestor
6224739|NCT02392507|Paclitaxel|paclitaxel|mesh-list
6224740|NCT02392507|Carboplatin|carboplatin|mesh-list
6224741|NCT02392507|Necitumumab|necitumumab|mesh-list
6499651|NCT00642057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6499652|NCT00642057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6499653|NCT00642057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499654|NCT00642057|Adrenergic Agents|adrenergic agents|mesh-ancestor
6499655|NCT00642057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6499656|NCT00642057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499657|NCT00642096|Metoprolol|metoprolol|mesh-list
6499658|NCT00642096|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6499659|NCT00642096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6499660|NCT00642096|Diuretics|diuretics|mesh-ancestor
6499661|NCT00642096|Natriuretic Agents|natriuretic agents|mesh-ancestor
6224742|NCT02392507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6224743|NCT02392507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6676419|NCT01581242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6224744|NCT02392507|Tubulin Modulators|tubulin modulators|mesh-ancestor
6224745|NCT02392507|Antimitotic Agents|antimitotic agents|mesh-ancestor
6224746|NCT02392507|Mitosis Modulators|mitosis modulators|mesh-ancestor
6224747|NCT02392507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224748|NCT02392507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6224749|NCT02392559|Evolocumab|evolocumab|mesh-list
6224750|NCT02392559|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6224751|NCT02392559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6224752|NCT02392559|Antimetabolites|antimetabolites|mesh-ancestor
6224753|NCT02392559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224754|NCT02392559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6224755|NCT02392611|Fulvestrant|fulvestrant|mesh-list
6224756|NCT02392611|Exemestane|exemestane|mesh-list
6224757|NCT02392611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6224758|NCT02392611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6224759|NCT02392611|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6224760|NCT02392611|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6224761|NCT02392611|Hormone Antagonists|hormone antagonists|mesh-ancestor
6224762|NCT02392611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6224763|NCT02392611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224764|NCT02392611|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6224765|NCT02392611|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6224766|NCT02392611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6224767|NCT02392611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224768|NCT02392624|Omalizumab|omalizumab|mesh-list
6224769|NCT02392624|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6224770|NCT02392624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6224771|NCT02392624|Respiratory System Agents|respiratory system agents|mesh-ancestor
6224772|NCT02393209|Docetaxel|docetaxel|mesh-list
6224773|NCT02393209|Serabelisib|serabelisib|mesh-list
6224774|NCT02393209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6224775|NCT02393209|Tubulin Modulators|tubulin modulators|mesh-ancestor
6224776|NCT02393209|Antimitotic Agents|antimitotic agents|mesh-ancestor
6224777|NCT02393209|Mitosis Modulators|mitosis modulators|mesh-ancestor
6224778|NCT02393209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224779|NCT02393209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6224780|NCT02393339|Acetaminophen|acetaminophen|mesh-list
6224781|NCT02393339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6224782|NCT02393339|Analgesics|analgesics|mesh-ancestor
6224783|NCT02393339|Sensory System Agents|sensory system agents|mesh-ancestor
6224784|NCT02393339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6224785|NCT02393339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224786|NCT02393339|Antipyretics|antipyretics|mesh-ancestor
6224787|NCT02393378|Folic Acid|folic acid|mesh-list
6224788|NCT02393378|Adalimumab|adalimumab|mesh-list
6224789|NCT02393378|Methotrexate|methotrexate|mesh-list
6224790|NCT02393378|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6224791|NCT02393378|Abortifacient Agents|abortifacient agents|mesh-ancestor
6224792|NCT02393378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6224793|NCT02393378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224794|NCT02393378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6224795|NCT02393378|Antimetabolites|antimetabolites|mesh-ancestor
6224796|NCT02393378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224797|NCT02393378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6224798|NCT02393378|Dermatologic Agents|dermatologic agents|mesh-ancestor
6224799|NCT02393378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6224800|NCT02393378|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6224801|NCT02393378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6224802|NCT02393378|Immunologic Factors|immunologic factors|mesh-ancestor
6224803|NCT02393378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6224804|NCT02393378|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6224805|NCT02393378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6224806|NCT02393378|Hematinics|hematinics|mesh-ancestor
6224807|NCT02393378|Vitamin B Complex|vitamin b complex|mesh-ancestor
6224808|NCT02393378|Vitamins|vitamins|mesh-ancestor
6224809|NCT02393378|Micronutrients|micronutrients|mesh-ancestor
6224810|NCT02393547|Varenicline|varenicline|mesh-list
6224811|NCT02393547|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6224812|NCT02393547|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6224813|NCT02393547|Cholinergic Agents|cholinergic agents|mesh-ancestor
6224814|NCT02393547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6224815|NCT02393547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224816|NCT02393547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224817|NCT02393677|Dexmedetomidine|dexmedetomidine|mesh-list
6224818|NCT02393677|Ropivacaine|ropivacaine|mesh-list
6224819|NCT02393677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5704798|NCT03322267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5704799|NCT03322215|Capecitabine|capecitabine|mesh-list
5704800|NCT03322215|Fulvestrant|fulvestrant|mesh-list
5704801|NCT03322215|Palbociclib|palbociclib|mesh-list
6224820|NCT02393677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6224821|NCT02393677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224822|NCT02393677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6224823|NCT02393677|Analgesics|analgesics|mesh-ancestor
6224824|NCT02393677|Sensory System Agents|sensory system agents|mesh-ancestor
6224825|NCT02393677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6224826|NCT02393677|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6224827|NCT02393677|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6224828|NCT02393677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6224829|NCT02393677|Adrenergic Agents|adrenergic agents|mesh-ancestor
6224830|NCT02393677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6224831|NCT02393677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704802|NCT03322215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5704803|NCT03322215|Antimetabolites|antimetabolites|mesh-ancestor
5704804|NCT03322215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224832|NCT02393677|Anesthetics, Local|anesthetics, local|mesh-ancestor
6224833|NCT02393677|Anesthetics|anesthetics|mesh-ancestor
6224834|NCT02393690|Iodine|iodine|mesh-list
6224835|NCT02393690|Cadexomer iodine|cadexomer iodine|mesh-list
6224836|NCT02393690|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6224837|NCT02393690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6224838|NCT02393690|Trace Elements|trace elements|mesh-ancestor
6224839|NCT02393690|Micronutrients|micronutrients|mesh-ancestor
6224840|NCT02393690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224841|NCT02393755|Capecitabine|capecitabine|mesh-list
6224842|NCT02393755|Nintedanib|nintedanib|mesh-list
6224843|NCT02393755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6224844|NCT02393755|Antimetabolites|antimetabolites|mesh-ancestor
6224845|NCT02393755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224846|NCT02393755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6224847|NCT02393755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6224848|NCT02393755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6224849|NCT02394340|Luliconazole|luliconazole|mesh-list
6224850|NCT02394340|Omeprazole|omeprazole|mesh-list
6224851|NCT02394340|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6224852|NCT02394340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6224853|NCT02394340|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6224854|NCT02394340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6224855|NCT02394340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224856|NCT02394340|Antifungal Agents|antifungal agents|mesh-ancestor
6224857|NCT02394340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6224858|NCT02394457|Cosyntropin|cosyntropin|mesh-list
6224859|NCT02394457|Hormones|hormones|mesh-ancestor
6224860|NCT02394457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6224861|NCT02394457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224862|NCT02394730|Vorapaxar|vorapaxar|mesh-list
6224863|NCT02394730|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6224864|NCT02394769|Aspirin|aspirin|mesh-list
6224865|NCT02394769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6224866|NCT02394769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6224867|NCT02394769|Analgesics|analgesics|mesh-ancestor
6224868|NCT02394769|Sensory System Agents|sensory system agents|mesh-ancestor
6224869|NCT02394769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6224870|NCT02394769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224871|NCT02394769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6224872|NCT02394769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6224873|NCT02394769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5704805|NCT03322215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5704806|NCT03322215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6224874|NCT02394769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6224875|NCT02394769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224876|NCT02394769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6224877|NCT02394769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6224878|NCT02394769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6224879|NCT02394769|Antipyretics|antipyretics|mesh-ancestor
6224880|NCT02394951|Pregabalin|pregabalin|mesh-list
6224881|NCT02394951|Analgesics|analgesics|mesh-ancestor
6224882|NCT02394951|Sensory System Agents|sensory system agents|mesh-ancestor
6224883|NCT02394951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6499662|NCT00642096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704807|NCT03322215|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6224884|NCT02394951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224885|NCT02394951|Anticonvulsants|anticonvulsants|mesh-ancestor
6224886|NCT02394951|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6224887|NCT02394951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6224888|NCT02394951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224889|NCT02394951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6224890|NCT02394951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6224891|NCT02394951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6224892|NCT02394951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6224893|NCT02394951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6224894|NCT02395055|Adalimumab|adalimumab|mesh-list
6224895|NCT02395055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6224896|NCT02395055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6224897|NCT02395081|Vitamin D|vitamin d|mesh-list
6224898|NCT02395081|Ergocalciferols|ergocalciferols|mesh-list
6224899|NCT02395081|Cholecalciferol|cholecalciferol|mesh-list
6224900|NCT02395081|Vitamins|vitamins|mesh-list
6224901|NCT02395081|Micronutrients|micronutrients|mesh-ancestor
6224902|NCT02395081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224903|NCT02395081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6224904|NCT02395081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6224905|NCT02395172|Docetaxel|docetaxel|mesh-list
6224906|NCT02395172|Avelumab|avelumab|mesh-list
6224907|NCT02395172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6224908|NCT02395172|Tubulin Modulators|tubulin modulators|mesh-ancestor
6224909|NCT02395172|Antimitotic Agents|antimitotic agents|mesh-ancestor
6224910|NCT02395172|Mitosis Modulators|mitosis modulators|mesh-ancestor
6224911|NCT02395172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224912|NCT02395172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6224913|NCT02395627|Tamoxifen|tamoxifen|mesh-list
6224914|NCT02395627|Pembrolizumab|pembrolizumab|mesh-list
6224915|NCT02395627|Vorinostat|vorinostat|mesh-list
6224916|NCT02395627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6224917|NCT02395627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6224918|NCT02395627|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6499663|NCT00642096|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6499664|NCT00642096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6499665|NCT00642096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499666|NCT00642096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6499667|NCT00642096|Sympatholytics|sympatholytics|mesh-ancestor
6499668|NCT00642096|Autonomic Agents|autonomic agents|mesh-ancestor
6499669|NCT00642096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6499670|NCT00642096|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6499671|NCT00642096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6499672|NCT00642096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6499673|NCT00642096|Adrenergic Agents|adrenergic agents|mesh-ancestor
6499674|NCT00642096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6499675|NCT00642122|Budesonide|budesonide|mesh-list
6499676|NCT00642122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6499677|NCT00642122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6499678|NCT00642122|Autonomic Agents|autonomic agents|mesh-ancestor
6499679|NCT00642122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6499680|NCT00642122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499681|NCT00642122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6499682|NCT00642122|Respiratory System Agents|respiratory system agents|mesh-ancestor
6499683|NCT00642122|Glucocorticoids|glucocorticoids|mesh-ancestor
6499684|NCT00642122|Hormones|hormones|mesh-ancestor
6499685|NCT00642122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6499686|NCT00642135|Phenylephrine|phenylephrine|mesh-list
6499687|NCT00642135|Oxymetazoline|oxymetazoline|mesh-list
6499688|NCT00642135|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6499689|NCT00642135|Tropicamide|tropicamide|mesh-list
6499690|NCT00642135|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6499691|NCT00642135|Mydriatics|mydriatics|mesh-ancestor
6499692|NCT00642135|Autonomic Agents|autonomic agents|mesh-ancestor
6499693|NCT00642135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6499694|NCT00642135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499695|NCT00642135|Sympathomimetics|sympathomimetics|mesh-ancestor
6499696|NCT00642135|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6499697|NCT00642135|Nasal Decongestants|nasal decongestants|mesh-ancestor
6499698|NCT00642135|Respiratory System Agents|respiratory system agents|mesh-ancestor
6499699|NCT00642135|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6499700|NCT00642135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6499701|NCT00642135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6499702|NCT00642135|Adrenergic Agents|adrenergic agents|mesh-ancestor
6499703|NCT00642135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6224919|NCT02395627|Hormone Antagonists|hormone antagonists|mesh-ancestor
6224920|NCT02395627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6224921|NCT02395627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224922|NCT02395627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6224923|NCT02395627|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6224924|NCT02395627|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6224925|NCT02395627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6224926|NCT02395627|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6224927|NCT02395627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6224928|NCT02395627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224929|NCT02395653|Fentanyl|fentanyl|mesh-list
6224930|NCT02395653|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6224931|NCT02395653|Narcotics|narcotics|mesh-ancestor
6224932|NCT02395653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6224933|NCT02395653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224934|NCT02395653|Analgesics|analgesics|mesh-ancestor
5704808|NCT03322215|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5704809|NCT03322215|Hormone Antagonists|hormone antagonists|mesh-ancestor
5704810|NCT03322215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5704811|NCT03322215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704812|NCT03322215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5704813|NCT03322215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5704814|NCT03322150|Atropine|atropine|mesh-list
5704815|NCT03322150|Glycopyrrolate|glycopyrrolate|mesh-list
5704816|NCT03322150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5704817|NCT03322150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5704818|NCT03322150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5918707|NCT04989140|Protease Inhibitors|protease inhibitors|mesh-ancestor
5918708|NCT04989140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5918709|NCT04989140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918710|NCT04989218|Gemcitabine|gemcitabine|mesh-list
5918711|NCT04989218|Cisplatin|cisplatin|mesh-list
5918712|NCT04989218|Durvalumab|durvalumab|mesh-list
5918713|NCT04989218|Tremelimumab|tremelimumab|mesh-list
6224935|NCT02395653|Sensory System Agents|sensory system agents|mesh-ancestor
6224936|NCT02395653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6224937|NCT02395653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6224938|NCT02395653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6224939|NCT02395653|Anesthetics, General|anesthetics, general|mesh-ancestor
6499704|NCT00642135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499705|NCT00642135|Protective Agents|protective agents|mesh-ancestor
6499706|NCT00642135|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6499707|NCT00642135|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6499708|NCT00642135|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6499709|NCT00642135|Cholinergic Agents|cholinergic agents|mesh-ancestor
6499710|NCT00642161|Budesonide|budesonide|mesh-list
6499711|NCT00642161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6499712|NCT00642161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6499713|NCT00642161|Autonomic Agents|autonomic agents|mesh-ancestor
6499714|NCT00642161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6499715|NCT00642161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499716|NCT00642161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6499717|NCT00642161|Respiratory System Agents|respiratory system agents|mesh-ancestor
6499718|NCT00642161|Glucocorticoids|glucocorticoids|mesh-ancestor
6499719|NCT00642161|Hormones|hormones|mesh-ancestor
6499720|NCT00642161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6499721|NCT00642187|Budesonide|budesonide|mesh-list
6499722|NCT00642187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6499723|NCT00642187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6499724|NCT00642187|Autonomic Agents|autonomic agents|mesh-ancestor
6499725|NCT00642187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6499726|NCT00642187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499727|NCT00642187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6499728|NCT00642187|Respiratory System Agents|respiratory system agents|mesh-ancestor
6499729|NCT00642187|Glucocorticoids|glucocorticoids|mesh-ancestor
6499730|NCT00642187|Hormones|hormones|mesh-ancestor
6499731|NCT00642187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6499732|NCT00642226|Triamcinolone|triamcinolone|mesh-list
6499733|NCT00642226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6499734|NCT00642226|Glucocorticoids|glucocorticoids|mesh-ancestor
6499735|NCT00642226|Hormones|hormones|mesh-ancestor
5704819|NCT03322150|Autonomic Agents|autonomic agents|mesh-ancestor
5918714|NCT04989218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5918715|NCT04989218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5918716|NCT04989218|Antimetabolites|antimetabolites|mesh-ancestor
6224940|NCT02395653|Anesthetics|anesthetics|mesh-ancestor
6224941|NCT02395692|Temozolomide|temozolomide|mesh-list
6224942|NCT02395692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6224943|NCT02395692|Alkylating Agents|alkylating agents|mesh-ancestor
6224944|NCT02395692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224945|NCT02395692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6243458|NCT02668393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6243459|NCT02668393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6243460|NCT02668432|Amiodarone|amiodarone|mesh-list
6243461|NCT02668432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6243462|NCT02668432|Vasodilator Agents|vasodilator agents|mesh-ancestor
6243463|NCT02668432|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6243464|NCT02668432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6243465|NCT02668432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243466|NCT02668432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6243467|NCT02668432|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6243468|NCT02668432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6243469|NCT02668432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6243470|NCT02668432|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6243471|NCT02668432|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6243472|NCT02668432|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6243473|NCT02668640|Adalimumab|adalimumab|mesh-list
6243474|NCT02668640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6243475|NCT02668640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6243476|NCT02669017|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
6243477|NCT02669017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6243478|NCT02669017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6243479|NCT02669043|Ketamine|ketamine|mesh-list
6243480|NCT02669043|Analgesics|analgesics|mesh-ancestor
6243481|NCT02669043|Sensory System Agents|sensory system agents|mesh-ancestor
6243482|NCT02669043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6243483|NCT02669043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499736|NCT00642226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6499737|NCT00642226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499738|NCT00642252|Fluorides|fluorides|mesh-list
6499739|NCT00642252|Cariostatic Agents|cariostatic agents|mesh-ancestor
6499740|NCT00642252|Protective Agents|protective agents|mesh-ancestor
6499741|NCT00642252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704820|NCT03322150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5704821|NCT03322150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704822|NCT03322150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5704823|NCT03322150|Respiratory System Agents|respiratory system agents|mesh-ancestor
5704824|NCT03322150|Mydriatics|mydriatics|mesh-ancestor
5704825|NCT03322150|Parasympatholytics|parasympatholytics|mesh-ancestor
5704826|NCT03322150|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5704827|NCT03322150|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5704828|NCT03322150|Cholinergic Agents|cholinergic agents|mesh-ancestor
5704829|NCT03322150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6499742|NCT00642291|Emtricitabine|emtricitabine|mesh-list
6499743|NCT00642291|Antiviral Agents|antiviral agents|mesh-ancestor
6499744|NCT00642291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6499745|NCT00642291|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6499746|NCT00642291|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6499747|NCT00642291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6499748|NCT00642291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499749|NCT00642291|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6499750|NCT00642291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6499751|NCT00642330|Ibuprofen|ibuprofen|mesh-list
6499752|NCT00642330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6499753|NCT00642330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6499754|NCT00642330|Analgesics|analgesics|mesh-ancestor
6499755|NCT00642330|Sensory System Agents|sensory system agents|mesh-ancestor
6499756|NCT00642330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6499757|NCT00642330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499758|NCT00642330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6499759|NCT00642330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6499760|NCT00642330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6499761|NCT00642330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6499762|NCT00642330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499763|NCT00642395|Bortezomib|bortezomib|mesh-list
6499764|NCT00642395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5704830|NCT03322150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704831|NCT03322124|Octenidine|octenidine|mesh-list
6224946|NCT02396147|Relugolix|relugolix|mesh-list
6224947|NCT02396147|Androgen Antagonists|androgen antagonists|mesh-ancestor
6224948|NCT02396147|Hormone Antagonists|hormone antagonists|mesh-ancestor
6224949|NCT02396147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6224950|NCT02396147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224951|NCT02396316|Aflibercept|aflibercept|mesh-list
6224952|NCT02396316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6224953|NCT02396316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6224954|NCT02396316|Growth Substances|growth substances|mesh-ancestor
6224955|NCT02396316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224956|NCT02396316|Growth Inhibitors|growth inhibitors|mesh-ancestor
6224957|NCT02396316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6224958|NCT02396511|Bevacizumab|bevacizumab|mesh-list
6224959|NCT02396511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6224960|NCT02396511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6224961|NCT02396511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6224962|NCT02396511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6224963|NCT02396511|Growth Substances|growth substances|mesh-ancestor
6224964|NCT02396511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224965|NCT02396511|Growth Inhibitors|growth inhibitors|mesh-ancestor
6224966|NCT02396537|Lidocaine|lidocaine|mesh-list
6224967|NCT02396537|Midazolam|midazolam|mesh-list
6224968|NCT02396537|Anesthetics, Local|anesthetics, local|mesh-ancestor
6224969|NCT02396537|Anesthetics|anesthetics|mesh-ancestor
6224970|NCT02396537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6224971|NCT02396537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224972|NCT02396537|Sensory System Agents|sensory system agents|mesh-ancestor
6224973|NCT02396537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6224974|NCT02396537|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6224975|NCT02396537|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6224976|NCT02396537|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6224977|NCT02396537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6224978|NCT02396537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6224979|NCT02396537|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6224980|NCT02396537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6224981|NCT02396537|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6224982|NCT02396537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6224983|NCT02396537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6224984|NCT02396537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6224985|NCT02396537|Anesthetics, General|anesthetics, general|mesh-ancestor
6224986|NCT02396537|GABA Modulators|gaba modulators|mesh-ancestor
6224987|NCT02396537|GABA Agents|gaba agents|mesh-ancestor
6224988|NCT02396537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6224989|NCT02396732|Aspirin|aspirin|mesh-list
6224990|NCT02396732|Enoxaparin|enoxaparin|mesh-list
6224991|NCT02396732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6224992|NCT02396732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6224993|NCT02396732|Analgesics|analgesics|mesh-ancestor
6224994|NCT02396732|Sensory System Agents|sensory system agents|mesh-ancestor
6224995|NCT02396732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6224996|NCT02396732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6224997|NCT02396732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6224998|NCT02396732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6224999|NCT02396732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6225000|NCT02396732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6676420|NCT01581242|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6676421|NCT01581242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6676422|NCT01581242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6676423|NCT01581242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676424|NCT01581320|Vitamin D|vitamin d|mesh-list
6676425|NCT01581320|Cholecalciferol|cholecalciferol|mesh-list
5704832|NCT03322124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5704833|NCT03322124|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5704834|NCT03322098|Atropine|atropine|mesh-list
5704835|NCT03322098|Glycopyrrolate|glycopyrrolate|mesh-list
5704836|NCT03322098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5704837|NCT03322098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5704838|NCT03322098|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5704839|NCT03322098|Autonomic Agents|autonomic agents|mesh-ancestor
5704840|NCT03322098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5704841|NCT03322098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704842|NCT03322098|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5704843|NCT03322098|Respiratory System Agents|respiratory system agents|mesh-ancestor
5704844|NCT03322098|Mydriatics|mydriatics|mesh-ancestor
6676426|NCT01581320|Ibandronic Acid|ibandronic acid|mesh-list
6676427|NCT01581320|Vitamins|vitamins|mesh-ancestor
6225001|NCT02396732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225002|NCT02396732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6225003|NCT02396732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6225004|NCT02396732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6225005|NCT02396732|Antipyretics|antipyretics|mesh-ancestor
6225006|NCT02396732|Anticoagulants|anticoagulants|mesh-ancestor
6225007|NCT02396758|Plasminogen|plasminogen|mesh-list
6225008|NCT02396758|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6225009|NCT02396758|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6225010|NCT02396758|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6225011|NCT02396758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225012|NCT02396953|Lanreotide|lanreotide|mesh-list
6225013|NCT02396953|Somatostatin|somatostatin|mesh-list
6225014|NCT02396953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6225015|NCT02396953|Hormones|hormones|mesh-ancestor
6225016|NCT02396953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6225017|NCT02396953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225018|NCT02397096|Ritonavir|ritonavir|mesh-list
6225019|NCT02397096|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
6225020|NCT02397096|Tenofovir|tenofovir|mesh-list
6225021|NCT02397096|Lamivudine|lamivudine|mesh-list
5704845|NCT03322098|Parasympatholytics|parasympatholytics|mesh-ancestor
5704846|NCT03322098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5704847|NCT03322098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6225022|NCT02397096|Cobicistat|cobicistat|mesh-list
6225023|NCT02397096|Elvitegravir|elvitegravir|mesh-list
6225024|NCT02397096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
6225025|NCT02397096|Protease Inhibitors|protease inhibitors|mesh-list
6225026|NCT02397096|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6225027|NCT02397096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6225028|NCT02397096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225029|NCT02397096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6225030|NCT02397096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6225031|NCT02397096|Antiviral Agents|antiviral agents|mesh-ancestor
6225032|NCT02397096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6225033|NCT02397096|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6225034|NCT02397096|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6225035|NCT02397096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6225036|NCT02397096|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6225037|NCT02397265|Insulin|insulin|mesh-list
6225038|NCT02397265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6225039|NCT02397265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225040|NCT02397291|Inositol|inositol|mesh-list
6225041|NCT02397291|Vitamin B Complex|vitamin b complex|mesh-ancestor
6225042|NCT02397291|Vitamins|vitamins|mesh-ancestor
6225043|NCT02397291|Micronutrients|micronutrients|mesh-ancestor
6225044|NCT02397291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225045|NCT02397408|Choline|choline|mesh-list
6225046|NCT02397408|Lipotropic Agents|lipotropic agents|mesh-ancestor
6225047|NCT02397408|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6225048|NCT02397408|Antimetabolites|antimetabolites|mesh-ancestor
6225049|NCT02397408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225050|NCT02397408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6225051|NCT02397408|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6225052|NCT02397408|Nootropic Agents|nootropic agents|mesh-ancestor
6225053|NCT02397694|Dolutegravir|dolutegravir|mesh-list
6225054|NCT02397694|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6225055|NCT02397694|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6225056|NCT02397694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6225057|NCT02397694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225058|NCT02397694|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6225059|NCT02397694|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6225060|NCT02397694|Antiviral Agents|antiviral agents|mesh-ancestor
6225061|NCT02397694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6225062|NCT02397837|Pramipexole|pramipexole|mesh-list
6225063|NCT02397837|Antioxidants|antioxidants|mesh-ancestor
6225064|NCT02397837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225065|NCT02397837|Protective Agents|protective agents|mesh-ancestor
6225066|NCT02397837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225067|NCT02397837|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6225068|NCT02397837|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5704848|NCT03322098|Cholinergic Agents|cholinergic agents|mesh-ancestor
5704849|NCT03322098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5704850|NCT03322098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704851|NCT03321981|Trastuzumab|trastuzumab|mesh-list
5704852|NCT03321981|Letrozole|letrozole|mesh-list
5704853|NCT03321981|Vinorelbine|vinorelbine|mesh-list
6225069|NCT02397837|Dopamine Agonists|dopamine agonists|mesh-ancestor
6225070|NCT02397837|Dopamine Agents|dopamine agents|mesh-ancestor
6225071|NCT02397837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6225072|NCT02397889|Midazolam|midazolam|mesh-list
6225073|NCT02397889|Ketamine|ketamine|mesh-list
6225074|NCT02397889|Analgesics|analgesics|mesh-ancestor
6225075|NCT02397889|Sensory System Agents|sensory system agents|mesh-ancestor
6225076|NCT02397889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6225077|NCT02397889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225078|NCT02397889|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6225079|NCT02397889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6225080|NCT02397889|Anesthetics, General|anesthetics, general|mesh-ancestor
6225081|NCT02397889|Anesthetics|anesthetics|mesh-ancestor
6225082|NCT02397889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6225083|NCT02397889|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6225084|NCT02397889|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6225085|NCT02397889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6225086|NCT02397889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225087|NCT02397889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6225088|NCT02397889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6225089|NCT02397889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6225090|NCT02397889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6225091|NCT02397889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6225092|NCT02397889|GABA Modulators|gaba modulators|mesh-ancestor
6225093|NCT02397889|GABA Agents|gaba agents|mesh-ancestor
6225094|NCT02397954|Ranibizumab|ranibizumab|mesh-list
6225095|NCT02397954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6225096|NCT02397954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6225097|NCT02397954|Growth Substances|growth substances|mesh-ancestor
6225098|NCT02397954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225099|NCT02397954|Growth Inhibitors|growth inhibitors|mesh-ancestor
6225100|NCT02397954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6225101|NCT02398188|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6225102|NCT02398188|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6225103|NCT02398188|Autonomic Agents|autonomic agents|mesh-ancestor
5704854|NCT03321981|Fulvestrant|fulvestrant|mesh-list
5704855|NCT03321981|Exemestane|exemestane|mesh-list
5704856|NCT03321981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5704857|NCT03321981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5704858|NCT03321981|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5704859|NCT03321981|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5704860|NCT03321981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5704861|NCT03321981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704862|NCT03321981|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5704863|NCT03321981|Hormone Antagonists|hormone antagonists|mesh-ancestor
5704864|NCT03321981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5704865|NCT03321981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704866|NCT03321981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5704867|NCT03321981|Tubulin Modulators|tubulin modulators|mesh-ancestor
5704868|NCT03321981|Antimitotic Agents|antimitotic agents|mesh-ancestor
6225104|NCT02398188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6225105|NCT02398188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225106|NCT02398188|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6225107|NCT02398188|Respiratory System Agents|respiratory system agents|mesh-ancestor
6225108|NCT02398188|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6225109|NCT02398188|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6225110|NCT02398188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6225111|NCT02398188|Adrenergic Agents|adrenergic agents|mesh-ancestor
6225112|NCT02398188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6225113|NCT02398188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225114|NCT02399085|Lenalidomide|lenalidomide|mesh-list
6225115|NCT02399085|Immunologic Factors|immunologic factors|mesh-ancestor
6225116|NCT02399085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225117|NCT02399085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6225118|NCT02399085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6225119|NCT02399085|Growth Substances|growth substances|mesh-ancestor
6225120|NCT02399085|Growth Inhibitors|growth inhibitors|mesh-ancestor
6225121|NCT02399085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6225122|NCT02399163|Fluorides|fluorides|mesh-list
6225123|NCT02399163|Cariostatic Agents|cariostatic agents|mesh-ancestor
6225124|NCT02399163|Protective Agents|protective agents|mesh-ancestor
6225125|NCT02399163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225126|NCT02399345|Ritonavir|ritonavir|mesh-list
6225127|NCT02399345|Ribavirin|ribavirin|mesh-list
6225128|NCT02399345|Sofosbuvir|sofosbuvir|mesh-list
6225129|NCT02399345|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6225130|NCT02399345|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6225131|NCT02399345|Protease Inhibitors|protease inhibitors|mesh-ancestor
6225132|NCT02399345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6225133|NCT02399345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225134|NCT02399345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6225135|NCT02399345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6225136|NCT02399345|Antiviral Agents|antiviral agents|mesh-ancestor
6225137|NCT02399345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6225138|NCT02399345|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6225139|NCT02399345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6225140|NCT02399345|Antimetabolites|antimetabolites|mesh-ancestor
6225141|NCT02399475|Hormones|hormones|mesh-list
6225142|NCT02399475|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
6225143|NCT02399475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6225144|NCT02399475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225145|NCT02399917|Azacitidine|azacitidine|mesh-list
6225146|NCT02399917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6225147|NCT02399917|Antimetabolites|antimetabolites|mesh-ancestor
6225148|NCT02399917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225149|NCT02399917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6225150|NCT02399917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6225151|NCT02400333|Ticagrelor|ticagrelor|mesh-list
6225152|NCT02400333|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6225153|NCT02400333|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6225154|NCT02400333|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6225155|NCT02400333|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6225156|NCT02400333|Purinergic Agents|purinergic agents|mesh-ancestor
6225157|NCT02400333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6225158|NCT02400333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225159|NCT02400333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225160|NCT02400346|Brexpiprazole|brexpiprazole|mesh-list
6499765|NCT00642408|Micronutrients|micronutrients|mesh-list
6499766|NCT00642408|Trace Elements|trace elements|mesh-list
6499767|NCT00642408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499768|NCT00642421|Octreotide|octreotide|mesh-list
6499769|NCT00642421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6499770|NCT00642421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6499771|NCT00642421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6499772|NCT00642434|Metoprolol|metoprolol|mesh-list
6499773|NCT00642434|Carvedilol|carvedilol|mesh-list
6499774|NCT00642434|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6499775|NCT00642434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6499776|NCT00642434|Sympatholytics|sympatholytics|mesh-ancestor
6499777|NCT00642434|Autonomic Agents|autonomic agents|mesh-ancestor
6499778|NCT00642434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6499779|NCT00642434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499780|NCT00642434|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6499781|NCT00642434|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6499782|NCT00642434|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6499783|NCT00642434|Adrenergic Agents|adrenergic agents|mesh-ancestor
6499784|NCT00642434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6499785|NCT00642434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499786|NCT00642434|Antioxidants|antioxidants|mesh-ancestor
6499787|NCT00642434|Protective Agents|protective agents|mesh-ancestor
6499788|NCT00642434|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6499789|NCT00642434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6499790|NCT00642434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6499791|NCT00642434|Vasodilator Agents|vasodilator agents|mesh-ancestor
6499792|NCT00642434|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6499793|NCT00642434|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6499794|NCT00642499|Dronabinol|dronabinol|mesh-list
6499795|NCT00642499|Hallucinogens|hallucinogens|mesh-ancestor
6499796|NCT00642499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499797|NCT00642499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6499798|NCT00642499|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6499799|NCT00642499|Analgesics|analgesics|mesh-ancestor
6499800|NCT00642499|Sensory System Agents|sensory system agents|mesh-ancestor
6499801|NCT00642499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6499802|NCT00642499|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5704869|NCT03321981|Mitosis Modulators|mitosis modulators|mesh-ancestor
5704870|NCT03321981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5704871|NCT03321981|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5704872|NCT03321955|Ziconotide|ziconotide|mesh-list
5704873|NCT03321955|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5704874|NCT03321955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5704875|NCT03321955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704876|NCT03321955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5704877|NCT03321955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704878|NCT03321955|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6225161|NCT02400346|Serotonin Agents|serotonin agents|mesh-ancestor
6225162|NCT02400346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6225163|NCT02400346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225164|NCT02400346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225165|NCT02400346|Dopamine Agonists|dopamine agonists|mesh-ancestor
6225166|NCT02400346|Dopamine Agents|dopamine agents|mesh-ancestor
6225167|NCT02400437|Dexamethasone|dexamethasone|mesh-list
6225168|NCT02400437|Rituximab|rituximab|mesh-list
6225169|NCT02400437|Ixazomib|ixazomib|mesh-list
6225170|NCT02400437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6225171|NCT02400437|Antiemetics|antiemetics|mesh-ancestor
6225172|NCT02400437|Autonomic Agents|autonomic agents|mesh-ancestor
6225173|NCT02400437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6225174|NCT02400437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225175|NCT02400437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6225176|NCT02400437|Glucocorticoids|glucocorticoids|mesh-ancestor
6225177|NCT02400437|Hormones|hormones|mesh-ancestor
6225178|NCT02400437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6225179|NCT02400437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6225180|NCT02400437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6225181|NCT02400437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6225182|NCT02400437|Immunologic Factors|immunologic factors|mesh-ancestor
6225183|NCT02400437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6225184|NCT02400437|Protease Inhibitors|protease inhibitors|mesh-ancestor
6225185|NCT02400437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6225186|NCT02400437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225187|NCT02400580|Acetaminophen|acetaminophen|mesh-list
6225188|NCT02400580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5704879|NCT03321955|Protective Agents|protective agents|mesh-ancestor
5704880|NCT03321955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5704881|NCT03321955|Analgesics|analgesics|mesh-ancestor
5704882|NCT03321955|Sensory System Agents|sensory system agents|mesh-ancestor
5704883|NCT03321955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6225189|NCT02400580|Analgesics|analgesics|mesh-ancestor
6225190|NCT02400580|Sensory System Agents|sensory system agents|mesh-ancestor
6225191|NCT02400580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6225192|NCT02400580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225193|NCT02400580|Antipyretics|antipyretics|mesh-ancestor
6225194|NCT02400749|Apremilast|apremilast|mesh-list
6225195|NCT02400749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6225196|NCT02400749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6225197|NCT02400749|Analgesics|analgesics|mesh-ancestor
6225198|NCT02400749|Sensory System Agents|sensory system agents|mesh-ancestor
6225199|NCT02400749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6225200|NCT02400749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225201|NCT02400749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6225202|NCT02400749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6225203|NCT02400749|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6225204|NCT02400749|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6225205|NCT02400749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6225206|NCT02400749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225207|NCT02401048|Durvalumab|durvalumab|mesh-list
6225208|NCT02401048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6225209|NCT02401048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6225210|NCT02401230|Tenofovir|tenofovir|mesh-list
6225211|NCT02401230|Emtricitabine|emtricitabine|mesh-list
6225212|NCT02401230|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6225213|NCT02401230|Antiviral Agents|antiviral agents|mesh-ancestor
6225214|NCT02401230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6225215|NCT02401230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6225216|NCT02401230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6225217|NCT02401230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6225218|NCT02401230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225219|NCT02401230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6225220|NCT02401230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6225221|NCT02401256|Efavirenz|efavirenz|mesh-list
6225222|NCT02401256|Bupropion|bupropion|mesh-list
6225223|NCT02401256|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6225224|NCT02401256|Montelukast|montelukast|mesh-list
5704884|NCT03321903|Charcoal|charcoal|mesh-list
5704885|NCT03321903|Antidotes|antidotes|mesh-ancestor
5704886|NCT03321903|Protective Agents|protective agents|mesh-ancestor
5704887|NCT03321903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704888|NCT03321890|Prednisone|prednisone|mesh-list
5704889|NCT03321890|Cyclophosphamide|cyclophosphamide|mesh-list
5704890|NCT03321890|Methotrexate|methotrexate|mesh-list
5704891|NCT03321890|Etoposide|etoposide|mesh-list
5704892|NCT03321890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5704893|NCT03321890|Immunologic Factors|immunologic factors|mesh-ancestor
5704894|NCT03321890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704895|NCT03321890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5704896|NCT03321890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5704897|NCT03321890|Alkylating Agents|alkylating agents|mesh-ancestor
5704898|NCT03321890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225225|NCT02401256|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6225226|NCT02401256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6225227|NCT02401256|Antimetabolites|antimetabolites|mesh-ancestor
6225228|NCT02401256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225229|NCT02401256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6225230|NCT02401256|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6225231|NCT02401256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6225232|NCT02401256|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6225233|NCT02401256|Antidepressive Agents|antidepressive agents|mesh-ancestor
6225234|NCT02401256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6225235|NCT02401256|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5704899|NCT03321890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5704900|NCT03321890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5704901|NCT03321890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5704902|NCT03321890|Glucocorticoids|glucocorticoids|mesh-ancestor
5704903|NCT03321890|Hormones|hormones|mesh-ancestor
5704904|NCT03321890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5704905|NCT03321890|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5704906|NCT03321890|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5704907|NCT03321890|Abortifacient Agents|abortifacient agents|mesh-ancestor
5704908|NCT03321890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5704909|NCT03321890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6225236|NCT02401256|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6225237|NCT02401256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6225238|NCT02401256|Dopamine Agents|dopamine agents|mesh-ancestor
6225239|NCT02401256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6225240|NCT02401256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225241|NCT02401256|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6225242|NCT02401256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6225243|NCT02401256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6225244|NCT02401256|Respiratory System Agents|respiratory system agents|mesh-ancestor
6225245|NCT02401256|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6225246|NCT02401256|Hormone Antagonists|hormone antagonists|mesh-ancestor
6225247|NCT02401256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6225248|NCT02401256|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6225249|NCT02401256|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6225250|NCT02401256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6225251|NCT02401256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6225252|NCT02401256|Antiviral Agents|antiviral agents|mesh-ancestor
6225253|NCT02401256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5704910|NCT03321890|Antimetabolites|antimetabolites|mesh-ancestor
5704911|NCT03321890|Dermatologic Agents|dermatologic agents|mesh-ancestor
5704912|NCT03321890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5704913|NCT03321890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5704914|NCT03321890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5704915|NCT03321890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5704916|NCT03321890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5704917|NCT03321890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5704918|NCT03321825|Lidocaine|lidocaine|mesh-list
5704919|NCT03321825|Hyaluronic Acid|hyaluronic acid|mesh-list
5704920|NCT03321825|Anesthetics, Local|anesthetics, local|mesh-ancestor
5704921|NCT03321825|Anesthetics|anesthetics|mesh-ancestor
5704922|NCT03321825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5704923|NCT03321825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225254|NCT02401256|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6225255|NCT02401256|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5704924|NCT03321825|Sensory System Agents|sensory system agents|mesh-ancestor
6225256|NCT02401256|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6225257|NCT02401256|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6225258|NCT02401464|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
6225259|NCT02401464|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6225260|NCT02401464|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6225261|NCT02401464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225262|NCT02401529|Acetaminophen|acetaminophen|mesh-list
6225263|NCT02401529|Dexamethasone|dexamethasone|mesh-list
6225264|NCT02401529|Prednisolone|prednisolone|mesh-list
6225265|NCT02401529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6225266|NCT02401529|Antiemetics|antiemetics|mesh-ancestor
6225267|NCT02401529|Autonomic Agents|autonomic agents|mesh-ancestor
6225268|NCT02401529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6225269|NCT02401529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225270|NCT02401529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6225271|NCT02401529|Glucocorticoids|glucocorticoids|mesh-ancestor
6225272|NCT02401529|Hormones|hormones|mesh-ancestor
6225273|NCT02401529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6225274|NCT02401529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6225275|NCT02401529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6225276|NCT02401529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6225277|NCT02401529|Analgesics|analgesics|mesh-ancestor
6225278|NCT02401529|Sensory System Agents|sensory system agents|mesh-ancestor
6225279|NCT02401529|Antipyretics|antipyretics|mesh-ancestor
6225280|NCT02401542|Docetaxel|docetaxel|mesh-list
6225281|NCT02401542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6225282|NCT02401542|Tubulin Modulators|tubulin modulators|mesh-ancestor
6225283|NCT02401542|Antimitotic Agents|antimitotic agents|mesh-ancestor
6225284|NCT02401542|Mitosis Modulators|mitosis modulators|mesh-ancestor
6225285|NCT02401542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225286|NCT02402062|Sunitinib|sunitinib|mesh-list
5704925|NCT03321825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5704926|NCT03321825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5704927|NCT03321825|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6225287|NCT02402062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6225288|NCT02402062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6225289|NCT02402062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6225290|NCT02402062|Growth Substances|growth substances|mesh-ancestor
6225291|NCT02402062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225292|NCT02402062|Growth Inhibitors|growth inhibitors|mesh-ancestor
6225293|NCT02402062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6225294|NCT02402062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6225295|NCT02402062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704928|NCT03321825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5704929|NCT03321825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5704930|NCT03321825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704931|NCT03321825|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5704932|NCT03321825|Immunologic Factors|immunologic factors|mesh-ancestor
5704933|NCT03321825|Viscosupplements|viscosupplements|mesh-ancestor
5704934|NCT03321825|Protective Agents|protective agents|mesh-ancestor
5704935|NCT03321799|Anti-Infective Agents|anti-infective agents|mesh-list
5704936|NCT03321799|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5721204|NCT03207451|Analgesics|analgesics|mesh-ancestor
5721205|NCT03207451|Sensory System Agents|sensory system agents|mesh-ancestor
5721206|NCT03207451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5721207|NCT03207451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721208|NCT03207451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5721209|NCT03207451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5721210|NCT03207451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5721211|NCT03207451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5721212|NCT03207451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721213|NCT03207451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5721214|NCT03207451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5721215|NCT03207451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5721216|NCT03207451|Antipyretics|antipyretics|mesh-ancestor
5721217|NCT03207451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6225296|NCT02402907|Chlorhexidine|chlorhexidine|mesh-list
6225297|NCT02402907|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6676428|NCT01581320|Micronutrients|micronutrients|mesh-ancestor
6676429|NCT01581320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676430|NCT01581320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6676431|NCT01581320|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6676432|NCT01581333|Anti-Infective Agents|anti-infective agents|mesh-list
6225298|NCT02402907|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6225299|NCT02402907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6225300|NCT02402907|Disinfectants|disinfectants|mesh-ancestor
6225301|NCT02402907|Dermatologic Agents|dermatologic agents|mesh-ancestor
6225302|NCT02402933|Glucagon|glucagon|mesh-list
6225303|NCT02402933|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5704937|NCT03321773|Amoxicillin|amoxicillin|mesh-list
5704938|NCT03321773|Metronidazole|metronidazole|mesh-list
5704939|NCT03321773|Clarithromycin|clarithromycin|mesh-list
5704940|NCT03321773|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
5704941|NCT03321773|Pantoprazole|pantoprazole|mesh-list
5704942|NCT03321773|Bismuth|bismuth|mesh-list
6225304|NCT02402933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6225305|NCT02402933|Hormones|hormones|mesh-ancestor
6225306|NCT02402933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6225307|NCT02402933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225308|NCT02402933|Incretins|incretins|mesh-ancestor
6225309|NCT02403271|Durvalumab|durvalumab|mesh-list
6225310|NCT02403271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6225311|NCT02403271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6225312|NCT02403635|Midazolam|midazolam|mesh-list
6225313|NCT02403635|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6225314|NCT02403635|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6225315|NCT02403635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6225316|NCT02403635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225317|NCT02403635|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6225318|NCT02403635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6225319|NCT02403635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5704943|NCT03321773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5704944|NCT03321773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5704945|NCT03321773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5704946|NCT03321773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5704947|NCT03321773|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5704948|NCT03321773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5704949|NCT03321773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704950|NCT03321773|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5704951|NCT03321773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5704952|NCT03321773|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5704953|NCT03321773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5704954|NCT03321773|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6225320|NCT02403635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6225321|NCT02403635|Anesthetics, General|anesthetics, general|mesh-ancestor
6225322|NCT02403635|Anesthetics|anesthetics|mesh-ancestor
6225323|NCT02403635|GABA Modulators|gaba modulators|mesh-ancestor
6225324|NCT02403635|GABA Agents|gaba agents|mesh-ancestor
6225325|NCT02403635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5704955|NCT03321773|Antacids|antacids|mesh-ancestor
5704956|NCT03321734|Caffeine|caffeine|mesh-list
5704957|NCT03321734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5704958|NCT03321734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704959|NCT03321734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5704960|NCT03321734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5704961|NCT03321734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704962|NCT03321734|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5704963|NCT03321734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5704964|NCT03321734|Purinergic Agents|purinergic agents|mesh-ancestor
5704965|NCT03321734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5704966|NCT03321656|Tacrolimus|tacrolimus|mesh-list
5704967|NCT03321656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5704968|NCT03321656|Immunologic Factors|immunologic factors|mesh-ancestor
5704969|NCT03321656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704970|NCT03321656|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5704971|NCT03321656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5704972|NCT03321656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704973|NCT03321318|Cholecalciferol|cholecalciferol|mesh-list
5704974|NCT03321318|Bazedoxifene|bazedoxifene|mesh-list
6225326|NCT02403635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225327|NCT02403674|Tenofovir|tenofovir|mesh-list
6225328|NCT02403674|Lamivudine|lamivudine|mesh-list
6225329|NCT02403674|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6225330|NCT02403674|Antiviral Agents|antiviral agents|mesh-ancestor
6225331|NCT02403674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5704975|NCT03321318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6225332|NCT02403674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6225333|NCT02403674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5704976|NCT03321318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704977|NCT03321318|Vitamins|vitamins|mesh-ancestor
6225334|NCT02403674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6225335|NCT02403674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225336|NCT02403674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6225337|NCT02403674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6225338|NCT02403778|Ipilimumab|ipilimumab|mesh-list
6225339|NCT02403778|Tretinoin|tretinoin|mesh-list
6225340|NCT02403778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6225341|NCT02403778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6225342|NCT02403778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6225343|NCT02403778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225344|NCT02403778|Keratolytic Agents|keratolytic agents|mesh-ancestor
6225345|NCT02403778|Dermatologic Agents|dermatologic agents|mesh-ancestor
6225346|NCT02403830|Morphine|morphine|mesh-list
6225347|NCT02403830|Methylnaltrexone|methylnaltrexone|mesh-list
6225348|NCT02403830|Ticagrelor|ticagrelor|mesh-list
6225349|NCT02403830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6225350|NCT02403830|Narcotics|narcotics|mesh-ancestor
6225351|NCT02403830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6225352|NCT02403830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225353|NCT02403830|Analgesics|analgesics|mesh-ancestor
6225354|NCT02403830|Sensory System Agents|sensory system agents|mesh-ancestor
6225355|NCT02403830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6225356|NCT02403830|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6225357|NCT02403830|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6225358|NCT02403830|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6225359|NCT02403830|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6225360|NCT02403830|Purinergic Agents|purinergic agents|mesh-ancestor
6225361|NCT02403830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5704978|NCT03321318|Micronutrients|micronutrients|mesh-ancestor
5704979|NCT03321318|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5704980|NCT03321318|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5704981|NCT03321318|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5704982|NCT03321318|Hormone Antagonists|hormone antagonists|mesh-ancestor
6225362|NCT02403830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225363|NCT02403830|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6225364|NCT02403895|Paclitaxel|paclitaxel|mesh-list
6225365|NCT02403895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6225366|NCT02403895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6225367|NCT02403895|Tubulin Modulators|tubulin modulators|mesh-ancestor
6225368|NCT02403895|Antimitotic Agents|antimitotic agents|mesh-ancestor
6225369|NCT02403895|Mitosis Modulators|mitosis modulators|mesh-ancestor
6225370|NCT02403895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225371|NCT02403986|Lidocaine|lidocaine|mesh-list
6225372|NCT02403986|Anesthetics, Local|anesthetics, local|mesh-ancestor
6225373|NCT02403986|Anesthetics|anesthetics|mesh-ancestor
6225374|NCT02403986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6225375|NCT02403986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225376|NCT02403986|Sensory System Agents|sensory system agents|mesh-ancestor
6225377|NCT02403986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6225378|NCT02403986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6225379|NCT02403986|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6225380|NCT02403986|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6225381|NCT02403986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6225382|NCT02403986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225383|NCT02404025|Thymoglobulin|thymoglobulin|mesh-list
6225384|NCT02404025|Immunologic Factors|immunologic factors|mesh-ancestor
6225385|NCT02404025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5704983|NCT03321318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5704984|NCT03321292|Aspirin|aspirin|mesh-list
5704985|NCT03321292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5704986|NCT03321292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5704987|NCT03321292|Analgesics|analgesics|mesh-ancestor
5704988|NCT03321292|Sensory System Agents|sensory system agents|mesh-ancestor
5704989|NCT03321292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5704990|NCT03321292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225386|NCT02404025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6225387|NCT02404103|Flunisolide|flunisolide|mesh-list
6225388|NCT02404103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6225389|NCT02404103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6225390|NCT02404103|Respiratory System Agents|respiratory system agents|mesh-ancestor
6225391|NCT02404168|Lamotrigine|lamotrigine|mesh-list
6225392|NCT02404168|Anticonvulsants|anticonvulsants|mesh-list
6225393|NCT02404168|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6225394|NCT02404168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6225395|NCT02404168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225396|NCT02404168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6225397|NCT02404168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225398|NCT02404168|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6225399|NCT02404168|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6499803|NCT00642499|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6499804|NCT00642499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6499805|NCT00642499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499806|NCT00642499|Hormones|hormones|mesh-ancestor
6499807|NCT00642499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6499808|NCT00642512|Dronabinol|dronabinol|mesh-list
6499809|NCT00642512|Ondansetron|ondansetron|mesh-list
6499810|NCT00642512|Antiemetics|antiemetics|mesh-ancestor
6499811|NCT00642512|Autonomic Agents|autonomic agents|mesh-ancestor
6499812|NCT00642512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5704991|NCT03321292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5704992|NCT03321292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5704993|NCT03321292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5704994|NCT03321292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5704995|NCT03321292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5704996|NCT03321292|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5704997|NCT03321292|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5704998|NCT03321292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5704999|NCT03321292|Antipyretics|antipyretics|mesh-ancestor
5705000|NCT03321201|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
5705001|NCT03321201|Hemostatics|hemostatics|mesh-ancestor
5705002|NCT03321201|Coagulants|coagulants|mesh-ancestor
5705003|NCT03321136|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
6499813|NCT00642512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499814|NCT00642512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6499815|NCT00642512|Antipruritics|antipruritics|mesh-ancestor
6499816|NCT00642512|Dermatologic Agents|dermatologic agents|mesh-ancestor
6499817|NCT00642512|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6499818|NCT00642512|Serotonin Agents|serotonin agents|mesh-ancestor
6499819|NCT00642512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6499820|NCT00642512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499821|NCT00642512|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6499822|NCT00642512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6499823|NCT00642512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6499824|NCT00642512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6499825|NCT00642512|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6499826|NCT00642512|Hallucinogens|hallucinogens|mesh-ancestor
6499827|NCT00642512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6499828|NCT00642512|Analgesics|analgesics|mesh-ancestor
6499829|NCT00642512|Sensory System Agents|sensory system agents|mesh-ancestor
6499830|NCT00642512|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6499831|NCT00642512|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6499832|NCT00642512|Hormones|hormones|mesh-ancestor
6499833|NCT00642512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6499834|NCT00642551|Vitamin K 2|vitamin k 2|mesh-list
6499835|NCT00642551|Vitamin K|vitamin k|mesh-list
6499836|NCT00642551|Vitamin MK 7|vitamin mk 7|mesh-list
6499837|NCT00642551|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6499838|NCT00642551|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6499839|NCT00642551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499840|NCT00642551|Hemostatics|hemostatics|mesh-ancestor
6499841|NCT00642551|Coagulants|coagulants|mesh-ancestor
6499842|NCT00642551|Vitamins|vitamins|mesh-ancestor
6499843|NCT00642551|Micronutrients|micronutrients|mesh-ancestor
6499844|NCT00642551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499845|NCT00642577|Leucovorin|leucovorin|mesh-list
6499846|NCT00642577|Bevacizumab|bevacizumab|mesh-list
6499847|NCT00642577|Fluorouracil|fluorouracil|mesh-list
6499848|NCT00642577|Irinotecan|irinotecan|mesh-list
6499849|NCT00642577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6499850|NCT00642577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6499851|NCT00642577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6499852|NCT00642577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6499853|NCT00642577|Growth Substances|growth substances|mesh-ancestor
6499854|NCT00642577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705004|NCT03321136|Hallucinogens|hallucinogens|mesh-ancestor
6499855|NCT00642577|Growth Inhibitors|growth inhibitors|mesh-ancestor
6499856|NCT00642577|Antimetabolites|antimetabolites|mesh-ancestor
6676433|NCT01581333|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6225400|NCT02404168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6225401|NCT02404168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6225402|NCT02404168|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6225403|NCT02404220|Dexamethasone|dexamethasone|mesh-list
6225404|NCT02404220|Vincristine|vincristine|mesh-list
6225405|NCT02404220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6225406|NCT02404220|Antiemetics|antiemetics|mesh-ancestor
6225407|NCT02404220|Autonomic Agents|autonomic agents|mesh-ancestor
6225408|NCT02404220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6225409|NCT02404220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225410|NCT02404220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6225411|NCT02404220|Glucocorticoids|glucocorticoids|mesh-ancestor
6225412|NCT02404220|Hormones|hormones|mesh-ancestor
6225413|NCT02404220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6225414|NCT02404220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6225415|NCT02404220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6225416|NCT02404220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6225417|NCT02404220|Tubulin Modulators|tubulin modulators|mesh-ancestor
6225418|NCT02404220|Antimitotic Agents|antimitotic agents|mesh-ancestor
6225419|NCT02404220|Mitosis Modulators|mitosis modulators|mesh-ancestor
6225420|NCT02404220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225421|NCT02404311|MF59 oil emulsion|mf59 oil emulsion|mesh-list
6225422|NCT02404311|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6225423|NCT02404311|Immunologic Factors|immunologic factors|mesh-ancestor
6225424|NCT02404311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243484|NCT02669043|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6243485|NCT02669043|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6243486|NCT02669043|Anesthetics, General|anesthetics, general|mesh-ancestor
6243487|NCT02669043|Anesthetics|anesthetics|mesh-ancestor
6243488|NCT02669043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6243489|NCT02669043|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6243490|NCT02669043|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6243491|NCT02669043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6243492|NCT02669043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243493|NCT02669264|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
6243494|NCT02669264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6243495|NCT02669264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6243496|NCT02669407|Lidocaine|lidocaine|mesh-list
6243497|NCT02669407|Anesthetics, Local|anesthetics, local|mesh-list
6243498|NCT02669407|Anesthetics|anesthetics|mesh-list
6243499|NCT02669407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6243500|NCT02669407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243501|NCT02669407|Sensory System Agents|sensory system agents|mesh-ancestor
6243502|NCT02669407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6243503|NCT02669407|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6243504|NCT02669407|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6243505|NCT02669407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6243506|NCT02669407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6243507|NCT02669407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243508|NCT02669615|Melphalan|melphalan|mesh-list
6243509|NCT02669615|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6243510|NCT02669615|Alkylating Agents|alkylating agents|mesh-ancestor
6243511|NCT02669615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243512|NCT02669615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6243513|NCT02669615|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6243514|NCT02669615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6243515|NCT02669615|Immunologic Factors|immunologic factors|mesh-ancestor
6243516|NCT02669615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243517|NCT02669862|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6243518|NCT02669914|Durvalumab|durvalumab|mesh-list
6243519|NCT02669914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6243520|NCT02669914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6243521|NCT02670343|Methyltestosterone|methyltestosterone|mesh-list
5705005|NCT03321136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705006|NCT03321136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5705007|NCT03321136|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5705008|NCT03321136|Serotonin Agents|serotonin agents|mesh-ancestor
5705009|NCT03321136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5705010|NCT03321136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705011|NCT03321136|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5705012|NCT03321110|Ubiquinone|ubiquinone|mesh-list
5705013|NCT03321110|Coenzyme Q10|coenzyme q10|mesh-list
5705014|NCT03321110|Micronutrients|micronutrients|mesh-ancestor
6225425|NCT02404441|Spartalizumab|spartalizumab|mesh-list
6225426|NCT02404441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6225427|NCT02404441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225428|NCT02404441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6225429|NCT02404493|Decanoic acid|decanoic acid|mesh-list
6225430|NCT02404493|Antifungal Agents|antifungal agents|mesh-ancestor
6225431|NCT02404493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6225432|NCT02404610|Propofol|propofol|mesh-list
6225433|NCT02404610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
6225434|NCT02404610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6225435|NCT02404610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225436|NCT02404610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6225437|NCT02404610|Anesthetics, General|anesthetics, general|mesh-ancestor
6225438|NCT02404610|Anesthetics|anesthetics|mesh-ancestor
6225439|NCT02404805|Dolutegravir|dolutegravir|mesh-list
6225440|NCT02404805|Simeprevir|simeprevir|mesh-list
6225441|NCT02404805|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6225442|NCT02404805|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6225443|NCT02404805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6225444|NCT02404805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225445|NCT02404805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6225446|NCT02404805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6225447|NCT02404805|Antiviral Agents|antiviral agents|mesh-ancestor
6225448|NCT02404805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6225449|NCT02404805|Protease Inhibitors|protease inhibitors|mesh-ancestor
6225450|NCT02405780|Adalimumab|adalimumab|mesh-list
6225451|NCT02405780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6225452|NCT02405780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6225453|NCT02406248|Ticagrelor|ticagrelor|mesh-list
6225454|NCT02406248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6225455|NCT02406248|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6225456|NCT02406248|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6225457|NCT02406248|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6225458|NCT02406248|Purinergic Agents|purinergic agents|mesh-ancestor
6225459|NCT02406248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6225460|NCT02406248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225461|NCT02406248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225462|NCT02406261|Midazolam|midazolam|mesh-list
6225463|NCT02406261|Donepezil|donepezil|mesh-list
6225464|NCT02406261|Simvastatin|simvastatin|mesh-list
6225465|NCT02406261|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6225466|NCT02406261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6225467|NCT02406261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6225468|NCT02406261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225469|NCT02406261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6225470|NCT02406261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6225471|NCT02406261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6225472|NCT02406261|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6225473|NCT02406261|Anesthetics, General|anesthetics, general|mesh-ancestor
6225474|NCT02406261|Anesthetics|anesthetics|mesh-ancestor
6225475|NCT02406261|GABA Modulators|gaba modulators|mesh-ancestor
6225476|NCT02406261|GABA Agents|gaba agents|mesh-ancestor
6225477|NCT02406261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6225478|NCT02406261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225479|NCT02406261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6225480|NCT02406261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6225481|NCT02406261|Antimetabolites|antimetabolites|mesh-ancestor
6225482|NCT02406261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6225483|NCT02406261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6225484|NCT02406261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6225485|NCT02406261|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6225486|NCT02406261|Cholinergic Agents|cholinergic agents|mesh-ancestor
6225487|NCT02406261|Nootropic Agents|nootropic agents|mesh-ancestor
6225488|NCT02406443|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6225489|NCT02406443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6225490|NCT02406443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225491|NCT02406443|Incretins|incretins|mesh-ancestor
6225492|NCT02406443|Hormones|hormones|mesh-ancestor
6225493|NCT02406443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6225494|NCT02406443|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6225495|NCT02406443|Protease Inhibitors|protease inhibitors|mesh-ancestor
6225496|NCT02406443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6225497|NCT02406443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225498|NCT02406586|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
6225499|NCT02406586|Carvedilol|carvedilol|mesh-list
6225500|NCT02406586|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6225501|NCT02406586|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6225502|NCT02406586|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6225503|NCT02406586|Adrenergic Agents|adrenergic agents|mesh-ancestor
6225504|NCT02406586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6225505|NCT02406586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225506|NCT02406586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225507|NCT02406586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6225508|NCT02406586|Antioxidants|antioxidants|mesh-ancestor
6225509|NCT02406586|Protective Agents|protective agents|mesh-ancestor
6225510|NCT02406586|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6225511|NCT02406586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6225512|NCT02406586|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6225513|NCT02406586|Vasodilator Agents|vasodilator agents|mesh-ancestor
6225514|NCT02406586|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6225515|NCT02406586|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6225516|NCT02406586|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6499857|NCT00642577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499858|NCT00642577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6499859|NCT00642577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6499860|NCT00642577|Immunologic Factors|immunologic factors|mesh-ancestor
6499861|NCT00642577|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6499862|NCT00642577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6499863|NCT00642577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6499864|NCT00642577|Antidotes|antidotes|mesh-ancestor
6499865|NCT00642577|Protective Agents|protective agents|mesh-ancestor
5705015|NCT03321110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705016|NCT03321110|Vitamins|vitamins|mesh-ancestor
5705017|NCT03320967|Arginine Vasopressin|arginine vasopressin|mesh-list
5705018|NCT03320967|Hemostatics|hemostatics|mesh-ancestor
5705019|NCT03320967|Coagulants|coagulants|mesh-ancestor
5705020|NCT03320967|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5705021|NCT03320967|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5705022|NCT03320967|Natriuretic Agents|natriuretic agents|mesh-ancestor
5705023|NCT03320967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705024|NCT03320928|Methotrexate|methotrexate|mesh-list
5705025|NCT03320928|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5705026|NCT03320928|Abortifacient Agents|abortifacient agents|mesh-ancestor
5705027|NCT03320928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5705028|NCT03320928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705029|NCT03320928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5705030|NCT03320928|Antimetabolites|antimetabolites|mesh-ancestor
5705031|NCT03320928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705032|NCT03320928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5705033|NCT03320928|Dermatologic Agents|dermatologic agents|mesh-ancestor
5705034|NCT03320928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5705035|NCT03320928|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5705036|NCT03320928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5705037|NCT03320928|Immunologic Factors|immunologic factors|mesh-ancestor
5705038|NCT03320928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5705039|NCT03320928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5705040|NCT03320915|Cholecalciferol|cholecalciferol|mesh-list
5705041|NCT03320915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5705042|NCT03320915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705043|NCT03320915|Vitamins|vitamins|mesh-ancestor
5705044|NCT03320915|Micronutrients|micronutrients|mesh-ancestor
5705045|NCT03320915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5705046|NCT03320707|Daratumumab|daratumumab|mesh-list
5705047|NCT03320707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5705048|NCT03320694|Insulin|insulin|mesh-list
5705049|NCT03320694|Metformin|metformin|mesh-list
5705050|NCT03320694|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5705051|NCT03320694|Isophane Insulin, Human|isophane insulin, human|mesh-list
5705052|NCT03320694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6499866|NCT00642577|Vitamin B Complex|vitamin b complex|mesh-ancestor
6499867|NCT00642577|Vitamins|vitamins|mesh-ancestor
6499868|NCT00642577|Micronutrients|micronutrients|mesh-ancestor
6225517|NCT02406586|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6225518|NCT02406586|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6225519|NCT02406586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6225520|NCT02406586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6225521|NCT02406586|Analgesics|analgesics|mesh-ancestor
6225522|NCT02406586|Sensory System Agents|sensory system agents|mesh-ancestor
6225523|NCT02406586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5705053|NCT03320694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705054|NCT03320642|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
6225524|NCT02406586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6225525|NCT02406586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6225526|NCT02406742|Obinutuzumab|obinutuzumab|mesh-list
6225527|NCT02406742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6225528|NCT02406742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5705055|NCT03320642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5705056|NCT03320642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705057|NCT03320629|Apatinib|apatinib|mesh-list
5705058|NCT03320629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5705059|NCT03320629|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6225529|NCT02406885|Apixaban|apixaban|mesh-list
6225530|NCT02406885|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6225531|NCT02406885|Antithrombins|antithrombins|mesh-ancestor
6225532|NCT02406885|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6225533|NCT02406885|Protease Inhibitors|protease inhibitors|mesh-ancestor
6225534|NCT02406885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6225535|NCT02406885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225536|NCT02406885|Anticoagulants|anticoagulants|mesh-ancestor
6225537|NCT02407223|Ustekinumab|ustekinumab|mesh-list
6225538|NCT02407223|Dermatologic Agents|dermatologic agents|mesh-ancestor
6225539|NCT02407704|Lorazepam|lorazepam|mesh-list
6225540|NCT02407704|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6225541|NCT02407704|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6225542|NCT02407704|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6225543|NCT02407704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6225544|NCT02407704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225545|NCT02407704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6225546|NCT02407704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225547|NCT02407704|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6225548|NCT02407704|Antidepressive Agents|antidepressive agents|mesh-ancestor
6225549|NCT02407704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6225550|NCT02407704|Anticonvulsants|anticonvulsants|mesh-ancestor
6225551|NCT02407704|Antiemetics|antiemetics|mesh-ancestor
6225552|NCT02407704|Autonomic Agents|autonomic agents|mesh-ancestor
6225553|NCT02407704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5705060|NCT03320629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5705061|NCT03320629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705062|NCT03320603|Thrombin|thrombin|mesh-list
5705063|NCT03320603|Hemostatics|hemostatics|mesh-ancestor
6225554|NCT02407704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6225555|NCT02407704|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6225556|NCT02407704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6225557|NCT02407704|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6225558|NCT02407704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6225559|NCT02407704|GABA Modulators|gaba modulators|mesh-ancestor
6225560|NCT02407704|GABA Agents|gaba agents|mesh-ancestor
6225561|NCT02408016|Aldesleukin|aldesleukin|mesh-list
6225562|NCT02408016|Cyclophosphamide|cyclophosphamide|mesh-list
6225563|NCT02408016|Interleukin-2|interleukin-2|mesh-list
6225564|NCT02408016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6225565|NCT02408016|Immunologic Factors|immunologic factors|mesh-ancestor
6225566|NCT02408016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225567|NCT02408016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6225568|NCT02408016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6225569|NCT02408016|Alkylating Agents|alkylating agents|mesh-ancestor
6225570|NCT02408016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225571|NCT02408016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6225572|NCT02408016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6225573|NCT02408016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6225574|NCT02408016|Analgesics|analgesics|mesh-ancestor
6225575|NCT02408016|Sensory System Agents|sensory system agents|mesh-ancestor
6225576|NCT02408016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6225577|NCT02408016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6225578|NCT02408016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6225579|NCT02408016|Antiviral Agents|antiviral agents|mesh-ancestor
6225580|NCT02408016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6225581|NCT02408068|Dexamethasone|dexamethasone|mesh-list
6225582|NCT02408068|Hydrocortisone|hydrocortisone|mesh-list
5705064|NCT03320603|Coagulants|coagulants|mesh-ancestor
5705065|NCT03320538|Rabeprazole|rabeprazole|mesh-list
5705066|NCT03320538|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5705067|NCT03320538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6225583|NCT02408068|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
5705068|NCT03320538|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6225584|NCT02408068|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
5705069|NCT03320538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6225585|NCT02408068|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6225586|NCT02408068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6225587|NCT02408068|Antiemetics|antiemetics|mesh-ancestor
6225588|NCT02408068|Autonomic Agents|autonomic agents|mesh-ancestor
6225589|NCT02408068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6225590|NCT02408068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225591|NCT02408068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6225592|NCT02408068|Glucocorticoids|glucocorticoids|mesh-ancestor
6225593|NCT02408068|Hormones|hormones|mesh-ancestor
6225594|NCT02408068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6225595|NCT02408068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6225596|NCT02408068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6225597|NCT02408120|Insulin|insulin|mesh-list
6225598|NCT02408120|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6225599|NCT02408120|Insulin Glargine|insulin glargine|mesh-list
5705070|NCT03320538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705071|NCT03320486|Ketoconazole|ketoconazole|mesh-list
5705072|NCT03320486|Antifungal Agents|antifungal agents|mesh-ancestor
5705073|NCT03320486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5705074|NCT03320486|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5705075|NCT03320486|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5705076|NCT03320486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5705077|NCT03320486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705078|NCT03320486|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5705079|NCT03320486|Hormone Antagonists|hormone antagonists|mesh-ancestor
5705080|NCT03320486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5705081|NCT03320486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705082|NCT03320486|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5705083|NCT03320460|Clobetasol|clobetasol|mesh-list
5705084|NCT03320460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5705085|NCT03320460|Glucocorticoids|glucocorticoids|mesh-ancestor
5964072|NCT04595591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6225600|NCT02408120|Insulin Aspart|insulin aspart|mesh-list
6225601|NCT02408120|Insulin, Long-Acting|insulin, long-acting|mesh-list
6225602|NCT02408120|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6225603|NCT02408120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6225604|NCT02408120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225605|NCT02408315|Misoprostol|misoprostol|mesh-list
6225606|NCT02408315|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6225607|NCT02408315|Abortifacient Agents|abortifacient agents|mesh-ancestor
6225608|NCT02408315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6225609|NCT02408315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225610|NCT02408315|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6225611|NCT02408315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6225612|NCT02408315|Oxytocics|oxytocics|mesh-ancestor
6225613|NCT02408445|Methyltestosterone|methyltestosterone|mesh-list
6225614|NCT02408445|Testosterone|testosterone|mesh-list
6225615|NCT02408445|Testosterone undecanoate|testosterone undecanoate|mesh-list
6225616|NCT02408445|Testosterone enanthate|testosterone enanthate|mesh-list
6225617|NCT02408445|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6225618|NCT02408445|Androgens|androgens|mesh-ancestor
6225619|NCT02408445|Hormones|hormones|mesh-ancestor
6225620|NCT02408445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6225621|NCT02408445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225622|NCT02408445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6225623|NCT02408445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6225624|NCT02408445|Anabolic Agents|anabolic agents|mesh-ancestor
6225625|NCT02408523|Lacosamide|lacosamide|mesh-list
6225626|NCT02408523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6225627|NCT02408523|Anticonvulsants|anticonvulsants|mesh-ancestor
6225628|NCT02408523|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6225629|NCT02408523|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6225630|NCT02408523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6225631|NCT02408523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225632|NCT02408965|Methylergonovine|methylergonovine|mesh-list
6225633|NCT02408965|Oxytocics|oxytocics|mesh-ancestor
6225634|NCT02408965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6225635|NCT02408965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225636|NCT02409680|Aspirin|aspirin|mesh-list
6225637|NCT02409680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6225638|NCT02409680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6225639|NCT02409680|Analgesics|analgesics|mesh-ancestor
6225640|NCT02409680|Sensory System Agents|sensory system agents|mesh-ancestor
6243522|NCT02670343|Testosterone|testosterone|mesh-list
5918717|NCT04989218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918718|NCT04989218|Antiviral Agents|antiviral agents|mesh-ancestor
5918719|NCT04989218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5918720|NCT04989218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6225641|NCT02409680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6225642|NCT02409680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225643|NCT02409680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6225644|NCT02409680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6225645|NCT02409680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6225646|NCT02409680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6225647|NCT02409680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225648|NCT02409680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6225649|NCT02409680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6225650|NCT02409680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6225651|NCT02409680|Antipyretics|antipyretics|mesh-ancestor
6225652|NCT02409732|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6225653|NCT02409732|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6225654|NCT02409732|Dermatologic Agents|dermatologic agents|mesh-ancestor
6225655|NCT02410200|Dimethyl Fumarate|dimethyl fumarate|mesh-list
6225656|NCT02410200|Dermatologic Agents|dermatologic agents|mesh-ancestor
6225657|NCT02410200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6225658|NCT02410200|Immunologic Factors|immunologic factors|mesh-ancestor
6225659|NCT02410200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225660|NCT02410278|Dimethyl Fumarate|dimethyl fumarate|mesh-list
6225661|NCT02410278|Montelukast|montelukast|mesh-list
5705086|NCT03320460|Hormones|hormones|mesh-ancestor
5705087|NCT03320460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5705088|NCT03320460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705089|NCT03320447|Lidocaine|lidocaine|mesh-list
5705090|NCT03320447|Prilocaine|prilocaine|mesh-list
5705091|NCT03320447|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
5705092|NCT03320447|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5705093|NCT03320447|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
5705094|NCT03320447|Anesthetics, Local|anesthetics, local|mesh-ancestor
5705095|NCT03320447|Anesthetics|anesthetics|mesh-ancestor
5705096|NCT03320447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5705097|NCT03320447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705098|NCT03320447|Sensory System Agents|sensory system agents|mesh-ancestor
5705099|NCT03320447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6225662|NCT02410278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6225663|NCT02410278|Respiratory System Agents|respiratory system agents|mesh-ancestor
6225664|NCT02410278|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6225665|NCT02410278|Hormone Antagonists|hormone antagonists|mesh-ancestor
6225666|NCT02410278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6225667|NCT02410278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225668|NCT02410278|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6225669|NCT02410278|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6225670|NCT02410278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225671|NCT02410278|Dermatologic Agents|dermatologic agents|mesh-ancestor
6225672|NCT02410278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6225673|NCT02410278|Immunologic Factors|immunologic factors|mesh-ancestor
6225674|NCT02410382|Dexamethasone|dexamethasone|mesh-list
6225675|NCT02410382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6225676|NCT02410382|Antiemetics|antiemetics|mesh-ancestor
6225677|NCT02410382|Autonomic Agents|autonomic agents|mesh-ancestor
6225678|NCT02410382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6225679|NCT02410382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705100|NCT03320447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5705101|NCT03320447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5705102|NCT03320447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5705103|NCT03320447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5705104|NCT03320447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705105|NCT03320447|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5705106|NCT03320447|Dermatologic Agents|dermatologic agents|mesh-ancestor
5705107|NCT03320447|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
5705108|NCT03320187|Nitroglycerin|nitroglycerin|mesh-list
5705109|NCT03320187|Dinoprostone|dinoprostone|mesh-list
5705110|NCT03320187|Vasodilator Agents|vasodilator agents|mesh-ancestor
5705111|NCT03320187|Oxytocics|oxytocics|mesh-ancestor
5705112|NCT03320187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5705113|NCT03320187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705114|NCT03320174|Tafenoquine|tafenoquine|mesh-list
6225680|NCT02410382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5705115|NCT03320174|Antimalarials|antimalarials|mesh-ancestor
6225681|NCT02410382|Glucocorticoids|glucocorticoids|mesh-ancestor
6225682|NCT02410382|Hormones|hormones|mesh-ancestor
6225683|NCT02410382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6225684|NCT02410382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6225685|NCT02410382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6225686|NCT02410707|Nitrous Oxide|nitrous oxide|mesh-list
6225687|NCT02410707|Propofol|propofol|mesh-list
6225688|NCT02410707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6225689|NCT02410707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6225690|NCT02410707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225691|NCT02410707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6225692|NCT02410707|Anesthetics, General|anesthetics, general|mesh-ancestor
6225693|NCT02410707|Anesthetics|anesthetics|mesh-ancestor
6225694|NCT02410707|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6225695|NCT02410707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6225696|NCT02410707|Analgesics|analgesics|mesh-ancestor
6225697|NCT02410707|Sensory System Agents|sensory system agents|mesh-ancestor
5705116|NCT03320174|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5705117|NCT03320174|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5705118|NCT03320174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5705119|NCT03320109|Vitamin D|vitamin d|mesh-list
5705120|NCT03320109|Ergocalciferols|ergocalciferols|mesh-list
6225698|NCT02410707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6225699|NCT02410772|Moxifloxacin|moxifloxacin|mesh-list
6225700|NCT02410772|Rifapentine|rifapentine|mesh-list
6225701|NCT02410772|Rifampin|rifampin|mesh-list
6225702|NCT02410772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5705121|NCT03320109|Vitamins|vitamins|mesh-list
5705122|NCT03320109|Micronutrients|micronutrients|mesh-ancestor
5705123|NCT03320109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705124|NCT03320109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5705125|NCT03320109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5721218|NCT03207451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5721219|NCT03207451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5721220|NCT03207451|Purinergic Agents|purinergic agents|mesh-ancestor
5721221|NCT03207451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5721222|NCT03207334|Cytarabine|cytarabine|mesh-list
5721223|NCT03207334|Midostaurin|midostaurin|mesh-list
5721224|NCT03207334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6676434|NCT01581359|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5918721|NCT04989218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5918722|NCT04989218|Immunologic Factors|immunologic factors|mesh-ancestor
5918723|NCT04989218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918724|NCT04989218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5918725|NCT04988945|Durvalumab|durvalumab|mesh-list
5918726|NCT04988945|Tremelimumab|tremelimumab|mesh-list
6225703|NCT02410772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6225704|NCT02410772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6225705|NCT02410772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6225706|NCT02410772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6225707|NCT02410772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225708|NCT02410772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6225709|NCT02410772|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6225710|NCT02410772|Antitubercular Agents|antitubercular agents|mesh-ancestor
6225711|NCT02410772|Leprostatic Agents|leprostatic agents|mesh-ancestor
6225712|NCT02410772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6225713|NCT02410772|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6225714|NCT02410772|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6225715|NCT02410772|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6225716|NCT02410772|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6225717|NCT02410772|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6225718|NCT02410772|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6225719|NCT02411201|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
6225720|NCT02411201|Chelating Agents|chelating agents|mesh-ancestor
6225721|NCT02411201|Sequestering Agents|sequestering agents|mesh-ancestor
6499869|NCT00642655|Rituximab|rituximab|mesh-list
5721225|NCT03207334|Antimetabolites|antimetabolites|mesh-ancestor
5721226|NCT03207334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721227|NCT03207334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6499870|NCT00642655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6499871|NCT00642655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5721228|NCT03207334|Antiviral Agents|antiviral agents|mesh-ancestor
6499872|NCT00642655|Immunologic Factors|immunologic factors|mesh-ancestor
6499873|NCT00642655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499874|NCT00642655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6499875|NCT00642681|Insulin|insulin|mesh-list
6499876|NCT00642681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6499877|NCT00642681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225722|NCT02411201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225723|NCT02411292|Enoxaparin|enoxaparin|mesh-list
6225724|NCT02411292|Anticoagulants|anticoagulants|mesh-ancestor
6225725|NCT02411292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6225726|NCT02411292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6225727|NCT02411292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225728|NCT02411448|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6225729|NCT02411448|Gefitinib|gefitinib|mesh-list
6225730|NCT02411448|Osimertinib|osimertinib|mesh-list
6225731|NCT02411448|Ramucirumab|ramucirumab|mesh-list
6225732|NCT02411448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6225733|NCT02411448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6225734|NCT02411448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6225735|NCT02411448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225736|NCT02411578|Glucagon|glucagon|mesh-list
6225737|NCT02411578|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6225738|NCT02411578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6225739|NCT02411578|Hormones|hormones|mesh-ancestor
6225740|NCT02411578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6225741|NCT02411578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225742|NCT02411578|Incretins|incretins|mesh-ancestor
6225743|NCT02411591|Necitumumab|necitumumab|mesh-list
6225744|NCT02411591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6225745|NCT02411591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6225746|NCT02411916|Misoprostol|misoprostol|mesh-list
6225747|NCT02411916|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6225748|NCT02411916|Abortifacient Agents|abortifacient agents|mesh-ancestor
6225749|NCT02411916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6225750|NCT02411916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225751|NCT02411916|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6225752|NCT02411916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6225753|NCT02411916|Oxytocics|oxytocics|mesh-ancestor
6225754|NCT02411929|Ertugliflozin|ertugliflozin|mesh-list
6225755|NCT02411929|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6225756|NCT02411929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705126|NCT03320031|Insulin Lispro|insulin lispro|mesh-list
5705127|NCT03320031|Linagliptin|linagliptin|mesh-list
5705128|NCT03320031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5705129|NCT03320031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705130|NCT03320031|Incretins|incretins|mesh-ancestor
5705131|NCT03320031|Hormones|hormones|mesh-ancestor
5705132|NCT03320031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5705133|NCT03320031|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5705134|NCT03320031|Protease Inhibitors|protease inhibitors|mesh-ancestor
5705135|NCT03320031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5705136|NCT03320031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705137|NCT03319901|Venetoclax|venetoclax|mesh-list
5705138|NCT03319901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5705139|NCT03319823|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
5705140|NCT03319823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5705141|NCT03319823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705142|NCT03319823|Diuretics|diuretics|mesh-ancestor
5705143|NCT03319823|Natriuretic Agents|natriuretic agents|mesh-ancestor
5705144|NCT03319823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705145|NCT03319784|Triamcinolone|triamcinolone|mesh-list
5705146|NCT03319784|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5705147|NCT03319784|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5705148|NCT03319784|Ketorolac|ketorolac|mesh-list
6225757|NCT02411929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6225758|NCT02411929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225759|NCT02412111|Ivacaftor|ivacaftor|mesh-list
6225760|NCT02412111|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6225761|NCT02412111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6225762|NCT02412111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225763|NCT02412228|Dexamethasone|dexamethasone|mesh-list
6225764|NCT02412228|Cyclophosphamide|cyclophosphamide|mesh-list
6225765|NCT02412228|Ixazomib|ixazomib|mesh-list
5705149|NCT03319784|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5705150|NCT03319784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6225766|NCT02412228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5705151|NCT03319784|Glucocorticoids|glucocorticoids|mesh-ancestor
5705152|NCT03319784|Hormones|hormones|mesh-ancestor
6225767|NCT02412228|Immunologic Factors|immunologic factors|mesh-ancestor
5705153|NCT03319784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5705154|NCT03319784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705155|NCT03319784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6225768|NCT02412228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225769|NCT02412228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6225770|NCT02412228|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6225771|NCT02412228|Alkylating Agents|alkylating agents|mesh-ancestor
6225772|NCT02412228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225773|NCT02412228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6225774|NCT02412228|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6499878|NCT00642733|Gemcitabine|gemcitabine|mesh-list
6499879|NCT00642733|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6499880|NCT00642733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6499881|NCT00642733|Antimetabolites|antimetabolites|mesh-ancestor
6499882|NCT00642733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499883|NCT00642733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6499884|NCT00642733|Antiviral Agents|antiviral agents|mesh-ancestor
6499885|NCT00642733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6499886|NCT00642733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5705156|NCT03319784|Immunologic Factors|immunologic factors|mesh-ancestor
5705157|NCT03319784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5705158|NCT03319784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705159|NCT03319784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6499887|NCT00642733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6499888|NCT00642733|Immunologic Factors|immunologic factors|mesh-ancestor
6499889|NCT00642733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499890|NCT00642733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6499891|NCT00642798|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6499892|NCT00642798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6499893|NCT00642798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499894|NCT00642798|Incretins|incretins|mesh-ancestor
6499895|NCT00642798|Hormones|hormones|mesh-ancestor
6499896|NCT00642798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6499897|NCT00642798|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6499898|NCT00642798|Protease Inhibitors|protease inhibitors|mesh-ancestor
6499899|NCT00642798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5705160|NCT03319784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5705161|NCT03319784|Analgesics|analgesics|mesh-ancestor
5705162|NCT03319784|Sensory System Agents|sensory system agents|mesh-ancestor
5705163|NCT03319784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5705164|NCT03319784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5705165|NCT03319784|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5705166|NCT03319745|Pembrolizumab|pembrolizumab|mesh-list
5705167|NCT03319745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5705168|NCT03319745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5705169|NCT03319706|Olmesartan|olmesartan|mesh-list
5705170|NCT03319706|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
5705171|NCT03319706|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6499900|NCT00642798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499901|NCT00642824|Bevacizumab|bevacizumab|mesh-list
6499902|NCT00642824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6499903|NCT00642824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6499904|NCT00642824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6499905|NCT00642824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6499906|NCT00642824|Growth Substances|growth substances|mesh-ancestor
6499907|NCT00642824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676435|NCT01581359|Luteolytic Agents|luteolytic agents|mesh-ancestor
6676436|NCT01581359|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6676437|NCT01581359|Contraceptive Agents|contraceptive agents|mesh-ancestor
6676438|NCT01581359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6676439|NCT01581359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676440|NCT01581359|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6676441|NCT01581359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6676442|NCT01581359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6676443|NCT01581398|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6676444|NCT01581398|Interferon-alpha|interferon-alpha|mesh-list
6676445|NCT01581398|Antiviral Agents|antiviral agents|mesh-ancestor
6676446|NCT01581398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6676447|NCT01581398|Immunologic Factors|immunologic factors|mesh-ancestor
6676448|NCT01581398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676449|NCT01581411|Plasminogen|plasminogen|mesh-list
6676450|NCT01581411|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6676451|NCT01581411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5705172|NCT03319706|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5705173|NCT03319706|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5705174|NCT03319706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705175|NCT03319680|Dialysis Solutions|dialysis solutions|mesh-list
5705176|NCT03319680|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5705177|NCT03319563|Epinephrine|epinephrine|mesh-list
6225775|NCT02412228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6225776|NCT02412228|Antiemetics|antiemetics|mesh-ancestor
6225777|NCT02412228|Autonomic Agents|autonomic agents|mesh-ancestor
6225778|NCT02412228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6225779|NCT02412228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6225780|NCT02412228|Glucocorticoids|glucocorticoids|mesh-ancestor
6225781|NCT02412228|Hormones|hormones|mesh-ancestor
6225782|NCT02412228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6225783|NCT02412228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6225784|NCT02412228|Protease Inhibitors|protease inhibitors|mesh-ancestor
6225785|NCT02412228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6225786|NCT02412306|Blinatumomab|blinatumomab|mesh-list
6225787|NCT02412306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6225788|NCT02412371|Paclitaxel|paclitaxel|mesh-list
6225789|NCT02412371|Carboplatin|carboplatin|mesh-list
6225790|NCT02412371|Veliparib|veliparib|mesh-list
6225791|NCT02412371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6225792|NCT02412371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6225793|NCT02412371|Tubulin Modulators|tubulin modulators|mesh-ancestor
5705178|NCT03319563|Anesthetics|anesthetics|mesh-list
5705179|NCT03319563|Anesthetics, Local|anesthetics, local|mesh-list
5705180|NCT03319563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5705181|NCT03319563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5705182|NCT03319563|Adrenergic Agents|adrenergic agents|mesh-ancestor
5705183|NCT03319563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5705184|NCT03319563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705185|NCT03319563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705186|NCT03319563|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5705187|NCT03319563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5705188|NCT03319563|Autonomic Agents|autonomic agents|mesh-ancestor
5705189|NCT03319563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5705190|NCT03319563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5705191|NCT03319563|Respiratory System Agents|respiratory system agents|mesh-ancestor
5705192|NCT03319563|Mydriatics|mydriatics|mesh-ancestor
5705193|NCT03319563|Sympathomimetics|sympathomimetics|mesh-ancestor
5705194|NCT03319563|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5705195|NCT03319563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5705196|NCT03319563|Sensory System Agents|sensory system agents|mesh-ancestor
5705197|NCT03319550|Caseins|caseins|mesh-list
5705198|NCT03319550|Chelating Agents|chelating agents|mesh-ancestor
5705199|NCT03319550|Sequestering Agents|sequestering agents|mesh-ancestor
5705200|NCT03319550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705201|NCT03319537|Pemetrexed|pemetrexed|mesh-list
6225794|NCT02412371|Antimitotic Agents|antimitotic agents|mesh-ancestor
6225795|NCT02412371|Mitosis Modulators|mitosis modulators|mesh-ancestor
6225796|NCT02412371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225797|NCT02412371|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5918727|NCT04988945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5918728|NCT04988945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5918729|NCT04989270|Anesthetics|anesthetics|mesh-list
5918730|NCT04989270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5918731|NCT04989270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918732|NCT04989257|Clopidogrel|clopidogrel|mesh-list
5918733|NCT04989257|Ticagrelor|ticagrelor|mesh-list
5918734|NCT04989257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5918735|NCT04989257|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6225798|NCT02412371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6225799|NCT02412436|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
5705202|NCT03319537|Pevonedistat|pevonedistat|mesh-list
5705203|NCT03319537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5705204|NCT03319537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5705205|NCT03319537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705206|NCT03319537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5705207|NCT03319537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5705208|NCT03319498|Peppermint oil|peppermint oil|mesh-list
5705209|NCT03319498|Mineral Oil|mineral oil|mesh-list
5705210|NCT03319498|Antiemetics|antiemetics|mesh-ancestor
5705211|NCT03319498|Autonomic Agents|autonomic agents|mesh-ancestor
5705212|NCT03319498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5705213|NCT03319498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705214|NCT03319498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5705215|NCT03319498|Parasympatholytics|parasympatholytics|mesh-ancestor
5705216|NCT03319498|Emollients|emollients|mesh-ancestor
5705217|NCT03319498|Dermatologic Agents|dermatologic agents|mesh-ancestor
5705218|NCT03319420|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5705219|NCT03319420|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5705220|NCT03319238|Ketamine|ketamine|mesh-list
5705221|NCT03319238|Analgesics|analgesics|mesh-ancestor
5705222|NCT03319238|Sensory System Agents|sensory system agents|mesh-ancestor
5705223|NCT03319238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5705224|NCT03319238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705225|NCT03319238|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5705226|NCT03319238|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5705227|NCT03319238|Anesthetics, General|anesthetics, general|mesh-ancestor
5705228|NCT03319238|Anesthetics|anesthetics|mesh-ancestor
5705229|NCT03319238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5705230|NCT03319238|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5705231|NCT03319238|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5705232|NCT03319238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5705233|NCT03319238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705234|NCT03319121|Theophylline|theophylline|mesh-list
5705235|NCT03319121|Dexlansoprazole|dexlansoprazole|mesh-list
5705236|NCT03319121|Lansoprazole|lansoprazole|mesh-list
5705237|NCT03319121|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6225800|NCT02412436|Medroxyprogesterone|medroxyprogesterone|mesh-list
6225801|NCT02412436|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6225802|NCT02412436|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5705238|NCT03319121|Autonomic Agents|autonomic agents|mesh-ancestor
5705239|NCT03319121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5705240|NCT03319121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705241|NCT03319121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5705242|NCT03319121|Respiratory System Agents|respiratory system agents|mesh-ancestor
5705243|NCT03319121|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5705244|NCT03319121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5705245|NCT03319121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705246|NCT03319121|Vasodilator Agents|vasodilator agents|mesh-ancestor
5705247|NCT03319121|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5705248|NCT03319121|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5705249|NCT03319121|Purinergic Agents|purinergic agents|mesh-ancestor
5705250|NCT03319121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5705251|NCT03319121|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5705252|NCT03319121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5705253|NCT03319121|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5705254|NCT03319043|Budesonide|budesonide|mesh-list
5705255|NCT03319043|Formoterol Fumarate|formoterol fumarate|mesh-list
5705256|NCT03319043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5705257|NCT03319043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5705258|NCT03319043|Autonomic Agents|autonomic agents|mesh-ancestor
5705259|NCT03319043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5705260|NCT03319043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705261|NCT03319043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5705262|NCT03319043|Respiratory System Agents|respiratory system agents|mesh-ancestor
5705263|NCT03319043|Glucocorticoids|glucocorticoids|mesh-ancestor
5705264|NCT03319043|Hormones|hormones|mesh-ancestor
5705265|NCT03319043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5705266|NCT03319043|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5705267|NCT03319043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5705268|NCT03319043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5705269|NCT03319043|Adrenergic Agents|adrenergic agents|mesh-ancestor
5705270|NCT03319043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5705271|NCT03319043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225803|NCT02412436|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6225804|NCT02412436|Contraceptive Agents|contraceptive agents|mesh-ancestor
6225805|NCT02412436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6225806|NCT02412436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225807|NCT02412436|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6225808|NCT02412436|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6225809|NCT02412436|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6225810|NCT02412436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6225811|NCT02412436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6225812|NCT02412631|Varenicline|varenicline|mesh-list
6225813|NCT02412631|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5705272|NCT03318887|Ribavirin|ribavirin|mesh-list
6225814|NCT02412631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6225815|NCT02412631|Cholinergic Agents|cholinergic agents|mesh-ancestor
6225816|NCT02412631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6225817|NCT02412631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225818|NCT02412631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243523|NCT02670343|Testosterone undecanoate|testosterone undecanoate|mesh-list
6243524|NCT02670343|Testosterone enanthate|testosterone enanthate|mesh-list
6243525|NCT02670343|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6243526|NCT02670343|Androgens|androgens|mesh-ancestor
6243527|NCT02670343|Hormones|hormones|mesh-ancestor
6243528|NCT02670343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6243529|NCT02670343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243530|NCT02670343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6243531|NCT02670343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6243532|NCT02670343|Anabolic Agents|anabolic agents|mesh-ancestor
6243533|NCT02670538|Cariprazine|cariprazine|mesh-list
6243534|NCT02670538|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6243535|NCT02670538|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6243536|NCT02670538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6243537|NCT02670538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243538|NCT02670538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6243539|NCT02670551|Cariprazine|cariprazine|mesh-list
6243540|NCT02670551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6243541|NCT02670551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6243542|NCT02670551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6243543|NCT02670551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243544|NCT02670551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5705273|NCT03318887|Sofosbuvir|sofosbuvir|mesh-list
5705274|NCT03318887|Antimetabolites|antimetabolites|mesh-ancestor
5705275|NCT03318887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243545|NCT02670915|Insulin|insulin|mesh-list
6243546|NCT02670915|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6243547|NCT02670915|Insulin Aspart|insulin aspart|mesh-list
6243548|NCT02670915|Insulin, Long-Acting|insulin, long-acting|mesh-list
6243549|NCT02670915|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6243550|NCT02670915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6243551|NCT02670915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243552|NCT02671266|Oxytocin|oxytocin|mesh-list
6243553|NCT02671266|Oxytocics|oxytocics|mesh-ancestor
6243554|NCT02671266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6243555|NCT02671266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243556|NCT02671500|Sofosbuvir|sofosbuvir|mesh-list
6243557|NCT02671500|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
6243558|NCT02671500|Velpatasvir|velpatasvir|mesh-list
6243559|NCT02671500|Antiviral Agents|antiviral agents|mesh-ancestor
6243560|NCT02671500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6243561|NCT02672111|Buprenorphine|buprenorphine|mesh-list
6243562|NCT02672111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6243563|NCT02672111|Narcotics|narcotics|mesh-ancestor
6243564|NCT02672111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6243565|NCT02672111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243566|NCT02672111|Analgesics|analgesics|mesh-ancestor
6243567|NCT02672111|Sensory System Agents|sensory system agents|mesh-ancestor
5705276|NCT03318887|Antiviral Agents|antiviral agents|mesh-ancestor
5705277|NCT03318887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5705278|NCT03318835|Thalidomide|thalidomide|mesh-list
5705279|NCT03318835|Prednisone|prednisone|mesh-list
5705280|NCT03318835|Cyclophosphamide|cyclophosphamide|mesh-list
5705281|NCT03318835|Vincristine|vincristine|mesh-list
5705282|NCT03318835|Rituximab|rituximab|mesh-list
5705283|NCT03318835|Doxorubicin|doxorubicin|mesh-list
6243568|NCT02672111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6243569|NCT02672111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6243570|NCT02673138|Canagliflozin|canagliflozin|mesh-list
6243571|NCT02673138|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6243572|NCT02673138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243573|NCT02673138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6243574|NCT02673138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243575|NCT02673333|Pembrolizumab|pembrolizumab|mesh-list
6243576|NCT02673333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6243577|NCT02673333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6243578|NCT02673372|Morphine|morphine|mesh-list
6243579|NCT02673372|Ketamine|ketamine|mesh-list
6243580|NCT02673372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6243581|NCT02673372|Narcotics|narcotics|mesh-ancestor
5705284|NCT03318835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5705285|NCT03318835|Immunologic Factors|immunologic factors|mesh-ancestor
6499908|NCT00642824|Growth Inhibitors|growth inhibitors|mesh-ancestor
5705286|NCT03318835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705287|NCT03318835|Leprostatic Agents|leprostatic agents|mesh-ancestor
5705288|NCT03318835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5705289|NCT03318835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5705290|NCT03318835|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6225819|NCT02412644|Apremilast|apremilast|mesh-list
6225820|NCT02412644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6225821|NCT02412644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6225822|NCT02412644|Analgesics|analgesics|mesh-ancestor
6225823|NCT02412644|Sensory System Agents|sensory system agents|mesh-ancestor
6225824|NCT02412644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6225825|NCT02412644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225826|NCT02412644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6225827|NCT02412644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6225828|NCT02412644|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6225829|NCT02412644|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6225830|NCT02412644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6225831|NCT02412644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225832|NCT02412657|Dexamethasone|dexamethasone|mesh-list
6225833|NCT02412657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6225834|NCT02412657|Antiemetics|antiemetics|mesh-ancestor
6225835|NCT02412657|Autonomic Agents|autonomic agents|mesh-ancestor
6225836|NCT02412657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6225837|NCT02412657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225838|NCT02412657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6225839|NCT02412657|Glucocorticoids|glucocorticoids|mesh-ancestor
6225840|NCT02412657|Hormones|hormones|mesh-ancestor
6225841|NCT02412657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6225842|NCT02412657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6225843|NCT02412657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6225844|NCT02412722|Paclitaxel|paclitaxel|mesh-list
6225845|NCT02412722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6225846|NCT02412722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6225847|NCT02412722|Tubulin Modulators|tubulin modulators|mesh-ancestor
6225848|NCT02412722|Antimitotic Agents|antimitotic agents|mesh-ancestor
6225849|NCT02412722|Mitosis Modulators|mitosis modulators|mesh-ancestor
6225850|NCT02412722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225851|NCT02412761|Amlodipine|amlodipine|mesh-list
6225852|NCT02412761|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6225853|NCT02412761|Lisinopril|lisinopril|mesh-list
6225854|NCT02412761|Calcium Channel Blockers|calcium channel blockers|mesh-list
6225855|NCT02412761|Diuretics|diuretics|mesh-list
6225856|NCT02412761|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
6225857|NCT02412761|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6225858|NCT02412761|Enzyme Inhibitors|enzyme inhibitors|mesh-list
6225859|NCT02412761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6225860|NCT02412761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225861|NCT02412761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6225862|NCT02412761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6225863|NCT02412761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225864|NCT02412761|Vasodilator Agents|vasodilator agents|mesh-ancestor
6225865|NCT02412761|Natriuretic Agents|natriuretic agents|mesh-ancestor
6225866|NCT02412761|Protease Inhibitors|protease inhibitors|mesh-ancestor
6225867|NCT02412761|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6225868|NCT02412761|Protective Agents|protective agents|mesh-ancestor
6225869|NCT02412878|Dexamethasone|dexamethasone|mesh-list
6225870|NCT02412878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6225871|NCT02412878|Antiemetics|antiemetics|mesh-ancestor
6225872|NCT02412878|Autonomic Agents|autonomic agents|mesh-ancestor
6225873|NCT02412878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6225874|NCT02412878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225875|NCT02412878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6225876|NCT02412878|Glucocorticoids|glucocorticoids|mesh-ancestor
6225877|NCT02412878|Hormones|hormones|mesh-ancestor
6225878|NCT02412878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6225879|NCT02412878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6225880|NCT02412878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6225881|NCT02412982|Enoxaparin|enoxaparin|mesh-list
6225882|NCT02412982|Enoxaparin sodium|enoxaparin sodium|mesh-list
6225883|NCT02412982|Anticoagulants|anticoagulants|mesh-ancestor
6225884|NCT02412982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6225885|NCT02412982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6225886|NCT02412982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676452|NCT01581411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6225887|NCT02413034|Vancomycin|vancomycin|mesh-list
6225888|NCT02413034|Cefazolin|cefazolin|mesh-list
6225889|NCT02413034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6225890|NCT02413034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6225891|NCT02413203|Celecoxib|celecoxib|mesh-list
6225892|NCT02413203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6225893|NCT02413203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6225894|NCT02413203|Analgesics|analgesics|mesh-ancestor
6225895|NCT02413203|Sensory System Agents|sensory system agents|mesh-ancestor
6225896|NCT02413203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6225897|NCT02413203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225898|NCT02413203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6225899|NCT02413203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6225900|NCT02413203|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6225901|NCT02413203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6225902|NCT02413203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6225903|NCT02413203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225904|NCT02413320|Paclitaxel|paclitaxel|mesh-list
6225905|NCT02413320|Docetaxel|docetaxel|mesh-list
6225906|NCT02413320|Cyclophosphamide|cyclophosphamide|mesh-list
6225907|NCT02413320|Carboplatin|carboplatin|mesh-list
6225908|NCT02413320|Doxorubicin|doxorubicin|mesh-list
6225909|NCT02413320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6225910|NCT02413320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6225911|NCT02413320|Tubulin Modulators|tubulin modulators|mesh-ancestor
6225912|NCT02413320|Antimitotic Agents|antimitotic agents|mesh-ancestor
6225913|NCT02413320|Mitosis Modulators|mitosis modulators|mesh-ancestor
6225914|NCT02413320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225915|NCT02413320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6225916|NCT02413320|Immunologic Factors|immunologic factors|mesh-ancestor
6225917|NCT02413320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225918|NCT02413320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6225919|NCT02413320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6225920|NCT02413320|Alkylating Agents|alkylating agents|mesh-ancestor
6499909|NCT00642837|Acetaminophen|acetaminophen|mesh-list
6499910|NCT00642837|Tramadol|tramadol|mesh-list
6499911|NCT00642837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6499912|NCT00642837|Analgesics|analgesics|mesh-ancestor
6499913|NCT00642837|Sensory System Agents|sensory system agents|mesh-ancestor
6499914|NCT00642837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6499915|NCT00642837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499916|NCT00642837|Antipyretics|antipyretics|mesh-ancestor
6499917|NCT00642837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6499918|NCT00642837|Narcotics|narcotics|mesh-ancestor
6499919|NCT00642837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6499920|NCT00642863|Vitamin D|vitamin d|mesh-list
6499921|NCT00642863|Vitamins|vitamins|mesh-list
6499922|NCT00642863|Vitamin A|vitamin a|mesh-list
6499923|NCT00642863|Retinol palmitate|retinol palmitate|mesh-list
6499924|NCT00642863|Micronutrients|micronutrients|mesh-ancestor
6499925|NCT00642863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499926|NCT00642863|Antioxidants|antioxidants|mesh-ancestor
6499927|NCT00642863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499928|NCT00642863|Protective Agents|protective agents|mesh-ancestor
6499929|NCT00642863|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6499930|NCT00642863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6499931|NCT00642863|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6499932|NCT00642915|Insulin Glargine|insulin glargine|mesh-list
6499933|NCT00642915|Glimepiride|glimepiride|mesh-list
6499934|NCT00642915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6499935|NCT00642915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499936|NCT00642915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6499937|NCT00642915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6499938|NCT00642915|Immunologic Factors|immunologic factors|mesh-ancestor
6499939|NCT00642967|Epoetin Alfa|epoetin alfa|mesh-list
6499940|NCT00642967|Hematinics|hematinics|mesh-ancestor
6499941|NCT00642980|Clindamycin|clindamycin|mesh-list
6499942|NCT00642980|Clindamycin palmitate|clindamycin palmitate|mesh-list
6499943|NCT00642980|Clindamycin phosphate|clindamycin phosphate|mesh-list
6499944|NCT00642980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6499945|NCT00642980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6499946|NCT00642980|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6499947|NCT00642980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6499948|NCT00642980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705291|NCT03318835|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5705292|NCT03318835|Growth Substances|growth substances|mesh-ancestor
6225921|NCT02413320|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6676453|NCT01581411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705293|NCT03318835|Growth Inhibitors|growth inhibitors|mesh-ancestor
6225922|NCT02413320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6225923|NCT02413320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6225924|NCT02413320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6225925|NCT02413320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6225926|NCT02413333|Contact Lens Solutions|contact lens solutions|mesh-list
6225927|NCT02413333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6225928|NCT02413333|Disinfectants|disinfectants|mesh-ancestor
6225929|NCT02413333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6225930|NCT02413346|Sarecycline|sarecycline|mesh-list
6225931|NCT02413346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6225932|NCT02413346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6225933|NCT02413346|Dermatologic Agents|dermatologic agents|mesh-ancestor
6225934|NCT02413398|Dapagliflozin|dapagliflozin|mesh-list
6225935|NCT02413398|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6225936|NCT02413398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225937|NCT02413398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6225938|NCT02413398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225939|NCT02413489|Daratumumab|daratumumab|mesh-list
6225940|NCT02413489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6225941|NCT02413593|Sofosbuvir|sofosbuvir|mesh-list
6225942|NCT02413593|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
6225943|NCT02413593|Ledipasvir|ledipasvir|mesh-list
6225944|NCT02413593|Antiviral Agents|antiviral agents|mesh-ancestor
6225945|NCT02413593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6225946|NCT02413918|Iloperidone|iloperidone|mesh-list
6225947|NCT02413918|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6225948|NCT02413918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6225949|NCT02413918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6225950|NCT02413918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225951|NCT02413918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6225952|NCT02414204|Sildenafil Citrate|sildenafil citrate|mesh-list
6225953|NCT02414204|Vasodilator Agents|vasodilator agents|mesh-ancestor
6225954|NCT02414204|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6225955|NCT02414204|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6225956|NCT02414204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6225957|NCT02414204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225958|NCT02414204|Urological Agents|urological agents|mesh-ancestor
6225959|NCT02414854|Albuterol|albuterol|mesh-list
6225960|NCT02414854|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6225961|NCT02414854|Autonomic Agents|autonomic agents|mesh-ancestor
6225962|NCT02414854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6225963|NCT02414854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225964|NCT02414854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6225965|NCT02414854|Respiratory System Agents|respiratory system agents|mesh-ancestor
6225966|NCT02414854|Tocolytic Agents|tocolytic agents|mesh-ancestor
6225967|NCT02414854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6225968|NCT02414854|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6225969|NCT02414854|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6225970|NCT02414854|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6225971|NCT02414854|Adrenergic Agents|adrenergic agents|mesh-ancestor
6225972|NCT02414854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6225973|NCT02414854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225974|NCT02414932|Midazolam|midazolam|mesh-list
6225975|NCT02414932|Ketamine|ketamine|mesh-list
6499949|NCT00643071|Tacrolimus|tacrolimus|mesh-list
6499950|NCT00643071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6499951|NCT00643071|Immunologic Factors|immunologic factors|mesh-ancestor
6499952|NCT00643071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499953|NCT00643071|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6499954|NCT00643071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6499955|NCT00643071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499956|NCT00643136|Pregabalin|pregabalin|mesh-list
6499957|NCT00643136|Analgesics|analgesics|mesh-ancestor
6499958|NCT00643136|Sensory System Agents|sensory system agents|mesh-ancestor
6499959|NCT00643136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6225976|NCT02414932|Analgesics|analgesics|mesh-ancestor
6225977|NCT02414932|Sensory System Agents|sensory system agents|mesh-ancestor
6225978|NCT02414932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6225979|NCT02414932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225980|NCT02414932|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6225981|NCT02414932|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6225982|NCT02414932|Anesthetics, General|anesthetics, general|mesh-ancestor
6225983|NCT02414932|Anesthetics|anesthetics|mesh-ancestor
6225984|NCT02414932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6499960|NCT00643136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6225985|NCT02414932|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6225986|NCT02414932|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6225987|NCT02414932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6225988|NCT02414932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225989|NCT02414932|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6225990|NCT02414932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6225991|NCT02414932|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6225992|NCT02414932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6225993|NCT02414932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6225994|NCT02414932|GABA Modulators|gaba modulators|mesh-ancestor
6225995|NCT02414932|GABA Agents|gaba agents|mesh-ancestor
6225996|NCT02414958|Empagliflozin|empagliflozin|mesh-list
6225997|NCT02414958|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6225998|NCT02414958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6225999|NCT02414958|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6226000|NCT02414958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226001|NCT02415127|Interferons|interferons|mesh-list
6226002|NCT02415127|Interferon-gamma|interferon-gamma|mesh-list
6226003|NCT02415127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6226004|NCT02415127|Antiviral Agents|antiviral agents|mesh-ancestor
6226005|NCT02415127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6226006|NCT02415400|Aspirin|aspirin|mesh-list
6226007|NCT02415400|Vitamin K|vitamin k|mesh-list
6226008|NCT02415400|Apixaban|apixaban|mesh-list
6226009|NCT02415400|Vitamins|vitamins|mesh-ancestor
6226010|NCT02415400|Micronutrients|micronutrients|mesh-ancestor
6226011|NCT02415400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226012|NCT02415400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6226013|NCT02415400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6226014|NCT02415400|Analgesics|analgesics|mesh-ancestor
6226015|NCT02415400|Sensory System Agents|sensory system agents|mesh-ancestor
6226016|NCT02415400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6226017|NCT02415400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6226018|NCT02415400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6226019|NCT02415400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6226020|NCT02415400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6226021|NCT02415400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226022|NCT02415400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6226023|NCT02415400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6226024|NCT02415400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6226025|NCT02415400|Antipyretics|antipyretics|mesh-ancestor
6226026|NCT02415400|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6226027|NCT02415400|Antithrombins|antithrombins|mesh-ancestor
6226028|NCT02415400|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6226029|NCT02415400|Protease Inhibitors|protease inhibitors|mesh-ancestor
6226030|NCT02415400|Anticoagulants|anticoagulants|mesh-ancestor
6226031|NCT02415400|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6226032|NCT02415400|Hemostatics|hemostatics|mesh-ancestor
6226033|NCT02415400|Coagulants|coagulants|mesh-ancestor
6226034|NCT02415556|Insulin|insulin|mesh-list
6226035|NCT02415556|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6226036|NCT02415556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6226037|NCT02415556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226038|NCT02415595|BMS-955176|bms-955176|mesh-list
6226039|NCT02415595|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6226040|NCT02415595|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6226041|NCT02415595|Antiviral Agents|antiviral agents|mesh-ancestor
6226042|NCT02415595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6226043|NCT02415855|Dabigatran|dabigatran|mesh-list
6226044|NCT02415855|Antithrombins|antithrombins|mesh-ancestor
6226045|NCT02415855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6226046|NCT02415855|Protease Inhibitors|protease inhibitors|mesh-ancestor
6226047|NCT02415855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6226048|NCT02415855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226049|NCT02415855|Anticoagulants|anticoagulants|mesh-ancestor
6226050|NCT02415959|Pancrelipase|pancrelipase|mesh-list
6226051|NCT02415959|Pancreatin|pancreatin|mesh-list
6226052|NCT02415959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6226053|NCT02416102|Losartan|losartan|mesh-list
6226054|NCT02416102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6226055|NCT02416102|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6226056|NCT02416102|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6226057|NCT02416102|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6226058|NCT02416102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226059|NCT02416180|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6226060|NCT02416180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6226061|NCT02416180|Autonomic Agents|autonomic agents|mesh-ancestor
6226062|NCT02416180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6226063|NCT02416180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226064|NCT02416180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6226065|NCT02416180|Respiratory System Agents|respiratory system agents|mesh-ancestor
6226066|NCT02416180|Glucocorticoids|glucocorticoids|mesh-ancestor
6226067|NCT02416180|Hormones|hormones|mesh-ancestor
6226068|NCT02416180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6226069|NCT02416180|Sympathomimetics|sympathomimetics|mesh-ancestor
5705294|NCT03318835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5705295|NCT03318835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5705296|NCT03318835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5705297|NCT03318835|Alkylating Agents|alkylating agents|mesh-ancestor
5705298|NCT03318835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705299|NCT03318835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5705300|NCT03318835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5705301|NCT03318835|Glucocorticoids|glucocorticoids|mesh-ancestor
5705302|NCT03318835|Hormones|hormones|mesh-ancestor
5705303|NCT03318835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5705304|NCT03318835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5705305|NCT03318835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5705306|NCT03318835|Tubulin Modulators|tubulin modulators|mesh-ancestor
5705307|NCT03318835|Antimitotic Agents|antimitotic agents|mesh-ancestor
5705308|NCT03318835|Mitosis Modulators|mitosis modulators|mesh-ancestor
5705309|NCT03318835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6226070|NCT02416193|Vitamin D|vitamin d|mesh-list
6226071|NCT02416193|Ergocalciferols|ergocalciferols|mesh-list
6226072|NCT02416193|Cholecalciferol|cholecalciferol|mesh-list
6226073|NCT02416193|Vitamins|vitamins|mesh-list
6226074|NCT02416193|Micronutrients|micronutrients|mesh-ancestor
6226075|NCT02416193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226076|NCT02416193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6226077|NCT02416193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6226078|NCT02416908|Cytarabine|cytarabine|mesh-list
6226079|NCT02416908|Plerixafor|plerixafor|mesh-list
6226080|NCT02416908|2'-deoxyadenosine|2'-deoxyadenosine|mesh-list
6226081|NCT02416908|Cladribine|cladribine|mesh-list
6226082|NCT02416908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6226083|NCT02416908|Antimetabolites|antimetabolites|mesh-ancestor
6226084|NCT02416908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226085|NCT02416908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6226086|NCT02416908|Antiviral Agents|antiviral agents|mesh-ancestor
6226087|NCT02416908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6226088|NCT02416908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6226089|NCT02416908|Immunologic Factors|immunologic factors|mesh-ancestor
5705310|NCT03318835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6226090|NCT02416908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226091|NCT02416908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6226092|NCT02416908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6226093|NCT02416934|Dexamethasone|dexamethasone|mesh-list
6226094|NCT02416934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6226095|NCT02416934|Antiemetics|antiemetics|mesh-ancestor
6226096|NCT02416934|Autonomic Agents|autonomic agents|mesh-ancestor
6226097|NCT02416934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6226098|NCT02416934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226099|NCT02416934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6226100|NCT02416934|Glucocorticoids|glucocorticoids|mesh-ancestor
6226101|NCT02416934|Hormones|hormones|mesh-ancestor
5918736|NCT04989257|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5918737|NCT04989257|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5918738|NCT04989257|Purinergic Agents|purinergic agents|mesh-ancestor
5705311|NCT03318835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5705312|NCT03318835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5705313|NCT03318835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5705314|NCT03318770|Dasatinib|dasatinib|mesh-list
5705315|NCT03318770|Blinatumomab|blinatumomab|mesh-list
5705316|NCT03318770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5705317|NCT03318770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5705318|NCT03318770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5705319|NCT03318770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705320|NCT03318757|Bupivacaine|bupivacaine|mesh-list
5705321|NCT03318757|Anesthetics, Local|anesthetics, local|mesh-ancestor
5705322|NCT03318757|Anesthetics|anesthetics|mesh-ancestor
5918739|NCT04989257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5918740|NCT04989257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226102|NCT02416934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6226103|NCT02416934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6226104|NCT02416934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6226105|NCT02417064|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6226106|NCT02417064|Citalopram|citalopram|mesh-list
6226107|NCT02417064|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6226108|NCT02417064|Sertraline|sertraline|mesh-list
6226109|NCT02417064|Antidepressive Agents|antidepressive agents|mesh-list
5705323|NCT03318757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5705324|NCT03318757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705325|NCT03318757|Sensory System Agents|sensory system agents|mesh-ancestor
5705326|NCT03318757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5705327|NCT03318744|Aspirin|aspirin|mesh-list
5705328|NCT03318744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5705329|NCT03318744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5705330|NCT03318744|Analgesics|analgesics|mesh-ancestor
5705331|NCT03318744|Sensory System Agents|sensory system agents|mesh-ancestor
5705332|NCT03318744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5705333|NCT03318744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705334|NCT03318744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5705335|NCT03318744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5705336|NCT03318744|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5705337|NCT03318744|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5705338|NCT03318744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705339|NCT03318744|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5705340|NCT03318744|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5705341|NCT03318744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5705342|NCT03318744|Antipyretics|antipyretics|mesh-ancestor
5705343|NCT03318731|Fenugreek seed meal|fenugreek seed meal|mesh-list
5705344|NCT03318731|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5705345|NCT03318731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705346|NCT03318718|Rocuronium|rocuronium|mesh-list
5705347|NCT03318718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705348|NCT03318718|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5705349|NCT03318718|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5705350|NCT03318718|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5705351|NCT03318718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5705352|NCT03318536|Granisetron|granisetron|mesh-list
5705353|NCT03318536|Serotonin|serotonin|mesh-list
5705354|NCT03318536|Antiemetics|antiemetics|mesh-ancestor
5705355|NCT03318536|Autonomic Agents|autonomic agents|mesh-ancestor
5705356|NCT03318536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5705357|NCT03318536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705358|NCT03318536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5705359|NCT03318536|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5705360|NCT03318536|Serotonin Agents|serotonin agents|mesh-ancestor
5705361|NCT03318536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5705362|NCT03318536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705363|NCT03318536|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5705364|NCT03318471|Magnesium Sulfate|magnesium sulfate|mesh-list
5705365|NCT03318471|Analgesics|analgesics|mesh-ancestor
5705366|NCT03318471|Sensory System Agents|sensory system agents|mesh-ancestor
5705367|NCT03318471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5705368|NCT03318471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705369|NCT03318471|Anesthetics|anesthetics|mesh-ancestor
5705370|NCT03318471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5705371|NCT03318471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5705372|NCT03318471|Anticonvulsants|anticonvulsants|mesh-ancestor
5705373|NCT03318471|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5705374|NCT03318471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5705375|NCT03318471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705376|NCT03318471|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5705377|NCT03318471|Tocolytic Agents|tocolytic agents|mesh-ancestor
5705378|NCT03318471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5705379|NCT03318445|Irinotecan|irinotecan|mesh-list
5705380|NCT03318445|Rucaparib|rucaparib|mesh-list
5705381|NCT03318445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5705382|NCT03318445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6226110|NCT02417064|Esketamine|esketamine|mesh-list
6226111|NCT02417064|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6226112|NCT02417064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6226113|NCT02417064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6226114|NCT02417064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226115|NCT02417064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5705383|NCT03318445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6226116|NCT02417064|Serotonin Agents|serotonin agents|mesh-ancestor
6226117|NCT02417064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226118|NCT02417064|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6226119|NCT02417064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6226120|NCT02417064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6226121|NCT02417064|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6226122|NCT02417064|Analgesics|analgesics|mesh-ancestor
6226123|NCT02417064|Sensory System Agents|sensory system agents|mesh-ancestor
6226124|NCT02417064|Dopamine Agents|dopamine agents|mesh-ancestor
6226125|NCT02417129|Rituximab|rituximab|mesh-list
6226126|NCT02417129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5705384|NCT03318445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705385|NCT03318445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5705386|NCT03318445|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5721229|NCT03207334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5721230|NCT03207334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6226127|NCT02417129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6226128|NCT02417129|Immunologic Factors|immunologic factors|mesh-ancestor
6226129|NCT02417129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499961|NCT00643136|Anticonvulsants|anticonvulsants|mesh-ancestor
6499962|NCT00643136|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6499963|NCT00643136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6499964|NCT00643136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499965|NCT00643136|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6499966|NCT00643136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6499967|NCT00643136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5721231|NCT03207334|Immunologic Factors|immunologic factors|mesh-ancestor
6226130|NCT02417129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6226131|NCT02417246|Metoprolol|metoprolol|mesh-list
6226132|NCT02417246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6226133|NCT02417246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6226134|NCT02417246|Sympatholytics|sympatholytics|mesh-ancestor
6226135|NCT02417246|Autonomic Agents|autonomic agents|mesh-ancestor
6226136|NCT02417246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6226137|NCT02417246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226138|NCT02417246|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6226139|NCT02417246|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6226140|NCT02417246|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5721232|NCT03207334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721233|NCT03207334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5918741|NCT04989257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918742|NCT04989049|Folic Acid|folic acid|mesh-list
5918743|NCT04989049|Hematinics|hematinics|mesh-ancestor
6226141|NCT02417246|Adrenergic Agents|adrenergic agents|mesh-ancestor
6226142|NCT02417246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6226143|NCT02417246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226144|NCT02417831|Tamsulosin|tamsulosin|mesh-list
6226145|NCT02417831|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6226146|NCT02417831|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6226147|NCT02417831|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6226148|NCT02417831|Adrenergic Agents|adrenergic agents|mesh-ancestor
6226149|NCT02417831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6226150|NCT02417831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226151|NCT02417831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226152|NCT02417831|Urological Agents|urological agents|mesh-ancestor
6226153|NCT02417844|Tamsulosin|tamsulosin|mesh-list
6226154|NCT02417844|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6226155|NCT02417844|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6226156|NCT02417844|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6226157|NCT02417844|Adrenergic Agents|adrenergic agents|mesh-ancestor
6226158|NCT02417844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6226159|NCT02417844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226160|NCT02417844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226161|NCT02417844|Urological Agents|urological agents|mesh-ancestor
6226162|NCT02417935|Pregabalin|pregabalin|mesh-list
6226163|NCT02417935|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6226164|NCT02417935|Analgesics|analgesics|mesh-ancestor
5918744|NCT04989049|Vitamin B Complex|vitamin b complex|mesh-ancestor
5918745|NCT04989049|Vitamins|vitamins|mesh-ancestor
5918746|NCT04989049|Micronutrients|micronutrients|mesh-ancestor
5918747|NCT04989049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918748|NCT04988932|Nitric Oxide|nitric oxide|mesh-list
5918749|NCT04988932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6226165|NCT02417935|Sensory System Agents|sensory system agents|mesh-ancestor
6226166|NCT02417935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6226167|NCT02417935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226168|NCT02417935|Anticonvulsants|anticonvulsants|mesh-ancestor
6226169|NCT02417935|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6226170|NCT02417935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6226171|NCT02417935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226172|NCT02417935|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6226173|NCT02417935|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6226174|NCT02417935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6226175|NCT02417935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6226176|NCT02417935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6226177|NCT02417935|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6226178|NCT02417935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6226179|NCT02417935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6226180|NCT02417935|Antidepressive Agents|antidepressive agents|mesh-ancestor
6226181|NCT02417935|Dopamine Agents|dopamine agents|mesh-ancestor
6226182|NCT02417961|Benralizumab|benralizumab|mesh-list
6226183|NCT02417961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6226184|NCT02417961|Respiratory System Agents|respiratory system agents|mesh-ancestor
6226185|NCT02418182|Acetaminophen|acetaminophen|mesh-list
6226186|NCT02418182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6226187|NCT02418182|Analgesics|analgesics|mesh-ancestor
6226188|NCT02418182|Sensory System Agents|sensory system agents|mesh-ancestor
6226189|NCT02418182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6226190|NCT02418182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226191|NCT02418182|Antipyretics|antipyretics|mesh-ancestor
6226192|NCT02418312|Famotidine|famotidine|mesh-list
6226193|NCT02418312|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
6226194|NCT02418312|Histamine|histamine|mesh-list
6226195|NCT02418312|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6226196|NCT02418312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6226197|NCT02418312|Histamine Antagonists|histamine antagonists|mesh-ancestor
6226198|NCT02418312|Histamine Agents|histamine agents|mesh-ancestor
6226199|NCT02418312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6226200|NCT02418312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226201|NCT02418312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226202|NCT02418312|Histamine Agonists|histamine agonists|mesh-ancestor
6226203|NCT02418585|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6226204|NCT02418585|Citalopram|citalopram|mesh-list
6226205|NCT02418585|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6226206|NCT02418585|Sertraline|sertraline|mesh-list
6226207|NCT02418585|Antidepressive Agents|antidepressive agents|mesh-list
6226208|NCT02418585|Esketamine|esketamine|mesh-list
6226209|NCT02418585|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6226210|NCT02418585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6226211|NCT02418585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6226212|NCT02418585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226213|NCT02418585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6226214|NCT02418585|Serotonin Agents|serotonin agents|mesh-ancestor
6226215|NCT02418585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226216|NCT02418585|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6226217|NCT02418585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6226218|NCT02418585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6226219|NCT02418585|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6226220|NCT02418585|Analgesics|analgesics|mesh-ancestor
6226221|NCT02418585|Sensory System Agents|sensory system agents|mesh-ancestor
6226222|NCT02418585|Dopamine Agents|dopamine agents|mesh-ancestor
6226223|NCT02418676|Insulin|insulin|mesh-list
6226224|NCT02418676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6226225|NCT02418676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226226|NCT02418754|Aflibercept|aflibercept|mesh-list
6226227|NCT02418754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6226228|NCT02418754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6226229|NCT02418754|Growth Substances|growth substances|mesh-ancestor
6226230|NCT02418754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226231|NCT02418754|Growth Inhibitors|growth inhibitors|mesh-ancestor
6226232|NCT02418754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6226233|NCT02418949|Cyproheptadine|cyproheptadine|mesh-list
6226234|NCT02418949|Antipruritics|antipruritics|mesh-ancestor
5705387|NCT03318419|Cytarabine|cytarabine|mesh-list
5705388|NCT03318419|Pegaspargase|pegaspargase|mesh-list
5705389|NCT03318419|Asparaginase|asparaginase|mesh-list
5705390|NCT03318419|Cladribine|cladribine|mesh-list
6226235|NCT02418949|Dermatologic Agents|dermatologic agents|mesh-ancestor
5705391|NCT03318419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6226236|NCT02418949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6226237|NCT02418949|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6226238|NCT02418949|Histamine Antagonists|histamine antagonists|mesh-ancestor
6226239|NCT02418949|Histamine Agents|histamine agents|mesh-ancestor
6226240|NCT02418949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6226241|NCT02418949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226242|NCT02418949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226243|NCT02418949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6226244|NCT02418949|Serotonin Agents|serotonin agents|mesh-ancestor
6226245|NCT02418949|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6226246|NCT02419313|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
6226247|NCT02419313|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6226248|NCT02419313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6226249|NCT02419313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226250|NCT02419313|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6226251|NCT02419313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6226252|NCT02419313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226253|NCT02419313|Cholinergic Agents|cholinergic agents|mesh-ancestor
6226254|NCT02419313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6226255|NCT02419469|Cytarabine|cytarabine|mesh-list
6226256|NCT02419469|Dexamethasone|dexamethasone|mesh-list
6226257|NCT02419469|Prednisone|prednisone|mesh-list
6226258|NCT02419469|Dexamethasone acetate|dexamethasone acetate|mesh-list
6226259|NCT02419469|Cyclophosphamide|cyclophosphamide|mesh-list
6226260|NCT02419469|Rituximab|rituximab|mesh-list
6226261|NCT02419469|Doxorubicin|doxorubicin|mesh-list
6226262|NCT02419469|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6226263|NCT02419469|Methotrexate|methotrexate|mesh-list
6226264|NCT02419469|Vincristine|vincristine|mesh-list
6226265|NCT02419469|Daunorubicin|daunorubicin|mesh-list
6226266|NCT02419469|Asparaginase|asparaginase|mesh-list
6226267|NCT02419469|Mercaptopurine|mercaptopurine|mesh-list
6226268|NCT02419469|Ofatumumab|ofatumumab|mesh-list
6226269|NCT02419469|Pegaspargase|pegaspargase|mesh-list
6226270|NCT02419469|Thioguanine|thioguanine|mesh-list
6226271|NCT02419469|BB 1101|bb 1101|mesh-list
6226272|NCT02419469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6226273|NCT02419469|Immunologic Factors|immunologic factors|mesh-ancestor
6226274|NCT02419469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226275|NCT02419469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6226276|NCT02419469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6226277|NCT02419469|Alkylating Agents|alkylating agents|mesh-ancestor
6226278|NCT02419469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226279|NCT02419469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6226280|NCT02419469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6226281|NCT02419469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6226282|NCT02419469|Antiemetics|antiemetics|mesh-ancestor
6226283|NCT02419469|Autonomic Agents|autonomic agents|mesh-ancestor
6226284|NCT02419469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6226285|NCT02419469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6226286|NCT02419469|Glucocorticoids|glucocorticoids|mesh-ancestor
6226287|NCT02419469|Hormones|hormones|mesh-ancestor
6226288|NCT02419469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6226289|NCT02419469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6226290|NCT02419469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6226291|NCT02419469|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6226292|NCT02419469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6226293|NCT02419469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6226294|NCT02419469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6226295|NCT02419469|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6226296|NCT02419469|Abortifacient Agents|abortifacient agents|mesh-ancestor
6226297|NCT02419469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6226298|NCT02419469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6226299|NCT02419469|Antimetabolites|antimetabolites|mesh-ancestor
6226300|NCT02419469|Dermatologic Agents|dermatologic agents|mesh-ancestor
6226301|NCT02419469|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6226302|NCT02419469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6226303|NCT02419469|Antiviral Agents|antiviral agents|mesh-ancestor
6226304|NCT02419469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6226305|NCT02419469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6226306|NCT02419469|Tubulin Modulators|tubulin modulators|mesh-ancestor
6226307|NCT02419469|Antimitotic Agents|antimitotic agents|mesh-ancestor
6226308|NCT02419469|Mitosis Modulators|mitosis modulators|mesh-ancestor
6226309|NCT02419469|Protease Inhibitors|protease inhibitors|mesh-ancestor
6226310|NCT02419508|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6226311|NCT02419508|Bimatoprost|bimatoprost|mesh-list
6226312|NCT02419508|Travoprost|travoprost|mesh-list
6226313|NCT02419508|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6226314|NCT02419508|Latanoprost|latanoprost|mesh-list
6226315|NCT02419508|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6226316|NCT02419508|Brinzolamide|brinzolamide|mesh-list
6226317|NCT02419508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6226318|NCT02419508|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6226319|NCT02419508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6226320|NCT02419508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6226321|NCT02419508|Adrenergic Agents|adrenergic agents|mesh-ancestor
6226322|NCT02419508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6226323|NCT02419508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226324|NCT02419508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226325|NCT02419508|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5705392|NCT03318419|Antimetabolites|antimetabolites|mesh-ancestor
5705393|NCT03318419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705394|NCT03318419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5705395|NCT03318419|Antiviral Agents|antiviral agents|mesh-ancestor
5705396|NCT03318419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5705397|NCT03318419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5705398|NCT03318419|Immunologic Factors|immunologic factors|mesh-ancestor
5705399|NCT03318419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705400|NCT03318393|Heparin|heparin|mesh-list
5705401|NCT03318393|Calcium heparin|calcium heparin|mesh-list
5705402|NCT03318393|Bivalirudin|bivalirudin|mesh-list
6226326|NCT02419508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6226327|NCT02419547|Fentanyl|fentanyl|mesh-list
6226328|NCT02419547|Midazolam|midazolam|mesh-list
6226329|NCT02419547|Propofol|propofol|mesh-list
6226330|NCT02419547|Sevoflurane|sevoflurane|mesh-list
6226331|NCT02419547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6226332|NCT02419547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6226333|NCT02419547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226334|NCT02419547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6226335|NCT02419547|Anesthetics, General|anesthetics, general|mesh-ancestor
6226336|NCT02419547|Anesthetics|anesthetics|mesh-ancestor
6226337|NCT02419547|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5705403|NCT03318393|Anticoagulants|anticoagulants|mesh-ancestor
5705404|NCT03318393|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5705405|NCT03318393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5705406|NCT03318393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705407|NCT03318393|Antithrombins|antithrombins|mesh-ancestor
5705408|NCT03318393|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5705409|NCT03318393|Protease Inhibitors|protease inhibitors|mesh-ancestor
5705410|NCT03318393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6226338|NCT02419547|Narcotics|narcotics|mesh-ancestor
6226339|NCT02419547|Analgesics|analgesics|mesh-ancestor
6226340|NCT02419547|Sensory System Agents|sensory system agents|mesh-ancestor
6226341|NCT02419547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6226342|NCT02419547|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6226343|NCT02419547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6226344|NCT02419547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6226345|NCT02419547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6226346|NCT02419547|GABA Modulators|gaba modulators|mesh-ancestor
6226347|NCT02419547|GABA Agents|gaba agents|mesh-ancestor
6226348|NCT02419547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6226349|NCT02419547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226350|NCT02419547|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6226351|NCT02419547|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6226352|NCT02419612|Dapagliflozin|dapagliflozin|mesh-list
6226353|NCT02419612|Glimepiride|glimepiride|mesh-list
6226354|NCT02419612|Saxagliptin|saxagliptin|mesh-list
6226355|NCT02419612|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6226356|NCT02419612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226357|NCT02419612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6226358|NCT02419612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705411|NCT03318354|Olmesartan|olmesartan|mesh-list
5705412|NCT03318354|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
5705413|NCT03318354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5705414|NCT03318354|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5705415|NCT03318354|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5705416|NCT03318354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705417|NCT03318211|Magnesium Sulfate|magnesium sulfate|mesh-list
5705418|NCT03318211|Analgesics|analgesics|mesh-ancestor
5705419|NCT03318211|Sensory System Agents|sensory system agents|mesh-ancestor
6226359|NCT02419612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6226360|NCT02419612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5705420|NCT03318211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5705421|NCT03318211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705422|NCT03318211|Anesthetics|anesthetics|mesh-ancestor
5705423|NCT03318211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5705424|NCT03318211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5705425|NCT03318211|Anticonvulsants|anticonvulsants|mesh-ancestor
5705426|NCT03318211|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5705427|NCT03318211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5705428|NCT03318211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705429|NCT03318211|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5705430|NCT03318211|Tocolytic Agents|tocolytic agents|mesh-ancestor
6226361|NCT02419612|Immunologic Factors|immunologic factors|mesh-ancestor
6226362|NCT02419612|Incretins|incretins|mesh-ancestor
6226363|NCT02419612|Hormones|hormones|mesh-ancestor
6226364|NCT02419612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6226365|NCT02419612|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6226366|NCT02419612|Protease Inhibitors|protease inhibitors|mesh-ancestor
6226367|NCT02419612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6226368|NCT02419755|Cytarabine|cytarabine|mesh-list
6226369|NCT02419755|Dexamethasone|dexamethasone|mesh-list
6226370|NCT02419755|Hydrocortisone|hydrocortisone|mesh-list
6226371|NCT02419755|Doxorubicin|doxorubicin|mesh-list
6226372|NCT02419755|Methotrexate|methotrexate|mesh-list
6226373|NCT02419755|Bortezomib|bortezomib|mesh-list
6226374|NCT02419755|Asparaginase|asparaginase|mesh-list
6226375|NCT02419755|Mercaptopurine|mercaptopurine|mesh-list
6226376|NCT02419755|Mitoxantrone|mitoxantrone|mesh-list
6226377|NCT02419755|Vorinostat|vorinostat|mesh-list
6226378|NCT02419755|Pegaspargase|pegaspargase|mesh-list
6226379|NCT02419755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6226380|NCT02419755|Antiemetics|antiemetics|mesh-ancestor
6226381|NCT02419755|Autonomic Agents|autonomic agents|mesh-ancestor
6226382|NCT02419755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6226383|NCT02419755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226384|NCT02419755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6226385|NCT02419755|Glucocorticoids|glucocorticoids|mesh-ancestor
6226386|NCT02419755|Hormones|hormones|mesh-ancestor
6226387|NCT02419755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6226388|NCT02419755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6226389|NCT02419755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6226390|NCT02419755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6226391|NCT02419755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6226392|NCT02419755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6226393|NCT02419755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6226394|NCT02419755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226395|NCT02419755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6226396|NCT02419755|Abortifacient Agents|abortifacient agents|mesh-ancestor
6226397|NCT02419755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6226398|NCT02419755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6226399|NCT02419755|Antimetabolites|antimetabolites|mesh-ancestor
6226400|NCT02419755|Dermatologic Agents|dermatologic agents|mesh-ancestor
6226401|NCT02419755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6226402|NCT02419755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6226403|NCT02419755|Immunologic Factors|immunologic factors|mesh-ancestor
6226404|NCT02419755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6226405|NCT02419755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5705431|NCT03318211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5705432|NCT03318159|Posaconazole|posaconazole|mesh-list
5705433|NCT03318159|Antifungal Agents|antifungal agents|mesh-ancestor
5705434|NCT03318159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5705435|NCT03318159|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5705436|NCT03318159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5705437|NCT03318159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5705438|NCT03318159|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5705439|NCT03318159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5705440|NCT03318159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6226406|NCT02419755|Antiviral Agents|antiviral agents|mesh-ancestor
6226407|NCT02419755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6226408|NCT02419755|Analgesics|analgesics|mesh-ancestor
6226409|NCT02419755|Sensory System Agents|sensory system agents|mesh-ancestor
6226410|NCT02419755|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6226411|NCT02419807|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6226412|NCT02419807|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
6226413|NCT02419807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5721234|NCT03207334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6226414|NCT02419807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705441|NCT03318159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705442|NCT03318159|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5705443|NCT03318159|Hormone Antagonists|hormone antagonists|mesh-ancestor
6226415|NCT02420015|Bupropion|bupropion|mesh-list
6226416|NCT02420015|Nicotine|nicotine|mesh-list
6226417|NCT02420015|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6226418|NCT02420015|Autonomic Agents|autonomic agents|mesh-ancestor
6226419|NCT02420015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6226420|NCT02420015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226421|NCT02420015|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6226422|NCT02420015|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6499968|NCT00643136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6499969|NCT00643136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6499970|NCT00643149|Amoxicillin|amoxicillin|mesh-list
6499971|NCT00643149|Azithromycin|azithromycin|mesh-list
6499972|NCT00643149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6499973|NCT00643149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6499974|NCT00643227|Azithromycin|azithromycin|mesh-list
6499975|NCT00643227|Clarithromycin|clarithromycin|mesh-list
6499976|NCT00643227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6499977|NCT00643227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6499978|NCT00643227|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6499979|NCT00643227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6499980|NCT00643227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499981|NCT00643227|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6499982|NCT00643227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6499983|NCT00643240|Antibodies|antibodies|mesh-list
6499984|NCT00643240|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6499985|NCT00643240|Immunologic Factors|immunologic factors|mesh-ancestor
6499986|NCT00643240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6499987|NCT00643292|Amoxicillin|amoxicillin|mesh-list
6499988|NCT00643292|Azithromycin|azithromycin|mesh-list
6499989|NCT00643292|Clavulanic Acid|clavulanic acid|mesh-list
6499990|NCT00643292|Clavulanic Acids|clavulanic acids|mesh-list
6499991|NCT00643292|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6499992|NCT00643292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6499993|NCT00643292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6499994|NCT00643292|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6499995|NCT00643292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6499996|NCT00643292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6499997|NCT00643357|Nitrous Oxide|nitrous oxide|mesh-list
6499998|NCT00643357|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6499999|NCT00643357|Anesthetics, General|anesthetics, general|mesh-ancestor
6500000|NCT00643357|Anesthetics|anesthetics|mesh-ancestor
6500001|NCT00643357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6500002|NCT00643357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6500003|NCT00643357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6500004|NCT00643357|Analgesics|analgesics|mesh-ancestor
6500005|NCT00643357|Sensory System Agents|sensory system agents|mesh-ancestor
6500006|NCT00643357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6500007|NCT00643409|Azithromycin|azithromycin|mesh-list
6500008|NCT00643409|Levofloxacin|levofloxacin|mesh-list
6500009|NCT00643409|Ofloxacin|ofloxacin|mesh-list
5705444|NCT03318159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5705445|NCT03318159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705446|NCT03318146|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5705447|NCT03318146|Latanoprost|latanoprost|mesh-list
5705448|NCT03318146|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5705449|NCT03318133|Anesthetics|anesthetics|mesh-list
5705450|NCT03318133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5705451|NCT03318133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705452|NCT03318094|Nitroprusside|nitroprusside|mesh-list
5705453|NCT03318094|Phentolamine|phentolamine|mesh-list
5705454|NCT03318094|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
5705455|NCT03318094|Adrenergic Antagonists|adrenergic antagonists|mesh-list
5705456|NCT03318094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5705457|NCT03318094|Vasodilator Agents|vasodilator agents|mesh-ancestor
6500010|NCT00643409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6500011|NCT00643409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6500012|NCT00643409|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5705458|NCT03318094|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5705459|NCT03318094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226423|NCT02420015|Cholinergic Agents|cholinergic agents|mesh-ancestor
6500013|NCT00643409|Renal Agents|renal agents|mesh-ancestor
6500014|NCT00643409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6226424|NCT02420015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6226425|NCT02420015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226426|NCT02420015|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6226427|NCT02420015|Antidepressive Agents|antidepressive agents|mesh-ancestor
6226428|NCT02420015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6226429|NCT02420015|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6226430|NCT02420015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6226431|NCT02420015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6226432|NCT02420015|Dopamine Agents|dopamine agents|mesh-ancestor
6226433|NCT02420015|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6226434|NCT02420015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6226435|NCT02420015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6243582|NCT02673372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6243583|NCT02673372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243584|NCT02673372|Analgesics|analgesics|mesh-ancestor
6243585|NCT02673372|Sensory System Agents|sensory system agents|mesh-ancestor
6243586|NCT02673372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6243587|NCT02673372|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6243588|NCT02673372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6243589|NCT02673372|Anesthetics, General|anesthetics, general|mesh-ancestor
5705460|NCT03318094|Adrenergic Agents|adrenergic agents|mesh-ancestor
5705461|NCT03318094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5705462|NCT03318094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705463|NCT03318029|Vitamin D|vitamin d|mesh-list
5705464|NCT03318029|Vitamins|vitamins|mesh-ancestor
5705465|NCT03318029|Micronutrients|micronutrients|mesh-ancestor
5705466|NCT03318029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705467|NCT03318029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5705468|NCT03318016|Cyclophosphamide|cyclophosphamide|mesh-list
5705469|NCT03318016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5705470|NCT03318016|Immunologic Factors|immunologic factors|mesh-ancestor
5705471|NCT03318016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705472|NCT03318016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5705473|NCT03318016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5705474|NCT03318016|Alkylating Agents|alkylating agents|mesh-ancestor
5705475|NCT03318016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705476|NCT03318016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5705477|NCT03318016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5705478|NCT03317912|Lidocaine|lidocaine|mesh-list
5705479|NCT03317912|Anesthetics, Local|anesthetics, local|mesh-ancestor
5705480|NCT03317912|Anesthetics|anesthetics|mesh-ancestor
5705481|NCT03317912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5705482|NCT03317912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705483|NCT03317912|Sensory System Agents|sensory system agents|mesh-ancestor
5705484|NCT03317912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5705485|NCT03317912|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5705486|NCT03317912|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5705487|NCT03317912|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6243590|NCT02673372|Anesthetics|anesthetics|mesh-ancestor
6243591|NCT02673372|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6243592|NCT02673372|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6243593|NCT02673372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6243594|NCT02673372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243595|NCT02674061|Pembrolizumab|pembrolizumab|mesh-list
6243596|NCT02674061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6243597|NCT02674061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6243598|NCT02674399|Hylan|hylan|mesh-list
6500015|NCT00643409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6243599|NCT02674399|Viscosupplements|viscosupplements|mesh-ancestor
6243600|NCT02674399|Protective Agents|protective agents|mesh-ancestor
6243601|NCT02674399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243602|NCT02674412|Buspirone|buspirone|mesh-list
6243603|NCT02674412|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6243604|NCT02674412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6243605|NCT02674412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6243606|NCT02674412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243607|NCT02674412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6243608|NCT02674412|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6500016|NCT00643409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6500017|NCT00643409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500018|NCT00643409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6500019|NCT00643409|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6500020|NCT00643409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5705488|NCT03317912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5705489|NCT03317912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705490|NCT03317899|Lenograstim|lenograstim|mesh-list
5705491|NCT03317899|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5705492|NCT03317899|Immunologic Factors|immunologic factors|mesh-ancestor
5705493|NCT03317899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705494|NCT03317847|Dexamethasone|dexamethasone|mesh-list
5705495|NCT03317847|Bromfenac|bromfenac|mesh-list
5705496|NCT03317847|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5705497|NCT03317847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5705498|NCT03317847|Antiemetics|antiemetics|mesh-ancestor
5705499|NCT03317847|Autonomic Agents|autonomic agents|mesh-ancestor
5705500|NCT03317847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6226436|NCT02420041|Triamcinolone|triamcinolone|mesh-list
6226437|NCT02420041|Lidocaine|lidocaine|mesh-list
6226438|NCT02420041|Anesthetics, Local|anesthetics, local|mesh-ancestor
6226439|NCT02420041|Anesthetics|anesthetics|mesh-ancestor
6226440|NCT02420041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6226441|NCT02420041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226442|NCT02420041|Sensory System Agents|sensory system agents|mesh-ancestor
6226443|NCT02420041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5705501|NCT03317847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705502|NCT03317847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5705503|NCT03317847|Glucocorticoids|glucocorticoids|mesh-ancestor
5705504|NCT03317847|Hormones|hormones|mesh-ancestor
5918750|NCT04988932|Autonomic Agents|autonomic agents|mesh-ancestor
5918751|NCT04988932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5918752|NCT04988932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918753|NCT04988932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5918754|NCT04988932|Respiratory System Agents|respiratory system agents|mesh-ancestor
6226444|NCT02420041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6226445|NCT02420041|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6226446|NCT02420041|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6226447|NCT02420041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6226448|NCT02420041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226449|NCT02420041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6226450|NCT02420041|Glucocorticoids|glucocorticoids|mesh-ancestor
6226451|NCT02420041|Hormones|hormones|mesh-ancestor
6226452|NCT02420041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6226453|NCT02420210|Dexamethasone|dexamethasone|mesh-list
6226454|NCT02420210|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6226455|NCT02420210|Obinutuzumab|obinutuzumab|mesh-list
6226456|NCT02420210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6226457|NCT02420210|Antiemetics|antiemetics|mesh-ancestor
6226458|NCT02420210|Autonomic Agents|autonomic agents|mesh-ancestor
6226459|NCT02420210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6226460|NCT02420210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226461|NCT02420210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6226462|NCT02420210|Glucocorticoids|glucocorticoids|mesh-ancestor
6226463|NCT02420210|Hormones|hormones|mesh-ancestor
6226464|NCT02420210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6226465|NCT02420210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6226466|NCT02420210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6226467|NCT02420210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6226468|NCT02420210|Alkylating Agents|alkylating agents|mesh-ancestor
6226469|NCT02420210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226470|NCT02420210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6226471|NCT02420223|Propranolol|propranolol|mesh-list
6226472|NCT02420223|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6226473|NCT02420223|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6226474|NCT02420223|Adrenergic Agents|adrenergic agents|mesh-ancestor
6226475|NCT02420223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6226476|NCT02420223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226477|NCT02420223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226478|NCT02420223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6226479|NCT02420223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6226480|NCT02420223|Vasodilator Agents|vasodilator agents|mesh-ancestor
5721235|NCT03207165|Dobutamine|dobutamine|mesh-list
5918755|NCT04988932|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5918756|NCT04988932|Antioxidants|antioxidants|mesh-ancestor
5918757|NCT04988932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918758|NCT04988932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5918759|NCT04988932|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5721236|NCT03207165|Milrinone|milrinone|mesh-list
5705505|NCT03317847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6226481|NCT02420262|Insulin|insulin|mesh-list
6226482|NCT02420262|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6226483|NCT02420262|Insulin Glargine|insulin glargine|mesh-list
6226484|NCT02420262|Insulin Aspart|insulin aspart|mesh-list
6226485|NCT02420262|Liraglutide|liraglutide|mesh-list
6226486|NCT02420262|Xultophy|xultophy|mesh-list
6226487|NCT02420262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6226488|NCT02420262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226489|NCT02420262|Incretins|incretins|mesh-ancestor
6226490|NCT02420262|Hormones|hormones|mesh-ancestor
6226491|NCT02420262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6226492|NCT02420327|Galantamine|galantamine|mesh-list
6226493|NCT02420327|Nicotine|nicotine|mesh-list
6226494|NCT02420327|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6226495|NCT02420327|Autonomic Agents|autonomic agents|mesh-ancestor
6226496|NCT02420327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6226497|NCT02420327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226498|NCT02420327|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6226499|NCT02420327|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6226500|NCT02420327|Cholinergic Agents|cholinergic agents|mesh-ancestor
6226501|NCT02420327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6226502|NCT02420327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226503|NCT02420327|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6226504|NCT02420327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5705506|NCT03317847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5705507|NCT03317847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5705508|NCT03317847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5705509|NCT03317847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5705510|NCT03317847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5705511|NCT03317847|Analgesics|analgesics|mesh-ancestor
5705512|NCT03317847|Sensory System Agents|sensory system agents|mesh-ancestor
5705513|NCT03317847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5705514|NCT03317730|Oxycodone|oxycodone|mesh-list
5705515|NCT03317730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5705516|NCT03317730|Narcotics|narcotics|mesh-ancestor
5705517|NCT03317730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5705518|NCT03317730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705519|NCT03317730|Analgesics|analgesics|mesh-ancestor
5705520|NCT03317730|Sensory System Agents|sensory system agents|mesh-ancestor
5705521|NCT03317730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5705522|NCT03317717|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5705523|NCT03317717|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5705524|NCT03317717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5705525|NCT03317717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705526|NCT03317717|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5705527|NCT03317717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5705528|NCT03317717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705529|NCT03317717|Cholinergic Agents|cholinergic agents|mesh-ancestor
5705530|NCT03317717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5705531|NCT03317652|Nitroprusside|nitroprusside|mesh-list
5705532|NCT03317652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5705533|NCT03317652|Vasodilator Agents|vasodilator agents|mesh-ancestor
5705534|NCT03317652|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6226505|NCT02420327|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6226506|NCT02420327|Nootropic Agents|nootropic agents|mesh-ancestor
6226507|NCT02420873|Maytansine|maytansine|mesh-list
6226508|NCT02420873|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
6226509|NCT02420873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6226510|NCT02420873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6226511|NCT02420873|Tubulin Modulators|tubulin modulators|mesh-ancestor
6226512|NCT02420873|Antimitotic Agents|antimitotic agents|mesh-ancestor
6226513|NCT02420873|Mitosis Modulators|mitosis modulators|mesh-ancestor
6226514|NCT02420873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226515|NCT02420873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6226516|NCT02420951|Bupivacaine|bupivacaine|mesh-list
6226517|NCT02420951|Anesthetics, Local|anesthetics, local|mesh-ancestor
6226518|NCT02420951|Anesthetics|anesthetics|mesh-ancestor
6226519|NCT02420951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6226520|NCT02420951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226521|NCT02420951|Sensory System Agents|sensory system agents|mesh-ancestor
6226522|NCT02420951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6226523|NCT02421120|Tazobactam|tazobactam|mesh-list
6226524|NCT02421120|Ceftolozane|ceftolozane|mesh-list
6226525|NCT02421120|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
6226526|NCT02421120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6226527|NCT02421120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6226528|NCT02421120|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6226529|NCT02421120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6226530|NCT02421120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226531|NCT02421120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6226532|NCT02421120|Renal Agents|renal agents|mesh-ancestor
6226533|NCT02421211|Sofosbuvir|sofosbuvir|mesh-list
6226534|NCT02421211|Ledipasvir|ledipasvir|mesh-list
6226535|NCT02421211|Simeprevir|simeprevir|mesh-list
6226536|NCT02421211|Antiviral Agents|antiviral agents|mesh-ancestor
6226537|NCT02421211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6226538|NCT02421211|Protease Inhibitors|protease inhibitors|mesh-ancestor
6226539|NCT02421211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6226540|NCT02421211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226541|NCT02421354|Nivolumab|nivolumab|mesh-list
6226542|NCT02421354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6226543|NCT02421354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6226544|NCT02421354|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6226545|NCT02421354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226546|NCT02421419|Dexamethasone|dexamethasone|mesh-list
6226547|NCT02421419|Dexamethasone acetate|dexamethasone acetate|mesh-list
6226548|NCT02421419|Lidocaine|lidocaine|mesh-list
6226549|NCT02421419|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
6226550|NCT02421419|BB 1101|bb 1101|mesh-list
6226551|NCT02421419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6226552|NCT02421419|Antiemetics|antiemetics|mesh-ancestor
6226553|NCT02421419|Autonomic Agents|autonomic agents|mesh-ancestor
6226554|NCT02421419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6226555|NCT02421419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226556|NCT02421419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6226557|NCT02421419|Glucocorticoids|glucocorticoids|mesh-ancestor
6226558|NCT02421419|Hormones|hormones|mesh-ancestor
6226559|NCT02421419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6226560|NCT02421419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6226561|NCT02421419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6226562|NCT02421419|Anesthetics, Local|anesthetics, local|mesh-ancestor
6226563|NCT02421419|Anesthetics|anesthetics|mesh-ancestor
6226564|NCT02421419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6226565|NCT02421419|Sensory System Agents|sensory system agents|mesh-ancestor
6226566|NCT02421419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6226567|NCT02421419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6226568|NCT02421419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6226569|NCT02421419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6226570|NCT02421419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226571|NCT02421419|Protease Inhibitors|protease inhibitors|mesh-ancestor
6226572|NCT02421419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6226573|NCT02421510|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
6226574|NCT02421510|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6226575|NCT02421510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226576|NCT02421510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6226577|NCT02421510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226578|NCT02421588|Doxorubicin|doxorubicin|mesh-list
6226579|NCT02421588|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6226580|NCT02421588|Topotecan|topotecan|mesh-list
6226581|NCT02421588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6226582|NCT02421588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6226583|NCT02421588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6226584|NCT02421588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6226585|NCT02421588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6226586|NCT02421588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226587|NCT02421588|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6226588|NCT02421887|Antioxidants|antioxidants|mesh-list
6226589|NCT02421887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226590|NCT02421887|Protective Agents|protective agents|mesh-ancestor
6226591|NCT02421887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226592|NCT02422186|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6226593|NCT02422186|Citalopram|citalopram|mesh-list
6226594|NCT02422186|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6226595|NCT02422186|Sertraline|sertraline|mesh-list
6226596|NCT02422186|Antidepressive Agents|antidepressive agents|mesh-list
6226597|NCT02422186|Esketamine|esketamine|mesh-list
6226598|NCT02422186|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6226599|NCT02422186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6226600|NCT02422186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6226601|NCT02422186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226602|NCT02422186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6226603|NCT02422186|Serotonin Agents|serotonin agents|mesh-ancestor
6226604|NCT02422186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226605|NCT02422186|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6226606|NCT02422186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6226607|NCT02422186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6226608|NCT02422186|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6226609|NCT02422186|Analgesics|analgesics|mesh-ancestor
6226610|NCT02422186|Sensory System Agents|sensory system agents|mesh-ancestor
6226611|NCT02422186|Dopamine Agents|dopamine agents|mesh-ancestor
6226612|NCT02422264|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6226613|NCT02422264|Immunologic Factors|immunologic factors|mesh-ancestor
6226614|NCT02422264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226615|NCT02422290|Ketamine|ketamine|mesh-list
6226616|NCT02422290|Analgesics|analgesics|mesh-ancestor
6226617|NCT02422290|Sensory System Agents|sensory system agents|mesh-ancestor
6226618|NCT02422290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6226619|NCT02422290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226620|NCT02422290|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6226621|NCT02422290|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6226622|NCT02422290|Anesthetics, General|anesthetics, general|mesh-ancestor
6226623|NCT02422290|Anesthetics|anesthetics|mesh-ancestor
6226624|NCT02422290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6226625|NCT02422290|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6226626|NCT02422290|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6500021|NCT00643500|Levetiracetam|levetiracetam|mesh-list
6500022|NCT00643500|Anticonvulsants|anticonvulsants|mesh-ancestor
6500023|NCT00643500|Nootropic Agents|nootropic agents|mesh-ancestor
6226627|NCT02422290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6226628|NCT02422290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226629|NCT02422446|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
6226630|NCT02422446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6226631|NCT02422446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6226632|NCT02422940|4-Aminopyridine|4-aminopyridine|mesh-list
6226633|NCT02422940|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6226634|NCT02422940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6226635|NCT02422940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226636|NCT02423291|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5705535|NCT03317652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705536|NCT03317600|Lidocaine|lidocaine|mesh-list
5705537|NCT03317600|Anesthetics, Local|anesthetics, local|mesh-ancestor
5705538|NCT03317600|Anesthetics|anesthetics|mesh-ancestor
5705539|NCT03317600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6226637|NCT02423291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6226638|NCT02423291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6226639|NCT02423343|Nivolumab|nivolumab|mesh-list
6226640|NCT02423343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6226641|NCT02423343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6226642|NCT02423343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6226643|NCT02423343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226644|NCT02423980|Glucagon|glucagon|mesh-list
6226645|NCT02423980|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6226646|NCT02423980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6226647|NCT02423980|Hormones|hormones|mesh-ancestor
6226648|NCT02423980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6226649|NCT02423980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226650|NCT02423980|Incretins|incretins|mesh-ancestor
6226651|NCT02424097|Listerine|listerine|mesh-list
6226652|NCT02424097|Fluorides|fluorides|mesh-list
6226653|NCT02424097|Sodium Fluoride|sodium fluoride|mesh-list
6226654|NCT02424097|Fluorides, Topical|fluorides, topical|mesh-list
6226655|NCT02424097|Cariostatic Agents|cariostatic agents|mesh-ancestor
6226656|NCT02424097|Protective Agents|protective agents|mesh-ancestor
6226657|NCT02424097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226658|NCT02424097|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6226659|NCT02424097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6226660|NCT02424344|Formoterol Fumarate|formoterol fumarate|mesh-list
6226661|NCT02424344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6226662|NCT02424344|Autonomic Agents|autonomic agents|mesh-ancestor
6226663|NCT02424344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6243609|NCT02674412|Serotonin Agents|serotonin agents|mesh-ancestor
6226664|NCT02424344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226665|NCT02424344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6226666|NCT02424344|Respiratory System Agents|respiratory system agents|mesh-ancestor
6226667|NCT02424344|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5705540|NCT03317600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705541|NCT03317600|Sensory System Agents|sensory system agents|mesh-ancestor
5705542|NCT03317600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5705543|NCT03317600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5705544|NCT03317600|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5705545|NCT03317600|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5705546|NCT03317600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5705547|NCT03317600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705548|NCT03317574|Botulinum Toxins|botulinum toxins|mesh-list
5705549|NCT03317574|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5705550|NCT03317574|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5705551|NCT03317574|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5705552|NCT03317574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6226668|NCT02424344|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6226669|NCT02424344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6226670|NCT02424344|Adrenergic Agents|adrenergic agents|mesh-ancestor
6226671|NCT02424344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6226672|NCT02424344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226673|NCT02424357|Povidone-Iodine|povidone-iodine|mesh-list
6226674|NCT02424357|Povidone|povidone|mesh-list
6226675|NCT02424357|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6226676|NCT02424357|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6226677|NCT02424357|Plasma Substitutes|plasma substitutes|mesh-ancestor
6226678|NCT02424357|Blood Substitutes|blood substitutes|mesh-ancestor
6226679|NCT02424357|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6226680|NCT02424357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6226681|NCT02424578|Diclofenac|diclofenac|mesh-list
6226682|NCT02424578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5705553|NCT03317574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705554|NCT03317574|Cholinergic Agents|cholinergic agents|mesh-ancestor
5705555|NCT03317574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5705556|NCT03317574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705557|NCT03317574|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5705558|NCT03317574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5705559|NCT03317548|Progesterone|progesterone|mesh-list
5705560|NCT03317548|Progestins|progestins|mesh-ancestor
6226683|NCT02424578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6226684|NCT02424578|Analgesics|analgesics|mesh-ancestor
6226685|NCT02424578|Sensory System Agents|sensory system agents|mesh-ancestor
6226686|NCT02424578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6226687|NCT02424578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226688|NCT02424578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6226689|NCT02424578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6226690|NCT02424578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6226691|NCT02424578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6226692|NCT02424578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226693|NCT02424591|Ketamine|ketamine|mesh-list
6226694|NCT02424591|Analgesics|analgesics|mesh-ancestor
6226695|NCT02424591|Sensory System Agents|sensory system agents|mesh-ancestor
6226696|NCT02424591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6226697|NCT02424591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226698|NCT02424591|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6226699|NCT02424591|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6226700|NCT02424591|Anesthetics, General|anesthetics, general|mesh-ancestor
6226701|NCT02424591|Anesthetics|anesthetics|mesh-ancestor
6226702|NCT02424591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6226703|NCT02424591|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6226704|NCT02424591|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6226705|NCT02424591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6226706|NCT02424591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226707|NCT02424630|Ropivacaine|ropivacaine|mesh-list
6226708|NCT02424630|Anesthetics, Local|anesthetics, local|mesh-ancestor
6226709|NCT02424630|Anesthetics|anesthetics|mesh-ancestor
6226710|NCT02424630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6226711|NCT02424630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226712|NCT02424630|Sensory System Agents|sensory system agents|mesh-ancestor
6226713|NCT02424630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6226714|NCT02424734|Ampicillin|ampicillin|mesh-list
6226715|NCT02424734|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
6226716|NCT02424734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6226717|NCT02424734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6226718|NCT02424799|GSK2646264|gsk2646264|mesh-list
6226719|NCT02424799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6226720|NCT02424799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6226721|NCT02424799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226722|NCT02424968|Cyclosporine|cyclosporine|mesh-list
6226723|NCT02424968|Mycophenolic Acid|mycophenolic acid|mesh-list
6226724|NCT02424968|Cyclosporins|cyclosporins|mesh-list
6226725|NCT02424968|Thymoglobulin|thymoglobulin|mesh-list
6226726|NCT02424968|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6226727|NCT02424968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6226728|NCT02424968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226729|NCT02424968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6226730|NCT02424968|Immunologic Factors|immunologic factors|mesh-ancestor
6226731|NCT02424968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226732|NCT02424968|Antifungal Agents|antifungal agents|mesh-ancestor
6226733|NCT02424968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6226734|NCT02424968|Dermatologic Agents|dermatologic agents|mesh-ancestor
6226735|NCT02424968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6226736|NCT02424968|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6226737|NCT02424968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6226738|NCT02424968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6226739|NCT02424968|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6226740|NCT02424968|Antitubercular Agents|antitubercular agents|mesh-ancestor
6226741|NCT02424968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6226742|NCT02425098|Vaccines|vaccines|mesh-list
6226743|NCT02425098|Immunologic Factors|immunologic factors|mesh-ancestor
6226744|NCT02425098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226745|NCT02425111|Vedolizumab|vedolizumab|mesh-list
6226746|NCT02425111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6226747|NCT02425306|Cyclophosphamide|cyclophosphamide|mesh-list
6226748|NCT02425306|Poly ICLC|poly iclc|mesh-list
6226749|NCT02425306|Immunologic Factors|immunologic factors|mesh-ancestor
6226750|NCT02425306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226751|NCT02425306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6226752|NCT02425306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6226753|NCT02425306|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6226754|NCT02425306|Alkylating Agents|alkylating agents|mesh-ancestor
6226755|NCT02425306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226756|NCT02425306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6226757|NCT02425306|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6226758|NCT02425306|Interferon Inducers|interferon inducers|mesh-ancestor
6226759|NCT02425449|Succinylcholine|succinylcholine|mesh-list
6226760|NCT02425449|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
6226761|NCT02425449|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6226762|NCT02425449|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6226763|NCT02425449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6226764|NCT02425449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226765|NCT02425826|Thalidomide|thalidomide|mesh-list
6226766|NCT02425826|Apremilast|apremilast|mesh-list
6226767|NCT02425826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6226768|NCT02425826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6226769|NCT02425826|Analgesics|analgesics|mesh-ancestor
6226770|NCT02425826|Sensory System Agents|sensory system agents|mesh-ancestor
6226771|NCT02425826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6226772|NCT02425826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226773|NCT02425826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6226774|NCT02425826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6226775|NCT02425826|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6226776|NCT02425826|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6226777|NCT02425826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6226778|NCT02425826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226779|NCT02425826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6226780|NCT02425826|Immunologic Factors|immunologic factors|mesh-ancestor
6226781|NCT02425826|Leprostatic Agents|leprostatic agents|mesh-ancestor
6226782|NCT02425826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6226783|NCT02425826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6226784|NCT02425826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6226785|NCT02425826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6226786|NCT02425826|Growth Substances|growth substances|mesh-ancestor
6226787|NCT02425826|Growth Inhibitors|growth inhibitors|mesh-ancestor
6226788|NCT02425826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6226789|NCT02425891|Paclitaxel|paclitaxel|mesh-list
6226790|NCT02425891|Atezolizumab|atezolizumab|mesh-list
6226791|NCT02425891|Antibodies|antibodies|mesh-list
5705561|NCT03317548|Hormones|hormones|mesh-ancestor
5705562|NCT03317548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5705563|NCT03317548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705564|NCT03317535|Anesthetics|anesthetics|mesh-list
5705565|NCT03317535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5705566|NCT03317535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705567|NCT03317457|Doxorubicin|doxorubicin|mesh-list
5705568|NCT03317457|Durvalumab|durvalumab|mesh-list
5705569|NCT03317457|Tremelimumab|tremelimumab|mesh-list
6226792|NCT02425891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6226793|NCT02425891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6226794|NCT02425891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6226795|NCT02425891|Tubulin Modulators|tubulin modulators|mesh-ancestor
6226796|NCT02425891|Antimitotic Agents|antimitotic agents|mesh-ancestor
6226797|NCT02425891|Mitosis Modulators|mitosis modulators|mesh-ancestor
6226798|NCT02425891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226799|NCT02425891|Immunologic Factors|immunologic factors|mesh-ancestor
6226800|NCT02425891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226801|NCT02426086|Niacinamide|niacinamide|mesh-list
6226802|NCT02426086|Imetelstat|imetelstat|mesh-list
6226803|NCT02426086|Motesanib diphosphate|motesanib diphosphate|mesh-list
6226804|NCT02426086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6226805|NCT02426086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226806|NCT02426086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6226807|NCT02426086|Vitamin B Complex|vitamin b complex|mesh-ancestor
6226808|NCT02426086|Vitamins|vitamins|mesh-ancestor
6500024|NCT00643539|Azithromycin|azithromycin|mesh-list
6500025|NCT00643539|Amoxicillin|amoxicillin|mesh-list
6500026|NCT00643539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6500027|NCT00643539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6500028|NCT00643643|Maraviroc|maraviroc|mesh-list
6500029|NCT00643643|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5705570|NCT03317457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5705571|NCT03317457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5705572|NCT03317457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5705573|NCT03317457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5705574|NCT03317457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6500030|NCT00643643|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6500031|NCT00643643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500032|NCT00643643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6226809|NCT02426086|Micronutrients|micronutrients|mesh-ancestor
6226810|NCT02426086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226811|NCT02426541|Dapagliflozin|dapagliflozin|mesh-list
6226812|NCT02426541|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6226813|NCT02426541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226814|NCT02426541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6226815|NCT02426541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226816|NCT02426658|Pemetrexed|pemetrexed|mesh-list
6226817|NCT02426658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6226818|NCT02426658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6226819|NCT02426658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226820|NCT02426658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6226821|NCT02426658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6226822|NCT02426918|Vancomycin|vancomycin|mesh-list
6226823|NCT02426918|Linezolid|linezolid|mesh-list
6226824|NCT02426918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6226825|NCT02426918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6226826|NCT02426918|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6226827|NCT02426918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6226828|NCT02426918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226829|NCT02427646|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
6226830|NCT02427646|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6226831|NCT02427646|Botulinum Toxins|botulinum toxins|mesh-list
6226832|NCT02427646|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6226833|NCT02427646|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6226834|NCT02427646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6226835|NCT02427646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226836|NCT02427646|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6226837|NCT02427646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6226838|NCT02427646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226839|NCT02427646|Cholinergic Agents|cholinergic agents|mesh-ancestor
6226840|NCT02427646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6500033|NCT00643643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5705575|NCT03317457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226841|NCT02427737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
6226842|NCT02427737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6226843|NCT02427737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226844|NCT02427802|Gentamicins|gentamicins|mesh-list
6226845|NCT02427802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6226846|NCT02427802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6226847|NCT02427802|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6226848|NCT02427802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5705576|NCT03317457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5705577|NCT03317327|Nivolumab|nivolumab|mesh-list
5705578|NCT03317327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5705579|NCT03317327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5705580|NCT03317327|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5705581|NCT03317327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705582|NCT03317275|Fluorides|fluorides|mesh-list
5705583|NCT03317275|Cariostatic Agents|cariostatic agents|mesh-ancestor
5705584|NCT03317275|Protective Agents|protective agents|mesh-ancestor
5705585|NCT03317275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705586|NCT03317236|Quetiapine Fumarate|quetiapine fumarate|mesh-list
5705587|NCT03317236|Antidepressive Agents|antidepressive agents|mesh-ancestor
5705588|NCT03317236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5705589|NCT03317236|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5705590|NCT03317236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5705591|NCT03317236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5705592|NCT03317236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705593|NCT03317210|Epoetin Alfa|epoetin alfa|mesh-list
5705594|NCT03317210|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
5705595|NCT03317210|Hematinics|hematinics|mesh-ancestor
5705596|NCT03317197|Vasopressins|vasopressins|mesh-list
5705597|NCT03317197|Arginine Vasopressin|arginine vasopressin|mesh-list
5705598|NCT03317197|Epinephrine|epinephrine|mesh-list
5705599|NCT03317197|Racepinephrine|racepinephrine|mesh-list
5705600|NCT03317197|Epinephryl borate|epinephryl borate|mesh-list
5705601|NCT03317197|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5705602|NCT03317197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5705603|NCT03317197|Adrenergic Agents|adrenergic agents|mesh-ancestor
5705604|NCT03317197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5705605|NCT03317197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705606|NCT03317197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705607|NCT03317197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5705608|NCT03317197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5705609|NCT03317197|Autonomic Agents|autonomic agents|mesh-ancestor
5705610|NCT03317197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5705611|NCT03317197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6226849|NCT02427802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226850|NCT02427841|Gemcitabine|gemcitabine|mesh-list
6226851|NCT02427841|Paclitaxel|paclitaxel|mesh-list
6226852|NCT02427841|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6226853|NCT02427841|Fluorouracil|fluorouracil|mesh-list
6226854|NCT02427841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6226855|NCT02427841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6226856|NCT02427841|Tubulin Modulators|tubulin modulators|mesh-ancestor
6226857|NCT02427841|Antimitotic Agents|antimitotic agents|mesh-ancestor
6226858|NCT02427841|Mitosis Modulators|mitosis modulators|mesh-ancestor
6226859|NCT02427841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226860|NCT02427841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6226861|NCT02427841|Antimetabolites|antimetabolites|mesh-ancestor
6226862|NCT02427841|Antiviral Agents|antiviral agents|mesh-ancestor
6226863|NCT02427841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5705612|NCT03317197|Respiratory System Agents|respiratory system agents|mesh-ancestor
5705613|NCT03317197|Mydriatics|mydriatics|mesh-ancestor
5705614|NCT03317197|Sympathomimetics|sympathomimetics|mesh-ancestor
5705615|NCT03317197|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5705616|NCT03317197|Hemostatics|hemostatics|mesh-ancestor
6226864|NCT02427841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6226865|NCT02427841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6226866|NCT02427841|Immunologic Factors|immunologic factors|mesh-ancestor
6226867|NCT02427841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226868|NCT02427958|Leuprolide|leuprolide|mesh-list
6226869|NCT02427958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6226870|NCT02427958|Fertility Agents|fertility agents|mesh-ancestor
6226871|NCT02427958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6226872|NCT02427958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705617|NCT03317197|Coagulants|coagulants|mesh-ancestor
5705618|NCT03317197|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5705619|NCT03317197|Natriuretic Agents|natriuretic agents|mesh-ancestor
6226873|NCT02427958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6226874|NCT02427958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6226875|NCT02428192|Nivolumab|nivolumab|mesh-list
6226876|NCT02428192|Ipilimumab|ipilimumab|mesh-list
6226877|NCT02428192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6226878|NCT02428192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6226879|NCT02428192|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6226880|NCT02428192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226881|NCT02428296|Sirolimus|sirolimus|mesh-list
6226882|NCT02428296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6226883|NCT02428296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6226884|NCT02428296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6226885|NCT02428296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6226886|NCT02428296|Antifungal Agents|antifungal agents|mesh-ancestor
6226887|NCT02428296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6226888|NCT02428296|Immunologic Factors|immunologic factors|mesh-ancestor
6226889|NCT02428296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226890|NCT02428478|Desipramine|desipramine|mesh-list
6226891|NCT02428478|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6226892|NCT02428478|Antidepressive Agents|antidepressive agents|mesh-ancestor
6226893|NCT02428478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6226894|NCT02428478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6226895|NCT02428478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226896|NCT02428478|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6226897|NCT02428478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6226898|NCT02428478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6226899|NCT02428478|Adrenergic Agents|adrenergic agents|mesh-ancestor
6226900|NCT02428478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6226901|NCT02428478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226902|NCT02428608|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6226903|NCT02428608|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6226904|NCT02428608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6226905|NCT02428608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226906|NCT02428608|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6226907|NCT02428608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6226908|NCT02428608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226909|NCT02428608|Cholinergic Agents|cholinergic agents|mesh-ancestor
6226910|NCT02428608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6226911|NCT02428699|Cod Liver Oil|cod liver oil|mesh-list
6226912|NCT02428699|Liver Extracts|liver extracts|mesh-list
6226913|NCT02428699|Hematinics|hematinics|mesh-ancestor
6226914|NCT02428699|Vitamins|vitamins|mesh-ancestor
6226915|NCT02428699|Micronutrients|micronutrients|mesh-ancestor
6226916|NCT02428699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226917|NCT02428855|Dasatinib|dasatinib|mesh-list
6226918|NCT02428855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6226919|NCT02428855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6226920|NCT02428855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6226921|NCT02428855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226922|NCT02429258|Metformin|metformin|mesh-list
6226923|NCT02429258|Dapagliflozin|dapagliflozin|mesh-list
6226924|NCT02429258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6226925|NCT02429258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226926|NCT02429258|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6226927|NCT02429258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243610|NCT02674412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6243611|NCT02674412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244276|NCT02691572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6244277|NCT02691572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6244278|NCT02691572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6244279|NCT02691572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6244280|NCT02691572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5705620|NCT03317158|Durvalumab|durvalumab|mesh-list
5705621|NCT03317158|BCG Vaccine|bcg vaccine|mesh-list
5705622|NCT03317158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5705623|NCT03317158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5705624|NCT03317158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5705625|NCT03317158|Immunologic Factors|immunologic factors|mesh-ancestor
5705626|NCT03317158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705627|NCT03317093|Ceftobiprole|ceftobiprole|mesh-list
5705628|NCT03317093|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
5705629|NCT03317093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5705630|NCT03317093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5705631|NCT03317067|Dexmedetomidine|dexmedetomidine|mesh-list
6226928|NCT02429427|Celecoxib|celecoxib|mesh-list
6226929|NCT02429427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6226930|NCT02429427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6226931|NCT02429427|Analgesics|analgesics|mesh-ancestor
6226932|NCT02429427|Sensory System Agents|sensory system agents|mesh-ancestor
6226933|NCT02429427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6226934|NCT02429427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226935|NCT02429427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5705632|NCT03317067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5705633|NCT03317067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5705634|NCT03317067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705635|NCT03317067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5705636|NCT03317067|Analgesics|analgesics|mesh-ancestor
5705637|NCT03317067|Sensory System Agents|sensory system agents|mesh-ancestor
5705638|NCT03317067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5705639|NCT03317067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5705640|NCT03317067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5705641|NCT03317067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5705642|NCT03317067|Adrenergic Agents|adrenergic agents|mesh-ancestor
5705643|NCT03317067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6226936|NCT02429427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6226937|NCT02429427|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6226938|NCT02429427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5705644|NCT03317067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705645|NCT03317015|Fluticasone|fluticasone|mesh-list
5705646|NCT03317015|Triamcinolone|triamcinolone|mesh-list
5705647|NCT03317015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5705648|NCT03317015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5705649|NCT03317015|Autonomic Agents|autonomic agents|mesh-ancestor
5705650|NCT03317015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5705651|NCT03317015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705652|NCT03317015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5705653|NCT03317015|Respiratory System Agents|respiratory system agents|mesh-ancestor
5705654|NCT03317015|Dermatologic Agents|dermatologic agents|mesh-ancestor
5705655|NCT03317015|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5705656|NCT03317015|Glucocorticoids|glucocorticoids|mesh-ancestor
5705657|NCT03317015|Hormones|hormones|mesh-ancestor
5721237|NCT03207165|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-list
6226939|NCT02429427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6226940|NCT02429427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226941|NCT02429869|Everolimus|everolimus|mesh-list
6226942|NCT02429869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6226943|NCT02429869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6226944|NCT02429869|Immunologic Factors|immunologic factors|mesh-ancestor
6226945|NCT02429869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226946|NCT02429934|Abatacept|abatacept|mesh-list
6226947|NCT02429934|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6226948|NCT02429934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6226949|NCT02429934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6226950|NCT02429934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6226951|NCT02429934|Immunologic Factors|immunologic factors|mesh-ancestor
6226952|NCT02429934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226953|NCT02429934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6226954|NCT02430090|Fentanyl|fentanyl|mesh-list
6226955|NCT02430090|Sufentanil|sufentanil|mesh-list
6226956|NCT02430090|Levobupivacaine|levobupivacaine|mesh-list
6226957|NCT02430090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6226958|NCT02430090|Narcotics|narcotics|mesh-ancestor
6226959|NCT02430090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6226960|NCT02430090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226961|NCT02430090|Analgesics|analgesics|mesh-ancestor
6226962|NCT02430090|Sensory System Agents|sensory system agents|mesh-ancestor
6226963|NCT02430090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6226964|NCT02430090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6226965|NCT02430090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6226966|NCT02430090|Anesthetics, General|anesthetics, general|mesh-ancestor
6226967|NCT02430090|Anesthetics|anesthetics|mesh-ancestor
6226968|NCT02430090|Anesthetics, Local|anesthetics, local|mesh-ancestor
6226969|NCT02430311|Paclitaxel|paclitaxel|mesh-list
6226970|NCT02430311|Olaparib|olaparib|mesh-list
6226971|NCT02430311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6226972|NCT02430311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6226973|NCT02430311|Tubulin Modulators|tubulin modulators|mesh-ancestor
6226974|NCT02430311|Antimitotic Agents|antimitotic agents|mesh-ancestor
6226975|NCT02430311|Mitosis Modulators|mitosis modulators|mesh-ancestor
6226976|NCT02430311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705658|NCT03317015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5705659|NCT03316963|Neostigmine|neostigmine|mesh-list
5705660|NCT03316963|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5705661|NCT03316963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5705662|NCT03316963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705663|NCT03316963|Cholinergic Agents|cholinergic agents|mesh-ancestor
6226977|NCT02430311|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6226978|NCT02430311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6226979|NCT02430389|Remifentanil|remifentanil|mesh-list
6226980|NCT02430389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6226981|NCT02430389|Narcotics|narcotics|mesh-ancestor
6226982|NCT02430389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6226983|NCT02430389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226984|NCT02430389|Analgesics|analgesics|mesh-ancestor
6226985|NCT02430389|Sensory System Agents|sensory system agents|mesh-ancestor
6226986|NCT02430389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6226987|NCT02430480|Goserelin|goserelin|mesh-list
6226988|NCT02430480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6226989|NCT02430480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6226990|NCT02430818|Morphine|morphine|mesh-list
6226991|NCT02430818|Ketamine|ketamine|mesh-list
6226992|NCT02430818|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6226993|NCT02430818|Narcotics|narcotics|mesh-ancestor
6226994|NCT02430818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6226995|NCT02430818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6226996|NCT02430818|Analgesics|analgesics|mesh-ancestor
6226997|NCT02430818|Sensory System Agents|sensory system agents|mesh-ancestor
6226998|NCT02430818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6226999|NCT02430818|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6227000|NCT02430818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6227001|NCT02430818|Anesthetics, General|anesthetics, general|mesh-ancestor
6227002|NCT02430818|Anesthetics|anesthetics|mesh-ancestor
6227003|NCT02430818|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6227004|NCT02430818|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6227005|NCT02430818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6227006|NCT02430818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227007|NCT02431260|INCB054329|incb054329|mesh-list
6227008|NCT02431260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6227009|NCT02431468|Bryostatin 1|bryostatin 1|mesh-list
6227010|NCT02431468|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6227011|NCT02431468|Immunologic Factors|immunologic factors|mesh-ancestor
6227012|NCT02431468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227013|NCT02431468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6227014|NCT02431533|Calcium|calcium|mesh-list
6227015|NCT02431533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6227016|NCT02431533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227017|NCT02431559|Doxorubicin|doxorubicin|mesh-list
6227018|NCT02431559|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6227019|NCT02431559|Durvalumab|durvalumab|mesh-list
6227020|NCT02431559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6227021|NCT02431559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6227022|NCT02431559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6227023|NCT02431559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6227024|NCT02431559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6227025|NCT02431559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227026|NCT02431559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6227027|NCT02431572|Vaccines|vaccines|mesh-list
6227028|NCT02431572|Immunologic Factors|immunologic factors|mesh-ancestor
5705664|NCT03316963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5705665|NCT03316963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705666|NCT03316963|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5705667|NCT03316963|Autonomic Agents|autonomic agents|mesh-ancestor
6227029|NCT02431572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227030|NCT02431598|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
6227031|NCT02431598|Chelating Agents|chelating agents|mesh-ancestor
6227032|NCT02431598|Sequestering Agents|sequestering agents|mesh-ancestor
6227033|NCT02431598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227034|NCT02431637|Piperaquine|piperaquine|mesh-list
6227035|NCT02431637|Antimalarials|antimalarials|mesh-ancestor
6227036|NCT02431637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6500034|NCT00643643|Antiviral Agents|antiviral agents|mesh-ancestor
6500035|NCT00643643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6500036|NCT00643643|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6500037|NCT00643734|Azithromycin|azithromycin|mesh-list
6500038|NCT00643734|Levofloxacin|levofloxacin|mesh-list
6227037|NCT02431637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6227038|NCT02431637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6227039|NCT02431650|Primaquine|primaquine|mesh-list
6227040|NCT02431650|Antimalarials|antimalarials|mesh-ancestor
6227041|NCT02431650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6227042|NCT02431650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6227043|NCT02431650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6227044|NCT02431676|Metformin|metformin|mesh-list
6227045|NCT02431676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6227046|NCT02431676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227047|NCT02431754|Tadalafil|tadalafil|mesh-list
6227048|NCT02431754|Vasodilator Agents|vasodilator agents|mesh-ancestor
6227049|NCT02431754|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6227050|NCT02431754|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6227051|NCT02431754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6227052|NCT02431754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227053|NCT02431754|Urological Agents|urological agents|mesh-ancestor
6227054|NCT02431806|Milnacipran|milnacipran|mesh-list
6227055|NCT02431806|Fluoxetine|fluoxetine|mesh-list
6227056|NCT02431806|Levomilnacipran|levomilnacipran|mesh-list
6227057|NCT02431806|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6227058|NCT02431806|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6227059|NCT02431806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6227060|NCT02431806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227061|NCT02431806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6227062|NCT02431806|Serotonin Agents|serotonin agents|mesh-ancestor
6227063|NCT02431806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227064|NCT02431806|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6227065|NCT02431806|Antidepressive Agents|antidepressive agents|mesh-ancestor
6227066|NCT02431806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5705668|NCT03316963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5705669|NCT03316898|Memantine|memantine|mesh-list
5705670|NCT03316898|Donepezil|donepezil|mesh-list
5705671|NCT03316898|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5705672|NCT03316898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5705673|NCT03316898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705674|NCT03316898|Cholinergic Agents|cholinergic agents|mesh-ancestor
5705675|NCT03316898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5705676|NCT03316898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227067|NCT02431806|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6227068|NCT02431806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6227069|NCT02431806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6227070|NCT02431806|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6227071|NCT02431806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6227072|NCT02431806|Analgesics|analgesics|mesh-ancestor
6227073|NCT02431806|Sensory System Agents|sensory system agents|mesh-ancestor
6227074|NCT02431806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6227075|NCT02432040|Atorvastatin|atorvastatin|mesh-list
6227076|NCT02432040|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6227077|NCT02432040|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6227078|NCT02432040|Antimetabolites|antimetabolites|mesh-ancestor
6227079|NCT02432040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227080|NCT02432040|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6227081|NCT02432040|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6227082|NCT02432040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6227083|NCT02432274|Etoposide|etoposide|mesh-list
6227084|NCT02432274|Etoposide phosphate|etoposide phosphate|mesh-list
6227085|NCT02432274|Ifosfamide|ifosfamide|mesh-list
6227086|NCT02432274|Isophosphamide mustard|isophosphamide mustard|mesh-list
6227087|NCT02432274|Lenvatinib|lenvatinib|mesh-list
6227088|NCT02432274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6227089|NCT02432274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6227090|NCT02432274|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6227091|NCT02432274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6227092|NCT02432274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6227093|NCT02432274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227094|NCT02432274|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6227095|NCT02432274|Alkylating Agents|alkylating agents|mesh-ancestor
6227096|NCT02432274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6227097|NCT02432287|Metformin|metformin|mesh-list
6227098|NCT02432287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6227099|NCT02432287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227100|NCT02432456|Acetaminophen|acetaminophen|mesh-list
6227101|NCT02432456|Ibuprofen|ibuprofen|mesh-list
6227102|NCT02432456|Ketamine|ketamine|mesh-list
6227103|NCT02432456|Narcotics|narcotics|mesh-list
6227104|NCT02432456|Methocarbamol|methocarbamol|mesh-list
6227105|NCT02432456|Pantoprazole|pantoprazole|mesh-list
6227106|NCT02432456|Analgesics|analgesics|mesh-ancestor
6227107|NCT02432456|Sensory System Agents|sensory system agents|mesh-ancestor
6227108|NCT02432456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6227109|NCT02432456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227110|NCT02432456|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6227111|NCT02432456|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6227112|NCT02432456|Anesthetics, General|anesthetics, general|mesh-ancestor
6227113|NCT02432456|Anesthetics|anesthetics|mesh-ancestor
6227114|NCT02432456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6227115|NCT02432456|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6227116|NCT02432456|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6227117|NCT02432456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6227118|NCT02432456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227119|NCT02432456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6227120|NCT02432456|Antipyretics|antipyretics|mesh-ancestor
5705677|NCT03316898|Nootropic Agents|nootropic agents|mesh-ancestor
5705678|NCT03316898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5705679|NCT03316898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5705680|NCT03316898|Dopamine Agents|dopamine agents|mesh-ancestor
5705681|NCT03316898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5705682|NCT03316898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5705683|NCT03316859|Naloxegol|naloxegol|mesh-list
5705684|NCT03316859|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5705685|NCT03316859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705686|NCT03316859|Sensory System Agents|sensory system agents|mesh-ancestor
5705687|NCT03316859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5721238|NCT03207165|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5721239|NCT03207165|Sympathomimetics|sympathomimetics|mesh-ancestor
5721240|NCT03207165|Autonomic Agents|autonomic agents|mesh-ancestor
5721241|NCT03207165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5721242|NCT03207165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721243|NCT03207165|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5721244|NCT03207165|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5721245|NCT03207165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5721246|NCT03207165|Adrenergic Agents|adrenergic agents|mesh-ancestor
5721247|NCT03207165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5721248|NCT03207165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227121|NCT02432456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6227122|NCT02432456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6227123|NCT02432456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6227124|NCT02432456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6227125|NCT02432456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6227126|NCT02432456|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6227127|NCT02432456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6227128|NCT02432456|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6227129|NCT02432456|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6227130|NCT02432456|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6227131|NCT02432703|JNJ-42165279|jnj-42165279|mesh-list
5721249|NCT03207165|Protective Agents|protective agents|mesh-ancestor
6227132|NCT02432703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6227133|NCT02432703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227134|NCT02432716|Insulin|insulin|mesh-list
6227135|NCT02432716|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6227136|NCT02432716|Insulin glulisine|insulin glulisine|mesh-list
6227137|NCT02432716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6227138|NCT02432716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227139|NCT02432742|Hyaluronic Acid|hyaluronic acid|mesh-list
6227140|NCT02432742|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6227141|NCT02432742|Immunologic Factors|immunologic factors|mesh-ancestor
6227142|NCT02432742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227143|NCT02432742|Viscosupplements|viscosupplements|mesh-ancestor
6227144|NCT02432742|Protective Agents|protective agents|mesh-ancestor
6227145|NCT02433483|Cytarabine|cytarabine|mesh-list
6227146|NCT02433483|Hydrocortisone|hydrocortisone|mesh-list
6227147|NCT02433483|Methotrexate|methotrexate|mesh-list
6227148|NCT02433483|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6227149|NCT02433483|Abortifacient Agents|abortifacient agents|mesh-ancestor
6227150|NCT02433483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6227151|NCT02433483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227152|NCT02433483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6227153|NCT02433483|Antimetabolites|antimetabolites|mesh-ancestor
6227154|NCT02433483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227155|NCT02433483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6227156|NCT02433483|Dermatologic Agents|dermatologic agents|mesh-ancestor
6227157|NCT02433483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6227158|NCT02433483|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6227159|NCT02433483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6227160|NCT02433483|Immunologic Factors|immunologic factors|mesh-ancestor
6227161|NCT02433483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6227162|NCT02433483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6227163|NCT02433483|Antiviral Agents|antiviral agents|mesh-ancestor
6227164|NCT02433483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6227165|NCT02433483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6227166|NCT02433678|Dapagliflozin|dapagliflozin|mesh-list
6227167|NCT02433678|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6227168|NCT02433678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227169|NCT02433678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6227170|NCT02433678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227171|NCT02433834|Glycopyrrolate|glycopyrrolate|mesh-list
6227172|NCT02433834|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6227173|NCT02433834|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6227174|NCT02433834|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6227175|NCT02433834|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6227176|NCT02433834|Cholinergic Agents|cholinergic agents|mesh-ancestor
6227177|NCT02433834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6227178|NCT02433834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227179|NCT02433834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227180|NCT02433834|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6227181|NCT02433834|Autonomic Agents|autonomic agents|mesh-ancestor
6227182|NCT02433834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6227183|NCT02433834|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6227184|NCT02433834|Respiratory System Agents|respiratory system agents|mesh-ancestor
6227185|NCT02433834|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6227186|NCT02433834|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6227187|NCT02433834|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6227188|NCT02433834|Adrenergic Agents|adrenergic agents|mesh-ancestor
6227189|NCT02434081|Nivolumab|nivolumab|mesh-list
6227190|NCT02434081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6227191|NCT02434081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6227192|NCT02434081|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6227193|NCT02434081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227194|NCT02434328|Aflibercept|aflibercept|mesh-list
6227195|NCT02434328|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6227196|NCT02434328|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6227197|NCT02434328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6227198|NCT02434328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6227199|NCT02434328|Growth Substances|growth substances|mesh-ancestor
6227200|NCT02434328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227201|NCT02434328|Growth Inhibitors|growth inhibitors|mesh-ancestor
6227202|NCT02434328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5705688|NCT03316781|Adalimumab|adalimumab|mesh-list
5705689|NCT03316781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5705690|NCT03316781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5705691|NCT03316690|Metformin|metformin|mesh-list
5705692|NCT03316690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6227203|NCT02434497|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6227204|NCT02434497|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6227205|NCT02434497|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6227206|NCT02434497|Antimetabolites|antimetabolites|mesh-ancestor
6227207|NCT02434497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227208|NCT02434497|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6227209|NCT02434497|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6227210|NCT02434497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6227211|NCT02434523|Amitriptyline|amitriptyline|mesh-list
6227212|NCT02434523|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6227213|NCT02434523|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6227214|NCT02434523|Antidepressive Agents|antidepressive agents|mesh-ancestor
6227215|NCT02434523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6227216|NCT02434523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6227217|NCT02434523|Analgesics|analgesics|mesh-ancestor
6227218|NCT02434523|Sensory System Agents|sensory system agents|mesh-ancestor
6227219|NCT02434523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6227220|NCT02434523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227221|NCT02434523|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6500039|NCT00643734|Ofloxacin|ofloxacin|mesh-list
6500040|NCT00643734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5705693|NCT03316690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227222|NCT02434523|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6227223|NCT02434523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6227224|NCT02434523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227225|NCT02434523|Adrenergic Agents|adrenergic agents|mesh-ancestor
6227226|NCT02434523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6227227|NCT02434523|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6227228|NCT02434523|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6227229|NCT02434523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6227230|NCT02434770|Vaccines|vaccines|mesh-list
6227231|NCT02434770|Immunologic Factors|immunologic factors|mesh-ancestor
6227232|NCT02434770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227233|NCT02434939|Morphine|morphine|mesh-list
6227234|NCT02434939|Ketamine|ketamine|mesh-list
6227235|NCT02434939|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6227236|NCT02434939|Narcotics|narcotics|mesh-ancestor
6227237|NCT02434939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6227238|NCT02434939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227239|NCT02434939|Analgesics|analgesics|mesh-ancestor
6227240|NCT02434939|Sensory System Agents|sensory system agents|mesh-ancestor
6227241|NCT02434939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6227242|NCT02434939|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6227243|NCT02434939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6227244|NCT02434939|Anesthetics, General|anesthetics, general|mesh-ancestor
6227245|NCT02434939|Anesthetics|anesthetics|mesh-ancestor
6227246|NCT02434939|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5705694|NCT03316599|Gemcitabine|gemcitabine|mesh-list
5705695|NCT03316599|Paclitaxel|paclitaxel|mesh-list
5705696|NCT03316599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5705697|NCT03316599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5705698|NCT03316599|Tubulin Modulators|tubulin modulators|mesh-ancestor
5705699|NCT03316599|Antimitotic Agents|antimitotic agents|mesh-ancestor
5705700|NCT03316599|Mitosis Modulators|mitosis modulators|mesh-ancestor
5705701|NCT03316599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705702|NCT03316599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5705703|NCT03316599|Antimetabolites|antimetabolites|mesh-ancestor
5705704|NCT03316599|Antiviral Agents|antiviral agents|mesh-ancestor
5705705|NCT03316599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5705706|NCT03316599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5705707|NCT03316599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5705708|NCT03316599|Immunologic Factors|immunologic factors|mesh-ancestor
5705709|NCT03316599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705710|NCT03316573|Pembrolizumab|pembrolizumab|mesh-list
5705711|NCT03316573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5705712|NCT03316573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5705713|NCT03316534|Aspirin|aspirin|mesh-list
6227247|NCT02434939|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6227248|NCT02434939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6227249|NCT02434939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227250|NCT02435069|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6227251|NCT02435069|Glycerol|glycerol|mesh-list
6227252|NCT02435069|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6227253|NCT02435069|Protective Agents|protective agents|mesh-ancestor
6227254|NCT02435069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227255|NCT02435147|Denosumab|denosumab|mesh-list
6227256|NCT02435147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6227257|NCT02435147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227258|NCT02435277|Metformin|metformin|mesh-list
5705714|NCT03316534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5705715|NCT03316534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5705716|NCT03316534|Analgesics|analgesics|mesh-ancestor
5705717|NCT03316534|Sensory System Agents|sensory system agents|mesh-ancestor
5705718|NCT03316534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5705719|NCT03316534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705720|NCT03316534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5705721|NCT03316534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5705722|NCT03316534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5705723|NCT03316534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5705724|NCT03316534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705725|NCT03316534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6227259|NCT02435277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6227260|NCT02435277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227261|NCT02435680|Gemcitabine|gemcitabine|mesh-list
6227262|NCT02435680|Carboplatin|carboplatin|mesh-list
6227263|NCT02435680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5705726|NCT03316534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5705727|NCT03316534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5705728|NCT03316534|Antipyretics|antipyretics|mesh-ancestor
5705729|NCT03316482|Leuprolide|leuprolide|mesh-list
6227264|NCT02435680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6227265|NCT02435680|Antimetabolites|antimetabolites|mesh-ancestor
6227266|NCT02435680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227267|NCT02435680|Antiviral Agents|antiviral agents|mesh-ancestor
6227268|NCT02435680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6227269|NCT02435680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6227270|NCT02435680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6227271|NCT02435680|Immunologic Factors|immunologic factors|mesh-ancestor
6227272|NCT02435680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227273|NCT02435836|Aripiprazole|aripiprazole|mesh-list
6227274|NCT02435836|Antidepressive Agents|antidepressive agents|mesh-ancestor
6227275|NCT02435836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6227276|NCT02435836|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6227277|NCT02435836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6227278|NCT02435836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6227279|NCT02435836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227280|NCT02435836|Dopamine Agonists|dopamine agonists|mesh-ancestor
6227281|NCT02435836|Dopamine Agents|dopamine agents|mesh-ancestor
6227282|NCT02435836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6227283|NCT02435836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227284|NCT02435836|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6227285|NCT02435836|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6227286|NCT02435836|Serotonin Agents|serotonin agents|mesh-ancestor
6227287|NCT02435836|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6227288|NCT02435836|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6227289|NCT02435836|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6227290|NCT02435836|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6227291|NCT02435901|Cyclosporine|cyclosporine|mesh-list
6227292|NCT02435901|Mycophenolic Acid|mycophenolic acid|mesh-list
6227293|NCT02435901|Fludarabine|fludarabine|mesh-list
6227294|NCT02435901|Melphalan|melphalan|mesh-list
6227295|NCT02435901|Alemtuzumab|alemtuzumab|mesh-list
6227296|NCT02435901|Tacrolimus|tacrolimus|mesh-list
6227297|NCT02435901|Cyclosporins|cyclosporins|mesh-list
6227298|NCT02435901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6227299|NCT02435901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227300|NCT02435901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6227301|NCT02435901|Immunologic Factors|immunologic factors|mesh-ancestor
6227302|NCT02435901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227303|NCT02435901|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6227304|NCT02435901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6227305|NCT02435901|Antifungal Agents|antifungal agents|mesh-ancestor
6227306|NCT02435901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6227307|NCT02435901|Dermatologic Agents|dermatologic agents|mesh-ancestor
6227308|NCT02435901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6227309|NCT02435901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6227310|NCT02435901|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6227311|NCT02435901|Antitubercular Agents|antitubercular agents|mesh-ancestor
6227312|NCT02435901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6227313|NCT02435901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6227314|NCT02435901|Alkylating Agents|alkylating agents|mesh-ancestor
6227315|NCT02435901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6227316|NCT02435901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6227317|NCT02435914|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6227318|NCT02435914|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6227319|NCT02435992|Ozanimod|ozanimod|mesh-list
6227320|NCT02435992|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6227321|NCT02435992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227322|NCT02435992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6227323|NCT02435992|Immunologic Factors|immunologic factors|mesh-ancestor
6227324|NCT02435992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227325|NCT02436031|Desipramine|desipramine|mesh-list
6227326|NCT02436031|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5705730|NCT03316482|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5705731|NCT03316482|Fertility Agents|fertility agents|mesh-ancestor
5705732|NCT03316482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5705733|NCT03316482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705734|NCT03316482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5705735|NCT03316482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5705736|NCT03316469|Clomiphene|clomiphene|mesh-list
5705737|NCT03316469|Enclomiphene|enclomiphene|mesh-list
6227327|NCT02436031|Antidepressive Agents|antidepressive agents|mesh-ancestor
6227328|NCT02436031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6227329|NCT02436031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6227330|NCT02436031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227331|NCT02436031|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6227332|NCT02436031|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6227333|NCT02436031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6227334|NCT02436031|Adrenergic Agents|adrenergic agents|mesh-ancestor
6227335|NCT02436031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6227336|NCT02436031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227337|NCT02436135|Idelalisib|idelalisib|mesh-list
6227338|NCT02436135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6227339|NCT02436135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6227340|NCT02436135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227341|NCT02436239|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
6227342|NCT02436239|Antidepressive Agents|antidepressive agents|mesh-ancestor
6227343|NCT02436239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6227344|NCT02436239|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6227345|NCT02436239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6227346|NCT02436239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6227347|NCT02436239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227348|NCT02436239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6227349|NCT02436239|Serotonin Agents|serotonin agents|mesh-ancestor
6227350|NCT02436239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227351|NCT02436239|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6227352|NCT02436239|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6227353|NCT02436577|Ticagrelor|ticagrelor|mesh-list
6227354|NCT02436577|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6227355|NCT02436577|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6227356|NCT02436577|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6227357|NCT02436577|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6227358|NCT02436577|Purinergic Agents|purinergic agents|mesh-ancestor
6227359|NCT02436577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6227360|NCT02436577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227361|NCT02436577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227362|NCT02436668|Gemcitabine|gemcitabine|mesh-list
6227363|NCT02436668|Paclitaxel|paclitaxel|mesh-list
6227364|NCT02436668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6227365|NCT02436668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6227366|NCT02436668|Tubulin Modulators|tubulin modulators|mesh-ancestor
6227367|NCT02436668|Antimitotic Agents|antimitotic agents|mesh-ancestor
6227368|NCT02436668|Mitosis Modulators|mitosis modulators|mesh-ancestor
6227369|NCT02436668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227370|NCT02436668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6227371|NCT02436668|Antimetabolites|antimetabolites|mesh-ancestor
6227372|NCT02436668|Antiviral Agents|antiviral agents|mesh-ancestor
6227373|NCT02436668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6227374|NCT02436668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6227375|NCT02436668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6227376|NCT02436668|Immunologic Factors|immunologic factors|mesh-ancestor
6227377|NCT02436668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227378|NCT02436759|Phenylephrine|phenylephrine|mesh-list
6227379|NCT02436759|Oxymetazoline|oxymetazoline|mesh-list
6227380|NCT02436759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6227381|NCT02436759|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6227382|NCT02436759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6227383|NCT02436759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6227384|NCT02436759|Adrenergic Agents|adrenergic agents|mesh-ancestor
6227385|NCT02436759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6227386|NCT02436759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227387|NCT02436759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227388|NCT02436759|Sympathomimetics|sympathomimetics|mesh-ancestor
6227389|NCT02436759|Autonomic Agents|autonomic agents|mesh-ancestor
6227390|NCT02436759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6227391|NCT02436759|Nasal Decongestants|nasal decongestants|mesh-ancestor
6227392|NCT02436759|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6227393|NCT02436759|Respiratory System Agents|respiratory system agents|mesh-ancestor
6227394|NCT02436759|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6227395|NCT02436759|Mydriatics|mydriatics|mesh-ancestor
6227396|NCT02436759|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6227397|NCT02436759|Protective Agents|protective agents|mesh-ancestor
6227398|NCT02436889|Mirabegron|mirabegron|mesh-list
6227399|NCT02436889|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6227400|NCT02436889|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6227401|NCT02436889|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6227402|NCT02436889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6227403|NCT02436889|Adrenergic Agents|adrenergic agents|mesh-ancestor
6227404|NCT02436889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6227405|NCT02436889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227406|NCT02436889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227407|NCT02436889|Urological Agents|urological agents|mesh-ancestor
5705738|NCT03316469|Zuclomiphene|zuclomiphene|mesh-list
5705739|NCT03316469|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5705740|NCT03316469|Hormone Antagonists|hormone antagonists|mesh-ancestor
5705741|NCT03316469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5705742|NCT03316469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705743|NCT03316469|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5705744|NCT03316469|Fertility Agents|fertility agents|mesh-ancestor
5705745|NCT03316469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5705746|NCT03316469|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6227408|NCT02436889|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6227409|NCT02436889|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6227410|NCT02436889|Cholinergic Agents|cholinergic agents|mesh-ancestor
6227411|NCT02437084|Atorvastatin|atorvastatin|mesh-list
6227412|NCT02437084|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6227413|NCT02437084|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6227414|NCT02437084|Antimetabolites|antimetabolites|mesh-ancestor
6227415|NCT02437084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227416|NCT02437084|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6676454|NCT01581450|Nitrous Oxide|nitrous oxide|mesh-list
6676455|NCT01581450|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6676456|NCT01581450|Anesthetics, General|anesthetics, general|mesh-ancestor
6500041|NCT00643734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6500042|NCT00643734|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6500043|NCT00643734|Renal Agents|renal agents|mesh-ancestor
6500044|NCT00643734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6500045|NCT00643734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6500046|NCT00643734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6500047|NCT00643734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500048|NCT00643734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6500049|NCT00643734|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6500050|NCT00643734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6500051|NCT00643799|Celecoxib|celecoxib|mesh-list
6500052|NCT00643799|Naproxen|naproxen|mesh-list
6500053|NCT00643799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6500054|NCT00643799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6500055|NCT00643799|Analgesics|analgesics|mesh-ancestor
6500056|NCT00643799|Sensory System Agents|sensory system agents|mesh-ancestor
6500057|NCT00643799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6500058|NCT00643799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6500059|NCT00643799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6500060|NCT00643799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6500061|NCT00643799|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6500062|NCT00643799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6500063|NCT00643799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6500064|NCT00643799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500065|NCT00643799|Gout Suppressants|gout suppressants|mesh-ancestor
6500066|NCT00643825|Temozolomide|temozolomide|mesh-list
6500067|NCT00643825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6500068|NCT00643825|Alkylating Agents|alkylating agents|mesh-ancestor
6500069|NCT00643825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500070|NCT00643825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6500071|NCT00643877|Oxaliplatin|oxaliplatin|mesh-list
6500072|NCT00643877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5705747|NCT03316469|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5705748|NCT03316352|Bupivacaine|bupivacaine|mesh-list
5705749|NCT03316352|Anesthetics|anesthetics|mesh-list
5705750|NCT03316352|Anesthetics, Local|anesthetics, local|mesh-ancestor
5705751|NCT03316352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5705752|NCT03316352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6500073|NCT00644020|Fluorouracil|fluorouracil|mesh-list
6500074|NCT00644020|Mitomycins|mitomycins|mesh-list
6500075|NCT00644020|Mitomycin|mitomycin|mesh-list
6500076|NCT00644020|Antimetabolites|antimetabolites|mesh-ancestor
5705753|NCT03316352|Sensory System Agents|sensory system agents|mesh-ancestor
5705754|NCT03316352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5705755|NCT03316339|Dexmedetomidine|dexmedetomidine|mesh-list
5705756|NCT03316339|Remifentanil|remifentanil|mesh-list
5705757|NCT03316339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6676457|NCT01581450|Anesthetics|anesthetics|mesh-ancestor
5918760|NCT04988932|Vasodilator Agents|vasodilator agents|mesh-ancestor
5918761|NCT04988932|Gasotransmitters|gasotransmitters|mesh-ancestor
5918762|NCT04988932|Protective Agents|protective agents|mesh-ancestor
6227417|NCT02437084|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6227418|NCT02437084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6227419|NCT02437162|Golimumab|golimumab|mesh-list
6227420|NCT02437162|Ustekinumab|ustekinumab|mesh-list
6227421|NCT02437162|Dermatologic Agents|dermatologic agents|mesh-ancestor
6227422|NCT02437162|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
5705758|NCT03316339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5705759|NCT03316339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705760|NCT03316339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5705761|NCT03316339|Analgesics|analgesics|mesh-ancestor
5705762|NCT03316339|Sensory System Agents|sensory system agents|mesh-ancestor
5705763|NCT03316339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5705764|NCT03316339|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5705765|NCT03316339|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5705766|NCT03316339|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5705767|NCT03316339|Adrenergic Agents|adrenergic agents|mesh-ancestor
5705768|NCT03316339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5705769|NCT03316339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705770|NCT03316339|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5705771|NCT03316339|Narcotics|narcotics|mesh-ancestor
5705772|NCT03316326|Oxaliplatin|oxaliplatin|mesh-list
5705773|NCT03316326|Irinotecan|irinotecan|mesh-list
5705774|NCT03316326|Tegafur|tegafur|mesh-list
5705775|NCT03316326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5705776|NCT03316326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5705777|NCT03316326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5705778|NCT03316326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5705779|NCT03316326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705780|NCT03316326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5705781|NCT03316326|Antimetabolites|antimetabolites|mesh-ancestor
5705782|NCT03316313|Antibodies|antibodies|mesh-list
5705783|NCT03316313|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
5705784|NCT03316313|Immunologic Factors|immunologic factors|mesh-ancestor
5705785|NCT03316313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705786|NCT03316118|Bupivacaine|bupivacaine|mesh-list
5705787|NCT03316118|Anesthetics, Local|anesthetics, local|mesh-ancestor
5705788|NCT03316118|Anesthetics|anesthetics|mesh-ancestor
5705789|NCT03316118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5705790|NCT03316118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705791|NCT03316118|Sensory System Agents|sensory system agents|mesh-ancestor
5705792|NCT03316118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5705793|NCT03316066|Ropivacaine|ropivacaine|mesh-list
5705794|NCT03316066|Anesthetics, Local|anesthetics, local|mesh-ancestor
5705795|NCT03316066|Anesthetics|anesthetics|mesh-ancestor
5705796|NCT03316066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5705797|NCT03316066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705798|NCT03316066|Sensory System Agents|sensory system agents|mesh-ancestor
5705799|NCT03316066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6227423|NCT02437162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6227424|NCT02437162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6227425|NCT02437162|Immunologic Factors|immunologic factors|mesh-ancestor
6227426|NCT02437162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227427|NCT02437253|Adalimumab|adalimumab|mesh-list
6227428|NCT02437253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6227429|NCT02437253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6227430|NCT02437344|Naltrexone|naltrexone|mesh-list
6227431|NCT02437344|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6227432|NCT02437344|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6227433|NCT02437344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227434|NCT02437344|Sensory System Agents|sensory system agents|mesh-ancestor
6227435|NCT02437344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6227436|NCT02437383|Propranolol|propranolol|mesh-list
6227437|NCT02437383|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6227438|NCT02437383|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5705800|NCT03315923|Rituximab|rituximab|mesh-list
5705801|NCT03315923|Glatiramer Acetate|glatiramer acetate|mesh-list
5705802|NCT03315923|(T,G)-A-L|(t,g)-a-l|mesh-list
5705803|NCT03315923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5705804|NCT03315923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5705805|NCT03315923|Immunologic Factors|immunologic factors|mesh-ancestor
5918763|NCT04989348|Hormones|hormones|mesh-list
6227439|NCT02437383|Adrenergic Agents|adrenergic agents|mesh-ancestor
6227440|NCT02437383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6227441|NCT02437383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227442|NCT02437383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227443|NCT02437383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6227444|NCT02437383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6227445|NCT02437383|Vasodilator Agents|vasodilator agents|mesh-ancestor
6243612|NCT02674854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6243613|NCT02674854|Latanoprost|latanoprost|mesh-list
6243614|NCT02674854|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6243615|NCT02675426|Upadacitinib|upadacitinib|mesh-list
6243616|NCT02675426|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
6243617|NCT02675426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6243618|NCT02675426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6243619|NCT02675426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243620|NCT02675426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6243621|NCT02675907|Meloxicam|meloxicam|mesh-list
6243622|NCT02675907|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6243623|NCT02675907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6243624|NCT02675907|Analgesics|analgesics|mesh-ancestor
6243625|NCT02675907|Sensory System Agents|sensory system agents|mesh-ancestor
6243626|NCT02675907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5705806|NCT03315923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705807|NCT03315923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5705808|NCT03315923|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6243627|NCT02675907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243628|NCT02675907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6243629|NCT02675907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6243630|NCT02675907|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6243631|NCT02675907|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6243632|NCT02675907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6243633|NCT02675907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243634|NCT02676375|Bupropion|bupropion|mesh-list
6243635|NCT02676375|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6243636|NCT02676375|Antidepressive Agents|antidepressive agents|mesh-ancestor
6500077|NCT00644020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243637|NCT02676375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6243638|NCT02676375|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6243639|NCT02676375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6243640|NCT02676375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6243641|NCT02676375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243642|NCT02676375|Dopamine Agents|dopamine agents|mesh-ancestor
6243643|NCT02676375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6243644|NCT02676375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243645|NCT02676375|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6243646|NCT02676375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6243647|NCT02676375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6243648|NCT02676466|Losartan|losartan|mesh-list
6243649|NCT02676466|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6243650|NCT02676466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6243651|NCT02676466|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6243652|NCT02676466|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6243653|NCT02676466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243654|NCT02676895|Vaccines|vaccines|mesh-list
6243655|NCT02676895|Immunologic Factors|immunologic factors|mesh-ancestor
6243656|NCT02676895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243657|NCT02677116|Doxorubicin|doxorubicin|mesh-list
6243658|NCT02677116|Irinotecan|irinotecan|mesh-list
6243659|NCT02677116|Vincristine|vincristine|mesh-list
5705809|NCT03315923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5705810|NCT03315897|Epoetin Alfa|epoetin alfa|mesh-list
5705811|NCT03315897|Hematinics|hematinics|mesh-ancestor
5705812|NCT03315845|Anesthetics|anesthetics|mesh-list
5705813|NCT03315845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5705814|NCT03315845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705815|NCT03315741|Pirfenidone|pirfenidone|mesh-list
5705816|NCT03315741|Analgesics|analgesics|mesh-ancestor
5705817|NCT03315741|Sensory System Agents|sensory system agents|mesh-ancestor
5705818|NCT03315741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5705819|NCT03315741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705820|NCT03315741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5705821|NCT03315741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5705822|NCT03315741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5705823|NCT03315741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5705824|NCT03315741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5705825|NCT03315676|Esomeprazole|esomeprazole|mesh-list
6227446|NCT02437669|Hydromorphone|hydromorphone|mesh-list
6227447|NCT02437669|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6227448|NCT02437669|Narcotics|narcotics|mesh-ancestor
6227449|NCT02437669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6227450|NCT02437669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227451|NCT02437669|Analgesics|analgesics|mesh-ancestor
5705826|NCT03315676|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5705827|NCT03315676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5705828|NCT03315676|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5705829|NCT03315676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5705830|NCT03315676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705831|NCT03315533|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5705832|NCT03315533|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5705833|NCT03315533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5705834|NCT03315533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5705835|NCT03315533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705836|NCT03315533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5705837|NCT03315533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705838|NCT03315533|Analgesics|analgesics|mesh-ancestor
5705839|NCT03315533|Sensory System Agents|sensory system agents|mesh-ancestor
5705840|NCT03315533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5705841|NCT03315533|Antidepressive Agents|antidepressive agents|mesh-ancestor
5705842|NCT03315533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5705843|NCT03315533|Dopamine Agents|dopamine agents|mesh-ancestor
5705844|NCT03315520|Cytarabine|cytarabine|mesh-list
5705845|NCT03315520|Cyclophosphamide|cyclophosphamide|mesh-list
5705846|NCT03315520|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5705847|NCT03315520|Etoposide|etoposide|mesh-list
6227452|NCT02437669|Sensory System Agents|sensory system agents|mesh-ancestor
6227453|NCT02437669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6227454|NCT02438137|Dimethyl Fumarate|dimethyl fumarate|mesh-list
6227455|NCT02438137|Dermatologic Agents|dermatologic agents|mesh-ancestor
6227456|NCT02438137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6227457|NCT02438137|Immunologic Factors|immunologic factors|mesh-ancestor
6227458|NCT02438137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227459|NCT02438371|Indomethacin|indomethacin|mesh-list
6227460|NCT02438371|Nifedipine|nifedipine|mesh-list
6227461|NCT02438371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6227462|NCT02438371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6227463|NCT02438371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227464|NCT02438371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6227465|NCT02438371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227466|NCT02438371|Vasodilator Agents|vasodilator agents|mesh-ancestor
6227467|NCT02438371|Tocolytic Agents|tocolytic agents|mesh-ancestor
6227468|NCT02438371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6227469|NCT02438371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6227470|NCT02438371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6227471|NCT02438371|Analgesics|analgesics|mesh-ancestor
6227472|NCT02438371|Sensory System Agents|sensory system agents|mesh-ancestor
6227473|NCT02438371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6227474|NCT02438371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6227475|NCT02438371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6227476|NCT02438371|Gout Suppressants|gout suppressants|mesh-ancestor
6227477|NCT02438371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6227478|NCT02438371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5705848|NCT03315520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5705849|NCT03315520|Immunologic Factors|immunologic factors|mesh-ancestor
5705850|NCT03315520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705851|NCT03315520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5705852|NCT03315520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5705853|NCT03315520|Alkylating Agents|alkylating agents|mesh-ancestor
6227479|NCT02438540|Metformin|metformin|mesh-list
6227480|NCT02438540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6227481|NCT02438540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227482|NCT02438722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6227483|NCT02438722|Cetuximab|cetuximab|mesh-list
6227484|NCT02438722|Afatinib|afatinib|mesh-list
6227485|NCT02438722|Antibodies|antibodies|mesh-list
6227486|NCT02438722|Immunoglobulins|immunoglobulins|mesh-list
6227487|NCT02438722|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6227488|NCT02438722|Immunologic Factors|immunologic factors|mesh-ancestor
5918764|NCT04989348|Progestins|progestins|mesh-list
6227489|NCT02438722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227490|NCT02438722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6227491|NCT02438722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6676458|NCT01581450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6676459|NCT01581450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676460|NCT01581450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6676461|NCT01581450|Analgesics|analgesics|mesh-ancestor
6676462|NCT01581450|Sensory System Agents|sensory system agents|mesh-ancestor
6676463|NCT01581450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6676464|NCT01581476|Quinapril|quinapril|mesh-list
6227492|NCT02438722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6227493|NCT02438722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227494|NCT02438787|Golimumab|golimumab|mesh-list
6500078|NCT00644020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6500079|NCT00644020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6500080|NCT00644020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6500081|NCT00644020|Immunologic Factors|immunologic factors|mesh-ancestor
6500082|NCT00644020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6500083|NCT00644020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6500084|NCT00644020|Alkylating Agents|alkylating agents|mesh-ancestor
6500085|NCT00644020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6500086|NCT00644020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6500087|NCT00644033|Frovatriptan|frovatriptan|mesh-list
6500088|NCT00644033|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6500089|NCT00644033|Serotonin Agents|serotonin agents|mesh-ancestor
6500090|NCT00644033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6500091|NCT00644033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500092|NCT00644033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6500093|NCT00644085|Aspirin|aspirin|mesh-list
6500094|NCT00644085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6500095|NCT00644085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6500096|NCT00644085|Analgesics|analgesics|mesh-ancestor
6500097|NCT00644085|Sensory System Agents|sensory system agents|mesh-ancestor
5705854|NCT03315520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705855|NCT03315520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5705856|NCT03315520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5705857|NCT03315520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5705858|NCT03315520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5705859|NCT03315520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5705860|NCT03315520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5705861|NCT03315520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5705862|NCT03315520|Antimetabolites|antimetabolites|mesh-ancestor
6500098|NCT00644085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6500099|NCT00644085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6500100|NCT00644085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6500101|NCT00644085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6500102|NCT00644085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6500103|NCT00644085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6500104|NCT00644085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500105|NCT00644085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6500106|NCT00644085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6500107|NCT00644085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6500108|NCT00644085|Antipyretics|antipyretics|mesh-ancestor
6500109|NCT00644111|Hydromorphone|hydromorphone|mesh-list
6500110|NCT00644111|Bupivacaine|bupivacaine|mesh-list
5705863|NCT03315520|Antiviral Agents|antiviral agents|mesh-ancestor
5705864|NCT03315520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5705865|NCT03315507|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
5705866|NCT03315507|Vasodilator Agents|vasodilator agents|mesh-ancestor
6500111|NCT00644111|Anesthetics, Local|anesthetics, local|mesh-ancestor
6500112|NCT00644111|Anesthetics|anesthetics|mesh-ancestor
6500113|NCT00644111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6500114|NCT00644111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6500115|NCT00644111|Sensory System Agents|sensory system agents|mesh-ancestor
6500116|NCT00644111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6500117|NCT00644111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6500118|NCT00644111|Narcotics|narcotics|mesh-ancestor
6500119|NCT00644111|Analgesics|analgesics|mesh-ancestor
6500120|NCT00644124|Aflibercept|aflibercept|mesh-list
6500121|NCT00644124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6500122|NCT00644124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6500123|NCT00644124|Growth Substances|growth substances|mesh-ancestor
6500124|NCT00644124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6500125|NCT00644124|Growth Inhibitors|growth inhibitors|mesh-ancestor
6500126|NCT00644124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6500127|NCT00644137|Pregabalin|pregabalin|mesh-list
6500128|NCT00644137|Analgesics|analgesics|mesh-ancestor
6676465|NCT01581476|Atorvastatin|atorvastatin|mesh-list
6227495|NCT02438787|Ustekinumab|ustekinumab|mesh-list
6227496|NCT02438787|Dermatologic Agents|dermatologic agents|mesh-ancestor
6227497|NCT02438787|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6227498|NCT02438787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6227499|NCT02438787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6227500|NCT02438787|Immunologic Factors|immunologic factors|mesh-ancestor
6227501|NCT02438787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227502|NCT02438813|Deoxycholic Acid|deoxycholic acid|mesh-list
6227503|NCT02438813|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6227504|NCT02438813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6227505|NCT02439138|Idelalisib|idelalisib|mesh-list
6227506|NCT02439138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6227507|NCT02439138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6227508|NCT02439138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227509|NCT02439164|Midazolam|midazolam|mesh-list
6227510|NCT02439164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6227511|NCT02439164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6227512|NCT02439164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6227513|NCT02439164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227514|NCT02439164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6227515|NCT02439164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6227516|NCT02439164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6227517|NCT02439164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6227518|NCT02439164|Anesthetics, General|anesthetics, general|mesh-ancestor
6227519|NCT02439164|Anesthetics|anesthetics|mesh-ancestor
6227520|NCT02439164|GABA Modulators|gaba modulators|mesh-ancestor
6227521|NCT02439164|GABA Agents|gaba agents|mesh-ancestor
6227522|NCT02439164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6227523|NCT02439164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227524|NCT02439281|Clonidine|clonidine|mesh-list
6227525|NCT02439281|Ropivacaine|ropivacaine|mesh-list
6227526|NCT02439281|Anesthetics, Local|anesthetics, local|mesh-ancestor
6227527|NCT02439281|Anesthetics|anesthetics|mesh-ancestor
6227528|NCT02439281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6227529|NCT02439281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227530|NCT02439281|Sensory System Agents|sensory system agents|mesh-ancestor
6227531|NCT02439281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6227532|NCT02439281|Analgesics|analgesics|mesh-ancestor
5705867|NCT03315442|Caffeine|caffeine|mesh-list
5705868|NCT03315442|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5705869|NCT03315442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705870|NCT03315442|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6227533|NCT02439281|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6227534|NCT02439281|Sympatholytics|sympatholytics|mesh-ancestor
6227535|NCT02439281|Autonomic Agents|autonomic agents|mesh-ancestor
6227536|NCT02439281|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6227537|NCT02439281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6227538|NCT02439281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6227539|NCT02439281|Adrenergic Agents|adrenergic agents|mesh-ancestor
6227540|NCT02439281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6227541|NCT02439281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227542|NCT02439320|Lasmiditan|lasmiditan|mesh-list
6227543|NCT02439320|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6227544|NCT02439320|Serotonin Agents|serotonin agents|mesh-ancestor
6227545|NCT02439320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6227546|NCT02439320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705871|NCT03315442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5705872|NCT03315442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705873|NCT03315442|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5705874|NCT03315442|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5705875|NCT03315442|Purinergic Agents|purinergic agents|mesh-ancestor
5705876|NCT03315442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5705877|NCT03315364|Paclitaxel|paclitaxel|mesh-list
5705878|NCT03315364|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5705879|NCT03315364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5705880|NCT03315364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5705881|NCT03315364|Tubulin Modulators|tubulin modulators|mesh-ancestor
5705882|NCT03315364|Antimitotic Agents|antimitotic agents|mesh-ancestor
5705883|NCT03315364|Mitosis Modulators|mitosis modulators|mesh-ancestor
5705884|NCT03315364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705885|NCT03315338|Prednisone|prednisone|mesh-list
5705886|NCT03315338|Cortisone|cortisone|mesh-list
5705887|NCT03315338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5705888|NCT03315338|Glucocorticoids|glucocorticoids|mesh-ancestor
6227547|NCT02439320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227548|NCT02439879|Thioctic Acid|thioctic acid|mesh-list
6227549|NCT02439879|Antioxidants|antioxidants|mesh-ancestor
6227550|NCT02439879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227551|NCT02439879|Protective Agents|protective agents|mesh-ancestor
6227552|NCT02439879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227553|NCT02439879|Vitamin B Complex|vitamin b complex|mesh-ancestor
6227554|NCT02439879|Vitamins|vitamins|mesh-ancestor
6227555|NCT02439879|Micronutrients|micronutrients|mesh-ancestor
6227556|NCT02440178|Micafungin|micafungin|mesh-list
6227557|NCT02440178|Antifungal Agents|antifungal agents|mesh-ancestor
6227558|NCT02440178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6227559|NCT02440204|Remifentanil|remifentanil|mesh-list
6227560|NCT02440204|Sevoflurane|sevoflurane|mesh-list
6227561|NCT02440204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6227562|NCT02440204|Narcotics|narcotics|mesh-ancestor
6227563|NCT02440204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6227564|NCT02440204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705889|NCT03315338|Hormones|hormones|mesh-ancestor
5705890|NCT03315338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5705891|NCT03315338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705892|NCT03315338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5705893|NCT03315338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5705894|NCT03315312|Fluorides|fluorides|mesh-list
5705895|NCT03315312|Fluorides, Topical|fluorides, topical|mesh-list
5705896|NCT03315312|Cariostatic Agents|cariostatic agents|mesh-ancestor
5705897|NCT03315312|Protective Agents|protective agents|mesh-ancestor
5705898|NCT03315312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721250|NCT03207165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5721251|NCT03207165|Vasodilator Agents|vasodilator agents|mesh-ancestor
5721252|NCT03207165|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5721253|NCT03207165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5721254|NCT03207542|Daratumumab|daratumumab|mesh-list
5721255|NCT03207542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5721256|NCT03207204|Hydrogen Peroxide|hydrogen peroxide|mesh-list
5721257|NCT03207204|Carbamide Peroxide|carbamide peroxide|mesh-list
5721258|NCT03207204|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5721259|NCT03207204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5721260|NCT03207477|Mydriatics|mydriatics|mesh-list
5721261|NCT03207477|Autonomic Agents|autonomic agents|mesh-ancestor
5721262|NCT03207477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5721263|NCT03207477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721264|NCT03207100|Antihypertensive Agents|antihypertensive agents|mesh-list
5721265|NCT03206957|Endostatins|endostatins|mesh-list
5721266|NCT03206957|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-list
5721267|NCT03206957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6227565|NCT02440204|Analgesics|analgesics|mesh-ancestor
6227566|NCT02440204|Sensory System Agents|sensory system agents|mesh-ancestor
6227567|NCT02440204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6227568|NCT02440204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6227569|NCT02440204|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6227570|NCT02440204|Anesthetics, General|anesthetics, general|mesh-ancestor
6227571|NCT02440204|Anesthetics|anesthetics|mesh-ancestor
6227572|NCT02440308|Bombesin|bombesin|mesh-list
6227573|NCT02440308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227574|NCT02440308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6227575|NCT02440308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227576|NCT02440425|Paclitaxel|paclitaxel|mesh-list
6227577|NCT02440425|Pembrolizumab|pembrolizumab|mesh-list
6227578|NCT02440425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6227579|NCT02440425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5721268|NCT03206957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5721269|NCT03206957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5721270|NCT03206957|Growth Substances|growth substances|mesh-ancestor
5721271|NCT03206957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721272|NCT03206957|Growth Inhibitors|growth inhibitors|mesh-ancestor
5721273|NCT03206944|Aspirin|aspirin|mesh-list
5721274|NCT03206944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5721275|NCT03206944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5721276|NCT03206944|Analgesics|analgesics|mesh-ancestor
5721277|NCT03206944|Sensory System Agents|sensory system agents|mesh-ancestor
5721278|NCT03206944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5721279|NCT03206944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721280|NCT03206944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6227580|NCT02440425|Tubulin Modulators|tubulin modulators|mesh-ancestor
6227581|NCT02440425|Antimitotic Agents|antimitotic agents|mesh-ancestor
5721281|NCT03206944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6227582|NCT02440425|Mitosis Modulators|mitosis modulators|mesh-ancestor
6243660|NCT02677116|Ifosfamide|ifosfamide|mesh-list
5705899|NCT03315091|Adavosertib|adavosertib|mesh-list
5705900|NCT03315091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5705901|NCT03315091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705902|NCT03315078|Busulfan|busulfan|mesh-list
5705903|NCT03315078|Alkylating Agents|alkylating agents|mesh-ancestor
5705904|NCT03315078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705905|NCT03315078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5705906|NCT03315078|Immunologic Factors|immunologic factors|mesh-ancestor
5705907|NCT03315078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705908|NCT03315078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6227583|NCT02440425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227584|NCT02440425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6227585|NCT02440568|Cytarabine|cytarabine|mesh-list
6227586|NCT02440568|Idarubicin|idarubicin|mesh-list
6227587|NCT02440568|Homoharringtonine|homoharringtonine|mesh-list
6227588|NCT02440568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6227589|NCT02440568|Antimetabolites|antimetabolites|mesh-ancestor
6227590|NCT02440568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227591|NCT02440568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6227592|NCT02440568|Antiviral Agents|antiviral agents|mesh-ancestor
6227593|NCT02440568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6227594|NCT02440568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6227595|NCT02440568|Immunologic Factors|immunologic factors|mesh-ancestor
6227596|NCT02440568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227597|NCT02440568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6227598|NCT02440568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6227599|NCT02440568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6227600|NCT02440568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6227601|NCT02440568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6227602|NCT02440568|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6227603|NCT02440789|Sirolimus|sirolimus|mesh-list
6227604|NCT02440789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6227605|NCT02440789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6227606|NCT02440789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6227607|NCT02440789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6227608|NCT02440789|Antifungal Agents|antifungal agents|mesh-ancestor
6227609|NCT02440789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6227610|NCT02440789|Immunologic Factors|immunologic factors|mesh-ancestor
6227611|NCT02440789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227612|NCT02441062|Edotreotide|edotreotide|mesh-list
6227613|NCT02441062|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6227614|NCT02441062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227615|NCT02441114|Fluticasone|fluticasone|mesh-list
6227616|NCT02441114|Tiotropium Bromide|tiotropium bromide|mesh-list
6227617|NCT02441114|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6227618|NCT02441114|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
5705909|NCT03315078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5705910|NCT03315078|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5705911|NCT03315052|Mycophenolic Acid|mycophenolic acid|mesh-list
5705912|NCT03315052|Prednisone|prednisone|mesh-list
5705913|NCT03315052|Budesonide|budesonide|mesh-list
6227619|NCT02441114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6227620|NCT02441114|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6500129|NCT00644137|Sensory System Agents|sensory system agents|mesh-ancestor
6500130|NCT00644137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6500131|NCT00644137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6500132|NCT00644137|Anticonvulsants|anticonvulsants|mesh-ancestor
6500133|NCT00644137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6500134|NCT00644137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6500135|NCT00644137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500136|NCT00644137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6500137|NCT00644137|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6500138|NCT00644137|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6500139|NCT00644137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6500140|NCT00644137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6500141|NCT00644176|Azithromycin|azithromycin|mesh-list
6500142|NCT00644176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6500143|NCT00644176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6500144|NCT00644215|Mitomycins|mitomycins|mesh-list
6500145|NCT00644215|Mitomycin|mitomycin|mesh-list
6500146|NCT00644215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6500147|NCT00644215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6500148|NCT00644215|Alkylating Agents|alkylating agents|mesh-ancestor
5705914|NCT03315052|Tacrolimus|tacrolimus|mesh-list
5705915|NCT03315052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6227621|NCT02441114|Autonomic Agents|autonomic agents|mesh-ancestor
6227622|NCT02441114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6227623|NCT02441114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227624|NCT02441114|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6227625|NCT02441114|Respiratory System Agents|respiratory system agents|mesh-ancestor
6227626|NCT02441114|Dermatologic Agents|dermatologic agents|mesh-ancestor
6227627|NCT02441114|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6227628|NCT02441114|Parasympatholytics|parasympatholytics|mesh-ancestor
6227629|NCT02441114|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6227630|NCT02441114|Cholinergic Agents|cholinergic agents|mesh-ancestor
6227631|NCT02441114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6227632|NCT02441114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227633|NCT02441114|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6227634|NCT02441114|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6227635|NCT02441114|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6227636|NCT02441114|Adrenergic Agents|adrenergic agents|mesh-ancestor
6227637|NCT02441114|Glucocorticoids|glucocorticoids|mesh-ancestor
6227638|NCT02441114|Hormones|hormones|mesh-ancestor
6227639|NCT02441114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6227640|NCT02441114|Sympathomimetics|sympathomimetics|mesh-ancestor
6227641|NCT02441309|Ifosfamide|ifosfamide|mesh-list
5705916|NCT03315052|Glucocorticoids|glucocorticoids|mesh-ancestor
5705917|NCT03315052|Hormones|hormones|mesh-ancestor
5705918|NCT03315052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5705919|NCT03315052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705920|NCT03315052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5705921|NCT03315052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5705922|NCT03315052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5705923|NCT03315052|Immunologic Factors|immunologic factors|mesh-ancestor
5705924|NCT03315052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5705925|NCT03315052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5705926|NCT03315052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705927|NCT03315052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5705928|NCT03315052|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5705929|NCT03315052|Antitubercular Agents|antitubercular agents|mesh-ancestor
5705930|NCT03315052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5705931|NCT03315052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5705932|NCT03315052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5705933|NCT03315052|Autonomic Agents|autonomic agents|mesh-ancestor
5705934|NCT03315052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5705935|NCT03315052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5705936|NCT03315052|Respiratory System Agents|respiratory system agents|mesh-ancestor
5705937|NCT03315000|Fluticasone|fluticasone|mesh-list
6227642|NCT02441309|Mifamurtide|mifamurtide|mesh-list
6227643|NCT02441309|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6227644|NCT02441309|Alkylating Agents|alkylating agents|mesh-ancestor
6227645|NCT02441309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227646|NCT02441309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6227647|NCT02441309|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6676466|NCT01581476|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6676467|NCT01581476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6676468|NCT01581476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6676469|NCT01581476|Antimetabolites|antimetabolites|mesh-ancestor
6676470|NCT01581476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676471|NCT01581476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6676472|NCT01581476|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6676473|NCT01581476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6227648|NCT02441309|Immunologic Factors|immunologic factors|mesh-ancestor
6227649|NCT02441309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227650|NCT02441946|Anastrozole|anastrozole|mesh-list
6227651|NCT02441946|Loperamide|loperamide|mesh-list
6227652|NCT02441946|Antidiarrheals|antidiarrheals|mesh-list
6227653|NCT02441946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6227654|NCT02441946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6227655|NCT02441946|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6227656|NCT02441946|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6227657|NCT02441946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6227658|NCT02441946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227659|NCT02441946|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6227660|NCT02441946|Hormone Antagonists|hormone antagonists|mesh-ancestor
6227661|NCT02441946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6676474|NCT01581476|Protease Inhibitors|protease inhibitors|mesh-ancestor
6676475|NCT01581476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6676476|NCT01581515|Everolimus|everolimus|mesh-list
6676477|NCT01581515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6676478|NCT01581515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6676479|NCT01581515|Immunologic Factors|immunologic factors|mesh-ancestor
6676480|NCT01581515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676481|NCT01581736|Insulin|insulin|mesh-list
6676482|NCT01581736|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6676483|NCT01581736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6676484|NCT01581736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227662|NCT02441946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227663|NCT02441946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6227664|NCT02442271|Ritonavir|ritonavir|mesh-list
6227665|NCT02442271|Ribavirin|ribavirin|mesh-list
6227666|NCT02442271|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6227667|NCT02442271|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6227668|NCT02442271|Protease Inhibitors|protease inhibitors|mesh-ancestor
6227669|NCT02442271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6227670|NCT02442271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227671|NCT02442271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6227672|NCT02442271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6227673|NCT02442271|Antiviral Agents|antiviral agents|mesh-ancestor
6227674|NCT02442271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5705938|NCT03315000|Xhance|xhance|mesh-list
5705939|NCT03315000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5705940|NCT03315000|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5705941|NCT03315000|Autonomic Agents|autonomic agents|mesh-ancestor
5705942|NCT03315000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5705943|NCT03315000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705944|NCT03315000|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5705945|NCT03315000|Respiratory System Agents|respiratory system agents|mesh-ancestor
5705946|NCT03315000|Dermatologic Agents|dermatologic agents|mesh-ancestor
5705947|NCT03315000|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5705948|NCT03314792|Oxycodone|oxycodone|mesh-list
5705949|NCT03314792|Tapentadol|tapentadol|mesh-list
5705950|NCT03314792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5705951|NCT03314792|Narcotics|narcotics|mesh-ancestor
5705952|NCT03314792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5705953|NCT03314792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705954|NCT03314792|Analgesics|analgesics|mesh-ancestor
5705955|NCT03314792|Sensory System Agents|sensory system agents|mesh-ancestor
5705956|NCT03314792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5705957|NCT03314792|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5705958|NCT03314792|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5705959|NCT03314792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6227675|NCT02442271|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6227676|NCT02442271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6227677|NCT02442271|Antimetabolites|antimetabolites|mesh-ancestor
6227678|NCT02442284|Ritonavir|ritonavir|mesh-list
6227679|NCT02442284|Ribavirin|ribavirin|mesh-list
6227680|NCT02442284|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6227681|NCT02442284|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6227682|NCT02442284|Protease Inhibitors|protease inhibitors|mesh-ancestor
6227683|NCT02442284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6227684|NCT02442284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227685|NCT02442284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6227686|NCT02442284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6227687|NCT02442284|Antiviral Agents|antiviral agents|mesh-ancestor
6227688|NCT02442284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6227689|NCT02442284|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6227690|NCT02442284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6227691|NCT02442284|Antimetabolites|antimetabolites|mesh-ancestor
6227692|NCT02442310|Deferiprone|deferiprone|mesh-list
6227693|NCT02442310|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6227694|NCT02442310|Chelating Agents|chelating agents|mesh-ancestor
6227695|NCT02442310|Sequestering Agents|sequestering agents|mesh-ancestor
6227696|NCT02442310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227697|NCT02442700|Pitavastatin|pitavastatin|mesh-list
6227698|NCT02442700|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6227699|NCT02442700|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6227700|NCT02442700|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6227701|NCT02442700|Antimetabolites|antimetabolites|mesh-ancestor
6227702|NCT02442700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227703|NCT02442700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6676485|NCT01581775|Valproic Acid|valproic acid|mesh-list
5705960|NCT03314792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227704|NCT02442700|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6227705|NCT02443103|Guanabenz|guanabenz|mesh-list
6227706|NCT02443103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6227707|NCT02443103|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6227708|NCT02443103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5705961|NCT03314792|Adrenergic Agents|adrenergic agents|mesh-ancestor
5705962|NCT03314792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5705963|NCT03314740|Paclitaxel|paclitaxel|mesh-list
5705964|NCT03314740|Olaparib|olaparib|mesh-list
5705965|NCT03314740|Cediranib|cediranib|mesh-list
5705966|NCT03314740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5705967|NCT03314740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5705968|NCT03314740|Tubulin Modulators|tubulin modulators|mesh-ancestor
5705969|NCT03314740|Antimitotic Agents|antimitotic agents|mesh-ancestor
5705970|NCT03314740|Mitosis Modulators|mitosis modulators|mesh-ancestor
5705971|NCT03314740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5705972|NCT03314740|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5705973|NCT03314740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5705974|NCT03314740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5705975|NCT03314636|Dexamethasone|dexamethasone|mesh-list
5705976|NCT03314636|Lenalidomide|lenalidomide|mesh-list
6227709|NCT02443103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6227710|NCT02443103|Adrenergic Agents|adrenergic agents|mesh-ancestor
6227711|NCT02443103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6227712|NCT02443103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227713|NCT02443103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227714|NCT02443155|Liraglutide|liraglutide|mesh-list
6227715|NCT02443155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6227716|NCT02443155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227717|NCT02443155|Incretins|incretins|mesh-ancestor
6227718|NCT02443155|Hormones|hormones|mesh-ancestor
6227719|NCT02443155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6227720|NCT02443337|Necitumumab|necitumumab|mesh-list
6227721|NCT02443337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6227722|NCT02443337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6227723|NCT02443402|Insulin|insulin|mesh-list
6227724|NCT02443402|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6227725|NCT02443402|Insulin Glargine|insulin glargine|mesh-list
6227726|NCT02443402|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6227727|NCT02443402|Insulin Aspart|insulin aspart|mesh-list
6227728|NCT02443402|Insulin Lispro|insulin lispro|mesh-list
6227729|NCT02443402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6227730|NCT02443402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227731|NCT02443402|Incretins|incretins|mesh-ancestor
5705977|NCT03314636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5705978|NCT03314636|Antiemetics|antiemetics|mesh-ancestor
5705979|NCT03314636|Autonomic Agents|autonomic agents|mesh-ancestor
5705980|NCT03314636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5705981|NCT03314636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705982|NCT03314636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5705983|NCT03314636|Glucocorticoids|glucocorticoids|mesh-ancestor
5705984|NCT03314636|Hormones|hormones|mesh-ancestor
5705985|NCT03314636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5705986|NCT03314636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5705987|NCT03314636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5705988|NCT03314636|Immunologic Factors|immunologic factors|mesh-ancestor
5705989|NCT03314636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5705990|NCT03314636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5705991|NCT03314636|Growth Substances|growth substances|mesh-ancestor
5705992|NCT03314636|Growth Inhibitors|growth inhibitors|mesh-ancestor
5705993|NCT03314493|Spironolactone|spironolactone|mesh-list
5705994|NCT03314493|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5705995|NCT03314493|Hormone Antagonists|hormone antagonists|mesh-ancestor
5705996|NCT03314493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5705997|NCT03314493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5705998|NCT03314493|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5705999|NCT03314493|Diuretics|diuretics|mesh-ancestor
5706000|NCT03314493|Natriuretic Agents|natriuretic agents|mesh-ancestor
5706001|NCT03314363|Trace Elements|trace elements|mesh-list
5706002|NCT03314363|Micronutrients|micronutrients|mesh-list
5706003|NCT03314363|Citric Acid|citric acid|mesh-list
5706004|NCT03314363|Sodium Citrate|sodium citrate|mesh-list
5706005|NCT03314363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706006|NCT03314363|Anticoagulants|anticoagulants|mesh-ancestor
6227732|NCT02443402|Hormones|hormones|mesh-ancestor
6227733|NCT02443402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5706007|NCT03314363|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5706008|NCT03314363|Chelating Agents|chelating agents|mesh-ancestor
6227734|NCT02443402|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6227735|NCT02443402|Protease Inhibitors|protease inhibitors|mesh-ancestor
6227736|NCT02443402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6227737|NCT02443402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227738|NCT02443883|Ramucirumab|ramucirumab|mesh-list
6227739|NCT02443883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6227740|NCT02444143|Tacrolimus|tacrolimus|mesh-list
6227741|NCT02444143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6227742|NCT02444143|Immunologic Factors|immunologic factors|mesh-ancestor
6227743|NCT02444143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227744|NCT02444143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6227745|NCT02444143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6227746|NCT02444143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676486|NCT01581775|Anticonvulsants|anticonvulsants|mesh-ancestor
6676487|NCT01581775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6676488|NCT01581775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676489|NCT01581775|GABA Agents|gaba agents|mesh-ancestor
6676490|NCT01581775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6227747|NCT02444234|Tedizolid|tedizolid|mesh-list
6227748|NCT02444234|Oxazolidinones|oxazolidinones|mesh-list
6227749|NCT02444234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6227750|NCT02444234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6227751|NCT02444234|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6227752|NCT02444234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6227753|NCT02444234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227754|NCT02444533|Bupivacaine|bupivacaine|mesh-list
6227755|NCT02444533|Anesthetics, Local|anesthetics, local|mesh-ancestor
6227756|NCT02444533|Anesthetics|anesthetics|mesh-ancestor
6227757|NCT02444533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6227758|NCT02444533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227759|NCT02444533|Sensory System Agents|sensory system agents|mesh-ancestor
6227760|NCT02444533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6227761|NCT02444793|Mogamulizumab|mogamulizumab|mesh-list
6227762|NCT02444793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6227763|NCT02444936|Vaccines|vaccines|mesh-list
6227764|NCT02444936|Immunologic Factors|immunologic factors|mesh-ancestor
6227765|NCT02444936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227766|NCT02444988|Plasma-lyte 148|plasma-lyte 148|mesh-list
6227767|NCT02444988|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6227768|NCT02444988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6227769|NCT02445326|Dexamethasone|dexamethasone|mesh-list
6227770|NCT02445326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6227771|NCT02445326|Antiemetics|antiemetics|mesh-ancestor
6227772|NCT02445326|Autonomic Agents|autonomic agents|mesh-ancestor
6227773|NCT02445326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6227774|NCT02445326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227775|NCT02445326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6227776|NCT02445326|Glucocorticoids|glucocorticoids|mesh-ancestor
6227777|NCT02445326|Hormones|hormones|mesh-ancestor
6227778|NCT02445326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6227779|NCT02445326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6227780|NCT02445326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6227781|NCT02445586|Docetaxel|docetaxel|mesh-list
6227782|NCT02445586|Trastuzumab|trastuzumab|mesh-list
6227783|NCT02445586|Pertuzumab|pertuzumab|mesh-list
6227784|NCT02445586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6227785|NCT02445586|Tubulin Modulators|tubulin modulators|mesh-ancestor
6227786|NCT02445586|Antimitotic Agents|antimitotic agents|mesh-ancestor
6227787|NCT02445586|Mitosis Modulators|mitosis modulators|mesh-ancestor
6227788|NCT02445586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227789|NCT02445586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6227790|NCT02445807|Clobetasol|clobetasol|mesh-list
6500149|NCT00644215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500150|NCT00644215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6500151|NCT00644215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6500152|NCT00644293|Azithromycin|azithromycin|mesh-list
6500153|NCT00644293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6500154|NCT00644293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6500155|NCT00644306|Thalidomide|thalidomide|mesh-list
6500156|NCT00644306|Prednisone|prednisone|mesh-list
5706009|NCT03314363|Sequestering Agents|sequestering agents|mesh-ancestor
5706010|NCT03314363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227791|NCT02445807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6227792|NCT02445807|Glucocorticoids|glucocorticoids|mesh-ancestor
6227793|NCT02445807|Hormones|hormones|mesh-ancestor
6500157|NCT00644306|Melphalan|melphalan|mesh-list
6227794|NCT02445807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5706011|NCT03314298|Methyltestosterone|methyltestosterone|mesh-list
5706012|NCT03314298|Anastrozole|anastrozole|mesh-list
5706013|NCT03314298|Testosterone|testosterone|mesh-list
5706014|NCT03314298|Testosterone undecanoate|testosterone undecanoate|mesh-list
5706015|NCT03314298|Testosterone enanthate|testosterone enanthate|mesh-list
5706016|NCT03314298|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5706017|NCT03314298|Androgens|androgens|mesh-ancestor
5706018|NCT03314298|Hormones|hormones|mesh-ancestor
5706019|NCT03314298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5706020|NCT03314298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706021|NCT03314298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6227795|NCT02445807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227796|NCT02445859|Cefuroxime|cefuroxime|mesh-list
6227797|NCT02445859|Cefuroxime axetil|cefuroxime axetil|mesh-list
6227798|NCT02445859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6227799|NCT02445859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6227800|NCT02446015|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6227801|NCT02446015|Lubricant Eye Drops|lubricant eye drops|mesh-list
6227802|NCT02446015|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5706022|NCT03314298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5706023|NCT03314298|Anabolic Agents|anabolic agents|mesh-ancestor
5706024|NCT03314298|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5706025|NCT03314298|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5706026|NCT03314298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5706027|NCT03314298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706028|NCT03314298|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5706029|NCT03314298|Hormone Antagonists|hormone antagonists|mesh-ancestor
5706030|NCT03314259|Tamsulosin|tamsulosin|mesh-list
5706031|NCT03314259|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5706032|NCT03314259|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5706033|NCT03314259|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5706034|NCT03314259|Adrenergic Agents|adrenergic agents|mesh-ancestor
5706035|NCT03314259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5706036|NCT03314259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706037|NCT03314259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706038|NCT03314259|Urological Agents|urological agents|mesh-ancestor
5706039|NCT03314064|Dolutegravir|dolutegravir|mesh-list
5706040|NCT03314064|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5706041|NCT03314064|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5706042|NCT03314064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5706043|NCT03314064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706044|NCT03314064|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5706045|NCT03314064|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6227803|NCT02446171|Naloxegol|naloxegol|mesh-list
6227804|NCT02446171|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6227805|NCT02446171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227806|NCT02446171|Sensory System Agents|sensory system agents|mesh-ancestor
6227807|NCT02446171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6227808|NCT02446418|Fluticasone|fluticasone|mesh-list
6227809|NCT02446418|Xhance|xhance|mesh-list
6227810|NCT02446418|Budesonide|budesonide|mesh-list
6227811|NCT02446418|Formoterol Fumarate|formoterol fumarate|mesh-list
6227812|NCT02446418|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6227813|NCT02446418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6227814|NCT02446418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6227815|NCT02446418|Autonomic Agents|autonomic agents|mesh-ancestor
5706046|NCT03314064|Antiviral Agents|antiviral agents|mesh-ancestor
5706047|NCT03314064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5706048|NCT03314025|Tamsulosin|tamsulosin|mesh-list
5706049|NCT03314025|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5706050|NCT03314025|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5706051|NCT03314025|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5706052|NCT03314025|Adrenergic Agents|adrenergic agents|mesh-ancestor
5706053|NCT03314025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5706054|NCT03314025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706055|NCT03314025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706056|NCT03314025|Urological Agents|urological agents|mesh-ancestor
5706057|NCT03313960|Insulin|insulin|mesh-list
5706058|NCT03313960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5706059|NCT03313960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706060|NCT03313934|Hyaluronic Acid|hyaluronic acid|mesh-list
5706061|NCT03313934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5706062|NCT03313934|Immunologic Factors|immunologic factors|mesh-ancestor
6227816|NCT02446418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6227817|NCT02446418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706063|NCT03313934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706064|NCT03313934|Viscosupplements|viscosupplements|mesh-ancestor
5706065|NCT03313934|Protective Agents|protective agents|mesh-ancestor
5706066|NCT03313869|Vitamin E|vitamin e|mesh-list
5706067|NCT03313869|Selenium|selenium|mesh-list
5706068|NCT03313869|Vitamins|vitamins|mesh-ancestor
6227818|NCT02446418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6227819|NCT02446418|Respiratory System Agents|respiratory system agents|mesh-ancestor
6227820|NCT02446418|Dermatologic Agents|dermatologic agents|mesh-ancestor
6227821|NCT02446418|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6227822|NCT02446418|Glucocorticoids|glucocorticoids|mesh-ancestor
6227823|NCT02446418|Hormones|hormones|mesh-ancestor
6227824|NCT02446418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6227825|NCT02446418|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6227826|NCT02446418|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6227827|NCT02446418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6227828|NCT02446418|Adrenergic Agents|adrenergic agents|mesh-ancestor
6227829|NCT02446418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6227830|NCT02446418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227831|NCT02446483|Rabeprazole|rabeprazole|mesh-list
6227832|NCT02446483|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6227833|NCT02446483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6227834|NCT02446483|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6227835|NCT02446483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6227836|NCT02446483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243661|NCT02677116|Olaratumab|olaratumab|mesh-list
6243662|NCT02677116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6243663|NCT02677116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6243664|NCT02677116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5706069|NCT03313869|Micronutrients|micronutrients|mesh-ancestor
5706070|NCT03313869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706071|NCT03313869|Antioxidants|antioxidants|mesh-ancestor
5706072|NCT03313869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706073|NCT03313869|Protective Agents|protective agents|mesh-ancestor
5706074|NCT03313869|Trace Elements|trace elements|mesh-ancestor
5706075|NCT03313856|Magnesium Oxide|magnesium oxide|mesh-list
5706076|NCT03313856|Antacids|antacids|mesh-ancestor
5706077|NCT03313856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706078|NCT03313856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5706079|NCT03313804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5706080|NCT03313804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706081|NCT03313804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5706082|NCT03313791|Caseins|caseins|mesh-list
5706083|NCT03313791|Chelating Agents|chelating agents|mesh-ancestor
5706084|NCT03313791|Sequestering Agents|sequestering agents|mesh-ancestor
5706085|NCT03313791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706086|NCT03313752|Dapagliflozin|dapagliflozin|mesh-list
5706087|NCT03313752|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5706088|NCT03313752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706089|NCT03313752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5706090|NCT03313752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706091|NCT03313726|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
5706092|NCT03313726|Hormones|hormones|mesh-ancestor
5706093|NCT03313726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5706094|NCT03313726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706095|NCT03313661|Gliclazide|gliclazide|mesh-list
6243665|NCT02677116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6243666|NCT02677116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6243667|NCT02677116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243668|NCT02677116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6243669|NCT02677116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5706096|NCT03313661|Cabergoline|cabergoline|mesh-list
5706097|NCT03313661|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5706098|NCT03313661|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5706099|NCT03313661|Dopamine Agonists|dopamine agonists|mesh-ancestor
5706100|NCT03313661|Dopamine Agents|dopamine agents|mesh-ancestor
6243670|NCT02677116|Tubulin Modulators|tubulin modulators|mesh-ancestor
6243671|NCT02677116|Antimitotic Agents|antimitotic agents|mesh-ancestor
6243672|NCT02677116|Mitosis Modulators|mitosis modulators|mesh-ancestor
6243673|NCT02677116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6243674|NCT02677116|Alkylating Agents|alkylating agents|mesh-ancestor
6243675|NCT02677324|Venetoclax|venetoclax|mesh-list
6243676|NCT02677324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6243677|NCT02677493|Vaccines|vaccines|mesh-list
6227837|NCT02446496|Cefadroxil|cefadroxil|mesh-list
6227838|NCT02446496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6227839|NCT02446496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6227840|NCT02446717|Ribavirin|ribavirin|mesh-list
5706101|NCT03313661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5706102|NCT03313661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706103|NCT03313661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706104|NCT03313661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5721282|NCT03206944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5721283|NCT03206944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5721284|NCT03206944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721285|NCT03206944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5721286|NCT03206944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5721287|NCT03206944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6227841|NCT02446717|Antimetabolites|antimetabolites|mesh-ancestor
6227842|NCT02446717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227843|NCT02446717|Antiviral Agents|antiviral agents|mesh-ancestor
6227844|NCT02446717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6227845|NCT02446886|Hormones|hormones|mesh-list
6227846|NCT02446886|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6227847|NCT02446886|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
6227848|NCT02446886|beta-Endorphin|beta-endorphin|mesh-list
6227849|NCT02446886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6227850|NCT02446886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227851|NCT02446886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6227852|NCT02446886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227853|NCT02447003|Pembrolizumab|pembrolizumab|mesh-list
6227854|NCT02447003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6227855|NCT02447003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6227856|NCT02447029|Lidocaine|lidocaine|mesh-list
6227857|NCT02447029|Anesthetics, Local|anesthetics, local|mesh-ancestor
6227858|NCT02447029|Anesthetics|anesthetics|mesh-ancestor
6227859|NCT02447029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6227860|NCT02447029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227861|NCT02447029|Sensory System Agents|sensory system agents|mesh-ancestor
6227862|NCT02447029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6227863|NCT02447029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6227864|NCT02447029|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6227865|NCT02447029|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6227866|NCT02447029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6227867|NCT02447029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227868|NCT02447172|Gentamicins|gentamicins|mesh-list
6227869|NCT02447172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6227870|NCT02447172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6227871|NCT02447172|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6227872|NCT02447172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6676491|NCT01581775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676492|NCT01581775|Antimanic Agents|antimanic agents|mesh-ancestor
6676493|NCT01581775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6676494|NCT01581775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5721288|NCT03206944|Antipyretics|antipyretics|mesh-ancestor
5722296|NCT03200002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5722297|NCT03200002|Alkylating Agents|alkylating agents|mesh-ancestor
5722298|NCT03200002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722299|NCT03200002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5722300|NCT03200002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5722301|NCT03200002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5722302|NCT03200002|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5722303|NCT03200002|Antitubercular Agents|antitubercular agents|mesh-ancestor
5722304|NCT03200002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5722305|NCT03200002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5722306|NCT03200002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5722307|NCT03199794|Factor VIII|factor viii|mesh-list
5722308|NCT03199794|Coagulants|coagulants|mesh-ancestor
5722309|NCT03199976|Fluticasone|fluticasone|mesh-list
5722310|NCT03199976|Xhance|xhance|mesh-list
5722311|NCT03199976|Bromides|bromides|mesh-list
5722312|NCT03199976|Albuterol|albuterol|mesh-list
5722313|NCT03199976|Tiotropium Bromide|tiotropium bromide|mesh-list
5722314|NCT03199976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5722315|NCT03199976|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5722316|NCT03199976|Autonomic Agents|autonomic agents|mesh-ancestor
6227873|NCT02447172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227874|NCT02447250|Albuterol|albuterol|mesh-list
6227875|NCT02447250|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6227876|NCT02447250|Autonomic Agents|autonomic agents|mesh-ancestor
6227877|NCT02447250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6227878|NCT02447250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227879|NCT02447250|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6227880|NCT02447250|Respiratory System Agents|respiratory system agents|mesh-ancestor
6227881|NCT02447250|Tocolytic Agents|tocolytic agents|mesh-ancestor
6227882|NCT02447250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6227883|NCT02447250|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6227884|NCT02447250|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6227885|NCT02447250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6227886|NCT02447250|Adrenergic Agents|adrenergic agents|mesh-ancestor
6227887|NCT02447250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6227888|NCT02447250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227889|NCT02447328|Fulvestrant|fulvestrant|mesh-list
6227890|NCT02447328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6227891|NCT02447328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6227892|NCT02447328|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6227893|NCT02447328|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6227894|NCT02447328|Hormone Antagonists|hormone antagonists|mesh-ancestor
6227895|NCT02447328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6227896|NCT02447328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227897|NCT02447432|Vaccines|vaccines|mesh-list
6227898|NCT02447432|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6227899|NCT02447432|Immunologic Factors|immunologic factors|mesh-ancestor
6227900|NCT02447432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227901|NCT02447718|Vaccines|vaccines|mesh-list
6227902|NCT02447718|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6227903|NCT02447718|Immunologic Factors|immunologic factors|mesh-ancestor
6227904|NCT02447718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227905|NCT02447848|Sufentanil|sufentanil|mesh-list
6227906|NCT02447848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6227907|NCT02447848|Narcotics|narcotics|mesh-ancestor
6227908|NCT02447848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6227909|NCT02447848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227910|NCT02447848|Analgesics|analgesics|mesh-ancestor
6227911|NCT02447848|Sensory System Agents|sensory system agents|mesh-ancestor
6227912|NCT02447848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6227913|NCT02447848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6227914|NCT02447848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6227915|NCT02447848|Anesthetics, General|anesthetics, general|mesh-ancestor
6227916|NCT02447848|Anesthetics|anesthetics|mesh-ancestor
6227917|NCT02447991|Rizatriptan|rizatriptan|mesh-list
6227918|NCT02447991|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6227919|NCT02447991|Serotonin Agents|serotonin agents|mesh-ancestor
6227920|NCT02447991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6227921|NCT02447991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227922|NCT02447991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227923|NCT02448043|Bimatoprost|bimatoprost|mesh-list
6227924|NCT02448043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6227925|NCT02448303|Pembrolizumab|pembrolizumab|mesh-list
6227926|NCT02448303|Acalabrutinib|acalabrutinib|mesh-list
6227927|NCT02448303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6227928|NCT02448303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6227929|NCT02448368|Verinurad|verinurad|mesh-list
6227930|NCT02448368|Gout Suppressants|gout suppressants|mesh-ancestor
6227931|NCT02448368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6227932|NCT02448446|Ranibizumab|ranibizumab|mesh-list
6227933|NCT02448446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6227934|NCT02448446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6227935|NCT02448446|Growth Substances|growth substances|mesh-ancestor
6227936|NCT02448446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227937|NCT02448446|Growth Inhibitors|growth inhibitors|mesh-ancestor
6227938|NCT02448446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6227939|NCT02448537|Gemcitabine|gemcitabine|mesh-list
6227940|NCT02448537|Doxorubicin|doxorubicin|mesh-list
6227941|NCT02448537|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6227942|NCT02448537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6227943|NCT02448537|Antimetabolites|antimetabolites|mesh-ancestor
6227944|NCT02448537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227945|NCT02448537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6227946|NCT02448537|Antiviral Agents|antiviral agents|mesh-ancestor
6227947|NCT02448537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6227948|NCT02448537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6227949|NCT02448537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6227950|NCT02448537|Immunologic Factors|immunologic factors|mesh-ancestor
6227951|NCT02448537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227952|NCT02448537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6227953|NCT02448537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6227954|NCT02448537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6227955|NCT02448654|Tolcapone|tolcapone|mesh-list
6227956|NCT02448654|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6227957|NCT02448654|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6227958|NCT02448654|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6227959|NCT02448654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6227960|NCT02448654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227961|NCT02448771|Bazedoxifene|bazedoxifene|mesh-list
6227962|NCT02448771|Palbociclib|palbociclib|mesh-list
6227963|NCT02448771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6227964|NCT02448771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6227965|NCT02448771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6227966|NCT02448771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227967|NCT02448771|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6227968|NCT02448771|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6227969|NCT02448771|Hormone Antagonists|hormone antagonists|mesh-ancestor
6227970|NCT02448771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6227971|NCT02448771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227972|NCT02448771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6227973|NCT02448810|Fluorouracil|fluorouracil|mesh-list
6227974|NCT02448810|Panitumumab|panitumumab|mesh-list
6227975|NCT02448810|Antimetabolites|antimetabolites|mesh-ancestor
6227976|NCT02448810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6227977|NCT02448810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5706105|NCT03313557|Adavosertib|adavosertib|mesh-list
5706106|NCT03313557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5706107|NCT03313557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706108|NCT03313544|Nivolumab|nivolumab|mesh-list
5706109|NCT03313544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5706110|NCT03313544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5706111|NCT03313544|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5706112|NCT03313544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706113|NCT03313531|Thrombin|thrombin|mesh-list
5706114|NCT03313531|Hemostatics|hemostatics|mesh-ancestor
5706115|NCT03313531|Coagulants|coagulants|mesh-ancestor
5706116|NCT03313479|Dexmedetomidine|dexmedetomidine|mesh-list
5706117|NCT03313479|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5706118|NCT03313479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5706119|NCT03313479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706120|NCT03313479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5706121|NCT03313479|Analgesics|analgesics|mesh-ancestor
5706122|NCT03313479|Sensory System Agents|sensory system agents|mesh-ancestor
5706123|NCT03313479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5706124|NCT03313479|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5706125|NCT03313479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5706126|NCT03313479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5706127|NCT03313479|Adrenergic Agents|adrenergic agents|mesh-ancestor
5706128|NCT03313479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5706129|NCT03313479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706130|NCT03313414|Sofosbuvir|sofosbuvir|mesh-list
5706131|NCT03313414|Velpatasvir|velpatasvir|mesh-list
5706132|NCT03313414|Antiviral Agents|antiviral agents|mesh-ancestor
5706133|NCT03313414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5706134|NCT03313401|Aflibercept|aflibercept|mesh-list
5706135|NCT03313401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5706136|NCT03313401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5706137|NCT03313401|Growth Substances|growth substances|mesh-ancestor
6227978|NCT02448810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6227979|NCT02448810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6227980|NCT02448810|Immunologic Factors|immunologic factors|mesh-ancestor
6227981|NCT02448810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227982|NCT02448810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6227983|NCT02448862|Fentanyl|fentanyl|mesh-list
6227984|NCT02448862|Analgesics|analgesics|mesh-list
6227985|NCT02448862|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6227986|NCT02448862|Narcotics|narcotics|mesh-ancestor
6227987|NCT02448862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6227988|NCT02448862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243678|NCT02677493|Immunologic Factors|immunologic factors|mesh-ancestor
5706138|NCT03313401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6227989|NCT02448862|Sensory System Agents|sensory system agents|mesh-ancestor
6227990|NCT02448862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6227991|NCT02448862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6227992|NCT02448862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6227993|NCT02448862|Anesthetics, General|anesthetics, general|mesh-ancestor
6227994|NCT02448862|Anesthetics|anesthetics|mesh-ancestor
6227995|NCT02448914|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
6227996|NCT02448914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6227997|NCT02448914|Immunologic Factors|immunologic factors|mesh-ancestor
6500158|NCT00644306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6500159|NCT00644306|Glucocorticoids|glucocorticoids|mesh-ancestor
6500160|NCT00644306|Hormones|hormones|mesh-ancestor
6500161|NCT00644306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6500162|NCT00644306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6500163|NCT00644306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6500164|NCT00644306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6500165|NCT00644306|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5706139|NCT03313401|Growth Inhibitors|growth inhibitors|mesh-ancestor
5706140|NCT03313401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5706141|NCT03313336|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
5706142|NCT03313336|Anesthetics, Local|anesthetics, local|mesh-ancestor
5706143|NCT03313336|Anesthetics|anesthetics|mesh-ancestor
5706144|NCT03313336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5706145|NCT03313336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706146|NCT03313336|Sensory System Agents|sensory system agents|mesh-ancestor
5706147|NCT03313336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5706148|NCT03313336|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
5706149|NCT03313323|Ipilimumab|ipilimumab|mesh-list
5706150|NCT03313323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6500166|NCT00644306|Alkylating Agents|alkylating agents|mesh-ancestor
6500167|NCT00644306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500168|NCT00644306|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6500169|NCT00644306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6500170|NCT00644306|Immunologic Factors|immunologic factors|mesh-ancestor
6500171|NCT00644306|Leprostatic Agents|leprostatic agents|mesh-ancestor
6500172|NCT00644306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6500173|NCT00644306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6500174|NCT00644306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6500175|NCT00644306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6500176|NCT00644306|Growth Substances|growth substances|mesh-ancestor
6500177|NCT00644306|Growth Inhibitors|growth inhibitors|mesh-ancestor
6500178|NCT00644319|Ibuprofen|ibuprofen|mesh-list
6500179|NCT00644319|Morphine|morphine|mesh-list
6500180|NCT00644319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6500181|NCT00644319|Narcotics|narcotics|mesh-ancestor
6500182|NCT00644319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6500183|NCT00644319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6500184|NCT00644319|Analgesics|analgesics|mesh-ancestor
6500185|NCT00644319|Sensory System Agents|sensory system agents|mesh-ancestor
6500186|NCT00644319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6500187|NCT00644319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6500188|NCT00644319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6500189|NCT00644319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6500190|NCT00644319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6500191|NCT00644319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6500192|NCT00644319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6500193|NCT00644319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500194|NCT00644371|Rituximab|rituximab|mesh-list
6500195|NCT00644371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6500196|NCT00644371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6500197|NCT00644371|Immunologic Factors|immunologic factors|mesh-ancestor
5706151|NCT03313323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5706152|NCT03313323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5706153|NCT03313323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706154|NCT03313206|Pembrolizumab|pembrolizumab|mesh-list
5706155|NCT03313206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5706156|NCT03313206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5706157|NCT03312855|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
5706158|NCT03312855|Immunologic Factors|immunologic factors|mesh-ancestor
6227998|NCT02448914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6500198|NCT00644371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6500199|NCT00644371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6500200|NCT00644384|Acitretin|acitretin|mesh-list
6500201|NCT00644384|Keratolytic Agents|keratolytic agents|mesh-ancestor
6227999|NCT02448914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6228000|NCT02448914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6228001|NCT02448914|Dopamine Agonists|dopamine agonists|mesh-ancestor
6228002|NCT02448914|Dopamine Agents|dopamine agents|mesh-ancestor
6228003|NCT02448914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6228004|NCT02448914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228005|NCT02449044|Tolvaptan|tolvaptan|mesh-list
6228006|NCT02449044|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
5706159|NCT03312855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706160|NCT03312777|Tramadol|tramadol|mesh-list
5706161|NCT03312777|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5706162|NCT03312777|Narcotics|narcotics|mesh-ancestor
5706163|NCT03312777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5706164|NCT03312777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706165|NCT03312777|Analgesics|analgesics|mesh-ancestor
5706166|NCT03312777|Sensory System Agents|sensory system agents|mesh-ancestor
5706167|NCT03312777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5706168|NCT03312738|Everolimus|everolimus|mesh-list
5706169|NCT03312738|Exemestane|exemestane|mesh-list
5706170|NCT03312738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5706171|NCT03312738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5706172|NCT03312738|Immunologic Factors|immunologic factors|mesh-ancestor
5706173|NCT03312738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706174|NCT03312738|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5706175|NCT03312738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5706176|NCT03312738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5706177|NCT03312738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706178|NCT03312738|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5706179|NCT03312738|Hormone Antagonists|hormone antagonists|mesh-ancestor
5706180|NCT03312738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5706181|NCT03312699|Vaccines|vaccines|mesh-list
5706182|NCT03312699|Immunologic Factors|immunologic factors|mesh-ancestor
5706183|NCT03312699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228007|NCT02449044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228008|NCT02449044|Natriuretic Agents|natriuretic agents|mesh-ancestor
6228009|NCT02449044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228010|NCT02449889|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6228011|NCT02449889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6228012|NCT02449889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228013|NCT02449902|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6228014|NCT02449902|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6228015|NCT02449902|Estradiol|estradiol|mesh-list
6228016|NCT02449902|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6228017|NCT02449902|Estrogens|estrogens|mesh-ancestor
6228018|NCT02449902|Hormones|hormones|mesh-ancestor
6228019|NCT02449902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6228020|NCT02449902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228021|NCT02449902|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6228022|NCT02449902|Contraceptive Agents|contraceptive agents|mesh-ancestor
6228023|NCT02449902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6228024|NCT02449902|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6228025|NCT02449915|Bupivacaine|bupivacaine|mesh-list
6228026|NCT02449915|Anesthetics, Local|anesthetics, local|mesh-ancestor
6228027|NCT02449915|Anesthetics|anesthetics|mesh-ancestor
6228028|NCT02449915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6228029|NCT02449915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228030|NCT02449915|Sensory System Agents|sensory system agents|mesh-ancestor
6228031|NCT02449915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6228032|NCT02450487|Piroxicam|piroxicam|mesh-list
6228033|NCT02450487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6228034|NCT02450487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6228035|NCT02450487|Analgesics|analgesics|mesh-ancestor
6228036|NCT02450487|Sensory System Agents|sensory system agents|mesh-ancestor
6228037|NCT02450487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6228038|NCT02450487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228039|NCT02450487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6228040|NCT02450487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6228041|NCT02450487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6228042|NCT02450487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6228043|NCT02450487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228044|NCT02450526|Botulinum Toxins|botulinum toxins|mesh-list
6228045|NCT02450526|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6228046|NCT02450526|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6228047|NCT02450526|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6228048|NCT02450526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6228049|NCT02450526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228050|NCT02450526|Cholinergic Agents|cholinergic agents|mesh-ancestor
6228051|NCT02450526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6676495|NCT01581775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6779657|NCT02180334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779658|NCT02180334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5706184|NCT03312582|Metformin|metformin|mesh-list
5706185|NCT03312582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5706186|NCT03312582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706187|NCT03312530|Atezolizumab|atezolizumab|mesh-list
5706188|NCT03312530|Venetoclax|venetoclax|mesh-list
5706189|NCT03312530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5706190|NCT03312478|Antibodies|antibodies|mesh-list
5706191|NCT03312478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706192|NCT03312478|Immunologic Factors|immunologic factors|mesh-ancestor
5706193|NCT03312426|Linrodostat|linrodostat|mesh-list
5706194|NCT03312426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5706195|NCT03312426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779659|NCT02180334|Incretins|incretins|mesh-ancestor
6779660|NCT02180334|Hormones|hormones|mesh-ancestor
6779661|NCT02180334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6779662|NCT02180334|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6779663|NCT02180334|Protease Inhibitors|protease inhibitors|mesh-ancestor
6779664|NCT02180334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6779665|NCT02180334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6779666|NCT02180334|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6779667|NCT02180334|Serotonin Agents|serotonin agents|mesh-ancestor
5706196|NCT03312413|Dexmedetomidine|dexmedetomidine|mesh-list
5706197|NCT03312413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6228052|NCT02450526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228053|NCT02450526|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6228054|NCT02450526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6228055|NCT02450539|Docetaxel|docetaxel|mesh-list
6228056|NCT02450539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6228057|NCT02450539|Tubulin Modulators|tubulin modulators|mesh-ancestor
6228058|NCT02450539|Antimitotic Agents|antimitotic agents|mesh-ancestor
6228059|NCT02450539|Mitosis Modulators|mitosis modulators|mesh-ancestor
6228060|NCT02450539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228061|NCT02450552|Ezogabine|ezogabine|mesh-list
6228062|NCT02450552|Anticonvulsants|anticonvulsants|mesh-ancestor
5706198|NCT03312413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6228063|NCT02450552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6228064|NCT02450552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228065|NCT02450578|Atovaquone|atovaquone|mesh-list
6228066|NCT02450578|Proguanil|proguanil|mesh-list
6228067|NCT02450578|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
6228068|NCT02450578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6228069|NCT02450578|Antimalarials|antimalarials|mesh-ancestor
6228070|NCT02450578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6228071|NCT02450578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6228072|NCT02450578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6228073|NCT02450578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228074|NCT02450578|Antimetabolites|antimetabolites|mesh-ancestor
6228075|NCT02450903|Ceritinib|ceritinib|mesh-list
6228076|NCT02450903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6228077|NCT02450903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6228078|NCT02450903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6228079|NCT02450903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228080|NCT02451137|Insulin|insulin|mesh-list
6228081|NCT02451137|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6228082|NCT02451137|Insulin Glargine|insulin glargine|mesh-list
6228083|NCT02451137|Insulin Detemir|insulin detemir|mesh-list
6228084|NCT02451137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6228085|NCT02451137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228086|NCT02451150|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
6500202|NCT00644384|Dermatologic Agents|dermatologic agents|mesh-ancestor
6500203|NCT00644449|Azithromycin|azithromycin|mesh-list
6500204|NCT00644449|Levofloxacin|levofloxacin|mesh-list
6500205|NCT00644449|Ofloxacin|ofloxacin|mesh-list
6500206|NCT00644449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6500207|NCT00644449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6500208|NCT00644449|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6500209|NCT00644449|Renal Agents|renal agents|mesh-ancestor
6500210|NCT00644449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6500211|NCT00644449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6228087|NCT02451150|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6228088|NCT02451150|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6228089|NCT02451150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228090|NCT02451202|Rocuronium|rocuronium|mesh-list
6228091|NCT02451202|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6228092|NCT02451202|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6228093|NCT02451202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6228094|NCT02451202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6228095|NCT02451202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228096|NCT02451358|Vaccines|vaccines|mesh-list
6228097|NCT02451358|Immunologic Factors|immunologic factors|mesh-ancestor
6228098|NCT02451358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228099|NCT02451488|Sargramostim|sargramostim|mesh-list
6228100|NCT02451488|Immunologic Factors|immunologic factors|mesh-ancestor
6228101|NCT02451488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228102|NCT02451696|Everolimus|everolimus|mesh-list
6228103|NCT02451696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6228104|NCT02451696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6228105|NCT02451696|Immunologic Factors|immunologic factors|mesh-ancestor
6228106|NCT02451696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228107|NCT02451917|Insulin|insulin|mesh-list
6228108|NCT02451917|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6228109|NCT02451917|Insulin Glargine|insulin glargine|mesh-list
6228110|NCT02451917|Insulin, Isophane|insulin, isophane|mesh-list
6228111|NCT02451917|Isophane Insulin, Human|isophane insulin, human|mesh-list
6228112|NCT02451917|Isophane insulin, beef|isophane insulin, beef|mesh-list
6228113|NCT02451917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6228114|NCT02451917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228115|NCT02451930|Pembrolizumab|pembrolizumab|mesh-list
6228116|NCT02451930|Necitumumab|necitumumab|mesh-list
6228117|NCT02451930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6228118|NCT02451930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6228119|NCT02451943|Doxorubicin|doxorubicin|mesh-list
6228120|NCT02451943|Olaratumab|olaratumab|mesh-list
6228121|NCT02451943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6228122|NCT02451943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6228123|NCT02451943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6228124|NCT02451943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6228125|NCT02451943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5706199|NCT03312413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228126|NCT02451943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228127|NCT02452034|Posaconazole|posaconazole|mesh-list
6228128|NCT02452034|Antifungal Agents|antifungal agents|mesh-ancestor
6228129|NCT02452034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6228130|NCT02452034|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6228131|NCT02452034|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6228132|NCT02452034|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6228133|NCT02452034|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6228134|NCT02452034|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6228135|NCT02452034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6228136|NCT02452034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228137|NCT02452034|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6228138|NCT02452034|Hormone Antagonists|hormone antagonists|mesh-ancestor
6228139|NCT02452034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6228140|NCT02452034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228141|NCT02452047|Imipenem|imipenem|mesh-list
6228142|NCT02452047|Relebactam|relebactam|mesh-list
6228143|NCT02452047|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
6228144|NCT02452047|Cilastatin|cilastatin|mesh-list
6228145|NCT02452047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6228146|NCT02452047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6228147|NCT02452047|Protease Inhibitors|protease inhibitors|mesh-ancestor
6228148|NCT02452047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6228149|NCT02452047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228150|NCT02452047|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6228151|NCT02452060|Ketamine|ketamine|mesh-list
6228152|NCT02452060|Analgesics|analgesics|mesh-ancestor
6228153|NCT02452060|Sensory System Agents|sensory system agents|mesh-ancestor
6228154|NCT02452060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6500212|NCT00644449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5706200|NCT03312413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5706201|NCT03312413|Analgesics|analgesics|mesh-ancestor
5706202|NCT03312413|Sensory System Agents|sensory system agents|mesh-ancestor
5706203|NCT03312413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5706204|NCT03312413|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6228155|NCT02452060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228156|NCT02452060|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6228157|NCT02452060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6228158|NCT02452060|Anesthetics, General|anesthetics, general|mesh-ancestor
6228159|NCT02452060|Anesthetics|anesthetics|mesh-ancestor
6228160|NCT02452060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6228161|NCT02452060|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6228162|NCT02452060|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5706205|NCT03312413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5706206|NCT03312413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5706207|NCT03312413|Adrenergic Agents|adrenergic agents|mesh-ancestor
5706208|NCT03312413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5706209|NCT03312413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706210|NCT03312335|Aldesleukin|aldesleukin|mesh-list
5706211|NCT03312335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5706212|NCT03312335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5706213|NCT03312335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5706214|NCT03312335|Antiviral Agents|antiviral agents|mesh-ancestor
5706215|NCT03312335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5706216|NCT03312283|Ranibizumab|ranibizumab|mesh-list
5706217|NCT03312283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5706218|NCT03312283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6228163|NCT02452060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6228164|NCT02452060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706219|NCT03312283|Growth Substances|growth substances|mesh-ancestor
5706220|NCT03312283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706221|NCT03312283|Growth Inhibitors|growth inhibitors|mesh-ancestor
5706222|NCT03312283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5706223|NCT03312257|Atropine|atropine|mesh-list
5706224|NCT03312257|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5706225|NCT03312257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5706226|NCT03312257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5706227|NCT03312257|Autonomic Agents|autonomic agents|mesh-ancestor
6228165|NCT02452190|Reslizumab|reslizumab|mesh-list
6500213|NCT00644449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500214|NCT00644449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6500215|NCT00644449|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6500216|NCT00644449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6500217|NCT00644475|Candesartan|candesartan|mesh-list
6500218|NCT00644475|Imidapril|imidapril|mesh-list
6500219|NCT00644475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6500220|NCT00644475|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6500221|NCT00644475|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6500222|NCT00644475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500223|NCT00644475|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6500224|NCT00644475|Protease Inhibitors|protease inhibitors|mesh-ancestor
6500225|NCT00644475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6500226|NCT00644540|Vaccines|vaccines|mesh-list
6500227|NCT00644540|Immunologic Factors|immunologic factors|mesh-ancestor
6500228|NCT00644540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6500229|NCT00644553|Amoxicillin|amoxicillin|mesh-list
6500230|NCT00644553|Clarithromycin|clarithromycin|mesh-list
6500231|NCT00644553|Clavulanic Acid|clavulanic acid|mesh-list
6500232|NCT00644553|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6500233|NCT00644553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5706228|NCT03312257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5706229|NCT03312257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706230|NCT03312257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5706231|NCT03312257|Respiratory System Agents|respiratory system agents|mesh-ancestor
5706232|NCT03312257|Mydriatics|mydriatics|mesh-ancestor
5706233|NCT03312257|Parasympatholytics|parasympatholytics|mesh-ancestor
5706234|NCT03312257|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5706235|NCT03312257|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5706236|NCT03312257|Cholinergic Agents|cholinergic agents|mesh-ancestor
5706237|NCT03312257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5706238|NCT03312257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706239|NCT03312244|Bromides|bromides|mesh-list
5706240|NCT03312244|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
5706241|NCT03312244|Anticonvulsants|anticonvulsants|mesh-ancestor
5706242|NCT03312244|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5706243|NCT03312244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5706244|NCT03312244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706245|NCT03312244|Cholinergic Agents|cholinergic agents|mesh-ancestor
5706246|NCT03312244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5706247|NCT03312244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706248|NCT03312179|Incretins|incretins|mesh-list
5706249|NCT03312179|Hormones|hormones|mesh-ancestor
5706250|NCT03312179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5706251|NCT03312179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706252|NCT03312153|Sodium Hypochlorite|sodium hypochlorite|mesh-list
5706253|NCT03312153|Eusol|eusol|mesh-list
6228166|NCT02452190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6228167|NCT02452190|Respiratory System Agents|respiratory system agents|mesh-ancestor
6228168|NCT02452320|Acetaminophen|acetaminophen|mesh-list
6228169|NCT02452320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6228170|NCT02452320|Analgesics|analgesics|mesh-ancestor
6228171|NCT02452320|Sensory System Agents|sensory system agents|mesh-ancestor
6228172|NCT02452320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6228173|NCT02452320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228174|NCT02452320|Antipyretics|antipyretics|mesh-ancestor
6228175|NCT02452346|Tosedostat|tosedostat|mesh-list
6228176|NCT02452346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6228177|NCT02452346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228178|NCT02452424|Pembrolizumab|pembrolizumab|mesh-list
6228179|NCT02452424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6228180|NCT02452424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6228181|NCT02452463|Durvalumab|durvalumab|mesh-list
6228182|NCT02452463|Nintedanib|nintedanib|mesh-list
6228183|NCT02452463|Immunoglobulins|immunoglobulins|mesh-list
6228184|NCT02452463|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6228185|NCT02452463|Immunoglobulin G|immunoglobulin g|mesh-list
6228186|NCT02452463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6228187|NCT02452463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6228188|NCT02452463|Immunologic Factors|immunologic factors|mesh-ancestor
6228189|NCT02452463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228190|NCT02452463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6228191|NCT02452463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6228192|NCT02452463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228193|NCT02452476|Poractant alfa|poractant alfa|mesh-list
6228194|NCT02452476|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
6228195|NCT02452476|Respiratory System Agents|respiratory system agents|mesh-ancestor
6228196|NCT02452528|Diphenhydramine|diphenhydramine|mesh-list
6228197|NCT02452528|Promethazine|promethazine|mesh-list
6228198|NCT02452528|Tenofovir|tenofovir|mesh-list
6228199|NCT02452528|Entecavir|entecavir|mesh-list
6228200|NCT02452528|Antiviral Agents|antiviral agents|mesh-ancestor
6228201|NCT02452528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6228202|NCT02452528|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6228203|NCT02452528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5706254|NCT03312153|Disinfectants|disinfectants|mesh-ancestor
5706255|NCT03312153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5706256|NCT03312140|Choline|choline|mesh-list
5706257|NCT03312140|Lipotropic Agents|lipotropic agents|mesh-ancestor
5706258|NCT03312140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5706259|NCT03312140|Antimetabolites|antimetabolites|mesh-ancestor
5706260|NCT03312140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706261|NCT03312140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5706262|NCT03312140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5706263|NCT03312140|Nootropic Agents|nootropic agents|mesh-ancestor
5706264|NCT03311984|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5706265|NCT03311984|Dalteparin|dalteparin|mesh-list
6228204|NCT02452528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6228205|NCT02452528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228206|NCT02452528|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6228207|NCT02452528|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6228208|NCT02452528|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6228209|NCT02452528|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6228210|NCT02452528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6228211|NCT02452528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228212|NCT02452528|Anesthetics, Local|anesthetics, local|mesh-ancestor
6228213|NCT02452528|Anesthetics|anesthetics|mesh-ancestor
6228214|NCT02452528|Sensory System Agents|sensory system agents|mesh-ancestor
6228215|NCT02452528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6228216|NCT02452528|Antiemetics|antiemetics|mesh-ancestor
6228217|NCT02452528|Autonomic Agents|autonomic agents|mesh-ancestor
6228218|NCT02452528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6228219|NCT02452528|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6228220|NCT02452528|Histamine Antagonists|histamine antagonists|mesh-ancestor
6228221|NCT02452528|Histamine Agents|histamine agents|mesh-ancestor
6228222|NCT02452528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5706266|NCT03311984|Anticoagulants|anticoagulants|mesh-ancestor
6228223|NCT02452528|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6228224|NCT02452528|Antipruritics|antipruritics|mesh-ancestor
6228225|NCT02452528|Dermatologic Agents|dermatologic agents|mesh-ancestor
5706267|NCT03311984|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5706268|NCT03311984|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5706269|NCT03311984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706270|NCT03311971|Methamphetamine|methamphetamine|mesh-list
5706271|NCT03311971|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6228226|NCT02452762|Vitamin D|vitamin d|mesh-list
6228227|NCT02452762|Cholecalciferol|cholecalciferol|mesh-list
6228228|NCT02452762|Vitamins|vitamins|mesh-ancestor
6228229|NCT02452762|Micronutrients|micronutrients|mesh-ancestor
6228230|NCT02452762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228231|NCT02452762|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6228232|NCT02452762|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6228233|NCT02452866|Secnidazole|secnidazole|mesh-list
6228234|NCT02452866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6228235|NCT02452866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6228236|NCT02452866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6228237|NCT02452931|Leuprolide|leuprolide|mesh-list
6228238|NCT02452931|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6228239|NCT02452931|Fertility Agents|fertility agents|mesh-ancestor
6228240|NCT02452931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6228241|NCT02452931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228242|NCT02452931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6228243|NCT02452931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6228244|NCT02453191|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
6228245|NCT02453191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6228246|NCT02453191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6228247|NCT02453282|Gemcitabine|gemcitabine|mesh-list
6228248|NCT02453282|Paclitaxel|paclitaxel|mesh-list
6228249|NCT02453282|Cisplatin|cisplatin|mesh-list
6228250|NCT02453282|Carboplatin|carboplatin|mesh-list
6228251|NCT02453282|Pemetrexed|pemetrexed|mesh-list
6228252|NCT02453282|Durvalumab|durvalumab|mesh-list
6228253|NCT02453282|Tremelimumab|tremelimumab|mesh-list
6228254|NCT02453282|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6228255|NCT02453282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6228256|NCT02453282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6228257|NCT02453282|Tubulin Modulators|tubulin modulators|mesh-ancestor
6228258|NCT02453282|Antimitotic Agents|antimitotic agents|mesh-ancestor
6228259|NCT02453282|Mitosis Modulators|mitosis modulators|mesh-ancestor
6228260|NCT02453282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228261|NCT02453282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6228262|NCT02453282|Antimetabolites|antimetabolites|mesh-ancestor
6228263|NCT02453282|Antiviral Agents|antiviral agents|mesh-ancestor
6228264|NCT02453282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6228265|NCT02453282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5706272|NCT03311971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706273|NCT03311971|Sympathomimetics|sympathomimetics|mesh-ancestor
5706274|NCT03311971|Autonomic Agents|autonomic agents|mesh-ancestor
5706275|NCT03311971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5706276|NCT03311971|Dopamine Agents|dopamine agents|mesh-ancestor
5706277|NCT03311971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5706278|NCT03311971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706279|NCT03311971|Adrenergic Agents|adrenergic agents|mesh-ancestor
6228266|NCT02453282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6228267|NCT02453282|Immunologic Factors|immunologic factors|mesh-ancestor
6228268|NCT02453282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228269|NCT02453282|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6228270|NCT02453282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6228271|NCT02453282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6228272|NCT02453321|Bupivacaine|bupivacaine|mesh-list
6228273|NCT02453321|Anesthetics, Local|anesthetics, local|mesh-ancestor
6228274|NCT02453321|Anesthetics|anesthetics|mesh-ancestor
6228275|NCT02453321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6228276|NCT02453321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228277|NCT02453321|Sensory System Agents|sensory system agents|mesh-ancestor
6228278|NCT02453321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6243679|NCT02677493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243680|NCT02677623|Mannitol|mannitol|mesh-list
6243681|NCT02677623|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6243682|NCT02677623|Diuretics|diuretics|mesh-ancestor
6243683|NCT02677623|Natriuretic Agents|natriuretic agents|mesh-ancestor
6243684|NCT02677623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243685|NCT02677701|Azithromycin|azithromycin|mesh-list
6243686|NCT02677701|Tobramycin|tobramycin|mesh-list
6243687|NCT02677701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6228279|NCT02453360|Bupivacaine|bupivacaine|mesh-list
6228280|NCT02453360|Anesthetics, Local|anesthetics, local|mesh-ancestor
6228281|NCT02453360|Anesthetics|anesthetics|mesh-ancestor
6228282|NCT02453360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6228283|NCT02453360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228284|NCT02453360|Sensory System Agents|sensory system agents|mesh-ancestor
6228285|NCT02453360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6228286|NCT02453555|Empagliflozin|empagliflozin|mesh-list
6228287|NCT02453555|Linagliptin|linagliptin|mesh-list
6228288|NCT02453555|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6228289|NCT02453555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228290|NCT02453555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6228291|NCT02453555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228292|NCT02453555|Incretins|incretins|mesh-ancestor
6228293|NCT02453555|Hormones|hormones|mesh-ancestor
6228294|NCT02453555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6228295|NCT02453555|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6228296|NCT02453555|Protease Inhibitors|protease inhibitors|mesh-ancestor
6228297|NCT02453555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6228298|NCT02453581|Artefenomel|artefenomel|mesh-list
6228299|NCT02453581|Antimalarials|antimalarials|mesh-ancestor
6228300|NCT02453581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6228301|NCT02453581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6228302|NCT02453581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6228303|NCT02453672|Bevacizumab|bevacizumab|mesh-list
6228304|NCT02453672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6228305|NCT02453672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6228306|NCT02453672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6228307|NCT02453672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6228308|NCT02453672|Growth Substances|growth substances|mesh-ancestor
6228309|NCT02453672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228310|NCT02453672|Growth Inhibitors|growth inhibitors|mesh-ancestor
6228311|NCT02453685|Insulin|insulin|mesh-list
6228312|NCT02453685|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6228313|NCT02453685|Insulin Glargine|insulin glargine|mesh-list
6228314|NCT02453685|Insulin Aspart|insulin aspart|mesh-list
6228315|NCT02453685|Insulin, Long-Acting|insulin, long-acting|mesh-list
6228316|NCT02453685|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6228317|NCT02453685|Biphasic Insulins|biphasic insulins|mesh-list
6228318|NCT02453685|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6228319|NCT02453685|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6228320|NCT02453685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228321|NCT02453711|Liraglutide|liraglutide|mesh-list
6228322|NCT02453711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6228323|NCT02453711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228324|NCT02453711|Incretins|incretins|mesh-ancestor
6228325|NCT02453711|Hormones|hormones|mesh-ancestor
6228326|NCT02453711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6228327|NCT02453750|Bronchodilator Agents|bronchodilator agents|mesh-list
6228328|NCT02453750|Autonomic Agents|autonomic agents|mesh-ancestor
6228329|NCT02453750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6228330|NCT02453750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228331|NCT02453750|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6228332|NCT02453750|Respiratory System Agents|respiratory system agents|mesh-ancestor
6228333|NCT02453841|Phenylephrine|phenylephrine|mesh-list
5706280|NCT03311971|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5706281|NCT03311971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5706282|NCT03311971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5706283|NCT03311971|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5721289|NCT03206931|Selitrectinib|selitrectinib|mesh-list
5721290|NCT03206931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5721291|NCT03206931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721292|NCT03206671|Cytarabine|cytarabine|mesh-list
5721293|NCT03206671|Dexamethasone|dexamethasone|mesh-list
5721294|NCT03206671|Prednisolone|prednisolone|mesh-list
5721295|NCT03206671|Cyclophosphamide|cyclophosphamide|mesh-list
5721296|NCT03206671|Ifosfamide|ifosfamide|mesh-list
5721297|NCT03206671|Rituximab|rituximab|mesh-list
5721298|NCT03206671|Doxorubicin|doxorubicin|mesh-list
5721299|NCT03206671|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6228334|NCT02453841|Oxymetazoline|oxymetazoline|mesh-list
6228335|NCT02453841|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6228336|NCT02453841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6228337|NCT02453841|Adrenergic Agents|adrenergic agents|mesh-ancestor
6228338|NCT02453841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5721300|NCT03206671|Methotrexate|methotrexate|mesh-list
5721301|NCT03206671|Etoposide|etoposide|mesh-list
6228339|NCT02453841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228340|NCT02453841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228341|NCT02453841|Sympathomimetics|sympathomimetics|mesh-ancestor
6228342|NCT02453841|Autonomic Agents|autonomic agents|mesh-ancestor
6228343|NCT02453841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6228344|NCT02453841|Nasal Decongestants|nasal decongestants|mesh-ancestor
6228345|NCT02453841|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6228346|NCT02453841|Respiratory System Agents|respiratory system agents|mesh-ancestor
6228347|NCT02453841|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6228348|NCT02453841|Mydriatics|mydriatics|mesh-ancestor
6228349|NCT02453841|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6228350|NCT02453841|Protective Agents|protective agents|mesh-ancestor
6228351|NCT02454179|Pembrolizumab|pembrolizumab|mesh-list
6228352|NCT02454179|Acalabrutinib|acalabrutinib|mesh-list
6228353|NCT02454179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6228354|NCT02454179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6228355|NCT02454283|Vanoxerine|vanoxerine|mesh-list
6228356|NCT02454283|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6228357|NCT02454283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6228358|NCT02454283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6228359|NCT02454283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228360|NCT02454283|Dopamine Agents|dopamine agents|mesh-ancestor
6228361|NCT02454283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6228362|NCT02454283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228363|NCT02454296|Lidocaine|lidocaine|mesh-list
6228364|NCT02454296|Anesthetics, Local|anesthetics, local|mesh-ancestor
6228365|NCT02454296|Anesthetics|anesthetics|mesh-ancestor
6228366|NCT02454296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6228367|NCT02454296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228368|NCT02454296|Sensory System Agents|sensory system agents|mesh-ancestor
6228369|NCT02454296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6228370|NCT02454296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6228371|NCT02454296|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6228372|NCT02454296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6228373|NCT02454296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5706284|NCT03311958|Nivolumab|nivolumab|mesh-list
5706285|NCT03311958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5706286|NCT03311958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5706287|NCT03311958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5706288|NCT03311958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706289|NCT03311945|Lamivudine|lamivudine|mesh-list
5706290|NCT03311945|Raltegravir Potassium|raltegravir potassium|mesh-list
5706291|NCT03311945|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5706292|NCT03311945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5706293|NCT03311945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5706294|NCT03311945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706295|NCT03311945|Antiviral Agents|antiviral agents|mesh-ancestor
5706296|NCT03311945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5706297|NCT03311945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5706298|NCT03311945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5706299|NCT03311945|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5706300|NCT03311945|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5706301|NCT03311906|Hyaluronic Acid|hyaluronic acid|mesh-list
5706302|NCT03311906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5706303|NCT03311906|Immunologic Factors|immunologic factors|mesh-ancestor
5706304|NCT03311906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706305|NCT03311906|Viscosupplements|viscosupplements|mesh-ancestor
5706306|NCT03311906|Protective Agents|protective agents|mesh-ancestor
5706307|NCT03311828|Daratumumab|daratumumab|mesh-list
6228374|NCT02454296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228375|NCT02454478|Everolimus|everolimus|mesh-list
6228376|NCT02454478|Lenvatinib|lenvatinib|mesh-list
5706308|NCT03311828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5706309|NCT03311789|Gemcitabine|gemcitabine|mesh-list
5706310|NCT03311789|Nivolumab|nivolumab|mesh-list
5706311|NCT03311789|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5706312|NCT03311789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5706313|NCT03311789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5706314|NCT03311789|Antimetabolites|antimetabolites|mesh-ancestor
5706315|NCT03311789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706316|NCT03311789|Antiviral Agents|antiviral agents|mesh-ancestor
5706317|NCT03311789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5706318|NCT03311789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5706319|NCT03311789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5706320|NCT03311789|Immunologic Factors|immunologic factors|mesh-ancestor
6228377|NCT02454478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6228378|NCT02454478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6228379|NCT02454478|Immunologic Factors|immunologic factors|mesh-ancestor
6228380|NCT02454478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228381|NCT02454478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6228382|NCT02454478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6228383|NCT02454478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228384|NCT02454608|Verapamil|verapamil|mesh-list
6228385|NCT02454608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6228386|NCT02454608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6228387|NCT02454608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6228388|NCT02454608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228389|NCT02454608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6228390|NCT02454608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228391|NCT02454608|Vasodilator Agents|vasodilator agents|mesh-ancestor
6228392|NCT02455050|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6228393|NCT02455050|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6228394|NCT02455050|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6228395|NCT02455050|Laxatives|laxatives|mesh-ancestor
6228396|NCT02455050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6228397|NCT02455076|Exenatide|exenatide|mesh-list
6228398|NCT02455076|Insulin, Short-Acting|insulin, short-acting|mesh-list
6228399|NCT02455076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6228400|NCT02455076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228401|NCT02455076|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6228402|NCT02455076|Incretins|incretins|mesh-ancestor
6228403|NCT02455076|Hormones|hormones|mesh-ancestor
6228404|NCT02455076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6228405|NCT02455167|Ribavirin|ribavirin|mesh-list
6228406|NCT02455167|Sofosbuvir|sofosbuvir|mesh-list
6228407|NCT02455167|Antimetabolites|antimetabolites|mesh-ancestor
6228408|NCT02455167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228409|NCT02455167|Antiviral Agents|antiviral agents|mesh-ancestor
6228410|NCT02455167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6228411|NCT02455336|Fenofibrate|fenofibrate|mesh-list
6228412|NCT02455336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6228413|NCT02455336|Antimetabolites|antimetabolites|mesh-ancestor
6228414|NCT02455336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228415|NCT02455336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6228416|NCT02455453|Estradiol|estradiol|mesh-list
6228417|NCT02455453|Estrogens|estrogens|mesh-ancestor
6228418|NCT02455453|Hormones|hormones|mesh-ancestor
6228419|NCT02455453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6228420|NCT02455453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228421|NCT02455518|Acetaminophen|acetaminophen|mesh-list
6228422|NCT02455518|Ibuprofen|ibuprofen|mesh-list
6228423|NCT02455518|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
6228424|NCT02455518|Oxycodone|oxycodone|mesh-list
6228425|NCT02455518|Hydrocodone|hydrocodone|mesh-list
6228426|NCT02455518|Codeine|codeine|mesh-list
6228427|NCT02455518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6228428|NCT02455518|Analgesics|analgesics|mesh-ancestor
6228429|NCT02455518|Sensory System Agents|sensory system agents|mesh-ancestor
6228430|NCT02455518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6228431|NCT02455518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228432|NCT02455518|Antipyretics|antipyretics|mesh-ancestor
6228433|NCT02455518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6228434|NCT02455518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6228435|NCT02455518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6500234|NCT00644553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6500235|NCT00644553|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6500236|NCT00644553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6500237|NCT00644553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500238|NCT00644553|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6500239|NCT00644553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6500240|NCT00644553|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6500241|NCT00644605|Sildenafil Citrate|sildenafil citrate|mesh-list
6500242|NCT00644605|Vasodilator Agents|vasodilator agents|mesh-ancestor
6500243|NCT00644605|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6500244|NCT00644605|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6500245|NCT00644605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6500246|NCT00644605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228436|NCT02455518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6228437|NCT02455518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6228438|NCT02455518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228439|NCT02455518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5706321|NCT03311789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706322|NCT03311789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5706323|NCT03311750|Panitumumab|panitumumab|mesh-list
5706324|NCT03311750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5706325|NCT03311750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5706326|NCT03311737|Anesthetics|anesthetics|mesh-list
5706327|NCT03311737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5706328|NCT03311737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706329|NCT03311672|Pembrolizumab|pembrolizumab|mesh-list
5706330|NCT03311672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5706331|NCT03311672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5706332|NCT03311607|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6228440|NCT02455518|Narcotics|narcotics|mesh-ancestor
6228441|NCT02455518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6228442|NCT02455518|Antitussive Agents|antitussive agents|mesh-ancestor
6228443|NCT02455518|Respiratory System Agents|respiratory system agents|mesh-ancestor
6228444|NCT02455557|Temozolomide|temozolomide|mesh-list
6228445|NCT02455557|Sargramostim|sargramostim|mesh-list
6228446|NCT02455557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6228447|NCT02455557|Alkylating Agents|alkylating agents|mesh-ancestor
6228448|NCT02455557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228449|NCT02455557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6228450|NCT02455557|Immunologic Factors|immunologic factors|mesh-ancestor
6228451|NCT02455557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228452|NCT02456662|Ondansetron|ondansetron|mesh-list
6228453|NCT02456662|Antiemetics|antiemetics|mesh-ancestor
6228454|NCT02456662|Autonomic Agents|autonomic agents|mesh-ancestor
6228455|NCT02456662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6228456|NCT02456662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228457|NCT02456662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6228458|NCT02456662|Antipruritics|antipruritics|mesh-ancestor
6228459|NCT02456662|Dermatologic Agents|dermatologic agents|mesh-ancestor
6228460|NCT02456662|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6228461|NCT02456662|Serotonin Agents|serotonin agents|mesh-ancestor
6228462|NCT02456662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6228463|NCT02456662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228464|NCT02456662|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6228465|NCT02456662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6228466|NCT02456662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6228467|NCT02456662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6228468|NCT02456662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6228469|NCT02456740|Erenumab|erenumab|mesh-list
6228470|NCT02456740|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
6228471|NCT02456740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228472|NCT02456740|Analgesics|analgesics|mesh-ancestor
6228473|NCT02456740|Sensory System Agents|sensory system agents|mesh-ancestor
6228474|NCT02456740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5706333|NCT03311607|Antifungal Agents|antifungal agents|mesh-ancestor
5706334|NCT03311607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5706335|NCT03311607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5706336|NCT03311607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6228475|NCT02456740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228476|NCT02456896|Oxcarbazepine|oxcarbazepine|mesh-list
6228477|NCT02456896|Anticonvulsants|anticonvulsants|mesh-ancestor
6228478|NCT02456896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6228479|NCT02456896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6228480|NCT02456896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6228481|NCT02456896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228482|NCT02456896|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6228483|NCT02456896|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6228484|NCT02456909|Morphine|morphine|mesh-list
6228485|NCT02456909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6228486|NCT02456909|Narcotics|narcotics|mesh-ancestor
6228487|NCT02456909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6228488|NCT02456909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228489|NCT02456909|Analgesics|analgesics|mesh-ancestor
6228490|NCT02456909|Sensory System Agents|sensory system agents|mesh-ancestor
6228491|NCT02456909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6228492|NCT02457195|Granisetron|granisetron|mesh-list
6228493|NCT02457195|Antiemetics|antiemetics|mesh-ancestor
6228494|NCT02457195|Autonomic Agents|autonomic agents|mesh-ancestor
6228495|NCT02457195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6228496|NCT02457195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228497|NCT02457195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6228498|NCT02457195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6228499|NCT02457195|Serotonin Agents|serotonin agents|mesh-ancestor
5706337|NCT03311594|Ethanol|ethanol|mesh-list
5706338|NCT03311594|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5706339|NCT03311594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5706340|NCT03311594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5706341|NCT03311594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706342|NCT03311581|Propofol|propofol|mesh-list
5706343|NCT03311581|Sevoflurane|sevoflurane|mesh-list
6228500|NCT02457195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6228501|NCT02457195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228502|NCT02457247|Calcium Carbonate|calcium carbonate|mesh-list
6228503|NCT02457247|Antacids|antacids|mesh-ancestor
6228504|NCT02457247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228505|NCT02457247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6228506|NCT02457325|Carticaine|carticaine|mesh-list
6228507|NCT02457325|Anesthetics, Local|anesthetics, local|mesh-ancestor
6228508|NCT02457325|Anesthetics|anesthetics|mesh-ancestor
6228509|NCT02457325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6228510|NCT02457325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228511|NCT02457325|Sensory System Agents|sensory system agents|mesh-ancestor
6228512|NCT02457325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6228513|NCT02457520|Isotretinoin|isotretinoin|mesh-list
6228514|NCT02457520|Dermatologic Agents|dermatologic agents|mesh-ancestor
6228515|NCT02457546|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6228516|NCT02457546|Hemostatics|hemostatics|mesh-ancestor
6228517|NCT02457546|Coagulants|coagulants|mesh-ancestor
6228518|NCT02457611|Sofosbuvir|sofosbuvir|mesh-list
6228519|NCT02457611|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
6228520|NCT02457611|Ledipasvir|ledipasvir|mesh-list
6228521|NCT02457611|Antiviral Agents|antiviral agents|mesh-ancestor
6228522|NCT02457611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6228523|NCT02457793|Ravoxertinib|ravoxertinib|mesh-list
6228524|NCT02457793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6228525|NCT02457793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6228526|NCT02457793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6228527|NCT02457793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228528|NCT02458235|Azacitidine|azacitidine|mesh-list
6228529|NCT02458235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6228530|NCT02458235|Antimetabolites|antimetabolites|mesh-ancestor
6228531|NCT02458235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228532|NCT02458235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6228533|NCT02458235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6228534|NCT02458287|Bococizumab|bococizumab|mesh-list
6228535|NCT02458287|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6228536|NCT02458287|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6228537|NCT02458287|Antimetabolites|antimetabolites|mesh-ancestor
6500247|NCT00644605|Urological Agents|urological agents|mesh-ancestor
5706344|NCT03311581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5721302|NCT03206671|Vincristine|vincristine|mesh-list
6228538|NCT02458287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228539|NCT02458287|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6228540|NCT02458469|Buspirone|buspirone|mesh-list
6228541|NCT02458469|Trazodone|trazodone|mesh-list
6228542|NCT02458469|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6228543|NCT02458469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6228544|NCT02458469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6228545|NCT02458469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228546|NCT02458469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6228547|NCT02458469|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6228548|NCT02458469|Serotonin Agents|serotonin agents|mesh-ancestor
6228549|NCT02458469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6228550|NCT02458469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228551|NCT02458469|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6228552|NCT02458469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6228553|NCT02458469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6228554|NCT02458469|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6228555|NCT02458469|Antidepressive Agents|antidepressive agents|mesh-ancestor
6228556|NCT02458638|Atezolizumab|atezolizumab|mesh-list
6228557|NCT02458638|Antibodies|antibodies|mesh-list
6228558|NCT02458638|Immunologic Factors|immunologic factors|mesh-ancestor
6228559|NCT02458638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228560|NCT02458638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6228561|NCT02458690|Dopamine|dopamine|mesh-list
6228562|NCT02458690|Norepinephrine|norepinephrine|mesh-list
6228563|NCT02458690|Antidepressive Agents|antidepressive agents|mesh-list
6228564|NCT02458690|Serotonin|serotonin|mesh-list
6228565|NCT02458690|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
6228566|NCT02458690|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-list
6228567|NCT02458690|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6228568|NCT02458690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6228569|NCT02458690|Adrenergic Agents|adrenergic agents|mesh-ancestor
6228570|NCT02458690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6228571|NCT02458690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228572|NCT02458690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228573|NCT02458690|Sympathomimetics|sympathomimetics|mesh-ancestor
6228574|NCT02458690|Autonomic Agents|autonomic agents|mesh-ancestor
6228575|NCT02458690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6228576|NCT02458690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6228577|NCT02458690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6228578|NCT02458690|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6228579|NCT02458690|Dopamine Agents|dopamine agents|mesh-ancestor
6228580|NCT02458690|Protective Agents|protective agents|mesh-ancestor
6228581|NCT02458690|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6228582|NCT02458690|Serotonin Agents|serotonin agents|mesh-ancestor
6228583|NCT02458690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6228584|NCT02458690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6228585|NCT02458768|Menotropins|menotropins|mesh-list
6228586|NCT02458768|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6228587|NCT02458768|Fertility Agents|fertility agents|mesh-ancestor
6228588|NCT02458768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6228589|NCT02458768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228590|NCT02459275|Metoclopramide|metoclopramide|mesh-list
6228591|NCT02459275|Antiemetics|antiemetics|mesh-ancestor
6228592|NCT02459275|Autonomic Agents|autonomic agents|mesh-ancestor
6228593|NCT02459275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6228594|NCT02459275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228595|NCT02459275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6228596|NCT02459275|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6228597|NCT02459275|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6228598|NCT02459275|Dopamine Agents|dopamine agents|mesh-ancestor
6228599|NCT02459275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6228600|NCT02459275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228601|NCT02459418|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6228602|NCT02459418|Hormones|hormones|mesh-ancestor
6228603|NCT02459418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6228604|NCT02459418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228605|NCT02459665|Metronidazole|metronidazole|mesh-list
6228606|NCT02459665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6228607|NCT02459665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6228608|NCT02459665|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6228609|NCT02459665|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6243688|NCT02677701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6500248|NCT00644618|Gemcitabine|gemcitabine|mesh-list
5721303|NCT03206671|Vindesine|vindesine|mesh-list
6243689|NCT02677844|Loperamide|loperamide|mesh-list
5706345|NCT03311581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5706346|NCT03311581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706347|NCT03311581|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5706348|NCT03311581|Anesthetics, General|anesthetics, general|mesh-ancestor
5706349|NCT03311581|Anesthetics|anesthetics|mesh-ancestor
5706350|NCT03311581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5706351|NCT03311581|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5706352|NCT03311542|Pembrolizumab|pembrolizumab|mesh-list
5706353|NCT03311542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6228610|NCT02459899|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
6228611|NCT02459899|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6228612|NCT02459899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228613|NCT02459899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6228614|NCT02459899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228615|NCT02459964|Fentanyl|fentanyl|mesh-list
6228616|NCT02459964|Hydromorphone|hydromorphone|mesh-list
6228617|NCT02459964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6228618|NCT02459964|Narcotics|narcotics|mesh-ancestor
6228619|NCT02459964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6228620|NCT02459964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228621|NCT02459964|Analgesics|analgesics|mesh-ancestor
6228622|NCT02459964|Sensory System Agents|sensory system agents|mesh-ancestor
5706354|NCT03311542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5706355|NCT03311516|Insulin|insulin|mesh-list
5706356|NCT03311516|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5706357|NCT03311516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5706358|NCT03311516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706359|NCT03311464|Adalimumab|adalimumab|mesh-list
5706360|NCT03311464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5706361|NCT03311464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5706362|NCT03311425|Dexamethasone|dexamethasone|mesh-list
5706363|NCT03311425|Methylprednisolone|methylprednisolone|mesh-list
5706364|NCT03311425|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5706365|NCT03311425|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5706366|NCT03311425|Prednisolone|prednisolone|mesh-list
5706367|NCT03311425|Prednisolone acetate|prednisolone acetate|mesh-list
5706368|NCT03311425|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5706369|NCT03311425|Prednisolone phosphate|prednisolone phosphate|mesh-list
5706370|NCT03311425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5706371|NCT03311425|Antiemetics|antiemetics|mesh-ancestor
5706372|NCT03311425|Autonomic Agents|autonomic agents|mesh-ancestor
5706373|NCT03311425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5706374|NCT03311425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706375|NCT03311425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5706376|NCT03311425|Glucocorticoids|glucocorticoids|mesh-ancestor
5706377|NCT03311425|Hormones|hormones|mesh-ancestor
5706378|NCT03311425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5706379|NCT03311425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6228623|NCT02459964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6228624|NCT02459964|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6228625|NCT02459964|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6228626|NCT02459964|Anesthetics, General|anesthetics, general|mesh-ancestor
6228627|NCT02459964|Anesthetics|anesthetics|mesh-ancestor
6228628|NCT02460198|Pembrolizumab|pembrolizumab|mesh-list
6228629|NCT02460198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6228630|NCT02460198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6228631|NCT02460380|Vitamin D|vitamin d|mesh-list
6228632|NCT02460380|Cholecalciferol|cholecalciferol|mesh-list
6228633|NCT02460380|Vitamins|vitamins|mesh-ancestor
6228634|NCT02460380|Micronutrients|micronutrients|mesh-ancestor
6228635|NCT02460380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228636|NCT02460380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6228637|NCT02460380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6228638|NCT02460978|Dapagliflozin|dapagliflozin|mesh-list
6228639|NCT02460978|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6228640|NCT02460978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228641|NCT02460978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6228642|NCT02460978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228643|NCT02460991|Sorafenib|sorafenib|mesh-list
6228644|NCT02460991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6228645|NCT02460991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6228646|NCT02460991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6243690|NCT02677844|Antidiarrheals|antidiarrheals|mesh-list
5706380|NCT03311425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5706381|NCT03311425|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5706382|NCT03311425|Protective Agents|protective agents|mesh-ancestor
5706383|NCT03311386|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5706384|NCT03311386|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5706385|NCT03311386|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5706386|NCT03311386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228647|NCT02460991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228648|NCT02461134|Ponesimod|ponesimod|mesh-list
6228649|NCT02461134|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6228650|NCT02461134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228651|NCT02461134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6228652|NCT02461134|Immunologic Factors|immunologic factors|mesh-ancestor
6228653|NCT02461134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228654|NCT02461160|Midazolam|midazolam|mesh-list
6228655|NCT02461160|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6228656|NCT02461160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6228657|NCT02461160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6228658|NCT02461160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228659|NCT02461160|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6228660|NCT02461160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6228661|NCT02461160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6228662|NCT02461160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6228663|NCT02461160|Anesthetics, General|anesthetics, general|mesh-ancestor
6228664|NCT02461160|Anesthetics|anesthetics|mesh-ancestor
6228665|NCT02461160|GABA Modulators|gaba modulators|mesh-ancestor
6228666|NCT02461160|GABA Agents|gaba agents|mesh-ancestor
6228667|NCT02461160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6228668|NCT02461160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228669|NCT02461290|Rituximab|rituximab|mesh-list
6228670|NCT02461290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6228671|NCT02461290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6228672|NCT02461290|Immunologic Factors|immunologic factors|mesh-ancestor
6228673|NCT02461290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228674|NCT02461290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6228675|NCT02461589|Liraglutide|liraglutide|mesh-list
6228676|NCT02461589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6228677|NCT02461589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918765|NCT04989348|Hormone Antagonists|hormone antagonists|mesh-list
5918766|NCT04989348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5918767|NCT04989348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676496|NCT01581788|Valproic Acid|valproic acid|mesh-list
6676497|NCT01581788|Anticonvulsants|anticonvulsants|mesh-ancestor
6676498|NCT01581788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6676499|NCT01581788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706387|NCT03311334|Pembrolizumab|pembrolizumab|mesh-list
6228678|NCT02461589|Incretins|incretins|mesh-ancestor
5706388|NCT03311334|Nivolumab|nivolumab|mesh-list
5706389|NCT03311334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5706390|NCT03311334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5706391|NCT03311334|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5706392|NCT03311334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706393|NCT03311321|Vitamin K|vitamin k|mesh-list
5706394|NCT03311321|Vitamin K 2|vitamin k 2|mesh-list
5706395|NCT03311321|Vitamin MK 7|vitamin mk 7|mesh-list
5706396|NCT03311321|Vitamins|vitamins|mesh-ancestor
5706397|NCT03311321|Micronutrients|micronutrients|mesh-ancestor
5706398|NCT03311321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706399|NCT03311321|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5706400|NCT03311321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5706401|NCT03311321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706402|NCT03311321|Hemostatics|hemostatics|mesh-ancestor
5706403|NCT03311321|Coagulants|coagulants|mesh-ancestor
5706404|NCT03311269|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
5706405|NCT03311269|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
5706406|NCT03311269|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5706407|NCT03311178|Dobutamine|dobutamine|mesh-list
5706408|NCT03311178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5706409|NCT03311178|Sympathomimetics|sympathomimetics|mesh-ancestor
5706410|NCT03311178|Autonomic Agents|autonomic agents|mesh-ancestor
5706411|NCT03311178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5706412|NCT03311178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706413|NCT03311178|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5706414|NCT03311178|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5706415|NCT03311178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6228679|NCT02461589|Hormones|hormones|mesh-ancestor
6676500|NCT01581788|GABA Agents|gaba agents|mesh-ancestor
5706416|NCT03311178|Adrenergic Agents|adrenergic agents|mesh-ancestor
6228680|NCT02461589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6228681|NCT02461693|Caffeine|caffeine|mesh-list
6228682|NCT02461693|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6228683|NCT02461693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228684|NCT02461693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6228685|NCT02461693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6228686|NCT02461693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228687|NCT02461693|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6228688|NCT02461693|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6228689|NCT02461693|Purinergic Agents|purinergic agents|mesh-ancestor
6228690|NCT02461693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6228691|NCT02461745|Ribavirin|ribavirin|mesh-list
6228692|NCT02461745|Ritonavir|ritonavir|mesh-list
6228693|NCT02461745|Antimetabolites|antimetabolites|mesh-ancestor
6228694|NCT02461745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228695|NCT02461745|Antiviral Agents|antiviral agents|mesh-ancestor
6228696|NCT02461745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6228697|NCT02461745|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6228698|NCT02461745|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6228699|NCT02461745|Protease Inhibitors|protease inhibitors|mesh-ancestor
6228700|NCT02461745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6228701|NCT02461745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6228702|NCT02461745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6228703|NCT02461745|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6228704|NCT02461745|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6228705|NCT02461758|Vaccines|vaccines|mesh-list
6228706|NCT02461758|Immunologic Factors|immunologic factors|mesh-ancestor
6228707|NCT02461758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243691|NCT02677844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6243692|NCT02678286|Meloxicam|meloxicam|mesh-list
6243693|NCT02678286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6243694|NCT02678286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6243695|NCT02678286|Analgesics|analgesics|mesh-ancestor
6243696|NCT02678286|Sensory System Agents|sensory system agents|mesh-ancestor
6243697|NCT02678286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6243698|NCT02678286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243699|NCT02678286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6243700|NCT02678286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6243701|NCT02678286|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6243702|NCT02678286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6243703|NCT02678286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6243704|NCT02678286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243705|NCT02678416|Acetaminophen|acetaminophen|mesh-list
6243706|NCT02678416|Morphine|morphine|mesh-list
5706417|NCT03311178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5706418|NCT03311178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706419|NCT03311178|Protective Agents|protective agents|mesh-ancestor
5706420|NCT03311139|Fibrinolytic Agents|fibrinolytic agents|mesh-list
5706421|NCT03311139|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6243707|NCT02678416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6243708|NCT02678416|Narcotics|narcotics|mesh-ancestor
6243709|NCT02678416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6243710|NCT02678416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243711|NCT02678416|Analgesics|analgesics|mesh-ancestor
6243712|NCT02678416|Sensory System Agents|sensory system agents|mesh-ancestor
6243713|NCT02678416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6243714|NCT02678416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6243715|NCT02678416|Antipyretics|antipyretics|mesh-ancestor
6243716|NCT02679274|Methyltestosterone|methyltestosterone|mesh-list
6243717|NCT02679274|Testosterone|testosterone|mesh-list
6243718|NCT02679274|Testosterone undecanoate|testosterone undecanoate|mesh-list
6243719|NCT02679274|Testosterone enanthate|testosterone enanthate|mesh-list
5918768|NCT04988685|Sirolimus|sirolimus|mesh-list
6228708|NCT02462148|Dexamethasone|dexamethasone|mesh-list
6228709|NCT02462148|Dexamethasone acetate|dexamethasone acetate|mesh-list
6228710|NCT02462148|Epinephrine|epinephrine|mesh-list
6228711|NCT02462148|Bupivacaine|bupivacaine|mesh-list
6228712|NCT02462148|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
6228713|NCT02462148|BB 1101|bb 1101|mesh-list
6228714|NCT02462148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6228715|NCT02462148|Antiemetics|antiemetics|mesh-ancestor
6228716|NCT02462148|Autonomic Agents|autonomic agents|mesh-ancestor
6228717|NCT02462148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6228718|NCT02462148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228719|NCT02462148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6228720|NCT02462148|Glucocorticoids|glucocorticoids|mesh-ancestor
6228721|NCT02462148|Hormones|hormones|mesh-ancestor
6228722|NCT02462148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6228723|NCT02462148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6228724|NCT02462148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6228725|NCT02462148|Protease Inhibitors|protease inhibitors|mesh-ancestor
6228726|NCT02462148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6228727|NCT02462148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228728|NCT02462148|Anesthetics, Local|anesthetics, local|mesh-ancestor
6228729|NCT02462148|Anesthetics|anesthetics|mesh-ancestor
6228730|NCT02462148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6228731|NCT02462148|Sensory System Agents|sensory system agents|mesh-ancestor
6228732|NCT02462148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6228733|NCT02462148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6228734|NCT02462148|Adrenergic Agents|adrenergic agents|mesh-ancestor
6228735|NCT02462148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6228736|NCT02462148|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6228737|NCT02462148|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6228738|NCT02462148|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6228739|NCT02462148|Respiratory System Agents|respiratory system agents|mesh-ancestor
6228740|NCT02462148|Mydriatics|mydriatics|mesh-ancestor
6228741|NCT02462148|Sympathomimetics|sympathomimetics|mesh-ancestor
6228742|NCT02462148|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6228743|NCT02462382|Ropivacaine|ropivacaine|mesh-list
6228744|NCT02462382|Anesthetics, Local|anesthetics, local|mesh-ancestor
6228745|NCT02462382|Anesthetics|anesthetics|mesh-ancestor
6228746|NCT02462382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6228747|NCT02462382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228748|NCT02462382|Sensory System Agents|sensory system agents|mesh-ancestor
5706422|NCT03311139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706423|NCT03311126|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5706424|NCT03311126|Obinutuzumab|obinutuzumab|mesh-list
5706425|NCT03311126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5706426|NCT03311126|Alkylating Agents|alkylating agents|mesh-ancestor
5706427|NCT03311126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706428|NCT03311126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5706429|NCT03311126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5706430|NCT03311022|Nefopam|nefopam|mesh-list
5706431|NCT03311022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5706432|NCT03311022|Analgesics|analgesics|mesh-ancestor
5706433|NCT03311022|Sensory System Agents|sensory system agents|mesh-ancestor
5706434|NCT03311022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5706435|NCT03311022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706436|NCT03310944|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
5706437|NCT03310944|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5706438|NCT03310944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706439|NCT03310944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5706440|NCT03310944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706441|NCT03310762|Silicon|silicon|mesh-list
5706442|NCT03310762|Trace Elements|trace elements|mesh-ancestor
5706443|NCT03310762|Micronutrients|micronutrients|mesh-ancestor
5706444|NCT03310762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706445|NCT03310749|Metformin|metformin|mesh-list
5706446|NCT03310749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5706447|NCT03310749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706448|NCT03310736|Hepcidins|hepcidins|mesh-list
6228749|NCT02462382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6228750|NCT02462473|Olanzapine|olanzapine|mesh-list
6228751|NCT02462473|Risperidone|risperidone|mesh-list
6228752|NCT02462473|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6228753|NCT02462473|Aripiprazole|aripiprazole|mesh-list
6228754|NCT02462473|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6500249|NCT00644618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6228755|NCT02462473|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6228756|NCT02462473|Serotonin Agents|serotonin agents|mesh-ancestor
6228757|NCT02462473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6228758|NCT02462473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228759|NCT02462473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228760|NCT02462473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6228761|NCT02462473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6228762|NCT02462473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6228763|NCT02462473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6228764|NCT02462473|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6228765|NCT02462473|Dopamine Agents|dopamine agents|mesh-ancestor
6228766|NCT02462473|Antiemetics|antiemetics|mesh-ancestor
6228767|NCT02462473|Autonomic Agents|autonomic agents|mesh-ancestor
6228768|NCT02462473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6228769|NCT02462473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6228770|NCT02462473|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6228771|NCT02462473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6228772|NCT02462473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6228773|NCT02462473|Antidepressive Agents|antidepressive agents|mesh-ancestor
6228774|NCT02462473|Dopamine Agonists|dopamine agonists|mesh-ancestor
6228775|NCT02462473|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6228776|NCT02462473|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6228777|NCT02462473|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6228778|NCT02462473|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6228779|NCT02462486|Ranibizumab|ranibizumab|mesh-list
6228780|NCT02462486|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6228781|NCT02462486|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6228782|NCT02462486|Growth Substances|growth substances|mesh-ancestor
6228783|NCT02462486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228784|NCT02462486|Growth Inhibitors|growth inhibitors|mesh-ancestor
6228785|NCT02462486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5706449|NCT03310736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5706450|NCT03310606|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5706451|NCT03310606|Lactams|lactams|mesh-list
5706452|NCT03310606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5706453|NCT03310593|Cannabidiol|cannabidiol|mesh-list
5706454|NCT03310593|Anticonvulsants|anticonvulsants|mesh-ancestor
5706455|NCT03310567|Pembrolizumab|pembrolizumab|mesh-list
5706456|NCT03310567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6228786|NCT02462720|Polidocanol|polidocanol|mesh-list
6228787|NCT02462720|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
6228788|NCT02462720|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6228789|NCT02462928|Ranibizumab|ranibizumab|mesh-list
6228790|NCT02462928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6228791|NCT02462928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6228792|NCT02462928|Growth Substances|growth substances|mesh-ancestor
6228793|NCT02462928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228794|NCT02462928|Growth Inhibitors|growth inhibitors|mesh-ancestor
6228795|NCT02462928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6228796|NCT02463097|Insulin|insulin|mesh-list
6228797|NCT02463097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6228798|NCT02463097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228799|NCT02463331|Chloroquine|chloroquine|mesh-list
6500250|NCT00644618|Antimetabolites|antimetabolites|mesh-ancestor
6500251|NCT00644618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500252|NCT00644618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6500253|NCT00644618|Antiviral Agents|antiviral agents|mesh-ancestor
6500254|NCT00644618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6500255|NCT00644618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6500256|NCT00644618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6500257|NCT00644618|Immunologic Factors|immunologic factors|mesh-ancestor
6500258|NCT00644618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6500259|NCT00644631|Sildenafil Citrate|sildenafil citrate|mesh-list
6500260|NCT00644631|Vasodilator Agents|vasodilator agents|mesh-ancestor
6500261|NCT00644631|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5706457|NCT03310567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5706458|NCT03310541|Fulvestrant|fulvestrant|mesh-list
6228800|NCT02463331|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
6228801|NCT02463331|Prednisone|prednisone|mesh-list
6228802|NCT02463331|Azathioprine|azathioprine|mesh-list
6228803|NCT02463331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6228804|NCT02463331|Glucocorticoids|glucocorticoids|mesh-ancestor
6228805|NCT02463331|Hormones|hormones|mesh-ancestor
6228806|NCT02463331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6228807|NCT02463331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228808|NCT02463331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6228809|NCT02463331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6228810|NCT02463331|Amebicides|amebicides|mesh-ancestor
6228811|NCT02463331|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6228812|NCT02463331|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6228813|NCT02463331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6228814|NCT02463331|Antimalarials|antimalarials|mesh-ancestor
6228815|NCT02463331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6228816|NCT02463331|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5706459|NCT03310541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5706460|NCT03310541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5706461|NCT03310541|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5706462|NCT03310541|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6228817|NCT02463331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6228818|NCT02463331|Analgesics|analgesics|mesh-ancestor
6228819|NCT02463331|Sensory System Agents|sensory system agents|mesh-ancestor
6228820|NCT02463331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6228821|NCT02463331|Filaricides|filaricides|mesh-ancestor
6228822|NCT02463331|Antinematodal Agents|antinematodal agents|mesh-ancestor
6228823|NCT02463331|Anthelmintics|anthelmintics|mesh-ancestor
6228824|NCT02463331|Antimetabolites|antimetabolites|mesh-ancestor
6228825|NCT02463331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228826|NCT02463331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6228827|NCT02463331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6228828|NCT02463331|Immunologic Factors|immunologic factors|mesh-ancestor
6228829|NCT02463357|Metformin|metformin|mesh-list
6228830|NCT02463357|Nifedipine|nifedipine|mesh-list
6228831|NCT02463357|Methazolamide|methazolamide|mesh-list
6228832|NCT02463357|Quercetin|quercetin|mesh-list
6228833|NCT02463357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6228834|NCT02463357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228835|NCT02463357|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6228836|NCT02463357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6228837|NCT02463357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228838|NCT02463357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6228839|NCT02463357|Vasodilator Agents|vasodilator agents|mesh-ancestor
6228840|NCT02463357|Tocolytic Agents|tocolytic agents|mesh-ancestor
6228841|NCT02463357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6228842|NCT02463357|Antioxidants|antioxidants|mesh-ancestor
6228843|NCT02463357|Protective Agents|protective agents|mesh-ancestor
6228844|NCT02463357|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6228845|NCT02463357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6228846|NCT02463357|Diuretics|diuretics|mesh-ancestor
6228847|NCT02463357|Natriuretic Agents|natriuretic agents|mesh-ancestor
6228848|NCT02463409|Theophylline|theophylline|mesh-list
6228849|NCT02463409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6228850|NCT02463409|Autonomic Agents|autonomic agents|mesh-ancestor
6228851|NCT02463409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6228852|NCT02463409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228853|NCT02463409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6228854|NCT02463409|Respiratory System Agents|respiratory system agents|mesh-ancestor
6228855|NCT02463409|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6228856|NCT02463409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6228857|NCT02463409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228858|NCT02463409|Vasodilator Agents|vasodilator agents|mesh-ancestor
5706463|NCT03310541|Hormone Antagonists|hormone antagonists|mesh-ancestor
6228859|NCT02463409|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6228860|NCT02463409|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6228861|NCT02463409|Purinergic Agents|purinergic agents|mesh-ancestor
6228862|NCT02463409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6228863|NCT02464033|Vitamin D|vitamin d|mesh-list
6228864|NCT02464033|Cholecalciferol|cholecalciferol|mesh-list
6228865|NCT02464033|Etanercept|etanercept|mesh-list
6228866|NCT02464033|Vitamins|vitamins|mesh-ancestor
5706464|NCT03310541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5706465|NCT03310541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706466|NCT03310372|Temozolomide|temozolomide|mesh-list
5706467|NCT03310372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5706468|NCT03310372|Alkylating Agents|alkylating agents|mesh-ancestor
5706469|NCT03310372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706470|NCT03310372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5721304|NCT03206671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5721305|NCT03206671|Immunologic Factors|immunologic factors|mesh-ancestor
5721306|NCT03206671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721307|NCT03206671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5721308|NCT03206671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5721309|NCT03206671|Alkylating Agents|alkylating agents|mesh-ancestor
6228867|NCT02464033|Micronutrients|micronutrients|mesh-ancestor
6228868|NCT02464033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228869|NCT02464033|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6228870|NCT02464033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6228871|NCT02464033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6228872|NCT02464033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6228873|NCT02464033|Analgesics|analgesics|mesh-ancestor
6228874|NCT02464033|Sensory System Agents|sensory system agents|mesh-ancestor
6228875|NCT02464033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6228876|NCT02464033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6228877|NCT02464033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5721310|NCT03206671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721311|NCT03206671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5721312|NCT03206671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5721313|NCT03206671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5721314|NCT03206671|Antiemetics|antiemetics|mesh-ancestor
6228878|NCT02464033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6228879|NCT02464033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6228880|NCT02464033|Immunologic Factors|immunologic factors|mesh-ancestor
6228881|NCT02464059|Vitamin D|vitamin d|mesh-list
6228882|NCT02464059|Cholecalciferol|cholecalciferol|mesh-list
5721315|NCT03206671|Autonomic Agents|autonomic agents|mesh-ancestor
5721316|NCT03206671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5721317|NCT03206671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5721318|NCT03206671|Glucocorticoids|glucocorticoids|mesh-ancestor
5721319|NCT03206671|Hormones|hormones|mesh-ancestor
5721320|NCT03206671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5721321|NCT03206671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5721322|NCT03206671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5721323|NCT03206671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5721324|NCT03206671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5721325|NCT03206671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5721326|NCT03206671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5721327|NCT03206671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6228883|NCT02464059|Vitamins|vitamins|mesh-ancestor
6228884|NCT02464059|Micronutrients|micronutrients|mesh-ancestor
6228885|NCT02464059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228886|NCT02464059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6228887|NCT02464059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6228888|NCT02464163|Hemagglutinins|hemagglutinins|mesh-list
6228889|NCT02464163|Agglutinins|agglutinins|mesh-ancestor
6228890|NCT02464163|Immunologic Factors|immunologic factors|mesh-ancestor
6228891|NCT02464163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228892|NCT02464176|Dexamethasone|dexamethasone|mesh-list
6228893|NCT02464176|Dexamethasone acetate|dexamethasone acetate|mesh-list
6228894|NCT02464176|Epinephrine|epinephrine|mesh-list
6228895|NCT02464176|Bupivacaine|bupivacaine|mesh-list
6228896|NCT02464176|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
6228897|NCT02464176|BB 1101|bb 1101|mesh-list
6228898|NCT02464176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6228899|NCT02464176|Antiemetics|antiemetics|mesh-ancestor
6228900|NCT02464176|Autonomic Agents|autonomic agents|mesh-ancestor
6228901|NCT02464176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6228902|NCT02464176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228903|NCT02464176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6676501|NCT01581788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6228904|NCT02464176|Glucocorticoids|glucocorticoids|mesh-ancestor
6228905|NCT02464176|Hormones|hormones|mesh-ancestor
6228906|NCT02464176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6228907|NCT02464176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6228908|NCT02464176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6228909|NCT02464176|Protease Inhibitors|protease inhibitors|mesh-ancestor
6228910|NCT02464176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6228911|NCT02464176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228912|NCT02464176|Anesthetics, Local|anesthetics, local|mesh-ancestor
6228913|NCT02464176|Anesthetics|anesthetics|mesh-ancestor
6228914|NCT02464176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6228915|NCT02464176|Sensory System Agents|sensory system agents|mesh-ancestor
6228916|NCT02464176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6228917|NCT02464176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6228918|NCT02464176|Adrenergic Agents|adrenergic agents|mesh-ancestor
6228919|NCT02464176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5706471|NCT03310333|Dinoprostone|dinoprostone|mesh-list
5706472|NCT03310333|Oxytocics|oxytocics|mesh-ancestor
5706473|NCT03310333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5706474|NCT03310333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706475|NCT03310242|Vitamin D|vitamin d|mesh-list
5706476|NCT03310242|Vitamins|vitamins|mesh-ancestor
5706477|NCT03310242|Micronutrients|micronutrients|mesh-ancestor
5706478|NCT03310242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706479|NCT03310242|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5706480|NCT03310125|Colchicine|colchicine|mesh-list
5706481|NCT03310125|Gout Suppressants|gout suppressants|mesh-ancestor
5706482|NCT03310125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5706483|NCT03310125|Tubulin Modulators|tubulin modulators|mesh-ancestor
5706484|NCT03310125|Antimitotic Agents|antimitotic agents|mesh-ancestor
5706485|NCT03310125|Mitosis Modulators|mitosis modulators|mesh-ancestor
5706486|NCT03310125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706487|NCT03310125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5706488|NCT03310073|Vaccines|vaccines|mesh-list
5706489|NCT03310073|Immunologic Factors|immunologic factors|mesh-ancestor
5706490|NCT03310073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706491|NCT03310060|Tranexamic Acid|tranexamic acid|mesh-list
5706492|NCT03310060|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
5706493|NCT03310060|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5706494|NCT03310060|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5706495|NCT03310060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706496|NCT03310060|Hemostatics|hemostatics|mesh-ancestor
5706497|NCT03310060|Coagulants|coagulants|mesh-ancestor
6228920|NCT02464176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6228921|NCT02464176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5706498|NCT03310047|Lidocaine|lidocaine|mesh-list
5706499|NCT03310047|Anesthetics, Local|anesthetics, local|mesh-ancestor
5706500|NCT03310047|Anesthetics|anesthetics|mesh-ancestor
5706501|NCT03310047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5706502|NCT03310047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706503|NCT03310047|Sensory System Agents|sensory system agents|mesh-ancestor
5706504|NCT03310047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6228922|NCT02464176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6228923|NCT02464176|Respiratory System Agents|respiratory system agents|mesh-ancestor
6228924|NCT02464176|Mydriatics|mydriatics|mesh-ancestor
6228925|NCT02464176|Sympathomimetics|sympathomimetics|mesh-ancestor
6228926|NCT02464176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6228927|NCT02464657|Cytarabine|cytarabine|mesh-list
6228928|NCT02464657|Dexamethasone|dexamethasone|mesh-list
6228929|NCT02464657|Methylprednisolone|methylprednisolone|mesh-list
6228930|NCT02464657|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6228931|NCT02464657|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6228932|NCT02464657|Prednisolone|prednisolone|mesh-list
6228933|NCT02464657|Prednisolone acetate|prednisolone acetate|mesh-list
6228934|NCT02464657|Nivolumab|nivolumab|mesh-list
6228935|NCT02464657|Idarubicin|idarubicin|mesh-list
6228936|NCT02464657|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6228937|NCT02464657|Prednisolone phosphate|prednisolone phosphate|mesh-list
6228938|NCT02464657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5706505|NCT03310047|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6228939|NCT02464657|Antiemetics|antiemetics|mesh-ancestor
6228940|NCT02464657|Autonomic Agents|autonomic agents|mesh-ancestor
6228941|NCT02464657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6228942|NCT02464657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228943|NCT02464657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6228944|NCT02464657|Glucocorticoids|glucocorticoids|mesh-ancestor
6228945|NCT02464657|Hormones|hormones|mesh-ancestor
6228946|NCT02464657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6228947|NCT02464657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6228948|NCT02464657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6228949|NCT02464657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6228950|NCT02464657|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6228951|NCT02464657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228952|NCT02464657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6228953|NCT02464657|Antimetabolites|antimetabolites|mesh-ancestor
6228954|NCT02464657|Antiviral Agents|antiviral agents|mesh-ancestor
6228955|NCT02464657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6228956|NCT02464657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6228957|NCT02464657|Immunologic Factors|immunologic factors|mesh-ancestor
6228958|NCT02464657|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6228959|NCT02464657|Protective Agents|protective agents|mesh-ancestor
6228960|NCT02464657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6228961|NCT02464657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6228962|NCT02464657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6228963|NCT02464657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6228964|NCT02465489|Deferiprone|deferiprone|mesh-list
6228965|NCT02465489|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6228966|NCT02465489|Chelating Agents|chelating agents|mesh-ancestor
6228967|NCT02465489|Sequestering Agents|sequestering agents|mesh-ancestor
6228968|NCT02465489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228969|NCT02465515|rGLP-1 protein|rglp-1 protein|mesh-list
6228970|NCT02465515|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6228971|NCT02465515|Incretins|incretins|mesh-ancestor
6228972|NCT02465515|Hormones|hormones|mesh-ancestor
6228973|NCT02465515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6228974|NCT02465515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228975|NCT02465528|Ceritinib|ceritinib|mesh-list
6228976|NCT02465528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6228977|NCT02465528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6228978|NCT02465528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6228979|NCT02465528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228980|NCT02465632|Clindamycin|clindamycin|mesh-list
6228981|NCT02465632|Clindamycin palmitate|clindamycin palmitate|mesh-list
6228982|NCT02465632|Clindamycin phosphate|clindamycin phosphate|mesh-list
6228983|NCT02465632|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6228984|NCT02465632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6228985|NCT02465632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6228986|NCT02465632|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6228987|NCT02465632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6228988|NCT02465632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228989|NCT02465632|Dermatologic Agents|dermatologic agents|mesh-ancestor
6228990|NCT02465866|Promethazine|promethazine|mesh-list
6228991|NCT02465866|Antipruritics|antipruritics|mesh-ancestor
5706506|NCT03310047|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5706507|NCT03310047|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5706508|NCT03310047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5706509|NCT03310047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706510|NCT03309865|Vedolizumab|vedolizumab|mesh-list
5706511|NCT03309865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5706512|NCT03309748|Anti-Infective Agents|anti-infective agents|mesh-list
6228992|NCT02465866|Dermatologic Agents|dermatologic agents|mesh-ancestor
6228993|NCT02465866|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6228994|NCT02465866|Histamine Antagonists|histamine antagonists|mesh-ancestor
6228995|NCT02465866|Histamine Agents|histamine agents|mesh-ancestor
6228996|NCT02465866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6228997|NCT02465866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6228998|NCT02465866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6228999|NCT02465866|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6229000|NCT02466386|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6229001|NCT02466386|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6229002|NCT02466386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229003|NCT02466386|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6229004|NCT02466386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5706513|NCT03309748|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5706514|NCT03309735|Progesterone|progesterone|mesh-list
5706515|NCT03309735|Dydrogesterone|dydrogesterone|mesh-list
5706516|NCT03309735|Progestins|progestins|mesh-ancestor
5706517|NCT03309735|Hormones|hormones|mesh-ancestor
5706518|NCT03309735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5706519|NCT03309735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706520|NCT03309709|Progesterone|progesterone|mesh-list
5706521|NCT03309709|Progestins|progestins|mesh-ancestor
5706522|NCT03309709|Hormones|hormones|mesh-ancestor
5706523|NCT03309709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5706524|NCT03309709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706525|NCT03309644|Iodine|iodine|mesh-list
5706526|NCT03309644|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5706527|NCT03309644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5706528|NCT03309644|Trace Elements|trace elements|mesh-ancestor
5706529|NCT03309644|Micronutrients|micronutrients|mesh-ancestor
5706530|NCT03309644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706531|NCT03309618|Valsartan|valsartan|mesh-list
5706532|NCT03309618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5706533|NCT03309618|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6229005|NCT02466386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6229006|NCT02466386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229007|NCT02466386|Dopamine Agents|dopamine agents|mesh-ancestor
6229008|NCT02466386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6229009|NCT02466399|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6229010|NCT02466399|Latanoprost|latanoprost|mesh-list
6229011|NCT02466399|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6229012|NCT02466958|Milnacipran|milnacipran|mesh-list
6229013|NCT02466958|Levomilnacipran|levomilnacipran|mesh-list
6229014|NCT02466958|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6229015|NCT02466958|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6229016|NCT02466958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6229017|NCT02466958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229018|NCT02466958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6676502|NCT01581788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229019|NCT02466958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229020|NCT02466958|Antidepressive Agents|antidepressive agents|mesh-ancestor
6229021|NCT02466958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6229022|NCT02466958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6229023|NCT02466958|Analgesics|analgesics|mesh-ancestor
6229024|NCT02466958|Sensory System Agents|sensory system agents|mesh-ancestor
6229025|NCT02466958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6229026|NCT02467504|Folic Acid|folic acid|mesh-list
6229027|NCT02467504|Loxoprofen|loxoprofen|mesh-list
6229028|NCT02467504|Hematinics|hematinics|mesh-ancestor
6229029|NCT02467504|Vitamin B Complex|vitamin b complex|mesh-ancestor
6229030|NCT02467504|Vitamins|vitamins|mesh-ancestor
6229031|NCT02467504|Micronutrients|micronutrients|mesh-ancestor
6229032|NCT02467504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229033|NCT02467504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6229034|NCT02467504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6229035|NCT02467504|Analgesics|analgesics|mesh-ancestor
6229036|NCT02467504|Sensory System Agents|sensory system agents|mesh-ancestor
6229037|NCT02467504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6229038|NCT02467504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6229039|NCT02467504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6229040|NCT02467621|Pantoprazole|pantoprazole|mesh-list
6229041|NCT02467621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6229042|NCT02467621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6229043|NCT02467621|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6229044|NCT02467621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6229045|NCT02467621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229046|NCT02468557|Paclitaxel|paclitaxel|mesh-list
6229047|NCT02468557|Idelalisib|idelalisib|mesh-list
6229048|NCT02468557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6229049|NCT02468557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6229050|NCT02468557|Tubulin Modulators|tubulin modulators|mesh-ancestor
6229051|NCT02468557|Antimitotic Agents|antimitotic agents|mesh-ancestor
6229052|NCT02468557|Mitosis Modulators|mitosis modulators|mesh-ancestor
6229053|NCT02468557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229054|NCT02468557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6229055|NCT02468648|Sofosbuvir|sofosbuvir|mesh-list
6229056|NCT02468648|Velpatasvir|velpatasvir|mesh-list
6229057|NCT02468648|Antiviral Agents|antiviral agents|mesh-ancestor
6229058|NCT02468648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6229059|NCT02468700|Dexamethasone|dexamethasone|mesh-list
6229060|NCT02468700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6229061|NCT02468700|Antiemetics|antiemetics|mesh-ancestor
6229062|NCT02468700|Autonomic Agents|autonomic agents|mesh-ancestor
6229063|NCT02468700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6229064|NCT02468700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229065|NCT02468700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6229066|NCT02468700|Glucocorticoids|glucocorticoids|mesh-ancestor
6229067|NCT02468700|Hormones|hormones|mesh-ancestor
6229068|NCT02468700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6500262|NCT00644631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6500263|NCT00644631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6500264|NCT00644631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500265|NCT00644631|Urological Agents|urological agents|mesh-ancestor
6676503|NCT01581788|Antimanic Agents|antimanic agents|mesh-ancestor
6676504|NCT01581788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6676505|NCT01581788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6676506|NCT01581788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6229069|NCT02468700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6229070|NCT02468700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6229071|NCT02468830|Mirabegron|mirabegron|mesh-list
6229072|NCT02468830|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6229073|NCT02468830|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6229074|NCT02468830|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6229075|NCT02468830|Adrenergic Agents|adrenergic agents|mesh-ancestor
6229076|NCT02468830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6229077|NCT02468830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229078|NCT02468830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229079|NCT02468830|Urological Agents|urological agents|mesh-ancestor
6229080|NCT02469077|Morphine|morphine|mesh-list
6229081|NCT02469077|Naloxone|naloxone|mesh-list
6229082|NCT02469077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6229083|NCT02469077|Narcotics|narcotics|mesh-ancestor
6229084|NCT02469077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6229085|NCT02469077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229086|NCT02469077|Analgesics|analgesics|mesh-ancestor
6229087|NCT02469077|Sensory System Agents|sensory system agents|mesh-ancestor
6229088|NCT02469077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6229089|NCT02469077|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6229090|NCT02469090|Apomorphine|apomorphine|mesh-list
6229091|NCT02469090|Emetics|emetics|mesh-ancestor
6229092|NCT02469090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229093|NCT02469090|Autonomic Agents|autonomic agents|mesh-ancestor
6500266|NCT00644670|Atorvastatin|atorvastatin|mesh-list
6500267|NCT00644670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6500268|NCT00644670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6500269|NCT00644670|Antimetabolites|antimetabolites|mesh-ancestor
6500270|NCT00644670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500271|NCT00644670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6500272|NCT00644670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6500273|NCT00644670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6500274|NCT00644696|Cefixime|cefixime|mesh-list
6500275|NCT00644696|Cefpodoxime|cefpodoxime|mesh-list
6500276|NCT00644696|Irinotecan|irinotecan|mesh-list
6500277|NCT00644696|Bortezomib|bortezomib|mesh-list
6500278|NCT00644696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6500279|NCT00644696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6500280|NCT00644696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6500281|NCT00644696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500282|NCT00644696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6500283|NCT00644696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6500284|NCT00644696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6500285|NCT00644709|Atorvastatin|atorvastatin|mesh-list
6500286|NCT00644709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6500287|NCT00644709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6500288|NCT00644709|Antimetabolites|antimetabolites|mesh-ancestor
6500289|NCT00644709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500290|NCT00644709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6500291|NCT00644709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6500292|NCT00644709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6500293|NCT00644722|Pyrithione zinc|pyrithione zinc|mesh-list
6500294|NCT00644722|Keratolytic Agents|keratolytic agents|mesh-ancestor
6500295|NCT00644722|Dermatologic Agents|dermatologic agents|mesh-ancestor
6500296|NCT00644735|Esomeprazole|esomeprazole|mesh-list
6500297|NCT00644735|Lansoprazole|lansoprazole|mesh-list
6500298|NCT00644735|Dexlansoprazole|dexlansoprazole|mesh-list
6500299|NCT00644735|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5706534|NCT03309618|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5706535|NCT03309618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706536|NCT03309592|Ambrisentan|ambrisentan|mesh-list
5706537|NCT03309592|Tadalafil|tadalafil|mesh-list
5706538|NCT03309592|Vasodilator Agents|vasodilator agents|mesh-ancestor
5706539|NCT03309592|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5706540|NCT03309592|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5706541|NCT03309592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5706542|NCT03309592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706543|NCT03309592|Urological Agents|urological agents|mesh-ancestor
6500300|NCT00644735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6500301|NCT00644735|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6500302|NCT00644735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6500303|NCT00644735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500304|NCT00644748|Gabapentin|gabapentin|mesh-list
6500305|NCT00644748|Analgesics|analgesics|mesh-ancestor
6500306|NCT00644748|Sensory System Agents|sensory system agents|mesh-ancestor
6500307|NCT00644748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6500308|NCT00644748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6500309|NCT00644748|Anticonvulsants|anticonvulsants|mesh-ancestor
6500310|NCT00644748|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6500311|NCT00644748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6500312|NCT00644748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6500313|NCT00644748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6500314|NCT00644748|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6500315|NCT00644748|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6500316|NCT00644748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6500317|NCT00644748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500318|NCT00644748|Antimanic Agents|antimanic agents|mesh-ancestor
6676507|NCT01581814|Metformin|metformin|mesh-list
6676508|NCT01581814|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
6676509|NCT01581814|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6676510|NCT01581814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6500319|NCT00644761|Adefovir|adefovir|mesh-list
6500320|NCT00644761|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6500321|NCT00644761|Antiviral Agents|antiviral agents|mesh-ancestor
5706544|NCT03309592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5706545|NCT03309566|Tenofovir|tenofovir|mesh-list
5706546|NCT03309566|Emtricitabine|emtricitabine|mesh-list
5706547|NCT03309566|Efavirenz|efavirenz|mesh-list
5706548|NCT03309566|Antiviral Agents|antiviral agents|mesh-ancestor
5706549|NCT03309566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5706550|NCT03309566|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5706551|NCT03309566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5706552|NCT03309566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5706553|NCT03309566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706554|NCT03309566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5706555|NCT03309566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5706556|NCT03309566|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5706557|NCT03309566|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5706558|NCT03309566|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5706559|NCT03309566|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5706560|NCT03309566|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5706561|NCT03309566|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5706562|NCT03309527|Diphenhydramine|diphenhydramine|mesh-list
5706563|NCT03309527|Promethazine|promethazine|mesh-list
5706564|NCT03309527|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5706565|NCT03309527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5706566|NCT03309527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6229094|NCT02469090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6229095|NCT02469090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6229096|NCT02469090|Dopamine Agonists|dopamine agonists|mesh-ancestor
6229097|NCT02469090|Dopamine Agents|dopamine agents|mesh-ancestor
6229098|NCT02469090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6229099|NCT02469090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229100|NCT02469116|Carboplatin|carboplatin|mesh-list
6229101|NCT02469116|Docetaxel|docetaxel|mesh-list
6229102|NCT02469116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6229103|NCT02469116|Tubulin Modulators|tubulin modulators|mesh-ancestor
6229104|NCT02469116|Antimitotic Agents|antimitotic agents|mesh-ancestor
6229105|NCT02469116|Mitosis Modulators|mitosis modulators|mesh-ancestor
6229106|NCT02469116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229107|NCT02469246|Lamivudine|lamivudine|mesh-list
6229108|NCT02469246|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6229109|NCT02469246|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6229110|NCT02469246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6229111|NCT02469246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229112|NCT02469246|Antiviral Agents|antiviral agents|mesh-ancestor
6229113|NCT02469246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6229114|NCT02469246|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6229115|NCT02469246|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6229116|NCT02469298|Oseltamivir|oseltamivir|mesh-list
6229117|NCT02469298|Antiviral Agents|antiviral agents|mesh-ancestor
6229118|NCT02469298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6229119|NCT02469298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6229120|NCT02469298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229121|NCT02469597|Furosemide|furosemide|mesh-list
6229122|NCT02469597|Diuretics|diuretics|mesh-ancestor
6229123|NCT02469597|Natriuretic Agents|natriuretic agents|mesh-ancestor
6229124|NCT02469597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229125|NCT02469597|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6229126|NCT02469597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6229127|NCT02469597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229128|NCT02469610|Bupivacaine|bupivacaine|mesh-list
6229129|NCT02469610|Anesthetics, Local|anesthetics, local|mesh-ancestor
6229130|NCT02469610|Anesthetics|anesthetics|mesh-ancestor
6229131|NCT02469610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6229132|NCT02469610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229133|NCT02469610|Sensory System Agents|sensory system agents|mesh-ancestor
6229134|NCT02469610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6229135|NCT02469701|Nivolumab|nivolumab|mesh-list
6229136|NCT02469701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6229137|NCT02469701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6229138|NCT02469701|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6229139|NCT02469701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229140|NCT02469961|Dexmedetomidine|dexmedetomidine|mesh-list
6229141|NCT02469961|Propofol|propofol|mesh-list
6229142|NCT02469961|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6229143|NCT02469961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5706567|NCT03309527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706568|NCT03309527|Anesthetics, Local|anesthetics, local|mesh-ancestor
5706569|NCT03309527|Anesthetics|anesthetics|mesh-ancestor
5706570|NCT03309527|Sensory System Agents|sensory system agents|mesh-ancestor
5706571|NCT03309527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5706572|NCT03309527|Antiemetics|antiemetics|mesh-ancestor
5706573|NCT03309527|Autonomic Agents|autonomic agents|mesh-ancestor
5706574|NCT03309527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5706575|NCT03309527|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5706576|NCT03309527|Histamine Antagonists|histamine antagonists|mesh-ancestor
5706577|NCT03309527|Histamine Agents|histamine agents|mesh-ancestor
5706578|NCT03309527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5706579|NCT03309527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706580|NCT03309527|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5706581|NCT03309527|Antipruritics|antipruritics|mesh-ancestor
5706582|NCT03309527|Dermatologic Agents|dermatologic agents|mesh-ancestor
5706583|NCT03309475|Psychotropic Drugs|psychotropic drugs|mesh-list
5706584|NCT03309436|Clomiphene|clomiphene|mesh-list
5706585|NCT03309436|Enclomiphene|enclomiphene|mesh-list
5706586|NCT03309436|Zuclomiphene|zuclomiphene|mesh-list
5706587|NCT03309436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6229144|NCT02469961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229145|NCT02469961|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6229146|NCT02469961|Anesthetics, General|anesthetics, general|mesh-ancestor
6229147|NCT02469961|Anesthetics|anesthetics|mesh-ancestor
6229148|NCT02469961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6229149|NCT02469961|Analgesics|analgesics|mesh-ancestor
6229150|NCT02469961|Sensory System Agents|sensory system agents|mesh-ancestor
6229151|NCT02469961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6229152|NCT02469961|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6229153|NCT02469961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6229154|NCT02469961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6229155|NCT02469961|Adrenergic Agents|adrenergic agents|mesh-ancestor
6229156|NCT02469961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6229157|NCT02469961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229158|NCT02470091|Denosumab|denosumab|mesh-list
6229159|NCT02470091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6229160|NCT02470091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229161|NCT02470234|Methylphenidate|methylphenidate|mesh-list
6229162|NCT02470234|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6229163|NCT02470234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229164|NCT02470234|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6229165|NCT02470234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6229166|NCT02470234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6229167|NCT02470234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229168|NCT02470234|Dopamine Agents|dopamine agents|mesh-ancestor
6229169|NCT02470234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6243720|NCT02679274|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6243721|NCT02679274|Androgens|androgens|mesh-ancestor
6243722|NCT02679274|Hormones|hormones|mesh-ancestor
5706588|NCT03309436|Hormone Antagonists|hormone antagonists|mesh-ancestor
5706589|NCT03309436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5706590|NCT03309436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706591|NCT03309436|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5706592|NCT03309436|Fertility Agents|fertility agents|mesh-ancestor
5706593|NCT03309436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5706594|NCT03309436|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5706595|NCT03309436|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5706596|NCT03309319|Rosiglitazone|rosiglitazone|mesh-list
5706597|NCT03309319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5706598|NCT03309319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706599|NCT03309215|Nickel|nickel|mesh-list
5706600|NCT03309215|Trace Elements|trace elements|mesh-ancestor
5706601|NCT03309215|Micronutrients|micronutrients|mesh-ancestor
5706602|NCT03309215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706603|NCT03309176|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
5706604|NCT03309176|Medroxyprogesterone|medroxyprogesterone|mesh-list
5706605|NCT03309176|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6243723|NCT02679274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6243724|NCT02679274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243725|NCT02679274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5706606|NCT03309176|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5706607|NCT03309176|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5706608|NCT03309176|Contraceptive Agents|contraceptive agents|mesh-ancestor
6229170|NCT02470390|Fentanyl|fentanyl|mesh-list
6229171|NCT02470390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6229172|NCT02470390|Narcotics|narcotics|mesh-ancestor
6229173|NCT02470390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6229174|NCT02470390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229175|NCT02470390|Analgesics|analgesics|mesh-ancestor
6229176|NCT02470390|Sensory System Agents|sensory system agents|mesh-ancestor
6229177|NCT02470390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6229178|NCT02470390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5706609|NCT03309176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5706610|NCT03309176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706611|NCT03309176|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5706612|NCT03309176|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5706613|NCT03309176|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5706614|NCT03309176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5706615|NCT03309176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5706616|NCT03309163|Tramadol|tramadol|mesh-list
5706617|NCT03309163|Hydromorphone|hydromorphone|mesh-list
6229179|NCT02470390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6229180|NCT02470390|Anesthetics, General|anesthetics, general|mesh-ancestor
6229181|NCT02470390|Anesthetics|anesthetics|mesh-ancestor
6229182|NCT02470403|Licogliflozin|licogliflozin|mesh-list
6229183|NCT02470403|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6229184|NCT02470403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229185|NCT02470403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5706618|NCT03309163|Ropivacaine|ropivacaine|mesh-list
5706619|NCT03309163|Anesthetics, Local|anesthetics, local|mesh-ancestor
5706620|NCT03309163|Anesthetics|anesthetics|mesh-ancestor
5706621|NCT03309163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5706622|NCT03309163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706623|NCT03309163|Sensory System Agents|sensory system agents|mesh-ancestor
5706624|NCT03309163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5706625|NCT03309163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5706626|NCT03309163|Narcotics|narcotics|mesh-ancestor
5706627|NCT03309163|Analgesics|analgesics|mesh-ancestor
5706628|NCT03309137|Chlorhexidine|chlorhexidine|mesh-list
5706629|NCT03309137|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5706630|NCT03309137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5706631|NCT03309137|Disinfectants|disinfectants|mesh-ancestor
5706632|NCT03309059|Zinc Oxide|zinc oxide|mesh-list
5706633|NCT03309059|Dermatologic Agents|dermatologic agents|mesh-ancestor
5706634|NCT03309059|Sunscreening Agents|sunscreening agents|mesh-ancestor
5706635|NCT03309059|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5706636|NCT03309059|Protective Agents|protective agents|mesh-ancestor
6676511|NCT01581814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229186|NCT02470403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229187|NCT02470429|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6229188|NCT02470429|Lubricant Eye Drops|lubricant eye drops|mesh-list
6229189|NCT02470429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6229190|NCT02470585|Paclitaxel|paclitaxel|mesh-list
6229191|NCT02470585|Carboplatin|carboplatin|mesh-list
6229192|NCT02470585|Veliparib|veliparib|mesh-list
6229193|NCT02470585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6229194|NCT02470585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6229195|NCT02470585|Tubulin Modulators|tubulin modulators|mesh-ancestor
6229196|NCT02470585|Antimitotic Agents|antimitotic agents|mesh-ancestor
6229197|NCT02470585|Mitosis Modulators|mitosis modulators|mesh-ancestor
6229198|NCT02470585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229199|NCT02470585|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6229200|NCT02470585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6229201|NCT02470741|Letrozole|letrozole|mesh-list
6229202|NCT02470741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6229203|NCT02470741|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6229204|NCT02470741|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6229205|NCT02470741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6676512|NCT01581814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6676513|NCT01581814|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6676514|NCT01581814|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6676515|NCT01581814|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6676516|NCT01581814|Contraceptive Agents|contraceptive agents|mesh-ancestor
6676517|NCT01581814|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6676518|NCT01581814|Estrogens|estrogens|mesh-ancestor
5918769|NCT04988685|Paclitaxel|paclitaxel|mesh-list
5918770|NCT04988685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6229206|NCT02470741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676519|NCT01581814|Hormones|hormones|mesh-ancestor
5706637|NCT03309059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706645|NCT03308955|Tramadol|tramadol|mesh-list
5706646|NCT03308955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5706647|NCT03308955|Narcotics|narcotics|mesh-ancestor
5706648|NCT03308955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5706649|NCT03308955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706650|NCT03308955|Analgesics|analgesics|mesh-ancestor
5706651|NCT03308955|Sensory System Agents|sensory system agents|mesh-ancestor
5706652|NCT03308955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5706653|NCT03308916|Liver Extracts|liver extracts|mesh-list
5706654|NCT03308916|Hematinics|hematinics|mesh-ancestor
5706655|NCT03308890|Entecavir|entecavir|mesh-list
5706656|NCT03308890|Antiviral Agents|antiviral agents|mesh-ancestor
5706657|NCT03308890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5706658|NCT03308786|Aldesleukin|aldesleukin|mesh-list
5706659|NCT03308786|Interleukin-2|interleukin-2|mesh-list
5706660|NCT03308786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5706661|NCT03308786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5706662|NCT03308786|Analgesics|analgesics|mesh-ancestor
5706663|NCT03308786|Sensory System Agents|sensory system agents|mesh-ancestor
5706664|NCT03308786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5706665|NCT03308786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229207|NCT02470741|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6229208|NCT02470741|Hormone Antagonists|hormone antagonists|mesh-ancestor
6229209|NCT02470741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6229210|NCT02470741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229211|NCT02471014|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6229212|NCT02471014|Immunologic Factors|immunologic factors|mesh-ancestor
6229213|NCT02471014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229214|NCT02471183|Selexipag|selexipag|mesh-list
6229215|NCT02471183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6229216|NCT02471404|Dapagliflozin|dapagliflozin|mesh-list
6229217|NCT02471404|Glimepiride|glimepiride|mesh-list
6229218|NCT02471404|Saxagliptin|saxagliptin|mesh-list
6229219|NCT02471404|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6229220|NCT02471404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229221|NCT02471404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6229222|NCT02471404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229223|NCT02471404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6229224|NCT02471404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6229225|NCT02471404|Immunologic Factors|immunologic factors|mesh-ancestor
6229226|NCT02471404|Incretins|incretins|mesh-ancestor
6229227|NCT02471404|Hormones|hormones|mesh-ancestor
6229228|NCT02471404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6229229|NCT02471404|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5706666|NCT03308786|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5706667|NCT03308786|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5706668|NCT03308786|Antiviral Agents|antiviral agents|mesh-ancestor
5706669|NCT03308786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5721328|NCT03206671|Abortifacient Agents|abortifacient agents|mesh-ancestor
5721329|NCT03206671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5721330|NCT03206671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6229230|NCT02471404|Protease Inhibitors|protease inhibitors|mesh-ancestor
6229231|NCT02471404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6229232|NCT02471521|Rocuronium|rocuronium|mesh-list
6229233|NCT02471521|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6229234|NCT02471521|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6229235|NCT02471521|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6229236|NCT02471521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6229237|NCT02471521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229238|NCT02471651|Dexamethasone|dexamethasone|mesh-list
6229239|NCT02471651|Ranibizumab|ranibizumab|mesh-list
6229240|NCT02471651|Aflibercept|aflibercept|mesh-list
6229241|NCT02471651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6229242|NCT02471651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6229243|NCT02471651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5721331|NCT03206671|Antimetabolites|antimetabolites|mesh-ancestor
5721332|NCT03206671|Dermatologic Agents|dermatologic agents|mesh-ancestor
6229244|NCT02471651|Growth Substances|growth substances|mesh-ancestor
6229245|NCT02471651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229246|NCT02471651|Growth Inhibitors|growth inhibitors|mesh-ancestor
6229247|NCT02471651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6229248|NCT02471651|Antiemetics|antiemetics|mesh-ancestor
6229249|NCT02471651|Autonomic Agents|autonomic agents|mesh-ancestor
5706670|NCT03308708|Norepinephrine|norepinephrine|mesh-list
5706671|NCT03308708|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6229250|NCT02471651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6229251|NCT02471651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6229252|NCT02471651|Glucocorticoids|glucocorticoids|mesh-ancestor
6229253|NCT02471651|Hormones|hormones|mesh-ancestor
6229254|NCT02471651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6229255|NCT02471651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6229256|NCT02472145|Decitabine|decitabine|mesh-list
6229257|NCT02472145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6229258|NCT02472145|Antimetabolites|antimetabolites|mesh-ancestor
6229259|NCT02472145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229260|NCT02472145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6229261|NCT02472145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6229262|NCT02472223|Povidone-Iodine|povidone-iodine|mesh-list
6229263|NCT02472223|Povidone|povidone|mesh-list
6229264|NCT02472223|Lubricant Eye Drops|lubricant eye drops|mesh-list
6229265|NCT02472223|Plasma Substitutes|plasma substitutes|mesh-ancestor
6229266|NCT02472223|Blood Substitutes|blood substitutes|mesh-ancestor
6229267|NCT02472223|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6229268|NCT02472223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6229269|NCT02472223|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6229270|NCT02472223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6229271|NCT02472314|Bupivacaine|bupivacaine|mesh-list
6229272|NCT02472314|Anesthetics, Local|anesthetics, local|mesh-ancestor
6229273|NCT02472314|Anesthetics|anesthetics|mesh-ancestor
6229274|NCT02472314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6229275|NCT02472314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229276|NCT02472314|Sensory System Agents|sensory system agents|mesh-ancestor
6229277|NCT02472314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6676520|NCT01581814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6676521|NCT01581840|Panitumumab|panitumumab|mesh-list
6676522|NCT01581840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6676523|NCT01581840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6676524|NCT01581853|Ritonavir|ritonavir|mesh-list
5706672|NCT03308708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5706673|NCT03308708|Adrenergic Agents|adrenergic agents|mesh-ancestor
5706674|NCT03308708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5706675|NCT03308708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706676|NCT03308708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706677|NCT03308708|Sympathomimetics|sympathomimetics|mesh-ancestor
5706678|NCT03308708|Autonomic Agents|autonomic agents|mesh-ancestor
5918771|NCT04988685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5918772|NCT04988685|Tubulin Modulators|tubulin modulators|mesh-ancestor
5918773|NCT04988685|Antimitotic Agents|antimitotic agents|mesh-ancestor
5918774|NCT04988685|Mitosis Modulators|mitosis modulators|mesh-ancestor
5918775|NCT04988685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918776|NCT04988685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5918777|NCT04988685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5918778|NCT04988685|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5918779|NCT04988685|Antifungal Agents|antifungal agents|mesh-ancestor
5918780|NCT04988685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5918781|NCT04988685|Immunologic Factors|immunologic factors|mesh-ancestor
5918782|NCT04988685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918783|NCT04988776|Bupivacaine|bupivacaine|mesh-list
5918784|NCT04988776|Anesthetics, Local|anesthetics, local|mesh-ancestor
5918785|NCT04988776|Anesthetics|anesthetics|mesh-ancestor
5918786|NCT04988776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5918787|NCT04988776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918788|NCT04988776|Sensory System Agents|sensory system agents|mesh-ancestor
5918789|NCT04988776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5918790|NCT04988789|Paclitaxel|paclitaxel|mesh-list
5918791|NCT04988789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5918792|NCT04988789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5918793|NCT04988789|Tubulin Modulators|tubulin modulators|mesh-ancestor
5918794|NCT04988789|Antimitotic Agents|antimitotic agents|mesh-ancestor
5918795|NCT04988789|Mitosis Modulators|mitosis modulators|mesh-ancestor
5918796|NCT04988789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229278|NCT02472353|Metformin|metformin|mesh-list
6229279|NCT02472353|Doxorubicin|doxorubicin|mesh-list
6229280|NCT02472353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6229281|NCT02472353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229282|NCT02472353|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6229283|NCT02472353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6229284|NCT02472353|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6229285|NCT02472353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6229286|NCT02472353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6229287|NCT02472353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229288|NCT02472366|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
6229289|NCT02472366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6229290|NCT02472366|Glucocorticoids|glucocorticoids|mesh-ancestor
6229291|NCT02472366|Hormones|hormones|mesh-ancestor
6229292|NCT02472366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5706679|NCT03308708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5706680|NCT03308708|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5706681|NCT03308682|(177)Lu-DOTA-EB-TATE|(177)lu-dota-eb-tate|mesh-list
5706682|NCT03308682|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5706683|NCT03308682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706684|NCT03308643|Oxytocin|oxytocin|mesh-list
5706685|NCT03308643|Oxytocics|oxytocics|mesh-ancestor
5706686|NCT03308643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5706687|NCT03308643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706688|NCT03308604|Cisplatin|cisplatin|mesh-list
5706689|NCT03308604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5706690|NCT03308578|Atorvastatin|atorvastatin|mesh-list
5706691|NCT03308578|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5706692|NCT03308578|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5706693|NCT03308578|Antimetabolites|antimetabolites|mesh-ancestor
6229293|NCT02472366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229294|NCT02472522|Dexmedetomidine|dexmedetomidine|mesh-list
6229295|NCT02472522|Ropivacaine|ropivacaine|mesh-list
6229296|NCT02472522|Adrenergic Agonists|adrenergic agonists|mesh-list
6676525|NCT01581853|Lopinavir|lopinavir|mesh-list
6676526|NCT01581853|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6676527|NCT01581853|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6676528|NCT01581853|Protease Inhibitors|protease inhibitors|mesh-ancestor
6676529|NCT01581853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5706694|NCT03308578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706695|NCT03308578|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5706696|NCT03308578|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5706697|NCT03308578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6676530|NCT01581853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676531|NCT01581853|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6676532|NCT01581853|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6676533|NCT01581853|Antiviral Agents|antiviral agents|mesh-ancestor
6229297|NCT02472522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6229298|NCT02472522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6229299|NCT02472522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229300|NCT02472522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6229301|NCT02472522|Analgesics|analgesics|mesh-ancestor
6229302|NCT02472522|Sensory System Agents|sensory system agents|mesh-ancestor
6229303|NCT02472522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6229304|NCT02472522|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6229305|NCT02472522|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6229306|NCT02472522|Adrenergic Agents|adrenergic agents|mesh-ancestor
6229307|NCT02472522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6229308|NCT02472522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229309|NCT02472522|Anesthetics, Local|anesthetics, local|mesh-ancestor
6229310|NCT02472522|Anesthetics|anesthetics|mesh-ancestor
6229311|NCT02472652|Aripiprazole|aripiprazole|mesh-list
6229312|NCT02472652|Antidepressive Agents|antidepressive agents|mesh-ancestor
5706698|NCT03308552|Paclitaxel|paclitaxel|mesh-list
5706699|NCT03308552|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5706700|NCT03308552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6229313|NCT02472652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6676534|NCT01581853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6676535|NCT01581853|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6676536|NCT01581853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6676537|NCT01581866|Ziprasidone|ziprasidone|mesh-list
6676538|NCT01581866|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6676539|NCT01581866|Serotonin Agents|serotonin agents|mesh-ancestor
6676540|NCT01581866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6779668|NCT02180334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5706701|NCT03308552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5706702|NCT03308552|Tubulin Modulators|tubulin modulators|mesh-ancestor
5706703|NCT03308552|Antimitotic Agents|antimitotic agents|mesh-ancestor
5706704|NCT03308552|Mitosis Modulators|mitosis modulators|mesh-ancestor
5706705|NCT03308552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706706|NCT03308487|Vitamin D|vitamin d|mesh-list
5706707|NCT03308487|Ergocalciferols|ergocalciferols|mesh-list
5706708|NCT03308487|Cholecalciferol|cholecalciferol|mesh-list
5706709|NCT03308487|Vitamins|vitamins|mesh-list
5706710|NCT03308487|Micronutrients|micronutrients|mesh-ancestor
5706711|NCT03308487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676541|NCT01581866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676542|NCT01581866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676543|NCT01581866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6676544|NCT01581866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5706712|NCT03308487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5706713|NCT03308487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5706714|NCT03308357|Infliximab|infliximab|mesh-list
5706715|NCT03308357|Dermatologic Agents|dermatologic agents|mesh-ancestor
5706716|NCT03308357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5706717|NCT03308357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6676545|NCT01581866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6676546|NCT01581866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6676547|NCT01581866|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6676548|NCT01581866|Dopamine Agents|dopamine agents|mesh-ancestor
6676549|NCT01581879|Ziprasidone|ziprasidone|mesh-list
6676550|NCT01581879|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6676551|NCT01581879|Serotonin Agents|serotonin agents|mesh-ancestor
6676552|NCT01581879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6676553|NCT01581879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676554|NCT01581879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676555|NCT01581879|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6676556|NCT01581879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6229314|NCT02472652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6229315|NCT02472652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6229316|NCT02472652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6229317|NCT02472652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229318|NCT02472652|Dopamine Agonists|dopamine agonists|mesh-ancestor
6229319|NCT02472652|Dopamine Agents|dopamine agents|mesh-ancestor
6229320|NCT02472652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6229321|NCT02472652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229322|NCT02472652|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6229323|NCT02472652|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6229324|NCT02472652|Serotonin Agents|serotonin agents|mesh-ancestor
6229325|NCT02472652|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6229326|NCT02472652|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6229327|NCT02472652|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6229328|NCT02472652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6229329|NCT02472756|Rituximab|rituximab|mesh-list
6676557|NCT01581879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5706718|NCT03308331|Nicotine|nicotine|mesh-list
5706719|NCT03308331|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5706720|NCT03308331|Autonomic Agents|autonomic agents|mesh-ancestor
5706721|NCT03308331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5706722|NCT03308331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706723|NCT03308331|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5706724|NCT03308331|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5706725|NCT03308331|Cholinergic Agents|cholinergic agents|mesh-ancestor
5706726|NCT03308331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5706727|NCT03308331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706728|NCT03308253|Vancomycin|vancomycin|mesh-list
5706729|NCT03308253|Tobramycin|tobramycin|mesh-list
5706730|NCT03308253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5706731|NCT03308253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5706732|NCT03308214|Imipenem|imipenem|mesh-list
5706733|NCT03308214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5706734|NCT03308214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5706735|NCT03308201|Letrozole|letrozole|mesh-list
5706736|NCT03308201|Fulvestrant|fulvestrant|mesh-list
5706737|NCT03308201|Exemestane|exemestane|mesh-list
5706738|NCT03308201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5706739|NCT03308201|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5706740|NCT03308201|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5706741|NCT03308201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5706742|NCT03308201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706743|NCT03308201|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6229330|NCT02472756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6229331|NCT02472756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6229332|NCT02472756|Immunologic Factors|immunologic factors|mesh-ancestor
6229333|NCT02472756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229334|NCT02472756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6229335|NCT02472847|Dronabinol|dronabinol|mesh-list
6229336|NCT02472847|Hallucinogens|hallucinogens|mesh-ancestor
6229337|NCT02472847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229338|NCT02472847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6229339|NCT02472847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6229340|NCT02472847|Analgesics|analgesics|mesh-ancestor
6229341|NCT02472847|Sensory System Agents|sensory system agents|mesh-ancestor
6229342|NCT02472847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6229343|NCT02472847|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6229344|NCT02472847|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6229345|NCT02472847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6229346|NCT02472847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229347|NCT02472847|Hormones|hormones|mesh-ancestor
6229348|NCT02472847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6229349|NCT02472886|Sofosbuvir|sofosbuvir|mesh-list
6229350|NCT02472886|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
6229351|NCT02472886|Ledipasvir|ledipasvir|mesh-list
6229352|NCT02472886|Antiviral Agents|antiviral agents|mesh-ancestor
6229353|NCT02472886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6229354|NCT02472977|Nivolumab|nivolumab|mesh-list
6229355|NCT02472977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6229356|NCT02472977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6229357|NCT02472977|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5706744|NCT03308201|Hormone Antagonists|hormone antagonists|mesh-ancestor
5706745|NCT03308201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5706746|NCT03308201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706747|NCT03308201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5706748|NCT03308201|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5706749|NCT03308149|Triamcinolone|triamcinolone|mesh-list
5706750|NCT03308149|Bupivacaine|bupivacaine|mesh-list
5706751|NCT03308149|Anesthetics, Local|anesthetics, local|mesh-ancestor
5706752|NCT03308149|Anesthetics|anesthetics|mesh-ancestor
5706753|NCT03308149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6229358|NCT02472977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229359|NCT02473250|Fluoxetine|fluoxetine|mesh-list
6229360|NCT02473250|Citalopram|citalopram|mesh-list
6229361|NCT02473250|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6229362|NCT02473250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6229363|NCT02473250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6229364|NCT02473250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229365|NCT02473250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6229366|NCT02473250|Serotonin Agents|serotonin agents|mesh-ancestor
5706754|NCT03308149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706755|NCT03308149|Sensory System Agents|sensory system agents|mesh-ancestor
5706756|NCT03308149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5706757|NCT03308149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5706758|NCT03308149|Glucocorticoids|glucocorticoids|mesh-ancestor
5706759|NCT03308149|Hormones|hormones|mesh-ancestor
5706760|NCT03308149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5706761|NCT03308136|Lidocaine|lidocaine|mesh-list
5706762|NCT03308136|Anesthetics, Local|anesthetics, local|mesh-list
5706763|NCT03308136|Anesthetics|anesthetics|mesh-list
5706764|NCT03308136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5706765|NCT03308136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706766|NCT03308136|Sensory System Agents|sensory system agents|mesh-ancestor
6229367|NCT02473250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229368|NCT02473250|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6229369|NCT02473250|Antidepressive Agents|antidepressive agents|mesh-ancestor
6229370|NCT02473250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6229371|NCT02473250|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6229372|NCT02473250|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6229373|NCT02473250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6229374|NCT02473367|Raltegravir Potassium|raltegravir potassium|mesh-list
6229375|NCT02473367|Antacids|antacids|mesh-list
6229376|NCT02473367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6229377|NCT02473367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6229378|NCT02473367|Antiviral Agents|antiviral agents|mesh-ancestor
6229379|NCT02473367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5706767|NCT03308136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5706768|NCT03308136|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5706769|NCT03308136|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5706770|NCT03308136|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6229380|NCT02473367|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6229381|NCT02473367|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6229382|NCT02473367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6229383|NCT02473367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229384|NCT02473367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6229385|NCT02473640|Ceftriaxone|ceftriaxone|mesh-list
6229386|NCT02473640|Esomeprazole|esomeprazole|mesh-list
6229387|NCT02473640|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6500322|NCT00644761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6500323|NCT00644761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6500324|NCT00644761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6500325|NCT00644761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6500326|NCT00644761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500327|NCT00644774|Azithromycin|azithromycin|mesh-list
6500328|NCT00644774|Cefdinir|cefdinir|mesh-list
6500329|NCT00644774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6500330|NCT00644774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6500331|NCT00644800|Ziprasidone|ziprasidone|mesh-list
6500332|NCT00644800|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6500333|NCT00644800|Serotonin Agents|serotonin agents|mesh-ancestor
6500334|NCT00644800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6500335|NCT00644800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500336|NCT00644800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6500337|NCT00644800|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6500338|NCT00644800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6500339|NCT00644800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6500340|NCT00644800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6500341|NCT00644800|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6500342|NCT00644800|Dopamine Agents|dopamine agents|mesh-ancestor
6500343|NCT00644891|Amoxicillin|amoxicillin|mesh-list
6500344|NCT00644891|Cefdinir|cefdinir|mesh-list
6500345|NCT00644891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6500346|NCT00644891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6500347|NCT00644904|Vitamin D|vitamin d|mesh-list
6500348|NCT00644904|Ergocalciferols|ergocalciferols|mesh-list
6500349|NCT00644904|Cholecalciferol|cholecalciferol|mesh-list
6500350|NCT00644904|Vitamins|vitamins|mesh-list
6500351|NCT00644904|Micronutrients|micronutrients|mesh-ancestor
6500352|NCT00644904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6500353|NCT00644904|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6500354|NCT00644904|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6500355|NCT00644943|Amoxicillin|amoxicillin|mesh-list
6500356|NCT00644943|Cefdinir|cefdinir|mesh-list
6500357|NCT00644943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6500358|NCT00644943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6500359|NCT00644956|Sildenafil Citrate|sildenafil citrate|mesh-list
6500360|NCT00644956|Tadalafil|tadalafil|mesh-list
6500361|NCT00644956|Vasodilator Agents|vasodilator agents|mesh-ancestor
6500362|NCT00644956|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6500363|NCT00644956|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6500364|NCT00644956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6500365|NCT00644956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500366|NCT00644956|Urological Agents|urological agents|mesh-ancestor
6500367|NCT00644982|Sertraline|sertraline|mesh-list
6500368|NCT00644982|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6500369|NCT00644982|Antidepressive Agents|antidepressive agents|mesh-ancestor
6500370|NCT00644982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6500371|NCT00644982|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6500372|NCT00644982|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6500373|NCT00644982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6500374|NCT00644982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500375|NCT00644982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6229388|NCT02473640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6229389|NCT02473640|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6229390|NCT02473640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6229391|NCT02473640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229392|NCT02473640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6229393|NCT02473640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6229394|NCT02473783|Sertraline|sertraline|mesh-list
6229395|NCT02473783|Antidepressive Agents|antidepressive agents|mesh-ancestor
6229396|NCT02473783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6229397|NCT02473783|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6229398|NCT02473783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6229399|NCT02473783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6229400|NCT02473783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229401|NCT02473783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6229402|NCT02473783|Serotonin Agents|serotonin agents|mesh-ancestor
6229403|NCT02473783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229404|NCT02473913|Silymarin|silymarin|mesh-list
6229405|NCT02473913|Antioxidants|antioxidants|mesh-ancestor
6229406|NCT02473913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229407|NCT02473913|Protective Agents|protective agents|mesh-ancestor
5918797|NCT04988607|Bevacizumab|bevacizumab|mesh-list
5918798|NCT04988607|Osimertinib|osimertinib|mesh-list
5918799|NCT04988607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5918800|NCT04988607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5918801|NCT04988607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6229408|NCT02473913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229409|NCT02474199|Acetaminophen|acetaminophen|mesh-list
6229410|NCT02474199|Diphenhydramine|diphenhydramine|mesh-list
6229411|NCT02474199|Promethazine|promethazine|mesh-list
6229412|NCT02474199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6229413|NCT02474199|Analgesics|analgesics|mesh-ancestor
6229414|NCT02474199|Sensory System Agents|sensory system agents|mesh-ancestor
6229415|NCT02474199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6229416|NCT02474199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229417|NCT02474199|Antipyretics|antipyretics|mesh-ancestor
6229418|NCT02474199|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6229419|NCT02474199|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6229420|NCT02474199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6229421|NCT02474199|Anesthetics, Local|anesthetics, local|mesh-ancestor
6500376|NCT00644982|Serotonin Agents|serotonin agents|mesh-ancestor
5706771|NCT03308136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5706772|NCT03308136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706773|NCT03308084|Dexamethasone|dexamethasone|mesh-list
5706774|NCT03308084|Methylprednisolone|methylprednisolone|mesh-list
5706775|NCT03308084|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5706776|NCT03308084|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5706777|NCT03308084|Prednisolone|prednisolone|mesh-list
5706778|NCT03308084|Prednisolone acetate|prednisolone acetate|mesh-list
5706779|NCT03308084|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5706780|NCT03308084|Prednisolone phosphate|prednisolone phosphate|mesh-list
5706781|NCT03308084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5918802|NCT04988607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5918803|NCT04988607|Growth Substances|growth substances|mesh-ancestor
5918804|NCT04988607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918805|NCT04988607|Growth Inhibitors|growth inhibitors|mesh-ancestor
5918806|NCT04988607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5918807|NCT04988607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5918808|NCT04988607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918809|NCT04988646|Acyclovir|acyclovir|mesh-list
5918810|NCT04988646|Antiviral Agents|antiviral agents|mesh-ancestor
5918811|NCT04988646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6500377|NCT00644982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676558|NCT01581879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6229422|NCT02474199|Anesthetics|anesthetics|mesh-ancestor
6229423|NCT02474199|Antiemetics|antiemetics|mesh-ancestor
6229424|NCT02474199|Autonomic Agents|autonomic agents|mesh-ancestor
6229425|NCT02474199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6229426|NCT02474199|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6229427|NCT02474199|Histamine Antagonists|histamine antagonists|mesh-ancestor
6229428|NCT02474199|Histamine Agents|histamine agents|mesh-ancestor
6229429|NCT02474199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6229430|NCT02474199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229431|NCT02474199|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6229432|NCT02474199|Antipruritics|antipruritics|mesh-ancestor
6229433|NCT02474199|Dermatologic Agents|dermatologic agents|mesh-ancestor
6229434|NCT02474355|Osimertinib|osimertinib|mesh-list
6229435|NCT02474355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6229436|NCT02474355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6229437|NCT02474355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6229438|NCT02474355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229439|NCT02474407|Diazepam|diazepam|mesh-list
6229440|NCT02474407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6229441|NCT02474407|Anticonvulsants|anticonvulsants|mesh-ancestor
6229442|NCT02474407|Antiemetics|antiemetics|mesh-ancestor
6229443|NCT02474407|Autonomic Agents|autonomic agents|mesh-ancestor
6229444|NCT02474407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6229445|NCT02474407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229446|NCT02474407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6229447|NCT02474407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6229448|NCT02474407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6229449|NCT02474407|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6229450|NCT02474407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6229451|NCT02474407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6229452|NCT02474407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6229453|NCT02474407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6229454|NCT02474407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6229455|NCT02474407|Anesthetics, General|anesthetics, general|mesh-ancestor
6229456|NCT02474407|Anesthetics|anesthetics|mesh-ancestor
6229457|NCT02474407|GABA Modulators|gaba modulators|mesh-ancestor
6229458|NCT02474407|GABA Agents|gaba agents|mesh-ancestor
6229459|NCT02474407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6229460|NCT02474407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229461|NCT02475070|Dapagliflozin|dapagliflozin|mesh-list
6229462|NCT02475070|Vildagliptin|vildagliptin|mesh-list
6229463|NCT02475070|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6229464|NCT02475070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229465|NCT02475070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6229466|NCT02475070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229467|NCT02475070|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6229468|NCT02475070|Protease Inhibitors|protease inhibitors|mesh-ancestor
6229469|NCT02475070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6229470|NCT02475265|Levonorgestrel|levonorgestrel|mesh-list
6229471|NCT02475265|Estradiol|estradiol|mesh-list
6229472|NCT02475265|Estrogens|estrogens|mesh-ancestor
6229473|NCT02475265|Hormones|hormones|mesh-ancestor
6500378|NCT00644982|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6500379|NCT00644982|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6500380|NCT00645034|Sildenafil Citrate|sildenafil citrate|mesh-list
6500381|NCT00645034|Vasodilator Agents|vasodilator agents|mesh-ancestor
6500382|NCT00645034|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6500383|NCT00645034|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6500384|NCT00645034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6500385|NCT00645034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500386|NCT00645034|Urological Agents|urological agents|mesh-ancestor
6500387|NCT00645060|Antibodies|antibodies|mesh-list
6500388|NCT00645060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6500389|NCT00645060|Immunologic Factors|immunologic factors|mesh-ancestor
6229474|NCT02475265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6229475|NCT02475265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229476|NCT02475265|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6229477|NCT02475265|Contraceptive Agents|contraceptive agents|mesh-ancestor
5706782|NCT03308084|Antiemetics|antiemetics|mesh-ancestor
5706783|NCT03308084|Autonomic Agents|autonomic agents|mesh-ancestor
5706784|NCT03308084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6229478|NCT02475265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6229479|NCT02475265|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6229480|NCT02475265|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6229481|NCT02475265|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6229482|NCT02475369|Pancrelipase|pancrelipase|mesh-list
6229483|NCT02475369|Pancreatin|pancreatin|mesh-list
6229484|NCT02475369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6229485|NCT02475564|Resveratrol|resveratrol|mesh-list
6229486|NCT02475564|Antioxidants|antioxidants|mesh-ancestor
6229487|NCT02475564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229488|NCT02475564|Protective Agents|protective agents|mesh-ancestor
6229489|NCT02475564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229490|NCT02475564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6229491|NCT02475564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6229492|NCT02475629|Ibalizumab|ibalizumab|mesh-list
6229493|NCT02475629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5706785|NCT03308084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706786|NCT03308084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5706787|NCT03308084|Glucocorticoids|glucocorticoids|mesh-ancestor
5706788|NCT03308084|Hormones|hormones|mesh-ancestor
5706789|NCT03308084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5706790|NCT03308084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6229494|NCT02475629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6229495|NCT02475629|Antiviral Agents|antiviral agents|mesh-ancestor
6229496|NCT02475629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6229497|NCT02475733|Metronidazole|metronidazole|mesh-list
6229498|NCT02475733|Meropenem|meropenem|mesh-list
6229499|NCT02475733|Ceftazidime|ceftazidime|mesh-list
6229500|NCT02475733|Avibactam|avibactam|mesh-list
6229501|NCT02475733|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
6229502|NCT02475733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6229503|NCT02475733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6229504|NCT02475733|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6229505|NCT02475733|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6229506|NCT02475733|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6229507|NCT02475733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6229508|NCT02475733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229509|NCT02475837|Vorapaxar|vorapaxar|mesh-list
6229510|NCT02475837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6229511|NCT02476006|Atorvastatin|atorvastatin|mesh-list
6229512|NCT02476006|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6229513|NCT02476006|Simvastatin|simvastatin|mesh-list
6229514|NCT02476006|Ezetimibe|ezetimibe|mesh-list
6229515|NCT02476006|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6229516|NCT02476006|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6229517|NCT02476006|Antimetabolites|antimetabolites|mesh-ancestor
6229518|NCT02476006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229519|NCT02476006|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6229520|NCT02476006|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6229521|NCT02476006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6229522|NCT02476175|Mirabegron|mirabegron|mesh-list
6229523|NCT02476175|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6229524|NCT02476175|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6229525|NCT02476175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6229526|NCT02476175|Adrenergic Agents|adrenergic agents|mesh-ancestor
6229527|NCT02476175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6229528|NCT02476175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229529|NCT02476175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229530|NCT02476175|Urological Agents|urological agents|mesh-ancestor
6229531|NCT02476422|Ibuprofen|ibuprofen|mesh-list
6229532|NCT02476422|Diclofenac|diclofenac|mesh-list
5706791|NCT03308084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5706792|NCT03308084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5706793|NCT03308084|Protective Agents|protective agents|mesh-ancestor
5706794|NCT03307941|Fluorouracil|fluorouracil|mesh-list
5706795|NCT03307941|Oxaliplatin|oxaliplatin|mesh-list
5706796|NCT03307941|Antimetabolites|antimetabolites|mesh-ancestor
5706797|NCT03307941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706798|NCT03307941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5706799|NCT03307941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5706800|NCT03307941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6229533|NCT02476422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6229534|NCT02476422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6229535|NCT02476422|Analgesics|analgesics|mesh-ancestor
6229536|NCT02476422|Sensory System Agents|sensory system agents|mesh-ancestor
6229537|NCT02476422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6229538|NCT02476422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229539|NCT02476422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6229540|NCT02476422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6229541|NCT02476422|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6229542|NCT02476422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6229543|NCT02476422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229544|NCT02476617|Ritonavir|ritonavir|mesh-list
6229545|NCT02476617|Ribavirin|ribavirin|mesh-list
6229546|NCT02476617|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6229547|NCT02476617|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6229548|NCT02476617|Protease Inhibitors|protease inhibitors|mesh-ancestor
6229549|NCT02476617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6229550|NCT02476617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229551|NCT02476617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6229552|NCT02476617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6229553|NCT02476617|Antiviral Agents|antiviral agents|mesh-ancestor
6229554|NCT02476617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6229555|NCT02476617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6229556|NCT02476617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6229557|NCT02476617|Antimetabolites|antimetabolites|mesh-ancestor
6229558|NCT02477215|Dexamethasone|dexamethasone|mesh-list
6229559|NCT02477215|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5706801|NCT03307941|Immunologic Factors|immunologic factors|mesh-ancestor
5706802|NCT03307941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706803|NCT03307902|Imiquimod|imiquimod|mesh-list
5706804|NCT03307902|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5706805|NCT03307902|Immunologic Factors|immunologic factors|mesh-ancestor
5706806|NCT03307902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706807|NCT03307902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5706808|NCT03307902|Interferon Inducers|interferon inducers|mesh-ancestor
5706809|NCT03307863|Topiramate|topiramate|mesh-list
5706810|NCT03307863|Carbamazepine|carbamazepine|mesh-list
5706811|NCT03307863|Anticonvulsants|anticonvulsants|mesh-ancestor
5706812|NCT03307863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6229560|NCT02477215|Ixazomib|ixazomib|mesh-list
6229561|NCT02477215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6229562|NCT02477215|Antiemetics|antiemetics|mesh-ancestor
6229563|NCT02477215|Autonomic Agents|autonomic agents|mesh-ancestor
6229564|NCT02477215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5918812|NCT04988425|Methylprednisolone|methylprednisolone|mesh-list
5918813|NCT04988425|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5918814|NCT04988425|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5918815|NCT04988425|Prednisolone|prednisolone|mesh-list
5918816|NCT04988425|Prednisolone acetate|prednisolone acetate|mesh-list
5918817|NCT04988425|Antibodies|antibodies|mesh-list
5918818|NCT04988425|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5918819|NCT04988425|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5918820|NCT04988425|Prednisolone phosphate|prednisolone phosphate|mesh-list
5706813|NCT03307863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706814|NCT03307863|Antimanic Agents|antimanic agents|mesh-ancestor
5706815|NCT03307863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5706816|NCT03307863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5706817|NCT03307863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5706818|NCT03307863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5706819|NCT03307863|Analgesics|analgesics|mesh-ancestor
5706820|NCT03307863|Sensory System Agents|sensory system agents|mesh-ancestor
5706821|NCT03307863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5706822|NCT03307863|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5706823|NCT03307863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5706824|NCT03307863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706825|NCT03307863|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5706826|NCT03307863|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5706827|NCT03307759|Pembrolizumab|pembrolizumab|mesh-list
5706828|NCT03307759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6229565|NCT02477215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229566|NCT02477215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6229567|NCT02477215|Glucocorticoids|glucocorticoids|mesh-ancestor
6676559|NCT01581879|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6676560|NCT01581879|Dopamine Agents|dopamine agents|mesh-ancestor
5706829|NCT03307759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5918821|NCT04988425|Immunologic Factors|immunologic factors|mesh-ancestor
6229568|NCT02477215|Hormones|hormones|mesh-ancestor
6676561|NCT01581918|Carbamazepine|carbamazepine|mesh-list
6676562|NCT01581918|Anticonvulsants|anticonvulsants|mesh-ancestor
6676563|NCT01581918|Antimanic Agents|antimanic agents|mesh-ancestor
6676564|NCT01581918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6676565|NCT01581918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6676566|NCT01581918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676567|NCT01581918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6676568|NCT01581918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6676569|NCT01581918|Analgesics|analgesics|mesh-ancestor
6676570|NCT01581918|Sensory System Agents|sensory system agents|mesh-ancestor
6676571|NCT01581918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6676572|NCT01581918|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6676573|NCT01581918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6676574|NCT01581918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676575|NCT01581918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6676576|NCT01581918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6229569|NCT02477215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6229570|NCT02477215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6229571|NCT02477215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6229572|NCT02477215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6229573|NCT02477215|Alkylating Agents|alkylating agents|mesh-ancestor
6229574|NCT02477215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229575|NCT02477215|Protease Inhibitors|protease inhibitors|mesh-ancestor
6229576|NCT02477215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6229577|NCT02477332|Omalizumab|omalizumab|mesh-list
6229578|NCT02477332|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6229579|NCT02477332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6229580|NCT02477332|Respiratory System Agents|respiratory system agents|mesh-ancestor
6229581|NCT02477423|Gentamicins|gentamicins|mesh-list
6229582|NCT02477423|Ampicillin|ampicillin|mesh-list
6229583|NCT02477423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6229584|NCT02477423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6229585|NCT02477423|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6229586|NCT02477423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6229587|NCT02477423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229588|NCT02477527|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6229589|NCT02477527|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6229590|NCT02477527|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6229591|NCT02477527|Antiviral Agents|antiviral agents|mesh-ancestor
6229592|NCT02477527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6229593|NCT02477839|Lacosamide|lacosamide|mesh-list
6229594|NCT02477839|Anticonvulsants|anticonvulsants|mesh-ancestor
6229595|NCT02477839|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6229596|NCT02477839|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6229597|NCT02477839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6229598|NCT02477839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229599|NCT02478164|Ponatinib|ponatinib|mesh-list
6229600|NCT02478164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6229601|NCT02478164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6229602|NCT02478164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6229603|NCT02478164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229604|NCT02478372|Bupivacaine|bupivacaine|mesh-list
6229605|NCT02478372|Ropivacaine|ropivacaine|mesh-list
6229606|NCT02478372|Levobupivacaine|levobupivacaine|mesh-list
6229607|NCT02478372|Anesthetics, Local|anesthetics, local|mesh-ancestor
6229608|NCT02478372|Anesthetics|anesthetics|mesh-ancestor
6229609|NCT02478372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6229610|NCT02478372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229611|NCT02478372|Sensory System Agents|sensory system agents|mesh-ancestor
6229612|NCT02478372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6243726|NCT02679274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6243727|NCT02679274|Anabolic Agents|anabolic agents|mesh-ancestor
6243728|NCT02679469|Nalmefene|nalmefene|mesh-list
6243729|NCT02679469|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6243730|NCT02679469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676577|NCT01581944|Goserelin|goserelin|mesh-list
6676578|NCT01581944|Hormones|hormones|mesh-list
5706830|NCT03307746|Rituximab|rituximab|mesh-list
5706831|NCT03307746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5706832|NCT03307746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5706833|NCT03307746|Immunologic Factors|immunologic factors|mesh-ancestor
5706834|NCT03307746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706835|NCT03307746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5706836|NCT03307720|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5706837|NCT03307720|Hormones|hormones|mesh-list
6229613|NCT02478398|Mometasone Furoate|mometasone furoate|mesh-list
6229614|NCT02478398|Loratadine|loratadine|mesh-list
6229615|NCT02478398|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
6229616|NCT02478398|Epinephrine|epinephrine|mesh-list
6229617|NCT02478398|Albuterol|albuterol|mesh-list
6229618|NCT02478398|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6229619|NCT02478398|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6229620|NCT02478398|Adrenergic Agents|adrenergic agents|mesh-ancestor
6229621|NCT02478398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6229622|NCT02478398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229623|NCT02478398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229624|NCT02478398|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6229625|NCT02478398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6229626|NCT02478398|Autonomic Agents|autonomic agents|mesh-ancestor
6229627|NCT02478398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6229628|NCT02478398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6229629|NCT02478398|Respiratory System Agents|respiratory system agents|mesh-ancestor
6229630|NCT02478398|Mydriatics|mydriatics|mesh-ancestor
6229631|NCT02478398|Sympathomimetics|sympathomimetics|mesh-ancestor
6229632|NCT02478398|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5706838|NCT03307720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5706839|NCT03307720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706840|NCT03307720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6229633|NCT02478398|Tocolytic Agents|tocolytic agents|mesh-ancestor
6229634|NCT02478398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6229635|NCT02478398|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6229636|NCT02478398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6229637|NCT02478398|Dermatologic Agents|dermatologic agents|mesh-ancestor
6229638|NCT02478398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6229639|NCT02478398|Antipruritics|antipruritics|mesh-ancestor
5706847|NCT03307603|Nivolumab|nivolumab|mesh-list
5706848|NCT03307603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5706849|NCT03307603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5706850|NCT03307603|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5706851|NCT03307603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706852|NCT03307590|Dexmedetomidine|dexmedetomidine|mesh-list
5706853|NCT03307590|Bupivacaine|bupivacaine|mesh-list
5706854|NCT03307590|Anesthetics, Local|anesthetics, local|mesh-ancestor
5706855|NCT03307590|Anesthetics|anesthetics|mesh-ancestor
5706856|NCT03307590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5706857|NCT03307590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706858|NCT03307590|Sensory System Agents|sensory system agents|mesh-ancestor
5706859|NCT03307590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5706860|NCT03307590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5706861|NCT03307590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5706862|NCT03307590|Analgesics|analgesics|mesh-ancestor
5706863|NCT03307590|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6229640|NCT02478398|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6229641|NCT02478398|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6229642|NCT02478398|Histamine Antagonists|histamine antagonists|mesh-ancestor
6229643|NCT02478398|Histamine Agents|histamine agents|mesh-ancestor
6229644|NCT02478398|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6229645|NCT02478398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5706864|NCT03307590|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5706865|NCT03307590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5706866|NCT03307590|Adrenergic Agents|adrenergic agents|mesh-ancestor
6229646|NCT02478398|Analgesics|analgesics|mesh-ancestor
6229647|NCT02478398|Sensory System Agents|sensory system agents|mesh-ancestor
6229648|NCT02478398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6229649|NCT02478463|Cabotegravir|cabotegravir|mesh-list
6229650|NCT02478463|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6229651|NCT02478463|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6229652|NCT02478463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6229653|NCT02478463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229654|NCT02478463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6229655|NCT02478463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6229656|NCT02478463|Antiviral Agents|antiviral agents|mesh-ancestor
6229657|NCT02478463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6229658|NCT02478489|Naltrexone|naltrexone|mesh-list
6229659|NCT02478489|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6229660|NCT02478489|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6229661|NCT02478489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229662|NCT02478489|Sensory System Agents|sensory system agents|mesh-ancestor
6229663|NCT02478489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6229664|NCT02478580|Modafinil|modafinil|mesh-list
6676579|NCT01581944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6676580|NCT01581944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676581|NCT01581944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6676582|NCT01581944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6229665|NCT02478580|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6229666|NCT02478580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229667|NCT02478580|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6229668|NCT02478580|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6229669|NCT02478580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6229670|NCT02478580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229671|NCT02479412|Albuterol|albuterol|mesh-list
6229672|NCT02479412|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6229673|NCT02479412|Autonomic Agents|autonomic agents|mesh-ancestor
6229674|NCT02479412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6229675|NCT02479412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706867|NCT03307590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5706868|NCT03307590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706869|NCT03307551|Propofol|propofol|mesh-list
5706870|NCT03307551|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5706871|NCT03307551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5706872|NCT03307551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706873|NCT03307551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5706874|NCT03307551|Anesthetics, General|anesthetics, general|mesh-ancestor
5706875|NCT03307551|Anesthetics|anesthetics|mesh-ancestor
5706876|NCT03307512|Insulin|insulin|mesh-list
6229676|NCT02479412|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6229677|NCT02479412|Respiratory System Agents|respiratory system agents|mesh-ancestor
6500390|NCT00645060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6500391|NCT00645073|Levofloxacin|levofloxacin|mesh-list
6500392|NCT00645073|Ofloxacin|ofloxacin|mesh-list
6500393|NCT00645073|Cefdinir|cefdinir|mesh-list
6500394|NCT00645073|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6500395|NCT00645073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6500396|NCT00645073|Renal Agents|renal agents|mesh-ancestor
6500397|NCT00645073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6500398|NCT00645073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6500399|NCT00645073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6500400|NCT00645073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6500401|NCT00645073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500402|NCT00645073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6500403|NCT00645073|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6500404|NCT00645073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6500405|NCT00645086|Clarithromycin|clarithromycin|mesh-list
6500406|NCT00645086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6500407|NCT00645086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6500408|NCT00645086|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6500409|NCT00645086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6500410|NCT00645086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500411|NCT00645086|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6500412|NCT00645086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6500413|NCT00645112|Azithromycin|azithromycin|mesh-list
6500414|NCT00645112|Cefdinir|cefdinir|mesh-list
6500415|NCT00645112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6500416|NCT00645112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6500417|NCT00645125|Amoxicillin|amoxicillin|mesh-list
6500418|NCT00645125|Cefdinir|cefdinir|mesh-list
6500419|NCT00645125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6500420|NCT00645125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6500421|NCT00645138|Anesthetics|anesthetics|mesh-list
6500422|NCT00645138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6500423|NCT00645138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6500424|NCT00645151|Atorvastatin|atorvastatin|mesh-list
6500425|NCT00645151|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6500426|NCT00645151|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5706877|NCT03307512|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5706878|NCT03307512|Insulin Lispro|insulin lispro|mesh-list
5706879|NCT03307512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6500427|NCT00645151|Antimetabolites|antimetabolites|mesh-ancestor
6229678|NCT02479412|Tocolytic Agents|tocolytic agents|mesh-ancestor
6229679|NCT02479412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6229680|NCT02479412|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6229681|NCT02479412|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6229682|NCT02479412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6229683|NCT02479412|Adrenergic Agents|adrenergic agents|mesh-ancestor
6229684|NCT02479412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6229685|NCT02479412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229686|NCT02479880|Tenofovir|tenofovir|mesh-list
6229687|NCT02479880|Antiviral Agents|antiviral agents|mesh-ancestor
6229688|NCT02479880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6229689|NCT02479880|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6229690|NCT02479880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6229691|NCT02479880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6229692|NCT02479880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229693|NCT02479880|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6229694|NCT02479880|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6229695|NCT02480010|Pertuzumab|pertuzumab|mesh-list
6229696|NCT02480010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6229697|NCT02480010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6229698|NCT02480114|Acetaminophen|acetaminophen|mesh-list
6229699|NCT02480114|Ibuprofen|ibuprofen|mesh-list
6229700|NCT02480114|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
6229701|NCT02480114|Fentanyl|fentanyl|mesh-list
6229702|NCT02480114|Oxycodone|oxycodone|mesh-list
6229703|NCT02480114|Hydrocodone|hydrocodone|mesh-list
6229704|NCT02480114|Gabapentin|gabapentin|mesh-list
5706880|NCT03307512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706881|NCT03307213|Sirolimus|sirolimus|mesh-list
5706882|NCT03307213|Umirolimus|umirolimus|mesh-list
5706883|NCT03307213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5706884|NCT03307213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5706885|NCT03307213|Immunologic Factors|immunologic factors|mesh-ancestor
6229705|NCT02480114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6229706|NCT02480114|Narcotics|narcotics|mesh-ancestor
6229707|NCT02480114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6229708|NCT02480114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229709|NCT02480114|Analgesics|analgesics|mesh-ancestor
6229710|NCT02480114|Sensory System Agents|sensory system agents|mesh-ancestor
6229711|NCT02480114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6229712|NCT02480114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6500428|NCT00645151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500429|NCT00645151|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6500430|NCT00645151|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6500431|NCT00645151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6500432|NCT00645190|Galantamine|galantamine|mesh-list
5706886|NCT03307213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706887|NCT03307213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5706888|NCT03307213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5706889|NCT03307213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5706890|NCT03307213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5706891|NCT03307213|Antifungal Agents|antifungal agents|mesh-ancestor
5721333|NCT03206671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5721334|NCT03206671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5721335|NCT03206671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5721336|NCT03206671|Antiviral Agents|antiviral agents|mesh-ancestor
5721337|NCT03206671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5721338|NCT03206671|Tubulin Modulators|tubulin modulators|mesh-ancestor
5721339|NCT03206671|Antimitotic Agents|antimitotic agents|mesh-ancestor
6500433|NCT00645190|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5721340|NCT03206671|Mitosis Modulators|mitosis modulators|mesh-ancestor
5721341|NCT03206723|Hydrocodone|hydrocodone|mesh-list
5721342|NCT03206723|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5721343|NCT03206723|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5721344|NCT03206723|Narcotics|narcotics|mesh-ancestor
5721345|NCT03206723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5721346|NCT03206723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721347|NCT03206723|Analgesics|analgesics|mesh-ancestor
5721348|NCT03206723|Sensory System Agents|sensory system agents|mesh-ancestor
5721349|NCT03206723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5721350|NCT03206723|Antitussive Agents|antitussive agents|mesh-ancestor
5721351|NCT03206723|Respiratory System Agents|respiratory system agents|mesh-ancestor
5721352|NCT03206723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5721353|NCT03206658|Spironolactone|spironolactone|mesh-list
6229713|NCT02480114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6500434|NCT00645190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6500435|NCT00645190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500436|NCT00645190|Cholinergic Agents|cholinergic agents|mesh-ancestor
6500437|NCT00645190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6676583|NCT01582022|Bupivacaine|bupivacaine|mesh-list
6676584|NCT01582022|Anesthetics, Local|anesthetics, local|mesh-ancestor
6676585|NCT01582022|Anesthetics|anesthetics|mesh-ancestor
6676586|NCT01582022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5706892|NCT03307148|Gemcitabine|gemcitabine|mesh-list
5706893|NCT03307148|Paclitaxel|paclitaxel|mesh-list
5706894|NCT03307148|Tretinoin|tretinoin|mesh-list
5706895|NCT03307148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5706896|NCT03307148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5706897|NCT03307148|Tubulin Modulators|tubulin modulators|mesh-ancestor
6229714|NCT02480114|Anesthetics, General|anesthetics, general|mesh-ancestor
6229715|NCT02480114|Anesthetics|anesthetics|mesh-ancestor
6229716|NCT02480114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6229717|NCT02480114|Antipyretics|antipyretics|mesh-ancestor
6229718|NCT02480114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6229719|NCT02480114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6229720|NCT02480114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6229721|NCT02480114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6229722|NCT02480114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6229723|NCT02480114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229724|NCT02480114|Anticonvulsants|anticonvulsants|mesh-ancestor
6229725|NCT02480114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6229726|NCT02480114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6229727|NCT02480114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6229728|NCT02480114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6229729|NCT02480114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5706898|NCT03307148|Antimitotic Agents|antimitotic agents|mesh-ancestor
5706899|NCT03307148|Mitosis Modulators|mitosis modulators|mesh-ancestor
5706900|NCT03307148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706901|NCT03307148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5706902|NCT03307148|Antimetabolites|antimetabolites|mesh-ancestor
5706903|NCT03307148|Antiviral Agents|antiviral agents|mesh-ancestor
5706904|NCT03307148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5706905|NCT03307148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5706906|NCT03307148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5706907|NCT03307148|Immunologic Factors|immunologic factors|mesh-ancestor
5706908|NCT03307148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706909|NCT03307148|Keratolytic Agents|keratolytic agents|mesh-ancestor
5706910|NCT03307148|Dermatologic Agents|dermatologic agents|mesh-ancestor
5706923|NCT03306940|Botulinum Toxins|botulinum toxins|mesh-list
5706924|NCT03306940|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5706925|NCT03306940|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5706926|NCT03306940|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5706927|NCT03306940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5706928|NCT03306940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706929|NCT03306940|Cholinergic Agents|cholinergic agents|mesh-ancestor
5706930|NCT03306940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6229730|NCT02480114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6229731|NCT02480114|Antimanic Agents|antimanic agents|mesh-ancestor
6229732|NCT02480114|Antitussive Agents|antitussive agents|mesh-ancestor
6229733|NCT02480114|Respiratory System Agents|respiratory system agents|mesh-ancestor
6229734|NCT02480153|Adalimumab|adalimumab|mesh-list
6229735|NCT02480153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6229736|NCT02480153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6229737|NCT02480166|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
6500438|NCT00645190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6500439|NCT00645190|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6500440|NCT00645190|Autonomic Agents|autonomic agents|mesh-ancestor
6500441|NCT00645190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6500442|NCT00645190|Nootropic Agents|nootropic agents|mesh-ancestor
6500443|NCT00645203|Cefdinir|cefdinir|mesh-list
6229738|NCT02480166|Antiviral Agents|antiviral agents|mesh-ancestor
6229739|NCT02480166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6229740|NCT02480621|Bupivacaine|bupivacaine|mesh-list
6229741|NCT02480621|Anesthetics, Local|anesthetics, local|mesh-ancestor
6229742|NCT02480621|Anesthetics|anesthetics|mesh-ancestor
6229743|NCT02480621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6229744|NCT02480621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229745|NCT02480621|Sensory System Agents|sensory system agents|mesh-ancestor
6229746|NCT02480621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6229747|NCT02480712|Sofosbuvir|sofosbuvir|mesh-list
6229748|NCT02480712|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
6229749|NCT02480712|Velpatasvir|velpatasvir|mesh-list
6229750|NCT02480712|Antiviral Agents|antiviral agents|mesh-ancestor
6229751|NCT02480712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6229752|NCT02480764|Valsartan|valsartan|mesh-list
6229753|NCT02480764|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
6229754|NCT02480764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6229755|NCT02480764|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6229756|NCT02480764|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6229757|NCT02480764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229758|NCT02480998|Vaccines|vaccines|mesh-list
6229759|NCT02480998|Immunologic Factors|immunologic factors|mesh-ancestor
6229760|NCT02480998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229761|NCT02481219|Erythromycin|erythromycin|mesh-list
6229762|NCT02481219|Erythromycin Estolate|erythromycin estolate|mesh-list
6229763|NCT02481219|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
6229764|NCT02481219|Erythromycin stearate|erythromycin stearate|mesh-list
6229765|NCT02481219|Metoclopramide|metoclopramide|mesh-list
6229766|NCT02481219|Bisacodyl|bisacodyl|mesh-list
6229767|NCT02481219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6676587|NCT01582022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676588|NCT01582022|Sensory System Agents|sensory system agents|mesh-ancestor
6676589|NCT01582022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6676590|NCT01582113|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
6676591|NCT01582113|Nootropic Agents|nootropic agents|mesh-ancestor
6676592|NCT01582165|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6229768|NCT02481219|Antiemetics|antiemetics|mesh-ancestor
6229769|NCT02481219|Autonomic Agents|autonomic agents|mesh-ancestor
6229770|NCT02481219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6229771|NCT02481219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229772|NCT02481219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5706931|NCT03306940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706932|NCT03306940|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5706933|NCT03306940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5706934|NCT03306914|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
5706935|NCT03306914|Plasma Substitutes|plasma substitutes|mesh-ancestor
5706936|NCT03306914|Blood Substitutes|blood substitutes|mesh-ancestor
5706937|NCT03306901|Fluorouracil|fluorouracil|mesh-list
5706938|NCT03306901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6229773|NCT02481219|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6229774|NCT02481219|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6229775|NCT02481219|Dopamine Agents|dopamine agents|mesh-ancestor
6229776|NCT02481219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6229777|NCT02481219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229778|NCT02481219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6229779|NCT02481219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6229780|NCT02481219|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6229781|NCT02481219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5706939|NCT03306901|Antimetabolites|antimetabolites|mesh-ancestor
5706940|NCT03306901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706941|NCT03306901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5706942|NCT03306901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5706943|NCT03306901|Immunologic Factors|immunologic factors|mesh-ancestor
5706944|NCT03306901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706945|NCT03306836|Heparin|heparin|mesh-list
5706946|NCT03306836|Calcium heparin|calcium heparin|mesh-list
6229782|NCT02481219|Cathartics|cathartics|mesh-ancestor
6229783|NCT02481219|Laxatives|laxatives|mesh-ancestor
6229784|NCT02481258|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide|mesh-list
6229785|NCT02481258|Enzyme Activators|enzyme activators|mesh-ancestor
6229786|NCT02481258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229787|NCT02481297|Rituximab|rituximab|mesh-list
6676593|NCT01582165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5706947|NCT03306836|Anticoagulants|anticoagulants|mesh-ancestor
5706948|NCT03306836|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5706949|NCT03306836|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5706950|NCT03306836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706951|NCT03306745|Folic Acid|folic acid|mesh-list
5706952|NCT03306745|Hematinics|hematinics|mesh-ancestor
5706953|NCT03306745|Vitamin B Complex|vitamin b complex|mesh-ancestor
5706954|NCT03306745|Vitamins|vitamins|mesh-ancestor
5706955|NCT03306745|Micronutrients|micronutrients|mesh-ancestor
5706956|NCT03306745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706957|NCT03306732|Thiamine|thiamine|mesh-list
5706958|NCT03306732|Vitamin B Complex|vitamin b complex|mesh-ancestor
5706959|NCT03306732|Vitamins|vitamins|mesh-ancestor
5706960|NCT03306732|Micronutrients|micronutrients|mesh-ancestor
6229788|NCT02481297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6229789|NCT02481297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6229790|NCT02481297|Immunologic Factors|immunologic factors|mesh-ancestor
6229791|NCT02481297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229792|NCT02481297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6229793|NCT02481375|Iron|iron|mesh-list
6229794|NCT02481375|Trace Elements|trace elements|mesh-list
6229795|NCT02481375|Micronutrients|micronutrients|mesh-list
6229796|NCT02481375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229797|NCT02481505|Chloroprocaine|chloroprocaine|mesh-list
6229798|NCT02481505|Anesthetics, Local|anesthetics, local|mesh-ancestor
6229799|NCT02481505|Anesthetics|anesthetics|mesh-ancestor
6229800|NCT02481505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6229801|NCT02481505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229802|NCT02481505|Sensory System Agents|sensory system agents|mesh-ancestor
6229803|NCT02481505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6229804|NCT02481934|Lenalidomide|lenalidomide|mesh-list
6229805|NCT02481934|Bortezomib|bortezomib|mesh-list
6229806|NCT02481934|Immunologic Factors|immunologic factors|mesh-ancestor
6229807|NCT02481934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229808|NCT02481934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6229809|NCT02481934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6229810|NCT02481934|Growth Substances|growth substances|mesh-ancestor
6229811|NCT02481934|Growth Inhibitors|growth inhibitors|mesh-ancestor
6229812|NCT02481934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6229813|NCT02481947|Laxatives|laxatives|mesh-list
6229814|NCT02481947|Lubiprostone|lubiprostone|mesh-list
5706961|NCT03306732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706962|NCT03306667|Dotinurad|dotinurad|mesh-list
5706963|NCT03306667|Uricosuric Agents|uricosuric agents|mesh-ancestor
5706964|NCT03306667|Gout Suppressants|gout suppressants|mesh-ancestor
5706965|NCT03306667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5706966|NCT03306667|Renal Agents|renal agents|mesh-ancestor
5706967|NCT03306602|Z 350|z 350|mesh-list
5706968|NCT03306602|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
5706969|NCT03306602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5706970|NCT03306602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5706971|NCT03306602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706972|NCT03306602|Hormone Antagonists|hormone antagonists|mesh-ancestor
5706973|NCT03306602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5706974|NCT03306602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706975|NCT03306550|Aspirin|aspirin|mesh-list
5706976|NCT03306550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5706977|NCT03306550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5706978|NCT03306550|Analgesics|analgesics|mesh-ancestor
5706979|NCT03306550|Sensory System Agents|sensory system agents|mesh-ancestor
5706980|NCT03306550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5706981|NCT03306550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5706982|NCT03306550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5706983|NCT03306550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5706984|NCT03306550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5706985|NCT03306550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5706986|NCT03306550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706987|NCT03306550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5706988|NCT03306550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5706989|NCT03306550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5706990|NCT03306550|Antipyretics|antipyretics|mesh-ancestor
5706991|NCT03306472|Letrozole|letrozole|mesh-list
5706992|NCT03306472|Megestrol|megestrol|mesh-list
5706993|NCT03306472|Megestrol Acetate|megestrol acetate|mesh-list
5706994|NCT03306472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5706995|NCT03306472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5706996|NCT03306472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5706997|NCT03306472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6229815|NCT02481947|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6229816|NCT02481947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6229817|NCT02481947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229818|NCT02481947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6229819|NCT02482129|Dexamethasone|dexamethasone|mesh-list
6229820|NCT02482129|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6229821|NCT02482129|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6229822|NCT02482129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6229823|NCT02482129|Antiemetics|antiemetics|mesh-ancestor
6229824|NCT02482129|Autonomic Agents|autonomic agents|mesh-ancestor
6229825|NCT02482129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6229826|NCT02482129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229827|NCT02482129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6229828|NCT02482129|Glucocorticoids|glucocorticoids|mesh-ancestor
6229829|NCT02482129|Hormones|hormones|mesh-ancestor
6229830|NCT02482129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6229831|NCT02482129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6229832|NCT02482129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6229833|NCT02482233|Nicotine|nicotine|mesh-list
6229834|NCT02482233|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6229835|NCT02482233|Autonomic Agents|autonomic agents|mesh-ancestor
6229836|NCT02482233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6229837|NCT02482233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229838|NCT02482233|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6229839|NCT02482233|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6229840|NCT02482233|Cholinergic Agents|cholinergic agents|mesh-ancestor
6229841|NCT02482233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6229842|NCT02482233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229843|NCT02482298|Ticagrelor|ticagrelor|mesh-list
6229844|NCT02482298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6229845|NCT02482298|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6229846|NCT02482298|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6229847|NCT02482298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6229848|NCT02482298|Purinergic Agents|purinergic agents|mesh-ancestor
6229849|NCT02482298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6229850|NCT02482298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229851|NCT02482298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229852|NCT02482428|Imiquimod|imiquimod|mesh-list
5706998|NCT03306472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5706999|NCT03306472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5707000|NCT03306472|Hormone Antagonists|hormone antagonists|mesh-ancestor
5707001|NCT03306472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5707002|NCT03306472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707003|NCT03306472|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5707004|NCT03306472|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5707005|NCT03306472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5707006|NCT03306472|Contraceptive Agents|contraceptive agents|mesh-ancestor
5707007|NCT03306472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5707008|NCT03306472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5707009|NCT03306472|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5707010|NCT03306472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6229853|NCT02482428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6229854|NCT02482428|Immunologic Factors|immunologic factors|mesh-ancestor
6229855|NCT02482428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229856|NCT02482428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6229857|NCT02482428|Interferon Inducers|interferon inducers|mesh-ancestor
6229858|NCT02482675|Caseins|caseins|mesh-list
6229859|NCT02482675|Chelating Agents|chelating agents|mesh-ancestor
6229860|NCT02482675|Sequestering Agents|sequestering agents|mesh-ancestor
6229861|NCT02482675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229862|NCT02483000|Biotin|biotin|mesh-list
6229863|NCT02483000|Cytarabine|cytarabine|mesh-list
6229864|NCT02483000|Etoposide|etoposide|mesh-list
6229865|NCT02483000|Podophyllotoxin|podophyllotoxin|mesh-list
6229866|NCT02483000|Etoposide phosphate|etoposide phosphate|mesh-list
6229867|NCT02483000|Melphalan|melphalan|mesh-list
6229868|NCT02483000|Mechlorethamine|mechlorethamine|mesh-list
6229869|NCT02483000|Carmustine|carmustine|mesh-list
6229870|NCT02483000|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
6229871|NCT02483000|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
6229872|NCT02483000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6229873|NCT02483000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6229874|NCT02483000|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6229875|NCT02483000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6229876|NCT02483000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6676594|NCT01582165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5707011|NCT03306472|Appetite Stimulants|appetite stimulants|mesh-ancestor
5707012|NCT03306472|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5707013|NCT03306446|Adalimumab|adalimumab|mesh-list
5707014|NCT03306446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5707015|NCT03306446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5707016|NCT03306368|Analgesics, Opioid|analgesics, opioid|mesh-list
5707017|NCT03306368|Narcotics|narcotics|mesh-ancestor
5707018|NCT03306368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5707019|NCT03306368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707020|NCT03306368|Analgesics|analgesics|mesh-ancestor
5707021|NCT03306368|Sensory System Agents|sensory system agents|mesh-ancestor
6229877|NCT02483000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229878|NCT02483000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6229879|NCT02483000|Antimetabolites|antimetabolites|mesh-ancestor
6229880|NCT02483000|Antiviral Agents|antiviral agents|mesh-ancestor
6229881|NCT02483000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6229882|NCT02483000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5707022|NCT03306368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5707023|NCT03306290|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5707024|NCT03306290|Cefoxitin|cefoxitin|mesh-list
5707025|NCT03306290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5707026|NCT03306264|Decitabine|decitabine|mesh-list
5707027|NCT03306264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5707028|NCT03306264|Antimetabolites|antimetabolites|mesh-ancestor
5707029|NCT03306264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707030|NCT03306264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5707031|NCT03306264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5707032|NCT03306212|Botulinum Toxins|botulinum toxins|mesh-list
5707033|NCT03306212|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5707034|NCT03306212|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5707035|NCT03306212|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5707036|NCT03306212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5707037|NCT03306212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707038|NCT03306212|Cholinergic Agents|cholinergic agents|mesh-ancestor
5707039|NCT03306212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5707040|NCT03306212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707041|NCT03306212|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5707042|NCT03306212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5707043|NCT03305978|Ivermectin|ivermectin|mesh-list
6229883|NCT02483000|Immunologic Factors|immunologic factors|mesh-ancestor
6229884|NCT02483000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707044|NCT03305978|Selamectin|selamectin|mesh-list
5707045|NCT03305978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5707046|NCT03305978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5707047|NCT03305536|Vitamin D|vitamin d|mesh-list
5707048|NCT03305536|Vitamins|vitamins|mesh-list
5707049|NCT03305536|Vitamin K|vitamin k|mesh-list
5707050|NCT03305536|Vitamin K 2|vitamin k 2|mesh-list
5707051|NCT03305536|Vitamin MK 7|vitamin mk 7|mesh-list
5707052|NCT03305536|Micronutrients|micronutrients|mesh-ancestor
5707053|NCT03305536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707054|NCT03305536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6229885|NCT02483000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6229886|NCT02483000|Alkylating Agents|alkylating agents|mesh-ancestor
6229887|NCT02483000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6229888|NCT02483000|Chelating Agents|chelating agents|mesh-ancestor
6229889|NCT02483000|Sequestering Agents|sequestering agents|mesh-ancestor
6229890|NCT02483000|Keratolytic Agents|keratolytic agents|mesh-ancestor
6229891|NCT02483000|Dermatologic Agents|dermatologic agents|mesh-ancestor
6229892|NCT02483000|Tubulin Modulators|tubulin modulators|mesh-ancestor
6229893|NCT02483000|Antimitotic Agents|antimitotic agents|mesh-ancestor
6229894|NCT02483000|Mitosis Modulators|mitosis modulators|mesh-ancestor
6229895|NCT02483000|Vitamin B Complex|vitamin b complex|mesh-ancestor
6229896|NCT02483000|Vitamins|vitamins|mesh-ancestor
5707055|NCT03305536|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5707056|NCT03305536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6229897|NCT02483000|Micronutrients|micronutrients|mesh-ancestor
6229898|NCT02483585|Erenumab|erenumab|mesh-list
6229899|NCT02483585|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
6229900|NCT02483585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707057|NCT03305536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707058|NCT03305536|Hemostatics|hemostatics|mesh-ancestor
6229901|NCT02483585|Analgesics|analgesics|mesh-ancestor
6229902|NCT02483585|Sensory System Agents|sensory system agents|mesh-ancestor
6676595|NCT01582165|Antimetabolites|antimetabolites|mesh-ancestor
5707059|NCT03305536|Coagulants|coagulants|mesh-ancestor
5707060|NCT03305510|Vitamin D|vitamin d|mesh-list
5707061|NCT03305510|Vitamins|vitamins|mesh-ancestor
6229903|NCT02483585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6229904|NCT02483585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229905|NCT02483611|Lidocaine|lidocaine|mesh-list
6229906|NCT02483611|Magnesium Sulfate|magnesium sulfate|mesh-list
6229907|NCT02483611|Cisatracurium|cisatracurium|mesh-list
6229908|NCT02483611|Anesthetics, Local|anesthetics, local|mesh-ancestor
6229909|NCT02483611|Anesthetics|anesthetics|mesh-ancestor
5707062|NCT03305510|Micronutrients|micronutrients|mesh-ancestor
5707063|NCT03305510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707064|NCT03305510|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5721354|NCT03206658|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5721355|NCT03206658|Hormone Antagonists|hormone antagonists|mesh-ancestor
5721356|NCT03206658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5721357|NCT03206658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721358|NCT03206658|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5721359|NCT03206658|Diuretics|diuretics|mesh-ancestor
5721360|NCT03206658|Natriuretic Agents|natriuretic agents|mesh-ancestor
5721361|NCT03206554|Ropivacaine|ropivacaine|mesh-list
5721362|NCT03206554|Anesthetics, Local|anesthetics, local|mesh-ancestor
6229910|NCT02483611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6229911|NCT02483611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229912|NCT02483611|Sensory System Agents|sensory system agents|mesh-ancestor
6229913|NCT02483611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6229914|NCT02483611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6229915|NCT02483611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6229916|NCT02483611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6229917|NCT02483611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6229918|NCT02483611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229919|NCT02483611|Analgesics|analgesics|mesh-ancestor
6229920|NCT02483611|Anticonvulsants|anticonvulsants|mesh-ancestor
6229921|NCT02483611|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6229922|NCT02483611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6229923|NCT02483611|Tocolytic Agents|tocolytic agents|mesh-ancestor
6229924|NCT02483611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6229925|NCT02483611|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6229926|NCT02483611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6229927|NCT02483975|Albuterol|albuterol|mesh-list
6229928|NCT02483975|Montelukast|montelukast|mesh-list
6229929|NCT02483975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6229930|NCT02483975|Respiratory System Agents|respiratory system agents|mesh-ancestor
6229931|NCT02483975|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6229932|NCT02483975|Hormone Antagonists|hormone antagonists|mesh-ancestor
6229933|NCT02483975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6229934|NCT02483975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229935|NCT02483975|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6229936|NCT02483975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6229937|NCT02483975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229938|NCT02483975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6229939|NCT02483975|Autonomic Agents|autonomic agents|mesh-ancestor
6229940|NCT02483975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6229941|NCT02483975|Tocolytic Agents|tocolytic agents|mesh-ancestor
6229942|NCT02483975|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6229943|NCT02483975|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6229944|NCT02483975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6229945|NCT02483975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6229946|NCT02483975|Adrenergic Agents|adrenergic agents|mesh-ancestor
6229947|NCT02483975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6229948|NCT02484222|Fentanyl|fentanyl|mesh-list
6229949|NCT02484222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6229950|NCT02484222|Narcotics|narcotics|mesh-ancestor
6229951|NCT02484222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6229952|NCT02484222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229953|NCT02484222|Analgesics|analgesics|mesh-ancestor
6229954|NCT02484222|Sensory System Agents|sensory system agents|mesh-ancestor
6229955|NCT02484222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6229956|NCT02484222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6229957|NCT02484222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6229958|NCT02484222|Anesthetics, General|anesthetics, general|mesh-ancestor
6229959|NCT02484222|Anesthetics|anesthetics|mesh-ancestor
6229960|NCT02484443|Dinutuximab|dinutuximab|mesh-list
6229961|NCT02484443|Sargramostim|sargramostim|mesh-list
6229962|NCT02484443|Immunologic Factors|immunologic factors|mesh-ancestor
6229963|NCT02484443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229964|NCT02484443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6229965|NCT02484651|Rocuronium|rocuronium|mesh-list
6229966|NCT02484651|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6229967|NCT02484651|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6229968|NCT02484651|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6229969|NCT02484651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6229970|NCT02484651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229971|NCT02484690|Ranibizumab|ranibizumab|mesh-list
6229972|NCT02484690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6229973|NCT02484690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5707065|NCT03305471|Sevelamer|sevelamer|mesh-list
5707066|NCT03305471|Chelating Agents|chelating agents|mesh-ancestor
5707067|NCT03305471|Sequestering Agents|sequestering agents|mesh-ancestor
5707068|NCT03305471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707069|NCT03305445|Nivolumab|nivolumab|mesh-list
5707070|NCT03305445|Ipilimumab|ipilimumab|mesh-list
5707071|NCT03305445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5707072|NCT03305445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5707073|NCT03305445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5707074|NCT03305445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707075|NCT03305263|Hydroxychloroquine|hydroxychloroquine|mesh-list
5707076|NCT03305263|Antimalarials|antimalarials|mesh-ancestor
5707077|NCT03305263|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5707078|NCT03305263|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5707079|NCT03305263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5707080|NCT03305263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5707081|NCT03305263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707082|NCT03305263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5707083|NCT03305068|Celecoxib|celecoxib|mesh-list
5721363|NCT03206554|Anesthetics|anesthetics|mesh-ancestor
6229974|NCT02484690|Growth Substances|growth substances|mesh-ancestor
6229975|NCT02484690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229976|NCT02484690|Growth Inhibitors|growth inhibitors|mesh-ancestor
6229977|NCT02484690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6229978|NCT02484859|Metoprolol|metoprolol|mesh-list
6229979|NCT02484859|Remifentanil|remifentanil|mesh-list
6229980|NCT02484859|Tramadol|tramadol|mesh-list
6229981|NCT02484859|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6229982|NCT02484859|Narcotics|narcotics|mesh-ancestor
6229983|NCT02484859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6229984|NCT02484859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6229985|NCT02484859|Analgesics|analgesics|mesh-ancestor
6229986|NCT02484859|Sensory System Agents|sensory system agents|mesh-ancestor
6229987|NCT02484859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6229988|NCT02484859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6229989|NCT02484859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6229990|NCT02484859|Sympatholytics|sympatholytics|mesh-ancestor
6229991|NCT02484859|Autonomic Agents|autonomic agents|mesh-ancestor
6229992|NCT02484859|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6229993|NCT02484859|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6229994|NCT02484859|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6229995|NCT02484859|Adrenergic Agents|adrenergic agents|mesh-ancestor
6229996|NCT02484859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6229997|NCT02484859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6229998|NCT02484911|Dexamethasone|dexamethasone|mesh-list
6229999|NCT02484911|Olanzapine|olanzapine|mesh-list
6230000|NCT02484911|Aprepitant|aprepitant|mesh-list
6230001|NCT02484911|Palonosetron|palonosetron|mesh-list
6230002|NCT02484911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6230003|NCT02484911|Antiemetics|antiemetics|mesh-ancestor
6230004|NCT02484911|Autonomic Agents|autonomic agents|mesh-ancestor
6230005|NCT02484911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6230006|NCT02484911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230007|NCT02484911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6230008|NCT02484911|Glucocorticoids|glucocorticoids|mesh-ancestor
6230009|NCT02484911|Hormones|hormones|mesh-ancestor
6230010|NCT02484911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6230011|NCT02484911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6230012|NCT02484911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6230013|NCT02484911|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6230014|NCT02484911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6230015|NCT02484911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6500444|NCT00645203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6500445|NCT00645203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6500446|NCT00645229|Ziprasidone|ziprasidone|mesh-list
6500447|NCT00645229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6500448|NCT00645229|Serotonin Agents|serotonin agents|mesh-ancestor
6230016|NCT02484911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6230017|NCT02484911|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6230018|NCT02484911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6230019|NCT02484911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6230020|NCT02484911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230021|NCT02484911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6230022|NCT02484911|Serotonin Agents|serotonin agents|mesh-ancestor
6230023|NCT02484911|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6230024|NCT02484911|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6230025|NCT02484911|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6230026|NCT02485158|Dronabinol|dronabinol|mesh-list
6230027|NCT02485158|Amphetamine|amphetamine|mesh-list
6230028|NCT02485158|Dextroamphetamine|dextroamphetamine|mesh-list
6230029|NCT02485158|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6230030|NCT02485158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230031|NCT02485158|Sympathomimetics|sympathomimetics|mesh-ancestor
6230032|NCT02485158|Autonomic Agents|autonomic agents|mesh-ancestor
6230033|NCT02485158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6230034|NCT02485158|Dopamine Agents|dopamine agents|mesh-ancestor
6230035|NCT02485158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6230036|NCT02485158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230037|NCT02485158|Adrenergic Agents|adrenergic agents|mesh-ancestor
6230038|NCT02485158|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6230039|NCT02485158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6230040|NCT02485158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6230041|NCT02485158|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6230042|NCT02485158|Hallucinogens|hallucinogens|mesh-ancestor
6230043|NCT02485158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6230044|NCT02485158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6230045|NCT02485158|Analgesics|analgesics|mesh-ancestor
6230046|NCT02485158|Sensory System Agents|sensory system agents|mesh-ancestor
6230047|NCT02485158|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6230048|NCT02485158|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6230049|NCT02485158|Hormones|hormones|mesh-ancestor
6230050|NCT02485158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6230051|NCT02485353|Cytarabine|cytarabine|mesh-list
6230052|NCT02485353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6230053|NCT02485353|Antimetabolites|antimetabolites|mesh-ancestor
6500449|NCT00645229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6500450|NCT00645229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707084|NCT03305068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5707085|NCT03305068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5707086|NCT03305068|Analgesics|analgesics|mesh-ancestor
5707087|NCT03305068|Sensory System Agents|sensory system agents|mesh-ancestor
5707088|NCT03305068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5707089|NCT03305068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707090|NCT03305068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5707091|NCT03305068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6500451|NCT00645229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6500452|NCT00645229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6230054|NCT02485353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230055|NCT02485353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6230056|NCT02485353|Antiviral Agents|antiviral agents|mesh-ancestor
6230057|NCT02485353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6230058|NCT02485353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6230059|NCT02485353|Immunologic Factors|immunologic factors|mesh-ancestor
5707092|NCT03305068|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5707093|NCT03305068|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5707094|NCT03305068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5707095|NCT03305068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707096|NCT03304652|Zaleplon|zaleplon|mesh-list
5707097|NCT03304652|Anticonvulsants|anticonvulsants|mesh-ancestor
5707098|NCT03304652|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5707099|NCT03304652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5707100|NCT03304652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707101|NCT03304652|GABA Modulators|gaba modulators|mesh-ancestor
5707102|NCT03304652|GABA Agents|gaba agents|mesh-ancestor
6230060|NCT02485353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230061|NCT02485834|Docetaxel|docetaxel|mesh-list
6230062|NCT02485834|Capecitabine|capecitabine|mesh-list
6230063|NCT02485834|Irinotecan|irinotecan|mesh-list
6230064|NCT02485834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6230065|NCT02485834|Tubulin Modulators|tubulin modulators|mesh-ancestor
6230066|NCT02485834|Antimitotic Agents|antimitotic agents|mesh-ancestor
5707103|NCT03304652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5707104|NCT03304652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230067|NCT02485834|Mitosis Modulators|mitosis modulators|mesh-ancestor
6230068|NCT02485834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230069|NCT02485834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6230070|NCT02485834|Antimetabolites|antimetabolites|mesh-ancestor
6230071|NCT02485834|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6230072|NCT02485834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6230073|NCT02485834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6230074|NCT02486016|Fentanyl|fentanyl|mesh-list
6230075|NCT02486016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6230076|NCT02486016|Narcotics|narcotics|mesh-ancestor
6230077|NCT02486016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6230078|NCT02486016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707105|NCT03304496|Nitroglycerin|nitroglycerin|mesh-list
5707106|NCT03304496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5707107|NCT03304496|Vasodilator Agents|vasodilator agents|mesh-ancestor
5707108|NCT03304457|Olanzapine|olanzapine|mesh-list
5707109|NCT03304457|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
5707110|NCT03304457|Antiemetics|antiemetics|mesh-ancestor
5707111|NCT03304457|Autonomic Agents|autonomic agents|mesh-ancestor
5707112|NCT03304457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5707113|NCT03304457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707114|NCT03304457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5707115|NCT03304457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5707116|NCT03304457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5707117|NCT03304457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5707118|NCT03304457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5707119|NCT03304457|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5707120|NCT03304457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6230079|NCT02486016|Analgesics|analgesics|mesh-ancestor
6230080|NCT02486016|Sensory System Agents|sensory system agents|mesh-ancestor
6230081|NCT02486016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6230082|NCT02486016|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6230083|NCT02486016|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6230084|NCT02486016|Anesthetics, General|anesthetics, general|mesh-ancestor
6230085|NCT02486016|Anesthetics|anesthetics|mesh-ancestor
6230086|NCT02486211|Amantadine|amantadine|mesh-list
6230087|NCT02486211|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6230088|NCT02486211|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6230089|NCT02486211|Antiviral Agents|antiviral agents|mesh-ancestor
6230090|NCT02486211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6230091|NCT02486211|Dopamine Agents|dopamine agents|mesh-ancestor
6230092|NCT02486211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6230093|NCT02486211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230094|NCT02486211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230095|NCT02486211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6230096|NCT02486211|Analgesics|analgesics|mesh-ancestor
6230097|NCT02486211|Sensory System Agents|sensory system agents|mesh-ancestor
6230098|NCT02486211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6230099|NCT02486302|Etanercept|etanercept|mesh-list
6230100|NCT02486302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6230101|NCT02486302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6230102|NCT02486302|Analgesics|analgesics|mesh-ancestor
6230103|NCT02486302|Sensory System Agents|sensory system agents|mesh-ancestor
6230104|NCT02486302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6230105|NCT02486302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230106|NCT02486302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6230107|NCT02486302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6230108|NCT02486302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6230109|NCT02486302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6230110|NCT02486302|Immunologic Factors|immunologic factors|mesh-ancestor
6230111|NCT02486328|Midazolam|midazolam|mesh-list
6230112|NCT02486328|Meperidine|meperidine|mesh-list
6230113|NCT02486328|Remifentanil|remifentanil|mesh-list
6230114|NCT02486328|Propofol|propofol|mesh-list
6230115|NCT02486328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6230116|NCT02486328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5707121|NCT03304457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5707122|NCT03304457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707123|NCT03304457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5707124|NCT03304457|Serotonin Agents|serotonin agents|mesh-ancestor
5707125|NCT03304457|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5707126|NCT03304457|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6230117|NCT02486328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230118|NCT02486328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6230119|NCT02486328|Anesthetics, General|anesthetics, general|mesh-ancestor
6230120|NCT02486328|Anesthetics|anesthetics|mesh-ancestor
6230121|NCT02486328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6230122|NCT02486328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6230123|NCT02486328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6230124|NCT02486328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6230125|NCT02486328|GABA Modulators|gaba modulators|mesh-ancestor
5707127|NCT03304457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5707128|NCT03304457|Adrenergic Agents|adrenergic agents|mesh-ancestor
5707129|NCT03304457|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5707130|NCT03304457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5707131|NCT03304457|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5707132|NCT03304457|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5707133|NCT03304457|Dopamine Agents|dopamine agents|mesh-ancestor
5707134|NCT03304444|Bupivacaine|bupivacaine|mesh-list
5707135|NCT03304444|Anesthetics, Local|anesthetics, local|mesh-ancestor
5707136|NCT03304444|Anesthetics|anesthetics|mesh-ancestor
5707137|NCT03304444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5707138|NCT03304444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707139|NCT03304444|Sensory System Agents|sensory system agents|mesh-ancestor
5707140|NCT03304444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5707141|NCT03304431|Lidocaine|lidocaine|mesh-list
5707142|NCT03304431|Anesthetics, Local|anesthetics, local|mesh-ancestor
5707143|NCT03304431|Anesthetics|anesthetics|mesh-ancestor
5707144|NCT03304431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6230126|NCT02486328|GABA Agents|gaba agents|mesh-ancestor
6230127|NCT02486328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6230128|NCT02486328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230129|NCT02486328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6230130|NCT02486328|Narcotics|narcotics|mesh-ancestor
6230131|NCT02486328|Analgesics|analgesics|mesh-ancestor
5707145|NCT03304431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707146|NCT03304431|Sensory System Agents|sensory system agents|mesh-ancestor
5707147|NCT03304431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5707148|NCT03304431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5707149|NCT03304431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6230132|NCT02486328|Sensory System Agents|sensory system agents|mesh-ancestor
6230133|NCT02486328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5918822|NCT04988425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918823|NCT04988425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5918824|NCT04988425|Antiemetics|antiemetics|mesh-ancestor
5918825|NCT04988425|Autonomic Agents|autonomic agents|mesh-ancestor
5918826|NCT04988425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5918827|NCT04988425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5918828|NCT04988425|Glucocorticoids|glucocorticoids|mesh-ancestor
5918829|NCT04988425|Hormones|hormones|mesh-ancestor
5918830|NCT04988425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5918831|NCT04988425|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5918832|NCT04988425|Protective Agents|protective agents|mesh-ancestor
5918833|NCT04988425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5918834|NCT04988425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5707150|NCT03304431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5707151|NCT03304431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5707152|NCT03304431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707153|NCT03304418|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
5707154|NCT03304418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6230134|NCT02486406|Ritonavir|ritonavir|mesh-list
6230135|NCT02486406|Ribavirin|ribavirin|mesh-list
6230136|NCT02486406|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6230137|NCT02486406|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6230138|NCT02486406|Protease Inhibitors|protease inhibitors|mesh-ancestor
6230139|NCT02486406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6230140|NCT02486406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230141|NCT02486406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6230142|NCT02486406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6230143|NCT02486406|Antiviral Agents|antiviral agents|mesh-ancestor
5707155|NCT03304288|Rituximab|rituximab|mesh-list
6230144|NCT02486406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6230145|NCT02486406|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6230146|NCT02486406|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6230147|NCT02486406|Antimetabolites|antimetabolites|mesh-ancestor
6230148|NCT02486627|Levofloxacin|levofloxacin|mesh-list
6230149|NCT02486627|Ofloxacin|ofloxacin|mesh-list
6230150|NCT02486627|Meropenem|meropenem|mesh-list
6230151|NCT02486627|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6230152|NCT02486627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6230153|NCT02486627|Renal Agents|renal agents|mesh-ancestor
6230154|NCT02486627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6230155|NCT02486627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6230156|NCT02486627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6230157|NCT02486627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6230158|NCT02486627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230159|NCT02486627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6230160|NCT02486627|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6230161|NCT02486627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6230162|NCT02486653|Tamsulosin|tamsulosin|mesh-list
6230163|NCT02486653|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6230164|NCT02486653|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6230165|NCT02486653|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6230166|NCT02486653|Adrenergic Agents|adrenergic agents|mesh-ancestor
6230167|NCT02486653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6230168|NCT02486653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230169|NCT02486653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230170|NCT02486653|Urological Agents|urological agents|mesh-ancestor
6230171|NCT02486757|Estradiol|estradiol|mesh-list
6230172|NCT02486757|Progesterone|progesterone|mesh-list
6230173|NCT02486757|Estrogens|estrogens|mesh-ancestor
6230174|NCT02486757|Hormones|hormones|mesh-ancestor
6230175|NCT02486757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6230176|NCT02486757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707156|NCT03304288|Tretinoin|tretinoin|mesh-list
5707157|NCT03304288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5707158|NCT03304288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5707159|NCT03304288|Immunologic Factors|immunologic factors|mesh-ancestor
5707160|NCT03304288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707161|NCT03304288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5707162|NCT03304288|Keratolytic Agents|keratolytic agents|mesh-ancestor
5707163|NCT03304288|Dermatologic Agents|dermatologic agents|mesh-ancestor
5707164|NCT03304210|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5707165|NCT03304210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5707166|NCT03304093|Nivolumab|nivolumab|mesh-list
5707167|NCT03304093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5707168|NCT03304093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5707169|NCT03304093|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5707170|NCT03304093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707171|NCT03304080|Trastuzumab|trastuzumab|mesh-list
5707172|NCT03304080|Pertuzumab|pertuzumab|mesh-list
5707173|NCT03304080|Palbociclib|palbociclib|mesh-list
5707174|NCT03304080|Anastrozole|anastrozole|mesh-list
5707175|NCT03304080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5707176|NCT03304080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5707177|NCT03304080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5707178|NCT03304080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5707179|NCT03304080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707180|NCT03304080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5707181|NCT03304080|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5707182|NCT03304080|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5707183|NCT03304080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5707184|NCT03304080|Hormone Antagonists|hormone antagonists|mesh-ancestor
5707185|NCT03304080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5707186|NCT03304080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707187|NCT03303976|Vaccines|vaccines|mesh-list
5707188|NCT03303976|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5707189|NCT03303976|Immunologic Factors|immunologic factors|mesh-ancestor
5707190|NCT03303976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707191|NCT03303924|Sulbactam|sulbactam|mesh-list
5707192|NCT03303924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5707193|NCT03303924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5707194|NCT03303924|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5707195|NCT03303924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5707196|NCT03303924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721364|NCT03206554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5721365|NCT03206554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721366|NCT03206554|Sensory System Agents|sensory system agents|mesh-ancestor
5721367|NCT03206554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5721368|NCT03206866|Antibodies|antibodies|mesh-list
5721369|NCT03206866|Immunologic Factors|immunologic factors|mesh-ancestor
5721370|NCT03206866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230177|NCT02486757|Progestins|progestins|mesh-ancestor
5707197|NCT03303677|Vancomycin|vancomycin|mesh-list
5707198|NCT03303677|Ciprofloxacin|ciprofloxacin|mesh-list
5707199|NCT03303677|Gentamicins|gentamicins|mesh-list
5707200|NCT03303677|Mupirocin|mupirocin|mesh-list
5707201|NCT03303677|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5707202|NCT03303677|Trimethoprim|trimethoprim|mesh-list
6230178|NCT02486796|Ubiquinone|ubiquinone|mesh-list
6230179|NCT02486796|Coenzyme Q10|coenzyme q10|mesh-list
6230180|NCT02486796|Melatonin|melatonin|mesh-list
6230181|NCT02486796|Antioxidants|antioxidants|mesh-ancestor
6230182|NCT02486796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230183|NCT02486796|Protective Agents|protective agents|mesh-ancestor
6230184|NCT02486796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230185|NCT02486796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6230186|NCT02486796|Micronutrients|micronutrients|mesh-ancestor
6230187|NCT02486796|Vitamins|vitamins|mesh-ancestor
6230188|NCT02486952|Prednisone|prednisone|mesh-list
6230189|NCT02486952|Cyclophosphamide|cyclophosphamide|mesh-list
6230190|NCT02486952|Rituximab|rituximab|mesh-list
6230191|NCT02486952|Vincristine|vincristine|mesh-list
6230192|NCT02486952|Doxorubicin|doxorubicin|mesh-list
6230193|NCT02486952|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6230194|NCT02486952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6230195|NCT02486952|Immunologic Factors|immunologic factors|mesh-ancestor
6230196|NCT02486952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230197|NCT02486952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6230198|NCT02486952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6230199|NCT02486952|Alkylating Agents|alkylating agents|mesh-ancestor
6230200|NCT02486952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230201|NCT02486952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6230202|NCT02486952|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6676596|NCT01582165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676597|NCT01582165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6676598|NCT01582165|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6676599|NCT01582165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6676600|NCT01582191|Everolimus|everolimus|mesh-list
6676601|NCT01582191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5918835|NCT04988217|Interferons|interferons|mesh-list
5918836|NCT04988217|Interferon-alpha|interferon-alpha|mesh-list
5918837|NCT04988217|Interferon alpha-2|interferon alpha-2|mesh-list
6676602|NCT01582191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6676603|NCT01582191|Immunologic Factors|immunologic factors|mesh-ancestor
6676604|NCT01582191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676605|NCT01582230|Vildagliptin|vildagliptin|mesh-list
6676606|NCT01582230|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6230203|NCT02486952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6230204|NCT02486952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6230205|NCT02486952|Glucocorticoids|glucocorticoids|mesh-ancestor
5707203|NCT03303677|Sulfamethoxazole|sulfamethoxazole|mesh-list
5707204|NCT03303677|Budesonide|budesonide|mesh-list
5707205|NCT03303677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5707206|NCT03303677|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5707207|NCT03303677|Autonomic Agents|autonomic agents|mesh-ancestor
5707208|NCT03303677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5707209|NCT03303677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707210|NCT03303677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6230206|NCT02486952|Hormones|hormones|mesh-ancestor
6230207|NCT02486952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6230208|NCT02486952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6230209|NCT02486952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6230210|NCT02486952|Tubulin Modulators|tubulin modulators|mesh-ancestor
6230211|NCT02486952|Antimitotic Agents|antimitotic agents|mesh-ancestor
6230212|NCT02486952|Mitosis Modulators|mitosis modulators|mesh-ancestor
6230213|NCT02486952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6230214|NCT02486952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6230215|NCT02486952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6230216|NCT02486952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6230217|NCT02487030|Sofosbuvir|sofosbuvir|mesh-list
6230218|NCT02487030|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
6230219|NCT02487030|Ledipasvir|ledipasvir|mesh-list
6230220|NCT02487030|Antiviral Agents|antiviral agents|mesh-ancestor
5707211|NCT03303677|Respiratory System Agents|respiratory system agents|mesh-ancestor
6230221|NCT02487030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5707212|NCT03303677|Glucocorticoids|glucocorticoids|mesh-ancestor
5707213|NCT03303677|Hormones|hormones|mesh-ancestor
5722317|NCT03199976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6230222|NCT02487199|Ritonavir|ritonavir|mesh-list
6230223|NCT02487199|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5707214|NCT03303677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5707215|NCT03303677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5707216|NCT03303677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5707217|NCT03303677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5707218|NCT03303677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5707219|NCT03303677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230224|NCT02487199|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6230225|NCT02487199|Protease Inhibitors|protease inhibitors|mesh-ancestor
6230226|NCT02487199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6230227|NCT02487199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230228|NCT02487199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6230229|NCT02487199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6230230|NCT02487199|Antiviral Agents|antiviral agents|mesh-ancestor
6230231|NCT02487199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6230232|NCT02487199|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6230233|NCT02487199|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6230234|NCT02487225|Pentoxifylline|pentoxifylline|mesh-list
6230235|NCT02487225|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6230236|NCT02487225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6230237|NCT02487225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230238|NCT02487225|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6230239|NCT02487225|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6230240|NCT02487225|Protective Agents|protective agents|mesh-ancestor
6230241|NCT02487225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230242|NCT02487225|Vasodilator Agents|vasodilator agents|mesh-ancestor
6230243|NCT02487225|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6230244|NCT02487225|Antioxidants|antioxidants|mesh-ancestor
6230245|NCT02487303|Acetaminophen|acetaminophen|mesh-list
6230246|NCT02487303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6230247|NCT02487303|Analgesics|analgesics|mesh-ancestor
6230248|NCT02487303|Sensory System Agents|sensory system agents|mesh-ancestor
6230249|NCT02487303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6230250|NCT02487303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230251|NCT02487303|Antipyretics|antipyretics|mesh-ancestor
6230252|NCT02487446|Glycopyrrolate|glycopyrrolate|mesh-list
6230253|NCT02487446|Bromides|bromides|mesh-list
6230254|NCT02487446|Anticonvulsants|anticonvulsants|mesh-ancestor
6230255|NCT02487446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230256|NCT02487446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6230257|NCT02487446|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6230258|NCT02487446|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6230259|NCT02487446|Cholinergic Agents|cholinergic agents|mesh-ancestor
6676607|NCT01582230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676608|NCT01582230|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6676609|NCT01582230|Protease Inhibitors|protease inhibitors|mesh-ancestor
6676610|NCT01582230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5918838|NCT04988217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5918839|NCT04988217|Antiviral Agents|antiviral agents|mesh-ancestor
5918840|NCT04988217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5918841|NCT04988217|Immunologic Factors|immunologic factors|mesh-ancestor
5918842|NCT04988217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918843|NCT04988191|Bevacizumab|bevacizumab|mesh-list
5707220|NCT03303677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5707221|NCT03303677|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5707222|NCT03303677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5707223|NCT03303677|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5707224|NCT03303677|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5707225|NCT03303677|Renal Agents|renal agents|mesh-ancestor
5707226|NCT03303677|Antimalarials|antimalarials|mesh-ancestor
5707227|NCT03303677|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5707228|NCT03303677|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5707229|NCT03303677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5707230|NCT03303677|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6230260|NCT02487446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6230261|NCT02487446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230262|NCT02487485|Sirolimus|sirolimus|mesh-list
6230263|NCT02487485|Ketamine|ketamine|mesh-list
6230264|NCT02487485|Analgesics|analgesics|mesh-ancestor
6230265|NCT02487485|Sensory System Agents|sensory system agents|mesh-ancestor
6230266|NCT02487485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5707231|NCT03303677|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
5918844|NCT04988191|Irinotecan|irinotecan|mesh-list
5918845|NCT04988191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6500453|NCT00645229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6230267|NCT02487485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230268|NCT02487485|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6230269|NCT02487485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6230270|NCT02487485|Anesthetics, General|anesthetics, general|mesh-ancestor
6230271|NCT02487485|Anesthetics|anesthetics|mesh-ancestor
6230272|NCT02487485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6500454|NCT00645229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6500455|NCT00645229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6500456|NCT00645229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6500457|NCT00645229|Dopamine Agents|dopamine agents|mesh-ancestor
6500458|NCT00645242|Fluconazole|fluconazole|mesh-list
6500459|NCT00645242|Antifungal Agents|antifungal agents|mesh-ancestor
6500460|NCT00645242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6230273|NCT02487485|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6230274|NCT02487485|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6230275|NCT02487485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6230276|NCT02487485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230277|NCT02487485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6230278|NCT02487485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6230279|NCT02487485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6500461|NCT00645242|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6500462|NCT00645242|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6500463|NCT00645242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6500464|NCT00645242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500465|NCT00645242|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6500466|NCT00645242|Hormone Antagonists|hormone antagonists|mesh-ancestor
6500467|NCT00645242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6500468|NCT00645242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6500469|NCT00645242|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6779669|NCT02180425|Adapalene|adapalene|mesh-list
6230280|NCT02487485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6230281|NCT02487485|Antifungal Agents|antifungal agents|mesh-ancestor
6230282|NCT02487485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6230283|NCT02487485|Immunologic Factors|immunologic factors|mesh-ancestor
6243731|NCT02679469|Sensory System Agents|sensory system agents|mesh-ancestor
6243732|NCT02679469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6243733|NCT02679573|Moxifloxacin|moxifloxacin|mesh-list
6243734|NCT02679573|Linezolid|linezolid|mesh-list
6243735|NCT02679573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6243736|NCT02679573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6243737|NCT02679573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6243738|NCT02679573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6243739|NCT02679573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6243740|NCT02679573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243741|NCT02679573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6243742|NCT02679573|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6243743|NCT02679755|Letrozole|letrozole|mesh-list
6243744|NCT02679755|Palbociclib|palbociclib|mesh-list
6243745|NCT02679755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6243746|NCT02679755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6243747|NCT02679755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5707232|NCT03303651|Analgesics, Opioid|analgesics, opioid|mesh-list
5707233|NCT03303651|Narcotics|narcotics|mesh-ancestor
5707234|NCT03303651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5707235|NCT03303651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707236|NCT03303651|Analgesics|analgesics|mesh-ancestor
5707237|NCT03303651|Sensory System Agents|sensory system agents|mesh-ancestor
5707238|NCT03303651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5707239|NCT03303573|Epoetin Alfa|epoetin alfa|mesh-list
5707240|NCT03303573|Hematinics|hematinics|mesh-ancestor
5707241|NCT03303495|Leucovorin|leucovorin|mesh-list
5707242|NCT03303495|Bevacizumab|bevacizumab|mesh-list
5707243|NCT03303495|Fluorouracil|fluorouracil|mesh-list
5707244|NCT03303495|Irinotecan|irinotecan|mesh-list
5707245|NCT03303495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5707246|NCT03303495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5707247|NCT03303495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5707248|NCT03303495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5707249|NCT03303495|Growth Substances|growth substances|mesh-ancestor
5707250|NCT03303495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707251|NCT03303495|Growth Inhibitors|growth inhibitors|mesh-ancestor
5707252|NCT03303495|Antimetabolites|antimetabolites|mesh-ancestor
5707253|NCT03303495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707254|NCT03303495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6230284|NCT02487498|Glycopyrrolate|glycopyrrolate|mesh-list
6230285|NCT02487498|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6230286|NCT02487498|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6230287|NCT02487498|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6230288|NCT02487498|Cholinergic Agents|cholinergic agents|mesh-ancestor
6230289|NCT02487498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6230290|NCT02487498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230291|NCT02487498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230292|NCT02487563|Decitabine|decitabine|mesh-list
6230293|NCT02487563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6230294|NCT02487563|Antimetabolites|antimetabolites|mesh-ancestor
6230295|NCT02487563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230296|NCT02487563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6230297|NCT02487563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6230298|NCT02488070|Edetic Acid|edetic acid|mesh-list
6230299|NCT02488070|Chelating Agents|chelating agents|mesh-ancestor
6230300|NCT02488070|Sequestering Agents|sequestering agents|mesh-ancestor
6230301|NCT02488070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230302|NCT02488070|Anticoagulants|anticoagulants|mesh-ancestor
6230303|NCT02488070|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6230304|NCT02488330|Bevacizumab|bevacizumab|mesh-list
6230305|NCT02488330|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6230306|NCT02488330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6230307|NCT02488330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6230308|NCT02488330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6230309|NCT02488330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6230310|NCT02488330|Growth Substances|growth substances|mesh-ancestor
6230311|NCT02488330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230312|NCT02488330|Growth Inhibitors|growth inhibitors|mesh-ancestor
6230313|NCT02488330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6230314|NCT02488330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6230315|NCT02488330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230316|NCT02488980|Mefloquine|mefloquine|mesh-list
6230317|NCT02488980|Tafenoquine|tafenoquine|mesh-list
6230318|NCT02488980|Antimalarials|antimalarials|mesh-ancestor
6230319|NCT02488980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6230320|NCT02488980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6230321|NCT02488980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6230322|NCT02489227|Adalimumab|adalimumab|mesh-list
6230323|NCT02489227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6230324|NCT02489227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6230325|NCT02489357|Pembrolizumab|pembrolizumab|mesh-list
6230326|NCT02489357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6230327|NCT02489357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6230328|NCT02489500|Bortezomib|bortezomib|mesh-list
6230329|NCT02489500|Melphalan|melphalan|mesh-list
6230330|NCT02489500|Sargramostim|sargramostim|mesh-list
6230331|NCT02489500|Lenograstim|lenograstim|mesh-list
6500470|NCT00645242|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6500471|NCT00645255|Sibutramine|sibutramine|mesh-list
6500472|NCT00645255|Antidepressive Agents|antidepressive agents|mesh-ancestor
6500473|NCT00645255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6500474|NCT00645255|Appetite Depressants|appetite depressants|mesh-ancestor
6500475|NCT00645255|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6500476|NCT00645268|Sildenafil Citrate|sildenafil citrate|mesh-list
6500477|NCT00645268|Vasodilator Agents|vasodilator agents|mesh-ancestor
6500478|NCT00645268|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6500479|NCT00645268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6500480|NCT00645268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6500481|NCT00645268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500482|NCT00645268|Urological Agents|urological agents|mesh-ancestor
6230332|NCT02489500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6230333|NCT02489500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5707255|NCT03303495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5707256|NCT03303495|Immunologic Factors|immunologic factors|mesh-ancestor
5707257|NCT03303495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5707258|NCT03303495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6230334|NCT02489500|Alkylating Agents|alkylating agents|mesh-ancestor
6230335|NCT02489500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230336|NCT02489500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6230337|NCT02489500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6230338|NCT02489500|Immunologic Factors|immunologic factors|mesh-ancestor
6230339|NCT02489500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230340|NCT02489500|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6230341|NCT02489630|Ketamine|ketamine|mesh-list
6230342|NCT02489630|Analgesics|analgesics|mesh-list
6230343|NCT02489630|Sensory System Agents|sensory system agents|mesh-ancestor
6230344|NCT02489630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6230345|NCT02489630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230346|NCT02489630|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6230347|NCT02489630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6230348|NCT02489630|Anesthetics, General|anesthetics, general|mesh-ancestor
6230349|NCT02489630|Anesthetics|anesthetics|mesh-ancestor
6230350|NCT02489630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6230351|NCT02489630|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6230352|NCT02489630|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6230353|NCT02489630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6500483|NCT00645281|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6500484|NCT00645281|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6500485|NCT00645281|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6500486|NCT00645281|Cholinergic Agents|cholinergic agents|mesh-ancestor
6500487|NCT00645281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6500488|NCT00645281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500489|NCT00645281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6500490|NCT00645281|Urological Agents|urological agents|mesh-ancestor
6230354|NCT02489630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230355|NCT02489734|Sevoflurane|sevoflurane|mesh-list
6230356|NCT02489734|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6230357|NCT02489734|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6230358|NCT02489734|Anesthetics, General|anesthetics, general|mesh-ancestor
6230359|NCT02489734|Anesthetics|anesthetics|mesh-ancestor
6230360|NCT02489734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6230361|NCT02489734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230362|NCT02489968|Empagliflozin|empagliflozin|mesh-list
5707259|NCT03303495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5707260|NCT03303495|Antidotes|antidotes|mesh-ancestor
5707261|NCT03303495|Protective Agents|protective agents|mesh-ancestor
5707262|NCT03303495|Vitamin B Complex|vitamin b complex|mesh-ancestor
5707263|NCT03303495|Vitamins|vitamins|mesh-ancestor
5707264|NCT03303495|Micronutrients|micronutrients|mesh-ancestor
5707265|NCT03303378|Melatonin|melatonin|mesh-list
5707266|NCT03303378|Antioxidants|antioxidants|mesh-ancestor
5707267|NCT03303378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707268|NCT03303378|Protective Agents|protective agents|mesh-ancestor
5707269|NCT03303378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707270|NCT03303378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6230363|NCT02489968|Linagliptin|linagliptin|mesh-list
6230364|NCT02489968|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6230365|NCT02489968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230366|NCT02489968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6230367|NCT02489968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230368|NCT02489968|Incretins|incretins|mesh-ancestor
6230369|NCT02489968|Hormones|hormones|mesh-ancestor
6230370|NCT02489968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6230371|NCT02489968|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6230372|NCT02489968|Protease Inhibitors|protease inhibitors|mesh-ancestor
6230373|NCT02489968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6230374|NCT02489981|Tiotropium Bromide|tiotropium bromide|mesh-list
6230375|NCT02489981|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6230376|NCT02489981|Autonomic Agents|autonomic agents|mesh-ancestor
6230377|NCT02489981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6230378|NCT02489981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230379|NCT02489981|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6230380|NCT02489981|Respiratory System Agents|respiratory system agents|mesh-ancestor
6500491|NCT00645294|Adefovir|adefovir|mesh-list
6500492|NCT00645294|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
5707271|NCT03303235|Methylergonovine|methylergonovine|mesh-list
5707272|NCT03303235|Oxytocics|oxytocics|mesh-ancestor
6230381|NCT02489981|Parasympatholytics|parasympatholytics|mesh-ancestor
6230382|NCT02489981|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6230383|NCT02489981|Cholinergic Agents|cholinergic agents|mesh-ancestor
6230384|NCT02489981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6230385|NCT02489981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230386|NCT02490293|Cephalosporins|cephalosporins|mesh-list
6230387|NCT02490293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6230388|NCT02490293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6230389|NCT02490475|Docetaxel|docetaxel|mesh-list
6230390|NCT02490475|Pertuzumab|pertuzumab|mesh-list
6230391|NCT02490475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6230392|NCT02490475|Tubulin Modulators|tubulin modulators|mesh-ancestor
6230393|NCT02490475|Antimitotic Agents|antimitotic agents|mesh-ancestor
6230394|NCT02490475|Mitosis Modulators|mitosis modulators|mesh-ancestor
6230395|NCT02490475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230396|NCT02490475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6230397|NCT02490631|Chlorhexidine|chlorhexidine|mesh-list
6230398|NCT02490631|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6230399|NCT02490631|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6230400|NCT02490631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6230401|NCT02490631|Disinfectants|disinfectants|mesh-ancestor
6230402|NCT02490631|Dermatologic Agents|dermatologic agents|mesh-ancestor
6230403|NCT02490670|Cephalexin|cephalexin|mesh-list
6230404|NCT02490670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6230405|NCT02490670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6230406|NCT02490878|Bevacizumab|bevacizumab|mesh-list
6230407|NCT02490878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6230408|NCT02490878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6230409|NCT02490878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6230410|NCT02490878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6230411|NCT02490878|Growth Substances|growth substances|mesh-ancestor
6230412|NCT02490878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676611|NCT01582230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676612|NCT01582321|Cantharidin|cantharidin|mesh-list
6676613|NCT01582321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6676614|NCT01582321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676615|NCT01582412|Isavuconazole|isavuconazole|mesh-list
6676616|NCT01582412|Digoxin|digoxin|mesh-list
6676617|NCT01582412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6676618|NCT01582412|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6676619|NCT01582412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6230413|NCT02490878|Growth Inhibitors|growth inhibitors|mesh-ancestor
6230414|NCT02491437|Progesterone|progesterone|mesh-list
6230415|NCT02491437|Dydrogesterone|dydrogesterone|mesh-list
6230416|NCT02491437|Progestins|progestins|mesh-ancestor
6230417|NCT02491437|Hormones|hormones|mesh-ancestor
6230418|NCT02491437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5707273|NCT03303235|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5707274|NCT03303235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707275|NCT03303209|Analgesics, Opioid|analgesics, opioid|mesh-list
5707276|NCT03303209|Narcotics|narcotics|mesh-ancestor
5707277|NCT03303209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5707278|NCT03303209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707279|NCT03303209|Analgesics|analgesics|mesh-ancestor
5707280|NCT03303209|Sensory System Agents|sensory system agents|mesh-ancestor
5707281|NCT03303209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5707282|NCT03303053|Prednisolone|prednisolone|mesh-list
5707283|NCT03303053|Cholestyramine Resin|cholestyramine resin|mesh-list
5707284|NCT03303053|Carbimazole|carbimazole|mesh-list
5707285|NCT03303053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5707286|NCT03303053|Glucocorticoids|glucocorticoids|mesh-ancestor
5707287|NCT03303053|Hormones|hormones|mesh-ancestor
5707288|NCT03303053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5707289|NCT03303053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707290|NCT03303053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5707291|NCT03303053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5707292|NCT03303053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5707293|NCT03303053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5707294|NCT03303053|Antimetabolites|antimetabolites|mesh-ancestor
5707295|NCT03303053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707296|NCT03303053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5707297|NCT03303053|Antithyroid Agents|antithyroid agents|mesh-ancestor
5707298|NCT03303053|Hormone Antagonists|hormone antagonists|mesh-ancestor
5707299|NCT03302871|Botulinum Toxins|botulinum toxins|mesh-list
6230419|NCT02491437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230420|NCT02491463|Vaccines|vaccines|mesh-list
6230421|NCT02491463|Immunologic Factors|immunologic factors|mesh-ancestor
6230422|NCT02491463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230423|NCT02491684|Interferons|interferons|mesh-list
6230424|NCT02491684|Interferon-beta|interferon-beta|mesh-list
6230425|NCT02491684|Interferon beta-1a|interferon beta-1a|mesh-list
6230426|NCT02491684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6230427|NCT02491684|Antiviral Agents|antiviral agents|mesh-ancestor
6230428|NCT02491684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6230429|NCT02491684|Immunologic Factors|immunologic factors|mesh-ancestor
6230430|NCT02491684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230431|NCT02491684|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6230432|NCT02491788|Suvorexant|suvorexant|mesh-list
6230433|NCT02491788|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6230434|NCT02491788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6230435|NCT02491788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6230436|NCT02491788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230437|NCT02491788|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
6230438|NCT02491788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6230439|NCT02491788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230440|NCT02491892|Pertuzumab|pertuzumab|mesh-list
6230441|NCT02491892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5707300|NCT03302871|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5707301|NCT03302871|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5707302|NCT03302871|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5707303|NCT03302871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5707304|NCT03302871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707305|NCT03302871|Cholinergic Agents|cholinergic agents|mesh-ancestor
5707306|NCT03302871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5707307|NCT03302871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707308|NCT03302871|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5707309|NCT03302871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5707310|NCT03302845|Omeprazole|omeprazole|mesh-list
5707311|NCT03302845|Famotidine|famotidine|mesh-list
5707312|NCT03302845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5707313|NCT03302845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5707314|NCT03302845|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5707315|NCT03302845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5707316|NCT03302845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707317|NCT03302845|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5707318|NCT03302845|Histamine Antagonists|histamine antagonists|mesh-ancestor
5707319|NCT03302845|Histamine Agents|histamine agents|mesh-ancestor
5707320|NCT03302845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5707321|NCT03302845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707322|NCT03302754|Alemtuzumab|alemtuzumab|mesh-list
5707323|NCT03302754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5707324|NCT03302754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5707325|NCT03302728|Lenalidomide|lenalidomide|mesh-list
5707326|NCT03302728|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5707327|NCT03302728|Immunologic Factors|immunologic factors|mesh-ancestor
5707328|NCT03302728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230442|NCT02491892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6230443|NCT02491944|Osimertinib|osimertinib|mesh-list
6230444|NCT02491944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6230445|NCT02491944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6230446|NCT02491944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5707329|NCT03302728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5707330|NCT03302728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5707331|NCT03302728|Growth Substances|growth substances|mesh-ancestor
5707332|NCT03302728|Growth Inhibitors|growth inhibitors|mesh-ancestor
5707333|NCT03302728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5707334|NCT03302728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5707335|NCT03302689|Ropivacaine|ropivacaine|mesh-list
5707336|NCT03302689|Levobupivacaine|levobupivacaine|mesh-list
5707337|NCT03302689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6230447|NCT02491944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230448|NCT02492165|Vaccines|vaccines|mesh-list
6230449|NCT02492165|Immunologic Factors|immunologic factors|mesh-ancestor
6230450|NCT02492165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230451|NCT02492451|Progesterone|progesterone|mesh-list
6230452|NCT02492451|Progestins|progestins|mesh-ancestor
6230453|NCT02492451|Hormones|hormones|mesh-ancestor
6230454|NCT02492451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5707338|NCT03302689|Anesthetics, Local|anesthetics, local|mesh-ancestor
5707339|NCT03302689|Anesthetics|anesthetics|mesh-ancestor
5707340|NCT03302689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6230455|NCT02492451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230456|NCT02492750|Dexamethasone|dexamethasone|mesh-list
6230457|NCT02492750|Dexamethasone acetate|dexamethasone acetate|mesh-list
5707341|NCT03302689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707342|NCT03302689|Sensory System Agents|sensory system agents|mesh-ancestor
5707343|NCT03302689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5707344|NCT03302650|Norepinephrine|norepinephrine|mesh-list
5707345|NCT03302650|Angiotensin II|angiotensin ii|mesh-list
5707346|NCT03302650|Giapreza|giapreza|mesh-list
5707347|NCT03302650|Angiotensinogen|angiotensinogen|mesh-list
5707348|NCT03302650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5707349|NCT03302650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5707350|NCT03302650|Adrenergic Agents|adrenergic agents|mesh-ancestor
5707351|NCT03302650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5707352|NCT03302650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230458|NCT02492750|Lenalidomide|lenalidomide|mesh-list
6230459|NCT02492750|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6230460|NCT02492750|Ichthammol|ichthammol|mesh-list
6230461|NCT02492750|BB 1101|bb 1101|mesh-list
6230462|NCT02492750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6230463|NCT02492750|Antiemetics|antiemetics|mesh-ancestor
6230464|NCT02492750|Autonomic Agents|autonomic agents|mesh-ancestor
6230465|NCT02492750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6230466|NCT02492750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230467|NCT02492750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6230468|NCT02492750|Glucocorticoids|glucocorticoids|mesh-ancestor
6230469|NCT02492750|Hormones|hormones|mesh-ancestor
6230470|NCT02492750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6230471|NCT02492750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6230472|NCT02492750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5707353|NCT03302650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707354|NCT03302650|Sympathomimetics|sympathomimetics|mesh-ancestor
5707355|NCT03302650|Autonomic Agents|autonomic agents|mesh-ancestor
5707356|NCT03302650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5707357|NCT03302650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5707358|NCT03302650|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5707359|NCT03302650|Protease Inhibitors|protease inhibitors|mesh-ancestor
5707360|NCT03302650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5707361|NCT03302585|Vitamin D|vitamin d|mesh-list
5707362|NCT03302585|Ergocalciferols|ergocalciferols|mesh-list
5707363|NCT03302585|Cholecalciferol|cholecalciferol|mesh-list
5707364|NCT03302585|Vitamins|vitamins|mesh-list
5707365|NCT03302585|Micronutrients|micronutrients|mesh-ancestor
5707366|NCT03302585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707367|NCT03302585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5707368|NCT03302585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5707369|NCT03302403|Cyclophosphamide|cyclophosphamide|mesh-list
5707370|NCT03302403|Fludarabine|fludarabine|mesh-list
5707371|NCT03302403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5707372|NCT03302403|Immunologic Factors|immunologic factors|mesh-ancestor
5707373|NCT03302403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707374|NCT03302403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5707375|NCT03302403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5707376|NCT03302403|Alkylating Agents|alkylating agents|mesh-ancestor
5707377|NCT03302403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707378|NCT03302403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5707379|NCT03302403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5707380|NCT03302390|Lidocaine|lidocaine|mesh-list
5707381|NCT03302390|Epinephrine|epinephrine|mesh-list
5707382|NCT03302390|Anesthetics, Local|anesthetics, local|mesh-ancestor
5707383|NCT03302390|Anesthetics|anesthetics|mesh-ancestor
5707384|NCT03302390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5707385|NCT03302390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707386|NCT03302390|Sensory System Agents|sensory system agents|mesh-ancestor
5707387|NCT03302390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5707388|NCT03302390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5707389|NCT03302390|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5707390|NCT03302390|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5707391|NCT03302390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5707392|NCT03302390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707393|NCT03302390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5707394|NCT03302390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5707395|NCT03302390|Adrenergic Agents|adrenergic agents|mesh-ancestor
5707396|NCT03302390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6230473|NCT02492750|Immunologic Factors|immunologic factors|mesh-ancestor
6230474|NCT02492750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6230475|NCT02492750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6230476|NCT02492750|Growth Substances|growth substances|mesh-ancestor
6230477|NCT02492750|Growth Inhibitors|growth inhibitors|mesh-ancestor
6230478|NCT02492750|Protease Inhibitors|protease inhibitors|mesh-ancestor
6230479|NCT02492750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6230480|NCT02492750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230481|NCT02492750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6230482|NCT02492750|Dermatologic Agents|dermatologic agents|mesh-ancestor
6230483|NCT02492763|Metformin|metformin|mesh-list
6230484|NCT02492763|Liraglutide|liraglutide|mesh-list
6230485|NCT02492763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6230486|NCT02492763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230487|NCT02492763|Incretins|incretins|mesh-ancestor
6230488|NCT02492763|Hormones|hormones|mesh-ancestor
6230489|NCT02492763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6230490|NCT02492802|Posaconazole|posaconazole|mesh-list
6230491|NCT02492802|Antifungal Agents|antifungal agents|mesh-ancestor
6230492|NCT02492802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6230493|NCT02492802|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6230494|NCT02492802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6230495|NCT02492802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6230496|NCT02492802|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6230497|NCT02492802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6230498|NCT02492802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6230499|NCT02492802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230500|NCT02492802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6230501|NCT02492802|Hormone Antagonists|hormone antagonists|mesh-ancestor
6230502|NCT02492802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6230503|NCT02492802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230504|NCT02492841|Calcium, Dietary|calcium, dietary|mesh-list
6230505|NCT02492841|Calcium|calcium|mesh-list
6230506|NCT02492841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6230507|NCT02492841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230508|NCT02492841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6230509|NCT02492984|Factor VIII|factor viii|mesh-list
6230510|NCT02492984|Coagulants|coagulants|mesh-ancestor
6230511|NCT02492997|Glycerol|glycerol|mesh-list
5707397|NCT03302390|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5707398|NCT03302390|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5707399|NCT03302390|Autonomic Agents|autonomic agents|mesh-ancestor
5707400|NCT03302390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5707401|NCT03302390|Respiratory System Agents|respiratory system agents|mesh-ancestor
5707402|NCT03302390|Mydriatics|mydriatics|mesh-ancestor
5707403|NCT03302390|Sympathomimetics|sympathomimetics|mesh-ancestor
5707404|NCT03302390|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5707405|NCT03302364|Risperidone|risperidone|mesh-list
5707406|NCT03302364|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5707407|NCT03302364|Serotonin Agents|serotonin agents|mesh-ancestor
5707408|NCT03302364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6230512|NCT02492997|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6230513|NCT02492997|Protective Agents|protective agents|mesh-ancestor
6230514|NCT02492997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230515|NCT02493257|Ethanol|ethanol|mesh-list
6230516|NCT02493257|Capsaicin|capsaicin|mesh-list
6230517|NCT02493257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6230518|NCT02493257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6230519|NCT02493257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6230520|NCT02493257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230521|NCT02493257|Antipruritics|antipruritics|mesh-ancestor
6230522|NCT02493257|Dermatologic Agents|dermatologic agents|mesh-ancestor
6230523|NCT02493257|Sensory System Agents|sensory system agents|mesh-ancestor
6230524|NCT02493257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6230525|NCT02493361|Pembrolizumab|pembrolizumab|mesh-list
6230526|NCT02493361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6230527|NCT02493361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6676620|NCT01582412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676621|NCT01582412|Protective Agents|protective agents|mesh-ancestor
6676622|NCT01582412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676623|NCT01582412|Antifungal Agents|antifungal agents|mesh-ancestor
6676624|NCT01582412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6676625|NCT01582425|Isavuconazole|isavuconazole|mesh-list
5722318|NCT03199976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918846|NCT04988191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5918847|NCT04988191|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6230528|NCT02493452|Plecanatide|plecanatide|mesh-list
6676626|NCT01582425|Methadone|methadone|mesh-list
6230529|NCT02493452|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
6230530|NCT02493452|Enzyme Activators|enzyme activators|mesh-ancestor
6230531|NCT02493452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230532|NCT02493452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6230533|NCT02493517|Lanreotide|lanreotide|mesh-list
6230534|NCT02493517|Somatostatin|somatostatin|mesh-list
6230535|NCT02493517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6230536|NCT02493517|Hormones|hormones|mesh-ancestor
6230537|NCT02493517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6230538|NCT02493517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230539|NCT02493712|Mesalamine|mesalamine|mesh-list
6230540|NCT02493712|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6230541|NCT02493712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6230542|NCT02493712|Analgesics|analgesics|mesh-ancestor
6230543|NCT02493712|Sensory System Agents|sensory system agents|mesh-ancestor
6230544|NCT02493712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6230545|NCT02493712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230546|NCT02493712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5707409|NCT03302364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707410|NCT03302364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707411|NCT03302364|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5707412|NCT03302364|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5707413|NCT03302364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5707414|NCT03302364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5707415|NCT03302364|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5707416|NCT03302364|Dopamine Agents|dopamine agents|mesh-ancestor
5707417|NCT03302351|Dexmedetomidine|dexmedetomidine|mesh-list
5707418|NCT03302351|Ketamine|ketamine|mesh-list
5707419|NCT03302351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5707420|NCT03302351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5707421|NCT03302351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707422|NCT03302351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5707423|NCT03302351|Analgesics|analgesics|mesh-ancestor
5707424|NCT03302351|Sensory System Agents|sensory system agents|mesh-ancestor
5707425|NCT03302351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5707426|NCT03302351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5707427|NCT03302351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5707428|NCT03302351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5707429|NCT03302351|Adrenergic Agents|adrenergic agents|mesh-ancestor
5707430|NCT03302351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5707431|NCT03302351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230547|NCT02493712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6230548|NCT02493764|Tazobactam|tazobactam|mesh-list
6230549|NCT02493764|Linezolid|linezolid|mesh-list
6230550|NCT02493764|Piperacillin|piperacillin|mesh-list
6230551|NCT02493764|Imipenem|imipenem|mesh-list
6230552|NCT02493764|Relebactam|relebactam|mesh-list
6230553|NCT02493764|Cilastatin|cilastatin|mesh-list
6230554|NCT02493764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6230555|NCT02493764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6230556|NCT02493764|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6230557|NCT02493764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6230558|NCT02493764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676627|NCT01582425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6676628|NCT01582425|Narcotics|narcotics|mesh-ancestor
6676629|NCT01582425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6676630|NCT01582425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676631|NCT01582425|Analgesics|analgesics|mesh-ancestor
6676632|NCT01582425|Sensory System Agents|sensory system agents|mesh-ancestor
6676633|NCT01582425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6676634|NCT01582425|Antitussive Agents|antitussive agents|mesh-ancestor
5707432|NCT03302351|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5707433|NCT03302351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5707434|NCT03302351|Anesthetics, General|anesthetics, general|mesh-ancestor
5707435|NCT03302351|Anesthetics|anesthetics|mesh-ancestor
5707436|NCT03302351|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5707437|NCT03302351|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5707438|NCT03302299|Pyridoxine|pyridoxine|mesh-list
5918848|NCT04988191|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5918849|NCT04988191|Growth Substances|growth substances|mesh-ancestor
5918850|NCT04988191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918851|NCT04988191|Growth Inhibitors|growth inhibitors|mesh-ancestor
5918852|NCT04988191|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6230559|NCT02493764|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6230560|NCT02493764|Protease Inhibitors|protease inhibitors|mesh-ancestor
5707439|NCT03302299|Vitamin B 6|vitamin b 6|mesh-list
5707440|NCT03302299|Isoniazid|isoniazid|mesh-list
5707441|NCT03302299|Vitamins|vitamins|mesh-ancestor
5707442|NCT03302299|Micronutrients|micronutrients|mesh-ancestor
5707443|NCT03302299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230561|NCT02493777|Methylphenidate|methylphenidate|mesh-list
6230562|NCT02493777|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6230563|NCT02493777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676635|NCT01582425|Respiratory System Agents|respiratory system agents|mesh-ancestor
6676636|NCT01582425|Antifungal Agents|antifungal agents|mesh-ancestor
6676637|NCT01582425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6676638|NCT01582438|Sildenafil Citrate|sildenafil citrate|mesh-list
6676639|NCT01582438|Citric Acid|citric acid|mesh-list
6676640|NCT01582438|Sodium Citrate|sodium citrate|mesh-list
6676641|NCT01582438|Anticoagulants|anticoagulants|mesh-ancestor
6230564|NCT02493777|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6230565|NCT02493777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6230566|NCT02493777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6230567|NCT02493777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230568|NCT02493777|Dopamine Agents|dopamine agents|mesh-ancestor
6230569|NCT02493777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6230570|NCT02493855|Ritonavir|ritonavir|mesh-list
6230571|NCT02493855|Ribavirin|ribavirin|mesh-list
6230572|NCT02493855|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6230573|NCT02493855|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6230574|NCT02493855|Protease Inhibitors|protease inhibitors|mesh-ancestor
6230575|NCT02493855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6230576|NCT02493855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230577|NCT02493855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6230578|NCT02493855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6230579|NCT02493855|Antiviral Agents|antiviral agents|mesh-ancestor
6230580|NCT02493855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6230581|NCT02493855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6230582|NCT02493855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6230583|NCT02493855|Antimetabolites|antimetabolites|mesh-ancestor
6230584|NCT02493868|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6230585|NCT02493868|Citalopram|citalopram|mesh-list
6230586|NCT02493868|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6230587|NCT02493868|Sertraline|sertraline|mesh-list
6230588|NCT02493868|Antidepressive Agents|antidepressive agents|mesh-list
6230589|NCT02493868|Esketamine|esketamine|mesh-list
6230590|NCT02493868|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6230591|NCT02493868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6230592|NCT02493868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6230593|NCT02493868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230594|NCT02493868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6230595|NCT02493868|Serotonin Agents|serotonin agents|mesh-ancestor
6230596|NCT02493868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230597|NCT02493868|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6230598|NCT02493868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6230599|NCT02493868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6230600|NCT02493868|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6230601|NCT02493868|Analgesics|analgesics|mesh-ancestor
6230602|NCT02493868|Sensory System Agents|sensory system agents|mesh-ancestor
6230603|NCT02493868|Dopamine Agents|dopamine agents|mesh-ancestor
6230604|NCT02493946|Botulinum Toxins|botulinum toxins|mesh-list
6230605|NCT02493946|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6230606|NCT02493946|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6230607|NCT02493946|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6230608|NCT02493946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6230609|NCT02493946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230610|NCT02493946|Cholinergic Agents|cholinergic agents|mesh-ancestor
6230611|NCT02493946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6230612|NCT02493946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230613|NCT02493946|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6230614|NCT02493946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6230615|NCT02494102|Modafinil|modafinil|mesh-list
6230616|NCT02494102|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6230617|NCT02494102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676642|NCT01582438|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5707444|NCT03302299|Vitamin B Complex|vitamin b complex|mesh-ancestor
5707445|NCT03302299|Antitubercular Agents|antitubercular agents|mesh-ancestor
5707446|NCT03302299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5707447|NCT03302299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6230618|NCT02494102|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6230619|NCT02494102|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6230620|NCT02494102|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5707448|NCT03302299|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5707449|NCT03302299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5707450|NCT03302299|Antimetabolites|antimetabolites|mesh-ancestor
5707451|NCT03302299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707452|NCT03302299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5707453|NCT03302221|Ropivacaine|ropivacaine|mesh-list
5707454|NCT03302221|Anesthetics|anesthetics|mesh-ancestor
5707455|NCT03302221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5707456|NCT03302221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707457|NCT03302221|Anesthetics, Local|anesthetics, local|mesh-ancestor
5707458|NCT03302221|Sensory System Agents|sensory system agents|mesh-ancestor
5707459|NCT03302221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5707460|NCT03302208|Pregabalin|pregabalin|mesh-list
5707461|NCT03302208|Analgesics|analgesics|mesh-ancestor
5707462|NCT03302208|Sensory System Agents|sensory system agents|mesh-ancestor
5707463|NCT03302208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6230621|NCT02494102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230622|NCT02494180|Fentanyl|fentanyl|mesh-list
6230623|NCT02494180|Midazolam|midazolam|mesh-list
6230624|NCT02494180|Diazepam|diazepam|mesh-list
6230625|NCT02494180|Meperidine|meperidine|mesh-list
6230626|NCT02494180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6230627|NCT02494180|Narcotics|narcotics|mesh-ancestor
6230628|NCT02494180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6230629|NCT02494180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230630|NCT02494180|Analgesics|analgesics|mesh-ancestor
6230631|NCT02494180|Sensory System Agents|sensory system agents|mesh-ancestor
6230632|NCT02494180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6230633|NCT02494180|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6230634|NCT02494180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6230635|NCT02494180|Anesthetics, General|anesthetics, general|mesh-ancestor
6230636|NCT02494180|Anesthetics|anesthetics|mesh-ancestor
6230637|NCT02494180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6230638|NCT02494180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5707464|NCT03302208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707465|NCT03302208|Anticonvulsants|anticonvulsants|mesh-ancestor
5707466|NCT03302208|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5707467|NCT03302208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5707468|NCT03302208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707469|NCT03302208|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5707470|NCT03302208|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6230639|NCT02494180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6230640|NCT02494180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6230641|NCT02494180|GABA Modulators|gaba modulators|mesh-ancestor
6230642|NCT02494180|GABA Agents|gaba agents|mesh-ancestor
6230643|NCT02494180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6230644|NCT02494180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230645|NCT02494180|Anticonvulsants|anticonvulsants|mesh-ancestor
6230646|NCT02494180|Antiemetics|antiemetics|mesh-ancestor
6230647|NCT02494180|Autonomic Agents|autonomic agents|mesh-ancestor
6230648|NCT02494180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6230649|NCT02494180|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6230650|NCT02494180|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6230651|NCT02494336|Ropivacaine|ropivacaine|mesh-list
6230652|NCT02494336|Anesthetics, Local|anesthetics, local|mesh-ancestor
6230653|NCT02494336|Anesthetics|anesthetics|mesh-ancestor
6230654|NCT02494336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6230655|NCT02494336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230656|NCT02494336|Sensory System Agents|sensory system agents|mesh-ancestor
6230657|NCT02494336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6230658|NCT02494583|Pembrolizumab|pembrolizumab|mesh-list
6230659|NCT02494583|Capecitabine|capecitabine|mesh-list
6230660|NCT02494583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6230661|NCT02494583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6230662|NCT02494583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6230663|NCT02494583|Antimetabolites|antimetabolites|mesh-ancestor
6230664|NCT02494583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230665|NCT02494596|Capecitabine|capecitabine|mesh-list
6230666|NCT02494596|Pertuzumab|pertuzumab|mesh-list
6230667|NCT02494596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6230668|NCT02494596|Antimetabolites|antimetabolites|mesh-ancestor
6230669|NCT02494596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707471|NCT03302208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5707472|NCT03302208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5707473|NCT03302208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5721371|NCT03206346|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
5721372|NCT03206346|Antiviral Agents|antiviral agents|mesh-ancestor
5721373|NCT03206346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5721374|NCT03206138|Imiquimod|imiquimod|mesh-list
5721375|NCT03206138|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5721376|NCT03206138|Immunologic Factors|immunologic factors|mesh-ancestor
5721377|NCT03206138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721378|NCT03206138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5721379|NCT03206138|Interferon Inducers|interferon inducers|mesh-ancestor
5721380|NCT03206177|Paclitaxel|paclitaxel|mesh-list
5721381|NCT03206177|Carboplatin|carboplatin|mesh-list
5721382|NCT03206177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5721383|NCT03206177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5721384|NCT03206177|Tubulin Modulators|tubulin modulators|mesh-ancestor
5721385|NCT03206177|Antimitotic Agents|antimitotic agents|mesh-ancestor
5721386|NCT03206177|Mitosis Modulators|mitosis modulators|mesh-ancestor
5721387|NCT03206177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721388|NCT03206255|Vaccines|vaccines|mesh-list
5721389|NCT03206255|Immunologic Factors|immunologic factors|mesh-ancestor
5721390|NCT03206255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721391|NCT03206411|Hormones|hormones|mesh-list
6230670|NCT02494596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6230671|NCT02494596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6230672|NCT02494713|Ketoconazole|ketoconazole|mesh-list
6230673|NCT02494713|Docetaxel|docetaxel|mesh-list
6230674|NCT02494713|Doxorubicin|doxorubicin|mesh-list
6230675|NCT02494713|Estramustine|estramustine|mesh-list
6230676|NCT02494713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6230677|NCT02494713|Tubulin Modulators|tubulin modulators|mesh-ancestor
6230678|NCT02494713|Antimitotic Agents|antimitotic agents|mesh-ancestor
6230679|NCT02494713|Mitosis Modulators|mitosis modulators|mesh-ancestor
6230680|NCT02494713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230681|NCT02494713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6230682|NCT02494713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6230683|NCT02494713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6230684|NCT02494713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6230685|NCT02494713|Antifungal Agents|antifungal agents|mesh-ancestor
6230686|NCT02494713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6230687|NCT02494713|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6230688|NCT02494713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6243748|NCT02679755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5721392|NCT03206411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5721393|NCT03206411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721394|NCT03206203|Carboplatin|carboplatin|mesh-list
5721395|NCT03206203|Atezolizumab|atezolizumab|mesh-list
5721396|NCT03206203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5721397|NCT03206320|Lidocaine|lidocaine|mesh-list
5721398|NCT03206320|Anesthetics, Local|anesthetics, local|mesh-ancestor
5721399|NCT03206320|Anesthetics|anesthetics|mesh-ancestor
5721400|NCT03206320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5721401|NCT03206320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918853|NCT04988191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5918854|NCT04988191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5918855|NCT04988191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918856|NCT04988048|Vaccines|vaccines|mesh-list
5918857|NCT04988048|Immunologic Factors|immunologic factors|mesh-ancestor
5721402|NCT03206320|Sensory System Agents|sensory system agents|mesh-ancestor
5721403|NCT03206320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5721404|NCT03206320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5721405|NCT03206320|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5721406|NCT03206320|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5721407|NCT03206320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5721408|NCT03206320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721409|NCT03206021|Carboplatin|carboplatin|mesh-list
5721410|NCT03206021|Azacitidine|azacitidine|mesh-list
5918858|NCT04988048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918859|NCT04988256|Cyclosporine|cyclosporine|mesh-list
5918860|NCT04988256|Prednisone|prednisone|mesh-list
5918861|NCT04988256|Methylprednisolone|methylprednisolone|mesh-list
5918862|NCT04988256|Cyclosporins|cyclosporins|mesh-list
5918863|NCT04988256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5918864|NCT04988256|Glucocorticoids|glucocorticoids|mesh-ancestor
5918865|NCT04988256|Hormones|hormones|mesh-ancestor
5918866|NCT04988256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6230689|NCT02494713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6230690|NCT02494713|Hormone Antagonists|hormone antagonists|mesh-ancestor
6230691|NCT02494713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6230692|NCT02494713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230693|NCT02494713|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6230694|NCT02494713|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6230695|NCT02494713|Alkylating Agents|alkylating agents|mesh-ancestor
6230696|NCT02494713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6230697|NCT02495038|Rocuronium|rocuronium|mesh-list
6230698|NCT02495038|Atracurium|atracurium|mesh-list
6230699|NCT02495038|Cisatracurium|cisatracurium|mesh-list
6230700|NCT02495038|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6230701|NCT02495038|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6230702|NCT02495038|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5707474|NCT03302195|Heparin|heparin|mesh-list
5707475|NCT03302195|Anticoagulants|anticoagulants|mesh-ancestor
5707476|NCT03302195|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5707477|NCT03302195|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5707478|NCT03302195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707479|NCT03302182|Ritonavir|ritonavir|mesh-list
5707480|NCT03302182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5707481|NCT03302182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5707482|NCT03302182|Protease Inhibitors|protease inhibitors|mesh-ancestor
5707483|NCT03302182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5707484|NCT03302182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707485|NCT03302182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5707486|NCT03302182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5707487|NCT03302182|Antiviral Agents|antiviral agents|mesh-ancestor
5707488|NCT03302182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5707489|NCT03302182|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5707490|NCT03302182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5707491|NCT03302065|Tiotropium Bromide|tiotropium bromide|mesh-list
5707492|NCT03302065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5707493|NCT03302065|Autonomic Agents|autonomic agents|mesh-ancestor
5707494|NCT03302065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5707495|NCT03302065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707496|NCT03302065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5707497|NCT03302065|Respiratory System Agents|respiratory system agents|mesh-ancestor
5707498|NCT03302065|Parasympatholytics|parasympatholytics|mesh-ancestor
5707499|NCT03302065|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5707500|NCT03302065|Cholinergic Agents|cholinergic agents|mesh-ancestor
5707501|NCT03302065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5707502|NCT03302065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707503|NCT03302039|Phenylephrine|phenylephrine|mesh-list
5707504|NCT03302039|Oxymetazoline|oxymetazoline|mesh-list
5707505|NCT03302039|Bupivacaine|bupivacaine|mesh-list
5707506|NCT03302039|Anesthetics, Local|anesthetics, local|mesh-ancestor
5707507|NCT03302039|Anesthetics|anesthetics|mesh-ancestor
5707508|NCT03302039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5707509|NCT03302039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707510|NCT03302039|Sensory System Agents|sensory system agents|mesh-ancestor
5707511|NCT03302039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5707512|NCT03302039|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5707513|NCT03302039|Mydriatics|mydriatics|mesh-ancestor
5707514|NCT03302039|Autonomic Agents|autonomic agents|mesh-ancestor
5707515|NCT03302039|Sympathomimetics|sympathomimetics|mesh-ancestor
6230703|NCT02495038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6230704|NCT02495038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230705|NCT02495038|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
6230706|NCT02495038|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6230707|NCT02495038|Cholinergic Agents|cholinergic agents|mesh-ancestor
6230708|NCT02495038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6230709|NCT02495038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230710|NCT02495103|Metformin|metformin|mesh-list
6230711|NCT02495103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6230712|NCT02495103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230713|NCT02495168|Budesonide|budesonide|mesh-list
6230714|NCT02495168|Formoterol Fumarate|formoterol fumarate|mesh-list
6230715|NCT02495168|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6230716|NCT02495168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6230717|NCT02495168|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6230718|NCT02495168|Autonomic Agents|autonomic agents|mesh-ancestor
6500493|NCT00645294|Antiviral Agents|antiviral agents|mesh-ancestor
5707516|NCT03302039|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5707517|NCT03302039|Nasal Decongestants|nasal decongestants|mesh-ancestor
6230719|NCT02495168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6230720|NCT02495168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230721|NCT02495168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6230722|NCT02495168|Respiratory System Agents|respiratory system agents|mesh-ancestor
6230723|NCT02495168|Glucocorticoids|glucocorticoids|mesh-ancestor
6230724|NCT02495168|Hormones|hormones|mesh-ancestor
6230725|NCT02495168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6230726|NCT02495168|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6230727|NCT02495168|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6230728|NCT02495168|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6230729|NCT02495168|Adrenergic Agents|adrenergic agents|mesh-ancestor
6230730|NCT02495168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6230731|NCT02495168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707518|NCT03302039|Respiratory System Agents|respiratory system agents|mesh-ancestor
5707519|NCT03302039|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5707520|NCT03302039|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5707521|NCT03302039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5707522|NCT03302039|Adrenergic Agents|adrenergic agents|mesh-ancestor
5707523|NCT03302039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5707524|NCT03302039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707525|NCT03302039|Protective Agents|protective agents|mesh-ancestor
5707526|NCT03301974|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6230732|NCT02495233|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6230733|NCT02495233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6230734|NCT02495233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6230735|NCT02495233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6230736|NCT02495233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230737|NCT02495389|Mirabegron|mirabegron|mesh-list
6230738|NCT02495389|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6230739|NCT02495389|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6230740|NCT02495389|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6230741|NCT02495389|Adrenergic Agents|adrenergic agents|mesh-ancestor
6230742|NCT02495389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6230743|NCT02495389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230744|NCT02495389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230745|NCT02495389|Urological Agents|urological agents|mesh-ancestor
6230746|NCT02495454|Obinutuzumab|obinutuzumab|mesh-list
6500494|NCT00645294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6500495|NCT00645294|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6500496|NCT00645294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6500497|NCT00645294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6500498|NCT00645294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500499|NCT00645307|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6500500|NCT00645307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6500501|NCT00645307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6500502|NCT00645307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6500503|NCT00645307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707527|NCT03301974|Hemostatics|hemostatics|mesh-ancestor
5707528|NCT03301974|Coagulants|coagulants|mesh-ancestor
5707529|NCT03301766|Lidocaine|lidocaine|mesh-list
5707530|NCT03301766|Anesthetics, Local|anesthetics, local|mesh-ancestor
5707531|NCT03301766|Anesthetics|anesthetics|mesh-ancestor
5707532|NCT03301766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5707533|NCT03301766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707534|NCT03301766|Sensory System Agents|sensory system agents|mesh-ancestor
5707535|NCT03301766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5707536|NCT03301766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5707537|NCT03301766|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6500504|NCT00645307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6500505|NCT00645307|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6500506|NCT00645307|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6500507|NCT00645307|Serotonin Agents|serotonin agents|mesh-ancestor
6500508|NCT00645307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6500509|NCT00645307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500510|NCT00645307|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6500511|NCT00645307|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6500512|NCT00645307|Dopamine Agents|dopamine agents|mesh-ancestor
6500513|NCT00645320|Ziprasidone|ziprasidone|mesh-list
6500514|NCT00645320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6500515|NCT00645320|Serotonin Agents|serotonin agents|mesh-ancestor
6500516|NCT00645320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6500517|NCT00645320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707538|NCT03301766|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5707539|NCT03301766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5707540|NCT03301766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707541|NCT03301636|Pembrolizumab|pembrolizumab|mesh-list
5707542|NCT03301636|Nivolumab|nivolumab|mesh-list
5707543|NCT03301636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5707544|NCT03301636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5707545|NCT03301636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5707546|NCT03301636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707547|NCT03301454|Paclitaxel|paclitaxel|mesh-list
5707548|NCT03301454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5707549|NCT03301454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5707550|NCT03301454|Tubulin Modulators|tubulin modulators|mesh-ancestor
5707551|NCT03301454|Antimitotic Agents|antimitotic agents|mesh-ancestor
5707552|NCT03301454|Mitosis Modulators|mitosis modulators|mesh-ancestor
5707553|NCT03301454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707554|NCT03301350|Paclitaxel|paclitaxel|mesh-list
5707555|NCT03301350|Cyclophosphamide|cyclophosphamide|mesh-list
5707556|NCT03301350|Carboplatin|carboplatin|mesh-list
5707557|NCT03301350|Doxorubicin|doxorubicin|mesh-list
5707558|NCT03301350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5707559|NCT03301350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5707560|NCT03301350|Tubulin Modulators|tubulin modulators|mesh-ancestor
5707561|NCT03301350|Antimitotic Agents|antimitotic agents|mesh-ancestor
5707562|NCT03301350|Mitosis Modulators|mitosis modulators|mesh-ancestor
5707563|NCT03301350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707564|NCT03301350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5707565|NCT03301350|Immunologic Factors|immunologic factors|mesh-ancestor
5707566|NCT03301350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707567|NCT03301350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5707568|NCT03301350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5707569|NCT03301350|Alkylating Agents|alkylating agents|mesh-ancestor
5707570|NCT03301350|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5707571|NCT03301350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5707572|NCT03301350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5707573|NCT03301350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5707574|NCT03301350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5707575|NCT03301285|Zoledronic Acid|zoledronic acid|mesh-list
5707576|NCT03301285|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6230747|NCT02495454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6230748|NCT02495454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6230749|NCT02495467|Nitroglycerin|nitroglycerin|mesh-list
6230750|NCT02495467|Vasodilator Agents|vasodilator agents|mesh-ancestor
6230751|NCT02495779|Tenofovir|tenofovir|mesh-list
6230752|NCT02495779|Emtricitabine|emtricitabine|mesh-list
6230753|NCT02495779|Antiviral Agents|antiviral agents|mesh-ancestor
6230754|NCT02495779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6230755|NCT02495779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6230756|NCT02495779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6230757|NCT02495779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6230758|NCT02495779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230759|NCT02495779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6230760|NCT02495779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6230761|NCT02495831|Diclofenac|diclofenac|mesh-list
6230762|NCT02495831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6230763|NCT02495831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6230764|NCT02495831|Analgesics|analgesics|mesh-ancestor
6230765|NCT02495831|Sensory System Agents|sensory system agents|mesh-ancestor
6230766|NCT02495831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6230767|NCT02495831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230768|NCT02495831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6230769|NCT02495831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6230770|NCT02495831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6230771|NCT02495831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6230772|NCT02495831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243749|NCT02679755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243750|NCT02679755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6243751|NCT02679755|Hormone Antagonists|hormone antagonists|mesh-ancestor
6243752|NCT02679755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6243753|NCT02679755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243754|NCT02679755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6676643|NCT01582438|Chelating Agents|chelating agents|mesh-ancestor
5707577|NCT03301285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707578|NCT03301233|Sildenafil Citrate|sildenafil citrate|mesh-list
6230773|NCT02495857|Hyaluronic Acid|hyaluronic acid|mesh-list
6230774|NCT02495857|Viscosupplements|viscosupplements|mesh-list
6230775|NCT02495857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6230776|NCT02495857|Immunologic Factors|immunologic factors|mesh-ancestor
6230777|NCT02495857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230778|NCT02495857|Protective Agents|protective agents|mesh-ancestor
6230779|NCT02495883|Ethanol|ethanol|mesh-list
6230780|NCT02495883|Propranolol|propranolol|mesh-list
6230781|NCT02495883|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6230782|NCT02495883|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6230783|NCT02495883|Adrenergic Agents|adrenergic agents|mesh-ancestor
6230784|NCT02495883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6230785|NCT02495883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230786|NCT02495883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230787|NCT02495883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6230788|NCT02495883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6230789|NCT02495883|Vasodilator Agents|vasodilator agents|mesh-ancestor
6230790|NCT02495883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6230791|NCT02495883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6230792|NCT02495883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6230793|NCT02495948|Hydrogen Peroxide|hydrogen peroxide|mesh-list
6230794|NCT02495948|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6230795|NCT02495948|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6230796|NCT02495948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6230797|NCT02496000|Insulin|insulin|mesh-list
5707579|NCT03301233|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5707580|NCT03301233|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5707581|NCT03301233|Estradiol|estradiol|mesh-list
5707582|NCT03301233|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5707583|NCT03301233|Estrogens|estrogens|mesh-ancestor
5707584|NCT03301233|Hormones|hormones|mesh-ancestor
5707585|NCT03301233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6230798|NCT02496000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6230799|NCT02496000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230800|NCT02496221|rGLP-1 protein|rglp-1 protein|mesh-list
6230801|NCT02496221|Incretins|incretins|mesh-ancestor
6230802|NCT02496221|Hormones|hormones|mesh-ancestor
6230803|NCT02496221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6230804|NCT02496221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230805|NCT02497001|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6230806|NCT02497001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6230807|NCT02497001|Respiratory System Agents|respiratory system agents|mesh-ancestor
6230808|NCT02497040|Bupivacaine|bupivacaine|mesh-list
6230809|NCT02497040|Levobupivacaine|levobupivacaine|mesh-list
6230810|NCT02497040|Anesthetics, Local|anesthetics, local|mesh-ancestor
6230811|NCT02497040|Anesthetics|anesthetics|mesh-ancestor
6230812|NCT02497040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6230813|NCT02497040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230814|NCT02497040|Sensory System Agents|sensory system agents|mesh-ancestor
6230815|NCT02497040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6230816|NCT02497287|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6230817|NCT02497287|Citalopram|citalopram|mesh-list
6230818|NCT02497287|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6230819|NCT02497287|Sertraline|sertraline|mesh-list
6230820|NCT02497287|Antidepressive Agents|antidepressive agents|mesh-list
6230821|NCT02497287|Esketamine|esketamine|mesh-list
6230822|NCT02497287|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6230823|NCT02497287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6230824|NCT02497287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6230825|NCT02497287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230826|NCT02497287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6230827|NCT02497287|Serotonin Agents|serotonin agents|mesh-ancestor
6230828|NCT02497287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707586|NCT03301233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707587|NCT03301233|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5707588|NCT03301233|Contraceptive Agents|contraceptive agents|mesh-ancestor
5707589|NCT03301233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5707590|NCT03301233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5707591|NCT03301233|Vasodilator Agents|vasodilator agents|mesh-ancestor
5707592|NCT03301233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5707593|NCT03301233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6230829|NCT02497287|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6230830|NCT02497287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6230831|NCT02497287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6230832|NCT02497287|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6230833|NCT02497287|Analgesics|analgesics|mesh-ancestor
6230834|NCT02497287|Sensory System Agents|sensory system agents|mesh-ancestor
6230835|NCT02497287|Dopamine Agents|dopamine agents|mesh-ancestor
6230836|NCT02497391|Evacetrapib|evacetrapib|mesh-list
6230837|NCT02497391|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6230838|NCT02497391|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6230839|NCT02497391|Antimetabolites|antimetabolites|mesh-ancestor
6230840|NCT02497391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230841|NCT02497391|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6230842|NCT02497404|Fludarabine|fludarabine|mesh-list
6230843|NCT02497404|Azacitidine|azacitidine|mesh-list
6230844|NCT02497404|Melphalan|melphalan|mesh-list
5707594|NCT03301233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5707595|NCT03301233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707596|NCT03301233|Urological Agents|urological agents|mesh-ancestor
5707597|NCT03301207|Midazolam|midazolam|mesh-list
5707598|NCT03301207|Bupropion|bupropion|mesh-list
5707599|NCT03301207|Levonorgestrel|levonorgestrel|mesh-list
5707600|NCT03301207|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5707601|NCT03301207|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
5707602|NCT03301207|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5707603|NCT03301207|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5707604|NCT03301207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6230845|NCT02497404|Alemtuzumab|alemtuzumab|mesh-list
6230846|NCT02497404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6230847|NCT02497404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6230848|NCT02497404|Antimetabolites|antimetabolites|mesh-ancestor
6230849|NCT02497404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230850|NCT02497404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6230851|NCT02497404|Immunologic Factors|immunologic factors|mesh-ancestor
6230852|NCT02497404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230853|NCT02497404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6230854|NCT02497404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6230855|NCT02497404|Alkylating Agents|alkylating agents|mesh-ancestor
6230856|NCT02497404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6230857|NCT02497404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6230858|NCT02497469|Adalimumab|adalimumab|mesh-list
6230859|NCT02497469|Vedolizumab|vedolizumab|mesh-list
6230860|NCT02497469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6230861|NCT02497469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6230862|NCT02497469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6230863|NCT02497612|Artefenomel|artefenomel|mesh-list
6230864|NCT02497612|Ferroquine|ferroquine|mesh-list
6230865|NCT02497612|Antimalarials|antimalarials|mesh-ancestor
6230866|NCT02497612|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6230867|NCT02497612|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6230868|NCT02497612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6230869|NCT02497781|Ceftazidime|ceftazidime|mesh-list
6230870|NCT02497781|Cefepime|cefepime|mesh-list
6230871|NCT02497781|Avibactam|avibactam|mesh-list
6230872|NCT02497781|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
6230873|NCT02497781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6230874|NCT02497781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6230875|NCT02497781|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6230876|NCT02497781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6230877|NCT02497781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230878|NCT02497976|Certolizumab Pegol|certolizumab pegol|mesh-list
6230879|NCT02497976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6230880|NCT02497976|Immunologic Factors|immunologic factors|mesh-ancestor
6230881|NCT02497976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230882|NCT02497976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6230883|NCT02498236|Oxytocin|oxytocin|mesh-list
6230884|NCT02498236|Oxytocics|oxytocics|mesh-ancestor
6230885|NCT02498236|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6230886|NCT02498236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230887|NCT02498418|Rifaximin|rifaximin|mesh-list
6230888|NCT02498418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6230889|NCT02498418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6230890|NCT02498418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6230891|NCT02498483|Acetaminophen|acetaminophen|mesh-list
6230892|NCT02498483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6230893|NCT02498483|Analgesics|analgesics|mesh-ancestor
6230894|NCT02498483|Sensory System Agents|sensory system agents|mesh-ancestor
6230895|NCT02498483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5707605|NCT03301207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230896|NCT02498483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230897|NCT02498483|Antipyretics|antipyretics|mesh-ancestor
6230898|NCT02498522|Metformin|metformin|mesh-list
6230899|NCT02498522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6230900|NCT02498522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230901|NCT02498652|Allopurinol|allopurinol|mesh-list
6230902|NCT02498652|Verinurad|verinurad|mesh-list
6230903|NCT02498652|Antimetabolites|antimetabolites|mesh-ancestor
6230904|NCT02498652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230905|NCT02498652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6230906|NCT02498652|Gout Suppressants|gout suppressants|mesh-ancestor
6230907|NCT02498652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6230908|NCT02498652|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6230909|NCT02498652|Antioxidants|antioxidants|mesh-ancestor
6230910|NCT02498652|Protective Agents|protective agents|mesh-ancestor
6230911|NCT02498652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230912|NCT02498769|Botulinum Toxins|botulinum toxins|mesh-list
6230913|NCT02498769|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6230914|NCT02498769|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5707606|NCT03301207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5707607|NCT03301207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5707608|NCT03301207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5707609|NCT03301207|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5707610|NCT03301207|Anesthetics, General|anesthetics, general|mesh-ancestor
5707611|NCT03301207|Anesthetics|anesthetics|mesh-ancestor
5707612|NCT03301207|GABA Modulators|gaba modulators|mesh-ancestor
5707613|NCT03301207|GABA Agents|gaba agents|mesh-ancestor
5707614|NCT03301207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5707615|NCT03301207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707616|NCT03301207|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5707617|NCT03301207|Antidepressive Agents|antidepressive agents|mesh-ancestor
6230915|NCT02498769|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6230916|NCT02498769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6230917|NCT02498769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230918|NCT02498769|Cholinergic Agents|cholinergic agents|mesh-ancestor
6230919|NCT02498769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6230920|NCT02498769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230921|NCT02498769|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6230922|NCT02498769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6230923|NCT02499029|Acetylcysteine|acetylcysteine|mesh-list
6230924|NCT02499029|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6230925|NCT02499029|Antiviral Agents|antiviral agents|mesh-ancestor
6230926|NCT02499029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6230927|NCT02499029|Expectorants|expectorants|mesh-ancestor
6230928|NCT02499029|Respiratory System Agents|respiratory system agents|mesh-ancestor
6230929|NCT02499029|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6230930|NCT02499029|Antioxidants|antioxidants|mesh-ancestor
6230931|NCT02499029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230932|NCT02499029|Protective Agents|protective agents|mesh-ancestor
6230933|NCT02499029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230934|NCT02499029|Antidotes|antidotes|mesh-ancestor
5707618|NCT03301207|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5707619|NCT03301207|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5707620|NCT03301207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5707621|NCT03301207|Dopamine Agents|dopamine agents|mesh-ancestor
5707622|NCT03301207|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5707623|NCT03301207|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5707624|NCT03301207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5707625|NCT03301207|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5707626|NCT03301207|Contraceptive Agents|contraceptive agents|mesh-ancestor
6230935|NCT02499081|Ixazomib|ixazomib|mesh-list
6230936|NCT02499081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6230937|NCT02499081|Protease Inhibitors|protease inhibitors|mesh-ancestor
6230938|NCT02499081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6230939|NCT02499081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230940|NCT02499120|Cetuximab|cetuximab|mesh-list
6230941|NCT02499120|Palbociclib|palbociclib|mesh-list
6500518|NCT00645320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707627|NCT03301207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5707628|NCT03301207|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5707629|NCT03301207|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5707630|NCT03301207|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5707631|NCT03301207|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5707632|NCT03301207|Estrogens|estrogens|mesh-ancestor
5707633|NCT03301207|Hormones|hormones|mesh-ancestor
5707634|NCT03301207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6230942|NCT02499120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6230943|NCT02499120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6230944|NCT02499120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6230945|NCT02499120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6230946|NCT02499120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230947|NCT02499146|Letrozole|letrozole|mesh-list
6230948|NCT02499146|Palbociclib|palbociclib|mesh-list
6230949|NCT02499146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6230950|NCT02499146|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6230951|NCT02499146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6230952|NCT02499146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6230953|NCT02499146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230954|NCT02499146|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6230955|NCT02499146|Hormone Antagonists|hormone antagonists|mesh-ancestor
6230956|NCT02499146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6230957|NCT02499146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230958|NCT02499146|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6230959|NCT02499159|Bupivacaine|bupivacaine|mesh-list
6230960|NCT02499159|Anesthetics, Local|anesthetics, local|mesh-ancestor
6230961|NCT02499159|Anesthetics|anesthetics|mesh-ancestor
6230962|NCT02499159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6230963|NCT02499159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230964|NCT02499159|Sensory System Agents|sensory system agents|mesh-ancestor
6230965|NCT02499159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6230966|NCT02499497|Androgens|androgens|mesh-list
6230967|NCT02499497|Hormones|hormones|mesh-ancestor
6230968|NCT02499497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6500519|NCT00645320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6500520|NCT00645320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6500521|NCT00645320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6500522|NCT00645320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6500523|NCT00645320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6676644|NCT01582438|Sequestering Agents|sequestering agents|mesh-ancestor
6676645|NCT01582438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676646|NCT01582438|Vasodilator Agents|vasodilator agents|mesh-ancestor
6676647|NCT01582438|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6676648|NCT01582438|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6676649|NCT01582438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6676650|NCT01582438|Urological Agents|urological agents|mesh-ancestor
6676651|NCT01582542|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
6676652|NCT01582542|Hemostatics|hemostatics|mesh-ancestor
6676653|NCT01582542|Coagulants|coagulants|mesh-ancestor
6676654|NCT01582542|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6676655|NCT01582542|Natriuretic Agents|natriuretic agents|mesh-ancestor
6676656|NCT01582542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676657|NCT01582555|Acetylcysteine|acetylcysteine|mesh-list
6676658|NCT01582555|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5707635|NCT03301207|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5707636|NCT03301181|Itraconazole|itraconazole|mesh-list
5707637|NCT03301181|Rifampin|rifampin|mesh-list
5707638|NCT03301181|Zanubrutinib|zanubrutinib|mesh-list
5707639|NCT03301181|Antifungal Agents|antifungal agents|mesh-ancestor
6230969|NCT02499497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230970|NCT02499575|Bupivacaine|bupivacaine|mesh-list
6230971|NCT02499575|Ropivacaine|ropivacaine|mesh-list
6230972|NCT02499575|Anesthetics, Local|anesthetics, local|mesh-ancestor
6230973|NCT02499575|Anesthetics|anesthetics|mesh-ancestor
6230974|NCT02499575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6230975|NCT02499575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6230976|NCT02499575|Sensory System Agents|sensory system agents|mesh-ancestor
6230977|NCT02499575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6230978|NCT02499770|Carboplatin|carboplatin|mesh-list
6230979|NCT02499770|Etoposide|etoposide|mesh-list
6230980|NCT02499770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6500524|NCT00645320|Dopamine Agents|dopamine agents|mesh-ancestor
6500525|NCT00645372|Risperidone|risperidone|mesh-list
6500526|NCT00645372|Ziprasidone|ziprasidone|mesh-list
6500527|NCT00645372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6500528|NCT00645372|Serotonin Agents|serotonin agents|mesh-ancestor
6500529|NCT00645372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6500530|NCT00645372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500531|NCT00645372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6500532|NCT00645372|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6500533|NCT00645372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6500534|NCT00645372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6500535|NCT00645372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6500536|NCT00645372|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6230981|NCT02499770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6230982|NCT02499770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6230983|NCT02499770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6230984|NCT02499770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6230985|NCT02499770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6230986|NCT02499783|Adalimumab|adalimumab|mesh-list
6230987|NCT02499783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6230988|NCT02499783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6230989|NCT02499952|Pembrolizumab|pembrolizumab|mesh-list
6230990|NCT02499952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6230991|NCT02499952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6230992|NCT02500602|Doxazosin|doxazosin|mesh-list
6230993|NCT02500602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6230994|NCT02500602|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6230995|NCT02500602|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6230996|NCT02500602|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6230997|NCT02500602|Adrenergic Agents|adrenergic agents|mesh-ancestor
6230998|NCT02500602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6230999|NCT02500602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231000|NCT02500602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231001|NCT02500628|Metformin|metformin|mesh-list
6231002|NCT02500628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6231003|NCT02500628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231004|NCT02500641|Naproxen|naproxen|mesh-list
6231005|NCT02500641|Colchicine|colchicine|mesh-list
6231006|NCT02500641|Allopurinol|allopurinol|mesh-list
6231007|NCT02500641|Febuxostat|febuxostat|mesh-list
6231008|NCT02500641|Omeprazole|omeprazole|mesh-list
6231009|NCT02500641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6231010|NCT02500641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6231011|NCT02500641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6231012|NCT02500641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6231013|NCT02500641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231014|NCT02500641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6231015|NCT02500641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6231016|NCT02500641|Analgesics|analgesics|mesh-ancestor
6231017|NCT02500641|Sensory System Agents|sensory system agents|mesh-ancestor
6231018|NCT02500641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6231019|NCT02500641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231020|NCT02500641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6231021|NCT02500641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6231022|NCT02500641|Gout Suppressants|gout suppressants|mesh-ancestor
6231023|NCT02500641|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6231024|NCT02500641|Tubulin Modulators|tubulin modulators|mesh-ancestor
6231025|NCT02500641|Antimitotic Agents|antimitotic agents|mesh-ancestor
6231026|NCT02500641|Mitosis Modulators|mitosis modulators|mesh-ancestor
6231027|NCT02500641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6231028|NCT02500641|Antimetabolites|antimetabolites|mesh-ancestor
6231029|NCT02500641|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6231030|NCT02500641|Antioxidants|antioxidants|mesh-ancestor
6231031|NCT02500641|Protective Agents|protective agents|mesh-ancestor
6231032|NCT02500706|Insulin|insulin|mesh-list
6231033|NCT02500706|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6231034|NCT02500706|Insulin Aspart|insulin aspart|mesh-list
6231035|NCT02500706|Insulin, Long-Acting|insulin, long-acting|mesh-list
6231036|NCT02500706|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6231037|NCT02500706|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6231038|NCT02500706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231039|NCT02500732|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6231040|NCT02500732|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6231041|NCT02500732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6231042|NCT02500732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6231043|NCT02500732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231044|NCT02500732|Adrenergic Agents|adrenergic agents|mesh-ancestor
6231045|NCT02500732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6231046|NCT02500732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231047|NCT02500758|Chloroxylenol|chloroxylenol|mesh-list
6231048|NCT02500758|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6231049|NCT02500758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6231050|NCT02500758|Disinfectants|disinfectants|mesh-ancestor
6231051|NCT02500758|Schistosomicides|schistosomicides|mesh-ancestor
6231052|NCT02500758|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6231053|NCT02500758|Anthelmintics|anthelmintics|mesh-ancestor
6231054|NCT02500758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6231055|NCT02500836|Cocaine|cocaine|mesh-list
6231056|NCT02500836|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6231057|NCT02500836|Anesthetics, Local|anesthetics, local|mesh-ancestor
6231058|NCT02500836|Anesthetics|anesthetics|mesh-ancestor
6231059|NCT02500836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6231060|NCT02500836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231061|NCT02500836|Sensory System Agents|sensory system agents|mesh-ancestor
6231062|NCT02500836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6231063|NCT02500836|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6231064|NCT02500836|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6231065|NCT02500836|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6231066|NCT02500836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6231067|NCT02500836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231068|NCT02500836|Dopamine Agents|dopamine agents|mesh-ancestor
6231069|NCT02500836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6231070|NCT02500979|Insulin|insulin|mesh-list
6231071|NCT02500979|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6231072|NCT02500979|Insulin Lispro|insulin lispro|mesh-list
6231073|NCT02500979|Pramlintide|pramlintide|mesh-list
6231074|NCT02500979|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
6231075|NCT02500979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6231076|NCT02500979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231077|NCT02500979|Appetite Depressants|appetite depressants|mesh-ancestor
6231078|NCT02500979|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6231079|NCT02500979|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
6231080|NCT02500979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231081|NCT02501135|Bupivacaine|bupivacaine|mesh-list
6231082|NCT02501135|Ropivacaine|ropivacaine|mesh-list
6231083|NCT02501135|Anesthetics, Local|anesthetics, local|mesh-ancestor
6231084|NCT02501135|Anesthetics|anesthetics|mesh-ancestor
6231085|NCT02501135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6231086|NCT02501135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231087|NCT02501135|Sensory System Agents|sensory system agents|mesh-ancestor
6231088|NCT02501135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6231089|NCT02501161|Insulin|insulin|mesh-list
6231090|NCT02501161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6231091|NCT02501161|Insulin Glargine|insulin glargine|mesh-list
6231092|NCT02501161|Liraglutide|liraglutide|mesh-list
6231093|NCT02501161|Xultophy|xultophy|mesh-list
5707640|NCT03301181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5707641|NCT03301181|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5707642|NCT03301181|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5707643|NCT03301181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5707644|NCT03301181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707645|NCT03301181|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5707646|NCT03301181|Hormone Antagonists|hormone antagonists|mesh-ancestor
5707647|NCT03301181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5707648|NCT03301181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707649|NCT03301181|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5707650|NCT03301181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6231094|NCT02501161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6231095|NCT02501161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231096|NCT02501161|Incretins|incretins|mesh-ancestor
6231097|NCT02501161|Hormones|hormones|mesh-ancestor
6231098|NCT02501161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6231099|NCT02501265|Nicotine|nicotine|mesh-list
6231100|NCT02501265|Varenicline|varenicline|mesh-list
6231101|NCT02501265|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6231102|NCT02501265|Autonomic Agents|autonomic agents|mesh-ancestor
5707651|NCT03301181|Antitubercular Agents|antitubercular agents|mesh-ancestor
6231103|NCT02501265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6231104|NCT02501265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231105|NCT02501265|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6231106|NCT02501265|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6231107|NCT02501265|Cholinergic Agents|cholinergic agents|mesh-ancestor
6231108|NCT02501265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6231109|NCT02501265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231110|NCT02501473|Rituximab|rituximab|mesh-list
6231111|NCT02501473|Pembrolizumab|pembrolizumab|mesh-list
6231112|NCT02501473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6231113|NCT02501473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6231114|NCT02501473|Immunologic Factors|immunologic factors|mesh-ancestor
6231115|NCT02501473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231116|NCT02501473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6231117|NCT02501629|Reslizumab|reslizumab|mesh-list
6231118|NCT02501629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6231119|NCT02501629|Respiratory System Agents|respiratory system agents|mesh-ancestor
6231120|NCT02501811|Plasma-lyte 148|plasma-lyte 148|mesh-list
6231121|NCT02501811|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6231122|NCT02501811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6231123|NCT02501902|Paclitaxel|paclitaxel|mesh-list
6231124|NCT02501902|Palbociclib|palbociclib|mesh-list
6231125|NCT02501902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6231126|NCT02501902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6231127|NCT02501902|Tubulin Modulators|tubulin modulators|mesh-ancestor
6231128|NCT02501902|Antimitotic Agents|antimitotic agents|mesh-ancestor
6231129|NCT02501902|Mitosis Modulators|mitosis modulators|mesh-ancestor
6231130|NCT02501902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231131|NCT02501902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6231132|NCT02501902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6231133|NCT02501928|Fesoterodine|fesoterodine|mesh-list
6231134|NCT02501928|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6231135|NCT02501928|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6231136|NCT02501928|Cholinergic Agents|cholinergic agents|mesh-ancestor
6231137|NCT02501928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6231138|NCT02501928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231139|NCT02501928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231140|NCT02501928|Urological Agents|urological agents|mesh-ancestor
6231141|NCT02502149|Factor VIII|factor viii|mesh-list
6231142|NCT02502149|Coagulants|coagulants|mesh-ancestor
6231143|NCT02502487|Ropivacaine|ropivacaine|mesh-list
6231144|NCT02502487|Tetracaine|tetracaine|mesh-list
6231145|NCT02502487|Anesthetics, Local|anesthetics, local|mesh-ancestor
6231146|NCT02502487|Anesthetics|anesthetics|mesh-ancestor
6231147|NCT02502487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6231148|NCT02502487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231149|NCT02502487|Sensory System Agents|sensory system agents|mesh-ancestor
6231150|NCT02502487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6231151|NCT02502734|Fluticasone|fluticasone|mesh-list
6231152|NCT02502734|Xhance|xhance|mesh-list
6231153|NCT02502734|Albuterol|albuterol|mesh-list
6231154|NCT02502734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5707652|NCT03301181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5707653|NCT03301181|Leprostatic Agents|leprostatic agents|mesh-ancestor
5707654|NCT03301181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5707655|NCT03301181|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5707656|NCT03301181|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6231155|NCT02502734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6231156|NCT02502734|Autonomic Agents|autonomic agents|mesh-ancestor
6231157|NCT02502734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6231158|NCT02502734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231159|NCT02502734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6231160|NCT02502734|Respiratory System Agents|respiratory system agents|mesh-ancestor
6231161|NCT02502734|Dermatologic Agents|dermatologic agents|mesh-ancestor
6231162|NCT02502734|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6231163|NCT02502734|Tocolytic Agents|tocolytic agents|mesh-ancestor
6231164|NCT02502734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6231165|NCT02502734|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6231166|NCT02502734|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6231167|NCT02502734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6231168|NCT02502734|Adrenergic Agents|adrenergic agents|mesh-ancestor
6231169|NCT02502734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6231170|NCT02502734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231171|NCT02502864|Cyclophosphamide|cyclophosphamide|mesh-list
6231172|NCT02502864|Docetaxel|docetaxel|mesh-list
6231173|NCT02502864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6231174|NCT02502864|Immunologic Factors|immunologic factors|mesh-ancestor
6231175|NCT02502864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231176|NCT02502864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6231177|NCT02502864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6231178|NCT02502864|Alkylating Agents|alkylating agents|mesh-ancestor
6231179|NCT02502864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231180|NCT02502864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6231181|NCT02502864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6231182|NCT02502864|Tubulin Modulators|tubulin modulators|mesh-ancestor
6231183|NCT02502864|Antimitotic Agents|antimitotic agents|mesh-ancestor
6231184|NCT02502864|Mitosis Modulators|mitosis modulators|mesh-ancestor
6231185|NCT02503085|Ibuprofen|ibuprofen|mesh-list
6231186|NCT02503085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6231187|NCT02503085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6231188|NCT02503085|Analgesics|analgesics|mesh-ancestor
6231189|NCT02503085|Sensory System Agents|sensory system agents|mesh-ancestor
6231190|NCT02503085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5707657|NCT03301181|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5707658|NCT03301181|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5707659|NCT03301181|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5707660|NCT03301181|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5707661|NCT03301181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5707662|NCT03301181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5707663|NCT03301025|Pregabalin|pregabalin|mesh-list
5707664|NCT03301025|Analgesics|analgesics|mesh-ancestor
5707665|NCT03301025|Sensory System Agents|sensory system agents|mesh-ancestor
5707666|NCT03301025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5707667|NCT03301025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707668|NCT03301025|Anticonvulsants|anticonvulsants|mesh-ancestor
5707669|NCT03301025|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5707670|NCT03301025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5707671|NCT03301025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707672|NCT03301025|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5707673|NCT03301025|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6231191|NCT02503085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231192|NCT02503085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6231193|NCT02503085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6231194|NCT02503085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5707674|NCT03301025|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5707675|NCT03301025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5707676|NCT03301025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5707677|NCT03300960|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
5707678|NCT03300960|Ganirelix|ganirelix|mesh-list
5707679|NCT03300960|Hormone Antagonists|hormone antagonists|mesh-ancestor
5707680|NCT03300960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5707681|NCT03300960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707682|NCT03300960|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5707683|NCT03300960|Contraceptive Agents|contraceptive agents|mesh-ancestor
5707684|NCT03300960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5707685|NCT03300960|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5707686|NCT03300960|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5707687|NCT03300960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5707688|NCT03300960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5707689|NCT03300947|Lorazepam|lorazepam|mesh-list
5707690|NCT03300947|Psilocybin|psilocybin|mesh-list
5707691|NCT03300947|Anticonvulsants|anticonvulsants|mesh-ancestor
6231195|NCT02503085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6231196|NCT02503085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231197|NCT02503501|Insulin glulisine|insulin glulisine|mesh-list
6231198|NCT02503501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6231199|NCT02503501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231200|NCT02503540|Aflibercept|aflibercept|mesh-list
6231201|NCT02503540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6231202|NCT02503540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6231203|NCT02503540|Growth Substances|growth substances|mesh-ancestor
6231204|NCT02503540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231205|NCT02503540|Growth Inhibitors|growth inhibitors|mesh-ancestor
6231206|NCT02503540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6231207|NCT02503735|Sofosbuvir|sofosbuvir|mesh-list
6231208|NCT02503735|Ledipasvir|ledipasvir|mesh-list
6231209|NCT02503735|Antiviral Agents|antiviral agents|mesh-ancestor
6231210|NCT02503735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6231211|NCT02503865|Orlistat|orlistat|mesh-list
6231212|NCT02503865|Diltiazem|diltiazem|mesh-list
6231213|NCT02503865|Atorvastatin|atorvastatin|mesh-list
6231214|NCT02503865|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5707692|NCT03300947|Antiemetics|antiemetics|mesh-ancestor
5707693|NCT03300947|Autonomic Agents|autonomic agents|mesh-ancestor
5707694|NCT03300947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6231215|NCT02503865|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6231216|NCT02503865|Antimetabolites|antimetabolites|mesh-ancestor
6676659|NCT01582555|Antidotes|antidotes|mesh-ancestor
6676660|NCT01582555|Protective Agents|protective agents|mesh-ancestor
6676661|NCT01582555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676662|NCT01582555|Antioxidants|antioxidants|mesh-ancestor
6676663|NCT01582555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676664|NCT01582555|Antiviral Agents|antiviral agents|mesh-ancestor
6676665|NCT01582555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6676666|NCT01582555|Expectorants|expectorants|mesh-ancestor
6676667|NCT01582555|Respiratory System Agents|respiratory system agents|mesh-ancestor
6676668|NCT01582555|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6676669|NCT01582568|Certolizumab Pegol|certolizumab pegol|mesh-list
6231217|NCT02503865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231218|NCT02503865|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5707695|NCT03300947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707696|NCT03300947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5707697|NCT03300947|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5707698|NCT03300947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5707699|NCT03300947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5707700|NCT03300947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5707701|NCT03300947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5707702|NCT03300947|GABA Modulators|gaba modulators|mesh-ancestor
5707703|NCT03300947|GABA Agents|gaba agents|mesh-ancestor
5707704|NCT03300947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5707705|NCT03300947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707706|NCT03300947|Hallucinogens|hallucinogens|mesh-ancestor
5707707|NCT03300765|Apatinib|apatinib|mesh-list
5707708|NCT03300765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5707709|NCT03300765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5707710|NCT03300765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5707711|NCT03300765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707712|NCT03300609|Calcium, Dietary|calcium, dietary|mesh-list
5707713|NCT03300609|Leucovorin|leucovorin|mesh-list
5707714|NCT03300609|Folic Acid|folic acid|mesh-list
5707715|NCT03300609|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
5707716|NCT03300609|Tetrahydrofolates|tetrahydrofolates|mesh-list
5707717|NCT03300609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5707718|NCT03300609|Panitumumab|panitumumab|mesh-list
5707719|NCT03300609|Fluorouracil|fluorouracil|mesh-list
5707720|NCT03300609|Capecitabine|capecitabine|mesh-list
5707721|NCT03300609|Oxaliplatin|oxaliplatin|mesh-list
5707722|NCT03300609|Antibodies|antibodies|mesh-list
5707723|NCT03300609|Immunoglobulins|immunoglobulins|mesh-list
5707724|NCT03300609|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5707725|NCT03300609|Calcium|calcium|mesh-list
5707726|NCT03300609|Levoleucovorin|levoleucovorin|mesh-list
5707727|NCT03300609|Immunologic Factors|immunologic factors|mesh-ancestor
6231219|NCT02503865|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6231220|NCT02503865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6231221|NCT02503865|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6231222|NCT02503865|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6231223|NCT02503865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6231224|NCT02503865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6231225|NCT02503865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231226|NCT02503865|Vasodilator Agents|vasodilator agents|mesh-ancestor
6231227|NCT02503865|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6231228|NCT02503982|Valganciclovir|valganciclovir|mesh-list
6231229|NCT02503982|Antiviral Agents|antiviral agents|mesh-ancestor
6231230|NCT02503982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6231231|NCT02504216|Rivaroxaban|rivaroxaban|mesh-list
6231232|NCT02504216|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6231233|NCT02504216|Antithrombins|antithrombins|mesh-ancestor
6231234|NCT02504216|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6231235|NCT02504216|Protease Inhibitors|protease inhibitors|mesh-ancestor
6231236|NCT02504216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6231237|NCT02504216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707728|NCT03300609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707729|NCT03300609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5707730|NCT03300609|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5707731|NCT03300609|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5707732|NCT03300609|Antimetabolites|antimetabolites|mesh-ancestor
5707733|NCT03300609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231238|NCT02504216|Anticoagulants|anticoagulants|mesh-ancestor
6231239|NCT02504268|Methotrexate|methotrexate|mesh-list
6231240|NCT02504268|Abatacept|abatacept|mesh-list
6231241|NCT02504268|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6231242|NCT02504268|Abortifacient Agents|abortifacient agents|mesh-ancestor
6231243|NCT02504268|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6231244|NCT02504268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231245|NCT02504268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6231246|NCT02504268|Antimetabolites|antimetabolites|mesh-ancestor
6231247|NCT02504268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231248|NCT02504268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6231249|NCT02504268|Dermatologic Agents|dermatologic agents|mesh-ancestor
6231250|NCT02504268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5707734|NCT03300609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5707735|NCT03300609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5707736|NCT03300609|Antidotes|antidotes|mesh-ancestor
5707737|NCT03300609|Protective Agents|protective agents|mesh-ancestor
5707738|NCT03300609|Vitamin B Complex|vitamin b complex|mesh-ancestor
5707739|NCT03300609|Vitamins|vitamins|mesh-ancestor
5707740|NCT03300609|Micronutrients|micronutrients|mesh-ancestor
5707741|NCT03300609|Hematinics|hematinics|mesh-ancestor
5707742|NCT03300531|Betamethasone|betamethasone|mesh-list
5707743|NCT03300531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6231251|NCT02504268|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6231252|NCT02504268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6231253|NCT02504268|Immunologic Factors|immunologic factors|mesh-ancestor
6231254|NCT02504268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6231255|NCT02504268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5707744|NCT03300531|Glucocorticoids|glucocorticoids|mesh-ancestor
5707745|NCT03300531|Hormones|hormones|mesh-ancestor
5707746|NCT03300531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5707747|NCT03300531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707748|NCT03300531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5707749|NCT03300531|Respiratory System Agents|respiratory system agents|mesh-ancestor
5707750|NCT03300440|Vitamins|vitamins|mesh-list
5707751|NCT03300440|Biotin|biotin|mesh-list
5707752|NCT03300440|Vitamin B Complex|vitamin b complex|mesh-list
5707753|NCT03300440|Micronutrients|micronutrients|mesh-ancestor
5707754|NCT03300440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721411|NCT03206021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5721412|NCT03206021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5721413|NCT03206021|Antimetabolites|antimetabolites|mesh-ancestor
5721414|NCT03206021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721415|NCT03206021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6231256|NCT02504268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6231257|NCT02504294|Epoetin Alfa|epoetin alfa|mesh-list
6231258|NCT02504294|Hematinics|hematinics|mesh-ancestor
6231259|NCT02504320|Febuxostat|febuxostat|mesh-list
6231260|NCT02504320|Gout Suppressants|gout suppressants|mesh-ancestor
6231261|NCT02504320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6243755|NCT02679911|Amorolfine|amorolfine|mesh-list
6243756|NCT02679911|Ciclopirox|ciclopirox|mesh-list
6243757|NCT02679911|Antifungal Agents|antifungal agents|mesh-ancestor
6500537|NCT00645372|Dopamine Agents|dopamine agents|mesh-ancestor
6500538|NCT00645398|Pregabalin|pregabalin|mesh-list
6500539|NCT00645398|Analgesics|analgesics|mesh-ancestor
6500540|NCT00645398|Sensory System Agents|sensory system agents|mesh-ancestor
6500541|NCT00645398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6500542|NCT00645398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6500543|NCT00645398|Anticonvulsants|anticonvulsants|mesh-ancestor
6500544|NCT00645398|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6500545|NCT00645398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5721416|NCT03206008|Magnesium Sulfate|magnesium sulfate|mesh-list
5721417|NCT03206008|Analgesics|analgesics|mesh-ancestor
5721418|NCT03206008|Sensory System Agents|sensory system agents|mesh-ancestor
5721419|NCT03206008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5721420|NCT03206008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721421|NCT03206008|Anesthetics|anesthetics|mesh-ancestor
5721422|NCT03206008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5721423|NCT03206008|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6500546|NCT00645398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500547|NCT00645398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6500548|NCT00645398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6500549|NCT00645398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6500550|NCT00645398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6500551|NCT00645398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6500552|NCT00645424|Atorvastatin|atorvastatin|mesh-list
6500553|NCT00645424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6500554|NCT00645424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6500555|NCT00645424|Antimetabolites|antimetabolites|mesh-ancestor
6500556|NCT00645424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500557|NCT00645424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6500558|NCT00645424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6500559|NCT00645424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6500560|NCT00645437|Levofloxacin|levofloxacin|mesh-list
6500561|NCT00645437|Ofloxacin|ofloxacin|mesh-list
6500562|NCT00645437|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6500563|NCT00645437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6500564|NCT00645437|Renal Agents|renal agents|mesh-ancestor
5721424|NCT03206008|Anticonvulsants|anticonvulsants|mesh-ancestor
5721425|NCT03206008|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6243758|NCT02679911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6243759|NCT02680002|MF59 oil emulsion|mf59 oil emulsion|mesh-list
6243760|NCT02680002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6231262|NCT02504541|Methyltestosterone|methyltestosterone|mesh-list
6231263|NCT02504541|Testosterone|testosterone|mesh-list
6231264|NCT02504541|Testosterone undecanoate|testosterone undecanoate|mesh-list
6231265|NCT02504541|Testosterone enanthate|testosterone enanthate|mesh-list
6231266|NCT02504541|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6231267|NCT02504541|Androgens|androgens|mesh-ancestor
6231268|NCT02504541|Hormones|hormones|mesh-ancestor
6231269|NCT02504541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6231270|NCT02504541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231271|NCT02504541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6231272|NCT02504541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6231273|NCT02504541|Anabolic Agents|anabolic agents|mesh-ancestor
6231274|NCT02504554|Vancomycin|vancomycin|mesh-list
5707755|NCT03300362|Vaccines|vaccines|mesh-list
5707756|NCT03300362|Immunologic Factors|immunologic factors|mesh-ancestor
5918867|NCT04988256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918868|NCT04988256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5918869|NCT04988256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5918870|NCT04988256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5918871|NCT04988256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231275|NCT02504554|Omeprazole|omeprazole|mesh-list
5707757|NCT03300362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707758|NCT03300115|Abivertinib|abivertinib|mesh-list
5707759|NCT03300115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5707760|NCT03300115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5707761|NCT03300115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707762|NCT03300089|Anesthetics|anesthetics|mesh-list
5707763|NCT03300089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5707764|NCT03300089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707765|NCT03299998|Anesthetics|anesthetics|mesh-list
5707766|NCT03299998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5707767|NCT03299998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707768|NCT03299946|Nivolumab|nivolumab|mesh-list
5707769|NCT03299946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5707770|NCT03299946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5707771|NCT03299946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5707772|NCT03299946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707773|NCT03299842|Fenfluramine|fenfluramine|mesh-list
5707774|NCT03299842|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5707775|NCT03299842|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5707776|NCT03299842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5707777|NCT03299842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707778|NCT03299842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5707779|NCT03299842|Serotonin Agents|serotonin agents|mesh-ancestor
5707780|NCT03299842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707781|NCT03299829|Trientine|trientine|mesh-list
5707782|NCT03299829|Chelating Agents|chelating agents|mesh-ancestor
6231276|NCT02504554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6231277|NCT02504554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6231278|NCT02504554|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6231279|NCT02504554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6231280|NCT02504554|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6231281|NCT02504554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6231282|NCT02504554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500565|NCT00645437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5707783|NCT03299829|Sequestering Agents|sequestering agents|mesh-ancestor
5707784|NCT03299829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707785|NCT03299725|Bismuth|bismuth|mesh-list
5707786|NCT03299725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707787|NCT03299725|Antacids|antacids|mesh-ancestor
5707788|NCT03299725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5707789|NCT03299712|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
5707790|NCT03299712|Vasodilator Agents|vasodilator agents|mesh-ancestor
5707791|NCT03299712|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
5707792|NCT03299712|Protective Agents|protective agents|mesh-ancestor
5707793|NCT03299712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707794|NCT03299660|Fluorouracil|fluorouracil|mesh-list
5707795|NCT03299660|Capecitabine|capecitabine|mesh-list
5707796|NCT03299660|Avelumab|avelumab|mesh-list
5707797|NCT03299660|Antimetabolites|antimetabolites|mesh-ancestor
6231283|NCT02504671|Folic Acid|folic acid|mesh-list
6231284|NCT02504671|Hematinics|hematinics|mesh-ancestor
6231285|NCT02504671|Vitamin B Complex|vitamin b complex|mesh-ancestor
6500566|NCT00645437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6500567|NCT00645437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6231286|NCT02504671|Vitamins|vitamins|mesh-ancestor
6231287|NCT02504671|Micronutrients|micronutrients|mesh-ancestor
6231288|NCT02504671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231289|NCT02504723|Carvedilol|carvedilol|mesh-list
6231290|NCT02504723|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6231291|NCT02504723|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6231292|NCT02504723|Adrenergic Agents|adrenergic agents|mesh-ancestor
6231293|NCT02504723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6231294|NCT02504723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231295|NCT02504723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231296|NCT02504723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6500568|NCT00645437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6500569|NCT00645437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500570|NCT00645437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6500571|NCT00645437|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6500572|NCT00645437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5707798|NCT03299660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707799|NCT03299660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5707800|NCT03299660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5707801|NCT03299660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5707802|NCT03299660|Immunologic Factors|immunologic factors|mesh-ancestor
5707803|NCT03299660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707804|NCT03299660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5707805|NCT03299621|Rocuronium|rocuronium|mesh-list
5707806|NCT03299621|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5707807|NCT03299621|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6500573|NCT00645502|Risperidone|risperidone|mesh-list
6500574|NCT00645502|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6500575|NCT00645502|Serotonin Agents|serotonin agents|mesh-ancestor
6500576|NCT00645502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6231297|NCT02504723|Antioxidants|antioxidants|mesh-ancestor
6231298|NCT02504723|Protective Agents|protective agents|mesh-ancestor
6231299|NCT02504723|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6231300|NCT02504723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6231301|NCT02504723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6231302|NCT02504723|Vasodilator Agents|vasodilator agents|mesh-ancestor
6231303|NCT02504723|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6231304|NCT02504723|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6231305|NCT02504775|Acetaminophen|acetaminophen|mesh-list
6500577|NCT00645502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231306|NCT02504775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6231307|NCT02504775|Analgesics|analgesics|mesh-ancestor
6231308|NCT02504775|Sensory System Agents|sensory system agents|mesh-ancestor
6231309|NCT02504775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6231310|NCT02504775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231311|NCT02504775|Antipyretics|antipyretics|mesh-ancestor
6231312|NCT02504827|Ceftazidime|ceftazidime|mesh-list
6231313|NCT02504827|Avibactam|avibactam|mesh-list
6231314|NCT02504827|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
6231315|NCT02504827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6231316|NCT02504827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6500578|NCT00645502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676670|NCT01582568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6676671|NCT01582568|Immunologic Factors|immunologic factors|mesh-ancestor
6676672|NCT01582568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676673|NCT01582568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6676674|NCT01582607|Fentanyl|fentanyl|mesh-list
6676675|NCT01582607|Bupivacaine|bupivacaine|mesh-list
6676676|NCT01582607|Ropivacaine|ropivacaine|mesh-list
5707808|NCT03299621|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5707809|NCT03299621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5707810|NCT03299621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707811|NCT03299517|Lidocaine|lidocaine|mesh-list
5707812|NCT03299517|Amiodarone|amiodarone|mesh-list
5707813|NCT03299517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
5707814|NCT03299517|Anesthetics, Local|anesthetics, local|mesh-ancestor
5707815|NCT03299517|Anesthetics|anesthetics|mesh-ancestor
5707816|NCT03299517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5707817|NCT03299517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707818|NCT03299517|Sensory System Agents|sensory system agents|mesh-ancestor
5707819|NCT03299517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6676677|NCT01582607|Levobupivacaine|levobupivacaine|mesh-list
6676678|NCT01582607|Anesthetics, Local|anesthetics, local|mesh-ancestor
6676679|NCT01582607|Anesthetics|anesthetics|mesh-ancestor
6779670|NCT02180425|Tretinoin|tretinoin|mesh-list
5707820|NCT03299517|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5707821|NCT03299517|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5707822|NCT03299517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5707823|NCT03299517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707824|NCT03299517|Vasodilator Agents|vasodilator agents|mesh-ancestor
5707825|NCT03299517|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5707826|NCT03299517|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5707827|NCT03299517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5707828|NCT03299517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5707829|NCT03299517|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5707830|NCT03299517|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5707831|NCT03299517|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5707832|NCT03299426|Vaccines|vaccines|mesh-list
5707833|NCT03299426|Immunologic Factors|immunologic factors|mesh-ancestor
5707834|NCT03299426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707835|NCT03299387|Gentamicins|gentamicins|mesh-list
5707836|NCT03299387|Nitrofurantoin|nitrofurantoin|mesh-list
5707837|NCT03299387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5707838|NCT03299387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5707839|NCT03299387|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6500579|NCT00645502|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6500580|NCT00645502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6500581|NCT00645502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6500582|NCT00645502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6231317|NCT02504827|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6231318|NCT02504827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6231319|NCT02504827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231320|NCT02504892|Everolimus|everolimus|mesh-list
6231321|NCT02504892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6231322|NCT02504892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6231323|NCT02504892|Immunologic Factors|immunologic factors|mesh-ancestor
6231324|NCT02504892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707840|NCT03299387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5707841|NCT03299387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707842|NCT03299387|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5707843|NCT03299387|Renal Agents|renal agents|mesh-ancestor
6500583|NCT00645502|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6500584|NCT00645502|Dopamine Agents|dopamine agents|mesh-ancestor
6231325|NCT02504931|Sertraline|sertraline|mesh-list
6231326|NCT02504931|Antidepressive Agents|antidepressive agents|mesh-ancestor
6231327|NCT02504931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6231328|NCT02504931|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6500585|NCT00645515|Risperidone|risperidone|mesh-list
6500586|NCT00645515|Ziprasidone|ziprasidone|mesh-list
6500587|NCT00645515|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6500588|NCT00645515|Serotonin Agents|serotonin agents|mesh-ancestor
6500589|NCT00645515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5707844|NCT03299296|Enoxaparin|enoxaparin|mesh-list
5707845|NCT03299296|Rivaroxaban|rivaroxaban|mesh-list
5707846|NCT03299296|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5707847|NCT03299296|Antithrombins|antithrombins|mesh-ancestor
5707848|NCT03299296|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5707849|NCT03299296|Protease Inhibitors|protease inhibitors|mesh-ancestor
5707850|NCT03299296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5707851|NCT03299296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707852|NCT03299296|Anticoagulants|anticoagulants|mesh-ancestor
5707853|NCT03299296|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5707854|NCT03299296|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5707855|NCT03299257|Donepezil|donepezil|mesh-list
5707856|NCT03299257|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5707857|NCT03299257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5707858|NCT03299257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707859|NCT03299257|Cholinergic Agents|cholinergic agents|mesh-ancestor
6500590|NCT00645515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707860|NCT03299257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5918872|NCT04988256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5918873|NCT04988256|Immunologic Factors|immunologic factors|mesh-ancestor
5918874|NCT04988256|Antifungal Agents|antifungal agents|mesh-ancestor
5918875|NCT04988256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5918876|NCT04988256|Dermatologic Agents|dermatologic agents|mesh-ancestor
5918877|NCT04988256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5918878|NCT04988256|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5918879|NCT04988256|Antiemetics|antiemetics|mesh-ancestor
5918880|NCT04988256|Autonomic Agents|autonomic agents|mesh-ancestor
6243761|NCT02680002|Immunologic Factors|immunologic factors|mesh-ancestor
6231329|NCT02504931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6231330|NCT02504931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6231331|NCT02504931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231332|NCT02504931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6231333|NCT02504931|Serotonin Agents|serotonin agents|mesh-ancestor
6231334|NCT02504931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707861|NCT03299257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707862|NCT03299257|Nootropic Agents|nootropic agents|mesh-ancestor
5707863|NCT03299036|Doxorubicin|doxorubicin|mesh-list
5707864|NCT03299036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6231335|NCT02505269|Doxorubicin|doxorubicin|mesh-list
6231336|NCT02505269|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6231337|NCT02505269|Dacarbazine|dacarbazine|mesh-list
6231338|NCT02505269|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6231339|NCT02505269|Imidazole|imidazole|mesh-list
5707865|NCT03299036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5707866|NCT03299036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5707867|NCT03299036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5707868|NCT03299036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5707869|NCT03299036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707870|NCT03298958|Sirolimus|sirolimus|mesh-list
5707871|NCT03298958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5707872|NCT03298958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5707873|NCT03298958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5707874|NCT03298958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5707875|NCT03298958|Antifungal Agents|antifungal agents|mesh-ancestor
5707876|NCT03298958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5707877|NCT03298958|Immunologic Factors|immunologic factors|mesh-ancestor
5707878|NCT03298958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707879|NCT03298906|Ticlopidine|ticlopidine|mesh-list
6231340|NCT02505269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6231341|NCT02505269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6231342|NCT02505269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6231343|NCT02505269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6231344|NCT02505269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6231345|NCT02505269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231346|NCT02505269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6231347|NCT02505269|Alkylating Agents|alkylating agents|mesh-ancestor
6231348|NCT02505269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6231349|NCT02505334|Liraglutide|liraglutide|mesh-list
6231350|NCT02505334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6231351|NCT02505334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231352|NCT02505334|Incretins|incretins|mesh-ancestor
6231353|NCT02505334|Hormones|hormones|mesh-ancestor
6231354|NCT02505334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6231355|NCT02505542|Certolizumab Pegol|certolizumab pegol|mesh-list
6231356|NCT02505542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6231357|NCT02505542|Immunologic Factors|immunologic factors|mesh-ancestor
6231358|NCT02505542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231359|NCT02505542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6231360|NCT02505945|Omeprazole|omeprazole|mesh-list
6231361|NCT02505945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6231362|NCT02505945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6231363|NCT02505945|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6231364|NCT02505945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6231365|NCT02505945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231366|NCT02506114|Ipilimumab|ipilimumab|mesh-list
6231367|NCT02506114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6231368|NCT02506114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6231369|NCT02506114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6231370|NCT02506114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231371|NCT02506257|Biguanides|biguanides|mesh-list
6231372|NCT02506257|Polihexanide|polihexanide|mesh-list
6231373|NCT02506257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6231374|NCT02506257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231375|NCT02506257|Disinfectants|disinfectants|mesh-ancestor
6231376|NCT02506257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6231377|NCT02506634|Esomeprazole|esomeprazole|mesh-list
6676680|NCT01582607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6676681|NCT01582607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676682|NCT01582607|Sensory System Agents|sensory system agents|mesh-ancestor
6676683|NCT01582607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6676684|NCT01582607|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6676685|NCT01582607|Narcotics|narcotics|mesh-ancestor
6676686|NCT01582607|Analgesics|analgesics|mesh-ancestor
6676687|NCT01582607|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6231378|NCT02506634|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6231379|NCT02506634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6231380|NCT02506634|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6231381|NCT02506634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6231382|NCT02506634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231383|NCT02506660|Dexamethasone|dexamethasone|mesh-list
6231384|NCT02506660|Dexamethasone acetate|dexamethasone acetate|mesh-list
6231385|NCT02506660|Bupivacaine|bupivacaine|mesh-list
6231386|NCT02506660|BB 1101|bb 1101|mesh-list
6231387|NCT02506660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6231388|NCT02506660|Antiemetics|antiemetics|mesh-ancestor
6231389|NCT02506660|Autonomic Agents|autonomic agents|mesh-ancestor
6231390|NCT02506660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6231391|NCT02506660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707880|NCT03298906|Esketamine|esketamine|mesh-list
5707881|NCT03298906|Antidepressive Agents|antidepressive agents|mesh-ancestor
5707882|NCT03298906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5707883|NCT03298906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5707884|NCT03298906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5707885|NCT03298906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707886|NCT03298906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5707887|NCT03298906|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6231392|NCT02506660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6231393|NCT02506660|Glucocorticoids|glucocorticoids|mesh-ancestor
6231394|NCT02506660|Hormones|hormones|mesh-ancestor
6231395|NCT02506660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6231396|NCT02506660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6231397|NCT02506660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6231398|NCT02506660|Protease Inhibitors|protease inhibitors|mesh-ancestor
6231399|NCT02506660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6231400|NCT02506660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231401|NCT02506660|Anesthetics, Local|anesthetics, local|mesh-ancestor
6231402|NCT02506660|Anesthetics|anesthetics|mesh-ancestor
6231403|NCT02506660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6231404|NCT02506660|Sensory System Agents|sensory system agents|mesh-ancestor
6231405|NCT02506673|Midazolam|midazolam|mesh-list
6231406|NCT02506673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5707888|NCT03298906|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5707889|NCT03298906|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5707890|NCT03298906|Purinergic Agents|purinergic agents|mesh-ancestor
5707891|NCT03298906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5707892|NCT03298906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231407|NCT02506673|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6231408|NCT02506673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6231409|NCT02506673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231410|NCT02506673|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6231411|NCT02506673|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6231412|NCT02506673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6231413|NCT02506673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6231414|NCT02506673|Anesthetics, General|anesthetics, general|mesh-ancestor
6231415|NCT02506673|Anesthetics|anesthetics|mesh-ancestor
6231416|NCT02506673|GABA Modulators|gaba modulators|mesh-ancestor
6231417|NCT02506673|GABA Agents|gaba agents|mesh-ancestor
6231418|NCT02506673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6231419|NCT02506673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231420|NCT02506816|Olaparib|olaparib|mesh-list
6231421|NCT02506816|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6231422|NCT02506816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6231423|NCT02506816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231424|NCT02506816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6231425|NCT02506868|Darbepoetin alfa|darbepoetin alfa|mesh-list
6231426|NCT02506868|Hematinics|hematinics|mesh-ancestor
6231427|NCT02506881|Darbepoetin alfa|darbepoetin alfa|mesh-list
6231428|NCT02506881|Hematinics|hematinics|mesh-ancestor
6231429|NCT02507011|Carvedilol|carvedilol|mesh-list
6231430|NCT02507011|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6231431|NCT02507011|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6231432|NCT02507011|Adrenergic Agents|adrenergic agents|mesh-ancestor
6231433|NCT02507011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6231434|NCT02507011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231435|NCT02507011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231436|NCT02507011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6231437|NCT02507011|Antioxidants|antioxidants|mesh-ancestor
6231438|NCT02507011|Protective Agents|protective agents|mesh-ancestor
5707893|NCT03298906|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6231439|NCT02507011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6231440|NCT02507011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6231441|NCT02507011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6231442|NCT02507011|Vasodilator Agents|vasodilator agents|mesh-ancestor
6231443|NCT02507011|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6231444|NCT02507011|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6231445|NCT02507219|Ibuprofen|ibuprofen|mesh-list
6231446|NCT02507219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6231447|NCT02507219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6231448|NCT02507219|Analgesics|analgesics|mesh-ancestor
6231449|NCT02507219|Sensory System Agents|sensory system agents|mesh-ancestor
6500591|NCT00645515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6500592|NCT00645515|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5707894|NCT03298906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5707895|NCT03298906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5707896|NCT03298893|Nivolumab|nivolumab|mesh-list
6500593|NCT00645515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6500594|NCT00645515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6231450|NCT02507219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6231451|NCT02507219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231452|NCT02507219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5707897|NCT03298893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5707898|NCT03298893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5707899|NCT03298893|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5707900|NCT03298893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707901|NCT03298854|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
5707902|NCT03298854|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5707903|NCT03298854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707904|NCT03298815|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5707905|NCT03298815|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5721426|NCT03206008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5721427|NCT03206008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231453|NCT02507219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6231454|NCT02507219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6231455|NCT02507219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6231456|NCT02507219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231457|NCT02507375|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6231458|NCT02507375|Pertuzumab|pertuzumab|mesh-list
6231459|NCT02507375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6231460|NCT02507375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6231461|NCT02507375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6231462|NCT02507375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231463|NCT02507375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6231464|NCT02508077|Calcium, Dietary|calcium, dietary|mesh-list
6231465|NCT02508077|Leucovorin|leucovorin|mesh-list
6231466|NCT02508077|Folic Acid|folic acid|mesh-list
6500595|NCT00645515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6500596|NCT00645515|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6500597|NCT00645515|Dopamine Agents|dopamine agents|mesh-ancestor
6500598|NCT00645554|Galantamine|galantamine|mesh-list
6500599|NCT00645554|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5721428|NCT03206008|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5721429|NCT03206008|Tocolytic Agents|tocolytic agents|mesh-ancestor
5721430|NCT03206008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5721431|NCT03205605|Mandelic Acids|mandelic acids|mesh-list
5721432|NCT03205605|Oxybutynin|oxybutynin|mesh-list
5721433|NCT03205605|Parasympatholytics|parasympatholytics|mesh-ancestor
5721434|NCT03205605|Autonomic Agents|autonomic agents|mesh-ancestor
5721435|NCT03205605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5721436|NCT03205605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721437|NCT03205605|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5721438|NCT03205605|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5721439|NCT03205605|Cholinergic Agents|cholinergic agents|mesh-ancestor
5721440|NCT03205605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5721441|NCT03205605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721442|NCT03205605|Urological Agents|urological agents|mesh-ancestor
5721443|NCT03205605|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5721444|NCT03205605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5721445|NCT03205605|Renal Agents|renal agents|mesh-ancestor
6231467|NCT02508077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6500600|NCT00645554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6500601|NCT00645554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500602|NCT00645554|Cholinergic Agents|cholinergic agents|mesh-ancestor
6231468|NCT02508077|Panitumumab|panitumumab|mesh-list
6231469|NCT02508077|Fluorouracil|fluorouracil|mesh-list
6231470|NCT02508077|Irinotecan|irinotecan|mesh-list
6500603|NCT00645554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6500604|NCT00645554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676688|NCT01582607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6676689|NCT01582607|Anesthetics, General|anesthetics, general|mesh-ancestor
6676690|NCT01582646|Terbutaline|terbutaline|mesh-list
6676691|NCT01582646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6676692|NCT01582646|Autonomic Agents|autonomic agents|mesh-ancestor
6676693|NCT01582646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6676694|NCT01582646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676695|NCT01582646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6676696|NCT01582646|Respiratory System Agents|respiratory system agents|mesh-ancestor
6676697|NCT01582646|Sympathomimetics|sympathomimetics|mesh-ancestor
6676698|NCT01582646|Tocolytic Agents|tocolytic agents|mesh-ancestor
6676699|NCT01582646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6676700|NCT01582646|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6676701|NCT01582646|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6231471|NCT02508077|Camptothecin|camptothecin|mesh-list
6231472|NCT02508077|Antibodies|antibodies|mesh-list
6231473|NCT02508077|Immunoglobulins|immunoglobulins|mesh-list
6231474|NCT02508077|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6231475|NCT02508077|Calcium|calcium|mesh-list
6231476|NCT02508077|Levoleucovorin|levoleucovorin|mesh-list
6231477|NCT02508077|Immunologic Factors|immunologic factors|mesh-ancestor
6231478|NCT02508077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231479|NCT02508077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6231480|NCT02508077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6231481|NCT02508077|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6231482|NCT02508077|Antimetabolites|antimetabolites|mesh-ancestor
6231483|NCT02508077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231484|NCT02508077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6231485|NCT02508077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6231486|NCT02508077|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6231487|NCT02508077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6231488|NCT02508077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6231489|NCT02508077|Antidotes|antidotes|mesh-ancestor
6231490|NCT02508077|Protective Agents|protective agents|mesh-ancestor
6231491|NCT02508077|Vitamin B Complex|vitamin b complex|mesh-ancestor
6231492|NCT02508077|Vitamins|vitamins|mesh-ancestor
6231493|NCT02508077|Micronutrients|micronutrients|mesh-ancestor
6231494|NCT02508077|Hematinics|hematinics|mesh-ancestor
6231495|NCT02508077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6231496|NCT02508103|Oxytocin|oxytocin|mesh-list
6231497|NCT02508103|Oxytocics|oxytocics|mesh-ancestor
6231498|NCT02508103|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6231499|NCT02508103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231500|NCT02508207|Ivacaftor|ivacaftor|mesh-list
6231501|NCT02508207|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6231502|NCT02508207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6231503|NCT02508207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231504|NCT02508259|Suramin|suramin|mesh-list
6500605|NCT00645554|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6500606|NCT00645554|Autonomic Agents|autonomic agents|mesh-ancestor
6500607|NCT00645554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6500608|NCT00645554|Nootropic Agents|nootropic agents|mesh-ancestor
6500609|NCT00645580|Fluvoxamine|fluvoxamine|mesh-list
6500610|NCT00645580|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6676702|NCT01582646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6676703|NCT01582646|Adrenergic Agents|adrenergic agents|mesh-ancestor
6676704|NCT01582646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6676705|NCT01582646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676706|NCT01582672|Sunitinib|sunitinib|mesh-list
6676707|NCT01582672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6676708|NCT01582672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6676709|NCT01582672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6676710|NCT01582672|Growth Substances|growth substances|mesh-ancestor
6676711|NCT01582672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676712|NCT01582672|Growth Inhibitors|growth inhibitors|mesh-ancestor
6231505|NCT02508259|Antinematodal Agents|antinematodal agents|mesh-ancestor
6231506|NCT02508259|Anthelmintics|anthelmintics|mesh-ancestor
6231507|NCT02508259|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6231508|NCT02508259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6676713|NCT01582672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6231509|NCT02508259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6231510|NCT02508259|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6231511|NCT02508259|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6231512|NCT02508389|Avasopasem manganese|avasopasem manganese|mesh-list
6231513|NCT02508389|Antioxidants|antioxidants|mesh-ancestor
6231514|NCT02508389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231515|NCT02508389|Protective Agents|protective agents|mesh-ancestor
6231516|NCT02508389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6500611|NCT00645580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6500612|NCT00645580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6500613|NCT00645580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6500614|NCT00645580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6500615|NCT00645580|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6500616|NCT00645580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6500617|NCT00645580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6500618|NCT00645580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500619|NCT00645580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6500620|NCT00645580|Serotonin Agents|serotonin agents|mesh-ancestor
6500621|NCT00645580|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5918881|NCT04988256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5918882|NCT04988256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5918883|NCT04988256|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5918884|NCT04988256|Protective Agents|protective agents|mesh-ancestor
5918885|NCT04987892|Tamsulosin|tamsulosin|mesh-list
5918886|NCT04987892|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5918887|NCT04987892|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5918888|NCT04987892|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5918889|NCT04987892|Adrenergic Agents|adrenergic agents|mesh-ancestor
6500622|NCT00645580|Antidepressive Agents|antidepressive agents|mesh-ancestor
6500623|NCT00645580|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6500624|NCT00645580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6500625|NCT00645580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6500626|NCT00645580|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6500627|NCT00645606|Rituximab|rituximab|mesh-list
6500628|NCT00645606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6500629|NCT00645606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6500630|NCT00645606|Immunologic Factors|immunologic factors|mesh-ancestor
6500631|NCT00645606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676714|NCT01582672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6676715|NCT01582672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676716|NCT01582711|Isoniazid|isoniazid|mesh-list
6676717|NCT01582711|Rifapentine|rifapentine|mesh-list
6676718|NCT01582711|Antitubercular Agents|antitubercular agents|mesh-ancestor
6676719|NCT01582711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6676720|NCT01582711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6676721|NCT01582711|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6676722|NCT01582711|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6676723|NCT01582711|Antimetabolites|antimetabolites|mesh-ancestor
5707906|NCT03298698|Prednisone|prednisone|mesh-list
5707907|NCT03298698|Prednisolone|prednisolone|mesh-list
5707908|NCT03298698|Rituximab|rituximab|mesh-list
5707909|NCT03298698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6676724|NCT01582711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676725|NCT01582711|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6676726|NCT01582711|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5707910|NCT03298698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5707911|NCT03298698|Immunologic Factors|immunologic factors|mesh-ancestor
5707912|NCT03298698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707913|NCT03298698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5707914|NCT03298698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5707915|NCT03298698|Glucocorticoids|glucocorticoids|mesh-ancestor
5707916|NCT03298698|Hormones|hormones|mesh-ancestor
5707917|NCT03298698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5918890|NCT04987892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5918891|NCT04987892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918892|NCT04987892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918893|NCT04987892|Urological Agents|urological agents|mesh-ancestor
5964073|NCT04595591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964074|NCT04595591|Analgesics|analgesics|mesh-ancestor
5964075|NCT04595591|Sensory System Agents|sensory system agents|mesh-ancestor
5964076|NCT04595591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5964077|NCT04595591|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6500632|NCT00645606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6500633|NCT00645632|Doxorubicin|doxorubicin|mesh-list
6500634|NCT00645632|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6500635|NCT00645632|Methotrexate|methotrexate|mesh-list
6500636|NCT00645632|Ifosfamide|ifosfamide|mesh-list
6500637|NCT00645632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6500638|NCT00645632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6500639|NCT00645632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6231517|NCT02508428|Methyclothiazide|methyclothiazide|mesh-list
6231518|NCT02508428|Diuretics|diuretics|mesh-ancestor
6231519|NCT02508428|Natriuretic Agents|natriuretic agents|mesh-ancestor
6231520|NCT02508428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231521|NCT02508428|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6500640|NCT00645632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6500641|NCT00645632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6500642|NCT00645632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500643|NCT00645632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6500644|NCT00645632|Abortifacient Agents|abortifacient agents|mesh-ancestor
6500645|NCT00645632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6231522|NCT02508428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6231523|NCT02508428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231524|NCT02508636|Leuprolide|leuprolide|mesh-list
6231525|NCT02508636|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6231526|NCT02508636|Fertility Agents|fertility agents|mesh-ancestor
6231527|NCT02508636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5707918|NCT03298698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5707919|NCT03298646|Diclofenac|diclofenac|mesh-list
5707920|NCT03298646|Lidocaine|lidocaine|mesh-list
5707921|NCT03298646|Anesthetics, Local|anesthetics, local|mesh-ancestor
5707922|NCT03298646|Anesthetics|anesthetics|mesh-ancestor
5707923|NCT03298646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5707924|NCT03298646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707925|NCT03298646|Sensory System Agents|sensory system agents|mesh-ancestor
5707926|NCT03298646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5707927|NCT03298646|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5707928|NCT03298646|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5707929|NCT03298646|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5707930|NCT03298646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5707931|NCT03298646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707932|NCT03298646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5707933|NCT03298646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6231528|NCT02508636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231529|NCT02508636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6231530|NCT02508636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6231531|NCT02508701|Vaccines|vaccines|mesh-list
6231532|NCT02508701|Immunologic Factors|immunologic factors|mesh-ancestor
6231533|NCT02508701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231534|NCT02508935|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
5707934|NCT03298646|Analgesics|analgesics|mesh-ancestor
5707935|NCT03298646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5707936|NCT03298646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5707937|NCT03298646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5707938|NCT03298646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5707939|NCT03298581|Clobetasol|clobetasol|mesh-list
5707940|NCT03298581|Halobetasol|halobetasol|mesh-list
5707941|NCT03298581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5707942|NCT03298581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5707943|NCT03298581|Glucocorticoids|glucocorticoids|mesh-ancestor
5707944|NCT03298581|Hormones|hormones|mesh-ancestor
6231535|NCT02508935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6231536|NCT02508935|Narcotics|narcotics|mesh-ancestor
6231537|NCT02508935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6231538|NCT02508935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231539|NCT02508935|Analgesics|analgesics|mesh-ancestor
6231540|NCT02508935|Sensory System Agents|sensory system agents|mesh-ancestor
6231541|NCT02508935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6231542|NCT02508935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6231543|NCT02508935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6231544|NCT02508935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6231545|NCT02508935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6231546|NCT02509026|Etanercept|etanercept|mesh-list
6231547|NCT02509026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6231548|NCT02509026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5707945|NCT03298581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6231549|NCT02509026|Analgesics|analgesics|mesh-ancestor
6231550|NCT02509026|Sensory System Agents|sensory system agents|mesh-ancestor
6231551|NCT02509026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5707946|NCT03298581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707947|NCT03298542|Golimumab|golimumab|mesh-list
5707948|NCT03298542|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
5707949|NCT03298542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5707950|NCT03298542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5707951|NCT03298542|Immunologic Factors|immunologic factors|mesh-ancestor
5707952|NCT03298542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707953|NCT03298516|Azacitidine|azacitidine|mesh-list
5707954|NCT03298516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5707955|NCT03298516|Antimetabolites|antimetabolites|mesh-ancestor
5707956|NCT03298516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707957|NCT03298516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5707958|NCT03298516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5707959|NCT03298464|Pioglitazone|pioglitazone|mesh-list
5707960|NCT03298464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6231552|NCT02509026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6500646|NCT00645632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6500647|NCT00645632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6500648|NCT00645632|Antimetabolites|antimetabolites|mesh-ancestor
6231553|NCT02509026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5707961|NCT03298464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707962|NCT03298373|Nandrolone Decanoate|nandrolone decanoate|mesh-list
5707963|NCT03298373|Nandrolone|nandrolone|mesh-list
5707964|NCT03298373|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
5707965|NCT03298373|Androgens|androgens|mesh-ancestor
5707966|NCT03298373|Hormones|hormones|mesh-ancestor
5707967|NCT03298373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5707968|NCT03298373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707969|NCT03298373|Anabolic Agents|anabolic agents|mesh-ancestor
5707970|NCT03298373|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6231554|NCT02509026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6231555|NCT02509026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6231556|NCT02509026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6231557|NCT02509026|Immunologic Factors|immunologic factors|mesh-ancestor
6231558|NCT02509065|Pancrelipase|pancrelipase|mesh-list
6231559|NCT02509065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6231560|NCT02509078|Cisatracurium|cisatracurium|mesh-list
6231561|NCT02509078|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6231562|NCT02509078|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6231563|NCT02509078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6231564|NCT02509078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231565|NCT02509481|Ivermectin|ivermectin|mesh-list
6231566|NCT02509481|Albendazole|albendazole|mesh-list
6231567|NCT02509481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6231568|NCT02509481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6231569|NCT02509481|Anthelmintics|anthelmintics|mesh-ancestor
6231570|NCT02509481|Anticestodal Agents|anticestodal agents|mesh-ancestor
6231571|NCT02509481|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6231572|NCT02509481|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6231573|NCT02509481|Tubulin Modulators|tubulin modulators|mesh-ancestor
6231574|NCT02509481|Antimitotic Agents|antimitotic agents|mesh-ancestor
6231575|NCT02509481|Mitosis Modulators|mitosis modulators|mesh-ancestor
6231576|NCT02509481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231577|NCT02509481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6231578|NCT02509624|Selonsertib|selonsertib|mesh-list
6231579|NCT02509624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6231580|NCT02509624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6231581|NCT02509624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231582|NCT02509767|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6231583|NCT02509767|Medroxyprogesterone|medroxyprogesterone|mesh-list
6500649|NCT00645632|Dermatologic Agents|dermatologic agents|mesh-ancestor
6500650|NCT00645632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6500651|NCT00645632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6500652|NCT00645632|Immunologic Factors|immunologic factors|mesh-ancestor
6500653|NCT00645632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6500654|NCT00645632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6500655|NCT00645632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6500656|NCT00645632|Alkylating Agents|alkylating agents|mesh-ancestor
6500657|NCT00645658|Testosterone|testosterone|mesh-list
6500658|NCT00645658|Androgens|androgens|mesh-ancestor
6500659|NCT00645658|Hormones|hormones|mesh-ancestor
6500660|NCT00645658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6231584|NCT02509767|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6231585|NCT02509767|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6231586|NCT02509767|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6231587|NCT02509767|Contraceptive Agents|contraceptive agents|mesh-ancestor
6231588|NCT02509767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6231589|NCT02509767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231590|NCT02509767|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6231591|NCT02509767|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6231592|NCT02509767|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6231593|NCT02509767|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6231594|NCT02509767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6231595|NCT02510001|Crizotinib|crizotinib|mesh-list
6231596|NCT02510001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6231597|NCT02510001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6231598|NCT02510001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6231599|NCT02510001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231600|NCT02510014|Buprenorphine|buprenorphine|mesh-list
6231601|NCT02510014|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6231602|NCT02510014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6231603|NCT02510014|Narcotics|narcotics|mesh-ancestor
6231604|NCT02510014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6231605|NCT02510014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231606|NCT02510014|Analgesics|analgesics|mesh-ancestor
6231607|NCT02510014|Sensory System Agents|sensory system agents|mesh-ancestor
6231608|NCT02510014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6231609|NCT02510014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6231610|NCT02510144|Chlorhexidine|chlorhexidine|mesh-list
6231611|NCT02510144|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6231612|NCT02510144|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6231613|NCT02510144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6231614|NCT02510144|Disinfectants|disinfectants|mesh-ancestor
6231615|NCT02510144|Dermatologic Agents|dermatologic agents|mesh-ancestor
6231616|NCT02510794|Ranibizumab|ranibizumab|mesh-list
6231617|NCT02510794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6231618|NCT02510794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6231619|NCT02510794|Growth Substances|growth substances|mesh-ancestor
6231620|NCT02510794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231621|NCT02510794|Growth Inhibitors|growth inhibitors|mesh-ancestor
6231622|NCT02510794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6231623|NCT02511184|Pembrolizumab|pembrolizumab|mesh-list
6500661|NCT00645658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6500662|NCT00645723|Colistin|colistin|mesh-list
6500663|NCT00645723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6500664|NCT00645723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6500665|NCT00645801|Lubiprostone|lubiprostone|mesh-list
6500666|NCT00645801|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6500667|NCT00645801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6500668|NCT00645801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500669|NCT00645814|Adalimumab|adalimumab|mesh-list
6500670|NCT00645814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6500671|NCT00645814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6500672|NCT00645866|Docetaxel|docetaxel|mesh-list
6676727|NCT01582711|Leprostatic Agents|leprostatic agents|mesh-ancestor
6676728|NCT01582737|Rivaroxaban|rivaroxaban|mesh-list
6676729|NCT01582737|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6676730|NCT01582737|Antithrombins|antithrombins|mesh-ancestor
6676731|NCT01582737|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6676732|NCT01582737|Protease Inhibitors|protease inhibitors|mesh-ancestor
6676733|NCT01582737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5707971|NCT03298347|Caffeine|caffeine|mesh-list
5707972|NCT03298347|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5707973|NCT03298347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707974|NCT03298347|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5707975|NCT03298347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5707976|NCT03298347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707977|NCT03298347|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5707978|NCT03298347|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5707979|NCT03298347|Purinergic Agents|purinergic agents|mesh-ancestor
5707980|NCT03298347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6231624|NCT02511184|Crizotinib|crizotinib|mesh-list
6231625|NCT02511184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6676734|NCT01582737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500673|NCT00645866|Capecitabine|capecitabine|mesh-list
6500674|NCT00645866|Epirubicin|epirubicin|mesh-list
6231626|NCT02511184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6231627|NCT02511184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6231628|NCT02511184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6231629|NCT02511184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231630|NCT02511236|Nicotine|nicotine|mesh-list
6231631|NCT02511236|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6231632|NCT02511236|Autonomic Agents|autonomic agents|mesh-ancestor
6231633|NCT02511236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6231634|NCT02511236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707981|NCT03298321|Azacitidine|azacitidine|mesh-list
5707982|NCT03298321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5707983|NCT03298321|Antimetabolites|antimetabolites|mesh-ancestor
5707984|NCT03298321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5707985|NCT03298321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5707986|NCT03298321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5707987|NCT03298295|Insulin|insulin|mesh-list
5707988|NCT03298295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5707989|NCT03298295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707990|NCT03298191|Magnesium Sulfate|magnesium sulfate|mesh-list
5707991|NCT03298191|Calcium Channel Blockers|calcium channel blockers|mesh-list
5707992|NCT03298191|Ritodrine|ritodrine|mesh-list
5707993|NCT03298191|Calcium|calcium|mesh-list
5707994|NCT03298191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5707995|NCT03298191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5707996|NCT03298191|Analgesics|analgesics|mesh-ancestor
5707997|NCT03298191|Sensory System Agents|sensory system agents|mesh-ancestor
5707998|NCT03298191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5707999|NCT03298191|Anesthetics|anesthetics|mesh-ancestor
5708000|NCT03298191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6231635|NCT02511236|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6231636|NCT02511236|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6231637|NCT02511236|Cholinergic Agents|cholinergic agents|mesh-ancestor
6231638|NCT02511236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6231639|NCT02511236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231640|NCT02511379|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6231641|NCT02511379|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6231642|NCT02511431|Ritonavir|ritonavir|mesh-list
6231643|NCT02511431|Lonafarnib|lonafarnib|mesh-list
6231644|NCT02511431|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6231645|NCT02511431|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6231646|NCT02511431|Protease Inhibitors|protease inhibitors|mesh-ancestor
6231647|NCT02511431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6231648|NCT02511431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231649|NCT02511431|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6231650|NCT02511431|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6231651|NCT02511431|Antiviral Agents|antiviral agents|mesh-ancestor
6231652|NCT02511431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6231653|NCT02511431|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6231654|NCT02511431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6231655|NCT02511535|Vaccines|vaccines|mesh-list
6231656|NCT02511535|Immunologic Factors|immunologic factors|mesh-ancestor
6231657|NCT02511535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6500675|NCT00645866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6500676|NCT00645866|Tubulin Modulators|tubulin modulators|mesh-ancestor
6500677|NCT00645866|Antimitotic Agents|antimitotic agents|mesh-ancestor
6500678|NCT00645866|Mitosis Modulators|mitosis modulators|mesh-ancestor
6500679|NCT00645866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231658|NCT02511561|Ciprofloxacin|ciprofloxacin|mesh-list
6231659|NCT02511561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6231660|NCT02511561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6231661|NCT02511561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6231662|NCT02511561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6231663|NCT02511561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6231664|NCT02511561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231665|NCT02511561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6231666|NCT02511561|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6231667|NCT02511561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6231668|NCT02511587|Vaccines|vaccines|mesh-list
6231669|NCT02511587|Immunologic Factors|immunologic factors|mesh-ancestor
5708001|NCT03298191|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6231670|NCT02511587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231671|NCT02512042|Brinzolamide|brinzolamide|mesh-list
5708002|NCT03298191|Anticonvulsants|anticonvulsants|mesh-ancestor
5721446|NCT03205891|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5708003|NCT03298191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5708004|NCT03298191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5708005|NCT03298191|Tocolytic Agents|tocolytic agents|mesh-ancestor
5708006|NCT03298191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5708007|NCT03298191|Sympathomimetics|sympathomimetics|mesh-ancestor
5708008|NCT03298191|Autonomic Agents|autonomic agents|mesh-ancestor
5708009|NCT03298191|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5708010|NCT03298191|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5708011|NCT03298191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5708012|NCT03298191|Adrenergic Agents|adrenergic agents|mesh-ancestor
5708013|NCT03298191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5708014|NCT03298087|Leuprolide|leuprolide|mesh-list
5708015|NCT03298087|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6231672|NCT02512042|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6231673|NCT02512042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6231674|NCT02512042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231675|NCT02512302|Glycopyrrolate|glycopyrrolate|mesh-list
6231676|NCT02512302|Bromides|bromides|mesh-list
6231677|NCT02512302|Charcoal|charcoal|mesh-list
6231678|NCT02512302|Anticonvulsants|anticonvulsants|mesh-ancestor
6231679|NCT02512302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6231680|NCT02512302|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6231681|NCT02512302|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6231682|NCT02512302|Cholinergic Agents|cholinergic agents|mesh-ancestor
6231683|NCT02512302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6231684|NCT02512302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231685|NCT02512302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231686|NCT02512302|Antidotes|antidotes|mesh-ancestor
6231687|NCT02512302|Protective Agents|protective agents|mesh-ancestor
6231688|NCT02512575|Prednisolone|prednisolone|mesh-list
5708016|NCT03298087|Fertility Agents|fertility agents|mesh-ancestor
5708017|NCT03298087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5708018|NCT03298087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708019|NCT03298087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5708020|NCT03298087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5708021|NCT03298074|Etoposide|etoposide|mesh-list
5708022|NCT03298074|Apatinib|apatinib|mesh-list
5708023|NCT03298074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5708024|NCT03298074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5708025|NCT03298074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5708026|NCT03298074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6231689|NCT02512575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6231690|NCT02512575|Glucocorticoids|glucocorticoids|mesh-ancestor
6231691|NCT02512575|Hormones|hormones|mesh-ancestor
6231692|NCT02512575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6676735|NCT01582737|Anticoagulants|anticoagulants|mesh-ancestor
6676736|NCT01582776|Lenalidomide|lenalidomide|mesh-list
6231693|NCT02512575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231694|NCT02512575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6231695|NCT02512575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6231696|NCT02512679|Cyclophosphamide|cyclophosphamide|mesh-list
6231697|NCT02512679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6231698|NCT02512679|Immunologic Factors|immunologic factors|mesh-ancestor
6231699|NCT02512679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231700|NCT02512679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6231701|NCT02512679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6231702|NCT02512679|Alkylating Agents|alkylating agents|mesh-ancestor
6231703|NCT02512679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231704|NCT02512679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6231705|NCT02512679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6231706|NCT02512783|Lidocaine|lidocaine|mesh-list
6231707|NCT02512783|Propofol|propofol|mesh-list
5708027|NCT03298074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5708028|NCT03298074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5708029|NCT03298074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5708030|NCT03298061|Prednisolone|prednisolone|mesh-list
5708031|NCT03298061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5708032|NCT03298061|Glucocorticoids|glucocorticoids|mesh-ancestor
5708033|NCT03298061|Hormones|hormones|mesh-ancestor
5708034|NCT03298061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5708035|NCT03298061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708036|NCT03298061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5708037|NCT03298061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5708038|NCT03298009|Canagliflozin|canagliflozin|mesh-list
6231708|NCT02512783|Anesthetics, Local|anesthetics, local|mesh-ancestor
6676737|NCT01582776|Obinutuzumab|obinutuzumab|mesh-list
6231709|NCT02512783|Anesthetics|anesthetics|mesh-ancestor
6231710|NCT02512783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6231711|NCT02512783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231712|NCT02512783|Sensory System Agents|sensory system agents|mesh-ancestor
5708039|NCT03298009|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5708040|NCT03298009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5708041|NCT03298009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5708042|NCT03298009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708043|NCT03297931|Iproplatin|iproplatin|mesh-list
5708044|NCT03297931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5708045|NCT03297879|Metformin|metformin|mesh-list
5708046|NCT03297879|Exenatide|exenatide|mesh-list
5708047|NCT03297879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5708048|NCT03297879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708049|NCT03297879|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5708050|NCT03297879|Incretins|incretins|mesh-ancestor
5708051|NCT03297879|Hormones|hormones|mesh-ancestor
5708052|NCT03297879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5708053|NCT03297593|Nivolumab|nivolumab|mesh-list
5708054|NCT03297593|Ipilimumab|ipilimumab|mesh-list
5708055|NCT03297593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5708056|NCT03297593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5708057|NCT03297593|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5708058|NCT03297593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5708059|NCT03297502|Pimecrolimus|pimecrolimus|mesh-list
5708060|NCT03297502|Tacrolimus|tacrolimus|mesh-list
5708061|NCT03297502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5708062|NCT03297502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5708063|NCT03297502|Analgesics|analgesics|mesh-ancestor
5708064|NCT03297502|Sensory System Agents|sensory system agents|mesh-ancestor
5708065|NCT03297502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5708066|NCT03297502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708067|NCT03297502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5708068|NCT03297502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6231713|NCT02512783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6231714|NCT02512783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6231715|NCT02512783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6231716|NCT02512783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5708069|NCT03297502|Dermatologic Agents|dermatologic agents|mesh-ancestor
5708070|NCT03297502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5708071|NCT03297502|Immunologic Factors|immunologic factors|mesh-ancestor
5708072|NCT03297502|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5708073|NCT03297502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5708074|NCT03297502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5708075|NCT03297463|Ipilimumab|ipilimumab|mesh-list
5708076|NCT03297463|Interleukin-2|interleukin-2|mesh-list
5708077|NCT03297463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5708078|NCT03297463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5708079|NCT03297463|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5708080|NCT03297463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5708081|NCT03297463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5708082|NCT03297463|Analgesics|analgesics|mesh-ancestor
5708083|NCT03297463|Sensory System Agents|sensory system agents|mesh-ancestor
5708084|NCT03297463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5708085|NCT03297463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708086|NCT03297359|Dalteparin|dalteparin|mesh-list
5708087|NCT03297359|Tinzaparin|tinzaparin|mesh-list
5708088|NCT03297359|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5708089|NCT03297359|Anticoagulants|anticoagulants|mesh-ancestor
5708090|NCT03297359|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5708091|NCT03297359|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5708092|NCT03297359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721447|NCT03205891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5721448|NCT03205891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5721449|NCT03205696|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
5721450|NCT03205696|Antiviral Agents|antiviral agents|mesh-ancestor
5721451|NCT03205696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5721452|NCT03205228|Flupenthixol|flupenthixol|mesh-list
5721453|NCT03205228|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
5721454|NCT03205228|Omeprazole|omeprazole|mesh-list
5721455|NCT03205228|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5721456|NCT03205228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5721457|NCT03205228|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5721458|NCT03205228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6231717|NCT02512783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5708093|NCT03297073|Acetaminophen|acetaminophen|mesh-list
6231718|NCT02512783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231719|NCT02512783|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6231720|NCT02512783|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6231721|NCT02512783|Anesthetics, General|anesthetics, general|mesh-ancestor
6231722|NCT02512809|Dexmedetomidine|dexmedetomidine|mesh-list
6231723|NCT02512809|Isoflurane|isoflurane|mesh-list
6231724|NCT02512809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6231725|NCT02512809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6231726|NCT02512809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231727|NCT02512809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6231728|NCT02512809|Analgesics|analgesics|mesh-ancestor
6231729|NCT02512809|Sensory System Agents|sensory system agents|mesh-ancestor
5708094|NCT03297073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5708095|NCT03297073|Analgesics|analgesics|mesh-ancestor
5708096|NCT03297073|Sensory System Agents|sensory system agents|mesh-ancestor
5708097|NCT03297073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5708098|NCT03297073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708099|NCT03297073|Antipyretics|antipyretics|mesh-ancestor
5708100|NCT03296982|Enoxaparin|enoxaparin|mesh-list
6231730|NCT02512809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6231731|NCT02512809|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6231732|NCT02512809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6231733|NCT02512809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6231734|NCT02512809|Adrenergic Agents|adrenergic agents|mesh-ancestor
6231735|NCT02512809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6231736|NCT02512809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231737|NCT02512809|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6231738|NCT02512809|Anesthetics, General|anesthetics, general|mesh-ancestor
6231739|NCT02512809|Anesthetics|anesthetics|mesh-ancestor
6231740|NCT02512861|Bupivacaine|bupivacaine|mesh-list
6231741|NCT02512861|Anesthetics, Local|anesthetics, local|mesh-ancestor
5708101|NCT03296982|Edoxaban|edoxaban|mesh-list
5708102|NCT03296982|Anticoagulants|anticoagulants|mesh-ancestor
5708103|NCT03296982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6231742|NCT02512861|Anesthetics|anesthetics|mesh-ancestor
6500680|NCT00645866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6500681|NCT00645866|Antimetabolites|antimetabolites|mesh-ancestor
6500682|NCT00645866|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6500683|NCT00645866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6500684|NCT00645866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6500685|NCT00645866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6500686|NCT00645879|Citric Acid|citric acid|mesh-list
6500687|NCT00645879|Sodium Citrate|sodium citrate|mesh-list
6500688|NCT00645879|Anticoagulants|anticoagulants|mesh-ancestor
6500689|NCT00645879|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6500690|NCT00645879|Chelating Agents|chelating agents|mesh-ancestor
6231743|NCT02512861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6231744|NCT02512861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231745|NCT02512861|Sensory System Agents|sensory system agents|mesh-ancestor
6231746|NCT02512861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6231747|NCT02513095|Dantrolene|dantrolene|mesh-list
6231748|NCT02513095|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6231749|NCT02513095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231750|NCT02513095|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6231751|NCT02513095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6231752|NCT02513160|Beclomethasone|beclomethasone|mesh-list
6231753|NCT02513160|Albuterol|albuterol|mesh-list
6500691|NCT00645879|Sequestering Agents|sequestering agents|mesh-ancestor
6500692|NCT00645879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231754|NCT02513160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6231755|NCT02513160|Autonomic Agents|autonomic agents|mesh-ancestor
6231756|NCT02513160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6231757|NCT02513160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231758|NCT02513160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6231759|NCT02513160|Respiratory System Agents|respiratory system agents|mesh-ancestor
6231760|NCT02513160|Tocolytic Agents|tocolytic agents|mesh-ancestor
5708104|NCT03296982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5918894|NCT04987996|Pembrolizumab|pembrolizumab|mesh-list
5918895|NCT04987996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5918896|NCT04987996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5918897|NCT04988282|Methylprednisolone|methylprednisolone|mesh-list
5918898|NCT04988282|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5918899|NCT04988282|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5918900|NCT04988282|Prednisolone|prednisolone|mesh-list
5918901|NCT04988282|Prednisolone acetate|prednisolone acetate|mesh-list
5918902|NCT04988282|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6231761|NCT02513160|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6231762|NCT02513160|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6231763|NCT02513160|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6231764|NCT02513160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6231765|NCT02513160|Adrenergic Agents|adrenergic agents|mesh-ancestor
6231766|NCT02513160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6231767|NCT02513160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231768|NCT02513160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6231769|NCT02513160|Glucocorticoids|glucocorticoids|mesh-ancestor
6231770|NCT02513160|Hormones|hormones|mesh-ancestor
6231771|NCT02513160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6231772|NCT02513212|Fluorides|fluorides|mesh-list
6231773|NCT02513212|Tin Fluorides|tin fluorides|mesh-list
6231774|NCT02513212|Cariostatic Agents|cariostatic agents|mesh-ancestor
6231775|NCT02513212|Protective Agents|protective agents|mesh-ancestor
6231776|NCT02513212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231777|NCT02513446|Itraconazole|itraconazole|mesh-list
6231778|NCT02513446|Antifungal Agents|antifungal agents|mesh-ancestor
6231779|NCT02513446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6231780|NCT02513446|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6231781|NCT02513446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6231782|NCT02513446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6231783|NCT02513446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231784|NCT02513446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6231785|NCT02513446|Hormone Antagonists|hormone antagonists|mesh-ancestor
6231786|NCT02513446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6231787|NCT02513446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231788|NCT02513446|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6231789|NCT02513459|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6231790|NCT02513459|Immunologic Factors|immunologic factors|mesh-ancestor
6231791|NCT02513459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231792|NCT02513472|Pembrolizumab|pembrolizumab|mesh-list
6231793|NCT02513472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6231794|NCT02513472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6231795|NCT02513498|Ixazomib|ixazomib|mesh-list
6231796|NCT02513498|Glycine|glycine|mesh-list
6231797|NCT02513498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231798|NCT02513498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6231799|NCT02513498|Protease Inhibitors|protease inhibitors|mesh-ancestor
6231800|NCT02513498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6231801|NCT02513498|Glycine Agents|glycine agents|mesh-ancestor
5708105|NCT03296982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5708106|NCT03296982|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5708107|NCT03296982|Antithrombins|antithrombins|mesh-ancestor
5708108|NCT03296982|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5708109|NCT03296982|Protease Inhibitors|protease inhibitors|mesh-ancestor
5708110|NCT03296982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5708111|NCT03296930|Ritonavir|ritonavir|mesh-list
5708112|NCT03296930|Ribavirin|ribavirin|mesh-list
5708113|NCT03296930|Sofosbuvir|sofosbuvir|mesh-list
5708114|NCT03296930|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5708115|NCT03296930|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5708116|NCT03296930|Protease Inhibitors|protease inhibitors|mesh-ancestor
5708117|NCT03296930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5708118|NCT03296930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5708119|NCT03296930|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5708120|NCT03296930|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5708121|NCT03296930|Antiviral Agents|antiviral agents|mesh-ancestor
5708122|NCT03296930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5708123|NCT03296930|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5708124|NCT03296930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6231802|NCT02513498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6231803|NCT02513498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243762|NCT02680002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708125|NCT03296930|Antimetabolites|antimetabolites|mesh-ancestor
5708126|NCT03296670|Nitroglycerin|nitroglycerin|mesh-list
5708127|NCT03296670|Alprostadil|alprostadil|mesh-list
5708128|NCT03296670|Vasodilator Agents|vasodilator agents|mesh-ancestor
5708129|NCT03296670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5708130|NCT03296670|Urological Agents|urological agents|mesh-ancestor
5708131|NCT03296657|Fluorides|fluorides|mesh-list
5708132|NCT03296657|Tin Fluorides|tin fluorides|mesh-list
5708133|NCT03296657|Cariostatic Agents|cariostatic agents|mesh-ancestor
6243763|NCT02680054|Insulin|insulin|mesh-list
6243764|NCT02680054|Insulin Aspart|insulin aspart|mesh-list
6243765|NCT02680054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5708134|NCT03296657|Protective Agents|protective agents|mesh-ancestor
5708135|NCT03296657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708136|NCT03296579|Magnesium Sulfate|magnesium sulfate|mesh-list
5708137|NCT03296579|Aminophylline|aminophylline|mesh-list
5708138|NCT03296579|Albuterol|albuterol|mesh-list
5708139|NCT03296579|Ipratropium|ipratropium|mesh-list
5708140|NCT03296579|Analgesics|analgesics|mesh-ancestor
5708141|NCT03296579|Sensory System Agents|sensory system agents|mesh-ancestor
5708142|NCT03296579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5708143|NCT03296579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708144|NCT03296579|Anesthetics|anesthetics|mesh-ancestor
5708145|NCT03296579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5708146|NCT03296579|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5708147|NCT03296579|Anticonvulsants|anticonvulsants|mesh-ancestor
5708148|NCT03296579|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5708149|NCT03296579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5708150|NCT03296579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5708151|NCT03296579|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5708152|NCT03296579|Tocolytic Agents|tocolytic agents|mesh-ancestor
5708153|NCT03296579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5708154|NCT03296579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6231804|NCT02513550|Ixekizumab|ixekizumab|mesh-list
6231805|NCT02513550|Dermatologic Agents|dermatologic agents|mesh-ancestor
6231806|NCT02513719|Everolimus|everolimus|mesh-list
6231807|NCT02513719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6231808|NCT02513719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6231809|NCT02513719|Immunologic Factors|immunologic factors|mesh-ancestor
6231810|NCT02513719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231811|NCT02513771|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6231812|NCT02513771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6231813|NCT02513771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231814|NCT02513771|Incretins|incretins|mesh-ancestor
6500693|NCT00645892|Adalimumab|adalimumab|mesh-list
6500694|NCT00645892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6500695|NCT00645892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6500696|NCT00645905|Adalimumab|adalimumab|mesh-list
6500697|NCT00645905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6231815|NCT02513771|Hormones|hormones|mesh-ancestor
6231816|NCT02513771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6231817|NCT02513771|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6231818|NCT02513771|Protease Inhibitors|protease inhibitors|mesh-ancestor
6231819|NCT02513771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6231820|NCT02513771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231821|NCT02513823|Vitamin D|vitamin d|mesh-list
6231822|NCT02513823|Cholecalciferol|cholecalciferol|mesh-list
6231823|NCT02513823|Vitamins|vitamins|mesh-ancestor
6231824|NCT02513823|Micronutrients|micronutrients|mesh-ancestor
6231825|NCT02513823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231826|NCT02513823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6231827|NCT02513823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6500698|NCT00645905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6500699|NCT00645918|Clopidogrel|clopidogrel|mesh-list
6500700|NCT00645918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6676738|NCT01582776|Immunologic Factors|immunologic factors|mesh-ancestor
6676739|NCT01582776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676740|NCT01582776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6676741|NCT01582776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6676742|NCT01582776|Growth Substances|growth substances|mesh-ancestor
6676743|NCT01582776|Growth Inhibitors|growth inhibitors|mesh-ancestor
6676744|NCT01582776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6676745|NCT01582776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6676746|NCT01582932|Calcipotriene|calcipotriene|mesh-list
6676747|NCT01582932|Dermatologic Agents|dermatologic agents|mesh-ancestor
6676748|NCT01582997|Dabrafenib|dabrafenib|mesh-list
6676749|NCT01582997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6676750|NCT01582997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6676751|NCT01582997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6676752|NCT01582997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676753|NCT01583023|Bupropion|bupropion|mesh-list
6676754|NCT01583023|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6676755|NCT01583023|Antidepressive Agents|antidepressive agents|mesh-ancestor
6676756|NCT01583023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5708155|NCT03296579|Autonomic Agents|autonomic agents|mesh-ancestor
6231828|NCT02513940|Ibutilide|ibutilide|mesh-list
6231829|NCT02513940|Testosterone|testosterone|mesh-list
6500701|NCT00645918|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6231830|NCT02513940|Progesterone|progesterone|mesh-list
6231831|NCT02513940|Androgens|androgens|mesh-ancestor
6231832|NCT02513940|Hormones|hormones|mesh-ancestor
6231833|NCT02513940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6231834|NCT02513940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231835|NCT02513940|Progestins|progestins|mesh-ancestor
6231836|NCT02513940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6231837|NCT02514044|Adderall|adderall|mesh-list
6231838|NCT02514044|Dextroamphetamine|dextroamphetamine|mesh-list
6231839|NCT02514044|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6231840|NCT02514044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231841|NCT02514044|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6500702|NCT00645918|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6500703|NCT00645918|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6500704|NCT00645918|Purinergic Agents|purinergic agents|mesh-ancestor
6500705|NCT00645918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6500706|NCT00645918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500707|NCT00645918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6500708|NCT00645931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
6500709|NCT00645931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6500710|NCT00645931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6500711|NCT00646009|Fluticasone|fluticasone|mesh-list
6500712|NCT00646009|Budesonide|budesonide|mesh-list
6500713|NCT00646009|Albuterol|albuterol|mesh-list
6500714|NCT00646009|Formoterol Fumarate|formoterol fumarate|mesh-list
6500715|NCT00646009|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6500716|NCT00646009|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6500717|NCT00646009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6500718|NCT00646009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6500719|NCT00646009|Autonomic Agents|autonomic agents|mesh-ancestor
5708156|NCT03296579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5708157|NCT03296579|Respiratory System Agents|respiratory system agents|mesh-ancestor
5708158|NCT03296579|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5708159|NCT03296579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5708160|NCT03296579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5708161|NCT03296579|Adrenergic Agents|adrenergic agents|mesh-ancestor
5708162|NCT03296579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5708163|NCT03296579|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5708164|NCT03296579|Cholinergic Agents|cholinergic agents|mesh-ancestor
5708165|NCT03296579|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5708166|NCT03296579|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5708167|NCT03296579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5708168|NCT03296579|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5708169|NCT03296579|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5708170|NCT03296579|Purinergic Agents|purinergic agents|mesh-ancestor
5708171|NCT03296579|Protective Agents|protective agents|mesh-ancestor
5708172|NCT03296540|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
5708173|NCT03296540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5708174|NCT03296488|Fentanyl|fentanyl|mesh-list
5708175|NCT03296488|Nalbuphine|nalbuphine|mesh-list
5708176|NCT03296488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5708177|NCT03296488|Narcotics|narcotics|mesh-ancestor
5708178|NCT03296488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5708179|NCT03296488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708180|NCT03296488|Analgesics|analgesics|mesh-ancestor
5708181|NCT03296488|Sensory System Agents|sensory system agents|mesh-ancestor
5708182|NCT03296488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5708183|NCT03296488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5708184|NCT03296488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5708185|NCT03296488|Anesthetics, General|anesthetics, general|mesh-ancestor
5708186|NCT03296488|Anesthetics|anesthetics|mesh-ancestor
5708187|NCT03296423|Vaccines|vaccines|mesh-list
5708188|NCT03296423|Immunologic Factors|immunologic factors|mesh-ancestor
5708189|NCT03296423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708190|NCT03296410|Vaccines|vaccines|mesh-list
5708191|NCT03296410|Immunoglobulins|immunoglobulins|mesh-list
5708192|NCT03296410|Immunologic Factors|immunologic factors|mesh-ancestor
5708193|NCT03296410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708194|NCT03296397|Vaccines|vaccines|mesh-list
6231842|NCT02514044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6231843|NCT02514044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6231844|NCT02514044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231845|NCT02514044|Dopamine Agents|dopamine agents|mesh-ancestor
6231846|NCT02514044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6231847|NCT02514122|Ketamine|ketamine|mesh-list
6231848|NCT02514122|Analgesics|analgesics|mesh-ancestor
6500720|NCT00646009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6500721|NCT00646009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231849|NCT02514122|Sensory System Agents|sensory system agents|mesh-ancestor
6231850|NCT02514122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6231851|NCT02514122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231852|NCT02514122|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6231853|NCT02514122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6231854|NCT02514122|Anesthetics, General|anesthetics, general|mesh-ancestor
6231855|NCT02514122|Anesthetics|anesthetics|mesh-ancestor
5708195|NCT03296397|Immunologic Factors|immunologic factors|mesh-ancestor
5708196|NCT03296397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708197|NCT03296358|Dexamethasone|dexamethasone|mesh-list
5708198|NCT03296358|Prednisolone|prednisolone|mesh-list
5708199|NCT03296358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6231856|NCT02514122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6231857|NCT02514122|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6231858|NCT02514122|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6231859|NCT02514122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6231860|NCT02514122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231861|NCT02514174|Afatinib|afatinib|mesh-list
6231862|NCT02514174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6231863|NCT02514174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6231864|NCT02514174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6231865|NCT02514174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231866|NCT02514473|Ivacaftor|ivacaftor|mesh-list
6231867|NCT02514473|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6231868|NCT02514473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6231869|NCT02514473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231870|NCT02514551|Paclitaxel|paclitaxel|mesh-list
6500722|NCT00646009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6500723|NCT00646009|Respiratory System Agents|respiratory system agents|mesh-ancestor
6676757|NCT01583023|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6676758|NCT01583023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6676759|NCT01583023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6676760|NCT01583023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676761|NCT01583023|Dopamine Agents|dopamine agents|mesh-ancestor
6676762|NCT01583023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6676763|NCT01583023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676764|NCT01583023|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6676765|NCT01583023|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6676766|NCT01583023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6676767|NCT01583036|Digoxin|digoxin|mesh-list
6676768|NCT01583036|Ezogabine|ezogabine|mesh-list
6676769|NCT01583036|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6676770|NCT01583036|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6676771|NCT01583036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6676772|NCT01583036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676773|NCT01583036|Protective Agents|protective agents|mesh-ancestor
6676774|NCT01583036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676775|NCT01583036|Anticonvulsants|anticonvulsants|mesh-ancestor
6676776|NCT01583036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6676777|NCT01583062|Amoxicillin|amoxicillin|mesh-list
5708200|NCT03296358|Antiemetics|antiemetics|mesh-ancestor
5708201|NCT03296358|Autonomic Agents|autonomic agents|mesh-ancestor
6231871|NCT02514551|Ramucirumab|ramucirumab|mesh-list
6231872|NCT02514551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6231873|NCT02514551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6231874|NCT02514551|Tubulin Modulators|tubulin modulators|mesh-ancestor
6231875|NCT02514551|Antimitotic Agents|antimitotic agents|mesh-ancestor
6231876|NCT02514551|Mitosis Modulators|mitosis modulators|mesh-ancestor
6231877|NCT02514551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231878|NCT02514772|Rituximab|rituximab|mesh-list
6231879|NCT02514772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6231880|NCT02514772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6231881|NCT02514772|Immunologic Factors|immunologic factors|mesh-ancestor
6500724|NCT00646009|Dermatologic Agents|dermatologic agents|mesh-ancestor
6500725|NCT00646009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6500726|NCT00646009|Glucocorticoids|glucocorticoids|mesh-ancestor
6500727|NCT00646009|Hormones|hormones|mesh-ancestor
6500728|NCT00646009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6500729|NCT00646009|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6500730|NCT00646009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6500731|NCT00646009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6231882|NCT02514772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231883|NCT02514772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6231884|NCT02515045|Moxifloxacin|moxifloxacin|mesh-list
5708202|NCT03296358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5708203|NCT03296358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708204|NCT03296358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5708205|NCT03296358|Glucocorticoids|glucocorticoids|mesh-ancestor
5708206|NCT03296358|Hormones|hormones|mesh-ancestor
5708207|NCT03296358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5708208|NCT03296358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5708209|NCT03296358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5708210|NCT03296306|Cisplatin|cisplatin|mesh-list
5708211|NCT03296306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5708212|NCT03296189|Dexamethasone|dexamethasone|mesh-list
5708213|NCT03296189|Dexamethasone acetate|dexamethasone acetate|mesh-list
5708214|NCT03296189|Levobupivacaine|levobupivacaine|mesh-list
5708215|NCT03296189|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
5708216|NCT03296189|BB 1101|bb 1101|mesh-list
5708217|NCT03296189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5708218|NCT03296189|Antiemetics|antiemetics|mesh-ancestor
5708219|NCT03296189|Autonomic Agents|autonomic agents|mesh-ancestor
5708220|NCT03296189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6231885|NCT02515045|Prednisolone|prednisolone|mesh-list
6231886|NCT02515045|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6231887|NCT02515045|Methylprednisolone|methylprednisolone|mesh-list
6231888|NCT02515045|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6231889|NCT02515045|Prednisolone acetate|prednisolone acetate|mesh-list
6231890|NCT02515045|Nepafenac|nepafenac|mesh-list
6231891|NCT02515045|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6231892|NCT02515045|Prednisolone phosphate|prednisolone phosphate|mesh-list
6231893|NCT02515045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6231894|NCT02515045|Glucocorticoids|glucocorticoids|mesh-ancestor
6231895|NCT02515045|Hormones|hormones|mesh-ancestor
6231896|NCT02515045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6231897|NCT02515045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231898|NCT02515045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6231899|NCT02515045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6231900|NCT02515045|Antiemetics|antiemetics|mesh-ancestor
6231901|NCT02515045|Autonomic Agents|autonomic agents|mesh-ancestor
6231902|NCT02515045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6231903|NCT02515045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6231904|NCT02515045|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6231905|NCT02515045|Protective Agents|protective agents|mesh-ancestor
6231906|NCT02515045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6231907|NCT02515045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6231908|NCT02515045|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6231909|NCT02515045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6231910|NCT02515045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6231911|NCT02515045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231912|NCT02515045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6231913|NCT02515045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6231914|NCT02515045|Analgesics|analgesics|mesh-ancestor
6231915|NCT02515045|Sensory System Agents|sensory system agents|mesh-ancestor
6231916|NCT02515045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6500732|NCT00646009|Adrenergic Agents|adrenergic agents|mesh-ancestor
6500733|NCT00646009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6500734|NCT00646009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500735|NCT00646009|Tocolytic Agents|tocolytic agents|mesh-ancestor
6500736|NCT00646009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6500737|NCT00646009|Sympathomimetics|sympathomimetics|mesh-ancestor
6500738|NCT00646035|Ergocalciferols|ergocalciferols|mesh-list
6500739|NCT00646035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6500740|NCT00646035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6500741|NCT00646035|Vitamins|vitamins|mesh-ancestor
6500742|NCT00646035|Micronutrients|micronutrients|mesh-ancestor
6500743|NCT00646035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6500744|NCT00646061|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
6500745|NCT00646061|Parasympatholytics|parasympatholytics|mesh-ancestor
6231917|NCT02515279|Ribavirin|ribavirin|mesh-list
6231918|NCT02515279|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6500746|NCT00646061|Autonomic Agents|autonomic agents|mesh-ancestor
6500747|NCT00646061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6500748|NCT00646061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708221|NCT03296189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231919|NCT02515279|Antimetabolites|antimetabolites|mesh-ancestor
5708222|NCT03296189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5708223|NCT03296189|Glucocorticoids|glucocorticoids|mesh-ancestor
5708224|NCT03296189|Hormones|hormones|mesh-ancestor
6231920|NCT02515279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231921|NCT02515279|Antiviral Agents|antiviral agents|mesh-ancestor
6231922|NCT02515279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6231923|NCT02515305|Clindamycin|clindamycin|mesh-list
6231924|NCT02515305|Clindamycin palmitate|clindamycin palmitate|mesh-list
6231925|NCT02515305|Clindamycin phosphate|clindamycin phosphate|mesh-list
6231926|NCT02515305|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6231927|NCT02515305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6231928|NCT02515305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6231929|NCT02515305|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6231930|NCT02515305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6231931|NCT02515305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231932|NCT02515305|Dermatologic Agents|dermatologic agents|mesh-ancestor
6231933|NCT02515630|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
6231934|NCT02515630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6231935|NCT02515630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6231936|NCT02515630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231937|NCT02515890|Midazolam|midazolam|mesh-list
6231938|NCT02515890|Dexmedetomidine|dexmedetomidine|mesh-list
6231939|NCT02515890|Ketamine|ketamine|mesh-list
6231940|NCT02515890|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6231941|NCT02515890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6231942|NCT02515890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231943|NCT02515890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6231944|NCT02515890|Analgesics|analgesics|mesh-ancestor
6231945|NCT02515890|Sensory System Agents|sensory system agents|mesh-ancestor
6231946|NCT02515890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6231947|NCT02515890|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6231948|NCT02515890|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6231949|NCT02515890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5708225|NCT03296189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5708226|NCT03296189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5708227|NCT03296189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5708228|NCT03296189|Anesthetics, Local|anesthetics, local|mesh-ancestor
5708229|NCT03296189|Anesthetics|anesthetics|mesh-ancestor
5708230|NCT03296189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5708231|NCT03296189|Sensory System Agents|sensory system agents|mesh-ancestor
5708232|NCT03296189|Protease Inhibitors|protease inhibitors|mesh-ancestor
5708233|NCT03296189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5708234|NCT03296189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918903|NCT04988282|Prednisolone phosphate|prednisolone phosphate|mesh-list
6231950|NCT02515890|Adrenergic Agents|adrenergic agents|mesh-ancestor
6231951|NCT02515890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6231952|NCT02515890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6231953|NCT02515890|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6231954|NCT02515890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6231955|NCT02515890|Anesthetics, General|anesthetics, general|mesh-ancestor
6231956|NCT02515890|Anesthetics|anesthetics|mesh-ancestor
6231957|NCT02515890|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6231958|NCT02515890|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6231959|NCT02515890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6231960|NCT02515890|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6231961|NCT02515890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6231962|NCT02515890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6231963|NCT02515890|GABA Modulators|gaba modulators|mesh-ancestor
6231964|NCT02515890|GABA Agents|gaba agents|mesh-ancestor
6231965|NCT02516098|Scopolamine|scopolamine|mesh-list
6231966|NCT02516098|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
6231967|NCT02516098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5918904|NCT04988282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5918905|NCT04988282|Antiemetics|antiemetics|mesh-ancestor
5918906|NCT04988282|Autonomic Agents|autonomic agents|mesh-ancestor
5918907|NCT04988282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5918908|NCT04988282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918909|NCT04988282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6231968|NCT02516098|Antiemetics|antiemetics|mesh-ancestor
6231969|NCT02516098|Autonomic Agents|autonomic agents|mesh-ancestor
5918910|NCT04988282|Glucocorticoids|glucocorticoids|mesh-ancestor
5918911|NCT04988282|Hormones|hormones|mesh-ancestor
5918912|NCT04988282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5918913|NCT04988282|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5708235|NCT03296137|Aldesleukin|aldesleukin|mesh-list
5708236|NCT03296137|Cyclophosphamide|cyclophosphamide|mesh-list
5708237|NCT03296137|Nivolumab|nivolumab|mesh-list
5708238|NCT03296137|Ipilimumab|ipilimumab|mesh-list
5708239|NCT03296137|Fludarabine phosphate|fludarabine phosphate|mesh-list
5708240|NCT03296137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5708241|NCT03296137|Immunologic Factors|immunologic factors|mesh-ancestor
5708242|NCT03296137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708243|NCT03296137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5708244|NCT03296137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6231970|NCT02516098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6231971|NCT02516098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231972|NCT02516098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6231973|NCT02516098|Mydriatics|mydriatics|mesh-ancestor
6231974|NCT02516098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6231975|NCT02516098|Cholinergic Agents|cholinergic agents|mesh-ancestor
6231976|NCT02516098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6231977|NCT02516098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500749|NCT00646061|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6500750|NCT00646061|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6500751|NCT00646061|Cholinergic Agents|cholinergic agents|mesh-ancestor
6500752|NCT00646061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6500753|NCT00646061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500754|NCT00646087|Ketamine|ketamine|mesh-list
6500755|NCT00646087|Analgesics|analgesics|mesh-ancestor
6500756|NCT00646087|Sensory System Agents|sensory system agents|mesh-ancestor
6500757|NCT00646087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6500758|NCT00646087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6500759|NCT00646087|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6500760|NCT00646087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6500761|NCT00646087|Anesthetics, General|anesthetics, general|mesh-ancestor
6500762|NCT00646087|Anesthetics|anesthetics|mesh-ancestor
6500763|NCT00646087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6500764|NCT00646087|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6500765|NCT00646087|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6231978|NCT02516098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6231979|NCT02516098|Parasympatholytics|parasympatholytics|mesh-ancestor
6231980|NCT02516150|Ethanol|ethanol|mesh-list
6231981|NCT02516150|Glucagon|glucagon|mesh-list
6231982|NCT02516150|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6231983|NCT02516150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6500766|NCT00646087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6500767|NCT00646087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500768|NCT00646126|Artesunate|artesunate|mesh-list
6676778|NCT01583062|Clavulanic Acids|clavulanic acids|mesh-list
6676779|NCT01583062|Clavulanic Acid|clavulanic acid|mesh-list
6676780|NCT01583062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6676781|NCT01583062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6676782|NCT01583062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6676783|NCT01583062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676784|NCT01583062|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6676785|NCT01583114|Perindopril|perindopril|mesh-list
6779671|NCT02180425|Isotretinoin|isotretinoin|mesh-list
5708245|NCT03296137|Alkylating Agents|alkylating agents|mesh-ancestor
6231984|NCT02516150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6231985|NCT02516150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231986|NCT02516150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6231987|NCT02516150|Hormones|hormones|mesh-ancestor
6231988|NCT02516150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6231989|NCT02516202|Estradiol|estradiol|mesh-list
6231990|NCT02516202|Estrogens|estrogens|mesh-ancestor
6231991|NCT02516202|Hormones|hormones|mesh-ancestor
6231992|NCT02516202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6231993|NCT02516202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6231994|NCT02516306|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6231995|NCT02516306|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6231996|NCT02516332|Citalopram|citalopram|mesh-list
6231997|NCT02516332|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6231998|NCT02516332|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6231999|NCT02516332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6232000|NCT02516332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232001|NCT02516332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6232002|NCT02516332|Serotonin Agents|serotonin agents|mesh-ancestor
6232003|NCT02516332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6500769|NCT00646126|Pyrimethamine|pyrimethamine|mesh-list
6232004|NCT02516332|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6232005|NCT02516332|Antidepressive Agents|antidepressive agents|mesh-ancestor
6232006|NCT02516332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6232007|NCT02516410|Ivacaftor|ivacaftor|mesh-list
6232008|NCT02516410|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6232009|NCT02516410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6232010|NCT02516410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232011|NCT02516592|Fluticasone|fluticasone|mesh-list
6232012|NCT02516592|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6232013|NCT02516592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6232014|NCT02516592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6232015|NCT02516592|Autonomic Agents|autonomic agents|mesh-ancestor
5708246|NCT03296137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5708247|NCT03296137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5708248|NCT03296137|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5708249|NCT03296137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5708250|NCT03296137|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5708251|NCT03296137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5708252|NCT03296137|Antimetabolites|antimetabolites|mesh-ancestor
5708253|NCT03296137|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5708254|NCT03296137|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5708255|NCT03296137|Antiviral Agents|antiviral agents|mesh-ancestor
5708256|NCT03296137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5708257|NCT03296098|Ulipristal acetate|ulipristal acetate|mesh-list
5708258|NCT03296098|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5708259|NCT03296098|Contraceptive Agents|contraceptive agents|mesh-ancestor
5708260|NCT03296098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5708261|NCT03296098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708262|NCT03296098|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5708263|NCT03295968|Ibuprofen|ibuprofen|mesh-list
5708264|NCT03295968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5708265|NCT03295968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5708266|NCT03295968|Analgesics|analgesics|mesh-ancestor
5708267|NCT03295968|Sensory System Agents|sensory system agents|mesh-ancestor
5918914|NCT04988282|Protective Agents|protective agents|mesh-ancestor
5918915|NCT04988282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5918916|NCT04988282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6232016|NCT02516592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6232017|NCT02516592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232018|NCT02516592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6232019|NCT02516592|Respiratory System Agents|respiratory system agents|mesh-ancestor
6232020|NCT02516592|Dermatologic Agents|dermatologic agents|mesh-ancestor
6232021|NCT02516592|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6232022|NCT02516592|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6232023|NCT02516592|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6232024|NCT02516592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6232025|NCT02516592|Adrenergic Agents|adrenergic agents|mesh-ancestor
6232026|NCT02516592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6232027|NCT02516592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232028|NCT02517021|Dexamethasone|dexamethasone|mesh-list
6232029|NCT02517021|Palonosetron|palonosetron|mesh-list
6232030|NCT02517021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6500770|NCT00646126|Sulfadoxine|sulfadoxine|mesh-list
6500771|NCT00646126|Antimalarials|antimalarials|mesh-ancestor
6500772|NCT00646126|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6500773|NCT00646126|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6500774|NCT00646126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6500775|NCT00646126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6232031|NCT02517021|Antiemetics|antiemetics|mesh-ancestor
6232032|NCT02517021|Autonomic Agents|autonomic agents|mesh-ancestor
6232033|NCT02517021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6232034|NCT02517021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6500776|NCT00646126|Antiviral Agents|antiviral agents|mesh-ancestor
6500777|NCT00646126|Schistosomicides|schistosomicides|mesh-ancestor
6500778|NCT00646126|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6500779|NCT00646126|Anthelmintics|anthelmintics|mesh-ancestor
6500780|NCT00646126|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6500781|NCT00646126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6500782|NCT00646126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232035|NCT02517021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6232036|NCT02517021|Glucocorticoids|glucocorticoids|mesh-ancestor
6232037|NCT02517021|Hormones|hormones|mesh-ancestor
6232038|NCT02517021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6232039|NCT02517021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6232040|NCT02517021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6232041|NCT02517021|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6232042|NCT02517021|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6232043|NCT02517021|Serotonin Agents|serotonin agents|mesh-ancestor
6232044|NCT02517021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6232045|NCT02517021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232046|NCT02517463|Ulipristal acetate|ulipristal acetate|mesh-list
6232047|NCT02517463|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6232048|NCT02517463|Contraceptive Agents|contraceptive agents|mesh-ancestor
6232049|NCT02517463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6232050|NCT02517463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232051|NCT02517463|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5708268|NCT03295968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5708269|NCT03295968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708270|NCT03295968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5708271|NCT03295968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5708272|NCT03295968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5708273|NCT03295968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5708274|NCT03295968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5708275|NCT03295955|Amoxicillin|amoxicillin|mesh-list
5708276|NCT03295955|Clavulanic Acid|clavulanic acid|mesh-list
5708277|NCT03295955|Clavulanic Acids|clavulanic acids|mesh-list
5708278|NCT03295955|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5708279|NCT03295955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5708280|NCT03295955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5708281|NCT03295955|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5708282|NCT03295955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5708283|NCT03295955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5708284|NCT03295903|Cannabidiol|cannabidiol|mesh-list
5708285|NCT03295903|Anticonvulsants|anticonvulsants|mesh-ancestor
5708286|NCT03295851|Iron|iron|mesh-list
5708287|NCT03295851|Ferrous fumarate|ferrous fumarate|mesh-list
6232052|NCT02517515|Ritonavir|ritonavir|mesh-list
6232053|NCT02517515|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6232054|NCT02517515|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6232055|NCT02517515|Protease Inhibitors|protease inhibitors|mesh-ancestor
6232056|NCT02517515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6232057|NCT02517515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232058|NCT02517515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5708288|NCT03295851|Trace Elements|trace elements|mesh-ancestor
5708289|NCT03295851|Micronutrients|micronutrients|mesh-ancestor
5708290|NCT03295851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708291|NCT03295825|Heparin|heparin|mesh-list
5708292|NCT03295825|Anticoagulants|anticoagulants|mesh-ancestor
5708293|NCT03295825|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5708294|NCT03295825|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5708295|NCT03295825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5708296|NCT03295786|Dopamine|dopamine|mesh-list
6232059|NCT02517515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6232060|NCT02517515|Antiviral Agents|antiviral agents|mesh-ancestor
6232061|NCT02517515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6676786|NCT01583114|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6676787|NCT01583114|Protease Inhibitors|protease inhibitors|mesh-ancestor
6676788|NCT01583114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6676789|NCT01583114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676790|NCT01583114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6676791|NCT01583244|Abatacept|abatacept|mesh-list
6676792|NCT01583244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5708297|NCT03295786|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6232062|NCT02517515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6500783|NCT00646126|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6500784|NCT00646126|Renal Agents|renal agents|mesh-ancestor
6232063|NCT02517515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6232064|NCT02517528|Ritonavir|ritonavir|mesh-list
6232065|NCT02517528|Ribavirin|ribavirin|mesh-list
6232066|NCT02517528|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6232067|NCT02517528|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6232068|NCT02517528|Protease Inhibitors|protease inhibitors|mesh-ancestor
6232069|NCT02517528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6232070|NCT02517528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232071|NCT02517528|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6232072|NCT02517528|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6232073|NCT02517528|Antiviral Agents|antiviral agents|mesh-ancestor
6232074|NCT02517528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5708298|NCT03295786|Sympathomimetics|sympathomimetics|mesh-ancestor
5708299|NCT03295786|Autonomic Agents|autonomic agents|mesh-ancestor
5708300|NCT03295786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5708301|NCT03295786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708302|NCT03295786|Dopamine Agents|dopamine agents|mesh-ancestor
5708303|NCT03295786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5708304|NCT03295786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5708305|NCT03295786|Protective Agents|protective agents|mesh-ancestor
5708306|NCT03295760|Ubiquinone|ubiquinone|mesh-list
5708307|NCT03295760|Coenzyme Q10|coenzyme q10|mesh-list
5708308|NCT03295760|Micronutrients|micronutrients|mesh-ancestor
5708309|NCT03295760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708310|NCT03295760|Vitamins|vitamins|mesh-ancestor
6232075|NCT02517528|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6232076|NCT02517528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6232077|NCT02517528|Antimetabolites|antimetabolites|mesh-ancestor
6232078|NCT02517580|Vitamin K|vitamin k|mesh-list
6232079|NCT02517580|Vitamin K 2|vitamin k 2|mesh-list
6232080|NCT02517580|Vitamins|vitamins|mesh-ancestor
6232081|NCT02517580|Micronutrients|micronutrients|mesh-ancestor
6232082|NCT02517580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232083|NCT02517580|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6232084|NCT02517580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6232085|NCT02517580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232086|NCT02517580|Hemostatics|hemostatics|mesh-ancestor
6500785|NCT00646139|Tirbanibulin|tirbanibulin|mesh-list
6500786|NCT00646139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6500787|NCT00646139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500788|NCT00646152|Poly ICLC|poly iclc|mesh-list
6500789|NCT00646152|Interferon Inducers|interferon inducers|mesh-ancestor
6500790|NCT00646152|Immunologic Factors|immunologic factors|mesh-ancestor
6500791|NCT00646152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6500792|NCT00646178|Adalimumab|adalimumab|mesh-list
6500793|NCT00646178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5708311|NCT03295747|Peppermint oil|peppermint oil|mesh-list
5708312|NCT03295747|Antiemetics|antiemetics|mesh-ancestor
5708313|NCT03295747|Autonomic Agents|autonomic agents|mesh-ancestor
5708314|NCT03295747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6232087|NCT02517580|Coagulants|coagulants|mesh-ancestor
6500794|NCT00646178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6500795|NCT00646191|Adalimumab|adalimumab|mesh-list
6500796|NCT00646191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6500797|NCT00646191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6500798|NCT00646204|Memantine|memantine|mesh-list
6500799|NCT00646204|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6500800|NCT00646204|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6500801|NCT00646204|Dopamine Agents|dopamine agents|mesh-ancestor
6500802|NCT00646204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6232088|NCT02517866|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
6232089|NCT02517866|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6232090|NCT02517866|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6232091|NCT02517866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232092|NCT02517905|Bupivacaine|bupivacaine|mesh-list
6232093|NCT02517905|Anesthetics, Local|anesthetics, local|mesh-ancestor
6232094|NCT02517905|Anesthetics|anesthetics|mesh-ancestor
6232095|NCT02517905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6232096|NCT02517905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232097|NCT02517905|Sensory System Agents|sensory system agents|mesh-ancestor
6232098|NCT02517905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6232099|NCT02517996|Lidocaine|lidocaine|mesh-list
6232100|NCT02517996|Anesthetics, Local|anesthetics, local|mesh-ancestor
6676793|NCT01583244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5708315|NCT03295747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6500803|NCT00646204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500804|NCT00646204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232101|NCT02517996|Anesthetics|anesthetics|mesh-ancestor
6232102|NCT02517996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6232103|NCT02517996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232104|NCT02517996|Sensory System Agents|sensory system agents|mesh-ancestor
6232105|NCT02517996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6232106|NCT02517996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6232107|NCT02517996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6232108|NCT02517996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6232109|NCT02517996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6232110|NCT02517996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5708316|NCT03295747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5708317|NCT03295747|Parasympatholytics|parasympatholytics|mesh-ancestor
5708318|NCT03295734|Losartan|losartan|mesh-list
5708319|NCT03295734|Perindopril|perindopril|mesh-list
5708320|NCT03295734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5708321|NCT03295734|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5708322|NCT03295734|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6232111|NCT02518113|Dexamethasone|dexamethasone|mesh-list
6232112|NCT02518113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6232113|NCT02518113|Antiemetics|antiemetics|mesh-ancestor
6232114|NCT02518113|Autonomic Agents|autonomic agents|mesh-ancestor
6232115|NCT02518113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6232116|NCT02518113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232117|NCT02518113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6232118|NCT02518113|Glucocorticoids|glucocorticoids|mesh-ancestor
6232119|NCT02518113|Hormones|hormones|mesh-ancestor
6232120|NCT02518113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6232121|NCT02518113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6232122|NCT02518113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6232123|NCT02518191|Goserelin|goserelin|mesh-list
5708323|NCT03295734|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5708324|NCT03295734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5708325|NCT03295734|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5708326|NCT03295734|Protease Inhibitors|protease inhibitors|mesh-ancestor
5708327|NCT03295734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5708328|NCT03295695|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5708329|NCT03295695|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5708330|NCT03295695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721459|NCT03205228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721460|NCT03205228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5721461|NCT03205228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5721462|NCT03205228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5721463|NCT03205228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721464|NCT03205228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5721465|NCT03205228|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5721466|NCT03205228|Dopamine Agents|dopamine agents|mesh-ancestor
5721467|NCT03205228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5721468|NCT03205176|Olaparib|olaparib|mesh-list
5721469|NCT03205176|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5721470|NCT03205176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5721471|NCT03205176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721472|NCT03205176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5722319|NCT03199976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5722320|NCT03199976|Respiratory System Agents|respiratory system agents|mesh-ancestor
5722321|NCT03199976|Dermatologic Agents|dermatologic agents|mesh-ancestor
6232124|NCT02518191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6232125|NCT02518191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6232126|NCT02518464|Ticagrelor|ticagrelor|mesh-list
6232127|NCT02518464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6232128|NCT02518464|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5708331|NCT03295552|Carboplatin|carboplatin|mesh-list
5708332|NCT03295552|Decitabine|decitabine|mesh-list
5708333|NCT03295552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5708334|NCT03295552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5708335|NCT03295552|Antimetabolites|antimetabolites|mesh-ancestor
5708336|NCT03295552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5708337|NCT03295552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5708338|NCT03295487|Estrogens|estrogens|mesh-list
5708339|NCT03295487|Hormones|hormones|mesh-ancestor
5708340|NCT03295487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5708341|NCT03295487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708342|NCT03295461|Chlorhexidine|chlorhexidine|mesh-list
5708343|NCT03295461|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6232129|NCT02518464|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6232130|NCT02518464|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6232131|NCT02518464|Purinergic Agents|purinergic agents|mesh-ancestor
6232132|NCT02518464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6232133|NCT02518464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232134|NCT02518464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232135|NCT02518971|Tamsulosin|tamsulosin|mesh-list
6232136|NCT02518971|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6232137|NCT02518971|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6232138|NCT02518971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6232139|NCT02518971|Adrenergic Agents|adrenergic agents|mesh-ancestor
5708344|NCT03295461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5708345|NCT03295461|Disinfectants|disinfectants|mesh-ancestor
5708346|NCT03295383|Cyclophosphamide|cyclophosphamide|mesh-list
5708347|NCT03295383|Rituximab|rituximab|mesh-list
5708348|NCT03295383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5708349|NCT03295383|Immunologic Factors|immunologic factors|mesh-ancestor
5708350|NCT03295383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708351|NCT03295383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5708352|NCT03295383|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5708353|NCT03295383|Alkylating Agents|alkylating agents|mesh-ancestor
5708354|NCT03295383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5708355|NCT03295383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5708356|NCT03295383|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5708357|NCT03295383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5708358|NCT03295227|Pembrolizumab|pembrolizumab|mesh-list
5708359|NCT03295227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5708360|NCT03295227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5708361|NCT03295214|Acetaminophen|acetaminophen|mesh-list
5708362|NCT03295214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5708363|NCT03295214|Analgesics|analgesics|mesh-ancestor
5708364|NCT03295214|Sensory System Agents|sensory system agents|mesh-ancestor
5708365|NCT03295214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5708366|NCT03295214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708367|NCT03295214|Antipyretics|antipyretics|mesh-ancestor
6232140|NCT02518971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6232141|NCT02518971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232142|NCT02518971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232143|NCT02518971|Urological Agents|urological agents|mesh-ancestor
6232144|NCT02519023|Acetaminophen|acetaminophen|mesh-list
6232145|NCT02519023|Ibuprofen|ibuprofen|mesh-list
6232146|NCT02519023|Epinephrine|epinephrine|mesh-list
6232147|NCT02519023|Oxycodone|oxycodone|mesh-list
6232148|NCT02519023|Bupivacaine|bupivacaine|mesh-list
6232149|NCT02519023|Anesthetics, Local|anesthetics, local|mesh-ancestor
6232150|NCT02519023|Anesthetics|anesthetics|mesh-ancestor
6232151|NCT02519023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6232152|NCT02519023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232153|NCT02519023|Sensory System Agents|sensory system agents|mesh-ancestor
6232154|NCT02519023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6500805|NCT00646204|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6500806|NCT00646204|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6500807|NCT00646230|Fenretinide|fenretinide|mesh-list
6500808|NCT00646230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6232155|NCT02519023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6232156|NCT02519023|Analgesics|analgesics|mesh-ancestor
6232157|NCT02519023|Antipyretics|antipyretics|mesh-ancestor
6232158|NCT02519023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6232159|NCT02519023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6500809|NCT00646230|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5708368|NCT03295162|Melatonin|melatonin|mesh-list
5708369|NCT03295162|Antioxidants|antioxidants|mesh-ancestor
6232160|NCT02519023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6232161|NCT02519023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6232162|NCT02519023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6232163|NCT02519023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232164|NCT02519023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6232165|NCT02519023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6232166|NCT02519023|Adrenergic Agents|adrenergic agents|mesh-ancestor
6232167|NCT02519023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6232168|NCT02519023|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6232169|NCT02519023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6500810|NCT00646230|Protective Agents|protective agents|mesh-ancestor
6500811|NCT00646230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6500812|NCT00646321|Budesonide|budesonide|mesh-list
6500813|NCT00646321|Formoterol Fumarate|formoterol fumarate|mesh-list
6500814|NCT00646321|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6500815|NCT00646321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6500816|NCT00646321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6500817|NCT00646321|Autonomic Agents|autonomic agents|mesh-ancestor
6500818|NCT00646321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6676794|NCT01583244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6676795|NCT01583244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6232170|NCT02519023|Autonomic Agents|autonomic agents|mesh-ancestor
6232171|NCT02519023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6232172|NCT02519023|Respiratory System Agents|respiratory system agents|mesh-ancestor
6232173|NCT02519023|Mydriatics|mydriatics|mesh-ancestor
6232174|NCT02519023|Sympathomimetics|sympathomimetics|mesh-ancestor
6232175|NCT02519023|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6232176|NCT02519023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6232177|NCT02519023|Narcotics|narcotics|mesh-ancestor
6232178|NCT02519231|Naproxen|naproxen|mesh-list
5708370|NCT03295162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5708371|NCT03295162|Protective Agents|protective agents|mesh-ancestor
5708372|NCT03295162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708373|NCT03295162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5708374|NCT03295110|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5708375|NCT03295084|Capecitabine|capecitabine|mesh-list
5708376|NCT03295084|Irinotecan|irinotecan|mesh-list
5708377|NCT03295084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5708378|NCT03295084|Antimetabolites|antimetabolites|mesh-ancestor
5708379|NCT03295084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5708380|NCT03295084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5708381|NCT03295084|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5708382|NCT03295084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5708383|NCT03295084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5708384|NCT03294967|Vitamin E|vitamin e|mesh-list
5708385|NCT03294967|Caffeine|caffeine|mesh-list
5708386|NCT03294967|Vitamins|vitamins|mesh-ancestor
5708387|NCT03294967|Micronutrients|micronutrients|mesh-ancestor
5708388|NCT03294967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708389|NCT03294967|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5708390|NCT03294967|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5708391|NCT03294967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5708392|NCT03294967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5708393|NCT03294967|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5708394|NCT03294967|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5708395|NCT03294967|Purinergic Agents|purinergic agents|mesh-ancestor
5708396|NCT03294967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5708397|NCT03294967|Antioxidants|antioxidants|mesh-ancestor
6232179|NCT02519231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6232180|NCT02519231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6232181|NCT02519231|Analgesics|analgesics|mesh-ancestor
6232182|NCT02519231|Sensory System Agents|sensory system agents|mesh-ancestor
6232183|NCT02519231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6232184|NCT02519231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232185|NCT02519231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6676796|NCT01583244|Immunologic Factors|immunologic factors|mesh-ancestor
6676797|NCT01583244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232186|NCT02519231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6232187|NCT02519231|Gout Suppressants|gout suppressants|mesh-ancestor
6232188|NCT02519231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6232189|NCT02519231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6676798|NCT01583244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6676799|NCT01583361|Oxaliplatin|oxaliplatin|mesh-list
6676800|NCT01583361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6232190|NCT02519231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232191|NCT02519387|Buprenorphine|buprenorphine|mesh-list
6232192|NCT02519387|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6232193|NCT02519387|Narcotics|narcotics|mesh-ancestor
6232194|NCT02519387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6232195|NCT02519387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232196|NCT02519387|Analgesics|analgesics|mesh-ancestor
6232197|NCT02519387|Sensory System Agents|sensory system agents|mesh-ancestor
6500819|NCT00646321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6500820|NCT00646321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6500821|NCT00646321|Respiratory System Agents|respiratory system agents|mesh-ancestor
6500822|NCT00646321|Glucocorticoids|glucocorticoids|mesh-ancestor
6500823|NCT00646321|Hormones|hormones|mesh-ancestor
6500824|NCT00646321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6500825|NCT00646321|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6500826|NCT00646321|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6500827|NCT00646321|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6500828|NCT00646321|Adrenergic Agents|adrenergic agents|mesh-ancestor
6500829|NCT00646321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6500830|NCT00646321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500831|NCT00646386|Adalimumab|adalimumab|mesh-list
6500832|NCT00646386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6500833|NCT00646386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6676801|NCT01583426|Paclitaxel|paclitaxel|mesh-list
6232198|NCT02519387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6232199|NCT02519387|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6232200|NCT02519595|Ketamine|ketamine|mesh-list
6676802|NCT01583426|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6676803|NCT01583426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6676804|NCT01583426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6676805|NCT01583426|Tubulin Modulators|tubulin modulators|mesh-ancestor
6676806|NCT01583426|Antimitotic Agents|antimitotic agents|mesh-ancestor
6676807|NCT01583426|Mitosis Modulators|mitosis modulators|mesh-ancestor
6676808|NCT01583426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676809|NCT01583439|Ritonavir|ritonavir|mesh-list
6676810|NCT01583439|Lopinavir|lopinavir|mesh-list
6676811|NCT01583439|Tenofovir|tenofovir|mesh-list
6676812|NCT01583439|Lamivudine|lamivudine|mesh-list
6676813|NCT01583439|Zidovudine|zidovudine|mesh-list
6676814|NCT01583439|Emtricitabine|emtricitabine|mesh-list
6676815|NCT01583439|Efavirenz|efavirenz|mesh-list
6676816|NCT01583439|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6676817|NCT01583439|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6232201|NCT02519595|Analgesics|analgesics|mesh-ancestor
6232202|NCT02519595|Sensory System Agents|sensory system agents|mesh-ancestor
6676818|NCT01583439|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6676819|NCT01583439|Protease Inhibitors|protease inhibitors|mesh-ancestor
6676820|NCT01583439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6676821|NCT01583439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676822|NCT01583439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6676823|NCT01583439|Antiviral Agents|antiviral agents|mesh-ancestor
6676824|NCT01583439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6676825|NCT01583439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6676826|NCT01583439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6676827|NCT01583439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6676828|NCT01583439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6676829|NCT01583439|Antimetabolites|antimetabolites|mesh-ancestor
6676830|NCT01583439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6676831|NCT01583439|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6676832|NCT01583439|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6676833|NCT01583439|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6676834|NCT01583439|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6676835|NCT01583478|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
6676836|NCT01583478|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6676837|NCT01583478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6676838|NCT01583478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676839|NCT01583478|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6676840|NCT01583478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6779672|NCT02180425|Dermatologic Agents|dermatologic agents|mesh-ancestor
6779673|NCT02180425|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5708398|NCT03294967|Protective Agents|protective agents|mesh-ancestor
5708399|NCT03294798|Interferons|interferons|mesh-list
5708400|NCT03294798|Interferon-alpha|interferon-alpha|mesh-list
5708401|NCT03294798|Interferon alpha-2|interferon alpha-2|mesh-list
5708402|NCT03294798|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5708403|NCT03294798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5708404|NCT03294798|Antiviral Agents|antiviral agents|mesh-ancestor
5708405|NCT03294798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5708406|NCT03294798|Immunologic Factors|immunologic factors|mesh-ancestor
5708407|NCT03294798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708408|NCT03294772|Hand Sanitizers|hand sanitizers|mesh-list
5708409|NCT03294772|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6232203|NCT02519595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6232204|NCT02519595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232205|NCT02519595|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5708410|NCT03294772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5708411|NCT03294772|Disinfectants|disinfectants|mesh-ancestor
5708412|NCT03294707|Coal Tar|coal tar|mesh-list
5708413|NCT03294707|Keratolytic Agents|keratolytic agents|mesh-ancestor
5708414|NCT03294707|Dermatologic Agents|dermatologic agents|mesh-ancestor
5708415|NCT03294694|Fulvestrant|fulvestrant|mesh-list
5708416|NCT03294694|Spartalizumab|spartalizumab|mesh-list
5708417|NCT03294694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5708418|NCT03294694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5708419|NCT03294694|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5708420|NCT03294694|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5708421|NCT03294694|Hormone Antagonists|hormone antagonists|mesh-ancestor
5708422|NCT03294694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5708423|NCT03294694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708424|NCT03294694|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5708425|NCT03294694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5708426|NCT03294577|Cyclophosphamide|cyclophosphamide|mesh-list
5708427|NCT03294577|Docetaxel|docetaxel|mesh-list
5708428|NCT03294577|Doxorubicin|doxorubicin|mesh-list
5708429|NCT03294577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5708430|NCT03294577|Immunologic Factors|immunologic factors|mesh-ancestor
5708431|NCT03294577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708432|NCT03294577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5708433|NCT03294577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5708434|NCT03294577|Alkylating Agents|alkylating agents|mesh-ancestor
5708435|NCT03294577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5708436|NCT03294577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6232206|NCT02519595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6232207|NCT02519595|Anesthetics, General|anesthetics, general|mesh-ancestor
6232208|NCT02519595|Anesthetics|anesthetics|mesh-ancestor
5708437|NCT03294577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5708438|NCT03294577|Tubulin Modulators|tubulin modulators|mesh-ancestor
5708439|NCT03294577|Antimitotic Agents|antimitotic agents|mesh-ancestor
5708440|NCT03294577|Mitosis Modulators|mitosis modulators|mesh-ancestor
5708441|NCT03294577|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5708442|NCT03294577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5708443|NCT03294577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5708444|NCT03294577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5708445|NCT03294551|Vaccines|vaccines|mesh-list
5708446|NCT03294551|Immunologic Factors|immunologic factors|mesh-ancestor
5708447|NCT03294551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708448|NCT03294525|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5708449|NCT03294525|Mirtazapine|mirtazapine|mesh-list
5708450|NCT03294525|Citalopram|citalopram|mesh-list
5708451|NCT03294525|Antidepressive Agents|antidepressive agents|mesh-list
5708452|NCT03294525|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5708453|NCT03294525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5708454|NCT03294525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5708455|NCT03294525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5708456|NCT03294525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5708457|NCT03294525|Serotonin Agents|serotonin agents|mesh-ancestor
5708458|NCT03294525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708459|NCT03294525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5708460|NCT03294525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5708461|NCT03294525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5708462|NCT03294525|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5708463|NCT03294525|Analgesics|analgesics|mesh-ancestor
5708464|NCT03294525|Sensory System Agents|sensory system agents|mesh-ancestor
6232209|NCT02519595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5708465|NCT03294525|Dopamine Agents|dopamine agents|mesh-ancestor
6232210|NCT02519595|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6232211|NCT02519595|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6232212|NCT02519595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6232213|NCT02519595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232214|NCT02519842|Dexamethasone|dexamethasone|mesh-list
6232215|NCT02519842|Ondansetron|ondansetron|mesh-list
6232216|NCT02519842|Fosaprepitant|fosaprepitant|mesh-list
6232217|NCT02519842|Aprepitant|aprepitant|mesh-list
6232218|NCT02519842|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
5708466|NCT03294525|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5708467|NCT03294525|Histamine Antagonists|histamine antagonists|mesh-ancestor
5708468|NCT03294525|Histamine Agents|histamine agents|mesh-ancestor
5708469|NCT03294525|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5708470|NCT03294525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5708471|NCT03294525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5708472|NCT03294525|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5708473|NCT03294525|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5708474|NCT03294525|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5708475|NCT03294525|Adrenergic Agents|adrenergic agents|mesh-ancestor
5708476|NCT03294525|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5708477|NCT03294525|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5708478|NCT03294525|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5708479|NCT03294486|Flucytosine|flucytosine|mesh-list
5708480|NCT03294486|Antifungal Agents|antifungal agents|mesh-ancestor
5708481|NCT03294486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5708482|NCT03294486|Antimetabolites|antimetabolites|mesh-ancestor
5708483|NCT03294486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5708484|NCT03294395|Gentamicins|gentamicins|mesh-list
5708485|NCT03294395|Ceftriaxone|ceftriaxone|mesh-list
5708486|NCT03294395|Ertapenem|ertapenem|mesh-list
5708487|NCT03294395|Fosfomycin|fosfomycin|mesh-list
5708488|NCT03294395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5708489|NCT03294395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5708490|NCT03294395|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5708491|NCT03294395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5708492|NCT03294395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5708493|NCT03294382|Botulinum Toxins|botulinum toxins|mesh-list
5708494|NCT03294382|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5708495|NCT03294382|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5708496|NCT03294382|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5708497|NCT03294382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5708498|NCT03294382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5708499|NCT03294382|Cholinergic Agents|cholinergic agents|mesh-ancestor
5708500|NCT03294382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5708501|NCT03294382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708502|NCT03294382|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5708503|NCT03294382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5708504|NCT03294252|Leucovorin|leucovorin|mesh-list
5708505|NCT03294252|Folic Acid|folic acid|mesh-list
5708506|NCT03294252|Fluorouracil|fluorouracil|mesh-list
5708507|NCT03294252|Oxaliplatin|oxaliplatin|mesh-list
5708508|NCT03294252|Levoleucovorin|levoleucovorin|mesh-list
5708509|NCT03294252|Antimetabolites|antimetabolites|mesh-ancestor
5708510|NCT03294252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5708511|NCT03294252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5708512|NCT03294252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5708513|NCT03294252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5708514|NCT03294252|Immunologic Factors|immunologic factors|mesh-ancestor
5708515|NCT03294252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708516|NCT03294252|Antidotes|antidotes|mesh-ancestor
5708517|NCT03294252|Protective Agents|protective agents|mesh-ancestor
5708518|NCT03294252|Vitamin B Complex|vitamin b complex|mesh-ancestor
5708519|NCT03294252|Vitamins|vitamins|mesh-ancestor
5708520|NCT03294252|Micronutrients|micronutrients|mesh-ancestor
5708521|NCT03294252|Hematinics|hematinics|mesh-ancestor
5708522|NCT03294174|Ropivacaine|ropivacaine|mesh-list
5708523|NCT03294174|Anesthetics, Local|anesthetics, local|mesh-ancestor
5708524|NCT03294174|Anesthetics|anesthetics|mesh-ancestor
5708525|NCT03294174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6232219|NCT02519842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6232220|NCT02519842|Antiemetics|antiemetics|mesh-ancestor
6232221|NCT02519842|Autonomic Agents|autonomic agents|mesh-ancestor
6232222|NCT02519842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6232223|NCT02519842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232224|NCT02519842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5708526|NCT03294174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232225|NCT02519842|Glucocorticoids|glucocorticoids|mesh-ancestor
5708527|NCT03294174|Sensory System Agents|sensory system agents|mesh-ancestor
5708528|NCT03294174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5708529|NCT03294161|Meglumine Antimoniate|meglumine antimoniate|mesh-list
5708530|NCT03294161|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5708531|NCT03294161|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5708532|NCT03294161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5708533|NCT03294083|Cemiplimab|cemiplimab|mesh-list
5708534|NCT03294083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5708535|NCT03294083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5708536|NCT03294070|Amlodipine|amlodipine|mesh-list
5708537|NCT03294070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5708538|NCT03294070|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5708539|NCT03294070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6232226|NCT02519842|Hormones|hormones|mesh-ancestor
6232227|NCT02519842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6232228|NCT02519842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6232229|NCT02519842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6232230|NCT02519842|Antipruritics|antipruritics|mesh-ancestor
6232231|NCT02519842|Dermatologic Agents|dermatologic agents|mesh-ancestor
6232232|NCT02519842|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6232233|NCT02519842|Serotonin Agents|serotonin agents|mesh-ancestor
6232234|NCT02519842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6232235|NCT02519842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232236|NCT02519842|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6232237|NCT02519842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6232238|NCT02519842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6232239|NCT02519842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6232240|NCT02519842|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6232241|NCT02519842|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6232242|NCT02520011|Cytarabine|cytarabine|mesh-list
6232243|NCT02520011|Mitoxantrone|mitoxantrone|mesh-list
6232244|NCT02520011|Alvocidib|alvocidib|mesh-list
6232245|NCT02520011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6232246|NCT02520011|Antimetabolites|antimetabolites|mesh-ancestor
6232247|NCT02520011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232248|NCT02520011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6232249|NCT02520011|Antiviral Agents|antiviral agents|mesh-ancestor
6232250|NCT02520011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6232251|NCT02520011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6232252|NCT02520011|Immunologic Factors|immunologic factors|mesh-ancestor
6232253|NCT02520011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232254|NCT02520011|Analgesics|analgesics|mesh-ancestor
6232255|NCT02520011|Sensory System Agents|sensory system agents|mesh-ancestor
6232256|NCT02520011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6232257|NCT02520011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6232258|NCT02520011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6232259|NCT02520011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6232260|NCT02520011|Growth Inhibitors|growth inhibitors|mesh-ancestor
6232261|NCT02520011|Growth Substances|growth substances|mesh-ancestor
6232262|NCT02520011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6232263|NCT02520388|Methylphenidate|methylphenidate|mesh-list
6232264|NCT02520388|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6232265|NCT02520388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232266|NCT02520388|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6232267|NCT02520388|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6232268|NCT02520388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6232269|NCT02520388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232270|NCT02520388|Dopamine Agents|dopamine agents|mesh-ancestor
6232271|NCT02520388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6232272|NCT02520518|Dapagliflozin|dapagliflozin|mesh-list
6232273|NCT02520518|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6232274|NCT02520518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232275|NCT02520518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6232276|NCT02520518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232277|NCT02521870|Pembrolizumab|pembrolizumab|mesh-list
6232278|NCT02521870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6232279|NCT02521870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6232280|NCT02522104|Hydroxyurea|hydroxyurea|mesh-list
6232281|NCT02522104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6232282|NCT02522104|Antisickling Agents|antisickling agents|mesh-ancestor
6232283|NCT02522104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6232284|NCT02522104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232285|NCT02522104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6232286|NCT02522299|Nemiralisib|nemiralisib|mesh-list
6232287|NCT02522299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6232288|NCT02522299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6232289|NCT02522299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232290|NCT02522325|Cocaine|cocaine|mesh-list
6232291|NCT02522325|Phendimetrazine|phendimetrazine|mesh-list
6232292|NCT02522325|Anesthetics, Local|anesthetics, local|mesh-ancestor
6232293|NCT02522325|Anesthetics|anesthetics|mesh-ancestor
6232294|NCT02522325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6232295|NCT02522325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232296|NCT02522325|Sensory System Agents|sensory system agents|mesh-ancestor
6500834|NCT00646425|Basiliximab|basiliximab|mesh-list
5708540|NCT03294070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5708541|NCT03294070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5708542|NCT03294070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6500835|NCT00646425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6500836|NCT00646425|Immunologic Factors|immunologic factors|mesh-ancestor
6500837|NCT00646425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708543|NCT03294070|Vasodilator Agents|vasodilator agents|mesh-ancestor
5721473|NCT03204955|Plasma-lyte 148|plasma-lyte 148|mesh-list
5721474|NCT03204955|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5721475|NCT03204955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5721476|NCT03204812|Durvalumab|durvalumab|mesh-list
6779674|NCT02180425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5721477|NCT03204812|Ipilimumab|ipilimumab|mesh-list
5721478|NCT03204812|Tremelimumab|tremelimumab|mesh-list
5721479|NCT03204812|Immunoglobulins|immunoglobulins|mesh-list
5721480|NCT03204812|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5721481|NCT03204812|Immunoglobulin G|immunoglobulin g|mesh-list
5721482|NCT03204812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6232297|NCT02522325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6232298|NCT02522325|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6232299|NCT02522325|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6232300|NCT02522325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5721483|NCT03204812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5721484|NCT03204812|Immunologic Factors|immunologic factors|mesh-ancestor
5721485|NCT03204812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721486|NCT03204812|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5721487|NCT03204812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721488|NCT03204929|Copper|copper|mesh-list
5721489|NCT03204929|Trace Elements|trace elements|mesh-ancestor
5721490|NCT03204929|Micronutrients|micronutrients|mesh-ancestor
5721491|NCT03204929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721492|NCT03204786|Vasopressins|vasopressins|mesh-list
5721493|NCT03204786|Arginine Vasopressin|arginine vasopressin|mesh-list
5721494|NCT03204786|Hemostatics|hemostatics|mesh-ancestor
5721495|NCT03204786|Coagulants|coagulants|mesh-ancestor
5721496|NCT03204786|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5721497|NCT03204786|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5721498|NCT03204786|Natriuretic Agents|natriuretic agents|mesh-ancestor
6232301|NCT02522325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6232302|NCT02522325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232303|NCT02522325|Dopamine Agents|dopamine agents|mesh-ancestor
6232304|NCT02522325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6232305|NCT02522325|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6243766|NCT02680054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243767|NCT02680301|Triamcinolone|triamcinolone|mesh-list
6500838|NCT00646503|Telbivudine|telbivudine|mesh-list
6500839|NCT00646503|Antiviral Agents|antiviral agents|mesh-ancestor
6500840|NCT00646503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6500841|NCT00646503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6500842|NCT00646503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6500843|NCT00646503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500844|NCT00646516|Budesonide|budesonide|mesh-list
6500845|NCT00646516|Formoterol Fumarate|formoterol fumarate|mesh-list
6500846|NCT00646516|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6500847|NCT00646516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6500848|NCT00646516|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6500849|NCT00646516|Autonomic Agents|autonomic agents|mesh-ancestor
6500850|NCT00646516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6500851|NCT00646516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6500852|NCT00646516|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6500853|NCT00646516|Respiratory System Agents|respiratory system agents|mesh-ancestor
6500854|NCT00646516|Glucocorticoids|glucocorticoids|mesh-ancestor
6500855|NCT00646516|Hormones|hormones|mesh-ancestor
5708544|NCT03293992|Latanoprost|latanoprost|mesh-list
5708545|NCT03293992|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5708546|NCT03293992|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5708547|NCT03293927|Fentanyl|fentanyl|mesh-list
5708548|NCT03293927|Dexmedetomidine|dexmedetomidine|mesh-list
5708549|NCT03293927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5708550|NCT03293927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6500856|NCT00646516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6500857|NCT00646516|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6500858|NCT00646516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6500859|NCT00646516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6232306|NCT02522377|Midazolam|midazolam|mesh-list
6232307|NCT02522377|Ketamine|ketamine|mesh-list
6232308|NCT02522377|Analgesics|analgesics|mesh-ancestor
5708551|NCT03293927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708552|NCT03293927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5708553|NCT03293927|Analgesics|analgesics|mesh-ancestor
5708554|NCT03293927|Sensory System Agents|sensory system agents|mesh-ancestor
5708555|NCT03293927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5708556|NCT03293927|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6232309|NCT02522377|Sensory System Agents|sensory system agents|mesh-ancestor
6232310|NCT02522377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6232311|NCT02522377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232312|NCT02522377|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6232313|NCT02522377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6500860|NCT00646516|Adrenergic Agents|adrenergic agents|mesh-ancestor
6500861|NCT00646516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6500862|NCT00646516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500863|NCT00646529|Budesonide|budesonide|mesh-list
6500864|NCT00646529|Formoterol Fumarate|formoterol fumarate|mesh-list
6500865|NCT00646529|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6500866|NCT00646529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6500867|NCT00646529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6232314|NCT02522377|Anesthetics, General|anesthetics, general|mesh-ancestor
6232315|NCT02522377|Anesthetics|anesthetics|mesh-ancestor
6232316|NCT02522377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6232317|NCT02522377|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6232318|NCT02522377|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6500868|NCT00646529|Autonomic Agents|autonomic agents|mesh-ancestor
6500869|NCT00646529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6500870|NCT00646529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708557|NCT03293927|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5708558|NCT03293927|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5708559|NCT03293927|Adrenergic Agents|adrenergic agents|mesh-ancestor
5708560|NCT03293927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5708561|NCT03293927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5708562|NCT03293927|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5708563|NCT03293927|Narcotics|narcotics|mesh-ancestor
5708564|NCT03293927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5708565|NCT03293927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5708566|NCT03293927|Anesthetics, General|anesthetics, general|mesh-ancestor
5708567|NCT03293927|Anesthetics|anesthetics|mesh-ancestor
5708568|NCT03293680|Pembrolizumab|pembrolizumab|mesh-list
5708569|NCT03293680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5708570|NCT03293680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6232319|NCT02522377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6500871|NCT00646529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6232320|NCT02522377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232321|NCT02522377|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6232322|NCT02522377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6232323|NCT02522377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6232324|NCT02522377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6232325|NCT02522377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6500872|NCT00646529|Respiratory System Agents|respiratory system agents|mesh-ancestor
6676841|NCT01583478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676842|NCT01583478|Cholinergic Agents|cholinergic agents|mesh-ancestor
6676843|NCT01583478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6779675|NCT02180425|Analgesics|analgesics|mesh-ancestor
6779676|NCT02180425|Sensory System Agents|sensory system agents|mesh-ancestor
6779677|NCT02180425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6779678|NCT02180425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708571|NCT03293641|Folic Acid|folic acid|mesh-list
5708572|NCT03293641|Penicillins|penicillins|mesh-list
5708573|NCT03293641|Penicillin V|penicillin v|mesh-list
6500873|NCT00646529|Glucocorticoids|glucocorticoids|mesh-ancestor
6500874|NCT00646529|Hormones|hormones|mesh-ancestor
6500875|NCT00646529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6500876|NCT00646529|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6500877|NCT00646529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6500878|NCT00646529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6500879|NCT00646529|Adrenergic Agents|adrenergic agents|mesh-ancestor
6500880|NCT00646529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6232326|NCT02522377|GABA Modulators|gaba modulators|mesh-ancestor
6232327|NCT02522377|GABA Agents|gaba agents|mesh-ancestor
6232328|NCT02522715|Prednisone|prednisone|mesh-list
6232329|NCT02522715|Cortisone|cortisone|mesh-list
6232330|NCT02522715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6232331|NCT02522715|Glucocorticoids|glucocorticoids|mesh-ancestor
6232332|NCT02522715|Hormones|hormones|mesh-ancestor
6232333|NCT02522715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6232334|NCT02522715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232335|NCT02522715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6232336|NCT02522715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6232337|NCT02522767|Mesalamine|mesalamine|mesh-list
6232338|NCT02522767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6232339|NCT02522767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5708574|NCT03293641|Proguanil|proguanil|mesh-list
5708575|NCT03293641|Hydroxyurea|hydroxyurea|mesh-list
5708576|NCT03293641|Zinc Sulfate|zinc sulfate|mesh-list
5708577|NCT03293641|Hematinics|hematinics|mesh-ancestor
5708578|NCT03293641|Vitamin B Complex|vitamin b complex|mesh-ancestor
5708579|NCT03293641|Vitamins|vitamins|mesh-ancestor
5708580|NCT03293641|Micronutrients|micronutrients|mesh-ancestor
5708581|NCT03293641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708582|NCT03293641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5708583|NCT03293641|Antisickling Agents|antisickling agents|mesh-ancestor
6232340|NCT02522767|Analgesics|analgesics|mesh-ancestor
6232341|NCT02522767|Sensory System Agents|sensory system agents|mesh-ancestor
6232342|NCT02522767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6232343|NCT02522767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232344|NCT02522767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6232345|NCT02522767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6232346|NCT02522780|Mesalamine|mesalamine|mesh-list
6232347|NCT02522780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6232348|NCT02522780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6232349|NCT02522780|Analgesics|analgesics|mesh-ancestor
6232350|NCT02522780|Sensory System Agents|sensory system agents|mesh-ancestor
6232351|NCT02522780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6232352|NCT02522780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232353|NCT02522780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6232354|NCT02522780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6232355|NCT02523235|Ropivacaine|ropivacaine|mesh-list
6232356|NCT02523235|Anesthetics, Local|anesthetics, local|mesh-ancestor
6500881|NCT00646529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500882|NCT00646568|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5708584|NCT03293641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6232357|NCT02523235|Anesthetics|anesthetics|mesh-ancestor
6232358|NCT02523235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6232359|NCT02523235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232360|NCT02523235|Sensory System Agents|sensory system agents|mesh-ancestor
6232361|NCT02523235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6232362|NCT02523586|Anesthetics|anesthetics|mesh-list
6232363|NCT02523586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6232364|NCT02523586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232365|NCT02523599|Bupivacaine|bupivacaine|mesh-list
6232366|NCT02523599|Anesthetics, Local|anesthetics, local|mesh-ancestor
6232367|NCT02523599|Anesthetics|anesthetics|mesh-ancestor
6232368|NCT02523599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6232369|NCT02523599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232370|NCT02523599|Sensory System Agents|sensory system agents|mesh-ancestor
6232371|NCT02523599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6232372|NCT02524054|Furosemide|furosemide|mesh-list
6232373|NCT02524054|Diuretics|diuretics|mesh-ancestor
6232374|NCT02524054|Natriuretic Agents|natriuretic agents|mesh-ancestor
6232375|NCT02524054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232376|NCT02524054|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5708585|NCT03293641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232377|NCT02524054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5708586|NCT03293641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6243768|NCT02680301|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6232378|NCT02524054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232379|NCT02524106|Bococizumab|bococizumab|mesh-list
5708587|NCT03293641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5708588|NCT03293641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5708589|NCT03293641|Astringents|astringents|mesh-ancestor
5708590|NCT03293641|Dermatologic Agents|dermatologic agents|mesh-ancestor
5708591|NCT03293641|Antimalarials|antimalarials|mesh-ancestor
5708592|NCT03293641|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5708593|NCT03293641|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5708594|NCT03293641|Antimetabolites|antimetabolites|mesh-ancestor
5708595|NCT03293511|Oxytocin|oxytocin|mesh-list
6232380|NCT02524106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6232381|NCT02524106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6232382|NCT02524106|Antimetabolites|antimetabolites|mesh-ancestor
6232383|NCT02524106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232384|NCT02524106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6232385|NCT02524145|Isoproterenol|isoproterenol|mesh-list
6232386|NCT02524145|Glycopyrrolate|glycopyrrolate|mesh-list
6232387|NCT02524145|Dexmedetomidine|dexmedetomidine|mesh-list
6232388|NCT02524145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6232389|NCT02524145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6232390|NCT02524145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708596|NCT03293511|Oxytocics|oxytocics|mesh-ancestor
5708597|NCT03293511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5708598|NCT03293511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708599|NCT03293472|Bupivacaine|bupivacaine|mesh-list
5708600|NCT03293472|Ropivacaine|ropivacaine|mesh-list
5708601|NCT03293472|Anesthetics, Local|anesthetics, local|mesh-ancestor
5708602|NCT03293472|Anesthetics|anesthetics|mesh-ancestor
5708603|NCT03293472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5708604|NCT03293472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708605|NCT03293472|Sensory System Agents|sensory system agents|mesh-ancestor
5708606|NCT03293472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5708607|NCT03293407|Iloprost|iloprost|mesh-list
5708608|NCT03293407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5708609|NCT03293407|Vasodilator Agents|vasodilator agents|mesh-ancestor
5708610|NCT03293368|Triamcinolone|triamcinolone|mesh-list
5708611|NCT03293368|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5708612|NCT03293368|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5708613|NCT03293368|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5708614|NCT03293368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5708615|NCT03293368|Glucocorticoids|glucocorticoids|mesh-ancestor
5708616|NCT03293368|Hormones|hormones|mesh-ancestor
5708617|NCT03293368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5708618|NCT03293368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708619|NCT03293368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5708620|NCT03293368|Immunologic Factors|immunologic factors|mesh-ancestor
5708621|NCT03293368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5708622|NCT03293368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5708623|NCT03293277|Dexmedetomidine|dexmedetomidine|mesh-list
5708624|NCT03293277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5708625|NCT03293277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5708626|NCT03293277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232391|NCT02524145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6232392|NCT02524145|Analgesics|analgesics|mesh-ancestor
6232393|NCT02524145|Sensory System Agents|sensory system agents|mesh-ancestor
6232394|NCT02524145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5708627|NCT03293277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5708628|NCT03293277|Analgesics|analgesics|mesh-ancestor
5708629|NCT03293277|Sensory System Agents|sensory system agents|mesh-ancestor
5708630|NCT03293277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5708631|NCT03293277|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5708632|NCT03293277|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5708633|NCT03293277|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5708634|NCT03293277|Adrenergic Agents|adrenergic agents|mesh-ancestor
5708635|NCT03293277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5708636|NCT03293277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5708637|NCT03293108|Vitamin D|vitamin d|mesh-list
5708638|NCT03293108|Denosumab|denosumab|mesh-list
5708639|NCT03293108|Calcium|calcium|mesh-list
5708640|NCT03293108|Vitamins|vitamins|mesh-ancestor
5708641|NCT03293108|Micronutrients|micronutrients|mesh-ancestor
5708642|NCT03293108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708643|NCT03293108|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6232395|NCT02524145|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5722322|NCT03199976|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6232396|NCT02524145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6232397|NCT02524145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6232398|NCT02524145|Adrenergic Agents|adrenergic agents|mesh-ancestor
6232399|NCT02524145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6232400|NCT02524145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232401|NCT02524145|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6232402|NCT02524145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6232403|NCT02524145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6232404|NCT02524145|Cholinergic Agents|cholinergic agents|mesh-ancestor
6232405|NCT02524145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6232406|NCT02524145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6232407|NCT02524145|Autonomic Agents|autonomic agents|mesh-ancestor
6232408|NCT02524145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6232409|NCT02524145|Respiratory System Agents|respiratory system agents|mesh-ancestor
6232410|NCT02524145|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6232411|NCT02524145|Sympathomimetics|sympathomimetics|mesh-ancestor
6232412|NCT02524145|Protective Agents|protective agents|mesh-ancestor
6232413|NCT02524561|Estradiol|estradiol|mesh-list
6232414|NCT02524561|Progesterone|progesterone|mesh-list
6232415|NCT02524561|Estrogens|estrogens|mesh-ancestor
6232416|NCT02524561|Hormones|hormones|mesh-ancestor
6232417|NCT02524561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6232418|NCT02524561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232419|NCT02524561|Progestins|progestins|mesh-ancestor
6232420|NCT02524665|Salicylic Acid|salicylic acid|mesh-list
6232421|NCT02524665|Salicylates|salicylates|mesh-list
6232422|NCT02524665|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6232423|NCT02524665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6232424|NCT02524665|Antifungal Agents|antifungal agents|mesh-ancestor
6232425|NCT02524665|Keratolytic Agents|keratolytic agents|mesh-ancestor
6232426|NCT02524665|Dermatologic Agents|dermatologic agents|mesh-ancestor
6232427|NCT02524665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6232428|NCT02524665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6232429|NCT02524665|Analgesics|analgesics|mesh-ancestor
6232430|NCT02524665|Sensory System Agents|sensory system agents|mesh-ancestor
6232431|NCT02524665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6232432|NCT02524665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232433|NCT02524665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6232434|NCT02524665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6232435|NCT02524665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6232436|NCT02524665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6232437|NCT02524665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232438|NCT02524769|Estrogens|estrogens|mesh-list
6232439|NCT02524769|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6232440|NCT02524769|Hormones|hormones|mesh-ancestor
6232441|NCT02524769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6232442|NCT02524769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708644|NCT03293108|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5708645|NCT03293069|Deferiprone|deferiprone|mesh-list
5708646|NCT03293069|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5708647|NCT03293069|Chelating Agents|chelating agents|mesh-ancestor
5708648|NCT03293069|Sequestering Agents|sequestering agents|mesh-ancestor
6232443|NCT02524847|Methoxsalen|methoxsalen|mesh-list
6232444|NCT02524847|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6232445|NCT02524847|Dermatologic Agents|dermatologic agents|mesh-ancestor
6232446|NCT02525133|Bupivacaine|bupivacaine|mesh-list
6232447|NCT02525133|Anesthetics, Local|anesthetics, local|mesh-ancestor
6232448|NCT02525133|Anesthetics|anesthetics|mesh-ancestor
6232449|NCT02525133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6232450|NCT02525133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232451|NCT02525133|Sensory System Agents|sensory system agents|mesh-ancestor
6232452|NCT02525133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5708649|NCT03293069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5708650|NCT03293004|Vitamins|vitamins|mesh-list
5708651|NCT03293004|Ascorbic Acid|ascorbic acid|mesh-list
5708652|NCT03293004|Micronutrients|micronutrients|mesh-ancestor
5708653|NCT03293004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708654|NCT03293004|Antioxidants|antioxidants|mesh-ancestor
5708655|NCT03293004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5708656|NCT03293004|Protective Agents|protective agents|mesh-ancestor
5708657|NCT03292965|Neostigmine|neostigmine|mesh-list
5708658|NCT03292965|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5708659|NCT03292965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5708660|NCT03292965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232453|NCT02525471|RNS60|rns60|mesh-list
6232454|NCT02525471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5708661|NCT03292965|Cholinergic Agents|cholinergic agents|mesh-ancestor
6232455|NCT02525471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6500883|NCT00646568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6500884|NCT00646568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6500885|NCT00646594|Fluticasone|fluticasone|mesh-list
6500886|NCT00646594|Budesonide|budesonide|mesh-list
6500887|NCT00646594|Formoterol Fumarate|formoterol fumarate|mesh-list
6500888|NCT00646594|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6500889|NCT00646594|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6500890|NCT00646594|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6500891|NCT00646594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6500892|NCT00646594|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6232456|NCT02525471|Analgesics|analgesics|mesh-ancestor
6232457|NCT02525471|Sensory System Agents|sensory system agents|mesh-ancestor
6232458|NCT02525471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6232459|NCT02525471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232460|NCT02525471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6232461|NCT02525471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6232462|NCT02525471|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6500893|NCT00646594|Autonomic Agents|autonomic agents|mesh-ancestor
6500894|NCT00646594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6500895|NCT00646594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6500896|NCT00646594|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6500897|NCT00646594|Respiratory System Agents|respiratory system agents|mesh-ancestor
6232463|NCT02525523|Alicaforsen|alicaforsen|mesh-list
6232464|NCT02525523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6232465|NCT02525523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6232466|NCT02525523|Immunologic Factors|immunologic factors|mesh-ancestor
6232467|NCT02525523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232468|NCT02525536|Trebananib|trebananib|mesh-list
6232469|NCT02525536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6232470|NCT02525536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6232471|NCT02525536|Growth Substances|growth substances|mesh-ancestor
6232472|NCT02525536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232473|NCT02525536|Growth Inhibitors|growth inhibitors|mesh-ancestor
6232474|NCT02525536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5708662|NCT03292965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5708663|NCT03292965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708664|NCT03292965|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5708665|NCT03292965|Autonomic Agents|autonomic agents|mesh-ancestor
5708666|NCT03292965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6232475|NCT02525549|Adapalene|adapalene|mesh-list
6232476|NCT02525549|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6232477|NCT02525549|Dermatologic Agents|dermatologic agents|mesh-ancestor
6232478|NCT02525549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6232479|NCT02525549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6232480|NCT02525549|Analgesics|analgesics|mesh-ancestor
6232481|NCT02525549|Sensory System Agents|sensory system agents|mesh-ancestor
6232482|NCT02525549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6232483|NCT02525549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232484|NCT02525549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6232485|NCT02525549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6232486|NCT02525653|Gemcitabine|gemcitabine|mesh-list
6232487|NCT02525653|Paclitaxel|paclitaxel|mesh-list
6232488|NCT02525653|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6232489|NCT02525653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5708667|NCT03292926|Dexamethasone|dexamethasone|mesh-list
5708668|NCT03292926|Dexamethasone acetate|dexamethasone acetate|mesh-list
5708669|NCT03292926|Bupivacaine|bupivacaine|mesh-list
5708670|NCT03292926|BB 1101|bb 1101|mesh-list
5708671|NCT03292926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5708672|NCT03292926|Antiemetics|antiemetics|mesh-ancestor
5708673|NCT03292926|Autonomic Agents|autonomic agents|mesh-ancestor
5708674|NCT03292926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5708675|NCT03292926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708676|NCT03292926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5708677|NCT03292926|Glucocorticoids|glucocorticoids|mesh-ancestor
5708678|NCT03292926|Hormones|hormones|mesh-ancestor
6232490|NCT02525653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6500898|NCT00646594|Dermatologic Agents|dermatologic agents|mesh-ancestor
6232491|NCT02525653|Tubulin Modulators|tubulin modulators|mesh-ancestor
6232492|NCT02525653|Antimitotic Agents|antimitotic agents|mesh-ancestor
6232493|NCT02525653|Mitosis Modulators|mitosis modulators|mesh-ancestor
6500899|NCT00646594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6232494|NCT02525653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5708679|NCT03292926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6232495|NCT02525653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6232496|NCT02525653|Antimetabolites|antimetabolites|mesh-ancestor
6232497|NCT02525653|Antiviral Agents|antiviral agents|mesh-ancestor
5708680|NCT03292926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5708681|NCT03292926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5708682|NCT03292926|Protease Inhibitors|protease inhibitors|mesh-ancestor
5708683|NCT03292926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5708684|NCT03292926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5708685|NCT03292926|Anesthetics, Local|anesthetics, local|mesh-ancestor
5708686|NCT03292926|Anesthetics|anesthetics|mesh-ancestor
5708687|NCT03292926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5708688|NCT03292926|Sensory System Agents|sensory system agents|mesh-ancestor
5708689|NCT03292848|Brexpiprazole|brexpiprazole|mesh-list
5708690|NCT03292848|Serotonin Agents|serotonin agents|mesh-ancestor
5708691|NCT03292848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5708692|NCT03292848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5708693|NCT03292848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708694|NCT03292848|Dopamine Agonists|dopamine agonists|mesh-ancestor
5708695|NCT03292848|Dopamine Agents|dopamine agents|mesh-ancestor
5708696|NCT03292822|Paclitaxel|paclitaxel|mesh-list
5708697|NCT03292822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6232498|NCT02525653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6232499|NCT02525653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6232500|NCT02525653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6232501|NCT02525653|Immunologic Factors|immunologic factors|mesh-ancestor
6232502|NCT02525653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232503|NCT02525718|Dexamethasone|dexamethasone|mesh-list
6232504|NCT02525718|Epinephrine|epinephrine|mesh-list
6232505|NCT02525718|Bupivacaine|bupivacaine|mesh-list
6232506|NCT02525718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6232507|NCT02525718|Antiemetics|antiemetics|mesh-ancestor
6232508|NCT02525718|Autonomic Agents|autonomic agents|mesh-ancestor
6232509|NCT02525718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6232510|NCT02525718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232511|NCT02525718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6500900|NCT00646594|Glucocorticoids|glucocorticoids|mesh-ancestor
6500901|NCT00646594|Hormones|hormones|mesh-ancestor
6500902|NCT00646594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6500903|NCT00646594|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6232512|NCT02525718|Glucocorticoids|glucocorticoids|mesh-ancestor
6232513|NCT02525718|Hormones|hormones|mesh-ancestor
6232514|NCT02525718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6232515|NCT02525718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6232516|NCT02525718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6232517|NCT02525718|Anesthetics, Local|anesthetics, local|mesh-ancestor
5708698|NCT03292822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5708699|NCT03292822|Tubulin Modulators|tubulin modulators|mesh-ancestor
5708700|NCT03292822|Antimitotic Agents|antimitotic agents|mesh-ancestor
5708701|NCT03292822|Mitosis Modulators|mitosis modulators|mesh-ancestor
5708702|NCT03292822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5708703|NCT03292796|Bimatoprost|bimatoprost|mesh-list
5708704|NCT03292796|Latanoprost|latanoprost|mesh-list
5708705|NCT03292796|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5708706|NCT03292796|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5708707|NCT03292796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5708708|NCT03292744|Cholecalciferol|cholecalciferol|mesh-list
5708709|NCT03292744|Alfacalcidol|alfacalcidol|mesh-list
5708710|NCT03292744|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
5708711|NCT03292744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6232518|NCT02525718|Anesthetics|anesthetics|mesh-ancestor
6232519|NCT02525718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6232520|NCT02525718|Sensory System Agents|sensory system agents|mesh-ancestor
6232521|NCT02525718|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6232522|NCT02525718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6232523|NCT02525718|Adrenergic Agents|adrenergic agents|mesh-ancestor
6232524|NCT02525718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6232525|NCT02525718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232526|NCT02525718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6232527|NCT02525718|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6232528|NCT02525718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6232529|NCT02525718|Respiratory System Agents|respiratory system agents|mesh-ancestor
6232530|NCT02525718|Mydriatics|mydriatics|mesh-ancestor
6232531|NCT02525718|Sympathomimetics|sympathomimetics|mesh-ancestor
5708712|NCT03292744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708713|NCT03292744|Vitamins|vitamins|mesh-ancestor
6232532|NCT02525718|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6232533|NCT02525744|Insulin Lispro|insulin lispro|mesh-list
6232534|NCT02525744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6232535|NCT02525744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232536|NCT02525861|Protease Inhibitors|protease inhibitors|mesh-list
6232537|NCT02525861|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
6232538|NCT02525861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6232539|NCT02525861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232540|NCT02525861|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6232541|NCT02525861|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6232542|NCT02525874|Dimethyl Fumarate|dimethyl fumarate|mesh-list
6232543|NCT02525874|Dermatologic Agents|dermatologic agents|mesh-ancestor
6232544|NCT02525874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6232545|NCT02525874|Immunologic Factors|immunologic factors|mesh-ancestor
6232546|NCT02525874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232547|NCT02526212|Buprenorphine|buprenorphine|mesh-list
6232548|NCT02526212|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6232549|NCT02526212|Narcotics|narcotics|mesh-ancestor
6232550|NCT02526212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6500904|NCT00646594|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6500905|NCT00646594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6500906|NCT00646594|Adrenergic Agents|adrenergic agents|mesh-ancestor
6500907|NCT00646594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6500908|NCT00646594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500909|NCT00646594|Sympathomimetics|sympathomimetics|mesh-ancestor
6500910|NCT00646607|Leucovorin|leucovorin|mesh-list
6676844|NCT01583504|Anesthetics|anesthetics|mesh-list
6676845|NCT01583504|Anesthetics, Local|anesthetics, local|mesh-list
6676846|NCT01583504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6676847|NCT01583504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676848|NCT01583504|Sensory System Agents|sensory system agents|mesh-ancestor
6676849|NCT01583504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6676850|NCT01583621|Cholecalciferol|cholecalciferol|mesh-list
6676851|NCT01583621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6676852|NCT01583621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708714|NCT03292744|Micronutrients|micronutrients|mesh-ancestor
5708715|NCT03292744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5708716|NCT03292731|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
5708717|NCT03292731|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
5708718|NCT03292731|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6676853|NCT01583621|Vitamins|vitamins|mesh-ancestor
6676854|NCT01583621|Micronutrients|micronutrients|mesh-ancestor
5708719|NCT03292731|Hormone Antagonists|hormone antagonists|mesh-ancestor
5708720|NCT03292731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5708721|NCT03292731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708722|NCT03292731|Progestins|progestins|mesh-ancestor
5708723|NCT03292731|Hormones|hormones|mesh-ancestor
5708724|NCT03292575|Anticoagulants|anticoagulants|mesh-list
5721499|NCT03204786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721500|NCT03205033|Melatonin|melatonin|mesh-list
5721501|NCT03205033|Antioxidants|antioxidants|mesh-ancestor
5721502|NCT03205033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721503|NCT03205033|Protective Agents|protective agents|mesh-ancestor
5721504|NCT03205033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721505|NCT03205033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5721506|NCT03204734|Capecitabine|capecitabine|mesh-list
5721507|NCT03204734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5721508|NCT03204734|Antimetabolites|antimetabolites|mesh-ancestor
5721509|NCT03204734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721510|NCT03204734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5721511|NCT03204760|Dexamethasone|dexamethasone|mesh-list
5721512|NCT03204760|Prednisolone|prednisolone|mesh-list
5721513|NCT03204760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5721514|NCT03204760|Antiemetics|antiemetics|mesh-ancestor
5721515|NCT03204760|Autonomic Agents|autonomic agents|mesh-ancestor
5721516|NCT03204760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5721517|NCT03204760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721518|NCT03204760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5721519|NCT03204760|Glucocorticoids|glucocorticoids|mesh-ancestor
5721520|NCT03204760|Hormones|hormones|mesh-ancestor
5721521|NCT03204760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5721522|NCT03204760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5721523|NCT03204760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6232551|NCT02526212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6500911|NCT00646607|Fluorouracil|fluorouracil|mesh-list
6500912|NCT00646607|Oxaliplatin|oxaliplatin|mesh-list
6500913|NCT00646607|Levoleucovorin|levoleucovorin|mesh-list
6500914|NCT00646607|Antimetabolites|antimetabolites|mesh-ancestor
6500915|NCT00646607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500916|NCT00646607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6676855|NCT01583621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6232552|NCT02526212|Analgesics|analgesics|mesh-ancestor
6232553|NCT02526212|Sensory System Agents|sensory system agents|mesh-ancestor
6232554|NCT02526212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6232555|NCT02526212|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6232556|NCT02526550|Vaccines|vaccines|mesh-list
6232557|NCT02526550|Immunologic Factors|immunologic factors|mesh-ancestor
6232558|NCT02526550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232559|NCT02526667|Chlorhexidine|chlorhexidine|mesh-list
6232560|NCT02526667|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5708725|NCT03292315|Exenatide|exenatide|mesh-list
5708726|NCT03292315|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5708727|NCT03292315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708728|NCT03292315|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5708729|NCT03292315|Incretins|incretins|mesh-ancestor
5708730|NCT03292315|Hormones|hormones|mesh-ancestor
5708731|NCT03292315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5708732|NCT03292263|Nivolumab|nivolumab|mesh-list
5708733|NCT03292263|Melphalan|melphalan|mesh-list
5708734|NCT03292263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5708735|NCT03292263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5708736|NCT03292263|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5708737|NCT03292263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5708738|NCT03292263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5708739|NCT03292263|Alkylating Agents|alkylating agents|mesh-ancestor
5708740|NCT03292263|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5708741|NCT03292263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5708742|NCT03292263|Immunologic Factors|immunologic factors|mesh-ancestor
5708743|NCT03292263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708744|NCT03292250|Durvalumab|durvalumab|mesh-list
5708745|NCT03292250|Tremelimumab|tremelimumab|mesh-list
5708746|NCT03292250|Nintedanib|nintedanib|mesh-list
5708747|NCT03292250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5708748|NCT03292250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5708749|NCT03292250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5708750|NCT03292250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5708751|NCT03292250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5708752|NCT03292185|Insulin|insulin|mesh-list
5708753|NCT03292185|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5708754|NCT03292185|Liraglutide|liraglutide|mesh-list
5708755|NCT03292185|Insulin, Long-Acting|insulin, long-acting|mesh-list
5708756|NCT03292185|Xultophy|xultophy|mesh-list
5708757|NCT03292185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5708758|NCT03292185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232561|NCT02526667|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6500917|NCT00646607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6500918|NCT00646607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6500919|NCT00646607|Immunologic Factors|immunologic factors|mesh-ancestor
6500920|NCT00646607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6500921|NCT00646607|Antidotes|antidotes|mesh-ancestor
6500922|NCT00646607|Protective Agents|protective agents|mesh-ancestor
6500923|NCT00646607|Vitamin B Complex|vitamin b complex|mesh-ancestor
6500924|NCT00646607|Vitamins|vitamins|mesh-ancestor
6500925|NCT00646607|Micronutrients|micronutrients|mesh-ancestor
6500926|NCT00646620|Fluticasone|fluticasone|mesh-list
6500927|NCT00646620|Budesonide|budesonide|mesh-list
6500928|NCT00646620|Albuterol|albuterol|mesh-list
6500929|NCT00646620|Formoterol Fumarate|formoterol fumarate|mesh-list
6500930|NCT00646620|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6500931|NCT00646620|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
5708759|NCT03292185|Incretins|incretins|mesh-ancestor
5708760|NCT03292185|Hormones|hormones|mesh-ancestor
5708761|NCT03292185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5708762|NCT03292172|Atezolizumab|atezolizumab|mesh-list
5708763|NCT03292172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5708764|NCT03291899|Folfirinox|folfirinox|mesh-list
5708765|NCT03291899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5708766|NCT03291886|Exemestane|exemestane|mesh-list
5708767|NCT03291886|Entinostat|entinostat|mesh-list
5708768|NCT03291886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5708769|NCT03291886|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5708770|NCT03291886|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5708771|NCT03291886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5708772|NCT03291886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232562|NCT02526667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6232563|NCT02526667|Disinfectants|disinfectants|mesh-ancestor
6232564|NCT02526667|Dermatologic Agents|dermatologic agents|mesh-ancestor
6232565|NCT02527265|Insulin|insulin|mesh-list
6232566|NCT02527265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6232567|NCT02527265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232568|NCT02527421|Betamethasone|betamethasone|mesh-list
6232569|NCT02527421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5708773|NCT03291886|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5708774|NCT03291886|Hormone Antagonists|hormone antagonists|mesh-ancestor
5708775|NCT03291886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5708776|NCT03291886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708777|NCT03291886|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5708778|NCT03291847|Buprenorphine|buprenorphine|mesh-list
5708779|NCT03291847|Methadone|methadone|mesh-list
6232570|NCT02527421|Glucocorticoids|glucocorticoids|mesh-ancestor
6232571|NCT02527421|Hormones|hormones|mesh-ancestor
6232572|NCT02527421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6232573|NCT02527421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232574|NCT02527421|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6232575|NCT02527421|Respiratory System Agents|respiratory system agents|mesh-ancestor
6232576|NCT02527512|Povidone-Iodine|povidone-iodine|mesh-list
6232577|NCT02527512|Povidone|povidone|mesh-list
6232578|NCT02527512|Plasma Substitutes|plasma substitutes|mesh-ancestor
6232579|NCT02527512|Blood Substitutes|blood substitutes|mesh-ancestor
6232580|NCT02527512|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6232581|NCT02527512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6232582|NCT02527681|Ceftobiprole|ceftobiprole|mesh-list
6232583|NCT02527681|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
5708780|NCT03291847|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
5708781|NCT03291847|Naloxone|naloxone|mesh-list
5708782|NCT03291847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6232584|NCT02527681|Cephalosporins|cephalosporins|mesh-list
6232585|NCT02527681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6232586|NCT02527681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6232587|NCT02528188|Tanezumab|tanezumab|mesh-list
6232588|NCT02528188|Analgesics|analgesics|mesh-ancestor
6232589|NCT02528188|Sensory System Agents|sensory system agents|mesh-ancestor
6232590|NCT02528188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6232591|NCT02528188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6500932|NCT00646620|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6500933|NCT00646620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6500934|NCT00646620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5708783|NCT03291847|Narcotics|narcotics|mesh-ancestor
5708784|NCT03291847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5708785|NCT03291847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708786|NCT03291847|Analgesics|analgesics|mesh-ancestor
5708787|NCT03291847|Sensory System Agents|sensory system agents|mesh-ancestor
5708788|NCT03291847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5708789|NCT03291847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5708790|NCT03291847|Antitussive Agents|antitussive agents|mesh-ancestor
5708791|NCT03291847|Respiratory System Agents|respiratory system agents|mesh-ancestor
5708792|NCT03291821|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5708793|NCT03291821|Cetrorelix|cetrorelix|mesh-list
5708794|NCT03291821|Menotropins|menotropins|mesh-list
6500935|NCT00646620|Autonomic Agents|autonomic agents|mesh-ancestor
6500936|NCT00646620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6500937|NCT00646620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6500938|NCT00646620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5708795|NCT03291821|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
6232592|NCT02528214|Prednisone|prednisone|mesh-list
6232593|NCT02528214|Prednisolone|prednisolone|mesh-list
6232594|NCT02528214|Albuterol|albuterol|mesh-list
6232595|NCT02528214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6500939|NCT00646620|Respiratory System Agents|respiratory system agents|mesh-ancestor
6500940|NCT00646620|Dermatologic Agents|dermatologic agents|mesh-ancestor
6500941|NCT00646620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6500942|NCT00646620|Glucocorticoids|glucocorticoids|mesh-ancestor
6500943|NCT00646620|Hormones|hormones|mesh-ancestor
6232596|NCT02528214|Glucocorticoids|glucocorticoids|mesh-ancestor
6232597|NCT02528214|Hormones|hormones|mesh-ancestor
6232598|NCT02528214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6232599|NCT02528214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232600|NCT02528214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6232601|NCT02528214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5708796|NCT03291821|Ganirelix|ganirelix|mesh-list
5708797|NCT03291821|Hormones|hormones|mesh-ancestor
5708798|NCT03291821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5708799|NCT03291821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708800|NCT03291821|Luteolytic Agents|luteolytic agents|mesh-ancestor
5708801|NCT03291821|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5708802|NCT03291821|Contraceptive Agents|contraceptive agents|mesh-ancestor
5708803|NCT03291821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5708804|NCT03291821|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5708805|NCT03291821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5708806|NCT03291821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5708807|NCT03291821|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5708808|NCT03291821|Fertility Agents|fertility agents|mesh-ancestor
5708809|NCT03291821|Hormone Antagonists|hormone antagonists|mesh-ancestor
5708810|NCT03291457|Glucocorticoids|glucocorticoids|mesh-list
6232602|NCT02528214|Autonomic Agents|autonomic agents|mesh-ancestor
6232603|NCT02528214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6232604|NCT02528214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6232605|NCT02528214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6232606|NCT02528214|Respiratory System Agents|respiratory system agents|mesh-ancestor
6500944|NCT00646620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6500945|NCT00646620|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6500946|NCT00646620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5708811|NCT03291457|Hormones|hormones|mesh-ancestor
5708812|NCT03291457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5708813|NCT03291457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708814|NCT03291418|Naproxen|naproxen|mesh-list
5708815|NCT03291418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5708816|NCT03291418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5708817|NCT03291418|Analgesics|analgesics|mesh-ancestor
5708818|NCT03291418|Sensory System Agents|sensory system agents|mesh-ancestor
5708819|NCT03291418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5708820|NCT03291418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708821|NCT03291418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5708822|NCT03291418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5708823|NCT03291418|Gout Suppressants|gout suppressants|mesh-ancestor
5708824|NCT03291418|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5708825|NCT03291418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5708826|NCT03291418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5708827|NCT03291353|Pembrolizumab|pembrolizumab|mesh-list
5708828|NCT03291353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5708829|NCT03291353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5708830|NCT03291314|Avelumab|avelumab|mesh-list
5708831|NCT03291314|Axitinib|axitinib|mesh-list
5721524|NCT03204877|Melatonin|melatonin|mesh-list
6232607|NCT02528214|Tocolytic Agents|tocolytic agents|mesh-ancestor
6232608|NCT02528214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6500947|NCT00646620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6500948|NCT00646620|Adrenergic Agents|adrenergic agents|mesh-ancestor
6500949|NCT00646620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6500950|NCT00646620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500951|NCT00646620|Tocolytic Agents|tocolytic agents|mesh-ancestor
6232609|NCT02528214|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6232610|NCT02528214|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6232611|NCT02528214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6232612|NCT02528214|Adrenergic Agents|adrenergic agents|mesh-ancestor
6232613|NCT02528214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6500952|NCT00646620|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6500953|NCT00646620|Sympathomimetics|sympathomimetics|mesh-ancestor
6500954|NCT00646659|Carboplatin|carboplatin|mesh-list
6500955|NCT00646659|Docetaxel|docetaxel|mesh-list
6500956|NCT00646659|Fluorouracil|fluorouracil|mesh-list
6500957|NCT00646659|Cetuximab|cetuximab|mesh-list
6676856|NCT01583660|Acetaminophen|acetaminophen|mesh-list
6676857|NCT01583660|Celecoxib|celecoxib|mesh-list
6500958|NCT00646659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6500959|NCT00646659|Tubulin Modulators|tubulin modulators|mesh-ancestor
6500960|NCT00646659|Antimitotic Agents|antimitotic agents|mesh-ancestor
6500961|NCT00646659|Mitosis Modulators|mitosis modulators|mesh-ancestor
6500962|NCT00646659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500963|NCT00646659|Antimetabolites|antimetabolites|mesh-ancestor
6676858|NCT01583660|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
6676859|NCT01583660|Oxycodone|oxycodone|mesh-list
6232614|NCT02528214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232615|NCT02528253|Tramadol|tramadol|mesh-list
6232616|NCT02528253|Tanezumab|tanezumab|mesh-list
6232617|NCT02528253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6232618|NCT02528253|Narcotics|narcotics|mesh-ancestor
6232619|NCT02528253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6232620|NCT02528253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232621|NCT02528253|Analgesics|analgesics|mesh-ancestor
6232622|NCT02528253|Sensory System Agents|sensory system agents|mesh-ancestor
6232623|NCT02528253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6232624|NCT02528357|Pembrolizumab|pembrolizumab|mesh-list
6232625|NCT02528357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6232626|NCT02528357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6232627|NCT02528409|Vortioxetine|vortioxetine|mesh-list
6232628|NCT02528409|Antidepressive Agents|antidepressive agents|mesh-ancestor
6232629|NCT02528409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6232630|NCT02528409|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6232631|NCT02528409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6232632|NCT02528409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6232633|NCT02528409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232634|NCT02528409|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6232635|NCT02528409|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6232636|NCT02528409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6232637|NCT02528409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232638|NCT02528409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6232639|NCT02528409|Serotonin Agents|serotonin agents|mesh-ancestor
6232640|NCT02528409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6232641|NCT02528409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6232642|NCT02528409|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6232643|NCT02528409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6232644|NCT02529072|Nivolumab|nivolumab|mesh-list
6232645|NCT02529072|Vaccines|vaccines|mesh-list
6232646|NCT02529072|Immunologic Factors|immunologic factors|mesh-ancestor
6232647|NCT02529072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232648|NCT02529072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6232649|NCT02529072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6232650|NCT02529072|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6232651|NCT02529072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232652|NCT02529995|Osimertinib|osimertinib|mesh-list
6232653|NCT02529995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6232654|NCT02529995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6232655|NCT02529995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6232656|NCT02529995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232657|NCT02530125|Pidilizumab|pidilizumab|mesh-list
6232658|NCT02530125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6232659|NCT02530125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6232660|NCT02530151|Clonidine|clonidine|mesh-list
6232661|NCT02530151|Morphine|morphine|mesh-list
6232662|NCT02530151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6232663|NCT02530151|Narcotics|narcotics|mesh-ancestor
6232664|NCT02530151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6232665|NCT02530151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232666|NCT02530151|Analgesics|analgesics|mesh-ancestor
6500964|NCT00646659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6500965|NCT00646659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6676860|NCT01583660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6676861|NCT01583660|Analgesics|analgesics|mesh-ancestor
6676862|NCT01583660|Sensory System Agents|sensory system agents|mesh-ancestor
6676863|NCT01583660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6676864|NCT01583660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676865|NCT01583660|Antipyretics|antipyretics|mesh-ancestor
6676866|NCT01583660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6676867|NCT01583660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6676868|NCT01583660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6676869|NCT01583660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6500966|NCT00646659|Immunologic Factors|immunologic factors|mesh-ancestor
6500967|NCT00646659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6500968|NCT00646659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6500969|NCT00646711|Valproic Acid|valproic acid|mesh-list
6500970|NCT00646711|Anticonvulsants|anticonvulsants|mesh-ancestor
6500971|NCT00646711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6500972|NCT00646711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500973|NCT00646711|GABA Agents|gaba agents|mesh-ancestor
6500974|NCT00646711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6500975|NCT00646711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232667|NCT02530151|Sensory System Agents|sensory system agents|mesh-ancestor
6232668|NCT02530151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6232669|NCT02530151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6232670|NCT02530151|Sympatholytics|sympatholytics|mesh-ancestor
6232671|NCT02530151|Autonomic Agents|autonomic agents|mesh-ancestor
6232672|NCT02530151|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6232673|NCT02530151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6232674|NCT02530151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6232675|NCT02530151|Adrenergic Agents|adrenergic agents|mesh-ancestor
6500976|NCT00646711|Antimanic Agents|antimanic agents|mesh-ancestor
6232676|NCT02530151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6232677|NCT02530151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232678|NCT02530242|Carbon Monoxide|carbon monoxide|mesh-list
6232679|NCT02530242|Antimetabolites|antimetabolites|mesh-ancestor
6232680|NCT02530242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232681|NCT02530242|Gasotransmitters|gasotransmitters|mesh-ancestor
6500977|NCT00646711|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6500978|NCT00646711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6500979|NCT00646711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6500980|NCT00646737|Mycophenolic Acid|mycophenolic acid|mesh-list
5708832|NCT03291314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5708833|NCT03291314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5708834|NCT03291314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5708835|NCT03291314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5708836|NCT03291314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5708837|NCT03291249|Omeprazole|omeprazole|mesh-list
5708838|NCT03291249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5708839|NCT03291249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5708840|NCT03291249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5708841|NCT03291249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5708842|NCT03291249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5708843|NCT03291158|Minocycline|minocycline|mesh-list
5708844|NCT03291158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5708845|NCT03291158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5708846|NCT03291145|Spironolactone|spironolactone|mesh-list
5708847|NCT03291145|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
5708848|NCT03291145|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5708849|NCT03291145|Hormone Antagonists|hormone antagonists|mesh-ancestor
5708850|NCT03291145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5708851|NCT03291145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708852|NCT03291145|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5708853|NCT03291145|Diuretics|diuretics|mesh-ancestor
5708854|NCT03291145|Natriuretic Agents|natriuretic agents|mesh-ancestor
5708855|NCT03291145|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5708856|NCT03291145|Adrenergic Agents|adrenergic agents|mesh-ancestor
5708857|NCT03291145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5708858|NCT03291145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5708859|NCT03291093|Flutemetamol|flutemetamol|mesh-list
5708860|NCT03291093|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5708861|NCT03291093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5708862|NCT03291054|Pembrolizumab|pembrolizumab|mesh-list
5708863|NCT03291054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5708864|NCT03291054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5708865|NCT03290963|Ketamine|ketamine|mesh-list
5708866|NCT03290963|Analgesics|analgesics|mesh-ancestor
5708867|NCT03290963|Sensory System Agents|sensory system agents|mesh-ancestor
5708868|NCT03290963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5708869|NCT03290963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708870|NCT03290963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5708871|NCT03290963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5708872|NCT03290963|Anesthetics, General|anesthetics, general|mesh-ancestor
5708873|NCT03290963|Anesthetics|anesthetics|mesh-ancestor
5708874|NCT03290963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5721525|NCT03204877|Antioxidants|antioxidants|mesh-ancestor
5708875|NCT03290963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5708876|NCT03290963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5708877|NCT03290963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5708878|NCT03290963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232682|NCT02530242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6232683|NCT02530242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232684|NCT02530281|Glycopyrrolate|glycopyrrolate|mesh-list
6232685|NCT02530281|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6232686|NCT02530281|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6232687|NCT02530281|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6232688|NCT02530281|Cholinergic Agents|cholinergic agents|mesh-ancestor
6232689|NCT02530281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6232690|NCT02530281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232691|NCT02530281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232692|NCT02530294|Glycopyrrolate|glycopyrrolate|mesh-list
6500981|NCT00646737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6232693|NCT02530294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6232694|NCT02530294|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6500982|NCT00646737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6500983|NCT00646737|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6500984|NCT00646737|Antitubercular Agents|antitubercular agents|mesh-ancestor
6500985|NCT00646737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6500986|NCT00646737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6500987|NCT00646737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6500988|NCT00646737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6500989|NCT00646750|Rituximab|rituximab|mesh-list
6500990|NCT00646750|Melphalan|melphalan|mesh-list
6500991|NCT00646750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6500992|NCT00646750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6500993|NCT00646750|Immunologic Factors|immunologic factors|mesh-ancestor
6500994|NCT00646750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708895|NCT03290859|Propofol|propofol|mesh-list
5708896|NCT03290859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5708897|NCT03290859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5708898|NCT03290859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708899|NCT03290859|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5708900|NCT03290859|Anesthetics, General|anesthetics, general|mesh-ancestor
6232695|NCT02530294|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6232696|NCT02530294|Cholinergic Agents|cholinergic agents|mesh-ancestor
6232697|NCT02530294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6232698|NCT02530294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232699|NCT02530294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232700|NCT02530476|Sorafenib|sorafenib|mesh-list
6232701|NCT02530476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6232702|NCT02530476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6232703|NCT02530476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6232704|NCT02530476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232705|NCT02530528|Chlorhexidine|chlorhexidine|mesh-list
6232706|NCT02530528|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6232707|NCT02530528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6232708|NCT02530528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6232709|NCT02530528|Disinfectants|disinfectants|mesh-ancestor
6232710|NCT02530528|Dermatologic Agents|dermatologic agents|mesh-ancestor
6232711|NCT02530541|Chlorhexidine|chlorhexidine|mesh-list
6232712|NCT02530541|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6232713|NCT02530541|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6232714|NCT02530541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6500995|NCT00646750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6232715|NCT02530541|Disinfectants|disinfectants|mesh-ancestor
6232716|NCT02530541|Dermatologic Agents|dermatologic agents|mesh-ancestor
6500996|NCT00646750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6500997|NCT00646750|Alkylating Agents|alkylating agents|mesh-ancestor
6676870|NCT01583660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5708901|NCT03290859|Anesthetics|anesthetics|mesh-ancestor
5708902|NCT03290846|Secretin|secretin|mesh-list
5708903|NCT03290846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5708904|NCT03290846|Hormones|hormones|mesh-ancestor
5708905|NCT03290846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5708906|NCT03290846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708907|NCT03290820|Aspirin|aspirin|mesh-list
5708908|NCT03290820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6232717|NCT02530554|Chlorhexidine|chlorhexidine|mesh-list
6232718|NCT02530554|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6232719|NCT02530554|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6232720|NCT02530554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6232721|NCT02530554|Disinfectants|disinfectants|mesh-ancestor
6232722|NCT02530554|Dermatologic Agents|dermatologic agents|mesh-ancestor
6232723|NCT02531035|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
6232724|NCT02531035|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6232725|NCT02531035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232726|NCT02531035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6232727|NCT02531035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6500998|NCT00646750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918917|NCT04987775|Acetylcysteine|acetylcysteine|mesh-list
5918918|NCT04987775|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5918919|NCT04987775|Antiviral Agents|antiviral agents|mesh-ancestor
5918920|NCT04987775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5708909|NCT03290820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5708910|NCT03290820|Analgesics|analgesics|mesh-ancestor
5708911|NCT03290820|Sensory System Agents|sensory system agents|mesh-ancestor
5708912|NCT03290820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5708913|NCT03290820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918921|NCT04987775|Expectorants|expectorants|mesh-ancestor
5918922|NCT04987775|Respiratory System Agents|respiratory system agents|mesh-ancestor
5918923|NCT04987775|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5708914|NCT03290820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5708915|NCT03290820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5708916|NCT03290820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5708917|NCT03290820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5918924|NCT04987775|Antioxidants|antioxidants|mesh-ancestor
5918925|NCT04987775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918926|NCT04987775|Protective Agents|protective agents|mesh-ancestor
5918927|NCT04987775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708918|NCT03290820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5708919|NCT03290820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5708920|NCT03290820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5708921|NCT03290820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5708922|NCT03290820|Antipyretics|antipyretics|mesh-ancestor
5721526|NCT03204877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721527|NCT03204877|Protective Agents|protective agents|mesh-ancestor
5721528|NCT03204877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721529|NCT03204877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5721530|NCT03204799|Metformin|metformin|mesh-list
5721531|NCT03204799|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
5721532|NCT03204799|Ezetimibe|ezetimibe|mesh-list
5721533|NCT03204799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5721534|NCT03204799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721535|NCT03204799|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5918928|NCT04987775|Antidotes|antidotes|mesh-ancestor
5918929|NCT04987632|Letrozole|letrozole|mesh-list
5918930|NCT04987632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5918931|NCT04987632|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6500999|NCT00646750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6501000|NCT00646750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6501001|NCT00646802|Progesterone|progesterone|mesh-list
6501002|NCT00646802|Progestins|progestins|mesh-ancestor
6501003|NCT00646802|Hormones|hormones|mesh-ancestor
6501004|NCT00646802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6501005|NCT00646802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501006|NCT00646815|Hormones|hormones|mesh-list
5708923|NCT03290703|Rabeprazole|rabeprazole|mesh-list
5708924|NCT03290703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5708925|NCT03290703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5708926|NCT03290703|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5708927|NCT03290703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5708928|NCT03290703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5708929|NCT03290625|Dexmedetomidine|dexmedetomidine|mesh-list
5918932|NCT04987632|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5918933|NCT04987632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5918934|NCT04987632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918935|NCT04987632|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5918936|NCT04987632|Hormone Antagonists|hormone antagonists|mesh-ancestor
6501007|NCT00646815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6501008|NCT00646815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501009|NCT00646841|Doxazosin|doxazosin|mesh-list
6232728|NCT02531113|Ozanimod|ozanimod|mesh-list
6232729|NCT02531113|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6232730|NCT02531113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232731|NCT02531113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6232732|NCT02531113|Immunologic Factors|immunologic factors|mesh-ancestor
6232733|NCT02531113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232734|NCT02531321|Levonorgestrel|levonorgestrel|mesh-list
6232735|NCT02531321|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6501010|NCT00646841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6501011|NCT00646841|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6501012|NCT00646841|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6501013|NCT00646841|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6501014|NCT00646841|Adrenergic Agents|adrenergic agents|mesh-ancestor
6501015|NCT00646841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6501016|NCT00646841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232736|NCT02531321|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
6232737|NCT02531321|Estradiol|estradiol|mesh-list
6232738|NCT02531321|Estrogens|estrogens|mesh-ancestor
6232739|NCT02531321|Hormones|hormones|mesh-ancestor
6232740|NCT02531321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6232741|NCT02531321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232742|NCT02531321|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6232743|NCT02531321|Contraceptive Agents|contraceptive agents|mesh-ancestor
6232744|NCT02531321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6232745|NCT02531321|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6232746|NCT02531321|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6232747|NCT02531321|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6232748|NCT02531321|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6232749|NCT02531321|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6232750|NCT02531373|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6232751|NCT02531373|Immunologic Factors|immunologic factors|mesh-ancestor
6232752|NCT02531373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232753|NCT02531438|Moxifloxacin|moxifloxacin|mesh-list
6501017|NCT00646841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501018|NCT00646854|Cyclophosphamide|cyclophosphamide|mesh-list
6501019|NCT00646854|Alemtuzumab|alemtuzumab|mesh-list
6501020|NCT00646854|Doxorubicin|doxorubicin|mesh-list
6501021|NCT00646854|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6501022|NCT00646854|Vincristine|vincristine|mesh-list
6501023|NCT00646854|Lenograstim|lenograstim|mesh-list
6232754|NCT02531438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6676871|NCT01583660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5708930|NCT03290625|Ketamine|ketamine|mesh-list
5708931|NCT03290625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5708932|NCT03290625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5708933|NCT03290625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708934|NCT03290625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5708935|NCT03290625|Analgesics|analgesics|mesh-ancestor
5708936|NCT03290625|Sensory System Agents|sensory system agents|mesh-ancestor
5708937|NCT03290625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5708938|NCT03290625|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5708939|NCT03290625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5708940|NCT03290625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5708941|NCT03290625|Adrenergic Agents|adrenergic agents|mesh-ancestor
5708942|NCT03290625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5708943|NCT03290625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5708944|NCT03290625|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5708945|NCT03290625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6232755|NCT02531438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6232756|NCT02531438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6232757|NCT02531438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6232758|NCT02531438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6232759|NCT02531438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232760|NCT02531438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6232761|NCT02531633|Prednisone|prednisone|mesh-list
6232762|NCT02531633|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6232763|NCT02531633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6232764|NCT02531633|Glucocorticoids|glucocorticoids|mesh-ancestor
6232765|NCT02531633|Hormones|hormones|mesh-ancestor
6232766|NCT02531633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6232767|NCT02531633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232768|NCT02531633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6232769|NCT02531633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6232770|NCT02531633|Immunologic Factors|immunologic factors|mesh-ancestor
6232771|NCT02531698|Vaccines|vaccines|mesh-list
6232772|NCT02531698|Immunologic Factors|immunologic factors|mesh-ancestor
6232773|NCT02531698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708946|NCT03290625|Anesthetics, General|anesthetics, general|mesh-ancestor
5708947|NCT03290625|Anesthetics|anesthetics|mesh-ancestor
5708948|NCT03290625|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5708949|NCT03290625|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5708950|NCT03290560|Kallikreins|kallikreins|mesh-list
5708951|NCT03290560|Coagulants|coagulants|mesh-ancestor
5708952|NCT03290560|Fertility Agents, Male|fertility agents, male|mesh-ancestor
5708953|NCT03290560|Fertility Agents|fertility agents|mesh-ancestor
5708954|NCT03290560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5708955|NCT03290560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708956|NCT03290495|Ketamine|ketamine|mesh-list
5708957|NCT03290495|Analgesics|analgesics|mesh-ancestor
5708958|NCT03290495|Sensory System Agents|sensory system agents|mesh-ancestor
5708959|NCT03290495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5708960|NCT03290495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708961|NCT03290495|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5708962|NCT03290495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5708963|NCT03290495|Anesthetics, General|anesthetics, general|mesh-ancestor
5708964|NCT03290495|Anesthetics|anesthetics|mesh-ancestor
5708965|NCT03290495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5708966|NCT03290495|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5708967|NCT03290495|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5708968|NCT03290495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5708969|NCT03290495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5708970|NCT03290456|Prednisone|prednisone|mesh-list
5708971|NCT03290456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5708972|NCT03290456|Glucocorticoids|glucocorticoids|mesh-ancestor
5708973|NCT03290456|Hormones|hormones|mesh-ancestor
5708974|NCT03290456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5708975|NCT03290456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232774|NCT02531971|Fentanyl|fentanyl|mesh-list
6232775|NCT02531971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6232776|NCT02531971|Narcotics|narcotics|mesh-ancestor
6232777|NCT02531971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6232778|NCT02531971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708976|NCT03290456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5708977|NCT03290456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6232779|NCT02531971|Analgesics|analgesics|mesh-ancestor
6232780|NCT02531971|Sensory System Agents|sensory system agents|mesh-ancestor
6232781|NCT02531971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6232782|NCT02531971|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6232783|NCT02531971|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6232784|NCT02531971|Anesthetics, General|anesthetics, general|mesh-ancestor
6232785|NCT02531971|Anesthetics|anesthetics|mesh-ancestor
6232786|NCT02532010|Cytarabine|cytarabine|mesh-list
6232787|NCT02532010|Decitabine|decitabine|mesh-list
5708978|NCT03290430|Nicotine|nicotine|mesh-list
5708979|NCT03290430|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5708980|NCT03290430|Autonomic Agents|autonomic agents|mesh-ancestor
5708981|NCT03290430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5708982|NCT03290430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708983|NCT03290430|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5708984|NCT03290430|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5708985|NCT03290430|Cholinergic Agents|cholinergic agents|mesh-ancestor
5708986|NCT03290430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5721536|NCT03204799|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6232788|NCT02532010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6232789|NCT02532010|Antimetabolites|antimetabolites|mesh-ancestor
6232790|NCT02532010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232791|NCT02532010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6232792|NCT02532010|Antiviral Agents|antiviral agents|mesh-ancestor
6232793|NCT02532010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6232794|NCT02532010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6232795|NCT02532010|Immunologic Factors|immunologic factors|mesh-ancestor
6232796|NCT02532010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232797|NCT02532010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6232798|NCT02532283|Oseltamivir|oseltamivir|mesh-list
6232799|NCT02532283|Antiviral Agents|antiviral agents|mesh-ancestor
6501024|NCT00646854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6501025|NCT00646854|Immunologic Factors|immunologic factors|mesh-ancestor
6501026|NCT00646854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501027|NCT00646854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6501028|NCT00646854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6501029|NCT00646854|Alkylating Agents|alkylating agents|mesh-ancestor
6501030|NCT00646854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501031|NCT00646854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6501032|NCT00646854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5708987|NCT03290430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5708988|NCT03290417|Vitamin D|vitamin d|mesh-list
5708989|NCT03290417|Ergocalciferols|ergocalciferols|mesh-list
5708990|NCT03290417|Vitamins|vitamins|mesh-list
5708991|NCT03290417|Curcumin|curcumin|mesh-list
5708992|NCT03290417|Turmeric extract|turmeric extract|mesh-list
5708993|NCT03290417|Micronutrients|micronutrients|mesh-ancestor
5708994|NCT03290417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5708995|NCT03290417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5708996|NCT03290417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5708997|NCT03290417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6232800|NCT02532283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6232801|NCT02532283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6232802|NCT02532283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232803|NCT02532374|Nicotine|nicotine|mesh-list
6232804|NCT02532374|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6232805|NCT02532374|Autonomic Agents|autonomic agents|mesh-ancestor
6232806|NCT02532374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6501033|NCT00646854|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6501034|NCT00646854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6501035|NCT00646854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6676872|NCT01583660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676873|NCT01583660|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6676874|NCT01583660|Narcotics|narcotics|mesh-ancestor
6676875|NCT01583660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6676876|NCT01583777|Belinostat|belinostat|mesh-list
6501036|NCT00646854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6501037|NCT00646854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6501038|NCT00646854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6501039|NCT00646854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6501040|NCT00646854|Tubulin Modulators|tubulin modulators|mesh-ancestor
6501041|NCT00646854|Antimitotic Agents|antimitotic agents|mesh-ancestor
6501042|NCT00646854|Mitosis Modulators|mitosis modulators|mesh-ancestor
6501043|NCT00646880|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6501044|NCT00646880|Propiverine|propiverine|mesh-list
6501045|NCT00646880|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6501046|NCT00646880|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6232807|NCT02532374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232808|NCT02532374|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5708998|NCT03290417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6232809|NCT02532374|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6232810|NCT02532374|Cholinergic Agents|cholinergic agents|mesh-ancestor
6232811|NCT02532374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6232812|NCT02532374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232813|NCT02532647|Midazolam|midazolam|mesh-list
6232814|NCT02532647|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6232815|NCT02532647|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6232816|NCT02532647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6232817|NCT02532647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232818|NCT02532647|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6232819|NCT02532647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6232820|NCT02532647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6232821|NCT02532647|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6232822|NCT02532647|Anesthetics, General|anesthetics, general|mesh-ancestor
6232823|NCT02532647|Anesthetics|anesthetics|mesh-ancestor
6232824|NCT02532647|GABA Modulators|gaba modulators|mesh-ancestor
6232825|NCT02532647|GABA Agents|gaba agents|mesh-ancestor
6232826|NCT02532647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6232827|NCT02532647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232828|NCT02532855|Metformin|metformin|mesh-list
6232829|NCT02532855|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6232830|NCT02532855|Dapagliflozin|dapagliflozin|mesh-list
6232831|NCT02532855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6232832|NCT02532855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232833|NCT02532855|Incretins|incretins|mesh-ancestor
6232834|NCT02532855|Hormones|hormones|mesh-ancestor
6232835|NCT02532855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6232836|NCT02532855|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6232837|NCT02532855|Protease Inhibitors|protease inhibitors|mesh-ancestor
6232838|NCT02532855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6501047|NCT00646880|Cholinergic Agents|cholinergic agents|mesh-ancestor
6676877|NCT01583777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6676878|NCT01583777|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6676879|NCT01583777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6232839|NCT02532855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232840|NCT02532855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6232841|NCT02532998|Fludrocortisone|fludrocortisone|mesh-list
6232842|NCT02532998|Eplerenone|eplerenone|mesh-list
6232843|NCT02532998|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6232844|NCT02532998|Hormone Antagonists|hormone antagonists|mesh-ancestor
6232845|NCT02532998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6232846|NCT02532998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232847|NCT02532998|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6232848|NCT02532998|Diuretics|diuretics|mesh-ancestor
6232849|NCT02532998|Natriuretic Agents|natriuretic agents|mesh-ancestor
5708999|NCT03290417|Analgesics|analgesics|mesh-ancestor
5709000|NCT03290417|Sensory System Agents|sensory system agents|mesh-ancestor
5709001|NCT03290417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5709002|NCT03290417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5709003|NCT03290417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5709004|NCT03290417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6232850|NCT02532998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6232851|NCT02532998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6232852|NCT02533375|Adalimumab|adalimumab|mesh-list
6232853|NCT02533375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6232854|NCT02533375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6232855|NCT02533401|Cyclophosphamide|cyclophosphamide|mesh-list
6232856|NCT02533401|Rituximab|rituximab|mesh-list
6232857|NCT02533401|Fludarabine|fludarabine|mesh-list
6232858|NCT02533401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6232859|NCT02533401|Immunologic Factors|immunologic factors|mesh-ancestor
6232860|NCT02533401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709005|NCT03290417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5709006|NCT03290417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5709007|NCT03290417|Antioxidants|antioxidants|mesh-ancestor
5709008|NCT03290417|Protective Agents|protective agents|mesh-ancestor
5709009|NCT03290391|Naltrexone|naltrexone|mesh-list
5709010|NCT03290391|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5709011|NCT03290391|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5709012|NCT03290391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709013|NCT03290391|Sensory System Agents|sensory system agents|mesh-ancestor
5709014|NCT03290391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5709015|NCT03290365|Hyaluronic Acid|hyaluronic acid|mesh-list
5709016|NCT03290365|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5709017|NCT03290365|Immunologic Factors|immunologic factors|mesh-ancestor
6232861|NCT02533401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6232862|NCT02533401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6232863|NCT02533401|Alkylating Agents|alkylating agents|mesh-ancestor
6232864|NCT02533401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232865|NCT02533401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6232866|NCT02533401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6232867|NCT02533401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6232868|NCT02533427|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6232869|NCT02533427|Norgestimate|norgestimate|mesh-list
5709018|NCT03290365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709019|NCT03290365|Viscosupplements|viscosupplements|mesh-ancestor
6232870|NCT02533427|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6232871|NCT02533427|Estradiol|estradiol|mesh-list
6501048|NCT00646880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5709020|NCT03290365|Protective Agents|protective agents|mesh-ancestor
5709021|NCT03290196|Bupivacaine|bupivacaine|mesh-list
5709022|NCT03290196|Anesthetics, Local|anesthetics, local|mesh-ancestor
5709023|NCT03290196|Anesthetics|anesthetics|mesh-ancestor
6232872|NCT02533427|Estrogens|estrogens|mesh-ancestor
6232873|NCT02533427|Hormones|hormones|mesh-ancestor
6232874|NCT02533427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6232875|NCT02533427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232876|NCT02533427|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6232877|NCT02533427|Contraceptive Agents|contraceptive agents|mesh-ancestor
6232878|NCT02533427|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5709024|NCT03290196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5709025|NCT03290196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709026|NCT03290196|Sensory System Agents|sensory system agents|mesh-ancestor
5709027|NCT03290196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5709028|NCT03289949|Ketanserin|ketanserin|mesh-list
5709029|NCT03289949|Psilocybin|psilocybin|mesh-list
5709030|NCT03289949|Hallucinogens|hallucinogens|mesh-ancestor
5709031|NCT03289949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709032|NCT03289949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5709033|NCT03289949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5709034|NCT03289949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5709035|NCT03289949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5709036|NCT03289949|Serotonin Agents|serotonin agents|mesh-ancestor
5709037|NCT03289949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5709038|NCT03289949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5709039|NCT03289910|Carboplatin|carboplatin|mesh-list
6232879|NCT02533427|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6232880|NCT02533427|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6232881|NCT02533427|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6232882|NCT02533427|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6232883|NCT02533427|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6232884|NCT02533453|Exenatide|exenatide|mesh-list
6232885|NCT02533453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6232886|NCT02533453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232887|NCT02533453|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6232888|NCT02533453|Incretins|incretins|mesh-ancestor
6232889|NCT02533453|Hormones|hormones|mesh-ancestor
6232890|NCT02533453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6232891|NCT02533466|Listerine|listerine|mesh-list
6232892|NCT02533466|Fluorides|fluorides|mesh-list
6232893|NCT02533466|Sodium Fluoride|sodium fluoride|mesh-list
6232894|NCT02533466|Cariostatic Agents|cariostatic agents|mesh-ancestor
6232895|NCT02533466|Protective Agents|protective agents|mesh-ancestor
6232896|NCT02533466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232897|NCT02533466|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6232898|NCT02533466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5709040|NCT03289910|Topotecan|topotecan|mesh-list
5709041|NCT03289910|Veliparib|veliparib|mesh-list
5709042|NCT03289910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5709043|NCT03289910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5709044|NCT03289910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5709045|NCT03289910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5709046|NCT03289910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5709047|NCT03289910|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6232899|NCT02533505|Budesonide|budesonide|mesh-list
6232900|NCT02533505|Formoterol Fumarate|formoterol fumarate|mesh-list
6232901|NCT02533505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6232902|NCT02533505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6232903|NCT02533505|Autonomic Agents|autonomic agents|mesh-ancestor
6232904|NCT02533505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6232905|NCT02533505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232906|NCT02533505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6232907|NCT02533505|Respiratory System Agents|respiratory system agents|mesh-ancestor
6232908|NCT02533505|Glucocorticoids|glucocorticoids|mesh-ancestor
6232909|NCT02533505|Hormones|hormones|mesh-ancestor
6232910|NCT02533505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6232911|NCT02533505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6232912|NCT02533505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6232913|NCT02533505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6232914|NCT02533505|Adrenergic Agents|adrenergic agents|mesh-ancestor
6232915|NCT02533505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6232916|NCT02533505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5709048|NCT03289871|Amorolfine|amorolfine|mesh-list
6232917|NCT02533570|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6232918|NCT02533570|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6232919|NCT02533570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6232920|NCT02533570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6232921|NCT02533570|Immunologic Factors|immunologic factors|mesh-ancestor
6232922|NCT02533570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232923|NCT02533674|Gemcitabine|gemcitabine|mesh-list
6232924|NCT02533674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6232925|NCT02533674|Antimetabolites|antimetabolites|mesh-ancestor
6232926|NCT02533674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232927|NCT02533674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6232928|NCT02533674|Antiviral Agents|antiviral agents|mesh-ancestor
6232929|NCT02533674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6232930|NCT02533674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6232931|NCT02533674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6232932|NCT02533674|Immunologic Factors|immunologic factors|mesh-ancestor
6232933|NCT02533674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232934|NCT02533934|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
6232935|NCT02533934|Antiviral Agents|antiviral agents|mesh-ancestor
6501049|NCT00646880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501050|NCT00646880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501051|NCT00646880|Urological Agents|urological agents|mesh-ancestor
6501052|NCT00646880|Parasympatholytics|parasympatholytics|mesh-ancestor
6232936|NCT02533934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6232937|NCT02534129|Petrolatum|petrolatum|mesh-list
6232938|NCT02534129|Emollients|emollients|mesh-ancestor
6232939|NCT02534129|Dermatologic Agents|dermatologic agents|mesh-ancestor
6232940|NCT02534324|Antihypertensive Agents|antihypertensive agents|mesh-list
6232941|NCT02534883|Misoprostol|misoprostol|mesh-list
6501053|NCT00646880|Autonomic Agents|autonomic agents|mesh-ancestor
6501054|NCT00646880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6232942|NCT02534883|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6232943|NCT02534883|Abortifacient Agents|abortifacient agents|mesh-ancestor
6232944|NCT02534883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6232945|NCT02534883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232946|NCT02534883|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6232947|NCT02534883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6232948|NCT02534883|Oxytocics|oxytocics|mesh-ancestor
6232949|NCT02534935|Vaccines|vaccines|mesh-list
6232950|NCT02534935|Immunologic Factors|immunologic factors|mesh-ancestor
6232951|NCT02534935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232952|NCT02535000|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6232953|NCT02535000|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6232954|NCT02535000|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6501055|NCT00646932|Ergocalciferols|ergocalciferols|mesh-list
6501056|NCT00646932|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6501057|NCT00646932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501058|NCT00646932|Vitamins|vitamins|mesh-ancestor
6501059|NCT00646932|Micronutrients|micronutrients|mesh-ancestor
6501060|NCT00646932|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6501061|NCT00646945|Nitrous Oxide|nitrous oxide|mesh-list
6501062|NCT00646945|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6501063|NCT00646945|Anesthetics, General|anesthetics, general|mesh-ancestor
6501064|NCT00646945|Anesthetics|anesthetics|mesh-ancestor
6501065|NCT00646945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6501066|NCT00646945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501067|NCT00646945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6501068|NCT00646945|Analgesics|analgesics|mesh-ancestor
6501069|NCT00646945|Sensory System Agents|sensory system agents|mesh-ancestor
6676880|NCT01583777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5709049|NCT03289871|Antifungal Agents|antifungal agents|mesh-ancestor
5709050|NCT03289871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5709051|NCT03289819|Paclitaxel|paclitaxel|mesh-list
5709052|NCT03289819|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5709053|NCT03289819|Cyclophosphamide|cyclophosphamide|mesh-list
5709054|NCT03289819|Pembrolizumab|pembrolizumab|mesh-list
5709055|NCT03289819|Epirubicin|epirubicin|mesh-list
5709056|NCT03289819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5709057|NCT03289819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6232955|NCT02535000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6232956|NCT02535000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232957|NCT02535000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6232958|NCT02535000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232959|NCT02535000|Analgesics|analgesics|mesh-ancestor
5709058|NCT03289819|Tubulin Modulators|tubulin modulators|mesh-ancestor
5709059|NCT03289819|Antimitotic Agents|antimitotic agents|mesh-ancestor
6232960|NCT02535000|Sensory System Agents|sensory system agents|mesh-ancestor
6232961|NCT02535000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6232962|NCT02535000|Antidepressive Agents|antidepressive agents|mesh-ancestor
6232963|NCT02535000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6232964|NCT02535000|Dopamine Agents|dopamine agents|mesh-ancestor
6232965|NCT02535416|Diphenhydramine|diphenhydramine|mesh-list
6232966|NCT02535416|Promethazine|promethazine|mesh-list
6232967|NCT02535416|Cetirizine|cetirizine|mesh-list
6501070|NCT00646945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6501071|NCT00646984|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6501072|NCT00646984|Antiviral Agents|antiviral agents|mesh-ancestor
6501073|NCT00646984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6501074|NCT00647023|Metformin|metformin|mesh-list
6501075|NCT00647023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6232968|NCT02535416|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6232969|NCT02535416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6232970|NCT02535416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6232971|NCT02535416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232972|NCT02535416|Anesthetics, Local|anesthetics, local|mesh-ancestor
6232973|NCT02535416|Anesthetics|anesthetics|mesh-ancestor
6232974|NCT02535416|Sensory System Agents|sensory system agents|mesh-ancestor
6232975|NCT02535416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6232976|NCT02535416|Antiemetics|antiemetics|mesh-ancestor
6232977|NCT02535416|Autonomic Agents|autonomic agents|mesh-ancestor
6232978|NCT02535416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6232979|NCT02535416|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6232980|NCT02535416|Histamine Antagonists|histamine antagonists|mesh-ancestor
6232981|NCT02535416|Histamine Agents|histamine agents|mesh-ancestor
6232982|NCT02535416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6232983|NCT02535416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232984|NCT02535416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6232985|NCT02535416|Antipruritics|antipruritics|mesh-ancestor
6232986|NCT02535416|Dermatologic Agents|dermatologic agents|mesh-ancestor
6501076|NCT00647023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501077|NCT00647049|Cytarabine|cytarabine|mesh-list
5709060|NCT03289819|Mitosis Modulators|mitosis modulators|mesh-ancestor
5709061|NCT03289819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232987|NCT02535416|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6232988|NCT02535611|Memantine|memantine|mesh-list
6232989|NCT02535611|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6232990|NCT02535611|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6232991|NCT02535611|Dopamine Agents|dopamine agents|mesh-ancestor
6232992|NCT02535611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6232993|NCT02535611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6232994|NCT02535611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6232995|NCT02535611|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6232996|NCT02535611|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6232997|NCT02535715|Insulin|insulin|mesh-list
6232998|NCT02535715|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6232999|NCT02535715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6233000|NCT02535715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233001|NCT02535806|Cytarabine|cytarabine|mesh-list
6233002|NCT02535806|Dexamethasone|dexamethasone|mesh-list
6233003|NCT02535806|Hydrocortisone|hydrocortisone|mesh-list
6233004|NCT02535806|Methotrexate|methotrexate|mesh-list
6233005|NCT02535806|Vincristine|vincristine|mesh-list
6233006|NCT02535806|Bortezomib|bortezomib|mesh-list
5709062|NCT03289819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5709063|NCT03289819|Immunologic Factors|immunologic factors|mesh-ancestor
5709064|NCT03289819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233007|NCT02535806|Mitoxantrone|mitoxantrone|mesh-list
6233008|NCT02535806|Pegaspargase|pegaspargase|mesh-list
6233009|NCT02535806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6233010|NCT02535806|Antiemetics|antiemetics|mesh-ancestor
6233011|NCT02535806|Autonomic Agents|autonomic agents|mesh-ancestor
6233012|NCT02535806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6233013|NCT02535806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233014|NCT02535806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6233015|NCT02535806|Glucocorticoids|glucocorticoids|mesh-ancestor
6233016|NCT02535806|Hormones|hormones|mesh-ancestor
6233017|NCT02535806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6233018|NCT02535806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6233019|NCT02535806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6233020|NCT02535806|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6233021|NCT02535806|Abortifacient Agents|abortifacient agents|mesh-ancestor
6233022|NCT02535806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6501078|NCT00647049|Rituximab|rituximab|mesh-list
6501079|NCT00647049|Methotrexate|methotrexate|mesh-list
6233023|NCT02535806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6233024|NCT02535806|Antimetabolites|antimetabolites|mesh-ancestor
6501080|NCT00647049|Thiotepa|thiotepa|mesh-list
6501081|NCT00647049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6501082|NCT00647049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6501083|NCT00647049|Immunologic Factors|immunologic factors|mesh-ancestor
6501084|NCT00647049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501085|NCT00647049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6501086|NCT00647049|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6501087|NCT00647049|Abortifacient Agents|abortifacient agents|mesh-ancestor
6501088|NCT00647049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6501089|NCT00647049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6501090|NCT00647049|Antimetabolites|antimetabolites|mesh-ancestor
6501091|NCT00647049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501092|NCT00647049|Dermatologic Agents|dermatologic agents|mesh-ancestor
6501093|NCT00647049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6501094|NCT00647049|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5709065|NCT03289819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5709066|NCT03289819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5709067|NCT03289819|Alkylating Agents|alkylating agents|mesh-ancestor
5709068|NCT03289819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5709069|NCT03289819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5709070|NCT03289819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5709071|NCT03289819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5709072|NCT03289819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5709073|NCT03289819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5709074|NCT03289741|Octreotide|octreotide|mesh-list
5709075|NCT03289741|Lanreotide|lanreotide|mesh-list
5709076|NCT03289741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5709077|NCT03289741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5709078|NCT03289741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5709079|NCT03289728|Dobutamine|dobutamine|mesh-list
5709080|NCT03289728|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5709081|NCT03289728|Sympathomimetics|sympathomimetics|mesh-ancestor
5709082|NCT03289728|Autonomic Agents|autonomic agents|mesh-ancestor
5709083|NCT03289728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5709084|NCT03289728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709085|NCT03289728|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5709086|NCT03289728|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6501095|NCT00647049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6501096|NCT00647049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6501097|NCT00647049|Antiviral Agents|antiviral agents|mesh-ancestor
6501098|NCT00647049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6501099|NCT00647049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6233025|NCT02535806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233026|NCT02535806|Dermatologic Agents|dermatologic agents|mesh-ancestor
6233027|NCT02535806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6233028|NCT02535806|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6233029|NCT02535806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6233030|NCT02535806|Immunologic Factors|immunologic factors|mesh-ancestor
6233031|NCT02535806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6233032|NCT02535806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5709087|NCT03289728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5709088|NCT03289728|Adrenergic Agents|adrenergic agents|mesh-ancestor
5709089|NCT03289728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5709090|NCT03289728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5709091|NCT03289728|Protective Agents|protective agents|mesh-ancestor
5709092|NCT03289637|Vitamin D|vitamin d|mesh-list
5709093|NCT03289637|Vitamins|vitamins|mesh-ancestor
5709094|NCT03289637|Micronutrients|micronutrients|mesh-ancestor
5709095|NCT03289637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709096|NCT03289637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6233033|NCT02535806|Antiviral Agents|antiviral agents|mesh-ancestor
6233034|NCT02535806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6233035|NCT02535806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6233036|NCT02535806|Tubulin Modulators|tubulin modulators|mesh-ancestor
6233037|NCT02535806|Antimitotic Agents|antimitotic agents|mesh-ancestor
6676881|NCT01583842|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
6676882|NCT01583842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6676883|NCT01583842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6676884|NCT01583842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676885|NCT01583842|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6233038|NCT02535806|Mitosis Modulators|mitosis modulators|mesh-ancestor
6233039|NCT02535806|Analgesics|analgesics|mesh-ancestor
5709097|NCT03289559|Testosterone|testosterone|mesh-list
6233040|NCT02535806|Sensory System Agents|sensory system agents|mesh-ancestor
6233041|NCT02535806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6233042|NCT02535806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6233043|NCT02535949|Tranexamic Acid|tranexamic acid|mesh-list
6233044|NCT02535949|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6233045|NCT02535949|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6233046|NCT02535949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233047|NCT02535949|Hemostatics|hemostatics|mesh-ancestor
6233048|NCT02535949|Coagulants|coagulants|mesh-ancestor
6233049|NCT02536040|Fluorides|fluorides|mesh-list
6233050|NCT02536040|Cariostatic Agents|cariostatic agents|mesh-ancestor
6233051|NCT02536040|Protective Agents|protective agents|mesh-ancestor
6233052|NCT02536040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233053|NCT02536105|Methylphenidate|methylphenidate|mesh-list
6233054|NCT02536105|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6233055|NCT02536105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233056|NCT02536105|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6233057|NCT02536105|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6233058|NCT02536105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6233059|NCT02536105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233060|NCT02536105|Dopamine Agents|dopamine agents|mesh-ancestor
6233061|NCT02536105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6233062|NCT02536248|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6233063|NCT02536248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6233064|NCT02536248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233065|NCT02536248|Incretins|incretins|mesh-ancestor
6233066|NCT02536248|Hormones|hormones|mesh-ancestor
6233067|NCT02536248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6233068|NCT02536248|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6233069|NCT02536248|Protease Inhibitors|protease inhibitors|mesh-ancestor
6501100|NCT00647049|Alkylating Agents|alkylating agents|mesh-ancestor
6676886|NCT01583959|Folic Acid|folic acid|mesh-list
5709098|NCT03289559|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5709099|NCT03289559|Androgens|androgens|mesh-ancestor
5709100|NCT03289559|Hormones|hormones|mesh-ancestor
5709101|NCT03289559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6233070|NCT02536248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6233071|NCT02536248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233072|NCT02536313|Sofosbuvir|sofosbuvir|mesh-list
6233073|NCT02536313|Velpatasvir|velpatasvir|mesh-list
6233074|NCT02536313|Antiviral Agents|antiviral agents|mesh-ancestor
6233075|NCT02536313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6233076|NCT02536664|Rituximab|rituximab|mesh-list
6233077|NCT02536664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6233078|NCT02536664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6233079|NCT02536664|Immunologic Factors|immunologic factors|mesh-ancestor
6233080|NCT02536664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233081|NCT02536664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6233082|NCT02536794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6233083|NCT02536794|Durvalumab|durvalumab|mesh-list
6233084|NCT02536794|Ipilimumab|ipilimumab|mesh-list
5709102|NCT03289559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709103|NCT03289559|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5709104|NCT03289559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6233085|NCT02536794|Tremelimumab|tremelimumab|mesh-list
6233086|NCT02536794|Antibodies|antibodies|mesh-list
6233087|NCT02536794|Immunoglobulins|immunoglobulins|mesh-list
6233088|NCT02536794|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6233089|NCT02536794|Immunologic Factors|immunologic factors|mesh-ancestor
6233090|NCT02536794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233091|NCT02536794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6233092|NCT02536794|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6233093|NCT02536794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233094|NCT02536833|Lorecivivint|lorecivivint|mesh-list
6233095|NCT02536833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5709105|NCT03289559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5709106|NCT03289559|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5709107|NCT03289559|Hormone Antagonists|hormone antagonists|mesh-ancestor
5709108|NCT03289520|Clopidogrel|clopidogrel|mesh-list
5709109|NCT03289520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5709110|NCT03289520|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6233096|NCT02536846|Olanzapine|olanzapine|mesh-list
6233097|NCT02536846|Antiemetics|antiemetics|mesh-ancestor
6233098|NCT02536846|Autonomic Agents|autonomic agents|mesh-ancestor
6233099|NCT02536846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6676887|NCT01583959|Hematinics|hematinics|mesh-ancestor
6233100|NCT02536846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233101|NCT02536846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6233102|NCT02536846|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6233103|NCT02536846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6233104|NCT02536846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6233105|NCT02536846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6233106|NCT02536846|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6233107|NCT02536846|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6233108|NCT02536846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6233109|NCT02536846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233110|NCT02536846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6233111|NCT02536846|Serotonin Agents|serotonin agents|mesh-ancestor
6233112|NCT02536976|Mirabegron|mirabegron|mesh-list
6233113|NCT02536976|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6233114|NCT02536976|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6233115|NCT02536976|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6233116|NCT02536976|Adrenergic Agents|adrenergic agents|mesh-ancestor
6233117|NCT02536976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6233118|NCT02536976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233119|NCT02536976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233120|NCT02536976|Urological Agents|urological agents|mesh-ancestor
6233121|NCT02537015|Bimatoprost|bimatoprost|mesh-list
6233122|NCT02537015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6233123|NCT02537444|Pembrolizumab|pembrolizumab|mesh-list
6233124|NCT02537444|Acalabrutinib|acalabrutinib|mesh-list
6233125|NCT02537444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6233126|NCT02537444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6233127|NCT02537873|Cocaine|cocaine|mesh-list
6233128|NCT02537873|Anesthetics, Local|anesthetics, local|mesh-ancestor
6233129|NCT02537873|Anesthetics|anesthetics|mesh-ancestor
6233130|NCT02537873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5709111|NCT03289520|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5709112|NCT03289520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5709113|NCT03289520|Purinergic Agents|purinergic agents|mesh-ancestor
6501101|NCT00647049|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6501102|NCT00647101|Latanoprost|latanoprost|mesh-list
6501103|NCT00647101|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6501104|NCT00647101|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6501105|NCT00647127|Fentanyl|fentanyl|mesh-list
6501106|NCT00647127|Buprenorphine|buprenorphine|mesh-list
6233131|NCT02537873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233132|NCT02537873|Sensory System Agents|sensory system agents|mesh-ancestor
6233133|NCT02537873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6233134|NCT02537873|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6233135|NCT02537873|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6233136|NCT02537873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6233137|NCT02537873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6233138|NCT02537873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233139|NCT02537873|Dopamine Agents|dopamine agents|mesh-ancestor
6233140|NCT02537873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6501107|NCT00647127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6501108|NCT00647127|Narcotics|narcotics|mesh-ancestor
6501109|NCT00647127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6501110|NCT00647127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501111|NCT00647127|Analgesics|analgesics|mesh-ancestor
6501112|NCT00647127|Sensory System Agents|sensory system agents|mesh-ancestor
6501113|NCT00647127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6501114|NCT00647127|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6676888|NCT01583959|Vitamin B Complex|vitamin b complex|mesh-ancestor
6233141|NCT02537951|Lidocaine|lidocaine|mesh-list
6233142|NCT02537951|Prilocaine|prilocaine|mesh-list
6233143|NCT02537951|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
6676889|NCT01583959|Vitamins|vitamins|mesh-ancestor
6676890|NCT01583959|Micronutrients|micronutrients|mesh-ancestor
6676891|NCT01583959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709114|NCT03289520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5709115|NCT03289520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5709116|NCT03289520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709117|NCT03289429|Magnesium Sulfate|magnesium sulfate|mesh-list
5709118|NCT03289429|Atorvastatin|atorvastatin|mesh-list
5709119|NCT03289429|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6233144|NCT02537951|Capsaicin|capsaicin|mesh-list
6501115|NCT00647127|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6501116|NCT00647127|Anesthetics, General|anesthetics, general|mesh-ancestor
6676892|NCT01583972|Vitamin A|vitamin a|mesh-list
6676893|NCT01583972|Retinol palmitate|retinol palmitate|mesh-list
6501117|NCT00647127|Anesthetics|anesthetics|mesh-ancestor
6501118|NCT00647127|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6501119|NCT00647140|Levodopa|levodopa|mesh-list
6501120|NCT00647140|Dopamine Agents|dopamine agents|mesh-ancestor
6501121|NCT00647140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6501122|NCT00647140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501123|NCT00647140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501124|NCT00647140|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6501125|NCT00647140|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6501126|NCT00647166|Azathioprine|azathioprine|mesh-list
6501127|NCT00647166|Antimetabolites|antimetabolites|mesh-ancestor
6501128|NCT00647166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501129|NCT00647166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6501130|NCT00647166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6501131|NCT00647166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6501132|NCT00647166|Immunologic Factors|immunologic factors|mesh-ancestor
6501133|NCT00647166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501134|NCT00647166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6501135|NCT00647192|Eplerenone|eplerenone|mesh-list
6501136|NCT00647192|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6501137|NCT00647192|Hormone Antagonists|hormone antagonists|mesh-ancestor
6501138|NCT00647192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6501139|NCT00647192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501140|NCT00647192|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6501141|NCT00647192|Diuretics|diuretics|mesh-ancestor
6501142|NCT00647192|Natriuretic Agents|natriuretic agents|mesh-ancestor
6676894|NCT01583972|Vitamins|vitamins|mesh-ancestor
6676895|NCT01583972|Micronutrients|micronutrients|mesh-ancestor
6676896|NCT01583972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233145|NCT02537951|Anesthetics, Local|anesthetics, local|mesh-ancestor
6233146|NCT02537951|Anesthetics|anesthetics|mesh-ancestor
5709120|NCT03289429|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5709121|NCT03289429|Antimetabolites|antimetabolites|mesh-ancestor
5709122|NCT03289429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5709123|NCT03289429|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5709124|NCT03289429|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5709125|NCT03289429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5709126|NCT03289429|Analgesics|analgesics|mesh-ancestor
5709127|NCT03289429|Sensory System Agents|sensory system agents|mesh-ancestor
5709128|NCT03289429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5709129|NCT03289429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709130|NCT03289429|Anesthetics|anesthetics|mesh-ancestor
5709131|NCT03289429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5709132|NCT03289429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5709133|NCT03289429|Anticonvulsants|anticonvulsants|mesh-ancestor
5709134|NCT03289429|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5709135|NCT03289429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5709136|NCT03289429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5709137|NCT03289429|Tocolytic Agents|tocolytic agents|mesh-ancestor
5709138|NCT03289429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5709139|NCT03289390|Acetaminophen|acetaminophen|mesh-list
5709140|NCT03289390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5709141|NCT03289390|Analgesics|analgesics|mesh-ancestor
6233147|NCT02537951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6233148|NCT02537951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233149|NCT02537951|Sensory System Agents|sensory system agents|mesh-ancestor
6233150|NCT02537951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6676897|NCT01583972|Antioxidants|antioxidants|mesh-ancestor
6676898|NCT01583972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676899|NCT01583972|Protective Agents|protective agents|mesh-ancestor
6676900|NCT01583972|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6676901|NCT01583972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6676902|NCT01584050|Folic Acid|folic acid|mesh-list
6676903|NCT01584050|Hematinics|hematinics|mesh-ancestor
6676904|NCT01584050|Vitamin B Complex|vitamin b complex|mesh-ancestor
5709142|NCT03289390|Sensory System Agents|sensory system agents|mesh-ancestor
5709143|NCT03289390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5709144|NCT03289390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709145|NCT03289390|Antipyretics|antipyretics|mesh-ancestor
5709146|NCT03289351|Tazobactam|tazobactam|mesh-list
5709147|NCT03289351|Piperacillin|piperacillin|mesh-list
5709148|NCT03289351|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
6233151|NCT02537951|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6501143|NCT00647192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6676905|NCT01584050|Vitamins|vitamins|mesh-ancestor
6501144|NCT00647218|Paclitaxel|paclitaxel|mesh-list
5709149|NCT03289351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5709150|NCT03289351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5709151|NCT03289351|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5709152|NCT03289351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5709153|NCT03289351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5709154|NCT03289338|Zoledronic Acid|zoledronic acid|mesh-list
5709155|NCT03289338|Methylprednisolone|methylprednisolone|mesh-list
5709156|NCT03289338|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5709157|NCT03289338|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6233152|NCT02537951|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6233153|NCT02537951|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6233154|NCT02537951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6233155|NCT02537951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233156|NCT02537951|Antipruritics|antipruritics|mesh-ancestor
5709158|NCT03289338|Prednisolone|prednisolone|mesh-list
5709159|NCT03289338|Prednisolone acetate|prednisolone acetate|mesh-list
5709160|NCT03289338|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5709161|NCT03289338|Prednisolone phosphate|prednisolone phosphate|mesh-list
5709162|NCT03289338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5709163|NCT03289338|Antiemetics|antiemetics|mesh-ancestor
5709164|NCT03289338|Autonomic Agents|autonomic agents|mesh-ancestor
5709165|NCT03289338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5709166|NCT03289338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709167|NCT03289338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5709168|NCT03289338|Glucocorticoids|glucocorticoids|mesh-ancestor
6233157|NCT02537951|Dermatologic Agents|dermatologic agents|mesh-ancestor
6501145|NCT00647218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6501146|NCT00647218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6676906|NCT01584050|Micronutrients|micronutrients|mesh-ancestor
5709169|NCT03289338|Hormones|hormones|mesh-ancestor
5709170|NCT03289338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5709171|NCT03289338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5709172|NCT03289338|Protective Agents|protective agents|mesh-ancestor
5709173|NCT03289338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5709174|NCT03289338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5709175|NCT03289338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5709176|NCT03289260|Imiquimod|imiquimod|mesh-list
5709177|NCT03289260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5709178|NCT03289260|Immunologic Factors|immunologic factors|mesh-ancestor
5709179|NCT03289260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709180|NCT03289260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5709181|NCT03289260|Interferon Inducers|interferon inducers|mesh-ancestor
5709182|NCT03289182|Rituximab|rituximab|mesh-list
5709183|NCT03289182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5709184|NCT03289182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6233158|NCT02537951|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
6233159|NCT02538016|Tolvaptan|tolvaptan|mesh-list
6233160|NCT02538016|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6233161|NCT02538016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233162|NCT02538016|Natriuretic Agents|natriuretic agents|mesh-ancestor
6233163|NCT02538016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233164|NCT02538042|Nicotine|nicotine|mesh-list
6233165|NCT02538042|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6233166|NCT02538042|Autonomic Agents|autonomic agents|mesh-ancestor
6233167|NCT02538042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6233168|NCT02538042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501147|NCT00647218|Tubulin Modulators|tubulin modulators|mesh-ancestor
6501148|NCT00647218|Antimitotic Agents|antimitotic agents|mesh-ancestor
6501149|NCT00647218|Mitosis Modulators|mitosis modulators|mesh-ancestor
6501150|NCT00647218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501151|NCT00647244|Tenofovir|tenofovir|mesh-list
6501152|NCT00647244|Abacavir|abacavir|mesh-list
6501153|NCT00647244|Antiviral Agents|antiviral agents|mesh-ancestor
6501154|NCT00647244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6501155|NCT00647244|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6501156|NCT00647244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6501157|NCT00647244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6501158|NCT00647244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501159|NCT00647244|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6501160|NCT00647244|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6501161|NCT00647257|Losartan|losartan|mesh-list
6501162|NCT00647257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6501163|NCT00647257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6501164|NCT00647257|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6501165|NCT00647257|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6501166|NCT00647257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501167|NCT00647322|Anticonvulsants|anticonvulsants|mesh-list
6501168|NCT00647465|Vaccines|vaccines|mesh-list
6501169|NCT00647465|Immunologic Factors|immunologic factors|mesh-ancestor
6501170|NCT00647465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501171|NCT00647491|Adalimumab|adalimumab|mesh-list
6501172|NCT00647491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6501173|NCT00647491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6501174|NCT00647530|Fluorouracil|fluorouracil|mesh-list
6501175|NCT00647530|Capecitabine|capecitabine|mesh-list
6501176|NCT00647530|Oxaliplatin|oxaliplatin|mesh-list
6501177|NCT00647530|Panitumumab|panitumumab|mesh-list
6501178|NCT00647530|Antimetabolites|antimetabolites|mesh-ancestor
6501179|NCT00647530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501180|NCT00647530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6501181|NCT00647530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6501182|NCT00647530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6501183|NCT00647530|Immunologic Factors|immunologic factors|mesh-ancestor
6501184|NCT00647530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501185|NCT00647530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6501186|NCT00647543|Atorvastatin|atorvastatin|mesh-list
6501187|NCT00647543|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6501188|NCT00647543|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6501189|NCT00647543|Antimetabolites|antimetabolites|mesh-ancestor
6676907|NCT01584050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676908|NCT01584076|Donepezil|donepezil|mesh-list
6676909|NCT01584076|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6233169|NCT02538042|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6233170|NCT02538042|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6676910|NCT01584076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6676911|NCT01584076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676912|NCT01584076|Cholinergic Agents|cholinergic agents|mesh-ancestor
6676913|NCT01584076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6676914|NCT01584076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709185|NCT03289182|Immunologic Factors|immunologic factors|mesh-ancestor
5709186|NCT03289182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709187|NCT03289182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5709188|NCT03289169|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5709189|NCT03289169|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5709190|NCT03289169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5709191|NCT03289169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709192|NCT03289169|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5709193|NCT03289169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5709194|NCT03289169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5709195|NCT03289169|Cholinergic Agents|cholinergic agents|mesh-ancestor
5709196|NCT03289169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5721537|NCT03204799|Antimetabolites|antimetabolites|mesh-ancestor
5721538|NCT03204799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721539|NCT03204799|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5721540|NCT03204669|Trace Elements|trace elements|mesh-list
5721541|NCT03204669|Micronutrients|micronutrients|mesh-list
5721542|NCT03204669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233171|NCT02538042|Cholinergic Agents|cholinergic agents|mesh-ancestor
6233172|NCT02538042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6233173|NCT02538042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233174|NCT02538107|Epoetin Alfa|epoetin alfa|mesh-list
6233175|NCT02538107|Hematinics|hematinics|mesh-ancestor
6233176|NCT02538354|Riboflavin|riboflavin|mesh-list
6233177|NCT02538354|Vitamins|vitamins|mesh-ancestor
6233178|NCT02538354|Micronutrients|micronutrients|mesh-ancestor
6233179|NCT02538354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233180|NCT02538354|Vitamin B Complex|vitamin b complex|mesh-ancestor
6233181|NCT02538354|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6233182|NCT02538354|Dermatologic Agents|dermatologic agents|mesh-ancestor
6233183|NCT02538614|Idelalisib|idelalisib|mesh-list
6233184|NCT02538614|BI 836826|bi 836826|mesh-list
6233185|NCT02538614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6233186|NCT02538614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6233187|NCT02538614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233188|NCT02538614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6233189|NCT02538679|Epinephrine|epinephrine|mesh-list
6233190|NCT02538679|Racepinephrine|racepinephrine|mesh-list
6233191|NCT02538679|Bupivacaine|bupivacaine|mesh-list
6501190|NCT00647543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501191|NCT00647543|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6501192|NCT00647543|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5709197|NCT03289026|Aripiprazole|aripiprazole|mesh-list
5709198|NCT03289026|Antidepressive Agents|antidepressive agents|mesh-ancestor
5709199|NCT03289026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5709200|NCT03289026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5709201|NCT03289026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5709202|NCT03289026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5709203|NCT03289026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709204|NCT03289026|Dopamine Agonists|dopamine agonists|mesh-ancestor
5709205|NCT03289026|Dopamine Agents|dopamine agents|mesh-ancestor
5709206|NCT03289026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5709207|NCT03289026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5709208|NCT03289026|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5709209|NCT03289026|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5709210|NCT03289026|Serotonin Agents|serotonin agents|mesh-ancestor
5709211|NCT03289026|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5709212|NCT03289026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5709213|NCT03289026|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5709214|NCT03289026|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5709215|NCT03288974|Pomalidomide|pomalidomide|mesh-list
5709216|NCT03288974|Immunologic Factors|immunologic factors|mesh-ancestor
5709217|NCT03288974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709218|NCT03288974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5709219|NCT03288974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5709220|NCT03288974|Growth Substances|growth substances|mesh-ancestor
5709221|NCT03288974|Growth Inhibitors|growth inhibitors|mesh-ancestor
5709222|NCT03288974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5709223|NCT03288896|Ethanol|ethanol|mesh-list
5709224|NCT03288896|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5709225|NCT03288896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5709226|NCT03288896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5709227|NCT03288896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709228|NCT03288870|Docetaxel|docetaxel|mesh-list
5709229|NCT03288870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5709230|NCT03288870|Tubulin Modulators|tubulin modulators|mesh-ancestor
5709231|NCT03288870|Antimitotic Agents|antimitotic agents|mesh-ancestor
5709232|NCT03288870|Mitosis Modulators|mitosis modulators|mesh-ancestor
5709233|NCT03288870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5709234|NCT03288818|Mechlorethamine|mechlorethamine|mesh-list
5709235|NCT03288818|Alkylating Agents|alkylating agents|mesh-ancestor
5709236|NCT03288818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5709237|NCT03288818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5709238|NCT03288818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5709239|NCT03288675|Serotonin|serotonin|mesh-list
5709240|NCT03288675|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
5709241|NCT03288675|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5709242|NCT03288675|Serotonin Agents|serotonin agents|mesh-ancestor
5709243|NCT03288675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5709244|NCT03288675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5709245|NCT03288675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709246|NCT03288675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5709247|NCT03288675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5709248|NCT03288636|Ritonavir|ritonavir|mesh-list
5709249|NCT03288636|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5709250|NCT03288636|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5709251|NCT03288636|Protease Inhibitors|protease inhibitors|mesh-ancestor
5709252|NCT03288636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5709253|NCT03288636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5709254|NCT03288636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5709255|NCT03288636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5709256|NCT03288636|Antiviral Agents|antiviral agents|mesh-ancestor
5709257|NCT03288636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5709258|NCT03288636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5709259|NCT03288636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5709260|NCT03288610|Vasopressins|vasopressins|mesh-list
5709261|NCT03288610|Hemostatics|hemostatics|mesh-ancestor
5709262|NCT03288610|Coagulants|coagulants|mesh-ancestor
5709263|NCT03288610|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5709264|NCT03288610|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5709265|NCT03288610|Natriuretic Agents|natriuretic agents|mesh-ancestor
5722323|NCT03199976|Parasympatholytics|parasympatholytics|mesh-ancestor
5709266|NCT03288610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709267|NCT03288597|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5709268|NCT03288597|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5709269|NCT03288597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5709270|NCT03288532|Durvalumab|durvalumab|mesh-list
5709271|NCT03288532|Tremelimumab|tremelimumab|mesh-list
5709272|NCT03288532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5709273|NCT03288532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5709274|NCT03288428|Morphine|morphine|mesh-list
5709275|NCT03288428|Nalbuphine|nalbuphine|mesh-list
5709276|NCT03288428|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5709277|NCT03288428|Narcotics|narcotics|mesh-ancestor
5709278|NCT03288428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5709279|NCT03288428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709280|NCT03288428|Analgesics|analgesics|mesh-ancestor
5709281|NCT03288428|Sensory System Agents|sensory system agents|mesh-ancestor
5709282|NCT03288428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5709283|NCT03288402|Caffeine|caffeine|mesh-list
5709284|NCT03288402|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5709285|NCT03288402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709286|NCT03288402|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5709287|NCT03288402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5709288|NCT03288402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5709289|NCT03288402|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5709290|NCT03288402|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5709291|NCT03288402|Purinergic Agents|purinergic agents|mesh-ancestor
5709292|NCT03288402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5709293|NCT03288350|Avelumab|avelumab|mesh-list
5709294|NCT03288350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5709295|NCT03288350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5709296|NCT03288259|Anesthetics|anesthetics|mesh-list
5709297|NCT03288259|Anesthetics, Local|anesthetics, local|mesh-list
5709298|NCT03288259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5709299|NCT03288259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709300|NCT03288259|Sensory System Agents|sensory system agents|mesh-ancestor
5709301|NCT03288259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5709302|NCT03288233|Carbon Monoxide|carbon monoxide|mesh-list
5709303|NCT03288233|Antimetabolites|antimetabolites|mesh-ancestor
5709304|NCT03288233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5709305|NCT03288233|Gasotransmitters|gasotransmitters|mesh-ancestor
5709306|NCT03288233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5709307|NCT03288233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709308|NCT03288077|Tryptophan|tryptophan|mesh-list
5721543|NCT03204331|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6233192|NCT02538679|Epinephryl borate|epinephryl borate|mesh-list
6233193|NCT02538679|Anesthetics, Local|anesthetics, local|mesh-ancestor
6233194|NCT02538679|Anesthetics|anesthetics|mesh-ancestor
6233195|NCT02538679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6233196|NCT02538679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233197|NCT02538679|Sensory System Agents|sensory system agents|mesh-ancestor
6233198|NCT02538679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6233199|NCT02538679|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6233200|NCT02538679|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6233201|NCT02538679|Adrenergic Agents|adrenergic agents|mesh-ancestor
6233202|NCT02538679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6233203|NCT02538679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233204|NCT02538679|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6233205|NCT02538679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6233206|NCT02538679|Autonomic Agents|autonomic agents|mesh-ancestor
6233207|NCT02538679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6233208|NCT02538679|Respiratory System Agents|respiratory system agents|mesh-ancestor
6233209|NCT02538679|Mydriatics|mydriatics|mesh-ancestor
6233210|NCT02538679|Sympathomimetics|sympathomimetics|mesh-ancestor
6233211|NCT02538679|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6243769|NCT02680301|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6243770|NCT02680301|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6243771|NCT02680301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6243772|NCT02680301|Glucocorticoids|glucocorticoids|mesh-ancestor
6243773|NCT02680301|Hormones|hormones|mesh-ancestor
6243774|NCT02680301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6243775|NCT02680301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243776|NCT02680301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6243777|NCT02680301|Immunologic Factors|immunologic factors|mesh-ancestor
6243778|NCT02680301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6233212|NCT02538965|Lenalidomide|lenalidomide|mesh-list
6233213|NCT02538965|Immunologic Factors|immunologic factors|mesh-ancestor
6233214|NCT02538965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233215|NCT02538965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6233216|NCT02538965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6233217|NCT02538965|Growth Substances|growth substances|mesh-ancestor
6233218|NCT02538965|Growth Inhibitors|growth inhibitors|mesh-ancestor
6233219|NCT02538965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6233220|NCT02539108|Vaccines|vaccines|mesh-list
6233221|NCT02539108|Immunologic Factors|immunologic factors|mesh-ancestor
6233222|NCT02539108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233223|NCT02539225|Paclitaxel|paclitaxel|mesh-list
6233224|NCT02539225|Oxaliplatin|oxaliplatin|mesh-list
6233225|NCT02539225|Ramucirumab|ramucirumab|mesh-list
6233226|NCT02539225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6233227|NCT02539225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6233228|NCT02539225|Tubulin Modulators|tubulin modulators|mesh-ancestor
6233229|NCT02539225|Antimitotic Agents|antimitotic agents|mesh-ancestor
6233230|NCT02539225|Mitosis Modulators|mitosis modulators|mesh-ancestor
6233231|NCT02539225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233232|NCT02539342|Calcium|calcium|mesh-list
6233233|NCT02539342|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6233234|NCT02539342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233235|NCT02539368|Infliximab|infliximab|mesh-list
6233236|NCT02539368|Dermatologic Agents|dermatologic agents|mesh-ancestor
6233237|NCT02539368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6233238|NCT02539368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6233239|NCT02539459|Everolimus|everolimus|mesh-list
6233240|NCT02539459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6233241|NCT02539459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6233242|NCT02539459|Immunologic Factors|immunologic factors|mesh-ancestor
6233243|NCT02539459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233244|NCT02539511|Ketamine|ketamine|mesh-list
6233245|NCT02539511|Analgesics|analgesics|mesh-ancestor
6233246|NCT02539511|Sensory System Agents|sensory system agents|mesh-ancestor
6233247|NCT02539511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6233248|NCT02539511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233249|NCT02539511|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6233250|NCT02539511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6233251|NCT02539511|Anesthetics, General|anesthetics, general|mesh-ancestor
6501193|NCT00647543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6501194|NCT00647608|Propranolol|propranolol|mesh-list
6501195|NCT00647608|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6501196|NCT00647608|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6501197|NCT00647608|Adrenergic Agents|adrenergic agents|mesh-ancestor
6233252|NCT02539511|Anesthetics|anesthetics|mesh-ancestor
6233253|NCT02539511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6233254|NCT02539511|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6233255|NCT02539511|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6233256|NCT02539511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6233257|NCT02539511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501198|NCT00647608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6501199|NCT00647608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676915|NCT01584076|Nootropic Agents|nootropic agents|mesh-ancestor
6676916|NCT01584115|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
6676917|NCT01584115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6676918|NCT01584115|Immunologic Factors|immunologic factors|mesh-ancestor
6676919|NCT01584115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676920|NCT01584206|Ezetimibe|ezetimibe|mesh-list
6676921|NCT01584206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6676922|NCT01584206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6676923|NCT01584206|Antimetabolites|antimetabolites|mesh-ancestor
6676924|NCT01584206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676925|NCT01584206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6676926|NCT01584271|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6676927|NCT01584271|Carbamide Peroxide|carbamide peroxide|mesh-list
6676928|NCT01584271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6233258|NCT02540161|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6233259|NCT02540161|Immunologic Factors|immunologic factors|mesh-ancestor
6233260|NCT02540161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233261|NCT02540226|Tranexamic Acid|tranexamic acid|mesh-list
6233262|NCT02540226|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6233263|NCT02540226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6233264|NCT02540226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233265|NCT02540226|Hemostatics|hemostatics|mesh-ancestor
6233266|NCT02540226|Coagulants|coagulants|mesh-ancestor
5709309|NCT03288077|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5709310|NCT03288077|Antidepressive Agents|antidepressive agents|mesh-ancestor
5709311|NCT03288077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5709312|NCT03288051|Dobutamine|dobutamine|mesh-list
5709313|NCT03288051|Norepinephrine|norepinephrine|mesh-list
5709314|NCT03288051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5709315|NCT03288051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5709316|NCT03288051|Adrenergic Agents|adrenergic agents|mesh-ancestor
5709317|NCT03288051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5709318|NCT03288051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5709319|NCT03288051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709320|NCT03288051|Sympathomimetics|sympathomimetics|mesh-ancestor
5709321|NCT03288051|Autonomic Agents|autonomic agents|mesh-ancestor
5709322|NCT03288051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5709323|NCT03288051|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5709324|NCT03288051|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5709325|NCT03288051|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5709326|NCT03288051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5709327|NCT03288051|Protective Agents|protective agents|mesh-ancestor
5709328|NCT03288038|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5709329|NCT03288038|Ezetimibe|ezetimibe|mesh-list
5709330|NCT03288038|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5709331|NCT03288038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5709332|NCT03288038|Antimetabolites|antimetabolites|mesh-ancestor
5709333|NCT03288038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5709334|NCT03288038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5709335|NCT03288038|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5709336|NCT03288038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5709337|NCT03287921|Bronchodilator Agents|bronchodilator agents|mesh-list
5709338|NCT03287921|Autonomic Agents|autonomic agents|mesh-ancestor
5709339|NCT03287921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5709340|NCT03287921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709341|NCT03287921|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5709342|NCT03287921|Respiratory System Agents|respiratory system agents|mesh-ancestor
5709343|NCT03287882|Micronutrients|micronutrients|mesh-list
5709344|NCT03287882|Trace Elements|trace elements|mesh-list
5709345|NCT03287882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709346|NCT03287609|Evolocumab|evolocumab|mesh-list
5709347|NCT03287609|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5709348|NCT03287609|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5709349|NCT03287609|Antimetabolites|antimetabolites|mesh-ancestor
6233267|NCT02540265|Meloxicam|meloxicam|mesh-list
6501200|NCT00647608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501201|NCT00647608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6501202|NCT00647608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6501203|NCT00647608|Vasodilator Agents|vasodilator agents|mesh-ancestor
6501204|NCT00647621|Phenytoin|phenytoin|mesh-list
6501205|NCT00647621|Anticonvulsants|anticonvulsants|mesh-ancestor
6501206|NCT00647621|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6501207|NCT00647621|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6501208|NCT00647621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6501209|NCT00647621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501210|NCT00647621|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6501211|NCT00647621|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6501212|NCT00647634|Alprazolam|alprazolam|mesh-list
6501213|NCT00647634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6501214|NCT00647634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6501215|NCT00647634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501216|NCT00647634|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6233268|NCT02540265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6233269|NCT02540265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6233270|NCT02540265|Analgesics|analgesics|mesh-ancestor
6233271|NCT02540265|Sensory System Agents|sensory system agents|mesh-ancestor
6501217|NCT00647634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6501218|NCT00647634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6501219|NCT00647634|GABA Modulators|gaba modulators|mesh-ancestor
6501220|NCT00647634|GABA Agents|gaba agents|mesh-ancestor
6501221|NCT00647634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6501222|NCT00647634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501223|NCT00647647|Terbinafine|terbinafine|mesh-list
5709350|NCT03287609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233272|NCT02540265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6233273|NCT02540265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233274|NCT02540265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6501224|NCT00647647|Antifungal Agents|antifungal agents|mesh-ancestor
6501225|NCT00647647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5709351|NCT03287609|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5709352|NCT03287505|Aripiprazole|aripiprazole|mesh-list
5709353|NCT03287505|Antidepressive Agents|antidepressive agents|mesh-ancestor
5709354|NCT03287505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5709355|NCT03287505|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6501226|NCT00647647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6501227|NCT00647647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501228|NCT00647660|Nadolol|nadolol|mesh-list
6501229|NCT00647660|Bendroflumethiazide|bendroflumethiazide|mesh-list
6501230|NCT00647660|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6501231|NCT00647660|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6501232|NCT00647660|Adrenergic Agents|adrenergic agents|mesh-ancestor
6501233|NCT00647660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6501234|NCT00647660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501235|NCT00647660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501236|NCT00647660|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6501237|NCT00647660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6501238|NCT00647660|Sympatholytics|sympatholytics|mesh-ancestor
6501239|NCT00647660|Autonomic Agents|autonomic agents|mesh-ancestor
6501240|NCT00647660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6501241|NCT00647660|Diuretics|diuretics|mesh-ancestor
6501242|NCT00647660|Natriuretic Agents|natriuretic agents|mesh-ancestor
6501243|NCT00647660|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6501244|NCT00647660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6501245|NCT00647673|Verapamil|verapamil|mesh-list
6501246|NCT00647673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6501247|NCT00647673|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6501248|NCT00647673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6501249|NCT00647673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501250|NCT00647673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5709356|NCT03287505|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5709357|NCT03287505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5709358|NCT03287505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709359|NCT03287505|Dopamine Agonists|dopamine agonists|mesh-ancestor
5709360|NCT03287505|Dopamine Agents|dopamine agents|mesh-ancestor
5709361|NCT03287505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5709362|NCT03287505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721544|NCT03204331|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6233275|NCT02540265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6233276|NCT02540265|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6233277|NCT02540265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6233278|NCT02540265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6233279|NCT02540265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233280|NCT02540356|Antibodies|antibodies|mesh-list
6233281|NCT02540356|Immunoglobulins|immunoglobulins|mesh-list
6233282|NCT02540356|Immunologic Factors|immunologic factors|mesh-ancestor
6233283|NCT02540356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233284|NCT02540668|Warfarin|warfarin|mesh-list
6233285|NCT02540668|Anticoagulants|anticoagulants|mesh-ancestor
6233286|NCT02540954|Aflibercept|aflibercept|mesh-list
6233287|NCT02540954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6233288|NCT02540954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6233289|NCT02540954|Growth Substances|growth substances|mesh-ancestor
6233290|NCT02540954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233291|NCT02540954|Growth Inhibitors|growth inhibitors|mesh-ancestor
6233292|NCT02540954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6233293|NCT02541409|Interferons|interferons|mesh-list
6233294|NCT02541409|Ribavirin|ribavirin|mesh-list
6233295|NCT02541409|Interferon-alpha|interferon-alpha|mesh-list
6233296|NCT02541409|Interferon alpha-2|interferon alpha-2|mesh-list
6233297|NCT02541409|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6233298|NCT02541409|Sofosbuvir|sofosbuvir|mesh-list
6233299|NCT02541409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6233300|NCT02541409|Antiviral Agents|antiviral agents|mesh-ancestor
6233301|NCT02541409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6233302|NCT02541409|Antimetabolites|antimetabolites|mesh-ancestor
6233303|NCT02541409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233304|NCT02541409|Immunologic Factors|immunologic factors|mesh-ancestor
6233305|NCT02541409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233306|NCT02541422|Acetylcysteine|acetylcysteine|mesh-list
6233307|NCT02541422|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6233308|NCT02541422|Antiviral Agents|antiviral agents|mesh-ancestor
6233309|NCT02541422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6233310|NCT02541422|Expectorants|expectorants|mesh-ancestor
6233311|NCT02541422|Respiratory System Agents|respiratory system agents|mesh-ancestor
6233312|NCT02541422|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6233313|NCT02541422|Antioxidants|antioxidants|mesh-ancestor
6233314|NCT02541422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233315|NCT02541422|Protective Agents|protective agents|mesh-ancestor
6233316|NCT02541422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233317|NCT02541422|Antidotes|antidotes|mesh-ancestor
6233318|NCT02541565|Prednisone|prednisone|mesh-list
5709363|NCT03287505|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5709364|NCT03287505|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5709365|NCT03287505|Serotonin Agents|serotonin agents|mesh-ancestor
5709366|NCT03287505|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5709367|NCT03287505|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5709368|NCT03287505|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5709369|NCT03287505|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5721545|NCT03204331|Norethindrone|norethindrone|mesh-list
5721546|NCT03204331|Norethindrone Acetate|norethindrone acetate|mesh-list
5721547|NCT03204331|Estradiol|estradiol|mesh-list
5721548|NCT03204331|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5721549|NCT03204331|Relugolix|relugolix|mesh-list
5721550|NCT03204331|Estrogens|estrogens|mesh-ancestor
5721551|NCT03204331|Hormones|hormones|mesh-ancestor
5721552|NCT03204331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6233319|NCT02541565|Cortisone|cortisone|mesh-list
6233320|NCT02541565|Cyclophosphamide|cyclophosphamide|mesh-list
6233321|NCT02541565|Rituximab|rituximab|mesh-list
6233322|NCT02541565|Doxorubicin|doxorubicin|mesh-list
6501251|NCT00647673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501252|NCT00647673|Vasodilator Agents|vasodilator agents|mesh-ancestor
5721553|NCT03204331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233323|NCT02541565|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6233324|NCT02541565|Pembrolizumab|pembrolizumab|mesh-list
6233325|NCT02541565|Vincristine|vincristine|mesh-list
6233326|NCT02541565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6233327|NCT02541565|Antibodies|antibodies|mesh-list
6233328|NCT02541565|Immunoglobulins|immunoglobulins|mesh-list
6233329|NCT02541565|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6233330|NCT02541565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6233331|NCT02541565|Immunologic Factors|immunologic factors|mesh-ancestor
6233332|NCT02541565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233333|NCT02541565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6233334|NCT02541565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6233335|NCT02541565|Alkylating Agents|alkylating agents|mesh-ancestor
6233336|NCT02541565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233337|NCT02541565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6233338|NCT02541565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6233339|NCT02541565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6233340|NCT02541565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6233341|NCT02541565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6233342|NCT02541565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6233343|NCT02541565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6233344|NCT02541565|Glucocorticoids|glucocorticoids|mesh-ancestor
6233345|NCT02541565|Hormones|hormones|mesh-ancestor
6233346|NCT02541565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6233347|NCT02541565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6233348|NCT02541565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6233349|NCT02541565|Tubulin Modulators|tubulin modulators|mesh-ancestor
6233350|NCT02541565|Antimitotic Agents|antimitotic agents|mesh-ancestor
6233351|NCT02541565|Mitosis Modulators|mitosis modulators|mesh-ancestor
6233352|NCT02541604|Atezolizumab|atezolizumab|mesh-list
6233353|NCT02541604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6233354|NCT02541669|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
6233355|NCT02541669|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6233356|NCT02541669|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6233357|NCT02541669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233358|NCT02541864|Amoxicillin|amoxicillin|mesh-list
6233359|NCT02541864|Metronidazole|metronidazole|mesh-list
6233360|NCT02541864|Clarithromycin|clarithromycin|mesh-list
6233361|NCT02541864|Tetracycline|tetracycline|mesh-list
6233362|NCT02541864|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
6233363|NCT02541864|Pantoprazole|pantoprazole|mesh-list
6233364|NCT02541864|Bismuth|bismuth|mesh-list
6233365|NCT02541864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6233366|NCT02541864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6233367|NCT02541864|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6501253|NCT00647686|Fentanyl|fentanyl|mesh-list
6233368|NCT02541864|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5709370|NCT03287388|Rocuronium|rocuronium|mesh-list
5709371|NCT03287388|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5709372|NCT03287388|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5709373|NCT03287388|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6233369|NCT02541864|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6233370|NCT02541864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6233371|NCT02541864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233372|NCT02541864|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6233373|NCT02541864|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6233374|NCT02541864|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6233375|NCT02541864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6233376|NCT02541864|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6233377|NCT02541864|Antacids|antacids|mesh-ancestor
6233378|NCT02541903|Afatinib|afatinib|mesh-list
6233379|NCT02541903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6233380|NCT02541903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6233381|NCT02541903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6233382|NCT02541903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233383|NCT02542150|Ethanol|ethanol|mesh-list
6233384|NCT02542150|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6233385|NCT02542150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6233386|NCT02542150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6233387|NCT02542150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233388|NCT02542410|Cabergoline|cabergoline|mesh-list
6233389|NCT02542410|Norethindrone|norethindrone|mesh-list
6233390|NCT02542410|Norethindrone Acetate|norethindrone acetate|mesh-list
6233391|NCT02542410|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6233392|NCT02542410|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6233393|NCT02542410|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6233394|NCT02542410|Contraceptive Agents|contraceptive agents|mesh-ancestor
6233395|NCT02542410|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6233396|NCT02542410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233397|NCT02542410|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6501254|NCT00647686|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6501255|NCT00647686|Narcotics|narcotics|mesh-ancestor
6233398|NCT02542410|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6233399|NCT02542410|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6233400|NCT02542410|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6233401|NCT02542410|Dopamine Agonists|dopamine agonists|mesh-ancestor
6233402|NCT02542410|Dopamine Agents|dopamine agents|mesh-ancestor
6233403|NCT02542410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6233404|NCT02542410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233405|NCT02542462|Vaccines|vaccines|mesh-list
6233406|NCT02542462|Immunologic Factors|immunologic factors|mesh-ancestor
6233407|NCT02542462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233408|NCT02542605|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
6233409|NCT02542605|Erenumab|erenumab|mesh-list
6233410|NCT02542605|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
6233411|NCT02542605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233412|NCT02542605|Analgesics|analgesics|mesh-ancestor
6233413|NCT02542605|Sensory System Agents|sensory system agents|mesh-ancestor
6233414|NCT02542605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6233415|NCT02542605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233416|NCT02542605|Growth Substances|growth substances|mesh-ancestor
6233417|NCT02542605|Vasodilator Agents|vasodilator agents|mesh-ancestor
6233418|NCT02542605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6233419|NCT02542631|Insulin|insulin|mesh-list
6233420|NCT02542631|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6233421|NCT02542631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6233422|NCT02542631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233423|NCT02542761|Carbon Fiber|carbon fiber|mesh-list
6233424|NCT02542761|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6233425|NCT02542761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6233426|NCT02542943|Fluorides|fluorides|mesh-list
6233427|NCT02542943|Cariostatic Agents|cariostatic agents|mesh-ancestor
6233428|NCT02542943|Protective Agents|protective agents|mesh-ancestor
6233429|NCT02542943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233430|NCT02543346|Cetirizine|cetirizine|mesh-list
6233431|NCT02543346|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6233432|NCT02543346|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6233433|NCT02543346|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6233434|NCT02543346|Histamine Antagonists|histamine antagonists|mesh-ancestor
6233435|NCT02543346|Histamine Agents|histamine agents|mesh-ancestor
6233436|NCT02543346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6233437|NCT02543346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233438|NCT02543346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709374|NCT03287388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5709375|NCT03287388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709376|NCT03287375|Cisplatin|cisplatin|mesh-list
5709377|NCT03287375|Doxorubicin|doxorubicin|mesh-list
5709378|NCT03287375|Oxaliplatin|oxaliplatin|mesh-list
5709379|NCT03287375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5709380|NCT03287375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5709381|NCT03287375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5709382|NCT03287375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5709383|NCT03287375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5709384|NCT03287375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5709385|NCT03287336|Tranexamic Acid|tranexamic acid|mesh-list
5709386|NCT03287336|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5709387|NCT03287336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5709388|NCT03287336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5709389|NCT03287336|Hemostatics|hemostatics|mesh-ancestor
5709390|NCT03287336|Coagulants|coagulants|mesh-ancestor
5709391|NCT03287271|Paclitaxel|paclitaxel|mesh-list
5709392|NCT03287271|Carboplatin|carboplatin|mesh-list
5709393|NCT03287271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5709394|NCT03287271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5709395|NCT03287271|Tubulin Modulators|tubulin modulators|mesh-ancestor
5709396|NCT03287271|Antimitotic Agents|antimitotic agents|mesh-ancestor
5709397|NCT03287271|Mitosis Modulators|mitosis modulators|mesh-ancestor
5709398|NCT03287271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5709399|NCT03287180|Buprenorphine|buprenorphine|mesh-list
5709400|NCT03287180|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
5709401|NCT03287180|Naloxone|naloxone|mesh-list
5709402|NCT03287180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5709403|NCT03287180|Narcotics|narcotics|mesh-ancestor
5709404|NCT03287180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5709405|NCT03287180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709406|NCT03287180|Analgesics|analgesics|mesh-ancestor
5709407|NCT03287180|Sensory System Agents|sensory system agents|mesh-ancestor
5709408|NCT03287180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5709409|NCT03287180|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5709410|NCT03287128|Gemtuzumab|gemtuzumab|mesh-list
5709411|NCT03287128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5709412|NCT03287128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5709413|NCT03287076|Exenatide|exenatide|mesh-list
5709414|NCT03287076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5709415|NCT03287076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709416|NCT03287076|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5709417|NCT03287076|Incretins|incretins|mesh-ancestor
5709418|NCT03287076|Hormones|hormones|mesh-ancestor
5709419|NCT03287076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5709420|NCT03287011|Listerine|listerine|mesh-list
5709421|NCT03287011|Sodium Fluoride|sodium fluoride|mesh-list
5709422|NCT03287011|Cariostatic Agents|cariostatic agents|mesh-ancestor
5709423|NCT03287011|Protective Agents|protective agents|mesh-ancestor
5709424|NCT03287011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709425|NCT03287011|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5709426|NCT03287011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5709427|NCT03286959|Calcium|calcium|mesh-list
5709428|NCT03286959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5709429|NCT03286959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233439|NCT02543658|Neostigmine|neostigmine|mesh-list
6233440|NCT02543658|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6501256|NCT00647686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6501257|NCT00647686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501258|NCT00647686|Analgesics|analgesics|mesh-ancestor
6501259|NCT00647686|Sensory System Agents|sensory system agents|mesh-ancestor
6501260|NCT00647686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5709430|NCT03286803|Vaccines|vaccines|mesh-list
5709431|NCT03286803|Immunologic Factors|immunologic factors|mesh-ancestor
5709432|NCT03286803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709433|NCT03286764|Peppermint oil|peppermint oil|mesh-list
5709434|NCT03286764|Antiemetics|antiemetics|mesh-ancestor
5709435|NCT03286764|Autonomic Agents|autonomic agents|mesh-ancestor
5709436|NCT03286764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5709437|NCT03286764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709438|NCT03286764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5709439|NCT03286764|Parasympatholytics|parasympatholytics|mesh-ancestor
5709440|NCT03286673|Calcium, Dietary|calcium, dietary|mesh-list
6233441|NCT02543658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6233442|NCT02543658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233443|NCT02543658|Cholinergic Agents|cholinergic agents|mesh-ancestor
6233444|NCT02543658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6233445|NCT02543658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233446|NCT02543658|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6233447|NCT02543658|Autonomic Agents|autonomic agents|mesh-ancestor
5709441|NCT03286673|Calcium Carbonate|calcium carbonate|mesh-list
5709442|NCT03286673|Calcium|calcium|mesh-list
5709443|NCT03286673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5709444|NCT03286673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709445|NCT03286673|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5709446|NCT03286673|Antacids|antacids|mesh-ancestor
5709447|NCT03286673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5709448|NCT03286673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5709449|NCT03286634|Cytarabine|cytarabine|mesh-list
5709450|NCT03286634|Prednisolone|prednisolone|mesh-list
5709451|NCT03286634|Hydrocortisone|hydrocortisone|mesh-list
5709452|NCT03286634|Cyclophosphamide|cyclophosphamide|mesh-list
5709453|NCT03286634|Methotrexate|methotrexate|mesh-list
5709454|NCT03286634|Vincristine|vincristine|mesh-list
5709455|NCT03286634|Daunorubicin|daunorubicin|mesh-list
5709456|NCT03286634|Asparaginase|asparaginase|mesh-list
5709457|NCT03286634|Epirubicin|epirubicin|mesh-list
5709458|NCT03286634|Mercaptopurine|mercaptopurine|mesh-list
5709459|NCT03286634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5709460|NCT03286634|Immunologic Factors|immunologic factors|mesh-ancestor
5709461|NCT03286634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709462|NCT03286634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5709463|NCT03286634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5709464|NCT03286634|Alkylating Agents|alkylating agents|mesh-ancestor
5709465|NCT03286634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5709466|NCT03286634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5709467|NCT03286634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5709468|NCT03286634|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5709469|NCT03286634|Abortifacient Agents|abortifacient agents|mesh-ancestor
5709470|NCT03286634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5709471|NCT03286634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5709472|NCT03286634|Antimetabolites|antimetabolites|mesh-ancestor
5709473|NCT03286634|Dermatologic Agents|dermatologic agents|mesh-ancestor
5709474|NCT03286634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5709475|NCT03286634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5709476|NCT03286634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5709477|NCT03286634|Antiviral Agents|antiviral agents|mesh-ancestor
5709478|NCT03286634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5709479|NCT03286634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5709480|NCT03286634|Tubulin Modulators|tubulin modulators|mesh-ancestor
5709481|NCT03286634|Antimitotic Agents|antimitotic agents|mesh-ancestor
5709482|NCT03286634|Mitosis Modulators|mitosis modulators|mesh-ancestor
5709483|NCT03286634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5709484|NCT03286634|Glucocorticoids|glucocorticoids|mesh-ancestor
5709485|NCT03286634|Hormones|hormones|mesh-ancestor
5709486|NCT03286634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6233448|NCT02543658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6233449|NCT02543801|Ketorolac|ketorolac|mesh-list
6233450|NCT02543801|Clonidine|clonidine|mesh-list
6233451|NCT02543801|Epinephrine|epinephrine|mesh-list
6233452|NCT02543801|Bupivacaine|bupivacaine|mesh-list
6233453|NCT02543801|Ropivacaine|ropivacaine|mesh-list
6233454|NCT02543801|Anesthetics, Local|anesthetics, local|mesh-ancestor
6233455|NCT02543801|Anesthetics|anesthetics|mesh-ancestor
6233456|NCT02543801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6233457|NCT02543801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233458|NCT02543801|Sensory System Agents|sensory system agents|mesh-ancestor
6233459|NCT02543801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6233460|NCT02543801|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6233461|NCT02543801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6233462|NCT02543801|Adrenergic Agents|adrenergic agents|mesh-ancestor
6233463|NCT02543801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6233464|NCT02543801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233465|NCT02543801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6233466|NCT02543801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6233467|NCT02543801|Autonomic Agents|autonomic agents|mesh-ancestor
5709487|NCT03286634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5709488|NCT03286634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5709489|NCT03286634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6233468|NCT02543801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6233469|NCT02543801|Respiratory System Agents|respiratory system agents|mesh-ancestor
6233470|NCT02543801|Mydriatics|mydriatics|mesh-ancestor
6233471|NCT02543801|Sympathomimetics|sympathomimetics|mesh-ancestor
6233472|NCT02543801|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6233473|NCT02543801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6233474|NCT02543801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6233475|NCT02543801|Analgesics|analgesics|mesh-ancestor
6233476|NCT02543801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6233477|NCT02543801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6233478|NCT02543801|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6233479|NCT02543801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6501261|NCT00647686|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6501262|NCT00647686|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6501263|NCT00647686|Anesthetics, General|anesthetics, general|mesh-ancestor
6501264|NCT00647686|Anesthetics|anesthetics|mesh-ancestor
6501265|NCT00647712|Valproic Acid|valproic acid|mesh-list
6501266|NCT00647712|Anticonvulsants|anticonvulsants|mesh-ancestor
6501267|NCT00647712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6501268|NCT00647712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233480|NCT02543801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6233481|NCT02543801|Sympatholytics|sympatholytics|mesh-ancestor
6233482|NCT02543801|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6233483|NCT02543918|Ixekizumab|ixekizumab|mesh-list
6233484|NCT02543918|Vaccines|vaccines|mesh-list
6233485|NCT02543918|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6233486|NCT02543918|Immunologic Factors|immunologic factors|mesh-ancestor
6233487|NCT02543918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233488|NCT02543918|Dermatologic Agents|dermatologic agents|mesh-ancestor
6233489|NCT02544113|Thymoglobulin|thymoglobulin|mesh-list
6233490|NCT02544113|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6233491|NCT02544113|Immunologic Factors|immunologic factors|mesh-ancestor
6233492|NCT02544113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233493|NCT02544113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6233494|NCT02544152|Lubiprostone|lubiprostone|mesh-list
6233495|NCT02544152|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6233496|NCT02544152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6233497|NCT02544152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233498|NCT02544217|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
6233499|NCT02544217|Antioxidants|antioxidants|mesh-ancestor
6233500|NCT02544217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233501|NCT02544217|Protective Agents|protective agents|mesh-ancestor
6233502|NCT02544217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233503|NCT02544321|Bromocriptine|bromocriptine|mesh-list
6233504|NCT02544321|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6233505|NCT02544321|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6233506|NCT02544321|Hormone Antagonists|hormone antagonists|mesh-ancestor
6233507|NCT02544321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6233508|NCT02544321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233509|NCT02544321|Dopamine Agonists|dopamine agonists|mesh-ancestor
6233510|NCT02544321|Dopamine Agents|dopamine agents|mesh-ancestor
6233511|NCT02544321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6233512|NCT02544321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233513|NCT02544451|Ivacaftor|ivacaftor|mesh-list
6233514|NCT02544451|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6233515|NCT02544451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6233516|NCT02544451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233517|NCT02544607|Ketamine|ketamine|mesh-list
6233518|NCT02544607|Analgesics|analgesics|mesh-ancestor
6501269|NCT00647712|GABA Agents|gaba agents|mesh-ancestor
6501270|NCT00647712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6501271|NCT00647712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676929|NCT01584271|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6676930|NCT01584297|Ketoconazole|ketoconazole|mesh-list
6676931|NCT01584297|Antifungal Agents|antifungal agents|mesh-ancestor
6676932|NCT01584297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6501272|NCT00647712|Antimanic Agents|antimanic agents|mesh-ancestor
6501273|NCT00647712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6501274|NCT00647712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6501275|NCT00647712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6501276|NCT00647738|Baclofen|baclofen|mesh-list
6501277|NCT00647738|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6501278|NCT00647738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501279|NCT00647738|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6501280|NCT00647738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6501281|NCT00647738|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6501282|NCT00647738|GABA Agonists|gaba agonists|mesh-ancestor
6501283|NCT00647738|GABA Agents|gaba agents|mesh-ancestor
6501284|NCT00647738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6501285|NCT00647738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501286|NCT00647751|Lamotrigine|lamotrigine|mesh-list
6501287|NCT00647751|Anticonvulsants|anticonvulsants|mesh-ancestor
6501288|NCT00647751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6501289|NCT00647751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6501290|NCT00647751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501291|NCT00647751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6501292|NCT00647751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501293|NCT00647751|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6501294|NCT00647751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6501295|NCT00647751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6501296|NCT00647751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6233519|NCT02544607|Sensory System Agents|sensory system agents|mesh-ancestor
6233520|NCT02544607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6233521|NCT02544607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709490|NCT03286634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5709491|NCT03286582|Clobetasol|clobetasol|mesh-list
5709492|NCT03286582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5709493|NCT03286582|Glucocorticoids|glucocorticoids|mesh-ancestor
5709494|NCT03286582|Hormones|hormones|mesh-ancestor
5709495|NCT03286582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5709496|NCT03286582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709497|NCT03286452|Anti-Infective Agents|anti-infective agents|mesh-list
5709498|NCT03286452|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5709499|NCT03286296|Antibodies|antibodies|mesh-list
5709500|NCT03286296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5709501|NCT03286296|Immunologic Factors|immunologic factors|mesh-ancestor
5709502|NCT03286296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709503|NCT03286244|Paclitaxel|paclitaxel|mesh-list
5709504|NCT03286244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5709505|NCT03286244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5709506|NCT03286244|Tubulin Modulators|tubulin modulators|mesh-ancestor
6233522|NCT02544607|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6233523|NCT02544607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6233524|NCT02544607|Anesthetics, General|anesthetics, general|mesh-ancestor
6233525|NCT02544607|Anesthetics|anesthetics|mesh-ancestor
6233526|NCT02544607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6233527|NCT02544607|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6233528|NCT02544607|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6233529|NCT02544607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6233530|NCT02544607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233531|NCT02544763|Cannabidiol|cannabidiol|mesh-list
5709507|NCT03286244|Antimitotic Agents|antimitotic agents|mesh-ancestor
5709508|NCT03286244|Mitosis Modulators|mitosis modulators|mesh-ancestor
5709509|NCT03286244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5709510|NCT03286114|Pembrolizumab|pembrolizumab|mesh-list
5709511|NCT03286114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5709512|NCT03286114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5709513|NCT03286101|Ivermectin|ivermectin|mesh-list
5709514|NCT03286101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5709515|NCT03286101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5709516|NCT03285906|Apatinib|apatinib|mesh-list
5709517|NCT03285906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5709518|NCT03285906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5709519|NCT03285906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5709520|NCT03285906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721554|NCT03204331|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6501297|NCT00647751|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6501298|NCT00647777|Olanzapine|olanzapine|mesh-list
6501299|NCT00647777|Antiemetics|antiemetics|mesh-ancestor
6501300|NCT00647777|Autonomic Agents|autonomic agents|mesh-ancestor
6501301|NCT00647777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5721555|NCT03204331|Contraceptive Agents|contraceptive agents|mesh-ancestor
5721556|NCT03204331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6501302|NCT00647777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709521|NCT03285802|Everolimus|everolimus|mesh-list
5709522|NCT03285802|Letrozole|letrozole|mesh-list
5709523|NCT03285802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5709524|NCT03285802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5709525|NCT03285802|Immunologic Factors|immunologic factors|mesh-ancestor
5709526|NCT03285802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709527|NCT03285802|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5709528|NCT03285802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5709529|NCT03285802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6233532|NCT02544763|Anticonvulsants|anticonvulsants|mesh-ancestor
6233533|NCT02544984|Azithromycin|azithromycin|mesh-list
6233534|NCT02544984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6233535|NCT02544984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6233536|NCT02545075|Ipilimumab|ipilimumab|mesh-list
6233537|NCT02545075|Dacarbazine|dacarbazine|mesh-list
6233538|NCT02545075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6233539|NCT02545075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6233540|NCT02545075|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6233541|NCT02545075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233542|NCT02545075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6233543|NCT02545075|Alkylating Agents|alkylating agents|mesh-ancestor
6233544|NCT02545504|Leucovorin|leucovorin|mesh-list
6233545|NCT02545504|Fluorouracil|fluorouracil|mesh-list
6233546|NCT02545504|Oxaliplatin|oxaliplatin|mesh-list
6233547|NCT02545504|Antimetabolites|antimetabolites|mesh-ancestor
6233548|NCT02545504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501303|NCT00647777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6501304|NCT00647777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6501305|NCT00647777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6501306|NCT00647777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6501307|NCT00647777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6501308|NCT00647777|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6501309|NCT00647777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6501310|NCT00647777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6501311|NCT00647777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676933|NCT01584297|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6676934|NCT01584297|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6676935|NCT01584297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5709530|NCT03285802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5709531|NCT03285802|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5709532|NCT03285802|Hormone Antagonists|hormone antagonists|mesh-ancestor
5709533|NCT03285802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5709534|NCT03285607|Paclitaxel|paclitaxel|mesh-list
5709535|NCT03285607|Cyclophosphamide|cyclophosphamide|mesh-list
5709536|NCT03285607|Doxorubicin|doxorubicin|mesh-list
5709537|NCT03285607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5709538|NCT03285607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5709539|NCT03285607|Tubulin Modulators|tubulin modulators|mesh-ancestor
5709540|NCT03285607|Antimitotic Agents|antimitotic agents|mesh-ancestor
5709541|NCT03285607|Mitosis Modulators|mitosis modulators|mesh-ancestor
5709542|NCT03285607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5709543|NCT03285607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5709544|NCT03285607|Immunologic Factors|immunologic factors|mesh-ancestor
5709545|NCT03285607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709546|NCT03285607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5709547|NCT03285607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5709548|NCT03285607|Alkylating Agents|alkylating agents|mesh-ancestor
5709549|NCT03285607|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5709550|NCT03285607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5709551|NCT03285607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5709552|NCT03285607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5709553|NCT03285607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5709554|NCT03285568|Palbociclib|palbociclib|mesh-list
6676936|NCT01584297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676937|NCT01584297|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6676938|NCT01584297|Hormone Antagonists|hormone antagonists|mesh-ancestor
6676939|NCT01584297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6676940|NCT01584297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676941|NCT01584297|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6676942|NCT01584362|Oxfendazole|oxfendazole|mesh-list
6501312|NCT00647777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6233549|NCT02545504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5709555|NCT03285568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5709556|NCT03285568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5709557|NCT03285568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5709558|NCT03285568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5709559|NCT03285503|Aripiprazole|aripiprazole|mesh-list
6233550|NCT02545504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6233551|NCT02545504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6233552|NCT02545504|Immunologic Factors|immunologic factors|mesh-ancestor
6233553|NCT02545504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233554|NCT02545504|Antidotes|antidotes|mesh-ancestor
6233555|NCT02545504|Protective Agents|protective agents|mesh-ancestor
6233556|NCT02545504|Vitamin B Complex|vitamin b complex|mesh-ancestor
6233557|NCT02545504|Vitamins|vitamins|mesh-ancestor
6501313|NCT00647777|Serotonin Agents|serotonin agents|mesh-ancestor
6501314|NCT00647816|Propranolol|propranolol|mesh-list
6501315|NCT00647816|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6501316|NCT00647816|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6501317|NCT00647816|Adrenergic Agents|adrenergic agents|mesh-ancestor
6501318|NCT00647816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6501319|NCT00647816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501320|NCT00647816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501321|NCT00647816|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6233558|NCT02545504|Micronutrients|micronutrients|mesh-ancestor
6233559|NCT02545907|Thalidomide|thalidomide|mesh-list
6233560|NCT02545907|Dexamethasone|dexamethasone|mesh-list
6233561|NCT02545907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6233562|NCT02545907|Antiemetics|antiemetics|mesh-ancestor
6233563|NCT02545907|Autonomic Agents|autonomic agents|mesh-ancestor
6233564|NCT02545907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6233565|NCT02545907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233566|NCT02545907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6233567|NCT02545907|Glucocorticoids|glucocorticoids|mesh-ancestor
6233568|NCT02545907|Hormones|hormones|mesh-ancestor
6233569|NCT02545907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6233570|NCT02545907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6233571|NCT02545907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6501322|NCT00647816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6501323|NCT00647816|Vasodilator Agents|vasodilator agents|mesh-ancestor
6501324|NCT00647829|Valdecoxib|valdecoxib|mesh-list
6501325|NCT00647829|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6501326|NCT00647829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6501327|NCT00647829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6501328|NCT00647829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501329|NCT00647829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6501330|NCT00647829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6501331|NCT00647829|Analgesics|analgesics|mesh-ancestor
6501332|NCT00647829|Sensory System Agents|sensory system agents|mesh-ancestor
6233572|NCT02545907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6233573|NCT02545907|Immunologic Factors|immunologic factors|mesh-ancestor
6233574|NCT02545907|Leprostatic Agents|leprostatic agents|mesh-ancestor
6233575|NCT02545907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6233576|NCT02545907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6233577|NCT02545907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6233578|NCT02545907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6233579|NCT02545907|Growth Substances|growth substances|mesh-ancestor
6233580|NCT02545907|Growth Inhibitors|growth inhibitors|mesh-ancestor
5709560|NCT03285503|Antidepressive Agents|antidepressive agents|mesh-ancestor
6233581|NCT02545933|Aspirin|aspirin|mesh-list
6233582|NCT02545933|Ticagrelor|ticagrelor|mesh-list
6233583|NCT02545933|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6233584|NCT02545933|Vorapaxar|vorapaxar|mesh-list
6233585|NCT02545933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6233586|NCT02545933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6233587|NCT02545933|Analgesics|analgesics|mesh-ancestor
6233588|NCT02545933|Sensory System Agents|sensory system agents|mesh-ancestor
6233589|NCT02545933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6233590|NCT02545933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233591|NCT02545933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6233592|NCT02545933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6233593|NCT02545933|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6233594|NCT02545933|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6233595|NCT02545933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233596|NCT02545933|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6233597|NCT02545933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6233598|NCT02545933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6233599|NCT02545933|Antipyretics|antipyretics|mesh-ancestor
6233600|NCT02545933|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6233601|NCT02545933|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6233602|NCT02545933|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6233603|NCT02545933|Purinergic Agents|purinergic agents|mesh-ancestor
6233604|NCT02545933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6233605|NCT02546193|Misoprostol|misoprostol|mesh-list
6233606|NCT02546193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6233607|NCT02546193|Abortifacient Agents|abortifacient agents|mesh-ancestor
6233608|NCT02546193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6233609|NCT02546193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233610|NCT02546193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6233611|NCT02546193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6233612|NCT02546193|Oxytocics|oxytocics|mesh-ancestor
6233613|NCT02546323|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6233614|NCT02546323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6233615|NCT02546323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6233616|NCT02546323|Antimetabolites|antimetabolites|mesh-ancestor
6233617|NCT02546323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233618|NCT02546323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6233619|NCT02546323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6233620|NCT02546323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6233621|NCT02546570|Oxytocin|oxytocin|mesh-list
6233622|NCT02546570|Oxytocics|oxytocics|mesh-ancestor
6501333|NCT00647829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6501334|NCT00647829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501335|NCT00647829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6501336|NCT00647829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6501337|NCT00647842|Fentanyl|fentanyl|mesh-list
6501338|NCT00647842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6501339|NCT00647842|Narcotics|narcotics|mesh-ancestor
6501340|NCT00647842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6501341|NCT00647842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676943|NCT01584362|Anthelmintics|anthelmintics|mesh-ancestor
6676944|NCT01584362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6676945|NCT01584362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5709561|NCT03285503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5709562|NCT03285503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5709563|NCT03285503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5709564|NCT03285503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5709565|NCT03285503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709566|NCT03285503|Dopamine Agonists|dopamine agonists|mesh-ancestor
5709567|NCT03285503|Dopamine Agents|dopamine agents|mesh-ancestor
5709568|NCT03285503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5709569|NCT03285503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5709570|NCT03285503|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5709571|NCT03285503|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5709572|NCT03285503|Serotonin Agents|serotonin agents|mesh-ancestor
5709573|NCT03285503|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5709574|NCT03285503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5709575|NCT03285503|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5709576|NCT03285503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5709577|NCT03285360|Fluorides|fluorides|mesh-list
5709578|NCT03285360|Fluorides, Topical|fluorides, topical|mesh-list
6676946|NCT01584362|Antinematodal Agents|antinematodal agents|mesh-ancestor
6676947|NCT01584466|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6233623|NCT02546570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6501342|NCT00647842|Analgesics|analgesics|mesh-ancestor
6501343|NCT00647842|Sensory System Agents|sensory system agents|mesh-ancestor
6501344|NCT00647842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6501345|NCT00647842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6501346|NCT00647842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6501347|NCT00647842|Anesthetics, General|anesthetics, general|mesh-ancestor
6501348|NCT00647842|Anesthetics|anesthetics|mesh-ancestor
5709579|NCT03285360|Cariostatic Agents|cariostatic agents|mesh-ancestor
5709580|NCT03285360|Protective Agents|protective agents|mesh-ancestor
5709581|NCT03285360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709582|NCT03285165|Propofol|propofol|mesh-list
5709583|NCT03285165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5709584|NCT03285165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5709585|NCT03285165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709586|NCT03285165|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5709587|NCT03285165|Anesthetics, General|anesthetics, general|mesh-ancestor
5709588|NCT03285165|Anesthetics|anesthetics|mesh-ancestor
5709589|NCT03285087|Dexmedetomidine|dexmedetomidine|mesh-list
5709590|NCT03285087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5709591|NCT03285087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5709592|NCT03285087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709593|NCT03285087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5709594|NCT03285087|Analgesics|analgesics|mesh-ancestor
5709595|NCT03285087|Sensory System Agents|sensory system agents|mesh-ancestor
5709596|NCT03285087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5709597|NCT03285087|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5709598|NCT03285087|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5709599|NCT03285087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5709600|NCT03285087|Adrenergic Agents|adrenergic agents|mesh-ancestor
5709601|NCT03285087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6501349|NCT00647868|Testosterone|testosterone|mesh-list
6501350|NCT00647868|Androgens|androgens|mesh-ancestor
6501351|NCT00647868|Hormones|hormones|mesh-ancestor
6501352|NCT00647868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6501353|NCT00647868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501354|NCT00647881|Paroxetine|paroxetine|mesh-list
6501355|NCT00647881|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6501356|NCT00647881|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6501357|NCT00647881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6501358|NCT00647881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501359|NCT00647881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6501360|NCT00647881|Serotonin Agents|serotonin agents|mesh-ancestor
6501361|NCT00647881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501362|NCT00647881|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6501363|NCT00647881|Antidepressive Agents|antidepressive agents|mesh-ancestor
6501364|NCT00647881|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6233624|NCT02546570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233625|NCT02546765|Acetaminophen|acetaminophen|mesh-list
6233626|NCT02546765|Dexmedetomidine|dexmedetomidine|mesh-list
6233627|NCT02546765|Propofol|propofol|mesh-list
6233628|NCT02546765|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6233629|NCT02546765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6233630|NCT02546765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233631|NCT02546765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6233632|NCT02546765|Anesthetics, General|anesthetics, general|mesh-ancestor
6501365|NCT00647881|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6501366|NCT00647881|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6501367|NCT00647881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6501368|NCT00647894|Alprazolam|alprazolam|mesh-list
6501369|NCT00647894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6501370|NCT00647894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6501371|NCT00647894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501372|NCT00647894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6501373|NCT00647894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6501374|NCT00647894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6501375|NCT00647894|GABA Modulators|gaba modulators|mesh-ancestor
6501376|NCT00647894|GABA Agents|gaba agents|mesh-ancestor
6501377|NCT00647894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6676948|NCT01584466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6676949|NCT01584466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5709602|NCT03285087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5709603|NCT03284762|Rivaroxaban|rivaroxaban|mesh-list
5709604|NCT03284762|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5709605|NCT03284762|Antithrombins|antithrombins|mesh-ancestor
6676950|NCT01584466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5709606|NCT03284762|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5709607|NCT03284762|Protease Inhibitors|protease inhibitors|mesh-ancestor
5709608|NCT03284762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5709609|NCT03284762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5709610|NCT03284762|Anticoagulants|anticoagulants|mesh-ancestor
5709611|NCT03284749|Copper|copper|mesh-list
5709612|NCT03284749|Trace Elements|trace elements|mesh-ancestor
6501378|NCT00647894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501379|NCT00647907|Voriconazole|voriconazole|mesh-list
6501380|NCT00647907|Antifungal Agents|antifungal agents|mesh-ancestor
6501381|NCT00647907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6501382|NCT00647907|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6501383|NCT00647907|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6501384|NCT00647907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6501385|NCT00647907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501386|NCT00647907|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6501387|NCT00647907|Hormone Antagonists|hormone antagonists|mesh-ancestor
6676951|NCT01584466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709613|NCT03284749|Micronutrients|micronutrients|mesh-ancestor
5709614|NCT03284749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709615|NCT03284645|Tenofovir|tenofovir|mesh-list
5709616|NCT03284645|Lamivudine|lamivudine|mesh-list
5709617|NCT03284645|Zidovudine|zidovudine|mesh-list
5709618|NCT03284645|Efavirenz|efavirenz|mesh-list
5709619|NCT03284645|Abacavir|abacavir|mesh-list
5709620|NCT03284645|Antiviral Agents|antiviral agents|mesh-ancestor
5709621|NCT03284645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5709622|NCT03284645|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5709623|NCT03284645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6676952|NCT01584466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6676953|NCT01584466|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6676954|NCT01584466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6676955|NCT01584466|Serotonin Agents|serotonin agents|mesh-ancestor
6676956|NCT01584466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6676957|NCT01584466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676958|NCT01584466|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6676959|NCT01584466|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6676960|NCT01584466|Dopamine Agents|dopamine agents|mesh-ancestor
6676961|NCT01584492|Beclomethasone|beclomethasone|mesh-list
6676962|NCT01584492|Albuterol|albuterol|mesh-list
6676963|NCT01584492|Formoterol Fumarate|formoterol fumarate|mesh-list
6676964|NCT01584492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6676965|NCT01584492|Autonomic Agents|autonomic agents|mesh-ancestor
6676966|NCT01584492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6676967|NCT01584492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676968|NCT01584492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6676969|NCT01584492|Respiratory System Agents|respiratory system agents|mesh-ancestor
6676970|NCT01584492|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6676971|NCT01584492|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6676972|NCT01584492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6676973|NCT01584492|Adrenergic Agents|adrenergic agents|mesh-ancestor
6676974|NCT01584492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6676975|NCT01584492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676976|NCT01584492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6676977|NCT01584492|Glucocorticoids|glucocorticoids|mesh-ancestor
6676978|NCT01584492|Hormones|hormones|mesh-ancestor
6676979|NCT01584492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6233633|NCT02546765|Anesthetics|anesthetics|mesh-ancestor
6233634|NCT02546765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6233635|NCT02546765|Analgesics|analgesics|mesh-ancestor
6233636|NCT02546765|Sensory System Agents|sensory system agents|mesh-ancestor
6233637|NCT02546765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6233638|NCT02546765|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5709624|NCT03284645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5709625|NCT03284645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5709626|NCT03284645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5709627|NCT03284645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5709628|NCT03284645|Antimetabolites|antimetabolites|mesh-ancestor
5709629|NCT03284645|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5709630|NCT03284645|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6233639|NCT02546765|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6233640|NCT02546765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6233641|NCT02546765|Adrenergic Agents|adrenergic agents|mesh-ancestor
5709631|NCT03284645|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5709632|NCT03284645|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5709633|NCT03284645|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5709634|NCT03284645|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5709635|NCT03284593|Azacitidine|azacitidine|mesh-list
5709636|NCT03284593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5709637|NCT03284593|Antimetabolites|antimetabolites|mesh-ancestor
5709638|NCT03284593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5709639|NCT03284593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5709640|NCT03284593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5709641|NCT03284515|Vaccines|vaccines|mesh-list
6501388|NCT00647907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6501389|NCT00647907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501390|NCT00647907|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6501391|NCT00647920|Adalimumab|adalimumab|mesh-list
6501392|NCT00647920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6501393|NCT00647920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5709642|NCT03284515|Immunologic Factors|immunologic factors|mesh-ancestor
6233642|NCT02546765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6233643|NCT02546765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233644|NCT02546765|Antipyretics|antipyretics|mesh-ancestor
6233645|NCT02547012|Amoxicillin|amoxicillin|mesh-list
6233646|NCT02547012|Levofloxacin|levofloxacin|mesh-list
6233647|NCT02547012|Ofloxacin|ofloxacin|mesh-list
6233648|NCT02547012|Tetracycline|tetracycline|mesh-list
6233649|NCT02547012|Esomeprazole|esomeprazole|mesh-list
6233650|NCT02547012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6233651|NCT02547012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6233652|NCT02547012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6233653|NCT02547012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6233654|NCT02547012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6233655|NCT02547012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6233656|NCT02547012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233657|NCT02547012|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6233658|NCT02547012|Renal Agents|renal agents|mesh-ancestor
6501394|NCT00647946|Tenofovir|tenofovir|mesh-list
6501395|NCT00647946|Abacavir|abacavir|mesh-list
6501396|NCT00647946|Antiviral Agents|antiviral agents|mesh-ancestor
6501397|NCT00647946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6501398|NCT00647946|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6501399|NCT00647946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6501400|NCT00647946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6501401|NCT00647946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501402|NCT00647946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6501403|NCT00647946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6501404|NCT00647959|Doxycycline|doxycycline|mesh-list
6501405|NCT00647959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6676980|NCT01584492|Tocolytic Agents|tocolytic agents|mesh-ancestor
6233659|NCT02547012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6233660|NCT02547012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6233661|NCT02547012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6233662|NCT02547012|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6233663|NCT02547012|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6233664|NCT02547012|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6233665|NCT02547038|Amoxicillin|amoxicillin|mesh-list
6233666|NCT02547038|Metronidazole|metronidazole|mesh-list
6233667|NCT02547038|Clarithromycin|clarithromycin|mesh-list
6233668|NCT02547038|Tetracycline|tetracycline|mesh-list
6233669|NCT02547038|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
6233670|NCT02547038|Pantoprazole|pantoprazole|mesh-list
6233671|NCT02547038|Bismuth|bismuth|mesh-list
6233672|NCT02547038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6233673|NCT02547038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6233674|NCT02547038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6233675|NCT02547038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6233676|NCT02547038|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6233677|NCT02547038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5709643|NCT03284515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709644|NCT03284502|Cetuximab|cetuximab|mesh-list
5709645|NCT03284502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5709646|NCT03284502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5709647|NCT03284463|Glyburide|glyburide|mesh-list
5709648|NCT03284463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5709649|NCT03284463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709650|NCT03284307|Midazolam|midazolam|mesh-list
5709651|NCT03284307|Dexmedetomidine|dexmedetomidine|mesh-list
5709652|NCT03284307|Ketamine|ketamine|mesh-list
6233678|NCT02547038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5709653|NCT03284307|Propofol|propofol|mesh-list
6233679|NCT02547038|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6233680|NCT02547038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6233681|NCT02547038|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6233682|NCT02547038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6233683|NCT02547038|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6233684|NCT02547038|Antacids|antacids|mesh-ancestor
6233685|NCT02547220|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
6233686|NCT02547220|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6233687|NCT02547220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6233688|NCT02547220|Immunologic Factors|immunologic factors|mesh-ancestor
6233689|NCT02547220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233690|NCT02547454|Epoetin Alfa|epoetin alfa|mesh-list
6233691|NCT02547454|Hematinics|hematinics|mesh-ancestor
6233692|NCT02547623|Dexamethasone|dexamethasone|mesh-list
6233693|NCT02547623|Prednisolone|prednisolone|mesh-list
6233694|NCT02547623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6233695|NCT02547623|Antiemetics|antiemetics|mesh-ancestor
6501406|NCT00647959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6501407|NCT00647959|Antimalarials|antimalarials|mesh-ancestor
6501408|NCT00647959|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6501409|NCT00647959|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6501410|NCT00647972|Olanzapine|olanzapine|mesh-list
6501411|NCT00647972|Antiemetics|antiemetics|mesh-ancestor
6501412|NCT00647972|Autonomic Agents|autonomic agents|mesh-ancestor
6501413|NCT00647972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6501414|NCT00647972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501415|NCT00647972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6501416|NCT00647972|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6501417|NCT00647972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6676981|NCT01584492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6676982|NCT01584557|Tolvaptan|tolvaptan|mesh-list
6676983|NCT01584557|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6676984|NCT01584557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6676985|NCT01584557|Natriuretic Agents|natriuretic agents|mesh-ancestor
6676986|NCT01584557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676987|NCT01584687|Omalizumab|omalizumab|mesh-list
6676988|NCT01584687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6676989|NCT01584687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5709654|NCT03284307|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5709655|NCT03284307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5709656|NCT03284307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709657|NCT03284307|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5709658|NCT03284307|Anesthetics, General|anesthetics, general|mesh-ancestor
5709659|NCT03284307|Anesthetics|anesthetics|mesh-ancestor
5709660|NCT03284307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5709661|NCT03284307|Analgesics|analgesics|mesh-ancestor
5709662|NCT03284307|Sensory System Agents|sensory system agents|mesh-ancestor
5709663|NCT03284307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6676990|NCT01584687|Respiratory System Agents|respiratory system agents|mesh-ancestor
6676991|NCT01584726|Magnesium Sulfate|magnesium sulfate|mesh-list
6676992|NCT01584726|Analgesics|analgesics|mesh-ancestor
6676993|NCT01584726|Sensory System Agents|sensory system agents|mesh-ancestor
6233696|NCT02547623|Autonomic Agents|autonomic agents|mesh-ancestor
6233697|NCT02547623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6233698|NCT02547623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233699|NCT02547623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6233700|NCT02547623|Glucocorticoids|glucocorticoids|mesh-ancestor
6233701|NCT02547623|Hormones|hormones|mesh-ancestor
6233702|NCT02547623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6233703|NCT02547623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6233704|NCT02547623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6243779|NCT02680301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243780|NCT02680314|Methotrexate|methotrexate|mesh-list
6243781|NCT02680314|Misoprostol|misoprostol|mesh-list
6243782|NCT02680314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6243783|NCT02680314|Abortifacient Agents|abortifacient agents|mesh-ancestor
6243784|NCT02680314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6243785|NCT02680314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243786|NCT02680314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6243787|NCT02680314|Antimetabolites|antimetabolites|mesh-ancestor
6243788|NCT02680314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501418|NCT00647972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6501419|NCT00647972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6676994|NCT01584726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5709664|NCT03284307|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5709665|NCT03284307|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5709666|NCT03284307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5709667|NCT03284307|Adrenergic Agents|adrenergic agents|mesh-ancestor
5709668|NCT03284307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6501420|NCT00647972|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6501421|NCT00647972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6676995|NCT01584726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6676996|NCT01584726|Anesthetics|anesthetics|mesh-ancestor
6676997|NCT01584726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6676998|NCT01584726|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6676999|NCT01584726|Anticonvulsants|anticonvulsants|mesh-ancestor
5709669|NCT03284307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5709670|NCT03284307|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5709671|NCT03284307|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5709672|NCT03284307|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5709673|NCT03284307|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6233705|NCT02547649|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6233706|NCT02547649|Immunologic Factors|immunologic factors|mesh-ancestor
6233707|NCT02547649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233708|NCT02547766|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6233709|NCT02547766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6233710|NCT02547779|Plasma-lyte 148|plasma-lyte 148|mesh-list
6233711|NCT02547779|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6233712|NCT02547779|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6233713|NCT02547935|Dapagliflozin|dapagliflozin|mesh-list
6233714|NCT02547935|Saxagliptin|saxagliptin|mesh-list
6233715|NCT02547935|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6233716|NCT02547935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233717|NCT02547935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6233718|NCT02547935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233719|NCT02547935|Incretins|incretins|mesh-ancestor
6233720|NCT02547935|Hormones|hormones|mesh-ancestor
6233721|NCT02547935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6233722|NCT02547935|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6233723|NCT02547935|Protease Inhibitors|protease inhibitors|mesh-ancestor
6233724|NCT02547935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6233725|NCT02547974|Vaccines|vaccines|mesh-list
6233726|NCT02547974|Immunologic Factors|immunologic factors|mesh-ancestor
6233727|NCT02547974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233728|NCT02547987|Carboplatin|carboplatin|mesh-list
6233729|NCT02547987|Docetaxel|docetaxel|mesh-list
6233730|NCT02547987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6233731|NCT02547987|Tubulin Modulators|tubulin modulators|mesh-ancestor
6233732|NCT02547987|Antimitotic Agents|antimitotic agents|mesh-ancestor
6233733|NCT02547987|Mitosis Modulators|mitosis modulators|mesh-ancestor
6233734|NCT02547987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233735|NCT02548078|Vaccines|vaccines|mesh-list
6233736|NCT02548078|Immunologic Factors|immunologic factors|mesh-ancestor
6233737|NCT02548078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233738|NCT02548455|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
6233739|NCT02548455|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6233740|NCT02548455|Contraceptive Agents|contraceptive agents|mesh-ancestor
6233741|NCT02548455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6233742|NCT02548455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233743|NCT02548455|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6233744|NCT02548455|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6233745|NCT02548455|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6233746|NCT02548650|Aspirin|aspirin|mesh-list
6233747|NCT02548650|Clopidogrel|clopidogrel|mesh-list
6233748|NCT02548650|Vorapaxar|vorapaxar|mesh-list
6233749|NCT02548650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6233750|NCT02548650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6233751|NCT02548650|Analgesics|analgesics|mesh-ancestor
6233752|NCT02548650|Sensory System Agents|sensory system agents|mesh-ancestor
6233753|NCT02548650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6233754|NCT02548650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233755|NCT02548650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6501422|NCT00647972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6501423|NCT00647972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501424|NCT00647972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6501425|NCT00647972|Serotonin Agents|serotonin agents|mesh-ancestor
6501426|NCT00647985|Fexofenadine|fexofenadine|mesh-list
6233756|NCT02548650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6233757|NCT02548650|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6233758|NCT02548650|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6233759|NCT02548650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233760|NCT02548650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6233761|NCT02548650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6233762|NCT02548650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6233763|NCT02548650|Antipyretics|antipyretics|mesh-ancestor
6233764|NCT02548650|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6233765|NCT02548650|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6233766|NCT02548650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6233767|NCT02548650|Purinergic Agents|purinergic agents|mesh-ancestor
5709674|NCT03284307|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5709675|NCT03284307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5709676|NCT03284307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5709677|NCT03284307|GABA Modulators|gaba modulators|mesh-ancestor
5709678|NCT03284307|GABA Agents|gaba agents|mesh-ancestor
5709679|NCT03284294|Cholecalciferol|cholecalciferol|mesh-list
5709680|NCT03284294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5709681|NCT03284294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709682|NCT03284294|Vitamins|vitamins|mesh-ancestor
5709683|NCT03284294|Micronutrients|micronutrients|mesh-ancestor
5709684|NCT03284294|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5709685|NCT03284177|Calcium|calcium|mesh-list
5709686|NCT03284177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5709687|NCT03284177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709688|NCT03284164|Tenofovir|tenofovir|mesh-list
5709689|NCT03284164|Antiviral Agents|antiviral agents|mesh-ancestor
5709690|NCT03284164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5709691|NCT03284164|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5709692|NCT03284164|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5709693|NCT03284164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5709694|NCT03284164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5709695|NCT03284164|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5709696|NCT03284164|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5721557|NCT03204331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5721558|NCT03204331|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6233768|NCT02548650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6233769|NCT02548728|Oxytocin|oxytocin|mesh-list
6233770|NCT02548728|Oxytocics|oxytocics|mesh-ancestor
6501427|NCT00647985|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6501428|NCT00647985|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6501429|NCT00647985|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6501430|NCT00647985|Histamine Antagonists|histamine antagonists|mesh-ancestor
6501431|NCT00647985|Histamine Agents|histamine agents|mesh-ancestor
6501432|NCT00647985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6501433|NCT00647985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501434|NCT00647985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677000|NCT01584726|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6677001|NCT01584726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6677002|NCT01584726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677003|NCT01584726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6677004|NCT01584726|Tocolytic Agents|tocolytic agents|mesh-ancestor
6677005|NCT01584726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6677006|NCT01584778|Eosinophil Cationic Protein|eosinophil cationic protein|mesh-list
6677007|NCT01584778|Immunologic Factors|immunologic factors|mesh-ancestor
6233771|NCT02548728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6233772|NCT02548728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233773|NCT02548910|Sodium Citrate|sodium citrate|mesh-list
6233774|NCT02548910|Citric Acid|citric acid|mesh-list
6233775|NCT02548910|Anticoagulants|anticoagulants|mesh-ancestor
6233776|NCT02548910|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6233777|NCT02548910|Chelating Agents|chelating agents|mesh-ancestor
6233778|NCT02548910|Sequestering Agents|sequestering agents|mesh-ancestor
6233779|NCT02548910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233780|NCT02548962|Dexamethasone|dexamethasone|mesh-list
6233781|NCT02548962|Pomalidomide|pomalidomide|mesh-list
6233782|NCT02548962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6233783|NCT02548962|Antiemetics|antiemetics|mesh-ancestor
6233784|NCT02548962|Autonomic Agents|autonomic agents|mesh-ancestor
6233785|NCT02548962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6233786|NCT02548962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233787|NCT02548962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5721559|NCT03204331|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5709697|NCT03283943|Durvalumab|durvalumab|mesh-list
5709698|NCT03283943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5709699|NCT03283943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5709700|NCT03283917|Dexamethasone|dexamethasone|mesh-list
5709701|NCT03283917|Dexamethasone acetate|dexamethasone acetate|mesh-list
5709702|NCT03283917|Daratumumab|daratumumab|mesh-list
5709703|NCT03283917|Ixazomib|ixazomib|mesh-list
5709704|NCT03283917|Ichthammol|ichthammol|mesh-list
5709705|NCT03283917|BB 1101|bb 1101|mesh-list
5709706|NCT03283917|Glycine|glycine|mesh-list
5709707|NCT03283917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5709708|NCT03283917|Antiemetics|antiemetics|mesh-ancestor
5709709|NCT03283917|Autonomic Agents|autonomic agents|mesh-ancestor
6233788|NCT02548962|Glucocorticoids|glucocorticoids|mesh-ancestor
6233789|NCT02548962|Hormones|hormones|mesh-ancestor
6233790|NCT02548962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6233791|NCT02548962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6233792|NCT02548962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6233793|NCT02548962|Immunologic Factors|immunologic factors|mesh-ancestor
6233794|NCT02548962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6501435|NCT00648011|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6501436|NCT00648011|Quinapril|quinapril|mesh-list
5709710|NCT03283917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5709711|NCT03283917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709712|NCT03283917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5709713|NCT03283917|Glucocorticoids|glucocorticoids|mesh-ancestor
5709714|NCT03283917|Hormones|hormones|mesh-ancestor
5709715|NCT03283917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5709716|NCT03283917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5709717|NCT03283917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5709718|NCT03283917|Protease Inhibitors|protease inhibitors|mesh-ancestor
5709719|NCT03283917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5709720|NCT03283917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5709721|NCT03283917|Dermatologic Agents|dermatologic agents|mesh-ancestor
5709722|NCT03283917|Glycine Agents|glycine agents|mesh-ancestor
5709723|NCT03283917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5709724|NCT03283878|Cefazolin|cefazolin|mesh-list
6501437|NCT00648011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6501438|NCT00648011|Diuretics|diuretics|mesh-ancestor
6501439|NCT00648011|Natriuretic Agents|natriuretic agents|mesh-ancestor
6501440|NCT00648011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501441|NCT00648011|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6501442|NCT00648011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5709725|NCT03283878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5709726|NCT03283878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5709727|NCT03283813|Inositol|inositol|mesh-list
5709728|NCT03283813|Vitamin B Complex|vitamin b complex|mesh-ancestor
5709729|NCT03283813|Vitamins|vitamins|mesh-ancestor
5709730|NCT03283813|Micronutrients|micronutrients|mesh-ancestor
5709731|NCT03283813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709732|NCT03283800|Copper|copper|mesh-list
5709733|NCT03283800|Trace Elements|trace elements|mesh-ancestor
5709734|NCT03283800|Micronutrients|micronutrients|mesh-ancestor
5709735|NCT03283800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501443|NCT00648011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501444|NCT00648011|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6501445|NCT00648011|Protease Inhibitors|protease inhibitors|mesh-ancestor
6501446|NCT00648011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6501447|NCT00648024|Anagrelide|anagrelide|mesh-list
6677008|NCT01584778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677009|NCT01584791|Aspirin|aspirin|mesh-list
6677010|NCT01584791|Clopidogrel|clopidogrel|mesh-list
6677011|NCT01584791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6677012|NCT01584791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5709736|NCT03283670|Nitrous Oxide|nitrous oxide|mesh-list
5709737|NCT03283670|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6677013|NCT01584791|Analgesics|analgesics|mesh-ancestor
6677014|NCT01584791|Sensory System Agents|sensory system agents|mesh-ancestor
6677015|NCT01584791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6677016|NCT01584791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677017|NCT01584791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6677018|NCT01584791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6677019|NCT01584791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6677020|NCT01584791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5709738|NCT03283670|Anesthetics, General|anesthetics, general|mesh-ancestor
5709739|NCT03283670|Anesthetics|anesthetics|mesh-ancestor
5709740|NCT03283670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5709741|NCT03283670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233795|NCT02548962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6233796|NCT02548962|Growth Substances|growth substances|mesh-ancestor
6233797|NCT02548962|Growth Inhibitors|growth inhibitors|mesh-ancestor
6233798|NCT02549196|Donepezil|donepezil|mesh-list
6233799|NCT02549196|Solifenacin Succinate|solifenacin succinate|mesh-list
6233800|NCT02549196|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6233801|NCT02549196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6233802|NCT02549196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5709742|NCT03283670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5709743|NCT03283670|Analgesics|analgesics|mesh-ancestor
5709744|NCT03283670|Sensory System Agents|sensory system agents|mesh-ancestor
5709745|NCT03283670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5709746|NCT03283566|Hydroxychloroquine|hydroxychloroquine|mesh-list
5709747|NCT03283566|Antimalarials|antimalarials|mesh-ancestor
5709748|NCT03283566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5709749|NCT03283566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5709750|NCT03283566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5709751|NCT03283566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5709752|NCT03283566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233803|NCT02549196|Cholinergic Agents|cholinergic agents|mesh-ancestor
6233804|NCT02549196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6233805|NCT02549196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233806|NCT02549196|Nootropic Agents|nootropic agents|mesh-ancestor
6233807|NCT02549196|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6233808|NCT02549196|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6233809|NCT02549196|Urological Agents|urological agents|mesh-ancestor
6233810|NCT02549209|Paclitaxel|paclitaxel|mesh-list
6233811|NCT02549209|Carboplatin|carboplatin|mesh-list
6233812|NCT02549209|Pembrolizumab|pembrolizumab|mesh-list
5709753|NCT03283566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5709754|NCT03283488|Megestrol|megestrol|mesh-list
5709755|NCT03283488|Megestrol Acetate|megestrol acetate|mesh-list
5709756|NCT03283488|Mirtazapine|mirtazapine|mesh-list
5709757|NCT03283488|Antidepressive Agents|antidepressive agents|mesh-ancestor
5709758|NCT03283488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5709759|NCT03283488|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5709760|NCT03283488|Histamine Antagonists|histamine antagonists|mesh-ancestor
5709761|NCT03283488|Histamine Agents|histamine agents|mesh-ancestor
5709762|NCT03283488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5709763|NCT03283488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5709764|NCT03283488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709765|NCT03283488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6233813|NCT02549209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6233814|NCT02549209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6233815|NCT02549209|Tubulin Modulators|tubulin modulators|mesh-ancestor
6233816|NCT02549209|Antimitotic Agents|antimitotic agents|mesh-ancestor
6233817|NCT02549209|Mitosis Modulators|mitosis modulators|mesh-ancestor
6501448|NCT00648024|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5709766|NCT03283488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5709767|NCT03283488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6233818|NCT02549209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233819|NCT02549209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6233820|NCT02549573|Apomorphine|apomorphine|mesh-list
6233821|NCT02549573|Emetics|emetics|mesh-ancestor
6233822|NCT02549573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233823|NCT02549573|Autonomic Agents|autonomic agents|mesh-ancestor
6233824|NCT02549573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6233825|NCT02549573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6233826|NCT02549573|Dopamine Agonists|dopamine agonists|mesh-ancestor
6233827|NCT02549573|Dopamine Agents|dopamine agents|mesh-ancestor
5709768|NCT03283488|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5709769|NCT03283488|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5709770|NCT03283488|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5709771|NCT03283488|Adrenergic Agents|adrenergic agents|mesh-ancestor
5709772|NCT03283488|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5709773|NCT03283488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5709774|NCT03283488|Serotonin Agents|serotonin agents|mesh-ancestor
5709775|NCT03283488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6233828|NCT02549573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6233829|NCT02549573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233830|NCT02550106|Omalizumab|omalizumab|mesh-list
6233831|NCT02550106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6233832|NCT02550106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6233833|NCT02550106|Respiratory System Agents|respiratory system agents|mesh-ancestor
6233834|NCT02550197|Vaccines|vaccines|mesh-list
5709776|NCT03283488|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6501449|NCT00648024|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6501450|NCT00648024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501451|NCT00648024|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6501452|NCT00648050|Verapamil|verapamil|mesh-list
6501453|NCT00648050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6501454|NCT00648050|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6501455|NCT00648050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6501456|NCT00648050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501457|NCT00648050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6501458|NCT00648050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233835|NCT02550197|Immunologic Factors|immunologic factors|mesh-ancestor
6233836|NCT02550197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233837|NCT02550743|Capecitabine|capecitabine|mesh-list
6233838|NCT02550743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6233839|NCT02550743|Antimetabolites|antimetabolites|mesh-ancestor
6233840|NCT02550743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233841|NCT02550743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6233842|NCT02550795|Dexamethasone|dexamethasone|mesh-list
6233843|NCT02550795|Dexmedetomidine|dexmedetomidine|mesh-list
6233844|NCT02550795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6233845|NCT02550795|Antiemetics|antiemetics|mesh-ancestor
5709777|NCT03283488|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5709778|NCT03283488|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5709779|NCT03283488|Contraceptive Agents|contraceptive agents|mesh-ancestor
5709780|NCT03283488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5709781|NCT03283488|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5709782|NCT03283488|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5709783|NCT03283488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5709784|NCT03283488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5709785|NCT03283488|Appetite Stimulants|appetite stimulants|mesh-ancestor
6233846|NCT02550795|Autonomic Agents|autonomic agents|mesh-ancestor
6233847|NCT02550795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6233848|NCT02550795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233849|NCT02550795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6233850|NCT02550795|Glucocorticoids|glucocorticoids|mesh-ancestor
6233851|NCT02550795|Hormones|hormones|mesh-ancestor
6233852|NCT02550795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6233853|NCT02550795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6233854|NCT02550795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6233855|NCT02550795|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6779679|NCT02180425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6233856|NCT02550795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5709786|NCT03283488|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5709787|NCT03283410|Propofol|propofol|mesh-list
5709788|NCT03283410|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5709789|NCT03283410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5709790|NCT03283410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709791|NCT03283410|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5709792|NCT03283410|Anesthetics, General|anesthetics, general|mesh-ancestor
5709793|NCT03283410|Anesthetics|anesthetics|mesh-ancestor
5709794|NCT03283384|Letrozole|letrozole|mesh-list
5709795|NCT03283384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5709796|NCT03283384|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5709797|NCT03283384|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5709798|NCT03283384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5709799|NCT03283384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5709800|NCT03283384|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5709801|NCT03283384|Hormone Antagonists|hormone antagonists|mesh-ancestor
5709802|NCT03283384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5709803|NCT03283384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709804|NCT03283202|Prednisone|prednisone|mesh-list
5709805|NCT03283202|Prednisolone|prednisolone|mesh-list
5709806|NCT03283202|Cyclophosphamide|cyclophosphamide|mesh-list
5709807|NCT03283202|Rituximab|rituximab|mesh-list
5709808|NCT03283202|Vincristine|vincristine|mesh-list
5709809|NCT03283202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5709810|NCT03283202|Immunologic Factors|immunologic factors|mesh-ancestor
5709811|NCT03283202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709812|NCT03283202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5709813|NCT03283202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5709814|NCT03283202|Alkylating Agents|alkylating agents|mesh-ancestor
5709815|NCT03283202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5709816|NCT03283202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5709817|NCT03283202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5709818|NCT03283202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5709819|NCT03283202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5709820|NCT03283202|Glucocorticoids|glucocorticoids|mesh-ancestor
5709821|NCT03283202|Hormones|hormones|mesh-ancestor
5709822|NCT03283202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5709823|NCT03283202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5709824|NCT03283202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5709825|NCT03283202|Tubulin Modulators|tubulin modulators|mesh-ancestor
5709826|NCT03283202|Antimitotic Agents|antimitotic agents|mesh-ancestor
5709827|NCT03283202|Mitosis Modulators|mitosis modulators|mesh-ancestor
5709828|NCT03283176|Folic Acid|folic acid|mesh-list
5709829|NCT03283176|Vitamin B 12|vitamin b 12|mesh-list
5709830|NCT03283176|Hydroxocobalamin|hydroxocobalamin|mesh-list
5709831|NCT03283176|Vitamins|vitamins|mesh-ancestor
5709832|NCT03283176|Micronutrients|micronutrients|mesh-ancestor
5709833|NCT03283176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709834|NCT03283176|Hematinics|hematinics|mesh-ancestor
5709835|NCT03283176|Vitamin B Complex|vitamin b complex|mesh-ancestor
5709836|NCT03283150|Dexmedetomidine|dexmedetomidine|mesh-list
5709837|NCT03283150|Remifentanil|remifentanil|mesh-list
5709838|NCT03283150|Propofol|propofol|mesh-list
5709839|NCT03283150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5709840|NCT03283150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5709841|NCT03283150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709842|NCT03283150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5709843|NCT03283150|Anesthetics, General|anesthetics, general|mesh-ancestor
5709844|NCT03283150|Anesthetics|anesthetics|mesh-ancestor
5709845|NCT03283150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5709846|NCT03283150|Analgesics|analgesics|mesh-ancestor
5709847|NCT03283150|Sensory System Agents|sensory system agents|mesh-ancestor
5709848|NCT03283150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5709849|NCT03283150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5709850|NCT03283150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5709851|NCT03283150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5709852|NCT03283150|Adrenergic Agents|adrenergic agents|mesh-ancestor
5709853|NCT03283150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5709854|NCT03283150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5709855|NCT03283150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5709856|NCT03283150|Narcotics|narcotics|mesh-ancestor
5709857|NCT03283059|Donepezil|donepezil|mesh-list
5709858|NCT03283059|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5709859|NCT03283059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5709860|NCT03283059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5709861|NCT03283059|Cholinergic Agents|cholinergic agents|mesh-ancestor
6233857|NCT02550795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6501459|NCT00648050|Vasodilator Agents|vasodilator agents|mesh-ancestor
6501460|NCT00648063|Letrozole|letrozole|mesh-list
6501461|NCT00648063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6501462|NCT00648063|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6501463|NCT00648063|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6501464|NCT00648063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6501465|NCT00648063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233858|NCT02550795|Analgesics|analgesics|mesh-ancestor
6233859|NCT02550795|Sensory System Agents|sensory system agents|mesh-ancestor
6233860|NCT02550795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6233861|NCT02550795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6233862|NCT02550795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6233863|NCT02550795|Adrenergic Agents|adrenergic agents|mesh-ancestor
6233864|NCT02550795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6233865|NCT02550795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233866|NCT02551055|Paclitaxel|paclitaxel|mesh-list
6233867|NCT02551055|Docetaxel|docetaxel|mesh-list
6233868|NCT02551055|Serabelisib|serabelisib|mesh-list
6233869|NCT02551055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6233870|NCT02551055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6233871|NCT02551055|Tubulin Modulators|tubulin modulators|mesh-ancestor
6233872|NCT02551055|Antimitotic Agents|antimitotic agents|mesh-ancestor
6233873|NCT02551055|Mitosis Modulators|mitosis modulators|mesh-ancestor
6233874|NCT02551055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233875|NCT02551055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6233876|NCT02551094|Colchicine|colchicine|mesh-list
6233877|NCT02551094|Gout Suppressants|gout suppressants|mesh-ancestor
6233878|NCT02551094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6233879|NCT02551094|Tubulin Modulators|tubulin modulators|mesh-ancestor
6501466|NCT00648063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6233880|NCT02551094|Antimitotic Agents|antimitotic agents|mesh-ancestor
5709862|NCT03283059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5709863|NCT03283059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709864|NCT03283059|Nootropic Agents|nootropic agents|mesh-ancestor
5709865|NCT03283046|Dexamethasone|dexamethasone|mesh-list
5709866|NCT03283046|Nivolumab|nivolumab|mesh-list
5709867|NCT03283046|Lenalidomide|lenalidomide|mesh-list
5709868|NCT03283046|Ipilimumab|ipilimumab|mesh-list
5709869|NCT03283046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5709870|NCT03283046|Antiemetics|antiemetics|mesh-ancestor
5709871|NCT03283046|Autonomic Agents|autonomic agents|mesh-ancestor
5709872|NCT03283046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5709873|NCT03283046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709874|NCT03283046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5709875|NCT03283046|Glucocorticoids|glucocorticoids|mesh-ancestor
5709876|NCT03283046|Hormones|hormones|mesh-ancestor
6501467|NCT00648063|Hormone Antagonists|hormone antagonists|mesh-ancestor
6501468|NCT00648063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6501469|NCT00648063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501470|NCT00648076|Valproic Acid|valproic acid|mesh-list
6501471|NCT00648076|Anticonvulsants|anticonvulsants|mesh-ancestor
6501472|NCT00648076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6501473|NCT00648076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501474|NCT00648076|GABA Agents|gaba agents|mesh-ancestor
6501475|NCT00648076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6501476|NCT00648076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501477|NCT00648076|Antimanic Agents|antimanic agents|mesh-ancestor
6501478|NCT00648076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6677021|NCT01584791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677022|NCT01584791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6677023|NCT01584791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6233881|NCT02551094|Mitosis Modulators|mitosis modulators|mesh-ancestor
6233882|NCT02551094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233883|NCT02551094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6233884|NCT02551159|Carboplatin|carboplatin|mesh-list
6233885|NCT02551159|Fluorouracil|fluorouracil|mesh-list
6233886|NCT02551159|Cetuximab|cetuximab|mesh-list
6233887|NCT02551159|Durvalumab|durvalumab|mesh-list
6233888|NCT02551159|Tremelimumab|tremelimumab|mesh-list
6233889|NCT02551159|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6233890|NCT02551159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6233891|NCT02551159|Antimetabolites|antimetabolites|mesh-ancestor
6233892|NCT02551159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233893|NCT02551159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6233894|NCT02551159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6233895|NCT02551159|Immunologic Factors|immunologic factors|mesh-ancestor
6233896|NCT02551159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233897|NCT02551159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6233898|NCT02551432|Paclitaxel|paclitaxel|mesh-list
6677024|NCT01584791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6677025|NCT01584791|Antipyretics|antipyretics|mesh-ancestor
6677026|NCT01584791|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5709877|NCT03283046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5709878|NCT03283046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6233899|NCT02551432|Pembrolizumab|pembrolizumab|mesh-list
6233900|NCT02551432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6233901|NCT02551432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6233902|NCT02551432|Tubulin Modulators|tubulin modulators|mesh-ancestor
6233903|NCT02551432|Antimitotic Agents|antimitotic agents|mesh-ancestor
6233904|NCT02551432|Mitosis Modulators|mitosis modulators|mesh-ancestor
6233905|NCT02551432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233906|NCT02551432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6233907|NCT02551692|Nicotine|nicotine|mesh-list
6233908|NCT02551692|Varenicline|varenicline|mesh-list
6233909|NCT02551692|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6233910|NCT02551692|Autonomic Agents|autonomic agents|mesh-ancestor
6233911|NCT02551692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6233912|NCT02551692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233913|NCT02551692|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6233914|NCT02551692|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6233915|NCT02551692|Cholinergic Agents|cholinergic agents|mesh-ancestor
6233916|NCT02551692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6233917|NCT02551692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233918|NCT02551731|Cannabidiol|cannabidiol|mesh-list
6233919|NCT02551731|Anticonvulsants|anticonvulsants|mesh-ancestor
6233920|NCT02551744|Pantoprazole|pantoprazole|mesh-list
6233921|NCT02551744|Famotidine|famotidine|mesh-list
6233922|NCT02551744|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
6233923|NCT02551744|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
6233924|NCT02551744|Histamine|histamine|mesh-list
6233925|NCT02551744|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6233926|NCT02551744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6233927|NCT02551744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6233928|NCT02551744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233929|NCT02551744|Histamine Antagonists|histamine antagonists|mesh-ancestor
6233930|NCT02551744|Histamine Agents|histamine agents|mesh-ancestor
6233931|NCT02551744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6233932|NCT02551744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233933|NCT02551744|Histamine Agonists|histamine agonists|mesh-ancestor
6233934|NCT02551822|Neurotransmitter Agents|neurotransmitter agents|mesh-list
6233935|NCT02551822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233936|NCT02551822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233937|NCT02551874|Metformin|metformin|mesh-list
6233938|NCT02551874|Insulin Glargine|insulin glargine|mesh-list
6233939|NCT02551874|Dapagliflozin|dapagliflozin|mesh-list
6233940|NCT02551874|Saxagliptin|saxagliptin|mesh-list
6233941|NCT02551874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6233942|NCT02551874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233943|NCT02551874|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5709879|NCT03283046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5709880|NCT03283046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5709881|NCT03283046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5709882|NCT03283046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5709883|NCT03283046|Immunologic Factors|immunologic factors|mesh-ancestor
5709884|NCT03283046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5709885|NCT03283046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5709886|NCT03283046|Growth Substances|growth substances|mesh-ancestor
6233944|NCT02551874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233945|NCT02551874|Incretins|incretins|mesh-ancestor
6233946|NCT02551874|Hormones|hormones|mesh-ancestor
6233947|NCT02551874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6233948|NCT02551874|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5709887|NCT03283046|Growth Inhibitors|growth inhibitors|mesh-ancestor
5709888|NCT03283020|Naltrexone|naltrexone|mesh-list
5709889|NCT03283020|Remifentanil|remifentanil|mesh-list
5709890|NCT03283020|Methylnaltrexone|methylnaltrexone|mesh-list
5709891|NCT03283020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5709892|NCT03283020|Narcotics|narcotics|mesh-ancestor
5709893|NCT03283020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6233949|NCT02551874|Protease Inhibitors|protease inhibitors|mesh-ancestor
6233950|NCT02551874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6233951|NCT02552121|Tisotumab vedotin|tisotumab vedotin|mesh-list
6501479|NCT00648076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6501480|NCT00648076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6501481|NCT00648128|Clarithromycin|clarithromycin|mesh-list
6233952|NCT02552121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6233953|NCT02552121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6233954|NCT02552147|Nicotine|nicotine|mesh-list
6233955|NCT02552147|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6233956|NCT02552147|Autonomic Agents|autonomic agents|mesh-ancestor
6233957|NCT02552147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6233958|NCT02552147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501482|NCT00648128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6501483|NCT00648128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6501484|NCT00648128|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6501485|NCT00648128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6501486|NCT00648128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501487|NCT00648128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6501488|NCT00648128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6501489|NCT00648141|Celecoxib|celecoxib|mesh-list
5709894|NCT03283020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233959|NCT02552147|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6233960|NCT02552147|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6233961|NCT02552147|Cholinergic Agents|cholinergic agents|mesh-ancestor
6233962|NCT02552147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6233963|NCT02552147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233964|NCT02552212|Certolizumab Pegol|certolizumab pegol|mesh-list
6233965|NCT02552212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6233966|NCT02552212|Immunologic Factors|immunologic factors|mesh-ancestor
6233967|NCT02552212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233968|NCT02552212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6233969|NCT02552225|Amitriptyline|amitriptyline|mesh-list
6233970|NCT02552225|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6233971|NCT02552225|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6233972|NCT02552225|Antidepressive Agents|antidepressive agents|mesh-ancestor
6233973|NCT02552225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6233974|NCT02552225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6233975|NCT02552225|Analgesics|analgesics|mesh-ancestor
6233976|NCT02552225|Sensory System Agents|sensory system agents|mesh-ancestor
6233977|NCT02552225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6233978|NCT02552225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233979|NCT02552225|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6233980|NCT02552225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6233981|NCT02552225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6233982|NCT02552225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233983|NCT02552225|Adrenergic Agents|adrenergic agents|mesh-ancestor
6233984|NCT02552225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6233985|NCT02552225|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6233986|NCT02552225|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6233987|NCT02552225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6233988|NCT02552303|Modafinil|modafinil|mesh-list
6233989|NCT02552303|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6233990|NCT02552303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233991|NCT02552303|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6233992|NCT02552303|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6233993|NCT02552303|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6233994|NCT02552303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6233995|NCT02552355|Metformin|metformin|mesh-list
6233996|NCT02552355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6233997|NCT02552355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6233998|NCT02553499|Pembrolizumab|pembrolizumab|mesh-list
6233999|NCT02553499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6234000|NCT02553499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6234001|NCT02553629|Rocuronium|rocuronium|mesh-list
6234002|NCT02553629|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6234003|NCT02553629|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6501490|NCT00648141|Diclofenac|diclofenac|mesh-list
6501491|NCT00648141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6501492|NCT00648141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6501493|NCT00648141|Analgesics|analgesics|mesh-ancestor
6501494|NCT00648141|Sensory System Agents|sensory system agents|mesh-ancestor
6501495|NCT00648141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6501496|NCT00648141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501497|NCT00648141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6501498|NCT00648141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6501499|NCT00648141|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6501500|NCT00648141|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6501501|NCT00648141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6501502|NCT00648141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501503|NCT00648154|Letrozole|letrozole|mesh-list
6501504|NCT00648154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6501505|NCT00648154|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6677027|NCT01584791|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6677028|NCT01584791|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6677029|NCT01584791|Purinergic Agents|purinergic agents|mesh-ancestor
6677030|NCT01584791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6677031|NCT01584804|Antitussive Agents|antitussive agents|mesh-list
6677032|NCT01584804|Respiratory System Agents|respiratory system agents|mesh-ancestor
6234004|NCT02553629|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6234005|NCT02553629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6234006|NCT02553629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234007|NCT02553772|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6234008|NCT02553772|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6677033|NCT01584921|Epoetin Alfa|epoetin alfa|mesh-list
6677034|NCT01584921|Hematinics|hematinics|mesh-ancestor
6677035|NCT01584934|Sodium Oxybate|sodium oxybate|mesh-list
6677036|NCT01584934|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6234009|NCT02553772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6234010|NCT02553772|Laxatives|laxatives|mesh-ancestor
6234011|NCT02553772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6234012|NCT02553798|Glycopyrrolate|glycopyrrolate|mesh-list
6234013|NCT02553798|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6501506|NCT00648154|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6501507|NCT00648154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6677037|NCT01584934|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5709895|NCT03283020|Analgesics|analgesics|mesh-ancestor
6234014|NCT02553798|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6234015|NCT02553798|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6234016|NCT02553798|Cholinergic Agents|cholinergic agents|mesh-ancestor
6234017|NCT02553798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6234018|NCT02553798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234019|NCT02553798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234020|NCT02553928|Memantine|memantine|mesh-list
6234021|NCT02553928|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6234022|NCT02553928|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6234023|NCT02553928|Dopamine Agents|dopamine agents|mesh-ancestor
6234024|NCT02553928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6234025|NCT02553928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234026|NCT02553928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234027|NCT02553928|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6501508|NCT00648154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501509|NCT00648154|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6501510|NCT00648154|Hormone Antagonists|hormone antagonists|mesh-ancestor
6501511|NCT00648154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6501512|NCT00648154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501513|NCT00648180|Doxycycline|doxycycline|mesh-list
6501514|NCT00648180|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6501515|NCT00648180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6501516|NCT00648180|Antimalarials|antimalarials|mesh-ancestor
6501517|NCT00648180|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5709896|NCT03283020|Sensory System Agents|sensory system agents|mesh-ancestor
5709897|NCT03283020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5709898|NCT03283020|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5709899|NCT03283020|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5709900|NCT03283007|Nintedanib|nintedanib|mesh-list
5709901|NCT03283007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5709902|NCT03283007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5709903|NCT03283007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5709904|NCT03283007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5709905|NCT03282838|Celecoxib|celecoxib|mesh-list
5709906|NCT03282838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5709907|NCT03282838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5709908|NCT03282838|Analgesics|analgesics|mesh-ancestor
5709909|NCT03282838|Sensory System Agents|sensory system agents|mesh-ancestor
6234028|NCT02553928|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6234029|NCT02554279|Menotropins|menotropins|mesh-list
6234030|NCT02554279|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5709910|NCT03282838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5709911|NCT03282838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709912|NCT03282838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5709913|NCT03282838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5709914|NCT03282838|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5709915|NCT03282838|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5709916|NCT03282838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5709917|NCT03282838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5709918|NCT03282825|Paclitaxel|paclitaxel|mesh-list
5709919|NCT03282825|Decitabine|decitabine|mesh-list
5709920|NCT03282825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5709921|NCT03282825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5709922|NCT03282825|Tubulin Modulators|tubulin modulators|mesh-ancestor
5709923|NCT03282825|Antimitotic Agents|antimitotic agents|mesh-ancestor
6234031|NCT02554279|Fertility Agents|fertility agents|mesh-ancestor
6234032|NCT02554279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6234033|NCT02554279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234034|NCT02554721|Aspirin|aspirin|mesh-list
6234035|NCT02554721|Cilostazol|cilostazol|mesh-list
6234036|NCT02554721|Clopidogrel|clopidogrel|mesh-list
6234037|NCT02554721|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6234038|NCT02554721|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6234039|NCT02554721|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6234040|NCT02554721|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6234041|NCT02554721|Purinergic Agents|purinergic agents|mesh-ancestor
6234042|NCT02554721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6234043|NCT02554721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234044|NCT02554721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234045|NCT02554721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6234046|NCT02554721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5709924|NCT03282825|Mitosis Modulators|mitosis modulators|mesh-ancestor
6234047|NCT02554721|Analgesics|analgesics|mesh-ancestor
6234048|NCT02554721|Sensory System Agents|sensory system agents|mesh-ancestor
6501518|NCT00648180|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6501519|NCT00648193|Paroxetine|paroxetine|mesh-list
6501520|NCT00648193|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6501521|NCT00648193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6501522|NCT00648193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6501523|NCT00648193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677038|NCT01584934|Anesthetics, General|anesthetics, general|mesh-ancestor
6677039|NCT01584934|Anesthetics|anesthetics|mesh-ancestor
6677040|NCT01584934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6677041|NCT01584934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677042|NCT01584947|Bupivacaine|bupivacaine|mesh-list
6677043|NCT01584947|Anesthetics, Local|anesthetics, local|mesh-ancestor
6677044|NCT01584947|Anesthetics|anesthetics|mesh-ancestor
6677045|NCT01584947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6677046|NCT01584947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677047|NCT01584947|Sensory System Agents|sensory system agents|mesh-ancestor
6677048|NCT01584947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6677049|NCT01585051|Vitamin D|vitamin d|mesh-list
6677050|NCT01585051|Vitamins|vitamins|mesh-ancestor
6677051|NCT01585051|Micronutrients|micronutrients|mesh-ancestor
6677052|NCT01585051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677053|NCT01585051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6779680|NCT02180425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6779681|NCT02180425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6779682|NCT02180425|Keratolytic Agents|keratolytic agents|mesh-ancestor
6779683|NCT02180503|Linagliptin|linagliptin|mesh-list
5709925|NCT03282825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5709926|NCT03282825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5709927|NCT03282825|Antimetabolites|antimetabolites|mesh-ancestor
6234049|NCT02554721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6234050|NCT02554721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6234051|NCT02554721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6234052|NCT02554721|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6234053|NCT02554721|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6234054|NCT02554721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6234055|NCT02554721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6234056|NCT02554721|Antipyretics|antipyretics|mesh-ancestor
6234057|NCT02554721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6234058|NCT02554721|Autonomic Agents|autonomic agents|mesh-ancestor
6234059|NCT02554721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6234060|NCT02554721|Respiratory System Agents|respiratory system agents|mesh-ancestor
6234061|NCT02554721|Vasodilator Agents|vasodilator agents|mesh-ancestor
6234062|NCT02554721|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6234063|NCT02554721|Protective Agents|protective agents|mesh-ancestor
6234064|NCT02554721|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6234065|NCT02554721|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6234066|NCT02554786|Fluticasone|fluticasone|mesh-list
6234067|NCT02554786|Xhance|xhance|mesh-list
6234068|NCT02554786|Mometasone Furoate|mometasone furoate|mesh-list
6234069|NCT02554786|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6234070|NCT02554786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5709928|NCT03282825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5709929|NCT03282799|Etonogestrel|etonogestrel|mesh-list
5709930|NCT03282799|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5709931|NCT03282799|Contraceptive Agents|contraceptive agents|mesh-ancestor
5709932|NCT03282799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6234071|NCT02554786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6234072|NCT02554786|Autonomic Agents|autonomic agents|mesh-ancestor
6234073|NCT02554786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6234074|NCT02554786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234075|NCT02554786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6234076|NCT02554786|Respiratory System Agents|respiratory system agents|mesh-ancestor
6234077|NCT02554786|Dermatologic Agents|dermatologic agents|mesh-ancestor
6234078|NCT02554786|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6234079|NCT02554786|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6234080|NCT02554786|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6234081|NCT02554786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6234082|NCT02554786|Adrenergic Agents|adrenergic agents|mesh-ancestor
6501524|NCT00648193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6501525|NCT00648193|Serotonin Agents|serotonin agents|mesh-ancestor
6501526|NCT00648193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501527|NCT00648193|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6779684|NCT02180503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6779685|NCT02180503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234083|NCT02554786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6234084|NCT02554786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234085|NCT02554890|Valsartan|valsartan|mesh-list
6234086|NCT02554890|Enalapril|enalapril|mesh-list
6234087|NCT02554890|Enalaprilat|enalaprilat|mesh-list
6234088|NCT02554890|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
6234089|NCT02554890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6234090|NCT02554890|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6234091|NCT02554890|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6234092|NCT02554890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234093|NCT02554890|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6234094|NCT02554890|Protease Inhibitors|protease inhibitors|mesh-ancestor
6234095|NCT02554890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6234096|NCT02554903|Macitentan|macitentan|mesh-list
6234097|NCT02554903|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
6234098|NCT02554903|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6234099|NCT02554903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501528|NCT00648193|Antidepressive Agents|antidepressive agents|mesh-ancestor
6501529|NCT00648193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6501530|NCT00648193|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6501531|NCT00648193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6501532|NCT00648193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6501533|NCT00648219|Olmesartan|olmesartan|mesh-list
6501534|NCT00648219|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6501535|NCT00648219|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6501536|NCT00648219|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6501537|NCT00648219|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6501538|NCT00648219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501539|NCT00648245|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6501540|NCT00648258|Naproxen|naproxen|mesh-list
6501541|NCT00648258|Valdecoxib|valdecoxib|mesh-list
6234100|NCT02554903|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
6234101|NCT02554981|Cyclosporine|cyclosporine|mesh-list
6234102|NCT02554981|Cyclosporins|cyclosporins|mesh-list
6234103|NCT02554981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6234104|NCT02554981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234105|NCT02554981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6234106|NCT02554981|Immunologic Factors|immunologic factors|mesh-ancestor
6501542|NCT00648258|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6501543|NCT00648258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6501544|NCT00648258|Analgesics|analgesics|mesh-ancestor
6501545|NCT00648258|Sensory System Agents|sensory system agents|mesh-ancestor
6501546|NCT00648258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6501547|NCT00648258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501548|NCT00648258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6501549|NCT00648258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6501550|NCT00648258|Gout Suppressants|gout suppressants|mesh-ancestor
6234107|NCT02554981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234108|NCT02554981|Antifungal Agents|antifungal agents|mesh-ancestor
6234109|NCT02554981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6234110|NCT02554981|Dermatologic Agents|dermatologic agents|mesh-ancestor
6234111|NCT02554981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6234112|NCT02554981|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6234113|NCT02555215|Dimethyl Fumarate|dimethyl fumarate|mesh-list
6234114|NCT02555215|Dermatologic Agents|dermatologic agents|mesh-ancestor
6234115|NCT02555215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6234116|NCT02555215|Immunologic Factors|immunologic factors|mesh-ancestor
6234117|NCT02555215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243789|NCT02680314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6243790|NCT02680314|Dermatologic Agents|dermatologic agents|mesh-ancestor
6243791|NCT02680314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6243792|NCT02680314|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6243793|NCT02680314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6243794|NCT02680314|Immunologic Factors|immunologic factors|mesh-ancestor
6243795|NCT02680314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6243796|NCT02680314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6243797|NCT02680314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6243798|NCT02680314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6243799|NCT02680314|Oxytocics|oxytocics|mesh-ancestor
6243800|NCT02680457|Insulin|insulin|mesh-list
6243801|NCT02680457|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6243802|NCT02680457|Insulin Glargine|insulin glargine|mesh-list
6501551|NCT00648258|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6501552|NCT00648258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6234118|NCT02555228|Simethicone|simethicone|mesh-list
6234119|NCT02555228|Antifoaming Agents|antifoaming agents|mesh-ancestor
6234120|NCT02555228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234121|NCT02555228|Emollients|emollients|mesh-ancestor
6234122|NCT02555228|Dermatologic Agents|dermatologic agents|mesh-ancestor
6234123|NCT02555683|Indoleacetic Acids|indoleacetic acids|mesh-list
6234124|NCT02555683|Plant Growth Regulators|plant growth regulators|mesh-ancestor
6234125|NCT02555683|Growth Substances|growth substances|mesh-ancestor
6234126|NCT02555683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234127|NCT02555878|Rivaroxaban|rivaroxaban|mesh-list
6234128|NCT02555878|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6234129|NCT02555878|Antithrombins|antithrombins|mesh-ancestor
6234130|NCT02555878|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6234131|NCT02555878|Protease Inhibitors|protease inhibitors|mesh-ancestor
6234132|NCT02555878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6234133|NCT02555878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234134|NCT02555878|Anticoagulants|anticoagulants|mesh-ancestor
6234135|NCT02556203|Aspirin|aspirin|mesh-list
6234136|NCT02556203|Vitamin K|vitamin k|mesh-list
6234137|NCT02556203|Rivaroxaban|rivaroxaban|mesh-list
6234138|NCT02556203|Clopidogrel|clopidogrel|mesh-list
6234139|NCT02556203|Vitamins|vitamins|mesh-ancestor
6234140|NCT02556203|Micronutrients|micronutrients|mesh-ancestor
6234141|NCT02556203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234142|NCT02556203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6234143|NCT02556203|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6234144|NCT02556203|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6234145|NCT02556203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6234146|NCT02556203|Purinergic Agents|purinergic agents|mesh-ancestor
6234147|NCT02556203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6234148|NCT02556203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234149|NCT02556203|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6234150|NCT02556203|Antithrombins|antithrombins|mesh-ancestor
6234151|NCT02556203|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6234152|NCT02556203|Protease Inhibitors|protease inhibitors|mesh-ancestor
6234153|NCT02556203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6234154|NCT02556203|Anticoagulants|anticoagulants|mesh-ancestor
6234155|NCT02556203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6234156|NCT02556203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6234157|NCT02556203|Analgesics|analgesics|mesh-ancestor
6234158|NCT02556203|Sensory System Agents|sensory system agents|mesh-ancestor
6234159|NCT02556203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6234160|NCT02556203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6234161|NCT02556203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5709933|NCT03282799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709934|NCT03282799|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5709935|NCT03282669|Morphine|morphine|mesh-list
6234162|NCT02556203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6234163|NCT02556203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6234164|NCT02556203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6234165|NCT02556203|Antipyretics|antipyretics|mesh-ancestor
6234166|NCT02556203|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6234167|NCT02556203|Hemostatics|hemostatics|mesh-ancestor
5709936|NCT03282669|Hydromorphone|hydromorphone|mesh-list
5709937|NCT03282669|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5709938|NCT03282669|Narcotics|narcotics|mesh-ancestor
5709939|NCT03282669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5709940|NCT03282669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709941|NCT03282669|Analgesics|analgesics|mesh-ancestor
5709942|NCT03282669|Sensory System Agents|sensory system agents|mesh-ancestor
5709943|NCT03282669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5709944|NCT03282643|Heparin|heparin|mesh-list
5709945|NCT03282643|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5709946|NCT03282643|Tinzaparin|tinzaparin|mesh-list
5709947|NCT03282643|Dalteparin|dalteparin|mesh-list
5709948|NCT03282643|Rivaroxaban|rivaroxaban|mesh-list
5709949|NCT03282643|Anticoagulants|anticoagulants|mesh-ancestor
5709950|NCT03282643|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5709951|NCT03282643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5709952|NCT03282643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5709953|NCT03282643|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5709954|NCT03282643|Antithrombins|antithrombins|mesh-ancestor
5709955|NCT03282643|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6234168|NCT02556203|Coagulants|coagulants|mesh-ancestor
5709956|NCT03282643|Protease Inhibitors|protease inhibitors|mesh-ancestor
5709957|NCT03282643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5709958|NCT03282513|Ivosidenib|ivosidenib|mesh-list
5709959|NCT03282513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6234169|NCT02556307|Ribavirin|ribavirin|mesh-list
5709960|NCT03282513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5709961|NCT03282513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5709962|NCT03282487|Hydrocortisone|hydrocortisone|mesh-list
5709963|NCT03282487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5709964|NCT03282474|Sofosbuvir|sofosbuvir|mesh-list
6234170|NCT02556307|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6234171|NCT02556307|Antimetabolites|antimetabolites|mesh-ancestor
6234172|NCT02556307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234173|NCT02556307|Antiviral Agents|antiviral agents|mesh-ancestor
6234174|NCT02556307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6234175|NCT02556333|Tenofovir|tenofovir|mesh-list
6234176|NCT02556333|Emtricitabine|emtricitabine|mesh-list
6234177|NCT02556333|Antiviral Agents|antiviral agents|mesh-ancestor
6234178|NCT02556333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5709965|NCT03282474|Antiviral Agents|antiviral agents|mesh-ancestor
5709966|NCT03282474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5721560|NCT03204331|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5721561|NCT03204331|Androgen Antagonists|androgen antagonists|mesh-ancestor
5721562|NCT03204331|Hormone Antagonists|hormone antagonists|mesh-ancestor
5721563|NCT03204578|Midazolam|midazolam|mesh-list
6234179|NCT02556333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6234180|NCT02556333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6234181|NCT02556333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6234182|NCT02556333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234183|NCT02556333|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6234184|NCT02556333|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6234185|NCT02556632|Curcumin|curcumin|mesh-list
6234186|NCT02556632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6234187|NCT02556632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6234188|NCT02556632|Analgesics|analgesics|mesh-ancestor
6234189|NCT02556632|Sensory System Agents|sensory system agents|mesh-ancestor
6234190|NCT02556632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6234191|NCT02556632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234192|NCT02556632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6234193|NCT02556632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6234194|NCT02556632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6234195|NCT02556632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6234196|NCT02556632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234197|NCT02556775|Immunoglobulins|immunoglobulins|mesh-list
6234198|NCT02556775|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6234199|NCT02556775|Antibodies|antibodies|mesh-list
6234200|NCT02556775|gamma-Globulins|gamma-globulins|mesh-list
6234201|NCT02556775|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6234202|NCT02556775|Immunologic Factors|immunologic factors|mesh-ancestor
6234203|NCT02556775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234204|NCT02556788|Trifarotene|trifarotene|mesh-list
6234205|NCT02556788|Dermatologic Agents|dermatologic agents|mesh-ancestor
6234206|NCT02556918|Insulin|insulin|mesh-list
6234207|NCT02556918|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6234208|NCT02556918|Insulin Glargine|insulin glargine|mesh-list
6234209|NCT02556918|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6234210|NCT02556918|Insulin Aspart|insulin aspart|mesh-list
6234211|NCT02556918|Insulin Lispro|insulin lispro|mesh-list
6234212|NCT02556918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6234213|NCT02556918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721564|NCT03204578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5721565|NCT03204578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5721566|NCT03204578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5721567|NCT03204578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721568|NCT03204578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5721569|NCT03204578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5918937|NCT04987632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5918938|NCT04987632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918939|NCT04987463|Sirolimus|sirolimus|mesh-list
5918940|NCT04987463|Vigabatrin|vigabatrin|mesh-list
5918941|NCT04987463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5918942|NCT04987463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5918943|NCT04987463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5918944|NCT04987463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5918945|NCT04987463|Antifungal Agents|antifungal agents|mesh-ancestor
5918946|NCT04987463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5918947|NCT04987463|Immunologic Factors|immunologic factors|mesh-ancestor
5918948|NCT04987463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721570|NCT03204578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6234214|NCT02556918|Incretins|incretins|mesh-ancestor
6234215|NCT02556918|Hormones|hormones|mesh-ancestor
6234216|NCT02556918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6234217|NCT02556918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6234218|NCT02556918|Protease Inhibitors|protease inhibitors|mesh-ancestor
6234219|NCT02556918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6234220|NCT02556918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234221|NCT02557035|Dexamethasone|dexamethasone|mesh-list
6234222|NCT02557035|Palonosetron|palonosetron|mesh-list
6234223|NCT02557035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6234224|NCT02557035|Antiemetics|antiemetics|mesh-ancestor
6234225|NCT02557035|Autonomic Agents|autonomic agents|mesh-ancestor
6234226|NCT02557035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6234227|NCT02557035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234228|NCT02557035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6234229|NCT02557035|Glucocorticoids|glucocorticoids|mesh-ancestor
6234230|NCT02557035|Hormones|hormones|mesh-ancestor
6234231|NCT02557035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6234232|NCT02557035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6234233|NCT02557035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6234234|NCT02557035|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6234235|NCT02557035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6234236|NCT02557035|Serotonin Agents|serotonin agents|mesh-ancestor
6234237|NCT02557035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6234238|NCT02557035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234239|NCT02557100|Adalimumab|adalimumab|mesh-list
6234240|NCT02557100|Methotrexate|methotrexate|mesh-list
6234241|NCT02557100|Abatacept|abatacept|mesh-list
6234242|NCT02557100|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6234243|NCT02557100|Abortifacient Agents|abortifacient agents|mesh-ancestor
6234244|NCT02557100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6234245|NCT02557100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234246|NCT02557100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6234247|NCT02557100|Antimetabolites|antimetabolites|mesh-ancestor
6234248|NCT02557100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234249|NCT02557100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6234250|NCT02557100|Dermatologic Agents|dermatologic agents|mesh-ancestor
6234251|NCT02557100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6234252|NCT02557100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6234253|NCT02557100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6234254|NCT02557100|Immunologic Factors|immunologic factors|mesh-ancestor
6234255|NCT02557100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5709967|NCT03282344|Nivolumab|nivolumab|mesh-list
5709968|NCT03282344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5709969|NCT03282344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5709970|NCT03282344|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5709971|NCT03282344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5709972|NCT03282188|Sargramostim|sargramostim|mesh-list
5709973|NCT03282188|Immunologic Factors|immunologic factors|mesh-ancestor
5709974|NCT03282188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709975|NCT03282162|Oxytocin|oxytocin|mesh-list
5709976|NCT03282162|Oxytocics|oxytocics|mesh-ancestor
6234256|NCT02557100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6234257|NCT02557100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6234258|NCT02557100|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6234259|NCT02557646|Ribavirin|ribavirin|mesh-list
6234260|NCT02557646|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6234261|NCT02557646|Antimetabolites|antimetabolites|mesh-ancestor
6234262|NCT02557646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234263|NCT02557646|Antiviral Agents|antiviral agents|mesh-ancestor
6234264|NCT02557646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6234265|NCT02558231|Selexipag|selexipag|mesh-list
6234266|NCT02558231|Tadalafil|tadalafil|mesh-list
6234267|NCT02558231|Macitentan|macitentan|mesh-list
6234268|NCT02558231|Vasodilator Agents|vasodilator agents|mesh-ancestor
6234269|NCT02558231|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6234270|NCT02558231|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5709977|NCT03282162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5709978|NCT03282162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709979|NCT03282136|Incretins|incretins|mesh-list
5709980|NCT03282136|Hormones|hormones|mesh-ancestor
5709981|NCT03282136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5709982|NCT03282136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709983|NCT03282110|Citalopram|citalopram|mesh-list
5709984|NCT03282110|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6234271|NCT02558231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6234272|NCT02558231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234273|NCT02558231|Urological Agents|urological agents|mesh-ancestor
5709985|NCT03282110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5709986|NCT03282110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5709987|NCT03282110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5709988|NCT03282110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5709989|NCT03282110|Serotonin Agents|serotonin agents|mesh-ancestor
6234274|NCT02558231|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
6234275|NCT02558231|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6234276|NCT02558231|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
6234277|NCT02558231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6234278|NCT02558296|Bexagliflozin|bexagliflozin|mesh-list
6234279|NCT02558296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6234280|NCT02558296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234281|NCT02558374|Timolol|timolol|mesh-list
6234282|NCT02558374|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6234283|NCT02558374|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6234284|NCT02558374|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6234285|NCT02558374|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6501553|NCT00648258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501554|NCT00648258|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6501555|NCT00648271|Metoprolol|metoprolol|mesh-list
6501556|NCT00648271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6501557|NCT00648271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6234286|NCT02558374|Adrenergic Agents|adrenergic agents|mesh-ancestor
6234287|NCT02558374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6234288|NCT02558374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234289|NCT02558374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234290|NCT02558374|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6234291|NCT02558374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5709990|NCT03282110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5709991|NCT03282110|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5709992|NCT03282110|Antidepressive Agents|antidepressive agents|mesh-ancestor
5709993|NCT03282110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5709994|NCT03282006|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
5918949|NCT04987463|Anticonvulsants|anticonvulsants|mesh-ancestor
5918950|NCT04987463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5918951|NCT04987463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918952|NCT04987463|GABA Agents|gaba agents|mesh-ancestor
5918953|NCT04987463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5918954|NCT04987450|Prednisone|prednisone|mesh-list
5918955|NCT04987450|Methylprednisolone|methylprednisolone|mesh-list
5918956|NCT04987450|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5918957|NCT04987450|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5918958|NCT04987450|Prednisolone|prednisolone|mesh-list
5918959|NCT04987450|Prednisolone acetate|prednisolone acetate|mesh-list
5918960|NCT04987450|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5918961|NCT04987450|Prednisolone phosphate|prednisolone phosphate|mesh-list
5918962|NCT04987450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5918963|NCT04987450|Glucocorticoids|glucocorticoids|mesh-ancestor
5918964|NCT04987450|Hormones|hormones|mesh-ancestor
5918965|NCT04987450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5918966|NCT04987450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918967|NCT04987450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6234292|NCT02558400|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6234293|NCT02558400|Latanoprost|latanoprost|mesh-list
5709995|NCT03282006|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5709996|NCT03282006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5709997|NCT03282006|Renal Agents|renal agents|mesh-ancestor
5709998|NCT03282006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5709999|NCT03281954|Atezolizumab|atezolizumab|mesh-list
5710000|NCT03281954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5710001|NCT03281941|Capsaicin|capsaicin|mesh-list
5710002|NCT03281941|Antipruritics|antipruritics|mesh-ancestor
5710003|NCT03281941|Dermatologic Agents|dermatologic agents|mesh-ancestor
5710004|NCT03281941|Sensory System Agents|sensory system agents|mesh-ancestor
5710005|NCT03281941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5710006|NCT03281941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710007|NCT03281928|Potassium Citrate|potassium citrate|mesh-list
5710008|NCT03281928|Diuretics|diuretics|mesh-ancestor
6234294|NCT02558400|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6234295|NCT02558829|Insulin|insulin|mesh-list
6501558|NCT00648271|Sympatholytics|sympatholytics|mesh-ancestor
6501559|NCT00648271|Autonomic Agents|autonomic agents|mesh-ancestor
6501560|NCT00648271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5918968|NCT04987450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5918969|NCT04987450|Antiemetics|antiemetics|mesh-ancestor
6501561|NCT00648271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501562|NCT00648271|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6501563|NCT00648271|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6234296|NCT02558829|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6234297|NCT02558829|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6501564|NCT00648271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6501565|NCT00648271|Adrenergic Agents|adrenergic agents|mesh-ancestor
6501566|NCT00648271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6501567|NCT00648271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501568|NCT00648297|Nadolol|nadolol|mesh-list
6234298|NCT02558829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234299|NCT02558894|Durvalumab|durvalumab|mesh-list
6234300|NCT02558894|Tremelimumab|tremelimumab|mesh-list
6234301|NCT02558894|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6234302|NCT02558894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6234303|NCT02558894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6234304|NCT02558894|Immunologic Factors|immunologic factors|mesh-ancestor
6234305|NCT02558894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234306|NCT02559206|Linaclotide|linaclotide|mesh-list
6234307|NCT02559206|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
6234308|NCT02559206|Enzyme Activators|enzyme activators|mesh-ancestor
6234309|NCT02559206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234310|NCT02559206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6234311|NCT02559310|Moxifloxacin|moxifloxacin|mesh-list
6234312|NCT02559310|Linezolid|linezolid|mesh-list
6234313|NCT02559310|Lefamulin|lefamulin|mesh-list
6234314|NCT02559310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6234315|NCT02559310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6234316|NCT02559310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6234317|NCT02559310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6234318|NCT02559310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6234319|NCT02559310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234320|NCT02559310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6234321|NCT02559310|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6234322|NCT02559414|Aspirin|aspirin|mesh-list
6234323|NCT02559414|Clopidogrel|clopidogrel|mesh-list
6234324|NCT02559414|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6234325|NCT02559414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6234326|NCT02559414|Analgesics|analgesics|mesh-ancestor
6234327|NCT02559414|Sensory System Agents|sensory system agents|mesh-ancestor
6234328|NCT02559414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6234329|NCT02559414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234330|NCT02559414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6234331|NCT02559414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6234332|NCT02559414|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6234333|NCT02559414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6234334|NCT02559414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234335|NCT02559414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6234336|NCT02559414|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6234337|NCT02559414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6234338|NCT02559414|Antipyretics|antipyretics|mesh-ancestor
6234339|NCT02559414|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5710009|NCT03281928|Natriuretic Agents|natriuretic agents|mesh-ancestor
5710010|NCT03281928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710011|NCT03281928|Expectorants|expectorants|mesh-ancestor
5710012|NCT03281928|Respiratory System Agents|respiratory system agents|mesh-ancestor
5710013|NCT03281863|Antibodies|antibodies|mesh-list
5710014|NCT03281863|Antistreptolysin|antistreptolysin|mesh-list
5710015|NCT03281863|Immunologic Factors|immunologic factors|mesh-ancestor
5710016|NCT03281863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710017|NCT03281811|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5710018|NCT03281811|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5710019|NCT03281811|Dermatologic Agents|dermatologic agents|mesh-ancestor
5710020|NCT03281694|Nicotine|nicotine|mesh-list
5710021|NCT03281694|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5710022|NCT03281694|Autonomic Agents|autonomic agents|mesh-ancestor
5710023|NCT03281694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5710024|NCT03281694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710025|NCT03281694|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5710026|NCT03281694|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5918970|NCT04987450|Autonomic Agents|autonomic agents|mesh-ancestor
5918971|NCT04987450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6234340|NCT02559414|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5710027|NCT03281694|Cholinergic Agents|cholinergic agents|mesh-ancestor
5710028|NCT03281694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6234341|NCT02559414|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6234342|NCT02559414|Purinergic Agents|purinergic agents|mesh-ancestor
6234343|NCT02559414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6234344|NCT02559505|Vaccines|vaccines|mesh-list
6234345|NCT02559505|Immunologic Factors|immunologic factors|mesh-ancestor
6234346|NCT02559505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234347|NCT02559570|Linaclotide|linaclotide|mesh-list
6234348|NCT02559570|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
6234349|NCT02559570|Enzyme Activators|enzyme activators|mesh-ancestor
6234350|NCT02559570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234351|NCT02559570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6234352|NCT02559622|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6234353|NCT02559622|Immunologic Factors|immunologic factors|mesh-ancestor
5710029|NCT03281694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710030|NCT03281681|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
5710031|NCT03281681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6234354|NCT02559622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234355|NCT02559687|Pembrolizumab|pembrolizumab|mesh-list
6234356|NCT02559687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6234357|NCT02559687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6234358|NCT02559713|Vedolizumab|vedolizumab|mesh-list
6234359|NCT02559713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6234360|NCT02559817|Linaclotide|linaclotide|mesh-list
6234361|NCT02559817|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
6234362|NCT02559817|Enzyme Activators|enzyme activators|mesh-ancestor
6234363|NCT02559817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234364|NCT02559817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6234365|NCT02560012|Sirolimus|sirolimus|mesh-list
6234366|NCT02560012|Everolimus|everolimus|mesh-list
6234367|NCT02560012|Sorafenib|sorafenib|mesh-list
6234368|NCT02560012|Sunitinib|sunitinib|mesh-list
6234369|NCT02560012|Axitinib|axitinib|mesh-list
6234370|NCT02560012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6234371|NCT02560012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6234372|NCT02560012|Immunologic Factors|immunologic factors|mesh-ancestor
6234373|NCT02560012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234374|NCT02560012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6234375|NCT02560012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6234376|NCT02560012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234377|NCT02560012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6234378|NCT02560012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6234379|NCT02560012|Growth Substances|growth substances|mesh-ancestor
6234380|NCT02560012|Growth Inhibitors|growth inhibitors|mesh-ancestor
6234381|NCT02560012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6234382|NCT02560012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6234383|NCT02560012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6234384|NCT02560012|Antifungal Agents|antifungal agents|mesh-ancestor
6234385|NCT02560025|Cytarabine|cytarabine|mesh-list
6234386|NCT02560025|Daunorubicin|daunorubicin|mesh-list
6234387|NCT02560025|Idarubicin|idarubicin|mesh-list
6501569|NCT00648297|Bendroflumethiazide|bendroflumethiazide|mesh-list
6501570|NCT00648297|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6501571|NCT00648297|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6501572|NCT00648297|Adrenergic Agents|adrenergic agents|mesh-ancestor
5710032|NCT03281681|Alkylating Agents|alkylating agents|mesh-ancestor
5710033|NCT03281681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710034|NCT03281681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5710035|NCT03281187|Methyltestosterone|methyltestosterone|mesh-list
5710036|NCT03281187|Testosterone|testosterone|mesh-list
5710037|NCT03281187|Testosterone undecanoate|testosterone undecanoate|mesh-list
5710038|NCT03281187|Testosterone enanthate|testosterone enanthate|mesh-list
5710039|NCT03281187|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5710040|NCT03281187|Androgens|androgens|mesh-ancestor
5710041|NCT03281187|Hormones|hormones|mesh-ancestor
5710042|NCT03281187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5710043|NCT03281187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501573|NCT00648297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6501574|NCT00648297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501575|NCT00648297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501576|NCT00648297|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6501577|NCT00648297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6234388|NCT02560025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6234389|NCT02560025|Antimetabolites|antimetabolites|mesh-ancestor
6234390|NCT02560025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501578|NCT00648297|Sympatholytics|sympatholytics|mesh-ancestor
6501579|NCT00648297|Autonomic Agents|autonomic agents|mesh-ancestor
6501580|NCT00648297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6501581|NCT00648297|Diuretics|diuretics|mesh-ancestor
6501582|NCT00648297|Natriuretic Agents|natriuretic agents|mesh-ancestor
6501583|NCT00648297|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6501584|NCT00648297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6501585|NCT00648310|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6501586|NCT00648310|Estrogens|estrogens|mesh-list
6234391|NCT02560025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6234392|NCT02560025|Antiviral Agents|antiviral agents|mesh-ancestor
6234393|NCT02560025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6234394|NCT02560025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6234395|NCT02560025|Immunologic Factors|immunologic factors|mesh-ancestor
6234396|NCT02560025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234397|NCT02560025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6234398|NCT02560025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6234399|NCT02560025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6234400|NCT02560025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6234401|NCT02560038|Gemcitabine|gemcitabine|mesh-list
6234402|NCT02560038|Paclitaxel|paclitaxel|mesh-list
6234403|NCT02560038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6234404|NCT02560038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6234405|NCT02560038|Tubulin Modulators|tubulin modulators|mesh-ancestor
6234406|NCT02560038|Antimitotic Agents|antimitotic agents|mesh-ancestor
6234407|NCT02560038|Mitosis Modulators|mitosis modulators|mesh-ancestor
6234408|NCT02560038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234409|NCT02560038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6234410|NCT02560038|Antimetabolites|antimetabolites|mesh-ancestor
6234411|NCT02560038|Antiviral Agents|antiviral agents|mesh-ancestor
6234412|NCT02560038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6234413|NCT02560038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6234414|NCT02560038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6234415|NCT02560038|Immunologic Factors|immunologic factors|mesh-ancestor
6234416|NCT02560038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234417|NCT02560051|Ketoconazole|ketoconazole|mesh-list
6234418|NCT02560051|Docetaxel|docetaxel|mesh-list
6234419|NCT02560051|Doxorubicin|doxorubicin|mesh-list
6234420|NCT02560051|Estramustine|estramustine|mesh-list
6501587|NCT00648310|Hormones|hormones|mesh-ancestor
6501588|NCT00648310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6501589|NCT00648310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710044|NCT03281187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5710045|NCT03281187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5710046|NCT03281187|Anabolic Agents|anabolic agents|mesh-ancestor
5710047|NCT03280927|Efinaconazole|efinaconazole|mesh-list
5710048|NCT03280927|Antifungal Agents|antifungal agents|mesh-ancestor
5710049|NCT03280927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5710050|NCT03280849|Chitosan|chitosan|mesh-list
5710051|NCT03280849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5710052|NCT03280849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5710053|NCT03280849|Antimetabolites|antimetabolites|mesh-ancestor
5721571|NCT03204578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6234421|NCT02560051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6234422|NCT02560051|Tubulin Modulators|tubulin modulators|mesh-ancestor
6234423|NCT02560051|Antimitotic Agents|antimitotic agents|mesh-ancestor
6234424|NCT02560051|Mitosis Modulators|mitosis modulators|mesh-ancestor
6234425|NCT02560051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234426|NCT02560051|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6234427|NCT02560051|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6234428|NCT02560051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6234429|NCT02560051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6234430|NCT02560051|Antifungal Agents|antifungal agents|mesh-ancestor
6234431|NCT02560051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6234432|NCT02560051|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6234433|NCT02560051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6234434|NCT02560051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6234435|NCT02560051|Hormone Antagonists|hormone antagonists|mesh-ancestor
6234436|NCT02560051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6234437|NCT02560051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234438|NCT02560051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6234439|NCT02560051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6234440|NCT02560051|Alkylating Agents|alkylating agents|mesh-ancestor
6234441|NCT02560051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6234442|NCT02560389|Levodopa|levodopa|mesh-list
6501590|NCT00648310|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6501591|NCT00648310|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6501592|NCT00648310|Cholinergic Agents|cholinergic agents|mesh-ancestor
6501593|NCT00648310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6501594|NCT00648310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501595|NCT00648310|Urological Agents|urological agents|mesh-ancestor
6501596|NCT00648323|Doxazosin|doxazosin|mesh-list
6501597|NCT00648323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6501598|NCT00648323|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6501599|NCT00648323|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6501600|NCT00648323|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6501601|NCT00648323|Adrenergic Agents|adrenergic agents|mesh-ancestor
6501602|NCT00648323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6501603|NCT00648323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501604|NCT00648323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501605|NCT00648336|Mercaptopurine|mercaptopurine|mesh-list
6501606|NCT00648336|Antimetabolites|antimetabolites|mesh-ancestor
6677054|NCT01585350|Freund's Adjuvant|freund's adjuvant|mesh-list
6677055|NCT01585350|Poly ICLC|poly iclc|mesh-list
6234443|NCT02560389|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6234444|NCT02560389|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6234445|NCT02560389|Dopamine Agents|dopamine agents|mesh-ancestor
6234446|NCT02560389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6234447|NCT02560389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234448|NCT02560389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234449|NCT02560558|Abatacept|abatacept|mesh-list
6234450|NCT02560558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6234451|NCT02560558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234452|NCT02560558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6234453|NCT02560558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6234454|NCT02560558|Immunologic Factors|immunologic factors|mesh-ancestor
6234455|NCT02560558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234456|NCT02560558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6234457|NCT02560584|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6234458|NCT02560584|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6234459|NCT02560584|Dermatologic Agents|dermatologic agents|mesh-ancestor
6234460|NCT02560779|Sorafenib|sorafenib|mesh-list
6234461|NCT02560779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6234462|NCT02560779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5710054|NCT03280849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710055|NCT03280849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5710056|NCT03280849|Chelating Agents|chelating agents|mesh-ancestor
5710057|NCT03280849|Sequestering Agents|sequestering agents|mesh-ancestor
5710058|NCT03280849|Hemostatics|hemostatics|mesh-ancestor
5710059|NCT03280849|Coagulants|coagulants|mesh-ancestor
5721572|NCT03204578|Anesthetics, General|anesthetics, general|mesh-ancestor
5721573|NCT03204578|Anesthetics|anesthetics|mesh-ancestor
5721574|NCT03204578|GABA Modulators|gaba modulators|mesh-ancestor
5721575|NCT03204578|GABA Agents|gaba agents|mesh-ancestor
5721576|NCT03204578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5721577|NCT03204578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721578|NCT03204474|Lacosamide|lacosamide|mesh-list
5721579|NCT03204474|Anticonvulsants|anticonvulsants|mesh-ancestor
5721580|NCT03204474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5721581|NCT03204474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5721582|NCT03204474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5721583|NCT03204474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234463|NCT02560779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6234464|NCT02560779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234465|NCT02561078|Insulin|insulin|mesh-list
6234466|NCT02561078|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6234467|NCT02561078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6234468|NCT02561078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234469|NCT02561130|Metformin|metformin|mesh-list
6234470|NCT02561130|Insulin Glargine|insulin glargine|mesh-list
6234471|NCT02561130|Dapagliflozin|dapagliflozin|mesh-list
6234472|NCT02561130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6234473|NCT02561130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234474|NCT02561130|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6677056|NCT01585350|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6677057|NCT01585350|Immunologic Factors|immunologic factors|mesh-ancestor
5721584|NCT03204565|Hyaluronic Acid|hyaluronic acid|mesh-list
6234475|NCT02561130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234476|NCT02561273|Prednisone|prednisone|mesh-list
6234477|NCT02561273|Cortisone|cortisone|mesh-list
6677058|NCT01585350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234478|NCT02561273|Cyclophosphamide|cyclophosphamide|mesh-list
6234479|NCT02561273|Doxorubicin|doxorubicin|mesh-list
6234480|NCT02561273|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6234481|NCT02561273|Etoposide|etoposide|mesh-list
6234482|NCT02561273|Vincristine|vincristine|mesh-list
6234483|NCT02561273|Lenalidomide|lenalidomide|mesh-list
6501607|NCT00648336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501608|NCT00648336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6501609|NCT00648336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6234484|NCT02561273|Etoposide phosphate|etoposide phosphate|mesh-list
6234485|NCT02561273|Podophyllotoxin|podophyllotoxin|mesh-list
6234486|NCT02561273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6234487|NCT02561273|Immunologic Factors|immunologic factors|mesh-ancestor
6234488|NCT02561273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234489|NCT02561273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6234490|NCT02561273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6234491|NCT02561273|Alkylating Agents|alkylating agents|mesh-ancestor
6234492|NCT02561273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234493|NCT02561273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6234494|NCT02561273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6234495|NCT02561273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6234496|NCT02561273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6234497|NCT02561273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6234498|NCT02561273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6234499|NCT02561273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6234500|NCT02561273|Glucocorticoids|glucocorticoids|mesh-ancestor
6234501|NCT02561273|Hormones|hormones|mesh-ancestor
6234502|NCT02561273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6234503|NCT02561273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6234504|NCT02561273|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6234505|NCT02561273|Tubulin Modulators|tubulin modulators|mesh-ancestor
6234506|NCT02561273|Antimitotic Agents|antimitotic agents|mesh-ancestor
6234507|NCT02561273|Mitosis Modulators|mitosis modulators|mesh-ancestor
6234508|NCT02561273|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6234509|NCT02561273|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6234510|NCT02561273|Growth Substances|growth substances|mesh-ancestor
6234511|NCT02561273|Growth Inhibitors|growth inhibitors|mesh-ancestor
6234512|NCT02561273|Keratolytic Agents|keratolytic agents|mesh-ancestor
6234513|NCT02561273|Dermatologic Agents|dermatologic agents|mesh-ancestor
6234514|NCT02561481|Sulforaphane|sulforaphane|mesh-list
6234515|NCT02561481|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6234516|NCT02561481|Protective Agents|protective agents|mesh-ancestor
6234517|NCT02561481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234518|NCT02561481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6234519|NCT02561702|Mexiletine|mexiletine|mesh-list
6234520|NCT02561702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6234521|NCT02561702|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6234522|NCT02561702|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6234523|NCT02561702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6234524|NCT02561702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234525|NCT02561806|Ustekinumab|ustekinumab|mesh-list
6234526|NCT02561806|Ixekizumab|ixekizumab|mesh-list
6234527|NCT02561806|Dermatologic Agents|dermatologic agents|mesh-ancestor
6234528|NCT02561832|Cyclophosphamide|cyclophosphamide|mesh-list
6234529|NCT02561832|Carboplatin|carboplatin|mesh-list
6234530|NCT02561832|Olaparib|olaparib|mesh-list
6234531|NCT02561832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6234532|NCT02561832|Immunologic Factors|immunologic factors|mesh-ancestor
6234533|NCT02561832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234534|NCT02561832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6234535|NCT02561832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6234536|NCT02561832|Alkylating Agents|alkylating agents|mesh-ancestor
6234537|NCT02561832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234538|NCT02561832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6234539|NCT02561832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6234540|NCT02561832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5710060|NCT03280667|Denosumab|denosumab|mesh-list
5710061|NCT03280667|Pembrolizumab|pembrolizumab|mesh-list
6234541|NCT02561832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6234542|NCT02561897|Warfarin|warfarin|mesh-list
6234543|NCT02561897|Edoxaban|edoxaban|mesh-list
6234544|NCT02561897|Anticoagulants|anticoagulants|mesh-ancestor
6234545|NCT02561897|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5710062|NCT03280667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6234546|NCT02561897|Antithrombins|antithrombins|mesh-ancestor
6234547|NCT02561897|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6234548|NCT02561897|Protease Inhibitors|protease inhibitors|mesh-ancestor
6234549|NCT02561897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6234550|NCT02561897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234551|NCT02562066|Amifampridine|amifampridine|mesh-list
6234552|NCT02562066|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6234553|NCT02562066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6234554|NCT02562066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234555|NCT02562066|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6234556|NCT02562066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6234557|NCT02562066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234558|NCT02562521|Nicotine|nicotine|mesh-list
6234559|NCT02562521|Varenicline|varenicline|mesh-list
6234560|NCT02562521|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6234561|NCT02562521|Autonomic Agents|autonomic agents|mesh-ancestor
6234562|NCT02562521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6234563|NCT02562521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234564|NCT02562521|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6234565|NCT02562521|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6234566|NCT02562521|Cholinergic Agents|cholinergic agents|mesh-ancestor
6234567|NCT02562521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6234568|NCT02562521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234569|NCT02562755|Sorafenib|sorafenib|mesh-list
6234570|NCT02562755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6234571|NCT02562755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6234572|NCT02562755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6234573|NCT02562755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234574|NCT02562898|Gemcitabine|gemcitabine|mesh-list
6234575|NCT02562898|Paclitaxel|paclitaxel|mesh-list
6234576|NCT02562898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5710063|NCT03280667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5710064|NCT03280667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6234577|NCT02562898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6234578|NCT02562898|Tubulin Modulators|tubulin modulators|mesh-ancestor
6234579|NCT02562898|Antimitotic Agents|antimitotic agents|mesh-ancestor
6234580|NCT02562898|Mitosis Modulators|mitosis modulators|mesh-ancestor
6234581|NCT02562898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234582|NCT02562898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6234583|NCT02562898|Antimetabolites|antimetabolites|mesh-ancestor
6234584|NCT02562898|Antiviral Agents|antiviral agents|mesh-ancestor
6234585|NCT02562898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6234586|NCT02562898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6234587|NCT02562898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6234588|NCT02562898|Immunologic Factors|immunologic factors|mesh-ancestor
6234589|NCT02562898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234590|NCT02562924|Prednisone|prednisone|mesh-list
6234591|NCT02562924|Budesonide|budesonide|mesh-list
6234592|NCT02562924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6234593|NCT02562924|Glucocorticoids|glucocorticoids|mesh-ancestor
6234594|NCT02562924|Hormones|hormones|mesh-ancestor
6234595|NCT02562924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6234596|NCT02562924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234597|NCT02562924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6234598|NCT02562924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6234599|NCT02562924|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6234600|NCT02562924|Autonomic Agents|autonomic agents|mesh-ancestor
6234601|NCT02562924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6234602|NCT02562924|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6234603|NCT02562924|Respiratory System Agents|respiratory system agents|mesh-ancestor
6234604|NCT02563067|Indoleacetic Acids|indoleacetic acids|mesh-list
6234605|NCT02563067|Plant Growth Regulators|plant growth regulators|mesh-ancestor
6234606|NCT02563067|Growth Substances|growth substances|mesh-ancestor
6234607|NCT02563067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234608|NCT02563093|Vaccines|vaccines|mesh-list
6234609|NCT02563093|Immunologic Factors|immunologic factors|mesh-ancestor
6234610|NCT02563093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234611|NCT02563496|Chloroquine|chloroquine|mesh-list
6234612|NCT02563496|Tafenoquine|tafenoquine|mesh-list
6234613|NCT02563496|Amebicides|amebicides|mesh-ancestor
6234614|NCT02563496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6234615|NCT02563496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6234616|NCT02563496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6234617|NCT02563496|Antimalarials|antimalarials|mesh-ancestor
6234618|NCT02563496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6234619|NCT02563548|Pembrolizumab|pembrolizumab|mesh-list
6234620|NCT02563548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6234621|NCT02563548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6234622|NCT02563561|Apaziquone|apaziquone|mesh-list
6234623|NCT02563561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6234624|NCT02563834|Insulin|insulin|mesh-list
6234625|NCT02563834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6234626|NCT02563834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234627|NCT02563860|Lovastatin|lovastatin|mesh-list
6234628|NCT02563860|L 647318|l 647318|mesh-list
6234629|NCT02563860|Dihydromevinolin|dihydromevinolin|mesh-list
6234630|NCT02563860|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6234631|NCT02563860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6234632|NCT02563860|Antimetabolites|antimetabolites|mesh-ancestor
6234633|NCT02563860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234634|NCT02563860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6234635|NCT02563860|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6234636|NCT02563860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6243803|NCT02680457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6243804|NCT02680457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243805|NCT02680756|Ferric maltol|ferric maltol|mesh-list
6243806|NCT02680756|Hematinics|hematinics|mesh-ancestor
6243807|NCT02680847|Naltrexone|naltrexone|mesh-list
6243808|NCT02680847|Oxycodone|oxycodone|mesh-list
6243809|NCT02680847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6243810|NCT02680847|Narcotics|narcotics|mesh-ancestor
6243811|NCT02680847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5710065|NCT03280667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710066|NCT03280641|Warfarin|warfarin|mesh-list
5710067|NCT03280641|Dabigatran|dabigatran|mesh-list
6243812|NCT02680847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243813|NCT02680847|Analgesics|analgesics|mesh-ancestor
6243814|NCT02680847|Sensory System Agents|sensory system agents|mesh-ancestor
6243815|NCT02680847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6243816|NCT02680847|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6243817|NCT02680847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6243818|NCT02681094|Dapagliflozin|dapagliflozin|mesh-list
6243819|NCT02681094|Saxagliptin|saxagliptin|mesh-list
6243820|NCT02681094|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6243821|NCT02681094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243822|NCT02681094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6243823|NCT02681094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243824|NCT02681094|Incretins|incretins|mesh-ancestor
6243825|NCT02681094|Hormones|hormones|mesh-ancestor
6243826|NCT02681094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6243827|NCT02681094|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6243828|NCT02681094|Protease Inhibitors|protease inhibitors|mesh-ancestor
6243829|NCT02681094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6243830|NCT02681510|Nicotine|nicotine|mesh-list
6243831|NCT02681510|Varenicline|varenicline|mesh-list
6243832|NCT02681510|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6243833|NCT02681510|Autonomic Agents|autonomic agents|mesh-ancestor
6243834|NCT02681510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6243835|NCT02681510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243836|NCT02681510|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6243837|NCT02681510|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6243838|NCT02681510|Cholinergic Agents|cholinergic agents|mesh-ancestor
6243839|NCT02681510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6243840|NCT02681510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243841|NCT02681757|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6501610|NCT00648336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6501611|NCT00648336|Immunologic Factors|immunologic factors|mesh-ancestor
6501612|NCT00648336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501613|NCT00648336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6501614|NCT00648336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6501615|NCT00648349|Rabeprazole|rabeprazole|mesh-list
6501616|NCT00648349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6501617|NCT00648349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6501618|NCT00648349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6501619|NCT00648349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6501620|NCT00648349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501621|NCT00648362|Glimepiride|glimepiride|mesh-list
6501622|NCT00648362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6501623|NCT00648362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5710068|NCT03280641|Anticoagulants|anticoagulants|mesh-ancestor
5710069|NCT03280641|Antithrombins|antithrombins|mesh-ancestor
5710070|NCT03280641|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5710071|NCT03280641|Protease Inhibitors|protease inhibitors|mesh-ancestor
5710072|NCT03280641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5721585|NCT03204565|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6677059|NCT01585350|Interferon Inducers|interferon inducers|mesh-ancestor
6501624|NCT00648362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501625|NCT00648362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6501626|NCT00648362|Immunologic Factors|immunologic factors|mesh-ancestor
6234637|NCT02564029|Lorazepam|lorazepam|mesh-list
6234638|NCT02564029|PF-06372865|pf-06372865|mesh-list
6677060|NCT01585402|Etidronic Acid|etidronic acid|mesh-list
6677061|NCT01585402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6677062|NCT01585402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677063|NCT01585415|Aldesleukin|aldesleukin|mesh-list
6677064|NCT01585415|Cyclophosphamide|cyclophosphamide|mesh-list
6677065|NCT01585415|Fludarabine|fludarabine|mesh-list
6677066|NCT01585415|Vemurafenib|vemurafenib|mesh-list
6234639|NCT02564029|Anticonvulsants|anticonvulsants|mesh-ancestor
6234640|NCT02564029|Antiemetics|antiemetics|mesh-ancestor
6234641|NCT02564029|Autonomic Agents|autonomic agents|mesh-ancestor
6234642|NCT02564029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6234643|NCT02564029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234644|NCT02564029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6234645|NCT02564029|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6677067|NCT01585415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6677068|NCT01585415|Immunologic Factors|immunologic factors|mesh-ancestor
6677069|NCT01585415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677070|NCT01585415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6677071|NCT01585415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6677072|NCT01585415|Alkylating Agents|alkylating agents|mesh-ancestor
6677073|NCT01585415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677074|NCT01585415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6677075|NCT01585415|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6677076|NCT01585415|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6677077|NCT01585415|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6677078|NCT01585415|Antiviral Agents|antiviral agents|mesh-ancestor
6677079|NCT01585415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6677080|NCT01585415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6677081|NCT01585415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6234646|NCT02564029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6234647|NCT02564029|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6234648|NCT02564029|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6234649|NCT02564029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6234650|NCT02564029|GABA Modulators|gaba modulators|mesh-ancestor
6234651|NCT02564029|GABA Agents|gaba agents|mesh-ancestor
6234652|NCT02564029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6234653|NCT02564029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677082|NCT01585623|Metoprolol|metoprolol|mesh-list
6677083|NCT01585623|Midazolam|midazolam|mesh-list
6677084|NCT01585623|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6677085|NCT01585623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6677086|NCT01585623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5710073|NCT03280641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710074|NCT03280511|Oxaliplatin|oxaliplatin|mesh-list
5710075|NCT03280511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5710076|NCT03280407|Leucovorin|leucovorin|mesh-list
5710077|NCT03280407|Capecitabine|capecitabine|mesh-list
5710078|NCT03280407|Oxaliplatin|oxaliplatin|mesh-list
5710079|NCT03280407|Levoleucovorin|levoleucovorin|mesh-list
5710080|NCT03280407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5710081|NCT03280407|Antimetabolites|antimetabolites|mesh-ancestor
6234654|NCT02564198|Ramucirumab|ramucirumab|mesh-list
6234655|NCT02564198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6234656|NCT02564211|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6234657|NCT02564211|Ipragliflozin|ipragliflozin|mesh-list
6234658|NCT02564211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6234659|NCT02564211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234660|NCT02564211|Incretins|incretins|mesh-ancestor
6234661|NCT02564211|Hormones|hormones|mesh-ancestor
6234662|NCT02564211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6234663|NCT02564211|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6234664|NCT02564211|Protease Inhibitors|protease inhibitors|mesh-ancestor
6234665|NCT02564211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6234666|NCT02564211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501627|NCT00648388|Cilostazol|cilostazol|mesh-list
6501628|NCT00648388|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6501629|NCT00648388|Autonomic Agents|autonomic agents|mesh-ancestor
6501630|NCT00648388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6501631|NCT00648388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501632|NCT00648388|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6501633|NCT00648388|Respiratory System Agents|respiratory system agents|mesh-ancestor
6677087|NCT01585623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501634|NCT00648388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6501635|NCT00648388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6501636|NCT00648388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501637|NCT00648388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6501638|NCT00648388|Vasodilator Agents|vasodilator agents|mesh-ancestor
6501639|NCT00648388|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6501640|NCT00648388|Protective Agents|protective agents|mesh-ancestor
6501641|NCT00648388|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6501642|NCT00648388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6501643|NCT00648388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6501644|NCT00648401|Verapamil|verapamil|mesh-list
6501645|NCT00648401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6501646|NCT00648401|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6501647|NCT00648401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6501648|NCT00648401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501649|NCT00648401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6501650|NCT00648401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234667|NCT02564211|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6234668|NCT02564471|Doxycycline|doxycycline|mesh-list
6234669|NCT02564471|Chloroquine|chloroquine|mesh-list
6234670|NCT02564471|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
6234671|NCT02564471|Atovaquone|atovaquone|mesh-list
6234672|NCT02564471|Proguanil|proguanil|mesh-list
6234673|NCT02564471|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6234674|NCT02564471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6234675|NCT02564471|Antimalarials|antimalarials|mesh-ancestor
6234676|NCT02564471|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6234677|NCT02564471|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6234678|NCT02564471|Amebicides|amebicides|mesh-ancestor
6234679|NCT02564471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6234680|NCT02564471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6234681|NCT02564471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6234682|NCT02564471|Analgesics|analgesics|mesh-ancestor
6234683|NCT02564471|Sensory System Agents|sensory system agents|mesh-ancestor
6234684|NCT02564471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5710082|NCT03280407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710083|NCT03280407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5710084|NCT03280407|Antidotes|antidotes|mesh-ancestor
5710085|NCT03280407|Protective Agents|protective agents|mesh-ancestor
5710086|NCT03280407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710087|NCT03280407|Vitamin B Complex|vitamin b complex|mesh-ancestor
5710088|NCT03280407|Vitamins|vitamins|mesh-ancestor
5710089|NCT03280407|Micronutrients|micronutrients|mesh-ancestor
5710090|NCT03280342|Topiramate|topiramate|mesh-list
5710091|NCT03280342|Anticonvulsants|anticonvulsants|mesh-ancestor
5710092|NCT03280342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5710093|NCT03280342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710094|NCT03280316|Tolterodine Tartrate|tolterodine tartrate|mesh-list
5710095|NCT03280316|Botulinum Toxins|botulinum toxins|mesh-list
5710096|NCT03280316|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5710097|NCT03280316|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5710098|NCT03280316|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5710099|NCT03280316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5710100|NCT03280316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710101|NCT03280316|Cholinergic Agents|cholinergic agents|mesh-ancestor
5710102|NCT03280316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5710103|NCT03280316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710104|NCT03280316|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5710105|NCT03280316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5710106|NCT03280316|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5710107|NCT03280316|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5710108|NCT03280316|Urological Agents|urological agents|mesh-ancestor
5710109|NCT03280277|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
5710110|NCT03280277|Hematinics|hematinics|mesh-ancestor
5710111|NCT03280277|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5710112|NCT03280277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5710113|NCT03280251|Methylphenidate|methylphenidate|mesh-list
5710114|NCT03280251|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5710115|NCT03280251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710116|NCT03280251|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5710117|NCT03280251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5710118|NCT03280251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5710119|NCT03280251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234685|NCT02564471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234686|NCT02564471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6234687|NCT02564471|Filaricides|filaricides|mesh-ancestor
6234688|NCT02564471|Antinematodal Agents|antinematodal agents|mesh-ancestor
6234689|NCT02564471|Anthelmintics|anthelmintics|mesh-ancestor
5710120|NCT03280251|Dopamine Agents|dopamine agents|mesh-ancestor
5710121|NCT03280251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5710122|NCT03280212|Tranexamic Acid|tranexamic acid|mesh-list
5710123|NCT03280212|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6234690|NCT02564471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6234691|NCT02564471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234692|NCT02564471|Antimetabolites|antimetabolites|mesh-ancestor
6234693|NCT02564497|Abatacept|abatacept|mesh-list
6234694|NCT02564497|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6234695|NCT02564497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234696|NCT02564497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6234697|NCT02564497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6234698|NCT02564497|Immunologic Factors|immunologic factors|mesh-ancestor
6234699|NCT02564497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234700|NCT02564497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6234701|NCT02564718|Rivaroxaban|rivaroxaban|mesh-list
6234702|NCT02564718|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6234703|NCT02564718|Antithrombins|antithrombins|mesh-ancestor
6234704|NCT02564718|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6234705|NCT02564718|Protease Inhibitors|protease inhibitors|mesh-ancestor
6234706|NCT02564718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6234707|NCT02564718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234708|NCT02564718|Anticoagulants|anticoagulants|mesh-ancestor
6234709|NCT02564926|Dapagliflozin|dapagliflozin|mesh-list
6234710|NCT02564926|Glimepiride|glimepiride|mesh-list
6234711|NCT02564926|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6234712|NCT02564926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234713|NCT02564926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6234714|NCT02564926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710124|NCT03280212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5710125|NCT03280212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710126|NCT03280212|Hemostatics|hemostatics|mesh-ancestor
6234715|NCT02564926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6234716|NCT02564926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6234717|NCT02564926|Immunologic Factors|immunologic factors|mesh-ancestor
6234718|NCT02564952|Cannabidiol|cannabidiol|mesh-list
5710127|NCT03280212|Coagulants|coagulants|mesh-ancestor
5710128|NCT03280160|Ofatumumab|ofatumumab|mesh-list
5710129|NCT03280160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5710130|NCT03280147|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5710131|NCT03280147|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5710132|NCT03280147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5710133|NCT03280147|Antitubercular Agents|antitubercular agents|mesh-ancestor
5710134|NCT03280095|Acetaminophen|acetaminophen|mesh-list
5710135|NCT03280095|Codeine|codeine|mesh-list
5710136|NCT03280095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5710137|NCT03280095|Analgesics|analgesics|mesh-ancestor
5710138|NCT03280095|Sensory System Agents|sensory system agents|mesh-ancestor
5710139|NCT03280095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5710140|NCT03280095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710141|NCT03280095|Antipyretics|antipyretics|mesh-ancestor
5710142|NCT03280095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5710143|NCT03280095|Narcotics|narcotics|mesh-ancestor
5710144|NCT03280095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5710145|NCT03280095|Antitussive Agents|antitussive agents|mesh-ancestor
5710146|NCT03280095|Respiratory System Agents|respiratory system agents|mesh-ancestor
5710147|NCT03280030|Midostaurin|midostaurin|mesh-list
5710148|NCT03280030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5710149|NCT03280030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5710150|NCT03280030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5710151|NCT03280030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710152|NCT03280017|Ketamine|ketamine|mesh-list
5710153|NCT03280017|Analgesics|analgesics|mesh-ancestor
5710154|NCT03280017|Sensory System Agents|sensory system agents|mesh-ancestor
5710155|NCT03280017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5710156|NCT03280017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710157|NCT03280017|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5710158|NCT03280017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5710159|NCT03280017|Anesthetics, General|anesthetics, general|mesh-ancestor
6234719|NCT02564952|Clobazam|clobazam|mesh-list
5710160|NCT03280017|Anesthetics|anesthetics|mesh-ancestor
5710161|NCT03280017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5721586|NCT03204565|Immunologic Factors|immunologic factors|mesh-ancestor
6234720|NCT02564952|Anticonvulsants|anticonvulsants|mesh-ancestor
6234721|NCT02564952|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6234722|NCT02564952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6234723|NCT02564952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6234724|NCT02564952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234725|NCT02564952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6501651|NCT00648401|Vasodilator Agents|vasodilator agents|mesh-ancestor
6501652|NCT00648414|Fentanyl|fentanyl|mesh-list
6234726|NCT02564952|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6234727|NCT02564952|GABA Agonists|gaba agonists|mesh-ancestor
6501653|NCT00648414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6501654|NCT00648414|Narcotics|narcotics|mesh-ancestor
6501655|NCT00648414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6677088|NCT01585623|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6677089|NCT01585623|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6677090|NCT01585623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6677091|NCT01585623|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6677092|NCT01585623|Anesthetics, General|anesthetics, general|mesh-ancestor
6677093|NCT01585623|Anesthetics|anesthetics|mesh-ancestor
6677094|NCT01585623|GABA Modulators|gaba modulators|mesh-ancestor
6677095|NCT01585623|GABA Agents|gaba agents|mesh-ancestor
6677096|NCT01585623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6677097|NCT01585623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677098|NCT01585623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6677099|NCT01585623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6677100|NCT01585623|Sympatholytics|sympatholytics|mesh-ancestor
5710162|NCT03280017|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5710163|NCT03280017|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5710164|NCT03280017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5710165|NCT03280017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710166|NCT03280004|Moxifloxacin|moxifloxacin|mesh-list
5710167|NCT03280004|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
5710168|NCT03280004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5710169|NCT03280004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5710170|NCT03280004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5710171|NCT03280004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5710172|NCT03280004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5710173|NCT03280004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710174|NCT03280004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5710175|NCT03280004|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5710176|NCT03280004|Contraceptive Agents|contraceptive agents|mesh-ancestor
5710177|NCT03280004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5710178|NCT03280004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710179|NCT03280004|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5710180|NCT03280004|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5710181|NCT03280004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5710182|NCT03279978|Midazolam|midazolam|mesh-list
5710183|NCT03279978|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5710184|NCT03279978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5710185|NCT03279978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5710186|NCT03279978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710187|NCT03279978|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5710188|NCT03279978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5710189|NCT03279978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6234728|NCT02564952|GABA Agents|gaba agents|mesh-ancestor
6501656|NCT00648414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677101|NCT01585623|Autonomic Agents|autonomic agents|mesh-ancestor
6677102|NCT01585623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6677103|NCT01585623|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6677104|NCT01585623|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6677105|NCT01585623|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6677106|NCT01585623|Adrenergic Agents|adrenergic agents|mesh-ancestor
6677107|NCT01585753|Maraviroc|maraviroc|mesh-list
6677108|NCT01585753|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6677109|NCT01585753|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6677110|NCT01585753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677111|NCT01585753|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6677112|NCT01585753|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6677113|NCT01585753|Antiviral Agents|antiviral agents|mesh-ancestor
6501657|NCT00648414|Analgesics|analgesics|mesh-ancestor
6501658|NCT00648414|Sensory System Agents|sensory system agents|mesh-ancestor
6501659|NCT00648414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6501660|NCT00648414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6234729|NCT02564952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6234730|NCT02564952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234731|NCT02565108|Cannabidiol|cannabidiol|mesh-list
6234732|NCT02565108|Clobazam|clobazam|mesh-list
6234733|NCT02565108|Anticonvulsants|anticonvulsants|mesh-ancestor
6234734|NCT02565108|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6234735|NCT02565108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6234736|NCT02565108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6234737|NCT02565108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234738|NCT02565108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6234739|NCT02565108|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6234740|NCT02565108|GABA Agonists|gaba agonists|mesh-ancestor
6234741|NCT02565108|GABA Agents|gaba agents|mesh-ancestor
6234742|NCT02565108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6234743|NCT02565108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234744|NCT02565147|Heparin|heparin|mesh-list
6234745|NCT02565147|Bivalirudin|bivalirudin|mesh-list
5710190|NCT03279978|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5710191|NCT03279978|Anesthetics, General|anesthetics, general|mesh-ancestor
5710192|NCT03279978|Anesthetics|anesthetics|mesh-ancestor
6234746|NCT02565147|Anticoagulants|anticoagulants|mesh-ancestor
6234747|NCT02565147|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6234748|NCT02565147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6234749|NCT02565147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234750|NCT02565147|Antithrombins|antithrombins|mesh-ancestor
6234751|NCT02565147|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6234752|NCT02565147|Protease Inhibitors|protease inhibitors|mesh-ancestor
6234753|NCT02565147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6234754|NCT02565186|Lasmiditan|lasmiditan|mesh-list
6234755|NCT02565186|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6501661|NCT00648414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6501662|NCT00648414|Anesthetics, General|anesthetics, general|mesh-ancestor
6501663|NCT00648414|Anesthetics|anesthetics|mesh-ancestor
6501664|NCT00648427|Paroxetine|paroxetine|mesh-list
6501665|NCT00648427|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6501666|NCT00648427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6501667|NCT00648427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6501668|NCT00648427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501669|NCT00648427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6501670|NCT00648427|Serotonin Agents|serotonin agents|mesh-ancestor
6501671|NCT00648427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501672|NCT00648427|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6501673|NCT00648427|Antidepressive Agents|antidepressive agents|mesh-ancestor
6501674|NCT00648427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6501675|NCT00648427|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6677114|NCT01585753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6677115|NCT01585753|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
5710193|NCT03279978|GABA Modulators|gaba modulators|mesh-ancestor
5710194|NCT03279978|GABA Agents|gaba agents|mesh-ancestor
5710195|NCT03279978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5710196|NCT03279978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710197|NCT03279952|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
5710198|NCT03279952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710199|NCT03279861|Valsartan|valsartan|mesh-list
5710200|NCT03279861|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5710201|NCT03279861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5710202|NCT03279861|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5710203|NCT03279861|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5710204|NCT03279861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710205|NCT03279809|Aspirin|aspirin|mesh-list
6677116|NCT01585792|Glimepiride|glimepiride|mesh-list
6677117|NCT01585792|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6677118|NCT01585792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6677119|NCT01585792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677120|NCT01585792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6677121|NCT01585792|Immunologic Factors|immunologic factors|mesh-ancestor
5710206|NCT03279809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5710207|NCT03279809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5710208|NCT03279809|Analgesics|analgesics|mesh-ancestor
5710209|NCT03279809|Sensory System Agents|sensory system agents|mesh-ancestor
5710210|NCT03279809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5710211|NCT03279809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710212|NCT03279809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5710213|NCT03279809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5710214|NCT03279809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5710215|NCT03279809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5710216|NCT03279809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710217|NCT03279809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5710218|NCT03279809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5710219|NCT03279809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5710220|NCT03279809|Antipyretics|antipyretics|mesh-ancestor
5710221|NCT03279796|Betamethasone|betamethasone|mesh-list
5710222|NCT03279796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5710223|NCT03279796|Glucocorticoids|glucocorticoids|mesh-ancestor
5710224|NCT03279796|Hormones|hormones|mesh-ancestor
5710225|NCT03279796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5710226|NCT03279796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710227|NCT03279796|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5710228|NCT03279796|Respiratory System Agents|respiratory system agents|mesh-ancestor
5710229|NCT03279757|Lidocaine|lidocaine|mesh-list
5710230|NCT03279757|Epinephrine|epinephrine|mesh-list
5710231|NCT03279757|Racepinephrine|racepinephrine|mesh-list
5710232|NCT03279757|Tetracaine|tetracaine|mesh-list
5710233|NCT03279757|Carticaine|carticaine|mesh-list
5710234|NCT03279757|Epinephryl borate|epinephryl borate|mesh-list
5710235|NCT03279757|Anesthetics, Local|anesthetics, local|mesh-ancestor
5710236|NCT03279757|Anesthetics|anesthetics|mesh-ancestor
5710237|NCT03279757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5710238|NCT03279757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710239|NCT03279757|Sensory System Agents|sensory system agents|mesh-ancestor
5710240|NCT03279757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5710241|NCT03279757|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6501676|NCT00648427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6501677|NCT00648427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6501678|NCT00648440|Midodrine|midodrine|mesh-list
6501679|NCT00648440|Sympathomimetics|sympathomimetics|mesh-ancestor
6501680|NCT00648440|Autonomic Agents|autonomic agents|mesh-ancestor
6501681|NCT00648440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6501682|NCT00648440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501683|NCT00648440|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6501684|NCT00648440|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6501685|NCT00648440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6501686|NCT00648440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6501687|NCT00648440|Adrenergic Agents|adrenergic agents|mesh-ancestor
6501688|NCT00648440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6677122|NCT01585870|Sorafenib|sorafenib|mesh-list
6677123|NCT01585870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6677124|NCT01585870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6677125|NCT01585870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6677126|NCT01585870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677127|NCT01585935|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6677128|NCT01585935|SMOFlipid|smoflipid|mesh-list
6677129|NCT01585935|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6677130|NCT01585935|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6677131|NCT01585935|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6677132|NCT01586013|Propofol|propofol|mesh-list
6677133|NCT01586013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6677134|NCT01586013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6677135|NCT01586013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677136|NCT01586013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6677137|NCT01586013|Anesthetics, General|anesthetics, general|mesh-ancestor
6677138|NCT01586013|Anesthetics|anesthetics|mesh-ancestor
6677139|NCT01586052|Epoetin Alfa|epoetin alfa|mesh-list
6677140|NCT01586052|Hematinics|hematinics|mesh-ancestor
6677141|NCT01586117|Amifostine|amifostine|mesh-list
6677142|NCT01586117|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6677143|NCT01586117|Protective Agents|protective agents|mesh-ancestor
6677144|NCT01586117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710242|NCT03279757|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5710243|NCT03279757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6234756|NCT02565186|Serotonin Agents|serotonin agents|mesh-ancestor
6677145|NCT01586143|Acetaminophen|acetaminophen|mesh-list
6501689|NCT00648440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501690|NCT00648453|Clopidogrel|clopidogrel|mesh-list
6501691|NCT00648453|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6501692|NCT00648453|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6501693|NCT00648453|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6501694|NCT00648453|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6501695|NCT00648453|Purinergic Agents|purinergic agents|mesh-ancestor
5710244|NCT03279757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5710245|NCT03279757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710246|NCT03279757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5710247|NCT03279757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5710248|NCT03279757|Adrenergic Agents|adrenergic agents|mesh-ancestor
5710249|NCT03279757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5710250|NCT03279757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5710251|NCT03279757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5710252|NCT03279757|Autonomic Agents|autonomic agents|mesh-ancestor
5710253|NCT03279757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5710254|NCT03279757|Respiratory System Agents|respiratory system agents|mesh-ancestor
5710255|NCT03279757|Mydriatics|mydriatics|mesh-ancestor
5710256|NCT03279757|Sympathomimetics|sympathomimetics|mesh-ancestor
5710257|NCT03279757|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5710258|NCT03279692|Pembrolizumab|pembrolizumab|mesh-list
5710259|NCT03279692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5710260|NCT03279692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5710261|NCT03279679|Ropivacaine|ropivacaine|mesh-list
5710262|NCT03279679|Anesthetics, Local|anesthetics, local|mesh-ancestor
6501696|NCT00648453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6677146|NCT01586143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6234757|NCT02565186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6234758|NCT02565186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234759|NCT02565186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234760|NCT02565381|Nicotine|nicotine|mesh-list
6234761|NCT02565381|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6234762|NCT02565381|Autonomic Agents|autonomic agents|mesh-ancestor
6234763|NCT02565381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6234764|NCT02565381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234765|NCT02565381|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6234766|NCT02565381|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6234767|NCT02565381|Cholinergic Agents|cholinergic agents|mesh-ancestor
6234768|NCT02565381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6234769|NCT02565381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234770|NCT02565511|CNP520|cnp520|mesh-list
6234771|NCT02565511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6234772|NCT02565511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234773|NCT02565628|PF-06669571|pf-06669571|mesh-list
6234774|NCT02565628|Dopamine Agonists|dopamine agonists|mesh-ancestor
6234775|NCT02565628|Dopamine Agents|dopamine agents|mesh-ancestor
6234776|NCT02565628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6234777|NCT02565628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234778|NCT02565628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677147|NCT01586143|Analgesics|analgesics|mesh-ancestor
6234779|NCT02565810|Adalimumab|adalimumab|mesh-list
6234780|NCT02565810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6234781|NCT02565810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6677148|NCT01586143|Sensory System Agents|sensory system agents|mesh-ancestor
6677149|NCT01586143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6677150|NCT01586143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677151|NCT01586143|Antipyretics|antipyretics|mesh-ancestor
6677152|NCT01586169|Azithromycin|azithromycin|mesh-list
6677153|NCT01586169|Ivermectin|ivermectin|mesh-list
6677154|NCT01586169|Albendazole|albendazole|mesh-list
5710263|NCT03279679|Anesthetics|anesthetics|mesh-ancestor
6234782|NCT02565901|Sirolimus|sirolimus|mesh-list
6234783|NCT02565901|Carboplatin|carboplatin|mesh-list
6234784|NCT02565901|Docetaxel|docetaxel|mesh-list
6234785|NCT02565901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6234786|NCT02565901|Tubulin Modulators|tubulin modulators|mesh-ancestor
6234787|NCT02565901|Antimitotic Agents|antimitotic agents|mesh-ancestor
6234788|NCT02565901|Mitosis Modulators|mitosis modulators|mesh-ancestor
6234789|NCT02565901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710264|NCT03279679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6234790|NCT02565901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6677155|NCT01586169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6677156|NCT01586169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6677157|NCT01586169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5918972|NCT04987450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5918973|NCT04987450|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5918974|NCT04987450|Protective Agents|protective agents|mesh-ancestor
5710265|NCT03279679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710266|NCT03279679|Sensory System Agents|sensory system agents|mesh-ancestor
5710267|NCT03279679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5710268|NCT03279601|Capecitabine|capecitabine|mesh-list
5710269|NCT03279601|Temozolomide|temozolomide|mesh-list
5710270|NCT03279601|Dacarbazine|dacarbazine|mesh-list
5710271|NCT03279601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5710272|NCT03279601|Antimetabolites|antimetabolites|mesh-ancestor
5710273|NCT03279601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710274|NCT03279601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6234791|NCT02565901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6234792|NCT02565901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6234793|NCT02565901|Antifungal Agents|antifungal agents|mesh-ancestor
6234794|NCT02565901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6234795|NCT02565901|Immunologic Factors|immunologic factors|mesh-ancestor
6234796|NCT02565901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234797|NCT02565914|Ivacaftor|ivacaftor|mesh-list
6234798|NCT02565914|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6234799|NCT02565914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6234800|NCT02565914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234801|NCT02566005|Misoprostol|misoprostol|mesh-list
6234802|NCT02566005|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6234803|NCT02566005|Abortifacient Agents|abortifacient agents|mesh-ancestor
6234804|NCT02566005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6234805|NCT02566005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234806|NCT02566005|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6234807|NCT02566005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5918975|NCT04987567|Antioxidants|antioxidants|mesh-list
5918976|NCT04987567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918977|NCT04987567|Protective Agents|protective agents|mesh-ancestor
5918978|NCT04987567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918979|NCT04987554|Immunoferon|immunoferon|mesh-list
5918980|NCT04987554|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5918981|NCT04987554|Immunologic Factors|immunologic factors|mesh-ancestor
5918982|NCT04987554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5918983|NCT04987242|Rasburicase|rasburicase|mesh-list
5918984|NCT04987242|Gout Suppressants|gout suppressants|mesh-ancestor
5918985|NCT04987242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5918986|NCT04986982|Opicapone|opicapone|mesh-list
6234808|NCT02566005|Oxytocics|oxytocics|mesh-ancestor
6234809|NCT02566031|Glycopyrrolate|glycopyrrolate|mesh-list
6234810|NCT02566031|Tiotropium Bromide|tiotropium bromide|mesh-list
6234811|NCT02566031|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6234812|NCT02566031|Autonomic Agents|autonomic agents|mesh-ancestor
6234813|NCT02566031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6234814|NCT02566031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234815|NCT02566031|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6234816|NCT02566031|Respiratory System Agents|respiratory system agents|mesh-ancestor
5710275|NCT03279601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5710276|NCT03279601|Alkylating Agents|alkylating agents|mesh-ancestor
5710277|NCT03279562|Nalmefene|nalmefene|mesh-list
5710278|NCT03279562|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5710279|NCT03279562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710280|NCT03279562|Sensory System Agents|sensory system agents|mesh-ancestor
6234817|NCT02566031|Parasympatholytics|parasympatholytics|mesh-ancestor
6234818|NCT02566031|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6501697|NCT00648453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501698|NCT00648453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501699|NCT00648466|Sumatriptan|sumatriptan|mesh-list
6501700|NCT00648466|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6501701|NCT00648466|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6501702|NCT00648466|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6501703|NCT00648466|Serotonin Agents|serotonin agents|mesh-ancestor
6501704|NCT00648466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6501705|NCT00648466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234819|NCT02566031|Cholinergic Agents|cholinergic agents|mesh-ancestor
6234820|NCT02566031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6234821|NCT02566031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234822|NCT02566031|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5918987|NCT04986982|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
5918988|NCT04986982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5710281|NCT03279562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5710282|NCT03279549|Mitogens|mitogens|mesh-list
5710283|NCT03279549|Mitosis Modulators|mitosis modulators|mesh-ancestor
5710284|NCT03279549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710285|NCT03279536|Lactoferrin|lactoferrin|mesh-list
6234823|NCT02566031|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6234824|NCT02566369|Trifarotene|trifarotene|mesh-list
6234825|NCT02566369|Dermatologic Agents|dermatologic agents|mesh-ancestor
6234826|NCT02566889|Infliximab|infliximab|mesh-list
6234827|NCT02566889|Dermatologic Agents|dermatologic agents|mesh-ancestor
6234828|NCT02566889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6234829|NCT02566889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6234830|NCT02566902|Albuterol|albuterol|mesh-list
6234831|NCT02566902|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6234832|NCT02566902|Autonomic Agents|autonomic agents|mesh-ancestor
6501706|NCT00648466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501707|NCT00648492|Metformin|metformin|mesh-list
6501708|NCT00648492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5710286|NCT03279536|Dextrans|dextrans|mesh-list
5710287|NCT03279536|Iron-Dextran Complex|iron-dextran complex|mesh-list
5710288|NCT03279536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5710289|NCT03279536|Anticoagulants|anticoagulants|mesh-ancestor
5710290|NCT03279536|Plasma Substitutes|plasma substitutes|mesh-ancestor
5710291|NCT03279536|Blood Substitutes|blood substitutes|mesh-ancestor
5710292|NCT03279536|Hematinics|hematinics|mesh-ancestor
5710293|NCT03279393|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5710294|NCT03279393|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5710295|NCT03279393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710296|NCT03279341|Prucalopride|prucalopride|mesh-list
5710297|NCT03279341|Bisacodyl|bisacodyl|mesh-list
5710298|NCT03279341|Laxatives|laxatives|mesh-ancestor
5710299|NCT03279341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5710300|NCT03279341|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
5710301|NCT03279341|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5710302|NCT03279341|Serotonin Agents|serotonin agents|mesh-ancestor
5710303|NCT03279341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5710304|NCT03279341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710305|NCT03279341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710306|NCT03279341|Cathartics|cathartics|mesh-ancestor
5710307|NCT03279328|Petrolatum|petrolatum|mesh-list
5710308|NCT03279328|Emollients|emollients|mesh-ancestor
5710309|NCT03279328|Dermatologic Agents|dermatologic agents|mesh-ancestor
5721587|NCT03204565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721588|NCT03204565|Viscosupplements|viscosupplements|mesh-ancestor
5721589|NCT03204565|Protective Agents|protective agents|mesh-ancestor
5721590|NCT03204318|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5721591|NCT03204318|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6501709|NCT00648492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677158|NCT01586169|Anthelmintics|anthelmintics|mesh-ancestor
6677159|NCT01586169|Anticestodal Agents|anticestodal agents|mesh-ancestor
6677160|NCT01586169|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6677161|NCT01586169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6677162|NCT01586169|Tubulin Modulators|tubulin modulators|mesh-ancestor
6677163|NCT01586169|Antimitotic Agents|antimitotic agents|mesh-ancestor
6677164|NCT01586169|Mitosis Modulators|mitosis modulators|mesh-ancestor
6677165|NCT01586169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677166|NCT01586169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6677167|NCT01586208|Phenytoin|phenytoin|mesh-list
6677168|NCT01586208|Valproic Acid|valproic acid|mesh-list
6677169|NCT01586208|Anticonvulsants|anticonvulsants|mesh-ancestor
5721592|NCT03204318|Norethindrone|norethindrone|mesh-list
5721593|NCT03204318|Norethindrone Acetate|norethindrone acetate|mesh-list
5721594|NCT03204318|Estradiol|estradiol|mesh-list
5721595|NCT03204318|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6234833|NCT02566902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6501710|NCT00648505|Metformin|metformin|mesh-list
5721596|NCT03204318|Relugolix|relugolix|mesh-list
5721597|NCT03204318|Estrogens|estrogens|mesh-ancestor
6501711|NCT00648505|Glipizide|glipizide|mesh-list
6501712|NCT00648505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6501713|NCT00648505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721598|NCT03204318|Hormones|hormones|mesh-ancestor
5918989|NCT04986982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5918990|NCT04986982|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5918991|NCT04986982|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5918992|NCT04986995|Opicapone|opicapone|mesh-list
5918993|NCT04986995|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6501714|NCT00648518|Metformin|metformin|mesh-list
6501715|NCT00648518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6677170|NCT01586208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5710310|NCT03279289|Leucovorin|leucovorin|mesh-list
6501716|NCT00648518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501717|NCT00648531|Balsalazide|balsalazide|mesh-list
6501718|NCT00648531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6501719|NCT00648531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6501720|NCT00648531|Analgesics|analgesics|mesh-ancestor
6501721|NCT00648531|Sensory System Agents|sensory system agents|mesh-ancestor
6501722|NCT00648531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6501723|NCT00648531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501724|NCT00648531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6501725|NCT00648531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6234834|NCT02566902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234835|NCT02566902|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6234836|NCT02566902|Respiratory System Agents|respiratory system agents|mesh-ancestor
6234837|NCT02566902|Tocolytic Agents|tocolytic agents|mesh-ancestor
6234838|NCT02566902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6234839|NCT02566902|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6234840|NCT02566902|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6234841|NCT02566902|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6234842|NCT02566902|Adrenergic Agents|adrenergic agents|mesh-ancestor
6234843|NCT02566902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6234844|NCT02566902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234845|NCT02566993|Cyclophosphamide|cyclophosphamide|mesh-list
6234846|NCT02566993|Doxorubicin|doxorubicin|mesh-list
6234847|NCT02566993|Vincristine|vincristine|mesh-list
6234848|NCT02566993|Topotecan|topotecan|mesh-list
6234849|NCT02566993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6234850|NCT02566993|Immunologic Factors|immunologic factors|mesh-ancestor
6501726|NCT00648531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6501727|NCT00648544|Pravastatin|pravastatin|mesh-list
6501728|NCT00648544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6501729|NCT00648544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6501730|NCT00648544|Antimetabolites|antimetabolites|mesh-ancestor
6501731|NCT00648544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501732|NCT00648544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6501733|NCT00648544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6677171|NCT01586208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677172|NCT01586208|GABA Agents|gaba agents|mesh-ancestor
6677173|NCT01586208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6677174|NCT01586208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677175|NCT01586208|Antimanic Agents|antimanic agents|mesh-ancestor
6677176|NCT01586208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6677177|NCT01586208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6677178|NCT01586208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6677179|NCT01586208|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5710311|NCT03279289|Folic Acid|folic acid|mesh-list
5710312|NCT03279289|Fluorouracil|fluorouracil|mesh-list
5710313|NCT03279289|Irinotecan|irinotecan|mesh-list
6234851|NCT02566993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234852|NCT02566993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6234853|NCT02566993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6234854|NCT02566993|Alkylating Agents|alkylating agents|mesh-ancestor
6234855|NCT02566993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234856|NCT02566993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6234857|NCT02566993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6234858|NCT02566993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6234859|NCT02566993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6234860|NCT02566993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6234861|NCT02566993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6234862|NCT02566993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6234863|NCT02566993|Tubulin Modulators|tubulin modulators|mesh-ancestor
6234864|NCT02566993|Antimitotic Agents|antimitotic agents|mesh-ancestor
6234865|NCT02566993|Mitosis Modulators|mitosis modulators|mesh-ancestor
6234866|NCT02566993|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6234867|NCT02567552|Progesterone|progesterone|mesh-list
6234868|NCT02567552|Progestins|progestins|mesh-ancestor
6234869|NCT02567552|Hormones|hormones|mesh-ancestor
6234870|NCT02567552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6234871|NCT02567552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234872|NCT02567656|Tenalisib|tenalisib|mesh-list
6234873|NCT02567656|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
6234874|NCT02567656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6234875|NCT02567656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234876|NCT02567708|Nemiralisib|nemiralisib|mesh-list
6234877|NCT02567708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6234878|NCT02567708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6234879|NCT02567708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234880|NCT02567968|Caffeine|caffeine|mesh-list
6234881|NCT02567968|Caffeine citrate|caffeine citrate|mesh-list
6234882|NCT02567968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234883|NCT02567968|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6234884|NCT02567968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234885|NCT02567968|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6234886|NCT02567968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6234887|NCT02567968|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6234888|NCT02567968|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6234889|NCT02567968|Purinergic Agents|purinergic agents|mesh-ancestor
6234890|NCT02567968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6234891|NCT02568046|Leucovorin|leucovorin|mesh-list
5710314|NCT03279289|Aflibercept|aflibercept|mesh-list
5710315|NCT03279289|Levoleucovorin|levoleucovorin|mesh-list
5710316|NCT03279289|Antimetabolites|antimetabolites|mesh-ancestor
5710317|NCT03279289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710318|NCT03279289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5710319|NCT03279289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5710320|NCT03279289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5710321|NCT03279289|Immunologic Factors|immunologic factors|mesh-ancestor
5710322|NCT03279289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710323|NCT03279289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5710324|NCT03279289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5710325|NCT03279289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5710326|NCT03279289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5710327|NCT03279289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5710328|NCT03279289|Growth Substances|growth substances|mesh-ancestor
5710329|NCT03279289|Growth Inhibitors|growth inhibitors|mesh-ancestor
5710330|NCT03279289|Antidotes|antidotes|mesh-ancestor
5710331|NCT03279289|Protective Agents|protective agents|mesh-ancestor
5710332|NCT03279289|Vitamin B Complex|vitamin b complex|mesh-ancestor
5710333|NCT03279289|Vitamins|vitamins|mesh-ancestor
5710334|NCT03279289|Micronutrients|micronutrients|mesh-ancestor
5710335|NCT03279289|Hematinics|hematinics|mesh-ancestor
5710336|NCT03279250|Prednisone|prednisone|mesh-list
5710337|NCT03279250|Cortisone|cortisone|mesh-list
5710338|NCT03279250|Abiraterone Acetate|abiraterone acetate|mesh-list
5710339|NCT03279250|Hormones|hormones|mesh-list
5710340|NCT03279250|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
5710341|NCT03279250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5710342|NCT03279250|Glucocorticoids|glucocorticoids|mesh-ancestor
5710343|NCT03279250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5710344|NCT03279250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710345|NCT03279250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5710346|NCT03279250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5710347|NCT03279250|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5710348|NCT03279250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5710349|NCT03279250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710350|NCT03279250|Hormone Antagonists|hormone antagonists|mesh-ancestor
5710351|NCT03279250|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5710352|NCT03279146|Tenofovir|tenofovir|mesh-list
5710353|NCT03279146|Antiviral Agents|antiviral agents|mesh-ancestor
5918994|NCT04986995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5918995|NCT04986995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234892|NCT02568046|Fluorouracil|fluorouracil|mesh-list
6234893|NCT02568046|Irinotecan|irinotecan|mesh-list
6234894|NCT02568046|Antimetabolites|antimetabolites|mesh-ancestor
6234895|NCT02568046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234896|NCT02568046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6234897|NCT02568046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5710354|NCT03279146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5918996|NCT04986995|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5918997|NCT04986995|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5918998|NCT04986813|Tranexamic Acid|tranexamic acid|mesh-list
5918999|NCT04986813|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5919000|NCT04986813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5919001|NCT04986813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919002|NCT04986813|Hemostatics|hemostatics|mesh-ancestor
5919003|NCT04986813|Coagulants|coagulants|mesh-ancestor
5919004|NCT04986644|Hyaluronic Acid|hyaluronic acid|mesh-list
5919005|NCT04986644|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5919006|NCT04986644|Immunologic Factors|immunologic factors|mesh-ancestor
6234898|NCT02568046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6234899|NCT02568046|Immunologic Factors|immunologic factors|mesh-ancestor
6234900|NCT02568046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501734|NCT00648544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6501735|NCT00648570|Dexetimide|dexetimide|mesh-list
6501736|NCT00648570|Citalopram|citalopram|mesh-list
6501737|NCT00648570|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5710355|NCT03279146|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5710356|NCT03279146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5710357|NCT03279146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5710358|NCT03279146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710359|NCT03279146|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5710360|NCT03279146|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5710361|NCT03279133|Ledipasvir|ledipasvir|mesh-list
5710362|NCT03279133|Antiviral Agents|antiviral agents|mesh-ancestor
6234901|NCT02568046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6234902|NCT02568046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6234903|NCT02568046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6234904|NCT02568046|Antidotes|antidotes|mesh-ancestor
6234905|NCT02568046|Protective Agents|protective agents|mesh-ancestor
6234906|NCT02568046|Vitamin B Complex|vitamin b complex|mesh-ancestor
6234907|NCT02568046|Vitamins|vitamins|mesh-ancestor
6234908|NCT02568046|Micronutrients|micronutrients|mesh-ancestor
6234909|NCT02568397|Dabigatran|dabigatran|mesh-list
6234910|NCT02568397|Antithrombins|antithrombins|mesh-ancestor
6234911|NCT02568397|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6234912|NCT02568397|Protease Inhibitors|protease inhibitors|mesh-ancestor
5710363|NCT03279133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5710364|NCT03279120|Tenofovir|tenofovir|mesh-list
5710365|NCT03279120|Levonorgestrel|levonorgestrel|mesh-list
5710366|NCT03279120|Antiviral Agents|antiviral agents|mesh-ancestor
5710367|NCT03279120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5710368|NCT03279120|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5710369|NCT03279120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5710370|NCT03279120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5710371|NCT03279120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710372|NCT03279120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5710373|NCT03279120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5710374|NCT03279120|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5710375|NCT03279120|Contraceptive Agents|contraceptive agents|mesh-ancestor
5710376|NCT03279120|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5710377|NCT03279120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710378|NCT03279120|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5710379|NCT03279120|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6234913|NCT02568397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6234914|NCT02568397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234915|NCT02568397|Anticoagulants|anticoagulants|mesh-ancestor
6234916|NCT02568644|Ketoprofen|ketoprofen|mesh-list
6234917|NCT02568644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
6234918|NCT02568644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
6234919|NCT02568644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6234920|NCT02568644|Analgesics|analgesics|mesh-ancestor
6234921|NCT02568644|Sensory System Agents|sensory system agents|mesh-ancestor
6234922|NCT02568644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6234923|NCT02568644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234924|NCT02568644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6234925|NCT02568644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6234926|NCT02568644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6234927|NCT02568644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234928|NCT02568683|Vincristine|vincristine|mesh-list
6234929|NCT02568683|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6234930|NCT02568683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6234931|NCT02568683|Tubulin Modulators|tubulin modulators|mesh-ancestor
6234932|NCT02568683|Antimitotic Agents|antimitotic agents|mesh-ancestor
6234933|NCT02568683|Mitosis Modulators|mitosis modulators|mesh-ancestor
6234934|NCT02568683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234935|NCT02568852|Anesthetics|anesthetics|mesh-list
6234936|NCT02568852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6234937|NCT02568852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234938|NCT02569437|Fluticasone|fluticasone|mesh-list
6234939|NCT02569437|Doxycycline|doxycycline|mesh-list
6234940|NCT02569437|Methylprednisolone|methylprednisolone|mesh-list
6501738|NCT00648570|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6234941|NCT02569437|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6234942|NCT02569437|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6234943|NCT02569437|Prednisolone|prednisolone|mesh-list
6234944|NCT02569437|Prednisolone acetate|prednisolone acetate|mesh-list
6234945|NCT02569437|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6234946|NCT02569437|Prednisolone phosphate|prednisolone phosphate|mesh-list
5710380|NCT03279120|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5710381|NCT03278938|Bupropion|bupropion|mesh-list
5710382|NCT03278938|Citalopram|citalopram|mesh-list
5710383|NCT03278938|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5710384|NCT03278938|Antidepressive Agents|antidepressive agents|mesh-ancestor
5710385|NCT03278938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5710386|NCT03278938|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5710387|NCT03278938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5710388|NCT03278938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6234947|NCT02569437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6234948|NCT02569437|Antiemetics|antiemetics|mesh-ancestor
6501739|NCT00648570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6501740|NCT00648570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501741|NCT00648570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6501742|NCT00648570|Serotonin Agents|serotonin agents|mesh-ancestor
6501743|NCT00648570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501744|NCT00648570|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6501745|NCT00648570|Antidepressive Agents|antidepressive agents|mesh-ancestor
6501746|NCT00648570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6501747|NCT00648570|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6501748|NCT00648570|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6501749|NCT00648570|Parasympatholytics|parasympatholytics|mesh-ancestor
6501750|NCT00648570|Autonomic Agents|autonomic agents|mesh-ancestor
6501751|NCT00648570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5710389|NCT03278938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234949|NCT02569437|Autonomic Agents|autonomic agents|mesh-ancestor
6234950|NCT02569437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6234951|NCT02569437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6234952|NCT02569437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6234953|NCT02569437|Glucocorticoids|glucocorticoids|mesh-ancestor
6234954|NCT02569437|Hormones|hormones|mesh-ancestor
6234955|NCT02569437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6234956|NCT02569437|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6234957|NCT02569437|Protective Agents|protective agents|mesh-ancestor
6234958|NCT02569437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6234959|NCT02569437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6234960|NCT02569437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6234961|NCT02569437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6234962|NCT02569437|Antimalarials|antimalarials|mesh-ancestor
6234963|NCT02569437|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6234964|NCT02569437|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6234965|NCT02569437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6234966|NCT02569437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6234967|NCT02569437|Respiratory System Agents|respiratory system agents|mesh-ancestor
6234968|NCT02569437|Dermatologic Agents|dermatologic agents|mesh-ancestor
6234969|NCT02569437|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6234970|NCT02569476|Obinutuzumab|obinutuzumab|mesh-list
6234971|NCT02569476|Zanubrutinib|zanubrutinib|mesh-list
6234972|NCT02569476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6234973|NCT02569476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6234974|NCT02569476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6234975|NCT02569476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6234976|NCT02569476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234977|NCT02569541|Fusidic Acid|fusidic acid|mesh-list
6234978|NCT02569541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6234979|NCT02569541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6234980|NCT02569541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6234981|NCT02569541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6234982|NCT02569541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234983|NCT02569658|Tranexamic Acid|tranexamic acid|mesh-list
6234984|NCT02569658|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6234985|NCT02569658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6234986|NCT02569658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710390|NCT03278938|Dopamine Agents|dopamine agents|mesh-ancestor
5710391|NCT03278938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5710392|NCT03278938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710393|NCT03278938|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5710394|NCT03278938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5710395|NCT03278938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6234987|NCT02569658|Hemostatics|hemostatics|mesh-ancestor
5710396|NCT03278938|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5710397|NCT03278938|Serotonin Agents|serotonin agents|mesh-ancestor
5919007|NCT04986644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919008|NCT04986644|Viscosupplements|viscosupplements|mesh-ancestor
5919009|NCT04986644|Protective Agents|protective agents|mesh-ancestor
5919010|NCT04986735|Empagliflozin|empagliflozin|mesh-list
5919011|NCT04986735|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5919012|NCT04986735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919013|NCT04986735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5919014|NCT04986735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919015|NCT04986371|Niraparib|niraparib|mesh-list
5919016|NCT04986371|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5919017|NCT04986371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5919018|NCT04986371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919019|NCT04986371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6234988|NCT02569658|Coagulants|coagulants|mesh-ancestor
5710398|NCT03278860|Oxytocin|oxytocin|mesh-list
5710399|NCT03278860|Oxytocics|oxytocics|mesh-ancestor
5710400|NCT03278860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5710401|NCT03278860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710402|NCT03278808|Azithromycin|azithromycin|mesh-list
5710403|NCT03278808|Chloroquine|chloroquine|mesh-list
5710404|NCT03278808|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
5710405|NCT03278808|Atovaquone|atovaquone|mesh-list
5710406|NCT03278808|Proguanil|proguanil|mesh-list
5710407|NCT03278808|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
5710408|NCT03278808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5710409|NCT03278808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5710410|NCT03278808|Amebicides|amebicides|mesh-ancestor
5710411|NCT03278808|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5710412|NCT03278808|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5710413|NCT03278808|Antimalarials|antimalarials|mesh-ancestor
5710414|NCT03278808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5710415|NCT03278808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5710416|NCT03278808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5710417|NCT03278808|Analgesics|analgesics|mesh-ancestor
5710418|NCT03278808|Sensory System Agents|sensory system agents|mesh-ancestor
5710419|NCT03278808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5710420|NCT03278808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710421|NCT03278808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5710422|NCT03278808|Filaricides|filaricides|mesh-ancestor
5710423|NCT03278808|Antinematodal Agents|antinematodal agents|mesh-ancestor
5710424|NCT03278808|Anthelmintics|anthelmintics|mesh-ancestor
5710425|NCT03278808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5710426|NCT03278808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710427|NCT03278808|Antimetabolites|antimetabolites|mesh-ancestor
5710428|NCT03278782|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5710429|NCT03278782|Pembrolizumab|pembrolizumab|mesh-list
5710430|NCT03278782|Romidepsin|romidepsin|mesh-list
5710431|NCT03278782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5710432|NCT03278782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5710433|NCT03278782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5710434|NCT03278782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5710435|NCT03278652|Analgesics|analgesics|mesh-list
5710436|NCT03278652|Sensory System Agents|sensory system agents|mesh-ancestor
5710437|NCT03278652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6234989|NCT02569710|Simeprevir|simeprevir|mesh-list
6234990|NCT02569710|Odalasvir|odalasvir|mesh-list
6234991|NCT02569710|Antiviral Agents|antiviral agents|mesh-ancestor
6234992|NCT02569710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6234993|NCT02569710|Protease Inhibitors|protease inhibitors|mesh-ancestor
6234994|NCT02569710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6234995|NCT02569710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6234996|NCT02569723|Oxaliplatin|oxaliplatin|mesh-list
6234997|NCT02569723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6234998|NCT02569801|Fulvestrant|fulvestrant|mesh-list
6234999|NCT02569801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6235000|NCT02569801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6235001|NCT02569801|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6235002|NCT02569801|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6235003|NCT02569801|Hormone Antagonists|hormone antagonists|mesh-ancestor
6235004|NCT02569801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5710438|NCT03278652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710439|NCT03278626|Paclitaxel|paclitaxel|mesh-list
5710440|NCT03278626|Carboplatin|carboplatin|mesh-list
5710441|NCT03278626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5710442|NCT03278626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5710443|NCT03278626|Tubulin Modulators|tubulin modulators|mesh-ancestor
5710444|NCT03278626|Antimitotic Agents|antimitotic agents|mesh-ancestor
5710445|NCT03278626|Mitosis Modulators|mitosis modulators|mesh-ancestor
5710446|NCT03278626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710447|NCT03278522|Ramosetron|ramosetron|mesh-list
5710448|NCT03278522|Antiemetics|antiemetics|mesh-ancestor
5710449|NCT03278522|Autonomic Agents|autonomic agents|mesh-ancestor
5710450|NCT03278522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5710451|NCT03278522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710452|NCT03278522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5710453|NCT03278522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5710454|NCT03278522|Serotonin Agents|serotonin agents|mesh-ancestor
5710455|NCT03278522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5710456|NCT03278522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710457|NCT03278509|Metoprolol|metoprolol|mesh-list
5710458|NCT03278509|Bisoprolol|bisoprolol|mesh-list
6235005|NCT02569801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235006|NCT02569996|Rituximab|rituximab|mesh-list
6235007|NCT02569996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6235008|NCT02569996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6235009|NCT02569996|Immunologic Factors|immunologic factors|mesh-ancestor
6501752|NCT00648570|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6501753|NCT00648570|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6501754|NCT00648570|Cholinergic Agents|cholinergic agents|mesh-ancestor
6501755|NCT00648583|Ondansetron|ondansetron|mesh-list
6501756|NCT00648583|Antiemetics|antiemetics|mesh-ancestor
6501757|NCT00648583|Autonomic Agents|autonomic agents|mesh-ancestor
6501758|NCT00648583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6677180|NCT01586208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6235010|NCT02569996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235011|NCT02569996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6235012|NCT02570022|Bupivacaine|bupivacaine|mesh-list
6235013|NCT02570022|Ropivacaine|ropivacaine|mesh-list
6235014|NCT02570022|Anesthetics, Local|anesthetics, local|mesh-ancestor
6235015|NCT02570022|Anesthetics|anesthetics|mesh-ancestor
6235016|NCT02570022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6235017|NCT02570022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235018|NCT02570022|Sensory System Agents|sensory system agents|mesh-ancestor
6235019|NCT02570022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6235020|NCT02570074|Fosfomycin|fosfomycin|mesh-list
5710459|NCT03278509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5710460|NCT03278509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5710461|NCT03278509|Sympatholytics|sympatholytics|mesh-ancestor
5710462|NCT03278509|Autonomic Agents|autonomic agents|mesh-ancestor
5710463|NCT03278509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5710464|NCT03278509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710465|NCT03278509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5710466|NCT03278509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5710467|NCT03278509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5710468|NCT03278509|Adrenergic Agents|adrenergic agents|mesh-ancestor
5710469|NCT03278509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5710470|NCT03278509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710471|NCT03278483|Rifampin|rifampin|mesh-list
5710472|NCT03278483|Isoniazid|isoniazid|mesh-list
5710473|NCT03278483|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6235021|NCT02570074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6235022|NCT02570074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6235023|NCT02570139|Protective Agents|protective agents|mesh-list
6235024|NCT02570139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235025|NCT02570425|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6235026|NCT02570425|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6235027|NCT02570425|Respiratory System Agents|respiratory system agents|mesh-ancestor
6235028|NCT02570711|Gemcitabine|gemcitabine|mesh-list
6235029|NCT02570711|Paclitaxel|paclitaxel|mesh-list
6235030|NCT02570711|Acalabrutinib|acalabrutinib|mesh-list
6235031|NCT02570711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6235032|NCT02570711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6235033|NCT02570711|Tubulin Modulators|tubulin modulators|mesh-ancestor
6235034|NCT02570711|Antimitotic Agents|antimitotic agents|mesh-ancestor
6235035|NCT02570711|Mitosis Modulators|mitosis modulators|mesh-ancestor
6677181|NCT01586208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6677182|NCT01586208|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5710474|NCT03278483|Antitubercular Agents|antitubercular agents|mesh-ancestor
6501759|NCT00648583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710475|NCT03278483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6501760|NCT00648583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5710476|NCT03278483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5710477|NCT03278483|Leprostatic Agents|leprostatic agents|mesh-ancestor
5710478|NCT03278483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5710479|NCT03278483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5710480|NCT03278483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710481|NCT03278483|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5710482|NCT03278483|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5710483|NCT03278483|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5710484|NCT03278483|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5710485|NCT03278483|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5710486|NCT03278483|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5710487|NCT03278483|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5710488|NCT03278483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6501761|NCT00648583|Antipruritics|antipruritics|mesh-ancestor
6501762|NCT00648583|Dermatologic Agents|dermatologic agents|mesh-ancestor
6501763|NCT00648583|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6501764|NCT00648583|Serotonin Agents|serotonin agents|mesh-ancestor
6501765|NCT00648583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6501766|NCT00648583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501767|NCT00648583|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6501768|NCT00648583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6501769|NCT00648583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6501770|NCT00648583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6501771|NCT00648583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5710489|NCT03278483|Antimetabolites|antimetabolites|mesh-ancestor
6235036|NCT02570711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235037|NCT02570711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6235038|NCT02570711|Antimetabolites|antimetabolites|mesh-ancestor
6235039|NCT02570711|Antiviral Agents|antiviral agents|mesh-ancestor
6235040|NCT02570711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6235041|NCT02570711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6235042|NCT02570711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6235043|NCT02570711|Immunologic Factors|immunologic factors|mesh-ancestor
6235044|NCT02570711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235045|NCT02571049|Sumatriptan|sumatriptan|mesh-list
6235046|NCT02571049|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6235047|NCT02571049|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6235048|NCT02571049|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6235049|NCT02571049|Serotonin Agents|serotonin agents|mesh-ancestor
6235050|NCT02571049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6235051|NCT02571049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919020|NCT04986254|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5919021|NCT04986254|Meropenem|meropenem|mesh-list
5919022|NCT04986254|Tazobactam|tazobactam|mesh-list
5919023|NCT04986254|Ceftriaxone|ceftriaxone|mesh-list
5919024|NCT04986254|Piperacillin|piperacillin|mesh-list
5919025|NCT04986254|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
5919026|NCT04986254|Penicillin G|penicillin g|mesh-list
6235052|NCT02571049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710490|NCT03278483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5710491|NCT03278444|Trimetazidine|trimetazidine|mesh-list
5710492|NCT03278444|Vasodilator Agents|vasodilator agents|mesh-ancestor
5919027|NCT04986254|Penicillin G Benzathine|penicillin g benzathine|mesh-list
6235053|NCT02571153|Ketamine|ketamine|mesh-list
6235054|NCT02571153|Analgesics|analgesics|mesh-ancestor
6235055|NCT02571153|Sensory System Agents|sensory system agents|mesh-ancestor
6235056|NCT02571153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6235057|NCT02571153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235058|NCT02571153|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6235059|NCT02571153|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6235060|NCT02571153|Anesthetics, General|anesthetics, general|mesh-ancestor
6235061|NCT02571153|Anesthetics|anesthetics|mesh-ancestor
6235062|NCT02571153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6235063|NCT02571153|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6235064|NCT02571153|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6235065|NCT02571153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6235066|NCT02571153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235067|NCT02571439|Ropivacaine|ropivacaine|mesh-list
6235068|NCT02571439|Anesthetics, Local|anesthetics, local|mesh-ancestor
6235069|NCT02571439|Anesthetics|anesthetics|mesh-ancestor
6235070|NCT02571439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6235071|NCT02571439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501772|NCT00648596|Sildenafil Citrate|sildenafil citrate|mesh-list
5919028|NCT04986254|Penicillin G Procaine|penicillin g procaine|mesh-list
6235072|NCT02571439|Sensory System Agents|sensory system agents|mesh-ancestor
6235073|NCT02571439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6677183|NCT01586208|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6677184|NCT01586286|Nifedipine|nifedipine|mesh-list
6677185|NCT01586286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6677186|NCT01586286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6235074|NCT02571634|Fentanyl|fentanyl|mesh-list
6235075|NCT02571634|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6235076|NCT02571634|Narcotics|narcotics|mesh-ancestor
6235077|NCT02571634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6235078|NCT02571634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235079|NCT02571634|Analgesics|analgesics|mesh-ancestor
6235080|NCT02571634|Sensory System Agents|sensory system agents|mesh-ancestor
5710493|NCT03278431|Albendazole|albendazole|mesh-list
5710494|NCT03278431|Mebendazole|mebendazole|mesh-list
5710495|NCT03278431|Piperazine|piperazine|mesh-list
5710496|NCT03278431|Piperazine citrate|piperazine citrate|mesh-list
5710497|NCT03278431|Pyrantel|pyrantel|mesh-list
5710498|NCT03278431|Pyrantel Pamoate|pyrantel pamoate|mesh-list
5710499|NCT03278431|Oxantel|oxantel|mesh-list
5710500|NCT03278431|Oxantel pamoate|oxantel pamoate|mesh-list
5710501|NCT03278431|DMP 777|dmp 777|mesh-list
5710502|NCT03278431|Anthelmintics|anthelmintics|mesh-ancestor
5710503|NCT03278431|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5710504|NCT03278431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5710505|NCT03278431|Anticestodal Agents|anticestodal agents|mesh-ancestor
5710506|NCT03278431|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5710507|NCT03278431|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5710508|NCT03278431|Tubulin Modulators|tubulin modulators|mesh-ancestor
5710509|NCT03278431|Antimitotic Agents|antimitotic agents|mesh-ancestor
5710510|NCT03278431|Mitosis Modulators|mitosis modulators|mesh-ancestor
5710511|NCT03278431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710512|NCT03278431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5710513|NCT03278431|Antinematodal Agents|antinematodal agents|mesh-ancestor
5710514|NCT03278431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5710515|NCT03278431|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
5710516|NCT03278431|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5710517|NCT03278431|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5710518|NCT03278431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5710519|NCT03278431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710520|NCT03278405|Avelumab|avelumab|mesh-list
5710521|NCT03278405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5710522|NCT03278405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5710523|NCT03278379|Avelumab|avelumab|mesh-list
5710524|NCT03278379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5710525|NCT03278379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5710526|NCT03278314|Ivacaftor|ivacaftor|mesh-list
5710527|NCT03278314|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
5710528|NCT03278314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6235081|NCT02571634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6235082|NCT02571634|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6235083|NCT02571634|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6235084|NCT02571634|Anesthetics, General|anesthetics, general|mesh-ancestor
6235085|NCT02571634|Anesthetics|anesthetics|mesh-ancestor
6235086|NCT02571777|Fluticasone|fluticasone|mesh-list
6235087|NCT02571777|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6235088|NCT02571777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6235089|NCT02571777|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6235090|NCT02571777|Autonomic Agents|autonomic agents|mesh-ancestor
6235091|NCT02571777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6235092|NCT02571777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235093|NCT02571777|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6235094|NCT02571777|Respiratory System Agents|respiratory system agents|mesh-ancestor
6235095|NCT02571777|Dermatologic Agents|dermatologic agents|mesh-ancestor
6235096|NCT02571777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6235097|NCT02571777|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6235098|NCT02571777|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6235099|NCT02571777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6235100|NCT02571777|Adrenergic Agents|adrenergic agents|mesh-ancestor
6235101|NCT02571777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6235102|NCT02571777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235103|NCT02571972|Timolol|timolol|mesh-list
6235104|NCT02571972|Dorzolamide|dorzolamide|mesh-list
6235105|NCT02571972|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6235106|NCT02571972|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6677187|NCT01586286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710529|NCT03278314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710530|NCT03278262|Aflibercept|aflibercept|mesh-list
5710531|NCT03278262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5710532|NCT03278262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6235107|NCT02571972|Adrenergic Agents|adrenergic agents|mesh-ancestor
6235108|NCT02571972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6235109|NCT02571972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235110|NCT02571972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235111|NCT02571972|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6235112|NCT02571972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6235113|NCT02571972|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6235114|NCT02571972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6243842|NCT02681757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6243843|NCT02681809|Fibrinolysin|fibrinolysin|mesh-list
6243844|NCT02681809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6243845|NCT02681809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6243846|NCT02681809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243847|NCT02682381|Teduglutide|teduglutide|mesh-list
5710533|NCT03278262|Growth Substances|growth substances|mesh-ancestor
5710534|NCT03278262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710535|NCT03278262|Growth Inhibitors|growth inhibitors|mesh-ancestor
5710536|NCT03278262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5710537|NCT03278015|Gemcitabine|gemcitabine|mesh-list
5710538|NCT03278015|Paclitaxel|paclitaxel|mesh-list
5710539|NCT03278015|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5710540|NCT03278015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5710541|NCT03278015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5710542|NCT03278015|Tubulin Modulators|tubulin modulators|mesh-ancestor
5710543|NCT03278015|Antimitotic Agents|antimitotic agents|mesh-ancestor
5710544|NCT03278015|Mitosis Modulators|mitosis modulators|mesh-ancestor
5710545|NCT03278015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710546|NCT03278015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5710547|NCT03278015|Antimetabolites|antimetabolites|mesh-ancestor
5710548|NCT03278015|Antiviral Agents|antiviral agents|mesh-ancestor
5710549|NCT03278015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5710550|NCT03278015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5710551|NCT03278015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5710552|NCT03278015|Immunologic Factors|immunologic factors|mesh-ancestor
5710553|NCT03278015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710554|NCT03277872|Pyrithione zinc|pyrithione zinc|mesh-list
5710555|NCT03277872|Keratolytic Agents|keratolytic agents|mesh-ancestor
5710556|NCT03277872|Dermatologic Agents|dermatologic agents|mesh-ancestor
5710557|NCT03277755|Adafosbuvir|adafosbuvir|mesh-list
5710558|NCT03277755|Antiviral Agents|antiviral agents|mesh-ancestor
5710559|NCT03277755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5721599|NCT03204318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5721600|NCT03204318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721601|NCT03204318|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5721602|NCT03204318|Contraceptive Agents|contraceptive agents|mesh-ancestor
5721603|NCT03204318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6243848|NCT02682381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6243849|NCT02682381|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6243850|NCT02682381|Protective Agents|protective agents|mesh-ancestor
6243851|NCT02682381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243852|NCT02682498|Bupivacaine|bupivacaine|mesh-list
6243853|NCT02682498|Anesthetics, Local|anesthetics, local|mesh-ancestor
6243854|NCT02682498|Anesthetics|anesthetics|mesh-ancestor
6243855|NCT02682498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6243856|NCT02682498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243857|NCT02682498|Sensory System Agents|sensory system agents|mesh-ancestor
6243858|NCT02682498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6243859|NCT02682563|Dapagliflozin|dapagliflozin|mesh-list
6243860|NCT02682563|Gliclazide|gliclazide|mesh-list
6243861|NCT02682563|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6243862|NCT02682563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243863|NCT02682563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6243864|NCT02682563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243865|NCT02682602|Tacrine|tacrine|mesh-list
6243866|NCT02682602|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6243867|NCT02682602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6243868|NCT02682602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243869|NCT02682602|Cholinergic Agents|cholinergic agents|mesh-ancestor
6243870|NCT02682602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6243871|NCT02682602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779686|NCT02180503|Incretins|incretins|mesh-ancestor
5710560|NCT03277599|Tramadol|tramadol|mesh-list
5710561|NCT03277599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5710562|NCT03277599|Narcotics|narcotics|mesh-ancestor
5710563|NCT03277599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5710564|NCT03277599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710565|NCT03277599|Analgesics|analgesics|mesh-ancestor
5710566|NCT03277599|Sensory System Agents|sensory system agents|mesh-ancestor
5710567|NCT03277599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5710568|NCT03277573|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
5710569|NCT03277573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5710570|NCT03277573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5710571|NCT03277573|Analgesics|analgesics|mesh-ancestor
5710572|NCT03277573|Sensory System Agents|sensory system agents|mesh-ancestor
5710573|NCT03277573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5710574|NCT03277573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710575|NCT03277573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5710576|NCT03277573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5710577|NCT03277482|Durvalumab|durvalumab|mesh-list
5710578|NCT03277482|Tremelimumab|tremelimumab|mesh-list
5710579|NCT03277482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5710580|NCT03277482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5710581|NCT03277430|Tacrolimus|tacrolimus|mesh-list
5710582|NCT03277430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5710583|NCT03277430|Immunologic Factors|immunologic factors|mesh-ancestor
5710584|NCT03277430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710585|NCT03277430|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5710586|NCT03277430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5710587|NCT03277430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710588|NCT03277391|Droperidol|droperidol|mesh-list
5710589|NCT03277391|Morphine|morphine|mesh-list
5710590|NCT03277391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5710591|NCT03277391|Narcotics|narcotics|mesh-ancestor
6235115|NCT02572167|Nivolumab|nivolumab|mesh-list
6235116|NCT02572167|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6235117|NCT02572167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6235118|NCT02572167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6235119|NCT02572167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6235120|NCT02572167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235121|NCT02572609|Ambroxol|ambroxol|mesh-list
6235122|NCT02572609|Expectorants|expectorants|mesh-ancestor
6235123|NCT02572609|Respiratory System Agents|respiratory system agents|mesh-ancestor
6235124|NCT02572752|Nintedanib|nintedanib|mesh-list
6235125|NCT02572752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6235126|NCT02572752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6235127|NCT02572752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6235128|NCT02572752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710592|NCT03277391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5710593|NCT03277391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710594|NCT03277391|Analgesics|analgesics|mesh-ancestor
5710595|NCT03277391|Sensory System Agents|sensory system agents|mesh-ancestor
5710596|NCT03277391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6235129|NCT02573012|Prednisone|prednisone|mesh-list
6235130|NCT02573012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6235131|NCT02573012|Glucocorticoids|glucocorticoids|mesh-ancestor
6235132|NCT02573012|Hormones|hormones|mesh-ancestor
6235133|NCT02573012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6235134|NCT02573012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235135|NCT02573012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6235136|NCT02573012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6235137|NCT02573155|Tiotropium Bromide|tiotropium bromide|mesh-list
6235138|NCT02573155|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6501773|NCT00648596|Vasodilator Agents|vasodilator agents|mesh-ancestor
6501774|NCT00648596|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6501775|NCT00648596|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6501776|NCT00648596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5919029|NCT04986254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6235139|NCT02573155|Autonomic Agents|autonomic agents|mesh-ancestor
6243872|NCT02682602|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6501777|NCT00648596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501778|NCT00648596|Urological Agents|urological agents|mesh-ancestor
6501779|NCT00648622|Carvedilol|carvedilol|mesh-list
6501780|NCT00648622|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6501781|NCT00648622|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5710597|NCT03277391|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5919030|NCT04986254|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5919031|NCT04986254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5710598|NCT03277391|Antiemetics|antiemetics|mesh-ancestor
5710599|NCT03277391|Autonomic Agents|autonomic agents|mesh-ancestor
5710600|NCT03277391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5710601|NCT03277391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5710602|NCT03277391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5710603|NCT03277391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5710604|NCT03277391|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5710605|NCT03277391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5710606|NCT03277391|Dopamine Agents|dopamine agents|mesh-ancestor
5710607|NCT03277391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5710608|NCT03277391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710609|NCT03277339|Paroxetine|paroxetine|mesh-list
5710610|NCT03277339|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5710611|NCT03277339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5710612|NCT03277339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5710613|NCT03277339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710614|NCT03277339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5710615|NCT03277339|Serotonin Agents|serotonin agents|mesh-ancestor
5710616|NCT03277339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710617|NCT03277339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5710618|NCT03277339|Antidepressive Agents|antidepressive agents|mesh-ancestor
5710619|NCT03277339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5710620|NCT03277339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5710621|NCT03277339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5710622|NCT03277339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5710623|NCT03277313|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5710624|NCT03277313|Immunologic Factors|immunologic factors|mesh-ancestor
6235140|NCT02573155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6235141|NCT02573155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235142|NCT02573155|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6235143|NCT02573155|Respiratory System Agents|respiratory system agents|mesh-ancestor
6235144|NCT02573155|Parasympatholytics|parasympatholytics|mesh-ancestor
6235145|NCT02573155|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6235146|NCT02573155|Cholinergic Agents|cholinergic agents|mesh-ancestor
6235147|NCT02573155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6235148|NCT02573155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235149|NCT02573181|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6235150|NCT02573181|Immunologic Factors|immunologic factors|mesh-ancestor
6235151|NCT02573181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235152|NCT02573233|Fluticasone|fluticasone|mesh-list
6235153|NCT02573233|Xhance|xhance|mesh-list
6235154|NCT02573233|Mometasone Furoate|mometasone furoate|mesh-list
6235155|NCT02573233|Budesonide|budesonide|mesh-list
6235156|NCT02573233|Formoterol Fumarate|formoterol fumarate|mesh-list
6235157|NCT02573233|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6235158|NCT02573233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6235159|NCT02573233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6235160|NCT02573233|Autonomic Agents|autonomic agents|mesh-ancestor
6235161|NCT02573233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6235162|NCT02573233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235163|NCT02573233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6235164|NCT02573233|Respiratory System Agents|respiratory system agents|mesh-ancestor
6235165|NCT02573233|Dermatologic Agents|dermatologic agents|mesh-ancestor
5710625|NCT03277313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710626|NCT03277222|Insulin|insulin|mesh-list
5710627|NCT03277222|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5710628|NCT03277222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5710629|NCT03277222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710630|NCT03277209|Plerixafor|plerixafor|mesh-list
5710631|NCT03277209|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5710632|NCT03277209|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5710633|NCT03277209|Antiviral Agents|antiviral agents|mesh-ancestor
5710634|NCT03277209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5710635|NCT03277079|Ezetimibe|ezetimibe|mesh-list
5710636|NCT03277079|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
5710637|NCT03277079|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5710638|NCT03277079|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5710639|NCT03277079|Antimetabolites|antimetabolites|mesh-ancestor
5710640|NCT03277079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710641|NCT03277079|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5710642|NCT03277079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5710643|NCT03277001|Enoxaparin|enoxaparin|mesh-list
5710644|NCT03277001|Rivaroxaban|rivaroxaban|mesh-list
5710645|NCT03277001|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5710646|NCT03277001|Antithrombins|antithrombins|mesh-ancestor
6235166|NCT02573233|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6235167|NCT02573233|Glucocorticoids|glucocorticoids|mesh-ancestor
6235168|NCT02573233|Hormones|hormones|mesh-ancestor
6235169|NCT02573233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6235170|NCT02573233|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6235171|NCT02573233|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6235172|NCT02573233|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6235173|NCT02573233|Adrenergic Agents|adrenergic agents|mesh-ancestor
6235174|NCT02573233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6235175|NCT02573233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235176|NCT02573311|Tamsulosin|tamsulosin|mesh-list
6235177|NCT02573311|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6235178|NCT02573311|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6235179|NCT02573311|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6235180|NCT02573311|Adrenergic Agents|adrenergic agents|mesh-ancestor
6235181|NCT02573311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6235182|NCT02573311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235183|NCT02573311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235184|NCT02573311|Urological Agents|urological agents|mesh-ancestor
6235185|NCT02573493|Paclitaxel|paclitaxel|mesh-list
6235186|NCT02573493|Cisplatin|cisplatin|mesh-list
6235187|NCT02573493|Cetuximab|cetuximab|mesh-list
6235188|NCT02573493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6235189|NCT02573493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6235190|NCT02573493|Tubulin Modulators|tubulin modulators|mesh-ancestor
6235191|NCT02573493|Antimitotic Agents|antimitotic agents|mesh-ancestor
6235192|NCT02573493|Mitosis Modulators|mitosis modulators|mesh-ancestor
6235193|NCT02573493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235194|NCT02573493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6235195|NCT02573857|Artefenomel|artefenomel|mesh-list
6235196|NCT02573857|Antimalarials|antimalarials|mesh-ancestor
6235197|NCT02573857|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6235198|NCT02573857|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5710647|NCT03277001|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5710648|NCT03277001|Protease Inhibitors|protease inhibitors|mesh-ancestor
5710649|NCT03277001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5710650|NCT03277001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710651|NCT03277001|Anticoagulants|anticoagulants|mesh-ancestor
5710652|NCT03277001|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5710653|NCT03277001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5710654|NCT03276858|Midazolam|midazolam|mesh-list
5710655|NCT03276858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5710656|NCT03276858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6235199|NCT02573857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6235200|NCT02573870|Fluticasone|fluticasone|mesh-list
6235201|NCT02573870|Xhance|xhance|mesh-list
6235202|NCT02573870|Albuterol|albuterol|mesh-list
6235203|NCT02573870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6235204|NCT02573870|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6235205|NCT02573870|Autonomic Agents|autonomic agents|mesh-ancestor
6235206|NCT02573870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6235207|NCT02573870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235208|NCT02573870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6235209|NCT02573870|Respiratory System Agents|respiratory system agents|mesh-ancestor
6235210|NCT02573870|Dermatologic Agents|dermatologic agents|mesh-ancestor
6235211|NCT02573870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6235212|NCT02573870|Tocolytic Agents|tocolytic agents|mesh-ancestor
6235213|NCT02573870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6235214|NCT02573870|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6235215|NCT02573870|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6235216|NCT02573870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6235217|NCT02573870|Adrenergic Agents|adrenergic agents|mesh-ancestor
6235218|NCT02573870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6235219|NCT02573870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235220|NCT02573883|Clobetasol|clobetasol|mesh-list
6235221|NCT02573883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6235222|NCT02573883|Glucocorticoids|glucocorticoids|mesh-ancestor
6235223|NCT02573883|Hormones|hormones|mesh-ancestor
6235224|NCT02573883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6235225|NCT02573883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235226|NCT02574078|Gemcitabine|gemcitabine|mesh-list
6235227|NCT02574078|Paclitaxel|paclitaxel|mesh-list
6235228|NCT02574078|Docetaxel|docetaxel|mesh-list
6235229|NCT02574078|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6235230|NCT02574078|Bevacizumab|bevacizumab|mesh-list
5710657|NCT03276858|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6235231|NCT02574078|Carboplatin|carboplatin|mesh-list
6235232|NCT02574078|Nivolumab|nivolumab|mesh-list
6235233|NCT02574078|Pemetrexed|pemetrexed|mesh-list
6235234|NCT02574078|Crizotinib|crizotinib|mesh-list
6235235|NCT02574078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6235236|NCT02574078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6235237|NCT02574078|Tubulin Modulators|tubulin modulators|mesh-ancestor
6235238|NCT02574078|Antimitotic Agents|antimitotic agents|mesh-ancestor
6235239|NCT02574078|Mitosis Modulators|mitosis modulators|mesh-ancestor
6235240|NCT02574078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710658|NCT03276858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5710659|NCT03276858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710660|NCT03276858|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5710661|NCT03276858|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5710662|NCT03276858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5710663|NCT03276858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5710664|NCT03276858|Anesthetics, General|anesthetics, general|mesh-ancestor
5710665|NCT03276858|Anesthetics|anesthetics|mesh-ancestor
5710666|NCT03276858|GABA Modulators|gaba modulators|mesh-ancestor
5710667|NCT03276858|GABA Agents|gaba agents|mesh-ancestor
5710668|NCT03276858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5710669|NCT03276858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710670|NCT03276832|Pembrolizumab|pembrolizumab|mesh-list
5710671|NCT03276832|Imiquimod|imiquimod|mesh-list
5710672|NCT03276832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5710673|NCT03276832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5710674|NCT03276832|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5710675|NCT03276832|Immunologic Factors|immunologic factors|mesh-ancestor
5710676|NCT03276832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710677|NCT03276832|Interferon Inducers|interferon inducers|mesh-ancestor
5710678|NCT03276689|Pregabalin|pregabalin|mesh-list
5710679|NCT03276689|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6235241|NCT02574078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6235242|NCT02574078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6235243|NCT02574078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6235244|NCT02574078|Growth Substances|growth substances|mesh-ancestor
6235245|NCT02574078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235246|NCT02574078|Growth Inhibitors|growth inhibitors|mesh-ancestor
6235247|NCT02574078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6501782|NCT00648622|Adrenergic Agents|adrenergic agents|mesh-ancestor
6501783|NCT00648622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6779687|NCT02180503|Hormones|hormones|mesh-ancestor
6235248|NCT02574078|Antimetabolites|antimetabolites|mesh-ancestor
6235249|NCT02574078|Antiviral Agents|antiviral agents|mesh-ancestor
6235250|NCT02574078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6235251|NCT02574078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6235252|NCT02574078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6235253|NCT02574078|Immunologic Factors|immunologic factors|mesh-ancestor
6235254|NCT02574078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6235255|NCT02574078|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6235256|NCT02574078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6235257|NCT02574078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6235258|NCT02574260|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
5710680|NCT03276689|Analgesics|analgesics|mesh-ancestor
5710681|NCT03276689|Sensory System Agents|sensory system agents|mesh-ancestor
5710682|NCT03276689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5710683|NCT03276689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710684|NCT03276689|Anticonvulsants|anticonvulsants|mesh-ancestor
5710685|NCT03276689|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5710686|NCT03276689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5710687|NCT03276689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710688|NCT03276689|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5710689|NCT03276689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5710690|NCT03276689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5710691|NCT03276689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5710692|NCT03276689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5710693|NCT03276689|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5710694|NCT03276689|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5710695|NCT03276689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5710696|NCT03276689|Antidepressive Agents|antidepressive agents|mesh-ancestor
5710697|NCT03276689|Dopamine Agents|dopamine agents|mesh-ancestor
5710698|NCT03276598|Losartan|losartan|mesh-list
5710699|NCT03276598|Amlodipine|amlodipine|mesh-list
6243873|NCT02682602|Autonomic Agents|autonomic agents|mesh-ancestor
5710700|NCT03276598|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5710701|NCT03276598|Bisoprolol|bisoprolol|mesh-list
6235259|NCT02574260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6235260|NCT02574260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6235261|NCT02574520|Bupivacaine|bupivacaine|mesh-list
6235262|NCT02574520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6235263|NCT02574520|Anesthetics, Local|anesthetics, local|mesh-ancestor
6235264|NCT02574520|Anesthetics|anesthetics|mesh-ancestor
6235265|NCT02574520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6235266|NCT02574520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235267|NCT02574520|Sensory System Agents|sensory system agents|mesh-ancestor
6235268|NCT02574520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5710702|NCT03276598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5710703|NCT03276598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5710704|NCT03276598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5710705|NCT03276598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710706|NCT03276598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5710707|NCT03276598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710708|NCT03276598|Vasodilator Agents|vasodilator agents|mesh-ancestor
5710709|NCT03276598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5710710|NCT03276598|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5710711|NCT03276598|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5710712|NCT03276598|Diuretics|diuretics|mesh-ancestor
5710713|NCT03276598|Natriuretic Agents|natriuretic agents|mesh-ancestor
5710714|NCT03276598|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5710715|NCT03276598|Sympatholytics|sympatholytics|mesh-ancestor
5710716|NCT03276598|Autonomic Agents|autonomic agents|mesh-ancestor
5710717|NCT03276598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5710718|NCT03276598|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5710719|NCT03276598|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5710720|NCT03276598|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6235269|NCT02574598|Docetaxel|docetaxel|mesh-list
6235270|NCT02574598|Pembrolizumab|pembrolizumab|mesh-list
6235271|NCT02574598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6235272|NCT02574598|Tubulin Modulators|tubulin modulators|mesh-ancestor
6235273|NCT02574598|Antimitotic Agents|antimitotic agents|mesh-ancestor
6235274|NCT02574598|Mitosis Modulators|mitosis modulators|mesh-ancestor
5710721|NCT03276598|Adrenergic Agents|adrenergic agents|mesh-ancestor
5710722|NCT03276598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5710723|NCT03276572|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
6235275|NCT02574598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235276|NCT02574598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6235277|NCT02574637|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6501784|NCT00648622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501785|NCT00648622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501786|NCT00648622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6501787|NCT00648622|Antioxidants|antioxidants|mesh-ancestor
6501788|NCT00648622|Protective Agents|protective agents|mesh-ancestor
6501789|NCT00648622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6501790|NCT00648622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6501791|NCT00648622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6501792|NCT00648622|Vasodilator Agents|vasodilator agents|mesh-ancestor
6501793|NCT00648622|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6501794|NCT00648622|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6501795|NCT00648661|Dexetimide|dexetimide|mesh-list
6501796|NCT00648661|Citalopram|citalopram|mesh-list
6501797|NCT00648661|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6501798|NCT00648661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6501799|NCT00648661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6501800|NCT00648661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501801|NCT00648661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6501802|NCT00648661|Serotonin Agents|serotonin agents|mesh-ancestor
6501803|NCT00648661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501804|NCT00648661|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6501805|NCT00648661|Antidepressive Agents|antidepressive agents|mesh-ancestor
6501806|NCT00648661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6501807|NCT00648661|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6501808|NCT00648661|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6501809|NCT00648661|Parasympatholytics|parasympatholytics|mesh-ancestor
6235278|NCT02574637|Immunologic Factors|immunologic factors|mesh-ancestor
6235279|NCT02574637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235280|NCT02574832|Lidocaine|lidocaine|mesh-list
6235281|NCT02574832|Fentanyl|fentanyl|mesh-list
6235282|NCT02574832|Anesthetics, Local|anesthetics, local|mesh-ancestor
6235283|NCT02574832|Anesthetics|anesthetics|mesh-ancestor
6235284|NCT02574832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6501810|NCT00648661|Autonomic Agents|autonomic agents|mesh-ancestor
6501811|NCT00648661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6501812|NCT00648661|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6677188|NCT01586286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6677189|NCT01586286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677190|NCT01586286|Vasodilator Agents|vasodilator agents|mesh-ancestor
6677191|NCT01586286|Tocolytic Agents|tocolytic agents|mesh-ancestor
6677192|NCT01586286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6677193|NCT01586299|Acetaminophen|acetaminophen|mesh-list
6677194|NCT01586299|Ibuprofen|ibuprofen|mesh-list
6677195|NCT01586299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6677196|NCT01586299|Analgesics|analgesics|mesh-ancestor
6677197|NCT01586299|Sensory System Agents|sensory system agents|mesh-ancestor
5710724|NCT03276572|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5710725|NCT03276572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710726|NCT03276533|Lidocaine|lidocaine|mesh-list
5710727|NCT03276533|Dexmedetomidine|dexmedetomidine|mesh-list
5710728|NCT03276533|Anesthetics, Local|anesthetics, local|mesh-ancestor
5710729|NCT03276533|Anesthetics|anesthetics|mesh-ancestor
5710730|NCT03276533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5710731|NCT03276533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710732|NCT03276533|Sensory System Agents|sensory system agents|mesh-ancestor
5710733|NCT03276533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5710734|NCT03276533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5710735|NCT03276533|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5710736|NCT03276533|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5710737|NCT03276533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5710738|NCT03276533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710739|NCT03276533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5710740|NCT03276533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5710741|NCT03276533|Analgesics|analgesics|mesh-ancestor
5710742|NCT03276533|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5710743|NCT03276533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5710744|NCT03276533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5710745|NCT03276533|Adrenergic Agents|adrenergic agents|mesh-ancestor
5710746|NCT03276533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5710747|NCT03276520|Ethanol|ethanol|mesh-list
5710748|NCT03276520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5710749|NCT03276520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5710750|NCT03276520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5710751|NCT03276520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710752|NCT03276325|Dexamethasone|dexamethasone|mesh-list
5710753|NCT03276325|Nalbuphine|nalbuphine|mesh-list
5710754|NCT03276325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5710755|NCT03276325|Antiemetics|antiemetics|mesh-ancestor
5710756|NCT03276325|Autonomic Agents|autonomic agents|mesh-ancestor
6235285|NCT02574832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677198|NCT01586299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6677199|NCT01586299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677200|NCT01586299|Antipyretics|antipyretics|mesh-ancestor
6677201|NCT01586299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6235286|NCT02574832|Sensory System Agents|sensory system agents|mesh-ancestor
6235287|NCT02574832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6235288|NCT02574832|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6235289|NCT02574832|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6235290|NCT02574832|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6235291|NCT02574832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6235292|NCT02574832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235293|NCT02574832|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6235294|NCT02574832|Narcotics|narcotics|mesh-ancestor
6235295|NCT02574832|Analgesics|analgesics|mesh-ancestor
6235296|NCT02574832|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6235297|NCT02574832|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6235298|NCT02574832|Anesthetics, General|anesthetics, general|mesh-ancestor
6501813|NCT00648661|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6501814|NCT00648661|Cholinergic Agents|cholinergic agents|mesh-ancestor
6501815|NCT00648713|Terbinafine|terbinafine|mesh-list
6501816|NCT00648713|Antifungal Agents|antifungal agents|mesh-ancestor
6501817|NCT00648713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6501818|NCT00648713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6501819|NCT00648713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501820|NCT00648726|Azithromycin|azithromycin|mesh-list
6501821|NCT00648726|Erythromycin|erythromycin|mesh-list
6501822|NCT00648726|Erythromycin Estolate|erythromycin estolate|mesh-list
6501823|NCT00648726|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
6501824|NCT00648726|Erythromycin stearate|erythromycin stearate|mesh-list
6501825|NCT00648726|Cefuroxime|cefuroxime|mesh-list
6501826|NCT00648726|Cefuroxime axetil|cefuroxime axetil|mesh-list
5710757|NCT03276325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5710758|NCT03276325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710759|NCT03276325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5710760|NCT03276325|Glucocorticoids|glucocorticoids|mesh-ancestor
5710761|NCT03276325|Hormones|hormones|mesh-ancestor
5710762|NCT03276325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5710763|NCT03276325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5710764|NCT03276325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5710765|NCT03276325|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5710766|NCT03276325|Narcotics|narcotics|mesh-ancestor
5710767|NCT03276325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5710768|NCT03276325|Analgesics|analgesics|mesh-ancestor
5710769|NCT03276325|Sensory System Agents|sensory system agents|mesh-ancestor
5710770|NCT03276156|Apatinib|apatinib|mesh-list
5710771|NCT03276156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5710772|NCT03276156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5710773|NCT03276156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5710774|NCT03276156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235299|NCT02574845|Metformin|metformin|mesh-list
6235300|NCT02574845|Furosemide|furosemide|mesh-list
6235301|NCT02574845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6235302|NCT02574845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6235303|NCT02574845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235304|NCT02574845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6235305|NCT02574845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6235306|NCT02574845|Antimetabolites|antimetabolites|mesh-ancestor
6235307|NCT02574845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235308|NCT02574845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6235309|NCT02574845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6235310|NCT02574845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6235311|NCT02574845|Diuretics|diuretics|mesh-ancestor
6235312|NCT02574845|Natriuretic Agents|natriuretic agents|mesh-ancestor
6235313|NCT02574845|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6235314|NCT02574845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6235315|NCT02575807|Pembrolizumab|pembrolizumab|mesh-list
6235316|NCT02575807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6501827|NCT00648726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6501828|NCT00648726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6501829|NCT00648726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6501830|NCT00648726|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6235317|NCT02575807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6235318|NCT02575833|Erenumab|erenumab|mesh-list
6235319|NCT02575833|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
6235320|NCT02575833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235321|NCT02575833|Analgesics|analgesics|mesh-ancestor
6235322|NCT02575833|Sensory System Agents|sensory system agents|mesh-ancestor
6235323|NCT02575833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6235324|NCT02575833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235325|NCT02576067|Methotrexate|methotrexate|mesh-list
6235326|NCT02576067|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6235327|NCT02576067|Abortifacient Agents|abortifacient agents|mesh-ancestor
6235328|NCT02576067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6235329|NCT02576067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501831|NCT00648726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6501832|NCT00648726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501833|NCT00648765|Anagrelide|anagrelide|mesh-list
6501834|NCT00648765|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6501835|NCT00648765|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6501836|NCT00648765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501837|NCT00648765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6501838|NCT00648778|Loxapine|loxapine|mesh-list
6501839|NCT00648778|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6501840|NCT00648778|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6235330|NCT02576067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6235331|NCT02576067|Antimetabolites|antimetabolites|mesh-ancestor
6235332|NCT02576067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501841|NCT00648778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5710775|NCT03276143|Enoxaparin|enoxaparin|mesh-list
6235333|NCT02576067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6235334|NCT02576067|Dermatologic Agents|dermatologic agents|mesh-ancestor
5710776|NCT03276143|Apixaban|apixaban|mesh-list
5710777|NCT03276143|Anticoagulants|anticoagulants|mesh-ancestor
5710778|NCT03276143|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5710779|NCT03276143|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5710780|NCT03276143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710781|NCT03276143|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6235335|NCT02576067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6235336|NCT02576067|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6235337|NCT02576067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6235338|NCT02576067|Immunologic Factors|immunologic factors|mesh-ancestor
6235339|NCT02576067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6235340|NCT02576067|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6235341|NCT02576145|Daclizumab|daclizumab|mesh-list
6235342|NCT02576145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6235343|NCT02576145|Immunologic Factors|immunologic factors|mesh-ancestor
6235344|NCT02576145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710782|NCT03276143|Antithrombins|antithrombins|mesh-ancestor
5710783|NCT03276143|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5710784|NCT03276143|Protease Inhibitors|protease inhibitors|mesh-ancestor
5710785|NCT03276143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5721604|NCT03204318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5721605|NCT03204318|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5721606|NCT03204318|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5721607|NCT03204318|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5721608|NCT03204318|Androgen Antagonists|androgen antagonists|mesh-ancestor
5721609|NCT03204318|Hormone Antagonists|hormone antagonists|mesh-ancestor
5721610|NCT03204097|Alendronate|alendronate|mesh-list
5721611|NCT03204097|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5721612|NCT03204097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721613|NCT03203967|Morphine|morphine|mesh-list
5721614|NCT03203967|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5721615|NCT03203967|Narcotics|narcotics|mesh-ancestor
5721616|NCT03203967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5721617|NCT03203967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721618|NCT03203967|Analgesics|analgesics|mesh-ancestor
5721619|NCT03203967|Sensory System Agents|sensory system agents|mesh-ancestor
5721620|NCT03203967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5721621|NCT03204006|Dexmedetomidine|dexmedetomidine|mesh-list
5721622|NCT03204006|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5721623|NCT03204006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5721624|NCT03204006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721625|NCT03204006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5721626|NCT03204006|Analgesics|analgesics|mesh-ancestor
5721627|NCT03204006|Sensory System Agents|sensory system agents|mesh-ancestor
5721628|NCT03204006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5721629|NCT03204006|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5721630|NCT03204006|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5721631|NCT03204006|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5721632|NCT03204006|Adrenergic Agents|adrenergic agents|mesh-ancestor
5721633|NCT03204006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5721634|NCT03204006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721635|NCT03204032|Thalidomide|thalidomide|mesh-list
5721636|NCT03204032|Temozolomide|temozolomide|mesh-list
5721637|NCT03204032|Tegafur|tegafur|mesh-list
5721638|NCT03204032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5721639|NCT03204032|Alkylating Agents|alkylating agents|mesh-ancestor
5721640|NCT03204032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721641|NCT03204032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5721642|NCT03204032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5721643|NCT03204032|Immunologic Factors|immunologic factors|mesh-ancestor
5721644|NCT03204032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235345|NCT02576249|Methylprednisolone|methylprednisolone|mesh-list
6235346|NCT02576249|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6235347|NCT02576249|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6501842|NCT00648778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501843|NCT00648778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6501844|NCT00648778|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6501845|NCT00648778|Dopamine Agents|dopamine agents|mesh-ancestor
6501846|NCT00648778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6501847|NCT00648778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501848|NCT00648791|Finasteride|finasteride|mesh-list
5721645|NCT03204032|Leprostatic Agents|leprostatic agents|mesh-ancestor
5721646|NCT03204032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5710786|NCT03276013|Pembrolizumab|pembrolizumab|mesh-list
5710787|NCT03276013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5710788|NCT03276013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5710789|NCT03275818|Paclitaxel|paclitaxel|mesh-list
5710790|NCT03275818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6235348|NCT02576249|Prednisolone|prednisolone|mesh-list
6235349|NCT02576249|Prednisolone acetate|prednisolone acetate|mesh-list
6235350|NCT02576249|Ropivacaine|ropivacaine|mesh-list
6235351|NCT02576249|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6235352|NCT02576249|Prednisolone phosphate|prednisolone phosphate|mesh-list
6235353|NCT02576249|Anesthetics, Local|anesthetics, local|mesh-ancestor
6235354|NCT02576249|Anesthetics|anesthetics|mesh-ancestor
6235355|NCT02576249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6235356|NCT02576249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235357|NCT02576249|Sensory System Agents|sensory system agents|mesh-ancestor
6235358|NCT02576249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6235359|NCT02576249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6235360|NCT02576249|Antiemetics|antiemetics|mesh-ancestor
6235361|NCT02576249|Autonomic Agents|autonomic agents|mesh-ancestor
6235362|NCT02576249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6235363|NCT02576249|Glucocorticoids|glucocorticoids|mesh-ancestor
6235364|NCT02576249|Hormones|hormones|mesh-ancestor
6235365|NCT02576249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6235366|NCT02576249|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6235367|NCT02576249|Protective Agents|protective agents|mesh-ancestor
6235368|NCT02576249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6235369|NCT02576249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6235370|NCT02576509|Nivolumab|nivolumab|mesh-list
6235371|NCT02576509|Sorafenib|sorafenib|mesh-list
6235372|NCT02576509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6235373|NCT02576509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6235374|NCT02576509|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6235375|NCT02576509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235376|NCT02576509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6235377|NCT02576509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6235378|NCT02576639|CNP520|cnp520|mesh-list
6235379|NCT02576639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6235380|NCT02576639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235381|NCT02576652|Tetracycline|tetracycline|mesh-list
6235382|NCT02576652|Demeclocycline|demeclocycline|mesh-list
6235383|NCT02576652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6235384|NCT02576652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6235385|NCT02576652|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6235386|NCT02576652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6235387|NCT02576652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235388|NCT02576678|Apremilast|apremilast|mesh-list
6235389|NCT02576678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6235390|NCT02576678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6235391|NCT02576678|Analgesics|analgesics|mesh-ancestor
6235392|NCT02576678|Sensory System Agents|sensory system agents|mesh-ancestor
6235393|NCT02576678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6235394|NCT02576678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235395|NCT02576678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6235396|NCT02576678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6235397|NCT02576678|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6235398|NCT02576678|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6235399|NCT02576678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6235400|NCT02576678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235401|NCT02576938|Triamcinolone|triamcinolone|mesh-list
6235402|NCT02576938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6235403|NCT02576938|Glucocorticoids|glucocorticoids|mesh-ancestor
6235404|NCT02576938|Hormones|hormones|mesh-ancestor
6235405|NCT02576938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6235406|NCT02576938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235407|NCT02576977|Dexamethasone|dexamethasone|mesh-list
6235408|NCT02576977|Pembrolizumab|pembrolizumab|mesh-list
6235409|NCT02576977|Pomalidomide|pomalidomide|mesh-list
6501849|NCT00648791|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6501850|NCT00648791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6501851|NCT00648791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6501852|NCT00648791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501853|NCT00648791|Hormone Antagonists|hormone antagonists|mesh-ancestor
6501854|NCT00648791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5710791|NCT03275818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6501855|NCT00648791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501856|NCT00648791|Urological Agents|urological agents|mesh-ancestor
6501857|NCT00648804|Ondansetron|ondansetron|mesh-list
6501858|NCT00648804|Antiemetics|antiemetics|mesh-ancestor
6501859|NCT00648804|Autonomic Agents|autonomic agents|mesh-ancestor
6501860|NCT00648804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5710792|NCT03275818|Tubulin Modulators|tubulin modulators|mesh-ancestor
6235410|NCT02576977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6235411|NCT02576977|Antiemetics|antiemetics|mesh-ancestor
6235412|NCT02576977|Autonomic Agents|autonomic agents|mesh-ancestor
6235413|NCT02576977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6235414|NCT02576977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235415|NCT02576977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6235416|NCT02576977|Glucocorticoids|glucocorticoids|mesh-ancestor
6235417|NCT02576977|Hormones|hormones|mesh-ancestor
5710793|NCT03275818|Antimitotic Agents|antimitotic agents|mesh-ancestor
5710794|NCT03275818|Mitosis Modulators|mitosis modulators|mesh-ancestor
5710795|NCT03275818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710796|NCT03275701|Triumeq|triumeq|mesh-list
5710797|NCT03275701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5710798|NCT03275701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5710799|NCT03275701|Antiviral Agents|antiviral agents|mesh-ancestor
5710800|NCT03275701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5710801|NCT03275597|Durvalumab|durvalumab|mesh-list
5710802|NCT03275597|Tremelimumab|tremelimumab|mesh-list
5710803|NCT03275597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5710804|NCT03275597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5710805|NCT03275558|Sunitinib|sunitinib|mesh-list
5710806|NCT03275558|Axitinib|axitinib|mesh-list
5710807|NCT03275558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5710808|NCT03275558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5710809|NCT03275558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5710810|NCT03275558|Growth Substances|growth substances|mesh-ancestor
5710811|NCT03275558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710812|NCT03275558|Growth Inhibitors|growth inhibitors|mesh-ancestor
5710813|NCT03275558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5710814|NCT03275558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6235418|NCT02576977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6235419|NCT02576977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6235420|NCT02576977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6235421|NCT02576977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6235422|NCT02576977|Immunologic Factors|immunologic factors|mesh-ancestor
6235423|NCT02576977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6235424|NCT02576977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6235425|NCT02576977|Growth Substances|growth substances|mesh-ancestor
6235426|NCT02576977|Growth Inhibitors|growth inhibitors|mesh-ancestor
6235427|NCT02576990|Pembrolizumab|pembrolizumab|mesh-list
6235428|NCT02576990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6235429|NCT02576990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6235430|NCT02577003|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6235431|NCT02577003|Ipragliflozin|ipragliflozin|mesh-list
6235432|NCT02577003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6235433|NCT02577003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235434|NCT02577003|Incretins|incretins|mesh-ancestor
6235435|NCT02577003|Hormones|hormones|mesh-ancestor
6235436|NCT02577003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6235437|NCT02577003|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6235438|NCT02577003|Protease Inhibitors|protease inhibitors|mesh-ancestor
5710815|NCT03275558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235439|NCT02577003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6235440|NCT02577003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235441|NCT02577003|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6235442|NCT02577016|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6235443|NCT02577016|Ipragliflozin|ipragliflozin|mesh-list
6235444|NCT02577016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6235445|NCT02577016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235446|NCT02577016|Incretins|incretins|mesh-ancestor
6235447|NCT02577016|Hormones|hormones|mesh-ancestor
6235448|NCT02577016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6235449|NCT02577016|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6235450|NCT02577016|Protease Inhibitors|protease inhibitors|mesh-ancestor
6235451|NCT02577016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6235452|NCT02577016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677202|NCT01586299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5710816|NCT03275519|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5710817|NCT03275519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5710818|NCT03275519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5710819|NCT03275519|Antitubercular Agents|antitubercular agents|mesh-ancestor
5710820|NCT03275506|Bevacizumab|bevacizumab|mesh-list
5710821|NCT03275506|Pembrolizumab|pembrolizumab|mesh-list
5710822|NCT03275506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5710823|NCT03275506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5710824|NCT03275506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6677203|NCT01586299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6235453|NCT02577016|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6235454|NCT02577029|Interferons|interferons|mesh-list
6235455|NCT02577029|Tenofovir|tenofovir|mesh-list
6235456|NCT02577029|Interferon-alpha|interferon-alpha|mesh-list
6235457|NCT02577029|Interferon alpha-2|interferon alpha-2|mesh-list
6235458|NCT02577029|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6235459|NCT02577029|Entecavir|entecavir|mesh-list
6235460|NCT02577029|Histamine Antagonists|histamine antagonists|mesh-list
6235461|NCT02577029|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
6235462|NCT02577029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6235463|NCT02577029|Antiviral Agents|antiviral agents|mesh-ancestor
6235464|NCT02577029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6235465|NCT02577029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6235466|NCT02577029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6235467|NCT02577029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6235468|NCT02577029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235469|NCT02577029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6235470|NCT02577029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6235471|NCT02577029|Immunologic Factors|immunologic factors|mesh-ancestor
6235472|NCT02577029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235473|NCT02577029|Histamine Agents|histamine agents|mesh-ancestor
6235474|NCT02577029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6235475|NCT02577042|Raltegravir Potassium|raltegravir potassium|mesh-list
6235476|NCT02577042|Atorvastatin|atorvastatin|mesh-list
6235477|NCT02577042|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6235478|NCT02577042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6235479|NCT02577042|Antimetabolites|antimetabolites|mesh-ancestor
6235480|NCT02577042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235481|NCT02577042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6235482|NCT02577042|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6235483|NCT02577042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6235484|NCT02577042|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6235485|NCT02577042|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6235486|NCT02577042|Antiviral Agents|antiviral agents|mesh-ancestor
6235487|NCT02577042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6235488|NCT02577042|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6235489|NCT02577042|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6235490|NCT02577107|Ranibizumab|ranibizumab|mesh-list
6235491|NCT02577107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6235492|NCT02577107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6235493|NCT02577107|Growth Substances|growth substances|mesh-ancestor
6235494|NCT02577107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235495|NCT02577107|Growth Inhibitors|growth inhibitors|mesh-ancestor
6235496|NCT02577107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6235497|NCT02577315|Metformin|metformin|mesh-list
5710825|NCT03275506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5710826|NCT03275506|Growth Substances|growth substances|mesh-ancestor
5710827|NCT03275506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710828|NCT03275506|Growth Inhibitors|growth inhibitors|mesh-ancestor
5710829|NCT03275415|Budesonide|budesonide|mesh-list
5710830|NCT03275415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5710831|NCT03275415|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5710832|NCT03275415|Autonomic Agents|autonomic agents|mesh-ancestor
5710833|NCT03275415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5710834|NCT03275415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710835|NCT03275415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5710836|NCT03275415|Respiratory System Agents|respiratory system agents|mesh-ancestor
6235498|NCT02577315|Empagliflozin|empagliflozin|mesh-list
6235499|NCT02577315|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6235500|NCT02577315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235501|NCT02577315|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6235502|NCT02577315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710837|NCT03275415|Glucocorticoids|glucocorticoids|mesh-ancestor
5710838|NCT03275415|Hormones|hormones|mesh-ancestor
5710839|NCT03275415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5710840|NCT03275376|Atorvastatin|atorvastatin|mesh-list
6235503|NCT02577601|Levonorgestrel|levonorgestrel|mesh-list
6235504|NCT02577601|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6235505|NCT02577601|Ulipristal acetate|ulipristal acetate|mesh-list
6235506|NCT02577601|Contraceptives, Oral|contraceptives, oral|mesh-list
6501861|NCT00648804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501862|NCT00648804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6501863|NCT00648804|Antipruritics|antipruritics|mesh-ancestor
6501864|NCT00648804|Dermatologic Agents|dermatologic agents|mesh-ancestor
6501865|NCT00648804|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6501866|NCT00648804|Serotonin Agents|serotonin agents|mesh-ancestor
6677204|NCT01586299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6677205|NCT01586299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6677206|NCT01586299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677207|NCT01586442|Eplerenone|eplerenone|mesh-list
6677208|NCT01586442|Spironolactone|spironolactone|mesh-list
6677209|NCT01586442|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6677210|NCT01586442|Hormone Antagonists|hormone antagonists|mesh-ancestor
5710841|NCT03275376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5710842|NCT03275376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5710843|NCT03275376|Antimetabolites|antimetabolites|mesh-ancestor
5710844|NCT03275376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710845|NCT03275376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5710846|NCT03275376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5710847|NCT03275376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5710848|NCT03275350|Naltrexone|naltrexone|mesh-list
5710849|NCT03275350|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5710850|NCT03275350|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5710851|NCT03275350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710852|NCT03275350|Sensory System Agents|sensory system agents|mesh-ancestor
5710853|NCT03275350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6677211|NCT01586442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6677212|NCT01586442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677213|NCT01586442|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6677214|NCT01586442|Diuretics|diuretics|mesh-ancestor
6677215|NCT01586442|Natriuretic Agents|natriuretic agents|mesh-ancestor
6677216|NCT01586442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5710854|NCT03275285|Dexamethasone|dexamethasone|mesh-list
5710855|NCT03275285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5710856|NCT03275285|Antiemetics|antiemetics|mesh-ancestor
5710857|NCT03275285|Autonomic Agents|autonomic agents|mesh-ancestor
5710858|NCT03275285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5710859|NCT03275285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710860|NCT03275285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5710861|NCT03275285|Glucocorticoids|glucocorticoids|mesh-ancestor
5710862|NCT03275285|Hormones|hormones|mesh-ancestor
5710863|NCT03275285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5710864|NCT03275285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5710865|NCT03275285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5710866|NCT03275207|Dexmedetomidine|dexmedetomidine|mesh-list
5710867|NCT03275207|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5710868|NCT03275207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5919032|NCT04986254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501867|NCT00648804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6501868|NCT00648804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919033|NCT04986319|Vitamin D|vitamin d|mesh-list
5919034|NCT04986319|Vitamins|vitamins|mesh-ancestor
5919035|NCT04986319|Micronutrients|micronutrients|mesh-ancestor
5919036|NCT04986319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919037|NCT04986319|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5919038|NCT04986631|Topiramate|topiramate|mesh-list
5919039|NCT04986631|Anticonvulsants|anticonvulsants|mesh-ancestor
5919040|NCT04986631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6235507|NCT02577601|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
6235508|NCT02577601|Estradiol|estradiol|mesh-list
6501869|NCT00648804|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6501870|NCT00648804|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6501871|NCT00648804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6501872|NCT00648804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6501873|NCT00648804|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6501874|NCT00648817|Tenofovir|tenofovir|mesh-list
6501875|NCT00648817|Antiviral Agents|antiviral agents|mesh-ancestor
6501876|NCT00648817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6501877|NCT00648817|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6501878|NCT00648817|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6235509|NCT02577601|Estrogens|estrogens|mesh-ancestor
6235510|NCT02577601|Hormones|hormones|mesh-ancestor
6235511|NCT02577601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6235512|NCT02577601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235513|NCT02577601|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6235514|NCT02577601|Contraceptive Agents|contraceptive agents|mesh-ancestor
6235515|NCT02577601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6235516|NCT02577601|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6235517|NCT02577601|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6235518|NCT02577601|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6235519|NCT02577718|Ethanol|ethanol|mesh-list
6235520|NCT02577718|Nitroglycerin|nitroglycerin|mesh-list
6235521|NCT02577718|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6235522|NCT02577718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6235523|NCT02577718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6235524|NCT02577718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235525|NCT02577718|Vasodilator Agents|vasodilator agents|mesh-ancestor
6235526|NCT02577991|Triamcinolone|triamcinolone|mesh-list
6235527|NCT02577991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6501879|NCT00648817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6501880|NCT00648817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501881|NCT00648817|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6501882|NCT00648817|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6501883|NCT00648830|Clarithromycin|clarithromycin|mesh-list
6235528|NCT02577991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235529|NCT02577991|Glucocorticoids|glucocorticoids|mesh-ancestor
6235530|NCT02577991|Hormones|hormones|mesh-ancestor
6235531|NCT02577991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6235532|NCT02578186|Diphenhydramine|diphenhydramine|mesh-list
6235533|NCT02578186|Promethazine|promethazine|mesh-list
6235534|NCT02578186|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6235535|NCT02578186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6235536|NCT02578186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6235537|NCT02578186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235538|NCT02578186|Anesthetics, Local|anesthetics, local|mesh-ancestor
6235539|NCT02578186|Anesthetics|anesthetics|mesh-ancestor
6235540|NCT02578186|Sensory System Agents|sensory system agents|mesh-ancestor
6501884|NCT00648830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6235541|NCT02578186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6235542|NCT02578186|Antiemetics|antiemetics|mesh-ancestor
6235543|NCT02578186|Autonomic Agents|autonomic agents|mesh-ancestor
6235544|NCT02578186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6235545|NCT02578186|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6235546|NCT02578186|Histamine Antagonists|histamine antagonists|mesh-ancestor
6235547|NCT02578186|Histamine Agents|histamine agents|mesh-ancestor
6235548|NCT02578186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6235549|NCT02578186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235550|NCT02578186|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6235551|NCT02578186|Antipruritics|antipruritics|mesh-ancestor
6235552|NCT02578186|Dermatologic Agents|dermatologic agents|mesh-ancestor
6235553|NCT02578316|Lenvatinib|lenvatinib|mesh-list
6235554|NCT02578316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6235555|NCT02578316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6501885|NCT00648830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6501886|NCT00648830|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6501887|NCT00648830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6501888|NCT00648830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501889|NCT00648830|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6501890|NCT00648830|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6501891|NCT00648843|Oxybutynin|oxybutynin|mesh-list
6677217|NCT01586494|Tramadol|tramadol|mesh-list
6677218|NCT01586494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6677219|NCT01586494|Narcotics|narcotics|mesh-ancestor
6677220|NCT01586494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6677221|NCT01586494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677222|NCT01586494|Analgesics|analgesics|mesh-ancestor
6677223|NCT01586494|Sensory System Agents|sensory system agents|mesh-ancestor
6677224|NCT01586494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6235556|NCT02578316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6235557|NCT02578316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235558|NCT02578680|Folic Acid|folic acid|mesh-list
6235559|NCT02578680|Vitamin B 12|vitamin b 12|mesh-list
6235560|NCT02578680|Hydroxocobalamin|hydroxocobalamin|mesh-list
6677225|NCT01586507|Tramadol|tramadol|mesh-list
6235561|NCT02578680|Dexamethasone|dexamethasone|mesh-list
6677226|NCT01586507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5710869|NCT03275207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710870|NCT03275207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6235562|NCT02578680|Carboplatin|carboplatin|mesh-list
6235563|NCT02578680|Pembrolizumab|pembrolizumab|mesh-list
6235564|NCT02578680|Pemetrexed|pemetrexed|mesh-list
6235565|NCT02578680|Vitamins|vitamins|mesh-ancestor
6235566|NCT02578680|Micronutrients|micronutrients|mesh-ancestor
6235567|NCT02578680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235568|NCT02578680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6235569|NCT02578680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6235570|NCT02578680|Antiemetics|antiemetics|mesh-ancestor
6235571|NCT02578680|Autonomic Agents|autonomic agents|mesh-ancestor
6235572|NCT02578680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6235573|NCT02578680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6235574|NCT02578680|Glucocorticoids|glucocorticoids|mesh-ancestor
6235575|NCT02578680|Hormones|hormones|mesh-ancestor
6235576|NCT02578680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6235577|NCT02578680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6235578|NCT02578680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6235579|NCT02578680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6235580|NCT02578680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235581|NCT02578680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6235582|NCT02578680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6235583|NCT02578680|Hematinics|hematinics|mesh-ancestor
6235584|NCT02578680|Vitamin B Complex|vitamin b complex|mesh-ancestor
6235585|NCT02578706|Aspirin|aspirin|mesh-list
5710871|NCT03275207|Analgesics|analgesics|mesh-ancestor
5710872|NCT03275207|Sensory System Agents|sensory system agents|mesh-ancestor
6235586|NCT02578706|Clopidogrel|clopidogrel|mesh-list
6235587|NCT02578706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6235588|NCT02578706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6235589|NCT02578706|Analgesics|analgesics|mesh-ancestor
6235590|NCT02578706|Sensory System Agents|sensory system agents|mesh-ancestor
6235591|NCT02578706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6235592|NCT02578706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235593|NCT02578706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6235594|NCT02578706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6235595|NCT02578706|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6235596|NCT02578706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6235597|NCT02578706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235598|NCT02578706|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6235599|NCT02578706|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6235600|NCT02578706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6235601|NCT02578706|Antipyretics|antipyretics|mesh-ancestor
6235602|NCT02578706|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6235603|NCT02578706|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6235604|NCT02578706|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6235605|NCT02578706|Purinergic Agents|purinergic agents|mesh-ancestor
6235606|NCT02578706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6501892|NCT00648843|Parasympatholytics|parasympatholytics|mesh-ancestor
6501893|NCT00648843|Autonomic Agents|autonomic agents|mesh-ancestor
6501894|NCT00648843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6235607|NCT02578732|Leucovorin|leucovorin|mesh-list
6235608|NCT02578732|Oxaliplatin|oxaliplatin|mesh-list
6235609|NCT02578732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6235610|NCT02578732|Antidotes|antidotes|mesh-ancestor
6235611|NCT02578732|Protective Agents|protective agents|mesh-ancestor
6235612|NCT02578732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235613|NCT02578732|Vitamin B Complex|vitamin b complex|mesh-ancestor
6235614|NCT02578732|Vitamins|vitamins|mesh-ancestor
6235615|NCT02578732|Micronutrients|micronutrients|mesh-ancestor
6235616|NCT02578862|Propofol|propofol|mesh-list
6235617|NCT02578862|Sevoflurane|sevoflurane|mesh-list
6235618|NCT02578862|Isoflurane|isoflurane|mesh-list
6235619|NCT02578862|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6235620|NCT02578862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6235621|NCT02578862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235622|NCT02578862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6235623|NCT02578862|Anesthetics, General|anesthetics, general|mesh-ancestor
6235624|NCT02578862|Anesthetics|anesthetics|mesh-ancestor
6235625|NCT02578862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6235626|NCT02578862|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6501895|NCT00648843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235627|NCT02578901|Tranexamic Acid|tranexamic acid|mesh-list
6235628|NCT02578901|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6235629|NCT02578901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6235630|NCT02578901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235631|NCT02578901|Hemostatics|hemostatics|mesh-ancestor
6235632|NCT02578901|Coagulants|coagulants|mesh-ancestor
6235633|NCT02579057|Furosemide|furosemide|mesh-list
6235634|NCT02579057|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6235635|NCT02579057|Diuretics|diuretics|mesh-ancestor
6235636|NCT02579057|Natriuretic Agents|natriuretic agents|mesh-ancestor
6235637|NCT02579057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235638|NCT02579057|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6235639|NCT02579057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6235640|NCT02579057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235641|NCT02579343|Dexetimide|dexetimide|mesh-list
6235642|NCT02579343|Citalopram|citalopram|mesh-list
6235643|NCT02579343|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6501896|NCT00648843|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6501897|NCT00648843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6501898|NCT00648843|Cholinergic Agents|cholinergic agents|mesh-ancestor
6501899|NCT00648843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6235644|NCT02579343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6235645|NCT02579343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6235646|NCT02579343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235647|NCT02579343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5710873|NCT03275207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5710874|NCT03275207|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5710875|NCT03275207|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5710876|NCT03275207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5710877|NCT03275207|Adrenergic Agents|adrenergic agents|mesh-ancestor
5710878|NCT03275207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5710879|NCT03275207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710880|NCT03275116|Bromides|bromides|mesh-list
5710881|NCT03275116|Formoterol Fumarate|formoterol fumarate|mesh-list
5710882|NCT03275116|Tiotropium Bromide|tiotropium bromide|mesh-list
5710883|NCT03275116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5710884|NCT03275116|Autonomic Agents|autonomic agents|mesh-ancestor
5710885|NCT03275116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5710886|NCT03275116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710887|NCT03275116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5710888|NCT03275116|Respiratory System Agents|respiratory system agents|mesh-ancestor
5710889|NCT03275116|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5710890|NCT03275116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5710891|NCT03275116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5710892|NCT03275116|Adrenergic Agents|adrenergic agents|mesh-ancestor
5710893|NCT03275116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5710894|NCT03275116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710895|NCT03275116|Parasympatholytics|parasympatholytics|mesh-ancestor
6235648|NCT02579343|Serotonin Agents|serotonin agents|mesh-ancestor
6235649|NCT02579343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235650|NCT02579343|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6235651|NCT02579343|Antidepressive Agents|antidepressive agents|mesh-ancestor
6235652|NCT02579343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6235653|NCT02579343|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6235654|NCT02579343|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6235655|NCT02579343|Parasympatholytics|parasympatholytics|mesh-ancestor
6235656|NCT02579343|Autonomic Agents|autonomic agents|mesh-ancestor
6235657|NCT02579343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6235658|NCT02579343|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6235659|NCT02579343|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6235660|NCT02579343|Cholinergic Agents|cholinergic agents|mesh-ancestor
6235661|NCT02579382|Vesatolimod|vesatolimod|mesh-list
6235662|NCT02579382|Antiviral Agents|antiviral agents|mesh-ancestor
6235663|NCT02579382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6235664|NCT02579421|Progesterone|progesterone|mesh-list
6235665|NCT02579421|Progestins|progestins|mesh-ancestor
6235666|NCT02579421|Hormones|hormones|mesh-ancestor
6235667|NCT02579421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6235668|NCT02579421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235669|NCT02579603|Pirfenidone|pirfenidone|mesh-list
6235670|NCT02579603|Nintedanib|nintedanib|mesh-list
6235671|NCT02579603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6235672|NCT02579603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6235673|NCT02579603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6235674|NCT02579603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235675|NCT02579603|Analgesics|analgesics|mesh-ancestor
6235676|NCT02579603|Sensory System Agents|sensory system agents|mesh-ancestor
6501900|NCT00648843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235677|NCT02579603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6235678|NCT02579603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235679|NCT02579603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6235680|NCT02579603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6235681|NCT02579603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6235682|NCT02579603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6235683|NCT02579616|Lenvatinib|lenvatinib|mesh-list
5710896|NCT03275116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5710897|NCT03275116|Cholinergic Agents|cholinergic agents|mesh-ancestor
5710898|NCT03275116|Anticonvulsants|anticonvulsants|mesh-ancestor
5710899|NCT03275090|SMOFlipid|smoflipid|mesh-list
5710900|NCT03275090|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
5710901|NCT03275090|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5710902|NCT03275090|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5710903|NCT03275012|Morphine|morphine|mesh-list
5710904|NCT03275012|Gabapentin|gabapentin|mesh-list
5710905|NCT03275012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5710906|NCT03275012|Narcotics|narcotics|mesh-ancestor
5710907|NCT03275012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5710908|NCT03275012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710909|NCT03275012|Analgesics|analgesics|mesh-ancestor
5710910|NCT03275012|Sensory System Agents|sensory system agents|mesh-ancestor
5710911|NCT03275012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5710912|NCT03275012|Anticonvulsants|anticonvulsants|mesh-ancestor
5710913|NCT03275012|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5710914|NCT03275012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5710915|NCT03275012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5710916|NCT03275012|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6235684|NCT02579616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6235685|NCT02579616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6235686|NCT02579616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6235687|NCT02579616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235688|NCT02579629|Ropivacaine|ropivacaine|mesh-list
6235689|NCT02579629|Anesthetics, Local|anesthetics, local|mesh-ancestor
6235690|NCT02579629|Anesthetics|anesthetics|mesh-ancestor
6235691|NCT02579629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6235692|NCT02579629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235693|NCT02579629|Sensory System Agents|sensory system agents|mesh-ancestor
6235694|NCT02579629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6235695|NCT02579772|Acetylcysteine|acetylcysteine|mesh-list
6235696|NCT02579772|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6235697|NCT02579772|Antiviral Agents|antiviral agents|mesh-ancestor
6235698|NCT02579772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6235699|NCT02579772|Expectorants|expectorants|mesh-ancestor
6235700|NCT02579772|Respiratory System Agents|respiratory system agents|mesh-ancestor
6235701|NCT02579772|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6501901|NCT00648843|Urological Agents|urological agents|mesh-ancestor
6501902|NCT00648856|Sertraline|sertraline|mesh-list
6235702|NCT02579772|Antioxidants|antioxidants|mesh-ancestor
6235703|NCT02579772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235704|NCT02579772|Protective Agents|protective agents|mesh-ancestor
6235705|NCT02579772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235706|NCT02579772|Antidotes|antidotes|mesh-ancestor
6235707|NCT02579811|Axitinib|axitinib|mesh-list
6235708|NCT02579811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6235709|NCT02579811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6235710|NCT02579811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6235711|NCT02579811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235712|NCT02579863|Dexamethasone|dexamethasone|mesh-list
6235713|NCT02579863|Pembrolizumab|pembrolizumab|mesh-list
6235714|NCT02579863|Lenalidomide|lenalidomide|mesh-list
6235715|NCT02579863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6235716|NCT02579863|Antiemetics|antiemetics|mesh-ancestor
6235717|NCT02579863|Autonomic Agents|autonomic agents|mesh-ancestor
6235718|NCT02579863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6235719|NCT02579863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235720|NCT02579863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6235721|NCT02579863|Glucocorticoids|glucocorticoids|mesh-ancestor
6235722|NCT02579863|Hormones|hormones|mesh-ancestor
6235723|NCT02579863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6235724|NCT02579863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6235725|NCT02579863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6235726|NCT02579863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6235727|NCT02579863|Immunologic Factors|immunologic factors|mesh-ancestor
6235728|NCT02579863|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5710917|NCT03275012|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6235729|NCT02579863|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6235730|NCT02579863|Growth Substances|growth substances|mesh-ancestor
6235731|NCT02579863|Growth Inhibitors|growth inhibitors|mesh-ancestor
6235732|NCT02579876|Immunologic Factors|immunologic factors|mesh-list
6235733|NCT02579876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235734|NCT02579928|Midazolam|midazolam|mesh-list
6235735|NCT02579928|Ketamine|ketamine|mesh-list
6235736|NCT02579928|Analgesics|analgesics|mesh-ancestor
6235737|NCT02579928|Sensory System Agents|sensory system agents|mesh-ancestor
6501903|NCT00648856|Antidepressive Agents|antidepressive agents|mesh-ancestor
6501904|NCT00648856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6501905|NCT00648856|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6235738|NCT02579928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6235739|NCT02579928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235740|NCT02579928|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6235741|NCT02579928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6501906|NCT00648856|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6501907|NCT00648856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6501908|NCT00648856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501909|NCT00648856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6501910|NCT00648856|Serotonin Agents|serotonin agents|mesh-ancestor
6501911|NCT00648856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710918|NCT03275012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5710919|NCT03275012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710920|NCT03275012|Antimanic Agents|antimanic agents|mesh-ancestor
5710921|NCT03274895|Biguanides|biguanides|mesh-list
5710922|NCT03274895|Polihexanide|polihexanide|mesh-list
5710923|NCT03274895|Dibrompropamidine|dibrompropamidine|mesh-list
5710924|NCT03274895|Propamidine|propamidine|mesh-list
5710925|NCT03274895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5710926|NCT03274895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710927|NCT03274895|Disinfectants|disinfectants|mesh-ancestor
5710928|NCT03274895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5710929|NCT03274895|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5710930|NCT03274895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5710931|NCT03274895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5710932|NCT03274817|Citalopram|citalopram|mesh-list
6501912|NCT00648869|Metformin|metformin|mesh-list
6501913|NCT00648869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6501914|NCT00648869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501915|NCT00648921|Olanzapine|olanzapine|mesh-list
6501916|NCT00648921|Antiemetics|antiemetics|mesh-ancestor
6501917|NCT00648921|Autonomic Agents|autonomic agents|mesh-ancestor
6501918|NCT00648921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6501919|NCT00648921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501920|NCT00648921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6501921|NCT00648921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6501922|NCT00648921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6501923|NCT00648921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6501924|NCT00648921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6501925|NCT00648921|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6501926|NCT00648921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6501927|NCT00648921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6501928|NCT00648921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501929|NCT00648921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6501930|NCT00648921|Serotonin Agents|serotonin agents|mesh-ancestor
6501931|NCT00648934|Topiramate|topiramate|mesh-list
6501932|NCT00648934|Anticonvulsants|anticonvulsants|mesh-ancestor
6677227|NCT01586507|Narcotics|narcotics|mesh-ancestor
6677228|NCT01586507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6677229|NCT01586507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677230|NCT01586507|Analgesics|analgesics|mesh-ancestor
6677231|NCT01586507|Sensory System Agents|sensory system agents|mesh-ancestor
6677232|NCT01586507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6677233|NCT01586533|Mesalamine|mesalamine|mesh-list
6677234|NCT01586533|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6501933|NCT00648934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6501934|NCT00648934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501935|NCT00648947|Clopidogrel|clopidogrel|mesh-list
6501936|NCT00648947|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6501937|NCT00648947|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6501938|NCT00648947|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6501939|NCT00648947|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5710933|NCT03274817|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6235742|NCT02579928|Anesthetics, General|anesthetics, general|mesh-ancestor
6235743|NCT02579928|Anesthetics|anesthetics|mesh-ancestor
6235744|NCT02579928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6235745|NCT02579928|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6235746|NCT02579928|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6235747|NCT02579928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6235748|NCT02579928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235749|NCT02579928|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6235750|NCT02579928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6235751|NCT02579928|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6235752|NCT02579928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6235753|NCT02579928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6235754|NCT02579928|GABA Modulators|gaba modulators|mesh-ancestor
6235755|NCT02579928|GABA Agents|gaba agents|mesh-ancestor
6235756|NCT02580058|Doxorubicin|doxorubicin|mesh-list
6235757|NCT02580058|Avelumab|avelumab|mesh-list
6235758|NCT02580058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6235759|NCT02580058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6235760|NCT02580058|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6235761|NCT02580058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6235762|NCT02580058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6235763|NCT02580058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235764|NCT02580058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6243874|NCT02682602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6243875|NCT02682602|Nootropic Agents|nootropic agents|mesh-ancestor
6243876|NCT02682784|Oxytocin|oxytocin|mesh-list
6243877|NCT02682784|Oxytocics|oxytocics|mesh-ancestor
6243878|NCT02682784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6243879|NCT02682784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243880|NCT02683109|Tiotropium Bromide|tiotropium bromide|mesh-list
6501940|NCT00648947|Purinergic Agents|purinergic agents|mesh-ancestor
6501941|NCT00648947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6501942|NCT00648947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677235|NCT01586533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6677236|NCT01586533|Analgesics|analgesics|mesh-ancestor
6243881|NCT02683109|Olodaterol|olodaterol|mesh-list
6243882|NCT02683109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6243883|NCT02683109|Autonomic Agents|autonomic agents|mesh-ancestor
6243884|NCT02683109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6243885|NCT02683109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677237|NCT01586533|Sensory System Agents|sensory system agents|mesh-ancestor
6677238|NCT01586533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6677239|NCT01586533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677240|NCT01586533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6677241|NCT01586533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6243886|NCT02683109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6243887|NCT02683109|Respiratory System Agents|respiratory system agents|mesh-ancestor
6243888|NCT02683109|Parasympatholytics|parasympatholytics|mesh-ancestor
6243889|NCT02683109|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6243890|NCT02683109|Cholinergic Agents|cholinergic agents|mesh-ancestor
6243891|NCT02683109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6243892|NCT02683109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243893|NCT02683161|Varenicline|varenicline|mesh-list
6243894|NCT02683161|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6243895|NCT02683161|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6243896|NCT02683161|Cholinergic Agents|cholinergic agents|mesh-ancestor
6243897|NCT02683161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6677242|NCT01586572|Vaccines|vaccines|mesh-list
6677243|NCT01586572|Immunologic Factors|immunologic factors|mesh-ancestor
6677244|NCT01586572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677245|NCT01586611|Leucovorin|leucovorin|mesh-list
6677246|NCT01586611|Gemcitabine|gemcitabine|mesh-list
6677247|NCT01586611|Oxaliplatin|oxaliplatin|mesh-list
6677248|NCT01586611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6677249|NCT01586611|Antimetabolites|antimetabolites|mesh-ancestor
6677250|NCT01586611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243898|NCT02683161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243899|NCT02683161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501943|NCT00648947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501944|NCT00648960|Clarithromycin|clarithromycin|mesh-list
6501945|NCT00648960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6501946|NCT00648960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6501947|NCT00648960|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6501948|NCT00648960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6501949|NCT00648960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235765|NCT02580240|Hydrocortisone|hydrocortisone|mesh-list
6235766|NCT02580240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6235767|NCT02580591|Empagliflozin|empagliflozin|mesh-list
6235768|NCT02580591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6235769|NCT02580591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235770|NCT02580591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6235771|NCT02580591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235772|NCT02580877|Insulin|insulin|mesh-list
6235773|NCT02580877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6235774|NCT02580877|Insulin, Isophane|insulin, isophane|mesh-list
6235775|NCT02580877|Methamphetamine|methamphetamine|mesh-list
6235776|NCT02580877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6235777|NCT02580877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235778|NCT02580877|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6235779|NCT02580877|Sympathomimetics|sympathomimetics|mesh-ancestor
6235780|NCT02580877|Autonomic Agents|autonomic agents|mesh-ancestor
6235781|NCT02580877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6501950|NCT00648960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6501951|NCT00648960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6501952|NCT00648973|Diphenhydramine|diphenhydramine|mesh-list
6235782|NCT02580877|Dopamine Agents|dopamine agents|mesh-ancestor
6235783|NCT02580877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6235784|NCT02580877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235785|NCT02580877|Adrenergic Agents|adrenergic agents|mesh-ancestor
6235786|NCT02580877|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6235787|NCT02580877|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6235788|NCT02580877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6235789|NCT02580877|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6235790|NCT02581111|Naloxone|naloxone|mesh-list
6235791|NCT02581111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6235792|NCT02581111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235793|NCT02581111|Sensory System Agents|sensory system agents|mesh-ancestor
6235794|NCT02581111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6235795|NCT02581163|Ritonavir|ritonavir|mesh-list
6235796|NCT02581163|Ribavirin|ribavirin|mesh-list
6235797|NCT02581163|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6235798|NCT02581163|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6235799|NCT02581163|Protease Inhibitors|protease inhibitors|mesh-ancestor
6501953|NCT00648973|Promethazine|promethazine|mesh-list
6501954|NCT00648973|Pseudoephedrine|pseudoephedrine|mesh-list
6501955|NCT00648973|Ephedrine|ephedrine|mesh-list
6501956|NCT00648973|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6501957|NCT00648973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6501958|NCT00648973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6501959|NCT00648973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501960|NCT00648973|Anesthetics, Local|anesthetics, local|mesh-ancestor
6501961|NCT00648973|Anesthetics|anesthetics|mesh-ancestor
6501962|NCT00648973|Sensory System Agents|sensory system agents|mesh-ancestor
6677251|NCT01586611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5710934|NCT03274817|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6501963|NCT00648973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5710935|NCT03274817|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5710936|NCT03274817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5710937|NCT03274817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710938|NCT03274817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5710939|NCT03274817|Serotonin Agents|serotonin agents|mesh-ancestor
5710940|NCT03274817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710941|NCT03274817|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5710942|NCT03274817|Antidepressive Agents|antidepressive agents|mesh-ancestor
5710943|NCT03274817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5710944|NCT03274817|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5710945|NCT03274765|Estradiol|estradiol|mesh-list
5919041|NCT04986631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677252|NCT01586611|Antiviral Agents|antiviral agents|mesh-ancestor
6677253|NCT01586611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6677254|NCT01586611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6677255|NCT01586611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6677256|NCT01586611|Immunologic Factors|immunologic factors|mesh-ancestor
6677257|NCT01586611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677258|NCT01586611|Antidotes|antidotes|mesh-ancestor
6677259|NCT01586611|Protective Agents|protective agents|mesh-ancestor
6677260|NCT01586611|Vitamin B Complex|vitamin b complex|mesh-ancestor
6677261|NCT01586611|Vitamins|vitamins|mesh-ancestor
6677262|NCT01586611|Micronutrients|micronutrients|mesh-ancestor
6677263|NCT01586845|Cyclosporine|cyclosporine|mesh-list
5710946|NCT03274765|Estrogens|estrogens|mesh-ancestor
5710947|NCT03274765|Hormones|hormones|mesh-ancestor
5710948|NCT03274765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5710949|NCT03274765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710950|NCT03274752|Paroxetine|paroxetine|mesh-list
5710951|NCT03274752|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5710952|NCT03274752|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5710953|NCT03274752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6677264|NCT01586845|Tacrolimus|tacrolimus|mesh-list
6677265|NCT01586845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6677266|NCT01586845|Immunologic Factors|immunologic factors|mesh-ancestor
6677267|NCT01586845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6501964|NCT00648973|Antiemetics|antiemetics|mesh-ancestor
6501965|NCT00648973|Autonomic Agents|autonomic agents|mesh-ancestor
6501966|NCT00648973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6501967|NCT00648973|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6501968|NCT00648973|Histamine Antagonists|histamine antagonists|mesh-ancestor
6501969|NCT00648973|Histamine Agents|histamine agents|mesh-ancestor
6501970|NCT00648973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6501971|NCT00648973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501972|NCT00648973|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6235800|NCT02581163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6235801|NCT02581163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235802|NCT02581163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6235803|NCT02581163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6235804|NCT02581163|Antiviral Agents|antiviral agents|mesh-ancestor
6501973|NCT00648973|Antipruritics|antipruritics|mesh-ancestor
6501974|NCT00648973|Dermatologic Agents|dermatologic agents|mesh-ancestor
6501975|NCT00648973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6501976|NCT00648973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6501977|NCT00648973|Respiratory System Agents|respiratory system agents|mesh-ancestor
6501978|NCT00648973|Nasal Decongestants|nasal decongestants|mesh-ancestor
6501979|NCT00648973|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6501980|NCT00648973|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6501981|NCT00648973|Sympathomimetics|sympathomimetics|mesh-ancestor
6501982|NCT00648973|Adrenergic Agents|adrenergic agents|mesh-ancestor
5710954|NCT03274752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710955|NCT03274752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5710956|NCT03274752|Serotonin Agents|serotonin agents|mesh-ancestor
5710957|NCT03274752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710958|NCT03274752|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5710959|NCT03274752|Antidepressive Agents|antidepressive agents|mesh-ancestor
5710960|NCT03274752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5710961|NCT03274752|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5710962|NCT03274752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5710963|NCT03274752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5710964|NCT03274700|Tamsulosin|tamsulosin|mesh-list
5710965|NCT03274700|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5710966|NCT03274700|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5710967|NCT03274700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5710968|NCT03274700|Adrenergic Agents|adrenergic agents|mesh-ancestor
5710969|NCT03274700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5710970|NCT03274700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710971|NCT03274700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235805|NCT02581163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6501983|NCT00648986|Tazarotene|tazarotene|mesh-list
6501984|NCT00648986|Dermatologic Agents|dermatologic agents|mesh-ancestor
6501985|NCT00648986|Keratolytic Agents|keratolytic agents|mesh-ancestor
6501986|NCT00648999|Ritonavir|ritonavir|mesh-list
6235806|NCT02581163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6235807|NCT02581163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6235808|NCT02581163|Antimetabolites|antimetabolites|mesh-ancestor
6235809|NCT02581189|Ritonavir|ritonavir|mesh-list
6235810|NCT02581189|Ribavirin|ribavirin|mesh-list
6235811|NCT02581189|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6235812|NCT02581189|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6235813|NCT02581189|Protease Inhibitors|protease inhibitors|mesh-ancestor
6235814|NCT02581189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6235815|NCT02581189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235816|NCT02581189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6235817|NCT02581189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6235818|NCT02581189|Antiviral Agents|antiviral agents|mesh-ancestor
6235819|NCT02581189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6501987|NCT00648999|Lopinavir|lopinavir|mesh-list
6677268|NCT01586845|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5710972|NCT03274700|Urological Agents|urological agents|mesh-ancestor
5710973|NCT03274596|Vitamin E|vitamin e|mesh-list
5710974|NCT03274596|Vitamins|vitamins|mesh-ancestor
5710975|NCT03274596|Micronutrients|micronutrients|mesh-ancestor
5710976|NCT03274596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5710977|NCT03274596|Antioxidants|antioxidants|mesh-ancestor
5710978|NCT03274596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710979|NCT03274596|Protective Agents|protective agents|mesh-ancestor
6235820|NCT02581189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6235821|NCT02581189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6235822|NCT02581189|Antimetabolites|antimetabolites|mesh-ancestor
6235823|NCT02581202|Ritonavir|ritonavir|mesh-list
6235824|NCT02581202|Lopinavir|lopinavir|mesh-list
6235825|NCT02581202|Lamivudine|lamivudine|mesh-list
6235826|NCT02581202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6235827|NCT02581202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6235828|NCT02581202|Protease Inhibitors|protease inhibitors|mesh-ancestor
6235829|NCT02581202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5710980|NCT03274427|Trimetazidine|trimetazidine|mesh-list
5710981|NCT03274427|Vasodilator Agents|vasodilator agents|mesh-ancestor
5710982|NCT03274414|Cisplatin|cisplatin|mesh-list
6235830|NCT02581202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235831|NCT02581202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6235832|NCT02581202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6235833|NCT02581202|Antiviral Agents|antiviral agents|mesh-ancestor
6235834|NCT02581202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6235835|NCT02581202|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6235836|NCT02581202|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6235837|NCT02581202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6501988|NCT00648999|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6501989|NCT00648999|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6501990|NCT00648999|Protease Inhibitors|protease inhibitors|mesh-ancestor
6501991|NCT00648999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6501992|NCT00648999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6501993|NCT00648999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6501994|NCT00648999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6501995|NCT00648999|Antiviral Agents|antiviral agents|mesh-ancestor
6501996|NCT00648999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6235838|NCT02581202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6235839|NCT02581345|Adalimumab|adalimumab|mesh-list
6235840|NCT02581345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6235841|NCT02581345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6501997|NCT00648999|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6501998|NCT00648999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6501999|NCT00649012|Pioglitazone|pioglitazone|mesh-list
6502000|NCT00649012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6502001|NCT00649012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502002|NCT00649038|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6502003|NCT00649038|Benazepril|benazepril|mesh-list
6502004|NCT00649038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5710983|NCT03274414|Etoposide|etoposide|mesh-list
5710984|NCT03274414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5710985|NCT03274414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5710986|NCT03274414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5710987|NCT03274414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5710988|NCT03274414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5710989|NCT03274414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5710990|NCT03274401|Anticoagulants|anticoagulants|mesh-list
5721647|NCT03204032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6235842|NCT02581839|Dexamethasone|dexamethasone|mesh-list
6502005|NCT00649038|Diuretics|diuretics|mesh-ancestor
6677269|NCT01586845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5721648|NCT03204032|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6235843|NCT02581839|Dexamethasone acetate|dexamethasone acetate|mesh-list
6235844|NCT02581839|Ondansetron|ondansetron|mesh-list
6235845|NCT02581839|BB 1101|bb 1101|mesh-list
6235846|NCT02581839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6235847|NCT02581839|Antiemetics|antiemetics|mesh-ancestor
6235848|NCT02581839|Autonomic Agents|autonomic agents|mesh-ancestor
6235849|NCT02581839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6235850|NCT02581839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235851|NCT02581839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6235852|NCT02581839|Glucocorticoids|glucocorticoids|mesh-ancestor
5721649|NCT03204032|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5721650|NCT03204032|Growth Substances|growth substances|mesh-ancestor
6235853|NCT02581839|Hormones|hormones|mesh-ancestor
6243900|NCT02683187|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6502006|NCT00649038|Natriuretic Agents|natriuretic agents|mesh-ancestor
6235854|NCT02581839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6235855|NCT02581839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6235856|NCT02581839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6235857|NCT02581839|Protease Inhibitors|protease inhibitors|mesh-ancestor
6235858|NCT02581839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6235859|NCT02581839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235860|NCT02581839|Antipruritics|antipruritics|mesh-ancestor
6235861|NCT02581839|Dermatologic Agents|dermatologic agents|mesh-ancestor
6235862|NCT02581839|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6235863|NCT02581839|Serotonin Agents|serotonin agents|mesh-ancestor
6235864|NCT02581839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6235865|NCT02581839|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6235866|NCT02581839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6235867|NCT02581839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6235868|NCT02581839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6235869|NCT02581839|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6235870|NCT02581891|Aflibercept|aflibercept|mesh-list
6235871|NCT02581891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6235872|NCT02581891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6235873|NCT02581891|Growth Substances|growth substances|mesh-ancestor
6235874|NCT02581891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235875|NCT02581891|Growth Inhibitors|growth inhibitors|mesh-ancestor
6235876|NCT02581891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6235877|NCT02581995|Aflibercept|aflibercept|mesh-list
6235878|NCT02581995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6235879|NCT02581995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6235880|NCT02581995|Growth Substances|growth substances|mesh-ancestor
6235881|NCT02581995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235882|NCT02581995|Growth Inhibitors|growth inhibitors|mesh-ancestor
6235883|NCT02581995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6235884|NCT02582242|Insulin Aspart|insulin aspart|mesh-list
6235885|NCT02582242|Biphasic Insulins|biphasic insulins|mesh-list
6235886|NCT02582242|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6235887|NCT02582242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6235888|NCT02582242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235889|NCT02582515|Cycloserine|cycloserine|mesh-list
6235890|NCT02582515|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6235891|NCT02582515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6235892|NCT02582515|Renal Agents|renal agents|mesh-ancestor
6235893|NCT02582515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6235894|NCT02582515|Antitubercular Agents|antitubercular agents|mesh-ancestor
6235895|NCT02582515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6235896|NCT02582515|Antimetabolites|antimetabolites|mesh-ancestor
6235897|NCT02582515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235898|NCT02582632|Ritonavir|ritonavir|mesh-list
6235899|NCT02582632|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6235900|NCT02582632|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6235901|NCT02582632|Protease Inhibitors|protease inhibitors|mesh-ancestor
6235902|NCT02582632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6235903|NCT02582632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235904|NCT02582632|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6235905|NCT02582632|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6235906|NCT02582632|Antiviral Agents|antiviral agents|mesh-ancestor
6235907|NCT02582632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6235908|NCT02582632|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6235909|NCT02582632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6235910|NCT02582671|Ritonavir|ritonavir|mesh-list
6235911|NCT02582671|Ribavirin|ribavirin|mesh-list
6235912|NCT02582671|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6235913|NCT02582671|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6235914|NCT02582671|Protease Inhibitors|protease inhibitors|mesh-ancestor
6235915|NCT02582671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6235916|NCT02582671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235917|NCT02582671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6235918|NCT02582671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6235919|NCT02582671|Antiviral Agents|antiviral agents|mesh-ancestor
6235920|NCT02582671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6235921|NCT02582671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6235922|NCT02582671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6235923|NCT02582671|Antimetabolites|antimetabolites|mesh-ancestor
6235924|NCT02582684|Lamivudine|lamivudine|mesh-list
6235925|NCT02582684|Dolutegravir|dolutegravir|mesh-list
6235926|NCT02582684|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6235927|NCT02582684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5710991|NCT03274323|Travoprost|travoprost|mesh-list
5710992|NCT03274323|Latanoprost|latanoprost|mesh-list
5710993|NCT03274323|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5710994|NCT03274323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5710995|NCT03274323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5710996|NCT03274258|Nivolumab|nivolumab|mesh-list
5710997|NCT03274258|Ipilimumab|ipilimumab|mesh-list
5710998|NCT03274258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5710999|NCT03274258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5711000|NCT03274258|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6235928|NCT02582684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6235929|NCT02582684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235930|NCT02582684|Antiviral Agents|antiviral agents|mesh-ancestor
6235931|NCT02582684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6502007|NCT00649038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711001|NCT03274258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235932|NCT02582684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6235933|NCT02582684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6235934|NCT02582684|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6235935|NCT02582684|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6235936|NCT02582814|Dapagliflozin|dapagliflozin|mesh-list
6235937|NCT02582814|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6235938|NCT02582814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235939|NCT02582814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6235940|NCT02582814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711002|NCT03274167|Gabapentin|gabapentin|mesh-list
5711003|NCT03274167|Analgesics|analgesics|mesh-ancestor
6235941|NCT02582840|Dapagliflozin|dapagliflozin|mesh-list
6235942|NCT02582840|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6235943|NCT02582840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235944|NCT02582840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6235945|NCT02582840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235946|NCT02582866|Lacosamide|lacosamide|mesh-list
6235947|NCT02582866|Anticonvulsants|anticonvulsants|mesh-ancestor
6235948|NCT02582866|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6235949|NCT02582866|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6235950|NCT02582866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6235951|NCT02582866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235952|NCT02582970|Bevacizumab|bevacizumab|mesh-list
6235953|NCT02582970|Fluorouracil|fluorouracil|mesh-list
6235954|NCT02582970|Oxaliplatin|oxaliplatin|mesh-list
6235955|NCT02582970|Irinotecan|irinotecan|mesh-list
6235956|NCT02582970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6235957|NCT02582970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6235958|NCT02582970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6235959|NCT02582970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6235960|NCT02582970|Growth Substances|growth substances|mesh-ancestor
6235961|NCT02582970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235962|NCT02582970|Growth Inhibitors|growth inhibitors|mesh-ancestor
6235963|NCT02582970|Antimetabolites|antimetabolites|mesh-ancestor
6235964|NCT02582970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235965|NCT02582970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6235966|NCT02582970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6235967|NCT02582970|Immunologic Factors|immunologic factors|mesh-ancestor
6235968|NCT02582970|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6235969|NCT02582970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6235970|NCT02582970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6235971|NCT02582983|Enfuvirtide|enfuvirtide|mesh-list
6235972|NCT02582983|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6235973|NCT02582983|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6235974|NCT02582983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235975|NCT02582983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6235976|NCT02582983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6235977|NCT02582983|Antiviral Agents|antiviral agents|mesh-ancestor
6235978|NCT02582983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6235979|NCT02583399|Ibuprofen|ibuprofen|mesh-list
6235980|NCT02583399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6235981|NCT02583399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6235982|NCT02583399|Analgesics|analgesics|mesh-ancestor
6235983|NCT02583399|Sensory System Agents|sensory system agents|mesh-ancestor
6235984|NCT02583399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6235985|NCT02583399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6235986|NCT02583399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5711004|NCT03274167|Sensory System Agents|sensory system agents|mesh-ancestor
5711005|NCT03274167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5711006|NCT03274167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711007|NCT03274167|Anticonvulsants|anticonvulsants|mesh-ancestor
5711008|NCT03274167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5711009|NCT03274167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5711010|NCT03274167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5711011|NCT03274167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5711012|NCT03274167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5711013|NCT03274167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5711014|NCT03274167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5711015|NCT03274167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711016|NCT03274167|Antimanic Agents|antimanic agents|mesh-ancestor
5711017|NCT03274102|Vaccines|vaccines|mesh-list
5711018|NCT03274102|Immunologic Factors|immunologic factors|mesh-ancestor
5711019|NCT03274102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711020|NCT03274024|Mitomycins|mitomycins|mesh-list
5711021|NCT03274024|Mitomycin|mitomycin|mesh-list
5711022|NCT03274024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5711023|NCT03274024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5711024|NCT03274024|Alkylating Agents|alkylating agents|mesh-ancestor
5711025|NCT03274024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711026|NCT03274024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5711027|NCT03274024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5711028|NCT03274011|Apatinib|apatinib|mesh-list
5711029|NCT03274011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5711030|NCT03274011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5711031|NCT03274011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5711032|NCT03274011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711033|NCT03273881|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5711034|NCT03273712|Octreotide|octreotide|mesh-list
5711035|NCT03273712|Edotreotide|edotreotide|mesh-list
5711036|NCT03273712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5711037|NCT03273712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5711038|NCT03273712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5711039|NCT03273712|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5711040|NCT03273712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711041|NCT03273634|Lansoprazole|lansoprazole|mesh-list
5711042|NCT03273634|Dexlansoprazole|dexlansoprazole|mesh-list
5711043|NCT03273634|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5711044|NCT03273634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5711045|NCT03273634|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5711046|NCT03273634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5711047|NCT03273634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711048|NCT03273595|Paclitaxel|paclitaxel|mesh-list
5711049|NCT03273595|Cyclophosphamide|cyclophosphamide|mesh-list
5711050|NCT03273595|Trastuzumab|trastuzumab|mesh-list
5711051|NCT03273595|Epirubicin|epirubicin|mesh-list
5711052|NCT03273595|Lapatinib|lapatinib|mesh-list
5711053|NCT03273595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5711054|NCT03273595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5711055|NCT03273595|Tubulin Modulators|tubulin modulators|mesh-ancestor
5711056|NCT03273595|Antimitotic Agents|antimitotic agents|mesh-ancestor
5711057|NCT03273595|Mitosis Modulators|mitosis modulators|mesh-ancestor
5711058|NCT03273595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711059|NCT03273595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5711060|NCT03273595|Immunologic Factors|immunologic factors|mesh-ancestor
5711061|NCT03273595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711062|NCT03273595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5711063|NCT03273595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5711064|NCT03273595|Alkylating Agents|alkylating agents|mesh-ancestor
5711065|NCT03273595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5711066|NCT03273595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5711067|NCT03273595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5711068|NCT03273595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5711069|NCT03273595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5711070|NCT03273595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5711071|NCT03273595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5711072|NCT03273556|Lidocaine|lidocaine|mesh-list
5711073|NCT03273556|Anesthetics, Local|anesthetics, local|mesh-ancestor
5711074|NCT03273556|Anesthetics|anesthetics|mesh-ancestor
5711075|NCT03273556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5711076|NCT03273556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711077|NCT03273556|Sensory System Agents|sensory system agents|mesh-ancestor
5711078|NCT03273556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5711079|NCT03273556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6235987|NCT02583399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5711080|NCT03273556|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5711081|NCT03273556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5711082|NCT03273556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5711083|NCT03273556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711084|NCT03273296|Amoxicillin|amoxicillin|mesh-list
5711085|NCT03273296|Azithromycin|azithromycin|mesh-list
5711086|NCT03273296|Vancomycin|vancomycin|mesh-list
5711087|NCT03273296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5711088|NCT03273296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5711089|NCT03273231|Ketamine|ketamine|mesh-list
5711090|NCT03273231|Analgesics|analgesics|mesh-ancestor
5711091|NCT03273231|Sensory System Agents|sensory system agents|mesh-ancestor
5711092|NCT03273231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5711093|NCT03273231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711094|NCT03273231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5711095|NCT03273231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5711096|NCT03273231|Anesthetics, General|anesthetics, general|mesh-ancestor
5711097|NCT03273231|Anesthetics|anesthetics|mesh-ancestor
5711098|NCT03273231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5711099|NCT03273231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5711100|NCT03273231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5711101|NCT03273231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5711102|NCT03273231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711103|NCT03273192|Adalimumab|adalimumab|mesh-list
5711104|NCT03273192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5711105|NCT03273192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5711106|NCT03273088|Etanercept|etanercept|mesh-list
5711107|NCT03273088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5711108|NCT03273088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5711109|NCT03273088|Analgesics|analgesics|mesh-ancestor
5711110|NCT03273088|Sensory System Agents|sensory system agents|mesh-ancestor
5711111|NCT03273088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5711112|NCT03273088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711113|NCT03273088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5711114|NCT03273088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5711115|NCT03273088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5711116|NCT03273088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5711117|NCT03273088|Immunologic Factors|immunologic factors|mesh-ancestor
5711118|NCT03273075|Ticagrelor|ticagrelor|mesh-list
5711119|NCT03273075|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
5711120|NCT03273075|Cangrelor|cangrelor|mesh-list
5711121|NCT03273075|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5711122|NCT03273075|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5711123|NCT03273075|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5711124|NCT03273075|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5711125|NCT03273075|Purinergic Agents|purinergic agents|mesh-ancestor
5711126|NCT03273075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5711127|NCT03273075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711128|NCT03273075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711129|NCT03273062|Tolcapone|tolcapone|mesh-list
5711130|NCT03273062|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5711131|NCT03273062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5711132|NCT03273062|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
5711133|NCT03273062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5711134|NCT03273062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235988|NCT02583399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6235989|NCT02583399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6235990|NCT02583399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6235991|NCT02583477|Gemcitabine|gemcitabine|mesh-list
6235992|NCT02583477|Paclitaxel|paclitaxel|mesh-list
6235993|NCT02583477|Durvalumab|durvalumab|mesh-list
6235994|NCT02583477|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6235995|NCT02583477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6235996|NCT02583477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6235997|NCT02583477|Tubulin Modulators|tubulin modulators|mesh-ancestor
6235998|NCT02583477|Antimitotic Agents|antimitotic agents|mesh-ancestor
6502008|NCT00649038|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6502009|NCT00649038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6502010|NCT00649038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502011|NCT00649038|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6502012|NCT00649038|Protease Inhibitors|protease inhibitors|mesh-ancestor
6502013|NCT00649038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5711135|NCT03273036|Triamcinolone|triamcinolone|mesh-list
6235999|NCT02583477|Mitosis Modulators|mitosis modulators|mesh-ancestor
6236000|NCT02583477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236001|NCT02583477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6236002|NCT02583477|Antimetabolites|antimetabolites|mesh-ancestor
6236003|NCT02583477|Antiviral Agents|antiviral agents|mesh-ancestor
6236004|NCT02583477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6236005|NCT02583477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6236006|NCT02583477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6236007|NCT02583477|Immunologic Factors|immunologic factors|mesh-ancestor
6236008|NCT02583477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236009|NCT02583477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6236010|NCT02584257|Albuterol|albuterol|mesh-list
6236011|NCT02584257|Procaterol|procaterol|mesh-list
6236012|NCT02584257|Methacholine Chloride|methacholine chloride|mesh-list
6236013|NCT02584257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6236014|NCT02584257|Autonomic Agents|autonomic agents|mesh-ancestor
6236015|NCT02584257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6236016|NCT02584257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236017|NCT02584257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6236018|NCT02584257|Respiratory System Agents|respiratory system agents|mesh-ancestor
6236019|NCT02584257|Tocolytic Agents|tocolytic agents|mesh-ancestor
6236020|NCT02584257|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5711136|NCT03273036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5711137|NCT03273036|Glucocorticoids|glucocorticoids|mesh-ancestor
5711138|NCT03273036|Hormones|hormones|mesh-ancestor
5711139|NCT03273036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5711140|NCT03273036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711141|NCT03272867|Mannitol|mannitol|mesh-list
5711142|NCT03272867|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5711143|NCT03272867|Diuretics|diuretics|mesh-ancestor
5711144|NCT03272867|Natriuretic Agents|natriuretic agents|mesh-ancestor
5711145|NCT03272867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711146|NCT03272802|Riluzole|riluzole|mesh-list
5711147|NCT03272802|Edaravone|edaravone|mesh-list
5711148|NCT03272802|Anticonvulsants|anticonvulsants|mesh-ancestor
5711149|NCT03272802|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5711150|NCT03272802|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5711151|NCT03272802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5711152|NCT03272802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711153|NCT03272802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711154|NCT03272802|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5711155|NCT03272802|Protective Agents|protective agents|mesh-ancestor
5711156|NCT03272802|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5711157|NCT03272802|Antioxidants|antioxidants|mesh-ancestor
5721651|NCT03204032|Growth Inhibitors|growth inhibitors|mesh-ancestor
5721652|NCT03204032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5721653|NCT03204032|Antimetabolites|antimetabolites|mesh-ancestor
5721654|NCT03204045|Fentanyl|fentanyl|mesh-list
5721655|NCT03204045|Oxycodone|oxycodone|mesh-list
6236021|NCT02584257|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6236022|NCT02584257|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6236023|NCT02584257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6236024|NCT02584257|Adrenergic Agents|adrenergic agents|mesh-ancestor
6236025|NCT02584257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6236026|NCT02584257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236027|NCT02584257|Miotics|miotics|mesh-ancestor
6236028|NCT02584257|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6236029|NCT02584257|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
6236030|NCT02584257|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6236031|NCT02584257|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6236032|NCT02584257|Cholinergic Agents|cholinergic agents|mesh-ancestor
6236033|NCT02584257|Sympathomimetics|sympathomimetics|mesh-ancestor
6236034|NCT02584452|Dexamethasone|dexamethasone|mesh-list
6236035|NCT02584452|Fentanyl|fentanyl|mesh-list
6236036|NCT02584452|Bupivacaine|bupivacaine|mesh-list
6236037|NCT02584452|Ropivacaine|ropivacaine|mesh-list
6236038|NCT02584452|Mepivacaine|mepivacaine|mesh-list
6236039|NCT02584452|Propofol|propofol|mesh-list
6236040|NCT02584452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6236041|NCT02584452|Antiemetics|antiemetics|mesh-ancestor
6236042|NCT02584452|Autonomic Agents|autonomic agents|mesh-ancestor
6236043|NCT02584452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6236044|NCT02584452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236045|NCT02584452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5721656|NCT03204045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5721657|NCT03204045|Narcotics|narcotics|mesh-ancestor
6236046|NCT02584452|Glucocorticoids|glucocorticoids|mesh-ancestor
6236047|NCT02584452|Hormones|hormones|mesh-ancestor
6243901|NCT02683187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6236048|NCT02584452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6236049|NCT02584452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6236050|NCT02584452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6236051|NCT02584452|Anesthetics, Local|anesthetics, local|mesh-ancestor
6236052|NCT02584452|Anesthetics|anesthetics|mesh-ancestor
6236053|NCT02584452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6236054|NCT02584452|Sensory System Agents|sensory system agents|mesh-ancestor
6236055|NCT02584452|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6236056|NCT02584452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6236057|NCT02584452|Anesthetics, General|anesthetics, general|mesh-ancestor
6236058|NCT02584452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6236059|NCT02584452|Narcotics|narcotics|mesh-ancestor
6236060|NCT02584452|Analgesics|analgesics|mesh-ancestor
5711158|NCT03272711|Vortioxetine|vortioxetine|mesh-list
5711159|NCT03272711|Antidepressive Agents|antidepressive agents|mesh-ancestor
5711160|NCT03272711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5711161|NCT03272711|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5711162|NCT03272711|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5711163|NCT03272711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5711164|NCT03272711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711165|NCT03272711|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5711166|NCT03272711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5711167|NCT03272711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5711168|NCT03272711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711169|NCT03272711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5711170|NCT03272711|Serotonin Agents|serotonin agents|mesh-ancestor
6236061|NCT02584452|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6236062|NCT02584504|Atorvastatin|atorvastatin|mesh-list
6236063|NCT02584504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6236064|NCT02584504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6236065|NCT02584504|Antimetabolites|antimetabolites|mesh-ancestor
6236066|NCT02584504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236067|NCT02584504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6236068|NCT02584504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6236069|NCT02584504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6236070|NCT02584608|Interferon-gamma|interferon-gamma|mesh-list
6236071|NCT02584608|Antiviral Agents|antiviral agents|mesh-ancestor
6236072|NCT02584608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6236073|NCT02584660|Rivaroxaban|rivaroxaban|mesh-list
6236074|NCT02584660|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6236075|NCT02584660|Antithrombins|antithrombins|mesh-ancestor
5711171|NCT03272711|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6236076|NCT02584660|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6236077|NCT02584660|Protease Inhibitors|protease inhibitors|mesh-ancestor
6236078|NCT02584660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6236079|NCT02584660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236080|NCT02584660|Anticoagulants|anticoagulants|mesh-ancestor
6236081|NCT02584686|Botulinum Toxins|botulinum toxins|mesh-list
6236082|NCT02584686|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6236083|NCT02584686|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6236084|NCT02584686|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6236085|NCT02584686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6236086|NCT02584686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236087|NCT02584686|Cholinergic Agents|cholinergic agents|mesh-ancestor
6236088|NCT02584686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6236089|NCT02584686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711172|NCT03272711|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5711173|NCT03272711|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5711174|NCT03272711|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6236090|NCT02584686|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6236091|NCT02584686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6236092|NCT02584725|Tranexamic Acid|tranexamic acid|mesh-list
6236093|NCT02584725|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6236094|NCT02584725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6236095|NCT02584725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236096|NCT02584725|Hemostatics|hemostatics|mesh-ancestor
6236097|NCT02584725|Coagulants|coagulants|mesh-ancestor
6236098|NCT02584855|Ixekizumab|ixekizumab|mesh-list
6236099|NCT02584855|Dermatologic Agents|dermatologic agents|mesh-ancestor
6236100|NCT02584868|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
6236101|NCT02584868|Plasma Substitutes|plasma substitutes|mesh-ancestor
6236102|NCT02584868|Blood Substitutes|blood substitutes|mesh-ancestor
6236103|NCT02584959|Complement C1s|complement c1s|mesh-list
6236104|NCT02584959|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
6236105|NCT02584959|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
6236106|NCT02584959|Immunologic Factors|immunologic factors|mesh-ancestor
5711175|NCT05075460|Azacitidine|azacitidine|mesh-list
5711176|NCT05075460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5711177|NCT05075460|Antimetabolites|antimetabolites|mesh-ancestor
5711178|NCT05075460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711179|NCT05075460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5711180|NCT05075460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5711181|NCT05075512|Fulvestrant|fulvestrant|mesh-list
5711182|NCT05075512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5711183|NCT05075512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5711184|NCT05075512|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6236107|NCT02584959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236108|NCT02584959|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6236109|NCT02584959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6236110|NCT02585713|Dalteparin|dalteparin|mesh-list
6236111|NCT02585713|Tinzaparin|tinzaparin|mesh-list
6236112|NCT02585713|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6236113|NCT02585713|Apixaban|apixaban|mesh-list
6236114|NCT02585713|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6236115|NCT02585713|Antithrombins|antithrombins|mesh-ancestor
6236116|NCT02585713|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6236117|NCT02585713|Protease Inhibitors|protease inhibitors|mesh-ancestor
6236118|NCT02585713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6236119|NCT02585713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236120|NCT02585713|Anticoagulants|anticoagulants|mesh-ancestor
6236121|NCT02585713|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6236122|NCT02585713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6236123|NCT02585778|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6236124|NCT02585778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236125|NCT02585843|Spironolactone|spironolactone|mesh-list
6236126|NCT02585843|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6236127|NCT02585843|Hormone Antagonists|hormone antagonists|mesh-ancestor
6236128|NCT02585843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6236129|NCT02585843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236130|NCT02585843|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6236131|NCT02585843|Diuretics|diuretics|mesh-ancestor
6236132|NCT02585843|Natriuretic Agents|natriuretic agents|mesh-ancestor
6236133|NCT02585895|Evolocumab|evolocumab|mesh-list
6502014|NCT00649051|Metolazone|metolazone|mesh-list
6502015|NCT00649051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6502016|NCT00649051|Diuretics|diuretics|mesh-ancestor
6502017|NCT00649051|Natriuretic Agents|natriuretic agents|mesh-ancestor
6502018|NCT00649051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502019|NCT00649051|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6502020|NCT00649051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6236134|NCT02585895|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6236135|NCT02585895|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6236136|NCT02585895|Antimetabolites|antimetabolites|mesh-ancestor
6236137|NCT02585895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236138|NCT02585895|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6236139|NCT02585960|Factor VIII|factor viii|mesh-list
6236140|NCT02585960|BAX 855|bax 855|mesh-list
6236141|NCT02585960|Coagulants|coagulants|mesh-ancestor
6236142|NCT02585999|Contraceptive Agents|contraceptive agents|mesh-list
6236143|NCT02585999|Ortho Evra|ortho evra|mesh-list
6236144|NCT02585999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6502021|NCT00649051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711185|NCT05075512|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5711186|NCT05075512|Hormone Antagonists|hormone antagonists|mesh-ancestor
5711187|NCT05075512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5711188|NCT05075512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711189|NCT05075265|Methadone|methadone|mesh-list
5711190|NCT05075265|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5711191|NCT05075265|Narcotics|narcotics|mesh-ancestor
5711192|NCT05075265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5919042|NCT04986072|Nitroprusside|nitroprusside|mesh-list
6502022|NCT00649064|Ziprasidone|ziprasidone|mesh-list
6502023|NCT00649064|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6502024|NCT00649064|Serotonin Agents|serotonin agents|mesh-ancestor
6677270|NCT01586845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677271|NCT01586845|Antifungal Agents|antifungal agents|mesh-ancestor
6236145|NCT02585999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236146|NCT02585999|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6502025|NCT00649064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5711193|NCT05075265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711194|NCT05075265|Analgesics|analgesics|mesh-ancestor
5711195|NCT05075265|Sensory System Agents|sensory system agents|mesh-ancestor
5711196|NCT05075265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6502026|NCT00649064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502027|NCT00649064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502028|NCT00649064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5711197|NCT05075265|Antitussive Agents|antitussive agents|mesh-ancestor
5711198|NCT05075265|Respiratory System Agents|respiratory system agents|mesh-ancestor
5711199|NCT05075330|Analgesics, Opioid|analgesics, opioid|mesh-list
5711200|NCT05075330|Narcotics|narcotics|mesh-ancestor
5711201|NCT05075330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5711202|NCT05075330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711203|NCT05075330|Analgesics|analgesics|mesh-ancestor
5711204|NCT05075330|Sensory System Agents|sensory system agents|mesh-ancestor
5711205|NCT05075330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5711206|NCT05075499|Vaccines|vaccines|mesh-list
5711207|NCT05075499|Immunologic Factors|immunologic factors|mesh-ancestor
5711208|NCT05075499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711209|NCT05075122|Pembrolizumab|pembrolizumab|mesh-list
5711210|NCT05075122|Sargramostim|sargramostim|mesh-list
5711211|NCT05075122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6502029|NCT00649064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6502030|NCT00649064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6677272|NCT01586845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6677273|NCT01586845|Dermatologic Agents|dermatologic agents|mesh-ancestor
6677274|NCT01586845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6236147|NCT02586155|Atorvastatin|atorvastatin|mesh-list
6236148|NCT02586155|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6236149|NCT02586155|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6236150|NCT02586155|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6236151|NCT02586155|Antimetabolites|antimetabolites|mesh-ancestor
6236152|NCT02586155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236153|NCT02586155|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6236154|NCT02586155|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6236155|NCT02586155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6236156|NCT02586207|Cisplatin|cisplatin|mesh-list
6236157|NCT02586207|Pembrolizumab|pembrolizumab|mesh-list
6236158|NCT02586207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6236159|NCT02586207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6236160|NCT02586727|Aflibercept|aflibercept|mesh-list
6236161|NCT02586727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6236162|NCT02586727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6236163|NCT02586727|Growth Substances|growth substances|mesh-ancestor
6236164|NCT02586727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236165|NCT02586727|Growth Inhibitors|growth inhibitors|mesh-ancestor
6236166|NCT02586727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6236167|NCT02586805|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6236168|NCT02586805|Immunologic Factors|immunologic factors|mesh-ancestor
6236169|NCT02586805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236170|NCT02587065|Interferons|interferons|mesh-list
6236171|NCT02587065|Interferon-beta|interferon-beta|mesh-list
6236172|NCT02587065|Interferon beta-1a|interferon beta-1a|mesh-list
6236173|NCT02587065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6236174|NCT02587065|Antiviral Agents|antiviral agents|mesh-ancestor
6236175|NCT02587065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6236176|NCT02587065|Immunologic Factors|immunologic factors|mesh-ancestor
6236177|NCT02587065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236178|NCT02587065|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6236179|NCT02587117|Prednisolone|prednisolone|mesh-list
6236180|NCT02587117|Lycopene|lycopene|mesh-list
6236181|NCT02587117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6502031|NCT00649064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6779688|NCT02180503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6779689|NCT02180503|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6779690|NCT02180503|Protease Inhibitors|protease inhibitors|mesh-ancestor
6779691|NCT02180503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5711212|NCT05075122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6236182|NCT02587117|Glucocorticoids|glucocorticoids|mesh-ancestor
6236183|NCT02587117|Hormones|hormones|mesh-ancestor
6502032|NCT00649064|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6502033|NCT00649064|Dopamine Agents|dopamine agents|mesh-ancestor
6502034|NCT00649077|Meloxicam|meloxicam|mesh-list
6502035|NCT00649077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6502036|NCT00649077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6502037|NCT00649077|Analgesics|analgesics|mesh-ancestor
6502038|NCT00649077|Sensory System Agents|sensory system agents|mesh-ancestor
6502039|NCT00649077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6502040|NCT00649077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502041|NCT00649077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6502042|NCT00649077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6502043|NCT00649077|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6236184|NCT02587117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6236185|NCT02587117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236186|NCT02587117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6236187|NCT02587117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6236188|NCT02587117|Protective Agents|protective agents|mesh-ancestor
6236189|NCT02587117|Antioxidants|antioxidants|mesh-ancestor
6236190|NCT02587117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236191|NCT02587117|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6236192|NCT02587117|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6236193|NCT02587143|Ethyl Chloride|ethyl chloride|mesh-list
6236194|NCT02587143|Anesthetics, Local|anesthetics, local|mesh-ancestor
6236195|NCT02587143|Anesthetics|anesthetics|mesh-ancestor
6236196|NCT02587143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6236197|NCT02587143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236198|NCT02587143|Sensory System Agents|sensory system agents|mesh-ancestor
6236199|NCT02587143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6236200|NCT02587351|Metoprolol|metoprolol|mesh-list
6236201|NCT02587351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6236202|NCT02587351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6236203|NCT02587351|Sympatholytics|sympatholytics|mesh-ancestor
6236204|NCT02587351|Autonomic Agents|autonomic agents|mesh-ancestor
6236205|NCT02587351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6236206|NCT02587351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236207|NCT02587351|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6236208|NCT02587351|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6236209|NCT02587351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6236210|NCT02587351|Adrenergic Agents|adrenergic agents|mesh-ancestor
6236211|NCT02587351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6236212|NCT02587351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236213|NCT02587520|Vaccines|vaccines|mesh-list
6236214|NCT02587520|Immunologic Factors|immunologic factors|mesh-ancestor
6236215|NCT02587520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236216|NCT02587962|Pembrolizumab|pembrolizumab|mesh-list
6236217|NCT02587962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6236218|NCT02587962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6236219|NCT05249634|Testosterone|testosterone|mesh-list
6236220|NCT05249634|Androgens|androgens|mesh-ancestor
6236221|NCT05249634|Hormones|hormones|mesh-ancestor
6236222|NCT05249634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5711213|NCT05075122|Immunologic Factors|immunologic factors|mesh-ancestor
5711214|NCT05075122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711215|NCT05074875|Carbon Monoxide|carbon monoxide|mesh-list
5711216|NCT05074875|Antimetabolites|antimetabolites|mesh-ancestor
5711217|NCT05074875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711218|NCT05074875|Gasotransmitters|gasotransmitters|mesh-ancestor
5711219|NCT05074875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5711220|NCT05074875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711221|NCT05074966|Cetuximab|cetuximab|mesh-list
5711222|NCT05074966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5711223|NCT05074966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5711224|NCT05074992|Ipilimumab|ipilimumab|mesh-list
5711225|NCT05074992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6236223|NCT05249634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236224|NCT05249569|Avelumab|avelumab|mesh-list
6236225|NCT05249569|Bavituximab|bavituximab|mesh-list
6236226|NCT05249569|Axitinib|axitinib|mesh-list
6236227|NCT05249569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6236228|NCT05249569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6236229|NCT05249569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6236230|NCT05249569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6236231|NCT05249569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236232|NCT05249556|Ganaxolone|ganaxolone|mesh-list
6236233|NCT05249556|Neurosteroids|neurosteroids|mesh-ancestor
6236234|NCT05249556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6236235|NCT05249556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236236|NCT05249556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236237|NCT05249556|GABA Modulators|gaba modulators|mesh-ancestor
6236238|NCT05249556|GABA Agents|gaba agents|mesh-ancestor
6236239|NCT05249478|Fentanyl|fentanyl|mesh-list
6236240|NCT05249478|Bupivacaine|bupivacaine|mesh-list
6236241|NCT05249478|Anesthetics, Local|anesthetics, local|mesh-ancestor
6236242|NCT05249478|Anesthetics|anesthetics|mesh-ancestor
6236243|NCT05249478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6236244|NCT05249478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236245|NCT05249478|Sensory System Agents|sensory system agents|mesh-ancestor
6236246|NCT05249478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6236247|NCT05249478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6236248|NCT05249478|Narcotics|narcotics|mesh-ancestor
6236249|NCT05249478|Analgesics|analgesics|mesh-ancestor
6236250|NCT05249478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6236251|NCT05249478|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6236252|NCT05249478|Anesthetics, General|anesthetics, general|mesh-ancestor
6236253|NCT05249452|Hydroxyurea|hydroxyurea|mesh-list
6236254|NCT05249452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6236255|NCT05249452|Antisickling Agents|antisickling agents|mesh-ancestor
6236256|NCT05249452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6236257|NCT05249452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236258|NCT05249452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6236259|NCT05249426|Cetuximab|cetuximab|mesh-list
6236260|NCT05249426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6236261|NCT05249426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6236262|NCT05249309|Ketamine|ketamine|mesh-list
6236263|NCT05249309|Analgesics|analgesics|mesh-ancestor
6236264|NCT05249309|Sensory System Agents|sensory system agents|mesh-ancestor
6236265|NCT05249309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6236266|NCT05249309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236267|NCT05249309|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6236268|NCT05249309|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6236269|NCT05249309|Anesthetics, General|anesthetics, general|mesh-ancestor
6236270|NCT05249309|Anesthetics|anesthetics|mesh-ancestor
6236271|NCT05249309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6236272|NCT05249309|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6236273|NCT05249309|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6236274|NCT05249309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6502044|NCT00649077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6502045|NCT00649077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6502046|NCT00649077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502047|NCT00649090|Exemestane|exemestane|mesh-list
6502048|NCT00649090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6502049|NCT00649090|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6502050|NCT00649090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6502051|NCT00649090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6502052|NCT00649090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236275|NCT05249309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236276|NCT05249231|Fluorides|fluorides|mesh-list
6236277|NCT05249231|Cariostatic Agents|cariostatic agents|mesh-ancestor
6236278|NCT05249231|Protective Agents|protective agents|mesh-ancestor
6236279|NCT05249231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236280|NCT05249153|Sufentanil|sufentanil|mesh-list
6236281|NCT05249153|Dexmedetomidine|dexmedetomidine|mesh-list
6236282|NCT05249153|Dsuvia|dsuvia|mesh-list
6236283|NCT05249153|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6236284|NCT05249153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6236285|NCT05249153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711226|NCT05074992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5711227|NCT05074992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5711228|NCT05074992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711229|NCT05074706|Antibodies|antibodies|mesh-list
5711230|NCT05074706|Immunoglobulin G|immunoglobulin g|mesh-list
5711231|NCT05074706|Immunologic Factors|immunologic factors|mesh-ancestor
5711232|NCT05074706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711233|NCT05074628|Nitrofurantoin|nitrofurantoin|mesh-list
5711234|NCT05074628|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5711235|NCT05074628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5711236|NCT05074628|Renal Agents|renal agents|mesh-ancestor
5711237|NCT05074628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5711238|NCT05074602|Fluconazole|fluconazole|mesh-list
6236286|NCT05249153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6236287|NCT05249153|Analgesics|analgesics|mesh-ancestor
5711239|NCT05074602|Antifungal Agents|antifungal agents|mesh-ancestor
5711240|NCT05074602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5711241|NCT05074602|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6236288|NCT05249153|Sensory System Agents|sensory system agents|mesh-ancestor
6236289|NCT05249153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6236290|NCT05249153|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6236291|NCT05249153|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6236292|NCT05249153|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6236293|NCT05249153|Adrenergic Agents|adrenergic agents|mesh-ancestor
6236294|NCT05249153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6236295|NCT05249153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236296|NCT05249153|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6236297|NCT05249153|Narcotics|narcotics|mesh-ancestor
6236298|NCT05249153|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6236299|NCT05249153|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6236300|NCT05249153|Anesthetics, General|anesthetics, general|mesh-ancestor
6236301|NCT05249153|Anesthetics|anesthetics|mesh-ancestor
6236302|NCT05249114|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
6502053|NCT00649090|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6502054|NCT00649090|Hormone Antagonists|hormone antagonists|mesh-ancestor
6502055|NCT00649090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6502056|NCT00649090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502057|NCT00649103|Quinapril|quinapril|mesh-list
6502058|NCT00649103|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6502059|NCT00649103|Protease Inhibitors|protease inhibitors|mesh-ancestor
6502060|NCT00649103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6502061|NCT00649103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502062|NCT00649103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6502063|NCT00649116|Metoprolol|metoprolol|mesh-list
6502064|NCT00649116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5711242|NCT05074602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5711243|NCT05074602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5711244|NCT05074602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677275|NCT01587066|Valproic Acid|valproic acid|mesh-list
6677276|NCT01587066|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6677277|NCT01587066|Antidepressive Agents|antidepressive agents|mesh-ancestor
6677278|NCT01587066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6677279|NCT01587066|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6677280|NCT01587066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6677281|NCT01587066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6677282|NCT01587066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677283|NCT01587066|Anticonvulsants|anticonvulsants|mesh-ancestor
6677284|NCT01587066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6677285|NCT01587066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677286|NCT01587066|GABA Agents|gaba agents|mesh-ancestor
6677287|NCT01587066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6677288|NCT01587066|Antimanic Agents|antimanic agents|mesh-ancestor
6677289|NCT01587196|Naltrexone|naltrexone|mesh-list
6677290|NCT01587196|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6677291|NCT01587196|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6677292|NCT01587196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677293|NCT01587196|Sensory System Agents|sensory system agents|mesh-ancestor
6677294|NCT01587196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6677295|NCT01587222|Octreotide|octreotide|mesh-list
6677296|NCT01587222|Midodrine|midodrine|mesh-list
6677297|NCT01587222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6677298|NCT01587222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6677299|NCT01587222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6677300|NCT01587222|Sympathomimetics|sympathomimetics|mesh-ancestor
6677301|NCT01587222|Autonomic Agents|autonomic agents|mesh-ancestor
6677302|NCT01587222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6677303|NCT01587222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711245|NCT05074602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5711246|NCT05074602|Hormone Antagonists|hormone antagonists|mesh-ancestor
5711247|NCT05074602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5711248|NCT05074602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711249|NCT05074602|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6236303|NCT05249114|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6236304|NCT05249114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677304|NCT01587222|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6677305|NCT01587222|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6677306|NCT01587222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6677307|NCT01587222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6677308|NCT01587222|Adrenergic Agents|adrenergic agents|mesh-ancestor
6677309|NCT01587222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6236305|NCT05249101|Capecitabine|capecitabine|mesh-list
6677310|NCT01587222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677311|NCT01587261|Ascorbic Acid|ascorbic acid|mesh-list
6236306|NCT05249101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6236307|NCT05249101|Antimetabolites|antimetabolites|mesh-ancestor
6236308|NCT05249101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236309|NCT05249101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6236310|NCT05249023|Butyric Acid|butyric acid|mesh-list
6236311|NCT05249023|Histamine Antagonists|histamine antagonists|mesh-ancestor
6236312|NCT05249023|Histamine Agents|histamine agents|mesh-ancestor
6236313|NCT05249023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6236314|NCT05249023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236315|NCT05249023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236316|NCT05248984|Ketorolac|ketorolac|mesh-list
6236317|NCT05248984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6236318|NCT05248984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6236319|NCT05248984|Analgesics|analgesics|mesh-ancestor
6236320|NCT05248984|Sensory System Agents|sensory system agents|mesh-ancestor
6236321|NCT05248984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6236322|NCT05248984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236323|NCT05248984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6236324|NCT05248984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6236325|NCT05248984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6236326|NCT05248984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6236327|NCT05248984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236328|NCT05248945|Carbamazepine|carbamazepine|mesh-list
6236329|NCT05248945|Anticonvulsants|anticonvulsants|mesh-ancestor
6236330|NCT05248945|Antimanic Agents|antimanic agents|mesh-ancestor
6236331|NCT05248945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6236332|NCT05248945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6236333|NCT05248945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236334|NCT05248945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5711250|NCT05074602|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5711251|NCT05074589|Leucovorin|leucovorin|mesh-list
5711252|NCT05074589|Fluorouracil|fluorouracil|mesh-list
5711253|NCT05074589|Irinotecan|irinotecan|mesh-list
5711254|NCT05074589|Levoleucovorin|levoleucovorin|mesh-list
5711255|NCT05074589|Antimetabolites|antimetabolites|mesh-ancestor
5711256|NCT05074589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711257|NCT05074589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6236335|NCT05248945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6236336|NCT05248945|Analgesics|analgesics|mesh-ancestor
6236337|NCT05248945|Sensory System Agents|sensory system agents|mesh-ancestor
6236338|NCT05248945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6236339|NCT05248945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6236340|NCT05248945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6236341|NCT05248945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236342|NCT05248945|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6236343|NCT05248945|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6236344|NCT05248932|Norepinephrine|norepinephrine|mesh-list
6236345|NCT05248932|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6236346|NCT05248932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6236347|NCT05248932|Adrenergic Agents|adrenergic agents|mesh-ancestor
6236348|NCT05248932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6236349|NCT05248932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236350|NCT05248932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236351|NCT05248932|Sympathomimetics|sympathomimetics|mesh-ancestor
6236352|NCT05248932|Autonomic Agents|autonomic agents|mesh-ancestor
6236353|NCT05248932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6236354|NCT05248932|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6236355|NCT05248841|Insulin Glargine|insulin glargine|mesh-list
6236356|NCT05248841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6236357|NCT05248841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236358|NCT05248724|Ketorolac|ketorolac|mesh-list
6236359|NCT05248724|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6236360|NCT05248724|Epinephrine|epinephrine|mesh-list
6236361|NCT05248724|Racepinephrine|racepinephrine|mesh-list
5711258|NCT05074589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5711259|NCT05074589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5711260|NCT05074589|Immunologic Factors|immunologic factors|mesh-ancestor
5711261|NCT05074589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711262|NCT05074589|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6236362|NCT05248724|Morphine|morphine|mesh-list
6236363|NCT05248724|Ropivacaine|ropivacaine|mesh-list
6236364|NCT05248724|Epinephryl borate|epinephryl borate|mesh-list
6236365|NCT05248724|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5711263|NCT05074589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5711264|NCT05074589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6236366|NCT05248724|Narcotics|narcotics|mesh-ancestor
6236367|NCT05248724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6236368|NCT05248724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236369|NCT05248724|Analgesics|analgesics|mesh-ancestor
6236370|NCT05248724|Sensory System Agents|sensory system agents|mesh-ancestor
6236371|NCT05248724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6236372|NCT05248724|Anesthetics, Local|anesthetics, local|mesh-ancestor
5711265|NCT05074589|Antidotes|antidotes|mesh-ancestor
5711266|NCT05074589|Protective Agents|protective agents|mesh-ancestor
5711267|NCT05074589|Vitamin B Complex|vitamin b complex|mesh-ancestor
5711268|NCT05074589|Vitamins|vitamins|mesh-ancestor
5711269|NCT05074589|Micronutrients|micronutrients|mesh-ancestor
5711270|NCT05074355|Azacitidine|azacitidine|mesh-list
5711271|NCT05074355|Venetoclax|venetoclax|mesh-list
5711272|NCT05074355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5711273|NCT05074355|Antimetabolites|antimetabolites|mesh-ancestor
5711274|NCT05074355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711275|NCT05074355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5711276|NCT05074355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5711277|NCT05074147|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5711278|NCT05074147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5711279|NCT05074043|Antiviral Agents|antiviral agents|mesh-list
5711280|NCT05074043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5711281|NCT05073965|Vitamin D|vitamin d|mesh-list
5711282|NCT05073965|Vitamins|vitamins|mesh-ancestor
5711283|NCT05073965|Micronutrients|micronutrients|mesh-ancestor
5711284|NCT05073965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711285|NCT05073965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5711286|NCT05065775|Dexmedetomidine|dexmedetomidine|mesh-list
5711287|NCT05065775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5711288|NCT05065775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5711289|NCT05065775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711290|NCT05065775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5711291|NCT05065775|Analgesics|analgesics|mesh-ancestor
6236373|NCT05248724|Anesthetics|anesthetics|mesh-ancestor
6236374|NCT05248724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6236375|NCT05248724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6236376|NCT05248724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6236377|NCT05248724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6236378|NCT05248724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5711292|NCT05065775|Sensory System Agents|sensory system agents|mesh-ancestor
5711293|NCT05065775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5711294|NCT05065775|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6236379|NCT05248724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6236380|NCT05248724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236381|NCT05248724|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6236382|NCT05248724|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6236383|NCT05248724|Adrenergic Agents|adrenergic agents|mesh-ancestor
6236384|NCT05248724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6236385|NCT05248724|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5711295|NCT05065775|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5711296|NCT05065775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5711297|NCT05065775|Adrenergic Agents|adrenergic agents|mesh-ancestor
5711298|NCT05065775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5711299|NCT05065775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711300|NCT05068063|Bupivacaine|bupivacaine|mesh-list
5711301|NCT05068063|Anesthetics, Local|anesthetics, local|mesh-ancestor
5711302|NCT05068063|Anesthetics|anesthetics|mesh-ancestor
5711303|NCT05068063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5711304|NCT05068063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711305|NCT05068063|Sensory System Agents|sensory system agents|mesh-ancestor
5711306|NCT05068063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5711307|NCT05014061|Adenosine|adenosine|mesh-list
5711308|NCT05014061|Analgesics|analgesics|mesh-ancestor
5711309|NCT05014061|Sensory System Agents|sensory system agents|mesh-ancestor
5711310|NCT05014061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5711311|NCT05014061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711312|NCT05014061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5711313|NCT05014061|Vasodilator Agents|vasodilator agents|mesh-ancestor
5711314|NCT05014061|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5711315|NCT05014061|Purinergic Agonists|purinergic agonists|mesh-ancestor
5711316|NCT05014061|Purinergic Agents|purinergic agents|mesh-ancestor
6677312|NCT01587261|Vitamins|vitamins|mesh-ancestor
5711317|NCT05014061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5711318|NCT05014061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711319|NCT05045586|Hyaluronic Acid|hyaluronic acid|mesh-list
6236386|NCT05248724|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6236387|NCT05248724|Autonomic Agents|autonomic agents|mesh-ancestor
6236388|NCT05248724|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6236389|NCT05248724|Respiratory System Agents|respiratory system agents|mesh-ancestor
6236390|NCT05248724|Mydriatics|mydriatics|mesh-ancestor
6236391|NCT05248724|Sympathomimetics|sympathomimetics|mesh-ancestor
6236392|NCT05248724|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6236393|NCT05248633|Dexamethasone|dexamethasone|mesh-list
6236394|NCT05248633|Lenalidomide|lenalidomide|mesh-list
6236395|NCT05248633|Bortezomib|bortezomib|mesh-list
6502065|NCT00649116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6502066|NCT00649116|Sympatholytics|sympatholytics|mesh-ancestor
6502067|NCT00649116|Autonomic Agents|autonomic agents|mesh-ancestor
6502068|NCT00649116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6502069|NCT00649116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502070|NCT00649116|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6502071|NCT00649116|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6502072|NCT00649116|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6502073|NCT00649116|Adrenergic Agents|adrenergic agents|mesh-ancestor
6677313|NCT01587261|Micronutrients|micronutrients|mesh-ancestor
6677314|NCT01587261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677315|NCT01587261|Antioxidants|antioxidants|mesh-ancestor
6677316|NCT01587261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677317|NCT01587261|Protective Agents|protective agents|mesh-ancestor
6236396|NCT05248633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6236397|NCT05248633|Antiemetics|antiemetics|mesh-ancestor
6236398|NCT05248633|Autonomic Agents|autonomic agents|mesh-ancestor
6236399|NCT05248633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6236400|NCT05248633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236401|NCT05248633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6236402|NCT05248633|Glucocorticoids|glucocorticoids|mesh-ancestor
6236403|NCT05248633|Hormones|hormones|mesh-ancestor
6236404|NCT05248633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6236405|NCT05248633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6236406|NCT05248633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6236407|NCT05248633|Immunologic Factors|immunologic factors|mesh-ancestor
5711320|NCT05045586|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5711321|NCT05045586|Immunologic Factors|immunologic factors|mesh-ancestor
5711322|NCT05045586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711323|NCT05045586|Viscosupplements|viscosupplements|mesh-ancestor
5711324|NCT05045586|Protective Agents|protective agents|mesh-ancestor
5721658|NCT03204045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5721659|NCT03204045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721660|NCT03204045|Analgesics|analgesics|mesh-ancestor
5721661|NCT03204045|Sensory System Agents|sensory system agents|mesh-ancestor
5721662|NCT03204045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5721663|NCT03204045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5721664|NCT03204045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5721665|NCT03204045|Anesthetics, General|anesthetics, general|mesh-ancestor
5721666|NCT03204045|Anesthetics|anesthetics|mesh-ancestor
5721667|NCT03204058|Metformin|metformin|mesh-list
5721668|NCT03204058|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5721669|NCT03204058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5721670|NCT03204058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721671|NCT03204058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5721672|NCT03204058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5721673|NCT03204058|Antimetabolites|antimetabolites|mesh-ancestor
5721674|NCT03204058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677318|NCT01587313|Hydralazine|hydralazine|mesh-list
6677319|NCT01587313|Isosorbide|isosorbide|mesh-list
6677320|NCT01587313|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
5721675|NCT03204058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5721676|NCT03204058|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5721677|NCT03204058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5721678|NCT03204071|Metformin|metformin|mesh-list
5721679|NCT03204071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5721680|NCT03204071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721681|NCT03203876|Nivolumab|nivolumab|mesh-list
5721682|NCT03203876|Ipilimumab|ipilimumab|mesh-list
5721683|NCT03203876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5721684|NCT03203876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5721685|NCT03203876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6236408|NCT05248633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6677321|NCT01587313|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
5721686|NCT03203876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722324|NCT03199976|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5711325|NCT04981678|Buprenorphine|buprenorphine|mesh-list
5711326|NCT04981678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5711327|NCT04981678|Narcotics|narcotics|mesh-ancestor
5711328|NCT04981678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5711329|NCT04981678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711330|NCT04981678|Analgesics|analgesics|mesh-ancestor
5711331|NCT04981678|Sensory System Agents|sensory system agents|mesh-ancestor
5711332|NCT04981678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5711333|NCT04981678|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5711334|NCT04962022|Ritonavir|ritonavir|mesh-list
5711335|NCT04962022|Itraconazole|itraconazole|mesh-list
6502074|NCT00649116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6502075|NCT00649116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502076|NCT00649129|Oxybutynin|oxybutynin|mesh-list
6502077|NCT00649129|Parasympatholytics|parasympatholytics|mesh-ancestor
6502078|NCT00649129|Autonomic Agents|autonomic agents|mesh-ancestor
6502079|NCT00649129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6502080|NCT00649129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236409|NCT05248633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6236410|NCT05248633|Growth Substances|growth substances|mesh-ancestor
6236411|NCT05248633|Growth Inhibitors|growth inhibitors|mesh-ancestor
6502081|NCT00649129|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6502082|NCT00649129|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6502083|NCT00649129|Cholinergic Agents|cholinergic agents|mesh-ancestor
6502084|NCT00649129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6502085|NCT00649129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502086|NCT00649129|Urological Agents|urological agents|mesh-ancestor
6502087|NCT00649155|Ciprofloxacin|ciprofloxacin|mesh-list
6502088|NCT00649155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6502089|NCT00649155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6502090|NCT00649155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6502091|NCT00649155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6502092|NCT00649155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6502093|NCT00649155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502094|NCT00649155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6502095|NCT00649155|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6677322|NCT01587313|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6677323|NCT01587313|Diuretics|diuretics|mesh-ancestor
6677324|NCT01587313|Natriuretic Agents|natriuretic agents|mesh-ancestor
6677325|NCT01587313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677326|NCT01587313|Vasodilator Agents|vasodilator agents|mesh-ancestor
6236412|NCT05248620|Amoxicillin|amoxicillin|mesh-list
6236413|NCT05248620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6236414|NCT05248620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6236415|NCT05248360|Hydrogen Peroxide|hydrogen peroxide|mesh-list
6236416|NCT05248360|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6236417|NCT05248360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6236418|NCT05248334|Ranibizumab|ranibizumab|mesh-list
6236419|NCT05248334|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6236420|NCT05248334|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6236421|NCT05248334|Growth Substances|growth substances|mesh-ancestor
6236422|NCT05248334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236423|NCT05248334|Growth Inhibitors|growth inhibitors|mesh-ancestor
6236424|NCT05248334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5711336|NCT04962022|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5711337|NCT04962022|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5711338|NCT04962022|Protease Inhibitors|protease inhibitors|mesh-ancestor
5711339|NCT04962022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5711340|NCT04962022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711341|NCT04962022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5711342|NCT04962022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5711343|NCT04962022|Antiviral Agents|antiviral agents|mesh-ancestor
5711344|NCT04962022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5711345|NCT04962022|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5711346|NCT04962022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5711347|NCT04962022|Antifungal Agents|antifungal agents|mesh-ancestor
5711348|NCT04962022|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5711349|NCT04962022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5711350|NCT04962022|Hormone Antagonists|hormone antagonists|mesh-ancestor
5711351|NCT04962022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5711352|NCT04962022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711353|NCT04955158|Dexmedetomidine|dexmedetomidine|mesh-list
5711354|NCT04955158|Ketamine|ketamine|mesh-list
5721687|NCT03204019|Thalidomide|thalidomide|mesh-list
6502096|NCT00649155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6236425|NCT05248321|Tranexamic Acid|tranexamic acid|mesh-list
6236426|NCT05248321|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6236427|NCT05248321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6236428|NCT05248321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236429|NCT05248321|Hemostatics|hemostatics|mesh-ancestor
6236430|NCT05248321|Coagulants|coagulants|mesh-ancestor
6243902|NCT02683187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243903|NCT02683187|Incretins|incretins|mesh-ancestor
6243904|NCT02683187|Hormones|hormones|mesh-ancestor
6243905|NCT02683187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6243906|NCT02683187|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6243907|NCT02683187|Protease Inhibitors|protease inhibitors|mesh-ancestor
6243908|NCT02683187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6243909|NCT02683187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243910|NCT02683525|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6502097|NCT00649168|Bromocriptine|bromocriptine|mesh-list
6502098|NCT00649168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6502099|NCT00649168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6502100|NCT00649168|Hormone Antagonists|hormone antagonists|mesh-ancestor
6502101|NCT00649168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6502102|NCT00649168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502103|NCT00649168|Dopamine Agonists|dopamine agonists|mesh-ancestor
6502104|NCT00649168|Dopamine Agents|dopamine agents|mesh-ancestor
6502105|NCT00649168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6502106|NCT00649168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711355|NCT04955158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5711356|NCT04955158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5711357|NCT04955158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711358|NCT04955158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5711359|NCT04955158|Analgesics|analgesics|mesh-ancestor
5711360|NCT04955158|Sensory System Agents|sensory system agents|mesh-ancestor
5711361|NCT04955158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5711362|NCT04955158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5711363|NCT04955158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6502107|NCT00649181|Metolazone|metolazone|mesh-list
6502108|NCT00649181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6502109|NCT00649181|Diuretics|diuretics|mesh-ancestor
6502110|NCT00649181|Natriuretic Agents|natriuretic agents|mesh-ancestor
6502111|NCT00649181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502112|NCT00649181|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6677327|NCT01587313|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6677328|NCT01587313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677329|NCT01587313|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6677330|NCT01587326|Citalopram|citalopram|mesh-list
6677331|NCT01587326|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6677332|NCT01587326|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6677333|NCT01587326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6677334|NCT01587326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677335|NCT01587326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6677336|NCT01587326|Serotonin Agents|serotonin agents|mesh-ancestor
5711364|NCT04955158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5711365|NCT04955158|Adrenergic Agents|adrenergic agents|mesh-ancestor
5711366|NCT04955158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5711367|NCT04955158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711368|NCT04955158|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5711369|NCT04955158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5711370|NCT04955158|Anesthetics, General|anesthetics, general|mesh-ancestor
5711371|NCT04955158|Anesthetics|anesthetics|mesh-ancestor
5711372|NCT04955158|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5711373|NCT04955158|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5711374|NCT04928300|Dexmedetomidine|dexmedetomidine|mesh-list
5711375|NCT04928300|Ketamine|ketamine|mesh-list
5711376|NCT04928300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5711377|NCT04928300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5711378|NCT04928300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243911|NCT02683525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6243912|NCT02683525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677337|NCT01587326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243913|NCT02683525|Incretins|incretins|mesh-ancestor
6243914|NCT02683525|Hormones|hormones|mesh-ancestor
6243915|NCT02683525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6243916|NCT02683525|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5711379|NCT04928300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5711380|NCT04928300|Analgesics|analgesics|mesh-ancestor
5711381|NCT04928300|Sensory System Agents|sensory system agents|mesh-ancestor
6236431|NCT05248152|Acetaminophen|acetaminophen|mesh-list
6236432|NCT05248152|Ibuprofen|ibuprofen|mesh-list
6236433|NCT05248152|Pregabalin|pregabalin|mesh-list
6236434|NCT05248152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6236435|NCT05248152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6236436|NCT05248152|Analgesics|analgesics|mesh-ancestor
6236437|NCT05248152|Sensory System Agents|sensory system agents|mesh-ancestor
6236438|NCT05248152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6236439|NCT05248152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236440|NCT05248152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6502113|NCT00649181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5711382|NCT04928300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5711383|NCT04928300|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5711384|NCT04928300|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5711385|NCT04928300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5711386|NCT04928300|Adrenergic Agents|adrenergic agents|mesh-ancestor
6502114|NCT00649181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502115|NCT00649194|Rabeprazole|rabeprazole|mesh-list
6502116|NCT00649194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6502117|NCT00649194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6502118|NCT00649194|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6236441|NCT05248152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6236442|NCT05248152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5711387|NCT04928300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5711388|NCT04928300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236443|NCT05248152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6236444|NCT05248152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236445|NCT05248152|Anticonvulsants|anticonvulsants|mesh-ancestor
6236446|NCT05248152|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6236447|NCT05248152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6236448|NCT05248152|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6236449|NCT05248152|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6236450|NCT05248152|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6236451|NCT05248152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6236452|NCT05248152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6236453|NCT05248152|Antipyretics|antipyretics|mesh-ancestor
6236454|NCT05248139|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5711389|NCT04928300|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5711390|NCT04928300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5711391|NCT04928300|Anesthetics, General|anesthetics, general|mesh-ancestor
5711392|NCT04928300|Anesthetics|anesthetics|mesh-ancestor
5711393|NCT04928300|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5711394|NCT04928300|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5711395|NCT04933669|Imatinib Mesylate|imatinib mesylate|mesh-list
5711396|NCT04933669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5711397|NCT04933669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5711398|NCT04933669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5711399|NCT04933669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711400|NCT04905901|Tranexamic Acid|tranexamic acid|mesh-list
5711401|NCT04905901|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5711402|NCT04905901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5711403|NCT04905901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711404|NCT04905901|Hemostatics|hemostatics|mesh-ancestor
5711405|NCT04905901|Coagulants|coagulants|mesh-ancestor
5711406|NCT04897841|Bupivacaine|bupivacaine|mesh-list
5711407|NCT04897841|Anesthetics, Local|anesthetics, local|mesh-ancestor
5711408|NCT04897841|Anesthetics|anesthetics|mesh-ancestor
5711409|NCT04897841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5711410|NCT04897841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711411|NCT04897841|Sensory System Agents|sensory system agents|mesh-ancestor
5711412|NCT04897841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5711413|NCT04878315|Captopril|captopril|mesh-list
5711414|NCT04878315|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5711415|NCT04878315|Protease Inhibitors|protease inhibitors|mesh-ancestor
5711416|NCT04878315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5711417|NCT04878315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711418|NCT04878315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5711419|NCT04889287|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5711420|NCT04889287|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5711421|NCT04889287|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6502119|NCT00649194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6236455|NCT05248139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6236456|NCT05248022|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
6236457|NCT05248022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236458|NCT05248022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6236459|NCT05247970|Midazolam|midazolam|mesh-list
6236460|NCT05247970|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6236461|NCT05247970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6236462|NCT05247970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6236463|NCT05247970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236464|NCT05247970|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6236465|NCT05247970|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6236466|NCT05247970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6236467|NCT05247970|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6236468|NCT05247970|Anesthetics, General|anesthetics, general|mesh-ancestor
6236469|NCT05247970|Anesthetics|anesthetics|mesh-ancestor
6236470|NCT05247970|GABA Modulators|gaba modulators|mesh-ancestor
6236471|NCT05247970|GABA Agents|gaba agents|mesh-ancestor
6236472|NCT05247970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6236473|NCT05247970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236474|NCT05247905|Capecitabine|capecitabine|mesh-list
6236475|NCT05247905|Temozolomide|temozolomide|mesh-list
6236476|NCT05247905|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
6236477|NCT05247905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6502120|NCT00649194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502121|NCT00649207|Veliparib|veliparib|mesh-list
6502122|NCT00649207|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6502123|NCT00649207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6502124|NCT00649207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502125|NCT00649207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6502126|NCT00649233|Metoprolol|metoprolol|mesh-list
6502127|NCT00649233|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6502128|NCT00649233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6502129|NCT00649233|Diuretics|diuretics|mesh-ancestor
6502130|NCT00649233|Natriuretic Agents|natriuretic agents|mesh-ancestor
6502131|NCT00649233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502132|NCT00649233|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6502133|NCT00649233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6677338|NCT01587326|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6677339|NCT01587326|Antidepressive Agents|antidepressive agents|mesh-ancestor
6677340|NCT01587326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6677341|NCT01587339|Pregabalin|pregabalin|mesh-list
6677342|NCT01587339|Zonisamide|zonisamide|mesh-list
6236478|NCT05247905|Antimetabolites|antimetabolites|mesh-ancestor
6236479|NCT05247905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236480|NCT05247905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6236481|NCT05247905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6236482|NCT05247905|Alkylating Agents|alkylating agents|mesh-ancestor
6236483|NCT05247905|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6236484|NCT05247788|Ethanol|ethanol|mesh-list
6236485|NCT05247788|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6236486|NCT05247788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6236487|NCT05247788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6236488|NCT05247788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236489|NCT05247697|Mirtazapine|mirtazapine|mesh-list
6236490|NCT05247697|Antidepressive Agents|antidepressive agents|mesh-ancestor
6236491|NCT05247697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6236492|NCT05247697|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6236493|NCT05247697|Histamine Antagonists|histamine antagonists|mesh-ancestor
6236494|NCT05247697|Histamine Agents|histamine agents|mesh-ancestor
6236495|NCT05247697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6236496|NCT05247697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236497|NCT05247697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236498|NCT05247697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6236499|NCT05247697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6236500|NCT05247697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6236501|NCT05247697|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6677343|NCT01587339|Lacosamide|lacosamide|mesh-list
6677344|NCT01587339|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
6677345|NCT01587339|Ezogabine|ezogabine|mesh-list
6236502|NCT05247697|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6236503|NCT05247697|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6236504|NCT05247697|Adrenergic Agents|adrenergic agents|mesh-ancestor
6236505|NCT05247697|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6677346|NCT01587339|Analgesics|analgesics|mesh-ancestor
5919043|NCT04986072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5919044|NCT04986072|Vasodilator Agents|vasodilator agents|mesh-ancestor
5919045|NCT04986072|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5919046|NCT04986072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919047|NCT04985890|UB-421|ub-421|mesh-list
5919048|NCT04985890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5919049|NCT04985890|Antiviral Agents|antiviral agents|mesh-ancestor
5919050|NCT04985890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5919051|NCT04985929|Sildenafil Citrate|sildenafil citrate|mesh-list
5919052|NCT04985929|Vasodilator Agents|vasodilator agents|mesh-ancestor
5919053|NCT04985929|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5919054|NCT04985929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5919055|NCT04985929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5919056|NCT04985929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919057|NCT04985929|Urological Agents|urological agents|mesh-ancestor
5919058|NCT04986098|Paclitaxel|paclitaxel|mesh-list
5919059|NCT04986098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5919060|NCT04986098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5919061|NCT04986098|Tubulin Modulators|tubulin modulators|mesh-ancestor
5919062|NCT04986098|Antimitotic Agents|antimitotic agents|mesh-ancestor
5919063|NCT04986098|Mitosis Modulators|mitosis modulators|mesh-ancestor
5919064|NCT04986098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919065|NCT04985656|Decitabine|decitabine|mesh-list
5919066|NCT04985656|Pevonedistat|pevonedistat|mesh-list
5919067|NCT04985656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5919068|NCT04985656|Antimetabolites|antimetabolites|mesh-ancestor
5919069|NCT04985656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919070|NCT04985656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5919071|NCT04985656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5919072|NCT04985435|Adalimumab|adalimumab|mesh-list
5919073|NCT04985435|Etanercept|etanercept|mesh-list
5919074|NCT04985435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5919075|NCT04985435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5919076|NCT04985435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5919077|NCT04985435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5919078|NCT04985435|Analgesics|analgesics|mesh-ancestor
5919079|NCT04985435|Sensory System Agents|sensory system agents|mesh-ancestor
6236506|NCT05247697|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6236507|NCT05247697|Serotonin Agents|serotonin agents|mesh-ancestor
6236508|NCT05247697|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6236509|NCT05247684|Paclitaxel|paclitaxel|mesh-list
6236510|NCT05247684|Carboplatin|carboplatin|mesh-list
6236511|NCT05247684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6236512|NCT05247684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6236513|NCT05247684|Tubulin Modulators|tubulin modulators|mesh-ancestor
6236514|NCT05247684|Antimitotic Agents|antimitotic agents|mesh-ancestor
6236515|NCT05247684|Mitosis Modulators|mitosis modulators|mesh-ancestor
6236516|NCT05247684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236517|NCT05247619|Paclitaxel|paclitaxel|mesh-list
6236518|NCT05247619|Bevacizumab|bevacizumab|mesh-list
6236519|NCT05247619|Carboplatin|carboplatin|mesh-list
6236520|NCT05247619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6236521|NCT05247619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6236522|NCT05247619|Tubulin Modulators|tubulin modulators|mesh-ancestor
6236523|NCT05247619|Antimitotic Agents|antimitotic agents|mesh-ancestor
6236524|NCT05247619|Mitosis Modulators|mitosis modulators|mesh-ancestor
6502134|NCT00649233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502135|NCT00649233|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5711422|NCT04889287|Antimetabolites|antimetabolites|mesh-ancestor
5711423|NCT04889287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711424|NCT04889287|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5711425|NCT04889287|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5711426|NCT04889287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5711427|NCT04878107|Docetaxel|docetaxel|mesh-list
5711428|NCT04878107|Apatinib|apatinib|mesh-list
5711429|NCT04878107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5711430|NCT04878107|Tubulin Modulators|tubulin modulators|mesh-ancestor
5711431|NCT04878107|Antimitotic Agents|antimitotic agents|mesh-ancestor
5711432|NCT04878107|Mitosis Modulators|mitosis modulators|mesh-ancestor
6502136|NCT00649233|Sympatholytics|sympatholytics|mesh-ancestor
6502137|NCT00649233|Autonomic Agents|autonomic agents|mesh-ancestor
6502138|NCT00649233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6502139|NCT00649233|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6236525|NCT05247619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236526|NCT05247619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6502140|NCT00649233|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6502141|NCT00649233|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6502142|NCT00649233|Adrenergic Agents|adrenergic agents|mesh-ancestor
6502143|NCT00649233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6502144|NCT00649259|Oxybutynin|oxybutynin|mesh-list
6502145|NCT00649259|Parasympatholytics|parasympatholytics|mesh-ancestor
6502146|NCT00649259|Autonomic Agents|autonomic agents|mesh-ancestor
6502147|NCT00649259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6502148|NCT00649259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502149|NCT00649259|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6502150|NCT00649259|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6236527|NCT05247619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5711433|NCT04878107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711434|NCT04878107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5711435|NCT04878107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5711436|NCT04877821|Paclitaxel|paclitaxel|mesh-list
5711437|NCT04877821|Cyclophosphamide|cyclophosphamide|mesh-list
5711438|NCT04877821|Carboplatin|carboplatin|mesh-list
5711439|NCT04877821|Epirubicin|epirubicin|mesh-list
5711440|NCT04877821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5711441|NCT04877821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6236528|NCT05247619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6236529|NCT05247619|Growth Substances|growth substances|mesh-ancestor
6236530|NCT05247619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236531|NCT05247619|Growth Inhibitors|growth inhibitors|mesh-ancestor
6236532|NCT05247554|Hydroxychloroquine|hydroxychloroquine|mesh-list
6236533|NCT05247554|Prednisone|prednisone|mesh-list
6236534|NCT05247554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6236535|NCT05247554|Glucocorticoids|glucocorticoids|mesh-ancestor
6236536|NCT05247554|Hormones|hormones|mesh-ancestor
6236537|NCT05247554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6502151|NCT00649259|Cholinergic Agents|cholinergic agents|mesh-ancestor
6502152|NCT00649259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6502153|NCT00649259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502154|NCT00649259|Urological Agents|urological agents|mesh-ancestor
6677347|NCT01587339|Sensory System Agents|sensory system agents|mesh-ancestor
6677348|NCT01587339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6677349|NCT01587339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711442|NCT04877821|Tubulin Modulators|tubulin modulators|mesh-ancestor
6236538|NCT05247554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236539|NCT05247554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6236540|NCT05247554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6236541|NCT05247554|Antimalarials|antimalarials|mesh-ancestor
6236542|NCT05247554|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6236543|NCT05247554|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6236544|NCT05247554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6236545|NCT05247554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6236546|NCT05247554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677350|NCT01587339|Anticonvulsants|anticonvulsants|mesh-ancestor
6677351|NCT01587339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6677352|NCT01587339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6677353|NCT01587339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677354|NCT01587339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6677355|NCT01587339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6677356|NCT01587339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6677357|NCT01587339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6236547|NCT05247554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6502155|NCT00649272|Oxybutynin|oxybutynin|mesh-list
6502156|NCT00649272|Parasympatholytics|parasympatholytics|mesh-ancestor
6677358|NCT01587339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6677359|NCT01587339|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6677360|NCT01587339|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6677361|NCT01587378|Metformin|metformin|mesh-list
6677362|NCT01587378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5711443|NCT04877821|Antimitotic Agents|antimitotic agents|mesh-ancestor
5711444|NCT04877821|Mitosis Modulators|mitosis modulators|mesh-ancestor
5711445|NCT04877821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711446|NCT04877821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5711447|NCT04877821|Immunologic Factors|immunologic factors|mesh-ancestor
5711448|NCT04877821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711449|NCT04877821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5711450|NCT04877821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5711451|NCT04877821|Alkylating Agents|alkylating agents|mesh-ancestor
5711452|NCT04877821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5711453|NCT04877821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6236548|NCT05245292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6236549|NCT05245292|Antibodies|antibodies|mesh-list
6236550|NCT05245292|Immunoglobulins|immunoglobulins|mesh-list
6236551|NCT05245292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6236552|NCT05245292|Antibodies, Blocking|antibodies, blocking|mesh-list
6236553|NCT05245292|Immunologic Factors|immunologic factors|mesh-ancestor
6236554|NCT05245292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236555|NCT05245292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6236556|NCT05243563|Clobetasol|clobetasol|mesh-list
6236557|NCT05243563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6236558|NCT05243563|Glucocorticoids|glucocorticoids|mesh-ancestor
6236559|NCT05243563|Hormones|hormones|mesh-ancestor
6236560|NCT05243563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6236561|NCT05243563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236562|NCT05231694|Mitogens|mitogens|mesh-list
6236563|NCT05231694|Mitosis Modulators|mitosis modulators|mesh-ancestor
6236564|NCT05231694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236565|NCT05227131|Capecitabine|capecitabine|mesh-list
5711454|NCT04877821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5711455|NCT04877821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6236566|NCT05227131|Tucatinib|tucatinib|mesh-list
6236567|NCT05227131|Margetuximab|margetuximab|mesh-list
6236568|NCT05227131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6236569|NCT05227131|Antimetabolites|antimetabolites|mesh-ancestor
6236570|NCT05227131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236571|NCT05227131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6236572|NCT05227131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6236573|NCT05227131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6236574|NCT05220813|Lidocaine|lidocaine|mesh-list
6236575|NCT05220813|Bupivacaine|bupivacaine|mesh-list
6236576|NCT05220813|Anesthetics, Local|anesthetics, local|mesh-ancestor
6236577|NCT05220813|Anesthetics|anesthetics|mesh-ancestor
6236578|NCT05220813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6236579|NCT05220813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236580|NCT05220813|Sensory System Agents|sensory system agents|mesh-ancestor
6236581|NCT05220813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6236582|NCT05220813|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6236583|NCT05220813|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6236584|NCT05220813|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5711456|NCT04877821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5711457|NCT04824417|Itraconazole|itraconazole|mesh-list
5711458|NCT04824417|Voriconazole|voriconazole|mesh-list
5711459|NCT04824417|Antifungal Agents|antifungal agents|mesh-ancestor
5711460|NCT04824417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5711461|NCT04824417|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5711462|NCT04824417|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5711463|NCT04824417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5711464|NCT04824417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711465|NCT04824417|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5711466|NCT04824417|Hormone Antagonists|hormone antagonists|mesh-ancestor
6236585|NCT05220813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6236586|NCT05220813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236587|NCT05216497|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
6236588|NCT05216497|Antiviral Agents|antiviral agents|mesh-ancestor
6236589|NCT05216497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6236590|NCT05215236|Opiate Alkaloids|opiate alkaloids|mesh-list
6236591|NCT05215236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6236592|NCT05215236|Narcotics|narcotics|mesh-ancestor
6236593|NCT05215236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6236594|NCT05215236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236595|NCT05215236|Analgesics|analgesics|mesh-ancestor
6236596|NCT05215236|Sensory System Agents|sensory system agents|mesh-ancestor
6236597|NCT05215236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6236598|NCT05204927|Prednisone|prednisone|mesh-list
6236599|NCT05204927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6236600|NCT05204927|Glucocorticoids|glucocorticoids|mesh-ancestor
6236601|NCT05204927|Hormones|hormones|mesh-ancestor
6236602|NCT05204927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6236603|NCT05204927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236604|NCT05204927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6236605|NCT05204927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6236606|NCT05184348|Acitretin|acitretin|mesh-list
6236607|NCT05184348|Keratolytic Agents|keratolytic agents|mesh-ancestor
6236608|NCT05184348|Dermatologic Agents|dermatologic agents|mesh-ancestor
6236609|NCT05183828|Letrozole|letrozole|mesh-list
6236610|NCT05183828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6236611|NCT05183828|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6236612|NCT05183828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6236613|NCT05183828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6236614|NCT05183828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236615|NCT05183828|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6236616|NCT05183828|Hormone Antagonists|hormone antagonists|mesh-ancestor
6236617|NCT05183828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6236618|NCT05183828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243917|NCT02683525|Protease Inhibitors|protease inhibitors|mesh-ancestor
6243918|NCT02683525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6243919|NCT02683525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243920|NCT02683668|Tiotropium Bromide|tiotropium bromide|mesh-list
6243921|NCT02683668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6243922|NCT02683668|Autonomic Agents|autonomic agents|mesh-ancestor
6243923|NCT02683668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6243924|NCT02683668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243925|NCT02683668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6243926|NCT02683668|Respiratory System Agents|respiratory system agents|mesh-ancestor
6243927|NCT02683668|Parasympatholytics|parasympatholytics|mesh-ancestor
6243928|NCT02683668|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6502157|NCT00649272|Autonomic Agents|autonomic agents|mesh-ancestor
6502158|NCT00649272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6502159|NCT00649272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502160|NCT00649272|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6502161|NCT00649272|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6502162|NCT00649272|Cholinergic Agents|cholinergic agents|mesh-ancestor
6502163|NCT00649272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6502164|NCT00649272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502165|NCT00649272|Urological Agents|urological agents|mesh-ancestor
6502166|NCT00649285|Nitrofurantoin|nitrofurantoin|mesh-list
6243929|NCT02683668|Cholinergic Agents|cholinergic agents|mesh-ancestor
6243930|NCT02683668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6243931|NCT02683668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243932|NCT02683707|Lidocaine|lidocaine|mesh-list
6243933|NCT02683707|Fentanyl|fentanyl|mesh-list
6243934|NCT02683707|Midazolam|midazolam|mesh-list
6243935|NCT02683707|Anesthetics, Local|anesthetics, local|mesh-ancestor
6243936|NCT02683707|Anesthetics|anesthetics|mesh-ancestor
6243937|NCT02683707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6243938|NCT02683707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243939|NCT02683707|Sensory System Agents|sensory system agents|mesh-ancestor
6243940|NCT02683707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6243941|NCT02683707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6243942|NCT02683707|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6243943|NCT02683707|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6243944|NCT02683707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6243945|NCT02683707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243946|NCT02683707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6243947|NCT02683707|Narcotics|narcotics|mesh-ancestor
6243948|NCT02683707|Analgesics|analgesics|mesh-ancestor
6502167|NCT00649285|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6502168|NCT00649285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6502169|NCT00649285|Renal Agents|renal agents|mesh-ancestor
6502170|NCT00649285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6502171|NCT00649311|Losartan|losartan|mesh-list
6502172|NCT00649311|Eplerenone|eplerenone|mesh-list
6502173|NCT00649311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6502174|NCT00649311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6502175|NCT00649311|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6502176|NCT00649311|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6502177|NCT00649311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502178|NCT00649311|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6502179|NCT00649311|Hormone Antagonists|hormone antagonists|mesh-ancestor
6502180|NCT00649311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6502181|NCT00649311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711467|NCT04824417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6236619|NCT05171816|Olaparib|olaparib|mesh-list
6236620|NCT05171816|Abiraterone Acetate|abiraterone acetate|mesh-list
6236621|NCT05171816|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6236622|NCT05171816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6236623|NCT05171816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236624|NCT05171816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6236625|NCT05171816|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6236626|NCT05171816|Hormone Antagonists|hormone antagonists|mesh-ancestor
6236627|NCT05171816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6236628|NCT05171816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236629|NCT05171816|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6236630|NCT05171062|Pembrolizumab|pembrolizumab|mesh-list
5711468|NCT04824417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236631|NCT05171062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6236632|NCT05171062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6236633|NCT05169567|Fulvestrant|fulvestrant|mesh-list
6236634|NCT05169567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6236635|NCT05169567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6236636|NCT05169567|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6236637|NCT05169567|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6236638|NCT05169567|Hormone Antagonists|hormone antagonists|mesh-ancestor
6236639|NCT05169567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6236640|NCT05169567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236641|NCT05159193|Cyclophosphamide|cyclophosphamide|mesh-list
6236642|NCT05159193|Carboplatin|carboplatin|mesh-list
6236643|NCT05159193|Docetaxel|docetaxel|mesh-list
6236644|NCT05159193|Doxorubicin|doxorubicin|mesh-list
6236645|NCT05159193|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6236646|NCT05159193|Trastuzumab|trastuzumab|mesh-list
6236647|NCT05159193|Pertuzumab|pertuzumab|mesh-list
6236648|NCT05159193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6236649|NCT05159193|Immunologic Factors|immunologic factors|mesh-ancestor
6236650|NCT05159193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236651|NCT05159193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6236652|NCT05159193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6236653|NCT05159193|Alkylating Agents|alkylating agents|mesh-ancestor
6236654|NCT05159193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236655|NCT05159193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6236656|NCT05159193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6236657|NCT05159193|Tubulin Modulators|tubulin modulators|mesh-ancestor
6236658|NCT05159193|Antimitotic Agents|antimitotic agents|mesh-ancestor
6236659|NCT05159193|Mitosis Modulators|mitosis modulators|mesh-ancestor
6236660|NCT05159193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6236661|NCT05159193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6236662|NCT05159193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6236663|NCT05159193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6236664|NCT05159193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6236665|NCT05156437|Amoxicillin|amoxicillin|mesh-list
6236666|NCT05156437|Vancomycin|vancomycin|mesh-list
6236667|NCT05156437|Levofloxacin|levofloxacin|mesh-list
6236668|NCT05156437|Rifampin|rifampin|mesh-list
6236669|NCT05156437|Ceftriaxone|ceftriaxone|mesh-list
6236670|NCT05156437|Linezolid|linezolid|mesh-list
6236671|NCT05156437|Daptomycin|daptomycin|mesh-list
6236672|NCT05156437|Ampicillin|ampicillin|mesh-list
6236673|NCT05156437|Cephalexin|cephalexin|mesh-list
6236674|NCT05156437|Cefepime|cefepime|mesh-list
6236675|NCT05156437|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
6236676|NCT05156437|Oxacillin|oxacillin|mesh-list
6236677|NCT05156437|Dicloxacillin|dicloxacillin|mesh-list
6236678|NCT05156437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6236679|NCT05156437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6236680|NCT05156437|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6236681|NCT05156437|Renal Agents|renal agents|mesh-ancestor
6236682|NCT05156437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6236683|NCT05156437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6236684|NCT05156437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6236685|NCT05156437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236686|NCT05156437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6236687|NCT05156437|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6236688|NCT05156437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6502182|NCT00649311|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6502183|NCT00649311|Diuretics|diuretics|mesh-ancestor
6502184|NCT00649311|Natriuretic Agents|natriuretic agents|mesh-ancestor
6502185|NCT00649324|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6502186|NCT00649324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6502187|NCT00649324|Diuretics|diuretics|mesh-ancestor
6502188|NCT00649324|Natriuretic Agents|natriuretic agents|mesh-ancestor
6502189|NCT00649324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502190|NCT00649324|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6502191|NCT00649324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6677363|NCT01587378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677364|NCT01587430|Cytarabine|cytarabine|mesh-list
6677365|NCT01587430|Daunorubicin|daunorubicin|mesh-list
6677366|NCT01587430|Mitoxantrone|mitoxantrone|mesh-list
6677367|NCT01587430|Idarubicin|idarubicin|mesh-list
6677368|NCT01587430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6677369|NCT01587430|Antimetabolites|antimetabolites|mesh-ancestor
6677370|NCT01587430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677371|NCT01587430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6677372|NCT01587430|Antiviral Agents|antiviral agents|mesh-ancestor
6677373|NCT01587430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6677374|NCT01587430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6677375|NCT01587430|Immunologic Factors|immunologic factors|mesh-ancestor
6677376|NCT01587430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677377|NCT01587430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6677378|NCT01587430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6677379|NCT01587430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6677380|NCT01587430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6677381|NCT01587430|Analgesics|analgesics|mesh-ancestor
6677382|NCT01587430|Sensory System Agents|sensory system agents|mesh-ancestor
6677383|NCT01587430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6677384|NCT01587482|Paclitaxel|paclitaxel|mesh-list
6677385|NCT01587482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6677386|NCT01587482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6677387|NCT01587482|Tubulin Modulators|tubulin modulators|mesh-ancestor
6677388|NCT01587482|Antimitotic Agents|antimitotic agents|mesh-ancestor
6677389|NCT01587482|Mitosis Modulators|mitosis modulators|mesh-ancestor
6677390|NCT01587482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677391|NCT01587495|Ertapenem|ertapenem|mesh-list
6236689|NCT05156437|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6236690|NCT05156437|Antitubercular Agents|antitubercular agents|mesh-ancestor
6236691|NCT05156437|Leprostatic Agents|leprostatic agents|mesh-ancestor
6236692|NCT05156437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6236693|NCT05156437|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6236694|NCT05156437|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6236695|NCT05156437|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6236696|NCT05156437|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6236697|NCT05156437|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6236698|NCT05156437|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6236699|NCT05156437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6236700|NCT05153915|Tacrolimus|tacrolimus|mesh-list
6677392|NCT01587495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6677393|NCT01587495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6677394|NCT01587508|Meloxicam|meloxicam|mesh-list
6677395|NCT01587508|Amitriptyline|amitriptyline|mesh-list
6677396|NCT01587508|Cyclobenzaprine|cyclobenzaprine|mesh-list
5711469|NCT04824417|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5711470|NCT04818866|Fibrin fragment D|fibrin fragment d|mesh-list
5711471|NCT04818866|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5711472|NCT04818866|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5711473|NCT04818866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711474|NCT04818866|Hemostatics|hemostatics|mesh-ancestor
5711475|NCT04818866|Coagulants|coagulants|mesh-ancestor
5711476|NCT04797325|Prednisolone|prednisolone|mesh-list
5711477|NCT04797325|Infliximab|infliximab|mesh-list
5711478|NCT04797325|Vedolizumab|vedolizumab|mesh-list
5711479|NCT04797325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5711480|NCT04797325|Glucocorticoids|glucocorticoids|mesh-ancestor
5711481|NCT04797325|Hormones|hormones|mesh-ancestor
5711482|NCT04797325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6677397|NCT01587508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6677398|NCT01587508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5711483|NCT04797325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711484|NCT04797325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6236701|NCT05153915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6236702|NCT05153915|Immunologic Factors|immunologic factors|mesh-ancestor
6236703|NCT05153915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236704|NCT05153915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6236705|NCT05153915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6236706|NCT05153915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236707|NCT05148546|Nivolumab|nivolumab|mesh-list
6236708|NCT05148546|Ipilimumab|ipilimumab|mesh-list
6236709|NCT05148546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6236710|NCT05148546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6236711|NCT05148546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6236712|NCT05148546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236713|NCT05146154|Imipenem|imipenem|mesh-list
6236714|NCT05146154|Relebactam|relebactam|mesh-list
6236715|NCT05146154|Cilastatin|cilastatin|mesh-list
6236716|NCT05146154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6236717|NCT05146154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6236718|NCT05146154|Protease Inhibitors|protease inhibitors|mesh-ancestor
6236719|NCT05146154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6236720|NCT05146154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236721|NCT05146154|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6236722|NCT05144945|Vaccines|vaccines|mesh-list
6236723|NCT05144945|Immunologic Factors|immunologic factors|mesh-ancestor
6236724|NCT05144945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236725|NCT05143424|Morphine|morphine|mesh-list
6236726|NCT05143424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6236727|NCT05143424|Narcotics|narcotics|mesh-ancestor
6236728|NCT05143424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6236729|NCT05143424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236730|NCT05143424|Analgesics|analgesics|mesh-ancestor
6236731|NCT05143424|Sensory System Agents|sensory system agents|mesh-ancestor
6236732|NCT05143424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6502192|NCT00649324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502193|NCT00649350|Metformin|metformin|mesh-list
6502194|NCT00649350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6502195|NCT00649350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502196|NCT00649363|Ondansetron|ondansetron|mesh-list
6677399|NCT01587508|Analgesics|analgesics|mesh-ancestor
6677400|NCT01587508|Sensory System Agents|sensory system agents|mesh-ancestor
6677401|NCT01587508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6677402|NCT01587508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677403|NCT01587508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6677404|NCT01587508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6677405|NCT01587508|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6677406|NCT01587508|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6677407|NCT01587508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6677408|NCT01587508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677409|NCT01587508|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6236733|NCT05136690|Nicotine|nicotine|mesh-list
6236734|NCT05136690|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6502197|NCT00649363|Antiemetics|antiemetics|mesh-ancestor
6502198|NCT00649363|Autonomic Agents|autonomic agents|mesh-ancestor
6502199|NCT00649363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6502200|NCT00649363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502201|NCT00649363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6502202|NCT00649363|Antipruritics|antipruritics|mesh-ancestor
6502203|NCT00649363|Dermatologic Agents|dermatologic agents|mesh-ancestor
6502204|NCT00649363|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6502205|NCT00649363|Serotonin Agents|serotonin agents|mesh-ancestor
6502206|NCT00649363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6502207|NCT00649363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502208|NCT00649363|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6502209|NCT00649363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6502210|NCT00649363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6502211|NCT00649363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6502212|NCT00649363|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6502213|NCT00649376|Fexofenadine|fexofenadine|mesh-list
6502214|NCT00649376|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6502215|NCT00649376|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6502216|NCT00649376|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6502217|NCT00649376|Histamine Antagonists|histamine antagonists|mesh-ancestor
6502218|NCT00649376|Histamine Agents|histamine agents|mesh-ancestor
6502219|NCT00649376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6502220|NCT00649376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502221|NCT00649376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236735|NCT05136690|Autonomic Agents|autonomic agents|mesh-ancestor
6236736|NCT05136690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6236737|NCT05136690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236738|NCT05136690|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6236739|NCT05136690|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6236740|NCT05136690|Cholinergic Agents|cholinergic agents|mesh-ancestor
6236741|NCT05136690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6236742|NCT05136690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236743|NCT05132166|Sirolimus|sirolimus|mesh-list
6236744|NCT05132166|Everolimus|everolimus|mesh-list
6236745|NCT05132166|Vedolizumab|vedolizumab|mesh-list
5711485|NCT04797325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5711486|NCT04797325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5711487|NCT04797325|Dermatologic Agents|dermatologic agents|mesh-ancestor
5711488|NCT04797325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5711489|NCT04780464|Prednisolone|prednisolone|mesh-list
6236746|NCT05132166|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6236747|NCT05132166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6236748|NCT05132166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6502222|NCT00649402|Amlodipine|amlodipine|mesh-list
6502223|NCT00649402|Benazepril|benazepril|mesh-list
6502224|NCT00649402|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6236749|NCT05132166|Immunologic Factors|immunologic factors|mesh-ancestor
6236750|NCT05132166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236751|NCT05132166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6236752|NCT05132166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6236753|NCT05132166|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6236754|NCT05132166|Antifungal Agents|antifungal agents|mesh-ancestor
6502225|NCT00649402|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6502226|NCT00649402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6236755|NCT05132166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6502227|NCT00649402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502228|NCT00649402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6502229|NCT00649402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502230|NCT00649402|Vasodilator Agents|vasodilator agents|mesh-ancestor
6502231|NCT00649402|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6502232|NCT00649402|Protease Inhibitors|protease inhibitors|mesh-ancestor
6502233|NCT00649402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6502234|NCT00649415|Valdecoxib|valdecoxib|mesh-list
6502235|NCT00649415|Piroxicam|piroxicam|mesh-list
6502236|NCT00649415|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6502237|NCT00649415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6502238|NCT00649415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6502239|NCT00649415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502240|NCT00649415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6502241|NCT00649415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6502242|NCT00649415|Analgesics|analgesics|mesh-ancestor
6502243|NCT00649415|Sensory System Agents|sensory system agents|mesh-ancestor
6502244|NCT00649415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6502245|NCT00649415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502246|NCT00649415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6502247|NCT00649415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6502248|NCT00649441|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6502249|NCT00649441|Quinapril|quinapril|mesh-list
6502250|NCT00649441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6502251|NCT00649441|Diuretics|diuretics|mesh-ancestor
6502252|NCT00649441|Natriuretic Agents|natriuretic agents|mesh-ancestor
6502253|NCT00649441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502254|NCT00649441|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6502255|NCT00649441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6502256|NCT00649441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502257|NCT00649441|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6502258|NCT00649441|Protease Inhibitors|protease inhibitors|mesh-ancestor
6502259|NCT00649441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6502260|NCT00649454|Metformin|metformin|mesh-list
6502261|NCT00649454|Glipizide|glipizide|mesh-list
6502262|NCT00649454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5711490|NCT04780464|Cyclophosphamide|cyclophosphamide|mesh-list
5711491|NCT04780464|Doxorubicin|doxorubicin|mesh-list
5711492|NCT04780464|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5711493|NCT04780464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5711494|NCT04780464|Immunologic Factors|immunologic factors|mesh-ancestor
6502263|NCT00649454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502264|NCT00649467|Topiramate|topiramate|mesh-list
6502265|NCT00649467|Anticonvulsants|anticonvulsants|mesh-ancestor
5711495|NCT04780464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711496|NCT04780464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5711497|NCT04780464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5711498|NCT04780464|Alkylating Agents|alkylating agents|mesh-ancestor
5711499|NCT04780464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711500|NCT04780464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5711501|NCT04780464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6236772|NCT05115630|Mycophenolic Acid|mycophenolic acid|mesh-list
6236773|NCT05115630|Cyclophosphamide|cyclophosphamide|mesh-list
6236774|NCT05115630|Melphalan|melphalan|mesh-list
6236775|NCT05115630|Fludarabine|fludarabine|mesh-list
6236776|NCT05115630|Fludarabine phosphate|fludarabine phosphate|mesh-list
6236777|NCT05115630|Tacrolimus|tacrolimus|mesh-list
6236778|NCT05115630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6236779|NCT05115630|Immunologic Factors|immunologic factors|mesh-ancestor
6236780|NCT05115630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236781|NCT05115630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6236782|NCT05115630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6236783|NCT05115630|Alkylating Agents|alkylating agents|mesh-ancestor
6236784|NCT05115630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236785|NCT05115630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6236786|NCT05115630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6236787|NCT05115630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6236788|NCT05115630|Antimetabolites|antimetabolites|mesh-ancestor
6236789|NCT05115630|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6236790|NCT05115630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6236791|NCT05115630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6236792|NCT05115630|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6236793|NCT05115630|Antitubercular Agents|antitubercular agents|mesh-ancestor
6236794|NCT05115630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6236795|NCT05115630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6236796|NCT05114746|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
6236797|NCT05114746|177Lu-PSMA-617|177lu-psma-617|mesh-list
6236798|NCT05114746|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6236799|NCT05114746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236800|NCT05111392|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6236801|NCT05109416|Bupivacaine|bupivacaine|mesh-list
5711502|NCT04780464|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5711503|NCT04780464|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5711504|NCT04780464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5711505|NCT04780464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6236802|NCT05109416|Anesthetics, Local|anesthetics, local|mesh-ancestor
6236803|NCT05109416|Anesthetics|anesthetics|mesh-ancestor
6236804|NCT05109416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6236805|NCT05109416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236806|NCT05109416|Sensory System Agents|sensory system agents|mesh-ancestor
6236807|NCT05109416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6236808|NCT05100628|Doxorubicin|doxorubicin|mesh-list
6236809|NCT05100628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6236810|NCT05100628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6236811|NCT05100628|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6236812|NCT05100628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6502266|NCT00649467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6502267|NCT00649467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677410|NCT01587508|Antidepressive Agents|antidepressive agents|mesh-ancestor
6677411|NCT01587508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6677412|NCT01587508|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6677413|NCT01587508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6677414|NCT01587508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5711506|NCT04780464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5711507|NCT04780464|Glucocorticoids|glucocorticoids|mesh-ancestor
5711508|NCT04780464|Hormones|hormones|mesh-ancestor
5711509|NCT04780464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5711510|NCT04780464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5711511|NCT04756804|Ethanol|ethanol|mesh-list
5711512|NCT04756804|Chlorhexidine|chlorhexidine|mesh-list
6236813|NCT05100628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6236814|NCT05100628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236815|NCT05094336|Docetaxel|docetaxel|mesh-list
6236816|NCT05094336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6236817|NCT05094336|Tubulin Modulators|tubulin modulators|mesh-ancestor
6236818|NCT05094336|Antimitotic Agents|antimitotic agents|mesh-ancestor
6236819|NCT05094336|Mitosis Modulators|mitosis modulators|mesh-ancestor
6236820|NCT05094336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236821|NCT05082155|Bupivacaine|bupivacaine|mesh-list
6236822|NCT05082155|Anesthetics, Local|anesthetics, local|mesh-ancestor
6236823|NCT05082155|Anesthetics|anesthetics|mesh-ancestor
6236824|NCT05082155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6236825|NCT05082155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236826|NCT05082155|Sensory System Agents|sensory system agents|mesh-ancestor
6236827|NCT05082155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6236828|NCT05078606|Anesthetics|anesthetics|mesh-list
6236829|NCT05078606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6236830|NCT05078606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236831|NCT05073315|Adalimumab|adalimumab|mesh-list
6236832|NCT05073315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6236833|NCT05073315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6236834|NCT05066308|Cannabidiol|cannabidiol|mesh-list
6236835|NCT05066308|Anticonvulsants|anticonvulsants|mesh-ancestor
6236836|NCT05064319|Gabapentin|gabapentin|mesh-list
6236837|NCT05064319|Analgesics|analgesics|mesh-ancestor
6236838|NCT05064319|Sensory System Agents|sensory system agents|mesh-ancestor
6236839|NCT05064319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6236840|NCT05064319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236841|NCT05064319|Anticonvulsants|anticonvulsants|mesh-ancestor
6236842|NCT05064319|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6236843|NCT05064319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6236844|NCT05064319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6236845|NCT05064319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6236846|NCT05064319|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6236847|NCT05064319|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6236848|NCT05064319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6236849|NCT05064319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236850|NCT05064319|Antimanic Agents|antimanic agents|mesh-ancestor
6236854|NCT05055050|Imiquimod|imiquimod|mesh-list
6236855|NCT05055050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6236856|NCT05055050|Immunologic Factors|immunologic factors|mesh-ancestor
6236857|NCT05055050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236858|NCT05055050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6236859|NCT05055050|Interferon Inducers|interferon inducers|mesh-ancestor
6236860|NCT05052801|Bemarituzumab|bemarituzumab|mesh-list
6236861|NCT05052801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5711513|NCT04756804|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5711514|NCT04756804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5711515|NCT04756804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5711516|NCT04756804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5711517|NCT04756804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711518|NCT04756804|Disinfectants|disinfectants|mesh-ancestor
5711519|NCT04756804|Dermatologic Agents|dermatologic agents|mesh-ancestor
5711520|NCT04744181|Folic Acid|folic acid|mesh-list
5711521|NCT04744181|Vitamin B Complex|vitamin b complex|mesh-list
5711522|NCT04744181|Vitamins|vitamins|mesh-ancestor
5711523|NCT04744181|Micronutrients|micronutrients|mesh-ancestor
5711524|NCT04744181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236862|NCT05052801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5711525|NCT04744181|Hematinics|hematinics|mesh-ancestor
5711526|NCT04733560|Bupivacaine|bupivacaine|mesh-list
5711527|NCT04733560|Anesthetics, Local|anesthetics, local|mesh-ancestor
5711528|NCT04733560|Anesthetics|anesthetics|mesh-ancestor
5711529|NCT04733560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5711530|NCT04733560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236863|NCT05035836|Tamoxifen|tamoxifen|mesh-list
6236864|NCT05035836|Letrozole|letrozole|mesh-list
6236865|NCT05035836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6236866|NCT05035836|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6236867|NCT05035836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6236868|NCT05035836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6236869|NCT05035836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236870|NCT05035836|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6236871|NCT05035836|Hormone Antagonists|hormone antagonists|mesh-ancestor
6236872|NCT05035836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6236873|NCT05035836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236874|NCT05035836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6236875|NCT05035836|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6502268|NCT00649480|Balsalazide|balsalazide|mesh-list
6502269|NCT00649480|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6502270|NCT00649480|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6502271|NCT00649480|Analgesics|analgesics|mesh-ancestor
6502272|NCT00649480|Sensory System Agents|sensory system agents|mesh-ancestor
6236876|NCT05035836|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6236877|NCT05035836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6236878|NCT05033080|Ivacaftor|ivacaftor|mesh-list
6236879|NCT05033080|Elexacaftor|elexacaftor|mesh-list
6236880|NCT05033080|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6236881|NCT05033080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6236882|NCT05033080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236883|NCT05030506|Pembrolizumab|pembrolizumab|mesh-list
6236884|NCT05030506|Lenvatinib|lenvatinib|mesh-list
6236885|NCT05030506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6236886|NCT05030506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6236887|NCT05030506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6236888|NCT05030506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6236889|NCT05030506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236890|NCT05028829|Atorvastatin|atorvastatin|mesh-list
6236891|NCT05028829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6502273|NCT00649480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6502274|NCT00649480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502275|NCT00649480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6502276|NCT00649480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5711531|NCT04733560|Sensory System Agents|sensory system agents|mesh-ancestor
5711532|NCT04733560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5711533|NCT04713098|Coal Tar|coal tar|mesh-list
5711534|NCT04713098|Keratolytic Agents|keratolytic agents|mesh-ancestor
5711535|NCT04713098|Dermatologic Agents|dermatologic agents|mesh-ancestor
5711536|NCT04669561|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5711537|NCT04669561|Lifitegrast|lifitegrast|mesh-list
5711538|NCT04669561|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5711539|NCT04647383|Lemborexant|lemborexant|mesh-list
5711540|NCT04647383|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
5711541|NCT04647383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5711542|NCT04647383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711543|NCT04647383|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5711544|NCT04647383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5711545|NCT04647383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5711546|NCT04647383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711547|NCT04630002|Ritonavir|ritonavir|mesh-list
5711548|NCT04630002|Darunavir|darunavir|mesh-list
5711549|NCT04630002|Etravirine|etravirine|mesh-list
5711550|NCT04630002|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6502277|NCT00649480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6502278|NCT00649493|Rabeprazole|rabeprazole|mesh-list
6502279|NCT00649493|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6502280|NCT00649493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6502281|NCT00649493|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6502282|NCT00649493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6502283|NCT00649493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502284|NCT00649506|Nitrofurantoin|nitrofurantoin|mesh-list
6502285|NCT00649506|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6502286|NCT00649506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6502287|NCT00649506|Renal Agents|renal agents|mesh-ancestor
6502288|NCT00649506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6502289|NCT00649519|Amlodipine|amlodipine|mesh-list
6502290|NCT00649519|Benazepril|benazepril|mesh-list
6502291|NCT00649519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6502292|NCT00649519|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6502293|NCT00649519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5711551|NCT04630002|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6502294|NCT00649519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502295|NCT00649519|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6502296|NCT00649519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502297|NCT00649519|Vasodilator Agents|vasodilator agents|mesh-ancestor
6236892|NCT05028829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6236893|NCT05028829|Antimetabolites|antimetabolites|mesh-ancestor
6236894|NCT05028829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236895|NCT05028829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6236896|NCT05028829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6236897|NCT05028829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6236898|NCT05021991|Pramoxine|pramoxine|mesh-list
6236899|NCT05021991|Anesthetics, Local|anesthetics, local|mesh-ancestor
6236900|NCT05021991|Anesthetics|anesthetics|mesh-ancestor
6236901|NCT05021991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6236902|NCT05021991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236903|NCT05021991|Sensory System Agents|sensory system agents|mesh-ancestor
6236904|NCT05021991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6236905|NCT05005442|Pembrolizumab|pembrolizumab|mesh-list
6236906|NCT05005442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6236907|NCT05005442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6236908|NCT04998604|Omalizumab|omalizumab|mesh-list
6236909|NCT04998604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6236910|NCT04998604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6236911|NCT04998604|Respiratory System Agents|respiratory system agents|mesh-ancestor
6243949|NCT02683707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6243950|NCT02683707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6243951|NCT02683707|Anesthetics, General|anesthetics, general|mesh-ancestor
6243952|NCT02683707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6243953|NCT02683707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6502298|NCT00649519|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6502299|NCT00649519|Protease Inhibitors|protease inhibitors|mesh-ancestor
6502300|NCT00649519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6502301|NCT00649532|Ondansetron|ondansetron|mesh-list
6502302|NCT00649532|Antiemetics|antiemetics|mesh-ancestor
6502303|NCT00649532|Autonomic Agents|autonomic agents|mesh-ancestor
6502304|NCT00649532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6502305|NCT00649532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502306|NCT00649532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6502307|NCT00649532|Antipruritics|antipruritics|mesh-ancestor
6677415|NCT01587508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6243954|NCT02683707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6243955|NCT02683707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6243956|NCT02683707|GABA Modulators|gaba modulators|mesh-ancestor
6243957|NCT02683707|GABA Agents|gaba agents|mesh-ancestor
6243958|NCT02683707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6243959|NCT02683746|rGLP-1 protein|rglp-1 protein|mesh-list
6243960|NCT02683746|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6243961|NCT02683746|Incretins|incretins|mesh-ancestor
6243962|NCT02683746|Hormones|hormones|mesh-ancestor
6243963|NCT02683746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6243964|NCT02683746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244281|NCT02691572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244282|NCT02691702|Melatonin|melatonin|mesh-list
6244283|NCT02691702|Antioxidants|antioxidants|mesh-ancestor
6244284|NCT02691702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244285|NCT02691702|Protective Agents|protective agents|mesh-ancestor
6244286|NCT02691702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711552|NCT04630002|Protease Inhibitors|protease inhibitors|mesh-ancestor
5711553|NCT04630002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5711554|NCT04630002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711555|NCT04630002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5711556|NCT04630002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5711557|NCT04630002|Antiviral Agents|antiviral agents|mesh-ancestor
5711558|NCT04630002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5711559|NCT04630002|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5711560|NCT04630002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5711561|NCT04630002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5711562|NCT04630002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5711563|NCT04542408|Heparin|heparin|mesh-list
5711564|NCT04542408|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5711565|NCT04542408|Tinzaparin|tinzaparin|mesh-list
5711566|NCT04542408|Dalteparin|dalteparin|mesh-list
5711567|NCT04542408|Edoxaban|edoxaban|mesh-list
5711568|NCT04542408|Anticoagulants|anticoagulants|mesh-list
6244287|NCT02691702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6236912|NCT04992312|Glucagon|glucagon|mesh-list
6236913|NCT04992312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6236914|NCT04992312|Hormones|hormones|mesh-ancestor
6236915|NCT04992312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6236916|NCT04992312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236917|NCT04990128|Triamcinolone|triamcinolone|mesh-list
6236918|NCT04990128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6236919|NCT04990128|Glucocorticoids|glucocorticoids|mesh-ancestor
6236920|NCT04990128|Hormones|hormones|mesh-ancestor
6502308|NCT00649532|Dermatologic Agents|dermatologic agents|mesh-ancestor
6502309|NCT00649532|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6502310|NCT00649532|Serotonin Agents|serotonin agents|mesh-ancestor
6502311|NCT00649532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6502312|NCT00649532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236921|NCT04990128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6236922|NCT04990128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236923|NCT04989803|Cyclophosphamide|cyclophosphamide|mesh-list
6236924|NCT04989803|Fludarabine|fludarabine|mesh-list
6236925|NCT04989803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6236926|NCT04989803|Immunologic Factors|immunologic factors|mesh-ancestor
6236927|NCT04989803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236928|NCT04989803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6236929|NCT04989803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6236930|NCT04989803|Alkylating Agents|alkylating agents|mesh-ancestor
6236931|NCT04989803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236932|NCT04989803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6236933|NCT04989803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5711569|NCT04542408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5711570|NCT04542408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5711571|NCT04542408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711572|NCT04542408|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5711573|NCT04542408|Antithrombins|antithrombins|mesh-ancestor
5711574|NCT04542408|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5711575|NCT04542408|Protease Inhibitors|protease inhibitors|mesh-ancestor
5711576|NCT04542408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5721688|NCT03204019|Temozolomide|temozolomide|mesh-list
5721689|NCT03204019|Tegafur|tegafur|mesh-list
5721690|NCT03204019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5721691|NCT03204019|Alkylating Agents|alkylating agents|mesh-ancestor
6236939|NCT04969224|Ivacaftor|ivacaftor|mesh-list
5721692|NCT03204019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721693|NCT03204019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5721694|NCT03204019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5721695|NCT03204019|Immunologic Factors|immunologic factors|mesh-ancestor
6236940|NCT04969224|Elexacaftor|elexacaftor|mesh-list
6236941|NCT04969224|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6236942|NCT04969224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6236943|NCT04969224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236944|NCT04964544|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6236945|NCT04964544|Calcium|calcium|mesh-list
6236946|NCT04964544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6236947|NCT04964544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236948|NCT04964544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6236949|NCT04964544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6236950|NCT04964544|Antimetabolites|antimetabolites|mesh-ancestor
6236951|NCT04964544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502313|NCT00649532|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5721696|NCT03204019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721697|NCT03204019|Leprostatic Agents|leprostatic agents|mesh-ancestor
5721698|NCT03204019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5721699|NCT03204019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5721700|NCT03204019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5721701|NCT03204019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5721702|NCT03204019|Growth Substances|growth substances|mesh-ancestor
5721703|NCT03204019|Growth Inhibitors|growth inhibitors|mesh-ancestor
5721704|NCT03204019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5721705|NCT03204019|Antimetabolites|antimetabolites|mesh-ancestor
5721706|NCT03203746|Lycopene|lycopene|mesh-list
5721707|NCT03203746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6236952|NCT04964544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6236953|NCT04964544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6236954|NCT04964544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5711577|NCT04486716|Ofatumumab|ofatumumab|mesh-list
5711578|NCT04486716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5711579|NCT04495452|Fentanyl|fentanyl|mesh-list
6236970|NCT04932915|Niclosamide|niclosamide|mesh-list
6236971|NCT04932915|Anticestodal Agents|anticestodal agents|mesh-ancestor
6236972|NCT04932915|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6236973|NCT04932915|Anthelmintics|anthelmintics|mesh-ancestor
6236974|NCT04932915|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6236975|NCT04932915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6236976|NCT04932915|Antinematodal Agents|antinematodal agents|mesh-ancestor
6236977|NCT04926818|Ofatumumab|ofatumumab|mesh-list
6236978|NCT04926818|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5711580|NCT04495452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5711581|NCT04495452|Narcotics|narcotics|mesh-ancestor
5711582|NCT04495452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5711583|NCT04495452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711584|NCT04495452|Analgesics|analgesics|mesh-ancestor
5711585|NCT04495452|Sensory System Agents|sensory system agents|mesh-ancestor
5711586|NCT04495452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5711587|NCT04495452|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5711588|NCT04495452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6236979|NCT04926818|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6236980|NCT04926818|Siponimod|siponimod|mesh-list
6236981|NCT04926818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6236982|NCT04926818|Immunologic Factors|immunologic factors|mesh-ancestor
5711589|NCT04495452|Anesthetics, General|anesthetics, general|mesh-ancestor
5711590|NCT04495452|Anesthetics|anesthetics|mesh-ancestor
5711591|NCT04431466|Ivermectin|ivermectin|mesh-list
5711592|NCT04431466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5711593|NCT04431466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5711594|NCT04427904|Lidocaine|lidocaine|mesh-list
5711595|NCT04427904|Epinephrine|epinephrine|mesh-list
5711596|NCT04427904|Racepinephrine|racepinephrine|mesh-list
5711597|NCT04427904|Bupivacaine|bupivacaine|mesh-list
5711598|NCT04427904|Epinephryl borate|epinephryl borate|mesh-list
6236983|NCT04926818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236984|NCT04926818|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6236985|NCT04926818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6236986|NCT04926818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6236987|NCT04908189|Apremilast|apremilast|mesh-list
6502314|NCT00649532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6502315|NCT00649532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6502316|NCT00649532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6502317|NCT00649532|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6502318|NCT00649545|Adalimumab|adalimumab|mesh-list
6502319|NCT00649545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5711599|NCT04427904|Anesthetics, Local|anesthetics, local|mesh-ancestor
5711600|NCT04427904|Anesthetics|anesthetics|mesh-ancestor
6236988|NCT04908189|BMS-986165|bms-986165|mesh-list
6236989|NCT04908189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6236990|NCT04908189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6236991|NCT04908189|Analgesics|analgesics|mesh-ancestor
6236992|NCT04908189|Sensory System Agents|sensory system agents|mesh-ancestor
6236993|NCT04908189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6236994|NCT04908189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6236995|NCT04908189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6236996|NCT04908189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6236997|NCT04908189|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6236998|NCT04908189|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6236999|NCT04908189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6502320|NCT00649545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6502321|NCT00649558|Pioglitazone|pioglitazone|mesh-list
6502322|NCT00649558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6502323|NCT00649558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502324|NCT00649571|Doxycycline|doxycycline|mesh-list
6502325|NCT00649571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6502326|NCT00649571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6502327|NCT00649571|Antimalarials|antimalarials|mesh-ancestor
6502328|NCT00649571|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6502329|NCT00649571|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6502330|NCT00649584|Gemcitabine|gemcitabine|mesh-list
6502331|NCT00649584|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6502332|NCT00649584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6502333|NCT00649584|Antimetabolites|antimetabolites|mesh-ancestor
6502334|NCT00649584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502335|NCT00649584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6502336|NCT00649584|Antiviral Agents|antiviral agents|mesh-ancestor
6237000|NCT04908189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6237001|NCT04908189|Dermatologic Agents|dermatologic agents|mesh-ancestor
6237002|NCT04908189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5711601|NCT04427904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5711602|NCT04427904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711603|NCT04427904|Sensory System Agents|sensory system agents|mesh-ancestor
5711604|NCT04427904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5711605|NCT04427904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5711606|NCT04427904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5711607|NCT04427904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5711608|NCT04427904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5711609|NCT04427904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711610|NCT04427904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5711611|NCT04427904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5711612|NCT04427904|Adrenergic Agents|adrenergic agents|mesh-ancestor
6502337|NCT00649584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6502338|NCT00649584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6502339|NCT00649584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6502340|NCT00649584|Immunologic Factors|immunologic factors|mesh-ancestor
6502341|NCT00649584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502342|NCT00649584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6502343|NCT00649597|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6502344|NCT00649597|Benazepril|benazepril|mesh-list
6502345|NCT00649597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5711613|NCT04427904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5711614|NCT04427904|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5711615|NCT04427904|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5711616|NCT04427904|Autonomic Agents|autonomic agents|mesh-ancestor
5711617|NCT04427904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5711618|NCT04427904|Respiratory System Agents|respiratory system agents|mesh-ancestor
5711619|NCT04427904|Mydriatics|mydriatics|mesh-ancestor
5711620|NCT04427904|Sympathomimetics|sympathomimetics|mesh-ancestor
5711621|NCT04427904|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5711622|NCT04416282|Terlipressin|terlipressin|mesh-list
5711623|NCT04416282|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5711624|NCT04416282|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5711625|NCT04377451|Metformin|metformin|mesh-list
5711626|NCT04377451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5711627|NCT04377451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502346|NCT00649597|Diuretics|diuretics|mesh-ancestor
6502347|NCT00649597|Natriuretic Agents|natriuretic agents|mesh-ancestor
6502348|NCT00649597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721708|NCT03203746|Antioxidants|antioxidants|mesh-ancestor
6502349|NCT00649597|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5711628|NCT04341129|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
5711629|NCT04341129|Chelating Agents|chelating agents|mesh-ancestor
5711630|NCT04341129|Sequestering Agents|sequestering agents|mesh-ancestor
5711631|NCT04341129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711632|NCT04239040|Nivolumab|nivolumab|mesh-list
5711633|NCT04239040|Ipilimumab|ipilimumab|mesh-list
5711634|NCT04239040|Vaccines|vaccines|mesh-list
5711635|NCT04239040|Immunologic Factors|immunologic factors|mesh-ancestor
5711636|NCT04239040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502350|NCT00649597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6502351|NCT00649597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502352|NCT00649597|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6502353|NCT00649597|Protease Inhibitors|protease inhibitors|mesh-ancestor
6677416|NCT01587508|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6677417|NCT01587508|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6677418|NCT01587508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5711637|NCT04239040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6237022|NCT04893109|Paclitaxel|paclitaxel|mesh-list
6237023|NCT04893109|Maytansine|maytansine|mesh-list
6237024|NCT04893109|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
6237025|NCT04893109|Trastuzumab|trastuzumab|mesh-list
6237026|NCT04893109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6237027|NCT04893109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6237028|NCT04893109|Tubulin Modulators|tubulin modulators|mesh-ancestor
6237029|NCT04893109|Antimitotic Agents|antimitotic agents|mesh-ancestor
6237030|NCT04893109|Mitosis Modulators|mitosis modulators|mesh-ancestor
6237031|NCT04893109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711638|NCT04239040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5711639|NCT04239040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6237032|NCT04893109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6237033|NCT04892277|Cyclophosphamide|cyclophosphamide|mesh-list
6237034|NCT04892277|Fludarabine|fludarabine|mesh-list
6237035|NCT04892277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5711640|NCT04239040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6237036|NCT04892277|Immunologic Factors|immunologic factors|mesh-ancestor
6237037|NCT04892277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6237038|NCT04892277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6237039|NCT04892277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6237040|NCT04892277|Alkylating Agents|alkylating agents|mesh-ancestor
6237041|NCT04892277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6237042|NCT04892277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6237043|NCT04892277|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6237044|NCT04882241|Leucovorin|leucovorin|mesh-list
6237045|NCT04882241|Docetaxel|docetaxel|mesh-list
6502354|NCT00649597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6502355|NCT00649610|Diclofenac|diclofenac|mesh-list
6502356|NCT00649610|Valdecoxib|valdecoxib|mesh-list
6502357|NCT00649610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6502358|NCT00649610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6502359|NCT00649610|Analgesics|analgesics|mesh-ancestor
6502360|NCT00649610|Sensory System Agents|sensory system agents|mesh-ancestor
6502361|NCT00649610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6502362|NCT00649610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502363|NCT00649610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6502364|NCT00649610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6502365|NCT00649610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6502366|NCT00649610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6502367|NCT00649610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6237046|NCT04882241|Fluorouracil|fluorouracil|mesh-list
6237047|NCT04882241|Pembrolizumab|pembrolizumab|mesh-list
6237048|NCT04882241|Capecitabine|capecitabine|mesh-list
6237049|NCT04882241|Oxaliplatin|oxaliplatin|mesh-list
6237050|NCT04882241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6237051|NCT04882241|Tubulin Modulators|tubulin modulators|mesh-ancestor
6237052|NCT04882241|Antimitotic Agents|antimitotic agents|mesh-ancestor
6237053|NCT04882241|Mitosis Modulators|mitosis modulators|mesh-ancestor
6237054|NCT04882241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6237055|NCT04882241|Antimetabolites|antimetabolites|mesh-ancestor
6237056|NCT04882241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6237057|NCT04882241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6237058|NCT04882241|Immunologic Factors|immunologic factors|mesh-ancestor
6237059|NCT04882241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6237060|NCT04882241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6237061|NCT04882241|Antidotes|antidotes|mesh-ancestor
6237062|NCT04882241|Protective Agents|protective agents|mesh-ancestor
6237063|NCT04882241|Vitamin B Complex|vitamin b complex|mesh-ancestor
6237064|NCT04882241|Vitamins|vitamins|mesh-ancestor
6237065|NCT04882241|Micronutrients|micronutrients|mesh-ancestor
6237066|NCT04880278|Nabilone|nabilone|mesh-list
6237067|NCT04880278|Antiemetics|antiemetics|mesh-ancestor
6237068|NCT04880278|Autonomic Agents|autonomic agents|mesh-ancestor
6237069|NCT04880278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6237070|NCT04880278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6237071|NCT04880278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6237072|NCT04880278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6237073|NCT04880278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6237074|NCT04880278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6237075|NCT04880278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6237076|NCT04874038|Lidocaine|lidocaine|mesh-list
6237077|NCT04874038|Anesthetics, Local|anesthetics, local|mesh-ancestor
6237078|NCT04874038|Anesthetics|anesthetics|mesh-ancestor
6237079|NCT04874038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6237080|NCT04874038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6237081|NCT04874038|Sensory System Agents|sensory system agents|mesh-ancestor
6237082|NCT04874038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6237083|NCT04874038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6237084|NCT04874038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6237085|NCT04874038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6237086|NCT04874038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6237087|NCT04874038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6237088|NCT04867785|Dulaglutide|dulaglutide|mesh-list
6237089|NCT04867785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6237090|NCT04867785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6237096|NCT04852887|Tamoxifen|tamoxifen|mesh-list
6237097|NCT04852887|Letrozole|letrozole|mesh-list
6237098|NCT04852887|Exemestane|exemestane|mesh-list
6237099|NCT04852887|Anastrozole|anastrozole|mesh-list
6237100|NCT04852887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6237101|NCT04852887|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6237102|NCT04852887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6237103|NCT04852887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6502368|NCT00649610|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6502369|NCT00649623|Olmesartan|olmesartan|mesh-list
6502370|NCT00649623|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6502371|NCT00649623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6502372|NCT00649623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6237104|NCT04852887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6237105|NCT04852887|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6237106|NCT04852887|Hormone Antagonists|hormone antagonists|mesh-ancestor
6502373|NCT00649623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6502374|NCT00649623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502375|NCT00649636|Fluoxetine|fluoxetine|mesh-list
6502376|NCT00649636|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6502377|NCT00649636|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6502378|NCT00649636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6502379|NCT00649636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6237107|NCT04852887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6237108|NCT04852887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6237109|NCT04852887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6502380|NCT00649636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6502381|NCT00649636|Serotonin Agents|serotonin agents|mesh-ancestor
6502382|NCT00649636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502383|NCT00649636|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6502384|NCT00649636|Antidepressive Agents|antidepressive agents|mesh-ancestor
6502385|NCT00649636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6237110|NCT04852887|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6237111|NCT04852887|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6237112|NCT04852887|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6237113|NCT04845490|Mitomycins|mitomycins|mesh-list
6237114|NCT04845490|Mitomycin|mitomycin|mesh-list
6237115|NCT04845490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6237116|NCT04845490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6237117|NCT04845490|Alkylating Agents|alkylating agents|mesh-ancestor
6237118|NCT04845490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6237119|NCT04845490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6237120|NCT04845490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6237121|NCT04830397|Timolol|timolol|mesh-list
6237122|NCT04830397|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6237123|NCT04830397|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6237124|NCT04830397|Adrenergic Agents|adrenergic agents|mesh-ancestor
6237125|NCT04830397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6237126|NCT04830397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6237127|NCT04830397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6237128|NCT04830397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6237129|NCT04830397|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6237130|NCT04825223|Vaccines|vaccines|mesh-list
6237131|NCT04825223|Immunologic Factors|immunologic factors|mesh-ancestor
6237132|NCT04825223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6237133|NCT04819360|Solifenacin Succinate|solifenacin succinate|mesh-list
6237134|NCT04819360|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6237135|NCT04819360|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6237136|NCT04819360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6237137|NCT04819360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6237138|NCT04819360|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6237139|NCT04819360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6237140|NCT04819360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6237141|NCT04819360|Cholinergic Agents|cholinergic agents|mesh-ancestor
6237142|NCT04819360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6502386|NCT00649636|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6502387|NCT00649636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6502388|NCT00649636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6502389|NCT00649649|Quinapril|quinapril|mesh-list
6502390|NCT00649649|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6502391|NCT00649649|Protease Inhibitors|protease inhibitors|mesh-ancestor
6502392|NCT00649649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6502393|NCT00649649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6237143|NCT04819360|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6237144|NCT04819360|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6237145|NCT04819360|Urological Agents|urological agents|mesh-ancestor
5711641|NCT04179032|Belimumab|belimumab|mesh-list
5711642|NCT04179032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6237146|NCT04816643|Vaccines|vaccines|mesh-list
6237147|NCT04816643|Immunologic Factors|immunologic factors|mesh-ancestor
6237148|NCT04816643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711643|NCT04179032|Immunologic Factors|immunologic factors|mesh-ancestor
5711644|NCT04179032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711645|NCT04177758|Vitamin D|vitamin d|mesh-list
5711646|NCT04177758|Vitamins|vitamins|mesh-ancestor
5711647|NCT04177758|Micronutrients|micronutrients|mesh-ancestor
6237149|NCT04808466|Paclitaxel|paclitaxel|mesh-list
6237150|NCT04808466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6237151|NCT04808466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6237152|NCT04808466|Tubulin Modulators|tubulin modulators|mesh-ancestor
6237153|NCT04808466|Antimitotic Agents|antimitotic agents|mesh-ancestor
6237154|NCT04808466|Mitosis Modulators|mitosis modulators|mesh-ancestor
6237155|NCT04808466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6237156|NCT04797780|Azacitidine|azacitidine|mesh-list
6237157|NCT04797780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6237158|NCT04797780|Antimetabolites|antimetabolites|mesh-ancestor
6237159|NCT04797780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711648|NCT04177758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6237160|NCT04797780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6237161|NCT04797780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6237162|NCT04797767|Cytarabine|cytarabine|mesh-list
6237163|NCT04797767|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
6237164|NCT04797767|Venetoclax|venetoclax|mesh-list
6237165|NCT04797767|Mitoxantrone|mitoxantrone|mesh-list
6237166|NCT04797767|Cladribine|cladribine|mesh-list
6237167|NCT04797767|Sargramostim|sargramostim|mesh-list
6237168|NCT04797767|Lenograstim|lenograstim|mesh-list
6237169|NCT04797767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6237170|NCT04797767|Antimetabolites|antimetabolites|mesh-ancestor
6237171|NCT04797767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6237172|NCT04797767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6237173|NCT04797767|Antiviral Agents|antiviral agents|mesh-ancestor
6237174|NCT04797767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6237175|NCT04797767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6237176|NCT04797767|Immunologic Factors|immunologic factors|mesh-ancestor
6237177|NCT04797767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6237178|NCT04797767|Analgesics|analgesics|mesh-ancestor
6237179|NCT04797767|Sensory System Agents|sensory system agents|mesh-ancestor
6237180|NCT04797767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6237181|NCT04797767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6237182|NCT04797767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6237183|NCT04797767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6237184|NCT04797767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6237185|NCT04787354|Capecitabine|capecitabine|mesh-list
6237186|NCT04787354|Oxaliplatin|oxaliplatin|mesh-list
6237187|NCT04787354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6237188|NCT04787354|Antimetabolites|antimetabolites|mesh-ancestor
6237189|NCT04787354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6237190|NCT04787354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6237191|NCT04785820|Nivolumab|nivolumab|mesh-list
6237192|NCT04785820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6237193|NCT04785820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6237194|NCT04785820|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5711649|NCT04177758|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5711650|NCT04151667|Dexamethasone|dexamethasone|mesh-list
5711651|NCT04151667|Lenalidomide|lenalidomide|mesh-list
5711652|NCT04151667|Bortezomib|bortezomib|mesh-list
5711653|NCT04151667|Daratumumab|daratumumab|mesh-list
5711654|NCT04151667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5711655|NCT04151667|Antiemetics|antiemetics|mesh-ancestor
5711656|NCT04151667|Autonomic Agents|autonomic agents|mesh-ancestor
5711657|NCT04151667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5711658|NCT04151667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711659|NCT04151667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5711660|NCT04151667|Glucocorticoids|glucocorticoids|mesh-ancestor
5711661|NCT04151667|Hormones|hormones|mesh-ancestor
5711662|NCT04151667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5711663|NCT04151667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5711664|NCT04151667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5711665|NCT04151667|Immunologic Factors|immunologic factors|mesh-ancestor
5711666|NCT04151667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5711667|NCT04151667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5711668|NCT04151667|Growth Substances|growth substances|mesh-ancestor
5711669|NCT04151667|Growth Inhibitors|growth inhibitors|mesh-ancestor
5711670|NCT04149899|Timolol|timolol|mesh-list
6237195|NCT04785820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6237199|NCT04762758|Naltrexone|naltrexone|mesh-list
6237200|NCT04762758|Baclofen|baclofen|mesh-list
6237201|NCT04762758|Sorbitol|sorbitol|mesh-list
6237202|NCT04762758|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6237203|NCT04762758|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6237204|NCT04762758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6237205|NCT04762758|Sensory System Agents|sensory system agents|mesh-ancestor
6237206|NCT04762758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6237207|NCT04762758|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6237208|NCT04762758|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6237209|NCT04762758|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6237210|NCT04762758|GABA Agonists|gaba agonists|mesh-ancestor
6237211|NCT04762758|GABA Agents|gaba agents|mesh-ancestor
6237212|NCT04762758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6237213|NCT04762758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502394|NCT00649649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6502395|NCT00649662|Ciprofloxacin|ciprofloxacin|mesh-list
6502396|NCT00649662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6237214|NCT04762758|Cathartics|cathartics|mesh-ancestor
6237215|NCT04762758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6237216|NCT04745689|Carboplatin|carboplatin|mesh-list
6237217|NCT04745689|Etoposide|etoposide|mesh-list
5711671|NCT04149899|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5711672|NCT04149899|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5711673|NCT04149899|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5711674|NCT04149899|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5711675|NCT04149899|Adrenergic Agents|adrenergic agents|mesh-ancestor
5711676|NCT04149899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5711677|NCT04149899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711678|NCT04149899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711679|NCT04149899|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6237218|NCT04745689|Durvalumab|durvalumab|mesh-list
6502397|NCT00649662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6502398|NCT00649662|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6502399|NCT00649662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6502400|NCT00649662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6502401|NCT00649662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502402|NCT00649662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6502403|NCT00649662|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5711680|NCT04149899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5711681|NCT04130516|Pembrolizumab|pembrolizumab|mesh-list
5711682|NCT04130516|Antibodies|antibodies|mesh-list
5711683|NCT04130516|Immunologic Factors|immunologic factors|mesh-ancestor
5711684|NCT04130516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711685|NCT04130516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5711686|NCT04130516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5711687|NCT04126538|Pirfenidone|pirfenidone|mesh-list
5711688|NCT04126538|Analgesics|analgesics|mesh-ancestor
5711689|NCT04126538|Sensory System Agents|sensory system agents|mesh-ancestor
5711690|NCT04126538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5711691|NCT04126538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711692|NCT04126538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5711693|NCT04126538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5711694|NCT04126538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5711695|NCT04126538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5711696|NCT04126538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5711697|NCT04046263|Ferric Compounds|ferric compounds|mesh-list
5711698|NCT04046263|Hematinics|hematinics|mesh-ancestor
5711699|NCT03920527|Itraconazole|itraconazole|mesh-list
5711700|NCT03920527|Antifungal Agents|antifungal agents|mesh-ancestor
5711701|NCT03920527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5711702|NCT03920527|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5711703|NCT03920527|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5711704|NCT03920527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5711705|NCT03920527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711706|NCT03920527|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6502404|NCT00649662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6502405|NCT00649675|Meloxicam|meloxicam|mesh-list
6237219|NCT04745689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6237220|NCT04745689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6237221|NCT04745689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6237222|NCT04745689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6502406|NCT00649675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6502407|NCT00649675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6502408|NCT00649675|Analgesics|analgesics|mesh-ancestor
6502409|NCT00649675|Sensory System Agents|sensory system agents|mesh-ancestor
6677419|NCT01587508|Adrenergic Agents|adrenergic agents|mesh-ancestor
6677420|NCT01587508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6677421|NCT01587586|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6237223|NCT04745689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6237224|NCT04745689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6237225|NCT04745689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6237226|NCT04743453|Dapagliflozin|dapagliflozin|mesh-list
6237227|NCT04743453|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6237228|NCT04743453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6237229|NCT04743453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6237230|NCT04743453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6237231|NCT04740931|Aflibercept|aflibercept|mesh-list
6677422|NCT01587586|Antiviral Agents|antiviral agents|mesh-ancestor
5711707|NCT03920527|Hormone Antagonists|hormone antagonists|mesh-ancestor
5711708|NCT03920527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5711709|NCT03920527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711710|NCT03920527|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5711711|NCT03902509|Pirfenidone|pirfenidone|mesh-list
5711712|NCT03902509|Analgesics|analgesics|mesh-ancestor
5711713|NCT03902509|Sensory System Agents|sensory system agents|mesh-ancestor
5711714|NCT03902509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6237232|NCT04740931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6237233|NCT04740931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6237234|NCT04740931|Growth Substances|growth substances|mesh-ancestor
6237235|NCT04740931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6237236|NCT04740931|Growth Inhibitors|growth inhibitors|mesh-ancestor
6502410|NCT00649675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6502411|NCT00649675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502412|NCT00649675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6502413|NCT00649675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6502414|NCT00649675|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5711715|NCT03902509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711716|NCT03902509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5711717|NCT03902509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5711718|NCT03902509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5711719|NCT03902509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5711720|NCT03902509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5711721|NCT03873480|Epinephrine|epinephrine|mesh-list
5711722|NCT03873480|Bupivacaine|bupivacaine|mesh-list
5711723|NCT03873480|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5711724|NCT03873480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5711725|NCT03873480|Adrenergic Agents|adrenergic agents|mesh-ancestor
5711726|NCT03873480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5722325|NCT03199976|Cholinergic Agents|cholinergic agents|mesh-ancestor
6237237|NCT04740931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6502415|NCT00649675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6502416|NCT00649675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6502417|NCT00649675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502418|NCT00649688|Metoprolol|metoprolol|mesh-list
6502419|NCT00649688|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6502420|NCT00649688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6502421|NCT00649688|Diuretics|diuretics|mesh-ancestor
6502422|NCT00649688|Natriuretic Agents|natriuretic agents|mesh-ancestor
6502423|NCT00649688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502424|NCT00649688|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6243965|NCT02683941|Lanreotide|lanreotide|mesh-list
6243966|NCT02683941|Somatostatin|somatostatin|mesh-list
6243967|NCT02683941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6243968|NCT02683941|Hormones|hormones|mesh-ancestor
6243969|NCT02683941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6243970|NCT02683941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243971|NCT02684136|Suvorexant|suvorexant|mesh-list
6243972|NCT02684136|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6243973|NCT02684136|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6243974|NCT02684136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6243975|NCT02684136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243976|NCT02684136|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
6677423|NCT01587586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6677424|NCT01587625|Oxytocin|oxytocin|mesh-list
6677425|NCT01587625|Oxytocics|oxytocics|mesh-ancestor
6677426|NCT01587625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6243977|NCT02684136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6243978|NCT02684136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243979|NCT02684344|Tamsulosin|tamsulosin|mesh-list
6243980|NCT02684344|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6243981|NCT02684344|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6243982|NCT02684344|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6243983|NCT02684344|Adrenergic Agents|adrenergic agents|mesh-ancestor
6243984|NCT02684344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6243985|NCT02684344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6243986|NCT02684344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243987|NCT02684344|Urological Agents|urological agents|mesh-ancestor
6243988|NCT02684357|Ustekinumab|ustekinumab|mesh-list
6243989|NCT02684357|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6243990|NCT02684357|Dermatologic Agents|dermatologic agents|mesh-ancestor
6502425|NCT00649688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6237241|NCT04736173|Paclitaxel|paclitaxel|mesh-list
6237242|NCT04736173|Carboplatin|carboplatin|mesh-list
6237243|NCT04736173|Pemetrexed|pemetrexed|mesh-list
6237244|NCT04736173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6237245|NCT04736173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6237246|NCT04736173|Tubulin Modulators|tubulin modulators|mesh-ancestor
6237247|NCT04736173|Antimitotic Agents|antimitotic agents|mesh-ancestor
6237248|NCT04736173|Mitosis Modulators|mitosis modulators|mesh-ancestor
6237249|NCT04736173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6237250|NCT04736173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6237251|NCT04736173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6237252|NCT04736173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5711727|NCT03873480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711728|NCT03873480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711729|NCT03873480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5711730|NCT03873480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5711731|NCT03873480|Autonomic Agents|autonomic agents|mesh-ancestor
5711732|NCT03873480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5711733|NCT03873480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5711734|NCT03873480|Respiratory System Agents|respiratory system agents|mesh-ancestor
5711735|NCT03873480|Mydriatics|mydriatics|mesh-ancestor
5711736|NCT03873480|Sympathomimetics|sympathomimetics|mesh-ancestor
5711737|NCT03873480|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5711738|NCT03873480|Anesthetics, Local|anesthetics, local|mesh-ancestor
5711739|NCT03873480|Anesthetics|anesthetics|mesh-ancestor
5711740|NCT03873480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5711741|NCT03873480|Sensory System Agents|sensory system agents|mesh-ancestor
5711742|NCT03854370|Chlorhexidine|chlorhexidine|mesh-list
5711743|NCT03854370|Povidone-Iodine|povidone-iodine|mesh-list
5711744|NCT03854370|Povidone|povidone|mesh-list
5711745|NCT03854370|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5711746|NCT03854370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5711747|NCT03854370|Disinfectants|disinfectants|mesh-ancestor
5711748|NCT03854370|Plasma Substitutes|plasma substitutes|mesh-ancestor
5711749|NCT03854370|Blood Substitutes|blood substitutes|mesh-ancestor
5711750|NCT03849651|Cyclophosphamide|cyclophosphamide|mesh-list
5711751|NCT03849651|Melphalan|melphalan|mesh-list
5711752|NCT03849651|Thiotepa|thiotepa|mesh-list
5711753|NCT03849651|Fludarabine|fludarabine|mesh-list
5711754|NCT03849651|Blinatumomab|blinatumomab|mesh-list
5711755|NCT03849651|Thymoglobulin|thymoglobulin|mesh-list
5711756|NCT03849651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5711757|NCT03849651|Immunologic Factors|immunologic factors|mesh-ancestor
5711758|NCT03849651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711759|NCT03849651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5711760|NCT03849651|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5711761|NCT03849651|Alkylating Agents|alkylating agents|mesh-ancestor
5711762|NCT03849651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711763|NCT03849651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5711764|NCT03849651|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5721709|NCT03203746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721710|NCT03203746|Protective Agents|protective agents|mesh-ancestor
5721711|NCT03203746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721712|NCT03203746|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5721713|NCT03203746|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5721714|NCT03203746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5721715|NCT03203668|Choline|choline|mesh-list
5721716|NCT03203668|Lipotropic Agents|lipotropic agents|mesh-ancestor
5721717|NCT03203668|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5721718|NCT03203668|Antimetabolites|antimetabolites|mesh-ancestor
5721719|NCT03203668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721720|NCT03203668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5721721|NCT03203668|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5721722|NCT03203668|Nootropic Agents|nootropic agents|mesh-ancestor
5721723|NCT03203525|Leucovorin|leucovorin|mesh-list
5721724|NCT03203525|Sirolimus|sirolimus|mesh-list
5721725|NCT03203525|Bevacizumab|bevacizumab|mesh-list
5721726|NCT03203525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5721727|NCT03203525|Doxorubicin|doxorubicin|mesh-list
5721728|NCT03203525|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5721729|NCT03203525|Fluorouracil|fluorouracil|mesh-list
5721730|NCT03203525|Oxaliplatin|oxaliplatin|mesh-list
6237253|NCT04734652|Tenofovir|tenofovir|mesh-list
5721731|NCT03203525|Endothelial Growth Factors|endothelial growth factors|mesh-list
5721732|NCT03203525|Antibodies|antibodies|mesh-list
5721733|NCT03203525|Immunoglobulins|immunoglobulins|mesh-list
6237254|NCT04734652|Lamivudine|lamivudine|mesh-list
6237255|NCT04734652|Dolutegravir|dolutegravir|mesh-list
6237256|NCT04734652|Antiviral Agents|antiviral agents|mesh-ancestor
6237257|NCT04734652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6237258|NCT04734652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6237259|NCT04734652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6237260|NCT04734652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6237261|NCT04734652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502426|NCT00649688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502427|NCT00649688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6502428|NCT00649688|Sympatholytics|sympatholytics|mesh-ancestor
6502429|NCT00649688|Autonomic Agents|autonomic agents|mesh-ancestor
6502430|NCT00649688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6502431|NCT00649688|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6502432|NCT00649688|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5711765|NCT03821883|Aspirin|aspirin|mesh-list
5711766|NCT03821883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5711767|NCT03821883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5711768|NCT03821883|Analgesics|analgesics|mesh-ancestor
5711769|NCT03821883|Sensory System Agents|sensory system agents|mesh-ancestor
5711770|NCT03821883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5711771|NCT03821883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502433|NCT00649688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6502434|NCT00649688|Adrenergic Agents|adrenergic agents|mesh-ancestor
6502435|NCT00649688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6502436|NCT00649714|Zonisamide|zonisamide|mesh-list
6677427|NCT01587625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677428|NCT01587638|Metoprolol|metoprolol|mesh-list
5711772|NCT03821883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5711773|NCT03821883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5711774|NCT03821883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5711775|NCT03821883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5711776|NCT03821883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711777|NCT03821883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5711778|NCT03821883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5711779|NCT03821883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5711780|NCT03821883|Antipyretics|antipyretics|mesh-ancestor
5711781|NCT03783286|Ivacaftor|ivacaftor|mesh-list
5711782|NCT03783286|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
5711783|NCT03783286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5711784|NCT03783286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711785|NCT03765567|Vancomycin|vancomycin|mesh-list
5711786|NCT03765567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5711787|NCT03765567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5711788|NCT03752684|Calcium|calcium|mesh-list
5711789|NCT03752684|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5711790|NCT03752684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711791|NCT03545464|Prednisone|prednisone|mesh-list
5711792|NCT03545464|Levocetirizine|levocetirizine|mesh-list
5711793|NCT03545464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6237262|NCT04734652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6677429|NCT01587638|Atenolol|atenolol|mesh-list
6677430|NCT01587638|Carvedilol|carvedilol|mesh-list
6677431|NCT01587638|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-list
6677432|NCT01587638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6677433|NCT01587638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6677434|NCT01587638|Sympatholytics|sympatholytics|mesh-ancestor
6677435|NCT01587638|Autonomic Agents|autonomic agents|mesh-ancestor
6677436|NCT01587638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6677437|NCT01587638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677438|NCT01587638|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6677439|NCT01587638|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6677440|NCT01587638|Adrenergic Agents|adrenergic agents|mesh-ancestor
6677441|NCT01587638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6677442|NCT01587638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677443|NCT01587638|Antioxidants|antioxidants|mesh-ancestor
6677444|NCT01587638|Protective Agents|protective agents|mesh-ancestor
6237263|NCT04734652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6237264|NCT04734652|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6237265|NCT04734652|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6237266|NCT04730206|Camostat|camostat|mesh-list
6237267|NCT04730206|Protease Inhibitors|protease inhibitors|mesh-ancestor
6237268|NCT04730206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6237269|NCT04730206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6237270|NCT04730206|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6502437|NCT00649714|Anticonvulsants|anticonvulsants|mesh-ancestor
6502438|NCT00649714|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6502439|NCT00649714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6502440|NCT00649714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502441|NCT00649714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6502442|NCT00649714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6237271|NCT04730206|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6677445|NCT01587638|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6677446|NCT01587638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6677447|NCT01587638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6502443|NCT00649727|Oxybutynin|oxybutynin|mesh-list
6502444|NCT00649727|Parasympatholytics|parasympatholytics|mesh-ancestor
6502445|NCT00649727|Autonomic Agents|autonomic agents|mesh-ancestor
5711794|NCT03545464|Glucocorticoids|glucocorticoids|mesh-ancestor
5711795|NCT03545464|Hormones|hormones|mesh-ancestor
5711796|NCT03545464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5711797|NCT03545464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711798|NCT03545464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5711799|NCT03545464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5711800|NCT03545464|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5711801|NCT03545464|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5711802|NCT03545464|Histamine Antagonists|histamine antagonists|mesh-ancestor
5711803|NCT03545464|Histamine Agents|histamine agents|mesh-ancestor
5711804|NCT03545464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6677448|NCT01587638|Vasodilator Agents|vasodilator agents|mesh-ancestor
6677449|NCT01587638|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6677450|NCT01587638|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6677451|NCT01587729|Antidepressive Agents|antidepressive agents|mesh-list
6677452|NCT01587729|Serotonin|serotonin|mesh-list
6677453|NCT01587729|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
6677454|NCT01587729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6677455|NCT01587729|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6677456|NCT01587729|Serotonin Agents|serotonin agents|mesh-ancestor
6677457|NCT01587729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6677458|NCT01587729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677459|NCT01587729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677460|NCT01587729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6677461|NCT01587729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6677462|NCT01587768|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6677463|NCT01587768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6677464|NCT01587820|Cisplatin|cisplatin|mesh-list
6677465|NCT01587820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6677466|NCT01587937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6677467|NCT01587937|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6677468|NCT01587937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6677469|NCT01587937|Antitubercular Agents|antitubercular agents|mesh-ancestor
6677470|NCT01588002|Ritonavir|ritonavir|mesh-list
6677471|NCT01588002|Efavirenz|efavirenz|mesh-list
6677472|NCT01588002|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6677473|NCT01588002|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6677474|NCT01588002|Protease Inhibitors|protease inhibitors|mesh-ancestor
6237280|NCT04700176|Dexamethasone|dexamethasone|mesh-list
6237281|NCT04700176|Daratumumab|daratumumab|mesh-list
6237282|NCT04700176|Pomalidomide|pomalidomide|mesh-list
6237283|NCT04700176|Tretinoin|tretinoin|mesh-list
6237284|NCT04700176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6237285|NCT04700176|Antiemetics|antiemetics|mesh-ancestor
6237286|NCT04700176|Autonomic Agents|autonomic agents|mesh-ancestor
6237287|NCT04700176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6237288|NCT04700176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6237289|NCT04700176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6237290|NCT04700176|Glucocorticoids|glucocorticoids|mesh-ancestor
6237291|NCT04700176|Hormones|hormones|mesh-ancestor
6237292|NCT04700176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6237293|NCT04700176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6237294|NCT04700176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5711805|NCT03545464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711806|NCT03538938|Nicotine|nicotine|mesh-list
6237295|NCT04700176|Immunologic Factors|immunologic factors|mesh-ancestor
6237296|NCT04700176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6237297|NCT04700176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6237298|NCT04700176|Growth Substances|growth substances|mesh-ancestor
6237299|NCT04700176|Growth Inhibitors|growth inhibitors|mesh-ancestor
6237300|NCT04700176|Keratolytic Agents|keratolytic agents|mesh-ancestor
6237301|NCT04700176|Dermatologic Agents|dermatologic agents|mesh-ancestor
5711807|NCT03538938|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5711808|NCT03538938|Autonomic Agents|autonomic agents|mesh-ancestor
5711809|NCT03538938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5711810|NCT03538938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711811|NCT03538938|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5711812|NCT03538938|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5711813|NCT03538938|Cholinergic Agents|cholinergic agents|mesh-ancestor
5711814|NCT03538938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5721734|NCT03203525|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6502446|NCT00649727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6502447|NCT00649727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6237316|NCT04696055|Pembrolizumab|pembrolizumab|mesh-list
6237317|NCT04696055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6237318|NCT04696055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6237319|NCT04670679|Cetuximab|cetuximab|mesh-list
6237320|NCT04670679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6237321|NCT04670679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6237322|NCT04660812|Bevacizumab|bevacizumab|mesh-list
6237323|NCT04660812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6237324|NCT04660812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6237325|NCT04660812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6237326|NCT04660812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6237327|NCT04660812|Growth Substances|growth substances|mesh-ancestor
6237328|NCT04660812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502448|NCT00649727|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6502449|NCT00649727|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6502450|NCT00649727|Cholinergic Agents|cholinergic agents|mesh-ancestor
6502451|NCT00649727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6502452|NCT00649727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502453|NCT00649727|Urological Agents|urological agents|mesh-ancestor
6502454|NCT00649740|Topiramate|topiramate|mesh-list
6502455|NCT00649740|Anticonvulsants|anticonvulsants|mesh-ancestor
6502456|NCT00649740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6502457|NCT00649740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502458|NCT00649779|Albuterol|albuterol|mesh-list
6502459|NCT00649779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6502460|NCT00649779|Autonomic Agents|autonomic agents|mesh-ancestor
6502461|NCT00649779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6502462|NCT00649779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502463|NCT00649779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6502464|NCT00649779|Respiratory System Agents|respiratory system agents|mesh-ancestor
6502465|NCT00649779|Tocolytic Agents|tocolytic agents|mesh-ancestor
6502466|NCT00649779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6502467|NCT00649779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6502468|NCT00649779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6502469|NCT00649779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6502470|NCT00649779|Adrenergic Agents|adrenergic agents|mesh-ancestor
6502471|NCT00649779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6502472|NCT00649779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502473|NCT00649805|Verapamil|verapamil|mesh-list
6502474|NCT00649805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6237329|NCT04660812|Growth Inhibitors|growth inhibitors|mesh-ancestor
6237330|NCT04647916|Camptothecin|camptothecin|mesh-list
6237331|NCT04647916|Irinotecan|irinotecan|mesh-list
6237332|NCT04647916|Immunoconjugates|immunoconjugates|mesh-list
6237333|NCT04647916|Immunologic Factors|immunologic factors|mesh-ancestor
6237334|NCT04647916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6237335|NCT04647916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6237336|NCT04647916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6237337|NCT04647916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6237338|NCT04647916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6237339|NCT04647916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6237340|NCT04647916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6237353|NCT04633252|Prednisone|prednisone|mesh-list
6237354|NCT04633252|Docetaxel|docetaxel|mesh-list
6237355|NCT04633252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6237356|NCT04633252|Tubulin Modulators|tubulin modulators|mesh-ancestor
6237357|NCT04633252|Antimitotic Agents|antimitotic agents|mesh-ancestor
6237358|NCT04633252|Mitosis Modulators|mitosis modulators|mesh-ancestor
6237359|NCT04633252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6237360|NCT04633252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6237361|NCT04633252|Glucocorticoids|glucocorticoids|mesh-ancestor
6237362|NCT04633252|Hormones|hormones|mesh-ancestor
6237363|NCT04633252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6237364|NCT04633252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6237365|NCT04633252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6237366|NCT04631510|Gabapentin|gabapentin|mesh-list
6237367|NCT04631510|Analgesics|analgesics|mesh-ancestor
6237368|NCT04631510|Sensory System Agents|sensory system agents|mesh-ancestor
6237369|NCT04631510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6237370|NCT04631510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6237371|NCT04631510|Anticonvulsants|anticonvulsants|mesh-ancestor
6237372|NCT04631510|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6237373|NCT04631510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6237374|NCT04631510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5711815|NCT03538938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711816|NCT03536520|Acetazolamide|acetazolamide|mesh-list
5711817|NCT03536520|Anticonvulsants|anticonvulsants|mesh-ancestor
5711818|NCT03536520|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5711819|NCT03536520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6237375|NCT04631510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6237376|NCT04631510|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6237377|NCT04631510|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6237378|NCT04631510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6237379|NCT04631510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711820|NCT03536520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711821|NCT03536520|Diuretics|diuretics|mesh-ancestor
5711822|NCT03536520|Natriuretic Agents|natriuretic agents|mesh-ancestor
5711823|NCT03536520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711824|NCT03536455|Acetazolamide|acetazolamide|mesh-list
5711825|NCT03536455|Anticonvulsants|anticonvulsants|mesh-ancestor
5711826|NCT03536455|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5711827|NCT03536455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5711828|NCT03536455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711829|NCT03536455|Diuretics|diuretics|mesh-ancestor
5711830|NCT03536455|Natriuretic Agents|natriuretic agents|mesh-ancestor
5711831|NCT03536455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711832|NCT03536429|Acetazolamide|acetazolamide|mesh-list
5711833|NCT03536429|Anticonvulsants|anticonvulsants|mesh-ancestor
5711834|NCT03536429|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5711835|NCT03536429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5711836|NCT03536429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711837|NCT03536429|Diuretics|diuretics|mesh-ancestor
6237380|NCT04631510|Antimanic Agents|antimanic agents|mesh-ancestor
6237381|NCT04629547|Suvorexant|suvorexant|mesh-list
6237382|NCT04629547|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6237383|NCT04629547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6237384|NCT04629547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6237385|NCT04629547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6237386|NCT04629547|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
6237387|NCT04629547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6237388|NCT04629547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6237389|NCT04624243|Risperidone|risperidone|mesh-list
6237390|NCT04624243|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6237391|NCT04624243|Serotonin Agents|serotonin agents|mesh-ancestor
6237392|NCT04624243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6237393|NCT04624243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6237394|NCT04624243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6237395|NCT04624243|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6237396|NCT04624243|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6237397|NCT04624243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6237398|NCT04624243|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6237399|NCT04624243|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5711838|NCT03536429|Natriuretic Agents|natriuretic agents|mesh-ancestor
5711839|NCT03536429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711840|NCT03529825|Rifaximin|rifaximin|mesh-list
5711841|NCT03529825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5711842|NCT03529825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5711843|NCT03529825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5711844|NCT03475134|Cyclophosphamide|cyclophosphamide|mesh-list
5711845|NCT03475134|Nivolumab|nivolumab|mesh-list
5711846|NCT03475134|Fludarabine|fludarabine|mesh-list
5711847|NCT03475134|Interleukin-2|interleukin-2|mesh-list
5711848|NCT03475134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5711849|NCT03475134|Immunologic Factors|immunologic factors|mesh-ancestor
5711850|NCT03475134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6237400|NCT04624243|Dopamine Agents|dopamine agents|mesh-ancestor
6237401|NCT04623775|Paclitaxel|paclitaxel|mesh-list
6237402|NCT04623775|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6237403|NCT04623775|Carboplatin|carboplatin|mesh-list
6237404|NCT04623775|Nivolumab|nivolumab|mesh-list
6237405|NCT04623775|Pemetrexed|pemetrexed|mesh-list
6237406|NCT04623775|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6237407|NCT04623775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6237408|NCT04623775|Tubulin Modulators|tubulin modulators|mesh-ancestor
6237409|NCT04623775|Antimitotic Agents|antimitotic agents|mesh-ancestor
6237410|NCT04623775|Mitosis Modulators|mitosis modulators|mesh-ancestor
6237411|NCT04623775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6237412|NCT04623775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6237413|NCT04623775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6237414|NCT04623775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6237415|NCT04623775|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6237416|NCT04623775|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6237417|NCT04612725|Benralizumab|benralizumab|mesh-list
6237418|NCT04612725|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5711851|NCT03475134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5711852|NCT03475134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5711853|NCT03475134|Alkylating Agents|alkylating agents|mesh-ancestor
5711854|NCT03475134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711855|NCT03475134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5711856|NCT03475134|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5711857|NCT03475134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5711858|NCT03475134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5711859|NCT03475134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5711860|NCT03475134|Analgesics|analgesics|mesh-ancestor
5711861|NCT03475134|Sensory System Agents|sensory system agents|mesh-ancestor
5711862|NCT03475134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5711863|NCT03461120|Anesthetics|anesthetics|mesh-list
5711864|NCT03461120|Anesthetics, Local|anesthetics, local|mesh-list
6237419|NCT04612725|Respiratory System Agents|respiratory system agents|mesh-ancestor
6237420|NCT04603898|Ascorbic Acid|ascorbic acid|mesh-list
6237421|NCT04603898|Antioxidants|antioxidants|mesh-ancestor
6237422|NCT04603898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6237423|NCT04603898|Protective Agents|protective agents|mesh-ancestor
6502475|NCT00649805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6502476|NCT00649805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6502477|NCT00649805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677475|NCT01588002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5711865|NCT03461120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6502478|NCT00649805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6502479|NCT00649805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502480|NCT00649805|Vasodilator Agents|vasodilator agents|mesh-ancestor
6502481|NCT00649818|Lorazepam|lorazepam|mesh-list
5711866|NCT03461120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711867|NCT03461120|Sensory System Agents|sensory system agents|mesh-ancestor
5711868|NCT03461120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5711869|NCT03384212|Cytarabine|cytarabine|mesh-list
5711870|NCT03384212|Fludarabine|fludarabine|mesh-list
5711871|NCT03384212|Busulfan|busulfan|mesh-list
5711872|NCT03384212|Cladribine|cladribine|mesh-list
5711873|NCT03384212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5711874|NCT03384212|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5711875|NCT03384212|Antimetabolites|antimetabolites|mesh-ancestor
5711876|NCT03384212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711877|NCT03384212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5711878|NCT03384212|Immunologic Factors|immunologic factors|mesh-ancestor
5711879|NCT03384212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711880|NCT03384212|Antiviral Agents|antiviral agents|mesh-ancestor
5711881|NCT03384212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5711882|NCT03384212|Alkylating Agents|alkylating agents|mesh-ancestor
5711883|NCT03384212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5711884|NCT03384212|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5711885|NCT03384225|Cytarabine|cytarabine|mesh-list
5711886|NCT03384225|Fludarabine|fludarabine|mesh-list
5711887|NCT03384225|Busulfan|busulfan|mesh-list
5711888|NCT03384225|Cladribine|cladribine|mesh-list
5711889|NCT03384225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5711890|NCT03384225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5711891|NCT03384225|Antimetabolites|antimetabolites|mesh-ancestor
5711892|NCT03384225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711893|NCT03384225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5711894|NCT03384225|Immunologic Factors|immunologic factors|mesh-ancestor
5711895|NCT03384225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711896|NCT03384225|Antiviral Agents|antiviral agents|mesh-ancestor
5711897|NCT03384225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5711898|NCT03384225|Alkylating Agents|alkylating agents|mesh-ancestor
5711899|NCT03384225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5711900|NCT03384225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5919080|NCT04985435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5919081|NCT04985435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919082|NCT04985435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5919083|NCT04985435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5919084|NCT04985435|Immunologic Factors|immunologic factors|mesh-ancestor
5919085|NCT04985344|Propranolol|propranolol|mesh-list
5919086|NCT04985344|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5919087|NCT04985344|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5919088|NCT04985344|Adrenergic Agents|adrenergic agents|mesh-ancestor
5919089|NCT04985344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5919090|NCT04985344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6237424|NCT04603898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6237425|NCT04603898|Vitamins|vitamins|mesh-ancestor
6237426|NCT04603898|Micronutrients|micronutrients|mesh-ancestor
6502482|NCT00649818|Anticonvulsants|anticonvulsants|mesh-ancestor
6502483|NCT00649818|Antiemetics|antiemetics|mesh-ancestor
6502484|NCT00649818|Autonomic Agents|autonomic agents|mesh-ancestor
6502485|NCT00649818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5919091|NCT04985344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919092|NCT04985344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5919093|NCT04985344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5919094|NCT04985344|Vasodilator Agents|vasodilator agents|mesh-ancestor
5919095|NCT04985526|Octenidine|octenidine|mesh-list
5919096|NCT04985526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5919097|NCT04985526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5919098|NCT04985669|Prucalopride|prucalopride|mesh-list
5919099|NCT04985669|Laxatives|laxatives|mesh-ancestor
5919100|NCT04985669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5919101|NCT04985669|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
5919102|NCT04985669|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5919103|NCT04985669|Serotonin Agents|serotonin agents|mesh-ancestor
5919104|NCT04985669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6237427|NCT04590664|Verteporfin|verteporfin|mesh-list
6237428|NCT04590664|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6502486|NCT00649818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502487|NCT00649818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6502488|NCT00649818|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6237429|NCT04590664|Dermatologic Agents|dermatologic agents|mesh-ancestor
6237440|NCT04582266|Remdesivir|remdesivir|mesh-list
6237441|NCT04582266|Antimetabolites|antimetabolites|mesh-ancestor
6237442|NCT04582266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6237443|NCT04582266|Antiviral Agents|antiviral agents|mesh-ancestor
6237444|NCT04582266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6237445|NCT04571619|Buprenorphine|buprenorphine|mesh-list
6237446|NCT04571619|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6237447|NCT04571619|Narcotics|narcotics|mesh-ancestor
6237448|NCT04571619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6237449|NCT04571619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6237450|NCT04571619|Analgesics|analgesics|mesh-ancestor
6237451|NCT04571619|Sensory System Agents|sensory system agents|mesh-ancestor
6237452|NCT04571619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6237453|NCT04571619|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6237454|NCT04567615|Nivolumab|nivolumab|mesh-list
6237455|NCT04567615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6237456|NCT04567615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6237457|NCT04567615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6237458|NCT04567615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6237459|NCT04563923|Avdoralimab|avdoralimab|mesh-list
6237460|NCT04563923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6237461|NCT04563923|Antiviral Agents|antiviral agents|mesh-ancestor
6237462|NCT04563923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6237463|NCT04555577|Temozolomide|temozolomide|mesh-list
6237464|NCT04555577|Peposertib|peposertib|mesh-list
6237465|NCT04555577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6237466|NCT04555577|Alkylating Agents|alkylating agents|mesh-ancestor
6237467|NCT04555577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6237468|NCT04555577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6237469|NCT04555577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6237470|NCT04555577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6237471|NCT04542434|Niclosamide|niclosamide|mesh-list
6237472|NCT04542434|Anticestodal Agents|anticestodal agents|mesh-ancestor
6237473|NCT04542434|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6237474|NCT04542434|Anthelmintics|anthelmintics|mesh-ancestor
6237475|NCT04542434|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6237476|NCT04542434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6237477|NCT04542434|Antinematodal Agents|antinematodal agents|mesh-ancestor
6237478|NCT04529772|Prednisone|prednisone|mesh-list
6502489|NCT00649818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6502490|NCT00649818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6502491|NCT00649818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6677476|NCT01588002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677477|NCT01588002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6677478|NCT01588002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6677479|NCT01588002|Antiviral Agents|antiviral agents|mesh-ancestor
6677480|NCT01588002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6677481|NCT01588002|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6677482|NCT01588002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6677483|NCT01588002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6677484|NCT01588002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6677485|NCT01588002|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6677486|NCT01588002|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6677487|NCT01588002|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6677488|NCT01588002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6237479|NCT04529772|Cyclophosphamide|cyclophosphamide|mesh-list
6237480|NCT04529772|Rituximab|rituximab|mesh-list
6502492|NCT00649818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6502493|NCT00649818|GABA Modulators|gaba modulators|mesh-ancestor
6502494|NCT00649818|GABA Agents|gaba agents|mesh-ancestor
6502495|NCT00649818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6502496|NCT00649818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502497|NCT00649831|Amoxicillin|amoxicillin|mesh-list
6502498|NCT00649831|Azithromycin|azithromycin|mesh-list
6502499|NCT00649831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6502500|NCT00649831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6502501|NCT00649844|Ziprasidone|ziprasidone|mesh-list
6502502|NCT00649844|Clozapine|clozapine|mesh-list
6502503|NCT00649844|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6502504|NCT00649844|Serotonin Agents|serotonin agents|mesh-ancestor
6677489|NCT01588002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6677490|NCT01588093|Mecasermin|mecasermin|mesh-list
6677491|NCT01588093|Growth Substances|growth substances|mesh-ancestor
6677492|NCT01588093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6237481|NCT04529772|Doxorubicin|doxorubicin|mesh-list
6237482|NCT04529772|Vincristine|vincristine|mesh-list
6237483|NCT04529772|Acalabrutinib|acalabrutinib|mesh-list
6237484|NCT04529772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6237485|NCT04529772|Immunologic Factors|immunologic factors|mesh-ancestor
6237486|NCT04529772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6237487|NCT04529772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6237488|NCT04529772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6237489|NCT04529772|Alkylating Agents|alkylating agents|mesh-ancestor
6237490|NCT04529772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6237491|NCT04529772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6237492|NCT04529772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6237493|NCT04529772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6502505|NCT00649844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6502506|NCT00649844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502507|NCT00649844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502508|NCT00649844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6502509|NCT00649844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6502510|NCT00649844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5711901|NCT03272698|Ketamine|ketamine|mesh-list
5711902|NCT03272698|Analgesics|analgesics|mesh-ancestor
5711903|NCT03272698|Sensory System Agents|sensory system agents|mesh-ancestor
5711904|NCT03272698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5711905|NCT03272698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677493|NCT01588171|Enoxaparin|enoxaparin|mesh-list
5711906|NCT03272698|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5711907|NCT03272698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5711908|NCT03272698|Anesthetics, General|anesthetics, general|mesh-ancestor
5711909|NCT03272698|Anesthetics|anesthetics|mesh-ancestor
5711910|NCT03272698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5711911|NCT03272698|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5711912|NCT03272698|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5711913|NCT03272698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5711914|NCT03272698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711915|NCT03272568|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
5711916|NCT03272568|Immunologic Factors|immunologic factors|mesh-ancestor
5711917|NCT03272568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711918|NCT03272425|Allopurinol|allopurinol|mesh-list
5711919|NCT03272425|Lesinurad|lesinurad|mesh-list
5711920|NCT03272425|Antimetabolites|antimetabolites|mesh-ancestor
5711921|NCT03272425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711922|NCT03272425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5711923|NCT03272425|Gout Suppressants|gout suppressants|mesh-ancestor
5711924|NCT03272425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5711925|NCT03272425|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5711926|NCT03272425|Antioxidants|antioxidants|mesh-ancestor
5711927|NCT03272425|Protective Agents|protective agents|mesh-ancestor
5919105|NCT04985669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919106|NCT04985669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919107|NCT04985500|Bupivacaine|bupivacaine|mesh-list
5919108|NCT04985500|Anesthetics, Local|anesthetics, local|mesh-ancestor
5919109|NCT04985500|Anesthetics|anesthetics|mesh-ancestor
5919110|NCT04985500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5919111|NCT04985500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919112|NCT04985500|Sensory System Agents|sensory system agents|mesh-ancestor
5919113|NCT04985500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5919114|NCT04985266|Tamoxifen|tamoxifen|mesh-list
5919115|NCT04985266|Letrozole|letrozole|mesh-list
5919116|NCT04985266|Fulvestrant|fulvestrant|mesh-list
5919117|NCT04985266|Palbociclib|palbociclib|mesh-list
5919118|NCT04985266|Anastrozole|anastrozole|mesh-list
5919119|NCT04985266|Exemestane|exemestane|mesh-list
5919120|NCT04985266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5919121|NCT04985266|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5919122|NCT04985266|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5919123|NCT04985266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6237494|NCT04529772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6237495|NCT04529772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6237496|NCT04529772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6237497|NCT04529772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6237498|NCT04529772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6237499|NCT04529772|Glucocorticoids|glucocorticoids|mesh-ancestor
6502511|NCT00649844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6502512|NCT00649844|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6502513|NCT00649844|Dopamine Agents|dopamine agents|mesh-ancestor
6502514|NCT00649844|GABA Antagonists|gaba antagonists|mesh-ancestor
6502515|NCT00649844|GABA Agents|gaba agents|mesh-ancestor
6502516|NCT00649857|Cetirizine|cetirizine|mesh-list
5711928|NCT03272425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711929|NCT03272425|Uricosuric Agents|uricosuric agents|mesh-ancestor
5711930|NCT03272425|Renal Agents|renal agents|mesh-ancestor
5711931|NCT03272477|Tamoxifen|tamoxifen|mesh-list
5711932|NCT03272477|Paclitaxel|paclitaxel|mesh-list
5711933|NCT03272477|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5711934|NCT03272477|Cyclophosphamide|cyclophosphamide|mesh-list
5711935|NCT03272477|Trastuzumab|trastuzumab|mesh-list
5711936|NCT03272477|Letrozole|letrozole|mesh-list
5711937|NCT03272477|Epirubicin|epirubicin|mesh-list
5711938|NCT03272477|Anastrozole|anastrozole|mesh-list
5711939|NCT03272477|Exemestane|exemestane|mesh-list
5711940|NCT03272477|Goserelin|goserelin|mesh-list
5711941|NCT03272477|Pertuzumab|pertuzumab|mesh-list
5711942|NCT03272477|Leuprolide|leuprolide|mesh-list
5711943|NCT03272477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5711944|NCT03272477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5711945|NCT03272477|Tubulin Modulators|tubulin modulators|mesh-ancestor
5711946|NCT03272477|Antimitotic Agents|antimitotic agents|mesh-ancestor
5711947|NCT03272477|Mitosis Modulators|mitosis modulators|mesh-ancestor
5711948|NCT03272477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711949|NCT03272477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5711950|NCT03272477|Immunologic Factors|immunologic factors|mesh-ancestor
5711951|NCT03272477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711952|NCT03272477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6237500|NCT04529772|Hormones|hormones|mesh-ancestor
6502517|NCT00649857|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6502518|NCT00649857|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6502519|NCT00649857|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6502520|NCT00649857|Histamine Antagonists|histamine antagonists|mesh-ancestor
6502521|NCT00649857|Histamine Agents|histamine agents|mesh-ancestor
6502522|NCT00649857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5711953|NCT03272477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5711954|NCT03272477|Alkylating Agents|alkylating agents|mesh-ancestor
5711955|NCT03272477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5711956|NCT03272477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5711957|NCT03272477|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5711958|NCT03272477|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5711959|NCT03272477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5711960|NCT03272477|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5711961|NCT03272477|Hormone Antagonists|hormone antagonists|mesh-ancestor
5711962|NCT03272477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5711963|NCT03272477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5919124|NCT04985266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919125|NCT04985266|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5919126|NCT04985266|Hormone Antagonists|hormone antagonists|mesh-ancestor
5919127|NCT04985266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5919128|NCT04985266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919129|NCT04985266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5919130|NCT04985266|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5919131|NCT04985266|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5919132|NCT04985266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5919133|NCT04985266|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6502523|NCT00649857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919134|NCT04985266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6237501|NCT04529772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6237502|NCT04529772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6237503|NCT04529772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6237504|NCT04529772|Tubulin Modulators|tubulin modulators|mesh-ancestor
6502524|NCT00649857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502525|NCT00649870|Valacyclovir|valacyclovir|mesh-list
6502526|NCT00649870|Antiviral Agents|antiviral agents|mesh-ancestor
5711964|NCT03272477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5711965|NCT03272477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5711966|NCT03272477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5711967|NCT03272477|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5711968|NCT03272477|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5711969|NCT03272477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5711970|NCT03272477|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5711971|NCT03272477|Fertility Agents|fertility agents|mesh-ancestor
5711972|NCT03272477|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5711973|NCT03272503|Pimozide|pimozide|mesh-list
5711974|NCT03272503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5711975|NCT03272503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6237505|NCT04529772|Antimitotic Agents|antimitotic agents|mesh-ancestor
6237506|NCT04529772|Mitosis Modulators|mitosis modulators|mesh-ancestor
6237507|NCT04528082|Apremilast|apremilast|mesh-list
6237508|NCT04528082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6237509|NCT04528082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6237510|NCT04528082|Analgesics|analgesics|mesh-ancestor
6237511|NCT04528082|Sensory System Agents|sensory system agents|mesh-ancestor
6237512|NCT04528082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6237513|NCT04528082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6237514|NCT04528082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6237515|NCT04528082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6237516|NCT04528082|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6237517|NCT04528082|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6237518|NCT04528082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6237519|NCT04528082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6237520|NCT04526795|Cytarabine|cytarabine|mesh-list
6237521|NCT04526795|Fludarabine|fludarabine|mesh-list
6237522|NCT04526795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6237523|NCT04526795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6237524|NCT04526795|Antimetabolites|antimetabolites|mesh-ancestor
6237525|NCT04526795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502527|NCT00649870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6502528|NCT00649883|Vaccines|vaccines|mesh-list
6502529|NCT00649883|Immunologic Factors|immunologic factors|mesh-ancestor
6502530|NCT00649883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502531|NCT00649896|Estradiol|estradiol|mesh-list
6502532|NCT00649896|Estrogens|estrogens|mesh-ancestor
6502533|NCT00649896|Hormones|hormones|mesh-ancestor
6677494|NCT01588171|Bemiparin|bemiparin|mesh-list
5711976|NCT03272503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5711977|NCT03272503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711978|NCT03272503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5711979|NCT03272503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5711980|NCT03272503|Dopamine Agents|dopamine agents|mesh-ancestor
5711981|NCT03272503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5711982|NCT03272503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5711983|NCT03272503|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5711984|NCT03272412|Progesterone|progesterone|mesh-list
6237526|NCT04526795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6237527|NCT04526795|Immunologic Factors|immunologic factors|mesh-ancestor
6237528|NCT04526795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6237529|NCT04526795|Antiviral Agents|antiviral agents|mesh-ancestor
6237530|NCT04526795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6237531|NCT04518228|Ritonavir|ritonavir|mesh-list
6237532|NCT04518228|Lopinavir|lopinavir|mesh-list
6237533|NCT04518228|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6237534|NCT04518228|Darunavir|darunavir|mesh-list
6237535|NCT04518228|Tenofovir|tenofovir|mesh-list
6237536|NCT04518228|Dolutegravir|dolutegravir|mesh-list
6237537|NCT04518228|Cobicistat|cobicistat|mesh-list
6237538|NCT04518228|Cabotegravir|cabotegravir|mesh-list
6237539|NCT04518228|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6237540|NCT04518228|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6237541|NCT04518228|Protease Inhibitors|protease inhibitors|mesh-ancestor
6237542|NCT04518228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6237543|NCT04518228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6237544|NCT04518228|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6237545|NCT04518228|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6237546|NCT04518228|Antiviral Agents|antiviral agents|mesh-ancestor
6237547|NCT04518228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6237548|NCT04518228|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6237549|NCT04518228|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6502534|NCT00649896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6502535|NCT00649896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6237550|NCT04518228|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6237551|NCT04518228|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6237552|NCT04518228|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6237553|NCT04518228|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6237554|NCT04516057|Nabilone|nabilone|mesh-list
6237555|NCT04516057|Antiemetics|antiemetics|mesh-ancestor
6237556|NCT04516057|Autonomic Agents|autonomic agents|mesh-ancestor
6237557|NCT04516057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6237558|NCT04516057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6237559|NCT04516057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6237560|NCT04516057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6237561|NCT04516057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6237562|NCT04516057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6237563|NCT04516057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6237564|NCT04495855|Dienogest|dienogest|mesh-list
6237565|NCT04495855|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6237566|NCT04495855|Contraceptive Agents|contraceptive agents|mesh-ancestor
6237567|NCT04495855|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6237568|NCT04495855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6237569|NCT04495855|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6237570|NCT04495855|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6237571|NCT04495855|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6237572|NCT04495855|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6237573|NCT04495855|Hormone Antagonists|hormone antagonists|mesh-ancestor
6237574|NCT04495855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6237575|NCT04495855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6237576|NCT04495855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6237577|NCT04477850|Luspatercept|luspatercept|mesh-list
6237578|NCT04477850|Hematinics|hematinics|mesh-ancestor
6237579|NCT04477733|Butorphanol|butorphanol|mesh-list
6237580|NCT04477733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6237581|NCT04477733|Narcotics|narcotics|mesh-ancestor
6237582|NCT04477733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6237583|NCT04477733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6237584|NCT04477733|Analgesics|analgesics|mesh-ancestor
6237585|NCT04477733|Sensory System Agents|sensory system agents|mesh-ancestor
6237586|NCT04477733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6237587|NCT04477733|Antitussive Agents|antitussive agents|mesh-ancestor
6237588|NCT04477733|Respiratory System Agents|respiratory system agents|mesh-ancestor
6237589|NCT04477733|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6237590|NCT04436731|Phentolamine|phentolamine|mesh-list
6237591|NCT04436731|Phenylephrine|phenylephrine|mesh-list
6237592|NCT04436731|Oxymetazoline|oxymetazoline|mesh-list
6237593|NCT04436731|Norepinephrine|norepinephrine|mesh-list
6237594|NCT04436731|Dexmedetomidine|dexmedetomidine|mesh-list
6237595|NCT04436731|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6237596|NCT04436731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6237597|NCT04436731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6237598|NCT04436731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6237599|NCT04436731|Analgesics|analgesics|mesh-ancestor
6237600|NCT04436731|Sensory System Agents|sensory system agents|mesh-ancestor
6237601|NCT04436731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6237602|NCT04436731|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6237603|NCT04436731|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6237604|NCT04436731|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6237605|NCT04436731|Adrenergic Agents|adrenergic agents|mesh-ancestor
6237606|NCT04436731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6237607|NCT04436731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6237608|NCT04436731|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6237609|NCT04436731|Mydriatics|mydriatics|mesh-ancestor
6237610|NCT04436731|Autonomic Agents|autonomic agents|mesh-ancestor
6237611|NCT04436731|Sympathomimetics|sympathomimetics|mesh-ancestor
6237612|NCT04436731|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6237613|NCT04436731|Nasal Decongestants|nasal decongestants|mesh-ancestor
6237614|NCT04436731|Respiratory System Agents|respiratory system agents|mesh-ancestor
6237615|NCT04436731|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6237616|NCT04436731|Protective Agents|protective agents|mesh-ancestor
6237617|NCT04436731|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6237618|NCT04436731|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6237619|NCT04436731|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6237620|NCT04436458|Niclosamide|niclosamide|mesh-list
6237621|NCT04436458|Anticestodal Agents|anticestodal agents|mesh-ancestor
6237622|NCT04436458|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6237623|NCT04436458|Anthelmintics|anthelmintics|mesh-ancestor
6237624|NCT04436458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6237625|NCT04436458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6237626|NCT04436458|Antinematodal Agents|antinematodal agents|mesh-ancestor
6237627|NCT04428385|Artemisinins|artemisinins|mesh-list
6237628|NCT04428385|Artemisinin|artemisinin|mesh-list
6237629|NCT04428385|Antimalarials|antimalarials|mesh-ancestor
6237630|NCT04428385|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6237631|NCT04428385|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6237632|NCT04428385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6243991|NCT02684357|Immunologic Factors|immunologic factors|mesh-ancestor
6243992|NCT02684357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243993|NCT02684370|Ustekinumab|ustekinumab|mesh-list
6243994|NCT02684370|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6243995|NCT02684370|Dermatologic Agents|dermatologic agents|mesh-ancestor
6243996|NCT02684370|Immunologic Factors|immunologic factors|mesh-ancestor
6243997|NCT02684370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6243998|NCT02684617|Pembrolizumab|pembrolizumab|mesh-list
6243999|NCT02684617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6244000|NCT02684617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6244001|NCT02684851|Fibrinolytic Agents|fibrinolytic agents|mesh-list
6244002|NCT02684851|Tranexamic Acid|tranexamic acid|mesh-list
6244003|NCT02684851|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
6244004|NCT02684851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6244005|NCT02684851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244006|NCT02684851|Hemostatics|hemostatics|mesh-ancestor
6244007|NCT02684851|Coagulants|coagulants|mesh-ancestor
6244008|NCT02684942|Fentanyl|fentanyl|mesh-list
6244009|NCT02684942|Meperidine|meperidine|mesh-list
6244010|NCT02684942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6244011|NCT02684942|Narcotics|narcotics|mesh-ancestor
6244012|NCT02684942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6244013|NCT02684942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244014|NCT02684942|Analgesics|analgesics|mesh-ancestor
6244015|NCT02684942|Sensory System Agents|sensory system agents|mesh-ancestor
6244016|NCT02684942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6244017|NCT02684942|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6244018|NCT02684942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6244019|NCT02684942|Anesthetics, General|anesthetics, general|mesh-ancestor
6244020|NCT02684942|Anesthetics|anesthetics|mesh-ancestor
6244021|NCT02685033|Dalbavancin|dalbavancin|mesh-list
6244022|NCT02685033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6244023|NCT02685033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6244024|NCT02685072|Progesterone|progesterone|mesh-list
6244025|NCT02685072|Progestins|progestins|mesh-ancestor
6244026|NCT02685072|Hormones|hormones|mesh-ancestor
6244027|NCT02685072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6244028|NCT02685072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244029|NCT02685267|Prednisone|prednisone|mesh-list
6244030|NCT02685267|Docetaxel|docetaxel|mesh-list
6244031|NCT02685267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5711985|NCT03272412|Progestins|progestins|mesh-ancestor
5711986|NCT03272412|Hormones|hormones|mesh-ancestor
5711987|NCT03272412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5711988|NCT03272412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711989|NCT03272126|Vitamin D|vitamin d|mesh-list
5711990|NCT03272126|Vitamins|vitamins|mesh-ancestor
5711991|NCT03272126|Micronutrients|micronutrients|mesh-ancestor
5711992|NCT03272126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711993|NCT03272126|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5711994|NCT03272321|Oxytocin|oxytocin|mesh-list
5711995|NCT03272321|Oxytocics|oxytocics|mesh-ancestor
5711996|NCT03272321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5711997|NCT03272321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5711998|NCT03272295|Menthol|menthol|mesh-list
5711999|NCT03272295|Sorbitol|sorbitol|mesh-list
5712000|NCT03272295|Glycerol|glycerol|mesh-list
5712001|NCT03272295|Antipruritics|antipruritics|mesh-ancestor
5712002|NCT03272295|Dermatologic Agents|dermatologic agents|mesh-ancestor
5712003|NCT03272295|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
5712004|NCT03272295|Protective Agents|protective agents|mesh-ancestor
5712005|NCT03272295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712006|NCT03272295|Cathartics|cathartics|mesh-ancestor
5712007|NCT03272295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5721735|NCT03203525|Immunoglobulin G|immunoglobulin g|mesh-list
5721736|NCT03203525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5721737|NCT03203525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5721738|NCT03203525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6244032|NCT02685267|Tubulin Modulators|tubulin modulators|mesh-ancestor
6244033|NCT02685267|Antimitotic Agents|antimitotic agents|mesh-ancestor
6244034|NCT02685267|Mitosis Modulators|mitosis modulators|mesh-ancestor
6244035|NCT02685267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244036|NCT02685267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5712008|NCT03272334|Pembrolizumab|pembrolizumab|mesh-list
5712009|NCT03272334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5712010|NCT03272334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5712011|NCT03271866|Metformin|metformin|mesh-list
5712012|NCT03271866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5712013|NCT03271866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712014|NCT03271918|Cabergoline|cabergoline|mesh-list
5712015|NCT03271918|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5712016|NCT03271918|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5712017|NCT03271918|Dopamine Agonists|dopamine agonists|mesh-ancestor
5712018|NCT03271918|Dopamine Agents|dopamine agents|mesh-ancestor
6237633|NCT04404088|Rituximab|rituximab|mesh-list
6237634|NCT04404088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6237635|NCT04404088|Lenalidomide|lenalidomide|mesh-list
6237636|NCT04404088|Acalabrutinib|acalabrutinib|mesh-list
6237637|NCT04404088|Antibodies|antibodies|mesh-list
6237638|NCT04404088|Immunoglobulins|immunoglobulins|mesh-list
6237639|NCT04404088|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6237640|NCT04404088|Immunologic Factors|immunologic factors|mesh-ancestor
6237641|NCT04404088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6237642|NCT04404088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6237643|NCT04404088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6237644|NCT04404088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5712019|NCT03271918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5712020|NCT03271918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712021|NCT03271918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712022|NCT03272009|Interferons|interferons|mesh-list
5712023|NCT03272009|Interferon-alpha|interferon-alpha|mesh-list
5712024|NCT03272009|Interferon alpha-2|interferon alpha-2|mesh-list
5712025|NCT03272009|Entecavir|entecavir|mesh-list
5712026|NCT03272009|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5712027|NCT03272009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5712028|NCT03272009|Antiviral Agents|antiviral agents|mesh-ancestor
6237645|NCT04404088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6237646|NCT04404088|Growth Substances|growth substances|mesh-ancestor
6237647|NCT04404088|Growth Inhibitors|growth inhibitors|mesh-ancestor
6237648|NCT04339101|Sirolimus|sirolimus|mesh-list
6237649|NCT04339101|Fludarabine|fludarabine|mesh-list
6237650|NCT04339101|Melphalan|melphalan|mesh-list
6502536|NCT00649922|Adalimumab|adalimumab|mesh-list
6502537|NCT00649922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6502538|NCT00649922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6502539|NCT00649935|Azithromycin|azithromycin|mesh-list
6502540|NCT00649935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6502541|NCT00649935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6502542|NCT00649948|Metformin|metformin|mesh-list
6502543|NCT00649948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6502544|NCT00649948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502545|NCT00649974|Valacyclovir|valacyclovir|mesh-list
6502546|NCT00649974|Antiviral Agents|antiviral agents|mesh-ancestor
6502547|NCT00649974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6237651|NCT04339101|Mechlorethamine|mechlorethamine|mesh-list
6237652|NCT04339101|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
6237653|NCT04339101|Tacrolimus|tacrolimus|mesh-list
6237654|NCT04339101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6237655|NCT04339101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6237656|NCT04339101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6237657|NCT04339101|Immunologic Factors|immunologic factors|mesh-ancestor
6237658|NCT04339101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6237659|NCT04339101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6237660|NCT04339101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6237661|NCT04339101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6237662|NCT04339101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6237663|NCT04339101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6237664|NCT04339101|Antifungal Agents|antifungal agents|mesh-ancestor
6502548|NCT00649987|Albuterol|albuterol|mesh-list
6502549|NCT00649987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6502550|NCT00649987|Autonomic Agents|autonomic agents|mesh-ancestor
6237665|NCT04339101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6237666|NCT04339101|Alkylating Agents|alkylating agents|mesh-ancestor
6237667|NCT04339101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6237668|NCT04336098|Gemcitabine|gemcitabine|mesh-list
6237669|NCT04336098|Paclitaxel|paclitaxel|mesh-list
6502551|NCT00649987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5712029|NCT03272009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5712030|NCT03272009|Immunologic Factors|immunologic factors|mesh-ancestor
6237670|NCT04336098|Pembrolizumab|pembrolizumab|mesh-list
6237671|NCT04336098|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6237672|NCT04336098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6502552|NCT00649987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6237673|NCT04336098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6237674|NCT04336098|Tubulin Modulators|tubulin modulators|mesh-ancestor
6237675|NCT04336098|Antimitotic Agents|antimitotic agents|mesh-ancestor
6237676|NCT04336098|Mitosis Modulators|mitosis modulators|mesh-ancestor
6237677|NCT04336098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502553|NCT00649987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6502554|NCT00649987|Respiratory System Agents|respiratory system agents|mesh-ancestor
6502555|NCT00649987|Tocolytic Agents|tocolytic agents|mesh-ancestor
6502556|NCT00649987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6502557|NCT00649987|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6502558|NCT00649987|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6502559|NCT00649987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6502560|NCT00649987|Adrenergic Agents|adrenergic agents|mesh-ancestor
6502561|NCT00649987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6502562|NCT00649987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502563|NCT00650000|Modafinil|modafinil|mesh-list
6502564|NCT00650000|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6502565|NCT00650000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677495|NCT01588171|Anticoagulants|anticoagulants|mesh-ancestor
6677496|NCT01588171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6237678|NCT04336098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6237679|NCT04336098|Antimetabolites|antimetabolites|mesh-ancestor
6237680|NCT04336098|Antiviral Agents|antiviral agents|mesh-ancestor
6237681|NCT04336098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6237682|NCT04336098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6237683|NCT04336098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6237684|NCT04336098|Immunologic Factors|immunologic factors|mesh-ancestor
6237685|NCT04336098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6237686|NCT04336098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6237687|NCT04334941|Atezolizumab|atezolizumab|mesh-list
6237688|NCT04334941|Talazoparib|talazoparib|mesh-list
6237689|NCT04334941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6237690|NCT04334941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6237691|NCT04334941|Immunologic Factors|immunologic factors|mesh-ancestor
6237692|NCT04334941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6237693|NCT04334941|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6237694|NCT04334941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6237695|NCT04334941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6237696|NCT04329728|Dexamethasone|dexamethasone|mesh-list
6237697|NCT04329728|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
6237698|NCT04329728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6237699|NCT04329728|Antiemetics|antiemetics|mesh-ancestor
6237700|NCT04329728|Autonomic Agents|autonomic agents|mesh-ancestor
6237701|NCT04329728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6237702|NCT04329728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6237703|NCT04329728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6237704|NCT04329728|Glucocorticoids|glucocorticoids|mesh-ancestor
6237705|NCT04329728|Hormones|hormones|mesh-ancestor
6237706|NCT04329728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6237707|NCT04329728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6237708|NCT04329728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6237709|NCT04322357|Prednisone|prednisone|mesh-list
6237710|NCT04322357|Glucocorticoids|glucocorticoids|mesh-list
6237711|NCT04322357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6237712|NCT04322357|Hormones|hormones|mesh-ancestor
6237713|NCT04322357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6237714|NCT04322357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6237715|NCT04322357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6237716|NCT04322357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6237717|NCT04321954|Lenvatinib|lenvatinib|mesh-list
6237718|NCT04321954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6237719|NCT04321954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6237720|NCT04321954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6237721|NCT04321954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6237722|NCT04311411|Liraglutide|liraglutide|mesh-list
6237723|NCT04311411|Tirzepatide|tirzepatide|mesh-list
6237724|NCT04311411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6237725|NCT04311411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6237726|NCT04311411|Incretins|incretins|mesh-ancestor
6237727|NCT04311411|Hormones|hormones|mesh-ancestor
6237728|NCT04311411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6677497|NCT01588171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6237729|NCT04283656|Tenofovir|tenofovir|mesh-list
6237730|NCT04283656|Lamivudine|lamivudine|mesh-list
5712031|NCT03272009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712032|NCT03271879|Empagliflozin|empagliflozin|mesh-list
5712033|NCT03271879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5712034|NCT03271879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712035|NCT03271879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5712036|NCT03271879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712037|NCT03271983|Metronidazole|metronidazole|mesh-list
5712038|NCT03271983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5712039|NCT03271983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5712040|NCT03271983|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6237731|NCT04283656|Spironolactone|spironolactone|mesh-list
6237732|NCT04283656|Estradiol|estradiol|mesh-list
6237733|NCT04283656|Antiviral Agents|antiviral agents|mesh-ancestor
6237734|NCT04283656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6237735|NCT04283656|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6237736|NCT04283656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6237737|NCT04283656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6237738|NCT04283656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6237739|NCT04283656|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6237740|NCT04283656|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6237741|NCT04283656|Estrogens|estrogens|mesh-ancestor
6237742|NCT04283656|Hormones|hormones|mesh-ancestor
6237743|NCT04283656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6237744|NCT04283656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6237745|NCT04283656|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6237746|NCT04283656|Hormone Antagonists|hormone antagonists|mesh-ancestor
5712041|NCT03271983|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6237747|NCT04283656|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6237748|NCT04283656|Diuretics|diuretics|mesh-ancestor
6237749|NCT04283656|Natriuretic Agents|natriuretic agents|mesh-ancestor
6237750|NCT04263909|Sufentanil|sufentanil|mesh-list
6237751|NCT04263909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6237752|NCT04263909|Narcotics|narcotics|mesh-ancestor
6237753|NCT04263909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6237754|NCT04263909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6237755|NCT04263909|Analgesics|analgesics|mesh-ancestor
6237756|NCT04263909|Sensory System Agents|sensory system agents|mesh-ancestor
6237757|NCT04263909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6237758|NCT04263909|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6237759|NCT04263909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6237760|NCT04263909|Anesthetics, General|anesthetics, general|mesh-ancestor
6237761|NCT04263909|Anesthetics|anesthetics|mesh-ancestor
6237762|NCT04255433|Dulaglutide|dulaglutide|mesh-list
6237763|NCT04255433|Tirzepatide|tirzepatide|mesh-list
6237764|NCT04255433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6237765|NCT04255433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6237766|NCT04255433|Incretins|incretins|mesh-ancestor
6237767|NCT04255433|Hormones|hormones|mesh-ancestor
6237768|NCT04255433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6237769|NCT04250805|Lidocaine|lidocaine|mesh-list
6237770|NCT04250805|Ropivacaine|ropivacaine|mesh-list
6237771|NCT04250805|Anesthetics, Local|anesthetics, local|mesh-ancestor
6237772|NCT04250805|Anesthetics|anesthetics|mesh-ancestor
6237773|NCT04250805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5712042|NCT03271905|Bromides|bromides|mesh-list
5712043|NCT03271905|Albuterol|albuterol|mesh-list
5712044|NCT03271905|Ipratropium|ipratropium|mesh-list
5712045|NCT03271905|Anticonvulsants|anticonvulsants|mesh-ancestor
5712046|NCT03271905|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5712047|NCT03271905|Autonomic Agents|autonomic agents|mesh-ancestor
5712048|NCT03271905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5712049|NCT03271905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712050|NCT03271905|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5712051|NCT03271905|Respiratory System Agents|respiratory system agents|mesh-ancestor
5712052|NCT03271905|Tocolytic Agents|tocolytic agents|mesh-ancestor
5712053|NCT03271905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5712054|NCT03271905|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6237774|NCT04250805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6237775|NCT04250805|Sensory System Agents|sensory system agents|mesh-ancestor
6237776|NCT04250805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6237777|NCT04250805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6237778|NCT04250805|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6237779|NCT04250805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6237780|NCT04250805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5712055|NCT03271905|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6244037|NCT02685267|Glucocorticoids|glucocorticoids|mesh-ancestor
5712056|NCT03271905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5712057|NCT03271905|Adrenergic Agents|adrenergic agents|mesh-ancestor
5712058|NCT03271905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5712059|NCT03271905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712060|NCT03271905|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5712061|NCT03271905|Cholinergic Agents|cholinergic agents|mesh-ancestor
5712062|NCT03271749|Anesthetics|anesthetics|mesh-list
6237781|NCT04250805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6237782|NCT04247126|Gemcitabine|gemcitabine|mesh-list
6237783|NCT04247126|Paclitaxel|paclitaxel|mesh-list
6237784|NCT04247126|Fulvestrant|fulvestrant|mesh-list
6237785|NCT04247126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6237786|NCT04247126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6502566|NCT00650000|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6502567|NCT00650000|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6502568|NCT00650000|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6502569|NCT00650000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502570|NCT00650013|Midodrine|midodrine|mesh-list
6502571|NCT00650013|Sympathomimetics|sympathomimetics|mesh-ancestor
6502572|NCT00650013|Autonomic Agents|autonomic agents|mesh-ancestor
6502573|NCT00650013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6502574|NCT00650013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502575|NCT00650013|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6502576|NCT00650013|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6502577|NCT00650013|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6502578|NCT00650013|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6502579|NCT00650013|Adrenergic Agents|adrenergic agents|mesh-ancestor
6502580|NCT00650013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6502581|NCT00650013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502582|NCT00650026|Adalimumab|adalimumab|mesh-list
6502583|NCT00650026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6502584|NCT00650026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6502585|NCT00650039|Valdecoxib|valdecoxib|mesh-list
6502586|NCT00650039|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6502587|NCT00650039|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6237787|NCT04247126|Tubulin Modulators|tubulin modulators|mesh-ancestor
6237788|NCT04247126|Antimitotic Agents|antimitotic agents|mesh-ancestor
6237789|NCT04247126|Mitosis Modulators|mitosis modulators|mesh-ancestor
6237790|NCT04247126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6237791|NCT04247126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6237792|NCT04247126|Antimetabolites|antimetabolites|mesh-ancestor
6237793|NCT04247126|Antiviral Agents|antiviral agents|mesh-ancestor
6237794|NCT04247126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6237795|NCT04247126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6237796|NCT04247126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6237797|NCT04247126|Immunologic Factors|immunologic factors|mesh-ancestor
6237798|NCT04247126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6237799|NCT04247126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6237800|NCT04247126|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6237801|NCT04247126|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6237802|NCT04247126|Hormone Antagonists|hormone antagonists|mesh-ancestor
5712063|NCT03271749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5712064|NCT03271749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712065|NCT03271450|Warfarin|warfarin|mesh-list
6237803|NCT04247126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6237804|NCT04242173|Cemiplimab|cemiplimab|mesh-list
6237805|NCT04242173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6237806|NCT04242173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6237807|NCT04241185|Gemcitabine|gemcitabine|mesh-list
6237808|NCT04241185|Fluorouracil|fluorouracil|mesh-list
6237809|NCT04241185|Pembrolizumab|pembrolizumab|mesh-list
6237810|NCT04241185|Mitomycins|mitomycins|mesh-list
6237811|NCT04241185|Mitomycin|mitomycin|mesh-list
6237812|NCT04241185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6237813|NCT04241185|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6237814|NCT04241185|Antimetabolites|antimetabolites|mesh-ancestor
6237815|NCT04241185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6237816|NCT04241185|Antiviral Agents|antiviral agents|mesh-ancestor
6237817|NCT04241185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6237818|NCT04241185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6237819|NCT04241185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6502588|NCT00650039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5712066|NCT03271450|Rivaroxaban|rivaroxaban|mesh-list
6237820|NCT04241185|Immunologic Factors|immunologic factors|mesh-ancestor
6237821|NCT04241185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6237822|NCT04241185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6237823|NCT04241185|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6502589|NCT00650039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502590|NCT00650039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6502591|NCT00650039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6502592|NCT00650039|Analgesics|analgesics|mesh-ancestor
5712067|NCT03271450|Dabigatran|dabigatran|mesh-list
5712068|NCT03271450|Apixaban|apixaban|mesh-list
5712069|NCT03271450|Edoxaban|edoxaban|mesh-list
5712070|NCT03271450|Anticoagulants|anticoagulants|mesh-ancestor
5712071|NCT03271450|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5712072|NCT03271450|Antithrombins|antithrombins|mesh-ancestor
5712073|NCT03271450|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5712074|NCT03271450|Protease Inhibitors|protease inhibitors|mesh-ancestor
5712075|NCT03271450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5712076|NCT03271450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712077|NCT03271502|Anesthetics|anesthetics|mesh-list
5712078|NCT03271502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5712079|NCT03271502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712080|NCT03271151|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5712081|NCT03271151|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5712082|NCT03271151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5712083|NCT03271151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5712084|NCT03271151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712085|NCT03271151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5712086|NCT03271151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712087|NCT03271151|Analgesics|analgesics|mesh-ancestor
5712088|NCT03271151|Sensory System Agents|sensory system agents|mesh-ancestor
5712089|NCT03271151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5712090|NCT03271151|Antidepressive Agents|antidepressive agents|mesh-ancestor
6237824|NCT04241185|Alkylating Agents|alkylating agents|mesh-ancestor
6237825|NCT04241185|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6237826|NCT04240002|Cytarabine|cytarabine|mesh-list
6237827|NCT04240002|Fludarabine|fludarabine|mesh-list
6237828|NCT04240002|Sargramostim|sargramostim|mesh-list
6237829|NCT04240002|Lenograstim|lenograstim|mesh-list
6237830|NCT04240002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6237831|NCT04240002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6237832|NCT04240002|Antimetabolites|antimetabolites|mesh-ancestor
6237833|NCT04240002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6237834|NCT04240002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6237835|NCT04240002|Immunologic Factors|immunologic factors|mesh-ancestor
6237836|NCT04240002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6237837|NCT04240002|Antiviral Agents|antiviral agents|mesh-ancestor
6237838|NCT04240002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6237839|NCT04240002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6237840|NCT04232553|Mirikizumab|mirikizumab|mesh-list
6237841|NCT04232553|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6237842|NCT04232553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6237843|NCT04232553|Analgesics|analgesics|mesh-ancestor
6237844|NCT04232553|Sensory System Agents|sensory system agents|mesh-ancestor
6237845|NCT04232553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6237846|NCT04232553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6237847|NCT04232553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6237848|NCT04232553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6237849|NCT04232553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6237850|NCT04232553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6237851|NCT04229771|Proxymetacaine|proxymetacaine|mesh-list
6237852|NCT04229771|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6237853|NCT04229771|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6237854|NCT04229771|Anesthetics, Local|anesthetics, local|mesh-ancestor
6237855|NCT04229771|Anesthetics|anesthetics|mesh-ancestor
6237856|NCT04229771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6237857|NCT04229771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502593|NCT00650039|Sensory System Agents|sensory system agents|mesh-ancestor
6502594|NCT00650039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6502595|NCT00650039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502596|NCT00650039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6502597|NCT00650039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6502598|NCT00650052|Zonisamide|zonisamide|mesh-list
6502599|NCT00650052|Anticonvulsants|anticonvulsants|mesh-ancestor
6502600|NCT00650052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6502601|NCT00650052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5712091|NCT03271151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6237858|NCT04229771|Sensory System Agents|sensory system agents|mesh-ancestor
6237859|NCT04229771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6237860|NCT04221945|Cisplatin|cisplatin|mesh-list
5712092|NCT03271151|Dopamine Agents|dopamine agents|mesh-ancestor
5712093|NCT03271164|Vitamin E|vitamin e|mesh-list
5712094|NCT03271164|Vitamins|vitamins|mesh-ancestor
5712095|NCT03271164|Micronutrients|micronutrients|mesh-ancestor
5712096|NCT03271164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712097|NCT03271164|Antioxidants|antioxidants|mesh-ancestor
5712098|NCT03271164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712099|NCT03271164|Protective Agents|protective agents|mesh-ancestor
5712100|NCT03271255|Bevacizumab|bevacizumab|mesh-list
5712101|NCT03271255|Apatinib|apatinib|mesh-list
5712102|NCT03271255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5712103|NCT03271255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6237861|NCT04221945|Pembrolizumab|pembrolizumab|mesh-list
6237862|NCT04221945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6237863|NCT04221945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6237864|NCT04218773|Phenylephrine|phenylephrine|mesh-list
6237865|NCT04218773|Oxymetazoline|oxymetazoline|mesh-list
6237866|NCT04218773|Norepinephrine|norepinephrine|mesh-list
6237867|NCT04218773|Synephrine|synephrine|mesh-list
6237868|NCT04218773|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6237869|NCT04218773|Mydriatics|mydriatics|mesh-ancestor
6237870|NCT04218773|Autonomic Agents|autonomic agents|mesh-ancestor
6237871|NCT04218773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6237872|NCT04218773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6237873|NCT04218773|Sympathomimetics|sympathomimetics|mesh-ancestor
6237874|NCT04218773|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6237875|NCT04218773|Nasal Decongestants|nasal decongestants|mesh-ancestor
6237876|NCT04218773|Respiratory System Agents|respiratory system agents|mesh-ancestor
6237877|NCT04218773|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6237878|NCT04218773|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6237879|NCT04218773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6237880|NCT04218773|Adrenergic Agents|adrenergic agents|mesh-ancestor
6237881|NCT04218773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6237882|NCT04218773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6237883|NCT04218773|Protective Agents|protective agents|mesh-ancestor
5712104|NCT03271255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5712105|NCT03271255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6237940|NCT04203160|Gemcitabine|gemcitabine|mesh-list
6237941|NCT04203160|Cisplatin|cisplatin|mesh-list
6237942|NCT04203160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6237943|NCT04203160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6237944|NCT04203160|Antimetabolites|antimetabolites|mesh-ancestor
6237945|NCT04203160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6237946|NCT04203160|Antiviral Agents|antiviral agents|mesh-ancestor
6237947|NCT04203160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6237948|NCT04203160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6237949|NCT04203160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6237950|NCT04203160|Immunologic Factors|immunologic factors|mesh-ancestor
6237951|NCT04203160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6237952|NCT04201262|Ravulizumab|ravulizumab|mesh-list
6237953|NCT04201262|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6237954|NCT04201262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6237955|NCT04201262|Immunologic Factors|immunologic factors|mesh-ancestor
6237956|NCT04201262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6237957|NCT04199117|Nicotine|nicotine|mesh-list
6237958|NCT04199117|Varenicline|varenicline|mesh-list
6237959|NCT04199117|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5712106|NCT03271255|Growth Substances|growth substances|mesh-ancestor
5712107|NCT03271255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712108|NCT03271255|Growth Inhibitors|growth inhibitors|mesh-ancestor
5712109|NCT03271255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5712110|NCT03271255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5712111|NCT03271255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712112|NCT03271073|Apatinib|apatinib|mesh-list
5712113|NCT03271073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5712114|NCT03271073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5712115|NCT03271073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5712116|NCT03271073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712117|NCT03270969|Tenofovir|tenofovir|mesh-list
5712118|NCT03270969|Emtricitabine|emtricitabine|mesh-list
5712119|NCT03270969|Antiviral Agents|antiviral agents|mesh-ancestor
5712120|NCT03270969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5712121|NCT03270969|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5712122|NCT03270969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5712123|NCT03270969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5712124|NCT03270969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712125|NCT03270969|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5712126|NCT03270969|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5712127|NCT03270839|Meclizine|meclizine|mesh-list
5712128|NCT03270839|Scopolamine|scopolamine|mesh-list
5712129|NCT03270839|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5712130|NCT03270839|Antiemetics|antiemetics|mesh-ancestor
5712131|NCT03270839|Autonomic Agents|autonomic agents|mesh-ancestor
5712132|NCT03270839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5712133|NCT03270839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712134|NCT03270839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5712135|NCT03270839|Mydriatics|mydriatics|mesh-ancestor
6237960|NCT04199117|Autonomic Agents|autonomic agents|mesh-ancestor
6237961|NCT04199117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6237962|NCT04199117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6237963|NCT04199117|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6237964|NCT04199117|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6237965|NCT04199117|Cholinergic Agents|cholinergic agents|mesh-ancestor
5712136|NCT03270839|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6237966|NCT04199117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6237967|NCT04199117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6237968|NCT04188873|Varenicline|varenicline|mesh-list
6237969|NCT04188873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6237970|NCT04188873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6237971|NCT04188873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6237972|NCT04188873|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6237973|NCT04188873|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6237974|NCT04188873|Cholinergic Agents|cholinergic agents|mesh-ancestor
6237975|NCT04186286|Propranolol|propranolol|mesh-list
6237976|NCT04186286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6237977|NCT04186286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6237978|NCT04186286|Adrenergic Agents|adrenergic agents|mesh-ancestor
6502602|NCT00650052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502603|NCT00650052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6502604|NCT00650052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502605|NCT00650065|Cetirizine|cetirizine|mesh-list
6502606|NCT00650065|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6502607|NCT00650065|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6502608|NCT00650065|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6502609|NCT00650065|Histamine Antagonists|histamine antagonists|mesh-ancestor
6502610|NCT00650065|Histamine Agents|histamine agents|mesh-ancestor
6502611|NCT00650065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6502612|NCT00650065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502613|NCT00650065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502614|NCT00650117|Fentanyl|fentanyl|mesh-list
6502615|NCT00650117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6502616|NCT00650117|Narcotics|narcotics|mesh-ancestor
6502617|NCT00650117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6677498|NCT01588171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677499|NCT01588314|Gabapentin|gabapentin|mesh-list
6677500|NCT01588314|Analgesics|analgesics|mesh-ancestor
6677501|NCT01588314|Sensory System Agents|sensory system agents|mesh-ancestor
6677502|NCT01588314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6677503|NCT01588314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677504|NCT01588314|Anticonvulsants|anticonvulsants|mesh-ancestor
6677505|NCT01588314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6677506|NCT01588314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6677507|NCT01588314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6677508|NCT01588314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6677509|NCT01588314|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5712137|NCT03270839|Cholinergic Agents|cholinergic agents|mesh-ancestor
5712138|NCT03270839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5712139|NCT03270839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712140|NCT03270839|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5712141|NCT03270839|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5712142|NCT03270839|Histamine Antagonists|histamine antagonists|mesh-ancestor
5712143|NCT03270839|Histamine Agents|histamine agents|mesh-ancestor
5712144|NCT03270839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5712145|NCT03270735|Thrombin|thrombin|mesh-list
5712146|NCT03270735|Hemostatics|hemostatics|mesh-ancestor
5712147|NCT03270735|Coagulants|coagulants|mesh-ancestor
5712148|NCT03270709|Vitamin D|vitamin d|mesh-list
5712149|NCT03270709|Cholecalciferol|cholecalciferol|mesh-list
5712150|NCT03270709|Vitamins|vitamins|mesh-ancestor
5712151|NCT03270709|Micronutrients|micronutrients|mesh-ancestor
5712152|NCT03270709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677510|NCT01588314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5712153|NCT03270709|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5712154|NCT03270709|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5712155|NCT03270696|Propofol|propofol|mesh-list
5712156|NCT03270696|Rocuronium|rocuronium|mesh-list
5712157|NCT03270696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5712158|NCT03270696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5712159|NCT03270696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712160|NCT03270696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5712161|NCT03270696|Anesthetics, General|anesthetics, general|mesh-ancestor
5712162|NCT03270696|Anesthetics|anesthetics|mesh-ancestor
5712163|NCT03270696|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5712164|NCT03270696|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5712165|NCT03270696|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5712166|NCT03270696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5721739|NCT03203525|Growth Substances|growth substances|mesh-ancestor
5721740|NCT03203525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721741|NCT03203525|Growth Inhibitors|growth inhibitors|mesh-ancestor
5721742|NCT03203525|Immunologic Factors|immunologic factors|mesh-ancestor
6237979|NCT04186286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5712167|NCT03270553|Metformin|metformin|mesh-list
5712168|NCT03270553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5712169|NCT03270553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712170|NCT03270462|Tacrolimus|tacrolimus|mesh-list
5712171|NCT03270462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5712172|NCT03270462|Immunologic Factors|immunologic factors|mesh-ancestor
5712173|NCT03270462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712174|NCT03270462|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5712175|NCT03270462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5712176|NCT03270462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712177|NCT03269929|Midazolam|midazolam|mesh-list
5712178|NCT03269929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5712179|NCT03269929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6237980|NCT04186286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6237981|NCT04186286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712180|NCT03269929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5712181|NCT03269929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712182|NCT03269929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5712183|NCT03269929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5712184|NCT03269929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5712185|NCT03269929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5712186|NCT03269929|Anesthetics, General|anesthetics, general|mesh-ancestor
5712187|NCT03269929|Anesthetics|anesthetics|mesh-ancestor
5712188|NCT03269929|GABA Modulators|gaba modulators|mesh-ancestor
5712189|NCT03269929|GABA Agents|gaba agents|mesh-ancestor
5712190|NCT03269929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5712191|NCT03269929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712192|NCT03269760|Zolpidem|zolpidem|mesh-list
5712193|NCT03269760|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5712194|NCT03269760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5712195|NCT03269760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5712196|NCT03269760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712197|NCT03269760|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
5712198|NCT03269760|GABA Agonists|gaba agonists|mesh-ancestor
5712199|NCT03269760|GABA Agents|gaba agents|mesh-ancestor
5712200|NCT03269760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5712201|NCT03269760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712202|NCT03270007|Vinorelbine|vinorelbine|mesh-list
5712203|NCT03270007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5712204|NCT03270007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5712205|NCT03270007|Tubulin Modulators|tubulin modulators|mesh-ancestor
6237982|NCT04186286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6237983|NCT04186286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6237984|NCT04186286|Vasodilator Agents|vasodilator agents|mesh-ancestor
6237985|NCT04178460|Niraparib|niraparib|mesh-list
6237986|NCT04178460|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6237987|NCT04178460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6237988|NCT04178460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6237989|NCT04178460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6237990|NCT04175912|Paclitaxel|paclitaxel|mesh-list
6237991|NCT04175912|Carboplatin|carboplatin|mesh-list
6237992|NCT04175912|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6237993|NCT04175912|Enzyme Inhibitors|enzyme inhibitors|mesh-list
6237994|NCT04175912|Pevonedistat|pevonedistat|mesh-list
6237995|NCT04175912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6237996|NCT04175912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6237997|NCT04175912|Tubulin Modulators|tubulin modulators|mesh-ancestor
6237998|NCT04175912|Antimitotic Agents|antimitotic agents|mesh-ancestor
6237999|NCT04175912|Mitosis Modulators|mitosis modulators|mesh-ancestor
6238000|NCT04175912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6238001|NCT04166773|Tirzepatide|tirzepatide|mesh-list
6238002|NCT04166773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6238003|NCT04166773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6238004|NCT04166773|Incretins|incretins|mesh-ancestor
6238005|NCT04166773|Hormones|hormones|mesh-ancestor
6238006|NCT04166773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6238007|NCT04145115|Nivolumab|nivolumab|mesh-list
6238008|NCT04145115|Ipilimumab|ipilimumab|mesh-list
6238009|NCT04145115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6238010|NCT04145115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238011|NCT04145115|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6238012|NCT04145115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6238013|NCT04106219|Cyclophosphamide|cyclophosphamide|mesh-list
6238014|NCT04106219|Topotecan|topotecan|mesh-list
6238015|NCT04106219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6238016|NCT04106219|Immunologic Factors|immunologic factors|mesh-ancestor
6238017|NCT04106219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6238018|NCT04106219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6238019|NCT04106219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6238020|NCT04106219|Alkylating Agents|alkylating agents|mesh-ancestor
6238021|NCT04106219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6238022|NCT04106219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238023|NCT04106219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6238024|NCT04106219|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6238025|NCT04106219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6238026|NCT04106219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6238027|NCT04092894|Suvorexant|suvorexant|mesh-list
6238028|NCT04092894|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6238029|NCT04092894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5712206|NCT03270007|Antimitotic Agents|antimitotic agents|mesh-ancestor
5712207|NCT03270007|Mitosis Modulators|mitosis modulators|mesh-ancestor
5712208|NCT03270007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712209|NCT03270020|Denosumab|denosumab|mesh-list
6238030|NCT04092894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6238031|NCT04092894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6238032|NCT04092894|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
6238033|NCT04092894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6238034|NCT04092894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6238035|NCT04076059|Androgens|androgens|mesh-list
6238036|NCT04076059|Hormones|hormones|mesh-ancestor
6238037|NCT04076059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6238038|NCT04076059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6238039|NCT04072835|Etripamil|etripamil|mesh-list
6238040|NCT04072835|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6238041|NCT04072835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6238042|NCT04072835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6238043|NCT04072835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6238044|NCT04072835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6238045|NCT04055012|Metformin|metformin|mesh-list
6238046|NCT04055012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6238047|NCT04055012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6238048|NCT04044560|Blinatumomab|blinatumomab|mesh-list
6238049|NCT04044560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238056|NCT04026113|Linaclotide|linaclotide|mesh-list
6238057|NCT04026113|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
5712210|NCT03270020|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5712211|NCT03270020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712212|NCT03269786|Bilirubin|bilirubin|mesh-list
5712213|NCT03269786|Antioxidants|antioxidants|mesh-ancestor
5712214|NCT03269786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712215|NCT03269786|Protective Agents|protective agents|mesh-ancestor
5712216|NCT03269786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712217|NCT03270033|Dexamethasone|dexamethasone|mesh-list
6238058|NCT04026113|Enzyme Activators|enzyme activators|mesh-ancestor
6238059|NCT04026113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6238060|NCT04026113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6238061|NCT03990896|Talazoparib|talazoparib|mesh-list
6238062|NCT03990896|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6238063|NCT03990896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6238064|NCT03990896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6238065|NCT03990896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238066|NCT03978611|Ipilimumab|ipilimumab|mesh-list
6238067|NCT03978611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6238068|NCT03978611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238069|NCT03978611|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6238070|NCT03978611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6238071|NCT03959566|Moxifloxacin|moxifloxacin|mesh-list
6238072|NCT03959566|Bedaquiline|bedaquiline|mesh-list
6238073|NCT03959566|Midazolam|midazolam|mesh-list
6238074|NCT03959566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6238075|NCT03959566|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6244038|NCT02685267|Hormones|hormones|mesh-ancestor
5712218|NCT03270033|Dexamethasone acetate|dexamethasone acetate|mesh-list
5712219|NCT03270033|Dexmedetomidine|dexmedetomidine|mesh-list
5712220|NCT03270033|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
5712221|NCT03270033|BB 1101|bb 1101|mesh-list
5712222|NCT03270033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5712223|NCT03270033|Antiemetics|antiemetics|mesh-ancestor
5712224|NCT03270033|Autonomic Agents|autonomic agents|mesh-ancestor
5712225|NCT03270033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5712226|NCT03270033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712227|NCT03270033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5712228|NCT03270033|Glucocorticoids|glucocorticoids|mesh-ancestor
5712229|NCT03270033|Hormones|hormones|mesh-ancestor
5712230|NCT03270033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5712231|NCT03270033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5712232|NCT03270033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5712233|NCT03270033|Protease Inhibitors|protease inhibitors|mesh-ancestor
5712234|NCT03270033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5712235|NCT03270033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712236|NCT03270033|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5712237|NCT03270033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5712238|NCT03270033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5712239|NCT03270033|Analgesics|analgesics|mesh-ancestor
5712240|NCT03270033|Sensory System Agents|sensory system agents|mesh-ancestor
6238076|NCT03959566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5712241|NCT03270033|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5712242|NCT03270033|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5712243|NCT03270033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5712244|NCT03270033|Adrenergic Agents|adrenergic agents|mesh-ancestor
5712245|NCT03270033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5712246|NCT03269916|Hormones|hormones|mesh-list
5712247|NCT03269916|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5712248|NCT03269916|Estrogens|estrogens|mesh-list
5712249|NCT03269916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5712250|NCT03269916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6238077|NCT03959566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6238078|NCT03959566|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6238079|NCT03959566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6238080|NCT03959566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6238081|NCT03959566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6238082|NCT03959566|Anesthetics, General|anesthetics, general|mesh-ancestor
6238083|NCT03959566|Anesthetics|anesthetics|mesh-ancestor
6238084|NCT03959566|GABA Modulators|gaba modulators|mesh-ancestor
6238085|NCT03959566|GABA Agents|gaba agents|mesh-ancestor
6238086|NCT03959566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6238087|NCT03959566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6238088|NCT03959566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6238089|NCT03959566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6238090|NCT03959566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6238091|NCT03959566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6238092|NCT03959566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6238093|NCT03959566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238094|NCT03959566|Antitubercular Agents|antitubercular agents|mesh-ancestor
6238095|NCT03952130|Insulin|insulin|mesh-list
6238096|NCT03952130|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6238097|NCT03952130|Insulin Glargine|insulin glargine|mesh-list
6238098|NCT03952130|Insulin Lispro|insulin lispro|mesh-list
6238099|NCT03952130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6238100|NCT03952130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6238101|NCT03940586|Letermovir|letermovir|mesh-list
6238102|NCT03940586|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6238103|NCT03940586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6238104|NCT03940586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6238105|NCT03940586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238106|NCT03940586|Antiviral Agents|antiviral agents|mesh-ancestor
6238107|NCT03940586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6244039|NCT02685267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6244040|NCT02685267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244041|NCT02685267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6244042|NCT02685436|Domperidone|domperidone|mesh-list
6244043|NCT02685436|Omeprazole|omeprazole|mesh-list
6244044|NCT02685436|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6244045|NCT02685436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6244046|NCT02685436|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5712251|NCT03269747|Prednisone|prednisone|mesh-list
6502618|NCT00650117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502619|NCT00650117|Analgesics|analgesics|mesh-ancestor
6502620|NCT00650117|Sensory System Agents|sensory system agents|mesh-ancestor
6502621|NCT00650117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6502622|NCT00650117|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6677511|NCT01588314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5712252|NCT03269747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6238108|NCT03926130|Mirikizumab|mirikizumab|mesh-list
6238109|NCT03926130|Ustekinumab|ustekinumab|mesh-list
6238110|NCT03926130|Dermatologic Agents|dermatologic agents|mesh-ancestor
6238111|NCT03926130|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6238112|NCT03926130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6238113|NCT03926130|Analgesics|analgesics|mesh-ancestor
6238114|NCT03926130|Sensory System Agents|sensory system agents|mesh-ancestor
6238115|NCT03926130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6238116|NCT03926130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6238117|NCT03926130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6238118|NCT03926130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6238119|NCT03926130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6238120|NCT03926130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6238121|NCT03924869|Pembrolizumab|pembrolizumab|mesh-list
6238122|NCT03924869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6238123|NCT03924869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238137|NCT03922477|Atezolizumab|atezolizumab|mesh-list
6238138|NCT03922477|Magrolimab|magrolimab|mesh-list
6238139|NCT03922477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238140|NCT03922477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6238141|NCT03915405|Avelumab|avelumab|mesh-list
6238142|NCT03915405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6238143|NCT03915405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238144|NCT03907176|Acetaminophen|acetaminophen|mesh-list
6238145|NCT03907176|Ibuprofen|ibuprofen|mesh-list
6238146|NCT03907176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6238147|NCT03907176|Analgesics|analgesics|mesh-ancestor
6238148|NCT03907176|Sensory System Agents|sensory system agents|mesh-ancestor
6238149|NCT03907176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6238150|NCT03907176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6238151|NCT03907176|Antipyretics|antipyretics|mesh-ancestor
6238152|NCT03907176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6502623|NCT00650117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6502624|NCT00650117|Anesthetics, General|anesthetics, general|mesh-ancestor
6238153|NCT03907176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6238154|NCT03907176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6238155|NCT03907176|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6238156|NCT03907176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6238157|NCT03907176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6238158|NCT03884998|Nivolumab|nivolumab|mesh-list
6238159|NCT03884998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6238160|NCT03884998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238161|NCT03884998|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6238162|NCT03884998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6238163|NCT03838042|Nivolumab|nivolumab|mesh-list
6238164|NCT03838042|Entinostat|entinostat|mesh-list
5712253|NCT03269747|Glucocorticoids|glucocorticoids|mesh-ancestor
5712254|NCT03269747|Hormones|hormones|mesh-ancestor
5712255|NCT03269747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5712256|NCT03269747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712257|NCT03269747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5712258|NCT03269747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238165|NCT03838042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6238166|NCT03838042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238167|NCT03838042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6238168|NCT03838042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712259|NCT03269721|Carbon Monoxide|carbon monoxide|mesh-list
5712260|NCT03269721|Antimetabolites|antimetabolites|mesh-ancestor
5712261|NCT03269721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712262|NCT03269721|Gasotransmitters|gasotransmitters|mesh-ancestor
5712263|NCT03269721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5712264|NCT03269721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712265|NCT03269955|Thrombin|thrombin|mesh-list
5712266|NCT03269955|Hemostatics|hemostatics|mesh-ancestor
5712267|NCT03269955|Coagulants|coagulants|mesh-ancestor
5712268|NCT03269604|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5712269|NCT03269604|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5712270|NCT03269604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5712271|NCT03269604|Antitubercular Agents|antitubercular agents|mesh-ancestor
5712272|NCT03269799|Ascorbic Acid|ascorbic acid|mesh-list
5712273|NCT03269799|Vitamins|vitamins|mesh-ancestor
5712274|NCT03269799|Micronutrients|micronutrients|mesh-ancestor
5712275|NCT03269799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712276|NCT03269799|Antioxidants|antioxidants|mesh-ancestor
5712277|NCT03269799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712278|NCT03269799|Protective Agents|protective agents|mesh-ancestor
5712279|NCT03269591|Diclofenac|diclofenac|mesh-list
5712280|NCT03269591|Progesterone|progesterone|mesh-list
6238169|NCT03838042|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6238170|NCT03838042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6238171|NCT03807440|Empagliflozin|empagliflozin|mesh-list
6238172|NCT03807440|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
6238173|NCT03807440|Linagliptin|linagliptin|mesh-list
6238174|NCT03807440|Metformin|metformin|mesh-list
6238175|NCT03807440|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
6238176|NCT03807440|Glucagon|glucagon|mesh-list
6238177|NCT03807440|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6238178|NCT03807440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6238179|NCT03807440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5712281|NCT03269591|Progestins|progestins|mesh-ancestor
5712282|NCT03269591|Hormones|hormones|mesh-ancestor
5712283|NCT03269591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5712284|NCT03269591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712285|NCT03269591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6238180|NCT03807440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6238181|NCT03807440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5712286|NCT03269591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5712287|NCT03269591|Analgesics|analgesics|mesh-ancestor
5712288|NCT03269591|Sensory System Agents|sensory system agents|mesh-ancestor
5712289|NCT03269591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5712290|NCT03269591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5712291|NCT03269591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5712292|NCT03269591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5712293|NCT03269591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5712294|NCT03269591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712295|NCT03269383|Bupivacaine|bupivacaine|mesh-list
5712296|NCT03269383|Anesthetics, Local|anesthetics, local|mesh-ancestor
5712297|NCT03269383|Anesthetics|anesthetics|mesh-ancestor
5712298|NCT03269383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5712299|NCT03269383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712300|NCT03269383|Sensory System Agents|sensory system agents|mesh-ancestor
5712301|NCT03269383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5712302|NCT03269357|Contraceptive Agents|contraceptive agents|mesh-list
5712303|NCT03269357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5712304|NCT03269357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712305|NCT03269214|Phenytoin|phenytoin|mesh-list
5712306|NCT03269214|Anticonvulsants|anticonvulsants|mesh-ancestor
5712307|NCT03269214|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5712308|NCT03269214|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5712309|NCT03269214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5712310|NCT03269214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712311|NCT03269214|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5712312|NCT03269214|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5712313|NCT03269279|Misoprostol|misoprostol|mesh-list
5712314|NCT03269279|Mifepristone|mifepristone|mesh-list
5712315|NCT03269279|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5712316|NCT03269279|Abortifacient Agents|abortifacient agents|mesh-ancestor
5712317|NCT03269279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6238182|NCT03807440|Hormones|hormones|mesh-ancestor
5712318|NCT03269279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712319|NCT03269279|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5712320|NCT03269279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5712321|NCT03269279|Oxytocics|oxytocics|mesh-ancestor
5712322|NCT03269279|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5712323|NCT03269279|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5712324|NCT03269279|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5712325|NCT03269279|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5712326|NCT03269279|Contraceptive Agents|contraceptive agents|mesh-ancestor
5712327|NCT03269279|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5712328|NCT03269279|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5712329|NCT03269279|Hormone Antagonists|hormone antagonists|mesh-ancestor
5712330|NCT03269279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5712331|NCT03269279|Luteolytic Agents|luteolytic agents|mesh-ancestor
5712332|NCT03269279|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5712333|NCT03269279|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5712334|NCT03269058|Dapagliflozin|dapagliflozin|mesh-list
5712335|NCT03269058|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5712336|NCT03269058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712337|NCT03269058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5712338|NCT03269058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502625|NCT00650117|Anesthetics|anesthetics|mesh-ancestor
6502626|NCT00650143|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6502627|NCT00650143|Lenograstim|lenograstim|mesh-list
6502628|NCT00650143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6502629|NCT00650143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502630|NCT00650143|Incretins|incretins|mesh-ancestor
6502631|NCT00650143|Hormones|hormones|mesh-ancestor
6502632|NCT00650143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6502633|NCT00650143|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6677512|NCT01588314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677513|NCT01588314|Antimanic Agents|antimanic agents|mesh-ancestor
6677514|NCT01588522|Calcitriol|calcitriol|mesh-list
5712339|NCT03269318|Theophylline|theophylline|mesh-list
5712340|NCT03269318|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5712341|NCT03269318|Montelukast|montelukast|mesh-list
5712342|NCT03269318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5712343|NCT03269318|Autonomic Agents|autonomic agents|mesh-ancestor
5712344|NCT03269318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5712345|NCT03269318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712346|NCT03269318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6238183|NCT03807440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6238184|NCT03807440|Incretins|incretins|mesh-ancestor
6238185|NCT03807440|Protease Inhibitors|protease inhibitors|mesh-ancestor
5712347|NCT03269318|Respiratory System Agents|respiratory system agents|mesh-ancestor
5712348|NCT03269318|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5712349|NCT03269318|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6238186|NCT03807440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5712350|NCT03269318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5712351|NCT03269318|Adrenergic Agents|adrenergic agents|mesh-ancestor
5712352|NCT03269318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5712353|NCT03269318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712354|NCT03269318|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5712355|NCT03269318|Hormone Antagonists|hormone antagonists|mesh-ancestor
5712356|NCT03269318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5712357|NCT03269318|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5712358|NCT03269318|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5712359|NCT03269318|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5712360|NCT03269318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5712361|NCT03269318|Vasodilator Agents|vasodilator agents|mesh-ancestor
5712362|NCT03269318|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5712363|NCT03269318|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5712364|NCT03269318|Purinergic Agents|purinergic agents|mesh-ancestor
6238187|NCT03801369|Durvalumab|durvalumab|mesh-list
6238188|NCT03801369|Olaparib|olaparib|mesh-list
6238189|NCT03801369|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
6238190|NCT03801369|Immunoglobulins|immunoglobulins|mesh-list
6238191|NCT03801369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6238192|NCT03801369|Immunoglobulin G|immunoglobulin g|mesh-list
6238193|NCT03801369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6238194|NCT03801369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238195|NCT03801369|Immunologic Factors|immunologic factors|mesh-ancestor
6238196|NCT03801369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502634|NCT00650143|Protease Inhibitors|protease inhibitors|mesh-ancestor
6502635|NCT00650143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6502636|NCT00650143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6238197|NCT03801369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6238198|NCT03801369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6238199|NCT03787680|Olaparib|olaparib|mesh-list
6238200|NCT03787680|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6238201|NCT03787680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6238202|NCT03787680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6238203|NCT03787680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238204|NCT03777436|Apremilast|apremilast|mesh-list
6238205|NCT03777436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6238206|NCT03777436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6238207|NCT03777436|Analgesics|analgesics|mesh-ancestor
6238208|NCT03777436|Sensory System Agents|sensory system agents|mesh-ancestor
6238209|NCT03777436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6238210|NCT03777436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6238211|NCT03777436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6238212|NCT03777436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6502637|NCT00650143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5919135|NCT04985201|Irinotecan|irinotecan|mesh-list
5919136|NCT04985201|Simvastatin|simvastatin|mesh-list
5919137|NCT04985201|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5919138|NCT04985201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5919139|NCT04985201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5919140|NCT04985201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919141|NCT04985201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5919142|NCT04985201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5919143|NCT04985201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5919144|NCT04985201|Antimetabolites|antimetabolites|mesh-ancestor
5919145|NCT04985201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5919146|NCT04985201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6502638|NCT00650143|Immunologic Factors|immunologic factors|mesh-ancestor
6502639|NCT00650156|Adalimumab|adalimumab|mesh-list
6502640|NCT00650156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6502641|NCT00650156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5919147|NCT04984759|Primaquine|primaquine|mesh-list
6238213|NCT03777436|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6238214|NCT03777436|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6238215|NCT03777436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6238216|NCT03777436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6238217|NCT03761914|Pembrolizumab|pembrolizumab|mesh-list
6238218|NCT03761914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6238219|NCT03761914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238220|NCT03759288|Adalimumab|adalimumab|mesh-list
6238221|NCT03759288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6238222|NCT03759288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6238223|NCT03753919|Durvalumab|durvalumab|mesh-list
6238224|NCT03753919|Tremelimumab|tremelimumab|mesh-list
6238225|NCT03753919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6238226|NCT03753919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238227|NCT03739814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6238228|NCT03739814|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
6238229|NCT03739814|Blinatumomab|blinatumomab|mesh-list
6238230|NCT03739814|Antibodies|antibodies|mesh-list
6238231|NCT03739814|Immunoglobulins|immunoglobulins|mesh-list
6238232|NCT03739814|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6238233|NCT03739814|Muromonab-CD3|muromonab-cd3|mesh-list
6238234|NCT03739814|Antibodies, Bispecific|antibodies, bispecific|mesh-list
6238235|NCT03739814|Immunologic Factors|immunologic factors|mesh-ancestor
6238236|NCT03739814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6238237|NCT03739814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238238|NCT03739814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6238239|NCT03739814|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6238240|NCT03737643|Paclitaxel|paclitaxel|mesh-list
6238241|NCT03737643|Bevacizumab|bevacizumab|mesh-list
6238242|NCT03737643|Carboplatin|carboplatin|mesh-list
6238243|NCT03737643|Durvalumab|durvalumab|mesh-list
6238244|NCT03737643|Olaparib|olaparib|mesh-list
6238245|NCT03737643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6238246|NCT03737643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6238247|NCT03737643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238248|NCT03737643|Tubulin Modulators|tubulin modulators|mesh-ancestor
6238249|NCT03737643|Antimitotic Agents|antimitotic agents|mesh-ancestor
6238250|NCT03737643|Mitosis Modulators|mitosis modulators|mesh-ancestor
6238251|NCT03737643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502642|NCT00650169|Clopidogrel|clopidogrel|mesh-list
6238252|NCT03737643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6238253|NCT03737643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6238254|NCT03737643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6238255|NCT03737643|Growth Substances|growth substances|mesh-ancestor
6502643|NCT00650169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6238256|NCT03737643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6238257|NCT03737643|Growth Inhibitors|growth inhibitors|mesh-ancestor
6238258|NCT03737643|Immunologic Factors|immunologic factors|mesh-ancestor
6238259|NCT03737643|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6238260|NCT03737643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6502644|NCT00650169|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6502645|NCT00650169|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6502646|NCT00650169|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6502647|NCT00650169|Purinergic Agents|purinergic agents|mesh-ancestor
6502648|NCT00650169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6502649|NCT00650169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502650|NCT00650169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502651|NCT00650182|Fentanyl|fentanyl|mesh-list
6502652|NCT00650182|Naltrexone|naltrexone|mesh-list
6502653|NCT00650182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6502654|NCT00650182|Narcotics|narcotics|mesh-ancestor
6502655|NCT00650182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6502656|NCT00650182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502657|NCT00650182|Analgesics|analgesics|mesh-ancestor
6502658|NCT00650182|Sensory System Agents|sensory system agents|mesh-ancestor
6502659|NCT00650182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6502660|NCT00650182|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6502661|NCT00650182|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6502662|NCT00650182|Anesthetics, General|anesthetics, general|mesh-ancestor
5712365|NCT03268954|Azacitidine|azacitidine|mesh-list
5712366|NCT03268954|Pevonedistat|pevonedistat|mesh-list
5712367|NCT03268954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5712368|NCT03268954|Antimetabolites|antimetabolites|mesh-ancestor
5712369|NCT03268954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712370|NCT03268954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5712371|NCT03268954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5712372|NCT03268733|Folic Acid|folic acid|mesh-list
5712373|NCT03268733|Hematinics|hematinics|mesh-ancestor
5712374|NCT03268733|Vitamin B Complex|vitamin b complex|mesh-ancestor
5712375|NCT03268733|Vitamins|vitamins|mesh-ancestor
5712376|NCT03268733|Micronutrients|micronutrients|mesh-ancestor
5712377|NCT03268733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712378|NCT03269162|Docetaxel|docetaxel|mesh-list
6677515|NCT01588522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6677516|NCT01588522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502663|NCT00650182|Anesthetics|anesthetics|mesh-ancestor
5712379|NCT03269162|Pemetrexed|pemetrexed|mesh-list
6502664|NCT00650182|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5712380|NCT03269162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5712381|NCT03269162|Tubulin Modulators|tubulin modulators|mesh-ancestor
5712382|NCT03269162|Antimitotic Agents|antimitotic agents|mesh-ancestor
5712383|NCT03269162|Mitosis Modulators|mitosis modulators|mesh-ancestor
5712384|NCT03269162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712385|NCT03269162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5712386|NCT03269162|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5712387|NCT03269162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5712388|NCT03268902|Niacinamide|niacinamide|mesh-list
5712389|NCT03268902|Niacin|niacin|mesh-list
5712390|NCT03268902|Nicotinic Acids|nicotinic acids|mesh-list
5712391|NCT03268902|Azithromycin|azithromycin|mesh-list
5712392|NCT03268902|Nitazoxanide|nitazoxanide|mesh-list
5712393|NCT03268902|Vitamins|vitamins|mesh-ancestor
5712394|NCT03268902|Micronutrients|micronutrients|mesh-ancestor
5712395|NCT03268902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712396|NCT03268902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5712397|NCT03268902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5712398|NCT03268902|Vitamin B Complex|vitamin b complex|mesh-ancestor
5712399|NCT03268902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5712400|NCT03268902|Antimetabolites|antimetabolites|mesh-ancestor
5712401|NCT03268902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712402|NCT03268902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5712403|NCT03268902|Vasodilator Agents|vasodilator agents|mesh-ancestor
6502665|NCT00650182|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6502666|NCT00650195|Metolazone|metolazone|mesh-list
6502667|NCT00650195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6238287|NCT03675672|Misoprostol|misoprostol|mesh-list
6238288|NCT03675672|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6238289|NCT03675672|Abortifacient Agents|abortifacient agents|mesh-ancestor
6238290|NCT03675672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6238291|NCT03675672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6238292|NCT03675672|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6238293|NCT03675672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5712404|NCT03268902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5712405|NCT03268863|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
5712406|NCT03268525|Bupivacaine|bupivacaine|mesh-list
5712407|NCT03268525|Anesthetics, Local|anesthetics, local|mesh-ancestor
5712408|NCT03268525|Anesthetics|anesthetics|mesh-ancestor
5712409|NCT03268525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5712410|NCT03268525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712411|NCT03268525|Sensory System Agents|sensory system agents|mesh-ancestor
5712412|NCT03268525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5712413|NCT03268499|Cisplatin|cisplatin|mesh-list
5712414|NCT03268499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5712415|NCT03268278|Lidocaine|lidocaine|mesh-list
6502668|NCT00650195|Diuretics|diuretics|mesh-ancestor
6502669|NCT00650195|Natriuretic Agents|natriuretic agents|mesh-ancestor
6502670|NCT00650195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502671|NCT00650195|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6502672|NCT00650195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6502673|NCT00650195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502674|NCT00650208|Lamotrigine|lamotrigine|mesh-list
6238294|NCT03675672|Oxytocics|oxytocics|mesh-ancestor
6238295|NCT03664830|Plerixafor|plerixafor|mesh-list
6238296|NCT03664830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6238297|NCT03664830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6502675|NCT00650208|Anticonvulsants|anticonvulsants|mesh-ancestor
6502676|NCT00650208|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5712416|NCT03268278|Epinephrine|epinephrine|mesh-list
6238298|NCT03664830|Antiviral Agents|antiviral agents|mesh-ancestor
6238299|NCT03664830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6238300|NCT03650114|Ofatumumab|ofatumumab|mesh-list
6238301|NCT03650114|Vaccines|vaccines|mesh-list
6238302|NCT03650114|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6238303|NCT03650114|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
6238304|NCT03650114|Immunologic Factors|immunologic factors|mesh-ancestor
6238305|NCT03650114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6238306|NCT03650114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238307|NCT03650114|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6238308|NCT03639948|Carboplatin|carboplatin|mesh-list
6238309|NCT03639948|Docetaxel|docetaxel|mesh-list
6238310|NCT03639948|Pembrolizumab|pembrolizumab|mesh-list
6238311|NCT03639948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238312|NCT03639948|Tubulin Modulators|tubulin modulators|mesh-ancestor
6238313|NCT03639948|Antimitotic Agents|antimitotic agents|mesh-ancestor
5712417|NCT03268278|Buprenorphine|buprenorphine|mesh-list
6238314|NCT03639948|Mitosis Modulators|mitosis modulators|mesh-ancestor
5712418|NCT03268278|Anesthetics, Local|anesthetics, local|mesh-list
5712419|NCT03268278|Anesthetics|anesthetics|mesh-list
6238315|NCT03639948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6238316|NCT03639948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6238317|NCT03623243|Siponimod|siponimod|mesh-list
6238318|NCT03623243|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5712420|NCT03268278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5712421|NCT03268278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712422|NCT03268278|Sensory System Agents|sensory system agents|mesh-ancestor
5712423|NCT03268278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5712424|NCT03268278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5712425|NCT03268278|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5712426|NCT03268278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5712427|NCT03268278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5712428|NCT03268278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712429|NCT03268278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5712430|NCT03268278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5712431|NCT03268278|Adrenergic Agents|adrenergic agents|mesh-ancestor
5712432|NCT03268278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5712433|NCT03268278|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5712434|NCT03268278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5712435|NCT03268278|Autonomic Agents|autonomic agents|mesh-ancestor
5712436|NCT03268278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5712437|NCT03268278|Respiratory System Agents|respiratory system agents|mesh-ancestor
5712438|NCT03268278|Mydriatics|mydriatics|mesh-ancestor
5712439|NCT03268278|Sympathomimetics|sympathomimetics|mesh-ancestor
5712440|NCT03268278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5712441|NCT03268278|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5712442|NCT03268278|Narcotics|narcotics|mesh-ancestor
5712443|NCT03268278|Analgesics|analgesics|mesh-ancestor
5712444|NCT03268278|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5712445|NCT03268382|Doxorubicin|doxorubicin|mesh-list
5712446|NCT03268382|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5712447|NCT03268382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5712448|NCT03268382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5712449|NCT03268382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5712450|NCT03268382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5712451|NCT03268382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5712452|NCT03268382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712453|NCT03268226|Beclomethasone|beclomethasone|mesh-list
5712454|NCT03268226|Glycopyrrolate|glycopyrrolate|mesh-list
5712455|NCT03268226|Formoterol Fumarate|formoterol fumarate|mesh-list
5712456|NCT03268226|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6238319|NCT03623243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712457|NCT03268226|Autonomic Agents|autonomic agents|mesh-ancestor
6238320|NCT03623243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6238321|NCT03623243|Immunologic Factors|immunologic factors|mesh-ancestor
6238322|NCT03623243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6238323|NCT03619707|Progesterone|progesterone|mesh-list
6238324|NCT03619707|Progestins|progestins|mesh-ancestor
6238325|NCT03619707|Hormones|hormones|mesh-ancestor
6238326|NCT03619707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6238327|NCT03619707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6238328|NCT03595124|Nivolumab|nivolumab|mesh-list
6238329|NCT03595124|Axitinib|axitinib|mesh-list
6238330|NCT03595124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5712458|NCT03268226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5712459|NCT03268226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712460|NCT03268226|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5712461|NCT03268226|Respiratory System Agents|respiratory system agents|mesh-ancestor
5712462|NCT03268226|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5712463|NCT03268226|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5712464|NCT03268226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5712465|NCT03268226|Adrenergic Agents|adrenergic agents|mesh-ancestor
5712466|NCT03268226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5712467|NCT03268226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712468|NCT03268226|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5712469|NCT03268226|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5712470|NCT03268226|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5712471|NCT03268226|Cholinergic Agents|cholinergic agents|mesh-ancestor
5712472|NCT03268226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5712473|NCT03268226|Glucocorticoids|glucocorticoids|mesh-ancestor
5712474|NCT03268226|Hormones|hormones|mesh-ancestor
5712475|NCT03268226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5712476|NCT03267836|Avelumab|avelumab|mesh-list
5919148|NCT04984759|Tafenoquine|tafenoquine|mesh-list
6238331|NCT03595124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238332|NCT03595124|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6238333|NCT03595124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6238334|NCT03595124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6238335|NCT03595124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6238336|NCT03586999|Nivolumab|nivolumab|mesh-list
6238337|NCT03586999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6238338|NCT03586999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238339|NCT03586999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6238340|NCT03586999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6238341|NCT03583307|Sirolimus|sirolimus|mesh-list
6238342|NCT03583307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6238343|NCT03583307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6238344|NCT03583307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6238345|NCT03583307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238346|NCT03583307|Antifungal Agents|antifungal agents|mesh-ancestor
6238347|NCT03583307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6238348|NCT03583307|Immunologic Factors|immunologic factors|mesh-ancestor
6238349|NCT03583307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6238350|NCT03539900|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
6238351|NCT03539900|Naltrexone|naltrexone|mesh-list
6238352|NCT03539900|Bupropion|bupropion|mesh-list
6238353|NCT03539900|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6238354|NCT03539900|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6238355|NCT03539900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6238356|NCT03539900|Sensory System Agents|sensory system agents|mesh-ancestor
6238357|NCT03539900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6238358|NCT03539900|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6238359|NCT03539900|Antidepressive Agents|antidepressive agents|mesh-ancestor
6238360|NCT03539900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6238361|NCT03539900|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6238362|NCT03539900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6238363|NCT03539900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6238364|NCT03539900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6238365|NCT03539900|Dopamine Agents|dopamine agents|mesh-ancestor
6238366|NCT03539900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6238367|NCT03539900|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6238368|NCT03539900|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6238369|NCT03539900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6238370|NCT03539900|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6238371|NCT03532022|Dexamethasone|dexamethasone|mesh-list
6238372|NCT03532022|Prednisone|prednisone|mesh-list
6238373|NCT03532022|Prednisolone|prednisolone|mesh-list
6238374|NCT03532022|Hydrocortisone|hydrocortisone|mesh-list
6238375|NCT03532022|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6238376|NCT03532022|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6238377|NCT03532022|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6238378|NCT03532022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6238379|NCT03532022|Antiemetics|antiemetics|mesh-ancestor
6238380|NCT03532022|Autonomic Agents|autonomic agents|mesh-ancestor
6238381|NCT03532022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6238382|NCT03532022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6238383|NCT03532022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6238384|NCT03532022|Glucocorticoids|glucocorticoids|mesh-ancestor
6238385|NCT03532022|Hormones|hormones|mesh-ancestor
6238386|NCT03532022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6238387|NCT03532022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6502677|NCT00650208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6502678|NCT00650208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502679|NCT00650208|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6502680|NCT00650208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712477|NCT03267836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6238388|NCT03532022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238389|NCT03524092|Mirikizumab|mirikizumab|mesh-list
6238390|NCT03524092|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6238391|NCT03524092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6238392|NCT03524092|Analgesics|analgesics|mesh-ancestor
5712478|NCT03267836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5712479|NCT03267888|Pembrolizumab|pembrolizumab|mesh-list
5712480|NCT03267888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5712481|NCT03267888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5712482|NCT03268057|Avelumab|avelumab|mesh-list
5712483|NCT03268057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5712484|NCT03268057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5712485|NCT03267771|Progesterone|progesterone|mesh-list
5712486|NCT03267771|Dydrogesterone|dydrogesterone|mesh-list
5712487|NCT03267771|Progestins|progestins|mesh-ancestor
5712488|NCT03267771|Hormones|hormones|mesh-ancestor
5712489|NCT03267771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5712490|NCT03267771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712491|NCT03267628|Morphine|morphine|mesh-list
5712492|NCT03267628|Anesthetics|anesthetics|mesh-list
5712493|NCT03267628|Anesthetics, Local|anesthetics, local|mesh-list
5712494|NCT03267628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5712495|NCT03267628|Narcotics|narcotics|mesh-ancestor
5712496|NCT03267628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5712497|NCT03267628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712498|NCT03267628|Analgesics|analgesics|mesh-ancestor
5712499|NCT03267628|Sensory System Agents|sensory system agents|mesh-ancestor
5712500|NCT03267628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5712501|NCT03268018|Calcium|calcium|mesh-list
5712502|NCT03268018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5712503|NCT03268018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712504|NCT03267654|Apatinib|apatinib|mesh-list
5712505|NCT03267654|Gefitinib|gefitinib|mesh-list
5712506|NCT03267654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5712507|NCT03267654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5712508|NCT03267654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5712509|NCT03267654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712510|NCT03267680|Indomethacin|indomethacin|mesh-list
5712511|NCT03267680|Cyclophosphamide|cyclophosphamide|mesh-list
5712512|NCT03267680|Omeprazole|omeprazole|mesh-list
5712513|NCT03267680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5712514|NCT03267680|Immunologic Factors|immunologic factors|mesh-ancestor
5712515|NCT03267680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712516|NCT03267680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6238393|NCT03524092|Sensory System Agents|sensory system agents|mesh-ancestor
6238394|NCT03524092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6238395|NCT03524092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6238396|NCT03524092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6238397|NCT03524092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6238398|NCT03524092|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6238399|NCT03524092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6238400|NCT03519945|Mirikizumab|mirikizumab|mesh-list
6238401|NCT03519945|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6238402|NCT03519945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6238403|NCT03519945|Analgesics|analgesics|mesh-ancestor
6238404|NCT03519945|Sensory System Agents|sensory system agents|mesh-ancestor
6238405|NCT03519945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6238406|NCT03519945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6238407|NCT03519945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6238408|NCT03519945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6238409|NCT03519945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6238410|NCT03519945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6238411|NCT03518034|Testosterone|testosterone|mesh-list
6238412|NCT03518034|Androgens|androgens|mesh-ancestor
6238413|NCT03518034|Hormones|hormones|mesh-ancestor
6238414|NCT03518034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6238415|NCT03518034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6238416|NCT03500380|Capecitabine|capecitabine|mesh-list
6238417|NCT03500380|Lapatinib|lapatinib|mesh-list
6238418|NCT03500380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6238419|NCT03500380|Antimetabolites|antimetabolites|mesh-ancestor
6238420|NCT03500380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6238421|NCT03500380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238422|NCT03500380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6238423|NCT03500380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6238424|NCT03494569|Fludarabine|fludarabine|mesh-list
6238425|NCT03494569|Melphalan|melphalan|mesh-list
6238426|NCT03494569|Mechlorethamine|mechlorethamine|mesh-list
6238427|NCT03494569|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
6238428|NCT03494569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238429|NCT03494569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6238430|NCT03494569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6238431|NCT03494569|Immunologic Factors|immunologic factors|mesh-ancestor
6238432|NCT03494569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6238433|NCT03494569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5712517|NCT03267680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5712518|NCT03267680|Alkylating Agents|alkylating agents|mesh-ancestor
6238434|NCT03494569|Alkylating Agents|alkylating agents|mesh-ancestor
6502681|NCT00650208|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6502682|NCT00650208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6502683|NCT00650208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6238435|NCT03494569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6238436|NCT03468218|Pembrolizumab|pembrolizumab|mesh-list
6238437|NCT03468218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6238438|NCT03468218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238439|NCT03401853|Rituximab|rituximab|mesh-list
6238440|NCT03401853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6238441|NCT03401853|Pembrolizumab|pembrolizumab|mesh-list
6238442|NCT03401853|Obinutuzumab|obinutuzumab|mesh-list
6238443|NCT03401853|Antibodies|antibodies|mesh-list
6238444|NCT03401853|Immunoglobulins|immunoglobulins|mesh-list
6238445|NCT03401853|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6238446|NCT03401853|Immunologic Factors|immunologic factors|mesh-ancestor
6238447|NCT03401853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6238448|NCT03401853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238449|NCT03401853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6238450|NCT03391973|Pembrolizumab|pembrolizumab|mesh-list
6238451|NCT03391973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6238452|NCT03391973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238453|NCT03389620|Dexamethasone|dexamethasone|mesh-list
6238454|NCT03389620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5712519|NCT03267680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712520|NCT03267680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5712521|NCT03267680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5712522|NCT03267680|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5712523|NCT03267680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5712524|NCT03267680|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5712525|NCT03267680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5712526|NCT03267680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5712527|NCT03267680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5712528|NCT03267680|Analgesics|analgesics|mesh-ancestor
5712529|NCT03267680|Sensory System Agents|sensory system agents|mesh-ancestor
5712530|NCT03267680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6238455|NCT03389620|Antiemetics|antiemetics|mesh-ancestor
6238456|NCT03389620|Autonomic Agents|autonomic agents|mesh-ancestor
6238457|NCT03389620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6238458|NCT03389620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6238459|NCT03389620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6238460|NCT03389620|Glucocorticoids|glucocorticoids|mesh-ancestor
6238461|NCT03389620|Hormones|hormones|mesh-ancestor
6238462|NCT03389620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6238463|NCT03389620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6238464|NCT03389620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238465|NCT03386721|Gemcitabine|gemcitabine|mesh-list
6238466|NCT03386721|Atezolizumab|atezolizumab|mesh-list
6238467|NCT03386721|Vinorelbine|vinorelbine|mesh-list
6238468|NCT03386721|Antibodies|antibodies|mesh-list
6238469|NCT03386721|Immunologic Factors|immunologic factors|mesh-ancestor
6238470|NCT03386721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6238471|NCT03386721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6238472|NCT03386721|Antimetabolites|antimetabolites|mesh-ancestor
6238473|NCT03386721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6238474|NCT03386721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238475|NCT03386721|Antiviral Agents|antiviral agents|mesh-ancestor
6238476|NCT03386721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6238477|NCT03386721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6238478|NCT03386721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6238479|NCT03386721|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6238480|NCT03386721|Tubulin Modulators|tubulin modulators|mesh-ancestor
6238481|NCT03386721|Antimitotic Agents|antimitotic agents|mesh-ancestor
6238482|NCT03386721|Mitosis Modulators|mitosis modulators|mesh-ancestor
6238483|NCT03377361|Nivolumab|nivolumab|mesh-list
6238484|NCT03377361|Ipilimumab|ipilimumab|mesh-list
6238485|NCT03377361|Trametinib|trametinib|mesh-list
6238486|NCT03377361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6238487|NCT03377361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238488|NCT03377361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6238489|NCT03377361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6238490|NCT03377361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6238491|NCT03377361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6238492|NCT03345849|Upadacitinib|upadacitinib|mesh-list
6238493|NCT03345849|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
6502684|NCT00650208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6238494|NCT03345849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6238495|NCT03345849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6238496|NCT03345849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677517|NCT01588522|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6677518|NCT01588522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6677519|NCT01588522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712531|NCT03267680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5712532|NCT03267680|Gout Suppressants|gout suppressants|mesh-ancestor
5712533|NCT03267680|Tocolytic Agents|tocolytic agents|mesh-ancestor
5712534|NCT03267680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5712535|NCT03267680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5712536|NCT03267407|Fluconazole|fluconazole|mesh-list
5712537|NCT03267407|Antifungal Agents|antifungal agents|mesh-ancestor
5712538|NCT03267407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5712539|NCT03267407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5712540|NCT03267407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5712541|NCT03267407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5712542|NCT03267407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712543|NCT03267407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5712544|NCT03267407|Hormone Antagonists|hormone antagonists|mesh-ancestor
5712545|NCT03267407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5712546|NCT03267407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712547|NCT03267407|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5712548|NCT03267407|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5721743|NCT03203525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5721744|NCT03203525|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5721745|NCT03203525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5721746|NCT03203525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5721747|NCT03203525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721748|NCT03203525|Antimetabolites|antimetabolites|mesh-ancestor
5721749|NCT03203525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5721750|NCT03203525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5721751|NCT03203525|Antidotes|antidotes|mesh-ancestor
6677520|NCT01588522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6238497|NCT03345849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6238498|NCT03342001|Calcitonin|calcitonin|mesh-list
6238499|NCT03342001|Salmon calcitonin|salmon calcitonin|mesh-list
6238500|NCT03342001|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
6238501|NCT03342001|Katacalcin|katacalcin|mesh-list
6238502|NCT03342001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6238503|NCT03342001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6238504|NCT03342001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6238505|NCT03342001|Vasodilator Agents|vasodilator agents|mesh-ancestor
6238506|NCT03325439|Brivaracetam|brivaracetam|mesh-list
6238507|NCT03325439|Anticonvulsants|anticonvulsants|mesh-ancestor
6238508|NCT03319940|Pembrolizumab|pembrolizumab|mesh-list
6677521|NCT01588522|Vitamins|vitamins|mesh-ancestor
6677522|NCT01588522|Micronutrients|micronutrients|mesh-ancestor
6677523|NCT01588522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6677524|NCT01588587|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6677525|NCT01588587|Vildagliptin|vildagliptin|mesh-list
6677526|NCT01588587|Alogliptin|alogliptin|mesh-list
6677527|NCT01588587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6677528|NCT01588587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677529|NCT01588587|Incretins|incretins|mesh-ancestor
6677530|NCT01588587|Hormones|hormones|mesh-ancestor
6238509|NCT03319940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6238510|NCT03319940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6677531|NCT01588587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6677532|NCT01588587|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5721752|NCT03203525|Protective Agents|protective agents|mesh-ancestor
5721753|NCT03203525|Vitamin B Complex|vitamin b complex|mesh-ancestor
5721754|NCT03203525|Vitamins|vitamins|mesh-ancestor
5721755|NCT03203525|Micronutrients|micronutrients|mesh-ancestor
5721756|NCT03203525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6677533|NCT01588587|Protease Inhibitors|protease inhibitors|mesh-ancestor
6238511|NCT03317119|Trifluridine|trifluridine|mesh-list
6238512|NCT03317119|Trametinib|trametinib|mesh-list
6238513|NCT03317119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238514|NCT03317119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6238515|NCT03317119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6238516|NCT03317119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677534|NCT01588587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6677535|NCT01588587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677536|NCT01588626|Ticagrelor|ticagrelor|mesh-list
6677537|NCT01588626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6677538|NCT01588626|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6677539|NCT01588626|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6677540|NCT01588626|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6677541|NCT01588626|Purinergic Agents|purinergic agents|mesh-ancestor
6677542|NCT01588626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6502685|NCT00650208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6502686|NCT00650221|Pravastatin|pravastatin|mesh-list
6502687|NCT00650221|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6502688|NCT00650221|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6502689|NCT00650221|Antimetabolites|antimetabolites|mesh-ancestor
5712549|NCT03267316|Gemcitabine|gemcitabine|mesh-list
5712550|NCT03267316|Paclitaxel|paclitaxel|mesh-list
5712551|NCT03267316|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5712552|NCT03267316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5712553|NCT03267316|Tubulin Modulators|tubulin modulators|mesh-ancestor
5712554|NCT03267316|Antimitotic Agents|antimitotic agents|mesh-ancestor
5712555|NCT03267316|Mitosis Modulators|mitosis modulators|mesh-ancestor
5712556|NCT03267316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712557|NCT03267316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5712558|NCT03267316|Antimetabolites|antimetabolites|mesh-ancestor
5712559|NCT03267316|Antiviral Agents|antiviral agents|mesh-ancestor
5712560|NCT03267316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6238517|NCT03317119|Antimetabolites|antimetabolites|mesh-ancestor
6238518|NCT03317119|Antiviral Agents|antiviral agents|mesh-ancestor
6238519|NCT03317119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6238520|NCT03297710|Trifluridine|trifluridine|mesh-list
6238521|NCT03297710|Antimetabolites|antimetabolites|mesh-ancestor
6238522|NCT03297710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6238523|NCT03297710|Antiviral Agents|antiviral agents|mesh-ancestor
6238524|NCT03297710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6244047|NCT02685436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6244048|NCT02685436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244049|NCT02685436|Antiemetics|antiemetics|mesh-ancestor
6244050|NCT02685436|Autonomic Agents|autonomic agents|mesh-ancestor
6244051|NCT02685436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5712561|NCT03267316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5712562|NCT03267316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5712563|NCT03267316|Immunologic Factors|immunologic factors|mesh-ancestor
5712564|NCT03267316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712565|NCT03267329|Telmisartan|telmisartan|mesh-list
5712566|NCT03267329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5712567|NCT03267329|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6244052|NCT02685436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244053|NCT02685436|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6244054|NCT02685436|Dopamine Agents|dopamine agents|mesh-ancestor
6244055|NCT02685436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6244056|NCT02685826|Dexamethasone|dexamethasone|mesh-list
6244057|NCT02685826|Lenalidomide|lenalidomide|mesh-list
6244058|NCT02685826|Durvalumab|durvalumab|mesh-list
6244059|NCT02685826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6244060|NCT02685826|Antiemetics|antiemetics|mesh-ancestor
6244061|NCT02685826|Autonomic Agents|autonomic agents|mesh-ancestor
6244062|NCT02685826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6244063|NCT02685826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244064|NCT02685826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6244065|NCT02685826|Glucocorticoids|glucocorticoids|mesh-ancestor
6244066|NCT02685826|Hormones|hormones|mesh-ancestor
6244067|NCT02685826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6244068|NCT02685826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6244288|NCT02691936|Estrogens|estrogens|mesh-list
6502690|NCT00650221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502691|NCT00650221|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6502692|NCT00650221|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6502693|NCT00650221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6502694|NCT00650234|Metformin|metformin|mesh-list
6238525|NCT03294460|Ethanol|ethanol|mesh-list
6238526|NCT03294460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6238527|NCT03294460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6238528|NCT03294460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6238529|NCT03294460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6238530|NCT03288545|Gemcitabine|gemcitabine|mesh-list
6238531|NCT03288545|Carboplatin|carboplatin|mesh-list
6238532|NCT03288545|Pembrolizumab|pembrolizumab|mesh-list
6238533|NCT03288545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238534|NCT03288545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6238535|NCT03288545|Antimetabolites|antimetabolites|mesh-ancestor
6238536|NCT03288545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6238537|NCT03288545|Antiviral Agents|antiviral agents|mesh-ancestor
6238538|NCT03288545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6238539|NCT03288545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6238540|NCT03288545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6238541|NCT03288545|Immunologic Factors|immunologic factors|mesh-ancestor
6238542|NCT03288545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6238543|NCT03288545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6238544|NCT03256916|Nelfinavir|nelfinavir|mesh-list
6238545|NCT03256916|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6238546|NCT03256916|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6238547|NCT03256916|Protease Inhibitors|protease inhibitors|mesh-ancestor
6502695|NCT00650234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6502696|NCT00650234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502697|NCT00650247|Sumatriptan|sumatriptan|mesh-list
6502698|NCT00650247|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6502699|NCT00650247|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6677543|NCT01588626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6238548|NCT03256916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6238549|NCT03256916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6238550|NCT03256916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6238551|NCT03256916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6238552|NCT03256916|Antiviral Agents|antiviral agents|mesh-ancestor
6238553|NCT03256916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6238554|NCT03255018|Pembrolizumab|pembrolizumab|mesh-list
6677544|NCT01588626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677545|NCT01588639|Insulin|insulin|mesh-list
6677546|NCT01588639|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6677547|NCT01588639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6677548|NCT01588639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677549|NCT01588704|Bevacizumab|bevacizumab|mesh-list
6238555|NCT03255018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6238556|NCT03255018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6502700|NCT00650247|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6502701|NCT00650247|Serotonin Agents|serotonin agents|mesh-ancestor
6502702|NCT00650247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6677550|NCT01588704|Pemetrexed|pemetrexed|mesh-list
5712568|NCT03267329|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5712569|NCT03267329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712570|NCT03267121|Apatinib|apatinib|mesh-list
5712571|NCT03267121|Tegafur|tegafur|mesh-list
5712572|NCT03267121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5712573|NCT03267121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5712574|NCT03267121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5712575|NCT03267121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712576|NCT03267121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5712577|NCT03267121|Antimetabolites|antimetabolites|mesh-ancestor
5712578|NCT03267199|Fibrinolytic Agents|fibrinolytic agents|mesh-list
5712579|NCT03267199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6238557|NCT03250377|Brivaracetam|brivaracetam|mesh-list
6238558|NCT03250377|Anticonvulsants|anticonvulsants|mesh-ancestor
6238559|NCT03241771|Naloxone|naloxone|mesh-list
6238560|NCT03241771|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6238561|NCT03241771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6238562|NCT03241771|Sensory System Agents|sensory system agents|mesh-ancestor
6238563|NCT03241771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6238564|NCT03233854|Cyclophosphamide|cyclophosphamide|mesh-list
6238565|NCT03233854|Fludarabine|fludarabine|mesh-list
6238566|NCT03233854|Fludarabine phosphate|fludarabine phosphate|mesh-list
6238567|NCT03233854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6238568|NCT03233854|Immunologic Factors|immunologic factors|mesh-ancestor
6238569|NCT03233854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6238570|NCT03233854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6238571|NCT03233854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5712580|NCT03267199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712581|NCT03266965|Carbidopa|carbidopa|mesh-list
5712582|NCT03266965|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6502703|NCT00650247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502704|NCT00650247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677551|NCT01588704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6677552|NCT01588704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6677553|NCT01588704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5712583|NCT03266965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5712584|NCT03266965|Dopamine Agents|dopamine agents|mesh-ancestor
5712585|NCT03266965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5712586|NCT03266965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712587|NCT03266965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919149|NCT04984759|Antimalarials|antimalarials|mesh-ancestor
6677554|NCT01588704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6677555|NCT01588704|Growth Substances|growth substances|mesh-ancestor
6677556|NCT01588704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677557|NCT01588704|Growth Inhibitors|growth inhibitors|mesh-ancestor
6677558|NCT01588704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6677559|NCT01588704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677560|NCT01588704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6677561|NCT01588704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6238572|NCT03233854|Alkylating Agents|alkylating agents|mesh-ancestor
6238573|NCT03233854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6238574|NCT03233854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238575|NCT03233854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6238576|NCT03233854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6238577|NCT03233854|Antimetabolites|antimetabolites|mesh-ancestor
6238578|NCT03220776|Acetylcysteine|acetylcysteine|mesh-list
6238579|NCT03220776|Gabapentin|gabapentin|mesh-list
6238580|NCT03220776|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6238581|NCT03220776|Analgesics|analgesics|mesh-ancestor
6238582|NCT03220776|Sensory System Agents|sensory system agents|mesh-ancestor
6238583|NCT03220776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6238584|NCT03220776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6238585|NCT03220776|Anticonvulsants|anticonvulsants|mesh-ancestor
6238586|NCT03220776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6238587|NCT03220776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6238588|NCT03220776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6238589|NCT03220776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6238590|NCT03220776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6238591|NCT03220776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6238592|NCT03220776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6238593|NCT03220776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6238594|NCT03220776|Antimanic Agents|antimanic agents|mesh-ancestor
6238595|NCT03220776|Antiviral Agents|antiviral agents|mesh-ancestor
6238596|NCT03220776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6238597|NCT03220776|Expectorants|expectorants|mesh-ancestor
6238598|NCT03220776|Respiratory System Agents|respiratory system agents|mesh-ancestor
6238599|NCT03220776|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6238600|NCT03220776|Antioxidants|antioxidants|mesh-ancestor
6238601|NCT03220776|Protective Agents|protective agents|mesh-ancestor
6238602|NCT03220776|Antidotes|antidotes|mesh-ancestor
6238603|NCT03182244|Cytarabine|cytarabine|mesh-list
6238604|NCT03182244|Fludarabine|fludarabine|mesh-list
6238605|NCT03182244|Etoposide|etoposide|mesh-list
6238606|NCT03182244|Mitoxantrone|mitoxantrone|mesh-list
6238607|NCT03182244|Sargramostim|sargramostim|mesh-list
6238608|NCT03182244|Lenograstim|lenograstim|mesh-list
6238609|NCT03182244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238610|NCT03182244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6677562|NCT01588717|Glycopyrrolate|glycopyrrolate|mesh-list
6677563|NCT01588717|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6677564|NCT01588717|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6677565|NCT01588717|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6677566|NCT01588717|Cholinergic Agents|cholinergic agents|mesh-ancestor
6677567|NCT01588717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6677568|NCT01588717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6238611|NCT03182244|Antimetabolites|antimetabolites|mesh-ancestor
6502705|NCT00650273|Azithromycin|azithromycin|mesh-list
6502706|NCT00650273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6502707|NCT00650273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6502708|NCT00650286|Modafinil|modafinil|mesh-list
6502709|NCT00650286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6502710|NCT00650286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502711|NCT00650286|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6502712|NCT00650286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6502713|NCT00650286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6502714|NCT00650286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502715|NCT00650299|Alprazolam|alprazolam|mesh-list
6502716|NCT00650299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6502717|NCT00650299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6238612|NCT03182244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6238613|NCT03182244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6238614|NCT03182244|Immunologic Factors|immunologic factors|mesh-ancestor
6238615|NCT03182244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6238616|NCT03182244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6238617|NCT03182244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6238618|NCT03182244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6238619|NCT03182244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6238620|NCT03182244|Antiviral Agents|antiviral agents|mesh-ancestor
6238621|NCT03182244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6238622|NCT03182244|Analgesics|analgesics|mesh-ancestor
6238623|NCT03182244|Sensory System Agents|sensory system agents|mesh-ancestor
6502718|NCT00650299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502719|NCT00650299|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6502720|NCT00650299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6502721|NCT00650299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6502722|NCT00650299|GABA Modulators|gaba modulators|mesh-ancestor
6502723|NCT00650299|GABA Agents|gaba agents|mesh-ancestor
6677569|NCT01588717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677570|NCT01588743|Insulin Aspart|insulin aspart|mesh-list
6677571|NCT01588743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6677572|NCT01588743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677573|NCT01588756|Mechlorethamine|mechlorethamine|mesh-list
6677574|NCT01588756|Goralatide|goralatide|mesh-list
6677575|NCT01588756|Alkylating Agents|alkylating agents|mesh-ancestor
6677576|NCT01588756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677577|NCT01588756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6677578|NCT01588756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6677579|NCT01588756|Growth Inhibitors|growth inhibitors|mesh-ancestor
5712588|NCT03266965|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5712589|NCT03266965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5712590|NCT03266926|Bupivacaine|bupivacaine|mesh-list
5712591|NCT03266926|Estrogens|estrogens|mesh-list
5712592|NCT03266926|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
5712593|NCT03266926|Anesthetics, Local|anesthetics, local|mesh-ancestor
5712594|NCT03266926|Anesthetics|anesthetics|mesh-ancestor
5712595|NCT03266926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5712596|NCT03266926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712597|NCT03266926|Sensory System Agents|sensory system agents|mesh-ancestor
6677580|NCT01588756|Growth Substances|growth substances|mesh-ancestor
6238624|NCT03182244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6238625|NCT03182244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6238626|NCT03176498|Aspirin|aspirin|mesh-list
6238627|NCT03176498|Atorvastatin|atorvastatin|mesh-list
6238628|NCT03176498|Calcium|calcium|mesh-list
6238629|NCT03176498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6238630|NCT03176498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6238631|NCT03176498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6238632|NCT03176498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6238633|NCT03176498|Analgesics|analgesics|mesh-ancestor
6238634|NCT03176498|Sensory System Agents|sensory system agents|mesh-ancestor
6238635|NCT03176498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6238636|NCT03176498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6238637|NCT03176498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6238638|NCT03176498|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6238639|NCT03176498|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6238640|NCT03176498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6238641|NCT03176498|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6238642|NCT03176498|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6238643|NCT03176498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6238644|NCT03176498|Antipyretics|antipyretics|mesh-ancestor
6238645|NCT03176498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6238646|NCT03176498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6238647|NCT03176498|Antimetabolites|antimetabolites|mesh-ancestor
6238648|NCT03176498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6238649|NCT03176498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5712598|NCT03266926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5712599|NCT03266926|Hormones|hormones|mesh-ancestor
5712600|NCT03266926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5712601|NCT03266991|Isoniazid|isoniazid|mesh-list
5712602|NCT03266991|Rifapentine|rifapentine|mesh-list
5712603|NCT03266991|Antitubercular Agents|antitubercular agents|mesh-ancestor
5712604|NCT03266991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5712605|NCT03266991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5712606|NCT03266991|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5712607|NCT03266991|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5712608|NCT03266991|Antimetabolites|antimetabolites|mesh-ancestor
5712609|NCT03266991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712610|NCT03266991|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5712611|NCT03266991|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6238650|NCT03169166|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6238651|NCT03169166|Luteolytic Agents|luteolytic agents|mesh-ancestor
6238652|NCT03169166|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6238653|NCT03169166|Contraceptive Agents|contraceptive agents|mesh-ancestor
6238654|NCT03169166|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6238655|NCT03169166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6238656|NCT03169166|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6238657|NCT03169166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6238658|NCT03169166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238659|NCT03128359|Mycophenolic Acid|mycophenolic acid|mesh-list
6238660|NCT03128359|Cyclophosphamide|cyclophosphamide|mesh-list
6238661|NCT03128359|Melphalan|melphalan|mesh-list
6238662|NCT03128359|Busulfan|busulfan|mesh-list
6238663|NCT03128359|Fludarabine|fludarabine|mesh-list
6502724|NCT00650299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5712612|NCT03266991|Leprostatic Agents|leprostatic agents|mesh-ancestor
5712613|NCT03266731|Aspirin|aspirin|mesh-list
5712614|NCT03266731|Clopidogrel|clopidogrel|mesh-list
5712615|NCT03266731|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5712616|NCT03266731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5712617|NCT03266731|Analgesics|analgesics|mesh-ancestor
5712618|NCT03266731|Sensory System Agents|sensory system agents|mesh-ancestor
5712619|NCT03266731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5712620|NCT03266731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6238664|NCT03128359|Fludarabine phosphate|fludarabine phosphate|mesh-list
6238665|NCT03128359|Tacrolimus|tacrolimus|mesh-list
6238666|NCT03128359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6238667|NCT03128359|Immunologic Factors|immunologic factors|mesh-ancestor
6238668|NCT03128359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6238669|NCT03128359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6238670|NCT03128359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6238671|NCT03128359|Alkylating Agents|alkylating agents|mesh-ancestor
6238672|NCT03128359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6238673|NCT03128359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238674|NCT03128359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5712621|NCT03266731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5712622|NCT03266731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5712623|NCT03266731|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5712624|NCT03266731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5712625|NCT03266731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712626|NCT03266731|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5712627|NCT03266731|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5712628|NCT03266731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5712629|NCT03266731|Antipyretics|antipyretics|mesh-ancestor
5712630|NCT03266731|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5712631|NCT03266731|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5712632|NCT03266731|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5712633|NCT03266731|Purinergic Agents|purinergic agents|mesh-ancestor
5712634|NCT03266731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5712635|NCT03266562|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5712636|NCT03266562|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6238675|NCT03128359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6238676|NCT03128359|Antimetabolites|antimetabolites|mesh-ancestor
6238677|NCT03128359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6238678|NCT03128359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6238679|NCT03128359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6238680|NCT03128359|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6238681|NCT03128359|Antitubercular Agents|antitubercular agents|mesh-ancestor
6238682|NCT03128359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6238683|NCT03128359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6238684|NCT03113487|Pembrolizumab|pembrolizumab|mesh-list
6238685|NCT03113487|Vaccines|vaccines|mesh-list
6238686|NCT03113487|Immunologic Factors|immunologic factors|mesh-ancestor
6238687|NCT03113487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6238688|NCT03113487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6238689|NCT03113487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238690|NCT03094884|Paclitaxel|paclitaxel|mesh-list
6238691|NCT03094884|Carboplatin|carboplatin|mesh-list
6238692|NCT03094884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6238693|NCT03094884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238694|NCT03094884|Tubulin Modulators|tubulin modulators|mesh-ancestor
6238695|NCT03094884|Antimitotic Agents|antimitotic agents|mesh-ancestor
6238696|NCT03094884|Mitosis Modulators|mitosis modulators|mesh-ancestor
6238697|NCT03094884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6238698|NCT03091192|Sunitinib|sunitinib|mesh-list
6238699|NCT03091192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238700|NCT03091192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6238701|NCT03091192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6238702|NCT03091192|Growth Substances|growth substances|mesh-ancestor
6238703|NCT03091192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6238704|NCT03091192|Growth Inhibitors|growth inhibitors|mesh-ancestor
6238705|NCT03091192|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6238706|NCT03091192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6238707|NCT03091192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712637|NCT03266562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712638|NCT03266549|Botulinum Toxins|botulinum toxins|mesh-list
5712639|NCT03266549|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5712640|NCT03266549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5712641|NCT03266549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712642|NCT03266549|Cholinergic Agents|cholinergic agents|mesh-ancestor
5712643|NCT03266549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5712644|NCT03266549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712645|NCT03266601|Interferons|interferons|mesh-list
5712646|NCT03266601|Ribavirin|ribavirin|mesh-list
5712647|NCT03266601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5712648|NCT03266601|Antiviral Agents|antiviral agents|mesh-ancestor
5712649|NCT03266601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5712650|NCT03266601|Antimetabolites|antimetabolites|mesh-ancestor
5712651|NCT03266601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712652|NCT03266393|Tacrolimus|tacrolimus|mesh-list
5712653|NCT03266393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5712654|NCT03266393|Immunologic Factors|immunologic factors|mesh-ancestor
5712655|NCT03266393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712656|NCT03266393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5712657|NCT03266393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5712658|NCT03266393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712659|NCT03266159|Trametinib|trametinib|mesh-list
5712660|NCT03266159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5712661|NCT03266159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5712662|NCT03266159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5712663|NCT03266159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712664|NCT03266250|Anesthetics|anesthetics|mesh-list
5712665|NCT03266250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5712666|NCT03266250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712667|NCT03266146|Methylprednisolone|methylprednisolone|mesh-list
5712668|NCT03266146|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5712669|NCT03266146|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5712670|NCT03266146|Prednisolone|prednisolone|mesh-list
5712671|NCT03266146|Prednisolone acetate|prednisolone acetate|mesh-list
5712672|NCT03266146|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6238708|NCT03083665|Brivaracetam|brivaracetam|mesh-list
6238709|NCT03083665|Anticonvulsants|anticonvulsants|mesh-ancestor
6238710|NCT03063606|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
6238711|NCT03063606|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6238712|NCT03047005|Naltrexone|naltrexone|mesh-list
6238713|NCT03047005|Bupropion|bupropion|mesh-list
6238714|NCT03047005|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6238715|NCT03047005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6238716|NCT03047005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6238717|NCT03047005|Sensory System Agents|sensory system agents|mesh-ancestor
6238718|NCT03047005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6238719|NCT03047005|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6238720|NCT03047005|Antidepressive Agents|antidepressive agents|mesh-ancestor
6502725|NCT00650299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502726|NCT00650312|Metformin|metformin|mesh-list
6238721|NCT03047005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6238722|NCT03047005|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6238723|NCT03047005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6238724|NCT03047005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6238725|NCT03047005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6238726|NCT03047005|Dopamine Agents|dopamine agents|mesh-ancestor
6238727|NCT03047005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6238728|NCT03047005|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6238729|NCT03047005|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6238730|NCT03047005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6238731|NCT03038594|Hormones|hormones|mesh-list
6238732|NCT03038594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6238733|NCT03038594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6238734|NCT03012529|Riboflavin|riboflavin|mesh-list
6238735|NCT03012529|Rifampin|rifampin|mesh-list
6238736|NCT03012529|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6238737|NCT03012529|Antitubercular Agents|antitubercular agents|mesh-ancestor
6238738|NCT03012529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6238739|NCT03012529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6238740|NCT03012529|Leprostatic Agents|leprostatic agents|mesh-ancestor
6238741|NCT03012529|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6238742|NCT03012529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6238743|NCT03012529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6238744|NCT03012529|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6238745|NCT03012529|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6238746|NCT03012529|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6238747|NCT03012529|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6238748|NCT03012529|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6238749|NCT03012529|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6238750|NCT03012529|Vitamin B Complex|vitamin b complex|mesh-ancestor
6238751|NCT03012529|Vitamins|vitamins|mesh-ancestor
6238752|NCT03012529|Micronutrients|micronutrients|mesh-ancestor
6238753|NCT03012529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6238754|NCT03012529|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6238755|NCT03012529|Dermatologic Agents|dermatologic agents|mesh-ancestor
6238756|NCT03009240|Decitabine|decitabine|mesh-list
6238757|NCT03009240|Enzyme Inhibitors|enzyme inhibitors|mesh-list
6238758|NCT03009240|Pevonedistat|pevonedistat|mesh-list
6238759|NCT03009240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6238760|NCT03009240|Antimetabolites|antimetabolites|mesh-ancestor
6238761|NCT03009240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712673|NCT03266146|Prednisolone phosphate|prednisolone phosphate|mesh-list
5712674|NCT03266146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5712675|NCT03266146|Antiemetics|antiemetics|mesh-ancestor
5712676|NCT03266146|Autonomic Agents|autonomic agents|mesh-ancestor
6238762|NCT03009240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238763|NCT03002103|Gemcitabine|gemcitabine|mesh-list
6238764|NCT03002103|Paclitaxel|paclitaxel|mesh-list
6238765|NCT03002103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6238766|NCT03002103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238767|NCT03002103|Tubulin Modulators|tubulin modulators|mesh-ancestor
6238768|NCT03002103|Antimitotic Agents|antimitotic agents|mesh-ancestor
6238769|NCT03002103|Mitosis Modulators|mitosis modulators|mesh-ancestor
6238770|NCT03002103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6238771|NCT03002103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6238772|NCT03002103|Antimetabolites|antimetabolites|mesh-ancestor
6238773|NCT03002103|Antiviral Agents|antiviral agents|mesh-ancestor
6238774|NCT03002103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6238775|NCT03002103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6677581|NCT01588756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677582|NCT01588756|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6677583|NCT01588756|Protective Agents|protective agents|mesh-ancestor
5712677|NCT03266146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6238776|NCT03002103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6238777|NCT03002103|Immunologic Factors|immunologic factors|mesh-ancestor
6238778|NCT03002103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6238779|NCT02996825|Gemcitabine|gemcitabine|mesh-list
6238780|NCT02996825|Maytansine|maytansine|mesh-list
6238781|NCT02996825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6238782|NCT02996825|Antimetabolites|antimetabolites|mesh-ancestor
6238783|NCT02996825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6238784|NCT02996825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238785|NCT02996825|Antiviral Agents|antiviral agents|mesh-ancestor
6502727|NCT00650312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6238786|NCT02996825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6238787|NCT02996825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6238788|NCT02996825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6238789|NCT02996825|Immunologic Factors|immunologic factors|mesh-ancestor
6238790|NCT02996825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502728|NCT00650312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502729|NCT00650325|Sertraline|sertraline|mesh-list
6502730|NCT00650325|Antidepressive Agents|antidepressive agents|mesh-ancestor
6502731|NCT00650325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6502732|NCT00650325|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6502733|NCT00650325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6502734|NCT00650325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6502735|NCT00650325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502736|NCT00650325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6502737|NCT00650325|Serotonin Agents|serotonin agents|mesh-ancestor
6238791|NCT02996825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6238792|NCT02996825|Tubulin Modulators|tubulin modulators|mesh-ancestor
6238793|NCT02996825|Antimitotic Agents|antimitotic agents|mesh-ancestor
6238794|NCT02996825|Mitosis Modulators|mitosis modulators|mesh-ancestor
6238795|NCT02944617|Micronutrients|micronutrients|mesh-list
6502738|NCT00650325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502739|NCT00650338|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6502740|NCT00650338|Latanoprost|latanoprost|mesh-list
6502741|NCT00650338|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6502742|NCT00650351|Ciprofloxacin|ciprofloxacin|mesh-list
6502743|NCT00650351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6502744|NCT00650351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6502745|NCT00650351|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6502746|NCT00650351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6502747|NCT00650351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6502748|NCT00650351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502749|NCT00650351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6677584|NCT01588782|Ketoconazole|ketoconazole|mesh-list
6677585|NCT01588782|Antifungal Agents|antifungal agents|mesh-ancestor
6677586|NCT01588782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6677587|NCT01588782|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6677588|NCT01588782|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6677589|NCT01588782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6677590|NCT01588782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677591|NCT01588782|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6677592|NCT01588782|Hormone Antagonists|hormone antagonists|mesh-ancestor
6677593|NCT01588782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6677594|NCT01588782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677595|NCT01588782|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6677596|NCT01588795|Vitamin D|vitamin d|mesh-list
6677597|NCT01588795|Cholecalciferol|cholecalciferol|mesh-list
6677598|NCT01588795|Diuretics|diuretics|mesh-list
6677599|NCT01588795|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
6677600|NCT01588795|Vitamins|vitamins|mesh-ancestor
6677601|NCT01588795|Micronutrients|micronutrients|mesh-ancestor
6677602|NCT01588795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712678|NCT03266146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712679|NCT03266146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5712680|NCT03266146|Glucocorticoids|glucocorticoids|mesh-ancestor
5712681|NCT03266146|Hormones|hormones|mesh-ancestor
5712682|NCT03266146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5712683|NCT03266146|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5712684|NCT03266146|Protective Agents|protective agents|mesh-ancestor
5712685|NCT03266146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5712686|NCT03266146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5712687|NCT03266445|Buprenorphine|buprenorphine|mesh-list
5712688|NCT03266445|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
5712689|NCT03266445|Naloxone|naloxone|mesh-list
5712690|NCT03266445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5712691|NCT03266445|Narcotics|narcotics|mesh-ancestor
5712692|NCT03266445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5712693|NCT03266445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712694|NCT03266445|Analgesics|analgesics|mesh-ancestor
5712695|NCT03266445|Sensory System Agents|sensory system agents|mesh-ancestor
5712696|NCT03266445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5712697|NCT03266445|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5712698|NCT03266081|Bupivacaine|bupivacaine|mesh-list
5712699|NCT03266081|Anesthetics, Local|anesthetics, local|mesh-ancestor
5712700|NCT03266081|Anesthetics|anesthetics|mesh-ancestor
6502750|NCT00650351|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6502751|NCT00650351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6502752|NCT00650364|Midodrine|midodrine|mesh-list
6502753|NCT00650364|Sympathomimetics|sympathomimetics|mesh-ancestor
5712701|NCT03266081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5712702|NCT03266081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712703|NCT03266081|Sensory System Agents|sensory system agents|mesh-ancestor
5712704|NCT03266081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5712705|NCT03265886|Bupivacaine|bupivacaine|mesh-list
5712706|NCT03265886|Anesthetics, Local|anesthetics, local|mesh-ancestor
6502754|NCT00650364|Autonomic Agents|autonomic agents|mesh-ancestor
6502755|NCT00650364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6502756|NCT00650364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502757|NCT00650364|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6502758|NCT00650364|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5712707|NCT03265886|Anesthetics|anesthetics|mesh-ancestor
5712708|NCT03265886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5712709|NCT03265886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712710|NCT03265886|Sensory System Agents|sensory system agents|mesh-ancestor
5712711|NCT03265886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5712712|NCT03265834|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5712713|NCT03265834|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5712714|NCT03265834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5712715|NCT03265834|Antitubercular Agents|antitubercular agents|mesh-ancestor
6238796|NCT02944617|Trace Elements|trace elements|mesh-list
6502759|NCT00650364|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6502760|NCT00650364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6502761|NCT00650364|Adrenergic Agents|adrenergic agents|mesh-ancestor
6502762|NCT00650364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6502763|NCT00650364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502764|NCT00650377|Finasteride|finasteride|mesh-list
6502765|NCT00650377|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6502766|NCT00650377|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6502767|NCT00650377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6502768|NCT00650377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502769|NCT00650377|Hormone Antagonists|hormone antagonists|mesh-ancestor
6238797|NCT02944617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6238798|NCT02923739|Paclitaxel|paclitaxel|mesh-list
6238799|NCT02923739|Bevacizumab|bevacizumab|mesh-list
6238800|NCT02923739|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6502770|NCT00650377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6502771|NCT00650377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502772|NCT00650377|Urological Agents|urological agents|mesh-ancestor
6238801|NCT02923739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6238802|NCT02923739|Endothelial Growth Factors|endothelial growth factors|mesh-list
6238803|NCT02923739|Antibodies|antibodies|mesh-list
6238804|NCT02923739|Immunoglobulins|immunoglobulins|mesh-list
6238805|NCT02923739|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6238806|NCT02923739|Immunoglobulin G|immunoglobulin g|mesh-list
6238807|NCT02923739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6238808|NCT02923739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238809|NCT02923739|Tubulin Modulators|tubulin modulators|mesh-ancestor
6238810|NCT02923739|Antimitotic Agents|antimitotic agents|mesh-ancestor
6238811|NCT02923739|Mitosis Modulators|mitosis modulators|mesh-ancestor
6238812|NCT02923739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6238813|NCT02923739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6238814|NCT02923739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6238815|NCT02923739|Growth Substances|growth substances|mesh-ancestor
6238816|NCT02923739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6238817|NCT02923739|Growth Inhibitors|growth inhibitors|mesh-ancestor
6238818|NCT02923739|Immunologic Factors|immunologic factors|mesh-ancestor
6238819|NCT02882282|Pembrolizumab|pembrolizumab|mesh-list
6238820|NCT02882282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6238821|NCT02882282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238822|NCT02865135|Vaccines|vaccines|mesh-list
6238823|NCT02865135|Immunologic Factors|immunologic factors|mesh-ancestor
6238824|NCT02865135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6238825|NCT02859558|Tenofovir|tenofovir|mesh-list
6238826|NCT02859558|Emtricitabine|emtricitabine|mesh-list
6238827|NCT02859558|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6238828|NCT02859558|Cobicistat|cobicistat|mesh-list
6238829|NCT02859558|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
6238830|NCT02859558|Elvitegravir|elvitegravir|mesh-list
6502773|NCT00650390|Adalimumab|adalimumab|mesh-list
6238831|NCT02859558|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6238832|NCT02859558|Antiviral Agents|antiviral agents|mesh-ancestor
6502774|NCT00650390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6502775|NCT00650390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6238833|NCT02859558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6677603|NCT01588795|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6238834|NCT02859558|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6238835|NCT02859558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6238836|NCT02859558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6238837|NCT02859558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6238838|NCT02859558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6238839|NCT02859558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6238840|NCT02859558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6238841|NCT02859558|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6238842|NCT02834013|Nivolumab|nivolumab|mesh-list
6238843|NCT02834013|Ipilimumab|ipilimumab|mesh-list
6238844|NCT02834013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6238845|NCT02834013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5712716|NCT03265782|Acetaminophen|acetaminophen|mesh-list
5712717|NCT03265782|Ibuprofen|ibuprofen|mesh-list
5712718|NCT03265782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5712719|NCT03265782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5712720|NCT03265782|Analgesics|analgesics|mesh-ancestor
5712721|NCT03265782|Sensory System Agents|sensory system agents|mesh-ancestor
5712722|NCT03265782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5712723|NCT03265782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712724|NCT03265782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5712725|NCT03265782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5712726|NCT03265782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5712727|NCT03265782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5712728|NCT03265782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712729|NCT03265782|Antipyretics|antipyretics|mesh-ancestor
5712730|NCT03265470|Fentanyl|fentanyl|mesh-list
5712731|NCT03265470|Dexmedetomidine|dexmedetomidine|mesh-list
5712732|NCT03265470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5712733|NCT03265470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5712734|NCT03265470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712735|NCT03265470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5712736|NCT03265470|Analgesics|analgesics|mesh-ancestor
5712737|NCT03265470|Sensory System Agents|sensory system agents|mesh-ancestor
5712738|NCT03265470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6502776|NCT00650403|Paroxetine|paroxetine|mesh-list
6502777|NCT00650403|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6502778|NCT00650403|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6502779|NCT00650403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6502780|NCT00650403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502781|NCT00650403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6502782|NCT00650403|Serotonin Agents|serotonin agents|mesh-ancestor
6502783|NCT00650403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502784|NCT00650403|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6502785|NCT00650403|Antidepressive Agents|antidepressive agents|mesh-ancestor
6502786|NCT00650403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6502787|NCT00650403|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6502788|NCT00650403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6502789|NCT00650403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6502790|NCT00650416|Carvedilol|carvedilol|mesh-list
6502791|NCT00650416|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6502792|NCT00650416|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6502793|NCT00650416|Adrenergic Agents|adrenergic agents|mesh-ancestor
6502794|NCT00650416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6502795|NCT00650416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502796|NCT00650416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6238846|NCT02834013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6238847|NCT02834013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6238848|NCT02818920|Pembrolizumab|pembrolizumab|mesh-list
6238849|NCT02818920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6502797|NCT00650416|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6502798|NCT00650416|Antioxidants|antioxidants|mesh-ancestor
6502799|NCT00650416|Protective Agents|protective agents|mesh-ancestor
6502800|NCT00650416|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6677604|NCT01588795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6677605|NCT01588795|Natriuretic Agents|natriuretic agents|mesh-ancestor
6677606|NCT01588795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779692|NCT02180503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779693|NCT02180516|Meloxicam|meloxicam|mesh-list
6779694|NCT02180516|Etodolac|etodolac|mesh-list
6779695|NCT02180516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
6779696|NCT02180516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
6779697|NCT02180516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6779698|NCT02180516|Analgesics|analgesics|mesh-ancestor
6779699|NCT02180516|Sensory System Agents|sensory system agents|mesh-ancestor
6779700|NCT02180516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6779701|NCT02180516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779702|NCT02180516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6779703|NCT02180516|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6238850|NCT02818920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238851|NCT02778685|Pembrolizumab|pembrolizumab|mesh-list
6238852|NCT02778685|Letrozole|letrozole|mesh-list
6238853|NCT02778685|Palbociclib|palbociclib|mesh-list
6238854|NCT02778685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6779704|NCT02180516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6779705|NCT02180516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5712739|NCT03265470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5712740|NCT03265470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5712741|NCT03265470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5712742|NCT03265470|Adrenergic Agents|adrenergic agents|mesh-ancestor
5712743|NCT03265470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5712744|NCT03265470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712745|NCT03265470|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5712746|NCT03265470|Narcotics|narcotics|mesh-ancestor
5712747|NCT03265470|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5712748|NCT03265470|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5712749|NCT03265470|Anesthetics, General|anesthetics, general|mesh-ancestor
5712750|NCT03265470|Anesthetics|anesthetics|mesh-ancestor
5712751|NCT03265899|Lactitol|lactitol|mesh-list
5919150|NCT04984759|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5919151|NCT04984759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6238855|NCT02778685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238856|NCT02778685|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6238857|NCT02778685|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6238858|NCT02778685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6238859|NCT02778685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919152|NCT04984759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5919153|NCT04984980|Gemcitabine|gemcitabine|mesh-list
5919154|NCT04984980|Bevacizumab|bevacizumab|mesh-list
5919155|NCT04984980|Oxaliplatin|oxaliplatin|mesh-list
5919156|NCT04984980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5919157|NCT04984980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5919158|NCT04984980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5919159|NCT04984980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5919160|NCT04984980|Growth Substances|growth substances|mesh-ancestor
5919161|NCT04984980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919162|NCT04984980|Growth Inhibitors|growth inhibitors|mesh-ancestor
5919163|NCT04984980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5919164|NCT04984980|Antimetabolites|antimetabolites|mesh-ancestor
6238860|NCT02778685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6238861|NCT02778685|Hormone Antagonists|hormone antagonists|mesh-ancestor
6238862|NCT02778685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6238863|NCT02778685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712752|NCT03265899|Oxytocin|oxytocin|mesh-list
5712753|NCT03265899|Oxytocics|oxytocics|mesh-ancestor
5712754|NCT03265899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5712755|NCT03265899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712756|NCT03265899|Cathartics|cathartics|mesh-ancestor
5712757|NCT03265899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5712758|NCT03265574|Enalapril|enalapril|mesh-list
5712759|NCT03265574|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5712760|NCT03265574|Protease Inhibitors|protease inhibitors|mesh-ancestor
5712761|NCT03265574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5712762|NCT03265574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712763|NCT03265574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5712764|NCT03265795|Ether|ether|mesh-list
5712765|NCT03265795|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5712766|NCT03265795|Anesthetics, General|anesthetics, general|mesh-ancestor
5712767|NCT03265795|Anesthetics|anesthetics|mesh-ancestor
5712768|NCT03265795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5712769|NCT03265795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712770|NCT03265405|Prednisolone|prednisolone|mesh-list
5712771|NCT03265405|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5712772|NCT03265405|Methylprednisolone|methylprednisolone|mesh-list
5712773|NCT03265405|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5712774|NCT03265405|Prednisolone acetate|prednisolone acetate|mesh-list
5712775|NCT03265405|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5712776|NCT03265405|Prednisolone phosphate|prednisolone phosphate|mesh-list
5712777|NCT03265405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5712778|NCT03265405|Glucocorticoids|glucocorticoids|mesh-ancestor
5712779|NCT03265405|Hormones|hormones|mesh-ancestor
6238864|NCT02778685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6238865|NCT02713386|Paclitaxel|paclitaxel|mesh-list
6238866|NCT02713386|Carboplatin|carboplatin|mesh-list
6238867|NCT02713386|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6238868|NCT02713386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6238869|NCT02713386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238870|NCT02713386|Tubulin Modulators|tubulin modulators|mesh-ancestor
6238871|NCT02713386|Antimitotic Agents|antimitotic agents|mesh-ancestor
6238872|NCT02713386|Mitosis Modulators|mitosis modulators|mesh-ancestor
6238873|NCT02713386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6238874|NCT02640664|Ranibizumab|ranibizumab|mesh-list
6238875|NCT02640664|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6238876|NCT02640664|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6238877|NCT02640664|Growth Substances|growth substances|mesh-ancestor
6238878|NCT02640664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6238879|NCT02640664|Growth Inhibitors|growth inhibitors|mesh-ancestor
6238880|NCT02640664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238881|NCT02632045|Fulvestrant|fulvestrant|mesh-list
6238882|NCT02632045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6238883|NCT02632045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238884|NCT02632045|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6238885|NCT02632045|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6238886|NCT02632045|Hormone Antagonists|hormone antagonists|mesh-ancestor
6238887|NCT02632045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6238888|NCT02632045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6238889|NCT02572791|Chlorhexidine|chlorhexidine|mesh-list
6238890|NCT02572791|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6238891|NCT02572791|Mupirocin|mupirocin|mesh-list
6238892|NCT02572791|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6502801|NCT00650416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6502802|NCT00650416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6502803|NCT00650416|Vasodilator Agents|vasodilator agents|mesh-ancestor
6502804|NCT00650416|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6502805|NCT00650416|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6502806|NCT00650429|Ziprasidone|ziprasidone|mesh-list
6502807|NCT00650429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6502808|NCT00650429|Serotonin Agents|serotonin agents|mesh-ancestor
6502809|NCT00650429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6502810|NCT00650429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502811|NCT00650429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502812|NCT00650429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6502813|NCT00650429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5712780|NCT03265405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6238893|NCT02572791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6238894|NCT02572791|Disinfectants|disinfectants|mesh-ancestor
5712781|NCT03265405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502814|NCT00650429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6502815|NCT00650429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6502816|NCT00650429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6502817|NCT00650429|Dopamine Agents|dopamine agents|mesh-ancestor
6502818|NCT00650442|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5712782|NCT03265405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6238895|NCT02572791|Dermatologic Agents|dermatologic agents|mesh-ancestor
6238896|NCT02572791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6238897|NCT02572791|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6238898|NCT02572791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6238899|NCT02572791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6238900|NCT02486718|Gemcitabine|gemcitabine|mesh-list
6238901|NCT02486718|Docetaxel|docetaxel|mesh-list
6238902|NCT02486718|Pemetrexed|pemetrexed|mesh-list
6238903|NCT02486718|Atezolizumab|atezolizumab|mesh-list
6238904|NCT02486718|Vinorelbine|vinorelbine|mesh-list
6238905|NCT02486718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238906|NCT02486718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6238907|NCT02486718|Antimetabolites|antimetabolites|mesh-ancestor
6238908|NCT02486718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6238909|NCT02486718|Antiviral Agents|antiviral agents|mesh-ancestor
6238910|NCT02486718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6238911|NCT02486718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6238912|NCT02486718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6238913|NCT02486718|Immunologic Factors|immunologic factors|mesh-ancestor
6238914|NCT02486718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6238915|NCT02486718|Tubulin Modulators|tubulin modulators|mesh-ancestor
5712783|NCT03265405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5712784|NCT03265405|Antiemetics|antiemetics|mesh-ancestor
5712785|NCT03265405|Autonomic Agents|autonomic agents|mesh-ancestor
5712786|NCT03265405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5712787|NCT03265405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5712788|NCT03265405|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5712789|NCT03265405|Protective Agents|protective agents|mesh-ancestor
5712790|NCT03265002|Psyllium|psyllium|mesh-list
6238916|NCT02486718|Antimitotic Agents|antimitotic agents|mesh-ancestor
6238917|NCT02486718|Mitosis Modulators|mitosis modulators|mesh-ancestor
6238918|NCT02486718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6238919|NCT02486718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6238920|NCT02486718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6238921|NCT02481310|Cytarabine|cytarabine|mesh-list
6238922|NCT02481310|Prednisone|prednisone|mesh-list
6238923|NCT02481310|Hydrocortisone|hydrocortisone|mesh-list
6238924|NCT02481310|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6238925|NCT02481310|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6238926|NCT02481310|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6238927|NCT02481310|Cortisone|cortisone|mesh-list
6238928|NCT02481310|Cyclophosphamide|cyclophosphamide|mesh-list
6238929|NCT02481310|Rituximab|rituximab|mesh-list
6238930|NCT02481310|Doxorubicin|doxorubicin|mesh-list
6238931|NCT02481310|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6238932|NCT02481310|Methotrexate|methotrexate|mesh-list
6502819|NCT00650442|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6502820|NCT00650442|Estradiol|estradiol|mesh-list
6502821|NCT00650442|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6502822|NCT00650442|Estrogens|estrogens|mesh-ancestor
6502823|NCT00650442|Hormones|hormones|mesh-ancestor
6502824|NCT00650442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6502825|NCT00650442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502826|NCT00650442|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6502827|NCT00650442|Contraceptive Agents|contraceptive agents|mesh-ancestor
6502828|NCT00650442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6502829|NCT00650442|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6502830|NCT00650455|Naproxen|naproxen|mesh-list
6502831|NCT00650455|Valdecoxib|valdecoxib|mesh-list
6502832|NCT00650455|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6502833|NCT00650455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6502834|NCT00650455|Analgesics|analgesics|mesh-ancestor
6502835|NCT00650455|Sensory System Agents|sensory system agents|mesh-ancestor
6502836|NCT00650455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6502837|NCT00650455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502838|NCT00650455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6238933|NCT02481310|Etoposide|etoposide|mesh-list
6238934|NCT02481310|Vincristine|vincristine|mesh-list
6238935|NCT02481310|Etoposide phosphate|etoposide phosphate|mesh-list
6238936|NCT02481310|Ixazomib|ixazomib|mesh-list
6238937|NCT02481310|Podophyllotoxin|podophyllotoxin|mesh-list
6238938|NCT02481310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6238939|NCT02481310|Antibodies|antibodies|mesh-list
6238940|NCT02481310|Immunoglobulins|immunoglobulins|mesh-list
6238941|NCT02481310|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6238942|NCT02481310|Glycine|glycine|mesh-list
6238943|NCT02481310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6238944|NCT02481310|Immunologic Factors|immunologic factors|mesh-ancestor
6238945|NCT02481310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502839|NCT00650455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6502840|NCT00650455|Gout Suppressants|gout suppressants|mesh-ancestor
6238946|NCT02481310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6238947|NCT02481310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6238948|NCT02481310|Alkylating Agents|alkylating agents|mesh-ancestor
6238949|NCT02481310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6238950|NCT02481310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238951|NCT02481310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6238952|NCT02481310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6238953|NCT02481310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6502841|NCT00650455|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6502842|NCT00650455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6502843|NCT00650455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502844|NCT00650455|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6502845|NCT00650468|Mycophenolic Acid|mycophenolic acid|mesh-list
6502846|NCT00650468|Prednisone|prednisone|mesh-list
6238954|NCT02481310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6502847|NCT00650468|Tacrolimus|tacrolimus|mesh-list
6502848|NCT00650468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6502849|NCT00650468|Glucocorticoids|glucocorticoids|mesh-ancestor
6502850|NCT00650468|Hormones|hormones|mesh-ancestor
5712791|NCT03265002|Calcium polycarbophil|calcium polycarbophil|mesh-list
5712792|NCT03265002|Cathartics|cathartics|mesh-ancestor
5712793|NCT03265002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5712794|NCT03265002|Antidiarrheals|antidiarrheals|mesh-ancestor
5712795|NCT03265288|Fenretinide|fenretinide|mesh-list
5712796|NCT03265288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5712797|NCT03265288|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5712798|NCT03265288|Protective Agents|protective agents|mesh-ancestor
5712799|NCT03265288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712800|NCT03265171|Plasminogen|plasminogen|mesh-list
5712801|NCT03265171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6502851|NCT00650468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6502852|NCT00650468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502853|NCT00650468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6677607|NCT01588847|Sufentanil|sufentanil|mesh-list
6238955|NCT02481310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6238956|NCT02481310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6238957|NCT02481310|Glucocorticoids|glucocorticoids|mesh-ancestor
6238958|NCT02481310|Hormones|hormones|mesh-ancestor
6238959|NCT02481310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6238960|NCT02481310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5712802|NCT03265171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6238961|NCT02481310|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6238962|NCT02481310|Abortifacient Agents|abortifacient agents|mesh-ancestor
6238963|NCT02481310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6238964|NCT02481310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6238965|NCT02481310|Antimetabolites|antimetabolites|mesh-ancestor
6238966|NCT02481310|Dermatologic Agents|dermatologic agents|mesh-ancestor
6238967|NCT02481310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6238968|NCT02481310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6238969|NCT02481310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6238970|NCT02481310|Antiviral Agents|antiviral agents|mesh-ancestor
6238971|NCT02481310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6238972|NCT02481310|Tubulin Modulators|tubulin modulators|mesh-ancestor
6238973|NCT02481310|Antimitotic Agents|antimitotic agents|mesh-ancestor
6238974|NCT02481310|Mitosis Modulators|mitosis modulators|mesh-ancestor
6238975|NCT02481310|Protease Inhibitors|protease inhibitors|mesh-ancestor
6238976|NCT02481310|Keratolytic Agents|keratolytic agents|mesh-ancestor
6238977|NCT02481310|Glycine Agents|glycine agents|mesh-ancestor
6238978|NCT02481310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6238979|NCT02443324|Pembrolizumab|pembrolizumab|mesh-list
6238980|NCT02443324|Ramucirumab|ramucirumab|mesh-list
6238981|NCT02443324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6502854|NCT00650468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6502855|NCT00650468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6502856|NCT00650468|Immunologic Factors|immunologic factors|mesh-ancestor
6502857|NCT00650468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6502858|NCT00650468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6502859|NCT00650468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502860|NCT00650468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6238982|NCT02443324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238983|NCT02386800|Panobinostat|panobinostat|mesh-list
6238984|NCT02386800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238985|NCT02386800|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6238986|NCT02386800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6238987|NCT02386800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6238988|NCT02343952|Pembrolizumab|pembrolizumab|mesh-list
6238989|NCT02343952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6238990|NCT02343952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238991|NCT02339571|Nivolumab|nivolumab|mesh-list
6238992|NCT02339571|Ipilimumab|ipilimumab|mesh-list
6238993|NCT02339571|Sargramostim|sargramostim|mesh-list
6238994|NCT02339571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6238995|NCT02339571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6238996|NCT02339571|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6238997|NCT02339571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6238998|NCT02339571|Immunologic Factors|immunologic factors|mesh-ancestor
6238999|NCT02339571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239000|NCT02331134|Lenograstim|lenograstim|mesh-list
6239001|NCT02331134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6239002|NCT02331134|Immunologic Factors|immunologic factors|mesh-ancestor
6239003|NCT02331134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239004|NCT02307812|Paclitaxel|paclitaxel|mesh-list
6239005|NCT02307812|Ramucirumab|ramucirumab|mesh-list
5712803|NCT03265171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712804|NCT03265223|Ropivacaine|ropivacaine|mesh-list
6239006|NCT02307812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6239007|NCT02307812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6239008|NCT02307812|Tubulin Modulators|tubulin modulators|mesh-ancestor
6239009|NCT02307812|Antimitotic Agents|antimitotic agents|mesh-ancestor
5712805|NCT03265223|Anesthetics, Local|anesthetics, local|mesh-ancestor
5712806|NCT03265223|Anesthetics|anesthetics|mesh-ancestor
5712807|NCT03265223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5712808|NCT03265223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712809|NCT03265223|Sensory System Agents|sensory system agents|mesh-ancestor
5712810|NCT03265223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5712811|NCT03265197|Lidocaine|lidocaine|mesh-list
5712812|NCT03265197|Anesthetics, Local|anesthetics, local|mesh-ancestor
5712813|NCT03265197|Anesthetics|anesthetics|mesh-ancestor
5712814|NCT03265197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5712815|NCT03265197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712816|NCT03265197|Sensory System Agents|sensory system agents|mesh-ancestor
5712817|NCT03265197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5712818|NCT03265197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6239010|NCT02307812|Mitosis Modulators|mitosis modulators|mesh-ancestor
6239011|NCT02307812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239012|NCT02205762|Cytarabine|cytarabine|mesh-list
6239013|NCT02205762|Prednisone|prednisone|mesh-list
6239014|NCT02205762|Indomethacin|indomethacin|mesh-list
6239015|NCT02205762|Methotrexate|methotrexate|mesh-list
6239016|NCT02205762|Mercaptopurine|mercaptopurine|mesh-list
6239017|NCT02205762|Vinblastine|vinblastine|mesh-list
6239018|NCT02205762|Cladribine|cladribine|mesh-list
6239019|NCT02205762|Immunoglobulins|immunoglobulins|mesh-list
6239020|NCT02205762|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6239021|NCT02205762|Antibodies|antibodies|mesh-list
6239022|NCT02205762|gamma-Globulins|gamma-globulins|mesh-list
6239023|NCT02205762|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6239024|NCT02205762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6239025|NCT02205762|Glucocorticoids|glucocorticoids|mesh-ancestor
6239026|NCT02205762|Hormones|hormones|mesh-ancestor
6239027|NCT02205762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6502861|NCT00650468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6502862|NCT00650468|Antitubercular Agents|antitubercular agents|mesh-ancestor
6502863|NCT00650468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6502864|NCT00650468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6502865|NCT00650481|Oxybutynin|oxybutynin|mesh-list
6502866|NCT00650481|Parasympatholytics|parasympatholytics|mesh-ancestor
6502867|NCT00650481|Autonomic Agents|autonomic agents|mesh-ancestor
6239028|NCT02205762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239029|NCT02205762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6239030|NCT02205762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6239031|NCT02205762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6239032|NCT02205762|Abortifacient Agents|abortifacient agents|mesh-ancestor
6502868|NCT00650481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6502869|NCT00650481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502870|NCT00650481|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6502871|NCT00650481|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6502872|NCT00650481|Cholinergic Agents|cholinergic agents|mesh-ancestor
6502873|NCT00650481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6502874|NCT00650481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502875|NCT00650481|Urological Agents|urological agents|mesh-ancestor
6502876|NCT00650494|Valacyclovir|valacyclovir|mesh-list
6502877|NCT00650494|Antiviral Agents|antiviral agents|mesh-ancestor
6502878|NCT00650494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6502879|NCT00650520|Bromocriptine|bromocriptine|mesh-list
6239033|NCT02205762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6239034|NCT02205762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6239035|NCT02205762|Antimetabolites|antimetabolites|mesh-ancestor
6239036|NCT02205762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239037|NCT02205762|Dermatologic Agents|dermatologic agents|mesh-ancestor
6239038|NCT02205762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6239039|NCT02205762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6239040|NCT02205762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6239041|NCT02205762|Immunologic Factors|immunologic factors|mesh-ancestor
6239042|NCT02205762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6502880|NCT00650520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6502881|NCT00650520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6502882|NCT00650520|Hormone Antagonists|hormone antagonists|mesh-ancestor
6239043|NCT02205762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6239044|NCT02205762|Antiviral Agents|antiviral agents|mesh-ancestor
6239045|NCT02205762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6239046|NCT02205762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6239047|NCT02205762|Tubulin Modulators|tubulin modulators|mesh-ancestor
6239048|NCT02205762|Antimitotic Agents|antimitotic agents|mesh-ancestor
6239049|NCT02205762|Mitosis Modulators|mitosis modulators|mesh-ancestor
6239050|NCT02205762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6239051|NCT02205762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6239052|NCT02205762|Analgesics|analgesics|mesh-ancestor
6239053|NCT02205762|Sensory System Agents|sensory system agents|mesh-ancestor
6239054|NCT02205762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6239055|NCT02205762|Gout Suppressants|gout suppressants|mesh-ancestor
6239056|NCT02205762|Tocolytic Agents|tocolytic agents|mesh-ancestor
6239057|NCT02205762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6239061|NCT02159495|Cyclophosphamide|cyclophosphamide|mesh-list
6502883|NCT00650520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6502884|NCT00650520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502885|NCT00650520|Dopamine Agonists|dopamine agonists|mesh-ancestor
6677608|NCT01588847|Bupivacaine|bupivacaine|mesh-list
6677609|NCT01588847|Anesthetics|anesthetics|mesh-list
6677610|NCT01588847|Propofol|propofol|mesh-list
6239062|NCT02159495|Fludarabine|fludarabine|mesh-list
6239063|NCT02159495|Fludarabine phosphate|fludarabine phosphate|mesh-list
6239064|NCT02159495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6239065|NCT02159495|Immunologic Factors|immunologic factors|mesh-ancestor
6239066|NCT02159495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239067|NCT02159495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6239068|NCT02159495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6239069|NCT02159495|Alkylating Agents|alkylating agents|mesh-ancestor
6239070|NCT02159495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239071|NCT02159495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6239072|NCT02159495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6502886|NCT00650520|Dopamine Agents|dopamine agents|mesh-ancestor
6677611|NCT01588847|Sevoflurane|sevoflurane|mesh-list
6502887|NCT00650520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6502888|NCT00650520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502889|NCT00650533|Glimepiride|glimepiride|mesh-list
6502890|NCT00650533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6502891|NCT00650533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6502892|NCT00650533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502893|NCT00650533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6502894|NCT00650533|Immunologic Factors|immunologic factors|mesh-ancestor
6502895|NCT00650598|Diclofenac|diclofenac|mesh-list
6502896|NCT00650598|Valdecoxib|valdecoxib|mesh-list
6502897|NCT00650598|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6502898|NCT00650598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6502899|NCT00650598|Analgesics|analgesics|mesh-ancestor
6502900|NCT00650598|Sensory System Agents|sensory system agents|mesh-ancestor
6239073|NCT02159495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6239074|NCT02159495|Antimetabolites|antimetabolites|mesh-ancestor
6239075|NCT02157051|Vaccines|vaccines|mesh-list
6239076|NCT02157051|Immunologic Factors|immunologic factors|mesh-ancestor
6239077|NCT02157051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244069|NCT02685826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6244070|NCT02685826|Immunologic Factors|immunologic factors|mesh-ancestor
6244071|NCT02685826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6244072|NCT02685826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6244073|NCT02685826|Growth Substances|growth substances|mesh-ancestor
6244074|NCT02685826|Growth Inhibitors|growth inhibitors|mesh-ancestor
6244075|NCT02685826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6244076|NCT02686164|Lenvatinib|lenvatinib|mesh-list
6244077|NCT02686164|Midazolam|midazolam|mesh-list
6244078|NCT02686164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6244079|NCT02686164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6244080|NCT02686164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6244081|NCT02686164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502901|NCT00650598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5712819|NCT03265197|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5712820|NCT03265197|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5712821|NCT03265197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5712822|NCT03265197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712823|NCT03264638|Cyproterone Acetate|cyproterone acetate|mesh-list
6502902|NCT00650598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502903|NCT00650598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6677612|NCT01588847|Rocuronium|rocuronium|mesh-list
6677613|NCT01588847|Anesthetics, Local|anesthetics, local|mesh-ancestor
6677614|NCT01588847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6677615|NCT01588847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677616|NCT01588847|Sensory System Agents|sensory system agents|mesh-ancestor
6677617|NCT01588847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6677618|NCT01588847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6677619|NCT01588847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6677620|NCT01588847|Anesthetics, General|anesthetics, general|mesh-ancestor
6677621|NCT01588847|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6677622|NCT01588847|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6677623|NCT01588847|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6244082|NCT02686164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6244083|NCT02686164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6244084|NCT02686164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6244085|NCT02686164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6244086|NCT02686164|Anesthetics, General|anesthetics, general|mesh-ancestor
6244087|NCT02686164|Anesthetics|anesthetics|mesh-ancestor
6677624|NCT01588847|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6677625|NCT01588847|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6677626|NCT01588847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6677627|NCT01588847|Narcotics|narcotics|mesh-ancestor
6677628|NCT01588847|Analgesics|analgesics|mesh-ancestor
6244088|NCT02686164|GABA Modulators|gaba modulators|mesh-ancestor
6244089|NCT02686164|GABA Agents|gaba agents|mesh-ancestor
6244090|NCT02686164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6244091|NCT02686164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677629|NCT01588847|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6677630|NCT01588873|Desogestrel|desogestrel|mesh-list
6677631|NCT01588873|NuvaRing|nuvaring|mesh-list
6677632|NCT01588873|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5712824|NCT03264638|Cyproterone|cyproterone|mesh-list
6244092|NCT02686164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6244093|NCT02686164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6502904|NCT00650598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6677633|NCT01588873|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6502905|NCT00650598|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6502906|NCT00650598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6502907|NCT00650598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502908|NCT00650598|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6502909|NCT00650611|Ziprasidone|ziprasidone|mesh-list
6502910|NCT00650611|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6502911|NCT00650611|Serotonin Agents|serotonin agents|mesh-ancestor
6502912|NCT00650611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6502913|NCT00650611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502914|NCT00650611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712825|NCT03264638|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
5712826|NCT03264638|Androgen Antagonists|androgen antagonists|mesh-ancestor
5712827|NCT03264638|Hormone Antagonists|hormone antagonists|mesh-ancestor
5712828|NCT03264638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5712829|NCT03264638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712830|NCT03264638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5712831|NCT03264638|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5712832|NCT03264638|Contraceptive Agents|contraceptive agents|mesh-ancestor
5712833|NCT03264638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5712834|NCT03264651|Anastrozole|anastrozole|mesh-list
5712835|NCT03264651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5712836|NCT03264651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5712837|NCT03264651|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5712838|NCT03264651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6239078|NCT02136901|Hyaluronic Acid|hyaluronic acid|mesh-list
6502915|NCT00650611|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6502916|NCT00650611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6502917|NCT00650611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6502918|NCT00650611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6502919|NCT00650611|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6502920|NCT00650611|Dopamine Agents|dopamine agents|mesh-ancestor
6502921|NCT00650624|Valdecoxib|valdecoxib|mesh-list
6502922|NCT00650624|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6502923|NCT00650624|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6502924|NCT00650624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6502925|NCT00650624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502926|NCT00650624|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6502927|NCT00650624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6502928|NCT00650624|Analgesics|analgesics|mesh-ancestor
6502929|NCT00650624|Sensory System Agents|sensory system agents|mesh-ancestor
6502930|NCT00650624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6502931|NCT00650624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502932|NCT00650624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6239079|NCT02136901|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6239080|NCT02136901|Immunologic Factors|immunologic factors|mesh-ancestor
6239081|NCT02136901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239082|NCT02136901|Viscosupplements|viscosupplements|mesh-ancestor
6239083|NCT02136901|Protective Agents|protective agents|mesh-ancestor
6239084|NCT02134301|Oritavancin|oritavancin|mesh-list
6239085|NCT02134301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6239086|NCT02134301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6239087|NCT02108496|Hyaluronic Acid|hyaluronic acid|mesh-list
6239088|NCT02108496|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6239089|NCT02108496|Immunologic Factors|immunologic factors|mesh-ancestor
6239090|NCT02108496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239091|NCT02108496|Viscosupplements|viscosupplements|mesh-ancestor
6239092|NCT02108496|Protective Agents|protective agents|mesh-ancestor
6239093|NCT02069730|Androgens|androgens|mesh-list
6239094|NCT02069730|Androgen Antagonists|androgen antagonists|mesh-list
6239095|NCT02069730|Hormones|hormones|mesh-ancestor
6239096|NCT02069730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6239097|NCT02069730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239098|NCT02069730|Hormone Antagonists|hormone antagonists|mesh-ancestor
6239099|NCT02065765|Ramucirumab|ramucirumab|mesh-list
6239100|NCT02065765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6239101|NCT02057133|Tamoxifen|tamoxifen|mesh-list
6239102|NCT02057133|Trastuzumab|trastuzumab|mesh-list
6239103|NCT02057133|Pertuzumab|pertuzumab|mesh-list
6239104|NCT02057133|Everolimus|everolimus|mesh-list
6239105|NCT02057133|Letrozole|letrozole|mesh-list
6239106|NCT02057133|Fulvestrant|fulvestrant|mesh-list
6239107|NCT02057133|Anastrozole|anastrozole|mesh-list
6239108|NCT02057133|Exemestane|exemestane|mesh-list
6239109|NCT02057133|Loperamide|loperamide|mesh-list
6239110|NCT02057133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6239111|NCT02057133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6239112|NCT02057133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6239113|NCT02057133|Immunologic Factors|immunologic factors|mesh-ancestor
6239114|NCT02057133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239115|NCT02057133|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6239116|NCT02057133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6239117|NCT02057133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6239118|NCT02057133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677634|NCT01588873|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6677635|NCT01588873|Contraceptive Agents|contraceptive agents|mesh-ancestor
6677636|NCT01588873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6677637|NCT01588873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677638|NCT01588873|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6239119|NCT02057133|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6239120|NCT02057133|Hormone Antagonists|hormone antagonists|mesh-ancestor
6239121|NCT02057133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6239122|NCT02057133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6239123|NCT02057133|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6239124|NCT02057133|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6239125|NCT02057133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6239126|NCT02057133|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6239127|NCT02057133|Antidiarrheals|antidiarrheals|mesh-ancestor
6239128|NCT02057133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6239129|NCT02056236|Midazolam|midazolam|mesh-list
6239130|NCT02056236|Levetiracetam|levetiracetam|mesh-list
6239131|NCT02056236|Valproic Acid|valproic acid|mesh-list
6239132|NCT02056236|Lorazepam|lorazepam|mesh-list
6239133|NCT02056236|Thiopental|thiopental|mesh-list
6239134|NCT02056236|Anticonvulsants|anticonvulsants|mesh-list
6239135|NCT02056236|Propofol|propofol|mesh-list
6239136|NCT02056236|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6239137|NCT02056236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6239138|NCT02056236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239139|NCT02056236|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6239140|NCT02056236|Anesthetics, General|anesthetics, general|mesh-ancestor
6239141|NCT02056236|Anesthetics|anesthetics|mesh-ancestor
6239142|NCT02056236|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6239143|NCT02056236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6239144|NCT02056236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6239145|NCT02056236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6239146|NCT02056236|GABA Modulators|gaba modulators|mesh-ancestor
6239147|NCT02056236|GABA Agents|gaba agents|mesh-ancestor
6239148|NCT02056236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5712839|NCT03264651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5712840|NCT03264651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712841|NCT03264651|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5712842|NCT03264651|Hormone Antagonists|hormone antagonists|mesh-ancestor
5712843|NCT03264651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5712844|NCT03264651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712845|NCT03264794|Gefitinib|gefitinib|mesh-list
5712846|NCT03264794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5919165|NCT04984980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239149|NCT02056236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239150|NCT02056236|Nootropic Agents|nootropic agents|mesh-ancestor
5919166|NCT04984980|Antiviral Agents|antiviral agents|mesh-ancestor
5919167|NCT04984980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5919168|NCT04984980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5919169|NCT04984980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5919170|NCT04984980|Immunologic Factors|immunologic factors|mesh-ancestor
5919171|NCT04985110|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
5919172|NCT04985110|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5919173|NCT04985110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5919174|NCT04985110|Renal Agents|renal agents|mesh-ancestor
5919175|NCT04985110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5919176|NCT04985110|Antimalarials|antimalarials|mesh-ancestor
5919177|NCT04985110|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5919178|NCT04985110|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5919179|NCT04984993|Tadalafil|tadalafil|mesh-list
5919180|NCT04984993|Vasodilator Agents|vasodilator agents|mesh-ancestor
5919181|NCT04984993|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5919182|NCT04984993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5919183|NCT04984993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5919184|NCT04984993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919185|NCT04984993|Urological Agents|urological agents|mesh-ancestor
6239151|NCT02056236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6239152|NCT02056236|Antimanic Agents|antimanic agents|mesh-ancestor
6239153|NCT02056236|Antiemetics|antiemetics|mesh-ancestor
6239154|NCT02056236|Autonomic Agents|autonomic agents|mesh-ancestor
6239155|NCT02056236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6239156|NCT02056236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6239157|NCT02007044|Rituximab|rituximab|mesh-list
6239158|NCT02007044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6239159|NCT02007044|Antibodies|antibodies|mesh-list
6239160|NCT02007044|Immunoglobulins|immunoglobulins|mesh-list
6239161|NCT02007044|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6239162|NCT02007044|Immunologic Factors|immunologic factors|mesh-ancestor
6239163|NCT02007044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239164|NCT02007044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6239165|NCT02007044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6239166|NCT01962246|Capecitabine|capecitabine|mesh-list
6239167|NCT01962246|Oxaliplatin|oxaliplatin|mesh-list
6239168|NCT01962246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6239169|NCT01962246|Antimetabolites|antimetabolites|mesh-ancestor
6239170|NCT01962246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239171|NCT01962246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6239172|NCT01896999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6502933|NCT00650624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6502934|NCT00650637|Calcium, Dietary|calcium, dietary|mesh-list
6502935|NCT00650637|Lamivudine|lamivudine|mesh-list
6502936|NCT00650637|Zidovudine|zidovudine|mesh-list
6502937|NCT00650637|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6502938|NCT00650637|Nelfinavir|nelfinavir|mesh-list
6502939|NCT00650637|Calcium Carbonate|calcium carbonate|mesh-list
5712847|NCT03264794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6239173|NCT01896999|Nivolumab|nivolumab|mesh-list
6239174|NCT01896999|Ipilimumab|ipilimumab|mesh-list
6239175|NCT01896999|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6239176|NCT01896999|Antibodies|antibodies|mesh-list
6239177|NCT01896999|Immunoglobulins|immunoglobulins|mesh-list
6239178|NCT01896999|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6239179|NCT01896999|Immunoconjugates|immunoconjugates|mesh-list
6239180|NCT01896999|Immunologic Factors|immunologic factors|mesh-ancestor
6239181|NCT01896999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239182|NCT01896999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6239183|NCT01896999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6239184|NCT01896999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239185|NCT01810705|Asparaginase|asparaginase|mesh-list
6239186|NCT01810705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6239187|NCT01568918|Tamsulosin|tamsulosin|mesh-list
6239188|NCT01568918|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6239189|NCT01568918|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6239190|NCT01568918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6239191|NCT01568918|Adrenergic Agents|adrenergic agents|mesh-ancestor
5712848|NCT03264794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5712849|NCT03264794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712850|NCT03264781|CycloProvera|cycloprovera|mesh-list
5712851|NCT03264781|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5712852|NCT03264781|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5712853|NCT03264781|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5712854|NCT03264781|Contraceptive Agents|contraceptive agents|mesh-ancestor
5712855|NCT03264781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5712856|NCT03264781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712857|NCT03264781|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5712858|NCT03264781|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5712859|NCT03264911|Amoxicillin|amoxicillin|mesh-list
5712860|NCT03264911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5712861|NCT03264911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5712862|NCT03264586|Lidocaine|lidocaine|mesh-list
5712863|NCT03264586|Prilocaine|prilocaine|mesh-list
6239192|NCT01568918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6239193|NCT01568918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239194|NCT01568918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239195|NCT01568918|Urological Agents|urological agents|mesh-ancestor
6239196|NCT01517243|Sirolimus|sirolimus|mesh-list
6239197|NCT01517243|Sunitinib|sunitinib|mesh-list
6239198|NCT01517243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6239199|NCT01517243|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6239200|NCT01517243|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6239201|NCT01517243|Growth Substances|growth substances|mesh-ancestor
6502940|NCT00650637|Loperamide|loperamide|mesh-list
6502941|NCT00650637|Antidiarrheals|antidiarrheals|mesh-list
6502942|NCT00650637|Calcium|calcium|mesh-list
6239202|NCT01517243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239203|NCT01517243|Growth Inhibitors|growth inhibitors|mesh-ancestor
6239204|NCT01517243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6239205|NCT01517243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6502943|NCT00650637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6502944|NCT00650637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502945|NCT00650637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6502946|NCT00650637|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6502947|NCT00650637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6502948|NCT00650637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6502949|NCT00650637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502950|NCT00650637|Antiviral Agents|antiviral agents|mesh-ancestor
6502951|NCT00650637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6502952|NCT00650637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6502953|NCT00650637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6502954|NCT00650637|Antimetabolites|antimetabolites|mesh-ancestor
6502955|NCT00650637|Antacids|antacids|mesh-ancestor
6502956|NCT00650637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6502957|NCT00650637|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6502958|NCT00650637|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6502959|NCT00650637|Protease Inhibitors|protease inhibitors|mesh-ancestor
6502960|NCT00650754|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
6677639|NCT01588873|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6677640|NCT01588873|Progestins|progestins|mesh-ancestor
6677641|NCT01588873|Hormones|hormones|mesh-ancestor
6677642|NCT01588873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6239206|NCT01517243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239207|NCT01517243|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6677643|NCT01588912|Tenofovir|tenofovir|mesh-list
6677644|NCT01588912|Entecavir|entecavir|mesh-list
6677645|NCT01588912|Telbivudine|telbivudine|mesh-list
6677646|NCT01588912|Antiviral Agents|antiviral agents|mesh-ancestor
6677647|NCT01588912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5712864|NCT03264586|Mepivacaine|mepivacaine|mesh-list
5712865|NCT03264586|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
5712866|NCT03264586|Anesthetics, Local|anesthetics, local|mesh-ancestor
5712867|NCT03264586|Anesthetics|anesthetics|mesh-ancestor
5712868|NCT03264586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5712869|NCT03264586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712870|NCT03264586|Sensory System Agents|sensory system agents|mesh-ancestor
5712871|NCT03264586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5712872|NCT03264586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5712873|NCT03264586|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5712874|NCT03264586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5712875|NCT03264586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5712876|NCT03264586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712877|NCT03264586|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
5712878|NCT03264625|Vitamin D|vitamin d|mesh-list
5712879|NCT03264625|Cholecalciferol|cholecalciferol|mesh-list
5712880|NCT03264625|Vitamins|vitamins|mesh-ancestor
5712881|NCT03264625|Micronutrients|micronutrients|mesh-ancestor
5712882|NCT03264625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712883|NCT03264625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5712884|NCT03264625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5712885|NCT03264547|Paclitaxel|paclitaxel|mesh-list
5712886|NCT03264547|Docetaxel|docetaxel|mesh-list
5712887|NCT03264547|Trastuzumab|trastuzumab|mesh-list
5712888|NCT03264547|Pertuzumab|pertuzumab|mesh-list
5712889|NCT03264547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5712890|NCT03264547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5712891|NCT03264547|Tubulin Modulators|tubulin modulators|mesh-ancestor
5712892|NCT03264547|Antimitotic Agents|antimitotic agents|mesh-ancestor
5712893|NCT03264547|Mitosis Modulators|mitosis modulators|mesh-ancestor
6239208|NCT01517243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6239209|NCT01517243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6239210|NCT01517243|Antifungal Agents|antifungal agents|mesh-ancestor
6239211|NCT01517243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6239212|NCT01517243|Immunologic Factors|immunologic factors|mesh-ancestor
6239213|NCT01460810|Silicon|silicon|mesh-list
6239214|NCT01460810|Trace Elements|trace elements|mesh-ancestor
6239215|NCT01460810|Micronutrients|micronutrients|mesh-ancestor
6239216|NCT01460810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677648|NCT01588912|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5712894|NCT03264547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712895|NCT03264547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5721757|NCT03203525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5721758|NCT03203525|Antifungal Agents|antifungal agents|mesh-ancestor
5721759|NCT03203356|Hormones|hormones|mesh-list
5721760|NCT03203356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5721761|NCT03203356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721762|NCT03203304|Nivolumab|nivolumab|mesh-list
5721763|NCT03203304|Ipilimumab|ipilimumab|mesh-list
5721764|NCT03203304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5721765|NCT03203304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6502961|NCT00650754|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6502962|NCT00650754|Immunologic Factors|immunologic factors|mesh-ancestor
6502963|NCT00650754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502964|NCT00650793|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6502965|NCT00650793|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6502966|NCT00650793|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6502967|NCT00650793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6502968|NCT00650793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502969|NCT00650793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5721766|NCT03203304|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5721767|NCT03203304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721768|NCT03203590|Carboplatin|carboplatin|mesh-list
5721769|NCT03203590|Vinorelbine|vinorelbine|mesh-list
5721770|NCT03203590|Gefitinib|gefitinib|mesh-list
5721771|NCT03203590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5721772|NCT03203590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5721773|NCT03203590|Tubulin Modulators|tubulin modulators|mesh-ancestor
5721774|NCT03203590|Antimitotic Agents|antimitotic agents|mesh-ancestor
5721775|NCT03203590|Mitosis Modulators|mitosis modulators|mesh-ancestor
5721776|NCT03203590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721777|NCT03203590|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5721778|NCT03203590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5721779|NCT03203642|XL647|xl647|mesh-list
5721780|NCT03203642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5721781|NCT03203642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5721782|NCT03203642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5721783|NCT03203642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721784|NCT03203616|Trastuzumab|trastuzumab|mesh-list
5721785|NCT03203616|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
5721786|NCT03203616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5721787|NCT03203616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5721788|NCT03203616|Tubulin Modulators|tubulin modulators|mesh-ancestor
5721789|NCT03203616|Antimitotic Agents|antimitotic agents|mesh-ancestor
5721790|NCT03203616|Mitosis Modulators|mitosis modulators|mesh-ancestor
5721791|NCT03203616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721792|NCT03203408|Hylan|hylan|mesh-list
5721793|NCT03203408|Viscosupplements|viscosupplements|mesh-ancestor
5721794|NCT03203408|Protective Agents|protective agents|mesh-ancestor
5721795|NCT03203408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239234|NCT01306045|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6239235|NCT01306045|Sunitinib|sunitinib|mesh-list
6239236|NCT01306045|Lapatinib|lapatinib|mesh-list
6239237|NCT01306045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6239238|NCT01306045|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6239239|NCT01306045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6239240|NCT01306045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239241|NCT01306045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6239242|NCT01306045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5721796|NCT03203317|Insulin|insulin|mesh-list
5712896|NCT03264430|Ketamine|ketamine|mesh-list
5712897|NCT03264430|Bupivacaine|bupivacaine|mesh-list
5712898|NCT03264430|Anesthetics, Local|anesthetics, local|mesh-ancestor
5712899|NCT03264430|Anesthetics|anesthetics|mesh-ancestor
5712900|NCT03264430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5712901|NCT03264430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712902|NCT03264430|Sensory System Agents|sensory system agents|mesh-ancestor
5712903|NCT03264430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5712904|NCT03264430|Analgesics|analgesics|mesh-ancestor
5712905|NCT03264430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5712906|NCT03264430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5712907|NCT03264430|Anesthetics, General|anesthetics, general|mesh-ancestor
5712908|NCT03264430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5712909|NCT03264430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5712910|NCT03264430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5712911|NCT03264430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712912|NCT03264118|Tolonium Chloride|tolonium chloride|mesh-list
5712913|NCT03264118|Hemostatics|hemostatics|mesh-ancestor
5712914|NCT03264118|Coagulants|coagulants|mesh-ancestor
5712915|NCT03264118|Heparin Antagonists|heparin antagonists|mesh-ancestor
5712916|NCT03264118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712917|NCT03264274|Aflibercept|aflibercept|mesh-list
5712918|NCT03264274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5712919|NCT03264274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5712920|NCT03264274|Growth Substances|growth substances|mesh-ancestor
6502970|NCT00650793|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6502971|NCT00650793|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6502972|NCT00650793|Serotonin Agents|serotonin agents|mesh-ancestor
5712921|NCT03264274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712922|NCT03264274|Growth Inhibitors|growth inhibitors|mesh-ancestor
5712923|NCT03264274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5712924|NCT03264131|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5712925|NCT03264131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5712926|NCT03264131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5712927|NCT03264079|Itraconazole|itraconazole|mesh-list
5712928|NCT03264079|Antifungal Agents|antifungal agents|mesh-ancestor
5712929|NCT03264079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5712930|NCT03264079|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5712931|NCT03264079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5712932|NCT03264079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5712933|NCT03264079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239243|NCT01306045|Growth Substances|growth substances|mesh-ancestor
6239244|NCT01306045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239245|NCT01306045|Growth Inhibitors|growth inhibitors|mesh-ancestor
6239246|NCT01269190|Proflavine|proflavine|mesh-list
6239247|NCT01269190|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6239248|NCT01269190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6239249|NCT01130519|Bevacizumab|bevacizumab|mesh-list
6239250|NCT01130519|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6239251|NCT01130519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6239252|NCT01130519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6239253|NCT01130519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6239254|NCT01130519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6239255|NCT01130519|Growth Substances|growth substances|mesh-ancestor
6239256|NCT01130519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239257|NCT01130519|Growth Inhibitors|growth inhibitors|mesh-ancestor
6239258|NCT01130519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6239259|NCT01130519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6239260|NCT01130519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239261|NCT00667121|Tamoxifen|tamoxifen|mesh-list
6239262|NCT00667121|Gabapentin|gabapentin|mesh-list
6239263|NCT00667121|Dexetimide|dexetimide|mesh-list
6239264|NCT00667121|Citalopram|citalopram|mesh-list
6239265|NCT00667121|Sertraline|sertraline|mesh-list
6239266|NCT00667121|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6239267|NCT00667121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239268|NCT00667121|Analgesics|analgesics|mesh-ancestor
6239269|NCT00667121|Sensory System Agents|sensory system agents|mesh-ancestor
6239270|NCT00667121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6239271|NCT00667121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239272|NCT00667121|Anticonvulsants|anticonvulsants|mesh-ancestor
6239273|NCT00667121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6239274|NCT00667121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6244094|NCT02686164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6502973|NCT00650793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5712934|NCT03264079|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5712935|NCT03264079|Hormone Antagonists|hormone antagonists|mesh-ancestor
5712936|NCT03264079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5712937|NCT03264079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712938|NCT03264079|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5712939|NCT03263936|Cytarabine|cytarabine|mesh-list
5712940|NCT03263936|Fludarabine|fludarabine|mesh-list
5712941|NCT03263936|Decitabine|decitabine|mesh-list
5712942|NCT03263936|Vorinostat|vorinostat|mesh-list
5712943|NCT03263936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5712944|NCT03263936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5712945|NCT03263936|Antimetabolites|antimetabolites|mesh-ancestor
5712946|NCT03263936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712947|NCT03263936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5712948|NCT03263936|Immunologic Factors|immunologic factors|mesh-ancestor
5712949|NCT03263936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712950|NCT03263936|Antiviral Agents|antiviral agents|mesh-ancestor
5712951|NCT03263936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5712952|NCT03263936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5712953|NCT03263936|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5712954|NCT03263741|Paclitaxel|paclitaxel|mesh-list
5712955|NCT03263741|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5712956|NCT03263741|Oxaliplatin|oxaliplatin|mesh-list
5712957|NCT03263741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5712958|NCT03263741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5712959|NCT03263741|Tubulin Modulators|tubulin modulators|mesh-ancestor
5712960|NCT03263741|Antimitotic Agents|antimitotic agents|mesh-ancestor
6239275|NCT00667121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6239276|NCT00667121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6239277|NCT00667121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6239278|NCT00667121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6239279|NCT00667121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5712961|NCT03263741|Mitosis Modulators|mitosis modulators|mesh-ancestor
5712962|NCT03263741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5712963|NCT03263962|Canrenone|canrenone|mesh-list
5712964|NCT03263962|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5712965|NCT03263962|Hormone Antagonists|hormone antagonists|mesh-ancestor
5712966|NCT03263962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5712967|NCT03263962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712968|NCT03263962|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5712969|NCT03263962|Diuretics|diuretics|mesh-ancestor
5712970|NCT03263962|Natriuretic Agents|natriuretic agents|mesh-ancestor
5712971|NCT03263871|Micronutrients|micronutrients|mesh-list
5712972|NCT03263871|Trace Elements|trace elements|mesh-list
5712973|NCT03263871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712974|NCT03263689|Morphine|morphine|mesh-list
5712975|NCT03263689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5712976|NCT03263689|Narcotics|narcotics|mesh-ancestor
5712977|NCT03263689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5712978|NCT03263689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712979|NCT03263689|Analgesics|analgesics|mesh-ancestor
5712980|NCT03263689|Sensory System Agents|sensory system agents|mesh-ancestor
5712981|NCT03263689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5712982|NCT03263767|Cyclophosphamide|cyclophosphamide|mesh-list
5712983|NCT03263767|Fludarabine|fludarabine|mesh-list
5712984|NCT03263767|Clofarabine|clofarabine|mesh-list
5712985|NCT03263767|Thymoglobulin|thymoglobulin|mesh-list
5712986|NCT03263767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5712987|NCT03263767|Immunologic Factors|immunologic factors|mesh-ancestor
5712988|NCT03263767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5712989|NCT03263767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5712990|NCT03263767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5712991|NCT03263767|Alkylating Agents|alkylating agents|mesh-ancestor
5712992|NCT03263767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239280|NCT00667121|Antimanic Agents|antimanic agents|mesh-ancestor
6239281|NCT00667121|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6239282|NCT00667121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6239283|NCT00667121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6239284|NCT00667121|Serotonin Agents|serotonin agents|mesh-ancestor
6239285|NCT00667121|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6502974|NCT00650793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502975|NCT00650793|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6502976|NCT00650793|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6502977|NCT00650793|Dopamine Agents|dopamine agents|mesh-ancestor
6502978|NCT00650871|Casopitant|casopitant|mesh-list
6502979|NCT00650871|Antiemetics|antiemetics|mesh-ancestor
6502980|NCT00650871|Autonomic Agents|autonomic agents|mesh-ancestor
6502981|NCT00650871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6502982|NCT00650871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502983|NCT00650871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6502984|NCT00650871|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6502985|NCT00650871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6677649|NCT01588912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6677650|NCT01588912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6677651|NCT01588912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677652|NCT01588912|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6677653|NCT01588912|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6677654|NCT01588925|Dexamethasone|dexamethasone|mesh-list
6677655|NCT01588925|Dexamethasone acetate|dexamethasone acetate|mesh-list
6239286|NCT00667121|Antidepressive Agents|antidepressive agents|mesh-ancestor
6239287|NCT00667121|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6239288|NCT00667121|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6239289|NCT00667121|Parasympatholytics|parasympatholytics|mesh-ancestor
6239290|NCT00667121|Autonomic Agents|autonomic agents|mesh-ancestor
6239291|NCT00667121|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6239292|NCT00667121|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6239293|NCT00667121|Cholinergic Agents|cholinergic agents|mesh-ancestor
6239294|NCT00667121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6239295|NCT00667121|Hormone Antagonists|hormone antagonists|mesh-ancestor
6239296|NCT00667121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6239297|NCT00667121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5712993|NCT03263767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5712994|NCT03263767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5712995|NCT03263767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5712996|NCT03263767|Antimetabolites|antimetabolites|mesh-ancestor
5712997|NCT03263715|Glucocorticoids|glucocorticoids|mesh-list
5712998|NCT03263715|Hormones|hormones|mesh-ancestor
5712999|NCT03263715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5713000|NCT03263715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713001|NCT03263650|Prednisone|prednisone|mesh-list
5713002|NCT03263650|Carboplatin|carboplatin|mesh-list
5713003|NCT03263650|Olaparib|olaparib|mesh-list
5713004|NCT03263650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5713005|NCT03263650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5713006|NCT03263650|Glucocorticoids|glucocorticoids|mesh-ancestor
5713007|NCT03263650|Hormones|hormones|mesh-ancestor
5713008|NCT03263650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5713009|NCT03263650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713010|NCT03263650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5713011|NCT03263650|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6239298|NCT00667121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6239299|NCT00667121|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6239300|NCT00667121|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6239301|NCT00667121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6239302|NCT00667121|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6239303|NCT00641381|Cyclophosphamide|cyclophosphamide|mesh-list
6677656|NCT01588925|BB 1101|bb 1101|mesh-list
6677657|NCT01588925|Hyaluronic Acid|hyaluronic acid|mesh-list
6677658|NCT01588925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6677659|NCT01588925|Antiemetics|antiemetics|mesh-ancestor
6677660|NCT01588925|Autonomic Agents|autonomic agents|mesh-ancestor
6677661|NCT01588925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6677662|NCT01588925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713012|NCT03263650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5713013|NCT03263650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713014|NCT03263624|Tazarotene|tazarotene|mesh-list
5713015|NCT03263624|Dermatologic Agents|dermatologic agents|mesh-ancestor
5713016|NCT03263624|Keratolytic Agents|keratolytic agents|mesh-ancestor
5713017|NCT03263390|Anti-Obesity Agents|anti-obesity agents|mesh-list
5713018|NCT03263481|Secretin|secretin|mesh-list
6239304|NCT00641381|Carmustine|carmustine|mesh-list
6677663|NCT01588925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6677664|NCT01588925|Glucocorticoids|glucocorticoids|mesh-ancestor
6677665|NCT01588925|Hormones|hormones|mesh-ancestor
6677666|NCT01588925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6677667|NCT01588925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6239305|NCT00641381|Etoposide|etoposide|mesh-list
6244095|NCT02687451|Oxymorphone|oxymorphone|mesh-list
6677668|NCT01588925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6239306|NCT00641381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6239307|NCT00641381|Immunologic Factors|immunologic factors|mesh-ancestor
6239308|NCT00641381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239309|NCT00641381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6239310|NCT00641381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6239311|NCT00641381|Alkylating Agents|alkylating agents|mesh-ancestor
6239312|NCT00641381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239313|NCT00641381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6239314|NCT00641381|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6239315|NCT00641381|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6239316|NCT00641381|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6239317|NCT00641381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6239318|NCT00641381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6239319|NCT00544414|Leucovorin|leucovorin|mesh-list
6239320|NCT00544414|Gemcitabine|gemcitabine|mesh-list
6239321|NCT00544414|Docetaxel|docetaxel|mesh-list
6239322|NCT00544414|Fluorouracil|fluorouracil|mesh-list
6239323|NCT00544414|Calcium|calcium|mesh-list
6239324|NCT00544414|Levoleucovorin|levoleucovorin|mesh-list
6239325|NCT00544414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6239326|NCT00544414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6239327|NCT00544414|Antimetabolites|antimetabolites|mesh-ancestor
6239328|NCT00544414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239329|NCT00544414|Antiviral Agents|antiviral agents|mesh-ancestor
6239330|NCT00544414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6239331|NCT00544414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5713019|NCT03263481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5713020|NCT03263481|Hormones|hormones|mesh-ancestor
5713021|NCT03263481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6239332|NCT00544414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6239333|NCT00544414|Immunologic Factors|immunologic factors|mesh-ancestor
6239334|NCT00544414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239335|NCT00544414|Tubulin Modulators|tubulin modulators|mesh-ancestor
6239336|NCT00544414|Antimitotic Agents|antimitotic agents|mesh-ancestor
6239337|NCT00544414|Mitosis Modulators|mitosis modulators|mesh-ancestor
6239338|NCT00544414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6239339|NCT00544414|Antidotes|antidotes|mesh-ancestor
6239340|NCT00544414|Protective Agents|protective agents|mesh-ancestor
6239341|NCT00544414|Vitamin B Complex|vitamin b complex|mesh-ancestor
6239342|NCT00544414|Vitamins|vitamins|mesh-ancestor
6239343|NCT00544414|Micronutrients|micronutrients|mesh-ancestor
6239344|NCT00534469|Cytarabine|cytarabine|mesh-list
6239345|NCT00534469|Aldesleukin|aldesleukin|mesh-list
6239346|NCT00534469|Etoposide|etoposide|mesh-list
6239347|NCT00534469|Idarubicin|idarubicin|mesh-list
6239348|NCT00534469|Busulfan|busulfan|mesh-list
6239349|NCT00534469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6239350|NCT00534469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6239351|NCT00534469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6239352|NCT00534469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6239353|NCT00534469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6239354|NCT00534469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239355|NCT00534469|Immunologic Factors|immunologic factors|mesh-ancestor
6239356|NCT00534469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239357|NCT00534469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6239358|NCT00534469|Antimetabolites|antimetabolites|mesh-ancestor
6239359|NCT00534469|Antiviral Agents|antiviral agents|mesh-ancestor
6239360|NCT00534469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6239361|NCT00534469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6239362|NCT00534469|Alkylating Agents|alkylating agents|mesh-ancestor
6239363|NCT00534469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6239364|NCT00534469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6239365|NCT00534469|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6239366|NCT00534469|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6239367|NCT00534469|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6239368|NCT00534430|Cyclosporine|cyclosporine|mesh-list
6239369|NCT00534430|Mycophenolic Acid|mycophenolic acid|mesh-list
6239370|NCT00534430|Etoposide|etoposide|mesh-list
6239371|NCT00534430|Busulfan|busulfan|mesh-list
6239372|NCT00534430|Cyclosporins|cyclosporins|mesh-list
6239373|NCT00534430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6239374|NCT00534430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6239375|NCT00534430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6239376|NCT00534430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6239377|NCT00534430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6239378|NCT00534430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239379|NCT00534430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6239380|NCT00534430|Immunologic Factors|immunologic factors|mesh-ancestor
6239381|NCT00534430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239382|NCT00534430|Antifungal Agents|antifungal agents|mesh-ancestor
6239383|NCT00534430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6239384|NCT00534430|Dermatologic Agents|dermatologic agents|mesh-ancestor
6239385|NCT00534430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6239386|NCT00534430|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6239387|NCT00534430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6239388|NCT00534430|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6239389|NCT00534430|Antitubercular Agents|antitubercular agents|mesh-ancestor
6239390|NCT00534430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6239391|NCT00534430|Alkylating Agents|alkylating agents|mesh-ancestor
6239392|NCT00534430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6239393|NCT00534430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6239394|NCT00003927|Paclitaxel|paclitaxel|mesh-list
6239395|NCT00003927|Cyclophosphamide|cyclophosphamide|mesh-list
6239396|NCT00003927|Doxorubicin|doxorubicin|mesh-list
6239397|NCT00003927|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6239398|NCT00003927|Amifostine|amifostine|mesh-list
6239399|NCT00003927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6239400|NCT00003927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6239401|NCT00003927|Tubulin Modulators|tubulin modulators|mesh-ancestor
6239402|NCT00003927|Antimitotic Agents|antimitotic agents|mesh-ancestor
6239403|NCT00003927|Mitosis Modulators|mitosis modulators|mesh-ancestor
6239404|NCT00003927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239405|NCT00003927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6239406|NCT00003927|Immunologic Factors|immunologic factors|mesh-ancestor
6239407|NCT00003927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239408|NCT00003927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6239409|NCT00003927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6239410|NCT00003927|Alkylating Agents|alkylating agents|mesh-ancestor
6677669|NCT01588925|Protease Inhibitors|protease inhibitors|mesh-ancestor
6239411|NCT00003927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6239412|NCT00003927|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5713022|NCT03263481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713023|NCT03263299|Aspirin|aspirin|mesh-list
5713024|NCT03263299|Cabergoline|cabergoline|mesh-list
5713025|NCT03263299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5713026|NCT03263299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5713027|NCT03263299|Analgesics|analgesics|mesh-ancestor
5713028|NCT03263299|Sensory System Agents|sensory system agents|mesh-ancestor
5713029|NCT03263299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5713030|NCT03263299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713031|NCT03263299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5713032|NCT03263299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5713033|NCT03263299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5713034|NCT03263299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5713035|NCT03263299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713036|NCT03263299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5713037|NCT03263299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5713038|NCT03263299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5713039|NCT03263299|Antipyretics|antipyretics|mesh-ancestor
5713040|NCT03263299|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5713041|NCT03263299|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5713042|NCT03263299|Dopamine Agonists|dopamine agonists|mesh-ancestor
5713043|NCT03263299|Dopamine Agents|dopamine agents|mesh-ancestor
5713044|NCT03263299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5713045|NCT03263429|Irinotecan|irinotecan|mesh-list
5919186|NCT04984408|Vaccines|vaccines|mesh-list
5919187|NCT04984408|Immunologic Factors|immunologic factors|mesh-ancestor
5919188|NCT04984408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919189|NCT04984200|Mydriatics|mydriatics|mesh-list
5919190|NCT04984200|Autonomic Agents|autonomic agents|mesh-ancestor
5919191|NCT04984200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5919192|NCT04984200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919193|NCT04984577|Edaravone|edaravone|mesh-list
5919194|NCT04984577|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5919195|NCT04984577|Antioxidants|antioxidants|mesh-ancestor
5919196|NCT04984577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919197|NCT04984577|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6239413|NCT00003927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5713046|NCT03263429|Panitumumab|panitumumab|mesh-list
5713047|NCT03263429|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6239414|NCT00003927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6239415|NCT00003927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6239416|NCT00003927|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6239417|NCT00003927|Protective Agents|protective agents|mesh-ancestor
6239427|NCT02588261|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5713048|NCT03263429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5713049|NCT03263429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5713050|NCT03263429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713051|NCT03263429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5713052|NCT03263429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5713053|NCT03263572|Cytarabine|cytarabine|mesh-list
5713054|NCT03263572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5713055|NCT03263572|Methotrexate|methotrexate|mesh-list
5713056|NCT03263572|Blinatumomab|blinatumomab|mesh-list
5713057|NCT03263572|Ponatinib|ponatinib|mesh-list
5713058|NCT03263572|Antibodies|antibodies|mesh-list
5713059|NCT03263572|Immunoglobulins|immunoglobulins|mesh-list
5713060|NCT03263572|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5713061|NCT03263572|Muromonab-CD3|muromonab-cd3|mesh-list
5713062|NCT03263572|Antibodies, Bispecific|antibodies, bispecific|mesh-list
5713063|NCT03263572|Immunologic Factors|immunologic factors|mesh-ancestor
5713064|NCT03263572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713065|NCT03263572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5713066|NCT03263572|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5713067|NCT03263572|Abortifacient Agents|abortifacient agents|mesh-ancestor
5713068|NCT03263572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6239428|NCT02588261|Gefitinib|gefitinib|mesh-list
6239429|NCT02588261|Naquotinib|naquotinib|mesh-list
6239430|NCT02588261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6239431|NCT02588261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6239432|NCT02588261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6239433|NCT02588261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239434|NCT02588339|Sirolimus|sirolimus|mesh-list
6239435|NCT02588339|Panobinostat|panobinostat|mesh-list
6239436|NCT02588339|Tacrolimus|tacrolimus|mesh-list
6239437|NCT02588339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6239438|NCT02588339|Immunologic Factors|immunologic factors|mesh-ancestor
6239439|NCT02588339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239440|NCT02588339|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6239441|NCT02588339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5713069|NCT03263572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5713070|NCT03263572|Antimetabolites|antimetabolites|mesh-ancestor
5713071|NCT03263572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239442|NCT02588339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713072|NCT03263572|Dermatologic Agents|dermatologic agents|mesh-ancestor
5713073|NCT03263572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5713074|NCT03263572|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5713075|NCT03263572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5713076|NCT03263572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5713077|NCT03263572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5713078|NCT03263572|Antiviral Agents|antiviral agents|mesh-ancestor
5713079|NCT03263572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5713080|NCT03263572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5713081|NCT03263533|Vorinostat|vorinostat|mesh-list
5713082|NCT03263533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5713083|NCT03263533|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5713084|NCT03263533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5713085|NCT03263533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713086|NCT03263520|Nandrolone Decanoate|nandrolone decanoate|mesh-list
5713087|NCT03263520|Dexamethasone|dexamethasone|mesh-list
6239443|NCT02588339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6239444|NCT02588339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6239445|NCT02588339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6239446|NCT02588339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5713088|NCT03263520|Dexamethasone acetate|dexamethasone acetate|mesh-list
6239447|NCT02588339|Antifungal Agents|antifungal agents|mesh-ancestor
5713089|NCT03263520|Nandrolone|nandrolone|mesh-list
5713090|NCT03263520|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
5713091|NCT03263520|BB 1101|bb 1101|mesh-list
5713092|NCT03263520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5713093|NCT03263520|Antiemetics|antiemetics|mesh-ancestor
5713094|NCT03263520|Autonomic Agents|autonomic agents|mesh-ancestor
5713095|NCT03263520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5713096|NCT03263520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713097|NCT03263520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5713098|NCT03263520|Glucocorticoids|glucocorticoids|mesh-ancestor
5713099|NCT03263520|Hormones|hormones|mesh-ancestor
5713100|NCT03263520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5713101|NCT03263520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5713102|NCT03263520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5713103|NCT03263520|Protease Inhibitors|protease inhibitors|mesh-ancestor
5713104|NCT03263520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5713105|NCT03263520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713106|NCT03263520|Androgens|androgens|mesh-ancestor
5713107|NCT03263520|Anabolic Agents|anabolic agents|mesh-ancestor
5713108|NCT03263520|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5713109|NCT03263208|Cyclophosphamide|cyclophosphamide|mesh-list
5713110|NCT03263208|Fludarabine|fludarabine|mesh-list
5713111|NCT03263208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5713112|NCT03263208|Immunologic Factors|immunologic factors|mesh-ancestor
5713113|NCT03263208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713114|NCT03263208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5713115|NCT03263208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5713116|NCT03263208|Alkylating Agents|alkylating agents|mesh-ancestor
5713117|NCT03263208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713118|NCT03263208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5713119|NCT03263208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5713120|NCT03262857|Lidocaine|lidocaine|mesh-list
5713121|NCT03262857|Magnesium Sulfate|magnesium sulfate|mesh-list
5713122|NCT03262857|Anesthetics, Local|anesthetics, local|mesh-ancestor
5713123|NCT03262857|Anesthetics|anesthetics|mesh-ancestor
5713124|NCT03262857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5713125|NCT03262857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713126|NCT03262857|Sensory System Agents|sensory system agents|mesh-ancestor
5713127|NCT03262857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5713128|NCT03262857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5713129|NCT03262857|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5713130|NCT03262857|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5713131|NCT03262857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6502986|NCT00650871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713132|NCT03262857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713133|NCT03262857|Analgesics|analgesics|mesh-ancestor
6239448|NCT02588339|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6244096|NCT02687451|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6244097|NCT02687451|Narcotics|narcotics|mesh-ancestor
6244098|NCT02687451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6244099|NCT02687451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244100|NCT02687451|Analgesics|analgesics|mesh-ancestor
6244101|NCT02687451|Sensory System Agents|sensory system agents|mesh-ancestor
6244102|NCT02687451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6244103|NCT02687451|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6244104|NCT02687815|Vitamin D|vitamin d|mesh-list
6244105|NCT02687815|Cholecalciferol|cholecalciferol|mesh-list
6244106|NCT02687815|Vitamins|vitamins|mesh-ancestor
5713134|NCT03262857|Anticonvulsants|anticonvulsants|mesh-ancestor
5713135|NCT03262857|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5713136|NCT03262857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5713137|NCT03262857|Tocolytic Agents|tocolytic agents|mesh-ancestor
5713138|NCT03262857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5713139|NCT03262948|Paclitaxel|paclitaxel|mesh-list
5713140|NCT03262948|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5713141|NCT03262948|Carboplatin|carboplatin|mesh-list
5713142|NCT03262948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5713143|NCT03262948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5713144|NCT03262948|Tubulin Modulators|tubulin modulators|mesh-ancestor
5713145|NCT03262948|Antimitotic Agents|antimitotic agents|mesh-ancestor
5713146|NCT03262948|Mitosis Modulators|mitosis modulators|mesh-ancestor
6244107|NCT02687815|Micronutrients|micronutrients|mesh-ancestor
6244108|NCT02687815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502987|NCT00650897|Citalopram|citalopram|mesh-list
6502988|NCT00650897|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6677670|NCT01588925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5713147|NCT03262948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713148|NCT03263065|Psyllium|psyllium|mesh-list
5713149|NCT03263065|Cathartics|cathartics|mesh-ancestor
5713150|NCT03263065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5713151|NCT03263052|Tacrolimus|tacrolimus|mesh-list
5713152|NCT03263052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5713153|NCT03263052|Immunologic Factors|immunologic factors|mesh-ancestor
5713154|NCT03263052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713155|NCT03263052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5713156|NCT03263052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5713157|NCT03263052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713158|NCT03263039|Pembrolizumab|pembrolizumab|mesh-list
5713159|NCT03263039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5713160|NCT03263039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5721797|NCT03203317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5721798|NCT03203317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721799|NCT03203473|Nivolumab|nivolumab|mesh-list
5721800|NCT03203473|Ipilimumab|ipilimumab|mesh-list
5721801|NCT03203473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5721802|NCT03203473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5721803|NCT03203473|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6239449|NCT02588586|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6239450|NCT02588586|Antiviral Agents|antiviral agents|mesh-ancestor
6239451|NCT02588586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6239452|NCT02588612|Cyclophosphamide|cyclophosphamide|mesh-list
6239453|NCT02588612|Fludarabine|fludarabine|mesh-list
6239454|NCT02588612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6239455|NCT02588612|Immunologic Factors|immunologic factors|mesh-ancestor
6239456|NCT02588612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239457|NCT02588612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6239458|NCT02588612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6239459|NCT02588612|Alkylating Agents|alkylating agents|mesh-ancestor
6239460|NCT02588612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239461|NCT02588612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6239462|NCT02588612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6239463|NCT02588872|Hyaluronic Acid|hyaluronic acid|mesh-list
6239464|NCT02588872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6239465|NCT02588872|Immunologic Factors|immunologic factors|mesh-ancestor
6239466|NCT02588872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239467|NCT02588872|Viscosupplements|viscosupplements|mesh-ancestor
6239468|NCT02588872|Protective Agents|protective agents|mesh-ancestor
5721804|NCT03203473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721805|NCT03203421|Heparin Cofactor II|heparin cofactor ii|mesh-list
5721806|NCT03203421|Antithrombins|antithrombins|mesh-ancestor
5721807|NCT03203421|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5721808|NCT03203421|Protease Inhibitors|protease inhibitors|mesh-ancestor
5721809|NCT03203421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5721810|NCT03203421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721811|NCT03203421|Anticoagulants|anticoagulants|mesh-ancestor
5721812|NCT03203174|Botulinum Toxins|botulinum toxins|mesh-list
5721813|NCT03203174|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6239469|NCT02589067|Chlorhexidine|chlorhexidine|mesh-list
6239470|NCT02589067|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6239471|NCT02589067|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6239472|NCT02589067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6239473|NCT02589067|Disinfectants|disinfectants|mesh-ancestor
6239474|NCT02589067|Dermatologic Agents|dermatologic agents|mesh-ancestor
6239475|NCT02589405|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6239476|NCT02589405|Dermatologic Agents|dermatologic agents|mesh-ancestor
6239477|NCT02589626|Empagliflozin|empagliflozin|mesh-list
6239478|NCT02589626|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6502989|NCT00650897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6502990|NCT00650897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6502991|NCT00650897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6502992|NCT00650897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6502993|NCT00650897|Serotonin Agents|serotonin agents|mesh-ancestor
6502994|NCT00650897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6502995|NCT00650897|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6502996|NCT00650897|Antidepressive Agents|antidepressive agents|mesh-ancestor
6502997|NCT00650897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6502998|NCT00650910|Lapatinib|lapatinib|mesh-list
6502999|NCT00650910|Digoxin|digoxin|mesh-list
6503000|NCT00650910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6503001|NCT00650910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6503002|NCT00650910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5713161|NCT03262961|Sildenafil Citrate|sildenafil citrate|mesh-list
5713162|NCT03262961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713163|NCT03262961|Vasodilator Agents|vasodilator agents|mesh-ancestor
5713164|NCT03262961|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5713165|NCT03262961|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6503003|NCT00650910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503004|NCT00650910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6503005|NCT00650910|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6503006|NCT00650910|Protective Agents|protective agents|mesh-ancestor
6503007|NCT00650910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713166|NCT03262961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5713167|NCT03262961|Urological Agents|urological agents|mesh-ancestor
5713168|NCT03262792|Andrographolide|andrographolide|mesh-list
5713169|NCT03262792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5713170|NCT03262792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5713171|NCT03262792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5713172|NCT03262792|Analgesics|analgesics|mesh-ancestor
5713173|NCT03262792|Sensory System Agents|sensory system agents|mesh-ancestor
5713174|NCT03262792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5713175|NCT03262792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713176|NCT03262792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5713177|NCT03262792|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5713178|NCT03262792|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5713179|NCT03262792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5713180|NCT03262792|Antiviral Agents|antiviral agents|mesh-ancestor
5713181|NCT03262792|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6503008|NCT00650923|Temozolomide|temozolomide|mesh-list
6503009|NCT00650923|Aflibercept|aflibercept|mesh-list
6503010|NCT00650923|Endothelial Growth Factors|endothelial growth factors|mesh-list
6503011|NCT00650923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6503012|NCT00650923|Alkylating Agents|alkylating agents|mesh-ancestor
5713182|NCT03262545|Apatinib|apatinib|mesh-list
5713183|NCT03262545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5713184|NCT03262545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5713185|NCT03262545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5713186|NCT03262545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713187|NCT03262688|Bupivacaine|bupivacaine|mesh-list
5713188|NCT03262688|Anesthetics, Local|anesthetics, local|mesh-ancestor
5713189|NCT03262688|Anesthetics|anesthetics|mesh-ancestor
5713190|NCT03262688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5713191|NCT03262688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713192|NCT03262688|Sensory System Agents|sensory system agents|mesh-ancestor
5713193|NCT03262688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5713194|NCT03262454|Atezolizumab|atezolizumab|mesh-list
5713195|NCT03262454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5713196|NCT03262740|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5713197|NCT03262740|Norethindrone|norethindrone|mesh-list
5713198|NCT03262740|Norethindrone Acetate|norethindrone acetate|mesh-list
6503013|NCT00650923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503014|NCT00650923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6503015|NCT00650923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6503016|NCT00650923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6503017|NCT00650923|Growth Substances|growth substances|mesh-ancestor
6239479|NCT02589626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239480|NCT02589626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6239481|NCT02589626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239482|NCT02589639|Empagliflozin|empagliflozin|mesh-list
6239483|NCT02589639|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6239484|NCT02589639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239485|NCT02589639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6239486|NCT02589639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239487|NCT02589665|Mirikizumab|mirikizumab|mesh-list
6239488|NCT02589665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6239489|NCT02589665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6239490|NCT02589665|Analgesics|analgesics|mesh-ancestor
6239491|NCT02589665|Sensory System Agents|sensory system agents|mesh-ancestor
6239492|NCT02589665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6239493|NCT02589665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239494|NCT02589665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6239495|NCT02589665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6239496|NCT02589665|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6239497|NCT02589665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6239498|NCT02589847|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5721814|NCT03203174|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6239499|NCT02589847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6239500|NCT02589847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6239501|NCT02589847|Antitubercular Agents|antitubercular agents|mesh-ancestor
6239502|NCT02589977|Regadenoson|regadenoson|mesh-list
6239503|NCT02589977|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
6239504|NCT02589977|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6239505|NCT02589977|Purinergic Agonists|purinergic agonists|mesh-ancestor
6239506|NCT02589977|Purinergic Agents|purinergic agents|mesh-ancestor
6239507|NCT02589977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6239508|NCT02589977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239509|NCT02589977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239510|NCT02590003|Paclitaxel|paclitaxel|mesh-list
6239511|NCT02590003|Carboplatin|carboplatin|mesh-list
6239512|NCT02590003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6239513|NCT02590003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6239514|NCT02590003|Tubulin Modulators|tubulin modulators|mesh-ancestor
6239515|NCT02590003|Antimitotic Agents|antimitotic agents|mesh-ancestor
6239516|NCT02590003|Mitosis Modulators|mitosis modulators|mesh-ancestor
6239517|NCT02590003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239518|NCT02590432|Linaclotide|linaclotide|mesh-list
6239519|NCT02590432|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
6239520|NCT02590432|Enzyme Activators|enzyme activators|mesh-ancestor
6239521|NCT02590432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239522|NCT02590432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6239523|NCT02590588|Idelalisib|idelalisib|mesh-list
6239524|NCT02590588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6239525|NCT02590588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6239526|NCT02590588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239527|NCT02591238|Melatonin|melatonin|mesh-list
6239528|NCT02591238|Antioxidants|antioxidants|mesh-ancestor
6239529|NCT02591238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239530|NCT02591238|Protective Agents|protective agents|mesh-ancestor
6239531|NCT02591238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239532|NCT02591238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6239533|NCT02592421|Dapagliflozin|dapagliflozin|mesh-list
6239534|NCT02592421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6239535|NCT02592421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239536|NCT02592421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5713199|NCT03262740|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
5713200|NCT03262740|Estradiol|estradiol|mesh-list
5713201|NCT03262740|Branebrutinib|branebrutinib|mesh-list
5713202|NCT03262740|Estrogens|estrogens|mesh-ancestor
5713203|NCT03262740|Hormones|hormones|mesh-ancestor
5713204|NCT03262740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5713205|NCT03262740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713206|NCT03262740|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6239537|NCT02592421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239538|NCT02592434|Tofacitinib|tofacitinib|mesh-list
5713207|NCT03262740|Contraceptive Agents|contraceptive agents|mesh-ancestor
5713208|NCT03262740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5713209|NCT03262740|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5713210|NCT03262740|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5713211|NCT03262740|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5713212|NCT03262740|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5713213|NCT03262740|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5713214|NCT03262740|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
5713215|NCT03262740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5713216|NCT03262740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5713217|NCT03262740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713218|NCT03262727|BMS-986165|bms-986165|mesh-list
5713219|NCT03262727|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5713220|NCT03262727|Norethindrone|norethindrone|mesh-list
5713221|NCT03262727|Norethindrone Acetate|norethindrone acetate|mesh-list
5713222|NCT03262727|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
5713223|NCT03262727|Estradiol|estradiol|mesh-list
5713224|NCT03262727|Estrogens|estrogens|mesh-ancestor
5713225|NCT03262727|Hormones|hormones|mesh-ancestor
5713226|NCT03262727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5713227|NCT03262727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713228|NCT03262727|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5713229|NCT03262727|Contraceptive Agents|contraceptive agents|mesh-ancestor
6239539|NCT02592434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6239540|NCT02592434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6239541|NCT02592434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239542|NCT02592486|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6239543|NCT02592486|Immunologic Factors|immunologic factors|mesh-ancestor
6239544|NCT02592486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239545|NCT02592629|Triamcinolone|triamcinolone|mesh-list
6239546|NCT02592629|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6239547|NCT02592629|Lidocaine|lidocaine|mesh-list
6239548|NCT02592629|Ethyl Chloride|ethyl chloride|mesh-list
6239549|NCT02592629|Anesthetics, Local|anesthetics, local|mesh-ancestor
6239550|NCT02592629|Anesthetics|anesthetics|mesh-ancestor
6239551|NCT02592629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6239552|NCT02592629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239553|NCT02592629|Sensory System Agents|sensory system agents|mesh-ancestor
6239554|NCT02592629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6239555|NCT02592629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6239556|NCT02592629|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6239557|NCT02592629|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6239558|NCT02592629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6239559|NCT02592629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239560|NCT02592629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6239561|NCT02592629|Glucocorticoids|glucocorticoids|mesh-ancestor
6239562|NCT02592629|Hormones|hormones|mesh-ancestor
6239563|NCT02592629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6239564|NCT02592629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6503018|NCT00650923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503019|NCT00650923|Growth Inhibitors|growth inhibitors|mesh-ancestor
6677671|NCT01588925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677672|NCT01588925|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6677673|NCT01588925|Immunologic Factors|immunologic factors|mesh-ancestor
6677674|NCT01588925|Viscosupplements|viscosupplements|mesh-ancestor
6677675|NCT01588925|Protective Agents|protective agents|mesh-ancestor
6677676|NCT01589055|Nicotine|nicotine|mesh-list
6677677|NCT01589055|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6677678|NCT01589055|Autonomic Agents|autonomic agents|mesh-ancestor
6677679|NCT01589055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6677680|NCT01589055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677681|NCT01589055|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6677682|NCT01589055|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6677683|NCT01589055|Cholinergic Agents|cholinergic agents|mesh-ancestor
6677684|NCT01589055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6677685|NCT01589055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677686|NCT01589068|Nicotine|nicotine|mesh-list
6677687|NCT01589068|Progesterone|progesterone|mesh-list
6677688|NCT01589068|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6677689|NCT01589068|Autonomic Agents|autonomic agents|mesh-ancestor
6677690|NCT01589068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6677691|NCT01589068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677692|NCT01589068|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6677693|NCT01589068|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6677694|NCT01589068|Cholinergic Agents|cholinergic agents|mesh-ancestor
6677695|NCT01589068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6677696|NCT01589068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677697|NCT01589068|Progestins|progestins|mesh-ancestor
6677698|NCT01589068|Hormones|hormones|mesh-ancestor
6677699|NCT01589068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6677700|NCT01589081|Nicotine|nicotine|mesh-list
6677701|NCT01589081|Progesterone|progesterone|mesh-list
6677702|NCT01589081|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6677703|NCT01589081|Autonomic Agents|autonomic agents|mesh-ancestor
6677704|NCT01589081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6677705|NCT01589081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677706|NCT01589081|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6677707|NCT01589081|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6677708|NCT01589081|Cholinergic Agents|cholinergic agents|mesh-ancestor
6677709|NCT01589081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6677710|NCT01589081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677711|NCT01589081|Progestins|progestins|mesh-ancestor
6677712|NCT01589081|Hormones|hormones|mesh-ancestor
6677713|NCT01589081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6677714|NCT01589146|Heparin|heparin|mesh-list
6677715|NCT01589146|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6677716|NCT01589146|Tinzaparin|tinzaparin|mesh-list
5713230|NCT03262727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5713231|NCT03262727|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5713232|NCT03262727|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5713233|NCT03262727|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5713234|NCT03262727|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5713235|NCT03262727|Dermatologic Agents|dermatologic agents|mesh-ancestor
6503020|NCT00651066|Ritonavir|ritonavir|mesh-list
6503021|NCT00651066|Lopinavir|lopinavir|mesh-list
6503022|NCT00651066|Rifabutin|rifabutin|mesh-list
6503023|NCT00651066|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6503024|NCT00651066|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6503025|NCT00651066|Protease Inhibitors|protease inhibitors|mesh-ancestor
6503026|NCT00651066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6503027|NCT00651066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503028|NCT00651066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6503029|NCT00651066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6239565|NCT02592629|Immunologic Factors|immunologic factors|mesh-ancestor
6239566|NCT02592798|Abatacept|abatacept|mesh-list
6239567|NCT02592798|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6239568|NCT02592798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239569|NCT02592798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6239570|NCT02592798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6239571|NCT02592798|Immunologic Factors|immunologic factors|mesh-ancestor
6239572|NCT02592798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239573|NCT02592798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6239574|NCT02592876|Rituximab|rituximab|mesh-list
6239575|NCT02592876|Carboplatin|carboplatin|mesh-list
6239576|NCT02592876|Etoposide|etoposide|mesh-list
6239577|NCT02592876|Ifosfamide|ifosfamide|mesh-list
6239578|NCT02592876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6239579|NCT02592876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6239580|NCT02592876|Immunologic Factors|immunologic factors|mesh-ancestor
6239581|NCT02592876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239582|NCT02592876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6239583|NCT02592876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6239584|NCT02592876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6239585|NCT02592876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6239586|NCT02592876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6239587|NCT02592876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239588|NCT02592876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6239589|NCT02592876|Alkylating Agents|alkylating agents|mesh-ancestor
6239590|NCT02593097|Metformin|metformin|mesh-list
6239591|NCT02593097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6239592|NCT02593097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239593|NCT02593305|Methamphetamine|methamphetamine|mesh-list
6239594|NCT02593305|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6239595|NCT02593305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239596|NCT02593305|Sympathomimetics|sympathomimetics|mesh-ancestor
6239597|NCT02593305|Autonomic Agents|autonomic agents|mesh-ancestor
6239598|NCT02593305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6239599|NCT02593305|Dopamine Agents|dopamine agents|mesh-ancestor
6239600|NCT02593305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6239601|NCT02593305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239602|NCT02593305|Adrenergic Agents|adrenergic agents|mesh-ancestor
6239603|NCT02593305|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6239604|NCT02593305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6239605|NCT02593305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6239606|NCT02593305|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6239607|NCT02593396|Bupropion|bupropion|mesh-list
6239608|NCT02593396|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6239609|NCT02593396|Antidepressive Agents|antidepressive agents|mesh-ancestor
6503030|NCT00651066|Antiviral Agents|antiviral agents|mesh-ancestor
6503031|NCT00651066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6503032|NCT00651066|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6239610|NCT02593396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6239611|NCT02593396|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6239612|NCT02593396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6239613|NCT02593396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6239614|NCT02593396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503033|NCT00651066|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5713236|NCT03262727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5713237|NCT03262727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5713238|NCT03262727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239615|NCT02593396|Dopamine Agents|dopamine agents|mesh-ancestor
6239616|NCT02593396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6239617|NCT02593396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239618|NCT02593396|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6239619|NCT02593396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6239620|NCT02593396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6239621|NCT02593539|Nemiralisib|nemiralisib|mesh-list
6239622|NCT02593539|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6239623|NCT02593539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6239624|NCT02593539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239625|NCT02593773|Interferons|interferons|mesh-list
6239626|NCT02593773|Interferon-gamma|interferon-gamma|mesh-list
6239627|NCT02593773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5713239|NCT03262727|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5713240|NCT03262727|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
5713241|NCT03262142|Ciprofloxacin|ciprofloxacin|mesh-list
5713242|NCT03262142|Tazobactam|tazobactam|mesh-list
5713243|NCT03262142|Piperacillin|piperacillin|mesh-list
5713244|NCT03262142|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
5713245|NCT03262142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5713246|NCT03262142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5713247|NCT03262142|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5713248|NCT03262142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5713249|NCT03262142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5713250|NCT03262142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713251|NCT03262142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5713252|NCT03262142|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5713253|NCT03262142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5713254|NCT03262142|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5713255|NCT03262077|Methylene Blue|methylene blue|mesh-list
5713256|NCT03262077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5713257|NCT03262077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713258|NCT03262090|Dexmedetomidine|dexmedetomidine|mesh-list
5713259|NCT03262090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5713260|NCT03262090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5713261|NCT03262090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713262|NCT03262090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5713263|NCT03262090|Analgesics|analgesics|mesh-ancestor
5713264|NCT03262090|Sensory System Agents|sensory system agents|mesh-ancestor
5713265|NCT03262090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5713266|NCT03262090|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5713267|NCT03262090|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5713268|NCT03262090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5713269|NCT03262090|Adrenergic Agents|adrenergic agents|mesh-ancestor
5713270|NCT03262090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5713271|NCT03262090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713272|NCT03262116|Insulin|insulin|mesh-list
5713273|NCT03262116|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5713274|NCT03262116|Insulin Lispro|insulin lispro|mesh-list
5713275|NCT03262116|Insulin Aspart|insulin aspart|mesh-list
5713276|NCT03262116|Pancrelipase|pancrelipase|mesh-list
5713277|NCT03262116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6239628|NCT02593773|Antiviral Agents|antiviral agents|mesh-ancestor
6239629|NCT02593773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6239630|NCT02593903|Trimethoprim|trimethoprim|mesh-list
6239631|NCT02593903|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6239632|NCT02593903|Sulfamethoxazole|sulfamethoxazole|mesh-list
6239633|NCT02593903|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6239634|NCT02593903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6239635|NCT02593903|Renal Agents|renal agents|mesh-ancestor
6239636|NCT02593903|Antimalarials|antimalarials|mesh-ancestor
6239637|NCT02593903|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6239638|NCT02593903|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6239639|NCT02593903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6239640|NCT02593903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6239641|NCT02593903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239642|NCT02593903|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6239643|NCT02593903|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6239644|NCT02593903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6239645|NCT02593903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6239646|NCT02594111|Colchicine|colchicine|mesh-list
6239647|NCT02594111|Gout Suppressants|gout suppressants|mesh-ancestor
6677717|NCT01589146|Dalteparin|dalteparin|mesh-list
6677718|NCT01589146|Anticoagulants|anticoagulants|mesh-ancestor
5713278|NCT03262116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713279|NCT03262116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5713280|NCT03262363|Curcumin|curcumin|mesh-list
5713281|NCT03262363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5713282|NCT03262363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5713283|NCT03262363|Analgesics|analgesics|mesh-ancestor
5713284|NCT03262363|Sensory System Agents|sensory system agents|mesh-ancestor
5713285|NCT03262363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5713286|NCT03262363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713287|NCT03262363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5713288|NCT03262363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5713289|NCT03262363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5713290|NCT03262363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5713291|NCT03262363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713292|NCT03262376|Vitamins|vitamins|mesh-list
6239648|NCT02594111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6239649|NCT02594111|Tubulin Modulators|tubulin modulators|mesh-ancestor
6239650|NCT02594111|Antimitotic Agents|antimitotic agents|mesh-ancestor
6239651|NCT02594111|Mitosis Modulators|mitosis modulators|mesh-ancestor
6239652|NCT02594111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239653|NCT02594111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6239654|NCT02594163|Rituximab|rituximab|mesh-list
6239655|NCT02594163|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6239656|NCT02594163|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6239657|NCT02594163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6239658|NCT02594163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6239659|NCT02594163|Immunologic Factors|immunologic factors|mesh-ancestor
6239660|NCT02594163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239661|NCT02594163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6503034|NCT00651066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6503035|NCT00651066|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6503036|NCT00651066|Antitubercular Agents|antitubercular agents|mesh-ancestor
6503037|NCT00651105|Vildagliptin|vildagliptin|mesh-list
6503038|NCT00651105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6503039|NCT00651105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503040|NCT00651105|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6503041|NCT00651105|Protease Inhibitors|protease inhibitors|mesh-ancestor
6503042|NCT00651105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6503043|NCT00651105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677719|NCT01589146|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6677720|NCT01589146|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6677721|NCT01589146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677722|NCT01589159|Capecitabine|capecitabine|mesh-list
6677723|NCT01589159|Etoposide|etoposide|mesh-list
6677724|NCT01589159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6677725|NCT01589159|Antimetabolites|antimetabolites|mesh-ancestor
6677726|NCT01589159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677727|NCT01589159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6677728|NCT01589159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6677729|NCT01589159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6677730|NCT01589159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6677731|NCT01589159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6677732|NCT01589354|Ropivacaine|ropivacaine|mesh-list
6677733|NCT01589354|Anesthetics, Local|anesthetics, local|mesh-ancestor
6677734|NCT01589354|Anesthetics|anesthetics|mesh-ancestor
6677735|NCT01589354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6677736|NCT01589354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677737|NCT01589354|Sensory System Agents|sensory system agents|mesh-ancestor
6677738|NCT01589354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5713293|NCT03262376|Micronutrients|micronutrients|mesh-ancestor
6239662|NCT02594163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6239663|NCT02594163|Alkylating Agents|alkylating agents|mesh-ancestor
6239664|NCT02594163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239665|NCT02594644|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6239666|NCT02594644|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6239667|NCT02594644|Dermatologic Agents|dermatologic agents|mesh-ancestor
6239668|NCT02595398|Triamcinolone|triamcinolone|mesh-list
6239669|NCT02595398|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6239670|NCT02595398|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6239671|NCT02595398|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6239672|NCT02595398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6239673|NCT02595398|Glucocorticoids|glucocorticoids|mesh-ancestor
6239674|NCT02595398|Hormones|hormones|mesh-ancestor
6503044|NCT00651131|Daptomycin|daptomycin|mesh-list
6503045|NCT00651131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6677739|NCT01589367|Metformin|metformin|mesh-list
5713294|NCT03262376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713295|NCT03262103|Poly I-C|poly i-c|mesh-list
5713296|NCT03262103|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
5713297|NCT03262103|Poly ICLC|poly iclc|mesh-list
6239675|NCT02595398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6239676|NCT02595398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239677|NCT02595398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6239678|NCT02595398|Immunologic Factors|immunologic factors|mesh-ancestor
6239679|NCT02595398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6503046|NCT00651131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6503047|NCT00651209|Tenofovir|tenofovir|mesh-list
6503048|NCT00651209|Antiviral Agents|antiviral agents|mesh-ancestor
6239680|NCT02595398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239681|NCT02595450|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6239682|NCT02595450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6239683|NCT02595450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6239684|NCT02595450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6239685|NCT02595450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503049|NCT00651209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6503050|NCT00651209|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6503051|NCT00651209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6503052|NCT00651209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6503053|NCT00651209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503054|NCT00651209|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6503055|NCT00651209|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6239686|NCT02595528|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6239687|NCT02595528|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6239688|NCT02595684|Tadalafil|tadalafil|mesh-list
6239689|NCT02595684|Vasodilator Agents|vasodilator agents|mesh-ancestor
6239690|NCT02595684|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6239691|NCT02595684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6239692|NCT02595684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6239693|NCT02595684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239694|NCT02595684|Urological Agents|urological agents|mesh-ancestor
6239695|NCT02595723|Megestrol|megestrol|mesh-list
6239696|NCT02595723|Megestrol Acetate|megestrol acetate|mesh-list
6239697|NCT02595723|Phenytoin|phenytoin|mesh-list
6239698|NCT02595723|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6239699|NCT02595723|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6239700|NCT02595723|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6239701|NCT02595723|Contraceptive Agents|contraceptive agents|mesh-ancestor
6239702|NCT02595723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6239703|NCT02595723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239704|NCT02595723|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6239705|NCT02595723|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6239706|NCT02595723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6239707|NCT02595723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6239708|NCT02595723|Appetite Stimulants|appetite stimulants|mesh-ancestor
6239709|NCT02595723|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6239710|NCT02595723|Anticonvulsants|anticonvulsants|mesh-ancestor
6239711|NCT02595723|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6239712|NCT02595723|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6239713|NCT02595723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6239714|NCT02595723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239715|NCT02595723|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6239716|NCT02595723|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6239717|NCT02595749|Oxytocin|oxytocin|mesh-list
6239718|NCT02595749|Oxytocics|oxytocics|mesh-ancestor
6239719|NCT02595749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6239720|NCT02595749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239721|NCT02596022|Ketamine|ketamine|mesh-list
6239722|NCT02596022|Analgesics|analgesics|mesh-ancestor
6239723|NCT02596022|Sensory System Agents|sensory system agents|mesh-ancestor
6239724|NCT02596022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6239725|NCT02596022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239726|NCT02596022|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6503056|NCT00651235|Losartan|losartan|mesh-list
6239727|NCT02596022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6239728|NCT02596022|Anesthetics, General|anesthetics, general|mesh-ancestor
6239729|NCT02596022|Anesthetics|anesthetics|mesh-ancestor
6239730|NCT02596022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6503057|NCT00651235|Propranolol|propranolol|mesh-list
6503058|NCT00651235|Atenolol|atenolol|mesh-list
5713298|NCT03262103|Interferon Inducers|interferon inducers|mesh-ancestor
5713299|NCT03262103|Immunologic Factors|immunologic factors|mesh-ancestor
5713300|NCT03262103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713301|NCT03262103|Laxatives|laxatives|mesh-ancestor
5713302|NCT03262103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5713303|NCT03262103|Antiviral Agents|antiviral agents|mesh-ancestor
5713304|NCT03262103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5713305|NCT03261635|Indomethacin|indomethacin|mesh-list
5713306|NCT03261635|Ranibizumab|ranibizumab|mesh-list
5713307|NCT03261635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5713308|NCT03261635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5713309|NCT03261635|Growth Substances|growth substances|mesh-ancestor
5713310|NCT03261635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713311|NCT03261635|Growth Inhibitors|growth inhibitors|mesh-ancestor
5713312|NCT03261635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5713313|NCT03261635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5713314|NCT03261635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5713315|NCT03261635|Analgesics|analgesics|mesh-ancestor
5713316|NCT03261635|Sensory System Agents|sensory system agents|mesh-ancestor
5713317|NCT03261635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5713318|NCT03261635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5713319|NCT03261635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5713320|NCT03261635|Gout Suppressants|gout suppressants|mesh-ancestor
5713321|NCT03261635|Tocolytic Agents|tocolytic agents|mesh-ancestor
6503059|NCT00651235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6503060|NCT00651235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6503061|NCT00651235|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6503062|NCT00651235|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6503063|NCT00651235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503064|NCT00651235|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6503065|NCT00651235|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6503066|NCT00651235|Adrenergic Agents|adrenergic agents|mesh-ancestor
6503067|NCT00651235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6503068|NCT00651235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503069|NCT00651235|Vasodilator Agents|vasodilator agents|mesh-ancestor
6503070|NCT00651235|Sympatholytics|sympatholytics|mesh-ancestor
6503071|NCT00651235|Autonomic Agents|autonomic agents|mesh-ancestor
6503072|NCT00651235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6503073|NCT00651235|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6239731|NCT02596022|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6239732|NCT02596022|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6239733|NCT02596022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6239734|NCT02596022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239735|NCT02596035|Nivolumab|nivolumab|mesh-list
6239736|NCT02596035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5713322|NCT03261635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5713323|NCT03261635|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5713324|NCT03261635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5713325|NCT03261635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713326|NCT03261570|Digoxin|digoxin|mesh-list
5713327|NCT03261570|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
5713328|NCT03261570|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5713329|NCT03261570|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5713330|NCT03261570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5713331|NCT03261570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713332|NCT03261570|Protective Agents|protective agents|mesh-ancestor
5713333|NCT03261570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239737|NCT02596035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6239738|NCT02596035|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6239739|NCT02596035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239740|NCT02596451|Diclofenac|diclofenac|mesh-list
6239741|NCT02596451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6239742|NCT02596451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6239743|NCT02596451|Analgesics|analgesics|mesh-ancestor
6239744|NCT02596451|Sensory System Agents|sensory system agents|mesh-ancestor
6239745|NCT02596451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6239746|NCT02596451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239747|NCT02596451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6239748|NCT02596451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6239749|NCT02596451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6503074|NCT00651287|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6239750|NCT02596451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6244109|NCT02687815|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6239751|NCT02596451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239752|NCT02596620|Amoxicillin|amoxicillin|mesh-list
6239753|NCT02596620|Metronidazole|metronidazole|mesh-list
6239754|NCT02596620|Levofloxacin|levofloxacin|mesh-list
5713334|NCT03261570|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5713335|NCT03261570|Cholinergic Agents|cholinergic agents|mesh-ancestor
5713336|NCT03261570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5713337|NCT03261921|Dexamethasone|dexamethasone|mesh-list
5713338|NCT03261921|Dexmedetomidine|dexmedetomidine|mesh-list
6239755|NCT02596620|Esomeprazole|esomeprazole|mesh-list
6503075|NCT00651287|Quinapril|quinapril|mesh-list
6503076|NCT00651287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6503077|NCT00651287|Diuretics|diuretics|mesh-ancestor
6503078|NCT00651287|Natriuretic Agents|natriuretic agents|mesh-ancestor
6503079|NCT00651287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503080|NCT00651287|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6503081|NCT00651287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5713339|NCT03261921|Bupivacaine|bupivacaine|mesh-list
5713340|NCT03261921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5713341|NCT03261921|Antiemetics|antiemetics|mesh-ancestor
5713342|NCT03261921|Autonomic Agents|autonomic agents|mesh-ancestor
5713343|NCT03261921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5713344|NCT03261921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713345|NCT03261921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5713346|NCT03261921|Glucocorticoids|glucocorticoids|mesh-ancestor
5713347|NCT03261921|Hormones|hormones|mesh-ancestor
5713348|NCT03261921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5713349|NCT03261921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5713350|NCT03261921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5713351|NCT03261921|Anesthetics, Local|anesthetics, local|mesh-ancestor
5713352|NCT03261921|Anesthetics|anesthetics|mesh-ancestor
5713353|NCT03261921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5713354|NCT03261921|Sensory System Agents|sensory system agents|mesh-ancestor
5713355|NCT03261921|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5713356|NCT03261921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5713357|NCT03261921|Analgesics|analgesics|mesh-ancestor
5713358|NCT03261921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5713359|NCT03261921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5713360|NCT03261921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5713361|NCT03261921|Adrenergic Agents|adrenergic agents|mesh-ancestor
5713362|NCT03261921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5713363|NCT03261921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713364|NCT03261596|Mebendazole|mebendazole|mesh-list
5713365|NCT03261596|Piperazine|piperazine|mesh-list
5713366|NCT03261596|Piperazine citrate|piperazine citrate|mesh-list
5713367|NCT03261596|DMP 777|dmp 777|mesh-list
5713368|NCT03261596|Antinematodal Agents|antinematodal agents|mesh-ancestor
5713369|NCT03261596|Anthelmintics|anthelmintics|mesh-ancestor
5713370|NCT03261596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5713371|NCT03261596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5713372|NCT03261596|Tubulin Modulators|tubulin modulators|mesh-ancestor
5713373|NCT03261596|Antimitotic Agents|antimitotic agents|mesh-ancestor
5713374|NCT03261596|Mitosis Modulators|mitosis modulators|mesh-ancestor
5713375|NCT03261596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713376|NCT03261596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5713377|NCT03261596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5713378|NCT03261791|Apatinib|apatinib|mesh-list
5713379|NCT03261791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5713380|NCT03261791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5713381|NCT03261791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5713382|NCT03261791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713383|NCT03261284|Warfarin|warfarin|mesh-list
5713384|NCT03261284|Dabigatran|dabigatran|mesh-list
5713385|NCT03261284|Anticoagulants|anticoagulants|mesh-ancestor
6239756|NCT02596620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6239757|NCT02596620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6239758|NCT02596620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6239759|NCT02596620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6239760|NCT02596620|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6239761|NCT02596620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6239762|NCT02596620|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6239763|NCT02596620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6239764|NCT02596620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239765|NCT02596620|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6239766|NCT02596620|Renal Agents|renal agents|mesh-ancestor
6239767|NCT02596620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6677740|NCT01589367|Letrozole|letrozole|mesh-list
5713386|NCT03261284|Antithrombins|antithrombins|mesh-ancestor
5713387|NCT03261284|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5713388|NCT03261284|Protease Inhibitors|protease inhibitors|mesh-ancestor
5713389|NCT03261284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6239768|NCT02596620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6239769|NCT02596620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6239770|NCT02596620|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6239771|NCT02596620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6239772|NCT02596711|Nicotine|nicotine|mesh-list
6239773|NCT02596711|Carbon Monoxide|carbon monoxide|mesh-list
6239774|NCT02596711|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6239775|NCT02596711|Autonomic Agents|autonomic agents|mesh-ancestor
6239776|NCT02596711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6239777|NCT02596711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239778|NCT02596711|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6239779|NCT02596711|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6239780|NCT02596711|Cholinergic Agents|cholinergic agents|mesh-ancestor
6239781|NCT02596711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6239782|NCT02596711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239783|NCT02596711|Antimetabolites|antimetabolites|mesh-ancestor
6239784|NCT02596711|Gasotransmitters|gasotransmitters|mesh-ancestor
6239785|NCT02596867|Propranolol|propranolol|mesh-list
6239786|NCT02596867|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6239787|NCT02596867|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6239788|NCT02596867|Adrenergic Agents|adrenergic agents|mesh-ancestor
6239789|NCT02596867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6239790|NCT02596867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239791|NCT02596867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239792|NCT02596867|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6239793|NCT02596867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6239794|NCT02596867|Vasodilator Agents|vasodilator agents|mesh-ancestor
6239795|NCT02596945|Epoetin Alfa|epoetin alfa|mesh-list
6239796|NCT02596945|Hematinics|hematinics|mesh-ancestor
6239797|NCT02596958|Bevacizumab|bevacizumab|mesh-list
6239798|NCT02596958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6239799|NCT02596958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6239800|NCT02596958|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6239801|NCT02596958|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6239802|NCT02596958|Growth Substances|growth substances|mesh-ancestor
6239803|NCT02596958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239804|NCT02596958|Growth Inhibitors|growth inhibitors|mesh-ancestor
6239805|NCT02596971|Prednisone|prednisone|mesh-list
6239806|NCT02596971|Cyclophosphamide|cyclophosphamide|mesh-list
6239807|NCT02596971|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6239808|NCT02596971|Rituximab|rituximab|mesh-list
6239809|NCT02596971|Doxorubicin|doxorubicin|mesh-list
6239810|NCT02596971|Vincristine|vincristine|mesh-list
6239811|NCT02596971|Atezolizumab|atezolizumab|mesh-list
6239812|NCT02596971|Obinutuzumab|obinutuzumab|mesh-list
6239813|NCT02596971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6239814|NCT02596971|Immunologic Factors|immunologic factors|mesh-ancestor
6239815|NCT02596971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239816|NCT02596971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6239817|NCT02596971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6239818|NCT02596971|Alkylating Agents|alkylating agents|mesh-ancestor
5713390|NCT03261284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713391|NCT03261193|Bupivacaine|bupivacaine|mesh-list
5713392|NCT03261193|Anesthetics, Local|anesthetics, local|mesh-ancestor
5713393|NCT03261193|Anesthetics|anesthetics|mesh-ancestor
5713394|NCT03261193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5713395|NCT03261193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919198|NCT04984577|Protective Agents|protective agents|mesh-ancestor
5919199|NCT04984577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964078|NCT04595591|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5964079|NCT04595591|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5964080|NCT04595409|Ustekinumab|ustekinumab|mesh-list
6239819|NCT02596971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239820|NCT02596971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5964081|NCT04595409|Dermatologic Agents|dermatologic agents|mesh-ancestor
5970631|NCT04533867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5970632|NCT04533867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970633|NCT04533867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5970634|NCT04533867|Antipruritics|antipruritics|mesh-ancestor
6239821|NCT02596971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5970635|NCT04533867|Dermatologic Agents|dermatologic agents|mesh-ancestor
6677741|NCT01589367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6239822|NCT02596971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6239823|NCT02596971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6239824|NCT02596971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6239825|NCT02596971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6503082|NCT00651287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503083|NCT00651287|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5713396|NCT03261193|Sensory System Agents|sensory system agents|mesh-ancestor
5713397|NCT03261193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5713398|NCT03261427|Pregabalin|pregabalin|mesh-list
5713399|NCT03261427|Analgesics|analgesics|mesh-ancestor
5713400|NCT03261427|Sensory System Agents|sensory system agents|mesh-ancestor
5713401|NCT03261427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5713402|NCT03261427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713403|NCT03261427|Anticonvulsants|anticonvulsants|mesh-ancestor
5713404|NCT03261427|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5713405|NCT03261427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6503084|NCT00651287|Protease Inhibitors|protease inhibitors|mesh-ancestor
6503085|NCT00651287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6503086|NCT00651300|Parecoxib|parecoxib|mesh-list
6503087|NCT00651300|Valdecoxib|valdecoxib|mesh-list
6503088|NCT00651300|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6503089|NCT00651300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6503090|NCT00651300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5713406|NCT03261427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713407|NCT03261427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5713408|NCT03261427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5713409|NCT03261427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5713410|NCT03261427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5713411|NCT03261427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5713412|NCT03261349|Sofosbuvir|sofosbuvir|mesh-list
5713413|NCT03261349|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
5713414|NCT03261349|Ledipasvir|ledipasvir|mesh-list
5713415|NCT03261349|Antiviral Agents|antiviral agents|mesh-ancestor
5713416|NCT03261349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5713417|NCT03261375|Antihypertensive Agents|antihypertensive agents|mesh-list
5721815|NCT03203174|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5721816|NCT03203174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5721817|NCT03203174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721818|NCT03203174|Cholinergic Agents|cholinergic agents|mesh-ancestor
5721819|NCT03203174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5721820|NCT03203174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919200|NCT04984278|Nabiximols|nabiximols|mesh-list
5919201|NCT04984278|Analgesics|analgesics|mesh-ancestor
5919202|NCT04984278|Sensory System Agents|sensory system agents|mesh-ancestor
5919203|NCT04984278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5919204|NCT04984278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919205|NCT04983836|Anesthetics|anesthetics|mesh-list
5919206|NCT04983836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5919207|NCT04983836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919208|NCT04984070|Metformin|metformin|mesh-list
5919209|NCT04984070|Drospirenone|drospirenone|mesh-list
5919210|NCT04984070|Contraceptive Agents|contraceptive agents|mesh-list
5919211|NCT04984070|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5919212|NCT04984070|Contraceptives, Oral|contraceptives, oral|mesh-list
6503091|NCT00651300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503092|NCT00651300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6503093|NCT00651300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6503094|NCT00651300|Analgesics|analgesics|mesh-ancestor
6503095|NCT00651300|Sensory System Agents|sensory system agents|mesh-ancestor
6503096|NCT00651300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6503097|NCT00651300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503098|NCT00651300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6503099|NCT00651300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6503100|NCT00651326|Docetaxel|docetaxel|mesh-list
6503101|NCT00651326|Leuprolide|leuprolide|mesh-list
6503102|NCT00651326|Goserelin|goserelin|mesh-list
6503103|NCT00651326|Bicalutamide|bicalutamide|mesh-list
6503104|NCT00651326|Flutamide|flutamide|mesh-list
6503105|NCT00651326|Buserelin|buserelin|mesh-list
5919213|NCT04984070|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
5919214|NCT04984070|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
5721821|NCT03203174|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5919215|NCT04984070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5919216|NCT04984070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239826|NCT02596971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6239827|NCT02596971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6239828|NCT02596971|Glucocorticoids|glucocorticoids|mesh-ancestor
6239829|NCT02596971|Hormones|hormones|mesh-ancestor
6239830|NCT02596971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6239831|NCT02596971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6239832|NCT02596971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6239833|NCT02596971|Tubulin Modulators|tubulin modulators|mesh-ancestor
6239834|NCT02596971|Antimitotic Agents|antimitotic agents|mesh-ancestor
6239835|NCT02596971|Mitosis Modulators|mitosis modulators|mesh-ancestor
6239836|NCT02597049|Metformin|metformin|mesh-list
6239837|NCT02597049|Dapagliflozin|dapagliflozin|mesh-list
6239838|NCT02597049|Empagliflozin|empagliflozin|mesh-list
6239839|NCT02597049|Canagliflozin|canagliflozin|mesh-list
6239840|NCT02597049|Dulaglutide|dulaglutide|mesh-list
6239841|NCT02597049|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
6503106|NCT00651326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6503107|NCT00651326|Tubulin Modulators|tubulin modulators|mesh-ancestor
6503108|NCT00651326|Antimitotic Agents|antimitotic agents|mesh-ancestor
6503109|NCT00651326|Mitosis Modulators|mitosis modulators|mesh-ancestor
6503110|NCT00651326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713418|NCT03261310|Acetaminophen|acetaminophen|mesh-list
6239842|NCT02597049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6239843|NCT02597049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239844|NCT02597049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239845|NCT02597101|Metformin|metformin|mesh-list
6239846|NCT02597101|Saxagliptin|saxagliptin|mesh-list
6239847|NCT02597101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6239848|NCT02597101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239849|NCT02597101|Incretins|incretins|mesh-ancestor
6239850|NCT02597101|Hormones|hormones|mesh-ancestor
6239851|NCT02597101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6239852|NCT02597101|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6239853|NCT02597101|Protease Inhibitors|protease inhibitors|mesh-ancestor
6239854|NCT02597101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6239855|NCT02597101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239856|NCT02597478|Fentanyl|fentanyl|mesh-list
6239857|NCT02597478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6239858|NCT02597478|Narcotics|narcotics|mesh-ancestor
6239859|NCT02597478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5713419|NCT03261310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5713420|NCT03261310|Analgesics|analgesics|mesh-ancestor
5713421|NCT03261310|Sensory System Agents|sensory system agents|mesh-ancestor
5713422|NCT03261310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5713423|NCT03261310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713424|NCT03261310|Antipyretics|antipyretics|mesh-ancestor
5713425|NCT03261102|Adalimumab|adalimumab|mesh-list
6239860|NCT02597478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239861|NCT02597478|Analgesics|analgesics|mesh-ancestor
6239862|NCT02597478|Sensory System Agents|sensory system agents|mesh-ancestor
6239863|NCT02597478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6239864|NCT02597478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6239865|NCT02597478|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6239866|NCT02597478|Anesthetics, General|anesthetics, general|mesh-ancestor
6239867|NCT02597478|Anesthetics|anesthetics|mesh-ancestor
6239868|NCT02597543|Regadenoson|regadenoson|mesh-list
6239869|NCT02597543|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
6239870|NCT02597543|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6239871|NCT02597543|Purinergic Agonists|purinergic agonists|mesh-ancestor
6239872|NCT02597543|Purinergic Agents|purinergic agents|mesh-ancestor
6239873|NCT02597543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6239874|NCT02597543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239875|NCT02597543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239876|NCT02597855|Aflibercept|aflibercept|mesh-list
6239877|NCT02597855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6239878|NCT02597855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6239879|NCT02597855|Growth Substances|growth substances|mesh-ancestor
6239880|NCT02597855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239881|NCT02597855|Growth Inhibitors|growth inhibitors|mesh-ancestor
6239882|NCT02597855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6239883|NCT02597907|Aprepitant|aprepitant|mesh-list
6239884|NCT02597907|Palonosetron|palonosetron|mesh-list
6239885|NCT02597907|Ramosetron|ramosetron|mesh-list
6239886|NCT02597907|Antiemetics|antiemetics|mesh-ancestor
5964082|NCT04594759|Isotretinoin|isotretinoin|mesh-list
6239887|NCT02597907|Autonomic Agents|autonomic agents|mesh-ancestor
6503111|NCT00651326|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6239888|NCT02597907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6239889|NCT02597907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239890|NCT02597907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6239891|NCT02597907|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6239892|NCT02597907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6239893|NCT02597907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239894|NCT02597907|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6239895|NCT02597907|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6239896|NCT02597907|Serotonin Agents|serotonin agents|mesh-ancestor
6239897|NCT02597933|Nintedanib|nintedanib|mesh-list
6239898|NCT02597933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6239899|NCT02597933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6239900|NCT02597933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6239901|NCT02597933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239902|NCT02597946|Paclitaxel|paclitaxel|mesh-list
6239903|NCT02597946|Afatinib|afatinib|mesh-list
6239904|NCT02597946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6239905|NCT02597946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6239906|NCT02597946|Tubulin Modulators|tubulin modulators|mesh-ancestor
6239907|NCT02597946|Antimitotic Agents|antimitotic agents|mesh-ancestor
6239908|NCT02597946|Mitosis Modulators|mitosis modulators|mesh-ancestor
6239909|NCT02597946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239910|NCT02597946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6239911|NCT02597946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6244110|NCT02687815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6244111|NCT02688387|Ambrisentan|ambrisentan|mesh-list
6244112|NCT02688387|Tadalafil|tadalafil|mesh-list
6244113|NCT02688387|Vasodilator Agents|vasodilator agents|mesh-ancestor
6244114|NCT02688387|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6244115|NCT02688387|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6244116|NCT02688387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6244117|NCT02688387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244118|NCT02688387|Urological Agents|urological agents|mesh-ancestor
6244119|NCT02688387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6244120|NCT02688556|Cyclosporine|cyclosporine|mesh-list
6244121|NCT02688556|Cyclosporins|cyclosporins|mesh-list
6244122|NCT02688556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5713426|NCT03261102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5713427|NCT03261102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5713428|NCT03260829|Ascorbic Acid|ascorbic acid|mesh-list
5713429|NCT03260829|Vitamins|vitamins|mesh-ancestor
5713430|NCT03260829|Micronutrients|micronutrients|mesh-ancestor
5713431|NCT03260829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713432|NCT03260829|Antioxidants|antioxidants|mesh-ancestor
5713433|NCT03260829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713434|NCT03260829|Protective Agents|protective agents|mesh-ancestor
5713435|NCT03260972|Chloroprocaine|chloroprocaine|mesh-list
6244123|NCT02688556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244124|NCT02688556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6244125|NCT02688556|Immunologic Factors|immunologic factors|mesh-ancestor
6244126|NCT02688556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244127|NCT02688556|Antifungal Agents|antifungal agents|mesh-ancestor
6244128|NCT02688556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6244129|NCT02688556|Dermatologic Agents|dermatologic agents|mesh-ancestor
6503112|NCT00651326|Fertility Agents|fertility agents|mesh-ancestor
6503113|NCT00651326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6503114|NCT00651326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503115|NCT00651326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6503116|NCT00651326|Androgen Antagonists|androgen antagonists|mesh-ancestor
6503117|NCT00651326|Hormone Antagonists|hormone antagonists|mesh-ancestor
6503118|NCT00651326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6503119|NCT00651352|Nicotine|nicotine|mesh-list
6503120|NCT00651352|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6503121|NCT00651352|Autonomic Agents|autonomic agents|mesh-ancestor
6503122|NCT00651352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6503123|NCT00651352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503124|NCT00651352|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6503125|NCT00651352|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6503126|NCT00651352|Cholinergic Agents|cholinergic agents|mesh-ancestor
6503127|NCT00651352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6503128|NCT00651352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503129|NCT00651443|Galiximab|galiximab|mesh-list
5713436|NCT03260972|Anesthetics, Local|anesthetics, local|mesh-ancestor
5713437|NCT03260972|Anesthetics|anesthetics|mesh-ancestor
5713438|NCT03260972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6239912|NCT02598193|Pirfenidone|pirfenidone|mesh-list
6239913|NCT02598193|Nintedanib|nintedanib|mesh-list
6239914|NCT02598193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6239915|NCT02598193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6239916|NCT02598193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6239917|NCT02598193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239918|NCT02598193|Analgesics|analgesics|mesh-ancestor
6239919|NCT02598193|Sensory System Agents|sensory system agents|mesh-ancestor
6239920|NCT02598193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6239921|NCT02598193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239922|NCT02598193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6239923|NCT02598193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6239924|NCT02598193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6239925|NCT02598193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6239926|NCT02598583|Ravulizumab|ravulizumab|mesh-list
6239927|NCT02598583|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6239928|NCT02598583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6239929|NCT02598583|Immunologic Factors|immunologic factors|mesh-ancestor
6239930|NCT02598583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239931|NCT02598934|Ibandronic Acid|ibandronic acid|mesh-list
6239932|NCT02598934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6239933|NCT02598934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239934|NCT02599402|Nivolumab|nivolumab|mesh-list
6239935|NCT02599402|Ipilimumab|ipilimumab|mesh-list
6239936|NCT02599402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6239937|NCT02599402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6239938|NCT02599402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6239939|NCT02599402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239940|NCT02599649|Nivolumab|nivolumab|mesh-list
6239941|NCT02599649|Azacitidine|azacitidine|mesh-list
6239942|NCT02599649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6239943|NCT02599649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6239944|NCT02599649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5713439|NCT03260972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713440|NCT03260972|Sensory System Agents|sensory system agents|mesh-ancestor
5713441|NCT03260972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5713442|NCT03260920|Oxytocin|oxytocin|mesh-list
5713443|NCT03260920|Oxytocics|oxytocics|mesh-ancestor
5713444|NCT03260920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5713445|NCT03260920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713446|NCT03261024|Nickel|nickel|mesh-list
5713447|NCT03261024|Trace Elements|trace elements|mesh-ancestor
6239945|NCT02599649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239946|NCT02599649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6239947|NCT02599649|Antimetabolites|antimetabolites|mesh-ancestor
6239948|NCT02599649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6239949|NCT02600325|Grazoprevir|grazoprevir|mesh-list
6239950|NCT02600325|Antiviral Agents|antiviral agents|mesh-ancestor
6239951|NCT02600325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6239952|NCT02600351|Sofosbuvir|sofosbuvir|mesh-list
6239953|NCT02600351|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
6239954|NCT02600351|Ledipasvir|ledipasvir|mesh-list
6239955|NCT02600351|Antiviral Agents|antiviral agents|mesh-ancestor
6239956|NCT02600351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6239957|NCT02600559|Ciprofloxacin|ciprofloxacin|mesh-list
6239958|NCT02600559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6239959|NCT02600559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6239960|NCT02600559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6239961|NCT02600559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6239962|NCT02600559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6239963|NCT02600559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239964|NCT02600559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6503130|NCT00651443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6503131|NCT00651443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6503132|NCT00651456|Bevacizumab|bevacizumab|mesh-list
6503133|NCT00651456|Cisplatin|cisplatin|mesh-list
6503134|NCT00651456|Pemetrexed|pemetrexed|mesh-list
6503135|NCT00651456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6503136|NCT00651456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5713448|NCT03261024|Micronutrients|micronutrients|mesh-ancestor
6239965|NCT02600559|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6239966|NCT02600559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6239967|NCT02600611|Vancomycin|vancomycin|mesh-list
6239968|NCT02600611|Iclaprim|iclaprim|mesh-list
6503137|NCT00651456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6503138|NCT00651456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6503139|NCT00651456|Growth Substances|growth substances|mesh-ancestor
6677742|NCT01589367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677743|NCT01589367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6677744|NCT01589367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6677745|NCT01589367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6677746|NCT01589367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6677747|NCT01589367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677748|NCT01589367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6677749|NCT01589367|Hormone Antagonists|hormone antagonists|mesh-ancestor
6677750|NCT01589367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6677751|NCT01589393|Enoxaparin|enoxaparin|mesh-list
6677752|NCT01589393|Anticoagulants|anticoagulants|mesh-ancestor
6677753|NCT01589393|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6677754|NCT01589393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6677755|NCT01589393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677756|NCT01589419|Capecitabine|capecitabine|mesh-list
6239969|NCT02600611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6239970|NCT02600611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6239971|NCT02600611|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6239972|NCT02600611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6239973|NCT02600611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239974|NCT02600715|Morphine|morphine|mesh-list
6239975|NCT02600715|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6239976|NCT02600715|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6239977|NCT02600715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6239978|NCT02600715|Narcotics|narcotics|mesh-ancestor
6239979|NCT02600715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6239980|NCT02600715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6239981|NCT02600715|Analgesics|analgesics|mesh-ancestor
6677757|NCT01589419|Veliparib|veliparib|mesh-list
5713449|NCT03261024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713450|NCT03260634|Voriconazole|voriconazole|mesh-list
5713451|NCT03260634|Antifungal Agents|antifungal agents|mesh-ancestor
5713452|NCT03260634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5713453|NCT03260634|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6677758|NCT01589419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5713454|NCT03260634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5713455|NCT03260634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5713456|NCT03260634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713457|NCT03260634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5713458|NCT03260634|Hormone Antagonists|hormone antagonists|mesh-ancestor
5713459|NCT03260634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5713460|NCT03260634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713461|NCT03260634|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5713462|NCT03261115|Anesthetics|anesthetics|mesh-list
6239982|NCT02600715|Sensory System Agents|sensory system agents|mesh-ancestor
6239983|NCT02600715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6239984|NCT02600715|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6503140|NCT00651456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503141|NCT00651456|Growth Inhibitors|growth inhibitors|mesh-ancestor
6503142|NCT00651456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6503143|NCT00651456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503144|NCT00651456|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6503145|NCT00651456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6503146|NCT00651547|Budesonide|budesonide|mesh-list
6503147|NCT00651547|Formoterol Fumarate|formoterol fumarate|mesh-list
6503148|NCT00651547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6503149|NCT00651547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6503150|NCT00651547|Autonomic Agents|autonomic agents|mesh-ancestor
6503151|NCT00651547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6503152|NCT00651547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503153|NCT00651547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6503154|NCT00651547|Respiratory System Agents|respiratory system agents|mesh-ancestor
6503155|NCT00651547|Glucocorticoids|glucocorticoids|mesh-ancestor
6503156|NCT00651547|Hormones|hormones|mesh-ancestor
6503157|NCT00651547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6503158|NCT00651547|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6503159|NCT00651547|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6503160|NCT00651547|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6677759|NCT01589419|Antimetabolites|antimetabolites|mesh-ancestor
6677760|NCT01589419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677761|NCT01589419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5919217|NCT04984070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5919218|NCT04984070|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5713463|NCT03261115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5713464|NCT03261115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713465|NCT03260439|Tramadol|tramadol|mesh-list
5713466|NCT03260439|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5713467|NCT03260439|Narcotics|narcotics|mesh-ancestor
5713468|NCT03260439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5713469|NCT03260439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713470|NCT03260439|Analgesics|analgesics|mesh-ancestor
5713471|NCT03260439|Sensory System Agents|sensory system agents|mesh-ancestor
5713472|NCT03260439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5713473|NCT03260712|Gemcitabine|gemcitabine|mesh-list
5713474|NCT03260712|Pembrolizumab|pembrolizumab|mesh-list
5713475|NCT03260712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5713476|NCT03260712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5713477|NCT03260712|Antimetabolites|antimetabolites|mesh-ancestor
5713478|NCT03260712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713479|NCT03260712|Antiviral Agents|antiviral agents|mesh-ancestor
6239985|NCT02600715|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6244130|NCT02688556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5713480|NCT03260712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5713481|NCT03260712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5713482|NCT03260712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5713483|NCT03260712|Immunologic Factors|immunologic factors|mesh-ancestor
5713484|NCT03260712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713485|NCT03260712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5713486|NCT03260569|Nitric Oxide|nitric oxide|mesh-list
5713487|NCT03260569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5713488|NCT03260569|Autonomic Agents|autonomic agents|mesh-ancestor
5713489|NCT03260569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5713490|NCT03260569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713491|NCT03260569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5713492|NCT03260569|Respiratory System Agents|respiratory system agents|mesh-ancestor
5713493|NCT03260569|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5713494|NCT03260569|Antioxidants|antioxidants|mesh-ancestor
5713495|NCT03260569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713496|NCT03260569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5713497|NCT03260569|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5919219|NCT04984070|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5919220|NCT04984070|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5919221|NCT04984070|Estrogens|estrogens|mesh-ancestor
5919222|NCT04984070|Hormones|hormones|mesh-ancestor
5919223|NCT04984070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5919224|NCT04984070|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5919225|NCT04984070|Hormone Antagonists|hormone antagonists|mesh-ancestor
5919226|NCT04984070|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5919227|NCT04984070|Diuretics|diuretics|mesh-ancestor
5919228|NCT04984070|Natriuretic Agents|natriuretic agents|mesh-ancestor
5919229|NCT04983940|Methyltestosterone|methyltestosterone|mesh-list
5919230|NCT04983940|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5919231|NCT04983940|Testosterone|testosterone|mesh-list
5919232|NCT04983940|Testosterone undecanoate|testosterone undecanoate|mesh-list
5919233|NCT04983940|Testosterone enanthate|testosterone enanthate|mesh-list
5919234|NCT04983940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5919235|NCT04983940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5919236|NCT04983940|Anabolic Agents|anabolic agents|mesh-ancestor
5919237|NCT04983940|Hormones|hormones|mesh-ancestor
5919238|NCT04983940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5919239|NCT04983940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919240|NCT04983940|Androgens|androgens|mesh-ancestor
5919241|NCT04983849|Metronidazole|metronidazole|mesh-list
5919242|NCT04983849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5919243|NCT04983849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5919244|NCT04983849|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5919245|NCT04983849|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5919246|NCT04983966|Desflurane|desflurane|mesh-list
5919247|NCT04983966|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5919248|NCT04983966|Anesthetics, General|anesthetics, general|mesh-ancestor
5919249|NCT04983966|Anesthetics|anesthetics|mesh-ancestor
5964083|NCT04594759|Dermatologic Agents|dermatologic agents|mesh-ancestor
6239986|NCT02600715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6239987|NCT02600715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6239988|NCT02600715|Cholinergic Agents|cholinergic agents|mesh-ancestor
6239989|NCT02600715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6239990|NCT02600767|Lumefantrine|lumefantrine|mesh-list
6239991|NCT02600767|Artemether|artemether|mesh-list
6239992|NCT02600767|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6239993|NCT02600767|Antimalarials|antimalarials|mesh-ancestor
6239994|NCT02600767|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6239995|NCT02600767|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6239996|NCT02600767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6239997|NCT02600819|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6239998|NCT02600819|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6239999|NCT02600819|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6240000|NCT02600819|Antiviral Agents|antiviral agents|mesh-ancestor
6240001|NCT02600819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6240002|NCT02600871|Povidone-Iodine|povidone-iodine|mesh-list
6240003|NCT02600871|Povidone|povidone|mesh-list
6503161|NCT00651547|Adrenergic Agents|adrenergic agents|mesh-ancestor
6503162|NCT00651547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6240004|NCT02600871|Plasma Substitutes|plasma substitutes|mesh-ancestor
6240005|NCT02600871|Blood Substitutes|blood substitutes|mesh-ancestor
6240006|NCT02600871|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6240007|NCT02600871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6240008|NCT02601027|Acetaminophen|acetaminophen|mesh-list
6503163|NCT00651547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503164|NCT00651586|Ciprofloxacin|ciprofloxacin|mesh-list
6503165|NCT00651586|Gatifloxacin|gatifloxacin|mesh-list
6503166|NCT00651586|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6503167|NCT00651586|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6503168|NCT00651586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6503169|NCT00651586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6503170|NCT00651586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6503171|NCT00651586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6503172|NCT00651586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6503173|NCT00651586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503174|NCT00651586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6677762|NCT01589419|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6677763|NCT01589419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6677764|NCT01589432|Lidocaine|lidocaine|mesh-list
6677765|NCT01589432|Anesthetics, Local|anesthetics, local|mesh-ancestor
6677766|NCT01589432|Anesthetics|anesthetics|mesh-ancestor
6240009|NCT02601027|Oxycodone|oxycodone|mesh-list
6240010|NCT02601027|Hydromorphone|hydromorphone|mesh-list
6677767|NCT01589432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6677768|NCT01589432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677769|NCT01589432|Sensory System Agents|sensory system agents|mesh-ancestor
6677770|NCT01589432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6677771|NCT01589432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6677772|NCT01589432|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6677773|NCT01589432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6677774|NCT01589432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6677775|NCT01589432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677776|NCT01589471|Botulinum Toxins|botulinum toxins|mesh-list
6677777|NCT01589471|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6677778|NCT01589471|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6677779|NCT01589471|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6677780|NCT01589471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6677781|NCT01589471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677782|NCT01589471|Cholinergic Agents|cholinergic agents|mesh-ancestor
6677783|NCT01589471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6677784|NCT01589471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677785|NCT01589471|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5713498|NCT03260569|Vasodilator Agents|vasodilator agents|mesh-ancestor
5713499|NCT03260569|Gasotransmitters|gasotransmitters|mesh-ancestor
5713500|NCT03260569|Protective Agents|protective agents|mesh-ancestor
5713501|NCT03260556|Pirfenidone|pirfenidone|mesh-list
5713502|NCT03260556|Analgesics|analgesics|mesh-ancestor
5713503|NCT03260556|Sensory System Agents|sensory system agents|mesh-ancestor
5713504|NCT03260556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5713505|NCT03260556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713506|NCT03260556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5964084|NCT04594915|Edoxaban|edoxaban|mesh-list
6240011|NCT02601027|Ondansetron|ondansetron|mesh-list
6503175|NCT00651586|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6503176|NCT00651586|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6503177|NCT00651599|Drospirenone|drospirenone|mesh-list
6503178|NCT00651599|Estradiol|estradiol|mesh-list
5713507|NCT03260556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5713508|NCT03260556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6240012|NCT02601027|Bupivacaine|bupivacaine|mesh-list
6240013|NCT02601027|Anesthetics, Local|anesthetics, local|mesh-ancestor
6240014|NCT02601027|Anesthetics|anesthetics|mesh-ancestor
6240015|NCT02601027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6240016|NCT02601027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240017|NCT02601027|Sensory System Agents|sensory system agents|mesh-ancestor
6240018|NCT02601027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6240019|NCT02601027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6240020|NCT02601027|Narcotics|narcotics|mesh-ancestor
6240021|NCT02601027|Analgesics|analgesics|mesh-ancestor
6240022|NCT02601027|Antiemetics|antiemetics|mesh-ancestor
6240023|NCT02601027|Autonomic Agents|autonomic agents|mesh-ancestor
6240024|NCT02601027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6240025|NCT02601027|Antipruritics|antipruritics|mesh-ancestor
6240026|NCT02601027|Dermatologic Agents|dermatologic agents|mesh-ancestor
5713509|NCT03260556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5713510|NCT03260556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5713511|NCT03260283|Fentanyl|fentanyl|mesh-list
5713512|NCT03260283|Meperidine|meperidine|mesh-list
5713513|NCT03260283|Ropivacaine|ropivacaine|mesh-list
5713514|NCT03260283|Anesthetics, Local|anesthetics, local|mesh-ancestor
5713515|NCT03260283|Anesthetics|anesthetics|mesh-ancestor
5713516|NCT03260283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5964085|NCT04594915|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6240027|NCT02601027|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6240028|NCT02601027|Serotonin Agents|serotonin agents|mesh-ancestor
6240029|NCT02601027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6240030|NCT02601027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240031|NCT02601027|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6240032|NCT02601027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6240033|NCT02601027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6240034|NCT02601027|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6240035|NCT02601027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6240036|NCT02601027|Antipyretics|antipyretics|mesh-ancestor
6240037|NCT02601170|Hyaluronic Acid|hyaluronic acid|mesh-list
6240038|NCT02601170|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6240039|NCT02601170|Immunologic Factors|immunologic factors|mesh-ancestor
6240040|NCT02601170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240041|NCT02601170|Viscosupplements|viscosupplements|mesh-ancestor
6240042|NCT02601170|Protective Agents|protective agents|mesh-ancestor
6240043|NCT02601313|Cyclophosphamide|cyclophosphamide|mesh-list
6240044|NCT02601313|Fludarabine|fludarabine|mesh-list
6240045|NCT02601313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6240046|NCT02601313|Immunologic Factors|immunologic factors|mesh-ancestor
6240047|NCT02601313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240048|NCT02601313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6240049|NCT02601313|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6240050|NCT02601313|Alkylating Agents|alkylating agents|mesh-ancestor
6240051|NCT02601313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240052|NCT02601313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6240053|NCT02601313|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6240054|NCT02601573|Ribavirin|ribavirin|mesh-list
6240055|NCT02601573|Sofosbuvir|sofosbuvir|mesh-list
6240056|NCT02601573|Grazoprevir|grazoprevir|mesh-list
6240057|NCT02601573|Antimetabolites|antimetabolites|mesh-ancestor
6240058|NCT02601573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240059|NCT02601573|Antiviral Agents|antiviral agents|mesh-ancestor
6240060|NCT02601573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6240061|NCT02601625|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6240062|NCT02601625|Immunologic Factors|immunologic factors|mesh-ancestor
6240063|NCT02601625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240064|NCT02601833|Fluorides|fluorides|mesh-list
6240065|NCT02601833|Cariostatic Agents|cariostatic agents|mesh-ancestor
6240066|NCT02601833|Protective Agents|protective agents|mesh-ancestor
6240067|NCT02601833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240068|NCT02601976|Ribavirin|ribavirin|mesh-list
6503179|NCT00651599|Estrogens|estrogens|mesh-ancestor
6503180|NCT00651599|Hormones|hormones|mesh-ancestor
6503181|NCT00651599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6503182|NCT00651599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503183|NCT00651599|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6503184|NCT00651599|Hormone Antagonists|hormone antagonists|mesh-ancestor
6240069|NCT02601976|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6240070|NCT02601976|Antimetabolites|antimetabolites|mesh-ancestor
6240071|NCT02601976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713517|NCT03260283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713518|NCT03260283|Sensory System Agents|sensory system agents|mesh-ancestor
5964086|NCT04594915|Antithrombins|antithrombins|mesh-ancestor
6240072|NCT02601976|Antiviral Agents|antiviral agents|mesh-ancestor
6240073|NCT02601976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6240074|NCT02603107|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
6240075|NCT02603107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6240076|NCT02603107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240077|NCT02603107|Antiviral Agents|antiviral agents|mesh-ancestor
6240078|NCT02603107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6240079|NCT02603107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6240080|NCT02603107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6240081|NCT02603107|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6240082|NCT02603107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6240083|NCT02603107|Protease Inhibitors|protease inhibitors|mesh-ancestor
6240084|NCT02603120|Tenofovir|tenofovir|mesh-list
6240085|NCT02603120|Emtricitabine|emtricitabine|mesh-list
6240086|NCT02603120|Lamivudine|lamivudine|mesh-list
6240087|NCT02603120|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
6240088|NCT02603120|Triumeq|triumeq|mesh-list
6240089|NCT02603120|Antiviral Agents|antiviral agents|mesh-ancestor
6240090|NCT02603120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6240091|NCT02603120|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6240092|NCT02603120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6240093|NCT02603120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6240094|NCT02603120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240095|NCT02603120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6240096|NCT02603120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6240097|NCT02603393|Fluticasone|fluticasone|mesh-list
6240098|NCT02603393|Tiotropium Bromide|tiotropium bromide|mesh-list
6240099|NCT02603393|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6240100|NCT02603393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6240101|NCT02603393|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6240102|NCT02603393|Autonomic Agents|autonomic agents|mesh-ancestor
6240103|NCT02603393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6240104|NCT02603393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240105|NCT02603393|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6240106|NCT02603393|Respiratory System Agents|respiratory system agents|mesh-ancestor
6240107|NCT02603393|Dermatologic Agents|dermatologic agents|mesh-ancestor
6240108|NCT02603393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6240109|NCT02603393|Parasympatholytics|parasympatholytics|mesh-ancestor
6240110|NCT02603393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6240111|NCT02603393|Cholinergic Agents|cholinergic agents|mesh-ancestor
6240112|NCT02603393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6240113|NCT02603393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240114|NCT02603393|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6240115|NCT02603393|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6240116|NCT02603393|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6240117|NCT02603393|Adrenergic Agents|adrenergic agents|mesh-ancestor
6240118|NCT02603419|Avelumab|avelumab|mesh-list
6240119|NCT02603419|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6240120|NCT02603419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6240121|NCT02603419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6240122|NCT02603419|Immunologic Factors|immunologic factors|mesh-ancestor
6240123|NCT02603419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240124|NCT02603809|Lisinopril|lisinopril|mesh-list
6240125|NCT02603809|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6240126|NCT02603809|Protease Inhibitors|protease inhibitors|mesh-ancestor
6240127|NCT02603809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6240128|NCT02603809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240129|NCT02603809|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6240130|NCT02603809|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6240131|NCT02603809|Protective Agents|protective agents|mesh-ancestor
6240132|NCT02603809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240133|NCT02603887|Pembrolizumab|pembrolizumab|mesh-list
6240134|NCT02603887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6240135|NCT02603887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6240136|NCT02603926|Pregnanolone|pregnanolone|mesh-list
6240137|NCT02603926|Brexanolone|brexanolone|mesh-list
6240138|NCT02603926|Anesthetics|anesthetics|mesh-ancestor
6240139|NCT02603926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6240140|NCT02603926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240141|NCT02603926|Neurosteroids|neurosteroids|mesh-ancestor
6240142|NCT02603926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6240143|NCT02603926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240144|NCT02603926|GABA Modulators|gaba modulators|mesh-ancestor
6240145|NCT02603926|GABA Agents|gaba agents|mesh-ancestor
6503185|NCT00651599|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6503186|NCT00651599|Diuretics|diuretics|mesh-ancestor
6503187|NCT00651599|Natriuretic Agents|natriuretic agents|mesh-ancestor
6503188|NCT00651612|Timolol|timolol|mesh-list
6503189|NCT00651612|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6503190|NCT00651612|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6503191|NCT00651612|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6503192|NCT00651612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6503193|NCT00651612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6503194|NCT00651612|Adrenergic Agents|adrenergic agents|mesh-ancestor
6503195|NCT00651612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6503196|NCT00651612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713519|NCT03260283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5713520|NCT03260283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5713521|NCT03260283|Narcotics|narcotics|mesh-ancestor
5713522|NCT03260283|Analgesics|analgesics|mesh-ancestor
5713523|NCT03260283|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5713524|NCT03260283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5713525|NCT03260283|Anesthetics, General|anesthetics, general|mesh-ancestor
5713526|NCT03260166|Niacinamide|niacinamide|mesh-list
5713527|NCT03260166|Niacin|niacin|mesh-list
5713528|NCT03260166|Nicotinic Acids|nicotinic acids|mesh-list
5713529|NCT03260166|Vitamin B Complex|vitamin b complex|mesh-ancestor
5713530|NCT03260166|Vitamins|vitamins|mesh-ancestor
5713531|NCT03260166|Micronutrients|micronutrients|mesh-ancestor
5713532|NCT03260166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713533|NCT03260166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5713534|NCT03260166|Antimetabolites|antimetabolites|mesh-ancestor
5713535|NCT03260166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713536|NCT03260166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5713537|NCT03260166|Vasodilator Agents|vasodilator agents|mesh-ancestor
5713538|NCT03260010|Fosfomycin|fosfomycin|mesh-list
5713539|NCT03260010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5713540|NCT03260010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5713541|NCT03260049|Antiviral Agents|antiviral agents|mesh-list
6503197|NCT00651612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503198|NCT00651612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6503199|NCT00651612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6503200|NCT00651612|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6677786|NCT01589471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6677787|NCT01589523|Cholic Acids|cholic acids|mesh-list
6677788|NCT01589523|Glycocholic Acid|glycocholic acid|mesh-list
6677789|NCT01589523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6677790|NCT01589523|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6677791|NCT01589549|Methylprednisolone|methylprednisolone|mesh-list
6677792|NCT01589549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6677793|NCT01589549|Antiemetics|antiemetics|mesh-ancestor
6677794|NCT01589549|Autonomic Agents|autonomic agents|mesh-ancestor
6240146|NCT02603952|Oseltamivir|oseltamivir|mesh-list
6240147|NCT02603952|MEDI8852|medi8852|mesh-list
6240148|NCT02603952|Antiviral Agents|antiviral agents|mesh-ancestor
6240149|NCT02603952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6240150|NCT02603952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6240151|NCT02603952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240152|NCT02604173|Budesonide|budesonide|mesh-list
6240153|NCT02604173|Acetazolamide|acetazolamide|mesh-list
6240154|NCT02604173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6240155|NCT02604173|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6677795|NCT01589549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6677796|NCT01589549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677797|NCT01589549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6677798|NCT01589549|Glucocorticoids|glucocorticoids|mesh-ancestor
6677799|NCT01589549|Hormones|hormones|mesh-ancestor
6677800|NCT01589549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6677801|NCT01589549|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6677802|NCT01589549|Protective Agents|protective agents|mesh-ancestor
6677803|NCT01589562|Megestrol|megestrol|mesh-list
5713542|NCT03260049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5713543|NCT03260088|Immunoglobulins|immunoglobulins|mesh-list
6240156|NCT02604173|Autonomic Agents|autonomic agents|mesh-ancestor
6677804|NCT01589562|Megestrol Acetate|megestrol acetate|mesh-list
6677805|NCT01589562|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6240157|NCT02604173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5713544|NCT03260088|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5713545|NCT03260088|Antibodies|antibodies|mesh-list
5713546|NCT03260088|Immunoglobulin G|immunoglobulin g|mesh-list
5713547|NCT03260088|Immunologic Factors|immunologic factors|mesh-ancestor
5713548|NCT03260088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240158|NCT02604173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240159|NCT02604173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6240160|NCT02604173|Respiratory System Agents|respiratory system agents|mesh-ancestor
6240161|NCT02604173|Glucocorticoids|glucocorticoids|mesh-ancestor
5713549|NCT03259919|Metformin|metformin|mesh-list
5713550|NCT03259919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5713551|NCT03259919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713552|NCT03259958|Donepezil|donepezil|mesh-list
5713553|NCT03259958|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5713554|NCT03259958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5713555|NCT03259958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713556|NCT03259958|Cholinergic Agents|cholinergic agents|mesh-ancestor
5713557|NCT03259958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5713558|NCT03259958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240162|NCT02604173|Hormones|hormones|mesh-ancestor
6240163|NCT02604173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6240164|NCT02604173|Anticonvulsants|anticonvulsants|mesh-ancestor
6240165|NCT02604173|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6240166|NCT02604173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6240167|NCT02604173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240168|NCT02604173|Diuretics|diuretics|mesh-ancestor
6240169|NCT02604173|Natriuretic Agents|natriuretic agents|mesh-ancestor
6240170|NCT02604199|Tenofovir|tenofovir|mesh-list
6240171|NCT02604199|Entecavir|entecavir|mesh-list
6240172|NCT02604199|Histamine Antagonists|histamine antagonists|mesh-list
6240173|NCT02604199|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
6240174|NCT02604199|Antiviral Agents|antiviral agents|mesh-ancestor
6240175|NCT02604199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6240176|NCT02604199|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6240177|NCT02604199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6240178|NCT02604199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6240179|NCT02604199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503201|NCT00651612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6503202|NCT00651612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6503203|NCT00651651|Budesonide|budesonide|mesh-list
6503204|NCT00651651|Formoterol Fumarate|formoterol fumarate|mesh-list
6503205|NCT00651651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6503206|NCT00651651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6503207|NCT00651651|Autonomic Agents|autonomic agents|mesh-ancestor
6503208|NCT00651651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6503209|NCT00651651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503210|NCT00651651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6503211|NCT00651651|Respiratory System Agents|respiratory system agents|mesh-ancestor
6503212|NCT00651651|Glucocorticoids|glucocorticoids|mesh-ancestor
6503213|NCT00651651|Hormones|hormones|mesh-ancestor
6503214|NCT00651651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6677806|NCT01589562|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5713559|NCT03259958|Nootropic Agents|nootropic agents|mesh-ancestor
5721822|NCT03203174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5721823|NCT03202836|Tocolytic Agents|tocolytic agents|mesh-list
5721824|NCT03202836|Progesterone|progesterone|mesh-list
5721825|NCT03202836|Progestins|progestins|mesh-ancestor
5721826|NCT03202836|Hormones|hormones|mesh-ancestor
5721827|NCT03202836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5721828|NCT03202836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240180|NCT02604199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6240181|NCT02604199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6240182|NCT02604199|Histamine Agents|histamine agents|mesh-ancestor
5721829|NCT03202836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5721830|NCT03202979|Trazodone|trazodone|mesh-list
5721831|NCT03202979|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5721832|NCT03202979|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5721833|NCT03202979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5721834|NCT03202979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721835|NCT03202979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6240183|NCT02604199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6677807|NCT01589562|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6677808|NCT01589562|Contraceptive Agents|contraceptive agents|mesh-ancestor
5721836|NCT03202979|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5721837|NCT03202979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5713560|NCT03259867|Pembrolizumab|pembrolizumab|mesh-list
5713561|NCT03259867|Tirapazamine|tirapazamine|mesh-list
5713562|NCT03259867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5713563|NCT03259867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5713564|NCT03259529|Gemcitabine|gemcitabine|mesh-list
5713565|NCT03259529|Rituximab|rituximab|mesh-list
5713566|NCT03259529|Nivolumab|nivolumab|mesh-list
6240184|NCT02604199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240185|NCT02604212|Tenofovir|tenofovir|mesh-list
6240186|NCT02604212|Entecavir|entecavir|mesh-list
6240187|NCT02604212|Histamine Antagonists|histamine antagonists|mesh-list
6240188|NCT02604212|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
6240189|NCT02604212|Antiviral Agents|antiviral agents|mesh-ancestor
6240190|NCT02604212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6240191|NCT02604212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6240192|NCT02604212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5713567|NCT03259529|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5713568|NCT03259529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5713569|NCT03259529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5713570|NCT03259529|Immunologic Factors|immunologic factors|mesh-ancestor
5713571|NCT03259529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713572|NCT03259529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5713573|NCT03259529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5713574|NCT03259529|Antimetabolites|antimetabolites|mesh-ancestor
5713575|NCT03259529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713576|NCT03259529|Antiviral Agents|antiviral agents|mesh-ancestor
5713577|NCT03259529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5713578|NCT03259529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5713579|NCT03259529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6240193|NCT02604212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6240194|NCT02604212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240195|NCT02604212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6240196|NCT02604212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6240197|NCT02604212|Histamine Agents|histamine agents|mesh-ancestor
6240198|NCT02604212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6240199|NCT02604212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240200|NCT02604342|Docetaxel|docetaxel|mesh-list
6240201|NCT02604342|Pemetrexed|pemetrexed|mesh-list
6240202|NCT02604342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6240203|NCT02604342|Tubulin Modulators|tubulin modulators|mesh-ancestor
6240204|NCT02604342|Antimitotic Agents|antimitotic agents|mesh-ancestor
5713580|NCT03259529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5713581|NCT03259529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5713582|NCT03259529|Alkylating Agents|alkylating agents|mesh-ancestor
5713583|NCT03259516|Cytarabine|cytarabine|mesh-list
5713584|NCT03259516|Cyclophosphamide|cyclophosphamide|mesh-list
5713585|NCT03259516|Melphalan|melphalan|mesh-list
5713586|NCT03259516|Nivolumab|nivolumab|mesh-list
5713587|NCT03259516|Fludarabine|fludarabine|mesh-list
5713588|NCT03259516|Azacitidine|azacitidine|mesh-list
5713589|NCT03259516|Tretinoin|tretinoin|mesh-list
5713590|NCT03259516|Sildenafil Citrate|sildenafil citrate|mesh-list
5713591|NCT03259516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5713592|NCT03259516|Immunologic Factors|immunologic factors|mesh-ancestor
5713593|NCT03259516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713594|NCT03259516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5713595|NCT03259516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5713596|NCT03259516|Alkylating Agents|alkylating agents|mesh-ancestor
5713597|NCT03259516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713598|NCT03259516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5713599|NCT03259516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5713600|NCT03259516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5713601|NCT03259516|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5713602|NCT03259516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5713603|NCT03259516|Antimetabolites|antimetabolites|mesh-ancestor
5713604|NCT03259516|Antiviral Agents|antiviral agents|mesh-ancestor
5713605|NCT03259516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5713606|NCT03259516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5713607|NCT03259516|Vasodilator Agents|vasodilator agents|mesh-ancestor
5713608|NCT03259516|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5713609|NCT03259516|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5713610|NCT03259516|Urological Agents|urological agents|mesh-ancestor
5713611|NCT03259516|Keratolytic Agents|keratolytic agents|mesh-ancestor
5713612|NCT03259516|Dermatologic Agents|dermatologic agents|mesh-ancestor
5713613|NCT03259672|Sevoflurane|sevoflurane|mesh-list
6240205|NCT02604342|Mitosis Modulators|mitosis modulators|mesh-ancestor
5713614|NCT03259672|Desflurane|desflurane|mesh-list
6240206|NCT02604342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240207|NCT02604342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6240208|NCT02604342|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6240209|NCT02604342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6240210|NCT02604550|Naproxen|naproxen|mesh-list
5713615|NCT03259672|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5713616|NCT03259672|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5713617|NCT03259672|Anesthetics, General|anesthetics, general|mesh-ancestor
5713618|NCT03259672|Anesthetics|anesthetics|mesh-ancestor
5713619|NCT03259672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5713620|NCT03259672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713621|NCT03259607|Nicotine|nicotine|mesh-list
5713622|NCT03259607|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5713623|NCT03259607|Autonomic Agents|autonomic agents|mesh-ancestor
5713624|NCT03259607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5713625|NCT03259607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713626|NCT03259607|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5713627|NCT03259607|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5713628|NCT03259607|Cholinergic Agents|cholinergic agents|mesh-ancestor
5713629|NCT03259607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5713630|NCT03259607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713631|NCT03259542|Itraconazole|itraconazole|mesh-list
5713632|NCT03259542|Mifepristone|mifepristone|mesh-list
5713633|NCT03259542|Antifungal Agents|antifungal agents|mesh-ancestor
5713634|NCT03259542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5713635|NCT03259542|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5713636|NCT03259542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6240211|NCT02604550|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
6240212|NCT02604550|Ropivacaine|ropivacaine|mesh-list
6240213|NCT02604550|Anesthetics, Local|anesthetics, local|mesh-ancestor
6240214|NCT02604550|Anesthetics|anesthetics|mesh-ancestor
6240215|NCT02604550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6240216|NCT02604550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240217|NCT02604550|Sensory System Agents|sensory system agents|mesh-ancestor
6240218|NCT02604550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6240219|NCT02604550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6240220|NCT02604550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6240221|NCT02604550|Analgesics|analgesics|mesh-ancestor
6240222|NCT02604550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6240223|NCT02604550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6240224|NCT02604550|Gout Suppressants|gout suppressants|mesh-ancestor
6240225|NCT02604550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6240226|NCT02604550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6240227|NCT02604550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240228|NCT02604550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6240229|NCT02604550|Narcotics|narcotics|mesh-ancestor
6240230|NCT02604589|Hydromorphone|hydromorphone|mesh-list
6240231|NCT02604589|Bupivacaine|bupivacaine|mesh-list
6240232|NCT02604589|Anesthetics, Local|anesthetics, local|mesh-ancestor
6240233|NCT02604589|Anesthetics|anesthetics|mesh-ancestor
6240234|NCT02604589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6240235|NCT02604589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240236|NCT02604589|Sensory System Agents|sensory system agents|mesh-ancestor
6240237|NCT02604589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6240238|NCT02604589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6240239|NCT02604589|Narcotics|narcotics|mesh-ancestor
6240240|NCT02604589|Analgesics|analgesics|mesh-ancestor
6240241|NCT02604810|Immunoglobulins|immunoglobulins|mesh-list
6240242|NCT02604810|Antibodies|antibodies|mesh-list
6240243|NCT02604810|gamma-Globulins|gamma-globulins|mesh-list
6240244|NCT02604810|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6240245|NCT02604810|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6240246|NCT02604810|Immunoglobulin G|immunoglobulin g|mesh-list
6240247|NCT02604810|Immunologic Factors|immunologic factors|mesh-ancestor
5713637|NCT03259542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5713638|NCT03259542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713639|NCT03259542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5713640|NCT03259542|Hormone Antagonists|hormone antagonists|mesh-ancestor
5713641|NCT03259542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5713642|NCT03259542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713643|NCT03259542|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5713644|NCT03259542|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5713645|NCT03259542|Abortifacient Agents|abortifacient agents|mesh-ancestor
6240248|NCT02604810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240249|NCT02605122|Amoxicillin|amoxicillin|mesh-list
6240250|NCT02605122|Azithromycin|azithromycin|mesh-list
6240251|NCT02605122|Ceftriaxone|ceftriaxone|mesh-list
6240252|NCT02605122|Erythromycin|erythromycin|mesh-list
6240253|NCT02605122|Erythromycin Estolate|erythromycin estolate|mesh-list
6240254|NCT02605122|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
6503215|NCT00651651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6503216|NCT00651651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6503217|NCT00651651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6503218|NCT00651651|Adrenergic Agents|adrenergic agents|mesh-ancestor
6503219|NCT00651651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6503220|NCT00651651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503221|NCT00651690|Botulinum Toxins|botulinum toxins|mesh-list
6503222|NCT00651690|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6503223|NCT00651690|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6503224|NCT00651690|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6503225|NCT00651690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6503226|NCT00651690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503227|NCT00651690|Cholinergic Agents|cholinergic agents|mesh-ancestor
6503228|NCT00651690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6503229|NCT00651690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503230|NCT00651690|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6503231|NCT00651690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6240255|NCT02605122|Erythromycin stearate|erythromycin stearate|mesh-list
6240256|NCT02605122|Ampicillin|ampicillin|mesh-list
6240257|NCT02605122|Clavulanic Acids|clavulanic acids|mesh-list
6240258|NCT02605122|Clavulanic Acid|clavulanic acid|mesh-list
6240259|NCT02605122|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6240260|NCT02605122|Solithromycin|solithromycin|mesh-list
6240261|NCT02605122|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
6240262|NCT02605122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6240263|NCT02605122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6240264|NCT02605122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6240265|NCT02605122|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6240266|NCT02605122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6240267|NCT02605122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240268|NCT02605122|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6240269|NCT02605174|Lasmiditan|lasmiditan|mesh-list
6240270|NCT02605174|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6240271|NCT02605174|Serotonin Agents|serotonin agents|mesh-ancestor
6240272|NCT02605174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6240273|NCT02605174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240274|NCT02605174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240275|NCT02605187|Acetaminophen|acetaminophen|mesh-list
6240276|NCT02605187|Ibuprofen|ibuprofen|mesh-list
6240277|NCT02605187|Morphine|morphine|mesh-list
6240278|NCT02605187|Gabapentin|gabapentin|mesh-list
6240279|NCT02605187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6240280|NCT02605187|Narcotics|narcotics|mesh-ancestor
6240281|NCT02605187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6240282|NCT02605187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240283|NCT02605187|Analgesics|analgesics|mesh-ancestor
6240284|NCT02605187|Sensory System Agents|sensory system agents|mesh-ancestor
6240285|NCT02605187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6240286|NCT02605187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6240287|NCT02605187|Antipyretics|antipyretics|mesh-ancestor
6240288|NCT02605187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6240289|NCT02605187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6240290|NCT02605187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6240291|NCT02605187|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6240292|NCT02605187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6240293|NCT02605187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240294|NCT02605187|Anticonvulsants|anticonvulsants|mesh-ancestor
6240295|NCT02605187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6240296|NCT02605187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6240297|NCT02605187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6240298|NCT02605187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6240299|NCT02605187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6240300|NCT02605187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6240301|NCT02605187|Antimanic Agents|antimanic agents|mesh-ancestor
6240302|NCT02605304|Ribavirin|ribavirin|mesh-list
6240303|NCT02605304|Sofosbuvir|sofosbuvir|mesh-list
6240304|NCT02605304|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
6240305|NCT02605304|Ledipasvir|ledipasvir|mesh-list
6240306|NCT02605304|Antimetabolites|antimetabolites|mesh-ancestor
6240307|NCT02605304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240308|NCT02605304|Antiviral Agents|antiviral agents|mesh-ancestor
5713646|NCT03259542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6240309|NCT02605304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6240310|NCT02605395|Rabeprazole|rabeprazole|mesh-list
6240311|NCT02605395|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6503232|NCT00651703|Imiquimod|imiquimod|mesh-list
6503233|NCT00651703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6503234|NCT00651703|Immunologic Factors|immunologic factors|mesh-ancestor
5713647|NCT03259542|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6240312|NCT02605395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6240313|NCT02605395|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6240314|NCT02605395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6240315|NCT02605395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240316|NCT02605642|Infliximab|infliximab|mesh-list
6240317|NCT02605642|Dermatologic Agents|dermatologic agents|mesh-ancestor
6240318|NCT02605642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6240319|NCT02605642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6240320|NCT02605837|Budesonide|budesonide|mesh-list
6240321|NCT02605837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6240322|NCT02605837|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6240323|NCT02605837|Autonomic Agents|autonomic agents|mesh-ancestor
6240324|NCT02605837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6240325|NCT02605837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240326|NCT02605837|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6240327|NCT02605837|Respiratory System Agents|respiratory system agents|mesh-ancestor
6240328|NCT02605837|Glucocorticoids|glucocorticoids|mesh-ancestor
6240329|NCT02605837|Hormones|hormones|mesh-ancestor
6240330|NCT02605837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6240331|NCT02605954|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6240332|NCT02605954|Antiviral Agents|antiviral agents|mesh-ancestor
6240333|NCT02605954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6240334|NCT02605993|Ravulizumab|ravulizumab|mesh-list
6240335|NCT02605993|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6240336|NCT02605993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6240337|NCT02605993|Immunologic Factors|immunologic factors|mesh-ancestor
6240338|NCT02605993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240339|NCT02606253|Metolazone|metolazone|mesh-list
5713648|NCT03259542|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5713649|NCT03259542|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5713650|NCT03259542|Contraceptive Agents|contraceptive agents|mesh-ancestor
5713651|NCT03259542|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5713652|NCT03259542|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5713653|NCT03259542|Luteolytic Agents|luteolytic agents|mesh-ancestor
5713654|NCT03259542|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5713655|NCT03259542|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5713656|NCT03259152|Denosumab|denosumab|mesh-list
5713657|NCT03259152|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5713658|NCT03259152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713659|NCT03259282|gamma-Globulins|gamma-globulins|mesh-list
5713660|NCT03259282|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5713661|NCT03259282|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5713662|NCT03259282|Immunologic Factors|immunologic factors|mesh-ancestor
5713663|NCT03259282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713664|NCT03258931|Cytarabine|cytarabine|mesh-list
5713665|NCT03258931|Midostaurin|midostaurin|mesh-list
5713666|NCT03258931|Crenolanib|crenolanib|mesh-list
5713667|NCT03258931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5713668|NCT03258931|Antimetabolites|antimetabolites|mesh-ancestor
5713669|NCT03258931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240340|NCT02606253|Chlorothiazide|chlorothiazide|mesh-list
6240341|NCT02606253|Tolvaptan|tolvaptan|mesh-list
6240342|NCT02606253|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
5713670|NCT03258931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6240343|NCT02606253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240344|NCT02606253|Natriuretic Agents|natriuretic agents|mesh-ancestor
6240345|NCT02606253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240346|NCT02606253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6240347|NCT02606253|Diuretics|diuretics|mesh-ancestor
6240348|NCT02606253|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6240349|NCT02606253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6240350|NCT02606877|Pirfenidone|pirfenidone|mesh-list
6240351|NCT02606877|Nintedanib|nintedanib|mesh-list
6240352|NCT02606877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6503235|NCT00651703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240353|NCT02606877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6240354|NCT02606877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6244131|NCT02688556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6240355|NCT02606877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240356|NCT02606877|Analgesics|analgesics|mesh-ancestor
6240357|NCT02606877|Sensory System Agents|sensory system agents|mesh-ancestor
6240358|NCT02606877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6240359|NCT02606877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240360|NCT02606877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6240361|NCT02606877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6240362|NCT02606877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6240363|NCT02606877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6240364|NCT02607254|Pregabalin|pregabalin|mesh-list
6240365|NCT02607254|Analgesics|analgesics|mesh-ancestor
6240366|NCT02607254|Sensory System Agents|sensory system agents|mesh-ancestor
6240367|NCT02607254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6240368|NCT02607254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240369|NCT02607254|Anticonvulsants|anticonvulsants|mesh-ancestor
6240370|NCT02607254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6240371|NCT02607254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6240372|NCT02607254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240373|NCT02607254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6240374|NCT02607254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6240375|NCT02607254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6240376|NCT02607254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6240377|NCT02607254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6240378|NCT02607306|Insulin|insulin|mesh-list
6240379|NCT02607306|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6240380|NCT02607306|Liraglutide|liraglutide|mesh-list
6240381|NCT02607306|Insulin, Long-Acting|insulin, long-acting|mesh-list
6240382|NCT02607306|Xultophy|xultophy|mesh-list
6240383|NCT02607306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6240384|NCT02607306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240385|NCT02607306|Incretins|incretins|mesh-ancestor
6240386|NCT02607306|Hormones|hormones|mesh-ancestor
6240387|NCT02607306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6240388|NCT02607618|Vancomycin|vancomycin|mesh-list
6240389|NCT02607618|Iclaprim|iclaprim|mesh-list
6240390|NCT02607618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6240391|NCT02607618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6240392|NCT02607618|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6240393|NCT02607618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6240394|NCT02607618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240395|NCT02607735|Sofosbuvir|sofosbuvir|mesh-list
6240396|NCT02607735|Velpatasvir|velpatasvir|mesh-list
6240397|NCT02607735|Antiviral Agents|antiviral agents|mesh-ancestor
6240398|NCT02607735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6240399|NCT02607800|Sofosbuvir|sofosbuvir|mesh-list
6240400|NCT02607800|Velpatasvir|velpatasvir|mesh-list
6240401|NCT02607800|Antiviral Agents|antiviral agents|mesh-ancestor
6240402|NCT02607800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6240403|NCT02607865|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6240404|NCT02607865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6240405|NCT02607865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240406|NCT02607865|Incretins|incretins|mesh-ancestor
6503236|NCT00651703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6503237|NCT00651703|Interferon Inducers|interferon inducers|mesh-ancestor
6503238|NCT00651729|Botulinum Toxins|botulinum toxins|mesh-list
6503239|NCT00651729|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6503240|NCT00651729|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6503241|NCT00651729|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6503242|NCT00651729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6503243|NCT00651729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503244|NCT00651729|Cholinergic Agents|cholinergic agents|mesh-ancestor
6503245|NCT00651729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6677809|NCT01589562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6677810|NCT01589562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677811|NCT01589562|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6677812|NCT01589562|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6677813|NCT01589562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6677814|NCT01589562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6240407|NCT02607865|Hormones|hormones|mesh-ancestor
6240408|NCT02607865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6240409|NCT02607865|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6240410|NCT02607865|Protease Inhibitors|protease inhibitors|mesh-ancestor
6240411|NCT02607865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6503246|NCT00651729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503247|NCT00651729|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6240412|NCT02607865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240413|NCT02607930|Lamivudine|lamivudine|mesh-list
6240414|NCT02607930|Triumeq|triumeq|mesh-list
6240415|NCT02607930|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6240416|NCT02607930|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6503248|NCT00651729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6503249|NCT00651768|Budesonide|budesonide|mesh-list
6503250|NCT00651768|Formoterol Fumarate|formoterol fumarate|mesh-list
6240417|NCT02607930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6240418|NCT02607930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240419|NCT02607930|Antiviral Agents|antiviral agents|mesh-ancestor
6240420|NCT02607930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6240421|NCT02607930|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6240422|NCT02607930|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6240423|NCT02607956|Dolutegravir|dolutegravir|mesh-list
6240424|NCT02607956|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
6240425|NCT02607956|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6240426|NCT02607956|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6240427|NCT02607956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6240428|NCT02607956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240429|NCT02607956|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6240430|NCT02607956|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6240431|NCT02607956|Antiviral Agents|antiviral agents|mesh-ancestor
6240432|NCT02607956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6503251|NCT00651768|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6503252|NCT00651768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6503253|NCT00651768|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6677815|NCT01589562|Appetite Stimulants|appetite stimulants|mesh-ancestor
6677816|NCT01589562|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6677817|NCT01589614|Erythromycin|erythromycin|mesh-list
6677818|NCT01589614|Erythromycin Estolate|erythromycin estolate|mesh-list
6677819|NCT01589614|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
6677820|NCT01589614|Erythromycin stearate|erythromycin stearate|mesh-list
6677821|NCT01589614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6677822|NCT01589614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5713671|NCT03258931|Antiviral Agents|antiviral agents|mesh-ancestor
5713672|NCT03258931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5713673|NCT03258931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6240433|NCT02607956|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6240434|NCT02607956|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6240435|NCT02608099|Apixaban|apixaban|mesh-list
6240436|NCT02608099|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6240437|NCT02608099|Antithrombins|antithrombins|mesh-ancestor
6240438|NCT02608099|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6240439|NCT02608099|Protease Inhibitors|protease inhibitors|mesh-ancestor
6677823|NCT01589614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6677824|NCT01589614|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6677825|NCT01589614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6240440|NCT02608099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6240441|NCT02608099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240442|NCT02608099|Anticoagulants|anticoagulants|mesh-ancestor
6240443|NCT02608177|Linagliptin|linagliptin|mesh-list
6240444|NCT02608177|Glipizide|glipizide|mesh-list
6240445|NCT02608177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6240446|NCT02608177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503254|NCT00651768|Autonomic Agents|autonomic agents|mesh-ancestor
6503255|NCT00651768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6503256|NCT00651768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503257|NCT00651768|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6503258|NCT00651768|Respiratory System Agents|respiratory system agents|mesh-ancestor
6503259|NCT00651768|Glucocorticoids|glucocorticoids|mesh-ancestor
5713674|NCT03258931|Immunologic Factors|immunologic factors|mesh-ancestor
5713675|NCT03258931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919250|NCT04983966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5919251|NCT04983966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919252|NCT04983550|Doxorubicin|doxorubicin|mesh-list
5713676|NCT03258931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5713677|NCT03258931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5919253|NCT04983550|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5919254|NCT04983550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5713678|NCT03259243|Bupivacaine|bupivacaine|mesh-list
5713679|NCT03259243|Anesthetics, Local|anesthetics, local|mesh-ancestor
5713680|NCT03259243|Anesthetics|anesthetics|mesh-ancestor
5713681|NCT03259243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6240447|NCT02608177|Incretins|incretins|mesh-ancestor
6240448|NCT02608177|Hormones|hormones|mesh-ancestor
6240449|NCT02608177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6240450|NCT02608177|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6240451|NCT02608177|Protease Inhibitors|protease inhibitors|mesh-ancestor
6240452|NCT02608177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6240453|NCT02608177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240454|NCT02608229|Gemcitabine|gemcitabine|mesh-list
6240455|NCT02608229|Paclitaxel|paclitaxel|mesh-list
6240456|NCT02608229|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6240457|NCT02608229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6240458|NCT02608229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6240459|NCT02608229|Tubulin Modulators|tubulin modulators|mesh-ancestor
6240460|NCT02608229|Antimitotic Agents|antimitotic agents|mesh-ancestor
6503260|NCT00651768|Hormones|hormones|mesh-ancestor
6503261|NCT00651768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6503262|NCT00651768|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6503263|NCT00651768|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6503264|NCT00651768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6677826|NCT01589614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677827|NCT01589640|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6677828|NCT01589640|Lubricant Eye Drops|lubricant eye drops|mesh-list
6677829|NCT01589640|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6677830|NCT01589744|Hemostatics|hemostatics|mesh-list
6677831|NCT01589744|Coagulants|coagulants|mesh-ancestor
6677832|NCT01589809|Niacinamide|niacinamide|mesh-list
6240461|NCT02608229|Mitosis Modulators|mitosis modulators|mesh-ancestor
6240462|NCT02608229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240463|NCT02608229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6240464|NCT02608229|Antimetabolites|antimetabolites|mesh-ancestor
6240465|NCT02608229|Antiviral Agents|antiviral agents|mesh-ancestor
6240466|NCT02608229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6240467|NCT02608229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6240468|NCT02608229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6240469|NCT02608229|Immunologic Factors|immunologic factors|mesh-ancestor
6240470|NCT02608229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244132|NCT02688764|Calcium|calcium|mesh-list
6244133|NCT02688764|Calcium acetate|calcium acetate|mesh-list
6503265|NCT00651768|Adrenergic Agents|adrenergic agents|mesh-ancestor
6503266|NCT00651768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6503267|NCT00651768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503268|NCT00651781|Bortezomib|bortezomib|mesh-list
6503269|NCT00651781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6503270|NCT00651846|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
6503271|NCT00651846|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
6503272|NCT00651846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6503273|NCT00651846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503274|NCT00651846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6503275|NCT00651846|Contraceptive Agents|contraceptive agents|mesh-ancestor
6503276|NCT00651846|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6503277|NCT00651846|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6503278|NCT00651846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6503279|NCT00651846|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6503280|NCT00651846|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6503281|NCT00651846|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
6503282|NCT00651846|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5713682|NCT03259243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713683|NCT03259243|Sensory System Agents|sensory system agents|mesh-ancestor
5713684|NCT03259243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5713685|NCT03258684|Ascorbic Acid|ascorbic acid|mesh-list
5713686|NCT03258684|Thiamine|thiamine|mesh-list
5713687|NCT03258684|Hydrocortisone|hydrocortisone|mesh-list
5713688|NCT03258684|Vitamins|vitamins|mesh-ancestor
5713689|NCT03258684|Micronutrients|micronutrients|mesh-ancestor
5713690|NCT03258684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713691|NCT03258684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5713692|NCT03258684|Antioxidants|antioxidants|mesh-ancestor
5713693|NCT03258684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713694|NCT03258684|Protective Agents|protective agents|mesh-ancestor
5713695|NCT03258684|Vitamin B Complex|vitamin b complex|mesh-ancestor
5713696|NCT03258697|Levobupivacaine|levobupivacaine|mesh-list
6503283|NCT00651846|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5713697|NCT03258697|Anesthetics, Local|anesthetics, local|mesh-ancestor
5713698|NCT03258697|Anesthetics|anesthetics|mesh-ancestor
6503284|NCT00651859|Bimatoprost|bimatoprost|mesh-list
6503285|NCT00651859|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6240471|NCT02608489|Hyaluronic Acid|hyaluronic acid|mesh-list
6240472|NCT02608489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6240473|NCT02608489|Immunologic Factors|immunologic factors|mesh-ancestor
6240474|NCT02608489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240475|NCT02608489|Viscosupplements|viscosupplements|mesh-ancestor
6240476|NCT02608489|Protective Agents|protective agents|mesh-ancestor
6240477|NCT02608684|Gemcitabine|gemcitabine|mesh-list
6240478|NCT02608684|Pembrolizumab|pembrolizumab|mesh-list
6240479|NCT02608684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6240480|NCT02608684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5713699|NCT03258697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5713700|NCT03258697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713701|NCT03258697|Sensory System Agents|sensory system agents|mesh-ancestor
5713702|NCT03258697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5713703|NCT03258866|Rituximab|rituximab|mesh-list
5713704|NCT03258866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5713705|NCT03258866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5713706|NCT03258866|Immunologic Factors|immunologic factors|mesh-ancestor
5713707|NCT03258866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713708|NCT03258866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5713709|NCT03258749|Formoterol Fumarate|formoterol fumarate|mesh-list
5713710|NCT03258749|Tiotropium Bromide|tiotropium bromide|mesh-list
5713711|NCT03258749|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5713712|NCT03258749|Autonomic Agents|autonomic agents|mesh-ancestor
5713713|NCT03258749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5713714|NCT03258749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713715|NCT03258749|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5713716|NCT03258749|Respiratory System Agents|respiratory system agents|mesh-ancestor
5713717|NCT03258749|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5713718|NCT03258749|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5713719|NCT03258749|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5713720|NCT03258749|Adrenergic Agents|adrenergic agents|mesh-ancestor
5713721|NCT03258749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5713722|NCT03258749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713723|NCT03258749|Parasympatholytics|parasympatholytics|mesh-ancestor
5713724|NCT03258749|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6240481|NCT02608684|Antimetabolites|antimetabolites|mesh-ancestor
6240482|NCT02608684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240483|NCT02608684|Antiviral Agents|antiviral agents|mesh-ancestor
6240484|NCT02608684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6240485|NCT02608684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6240486|NCT02608684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6240487|NCT02608684|Immunologic Factors|immunologic factors|mesh-ancestor
6240488|NCT02608684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240489|NCT02608684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6240490|NCT02608879|Chlorhexidine|chlorhexidine|mesh-list
6240491|NCT02608879|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6240492|NCT02608879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6240493|NCT02608879|Disinfectants|disinfectants|mesh-ancestor
6240494|NCT02609399|Oseltamivir|oseltamivir|mesh-list
6503286|NCT00651859|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6503287|NCT00651859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6503288|NCT00651885|Treprostinil|treprostinil|mesh-list
6503289|NCT00651885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6503290|NCT00651911|Rasburicase|rasburicase|mesh-list
6503291|NCT00651911|Gout Suppressants|gout suppressants|mesh-ancestor
6503292|NCT00651911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6503293|NCT00651976|Letrozole|letrozole|mesh-list
6503294|NCT00651976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5713725|NCT03258749|Cholinergic Agents|cholinergic agents|mesh-ancestor
5713726|NCT03258723|Metformin|metformin|mesh-list
5713727|NCT03258723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5713728|NCT03258723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713729|NCT03258515|Moxifloxacin|moxifloxacin|mesh-list
5713730|NCT03258515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5713731|NCT03258515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5713732|NCT03258515|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5713733|NCT03258515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5713734|NCT03258515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6240495|NCT02609399|Peramivir|peramivir|mesh-list
6240496|NCT02609399|Antiviral Agents|antiviral agents|mesh-ancestor
6503295|NCT00651976|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6503296|NCT00651976|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5713735|NCT03258515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503297|NCT00651976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6503298|NCT00651976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503299|NCT00651976|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6503300|NCT00651976|Hormone Antagonists|hormone antagonists|mesh-ancestor
6503301|NCT00651976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6503302|NCT00651976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503303|NCT00652002|Budesonide|budesonide|mesh-list
6503304|NCT00652002|Formoterol Fumarate|formoterol fumarate|mesh-list
5713736|NCT03258515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5713737|NCT03258372|Rifampin|rifampin|mesh-list
5713738|NCT03258372|Mifepristone|mifepristone|mesh-list
6503305|NCT00652002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6503306|NCT00652002|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6240497|NCT02609399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6240498|NCT02609399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6240499|NCT02609399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240500|NCT02609607|Bisacodyl|bisacodyl|mesh-list
6240501|NCT02609607|Cathartics|cathartics|mesh-ancestor
6240502|NCT02609607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6240503|NCT02609607|Laxatives|laxatives|mesh-ancestor
6240504|NCT02609659|Ritonavir|ritonavir|mesh-list
6240505|NCT02609659|Ribavirin|ribavirin|mesh-list
6240506|NCT02609659|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6240507|NCT02609659|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6240508|NCT02609659|Protease Inhibitors|protease inhibitors|mesh-ancestor
6240509|NCT02609659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6240510|NCT02609659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240511|NCT02609659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6240512|NCT02609659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6240513|NCT02609659|Antiviral Agents|antiviral agents|mesh-ancestor
6240514|NCT02609659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6240515|NCT02609659|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6240516|NCT02609659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6240517|NCT02609659|Antimetabolites|antimetabolites|mesh-ancestor
6240518|NCT02609984|Atezolizumab|atezolizumab|mesh-list
6240519|NCT02609984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6240520|NCT02610140|Vinorelbine|vinorelbine|mesh-list
6240521|NCT02610140|Maytansine|maytansine|mesh-list
6240522|NCT02610140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6240523|NCT02610140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6240524|NCT02610140|Tubulin Modulators|tubulin modulators|mesh-ancestor
6240525|NCT02610140|Antimitotic Agents|antimitotic agents|mesh-ancestor
6240526|NCT02610140|Mitosis Modulators|mitosis modulators|mesh-ancestor
6240527|NCT02610140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240528|NCT02610231|Istradefylline|istradefylline|mesh-list
6240529|NCT02610231|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
6240530|NCT02610231|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6240531|NCT02610231|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6677833|NCT01589809|Niacin|niacin|mesh-list
5713739|NCT03258372|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5713740|NCT03258372|Antitubercular Agents|antitubercular agents|mesh-ancestor
5713741|NCT03258372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5713742|NCT03258372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5713743|NCT03258372|Leprostatic Agents|leprostatic agents|mesh-ancestor
5713744|NCT03258372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5713745|NCT03258372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5713746|NCT03258372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713747|NCT03258372|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5713748|NCT03258372|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5713749|NCT03258372|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5713750|NCT03258372|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5713751|NCT03258372|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5713752|NCT03258372|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5713753|NCT03258372|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5713754|NCT03258372|Abortifacient Agents|abortifacient agents|mesh-ancestor
5713755|NCT03258372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5713756|NCT03258372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713757|NCT03258372|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5713758|NCT03258372|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5713759|NCT03258372|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5713760|NCT03258372|Contraceptive Agents|contraceptive agents|mesh-ancestor
5713761|NCT03258372|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5713762|NCT03258372|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6240532|NCT02610231|Purinergic Agents|purinergic agents|mesh-ancestor
6240533|NCT02610231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6503307|NCT00652002|Autonomic Agents|autonomic agents|mesh-ancestor
6677834|NCT01589809|Nicotinic Acids|nicotinic acids|mesh-list
5713763|NCT03258372|Hormone Antagonists|hormone antagonists|mesh-ancestor
5713764|NCT03258372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5713765|NCT03258372|Luteolytic Agents|luteolytic agents|mesh-ancestor
5713766|NCT03258372|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5713767|NCT03258372|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5713768|NCT03258385|Vitamin B 12|vitamin b 12|mesh-list
5713769|NCT03258385|Hydroxocobalamin|hydroxocobalamin|mesh-list
5713770|NCT03258385|Vitamins|vitamins|mesh-ancestor
6677835|NCT01589809|Vitamins|vitamins|mesh-ancestor
6677836|NCT01589809|Micronutrients|micronutrients|mesh-ancestor
6677837|NCT01589809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677838|NCT01589809|Vitamin B Complex|vitamin b complex|mesh-ancestor
6677839|NCT01589809|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6677840|NCT01589809|Antimetabolites|antimetabolites|mesh-ancestor
6677841|NCT01589809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713771|NCT03258385|Micronutrients|micronutrients|mesh-ancestor
5713772|NCT03258385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713773|NCT03258385|Vitamin B Complex|vitamin b complex|mesh-ancestor
5713774|NCT03258385|Hematinics|hematinics|mesh-ancestor
5919255|NCT04983550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5919256|NCT04983550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5919257|NCT04983550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6240534|NCT02610231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240535|NCT02610231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240536|NCT02610777|Azacitidine|azacitidine|mesh-list
6240537|NCT02610777|Pevonedistat|pevonedistat|mesh-list
6240538|NCT02610777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6240539|NCT02610777|Antimetabolites|antimetabolites|mesh-ancestor
6240540|NCT02610777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240541|NCT02610777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6240542|NCT02610777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6240543|NCT02610816|Fluticasone|fluticasone|mesh-list
6240544|NCT02610816|Xhance|xhance|mesh-list
6240545|NCT02610816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6240546|NCT02610816|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6240547|NCT02610816|Autonomic Agents|autonomic agents|mesh-ancestor
6240548|NCT02610816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6240549|NCT02610816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240550|NCT02610816|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6240551|NCT02610816|Respiratory System Agents|respiratory system agents|mesh-ancestor
6240552|NCT02610816|Dermatologic Agents|dermatologic agents|mesh-ancestor
6240553|NCT02610816|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6240554|NCT02610868|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
6240555|NCT02610868|Botulinum Toxins|botulinum toxins|mesh-list
6240556|NCT02610868|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6240557|NCT02610868|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6240558|NCT02610868|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6240559|NCT02610868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6240560|NCT02610868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240561|NCT02610868|Cholinergic Agents|cholinergic agents|mesh-ancestor
6240562|NCT02610868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6240563|NCT02610868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240564|NCT02610868|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6240565|NCT02610868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6240566|NCT02610868|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6240567|NCT02611154|Testosterone|testosterone|mesh-list
6240568|NCT02611154|Androgens|androgens|mesh-ancestor
6240569|NCT02611154|Hormones|hormones|mesh-ancestor
5919258|NCT04983550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5919259|NCT04983550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919260|NCT04983524|Propolis|propolis|mesh-list
5919261|NCT04983524|Calcium|calcium|mesh-list
5919262|NCT04983524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6503308|NCT00652002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6503309|NCT00652002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503310|NCT00652002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6503311|NCT00652002|Respiratory System Agents|respiratory system agents|mesh-ancestor
6503312|NCT00652002|Glucocorticoids|glucocorticoids|mesh-ancestor
6503313|NCT00652002|Hormones|hormones|mesh-ancestor
6503314|NCT00652002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6503315|NCT00652002|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6503316|NCT00652002|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6503317|NCT00652002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5713775|NCT03258476|Guanfacine|guanfacine|mesh-list
5713776|NCT03258476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5713777|NCT03258476|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5713778|NCT03258476|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5713779|NCT03258476|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5713780|NCT03258476|Adrenergic Agents|adrenergic agents|mesh-ancestor
5713781|NCT03258476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5713782|NCT03258476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713783|NCT03258476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713784|NCT03258294|Melatonin|melatonin|mesh-list
5713785|NCT03258294|Antioxidants|antioxidants|mesh-ancestor
5713786|NCT03258294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713787|NCT03258294|Protective Agents|protective agents|mesh-ancestor
5713788|NCT03258294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713789|NCT03258294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6503318|NCT00652002|Adrenergic Agents|adrenergic agents|mesh-ancestor
6503319|NCT00652002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6503320|NCT00652002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503321|NCT00652041|Thalidomide|thalidomide|mesh-list
6503322|NCT00652041|Bortezomib|bortezomib|mesh-list
6503323|NCT00652041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6503324|NCT00652041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6503325|NCT00652041|Immunologic Factors|immunologic factors|mesh-ancestor
6503326|NCT00652041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677842|NCT01589809|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6677843|NCT01589809|Vasodilator Agents|vasodilator agents|mesh-ancestor
6677844|NCT01589861|Lapatinib|lapatinib|mesh-list
6677845|NCT01589861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6677846|NCT01589861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6677847|NCT01589861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6677848|NCT01589861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240570|NCT02611154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6240571|NCT02611154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240572|NCT02611752|Buprenorphine|buprenorphine|mesh-list
6240573|NCT02611752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6240574|NCT02611752|Narcotics|narcotics|mesh-ancestor
6240575|NCT02611752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6240576|NCT02611752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240577|NCT02611752|Analgesics|analgesics|mesh-ancestor
6240578|NCT02611752|Sensory System Agents|sensory system agents|mesh-ancestor
6240579|NCT02611752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6240580|NCT02611752|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6240581|NCT02611765|Penicillins|penicillins|mesh-list
6240582|NCT02611765|Penicillin G|penicillin g|mesh-list
6240583|NCT02611765|Penicillin G Benzathine|penicillin g benzathine|mesh-list
5713790|NCT03258398|Avelumab|avelumab|mesh-list
5713791|NCT03258398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5713792|NCT03258398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5713793|NCT03258320|Docetaxel|docetaxel|mesh-list
5713794|NCT03258320|Mitoxantrone|mitoxantrone|mesh-list
5713795|NCT03258320|Satraplatin|satraplatin|mesh-list
5713796|NCT03258320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5713797|NCT03258320|Tubulin Modulators|tubulin modulators|mesh-ancestor
5713798|NCT03258320|Antimitotic Agents|antimitotic agents|mesh-ancestor
5713799|NCT03258320|Mitosis Modulators|mitosis modulators|mesh-ancestor
6240584|NCT02611765|Penicillin G Procaine|penicillin g procaine|mesh-list
6240585|NCT02611765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6240586|NCT02611765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6240587|NCT02611778|Ranibizumab|ranibizumab|mesh-list
6240588|NCT02611778|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6240589|NCT02611778|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6677849|NCT01589952|Interferons|interferons|mesh-list
6677850|NCT01589952|Entecavir|entecavir|mesh-list
5713800|NCT03258320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240590|NCT02611778|Growth Substances|growth substances|mesh-ancestor
6240591|NCT02611778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240592|NCT02611778|Growth Inhibitors|growth inhibitors|mesh-ancestor
6240593|NCT02611778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6240594|NCT02611817|Vedolizumab|vedolizumab|mesh-list
6240595|NCT02611817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6240596|NCT02611830|Vedolizumab|vedolizumab|mesh-list
6240597|NCT02611830|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6240598|NCT02611882|Edetic Acid|edetic acid|mesh-list
5713801|NCT03258320|Analgesics|analgesics|mesh-ancestor
6244289|NCT02691936|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6677851|NCT01589952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6677852|NCT01589952|Antiviral Agents|antiviral agents|mesh-ancestor
6240599|NCT02611882|N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid|n,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid|mesh-list
6240600|NCT02611882|Chelating Agents|chelating agents|mesh-ancestor
6240601|NCT02611882|Sequestering Agents|sequestering agents|mesh-ancestor
6240602|NCT02611882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240603|NCT02611882|Anticoagulants|anticoagulants|mesh-ancestor
6240604|NCT02611882|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6240605|NCT02612064|Fluorides|fluorides|mesh-list
6240606|NCT02612064|Tin Fluorides|tin fluorides|mesh-list
6240607|NCT02612064|Fluorophosphate|fluorophosphate|mesh-list
5919263|NCT04983524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919264|NCT04983524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5919265|NCT04983615|Fentanyl|fentanyl|mesh-list
5713802|NCT03258320|Sensory System Agents|sensory system agents|mesh-ancestor
5713803|NCT03258320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5713804|NCT03258320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713805|NCT03258320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5713806|NCT03258320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5713807|NCT03258320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5721838|NCT03202979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5721839|NCT03202979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721840|NCT03202979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5721841|NCT03202979|Serotonin Agents|serotonin agents|mesh-ancestor
5721842|NCT03202979|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5721843|NCT03202979|Antidepressive Agents|antidepressive agents|mesh-ancestor
5721844|NCT03202849|Vitamin D|vitamin d|mesh-list
6240608|NCT02612064|Cariostatic Agents|cariostatic agents|mesh-ancestor
6240609|NCT02612064|Protective Agents|protective agents|mesh-ancestor
6240610|NCT02612064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240611|NCT02612077|Bevacizumab|bevacizumab|mesh-list
6240612|NCT02612077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6240613|NCT02612077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6240614|NCT02612077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6240615|NCT02612077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6240616|NCT02612077|Growth Substances|growth substances|mesh-ancestor
6240617|NCT02612077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240618|NCT02612077|Growth Inhibitors|growth inhibitors|mesh-ancestor
6240619|NCT02612194|Crizotinib|crizotinib|mesh-list
6240620|NCT02612194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6240621|NCT02612194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6240622|NCT02612194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6240623|NCT02612194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240624|NCT02612779|Dexamethasone|dexamethasone|mesh-list
6503327|NCT00652041|Leprostatic Agents|leprostatic agents|mesh-ancestor
6240625|NCT02612779|Nivolumab|nivolumab|mesh-list
6240626|NCT02612779|Pomalidomide|pomalidomide|mesh-list
6240627|NCT02612779|Elotuzumab|elotuzumab|mesh-list
6240628|NCT02612779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6240629|NCT02612779|Antiemetics|antiemetics|mesh-ancestor
6240630|NCT02612779|Autonomic Agents|autonomic agents|mesh-ancestor
6240631|NCT02612779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6240632|NCT02612779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240633|NCT02612779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6240634|NCT02612779|Glucocorticoids|glucocorticoids|mesh-ancestor
6240635|NCT02612779|Hormones|hormones|mesh-ancestor
6240636|NCT02612779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6240637|NCT02612779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6503328|NCT00652041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6503329|NCT00652041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6503330|NCT00652041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6503331|NCT00652041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6503332|NCT00652041|Growth Substances|growth substances|mesh-ancestor
6503333|NCT00652041|Growth Inhibitors|growth inhibitors|mesh-ancestor
6503334|NCT00652106|Timolol|timolol|mesh-list
6503335|NCT00652106|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6240638|NCT02612779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6240639|NCT02612779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6240640|NCT02612779|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5721845|NCT03202849|Ergocalciferols|ergocalciferols|mesh-list
5721846|NCT03202849|Vitamins|vitamins|mesh-list
5721847|NCT03202849|Micronutrients|micronutrients|mesh-ancestor
5721848|NCT03202849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721849|NCT03202849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5721850|NCT03202849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5721851|NCT03203031|Anesthetics|anesthetics|mesh-list
5721852|NCT03203031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6240641|NCT02612779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240642|NCT02612779|Immunologic Factors|immunologic factors|mesh-ancestor
6240643|NCT02612779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6240644|NCT02612779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6240645|NCT02612779|Growth Substances|growth substances|mesh-ancestor
6240646|NCT02612779|Growth Inhibitors|growth inhibitors|mesh-ancestor
6240647|NCT02613117|Fluorides|fluorides|mesh-list
6240648|NCT02613117|Tin Fluorides|tin fluorides|mesh-list
6240649|NCT02613117|Cariostatic Agents|cariostatic agents|mesh-ancestor
6240650|NCT02613117|Protective Agents|protective agents|mesh-ancestor
5713808|NCT03257930|Ethanol|ethanol|mesh-list
5713809|NCT03257930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5713810|NCT03257930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5713811|NCT03257930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5713812|NCT03257930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713813|NCT03257943|Ivermectin|ivermectin|mesh-list
5713814|NCT03257943|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5713815|NCT03257943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5713816|NCT03257683|Ranolazine|ranolazine|mesh-list
5713817|NCT03257683|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5713818|NCT03257683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5713819|NCT03257683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713820|NCT03257670|Lidocaine|lidocaine|mesh-list
5713821|NCT03257670|Anesthetics, Local|anesthetics, local|mesh-ancestor
5713822|NCT03257670|Anesthetics|anesthetics|mesh-ancestor
5713823|NCT03257670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5713824|NCT03257670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713825|NCT03257670|Sensory System Agents|sensory system agents|mesh-ancestor
5713826|NCT03257670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5713827|NCT03257670|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5713828|NCT03257670|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5713829|NCT03257670|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5713830|NCT03257670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5713831|NCT03257670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713832|NCT03257722|Pembrolizumab|pembrolizumab|mesh-list
5713833|NCT03257722|Idelalisib|idelalisib|mesh-list
5713834|NCT03257722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5713835|NCT03257722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5713836|NCT03257722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5713837|NCT03257722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713838|NCT03257852|Methotrexate|methotrexate|mesh-list
5713839|NCT03257852|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5713840|NCT03257852|Abortifacient Agents|abortifacient agents|mesh-ancestor
5713841|NCT03257852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5713842|NCT03257852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713843|NCT03257852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5713844|NCT03257852|Antimetabolites|antimetabolites|mesh-ancestor
5713845|NCT03257852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713846|NCT03257852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5713847|NCT03257852|Dermatologic Agents|dermatologic agents|mesh-ancestor
5713848|NCT03257852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5713849|NCT03257852|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5713850|NCT03257852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5713851|NCT03257852|Immunologic Factors|immunologic factors|mesh-ancestor
5713852|NCT03257852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5713853|NCT03257852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5713854|NCT03257514|Thioctic Acid|thioctic acid|mesh-list
5713855|NCT03257514|Antioxidants|antioxidants|mesh-ancestor
5713856|NCT03257514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713857|NCT03257514|Protective Agents|protective agents|mesh-ancestor
5713858|NCT03257514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713859|NCT03257514|Vitamin B Complex|vitamin b complex|mesh-ancestor
5713860|NCT03257514|Vitamins|vitamins|mesh-ancestor
5713861|NCT03257514|Micronutrients|micronutrients|mesh-ancestor
5713862|NCT03257800|Ketamine|ketamine|mesh-list
5713863|NCT03257800|Nitrous Oxide|nitrous oxide|mesh-list
5713864|NCT03257800|Sevoflurane|sevoflurane|mesh-list
5713865|NCT03257800|Analgesics|analgesics|mesh-ancestor
5713866|NCT03257800|Sensory System Agents|sensory system agents|mesh-ancestor
5713867|NCT03257800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5713868|NCT03257800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713869|NCT03257800|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5713870|NCT03257800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5713871|NCT03257800|Anesthetics, General|anesthetics, general|mesh-ancestor
5713872|NCT03257800|Anesthetics|anesthetics|mesh-ancestor
5713873|NCT03257800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5713874|NCT03257800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5713875|NCT03257800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5713876|NCT03257800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5713877|NCT03257800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713878|NCT03257800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5713879|NCT03257800|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5713880|NCT03257800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5713881|NCT03257423|Moxifloxacin|moxifloxacin|mesh-list
5713882|NCT03257423|Metronidazole|metronidazole|mesh-list
5713883|NCT03257423|Levofloxacin|levofloxacin|mesh-list
5713884|NCT03257423|Ofloxacin|ofloxacin|mesh-list
5713885|NCT03257423|Ertapenem|ertapenem|mesh-list
5713886|NCT03257423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5713887|NCT03257423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5713888|NCT03257423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5713889|NCT03257423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5713890|NCT03257423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6240651|NCT02613117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240652|NCT02613169|Isoniazid|isoniazid|mesh-list
6240653|NCT02613169|Antitubercular Agents|antitubercular agents|mesh-ancestor
6503336|NCT00652106|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6677853|NCT01589952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6677854|NCT01590069|Aldesleukin|aldesleukin|mesh-list
6677855|NCT01590069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6677856|NCT01590069|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6677857|NCT01590069|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6677858|NCT01590069|Antiviral Agents|antiviral agents|mesh-ancestor
6677859|NCT01590069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6677860|NCT01590173|Prednisolone|prednisolone|mesh-list
6677861|NCT01590173|Heparin|heparin|mesh-list
6677862|NCT01590173|Anticoagulants|anticoagulants|mesh-ancestor
6677863|NCT01590173|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6677864|NCT01590173|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5713891|NCT03257423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713892|NCT03257423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5713893|NCT03257423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5713894|NCT03257423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5919266|NCT04983615|Midazolam|midazolam|mesh-list
5919267|NCT04983615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5919268|NCT04983615|Narcotics|narcotics|mesh-ancestor
6240654|NCT02613169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6240655|NCT02613169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6240656|NCT02613169|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6240657|NCT02613169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6240658|NCT02613169|Antimetabolites|antimetabolites|mesh-ancestor
6240659|NCT02613169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240660|NCT02613169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6240661|NCT02613208|Paclitaxel|paclitaxel|mesh-list
5919269|NCT04983615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5919270|NCT04983615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919271|NCT04983615|Analgesics|analgesics|mesh-ancestor
5919272|NCT04983615|Sensory System Agents|sensory system agents|mesh-ancestor
5919273|NCT04983615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5919274|NCT04983615|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5919275|NCT04983615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5919276|NCT04983615|Anesthetics, General|anesthetics, general|mesh-ancestor
5919277|NCT04983615|Anesthetics|anesthetics|mesh-ancestor
5919278|NCT04983615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5919279|NCT04983615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5919280|NCT04983615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5919281|NCT04983615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6240662|NCT02613208|Bevacizumab|bevacizumab|mesh-list
6240663|NCT02613208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6240664|NCT02613208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6240665|NCT02613208|Tubulin Modulators|tubulin modulators|mesh-ancestor
6240666|NCT02613208|Antimitotic Agents|antimitotic agents|mesh-ancestor
6240667|NCT02613208|Mitosis Modulators|mitosis modulators|mesh-ancestor
6503337|NCT00652106|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6503338|NCT00652106|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6503339|NCT00652106|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6503340|NCT00652106|Adrenergic Agents|adrenergic agents|mesh-ancestor
6503341|NCT00652106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6503342|NCT00652106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677865|NCT01590173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677866|NCT01590173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6503343|NCT00652106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503344|NCT00652106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6503345|NCT00652106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6503346|NCT00652106|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6503347|NCT00652106|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6503348|NCT00652106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6503349|NCT00652119|Paclitaxel|paclitaxel|mesh-list
6503350|NCT00652119|Bevacizumab|bevacizumab|mesh-list
6503351|NCT00652119|Carboplatin|carboplatin|mesh-list
6503352|NCT00652119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6503353|NCT00652119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6503354|NCT00652119|Tubulin Modulators|tubulin modulators|mesh-ancestor
6503355|NCT00652119|Antimitotic Agents|antimitotic agents|mesh-ancestor
6503356|NCT00652119|Mitosis Modulators|mitosis modulators|mesh-ancestor
6503357|NCT00652119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503358|NCT00652119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6503359|NCT00652119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6503360|NCT00652119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6503361|NCT00652119|Growth Substances|growth substances|mesh-ancestor
6503362|NCT00652119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503363|NCT00652119|Growth Inhibitors|growth inhibitors|mesh-ancestor
6503364|NCT00652132|Sodium thiosulfate|sodium thiosulfate|mesh-list
6503365|NCT00652132|Antidotes|antidotes|mesh-ancestor
6677867|NCT01590173|Glucocorticoids|glucocorticoids|mesh-ancestor
6677868|NCT01590173|Hormones|hormones|mesh-ancestor
6240668|NCT02613208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240669|NCT02613208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6240670|NCT02613208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6240671|NCT02613208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6240672|NCT02613208|Growth Substances|growth substances|mesh-ancestor
6240673|NCT02613208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240674|NCT02613208|Growth Inhibitors|growth inhibitors|mesh-ancestor
6240675|NCT02613221|Panitumumab|panitumumab|mesh-list
6240676|NCT02613221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6240677|NCT02613221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6240678|NCT02613403|Ribavirin|ribavirin|mesh-list
6240679|NCT02613403|Uprifosbuvir|uprifosbuvir|mesh-list
6240680|NCT02613403|Antimetabolites|antimetabolites|mesh-ancestor
6240681|NCT02613403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240682|NCT02613403|Antiviral Agents|antiviral agents|mesh-ancestor
6240683|NCT02613403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6240684|NCT02613507|Docetaxel|docetaxel|mesh-list
6240685|NCT02613507|Nivolumab|nivolumab|mesh-list
6240686|NCT02613507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6240687|NCT02613507|Tubulin Modulators|tubulin modulators|mesh-ancestor
6240688|NCT02613507|Antimitotic Agents|antimitotic agents|mesh-ancestor
6240689|NCT02613507|Mitosis Modulators|mitosis modulators|mesh-ancestor
6240690|NCT02613507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240691|NCT02613507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6240692|NCT02613507|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6240693|NCT02613572|Thioctic Acid|thioctic acid|mesh-list
6240694|NCT02613572|Antioxidants|antioxidants|mesh-ancestor
6240695|NCT02613572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240696|NCT02613572|Protective Agents|protective agents|mesh-ancestor
6240697|NCT02613572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240698|NCT02613572|Vitamin B Complex|vitamin b complex|mesh-ancestor
6240699|NCT02613572|Vitamins|vitamins|mesh-ancestor
6240700|NCT02613572|Micronutrients|micronutrients|mesh-ancestor
6240701|NCT02613871|Sofosbuvir|sofosbuvir|mesh-list
6240702|NCT02613871|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
6240703|NCT02613871|Ledipasvir|ledipasvir|mesh-list
6240704|NCT02613871|Antiviral Agents|antiviral agents|mesh-ancestor
6240705|NCT02613871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6240706|NCT02613897|Dapagliflozin|dapagliflozin|mesh-list
6240707|NCT02613897|Saxagliptin|saxagliptin|mesh-list
6240708|NCT02613897|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6240709|NCT02613897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240710|NCT02613897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6240711|NCT02613897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240712|NCT02613897|Incretins|incretins|mesh-ancestor
6240713|NCT02613897|Hormones|hormones|mesh-ancestor
6240714|NCT02613897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6240715|NCT02613897|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6240716|NCT02613897|Protease Inhibitors|protease inhibitors|mesh-ancestor
6240717|NCT02613897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6240718|NCT02613910|Acetaminophen|acetaminophen|mesh-list
6240719|NCT02613910|Cetirizine|cetirizine|mesh-list
6240720|NCT02613910|Prednisone|prednisone|mesh-list
6240721|NCT02613910|Prednisolone|prednisolone|mesh-list
6240722|NCT02613910|Ofatumumab|ofatumumab|mesh-list
6240723|NCT02613910|Histamine Antagonists|histamine antagonists|mesh-list
6240724|NCT02613910|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
6240725|NCT02613910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6240726|NCT02613910|Glucocorticoids|glucocorticoids|mesh-ancestor
6240727|NCT02613910|Hormones|hormones|mesh-ancestor
6240728|NCT02613910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6240729|NCT02613910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240730|NCT02613910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5713895|NCT03257423|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5713896|NCT03257423|Renal Agents|renal agents|mesh-ancestor
5713897|NCT03257423|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5713898|NCT03257423|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5713899|NCT03257319|Morphine|morphine|mesh-list
5713900|NCT03257319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5713901|NCT03257319|Narcotics|narcotics|mesh-ancestor
5713902|NCT03257319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5713903|NCT03257319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713904|NCT03257319|Analgesics|analgesics|mesh-ancestor
5713905|NCT03257319|Sensory System Agents|sensory system agents|mesh-ancestor
5713906|NCT03257319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5713907|NCT03257241|Cytarabine|cytarabine|mesh-list
5713908|NCT03257241|Fludarabine|fludarabine|mesh-list
5713909|NCT03257241|Daunorubicin|daunorubicin|mesh-list
5713910|NCT03257241|Mitoxantrone|mitoxantrone|mesh-list
5713911|NCT03257241|Idarubicin|idarubicin|mesh-list
5713912|NCT03257241|Cladribine|cladribine|mesh-list
5713913|NCT03257241|Lenograstim|lenograstim|mesh-list
5713914|NCT03257241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5713915|NCT03257241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6240731|NCT02613910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6240732|NCT02613910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6240733|NCT02613910|Analgesics|analgesics|mesh-ancestor
6240734|NCT02613910|Sensory System Agents|sensory system agents|mesh-ancestor
6240735|NCT02613910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6240736|NCT02613910|Antipyretics|antipyretics|mesh-ancestor
6240737|NCT02613910|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6240738|NCT02613910|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6503366|NCT00652132|Protective Agents|protective agents|mesh-ancestor
6503367|NCT00652132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503368|NCT00652132|Antioxidants|antioxidants|mesh-ancestor
6503369|NCT00652132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503370|NCT00652132|Antitubercular Agents|antitubercular agents|mesh-ancestor
6503371|NCT00652132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6503372|NCT00652132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6503373|NCT00652132|Chelating Agents|chelating agents|mesh-ancestor
6503374|NCT00652132|Sequestering Agents|sequestering agents|mesh-ancestor
6503375|NCT00652171|Lamotrigine|lamotrigine|mesh-list
6503376|NCT00652171|Anticonvulsants|anticonvulsants|mesh-ancestor
6503377|NCT00652171|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6503378|NCT00652171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6503379|NCT00652171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240739|NCT02613910|Histamine Agents|histamine agents|mesh-ancestor
6240740|NCT02613910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6240741|NCT02613910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713916|NCT03257241|Antimetabolites|antimetabolites|mesh-ancestor
5713917|NCT03257241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713918|NCT03257241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5713919|NCT03257241|Immunologic Factors|immunologic factors|mesh-ancestor
5713920|NCT03257241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713921|NCT03257241|Antiviral Agents|antiviral agents|mesh-ancestor
5713922|NCT03257241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5713923|NCT03257241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5713924|NCT03257241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5713925|NCT03257241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6503380|NCT00652171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6503381|NCT00652171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503382|NCT00652171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5713926|NCT03257241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5713927|NCT03257241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6240742|NCT02614560|Fludarabine|fludarabine|mesh-list
6240743|NCT02614560|Melphalan|melphalan|mesh-list
6240744|NCT02614560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6503383|NCT00652171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6503384|NCT00652171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6503385|NCT00652171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6503386|NCT00652171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6677869|NCT01590173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6677870|NCT01590173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677871|NCT01590173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6677872|NCT01590173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6677873|NCT01590199|Everolimus|everolimus|mesh-list
6677874|NCT01590199|Pasireotide|pasireotide|mesh-list
6677875|NCT01590199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6240745|NCT02614560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240746|NCT02614560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6240747|NCT02614560|Immunologic Factors|immunologic factors|mesh-ancestor
6240748|NCT02614560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240749|NCT02614560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6240750|NCT02614560|Alkylating Agents|alkylating agents|mesh-ancestor
6240751|NCT02614560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6240752|NCT02614703|Acetic Acid|acetic acid|mesh-list
6240753|NCT02614703|Retinol acetate|retinol acetate|mesh-list
6240754|NCT02614703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6240755|NCT02614703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6240756|NCT02614703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6240757|NCT02614703|Immunologic Factors|immunologic factors|mesh-ancestor
6240758|NCT02614703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240759|NCT02614703|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6240760|NCT02614703|Protective Agents|protective agents|mesh-ancestor
6677876|NCT01590199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6677877|NCT01590199|Immunologic Factors|immunologic factors|mesh-ancestor
6677878|NCT01590199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677879|NCT01590199|Hormones|hormones|mesh-ancestor
6677880|NCT01590199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6677881|NCT01590225|Ribavirin|ribavirin|mesh-list
6677882|NCT01590225|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6677883|NCT01590225|Interferon-alpha|interferon-alpha|mesh-list
6677884|NCT01590225|Antimetabolites|antimetabolites|mesh-ancestor
5713928|NCT03257241|Analgesics|analgesics|mesh-ancestor
6677885|NCT01590225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677886|NCT01590225|Antiviral Agents|antiviral agents|mesh-ancestor
6677887|NCT01590225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6677888|NCT01590225|Immunologic Factors|immunologic factors|mesh-ancestor
6240761|NCT02614703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6240762|NCT02614794|Capecitabine|capecitabine|mesh-list
6240763|NCT02614794|Trastuzumab|trastuzumab|mesh-list
6240764|NCT02614794|Tucatinib|tucatinib|mesh-list
6240765|NCT02614794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6503387|NCT00652184|Valacyclovir|valacyclovir|mesh-list
6503388|NCT00652184|Sorivudine|sorivudine|mesh-list
6503389|NCT00652184|Antiviral Agents|antiviral agents|mesh-ancestor
6503390|NCT00652184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6503391|NCT00652184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6503392|NCT00652184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503393|NCT00652262|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6503394|NCT00652262|Vasodilator Agents|vasodilator agents|mesh-ancestor
6503395|NCT00652262|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6503396|NCT00652262|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6503397|NCT00652262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6503398|NCT00652262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503399|NCT00652262|Urological Agents|urological agents|mesh-ancestor
6503400|NCT00652288|Insulin|insulin|mesh-list
6677889|NCT01590225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677890|NCT01590277|Ethanol|ethanol|mesh-list
6677891|NCT01590277|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6677892|NCT01590277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6677893|NCT01590277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6677894|NCT01590277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677895|NCT01590303|Ascorbic Acid|ascorbic acid|mesh-list
6677896|NCT01590303|Vitamins|vitamins|mesh-ancestor
6677897|NCT01590303|Micronutrients|micronutrients|mesh-ancestor
6677898|NCT01590303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677899|NCT01590303|Antioxidants|antioxidants|mesh-ancestor
5713929|NCT03257241|Sensory System Agents|sensory system agents|mesh-ancestor
6240766|NCT02614794|Antimetabolites|antimetabolites|mesh-ancestor
6240767|NCT02614794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503401|NCT00652288|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6503402|NCT00652288|Insulin Glargine|insulin glargine|mesh-list
6240768|NCT02614794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6240769|NCT02614794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6240770|NCT02614794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6240771|NCT02614794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6240772|NCT02615470|Vaccines|vaccines|mesh-list
6240773|NCT02615470|Immunologic Factors|immunologic factors|mesh-ancestor
6240774|NCT02615470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240775|NCT02615535|Alprostadil|alprostadil|mesh-list
6240776|NCT02615535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6240777|NCT02615535|Vasodilator Agents|vasodilator agents|mesh-ancestor
6240778|NCT02615535|Urological Agents|urological agents|mesh-ancestor
6240779|NCT02616029|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6240780|NCT02616029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6240781|NCT02616029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6240782|NCT02616029|Antiviral Agents|antiviral agents|mesh-ancestor
6240783|NCT02616029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6240784|NCT02616250|Ivermectin|ivermectin|mesh-list
6240785|NCT02616250|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6240786|NCT02616250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6240787|NCT02616250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6240788|NCT02616250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6240789|NCT02616250|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6240790|NCT02616250|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6240791|NCT02616250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6240792|NCT02616250|Adrenergic Agents|adrenergic agents|mesh-ancestor
6240793|NCT02616250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6240794|NCT02616250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240795|NCT02616250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240796|NCT02616393|XL647|xl647|mesh-list
6240797|NCT02616393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6240798|NCT02616393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6240799|NCT02616393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6240800|NCT02616393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240801|NCT02616523|Lidocaine|lidocaine|mesh-list
6240802|NCT02616523|Fentanyl|fentanyl|mesh-list
6240803|NCT02616523|Dexmedetomidine|dexmedetomidine|mesh-list
6503403|NCT00652288|Insulin Aspart|insulin aspart|mesh-list
6677900|NCT01590303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677901|NCT01590303|Protective Agents|protective agents|mesh-ancestor
6677902|NCT01590342|Diclofenac|diclofenac|mesh-list
6677903|NCT01590342|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6240804|NCT02616523|Anesthetics, Local|anesthetics, local|mesh-ancestor
6240805|NCT02616523|Anesthetics|anesthetics|mesh-ancestor
6240806|NCT02616523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6240807|NCT02616523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240808|NCT02616523|Sensory System Agents|sensory system agents|mesh-ancestor
6240809|NCT02616523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6240810|NCT02616523|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6240811|NCT02616523|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6240812|NCT02616523|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6240813|NCT02616523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6240814|NCT02616523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240815|NCT02616523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6240816|NCT02616523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6240817|NCT02616523|Analgesics|analgesics|mesh-ancestor
6240818|NCT02616523|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6240819|NCT02616523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6240820|NCT02616523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6240821|NCT02616523|Adrenergic Agents|adrenergic agents|mesh-ancestor
6240822|NCT02616523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6240823|NCT02616523|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6503404|NCT00652288|Insulin, Long-Acting|insulin, long-acting|mesh-list
6503405|NCT00652288|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6503406|NCT00652288|Insulin Lispro|insulin lispro|mesh-list
6503407|NCT00652288|Insulin Detemir|insulin detemir|mesh-list
6503408|NCT00652288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6503409|NCT00652288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503410|NCT00652379|Octreotide|octreotide|mesh-list
6503411|NCT00652379|Lanreotide|lanreotide|mesh-list
6503412|NCT00652379|Somatostatin|somatostatin|mesh-list
6503413|NCT00652379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6503414|NCT00652379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5713930|NCT03257241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5713931|NCT03257163|Pembrolizumab|pembrolizumab|mesh-list
5713932|NCT03257163|Capecitabine|capecitabine|mesh-list
5713933|NCT03257163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5713934|NCT03257163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5713935|NCT03257163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5713936|NCT03257163|Antimetabolites|antimetabolites|mesh-ancestor
5713937|NCT03257163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240824|NCT02616523|Narcotics|narcotics|mesh-ancestor
6240825|NCT02616523|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6240826|NCT02616523|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6240827|NCT02616523|Anesthetics, General|anesthetics, general|mesh-ancestor
6240828|NCT02616601|Fluorouracil|fluorouracil|mesh-list
6240829|NCT02616601|Antimetabolites|antimetabolites|mesh-ancestor
6240830|NCT02616601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240831|NCT02616601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6240832|NCT02616601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6240833|NCT02616601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6240834|NCT02616601|Immunologic Factors|immunologic factors|mesh-ancestor
6240835|NCT02616601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240836|NCT02616614|Clindamycin|clindamycin|mesh-list
6240837|NCT02616614|Clindamycin palmitate|clindamycin palmitate|mesh-list
6240838|NCT02616614|Clindamycin phosphate|clindamycin phosphate|mesh-list
6240839|NCT02616614|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6240840|NCT02616614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6240841|NCT02616614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6240842|NCT02616614|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6240843|NCT02616614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6240844|NCT02616614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240845|NCT02616614|Dermatologic Agents|dermatologic agents|mesh-ancestor
6240846|NCT02616783|Lamivudine|lamivudine|mesh-list
6240847|NCT02616783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6503415|NCT00652379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6503416|NCT00652379|Hormones|hormones|mesh-ancestor
6503417|NCT00652379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6503418|NCT00652379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503419|NCT00652392|Budesonide|budesonide|mesh-list
6503420|NCT00652392|Formoterol Fumarate|formoterol fumarate|mesh-list
6503421|NCT00652392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6503422|NCT00652392|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6503423|NCT00652392|Autonomic Agents|autonomic agents|mesh-ancestor
6503424|NCT00652392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6503425|NCT00652392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677904|NCT01590342|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5713938|NCT03257215|Vitamin D|vitamin d|mesh-list
6240848|NCT02616783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6240849|NCT02616783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5713939|NCT03257215|Ergocalciferols|ergocalciferols|mesh-list
5713940|NCT03257215|Cholecalciferol|cholecalciferol|mesh-list
5713941|NCT03257215|Vitamins|vitamins|mesh-list
6240850|NCT02616783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240851|NCT02616783|Antiviral Agents|antiviral agents|mesh-ancestor
6240852|NCT02616783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6240853|NCT02616783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6240854|NCT02616783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6240855|NCT02617589|Nivolumab|nivolumab|mesh-list
6240856|NCT02617589|Temozolomide|temozolomide|mesh-list
6240857|NCT02617589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6240858|NCT02617589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6240859|NCT02617589|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6240860|NCT02617589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240861|NCT02617589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6240862|NCT02617589|Alkylating Agents|alkylating agents|mesh-ancestor
6240863|NCT02617628|Naltrexone|naltrexone|mesh-list
6240864|NCT02617628|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6240865|NCT02617628|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6240866|NCT02617628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240867|NCT02617628|Sensory System Agents|sensory system agents|mesh-ancestor
6240868|NCT02617628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6240869|NCT02617667|Cyclosporine|cyclosporine|mesh-list
6240870|NCT02617667|Cyclosporins|cyclosporins|mesh-list
6240871|NCT02617667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6240872|NCT02617667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240873|NCT02617667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6503426|NCT00652392|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6240874|NCT02617667|Immunologic Factors|immunologic factors|mesh-ancestor
6240875|NCT02617667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240876|NCT02617667|Antifungal Agents|antifungal agents|mesh-ancestor
6240877|NCT02617667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6240878|NCT02617667|Dermatologic Agents|dermatologic agents|mesh-ancestor
6240879|NCT02617667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6240880|NCT02617667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6240881|NCT02617784|Oseltamivir|oseltamivir|mesh-list
6240882|NCT02617784|Antiviral Agents|antiviral agents|mesh-ancestor
6240883|NCT02617784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6240884|NCT02617784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6240885|NCT02617784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244134|NCT02688764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6244135|NCT02688764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244136|NCT02688764|Chelating Agents|chelating agents|mesh-ancestor
6244137|NCT02688764|Sequestering Agents|sequestering agents|mesh-ancestor
6244138|NCT02688764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244139|NCT02688829|Sirolimus|sirolimus|mesh-list
6244140|NCT02688829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6244141|NCT02688829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6244142|NCT02688829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6244143|NCT02688829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6244144|NCT02688829|Antifungal Agents|antifungal agents|mesh-ancestor
6244145|NCT02688829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6244146|NCT02688829|Immunologic Factors|immunologic factors|mesh-ancestor
6244147|NCT02688829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244148|NCT02688842|Sirolimus|sirolimus|mesh-list
6244149|NCT02688842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6244150|NCT02688842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6244151|NCT02688842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6244152|NCT02688842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6244153|NCT02688842|Antifungal Agents|antifungal agents|mesh-ancestor
6244154|NCT02688842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6244155|NCT02688842|Immunologic Factors|immunologic factors|mesh-ancestor
6244156|NCT02688842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244157|NCT02688933|Insulin|insulin|mesh-list
6244158|NCT02688933|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6244159|NCT02688933|Insulin Glargine|insulin glargine|mesh-list
6244160|NCT02688933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5713942|NCT03257215|Micronutrients|micronutrients|mesh-ancestor
5713943|NCT03257215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713944|NCT03257215|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5713945|NCT03257215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5713946|NCT03257124|Osimertinib|osimertinib|mesh-list
5713947|NCT03257124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5713948|NCT03257124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5713949|NCT03257124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5713950|NCT03257124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713951|NCT03256903|Methoxyflurane|methoxyflurane|mesh-list
5713952|NCT03256903|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5713953|NCT03256903|Anesthetics, General|anesthetics, general|mesh-ancestor
5713954|NCT03256903|Anesthetics|anesthetics|mesh-ancestor
5713955|NCT03256903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5713956|NCT03256903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713957|NCT03256721|Docetaxel|docetaxel|mesh-list
5713958|NCT03256721|Pemetrexed|pemetrexed|mesh-list
5713959|NCT03256721|Apatinib|apatinib|mesh-list
5713960|NCT03256721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5713961|NCT03256721|Tubulin Modulators|tubulin modulators|mesh-ancestor
5713962|NCT03256721|Antimitotic Agents|antimitotic agents|mesh-ancestor
5713963|NCT03256721|Mitosis Modulators|mitosis modulators|mesh-ancestor
6244161|NCT02688933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244162|NCT02689063|Acetaminophen|acetaminophen|mesh-list
6244163|NCT02689063|Ibuprofen|ibuprofen|mesh-list
6244164|NCT02689063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6244165|NCT02689063|Analgesics|analgesics|mesh-ancestor
6244166|NCT02689063|Sensory System Agents|sensory system agents|mesh-ancestor
6244167|NCT02689063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6244168|NCT02689063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244169|NCT02689063|Antipyretics|antipyretics|mesh-ancestor
6244170|NCT02689063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6244171|NCT02689063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6244172|NCT02689063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5721853|NCT03203031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244173|NCT02689063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6244174|NCT02689063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6240886|NCT02617888|Bismuth|bismuth|mesh-list
6240887|NCT02617888|Antacids|antacids|mesh-ancestor
6240888|NCT02617888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240889|NCT02617888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6240890|NCT02618187|Vancomycin|vancomycin|mesh-list
6240891|NCT02618187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6240892|NCT02618187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6240893|NCT02618343|Ondansetron|ondansetron|mesh-list
6240894|NCT02618343|Antiemetics|antiemetics|mesh-ancestor
5713964|NCT03256721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713965|NCT03256721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5713966|NCT03256721|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5713967|NCT03256721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5713968|NCT03256721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5713969|NCT03256825|Anti-Infective Agents|anti-infective agents|mesh-list
5713970|NCT03256825|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5713971|NCT03256864|Everolimus|everolimus|mesh-list
5713972|NCT03256864|Tacrolimus|tacrolimus|mesh-list
5713973|NCT03256864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5713974|NCT03256864|Immunologic Factors|immunologic factors|mesh-ancestor
5713975|NCT03256864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5713976|NCT03256864|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5713977|NCT03256864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5713978|NCT03256864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5713979|NCT03256864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5713980|NCT03256487|Morphine|morphine|mesh-list
5713981|NCT03256487|Buprenorphine|buprenorphine|mesh-list
5713982|NCT03256487|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5713983|NCT03256487|Narcotics|narcotics|mesh-ancestor
5713984|NCT03256487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5713985|NCT03256487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240895|NCT02618343|Autonomic Agents|autonomic agents|mesh-ancestor
6240896|NCT02618343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6240897|NCT02618343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240898|NCT02618343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6240899|NCT02618343|Antipruritics|antipruritics|mesh-ancestor
6240900|NCT02618343|Dermatologic Agents|dermatologic agents|mesh-ancestor
6240901|NCT02618343|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6240902|NCT02618343|Serotonin Agents|serotonin agents|mesh-ancestor
6240903|NCT02618343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6240904|NCT02618343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240905|NCT02618343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6240906|NCT02618343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6240907|NCT02618343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6240908|NCT02618343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6503427|NCT00652392|Respiratory System Agents|respiratory system agents|mesh-ancestor
6503428|NCT00652392|Glucocorticoids|glucocorticoids|mesh-ancestor
6240909|NCT02618343|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6240910|NCT02618382|Tranexamic Acid|tranexamic acid|mesh-list
6240911|NCT02618382|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6503429|NCT00652392|Hormones|hormones|mesh-ancestor
6503430|NCT00652392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6503431|NCT00652392|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6503432|NCT00652392|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6503433|NCT00652392|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6240912|NCT02618382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6240913|NCT02618382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240914|NCT02618382|Hemostatics|hemostatics|mesh-ancestor
6240915|NCT02618382|Coagulants|coagulants|mesh-ancestor
6240916|NCT02618772|Midazolam|midazolam|mesh-list
6240917|NCT02618772|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6240918|NCT02618772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6240919|NCT02618772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6240920|NCT02618772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503434|NCT00652392|Adrenergic Agents|adrenergic agents|mesh-ancestor
6503435|NCT00652392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6503436|NCT00652392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503437|NCT00652483|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6677905|NCT01590342|Analgesics|analgesics|mesh-ancestor
6240921|NCT02618772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6240922|NCT02618772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6240923|NCT02618772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5713986|NCT03256487|Analgesics|analgesics|mesh-ancestor
5713987|NCT03256487|Sensory System Agents|sensory system agents|mesh-ancestor
6240924|NCT02618772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6240925|NCT02618772|Anesthetics, General|anesthetics, general|mesh-ancestor
6503438|NCT00652483|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6677906|NCT01590342|Sensory System Agents|sensory system agents|mesh-ancestor
6677907|NCT01590342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6240926|NCT02618772|Anesthetics|anesthetics|mesh-ancestor
6240927|NCT02618772|GABA Modulators|gaba modulators|mesh-ancestor
6240928|NCT02618772|GABA Agents|gaba agents|mesh-ancestor
6240929|NCT02618772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6240930|NCT02618772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240931|NCT02619409|Bupivacaine|bupivacaine|mesh-list
6240932|NCT02619409|Anesthetics, Local|anesthetics, local|mesh-ancestor
5713988|NCT03256487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5713989|NCT03256487|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5721854|NCT03203070|Dipyrone|dipyrone|mesh-list
5721855|NCT03203070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5721856|NCT03203070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5721857|NCT03203070|Analgesics|analgesics|mesh-ancestor
5721858|NCT03203070|Sensory System Agents|sensory system agents|mesh-ancestor
5721859|NCT03203070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5721860|NCT03203070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721861|NCT03203070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5721862|NCT03203070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5721863|NCT03203070|Antipyretics|antipyretics|mesh-ancestor
6240933|NCT02619409|Anesthetics|anesthetics|mesh-ancestor
6240934|NCT02619409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6240935|NCT02619409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240936|NCT02619409|Sensory System Agents|sensory system agents|mesh-ancestor
6240937|NCT02619409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6240938|NCT02619617|Pasireotide|pasireotide|mesh-list
6677908|NCT01590342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677909|NCT01590342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6677910|NCT01590342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6677911|NCT01590342|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6677912|NCT01590342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6677913|NCT01590342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721864|NCT03202875|Insulin|insulin|mesh-list
5721865|NCT03202875|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5721866|NCT03202875|Insulin Aspart|insulin aspart|mesh-list
5721867|NCT03202875|Insulin, Long-Acting|insulin, long-acting|mesh-list
5721868|NCT03202875|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
5721869|NCT03202875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6779706|NCT02180516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779707|NCT02180529|Methylphenidate|methylphenidate|mesh-list
6779708|NCT02180529|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5721870|NCT03202875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240939|NCT02619617|Hormones|hormones|mesh-ancestor
6240940|NCT02619617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6240941|NCT02619617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240942|NCT02619799|Magnesium Sulfate|magnesium sulfate|mesh-list
6240943|NCT02619799|Midazolam|midazolam|mesh-list
6240944|NCT02619799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6240945|NCT02619799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6240946|NCT02619799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6240947|NCT02619799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240948|NCT02619799|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6240949|NCT02619799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6240950|NCT02619799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6240951|NCT02619799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6240952|NCT02619799|Anesthetics, General|anesthetics, general|mesh-ancestor
6240953|NCT02619799|Anesthetics|anesthetics|mesh-ancestor
6240954|NCT02619799|GABA Modulators|gaba modulators|mesh-ancestor
6240955|NCT02619799|GABA Agents|gaba agents|mesh-ancestor
6240956|NCT02619799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6240957|NCT02619799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240958|NCT02619799|Analgesics|analgesics|mesh-ancestor
6503439|NCT00652483|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6503440|NCT00652483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6503441|NCT00652483|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6503442|NCT00652483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6503443|NCT00652483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6503444|NCT00652483|Adrenergic Agents|adrenergic agents|mesh-ancestor
6503445|NCT00652483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6503446|NCT00652483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503447|NCT00652483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503448|NCT00652496|Bimatoprost|bimatoprost|mesh-list
5713990|NCT03256045|Dexamethasone|dexamethasone|mesh-list
5713991|NCT03256045|Dexamethasone acetate|dexamethasone acetate|mesh-list
5713992|NCT03256045|Panobinostat|panobinostat|mesh-list
5713993|NCT03256045|Ichthammol|ichthammol|mesh-list
5713994|NCT03256045|BB 1101|bb 1101|mesh-list
5713995|NCT03256045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5713996|NCT03256045|Antiemetics|antiemetics|mesh-ancestor
5713997|NCT03256045|Autonomic Agents|autonomic agents|mesh-ancestor
5713998|NCT03256045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5713999|NCT03256045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714000|NCT03256045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5714001|NCT03256045|Glucocorticoids|glucocorticoids|mesh-ancestor
5714002|NCT03256045|Hormones|hormones|mesh-ancestor
5714003|NCT03256045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5714004|NCT03256045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5714005|NCT03256045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5714006|NCT03256045|Protease Inhibitors|protease inhibitors|mesh-ancestor
5714007|NCT03256045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5714008|NCT03256045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5714009|NCT03256045|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5714010|NCT03256045|Dermatologic Agents|dermatologic agents|mesh-ancestor
5714011|NCT03256149|Dexamethasone|dexamethasone|mesh-list
5714012|NCT03256149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5714013|NCT03256149|Antiemetics|antiemetics|mesh-ancestor
5714014|NCT03256149|Autonomic Agents|autonomic agents|mesh-ancestor
5714015|NCT03256149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5714016|NCT03256149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714017|NCT03256149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5714018|NCT03256149|Glucocorticoids|glucocorticoids|mesh-ancestor
5714019|NCT03256149|Hormones|hormones|mesh-ancestor
5714020|NCT03256149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5714021|NCT03256149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5714022|NCT03256149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5714023|NCT03256071|Decitabine|decitabine|mesh-list
5714024|NCT03256071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5714025|NCT03256071|Antimetabolites|antimetabolites|mesh-ancestor
5714026|NCT03256071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503449|NCT00652496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6503450|NCT00652496|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6503451|NCT00652496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6240959|NCT02619799|Sensory System Agents|sensory system agents|mesh-ancestor
6240960|NCT02619799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6240961|NCT02619799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6240962|NCT02619799|Anticonvulsants|anticonvulsants|mesh-ancestor
6240963|NCT02619799|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6240964|NCT02619799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6240965|NCT02619799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6240966|NCT02619799|Tocolytic Agents|tocolytic agents|mesh-ancestor
6240967|NCT02619799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6240968|NCT02620020|Fasinumab|fasinumab|mesh-list
6240969|NCT02620020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6240970|NCT02620020|Analgesics|analgesics|mesh-ancestor
6240971|NCT02620020|Sensory System Agents|sensory system agents|mesh-ancestor
6240972|NCT02620020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6240973|NCT02620020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240974|NCT02620384|Metolazone|metolazone|mesh-list
6240975|NCT02620384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6240976|NCT02620384|Diuretics|diuretics|mesh-ancestor
6240977|NCT02620384|Natriuretic Agents|natriuretic agents|mesh-ancestor
5714027|NCT03256071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5714028|NCT03256071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5714029|NCT03256292|Testosterone|testosterone|mesh-list
5714030|NCT03256292|Androgens|androgens|mesh-ancestor
5714031|NCT03256292|Hormones|hormones|mesh-ancestor
5714032|NCT03256292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5714033|NCT03256292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714034|NCT03255811|Apatinib|apatinib|mesh-list
5714035|NCT03255811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5714036|NCT03255811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5714037|NCT03255811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5714038|NCT03255811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5714039|NCT03255915|Tenofovir|tenofovir|mesh-list
5714040|NCT03255915|Emtricitabine|emtricitabine|mesh-list
5714041|NCT03255915|Antiviral Agents|antiviral agents|mesh-ancestor
5714042|NCT03255915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6240978|NCT02620384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240979|NCT02620384|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6240980|NCT02620384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6240981|NCT02620384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240982|NCT02620683|Lidocaine|lidocaine|mesh-list
6240983|NCT02620683|Anesthetics, Local|anesthetics, local|mesh-ancestor
6240984|NCT02620683|Anesthetics|anesthetics|mesh-ancestor
6240985|NCT02620683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6240986|NCT02620683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6240987|NCT02620683|Sensory System Agents|sensory system agents|mesh-ancestor
6240988|NCT02620683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6240989|NCT02620683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6240990|NCT02620683|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6240991|NCT02620683|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6240992|NCT02620683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6240993|NCT02620683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6240994|NCT02620774|Tazobactam|tazobactam|mesh-list
6240995|NCT02620774|Ceftolozane|ceftolozane|mesh-list
6240996|NCT02620774|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
6240997|NCT02620774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6240998|NCT02620774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6240999|NCT02620774|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6241000|NCT02620774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6241001|NCT02620774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241002|NCT02620774|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6241003|NCT02620774|Renal Agents|renal agents|mesh-ancestor
6241004|NCT02620787|Tedizolid|tedizolid|mesh-list
6241005|NCT02620787|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6241006|NCT02620787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6241007|NCT02620878|Pancrelipase|pancrelipase|mesh-list
6241008|NCT02620878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6241009|NCT02620904|Mifepristone|mifepristone|mesh-list
6241010|NCT02620904|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6241011|NCT02620904|Abortifacient Agents|abortifacient agents|mesh-ancestor
6241012|NCT02620904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6241013|NCT02620904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241014|NCT02620904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6241015|NCT02620904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6241016|NCT02620904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6241017|NCT02620904|Contraceptive Agents|contraceptive agents|mesh-ancestor
6241018|NCT02620904|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6241019|NCT02620904|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6241020|NCT02620904|Hormone Antagonists|hormone antagonists|mesh-ancestor
6241021|NCT02620904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6241022|NCT02620904|Luteolytic Agents|luteolytic agents|mesh-ancestor
6241023|NCT02620904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6241024|NCT02620904|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6241025|NCT02621060|Magnesium Oxide|magnesium oxide|mesh-list
6241026|NCT02621060|Antacids|antacids|mesh-ancestor
6241027|NCT02621060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241028|NCT02621060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6241029|NCT02621619|Acetaminophen|acetaminophen|mesh-list
6241030|NCT02621619|Hydromorphone|hydromorphone|mesh-list
6241031|NCT02621619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6241032|NCT02621619|Analgesics|analgesics|mesh-ancestor
6241033|NCT02621619|Sensory System Agents|sensory system agents|mesh-ancestor
6241034|NCT02621619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6241035|NCT02621619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241036|NCT02621619|Antipyretics|antipyretics|mesh-ancestor
6241037|NCT02621619|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6241038|NCT02621619|Narcotics|narcotics|mesh-ancestor
6241039|NCT02621619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6241040|NCT02621931|Calcitonin|calcitonin|mesh-list
6241041|NCT02621931|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
6241042|NCT02621931|Katacalcin|katacalcin|mesh-list
6241043|NCT02621931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6241044|NCT02621931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241045|NCT02621931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6241046|NCT02621931|Vasodilator Agents|vasodilator agents|mesh-ancestor
6241047|NCT02622074|Paclitaxel|paclitaxel|mesh-list
6241048|NCT02622074|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6241049|NCT02622074|Cyclophosphamide|cyclophosphamide|mesh-list
6241050|NCT02622074|Carboplatin|carboplatin|mesh-list
6241051|NCT02622074|Doxorubicin|doxorubicin|mesh-list
6241052|NCT02622074|Pembrolizumab|pembrolizumab|mesh-list
6241053|NCT02622074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6503457|NCT00652600|Propranolol|propranolol|mesh-list
6503458|NCT00652600|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6503459|NCT00652600|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6503460|NCT00652600|Adrenergic Agents|adrenergic agents|mesh-ancestor
6503461|NCT00652600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6503462|NCT00652600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241054|NCT02622074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6241055|NCT02622074|Tubulin Modulators|tubulin modulators|mesh-ancestor
6241056|NCT02622074|Antimitotic Agents|antimitotic agents|mesh-ancestor
6241057|NCT02622074|Mitosis Modulators|mitosis modulators|mesh-ancestor
6241058|NCT02622074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241059|NCT02622074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6241060|NCT02622074|Immunologic Factors|immunologic factors|mesh-ancestor
6241061|NCT02622074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241062|NCT02622074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6241063|NCT02622074|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6241064|NCT02622074|Alkylating Agents|alkylating agents|mesh-ancestor
6241065|NCT02622074|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6241066|NCT02622074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6241067|NCT02622074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6241068|NCT02622074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6241069|NCT02622074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6241070|NCT02622074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6503463|NCT00652600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503464|NCT00652600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6503465|NCT00652600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6503466|NCT00652600|Vasodilator Agents|vasodilator agents|mesh-ancestor
6503467|NCT00652639|Clonazepam|clonazepam|mesh-list
6503468|NCT00652639|Anticonvulsants|anticonvulsants|mesh-ancestor
6677914|NCT01590537|Copper|copper|mesh-list
6677915|NCT01590537|Levonorgestrel|levonorgestrel|mesh-list
6677916|NCT01590537|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6677917|NCT01590537|Contraceptive Agents|contraceptive agents|mesh-ancestor
6677918|NCT01590537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6241071|NCT02622113|Canagliflozin|canagliflozin|mesh-list
6241072|NCT02622113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6241073|NCT02622113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241074|NCT02622113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6241075|NCT02622113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241076|NCT02622321|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
6241077|NCT02622321|Coagulants|coagulants|mesh-ancestor
6241078|NCT02622724|Interferons|interferons|mesh-list
6241079|NCT02622724|Interferon-beta|interferon-beta|mesh-list
6241080|NCT02622724|Interferon beta-1a|interferon beta-1a|mesh-list
6241081|NCT02622724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6241082|NCT02622724|Antiviral Agents|antiviral agents|mesh-ancestor
6241083|NCT02622724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6241084|NCT02622724|Immunologic Factors|immunologic factors|mesh-ancestor
6677919|NCT01590537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677920|NCT01590537|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6677921|NCT01590537|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6677922|NCT01590537|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6677923|NCT01590537|Trace Elements|trace elements|mesh-ancestor
6677924|NCT01590537|Micronutrients|micronutrients|mesh-ancestor
6677925|NCT01590641|Vesatolimod|vesatolimod|mesh-list
6677926|NCT01590641|Antiviral Agents|antiviral agents|mesh-ancestor
6677927|NCT01590641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6677928|NCT01590654|Vesatolimod|vesatolimod|mesh-list
6241085|NCT02622724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241086|NCT02622724|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6241087|NCT02623803|Lidocaine|lidocaine|mesh-list
6241088|NCT02623803|Anesthetics, Local|anesthetics, local|mesh-ancestor
6241089|NCT02623803|Anesthetics|anesthetics|mesh-ancestor
6241090|NCT02623803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6241091|NCT02623803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241092|NCT02623803|Sensory System Agents|sensory system agents|mesh-ancestor
6241093|NCT02623803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6241094|NCT02623803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6241095|NCT02623803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6677929|NCT01590654|Antiviral Agents|antiviral agents|mesh-ancestor
6241096|NCT02623803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6241097|NCT02623803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6241098|NCT02623803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241099|NCT02623829|Botulinum Toxins|botulinum toxins|mesh-list
6241100|NCT02623829|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6241101|NCT02623829|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6241102|NCT02623829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6241103|NCT02623829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241104|NCT02623829|Cholinergic Agents|cholinergic agents|mesh-ancestor
6241105|NCT02623829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6241106|NCT02623829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241107|NCT02623829|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6241108|NCT02623829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6241109|NCT02624050|Propofol|propofol|mesh-list
6241110|NCT02624050|Methohexital|methohexital|mesh-list
6503469|NCT00652639|GABA Modulators|gaba modulators|mesh-ancestor
6503470|NCT00652639|GABA Agents|gaba agents|mesh-ancestor
6503471|NCT00652639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6503472|NCT00652639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503473|NCT00652639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503474|NCT00652652|Furosemide|furosemide|mesh-list
6503475|NCT00652652|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6503476|NCT00652652|Diuretics|diuretics|mesh-ancestor
6503477|NCT00652652|Natriuretic Agents|natriuretic agents|mesh-ancestor
6503478|NCT00652652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503479|NCT00652652|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6503480|NCT00652652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6241111|NCT02624050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6241112|NCT02624050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6241113|NCT02624050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241114|NCT02624050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6503481|NCT00652652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503482|NCT00652665|Leflunomide|leflunomide|mesh-list
6503483|NCT00652665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6503484|NCT00652665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503485|NCT00652665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6503486|NCT00652665|Immunologic Factors|immunologic factors|mesh-ancestor
6503487|NCT00652665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503488|NCT00652691|Cyclophosphamide|cyclophosphamide|mesh-list
6503489|NCT00652691|Carboplatin|carboplatin|mesh-list
6503490|NCT00652691|Topotecan|topotecan|mesh-list
5714043|NCT03255915|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5714044|NCT03255915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5714045|NCT03255915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5714046|NCT03255915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5714047|NCT03255915|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5714048|NCT03255915|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5714049|NCT03255642|Clonazepam|clonazepam|mesh-list
5714050|NCT03255642|Melatonin|melatonin|mesh-list
5714051|NCT03255642|Antioxidants|antioxidants|mesh-ancestor
5714052|NCT03255642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5714053|NCT03255642|Protective Agents|protective agents|mesh-ancestor
5714054|NCT03255642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714055|NCT03255642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5714056|NCT03255642|Anticonvulsants|anticonvulsants|mesh-ancestor
5714057|NCT03255642|GABA Modulators|gaba modulators|mesh-ancestor
5714058|NCT03255642|GABA Agents|gaba agents|mesh-ancestor
5714059|NCT03255642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5714060|NCT03255629|Glucagon|glucagon|mesh-list
5714061|NCT03255629|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5714062|NCT03255629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5714063|NCT03255629|Hormones|hormones|mesh-ancestor
5714064|NCT03255629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5714065|NCT03255629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714066|NCT03255629|Incretins|incretins|mesh-ancestor
5714067|NCT03255226|Tolvaptan|tolvaptan|mesh-list
5714068|NCT03255226|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
5714069|NCT03255226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241115|NCT02624050|Anesthetics, General|anesthetics, general|mesh-ancestor
6503491|NCT00652691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6503492|NCT00652691|Immunologic Factors|immunologic factors|mesh-ancestor
6241116|NCT02624050|Anesthetics|anesthetics|mesh-ancestor
6503493|NCT00652691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241117|NCT02624180|Colchicine|colchicine|mesh-list
5714070|NCT03255226|Natriuretic Agents|natriuretic agents|mesh-ancestor
5714071|NCT03255226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714072|NCT03255278|Vaccines|vaccines|mesh-list
6241118|NCT02624180|Gout Suppressants|gout suppressants|mesh-ancestor
6241119|NCT02624180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6241120|NCT02624180|Tubulin Modulators|tubulin modulators|mesh-ancestor
6241121|NCT02624180|Antimitotic Agents|antimitotic agents|mesh-ancestor
6241122|NCT02624180|Mitosis Modulators|mitosis modulators|mesh-ancestor
6241123|NCT02624180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503494|NCT00652691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6503495|NCT00652691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6503496|NCT00652691|Alkylating Agents|alkylating agents|mesh-ancestor
6503497|NCT00652691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503498|NCT00652691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6241124|NCT02624180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6241125|NCT02624492|Rituximab|rituximab|mesh-list
6241126|NCT02624492|BI 836826|bi 836826|mesh-list
6241127|NCT02624492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6241128|NCT02624492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6241129|NCT02624492|Immunologic Factors|immunologic factors|mesh-ancestor
6241130|NCT02624492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241131|NCT02624492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6241132|NCT02624700|Pemetrexed|pemetrexed|mesh-list
6241133|NCT02624700|Sorafenib|sorafenib|mesh-list
6241134|NCT02624700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6241135|NCT02624700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6241136|NCT02624700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241137|NCT02624700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6241138|NCT02624700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6241139|NCT02624700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6241140|NCT02624843|Ethanol|ethanol|mesh-list
6241141|NCT02624843|Benzyl Alcohol|benzyl alcohol|mesh-list
6241142|NCT02624843|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6241143|NCT02624843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6241144|NCT02624843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6241145|NCT02624843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241146|NCT02624843|Anesthetics, Local|anesthetics, local|mesh-ancestor
6241147|NCT02624843|Anesthetics|anesthetics|mesh-ancestor
6241148|NCT02624843|Sensory System Agents|sensory system agents|mesh-ancestor
6241149|NCT02624843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6241150|NCT02624986|Rituximab|rituximab|mesh-list
6241151|NCT02624986|Obinutuzumab|obinutuzumab|mesh-list
6241152|NCT02624986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6241153|NCT02624986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6241154|NCT02624986|Immunologic Factors|immunologic factors|mesh-ancestor
6241155|NCT02624986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241156|NCT02624986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6241157|NCT02625181|Promethazine|promethazine|mesh-list
6241158|NCT02625181|Diphenhydramine|diphenhydramine|mesh-list
5714073|NCT03255278|Immunologic Factors|immunologic factors|mesh-ancestor
5714074|NCT03255278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714075|NCT03255330|Dipyrone|dipyrone|mesh-list
5714076|NCT03255330|Gabapentin|gabapentin|mesh-list
5714077|NCT03255330|Tramadol|tramadol|mesh-list
5714078|NCT03255330|Analgesics|analgesics|mesh-ancestor
5714079|NCT03255330|Sensory System Agents|sensory system agents|mesh-ancestor
5919282|NCT04983615|GABA Modulators|gaba modulators|mesh-ancestor
5919283|NCT04983615|GABA Agents|gaba agents|mesh-ancestor
5919284|NCT04983615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5919285|NCT04983615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919286|NCT04983095|Hormones|hormones|mesh-list
5919287|NCT04983095|Androgens|androgens|mesh-list
5919288|NCT04983095|Hormone Antagonists|hormone antagonists|mesh-list
6241159|NCT02625181|Meclizine|meclizine|mesh-list
6241160|NCT02625181|Dexamethasone|dexamethasone|mesh-list
6241161|NCT02625181|Fentanyl|fentanyl|mesh-list
6241162|NCT02625181|Sufentanil|sufentanil|mesh-list
6241163|NCT02625181|Scopolamine|scopolamine|mesh-list
6241164|NCT02625181|Oxymorphone|oxymorphone|mesh-list
6241165|NCT02625181|Meperidine|meperidine|mesh-list
6241166|NCT02625181|Droperidol|droperidol|mesh-list
6241167|NCT02625181|Morphine|morphine|mesh-list
6241168|NCT02625181|Remifentanil|remifentanil|mesh-list
6241169|NCT02625181|Oxycodone|oxycodone|mesh-list
6241170|NCT02625181|Methadone|methadone|mesh-list
6241171|NCT02625181|Hydromorphone|hydromorphone|mesh-list
6241172|NCT02625181|Hydrocodone|hydrocodone|mesh-list
6241173|NCT02625181|Alfentanil|alfentanil|mesh-list
6241174|NCT02625181|Ketamine|ketamine|mesh-list
6241175|NCT02625181|Haloperidol|haloperidol|mesh-list
6241176|NCT02625181|Ondansetron|ondansetron|mesh-list
6241177|NCT02625181|Aprepitant|aprepitant|mesh-list
6241178|NCT02625181|Palonosetron|palonosetron|mesh-list
6241179|NCT02625181|Metoclopramide|metoclopramide|mesh-list
6241180|NCT02625181|Granisetron|granisetron|mesh-list
6241181|NCT02625181|Ramosetron|ramosetron|mesh-list
6241182|NCT02625181|Tropisetron|tropisetron|mesh-list
6241183|NCT02625181|Dolasetron|dolasetron|mesh-list
6241184|NCT02625181|Anesthetics|anesthetics|mesh-list
6241185|NCT02625181|Propofol|propofol|mesh-list
6241186|NCT02625181|Sevoflurane|sevoflurane|mesh-list
6241187|NCT02625181|Desflurane|desflurane|mesh-list
6241188|NCT02625181|Isoflurane|isoflurane|mesh-list
6241189|NCT02625181|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
6241190|NCT02625181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6241191|NCT02625181|Antiemetics|antiemetics|mesh-ancestor
6241192|NCT02625181|Autonomic Agents|autonomic agents|mesh-ancestor
6503499|NCT00652691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6503500|NCT00652691|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6503501|NCT00652691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6503502|NCT00652691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6503503|NCT00652704|Doxycycline|doxycycline|mesh-list
6503504|NCT00652704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6503505|NCT00652704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6503506|NCT00652704|Antimalarials|antimalarials|mesh-ancestor
6677930|NCT01590654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6241193|NCT02625181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6241194|NCT02625181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241195|NCT02625181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6241196|NCT02625181|Glucocorticoids|glucocorticoids|mesh-ancestor
6241197|NCT02625181|Hormones|hormones|mesh-ancestor
5714080|NCT03255330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5714081|NCT03255330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241198|NCT02625181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6241199|NCT02625181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6241200|NCT02625181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6241201|NCT02625181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6677931|NCT01590680|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
6241202|NCT02625181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6241203|NCT02625181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6241204|NCT02625181|Anesthetics, General|anesthetics, general|mesh-ancestor
6241205|NCT02625181|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6241206|NCT02625181|Narcotics|narcotics|mesh-ancestor
6241207|NCT02625181|Analgesics|analgesics|mesh-ancestor
6241208|NCT02625181|Sensory System Agents|sensory system agents|mesh-ancestor
6241209|NCT02625181|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6241210|NCT02625181|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6241211|NCT02625181|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6241212|NCT02625181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6241213|NCT02625181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241214|NCT02625181|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6241215|NCT02625181|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6241216|NCT02625181|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6241217|NCT02625181|Antipruritics|antipruritics|mesh-ancestor
6241218|NCT02625181|Dermatologic Agents|dermatologic agents|mesh-ancestor
6241219|NCT02625181|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6241220|NCT02625181|Serotonin Agents|serotonin agents|mesh-ancestor
6241221|NCT02625181|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6241222|NCT02625181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6241223|NCT02625181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6241224|NCT02625181|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6241225|NCT02625181|Antitussive Agents|antitussive agents|mesh-ancestor
6241226|NCT02625181|Respiratory System Agents|respiratory system agents|mesh-ancestor
6241227|NCT02625181|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6241228|NCT02625181|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6241229|NCT02625181|Dopamine Agents|dopamine agents|mesh-ancestor
6241230|NCT02625181|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6241231|NCT02625181|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6241232|NCT02625181|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6241233|NCT02625181|Mydriatics|mydriatics|mesh-ancestor
6241234|NCT02625181|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6241235|NCT02625181|Cholinergic Agents|cholinergic agents|mesh-ancestor
6241236|NCT02625181|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6241237|NCT02625181|Parasympatholytics|parasympatholytics|mesh-ancestor
6241238|NCT02625181|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6241239|NCT02625181|Histamine Antagonists|histamine antagonists|mesh-ancestor
6241240|NCT02625181|Histamine Agents|histamine agents|mesh-ancestor
6241241|NCT02625181|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6503507|NCT00652704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6241242|NCT02625181|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6241243|NCT02625181|Anesthetics, Local|anesthetics, local|mesh-ancestor
6241244|NCT02625207|Maraviroc|maraviroc|mesh-list
6241245|NCT02625207|Darunavir|darunavir|mesh-list
6241246|NCT02625207|Cobicistat|cobicistat|mesh-list
6241247|NCT02625207|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5714082|NCT03255330|Anticonvulsants|anticonvulsants|mesh-ancestor
5714083|NCT03255330|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5714084|NCT03255330|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5714085|NCT03255330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5714086|NCT03255330|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5714087|NCT03255330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5714088|NCT03255330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5714089|NCT03255330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5714090|NCT03255330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5714091|NCT03255330|Antimanic Agents|antimanic agents|mesh-ancestor
5714092|NCT03255330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5714093|NCT03255330|Narcotics|narcotics|mesh-ancestor
5714094|NCT03255330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5714095|NCT03255330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5714096|NCT03255330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5714097|NCT03255330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5714098|NCT03255330|Antipyretics|antipyretics|mesh-ancestor
5714099|NCT03255473|Dexamethasone|dexamethasone|mesh-list
5714100|NCT03255473|Dexamethasone acetate|dexamethasone acetate|mesh-list
5714101|NCT03255473|Prednisone|prednisone|mesh-list
5714102|NCT03255473|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
5714103|NCT03255473|BB 1101|bb 1101|mesh-list
5714104|NCT03255473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5714105|NCT03255473|Antiemetics|antiemetics|mesh-ancestor
5714106|NCT03255473|Autonomic Agents|autonomic agents|mesh-ancestor
5714107|NCT03255473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5714108|NCT03255473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714109|NCT03255473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5714110|NCT03255473|Glucocorticoids|glucocorticoids|mesh-ancestor
5714111|NCT03255473|Hormones|hormones|mesh-ancestor
5714112|NCT03255473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5714113|NCT03255473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5714114|NCT03255473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5714115|NCT03255473|Protease Inhibitors|protease inhibitors|mesh-ancestor
5714116|NCT03255473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5714117|NCT03255473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241248|NCT02625207|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6241249|NCT02625207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241250|NCT02625207|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6241251|NCT02625207|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6241252|NCT02625207|Antiviral Agents|antiviral agents|mesh-ancestor
6241253|NCT02625207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6241254|NCT02625207|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6241255|NCT02625207|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6241256|NCT02625207|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6241257|NCT02625207|Protease Inhibitors|protease inhibitors|mesh-ancestor
6241258|NCT02625207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6241259|NCT02625207|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6241260|NCT02625207|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6241261|NCT02625259|Lansoprazole|lansoprazole|mesh-list
6241262|NCT02625259|Dexlansoprazole|dexlansoprazole|mesh-list
6241263|NCT02625259|Serabelisib|serabelisib|mesh-list
6241264|NCT02625259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6241265|NCT02625259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6241266|NCT02625259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6241267|NCT02625259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6241268|NCT02625259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241269|NCT02625298|Pemetrexed|pemetrexed|mesh-list
6241270|NCT02625298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6241271|NCT02625298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6241272|NCT02625298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241273|NCT02625298|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6241274|NCT02625298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6241275|NCT02625610|Leucovorin|leucovorin|mesh-list
6241276|NCT02625610|Fluorouracil|fluorouracil|mesh-list
6241277|NCT02625610|Capecitabine|capecitabine|mesh-list
6241278|NCT02625610|Oxaliplatin|oxaliplatin|mesh-list
5714118|NCT03255148|Oxytocin|oxytocin|mesh-list
5714119|NCT03255148|Oxytocics|oxytocics|mesh-ancestor
5721871|NCT03203005|Cyclophosphamide|cyclophosphamide|mesh-list
6241279|NCT02625610|Avelumab|avelumab|mesh-list
6241280|NCT02625610|Levoleucovorin|levoleucovorin|mesh-list
6241281|NCT02625610|Antimetabolites|antimetabolites|mesh-ancestor
6241282|NCT02625610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241283|NCT02625610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6241284|NCT02625610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6241285|NCT02625610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6241286|NCT02625610|Immunologic Factors|immunologic factors|mesh-ancestor
6241287|NCT02625610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241288|NCT02625610|Antidotes|antidotes|mesh-ancestor
6241289|NCT02625610|Protective Agents|protective agents|mesh-ancestor
6241290|NCT02625610|Vitamin B Complex|vitamin b complex|mesh-ancestor
6241291|NCT02625610|Vitamins|vitamins|mesh-ancestor
6241292|NCT02625610|Micronutrients|micronutrients|mesh-ancestor
6241293|NCT02625610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6241294|NCT02625623|Paclitaxel|paclitaxel|mesh-list
6241295|NCT02625623|Irinotecan|irinotecan|mesh-list
6241296|NCT02625623|Avelumab|avelumab|mesh-list
6241297|NCT02625623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6241298|NCT02625623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6241299|NCT02625623|Tubulin Modulators|tubulin modulators|mesh-ancestor
6241300|NCT02625623|Antimitotic Agents|antimitotic agents|mesh-ancestor
6241301|NCT02625623|Mitosis Modulators|mitosis modulators|mesh-ancestor
6241302|NCT02625623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241303|NCT02625623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6241304|NCT02625623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6241305|NCT02625623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6241306|NCT02625623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6241307|NCT02625909|Sofosbuvir|sofosbuvir|mesh-list
6241308|NCT02625909|Velpatasvir|velpatasvir|mesh-list
6241309|NCT02625909|Antiviral Agents|antiviral agents|mesh-ancestor
6241310|NCT02625909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6241311|NCT02625974|Nifurtimox|nifurtimox|mesh-list
6241312|NCT02625974|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6241313|NCT02625974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6241314|NCT02625974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6241315|NCT02625974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6241316|NCT02626000|Pembrolizumab|pembrolizumab|mesh-list
6241317|NCT02626000|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
6241318|NCT02626000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6241319|NCT02626000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6241320|NCT02626156|Methyl salicylate|methyl salicylate|mesh-list
6241321|NCT02626156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6241322|NCT02626182|Sildenafil Citrate|sildenafil citrate|mesh-list
6503508|NCT00652704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5714120|NCT03255148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5714121|NCT03255148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714122|NCT03254849|Empagliflozin|empagliflozin|mesh-list
5714123|NCT03254849|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5714124|NCT03254849|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5714125|NCT03254849|Diuretics|diuretics|mesh-ancestor
5714126|NCT03254849|Natriuretic Agents|natriuretic agents|mesh-ancestor
5714127|NCT03254849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714128|NCT03254849|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5714129|NCT03254849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5714130|NCT03254849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5714131|NCT03254849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6241323|NCT02626182|Vasodilator Agents|vasodilator agents|mesh-ancestor
6241324|NCT02626182|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6241325|NCT02626182|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6241326|NCT02626182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6241327|NCT02626182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241328|NCT02626182|Urological Agents|urological agents|mesh-ancestor
6241329|NCT02626611|Omalizumab|omalizumab|mesh-list
6241330|NCT02626611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6241331|NCT02626611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6241332|NCT02626611|Respiratory System Agents|respiratory system agents|mesh-ancestor
6241333|NCT02627144|Interferons|interferons|mesh-list
6241334|NCT02627144|Interferon-alpha|interferon-alpha|mesh-list
6503509|NCT00652730|Buspirone|buspirone|mesh-list
6503510|NCT00652730|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6503511|NCT00652730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6503512|NCT00652730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6503513|NCT00652730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503514|NCT00652730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6677932|NCT01590680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6241335|NCT02627144|Interferon alpha-2|interferon alpha-2|mesh-list
6241336|NCT02627144|Bevacizumab|bevacizumab|mesh-list
6677933|NCT01590680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6241337|NCT02627144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6241338|NCT02627144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6241339|NCT02627144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6241340|NCT02627144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6241341|NCT02627144|Growth Substances|growth substances|mesh-ancestor
6241342|NCT02627144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241343|NCT02627144|Growth Inhibitors|growth inhibitors|mesh-ancestor
6241344|NCT02627144|Antiviral Agents|antiviral agents|mesh-ancestor
6241345|NCT02627144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6503515|NCT00652730|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6503516|NCT00652730|Serotonin Agents|serotonin agents|mesh-ancestor
6503517|NCT00652730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6503518|NCT00652730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503519|NCT00652782|Rolofylline|rolofylline|mesh-list
6503520|NCT00652782|Diuretics|diuretics|mesh-ancestor
6503521|NCT00652782|Natriuretic Agents|natriuretic agents|mesh-ancestor
6503522|NCT00652782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503523|NCT00652795|Doxycycline|doxycycline|mesh-list
6241346|NCT02627144|Immunologic Factors|immunologic factors|mesh-ancestor
6241347|NCT02627677|Ponatinib|ponatinib|mesh-list
6241348|NCT02627677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6241349|NCT02627677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5714132|NCT03254849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5714133|NCT03254810|Adalimumab|adalimumab|mesh-list
5714134|NCT03254810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6241350|NCT02627677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6241351|NCT02627677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241352|NCT02628106|Alprostadil|alprostadil|mesh-list
5714135|NCT03254810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5714136|NCT03254927|Cetuximab|cetuximab|mesh-list
5714137|NCT03254927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5714138|NCT03254927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5714139|NCT03255044|Atorvastatin|atorvastatin|mesh-list
6241353|NCT02628106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6241354|NCT02628106|Vasodilator Agents|vasodilator agents|mesh-ancestor
6241355|NCT02628106|Urological Agents|urological agents|mesh-ancestor
6244175|NCT02689063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244176|NCT02689206|Glycine|glycine|mesh-list
6244177|NCT02689206|Glycine Agents|glycine agents|mesh-ancestor
6244178|NCT02689206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6244179|NCT02689206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244180|NCT02689206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244181|NCT02689219|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6244182|NCT02689219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6244183|NCT02689219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6244184|NCT02689804|Contraceptive Agents|contraceptive agents|mesh-list
6244185|NCT02689804|Levonorgestrel|levonorgestrel|mesh-list
6244186|NCT02689804|Ulipristal acetate|ulipristal acetate|mesh-list
6244187|NCT02689804|Contraceptives, Postcoital|contraceptives, postcoital|mesh-list
6244188|NCT02689804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6244189|NCT02689804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244190|NCT02689804|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6244191|NCT02689804|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6244192|NCT02689804|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6244193|NCT02689804|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6244194|NCT02690558|Gemcitabine|gemcitabine|mesh-list
6503524|NCT00652795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6503525|NCT00652795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6503526|NCT00652795|Antimalarials|antimalarials|mesh-ancestor
6503527|NCT00652795|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6503528|NCT00652795|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6503529|NCT00652808|Naproxen|naproxen|mesh-list
6503530|NCT00652808|Valdecoxib|valdecoxib|mesh-list
6503531|NCT00652808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6677934|NCT01590680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677935|NCT01590680|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6677936|NCT01590693|Botulinum Toxins|botulinum toxins|mesh-list
6677937|NCT01590693|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6677938|NCT01590693|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6677939|NCT01590693|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6677940|NCT01590693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6677941|NCT01590693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677942|NCT01590693|Cholinergic Agents|cholinergic agents|mesh-ancestor
6677943|NCT01590693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5714140|NCT03255044|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5714141|NCT03255044|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6503532|NCT00652808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6503533|NCT00652808|Analgesics|analgesics|mesh-ancestor
6503534|NCT00652808|Sensory System Agents|sensory system agents|mesh-ancestor
6503535|NCT00652808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6503536|NCT00652808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503537|NCT00652808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6503538|NCT00652808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6503539|NCT00652808|Gout Suppressants|gout suppressants|mesh-ancestor
6503540|NCT00652808|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6503541|NCT00652808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6241356|NCT02628236|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6241357|NCT02628236|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6241358|NCT02628236|Dermatologic Agents|dermatologic agents|mesh-ancestor
6241359|NCT02628600|Amikacin|amikacin|mesh-list
6241360|NCT02628600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6503542|NCT00652808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503543|NCT00652808|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6503544|NCT00652821|Tramadol|tramadol|mesh-list
6503545|NCT00652821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6503546|NCT00652821|Narcotics|narcotics|mesh-ancestor
6503547|NCT00652821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6503548|NCT00652821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677944|NCT01590693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677945|NCT01590693|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6677946|NCT01590693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6241361|NCT02628600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6241362|NCT02628769|Solithromycin|solithromycin|mesh-list
6241363|NCT02628769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6241364|NCT02628769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6241365|NCT02629094|Eplerenone|eplerenone|mesh-list
6241366|NCT02629094|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6241367|NCT02629094|Hormone Antagonists|hormone antagonists|mesh-ancestor
6241368|NCT02629094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6241369|NCT02629094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241370|NCT02629094|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6241371|NCT02629094|Diuretics|diuretics|mesh-ancestor
6241372|NCT02629094|Natriuretic Agents|natriuretic agents|mesh-ancestor
6241373|NCT02629094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6241374|NCT02629354|Ibuprofen|ibuprofen|mesh-list
6241375|NCT02629354|Caffeine|caffeine|mesh-list
6241376|NCT02629354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6241377|NCT02629354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6241378|NCT02629354|Analgesics|analgesics|mesh-ancestor
6241379|NCT02629354|Sensory System Agents|sensory system agents|mesh-ancestor
6241380|NCT02629354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6241381|NCT02629354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241382|NCT02629354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6241383|NCT02629354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6241384|NCT02629354|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6241385|NCT02629354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6241386|NCT02629354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241387|NCT02629354|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6241388|NCT02629354|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6677947|NCT01590732|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6241389|NCT02629354|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6241390|NCT02629354|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6241391|NCT02629354|Purinergic Agents|purinergic agents|mesh-ancestor
6241392|NCT02629354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6241393|NCT02629822|Tenofovir|tenofovir|mesh-list
6241394|NCT02629822|Lamivudine|lamivudine|mesh-list
6241395|NCT02629822|Antiviral Agents|antiviral agents|mesh-ancestor
6241396|NCT02629822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6241397|NCT02629822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6241398|NCT02629822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6241399|NCT02629822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6241400|NCT02629822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241401|NCT02629822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6241402|NCT02629822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6241403|NCT02629861|Calcitonin|calcitonin|mesh-list
6241404|NCT02629861|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
6241405|NCT02629861|Katacalcin|katacalcin|mesh-list
6241406|NCT02629861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6241407|NCT02629861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677948|NCT01590732|Carboplatin|carboplatin|mesh-list
6503549|NCT00652821|Analgesics|analgesics|mesh-ancestor
6503550|NCT00652821|Sensory System Agents|sensory system agents|mesh-ancestor
6241408|NCT02629861|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6241409|NCT02629861|Vasodilator Agents|vasodilator agents|mesh-ancestor
6241410|NCT02629965|Tiotropium Bromide|tiotropium bromide|mesh-list
6241411|NCT02629965|Olodaterol|olodaterol|mesh-list
6241412|NCT02629965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6241413|NCT02629965|Autonomic Agents|autonomic agents|mesh-ancestor
6241414|NCT02629965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6241415|NCT02629965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503551|NCT00652821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5714142|NCT03255044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5714143|NCT03255044|Antimetabolites|antimetabolites|mesh-ancestor
5714144|NCT03255044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5714145|NCT03255044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5714146|NCT03255044|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6241416|NCT02629965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6241417|NCT02629965|Respiratory System Agents|respiratory system agents|mesh-ancestor
6241418|NCT02629965|Parasympatholytics|parasympatholytics|mesh-ancestor
6241419|NCT02629965|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6241420|NCT02629965|Cholinergic Agents|cholinergic agents|mesh-ancestor
6241421|NCT02629965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6241422|NCT02629965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241423|NCT02629991|Oxytocin|oxytocin|mesh-list
6241424|NCT02629991|Oxytocics|oxytocics|mesh-ancestor
6241425|NCT02629991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6241426|NCT02629991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241427|NCT02630017|Methylphenidate|methylphenidate|mesh-list
6241428|NCT02630017|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6241429|NCT02630017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241430|NCT02630017|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6241431|NCT02630017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6241432|NCT02630017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6244195|NCT02690558|Pembrolizumab|pembrolizumab|mesh-list
6503552|NCT00652860|Doxorubicin|doxorubicin|mesh-list
5714147|NCT03255044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5714148|NCT03255070|Immunoconjugates|immunoconjugates|mesh-list
5714149|NCT03255070|Immunologic Factors|immunologic factors|mesh-ancestor
5714150|NCT03255070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714151|NCT03254732|Pembrolizumab|pembrolizumab|mesh-list
5714152|NCT03254732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5714153|NCT03254732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5721872|NCT03203005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5721873|NCT03203005|Immunologic Factors|immunologic factors|mesh-ancestor
5721874|NCT03203005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721875|NCT03203005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5721876|NCT03203005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5721877|NCT03203005|Alkylating Agents|alkylating agents|mesh-ancestor
5721878|NCT03203005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721879|NCT03203005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5721880|NCT03203005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5721881|NCT03202862|Fulvestrant|fulvestrant|mesh-list
5721882|NCT03202862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5721883|NCT03202862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5721884|NCT03202862|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5721885|NCT03202862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5721886|NCT03202862|Hormone Antagonists|hormone antagonists|mesh-ancestor
5721887|NCT03202862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5721888|NCT03202862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721889|NCT03202784|Berotralstat|berotralstat|mesh-list
5721890|NCT03202784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5721891|NCT03202784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721892|NCT03202758|Durvalumab|durvalumab|mesh-list
5721893|NCT03202758|Tremelimumab|tremelimumab|mesh-list
5721894|NCT03202758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5721895|NCT03202758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5721896|NCT03202563|Metformin|metformin|mesh-list
6503553|NCT00652860|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6503554|NCT00652860|Ifosfamide|ifosfamide|mesh-list
6503555|NCT00652860|Molgramostim|molgramostim|mesh-list
6503556|NCT00652860|Mitomycins|mitomycins|mesh-list
6503557|NCT00652860|Mitomycin|mitomycin|mesh-list
6503558|NCT00652860|Sargramostim|sargramostim|mesh-list
6503559|NCT00652860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6503560|NCT00652860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6241433|NCT02630017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241434|NCT02630017|Dopamine Agents|dopamine agents|mesh-ancestor
6241435|NCT02630017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6241436|NCT02630030|Ixazomib|ixazomib|mesh-list
6241437|NCT02630030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6241438|NCT02630030|Protease Inhibitors|protease inhibitors|mesh-ancestor
6241439|NCT02630030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6241440|NCT02630030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241441|NCT02630186|Atezolizumab|atezolizumab|mesh-list
6241442|NCT02630186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6241443|NCT02630316|Treprostinil|treprostinil|mesh-list
6241444|NCT02630316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6241445|NCT02630459|Erenumab|erenumab|mesh-list
6241446|NCT02630459|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6503561|NCT00652860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6503562|NCT00652860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6503563|NCT00652860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6503564|NCT00652860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503565|NCT00652860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6503566|NCT00652860|Alkylating Agents|alkylating agents|mesh-ancestor
6503567|NCT00652860|Immunologic Factors|immunologic factors|mesh-ancestor
6503568|NCT00652860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241447|NCT02630459|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
6241448|NCT02630459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241449|NCT02630459|Analgesics|analgesics|mesh-ancestor
6241450|NCT02630459|Sensory System Agents|sensory system agents|mesh-ancestor
6241451|NCT02630459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5714154|NCT03254511|Enoxaparin|enoxaparin|mesh-list
5714155|NCT03254511|Enoxaparin sodium|enoxaparin sodium|mesh-list
5714156|NCT03254511|Anticoagulants|anticoagulants|mesh-ancestor
5714157|NCT03254511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5714158|NCT03254511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5714159|NCT03254511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5714160|NCT03254589|Sulfasalazine|sulfasalazine|mesh-list
5714161|NCT03254589|Methotrexate|methotrexate|mesh-list
5714162|NCT03254589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5714163|NCT03254589|Abortifacient Agents|abortifacient agents|mesh-ancestor
5714164|NCT03254589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5714165|NCT03254589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714166|NCT03254589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5714167|NCT03254589|Antimetabolites|antimetabolites|mesh-ancestor
6241452|NCT02630459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241453|NCT02630459|Immunologic Factors|immunologic factors|mesh-ancestor
6241454|NCT02630563|Cyclosporine|cyclosporine|mesh-list
6241455|NCT02630563|Mycophenolic Acid|mycophenolic acid|mesh-list
6241456|NCT02630563|Cyclosporins|cyclosporins|mesh-list
6241457|NCT02630563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6241458|NCT02630563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241459|NCT02630563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6241460|NCT02630563|Immunologic Factors|immunologic factors|mesh-ancestor
6241461|NCT02630563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241462|NCT02630563|Antifungal Agents|antifungal agents|mesh-ancestor
6241463|NCT02630563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6241464|NCT02630563|Dermatologic Agents|dermatologic agents|mesh-ancestor
6241465|NCT02630563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6241466|NCT02630563|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6241467|NCT02630563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6241468|NCT02630563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6241469|NCT02630563|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6241470|NCT02630563|Antitubercular Agents|antitubercular agents|mesh-ancestor
6241471|NCT02630563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6503569|NCT00652860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6503570|NCT00652873|Cabergoline|cabergoline|mesh-list
6503571|NCT00652873|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6503572|NCT00652873|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6503573|NCT00652873|Dopamine Agonists|dopamine agonists|mesh-ancestor
6503574|NCT00652873|Dopamine Agents|dopamine agents|mesh-ancestor
6503575|NCT00652873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6503576|NCT00652873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241472|NCT02630693|Tamoxifen|tamoxifen|mesh-list
6241473|NCT02630693|Fulvestrant|fulvestrant|mesh-list
6241474|NCT02630693|Palbociclib|palbociclib|mesh-list
6241475|NCT02630693|Aromatase Inhibitors|aromatase inhibitors|mesh-list
6241476|NCT02630693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5714168|NCT03254589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5714169|NCT03254589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5714170|NCT03254589|Dermatologic Agents|dermatologic agents|mesh-ancestor
5714171|NCT03254589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5714172|NCT03254589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5714173|NCT03254589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5714174|NCT03254589|Immunologic Factors|immunologic factors|mesh-ancestor
5714175|NCT03254589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5714176|NCT03254589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5714177|NCT03254589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5714178|NCT03254589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5714179|NCT03254589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5714180|NCT03254589|Analgesics|analgesics|mesh-ancestor
5714181|NCT03254589|Sensory System Agents|sensory system agents|mesh-ancestor
5714182|NCT03254589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5714183|NCT03254589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5714184|NCT03254589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5714185|NCT03254784|BMS-986165|bms-986165|mesh-list
5714186|NCT03254784|Dermatologic Agents|dermatologic agents|mesh-ancestor
5714187|NCT03254784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5714188|NCT03254784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5714189|NCT03254784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5714190|NCT03254628|Misoprostol|misoprostol|mesh-list
5714191|NCT03254628|Oxytocin|oxytocin|mesh-list
5714192|NCT03254628|Oxytocics|oxytocics|mesh-ancestor
5714193|NCT03254628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5714194|NCT03254628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714195|NCT03254628|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5714196|NCT03254628|Abortifacient Agents|abortifacient agents|mesh-ancestor
5714197|NCT03254628|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5714198|NCT03254628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5714199|NCT03254641|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5714200|NCT03254641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5714201|NCT03254641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714202|NCT03254654|Apatinib|apatinib|mesh-list
5714203|NCT03254654|Vinorelbine|vinorelbine|mesh-list
5714204|NCT03254654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5714205|NCT03254654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5714206|NCT03254654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5714207|NCT03254654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241477|NCT02630693|Hormone Antagonists|hormone antagonists|mesh-ancestor
6241478|NCT02630693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6241479|NCT02630693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241480|NCT02630693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6241481|NCT02630693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6241482|NCT02630693|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6241483|NCT02630693|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6241484|NCT02630693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6241485|NCT02630693|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6241486|NCT02630693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6241487|NCT02630693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6241488|NCT02630693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241489|NCT02630693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6241490|NCT02630706|Metformin|metformin|mesh-list
6241491|NCT02630706|Glimepiride|glimepiride|mesh-list
6241492|NCT02630706|Ertugliflozin|ertugliflozin|mesh-list
6241493|NCT02630706|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6241494|NCT02630706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241495|NCT02630706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6241496|NCT02630706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6241497|NCT02630706|Immunologic Factors|immunologic factors|mesh-ancestor
6241498|NCT02630706|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6241499|NCT02630706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241500|NCT02630719|Timolol|timolol|mesh-list
6241501|NCT02630719|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6241502|NCT02630719|Lubricant Eye Drops|lubricant eye drops|mesh-list
6241503|NCT02630719|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6241504|NCT02630719|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6241505|NCT02630719|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6241506|NCT02630719|Adrenergic Agents|adrenergic agents|mesh-ancestor
6241507|NCT02630719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6241508|NCT02630719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241509|NCT02630719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241510|NCT02630719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5714208|NCT03254654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6241511|NCT02630719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6241512|NCT02630966|Vedolizumab|vedolizumab|mesh-list
6241513|NCT02630966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6241514|NCT02630992|Amoxicillin|amoxicillin|mesh-list
6503577|NCT00652873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503578|NCT00652886|Oxandrolone|oxandrolone|mesh-list
6503579|NCT00652886|Androgens|androgens|mesh-ancestor
6503580|NCT00652886|Hormones|hormones|mesh-ancestor
6503581|NCT00652886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6503582|NCT00652886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503583|NCT00652886|Anabolic Agents|anabolic agents|mesh-ancestor
6503584|NCT00652912|Clonazepam|clonazepam|mesh-list
5714209|NCT03254654|Tubulin Modulators|tubulin modulators|mesh-ancestor
5714210|NCT03254654|Antimitotic Agents|antimitotic agents|mesh-ancestor
5714211|NCT03254654|Mitosis Modulators|mitosis modulators|mesh-ancestor
5714212|NCT03254394|Lidocaine|lidocaine|mesh-list
5714213|NCT03254394|Anesthetics, Local|anesthetics, local|mesh-ancestor
5714214|NCT03254394|Anesthetics|anesthetics|mesh-ancestor
5714215|NCT03254394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5714216|NCT03254394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714217|NCT03254394|Sensory System Agents|sensory system agents|mesh-ancestor
5714218|NCT03254394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5714219|NCT03254394|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5714220|NCT03254394|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5714221|NCT03254394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5714222|NCT03254394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5714223|NCT03254394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5714224|NCT03254186|Propranolol|propranolol|mesh-list
5714225|NCT03254186|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5714226|NCT03254186|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5714227|NCT03254186|Adrenergic Agents|adrenergic agents|mesh-ancestor
6503585|NCT00652912|Anticonvulsants|anticonvulsants|mesh-ancestor
6503586|NCT00652912|GABA Modulators|gaba modulators|mesh-ancestor
6503587|NCT00652912|GABA Agents|gaba agents|mesh-ancestor
5714228|NCT03254186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5714229|NCT03254186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5714230|NCT03254186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714231|NCT03254186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5714232|NCT03254186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5714233|NCT03254186|Vasodilator Agents|vasodilator agents|mesh-ancestor
5714234|NCT03254173|Mirtazapine|mirtazapine|mesh-list
5714235|NCT03254173|Antidepressive Agents|antidepressive agents|mesh-ancestor
5714236|NCT03254173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5714237|NCT03254173|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5714238|NCT03254173|Histamine Antagonists|histamine antagonists|mesh-ancestor
5714239|NCT03254173|Histamine Agents|histamine agents|mesh-ancestor
5714240|NCT03254173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5714241|NCT03254173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5714242|NCT03254173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241515|NCT02630992|Clavulanic Acid|clavulanic acid|mesh-list
6503588|NCT00652912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6503589|NCT00652912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503590|NCT00652912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677949|NCT01590732|Etoposide|etoposide|mesh-list
6677950|NCT01590732|Etoposide phosphate|etoposide phosphate|mesh-list
6677951|NCT01590732|Ifosfamide|ifosfamide|mesh-list
6677952|NCT01590732|Isophosphamide mustard|isophosphamide mustard|mesh-list
6677953|NCT01590732|Podophyllotoxin|podophyllotoxin|mesh-list
6677954|NCT01590732|Romidepsin|romidepsin|mesh-list
6677955|NCT01590732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6677956|NCT01590732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6677957|NCT01590732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6677958|NCT01590732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6677959|NCT01590732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6677960|NCT01590732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677961|NCT01590732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6677962|NCT01590732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6677963|NCT01590732|Alkylating Agents|alkylating agents|mesh-ancestor
6677964|NCT01590732|Keratolytic Agents|keratolytic agents|mesh-ancestor
6677965|NCT01590732|Dermatologic Agents|dermatologic agents|mesh-ancestor
6677966|NCT01590732|Tubulin Modulators|tubulin modulators|mesh-ancestor
6677967|NCT01590732|Antimitotic Agents|antimitotic agents|mesh-ancestor
6677968|NCT01590732|Mitosis Modulators|mitosis modulators|mesh-ancestor
6677969|NCT01590732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6677970|NCT01590823|Dabigatran|dabigatran|mesh-list
6241516|NCT02630992|Clavulanic Acids|clavulanic acids|mesh-list
6241517|NCT02630992|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6241518|NCT02630992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6241519|NCT02630992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6241520|NCT02630992|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6503591|NCT00652925|Celecoxib|celecoxib|mesh-list
6503592|NCT00652925|Naproxen|naproxen|mesh-list
6503593|NCT00652925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6503594|NCT00652925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6503595|NCT00652925|Analgesics|analgesics|mesh-ancestor
6503596|NCT00652925|Sensory System Agents|sensory system agents|mesh-ancestor
6503597|NCT00652925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6503598|NCT00652925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503599|NCT00652925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6503600|NCT00652925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6503601|NCT00652925|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6503602|NCT00652925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6503603|NCT00652925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6503604|NCT00652925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503605|NCT00652925|Gout Suppressants|gout suppressants|mesh-ancestor
6503606|NCT00653003|Leflunomide|leflunomide|mesh-list
6503607|NCT00653003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6503608|NCT00653003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503609|NCT00653003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6503610|NCT00653003|Immunologic Factors|immunologic factors|mesh-ancestor
6241521|NCT02630992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6241522|NCT02630992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241523|NCT02631057|Warfarin|warfarin|mesh-list
6241524|NCT02631057|Dabigatran|dabigatran|mesh-list
6241525|NCT02631057|Anticoagulants|anticoagulants|mesh-ancestor
6241526|NCT02631057|Antithrombins|antithrombins|mesh-ancestor
6241527|NCT02631057|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5714243|NCT03254173|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5714244|NCT03254173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5721897|NCT03202563|Dapagliflozin|dapagliflozin|mesh-list
6241528|NCT02631057|Protease Inhibitors|protease inhibitors|mesh-ancestor
6241529|NCT02631057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6241530|NCT02631057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241531|NCT02631525|Propofol|propofol|mesh-list
6241532|NCT02631525|Desflurane|desflurane|mesh-list
6241533|NCT02631525|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6241534|NCT02631525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6241535|NCT02631525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241536|NCT02631525|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6241537|NCT02631525|Anesthetics, General|anesthetics, general|mesh-ancestor
6241538|NCT02631525|Anesthetics|anesthetics|mesh-ancestor
6241539|NCT02631525|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6241540|NCT02631538|Rituximab|rituximab|mesh-list
6241541|NCT02631538|Belimumab|belimumab|mesh-list
6241542|NCT02631538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6241543|NCT02631538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6241544|NCT02631538|Immunologic Factors|immunologic factors|mesh-ancestor
6241545|NCT02631538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241546|NCT02631538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6241547|NCT02631538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6241548|NCT02631551|Mometasone Furoate|mometasone furoate|mesh-list
6241549|NCT02631551|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
6241550|NCT02631551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6241551|NCT02631551|Dermatologic Agents|dermatologic agents|mesh-ancestor
6241552|NCT02631551|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6241553|NCT02631551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6241554|NCT02631551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6241555|NCT02631551|Analgesics|analgesics|mesh-ancestor
6241556|NCT02631551|Sensory System Agents|sensory system agents|mesh-ancestor
6241557|NCT02631551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6241558|NCT02631551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241559|NCT02631551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6241560|NCT02631551|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6241561|NCT02631551|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6241562|NCT02631551|Histamine Antagonists|histamine antagonists|mesh-ancestor
6241563|NCT02631551|Histamine Agents|histamine agents|mesh-ancestor
6241564|NCT02631551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6241565|NCT02631551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241566|NCT02631577|Lenalidomide|lenalidomide|mesh-list
6503611|NCT00653003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241567|NCT02631577|Atezolizumab|atezolizumab|mesh-list
6241568|NCT02631577|Obinutuzumab|obinutuzumab|mesh-list
6241569|NCT02631577|Immunologic Factors|immunologic factors|mesh-ancestor
6241570|NCT02631577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241571|NCT02631577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6241572|NCT02631577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6241573|NCT02631577|Growth Substances|growth substances|mesh-ancestor
6241574|NCT02631577|Growth Inhibitors|growth inhibitors|mesh-ancestor
6241575|NCT02631577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6241576|NCT02631577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6241577|NCT02631590|Gemcitabine|gemcitabine|mesh-list
6241578|NCT02631590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6241579|NCT02631590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6241580|NCT02631590|Antimetabolites|antimetabolites|mesh-ancestor
6241581|NCT02631590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241582|NCT02631590|Antiviral Agents|antiviral agents|mesh-ancestor
6241583|NCT02631590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6241584|NCT02631590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6241585|NCT02631590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6241586|NCT02631590|Immunologic Factors|immunologic factors|mesh-ancestor
6241587|NCT02631590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241588|NCT02631746|Nivolumab|nivolumab|mesh-list
6241589|NCT02631746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6241590|NCT02631746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6241591|NCT02631746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6241592|NCT02631746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241593|NCT02631772|Ribavirin|ribavirin|mesh-list
6241594|NCT02631772|Sofosbuvir|sofosbuvir|mesh-list
6241595|NCT02631772|Ledipasvir|ledipasvir|mesh-list
6241596|NCT02631772|Antimetabolites|antimetabolites|mesh-ancestor
6241597|NCT02631772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241598|NCT02631772|Antiviral Agents|antiviral agents|mesh-ancestor
6241599|NCT02631772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6241600|NCT02631876|Paclitaxel|paclitaxel|mesh-list
6241601|NCT02631876|Maytansine|maytansine|mesh-list
6241602|NCT02631876|Doxorubicin|doxorubicin|mesh-list
6241603|NCT02631876|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6241604|NCT02631876|Topotecan|topotecan|mesh-list
6241605|NCT02631876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6241606|NCT02631876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6241607|NCT02631876|Tubulin Modulators|tubulin modulators|mesh-ancestor
6241608|NCT02631876|Antimitotic Agents|antimitotic agents|mesh-ancestor
6241609|NCT02631876|Mitosis Modulators|mitosis modulators|mesh-ancestor
6241610|NCT02631876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241611|NCT02631876|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6241612|NCT02631876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6241613|NCT02631876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6503612|NCT00653016|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6503613|NCT00653016|Norelgestromin|norelgestromin|mesh-list
6503614|NCT00653016|Estradiol|estradiol|mesh-list
6503615|NCT00653016|Estrogens|estrogens|mesh-ancestor
6503616|NCT00653016|Hormones|hormones|mesh-ancestor
6503617|NCT00653016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6503618|NCT00653016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503619|NCT00653016|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6503620|NCT00653016|Contraceptive Agents|contraceptive agents|mesh-ancestor
6503621|NCT00653016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6503622|NCT00653016|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6503623|NCT00653016|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6503624|NCT00653016|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6503625|NCT00653042|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6503626|NCT00653042|Natriuretic Agents|natriuretic agents|mesh-ancestor
6503627|NCT00653042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503628|NCT00653055|Cabergoline|cabergoline|mesh-list
6503629|NCT00653055|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6503630|NCT00653055|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6503631|NCT00653055|Dopamine Agonists|dopamine agonists|mesh-ancestor
6503632|NCT00653055|Dopamine Agents|dopamine agents|mesh-ancestor
6677971|NCT01590823|Antithrombins|antithrombins|mesh-ancestor
6677972|NCT01590823|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6241614|NCT02631876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6241615|NCT02631876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6241616|NCT02631954|Voriconazole|voriconazole|mesh-list
6241617|NCT02631954|Antifungal Agents|antifungal agents|mesh-ancestor
6241618|NCT02631954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6677973|NCT01590823|Protease Inhibitors|protease inhibitors|mesh-ancestor
6677974|NCT01590823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6677975|NCT01590823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241619|NCT02631954|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6241620|NCT02631954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6503633|NCT00653055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6503634|NCT00653055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503635|NCT00653055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503636|NCT00653120|Propranolol|propranolol|mesh-list
6503637|NCT00653120|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6503638|NCT00653120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6241621|NCT02631954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6241622|NCT02631954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241623|NCT02631954|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6241624|NCT02631954|Hormone Antagonists|hormone antagonists|mesh-ancestor
6241625|NCT02631954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6241626|NCT02631954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241627|NCT02631954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6241628|NCT02632110|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6241629|NCT02632110|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6241630|NCT02632110|Dermatologic Agents|dermatologic agents|mesh-ancestor
6241631|NCT02632747|Empagliflozin|empagliflozin|mesh-list
6241632|NCT02632747|Ramipril|ramipril|mesh-list
6241633|NCT02632747|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6241634|NCT02632747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241635|NCT02632747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6241636|NCT02632747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241637|NCT02632747|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6241638|NCT02632747|Protease Inhibitors|protease inhibitors|mesh-ancestor
6241639|NCT02632747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5714245|NCT03254173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5714246|NCT03254173|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5714247|NCT03254173|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5714248|NCT03254173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5714249|NCT03254173|Adrenergic Agents|adrenergic agents|mesh-ancestor
5714250|NCT03254173|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5714251|NCT03254173|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5714252|NCT03254173|Serotonin Agents|serotonin agents|mesh-ancestor
5714253|NCT03254173|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5714254|NCT03254368|ZGN-1061|zgn-1061|mesh-list
5714255|NCT03254368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5714256|NCT03254368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241640|NCT02632747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6241641|NCT02632812|Naproxen|naproxen|mesh-list
6241642|NCT02632812|Rebamipide|rebamipide|mesh-list
6241643|NCT02632812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6241644|NCT02632812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6241645|NCT02632812|Analgesics|analgesics|mesh-ancestor
6241646|NCT02632812|Sensory System Agents|sensory system agents|mesh-ancestor
6241647|NCT02632812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6241648|NCT02632812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241649|NCT02632812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6241650|NCT02632812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6241651|NCT02632812|Gout Suppressants|gout suppressants|mesh-ancestor
6241652|NCT02632812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6241653|NCT02632812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6241654|NCT02632812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241655|NCT02632812|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6241656|NCT02632812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6241657|NCT02632812|Antioxidants|antioxidants|mesh-ancestor
5714257|NCT03254368|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5714258|NCT03254004|Pembrolizumab|pembrolizumab|mesh-list
5714259|NCT03254004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5714260|NCT03254004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5714261|NCT03253913|Sirolimus|sirolimus|mesh-list
5714262|NCT03253913|Resveratrol|resveratrol|mesh-list
5714263|NCT03253913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5714264|NCT03253913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5714265|NCT03253913|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5714266|NCT03253913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5714267|NCT03253913|Antifungal Agents|antifungal agents|mesh-ancestor
5714268|NCT03253913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5714269|NCT03253913|Immunologic Factors|immunologic factors|mesh-ancestor
5714270|NCT03253913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714271|NCT03253913|Antioxidants|antioxidants|mesh-ancestor
5721898|NCT03202563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5714272|NCT03253913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5714273|NCT03253913|Protective Agents|protective agents|mesh-ancestor
5714274|NCT03253913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5714275|NCT03253913|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5714276|NCT03253887|Ethanol|ethanol|mesh-list
5714277|NCT03253887|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5714278|NCT03253887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5714279|NCT03253887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5714280|NCT03253887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714281|NCT03253328|Acetylcysteine|acetylcysteine|mesh-list
5714282|NCT03253328|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5714283|NCT03253328|Antiviral Agents|antiviral agents|mesh-ancestor
5714284|NCT03253328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6241658|NCT02632812|Protective Agents|protective agents|mesh-ancestor
6241659|NCT02633046|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6241660|NCT02633046|Hormones|hormones|mesh-ancestor
6241661|NCT02633046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6241662|NCT02633046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241663|NCT02633371|Oxybutynin|oxybutynin|mesh-list
6241664|NCT02633371|Parasympatholytics|parasympatholytics|mesh-ancestor
6241665|NCT02633371|Autonomic Agents|autonomic agents|mesh-ancestor
6241666|NCT02633371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6241667|NCT02633371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241668|NCT02633371|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6241669|NCT02633371|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6241670|NCT02633371|Cholinergic Agents|cholinergic agents|mesh-ancestor
6241671|NCT02633371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6241672|NCT02633371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241673|NCT02633371|Urological Agents|urological agents|mesh-ancestor
6241674|NCT02633488|Metformin|metformin|mesh-list
6241675|NCT02633488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6241676|NCT02633488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241677|NCT02633800|Carboplatin|carboplatin|mesh-list
6241678|NCT02633800|Cetuximab|cetuximab|mesh-list
6241679|NCT02633800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6241680|NCT02633800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6241681|NCT02633956|Atorvastatin|atorvastatin|mesh-list
6241682|NCT02633956|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6241683|NCT02633956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6241684|NCT02633956|Antimetabolites|antimetabolites|mesh-ancestor
6241685|NCT02633956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241686|NCT02633956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6241687|NCT02633956|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6241688|NCT02633956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6241689|NCT02634073|Lamivudine|lamivudine|mesh-list
6241690|NCT02634073|Sorbitol|sorbitol|mesh-list
6241691|NCT02634073|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6241692|NCT02634073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6241693|NCT02634073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6241694|NCT02634073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503639|NCT00653120|Adrenergic Agents|adrenergic agents|mesh-ancestor
6503640|NCT00653120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6503641|NCT00653120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503642|NCT00653120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503643|NCT00653120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6503644|NCT00653120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6503645|NCT00653120|Vasodilator Agents|vasodilator agents|mesh-ancestor
6503646|NCT00653172|Streptogramin A|streptogramin a|mesh-list
6503647|NCT00653172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6503648|NCT00653172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6503649|NCT00653237|Chlorhexidine|chlorhexidine|mesh-list
6503650|NCT00653237|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6241695|NCT02634073|Antiviral Agents|antiviral agents|mesh-ancestor
6241696|NCT02634073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6241697|NCT02634073|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6241698|NCT02634073|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6241699|NCT02634073|Cathartics|cathartics|mesh-ancestor
6503651|NCT00653237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6503652|NCT00653237|Disinfectants|disinfectants|mesh-ancestor
6503653|NCT00653250|Celecoxib|celecoxib|mesh-list
6503654|NCT00653250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6503655|NCT00653250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6503656|NCT00653250|Analgesics|analgesics|mesh-ancestor
6241700|NCT02634073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5714285|NCT03253328|Expectorants|expectorants|mesh-ancestor
6241701|NCT02634320|Aripiprazole|aripiprazole|mesh-list
6241702|NCT02634320|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
6241703|NCT02634320|Antidepressive Agents|antidepressive agents|mesh-ancestor
6241704|NCT02634320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6241705|NCT02634320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6241706|NCT02634320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6241707|NCT02634320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6241708|NCT02634320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241709|NCT02634320|Dopamine Agonists|dopamine agonists|mesh-ancestor
6241710|NCT02634320|Dopamine Agents|dopamine agents|mesh-ancestor
6241711|NCT02634320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6241712|NCT02634320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241713|NCT02634320|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6241714|NCT02634320|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6241715|NCT02634320|Serotonin Agents|serotonin agents|mesh-ancestor
6241716|NCT02634320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6241717|NCT02634320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6241718|NCT02634320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6241719|NCT02634320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6241720|NCT02634333|Aflibercept|aflibercept|mesh-list
6241721|NCT02634333|Endothelial Growth Factors|endothelial growth factors|mesh-list
6241722|NCT02634333|Mitogens|mitogens|mesh-list
6241723|NCT02634333|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6241724|NCT02634333|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6241725|NCT02634333|Growth Substances|growth substances|mesh-ancestor
6241726|NCT02634333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241727|NCT02634333|Growth Inhibitors|growth inhibitors|mesh-ancestor
5714286|NCT03253328|Respiratory System Agents|respiratory system agents|mesh-ancestor
5714287|NCT03253328|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5714288|NCT03253328|Antioxidants|antioxidants|mesh-ancestor
5714289|NCT03253328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5714290|NCT03253328|Protective Agents|protective agents|mesh-ancestor
5714291|NCT03253328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714292|NCT03253328|Antidotes|antidotes|mesh-ancestor
5714293|NCT03253289|Meclizine|meclizine|mesh-list
6241728|NCT02634333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6241729|NCT02634333|Mitosis Modulators|mitosis modulators|mesh-ancestor
6241730|NCT02634333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241731|NCT02634346|Olanzapine|olanzapine|mesh-list
6241732|NCT02634346|Antiemetics|antiemetics|mesh-ancestor
6241733|NCT02634346|Autonomic Agents|autonomic agents|mesh-ancestor
6503657|NCT00653250|Sensory System Agents|sensory system agents|mesh-ancestor
6503658|NCT00653250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6503659|NCT00653250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503660|NCT00653250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6503661|NCT00653250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6503662|NCT00653250|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6503663|NCT00653250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6503664|NCT00653250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6503665|NCT00653250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503666|NCT00653302|Metformin|metformin|mesh-list
6503667|NCT00653302|Insulin Glargine|insulin glargine|mesh-list
6677976|NCT01590823|Anticoagulants|anticoagulants|mesh-ancestor
6677977|NCT01590836|Insulin|insulin|mesh-list
6677978|NCT01590836|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6677979|NCT01590836|Insulin Aspart|insulin aspart|mesh-list
6677980|NCT01590836|Insulin, Long-Acting|insulin, long-acting|mesh-list
6677981|NCT01590836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6677982|NCT01590836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677983|NCT01590849|Contraceptive Agents|contraceptive agents|mesh-list
6677984|NCT01590849|Contraceptives, Oral|contraceptives, oral|mesh-list
6241734|NCT02634346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6241735|NCT02634346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241736|NCT02634346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6241737|NCT02634346|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6241738|NCT02634346|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6241739|NCT02634346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6241740|NCT02634346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6241741|NCT02634346|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6241742|NCT02634346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6241743|NCT02634346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6241744|NCT02634346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503668|NCT00653302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6677985|NCT01590849|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
6677986|NCT01590849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6241745|NCT02634346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6241746|NCT02634346|Serotonin Agents|serotonin agents|mesh-ancestor
6241747|NCT02634580|Ezetimibe|ezetimibe|mesh-list
6241748|NCT02634580|Evolocumab|evolocumab|mesh-list
6241749|NCT02634580|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6241750|NCT02634580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6241751|NCT02634580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5714294|NCT03253289|Antiemetics|antiemetics|mesh-ancestor
5714295|NCT03253289|Autonomic Agents|autonomic agents|mesh-ancestor
5714296|NCT03253289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5714297|NCT03253289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714298|NCT03253289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5714299|NCT03253289|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6241752|NCT02634580|Antimetabolites|antimetabolites|mesh-ancestor
6241753|NCT02634580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241754|NCT02634580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6241755|NCT02634580|Immunologic Factors|immunologic factors|mesh-ancestor
6241756|NCT02634580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241757|NCT02634684|Amphetamine|amphetamine|mesh-list
6241758|NCT02634684|Dextroamphetamine|dextroamphetamine|mesh-list
6241759|NCT02634684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6241760|NCT02634684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241761|NCT02634684|Sympathomimetics|sympathomimetics|mesh-ancestor
6241762|NCT02634684|Autonomic Agents|autonomic agents|mesh-ancestor
6241763|NCT02634684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6241764|NCT02634684|Dopamine Agents|dopamine agents|mesh-ancestor
6241765|NCT02634684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6241766|NCT02634684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241767|NCT02634684|Adrenergic Agents|adrenergic agents|mesh-ancestor
6241768|NCT02634684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6241769|NCT02634684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6241770|NCT02634684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6241771|NCT02634684|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6241772|NCT02634788|Buprenorphine|buprenorphine|mesh-list
6241773|NCT02634788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6241774|NCT02634788|Narcotics|narcotics|mesh-ancestor
6241775|NCT02634788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5714300|NCT03253289|Histamine Antagonists|histamine antagonists|mesh-ancestor
5714301|NCT03253289|Histamine Agents|histamine agents|mesh-ancestor
5714302|NCT03253289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5714303|NCT03253289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5714304|NCT03253289|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5714305|NCT03253276|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
5714306|NCT03253276|Cathartics|cathartics|mesh-ancestor
5714307|NCT03253276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5714308|NCT03253224|Magnesium Sulfate|magnesium sulfate|mesh-list
5714309|NCT03253224|Analgesics|analgesics|mesh-ancestor
5714310|NCT03253224|Sensory System Agents|sensory system agents|mesh-ancestor
5714311|NCT03253224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5714312|NCT03253224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714313|NCT03253224|Anesthetics|anesthetics|mesh-ancestor
5714314|NCT03253224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5714315|NCT03253224|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5714316|NCT03253224|Anticonvulsants|anticonvulsants|mesh-ancestor
5714317|NCT03253224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5714318|NCT03253224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5714319|NCT03253224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5714320|NCT03253224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5714321|NCT03253224|Tocolytic Agents|tocolytic agents|mesh-ancestor
5714322|NCT03253224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5714323|NCT03253250|Tenofovir|tenofovir|mesh-list
5714324|NCT03253250|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5714325|NCT03253250|Entecavir|entecavir|mesh-list
5714326|NCT03253250|Adefovir|adefovir|mesh-list
5714327|NCT03253250|Antiviral Agents|antiviral agents|mesh-ancestor
5714328|NCT03253250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5714329|NCT03253250|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6241776|NCT02634788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241777|NCT02634788|Analgesics|analgesics|mesh-ancestor
6241778|NCT02634788|Sensory System Agents|sensory system agents|mesh-ancestor
6241779|NCT02634788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6241780|NCT02634788|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6241781|NCT02634801|Methotrexate|methotrexate|mesh-list
6241782|NCT02634801|Ixekizumab|ixekizumab|mesh-list
5714330|NCT03253250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5714331|NCT03253250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6241783|NCT02634801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6241784|NCT02634801|Abortifacient Agents|abortifacient agents|mesh-ancestor
6241785|NCT02634801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6241786|NCT02634801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241787|NCT02634801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6241788|NCT02634801|Antimetabolites|antimetabolites|mesh-ancestor
6241789|NCT02634801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503669|NCT00653302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503670|NCT00653315|Tramadol|tramadol|mesh-list
6241790|NCT02634801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6241791|NCT02634801|Dermatologic Agents|dermatologic agents|mesh-ancestor
6241792|NCT02634801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6241793|NCT02634801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6241794|NCT02634801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6241795|NCT02634801|Immunologic Factors|immunologic factors|mesh-ancestor
6241796|NCT02634801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6241797|NCT02634801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6241798|NCT02635035|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6241799|NCT02635035|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6241800|NCT02635035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241801|NCT02635035|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6241802|NCT02635035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6241803|NCT02635035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6241804|NCT02635035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241805|NCT02635035|Dopamine Agents|dopamine agents|mesh-ancestor
6241806|NCT02635035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6503671|NCT00653315|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6503672|NCT00653315|Narcotics|narcotics|mesh-ancestor
6503673|NCT00653315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6503674|NCT00653315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503675|NCT00653315|Analgesics|analgesics|mesh-ancestor
6677987|NCT01590849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6677988|NCT01590849|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6677989|NCT01590901|Probucol|probucol|mesh-list
6677990|NCT01590901|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6677991|NCT01590901|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6677992|NCT01590901|Antimetabolites|antimetabolites|mesh-ancestor
6677993|NCT01590901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6677994|NCT01590901|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6677995|NCT01590901|Antioxidants|antioxidants|mesh-ancestor
6241807|NCT02635204|Clobetasol|clobetasol|mesh-list
6241808|NCT02635204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6241809|NCT02635204|Glucocorticoids|glucocorticoids|mesh-ancestor
6241810|NCT02635204|Hormones|hormones|mesh-ancestor
6241811|NCT02635204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6241812|NCT02635204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241813|NCT02635386|Metformin|metformin|mesh-list
6241814|NCT02635386|Dapagliflozin|dapagliflozin|mesh-list
6241815|NCT02635386|Exenatide|exenatide|mesh-list
6241816|NCT02635386|Topiramate|topiramate|mesh-list
6241817|NCT02635386|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
6241818|NCT02635386|Phentermine|phentermine|mesh-list
6241819|NCT02635386|Glucagon|glucagon|mesh-list
6241820|NCT02635386|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6241821|NCT02635386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6241822|NCT02635386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241823|NCT02635386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241824|NCT02635386|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6241825|NCT02635386|Incretins|incretins|mesh-ancestor
6241826|NCT02635386|Hormones|hormones|mesh-ancestor
6241827|NCT02635386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6241828|NCT02635386|Anticonvulsants|anticonvulsants|mesh-ancestor
6241829|NCT02635386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6241830|NCT02635386|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6241831|NCT02635386|Appetite Depressants|appetite depressants|mesh-ancestor
6503676|NCT00653315|Sensory System Agents|sensory system agents|mesh-ancestor
6503677|NCT00653315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6503678|NCT00653341|Insulin|insulin|mesh-list
6503679|NCT00653341|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5714332|NCT03253250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5714333|NCT03253250|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5714334|NCT03253250|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6241832|NCT02635386|Sympathomimetics|sympathomimetics|mesh-ancestor
6241833|NCT02635386|Autonomic Agents|autonomic agents|mesh-ancestor
6241834|NCT02635386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6241835|NCT02635386|Adrenergic Agents|adrenergic agents|mesh-ancestor
6241836|NCT02635386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6241837|NCT02635542|Cisatracurium|cisatracurium|mesh-list
6241838|NCT02635542|Succinylcholine|succinylcholine|mesh-list
6241839|NCT02635542|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6241840|NCT02635542|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6241841|NCT02635542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6241842|NCT02635542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241843|NCT02635542|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
6241844|NCT02635724|Peramivir|peramivir|mesh-list
6241845|NCT02635724|Antiviral Agents|antiviral agents|mesh-ancestor
6241846|NCT02635724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6241847|NCT02635724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6241848|NCT02635724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241849|NCT02635828|Promethazine|promethazine|mesh-list
6241850|NCT02635828|Diphenhydramine|diphenhydramine|mesh-list
6241851|NCT02635828|Dexamethasone|dexamethasone|mesh-list
6241852|NCT02635828|Palonosetron|palonosetron|mesh-list
6241853|NCT02635828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6241854|NCT02635828|Antiemetics|antiemetics|mesh-ancestor
6241855|NCT02635828|Autonomic Agents|autonomic agents|mesh-ancestor
6241856|NCT02635828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6241857|NCT02635828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241858|NCT02635828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6241859|NCT02635828|Glucocorticoids|glucocorticoids|mesh-ancestor
6241860|NCT02635828|Hormones|hormones|mesh-ancestor
6241861|NCT02635828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6241862|NCT02635828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6241863|NCT02635828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6241864|NCT02635828|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6241865|NCT02635828|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6241866|NCT02635828|Serotonin Agents|serotonin agents|mesh-ancestor
5919289|NCT04983095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5919290|NCT04983095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919291|NCT04983121|Antibodies|antibodies|mesh-list
5919292|NCT04983121|Immunoconjugates|immunoconjugates|mesh-list
5919293|NCT04983121|Mitogens|mitogens|mesh-list
5919294|NCT04983121|Immunologic Factors|immunologic factors|mesh-ancestor
5919295|NCT04983121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919296|NCT04983121|Mitosis Modulators|mitosis modulators|mesh-ancestor
6241867|NCT02635828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5714335|NCT03253562|Metformin|metformin|mesh-list
5714336|NCT03253562|Vildagliptin|vildagliptin|mesh-list
5714337|NCT03253562|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5714338|NCT03253562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714339|NCT03253562|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5714340|NCT03253562|Protease Inhibitors|protease inhibitors|mesh-ancestor
5714341|NCT03253562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5714342|NCT03253562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721899|NCT03202563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721900|NCT03202563|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5721901|NCT03202563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721902|NCT03202615|Lactoferrin|lactoferrin|mesh-list
5721903|NCT03202615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5721904|NCT03202459|Pregabalin|pregabalin|mesh-list
5721905|NCT03202459|Gabapentin|gabapentin|mesh-list
5721906|NCT03202459|Analgesics|analgesics|mesh-ancestor
5721907|NCT03202459|Sensory System Agents|sensory system agents|mesh-ancestor
5721908|NCT03202459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5721909|NCT03202459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919297|NCT04983121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919298|NCT04983160|Allopurinol|allopurinol|mesh-list
5919299|NCT04983160|Antimetabolites|antimetabolites|mesh-ancestor
5919300|NCT04983160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919301|NCT04983160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5919302|NCT04983160|Gout Suppressants|gout suppressants|mesh-ancestor
5919303|NCT04983160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5919304|NCT04983160|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6244290|NCT02691936|Hormones|hormones|mesh-ancestor
5714343|NCT03253263|Mecasermin|mecasermin|mesh-list
5714344|NCT03253263|Growth Substances|growth substances|mesh-ancestor
5714345|NCT03253263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714346|NCT03253198|Bupivacaine|bupivacaine|mesh-list
5714347|NCT03253198|Anesthetics, Local|anesthetics, local|mesh-ancestor
5714348|NCT03253198|Anesthetics|anesthetics|mesh-ancestor
5714349|NCT03253198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5714350|NCT03253198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714351|NCT03253198|Sensory System Agents|sensory system agents|mesh-ancestor
5714352|NCT03253198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5714353|NCT03253133|Oxaliplatin|oxaliplatin|mesh-list
5714354|NCT03253133|Oxycodone|oxycodone|mesh-list
5714355|NCT03253133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5714356|NCT03253133|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5714357|NCT03253133|Narcotics|narcotics|mesh-ancestor
5714358|NCT03253133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5714359|NCT03253133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714360|NCT03253133|Analgesics|analgesics|mesh-ancestor
5714361|NCT03253133|Sensory System Agents|sensory system agents|mesh-ancestor
5714362|NCT03253133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5714363|NCT03253068|Pembrolizumab|pembrolizumab|mesh-list
5714364|NCT03253068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5714365|NCT03253068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5714366|NCT03253107|Trastuzumab|trastuzumab|mesh-list
5714367|NCT03253107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5714368|NCT03253107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6241868|NCT02635828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241869|NCT02635828|Antipruritics|antipruritics|mesh-ancestor
6241870|NCT02635828|Dermatologic Agents|dermatologic agents|mesh-ancestor
6241871|NCT02635828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6241872|NCT02635828|Histamine Antagonists|histamine antagonists|mesh-ancestor
6241873|NCT02635828|Histamine Agents|histamine agents|mesh-ancestor
6241874|NCT02635828|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6241875|NCT02635828|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6241876|NCT02635828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6241877|NCT02635828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6241878|NCT02635828|Anesthetics, Local|anesthetics, local|mesh-ancestor
6241879|NCT02635828|Anesthetics|anesthetics|mesh-ancestor
6241880|NCT02635828|Sensory System Agents|sensory system agents|mesh-ancestor
6241881|NCT02635984|Olanzapine|olanzapine|mesh-list
6241882|NCT02635984|Antiemetics|antiemetics|mesh-ancestor
6241883|NCT02635984|Autonomic Agents|autonomic agents|mesh-ancestor
6241884|NCT02635984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6241885|NCT02635984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241886|NCT02635984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6241887|NCT02635984|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6241888|NCT02635984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6241889|NCT02635984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6241890|NCT02635984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6241891|NCT02635984|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6241892|NCT02635984|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6241893|NCT02635984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6241894|NCT02635984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241895|NCT02635984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6241896|NCT02635984|Serotonin Agents|serotonin agents|mesh-ancestor
6241897|NCT02636361|Insulin Lispro|insulin lispro|mesh-list
6241898|NCT02636361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6241899|NCT02636361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241900|NCT02636725|Pembrolizumab|pembrolizumab|mesh-list
6241901|NCT02636725|Axitinib|axitinib|mesh-list
6241902|NCT02636725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6241903|NCT02636725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6241904|NCT02636725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6241905|NCT02636725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6241906|NCT02636725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241907|NCT02637037|Metformin|metformin|mesh-list
6241908|NCT02637037|Dapagliflozin|dapagliflozin|mesh-list
6241909|NCT02637037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6241910|NCT02637037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241911|NCT02637037|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6241912|NCT02637037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241913|NCT02637076|Sodium Oxybate|sodium oxybate|mesh-list
5714369|NCT03252808|Gemcitabine|gemcitabine|mesh-list
6241914|NCT02637076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6241915|NCT02637076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6241916|NCT02637076|Anesthetics, General|anesthetics, general|mesh-ancestor
6241917|NCT02637076|Anesthetics|anesthetics|mesh-ancestor
6241918|NCT02637076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6241919|NCT02637076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241920|NCT02637232|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6241921|NCT02637232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6241922|NCT02637232|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6241923|NCT02637232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6241924|NCT02637232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6241925|NCT02637232|Adrenergic Agents|adrenergic agents|mesh-ancestor
6241926|NCT02637232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6241927|NCT02637232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241928|NCT02637232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241929|NCT02637323|Triamcinolone|triamcinolone|mesh-list
6241930|NCT02637323|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6241931|NCT02637323|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6241932|NCT02637323|FX006|fx006|mesh-list
6241933|NCT02637323|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6241934|NCT02637323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6241935|NCT02637323|Glucocorticoids|glucocorticoids|mesh-ancestor
5714370|NCT03252808|Paclitaxel|paclitaxel|mesh-list
5714371|NCT03252808|Tegafur|tegafur|mesh-list
5714372|NCT03252808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5714373|NCT03252808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5714374|NCT03252808|Tubulin Modulators|tubulin modulators|mesh-ancestor
5714375|NCT03252808|Antimitotic Agents|antimitotic agents|mesh-ancestor
5714376|NCT03252808|Mitosis Modulators|mitosis modulators|mesh-ancestor
5714377|NCT03252808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5714378|NCT03252808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5714379|NCT03252808|Antimetabolites|antimetabolites|mesh-ancestor
5714380|NCT03252808|Antiviral Agents|antiviral agents|mesh-ancestor
5714381|NCT03252808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5714382|NCT03252808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5714383|NCT03252808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5714384|NCT03252808|Immunologic Factors|immunologic factors|mesh-ancestor
5714385|NCT03252808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241936|NCT02637323|Hormones|hormones|mesh-ancestor
6241937|NCT02637323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6241938|NCT02637323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241939|NCT02637323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6241940|NCT02637323|Immunologic Factors|immunologic factors|mesh-ancestor
6241941|NCT02637323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6241942|NCT02637323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244196|NCT02690558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6244197|NCT02690558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6244198|NCT02690558|Antimetabolites|antimetabolites|mesh-ancestor
6244199|NCT02690558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244200|NCT02690558|Antiviral Agents|antiviral agents|mesh-ancestor
6244201|NCT02690558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6244202|NCT02690558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6244203|NCT02690558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6244204|NCT02690558|Immunologic Factors|immunologic factors|mesh-ancestor
6244205|NCT02690558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244206|NCT02690558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6244207|NCT02690714|Plasminogen|plasminogen|mesh-list
6244208|NCT02690714|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6244209|NCT02690714|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6244210|NCT02690714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244211|NCT02690727|Tenalisib|tenalisib|mesh-list
6244212|NCT02690727|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
6244213|NCT02690727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6244214|NCT02690727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244215|NCT02690948|Pembrolizumab|pembrolizumab|mesh-list
6244216|NCT02690948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6244217|NCT02690948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6244218|NCT02690974|Valsartan|valsartan|mesh-list
6244219|NCT02690974|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
6244220|NCT02690974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6244221|NCT02690974|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6241943|NCT02637856|Ocrelizumab|ocrelizumab|mesh-list
6241944|NCT02637856|Immunologic Factors|immunologic factors|mesh-ancestor
6241945|NCT02637856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241946|NCT02637895|Vortioxetine|vortioxetine|mesh-list
6241947|NCT02637895|Antidepressive Agents|antidepressive agents|mesh-ancestor
6241948|NCT02637895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6241949|NCT02637895|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6241950|NCT02637895|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6241951|NCT02637895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6241952|NCT02637895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241953|NCT02637895|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6241954|NCT02637895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6241955|NCT02637895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6241956|NCT02637895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241957|NCT02637895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6241958|NCT02637895|Serotonin Agents|serotonin agents|mesh-ancestor
6241959|NCT02637895|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6241960|NCT02637895|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6241961|NCT02637895|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6241962|NCT02637895|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6241963|NCT02637999|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6241964|NCT02637999|Interferon alpha-2|interferon alpha-2|mesh-list
6241965|NCT02637999|Antiviral Agents|antiviral agents|mesh-ancestor
6241966|NCT02637999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6241967|NCT02637999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6241968|NCT02638012|Hemostatics|hemostatics|mesh-list
6241969|NCT02638012|Coagulants|coagulants|mesh-ancestor
6241970|NCT02638168|Methylphenidate|methylphenidate|mesh-list
6241971|NCT02638168|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6241972|NCT02638168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241973|NCT02638168|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6503680|NCT00653341|Insulin Glargine|insulin glargine|mesh-list
6503681|NCT00653341|Isophane Insulin, Human|isophane insulin, human|mesh-list
6503682|NCT00653341|Insulin, Isophane|insulin, isophane|mesh-list
6503683|NCT00653341|Isophane insulin, beef|isophane insulin, beef|mesh-list
6503684|NCT00653341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6503685|NCT00653341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503686|NCT00653354|Valdecoxib|valdecoxib|mesh-list
6503687|NCT00653354|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6503688|NCT00653354|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6503689|NCT00653354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6503690|NCT00653354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503691|NCT00653354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6503692|NCT00653354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6503693|NCT00653354|Analgesics|analgesics|mesh-ancestor
6503694|NCT00653354|Sensory System Agents|sensory system agents|mesh-ancestor
6677996|NCT01590901|Protective Agents|protective agents|mesh-ancestor
6241974|NCT02638168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6241975|NCT02638168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6241976|NCT02638168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241977|NCT02638168|Dopamine Agents|dopamine agents|mesh-ancestor
6241978|NCT02638168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5714391|NCT03252600|Dexamethasone|dexamethasone|mesh-list
5714392|NCT03252600|Dexamethasone acetate|dexamethasone acetate|mesh-list
5714393|NCT03252600|Cyclophosphamide|cyclophosphamide|mesh-list
5714394|NCT03252600|Lenalidomide|lenalidomide|mesh-list
5714395|NCT03252600|Elotuzumab|elotuzumab|mesh-list
5714396|NCT03252600|Ichthammol|ichthammol|mesh-list
5714397|NCT03252600|BB 1101|bb 1101|mesh-list
5714398|NCT03252600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5714399|NCT03252600|Immunologic Factors|immunologic factors|mesh-ancestor
5714400|NCT03252600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714401|NCT03252600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5714402|NCT03252600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5714403|NCT03252600|Alkylating Agents|alkylating agents|mesh-ancestor
5714404|NCT03252600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5714405|NCT03252600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5714406|NCT03252600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5714407|NCT03252600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5714408|NCT03252600|Antiemetics|antiemetics|mesh-ancestor
5714409|NCT03252600|Autonomic Agents|autonomic agents|mesh-ancestor
5714410|NCT03252600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5714411|NCT03252600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5714412|NCT03252600|Glucocorticoids|glucocorticoids|mesh-ancestor
5714413|NCT03252600|Hormones|hormones|mesh-ancestor
5721910|NCT03202459|Anticonvulsants|anticonvulsants|mesh-ancestor
6241979|NCT02638259|GP2015|gp2015|mesh-list
6241980|NCT02638259|Dermatologic Agents|dermatologic agents|mesh-ancestor
6241981|NCT02638597|Gemfibrozil|gemfibrozil|mesh-list
6241982|NCT02638597|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6241983|NCT02638597|Antimetabolites|antimetabolites|mesh-ancestor
6241984|NCT02638597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241985|NCT02638597|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6241986|NCT02638597|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6241987|NCT02638597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6241988|NCT02638597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6241989|NCT02638948|Methotrexate|methotrexate|mesh-list
6241990|NCT02638948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6241991|NCT02638948|Abortifacient Agents|abortifacient agents|mesh-ancestor
6241992|NCT02638948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6241993|NCT02638948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6241994|NCT02638948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6241995|NCT02638948|Antimetabolites|antimetabolites|mesh-ancestor
6241996|NCT02638948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6241997|NCT02638948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6241998|NCT02638948|Dermatologic Agents|dermatologic agents|mesh-ancestor
6241999|NCT02638948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6242000|NCT02638948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6242001|NCT02638948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6242002|NCT02638948|Immunologic Factors|immunologic factors|mesh-ancestor
6242003|NCT02638948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6242004|NCT02638948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6242005|NCT02639182|Axitinib|axitinib|mesh-list
5714414|NCT03252600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5714415|NCT03252600|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5714416|NCT03252600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5714417|NCT03252600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5714418|NCT03252600|Growth Substances|growth substances|mesh-ancestor
5714419|NCT03252600|Growth Inhibitors|growth inhibitors|mesh-ancestor
5714420|NCT03252600|Protease Inhibitors|protease inhibitors|mesh-ancestor
5714421|NCT03252600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6242006|NCT02639182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6242007|NCT02639182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6242008|NCT02639182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6242009|NCT02639182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242010|NCT02639247|Sofosbuvir|sofosbuvir|mesh-list
6242011|NCT02639247|Velpatasvir|velpatasvir|mesh-list
6242012|NCT02639247|Antiviral Agents|antiviral agents|mesh-ancestor
6242013|NCT02639247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6242014|NCT02639338|Sofosbuvir|sofosbuvir|mesh-list
6242015|NCT02639338|Velpatasvir|velpatasvir|mesh-list
6242016|NCT02639338|Antiviral Agents|antiviral agents|mesh-ancestor
6242017|NCT02639338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6242018|NCT02639429|Misoprostol|misoprostol|mesh-list
6242019|NCT02639429|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6503695|NCT00653354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6503696|NCT00653354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503697|NCT00653354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6242020|NCT02639429|Abortifacient Agents|abortifacient agents|mesh-ancestor
6242021|NCT02639429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6242022|NCT02639429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6242023|NCT02639429|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6242024|NCT02639429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6242025|NCT02639429|Oxytocics|oxytocics|mesh-ancestor
6503698|NCT00653354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6503699|NCT00653380|Doxycycline|doxycycline|mesh-list
6503700|NCT00653380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6503701|NCT00653380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6503702|NCT00653380|Antimalarials|antimalarials|mesh-ancestor
6503703|NCT00653380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6503704|NCT00653380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6503705|NCT00653393|Tranylcypromine|tranylcypromine|mesh-list
6503706|NCT00653393|Antidepressive Agents|antidepressive agents|mesh-ancestor
6503707|NCT00653393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6503708|NCT00653393|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6503709|NCT00653393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6503710|NCT00653393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503711|NCT00653393|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5714422|NCT03252600|Dermatologic Agents|dermatologic agents|mesh-ancestor
6242026|NCT02639637|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6242027|NCT02639637|Valsartan|valsartan|mesh-list
6242028|NCT02639637|Enalaprilat|enalaprilat|mesh-list
6503712|NCT00653393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6503713|NCT00653393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6503714|NCT00653393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503715|NCT00653406|Risperidone|risperidone|mesh-list
6503716|NCT00653406|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6503717|NCT00653406|Serotonin Agents|serotonin agents|mesh-ancestor
6503718|NCT00653406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6503719|NCT00653406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503720|NCT00653406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503721|NCT00653406|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6503722|NCT00653406|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6677997|NCT01590901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714423|NCT03252938|Avelumab|avelumab|mesh-list
5714424|NCT03252938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5714425|NCT03252938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5714426|NCT03252665|Nicorandil|nicorandil|mesh-list
5714427|NCT03252665|Nitroglycerin|nitroglycerin|mesh-list
5714428|NCT03252665|Alprostadil|alprostadil|mesh-list
5714429|NCT03252665|Vasodilator Agents|vasodilator agents|mesh-ancestor
5714430|NCT03252665|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5714431|NCT03252665|Urological Agents|urological agents|mesh-ancestor
6677998|NCT01590966|Certolizumab Pegol|certolizumab pegol|mesh-list
5714432|NCT03252665|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5714433|NCT03252665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5714434|NCT03252665|Vitamin B Complex|vitamin b complex|mesh-ancestor
5714435|NCT03252665|Vitamins|vitamins|mesh-ancestor
5714436|NCT03252665|Micronutrients|micronutrients|mesh-ancestor
5714437|NCT03252665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714438|NCT03252457|Dexamethasone|dexamethasone|mesh-list
5714439|NCT03252457|Hydrocortisone|hydrocortisone|mesh-list
5919305|NCT04983160|Antioxidants|antioxidants|mesh-ancestor
5919306|NCT04983160|Protective Agents|protective agents|mesh-ancestor
5919307|NCT04983160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919308|NCT04982861|Cefixime|cefixime|mesh-list
5919309|NCT04982861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5919310|NCT04982861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5919311|NCT04982874|Furosemide|furosemide|mesh-list
5919312|NCT04982874|Diuretics|diuretics|mesh-ancestor
5919313|NCT04982874|Natriuretic Agents|natriuretic agents|mesh-ancestor
5919314|NCT04982874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6242029|NCT02639637|Enalapril|enalapril|mesh-list
6242030|NCT02639637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6242031|NCT02639637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6242032|NCT02639637|Incretins|incretins|mesh-ancestor
6242033|NCT02639637|Hormones|hormones|mesh-ancestor
6242034|NCT02639637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6242035|NCT02639637|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6242036|NCT02639637|Protease Inhibitors|protease inhibitors|mesh-ancestor
6242037|NCT02639637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6242038|NCT02639637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242039|NCT02639637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6242040|NCT02639637|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6242041|NCT02639637|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6242042|NCT02639637|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6242043|NCT02640053|Paclitaxel|paclitaxel|mesh-list
6242044|NCT02640053|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6242045|NCT02640053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6242046|NCT02640053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5714440|NCT03252457|Decitabine|decitabine|mesh-list
5919315|NCT04982874|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5919316|NCT04982874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5919317|NCT04982874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919318|NCT04982705|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5919319|NCT04982705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5919320|NCT04982705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919321|NCT04982705|Incretins|incretins|mesh-ancestor
5919322|NCT04982705|Hormones|hormones|mesh-ancestor
5919323|NCT04982705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5919324|NCT04982705|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5919325|NCT04982705|Protease Inhibitors|protease inhibitors|mesh-ancestor
5919326|NCT04982705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5919327|NCT04982705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919328|NCT04982809|Dexamethasone|dexamethasone|mesh-list
5919329|NCT04982809|Prednisolone|prednisolone|mesh-list
5919330|NCT04982809|Betamethasone|betamethasone|mesh-list
6242047|NCT02640053|Tubulin Modulators|tubulin modulators|mesh-ancestor
6242048|NCT02640053|Antimitotic Agents|antimitotic agents|mesh-ancestor
6242049|NCT02640053|Mitosis Modulators|mitosis modulators|mesh-ancestor
6242050|NCT02640053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242051|NCT02640157|Sofosbuvir|sofosbuvir|mesh-list
6242052|NCT02640157|Antiviral Agents|antiviral agents|mesh-ancestor
6242053|NCT02640157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6242054|NCT02640404|Vaccines|vaccines|mesh-list
6242055|NCT02640404|Immunologic Factors|immunologic factors|mesh-ancestor
6242056|NCT02640404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6242057|NCT02640755|Paclitaxel|paclitaxel|mesh-list
6242058|NCT02640755|Fulvestrant|fulvestrant|mesh-list
6242059|NCT02640755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6242060|NCT02640755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6242061|NCT02640755|Tubulin Modulators|tubulin modulators|mesh-ancestor
6242062|NCT02640755|Antimitotic Agents|antimitotic agents|mesh-ancestor
6242063|NCT02640755|Mitosis Modulators|mitosis modulators|mesh-ancestor
6242064|NCT02640755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242065|NCT02640755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6242066|NCT02640755|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6242067|NCT02640755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6242068|NCT02640755|Hormone Antagonists|hormone antagonists|mesh-ancestor
6242069|NCT02640755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6242070|NCT02640755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6242071|NCT02641080|Aspirin|aspirin|mesh-list
6242072|NCT02641080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6242073|NCT02641080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6242074|NCT02641080|Analgesics|analgesics|mesh-ancestor
6242075|NCT02641080|Sensory System Agents|sensory system agents|mesh-ancestor
6242076|NCT02641080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6242077|NCT02641080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6242078|NCT02641080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6242079|NCT02641080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6242080|NCT02641080|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6242081|NCT02641080|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6242082|NCT02641080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242083|NCT02641080|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6242084|NCT02641080|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6242085|NCT02641080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6242086|NCT02641080|Antipyretics|antipyretics|mesh-ancestor
6242087|NCT02641353|Thalidomide|thalidomide|mesh-list
6242088|NCT02641353|Apremilast|apremilast|mesh-list
6242089|NCT02641353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6242090|NCT02641353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6242091|NCT02641353|Analgesics|analgesics|mesh-ancestor
6503723|NCT00653406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6503724|NCT00653406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6503725|NCT00653406|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6503726|NCT00653406|Dopamine Agents|dopamine agents|mesh-ancestor
6242092|NCT02641353|Sensory System Agents|sensory system agents|mesh-ancestor
6242093|NCT02641353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6242094|NCT02641353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6242095|NCT02641353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6242096|NCT02641353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6242097|NCT02641353|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6242098|NCT02641353|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6503727|NCT00653419|Buspirone|buspirone|mesh-list
6242099|NCT02641353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6242100|NCT02641353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503728|NCT00653419|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6503729|NCT00653419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6503730|NCT00653419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6242101|NCT02641353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6242102|NCT02641353|Immunologic Factors|immunologic factors|mesh-ancestor
6242103|NCT02641353|Leprostatic Agents|leprostatic agents|mesh-ancestor
6242104|NCT02641353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6503731|NCT00653419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503732|NCT00653419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6503733|NCT00653419|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6677999|NCT01590966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6678000|NCT01590966|Immunologic Factors|immunologic factors|mesh-ancestor
6678001|NCT01590966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714441|NCT03252457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5714442|NCT03252457|Antiemetics|antiemetics|mesh-ancestor
5714443|NCT03252457|Autonomic Agents|autonomic agents|mesh-ancestor
6242105|NCT02641353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6242106|NCT02641353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6242107|NCT02641353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6242108|NCT02641353|Growth Substances|growth substances|mesh-ancestor
6242109|NCT02641353|Growth Inhibitors|growth inhibitors|mesh-ancestor
5714444|NCT03252457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5714445|NCT03252457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714446|NCT03252457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5714447|NCT03252457|Glucocorticoids|glucocorticoids|mesh-ancestor
5714448|NCT03252457|Hormones|hormones|mesh-ancestor
5714449|NCT03252457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5714450|NCT03252457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5714451|NCT03252457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5714452|NCT03252457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5714453|NCT03252457|Antimetabolites|antimetabolites|mesh-ancestor
5714454|NCT03252457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5714455|NCT03252457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5714456|NCT03252496|Ephedrine|ephedrine|mesh-list
5714457|NCT03252496|Fentanyl|fentanyl|mesh-list
5714458|NCT03252496|Bupivacaine|bupivacaine|mesh-list
5714459|NCT03252496|Oxytocin|oxytocin|mesh-list
5714460|NCT03252496|Anesthetics, Local|anesthetics, local|mesh-ancestor
5714461|NCT03252496|Anesthetics|anesthetics|mesh-ancestor
5714462|NCT03252496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5714463|NCT03252496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714464|NCT03252496|Sensory System Agents|sensory system agents|mesh-ancestor
5714465|NCT03252496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5714466|NCT03252496|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5714467|NCT03252496|Narcotics|narcotics|mesh-ancestor
5714468|NCT03252496|Analgesics|analgesics|mesh-ancestor
5714469|NCT03252496|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6242110|NCT02641353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6242111|NCT02641379|Ribavirin|ribavirin|mesh-list
6242112|NCT02641379|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6242113|NCT02641379|Antimetabolites|antimetabolites|mesh-ancestor
6242114|NCT02641379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503734|NCT00653419|Serotonin Agents|serotonin agents|mesh-ancestor
6503735|NCT00653419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6503736|NCT00653419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503737|NCT00653445|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6503738|NCT00653445|Ezetimibe|ezetimibe|mesh-list
6503739|NCT00653445|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6503740|NCT00653445|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6678002|NCT01590966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6678003|NCT01591031|Sevoflurane|sevoflurane|mesh-list
6678004|NCT01591031|Rocuronium|rocuronium|mesh-list
6242115|NCT02641379|Antiviral Agents|antiviral agents|mesh-ancestor
6242116|NCT02641379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6242117|NCT02641522|Siltuximab|siltuximab|mesh-list
6242118|NCT02641522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6242119|NCT02641561|Indomethacin|indomethacin|mesh-list
6242120|NCT02641561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6242121|NCT02641561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6242122|NCT02641561|Analgesics|analgesics|mesh-ancestor
6242123|NCT02641561|Sensory System Agents|sensory system agents|mesh-ancestor
6242124|NCT02641561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6242125|NCT02641561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6242126|NCT02641561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5714470|NCT03252496|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5714471|NCT03252496|Anesthetics, General|anesthetics, general|mesh-ancestor
5714472|NCT03252496|Oxytocics|oxytocics|mesh-ancestor
5714473|NCT03252496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5714474|NCT03252496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5714475|NCT03252496|Sympathomimetics|sympathomimetics|mesh-ancestor
5714476|NCT03252496|Autonomic Agents|autonomic agents|mesh-ancestor
5714477|NCT03252496|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5714478|NCT03252496|Adrenergic Agents|adrenergic agents|mesh-ancestor
5714479|NCT03252496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5714480|NCT03252496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5714481|NCT03252418|Ascorbic Acid|ascorbic acid|mesh-list
5714482|NCT03252418|Antioxidants|antioxidants|mesh-ancestor
5714483|NCT03252418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5714484|NCT03252418|Protective Agents|protective agents|mesh-ancestor
5714485|NCT03252418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6242127|NCT02641561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6503741|NCT00653445|Antimetabolites|antimetabolites|mesh-ancestor
6678005|NCT01591031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6242128|NCT02641561|Gout Suppressants|gout suppressants|mesh-ancestor
6242129|NCT02641561|Tocolytic Agents|tocolytic agents|mesh-ancestor
6242130|NCT02641561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6242131|NCT02641561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6242132|NCT02641561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6242133|NCT02641561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242134|NCT02641691|Leucovorin|leucovorin|mesh-list
6242135|NCT02641691|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
6242136|NCT02641691|Tetrahydrofolates|tetrahydrofolates|mesh-list
6242137|NCT02641691|Fluorouracil|fluorouracil|mesh-list
6242138|NCT02641691|Oxaliplatin|oxaliplatin|mesh-list
6242139|NCT02641691|Levoleucovorin|levoleucovorin|mesh-list
6242140|NCT02641691|Antimetabolites|antimetabolites|mesh-ancestor
5714486|NCT03252418|Vitamins|vitamins|mesh-ancestor
5714487|NCT03252418|Micronutrients|micronutrients|mesh-ancestor
5714488|NCT03252561|Anesthetics|anesthetics|mesh-list
5714489|NCT03252561|Anesthetics, Local|anesthetics, local|mesh-list
6242141|NCT02641691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242142|NCT02641691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6242143|NCT02641691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6242144|NCT02641691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6242145|NCT02641691|Immunologic Factors|immunologic factors|mesh-ancestor
6242146|NCT02641691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6242147|NCT02641691|Antidotes|antidotes|mesh-ancestor
6242148|NCT02641691|Protective Agents|protective agents|mesh-ancestor
6242149|NCT02641691|Vitamin B Complex|vitamin b complex|mesh-ancestor
6242150|NCT02641691|Vitamins|vitamins|mesh-ancestor
6242151|NCT02641691|Micronutrients|micronutrients|mesh-ancestor
6242152|NCT02642159|Nicotinic Acids|nicotinic acids|mesh-list
6242153|NCT02642159|Niacin|niacin|mesh-list
6242154|NCT02642159|Niacinamide|niacinamide|mesh-list
6242155|NCT02642159|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6242156|NCT02642159|Ezetimibe|ezetimibe|mesh-list
6242157|NCT02642159|Fenofibrate|fenofibrate|mesh-list
6242158|NCT02642159|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6242159|NCT02642159|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6242160|NCT02642159|Antimetabolites|antimetabolites|mesh-ancestor
6242161|NCT02642159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242162|NCT02642159|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6242163|NCT02642159|Vitamin B Complex|vitamin b complex|mesh-ancestor
6242164|NCT02642159|Vitamins|vitamins|mesh-ancestor
6242165|NCT02642159|Micronutrients|micronutrients|mesh-ancestor
6242166|NCT02642159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6242167|NCT02642159|Vasodilator Agents|vasodilator agents|mesh-ancestor
6242168|NCT02642653|Lovastatin|lovastatin|mesh-list
6242169|NCT02642653|L 647318|l 647318|mesh-list
6242170|NCT02642653|Dihydromevinolin|dihydromevinolin|mesh-list
6242171|NCT02642653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6242172|NCT02642653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6242173|NCT02642653|Antimetabolites|antimetabolites|mesh-ancestor
6242174|NCT02642653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242175|NCT02642653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6242176|NCT02642653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6242177|NCT02642653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6242178|NCT02643251|Clonidine|clonidine|mesh-list
6242179|NCT02643251|Analgesics|analgesics|mesh-ancestor
6242180|NCT02643251|Sensory System Agents|sensory system agents|mesh-ancestor
6242181|NCT02643251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6242182|NCT02643251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6242183|NCT02643251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6242184|NCT02643251|Sympatholytics|sympatholytics|mesh-ancestor
6242185|NCT02643251|Autonomic Agents|autonomic agents|mesh-ancestor
6242186|NCT02643251|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6242187|NCT02643251|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6242188|NCT02643251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6242189|NCT02643251|Adrenergic Agents|adrenergic agents|mesh-ancestor
6242190|NCT02643251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6503742|NCT00653445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503743|NCT00653445|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6503744|NCT00653445|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6503745|NCT00653445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6503746|NCT00653458|Ondansetron|ondansetron|mesh-list
6503747|NCT00653458|Antiemetics|antiemetics|mesh-ancestor
5714490|NCT03252561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6242191|NCT02643251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242192|NCT02643355|Clonidine|clonidine|mesh-list
6242193|NCT02643355|Olanzapine|olanzapine|mesh-list
6242194|NCT02643355|Antiemetics|antiemetics|mesh-ancestor
6242195|NCT02643355|Autonomic Agents|autonomic agents|mesh-ancestor
6503748|NCT00653458|Autonomic Agents|autonomic agents|mesh-ancestor
6503749|NCT00653458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6503750|NCT00653458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503751|NCT00653458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6503752|NCT00653458|Antipruritics|antipruritics|mesh-ancestor
6242196|NCT02643355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6242197|NCT02643355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6242198|NCT02643355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6242199|NCT02643355|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6242200|NCT02643355|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6242201|NCT02643355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6242202|NCT02643355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6242203|NCT02643355|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6242204|NCT02643355|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6242205|NCT02643355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6242206|NCT02643355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242207|NCT02643355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6242208|NCT02643355|Serotonin Agents|serotonin agents|mesh-ancestor
6242209|NCT02643355|Analgesics|analgesics|mesh-ancestor
6242210|NCT02643355|Sensory System Agents|sensory system agents|mesh-ancestor
6242211|NCT02643355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6503753|NCT00653458|Dermatologic Agents|dermatologic agents|mesh-ancestor
6503754|NCT00653458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6503755|NCT00653458|Serotonin Agents|serotonin agents|mesh-ancestor
6503756|NCT00653458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6678006|NCT01591031|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6678007|NCT01591031|Anesthetics, General|anesthetics, general|mesh-ancestor
6678008|NCT01591031|Anesthetics|anesthetics|mesh-ancestor
6678009|NCT01591031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6678010|NCT01591031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678011|NCT01591031|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6678012|NCT01591031|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6678013|NCT01591031|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6678014|NCT01591031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6678015|NCT01591070|Tacrolimus|tacrolimus|mesh-list
6678016|NCT01591070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6678017|NCT01591070|Immunologic Factors|immunologic factors|mesh-ancestor
6678018|NCT01591070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678019|NCT01591070|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6678020|NCT01591070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6678021|NCT01591070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678022|NCT01591083|Esomeprazole|esomeprazole|mesh-list
6678023|NCT01591083|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6678024|NCT01591083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6678025|NCT01591083|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6678026|NCT01591083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6242212|NCT02643355|Sympatholytics|sympatholytics|mesh-ancestor
6242213|NCT02643355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6242214|NCT02643355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6678027|NCT01591083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678028|NCT01591122|Prednisone|prednisone|mesh-list
6678029|NCT01591122|Abiraterone Acetate|abiraterone acetate|mesh-list
6678030|NCT01591122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6678031|NCT01591122|Glucocorticoids|glucocorticoids|mesh-ancestor
6678032|NCT01591122|Hormones|hormones|mesh-ancestor
6678033|NCT01591122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6678034|NCT01591122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678035|NCT01591122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6678036|NCT01591122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6678037|NCT01591122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6678038|NCT01591122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6678039|NCT01591122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678040|NCT01591122|Hormone Antagonists|hormone antagonists|mesh-ancestor
6678041|NCT01591122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6678042|NCT01591135|Paclitaxel|paclitaxel|mesh-list
6678043|NCT01591135|Fluorouracil|fluorouracil|mesh-list
6678044|NCT01591135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6678045|NCT01591135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6242215|NCT02643355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6242216|NCT02643355|Adrenergic Agents|adrenergic agents|mesh-ancestor
6242217|NCT02643394|Acetaminophen|acetaminophen|mesh-list
6242218|NCT02643394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6242219|NCT02643394|Analgesics|analgesics|mesh-ancestor
6242220|NCT02643394|Sensory System Agents|sensory system agents|mesh-ancestor
6242221|NCT02643394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6242222|NCT02643394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6242223|NCT02643394|Antipyretics|antipyretics|mesh-ancestor
6242224|NCT02643615|Propofol|propofol|mesh-list
6242225|NCT02643615|Desflurane|desflurane|mesh-list
6242226|NCT02643615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6242227|NCT02643615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6242228|NCT02643615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6242229|NCT02643615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6242230|NCT02643615|Anesthetics, General|anesthetics, general|mesh-ancestor
6242231|NCT02643615|Anesthetics|anesthetics|mesh-ancestor
6242232|NCT02643615|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6242233|NCT02643862|Omalizumab|omalizumab|mesh-list
6242234|NCT02643862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6242235|NCT02643862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6242236|NCT02643862|Respiratory System Agents|respiratory system agents|mesh-ancestor
6242237|NCT02643979|Ketamine|ketamine|mesh-list
5714491|NCT03252561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714492|NCT03252561|Sensory System Agents|sensory system agents|mesh-ancestor
5714493|NCT03252561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5714494|NCT03252366|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
5714495|NCT03252366|Hemostatics|hemostatics|mesh-ancestor
5714496|NCT03252366|Coagulants|coagulants|mesh-ancestor
5714497|NCT03252093|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
5714498|NCT03252093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5714499|NCT03252093|Vasodilator Agents|vasodilator agents|mesh-ancestor
5714500|NCT03252067|Azithromycin|azithromycin|mesh-list
5714501|NCT03252067|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5714502|NCT03252067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5714503|NCT03252067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6242238|NCT02643979|Propofol|propofol|mesh-list
6242239|NCT02643979|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6242240|NCT02643979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5714504|NCT03252067|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5714505|NCT03252223|Hormones|hormones|mesh-list
6242241|NCT02643979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6242242|NCT02643979|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6242243|NCT02643979|Anesthetics, General|anesthetics, general|mesh-ancestor
6242244|NCT02643979|Anesthetics|anesthetics|mesh-ancestor
6242245|NCT02643979|Analgesics|analgesics|mesh-ancestor
6503757|NCT00653458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503758|NCT00653458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6503759|NCT00653458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6503760|NCT00653458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6503761|NCT00653458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6503762|NCT00653458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6503763|NCT00653510|Insulin|insulin|mesh-list
6242246|NCT02643979|Sensory System Agents|sensory system agents|mesh-ancestor
6242247|NCT02643979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6242248|NCT02643979|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6242249|NCT02643979|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6242250|NCT02643979|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6242251|NCT02643979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6242252|NCT02643979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242253|NCT02645617|Imidacloprid|imidacloprid|mesh-list
6242254|NCT02645617|Cholinergic Agents|cholinergic agents|mesh-ancestor
6242255|NCT02645617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6242256|NCT02645617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242257|NCT02645617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503764|NCT00653510|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6503765|NCT00653510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6242258|NCT02646124|Naproxen|naproxen|mesh-list
6503766|NCT00653510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503767|NCT00653549|Torsemide|torsemide|mesh-list
6503768|NCT00653549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6503769|NCT00653549|Diuretics|diuretics|mesh-ancestor
6503770|NCT00653549|Natriuretic Agents|natriuretic agents|mesh-ancestor
6503771|NCT00653549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503772|NCT00653549|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6503773|NCT00653549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6503774|NCT00653549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503775|NCT00653562|Zolpidem|zolpidem|mesh-list
6503776|NCT00653562|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6503777|NCT00653562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6503778|NCT00653562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5714506|NCT03252223|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6503779|NCT00653562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503780|NCT00653562|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6503781|NCT00653562|GABA Agonists|gaba agonists|mesh-ancestor
6503782|NCT00653562|GABA Agents|gaba agents|mesh-ancestor
6503783|NCT00653562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6503784|NCT00653562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503785|NCT00653588|Atorvastatin|atorvastatin|mesh-list
6503786|NCT00653588|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6678046|NCT01591135|Tubulin Modulators|tubulin modulators|mesh-ancestor
6678047|NCT01591135|Antimitotic Agents|antimitotic agents|mesh-ancestor
6678048|NCT01591135|Mitosis Modulators|mitosis modulators|mesh-ancestor
6678049|NCT01591135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678050|NCT01591135|Antimetabolites|antimetabolites|mesh-ancestor
6678051|NCT01591135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5714507|NCT03252223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5714508|NCT03252223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714509|NCT03251690|Tenofovir|tenofovir|mesh-list
5714510|NCT03251690|Emtricitabine|emtricitabine|mesh-list
5714511|NCT03251690|Efavirenz|efavirenz|mesh-list
5714512|NCT03251690|Rilpivirine|rilpivirine|mesh-list
5714513|NCT03251690|Antiviral Agents|antiviral agents|mesh-ancestor
5714514|NCT03251690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6678052|NCT01591135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6678053|NCT01591135|Immunologic Factors|immunologic factors|mesh-ancestor
6678054|NCT01591135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678055|NCT01591148|Propofol|propofol|mesh-list
6678056|NCT01591148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6678057|NCT01591148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6678058|NCT01591148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678059|NCT01591148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6678060|NCT01591148|Anesthetics, General|anesthetics, general|mesh-ancestor
6678061|NCT01591148|Anesthetics|anesthetics|mesh-ancestor
6678062|NCT01591226|Mannitol|mannitol|mesh-list
6678063|NCT01591226|Caffeine|caffeine|mesh-list
6678064|NCT01591226|Citric Acid|citric acid|mesh-list
6678065|NCT01591226|Sodium Citrate|sodium citrate|mesh-list
6678066|NCT01591226|Anticoagulants|anticoagulants|mesh-ancestor
6678067|NCT01591226|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6678068|NCT01591226|Chelating Agents|chelating agents|mesh-ancestor
6678069|NCT01591226|Sequestering Agents|sequestering agents|mesh-ancestor
6678070|NCT01591226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678071|NCT01591226|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6678072|NCT01591226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678073|NCT01591226|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6678074|NCT01591226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6678075|NCT01591226|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6678076|NCT01591226|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6678077|NCT01591226|Purinergic Agents|purinergic agents|mesh-ancestor
6678078|NCT01591226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5714515|NCT03251690|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6242259|NCT02646124|Diazepam|diazepam|mesh-list
6242260|NCT02646124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6242261|NCT02646124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6242262|NCT02646124|Analgesics|analgesics|mesh-ancestor
6242263|NCT02646124|Sensory System Agents|sensory system agents|mesh-ancestor
6242264|NCT02646124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6242265|NCT02646124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6242266|NCT02646124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6242267|NCT02646124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6242268|NCT02646124|Gout Suppressants|gout suppressants|mesh-ancestor
6242269|NCT02646124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6242270|NCT02646124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6242271|NCT02646124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242272|NCT02646124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6242273|NCT02646124|Anticonvulsants|anticonvulsants|mesh-ancestor
6242274|NCT02646124|Antiemetics|antiemetics|mesh-ancestor
6242275|NCT02646124|Autonomic Agents|autonomic agents|mesh-ancestor
6242276|NCT02646124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6242277|NCT02646124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6242278|NCT02646124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6242279|NCT02646124|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6242280|NCT02646124|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6242281|NCT02646124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6503787|NCT00653588|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6503788|NCT00653588|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6503789|NCT00653588|Antimetabolites|antimetabolites|mesh-ancestor
5714516|NCT03251690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5714517|NCT03251690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5714518|NCT03251690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5714519|NCT03251690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5714520|NCT03251690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5714521|NCT03251690|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5714522|NCT03251690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5714523|NCT03251690|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5714524|NCT03251690|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5714525|NCT03251690|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5714526|NCT03251690|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6242282|NCT02646124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6242283|NCT02646124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6242284|NCT02646124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6242285|NCT02646124|Anesthetics, General|anesthetics, general|mesh-ancestor
6242286|NCT02646124|Anesthetics|anesthetics|mesh-ancestor
6242287|NCT02646124|GABA Modulators|gaba modulators|mesh-ancestor
6242288|NCT02646124|GABA Agents|gaba agents|mesh-ancestor
6242289|NCT02646124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6242290|NCT02646332|Amoxicillin|amoxicillin|mesh-list
6242291|NCT02646332|Metronidazole|metronidazole|mesh-list
6242292|NCT02646332|Clarithromycin|clarithromycin|mesh-list
6242293|NCT02646332|Dexlansoprazole|dexlansoprazole|mesh-list
6242294|NCT02646332|Lansoprazole|lansoprazole|mesh-list
5714527|NCT03251924|Nivolumab|nivolumab|mesh-list
5714528|NCT03251924|Ipilimumab|ipilimumab|mesh-list
5714529|NCT03251924|Antibodies|antibodies|mesh-list
5714530|NCT03251924|Immunoglobulins|immunoglobulins|mesh-list
6242295|NCT02646332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6242296|NCT02646332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6503790|NCT00653588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503791|NCT00653588|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6242297|NCT02646332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6242298|NCT02646332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6242299|NCT02646332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6242300|NCT02646332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6242301|NCT02646332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242302|NCT02646332|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6242303|NCT02646332|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6242304|NCT02646332|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6242305|NCT02646332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6242306|NCT02646332|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6242307|NCT02646449|Mirtazapine|mirtazapine|mesh-list
6242308|NCT02646449|Antidepressive Agents|antidepressive agents|mesh-ancestor
6242309|NCT02646449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6242310|NCT02646449|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6242311|NCT02646449|Histamine Antagonists|histamine antagonists|mesh-ancestor
6242312|NCT02646449|Histamine Agents|histamine agents|mesh-ancestor
5714531|NCT03251924|Antibodies, Blocking|antibodies, blocking|mesh-list
5714532|NCT03251924|Immunologic Factors|immunologic factors|mesh-ancestor
5714533|NCT03251924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714534|NCT03251924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5714535|NCT03251924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5714536|NCT03251924|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5714537|NCT03251924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5714538|NCT03251859|Ticagrelor|ticagrelor|mesh-list
5714539|NCT03251859|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5714540|NCT03251859|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5714541|NCT03251859|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5714542|NCT03251859|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5714543|NCT03251859|Purinergic Agents|purinergic agents|mesh-ancestor
5714544|NCT03251859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5714545|NCT03251859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5714546|NCT03251859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714547|NCT03251768|Lenograstim|lenograstim|mesh-list
5714548|NCT03251768|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5714549|NCT03251768|Immunologic Factors|immunologic factors|mesh-ancestor
5714550|NCT03251768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714551|NCT03251872|Olaparib|olaparib|mesh-list
5714552|NCT03251872|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5714553|NCT03251872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5714554|NCT03251872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242313|NCT02646449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6244222|NCT02690974|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5714555|NCT03251872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5721911|NCT03202459|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5721912|NCT03202459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5721913|NCT03202459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721914|NCT03202459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5721915|NCT03202459|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5721916|NCT03202459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5721917|NCT03202459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5721918|NCT03202459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5721919|NCT03202459|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6242314|NCT02646449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242315|NCT02646449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6242316|NCT02646449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6242317|NCT02646449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6242318|NCT02646449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6242319|NCT02646449|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6242320|NCT02646449|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6242321|NCT02646449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6242322|NCT02646449|Adrenergic Agents|adrenergic agents|mesh-ancestor
6242323|NCT02646449|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6242324|NCT02646449|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6242325|NCT02646449|Serotonin Agents|serotonin agents|mesh-ancestor
6242326|NCT02646449|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6244223|NCT02690974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244224|NCT02691416|Propofol|propofol|mesh-list
6503792|NCT00653588|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6503793|NCT00653588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6503794|NCT00653614|Drospirenone|drospirenone|mesh-list
6503795|NCT00653614|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6244225|NCT02691416|Sevoflurane|sevoflurane|mesh-list
6244226|NCT02691416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6244227|NCT02691416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6244228|NCT02691416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244229|NCT02691416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6244230|NCT02691416|Anesthetics, General|anesthetics, general|mesh-ancestor
6244231|NCT02691416|Anesthetics|anesthetics|mesh-ancestor
6244232|NCT02691416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6244233|NCT02691416|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6244234|NCT02691468|Silicon|silicon|mesh-list
6244235|NCT02691468|Trace Elements|trace elements|mesh-ancestor
6244236|NCT02691468|Micronutrients|micronutrients|mesh-ancestor
6244237|NCT02691468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244238|NCT02691494|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6244239|NCT02691494|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6244240|NCT02691494|Norethindrone|norethindrone|mesh-list
6244241|NCT02691494|Norethindrone Acetate|norethindrone acetate|mesh-list
6244242|NCT02691494|Estradiol|estradiol|mesh-list
6244243|NCT02691494|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6244244|NCT02691494|Estrogens|estrogens|mesh-ancestor
6503796|NCT00653614|Hormone Antagonists|hormone antagonists|mesh-ancestor
6503797|NCT00653614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6503798|NCT00653614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503799|NCT00653614|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6503800|NCT00653614|Diuretics|diuretics|mesh-ancestor
6503801|NCT00653614|Natriuretic Agents|natriuretic agents|mesh-ancestor
6503802|NCT00653744|Atorvastatin|atorvastatin|mesh-list
6503803|NCT00653744|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6503804|NCT00653744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6503805|NCT00653744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6503806|NCT00653744|Antimetabolites|antimetabolites|mesh-ancestor
6503807|NCT00653744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503808|NCT00653744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6503809|NCT00653744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6503810|NCT00653744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6503811|NCT00653757|Leuprolide|leuprolide|mesh-list
6503812|NCT00653757|Goserelin|goserelin|mesh-list
6503813|NCT00653757|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6503814|NCT00653757|Fertility Agents|fertility agents|mesh-ancestor
6503815|NCT00653757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6503816|NCT00653757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678079|NCT01591226|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6678080|NCT01591226|Diuretics|diuretics|mesh-ancestor
6678081|NCT01591226|Natriuretic Agents|natriuretic agents|mesh-ancestor
6678082|NCT01591291|Ondansetron|ondansetron|mesh-list
5714556|NCT03251521|Botulinum Toxins|botulinum toxins|mesh-list
5714557|NCT03251521|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6242327|NCT02647203|Fluorides|fluorides|mesh-list
6242328|NCT02647203|Cariostatic Agents|cariostatic agents|mesh-ancestor
6242329|NCT02647203|Protective Agents|protective agents|mesh-ancestor
6242330|NCT02647203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6242331|NCT02647320|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6242332|NCT02647320|Firuglipel|firuglipel|mesh-list
6242333|NCT02647320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6242334|NCT02647320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6242335|NCT02647320|Incretins|incretins|mesh-ancestor
6242336|NCT02647320|Hormones|hormones|mesh-ancestor
6242337|NCT02647320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6242338|NCT02647320|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6242339|NCT02647320|Protease Inhibitors|protease inhibitors|mesh-ancestor
6242340|NCT02647320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6242341|NCT02647320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242342|NCT02647788|Acetaminophen|acetaminophen|mesh-list
6242343|NCT02647788|Ibuprofen|ibuprofen|mesh-list
6242344|NCT02647788|Codeine|codeine|mesh-list
6242345|NCT02647788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6242346|NCT02647788|Analgesics|analgesics|mesh-ancestor
6242347|NCT02647788|Sensory System Agents|sensory system agents|mesh-ancestor
6242348|NCT02647788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6242349|NCT02647788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714558|NCT03251521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5714559|NCT03251521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5714560|NCT03251521|Cholinergic Agents|cholinergic agents|mesh-ancestor
5714561|NCT03251521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5714562|NCT03251521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714563|NCT03251599|Nitroglycerin|nitroglycerin|mesh-list
5714564|NCT03251599|Vasodilator Agents|vasodilator agents|mesh-ancestor
5714565|NCT03251469|Tranexamic Acid|tranexamic acid|mesh-list
5714566|NCT03251469|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5714567|NCT03251469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5714568|NCT03251469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5714569|NCT03251469|Hemostatics|hemostatics|mesh-ancestor
5714570|NCT03251469|Coagulants|coagulants|mesh-ancestor
5714571|NCT03251365|Gemcitabine|gemcitabine|mesh-list
5714572|NCT03251365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6242350|NCT02647788|Antipyretics|antipyretics|mesh-ancestor
6242351|NCT02647788|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6242352|NCT02647788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6242353|NCT02647788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6242354|NCT02647788|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6242355|NCT02647788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6242356|NCT02647788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242357|NCT02647788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6242358|NCT02647788|Narcotics|narcotics|mesh-ancestor
6242359|NCT02647788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5714573|NCT03251365|Antimetabolites|antimetabolites|mesh-ancestor
5714574|NCT03251365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242360|NCT02647788|Antitussive Agents|antitussive agents|mesh-ancestor
5714575|NCT03251365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5714576|NCT03251365|Antiviral Agents|antiviral agents|mesh-ancestor
5714577|NCT03251365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5714578|NCT03251365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5714579|NCT03251365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5714580|NCT03251365|Immunologic Factors|immunologic factors|mesh-ancestor
5714581|NCT03251365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714582|NCT03251300|Mirabegron|mirabegron|mesh-list
5714583|NCT03251300|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
5714584|NCT03251300|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6242361|NCT02647788|Respiratory System Agents|respiratory system agents|mesh-ancestor
6242362|NCT02647866|KHK4083|khk4083|mesh-list
6242363|NCT02647866|Dermatologic Agents|dermatologic agents|mesh-ancestor
6242364|NCT02647944|Liraglutide|liraglutide|mesh-list
6242365|NCT02647944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6503817|NCT00653757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6503818|NCT00653757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6503819|NCT00653822|Alefacept|alefacept|mesh-list
6503820|NCT00653822|Dermatologic Agents|dermatologic agents|mesh-ancestor
6503821|NCT00653822|Immunologic Factors|immunologic factors|mesh-ancestor
6503822|NCT00653822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503823|NCT00653848|Docetaxel|docetaxel|mesh-list
6503824|NCT00653848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6242366|NCT02647944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6242367|NCT02647944|Incretins|incretins|mesh-ancestor
6242368|NCT02647944|Hormones|hormones|mesh-ancestor
6242369|NCT02647944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6242370|NCT02648204|Dulaglutide|dulaglutide|mesh-list
6242371|NCT02648204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6242372|NCT02648204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6242373|NCT02648217|Insulin|insulin|mesh-list
6242374|NCT02648217|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6242375|NCT02648217|Insulin Aspart|insulin aspart|mesh-list
6242376|NCT02648217|Insulin, Long-Acting|insulin, long-acting|mesh-list
6242377|NCT02648217|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6242378|NCT02648217|Biphasic Insulins|biphasic insulins|mesh-list
6242379|NCT02648217|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6242380|NCT02648217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6242381|NCT02649192|Vitamin D|vitamin d|mesh-list
6242382|NCT02649192|Vitamin A|vitamin a|mesh-list
6242383|NCT02649192|Vitamins|vitamins|mesh-ancestor
6242384|NCT02649192|Micronutrients|micronutrients|mesh-ancestor
6242385|NCT02649192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6242386|NCT02649192|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6242387|NCT02649231|Ketamine|ketamine|mesh-list
6242388|NCT02649231|Analgesics|analgesics|mesh-ancestor
6242389|NCT02649231|Sensory System Agents|sensory system agents|mesh-ancestor
6503825|NCT00653848|Tubulin Modulators|tubulin modulators|mesh-ancestor
6503826|NCT00653848|Antimitotic Agents|antimitotic agents|mesh-ancestor
6503827|NCT00653848|Mitosis Modulators|mitosis modulators|mesh-ancestor
6503828|NCT00653848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503829|NCT00653874|Bilirubin|bilirubin|mesh-list
6503830|NCT00653874|Antioxidants|antioxidants|mesh-ancestor
6503831|NCT00653874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242390|NCT02649231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6242391|NCT02649231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6242392|NCT02649231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6242393|NCT02649231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6242394|NCT02649231|Anesthetics, General|anesthetics, general|mesh-ancestor
6242395|NCT02649231|Anesthetics|anesthetics|mesh-ancestor
6242396|NCT02649231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6242397|NCT02649231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6242398|NCT02649231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6242399|NCT02649231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6242400|NCT02649231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242401|NCT02649894|Silver Nitrate|silver nitrate|mesh-list
6242402|NCT02649894|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6242403|NCT02649894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6242404|NCT02650193|Lenograstim|lenograstim|mesh-list
6242405|NCT02650193|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6242406|NCT02650193|Immunologic Factors|immunologic factors|mesh-ancestor
6242407|NCT02650193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6242408|NCT02650856|Tranexamic Acid|tranexamic acid|mesh-list
6242409|NCT02650856|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6242410|NCT02650856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6242411|NCT02650856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242412|NCT02650856|Hemostatics|hemostatics|mesh-ancestor
6242413|NCT02650856|Coagulants|coagulants|mesh-ancestor
6242414|NCT02650921|Lidocaine|lidocaine|mesh-list
6242415|NCT02650921|Anesthetics, Local|anesthetics, local|mesh-ancestor
6242416|NCT02650921|Anesthetics|anesthetics|mesh-ancestor
6242417|NCT02650921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6242418|NCT02650921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503832|NCT00653874|Protective Agents|protective agents|mesh-ancestor
6242419|NCT02650921|Sensory System Agents|sensory system agents|mesh-ancestor
6242420|NCT02650921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6242421|NCT02650921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6242422|NCT02650921|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6242423|NCT02650921|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6242424|NCT02650921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6242425|NCT02650921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242426|NCT02650999|Pembrolizumab|pembrolizumab|mesh-list
6242427|NCT02650999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6242428|NCT02650999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6242429|NCT02651116|Dextromethorphan|dextromethorphan|mesh-list
6242430|NCT02651116|Antitussive Agents|antitussive agents|mesh-ancestor
6678083|NCT01591291|Antiemetics|antiemetics|mesh-ancestor
6242431|NCT02651116|Respiratory System Agents|respiratory system agents|mesh-ancestor
6244245|NCT02691494|Hormones|hormones|mesh-ancestor
6242432|NCT02651116|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6242433|NCT02651116|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6242434|NCT02651116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6242435|NCT02651116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242436|NCT02651116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6242437|NCT02651155|Lubiprostone|lubiprostone|mesh-list
6242438|NCT02651155|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6503833|NCT00653874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503834|NCT00653926|Epinephrine|epinephrine|mesh-list
5714585|NCT03251300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5714586|NCT03251300|Adrenergic Agents|adrenergic agents|mesh-ancestor
5714587|NCT03251300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5714588|NCT03251300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5714589|NCT03251300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503835|NCT00653926|Ropivacaine|ropivacaine|mesh-list
6503836|NCT00653926|Anesthetics, Local|anesthetics, local|mesh-ancestor
6503837|NCT00653926|Anesthetics|anesthetics|mesh-ancestor
6503838|NCT00653926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6503839|NCT00653926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503840|NCT00653926|Sensory System Agents|sensory system agents|mesh-ancestor
6503841|NCT00653926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6503842|NCT00653926|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6503843|NCT00653926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6503844|NCT00653926|Adrenergic Agents|adrenergic agents|mesh-ancestor
6503845|NCT00653926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6503846|NCT00653926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503847|NCT00653926|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6503848|NCT00653926|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6503849|NCT00653926|Autonomic Agents|autonomic agents|mesh-ancestor
6503850|NCT00653926|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5714590|NCT03251300|Urological Agents|urological agents|mesh-ancestor
5714591|NCT03251417|Irinotecan|irinotecan|mesh-list
5714592|NCT03251417|Apatinib|apatinib|mesh-list
5714593|NCT03251417|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5714594|NCT03251417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5714595|NCT03251417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5714596|NCT03251417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5714597|NCT03251417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5714598|NCT03251417|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6503851|NCT00653926|Respiratory System Agents|respiratory system agents|mesh-ancestor
6503852|NCT00653926|Mydriatics|mydriatics|mesh-ancestor
6503853|NCT00653926|Sympathomimetics|sympathomimetics|mesh-ancestor
6678084|NCT01591291|Autonomic Agents|autonomic agents|mesh-ancestor
6678085|NCT01591291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6678086|NCT01591291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678087|NCT01591291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6678088|NCT01591291|Antipruritics|antipruritics|mesh-ancestor
6678089|NCT01591291|Dermatologic Agents|dermatologic agents|mesh-ancestor
6678090|NCT01591291|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6678091|NCT01591291|Serotonin Agents|serotonin agents|mesh-ancestor
6678092|NCT01591291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6678093|NCT01591291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678094|NCT01591291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6678095|NCT01591291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6678096|NCT01591291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6678097|NCT01591291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6678098|NCT01591291|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6678099|NCT01591421|Panitumumab|panitumumab|mesh-list
6678100|NCT01591421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6678101|NCT01591421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6678102|NCT01591434|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6678103|NCT01591434|Laxatives|laxatives|mesh-ancestor
6678104|NCT01591434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6503854|NCT00653926|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6503855|NCT00653952|Paclitaxel|paclitaxel|mesh-list
6503856|NCT00653952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6503857|NCT00653952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6503858|NCT00653952|Tubulin Modulators|tubulin modulators|mesh-ancestor
6503859|NCT00653952|Antimitotic Agents|antimitotic agents|mesh-ancestor
6503860|NCT00653952|Mitosis Modulators|mitosis modulators|mesh-ancestor
6503861|NCT00653952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503862|NCT00653965|Atorvastatin|atorvastatin|mesh-list
6503863|NCT00653965|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6503864|NCT00653965|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6503865|NCT00653965|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6503866|NCT00653965|Antimetabolites|antimetabolites|mesh-ancestor
5714599|NCT03251443|Apatinib|apatinib|mesh-list
5714600|NCT03251443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5714601|NCT03251443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5714602|NCT03251443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5714603|NCT03251443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5714604|NCT03251040|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
5714605|NCT03251040|Hemostatics|hemostatics|mesh-ancestor
5714606|NCT03251040|Coagulants|coagulants|mesh-ancestor
5714607|NCT03250923|Acemannan|acemannan|mesh-list
5714608|NCT03250923|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5714609|NCT03250923|Immunologic Factors|immunologic factors|mesh-ancestor
5714610|NCT03250923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714611|NCT03250923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5714612|NCT03250923|Antiviral Agents|antiviral agents|mesh-ancestor
5714613|NCT03250923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5714614|NCT03250923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5714615|NCT03251170|Fentanyl|fentanyl|mesh-list
5714616|NCT03251170|Midazolam|midazolam|mesh-list
5714617|NCT03251170|Ketamine|ketamine|mesh-list
5714618|NCT03251170|Analgesics|analgesics|mesh-ancestor
5714619|NCT03251170|Sensory System Agents|sensory system agents|mesh-ancestor
5714620|NCT03251170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5714621|NCT03251170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714622|NCT03251170|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5714623|NCT03251170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5714624|NCT03251170|Anesthetics, General|anesthetics, general|mesh-ancestor
5714625|NCT03251170|Anesthetics|anesthetics|mesh-ancestor
5714626|NCT03251170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5714627|NCT03251170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5714628|NCT03251170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5714629|NCT03251170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5714630|NCT03251170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5714631|NCT03251170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5714632|NCT03251170|Narcotics|narcotics|mesh-ancestor
5714633|NCT03251170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6503867|NCT00653965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503868|NCT00653965|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6503869|NCT00653965|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6503870|NCT00653965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6503871|NCT00654017|Sildenafil Citrate|sildenafil citrate|mesh-list
6503872|NCT00654017|Vasodilator Agents|vasodilator agents|mesh-ancestor
6503873|NCT00654017|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6503874|NCT00654017|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6503875|NCT00654017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6503876|NCT00654017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503877|NCT00654017|Urological Agents|urological agents|mesh-ancestor
6503878|NCT00654043|Torsemide|torsemide|mesh-list
6503879|NCT00654043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6503880|NCT00654043|Diuretics|diuretics|mesh-ancestor
6503881|NCT00654043|Natriuretic Agents|natriuretic agents|mesh-ancestor
6503882|NCT00654043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503883|NCT00654043|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6503884|NCT00654043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6503885|NCT00654043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503886|NCT00654056|Insulin|insulin|mesh-list
6503887|NCT00654056|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6503888|NCT00654056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6503889|NCT00654056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503890|NCT00654082|Sildenafil Citrate|sildenafil citrate|mesh-list
6503891|NCT00654082|Vasodilator Agents|vasodilator agents|mesh-ancestor
6503892|NCT00654082|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6503893|NCT00654082|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6503894|NCT00654082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6503895|NCT00654082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503896|NCT00654082|Urological Agents|urological agents|mesh-ancestor
6503897|NCT00654108|Ascorbic Acid|ascorbic acid|mesh-list
6503898|NCT00654108|Ciprofloxacin|ciprofloxacin|mesh-list
6503899|NCT00654108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6503900|NCT00654108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6503901|NCT00654108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6678105|NCT01591551|Natalizumab|natalizumab|mesh-list
5714634|NCT03251170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5714635|NCT03251170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6503902|NCT00654108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6503903|NCT00654108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6503904|NCT00654108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503905|NCT00654108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6503906|NCT00654108|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6503907|NCT00654108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6503908|NCT00654108|Antioxidants|antioxidants|mesh-ancestor
6503909|NCT00654108|Protective Agents|protective agents|mesh-ancestor
6503910|NCT00654108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714636|NCT03251170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5714637|NCT03251170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5714638|NCT03251170|GABA Modulators|gaba modulators|mesh-ancestor
5714639|NCT03251170|GABA Agents|gaba agents|mesh-ancestor
5714640|NCT03251222|Dexmedetomidine|dexmedetomidine|mesh-list
5714641|NCT03251222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5714642|NCT03251222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5714643|NCT03251222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714644|NCT03251222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5714645|NCT03251222|Analgesics|analgesics|mesh-ancestor
5714646|NCT03251222|Sensory System Agents|sensory system agents|mesh-ancestor
5714647|NCT03251222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5714648|NCT03251222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5714649|NCT03251222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5714650|NCT03251222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5714651|NCT03251222|Adrenergic Agents|adrenergic agents|mesh-ancestor
5714652|NCT03251222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5714653|NCT03251222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5714654|NCT03250910|Ribavirin|ribavirin|mesh-list
6503911|NCT00654108|Vitamins|vitamins|mesh-ancestor
6503912|NCT00654108|Micronutrients|micronutrients|mesh-ancestor
6503913|NCT00654121|Insulin|insulin|mesh-list
6503914|NCT00654121|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6503915|NCT00654121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6503916|NCT00654121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503917|NCT00654160|Leucovorin|leucovorin|mesh-list
6503918|NCT00654160|Fluorouracil|fluorouracil|mesh-list
6503919|NCT00654160|Irinotecan|irinotecan|mesh-list
6503920|NCT00654160|Calcium|calcium|mesh-list
6503921|NCT00654160|Levoleucovorin|levoleucovorin|mesh-list
6503922|NCT00654160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6678106|NCT01591551|Immunologic Factors|immunologic factors|mesh-ancestor
6678107|NCT01591551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678108|NCT01591629|Dronabinol|dronabinol|mesh-list
6678109|NCT01591629|Naloxone|naloxone|mesh-list
6678110|NCT01591629|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6678111|NCT01591629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678112|NCT01591629|Sensory System Agents|sensory system agents|mesh-ancestor
6678113|NCT01591629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6678114|NCT01591629|Hallucinogens|hallucinogens|mesh-ancestor
6678115|NCT01591629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6678116|NCT01591629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6678117|NCT01591629|Analgesics|analgesics|mesh-ancestor
6678118|NCT01591629|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6678119|NCT01591629|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6678120|NCT01591629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6678121|NCT01591629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678122|NCT01591629|Hormones|hormones|mesh-ancestor
6678123|NCT01591629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6678124|NCT01591668|Vesatolimod|vesatolimod|mesh-list
6678125|NCT01591668|Antiviral Agents|antiviral agents|mesh-ancestor
6678126|NCT01591668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6678127|NCT01591759|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
6678128|NCT01591759|Nootropic Agents|nootropic agents|mesh-ancestor
6678129|NCT01591850|Ritonavir|ritonavir|mesh-list
6678130|NCT01591850|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6678131|NCT01591850|Ketoconazole|ketoconazole|mesh-list
6503923|NCT00654160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503924|NCT00654160|Antimetabolites|antimetabolites|mesh-ancestor
6503925|NCT00654160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503926|NCT00654160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6503927|NCT00654160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6503928|NCT00654160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6678132|NCT01591850|Rifampin|rifampin|mesh-list
6678133|NCT01591850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6678134|NCT01591850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5714655|NCT03250910|Sofosbuvir|sofosbuvir|mesh-list
5714656|NCT03250910|Velpatasvir|velpatasvir|mesh-list
5714657|NCT03250910|Antimetabolites|antimetabolites|mesh-ancestor
5714658|NCT03250910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5714659|NCT03250910|Antiviral Agents|antiviral agents|mesh-ancestor
5714660|NCT03250910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5714661|NCT03250962|Decitabine|decitabine|mesh-list
5714662|NCT03250962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6503929|NCT00654160|Immunologic Factors|immunologic factors|mesh-ancestor
6503930|NCT00654160|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6503931|NCT00654160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6503932|NCT00654160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6503933|NCT00654160|Antidotes|antidotes|mesh-ancestor
6503934|NCT00654160|Protective Agents|protective agents|mesh-ancestor
6503935|NCT00654160|Vitamin B Complex|vitamin b complex|mesh-ancestor
6503936|NCT00654160|Vitamins|vitamins|mesh-ancestor
6503937|NCT00654160|Micronutrients|micronutrients|mesh-ancestor
6503938|NCT00654173|Atorvastatin|atorvastatin|mesh-list
6503939|NCT00654173|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6503940|NCT00654173|Simvastatin|simvastatin|mesh-list
6503941|NCT00654173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6503942|NCT00654173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6503943|NCT00654173|Antimetabolites|antimetabolites|mesh-ancestor
6503944|NCT00654173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503945|NCT00654173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6503946|NCT00654173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6503947|NCT00654173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6503948|NCT00654225|Atorvastatin|atorvastatin|mesh-list
6503949|NCT00654225|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6503950|NCT00654225|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6503951|NCT00654225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6503952|NCT00654225|Antimetabolites|antimetabolites|mesh-ancestor
6503953|NCT00654225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503954|NCT00654225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6503955|NCT00654225|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6503956|NCT00654225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6503957|NCT00654277|Ondansetron|ondansetron|mesh-list
6503958|NCT00654277|Antiemetics|antiemetics|mesh-ancestor
6503959|NCT00654277|Autonomic Agents|autonomic agents|mesh-ancestor
6503960|NCT00654277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5714663|NCT03250962|Antimetabolites|antimetabolites|mesh-ancestor
5714664|NCT03250962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5714665|NCT03250962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6503961|NCT00654277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503962|NCT00654277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6503963|NCT00654277|Antipruritics|antipruritics|mesh-ancestor
6503964|NCT00654277|Dermatologic Agents|dermatologic agents|mesh-ancestor
6503965|NCT00654277|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6503966|NCT00654277|Serotonin Agents|serotonin agents|mesh-ancestor
6503967|NCT00654277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6503968|NCT00654277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503969|NCT00654277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6503970|NCT00654277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6503971|NCT00654277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6503972|NCT00654277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6503973|NCT00654277|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6503974|NCT00654290|Propranolol|propranolol|mesh-list
6503975|NCT00654290|Amiodarone|amiodarone|mesh-list
6503976|NCT00654290|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6503977|NCT00654290|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6503978|NCT00654290|Adrenergic Agents|adrenergic agents|mesh-ancestor
6503979|NCT00654290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6503980|NCT00654290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503981|NCT00654290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6503982|NCT00654290|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6503983|NCT00654290|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6503984|NCT00654290|Vasodilator Agents|vasodilator agents|mesh-ancestor
6503985|NCT00654290|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6503986|NCT00654290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6503987|NCT00654290|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6503988|NCT00654290|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6503989|NCT00654290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6503990|NCT00654290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6503991|NCT00654290|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6503992|NCT00654290|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6503993|NCT00654290|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6503994|NCT00654303|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6503995|NCT00654303|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6503996|NCT00654303|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6503997|NCT00654303|Antimetabolites|antimetabolites|mesh-ancestor
6503998|NCT00654303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6503999|NCT00654303|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6504000|NCT00654303|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6504001|NCT00654303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6504002|NCT00654394|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6504003|NCT00654394|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6504004|NCT00654394|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6504005|NCT00654394|Antimetabolites|antimetabolites|mesh-ancestor
6504006|NCT00654394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504007|NCT00654394|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6504008|NCT00654394|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6504009|NCT00654394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6504010|NCT00654407|Atorvastatin|atorvastatin|mesh-list
6504011|NCT00654407|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6504012|NCT00654407|Simvastatin|simvastatin|mesh-list
6504013|NCT00654407|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6504014|NCT00654407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6504015|NCT00654407|Antimetabolites|antimetabolites|mesh-ancestor
6504016|NCT00654407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504017|NCT00654407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6504018|NCT00654407|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6504019|NCT00654407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6504020|NCT00654446|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6504021|NCT00654446|Simvastatin|simvastatin|mesh-list
6504022|NCT00654446|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6504023|NCT00654446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6504024|NCT00654446|Antimetabolites|antimetabolites|mesh-ancestor
6504025|NCT00654446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504026|NCT00654446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6504027|NCT00654446|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6504028|NCT00654446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6504029|NCT00654459|Policosanol|policosanol|mesh-list
6504030|NCT00654459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6504031|NCT00654459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6504032|NCT00654459|Antimetabolites|antimetabolites|mesh-ancestor
6504033|NCT00654459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504034|NCT00654459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6504035|NCT00654459|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6504036|NCT00654485|Atorvastatin|atorvastatin|mesh-list
6504037|NCT00654485|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6504038|NCT00654485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6504039|NCT00654485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6504040|NCT00654485|Antimetabolites|antimetabolites|mesh-ancestor
6504041|NCT00654485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504042|NCT00654485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6504043|NCT00654485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6504044|NCT00654485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6504045|NCT00654524|Vitamin D|vitamin d|mesh-list
6504046|NCT00654524|Goserelin|goserelin|mesh-list
6504047|NCT00654524|Hormones|hormones|mesh-list
6504048|NCT00654524|Vitamins|vitamins|mesh-ancestor
6504049|NCT00654524|Micronutrients|micronutrients|mesh-ancestor
6504050|NCT00654524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504051|NCT00654524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6504052|NCT00654524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6504053|NCT00654524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6504054|NCT00654524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6504055|NCT00654537|Atorvastatin|atorvastatin|mesh-list
6504056|NCT00654537|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6504057|NCT00654537|Simvastatin|simvastatin|mesh-list
6504058|NCT00654537|Pravastatin|pravastatin|mesh-list
6504059|NCT00654537|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6504060|NCT00654537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6504061|NCT00654537|Antimetabolites|antimetabolites|mesh-ancestor
6504062|NCT00654537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504063|NCT00654537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6504064|NCT00654537|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6504065|NCT00654537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6504066|NCT00654576|Olanzapine|olanzapine|mesh-list
6504067|NCT00654576|Chlorpromazine|chlorpromazine|mesh-list
5714666|NCT03250962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5714667|NCT03250832|Bevacizumab|bevacizumab|mesh-list
5714668|NCT03250832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5714669|NCT03250832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5714670|NCT03250832|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5714671|NCT03250832|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5714672|NCT03250832|Growth Substances|growth substances|mesh-ancestor
6504068|NCT00654576|Risperidone|risperidone|mesh-list
6504069|NCT00654576|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6504070|NCT00654576|Clozapine|clozapine|mesh-list
6504071|NCT00654576|Sulpiride|sulpiride|mesh-list
6504072|NCT00654576|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6504073|NCT00654576|Serotonin Agents|serotonin agents|mesh-ancestor
6504074|NCT00654576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6504075|NCT00654576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504076|NCT00654576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504077|NCT00654576|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6504078|NCT00654576|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6504079|NCT00654576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6504080|NCT00654576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6504081|NCT00654576|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6504082|NCT00654576|Dopamine Agents|dopamine agents|mesh-ancestor
6504083|NCT00654576|Antiemetics|antiemetics|mesh-ancestor
6504084|NCT00654576|Autonomic Agents|autonomic agents|mesh-ancestor
6504085|NCT00654576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6678135|NCT01591850|Protease Inhibitors|protease inhibitors|mesh-ancestor
6678136|NCT01591850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6678137|NCT01591850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678138|NCT01591850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6678139|NCT01591850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6678140|NCT01591850|Antiviral Agents|antiviral agents|mesh-ancestor
6678141|NCT01591850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6504086|NCT00654576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6504087|NCT00654576|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6504088|NCT00654576|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6504089|NCT00654576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5714673|NCT03250832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714674|NCT03250832|Growth Inhibitors|growth inhibitors|mesh-ancestor
5714675|NCT03250520|Titanium dioxide|titanium dioxide|mesh-list
5714676|NCT03250520|Sunscreening Agents|sunscreening agents|mesh-ancestor
5714677|NCT03250520|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5714678|NCT03250520|Protective Agents|protective agents|mesh-ancestor
6504090|NCT00654576|Antidepressive Agents|antidepressive agents|mesh-ancestor
6504091|NCT00654576|GABA Antagonists|gaba antagonists|mesh-ancestor
6504092|NCT00654576|GABA Agents|gaba agents|mesh-ancestor
6504093|NCT00654576|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5714679|NCT03250520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714680|NCT03250520|Dermatologic Agents|dermatologic agents|mesh-ancestor
5714681|NCT03250520|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5714682|NCT03250494|Dexamethasone|dexamethasone|mesh-list
5714683|NCT03250494|Dexamethasone acetate|dexamethasone acetate|mesh-list
5714684|NCT03250494|BB 1101|bb 1101|mesh-list
5714685|NCT03250494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5714686|NCT03250494|Antiemetics|antiemetics|mesh-ancestor
5714687|NCT03250494|Autonomic Agents|autonomic agents|mesh-ancestor
5714688|NCT03250494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5714689|NCT03250494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714690|NCT03250494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5714691|NCT03250494|Glucocorticoids|glucocorticoids|mesh-ancestor
5714692|NCT03250494|Hormones|hormones|mesh-ancestor
6504094|NCT00654589|Deferasirox|deferasirox|mesh-list
6504095|NCT00654589|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6504096|NCT00654589|Chelating Agents|chelating agents|mesh-ancestor
6504097|NCT00654589|Sequestering Agents|sequestering agents|mesh-ancestor
6504098|NCT00654589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504099|NCT00654602|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6504100|NCT00654602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6504101|NCT00654602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6504102|NCT00654602|Antimetabolites|antimetabolites|mesh-ancestor
6504103|NCT00654602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504104|NCT00654602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6504105|NCT00654602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6504106|NCT00654602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6504107|NCT00654667|Resveratrol|resveratrol|mesh-list
6504108|NCT00654667|Antioxidants|antioxidants|mesh-ancestor
5714693|NCT03250494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6504109|NCT00654667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504110|NCT00654667|Protective Agents|protective agents|mesh-ancestor
6504111|NCT00654667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504112|NCT00654667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6504113|NCT00654667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6504114|NCT00654680|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6504115|NCT00654680|Vasodilator Agents|vasodilator agents|mesh-ancestor
6504116|NCT00654680|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6504117|NCT00654680|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6504118|NCT00654680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6504119|NCT00654680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504120|NCT00654680|Urological Agents|urological agents|mesh-ancestor
6678142|NCT01591850|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6678143|NCT01591850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6678144|NCT01591850|Antifungal Agents|antifungal agents|mesh-ancestor
6678145|NCT01591850|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6678146|NCT01591850|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6678147|NCT01591850|Hormone Antagonists|hormone antagonists|mesh-ancestor
6678148|NCT01591850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6678149|NCT01591850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678150|NCT01591850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6678151|NCT01591850|Antitubercular Agents|antitubercular agents|mesh-ancestor
6678152|NCT01591850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6678153|NCT01591850|Leprostatic Agents|leprostatic agents|mesh-ancestor
6678154|NCT01591850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6678155|NCT01591850|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6678156|NCT01591850|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6678157|NCT01591850|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6678158|NCT01591850|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6678159|NCT01591850|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6678160|NCT01591850|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6678161|NCT01591889|Tinidazole|tinidazole|mesh-list
6678162|NCT01591889|Alkylating Agents|alkylating agents|mesh-ancestor
6678163|NCT01591889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678164|NCT01591889|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6678165|NCT01591889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6678166|NCT01591889|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
6678167|NCT01591889|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6678168|NCT01591889|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6678169|NCT01591902|Tesamorelin|tesamorelin|mesh-list
6678170|NCT01591902|Growth Substances|growth substances|mesh-ancestor
6678171|NCT01591902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678172|NCT01591980|Pregabalin|pregabalin|mesh-list
6678173|NCT01591980|Analgesics|analgesics|mesh-ancestor
6678174|NCT01591980|Sensory System Agents|sensory system agents|mesh-ancestor
6678175|NCT01591980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6678176|NCT01591980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678177|NCT01591980|Anticonvulsants|anticonvulsants|mesh-ancestor
6678178|NCT01591980|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6678179|NCT01591980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6678180|NCT01591980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678181|NCT01591980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6678182|NCT01591980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6678183|NCT01591980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6678184|NCT01591980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6678185|NCT01591980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6678186|NCT01592019|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
6678187|NCT01592019|Diclofenac|diclofenac|mesh-list
6678188|NCT01592019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6678189|NCT01592019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6678190|NCT01592019|Analgesics|analgesics|mesh-ancestor
6678191|NCT01592019|Sensory System Agents|sensory system agents|mesh-ancestor
6678192|NCT01592019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6678193|NCT01592019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678194|NCT01592019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6678195|NCT01592019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6678196|NCT01592019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6678197|NCT01592019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6678198|NCT01592019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678199|NCT01592032|Vancomycin|vancomycin|mesh-list
6678200|NCT01592032|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6504121|NCT00654758|Paclitaxel|paclitaxel|mesh-list
6504122|NCT00654758|Carboplatin|carboplatin|mesh-list
6504123|NCT00654758|Volociximab|volociximab|mesh-list
6504124|NCT00654758|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6504125|NCT00654758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6504126|NCT00654758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6504127|NCT00654758|Tubulin Modulators|tubulin modulators|mesh-ancestor
6504128|NCT00654758|Antimitotic Agents|antimitotic agents|mesh-ancestor
6504129|NCT00654758|Mitosis Modulators|mitosis modulators|mesh-ancestor
6504130|NCT00654758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504131|NCT00654758|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6504132|NCT00654758|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6504133|NCT00654758|Growth Substances|growth substances|mesh-ancestor
6504134|NCT00654758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504135|NCT00654758|Growth Inhibitors|growth inhibitors|mesh-ancestor
6504136|NCT00654758|Immunologic Factors|immunologic factors|mesh-ancestor
6504137|NCT00654888|Mitomycins|mitomycins|mesh-list
6504138|NCT00654888|Mitomycin|mitomycin|mesh-list
6504139|NCT00654888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6504140|NCT00654888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6504141|NCT00654888|Alkylating Agents|alkylating agents|mesh-ancestor
5714694|NCT03250494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5714695|NCT03250494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5714696|NCT03250494|Protease Inhibitors|protease inhibitors|mesh-ancestor
5714697|NCT03250494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5714698|NCT03250494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5714699|NCT03250507|Bupivacaine|bupivacaine|mesh-list
5714700|NCT03250507|Anesthetics, Local|anesthetics, local|mesh-ancestor
5714701|NCT03250507|Anesthetics|anesthetics|mesh-ancestor
5714702|NCT03250507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5714703|NCT03250507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714704|NCT03250507|Sensory System Agents|sensory system agents|mesh-ancestor
5714705|NCT03250507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5714706|NCT03250481|Oxycodone|oxycodone|mesh-list
5714707|NCT03250481|Propofol|propofol|mesh-list
5714708|NCT03250481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5714709|NCT03250481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5714710|NCT03250481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714711|NCT03250481|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5714712|NCT03250481|Anesthetics, General|anesthetics, general|mesh-ancestor
5714713|NCT03250481|Anesthetics|anesthetics|mesh-ancestor
6504142|NCT00654888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504143|NCT00654888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6504144|NCT00654888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6504145|NCT00654914|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6504146|NCT00654914|Vasodilator Agents|vasodilator agents|mesh-ancestor
6504147|NCT00654914|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6504148|NCT00654914|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6504149|NCT00654914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6504150|NCT00654914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504151|NCT00654914|Urological Agents|urological agents|mesh-ancestor
6504152|NCT00655018|Ascorbic Acid|ascorbic acid|mesh-list
6504153|NCT00655018|Tocopherols|tocopherols|mesh-list
6504154|NCT00655018|Vitamin E|vitamin e|mesh-list
6504155|NCT00655018|alpha-Tocopherol|alpha-tocopherol|mesh-list
6504156|NCT00655018|Vitamins|vitamins|mesh-ancestor
6504157|NCT00655018|Micronutrients|micronutrients|mesh-ancestor
6504158|NCT00655018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504159|NCT00655018|Antioxidants|antioxidants|mesh-ancestor
6504160|NCT00655018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504161|NCT00655018|Protective Agents|protective agents|mesh-ancestor
6504162|NCT00655044|Insulin Detemir|insulin detemir|mesh-list
6504163|NCT00655044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6504164|NCT00655044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504165|NCT00655109|Fluticasone|fluticasone|mesh-list
6504166|NCT00655109|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
6504167|NCT00655109|Lubricant Eye Drops|lubricant eye drops|mesh-list
6504168|NCT00655109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6504169|NCT00655109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6504170|NCT00655109|Autonomic Agents|autonomic agents|mesh-ancestor
6504171|NCT00655109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6504172|NCT00655109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504173|NCT00655109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6504174|NCT00655109|Respiratory System Agents|respiratory system agents|mesh-ancestor
6504175|NCT00655109|Dermatologic Agents|dermatologic agents|mesh-ancestor
6504176|NCT00655109|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6504177|NCT00655109|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6504178|NCT00655109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6504179|NCT00655109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6504180|NCT00655109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6504181|NCT00655109|Analgesics|analgesics|mesh-ancestor
6504182|NCT00655109|Sensory System Agents|sensory system agents|mesh-ancestor
6504183|NCT00655109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6504184|NCT00655109|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6504185|NCT00655109|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6504186|NCT00655109|Histamine Antagonists|histamine antagonists|mesh-ancestor
6504187|NCT00655109|Histamine Agents|histamine agents|mesh-ancestor
6504188|NCT00655109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6504189|NCT00655109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504190|NCT00655122|Dalteparin|dalteparin|mesh-list
6504191|NCT00655122|Tinzaparin|tinzaparin|mesh-list
6504192|NCT00655122|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6504193|NCT00655122|Anticoagulants|anticoagulants|mesh-ancestor
6504194|NCT00655122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6504195|NCT00655122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6504196|NCT00655122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504197|NCT00655135|Vedolizumab|vedolizumab|mesh-list
6504198|NCT00655135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6504199|NCT00655148|Vaccines|vaccines|mesh-list
6504200|NCT00655148|Immunologic Factors|immunologic factors|mesh-ancestor
6504201|NCT00655148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504202|NCT00655174|Fluvoxamine|fluvoxamine|mesh-list
6504203|NCT00655174|Sertraline|sertraline|mesh-list
6504204|NCT00655174|Antidepressive Agents|antidepressive agents|mesh-ancestor
6504205|NCT00655174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6504206|NCT00655174|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6678201|NCT01592032|Linezolid|linezolid|mesh-list
6678202|NCT01592032|Daptomycin|daptomycin|mesh-list
6678203|NCT01592032|Tigecycline|tigecycline|mesh-list
6678204|NCT01592032|Teicoplanin|teicoplanin|mesh-list
6678205|NCT01592032|Anti-Infective Agents|anti-infective agents|mesh-list
6678206|NCT01592032|Heparin|heparin|mesh-list
6678207|NCT01592032|Calcium heparin|calcium heparin|mesh-list
6504207|NCT00655174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6504208|NCT00655174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6504209|NCT00655174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504210|NCT00655174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6504211|NCT00655174|Serotonin Agents|serotonin agents|mesh-ancestor
6504212|NCT00655174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504213|NCT00655174|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6504214|NCT00655174|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6504215|NCT00655174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6504216|NCT00655174|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6504217|NCT00655174|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6504218|NCT00655174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5714714|NCT03250481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5714715|NCT03250481|Narcotics|narcotics|mesh-ancestor
5714716|NCT03250481|Analgesics|analgesics|mesh-ancestor
5714717|NCT03250481|Sensory System Agents|sensory system agents|mesh-ancestor
6504219|NCT00655174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6504220|NCT00655174|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6504221|NCT00655200|Insulin Detemir|insulin detemir|mesh-list
6504222|NCT00655200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6504223|NCT00655200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504224|NCT00655252|Everolimus|everolimus|mesh-list
6504225|NCT00655252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6504226|NCT00655252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6504227|NCT00655252|Immunologic Factors|immunologic factors|mesh-ancestor
6504228|NCT00655252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504229|NCT00655265|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
5714718|NCT03250481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5714719|NCT03250741|Rotigotine|rotigotine|mesh-list
5714720|NCT03250741|Dopamine Agonists|dopamine agonists|mesh-ancestor
5714721|NCT03250741|Dopamine Agents|dopamine agents|mesh-ancestor
5714722|NCT03250741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6504230|NCT00655265|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6504231|NCT00655265|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6504232|NCT00655265|Antimetabolites|antimetabolites|mesh-ancestor
6504233|NCT00655265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504234|NCT00655265|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6504235|NCT00655330|Valsartan|valsartan|mesh-list
6504236|NCT00655330|Probucol|probucol|mesh-list
6504237|NCT00655330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6504238|NCT00655330|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6504239|NCT00655330|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6504240|NCT00655330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504241|NCT00655330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6504242|NCT00655330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6504243|NCT00655330|Antimetabolites|antimetabolites|mesh-ancestor
6504244|NCT00655330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6504245|NCT00655330|Antioxidants|antioxidants|mesh-ancestor
6504246|NCT00655330|Protective Agents|protective agents|mesh-ancestor
6504247|NCT00655330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504248|NCT00655408|Iron|iron|mesh-list
6504249|NCT00655408|Trace Elements|trace elements|mesh-ancestor
6504250|NCT00655408|Micronutrients|micronutrients|mesh-ancestor
6504251|NCT00655408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504252|NCT00655421|Tolonium Chloride|tolonium chloride|mesh-list
6504253|NCT00655421|Hemostatics|hemostatics|mesh-ancestor
6504254|NCT00655421|Coagulants|coagulants|mesh-ancestor
6504255|NCT00655421|Heparin Antagonists|heparin antagonists|mesh-ancestor
6504256|NCT00655421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504257|NCT00655512|Clobetasol|clobetasol|mesh-list
6504258|NCT00655512|Pimecrolimus|pimecrolimus|mesh-list
6504259|NCT00655512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6504260|NCT00655512|Glucocorticoids|glucocorticoids|mesh-ancestor
6504261|NCT00655512|Hormones|hormones|mesh-ancestor
6504262|NCT00655512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6504263|NCT00655512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504264|NCT00655512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6504265|NCT00655512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6504266|NCT00655512|Analgesics|analgesics|mesh-ancestor
6504267|NCT00655512|Sensory System Agents|sensory system agents|mesh-ancestor
6504268|NCT00655512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6504269|NCT00655512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6504270|NCT00655512|Dermatologic Agents|dermatologic agents|mesh-ancestor
6504271|NCT00655512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6504272|NCT00655512|Immunologic Factors|immunologic factors|mesh-ancestor
6504273|NCT00655512|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6504274|NCT00655512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6504275|NCT00655512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504276|NCT00655590|Sildenafil Citrate|sildenafil citrate|mesh-list
6504277|NCT00655590|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6504278|NCT00655590|Vasodilator Agents|vasodilator agents|mesh-ancestor
6504279|NCT00655590|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6504280|NCT00655590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6504281|NCT00655590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6504282|NCT00655590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504283|NCT00655590|Urological Agents|urological agents|mesh-ancestor
6504284|NCT00655603|Pancrelipase|pancrelipase|mesh-list
6504285|NCT00655603|Hormones|hormones|mesh-list
6504286|NCT00655603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6504287|NCT00655603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504288|NCT00655603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6504289|NCT00655616|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6504290|NCT00655616|Montelukast|montelukast|mesh-list
6504291|NCT00655616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6504292|NCT00655616|Autonomic Agents|autonomic agents|mesh-ancestor
6504293|NCT00655616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6504294|NCT00655616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504295|NCT00655616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6504296|NCT00655616|Respiratory System Agents|respiratory system agents|mesh-ancestor
6504297|NCT00655616|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6504298|NCT00655616|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6504299|NCT00655616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6504300|NCT00655616|Adrenergic Agents|adrenergic agents|mesh-ancestor
6504301|NCT00655616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6504302|NCT00655616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504303|NCT00655616|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6504304|NCT00655616|Hormone Antagonists|hormone antagonists|mesh-ancestor
6504305|NCT00655616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6504306|NCT00655616|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6504307|NCT00655616|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6504308|NCT00655655|Everolimus|everolimus|mesh-list
6504309|NCT00655655|Vatalanib|vatalanib|mesh-list
6504310|NCT00655655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6678208|NCT01592032|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5714723|NCT03250741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5714724|NCT03250741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714725|NCT03250325|Cyclophosphamide|cyclophosphamide|mesh-list
5714726|NCT03250325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5714727|NCT03250325|Immunologic Factors|immunologic factors|mesh-ancestor
5714728|NCT03250325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714729|NCT03250325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5714730|NCT03250325|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5714731|NCT03250325|Alkylating Agents|alkylating agents|mesh-ancestor
5714732|NCT03250325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5714733|NCT03250325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5714734|NCT03250325|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6242439|NCT02651155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6242440|NCT02651155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242441|NCT02651220|Adapalene|adapalene|mesh-list
5714738|NCT03250338|Cytarabine|cytarabine|mesh-list
5714739|NCT03250338|Fludarabine|fludarabine|mesh-list
5714740|NCT03250338|Mitoxantrone|mitoxantrone|mesh-list
5714741|NCT03250338|Idarubicin|idarubicin|mesh-list
5714742|NCT03250338|Crenolanib|crenolanib|mesh-list
6242442|NCT02651220|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
6242443|NCT02651220|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6242444|NCT02651220|Dermatologic Agents|dermatologic agents|mesh-ancestor
6242445|NCT02651220|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6242446|NCT02651220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6242447|NCT02651220|Analgesics|analgesics|mesh-ancestor
6242448|NCT02651220|Sensory System Agents|sensory system agents|mesh-ancestor
6242449|NCT02651220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6242450|NCT02651220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6242451|NCT02651220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6242452|NCT02651220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6242453|NCT02651259|Vitamins|vitamins|mesh-list
6242454|NCT02651259|Pyridoxine|pyridoxine|mesh-list
6242455|NCT02651259|Pyridoxal|pyridoxal|mesh-list
6242456|NCT02651259|Vitamin B 6|vitamin b 6|mesh-list
6242457|NCT02651259|Vitamin B Complex|vitamin b complex|mesh-list
6242458|NCT02651259|Isoniazid|isoniazid|mesh-list
6242459|NCT02651259|Rifapentine|rifapentine|mesh-list
6242460|NCT02651259|Rifamycins|rifamycins|mesh-list
6242461|NCT02651259|Hydrazine|hydrazine|mesh-list
6242462|NCT02651259|Micronutrients|micronutrients|mesh-ancestor
6242463|NCT02651259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6242464|NCT02651259|Antitubercular Agents|antitubercular agents|mesh-ancestor
6242465|NCT02651259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6242466|NCT02651259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6242467|NCT02651259|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6242468|NCT02651259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6242469|NCT02651259|Antimetabolites|antimetabolites|mesh-ancestor
6242470|NCT02651259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242471|NCT02651259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6242472|NCT02651259|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6242473|NCT02651259|Leprostatic Agents|leprostatic agents|mesh-ancestor
6242474|NCT02651259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6242475|NCT02651272|Macitentan|macitentan|mesh-list
6242476|NCT02651272|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
6242477|NCT02651272|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6242478|NCT02651272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242479|NCT02651272|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
6242480|NCT02651415|Perindopril|perindopril|mesh-list
6242481|NCT02651415|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6242482|NCT02651415|Protease Inhibitors|protease inhibitors|mesh-ancestor
6242483|NCT02651415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6242484|NCT02651415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242485|NCT02651415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6242486|NCT02651428|Taurolidine|taurolidine|mesh-list
6242487|NCT02651428|Heparin|heparin|mesh-list
6242488|NCT02651428|Calcium heparin|calcium heparin|mesh-list
6242489|NCT02651428|Anticoagulants|anticoagulants|mesh-ancestor
6242490|NCT02651428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242491|NCT02651428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6242492|NCT02651428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6242493|NCT02651428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6242494|NCT02651428|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6242495|NCT02651428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6504311|NCT00655655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6504312|NCT00655655|Immunologic Factors|immunologic factors|mesh-ancestor
6504313|NCT00655655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504314|NCT00655655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6504315|NCT00655655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6504316|NCT00655655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504317|NCT00655681|Pamidronate|pamidronate|mesh-list
5714743|NCT03250338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6504318|NCT00655681|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6504319|NCT00655681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504320|NCT00655772|Chlorine dioxide|chlorine dioxide|mesh-list
6504321|NCT00655772|Dental Disinfectants|dental disinfectants|mesh-ancestor
6504322|NCT00655772|Disinfectants|disinfectants|mesh-ancestor
6504323|NCT00655772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6504324|NCT00655785|Gemcitabine|gemcitabine|mesh-list
6504325|NCT00655785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6504326|NCT00655785|Antimetabolites|antimetabolites|mesh-ancestor
6504327|NCT00655785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504328|NCT00655785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6504329|NCT00655785|Antiviral Agents|antiviral agents|mesh-ancestor
6504330|NCT00655785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6504331|NCT00655785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6504332|NCT00655785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6504333|NCT00655785|Immunologic Factors|immunologic factors|mesh-ancestor
6504334|NCT00655785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504335|NCT00655798|Antioxidants|antioxidants|mesh-list
6504336|NCT00655798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504337|NCT00655798|Protective Agents|protective agents|mesh-ancestor
6504338|NCT00655798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504339|NCT00655824|Ofatumumab|ofatumumab|mesh-list
6504340|NCT00655824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6504341|NCT00655837|Gemcitabine|gemcitabine|mesh-list
6504342|NCT00655837|Rituximab|rituximab|mesh-list
6504343|NCT00655837|Dacetuzumab|dacetuzumab|mesh-list
6504344|NCT00655837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6504345|NCT00655837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6504346|NCT00655837|Immunologic Factors|immunologic factors|mesh-ancestor
6504347|NCT00655837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504348|NCT00655837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6504349|NCT00655837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6504350|NCT00655837|Antimetabolites|antimetabolites|mesh-ancestor
6504351|NCT00655837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504352|NCT00655837|Antiviral Agents|antiviral agents|mesh-ancestor
6504353|NCT00655837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6504354|NCT00655837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6504355|NCT00655837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6504356|NCT00655915|Betamethasone|betamethasone|mesh-list
6504357|NCT00655915|Lidocaine|lidocaine|mesh-list
6504358|NCT00655915|Anesthetics, Local|anesthetics, local|mesh-ancestor
6504359|NCT00655915|Anesthetics|anesthetics|mesh-ancestor
6504360|NCT00655915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6504361|NCT00655915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504362|NCT00655915|Sensory System Agents|sensory system agents|mesh-ancestor
6504363|NCT00655915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6504364|NCT00655915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6504365|NCT00655915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6504366|NCT00655915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6504367|NCT00655915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6504368|NCT00655915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504369|NCT00655915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6504370|NCT00655915|Glucocorticoids|glucocorticoids|mesh-ancestor
6504371|NCT00655915|Hormones|hormones|mesh-ancestor
6504372|NCT00655915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6504373|NCT00655915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6504374|NCT00655915|Respiratory System Agents|respiratory system agents|mesh-ancestor
6504375|NCT00655967|Acamprosate|acamprosate|mesh-list
6504376|NCT00655967|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6504377|NCT00655993|Simvastatin|simvastatin|mesh-list
6504378|NCT00655993|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6504379|NCT00655993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6504380|NCT00655993|Antimetabolites|antimetabolites|mesh-ancestor
6504381|NCT00655993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504382|NCT00655993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6678209|NCT01592032|Anticoagulants|anticoagulants|mesh-ancestor
5714744|NCT03250338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5714745|NCT03250338|Antimetabolites|antimetabolites|mesh-ancestor
5714746|NCT03250338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5714747|NCT03250338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5714748|NCT03250338|Immunologic Factors|immunologic factors|mesh-ancestor
5714749|NCT03250338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714750|NCT03250338|Antiviral Agents|antiviral agents|mesh-ancestor
5714751|NCT03250338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5714752|NCT03250338|Analgesics|analgesics|mesh-ancestor
5714753|NCT03250338|Sensory System Agents|sensory system agents|mesh-ancestor
5714754|NCT03250338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5714755|NCT03250338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5714756|NCT03250338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5714757|NCT03250338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5714758|NCT03250338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6504383|NCT00655993|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6504384|NCT00655993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6504385|NCT00656006|Ribavirin|ribavirin|mesh-list
6504386|NCT00656006|Antimetabolites|antimetabolites|mesh-ancestor
6504387|NCT00656006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504388|NCT00656006|Antiviral Agents|antiviral agents|mesh-ancestor
6504389|NCT00656006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6504390|NCT00656032|Cinacalcet|cinacalcet|mesh-list
6504391|NCT00656032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6504392|NCT00656032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504393|NCT00656032|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6504394|NCT00656032|Hormone Antagonists|hormone antagonists|mesh-ancestor
6504395|NCT00656032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6504396|NCT00656110|Ethanol|ethanol|mesh-list
6504397|NCT00656110|Methylprednisolone|methylprednisolone|mesh-list
6504398|NCT00656110|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6678210|NCT01592032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6504399|NCT00656110|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6504400|NCT00656110|Prednisolone|prednisolone|mesh-list
6504401|NCT00656110|Prednisolone acetate|prednisolone acetate|mesh-list
6504402|NCT00656110|Lidocaine|lidocaine|mesh-list
6504403|NCT00656110|Bupivacaine|bupivacaine|mesh-list
6504404|NCT00656110|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6504405|NCT00656110|Prednisolone phosphate|prednisolone phosphate|mesh-list
6504406|NCT00656110|Anesthetics, Local|anesthetics, local|mesh-ancestor
6504407|NCT00656110|Anesthetics|anesthetics|mesh-ancestor
6504408|NCT00656110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5714759|NCT03250104|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5714760|NCT03250104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5721920|NCT03202459|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5721921|NCT03202459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6504409|NCT00656110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504410|NCT00656110|Sensory System Agents|sensory system agents|mesh-ancestor
6504411|NCT00656110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6504412|NCT00656110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6504413|NCT00656110|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6504414|NCT00656110|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6504415|NCT00656110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6504416|NCT00656110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504417|NCT00656110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6504418|NCT00656110|Antiemetics|antiemetics|mesh-ancestor
6504419|NCT00656110|Autonomic Agents|autonomic agents|mesh-ancestor
6504420|NCT00656110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5721922|NCT03202459|Antimanic Agents|antimanic agents|mesh-ancestor
5721923|NCT03202628|Dexamethasone|dexamethasone|mesh-list
6504421|NCT00656110|Glucocorticoids|glucocorticoids|mesh-ancestor
6504422|NCT00656110|Hormones|hormones|mesh-ancestor
6504423|NCT00656110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6504424|NCT00656110|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6504425|NCT00656110|Protective Agents|protective agents|mesh-ancestor
6504426|NCT00656110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6504427|NCT00656110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6504428|NCT00656110|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6504429|NCT00656110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6504430|NCT00656123|Cyclophosphamide|cyclophosphamide|mesh-list
6504431|NCT00656123|Molgramostim|molgramostim|mesh-list
6504432|NCT00656123|Sargramostim|sargramostim|mesh-list
5721924|NCT03202628|Dexamethasone acetate|dexamethasone acetate|mesh-list
5721925|NCT03202628|Pomalidomide|pomalidomide|mesh-list
6504433|NCT00656123|Immunologic Factors|immunologic factors|mesh-ancestor
6504434|NCT00656123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504435|NCT00656123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6504436|NCT00656123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6504437|NCT00656123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6504438|NCT00656123|Alkylating Agents|alkylating agents|mesh-ancestor
6504439|NCT00656123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504440|NCT00656123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6504441|NCT00656123|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6504442|NCT00656188|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6504443|NCT00656188|Vasodilator Agents|vasodilator agents|mesh-ancestor
6504444|NCT00656188|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6504445|NCT00656188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6504446|NCT00656188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6504447|NCT00656188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504448|NCT00656188|Urological Agents|urological agents|mesh-ancestor
6504449|NCT00656214|Lycopene|lycopene|mesh-list
6504450|NCT00656214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6504451|NCT00656214|Antioxidants|antioxidants|mesh-ancestor
6504452|NCT00656214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504453|NCT00656214|Protective Agents|protective agents|mesh-ancestor
6504454|NCT00656214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504455|NCT00656214|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6504456|NCT00656214|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6504457|NCT00656214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6504458|NCT00656240|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6504459|NCT00656240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6504460|NCT00656266|Mycophenolic Acid|mycophenolic acid|mesh-list
6504461|NCT00656266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6504462|NCT00656266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6504463|NCT00656266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6504464|NCT00656266|Antitubercular Agents|antitubercular agents|mesh-ancestor
6504465|NCT00656266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6504466|NCT00656266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6504467|NCT00656266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6504468|NCT00656266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504469|NCT00656318|Contraceptive Agents|contraceptive agents|mesh-list
6504470|NCT00656318|Contraceptives, Oral|contraceptives, oral|mesh-list
6504471|NCT00656318|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
6504472|NCT00656318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6504473|NCT00656318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504474|NCT00656318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6504475|NCT00656331|Amlodipine|amlodipine|mesh-list
6504476|NCT00656331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6504477|NCT00656331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6678211|NCT01592032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6678212|NCT01592032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504478|NCT00656331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6504479|NCT00656331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504480|NCT00656331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6504481|NCT00656331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504482|NCT00656331|Vasodilator Agents|vasodilator agents|mesh-ancestor
6504483|NCT00656409|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6504484|NCT00656409|Immunologic Factors|immunologic factors|mesh-ancestor
6504485|NCT00656409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504486|NCT00656422|Insulin|insulin|mesh-list
6504487|NCT00656422|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6504488|NCT00656422|Insulin Detemir|insulin detemir|mesh-list
6504489|NCT00656422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6504490|NCT00656422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504491|NCT00656435|Bevacizumab|bevacizumab|mesh-list
6504492|NCT00656435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6504493|NCT00656435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6504494|NCT00656435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6504495|NCT00656435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6504496|NCT00656435|Growth Substances|growth substances|mesh-ancestor
6504497|NCT00656435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504498|NCT00656435|Growth Inhibitors|growth inhibitors|mesh-ancestor
6504499|NCT00656526|Lidocaine|lidocaine|mesh-list
6504500|NCT00656526|Anesthetics, Local|anesthetics, local|mesh-ancestor
6504501|NCT00656526|Anesthetics|anesthetics|mesh-ancestor
6504502|NCT00656526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6504503|NCT00656526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504504|NCT00656526|Sensory System Agents|sensory system agents|mesh-ancestor
6504505|NCT00656526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5714761|NCT03249831|Mycophenolic Acid|mycophenolic acid|mesh-list
6504506|NCT00656526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6504507|NCT00656526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6504508|NCT00656526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5714762|NCT03249831|Cyclophosphamide|cyclophosphamide|mesh-list
5714763|NCT03249831|Pentostatin|pentostatin|mesh-list
5714764|NCT03249831|Tacrolimus|tacrolimus|mesh-list
5714765|NCT03249831|Thymoglobulin|thymoglobulin|mesh-list
5714766|NCT03249831|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5714767|NCT03249831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5714768|NCT03249831|Immunologic Factors|immunologic factors|mesh-ancestor
5714769|NCT03249831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714770|NCT03249831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5714771|NCT03249831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5714772|NCT03249831|Alkylating Agents|alkylating agents|mesh-ancestor
5714773|NCT03249831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5714774|NCT03249831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5714775|NCT03249831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5714776|NCT03249831|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5714777|NCT03249831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5714778|NCT03249831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5714779|NCT03249831|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5714780|NCT03249831|Antitubercular Agents|antitubercular agents|mesh-ancestor
5714781|NCT03249831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5714782|NCT03249831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5714783|NCT03249831|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
5714784|NCT03250143|Cyclosporine|cyclosporine|mesh-list
5714785|NCT03250143|Azathioprine|azathioprine|mesh-list
5714786|NCT03250143|Cyclosporins|cyclosporins|mesh-list
5714787|NCT03250143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6504509|NCT00656526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6504510|NCT00656526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504511|NCT00656552|Citalopram|citalopram|mesh-list
6504512|NCT00656552|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6504513|NCT00656552|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6504514|NCT00656552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6504515|NCT00656552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504516|NCT00656552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6504517|NCT00656552|Serotonin Agents|serotonin agents|mesh-ancestor
6504518|NCT00656552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504519|NCT00656552|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6504520|NCT00656552|Antidepressive Agents|antidepressive agents|mesh-ancestor
6504521|NCT00656552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6504522|NCT00656591|Methotrexate|methotrexate|mesh-list
6504523|NCT00656591|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6504524|NCT00656591|Abortifacient Agents|abortifacient agents|mesh-ancestor
6504525|NCT00656591|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6504526|NCT00656591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504527|NCT00656591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6504528|NCT00656591|Antimetabolites|antimetabolites|mesh-ancestor
6504529|NCT00656591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504530|NCT00656591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6504531|NCT00656591|Dermatologic Agents|dermatologic agents|mesh-ancestor
5714788|NCT03250143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5714789|NCT03250143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5714790|NCT03250143|Immunologic Factors|immunologic factors|mesh-ancestor
5714791|NCT03250143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714792|NCT03250143|Antifungal Agents|antifungal agents|mesh-ancestor
5714793|NCT03250143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5714794|NCT03250143|Dermatologic Agents|dermatologic agents|mesh-ancestor
5919331|NCT04982809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5919332|NCT04982809|Antiemetics|antiemetics|mesh-ancestor
5919333|NCT04982809|Autonomic Agents|autonomic agents|mesh-ancestor
5919334|NCT04982809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5919335|NCT04982809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919336|NCT04982809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5919337|NCT04982809|Glucocorticoids|glucocorticoids|mesh-ancestor
5919338|NCT04982809|Hormones|hormones|mesh-ancestor
5919339|NCT04982809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5919340|NCT04982809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6504532|NCT00656591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6504533|NCT00656591|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6504534|NCT00656591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6504535|NCT00656591|Immunologic Factors|immunologic factors|mesh-ancestor
6504536|NCT00656591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6504537|NCT00656591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6504538|NCT00656643|Sirolimus|sirolimus|mesh-list
6504539|NCT00656643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6504540|NCT00656643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5714795|NCT03250143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5714796|NCT03250143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5714797|NCT03250143|Antimetabolites|antimetabolites|mesh-ancestor
5714798|NCT03250143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5714799|NCT03250143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5714800|NCT03250039|Abrocitinib|abrocitinib|mesh-list
5714801|NCT03250039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5714802|NCT03250039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5714803|NCT03250039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5714804|NCT03250052|Linagliptin|linagliptin|mesh-list
5714805|NCT03250052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5714806|NCT03250052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714807|NCT03250052|Incretins|incretins|mesh-ancestor
6504541|NCT00656643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6504542|NCT00656643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6504543|NCT00656643|Antifungal Agents|antifungal agents|mesh-ancestor
6504544|NCT00656643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6504545|NCT00656643|Immunologic Factors|immunologic factors|mesh-ancestor
6504546|NCT00656643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504547|NCT00656695|Cyclosporine|cyclosporine|mesh-list
6504548|NCT00656695|Cyclosporins|cyclosporins|mesh-list
6504549|NCT00656695|Antifungal Agents|antifungal agents|mesh-ancestor
6504550|NCT00656695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6504551|NCT00656695|Dermatologic Agents|dermatologic agents|mesh-ancestor
6504552|NCT00656695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6504553|NCT00656695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504554|NCT00656695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6504555|NCT00656695|Immunologic Factors|immunologic factors|mesh-ancestor
6504556|NCT00656695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504557|NCT00656695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6678213|NCT01592032|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6678214|NCT01592032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6678215|NCT01592110|Risperidone|risperidone|mesh-list
6678216|NCT01592110|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6678217|NCT01592110|Serotonin Agents|serotonin agents|mesh-ancestor
6678218|NCT01592110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6678219|NCT01592110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678220|NCT01592110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678221|NCT01592110|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6678222|NCT01592110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5714808|NCT03250052|Hormones|hormones|mesh-ancestor
5714809|NCT03250052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5714810|NCT03250052|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5714811|NCT03250052|Protease Inhibitors|protease inhibitors|mesh-ancestor
5714812|NCT03250052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5714813|NCT03250052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5714814|NCT03249870|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
5919341|NCT04982809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6678223|NCT01592110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6678224|NCT01592110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6678225|NCT01592110|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6678226|NCT01592110|Dopamine Agents|dopamine agents|mesh-ancestor
5919342|NCT04982809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5919343|NCT04982809|Respiratory System Agents|respiratory system agents|mesh-ancestor
5919344|NCT04982900|Aflutinib|aflutinib|mesh-list
5919345|NCT04982900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5919346|NCT04982900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5919347|NCT04982900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919348|NCT04982913|Oseltamivir|oseltamivir|mesh-list
5919349|NCT04982913|Antiviral Agents|antiviral agents|mesh-ancestor
5919350|NCT04982913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5919351|NCT04982913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5919352|NCT04982913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919353|NCT04982939|Oxaliplatin|oxaliplatin|mesh-list
5919354|NCT04982939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5919355|NCT04982692|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
5714815|NCT03249870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5714816|NCT03249870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5714817|NCT03249870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5714818|NCT03249740|Sunitinib|sunitinib|mesh-list
5714819|NCT03249740|Aflibercept|aflibercept|mesh-list
5714820|NCT03249740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5714821|NCT03249740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5714822|NCT03249740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5714823|NCT03249740|Growth Substances|growth substances|mesh-ancestor
5714824|NCT03249740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714825|NCT03249740|Growth Inhibitors|growth inhibitors|mesh-ancestor
5714826|NCT03249740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5714827|NCT03249740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5714828|NCT03249740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5714829|NCT03249506|Dapagliflozin|dapagliflozin|mesh-list
5714830|NCT03249506|Empagliflozin|empagliflozin|mesh-list
5714831|NCT03249506|Canagliflozin|canagliflozin|mesh-list
5714832|NCT03249506|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
5714833|NCT03249506|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
5714834|NCT03249506|Glucagon|glucagon|mesh-list
5714835|NCT03249506|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5714836|NCT03249506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5714837|NCT03249506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714838|NCT03249506|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5714839|NCT03249506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5714840|NCT03249506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5714841|NCT03249506|Hormones|hormones|mesh-ancestor
5714842|NCT03249506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5714843|NCT03249506|Incretins|incretins|mesh-ancestor
5714844|NCT03249506|Protease Inhibitors|protease inhibitors|mesh-ancestor
5714845|NCT03249506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5714846|NCT03249402|Levonorgestrel|levonorgestrel|mesh-list
5714847|NCT03249402|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5714848|NCT03249402|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
5714849|NCT03249402|Estradiol|estradiol|mesh-list
5714850|NCT03249402|Estrogens|estrogens|mesh-ancestor
5714851|NCT03249402|Hormones|hormones|mesh-ancestor
5714852|NCT03249402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5714853|NCT03249402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714854|NCT03249402|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6504558|NCT00656695|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6678227|NCT01592136|Ponatinib|ponatinib|mesh-list
6678228|NCT01592136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6678229|NCT01592136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6678230|NCT01592136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6678231|NCT01592136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678232|NCT01592162|Remifentanil|remifentanil|mesh-list
6678233|NCT01592162|Propofol|propofol|mesh-list
6678234|NCT01592162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6678235|NCT01592162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6678236|NCT01592162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678237|NCT01592162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6678238|NCT01592162|Anesthetics, General|anesthetics, general|mesh-ancestor
6678239|NCT01592162|Anesthetics|anesthetics|mesh-ancestor
6678240|NCT01592162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6678241|NCT01592162|Narcotics|narcotics|mesh-ancestor
6678242|NCT01592162|Analgesics|analgesics|mesh-ancestor
6678243|NCT01592162|Sensory System Agents|sensory system agents|mesh-ancestor
6678244|NCT01592162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6678245|NCT01592201|Olanzapine|olanzapine|mesh-list
6678246|NCT01592201|Risperidone|risperidone|mesh-list
6678247|NCT01592201|Aripiprazole|aripiprazole|mesh-list
6678248|NCT01592201|Antipsychotic Agents|antipsychotic agents|mesh-list
6678249|NCT01592201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6678250|NCT01592201|Serotonin Agents|serotonin agents|mesh-ancestor
6678251|NCT01592201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6678252|NCT01592201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678253|NCT01592201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678254|NCT01592201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6678255|NCT01592201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6678256|NCT01592201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6678257|NCT01592201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6678258|NCT01592201|Dopamine Agents|dopamine agents|mesh-ancestor
6678259|NCT01592201|Antiemetics|antiemetics|mesh-ancestor
6678260|NCT01592201|Autonomic Agents|autonomic agents|mesh-ancestor
6678261|NCT01592201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6504559|NCT00656747|Amoxicillin|amoxicillin|mesh-list
6504560|NCT00656747|Moxifloxacin|moxifloxacin|mesh-list
6504561|NCT00656747|Clavulanic Acids|clavulanic acids|mesh-list
6504562|NCT00656747|Clavulanic Acid|clavulanic acid|mesh-list
6504563|NCT00656747|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6504564|NCT00656747|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6504565|NCT00656747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6504566|NCT00656747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6504567|NCT00656747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6504568|NCT00656747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6504569|NCT00656747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5714855|NCT03249402|Contraceptive Agents|contraceptive agents|mesh-ancestor
5714856|NCT03249402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5714857|NCT03249402|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5714858|NCT03249402|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5714859|NCT03249402|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5714860|NCT03249402|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5714861|NCT03249402|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5714862|NCT03249558|Morphine|morphine|mesh-list
5714863|NCT03249558|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6504570|NCT00656747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504571|NCT00656747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6504572|NCT00656747|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6504573|NCT00656747|Contraceptive Agents|contraceptive agents|mesh-ancestor
6504574|NCT00656747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6504575|NCT00656747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504576|NCT00656747|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6504577|NCT00656747|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6504578|NCT00656747|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6504579|NCT00656747|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6504580|NCT00656773|Sufentanil|sufentanil|mesh-list
6504581|NCT00656773|Morphine|morphine|mesh-list
6504582|NCT00656773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6504583|NCT00656773|Narcotics|narcotics|mesh-ancestor
6504584|NCT00656773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6504585|NCT00656773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504586|NCT00656773|Analgesics|analgesics|mesh-ancestor
6504587|NCT00656773|Sensory System Agents|sensory system agents|mesh-ancestor
6504588|NCT00656773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6504589|NCT00656773|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6504590|NCT00656773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6504591|NCT00656773|Anesthetics, General|anesthetics, general|mesh-ancestor
6504592|NCT00656773|Anesthetics|anesthetics|mesh-ancestor
6504593|NCT00656786|Vitamin K 3|vitamin k 3|mesh-list
6504594|NCT00656786|Vitamin K|vitamin k|mesh-list
6504595|NCT00656786|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6504596|NCT00656786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6504597|NCT00656786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504598|NCT00656786|Hemostatics|hemostatics|mesh-ancestor
6504599|NCT00656786|Coagulants|coagulants|mesh-ancestor
6504600|NCT00656786|Vitamins|vitamins|mesh-ancestor
6504601|NCT00656786|Micronutrients|micronutrients|mesh-ancestor
6504602|NCT00656786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504603|NCT00656812|Rituximab|rituximab|mesh-list
6504604|NCT00656812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6504605|NCT00656812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6504606|NCT00656812|Immunologic Factors|immunologic factors|mesh-ancestor
6504607|NCT00656812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504608|NCT00656812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6504609|NCT00656864|Pioglitazone|pioglitazone|mesh-list
6504610|NCT00656864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6504611|NCT00656864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504612|NCT00656929|Vitamin D|vitamin d|mesh-list
5714864|NCT03249558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6504613|NCT00656929|Cholecalciferol|cholecalciferol|mesh-list
6504614|NCT00656929|Vitamins|vitamins|mesh-ancestor
6504615|NCT00656929|Micronutrients|micronutrients|mesh-ancestor
6504616|NCT00656929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504617|NCT00656929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6504618|NCT00656929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6504619|NCT00657007|Belimumab|belimumab|mesh-list
6504620|NCT00657007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6504621|NCT00657007|Immunologic Factors|immunologic factors|mesh-ancestor
6504622|NCT00657007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504623|NCT00657033|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6504624|NCT00657033|Vasodilator Agents|vasodilator agents|mesh-ancestor
6504625|NCT00657033|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6504626|NCT00657033|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6504627|NCT00657033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6504628|NCT00657033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504629|NCT00657033|Urological Agents|urological agents|mesh-ancestor
6504630|NCT00657059|Mycophenolic Acid|mycophenolic acid|mesh-list
6504631|NCT00657059|Prednisone|prednisone|mesh-list
6504632|NCT00657059|Methylprednisolone|methylprednisolone|mesh-list
6504633|NCT00657059|Irbesartan|irbesartan|mesh-list
6504634|NCT00657059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6504635|NCT00657059|Glucocorticoids|glucocorticoids|mesh-ancestor
6504636|NCT00657059|Hormones|hormones|mesh-ancestor
6504637|NCT00657059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6504638|NCT00657059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504639|NCT00657059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6504640|NCT00657059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6504641|NCT00657059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6504642|NCT00657059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5714865|NCT03249558|Narcotics|narcotics|mesh-ancestor
5714866|NCT03249558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5714867|NCT03249558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714868|NCT03249558|Analgesics|analgesics|mesh-ancestor
5714869|NCT03249558|Sensory System Agents|sensory system agents|mesh-ancestor
5714870|NCT03249558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5714871|NCT03249558|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5714872|NCT03249558|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5714873|NCT03249558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5714874|NCT03249558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5714875|NCT03249558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5714876|NCT03249558|Antidepressive Agents|antidepressive agents|mesh-ancestor
5714877|NCT03249558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5714878|NCT03249558|Dopamine Agents|dopamine agents|mesh-ancestor
5714879|NCT03249662|Bupivacaine|bupivacaine|mesh-list
5714880|NCT03249662|Anesthetics, Local|anesthetics, local|mesh-ancestor
5714881|NCT03249662|Anesthetics|anesthetics|mesh-ancestor
5714882|NCT03249662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5714883|NCT03249662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714884|NCT03249662|Sensory System Agents|sensory system agents|mesh-ancestor
6504643|NCT00657059|Antitubercular Agents|antitubercular agents|mesh-ancestor
6504644|NCT00657059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6504645|NCT00657059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6504646|NCT00657059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6504647|NCT00657059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504648|NCT00657059|Antiemetics|antiemetics|mesh-ancestor
6504649|NCT00657059|Autonomic Agents|autonomic agents|mesh-ancestor
6504650|NCT00657059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6504651|NCT00657059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6504652|NCT00657059|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6504653|NCT00657059|Protective Agents|protective agents|mesh-ancestor
6504654|NCT00657059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6678262|NCT01592201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6678263|NCT01592201|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5714885|NCT03249662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5714886|NCT03249311|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5714887|NCT03249311|Milnacipran|milnacipran|mesh-list
5714888|NCT03249311|Levomilnacipran|levomilnacipran|mesh-list
5714889|NCT03249311|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5714890|NCT03249311|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5714891|NCT03249311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5714892|NCT03249311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5714893|NCT03249311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5714894|NCT03249311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714895|NCT03249311|Analgesics|analgesics|mesh-ancestor
5714896|NCT03249311|Sensory System Agents|sensory system agents|mesh-ancestor
5714897|NCT03249311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5714898|NCT03249311|Antidepressive Agents|antidepressive agents|mesh-ancestor
5714899|NCT03249311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5714900|NCT03249311|Dopamine Agents|dopamine agents|mesh-ancestor
5714901|NCT03249311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5714902|NCT03249285|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5714903|NCT03249285|Perindopril|perindopril|mesh-list
5714904|NCT03249285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5714905|NCT03249285|Diuretics|diuretics|mesh-ancestor
6504655|NCT00657059|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6504656|NCT00657059|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6504657|NCT00657137|Capecitabine|capecitabine|mesh-list
6504658|NCT00657137|Lapatinib|lapatinib|mesh-list
6504659|NCT00657137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6504660|NCT00657137|Antimetabolites|antimetabolites|mesh-ancestor
6504661|NCT00657137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504662|NCT00657137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6678264|NCT01592201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6678265|NCT01592201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6678266|NCT01592201|Antidepressive Agents|antidepressive agents|mesh-ancestor
6678267|NCT01592201|Dopamine Agonists|dopamine agonists|mesh-ancestor
6678268|NCT01592201|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6678269|NCT01592201|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5714906|NCT03249285|Natriuretic Agents|natriuretic agents|mesh-ancestor
5714907|NCT03249285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714908|NCT03249285|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5714909|NCT03249285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5714910|NCT03249285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5714911|NCT03249285|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5714912|NCT03249285|Protease Inhibitors|protease inhibitors|mesh-ancestor
5714913|NCT03249285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5714914|NCT03249428|Nicotine|nicotine|mesh-list
5714915|NCT03249428|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6678270|NCT01592201|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6678271|NCT01592201|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6678272|NCT01592214|Benzocaine|benzocaine|mesh-list
6678273|NCT01592214|Anesthetics, Local|anesthetics, local|mesh-ancestor
6678274|NCT01592214|Anesthetics|anesthetics|mesh-ancestor
6678275|NCT01592214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6678276|NCT01592214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714916|NCT03249428|Autonomic Agents|autonomic agents|mesh-ancestor
6504663|NCT00657137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6504664|NCT00657137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6504665|NCT00657163|Fluoxetine|fluoxetine|mesh-list
6504666|NCT00657163|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6504667|NCT00657163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6504668|NCT00657163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6504669|NCT00657163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504670|NCT00657163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6504671|NCT00657163|Serotonin Agents|serotonin agents|mesh-ancestor
6504672|NCT00657163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504673|NCT00657163|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6504674|NCT00657163|Antidepressive Agents|antidepressive agents|mesh-ancestor
6504675|NCT00657163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6504676|NCT00657163|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6504677|NCT00657163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6504678|NCT00657163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6504679|NCT00657202|Ranibizumab|ranibizumab|mesh-list
6504680|NCT00657202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6504681|NCT00657202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6504682|NCT00657202|Growth Substances|growth substances|mesh-ancestor
6504683|NCT00657202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504684|NCT00657202|Growth Inhibitors|growth inhibitors|mesh-ancestor
6504685|NCT00657202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6504686|NCT00657228|Heparin|heparin|mesh-list
6504687|NCT00657228|Anticoagulants|anticoagulants|mesh-ancestor
6504688|NCT00657228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6504689|NCT00657228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6504690|NCT00657228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504691|NCT00657241|Valsartan|valsartan|mesh-list
6504692|NCT00657241|Carvedilol|carvedilol|mesh-list
6504693|NCT00657241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6504694|NCT00657241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6504695|NCT00657241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6504696|NCT00657241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504697|NCT00657241|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6504698|NCT00657241|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6504699|NCT00657241|Adrenergic Agents|adrenergic agents|mesh-ancestor
6504700|NCT00657241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6504701|NCT00657241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504702|NCT00657241|Antioxidants|antioxidants|mesh-ancestor
5714917|NCT03249428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5714918|NCT03249428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714919|NCT03249428|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5714920|NCT03249428|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5714921|NCT03249428|Cholinergic Agents|cholinergic agents|mesh-ancestor
5714922|NCT03249428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5714923|NCT03249428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5714924|NCT03249519|Cisplatin|cisplatin|mesh-list
5714925|NCT03249519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5714926|NCT03249337|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5714927|NCT03249337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6504703|NCT00657241|Protective Agents|protective agents|mesh-ancestor
6504704|NCT00657241|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6504705|NCT00657241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6504706|NCT00657241|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6504707|NCT00657241|Vasodilator Agents|vasodilator agents|mesh-ancestor
6504708|NCT00657241|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6504709|NCT00657241|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6504710|NCT00657254|Sorafenib|sorafenib|mesh-list
6504711|NCT00657254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6504712|NCT00657254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6504713|NCT00657254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6504714|NCT00657254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504715|NCT00657306|Hydrocortisone|hydrocortisone|mesh-list
6504716|NCT00657306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6504717|NCT00657319|Insulin Aspart|insulin aspart|mesh-list
6504718|NCT00657319|Biphasic Insulins|biphasic insulins|mesh-list
6504719|NCT00657319|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6504720|NCT00657319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6504721|NCT00657319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504722|NCT00657384|Tranexamic Acid|tranexamic acid|mesh-list
6504723|NCT00657384|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6504724|NCT00657384|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6504725|NCT00657384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504726|NCT00657384|Hemostatics|hemostatics|mesh-ancestor
6504727|NCT00657384|Coagulants|coagulants|mesh-ancestor
6504728|NCT00657397|Methadone|methadone|mesh-list
6504729|NCT00657397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6504730|NCT00657397|Narcotics|narcotics|mesh-ancestor
6504731|NCT00657397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5714928|NCT03249298|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
5714929|NCT03249298|Plasma Substitutes|plasma substitutes|mesh-ancestor
5714930|NCT03249298|Blood Substitutes|blood substitutes|mesh-ancestor
5714931|NCT03249259|Choline|choline|mesh-list
5714932|NCT03249259|Lipotropic Agents|lipotropic agents|mesh-ancestor
5714933|NCT03249259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5714934|NCT03249259|Antimetabolites|antimetabolites|mesh-ancestor
5714935|NCT03249259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5714936|NCT03249259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5714937|NCT03249259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5714938|NCT03249259|Nootropic Agents|nootropic agents|mesh-ancestor
5714939|NCT03249194|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
5714940|NCT03249194|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
5714941|NCT03249194|Antiviral Agents|antiviral agents|mesh-list
5714942|NCT03249194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6504732|NCT00657397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504733|NCT00657397|Analgesics|analgesics|mesh-ancestor
6504734|NCT00657397|Sensory System Agents|sensory system agents|mesh-ancestor
6504735|NCT00657397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6504736|NCT00657397|Antitussive Agents|antitussive agents|mesh-ancestor
6504737|NCT00657397|Respiratory System Agents|respiratory system agents|mesh-ancestor
6504738|NCT00657410|Dexamethasone|dexamethasone|mesh-list
6504739|NCT00657410|Prednisone|prednisone|mesh-list
6504740|NCT00657410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6504741|NCT00657410|Antiemetics|antiemetics|mesh-ancestor
6504742|NCT00657410|Autonomic Agents|autonomic agents|mesh-ancestor
6504743|NCT00657410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6504744|NCT00657410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504745|NCT00657410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6504746|NCT00657410|Glucocorticoids|glucocorticoids|mesh-ancestor
6504747|NCT00657410|Hormones|hormones|mesh-ancestor
6504748|NCT00657410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6504749|NCT00657410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5714943|NCT03249181|Dolutegravir|dolutegravir|mesh-list
6504750|NCT00657410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6504751|NCT00657423|Cisplatin|cisplatin|mesh-list
6504752|NCT00657423|Docetaxel|docetaxel|mesh-list
6504753|NCT00657423|Endostar protein|endostar protein|mesh-list
6504754|NCT00657423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6504755|NCT00657423|Tubulin Modulators|tubulin modulators|mesh-ancestor
6504756|NCT00657423|Antimitotic Agents|antimitotic agents|mesh-ancestor
6504757|NCT00657423|Mitosis Modulators|mitosis modulators|mesh-ancestor
6504758|NCT00657423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504759|NCT00657423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6504760|NCT00657423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6504761|NCT00657423|Growth Substances|growth substances|mesh-ancestor
6504762|NCT00657423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504763|NCT00657423|Growth Inhibitors|growth inhibitors|mesh-ancestor
6504764|NCT00657449|Valdecoxib|valdecoxib|mesh-list
6504765|NCT00657449|Rofecoxib|rofecoxib|mesh-list
6504766|NCT00657449|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6504767|NCT00657449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6504768|NCT00657449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6504769|NCT00657449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504770|NCT00657449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5714944|NCT03249181|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5714945|NCT03249181|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5714946|NCT03249181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5714947|NCT03249181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5714948|NCT03249181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6504771|NCT00657449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6504772|NCT00657449|Analgesics|analgesics|mesh-ancestor
6504773|NCT00657449|Sensory System Agents|sensory system agents|mesh-ancestor
6504774|NCT00657449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6504775|NCT00657449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504776|NCT00657449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6504777|NCT00657449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6504778|NCT00657475|Heparin|heparin|mesh-list
6504779|NCT00657475|Calcium heparin|calcium heparin|mesh-list
6504780|NCT00657475|Anticoagulants|anticoagulants|mesh-ancestor
6504781|NCT00657475|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6504782|NCT00657475|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6504783|NCT00657475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504784|NCT00657488|Thalidomide|thalidomide|mesh-list
6504785|NCT00657488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6504786|NCT00657488|Immunologic Factors|immunologic factors|mesh-ancestor
6504787|NCT00657488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504788|NCT00657488|Leprostatic Agents|leprostatic agents|mesh-ancestor
6504789|NCT00657488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6504790|NCT00657488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6504791|NCT00657488|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6504792|NCT00657488|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6504793|NCT00657488|Growth Substances|growth substances|mesh-ancestor
6504794|NCT00657488|Growth Inhibitors|growth inhibitors|mesh-ancestor
6504795|NCT00657488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6504796|NCT00657514|Ranolazine|ranolazine|mesh-list
6504797|NCT00657514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6504798|NCT00657514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6504799|NCT00657514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504800|NCT00657527|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6504801|NCT00657527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6504802|NCT00657527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6504803|NCT00657527|Antimetabolites|antimetabolites|mesh-ancestor
6504804|NCT00657527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504805|NCT00657527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6504806|NCT00657527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6504807|NCT00657527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6504808|NCT00657566|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6504809|NCT00657566|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6504810|NCT00657566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6504811|NCT00657566|Antitubercular Agents|antitubercular agents|mesh-ancestor
6504812|NCT00657579|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6504813|NCT00657579|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6504814|NCT00657644|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6504815|NCT00657644|Vasodilator Agents|vasodilator agents|mesh-ancestor
6504816|NCT00657644|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6504817|NCT00657644|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6504818|NCT00657644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6504819|NCT00657644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504820|NCT00657644|Urological Agents|urological agents|mesh-ancestor
6504821|NCT00657748|Triacetin|triacetin|mesh-list
6504822|NCT00657748|Lithium Carbonate|lithium carbonate|mesh-list
6504823|NCT00657748|Antidepressive Agents|antidepressive agents|mesh-ancestor
6504824|NCT00657748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6504825|NCT00657748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6504826|NCT00657748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504827|NCT00657748|Antimanic Agents|antimanic agents|mesh-ancestor
6504828|NCT00657748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6504829|NCT00657748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6504830|NCT00657748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504831|NCT00657748|Antifungal Agents|antifungal agents|mesh-ancestor
6504832|NCT00657748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6504833|NCT00657761|Enfuvirtide|enfuvirtide|mesh-list
6504834|NCT00657761|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6504835|NCT00657761|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6504836|NCT00657761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504837|NCT00657761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6504838|NCT00657761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6504839|NCT00657761|Antiviral Agents|antiviral agents|mesh-ancestor
6504840|NCT00657761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5714949|NCT03249181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5714950|NCT03249181|Antiviral Agents|antiviral agents|mesh-ancestor
5714951|NCT03249181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5714952|NCT03249012|Calcium, Dietary|calcium, dietary|mesh-list
5714953|NCT03249012|Calcitriol|calcitriol|mesh-list
5714954|NCT03249012|Calcium Carbonate|calcium carbonate|mesh-list
5714955|NCT03249012|Calcium|calcium|mesh-list
5714956|NCT03249012|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5714957|NCT03249012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714958|NCT03249012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5714959|NCT03249012|Antacids|antacids|mesh-ancestor
5714960|NCT03249012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504841|NCT00657774|Prednisone|prednisone|mesh-list
6504842|NCT00657774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6504843|NCT00657774|Glucocorticoids|glucocorticoids|mesh-ancestor
6504844|NCT00657774|Hormones|hormones|mesh-ancestor
6504845|NCT00657774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6504846|NCT00657774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504847|NCT00657774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6504848|NCT00657774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6504849|NCT00657839|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6504850|NCT00657839|Vasodilator Agents|vasodilator agents|mesh-ancestor
6504851|NCT00657839|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6504852|NCT00657839|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6504853|NCT00657839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6504854|NCT00657839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504855|NCT00657839|Urological Agents|urological agents|mesh-ancestor
6504856|NCT00657852|Pamidronate|pamidronate|mesh-list
6504857|NCT00657852|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6504858|NCT00657852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504859|NCT00657865|Ramipril|ramipril|mesh-list
6504860|NCT00657865|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6504861|NCT00657865|Protease Inhibitors|protease inhibitors|mesh-ancestor
6504862|NCT00657865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6504863|NCT00657865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504864|NCT00657865|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6504865|NCT00657878|Gemcitabine|gemcitabine|mesh-list
5714961|NCT03249012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5714962|NCT03249012|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6504866|NCT00657878|Paclitaxel|paclitaxel|mesh-list
6504867|NCT00657878|Carboplatin|carboplatin|mesh-list
6504868|NCT00657878|Doxorubicin|doxorubicin|mesh-list
6504869|NCT00657878|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5714963|NCT03249012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5714964|NCT03249012|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5714965|NCT03249012|Vitamins|vitamins|mesh-ancestor
5714966|NCT03249012|Micronutrients|micronutrients|mesh-ancestor
5714967|NCT03249168|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5714968|NCT03249168|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5714969|NCT03249168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6504870|NCT00657878|Topotecan|topotecan|mesh-list
6504871|NCT00657878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6504872|NCT00657878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5714970|NCT03249168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5714971|NCT03249168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5714972|NCT03249168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5714973|NCT03249168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714974|NCT03249168|Analgesics|analgesics|mesh-ancestor
5714975|NCT03249168|Sensory System Agents|sensory system agents|mesh-ancestor
5714976|NCT03249168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5714977|NCT03249168|Antidepressive Agents|antidepressive agents|mesh-ancestor
5714978|NCT03249168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5714979|NCT03249168|Dopamine Agents|dopamine agents|mesh-ancestor
5714980|NCT03248856|Triamcinolone|triamcinolone|mesh-list
5714981|NCT03248856|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5714982|NCT03248856|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6504873|NCT00657878|Tubulin Modulators|tubulin modulators|mesh-ancestor
6504874|NCT00657878|Antimitotic Agents|antimitotic agents|mesh-ancestor
6678277|NCT01592214|Sensory System Agents|sensory system agents|mesh-ancestor
6678278|NCT01592214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5714983|NCT03248856|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5714984|NCT03248856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5714985|NCT03248856|Glucocorticoids|glucocorticoids|mesh-ancestor
6504875|NCT00657878|Mitosis Modulators|mitosis modulators|mesh-ancestor
5714986|NCT03248856|Hormones|hormones|mesh-ancestor
6504876|NCT00657878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504877|NCT00657878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6504878|NCT00657878|Antimetabolites|antimetabolites|mesh-ancestor
6504879|NCT00657878|Antiviral Agents|antiviral agents|mesh-ancestor
6504880|NCT00657878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6504881|NCT00657878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6504882|NCT00657878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6504883|NCT00657878|Immunologic Factors|immunologic factors|mesh-ancestor
6504884|NCT00657878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504885|NCT00657878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6504886|NCT00657878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6504887|NCT00657878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6504888|NCT00657878|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6504889|NCT00657891|Omalizumab|omalizumab|mesh-list
6504890|NCT00657891|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6504891|NCT00657891|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6504892|NCT00657891|Respiratory System Agents|respiratory system agents|mesh-ancestor
6504893|NCT00657904|Bicalutamide|bicalutamide|mesh-list
6504894|NCT00657904|Androgen Antagonists|androgen antagonists|mesh-ancestor
5714987|NCT03248856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5714988|NCT03248856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714989|NCT03248856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5714990|NCT03248856|Immunologic Factors|immunologic factors|mesh-ancestor
5714991|NCT03248856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5714992|NCT03248856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5714993|NCT03249025|Lidocaine|lidocaine|mesh-list
5714994|NCT03249025|Ketamine|ketamine|mesh-list
5714995|NCT03249025|Anesthetics, Local|anesthetics, local|mesh-ancestor
5714996|NCT03249025|Anesthetics|anesthetics|mesh-ancestor
5714997|NCT03249025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5714998|NCT03249025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5714999|NCT03249025|Sensory System Agents|sensory system agents|mesh-ancestor
5715000|NCT03249025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5919356|NCT04982692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5919357|NCT04982692|Immunologic Factors|immunologic factors|mesh-ancestor
5919358|NCT04982692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919359|NCT04982549|Paclitaxel|paclitaxel|mesh-list
5919360|NCT04982549|Carboplatin|carboplatin|mesh-list
5919361|NCT04982549|Pemetrexed|pemetrexed|mesh-list
5919362|NCT04982549|Durvalumab|durvalumab|mesh-list
5919363|NCT04982549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5919364|NCT04982549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5919365|NCT04982549|Tubulin Modulators|tubulin modulators|mesh-ancestor
5919366|NCT04982549|Antimitotic Agents|antimitotic agents|mesh-ancestor
5919367|NCT04982549|Mitosis Modulators|mitosis modulators|mesh-ancestor
5919368|NCT04982549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919369|NCT04982549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5919370|NCT04982549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5919371|NCT04982549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5919372|NCT04982549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5919373|NCT04981912|Rituximab|rituximab|mesh-list
5919374|NCT04981912|Venetoclax|venetoclax|mesh-list
5919375|NCT04981912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6504895|NCT00657904|Hormone Antagonists|hormone antagonists|mesh-ancestor
6504896|NCT00657904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6504897|NCT00657904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504898|NCT00657904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6504899|NCT00657930|Insulin Detemir|insulin detemir|mesh-list
6504900|NCT00657930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6504901|NCT00657930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504902|NCT00657943|Insulin|insulin|mesh-list
6504903|NCT00657943|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6504904|NCT00657943|Metformin|metformin|mesh-list
6504905|NCT00657943|Insulin Aspart|insulin aspart|mesh-list
6242496|NCT02651584|Buprenorphine|buprenorphine|mesh-list
6242497|NCT02651584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6242498|NCT02651584|Narcotics|narcotics|mesh-ancestor
6242499|NCT02651584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6242500|NCT02651584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6242501|NCT02651584|Analgesics|analgesics|mesh-ancestor
6242502|NCT02651584|Sensory System Agents|sensory system agents|mesh-ancestor
6242503|NCT02651584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6242504|NCT02651584|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6242505|NCT02651688|Enclomiphene|enclomiphene|mesh-list
6242506|NCT02651688|Clomiphene|clomiphene|mesh-list
6242507|NCT02651688|Zuclomiphene|zuclomiphene|mesh-list
6242508|NCT02651688|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6242509|NCT02651688|Hormone Antagonists|hormone antagonists|mesh-ancestor
6242510|NCT02651688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6242511|NCT02651688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6242512|NCT02651688|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6242513|NCT02651688|Fertility Agents|fertility agents|mesh-ancestor
6242514|NCT02651688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6242515|NCT02651688|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6242516|NCT02651688|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6242517|NCT02651987|Lanreotide|lanreotide|mesh-list
6242518|NCT02651987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6242519|NCT02652156|Bupivacaine|bupivacaine|mesh-list
6242520|NCT02652156|Ropivacaine|ropivacaine|mesh-list
6242521|NCT02652156|Anesthetics, Local|anesthetics, local|mesh-ancestor
6242522|NCT02652156|Anesthetics|anesthetics|mesh-ancestor
6242523|NCT02652156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6242524|NCT02652156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6242525|NCT02652156|Sensory System Agents|sensory system agents|mesh-ancestor
6242526|NCT02652156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6242527|NCT02652260|Tenofovir|tenofovir|mesh-list
6242528|NCT02652260|Lamivudine|lamivudine|mesh-list
6242529|NCT02652260|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6242530|NCT02652260|Antiviral Agents|antiviral agents|mesh-ancestor
6242531|NCT02652260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6242532|NCT02652260|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6242533|NCT02652260|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6242534|NCT02652260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6242535|NCT02652260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242536|NCT02652260|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6242537|NCT02652260|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6242538|NCT02652390|Methylprednisolone|methylprednisolone|mesh-list
6242539|NCT02652390|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6242540|NCT02652390|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6242541|NCT02652390|Prednisolone|prednisolone|mesh-list
6242542|NCT02652390|Prednisolone acetate|prednisolone acetate|mesh-list
6242543|NCT02652390|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6242544|NCT02652390|Prednisolone phosphate|prednisolone phosphate|mesh-list
6242545|NCT02652390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6242546|NCT02652390|Antiemetics|antiemetics|mesh-ancestor
6242547|NCT02652390|Autonomic Agents|autonomic agents|mesh-ancestor
6242548|NCT02652390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6242549|NCT02652390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6242550|NCT02652390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6242551|NCT02652390|Glucocorticoids|glucocorticoids|mesh-ancestor
6242552|NCT02652390|Hormones|hormones|mesh-ancestor
6242553|NCT02652390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6242554|NCT02652390|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6242555|NCT02652390|Protective Agents|protective agents|mesh-ancestor
6242556|NCT02652390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6242557|NCT02652390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6504906|NCT00657943|Insulin, Long-Acting|insulin, long-acting|mesh-list
6504907|NCT00657943|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6504908|NCT00657943|Insulin Detemir|insulin detemir|mesh-list
6504909|NCT00657943|Protamines|protamines|mesh-list
6504910|NCT00657943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6504911|NCT00657943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504912|NCT00657943|Heparin Antagonists|heparin antagonists|mesh-ancestor
6504913|NCT00657943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504914|NCT00657943|Coagulants|coagulants|mesh-ancestor
6504915|NCT00657982|Everolimus|everolimus|mesh-list
6504916|NCT00657982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6504917|NCT00657982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6504918|NCT00657982|Immunologic Factors|immunologic factors|mesh-ancestor
6504919|NCT00657982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504920|NCT00657995|Pancrelipase|pancrelipase|mesh-list
6504921|NCT00657995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6504922|NCT00658099|Insulin|insulin|mesh-list
6504923|NCT00658099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6504924|NCT00658099|Insulin Detemir|insulin detemir|mesh-list
6504925|NCT00658099|Isophane Insulin, Human|isophane insulin, human|mesh-list
6504926|NCT00658099|Insulin, Isophane|insulin, isophane|mesh-list
6504927|NCT00658099|Isophane insulin, beef|isophane insulin, beef|mesh-list
6504928|NCT00658099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6504929|NCT00658099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504930|NCT00658177|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6504931|NCT00658177|Vasodilator Agents|vasodilator agents|mesh-ancestor
6504932|NCT00658177|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6504933|NCT00658177|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6504934|NCT00658177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6504935|NCT00658177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504936|NCT00658177|Urological Agents|urological agents|mesh-ancestor
6504937|NCT00658255|Budesonide|budesonide|mesh-list
6504938|NCT00658255|Formoterol Fumarate|formoterol fumarate|mesh-list
6504939|NCT00658255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6504940|NCT00658255|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6504941|NCT00658255|Autonomic Agents|autonomic agents|mesh-ancestor
6504942|NCT00658255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6504943|NCT00658255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715001|NCT03249025|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5715002|NCT03249025|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6504944|NCT00658255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6504945|NCT00658255|Respiratory System Agents|respiratory system agents|mesh-ancestor
6678279|NCT01592227|Acetaminophen|acetaminophen|mesh-list
6678280|NCT01592227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6678281|NCT01592227|Analgesics|analgesics|mesh-ancestor
6678282|NCT01592227|Sensory System Agents|sensory system agents|mesh-ancestor
6678283|NCT01592227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6678284|NCT01592227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678285|NCT01592227|Antipyretics|antipyretics|mesh-ancestor
6678286|NCT01592253|Sirolimus|sirolimus|mesh-list
6678287|NCT01592253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6678288|NCT01592253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6678289|NCT01592253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6678290|NCT01592253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5715003|NCT03249025|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5715004|NCT03249025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5715005|NCT03249025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715006|NCT03249025|Analgesics|analgesics|mesh-ancestor
6504946|NCT00658255|Glucocorticoids|glucocorticoids|mesh-ancestor
6678291|NCT01592253|Antifungal Agents|antifungal agents|mesh-ancestor
6678292|NCT01592253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6504947|NCT00658255|Hormones|hormones|mesh-ancestor
6504948|NCT00658255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6504949|NCT00658255|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6504950|NCT00658255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6504951|NCT00658255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6504952|NCT00658255|Adrenergic Agents|adrenergic agents|mesh-ancestor
6504953|NCT00658255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6504954|NCT00658255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504955|NCT00658268|Clodronic Acid|clodronic acid|mesh-list
6504956|NCT00658268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6504957|NCT00658268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504958|NCT00658463|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6678293|NCT01592253|Immunologic Factors|immunologic factors|mesh-ancestor
6678294|NCT01592253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504959|NCT00658463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5715007|NCT03249025|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5715008|NCT03249025|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5715009|NCT03249025|Anesthetics, General|anesthetics, general|mesh-ancestor
6504960|NCT00658463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6504961|NCT00658463|Antimetabolites|antimetabolites|mesh-ancestor
6504962|NCT00658463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504963|NCT00658463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6504964|NCT00658463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6504965|NCT00658463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6678295|NCT01592279|Liraglutide|liraglutide|mesh-list
6678296|NCT01592279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6678297|NCT01592279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678298|NCT01592279|Incretins|incretins|mesh-ancestor
6678299|NCT01592279|Hormones|hormones|mesh-ancestor
6678300|NCT01592279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6779709|NCT02180529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779710|NCT02180529|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6779711|NCT02180529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6779712|NCT02180529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6779713|NCT02180529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779714|NCT02180529|Dopamine Agents|dopamine agents|mesh-ancestor
6779715|NCT02180529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6779716|NCT02180568|Ethiodized Oil|ethiodized oil|mesh-list
6779717|NCT02180568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6779718|NCT02180711|Rituximab|rituximab|mesh-list
6779719|NCT02180711|Lenalidomide|lenalidomide|mesh-list
6779720|NCT02180711|Acalabrutinib|acalabrutinib|mesh-list
6779721|NCT02180711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6779722|NCT02180711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6779723|NCT02180711|Immunologic Factors|immunologic factors|mesh-ancestor
6779724|NCT02180711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779725|NCT02180711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6779726|NCT02180711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6779727|NCT02180711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6779728|NCT02180711|Growth Substances|growth substances|mesh-ancestor
6779729|NCT02180711|Growth Inhibitors|growth inhibitors|mesh-ancestor
6779730|NCT02180737|Dexmedetomidine|dexmedetomidine|mesh-list
6779731|NCT02180737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6779732|NCT02180737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6779733|NCT02180737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779734|NCT02180737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6779735|NCT02180737|Analgesics|analgesics|mesh-ancestor
6779736|NCT02180737|Sensory System Agents|sensory system agents|mesh-ancestor
5715010|NCT03249025|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5721926|NCT03202628|Ixazomib|ixazomib|mesh-list
6779737|NCT02180737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6779738|NCT02180737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6779739|NCT02180737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6779740|NCT02180737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6779741|NCT02180737|Adrenergic Agents|adrenergic agents|mesh-ancestor
6779742|NCT02180737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6779743|NCT02180737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779744|NCT02180789|Tamsulosin|tamsulosin|mesh-list
6779745|NCT02180789|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6779746|NCT02180789|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6779747|NCT02180789|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6779748|NCT02180789|Adrenergic Agents|adrenergic agents|mesh-ancestor
6779749|NCT02180789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6779750|NCT02180789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779751|NCT02180789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779752|NCT02180789|Urological Agents|urological agents|mesh-ancestor
6779753|NCT02180880|Pregabalin|pregabalin|mesh-list
6779754|NCT02180880|Oxcarbazepine|oxcarbazepine|mesh-list
6779755|NCT02180880|Analgesics|analgesics|mesh-ancestor
6779756|NCT02180880|Sensory System Agents|sensory system agents|mesh-ancestor
6779757|NCT02180880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6779758|NCT02180880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779759|NCT02180880|Anticonvulsants|anticonvulsants|mesh-ancestor
6779760|NCT02180880|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6779761|NCT02180880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6779762|NCT02180880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779763|NCT02180880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6504966|NCT00658580|Etoposide|etoposide|mesh-list
6504967|NCT00658580|Etoposide phosphate|etoposide phosphate|mesh-list
5715011|NCT03249025|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5715012|NCT03249025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5715013|NCT03249142|Durvalumab|durvalumab|mesh-list
5715014|NCT03249142|Tremelimumab|tremelimumab|mesh-list
5715015|NCT03249142|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5715016|NCT03249142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5715017|NCT03249142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5715018|NCT03249142|Immunologic Factors|immunologic factors|mesh-ancestor
6504968|NCT00658580|Epirubicin|epirubicin|mesh-list
6504969|NCT00658580|Ifosfamide|ifosfamide|mesh-list
6504970|NCT00658580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6504971|NCT00658580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6504972|NCT00658580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6504973|NCT00658580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6504974|NCT00658580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6504975|NCT00658580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504976|NCT00658580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6504977|NCT00658580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6504978|NCT00658580|Alkylating Agents|alkylating agents|mesh-ancestor
6504979|NCT00658593|Gemcitabine|gemcitabine|mesh-list
6504980|NCT00658593|Capecitabine|capecitabine|mesh-list
6504981|NCT00658593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6504982|NCT00658593|Antimetabolites|antimetabolites|mesh-ancestor
6504983|NCT00658593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6504984|NCT00658593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6504985|NCT00658593|Antiviral Agents|antiviral agents|mesh-ancestor
6504986|NCT00658593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6504987|NCT00658593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6678301|NCT01592305|Ritonavir|ritonavir|mesh-list
6678302|NCT01592305|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6678303|NCT01592305|Tenofovir|tenofovir|mesh-list
6678304|NCT01592305|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5715019|NCT03249142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715020|NCT03248726|Bisacodyl|bisacodyl|mesh-list
5715021|NCT03248726|Cathartics|cathartics|mesh-ancestor
5715022|NCT03248726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5715023|NCT03248726|Laxatives|laxatives|mesh-ancestor
5715024|NCT03249207|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5715025|NCT03249207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5715026|NCT03248765|Analgesics, Opioid|analgesics, opioid|mesh-list
5715027|NCT03248765|Narcotics|narcotics|mesh-ancestor
5715028|NCT03248765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5715029|NCT03248765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715030|NCT03248765|Analgesics|analgesics|mesh-ancestor
5715031|NCT03248765|Sensory System Agents|sensory system agents|mesh-ancestor
5715032|NCT03248765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5715033|NCT03248817|Phenylephrine|phenylephrine|mesh-list
5715034|NCT03248817|Oxymetazoline|oxymetazoline|mesh-list
5715035|NCT03248817|Bupivacaine|bupivacaine|mesh-list
5715036|NCT03248817|Anesthetics, Local|anesthetics, local|mesh-ancestor
5715037|NCT03248817|Anesthetics|anesthetics|mesh-ancestor
5715038|NCT03248817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5715039|NCT03248817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715040|NCT03248817|Sensory System Agents|sensory system agents|mesh-ancestor
5715041|NCT03248817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5715042|NCT03248817|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5715043|NCT03248817|Mydriatics|mydriatics|mesh-ancestor
5715044|NCT03248817|Autonomic Agents|autonomic agents|mesh-ancestor
5715045|NCT03248817|Sympathomimetics|sympathomimetics|mesh-ancestor
5715046|NCT03248817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5715047|NCT03248817|Nasal Decongestants|nasal decongestants|mesh-ancestor
6504988|NCT00658593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6504989|NCT00658593|Immunologic Factors|immunologic factors|mesh-ancestor
6504990|NCT00658593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504991|NCT00658645|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6504992|NCT00658645|Antidepressive Agents|antidepressive agents|mesh-ancestor
6504993|NCT00658645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6504994|NCT00658645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6504995|NCT00658645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6504996|NCT00658645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6504997|NCT00658645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6504998|NCT00658840|Capecitabine|capecitabine|mesh-list
5715048|NCT03248817|Respiratory System Agents|respiratory system agents|mesh-ancestor
5715049|NCT03248817|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5715050|NCT03248817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6678305|NCT01592305|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6504999|NCT00658840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6505000|NCT00658840|Antimetabolites|antimetabolites|mesh-ancestor
6505001|NCT00658840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505002|NCT00658840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6505003|NCT00658892|Antibodies|antibodies|mesh-list
6505004|NCT00658892|Immunologic Factors|immunologic factors|mesh-ancestor
6505005|NCT00658892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505006|NCT00658918|Ciclesonide|ciclesonide|mesh-list
6505007|NCT00658918|Glucocorticoids|glucocorticoids|mesh-ancestor
6505008|NCT00658918|Hormones|hormones|mesh-ancestor
6505009|NCT00658918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6505010|NCT00658918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505011|NCT00658918|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6505012|NCT00658931|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6505013|NCT00658931|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6505014|NCT00658931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6505015|NCT00658931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6505016|NCT00658931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505017|NCT00658931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6505018|NCT00658931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505019|NCT00658931|Analgesics|analgesics|mesh-ancestor
6505020|NCT00658931|Sensory System Agents|sensory system agents|mesh-ancestor
6505021|NCT00658931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6505022|NCT00658931|Antidepressive Agents|antidepressive agents|mesh-ancestor
6505023|NCT00658931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6505024|NCT00658931|Dopamine Agents|dopamine agents|mesh-ancestor
6505025|NCT00658957|Gentamicins|gentamicins|mesh-list
6505026|NCT00658957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6505027|NCT00658957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5715051|NCT03248817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5715052|NCT03248817|Adrenergic Agents|adrenergic agents|mesh-ancestor
5715053|NCT03248817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6505028|NCT00658957|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6505029|NCT00658957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6505030|NCT00658957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505031|NCT00658970|Tirbanibulin|tirbanibulin|mesh-list
6505032|NCT00658970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6505033|NCT00658970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505034|NCT00659022|Bevacizumab|bevacizumab|mesh-list
5715054|NCT03248817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715055|NCT03248817|Protective Agents|protective agents|mesh-ancestor
5715056|NCT03248713|Mifepristone|mifepristone|mesh-list
5715057|NCT03248713|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5715058|NCT03248713|Abortifacient Agents|abortifacient agents|mesh-ancestor
5715059|NCT03248713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5715060|NCT03248713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715061|NCT03248713|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6505035|NCT00659022|Capecitabine|capecitabine|mesh-list
6505036|NCT00659022|Oxaliplatin|oxaliplatin|mesh-list
6505037|NCT00659022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6505038|NCT00659022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6505039|NCT00659022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6505040|NCT00659022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6505041|NCT00659022|Growth Substances|growth substances|mesh-ancestor
6505042|NCT00659022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505043|NCT00659022|Growth Inhibitors|growth inhibitors|mesh-ancestor
6505044|NCT00659022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6678306|NCT01592305|Protease Inhibitors|protease inhibitors|mesh-ancestor
5715062|NCT03248713|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5715063|NCT03248713|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5715064|NCT03248713|Contraceptive Agents|contraceptive agents|mesh-ancestor
5715065|NCT03248713|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5715066|NCT03248713|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5715067|NCT03248713|Hormone Antagonists|hormone antagonists|mesh-ancestor
5715068|NCT03248713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5715069|NCT03248713|Luteolytic Agents|luteolytic agents|mesh-ancestor
5715070|NCT03248713|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5715071|NCT03248713|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5715072|NCT03248544|Vitamin D|vitamin d|mesh-list
5715073|NCT03248544|Cholecalciferol|cholecalciferol|mesh-list
5715074|NCT03248544|Vitamins|vitamins|mesh-ancestor
5715075|NCT03248544|Micronutrients|micronutrients|mesh-ancestor
5715076|NCT03248544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715077|NCT03248544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5715078|NCT03248544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6678307|NCT01592305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6678308|NCT01592305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678309|NCT01592305|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6678310|NCT01592305|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5715079|NCT03248973|Ampicillin|ampicillin|mesh-list
6505045|NCT00659022|Antimetabolites|antimetabolites|mesh-ancestor
6505046|NCT00659022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505047|NCT00659048|Ciclesonide|ciclesonide|mesh-list
6505048|NCT00659048|Glucocorticoids|glucocorticoids|mesh-ancestor
6505049|NCT00659048|Hormones|hormones|mesh-ancestor
6505050|NCT00659048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6505051|NCT00659048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505052|NCT00659048|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6505053|NCT00659074|Ondansetron|ondansetron|mesh-list
6505054|NCT00659074|Antiemetics|antiemetics|mesh-ancestor
6505055|NCT00659074|Autonomic Agents|autonomic agents|mesh-ancestor
6505056|NCT00659074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6505057|NCT00659074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505058|NCT00659074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6505059|NCT00659074|Antipruritics|antipruritics|mesh-ancestor
6505060|NCT00659074|Dermatologic Agents|dermatologic agents|mesh-ancestor
6505061|NCT00659074|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6505062|NCT00659074|Serotonin Agents|serotonin agents|mesh-ancestor
6505063|NCT00659074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6505064|NCT00659074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505065|NCT00659074|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6505066|NCT00659074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6505067|NCT00659074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6505068|NCT00659074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6505069|NCT00659074|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6505070|NCT00659100|Gabapentin|gabapentin|mesh-list
6505071|NCT00659100|Analgesics|analgesics|mesh-ancestor
5715080|NCT03248973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5715081|NCT03248973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5715082|NCT03248791|Phenylephrine|phenylephrine|mesh-list
5715083|NCT03248791|Oxymetazoline|oxymetazoline|mesh-list
5715084|NCT03248791|Norepinephrine|norepinephrine|mesh-list
5715085|NCT03248791|Bupivacaine|bupivacaine|mesh-list
5715086|NCT03248791|Anesthetics, Local|anesthetics, local|mesh-ancestor
5715087|NCT03248791|Anesthetics|anesthetics|mesh-ancestor
6505072|NCT00659100|Sensory System Agents|sensory system agents|mesh-ancestor
6505073|NCT00659100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6505074|NCT00659100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505075|NCT00659100|Anticonvulsants|anticonvulsants|mesh-ancestor
6505076|NCT00659100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6505077|NCT00659100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6505078|NCT00659100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6505079|NCT00659100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6505080|NCT00659100|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6505081|NCT00659100|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6505082|NCT00659100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6505083|NCT00659100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505084|NCT00659100|Antimanic Agents|antimanic agents|mesh-ancestor
6505085|NCT00659113|Tegafur|tegafur|mesh-list
6505086|NCT00659113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6505087|NCT00659113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6505088|NCT00659113|Antimetabolites|antimetabolites|mesh-ancestor
6505089|NCT00659113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505090|NCT00659178|Doxorubicin|doxorubicin|mesh-list
6505091|NCT00659178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6505092|NCT00659178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6505093|NCT00659178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6505094|NCT00659178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6505095|NCT00659178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6505096|NCT00659178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6505097|NCT00659178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715088|NCT03248791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5715089|NCT03248791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715090|NCT03248791|Sensory System Agents|sensory system agents|mesh-ancestor
5715091|NCT03248791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5715092|NCT03248791|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5715093|NCT03248791|Mydriatics|mydriatics|mesh-ancestor
6505098|NCT00659282|Insulin Aspart|insulin aspart|mesh-list
6505099|NCT00659282|Biphasic Insulins|biphasic insulins|mesh-list
6505100|NCT00659282|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6505101|NCT00659282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6505102|NCT00659282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505103|NCT00659321|Nicotine|nicotine|mesh-list
5715094|NCT03248791|Autonomic Agents|autonomic agents|mesh-ancestor
5715095|NCT03248791|Sympathomimetics|sympathomimetics|mesh-ancestor
5715096|NCT03248791|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5715097|NCT03248791|Nasal Decongestants|nasal decongestants|mesh-ancestor
5715098|NCT03248791|Respiratory System Agents|respiratory system agents|mesh-ancestor
5715099|NCT03248791|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5715100|NCT03248791|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5715101|NCT03248791|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5715102|NCT03248791|Adrenergic Agents|adrenergic agents|mesh-ancestor
5715103|NCT03248791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5715104|NCT03248791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715105|NCT03248791|Protective Agents|protective agents|mesh-ancestor
5721927|NCT03202628|Ichthammol|ichthammol|mesh-list
5721928|NCT03202628|BB 1101|bb 1101|mesh-list
5721929|NCT03202628|Glycine|glycine|mesh-list
5721930|NCT03202628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5721931|NCT03202628|Antiemetics|antiemetics|mesh-ancestor
5721932|NCT03202628|Autonomic Agents|autonomic agents|mesh-ancestor
5721933|NCT03202628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5721934|NCT03202628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721935|NCT03202628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5721936|NCT03202628|Glucocorticoids|glucocorticoids|mesh-ancestor
6505104|NCT00659321|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6505105|NCT00659321|Autonomic Agents|autonomic agents|mesh-ancestor
6505106|NCT00659321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6505107|NCT00659321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505108|NCT00659321|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6505109|NCT00659321|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6505110|NCT00659321|Cholinergic Agents|cholinergic agents|mesh-ancestor
6505111|NCT00659321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6505112|NCT00659321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505113|NCT00659386|Immunoglobulins|immunoglobulins|mesh-list
6505114|NCT00659386|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6505115|NCT00659386|Antibodies|antibodies|mesh-list
6505116|NCT00659386|gamma-Globulins|gamma-globulins|mesh-list
6505117|NCT00659386|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6505118|NCT00659386|Immunologic Factors|immunologic factors|mesh-ancestor
6505119|NCT00659386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505120|NCT00659399|PENTA|penta|mesh-list
6505121|NCT00659399|Fondaparinux|fondaparinux|mesh-list
6505122|NCT00659399|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6505123|NCT00659399|Antithrombins|antithrombins|mesh-ancestor
6505124|NCT00659399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6505125|NCT00659399|Protease Inhibitors|protease inhibitors|mesh-ancestor
6505126|NCT00659399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6505127|NCT00659399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505128|NCT00659399|Anticoagulants|anticoagulants|mesh-ancestor
6505129|NCT00659399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6505130|NCT00659399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6505131|NCT00659412|Methotrexate|methotrexate|mesh-list
6505132|NCT00659412|Alefacept|alefacept|mesh-list
6505133|NCT00659412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6505134|NCT00659412|Abortifacient Agents|abortifacient agents|mesh-ancestor
6505135|NCT00659412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6505136|NCT00659412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505137|NCT00659412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6505138|NCT00659412|Antimetabolites|antimetabolites|mesh-ancestor
6505139|NCT00659412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505140|NCT00659412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6505141|NCT00659412|Dermatologic Agents|dermatologic agents|mesh-ancestor
6505142|NCT00659412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6505143|NCT00659412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6505144|NCT00659412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6505145|NCT00659412|Immunologic Factors|immunologic factors|mesh-ancestor
6505146|NCT00659412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6505147|NCT00659412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6505148|NCT00659451|Losartan|losartan|mesh-list
6505149|NCT00659451|Amlodipine|amlodipine|mesh-list
5721937|NCT03202628|Hormones|hormones|mesh-ancestor
5722326|NCT03199976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6505150|NCT00659451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6505151|NCT00659451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6505152|NCT00659451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6678311|NCT01592305|Antiviral Agents|antiviral agents|mesh-ancestor
6678312|NCT01592305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6678313|NCT01592305|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6678314|NCT01592305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6678315|NCT01592305|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6678316|NCT01592305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6505153|NCT00659451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505154|NCT00659451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6505155|NCT00659451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505156|NCT00659451|Vasodilator Agents|vasodilator agents|mesh-ancestor
6505157|NCT00659451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6505158|NCT00659451|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6505159|NCT00659451|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6505160|NCT00659477|Insulin Glargine|insulin glargine|mesh-list
6505161|NCT00659477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6505162|NCT00659477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505163|NCT00659503|Ciclesonide|ciclesonide|mesh-list
5715106|NCT03248700|Vitamins|vitamins|mesh-list
5715107|NCT03248700|Vitamin A|vitamin a|mesh-list
5715108|NCT03248700|Retinol palmitate|retinol palmitate|mesh-list
5715109|NCT03248700|Retinol acetate|retinol acetate|mesh-list
5715110|NCT03248700|Micronutrients|micronutrients|mesh-ancestor
5715111|NCT03248700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715112|NCT03248700|Antioxidants|antioxidants|mesh-ancestor
5715113|NCT03248700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715114|NCT03248700|Protective Agents|protective agents|mesh-ancestor
5715115|NCT03248700|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5715116|NCT03248700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5715117|NCT03248700|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5715118|NCT03248700|Immunologic Factors|immunologic factors|mesh-ancestor
5715119|NCT03248648|Ketamine|ketamine|mesh-list
5715120|NCT03248648|Neostigmine|neostigmine|mesh-list
5715121|NCT03248648|Analgesics|analgesics|mesh-ancestor
5715122|NCT03248648|Sensory System Agents|sensory system agents|mesh-ancestor
5715123|NCT03248648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5715124|NCT03248648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505164|NCT00659503|Glucocorticoids|glucocorticoids|mesh-ancestor
6505165|NCT00659503|Hormones|hormones|mesh-ancestor
6505166|NCT00659503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6505167|NCT00659503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505168|NCT00659503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6505169|NCT00659555|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6505170|NCT00659555|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6505171|NCT00659568|Metformin|metformin|mesh-list
6505172|NCT00659568|Sirolimus|sirolimus|mesh-list
6505173|NCT00659568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6505174|NCT00659568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505175|NCT00659568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6505176|NCT00659568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6505177|NCT00659568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6505178|NCT00659568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6505179|NCT00659568|Antifungal Agents|antifungal agents|mesh-ancestor
6678317|NCT01592318|Ritonavir|ritonavir|mesh-list
5715125|NCT03248648|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5715126|NCT03248648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5715127|NCT03248648|Anesthetics, General|anesthetics, general|mesh-ancestor
6505180|NCT00659568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6678318|NCT01592318|Lactams|lactams|mesh-list
5715128|NCT03248648|Anesthetics|anesthetics|mesh-ancestor
6505181|NCT00659568|Immunologic Factors|immunologic factors|mesh-ancestor
6505182|NCT00659594|Ciclesonide|ciclesonide|mesh-list
6505183|NCT00659594|Glucocorticoids|glucocorticoids|mesh-ancestor
6505184|NCT00659594|Hormones|hormones|mesh-ancestor
6505185|NCT00659594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6505186|NCT00659594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505187|NCT00659594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6505188|NCT00659659|Benralizumab|benralizumab|mesh-list
6505189|NCT00659659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6505190|NCT00659659|Respiratory System Agents|respiratory system agents|mesh-ancestor
6505191|NCT00659685|Ondansetron|ondansetron|mesh-list
6505192|NCT00659685|Antiemetics|antiemetics|mesh-ancestor
6505193|NCT00659685|Autonomic Agents|autonomic agents|mesh-ancestor
6505194|NCT00659685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6505195|NCT00659685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505196|NCT00659685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5715129|NCT03248648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5715130|NCT03248648|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5715131|NCT03248648|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5715132|NCT03248648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5715133|NCT03248648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715134|NCT03248648|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5715135|NCT03248648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5715136|NCT03248648|Cholinergic Agents|cholinergic agents|mesh-ancestor
5715137|NCT03248648|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5715138|NCT03248648|Autonomic Agents|autonomic agents|mesh-ancestor
5715139|NCT03248401|Aspirin|aspirin|mesh-list
5715140|NCT03248401|Cilostazol|cilostazol|mesh-list
5715141|NCT03248401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5715142|NCT03248401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5715143|NCT03248401|Analgesics|analgesics|mesh-ancestor
5715144|NCT03248401|Sensory System Agents|sensory system agents|mesh-ancestor
5715145|NCT03248401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5715146|NCT03248401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715147|NCT03248401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5715148|NCT03248401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5715149|NCT03248401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6505197|NCT00659685|Antipruritics|antipruritics|mesh-ancestor
6505198|NCT00659685|Dermatologic Agents|dermatologic agents|mesh-ancestor
6505199|NCT00659685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6505200|NCT00659685|Serotonin Agents|serotonin agents|mesh-ancestor
6505201|NCT00659685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6505202|NCT00659685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505203|NCT00659685|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6505204|NCT00659685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6505205|NCT00659685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6505206|NCT00659685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6505207|NCT00659685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6505208|NCT00659698|Pancrelipase|pancrelipase|mesh-list
6505209|NCT00659698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6505210|NCT00659750|Ciclesonide|ciclesonide|mesh-list
6505211|NCT00659750|Glucocorticoids|glucocorticoids|mesh-ancestor
6505212|NCT00659750|Hormones|hormones|mesh-ancestor
6505213|NCT00659750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6505214|NCT00659750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505215|NCT00659750|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6505216|NCT00659776|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
6505217|NCT00659776|Hematinics|hematinics|mesh-ancestor
6505218|NCT00659776|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6505219|NCT00659776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5715150|NCT03248401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5715151|NCT03248401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715152|NCT03248401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5715153|NCT03248401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5715154|NCT03248401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5715155|NCT03248401|Antipyretics|antipyretics|mesh-ancestor
5715156|NCT03248401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5715157|NCT03248401|Autonomic Agents|autonomic agents|mesh-ancestor
5715158|NCT03248401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5715159|NCT03248401|Respiratory System Agents|respiratory system agents|mesh-ancestor
5715160|NCT03248401|Vasodilator Agents|vasodilator agents|mesh-ancestor
5715161|NCT03248401|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5715162|NCT03248401|Protective Agents|protective agents|mesh-ancestor
5715163|NCT03248401|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5715164|NCT03248401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5715165|NCT03248427|Paclitaxel|paclitaxel|mesh-list
5715166|NCT03248427|Cyclophosphamide|cyclophosphamide|mesh-list
5715167|NCT03248427|Doxorubicin|doxorubicin|mesh-list
5715168|NCT03248427|Letrozole|letrozole|mesh-list
6505220|NCT00659841|Ciclesonide|ciclesonide|mesh-list
6505221|NCT00659841|Glucocorticoids|glucocorticoids|mesh-ancestor
6505222|NCT00659841|Hormones|hormones|mesh-ancestor
6505223|NCT00659841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6505224|NCT00659841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505225|NCT00659841|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6505226|NCT00659919|Trazodone|trazodone|mesh-list
6505227|NCT00659919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6505228|NCT00659919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5715169|NCT03248427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5715170|NCT03248427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6505229|NCT00659919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6779764|NCT02180880|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6678319|NCT01592318|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6678320|NCT01592318|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6678321|NCT01592318|Protease Inhibitors|protease inhibitors|mesh-ancestor
6678322|NCT01592318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6505230|NCT00659919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505231|NCT00659919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6505232|NCT00659919|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6505233|NCT00659919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6505234|NCT00659919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6505235|NCT00659919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505236|NCT00659919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6505237|NCT00659919|Serotonin Agents|serotonin agents|mesh-ancestor
6505238|NCT00659919|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6505239|NCT00659919|Antidepressive Agents|antidepressive agents|mesh-ancestor
6505240|NCT00659958|Zonisamide|zonisamide|mesh-list
6505241|NCT00659958|Anticonvulsants|anticonvulsants|mesh-ancestor
6505242|NCT00659958|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6505243|NCT00659958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6505244|NCT00659958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505245|NCT00659958|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6505246|NCT00659958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505247|NCT00659997|Albendazole|albendazole|mesh-list
6505248|NCT00659997|Levamisole|levamisole|mesh-list
6505249|NCT00659997|Anthelmintics|anthelmintics|mesh-ancestor
6505250|NCT00659997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6505251|NCT00659997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6505252|NCT00659997|Anticestodal Agents|anticestodal agents|mesh-ancestor
6505253|NCT00659997|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6505254|NCT00659997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6505255|NCT00659997|Tubulin Modulators|tubulin modulators|mesh-ancestor
6505256|NCT00659997|Antimitotic Agents|antimitotic agents|mesh-ancestor
6505257|NCT00659997|Mitosis Modulators|mitosis modulators|mesh-ancestor
6505258|NCT00659997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505259|NCT00659997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6505260|NCT00659997|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6505261|NCT00659997|Immunologic Factors|immunologic factors|mesh-ancestor
6505262|NCT00659997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505263|NCT00659997|Antinematodal Agents|antinematodal agents|mesh-ancestor
6505264|NCT00659997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6505265|NCT00660036|Etoposide|etoposide|mesh-list
6505266|NCT00660036|Mitoxantrone|mitoxantrone|mesh-list
6505267|NCT00660036|Gemtuzumab|gemtuzumab|mesh-list
6505268|NCT00660036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6505269|NCT00660036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6505270|NCT00660036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6505271|NCT00660036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6505272|NCT00660036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6505273|NCT00660036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678323|NCT01592318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678324|NCT01592318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6678325|NCT01592318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6678326|NCT01592318|Antiviral Agents|antiviral agents|mesh-ancestor
6678327|NCT01592318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6678328|NCT01592318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6678329|NCT01592318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6678330|NCT01592318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6505274|NCT00660036|Analgesics|analgesics|mesh-ancestor
6505275|NCT00660036|Sensory System Agents|sensory system agents|mesh-ancestor
6505276|NCT00660036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6505277|NCT00660036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505278|NCT00660036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6505279|NCT00660062|Dexetimide|dexetimide|mesh-list
6505280|NCT00660062|Citalopram|citalopram|mesh-list
6505281|NCT00660062|Nortriptyline|nortriptyline|mesh-list
6505282|NCT00660062|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6505283|NCT00660062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6505284|NCT00660062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6505285|NCT00660062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505286|NCT00660062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6505287|NCT00660062|Serotonin Agents|serotonin agents|mesh-ancestor
6505288|NCT00660062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505289|NCT00660062|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6678331|NCT01592526|Nicotine|nicotine|mesh-list
6505290|NCT00660062|Antidepressive Agents|antidepressive agents|mesh-ancestor
6505291|NCT00660062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6505292|NCT00660062|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6505293|NCT00660062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6505294|NCT00660062|Parasympatholytics|parasympatholytics|mesh-ancestor
6505295|NCT00660062|Autonomic Agents|autonomic agents|mesh-ancestor
6505296|NCT00660062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6505297|NCT00660062|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6505298|NCT00660062|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6505299|NCT00660062|Cholinergic Agents|cholinergic agents|mesh-ancestor
6505300|NCT00660062|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6505301|NCT00660062|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6505302|NCT00660062|Adrenergic Agents|adrenergic agents|mesh-ancestor
6505303|NCT00660140|Gemcitabine|gemcitabine|mesh-list
6505304|NCT00660140|Carboplatin|carboplatin|mesh-list
6505305|NCT00660140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6505306|NCT00660140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6505307|NCT00660140|Antimetabolites|antimetabolites|mesh-ancestor
6505308|NCT00660140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505309|NCT00660140|Antiviral Agents|antiviral agents|mesh-ancestor
6505310|NCT00660140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6505311|NCT00660140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6505312|NCT00660140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6505313|NCT00660140|Immunologic Factors|immunologic factors|mesh-ancestor
6505314|NCT00660140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505315|NCT00660231|Gemcitabine|gemcitabine|mesh-list
6505316|NCT00660231|Bexarotene|bexarotene|mesh-list
6505317|NCT00660231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6505318|NCT00660231|Antimetabolites|antimetabolites|mesh-ancestor
6505319|NCT00660231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505320|NCT00660231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6505321|NCT00660231|Antiviral Agents|antiviral agents|mesh-ancestor
6678332|NCT01592526|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6678333|NCT01592526|Autonomic Agents|autonomic agents|mesh-ancestor
6678334|NCT01592526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6678335|NCT01592526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678336|NCT01592526|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6678337|NCT01592526|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6678338|NCT01592526|Cholinergic Agents|cholinergic agents|mesh-ancestor
6678339|NCT01592526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6678340|NCT01592526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678341|NCT01592630|Ropivacaine|ropivacaine|mesh-list
5715171|NCT03248427|Tubulin Modulators|tubulin modulators|mesh-ancestor
6505322|NCT00660231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6505323|NCT00660231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6505324|NCT00660231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6505325|NCT00660231|Immunologic Factors|immunologic factors|mesh-ancestor
6505326|NCT00660231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505327|NCT00660244|Anastrozole|anastrozole|mesh-list
6505328|NCT00660244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6505329|NCT00660244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6505330|NCT00660244|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6505331|NCT00660244|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6505332|NCT00660244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6505333|NCT00660244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505334|NCT00660244|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6505335|NCT00660244|Hormone Antagonists|hormone antagonists|mesh-ancestor
6505336|NCT00660244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6505337|NCT00660244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505338|NCT00660257|Vaccines|vaccines|mesh-list
6505339|NCT00660257|Immunologic Factors|immunologic factors|mesh-ancestor
6505340|NCT00660257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505341|NCT00660270|Gemcitabine|gemcitabine|mesh-list
6505342|NCT00660270|Interferons|interferons|mesh-list
6505343|NCT00660270|Interferon-alpha|interferon-alpha|mesh-list
6505344|NCT00660270|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
6505345|NCT00660270|Fluorouracil|fluorouracil|mesh-list
6505346|NCT00660270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6505347|NCT00660270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6505348|NCT00660270|Antimetabolites|antimetabolites|mesh-ancestor
6505349|NCT00660270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505350|NCT00660270|Antiviral Agents|antiviral agents|mesh-ancestor
6505351|NCT00660270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6505352|NCT00660270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6505353|NCT00660270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6505354|NCT00660270|Immunologic Factors|immunologic factors|mesh-ancestor
6505355|NCT00660270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505356|NCT00660283|Temozolomide|temozolomide|mesh-list
6505357|NCT00660283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6505358|NCT00660283|Alkylating Agents|alkylating agents|mesh-ancestor
6505359|NCT00660283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505360|NCT00660283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6505361|NCT00660335|Secretin|secretin|mesh-list
6505362|NCT00660335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6505363|NCT00660335|Hormones|hormones|mesh-ancestor
6505364|NCT00660335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6505365|NCT00660335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505366|NCT00660374|Isophane Insulin, Human|isophane insulin, human|mesh-list
6505367|NCT00660374|Insulin, Isophane|insulin, isophane|mesh-list
6505368|NCT00660374|Isophane insulin, beef|isophane insulin, beef|mesh-list
6505369|NCT00660374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6505370|NCT00660374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505371|NCT00660426|Gemcitabine|gemcitabine|mesh-list
6505372|NCT00660426|Capecitabine|capecitabine|mesh-list
6505373|NCT00660426|Oxaliplatin|oxaliplatin|mesh-list
6505374|NCT00660426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6678342|NCT01592630|Anesthetics, Local|anesthetics, local|mesh-ancestor
5715172|NCT03248427|Antimitotic Agents|antimitotic agents|mesh-ancestor
5715173|NCT03248427|Mitosis Modulators|mitosis modulators|mesh-ancestor
5715174|NCT03248427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715175|NCT03248427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5715176|NCT03248427|Immunologic Factors|immunologic factors|mesh-ancestor
6505375|NCT00660426|Antimetabolites|antimetabolites|mesh-ancestor
6505376|NCT00660426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505377|NCT00660426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6505378|NCT00660426|Antiviral Agents|antiviral agents|mesh-ancestor
6505379|NCT00660426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6505380|NCT00660426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6505381|NCT00660426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6505382|NCT00660426|Immunologic Factors|immunologic factors|mesh-ancestor
6505383|NCT00660426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505384|NCT00660582|Leucovorin|leucovorin|mesh-list
6505385|NCT00660582|Folic Acid|folic acid|mesh-list
5715177|NCT03248427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715178|NCT03248427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5715179|NCT03248427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5715180|NCT03248427|Alkylating Agents|alkylating agents|mesh-ancestor
5715181|NCT03248427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5715182|NCT03248427|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5715183|NCT03248427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5715184|NCT03248427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5715185|NCT03248427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5715186|NCT03248427|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5715187|NCT03248427|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5715188|NCT03248427|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5715189|NCT03248427|Hormone Antagonists|hormone antagonists|mesh-ancestor
5715190|NCT03248427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5715191|NCT03248349|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5715192|NCT03248349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5715193|NCT03248271|Insulin Lispro|insulin lispro|mesh-list
5715194|NCT03248271|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5715195|NCT03248271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715196|NCT03248297|Amoxicillin|amoxicillin|mesh-list
5715197|NCT03248297|Azithromycin|azithromycin|mesh-list
5715198|NCT03248297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5715199|NCT03248297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5715200|NCT03248063|Cefazolin|cefazolin|mesh-list
5715201|NCT03248063|Cloxacillin|cloxacillin|mesh-list
6505386|NCT00660582|Fluorouracil|fluorouracil|mesh-list
6505387|NCT00660582|Oxaliplatin|oxaliplatin|mesh-list
6505388|NCT00660582|Cetuximab|cetuximab|mesh-list
6505389|NCT00660582|Levoleucovorin|levoleucovorin|mesh-list
6505390|NCT00660582|Antimetabolites|antimetabolites|mesh-ancestor
6505391|NCT00660582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505392|NCT00660582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6505393|NCT00660582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6505394|NCT00660582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6505395|NCT00660582|Immunologic Factors|immunologic factors|mesh-ancestor
6505396|NCT00660582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505397|NCT00660582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6505398|NCT00660582|Antidotes|antidotes|mesh-ancestor
6505399|NCT00660582|Protective Agents|protective agents|mesh-ancestor
6505400|NCT00660582|Vitamin B Complex|vitamin b complex|mesh-ancestor
6505401|NCT00660582|Vitamins|vitamins|mesh-ancestor
6505402|NCT00660582|Micronutrients|micronutrients|mesh-ancestor
6505403|NCT00660582|Hematinics|hematinics|mesh-ancestor
6505404|NCT00660621|Bevacizumab|bevacizumab|mesh-list
6505405|NCT00660621|Temozolomide|temozolomide|mesh-list
6505406|NCT00660621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6505407|NCT00660621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6505408|NCT00660621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6505409|NCT00660621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5715202|NCT03248063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5715203|NCT03248063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6505410|NCT00660621|Growth Substances|growth substances|mesh-ancestor
6505411|NCT00660621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505412|NCT00660621|Growth Inhibitors|growth inhibitors|mesh-ancestor
6505413|NCT00660621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6505414|NCT00660621|Alkylating Agents|alkylating agents|mesh-ancestor
6505415|NCT00660621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678343|NCT01592630|Anesthetics|anesthetics|mesh-ancestor
6678344|NCT01592630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6678345|NCT01592630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678346|NCT01592630|Sensory System Agents|sensory system agents|mesh-ancestor
6678347|NCT01592630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6678348|NCT01592981|Cyclophosphamide|cyclophosphamide|mesh-list
6678349|NCT01592981|Rituximab|rituximab|mesh-list
6678350|NCT01592981|Fludarabine|fludarabine|mesh-list
6678351|NCT01592981|Bortezomib|bortezomib|mesh-list
6678352|NCT01592981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6678353|NCT01592981|Immunologic Factors|immunologic factors|mesh-ancestor
6678354|NCT01592981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678355|NCT01592981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6678356|NCT01592981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6678357|NCT01592981|Alkylating Agents|alkylating agents|mesh-ancestor
6678358|NCT01592981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678359|NCT01592981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6678360|NCT01592981|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6678361|NCT01592981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6678362|NCT01593033|Micronutrients|micronutrients|mesh-list
6678363|NCT01593033|Trace Elements|trace elements|mesh-list
6678364|NCT01593033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678365|NCT01593046|Cabotegravir|cabotegravir|mesh-list
5715204|NCT03247972|Evolocumab|evolocumab|mesh-list
5715205|NCT03247972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5715206|NCT03247972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5715207|NCT03247972|Antimetabolites|antimetabolites|mesh-ancestor
6678366|NCT01593046|Rilpivirine|rilpivirine|mesh-list
6678367|NCT01593046|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6678368|NCT01593046|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6678369|NCT01593046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6678370|NCT01593046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678371|NCT01593046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6678372|NCT01593046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5715208|NCT03247972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715209|NCT03247972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6678373|NCT01593046|Antiviral Agents|antiviral agents|mesh-ancestor
5715210|NCT03248167|Cannabidiol|cannabidiol|mesh-list
5715211|NCT03248167|Anticonvulsants|anticonvulsants|mesh-ancestor
5715212|NCT03247998|Remifentanil|remifentanil|mesh-list
5715213|NCT03247998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6505416|NCT00660647|Adalimumab|adalimumab|mesh-list
6505417|NCT00660647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6505418|NCT00660647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5715214|NCT03247998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715215|NCT03247998|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5715216|NCT03247998|Narcotics|narcotics|mesh-ancestor
5715217|NCT03247998|Analgesics|analgesics|mesh-ancestor
5715218|NCT03247998|Sensory System Agents|sensory system agents|mesh-ancestor
5715219|NCT03247998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5715220|NCT03248076|Fentanyl|fentanyl|mesh-list
5715221|NCT03248076|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5715222|NCT03248076|Narcotics|narcotics|mesh-ancestor
5715223|NCT03248076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5715224|NCT03248076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505419|NCT00660725|Gemcitabine|gemcitabine|mesh-list
6505420|NCT00660725|Oxaliplatin|oxaliplatin|mesh-list
6505421|NCT00660725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6505422|NCT00660725|Antimetabolites|antimetabolites|mesh-ancestor
6505423|NCT00660725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505424|NCT00660725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6505425|NCT00660725|Antiviral Agents|antiviral agents|mesh-ancestor
6505426|NCT00660725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6505427|NCT00660725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6505428|NCT00660725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6505429|NCT00660725|Immunologic Factors|immunologic factors|mesh-ancestor
6505430|NCT00660725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715225|NCT03248076|Analgesics|analgesics|mesh-ancestor
5715226|NCT03248076|Sensory System Agents|sensory system agents|mesh-ancestor
5715227|NCT03248076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5715228|NCT03248076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5715229|NCT03248076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5715230|NCT03248076|Anesthetics, General|anesthetics, general|mesh-ancestor
5715231|NCT03248076|Anesthetics|anesthetics|mesh-ancestor
5715232|NCT03247920|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6505431|NCT00660751|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6505432|NCT00660751|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6505433|NCT00660751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6505434|NCT00660751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6505435|NCT00660751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505436|NCT00660751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6505437|NCT00660751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505438|NCT00660751|Analgesics|analgesics|mesh-ancestor
6505439|NCT00660751|Sensory System Agents|sensory system agents|mesh-ancestor
6505440|NCT00660751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6505441|NCT00660751|Antidepressive Agents|antidepressive agents|mesh-ancestor
6505442|NCT00660751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6505443|NCT00660751|Dopamine Agents|dopamine agents|mesh-ancestor
6505444|NCT00660764|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6505445|NCT00660764|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6505446|NCT00660764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6505447|NCT00660764|Antimetabolites|antimetabolites|mesh-ancestor
6505448|NCT00660764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505449|NCT00660764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6505450|NCT00660764|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6505451|NCT00660764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6505452|NCT00660803|Fulvestrant|fulvestrant|mesh-list
6505453|NCT00660803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6505454|NCT00660803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6505455|NCT00660803|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6505456|NCT00660803|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6505457|NCT00660803|Hormone Antagonists|hormone antagonists|mesh-ancestor
6505458|NCT00660803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6505459|NCT00660803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505460|NCT00660842|Paclitaxel|paclitaxel|mesh-list
6505461|NCT00660842|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6505462|NCT00660842|Carboplatin|carboplatin|mesh-list
6505463|NCT00660842|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6678374|NCT01593046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5715233|NCT03247920|Amoxicillin|amoxicillin|mesh-list
5715234|NCT03247920|Clavulanic Acid|clavulanic acid|mesh-list
5715235|NCT03247920|Clavulanic Acids|clavulanic acids|mesh-list
5715236|NCT03247920|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5715237|NCT03247920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5715238|NCT03247920|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5715239|NCT03247920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5715240|NCT03247920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715241|NCT03247868|Botulinum Toxins|botulinum toxins|mesh-list
5715242|NCT03247868|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5715243|NCT03247868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5715244|NCT03247868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715245|NCT03247868|Cholinergic Agents|cholinergic agents|mesh-ancestor
5715246|NCT03247868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5715247|NCT03247868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715248|NCT03247712|Nivolumab|nivolumab|mesh-list
5715249|NCT03247712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5715250|NCT03247712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5715251|NCT03247712|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6505464|NCT00660842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6505465|NCT00660842|Tubulin Modulators|tubulin modulators|mesh-ancestor
6505466|NCT00660842|Antimitotic Agents|antimitotic agents|mesh-ancestor
6505467|NCT00660842|Mitosis Modulators|mitosis modulators|mesh-ancestor
6505468|NCT00660842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505469|NCT00660855|Parecoxib|parecoxib|mesh-list
6505470|NCT00660855|Valdecoxib|valdecoxib|mesh-list
6505471|NCT00660855|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6505472|NCT00660855|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6505473|NCT00660855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6505474|NCT00660855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505475|NCT00660855|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6505476|NCT00660855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6505477|NCT00660855|Analgesics|analgesics|mesh-ancestor
6505478|NCT00660855|Sensory System Agents|sensory system agents|mesh-ancestor
6505479|NCT00660855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6505480|NCT00660855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505481|NCT00660855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6505482|NCT00660855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6505483|NCT00660868|Pentoxifylline|pentoxifylline|mesh-list
6505484|NCT00660868|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6505485|NCT00660868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6505486|NCT00660868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505487|NCT00660868|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6505488|NCT00660868|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6505489|NCT00660868|Protective Agents|protective agents|mesh-ancestor
6505490|NCT00660868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505491|NCT00660868|Vasodilator Agents|vasodilator agents|mesh-ancestor
6505492|NCT00660868|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6505493|NCT00660868|Antioxidants|antioxidants|mesh-ancestor
6505494|NCT00660894|Leucovorin|leucovorin|mesh-list
6505495|NCT00660894|Tegafur|tegafur|mesh-list
6505496|NCT00660894|Calcium|calcium|mesh-list
6505497|NCT00660894|Levoleucovorin|levoleucovorin|mesh-list
6505498|NCT00660894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5715252|NCT03247712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715253|NCT03247582|Edoxaban|edoxaban|mesh-list
5715254|NCT03247582|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5715255|NCT03247582|Antithrombins|antithrombins|mesh-ancestor
5715256|NCT03247582|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5715257|NCT03247582|Protease Inhibitors|protease inhibitors|mesh-ancestor
5715258|NCT03247582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5715259|NCT03247582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715260|NCT03247582|Anticoagulants|anticoagulants|mesh-ancestor
5715261|NCT03247595|Magnesium citrate|magnesium citrate|mesh-list
5715262|NCT03247595|Bisacodyl|bisacodyl|mesh-list
5715263|NCT03247595|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
5715264|NCT03247595|Cathartics|cathartics|mesh-ancestor
5715265|NCT03247595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5715266|NCT03247595|Laxatives|laxatives|mesh-ancestor
5715267|NCT03247452|Ascorbic Acid|ascorbic acid|mesh-list
5715268|NCT03247452|Antioxidants|antioxidants|mesh-ancestor
5715269|NCT03247452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715270|NCT03247452|Protective Agents|protective agents|mesh-ancestor
5715271|NCT03247452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715272|NCT03247452|Vitamins|vitamins|mesh-ancestor
6505499|NCT00660894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779765|NCT02180880|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5715273|NCT03247452|Micronutrients|micronutrients|mesh-ancestor
6505500|NCT00660894|Antidotes|antidotes|mesh-ancestor
6505501|NCT00660894|Protective Agents|protective agents|mesh-ancestor
6505502|NCT00660894|Vitamin B Complex|vitamin b complex|mesh-ancestor
6505503|NCT00660894|Vitamins|vitamins|mesh-ancestor
6505504|NCT00660894|Micronutrients|micronutrients|mesh-ancestor
6505505|NCT00660894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6505506|NCT00660894|Antimetabolites|antimetabolites|mesh-ancestor
6505507|NCT00660894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505508|NCT00660894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6505509|NCT00660920|Ponatinib|ponatinib|mesh-list
6505510|NCT00660920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6505511|NCT00660920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6505512|NCT00660920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6505513|NCT00660920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505514|NCT00660933|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6505515|NCT00660933|Hematinics|hematinics|mesh-ancestor
6505516|NCT00660972|Tenofovir|tenofovir|mesh-list
6505517|NCT00660972|Emtricitabine|emtricitabine|mesh-list
6505518|NCT00660972|Raltegravir Potassium|raltegravir potassium|mesh-list
6505519|NCT00660972|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6505520|NCT00660972|Antiviral Agents|antiviral agents|mesh-ancestor
6505521|NCT00660972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6505522|NCT00660972|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6505523|NCT00660972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6505524|NCT00660972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6505525|NCT00660972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505526|NCT00660972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6505527|NCT00660972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6505528|NCT00660972|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6505529|NCT00660972|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6505530|NCT00660998|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6505531|NCT00660998|Vasodilator Agents|vasodilator agents|mesh-ancestor
6505532|NCT00660998|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6505533|NCT00660998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6505534|NCT00660998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6505535|NCT00660998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505536|NCT00660998|Urological Agents|urological agents|mesh-ancestor
6505537|NCT00661063|Clonidine|clonidine|mesh-list
6505538|NCT00661063|Ketamine|ketamine|mesh-list
6505539|NCT00661063|Analgesics|analgesics|mesh-ancestor
6505540|NCT00661063|Sensory System Agents|sensory system agents|mesh-ancestor
6505541|NCT00661063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5715274|NCT03247283|Linrodostat|linrodostat|mesh-list
5715275|NCT03247283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5715276|NCT03247283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715277|NCT03247413|Dexamethasone|dexamethasone|mesh-list
5715278|NCT03247413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5715279|NCT03247413|Antiemetics|antiemetics|mesh-ancestor
5715280|NCT03247413|Autonomic Agents|autonomic agents|mesh-ancestor
5715281|NCT03247413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5715282|NCT03247413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715283|NCT03247413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5715284|NCT03247413|Glucocorticoids|glucocorticoids|mesh-ancestor
5715285|NCT03247413|Hormones|hormones|mesh-ancestor
5715286|NCT03247413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5715287|NCT03247413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5715288|NCT03247413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5715289|NCT03247140|Amlodipine|amlodipine|mesh-list
5715290|NCT03247140|Telmisartan|telmisartan|mesh-list
6505542|NCT00661063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505543|NCT00661063|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6505544|NCT00661063|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6505545|NCT00661063|Anesthetics, General|anesthetics, general|mesh-ancestor
6505546|NCT00661063|Anesthetics|anesthetics|mesh-ancestor
6505547|NCT00661063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6505548|NCT00661063|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6505549|NCT00661063|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6505550|NCT00661063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6505551|NCT00661063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505552|NCT00661063|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6505553|NCT00661063|Sympatholytics|sympatholytics|mesh-ancestor
6505554|NCT00661063|Autonomic Agents|autonomic agents|mesh-ancestor
6505555|NCT00661063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6505556|NCT00661063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5715291|NCT03247140|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
5715292|NCT03247140|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5715293|NCT03247140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5715294|NCT03247140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5715295|NCT03247140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5715296|NCT03247140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715297|NCT03247140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5715298|NCT03247140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715299|NCT03247140|Vasodilator Agents|vasodilator agents|mesh-ancestor
5715300|NCT03247140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5715301|NCT03247140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5715302|NCT03247140|Antimetabolites|antimetabolites|mesh-ancestor
6505557|NCT00661063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6505558|NCT00661063|Adrenergic Agents|adrenergic agents|mesh-ancestor
6505559|NCT00661076|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6505560|NCT00661076|Adefovir|adefovir|mesh-list
6505561|NCT00661076|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6242558|NCT02652624|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6242559|NCT02652624|Antiviral Agents|antiviral agents|mesh-ancestor
6242560|NCT02652624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6242561|NCT02652624|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6242562|NCT02652624|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6242563|NCT02653144|Dexamethasone|dexamethasone|mesh-list
6242564|NCT02653144|Dexmedetomidine|dexmedetomidine|mesh-list
6242565|NCT02653144|Ropivacaine|ropivacaine|mesh-list
6242566|NCT02653144|Anesthetics|anesthetics|mesh-list
6242567|NCT02653144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6505562|NCT00661076|Antiviral Agents|antiviral agents|mesh-ancestor
6505563|NCT00661076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6505564|NCT00661076|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6505565|NCT00661076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6505566|NCT00661076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6505567|NCT00661076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505568|NCT00661102|Capecitabine|capecitabine|mesh-list
6505569|NCT00661102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6505570|NCT00661102|Antimetabolites|antimetabolites|mesh-ancestor
6505571|NCT00661102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505572|NCT00661102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6505573|NCT00661115|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6505574|NCT00661115|Vasodilator Agents|vasodilator agents|mesh-ancestor
6505575|NCT00661115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6505576|NCT00661115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6505577|NCT00661115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6505578|NCT00661115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505579|NCT00661115|Urological Agents|urological agents|mesh-ancestor
6505580|NCT00661154|Bevacizumab|bevacizumab|mesh-list
6505581|NCT00661154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6242568|NCT02653144|Antiemetics|antiemetics|mesh-ancestor
6242569|NCT02653144|Autonomic Agents|autonomic agents|mesh-ancestor
6505582|NCT00661154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6505583|NCT00661154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6505584|NCT00661154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6505585|NCT00661154|Growth Substances|growth substances|mesh-ancestor
6505586|NCT00661154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505587|NCT00661154|Growth Inhibitors|growth inhibitors|mesh-ancestor
6505588|NCT00661167|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6505589|NCT00661167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6505590|NCT00661180|Sorafenib|sorafenib|mesh-list
6505591|NCT00661180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6505592|NCT00661180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6505593|NCT00661180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6505594|NCT00661180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505595|NCT00661206|Clopidogrel|clopidogrel|mesh-list
6505596|NCT00661206|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6505597|NCT00661206|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6505598|NCT00661206|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6505599|NCT00661206|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6505600|NCT00661206|Purinergic Agents|purinergic agents|mesh-ancestor
6505601|NCT00661206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6505602|NCT00661206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505603|NCT00661206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505604|NCT00661219|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6505605|NCT00661219|Vasodilator Agents|vasodilator agents|mesh-ancestor
6505606|NCT00661219|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6505607|NCT00661219|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6505608|NCT00661219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6505609|NCT00661219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505610|NCT00661219|Urological Agents|urological agents|mesh-ancestor
6505611|NCT00661297|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6505612|NCT00661297|Vasodilator Agents|vasodilator agents|mesh-ancestor
6505613|NCT00661297|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6505614|NCT00661297|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6505615|NCT00661297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6505616|NCT00661297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505617|NCT00661297|Urological Agents|urological agents|mesh-ancestor
6505618|NCT00661336|Melphalan|melphalan|mesh-list
6505619|NCT00661336|Buthionine Sulfoximine|buthionine sulfoximine|mesh-list
6505620|NCT00661336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6505621|NCT00661336|Alkylating Agents|alkylating agents|mesh-ancestor
6505622|NCT00661336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505623|NCT00661336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6505624|NCT00661336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6505625|NCT00661336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6505626|NCT00661336|Immunologic Factors|immunologic factors|mesh-ancestor
6505627|NCT00661336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505628|NCT00661336|Antimetabolites|antimetabolites|mesh-ancestor
6505629|NCT00661336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6505630|NCT00661336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6505631|NCT00661336|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6505632|NCT00661336|Protective Agents|protective agents|mesh-ancestor
6505633|NCT00661349|Ritonavir|ritonavir|mesh-list
6505634|NCT00661349|Lopinavir|lopinavir|mesh-list
6505635|NCT00661349|Nevirapine|nevirapine|mesh-list
6505636|NCT00661349|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6505637|NCT00661349|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6505638|NCT00661349|Protease Inhibitors|protease inhibitors|mesh-ancestor
6505639|NCT00661349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6505640|NCT00661349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505641|NCT00661349|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6505642|NCT00661349|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6505643|NCT00661349|Antiviral Agents|antiviral agents|mesh-ancestor
6505644|NCT00661349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6505645|NCT00661349|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6505646|NCT00661349|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5715303|NCT03247140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5715304|NCT03247140|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5715305|NCT03247140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5715306|NCT03247140|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5715307|NCT03247140|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5715308|NCT03247400|Atorvastatin|atorvastatin|mesh-list
5715309|NCT03247400|Simvastatin|simvastatin|mesh-list
5715310|NCT03247400|Calcium|calcium|mesh-list
5715311|NCT03247400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5715312|NCT03247400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715313|NCT03247400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5715314|NCT03247400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5715315|NCT03247400|Antimetabolites|antimetabolites|mesh-ancestor
5715316|NCT03247400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715317|NCT03247400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5715318|NCT03247400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5715319|NCT03247400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5715320|NCT03247296|Ribavirin|ribavirin|mesh-list
5715321|NCT03247296|Sofosbuvir|sofosbuvir|mesh-list
5715322|NCT03247296|Antimetabolites|antimetabolites|mesh-ancestor
5715323|NCT03247296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715324|NCT03247296|Antiviral Agents|antiviral agents|mesh-ancestor
5715325|NCT03247296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5715326|NCT03247257|Lidocaine|lidocaine|mesh-list
5715327|NCT03247257|Anesthetics|anesthetics|mesh-list
5715328|NCT03247257|Propofol|propofol|mesh-list
5715329|NCT03247257|Anesthetics, Local|anesthetics, local|mesh-ancestor
5715330|NCT03247257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6505647|NCT00661349|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6505648|NCT00661349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6505649|NCT00661349|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5715331|NCT03247257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715332|NCT03247257|Sensory System Agents|sensory system agents|mesh-ancestor
5715333|NCT03247257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5715334|NCT03247257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5715335|NCT03247257|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5715336|NCT03247257|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5715337|NCT03247257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5715338|NCT03247257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715339|NCT03247257|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5715340|NCT03247257|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5715341|NCT03247257|Anesthetics, General|anesthetics, general|mesh-ancestor
5715342|NCT03247218|Memantine|memantine|mesh-list
5715343|NCT03247218|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5715344|NCT03247218|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5715345|NCT03247218|Dopamine Agents|dopamine agents|mesh-ancestor
6505650|NCT00661349|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6505651|NCT00661375|Sorafenib|sorafenib|mesh-list
6505652|NCT00661375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6505653|NCT00661375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6505654|NCT00661375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6505655|NCT00661375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505656|NCT00661401|gamma-Globulins|gamma-globulins|mesh-list
6505657|NCT00661401|Immunologic Factors|immunologic factors|mesh-ancestor
6505658|NCT00661401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505659|NCT00661596|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6505660|NCT00661596|Vasodilator Agents|vasodilator agents|mesh-ancestor
6505661|NCT00661596|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6505662|NCT00661596|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6505663|NCT00661596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6505664|NCT00661596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505665|NCT00661596|Urological Agents|urological agents|mesh-ancestor
6505666|NCT00661635|Valdecoxib|valdecoxib|mesh-list
5715346|NCT03247218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5715347|NCT03247218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715348|NCT03247218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715349|NCT03247218|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5715350|NCT03247218|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5715351|NCT03246919|Oxytocin|oxytocin|mesh-list
5715352|NCT03246919|Oxytocics|oxytocics|mesh-ancestor
5715353|NCT03246919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5715354|NCT03246919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715355|NCT03247036|Fibrinolytic Agents|fibrinolytic agents|mesh-list
5715356|NCT03247036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5715357|NCT03247036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715358|NCT03246776|Triclosan|triclosan|mesh-list
6505667|NCT00661635|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6505668|NCT00661635|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6505669|NCT00661635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6505670|NCT00661635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505671|NCT00661635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6505672|NCT00661635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6505673|NCT00661635|Analgesics|analgesics|mesh-ancestor
6505674|NCT00661635|Sensory System Agents|sensory system agents|mesh-ancestor
6505675|NCT00661635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6505676|NCT00661635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505677|NCT00661635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6505678|NCT00661635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5715359|NCT03246776|Halometasone|halometasone|mesh-list
5715360|NCT03246776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6505679|NCT00661648|Pancrelipase|pancrelipase|mesh-list
6505680|NCT00661648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6505681|NCT00661700|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6505682|NCT00661700|Vasodilator Agents|vasodilator agents|mesh-ancestor
6505683|NCT00661700|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5715361|NCT03246776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5715362|NCT03246776|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5715363|NCT03246776|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5715364|NCT03246776|Antimetabolites|antimetabolites|mesh-ancestor
5715365|NCT03246776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715366|NCT03246776|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5715367|NCT03246776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5715368|NCT03246776|Dermatologic Agents|dermatologic agents|mesh-ancestor
5715369|NCT03246776|Glucocorticoids|glucocorticoids|mesh-ancestor
5715370|NCT03246776|Hormones|hormones|mesh-ancestor
6505684|NCT00661700|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6505685|NCT00661700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6505686|NCT00661700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505687|NCT00661700|Urological Agents|urological agents|mesh-ancestor
6505688|NCT00661739|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6505689|NCT00661739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6505690|NCT00661739|Alkylating Agents|alkylating agents|mesh-ancestor
6505691|NCT00661739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505692|NCT00661739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6505693|NCT00661765|Varenicline|varenicline|mesh-list
6505694|NCT00661765|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6505695|NCT00661765|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6505696|NCT00661765|Cholinergic Agents|cholinergic agents|mesh-ancestor
6505697|NCT00661765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6505698|NCT00661765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505699|NCT00661765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505700|NCT00661856|Genistein|genistein|mesh-list
6505701|NCT00661856|Daidzein|daidzein|mesh-list
6505702|NCT00661856|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6505703|NCT00661856|Protective Agents|protective agents|mesh-ancestor
6505704|NCT00661856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505705|NCT00661856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6505706|NCT00661856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6505707|NCT00661856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6505708|NCT00661856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505709|NCT00661856|Phytoestrogens|phytoestrogens|mesh-ancestor
6505710|NCT00661856|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6505711|NCT00661856|Estrogens|estrogens|mesh-ancestor
6505712|NCT00661856|Hormones|hormones|mesh-ancestor
6505713|NCT00661856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6505714|NCT00661973|Budesonide|budesonide|mesh-list
6505715|NCT00661973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6505716|NCT00661973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6505717|NCT00661973|Autonomic Agents|autonomic agents|mesh-ancestor
6505718|NCT00661973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6678375|NCT01593046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6678376|NCT01593046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6678377|NCT01593124|Imiquimod|imiquimod|mesh-list
6678378|NCT01593124|Nonoxynol|nonoxynol|mesh-list
6678379|NCT01593124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6678380|NCT01593124|Immunologic Factors|immunologic factors|mesh-ancestor
6678381|NCT01593124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678382|NCT01593124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6678383|NCT01593124|Interferon Inducers|interferon inducers|mesh-ancestor
6678384|NCT01593124|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
6678385|NCT01593124|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
6678386|NCT01593124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6505719|NCT00661973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505720|NCT00661973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6505721|NCT00661973|Respiratory System Agents|respiratory system agents|mesh-ancestor
6505722|NCT00661973|Glucocorticoids|glucocorticoids|mesh-ancestor
6505723|NCT00661973|Hormones|hormones|mesh-ancestor
6505724|NCT00661973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6678387|NCT01593124|Contraceptive Agents|contraceptive agents|mesh-ancestor
6678388|NCT01593124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6678389|NCT01593124|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6678390|NCT01593137|Metformin|metformin|mesh-list
6678391|NCT01593137|Liraglutide|liraglutide|mesh-list
6678392|NCT01593137|Glimepiride|glimepiride|mesh-list
6678393|NCT01593137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6678394|NCT01593137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678395|NCT01593137|Incretins|incretins|mesh-ancestor
6678396|NCT01593137|Hormones|hormones|mesh-ancestor
6678397|NCT01593137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6678398|NCT01593137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6678399|NCT01593137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6678400|NCT01593137|Immunologic Factors|immunologic factors|mesh-ancestor
6678401|NCT01593150|Dabigatran|dabigatran|mesh-list
6678402|NCT01593150|Antithrombins|antithrombins|mesh-ancestor
6678403|NCT01593150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6678404|NCT01593150|Protease Inhibitors|protease inhibitors|mesh-ancestor
6678405|NCT01593150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6678406|NCT01593150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678407|NCT01593150|Anticoagulants|anticoagulants|mesh-ancestor
6678408|NCT01593163|Ibuprofen|ibuprofen|mesh-list
6505725|NCT00662077|Ibandronic Acid|ibandronic acid|mesh-list
6505726|NCT00662077|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6505727|NCT00662077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505728|NCT00662220|Ribavirin|ribavirin|mesh-list
6505729|NCT00662220|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6505730|NCT00662220|Interferon-alpha|interferon-alpha|mesh-list
6505731|NCT00662220|Antimetabolites|antimetabolites|mesh-ancestor
6505732|NCT00662220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505733|NCT00662220|Antiviral Agents|antiviral agents|mesh-ancestor
6505734|NCT00662220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6505735|NCT00662220|Immunologic Factors|immunologic factors|mesh-ancestor
6505736|NCT00662220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505737|NCT00662233|Cyclophosphamide|cyclophosphamide|mesh-list
6505738|NCT00662233|Ifosfamide|ifosfamide|mesh-list
6505739|NCT00662233|Doxorubicin|doxorubicin|mesh-list
6505740|NCT00662233|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6505741|NCT00662233|Etoposide|etoposide|mesh-list
6505742|NCT00662233|Vincristine|vincristine|mesh-list
6505743|NCT00662233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6505744|NCT00662233|Immunologic Factors|immunologic factors|mesh-ancestor
6505745|NCT00662233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505746|NCT00662233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6505747|NCT00662233|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6505748|NCT00662233|Alkylating Agents|alkylating agents|mesh-ancestor
6505749|NCT00662233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505750|NCT00662233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6505751|NCT00662233|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6505752|NCT00662233|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6505753|NCT00662233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6505754|NCT00662233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6505755|NCT00662233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6505756|NCT00662233|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6505757|NCT00662233|Tubulin Modulators|tubulin modulators|mesh-ancestor
6505758|NCT00662233|Antimitotic Agents|antimitotic agents|mesh-ancestor
6505759|NCT00662233|Mitosis Modulators|mitosis modulators|mesh-ancestor
6505760|NCT00662272|Vaccines|vaccines|mesh-list
6505761|NCT00662272|Immunologic Factors|immunologic factors|mesh-ancestor
6505762|NCT00662272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505763|NCT00662337|Diphenhydramine|diphenhydramine|mesh-list
6505764|NCT00662337|Promethazine|promethazine|mesh-list
6505765|NCT00662337|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6505766|NCT00662337|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6505767|NCT00662337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6505768|NCT00662337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505769|NCT00662337|Anesthetics, Local|anesthetics, local|mesh-ancestor
6505770|NCT00662337|Anesthetics|anesthetics|mesh-ancestor
6505771|NCT00662337|Sensory System Agents|sensory system agents|mesh-ancestor
6505772|NCT00662337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6505773|NCT00662337|Antiemetics|antiemetics|mesh-ancestor
6505774|NCT00662337|Autonomic Agents|autonomic agents|mesh-ancestor
6505775|NCT00662337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6505776|NCT00662337|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6505777|NCT00662337|Histamine Antagonists|histamine antagonists|mesh-ancestor
6505778|NCT00662337|Histamine Agents|histamine agents|mesh-ancestor
6505779|NCT00662337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6505780|NCT00662337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505781|NCT00662337|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6505782|NCT00662337|Antipruritics|antipruritics|mesh-ancestor
6505783|NCT00662337|Dermatologic Agents|dermatologic agents|mesh-ancestor
6505784|NCT00662441|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6505785|NCT00662441|Vasodilator Agents|vasodilator agents|mesh-ancestor
6505786|NCT00662441|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6505787|NCT00662441|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6505788|NCT00662441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6505789|NCT00662441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505790|NCT00662441|Urological Agents|urological agents|mesh-ancestor
6505791|NCT00662454|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6505792|NCT00662454|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6505793|NCT00662454|Levonorgestrel|levonorgestrel|mesh-list
6505794|NCT00662454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6505795|NCT00662454|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
6505796|NCT00662454|Estradiol|estradiol|mesh-list
6505797|NCT00662454|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6505798|NCT00662454|Estrogens|estrogens|mesh-ancestor
6505799|NCT00662454|Hormones|hormones|mesh-ancestor
6505800|NCT00662454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6505801|NCT00662454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505802|NCT00662454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6505803|NCT00662454|Contraceptive Agents|contraceptive agents|mesh-ancestor
6505804|NCT00662454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6505805|NCT00662454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6505806|NCT00662454|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6505807|NCT00662454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6505808|NCT00662454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6505809|NCT00662454|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6505810|NCT00662467|Aspirin|aspirin|mesh-list
6505811|NCT00662467|Warfarin|warfarin|mesh-list
6505812|NCT00662467|Clopidogrel|clopidogrel|mesh-list
6505813|NCT00662467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6505814|NCT00662467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6505815|NCT00662467|Analgesics|analgesics|mesh-ancestor
6505816|NCT00662467|Sensory System Agents|sensory system agents|mesh-ancestor
6505817|NCT00662467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6505818|NCT00662467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505819|NCT00662467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6505820|NCT00662467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6505821|NCT00662467|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6505822|NCT00662467|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6505823|NCT00662467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505824|NCT00662467|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6505825|NCT00662467|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6505826|NCT00662467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6505827|NCT00662467|Antipyretics|antipyretics|mesh-ancestor
6505828|NCT00662467|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6505829|NCT00662467|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6505830|NCT00662467|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6505831|NCT00662467|Purinergic Agents|purinergic agents|mesh-ancestor
6505832|NCT00662467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6505833|NCT00662467|Anticoagulants|anticoagulants|mesh-ancestor
6505834|NCT00662519|Sargramostim|sargramostim|mesh-list
6505835|NCT00662519|Lenograstim|lenograstim|mesh-list
6505836|NCT00662519|Immunologic Factors|immunologic factors|mesh-ancestor
6505837|NCT00662519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505838|NCT00662519|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6505839|NCT00662571|Acamprosate|acamprosate|mesh-list
6505840|NCT00662571|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6505841|NCT00662610|Naproxen|naproxen|mesh-list
6505842|NCT00662610|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
6505843|NCT00662610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6505844|NCT00662610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6505845|NCT00662610|Analgesics|analgesics|mesh-ancestor
6505846|NCT00662610|Sensory System Agents|sensory system agents|mesh-ancestor
6505847|NCT00662610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6678409|NCT01593163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6678410|NCT01593163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6678411|NCT01593163|Analgesics|analgesics|mesh-ancestor
6678412|NCT01593163|Sensory System Agents|sensory system agents|mesh-ancestor
6678413|NCT01593163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6678414|NCT01593163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678415|NCT01593163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6678416|NCT01593163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6678417|NCT01593163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6678418|NCT01593163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6678419|NCT01593163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678420|NCT01593280|Morphine|morphine|mesh-list
6678421|NCT01593280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6678422|NCT01593280|Narcotics|narcotics|mesh-ancestor
6678423|NCT01593280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5722345|NCT03199924|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6505848|NCT00662610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505849|NCT00662610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6505850|NCT00662610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6505851|NCT00662610|Gout Suppressants|gout suppressants|mesh-ancestor
6505852|NCT00662610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6505853|NCT00662610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6505854|NCT00662610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505855|NCT00662610|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6505856|NCT00662636|Dasatinib|dasatinib|mesh-list
6505857|NCT00662636|Lapatinib|lapatinib|mesh-list
6505858|NCT00662636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6678424|NCT01593280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715371|NCT03246776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5715372|NCT03246776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721938|NCT03202628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5721939|NCT03202628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5721940|NCT03202628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5721941|NCT03202628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721942|NCT03202628|Protease Inhibitors|protease inhibitors|mesh-ancestor
5721943|NCT03202628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5721944|NCT03202628|Immunologic Factors|immunologic factors|mesh-ancestor
5721945|NCT03202628|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5721946|NCT03202628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5721947|NCT03202628|Growth Substances|growth substances|mesh-ancestor
5721948|NCT03202628|Growth Inhibitors|growth inhibitors|mesh-ancestor
5721949|NCT03202628|Dermatologic Agents|dermatologic agents|mesh-ancestor
5721950|NCT03202628|Glycine Agents|glycine agents|mesh-ancestor
5721951|NCT03202628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5721952|NCT03202719|Vaccines|vaccines|mesh-list
6505859|NCT00662636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6505860|NCT00662636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6505861|NCT00662636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678425|NCT01593280|Analgesics|analgesics|mesh-ancestor
6678426|NCT01593280|Sensory System Agents|sensory system agents|mesh-ancestor
6678427|NCT01593280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6678428|NCT01593293|Pemetrexed|pemetrexed|mesh-list
6678429|NCT01593293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6678430|NCT01593293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5721953|NCT03202719|Immunologic Factors|immunologic factors|mesh-ancestor
5721954|NCT03202719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721955|NCT03202407|Calcium|calcium|mesh-list
5721956|NCT03202407|Sevelamer|sevelamer|mesh-list
6678431|NCT01593293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678432|NCT01593293|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6678433|NCT01593293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6678434|NCT01593306|Paclitaxel|paclitaxel|mesh-list
6678435|NCT01593306|Cisplatin|cisplatin|mesh-list
6678436|NCT01593306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6678437|NCT01593306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6678438|NCT01593306|Tubulin Modulators|tubulin modulators|mesh-ancestor
6678439|NCT01593306|Antimitotic Agents|antimitotic agents|mesh-ancestor
6678440|NCT01593306|Mitosis Modulators|mitosis modulators|mesh-ancestor
6678441|NCT01593306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678442|NCT01593319|Ropivacaine|ropivacaine|mesh-list
6678443|NCT01593319|Anesthetics, Local|anesthetics, local|mesh-ancestor
6678444|NCT01593319|Anesthetics|anesthetics|mesh-ancestor
6678445|NCT01593319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6678446|NCT01593319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678447|NCT01593319|Sensory System Agents|sensory system agents|mesh-ancestor
6678448|NCT01593319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6678449|NCT01593332|Rituximab|rituximab|mesh-list
6678450|NCT01593332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6678451|NCT01593332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6678452|NCT01593332|Immunologic Factors|immunologic factors|mesh-ancestor
6678453|NCT01593332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678454|NCT01593332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6678455|NCT01593371|Metformin|metformin|mesh-list
6678456|NCT01593371|Pioglitazone|pioglitazone|mesh-list
6678457|NCT01593371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6678458|NCT01593371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721957|NCT03202407|Calcium acetate|calcium acetate|mesh-list
5721958|NCT03202407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5721959|NCT03202407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721960|NCT03202407|Chelating Agents|chelating agents|mesh-ancestor
5721961|NCT03202407|Sequestering Agents|sequestering agents|mesh-ancestor
5721962|NCT03202407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721963|NCT03202446|Cyclophosphamide|cyclophosphamide|mesh-list
5721964|NCT03202446|Chitosan|chitosan|mesh-list
6678459|NCT01593397|Fentanyl|fentanyl|mesh-list
6678460|NCT01593397|Propofol|propofol|mesh-list
6678461|NCT01593397|Anesthetics|anesthetics|mesh-list
6678462|NCT01593397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5721965|NCT03202446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6678463|NCT01593397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6678464|NCT01593397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505862|NCT00662714|Insulin|insulin|mesh-list
6505863|NCT00662714|Repaglinide|repaglinide|mesh-list
6505864|NCT00662714|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6505865|NCT00662714|Insulin, Short-Acting|insulin, short-acting|mesh-list
6505866|NCT00662714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6505867|NCT00662714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505868|NCT00662779|Formoterol Fumarate|formoterol fumarate|mesh-list
6505869|NCT00662779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6505870|NCT00662779|Autonomic Agents|autonomic agents|mesh-ancestor
6505871|NCT00662779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6505872|NCT00662779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505873|NCT00662779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6505874|NCT00662779|Respiratory System Agents|respiratory system agents|mesh-ancestor
6505875|NCT00662779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6505876|NCT00662779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6505877|NCT00662779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6505878|NCT00662779|Adrenergic Agents|adrenergic agents|mesh-ancestor
6505879|NCT00662779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6505880|NCT00662779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505881|NCT00662805|Fluticasone|fluticasone|mesh-list
6505882|NCT00662805|Xhance|xhance|mesh-list
6505883|NCT00662805|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6505884|NCT00662805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6505885|NCT00662805|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6505886|NCT00662805|Autonomic Agents|autonomic agents|mesh-ancestor
6505887|NCT00662805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6505888|NCT00662805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505889|NCT00662805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6505890|NCT00662805|Respiratory System Agents|respiratory system agents|mesh-ancestor
6505891|NCT00662805|Dermatologic Agents|dermatologic agents|mesh-ancestor
6505892|NCT00662805|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6505893|NCT00662805|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6505894|NCT00662805|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6505895|NCT00662805|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6505896|NCT00662805|Adrenergic Agents|adrenergic agents|mesh-ancestor
6505897|NCT00662805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6505898|NCT00662805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505899|NCT00662844|Vitamin D|vitamin d|mesh-list
5715373|NCT03246750|Cisplatin|cisplatin|mesh-list
6505900|NCT00662844|Cholecalciferol|cholecalciferol|mesh-list
6505901|NCT00662844|Vitamins|vitamins|mesh-ancestor
6505902|NCT00662844|Micronutrients|micronutrients|mesh-ancestor
6505903|NCT00662844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505904|NCT00662844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6505905|NCT00662844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6505906|NCT00662883|Mometasone Furoate|mometasone furoate|mesh-list
6505907|NCT00662883|Ketamine|ketamine|mesh-list
6505908|NCT00662883|Analgesics|analgesics|mesh-ancestor
6505909|NCT00662883|Sensory System Agents|sensory system agents|mesh-ancestor
6505910|NCT00662883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6505911|NCT00662883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505912|NCT00662883|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6505913|NCT00662883|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6505914|NCT00662883|Anesthetics, General|anesthetics, general|mesh-ancestor
6505915|NCT00662883|Anesthetics|anesthetics|mesh-ancestor
6505916|NCT00662883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6505917|NCT00662883|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6505918|NCT00662883|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6505919|NCT00662883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6505920|NCT00662883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505921|NCT00662883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6505922|NCT00662883|Dermatologic Agents|dermatologic agents|mesh-ancestor
6505923|NCT00662883|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6505924|NCT00662896|Ibuprofen|ibuprofen|mesh-list
6505925|NCT00662896|Naproxen|naproxen|mesh-list
6505926|NCT00662896|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
6505927|NCT00662896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6505928|NCT00662896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6505929|NCT00662896|Analgesics|analgesics|mesh-ancestor
6505930|NCT00662896|Sensory System Agents|sensory system agents|mesh-ancestor
6505931|NCT00662896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6505932|NCT00662896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505933|NCT00662896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6505934|NCT00662896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6505935|NCT00662896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6505936|NCT00662896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6505937|NCT00662896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505938|NCT00662896|Gout Suppressants|gout suppressants|mesh-ancestor
6505939|NCT00662896|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6505940|NCT00662948|Rituximab|rituximab|mesh-list
6505941|NCT00662948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6505942|NCT00662948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6505943|NCT00662948|Immunologic Factors|immunologic factors|mesh-ancestor
6505944|NCT00662948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505945|NCT00662948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6505946|NCT00662987|Amoxicillin|amoxicillin|mesh-list
6505947|NCT00662987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6505948|NCT00662987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6505949|NCT00663052|Etanercept|etanercept|mesh-list
6505950|NCT00663052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6505951|NCT00663052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6505952|NCT00663052|Analgesics|analgesics|mesh-ancestor
6505953|NCT00663052|Sensory System Agents|sensory system agents|mesh-ancestor
6505954|NCT00663052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6505955|NCT00663052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505956|NCT00663052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6505957|NCT00663052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6505958|NCT00663052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6505959|NCT00663052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6505960|NCT00663052|Immunologic Factors|immunologic factors|mesh-ancestor
6505961|NCT00663130|Tadalafil|tadalafil|mesh-list
6505962|NCT00663130|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6505963|NCT00663130|Vasodilator Agents|vasodilator agents|mesh-ancestor
6505964|NCT00663130|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6505965|NCT00663130|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6505966|NCT00663130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6505967|NCT00663130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505968|NCT00663130|Urological Agents|urological agents|mesh-ancestor
6505969|NCT00663182|Entecavir|entecavir|mesh-list
6505970|NCT00663182|Antiviral Agents|antiviral agents|mesh-ancestor
6678465|NCT01593397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6678466|NCT01593397|Anesthetics, General|anesthetics, general|mesh-ancestor
5715374|NCT03246750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5715375|NCT03246880|Tadalafil|tadalafil|mesh-list
5715376|NCT03246880|Tamsulosin|tamsulosin|mesh-list
6505971|NCT00663182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6505972|NCT00663195|Furosemide|furosemide|mesh-list
6505973|NCT00663195|Spironolactone|spironolactone|mesh-list
6505974|NCT00663195|Diuretics|diuretics|mesh-ancestor
6505975|NCT00663195|Natriuretic Agents|natriuretic agents|mesh-ancestor
6505976|NCT00663195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505977|NCT00663195|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6505978|NCT00663195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6505979|NCT00663195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6505980|NCT00663195|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6505981|NCT00663195|Hormone Antagonists|hormone antagonists|mesh-ancestor
6505982|NCT00663195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6505983|NCT00663195|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6505984|NCT00663221|Vitamin D|vitamin d|mesh-list
6505985|NCT00663221|Calcium|calcium|mesh-list
6505986|NCT00663221|Vitamins|vitamins|mesh-ancestor
6505987|NCT00663221|Micronutrients|micronutrients|mesh-ancestor
6505988|NCT00663221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505989|NCT00663221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6505990|NCT00663221|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5715377|NCT03246880|Vasodilator Agents|vasodilator agents|mesh-ancestor
5715378|NCT03246880|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5715379|NCT03246880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5715380|NCT03246880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5715381|NCT03246880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715382|NCT03246880|Urological Agents|urological agents|mesh-ancestor
5715383|NCT03246880|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5715384|NCT03246880|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5715385|NCT03246880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5715386|NCT03246880|Adrenergic Agents|adrenergic agents|mesh-ancestor
5715387|NCT03246880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5715388|NCT03246880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715389|NCT03246555|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5715390|NCT03246555|Perindopril|perindopril|mesh-list
6505991|NCT00663247|Mesalamine|mesalamine|mesh-list
6505992|NCT00663247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6505993|NCT00663247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5715391|NCT03246555|Indapamide|indapamide|mesh-list
5715392|NCT03246555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5715393|NCT03246555|Diuretics|diuretics|mesh-ancestor
5715394|NCT03246555|Natriuretic Agents|natriuretic agents|mesh-ancestor
5715395|NCT03246555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505994|NCT00663247|Analgesics|analgesics|mesh-ancestor
6505995|NCT00663247|Sensory System Agents|sensory system agents|mesh-ancestor
6505996|NCT00663247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6505997|NCT00663247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6505998|NCT00663247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6505999|NCT00663247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6506000|NCT00663286|Clindamycin|clindamycin|mesh-list
6506001|NCT00663286|Clindamycin palmitate|clindamycin palmitate|mesh-list
6506002|NCT00663286|Clindamycin phosphate|clindamycin phosphate|mesh-list
6506003|NCT00663286|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6506004|NCT00663286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6506005|NCT00663286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6506006|NCT00663286|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6506007|NCT00663286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5715396|NCT03246555|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5715397|NCT03246555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5715398|NCT03246555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715399|NCT03246555|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5715400|NCT03246555|Protease Inhibitors|protease inhibitors|mesh-ancestor
5715401|NCT03246555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5715402|NCT03246620|Diazepam|diazepam|mesh-list
5715403|NCT03246620|Haloperidol|haloperidol|mesh-list
5715404|NCT03246620|Olanzapine|olanzapine|mesh-list
5715405|NCT03246620|Haloperidol decanoate|haloperidol decanoate|mesh-list
5715406|NCT03246620|Antiemetics|antiemetics|mesh-ancestor
5715407|NCT03246620|Autonomic Agents|autonomic agents|mesh-ancestor
5715408|NCT03246620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5715409|NCT03246620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715410|NCT03246620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5715411|NCT03246620|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5715412|NCT03246620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5715413|NCT03246620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5715414|NCT03246620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5715415|NCT03246620|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5715416|NCT03246620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5715417|NCT03246620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5715418|NCT03246620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715419|NCT03246620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5715420|NCT03246620|Serotonin Agents|serotonin agents|mesh-ancestor
5715421|NCT03246620|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5715422|NCT03246620|Dopamine Agents|dopamine agents|mesh-ancestor
5715423|NCT03246620|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5715424|NCT03246620|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5715425|NCT03246620|Anticonvulsants|anticonvulsants|mesh-ancestor
5715426|NCT03246620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5715427|NCT03246620|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5715428|NCT03246620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5715429|NCT03246620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5715430|NCT03246620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5715431|NCT03246620|Anesthetics, General|anesthetics, general|mesh-ancestor
5715432|NCT03246620|Anesthetics|anesthetics|mesh-ancestor
5715433|NCT03246620|GABA Modulators|gaba modulators|mesh-ancestor
6242570|NCT02653144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6242571|NCT02653144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6242572|NCT02653144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6242573|NCT02653144|Glucocorticoids|glucocorticoids|mesh-ancestor
6242574|NCT02653144|Hormones|hormones|mesh-ancestor
6242575|NCT02653144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6242576|NCT02653144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6242577|NCT02653144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6242578|NCT02653144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6506008|NCT00663286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506009|NCT00663286|Dermatologic Agents|dermatologic agents|mesh-ancestor
6506010|NCT00663312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
6506011|NCT00663312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6506012|NCT00663312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506013|NCT00663338|Rotigotine|rotigotine|mesh-list
6506014|NCT00663338|Dopamine Agonists|dopamine agonists|mesh-ancestor
6506015|NCT00663338|Dopamine Agents|dopamine agents|mesh-ancestor
6506016|NCT00663338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6506017|NCT00663338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506018|NCT00663338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506019|NCT00663377|Losartan|losartan|mesh-list
6506020|NCT00663377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6506021|NCT00663377|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6506022|NCT00663377|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6506023|NCT00663377|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6506024|NCT00663377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506025|NCT00663442|Methylphenidate|methylphenidate|mesh-list
6506026|NCT00663442|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6506027|NCT00663442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678467|NCT01593397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6678468|NCT01593397|Narcotics|narcotics|mesh-ancestor
6506028|NCT00663442|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6506029|NCT00663442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6506030|NCT00663442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6506031|NCT00663442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506032|NCT00663442|Dopamine Agents|dopamine agents|mesh-ancestor
6506033|NCT00663442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6506034|NCT00663455|Cyclosporine|cyclosporine|mesh-list
6506035|NCT00663455|Cyclosporins|cyclosporins|mesh-list
6506036|NCT00663455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6506037|NCT00663455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506038|NCT00663455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6506039|NCT00663455|Immunologic Factors|immunologic factors|mesh-ancestor
6506040|NCT00663455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506041|NCT00663455|Antifungal Agents|antifungal agents|mesh-ancestor
6506042|NCT00663455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6506043|NCT00663455|Dermatologic Agents|dermatologic agents|mesh-ancestor
6506044|NCT00663455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6506045|NCT00663455|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6506046|NCT00663481|Leucovorin|leucovorin|mesh-list
6506047|NCT00663481|Antidotes|antidotes|mesh-ancestor
6506048|NCT00663481|Protective Agents|protective agents|mesh-ancestor
6506049|NCT00663481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506050|NCT00663481|Vitamin B Complex|vitamin b complex|mesh-ancestor
6506051|NCT00663481|Vitamins|vitamins|mesh-ancestor
6506052|NCT00663481|Micronutrients|micronutrients|mesh-ancestor
6506053|NCT00663559|Sunitinib|sunitinib|mesh-list
6506054|NCT00663559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6506055|NCT00663559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6506056|NCT00663559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6506057|NCT00663559|Growth Substances|growth substances|mesh-ancestor
6506058|NCT00663559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506059|NCT00663559|Growth Inhibitors|growth inhibitors|mesh-ancestor
6506060|NCT00663559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6506061|NCT00663559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6678469|NCT01593397|Analgesics|analgesics|mesh-ancestor
6506062|NCT00663559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506063|NCT00663598|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6506064|NCT00663598|Vasodilator Agents|vasodilator agents|mesh-ancestor
6506065|NCT00663598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6506066|NCT00663598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6506067|NCT00663598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6506068|NCT00663598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506069|NCT00663598|Urological Agents|urological agents|mesh-ancestor
6506070|NCT00663624|Insulin Aspart|insulin aspart|mesh-list
6506071|NCT00663624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6506072|NCT00663624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506073|NCT00663689|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6506074|NCT00663689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6506075|NCT00663689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6506076|NCT00663689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6506077|NCT00663689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506078|NCT00663728|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6506079|NCT00663728|Vasodilator Agents|vasodilator agents|mesh-ancestor
6506080|NCT00663728|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6506081|NCT00663728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6506082|NCT00663728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6506083|NCT00663728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678470|NCT01593397|Sensory System Agents|sensory system agents|mesh-ancestor
6506084|NCT00663728|Urological Agents|urological agents|mesh-ancestor
6506085|NCT00663741|Sorafenib|sorafenib|mesh-list
6506086|NCT00663741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6506087|NCT00663741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6506088|NCT00663741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6506089|NCT00663741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506090|NCT00663806|Ciprofloxacin|ciprofloxacin|mesh-list
6506091|NCT00663806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5715434|NCT03246620|GABA Agents|gaba agents|mesh-ancestor
5715435|NCT03246659|Polygeline|polygeline|mesh-list
5715436|NCT03246659|Gastrins|gastrins|mesh-list
5715437|NCT03246659|Plasma Substitutes|plasma substitutes|mesh-ancestor
5715438|NCT03246659|Blood Substitutes|blood substitutes|mesh-ancestor
5715439|NCT03246659|Hormones|hormones|mesh-ancestor
5715440|NCT03246659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5715441|NCT03246659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715442|NCT03246685|Pembrolizumab|pembrolizumab|mesh-list
5715443|NCT03246685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5715444|NCT03246685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5715445|NCT03246581|Tiotropium Bromide|tiotropium bromide|mesh-list
5715446|NCT03246581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5715447|NCT03246581|Autonomic Agents|autonomic agents|mesh-ancestor
5715448|NCT03246581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5715449|NCT03246581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715450|NCT03246581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5715451|NCT03246581|Respiratory System Agents|respiratory system agents|mesh-ancestor
5715452|NCT03246581|Parasympatholytics|parasympatholytics|mesh-ancestor
5715453|NCT03246581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5715454|NCT03246581|Cholinergic Agents|cholinergic agents|mesh-ancestor
5715455|NCT03246581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6506092|NCT00663806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6506093|NCT00663806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6506094|NCT00663806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6506095|NCT00663806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6506096|NCT00663806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506097|NCT00663806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6506098|NCT00663806|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6506099|NCT00663806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6506100|NCT00663832|Panobinostat|panobinostat|mesh-list
6506101|NCT00663832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6506102|NCT00663832|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6506103|NCT00663832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6506104|NCT00663832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506105|NCT00663845|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6506106|NCT00663845|Vasodilator Agents|vasodilator agents|mesh-ancestor
6506107|NCT00663845|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6506108|NCT00663845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5715456|NCT03246581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506109|NCT00663845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6506110|NCT00663845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506111|NCT00663845|Urological Agents|urological agents|mesh-ancestor
6506112|NCT00663884|Voglibose|voglibose|mesh-list
6506113|NCT00663884|Mitiglinide|mitiglinide|mesh-list
6506114|NCT00663884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6506115|NCT00663884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506116|NCT00663884|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6506117|NCT00663884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6506118|NCT00663884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506119|NCT00663897|Lansoprazole|lansoprazole|mesh-list
6506120|NCT00663897|Dexlansoprazole|dexlansoprazole|mesh-list
6506121|NCT00663897|Mosapride|mosapride|mesh-list
6506122|NCT00663897|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6506123|NCT00663897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6506124|NCT00663897|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6506125|NCT00663897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6506126|NCT00663897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506127|NCT00663897|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6506128|NCT00663897|Serotonin Agents|serotonin agents|mesh-ancestor
6506129|NCT00663897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6506130|NCT00663897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506131|NCT00663910|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6506132|NCT00663910|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6506133|NCT00663910|Dermatologic Agents|dermatologic agents|mesh-ancestor
5715457|NCT03246529|Lenograstim|lenograstim|mesh-list
6506134|NCT00663949|Captopril|captopril|mesh-list
6506135|NCT00663949|Pentoxifylline|pentoxifylline|mesh-list
6506136|NCT00663949|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6506137|NCT00663949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6506138|NCT00663949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506139|NCT00663949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6506140|NCT00663949|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5715458|NCT03246529|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5715459|NCT03246529|Immunologic Factors|immunologic factors|mesh-ancestor
5715460|NCT03246529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715461|NCT03246386|Posaconazole|posaconazole|mesh-list
5715462|NCT03246386|Antifungal Agents|antifungal agents|mesh-ancestor
5715463|NCT03246386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5715464|NCT03246386|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5715465|NCT03246386|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5715466|NCT03246386|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5715467|NCT03246386|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5715468|NCT03246386|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5715469|NCT03246386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5715470|NCT03246386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715471|NCT03246386|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5715472|NCT03246386|Hormone Antagonists|hormone antagonists|mesh-ancestor
5715473|NCT03246386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5715474|NCT03246386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715475|NCT03246451|Metformin|metformin|mesh-list
5715476|NCT03246451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5715477|NCT03246451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715478|NCT03246360|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5715479|NCT03246360|Cloxacillin|cloxacillin|mesh-list
5715480|NCT03246360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5715481|NCT03246295|Insulin|insulin|mesh-list
5715482|NCT03246295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5715483|NCT03246295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715484|NCT03246009|Lenograstim|lenograstim|mesh-list
5715485|NCT03246009|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5715486|NCT03246009|Immunologic Factors|immunologic factors|mesh-ancestor
5715487|NCT03246009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715488|NCT03246399|Lorecivivint|lorecivivint|mesh-list
5715489|NCT03246399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5715490|NCT03246113|Temozolomide|temozolomide|mesh-list
5715491|NCT03246113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5715492|NCT03246113|Alkylating Agents|alkylating agents|mesh-ancestor
5715493|NCT03246113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715494|NCT03246113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5715495|NCT03245853|Riboflavin|riboflavin|mesh-list
5715496|NCT03245853|Flavin Mononucleotide|flavin mononucleotide|mesh-list
5715497|NCT03245853|Vitamin B Complex|vitamin b complex|mesh-ancestor
5715498|NCT03245853|Vitamins|vitamins|mesh-ancestor
5715499|NCT03245853|Micronutrients|micronutrients|mesh-ancestor
5715500|NCT03245853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715501|NCT03245853|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5715502|NCT03245853|Dermatologic Agents|dermatologic agents|mesh-ancestor
5715503|NCT03245827|Clomiphene|clomiphene|mesh-list
5715504|NCT03245827|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5715505|NCT03245827|Hormone Antagonists|hormone antagonists|mesh-ancestor
5715506|NCT03245827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5715507|NCT03245827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715508|NCT03245827|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5715509|NCT03245827|Fertility Agents|fertility agents|mesh-ancestor
5715510|NCT03245827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5715511|NCT03245827|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5715512|NCT03245827|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5715513|NCT03245970|Atenolol|atenolol|mesh-list
5715514|NCT03245970|Labetalol|labetalol|mesh-list
5715515|NCT03245970|Nifedipine|nifedipine|mesh-list
5715516|NCT03245970|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5715517|NCT03245970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5715518|NCT03245970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715519|NCT03245970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5715520|NCT03245970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715521|NCT03245970|Vasodilator Agents|vasodilator agents|mesh-ancestor
5715522|NCT03245970|Tocolytic Agents|tocolytic agents|mesh-ancestor
5715523|NCT03245970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5715524|NCT03245970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6506141|NCT00663949|Protective Agents|protective agents|mesh-ancestor
5715525|NCT03245970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6506142|NCT00663949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506143|NCT00663949|Vasodilator Agents|vasodilator agents|mesh-ancestor
6506144|NCT00663949|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6506145|NCT00663949|Antioxidants|antioxidants|mesh-ancestor
6506146|NCT00663949|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6506147|NCT00663949|Protease Inhibitors|protease inhibitors|mesh-ancestor
6506148|NCT00663949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6506149|NCT00664001|Antioxidants|antioxidants|mesh-list
6506150|NCT00664001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506151|NCT00664001|Protective Agents|protective agents|mesh-ancestor
6506152|NCT00664001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506153|NCT00664014|Tolvaptan|tolvaptan|mesh-list
6506154|NCT00664014|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6506155|NCT00664014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506156|NCT00664014|Natriuretic Agents|natriuretic agents|mesh-ancestor
6506157|NCT00664014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506158|NCT00664040|Aspirin|aspirin|mesh-list
6506159|NCT00664040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6506160|NCT00664040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6506161|NCT00664040|Analgesics|analgesics|mesh-ancestor
6506162|NCT00664040|Sensory System Agents|sensory system agents|mesh-ancestor
6506163|NCT00664040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6506164|NCT00664040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506165|NCT00664040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6506166|NCT00664040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6506167|NCT00664040|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6506168|NCT00664040|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6506169|NCT00664040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506170|NCT00664040|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6506171|NCT00664040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6506172|NCT00664040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6506173|NCT00664040|Antipyretics|antipyretics|mesh-ancestor
6506174|NCT00664053|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
6506175|NCT00664053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6506176|NCT00664053|Immunologic Factors|immunologic factors|mesh-ancestor
6506177|NCT00664053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506178|NCT00664144|Rasburicase|rasburicase|mesh-list
6506179|NCT00664144|Gout Suppressants|gout suppressants|mesh-ancestor
6506180|NCT00664144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6506181|NCT00664170|Docetaxel|docetaxel|mesh-list
6506182|NCT00664170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6506183|NCT00664170|Tubulin Modulators|tubulin modulators|mesh-ancestor
6506184|NCT00664170|Antimitotic Agents|antimitotic agents|mesh-ancestor
6506185|NCT00664170|Mitosis Modulators|mitosis modulators|mesh-ancestor
6506186|NCT00664170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506187|NCT00664196|Hormones|hormones|mesh-list
6506188|NCT00664196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6506189|NCT00664196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678471|NCT01593397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6678472|NCT01593397|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6678473|NCT01593410|Dexamethasone|dexamethasone|mesh-list
6678474|NCT01593410|Lenalidomide|lenalidomide|mesh-list
6678475|NCT01593410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6506190|NCT00664222|Furosemide|furosemide|mesh-list
6506191|NCT00664222|Spironolactone|spironolactone|mesh-list
6506192|NCT00664222|Diuretics|diuretics|mesh-ancestor
6678476|NCT01593410|Antiemetics|antiemetics|mesh-ancestor
6678477|NCT01593410|Autonomic Agents|autonomic agents|mesh-ancestor
6678478|NCT01593410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6506193|NCT00664222|Natriuretic Agents|natriuretic agents|mesh-ancestor
6506194|NCT00664222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506195|NCT00664222|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6506196|NCT00664222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6506197|NCT00664222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678479|NCT01593410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678480|NCT01593410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6506198|NCT00664222|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6506199|NCT00664222|Hormone Antagonists|hormone antagonists|mesh-ancestor
6506200|NCT00664222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6506201|NCT00664222|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6506202|NCT00664248|Clindamycin|clindamycin|mesh-list
6506203|NCT00664248|Clindamycin palmitate|clindamycin palmitate|mesh-list
6506204|NCT00664248|Clindamycin phosphate|clindamycin phosphate|mesh-list
6506205|NCT00664248|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6506206|NCT00664248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6506207|NCT00664248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6506208|NCT00664248|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6506209|NCT00664248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6506210|NCT00664248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506211|NCT00664248|Dermatologic Agents|dermatologic agents|mesh-ancestor
6506212|NCT00664287|Niacin|niacin|mesh-list
6506213|NCT00664287|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6506214|NCT00664287|Antimetabolites|antimetabolites|mesh-ancestor
6506215|NCT00664287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506216|NCT00664287|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5715526|NCT03245970|Sympatholytics|sympatholytics|mesh-ancestor
5715527|NCT03245970|Autonomic Agents|autonomic agents|mesh-ancestor
5715528|NCT03245970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5715529|NCT03245970|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5715530|NCT03245970|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5715531|NCT03245970|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5715532|NCT03245970|Adrenergic Agents|adrenergic agents|mesh-ancestor
5715533|NCT03245970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5715534|NCT03245970|Sympathomimetics|sympathomimetics|mesh-ancestor
5715535|NCT03245970|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5715536|NCT03245970|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5715537|NCT03245996|Atenolol|atenolol|mesh-list
5715538|NCT03245996|Nebivolol|nebivolol|mesh-list
5715539|NCT03245996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5715540|NCT03245996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5715541|NCT03245996|Sympatholytics|sympatholytics|mesh-ancestor
5715542|NCT03245996|Autonomic Agents|autonomic agents|mesh-ancestor
5715543|NCT03245996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5715544|NCT03245996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715545|NCT03245996|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5715546|NCT03245996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5715547|NCT03245996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5715548|NCT03245996|Adrenergic Agents|adrenergic agents|mesh-ancestor
5715549|NCT03245996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5715550|NCT03245996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715551|NCT03245996|Vasodilator Agents|vasodilator agents|mesh-ancestor
5715552|NCT03245996|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5715553|NCT03245996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6506217|NCT00664287|Vasodilator Agents|vasodilator agents|mesh-ancestor
6506218|NCT00664287|Vitamin B Complex|vitamin b complex|mesh-ancestor
6506219|NCT00664287|Vitamins|vitamins|mesh-ancestor
6506220|NCT00664287|Micronutrients|micronutrients|mesh-ancestor
6506221|NCT00664287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506222|NCT00664313|Linezolid|linezolid|mesh-list
6506223|NCT00664313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6506224|NCT00664313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6506225|NCT00664313|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6506226|NCT00664313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6506227|NCT00664313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678481|NCT01593410|Glucocorticoids|glucocorticoids|mesh-ancestor
6678482|NCT01593410|Hormones|hormones|mesh-ancestor
6678483|NCT01593410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6678484|NCT01593410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6678485|NCT01593410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6678486|NCT01593410|Immunologic Factors|immunologic factors|mesh-ancestor
6678487|NCT01593410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6678488|NCT01593410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6678489|NCT01593410|Growth Substances|growth substances|mesh-ancestor
6678490|NCT01593410|Growth Inhibitors|growth inhibitors|mesh-ancestor
6678491|NCT01593488|Cytarabine|cytarabine|mesh-list
6678492|NCT01593488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6678493|NCT01593488|Antimetabolites|antimetabolites|mesh-ancestor
6678494|NCT01593488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678495|NCT01593488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6678496|NCT01593488|Antiviral Agents|antiviral agents|mesh-ancestor
6678497|NCT01593488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6678498|NCT01593488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6678499|NCT01593488|Immunologic Factors|immunologic factors|mesh-ancestor
6678500|NCT01593488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678501|NCT01593501|Vitamin D|vitamin d|mesh-list
6678502|NCT01593501|Cholecalciferol|cholecalciferol|mesh-list
6678503|NCT01593501|Vitamins|vitamins|mesh-ancestor
6678504|NCT01593501|Micronutrients|micronutrients|mesh-ancestor
6506228|NCT00664417|Vaccines|vaccines|mesh-list
6506229|NCT00664417|Immunologic Factors|immunologic factors|mesh-ancestor
6506230|NCT00664417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506231|NCT00664469|Atorvastatin|atorvastatin|mesh-list
6506232|NCT00664469|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6506233|NCT00664469|Simvastatin|simvastatin|mesh-list
6506234|NCT00664469|Ezetimibe|ezetimibe|mesh-list
5715554|NCT03245996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5715555|NCT03245918|Aprepitant|aprepitant|mesh-list
5715556|NCT03245918|Fosaprepitant|fosaprepitant|mesh-list
5715557|NCT03245918|Antiemetics|antiemetics|mesh-ancestor
5715558|NCT03245918|Autonomic Agents|autonomic agents|mesh-ancestor
5715559|NCT03245918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5715560|NCT03245918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715561|NCT03245918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5715562|NCT03245918|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5715563|NCT03245918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6506235|NCT00664469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6506236|NCT00664469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6506237|NCT00664469|Antimetabolites|antimetabolites|mesh-ancestor
6506238|NCT00664469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506239|NCT00664469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6506240|NCT00664469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6506241|NCT00664469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6506242|NCT00664586|Masoprocol|masoprocol|mesh-list
6506243|NCT00664586|Antioxidants|antioxidants|mesh-ancestor
6506244|NCT00664586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506245|NCT00664586|Protective Agents|protective agents|mesh-ancestor
6506246|NCT00664586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506247|NCT00664586|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6506248|NCT00664586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6506249|NCT00664586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6506250|NCT00664586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6506251|NCT00664586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6506252|NCT00664586|Analgesics|analgesics|mesh-ancestor
6506253|NCT00664586|Sensory System Agents|sensory system agents|mesh-ancestor
6506254|NCT00664586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6506255|NCT00664586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6506256|NCT00664586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6506257|NCT00664599|Rituximab|rituximab|mesh-list
5715564|NCT03245918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715565|NCT03245892|Paclitaxel|paclitaxel|mesh-list
5715566|NCT03245892|Carboplatin|carboplatin|mesh-list
5715567|NCT03245892|Nivolumab|nivolumab|mesh-list
5715568|NCT03245892|Ipilimumab|ipilimumab|mesh-list
5715569|NCT03245892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5715570|NCT03245892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5715571|NCT03245892|Tubulin Modulators|tubulin modulators|mesh-ancestor
5715572|NCT03245892|Antimitotic Agents|antimitotic agents|mesh-ancestor
5715573|NCT03245892|Mitosis Modulators|mitosis modulators|mesh-ancestor
5715574|NCT03245892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715575|NCT03245892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5715576|NCT03245892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5715577|NCT03245658|Nabiximols|nabiximols|mesh-list
5715578|NCT03245658|Analgesics|analgesics|mesh-ancestor
5715579|NCT03245658|Sensory System Agents|sensory system agents|mesh-ancestor
5715580|NCT03245658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5715581|NCT03245658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715582|NCT03245671|Dexamethasone|dexamethasone|mesh-list
5715583|NCT03245671|Dexamethasone acetate|dexamethasone acetate|mesh-list
5715584|NCT03245671|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5715585|NCT03245671|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
5715586|NCT03245671|BB 1101|bb 1101|mesh-list
5715587|NCT03245671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6506258|NCT00664599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6506259|NCT00664599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6506260|NCT00664599|Immunologic Factors|immunologic factors|mesh-ancestor
6506261|NCT00664599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506262|NCT00664599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6506263|NCT00664677|Masoprocol|masoprocol|mesh-list
6506264|NCT00664677|Antioxidants|antioxidants|mesh-ancestor
6506265|NCT00664677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506266|NCT00664677|Protective Agents|protective agents|mesh-ancestor
5715588|NCT03245671|Antiemetics|antiemetics|mesh-ancestor
5715589|NCT03245671|Autonomic Agents|autonomic agents|mesh-ancestor
5715590|NCT03245671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5721966|NCT03202446|Immunologic Factors|immunologic factors|mesh-ancestor
6506267|NCT00664677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506268|NCT00664677|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6506269|NCT00664677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6506270|NCT00664677|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6506271|NCT00664677|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6506272|NCT00664677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6506273|NCT00664677|Analgesics|analgesics|mesh-ancestor
6506274|NCT00664677|Sensory System Agents|sensory system agents|mesh-ancestor
6506275|NCT00664677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6506276|NCT00664677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6506277|NCT00664677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6506278|NCT00664690|Celecoxib|celecoxib|mesh-list
6506279|NCT00664690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6506280|NCT00664690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6506281|NCT00664690|Analgesics|analgesics|mesh-ancestor
6506282|NCT00664690|Sensory System Agents|sensory system agents|mesh-ancestor
6506283|NCT00664690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6678505|NCT01593501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678506|NCT01593501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6678507|NCT01593501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6678508|NCT01593514|Lactitol|lactitol|mesh-list
6678509|NCT01593514|Vaccines|vaccines|mesh-list
6678510|NCT01593514|Immunologic Factors|immunologic factors|mesh-ancestor
6678511|NCT01593514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678512|NCT01593514|Cathartics|cathartics|mesh-ancestor
6678513|NCT01593514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6678514|NCT01593566|Bupivacaine|bupivacaine|mesh-list
6678515|NCT01593566|Anesthetics, Local|anesthetics, local|mesh-ancestor
6678516|NCT01593566|Anesthetics|anesthetics|mesh-ancestor
6678517|NCT01593566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6678518|NCT01593566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678519|NCT01593566|Sensory System Agents|sensory system agents|mesh-ancestor
6678520|NCT01593566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6678521|NCT01593605|Resveratrol|resveratrol|mesh-list
6678522|NCT01593605|Antioxidants|antioxidants|mesh-ancestor
6678523|NCT01593605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678524|NCT01593605|Protective Agents|protective agents|mesh-ancestor
6678525|NCT01593605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678526|NCT01593605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6678527|NCT01593605|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6678528|NCT01593644|Adenosine|adenosine|mesh-list
6678529|NCT01593644|Dipyridamole|dipyridamole|mesh-list
6678530|NCT01593644|Analgesics|analgesics|mesh-ancestor
6678531|NCT01593644|Sensory System Agents|sensory system agents|mesh-ancestor
6678532|NCT01593644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6678533|NCT01593644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678534|NCT01593644|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6678535|NCT01593644|Vasodilator Agents|vasodilator agents|mesh-ancestor
6678536|NCT01593644|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6678537|NCT01593644|Purinergic Agonists|purinergic agonists|mesh-ancestor
6678538|NCT01593644|Purinergic Agents|purinergic agents|mesh-ancestor
6678539|NCT01593644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6678540|NCT01593644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678541|NCT01593644|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6678542|NCT01593644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5715591|NCT03245671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715592|NCT03245671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5715593|NCT03245671|Glucocorticoids|glucocorticoids|mesh-ancestor
5715594|NCT03245671|Hormones|hormones|mesh-ancestor
5715595|NCT03245671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5715596|NCT03245671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5715597|NCT03245671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5715598|NCT03245671|Protease Inhibitors|protease inhibitors|mesh-ancestor
5715599|NCT03245671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5715600|NCT03245671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506284|NCT00664690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506285|NCT00664690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6506286|NCT00664690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6506287|NCT00664690|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6506288|NCT00664690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6506289|NCT00664690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6506290|NCT00664690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506291|NCT00664703|Methylphenidate|methylphenidate|mesh-list
6506292|NCT00664703|Lobeline|lobeline|mesh-list
6506293|NCT00664703|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6506294|NCT00664703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506295|NCT00664703|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6506296|NCT00664703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6506297|NCT00664703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6506298|NCT00664703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506299|NCT00664703|Dopamine Agents|dopamine agents|mesh-ancestor
6506300|NCT00664703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6506301|NCT00664703|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6506302|NCT00664703|Autonomic Agents|autonomic agents|mesh-ancestor
6506303|NCT00664703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6506304|NCT00664703|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6506305|NCT00664703|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6506306|NCT00664703|Cholinergic Agents|cholinergic agents|mesh-ancestor
6506307|NCT00664703|Respiratory System Agents|respiratory system agents|mesh-ancestor
6506308|NCT00664781|Rucaparib|rucaparib|mesh-list
6506309|NCT00664781|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6506310|NCT00664781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6506311|NCT00664781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506312|NCT00664781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6506313|NCT00664833|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6506314|NCT00664833|Vasodilator Agents|vasodilator agents|mesh-ancestor
6678543|NCT01593644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6678544|NCT01593774|Melatonin|melatonin|mesh-list
6678545|NCT01593774|Antioxidants|antioxidants|mesh-ancestor
6678546|NCT01593774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678547|NCT01593774|Protective Agents|protective agents|mesh-ancestor
6678548|NCT01593774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506315|NCT00664833|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6506316|NCT00664833|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6506317|NCT00664833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6506318|NCT00664833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506319|NCT00664833|Urological Agents|urological agents|mesh-ancestor
6506320|NCT00664846|Aspirin|aspirin|mesh-list
6506321|NCT00664846|Clopidogrel|clopidogrel|mesh-list
6506322|NCT00664846|Atorvastatin|atorvastatin|mesh-list
6506323|NCT00664846|Simvastatin|simvastatin|mesh-list
6506324|NCT00664846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6506325|NCT00664846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6506326|NCT00664846|Analgesics|analgesics|mesh-ancestor
6506327|NCT00664846|Sensory System Agents|sensory system agents|mesh-ancestor
6506328|NCT00664846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6506329|NCT00664846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506330|NCT00664846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6506331|NCT00664846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6506332|NCT00664846|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6506333|NCT00664846|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6506334|NCT00664846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506335|NCT00664846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6506336|NCT00664846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6506337|NCT00664846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6506338|NCT00664846|Antipyretics|antipyretics|mesh-ancestor
6506339|NCT00664846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6506340|NCT00664846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5715601|NCT03245671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5715602|NCT03245671|Immunologic Factors|immunologic factors|mesh-ancestor
5715603|NCT03245515|Branebrutinib|branebrutinib|mesh-list
5715604|NCT03245515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5715605|NCT03245515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5715606|NCT03245515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715607|NCT03245528|Angiotensin II|angiotensin ii|mesh-list
5715608|NCT03245528|Giapreza|giapreza|mesh-list
5715609|NCT03245528|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5715610|NCT03245489|Aspirin|aspirin|mesh-list
5715611|NCT03245489|Pembrolizumab|pembrolizumab|mesh-list
5715612|NCT03245489|Clopidogrel|clopidogrel|mesh-list
5715613|NCT03245489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5715614|NCT03245489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5715615|NCT03245489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5715616|NCT03245489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5715617|NCT03245489|Analgesics|analgesics|mesh-ancestor
5715618|NCT03245489|Sensory System Agents|sensory system agents|mesh-ancestor
5715619|NCT03245489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6506341|NCT00664846|Antimetabolites|antimetabolites|mesh-ancestor
5715620|NCT03245489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715621|NCT03245489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5715622|NCT03245489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5715623|NCT03245489|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5715624|NCT03245489|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5715625|NCT03245489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506342|NCT00664846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6506343|NCT00664846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6506344|NCT00664846|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6506345|NCT00664846|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6506346|NCT00664846|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6506347|NCT00664846|Purinergic Agents|purinergic agents|mesh-ancestor
6506348|NCT00664846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6506349|NCT00664898|Bortezomib|bortezomib|mesh-list
6506350|NCT00664898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6506351|NCT00664963|Sirolimus|sirolimus|mesh-list
6506352|NCT00664963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6506353|NCT00664963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6506354|NCT00664963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6506355|NCT00664963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6506356|NCT00664963|Antifungal Agents|antifungal agents|mesh-ancestor
5715626|NCT03245489|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5715627|NCT03245489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5715628|NCT03245489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5715629|NCT03245489|Antipyretics|antipyretics|mesh-ancestor
5715630|NCT03245489|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6506357|NCT00664963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6678549|NCT01593774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6678550|NCT01593826|Budesonide|budesonide|mesh-list
6678551|NCT01593826|Formoterol Fumarate|formoterol fumarate|mesh-list
6678552|NCT01593826|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6678553|NCT01593826|Charcoal|charcoal|mesh-list
6678554|NCT01593826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6678555|NCT01593826|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6678556|NCT01593826|Autonomic Agents|autonomic agents|mesh-ancestor
6678557|NCT01593826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6678558|NCT01593826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678559|NCT01593826|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6678560|NCT01593826|Respiratory System Agents|respiratory system agents|mesh-ancestor
6678561|NCT01593826|Glucocorticoids|glucocorticoids|mesh-ancestor
6678562|NCT01593826|Hormones|hormones|mesh-ancestor
6678563|NCT01593826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6678564|NCT01593826|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6678565|NCT01593826|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6678566|NCT01593826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5715631|NCT03245489|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5715632|NCT03245489|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5715633|NCT03245489|Purinergic Agents|purinergic agents|mesh-ancestor
5715634|NCT03245489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5715635|NCT03245424|Ivosidenib|ivosidenib|mesh-list
5715636|NCT03245424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5715637|NCT03245424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5715638|NCT03245424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715639|NCT03245554|Propranolol|propranolol|mesh-list
5715640|NCT03245554|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5715641|NCT03245554|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5715642|NCT03245554|Adrenergic Agents|adrenergic agents|mesh-ancestor
5715643|NCT03245554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5715644|NCT03245554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715645|NCT03245554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715646|NCT03245554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5715647|NCT03245554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5715648|NCT03245554|Vasodilator Agents|vasodilator agents|mesh-ancestor
6506358|NCT00664963|Immunologic Factors|immunologic factors|mesh-ancestor
6506359|NCT00664963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506360|NCT00665041|Quinagolide|quinagolide|mesh-list
6506361|NCT00665041|Dopamine Agonists|dopamine agonists|mesh-ancestor
6506362|NCT00665041|Dopamine Agents|dopamine agents|mesh-ancestor
6506363|NCT00665041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6506364|NCT00665041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506365|NCT00665041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506366|NCT00665054|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6506367|NCT00665054|Vasodilator Agents|vasodilator agents|mesh-ancestor
6506368|NCT00665054|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6506369|NCT00665054|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6506370|NCT00665054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6506371|NCT00665054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506372|NCT00665054|Urological Agents|urological agents|mesh-ancestor
6506373|NCT00665093|Insulin|insulin|mesh-list
6506374|NCT00665093|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6506375|NCT00665093|Insulin Aspart|insulin aspart|mesh-list
6506376|NCT00665093|Insulin Detemir|insulin detemir|mesh-list
6506377|NCT00665093|Biphasic Insulins|biphasic insulins|mesh-list
6506378|NCT00665093|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6506379|NCT00665093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6506380|NCT00665093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506381|NCT00665119|Remifentanil|remifentanil|mesh-list
6506382|NCT00665119|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6506383|NCT00665119|Narcotics|narcotics|mesh-ancestor
6506384|NCT00665119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6506385|NCT00665119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506386|NCT00665119|Analgesics|analgesics|mesh-ancestor
6506387|NCT00665119|Sensory System Agents|sensory system agents|mesh-ancestor
6506388|NCT00665119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6506389|NCT00665314|Plerixafor|plerixafor|mesh-list
6506390|NCT00665314|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6506391|NCT00665314|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6506392|NCT00665314|Antiviral Agents|antiviral agents|mesh-ancestor
6506393|NCT00665314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6506394|NCT00665327|Moxifloxacin|moxifloxacin|mesh-list
6506395|NCT00665327|Levofloxacin|levofloxacin|mesh-list
6506396|NCT00665327|Ofloxacin|ofloxacin|mesh-list
6506397|NCT00665327|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6506398|NCT00665327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6506399|NCT00665327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6506400|NCT00665327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6506401|NCT00665327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6506402|NCT00665327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6506403|NCT00665327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506404|NCT00665327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6506405|NCT00665327|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6506406|NCT00665327|Contraceptive Agents|contraceptive agents|mesh-ancestor
6506407|NCT00665327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6506408|NCT00665327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506409|NCT00665327|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6506410|NCT00665327|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6506411|NCT00665327|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6506412|NCT00665327|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6506413|NCT00665327|Renal Agents|renal agents|mesh-ancestor
6506414|NCT00665327|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6506415|NCT00665327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6506416|NCT00665340|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6506417|NCT00665340|Vasodilator Agents|vasodilator agents|mesh-ancestor
6506418|NCT00665340|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5715649|NCT03245541|Durvalumab|durvalumab|mesh-list
5715650|NCT03245541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5715651|NCT03245541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5715652|NCT03245177|Pembrolizumab|pembrolizumab|mesh-list
5715653|NCT03245177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5715654|NCT03245177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5715655|NCT03245229|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5715656|NCT03245229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5715657|NCT03245229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5715658|NCT03245229|Antimetabolites|antimetabolites|mesh-ancestor
5715659|NCT03245229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715660|NCT03245229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5715661|NCT03245229|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5715662|NCT03245229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5715663|NCT03245385|Halobetasol|halobetasol|mesh-list
5715664|NCT03245385|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5715665|NCT03245333|Hormones|hormones|mesh-list
5715666|NCT03245333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5715667|NCT03245333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715668|NCT03245307|Apatinib|apatinib|mesh-list
5715669|NCT03245307|Nifedipine|nifedipine|mesh-list
5715670|NCT03245307|Warfarin|warfarin|mesh-list
5715671|NCT03245307|Anticoagulants|anticoagulants|mesh-ancestor
5715672|NCT03245307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6506419|NCT00665340|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6506420|NCT00665340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6506421|NCT00665340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506422|NCT00665340|Urological Agents|urological agents|mesh-ancestor
6506423|NCT00665418|Sevoflurane|sevoflurane|mesh-list
6506424|NCT00665418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6506425|NCT00665418|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6506426|NCT00665418|Anesthetics, General|anesthetics, general|mesh-ancestor
6506427|NCT00665418|Anesthetics|anesthetics|mesh-ancestor
6506428|NCT00665418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6506429|NCT00665418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506430|NCT00665496|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6506431|NCT00665496|Vasodilator Agents|vasodilator agents|mesh-ancestor
6506432|NCT00665496|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6506433|NCT00665496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6506434|NCT00665496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6506435|NCT00665496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506436|NCT00665496|Urological Agents|urological agents|mesh-ancestor
6506437|NCT00665522|Fentanyl|fentanyl|mesh-list
6506438|NCT00665522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6506439|NCT00665522|Narcotics|narcotics|mesh-ancestor
6506440|NCT00665522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6506441|NCT00665522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506442|NCT00665522|Analgesics|analgesics|mesh-ancestor
6506443|NCT00665522|Sensory System Agents|sensory system agents|mesh-ancestor
6506444|NCT00665522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6506445|NCT00665522|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6506446|NCT00665522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6506447|NCT00665522|Anesthetics, General|anesthetics, general|mesh-ancestor
6506448|NCT00665522|Anesthetics|anesthetics|mesh-ancestor
6506449|NCT00665600|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6506450|NCT00665600|Albuterol|albuterol|mesh-list
6506451|NCT00665600|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6506452|NCT00665600|Autonomic Agents|autonomic agents|mesh-ancestor
6506453|NCT00665600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6506454|NCT00665600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506455|NCT00665600|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6506456|NCT00665600|Respiratory System Agents|respiratory system agents|mesh-ancestor
6506457|NCT00665600|Tocolytic Agents|tocolytic agents|mesh-ancestor
6506458|NCT00665600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6506459|NCT00665600|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6506460|NCT00665600|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6506461|NCT00665600|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6506462|NCT00665600|Adrenergic Agents|adrenergic agents|mesh-ancestor
6506463|NCT00665600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6506464|NCT00665600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506465|NCT00665639|Caspofungin|caspofungin|mesh-list
6506466|NCT00665639|Micafungin|micafungin|mesh-list
6506467|NCT00665639|Antifungal Agents|antifungal agents|mesh-ancestor
6506468|NCT00665639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6506469|NCT00665639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5715673|NCT03245307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5715674|NCT03245307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5715675|NCT03245307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715676|NCT03245307|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5715677|NCT03245307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5715678|NCT03245307|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5715679|NCT03245307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715680|NCT03245307|Vasodilator Agents|vasodilator agents|mesh-ancestor
5715681|NCT03245307|Tocolytic Agents|tocolytic agents|mesh-ancestor
5715682|NCT03245307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5715683|NCT03245437|Oxytocin|oxytocin|mesh-list
5715684|NCT03245437|Oxytocics|oxytocics|mesh-ancestor
5715685|NCT03245437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6506470|NCT00665639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506471|NCT00665678|Paroxetine|paroxetine|mesh-list
6506472|NCT00665678|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5715686|NCT03245437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506473|NCT00665678|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6506474|NCT00665678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6506475|NCT00665678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506476|NCT00665678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6506477|NCT00665678|Serotonin Agents|serotonin agents|mesh-ancestor
6678567|NCT01593826|Adrenergic Agents|adrenergic agents|mesh-ancestor
6678568|NCT01593826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6506478|NCT00665678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506479|NCT00665678|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6506480|NCT00665678|Antidepressive Agents|antidepressive agents|mesh-ancestor
6506481|NCT00665678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6506482|NCT00665678|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6506483|NCT00665678|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6506484|NCT00665678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6506485|NCT00665717|Raltegravir Potassium|raltegravir potassium|mesh-list
6506486|NCT00665717|Pravastatin|pravastatin|mesh-list
6506487|NCT00665717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6506488|NCT00665717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6506489|NCT00665717|Antiviral Agents|antiviral agents|mesh-ancestor
6506490|NCT00665717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6506491|NCT00665717|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6506492|NCT00665717|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6506493|NCT00665717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6506494|NCT00665717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506495|NCT00665717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6506496|NCT00665717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6506497|NCT00665717|Antimetabolites|antimetabolites|mesh-ancestor
6506498|NCT00665717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6506499|NCT00665717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6506500|NCT00665743|Naproxen|naproxen|mesh-list
6506501|NCT00665743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6506502|NCT00665743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6506503|NCT00665743|Analgesics|analgesics|mesh-ancestor
6506504|NCT00665743|Sensory System Agents|sensory system agents|mesh-ancestor
6506505|NCT00665743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6506506|NCT00665743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506507|NCT00665743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6506508|NCT00665743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5715687|NCT03245450|Irinotecan|irinotecan|mesh-list
5715688|NCT03245450|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5715689|NCT03245450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5715690|NCT03245450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5715691|NCT03245450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715692|NCT03245450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5715693|NCT03245281|Diuretics|diuretics|mesh-list
5715694|NCT03245281|Natriuretic Agents|natriuretic agents|mesh-ancestor
5715695|NCT03245281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506509|NCT00665743|Gout Suppressants|gout suppressants|mesh-ancestor
6779766|NCT02180880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5715696|NCT03245190|Chiauranib|chiauranib|mesh-list
5715697|NCT03245190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5715698|NCT03245190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5715699|NCT03245190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5715700|NCT03245190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715701|NCT03245346|Anesthetics|anesthetics|mesh-list
5715702|NCT03245346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5715703|NCT03245346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715704|NCT03245021|Rituximab|rituximab|mesh-list
5715705|NCT03245021|Nivolumab|nivolumab|mesh-list
5715706|NCT03245021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5715707|NCT03245021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5715708|NCT03245021|Immunologic Factors|immunologic factors|mesh-ancestor
5715709|NCT03245021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715710|NCT03245021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5715711|NCT03245021|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5715712|NCT03245021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715713|NCT03244956|Trametinib|trametinib|mesh-list
5715714|NCT03244956|Dabrafenib|dabrafenib|mesh-list
6242579|NCT02653144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6242580|NCT02653144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6242581|NCT02653144|Analgesics|analgesics|mesh-ancestor
6242582|NCT02653144|Sensory System Agents|sensory system agents|mesh-ancestor
6242583|NCT02653144|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6242584|NCT02653144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6242585|NCT02653144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6242586|NCT02653144|Adrenergic Agents|adrenergic agents|mesh-ancestor
6242587|NCT02653144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6242588|NCT02653144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242589|NCT02653144|Anesthetics, Local|anesthetics, local|mesh-ancestor
5715715|NCT03244956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5715716|NCT03244956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5715717|NCT03244956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5715718|NCT03244956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715719|NCT03244774|Paclitaxel|paclitaxel|mesh-list
5715720|NCT03244774|Fluorouracil|fluorouracil|mesh-list
5715721|NCT03244774|Oxaliplatin|oxaliplatin|mesh-list
5715722|NCT03244774|Apatinib|apatinib|mesh-list
5715723|NCT03244774|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5715724|NCT03244774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5715725|NCT03244774|Tubulin Modulators|tubulin modulators|mesh-ancestor
5715726|NCT03244774|Antimitotic Agents|antimitotic agents|mesh-ancestor
5715727|NCT03244774|Mitosis Modulators|mitosis modulators|mesh-ancestor
5715728|NCT03244774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715729|NCT03244774|Antimetabolites|antimetabolites|mesh-ancestor
5715730|NCT03244774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5715731|NCT03244774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5715732|NCT03244774|Immunologic Factors|immunologic factors|mesh-ancestor
5715733|NCT03244774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715734|NCT03244774|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5715735|NCT03244774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5715736|NCT03244930|Plerixafor|plerixafor|mesh-list
5715737|NCT03244930|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5715738|NCT03244930|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5715739|NCT03244930|Antiviral Agents|antiviral agents|mesh-ancestor
5715740|NCT03244930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5715741|NCT03244943|Anesthetics|anesthetics|mesh-list
5715742|NCT03244943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5715743|NCT03244943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715744|NCT03244592|Minocycline|minocycline|mesh-list
5715745|NCT03244592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5715746|NCT03244592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5715747|NCT03244488|Mecamylamine|mecamylamine|mesh-list
5715748|NCT03244488|Scopolamine|scopolamine|mesh-list
5715749|NCT03244488|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
5715750|NCT03244488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5715751|NCT03244488|Antiemetics|antiemetics|mesh-ancestor
5715752|NCT03244488|Autonomic Agents|autonomic agents|mesh-ancestor
5715753|NCT03244488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5715754|NCT03244488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715755|NCT03244488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5715756|NCT03244488|Mydriatics|mydriatics|mesh-ancestor
5715757|NCT03244488|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5715758|NCT03244488|Cholinergic Agents|cholinergic agents|mesh-ancestor
5715759|NCT03244488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5715760|NCT03244488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715761|NCT03244488|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5715762|NCT03244488|Parasympatholytics|parasympatholytics|mesh-ancestor
5715763|NCT03244488|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5715764|NCT03244488|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
5715765|NCT03244488|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
5715766|NCT03244319|Warfarin|warfarin|mesh-list
5715767|NCT03244319|Edoxaban|edoxaban|mesh-list
5715768|NCT03244319|Anticoagulants|anticoagulants|mesh-list
5715769|NCT03244319|Coagulants|coagulants|mesh-list
5715770|NCT03244319|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5715771|NCT03244319|Antithrombins|antithrombins|mesh-ancestor
5715772|NCT03244319|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5715773|NCT03244319|Protease Inhibitors|protease inhibitors|mesh-ancestor
5715774|NCT03244319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5715775|NCT03244319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715776|NCT03244553|Prucalopride|prucalopride|mesh-list
5715777|NCT03244553|Laxatives|laxatives|mesh-ancestor
5715778|NCT03244553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5715779|NCT03244553|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
5715780|NCT03244553|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5715781|NCT03244553|Serotonin Agents|serotonin agents|mesh-ancestor
5715782|NCT03244553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5715783|NCT03244553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242590|NCT02653183|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
5715784|NCT03244553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715785|NCT03244176|Avelumab|avelumab|mesh-list
5715786|NCT03244176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5715787|NCT03244176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5715788|NCT03244423|Tranexamic Acid|tranexamic acid|mesh-list
5715789|NCT03244423|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5715790|NCT03244423|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6506510|NCT00665743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6506511|NCT00665743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6506512|NCT00665743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506513|NCT00665756|Mitomycins|mitomycins|mesh-list
6506514|NCT00665756|Mitomycin|mitomycin|mesh-list
6506515|NCT00665756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6506516|NCT00665756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6506517|NCT00665756|Alkylating Agents|alkylating agents|mesh-ancestor
6506518|NCT00665756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506519|NCT00665756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6506520|NCT00665756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6506521|NCT00665808|Insulin|insulin|mesh-list
6506522|NCT00665808|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6506523|NCT00665808|Insulin Detemir|insulin detemir|mesh-list
6506524|NCT00665808|Isophane Insulin, Human|isophane insulin, human|mesh-list
6506525|NCT00665808|Insulin, Isophane|insulin, isophane|mesh-list
6506526|NCT00665808|Isophane insulin, beef|isophane insulin, beef|mesh-list
6506527|NCT00665808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6506528|NCT00665808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506529|NCT00665834|Atorvastatin|atorvastatin|mesh-list
6506530|NCT00665834|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6506531|NCT00665834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6506532|NCT00665834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6506533|NCT00665834|Antimetabolites|antimetabolites|mesh-ancestor
6506534|NCT00665834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506535|NCT00665834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6506536|NCT00665834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6506537|NCT00665834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6506538|NCT00665873|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6506539|NCT00665873|Amoxicillin|amoxicillin|mesh-list
6506540|NCT00665873|Clavulanic Acids|clavulanic acids|mesh-list
6506541|NCT00665873|Clavulanic Acid|clavulanic acid|mesh-list
6506542|NCT00665873|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6506543|NCT00665873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6506544|NCT00665873|Antitubercular Agents|antitubercular agents|mesh-ancestor
6506545|NCT00665873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6506546|NCT00665873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678569|NCT01593826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678570|NCT01593826|Antidotes|antidotes|mesh-ancestor
5715791|NCT03244423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715792|NCT03244423|Hemostatics|hemostatics|mesh-ancestor
5715793|NCT03244423|Coagulants|coagulants|mesh-ancestor
5715794|NCT03244358|Epalrestat|epalrestat|mesh-list
5715795|NCT03244358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5715796|NCT03244358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715797|NCT03244462|Methotrexate|methotrexate|mesh-list
5715798|NCT03244462|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5715799|NCT03244462|Abortifacient Agents|abortifacient agents|mesh-ancestor
5715800|NCT03244462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5715801|NCT03244462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715802|NCT03244462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5715803|NCT03244462|Antimetabolites|antimetabolites|mesh-ancestor
5715804|NCT03244462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715805|NCT03244462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5715806|NCT03244462|Dermatologic Agents|dermatologic agents|mesh-ancestor
5715807|NCT03244462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5715808|NCT03244462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5715809|NCT03244462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5715810|NCT03244462|Immunologic Factors|immunologic factors|mesh-ancestor
5715811|NCT03244462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5715812|NCT03244462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5715813|NCT03244540|Acetaminophen|acetaminophen|mesh-list
5715814|NCT03244540|Dipyrone|dipyrone|mesh-list
5715815|NCT03244540|Ketoprofen|ketoprofen|mesh-list
5715816|NCT03244540|Bupivacaine|bupivacaine|mesh-list
5715817|NCT03244540|Ropivacaine|ropivacaine|mesh-list
5715818|NCT03244540|Anesthetics, Local|anesthetics, local|mesh-ancestor
5715819|NCT03244540|Anesthetics|anesthetics|mesh-ancestor
5715820|NCT03244540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5715821|NCT03244540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506547|NCT00665873|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6506548|NCT00665951|Ritonavir|ritonavir|mesh-list
6506549|NCT00665951|Lopinavir|lopinavir|mesh-list
6506550|NCT00665951|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5715822|NCT03244540|Sensory System Agents|sensory system agents|mesh-ancestor
6506551|NCT00665951|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6506552|NCT00665951|Protease Inhibitors|protease inhibitors|mesh-ancestor
6506553|NCT00665951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6506554|NCT00665951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506555|NCT00665951|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5715823|NCT03244540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5715824|NCT03244540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5715825|NCT03244540|Analgesics|analgesics|mesh-ancestor
5715826|NCT03244540|Antipyretics|antipyretics|mesh-ancestor
5715827|NCT03244540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5715828|NCT03244540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5715829|NCT03244540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5715830|NCT03244540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5715831|NCT03244540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5715832|NCT03244540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715833|NCT03244072|Moxifloxacin|moxifloxacin|mesh-list
5715834|NCT03244072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5715835|NCT03244072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5715836|NCT03244072|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5715837|NCT03244072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5715838|NCT03244072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5715839|NCT03244072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715840|NCT03244072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6506556|NCT00665951|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6506557|NCT00665951|Antiviral Agents|antiviral agents|mesh-ancestor
6506558|NCT00665951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6506559|NCT00665951|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6506560|NCT00665951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6506561|NCT00665977|Triamcinolone|triamcinolone|mesh-list
6506562|NCT00665977|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6506563|NCT00665977|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6506564|NCT00665977|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6506565|NCT00665977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5715841|NCT03244241|Insulin|insulin|mesh-list
5715842|NCT03244241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5715843|NCT03244241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715844|NCT03243903|Insulin|insulin|mesh-list
5715845|NCT03243903|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5715846|NCT03243903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5715847|NCT03243903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715848|NCT03243890|Vitamin D|vitamin d|mesh-list
5715849|NCT03243890|Vitamin K 2|vitamin k 2|mesh-list
5715850|NCT03243890|Vitamin K|vitamin k|mesh-list
5715851|NCT03243890|Vitamin MK 7|vitamin mk 7|mesh-list
5715852|NCT03243890|Vitamins|vitamins|mesh-ancestor
5715853|NCT03243890|Micronutrients|micronutrients|mesh-ancestor
5715854|NCT03243890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715855|NCT03243890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5715856|NCT03243890|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5715857|NCT03243890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5715858|NCT03243890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715859|NCT03243890|Hemostatics|hemostatics|mesh-ancestor
5715860|NCT03243890|Coagulants|coagulants|mesh-ancestor
5715861|NCT03243864|Ceftazidime|ceftazidime|mesh-list
5715862|NCT03243864|Avibactam|avibactam|mesh-list
5715863|NCT03243864|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
5715864|NCT03243864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5715865|NCT03243864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5715866|NCT03243864|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5715867|NCT03243864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5715868|NCT03243864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715869|NCT03244020|Aspirin|aspirin|mesh-list
5715870|NCT03244020|Enoxaparin|enoxaparin|mesh-list
5715871|NCT03244020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5715872|NCT03244020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5715873|NCT03244020|Analgesics|analgesics|mesh-ancestor
5715874|NCT03244020|Sensory System Agents|sensory system agents|mesh-ancestor
5715875|NCT03244020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5715876|NCT03244020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715877|NCT03244020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5715878|NCT03244020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5715879|NCT03244020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5715880|NCT03244020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5715881|NCT03244020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715882|NCT03244020|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5715883|NCT03244020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6506566|NCT00665977|Glucocorticoids|glucocorticoids|mesh-ancestor
6506567|NCT00665977|Hormones|hormones|mesh-ancestor
6506568|NCT00665977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6506569|NCT00665977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506570|NCT00665977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6506571|NCT00665977|Immunologic Factors|immunologic factors|mesh-ancestor
6506572|NCT00665977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5715884|NCT03244020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5715885|NCT03244020|Antipyretics|antipyretics|mesh-ancestor
5715886|NCT03244020|Anticoagulants|anticoagulants|mesh-ancestor
5715887|NCT03243851|Metformin|metformin|mesh-list
5715888|NCT03243851|Temozolomide|temozolomide|mesh-list
5715889|NCT03243851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6506573|NCT00665977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506574|NCT00665990|Cyclophosphamide|cyclophosphamide|mesh-list
6506575|NCT00665990|Bevacizumab|bevacizumab|mesh-list
6506576|NCT00665990|Sorafenib|sorafenib|mesh-list
6678571|NCT01593826|Protective Agents|protective agents|mesh-ancestor
5715890|NCT03243851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715891|NCT03243851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5715892|NCT03243851|Alkylating Agents|alkylating agents|mesh-ancestor
5715893|NCT03243851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715894|NCT03243851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5715895|NCT03243552|Levodopa|levodopa|mesh-list
5715896|NCT03243552|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5715897|NCT03243552|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5715898|NCT03243552|Dopamine Agents|dopamine agents|mesh-ancestor
5715899|NCT03243552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5715900|NCT03243552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715901|NCT03243552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715902|NCT03243500|Lidocaine|lidocaine|mesh-list
5715903|NCT03243500|Bupivacaine|bupivacaine|mesh-list
5715904|NCT03243500|Atracurium|atracurium|mesh-list
5715905|NCT03243500|Anesthetics, Local|anesthetics, local|mesh-ancestor
5715906|NCT03243500|Anesthetics|anesthetics|mesh-ancestor
5715907|NCT03243500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5715908|NCT03243500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715909|NCT03243500|Sensory System Agents|sensory system agents|mesh-ancestor
5715910|NCT03243500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5715911|NCT03243500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5715912|NCT03243500|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5715913|NCT03243500|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5715914|NCT03243500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5715915|NCT03243500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715916|NCT03243500|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5715917|NCT03243500|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5715918|NCT03243500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5715919|NCT03243500|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
5715920|NCT03243500|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5715921|NCT03243500|Cholinergic Agents|cholinergic agents|mesh-ancestor
5715922|NCT03243500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5721967|NCT03202446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721968|NCT03202446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5721969|NCT03202446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5721970|NCT03202446|Alkylating Agents|alkylating agents|mesh-ancestor
5721971|NCT03202446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721972|NCT03202446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5721973|NCT03202446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5721974|NCT03202446|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5721975|NCT03202446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5721976|NCT03202446|Antimetabolites|antimetabolites|mesh-ancestor
5721977|NCT03202446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5721978|NCT03202446|Chelating Agents|chelating agents|mesh-ancestor
5721979|NCT03202446|Sequestering Agents|sequestering agents|mesh-ancestor
5721980|NCT03202446|Hemostatics|hemostatics|mesh-ancestor
5721981|NCT03202446|Coagulants|coagulants|mesh-ancestor
5722327|NCT03199976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722328|NCT03199976|Anticonvulsants|anticonvulsants|mesh-ancestor
5722329|NCT03199976|Tocolytic Agents|tocolytic agents|mesh-ancestor
5722330|NCT03199976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5722331|NCT03199976|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5722332|NCT03199976|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5722333|NCT03199976|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5722334|NCT03199976|Adrenergic Agents|adrenergic agents|mesh-ancestor
5722335|NCT03199924|Diclofenac|diclofenac|mesh-list
5722336|NCT03199924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
6506577|NCT00665990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6506578|NCT00665990|Immunologic Factors|immunologic factors|mesh-ancestor
6506579|NCT00665990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506580|NCT00665990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6506581|NCT00665990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6506582|NCT00665990|Alkylating Agents|alkylating agents|mesh-ancestor
6506583|NCT00665990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506584|NCT00665990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6506585|NCT00665990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6506586|NCT00665990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6506587|NCT00665990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6506588|NCT00665990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6506589|NCT00665990|Growth Substances|growth substances|mesh-ancestor
6506590|NCT00665990|Growth Inhibitors|growth inhibitors|mesh-ancestor
6506591|NCT00665990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6506592|NCT00665990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6506593|NCT00666042|Moxifloxacin|moxifloxacin|mesh-list
6506594|NCT00666042|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6506595|NCT00666042|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6506596|NCT00666042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6506597|NCT00666042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5715923|NCT03243643|Apatinib|apatinib|mesh-list
5715924|NCT03243643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5715925|NCT03243643|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5715926|NCT03243643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5715927|NCT03243643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715928|NCT03243604|Hormones|hormones|mesh-list
5715929|NCT03243604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5715930|NCT03243604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715931|NCT03243461|Temozolomide|temozolomide|mesh-list
5715932|NCT03243461|Valproic Acid|valproic acid|mesh-list
5715933|NCT03243461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5715934|NCT03243461|Alkylating Agents|alkylating agents|mesh-ancestor
5715935|NCT03243461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715936|NCT03243461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5715937|NCT03243461|Anticonvulsants|anticonvulsants|mesh-ancestor
5715938|NCT03243461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5715939|NCT03243461|GABA Agents|gaba agents|mesh-ancestor
5715940|NCT03243461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5715941|NCT03243461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715942|NCT03243461|Antimanic Agents|antimanic agents|mesh-ancestor
5715943|NCT03243461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5715944|NCT03243461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5715945|NCT03243461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5715946|NCT03243331|Gedatolisib|gedatolisib|mesh-list
5715947|NCT03243331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5715948|NCT03243331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5715949|NCT03243331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715950|NCT03243344|Surgiflo|surgiflo|mesh-list
5715951|NCT03243344|Hemostatics|hemostatics|mesh-ancestor
5715952|NCT03243344|Coagulants|coagulants|mesh-ancestor
5715953|NCT03243175|Apixaban|apixaban|mesh-list
5715954|NCT03243175|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5715955|NCT03243175|Antithrombins|antithrombins|mesh-ancestor
5715956|NCT03243175|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5715957|NCT03243175|Protease Inhibitors|protease inhibitors|mesh-ancestor
5715958|NCT03243175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5715959|NCT03243175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715960|NCT03243175|Anticoagulants|anticoagulants|mesh-ancestor
5715961|NCT03243019|Sirolimus|sirolimus|mesh-list
5715962|NCT03243019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5715963|NCT03243019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5715964|NCT03243019|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5715965|NCT03243019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5715966|NCT03243019|Antifungal Agents|antifungal agents|mesh-ancestor
5715967|NCT03243019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5715968|NCT03243019|Immunologic Factors|immunologic factors|mesh-ancestor
5715969|NCT03243019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715970|NCT03243032|Ibuprofen|ibuprofen|mesh-list
5715971|NCT03243032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
5715972|NCT03243032|Anesthetics|anesthetics|mesh-list
5715973|NCT03243032|Anesthetics, Local|anesthetics, local|mesh-list
5715974|NCT03243032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5715975|NCT03243032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715976|NCT03243032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6506598|NCT00666042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6506599|NCT00666042|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6506600|NCT00666042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6506601|NCT00666042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6506602|NCT00666042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506603|NCT00666042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6506604|NCT00666042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6506605|NCT00666042|Contraceptive Agents|contraceptive agents|mesh-ancestor
6506606|NCT00666042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6506607|NCT00666042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506608|NCT00666042|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6506609|NCT00666042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6506610|NCT00666042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6506611|NCT00666055|Ritonavir|ritonavir|mesh-list
6506612|NCT00666055|Lopinavir|lopinavir|mesh-list
6506613|NCT00666055|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6506614|NCT00666055|Tenofovir|tenofovir|mesh-list
6678572|NCT01593930|Lidocaine|lidocaine|mesh-list
6678573|NCT01593930|Carticaine|carticaine|mesh-list
6678574|NCT01593930|Anesthetics, Local|anesthetics, local|mesh-ancestor
6678575|NCT01593930|Anesthetics|anesthetics|mesh-ancestor
6678576|NCT01593930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6678577|NCT01593930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678578|NCT01593930|Sensory System Agents|sensory system agents|mesh-ancestor
6678579|NCT01593930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5715977|NCT03243032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5715978|NCT03243032|Analgesics|analgesics|mesh-ancestor
5715979|NCT03243032|Sensory System Agents|sensory system agents|mesh-ancestor
5715980|NCT03243032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5715981|NCT03243032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5715982|NCT03243032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5715983|NCT03243032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5715984|NCT03243032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5715985|NCT03242993|Folic Acid|folic acid|mesh-list
5715986|NCT03242993|Hematinics|hematinics|mesh-ancestor
5715987|NCT03242993|Vitamin B Complex|vitamin b complex|mesh-ancestor
5715988|NCT03242993|Vitamins|vitamins|mesh-ancestor
5715989|NCT03242993|Micronutrients|micronutrients|mesh-ancestor
5715990|NCT03242993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715991|NCT03242772|Amphetamine|amphetamine|mesh-list
5715992|NCT03242772|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5715993|NCT03242772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5715994|NCT03242772|Sympathomimetics|sympathomimetics|mesh-ancestor
5715995|NCT03242772|Autonomic Agents|autonomic agents|mesh-ancestor
5715996|NCT03242772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5715997|NCT03242772|Dopamine Agents|dopamine agents|mesh-ancestor
5715998|NCT03242772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5715999|NCT03242772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716000|NCT03242772|Adrenergic Agents|adrenergic agents|mesh-ancestor
5716001|NCT03242772|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5716002|NCT03242772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5716003|NCT03242772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5716004|NCT03242772|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5716005|NCT03242967|Darbepoetin alfa|darbepoetin alfa|mesh-list
5716006|NCT03242967|Hematinics|hematinics|mesh-ancestor
5716007|NCT03243006|Acetaminophen|acetaminophen|mesh-list
5716008|NCT03243006|Tramadol|tramadol|mesh-list
5716009|NCT03243006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5716010|NCT03243006|Analgesics|analgesics|mesh-ancestor
5716011|NCT03243006|Sensory System Agents|sensory system agents|mesh-ancestor
5716012|NCT03243006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5716013|NCT03243006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716014|NCT03243006|Antipyretics|antipyretics|mesh-ancestor
5716015|NCT03243006|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5716016|NCT03243006|Narcotics|narcotics|mesh-ancestor
5716017|NCT03243006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5716018|NCT03242915|Carboplatin|carboplatin|mesh-list
5716019|NCT03242915|Pembrolizumab|pembrolizumab|mesh-list
5716020|NCT03242915|Pemetrexed|pemetrexed|mesh-list
5716021|NCT03242915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5716022|NCT03242915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5716023|NCT03242915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5716024|NCT03242915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716025|NCT03242915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5716026|NCT03242915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5716027|NCT03242707|Hyaluronic Acid|hyaluronic acid|mesh-list
5716028|NCT03242707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6506615|NCT00666055|Lamivudine|lamivudine|mesh-list
6506616|NCT00666055|Zidovudine|zidovudine|mesh-list
6506617|NCT00666055|Emtricitabine|emtricitabine|mesh-list
6506618|NCT00666055|Raltegravir Potassium|raltegravir potassium|mesh-list
6506619|NCT00666055|Maraviroc|maraviroc|mesh-list
6506620|NCT00666055|Efavirenz|efavirenz|mesh-list
6506621|NCT00666055|Etravirine|etravirine|mesh-list
6506622|NCT00666055|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6506623|NCT00666055|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6506624|NCT00666055|Protease Inhibitors|protease inhibitors|mesh-ancestor
6506625|NCT00666055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6506626|NCT00666055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716029|NCT03242707|Immunologic Factors|immunologic factors|mesh-ancestor
5716030|NCT03242707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716031|NCT03242707|Viscosupplements|viscosupplements|mesh-ancestor
6506627|NCT00666055|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6506628|NCT00666055|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5716032|NCT03242707|Protective Agents|protective agents|mesh-ancestor
5716033|NCT03242629|Chloral Hydrate|chloral hydrate|mesh-list
5716034|NCT03242629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5716035|NCT03242629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5716036|NCT03242629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716037|NCT03242382|Palbociclib|palbociclib|mesh-list
5716038|NCT03242382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5716039|NCT03242382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5716040|NCT03242382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5716041|NCT03242382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716042|NCT03242460|Dexamethasone|dexamethasone|mesh-list
5716043|NCT03242460|Cyclophosphamide|cyclophosphamide|mesh-list
5716044|NCT03242460|Pomalidomide|pomalidomide|mesh-list
5716045|NCT03242460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5716046|NCT03242460|Immunologic Factors|immunologic factors|mesh-ancestor
5716047|NCT03242460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716048|NCT03242460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5716049|NCT03242460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5716050|NCT03242460|Alkylating Agents|alkylating agents|mesh-ancestor
5716051|NCT03242460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716052|NCT03242460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5716053|NCT03242460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5716054|NCT03242460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5716055|NCT03242460|Antiemetics|antiemetics|mesh-ancestor
5716056|NCT03242460|Autonomic Agents|autonomic agents|mesh-ancestor
5716057|NCT03242460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5716058|NCT03242460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5716059|NCT03242460|Glucocorticoids|glucocorticoids|mesh-ancestor
5716060|NCT03242460|Hormones|hormones|mesh-ancestor
5716061|NCT03242460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5716062|NCT03242460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5716063|NCT03242460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5716064|NCT03242460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5716065|NCT03242460|Growth Substances|growth substances|mesh-ancestor
5716066|NCT03242460|Growth Inhibitors|growth inhibitors|mesh-ancestor
5716067|NCT03242499|Lovastatin|lovastatin|mesh-list
5716068|NCT03242499|L 647318|l 647318|mesh-list
5716069|NCT03242499|Dihydromevinolin|dihydromevinolin|mesh-list
5716070|NCT03242499|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5716071|NCT03242499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5716072|NCT03242499|Antimetabolites|antimetabolites|mesh-ancestor
5716073|NCT03242499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716074|NCT03242499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5716075|NCT03242499|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5716076|NCT03242499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5716077|NCT03242616|Pemetrexed|pemetrexed|mesh-list
5716078|NCT03242616|Vinorelbine|vinorelbine|mesh-list
5716079|NCT03242616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5716080|NCT03242616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5716081|NCT03242616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716082|NCT03242616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5716083|NCT03242616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5716084|NCT03242616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6506629|NCT00666055|Antiviral Agents|antiviral agents|mesh-ancestor
6506630|NCT00666055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6506631|NCT00666055|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6506632|NCT00666055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6506633|NCT00666055|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6779767|NCT02180880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5716085|NCT03242616|Tubulin Modulators|tubulin modulators|mesh-ancestor
5716086|NCT03242616|Antimitotic Agents|antimitotic agents|mesh-ancestor
5716087|NCT03242616|Mitosis Modulators|mitosis modulators|mesh-ancestor
5716088|NCT03242317|Mitomycins|mitomycins|mesh-list
5716089|NCT03242317|Mitomycin|mitomycin|mesh-list
5716090|NCT03242317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5716091|NCT03242317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5716092|NCT03242317|Alkylating Agents|alkylating agents|mesh-ancestor
5716093|NCT03242317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716094|NCT03242317|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5716095|NCT03242317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5716096|NCT03242278|Rivaroxaban|rivaroxaban|mesh-list
5716097|NCT03242278|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5716098|NCT03242278|Antithrombins|antithrombins|mesh-ancestor
5716099|NCT03242278|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5716100|NCT03242278|Protease Inhibitors|protease inhibitors|mesh-ancestor
5716101|NCT03242278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5716102|NCT03242278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716103|NCT03242278|Anticoagulants|anticoagulants|mesh-ancestor
5716104|NCT03242304|Hydrocortisone|hydrocortisone|mesh-list
5716105|NCT03242304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5721982|NCT03202186|Progesterone|progesterone|mesh-list
5721983|NCT03202186|Progestins|progestins|mesh-ancestor
5721984|NCT03202186|Hormones|hormones|mesh-ancestor
5721985|NCT03202186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5721986|NCT03202186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721987|NCT03202316|Atezolizumab|atezolizumab|mesh-list
5721988|NCT03202316|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5721989|NCT03202316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5721990|NCT03202316|Immunologic Factors|immunologic factors|mesh-ancestor
5721991|NCT03202316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5721992|NCT03201939|Lisinopril|lisinopril|mesh-list
5721993|NCT03201939|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5721994|NCT03201939|Protease Inhibitors|protease inhibitors|mesh-ancestor
5721995|NCT03201939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5721996|NCT03201939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5721997|NCT03201939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5721998|NCT03201939|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5721999|NCT03201939|Protective Agents|protective agents|mesh-ancestor
6506634|NCT00666055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6506635|NCT00666055|Antimetabolites|antimetabolites|mesh-ancestor
6506636|NCT00666055|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6506637|NCT00666055|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6506638|NCT00666055|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6506639|NCT00666055|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6506640|NCT00666055|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6506641|NCT00666055|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6506642|NCT00666055|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6506643|NCT00666055|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6506644|NCT00666055|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6506645|NCT00666055|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6506646|NCT00666068|Hormones|hormones|mesh-list
6506647|NCT00666068|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
5722000|NCT03201939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722001|NCT03201861|Paclitaxel|paclitaxel|mesh-list
5722002|NCT03201861|Docetaxel|docetaxel|mesh-list
5722003|NCT03201861|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5722004|NCT03201861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5722005|NCT03201861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5722006|NCT03201861|Tubulin Modulators|tubulin modulators|mesh-ancestor
5722007|NCT03201861|Antimitotic Agents|antimitotic agents|mesh-ancestor
5722008|NCT03201861|Mitosis Modulators|mitosis modulators|mesh-ancestor
5722009|NCT03201861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722010|NCT03202147|Cromolyn Sodium|cromolyn sodium|mesh-list
5722011|NCT03202147|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
5722012|NCT03202147|Immunologic Factors|immunologic factors|mesh-ancestor
5722013|NCT03202147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722014|NCT03202147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5722015|NCT03202147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5722016|NCT03202147|Respiratory System Agents|respiratory system agents|mesh-ancestor
5722017|NCT03201913|Estrogens|estrogens|mesh-list
5722018|NCT03201913|Hormones|hormones|mesh-ancestor
5722019|NCT03201913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5722020|NCT03201913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722021|NCT03201796|Levofloxacin|levofloxacin|mesh-list
6506648|NCT00666068|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
6506649|NCT00666068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6506650|NCT00666068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506651|NCT00666107|Vaccines|vaccines|mesh-list
5716106|NCT03242239|Trastuzumab|trastuzumab|mesh-list
5716107|NCT03242239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5716108|NCT03242239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5716109|NCT03241875|Pregabalin|pregabalin|mesh-list
5716110|NCT03241875|Gabapentin|gabapentin|mesh-list
5716111|NCT03241875|Analgesics|analgesics|mesh-ancestor
5716112|NCT03241875|Sensory System Agents|sensory system agents|mesh-ancestor
5716113|NCT03241875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5716114|NCT03241875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716115|NCT03241875|Anticonvulsants|anticonvulsants|mesh-ancestor
5716116|NCT03241875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5716117|NCT03241875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5716118|NCT03241875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716119|NCT03241875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5716120|NCT03241875|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5716121|NCT03241875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5716122|NCT03241875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5716123|NCT03241875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5716124|NCT03241875|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5716125|NCT03241875|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6506652|NCT00666107|Immunologic Factors|immunologic factors|mesh-ancestor
6506653|NCT00666107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678580|NCT01593930|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6678581|NCT01593930|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5716126|NCT03241875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5716127|NCT03241875|Antimanic Agents|antimanic agents|mesh-ancestor
5716128|NCT03241901|Lumefantrine|lumefantrine|mesh-list
5716129|NCT03241901|Artemether|artemether|mesh-list
5716130|NCT03241901|Primaquine|primaquine|mesh-list
5716131|NCT03241901|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
5716132|NCT03241901|Antimalarials|antimalarials|mesh-ancestor
5716133|NCT03241901|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5716134|NCT03241901|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5716135|NCT03241901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5716136|NCT03241914|Megestrol|megestrol|mesh-list
5716137|NCT03241914|Megestrol Acetate|megestrol acetate|mesh-list
5716138|NCT03241914|Levonorgestrel|levonorgestrel|mesh-list
5716139|NCT03241914|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5716140|NCT03241914|Contraceptive Agents|contraceptive agents|mesh-ancestor
5716141|NCT03241914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5716142|NCT03241914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716143|NCT03241914|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5716144|NCT03241914|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5716145|NCT03241914|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5716146|NCT03241914|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5716147|NCT03241914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5716148|NCT03241914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5716149|NCT03241914|Appetite Stimulants|appetite stimulants|mesh-ancestor
5716150|NCT03241914|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5716151|NCT03241784|Interleukin-2|interleukin-2|mesh-list
5716152|NCT03241784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5716153|NCT03241784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5716154|NCT03241784|Analgesics|analgesics|mesh-ancestor
5716155|NCT03241784|Sensory System Agents|sensory system agents|mesh-ancestor
5716156|NCT03241784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5716157|NCT03241784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716158|NCT03242096|Sirolimus|sirolimus|mesh-list
5716159|NCT03242096|Paclitaxel|paclitaxel|mesh-list
5716160|NCT03242096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5716161|NCT03242096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5716162|NCT03242096|Tubulin Modulators|tubulin modulators|mesh-ancestor
5716163|NCT03242096|Antimitotic Agents|antimitotic agents|mesh-ancestor
6678582|NCT01593930|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6678583|NCT01593930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6678584|NCT01593930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678585|NCT01593995|Mitogens|mitogens|mesh-list
6678586|NCT01593995|Mitosis Modulators|mitosis modulators|mesh-ancestor
6678587|NCT01593995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779768|NCT02180880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6779769|NCT02180880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6506654|NCT00666159|Pimecrolimus|pimecrolimus|mesh-list
6506655|NCT00666159|Tacrolimus|tacrolimus|mesh-list
6506656|NCT00666159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6506657|NCT00666159|Immunologic Factors|immunologic factors|mesh-ancestor
6506658|NCT00666159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506659|NCT00666159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6506660|NCT00666159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6506661|NCT00666159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506662|NCT00666159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6506663|NCT00666159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6506664|NCT00666159|Analgesics|analgesics|mesh-ancestor
6506665|NCT00666159|Sensory System Agents|sensory system agents|mesh-ancestor
6506666|NCT00666159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6506667|NCT00666159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6506668|NCT00666159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6506669|NCT00666159|Dermatologic Agents|dermatologic agents|mesh-ancestor
6506670|NCT00666185|Fluconazole|fluconazole|mesh-list
6506671|NCT00666185|Micafungin|micafungin|mesh-list
6506672|NCT00666185|Antifungal Agents|antifungal agents|mesh-ancestor
6506673|NCT00666185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6506674|NCT00666185|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6506675|NCT00666185|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6506676|NCT00666185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5716164|NCT03242096|Mitosis Modulators|mitosis modulators|mesh-ancestor
5716165|NCT03242096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716166|NCT03242096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5716167|NCT03242096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5716168|NCT03242096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5716169|NCT03242096|Antifungal Agents|antifungal agents|mesh-ancestor
5716170|NCT03242096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5716171|NCT03242096|Immunologic Factors|immunologic factors|mesh-ancestor
5716172|NCT03242096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716173|NCT03241888|Megestrol|megestrol|mesh-list
5716174|NCT03241888|Megestrol Acetate|megestrol acetate|mesh-list
5716175|NCT03241888|Levonorgestrel|levonorgestrel|mesh-list
5716176|NCT03241888|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5716177|NCT03241888|Contraceptive Agents|contraceptive agents|mesh-ancestor
5716178|NCT03241888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5716179|NCT03241888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716180|NCT03241888|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5716181|NCT03241888|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5716182|NCT03241888|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5716183|NCT03241888|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5716184|NCT03241888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5716185|NCT03241888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5716186|NCT03241888|Appetite Stimulants|appetite stimulants|mesh-ancestor
5716187|NCT03241888|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5716188|NCT03241472|Letrozole|letrozole|mesh-list
5716189|NCT03241472|Clomiphene|clomiphene|mesh-list
5716190|NCT03241472|Enclomiphene|enclomiphene|mesh-list
5716191|NCT03241472|Zuclomiphene|zuclomiphene|mesh-list
5716192|NCT03241472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716193|NCT03241472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5716194|NCT03241472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5716195|NCT03241472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5716196|NCT03241472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5716197|NCT03241472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5716198|NCT03241472|Hormone Antagonists|hormone antagonists|mesh-ancestor
5716199|NCT03241472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5716200|NCT03241472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716201|NCT03241472|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5716202|NCT03241472|Fertility Agents|fertility agents|mesh-ancestor
5716203|NCT03241472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5716204|NCT03241472|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5716205|NCT03241472|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5716206|NCT03241563|Triamcinolone|triamcinolone|mesh-list
5716207|NCT03241563|Deoxycholic Acid|deoxycholic acid|mesh-list
5716208|NCT03241563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5716209|NCT03241563|Glucocorticoids|glucocorticoids|mesh-ancestor
5716210|NCT03241563|Hormones|hormones|mesh-ancestor
5716211|NCT03241563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5716212|NCT03241563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716213|NCT03241563|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5716214|NCT03241563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6506677|NCT00666185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506678|NCT00666185|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6506679|NCT00666185|Hormone Antagonists|hormone antagonists|mesh-ancestor
5716215|NCT03241745|Nivolumab|nivolumab|mesh-list
5716216|NCT03241745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5716217|NCT03241745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5716218|NCT03241745|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5716219|NCT03241745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716220|NCT03241602|Lidocaine|lidocaine|mesh-list
5716221|NCT03241602|Anesthetics, Local|anesthetics, local|mesh-ancestor
5716222|NCT03241602|Anesthetics|anesthetics|mesh-ancestor
5716223|NCT03241602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5716224|NCT03241602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716225|NCT03241602|Sensory System Agents|sensory system agents|mesh-ancestor
5716226|NCT03241602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5716227|NCT03241602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5716228|NCT03241602|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5716229|NCT03241602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5716230|NCT03241602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5716231|NCT03241602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716232|NCT03241641|Tenofovir|tenofovir|mesh-list
5716233|NCT03241641|Antiviral Agents|antiviral agents|mesh-ancestor
5716234|NCT03241641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5716235|NCT03241641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5716236|NCT03241641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5716237|NCT03241641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5716238|NCT03241641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716239|NCT03241641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5716240|NCT03241641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5716241|NCT03241550|Isavuconazole|isavuconazole|mesh-list
5716242|NCT03241550|Antifungal Agents|antifungal agents|mesh-ancestor
5716243|NCT03241550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5716244|NCT03241407|Triclosan|triclosan|mesh-list
5716245|NCT03241407|Fluorides|fluorides|mesh-list
5716246|NCT03241407|Cariostatic Agents|cariostatic agents|mesh-ancestor
5716247|NCT03241407|Protective Agents|protective agents|mesh-ancestor
5716248|NCT03241407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716249|NCT03241407|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5716250|NCT03241407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5716251|NCT03241407|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5716252|NCT03241407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5716253|NCT03241407|Antimetabolites|antimetabolites|mesh-ancestor
5716254|NCT03241407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716255|NCT03241407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5716256|NCT03241706|Glucagon|glucagon|mesh-list
5716257|NCT03241706|Somatostatin|somatostatin|mesh-list
5716258|NCT03241706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716259|NCT03241706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5716260|NCT03241706|Hormones|hormones|mesh-ancestor
5716261|NCT03241706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5716262|NCT03241381|Vitamin D|vitamin d|mesh-list
5716263|NCT03241381|Vitamins|vitamins|mesh-ancestor
5716264|NCT03241381|Micronutrients|micronutrients|mesh-ancestor
5716265|NCT03241381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716266|NCT03241381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5716267|NCT03241303|Acarbose|acarbose|mesh-list
5716268|NCT03241303|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
5716269|NCT03241303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5716270|NCT03241303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716271|NCT03241303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5716272|NCT03241303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716273|NCT03241199|Imatinib Mesylate|imatinib mesylate|mesh-list
5716274|NCT03241199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5716275|NCT03241199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5716276|NCT03241199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5716277|NCT03241199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716278|NCT03241043|Tacrolimus|tacrolimus|mesh-list
5716279|NCT03241043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5716280|NCT03241043|Immunologic Factors|immunologic factors|mesh-ancestor
5716281|NCT03241043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716282|NCT03241043|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5716283|NCT03241043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5716284|NCT03241043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716285|NCT03241017|Durvalumab|durvalumab|mesh-list
6506680|NCT00666185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6506681|NCT00666185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506682|NCT00666185|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6506683|NCT00666185|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6506684|NCT00666237|Mitomycins|mitomycins|mesh-list
6506685|NCT00666237|Mitomycin|mitomycin|mesh-list
6506686|NCT00666237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6506687|NCT00666237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6506688|NCT00666237|Alkylating Agents|alkylating agents|mesh-ancestor
6678588|NCT01594047|Ketamine|ketamine|mesh-list
6678589|NCT01594047|Methadone|methadone|mesh-list
6678590|NCT01594047|Analgesics|analgesics|mesh-ancestor
6678591|NCT01594047|Sensory System Agents|sensory system agents|mesh-ancestor
5716286|NCT03241017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5716287|NCT03241017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5716288|NCT03240809|Brodalumab|brodalumab|mesh-list
5716289|NCT03240809|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5716290|NCT03240809|Dermatologic Agents|dermatologic agents|mesh-ancestor
5716291|NCT03240809|Immunologic Factors|immunologic factors|mesh-ancestor
5716292|NCT03240809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716293|NCT03240822|Antibodies|antibodies|mesh-list
5716294|NCT03240822|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5716295|NCT03240822|Tacrolimus|tacrolimus|mesh-list
5716296|NCT03240822|Immunologic Factors|immunologic factors|mesh-ancestor
5716297|NCT03240822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716298|NCT03240822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5716299|NCT03240822|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5716300|NCT03240822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5716301|NCT03240822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716302|NCT03240939|Tadalafil|tadalafil|mesh-list
5716303|NCT03240939|Dutasteride|dutasteride|mesh-list
5716304|NCT03240939|Vasodilator Agents|vasodilator agents|mesh-ancestor
5716305|NCT03240939|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5716306|NCT03240939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5716307|NCT03240939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5716308|NCT03240939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716309|NCT03240939|Urological Agents|urological agents|mesh-ancestor
5716310|NCT03240939|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
5716311|NCT03240939|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5716312|NCT03240939|Hormone Antagonists|hormone antagonists|mesh-ancestor
5716313|NCT03240939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5716314|NCT03240939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716315|NCT03240783|Dexamethasone|dexamethasone|mesh-list
5716316|NCT03240783|Dexamethasone acetate|dexamethasone acetate|mesh-list
5716317|NCT03240783|Betamethasone|betamethasone|mesh-list
5716318|NCT03240783|BB 1101|bb 1101|mesh-list
5716319|NCT03240783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5716320|NCT03240783|Antiemetics|antiemetics|mesh-ancestor
5716321|NCT03240783|Autonomic Agents|autonomic agents|mesh-ancestor
5716322|NCT03240783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5716323|NCT03240783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716324|NCT03240783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5716325|NCT03240783|Glucocorticoids|glucocorticoids|mesh-ancestor
5716326|NCT03240783|Hormones|hormones|mesh-ancestor
5716327|NCT03240783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5716328|NCT03240783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5716329|NCT03240783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5716330|NCT03240783|Protease Inhibitors|protease inhibitors|mesh-ancestor
5716331|NCT03240783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5716332|NCT03240783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716333|NCT03240783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5716334|NCT03240783|Respiratory System Agents|respiratory system agents|mesh-ancestor
5716335|NCT03240835|Docetaxel|docetaxel|mesh-list
5716336|NCT03240835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5716337|NCT03240835|Tubulin Modulators|tubulin modulators|mesh-ancestor
5716338|NCT03240835|Antimitotic Agents|antimitotic agents|mesh-ancestor
5716339|NCT03240835|Mitosis Modulators|mitosis modulators|mesh-ancestor
5716340|NCT03240835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722022|NCT03201796|Ofloxacin|ofloxacin|mesh-list
5722023|NCT03201796|Prulifloxacin|prulifloxacin|mesh-list
5722024|NCT03201796|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5722025|NCT03201796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5722026|NCT03201796|Renal Agents|renal agents|mesh-ancestor
6506689|NCT00666237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678592|NCT01594047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6678593|NCT01594047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678594|NCT01594047|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6678595|NCT01594047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6678596|NCT01594047|Anesthetics, General|anesthetics, general|mesh-ancestor
6678597|NCT01594047|Anesthetics|anesthetics|mesh-ancestor
6678598|NCT01594047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6678599|NCT01594047|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5716341|NCT03240471|Calpastatin|calpastatin|mesh-list
5716342|NCT03240471|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
5716343|NCT03240471|Protease Inhibitors|protease inhibitors|mesh-ancestor
5716344|NCT03240471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5716345|NCT03240471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716346|NCT03240549|Bevacizumab|bevacizumab|mesh-list
5716347|NCT03240549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5716348|NCT03240549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5716349|NCT03240549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5716350|NCT03240549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5716351|NCT03240549|Growth Substances|growth substances|mesh-ancestor
5716352|NCT03240549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716353|NCT03240549|Growth Inhibitors|growth inhibitors|mesh-ancestor
5716354|NCT03240120|Tinzaparin|tinzaparin|mesh-list
5716355|NCT03240120|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5716356|NCT03240120|Dalteparin|dalteparin|mesh-list
5716357|NCT03240120|Dabigatran|dabigatran|mesh-list
5716358|NCT03240120|Antithrombins|antithrombins|mesh-ancestor
5716359|NCT03240120|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5716360|NCT03240120|Protease Inhibitors|protease inhibitors|mesh-ancestor
5716361|NCT03240120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5716362|NCT03240120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716363|NCT03240120|Anticoagulants|anticoagulants|mesh-ancestor
5716364|NCT03240120|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5716365|NCT03240120|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5716366|NCT03240055|Etomidate|etomidate|mesh-list
5716367|NCT03240055|Anesthetics|anesthetics|mesh-ancestor
5716368|NCT03240055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5716369|NCT03240055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716370|NCT03240055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5716371|NCT03240055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5716372|NCT03240055|Anesthetics, General|anesthetics, general|mesh-ancestor
5716381|NCT03239691|ACT-709478|act-709478|mesh-list
5716382|NCT03239691|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5716383|NCT03239691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5716384|NCT03239691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716385|NCT03239691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5716386|NCT03239691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716387|NCT03239860|Antibodies|antibodies|mesh-list
5716388|NCT03239860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5716389|NCT03239860|Immunologic Factors|immunologic factors|mesh-ancestor
5716390|NCT03239860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716391|NCT03239743|Midazolam|midazolam|mesh-list
5716392|NCT03239743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5716393|NCT03239743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5716394|NCT03239743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5716395|NCT03239743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716396|NCT03239743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5716397|NCT03239743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5716398|NCT03239743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5716399|NCT03239743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5716400|NCT03239743|Anesthetics, General|anesthetics, general|mesh-ancestor
5716401|NCT03239743|Anesthetics|anesthetics|mesh-ancestor
5716402|NCT03239743|GABA Modulators|gaba modulators|mesh-ancestor
5716403|NCT03239743|GABA Agents|gaba agents|mesh-ancestor
5716404|NCT03239743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5716405|NCT03239743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716406|NCT03239821|Codeine|codeine|mesh-list
5716407|NCT03239821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5716408|NCT03239821|Narcotics|narcotics|mesh-ancestor
5716409|NCT03239821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5716410|NCT03239821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506690|NCT00666237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6506691|NCT00666237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6506692|NCT00666302|Pimecrolimus|pimecrolimus|mesh-list
6506693|NCT00666302|Tacrolimus|tacrolimus|mesh-list
6506694|NCT00666302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6506695|NCT00666302|Immunologic Factors|immunologic factors|mesh-ancestor
6506696|NCT00666302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506697|NCT00666302|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6506698|NCT00666302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6506699|NCT00666302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716411|NCT03239821|Analgesics|analgesics|mesh-ancestor
5716412|NCT03239821|Sensory System Agents|sensory system agents|mesh-ancestor
5716413|NCT03239821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5716414|NCT03239821|Antitussive Agents|antitussive agents|mesh-ancestor
5716415|NCT03239821|Respiratory System Agents|respiratory system agents|mesh-ancestor
5716416|NCT03239964|Dexamethasone|dexamethasone|mesh-list
5716417|NCT03239964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5716418|NCT03239964|Antiemetics|antiemetics|mesh-ancestor
5716419|NCT03239964|Autonomic Agents|autonomic agents|mesh-ancestor
5716420|NCT03239964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5716421|NCT03239964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716422|NCT03239964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5716423|NCT03239964|Glucocorticoids|glucocorticoids|mesh-ancestor
5716424|NCT03239964|Hormones|hormones|mesh-ancestor
5716425|NCT03239964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5716426|NCT03239964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5716427|NCT03239964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5716428|NCT03239886|Imatinib Mesylate|imatinib mesylate|mesh-list
5716429|NCT03239886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5716430|NCT03239886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5716431|NCT03239886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5716432|NCT03239886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716433|NCT03239600|Methotrexate|methotrexate|mesh-list
5716434|NCT03239600|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5716435|NCT03239600|Abortifacient Agents|abortifacient agents|mesh-ancestor
5716436|NCT03239600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5716437|NCT03239600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716438|NCT03239600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5716439|NCT03239600|Antimetabolites|antimetabolites|mesh-ancestor
5716440|NCT03239600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716441|NCT03239600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5716442|NCT03239600|Dermatologic Agents|dermatologic agents|mesh-ancestor
5716443|NCT03239600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5716444|NCT03239600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5716445|NCT03239600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5716446|NCT03239600|Immunologic Factors|immunologic factors|mesh-ancestor
5716447|NCT03239600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5716448|NCT03239600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5716449|NCT03239561|JNJ-64326067|jnj-64326067|mesh-list
5716450|NCT03239561|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5716451|NCT03239561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716452|NCT03239327|Alprostadil|alprostadil|mesh-list
5716453|NCT03239327|Misoprostol|misoprostol|mesh-list
5716454|NCT03239327|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5716455|NCT03239327|Abortifacient Agents|abortifacient agents|mesh-ancestor
5716456|NCT03239327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5716457|NCT03239327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716458|NCT03239327|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5716459|NCT03239327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5716460|NCT03239327|Oxytocics|oxytocics|mesh-ancestor
5716461|NCT03239327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5716462|NCT03239327|Vasodilator Agents|vasodilator agents|mesh-ancestor
5716463|NCT03239327|Urological Agents|urological agents|mesh-ancestor
5716464|NCT03239314|Dexamethasone|dexamethasone|mesh-list
5716465|NCT03239314|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5716466|NCT03239314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5716467|NCT03239314|Antiemetics|antiemetics|mesh-ancestor
5716468|NCT03239314|Autonomic Agents|autonomic agents|mesh-ancestor
5716469|NCT03239314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5716470|NCT03239314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506700|NCT00666302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6506701|NCT00666302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6506702|NCT00666302|Analgesics|analgesics|mesh-ancestor
6506703|NCT00666302|Sensory System Agents|sensory system agents|mesh-ancestor
6506704|NCT00666302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5716471|NCT03239314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5716472|NCT03239314|Glucocorticoids|glucocorticoids|mesh-ancestor
5716473|NCT03239314|Hormones|hormones|mesh-ancestor
5716474|NCT03239314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5716475|NCT03239314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5716476|NCT03239314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5716477|NCT03239353|Entecavir|entecavir|mesh-list
5716478|NCT03239353|Antiviral Agents|antiviral agents|mesh-ancestor
5716479|NCT03239353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5716480|NCT03239236|Anesthetics|anesthetics|mesh-list
5716481|NCT03239236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5716482|NCT03239236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716483|NCT03239457|Mitogens|mitogens|mesh-list
5716484|NCT03239457|Mitosis Modulators|mitosis modulators|mesh-ancestor
5716485|NCT03239457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716486|NCT03239210|Ondansetron|ondansetron|mesh-list
5716487|NCT03239210|Antiemetics|antiemetics|mesh-ancestor
5716488|NCT03239210|Autonomic Agents|autonomic agents|mesh-ancestor
5716489|NCT03239210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5716490|NCT03239210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716491|NCT03239210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5716492|NCT03239210|Antipruritics|antipruritics|mesh-ancestor
5716493|NCT03239210|Dermatologic Agents|dermatologic agents|mesh-ancestor
5716494|NCT03239210|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5716495|NCT03239210|Serotonin Agents|serotonin agents|mesh-ancestor
5716496|NCT03239210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5716497|NCT03239210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716498|NCT03239210|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5716499|NCT03239210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5716500|NCT03239210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5716501|NCT03239210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5716502|NCT03239210|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5716503|NCT03239145|Pembrolizumab|pembrolizumab|mesh-list
5716504|NCT03239145|Trebananib|trebananib|mesh-list
5716505|NCT03239145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5716506|NCT03239145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5716507|NCT03239145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5716508|NCT03239145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5716509|NCT03239145|Growth Substances|growth substances|mesh-ancestor
5716510|NCT03239145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716511|NCT03239145|Growth Inhibitors|growth inhibitors|mesh-ancestor
5716512|NCT03239080|Denosumab|denosumab|mesh-list
5716513|NCT03239080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5716514|NCT03239080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716515|NCT03238898|Botulinum Toxins|botulinum toxins|mesh-list
5716516|NCT03238898|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5716517|NCT03238898|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5716518|NCT03238898|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5716519|NCT03238898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5716520|NCT03238898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716521|NCT03238898|Cholinergic Agents|cholinergic agents|mesh-ancestor
5716522|NCT03238898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5716523|NCT03238898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716524|NCT03238898|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5716525|NCT03238898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5716526|NCT03238807|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5716527|NCT03238807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5716528|NCT03238807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722027|NCT03201796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5722028|NCT03201796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5722029|NCT03201796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5722030|NCT03201796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5722031|NCT03201796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722032|NCT03201796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5722033|NCT03201796|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5722034|NCT03201796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5722035|NCT03201770|Artesunate|artesunate|mesh-list
5722036|NCT03201770|Pyronaridine|pyronaridine|mesh-list
5722037|NCT03201770|Antimalarials|antimalarials|mesh-ancestor
5722038|NCT03201770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5722039|NCT03201770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5722040|NCT03201770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6506705|NCT00666302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6506706|NCT00666302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6506707|NCT00666302|Dermatologic Agents|dermatologic agents|mesh-ancestor
6506708|NCT00666341|Immunologic Factors|immunologic factors|mesh-list
6506709|NCT00666341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506710|NCT00666354|Methotrexate|methotrexate|mesh-list
6506711|NCT00666354|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6506712|NCT00666354|Abortifacient Agents|abortifacient agents|mesh-ancestor
6506713|NCT00666354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6506714|NCT00666354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506715|NCT00666354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6506716|NCT00666354|Antimetabolites|antimetabolites|mesh-ancestor
6506717|NCT00666354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506718|NCT00666354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6506719|NCT00666354|Dermatologic Agents|dermatologic agents|mesh-ancestor
6506720|NCT00666354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6506721|NCT00666354|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6506722|NCT00666354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6506723|NCT00666354|Immunologic Factors|immunologic factors|mesh-ancestor
6506724|NCT00666354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6506725|NCT00666354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6506726|NCT00666393|Fentanyl|fentanyl|mesh-list
6506727|NCT00666393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6506728|NCT00666393|Narcotics|narcotics|mesh-ancestor
6506729|NCT00666393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6506730|NCT00666393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506731|NCT00666393|Analgesics|analgesics|mesh-ancestor
6506732|NCT00666393|Sensory System Agents|sensory system agents|mesh-ancestor
6506733|NCT00666393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6506734|NCT00666393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6506735|NCT00666393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6506736|NCT00666393|Anesthetics, General|anesthetics, general|mesh-ancestor
6506737|NCT00666393|Anesthetics|anesthetics|mesh-ancestor
6506738|NCT00666484|Prednisolone|prednisolone|mesh-list
6506739|NCT00666484|Cyclophosphamide|cyclophosphamide|mesh-list
6506740|NCT00666484|Doxorubicin|doxorubicin|mesh-list
6506741|NCT00666484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6506742|NCT00666484|Etoposide|etoposide|mesh-list
6506743|NCT00666484|Vincristine|vincristine|mesh-list
6506744|NCT00666484|Procarbazine|procarbazine|mesh-list
6506745|NCT00666484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6506746|NCT00666484|Immunologic Factors|immunologic factors|mesh-ancestor
6506747|NCT00666484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506748|NCT00666484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6506749|NCT00666484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6506750|NCT00666484|Alkylating Agents|alkylating agents|mesh-ancestor
6506751|NCT00666484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506752|NCT00666484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6506753|NCT00666484|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6506754|NCT00666484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6506755|NCT00666484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6506756|NCT00666484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6506757|NCT00666484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6506758|NCT00666484|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6506759|NCT00666484|Tubulin Modulators|tubulin modulators|mesh-ancestor
6506760|NCT00666484|Antimitotic Agents|antimitotic agents|mesh-ancestor
6506761|NCT00666484|Mitosis Modulators|mitosis modulators|mesh-ancestor
6506762|NCT00666484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6506763|NCT00666484|Glucocorticoids|glucocorticoids|mesh-ancestor
6506764|NCT00666484|Hormones|hormones|mesh-ancestor
6506765|NCT00666484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6506766|NCT00666484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6506767|NCT00666575|Gabapentin|gabapentin|mesh-list
6506768|NCT00666575|Analgesics|analgesics|mesh-ancestor
6506769|NCT00666575|Sensory System Agents|sensory system agents|mesh-ancestor
6506770|NCT00666575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6506771|NCT00666575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506772|NCT00666575|Anticonvulsants|anticonvulsants|mesh-ancestor
6506773|NCT00666575|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6506774|NCT00666575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6506775|NCT00666575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6506776|NCT00666575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6506777|NCT00666575|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6506778|NCT00666575|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6506779|NCT00666575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6678600|NCT01594047|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6506780|NCT00666575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716529|NCT03239015|Trastuzumab|trastuzumab|mesh-list
5716530|NCT03239015|Everolimus|everolimus|mesh-list
5716531|NCT03239015|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5716532|NCT03239015|Olaparib|olaparib|mesh-list
5716533|NCT03239015|Gefitinib|gefitinib|mesh-list
5716534|NCT03239015|Palbociclib|palbociclib|mesh-list
5716535|NCT03239015|Afatinib|afatinib|mesh-list
5716536|NCT03239015|Vemurafenib|vemurafenib|mesh-list
5716537|NCT03239015|Dabrafenib|dabrafenib|mesh-list
5716538|NCT03239015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5716539|NCT03239015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5716540|NCT03239015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5716541|NCT03239015|Immunologic Factors|immunologic factors|mesh-ancestor
5716542|NCT03239015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716543|NCT03239015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5716544|NCT03239015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5716545|NCT03239015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716546|NCT03239015|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6506781|NCT00666575|Antimanic Agents|antimanic agents|mesh-ancestor
6506782|NCT00666601|Tedizolid phosphate|tedizolid phosphate|mesh-list
6506783|NCT00666601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6506784|NCT00666601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6506785|NCT00666627|Alendronate|alendronate|mesh-list
6678601|NCT01594047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6678602|NCT01594047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678603|NCT01594047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6678604|NCT01594047|Narcotics|narcotics|mesh-ancestor
6678605|NCT01594047|Antitussive Agents|antitussive agents|mesh-ancestor
6506786|NCT00666627|Risedronic Acid|risedronic acid|mesh-list
6506787|NCT00666627|Ibandronic Acid|ibandronic acid|mesh-list
6506788|NCT00666627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6506789|NCT00666627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506790|NCT00666627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6506791|NCT00666627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6506792|NCT00666627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506793|NCT00666627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6506794|NCT00666653|Pramipexole|pramipexole|mesh-list
6506795|NCT00666653|Antioxidants|antioxidants|mesh-ancestor
6506796|NCT00666653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506797|NCT00666653|Protective Agents|protective agents|mesh-ancestor
6506798|NCT00666653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506799|NCT00666653|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6506800|NCT00666653|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6506801|NCT00666653|Dopamine Agonists|dopamine agonists|mesh-ancestor
6506802|NCT00666653|Dopamine Agents|dopamine agents|mesh-ancestor
6506803|NCT00666653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6506804|NCT00666692|Paclitaxel|paclitaxel|mesh-list
6506805|NCT00666692|Bevacizumab|bevacizumab|mesh-list
6506806|NCT00666692|Carboplatin|carboplatin|mesh-list
6506807|NCT00666692|Volociximab|volociximab|mesh-list
6506808|NCT00666692|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6506809|NCT00666692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6506810|NCT00666692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6506811|NCT00666692|Tubulin Modulators|tubulin modulators|mesh-ancestor
6506812|NCT00666692|Antimitotic Agents|antimitotic agents|mesh-ancestor
6506813|NCT00666692|Mitosis Modulators|mitosis modulators|mesh-ancestor
6506814|NCT00666692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506815|NCT00666692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6506816|NCT00666692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6506817|NCT00666692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6506818|NCT00666692|Growth Substances|growth substances|mesh-ancestor
6506819|NCT00666692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506820|NCT00666692|Growth Inhibitors|growth inhibitors|mesh-ancestor
6506821|NCT00666692|Immunologic Factors|immunologic factors|mesh-ancestor
6506822|NCT00666770|Gabapentin|gabapentin|mesh-list
6506823|NCT00666770|Analgesics|analgesics|mesh-ancestor
6506824|NCT00666770|Sensory System Agents|sensory system agents|mesh-ancestor
6678606|NCT01594047|Respiratory System Agents|respiratory system agents|mesh-ancestor
6678607|NCT01594060|Insulin|insulin|mesh-list
6678608|NCT01594060|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6678609|NCT01594060|Insulin Glargine|insulin glargine|mesh-list
6678610|NCT01594060|Insulin glulisine|insulin glulisine|mesh-list
6678611|NCT01594060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5716547|NCT03238703|Tamoxifen|tamoxifen|mesh-list
5716548|NCT03238703|Toremifene|toremifene|mesh-list
6506825|NCT00666770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6506826|NCT00666770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506827|NCT00666770|Anticonvulsants|anticonvulsants|mesh-ancestor
6506828|NCT00666770|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6506829|NCT00666770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6506830|NCT00666770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6506831|NCT00666770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6506832|NCT00666770|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6506833|NCT00666770|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6506834|NCT00666770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6506835|NCT00666770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506836|NCT00666770|Antimanic Agents|antimanic agents|mesh-ancestor
6506837|NCT00666783|Palonosetron|palonosetron|mesh-list
6506838|NCT00666783|Granisetron|granisetron|mesh-list
6506839|NCT00666783|Antiemetics|antiemetics|mesh-ancestor
6506840|NCT00666783|Autonomic Agents|autonomic agents|mesh-ancestor
6506841|NCT00666783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6506842|NCT00666783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506843|NCT00666783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6506844|NCT00666783|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6506845|NCT00666783|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6506846|NCT00666783|Serotonin Agents|serotonin agents|mesh-ancestor
6506847|NCT00666783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6506848|NCT00666783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506849|NCT00666796|Ethanol|ethanol|mesh-list
6506850|NCT00666796|Gabapentin|gabapentin|mesh-list
6506851|NCT00666796|Analgesics|analgesics|mesh-ancestor
6506852|NCT00666796|Sensory System Agents|sensory system agents|mesh-ancestor
6506853|NCT00666796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6678612|NCT01594060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678613|NCT01594099|Paclitaxel|paclitaxel|mesh-list
6678614|NCT01594099|Cisplatin|cisplatin|mesh-list
6678615|NCT01594099|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6506854|NCT00666796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506855|NCT00666796|Anticonvulsants|anticonvulsants|mesh-ancestor
6506856|NCT00666796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6506857|NCT00666796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6506858|NCT00666796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6506859|NCT00666796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6506860|NCT00666796|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6506861|NCT00666796|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6506862|NCT00666796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6506863|NCT00666796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506864|NCT00666796|Antimanic Agents|antimanic agents|mesh-ancestor
6506865|NCT00666796|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6506866|NCT00666796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6506867|NCT00666809|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6506868|NCT00666809|Vasodilator Agents|vasodilator agents|mesh-ancestor
6506869|NCT00666809|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6506870|NCT00666809|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6506871|NCT00666809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6506872|NCT00666809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506873|NCT00666809|Urological Agents|urological agents|mesh-ancestor
6506874|NCT00666887|Minocycline|minocycline|mesh-list
6506875|NCT00666887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6506876|NCT00666887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6506877|NCT00666939|Gabapentin|gabapentin|mesh-list
6506878|NCT00666939|Analgesics|analgesics|mesh-ancestor
6678616|NCT01594099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6678617|NCT01594099|Tubulin Modulators|tubulin modulators|mesh-ancestor
6678618|NCT01594099|Antimitotic Agents|antimitotic agents|mesh-ancestor
6678619|NCT01594099|Mitosis Modulators|mitosis modulators|mesh-ancestor
6678620|NCT01594099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678621|NCT01594177|Paclitaxel|paclitaxel|mesh-list
6678622|NCT01594177|Cyclophosphamide|cyclophosphamide|mesh-list
6678623|NCT01594177|Trastuzumab|trastuzumab|mesh-list
6678624|NCT01594177|Epirubicin|epirubicin|mesh-list
6678625|NCT01594177|Afatinib|afatinib|mesh-list
6678626|NCT01594177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6506879|NCT00666939|Sensory System Agents|sensory system agents|mesh-ancestor
6678627|NCT01594177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6678628|NCT01594177|Tubulin Modulators|tubulin modulators|mesh-ancestor
6678629|NCT01594177|Antimitotic Agents|antimitotic agents|mesh-ancestor
6678630|NCT01594177|Mitosis Modulators|mitosis modulators|mesh-ancestor
6678631|NCT01594177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678632|NCT01594177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6678633|NCT01594177|Immunologic Factors|immunologic factors|mesh-ancestor
6506880|NCT00666939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6506881|NCT00666939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506882|NCT00666939|Anticonvulsants|anticonvulsants|mesh-ancestor
6678634|NCT01594177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678635|NCT01594177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6678636|NCT01594177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6506883|NCT00666939|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6506884|NCT00666939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6506885|NCT00666939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6506886|NCT00666939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6506887|NCT00666939|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6506888|NCT00666939|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6506889|NCT00666939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6678637|NCT01594177|Alkylating Agents|alkylating agents|mesh-ancestor
6678638|NCT01594177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6506890|NCT00666939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678639|NCT01594177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5716549|NCT03238703|Letrozole|letrozole|mesh-list
5716550|NCT03238703|Anastrozole|anastrozole|mesh-list
5716551|NCT03238703|Exemestane|exemestane|mesh-list
5716552|NCT03238703|Citric Acid|citric acid|mesh-list
5716553|NCT03238703|Sodium Citrate|sodium citrate|mesh-list
5716554|NCT03238703|Anticoagulants|anticoagulants|mesh-ancestor
5716555|NCT03238703|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5716556|NCT03238703|Chelating Agents|chelating agents|mesh-ancestor
5716557|NCT03238703|Sequestering Agents|sequestering agents|mesh-ancestor
5716558|NCT03238703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716559|NCT03238703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5716560|NCT03238703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5716561|NCT03238703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5716562|NCT03238703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5716563|NCT03238703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5716564|NCT03238703|Hormone Antagonists|hormone antagonists|mesh-ancestor
5716565|NCT03238703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5716566|NCT03238703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716567|NCT03238703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5716568|NCT03238703|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5716569|NCT03238703|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5716570|NCT03238703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5716571|NCT03238365|Nivolumab|nivolumab|mesh-list
5716572|NCT03238365|Tadalafil|tadalafil|mesh-list
5716573|NCT03238365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5716574|NCT03238365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5716575|NCT03238365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5716576|NCT03238365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716577|NCT03238365|Vasodilator Agents|vasodilator agents|mesh-ancestor
5716578|NCT03238365|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5716579|NCT03238365|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5716580|NCT03238365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5716581|NCT03238365|Urological Agents|urological agents|mesh-ancestor
5716582|NCT03238625|Lidocaine|lidocaine|mesh-list
5716583|NCT03238625|Anesthetics, Local|anesthetics, local|mesh-ancestor
5716584|NCT03238625|Anesthetics|anesthetics|mesh-ancestor
5716585|NCT03238625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6506891|NCT00666939|Antimanic Agents|antimanic agents|mesh-ancestor
6506892|NCT00666991|Paclitaxel|paclitaxel|mesh-list
6506893|NCT00666991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6506894|NCT00666991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6506895|NCT00666991|Tubulin Modulators|tubulin modulators|mesh-ancestor
6506896|NCT00666991|Antimitotic Agents|antimitotic agents|mesh-ancestor
6506897|NCT00666991|Mitosis Modulators|mitosis modulators|mesh-ancestor
6506898|NCT00666991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506899|NCT00667043|Fentanyl|fentanyl|mesh-list
6506900|NCT00667043|Midazolam|midazolam|mesh-list
6506901|NCT00667043|Remifentanil|remifentanil|mesh-list
6506902|NCT00667043|Propofol|propofol|mesh-list
6506903|NCT00667043|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6506904|NCT00667043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6506905|NCT00667043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506906|NCT00667043|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6506907|NCT00667043|Anesthetics, General|anesthetics, general|mesh-ancestor
6506908|NCT00667043|Anesthetics|anesthetics|mesh-ancestor
6506909|NCT00667043|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6506910|NCT00667043|Narcotics|narcotics|mesh-ancestor
6506911|NCT00667043|Analgesics|analgesics|mesh-ancestor
6506912|NCT00667043|Sensory System Agents|sensory system agents|mesh-ancestor
6506913|NCT00667043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6506914|NCT00667043|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5716586|NCT03238625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716587|NCT03238625|Sensory System Agents|sensory system agents|mesh-ancestor
5716588|NCT03238625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5716589|NCT03238625|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5716590|NCT03238625|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5716591|NCT03238625|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5716592|NCT03238625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5716593|NCT03238625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716594|NCT03238430|Morphine|morphine|mesh-list
5716595|NCT03238430|Ropivacaine|ropivacaine|mesh-list
5716596|NCT03238430|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5716597|NCT03238430|Narcotics|narcotics|mesh-ancestor
5716598|NCT03238430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5716599|NCT03238430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716600|NCT03238430|Analgesics|analgesics|mesh-ancestor
5716601|NCT03238430|Sensory System Agents|sensory system agents|mesh-ancestor
5716602|NCT03238430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5716603|NCT03238430|Anesthetics, Local|anesthetics, local|mesh-ancestor
5716604|NCT03238430|Anesthetics|anesthetics|mesh-ancestor
5716605|NCT03238482|Fluticasone|fluticasone|mesh-list
5716606|NCT03238482|Xhance|xhance|mesh-list
5716607|NCT03238482|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5716608|NCT03238482|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
5716609|NCT03238482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5716610|NCT03238482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5716611|NCT03238482|Autonomic Agents|autonomic agents|mesh-ancestor
5716612|NCT03238482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5716613|NCT03238482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716614|NCT03238482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5716615|NCT03238482|Respiratory System Agents|respiratory system agents|mesh-ancestor
5716616|NCT03238482|Dermatologic Agents|dermatologic agents|mesh-ancestor
5716617|NCT03238482|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5716618|NCT03238482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5716619|NCT03238482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5716620|NCT03238482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5716621|NCT03238482|Adrenergic Agents|adrenergic agents|mesh-ancestor
5716622|NCT03238482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5716623|NCT03238482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716624|NCT03238482|Glucocorticoids|glucocorticoids|mesh-ancestor
5716625|NCT03238482|Hormones|hormones|mesh-ancestor
5716626|NCT03238482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5716627|NCT03238482|Sympathomimetics|sympathomimetics|mesh-ancestor
5716628|NCT03238560|Montelukast|montelukast|mesh-list
5716629|NCT03238560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5716630|NCT03238560|Respiratory System Agents|respiratory system agents|mesh-ancestor
5716631|NCT03238560|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5716632|NCT03238560|Hormone Antagonists|hormone antagonists|mesh-ancestor
5716633|NCT03238560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5722337|NCT03199924|Lidocaine|lidocaine|mesh-list
6506915|NCT00667043|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6506916|NCT00667043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6506917|NCT00667043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6506918|NCT00667043|GABA Modulators|gaba modulators|mesh-ancestor
6506919|NCT00667043|GABA Agents|gaba agents|mesh-ancestor
6506920|NCT00667043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6506921|NCT00667043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506922|NCT00667056|Tacrolimus|tacrolimus|mesh-list
6506923|NCT00667056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6506924|NCT00667056|Immunologic Factors|immunologic factors|mesh-ancestor
6506925|NCT00667056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506926|NCT00667056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6506927|NCT00667056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6506928|NCT00667056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506929|NCT00667069|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6506930|NCT00667069|Luteolytic Agents|luteolytic agents|mesh-ancestor
6506931|NCT00667069|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6506932|NCT00667069|Contraceptive Agents|contraceptive agents|mesh-ancestor
6506933|NCT00667069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6506934|NCT00667069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506935|NCT00667069|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6506936|NCT00667069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6506937|NCT00667069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6506938|NCT00667082|Vorinostat|vorinostat|mesh-list
6506939|NCT00667082|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
6506940|NCT00667082|Proteasome Inhibitors|proteasome inhibitors|mesh-list
6506941|NCT00667082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6506942|NCT00667082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6506943|NCT00667082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506944|NCT00667082|Protease Inhibitors|protease inhibitors|mesh-ancestor
6506945|NCT00667108|Gabapentin|gabapentin|mesh-list
6506946|NCT00667108|Analgesics|analgesics|mesh-ancestor
6506947|NCT00667108|Sensory System Agents|sensory system agents|mesh-ancestor
6506948|NCT00667108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6506949|NCT00667108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506950|NCT00667108|Anticonvulsants|anticonvulsants|mesh-ancestor
6506951|NCT00667108|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6506952|NCT00667108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6506953|NCT00667108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6506954|NCT00667108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6506955|NCT00667108|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6506956|NCT00667108|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6506957|NCT00667108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6506958|NCT00667108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506959|NCT00667108|Antimanic Agents|antimanic agents|mesh-ancestor
6506960|NCT00667147|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6506961|NCT00667147|Paclitaxel|paclitaxel|mesh-list
6506962|NCT00667147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6506963|NCT00667147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6506964|NCT00667147|Tubulin Modulators|tubulin modulators|mesh-ancestor
6506965|NCT00667147|Antimitotic Agents|antimitotic agents|mesh-ancestor
6506966|NCT00667147|Mitosis Modulators|mitosis modulators|mesh-ancestor
6506967|NCT00667147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506968|NCT00667160|Pimecrolimus|pimecrolimus|mesh-list
6506969|NCT00667160|Tacrolimus|tacrolimus|mesh-list
6506970|NCT00667160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6506971|NCT00667160|Immunologic Factors|immunologic factors|mesh-ancestor
6506972|NCT00667160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506973|NCT00667160|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6506974|NCT00667160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6506975|NCT00667160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6506976|NCT00667160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6506977|NCT00667160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6506978|NCT00667160|Analgesics|analgesics|mesh-ancestor
6506979|NCT00667160|Sensory System Agents|sensory system agents|mesh-ancestor
6506980|NCT00667160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6506981|NCT00667160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6506982|NCT00667160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6506983|NCT00667160|Dermatologic Agents|dermatologic agents|mesh-ancestor
6506984|NCT00667199|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
6506985|NCT00667199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6506986|NCT00667264|Ropivacaine|ropivacaine|mesh-list
6506987|NCT00667264|Anesthetics, Local|anesthetics, local|mesh-ancestor
6506988|NCT00667264|Anesthetics|anesthetics|mesh-ancestor
6506989|NCT00667264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6506990|NCT00667264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506991|NCT00667264|Sensory System Agents|sensory system agents|mesh-ancestor
6506992|NCT00667264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6506993|NCT00667303|Antibodies|antibodies|mesh-list
6506994|NCT00667303|Immunologic Factors|immunologic factors|mesh-ancestor
6506995|NCT00667303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6506996|NCT00667329|Cyclophosphamide|cyclophosphamide|mesh-list
6506997|NCT00667329|Rituximab|rituximab|mesh-list
6506998|NCT00667329|Cladribine|cladribine|mesh-list
6506999|NCT00667329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6678640|NCT01594177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6678641|NCT01594177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6678642|NCT01594177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6678643|NCT01594177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6678644|NCT01594177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6678645|NCT01594229|Rituximab|rituximab|mesh-list
6678646|NCT01594229|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6678647|NCT01594229|Venetoclax|venetoclax|mesh-list
6678648|NCT01594229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6678649|NCT01594229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6507000|NCT00667329|Immunologic Factors|immunologic factors|mesh-ancestor
6507001|NCT00667329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6507002|NCT00667329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6507003|NCT00667329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6507004|NCT00667329|Alkylating Agents|alkylating agents|mesh-ancestor
6507005|NCT00667329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507006|NCT00667329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6507007|NCT00667329|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6507008|NCT00667329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6507009|NCT00667407|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5716634|NCT03238560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716635|NCT03238560|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5716636|NCT03238560|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5716637|NCT03238560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716638|NCT03238612|Clarithromycin|clarithromycin|mesh-list
5716639|NCT03238612|Oseltamivir|oseltamivir|mesh-list
5716640|NCT03238612|Antiviral Agents|antiviral agents|mesh-list
5716641|NCT03238612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5716642|NCT03238612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5716643|NCT03238612|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5716644|NCT03238612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5716645|NCT03238612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716646|NCT03238612|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5716647|NCT03238612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5716648|NCT03238638|Pembrolizumab|pembrolizumab|mesh-list
5716649|NCT03238638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5716650|NCT03238638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5716651|NCT03238248|Azacitidine|azacitidine|mesh-list
5716652|NCT03238248|Pevonedistat|pevonedistat|mesh-list
5716653|NCT03238248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5716654|NCT03238248|Antimetabolites|antimetabolites|mesh-ancestor
5716655|NCT03238248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716656|NCT03238248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5716657|NCT03238248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5716658|NCT03238131|Ivermectin|ivermectin|mesh-list
5716659|NCT03238131|Albendazole|albendazole|mesh-list
5716660|NCT03238131|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5716661|NCT03238131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5716662|NCT03238131|Anthelmintics|anthelmintics|mesh-ancestor
5716663|NCT03238131|Anticestodal Agents|anticestodal agents|mesh-ancestor
5716664|NCT03238131|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5716665|NCT03238131|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5716666|NCT03238131|Tubulin Modulators|tubulin modulators|mesh-ancestor
5716667|NCT03238131|Antimitotic Agents|antimitotic agents|mesh-ancestor
5716668|NCT03238131|Mitosis Modulators|mitosis modulators|mesh-ancestor
5716669|NCT03238131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716670|NCT03238131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5716671|NCT03238079|Immunoglobulins|immunoglobulins|mesh-list
5716672|NCT03238079|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5716673|NCT03238079|Immunologic Factors|immunologic factors|mesh-ancestor
5716674|NCT03238079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716675|NCT03238092|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5716676|NCT03238092|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5716677|NCT03238092|Estradiol|estradiol|mesh-list
5716678|NCT03238092|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5716679|NCT03238092|Testosterone|testosterone|mesh-list
5716680|NCT03238092|Estrogens|estrogens|mesh-ancestor
5716681|NCT03238092|Hormones|hormones|mesh-ancestor
5716682|NCT03238092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5716683|NCT03238092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919376|NCT04981912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5919377|NCT04981912|Immunologic Factors|immunologic factors|mesh-ancestor
6507010|NCT00667407|Albuterol|albuterol|mesh-list
6507011|NCT00667407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6507012|NCT00667407|Autonomic Agents|autonomic agents|mesh-ancestor
6507013|NCT00667407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6507014|NCT00667407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919378|NCT04981912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919379|NCT04981912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5964087|NCT04594915|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5964088|NCT04594915|Protease Inhibitors|protease inhibitors|mesh-ancestor
5964089|NCT04594915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5964090|NCT04594915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964091|NCT04594915|Anticoagulants|anticoagulants|mesh-ancestor
5964092|NCT04594772|Gemcitabine|gemcitabine|mesh-list
5964093|NCT04594772|Paclitaxel|paclitaxel|mesh-list
5964094|NCT04594772|Fluorouracil|fluorouracil|mesh-list
6507015|NCT00667407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6507016|NCT00667407|Respiratory System Agents|respiratory system agents|mesh-ancestor
6507017|NCT00667407|Tocolytic Agents|tocolytic agents|mesh-ancestor
6507018|NCT00667407|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6507019|NCT00667407|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6507020|NCT00667407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6507021|NCT00667407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6507022|NCT00667407|Adrenergic Agents|adrenergic agents|mesh-ancestor
6507023|NCT00667407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6507024|NCT00667407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507025|NCT00667433|Tenofovir|tenofovir|mesh-list
6507026|NCT00667433|Emtricitabine|emtricitabine|mesh-list
6507027|NCT00667433|Raltegravir Potassium|raltegravir potassium|mesh-list
6507028|NCT00667433|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6507029|NCT00667433|Antiviral Agents|antiviral agents|mesh-ancestor
5716684|NCT03238092|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5716685|NCT03238092|Contraceptive Agents|contraceptive agents|mesh-ancestor
5716686|NCT03238092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5716687|NCT03238092|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5716688|NCT03238092|Androgens|androgens|mesh-ancestor
5716689|NCT03238157|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
5716690|NCT03238157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5716691|NCT03238157|Glucocorticoids|glucocorticoids|mesh-ancestor
5716692|NCT03238157|Hormones|hormones|mesh-ancestor
5716693|NCT03238157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5716694|NCT03238157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6507030|NCT00667433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6507031|NCT00667433|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6507032|NCT00667433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6507033|NCT00667433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6507034|NCT00667433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507035|NCT00667433|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6507036|NCT00667433|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6507037|NCT00667433|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6507038|NCT00667433|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6507039|NCT00667472|Ranibizumab|ranibizumab|mesh-list
6507040|NCT00667472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6507041|NCT00667472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6507042|NCT00667472|Growth Substances|growth substances|mesh-ancestor
6507043|NCT00667472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6507044|NCT00667472|Growth Inhibitors|growth inhibitors|mesh-ancestor
6507045|NCT00667472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6507046|NCT00667485|Sirolimus|sirolimus|mesh-list
6507047|NCT00667485|Bevacizumab|bevacizumab|mesh-list
6507048|NCT00667485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6507049|NCT00667485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6678650|NCT01594229|Immunologic Factors|immunologic factors|mesh-ancestor
6678651|NCT01594229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678652|NCT01594229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6678653|NCT01594229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6678654|NCT01594229|Alkylating Agents|alkylating agents|mesh-ancestor
6678655|NCT01594229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678656|NCT01594242|Bortezomib|bortezomib|mesh-list
6678657|NCT01594242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6678658|NCT01594255|Moxifloxacin|moxifloxacin|mesh-list
6678659|NCT01594255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6678660|NCT01594255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6678661|NCT01594255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6678662|NCT01594255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6678663|NCT01594255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6678664|NCT01594255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678665|NCT01594255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6678666|NCT01594268|Everolimus|everolimus|mesh-list
6678667|NCT01594268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5716695|NCT03237936|Cyclosporine|cyclosporine|mesh-list
5716696|NCT03237936|Cyclosporins|cyclosporins|mesh-list
6507050|NCT00667485|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6507051|NCT00667485|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6507052|NCT00667485|Growth Substances|growth substances|mesh-ancestor
6507053|NCT00667485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6507054|NCT00667485|Growth Inhibitors|growth inhibitors|mesh-ancestor
6507055|NCT00667485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6507056|NCT00667485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6507057|NCT00667485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6507058|NCT00667485|Antifungal Agents|antifungal agents|mesh-ancestor
6507059|NCT00667485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6507060|NCT00667485|Immunologic Factors|immunologic factors|mesh-ancestor
6507061|NCT00667498|Metformin|metformin|mesh-list
6507062|NCT00667498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6507063|NCT00667498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6507064|NCT00667537|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
6507065|NCT00667537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6507066|NCT00667641|Paclitaxel|paclitaxel|mesh-list
6507067|NCT00667641|Bortezomib|bortezomib|mesh-list
6507068|NCT00667641|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6507069|NCT00667641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6507070|NCT00667641|Tubulin Modulators|tubulin modulators|mesh-ancestor
6507071|NCT00667641|Antimitotic Agents|antimitotic agents|mesh-ancestor
6507072|NCT00667641|Mitosis Modulators|mitosis modulators|mesh-ancestor
6678668|NCT01594268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6678669|NCT01594268|Immunologic Factors|immunologic factors|mesh-ancestor
6678670|NCT01594268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678671|NCT01594346|Vitamin E|vitamin e|mesh-list
6678672|NCT01594346|Tocopherols|tocopherols|mesh-list
6678673|NCT01594346|Tocotrienols|tocotrienols|mesh-list
6678674|NCT01594346|alpha-Tocopherol|alpha-tocopherol|mesh-list
5716697|NCT03237936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5716698|NCT03237936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716699|NCT03237936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5716700|NCT03237936|Immunologic Factors|immunologic factors|mesh-ancestor
6678675|NCT01594346|Vitamins|vitamins|mesh-ancestor
6678676|NCT01594346|Micronutrients|micronutrients|mesh-ancestor
6678677|NCT01594346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678678|NCT01594346|Antioxidants|antioxidants|mesh-ancestor
6507073|NCT00667641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507074|NCT00667758|Cetrorelix|cetrorelix|mesh-list
6507075|NCT00667758|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6507076|NCT00667758|Fertility Agents|fertility agents|mesh-ancestor
6507077|NCT00667758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6507078|NCT00667758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6507079|NCT00667758|Hormone Antagonists|hormone antagonists|mesh-ancestor
6507080|NCT00667758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6507081|NCT00667771|Naltrexone|naltrexone|mesh-list
6507082|NCT00667771|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6678679|NCT01594346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678680|NCT01594346|Protective Agents|protective agents|mesh-ancestor
6678681|NCT01594489|Aminophylline|aminophylline|mesh-list
6507083|NCT00667771|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6507084|NCT00667771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6507085|NCT00667771|Sensory System Agents|sensory system agents|mesh-ancestor
6507086|NCT00667771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6507087|NCT00667797|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6507088|NCT00667797|Albuterol|albuterol|mesh-list
6507089|NCT00667797|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6507090|NCT00667797|Autonomic Agents|autonomic agents|mesh-ancestor
6507091|NCT00667797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6507092|NCT00667797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6507093|NCT00667797|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6507094|NCT00667797|Respiratory System Agents|respiratory system agents|mesh-ancestor
6507095|NCT00667797|Tocolytic Agents|tocolytic agents|mesh-ancestor
6507096|NCT00667797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6507097|NCT00667797|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6507098|NCT00667797|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6507099|NCT00667797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6507100|NCT00667797|Adrenergic Agents|adrenergic agents|mesh-ancestor
6507101|NCT00667797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6507102|NCT00667797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716701|NCT03237936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716702|NCT03237936|Antifungal Agents|antifungal agents|mesh-ancestor
6678682|NCT01594489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6678683|NCT01594489|Autonomic Agents|autonomic agents|mesh-ancestor
6678684|NCT01594489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6507103|NCT00667901|Riluzole|riluzole|mesh-list
6507104|NCT00667901|Anticonvulsants|anticonvulsants|mesh-ancestor
6507105|NCT00667901|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6507106|NCT00667901|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6507107|NCT00667901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6507108|NCT00667901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507109|NCT00667901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6507110|NCT00667901|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6507111|NCT00667901|Protective Agents|protective agents|mesh-ancestor
6507112|NCT00667927|Cyclophosphamide|cyclophosphamide|mesh-list
6507113|NCT00667927|Busulfan|busulfan|mesh-list
6507114|NCT00667927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6507115|NCT00667927|Immunologic Factors|immunologic factors|mesh-ancestor
6507116|NCT00667927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6507117|NCT00667927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6507118|NCT00667927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6507119|NCT00667927|Alkylating Agents|alkylating agents|mesh-ancestor
6507120|NCT00667927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507121|NCT00667927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6507122|NCT00667927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6507123|NCT00667966|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6507124|NCT00667966|Vasodilator Agents|vasodilator agents|mesh-ancestor
6507125|NCT00667966|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6507126|NCT00667966|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6507127|NCT00667966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6507128|NCT00667966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507129|NCT00667966|Urological Agents|urological agents|mesh-ancestor
6507130|NCT00667979|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6507131|NCT00667979|Vasodilator Agents|vasodilator agents|mesh-ancestor
6507132|NCT00667979|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6507133|NCT00667979|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6507134|NCT00667979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6507135|NCT00667979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507136|NCT00667979|Urological Agents|urological agents|mesh-ancestor
6507137|NCT00668005|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6507138|NCT00668005|Vasodilator Agents|vasodilator agents|mesh-ancestor
6507139|NCT00668005|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6507140|NCT00668005|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6507141|NCT00668005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6507142|NCT00668005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507143|NCT00668005|Urological Agents|urological agents|mesh-ancestor
6507144|NCT00668018|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6678685|NCT01594489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6507145|NCT00668018|Vasodilator Agents|vasodilator agents|mesh-ancestor
6507146|NCT00668018|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6507147|NCT00668018|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6507148|NCT00668018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6507149|NCT00668018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507150|NCT00668018|Urological Agents|urological agents|mesh-ancestor
6507151|NCT00668031|Aprotinin|aprotinin|mesh-list
6507152|NCT00668031|Hemostatics|hemostatics|mesh-ancestor
6507153|NCT00668031|Coagulants|coagulants|mesh-ancestor
6507154|NCT00668031|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6507155|NCT00668031|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6507156|NCT00668031|Protease Inhibitors|protease inhibitors|mesh-ancestor
6507157|NCT00668031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6507158|NCT00668031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507159|NCT00668044|Ciprofloxacin|ciprofloxacin|mesh-list
6507160|NCT00668044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6507161|NCT00668044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6507162|NCT00668044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6507163|NCT00668044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6507164|NCT00668044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6507165|NCT00668044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507166|NCT00668044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6507167|NCT00668044|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6507168|NCT00668044|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6507169|NCT00668057|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6507170|NCT00668057|Vasodilator Agents|vasodilator agents|mesh-ancestor
6507171|NCT00668057|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6507172|NCT00668057|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6507173|NCT00668057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6507174|NCT00668057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507175|NCT00668057|Urological Agents|urological agents|mesh-ancestor
6507176|NCT00668096|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6507177|NCT00668096|Vasodilator Agents|vasodilator agents|mesh-ancestor
6507178|NCT00668096|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6507179|NCT00668096|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6507180|NCT00668096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6507181|NCT00668096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507182|NCT00668096|Urological Agents|urological agents|mesh-ancestor
6507183|NCT00668109|Tadalafil|tadalafil|mesh-list
6507184|NCT00668109|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6507185|NCT00668109|Vasodilator Agents|vasodilator agents|mesh-ancestor
6507186|NCT00668109|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6507187|NCT00668109|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6507188|NCT00668109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6507189|NCT00668109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507190|NCT00668109|Urological Agents|urological agents|mesh-ancestor
6507191|NCT00668122|Ciprofloxacin|ciprofloxacin|mesh-list
6507192|NCT00668122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6507193|NCT00668122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6507194|NCT00668122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6507195|NCT00668122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6507196|NCT00668122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6507197|NCT00668122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507198|NCT00668122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6507199|NCT00668122|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6507200|NCT00668122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6507201|NCT00668135|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6507202|NCT00668135|Vasodilator Agents|vasodilator agents|mesh-ancestor
6507203|NCT00668135|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6507204|NCT00668135|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6507205|NCT00668135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6507206|NCT00668135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507207|NCT00668135|Urological Agents|urological agents|mesh-ancestor
6678686|NCT01594489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6678687|NCT01594489|Respiratory System Agents|respiratory system agents|mesh-ancestor
6678688|NCT01594489|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6678689|NCT01594489|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6678690|NCT01594489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6678691|NCT01594489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678692|NCT01594489|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5716703|NCT03237936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5716704|NCT03237936|Dermatologic Agents|dermatologic agents|mesh-ancestor
5716705|NCT03237936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5716706|NCT03237936|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5716707|NCT03238183|Hyaluronic Acid|hyaluronic acid|mesh-list
5716708|NCT03238183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5716709|NCT03238183|Immunologic Factors|immunologic factors|mesh-ancestor
5716710|NCT03238183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716711|NCT03238183|Viscosupplements|viscosupplements|mesh-ancestor
5716712|NCT03238183|Protective Agents|protective agents|mesh-ancestor
5716713|NCT03238027|Durvalumab|durvalumab|mesh-list
5716714|NCT03238027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5716715|NCT03238027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6678693|NCT01594489|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6678694|NCT01594489|Purinergic Agents|purinergic agents|mesh-ancestor
6678695|NCT01594489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6678696|NCT01594489|Protective Agents|protective agents|mesh-ancestor
6678697|NCT01594502|Dutasteride|dutasteride|mesh-list
6678698|NCT01594502|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6678699|NCT01594502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6678700|NCT01594502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6678701|NCT01594502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678702|NCT01594502|Hormone Antagonists|hormone antagonists|mesh-ancestor
5716716|NCT03237637|Propranolol|propranolol|mesh-list
6678703|NCT01594502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6678704|NCT01594502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678705|NCT01594580|Anti-Infective Agents|anti-infective agents|mesh-list
6678706|NCT01594580|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6678707|NCT01594619|Diltiazem|diltiazem|mesh-list
6678708|NCT01594619|Naloxegol|naloxegol|mesh-list
6678709|NCT01594619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5716717|NCT03237637|Atenolol|atenolol|mesh-list
6507208|NCT00668239|Triamcinolone|triamcinolone|mesh-list
6507209|NCT00668239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6507210|NCT00668239|Glucocorticoids|glucocorticoids|mesh-ancestor
6507211|NCT00668239|Hormones|hormones|mesh-ancestor
6507212|NCT00668239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6507213|NCT00668239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6507214|NCT00668304|Moxifloxacin|moxifloxacin|mesh-list
6507215|NCT00668304|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6507216|NCT00668304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6507217|NCT00668304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6507218|NCT00668304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6507219|NCT00668304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6507220|NCT00668304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6507221|NCT00668304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507222|NCT00668304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6507223|NCT00668304|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6507224|NCT00668304|Contraceptive Agents|contraceptive agents|mesh-ancestor
6507225|NCT00668304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6507226|NCT00668304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6507227|NCT00668304|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6507228|NCT00668304|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6507229|NCT00668304|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6507230|NCT00668330|Calcium, Dietary|calcium, dietary|mesh-list
6507231|NCT00668330|Ibandronic Acid|ibandronic acid|mesh-list
6507232|NCT00668330|Alfacalcidol|alfacalcidol|mesh-list
6507233|NCT00668330|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
6507234|NCT00668330|Calcium|calcium|mesh-list
6507235|NCT00668330|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6507236|NCT00668330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6507237|NCT00668330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6507238|NCT00668330|Vitamins|vitamins|mesh-ancestor
6507239|NCT00668330|Micronutrients|micronutrients|mesh-ancestor
6507240|NCT00668343|Simvastatin|simvastatin|mesh-list
6507241|NCT00668343|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6507242|NCT00668343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6507243|NCT00668343|Antimetabolites|antimetabolites|mesh-ancestor
6507244|NCT00668343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507245|NCT00668343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6507246|NCT00668343|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6507247|NCT00668343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6507248|NCT00668356|Didanosine|didanosine|mesh-list
6507249|NCT00668356|Antimetabolites|antimetabolites|mesh-ancestor
6507250|NCT00668356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507251|NCT00668356|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6507252|NCT00668356|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6507253|NCT00668356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6507254|NCT00668356|Antiviral Agents|antiviral agents|mesh-ancestor
6507255|NCT00668356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6507256|NCT00668356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6507257|NCT00668356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6507258|NCT00668499|Pemetrexed|pemetrexed|mesh-list
6507259|NCT00668499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6507260|NCT00668499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6507261|NCT00668499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507262|NCT00668499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6507263|NCT00668499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6507264|NCT00668538|Miconazole|miconazole|mesh-list
6507265|NCT00668538|Clotrimazole|clotrimazole|mesh-list
6507266|NCT00668538|Antifungal Agents|antifungal agents|mesh-ancestor
6507267|NCT00668538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6507268|NCT00668538|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6507269|NCT00668538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6507270|NCT00668538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6507271|NCT00668538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507272|NCT00668538|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6507273|NCT00668538|Hormone Antagonists|hormone antagonists|mesh-ancestor
6507274|NCT00668538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6507275|NCT00668538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6507276|NCT00668538|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6507277|NCT00668538|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6507278|NCT00668538|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6507279|NCT00668603|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6507280|NCT00668603|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6507281|NCT00668603|Estradiol|estradiol|mesh-list
6507282|NCT00668603|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6507283|NCT00668603|Estrogens|estrogens|mesh-ancestor
6507284|NCT00668603|Hormones|hormones|mesh-ancestor
6507285|NCT00668603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5716718|NCT03237637|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5716719|NCT03237637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5716720|NCT03237637|Adrenergic Agents|adrenergic agents|mesh-ancestor
5716721|NCT03237637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5716722|NCT03237637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716723|NCT03237637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716724|NCT03237637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5716725|NCT03237637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5716726|NCT03237637|Vasodilator Agents|vasodilator agents|mesh-ancestor
5716727|NCT03237637|Sympatholytics|sympatholytics|mesh-ancestor
5716728|NCT03237637|Autonomic Agents|autonomic agents|mesh-ancestor
5716729|NCT03237637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5716730|NCT03237637|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5716731|NCT03237689|Hydrocortisone|hydrocortisone|mesh-list
5716732|NCT03237689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5716733|NCT03237715|Bilirubin|bilirubin|mesh-list
5716734|NCT03237715|Antioxidants|antioxidants|mesh-ancestor
5716735|NCT03237715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716736|NCT03237715|Protective Agents|protective agents|mesh-ancestor
5716737|NCT03237715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716738|NCT03237741|Rabeprazole|rabeprazole|mesh-list
5716739|NCT03237741|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5716740|NCT03237741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5716741|NCT03237741|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5716742|NCT03237741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5716743|NCT03237741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716744|NCT03237533|Promethazine|promethazine|mesh-list
6507286|NCT00668603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6507287|NCT00668603|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6507288|NCT00668603|Contraceptive Agents|contraceptive agents|mesh-ancestor
6507289|NCT00668603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6507290|NCT00668603|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6507291|NCT00668616|Paclitaxel|paclitaxel|mesh-list
6507292|NCT00668616|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6507293|NCT00668616|Cyclophosphamide|cyclophosphamide|mesh-list
6507294|NCT00668616|Epirubicin|epirubicin|mesh-list
6507295|NCT00668616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6507296|NCT00668616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6507297|NCT00668616|Tubulin Modulators|tubulin modulators|mesh-ancestor
6507298|NCT00668616|Antimitotic Agents|antimitotic agents|mesh-ancestor
6507299|NCT00668616|Mitosis Modulators|mitosis modulators|mesh-ancestor
6507300|NCT00668616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507301|NCT00668616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6507302|NCT00668616|Immunologic Factors|immunologic factors|mesh-ancestor
6507303|NCT00668616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6507304|NCT00668616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6507305|NCT00668616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6507306|NCT00668616|Alkylating Agents|alkylating agents|mesh-ancestor
6507307|NCT00668616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6507308|NCT00668616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6507309|NCT00668616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6507310|NCT00668616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5716745|NCT03237533|Doxycycline|doxycycline|mesh-list
5716746|NCT03237533|Nystatin|nystatin|mesh-list
5716747|NCT03237533|Dexamethasone|dexamethasone|mesh-list
5716748|NCT03237533|Triamcinolone|triamcinolone|mesh-list
5716749|NCT03237533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5716750|NCT03237533|Antiemetics|antiemetics|mesh-ancestor
5716751|NCT03237533|Autonomic Agents|autonomic agents|mesh-ancestor
6507311|NCT00668616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6507312|NCT00668642|Dutasteride|dutasteride|mesh-list
6507313|NCT00668642|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6507314|NCT00668642|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6507315|NCT00668642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6507316|NCT00668642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507317|NCT00668642|Hormone Antagonists|hormone antagonists|mesh-ancestor
6678710|NCT01594619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5716752|NCT03237533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5722338|NCT03199924|Magnesium Sulfate|magnesium sulfate|mesh-list
6507318|NCT00668642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6507319|NCT00668642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6507320|NCT00668655|Metronidazole|metronidazole|mesh-list
6507321|NCT00668655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6507322|NCT00668655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6678711|NCT01594619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6678712|NCT01594619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678713|NCT01594619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6678714|NCT01594619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678715|NCT01594619|Vasodilator Agents|vasodilator agents|mesh-ancestor
6678716|NCT01594619|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6507323|NCT00668655|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6507324|NCT00668655|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6507325|NCT00668759|Amiodarone|amiodarone|mesh-list
6507326|NCT00668759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6507327|NCT00668759|Vasodilator Agents|vasodilator agents|mesh-ancestor
6507328|NCT00668759|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6507329|NCT00668759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6507330|NCT00668759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507331|NCT00668759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6678717|NCT01594619|Sensory System Agents|sensory system agents|mesh-ancestor
6678718|NCT01594619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6507332|NCT00668759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6507333|NCT00668759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6507334|NCT00668759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6507335|NCT00668759|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6507336|NCT00668759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6507337|NCT00668759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6507338|NCT00668837|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6507339|NCT00668837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6507340|NCT00668837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6507341|NCT00668837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6507342|NCT00668837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6507343|NCT00668837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6507344|NCT00668837|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6507345|NCT00668837|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6507346|NCT00668837|Serotonin Agents|serotonin agents|mesh-ancestor
6507347|NCT00668837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6507348|NCT00668837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507349|NCT00668837|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6507350|NCT00668837|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6507351|NCT00668837|Dopamine Agents|dopamine agents|mesh-ancestor
6507352|NCT00668850|Insulin|insulin|mesh-list
6507353|NCT00668850|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6507354|NCT00668850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6507355|NCT00668850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6507356|NCT00668941|Vitamin D|vitamin d|mesh-list
6507357|NCT00668941|Cholecalciferol|cholecalciferol|mesh-list
6678719|NCT01594671|Tranexamic Acid|tranexamic acid|mesh-list
6678720|NCT01594671|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6678721|NCT01594671|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6678722|NCT01594671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678723|NCT01594671|Hemostatics|hemostatics|mesh-ancestor
6678724|NCT01594671|Coagulants|coagulants|mesh-ancestor
6678725|NCT01594697|Metformin|metformin|mesh-list
6678726|NCT01594697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6678727|NCT01594697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678728|NCT01594775|Oxytocin|oxytocin|mesh-list
6678729|NCT01594775|Oxytocics|oxytocics|mesh-ancestor
6678730|NCT01594775|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6678731|NCT01594775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678732|NCT01594866|Dexetimide|dexetimide|mesh-list
6678733|NCT01594866|Citalopram|citalopram|mesh-list
6678734|NCT01594866|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6678735|NCT01594866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6678736|NCT01594866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6678737|NCT01594866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678738|NCT01594866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6678739|NCT01594866|Serotonin Agents|serotonin agents|mesh-ancestor
6678740|NCT01594866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722339|NCT03199924|Anesthetics, Local|anesthetics, local|mesh-ancestor
6507358|NCT00668941|Alendronate|alendronate|mesh-list
6507359|NCT00668941|Teriparatide|teriparatide|mesh-list
6507360|NCT00668941|Calcium|calcium|mesh-list
6507361|NCT00668941|Vitamins|vitamins|mesh-ancestor
6507362|NCT00668941|Micronutrients|micronutrients|mesh-ancestor
6507363|NCT00668941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6507364|NCT00668941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6507365|NCT00668941|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6507366|NCT00668967|Verapamil|verapamil|mesh-list
6507367|NCT00668967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6507368|NCT00668967|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6507369|NCT00668967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6507370|NCT00668967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507371|NCT00668967|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6507372|NCT00668967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6507373|NCT00668967|Vasodilator Agents|vasodilator agents|mesh-ancestor
6507374|NCT00669149|Aspirin|aspirin|mesh-list
6507375|NCT00669149|Heparin|heparin|mesh-list
6507376|NCT00669149|Enoxaparin|enoxaparin|mesh-list
6507377|NCT00669149|Bivalirudin|bivalirudin|mesh-list
6507378|NCT00669149|Clopidogrel|clopidogrel|mesh-list
6507379|NCT00669149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6507380|NCT00669149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6507381|NCT00669149|Analgesics|analgesics|mesh-ancestor
6507382|NCT00669149|Sensory System Agents|sensory system agents|mesh-ancestor
6507383|NCT00669149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6507384|NCT00669149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6507385|NCT00669149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6507386|NCT00669149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6507387|NCT00669149|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6507388|NCT00669149|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6507389|NCT00669149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678741|NCT01594866|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6678742|NCT01594866|Antidepressive Agents|antidepressive agents|mesh-ancestor
6678743|NCT01594866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6678744|NCT01594866|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6678745|NCT01594866|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6678746|NCT01594866|Parasympatholytics|parasympatholytics|mesh-ancestor
5716753|NCT03237533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716754|NCT03237533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5716755|NCT03237533|Glucocorticoids|glucocorticoids|mesh-ancestor
5716756|NCT03237533|Hormones|hormones|mesh-ancestor
6507390|NCT00669149|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6507391|NCT00669149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6507392|NCT00669149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6507393|NCT00669149|Antipyretics|antipyretics|mesh-ancestor
6507394|NCT00669149|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6507395|NCT00669149|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6507396|NCT00669149|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6507397|NCT00669149|Purinergic Agents|purinergic agents|mesh-ancestor
6507398|NCT00669149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6507399|NCT00669149|Anticoagulants|anticoagulants|mesh-ancestor
6507400|NCT00669149|Antithrombins|antithrombins|mesh-ancestor
6507401|NCT00669149|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6507402|NCT00669149|Protease Inhibitors|protease inhibitors|mesh-ancestor
6507403|NCT00669344|Rivastigmine|rivastigmine|mesh-list
6507404|NCT00669344|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6507405|NCT00669344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6507406|NCT00669344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507407|NCT00669344|Cholinergic Agents|cholinergic agents|mesh-ancestor
6507408|NCT00669344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6507409|NCT00669344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716757|NCT03237533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5716758|NCT03237533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5716759|NCT03237533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5716760|NCT03237533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716761|NCT03237533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5716762|NCT03237533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5716763|NCT03237533|Antimalarials|antimalarials|mesh-ancestor
5716764|NCT03237533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5716765|NCT03237533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5716766|NCT03237533|Antipruritics|antipruritics|mesh-ancestor
5716767|NCT03237533|Dermatologic Agents|dermatologic agents|mesh-ancestor
6507410|NCT00669344|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6507411|NCT00669344|Protective Agents|protective agents|mesh-ancestor
6507412|NCT00669370|Docetaxel|docetaxel|mesh-list
6507413|NCT00669370|Capecitabine|capecitabine|mesh-list
5716768|NCT03237533|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5716769|NCT03237533|Histamine Antagonists|histamine antagonists|mesh-ancestor
5716770|NCT03237533|Histamine Agents|histamine agents|mesh-ancestor
5716771|NCT03237533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6507414|NCT00669370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6507415|NCT00669370|Tubulin Modulators|tubulin modulators|mesh-ancestor
6507416|NCT00669370|Antimitotic Agents|antimitotic agents|mesh-ancestor
6507417|NCT00669370|Mitosis Modulators|mitosis modulators|mesh-ancestor
6507418|NCT00669370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507419|NCT00669370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6507420|NCT00669370|Antimetabolites|antimetabolites|mesh-ancestor
6507421|NCT00669435|Losartan|losartan|mesh-list
6507422|NCT00669435|Amlodipine|amlodipine|mesh-list
6507423|NCT00669435|Simvastatin|simvastatin|mesh-list
6507424|NCT00669435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6507425|NCT00669435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6507426|NCT00669435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6507427|NCT00669435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507428|NCT00669435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6507429|NCT00669435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6507430|NCT00669435|Vasodilator Agents|vasodilator agents|mesh-ancestor
6507431|NCT00669435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6507432|NCT00669435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6507433|NCT00669435|Antimetabolites|antimetabolites|mesh-ancestor
6507434|NCT00669435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6507435|NCT00669435|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6507436|NCT00669435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6507437|NCT00669435|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6507438|NCT00669435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6507439|NCT00669435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6507440|NCT00669487|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6507441|NCT00669487|Lamivudine|lamivudine|mesh-list
6507442|NCT00669487|Stavudine|stavudine|mesh-list
6507443|NCT00669487|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6507444|NCT00669487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6507445|NCT00669487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6507446|NCT00669487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507447|NCT00669487|Antiviral Agents|antiviral agents|mesh-ancestor
6507448|NCT00669487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5716772|NCT03237533|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5716773|NCT03237533|Antifungal Agents|antifungal agents|mesh-ancestor
5716774|NCT03237533|Ionophores|ionophores|mesh-ancestor
5716775|NCT03237533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5716776|NCT03237572|Pembrolizumab|pembrolizumab|mesh-list
5716777|NCT03237572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5716778|NCT03237572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5716779|NCT03237312|Hormones|hormones|mesh-list
5716780|NCT03237312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5716781|NCT03237312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716782|NCT03237611|Dexamethasone|dexamethasone|mesh-list
5716783|NCT03237611|Ondansetron|ondansetron|mesh-list
5716784|NCT03237611|Aprepitant|aprepitant|mesh-list
5716785|NCT03237611|Fosaprepitant|fosaprepitant|mesh-list
5716786|NCT03237611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5716787|NCT03237611|Antiemetics|antiemetics|mesh-ancestor
5716788|NCT03237611|Autonomic Agents|autonomic agents|mesh-ancestor
5716789|NCT03237611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5716790|NCT03237611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716791|NCT03237611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5716792|NCT03237611|Glucocorticoids|glucocorticoids|mesh-ancestor
5716793|NCT03237611|Hormones|hormones|mesh-ancestor
5716794|NCT03237611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5716795|NCT03237611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5716796|NCT03237611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5716797|NCT03237611|Antipruritics|antipruritics|mesh-ancestor
5716798|NCT03237611|Dermatologic Agents|dermatologic agents|mesh-ancestor
5716799|NCT03237611|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5716800|NCT03237611|Serotonin Agents|serotonin agents|mesh-ancestor
5716801|NCT03237611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5716802|NCT03237611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507449|NCT00669487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6507450|NCT00669487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6507451|NCT00669487|Antimetabolites|antimetabolites|mesh-ancestor
6507452|NCT00669565|Bavituximab|bavituximab|mesh-list
5716803|NCT03237611|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6507453|NCT00669565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6507454|NCT00669565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6507455|NCT00669591|Bavituximab|bavituximab|mesh-list
6507456|NCT00669591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6507457|NCT00669591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6507458|NCT00669643|Rifampin|rifampin|mesh-list
6507459|NCT00669643|Dapsone|dapsone|mesh-list
6507460|NCT00669643|Clofazimine|clofazimine|mesh-list
6507461|NCT00669643|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5716804|NCT03237611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5716805|NCT03237611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5716806|NCT03237611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6507462|NCT00669643|Antitubercular Agents|antitubercular agents|mesh-ancestor
6507463|NCT00669643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6507464|NCT00669643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6507465|NCT00669643|Leprostatic Agents|leprostatic agents|mesh-ancestor
6507466|NCT00669643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6507467|NCT00669643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6507468|NCT00669643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507469|NCT00669643|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6507470|NCT00669643|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6507471|NCT00669643|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6507472|NCT00669643|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6507473|NCT00669643|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6507474|NCT00669643|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6507475|NCT00669643|Antimalarials|antimalarials|mesh-ancestor
6507476|NCT00669643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6507477|NCT00669643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6507478|NCT00669643|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6507479|NCT00669643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6507480|NCT00669656|Vitamin D|vitamin d|mesh-list
6507481|NCT00669656|Cholecalciferol|cholecalciferol|mesh-list
6507482|NCT00669656|Vitamins|vitamins|mesh-list
6507483|NCT00669656|Vitamin E|vitamin e|mesh-list
6507484|NCT00669656|Tocopherols|tocopherols|mesh-list
6507485|NCT00669656|alpha-Tocopherol|alpha-tocopherol|mesh-list
6507486|NCT00669656|Selenium|selenium|mesh-list
6507487|NCT00669656|Lycopene|lycopene|mesh-list
6507488|NCT00669656|Daidzein|daidzein|mesh-list
6507489|NCT00669656|Micronutrients|micronutrients|mesh-ancestor
6507490|NCT00669656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6507491|NCT00669656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6507492|NCT00669656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6507493|NCT00669656|Antioxidants|antioxidants|mesh-ancestor
6507494|NCT00669656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507495|NCT00669656|Protective Agents|protective agents|mesh-ancestor
6507496|NCT00669656|Trace Elements|trace elements|mesh-ancestor
6507497|NCT00669656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6507498|NCT00669656|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6507499|NCT00669656|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6507500|NCT00669656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6507501|NCT00669656|Phytoestrogens|phytoestrogens|mesh-ancestor
6507502|NCT00669656|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6507503|NCT00669656|Estrogens|estrogens|mesh-ancestor
6507504|NCT00669656|Hormones|hormones|mesh-ancestor
6507505|NCT00669656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6507506|NCT00669695|Atorvastatin|atorvastatin|mesh-list
6507507|NCT00669695|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6507508|NCT00669695|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6507509|NCT00669695|Antimetabolites|antimetabolites|mesh-ancestor
6507510|NCT00669695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507511|NCT00669695|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6507512|NCT00669695|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6507513|NCT00669695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6507514|NCT00669721|Heparin|heparin|mesh-list
6507515|NCT00669721|Calcium heparin|calcium heparin|mesh-list
6507516|NCT00669721|Nadroparin|nadroparin|mesh-list
6507517|NCT00669721|Anticoagulants|anticoagulants|mesh-ancestor
6507518|NCT00669721|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6507519|NCT00669721|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6507520|NCT00669721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507521|NCT00669747|Carboplatin|carboplatin|mesh-list
6507522|NCT00669747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6507523|NCT00669773|Docetaxel|docetaxel|mesh-list
6507524|NCT00669773|Doxorubicin|doxorubicin|mesh-list
6507525|NCT00669773|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6507526|NCT00669773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5716807|NCT03237611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5716808|NCT03237611|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5716809|NCT03237507|Paclitaxel|paclitaxel|mesh-list
5716810|NCT03237507|Oxaliplatin|oxaliplatin|mesh-list
5716811|NCT03237507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5716812|NCT03237507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5716813|NCT03237507|Tubulin Modulators|tubulin modulators|mesh-ancestor
5716814|NCT03237507|Antimitotic Agents|antimitotic agents|mesh-ancestor
5716815|NCT03237507|Mitosis Modulators|mitosis modulators|mesh-ancestor
5716816|NCT03237507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507527|NCT00669773|Tubulin Modulators|tubulin modulators|mesh-ancestor
6507528|NCT00669773|Antimitotic Agents|antimitotic agents|mesh-ancestor
6507529|NCT00669773|Mitosis Modulators|mitosis modulators|mesh-ancestor
6507530|NCT00669773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507531|NCT00669773|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6507532|NCT00669773|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6507533|NCT00669773|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6507534|NCT00669773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6507535|NCT00669786|Menotropins|menotropins|mesh-list
6507536|NCT00669786|Hormones|hormones|mesh-list
6507537|NCT00669786|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6507538|NCT00669786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6507539|NCT00669786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6507540|NCT00669786|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5716817|NCT03237416|Midazolam|midazolam|mesh-list
6507541|NCT00669786|Fertility Agents|fertility agents|mesh-ancestor
6507542|NCT00669786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6507543|NCT00669812|Cytarabine|cytarabine|mesh-list
6507544|NCT00669812|Prednisolone|prednisolone|mesh-list
6507545|NCT00669812|Cyclophosphamide|cyclophosphamide|mesh-list
6507546|NCT00669812|Melphalan|melphalan|mesh-list
5716818|NCT03237416|Dabigatran|dabigatran|mesh-list
5716819|NCT03237416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5716820|NCT03237416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5716821|NCT03237416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5716822|NCT03237416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716823|NCT03237416|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5716824|NCT03237416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5716825|NCT03237416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5716826|NCT03237416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6507547|NCT00669812|Ifosfamide|ifosfamide|mesh-list
6507548|NCT00669812|Carmustine|carmustine|mesh-list
6507549|NCT00669812|Doxorubicin|doxorubicin|mesh-list
6507550|NCT00669812|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6507551|NCT00669812|Methotrexate|methotrexate|mesh-list
6507552|NCT00669812|Etoposide|etoposide|mesh-list
6507553|NCT00669812|Vincristine|vincristine|mesh-list
6507554|NCT00669812|Epirubicin|epirubicin|mesh-list
6507555|NCT00669812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6507556|NCT00669812|Immunologic Factors|immunologic factors|mesh-ancestor
6507557|NCT00669812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6507558|NCT00669812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6507559|NCT00669812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6507560|NCT00669812|Alkylating Agents|alkylating agents|mesh-ancestor
6507561|NCT00669812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507562|NCT00669812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6507563|NCT00669812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6507564|NCT00669812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6507565|NCT00669812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6507566|NCT00669812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6507567|NCT00669812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6507568|NCT00669812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6507569|NCT00669812|Abortifacient Agents|abortifacient agents|mesh-ancestor
6507570|NCT00669812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6507571|NCT00669812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6507572|NCT00669812|Antimetabolites|antimetabolites|mesh-ancestor
6507573|NCT00669812|Dermatologic Agents|dermatologic agents|mesh-ancestor
6507574|NCT00669812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6507575|NCT00669812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6507576|NCT00669812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6507577|NCT00669812|Antiviral Agents|antiviral agents|mesh-ancestor
6507578|NCT00669812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6507579|NCT00669812|Tubulin Modulators|tubulin modulators|mesh-ancestor
6507580|NCT00669812|Antimitotic Agents|antimitotic agents|mesh-ancestor
6507581|NCT00669812|Mitosis Modulators|mitosis modulators|mesh-ancestor
6507582|NCT00669812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5716827|NCT03237416|Anesthetics, General|anesthetics, general|mesh-ancestor
6507583|NCT00669812|Glucocorticoids|glucocorticoids|mesh-ancestor
6507584|NCT00669812|Hormones|hormones|mesh-ancestor
6507585|NCT00669812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6507586|NCT00669812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6507587|NCT00669890|Mycophenolic Acid|mycophenolic acid|mesh-list
6507588|NCT00669890|Cyclophosphamide|cyclophosphamide|mesh-list
6507589|NCT00669890|Busulfan|busulfan|mesh-list
6507590|NCT00669890|Methotrexate|methotrexate|mesh-list
6507591|NCT00669890|Gemtuzumab|gemtuzumab|mesh-list
6507592|NCT00669890|Tacrolimus|tacrolimus|mesh-list
6507593|NCT00669890|Thymoglobulin|thymoglobulin|mesh-list
6507594|NCT00669890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6507595|NCT00669890|Immunologic Factors|immunologic factors|mesh-ancestor
6507596|NCT00669890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6507597|NCT00669890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6507598|NCT00669890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6507599|NCT00669890|Alkylating Agents|alkylating agents|mesh-ancestor
6507600|NCT00669890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507601|NCT00669890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6507602|NCT00669890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6507603|NCT00669890|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6507604|NCT00669890|Abortifacient Agents|abortifacient agents|mesh-ancestor
6507605|NCT00669890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6507606|NCT00669890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6507607|NCT00669890|Antimetabolites|antimetabolites|mesh-ancestor
6507608|NCT00669890|Dermatologic Agents|dermatologic agents|mesh-ancestor
6507609|NCT00669890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6507610|NCT00669890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6507611|NCT00669890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6507612|NCT00669890|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6507613|NCT00669890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6507614|NCT00669890|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6507615|NCT00669890|Antitubercular Agents|antitubercular agents|mesh-ancestor
6507616|NCT00669890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6507617|NCT00669890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6507618|NCT00669890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6507619|NCT00669994|Ciprofloxacin|ciprofloxacin|mesh-list
6507620|NCT00669994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6507621|NCT00669994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6507622|NCT00669994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6507623|NCT00669994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6507624|NCT00669994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6507625|NCT00669994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507626|NCT00669994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6507627|NCT00669994|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6507628|NCT00669994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6507629|NCT00670124|Menthol|menthol|mesh-list
6507630|NCT00670124|Antipruritics|antipruritics|mesh-ancestor
6507631|NCT00670124|Dermatologic Agents|dermatologic agents|mesh-ancestor
6507632|NCT00670150|Arsenic Trioxide|arsenic trioxide|mesh-list
6507633|NCT00670150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6678747|NCT01594866|Autonomic Agents|autonomic agents|mesh-ancestor
6678748|NCT01594866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6678749|NCT01594866|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6678750|NCT01594866|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6678751|NCT01594866|Cholinergic Agents|cholinergic agents|mesh-ancestor
6678752|NCT01594879|Levonorgestrel|levonorgestrel|mesh-list
6678753|NCT01594879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6678754|NCT01594879|Contraceptive Agents|contraceptive agents|mesh-ancestor
6678755|NCT01594879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6678756|NCT01594879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678757|NCT01594879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6678758|NCT01594879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6678759|NCT01594879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6678760|NCT01594905|Tenofovir|tenofovir|mesh-list
6678761|NCT01594905|Entecavir|entecavir|mesh-list
5716828|NCT03237416|Anesthetics|anesthetics|mesh-ancestor
5716829|NCT03237416|GABA Modulators|gaba modulators|mesh-ancestor
5716830|NCT03237416|GABA Agents|gaba agents|mesh-ancestor
5716831|NCT03237416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5716832|NCT03237416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716833|NCT03237416|Antithrombins|antithrombins|mesh-ancestor
5716834|NCT03237416|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5716835|NCT03237416|Protease Inhibitors|protease inhibitors|mesh-ancestor
5716836|NCT03237416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6678762|NCT01594905|Antiviral Agents|antiviral agents|mesh-ancestor
6507634|NCT00670215|Ciprofloxacin|ciprofloxacin|mesh-list
6507635|NCT00670215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6507636|NCT00670215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6507637|NCT00670215|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6507638|NCT00670215|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6507639|NCT00670215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6507640|NCT00670215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507641|NCT00670215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6507642|NCT00670215|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6507643|NCT00670215|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6507644|NCT00670254|Hydrocortisone|hydrocortisone|mesh-list
6507645|NCT00670254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6507646|NCT00670293|Raclopride|raclopride|mesh-list
6507647|NCT00670293|Methylphenidate|methylphenidate|mesh-list
6507648|NCT00670293|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6507649|NCT00670293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6507650|NCT00670293|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6507651|NCT00670293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6507652|NCT00670293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6507653|NCT00670293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507654|NCT00670293|Dopamine Agents|dopamine agents|mesh-ancestor
6507655|NCT00670293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6507656|NCT00670293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6507657|NCT00670293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6507658|NCT00670293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6507659|NCT00670293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6507660|NCT00670293|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6507661|NCT00670319|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
6507662|NCT00670319|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6507663|NCT00670319|Hormone Antagonists|hormone antagonists|mesh-ancestor
6507664|NCT00670319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6507665|NCT00670319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6507666|NCT00670319|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6507667|NCT00670319|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6507668|NCT00670319|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6507669|NCT00670345|Tranexamic Acid|tranexamic acid|mesh-list
6507670|NCT00670345|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6507671|NCT00670345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6507672|NCT00670345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507673|NCT00670345|Hemostatics|hemostatics|mesh-ancestor
6507674|NCT00670345|Coagulants|coagulants|mesh-ancestor
6507675|NCT00670410|Fludarabine|fludarabine|mesh-list
6507676|NCT00670410|Busulfan|busulfan|mesh-list
6507677|NCT00670410|Thymoglobulin|thymoglobulin|mesh-list
6507678|NCT00670410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6507679|NCT00670410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507680|NCT00670410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6507681|NCT00670410|Immunologic Factors|immunologic factors|mesh-ancestor
6507682|NCT00670410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6507683|NCT00670410|Alkylating Agents|alkylating agents|mesh-ancestor
6507684|NCT00670410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6507685|NCT00670410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6507686|NCT00670423|Sirolimus|sirolimus|mesh-list
6507687|NCT00670423|Bortezomib|bortezomib|mesh-list
6507688|NCT00670423|Tacrolimus|tacrolimus|mesh-list
6507689|NCT00670423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6507690|NCT00670423|Immunologic Factors|immunologic factors|mesh-ancestor
6507691|NCT00670423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6507692|NCT00670423|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6507693|NCT00670423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6507694|NCT00670423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507695|NCT00670423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6507696|NCT00670423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6507697|NCT00670423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6507698|NCT00670423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6507699|NCT00670423|Antifungal Agents|antifungal agents|mesh-ancestor
6507700|NCT00670436|Paclitaxel|paclitaxel|mesh-list
6507701|NCT00670436|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6507702|NCT00670436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6507703|NCT00670436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6507704|NCT00670436|Tubulin Modulators|tubulin modulators|mesh-ancestor
6507705|NCT00670436|Antimitotic Agents|antimitotic agents|mesh-ancestor
6507706|NCT00670436|Mitosis Modulators|mitosis modulators|mesh-ancestor
6507707|NCT00670436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507708|NCT00670475|Piroxicam|piroxicam|mesh-list
6507709|NCT00670475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6507710|NCT00670475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6507711|NCT00670475|Analgesics|analgesics|mesh-ancestor
6507712|NCT00670475|Sensory System Agents|sensory system agents|mesh-ancestor
6507713|NCT00670475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6507714|NCT00670475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6507715|NCT00670475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6507716|NCT00670475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6507717|NCT00670475|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6507718|NCT00670475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6507719|NCT00670475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507720|NCT00670501|Vitamin D|vitamin d|mesh-list
6507721|NCT00670501|Teriparatide|teriparatide|mesh-list
6507722|NCT00670501|Calcium|calcium|mesh-list
6507723|NCT00670501|Vitamins|vitamins|mesh-ancestor
6507724|NCT00670501|Micronutrients|micronutrients|mesh-ancestor
6507725|NCT00670501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6507726|NCT00670501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6507727|NCT00670501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6507728|NCT00670553|Panobinostat|panobinostat|mesh-list
6507729|NCT00670553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6507730|NCT00670553|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6507731|NCT00670553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6507732|NCT00670553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507733|NCT00670566|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6507734|NCT00670566|Irbesartan|irbesartan|mesh-list
6507735|NCT00670566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6507736|NCT00670566|Diuretics|diuretics|mesh-ancestor
6507737|NCT00670566|Natriuretic Agents|natriuretic agents|mesh-ancestor
6507738|NCT00670566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6507739|NCT00670566|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6507740|NCT00670566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6507741|NCT00670566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507742|NCT00670566|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6507743|NCT00670566|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6507744|NCT00670618|Fluorides|fluorides|mesh-list
6507745|NCT00670618|Cariostatic Agents|cariostatic agents|mesh-ancestor
6507746|NCT00670618|Protective Agents|protective agents|mesh-ancestor
6507747|NCT00670618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6507748|NCT00670657|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6507749|NCT00670657|Antifungal Agents|antifungal agents|mesh-ancestor
6507750|NCT00670657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6507751|NCT00670657|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6507752|NCT00670657|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6507753|NCT00670670|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
6507754|NCT00670670|Caseins|caseins|mesh-list
6507755|NCT00670670|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6507756|NCT00670670|Serotonin Agents|serotonin agents|mesh-ancestor
6507757|NCT00670670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6507758|NCT00670670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507759|NCT00670670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6507760|NCT00670670|Chelating Agents|chelating agents|mesh-ancestor
6507761|NCT00670670|Sequestering Agents|sequestering agents|mesh-ancestor
6507762|NCT00670683|Insulin Detemir|insulin detemir|mesh-list
6507763|NCT00670683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6507764|NCT00670683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6507765|NCT00670696|Tetracaine|tetracaine|mesh-list
6507766|NCT00670696|Anesthetics, Local|anesthetics, local|mesh-ancestor
6507767|NCT00670696|Anesthetics|anesthetics|mesh-ancestor
6678763|NCT01594905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5716837|NCT03237416|Anticoagulants|anticoagulants|mesh-ancestor
5722041|NCT03201770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5722042|NCT03201770|Antiviral Agents|antiviral agents|mesh-ancestor
5722043|NCT03201770|Schistosomicides|schistosomicides|mesh-ancestor
6678764|NCT01594905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6678765|NCT01594905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6678766|NCT01594905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5722044|NCT03201770|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6507768|NCT00670696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6507769|NCT00670696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6507770|NCT00670696|Sensory System Agents|sensory system agents|mesh-ancestor
6507771|NCT00670696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6507772|NCT00670722|Insulin|insulin|mesh-list
6507773|NCT00670722|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6507774|NCT00670722|Insulin Aspart|insulin aspart|mesh-list
6507775|NCT00670722|Insulin, Long-Acting|insulin, long-acting|mesh-list
6507776|NCT00670722|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6507777|NCT00670722|Insulin Detemir|insulin detemir|mesh-list
6507778|NCT00670722|Biphasic Insulins|biphasic insulins|mesh-list
6507779|NCT00670722|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6507780|NCT00670722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6507781|NCT00670722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6507782|NCT00670761|Misoprostol|misoprostol|mesh-list
6507783|NCT00670761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6507784|NCT00670761|Abortifacient Agents|abortifacient agents|mesh-ancestor
6507785|NCT00670761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6507786|NCT00670761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6507787|NCT00670761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6507788|NCT00670761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6507789|NCT00670761|Oxytocics|oxytocics|mesh-ancestor
6507790|NCT00670787|Losartan|losartan|mesh-list
6507791|NCT00670787|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6507792|NCT00670787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6507793|NCT00670787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6507794|NCT00670787|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6507795|NCT00670787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6507796|NCT00670787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507797|NCT00670787|Diuretics|diuretics|mesh-ancestor
6507798|NCT00670787|Natriuretic Agents|natriuretic agents|mesh-ancestor
5716838|NCT03237546|Anesthetics|anesthetics|mesh-list
5716839|NCT03237546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5716840|NCT03237546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716841|NCT03237624|Chitosan|chitosan|mesh-list
5716842|NCT03237624|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5716843|NCT03237624|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5716844|NCT03237624|Antimetabolites|antimetabolites|mesh-ancestor
5716845|NCT03237624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716846|NCT03237624|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5716847|NCT03237624|Chelating Agents|chelating agents|mesh-ancestor
5716848|NCT03237624|Sequestering Agents|sequestering agents|mesh-ancestor
5716849|NCT03237624|Hemostatics|hemostatics|mesh-ancestor
5716850|NCT03237624|Coagulants|coagulants|mesh-ancestor
5716851|NCT03237117|Hormones|hormones|mesh-list
5716852|NCT03237117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5716853|NCT03237117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716854|NCT03237260|Vedolizumab|vedolizumab|mesh-list
5716855|NCT03237260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5716856|NCT03237390|Gemcitabine|gemcitabine|mesh-list
5716857|NCT03237390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5716858|NCT03237390|Antimetabolites|antimetabolites|mesh-ancestor
5716859|NCT03237390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716860|NCT03237390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5716861|NCT03237390|Antiviral Agents|antiviral agents|mesh-ancestor
5716862|NCT03237390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5716863|NCT03237390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5716864|NCT03237390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5716865|NCT03237390|Immunologic Factors|immunologic factors|mesh-ancestor
5716866|NCT03237390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716867|NCT03236818|Bosentan|bosentan|mesh-list
5716868|NCT03236818|Sildenafil Citrate|sildenafil citrate|mesh-list
5716869|NCT03236818|Tadalafil|tadalafil|mesh-list
5716870|NCT03236818|Macitentan|macitentan|mesh-list
5716871|NCT03236818|Vasodilator Agents|vasodilator agents|mesh-ancestor
5716872|NCT03236818|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5716873|NCT03236818|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5716874|NCT03236818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5716875|NCT03236818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716876|NCT03236818|Urological Agents|urological agents|mesh-ancestor
5716877|NCT03236818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5716878|NCT03236818|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5716879|NCT03236818|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
5716880|NCT03236818|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
5716881|NCT03236805|Morphine|morphine|mesh-list
5716882|NCT03236805|Ketamine|ketamine|mesh-list
5716883|NCT03236805|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5716884|NCT03236805|Narcotics|narcotics|mesh-ancestor
5716885|NCT03236805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5716886|NCT03236805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716887|NCT03236805|Analgesics|analgesics|mesh-ancestor
5716888|NCT03236805|Sensory System Agents|sensory system agents|mesh-ancestor
5716889|NCT03236805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5716890|NCT03236805|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5716891|NCT03236805|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5716892|NCT03236805|Anesthetics, General|anesthetics, general|mesh-ancestor
5716893|NCT03236805|Anesthetics|anesthetics|mesh-ancestor
5716894|NCT03236805|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5716895|NCT03236805|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5716896|NCT03236805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6507799|NCT00670787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716897|NCT03236805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716898|NCT03236974|Fulvestrant|fulvestrant|mesh-list
5716899|NCT03236974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5716900|NCT03236974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5716901|NCT03236974|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5716902|NCT03236974|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6507800|NCT00670787|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6507801|NCT00670787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6507802|NCT00670813|Modafinil|modafinil|mesh-list
6507803|NCT00670813|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6507804|NCT00670813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6507805|NCT00670813|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6507806|NCT00670813|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6507807|NCT00670813|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6507808|NCT00670813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507809|NCT00670878|Gemcitabine|gemcitabine|mesh-list
6507810|NCT00670878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6507811|NCT00670878|Antimetabolites|antimetabolites|mesh-ancestor
5716903|NCT03236974|Hormone Antagonists|hormone antagonists|mesh-ancestor
5716904|NCT03236974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5716905|NCT03236974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716906|NCT03236792|Dexamethasone|dexamethasone|mesh-list
5716907|NCT03236792|Cyclophosphamide|cyclophosphamide|mesh-list
5716908|NCT03236792|Ixazomib|ixazomib|mesh-list
6507812|NCT00670878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507813|NCT00670878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6507814|NCT00670878|Antiviral Agents|antiviral agents|mesh-ancestor
6507815|NCT00670878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6507816|NCT00670878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6507817|NCT00670878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6507818|NCT00670878|Immunologic Factors|immunologic factors|mesh-ancestor
6507819|NCT00670878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6507820|NCT00671008|Insulin|insulin|mesh-list
6507821|NCT00671008|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6507822|NCT00671008|Insulin Aspart|insulin aspart|mesh-list
6507823|NCT00671008|Insulin Detemir|insulin detemir|mesh-list
6507824|NCT00671008|Biphasic Insulins|biphasic insulins|mesh-list
6507825|NCT00671008|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6507826|NCT00671008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6507827|NCT00671008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6507828|NCT00671112|Everolimus|everolimus|mesh-list
6507829|NCT00671112|Bortezomib|bortezomib|mesh-list
6507830|NCT00671112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6507831|NCT00671112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6507832|NCT00671112|Immunologic Factors|immunologic factors|mesh-ancestor
6507833|NCT00671112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6507834|NCT00671138|Vaccines|vaccines|mesh-list
6507835|NCT00671138|Immunologic Factors|immunologic factors|mesh-ancestor
6507836|NCT00671138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6507837|NCT00671151|Theophylline|theophylline|mesh-list
6507838|NCT00671151|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6507839|NCT00671151|Autonomic Agents|autonomic agents|mesh-ancestor
6507840|NCT00671151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6507841|NCT00671151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6507842|NCT00671151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6507843|NCT00671151|Respiratory System Agents|respiratory system agents|mesh-ancestor
6507844|NCT00671151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6507845|NCT00671151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6507846|NCT00671151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507847|NCT00671151|Vasodilator Agents|vasodilator agents|mesh-ancestor
6507848|NCT00671151|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6507849|NCT00671151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6507850|NCT00671151|Purinergic Agents|purinergic agents|mesh-ancestor
6507851|NCT00671151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6507852|NCT00671203|Erythromycin|erythromycin|mesh-list
6507853|NCT00671203|Erythromycin Estolate|erythromycin estolate|mesh-list
6507854|NCT00671203|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
6507855|NCT00671203|Erythromycin stearate|erythromycin stearate|mesh-list
6507856|NCT00671203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6507857|NCT00671203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6507858|NCT00671203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6507859|NCT00671203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6507860|NCT00671203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6507861|NCT00671203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507862|NCT00671281|Tranexamic Acid|tranexamic acid|mesh-list
6507863|NCT00671281|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6507864|NCT00671281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6507865|NCT00671281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507866|NCT00671281|Hemostatics|hemostatics|mesh-ancestor
6507867|NCT00671281|Coagulants|coagulants|mesh-ancestor
6507868|NCT00671320|Diclofenac|diclofenac|mesh-list
6507869|NCT00671320|Valdecoxib|valdecoxib|mesh-list
6507870|NCT00671320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6507871|NCT00671320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6507872|NCT00671320|Analgesics|analgesics|mesh-ancestor
6507873|NCT00671320|Sensory System Agents|sensory system agents|mesh-ancestor
6507874|NCT00671320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6507875|NCT00671320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6507876|NCT00671320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6507877|NCT00671320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6507878|NCT00671320|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6507879|NCT00671320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6507880|NCT00671320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507881|NCT00671320|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6507882|NCT00671359|Tedizolid phosphate|tedizolid phosphate|mesh-list
6507883|NCT00671359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6507884|NCT00671359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6507885|NCT00671372|Bevacizumab|bevacizumab|mesh-list
6507886|NCT00671372|Cetuximab|cetuximab|mesh-list
6507887|NCT00671372|Irinotecan|irinotecan|mesh-list
6507888|NCT00671372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6507889|NCT00671372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6507890|NCT00671372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6507891|NCT00671372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6507892|NCT00671372|Growth Substances|growth substances|mesh-ancestor
6507893|NCT00671372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6507894|NCT00671372|Growth Inhibitors|growth inhibitors|mesh-ancestor
6507895|NCT00671372|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6507896|NCT00671372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6507897|NCT00671372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6507898|NCT00671372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507899|NCT00671424|Remogliflozin etabonate|remogliflozin etabonate|mesh-list
6507900|NCT00671424|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6507901|NCT00671424|Furosemide|furosemide|mesh-list
6507902|NCT00671424|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6507903|NCT00671424|Diuretics|diuretics|mesh-ancestor
6507904|NCT00671424|Natriuretic Agents|natriuretic agents|mesh-ancestor
6507905|NCT00671424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6507906|NCT00671424|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6507907|NCT00671424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6507908|NCT00671424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507909|NCT00671424|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6507910|NCT00671424|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6507911|NCT00671424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6507912|NCT00671476|Doxorubicin|doxorubicin|mesh-list
6507913|NCT00671476|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6507914|NCT00671476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6507915|NCT00671476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6507916|NCT00671476|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6507917|NCT00671476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6507918|NCT00671476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6507919|NCT00671476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507920|NCT00671541|Gentamicins|gentamicins|mesh-list
6507921|NCT00671541|Bacitracin|bacitracin|mesh-list
5722045|NCT03201770|Anthelmintics|anthelmintics|mesh-ancestor
6507922|NCT00671541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6507923|NCT00671541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6507924|NCT00671541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6507925|NCT00671541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6242591|NCT02653183|Laxatives|laxatives|mesh-ancestor
6242592|NCT02653183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6242593|NCT02653300|Insulin|insulin|mesh-list
6242594|NCT02653300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6242595|NCT02653300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6242596|NCT02653391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6678767|NCT01594905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678768|NCT01594905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6678769|NCT01594905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6678770|NCT01594918|Prednisone|prednisone|mesh-list
6678771|NCT01594918|Mitoxantrone|mitoxantrone|mesh-list
6678772|NCT01594918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6678773|NCT01594918|Glucocorticoids|glucocorticoids|mesh-ancestor
6678774|NCT01594918|Hormones|hormones|mesh-ancestor
6678775|NCT01594918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6678776|NCT01594918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678777|NCT01594918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6678778|NCT01594918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6678779|NCT01594918|Analgesics|analgesics|mesh-ancestor
6678780|NCT01594918|Sensory System Agents|sensory system agents|mesh-ancestor
6242597|NCT02653391|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6242598|NCT02653560|Potassium Citrate|potassium citrate|mesh-list
6242599|NCT02653560|Magnesium citrate|magnesium citrate|mesh-list
6507926|NCT00671541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507927|NCT00671541|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6507928|NCT00671593|Phenol|phenol|mesh-list
6507929|NCT00671593|Glycerol|glycerol|mesh-list
6507930|NCT00671593|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6507931|NCT00671593|Protective Agents|protective agents|mesh-ancestor
6507932|NCT00671593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6507933|NCT00671593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6242600|NCT02653560|Citric Acid|citric acid|mesh-list
6242601|NCT02653560|Sodium Citrate|sodium citrate|mesh-list
6242602|NCT02653560|Anticoagulants|anticoagulants|mesh-ancestor
6242603|NCT02653560|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6242604|NCT02653560|Chelating Agents|chelating agents|mesh-ancestor
6242605|NCT02653560|Sequestering Agents|sequestering agents|mesh-ancestor
6242606|NCT02653560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242607|NCT02653560|Diuretics|diuretics|mesh-ancestor
6242608|NCT02653560|Natriuretic Agents|natriuretic agents|mesh-ancestor
6242609|NCT02653560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6242610|NCT02653560|Expectorants|expectorants|mesh-ancestor
6242611|NCT02653560|Respiratory System Agents|respiratory system agents|mesh-ancestor
6242612|NCT02653560|Cathartics|cathartics|mesh-ancestor
6242613|NCT02653560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6242614|NCT02653625|Cenicriviroc|cenicriviroc|mesh-list
6242615|NCT02653625|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6242616|NCT02653625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242617|NCT02653625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6242618|NCT02653625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6242619|NCT02653625|Antiviral Agents|antiviral agents|mesh-ancestor
6242620|NCT02653625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6242621|NCT02653872|Itraconazole|itraconazole|mesh-list
6242622|NCT02653872|Verapamil|verapamil|mesh-list
6242623|NCT02653872|Diltiazem|diltiazem|mesh-list
6242624|NCT02653872|Antifungal Agents|antifungal agents|mesh-ancestor
6242625|NCT02653872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6242626|NCT02653872|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6242627|NCT02653872|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6242628|NCT02653872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6242629|NCT02653872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242630|NCT02653872|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6242631|NCT02653872|Hormone Antagonists|hormone antagonists|mesh-ancestor
6242632|NCT02653872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6242633|NCT02653872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6242634|NCT02653872|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6242635|NCT02653872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6242636|NCT02653872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6242637|NCT02653872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6242638|NCT02653872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6242639|NCT02653872|Vasodilator Agents|vasodilator agents|mesh-ancestor
6678781|NCT01594918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6678782|NCT01594918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6678783|NCT01594918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6678784|NCT01594918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6678785|NCT01594918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678786|NCT01595009|Everolimus|everolimus|mesh-list
6678787|NCT01595009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6678788|NCT01595009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6507934|NCT00671593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6507935|NCT00671593|Disinfectants|disinfectants|mesh-ancestor
6507936|NCT00671593|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
6507937|NCT00671593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6507938|NCT00671632|Triazolam|triazolam|mesh-list
6507939|NCT00671632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6507940|NCT00671632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6507941|NCT00671632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6507942|NCT00671632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6507943|NCT00671632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6507944|NCT00671632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6507945|NCT00671632|GABA Modulators|gaba modulators|mesh-ancestor
6507946|NCT00671632|GABA Agents|gaba agents|mesh-ancestor
6507947|NCT00671632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6507948|NCT00671632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507949|NCT00671645|Bevacizumab|bevacizumab|mesh-list
6507950|NCT00671645|Capecitabine|capecitabine|mesh-list
6507951|NCT00671645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6507952|NCT00671645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6507953|NCT00671645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6507954|NCT00671645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6507955|NCT00671645|Growth Substances|growth substances|mesh-ancestor
6507956|NCT00671645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6507957|NCT00671645|Growth Inhibitors|growth inhibitors|mesh-ancestor
6507958|NCT00671645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6507959|NCT00671645|Antimetabolites|antimetabolites|mesh-ancestor
6507960|NCT00671645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507961|NCT00671697|Decitabine|decitabine|mesh-list
6507962|NCT00671697|Arsenic Trioxide|arsenic trioxide|mesh-list
6507963|NCT00671697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6507964|NCT00671697|Antimetabolites|antimetabolites|mesh-ancestor
6507965|NCT00671697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507966|NCT00671697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6507967|NCT00671697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6678789|NCT01595009|Immunologic Factors|immunologic factors|mesh-ancestor
6678790|NCT01595009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678791|NCT01595022|Contraceptive Agents|contraceptive agents|mesh-list
6678792|NCT01595022|Levonorgestrel|levonorgestrel|mesh-list
6507968|NCT00671710|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6507969|NCT00671710|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6507970|NCT00671710|Dermatologic Agents|dermatologic agents|mesh-ancestor
6507971|NCT00671801|Irinotecan|irinotecan|mesh-list
6507972|NCT00671801|Lenalidomide|lenalidomide|mesh-list
6507973|NCT00671801|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6507974|NCT00671801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6507975|NCT00671801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6507976|NCT00671801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507977|NCT00671801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6507978|NCT00671801|Immunologic Factors|immunologic factors|mesh-ancestor
6507979|NCT00671801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6507980|NCT00671801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6507981|NCT00671801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6507982|NCT00671801|Growth Substances|growth substances|mesh-ancestor
6507983|NCT00671801|Growth Inhibitors|growth inhibitors|mesh-ancestor
6507984|NCT00671814|Linezolid|linezolid|mesh-list
6507985|NCT00671814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6507986|NCT00671814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6507987|NCT00671814|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6507988|NCT00671814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6507989|NCT00671814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678793|NCT01595022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6678794|NCT01595022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678795|NCT01595022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6678796|NCT01595022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6678797|NCT01595022|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6678798|NCT01595022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6678799|NCT01595152|Solifenacin Succinate|solifenacin succinate|mesh-list
6507990|NCT00672022|Miglustat|miglustat|mesh-list
6507991|NCT00672022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6507992|NCT00672022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6507993|NCT00672022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6507994|NCT00672022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6507995|NCT00672022|Antiviral Agents|antiviral agents|mesh-ancestor
6507996|NCT00672022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6507997|NCT00672022|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6507998|NCT00672022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6507999|NCT00672022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508000|NCT00672113|Nifedipine|nifedipine|mesh-list
6508001|NCT00672113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6508002|NCT00672113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5919380|NCT04982016|Methamphetamine|methamphetamine|mesh-list
5919381|NCT04982016|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5919382|NCT04982016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919383|NCT04982016|Sympathomimetics|sympathomimetics|mesh-ancestor
5919384|NCT04982016|Autonomic Agents|autonomic agents|mesh-ancestor
5919385|NCT04982016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5919386|NCT04982016|Dopamine Agents|dopamine agents|mesh-ancestor
5919387|NCT04982016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5919388|NCT04982016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919389|NCT04982016|Adrenergic Agents|adrenergic agents|mesh-ancestor
5919390|NCT04982016|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5919391|NCT04982016|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5919392|NCT04982016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5919393|NCT04982016|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5919394|NCT04981899|Carboplatin|carboplatin|mesh-list
5919395|NCT04981899|Nivolumab|nivolumab|mesh-list
5919396|NCT04981899|Etoposide|etoposide|mesh-list
5919397|NCT04981899|Ifosfamide|ifosfamide|mesh-list
5919398|NCT04981899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5919399|NCT04981899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5919400|NCT04981899|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5919401|NCT04981899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508003|NCT00672113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508004|NCT00672113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6508005|NCT00672113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508006|NCT00672113|Vasodilator Agents|vasodilator agents|mesh-ancestor
6508007|NCT00672113|Tocolytic Agents|tocolytic agents|mesh-ancestor
6508008|NCT00672113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6508009|NCT00672165|Antibodies|antibodies|mesh-list
6508010|NCT00672165|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6508011|NCT00672165|Immunologic Factors|immunologic factors|mesh-ancestor
6508012|NCT00672165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508013|NCT00672282|Bicalutamide|bicalutamide|mesh-list
6508014|NCT00672282|Androgen Antagonists|androgen antagonists|mesh-ancestor
6508015|NCT00672282|Hormone Antagonists|hormone antagonists|mesh-ancestor
6508016|NCT00672282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6508017|NCT00672282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508018|NCT00672282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6508019|NCT00672295|Paclitaxel|paclitaxel|mesh-list
6508020|NCT00672295|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6508021|NCT00672295|Carboplatin|carboplatin|mesh-list
6508022|NCT00672295|Dasatinib|dasatinib|mesh-list
6508023|NCT00672295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6508024|NCT00672295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6508025|NCT00672295|Tubulin Modulators|tubulin modulators|mesh-ancestor
6508026|NCT00672295|Antimitotic Agents|antimitotic agents|mesh-ancestor
6508027|NCT00672295|Mitosis Modulators|mitosis modulators|mesh-ancestor
6508028|NCT00672295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508029|NCT00672295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6508030|NCT00672295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6508031|NCT00672347|Clonidine|clonidine|mesh-list
6508032|NCT00672347|Morphine|morphine|mesh-list
6508033|NCT00672347|Bupivacaine|bupivacaine|mesh-list
6508034|NCT00672347|Anesthetics, Local|anesthetics, local|mesh-ancestor
6508035|NCT00672347|Anesthetics|anesthetics|mesh-ancestor
6508036|NCT00672347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6508037|NCT00672347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508038|NCT00672347|Sensory System Agents|sensory system agents|mesh-ancestor
6508039|NCT00672347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6508040|NCT00672347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6508041|NCT00672347|Narcotics|narcotics|mesh-ancestor
5964095|NCT04594772|Oxaliplatin|oxaliplatin|mesh-list
5716909|NCT03236792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5716910|NCT03236792|Immunologic Factors|immunologic factors|mesh-ancestor
5716911|NCT03236792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716912|NCT03236792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5716913|NCT03236792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5716914|NCT03236792|Alkylating Agents|alkylating agents|mesh-ancestor
5716915|NCT03236792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716916|NCT03236792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5716917|NCT03236792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5716918|NCT03236792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5716919|NCT03236792|Antiemetics|antiemetics|mesh-ancestor
5716920|NCT03236792|Autonomic Agents|autonomic agents|mesh-ancestor
5716921|NCT03236792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5716922|NCT03236792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5716923|NCT03236792|Glucocorticoids|glucocorticoids|mesh-ancestor
5716924|NCT03236792|Hormones|hormones|mesh-ancestor
5716925|NCT03236792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5716926|NCT03236792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5716927|NCT03236792|Protease Inhibitors|protease inhibitors|mesh-ancestor
5716928|NCT03236792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5716929|NCT03236883|Gemcitabine|gemcitabine|mesh-list
5716930|NCT03236883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5716931|NCT03236883|Antimetabolites|antimetabolites|mesh-ancestor
5716932|NCT03236883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716933|NCT03236883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5716934|NCT03236883|Antiviral Agents|antiviral agents|mesh-ancestor
5716935|NCT03236883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5716936|NCT03236883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5716937|NCT03236883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6508042|NCT00672347|Analgesics|analgesics|mesh-ancestor
6508043|NCT00672347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6508044|NCT00672347|Sympatholytics|sympatholytics|mesh-ancestor
6508045|NCT00672347|Autonomic Agents|autonomic agents|mesh-ancestor
6508046|NCT00672347|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6508047|NCT00672347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6508048|NCT00672347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6508049|NCT00672347|Adrenergic Agents|adrenergic agents|mesh-ancestor
6508050|NCT00672347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6508051|NCT00672347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508052|NCT00672360|Folic Acid|folic acid|mesh-list
6508053|NCT00672360|Hematinics|hematinics|mesh-ancestor
6508054|NCT00672360|Vitamin B Complex|vitamin b complex|mesh-ancestor
6508055|NCT00672360|Vitamins|vitamins|mesh-ancestor
6508056|NCT00672360|Micronutrients|micronutrients|mesh-ancestor
6508057|NCT00672360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508058|NCT00672399|Exenatide|exenatide|mesh-list
6508059|NCT00672399|Moxifloxacin|moxifloxacin|mesh-list
6508060|NCT00672399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6508061|NCT00672399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6508062|NCT00672399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6508063|NCT00672399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6508064|NCT00672399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6508065|NCT00672399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508066|NCT00672399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6508067|NCT00672399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508068|NCT00672399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6508069|NCT00672399|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6508070|NCT00672399|Incretins|incretins|mesh-ancestor
6508071|NCT00672399|Hormones|hormones|mesh-ancestor
6508072|NCT00672399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6508073|NCT00672464|Metformin|metformin|mesh-list
6508074|NCT00672464|Olanzapine|olanzapine|mesh-list
6508075|NCT00672464|Simvastatin|simvastatin|mesh-list
6508076|NCT00672464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6508077|NCT00672464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508078|NCT00672464|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6508079|NCT00672464|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6508080|NCT00672464|Antimetabolites|antimetabolites|mesh-ancestor
6508081|NCT00672464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508082|NCT00672464|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6508083|NCT00672464|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6508084|NCT00672464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5716938|NCT03236883|Immunologic Factors|immunologic factors|mesh-ancestor
5722046|NCT03201627|Lithium Carbonate|lithium carbonate|mesh-list
6508085|NCT00672464|Antiemetics|antiemetics|mesh-ancestor
6508086|NCT00672464|Autonomic Agents|autonomic agents|mesh-ancestor
6508087|NCT00672464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6508088|NCT00672464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6508089|NCT00672464|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6508090|NCT00672464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6508091|NCT00672464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6508092|NCT00672464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6508093|NCT00672464|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6508094|NCT00672464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6508095|NCT00672464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6508096|NCT00672464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6508097|NCT00672464|Serotonin Agents|serotonin agents|mesh-ancestor
6508098|NCT00672568|Capsaicin|capsaicin|mesh-list
6508099|NCT00672568|Antipruritics|antipruritics|mesh-ancestor
6508100|NCT00672568|Dermatologic Agents|dermatologic agents|mesh-ancestor
6508101|NCT00672568|Sensory System Agents|sensory system agents|mesh-ancestor
6508102|NCT00672568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6508103|NCT00672568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508104|NCT00672659|Dexetimide|dexetimide|mesh-list
6508105|NCT00672659|Pipamperone|pipamperone|mesh-list
6508106|NCT00672659|Citalopram|citalopram|mesh-list
6508107|NCT00672659|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6508108|NCT00672659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6508109|NCT00672659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6508110|NCT00672659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716939|NCT03236883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716940|NCT03236961|Moxifloxacin|moxifloxacin|mesh-list
5716941|NCT03236961|Metronidazole|metronidazole|mesh-list
5716942|NCT03236961|Levofloxacin|levofloxacin|mesh-list
5716943|NCT03236961|Ertapenem|ertapenem|mesh-list
5716944|NCT03236961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5716945|NCT03236961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5716946|NCT03236961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5716947|NCT03236961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5716948|NCT03236961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5716949|NCT03236961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716950|NCT03236961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5716951|NCT03236961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5716952|NCT03236961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5716953|NCT03236961|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5716954|NCT03236961|Renal Agents|renal agents|mesh-ancestor
5716955|NCT03236961|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5716956|NCT03236961|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5716957|NCT03236610|Tenofovir|tenofovir|mesh-list
5716958|NCT03236610|Entecavir|entecavir|mesh-list
6508111|NCT00672659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6508112|NCT00672659|Serotonin Agents|serotonin agents|mesh-ancestor
6508113|NCT00672659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508114|NCT00672659|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6508115|NCT00672659|Antidepressive Agents|antidepressive agents|mesh-ancestor
6508116|NCT00672659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6508117|NCT00672659|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6508118|NCT00672659|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6508119|NCT00672659|Parasympatholytics|parasympatholytics|mesh-ancestor
6508120|NCT00672659|Autonomic Agents|autonomic agents|mesh-ancestor
6508121|NCT00672659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6508122|NCT00672659|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6508123|NCT00672659|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6508124|NCT00672659|Cholinergic Agents|cholinergic agents|mesh-ancestor
6508125|NCT00672659|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6508126|NCT00672659|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6508127|NCT00672659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6508128|NCT00672659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6508129|NCT00672763|Calcium, Dietary|calcium, dietary|mesh-list
6508130|NCT00672763|Vitamin D|vitamin d|mesh-list
6508131|NCT00672763|Ergocalciferols|ergocalciferols|mesh-list
6508132|NCT00672763|Cholecalciferol|cholecalciferol|mesh-list
6508133|NCT00672763|Vitamins|vitamins|mesh-list
6508134|NCT00672763|Calcium|calcium|mesh-list
6508135|NCT00672763|Micronutrients|micronutrients|mesh-ancestor
6508136|NCT00672763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508137|NCT00672763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6508138|NCT00672763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6508139|NCT00672776|Paroxetine|paroxetine|mesh-list
6508140|NCT00672776|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5716959|NCT03236610|Antiviral Agents|antiviral agents|mesh-ancestor
5722340|NCT03199924|Anesthetics|anesthetics|mesh-ancestor
6508141|NCT00672776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6508142|NCT00672776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6508143|NCT00672776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678800|NCT01595152|Fesoterodine|fesoterodine|mesh-list
6678801|NCT01595152|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6678802|NCT01595152|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6678803|NCT01595152|Cholinergic Agents|cholinergic agents|mesh-ancestor
6678804|NCT01595152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6678805|NCT01595152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678806|NCT01595152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678807|NCT01595152|Urological Agents|urological agents|mesh-ancestor
6508144|NCT00672776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6508145|NCT00672776|Serotonin Agents|serotonin agents|mesh-ancestor
6508146|NCT00672776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508147|NCT00672776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6508148|NCT00672776|Antidepressive Agents|antidepressive agents|mesh-ancestor
6508149|NCT00672776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6508150|NCT00672776|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6508151|NCT00672776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6508152|NCT00672776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6508153|NCT00672867|Adefovir|adefovir|mesh-list
6508154|NCT00672867|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6508155|NCT00672867|Clevudine|clevudine|mesh-list
6508156|NCT00672867|Antiviral Agents|antiviral agents|mesh-ancestor
6508157|NCT00672867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6508158|NCT00672867|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6508159|NCT00672867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6508160|NCT00672867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6508161|NCT00672867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508162|NCT00672919|Pioglitazone|pioglitazone|mesh-list
6508163|NCT00672919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6508164|NCT00672919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508165|NCT00672971|Permethrin|permethrin|mesh-list
6508166|NCT00672971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6508167|NCT00672971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508168|NCT00673010|Iodine|iodine|mesh-list
6508169|NCT00673010|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6508170|NCT00673010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6508171|NCT00673010|Trace Elements|trace elements|mesh-ancestor
6508172|NCT00673010|Micronutrients|micronutrients|mesh-ancestor
6508173|NCT00673010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508174|NCT00673088|Ropinirole|ropinirole|mesh-list
6508175|NCT00673088|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6508176|NCT00673088|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6508177|NCT00673088|Dopamine Agonists|dopamine agonists|mesh-ancestor
6508178|NCT00673088|Dopamine Agents|dopamine agents|mesh-ancestor
6508179|NCT00673088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6508180|NCT00673088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508181|NCT00673088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508182|NCT00673205|Bicalutamide|bicalutamide|mesh-list
6508183|NCT00673205|Androgen Antagonists|androgen antagonists|mesh-ancestor
6508184|NCT00673205|Hormone Antagonists|hormone antagonists|mesh-ancestor
6508185|NCT00673205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6508186|NCT00673205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508187|NCT00673205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6508188|NCT00673218|Omalizumab|omalizumab|mesh-list
6508189|NCT00673218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6508190|NCT00673218|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6508191|NCT00673218|Respiratory System Agents|respiratory system agents|mesh-ancestor
6508192|NCT00673270|Hydrocortisone|hydrocortisone|mesh-list
6508193|NCT00673270|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6508194|NCT00673270|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6508195|NCT00673270|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6508196|NCT00673270|Fludrocortisone|fludrocortisone|mesh-list
6508197|NCT00673270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6508198|NCT00673296|Bevacizumab|bevacizumab|mesh-list
6508199|NCT00673296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6508200|NCT00673296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6508201|NCT00673296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6508202|NCT00673296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6508203|NCT00673296|Growth Substances|growth substances|mesh-ancestor
6508204|NCT00673296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508205|NCT00673296|Growth Inhibitors|growth inhibitors|mesh-ancestor
6508206|NCT00673335|Letrozole|letrozole|mesh-list
6508207|NCT00673335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5964096|NCT04594772|Irinotecan|irinotecan|mesh-list
5716960|NCT03236610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5716961|NCT03236610|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5716962|NCT03236610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5716963|NCT03236610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5716964|NCT03236610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716965|NCT03236610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5716966|NCT03236610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5716967|NCT03236649|Sorafenib|sorafenib|mesh-list
5716968|NCT03236649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6508208|NCT00673335|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6508209|NCT00673335|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6508210|NCT00673335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6508211|NCT00673335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508212|NCT00673335|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6508213|NCT00673335|Hormone Antagonists|hormone antagonists|mesh-ancestor
6508214|NCT00673335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6508215|NCT00673335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508216|NCT00673426|Enoxaparin|enoxaparin|mesh-list
6508217|NCT00673426|Anticoagulants|anticoagulants|mesh-ancestor
6508218|NCT00673426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6508219|NCT00673426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6508220|NCT00673426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508221|NCT00673504|Gemcitabine|gemcitabine|mesh-list
6508222|NCT00673504|Sunitinib|sunitinib|mesh-list
6508223|NCT00673504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6508224|NCT00673504|Antimetabolites|antimetabolites|mesh-ancestor
6508225|NCT00673504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508226|NCT00673504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6508227|NCT00673504|Antiviral Agents|antiviral agents|mesh-ancestor
6508228|NCT00673504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6508229|NCT00673504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6508230|NCT00673504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6508231|NCT00673504|Immunologic Factors|immunologic factors|mesh-ancestor
6508232|NCT00673504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678808|NCT01595334|Cetrorelix|cetrorelix|mesh-list
6678809|NCT01595334|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6678810|NCT01595334|Fertility Agents|fertility agents|mesh-ancestor
6678811|NCT01595334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6678812|NCT01595334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678813|NCT01595334|Hormone Antagonists|hormone antagonists|mesh-ancestor
6678814|NCT01595334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6678815|NCT01595399|Atropine|atropine|mesh-list
6678816|NCT01595399|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6678817|NCT01595399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6678818|NCT01595399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5716969|NCT03236649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6508233|NCT00673504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6508234|NCT00673504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6508235|NCT00673504|Growth Substances|growth substances|mesh-ancestor
6508236|NCT00673504|Growth Inhibitors|growth inhibitors|mesh-ancestor
6508237|NCT00673504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6508238|NCT00673556|Alefacept|alefacept|mesh-list
6508239|NCT00673556|Dermatologic Agents|dermatologic agents|mesh-ancestor
6508240|NCT00673556|Immunologic Factors|immunologic factors|mesh-ancestor
6508241|NCT00673556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508242|NCT00673569|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6508243|NCT00673569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6508244|NCT00673569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6508245|NCT00673569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6508246|NCT00673569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508247|NCT00673582|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6508248|NCT00673582|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6508249|NCT00673582|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6508250|NCT00673582|Antimetabolites|antimetabolites|mesh-ancestor
6508251|NCT00673582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508252|NCT00673582|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6508253|NCT00673582|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6508254|NCT00673582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6508255|NCT00673608|Deferasirox|deferasirox|mesh-list
6508256|NCT00673608|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6508257|NCT00673608|Chelating Agents|chelating agents|mesh-ancestor
6508258|NCT00673608|Sequestering Agents|sequestering agents|mesh-ancestor
6678819|NCT01595399|Autonomic Agents|autonomic agents|mesh-ancestor
5716970|NCT03236649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5716971|NCT03236649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5716972|NCT03236740|Metformin|metformin|mesh-list
5716973|NCT03236740|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5716974|NCT03236740|Estradiol|estradiol|mesh-list
5716975|NCT03236740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5716976|NCT03236740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716977|NCT03236740|Estrogens|estrogens|mesh-ancestor
5716978|NCT03236740|Hormones|hormones|mesh-ancestor
5716979|NCT03236740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5716980|NCT03236740|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5716981|NCT03236740|Contraceptive Agents|contraceptive agents|mesh-ancestor
5716982|NCT03236740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5716983|NCT03236740|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5716984|NCT03236740|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5716985|NCT03236740|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5716986|NCT03236727|Dexmedetomidine|dexmedetomidine|mesh-list
5716987|NCT03236727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5716988|NCT03236727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5716989|NCT03236727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5716990|NCT03236727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5716991|NCT03236727|Analgesics|analgesics|mesh-ancestor
5716992|NCT03236727|Sensory System Agents|sensory system agents|mesh-ancestor
5716993|NCT03236727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5716994|NCT03236727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5716995|NCT03236727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5716996|NCT03236727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5716997|NCT03236727|Adrenergic Agents|adrenergic agents|mesh-ancestor
5716998|NCT03236727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5716999|NCT03236727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717000|NCT03236987|Azithromycin|azithromycin|mesh-list
5717001|NCT03236987|Clarithromycin|clarithromycin|mesh-list
5717002|NCT03236987|Rifampin|rifampin|mesh-list
5717003|NCT03236987|Ethambutol|ethambutol|mesh-list
5717004|NCT03236987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5717005|NCT03236987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5717006|NCT03236987|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5717007|NCT03236987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5717008|NCT03236987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717009|NCT03236987|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5717010|NCT03236987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5717011|NCT03236987|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5717012|NCT03236987|Antitubercular Agents|antitubercular agents|mesh-ancestor
6508259|NCT00673608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508260|NCT00673621|Albuterol|albuterol|mesh-list
6508261|NCT00673621|Methacholine Chloride|methacholine chloride|mesh-list
6508262|NCT00673621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508263|NCT00673621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6508264|NCT00673621|Autonomic Agents|autonomic agents|mesh-ancestor
6508265|NCT00673621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6508266|NCT00673621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6508267|NCT00673621|Respiratory System Agents|respiratory system agents|mesh-ancestor
6508268|NCT00673621|Tocolytic Agents|tocolytic agents|mesh-ancestor
6508269|NCT00673621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6508270|NCT00673621|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6508271|NCT00673621|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6508272|NCT00673621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6508273|NCT00673621|Adrenergic Agents|adrenergic agents|mesh-ancestor
6508274|NCT00673621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6508275|NCT00673621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508276|NCT00673621|Miotics|miotics|mesh-ancestor
6508277|NCT00673621|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6508278|NCT00673621|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
6508279|NCT00673621|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6508280|NCT00673621|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6508281|NCT00673621|Cholinergic Agents|cholinergic agents|mesh-ancestor
6508282|NCT00673686|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
6508283|NCT00673686|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6508284|NCT00673686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508285|NCT00673829|Interleukin-2|interleukin-2|mesh-list
6508286|NCT00673829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6508287|NCT00673829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6508288|NCT00673829|Analgesics|analgesics|mesh-ancestor
6508289|NCT00673829|Sensory System Agents|sensory system agents|mesh-ancestor
5717013|NCT03236987|Leprostatic Agents|leprostatic agents|mesh-ancestor
5717014|NCT03236987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5717015|NCT03236987|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5717016|NCT03236987|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6508290|NCT00673829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6508291|NCT00673829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508292|NCT00674011|Bevacizumab|bevacizumab|mesh-list
6508293|NCT00674011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6508294|NCT00674011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6508295|NCT00674011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6508296|NCT00674011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6508297|NCT00674011|Growth Substances|growth substances|mesh-ancestor
6508298|NCT00674011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508299|NCT00674011|Growth Inhibitors|growth inhibitors|mesh-ancestor
6508300|NCT00674050|Fluticasone|fluticasone|mesh-list
6508301|NCT00674050|Albuterol|albuterol|mesh-list
6508302|NCT00674050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678820|NCT01595399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6678821|NCT01595399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678822|NCT01595399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6678823|NCT01595399|Respiratory System Agents|respiratory system agents|mesh-ancestor
6678824|NCT01595399|Mydriatics|mydriatics|mesh-ancestor
6678825|NCT01595399|Parasympatholytics|parasympatholytics|mesh-ancestor
6678826|NCT01595399|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6678827|NCT01595399|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6508303|NCT00674050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6508304|NCT00674050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6508305|NCT00674050|Autonomic Agents|autonomic agents|mesh-ancestor
6508306|NCT00674050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6508307|NCT00674050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6508308|NCT00674050|Respiratory System Agents|respiratory system agents|mesh-ancestor
6508309|NCT00674050|Dermatologic Agents|dermatologic agents|mesh-ancestor
6678828|NCT01595399|Cholinergic Agents|cholinergic agents|mesh-ancestor
6678829|NCT01595399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6678830|NCT01595399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678831|NCT01595425|Esomeprazole|esomeprazole|mesh-list
6678832|NCT01595425|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6678833|NCT01595425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6678834|NCT01595425|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6678835|NCT01595425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6678836|NCT01595425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678837|NCT01595581|Testosterone|testosterone|mesh-list
6678838|NCT01595581|Androgens|androgens|mesh-ancestor
6678839|NCT01595581|Hormones|hormones|mesh-ancestor
6678840|NCT01595581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6678841|NCT01595581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678842|NCT01595594|Doxycycline|doxycycline|mesh-list
6678843|NCT01595594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6508310|NCT00674050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6508311|NCT00674050|Tocolytic Agents|tocolytic agents|mesh-ancestor
6508312|NCT00674050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6508313|NCT00674050|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6508314|NCT00674050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6508315|NCT00674050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6508316|NCT00674050|Adrenergic Agents|adrenergic agents|mesh-ancestor
6508317|NCT00674050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6508318|NCT00674050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508319|NCT00674063|Alefacept|alefacept|mesh-list
6508320|NCT00674063|Dermatologic Agents|dermatologic agents|mesh-ancestor
6508321|NCT00674063|Immunologic Factors|immunologic factors|mesh-ancestor
6508322|NCT00674063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508323|NCT00674089|Vitamin A|vitamin a|mesh-list
6508324|NCT00674089|Vitamins|vitamins|mesh-ancestor
6508325|NCT00674089|Micronutrients|micronutrients|mesh-ancestor
6508326|NCT00674089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678844|NCT01595594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6678845|NCT01595594|Antimalarials|antimalarials|mesh-ancestor
6678846|NCT01595594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6678847|NCT01595594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6678848|NCT01595620|Capsaicin|capsaicin|mesh-list
6678849|NCT01595620|Antipruritics|antipruritics|mesh-ancestor
6678850|NCT01595620|Dermatologic Agents|dermatologic agents|mesh-ancestor
6678851|NCT01595620|Sensory System Agents|sensory system agents|mesh-ancestor
6678852|NCT01595620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6678853|NCT01595620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678854|NCT01595633|Tenofovir|tenofovir|mesh-list
6678855|NCT01595633|Adefovir|adefovir|mesh-list
6678856|NCT01595633|Antiviral Agents|antiviral agents|mesh-ancestor
6678857|NCT01595633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6678858|NCT01595633|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6678859|NCT01595633|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6678860|NCT01595633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6678861|NCT01595633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678862|NCT01595633|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6678863|NCT01595633|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6678864|NCT01595685|Entecavir|entecavir|mesh-list
6678865|NCT01595685|Telbivudine|telbivudine|mesh-list
6678866|NCT01595685|Antiviral Agents|antiviral agents|mesh-ancestor
6678867|NCT01595685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6678868|NCT01595685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6678869|NCT01595685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6678870|NCT01595685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779770|NCT02180880|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6779771|NCT02180880|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6779772|NCT02180997|Tamsulosin|tamsulosin|mesh-list
6779773|NCT02180997|Solifenacin Succinate|solifenacin succinate|mesh-list
6779774|NCT02180997|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6779775|NCT02180997|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6779776|NCT02180997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6779777|NCT02180997|Adrenergic Agents|adrenergic agents|mesh-ancestor
6779778|NCT02180997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6779779|NCT02180997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779780|NCT02180997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779781|NCT02180997|Urological Agents|urological agents|mesh-ancestor
6779782|NCT02180997|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6779783|NCT02180997|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6779784|NCT02180997|Cholinergic Agents|cholinergic agents|mesh-ancestor
6779785|NCT02181023|Glycopyrrolate|glycopyrrolate|mesh-list
6779786|NCT02181023|Bromides|bromides|mesh-list
6779787|NCT02181023|Anticonvulsants|anticonvulsants|mesh-ancestor
6779788|NCT02181023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6779789|NCT02181023|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6779790|NCT02181023|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6779791|NCT02181023|Cholinergic Agents|cholinergic agents|mesh-ancestor
6779792|NCT02181023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6779793|NCT02181023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779794|NCT02181023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508327|NCT00674102|Vadimezan|vadimezan|mesh-list
6508328|NCT00674102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6508329|NCT00674141|Dexamethasone|dexamethasone|mesh-list
6508330|NCT00674141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6508331|NCT00674141|Antiemetics|antiemetics|mesh-ancestor
6508332|NCT00674141|Autonomic Agents|autonomic agents|mesh-ancestor
6508333|NCT00674141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6508334|NCT00674141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508335|NCT00674141|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6508336|NCT00674141|Glucocorticoids|glucocorticoids|mesh-ancestor
6508337|NCT00674141|Hormones|hormones|mesh-ancestor
6678871|NCT01595724|Dienogest|dienogest|mesh-list
6508338|NCT00674141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6508339|NCT00674141|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6508340|NCT00674141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6508341|NCT00674167|Docetaxel|docetaxel|mesh-list
6508342|NCT00674167|Capecitabine|capecitabine|mesh-list
6508343|NCT00674167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6508344|NCT00674167|Tubulin Modulators|tubulin modulators|mesh-ancestor
6508345|NCT00674167|Antimitotic Agents|antimitotic agents|mesh-ancestor
6508346|NCT00674167|Mitosis Modulators|mitosis modulators|mesh-ancestor
6508347|NCT00674167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508348|NCT00674167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6508349|NCT00674167|Antimetabolites|antimetabolites|mesh-ancestor
6508350|NCT00674232|Misoprostol|misoprostol|mesh-list
6508351|NCT00674232|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6678872|NCT01595724|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6678873|NCT01595724|Contraceptive Agents|contraceptive agents|mesh-ancestor
6678874|NCT01595724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6678875|NCT01595724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678876|NCT01595724|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6678877|NCT01595724|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6508352|NCT00674232|Abortifacient Agents|abortifacient agents|mesh-ancestor
6508353|NCT00674232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6508354|NCT00674232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508355|NCT00674232|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6508356|NCT00674232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6508357|NCT00674232|Oxytocics|oxytocics|mesh-ancestor
6508358|NCT00674245|Pantoprazole|pantoprazole|mesh-list
6508359|NCT00674245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6508360|NCT00674245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6508361|NCT00674245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6508362|NCT00674245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6508363|NCT00674245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508364|NCT00674310|Ropinirole|ropinirole|mesh-list
6508365|NCT00674310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6508366|NCT00674310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6508367|NCT00674310|Dopamine Agonists|dopamine agonists|mesh-ancestor
6508368|NCT00674310|Dopamine Agents|dopamine agents|mesh-ancestor
6508369|NCT00674310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6508370|NCT00674310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678878|NCT01595724|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6678879|NCT01595724|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6678880|NCT01595724|Hormone Antagonists|hormone antagonists|mesh-ancestor
6678881|NCT01595724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6678882|NCT01595724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6678883|NCT01595724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6678884|NCT01595737|Simendan|simendan|mesh-list
6678885|NCT01595737|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6678886|NCT01595737|Vasodilator Agents|vasodilator agents|mesh-ancestor
6678887|NCT01595737|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6678888|NCT01595737|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6508371|NCT00674310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508372|NCT00674414|Trastuzumab|trastuzumab|mesh-list
6508373|NCT00674414|Everolimus|everolimus|mesh-list
6508374|NCT00674414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6508375|NCT00674414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6508376|NCT00674414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6508377|NCT00674414|Immunologic Factors|immunologic factors|mesh-ancestor
6508378|NCT00674414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508379|NCT00674557|Exemestane|exemestane|mesh-list
6508380|NCT00674557|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
6508381|NCT00674557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6508382|NCT00674557|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6508383|NCT00674557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6508384|NCT00674557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6508385|NCT00674557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508386|NCT00674557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6508387|NCT00674557|Hormone Antagonists|hormone antagonists|mesh-ancestor
6508388|NCT00674557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6508389|NCT00674557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508390|NCT00674557|Chelating Agents|chelating agents|mesh-ancestor
6508391|NCT00674557|Sequestering Agents|sequestering agents|mesh-ancestor
6508392|NCT00674557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6508393|NCT00674557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6508394|NCT00674557|Growth Substances|growth substances|mesh-ancestor
6508395|NCT00674557|Growth Inhibitors|growth inhibitors|mesh-ancestor
6508396|NCT00674596|Ramipril|ramipril|mesh-list
6508397|NCT00674596|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6508398|NCT00674596|Protease Inhibitors|protease inhibitors|mesh-ancestor
6508399|NCT00674596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6508400|NCT00674596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508401|NCT00674596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6508402|NCT00674674|Topotecan|topotecan|mesh-list
5717017|NCT03236987|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5717018|NCT03236987|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5717019|NCT03236987|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5717020|NCT03236987|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5717021|NCT03236493|PF-06700841|pf-06700841|mesh-list
5717022|NCT03236493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5717023|NCT03236493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5717024|NCT03236493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717025|NCT03236584|Tenofovir|tenofovir|mesh-list
5717026|NCT03236584|Lamivudine|lamivudine|mesh-list
5717027|NCT03236584|Adefovir|adefovir|mesh-list
5717028|NCT03236584|Antiviral Agents|antiviral agents|mesh-ancestor
5717029|NCT03236584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5717030|NCT03236584|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5717031|NCT03236584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5717032|NCT03236584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5717033|NCT03236584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717034|NCT03236584|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5717035|NCT03236584|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5717036|NCT03236623|Menthol|menthol|mesh-list
5717037|NCT03236623|Antipruritics|antipruritics|mesh-ancestor
6508403|NCT00674674|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6508404|NCT00674674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6508405|NCT00674674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6508406|NCT00674674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508407|NCT00674674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6508408|NCT00674687|Gabapentin|gabapentin|mesh-list
6508409|NCT00674687|Analgesics|analgesics|mesh-ancestor
6508410|NCT00674687|Sensory System Agents|sensory system agents|mesh-ancestor
6508411|NCT00674687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6508412|NCT00674687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508413|NCT00674687|Anticonvulsants|anticonvulsants|mesh-ancestor
6508414|NCT00674687|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6508415|NCT00674687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6508416|NCT00674687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6508417|NCT00674687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6508418|NCT00674687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6508419|NCT00674687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6508420|NCT00674687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6508421|NCT00674687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508422|NCT00674687|Antimanic Agents|antimanic agents|mesh-ancestor
6508423|NCT00674713|Ondansetron|ondansetron|mesh-list
6508424|NCT00674713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6508425|NCT00674713|Antiemetics|antiemetics|mesh-ancestor
6508426|NCT00674713|Autonomic Agents|autonomic agents|mesh-ancestor
6508427|NCT00674713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6508428|NCT00674713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508429|NCT00674713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6508430|NCT00674713|Antipruritics|antipruritics|mesh-ancestor
6508431|NCT00674713|Dermatologic Agents|dermatologic agents|mesh-ancestor
6508432|NCT00674713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6508433|NCT00674713|Serotonin Agents|serotonin agents|mesh-ancestor
6508434|NCT00674713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6508435|NCT00674713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508436|NCT00674713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5717038|NCT03236623|Dermatologic Agents|dermatologic agents|mesh-ancestor
6508437|NCT00674713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6508438|NCT00674713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6508439|NCT00674713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6508440|NCT00674713|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6508441|NCT00674752|Gabapentin|gabapentin|mesh-list
6508442|NCT00674752|Analgesics|analgesics|mesh-ancestor
6508443|NCT00674752|Sensory System Agents|sensory system agents|mesh-ancestor
6508444|NCT00674752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6508445|NCT00674752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508446|NCT00674752|Anticonvulsants|anticonvulsants|mesh-ancestor
6508447|NCT00674752|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6508448|NCT00674752|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6508449|NCT00674752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6508450|NCT00674752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6508451|NCT00674752|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6508452|NCT00674752|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6508453|NCT00674752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6508454|NCT00674752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508455|NCT00674752|Antimanic Agents|antimanic agents|mesh-ancestor
6508456|NCT00674856|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
6508457|NCT00674856|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6508458|NCT00674856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508459|NCT00674921|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6508460|NCT00674921|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6508461|NCT00674921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6508462|NCT00674921|Renal Agents|renal agents|mesh-ancestor
6508463|NCT00674921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6508464|NCT00674921|Antimalarials|antimalarials|mesh-ancestor
6508465|NCT00674921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6508466|NCT00674921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6508467|NCT00674999|Bacitracin|bacitracin|mesh-list
6508468|NCT00674999|Nystatin|nystatin|mesh-list
6508469|NCT00674999|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6508470|NCT00674999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6508471|NCT00674999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6508472|NCT00674999|Antifungal Agents|antifungal agents|mesh-ancestor
6508473|NCT00674999|Ionophores|ionophores|mesh-ancestor
6508474|NCT00674999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6508475|NCT00674999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508476|NCT00675012|Capecitabine|capecitabine|mesh-list
6508477|NCT00675012|Oxaliplatin|oxaliplatin|mesh-list
6508478|NCT00675012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6508479|NCT00675012|Antimetabolites|antimetabolites|mesh-ancestor
6508480|NCT00675012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508481|NCT00675012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6508482|NCT00675181|Melatonin|melatonin|mesh-list
6508483|NCT00675181|Antioxidants|antioxidants|mesh-ancestor
6508484|NCT00675181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508485|NCT00675181|Protective Agents|protective agents|mesh-ancestor
6508486|NCT00675181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508487|NCT00675181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6508488|NCT00675194|Capecitabine|capecitabine|mesh-list
6508489|NCT00675194|Irinotecan|irinotecan|mesh-list
6508490|NCT00675194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6508491|NCT00675194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6508492|NCT00675194|Antimetabolites|antimetabolites|mesh-ancestor
6508493|NCT00675194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508494|NCT00675194|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6508495|NCT00675194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6508496|NCT00675194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6508497|NCT00675207|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6508498|NCT00675207|Dorzolamide|dorzolamide|mesh-list
6508499|NCT00675207|Brinzolamide|brinzolamide|mesh-list
6508500|NCT00675207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6508501|NCT00675207|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6508502|NCT00675207|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6508503|NCT00675207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6508504|NCT00675207|Adrenergic Agents|adrenergic agents|mesh-ancestor
6508505|NCT00675207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6508506|NCT00675207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508507|NCT00675207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508508|NCT00675207|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6508509|NCT00675207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6508510|NCT00675220|Insulin Aspart|insulin aspart|mesh-list
6508511|NCT00675220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6508512|NCT00675220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508513|NCT00675246|Betamethasone|betamethasone|mesh-list
6508514|NCT00675246|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
6508515|NCT00675246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6508516|NCT00675246|Glucocorticoids|glucocorticoids|mesh-ancestor
6508517|NCT00675246|Hormones|hormones|mesh-ancestor
6508518|NCT00675246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6508519|NCT00675246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508520|NCT00675246|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6508521|NCT00675246|Respiratory System Agents|respiratory system agents|mesh-ancestor
6508522|NCT00675246|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6508523|NCT00675246|Autonomic Agents|autonomic agents|mesh-ancestor
6508524|NCT00675246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6508525|NCT00675272|Hydrocortisone|hydrocortisone|mesh-list
6508526|NCT00675272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6508527|NCT00675285|Montelukast|montelukast|mesh-list
6508528|NCT00675285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6508529|NCT00675285|Respiratory System Agents|respiratory system agents|mesh-ancestor
6508530|NCT00675285|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6508531|NCT00675285|Hormone Antagonists|hormone antagonists|mesh-ancestor
6508532|NCT00675285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6508533|NCT00675285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508534|NCT00675285|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6508535|NCT00675285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6508536|NCT00675285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508537|NCT00675350|Homoharringtonine|homoharringtonine|mesh-list
6508538|NCT00675350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6508539|NCT00675350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6508540|NCT00675350|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6508541|NCT00675350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6508542|NCT00675350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508543|NCT00675493|Insulin Aspart|insulin aspart|mesh-list
6508544|NCT00675493|Biphasic Insulins|biphasic insulins|mesh-list
6508545|NCT00675493|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6508546|NCT00675493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6508547|NCT00675493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508548|NCT00675545|Carboplatin|carboplatin|mesh-list
6508549|NCT00675545|Docetaxel|docetaxel|mesh-list
6508550|NCT00675545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6678889|NCT01595737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6678890|NCT01595737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678891|NCT01595737|Protective Agents|protective agents|mesh-ancestor
6678892|NCT01595737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678893|NCT01595763|Fibrin fragment D|fibrin fragment d|mesh-list
6678894|NCT01595763|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6508551|NCT00675545|Tubulin Modulators|tubulin modulators|mesh-ancestor
6508552|NCT00675545|Antimitotic Agents|antimitotic agents|mesh-ancestor
6508553|NCT00675545|Mitosis Modulators|mitosis modulators|mesh-ancestor
6508554|NCT00675545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508555|NCT00675649|Golimumab|golimumab|mesh-list
6508556|NCT00675649|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6508557|NCT00675649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6508558|NCT00675649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6508559|NCT00675649|Immunologic Factors|immunologic factors|mesh-ancestor
6508560|NCT00675649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508561|NCT00675688|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
6508562|NCT00675688|Bazedoxifene|bazedoxifene|mesh-list
6508563|NCT00675688|Estrogens|estrogens|mesh-list
6508564|NCT00675688|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6508565|NCT00675688|Hormones|hormones|mesh-ancestor
6508566|NCT00675688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6508567|NCT00675688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508568|NCT00675688|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6508569|NCT00675688|Hormone Antagonists|hormone antagonists|mesh-ancestor
6508570|NCT00675688|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6508571|NCT00675688|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6508572|NCT00675688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6508573|NCT00675701|Moxifloxacin|moxifloxacin|mesh-list
6508574|NCT00675701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6508575|NCT00675701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6508576|NCT00675701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6779795|NCT02181101|Zoledronic Acid|zoledronic acid|mesh-list
6508577|NCT00675701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6508578|NCT00675701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6508579|NCT00675701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508580|NCT00675701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6508581|NCT00675714|Nandrolone Decanoate|nandrolone decanoate|mesh-list
6508582|NCT00675714|Itraconazole|itraconazole|mesh-list
6508583|NCT00675714|Fluconazole|fluconazole|mesh-list
6508584|NCT00675714|Ketoconazole|ketoconazole|mesh-list
6508585|NCT00675714|Methyltestosterone|methyltestosterone|mesh-list
6508586|NCT00675714|Propranolol|propranolol|mesh-list
6508587|NCT00675714|Metoprolol|metoprolol|mesh-list
6508588|NCT00675714|Hormones|hormones|mesh-list
6508589|NCT00675714|Testosterone|testosterone|mesh-list
6508590|NCT00675714|Testosterone undecanoate|testosterone undecanoate|mesh-list
6508591|NCT00675714|Testosterone enanthate|testosterone enanthate|mesh-list
6508592|NCT00675714|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6508593|NCT00675714|Oxandrolone|oxandrolone|mesh-list
6508594|NCT00675714|Nandrolone|nandrolone|mesh-list
6508595|NCT00675714|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
6508596|NCT00675714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6508597|NCT00675714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508598|NCT00675714|Androgens|androgens|mesh-ancestor
6508599|NCT00675714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6508600|NCT00675714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6508601|NCT00675714|Anabolic Agents|anabolic agents|mesh-ancestor
6508602|NCT00675714|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6678895|NCT01595763|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6678896|NCT01595763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508603|NCT00675714|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6508604|NCT00675714|Adrenergic Agents|adrenergic agents|mesh-ancestor
6508605|NCT00675714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6508606|NCT00675714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508607|NCT00675714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6508608|NCT00675714|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6508609|NCT00675714|Vasodilator Agents|vasodilator agents|mesh-ancestor
6508610|NCT00675714|Antifungal Agents|antifungal agents|mesh-ancestor
6508611|NCT00675714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6508612|NCT00675714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6508613|NCT00675714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6508614|NCT00675714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6508615|NCT00675714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6508616|NCT00675714|Hormone Antagonists|hormone antagonists|mesh-ancestor
6508617|NCT00675714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6508618|NCT00675714|Sympatholytics|sympatholytics|mesh-ancestor
6508619|NCT00675714|Autonomic Agents|autonomic agents|mesh-ancestor
6508620|NCT00675714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6508621|NCT00675714|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6508622|NCT00675714|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6508623|NCT00675714|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6508624|NCT00675714|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6678897|NCT01595763|Hemostatics|hemostatics|mesh-ancestor
6678898|NCT01595763|Coagulants|coagulants|mesh-ancestor
6678899|NCT01595789|Liraglutide|liraglutide|mesh-list
6678900|NCT01595789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6508625|NCT00675740|Rosiglitazone|rosiglitazone|mesh-list
6508626|NCT00675740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6508627|NCT00675740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508628|NCT00675779|Atorvastatin|atorvastatin|mesh-list
6508629|NCT00675779|Contraceptive Agents|contraceptive agents|mesh-list
6508630|NCT00675779|Contraceptives, Oral|contraceptives, oral|mesh-list
6508631|NCT00675779|Dacuronium|dacuronium|mesh-list
6508632|NCT00675779|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6508633|NCT00675779|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6508634|NCT00675779|Antimetabolites|antimetabolites|mesh-ancestor
6508635|NCT00675779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508636|NCT00675779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6678901|NCT01595789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678902|NCT01595789|Incretins|incretins|mesh-ancestor
6678903|NCT01595789|Hormones|hormones|mesh-ancestor
6678904|NCT01595789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6678905|NCT01595815|Calcium|calcium|mesh-list
6678906|NCT01595815|Ionophores|ionophores|mesh-list
6678907|NCT01595815|Calcium Ionophores|calcium ionophores|mesh-list
6678908|NCT01595815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6678909|NCT01595815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678910|NCT01595815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6508637|NCT00675779|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6508638|NCT00675779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6508639|NCT00675779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6508640|NCT00675779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508641|NCT00675779|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6508642|NCT00675779|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6508643|NCT00675779|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6508644|NCT00675779|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6508645|NCT00675779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6508646|NCT00675896|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6508647|NCT00675896|Antidepressive Agents|antidepressive agents|mesh-ancestor
6508648|NCT00675896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6508649|NCT00675896|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6508650|NCT00675896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6508651|NCT00675896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6508652|NCT00675896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508653|NCT00675961|Naltrexone|naltrexone|mesh-list
6508654|NCT00675961|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6508655|NCT00675961|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6508656|NCT00675961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508657|NCT00675961|Sensory System Agents|sensory system agents|mesh-ancestor
6508658|NCT00675961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6678911|NCT01595815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678912|NCT01595828|Pitavastatin|pitavastatin|mesh-list
6678913|NCT01595828|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6678914|NCT01595828|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6678915|NCT01595828|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6678916|NCT01595828|Antimetabolites|antimetabolites|mesh-ancestor
6678917|NCT01595828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678918|NCT01595828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6678919|NCT01595828|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6678920|NCT01595841|Sirolimus|sirolimus|mesh-list
6678921|NCT01595841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6678922|NCT01595841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6678923|NCT01595841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6678924|NCT01595841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6678925|NCT01595841|Antifungal Agents|antifungal agents|mesh-ancestor
6678926|NCT01595841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6678927|NCT01595841|Immunologic Factors|immunologic factors|mesh-ancestor
6678928|NCT01595841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678929|NCT01595867|Naltrexone|naltrexone|mesh-list
6678930|NCT01595867|Morphine|morphine|mesh-list
6678931|NCT01595867|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6678932|NCT01595867|Narcotics|narcotics|mesh-ancestor
6678933|NCT01595867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6678934|NCT01595867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678935|NCT01595867|Analgesics|analgesics|mesh-ancestor
6678936|NCT01595867|Sensory System Agents|sensory system agents|mesh-ancestor
6678937|NCT01595867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6678938|NCT01595867|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6678939|NCT01595867|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6678940|NCT01595880|Metformin|metformin|mesh-list
6678941|NCT01595880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6678942|NCT01595880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678943|NCT01595893|Vitamin D|vitamin d|mesh-list
6678944|NCT01595893|Cholecalciferol|cholecalciferol|mesh-list
6678945|NCT01595893|Vitamins|vitamins|mesh-ancestor
6678946|NCT01595893|Micronutrients|micronutrients|mesh-ancestor
6678947|NCT01595893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678948|NCT01595893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6678949|NCT01595893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6678950|NCT01595958|Cyclosporine|cyclosporine|mesh-list
6678951|NCT01595958|Cyclosporins|cyclosporins|mesh-list
6678952|NCT01595958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6678953|NCT01595958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678954|NCT01595958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6678955|NCT01595958|Immunologic Factors|immunologic factors|mesh-ancestor
6678956|NCT01595958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678957|NCT01595958|Antifungal Agents|antifungal agents|mesh-ancestor
6678958|NCT01595958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6678959|NCT01595958|Dermatologic Agents|dermatologic agents|mesh-ancestor
6678960|NCT01595958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6678961|NCT01595958|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6678962|NCT01595984|Cyclosporine|cyclosporine|mesh-list
6678963|NCT01595984|Mycophenolic Acid|mycophenolic acid|mesh-list
6678964|NCT01595984|Everolimus|everolimus|mesh-list
6508659|NCT00676039|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6508660|NCT00676039|Citalopram|citalopram|mesh-list
6508661|NCT00676039|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6508662|NCT00676039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6508663|NCT00676039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6508664|NCT00676039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508665|NCT00676039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6508666|NCT00676039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508667|NCT00676039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6508668|NCT00676039|Antidepressive Agents|antidepressive agents|mesh-ancestor
6508669|NCT00676039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6508670|NCT00676039|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6508671|NCT00676039|Serotonin Agents|serotonin agents|mesh-ancestor
6508672|NCT00676117|Loxoprofen|loxoprofen|mesh-list
6508673|NCT00676117|Esomeprazole|esomeprazole|mesh-list
6508674|NCT00676117|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5717039|NCT03236324|Epinephrine|epinephrine|mesh-list
5717040|NCT03236324|Bupivacaine|bupivacaine|mesh-list
5717041|NCT03236324|Anesthetics, Local|anesthetics, local|mesh-ancestor
5717042|NCT03236324|Anesthetics|anesthetics|mesh-ancestor
5717043|NCT03236324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5717044|NCT03236324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717045|NCT03236324|Sensory System Agents|sensory system agents|mesh-ancestor
5717046|NCT03236324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5717047|NCT03236324|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5717048|NCT03236324|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5717049|NCT03236324|Adrenergic Agents|adrenergic agents|mesh-ancestor
5717050|NCT03236324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5717051|NCT03236324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717052|NCT03236324|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5717053|NCT03236324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5717054|NCT03236324|Autonomic Agents|autonomic agents|mesh-ancestor
5717055|NCT03236324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5717056|NCT03236324|Respiratory System Agents|respiratory system agents|mesh-ancestor
5717057|NCT03236324|Mydriatics|mydriatics|mesh-ancestor
5717058|NCT03236324|Sympathomimetics|sympathomimetics|mesh-ancestor
6508675|NCT00676117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6508676|NCT00676117|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6508677|NCT00676117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6508678|NCT00676117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508679|NCT00676117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6508680|NCT00676117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6508681|NCT00676117|Analgesics|analgesics|mesh-ancestor
6508682|NCT00676117|Sensory System Agents|sensory system agents|mesh-ancestor
6508683|NCT00676117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6508684|NCT00676117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508685|NCT00676117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6508686|NCT00676117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6678965|NCT01595984|Cyclosporins|cyclosporins|mesh-list
6678966|NCT01595984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6678967|NCT01595984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6678968|NCT01595984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6678969|NCT01595984|Immunologic Factors|immunologic factors|mesh-ancestor
6678970|NCT01595984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678971|NCT01595984|Antifungal Agents|antifungal agents|mesh-ancestor
6678972|NCT01595984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6678973|NCT01595984|Dermatologic Agents|dermatologic agents|mesh-ancestor
6678974|NCT01595984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6678975|NCT01595984|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6678976|NCT01595984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6678977|NCT01595984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6678978|NCT01595984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5717059|NCT03236324|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5717060|NCT03236233|PC-786|pc-786|mesh-list
5717061|NCT03236233|Antiviral Agents|antiviral agents|mesh-ancestor
5717062|NCT03236233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5717063|NCT03236233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5717064|NCT03236233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717065|NCT03236220|Acetylcysteine|acetylcysteine|mesh-list
5717066|NCT03236220|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5717067|NCT03236220|Antiviral Agents|antiviral agents|mesh-ancestor
5717068|NCT03236220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5717069|NCT03236220|Expectorants|expectorants|mesh-ancestor
5717070|NCT03236220|Respiratory System Agents|respiratory system agents|mesh-ancestor
5717071|NCT03236220|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6508687|NCT00676156|Thioctic Acid|thioctic acid|mesh-list
6508688|NCT00676156|Antioxidants|antioxidants|mesh-ancestor
6508689|NCT00676156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508690|NCT00676156|Protective Agents|protective agents|mesh-ancestor
6508691|NCT00676156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508692|NCT00676156|Vitamin B Complex|vitamin b complex|mesh-ancestor
6508693|NCT00676156|Vitamins|vitamins|mesh-ancestor
6508694|NCT00676156|Micronutrients|micronutrients|mesh-ancestor
6508695|NCT00676221|Mycophenolic Acid|mycophenolic acid|mesh-list
6508696|NCT00676221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6508697|NCT00676221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6508698|NCT00676221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6508699|NCT00676221|Antitubercular Agents|antitubercular agents|mesh-ancestor
6508700|NCT00676221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6508701|NCT00676221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6508702|NCT00676221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6508703|NCT00676221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508704|NCT00676260|Pioglitazone|pioglitazone|mesh-list
6508705|NCT00676260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6508706|NCT00676260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508707|NCT00676286|Choline|choline|mesh-list
6508708|NCT00676286|Lipotropic Agents|lipotropic agents|mesh-ancestor
6508709|NCT00676286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6508710|NCT00676286|Antimetabolites|antimetabolites|mesh-ancestor
6508711|NCT00676286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508712|NCT00676286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6508713|NCT00676286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6508714|NCT00676286|Nootropic Agents|nootropic agents|mesh-ancestor
6508715|NCT00676377|Neostigmine|neostigmine|mesh-list
6508716|NCT00676377|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6508717|NCT00676377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6508718|NCT00676377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508719|NCT00676377|Cholinergic Agents|cholinergic agents|mesh-ancestor
6508720|NCT00676377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6508721|NCT00676377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508722|NCT00676377|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6508723|NCT00676377|Autonomic Agents|autonomic agents|mesh-ancestor
6508724|NCT00676377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6508725|NCT00676416|Propofol|propofol|mesh-list
6508726|NCT00676416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6508727|NCT00676416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6508728|NCT00676416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508729|NCT00676416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6508730|NCT00676416|Anesthetics, General|anesthetics, general|mesh-ancestor
6508731|NCT00676416|Anesthetics|anesthetics|mesh-ancestor
6508732|NCT00676429|Ziprasidone|ziprasidone|mesh-list
6508733|NCT00676429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6508734|NCT00676429|Serotonin Agents|serotonin agents|mesh-ancestor
6508735|NCT00676429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6508736|NCT00676429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508737|NCT00676429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508738|NCT00676429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6508739|NCT00676429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6508740|NCT00676429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6508741|NCT00676429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6508742|NCT00676429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6508743|NCT00676429|Dopamine Agents|dopamine agents|mesh-ancestor
6508744|NCT00676468|Montelukast|montelukast|mesh-list
6508745|NCT00676468|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6508746|NCT00676468|Respiratory System Agents|respiratory system agents|mesh-ancestor
6508747|NCT00676468|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6508748|NCT00676468|Hormone Antagonists|hormone antagonists|mesh-ancestor
6508749|NCT00676468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6508750|NCT00676468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508751|NCT00676468|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6508752|NCT00676468|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6508753|NCT00676468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508754|NCT00676533|Ciprofloxacin|ciprofloxacin|mesh-list
6508755|NCT00676533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6508756|NCT00676533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6508757|NCT00676533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6508758|NCT00676533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6508759|NCT00676533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6508760|NCT00676533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508761|NCT00676533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6508762|NCT00676533|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6508763|NCT00676533|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6508764|NCT00676559|Ranibizumab|ranibizumab|mesh-list
6508765|NCT00676559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6508766|NCT00676559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6508767|NCT00676559|Growth Substances|growth substances|mesh-ancestor
6508768|NCT00676559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508769|NCT00676559|Growth Inhibitors|growth inhibitors|mesh-ancestor
6508770|NCT00676559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6508771|NCT00676637|Timolol|timolol|mesh-list
6508772|NCT00676637|Travoprost|travoprost|mesh-list
6508773|NCT00676637|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6508774|NCT00676637|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6508775|NCT00676637|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6508776|NCT00676637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6508777|NCT00676637|Adrenergic Agents|adrenergic agents|mesh-ancestor
6508778|NCT00676637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6508779|NCT00676637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508780|NCT00676637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508781|NCT00676637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6508782|NCT00676637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6508783|NCT00676702|Vitamin K|vitamin k|mesh-list
6508784|NCT00676702|Pancrelipase|pancrelipase|mesh-list
6508785|NCT00676702|Pancreatin|pancreatin|mesh-list
6508786|NCT00676702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6508787|NCT00676702|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6508788|NCT00676702|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6508789|NCT00676702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508790|NCT00676702|Hemostatics|hemostatics|mesh-ancestor
6508791|NCT00676702|Coagulants|coagulants|mesh-ancestor
6508792|NCT00676702|Vitamins|vitamins|mesh-ancestor
6508793|NCT00676702|Micronutrients|micronutrients|mesh-ancestor
6508794|NCT00676702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508795|NCT00676741|Insulin|insulin|mesh-list
6508796|NCT00676741|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6508797|NCT00676741|Insulin Aspart|insulin aspart|mesh-list
6508798|NCT00676741|Insulin, Long-Acting|insulin, long-acting|mesh-list
6508799|NCT00676741|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6508800|NCT00676741|Insulin Detemir|insulin detemir|mesh-list
6508801|NCT00676741|Biphasic Insulins|biphasic insulins|mesh-list
6508802|NCT00676741|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6508803|NCT00676741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6508804|NCT00676741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508805|NCT00676819|Insulin|insulin|mesh-list
6508806|NCT00676819|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6508807|NCT00676819|Insulin Aspart|insulin aspart|mesh-list
6508808|NCT00676819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6508809|NCT00676819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508810|NCT00676845|Olmesartan|olmesartan|mesh-list
6508811|NCT00676845|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6508812|NCT00676845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6508813|NCT00676845|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6508814|NCT00676845|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6508815|NCT00676845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508816|NCT00676871|Blinatumomab|blinatumomab|mesh-list
6508817|NCT00676871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6508818|NCT00676936|Methylprednisolone|methylprednisolone|mesh-list
6508819|NCT00676936|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6508820|NCT00676936|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6508821|NCT00676936|Prednisolone|prednisolone|mesh-list
6508822|NCT00676936|Prednisolone acetate|prednisolone acetate|mesh-list
6508823|NCT00676936|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6508824|NCT00676936|Prednisolone phosphate|prednisolone phosphate|mesh-list
6508825|NCT00676936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6508826|NCT00676936|Antiemetics|antiemetics|mesh-ancestor
6508827|NCT00676936|Autonomic Agents|autonomic agents|mesh-ancestor
6508828|NCT00676936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6508829|NCT00676936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508830|NCT00676936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6508831|NCT00676936|Glucocorticoids|glucocorticoids|mesh-ancestor
6678979|NCT01595984|Antitubercular Agents|antitubercular agents|mesh-ancestor
6678980|NCT01595984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6678981|NCT01596010|Norethindrone|norethindrone|mesh-list
6508832|NCT00676936|Hormones|hormones|mesh-ancestor
6678982|NCT01596010|Norethindrone Acetate|norethindrone acetate|mesh-list
6508833|NCT00676936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6508834|NCT00676936|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6508835|NCT00676936|Protective Agents|protective agents|mesh-ancestor
6508836|NCT00676936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6508837|NCT00676936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6508838|NCT00677001|R 306465|r 306465|mesh-list
6508839|NCT00677001|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6508840|NCT00677001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6508841|NCT00677001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508842|NCT00677027|Lentinan|lentinan|mesh-list
6508843|NCT00677027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6508844|NCT00677027|Immunologic Factors|immunologic factors|mesh-ancestor
6508845|NCT00677027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508846|NCT00677027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6508847|NCT00677118|Cisplatin|cisplatin|mesh-list
6508848|NCT00677118|Fluorouracil|fluorouracil|mesh-list
6508849|NCT00677118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6508850|NCT00677118|Antimetabolites|antimetabolites|mesh-ancestor
6508851|NCT00677118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508852|NCT00677118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6508853|NCT00677118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6508854|NCT00677118|Immunologic Factors|immunologic factors|mesh-ancestor
6508855|NCT00677118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508856|NCT00677144|Capecitabine|capecitabine|mesh-list
6508857|NCT00677144|Oxaliplatin|oxaliplatin|mesh-list
6508858|NCT00677144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6508859|NCT00677144|Antimetabolites|antimetabolites|mesh-ancestor
6508860|NCT00677144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508861|NCT00677144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6508862|NCT00677170|Pevonedistat|pevonedistat|mesh-list
6508863|NCT00677170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6508864|NCT00677170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508865|NCT00677248|Ezetimibe|ezetimibe|mesh-list
6508866|NCT00677248|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6508867|NCT00677248|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6508868|NCT00677248|Antimetabolites|antimetabolites|mesh-ancestor
6508869|NCT00677248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508870|NCT00677248|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6508871|NCT00677261|Anesthetics|anesthetics|mesh-list
6508872|NCT00677261|Anesthetics, Local|anesthetics, local|mesh-list
6508873|NCT00677261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6508874|NCT00677261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508875|NCT00677261|Sensory System Agents|sensory system agents|mesh-ancestor
6508876|NCT00677261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6508877|NCT00677300|Ritonavir|ritonavir|mesh-list
6508878|NCT00677300|Darunavir|darunavir|mesh-list
6508879|NCT00677300|Tenofovir|tenofovir|mesh-list
6508880|NCT00677300|Emtricitabine|emtricitabine|mesh-list
6508881|NCT00677300|Raltegravir Potassium|raltegravir potassium|mesh-list
6508882|NCT00677300|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6508883|NCT00677300|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6508884|NCT00677300|Protease Inhibitors|protease inhibitors|mesh-ancestor
6508885|NCT00677300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6508886|NCT00677300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508887|NCT00677300|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6508888|NCT00677300|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6508889|NCT00677300|Antiviral Agents|antiviral agents|mesh-ancestor
6508890|NCT00677300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6508891|NCT00677300|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6508892|NCT00677300|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6508893|NCT00677300|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6508894|NCT00677300|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6508895|NCT00677300|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6508896|NCT00677300|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6508897|NCT00677339|Vitamin D|vitamin d|mesh-list
6508898|NCT00677339|Ergocalciferols|ergocalciferols|mesh-list
6508899|NCT00677339|Vitamins|vitamins|mesh-list
6508900|NCT00677339|Micronutrients|micronutrients|mesh-ancestor
6508901|NCT00677339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508902|NCT00677339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6508903|NCT00677339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6508904|NCT00677391|Sibutramine|sibutramine|mesh-list
6508905|NCT00677391|Antidepressive Agents|antidepressive agents|mesh-ancestor
6508906|NCT00677391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6508907|NCT00677391|Appetite Depressants|appetite depressants|mesh-ancestor
6508908|NCT00677391|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6508909|NCT00677443|Capecitabine|capecitabine|mesh-list
6508910|NCT00677443|Oxaliplatin|oxaliplatin|mesh-list
6508911|NCT00677443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6508912|NCT00677443|Antimetabolites|antimetabolites|mesh-ancestor
6508913|NCT00677443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508914|NCT00677443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6508915|NCT00677469|Cholestyramine Resin|cholestyramine resin|mesh-list
6508916|NCT00677469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5717072|NCT03236220|Antioxidants|antioxidants|mesh-ancestor
5717073|NCT03236220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717074|NCT03236220|Protective Agents|protective agents|mesh-ancestor
5717075|NCT03236220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717076|NCT03236220|Antidotes|antidotes|mesh-ancestor
5717077|NCT03235947|Trimethoprim|trimethoprim|mesh-list
5717078|NCT03235947|Sulfamethoxazole|sulfamethoxazole|mesh-list
5717079|NCT03235947|Fosfomycin|fosfomycin|mesh-list
5717080|NCT03235947|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5717081|NCT03235947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5717082|NCT03235947|Renal Agents|renal agents|mesh-ancestor
5717083|NCT03235947|Antimalarials|antimalarials|mesh-ancestor
5717084|NCT03235947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5717085|NCT03235947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5717086|NCT03235947|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6508917|NCT00677469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6508918|NCT00677469|Antimetabolites|antimetabolites|mesh-ancestor
6508919|NCT00677469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508920|NCT00677469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6508921|NCT00677521|Acarbose|acarbose|mesh-list
6508922|NCT00677521|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6508923|NCT00677521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6508924|NCT00677521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508925|NCT00677521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6508926|NCT00677521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508927|NCT00677586|Liver Extracts|liver extracts|mesh-list
6508928|NCT00677586|Hematinics|hematinics|mesh-ancestor
6508929|NCT00677664|Glatiramer Acetate|glatiramer acetate|mesh-list
6508930|NCT00677664|Mannitol|mannitol|mesh-list
6508931|NCT00677664|(T,G)-A-L|(t,g)-a-l|mesh-list
6508932|NCT00677664|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6508933|NCT00677664|Diuretics|diuretics|mesh-ancestor
6508934|NCT00677664|Natriuretic Agents|natriuretic agents|mesh-ancestor
6508935|NCT00677664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508936|NCT00677664|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6508937|NCT00677664|Immunologic Factors|immunologic factors|mesh-ancestor
6508938|NCT00677664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6508939|NCT00677664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6508940|NCT00677729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6508941|NCT00677729|Albuterol|albuterol|mesh-list
6508942|NCT00677729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6508943|NCT00677729|Autonomic Agents|autonomic agents|mesh-ancestor
6508944|NCT00677729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6508945|NCT00677729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508946|NCT00677729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5919402|NCT04981899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5919403|NCT04981899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5919404|NCT04981899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5919405|NCT04981899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5919406|NCT04981899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5919407|NCT04981899|Alkylating Agents|alkylating agents|mesh-ancestor
5919408|NCT04981951|Dexmedetomidine|dexmedetomidine|mesh-list
5919409|NCT04981951|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5919410|NCT04981951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5919411|NCT04981951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919412|NCT04981951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5919413|NCT04981951|Analgesics|analgesics|mesh-ancestor
5919414|NCT04981951|Sensory System Agents|sensory system agents|mesh-ancestor
5919415|NCT04981951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5919416|NCT04981951|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5919417|NCT04981951|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5919418|NCT04981951|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6508947|NCT00677729|Respiratory System Agents|respiratory system agents|mesh-ancestor
6508948|NCT00677729|Tocolytic Agents|tocolytic agents|mesh-ancestor
6508949|NCT00677729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5717087|NCT03235947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5717088|NCT03235947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508950|NCT00677729|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6508951|NCT00677729|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6508952|NCT00677729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6508953|NCT00677729|Adrenergic Agents|adrenergic agents|mesh-ancestor
6508954|NCT00677729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6508955|NCT00677729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508956|NCT00677755|Misoprostol|misoprostol|mesh-list
6508957|NCT00677755|Mifepristone|mifepristone|mesh-list
6678983|NCT01596010|Estradiol|estradiol|mesh-list
6678984|NCT01596010|Estrogens|estrogens|mesh-ancestor
6508958|NCT00677755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6508959|NCT00677755|Abortifacient Agents|abortifacient agents|mesh-ancestor
6508960|NCT00677755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6508961|NCT00677755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508962|NCT00677755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6508963|NCT00677755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6508964|NCT00677755|Oxytocics|oxytocics|mesh-ancestor
6508965|NCT00677755|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6508966|NCT00677755|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6508967|NCT00677755|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6508968|NCT00677755|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6508969|NCT00677755|Contraceptive Agents|contraceptive agents|mesh-ancestor
6508970|NCT00677755|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6508971|NCT00677755|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6508972|NCT00677755|Hormone Antagonists|hormone antagonists|mesh-ancestor
6508973|NCT00677755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6508974|NCT00677755|Luteolytic Agents|luteolytic agents|mesh-ancestor
6508975|NCT00677755|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6508976|NCT00677755|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6678985|NCT01596010|Hormones|hormones|mesh-ancestor
6678986|NCT01596010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6678987|NCT01596010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6678988|NCT01596010|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6678989|NCT01596010|Contraceptive Agents|contraceptive agents|mesh-ancestor
6678990|NCT01596010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6678991|NCT01596010|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6678992|NCT01596010|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6678993|NCT01596010|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6678994|NCT01596010|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6678995|NCT01596075|Cannabidiol|cannabidiol|mesh-list
6678996|NCT01596075|Anticonvulsants|anticonvulsants|mesh-ancestor
6678997|NCT01596114|Tin Fluorides|tin fluorides|mesh-list
6678998|NCT01596114|Cariostatic Agents|cariostatic agents|mesh-ancestor
6678999|NCT01596114|Protective Agents|protective agents|mesh-ancestor
6679000|NCT01596114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679001|NCT01596140|Sirolimus|sirolimus|mesh-list
6679002|NCT01596140|Everolimus|everolimus|mesh-list
6679003|NCT01596140|Vemurafenib|vemurafenib|mesh-list
6679004|NCT01596140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6679005|NCT01596140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6679006|NCT01596140|Immunologic Factors|immunologic factors|mesh-ancestor
6679007|NCT01596140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679008|NCT01596140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679009|NCT01596140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6679010|NCT01596140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6679011|NCT01596140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6679012|NCT01596140|Antifungal Agents|antifungal agents|mesh-ancestor
6679013|NCT01596140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6679014|NCT01596140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6679015|NCT01596166|Ketorolac|ketorolac|mesh-list
6679016|NCT01596166|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6679017|NCT01596166|Metoclopramide|metoclopramide|mesh-list
6679018|NCT01596166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6679019|NCT01596166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6679020|NCT01596166|Analgesics|analgesics|mesh-ancestor
6679021|NCT01596166|Sensory System Agents|sensory system agents|mesh-ancestor
6679022|NCT01596166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6679023|NCT01596166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679024|NCT01596166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6679025|NCT01596166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6679026|NCT01596166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6679027|NCT01596166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6679028|NCT01596166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679029|NCT01596166|Antiemetics|antiemetics|mesh-ancestor
6508977|NCT00678106|Dalbavancin|dalbavancin|mesh-list
6508978|NCT00678106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6508979|NCT00678106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6508980|NCT00678132|Gemcitabine|gemcitabine|mesh-list
6508981|NCT00678132|Olaparib|olaparib|mesh-list
5717089|NCT03235947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5717090|NCT03235947|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
5717091|NCT03235947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5717092|NCT03235947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5717093|NCT03236155|Analgesics, Opioid|analgesics, opioid|mesh-list
5717094|NCT03236155|Narcotics|narcotics|mesh-ancestor
5717095|NCT03236155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5717096|NCT03236155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717097|NCT03236155|Analgesics|analgesics|mesh-ancestor
5717098|NCT03236155|Sensory System Agents|sensory system agents|mesh-ancestor
5717099|NCT03236155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5717100|NCT03235921|Nitroglycerin|nitroglycerin|mesh-list
5717101|NCT03235921|Vasodilator Agents|vasodilator agents|mesh-ancestor
5717102|NCT03235973|Fludarabine|fludarabine|mesh-list
5717103|NCT03235973|Busulfan|busulfan|mesh-list
5717104|NCT03235973|Cladribine|cladribine|mesh-list
5717105|NCT03235973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5717106|NCT03235973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717107|NCT03235973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5717108|NCT03235973|Immunologic Factors|immunologic factors|mesh-ancestor
5717109|NCT03235973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717110|NCT03235973|Alkylating Agents|alkylating agents|mesh-ancestor
5717111|NCT03235973|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6508982|NCT00678132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6508983|NCT00678132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6508984|NCT00678132|Antimetabolites|antimetabolites|mesh-ancestor
6508985|NCT00678132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6508986|NCT00678132|Antiviral Agents|antiviral agents|mesh-ancestor
6508987|NCT00678132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6508988|NCT00678132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6508989|NCT00678132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6508990|NCT00678132|Immunologic Factors|immunologic factors|mesh-ancestor
6508991|NCT00678132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508992|NCT00678132|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6508993|NCT00678145|Epinephrine|epinephrine|mesh-list
6508994|NCT00678145|Morphine|morphine|mesh-list
6508995|NCT00678145|Naloxone|naloxone|mesh-list
6508996|NCT00678145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6508997|NCT00678145|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6508998|NCT00678145|Narcotics|narcotics|mesh-ancestor
6508999|NCT00678145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6509000|NCT00678145|Analgesics|analgesics|mesh-ancestor
6509001|NCT00678145|Sensory System Agents|sensory system agents|mesh-ancestor
6509002|NCT00678145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6509003|NCT00678145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6509004|NCT00678145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6509005|NCT00678145|Adrenergic Agents|adrenergic agents|mesh-ancestor
6509006|NCT00678145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6509007|NCT00678145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509008|NCT00678145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6509009|NCT00678145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6509010|NCT00678145|Autonomic Agents|autonomic agents|mesh-ancestor
6509011|NCT00678145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6509012|NCT00678145|Respiratory System Agents|respiratory system agents|mesh-ancestor
6509013|NCT00678145|Mydriatics|mydriatics|mesh-ancestor
6509014|NCT00678145|Sympathomimetics|sympathomimetics|mesh-ancestor
6509015|NCT00678145|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5717112|NCT03235973|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6509016|NCT00678145|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6509017|NCT00678184|Atorvastatin|atorvastatin|mesh-list
6509018|NCT00678184|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6509019|NCT00678184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6509020|NCT00678184|Antimetabolites|antimetabolites|mesh-ancestor
6509021|NCT00678184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509022|NCT00678184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6509023|NCT00678184|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6509024|NCT00678184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6509025|NCT00678236|Gentamicins|gentamicins|mesh-list
6509026|NCT00678236|Cimetidine|cimetidine|mesh-list
6509027|NCT00678236|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6509028|NCT00678236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6509029|NCT00678236|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6509030|NCT00678236|Histamine Antagonists|histamine antagonists|mesh-ancestor
6509031|NCT00678236|Histamine Agents|histamine agents|mesh-ancestor
6509032|NCT00678236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6509033|NCT00678236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509034|NCT00678236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509035|NCT00678236|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6509036|NCT00678236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6509037|NCT00678236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6509038|NCT00678236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6509039|NCT00678236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6509040|NCT00678236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6509041|NCT00678275|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6509042|NCT00678275|Immunologic Factors|immunologic factors|mesh-ancestor
6509043|NCT00678275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509044|NCT00678275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6509045|NCT00678314|Ropivacaine|ropivacaine|mesh-list
6509046|NCT00678314|Anesthetics, Local|anesthetics, local|mesh-ancestor
6509047|NCT00678314|Anesthetics|anesthetics|mesh-ancestor
6509048|NCT00678314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6509049|NCT00678314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509050|NCT00678314|Sensory System Agents|sensory system agents|mesh-ancestor
6509051|NCT00678314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6509052|NCT00678327|Prednisolone|prednisolone|mesh-list
6509053|NCT00678327|Cyclophosphamide|cyclophosphamide|mesh-list
6509054|NCT00678327|Dacarbazine|dacarbazine|mesh-list
6509055|NCT00678327|Doxorubicin|doxorubicin|mesh-list
6509056|NCT00678327|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6509057|NCT00678327|Etoposide|etoposide|mesh-list
6509058|NCT00678327|Vincristine|vincristine|mesh-list
6509059|NCT00678327|Bleomycin|bleomycin|mesh-list
6509060|NCT00678327|Vinblastine|vinblastine|mesh-list
6509061|NCT00678327|Procarbazine|procarbazine|mesh-list
6509062|NCT00678327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6509063|NCT00678327|Immunologic Factors|immunologic factors|mesh-ancestor
6509064|NCT00678327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509065|NCT00678327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6509066|NCT00678327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6509067|NCT00678327|Alkylating Agents|alkylating agents|mesh-ancestor
6509068|NCT00678327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509069|NCT00678327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6509070|NCT00678327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6509071|NCT00678327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6509072|NCT00678327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6509073|NCT00678327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6509074|NCT00678327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6509075|NCT00678327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6509076|NCT00678327|Tubulin Modulators|tubulin modulators|mesh-ancestor
6509077|NCT00678327|Antimitotic Agents|antimitotic agents|mesh-ancestor
6509078|NCT00678327|Mitosis Modulators|mitosis modulators|mesh-ancestor
6509079|NCT00678327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6509080|NCT00678327|Glucocorticoids|glucocorticoids|mesh-ancestor
6509081|NCT00678327|Hormones|hormones|mesh-ancestor
6509082|NCT00678327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6509083|NCT00678327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6509084|NCT00678431|Resveratrol|resveratrol|mesh-list
6509085|NCT00678431|Antioxidants|antioxidants|mesh-ancestor
6509086|NCT00678431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509087|NCT00678431|Protective Agents|protective agents|mesh-ancestor
6509088|NCT00678431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509089|NCT00678431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6509090|NCT00678431|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6509091|NCT00678457|Ondansetron|ondansetron|mesh-list
6509092|NCT00678457|Olanzapine|olanzapine|mesh-list
6509093|NCT00678457|Antiemetics|antiemetics|mesh-ancestor
6509094|NCT00678457|Autonomic Agents|autonomic agents|mesh-ancestor
6509095|NCT00678457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6509096|NCT00678457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509097|NCT00678457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6509098|NCT00678457|Antipruritics|antipruritics|mesh-ancestor
6509099|NCT00678457|Dermatologic Agents|dermatologic agents|mesh-ancestor
6509100|NCT00678457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6509101|NCT00678457|Serotonin Agents|serotonin agents|mesh-ancestor
6509102|NCT00678457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6509103|NCT00678457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509104|NCT00678457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6509105|NCT00678457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6509106|NCT00678457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6509107|NCT00678457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6509108|NCT00678457|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6509109|NCT00678457|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6509110|NCT00678457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6509111|NCT00678457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6509112|NCT00678483|Rimonabant|rimonabant|mesh-list
6509113|NCT00678483|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6509114|NCT00678483|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
6509115|NCT00678483|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6509116|NCT00678483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6509117|NCT00678483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509118|NCT00678483|Hormones|hormones|mesh-ancestor
6509119|NCT00678483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6509120|NCT00678483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509121|NCT00678522|Atorvastatin|atorvastatin|mesh-list
6509122|NCT00678522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6509123|NCT00678522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6509124|NCT00678522|Antimetabolites|antimetabolites|mesh-ancestor
6509125|NCT00678522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509126|NCT00678522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6509127|NCT00678522|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6509128|NCT00678522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6509129|NCT00678613|Norfloxacin|norfloxacin|mesh-list
6509130|NCT00678613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6509131|NCT00678613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6509132|NCT00678613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6509133|NCT00678613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6509134|NCT00678613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6509135|NCT00678613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509136|NCT00678613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6509137|NCT00678613|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6509138|NCT00678613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6509139|NCT00678626|Docetaxel|docetaxel|mesh-list
6509140|NCT00678626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6509141|NCT00678626|Tubulin Modulators|tubulin modulators|mesh-ancestor
6509142|NCT00678626|Antimitotic Agents|antimitotic agents|mesh-ancestor
6509143|NCT00678626|Mitosis Modulators|mitosis modulators|mesh-ancestor
6509144|NCT00678626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509145|NCT00678704|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6509146|NCT00678704|Vasodilator Agents|vasodilator agents|mesh-ancestor
6509147|NCT00678704|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6509148|NCT00678704|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6509149|NCT00678704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6509150|NCT00678704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509151|NCT00678704|Urological Agents|urological agents|mesh-ancestor
6509152|NCT00678730|Dronabinol|dronabinol|mesh-list
6509153|NCT00678730|Hallucinogens|hallucinogens|mesh-ancestor
6509154|NCT00678730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509155|NCT00678730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6509156|NCT00678730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6509157|NCT00678730|Analgesics|analgesics|mesh-ancestor
6509158|NCT00678730|Sensory System Agents|sensory system agents|mesh-ancestor
6509159|NCT00678730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6509160|NCT00678730|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6509161|NCT00678730|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6509162|NCT00678730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6509163|NCT00678730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509164|NCT00678730|Hormones|hormones|mesh-ancestor
6509165|NCT00678730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6509166|NCT00678743|Simvastatin|simvastatin|mesh-list
6509167|NCT00678743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6509168|NCT00678743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6509169|NCT00678743|Antimetabolites|antimetabolites|mesh-ancestor
6509170|NCT00678743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509171|NCT00678743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6509172|NCT00678743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6509173|NCT00678743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6509174|NCT00678756|Ketoconazole|ketoconazole|mesh-list
6509175|NCT00678756|Antifungal Agents|antifungal agents|mesh-ancestor
6509176|NCT00678756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6509177|NCT00678756|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6509178|NCT00678756|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6509179|NCT00678756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6509180|NCT00678756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509181|NCT00678756|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6509182|NCT00678756|Hormone Antagonists|hormone antagonists|mesh-ancestor
6509183|NCT00678756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6509184|NCT00678756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509185|NCT00678756|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6509186|NCT00678769|Sirolimus|sirolimus|mesh-list
6509187|NCT00678769|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6509188|NCT00678769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6509189|NCT00678769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6509190|NCT00678769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6509191|NCT00678769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6509192|NCT00678769|Antifungal Agents|antifungal agents|mesh-ancestor
6509193|NCT00678769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6509194|NCT00678769|Immunologic Factors|immunologic factors|mesh-ancestor
6509195|NCT00678769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509196|NCT00678782|Etanercept|etanercept|mesh-list
6509197|NCT00678782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6509198|NCT00678782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6509199|NCT00678782|Analgesics|analgesics|mesh-ancestor
6509200|NCT00678782|Sensory System Agents|sensory system agents|mesh-ancestor
6509201|NCT00678782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6509202|NCT00678782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509203|NCT00678782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6509204|NCT00678782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6509205|NCT00678782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6509206|NCT00678782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6509207|NCT00678782|Immunologic Factors|immunologic factors|mesh-ancestor
6509208|NCT00678964|Carboplatin|carboplatin|mesh-list
6509209|NCT00678964|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6679030|NCT01596166|Autonomic Agents|autonomic agents|mesh-ancestor
6679031|NCT01596166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6679032|NCT01596166|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6679033|NCT01596166|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6679034|NCT01596166|Dopamine Agents|dopamine agents|mesh-ancestor
6679035|NCT01596166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6679036|NCT01596218|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6679037|NCT01596218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6679038|NCT01596218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6679039|NCT01596296|Dinoprostone|dinoprostone|mesh-list
6679040|NCT01596296|Oxytocics|oxytocics|mesh-ancestor
6679041|NCT01596296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6679042|NCT01596296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679043|NCT01596387|Propofol|propofol|mesh-list
6679044|NCT01596387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6679045|NCT01596387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6509210|NCT00678964|Vinorelbine|vinorelbine|mesh-list
6679046|NCT01596387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679047|NCT01596387|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6679048|NCT01596387|Anesthetics, General|anesthetics, general|mesh-ancestor
6509211|NCT00678964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6509212|NCT00678964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6509213|NCT00678964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6509214|NCT00678964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509215|NCT00678964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6509216|NCT00678964|Tubulin Modulators|tubulin modulators|mesh-ancestor
6509217|NCT00678964|Antimitotic Agents|antimitotic agents|mesh-ancestor
6509218|NCT00678964|Mitosis Modulators|mitosis modulators|mesh-ancestor
6509219|NCT00678977|Gemcitabine|gemcitabine|mesh-list
6509220|NCT00678977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6509221|NCT00678977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6509222|NCT00678977|Antimetabolites|antimetabolites|mesh-ancestor
6509223|NCT00678977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509224|NCT00678977|Antiviral Agents|antiviral agents|mesh-ancestor
6509225|NCT00678977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6509226|NCT00678977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6509227|NCT00678977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5717113|NCT03235869|Durvalumab|durvalumab|mesh-list
5717114|NCT03235869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5717115|NCT03235869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5717116|NCT03236012|Botulinum Toxins|botulinum toxins|mesh-list
5717117|NCT03236012|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5717118|NCT03236012|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5717119|NCT03236012|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5717120|NCT03236012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5717121|NCT03236012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717122|NCT03236012|Cholinergic Agents|cholinergic agents|mesh-ancestor
5717123|NCT03236012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5717124|NCT03236012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717125|NCT03236012|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5717126|NCT03236012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5717127|NCT03235986|Poractant alfa|poractant alfa|mesh-list
5717128|NCT03235986|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
5717129|NCT03235986|Respiratory System Agents|respiratory system agents|mesh-ancestor
5717130|NCT03235609|Fentanyl|fentanyl|mesh-list
6509228|NCT00678977|Immunologic Factors|immunologic factors|mesh-ancestor
6509229|NCT00678977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509230|NCT00678990|Heparin|heparin|mesh-list
6509231|NCT00678990|Anticoagulants|anticoagulants|mesh-ancestor
6509232|NCT00678990|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6509233|NCT00678990|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6509234|NCT00678990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509235|NCT00679068|Bosentan|bosentan|mesh-list
6509236|NCT00679068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6509237|NCT00679068|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6509238|NCT00679068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509239|NCT00679120|Cimetidine|cimetidine|mesh-list
6509240|NCT00679120|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5717131|NCT03235609|Ketamine|ketamine|mesh-list
5717132|NCT03235609|Analgesics|analgesics|mesh-ancestor
5717133|NCT03235609|Sensory System Agents|sensory system agents|mesh-ancestor
5717134|NCT03235609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5717135|NCT03235609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717136|NCT03235609|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5717137|NCT03235609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5717138|NCT03235609|Anesthetics, General|anesthetics, general|mesh-ancestor
5717139|NCT03235609|Anesthetics|anesthetics|mesh-ancestor
5717140|NCT03235609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5717141|NCT03235609|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6509241|NCT00679120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6509242|NCT00679120|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6509243|NCT00679120|Histamine Antagonists|histamine antagonists|mesh-ancestor
6509244|NCT00679120|Histamine Agents|histamine agents|mesh-ancestor
6509245|NCT00679120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6509246|NCT00679120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509247|NCT00679120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509248|NCT00679120|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6509249|NCT00679120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6509250|NCT00679120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6509251|NCT00679146|Ketoprofen|ketoprofen|mesh-list
6509252|NCT00679146|Colchicine|colchicine|mesh-list
6509253|NCT00679146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6509254|NCT00679146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5717142|NCT03235609|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6509255|NCT00679146|Analgesics|analgesics|mesh-ancestor
6509256|NCT00679146|Sensory System Agents|sensory system agents|mesh-ancestor
6509257|NCT00679146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6509258|NCT00679146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509259|NCT00679146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6509260|NCT00679146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6509261|NCT00679146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6509262|NCT00679146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6509263|NCT00679146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509264|NCT00679146|Gout Suppressants|gout suppressants|mesh-ancestor
6509265|NCT00679146|Tubulin Modulators|tubulin modulators|mesh-ancestor
6509266|NCT00679146|Antimitotic Agents|antimitotic agents|mesh-ancestor
6509267|NCT00679146|Mitosis Modulators|mitosis modulators|mesh-ancestor
5717143|NCT03235609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6509268|NCT00679146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6509269|NCT00679159|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6509270|NCT00679159|Immunologic Factors|immunologic factors|mesh-ancestor
6509271|NCT00679159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509272|NCT00679224|Ambrisentan|ambrisentan|mesh-list
6509273|NCT00679224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6509274|NCT00679237|Metformin|metformin|mesh-list
6509275|NCT00679237|Glimepiride|glimepiride|mesh-list
6509276|NCT00679237|Ezetimibe|ezetimibe|mesh-list
6509277|NCT00679237|Diuretics|diuretics|mesh-list
6509278|NCT00679237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6509279|NCT00679237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509280|NCT00679237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6679049|NCT01596387|Anesthetics|anesthetics|mesh-ancestor
6679050|NCT01596400|Granisetron|granisetron|mesh-list
6679051|NCT01596400|Antiemetics|antiemetics|mesh-ancestor
6679052|NCT01596400|Autonomic Agents|autonomic agents|mesh-ancestor
6509281|NCT00679237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6509282|NCT00679237|Antimetabolites|antimetabolites|mesh-ancestor
6509283|NCT00679237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509284|NCT00679237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6509285|NCT00679237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6509286|NCT00679237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6509287|NCT00679237|Immunologic Factors|immunologic factors|mesh-ancestor
6509288|NCT00679237|Natriuretic Agents|natriuretic agents|mesh-ancestor
6509289|NCT00679250|Cetirizine|cetirizine|mesh-list
6509290|NCT00679250|Levocetirizine|levocetirizine|mesh-list
6509291|NCT00679250|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6509292|NCT00679250|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6509293|NCT00679250|Histamine Antagonists|histamine antagonists|mesh-ancestor
6509294|NCT00679250|Histamine Agents|histamine agents|mesh-ancestor
6509295|NCT00679250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6509296|NCT00679250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509297|NCT00679250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509298|NCT00679250|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6509299|NCT00679315|Alfuzosin|alfuzosin|mesh-list
6509300|NCT00679315|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6509301|NCT00679315|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6509302|NCT00679315|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6509303|NCT00679315|Adrenergic Agents|adrenergic agents|mesh-ancestor
6509304|NCT00679315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6509305|NCT00679315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509306|NCT00679315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509307|NCT00679315|Urological Agents|urological agents|mesh-ancestor
6509308|NCT00679458|Buprenorphine|buprenorphine|mesh-list
6509309|NCT00679458|Naloxone|naloxone|mesh-list
6509310|NCT00679458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6509311|NCT00679458|Narcotics|narcotics|mesh-ancestor
6509312|NCT00679458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6509313|NCT00679458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509314|NCT00679458|Analgesics|analgesics|mesh-ancestor
6509315|NCT00679458|Sensory System Agents|sensory system agents|mesh-ancestor
6509316|NCT00679458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6509317|NCT00679458|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6509318|NCT00679484|Candesartan|candesartan|mesh-list
6509319|NCT00679484|Candesartan cilexetil|candesartan cilexetil|mesh-list
6509320|NCT00679484|Olmesartan|olmesartan|mesh-list
6679053|NCT01596400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6509321|NCT00679484|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6509322|NCT00679484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6509323|NCT00679484|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6509324|NCT00679484|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6509325|NCT00679484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509326|NCT00679510|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6509327|NCT00679510|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6679054|NCT01596400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679055|NCT01596400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5717144|NCT03235609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717145|NCT03235609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5717146|NCT03235609|Narcotics|narcotics|mesh-ancestor
5717147|NCT03235609|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5722047|NCT03201627|Antidepressive Agents|antidepressive agents|mesh-ancestor
6679056|NCT01596400|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6679057|NCT01596400|Serotonin Agents|serotonin agents|mesh-ancestor
6509328|NCT00679510|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6509329|NCT00679510|Antimetabolites|antimetabolites|mesh-ancestor
6509330|NCT00679510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509331|NCT00679510|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6509332|NCT00679510|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5717148|NCT03235531|Valproic Acid|valproic acid|mesh-list
5717149|NCT03235531|Lorazepam|lorazepam|mesh-list
5717150|NCT03235531|Anticonvulsants|anticonvulsants|mesh-ancestor
5717151|NCT03235531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5717152|NCT03235531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509333|NCT00679510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6509334|NCT00679523|Tavaborole|tavaborole|mesh-list
6509335|NCT00679523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6509336|NCT00679523|Antifungal Agents|antifungal agents|mesh-ancestor
6509337|NCT00679523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6509338|NCT00679536|Fludarabine|fludarabine|mesh-list
6509339|NCT00679536|Busulfan|busulfan|mesh-list
6509340|NCT00679536|Thymoglobulin|thymoglobulin|mesh-list
6509341|NCT00679536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6509342|NCT00679536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509343|NCT00679536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6509344|NCT00679536|Immunologic Factors|immunologic factors|mesh-ancestor
6509345|NCT00679536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509346|NCT00679536|Alkylating Agents|alkylating agents|mesh-ancestor
6509347|NCT00679536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6509348|NCT00679536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6509349|NCT00679601|Tavaborole|tavaborole|mesh-list
6509350|NCT00679601|Antifungal Agents|antifungal agents|mesh-ancestor
6509351|NCT00679601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6509352|NCT00679614|Acetaminophen|acetaminophen|mesh-list
6509353|NCT00679614|Tramadol|tramadol|mesh-list
6509354|NCT00679614|Naloxone|naloxone|mesh-list
6509355|NCT00679614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6509356|NCT00679614|Analgesics|analgesics|mesh-ancestor
6509357|NCT00679614|Sensory System Agents|sensory system agents|mesh-ancestor
6509358|NCT00679614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6509359|NCT00679614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509360|NCT00679614|Antipyretics|antipyretics|mesh-ancestor
6509361|NCT00679614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6509362|NCT00679614|Narcotics|narcotics|mesh-ancestor
6509363|NCT00679614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6509364|NCT00679614|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6509365|NCT00679640|Candesartan|candesartan|mesh-list
6509366|NCT00679640|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6509367|NCT00679640|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6509368|NCT00679640|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6509369|NCT00679640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509370|NCT00679653|Sibutramine|sibutramine|mesh-list
6509371|NCT00679653|Metoprolol|metoprolol|mesh-list
6509372|NCT00679653|Verapamil|verapamil|mesh-list
6509373|NCT00679653|Felodipine|felodipine|mesh-list
6509374|NCT00679653|Ramipril|ramipril|mesh-list
6509375|NCT00679653|Trandolapril|trandolapril|mesh-list
6509376|NCT00679653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6509377|NCT00679653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6509378|NCT00679653|Sympatholytics|sympatholytics|mesh-ancestor
6509379|NCT00679653|Autonomic Agents|autonomic agents|mesh-ancestor
6509380|NCT00679653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6509381|NCT00679653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509382|NCT00679653|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6509383|NCT00679653|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6509384|NCT00679653|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6509385|NCT00679653|Adrenergic Agents|adrenergic agents|mesh-ancestor
6509386|NCT00679653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6509387|NCT00679653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509388|NCT00679653|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6509389|NCT00679653|Protease Inhibitors|protease inhibitors|mesh-ancestor
6509390|NCT00679653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6509391|NCT00679653|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6509392|NCT00679653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6509393|NCT00679653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6509394|NCT00679653|Vasodilator Agents|vasodilator agents|mesh-ancestor
6509395|NCT00679653|Antidepressive Agents|antidepressive agents|mesh-ancestor
6509396|NCT00679653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6509397|NCT00679653|Appetite Depressants|appetite depressants|mesh-ancestor
6509398|NCT00679653|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6509399|NCT00679666|Riboflavin|riboflavin|mesh-list
6509400|NCT00679666|Vitamins|vitamins|mesh-ancestor
5717153|NCT03235531|GABA Agents|gaba agents|mesh-ancestor
6509401|NCT00679666|Micronutrients|micronutrients|mesh-ancestor
6509402|NCT00679666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509403|NCT00679666|Vitamin B Complex|vitamin b complex|mesh-ancestor
6509404|NCT00679666|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6509405|NCT00679666|Dermatologic Agents|dermatologic agents|mesh-ancestor
6509406|NCT00679679|Metformin|metformin|mesh-list
6509407|NCT00679679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6509408|NCT00679679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509409|NCT00679705|Atosiban|atosiban|mesh-list
6509410|NCT00679705|Ritodrine|ritodrine|mesh-list
6509411|NCT00679705|Hormone Antagonists|hormone antagonists|mesh-ancestor
6509412|NCT00679705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6509413|NCT00679705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509414|NCT00679705|Tocolytic Agents|tocolytic agents|mesh-ancestor
6509415|NCT00679705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6509416|NCT00679705|Sympathomimetics|sympathomimetics|mesh-ancestor
6509417|NCT00679705|Autonomic Agents|autonomic agents|mesh-ancestor
6509418|NCT00679705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6509419|NCT00679705|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6509420|NCT00679705|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6509421|NCT00679705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6509422|NCT00679705|Adrenergic Agents|adrenergic agents|mesh-ancestor
6509423|NCT00679705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6509424|NCT00679705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509425|NCT00679718|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6509426|NCT00679718|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6509427|NCT00679744|Pyrimethamine|pyrimethamine|mesh-list
6509428|NCT00679744|Antimalarials|antimalarials|mesh-ancestor
6509429|NCT00679744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6509430|NCT00679744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6509431|NCT00679744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6509432|NCT00679744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6509433|NCT00679744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6509434|NCT00679744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509435|NCT00679770|Tavaborole|tavaborole|mesh-list
6509436|NCT00679770|Antifungal Agents|antifungal agents|mesh-ancestor
6509437|NCT00679770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6679058|NCT01596400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6679059|NCT01596400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679060|NCT01596413|Granisetron|granisetron|mesh-list
6679061|NCT01596413|Antiemetics|antiemetics|mesh-ancestor
6679062|NCT01596413|Autonomic Agents|autonomic agents|mesh-ancestor
6679063|NCT01596413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6679064|NCT01596413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679065|NCT01596413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6679066|NCT01596413|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6679067|NCT01596413|Serotonin Agents|serotonin agents|mesh-ancestor
6679068|NCT01596413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6679069|NCT01596413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679070|NCT01596426|Granisetron|granisetron|mesh-list
6679071|NCT01596426|Antiemetics|antiemetics|mesh-ancestor
6679072|NCT01596426|Autonomic Agents|autonomic agents|mesh-ancestor
6679073|NCT01596426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5717154|NCT03235531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5717155|NCT03235531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717156|NCT03235531|Antimanic Agents|antimanic agents|mesh-ancestor
5717157|NCT03235531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5717158|NCT03235531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5717159|NCT03235531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6679074|NCT01596426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679075|NCT01596426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6679076|NCT01596426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6679077|NCT01596426|Serotonin Agents|serotonin agents|mesh-ancestor
6679078|NCT01596426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6679079|NCT01596426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679080|NCT01596517|Ribavirin|ribavirin|mesh-list
6679081|NCT01596517|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6679082|NCT01596517|Interferon-alpha|interferon-alpha|mesh-list
5717160|NCT03235531|Antiemetics|antiemetics|mesh-ancestor
6679083|NCT01596517|Antimetabolites|antimetabolites|mesh-ancestor
6679084|NCT01596517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679085|NCT01596517|Antiviral Agents|antiviral agents|mesh-ancestor
6679086|NCT01596517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6679087|NCT01596517|Immunologic Factors|immunologic factors|mesh-ancestor
6679088|NCT01596517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509438|NCT00679835|Daptomycin|daptomycin|mesh-list
6509439|NCT00679835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6509440|NCT00679835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6509441|NCT00679900|SR 46349B|sr 46349b|mesh-list
6509442|NCT00679900|Lormetazepam|lormetazepam|mesh-list
6509443|NCT00679900|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6509444|NCT00679900|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6509445|NCT00679900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509446|NCT00679900|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6509447|NCT00679900|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6509448|NCT00679900|Serotonin Agents|serotonin agents|mesh-ancestor
6509449|NCT00679900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6509450|NCT00679900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509451|NCT00679900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6509452|NCT00679900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6509453|NCT00679965|Tavaborole|tavaborole|mesh-list
6509454|NCT00679965|Antifungal Agents|antifungal agents|mesh-ancestor
6509455|NCT00679965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6509456|NCT00680095|Tavaborole|tavaborole|mesh-list
6509457|NCT00680095|Antifungal Agents|antifungal agents|mesh-ancestor
6509458|NCT00680095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6509459|NCT00680108|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6509460|NCT00680108|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6509461|NCT00680134|Tavaborole|tavaborole|mesh-list
6509462|NCT00680134|Antifungal Agents|antifungal agents|mesh-ancestor
6509463|NCT00680134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6509464|NCT00680160|Tavaborole|tavaborole|mesh-list
6509465|NCT00680160|Antifungal Agents|antifungal agents|mesh-ancestor
6509466|NCT00680160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6509467|NCT00680173|Interferons|interferons|mesh-list
6509468|NCT00680173|Ribavirin|ribavirin|mesh-list
6509469|NCT00680173|Interferon-alpha|interferon-alpha|mesh-list
6509470|NCT00680173|Interferon alpha-2|interferon alpha-2|mesh-list
6509471|NCT00680173|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6509472|NCT00680173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6509473|NCT00680173|Antiviral Agents|antiviral agents|mesh-ancestor
6509474|NCT00680173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6509475|NCT00680173|Antimetabolites|antimetabolites|mesh-ancestor
6509476|NCT00680173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509477|NCT00680173|Immunologic Factors|immunologic factors|mesh-ancestor
6509478|NCT00680173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509479|NCT00680212|Beta Carotene|beta carotene|mesh-list
6509480|NCT00680212|Carotenoids|carotenoids|mesh-list
6509481|NCT00680212|Antioxidants|antioxidants|mesh-ancestor
6509482|NCT00680212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509483|NCT00680212|Protective Agents|protective agents|mesh-ancestor
6509484|NCT00680212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509485|NCT00680212|Provitamins|provitamins|mesh-ancestor
6509486|NCT00680212|Vitamins|vitamins|mesh-ancestor
6509487|NCT00680212|Micronutrients|micronutrients|mesh-ancestor
6509488|NCT00680277|Carotenoids|carotenoids|mesh-list
6509489|NCT00680277|Antioxidants|antioxidants|mesh-ancestor
6509490|NCT00680277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509491|NCT00680277|Protective Agents|protective agents|mesh-ancestor
6509492|NCT00680277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509493|NCT00680329|Timolol|timolol|mesh-list
6509494|NCT00680329|Travoprost|travoprost|mesh-list
6509495|NCT00680329|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6509496|NCT00680329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6509497|NCT00680329|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6509498|NCT00680329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6509499|NCT00680329|Adrenergic Agents|adrenergic agents|mesh-ancestor
6509500|NCT00680329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6509501|NCT00680329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509502|NCT00680329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509503|NCT00680329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6509504|NCT00680329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6509505|NCT00680355|Carotenoids|carotenoids|mesh-list
6509506|NCT00680355|Antioxidants|antioxidants|mesh-ancestor
6509507|NCT00680355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509508|NCT00680355|Protective Agents|protective agents|mesh-ancestor
6509509|NCT00680355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509510|NCT00680394|Misoprostol|misoprostol|mesh-list
6509511|NCT00680394|Mifepristone|mifepristone|mesh-list
6509512|NCT00680394|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6509513|NCT00680394|Abortifacient Agents|abortifacient agents|mesh-ancestor
6509514|NCT00680394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6509515|NCT00680394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509516|NCT00680394|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6509517|NCT00680394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6509518|NCT00680394|Oxytocics|oxytocics|mesh-ancestor
6509519|NCT00680394|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6509520|NCT00680394|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6509521|NCT00680394|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6509522|NCT00680394|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6509523|NCT00680394|Contraceptive Agents|contraceptive agents|mesh-ancestor
6509524|NCT00680394|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6509525|NCT00680394|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6509526|NCT00680394|Hormone Antagonists|hormone antagonists|mesh-ancestor
6509527|NCT00680394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6509528|NCT00680394|Luteolytic Agents|luteolytic agents|mesh-ancestor
6509529|NCT00680394|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6509530|NCT00680394|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6509531|NCT00680433|Ketamine|ketamine|mesh-list
6509532|NCT00680433|Analgesics|analgesics|mesh-ancestor
6509533|NCT00680433|Sensory System Agents|sensory system agents|mesh-ancestor
6509534|NCT00680433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6509535|NCT00680433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509536|NCT00680433|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6509537|NCT00680433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6509538|NCT00680433|Anesthetics, General|anesthetics, general|mesh-ancestor
6509539|NCT00680433|Anesthetics|anesthetics|mesh-ancestor
6509540|NCT00680433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6509541|NCT00680433|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6509542|NCT00680433|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6509543|NCT00680433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6509544|NCT00680433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509545|NCT00680446|Immunoglobulins|immunoglobulins|mesh-list
6509546|NCT00680446|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6509547|NCT00680446|Antibodies|antibodies|mesh-list
6509548|NCT00680446|Immunoglobulin G|immunoglobulin g|mesh-list
6509549|NCT00680446|Immunologic Factors|immunologic factors|mesh-ancestor
6509550|NCT00680446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509551|NCT00680485|Ketoconazole|ketoconazole|mesh-list
6509552|NCT00680485|Antifungal Agents|antifungal agents|mesh-ancestor
6509553|NCT00680485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6509554|NCT00680485|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6509555|NCT00680485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6509556|NCT00680485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6509557|NCT00680485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509558|NCT00680485|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6509559|NCT00680485|Hormone Antagonists|hormone antagonists|mesh-ancestor
5717161|NCT03235531|Autonomic Agents|autonomic agents|mesh-ancestor
5717162|NCT03235531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5717163|NCT03235531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5717164|NCT03235531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5717165|NCT03235531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5717166|NCT03235531|GABA Modulators|gaba modulators|mesh-ancestor
5717167|NCT03235700|Nicorandil|nicorandil|mesh-list
5717168|NCT03235700|Adenosine|adenosine|mesh-list
5717169|NCT03235700|Analgesics|analgesics|mesh-ancestor
5717170|NCT03235700|Sensory System Agents|sensory system agents|mesh-ancestor
5717171|NCT03235700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5717172|NCT03235700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717173|NCT03235700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5717174|NCT03235700|Vasodilator Agents|vasodilator agents|mesh-ancestor
5717175|NCT03235700|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5717176|NCT03235700|Purinergic Agonists|purinergic agonists|mesh-ancestor
5717177|NCT03235700|Purinergic Agents|purinergic agents|mesh-ancestor
5717178|NCT03235700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5717179|NCT03235700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717180|NCT03235700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6509560|NCT00680485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6509561|NCT00680485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509562|NCT00680485|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6509563|NCT00680498|Ranibizumab|ranibizumab|mesh-list
6509564|NCT00680498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6509565|NCT00680498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6509566|NCT00680498|Growth Substances|growth substances|mesh-ancestor
6509567|NCT00680498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509568|NCT00680498|Growth Inhibitors|growth inhibitors|mesh-ancestor
6509569|NCT00680498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6509570|NCT00680511|Methamphetamine|methamphetamine|mesh-list
6509571|NCT00680511|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6509572|NCT00680511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509573|NCT00680511|Sympathomimetics|sympathomimetics|mesh-ancestor
6509574|NCT00680511|Autonomic Agents|autonomic agents|mesh-ancestor
6509575|NCT00680511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6509576|NCT00680511|Dopamine Agents|dopamine agents|mesh-ancestor
6509577|NCT00680511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6509578|NCT00680511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509579|NCT00680511|Adrenergic Agents|adrenergic agents|mesh-ancestor
6509580|NCT00680511|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6509581|NCT00680511|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6509582|NCT00680511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6509583|NCT00680511|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6509584|NCT00680563|Epoetin Alfa|epoetin alfa|mesh-list
6509585|NCT00680563|Hematinics|hematinics|mesh-ancestor
6509586|NCT00680602|Sertraline|sertraline|mesh-list
6509587|NCT00680602|Fluoxetine|fluoxetine|mesh-list
6509588|NCT00680602|Paroxetine|paroxetine|mesh-list
6509589|NCT00680602|Citalopram|citalopram|mesh-list
6679089|NCT01596556|Nicotine|nicotine|mesh-list
6679090|NCT01596556|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6679091|NCT01596556|Autonomic Agents|autonomic agents|mesh-ancestor
6679092|NCT01596556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5717181|NCT03235700|Vitamin B Complex|vitamin b complex|mesh-ancestor
5717182|NCT03235700|Vitamins|vitamins|mesh-ancestor
5717183|NCT03235700|Micronutrients|micronutrients|mesh-ancestor
5717184|NCT03235778|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
5717185|NCT03235778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5717186|NCT03235778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5717187|NCT03235778|Analgesics|analgesics|mesh-ancestor
5717188|NCT03235778|Sensory System Agents|sensory system agents|mesh-ancestor
5717189|NCT03235778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5717190|NCT03235778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717191|NCT03235778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6509590|NCT00680602|Antidepressive Agents|antidepressive agents|mesh-ancestor
6509591|NCT00680602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6509592|NCT00680602|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6509593|NCT00680602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6509594|NCT00680602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6509595|NCT00680602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509596|NCT00680602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6509597|NCT00680602|Serotonin Agents|serotonin agents|mesh-ancestor
6509598|NCT00680602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509599|NCT00680602|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6509600|NCT00680602|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6509601|NCT00680602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6509602|NCT00680602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6509603|NCT00680641|Simvastatin|simvastatin|mesh-list
6509604|NCT00680641|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6509605|NCT00680641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6509606|NCT00680641|Antimetabolites|antimetabolites|mesh-ancestor
6509607|NCT00680641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509608|NCT00680641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6509609|NCT00680641|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6509610|NCT00680641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6509611|NCT00680654|Riociguat|riociguat|mesh-list
6509612|NCT00680654|Enzyme Activators|enzyme activators|mesh-ancestor
6509613|NCT00680654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509614|NCT00680680|Dutasteride|dutasteride|mesh-list
6509615|NCT00680680|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6509616|NCT00680680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6509617|NCT00680680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6509618|NCT00680680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509619|NCT00680680|Hormone Antagonists|hormone antagonists|mesh-ancestor
6509620|NCT00680680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6509621|NCT00680680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509622|NCT00680732|Folic Acid|folic acid|mesh-list
6509623|NCT00680732|Micronutrients|micronutrients|mesh-list
6509624|NCT00680732|Trace Elements|trace elements|mesh-list
6509625|NCT00680732|Chloroquine|chloroquine|mesh-list
6509626|NCT00680732|Pyrimethamine|pyrimethamine|mesh-list
6509627|NCT00680732|Hematinics|hematinics|mesh-ancestor
6509628|NCT00680732|Vitamin B Complex|vitamin b complex|mesh-ancestor
6509629|NCT00680732|Vitamins|vitamins|mesh-ancestor
6509630|NCT00680732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509631|NCT00680732|Amebicides|amebicides|mesh-ancestor
6509632|NCT00680732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6509633|NCT00680732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6509634|NCT00680732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6509635|NCT00680732|Antimalarials|antimalarials|mesh-ancestor
6509636|NCT00680732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6509637|NCT00680732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6509638|NCT00680732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6509639|NCT00680732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509640|NCT00680758|Paclitaxel|paclitaxel|mesh-list
6509641|NCT00680758|Everolimus|everolimus|mesh-list
6509642|NCT00680758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6509643|NCT00680758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6509644|NCT00680758|Tubulin Modulators|tubulin modulators|mesh-ancestor
6509645|NCT00680758|Antimitotic Agents|antimitotic agents|mesh-ancestor
6509646|NCT00680758|Mitosis Modulators|mitosis modulators|mesh-ancestor
6509647|NCT00680758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509648|NCT00680758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6509649|NCT00680758|Immunologic Factors|immunologic factors|mesh-ancestor
6509650|NCT00680758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509651|NCT00680940|Paclitaxel|paclitaxel|mesh-list
6509652|NCT00680940|Cisplatin|cisplatin|mesh-list
6509653|NCT00680940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6509654|NCT00680940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6509655|NCT00680940|Tubulin Modulators|tubulin modulators|mesh-ancestor
6509656|NCT00680940|Antimitotic Agents|antimitotic agents|mesh-ancestor
6509657|NCT00680940|Mitosis Modulators|mitosis modulators|mesh-ancestor
6509658|NCT00680940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509659|NCT00681005|Rabeprazole|rabeprazole|mesh-list
6509660|NCT00681005|Pantoprazole|pantoprazole|mesh-list
6509661|NCT00681005|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6509662|NCT00681005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6509663|NCT00681005|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6509664|NCT00681005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6509665|NCT00681005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509666|NCT00681135|Olaflur|olaflur|mesh-list
6509667|NCT00681135|Cariostatic Agents|cariostatic agents|mesh-ancestor
6509668|NCT00681135|Protective Agents|protective agents|mesh-ancestor
6509669|NCT00681135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509670|NCT00681148|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6509671|NCT00681148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6509672|NCT00681148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6509673|NCT00681148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509674|NCT00681148|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6509675|NCT00681148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6509676|NCT00681148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509677|NCT00681148|Cholinergic Agents|cholinergic agents|mesh-ancestor
6509678|NCT00681148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6509679|NCT00681174|Acetaminophen|acetaminophen|mesh-list
6509680|NCT00681174|Morphine|morphine|mesh-list
6509681|NCT00681174|Remifentanil|remifentanil|mesh-list
6509682|NCT00681174|Oxycodone|oxycodone|mesh-list
6509683|NCT00681174|Propofol|propofol|mesh-list
6509684|NCT00681174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6509685|NCT00681174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6509686|NCT00681174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509687|NCT00681174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6509688|NCT00681174|Anesthetics, General|anesthetics, general|mesh-ancestor
6509689|NCT00681174|Anesthetics|anesthetics|mesh-ancestor
6509690|NCT00681174|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6509691|NCT00681174|Narcotics|narcotics|mesh-ancestor
6509692|NCT00681174|Analgesics|analgesics|mesh-ancestor
6509693|NCT00681174|Sensory System Agents|sensory system agents|mesh-ancestor
6509694|NCT00681174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6509695|NCT00681174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6509696|NCT00681174|Antipyretics|antipyretics|mesh-ancestor
6509697|NCT00681213|Sirolimus|sirolimus|mesh-list
6509698|NCT00681213|Tacrolimus|tacrolimus|mesh-list
6509699|NCT00681213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6509700|NCT00681213|Immunologic Factors|immunologic factors|mesh-ancestor
5717192|NCT03235778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6509701|NCT00681213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509702|NCT00681213|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6509703|NCT00681213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6509704|NCT00681213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509705|NCT00681213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6509706|NCT00681213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6509707|NCT00681213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6509708|NCT00681213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6509709|NCT00681213|Antifungal Agents|antifungal agents|mesh-ancestor
6509710|NCT00681226|Ramipril|ramipril|mesh-list
6509711|NCT00681226|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6509712|NCT00681226|Protease Inhibitors|protease inhibitors|mesh-ancestor
6509713|NCT00681226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6509714|NCT00681226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509715|NCT00681226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6509716|NCT00681343|Alemtuzumab|alemtuzumab|mesh-list
6509717|NCT00681343|Thymoglobulin|thymoglobulin|mesh-list
6509718|NCT00681343|Daclizumab|daclizumab|mesh-list
6509719|NCT00681343|Immunologic Factors|immunologic factors|mesh-ancestor
6509720|NCT00681343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509721|NCT00681343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6509722|NCT00681343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6509723|NCT00681343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6509724|NCT00681395|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6509725|NCT00681395|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6509726|NCT00681395|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6509727|NCT00681395|Antimetabolites|antimetabolites|mesh-ancestor
6509728|NCT00681395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509729|NCT00681395|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6509730|NCT00681395|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6509731|NCT00681395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6509732|NCT00681460|Metformin|metformin|mesh-list
6509733|NCT00681460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6509734|NCT00681460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509735|NCT00681525|Atorvastatin|atorvastatin|mesh-list
6509736|NCT00681525|Ezetimibe|ezetimibe|mesh-list
6509737|NCT00681525|Fenofibric acid|fenofibric acid|mesh-list
6509738|NCT00681525|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6509739|NCT00681525|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6509740|NCT00681525|Antimetabolites|antimetabolites|mesh-ancestor
6509741|NCT00681525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509742|NCT00681525|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6509743|NCT00681525|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6509744|NCT00681525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6509745|NCT00681603|Bevacizumab|bevacizumab|mesh-list
6509746|NCT00681603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6509747|NCT00681603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6509748|NCT00681603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6679093|NCT01596556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679094|NCT01596556|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6679095|NCT01596556|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5717193|NCT03235232|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5717194|NCT03235232|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
6679096|NCT01596556|Cholinergic Agents|cholinergic agents|mesh-ancestor
6679097|NCT01596556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6679098|NCT01596556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679099|NCT01596634|Lactoferrin|lactoferrin|mesh-list
6679100|NCT01596634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6679101|NCT01596647|Diclofenac|diclofenac|mesh-list
6679102|NCT01596647|Midazolam|midazolam|mesh-list
6679103|NCT01596647|Caffeine|caffeine|mesh-list
6679104|NCT01596647|Omeprazole|omeprazole|mesh-list
5717195|NCT03235232|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5717196|NCT03235232|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5717197|NCT03235232|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5717198|NCT03235232|Adrenergic Agents|adrenergic agents|mesh-ancestor
5717199|NCT03235232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5717200|NCT03235232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717201|NCT03235232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717202|NCT03235232|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5717203|NCT03235232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5717204|NCT03235232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5717205|NCT03235245|Nivolumab|nivolumab|mesh-list
5717206|NCT03235245|Ipilimumab|ipilimumab|mesh-list
5717207|NCT03235245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6679105|NCT01596647|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6679106|NCT01596647|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6509749|NCT00681603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6509750|NCT00681603|Growth Substances|growth substances|mesh-ancestor
6509751|NCT00681603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509752|NCT00681603|Growth Inhibitors|growth inhibitors|mesh-ancestor
6679107|NCT01596647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6679108|NCT01596647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679109|NCT01596647|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6679110|NCT01596647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6679111|NCT01596647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6679112|NCT01596647|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6679113|NCT01596647|Anesthetics, General|anesthetics, general|mesh-ancestor
6679114|NCT01596647|Anesthetics|anesthetics|mesh-ancestor
6679115|NCT01596647|GABA Modulators|gaba modulators|mesh-ancestor
6679116|NCT01596647|GABA Agents|gaba agents|mesh-ancestor
6679117|NCT01596647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6679118|NCT01596647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679119|NCT01596647|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6679120|NCT01596647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6679121|NCT01596647|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6679122|NCT01596647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6679123|NCT01596647|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6679124|NCT01596647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6679125|NCT01596647|Analgesics|analgesics|mesh-ancestor
6679126|NCT01596647|Sensory System Agents|sensory system agents|mesh-ancestor
6679127|NCT01596647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6679128|NCT01596647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6679129|NCT01596647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6679130|NCT01596647|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6679131|NCT01596647|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6679132|NCT01596647|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6679133|NCT01596647|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6679134|NCT01596647|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6679135|NCT01596647|Purinergic Agents|purinergic agents|mesh-ancestor
6679136|NCT01596660|Bupivacaine|bupivacaine|mesh-list
6679137|NCT01596660|Anesthetics, Local|anesthetics, local|mesh-ancestor
6679138|NCT01596660|Anesthetics|anesthetics|mesh-ancestor
6679139|NCT01596660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6679140|NCT01596660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679141|NCT01596660|Sensory System Agents|sensory system agents|mesh-ancestor
6679142|NCT01596660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6679143|NCT01596673|Hydrocodone|hydrocodone|mesh-list
6679144|NCT01596673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6679145|NCT01596673|Narcotics|narcotics|mesh-ancestor
6679146|NCT01596673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6679147|NCT01596673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679148|NCT01596673|Analgesics|analgesics|mesh-ancestor
6679149|NCT01596673|Sensory System Agents|sensory system agents|mesh-ancestor
6679150|NCT01596673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6679151|NCT01596673|Antitussive Agents|antitussive agents|mesh-ancestor
6679152|NCT01596673|Respiratory System Agents|respiratory system agents|mesh-ancestor
6679153|NCT01596686|Picosulfate sodium|picosulfate sodium|mesh-list
6679154|NCT01596686|Cathartics|cathartics|mesh-ancestor
6679155|NCT01596686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6679156|NCT01596738|Tranexamic Acid|tranexamic acid|mesh-list
6679157|NCT01596738|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6679158|NCT01596738|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6679159|NCT01596738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679160|NCT01596738|Hemostatics|hemostatics|mesh-ancestor
6679161|NCT01596738|Coagulants|coagulants|mesh-ancestor
6679162|NCT01596764|Sulfasalazine|sulfasalazine|mesh-list
6679163|NCT01596764|Naloxone|naloxone|mesh-list
6679164|NCT01596764|Methylnaltrexone|methylnaltrexone|mesh-list
6679165|NCT01596764|Loperamide|loperamide|mesh-list
6679166|NCT01596764|Antidiarrheals|antidiarrheals|mesh-list
6679167|NCT01596764|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6679168|NCT01596764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679169|NCT01596764|Sensory System Agents|sensory system agents|mesh-ancestor
6679170|NCT01596764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6679171|NCT01596764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6679172|NCT01596764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6679173|NCT01596764|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6679174|NCT01596764|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6679175|NCT01596764|Analgesics|analgesics|mesh-ancestor
6679176|NCT01596764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6679177|NCT01596764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6679178|NCT01596777|Sulfasalazine|sulfasalazine|mesh-list
6679179|NCT01596777|Naltrexone|naltrexone|mesh-list
6509753|NCT00681720|Flumazenil|flumazenil|mesh-list
6509754|NCT00681720|Antidotes|antidotes|mesh-ancestor
6509755|NCT00681720|Protective Agents|protective agents|mesh-ancestor
6509756|NCT00681720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509757|NCT00681720|GABA Modulators|gaba modulators|mesh-ancestor
6509758|NCT00681720|GABA Agents|gaba agents|mesh-ancestor
6509759|NCT00681720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6509760|NCT00681720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509761|NCT00681733|Pioglitazone|pioglitazone|mesh-list
6509762|NCT00681733|Pentoxifylline|pentoxifylline|mesh-list
6509763|NCT00681733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6509764|NCT00681733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509765|NCT00681733|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6509766|NCT00681733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6509767|NCT00681733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509768|NCT00681733|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6509769|NCT00681733|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6509770|NCT00681733|Protective Agents|protective agents|mesh-ancestor
6509771|NCT00681733|Vasodilator Agents|vasodilator agents|mesh-ancestor
6509772|NCT00681733|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6509773|NCT00681733|Antioxidants|antioxidants|mesh-ancestor
6509774|NCT00681746|Flumazenil|flumazenil|mesh-list
6509775|NCT00681746|Antidotes|antidotes|mesh-ancestor
6509776|NCT00681746|Protective Agents|protective agents|mesh-ancestor
6509777|NCT00681746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509778|NCT00681746|GABA Modulators|gaba modulators|mesh-ancestor
6509779|NCT00681746|GABA Agents|gaba agents|mesh-ancestor
6509780|NCT00681746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6509781|NCT00681746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717208|NCT03235245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5717209|NCT03235245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5717210|NCT03235245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717211|NCT03235037|Levodopa|levodopa|mesh-list
5717212|NCT03235037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5717213|NCT03235037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5717214|NCT03235037|Dopamine Agents|dopamine agents|mesh-ancestor
5717215|NCT03235037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5717216|NCT03235037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717217|NCT03235037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717218|NCT03235141|Azithromycin|azithromycin|mesh-list
5717219|NCT03235141|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5717220|NCT03235141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5717221|NCT03235141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5717222|NCT03235141|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5717223|NCT03234816|Norepinephrine|norepinephrine|mesh-list
5717224|NCT03234816|Bupivacaine|bupivacaine|mesh-list
5717225|NCT03234816|Anesthetics, Local|anesthetics, local|mesh-ancestor
5717226|NCT03234816|Anesthetics|anesthetics|mesh-ancestor
5717227|NCT03234816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5717228|NCT03234816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717229|NCT03234816|Sensory System Agents|sensory system agents|mesh-ancestor
5717230|NCT03234816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6509782|NCT00681772|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6509783|NCT00681772|Vasodilator Agents|vasodilator agents|mesh-ancestor
6509784|NCT00681772|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6509785|NCT00681772|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6509786|NCT00681772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6509787|NCT00681772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509788|NCT00681772|Urological Agents|urological agents|mesh-ancestor
6509789|NCT00681785|Dalteparin|dalteparin|mesh-list
6509790|NCT00681785|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6509791|NCT00681785|Anticoagulants|anticoagulants|mesh-ancestor
6509792|NCT00681785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6509793|NCT00681785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6509794|NCT00681785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509795|NCT00681876|Bevacizumab|bevacizumab|mesh-list
6509796|NCT00681876|Cetuximab|cetuximab|mesh-list
6509797|NCT00681876|Irinotecan|irinotecan|mesh-list
6509798|NCT00681876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6509799|NCT00681876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6509800|NCT00681876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6509801|NCT00681876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5717231|NCT03234816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6509802|NCT00681876|Growth Substances|growth substances|mesh-ancestor
6509803|NCT00681876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509804|NCT00681876|Growth Inhibitors|growth inhibitors|mesh-ancestor
6509805|NCT00681876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6509806|NCT00681876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6509807|NCT00681876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6509808|NCT00681876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509809|NCT00681902|Lidocaine|lidocaine|mesh-list
6509810|NCT00681902|Anesthetics, Local|anesthetics, local|mesh-ancestor
6509811|NCT00681902|Anesthetics|anesthetics|mesh-ancestor
6509812|NCT00681902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6509813|NCT00681902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509814|NCT00681902|Sensory System Agents|sensory system agents|mesh-ancestor
6509815|NCT00681902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6509816|NCT00681902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6509817|NCT00681902|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6509818|NCT00681902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6509819|NCT00681902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6509820|NCT00681902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509821|NCT00681928|Letrozole|letrozole|mesh-list
6509822|NCT00681928|Anastrozole|anastrozole|mesh-list
5717232|NCT03234816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5717233|NCT03234816|Adrenergic Agents|adrenergic agents|mesh-ancestor
5717234|NCT03234816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5717235|NCT03234816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717236|NCT03234816|Sympathomimetics|sympathomimetics|mesh-ancestor
5717237|NCT03234816|Autonomic Agents|autonomic agents|mesh-ancestor
5717238|NCT03234816|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5717239|NCT03234751|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
5717240|NCT03234751|Natriuretic Agents|natriuretic agents|mesh-ancestor
5717241|NCT03234751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717242|NCT03234842|Paclitaxel|paclitaxel|mesh-list
5717243|NCT03234842|Carboplatin|carboplatin|mesh-list
5717244|NCT03234842|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5717245|NCT03234842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5717246|NCT03234842|Tubulin Modulators|tubulin modulators|mesh-ancestor
5717247|NCT03234842|Antimitotic Agents|antimitotic agents|mesh-ancestor
5717248|NCT03234842|Mitosis Modulators|mitosis modulators|mesh-ancestor
5717249|NCT03234842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717250|NCT03234673|Calcipotriene|calcipotriene|mesh-list
5717251|NCT03234673|Tacrolimus|tacrolimus|mesh-list
6509823|NCT00681928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6509824|NCT00681928|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6509825|NCT00681928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6509826|NCT00681928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6509827|NCT00681928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509828|NCT00681928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6509829|NCT00681928|Hormone Antagonists|hormone antagonists|mesh-ancestor
6509830|NCT00681928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6509831|NCT00681928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509832|NCT00681928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6509833|NCT00681941|Sevelamer|sevelamer|mesh-list
6509834|NCT00681941|Chelating Agents|chelating agents|mesh-ancestor
6509835|NCT00681941|Sequestering Agents|sequestering agents|mesh-ancestor
6509836|NCT00681941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509837|NCT00681967|Gefitinib|gefitinib|mesh-list
6509838|NCT00681967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6509839|NCT00681967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6509840|NCT00681967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6509841|NCT00681967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509842|NCT00681980|Valproic Acid|valproic acid|mesh-list
6509843|NCT00681980|Anticonvulsants|anticonvulsants|mesh-ancestor
6509844|NCT00681980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6679180|NCT01596777|Methylnaltrexone|methylnaltrexone|mesh-list
6679181|NCT01596777|Loperamide|loperamide|mesh-list
6679182|NCT01596777|Antidiarrheals|antidiarrheals|mesh-list
6679183|NCT01596777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6679184|NCT01596777|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6679185|NCT01596777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679186|NCT01596777|Sensory System Agents|sensory system agents|mesh-ancestor
6679187|NCT01596777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6679188|NCT01596777|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6679189|NCT01596777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6679190|NCT01596777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6679191|NCT01596777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6679192|NCT01596777|Analgesics|analgesics|mesh-ancestor
6679193|NCT01596777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5717252|NCT03234673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6509845|NCT00681980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509846|NCT00681980|GABA Agents|gaba agents|mesh-ancestor
6509847|NCT00681980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6509848|NCT00681980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509849|NCT00681980|Antimanic Agents|antimanic agents|mesh-ancestor
6509850|NCT00681980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6509851|NCT00681980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6509852|NCT00681980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6509853|NCT00681993|Cyclophosphamide|cyclophosphamide|mesh-list
6509854|NCT00681993|Carboplatin|carboplatin|mesh-list
6509855|NCT00681993|Docetaxel|docetaxel|mesh-list
6509856|NCT00681993|Trastuzumab|trastuzumab|mesh-list
6509857|NCT00681993|Doxorubicin|doxorubicin|mesh-list
6509858|NCT00681993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6509859|NCT00681993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6509860|NCT00681993|Immunologic Factors|immunologic factors|mesh-ancestor
6509861|NCT00681993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509862|NCT00681993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6509863|NCT00681993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6509864|NCT00681993|Alkylating Agents|alkylating agents|mesh-ancestor
6509865|NCT00681993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509866|NCT00681993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6509867|NCT00681993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6509868|NCT00681993|Tubulin Modulators|tubulin modulators|mesh-ancestor
6509869|NCT00681993|Antimitotic Agents|antimitotic agents|mesh-ancestor
6509870|NCT00681993|Mitosis Modulators|mitosis modulators|mesh-ancestor
6509871|NCT00681993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6509872|NCT00681993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6509873|NCT00681993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6509874|NCT00681993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6509875|NCT00681993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6509876|NCT00682006|Chlorhexidine|chlorhexidine|mesh-list
6509877|NCT00682006|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6509878|NCT00682006|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6509879|NCT00682006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6509880|NCT00682006|Disinfectants|disinfectants|mesh-ancestor
6509881|NCT00682006|Dermatologic Agents|dermatologic agents|mesh-ancestor
6509882|NCT00682019|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6509883|NCT00682019|Vasodilator Agents|vasodilator agents|mesh-ancestor
6509884|NCT00682019|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6509885|NCT00682019|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6509886|NCT00682019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6679194|NCT01596777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6679195|NCT01596803|Ascorbic Acid|ascorbic acid|mesh-list
6679196|NCT01596803|Vitamin E|vitamin e|mesh-list
6679197|NCT01596803|alpha-Tocopherol|alpha-tocopherol|mesh-list
6679198|NCT01596803|Tocopherols|tocopherols|mesh-list
6679199|NCT01596803|Antioxidants|antioxidants|mesh-list
6679200|NCT01596803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679201|NCT01596803|Protective Agents|protective agents|mesh-ancestor
6679202|NCT01596803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679203|NCT01596803|Vitamins|vitamins|mesh-ancestor
6679204|NCT01596803|Micronutrients|micronutrients|mesh-ancestor
6679205|NCT01596855|Epoetin Alfa|epoetin alfa|mesh-list
6679206|NCT01596855|Hematinics|hematinics|mesh-ancestor
6679207|NCT01596868|Gemcitabine|gemcitabine|mesh-list
6679208|NCT01596868|Cisplatin|cisplatin|mesh-list
6679209|NCT01596868|Docetaxel|docetaxel|mesh-list
6679210|NCT01596868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6679211|NCT01596868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6679212|NCT01596868|Antimetabolites|antimetabolites|mesh-ancestor
6679213|NCT01596868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679214|NCT01596868|Antiviral Agents|antiviral agents|mesh-ancestor
6679215|NCT01596868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6679216|NCT01596868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6509887|NCT00682019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509888|NCT00682019|Urological Agents|urological agents|mesh-ancestor
6509889|NCT00682136|Ropivacaine|ropivacaine|mesh-list
6509890|NCT00682136|Anesthetics, Local|anesthetics, local|mesh-ancestor
6509891|NCT00682136|Anesthetics|anesthetics|mesh-ancestor
6509892|NCT00682136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6509893|NCT00682136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509894|NCT00682136|Sensory System Agents|sensory system agents|mesh-ancestor
6509895|NCT00682136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6679217|NCT01596868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6679218|NCT01596868|Immunologic Factors|immunologic factors|mesh-ancestor
6509896|NCT00682149|Ascorbic Acid|ascorbic acid|mesh-list
6679219|NCT01596868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717253|NCT03234673|Immunologic Factors|immunologic factors|mesh-ancestor
5717254|NCT03234673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717255|NCT03234673|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5717256|NCT03234673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5717257|NCT03234673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717258|NCT03234673|Dermatologic Agents|dermatologic agents|mesh-ancestor
5717259|NCT03234517|Clindamycin|clindamycin|mesh-list
6509897|NCT00682149|Vitamins|vitamins|mesh-ancestor
6509898|NCT00682149|Micronutrients|micronutrients|mesh-ancestor
6509899|NCT00682149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509900|NCT00682149|Antioxidants|antioxidants|mesh-ancestor
6509901|NCT00682149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509902|NCT00682149|Protective Agents|protective agents|mesh-ancestor
6509903|NCT00682214|Vitamin D|vitamin d|mesh-list
6509904|NCT00682214|Cholecalciferol|cholecalciferol|mesh-list
6509905|NCT00682214|Vitamins|vitamins|mesh-ancestor
6509906|NCT00682214|Micronutrients|micronutrients|mesh-ancestor
6509907|NCT00682214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509908|NCT00682214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6509909|NCT00682214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6509910|NCT00682279|Topotecan|topotecan|mesh-list
6509911|NCT00682279|Lapatinib|lapatinib|mesh-list
6509912|NCT00682279|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6509913|NCT00682279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6509914|NCT00682279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6509915|NCT00682279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509916|NCT00682279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6509917|NCT00682279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6509918|NCT00682292|Thymoglobulin|thymoglobulin|mesh-list
6509919|NCT00682292|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6509920|NCT00682292|Daclizumab|daclizumab|mesh-list
6509921|NCT00682292|Immunologic Factors|immunologic factors|mesh-ancestor
6509922|NCT00682292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509923|NCT00682292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6509924|NCT00682318|Ethanol|ethanol|mesh-list
6509925|NCT00682318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6509926|NCT00682318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6509927|NCT00682318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6509928|NCT00682318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509929|NCT00682344|Levobupivacaine|levobupivacaine|mesh-list
6509930|NCT00682344|Anesthetics, Local|anesthetics, local|mesh-ancestor
6509931|NCT00682344|Anesthetics|anesthetics|mesh-ancestor
6509932|NCT00682344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6509933|NCT00682344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6509934|NCT00682344|Sensory System Agents|sensory system agents|mesh-ancestor
6509935|NCT00682344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6509936|NCT00682383|Docetaxel|docetaxel|mesh-list
6509937|NCT00682383|Etoposide|etoposide|mesh-list
6509938|NCT00682383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6509939|NCT00682383|Tubulin Modulators|tubulin modulators|mesh-ancestor
6509940|NCT00682383|Antimitotic Agents|antimitotic agents|mesh-ancestor
6509941|NCT00682383|Mitosis Modulators|mitosis modulators|mesh-ancestor
6509942|NCT00682383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509943|NCT00682383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6509944|NCT00682383|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5717260|NCT03234517|Clindamycin palmitate|clindamycin palmitate|mesh-list
6509945|NCT00682383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6509946|NCT00682383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6509947|NCT00682487|Hydrocortisone|hydrocortisone|mesh-list
6509948|NCT00682487|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6509949|NCT00682487|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6509950|NCT00682487|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6509951|NCT00682487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6509952|NCT00682500|Calfactant|calfactant|mesh-list
6509953|NCT00682500|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
6509954|NCT00682500|Respiratory System Agents|respiratory system agents|mesh-ancestor
6509955|NCT00682578|Artesunate|artesunate|mesh-list
6509956|NCT00682578|Chloroquine|chloroquine|mesh-list
6509957|NCT00682578|Pyrimethamine|pyrimethamine|mesh-list
6509958|NCT00682578|Piperaquine|piperaquine|mesh-list
6509959|NCT00682578|Artenimol|artenimol|mesh-list
6509960|NCT00682578|Antimalarials|antimalarials|mesh-ancestor
6509961|NCT00682578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6509962|NCT00682578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6509963|NCT00682578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6509964|NCT00682578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6509965|NCT00682578|Antiviral Agents|antiviral agents|mesh-ancestor
6509966|NCT00682578|Schistosomicides|schistosomicides|mesh-ancestor
6509967|NCT00682578|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6509968|NCT00682578|Anthelmintics|anthelmintics|mesh-ancestor
6509969|NCT00682578|Amebicides|amebicides|mesh-ancestor
6509970|NCT00682578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6509971|NCT00682578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6509972|NCT00682578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6509973|NCT00682578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6509974|NCT00682630|Artesunate|artesunate|mesh-list
6509975|NCT00682630|Pyronaridine|pyronaridine|mesh-list
6509976|NCT00682630|Antimalarials|antimalarials|mesh-ancestor
6509977|NCT00682630|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6509978|NCT00682630|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6509979|NCT00682630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6509980|NCT00682630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6509981|NCT00682630|Antiviral Agents|antiviral agents|mesh-ancestor
6509982|NCT00682630|Schistosomicides|schistosomicides|mesh-ancestor
6509983|NCT00682630|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6509984|NCT00682630|Anthelmintics|anthelmintics|mesh-ancestor
6509985|NCT00682656|Azithromycin|azithromycin|mesh-list
6509986|NCT00682656|Meglumine Antimoniate|meglumine antimoniate|mesh-list
6509987|NCT00682656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6509988|NCT00682656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6509989|NCT00682656|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5717261|NCT03234517|Clindamycin phosphate|clindamycin phosphate|mesh-list
5717262|NCT03234517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6509990|NCT00682656|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6509991|NCT00682721|Valacyclovir|valacyclovir|mesh-list
6509992|NCT00682721|Antiviral Agents|antiviral agents|mesh-ancestor
6509993|NCT00682721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6509994|NCT00682760|Botulinum Toxins|botulinum toxins|mesh-list
6509995|NCT00682760|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6509996|NCT00682760|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6509997|NCT00682760|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6509998|NCT00682760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6509999|NCT00682760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510000|NCT00682760|Cholinergic Agents|cholinergic agents|mesh-ancestor
6510001|NCT00682760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6510002|NCT00682760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510003|NCT00682760|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6510004|NCT00682760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6510005|NCT00682825|Anesthetics|anesthetics|mesh-list
6510006|NCT00682825|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
6510007|NCT00682825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6510008|NCT00682825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510009|NCT00682825|Anesthetics, General|anesthetics, general|mesh-ancestor
6510010|NCT00682955|Zinc|zinc|mesh-list
6510011|NCT00682955|Zinc Sulfate|zinc sulfate|mesh-list
6510012|NCT00682955|Trace Elements|trace elements|mesh-ancestor
6510013|NCT00682955|Micronutrients|micronutrients|mesh-ancestor
6510014|NCT00682955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510015|NCT00682955|Astringents|astringents|mesh-ancestor
6510016|NCT00682955|Dermatologic Agents|dermatologic agents|mesh-ancestor
6510017|NCT00683059|Paclitaxel|paclitaxel|mesh-list
6510018|NCT00683059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6510019|NCT00683059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6510020|NCT00683059|Tubulin Modulators|tubulin modulators|mesh-ancestor
6510021|NCT00683059|Antimitotic Agents|antimitotic agents|mesh-ancestor
6510022|NCT00683059|Mitosis Modulators|mitosis modulators|mesh-ancestor
6510023|NCT00683059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510024|NCT00683111|Esomeprazole|esomeprazole|mesh-list
6510025|NCT00683111|Famotidine|famotidine|mesh-list
6510026|NCT00683111|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6510027|NCT00683111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6510028|NCT00683111|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6510029|NCT00683111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6510030|NCT00683111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510031|NCT00683111|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6510032|NCT00683111|Histamine Antagonists|histamine antagonists|mesh-ancestor
6510033|NCT00683111|Histamine Agents|histamine agents|mesh-ancestor
6510034|NCT00683111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6510035|NCT00683111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510036|NCT00683124|Losartan|losartan|mesh-list
6510037|NCT00683124|Nebivolol|nebivolol|mesh-list
6510038|NCT00683124|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6510039|NCT00683124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6510040|NCT00683124|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6510041|NCT00683124|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6679220|NCT01596868|Tubulin Modulators|tubulin modulators|mesh-ancestor
5717263|NCT03234517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5717264|NCT03234517|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5717265|NCT03234517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6510042|NCT00683124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510043|NCT00683124|Vasodilator Agents|vasodilator agents|mesh-ancestor
6510044|NCT00683124|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6510045|NCT00683124|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6510046|NCT00683124|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6510047|NCT00683124|Adrenergic Agents|adrenergic agents|mesh-ancestor
6510048|NCT00683124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6510049|NCT00683124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510050|NCT00683137|Valdecoxib|valdecoxib|mesh-list
6510051|NCT00683137|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6510052|NCT00683137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6510053|NCT00683137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6510054|NCT00683137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510055|NCT00683137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6510056|NCT00683137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6510057|NCT00683137|Analgesics|analgesics|mesh-ancestor
6510058|NCT00683137|Sensory System Agents|sensory system agents|mesh-ancestor
6510059|NCT00683137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6510060|NCT00683137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510061|NCT00683137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6510062|NCT00683137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6510063|NCT00683176|Choline|choline|mesh-list
6510064|NCT00683176|Fenofibrate|fenofibrate|mesh-list
6679221|NCT01596868|Antimitotic Agents|antimitotic agents|mesh-ancestor
6510065|NCT00683176|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6510066|NCT00683176|Antimetabolites|antimetabolites|mesh-ancestor
6510067|NCT00683176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510068|NCT00683176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6510069|NCT00683176|Lipotropic Agents|lipotropic agents|mesh-ancestor
6510070|NCT00683176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6510071|NCT00683176|Nootropic Agents|nootropic agents|mesh-ancestor
6510072|NCT00683189|Warfarin|warfarin|mesh-list
6510073|NCT00683189|Anticoagulants|anticoagulants|mesh-ancestor
6510074|NCT00683202|Aspirin|aspirin|mesh-list
6510075|NCT00683202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6510076|NCT00683202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6510077|NCT00683202|Analgesics|analgesics|mesh-ancestor
6510078|NCT00683202|Sensory System Agents|sensory system agents|mesh-ancestor
6510079|NCT00683202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6510080|NCT00683202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510081|NCT00683202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6510082|NCT00683202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6510083|NCT00683202|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6510084|NCT00683202|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6510085|NCT00683202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510086|NCT00683202|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6510087|NCT00683202|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6510088|NCT00683202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6510089|NCT00683202|Antipyretics|antipyretics|mesh-ancestor
6510090|NCT00683267|Capsaicin|capsaicin|mesh-list
6510091|NCT00683267|Antipruritics|antipruritics|mesh-ancestor
6510092|NCT00683267|Dermatologic Agents|dermatologic agents|mesh-ancestor
6510093|NCT00683267|Sensory System Agents|sensory system agents|mesh-ancestor
6510094|NCT00683267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6510095|NCT00683267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717266|NCT03234517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717267|NCT03234491|Insulin|insulin|mesh-list
5717268|NCT03234491|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5717269|NCT03234491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5717270|NCT03234491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717271|NCT03234244|Cholecalciferol|cholecalciferol|mesh-list
5717272|NCT03234244|Bazedoxifene|bazedoxifene|mesh-list
5717273|NCT03234244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5717274|NCT03234244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510096|NCT00683306|Gefitinib|gefitinib|mesh-list
6510097|NCT00683306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6510098|NCT00683306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6510099|NCT00683306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6510100|NCT00683306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510101|NCT00683319|Cyclophosphamide|cyclophosphamide|mesh-list
6679222|NCT01596868|Mitosis Modulators|mitosis modulators|mesh-ancestor
6510102|NCT00683319|Carboplatin|carboplatin|mesh-list
6510103|NCT00683319|Methotrexate|methotrexate|mesh-list
6510104|NCT00683319|Vincristine|vincristine|mesh-list
6510105|NCT00683319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6510106|NCT00683319|Immunologic Factors|immunologic factors|mesh-ancestor
6510107|NCT00683319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510108|NCT00683319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6510109|NCT00683319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6510110|NCT00683319|Alkylating Agents|alkylating agents|mesh-ancestor
6510111|NCT00683319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510112|NCT00683319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6510113|NCT00683319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6510114|NCT00683319|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6510115|NCT00683319|Abortifacient Agents|abortifacient agents|mesh-ancestor
6510116|NCT00683319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6510117|NCT00683319|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6510118|NCT00683319|Antimetabolites|antimetabolites|mesh-ancestor
6510119|NCT00683319|Dermatologic Agents|dermatologic agents|mesh-ancestor
6510120|NCT00683319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6510121|NCT00683319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6510122|NCT00683319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5717275|NCT03234244|Vitamins|vitamins|mesh-ancestor
5717276|NCT03234244|Micronutrients|micronutrients|mesh-ancestor
5717277|NCT03234244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5717278|NCT03234244|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5717279|NCT03234244|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5717280|NCT03234244|Hormone Antagonists|hormone antagonists|mesh-ancestor
5717281|NCT03234244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5717282|NCT03234699|Midazolam|midazolam|mesh-list
5717283|NCT03234699|Cenobamate|cenobamate|mesh-list
5717284|NCT03234699|Bupropion|bupropion|mesh-list
5717285|NCT03234699|Omeprazole|omeprazole|mesh-list
5717286|NCT03234699|Warfarin|warfarin|mesh-list
5717287|NCT03234699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5717288|NCT03234699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5717289|NCT03234699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5717290|NCT03234699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679223|NCT01596894|Azithromycin|azithromycin|mesh-list
6679224|NCT01596894|Metronidazole|metronidazole|mesh-list
6679225|NCT01596894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6510123|NCT00683319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6510124|NCT00683319|Tubulin Modulators|tubulin modulators|mesh-ancestor
6510125|NCT00683319|Antimitotic Agents|antimitotic agents|mesh-ancestor
6510126|NCT00683319|Mitosis Modulators|mitosis modulators|mesh-ancestor
6510127|NCT00683345|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6510128|NCT00683345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6679226|NCT01596894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6679227|NCT01596894|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6679228|NCT01596894|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6679229|NCT01596907|Ephedrine|ephedrine|mesh-list
6679230|NCT01596907|Pseudoephedrine|pseudoephedrine|mesh-list
6679231|NCT01596907|Caffeine|caffeine|mesh-list
6679232|NCT01596907|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6679233|NCT01596907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679234|NCT01596907|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6679235|NCT01596907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6679236|NCT01596907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679237|NCT01596907|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6679238|NCT01596907|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6679239|NCT01596907|Purinergic Agents|purinergic agents|mesh-ancestor
6679240|NCT01596907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6679241|NCT01596907|Sympathomimetics|sympathomimetics|mesh-ancestor
6679242|NCT01596907|Autonomic Agents|autonomic agents|mesh-ancestor
6679243|NCT01596907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6679244|NCT01596907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6679245|NCT01596907|Adrenergic Agents|adrenergic agents|mesh-ancestor
6679246|NCT01596907|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6679247|NCT01596907|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6679248|NCT01596907|Respiratory System Agents|respiratory system agents|mesh-ancestor
6679249|NCT01596907|Nasal Decongestants|nasal decongestants|mesh-ancestor
6679250|NCT01596998|Epinephrine|epinephrine|mesh-list
6679251|NCT01596998|Racepinephrine|racepinephrine|mesh-list
6679252|NCT01596998|Levobupivacaine|levobupivacaine|mesh-list
6679253|NCT01596998|Epinephryl borate|epinephryl borate|mesh-list
6679254|NCT01596998|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5717291|NCT03234699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5717292|NCT03234699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6510129|NCT00683436|Adipiplon|adipiplon|mesh-list
6510130|NCT00683436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6510131|NCT00683436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510132|NCT00683436|GABA Agonists|gaba agonists|mesh-ancestor
6510133|NCT00683436|GABA Agents|gaba agents|mesh-ancestor
6510134|NCT00683436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6510135|NCT00683436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510136|NCT00683436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6510137|NCT00683436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6510138|NCT00683436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6510139|NCT00683514|Cisplatin|cisplatin|mesh-list
6510140|NCT00683514|Vinorelbine|vinorelbine|mesh-list
6510141|NCT00683514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6510142|NCT00683514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6510143|NCT00683514|Tubulin Modulators|tubulin modulators|mesh-ancestor
6510144|NCT00683514|Antimitotic Agents|antimitotic agents|mesh-ancestor
6510145|NCT00683514|Mitosis Modulators|mitosis modulators|mesh-ancestor
6510146|NCT00683514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510147|NCT00683670|Cyclophosphamide|cyclophosphamide|mesh-list
6510148|NCT00683670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6510149|NCT00683670|Immunologic Factors|immunologic factors|mesh-ancestor
6510150|NCT00683670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510151|NCT00683670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6510152|NCT00683670|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6510153|NCT00683670|Alkylating Agents|alkylating agents|mesh-ancestor
6510154|NCT00683670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510155|NCT00683670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6510156|NCT00683670|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6510157|NCT00683735|Metformin|metformin|mesh-list
6510158|NCT00683735|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6510159|NCT00683735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6510160|NCT00683735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510161|NCT00683735|Incretins|incretins|mesh-ancestor
6510162|NCT00683735|Hormones|hormones|mesh-ancestor
6510163|NCT00683735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6510164|NCT00683735|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6510165|NCT00683735|Protease Inhibitors|protease inhibitors|mesh-ancestor
6510166|NCT00683735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6679255|NCT01596998|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6679256|NCT01596998|Adrenergic Agents|adrenergic agents|mesh-ancestor
6679257|NCT01596998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6679258|NCT01596998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679259|NCT01596998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679260|NCT01596998|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6679261|NCT01596998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6679262|NCT01596998|Autonomic Agents|autonomic agents|mesh-ancestor
6679263|NCT01596998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6679264|NCT01596998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6679265|NCT01596998|Respiratory System Agents|respiratory system agents|mesh-ancestor
6679266|NCT01596998|Mydriatics|mydriatics|mesh-ancestor
6679267|NCT01596998|Sympathomimetics|sympathomimetics|mesh-ancestor
6679268|NCT01596998|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6679269|NCT01596998|Anesthetics, Local|anesthetics, local|mesh-ancestor
6679270|NCT01596998|Anesthetics|anesthetics|mesh-ancestor
6679271|NCT01596998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6679272|NCT01596998|Sensory System Agents|sensory system agents|mesh-ancestor
6679273|NCT01597011|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6679274|NCT01597011|Hemostatics|hemostatics|mesh-ancestor
6679275|NCT01597011|Coagulants|coagulants|mesh-ancestor
6510167|NCT00683735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510168|NCT00683865|Moxifloxacin|moxifloxacin|mesh-list
6510169|NCT00683865|Ofloxacin|ofloxacin|mesh-list
6510170|NCT00683865|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6510171|NCT00683865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6510172|NCT00683865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6510173|NCT00683865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6510174|NCT00683865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6510175|NCT00683865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6510176|NCT00683865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510177|NCT00683865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6510178|NCT00683865|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6679276|NCT01597167|Magnesium Sulfate|magnesium sulfate|mesh-list
6679277|NCT01597167|Analgesics|analgesics|mesh-ancestor
6679278|NCT01597167|Sensory System Agents|sensory system agents|mesh-ancestor
6679279|NCT01597167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6510179|NCT00683865|Contraceptive Agents|contraceptive agents|mesh-ancestor
6510180|NCT00683865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6510181|NCT00683865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510182|NCT00683865|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6510183|NCT00683865|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6510184|NCT00683865|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6510185|NCT00683865|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6510186|NCT00683865|Renal Agents|renal agents|mesh-ancestor
6510187|NCT00683865|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6510188|NCT00683865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6510189|NCT00683891|Clozapine|clozapine|mesh-list
6510190|NCT00683891|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6510191|NCT00683891|Serotonin Agents|serotonin agents|mesh-ancestor
6510192|NCT00683891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6510193|NCT00683891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510194|NCT00683891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510195|NCT00683891|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6510196|NCT00683891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6510197|NCT00683891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6510198|NCT00683891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6510199|NCT00683891|GABA Antagonists|gaba antagonists|mesh-ancestor
6510200|NCT00683891|GABA Agents|gaba agents|mesh-ancestor
6510201|NCT00683943|Lithium Carbonate|lithium carbonate|mesh-list
6510202|NCT00683943|Antidepressive Agents|antidepressive agents|mesh-ancestor
6510203|NCT00683943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6510204|NCT00683943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6510205|NCT00683943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510206|NCT00683943|Antimanic Agents|antimanic agents|mesh-ancestor
6510207|NCT00683943|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6510208|NCT00683943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6510209|NCT00683943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510210|NCT00683956|Propofol|propofol|mesh-list
6510211|NCT00683956|Anesthetics|anesthetics|mesh-ancestor
6510212|NCT00683956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6510213|NCT00683956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510214|NCT00683956|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6679280|NCT01597167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679281|NCT01597167|Anesthetics|anesthetics|mesh-ancestor
6679282|NCT01597167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6679283|NCT01597167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6679284|NCT01597167|Anticonvulsants|anticonvulsants|mesh-ancestor
6679285|NCT01597167|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6679286|NCT01597167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6679287|NCT01597167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679288|NCT01597167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6679289|NCT01597167|Tocolytic Agents|tocolytic agents|mesh-ancestor
6679290|NCT01597167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5717293|NCT03234699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5717294|NCT03234699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5717295|NCT03234699|Anesthetics, General|anesthetics, general|mesh-ancestor
5717296|NCT03234699|Anesthetics|anesthetics|mesh-ancestor
5717297|NCT03234699|GABA Modulators|gaba modulators|mesh-ancestor
5717298|NCT03234699|GABA Agents|gaba agents|mesh-ancestor
5717299|NCT03234699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5717300|NCT03234699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717301|NCT03234699|Anticoagulants|anticoagulants|mesh-ancestor
5717302|NCT03234699|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5717303|NCT03234699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5717304|NCT03234699|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5717305|NCT03234699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5717306|NCT03234699|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5717307|NCT03234699|Antidepressive Agents|antidepressive agents|mesh-ancestor
5717308|NCT03234699|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5717309|NCT03234699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5717310|NCT03234699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5717311|NCT03234699|Dopamine Agents|dopamine agents|mesh-ancestor
5717312|NCT03234699|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5722048|NCT03201627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6679291|NCT01597206|Cobalt|cobalt|mesh-list
6510215|NCT00683956|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6510216|NCT00683956|Anesthetics, General|anesthetics, general|mesh-ancestor
6510217|NCT00683969|Mycophenolic Acid|mycophenolic acid|mesh-list
6510218|NCT00683969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6510219|NCT00683969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6510220|NCT00683969|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6510221|NCT00683969|Antitubercular Agents|antitubercular agents|mesh-ancestor
6510222|NCT00683969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6510223|NCT00683969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6510224|NCT00683969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6510225|NCT00683969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510226|NCT00683982|Nitazoxanide|nitazoxanide|mesh-list
6510227|NCT00683982|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6510228|NCT00683982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6510229|NCT00683995|Fentanyl|fentanyl|mesh-list
6510230|NCT00683995|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6510231|NCT00683995|Narcotics|narcotics|mesh-ancestor
6510232|NCT00683995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6510233|NCT00683995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510234|NCT00683995|Analgesics|analgesics|mesh-ancestor
6510235|NCT00683995|Sensory System Agents|sensory system agents|mesh-ancestor
6510236|NCT00683995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6510237|NCT00683995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6510238|NCT00683995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6510239|NCT00683995|Anesthetics, General|anesthetics, general|mesh-ancestor
6510240|NCT00683995|Anesthetics|anesthetics|mesh-ancestor
6510241|NCT00684099|Docetaxel|docetaxel|mesh-list
6510242|NCT00684099|Pemetrexed|pemetrexed|mesh-list
6510243|NCT00684099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6510244|NCT00684099|Tubulin Modulators|tubulin modulators|mesh-ancestor
6510245|NCT00684099|Antimitotic Agents|antimitotic agents|mesh-ancestor
6510246|NCT00684099|Mitosis Modulators|mitosis modulators|mesh-ancestor
6510247|NCT00684099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510248|NCT00684099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6510249|NCT00684099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6510250|NCT00684099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6510251|NCT00684112|Gabapentin|gabapentin|mesh-list
6242640|NCT02653872|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6242641|NCT02654054|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6242642|NCT02654054|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6242643|NCT02654054|Norethindrone|norethindrone|mesh-list
6242644|NCT02654054|Norethindrone Acetate|norethindrone acetate|mesh-list
6510252|NCT00684112|Analgesics|analgesics|mesh-ancestor
6510253|NCT00684112|Sensory System Agents|sensory system agents|mesh-ancestor
6510254|NCT00684112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6510255|NCT00684112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510256|NCT00684112|Anticonvulsants|anticonvulsants|mesh-ancestor
6510257|NCT00684112|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6510258|NCT00684112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6510259|NCT00684112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6510260|NCT00684112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6510261|NCT00684112|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6510262|NCT00684112|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6510263|NCT00684112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6510264|NCT00684112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510265|NCT00684112|Antimanic Agents|antimanic agents|mesh-ancestor
6510266|NCT00684164|Conivaptan|conivaptan|mesh-list
6510267|NCT00684164|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6510268|NCT00684164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722049|NCT03201627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6510269|NCT00684164|Natriuretic Agents|natriuretic agents|mesh-ancestor
6510270|NCT00684164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510271|NCT00684190|Esomeprazole|esomeprazole|mesh-list
6510272|NCT00684190|Lesogaberan|lesogaberan|mesh-list
6510273|NCT00684190|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6510274|NCT00684190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6510275|NCT00684190|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6510276|NCT00684190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6510277|NCT00684190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510278|NCT00684190|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6510279|NCT00684190|GABA Agonists|gaba agonists|mesh-ancestor
6510280|NCT00684190|GABA Agents|gaba agents|mesh-ancestor
6510281|NCT00684190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6510282|NCT00684190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510283|NCT00684216|Tamoxifen|tamoxifen|mesh-list
6510284|NCT00684216|Capecitabine|capecitabine|mesh-list
6510285|NCT00684216|Letrozole|letrozole|mesh-list
6510286|NCT00684216|Anastrozole|anastrozole|mesh-list
6510287|NCT00684216|Exemestane|exemestane|mesh-list
6242645|NCT02654054|Estradiol|estradiol|mesh-list
6242646|NCT02654054|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6242647|NCT02654054|Estrogens|estrogens|mesh-ancestor
6242648|NCT02654054|Hormones|hormones|mesh-ancestor
6510288|NCT00684216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6510289|NCT00684216|Antimetabolites|antimetabolites|mesh-ancestor
6510290|NCT00684216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510291|NCT00684216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6510292|NCT00684216|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6510293|NCT00684216|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6510294|NCT00684216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6510295|NCT00684216|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6510296|NCT00684216|Hormone Antagonists|hormone antagonists|mesh-ancestor
5717313|NCT03234699|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5717314|NCT03234699|Anticonvulsants|anticonvulsants|mesh-ancestor
5717315|NCT03234400|Dapivirine|dapivirine|mesh-list
6510297|NCT00684216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6510298|NCT00684216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510299|NCT00684216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6510300|NCT00684216|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6510301|NCT00684216|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6510302|NCT00684216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6510303|NCT00684229|Anesthetics|anesthetics|mesh-list
6510304|NCT00684229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6510305|NCT00684229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510306|NCT00684268|Silybin|silybin|mesh-list
6510307|NCT00684268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6510308|NCT00684268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6510309|NCT00684268|Protective Agents|protective agents|mesh-ancestor
6510310|NCT00684268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510311|NCT00684346|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6510312|NCT00684346|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6510313|NCT00684346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510314|NCT00684372|Leflunomide|leflunomide|mesh-list
6510315|NCT00684372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6510316|NCT00684372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510317|NCT00684372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6510318|NCT00684372|Immunologic Factors|immunologic factors|mesh-ancestor
6510319|NCT00684372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510320|NCT00684385|Gefitinib|gefitinib|mesh-list
6510321|NCT00684385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6510322|NCT00684385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6510323|NCT00684385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6510324|NCT00684385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510325|NCT00684450|Protamines|protamines|mesh-list
6510326|NCT00684450|Heparin Antagonists|heparin antagonists|mesh-ancestor
6510327|NCT00684450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510328|NCT00684450|Coagulants|coagulants|mesh-ancestor
6510329|NCT00684463|Palonosetron|palonosetron|mesh-list
6510330|NCT00684463|Antiemetics|antiemetics|mesh-ancestor
6510331|NCT00684463|Autonomic Agents|autonomic agents|mesh-ancestor
6510332|NCT00684463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6510333|NCT00684463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510334|NCT00684463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6510335|NCT00684463|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6510336|NCT00684463|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6510337|NCT00684463|Serotonin Agents|serotonin agents|mesh-ancestor
6510338|NCT00684463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6510339|NCT00684463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510340|NCT00684489|Antihypertensive Agents|antihypertensive agents|mesh-list
6510341|NCT00684489|Coal Tar|coal tar|mesh-list
6510342|NCT00684489|Keratolytic Agents|keratolytic agents|mesh-ancestor
6510343|NCT00684489|Dermatologic Agents|dermatologic agents|mesh-ancestor
6510344|NCT00684528|Metformin|metformin|mesh-list
6510345|NCT00684528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5717316|NCT03234400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5717317|NCT03234400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5717318|NCT03234400|Antiviral Agents|antiviral agents|mesh-ancestor
5717319|NCT03234400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5717320|NCT03234413|Botulinum Toxins|botulinum toxins|mesh-list
5717321|NCT03234413|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5717322|NCT03234413|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5717323|NCT03234413|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5717324|NCT03234413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6510346|NCT00684528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510347|NCT00684606|Oxytocin|oxytocin|mesh-list
6510348|NCT00684606|Oxytocics|oxytocics|mesh-ancestor
5717325|NCT03234413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510349|NCT00684606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6510350|NCT00684606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510351|NCT00684632|Fentanyl|fentanyl|mesh-list
6510352|NCT00684632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6510353|NCT00684632|Narcotics|narcotics|mesh-ancestor
6510354|NCT00684632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6510355|NCT00684632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510356|NCT00684632|Analgesics|analgesics|mesh-ancestor
6510357|NCT00684632|Sensory System Agents|sensory system agents|mesh-ancestor
6510358|NCT00684632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6510359|NCT00684632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6510360|NCT00684632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6510361|NCT00684632|Anesthetics, General|anesthetics, general|mesh-ancestor
6510362|NCT00684632|Anesthetics|anesthetics|mesh-ancestor
6510363|NCT00684827|Albuterol|albuterol|mesh-list
6510364|NCT00684827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6510365|NCT00684827|Autonomic Agents|autonomic agents|mesh-ancestor
6510366|NCT00684827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6510367|NCT00684827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510368|NCT00684827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6510369|NCT00684827|Respiratory System Agents|respiratory system agents|mesh-ancestor
6510370|NCT00684827|Tocolytic Agents|tocolytic agents|mesh-ancestor
6510371|NCT00684827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6510372|NCT00684827|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6510373|NCT00684827|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6510374|NCT00684827|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6510375|NCT00684827|Adrenergic Agents|adrenergic agents|mesh-ancestor
6510376|NCT00684827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6510377|NCT00684827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510378|NCT00684853|Bevacizumab|bevacizumab|mesh-list
6510379|NCT00684853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5717326|NCT03234413|Cholinergic Agents|cholinergic agents|mesh-ancestor
5717327|NCT03234413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5717328|NCT03234413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717329|NCT03234413|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6510380|NCT00684853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6510381|NCT00684853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6510382|NCT00684853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6510383|NCT00684853|Growth Substances|growth substances|mesh-ancestor
6510384|NCT00684853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510385|NCT00684853|Growth Inhibitors|growth inhibitors|mesh-ancestor
6510386|NCT00684866|Albuterol|albuterol|mesh-list
6510387|NCT00684866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6510388|NCT00684866|Autonomic Agents|autonomic agents|mesh-ancestor
6510389|NCT00684866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6510390|NCT00684866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510391|NCT00684866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6510392|NCT00684866|Respiratory System Agents|respiratory system agents|mesh-ancestor
6510393|NCT00684866|Tocolytic Agents|tocolytic agents|mesh-ancestor
6510394|NCT00684866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6510395|NCT00684866|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6510396|NCT00684866|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6510397|NCT00684866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6679292|NCT01597206|Trace Elements|trace elements|mesh-ancestor
6679293|NCT01597206|Micronutrients|micronutrients|mesh-ancestor
6679294|NCT01597206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779796|NCT02181101|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6510398|NCT00684866|Adrenergic Agents|adrenergic agents|mesh-ancestor
6510399|NCT00684866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6510400|NCT00684866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510401|NCT00684905|Leuprolide|leuprolide|mesh-list
6510402|NCT00684905|Bicalutamide|bicalutamide|mesh-list
6510403|NCT00684905|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6510404|NCT00684905|Fertility Agents|fertility agents|mesh-ancestor
6510405|NCT00684905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6510406|NCT00684905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510407|NCT00684905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6510408|NCT00684905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6510409|NCT00684905|Androgen Antagonists|androgen antagonists|mesh-ancestor
6510410|NCT00684905|Hormone Antagonists|hormone antagonists|mesh-ancestor
6510411|NCT00684905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6779797|NCT02181101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510412|NCT00684957|Hormones|hormones|mesh-list
6779798|NCT02181205|Bupivacaine|bupivacaine|mesh-list
6779799|NCT02181205|Anesthetics, Local|anesthetics, local|mesh-ancestor
6510413|NCT00684957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6510414|NCT00684957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510415|NCT00685009|Hormones|hormones|mesh-list
6510416|NCT00685009|Progesterone|progesterone|mesh-list
6510417|NCT00685009|Estrogens|estrogens|mesh-list
6510418|NCT00685009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6510419|NCT00685009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510420|NCT00685009|Progestins|progestins|mesh-ancestor
6510421|NCT00685022|Albuterol|albuterol|mesh-list
6510422|NCT00685022|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6510423|NCT00685022|Autonomic Agents|autonomic agents|mesh-ancestor
5717330|NCT03234413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5717331|NCT03234660|Dexmedetomidine|dexmedetomidine|mesh-list
6510424|NCT00685022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6510425|NCT00685022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510426|NCT00685022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6510427|NCT00685022|Respiratory System Agents|respiratory system agents|mesh-ancestor
6510428|NCT00685022|Tocolytic Agents|tocolytic agents|mesh-ancestor
6510429|NCT00685022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6510430|NCT00685022|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6510431|NCT00685022|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6510432|NCT00685022|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6510433|NCT00685022|Adrenergic Agents|adrenergic agents|mesh-ancestor
6510434|NCT00685022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6510435|NCT00685022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510436|NCT00685061|Alemtuzumab|alemtuzumab|mesh-list
6510437|NCT00685061|Thymoglobulin|thymoglobulin|mesh-list
6510438|NCT00685061|Daclizumab|daclizumab|mesh-list
6510439|NCT00685061|Immunologic Factors|immunologic factors|mesh-ancestor
6510440|NCT00685061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510441|NCT00685061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6510442|NCT00685061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6510443|NCT00685061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6510444|NCT00685100|Triamcinolone|triamcinolone|mesh-list
6510445|NCT00685100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6510446|NCT00685100|Glucocorticoids|glucocorticoids|mesh-ancestor
6510447|NCT00685100|Hormones|hormones|mesh-ancestor
6510448|NCT00685100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6510449|NCT00685100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510450|NCT00685126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6510451|NCT00685126|Albuterol|albuterol|mesh-list
6510452|NCT00685126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6510453|NCT00685126|Autonomic Agents|autonomic agents|mesh-ancestor
6510454|NCT00685126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6510455|NCT00685126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510456|NCT00685126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6510457|NCT00685126|Respiratory System Agents|respiratory system agents|mesh-ancestor
6510458|NCT00685126|Tocolytic Agents|tocolytic agents|mesh-ancestor
6510459|NCT00685126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6510460|NCT00685126|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6510461|NCT00685126|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6510462|NCT00685126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6510463|NCT00685126|Adrenergic Agents|adrenergic agents|mesh-ancestor
6510464|NCT00685126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6510465|NCT00685126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510466|NCT00685191|Raltegravir Potassium|raltegravir potassium|mesh-list
6510467|NCT00685191|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6510468|NCT00685191|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6510469|NCT00685191|Antiviral Agents|antiviral agents|mesh-ancestor
6510470|NCT00685191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6510471|NCT00685191|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6510472|NCT00685191|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6510473|NCT00685191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6510474|NCT00685191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510475|NCT00685230|Antivenins|antivenins|mesh-list
6510476|NCT00685230|Immunologic Factors|immunologic factors|mesh-ancestor
6510477|NCT00685230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510478|NCT00685269|Eszopiclone|eszopiclone|mesh-list
6510479|NCT00685269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6510480|NCT00685269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6510481|NCT00685269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510482|NCT00685347|Albuterol|albuterol|mesh-list
6510483|NCT00685347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6510484|NCT00685347|Autonomic Agents|autonomic agents|mesh-ancestor
6510485|NCT00685347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6510486|NCT00685347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510487|NCT00685347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6510488|NCT00685347|Respiratory System Agents|respiratory system agents|mesh-ancestor
6510489|NCT00685347|Tocolytic Agents|tocolytic agents|mesh-ancestor
6510490|NCT00685347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6510491|NCT00685347|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6510492|NCT00685347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6510493|NCT00685347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6510494|NCT00685347|Adrenergic Agents|adrenergic agents|mesh-ancestor
6510495|NCT00685347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6510496|NCT00685347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510497|NCT00685425|Albuterol|albuterol|mesh-list
6510498|NCT00685425|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6510499|NCT00685425|Autonomic Agents|autonomic agents|mesh-ancestor
6510500|NCT00685425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6510501|NCT00685425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510502|NCT00685425|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6510503|NCT00685425|Respiratory System Agents|respiratory system agents|mesh-ancestor
6510504|NCT00685425|Tocolytic Agents|tocolytic agents|mesh-ancestor
6510505|NCT00685425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6510506|NCT00685425|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6510507|NCT00685425|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6510508|NCT00685425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6510509|NCT00685425|Adrenergic Agents|adrenergic agents|mesh-ancestor
6510510|NCT00685425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6510511|NCT00685425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510512|NCT00685464|Abciximab|abciximab|mesh-list
6510513|NCT00685464|Anticoagulants|anticoagulants|mesh-ancestor
6510514|NCT00685464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6510515|NCT00685503|Ranibizumab|ranibizumab|mesh-list
6510516|NCT00685503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6510517|NCT00685503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6510518|NCT00685503|Growth Substances|growth substances|mesh-ancestor
6510519|NCT00685503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510520|NCT00685503|Growth Inhibitors|growth inhibitors|mesh-ancestor
6510521|NCT00685503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6679295|NCT01597297|4-Aminopyridine|4-aminopyridine|mesh-list
6679296|NCT01597297|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6679297|NCT01597297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6679298|NCT01597297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679299|NCT01597310|Pramipexole|pramipexole|mesh-list
6679300|NCT01597310|Warfarin|warfarin|mesh-list
6679301|NCT01597310|Anticoagulants|anticoagulants|mesh-ancestor
6679302|NCT01597310|Antioxidants|antioxidants|mesh-ancestor
6679303|NCT01597310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679304|NCT01597310|Protective Agents|protective agents|mesh-ancestor
6679305|NCT01597310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679306|NCT01597310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6679307|NCT01597310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6679308|NCT01597310|Dopamine Agonists|dopamine agonists|mesh-ancestor
6679309|NCT01597310|Dopamine Agents|dopamine agents|mesh-ancestor
6679310|NCT01597310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6679311|NCT01597336|Plasminogen|plasminogen|mesh-list
6679312|NCT01597336|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6679313|NCT01597336|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6679314|NCT01597336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6679315|NCT01597336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679316|NCT01597414|Trastuzumab|trastuzumab|mesh-list
6679317|NCT01597414|Pertuzumab|pertuzumab|mesh-list
6679318|NCT01597414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6679319|NCT01597414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6679320|NCT01597427|Clonidine|clonidine|mesh-list
6679321|NCT01597427|Analgesics|analgesics|mesh-ancestor
6679322|NCT01597427|Sensory System Agents|sensory system agents|mesh-ancestor
6679323|NCT01597427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6679324|NCT01597427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679325|NCT01597427|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6679326|NCT01597427|Sympatholytics|sympatholytics|mesh-ancestor
6679327|NCT01597427|Autonomic Agents|autonomic agents|mesh-ancestor
6679328|NCT01597427|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6679329|NCT01597427|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6679330|NCT01597427|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6679331|NCT01597427|Adrenergic Agents|adrenergic agents|mesh-ancestor
6679332|NCT01597427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6679333|NCT01597427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510522|NCT00685529|Formoterol Fumarate|formoterol fumarate|mesh-list
6510523|NCT00685529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6510524|NCT00685529|Autonomic Agents|autonomic agents|mesh-ancestor
6510525|NCT00685529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6510526|NCT00685529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510527|NCT00685529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6510528|NCT00685529|Respiratory System Agents|respiratory system agents|mesh-ancestor
6510529|NCT00685529|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6510530|NCT00685529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6510531|NCT00685529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6510532|NCT00685529|Adrenergic Agents|adrenergic agents|mesh-ancestor
6510533|NCT00685529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6510534|NCT00685529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510535|NCT00685542|Diacetylrhein|diacetylrhein|mesh-list
6510536|NCT00685542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6510537|NCT00685568|Celecoxib|celecoxib|mesh-list
6510538|NCT00685568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6510539|NCT00685568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6510540|NCT00685568|Analgesics|analgesics|mesh-ancestor
6510541|NCT00685568|Sensory System Agents|sensory system agents|mesh-ancestor
6510542|NCT00685568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6510543|NCT00685568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510544|NCT00685568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6510545|NCT00685568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6510546|NCT00685568|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6510547|NCT00685568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6510548|NCT00685568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5717332|NCT03234660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5717333|NCT03234660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5717334|NCT03234660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717335|NCT03234660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5717336|NCT03234660|Analgesics|analgesics|mesh-ancestor
6510549|NCT00685568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510550|NCT00685594|Vitamin D|vitamin d|mesh-list
6510551|NCT00685594|Cholecalciferol|cholecalciferol|mesh-list
6510552|NCT00685594|Vitamins|vitamins|mesh-ancestor
6510553|NCT00685594|Micronutrients|micronutrients|mesh-ancestor
6510554|NCT00685594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510555|NCT00685594|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6510556|NCT00685594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6510557|NCT00685607|Simethicone|simethicone|mesh-list
6510558|NCT00685607|Loperamide|loperamide|mesh-list
6510559|NCT00685607|Antidiarrheals|antidiarrheals|mesh-list
6510560|NCT00685607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6510561|NCT00685607|Antifoaming Agents|antifoaming agents|mesh-ancestor
6510562|NCT00685607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510563|NCT00685607|Emollients|emollients|mesh-ancestor
6510564|NCT00685607|Dermatologic Agents|dermatologic agents|mesh-ancestor
6510565|NCT00685633|Bicalutamide|bicalutamide|mesh-list
6510566|NCT00685633|Androgen Antagonists|androgen antagonists|mesh-ancestor
6510567|NCT00685633|Hormone Antagonists|hormone antagonists|mesh-ancestor
6510568|NCT00685633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5717337|NCT03234660|Sensory System Agents|sensory system agents|mesh-ancestor
5717338|NCT03234660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5717339|NCT03234660|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6510569|NCT00685633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510570|NCT00685633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6510571|NCT00685646|Zoledronic Acid|zoledronic acid|mesh-list
6510572|NCT00685646|Androgen Antagonists|androgen antagonists|mesh-list
6510573|NCT00685646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6510574|NCT00685646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510575|NCT00685646|Hormone Antagonists|hormone antagonists|mesh-ancestor
6510576|NCT00685646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6510577|NCT00685672|Epinephrine|epinephrine|mesh-list
6510578|NCT00685672|Racepinephrine|racepinephrine|mesh-list
6510579|NCT00685672|Epinephryl borate|epinephryl borate|mesh-list
6510580|NCT00685672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6510581|NCT00685672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6510582|NCT00685672|Adrenergic Agents|adrenergic agents|mesh-ancestor
6510583|NCT00685672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6510584|NCT00685672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510585|NCT00685672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717340|NCT03234660|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5717341|NCT03234660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6510586|NCT00685672|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6510587|NCT00685672|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6510588|NCT00685672|Autonomic Agents|autonomic agents|mesh-ancestor
6510589|NCT00685672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6510590|NCT00685672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6510591|NCT00685672|Respiratory System Agents|respiratory system agents|mesh-ancestor
6510592|NCT00685672|Mydriatics|mydriatics|mesh-ancestor
6510593|NCT00685672|Sympathomimetics|sympathomimetics|mesh-ancestor
6510594|NCT00685672|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6510595|NCT00685776|Anacetrapib|anacetrapib|mesh-list
6510596|NCT00685776|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6510597|NCT00685776|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6510598|NCT00685776|Antimetabolites|antimetabolites|mesh-ancestor
6510599|NCT00685776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510600|NCT00685776|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6510601|NCT00685828|Imatinib Mesylate|imatinib mesylate|mesh-list
5717342|NCT03234660|Adrenergic Agents|adrenergic agents|mesh-ancestor
5717343|NCT03234660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5717344|NCT03234660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717345|NCT03234296|Metronidazole|metronidazole|mesh-list
5717346|NCT03234296|Levofloxacin|levofloxacin|mesh-list
5717347|NCT03234296|Ertapenem|ertapenem|mesh-list
5717348|NCT03234296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5717349|NCT03234296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5717350|NCT03234296|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5717351|NCT03234296|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5717352|NCT03234296|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6510602|NCT00685828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6510603|NCT00685828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6510604|NCT00685828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6510605|NCT00685828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510606|NCT00685841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6510607|NCT00685841|Formoterol Fumarate|formoterol fumarate|mesh-list
6510608|NCT00685841|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6510609|NCT00685841|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6510610|NCT00685841|Autonomic Agents|autonomic agents|mesh-ancestor
6510611|NCT00685841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6510612|NCT00685841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679334|NCT01597518|Riluzole|riluzole|mesh-list
6679335|NCT01597518|Anticonvulsants|anticonvulsants|mesh-ancestor
5717353|NCT03234296|Renal Agents|renal agents|mesh-ancestor
5717354|NCT03234296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5717355|NCT03234296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5717356|NCT03234296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5717357|NCT03234296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717358|NCT03234296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5717359|NCT03234296|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5717360|NCT03234296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5717361|NCT03234387|Acetylcholine|acetylcholine|mesh-list
6510613|NCT00685841|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6510614|NCT00685841|Respiratory System Agents|respiratory system agents|mesh-ancestor
6510615|NCT00685841|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6510616|NCT00685841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6510617|NCT00685841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6510618|NCT00685841|Adrenergic Agents|adrenergic agents|mesh-ancestor
6510619|NCT00685841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6510620|NCT00685841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510621|NCT00685854|Ranibizumab|ranibizumab|mesh-list
6510622|NCT00685854|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6510623|NCT00685854|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6510624|NCT00685854|Growth Substances|growth substances|mesh-ancestor
6510625|NCT00685854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510626|NCT00685854|Growth Inhibitors|growth inhibitors|mesh-ancestor
6510627|NCT00685854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6510628|NCT00685906|Ticagrelor|ticagrelor|mesh-list
6510629|NCT00685906|Levonorgestrel|levonorgestrel|mesh-list
6510630|NCT00685906|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6510631|NCT00685906|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
6510632|NCT00685906|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
6510633|NCT00685906|Estradiol|estradiol|mesh-list
6510634|NCT00685906|Estrogens|estrogens|mesh-ancestor
6510635|NCT00685906|Hormones|hormones|mesh-ancestor
6510636|NCT00685906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6510637|NCT00685906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679336|NCT01597518|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6510638|NCT00685906|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6510639|NCT00685906|Contraceptive Agents|contraceptive agents|mesh-ancestor
6510640|NCT00685906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6510641|NCT00685906|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6510642|NCT00685906|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6510643|NCT00685906|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6510644|NCT00685906|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6510645|NCT00685906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6510646|NCT00685906|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6510647|NCT00685906|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6510648|NCT00685906|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6510649|NCT00685906|Purinergic Agents|purinergic agents|mesh-ancestor
6510650|NCT00685906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6510651|NCT00685906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510652|NCT00685906|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6510653|NCT00685906|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
5717362|NCT03234387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717363|NCT03234387|Vasodilator Agents|vasodilator agents|mesh-ancestor
5717364|NCT03234387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5717365|NCT03234387|Cholinergic Agents|cholinergic agents|mesh-ancestor
5717366|NCT03234387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5717367|NCT03234387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717368|NCT03233828|Aldesleukin|aldesleukin|mesh-list
5717369|NCT03233828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5717370|NCT03233828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5717371|NCT03233828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5717372|NCT03233828|Antiviral Agents|antiviral agents|mesh-ancestor
5717373|NCT03233828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5722050|NCT03201627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510654|NCT00685906|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6510655|NCT00685906|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6510656|NCT00685958|Enoxaparin|enoxaparin|mesh-list
6510657|NCT00685958|Anticoagulants|anticoagulants|mesh-ancestor
6510658|NCT00685958|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6510659|NCT00685958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6510660|NCT00685958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510661|NCT00685971|Cholecalciferol|cholecalciferol|mesh-list
6510662|NCT00685971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6510663|NCT00685971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510664|NCT00685971|Vitamins|vitamins|mesh-ancestor
6510665|NCT00685971|Micronutrients|micronutrients|mesh-ancestor
6510666|NCT00685971|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6510667|NCT00686010|Dalcetrapib|dalcetrapib|mesh-list
6510668|NCT00686010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6510669|NCT00686010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6510670|NCT00686010|Antimetabolites|antimetabolites|mesh-ancestor
6510671|NCT00686010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510672|NCT00686010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6510673|NCT00686114|Paclitaxel|paclitaxel|mesh-list
6510674|NCT00686114|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6510675|NCT00686114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6510676|NCT00686114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6510677|NCT00686114|Tubulin Modulators|tubulin modulators|mesh-ancestor
6510678|NCT00686114|Antimitotic Agents|antimitotic agents|mesh-ancestor
6510679|NCT00686114|Mitosis Modulators|mitosis modulators|mesh-ancestor
6510680|NCT00686114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510681|NCT00686114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6510682|NCT00686114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6510683|NCT00686140|Celecoxib|celecoxib|mesh-list
6510684|NCT00686140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6510685|NCT00686140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6510686|NCT00686140|Analgesics|analgesics|mesh-ancestor
6510687|NCT00686140|Sensory System Agents|sensory system agents|mesh-ancestor
6510688|NCT00686140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6510689|NCT00686140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510690|NCT00686140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6510691|NCT00686140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6510692|NCT00686140|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6510693|NCT00686140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6510694|NCT00686140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6510695|NCT00686140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510696|NCT00686179|Moxifloxacin|moxifloxacin|mesh-list
6510697|NCT00686179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6510698|NCT00686179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6510699|NCT00686179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6510700|NCT00686179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6510701|NCT00686179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6510702|NCT00686179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510703|NCT00686179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6510704|NCT00686192|Calcium Carbonate|calcium carbonate|mesh-list
6510705|NCT00686192|Calcium|calcium|mesh-list
6510706|NCT00686192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6510707|NCT00686192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510708|NCT00686192|Antacids|antacids|mesh-ancestor
6510709|NCT00686192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510710|NCT00686192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6510711|NCT00686218|Imatinib Mesylate|imatinib mesylate|mesh-list
6510712|NCT00686218|Panobinostat|panobinostat|mesh-list
6510713|NCT00686218|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
6510714|NCT00686218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6510715|NCT00686218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6679337|NCT01597518|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6679338|NCT01597518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6679339|NCT01597518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679340|NCT01597518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679341|NCT01597518|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6679342|NCT01597518|Protective Agents|protective agents|mesh-ancestor
6679343|NCT01597531|Liraglutide|liraglutide|mesh-list
6679344|NCT01597531|Orlistat|orlistat|mesh-list
6679345|NCT01597531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6679346|NCT01597531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679347|NCT01597531|Incretins|incretins|mesh-ancestor
6679348|NCT01597531|Hormones|hormones|mesh-ancestor
6679349|NCT01597531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6679350|NCT01597531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6679351|NCT01597531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679352|NCT01597531|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6679353|NCT01597531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6679354|NCT01597609|Sibutramine|sibutramine|mesh-list
6679355|NCT01597609|Antidepressive Agents|antidepressive agents|mesh-ancestor
6510716|NCT00686218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6510717|NCT00686218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510718|NCT00686322|Paclitaxel|paclitaxel|mesh-list
6510719|NCT00686322|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6510720|NCT00686322|Cisplatin|cisplatin|mesh-list
6510721|NCT00686322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6510722|NCT00686322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6510723|NCT00686322|Tubulin Modulators|tubulin modulators|mesh-ancestor
6679356|NCT01597609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6679357|NCT01597609|Appetite Depressants|appetite depressants|mesh-ancestor
6679358|NCT01597609|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6679359|NCT01597648|Maraviroc|maraviroc|mesh-list
6679360|NCT01597648|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6679361|NCT01597648|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6679362|NCT01597648|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6679363|NCT01597648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679364|NCT01597648|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6679365|NCT01597648|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6679366|NCT01597648|Antiviral Agents|antiviral agents|mesh-ancestor
6679367|NCT01597648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6679368|NCT01597648|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6679369|NCT01597648|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6679370|NCT01597648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6679371|NCT01597648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6679372|NCT01597661|Bupropion|bupropion|mesh-list
6679373|NCT01597661|Antidepressive Agents|antidepressive agents|mesh-list
6679374|NCT01597661|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6679375|NCT01597661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6679376|NCT01597661|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6679377|NCT01597661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6679378|NCT01597661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6679379|NCT01597661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679380|NCT01597661|Dopamine Agents|dopamine agents|mesh-ancestor
6510724|NCT00686322|Antimitotic Agents|antimitotic agents|mesh-ancestor
6510725|NCT00686322|Mitosis Modulators|mitosis modulators|mesh-ancestor
6779800|NCT02181205|Anesthetics|anesthetics|mesh-ancestor
6510726|NCT00686322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510727|NCT00686361|Choline|choline|mesh-list
6510728|NCT00686361|Lipotropic Agents|lipotropic agents|mesh-ancestor
6510729|NCT00686361|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6510730|NCT00686361|Antimetabolites|antimetabolites|mesh-ancestor
6510731|NCT00686361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510732|NCT00686361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6510733|NCT00686361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6510734|NCT00686361|Nootropic Agents|nootropic agents|mesh-ancestor
6510735|NCT00686374|Adalimumab|adalimumab|mesh-list
6679381|NCT01597661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6679382|NCT01597661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679383|NCT01597661|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6679384|NCT01597661|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6679385|NCT01597661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6679386|NCT01597700|Ezetimibe|ezetimibe|mesh-list
6510736|NCT00686374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6510737|NCT00686374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6510738|NCT00686439|Adalimumab|adalimumab|mesh-list
6510739|NCT00686439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6510740|NCT00686439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6510741|NCT00686478|Interferons|interferons|mesh-list
6510742|NCT00686478|Interferon-alpha|interferon-alpha|mesh-list
6510743|NCT00686478|Interferon alpha-2|interferon alpha-2|mesh-list
5717374|NCT03234062|Choline|choline|mesh-list
5717375|NCT03234062|Lipotropic Agents|lipotropic agents|mesh-ancestor
5717376|NCT03234062|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5717377|NCT03234062|Antimetabolites|antimetabolites|mesh-ancestor
5717378|NCT03234062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717379|NCT03234062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5717380|NCT03234062|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5717381|NCT03234062|Nootropic Agents|nootropic agents|mesh-ancestor
5717382|NCT03233932|Leuprolide|leuprolide|mesh-list
5717383|NCT03233932|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6510744|NCT00686478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6510745|NCT00686478|Antiviral Agents|antiviral agents|mesh-ancestor
6510746|NCT00686478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6510747|NCT00686478|Immunologic Factors|immunologic factors|mesh-ancestor
6510748|NCT00686478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510749|NCT00686556|Cyclosporine|cyclosporine|mesh-list
6510750|NCT00686556|Mycophenolic Acid|mycophenolic acid|mesh-list
6510751|NCT00686556|Cyclophosphamide|cyclophosphamide|mesh-list
6510752|NCT00686556|Fludarabine|fludarabine|mesh-list
6510753|NCT00686556|Cyclosporins|cyclosporins|mesh-list
6510754|NCT00686556|Sargramostim|sargramostim|mesh-list
6510755|NCT00686556|Lenograstim|lenograstim|mesh-list
6510756|NCT00686556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6510757|NCT00686556|Immunologic Factors|immunologic factors|mesh-ancestor
6510758|NCT00686556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510759|NCT00686556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6510760|NCT00686556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6510761|NCT00686556|Alkylating Agents|alkylating agents|mesh-ancestor
6510762|NCT00686556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510763|NCT00686556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6510764|NCT00686556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6510765|NCT00686556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6510766|NCT00686556|Antifungal Agents|antifungal agents|mesh-ancestor
6510767|NCT00686556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6510768|NCT00686556|Dermatologic Agents|dermatologic agents|mesh-ancestor
6510769|NCT00686556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6510770|NCT00686556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6510771|NCT00686556|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6679387|NCT01597700|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6679388|NCT01597700|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6679389|NCT01597700|Antimetabolites|antimetabolites|mesh-ancestor
6510772|NCT00686556|Antitubercular Agents|antitubercular agents|mesh-ancestor
6510773|NCT00686556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6679390|NCT01597700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679391|NCT01597700|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6679392|NCT01597713|Insulin Glargine|insulin glargine|mesh-list
6679393|NCT01597713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6679394|NCT01597713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679395|NCT01597726|Misoprostol|misoprostol|mesh-list
6679396|NCT01597726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5717384|NCT03233932|Fertility Agents|fertility agents|mesh-ancestor
6510774|NCT00686556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6510775|NCT00686621|Posaconazole|posaconazole|mesh-list
6510776|NCT00686621|Antifungal Agents|antifungal agents|mesh-ancestor
6679397|NCT01597726|Abortifacient Agents|abortifacient agents|mesh-ancestor
6679398|NCT01597726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6679399|NCT01597726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679400|NCT01597726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6679401|NCT01597726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6679402|NCT01597726|Oxytocics|oxytocics|mesh-ancestor
6679403|NCT01597765|Vitamins|vitamins|mesh-list
6679404|NCT01597765|Vitamin E|vitamin e|mesh-list
6679405|NCT01597765|Tocopherols|tocopherols|mesh-list
6679406|NCT01597765|Tocotrienols|tocotrienols|mesh-list
6679407|NCT01597765|alpha-Tocopherol|alpha-tocopherol|mesh-list
6679408|NCT01597765|Acetylcysteine|acetylcysteine|mesh-list
6679409|NCT01597765|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6510777|NCT00686621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6510778|NCT00686621|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6510779|NCT00686621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6510780|NCT00686621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6510781|NCT00686621|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6510782|NCT00686621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6510783|NCT00686621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6510784|NCT00686621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510785|NCT00686621|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6510786|NCT00686621|Hormone Antagonists|hormone antagonists|mesh-ancestor
6510787|NCT00686621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6510788|NCT00686621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510789|NCT00686816|Sucrose polyester|sucrose polyester|mesh-list
6510790|NCT00686816|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6510791|NCT00686816|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6510792|NCT00686816|Antimetabolites|antimetabolites|mesh-ancestor
6510793|NCT00686816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679410|NCT01597765|Deferiprone|deferiprone|mesh-list
6510794|NCT00686816|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6510795|NCT00686868|Ofatumumab|ofatumumab|mesh-list
6510796|NCT00686868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6510797|NCT00686985|Carboplatin|carboplatin|mesh-list
6510798|NCT00686985|Docetaxel|docetaxel|mesh-list
6510799|NCT00686985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6510800|NCT00686985|Tubulin Modulators|tubulin modulators|mesh-ancestor
6510801|NCT00686985|Antimitotic Agents|antimitotic agents|mesh-ancestor
6679411|NCT01597765|Micronutrients|micronutrients|mesh-ancestor
6679412|NCT01597765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679413|NCT01597765|Antiviral Agents|antiviral agents|mesh-ancestor
6679414|NCT01597765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6679415|NCT01597765|Expectorants|expectorants|mesh-ancestor
6679416|NCT01597765|Respiratory System Agents|respiratory system agents|mesh-ancestor
5722051|NCT03201627|Antimanic Agents|antimanic agents|mesh-ancestor
6510802|NCT00686985|Mitosis Modulators|mitosis modulators|mesh-ancestor
6510803|NCT00686985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510804|NCT00687011|Dexamethasone|dexamethasone|mesh-list
6510805|NCT00687011|Palonosetron|palonosetron|mesh-list
6510806|NCT00687011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6510807|NCT00687011|Antiemetics|antiemetics|mesh-ancestor
6510808|NCT00687011|Autonomic Agents|autonomic agents|mesh-ancestor
6510809|NCT00687011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6510810|NCT00687011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510811|NCT00687011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6510812|NCT00687011|Glucocorticoids|glucocorticoids|mesh-ancestor
6510813|NCT00687011|Hormones|hormones|mesh-ancestor
6510814|NCT00687011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6510815|NCT00687011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6510816|NCT00687011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6510817|NCT00687011|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6510818|NCT00687011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6510819|NCT00687011|Serotonin Agents|serotonin agents|mesh-ancestor
6510820|NCT00687011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6510821|NCT00687011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510822|NCT00687037|Cetylpyridinium|cetylpyridinium|mesh-list
6510823|NCT00687037|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6510824|NCT00687037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6510825|NCT00687063|Insulin Detemir|insulin detemir|mesh-list
6510826|NCT00687063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6510827|NCT00687063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510828|NCT00687206|Valsartan|valsartan|mesh-list
6510829|NCT00687206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6679417|NCT01597765|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6679418|NCT01597765|Antioxidants|antioxidants|mesh-ancestor
6679419|NCT01597765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510830|NCT00687206|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6510831|NCT00687206|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6510832|NCT00687206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510833|NCT00687245|Esomeprazole|esomeprazole|mesh-list
6510834|NCT00687245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6510835|NCT00687245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6510836|NCT00687245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6510837|NCT00687245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6510838|NCT00687245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510839|NCT00687258|Vitamin E|vitamin e|mesh-list
6510840|NCT00687258|Vitamins|vitamins|mesh-ancestor
6510841|NCT00687258|Micronutrients|micronutrients|mesh-ancestor
6510842|NCT00687258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510843|NCT00687258|Antioxidants|antioxidants|mesh-ancestor
6510844|NCT00687258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510845|NCT00687258|Protective Agents|protective agents|mesh-ancestor
6510846|NCT00687284|Insulin Detemir|insulin detemir|mesh-list
6510847|NCT00687284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6510848|NCT00687284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510849|NCT00687388|Celecoxib|celecoxib|mesh-list
6510850|NCT00687388|Doxazosin|doxazosin|mesh-list
6510851|NCT00687388|Prazosin|prazosin|mesh-list
6510852|NCT00687388|Tamsulosin|tamsulosin|mesh-list
6510853|NCT00687388|Alfuzosin|alfuzosin|mesh-list
6510854|NCT00687388|Terazosin|terazosin|mesh-list
6510855|NCT00687388|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
6510856|NCT00687388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6510857|NCT00687388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6510858|NCT00687388|Analgesics|analgesics|mesh-ancestor
6510859|NCT00687388|Sensory System Agents|sensory system agents|mesh-ancestor
6510860|NCT00687388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6510861|NCT00687388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510862|NCT00687388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6510863|NCT00687388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6510864|NCT00687388|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6510865|NCT00687388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6510866|NCT00687388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6510867|NCT00687388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510868|NCT00687388|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6510869|NCT00687388|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6510870|NCT00687388|Adrenergic Agents|adrenergic agents|mesh-ancestor
6510871|NCT00687388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6510872|NCT00687388|Urological Agents|urological agents|mesh-ancestor
6510873|NCT00687388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6510874|NCT00687466|Insulin|insulin|mesh-list
6510875|NCT00687466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6510876|NCT00687466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510877|NCT00687518|Epoetin Alfa|epoetin alfa|mesh-list
6510878|NCT00687518|Hematinics|hematinics|mesh-ancestor
6510879|NCT00687622|Trametinib|trametinib|mesh-list
6510880|NCT00687622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6510881|NCT00687622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6510882|NCT00687622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6510883|NCT00687622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679420|NCT01597765|Protective Agents|protective agents|mesh-ancestor
6679421|NCT01597765|Antidotes|antidotes|mesh-ancestor
6679422|NCT01597765|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6679423|NCT01597765|Chelating Agents|chelating agents|mesh-ancestor
6679424|NCT01597765|Sequestering Agents|sequestering agents|mesh-ancestor
6679425|NCT01597817|Chitosan|chitosan|mesh-list
6679426|NCT01597817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6679427|NCT01597817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6679428|NCT01597817|Antimetabolites|antimetabolites|mesh-ancestor
6679429|NCT01597817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679430|NCT01597817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6679431|NCT01597817|Chelating Agents|chelating agents|mesh-ancestor
6679432|NCT01597817|Sequestering Agents|sequestering agents|mesh-ancestor
6679433|NCT01597817|Hemostatics|hemostatics|mesh-ancestor
6679434|NCT01597817|Coagulants|coagulants|mesh-ancestor
6679435|NCT01597895|Maraviroc|maraviroc|mesh-list
6679436|NCT01597895|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6679437|NCT01597895|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6679438|NCT01597895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679439|NCT01597895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6679440|NCT01597895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6679441|NCT01597895|Antiviral Agents|antiviral agents|mesh-ancestor
6679442|NCT01597895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6510884|NCT00687648|Prednisolone|prednisolone|mesh-list
6510885|NCT00687648|Cyclophosphamide|cyclophosphamide|mesh-list
6510886|NCT00687648|Methotrexate|methotrexate|mesh-list
6510887|NCT00687648|Letrozole|letrozole|mesh-list
6510888|NCT00687648|Anastrozole|anastrozole|mesh-list
6510889|NCT00687648|Exemestane|exemestane|mesh-list
6510890|NCT00687648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6510891|NCT00687648|Immunologic Factors|immunologic factors|mesh-ancestor
6510892|NCT00687648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510893|NCT00687648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5722052|NCT03201627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6510894|NCT00687648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6510895|NCT00687648|Alkylating Agents|alkylating agents|mesh-ancestor
6510896|NCT00687648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510897|NCT00687648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6510898|NCT00687648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6510899|NCT00687648|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6510900|NCT00687648|Abortifacient Agents|abortifacient agents|mesh-ancestor
6510901|NCT00687648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6510902|NCT00687648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6510903|NCT00687648|Antimetabolites|antimetabolites|mesh-ancestor
6510904|NCT00687648|Dermatologic Agents|dermatologic agents|mesh-ancestor
6510905|NCT00687648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6510906|NCT00687648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6510907|NCT00687648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6510908|NCT00687648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6510909|NCT00687648|Glucocorticoids|glucocorticoids|mesh-ancestor
6510910|NCT00687648|Hormones|hormones|mesh-ancestor
6510911|NCT00687648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6510912|NCT00687648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6510913|NCT00687648|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6510914|NCT00687648|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6510915|NCT00687648|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6510916|NCT00687648|Hormone Antagonists|hormone antagonists|mesh-ancestor
6510917|NCT00687661|Diphosphonates|diphosphonates|mesh-list
6510918|NCT00687661|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6510919|NCT00687661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510920|NCT00687700|Propranolol|propranolol|mesh-list
6510921|NCT00687700|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6510922|NCT00687700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6510923|NCT00687700|Adrenergic Agents|adrenergic agents|mesh-ancestor
6510924|NCT00687700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6510925|NCT00687700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510926|NCT00687700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510927|NCT00687700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6510928|NCT00687700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6510929|NCT00687700|Vasodilator Agents|vasodilator agents|mesh-ancestor
6510930|NCT00687765|Temozolomide|temozolomide|mesh-list
6510931|NCT00687765|Iniparib|iniparib|mesh-list
6510932|NCT00687765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6510933|NCT00687765|Alkylating Agents|alkylating agents|mesh-ancestor
6510934|NCT00687765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510935|NCT00687765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6510936|NCT00687765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6510937|NCT00687765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6510938|NCT00687817|Paclitaxel|paclitaxel|mesh-list
6510939|NCT00687817|Carboplatin|carboplatin|mesh-list
6510940|NCT00687817|Bavituximab|bavituximab|mesh-list
6510941|NCT00687817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6510942|NCT00687817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6510943|NCT00687817|Tubulin Modulators|tubulin modulators|mesh-ancestor
6510944|NCT00687817|Antimitotic Agents|antimitotic agents|mesh-ancestor
6510945|NCT00687817|Mitosis Modulators|mitosis modulators|mesh-ancestor
6510946|NCT00687817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510947|NCT00687817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6510948|NCT00687843|polysaccharide-K|polysaccharide-k|mesh-list
6510949|NCT00687843|Tegafur|tegafur|mesh-list
6510950|NCT00687843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6510951|NCT00687843|Antimetabolites|antimetabolites|mesh-ancestor
6510952|NCT00687843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510953|NCT00687843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6510954|NCT00687843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6510955|NCT00687843|Immunologic Factors|immunologic factors|mesh-ancestor
6510956|NCT00687843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510957|NCT00687843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6510958|NCT00687843|Antiviral Agents|antiviral agents|mesh-ancestor
6510959|NCT00687843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6510960|NCT00687843|Interferon Inducers|interferon inducers|mesh-ancestor
6510961|NCT00687843|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6510962|NCT00687843|Protective Agents|protective agents|mesh-ancestor
6510963|NCT00687999|Interferons|interferons|mesh-list
6510964|NCT00687999|Ribavirin|ribavirin|mesh-list
6510965|NCT00687999|Interferon-alpha|interferon-alpha|mesh-list
6510966|NCT00687999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6510967|NCT00687999|Antiviral Agents|antiviral agents|mesh-ancestor
6510968|NCT00687999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6510969|NCT00687999|Antimetabolites|antimetabolites|mesh-ancestor
6510970|NCT00687999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510971|NCT00687999|Immunologic Factors|immunologic factors|mesh-ancestor
6510972|NCT00687999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510973|NCT00688077|Calcitonin|calcitonin|mesh-list
6510974|NCT00688077|Salmon calcitonin|salmon calcitonin|mesh-list
6510975|NCT00688077|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
6510976|NCT00688077|Katacalcin|katacalcin|mesh-list
6510977|NCT00688077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6510978|NCT00688077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510979|NCT00688077|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6510980|NCT00688077|Vasodilator Agents|vasodilator agents|mesh-ancestor
6510981|NCT00688194|Letrozole|letrozole|mesh-list
6510982|NCT00688194|Fulvestrant|fulvestrant|mesh-list
6510983|NCT00688194|Lapatinib|lapatinib|mesh-list
6510984|NCT00688194|Anastrozole|anastrozole|mesh-list
6510985|NCT00688194|Exemestane|exemestane|mesh-list
6510986|NCT00688194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6510987|NCT00688194|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6510988|NCT00688194|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6510989|NCT00688194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6510990|NCT00688194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6510991|NCT00688194|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6510992|NCT00688194|Hormone Antagonists|hormone antagonists|mesh-ancestor
6510993|NCT00688194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6510994|NCT00688194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6510995|NCT00688194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6510996|NCT00688194|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6510997|NCT00688194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6510998|NCT00688207|Rosiglitazone|rosiglitazone|mesh-list
6510999|NCT00688207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6511000|NCT00688207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511001|NCT00688272|Ciprofloxacin|ciprofloxacin|mesh-list
6511002|NCT00688272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6511003|NCT00688272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6511004|NCT00688272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6511005|NCT00688272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6511006|NCT00688272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6511007|NCT00688272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511008|NCT00688272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6511009|NCT00688272|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6511010|NCT00688272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6511011|NCT00688298|Imidacloprid|imidacloprid|mesh-list
6511012|NCT00688298|Cholinergic Agents|cholinergic agents|mesh-ancestor
6511013|NCT00688298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6511014|NCT00688298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511015|NCT00688298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511016|NCT00688402|Lesogaberan|lesogaberan|mesh-list
6511017|NCT00688402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6511018|NCT00688402|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6511019|NCT00688402|GABA Agonists|gaba agonists|mesh-ancestor
6511020|NCT00688402|GABA Agents|gaba agents|mesh-ancestor
6511021|NCT00688402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6511022|NCT00688402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511023|NCT00688402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511024|NCT00688428|Aspirin|aspirin|mesh-list
6511025|NCT00688428|Esomeprazole|esomeprazole|mesh-list
6511026|NCT00688428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6511027|NCT00688428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6511028|NCT00688428|Analgesics|analgesics|mesh-ancestor
6511029|NCT00688428|Sensory System Agents|sensory system agents|mesh-ancestor
6511030|NCT00688428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6511031|NCT00688428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919419|NCT04981951|Adrenergic Agents|adrenergic agents|mesh-ancestor
6511032|NCT00688428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6511033|NCT00688428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6511034|NCT00688428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6511035|NCT00688428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6511036|NCT00688428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511037|NCT00688428|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6511038|NCT00688428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6511039|NCT00688428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6511040|NCT00688428|Antipyretics|antipyretics|mesh-ancestor
6511041|NCT00688428|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6511042|NCT00688428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6511043|NCT00688428|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6511044|NCT00688480|Allopurinol|allopurinol|mesh-list
6511045|NCT00688480|Antimetabolites|antimetabolites|mesh-ancestor
6511046|NCT00688480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511047|NCT00688480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6511048|NCT00688480|Gout Suppressants|gout suppressants|mesh-ancestor
6511049|NCT00688480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6511050|NCT00688480|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6511051|NCT00688480|Antioxidants|antioxidants|mesh-ancestor
6511052|NCT00688480|Protective Agents|protective agents|mesh-ancestor
6511053|NCT00688480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511054|NCT00688493|Dapagliflozin|dapagliflozin|mesh-list
6511055|NCT00688493|Moxifloxacin|moxifloxacin|mesh-list
6511056|NCT00688493|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6511057|NCT00688493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6511058|NCT00688493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6511059|NCT00688493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6511060|NCT00688493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6511061|NCT00688493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6511062|NCT00688493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511063|NCT00688493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6511064|NCT00688493|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6511065|NCT00688493|Contraceptive Agents|contraceptive agents|mesh-ancestor
6511066|NCT00688493|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6511067|NCT00688493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511068|NCT00688493|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6511069|NCT00688493|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6511070|NCT00688493|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6511071|NCT00688493|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6511072|NCT00688493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6511073|NCT00688558|Simvastatin|simvastatin|mesh-list
6511074|NCT00688558|Dalcetrapib|dalcetrapib|mesh-list
6511075|NCT00688558|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6511076|NCT00688558|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6511077|NCT00688558|Antimetabolites|antimetabolites|mesh-ancestor
6511078|NCT00688558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511079|NCT00688558|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6511080|NCT00688558|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6511081|NCT00688558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6511082|NCT00688805|Propranolol|propranolol|mesh-list
6511083|NCT00688805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5717385|NCT03233932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5717386|NCT03233932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717387|NCT03233932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5717388|NCT03233932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5717389|NCT03233880|Azithromycin|azithromycin|mesh-list
5717390|NCT03233880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5717391|NCT03233880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5717392|NCT03233815|Propofol|propofol|mesh-list
5717393|NCT03233815|Sevoflurane|sevoflurane|mesh-list
5717394|NCT03233815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5717395|NCT03233815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5717396|NCT03233815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717397|NCT03233815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5717398|NCT03233815|Anesthetics, General|anesthetics, general|mesh-ancestor
5717399|NCT03233815|Anesthetics|anesthetics|mesh-ancestor
5717400|NCT03233815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6511084|NCT00688805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6511085|NCT00688805|Adrenergic Agents|adrenergic agents|mesh-ancestor
6511086|NCT00688805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6511087|NCT00688805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511088|NCT00688805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717401|NCT03233815|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6511089|NCT00688805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6511090|NCT00688805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6511091|NCT00688805|Vasodilator Agents|vasodilator agents|mesh-ancestor
6679443|NCT01597895|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6679444|NCT01597934|Tenofovir|tenofovir|mesh-list
6679445|NCT01597934|Entecavir|entecavir|mesh-list
6679446|NCT01597934|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6679447|NCT01597934|Adefovir|adefovir|mesh-list
6679448|NCT01597934|Lamivudine|lamivudine|mesh-list
6679449|NCT01597934|Telbivudine|telbivudine|mesh-list
6679450|NCT01597934|Antiviral Agents|antiviral agents|mesh-ancestor
6679451|NCT01597934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6679452|NCT01597934|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6679453|NCT01597934|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6679454|NCT01597934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6679455|NCT01597934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679456|NCT01597934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6679457|NCT01597934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6679458|NCT01597986|Isavuconazole|isavuconazole|mesh-list
6679459|NCT01597986|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6679460|NCT01597986|Norethindrone|norethindrone|mesh-list
6679461|NCT01597986|Norethindrone Acetate|norethindrone acetate|mesh-list
6679462|NCT01597986|Norinyl|norinyl|mesh-list
6679463|NCT01597986|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
6679464|NCT01597986|Contraceptive Agents|contraceptive agents|mesh-list
6679465|NCT01597986|Contraceptives, Oral|contraceptives, oral|mesh-list
6679466|NCT01597986|Estradiol|estradiol|mesh-list
6679467|NCT01597986|Estrogens|estrogens|mesh-ancestor
6679468|NCT01597986|Hormones|hormones|mesh-ancestor
5717402|NCT03233893|Calcium, Dietary|calcium, dietary|mesh-list
5717403|NCT03233893|Calcium|calcium|mesh-list
5717404|NCT03233893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5717405|NCT03233893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717406|NCT03233893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5717407|NCT03234153|Durvalumab|durvalumab|mesh-list
5717408|NCT03234153|Tremelimumab|tremelimumab|mesh-list
5717409|NCT03234153|Immunologic Factors|immunologic factors|mesh-list
6511092|NCT00688818|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6511093|NCT00688818|Antidepressive Agents|antidepressive agents|mesh-ancestor
6511094|NCT00688818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6511095|NCT00688818|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6511096|NCT00688818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6511097|NCT00688818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6511098|NCT00688818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511099|NCT00688857|Diazoxide|diazoxide|mesh-list
6511100|NCT00688857|Choline|choline|mesh-list
6511101|NCT00688857|Lipotropic Agents|lipotropic agents|mesh-ancestor
6511102|NCT00688857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6511103|NCT00688857|Antimetabolites|antimetabolites|mesh-ancestor
6511104|NCT00688857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511105|NCT00688857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6511106|NCT00688857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6511107|NCT00688857|Nootropic Agents|nootropic agents|mesh-ancestor
6511108|NCT00688857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6511109|NCT00688857|Vasodilator Agents|vasodilator agents|mesh-ancestor
6511110|NCT00688883|Fludarabine|fludarabine|mesh-list
6511111|NCT00688883|Fludarabine phosphate|fludarabine phosphate|mesh-list
6511112|NCT00688883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6511113|NCT00688883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6511114|NCT00688883|Antimetabolites|antimetabolites|mesh-ancestor
6511115|NCT00688883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511116|NCT00688883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6511117|NCT00688883|Immunologic Factors|immunologic factors|mesh-ancestor
6511118|NCT00688883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511119|NCT00688896|Pravastatin|pravastatin|mesh-list
6511120|NCT00688896|Dalcetrapib|dalcetrapib|mesh-list
6511121|NCT00688896|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6511122|NCT00688896|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6511123|NCT00688896|Antimetabolites|antimetabolites|mesh-ancestor
6511124|NCT00688896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511125|NCT00688896|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6511126|NCT00688896|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6511127|NCT00688896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6511128|NCT00688922|Pravastatin|pravastatin|mesh-list
6511129|NCT00688922|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6511130|NCT00688922|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6679469|NCT01597986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6511131|NCT00688922|Antimetabolites|antimetabolites|mesh-ancestor
6511132|NCT00688922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511133|NCT00688922|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6511134|NCT00688922|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6511135|NCT00688922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6511136|NCT00688948|Alfuzosin|alfuzosin|mesh-list
6511137|NCT00688948|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6511138|NCT00688948|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6511139|NCT00688948|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6511140|NCT00688948|Adrenergic Agents|adrenergic agents|mesh-ancestor
6511141|NCT00688948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6511142|NCT00688948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511143|NCT00688948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511144|NCT00688948|Urological Agents|urological agents|mesh-ancestor
6511145|NCT00688961|Aspirin|aspirin|mesh-list
6511146|NCT00688961|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6511147|NCT00688961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6511148|NCT00688961|Analgesics|analgesics|mesh-ancestor
6511149|NCT00688961|Sensory System Agents|sensory system agents|mesh-ancestor
6511150|NCT00688961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6511151|NCT00688961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511152|NCT00688961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6511153|NCT00688961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6511154|NCT00688961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6511155|NCT00688961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6511156|NCT00688961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511157|NCT00688961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6511158|NCT00688961|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6511159|NCT00688961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6511160|NCT00688961|Antipyretics|antipyretics|mesh-ancestor
6511161|NCT00688987|Hydrocortisone|hydrocortisone|mesh-list
6511162|NCT00688987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6511163|NCT00689000|Tosedostat|tosedostat|mesh-list
6511164|NCT00689000|Glycine|glycine|mesh-list
6511165|NCT00689000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6511166|NCT00689000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511167|NCT00689000|Glycine Agents|glycine agents|mesh-ancestor
6511168|NCT00689000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6511169|NCT00689000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511170|NCT00689143|Sargramostim|sargramostim|mesh-list
6511171|NCT00689143|Immunologic Factors|immunologic factors|mesh-ancestor
6511172|NCT00689143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511173|NCT00689156|Cyclophosphamide|cyclophosphamide|mesh-list
6511174|NCT00689156|Docetaxel|docetaxel|mesh-list
6511175|NCT00689156|Epirubicin|epirubicin|mesh-list
6511176|NCT00689156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6511177|NCT00689156|Immunologic Factors|immunologic factors|mesh-ancestor
6511178|NCT00689156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511179|NCT00689156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6511180|NCT00689156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6511181|NCT00689156|Alkylating Agents|alkylating agents|mesh-ancestor
6511182|NCT00689156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511183|NCT00689156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6511184|NCT00689156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6511185|NCT00689156|Tubulin Modulators|tubulin modulators|mesh-ancestor
6511186|NCT00689156|Antimitotic Agents|antimitotic agents|mesh-ancestor
6511187|NCT00689156|Mitosis Modulators|mitosis modulators|mesh-ancestor
6511188|NCT00689156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6511189|NCT00689156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6511190|NCT00689156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6511191|NCT00689156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6511192|NCT00689169|Cytarabine|cytarabine|mesh-list
6511193|NCT00689169|Rituximab|rituximab|mesh-list
6511194|NCT00689169|Etoposide|etoposide|mesh-list
6511195|NCT00689169|Melphalan|melphalan|mesh-list
6511196|NCT00689169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6511197|NCT00689169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6511198|NCT00689169|Immunologic Factors|immunologic factors|mesh-ancestor
6511199|NCT00689169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511200|NCT00689169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6511201|NCT00689169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6511202|NCT00689169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6679470|NCT01597986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679471|NCT01597986|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6679472|NCT01597986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6679473|NCT01597986|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6679474|NCT01597986|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6679475|NCT01597986|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6679476|NCT01597986|Antifungal Agents|antifungal agents|mesh-ancestor
6679477|NCT01597986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5717410|NCT03234153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5717411|NCT03234153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5717412|NCT03234153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717413|NCT03233776|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5717414|NCT03233776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5717415|NCT03233750|Vaccines|vaccines|mesh-list
5717416|NCT03233750|Immunologic Factors|immunologic factors|mesh-ancestor
5717417|NCT03233750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679478|NCT01597986|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6679479|NCT01597986|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
6679480|NCT01598012|Mefenamic Acid|mefenamic acid|mesh-list
6679481|NCT01598012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6679482|NCT01598012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6679483|NCT01598012|Analgesics|analgesics|mesh-ancestor
6679484|NCT01598012|Sensory System Agents|sensory system agents|mesh-ancestor
6679485|NCT01598012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6679486|NCT01598012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679487|NCT01598012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6679488|NCT01598012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5717418|NCT03233633|Cannabidiol|cannabidiol|mesh-list
6511203|NCT00689169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6511204|NCT00689169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6511205|NCT00689169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511206|NCT00689169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6511207|NCT00689169|Alkylating Agents|alkylating agents|mesh-ancestor
6511208|NCT00689169|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6511209|NCT00689169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6511210|NCT00689169|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6511211|NCT00689169|Antimetabolites|antimetabolites|mesh-ancestor
5717419|NCT03233633|Anticonvulsants|anticonvulsants|mesh-ancestor
5717420|NCT03233321|Heparin|heparin|mesh-list
5717421|NCT03233321|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5717422|NCT03233321|Tinzaparin|tinzaparin|mesh-list
5717423|NCT03233321|Dalteparin|dalteparin|mesh-list
5717424|NCT03233321|Anticoagulants|anticoagulants|mesh-ancestor
5717425|NCT03233321|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5717426|NCT03233321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5717427|NCT03233321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717428|NCT03233412|Imiquimod|imiquimod|mesh-list
5717429|NCT03233412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5717430|NCT03233412|Immunologic Factors|immunologic factors|mesh-ancestor
5717431|NCT03233412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717432|NCT03233412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5717433|NCT03233412|Interferon Inducers|interferon inducers|mesh-ancestor
5717434|NCT03233347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5717435|NCT03233347|Nivolumab|nivolumab|mesh-list
5717436|NCT03233347|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5717437|NCT03233347|Doxorubicin|doxorubicin|mesh-list
5717438|NCT03233347|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5717439|NCT03233347|Daunorubicin|daunorubicin|mesh-list
5717440|NCT03233347|Dacarbazine|dacarbazine|mesh-list
5717441|NCT03233347|Vinblastine|vinblastine|mesh-list
5717442|NCT03233347|Antibodies|antibodies|mesh-list
5717443|NCT03233347|Immunoglobulins|immunoglobulins|mesh-list
5717444|NCT03233347|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5717445|NCT03233347|Immunoconjugates|immunoconjugates|mesh-list
6511212|NCT00689169|Antiviral Agents|antiviral agents|mesh-ancestor
6511213|NCT00689169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6511214|NCT00689195|Curcumin|curcumin|mesh-list
6511215|NCT00689195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6511216|NCT00689195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5717446|NCT03233347|Imidazole|imidazole|mesh-list
5717447|NCT03233347|Immunologic Factors|immunologic factors|mesh-ancestor
5717448|NCT03233347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717449|NCT03233347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6511217|NCT00689195|Analgesics|analgesics|mesh-ancestor
6511218|NCT00689195|Sensory System Agents|sensory system agents|mesh-ancestor
6679489|NCT01598012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5717450|NCT03233347|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5717451|NCT03233347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5717452|NCT03233347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5717453|NCT03233347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5717454|NCT03233347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717455|NCT03233347|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5717456|NCT03233347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5717457|NCT03233347|Alkylating Agents|alkylating agents|mesh-ancestor
5717458|NCT03233347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5717459|NCT03233347|Tubulin Modulators|tubulin modulators|mesh-ancestor
5717460|NCT03233347|Antimitotic Agents|antimitotic agents|mesh-ancestor
5717461|NCT03233347|Mitosis Modulators|mitosis modulators|mesh-ancestor
6511219|NCT00689195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6511220|NCT00689195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511221|NCT00689195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6511222|NCT00689195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6511223|NCT00689195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6511224|NCT00689195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6511225|NCT00689195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511226|NCT00689208|Atropine|atropine|mesh-list
6511227|NCT00689208|Physostigmine|physostigmine|mesh-list
6511228|NCT00689208|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6511229|NCT00689208|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6511230|NCT00689208|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6511231|NCT00689208|Autonomic Agents|autonomic agents|mesh-ancestor
6511232|NCT00689208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5717462|NCT03233295|Vitamin D|vitamin d|mesh-list
5717463|NCT03233295|Cholecalciferol|cholecalciferol|mesh-list
5717464|NCT03233295|Vitamins|vitamins|mesh-ancestor
5717465|NCT03233295|Micronutrients|micronutrients|mesh-ancestor
5717466|NCT03233295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717467|NCT03233295|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5717468|NCT03233295|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6511233|NCT00689208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511234|NCT00689208|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6511235|NCT00689208|Respiratory System Agents|respiratory system agents|mesh-ancestor
6511236|NCT00689208|Mydriatics|mydriatics|mesh-ancestor
6511237|NCT00689208|Parasympatholytics|parasympatholytics|mesh-ancestor
6511238|NCT00689208|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6511239|NCT00689208|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6511240|NCT00689208|Cholinergic Agents|cholinergic agents|mesh-ancestor
6511241|NCT00689208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6511242|NCT00689208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511243|NCT00689208|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6511244|NCT00689208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6511245|NCT00689208|Miotics|miotics|mesh-ancestor
6511246|NCT00689416|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6511247|NCT00689416|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6679490|NCT01598012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6679491|NCT01598012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679492|NCT01598051|Rivaroxaban|rivaroxaban|mesh-list
6511248|NCT00689416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6511249|NCT00689416|Antimetabolites|antimetabolites|mesh-ancestor
6511250|NCT00689416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511251|NCT00689416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6511252|NCT00689416|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5717469|NCT03233243|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5717470|NCT03233243|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5717471|NCT03233243|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5717472|NCT03233243|Antimetabolites|antimetabolites|mesh-ancestor
6511253|NCT00689416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6511254|NCT00689442|Atorvastatin|atorvastatin|mesh-list
6511255|NCT00689442|Dalcetrapib|dalcetrapib|mesh-list
6511256|NCT00689442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6511257|NCT00689442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6511258|NCT00689442|Antimetabolites|antimetabolites|mesh-ancestor
6511259|NCT00689442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511260|NCT00689442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6511261|NCT00689442|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6511262|NCT00689442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6511263|NCT00689494|Levonorgestrel|levonorgestrel|mesh-list
6511264|NCT00689494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6511265|NCT00689494|Contraceptive Agents|contraceptive agents|mesh-ancestor
6511266|NCT00689494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6511267|NCT00689494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511268|NCT00689494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6511269|NCT00689494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6511270|NCT00689494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6511271|NCT00689520|Vitamin K|vitamin k|mesh-list
6511272|NCT00689520|Tinzaparin|tinzaparin|mesh-list
6511273|NCT00689520|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6511274|NCT00689520|Dalteparin|dalteparin|mesh-list
6511275|NCT00689520|Acenocoumarol|acenocoumarol|mesh-list
6511276|NCT00689520|Vitamins|vitamins|mesh-ancestor
6511277|NCT00689520|Micronutrients|micronutrients|mesh-ancestor
6511278|NCT00689520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511279|NCT00689520|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6511280|NCT00689520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6511281|NCT00689520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511282|NCT00689520|Hemostatics|hemostatics|mesh-ancestor
6511283|NCT00689520|Coagulants|coagulants|mesh-ancestor
6511284|NCT00689520|Anticoagulants|anticoagulants|mesh-ancestor
6511285|NCT00689520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6511286|NCT00689559|Aripiprazole|aripiprazole|mesh-list
6511287|NCT00689559|Antidepressive Agents|antidepressive agents|mesh-ancestor
6511288|NCT00689559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6511289|NCT00689559|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6511290|NCT00689559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6511291|NCT00689559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6511292|NCT00689559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511293|NCT00689559|Dopamine Agonists|dopamine agonists|mesh-ancestor
6511294|NCT00689559|Dopamine Agents|dopamine agents|mesh-ancestor
6511295|NCT00689559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6511296|NCT00689559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511297|NCT00689559|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6511298|NCT00689559|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6511299|NCT00689559|Serotonin Agents|serotonin agents|mesh-ancestor
6511300|NCT00689559|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6511301|NCT00689559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6511302|NCT00689559|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6511303|NCT00689559|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6679493|NCT01598051|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6679494|NCT01598051|Antithrombins|antithrombins|mesh-ancestor
6679495|NCT01598051|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6679496|NCT01598051|Protease Inhibitors|protease inhibitors|mesh-ancestor
6679497|NCT01598051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6679498|NCT01598051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679499|NCT01598051|Anticoagulants|anticoagulants|mesh-ancestor
5717473|NCT03233243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717474|NCT03233243|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5717475|NCT03233243|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5717476|NCT03233243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5717477|NCT03233152|Nivolumab|nivolumab|mesh-list
5717478|NCT03233152|Ipilimumab|ipilimumab|mesh-list
5717479|NCT03233152|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5717480|NCT03233152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5717481|NCT03233152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5717482|NCT03233152|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5717483|NCT03233152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717484|NCT03233035|Ketamine|ketamine|mesh-list
5717485|NCT03233035|Analgesics|analgesics|mesh-ancestor
5717486|NCT03233035|Sensory System Agents|sensory system agents|mesh-ancestor
5717487|NCT03233035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5717488|NCT03233035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717489|NCT03233035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5717490|NCT03233035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5717491|NCT03233035|Anesthetics, General|anesthetics, general|mesh-ancestor
6679500|NCT01598168|Rivaroxaban|rivaroxaban|mesh-list
6679501|NCT01598168|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6679502|NCT01598168|Antithrombins|antithrombins|mesh-ancestor
6679503|NCT01598168|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6679504|NCT01598168|Protease Inhibitors|protease inhibitors|mesh-ancestor
6679505|NCT01598168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6679506|NCT01598168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679507|NCT01598168|Anticoagulants|anticoagulants|mesh-ancestor
6679508|NCT01598259|Melatonin|melatonin|mesh-list
6679509|NCT01598259|Antioxidants|antioxidants|mesh-ancestor
6679510|NCT01598259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679511|NCT01598259|Protective Agents|protective agents|mesh-ancestor
6679512|NCT01598259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511304|NCT00689585|Ethosuximide|ethosuximide|mesh-list
6511305|NCT00689585|Anticonvulsants|anticonvulsants|mesh-ancestor
6511306|NCT00689598|Spironolactone|spironolactone|mesh-list
6511307|NCT00689598|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6511308|NCT00689598|Hormone Antagonists|hormone antagonists|mesh-ancestor
6511309|NCT00689598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6511310|NCT00689598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511311|NCT00689598|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6511312|NCT00689598|Diuretics|diuretics|mesh-ancestor
6511313|NCT00689598|Natriuretic Agents|natriuretic agents|mesh-ancestor
6511314|NCT00689624|Leucovorin|leucovorin|mesh-list
6511315|NCT00689624|Fluorouracil|fluorouracil|mesh-list
6511316|NCT00689624|Oxaliplatin|oxaliplatin|mesh-list
6511317|NCT00689624|Irinotecan|irinotecan|mesh-list
6511318|NCT00689624|Cetuximab|cetuximab|mesh-list
6511319|NCT00689624|Antimetabolites|antimetabolites|mesh-ancestor
6511320|NCT00689624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511321|NCT00689624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6511322|NCT00689624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6511323|NCT00689624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6511324|NCT00689624|Immunologic Factors|immunologic factors|mesh-ancestor
6511325|NCT00689624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511326|NCT00689624|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6511327|NCT00689624|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6511328|NCT00689624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6511329|NCT00689624|Antidotes|antidotes|mesh-ancestor
6511330|NCT00689624|Protective Agents|protective agents|mesh-ancestor
6511331|NCT00689624|Vitamin B Complex|vitamin b complex|mesh-ancestor
6511332|NCT00689624|Vitamins|vitamins|mesh-ancestor
6511333|NCT00689624|Micronutrients|micronutrients|mesh-ancestor
6511334|NCT00689624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6511335|NCT00689637|Warfarin|warfarin|mesh-list
6511336|NCT00689637|Anticoagulants|anticoagulants|mesh-ancestor
6511337|NCT00689702|Capecitabine|capecitabine|mesh-list
6511338|NCT00689702|Cetuximab|cetuximab|mesh-list
6511339|NCT00689702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6511340|NCT00689702|Antimetabolites|antimetabolites|mesh-ancestor
6511341|NCT00689702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511342|NCT00689702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6511343|NCT00689702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6511344|NCT00689715|Ethanol|ethanol|mesh-list
6511345|NCT00689715|Paclitaxel|paclitaxel|mesh-list
6511346|NCT00689715|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6511347|NCT00689715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6511348|NCT00689715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6511349|NCT00689715|Tubulin Modulators|tubulin modulators|mesh-ancestor
6511350|NCT00689715|Antimitotic Agents|antimitotic agents|mesh-ancestor
6511351|NCT00689715|Mitosis Modulators|mitosis modulators|mesh-ancestor
6511352|NCT00689715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511353|NCT00689715|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6511354|NCT00689715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6511355|NCT00689715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6511356|NCT00689715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511357|NCT00689780|Midazolam|midazolam|mesh-list
6511358|NCT00689780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6511359|NCT00689780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6511360|NCT00689780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6679513|NCT01598259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5717492|NCT03233035|Anesthetics|anesthetics|mesh-ancestor
5717493|NCT03233035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5717494|NCT03233035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5717495|NCT03233035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5717496|NCT03233035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5717497|NCT03233035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717498|NCT03232918|Oxytocin|oxytocin|mesh-list
5717499|NCT03232918|Oxytocics|oxytocics|mesh-ancestor
5717500|NCT03232918|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5717501|NCT03232918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717502|NCT03232957|Morphine|morphine|mesh-list
5717503|NCT03232957|Bupivacaine|bupivacaine|mesh-list
5717504|NCT03232957|Anesthetics, Local|anesthetics, local|mesh-ancestor
5717505|NCT03232957|Anesthetics|anesthetics|mesh-ancestor
5717506|NCT03232957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5964097|NCT04594772|Folfirinox|folfirinox|mesh-list
6511361|NCT00689780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511362|NCT00689780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6511363|NCT00689780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6679514|NCT01598337|Aspirin|aspirin|mesh-list
6511364|NCT00689780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6511365|NCT00689780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6511366|NCT00689780|Anesthetics, General|anesthetics, general|mesh-ancestor
6511367|NCT00689780|Anesthetics|anesthetics|mesh-ancestor
6511368|NCT00689780|GABA Modulators|gaba modulators|mesh-ancestor
6511369|NCT00689780|GABA Agents|gaba agents|mesh-ancestor
6511370|NCT00689780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6511371|NCT00689780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511372|NCT00689806|Lovastatin|lovastatin|mesh-list
6511373|NCT00689806|L 647318|l 647318|mesh-list
6511374|NCT00689806|Dihydromevinolin|dihydromevinolin|mesh-list
6511375|NCT00689806|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6511376|NCT00689806|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6511377|NCT00689806|Antimetabolites|antimetabolites|mesh-ancestor
6511378|NCT00689806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679515|NCT01598337|Tirofiban|tirofiban|mesh-list
6679516|NCT01598337|Clopidogrel|clopidogrel|mesh-list
6679517|NCT01598337|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6511379|NCT00689806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6511380|NCT00689806|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6511381|NCT00689806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6511382|NCT00689832|Fluticasone|fluticasone|mesh-list
6511383|NCT00689832|Tacrolimus|tacrolimus|mesh-list
6511384|NCT00689832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6511385|NCT00689832|Immunologic Factors|immunologic factors|mesh-ancestor
6511386|NCT00689832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511387|NCT00689832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6511388|NCT00689832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6511389|NCT00689832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511390|NCT00689832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6511391|NCT00689832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6511392|NCT00689832|Autonomic Agents|autonomic agents|mesh-ancestor
6511393|NCT00689832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6511394|NCT00689832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6511395|NCT00689832|Respiratory System Agents|respiratory system agents|mesh-ancestor
6511396|NCT00689832|Dermatologic Agents|dermatologic agents|mesh-ancestor
6511397|NCT00689832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6511398|NCT00689845|Cytarabine|cytarabine|mesh-list
6511399|NCT00689845|Prednisone|prednisone|mesh-list
6511400|NCT00689845|Prednisolone|prednisolone|mesh-list
6511401|NCT00689845|Cyclophosphamide|cyclophosphamide|mesh-list
6679518|NCT01598337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6679519|NCT01598337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6679520|NCT01598337|Analgesics|analgesics|mesh-ancestor
6679521|NCT01598337|Sensory System Agents|sensory system agents|mesh-ancestor
6679522|NCT01598337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6679523|NCT01598337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679524|NCT01598337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6679525|NCT01598337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6679526|NCT01598337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6679527|NCT01598337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6679528|NCT01598337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679529|NCT01598337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6511402|NCT00689845|Ifosfamide|ifosfamide|mesh-list
6511403|NCT00689845|Rituximab|rituximab|mesh-list
6511404|NCT00689845|Doxorubicin|doxorubicin|mesh-list
6511405|NCT00689845|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6679530|NCT01598337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6679531|NCT01598337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6679532|NCT01598337|Antipyretics|antipyretics|mesh-ancestor
6511406|NCT00689845|Methotrexate|methotrexate|mesh-list
6511407|NCT00689845|Etoposide|etoposide|mesh-list
6511408|NCT00689845|Vincristine|vincristine|mesh-list
6511409|NCT00689845|Bleomycin|bleomycin|mesh-list
6511410|NCT00689845|Etoposide phosphate|etoposide phosphate|mesh-list
6511411|NCT00689845|Vindesine|vindesine|mesh-list
6511412|NCT00689845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6511413|NCT00689845|Immunologic Factors|immunologic factors|mesh-ancestor
6511414|NCT00689845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511415|NCT00689845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6511416|NCT00689845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6511417|NCT00689845|Alkylating Agents|alkylating agents|mesh-ancestor
6511418|NCT00689845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511419|NCT00689845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6511420|NCT00689845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6511421|NCT00689845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6511422|NCT00689845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6511423|NCT00689845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6511424|NCT00689845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6511425|NCT00689845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6511426|NCT00689845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6511427|NCT00689845|Glucocorticoids|glucocorticoids|mesh-ancestor
6511428|NCT00689845|Hormones|hormones|mesh-ancestor
6511429|NCT00689845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6511430|NCT00689845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6511431|NCT00689845|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6511432|NCT00689845|Abortifacient Agents|abortifacient agents|mesh-ancestor
6511433|NCT00689845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6511434|NCT00689845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6511435|NCT00689845|Antimetabolites|antimetabolites|mesh-ancestor
6511436|NCT00689845|Dermatologic Agents|dermatologic agents|mesh-ancestor
6511437|NCT00689845|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6511438|NCT00689845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6511439|NCT00689845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6511440|NCT00689845|Antiviral Agents|antiviral agents|mesh-ancestor
6511441|NCT00689845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6511442|NCT00689845|Tubulin Modulators|tubulin modulators|mesh-ancestor
6511443|NCT00689845|Antimitotic Agents|antimitotic agents|mesh-ancestor
6511444|NCT00689845|Mitosis Modulators|mitosis modulators|mesh-ancestor
6511445|NCT00689858|Cilostazol|cilostazol|mesh-list
6511446|NCT00689858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6511447|NCT00689858|Autonomic Agents|autonomic agents|mesh-ancestor
6511448|NCT00689858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6511449|NCT00689858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511450|NCT00689858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6511451|NCT00689858|Respiratory System Agents|respiratory system agents|mesh-ancestor
6511452|NCT00689858|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6511453|NCT00689858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6511454|NCT00689858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511455|NCT00689858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6511456|NCT00689858|Vasodilator Agents|vasodilator agents|mesh-ancestor
6511457|NCT00689858|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6511458|NCT00689858|Protective Agents|protective agents|mesh-ancestor
6511459|NCT00689858|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6511460|NCT00689858|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6511461|NCT00689858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6511462|NCT00689949|Folic Acid|folic acid|mesh-list
6511463|NCT00689949|Hematinics|hematinics|mesh-ancestor
6511464|NCT00689949|Vitamin B Complex|vitamin b complex|mesh-ancestor
6511465|NCT00689949|Vitamins|vitamins|mesh-ancestor
6511466|NCT00689949|Micronutrients|micronutrients|mesh-ancestor
6511467|NCT00689949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511468|NCT00690014|Probenecid|probenecid|mesh-list
6511469|NCT00690014|Uricosuric Agents|uricosuric agents|mesh-ancestor
6511470|NCT00690014|Gout Suppressants|gout suppressants|mesh-ancestor
6511471|NCT00690014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6511472|NCT00690014|Renal Agents|renal agents|mesh-ancestor
6511473|NCT00690105|Fluticasone|fluticasone|mesh-list
6511474|NCT00690105|Tacrolimus|tacrolimus|mesh-list
6511475|NCT00690105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6511476|NCT00690105|Immunologic Factors|immunologic factors|mesh-ancestor
6511477|NCT00690105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511478|NCT00690105|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6511479|NCT00690105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6511480|NCT00690105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511481|NCT00690105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6511482|NCT00690105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6511483|NCT00690105|Autonomic Agents|autonomic agents|mesh-ancestor
6511484|NCT00690105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6511485|NCT00690105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6511486|NCT00690105|Respiratory System Agents|respiratory system agents|mesh-ancestor
6511487|NCT00690105|Dermatologic Agents|dermatologic agents|mesh-ancestor
6511488|NCT00690105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6511489|NCT00690118|Pioglitazone|pioglitazone|mesh-list
5717507|NCT03232957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717508|NCT03232957|Sensory System Agents|sensory system agents|mesh-ancestor
6511490|NCT00690118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6511491|NCT00690118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717509|NCT03232957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5717510|NCT03232957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6511492|NCT00690170|Ketamine|ketamine|mesh-list
6511493|NCT00690170|Nicotine|nicotine|mesh-list
6511494|NCT00690170|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6511495|NCT00690170|Autonomic Agents|autonomic agents|mesh-ancestor
6511496|NCT00690170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6511497|NCT00690170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511498|NCT00690170|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6511499|NCT00690170|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6511500|NCT00690170|Cholinergic Agents|cholinergic agents|mesh-ancestor
6511501|NCT00690170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6511502|NCT00690170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511503|NCT00690170|Analgesics|analgesics|mesh-ancestor
6511504|NCT00690170|Sensory System Agents|sensory system agents|mesh-ancestor
6511505|NCT00690170|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6511506|NCT00690170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6511507|NCT00690170|Anesthetics, General|anesthetics, general|mesh-ancestor
6511508|NCT00690170|Anesthetics|anesthetics|mesh-ancestor
6511509|NCT00690170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6511510|NCT00690170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6511511|NCT00690170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6511512|NCT00690222|Mydriatics|mydriatics|mesh-list
6511513|NCT00690222|Autonomic Agents|autonomic agents|mesh-ancestor
6511514|NCT00690222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6511515|NCT00690222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511516|NCT00690300|Docetaxel|docetaxel|mesh-list
6511517|NCT00690300|Oxaliplatin|oxaliplatin|mesh-list
6511518|NCT00690300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6511519|NCT00690300|Tubulin Modulators|tubulin modulators|mesh-ancestor
6511520|NCT00690300|Antimitotic Agents|antimitotic agents|mesh-ancestor
6511521|NCT00690300|Mitosis Modulators|mitosis modulators|mesh-ancestor
6511522|NCT00690300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511523|NCT00690313|Moxifloxacin|moxifloxacin|mesh-list
6511524|NCT00690313|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6511525|NCT00690313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6511526|NCT00690313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6511527|NCT00690313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6511528|NCT00690313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6511529|NCT00690313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6511530|NCT00690313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511531|NCT00690313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6511532|NCT00690313|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6511533|NCT00690313|Contraceptive Agents|contraceptive agents|mesh-ancestor
6511534|NCT00690313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6511535|NCT00690313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511536|NCT00690313|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6511537|NCT00690313|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6511538|NCT00690313|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6511539|NCT00690417|Vitamin D|vitamin d|mesh-list
6511540|NCT00690417|Cholecalciferol|cholecalciferol|mesh-list
6511541|NCT00690417|Vitamins|vitamins|mesh-ancestor
6511542|NCT00690417|Micronutrients|micronutrients|mesh-ancestor
6511543|NCT00690417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511544|NCT00690417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6511545|NCT00690417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6511546|NCT00690521|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6511547|NCT00690521|Metolazone|metolazone|mesh-list
6511548|NCT00690521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6511549|NCT00690521|Diuretics|diuretics|mesh-ancestor
6511550|NCT00690521|Natriuretic Agents|natriuretic agents|mesh-ancestor
6511551|NCT00690521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511552|NCT00690521|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6511553|NCT00690521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6511554|NCT00690521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511555|NCT00690534|Insulin|insulin|mesh-list
6511556|NCT00690534|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6511557|NCT00690534|Nitroprusside|nitroprusside|mesh-list
6511558|NCT00690534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6511559|NCT00690534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511560|NCT00690534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6511561|NCT00690534|Vasodilator Agents|vasodilator agents|mesh-ancestor
6511562|NCT00690534|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6511563|NCT00690534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511564|NCT00690560|Prednisone|prednisone|mesh-list
6511565|NCT00690560|Cyclophosphamide|cyclophosphamide|mesh-list
6511566|NCT00690560|Rituximab|rituximab|mesh-list
6511567|NCT00690560|Doxorubicin|doxorubicin|mesh-list
6511568|NCT00690560|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6511569|NCT00690560|Vincristine|vincristine|mesh-list
6511570|NCT00690560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6511571|NCT00690560|Immunologic Factors|immunologic factors|mesh-ancestor
6511572|NCT00690560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511573|NCT00690560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6679533|NCT01598337|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6679534|NCT01598337|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6679535|NCT01598337|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6679536|NCT01598337|Purinergic Agents|purinergic agents|mesh-ancestor
6679537|NCT01598337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6679538|NCT01598363|Digoxin|digoxin|mesh-list
6679539|NCT01598363|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6679540|NCT01598363|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6679541|NCT01598363|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6679542|NCT01598363|Antimetabolites|antimetabolites|mesh-ancestor
6511574|NCT00690560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6511575|NCT00690560|Alkylating Agents|alkylating agents|mesh-ancestor
6511576|NCT00690560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511577|NCT00690560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6511578|NCT00690560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6679543|NCT01598363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679544|NCT01598363|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6679545|NCT01598363|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6679546|NCT01598363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6679547|NCT01598363|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6679548|NCT01598363|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6679549|NCT01598363|Protective Agents|protective agents|mesh-ancestor
6679550|NCT01598363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679551|NCT01598402|Amoxicillin|amoxicillin|mesh-list
6679552|NCT01598402|Clavulanic Acids|clavulanic acids|mesh-list
6679553|NCT01598402|Clavulanic Acid|clavulanic acid|mesh-list
6679554|NCT01598402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6679555|NCT01598402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6679556|NCT01598402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6679557|NCT01598402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679558|NCT01598402|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6679559|NCT01598441|Iloprost|iloprost|mesh-list
6679560|NCT01598441|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6679561|NCT01598441|Vasodilator Agents|vasodilator agents|mesh-ancestor
6511579|NCT00690560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6511580|NCT00690560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6511581|NCT00690560|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6511582|NCT00690560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6511583|NCT00690560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6511584|NCT00690560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6511585|NCT00690560|Glucocorticoids|glucocorticoids|mesh-ancestor
6511586|NCT00690560|Hormones|hormones|mesh-ancestor
6511587|NCT00690560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6511588|NCT00690560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6679562|NCT01598480|Anti-Infective Agents|anti-infective agents|mesh-list
6679563|NCT01598480|Silver Sulfadiazine|silver sulfadiazine|mesh-list
6679564|NCT01598480|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6679565|NCT01598480|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6679566|NCT01598493|Anti-Infective Agents|anti-infective agents|mesh-list
6679567|NCT01598493|Silver Sulfadiazine|silver sulfadiazine|mesh-list
6679568|NCT01598493|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6679569|NCT01598493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6679570|NCT01598558|Rituximab|rituximab|mesh-list
6679571|NCT01598558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6679572|NCT01598558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6679573|NCT01598558|Immunologic Factors|immunologic factors|mesh-ancestor
6679574|NCT01598558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679575|NCT01598558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6679576|NCT01598584|Gemcitabine|gemcitabine|mesh-list
6679577|NCT01598584|Mirtazapine|mirtazapine|mesh-list
6679578|NCT01598584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6679579|NCT01598584|Antimetabolites|antimetabolites|mesh-ancestor
6679580|NCT01598584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511589|NCT00690560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6511590|NCT00690560|Tubulin Modulators|tubulin modulators|mesh-ancestor
6511591|NCT00690560|Antimitotic Agents|antimitotic agents|mesh-ancestor
6511592|NCT00690560|Mitosis Modulators|mitosis modulators|mesh-ancestor
6511593|NCT00690677|Panobinostat|panobinostat|mesh-list
6511594|NCT00690677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6511595|NCT00690677|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6511596|NCT00690677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6511597|NCT00690677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511598|NCT00690768|Bevacizumab|bevacizumab|mesh-list
6511599|NCT00690768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6511600|NCT00690768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6511601|NCT00690768|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6511602|NCT00690768|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6511603|NCT00690768|Growth Substances|growth substances|mesh-ancestor
6511604|NCT00690768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511605|NCT00690768|Growth Inhibitors|growth inhibitors|mesh-ancestor
6511606|NCT00690781|Caseins|caseins|mesh-list
6511607|NCT00690781|Chelating Agents|chelating agents|mesh-ancestor
6511608|NCT00690781|Sequestering Agents|sequestering agents|mesh-ancestor
6511609|NCT00690781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511610|NCT00690846|Adalimumab|adalimumab|mesh-list
6511611|NCT00690846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6511612|NCT00690846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6511613|NCT00690872|Gemcitabine|gemcitabine|mesh-list
6511614|NCT00690872|Carboplatin|carboplatin|mesh-list
6511615|NCT00690872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6511616|NCT00690872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6511617|NCT00690872|Antimetabolites|antimetabolites|mesh-ancestor
6511618|NCT00690872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511619|NCT00690872|Antiviral Agents|antiviral agents|mesh-ancestor
6511620|NCT00690872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6511621|NCT00690872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6511622|NCT00690872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6511623|NCT00690872|Immunologic Factors|immunologic factors|mesh-ancestor
6511624|NCT00690872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511625|NCT00690885|Interferons|interferons|mesh-list
6511626|NCT00690885|Interferon-alpha|interferon-alpha|mesh-list
6511627|NCT00690885|Interferon alpha-2|interferon alpha-2|mesh-list
6511628|NCT00690885|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
6511629|NCT00690885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6511630|NCT00690885|Antiviral Agents|antiviral agents|mesh-ancestor
6511631|NCT00690885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6511632|NCT00690885|Immunologic Factors|immunologic factors|mesh-ancestor
6511633|NCT00690885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511634|NCT00690911|Adalimumab|adalimumab|mesh-list
6511635|NCT00690911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6511636|NCT00690911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6511637|NCT00690937|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
5717511|NCT03232957|Narcotics|narcotics|mesh-ancestor
5717512|NCT03232957|Analgesics|analgesics|mesh-ancestor
5717513|NCT03232632|Flutemetamol|flutemetamol|mesh-list
5717514|NCT03232632|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5717515|NCT03232632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717516|NCT03232710|Aripiprazole|aripiprazole|mesh-list
5717517|NCT03232710|Antidepressive Agents|antidepressive agents|mesh-ancestor
5717518|NCT03232710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5717519|NCT03232710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5717520|NCT03232710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5717521|NCT03232710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5717522|NCT03232710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717523|NCT03232710|Dopamine Agonists|dopamine agonists|mesh-ancestor
5717524|NCT03232710|Dopamine Agents|dopamine agents|mesh-ancestor
5717525|NCT03232710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5717526|NCT03232710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717527|NCT03232710|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5717528|NCT03232710|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5717529|NCT03232710|Serotonin Agents|serotonin agents|mesh-ancestor
5717530|NCT03232710|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5717531|NCT03232710|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5717532|NCT03232710|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6511638|NCT00690937|Sevelamer|sevelamer|mesh-list
6511639|NCT00690937|Chelating Agents|chelating agents|mesh-ancestor
6511640|NCT00690937|Sequestering Agents|sequestering agents|mesh-ancestor
6511641|NCT00690937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511642|NCT00690937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6511643|NCT00690937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6511644|NCT00690937|Antimetabolites|antimetabolites|mesh-ancestor
6511645|NCT00690937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6511646|NCT00690950|Dutasteride|dutasteride|mesh-list
6511647|NCT00690950|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6511648|NCT00690950|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6511649|NCT00690950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6511650|NCT00690950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511651|NCT00690950|Hormone Antagonists|hormone antagonists|mesh-ancestor
6511652|NCT00690950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6511653|NCT00690950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511654|NCT00691067|Mifepristone|mifepristone|mesh-list
6511655|NCT00691067|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6511656|NCT00691067|Abortifacient Agents|abortifacient agents|mesh-ancestor
6511657|NCT00691067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6511658|NCT00691067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511659|NCT00691067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6511660|NCT00691067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6511661|NCT00691067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6679581|NCT01598584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6679582|NCT01598584|Antiviral Agents|antiviral agents|mesh-ancestor
6679583|NCT01598584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6679584|NCT01598584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6679585|NCT01598584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6679586|NCT01598584|Immunologic Factors|immunologic factors|mesh-ancestor
6679587|NCT01598584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679588|NCT01598584|Antidepressive Agents|antidepressive agents|mesh-ancestor
6679589|NCT01598584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5717533|NCT03232710|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6511662|NCT00691067|Contraceptive Agents|contraceptive agents|mesh-ancestor
6679590|NCT01598584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6511663|NCT00691067|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6511664|NCT00691067|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6511665|NCT00691067|Hormone Antagonists|hormone antagonists|mesh-ancestor
6511666|NCT00691067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6511667|NCT00691067|Luteolytic Agents|luteolytic agents|mesh-ancestor
5717534|NCT03232554|Iron|iron|mesh-list
5717535|NCT03232554|Trace Elements|trace elements|mesh-ancestor
5717536|NCT03232554|Micronutrients|micronutrients|mesh-ancestor
5717537|NCT03232554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717538|NCT03232450|Aspirin|aspirin|mesh-list
5717539|NCT03232450|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5717540|NCT03232450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5717541|NCT03232450|Analgesics|analgesics|mesh-ancestor
5717542|NCT03232450|Sensory System Agents|sensory system agents|mesh-ancestor
6511668|NCT00691067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6511669|NCT00691067|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6511670|NCT00691145|Tacrolimus|tacrolimus|mesh-list
6511671|NCT00691145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6511672|NCT00691145|Immunologic Factors|immunologic factors|mesh-ancestor
6511673|NCT00691145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511674|NCT00691145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6511675|NCT00691145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6511676|NCT00691145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511677|NCT00691158|Pramlintide|pramlintide|mesh-list
6511678|NCT00691158|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
6511679|NCT00691158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6511680|NCT00691158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511681|NCT00691158|Appetite Depressants|appetite depressants|mesh-ancestor
6511682|NCT00691158|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6511683|NCT00691158|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
6511684|NCT00691158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511685|NCT00691184|Terbinafine|terbinafine|mesh-list
6511686|NCT00691184|Antifungal Agents|antifungal agents|mesh-ancestor
6511687|NCT00691184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6511688|NCT00691184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6511689|NCT00691184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511690|NCT00691236|Zoledronic Acid|zoledronic acid|mesh-list
6511691|NCT00691236|Doxorubicin|doxorubicin|mesh-list
6511692|NCT00691236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6511693|NCT00691236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5717543|NCT03232450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5717544|NCT03232450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717545|NCT03232450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5717546|NCT03232450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5717547|NCT03232450|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5717548|NCT03232450|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5717549|NCT03232450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717550|NCT03232450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5717551|NCT03232450|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5717552|NCT03232450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5717553|NCT03232450|Antipyretics|antipyretics|mesh-ancestor
5722053|NCT03201627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5722054|NCT03201627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722055|NCT03201835|Nabiximols|nabiximols|mesh-list
5722056|NCT03201835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722057|NCT03201835|Analgesics|analgesics|mesh-ancestor
5722058|NCT03201835|Sensory System Agents|sensory system agents|mesh-ancestor
5722059|NCT03201835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5722060|NCT03201952|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
5722061|NCT03201952|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5722062|NCT03201952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5722063|NCT03201393|Acetaminophen|acetaminophen|mesh-list
5722064|NCT03201393|Naltrexone|naltrexone|mesh-list
5722065|NCT03201393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5722066|NCT03201393|Analgesics|analgesics|mesh-ancestor
5722067|NCT03201393|Sensory System Agents|sensory system agents|mesh-ancestor
5722068|NCT03201393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5722069|NCT03201393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722070|NCT03201393|Antipyretics|antipyretics|mesh-ancestor
6511694|NCT00691236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6511695|NCT00691236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6511696|NCT00691236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5722071|NCT03201393|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5722072|NCT03201393|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5722073|NCT03201185|Ramipril|ramipril|mesh-list
6511697|NCT00691236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511698|NCT00691236|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6511699|NCT00691236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511700|NCT00691262|Tacrolimus|tacrolimus|mesh-list
6511701|NCT00691262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6511702|NCT00691262|Immunologic Factors|immunologic factors|mesh-ancestor
6511703|NCT00691262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511704|NCT00691262|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6511705|NCT00691262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6511706|NCT00691262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511707|NCT00691275|Ondansetron|ondansetron|mesh-list
6511708|NCT00691275|Antiemetics|antiemetics|mesh-ancestor
6511709|NCT00691275|Autonomic Agents|autonomic agents|mesh-ancestor
6511710|NCT00691275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6511711|NCT00691275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511712|NCT00691275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6511713|NCT00691275|Antipruritics|antipruritics|mesh-ancestor
6511714|NCT00691275|Dermatologic Agents|dermatologic agents|mesh-ancestor
6511715|NCT00691275|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6511716|NCT00691275|Serotonin Agents|serotonin agents|mesh-ancestor
6511717|NCT00691275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6511718|NCT00691275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511719|NCT00691275|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6511720|NCT00691275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6511721|NCT00691275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6511722|NCT00691275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6511723|NCT00691275|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6679591|NCT01598584|Histamine Antagonists|histamine antagonists|mesh-ancestor
6679592|NCT01598584|Histamine Agents|histamine agents|mesh-ancestor
6679593|NCT01598584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6679594|NCT01598584|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6679595|NCT01598584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6679596|NCT01598584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6679597|NCT01598584|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6679598|NCT01598584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6679599|NCT01598584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6679600|NCT01598584|Adrenergic Agents|adrenergic agents|mesh-ancestor
6679601|NCT01598584|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6679602|NCT01598584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6679603|NCT01598584|Serotonin Agents|serotonin agents|mesh-ancestor
6679604|NCT01598584|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6679605|NCT01598623|Oxytocin|oxytocin|mesh-list
6679606|NCT01598623|Oxytocics|oxytocics|mesh-ancestor
6679607|NCT01598623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6679608|NCT01598623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679609|NCT01598649|Mannitol|mannitol|mesh-list
6679610|NCT01598649|Caseins|caseins|mesh-list
6679611|NCT01598649|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6679612|NCT01598649|Diuretics|diuretics|mesh-ancestor
6679613|NCT01598649|Natriuretic Agents|natriuretic agents|mesh-ancestor
6679614|NCT01598649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679615|NCT01598649|Chelating Agents|chelating agents|mesh-ancestor
6679616|NCT01598649|Sequestering Agents|sequestering agents|mesh-ancestor
6679617|NCT01598649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679618|NCT01598675|Methamphetamine|methamphetamine|mesh-list
6679619|NCT01598675|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6679620|NCT01598675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679621|NCT01598675|Sympathomimetics|sympathomimetics|mesh-ancestor
6679622|NCT01598675|Autonomic Agents|autonomic agents|mesh-ancestor
6679623|NCT01598675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6679624|NCT01598675|Dopamine Agents|dopamine agents|mesh-ancestor
6679625|NCT01598675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6679626|NCT01598675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679627|NCT01598675|Adrenergic Agents|adrenergic agents|mesh-ancestor
6679628|NCT01598675|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6679629|NCT01598675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6679630|NCT01598675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6679631|NCT01598675|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6679632|NCT01598883|Heparin|heparin|mesh-list
6679633|NCT01598883|Calcium heparin|calcium heparin|mesh-list
6679634|NCT01598883|Antithrombins|antithrombins|mesh-list
6679635|NCT01598883|Anticoagulants|anticoagulants|mesh-ancestor
6679636|NCT01598883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6679637|NCT01598883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6779801|NCT02181205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6511724|NCT00691379|Paclitaxel|paclitaxel|mesh-list
6511725|NCT00691379|Bevacizumab|bevacizumab|mesh-list
6511726|NCT00691379|Carboplatin|carboplatin|mesh-list
6511727|NCT00691379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6511728|NCT00691379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6511729|NCT00691379|Tubulin Modulators|tubulin modulators|mesh-ancestor
6511730|NCT00691379|Antimitotic Agents|antimitotic agents|mesh-ancestor
6511731|NCT00691379|Mitosis Modulators|mitosis modulators|mesh-ancestor
6511732|NCT00691379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511733|NCT00691379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6511734|NCT00691379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6511735|NCT00691379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6511736|NCT00691379|Growth Substances|growth substances|mesh-ancestor
6511737|NCT00691379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511738|NCT00691379|Growth Inhibitors|growth inhibitors|mesh-ancestor
6511739|NCT00691392|Linezolid|linezolid|mesh-list
6511740|NCT00691392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6511741|NCT00691392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6511742|NCT00691392|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6511743|NCT00691392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6511744|NCT00691392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511745|NCT00691405|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6511746|NCT00691405|Formoterol Fumarate|formoterol fumarate|mesh-list
6511747|NCT00691405|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6511748|NCT00691405|Autonomic Agents|autonomic agents|mesh-ancestor
6511749|NCT00691405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6511750|NCT00691405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511751|NCT00691405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6511752|NCT00691405|Respiratory System Agents|respiratory system agents|mesh-ancestor
6511753|NCT00691405|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6511754|NCT00691405|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6511755|NCT00691405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6511756|NCT00691405|Adrenergic Agents|adrenergic agents|mesh-ancestor
6511757|NCT00691405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6511758|NCT00691405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511759|NCT00691457|Contact Lens Solutions|contact lens solutions|mesh-list
6511760|NCT00691457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6511761|NCT00691457|Disinfectants|disinfectants|mesh-ancestor
6511762|NCT00691457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6511763|NCT00691470|Warfarin|warfarin|mesh-list
6511764|NCT00691470|Anticoagulants|anticoagulants|mesh-ancestor
6511765|NCT00691548|Cetuximab|cetuximab|mesh-list
6511766|NCT00691548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6511767|NCT00691548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6511768|NCT00691613|Epoetin Alfa|epoetin alfa|mesh-list
6511769|NCT00691613|Hematinics|hematinics|mesh-ancestor
6511770|NCT00691795|Clonidine|clonidine|mesh-list
6511771|NCT00691795|Fentanyl|fentanyl|mesh-list
6511772|NCT00691795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6511773|NCT00691795|Narcotics|narcotics|mesh-ancestor
6511774|NCT00691795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6511775|NCT00691795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511776|NCT00691795|Analgesics|analgesics|mesh-ancestor
6511777|NCT00691795|Sensory System Agents|sensory system agents|mesh-ancestor
6679638|NCT01598883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679639|NCT01598883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6679640|NCT01598883|Protease Inhibitors|protease inhibitors|mesh-ancestor
6679641|NCT01598883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6679642|NCT01598948|Mipomersen|mipomersen|mesh-list
6679643|NCT01598948|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6679644|NCT01598948|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6679645|NCT01598948|Antimetabolites|antimetabolites|mesh-ancestor
6679646|NCT01598948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511778|NCT00691795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6511779|NCT00691795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6511780|NCT00691795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6511781|NCT00691795|Anesthetics, General|anesthetics, general|mesh-ancestor
6511782|NCT00691795|Anesthetics|anesthetics|mesh-ancestor
6511783|NCT00691795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6511784|NCT00691795|Sympatholytics|sympatholytics|mesh-ancestor
6511785|NCT00691795|Autonomic Agents|autonomic agents|mesh-ancestor
6511786|NCT00691795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6511787|NCT00691795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6511788|NCT00691795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6511789|NCT00691795|Adrenergic Agents|adrenergic agents|mesh-ancestor
6511790|NCT00691795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6511791|NCT00691795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511792|NCT00691873|Omalizumab|omalizumab|mesh-list
6511793|NCT00691873|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6511794|NCT00691873|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6511795|NCT00691873|Respiratory System Agents|respiratory system agents|mesh-ancestor
6511796|NCT00691886|Dexmedetomidine|dexmedetomidine|mesh-list
6511797|NCT00691886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6511798|NCT00691886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6511799|NCT00691886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511800|NCT00691886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6511801|NCT00691886|Analgesics|analgesics|mesh-ancestor
6511802|NCT00691886|Sensory System Agents|sensory system agents|mesh-ancestor
6511803|NCT00691886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6511804|NCT00691886|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6511805|NCT00691886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6511806|NCT00691886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6511807|NCT00691886|Adrenergic Agents|adrenergic agents|mesh-ancestor
6511808|NCT00691886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6511809|NCT00691886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511810|NCT00691912|Paclitaxel|paclitaxel|mesh-list
6511811|NCT00691912|Doxorubicin|doxorubicin|mesh-list
6511812|NCT00691912|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6511813|NCT00691912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6511814|NCT00691912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6511815|NCT00691912|Tubulin Modulators|tubulin modulators|mesh-ancestor
5717554|NCT03232424|Temozolomide|temozolomide|mesh-list
5717555|NCT03232424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5717556|NCT03232424|Alkylating Agents|alkylating agents|mesh-ancestor
5717557|NCT03232424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717558|NCT03232424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5717559|NCT03232398|Warfarin|warfarin|mesh-list
5717560|NCT03232398|Apixaban|apixaban|mesh-list
5717561|NCT03232398|Anticoagulants|anticoagulants|mesh-ancestor
5717562|NCT03232398|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5717563|NCT03232398|Antithrombins|antithrombins|mesh-ancestor
5717564|NCT03232398|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5717565|NCT03232398|Protease Inhibitors|protease inhibitors|mesh-ancestor
6511816|NCT00691912|Antimitotic Agents|antimitotic agents|mesh-ancestor
6511817|NCT00691912|Mitosis Modulators|mitosis modulators|mesh-ancestor
6511818|NCT00691912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511819|NCT00691912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6511820|NCT00691912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6511821|NCT00691912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6511822|NCT00691912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6511823|NCT00691951|Budesonide|budesonide|mesh-list
6511824|NCT00691951|Formoterol Fumarate|formoterol fumarate|mesh-list
6511825|NCT00691951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6511826|NCT00691951|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6511827|NCT00691951|Autonomic Agents|autonomic agents|mesh-ancestor
6511828|NCT00691951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6511829|NCT00691951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511830|NCT00691951|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6511831|NCT00691951|Respiratory System Agents|respiratory system agents|mesh-ancestor
6511832|NCT00691951|Glucocorticoids|glucocorticoids|mesh-ancestor
6511833|NCT00691951|Hormones|hormones|mesh-ancestor
6511834|NCT00691951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5717566|NCT03232398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5717567|NCT03232398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717568|NCT03232307|Dexamethasone|dexamethasone|mesh-list
5717569|NCT03232307|Dexamethasone acetate|dexamethasone acetate|mesh-list
5717570|NCT03232307|Rituximab|rituximab|mesh-list
5717571|NCT03232307|Lenalidomide|lenalidomide|mesh-list
6511835|NCT00691951|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5717572|NCT03232307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5717573|NCT03232307|Antibodies|antibodies|mesh-list
5717574|NCT03232307|Immunoglobulins|immunoglobulins|mesh-list
5717575|NCT03232307|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5717576|NCT03232307|BB 1101|bb 1101|mesh-list
5717577|NCT03232307|Immunologic Factors|immunologic factors|mesh-ancestor
6511836|NCT00691951|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6511837|NCT00691951|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6511838|NCT00691951|Adrenergic Agents|adrenergic agents|mesh-ancestor
6511839|NCT00691951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5717578|NCT03232307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717579|NCT03232307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6511840|NCT00691951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511841|NCT00692016|Naproxen|naproxen|mesh-list
6511842|NCT00692016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6511843|NCT00692016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6511844|NCT00692016|Analgesics|analgesics|mesh-ancestor
6511845|NCT00692016|Sensory System Agents|sensory system agents|mesh-ancestor
6511846|NCT00692016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6511847|NCT00692016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511848|NCT00692016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6511849|NCT00692016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6511850|NCT00692016|Gout Suppressants|gout suppressants|mesh-ancestor
6511851|NCT00692016|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6511852|NCT00692016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6511853|NCT00692016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679647|NCT01598948|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6679648|NCT01599000|Lumefantrine|lumefantrine|mesh-list
6679649|NCT01599000|Artemether|artemether|mesh-list
6511854|NCT00692055|Naproxen|naproxen|mesh-list
6511855|NCT00692055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6511856|NCT00692055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6511857|NCT00692055|Analgesics|analgesics|mesh-ancestor
6511858|NCT00692055|Sensory System Agents|sensory system agents|mesh-ancestor
6511859|NCT00692055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6511860|NCT00692055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511861|NCT00692055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6511862|NCT00692055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6511863|NCT00692055|Gout Suppressants|gout suppressants|mesh-ancestor
6511864|NCT00692055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6511865|NCT00692055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6511866|NCT00692055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511867|NCT00692120|Vitamin D|vitamin d|mesh-list
6511868|NCT00692120|Ergocalciferols|ergocalciferols|mesh-list
6511869|NCT00692120|Cholecalciferol|cholecalciferol|mesh-list
6511870|NCT00692120|Vitamins|vitamins|mesh-list
6511871|NCT00692120|Micronutrients|micronutrients|mesh-ancestor
6511872|NCT00692120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511873|NCT00692120|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6511874|NCT00692120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6679650|NCT01599000|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6679651|NCT01599000|Antimalarials|antimalarials|mesh-ancestor
6679652|NCT01599000|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6679653|NCT01599000|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6679654|NCT01599000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6679655|NCT01599013|Gemcitabine|gemcitabine|mesh-list
6679656|NCT01599013|Carboplatin|carboplatin|mesh-list
6679657|NCT01599013|Vinblastine|vinblastine|mesh-list
6679658|NCT01599013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6679659|NCT01599013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6679660|NCT01599013|Antimetabolites|antimetabolites|mesh-ancestor
6679661|NCT01599013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679662|NCT01599013|Antiviral Agents|antiviral agents|mesh-ancestor
6679663|NCT01599013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6679664|NCT01599013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6679665|NCT01599013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6679666|NCT01599013|Immunologic Factors|immunologic factors|mesh-ancestor
6679667|NCT01599013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679668|NCT01599013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6679669|NCT01599013|Tubulin Modulators|tubulin modulators|mesh-ancestor
6679670|NCT01599013|Antimitotic Agents|antimitotic agents|mesh-ancestor
6679671|NCT01599013|Mitosis Modulators|mitosis modulators|mesh-ancestor
6679672|NCT01599078|Paclitaxel|paclitaxel|mesh-list
6679673|NCT01599078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6679674|NCT01599078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6511875|NCT00692159|Pemetrexed|pemetrexed|mesh-list
6511876|NCT00692159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6511877|NCT00692159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6511878|NCT00692159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511879|NCT00692159|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6511880|NCT00692159|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6511881|NCT00692172|Alefacept|alefacept|mesh-list
6511882|NCT00692172|Dermatologic Agents|dermatologic agents|mesh-ancestor
6511883|NCT00692172|Immunologic Factors|immunologic factors|mesh-ancestor
6511884|NCT00692172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511885|NCT00692250|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
6679675|NCT01599078|Tubulin Modulators|tubulin modulators|mesh-ancestor
6511886|NCT00692250|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6511887|NCT00692250|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6511888|NCT00692250|Antimetabolites|antimetabolites|mesh-ancestor
6511889|NCT00692250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511890|NCT00692250|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6511891|NCT00692263|Tramadol|tramadol|mesh-list
6511892|NCT00692263|Citalopram|citalopram|mesh-list
6511893|NCT00692263|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6511894|NCT00692263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6511895|NCT00692263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6511896|NCT00692263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511897|NCT00692263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6511898|NCT00692263|Serotonin Agents|serotonin agents|mesh-ancestor
6511899|NCT00692263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511900|NCT00692263|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6511901|NCT00692263|Antidepressive Agents|antidepressive agents|mesh-ancestor
6511902|NCT00692263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6511903|NCT00692263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6511904|NCT00692263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6511905|NCT00692263|Narcotics|narcotics|mesh-ancestor
6511906|NCT00692263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6511907|NCT00692263|Analgesics|analgesics|mesh-ancestor
6511908|NCT00692263|Sensory System Agents|sensory system agents|mesh-ancestor
6511909|NCT00692315|Vitamin B 12|vitamin b 12|mesh-list
6679676|NCT01599078|Antimitotic Agents|antimitotic agents|mesh-ancestor
6679677|NCT01599078|Mitosis Modulators|mitosis modulators|mesh-ancestor
6679678|NCT01599078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679679|NCT01599117|Udenafil|udenafil|mesh-list
6679680|NCT01599117|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6511910|NCT00692315|Vitamins|vitamins|mesh-ancestor
6511911|NCT00692315|Micronutrients|micronutrients|mesh-ancestor
6511912|NCT00692315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511913|NCT00692315|Vitamin B Complex|vitamin b complex|mesh-ancestor
6511914|NCT00692328|Levodopa|levodopa|mesh-list
6511915|NCT00692328|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6511916|NCT00692328|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6511917|NCT00692328|Dopamine Agents|dopamine agents|mesh-ancestor
6511918|NCT00692328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6511919|NCT00692328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511920|NCT00692328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511921|NCT00692354|Tosedostat|tosedostat|mesh-list
6511922|NCT00692354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6511923|NCT00692354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511924|NCT00692510|Rosiglitazone|rosiglitazone|mesh-list
6511925|NCT00692510|Midazolam|midazolam|mesh-list
6511926|NCT00692510|Caffeine|caffeine|mesh-list
6511927|NCT00692510|Bupropion|bupropion|mesh-list
6511928|NCT00692510|Omeprazole|omeprazole|mesh-list
6511929|NCT00692510|Bilirubin|bilirubin|mesh-list
6511930|NCT00692510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6679681|NCT01599117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6679682|NCT01599117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6511931|NCT00692510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6511932|NCT00692510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6511933|NCT00692510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511934|NCT00692510|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6511935|NCT00692510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6511936|NCT00692510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6511937|NCT00692510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6511938|NCT00692510|Anesthetics, General|anesthetics, general|mesh-ancestor
6511939|NCT00692510|Anesthetics|anesthetics|mesh-ancestor
6511940|NCT00692510|GABA Modulators|gaba modulators|mesh-ancestor
6511941|NCT00692510|GABA Agents|gaba agents|mesh-ancestor
6511942|NCT00692510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6511943|NCT00692510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511944|NCT00692510|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6511945|NCT00692510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6511946|NCT00692510|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6511947|NCT00692510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6511948|NCT00692510|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6511949|NCT00692510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6511950|NCT00692510|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6511951|NCT00692510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6511952|NCT00692510|Purinergic Agents|purinergic agents|mesh-ancestor
6511953|NCT00692510|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6511954|NCT00692510|Antidepressive Agents|antidepressive agents|mesh-ancestor
6679683|NCT01599117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679684|NCT01599130|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6679685|NCT01599130|Entecavir|entecavir|mesh-list
6679686|NCT01599130|Antiviral Agents|antiviral agents|mesh-ancestor
6679687|NCT01599130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6779802|NCT02181205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779803|NCT02181205|Sensory System Agents|sensory system agents|mesh-ancestor
6779804|NCT02181205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6779805|NCT02181218|Gemcitabine|gemcitabine|mesh-list
6779806|NCT02181218|Dexamethasone|dexamethasone|mesh-list
6779807|NCT02181218|Dexamethasone acetate|dexamethasone acetate|mesh-list
6779808|NCT02181218|Oxaliplatin|oxaliplatin|mesh-list
5717580|NCT03232307|Antiemetics|antiemetics|mesh-ancestor
6511955|NCT00692510|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6511956|NCT00692510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6511957|NCT00692510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6511958|NCT00692510|Dopamine Agents|dopamine agents|mesh-ancestor
6511959|NCT00692510|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6511960|NCT00692510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6511961|NCT00692510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6511962|NCT00692510|Antioxidants|antioxidants|mesh-ancestor
6511963|NCT00692510|Protective Agents|protective agents|mesh-ancestor
6511964|NCT00692601|Capsaicin|capsaicin|mesh-list
6511965|NCT00692601|Antipruritics|antipruritics|mesh-ancestor
6511966|NCT00692601|Dermatologic Agents|dermatologic agents|mesh-ancestor
6511967|NCT00692601|Sensory System Agents|sensory system agents|mesh-ancestor
6511968|NCT00692601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6511969|NCT00692601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511970|NCT00692614|Triamcinolone|triamcinolone|mesh-list
6511971|NCT00692614|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6779809|NCT02181218|Romidepsin|romidepsin|mesh-list
5717581|NCT03232307|Autonomic Agents|autonomic agents|mesh-ancestor
5717582|NCT03232307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5717583|NCT03232307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5717584|NCT03232307|Glucocorticoids|glucocorticoids|mesh-ancestor
5717585|NCT03232307|Hormones|hormones|mesh-ancestor
5717586|NCT03232307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5717587|NCT03232307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5717588|NCT03232307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5717589|NCT03232307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5717590|NCT03232307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5717591|NCT03232307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5717592|NCT03232307|Growth Substances|growth substances|mesh-ancestor
5717593|NCT03232307|Growth Inhibitors|growth inhibitors|mesh-ancestor
5717594|NCT03232307|Protease Inhibitors|protease inhibitors|mesh-ancestor
5717595|NCT03232307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5717596|NCT03232307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717597|NCT03232346|Buprenorphine|buprenorphine|mesh-list
5717598|NCT03232346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5717599|NCT03232346|Narcotics|narcotics|mesh-ancestor
5717600|NCT03232346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5717601|NCT03232346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717602|NCT03232346|Analgesics|analgesics|mesh-ancestor
5717603|NCT03232346|Sensory System Agents|sensory system agents|mesh-ancestor
5717604|NCT03232346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5717605|NCT03232346|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5717606|NCT03232216|Vitamin D|vitamin d|mesh-list
5717607|NCT03232216|Cholecalciferol|cholecalciferol|mesh-list
5717608|NCT03232216|Vitamins|vitamins|mesh-ancestor
5717609|NCT03232216|Micronutrients|micronutrients|mesh-ancestor
5717610|NCT03232216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717611|NCT03232216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5717612|NCT03232216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5717613|NCT03232320|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5717614|NCT03232320|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5717615|NCT03232320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5717616|NCT03232320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717617|NCT03232320|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5717618|NCT03232320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5717619|NCT03232320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717620|NCT03232320|Cholinergic Agents|cholinergic agents|mesh-ancestor
5717621|NCT03232320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5717622|NCT03231982|Amlodipine|amlodipine|mesh-list
5717623|NCT03231982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5717624|NCT03231982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6779810|NCT02181218|BB 1101|bb 1101|mesh-list
6511972|NCT00692614|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6511973|NCT00692614|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6511974|NCT00692614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6511975|NCT00692614|Glucocorticoids|glucocorticoids|mesh-ancestor
6511976|NCT00692614|Hormones|hormones|mesh-ancestor
6511977|NCT00692614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6511978|NCT00692614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511979|NCT00692614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6511980|NCT00692614|Immunologic Factors|immunologic factors|mesh-ancestor
6511981|NCT00692614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6511982|NCT00692614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511983|NCT00692640|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6511984|NCT00692640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6511985|NCT00692640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6511986|NCT00692640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6511987|NCT00692640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511988|NCT00692731|Caffeine|caffeine|mesh-list
6511989|NCT00692731|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6511990|NCT00692731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6511991|NCT00692731|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6511992|NCT00692731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6511993|NCT00692731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6511994|NCT00692731|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6511995|NCT00692731|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6511996|NCT00692731|Purinergic Agents|purinergic agents|mesh-ancestor
6511997|NCT00692731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6511998|NCT00692757|Povidone-Iodine|povidone-iodine|mesh-list
6511999|NCT00692757|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6512000|NCT00692757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6512001|NCT00692900|Docetaxel|docetaxel|mesh-list
6512002|NCT00692900|Oxaliplatin|oxaliplatin|mesh-list
6512003|NCT00692900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6512004|NCT00692900|Tubulin Modulators|tubulin modulators|mesh-ancestor
6512005|NCT00692900|Antimitotic Agents|antimitotic agents|mesh-ancestor
6512006|NCT00692900|Mitosis Modulators|mitosis modulators|mesh-ancestor
6512007|NCT00692900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512008|NCT00692952|Benzalkonium Compounds|benzalkonium compounds|mesh-list
6512009|NCT00692952|Contraceptive Agents|contraceptive agents|mesh-list
6512010|NCT00692952|Nonoxynol|nonoxynol|mesh-list
6512011|NCT00692952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6512012|NCT00692952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512013|NCT00692952|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6512014|NCT00692952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6512015|NCT00692952|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
6512016|NCT00692952|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
6512017|NCT00692952|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6512018|NCT00692952|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6679688|NCT01599273|Triamcinolone|triamcinolone|mesh-list
6512019|NCT00693004|Donepezil|donepezil|mesh-list
6512020|NCT00693004|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6512021|NCT00693004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6512022|NCT00693004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512023|NCT00693004|Cholinergic Agents|cholinergic agents|mesh-ancestor
6512024|NCT00693004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6512025|NCT00693004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512026|NCT00693004|Nootropic Agents|nootropic agents|mesh-ancestor
6512027|NCT00693030|Sirolimus|sirolimus|mesh-list
6512028|NCT00693030|Paclitaxel|paclitaxel|mesh-list
6512029|NCT00693030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6512030|NCT00693030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6512031|NCT00693030|Tubulin Modulators|tubulin modulators|mesh-ancestor
6512032|NCT00693030|Antimitotic Agents|antimitotic agents|mesh-ancestor
6512033|NCT00693030|Mitosis Modulators|mitosis modulators|mesh-ancestor
6512034|NCT00693030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512035|NCT00693030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6512036|NCT00693030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6512037|NCT00693030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6512038|NCT00693030|Antifungal Agents|antifungal agents|mesh-ancestor
6512039|NCT00693030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6512040|NCT00693030|Immunologic Factors|immunologic factors|mesh-ancestor
6512041|NCT00693030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512042|NCT00693043|Lidocaine|lidocaine|mesh-list
6512043|NCT00693043|Anesthetics, Local|anesthetics, local|mesh-ancestor
6512044|NCT00693043|Anesthetics|anesthetics|mesh-ancestor
6679689|NCT01599273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6512045|NCT00693043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6512046|NCT00693043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512047|NCT00693043|Sensory System Agents|sensory system agents|mesh-ancestor
6512048|NCT00693043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6512049|NCT00693043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6512050|NCT00693043|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6512051|NCT00693043|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6512052|NCT00693043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6512053|NCT00693043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512054|NCT00693056|beta-Lactams|beta-lactams|mesh-list
6512055|NCT00693056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6512056|NCT00693056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6679690|NCT01599273|Glucocorticoids|glucocorticoids|mesh-ancestor
6679691|NCT01599273|Hormones|hormones|mesh-ancestor
6679692|NCT01599273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6679693|NCT01599273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679694|NCT01599312|Cobalt|cobalt|mesh-list
6679695|NCT01599312|Trace Elements|trace elements|mesh-ancestor
6679696|NCT01599312|Micronutrients|micronutrients|mesh-ancestor
6679697|NCT01599312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717625|NCT03231982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5717626|NCT03231982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717627|NCT03231982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5717628|NCT03231982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717629|NCT03231982|Vasodilator Agents|vasodilator agents|mesh-ancestor
5717630|NCT03232034|Calcium|calcium|mesh-list
5717631|NCT03232034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5717632|NCT03232034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717633|NCT03232125|Ramosetron|ramosetron|mesh-list
5717634|NCT03232125|Antiemetics|antiemetics|mesh-ancestor
5717635|NCT03232125|Autonomic Agents|autonomic agents|mesh-ancestor
5717636|NCT03232125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5717637|NCT03232125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717638|NCT03232125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6679698|NCT01599338|Liraglutide|liraglutide|mesh-list
6679699|NCT01599338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6679700|NCT01599338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679701|NCT01599338|Incretins|incretins|mesh-ancestor
6679702|NCT01599338|Hormones|hormones|mesh-ancestor
6679703|NCT01599338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6679704|NCT01599364|Ritonavir|ritonavir|mesh-list
6679705|NCT01599364|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6679706|NCT01599364|Lamivudine|lamivudine|mesh-list
6679707|NCT01599364|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6679708|NCT01599364|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6679709|NCT01599364|Protease Inhibitors|protease inhibitors|mesh-ancestor
6679710|NCT01599364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6679711|NCT01599364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679712|NCT01599364|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6679713|NCT01599364|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6679714|NCT01599364|Antiviral Agents|antiviral agents|mesh-ancestor
6679715|NCT01599364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6679716|NCT01599364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6679717|NCT01599364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6679718|NCT01599364|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6679719|NCT01599364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6679720|NCT01599377|Tofacitinib|tofacitinib|mesh-list
6679721|NCT01599377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6679722|NCT01599377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6679723|NCT01599377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679724|NCT01599468|Tranexamic Acid|tranexamic acid|mesh-list
6679725|NCT01599468|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6679726|NCT01599468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6679727|NCT01599468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679728|NCT01599468|Hemostatics|hemostatics|mesh-ancestor
6679729|NCT01599468|Coagulants|coagulants|mesh-ancestor
6679730|NCT01599572|Zinc|zinc|mesh-list
6679731|NCT01599572|Trace Elements|trace elements|mesh-ancestor
6679732|NCT01599572|Micronutrients|micronutrients|mesh-ancestor
6679733|NCT01599572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679734|NCT01599598|Imidacloprid|imidacloprid|mesh-list
6679735|NCT01599598|Cholinergic Agents|cholinergic agents|mesh-ancestor
6679736|NCT01599598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6512057|NCT00693069|Clopidogrel|clopidogrel|mesh-list
6512058|NCT00693069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6512059|NCT00693069|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6512060|NCT00693069|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6512061|NCT00693069|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6512062|NCT00693069|Purinergic Agents|purinergic agents|mesh-ancestor
6512063|NCT00693069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6512064|NCT00693069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512065|NCT00693069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512066|NCT00693108|Testosterone|testosterone|mesh-list
6512067|NCT00693108|Androgens|androgens|mesh-ancestor
6512068|NCT00693108|Hormones|hormones|mesh-ancestor
6512069|NCT00693108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6512070|NCT00693108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512071|NCT00693121|Amantadine|amantadine|mesh-list
6512072|NCT00693121|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6512073|NCT00693121|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6512074|NCT00693121|Antiviral Agents|antiviral agents|mesh-ancestor
6512075|NCT00693121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6512076|NCT00693121|Dopamine Agents|dopamine agents|mesh-ancestor
6512077|NCT00693121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6512078|NCT00693121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512079|NCT00693121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512080|NCT00693121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6512081|NCT00693121|Analgesics|analgesics|mesh-ancestor
6512082|NCT00693121|Sensory System Agents|sensory system agents|mesh-ancestor
6512083|NCT00693121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6512084|NCT00693199|Amlodipine|amlodipine|mesh-list
6512085|NCT00693199|Prazosin|prazosin|mesh-list
6512086|NCT00693199|Terazosin|terazosin|mesh-list
6512087|NCT00693199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6512088|NCT00693199|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6512089|NCT00693199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6512090|NCT00693199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512091|NCT00693199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6512092|NCT00693199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512093|NCT00693199|Vasodilator Agents|vasodilator agents|mesh-ancestor
6512094|NCT00693199|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6512095|NCT00693199|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6512096|NCT00693199|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6512097|NCT00693199|Adrenergic Agents|adrenergic agents|mesh-ancestor
6512098|NCT00693199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6512099|NCT00693199|Urological Agents|urological agents|mesh-ancestor
6512100|NCT00693212|Methylphenidate|methylphenidate|mesh-list
6512101|NCT00693212|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6512102|NCT00693212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512103|NCT00693212|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6512104|NCT00693212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6512105|NCT00693212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6512106|NCT00693212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512107|NCT00693212|Dopamine Agents|dopamine agents|mesh-ancestor
6512108|NCT00693212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6512109|NCT00693251|Sirolimus|sirolimus|mesh-list
6512110|NCT00693251|Paclitaxel|paclitaxel|mesh-list
6512111|NCT00693251|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6512112|NCT00693251|Everolimus|everolimus|mesh-list
6512113|NCT00693251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6512114|NCT00693251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6512115|NCT00693251|Tubulin Modulators|tubulin modulators|mesh-ancestor
6512116|NCT00693251|Antimitotic Agents|antimitotic agents|mesh-ancestor
6512117|NCT00693251|Mitosis Modulators|mitosis modulators|mesh-ancestor
6512118|NCT00693251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512119|NCT00693251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6512120|NCT00693251|Immunologic Factors|immunologic factors|mesh-ancestor
6512121|NCT00693251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512122|NCT00693251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6512123|NCT00693251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6512124|NCT00693251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6512125|NCT00693251|Antifungal Agents|antifungal agents|mesh-ancestor
6512126|NCT00693342|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
6512127|NCT00693342|Immunologic Factors|immunologic factors|mesh-ancestor
6512128|NCT00693342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512129|NCT00693355|Butyric Acid|butyric acid|mesh-list
6512130|NCT00693355|Histamine Antagonists|histamine antagonists|mesh-ancestor
6512131|NCT00693355|Histamine Agents|histamine agents|mesh-ancestor
6512132|NCT00693355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6512133|NCT00693355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512134|NCT00693355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512135|NCT00693381|Mycophenolic Acid|mycophenolic acid|mesh-list
6512136|NCT00693381|Prednisone|prednisone|mesh-list
6512137|NCT00693381|Methylprednisolone|methylprednisolone|mesh-list
6512138|NCT00693381|Tacrolimus|tacrolimus|mesh-list
6512139|NCT00693381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6512140|NCT00693381|Glucocorticoids|glucocorticoids|mesh-ancestor
6512141|NCT00693381|Hormones|hormones|mesh-ancestor
6512142|NCT00693381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6512143|NCT00693381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512144|NCT00693381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6512145|NCT00693381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6512146|NCT00693381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6512147|NCT00693381|Immunologic Factors|immunologic factors|mesh-ancestor
6512148|NCT00693381|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6512149|NCT00693381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6512150|NCT00693381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512151|NCT00693381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6512152|NCT00693381|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6512153|NCT00693381|Antitubercular Agents|antitubercular agents|mesh-ancestor
6512154|NCT00693381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6512155|NCT00693381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6512156|NCT00693381|Antiemetics|antiemetics|mesh-ancestor
5717639|NCT03232125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5717640|NCT03232125|Serotonin Agents|serotonin agents|mesh-ancestor
5717641|NCT03232125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5717642|NCT03232125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717643|NCT03232021|Pregabalin|pregabalin|mesh-list
5717644|NCT03232021|Analgesics|analgesics|mesh-ancestor
5717645|NCT03232021|Sensory System Agents|sensory system agents|mesh-ancestor
6512157|NCT00693381|Autonomic Agents|autonomic agents|mesh-ancestor
6512158|NCT00693381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6512159|NCT00693381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6512160|NCT00693381|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6512161|NCT00693381|Protective Agents|protective agents|mesh-ancestor
6512162|NCT00693407|Capsaicin|capsaicin|mesh-list
6512163|NCT00693407|Antipruritics|antipruritics|mesh-ancestor
6512164|NCT00693407|Dermatologic Agents|dermatologic agents|mesh-ancestor
6512165|NCT00693407|Sensory System Agents|sensory system agents|mesh-ancestor
6512166|NCT00693407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6512167|NCT00693407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512168|NCT00693433|Sirolimus|sirolimus|mesh-list
6512169|NCT00693433|Dexamethasone|dexamethasone|mesh-list
6512170|NCT00693433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6512171|NCT00693433|Antiemetics|antiemetics|mesh-ancestor
6512172|NCT00693433|Autonomic Agents|autonomic agents|mesh-ancestor
6512173|NCT00693433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6512174|NCT00693433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512175|NCT00693433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6512176|NCT00693433|Glucocorticoids|glucocorticoids|mesh-ancestor
6512177|NCT00693433|Hormones|hormones|mesh-ancestor
6512178|NCT00693433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6512179|NCT00693433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6512180|NCT00693433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6512181|NCT00693433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6512182|NCT00693433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6512183|NCT00693433|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6512184|NCT00693433|Antifungal Agents|antifungal agents|mesh-ancestor
6512185|NCT00693433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6512186|NCT00693433|Immunologic Factors|immunologic factors|mesh-ancestor
6512187|NCT00693446|Sirolimus|sirolimus|mesh-list
6512188|NCT00693446|Tacrolimus|tacrolimus|mesh-list
6512189|NCT00693446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6512190|NCT00693446|Immunologic Factors|immunologic factors|mesh-ancestor
6512191|NCT00693446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512192|NCT00693446|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6512193|NCT00693446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6512194|NCT00693446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512195|NCT00693446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6512196|NCT00693446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6512197|NCT00693446|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6512198|NCT00693446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6512199|NCT00693446|Antifungal Agents|antifungal agents|mesh-ancestor
6512200|NCT00693524|Mycophenolic Acid|mycophenolic acid|mesh-list
6512201|NCT00693524|Prednisone|prednisone|mesh-list
6512202|NCT00693524|Tacrolimus|tacrolimus|mesh-list
6512203|NCT00693524|Daclizumab|daclizumab|mesh-list
6512204|NCT00693524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6512205|NCT00693524|Glucocorticoids|glucocorticoids|mesh-ancestor
6512206|NCT00693524|Hormones|hormones|mesh-ancestor
6512207|NCT00693524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6512208|NCT00693524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512209|NCT00693524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6512210|NCT00693524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6512211|NCT00693524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6512212|NCT00693524|Immunologic Factors|immunologic factors|mesh-ancestor
6512213|NCT00693524|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6679737|NCT01599598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679738|NCT01599598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679739|NCT01599702|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
6679740|NCT01599702|Hematinics|hematinics|mesh-ancestor
6679741|NCT01599728|Substance P|substance p|mesh-list
6679742|NCT01599728|Neurokinin A|neurokinin a|mesh-list
6512214|NCT00693524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6512215|NCT00693524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512216|NCT00693524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6679743|NCT01599728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6679744|NCT01599728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679745|NCT01599728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679746|NCT01599819|Factor VIII|factor viii|mesh-list
6679747|NCT01599819|BAX 855|bax 855|mesh-list
6679748|NCT01599819|Coagulants|coagulants|mesh-ancestor
5717646|NCT03232021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5717647|NCT03232021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679749|NCT01599858|Omeprazole|omeprazole|mesh-list
6679750|NCT01599858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6679751|NCT01599858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6679752|NCT01599858|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6679753|NCT01599858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6679754|NCT01599858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679755|NCT01599871|Theophylline|theophylline|mesh-list
6679756|NCT01599871|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6679757|NCT01599871|Autonomic Agents|autonomic agents|mesh-ancestor
6679758|NCT01599871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6679759|NCT01599871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679760|NCT01599871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6679761|NCT01599871|Respiratory System Agents|respiratory system agents|mesh-ancestor
6679762|NCT01599871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6512217|NCT00693524|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6512218|NCT00693524|Antitubercular Agents|antitubercular agents|mesh-ancestor
6512219|NCT00693524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6512220|NCT00693524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6512221|NCT00693576|Simvastatin|simvastatin|mesh-list
6512222|NCT00693576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6512223|NCT00693576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6512224|NCT00693576|Antimetabolites|antimetabolites|mesh-ancestor
6512225|NCT00693576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679763|NCT01599871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6679764|NCT01599871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679765|NCT01599871|Vasodilator Agents|vasodilator agents|mesh-ancestor
6679766|NCT01599871|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6679767|NCT01599871|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6679768|NCT01599871|Purinergic Agents|purinergic agents|mesh-ancestor
6679769|NCT01599871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6679770|NCT01599884|Acetylcysteine|acetylcysteine|mesh-list
6679771|NCT01599884|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6679772|NCT01599884|Antiviral Agents|antiviral agents|mesh-ancestor
6679773|NCT01599884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6679774|NCT01599884|Expectorants|expectorants|mesh-ancestor
6512226|NCT00693576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6512227|NCT00693576|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6512228|NCT00693576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6512229|NCT00693589|Folic Acid|folic acid|mesh-list
6512230|NCT00693589|Vitamin B 12|vitamin b 12|mesh-list
6512231|NCT00693589|Hydroxocobalamin|hydroxocobalamin|mesh-list
6512232|NCT00693589|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6512233|NCT00693589|Vitamins|vitamins|mesh-ancestor
6512234|NCT00693589|Micronutrients|micronutrients|mesh-ancestor
6512235|NCT00693589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512236|NCT00693589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5717648|NCT03232021|Anticonvulsants|anticonvulsants|mesh-ancestor
6512237|NCT00693589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6512238|NCT00693589|Antimetabolites|antimetabolites|mesh-ancestor
6512239|NCT00693589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717649|NCT03232021|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5717650|NCT03232021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5717651|NCT03232021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717652|NCT03232021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5717653|NCT03232021|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5717654|NCT03232021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5717655|NCT03232021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5717656|NCT03232021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5717657|NCT03232112|Exenatide|exenatide|mesh-list
5717658|NCT03232112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6512240|NCT00693589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6512241|NCT00693589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6512242|NCT00693589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6512243|NCT00693589|Hematinics|hematinics|mesh-ancestor
6512244|NCT00693589|Vitamin B Complex|vitamin b complex|mesh-ancestor
6512245|NCT00693602|Asparaginase|asparaginase|mesh-list
6512246|NCT00693602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6512247|NCT00693615|Vaccines|vaccines|mesh-list
6512248|NCT00693615|Immunologic Factors|immunologic factors|mesh-ancestor
6512249|NCT00693615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512250|NCT00693680|Imipramine|imipramine|mesh-list
6512251|NCT00693680|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6512252|NCT00693680|Antidepressive Agents|antidepressive agents|mesh-ancestor
6512253|NCT00693680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6512254|NCT00693680|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6512255|NCT00693680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6512256|NCT00693680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6512257|NCT00693680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512258|NCT00693680|Adrenergic Agents|adrenergic agents|mesh-ancestor
6512259|NCT00693680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6512260|NCT00693680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512261|NCT00693732|Citalopram|citalopram|mesh-list
6512262|NCT00693732|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6512263|NCT00693732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6512264|NCT00693732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6512265|NCT00693732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512266|NCT00693732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6512267|NCT00693732|Serotonin Agents|serotonin agents|mesh-ancestor
6512268|NCT00693732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512269|NCT00693732|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6512270|NCT00693732|Antidepressive Agents|antidepressive agents|mesh-ancestor
6512271|NCT00693732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6512272|NCT00693758|Adenosine|adenosine|mesh-list
6512273|NCT00693758|Analgesics|analgesics|mesh-ancestor
6512274|NCT00693758|Sensory System Agents|sensory system agents|mesh-ancestor
6512275|NCT00693758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6512276|NCT00693758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512277|NCT00693758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6512278|NCT00693758|Vasodilator Agents|vasodilator agents|mesh-ancestor
6512279|NCT00693758|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6512280|NCT00693758|Purinergic Agonists|purinergic agonists|mesh-ancestor
6512281|NCT00693758|Purinergic Agents|purinergic agents|mesh-ancestor
6512282|NCT00693758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6512283|NCT00693758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512284|NCT00693771|Insulin Glargine|insulin glargine|mesh-list
6512285|NCT00693771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6512286|NCT00693771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512287|NCT00693849|Citalopram|citalopram|mesh-list
6512288|NCT00693849|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6512289|NCT00693849|Sertraline|sertraline|mesh-list
6512290|NCT00693849|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6512291|NCT00693849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6512292|NCT00693849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6512293|NCT00693849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512294|NCT00693849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6512295|NCT00693849|Serotonin Agents|serotonin agents|mesh-ancestor
6512296|NCT00693849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512297|NCT00693849|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5717659|NCT03232112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717660|NCT03232112|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5717661|NCT03232112|Incretins|incretins|mesh-ancestor
5717662|NCT03232112|Hormones|hormones|mesh-ancestor
5717663|NCT03232112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5717664|NCT03231722|Leucovorin|leucovorin|mesh-list
5717665|NCT03231722|Fluorouracil|fluorouracil|mesh-list
5717666|NCT03231722|Oxaliplatin|oxaliplatin|mesh-list
5717667|NCT03231722|Irinotecan|irinotecan|mesh-list
5717668|NCT03231722|Panitumumab|panitumumab|mesh-list
5717669|NCT03231722|Levoleucovorin|levoleucovorin|mesh-list
5717670|NCT03231722|Antimetabolites|antimetabolites|mesh-ancestor
6512298|NCT00693849|Antidepressive Agents|antidepressive agents|mesh-ancestor
6512299|NCT00693849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6512300|NCT00693849|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6512301|NCT00693862|Levodopa|levodopa|mesh-list
6512302|NCT00693862|Carbidopa|carbidopa|mesh-list
6512303|NCT00693862|Entacapone|entacapone|mesh-list
6512304|NCT00693862|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6512305|NCT00693862|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6512306|NCT00693862|Dopamine Agents|dopamine agents|mesh-ancestor
6512307|NCT00693862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6512308|NCT00693862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512309|NCT00693862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512310|NCT00693862|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6512311|NCT00693862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6512312|NCT00693862|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6512313|NCT00693927|Fludarabine|fludarabine|mesh-list
6512314|NCT00693927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6512315|NCT00693966|Vaccines|vaccines|mesh-list
6512316|NCT00693966|Immunologic Factors|immunologic factors|mesh-ancestor
6512317|NCT00693966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512318|NCT00693979|Paclitaxel|paclitaxel|mesh-list
6512319|NCT00693979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6679775|NCT01599884|Respiratory System Agents|respiratory system agents|mesh-ancestor
6679776|NCT01599884|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6679777|NCT01599884|Antioxidants|antioxidants|mesh-ancestor
6679778|NCT01599884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679779|NCT01599884|Protective Agents|protective agents|mesh-ancestor
6679780|NCT01599884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679781|NCT01599884|Antidotes|antidotes|mesh-ancestor
6679782|NCT01599923|Antivenins|antivenins|mesh-list
6512320|NCT00693979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6512321|NCT00693979|Tubulin Modulators|tubulin modulators|mesh-ancestor
6512322|NCT00693979|Antimitotic Agents|antimitotic agents|mesh-ancestor
6512323|NCT00693979|Mitosis Modulators|mitosis modulators|mesh-ancestor
6512324|NCT00693979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512325|NCT00694005|Sirolimus|sirolimus|mesh-list
6512326|NCT00694005|Paclitaxel|paclitaxel|mesh-list
6512327|NCT00694005|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6512328|NCT00694005|Everolimus|everolimus|mesh-list
6512329|NCT00694005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6512330|NCT00694005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6679783|NCT01599923|Immunologic Factors|immunologic factors|mesh-ancestor
6679784|NCT01599923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717671|NCT03231722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512331|NCT00694005|Tubulin Modulators|tubulin modulators|mesh-ancestor
6512332|NCT00694005|Antimitotic Agents|antimitotic agents|mesh-ancestor
6512333|NCT00694005|Mitosis Modulators|mitosis modulators|mesh-ancestor
6512334|NCT00694005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512335|NCT00694005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6512336|NCT00694005|Immunologic Factors|immunologic factors|mesh-ancestor
6512337|NCT00694005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512338|NCT00694005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6512339|NCT00694005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6512340|NCT00694005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6512341|NCT00694005|Antifungal Agents|antifungal agents|mesh-ancestor
6512342|NCT00694044|Varenicline|varenicline|mesh-list
6512343|NCT00694044|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6512344|NCT00694044|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6512345|NCT00694044|Cholinergic Agents|cholinergic agents|mesh-ancestor
6512346|NCT00694044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6512347|NCT00694044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512348|NCT00694044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512349|NCT00694148|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
6512350|NCT00694148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6512351|NCT00694148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6512352|NCT00694148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512353|NCT00694148|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6512354|NCT00694148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6512355|NCT00694148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512356|NCT00694148|Cholinergic Agents|cholinergic agents|mesh-ancestor
6512357|NCT00694148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6512358|NCT00694174|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6512359|NCT00694187|Zaleplon|zaleplon|mesh-list
6512360|NCT00694187|Anticonvulsants|anticonvulsants|mesh-ancestor
6512361|NCT00694187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6512362|NCT00694187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6512363|NCT00694187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512364|NCT00694187|GABA Modulators|gaba modulators|mesh-ancestor
6512365|NCT00694187|GABA Agents|gaba agents|mesh-ancestor
6512366|NCT00694187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6512367|NCT00694187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512368|NCT00694200|Bevacizumab|bevacizumab|mesh-list
6512369|NCT00694200|Vinorelbine|vinorelbine|mesh-list
6512370|NCT00694200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6512371|NCT00694200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6512372|NCT00694200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6512373|NCT00694200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6512374|NCT00694200|Growth Substances|growth substances|mesh-ancestor
6512375|NCT00694200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512376|NCT00694200|Growth Inhibitors|growth inhibitors|mesh-ancestor
6512377|NCT00694200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6512378|NCT00694200|Tubulin Modulators|tubulin modulators|mesh-ancestor
6512379|NCT00694200|Antimitotic Agents|antimitotic agents|mesh-ancestor
6512380|NCT00694200|Mitosis Modulators|mitosis modulators|mesh-ancestor
6512381|NCT00694200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512382|NCT00694252|Lapatinib|lapatinib|mesh-list
6512383|NCT00694252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6512384|NCT00694252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6512385|NCT00694252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6512386|NCT00694252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512387|NCT00694291|Sorafenib|sorafenib|mesh-list
6512388|NCT00694291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6512389|NCT00694291|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6512390|NCT00694291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6512391|NCT00694291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512392|NCT00694317|Zaleplon|zaleplon|mesh-list
6512393|NCT00694317|Anticonvulsants|anticonvulsants|mesh-ancestor
6512394|NCT00694317|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6512395|NCT00694317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6512396|NCT00694317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512397|NCT00694317|GABA Modulators|gaba modulators|mesh-ancestor
6512398|NCT00694317|GABA Agents|gaba agents|mesh-ancestor
6512399|NCT00694317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6512400|NCT00694317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512401|NCT00694330|Vaccines|vaccines|mesh-list
6512402|NCT00694330|Immunologic Factors|immunologic factors|mesh-ancestor
6512403|NCT00694330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512404|NCT00694343|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6512405|NCT00694408|Methylprednisolone|methylprednisolone|mesh-list
6512406|NCT00694408|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6512407|NCT00694408|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6512408|NCT00694408|Prednisolone|prednisolone|mesh-list
6512409|NCT00694408|Prednisolone acetate|prednisolone acetate|mesh-list
6512410|NCT00694408|Hydrocortisone|hydrocortisone|mesh-list
6512411|NCT00694408|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6512412|NCT00694408|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6512413|NCT00694408|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6512414|NCT00694408|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6512415|NCT00694408|Prednisolone phosphate|prednisolone phosphate|mesh-list
6512416|NCT00694408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6512417|NCT00694408|Antiemetics|antiemetics|mesh-ancestor
6512418|NCT00694408|Autonomic Agents|autonomic agents|mesh-ancestor
6512419|NCT00694408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6512420|NCT00694408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512421|NCT00694408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6512422|NCT00694408|Glucocorticoids|glucocorticoids|mesh-ancestor
6512423|NCT00694408|Hormones|hormones|mesh-ancestor
6679785|NCT01599936|Antivenins|antivenins|mesh-list
6512424|NCT00694408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6679786|NCT01599936|Immunologic Factors|immunologic factors|mesh-ancestor
6679787|NCT01599936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679788|NCT01599962|Cinacalcet|cinacalcet|mesh-list
6679789|NCT01599962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6679790|NCT01599962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512425|NCT00694408|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6512426|NCT00694408|Protective Agents|protective agents|mesh-ancestor
6512427|NCT00694408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6512428|NCT00694408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6512429|NCT00694460|Vaccines|vaccines|mesh-list
6512430|NCT00694460|Immunologic Factors|immunologic factors|mesh-ancestor
6512431|NCT00694460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512432|NCT00694590|Plerixafor|plerixafor|mesh-list
6512433|NCT00694590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6512434|NCT00694590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6512435|NCT00694590|Antiviral Agents|antiviral agents|mesh-ancestor
6512436|NCT00694590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6512437|NCT00694629|Rifampin|rifampin|mesh-list
6512438|NCT00694629|Rifapentine|rifapentine|mesh-list
6512439|NCT00694629|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6512440|NCT00694629|Antitubercular Agents|antitubercular agents|mesh-ancestor
6512441|NCT00694629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6679791|NCT01599962|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6679792|NCT01599962|Hormone Antagonists|hormone antagonists|mesh-ancestor
6679793|NCT01599962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6679794|NCT01599975|Methylphenidate|methylphenidate|mesh-list
6512442|NCT00694629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6512443|NCT00694629|Leprostatic Agents|leprostatic agents|mesh-ancestor
6512444|NCT00694629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6512445|NCT00694629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6512446|NCT00694629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512447|NCT00694629|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6512448|NCT00694629|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6512449|NCT00694629|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6512450|NCT00694629|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6512451|NCT00694629|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6512452|NCT00694629|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6512453|NCT00694694|Azithromycin|azithromycin|mesh-list
6512454|NCT00694694|Artesunate|artesunate|mesh-list
6512455|NCT00694694|Lumefantrine|lumefantrine|mesh-list
6512456|NCT00694694|Artemether|artemether|mesh-list
6512457|NCT00694694|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6512458|NCT00694694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6512459|NCT00694694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6512460|NCT00694694|Antimalarials|antimalarials|mesh-ancestor
6512461|NCT00694694|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6679795|NCT01599975|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6512462|NCT00694694|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6512463|NCT00694694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6512464|NCT00694694|Antiviral Agents|antiviral agents|mesh-ancestor
6512465|NCT00694694|Schistosomicides|schistosomicides|mesh-ancestor
6512466|NCT00694694|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6512467|NCT00694694|Anthelmintics|anthelmintics|mesh-ancestor
6512468|NCT00694733|Anastrozole|anastrozole|mesh-list
6512469|NCT00694733|Leuprolide|leuprolide|mesh-list
6512470|NCT00694733|Methyltestosterone|methyltestosterone|mesh-list
6512471|NCT00694733|Estradiol|estradiol|mesh-list
6512472|NCT00694733|Estrogens|estrogens|mesh-list
6512473|NCT00694733|Testosterone|testosterone|mesh-list
6512474|NCT00694733|Testosterone undecanoate|testosterone undecanoate|mesh-list
6512475|NCT00694733|Testosterone enanthate|testosterone enanthate|mesh-list
6512476|NCT00694733|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6512477|NCT00694733|Aromatase Inhibitors|aromatase inhibitors|mesh-list
6512478|NCT00694733|Hormones|hormones|mesh-ancestor
6512479|NCT00694733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6512480|NCT00694733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512481|NCT00694733|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6512482|NCT00694733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6512483|NCT00694733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6512484|NCT00694733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6512485|NCT00694733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6512486|NCT00694733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512487|NCT00694733|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6512488|NCT00694733|Hormone Antagonists|hormone antagonists|mesh-ancestor
6512489|NCT00694733|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6512490|NCT00694733|Fertility Agents|fertility agents|mesh-ancestor
6512491|NCT00694733|Androgens|androgens|mesh-ancestor
6512492|NCT00694733|Anabolic Agents|anabolic agents|mesh-ancestor
6512493|NCT00694759|Metformin|metformin|mesh-list
6512494|NCT00694759|Pioglitazone|pioglitazone|mesh-list
6512495|NCT00694759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6512496|NCT00694759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679796|NCT01599975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679797|NCT01599975|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6679798|NCT01599975|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6679799|NCT01599975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6679800|NCT01599975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679801|NCT01599975|Dopamine Agents|dopamine agents|mesh-ancestor
6679802|NCT01599975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6679803|NCT01599988|Caseins|caseins|mesh-list
6679804|NCT01599988|Chelating Agents|chelating agents|mesh-ancestor
6679805|NCT01599988|Sequestering Agents|sequestering agents|mesh-ancestor
6679806|NCT01599988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679807|NCT01600079|Vaccines|vaccines|mesh-list
6679808|NCT01600079|Immunologic Factors|immunologic factors|mesh-ancestor
6679809|NCT01600079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679810|NCT01600235|Phenylephrine|phenylephrine|mesh-list
6679811|NCT01600235|Oxymetazoline|oxymetazoline|mesh-list
6679812|NCT01600235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6679813|NCT01600235|Mydriatics|mydriatics|mesh-ancestor
6679814|NCT01600235|Autonomic Agents|autonomic agents|mesh-ancestor
6679815|NCT01600235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6679816|NCT01600235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679817|NCT01600235|Sympathomimetics|sympathomimetics|mesh-ancestor
6679818|NCT01600235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6679819|NCT01600235|Nasal Decongestants|nasal decongestants|mesh-ancestor
6679820|NCT01600235|Respiratory System Agents|respiratory system agents|mesh-ancestor
6679821|NCT01600235|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6679822|NCT01600235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6679823|NCT01600235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6679824|NCT01600235|Adrenergic Agents|adrenergic agents|mesh-ancestor
6679825|NCT01600235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6679826|NCT01600235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679827|NCT01600235|Protective Agents|protective agents|mesh-ancestor
6679828|NCT01600274|Dienogest|dienogest|mesh-list
6679829|NCT01600274|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6679830|NCT01600274|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6679831|NCT01600274|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6679832|NCT01600274|Estradiol|estradiol|mesh-list
6679833|NCT01600274|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6679834|NCT01600274|Nandrolone|nandrolone|mesh-list
6679835|NCT01600274|Estrogens|estrogens|mesh-ancestor
6679836|NCT01600274|Hormones|hormones|mesh-ancestor
6679837|NCT01600274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6679838|NCT01600274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679839|NCT01600274|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6679840|NCT01600274|Contraceptive Agents|contraceptive agents|mesh-ancestor
6679841|NCT01600274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6679842|NCT01600274|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6679843|NCT01600274|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6679844|NCT01600274|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6679845|NCT01600274|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6679846|NCT01600274|Hormone Antagonists|hormone antagonists|mesh-ancestor
6679847|NCT01600274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6679848|NCT01600274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6679849|NCT01600274|Androgens|androgens|mesh-ancestor
6679850|NCT01600274|Anabolic Agents|anabolic agents|mesh-ancestor
6679851|NCT01600365|Ganciclovir|ganciclovir|mesh-list
6679852|NCT01600365|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6679853|NCT01600365|Lubricant Eye Drops|lubricant eye drops|mesh-list
6679854|NCT01600365|Antiviral Agents|antiviral agents|mesh-ancestor
6679855|NCT01600365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6679856|NCT01600365|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6679857|NCT01600365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6679858|NCT01600365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679859|NCT01600365|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6679860|NCT01600365|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6679861|NCT01600404|Muscarinic Antagonists|muscarinic antagonists|mesh-list
6679862|NCT01600404|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6679863|NCT01600404|Cholinergic Agents|cholinergic agents|mesh-ancestor
6512497|NCT00694837|Nelfinavir|nelfinavir|mesh-list
6512498|NCT00694837|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6512499|NCT00694837|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6512500|NCT00694837|Protease Inhibitors|protease inhibitors|mesh-ancestor
6512501|NCT00694837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6512502|NCT00694837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512503|NCT00694837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6512504|NCT00694837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6512505|NCT00694837|Antiviral Agents|antiviral agents|mesh-ancestor
6512506|NCT00694837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6512507|NCT00694863|Cosyntropin|cosyntropin|mesh-list
6512508|NCT00694863|Adrenocorticotropin zinc|adrenocorticotropin zinc|mesh-list
6512509|NCT00694863|Hormones|hormones|mesh-ancestor
6512510|NCT00694863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6512511|NCT00694863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512512|NCT00694915|BCG Vaccine|bcg vaccine|mesh-list
6512513|NCT00694915|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6512514|NCT00694915|Immunologic Factors|immunologic factors|mesh-ancestor
6512515|NCT00694915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512516|NCT00694967|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
6512517|NCT00694967|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
6679864|NCT01600404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6679865|NCT01600404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679866|NCT01600404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679867|NCT01600430|Vitamin D|vitamin d|mesh-list
6679868|NCT01600430|Ergocalciferols|ergocalciferols|mesh-list
6679869|NCT01600430|Cholecalciferol|cholecalciferol|mesh-list
6679870|NCT01600430|Vitamins|vitamins|mesh-list
6679871|NCT01600430|Micronutrients|micronutrients|mesh-ancestor
6679872|NCT01600430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679873|NCT01600430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6679874|NCT01600430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6679875|NCT01600456|Sertraline|sertraline|mesh-list
6679876|NCT01600456|Antidepressive Agents|antidepressive agents|mesh-ancestor
6679877|NCT01600456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6512518|NCT00694967|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6512519|NCT00694967|Hormone Antagonists|hormone antagonists|mesh-ancestor
6512520|NCT00694967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6512521|NCT00694967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512522|NCT00694967|Progestins|progestins|mesh-ancestor
6512523|NCT00694967|Hormones|hormones|mesh-ancestor
6512524|NCT00694980|Etrolizumab|etrolizumab|mesh-list
6512525|NCT00694980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6512526|NCT00694980|Immunologic Factors|immunologic factors|mesh-ancestor
6512527|NCT00694980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512528|NCT00695032|Ifosfamide|ifosfamide|mesh-list
6512529|NCT00695032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6512530|NCT00695032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6512531|NCT00695032|Alkylating Agents|alkylating agents|mesh-ancestor
6512532|NCT00695032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512533|NCT00695045|Morphine|morphine|mesh-list
6512534|NCT00695045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6512535|NCT00695045|Narcotics|narcotics|mesh-ancestor
6512536|NCT00695045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6512537|NCT00695045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512538|NCT00695045|Analgesics|analgesics|mesh-ancestor
6512539|NCT00695045|Sensory System Agents|sensory system agents|mesh-ancestor
6512540|NCT00695045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6512541|NCT00695071|Itraconazole|itraconazole|mesh-list
6512542|NCT00695071|Antifungal Agents|antifungal agents|mesh-ancestor
6512543|NCT00695071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6512544|NCT00695071|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6512545|NCT00695071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6512546|NCT00695071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6512547|NCT00695071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512548|NCT00695071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6512549|NCT00695071|Hormone Antagonists|hormone antagonists|mesh-ancestor
6512550|NCT00695071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6512551|NCT00695071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512552|NCT00695071|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6512553|NCT00695201|Oxaliplatin|oxaliplatin|mesh-list
6679878|NCT01600456|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6679879|NCT01600456|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6512554|NCT00695201|Irinotecan|irinotecan|mesh-list
6512555|NCT00695201|Floxuridine|floxuridine|mesh-list
6512556|NCT00695201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6512557|NCT00695201|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6512558|NCT00695201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6512559|NCT00695201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6512560|NCT00695201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512561|NCT00695201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6512562|NCT00695201|Antimetabolites|antimetabolites|mesh-ancestor
6512563|NCT00695214|Propofol|propofol|mesh-list
6512564|NCT00695214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6512565|NCT00695214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6512566|NCT00695214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512567|NCT00695214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6512568|NCT00695214|Anesthetics, General|anesthetics, general|mesh-ancestor
6512569|NCT00695214|Anesthetics|anesthetics|mesh-ancestor
6512570|NCT00695240|Bupivacaine|bupivacaine|mesh-list
6512571|NCT00695240|Anesthetics, Local|anesthetics, local|mesh-ancestor
6512572|NCT00695240|Anesthetics|anesthetics|mesh-ancestor
6512573|NCT00695240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6512574|NCT00695240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512575|NCT00695240|Sensory System Agents|sensory system agents|mesh-ancestor
6512576|NCT00695240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6512577|NCT00695331|Misoprostol|misoprostol|mesh-list
6512578|NCT00695331|Oxytocin|oxytocin|mesh-list
6512579|NCT00695331|Oxytocics|oxytocics|mesh-ancestor
6512580|NCT00695331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6512581|NCT00695331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512582|NCT00695331|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6512583|NCT00695331|Abortifacient Agents|abortifacient agents|mesh-ancestor
6512584|NCT00695331|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6512585|NCT00695331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6512586|NCT00695344|Mycophenolic Acid|mycophenolic acid|mesh-list
6512587|NCT00695344|Everolimus|everolimus|mesh-list
6512588|NCT00695344|Azathioprine|azathioprine|mesh-list
6512589|NCT00695344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6512590|NCT00695344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6512591|NCT00695344|Immunologic Factors|immunologic factors|mesh-ancestor
6512592|NCT00695344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512593|NCT00695344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6512594|NCT00695344|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6512595|NCT00695344|Antitubercular Agents|antitubercular agents|mesh-ancestor
6512596|NCT00695344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6512597|NCT00695344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6512598|NCT00695344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6512599|NCT00695344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512600|NCT00695344|Antimetabolites|antimetabolites|mesh-ancestor
6512601|NCT00695344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6512602|NCT00695344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6512603|NCT00695604|Fluticasone|fluticasone|mesh-list
6512604|NCT00695604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6512605|NCT00695604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6512606|NCT00695604|Autonomic Agents|autonomic agents|mesh-ancestor
6512607|NCT00695604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6512608|NCT00695604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512609|NCT00695604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6512610|NCT00695604|Respiratory System Agents|respiratory system agents|mesh-ancestor
6512611|NCT00695604|Dermatologic Agents|dermatologic agents|mesh-ancestor
6512612|NCT00695604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6512613|NCT00695630|Flumazenil|flumazenil|mesh-list
6512614|NCT00695630|Antidotes|antidotes|mesh-ancestor
6512615|NCT00695630|Protective Agents|protective agents|mesh-ancestor
6512616|NCT00695630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512617|NCT00695630|GABA Modulators|gaba modulators|mesh-ancestor
6512618|NCT00695630|GABA Agents|gaba agents|mesh-ancestor
6512619|NCT00695630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6512620|NCT00695630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512621|NCT00695643|Mesalamine|mesalamine|mesh-list
6512622|NCT00695643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6512623|NCT00695643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6512624|NCT00695643|Analgesics|analgesics|mesh-ancestor
6512625|NCT00695643|Sensory System Agents|sensory system agents|mesh-ancestor
6512626|NCT00695643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6512627|NCT00695643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512628|NCT00695643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6512629|NCT00695643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6512630|NCT00695682|Infliximab|infliximab|mesh-list
6512631|NCT00695682|Dermatologic Agents|dermatologic agents|mesh-ancestor
6512632|NCT00695682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6512633|NCT00695682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6512634|NCT00695929|Simendan|simendan|mesh-list
6512635|NCT00695929|Milrinone|milrinone|mesh-list
6512636|NCT00695929|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6512637|NCT00695929|Vasodilator Agents|vasodilator agents|mesh-ancestor
6512638|NCT00695929|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6512639|NCT00695929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6512640|NCT00695929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6679880|NCT01600456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6679881|NCT01600456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679882|NCT01600456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6679883|NCT01600456|Serotonin Agents|serotonin agents|mesh-ancestor
6679884|NCT01600456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679885|NCT01600573|Topotecan|topotecan|mesh-list
6679886|NCT01600573|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6679887|NCT01600573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6679888|NCT01600573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6679889|NCT01600573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679890|NCT01600573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6679891|NCT01600599|Tranexamic Acid|tranexamic acid|mesh-list
6679892|NCT01600599|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6512641|NCT00695929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512642|NCT00695929|Protective Agents|protective agents|mesh-ancestor
6512643|NCT00695929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679893|NCT01600599|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6679894|NCT01600599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679895|NCT01600599|Hemostatics|hemostatics|mesh-ancestor
6679896|NCT01600599|Coagulants|coagulants|mesh-ancestor
6679897|NCT01600612|Oxytocin|oxytocin|mesh-list
6679898|NCT01600612|Carbetocin|carbetocin|mesh-list
6679899|NCT01600612|Oxytocics|oxytocics|mesh-ancestor
6679900|NCT01600612|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6679901|NCT01600612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512644|NCT00695929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6512645|NCT00695994|Gemcitabine|gemcitabine|mesh-list
6512646|NCT00695994|Carboplatin|carboplatin|mesh-list
6512647|NCT00695994|Docetaxel|docetaxel|mesh-list
6512648|NCT00695994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6512649|NCT00695994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6512650|NCT00695994|Antimetabolites|antimetabolites|mesh-ancestor
6512651|NCT00695994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512652|NCT00695994|Antiviral Agents|antiviral agents|mesh-ancestor
6512653|NCT00695994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6512654|NCT00695994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6512655|NCT00695994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6512656|NCT00695994|Immunologic Factors|immunologic factors|mesh-ancestor
6512657|NCT00695994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512658|NCT00695994|Tubulin Modulators|tubulin modulators|mesh-ancestor
6512659|NCT00695994|Antimitotic Agents|antimitotic agents|mesh-ancestor
6512660|NCT00695994|Mitosis Modulators|mitosis modulators|mesh-ancestor
6512661|NCT00696007|Gemcitabine|gemcitabine|mesh-list
6512662|NCT00696007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6512663|NCT00696007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6512664|NCT00696007|Antimetabolites|antimetabolites|mesh-ancestor
6512665|NCT00696007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512666|NCT00696007|Antiviral Agents|antiviral agents|mesh-ancestor
6512667|NCT00696007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6512668|NCT00696007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6512669|NCT00696007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6512670|NCT00696007|Immunologic Factors|immunologic factors|mesh-ancestor
6512671|NCT00696007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512672|NCT00696033|Diazepam|diazepam|mesh-list
6512673|NCT00696033|Lorazepam|lorazepam|mesh-list
6512674|NCT00696033|Anticonvulsants|anticonvulsants|mesh-ancestor
6512675|NCT00696033|Antiemetics|antiemetics|mesh-ancestor
6512676|NCT00696033|Autonomic Agents|autonomic agents|mesh-ancestor
6512677|NCT00696033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6512678|NCT00696033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512679|NCT00696033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6512680|NCT00696033|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6512681|NCT00696033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6512682|NCT00696033|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6512683|NCT00696033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6679902|NCT01600625|Minocycline|minocycline|mesh-list
6679903|NCT01600625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5717672|NCT03231722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5717673|NCT03231722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5717674|NCT03231722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5717675|NCT03231722|Immunologic Factors|immunologic factors|mesh-ancestor
6512684|NCT00696033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6512685|NCT00696033|GABA Modulators|gaba modulators|mesh-ancestor
6512686|NCT00696033|GABA Agents|gaba agents|mesh-ancestor
6512687|NCT00696033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6512688|NCT00696033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512689|NCT00696033|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6512690|NCT00696033|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6512691|NCT00696033|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6512692|NCT00696033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6512693|NCT00696033|Anesthetics, General|anesthetics, general|mesh-ancestor
6512694|NCT00696033|Anesthetics|anesthetics|mesh-ancestor
6512695|NCT00696059|Adalimumab|adalimumab|mesh-list
6512696|NCT00696059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6512697|NCT00696059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6512698|NCT00696098|Butyric Acid|butyric acid|mesh-list
6512699|NCT00696098|Histamine Antagonists|histamine antagonists|mesh-ancestor
6512700|NCT00696098|Histamine Agents|histamine agents|mesh-ancestor
6512701|NCT00696098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6512702|NCT00696098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512703|NCT00696098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512704|NCT00696111|Leuprolide|leuprolide|mesh-list
6512705|NCT00696111|Progesterone|progesterone|mesh-list
6512706|NCT00696111|Estrogens|estrogens|mesh-list
6512707|NCT00696111|Progestins|progestins|mesh-ancestor
6512708|NCT00696111|Hormones|hormones|mesh-ancestor
6512709|NCT00696111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6512710|NCT00696111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512711|NCT00696111|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6512712|NCT00696111|Fertility Agents|fertility agents|mesh-ancestor
6512713|NCT00696111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6512714|NCT00696111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6512715|NCT00696111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6512716|NCT00696163|Insulin Aspart|insulin aspart|mesh-list
6512717|NCT00696163|Biphasic Insulins|biphasic insulins|mesh-list
5717676|NCT03231722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717677|NCT03231722|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5717678|NCT03231722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5717679|NCT03231722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5717680|NCT03231722|Antidotes|antidotes|mesh-ancestor
5717681|NCT03231722|Protective Agents|protective agents|mesh-ancestor
5717682|NCT03231722|Vitamin B Complex|vitamin b complex|mesh-ancestor
6512718|NCT00696163|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6512719|NCT00696163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6512720|NCT00696163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512721|NCT00696202|Levonorgestrel|levonorgestrel|mesh-list
6512722|NCT00696202|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5717683|NCT03231722|Vitamins|vitamins|mesh-ancestor
6512723|NCT00696202|Contraceptive Agents|contraceptive agents|mesh-ancestor
6512724|NCT00696202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6512725|NCT00696202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512726|NCT00696202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6512727|NCT00696202|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6512728|NCT00696202|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6512729|NCT00696215|Rasagiline|rasagiline|mesh-list
6512730|NCT00696215|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6512731|NCT00696215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6512732|NCT00696215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512733|NCT00696215|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6512734|NCT00696215|Protective Agents|protective agents|mesh-ancestor
6512735|NCT00696215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512736|NCT00696475|Diazoxide|diazoxide|mesh-list
6512737|NCT00696475|Choline|choline|mesh-list
6512738|NCT00696475|Lipotropic Agents|lipotropic agents|mesh-ancestor
6512739|NCT00696475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6512740|NCT00696475|Antimetabolites|antimetabolites|mesh-ancestor
6512741|NCT00696475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512742|NCT00696475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6512743|NCT00696475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6512744|NCT00696475|Nootropic Agents|nootropic agents|mesh-ancestor
6512745|NCT00696475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6512746|NCT00696475|Vasodilator Agents|vasodilator agents|mesh-ancestor
6512747|NCT00696514|Vitamin D|vitamin d|mesh-list
6512748|NCT00696514|Ergocalciferols|ergocalciferols|mesh-list
6512749|NCT00696514|Cholecalciferol|cholecalciferol|mesh-list
6512750|NCT00696514|Vitamins|vitamins|mesh-list
6512751|NCT00696514|Folic Acid|folic acid|mesh-list
6512752|NCT00696514|Vitamin B 12|vitamin b 12|mesh-list
6512753|NCT00696514|Hydroxocobalamin|hydroxocobalamin|mesh-list
6512754|NCT00696514|Micronutrients|micronutrients|mesh-ancestor
6512755|NCT00696514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512756|NCT00696514|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6512757|NCT00696514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6512758|NCT00696514|Hematinics|hematinics|mesh-ancestor
6512759|NCT00696514|Vitamin B Complex|vitamin b complex|mesh-ancestor
6512760|NCT00696540|Albuterol|albuterol|mesh-list
6512761|NCT00696540|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6512762|NCT00696540|Autonomic Agents|autonomic agents|mesh-ancestor
6512763|NCT00696540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6512764|NCT00696540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512765|NCT00696540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6512766|NCT00696540|Respiratory System Agents|respiratory system agents|mesh-ancestor
6512767|NCT00696540|Tocolytic Agents|tocolytic agents|mesh-ancestor
6679904|NCT01600625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6679905|NCT01600742|Vorinostat|vorinostat|mesh-list
6679906|NCT01600742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6679907|NCT01600742|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6679908|NCT01600742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6679909|NCT01600742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679910|NCT01600768|Lactams|lactams|mesh-list
6679911|NCT01600768|beta-Lactams|beta-lactams|mesh-list
6512768|NCT00696540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6512769|NCT00696540|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6512770|NCT00696540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6512771|NCT00696540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6512772|NCT00696540|Adrenergic Agents|adrenergic agents|mesh-ancestor
6512773|NCT00696540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6512774|NCT00696540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512775|NCT00696566|Rifampin|rifampin|mesh-list
6512776|NCT00696566|Clopidogrel|clopidogrel|mesh-list
6512777|NCT00696566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6512778|NCT00696566|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6512779|NCT00696566|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6512780|NCT00696566|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6512781|NCT00696566|Purinergic Agents|purinergic agents|mesh-ancestor
6512782|NCT00696566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6512783|NCT00696566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512784|NCT00696566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512785|NCT00696566|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6512786|NCT00696566|Antitubercular Agents|antitubercular agents|mesh-ancestor
6512787|NCT00696566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6512788|NCT00696566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6512789|NCT00696566|Leprostatic Agents|leprostatic agents|mesh-ancestor
6512790|NCT00696566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6512791|NCT00696566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6512792|NCT00696566|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6512793|NCT00696566|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6512794|NCT00696566|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6512795|NCT00696566|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6512796|NCT00696566|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6512797|NCT00696566|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6512798|NCT00696579|Gemcitabine|gemcitabine|mesh-list
6512799|NCT00696579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6512800|NCT00696579|Antimetabolites|antimetabolites|mesh-ancestor
6512801|NCT00696579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512802|NCT00696579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6512803|NCT00696579|Antiviral Agents|antiviral agents|mesh-ancestor
6512804|NCT00696579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6512805|NCT00696579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6512806|NCT00696579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6512807|NCT00696579|Immunologic Factors|immunologic factors|mesh-ancestor
6512808|NCT00696579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512809|NCT00696592|Bevacizumab|bevacizumab|mesh-list
6512810|NCT00696592|Verteporfin|verteporfin|mesh-list
6512811|NCT00696592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6512812|NCT00696592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6512813|NCT00696592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6512814|NCT00696592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6512815|NCT00696592|Growth Substances|growth substances|mesh-ancestor
6512816|NCT00696592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512817|NCT00696592|Growth Inhibitors|growth inhibitors|mesh-ancestor
6512818|NCT00696592|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6512819|NCT00696592|Dermatologic Agents|dermatologic agents|mesh-ancestor
6679912|NCT01600768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6679913|NCT01600768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6679914|NCT01600807|Gemcitabine|gemcitabine|mesh-list
6679915|NCT01600807|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6679916|NCT01600807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6679917|NCT01600807|Antimetabolites|antimetabolites|mesh-ancestor
6679918|NCT01600807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679919|NCT01600807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6679920|NCT01600807|Antiviral Agents|antiviral agents|mesh-ancestor
6679921|NCT01600807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6679922|NCT01600807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6679923|NCT01600807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6679924|NCT01600807|Immunologic Factors|immunologic factors|mesh-ancestor
6679925|NCT01600807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679926|NCT01600807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6779811|NCT02181218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6779812|NCT02181218|Antiemetics|antiemetics|mesh-ancestor
6779813|NCT02181218|Autonomic Agents|autonomic agents|mesh-ancestor
6779814|NCT02181218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6779815|NCT02181218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779816|NCT02181218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6779817|NCT02181218|Glucocorticoids|glucocorticoids|mesh-ancestor
6779818|NCT02181218|Hormones|hormones|mesh-ancestor
6779819|NCT02181218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6779820|NCT02181218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6779821|NCT02181218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6779822|NCT02181218|Protease Inhibitors|protease inhibitors|mesh-ancestor
6779823|NCT02181218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6779824|NCT02181218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779825|NCT02181218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6779826|NCT02181218|Antimetabolites|antimetabolites|mesh-ancestor
6779827|NCT02181218|Antiviral Agents|antiviral agents|mesh-ancestor
6779828|NCT02181218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6779829|NCT02181218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6779830|NCT02181218|Immunologic Factors|immunologic factors|mesh-ancestor
6779831|NCT02181218|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6779832|NCT02181309|Meloxicam|meloxicam|mesh-list
6779833|NCT02181309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6779834|NCT02181309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6779835|NCT02181309|Analgesics|analgesics|mesh-ancestor
6779836|NCT02181309|Sensory System Agents|sensory system agents|mesh-ancestor
6779837|NCT02181309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6779838|NCT02181309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779839|NCT02181309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6779840|NCT02181309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6779841|NCT02181309|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6779842|NCT02181309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6779843|NCT02181309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6779844|NCT02181309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779845|NCT02181322|Meloxicam|meloxicam|mesh-list
6779846|NCT02181322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6779847|NCT02181322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6779848|NCT02181322|Analgesics|analgesics|mesh-ancestor
6779849|NCT02181322|Sensory System Agents|sensory system agents|mesh-ancestor
6779850|NCT02181322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6779851|NCT02181322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779852|NCT02181322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6779853|NCT02181322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6779854|NCT02181322|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6779855|NCT02181322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6779856|NCT02181322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6779857|NCT02181322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779858|NCT02181335|Budesonide|budesonide|mesh-list
6779859|NCT02181335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6779860|NCT02181335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6779861|NCT02181335|Autonomic Agents|autonomic agents|mesh-ancestor
6779862|NCT02181335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6512820|NCT00696631|Dronedarone|dronedarone|mesh-list
6512821|NCT00696631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6512822|NCT00696644|Teriparatide|teriparatide|mesh-list
6512823|NCT00696644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6512824|NCT00696644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512825|NCT00696644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6512826|NCT00696722|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6512827|NCT00696722|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6512828|NCT00696722|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6512829|NCT00696722|Protease Inhibitors|protease inhibitors|mesh-ancestor
6512830|NCT00696722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6512831|NCT00696722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512832|NCT00696722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6512833|NCT00696722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6512834|NCT00696722|Antiviral Agents|antiviral agents|mesh-ancestor
6512835|NCT00696722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6512836|NCT00696748|Methyltestosterone|methyltestosterone|mesh-list
6512837|NCT00696748|Testosterone|testosterone|mesh-list
6512838|NCT00696748|Testosterone undecanoate|testosterone undecanoate|mesh-list
6512839|NCT00696748|Testosterone enanthate|testosterone enanthate|mesh-list
6512840|NCT00696748|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6512841|NCT00696748|Androgens|androgens|mesh-ancestor
6512842|NCT00696748|Hormones|hormones|mesh-ancestor
6512843|NCT00696748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6512844|NCT00696748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512845|NCT00696748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6512846|NCT00696748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6512847|NCT00696748|Anabolic Agents|anabolic agents|mesh-ancestor
6512848|NCT00696826|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6512849|NCT00696826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6512850|NCT00696826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512851|NCT00696826|Incretins|incretins|mesh-ancestor
6512852|NCT00696826|Hormones|hormones|mesh-ancestor
6512853|NCT00696826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6512854|NCT00696826|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6512855|NCT00696826|Protease Inhibitors|protease inhibitors|mesh-ancestor
6512856|NCT00696826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6512857|NCT00696826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512858|NCT00696930|Edotreotide|edotreotide|mesh-list
6512859|NCT00696930|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6512860|NCT00696930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512861|NCT00696956|Paclitaxel|paclitaxel|mesh-list
5717684|NCT03231722|Micronutrients|micronutrients|mesh-ancestor
5717685|NCT03231722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5717686|NCT03231813|Emollients|emollients|mesh-list
5717687|NCT03231813|Dermatologic Agents|dermatologic agents|mesh-ancestor
5717688|NCT03231683|Ketamine|ketamine|mesh-list
5717689|NCT03231683|Remifentanil|remifentanil|mesh-list
5717690|NCT03231683|Propofol|propofol|mesh-list
5717691|NCT03231683|Esketamine|esketamine|mesh-list
5717692|NCT03231683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5717693|NCT03231683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5717694|NCT03231683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717695|NCT03231683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5717696|NCT03231683|Anesthetics, General|anesthetics, general|mesh-ancestor
5717697|NCT03231683|Anesthetics|anesthetics|mesh-ancestor
5717698|NCT03231683|Analgesics|analgesics|mesh-ancestor
5717699|NCT03231683|Sensory System Agents|sensory system agents|mesh-ancestor
5717700|NCT03231683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5717701|NCT03231683|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5717702|NCT03231683|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5717703|NCT03231683|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5717704|NCT03231683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5717705|NCT03231683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919420|NCT04981951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5919421|NCT04981951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919422|NCT04982237|Paclitaxel|paclitaxel|mesh-list
5919423|NCT04982237|Bevacizumab|bevacizumab|mesh-list
5919424|NCT04982237|Carboplatin|carboplatin|mesh-list
5919425|NCT04982237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5919426|NCT04982237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5919427|NCT04982237|Tubulin Modulators|tubulin modulators|mesh-ancestor
5919428|NCT04982237|Antimitotic Agents|antimitotic agents|mesh-ancestor
5919429|NCT04982237|Mitosis Modulators|mitosis modulators|mesh-ancestor
6679927|NCT01600963|Bedaquiline|bedaquiline|mesh-list
6679928|NCT01600963|Diarylquinolines|diarylquinolines|mesh-list
6679929|NCT01600963|Antitubercular Agents|antitubercular agents|mesh-ancestor
6512862|NCT00696956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6512863|NCT00696956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6512864|NCT00696956|Tubulin Modulators|tubulin modulators|mesh-ancestor
6512865|NCT00696956|Antimitotic Agents|antimitotic agents|mesh-ancestor
6512866|NCT00696956|Mitosis Modulators|mitosis modulators|mesh-ancestor
6512867|NCT00696956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512868|NCT00696969|Amphotericin B|amphotericin b|mesh-list
6512869|NCT00696969|Paromomycin|paromomycin|mesh-list
6512870|NCT00696969|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6512871|NCT00696969|Miltefosine|miltefosine|mesh-list
6512872|NCT00696969|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
6512873|NCT00696969|Deoxycholic Acid|deoxycholic acid|mesh-list
6512874|NCT00696969|Amebicides|amebicides|mesh-ancestor
6512875|NCT00696969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6512876|NCT00696969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6512877|NCT00696969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6512878|NCT00696969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6512879|NCT00696969|Antifungal Agents|antifungal agents|mesh-ancestor
6512880|NCT00696969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6512881|NCT00696969|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6512882|NCT00696969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6512883|NCT00696982|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6512884|NCT00696982|Glyburide|glyburide|mesh-list
6512885|NCT00696982|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6512886|NCT00696982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512887|NCT00696982|Incretins|incretins|mesh-ancestor
6512888|NCT00696982|Hormones|hormones|mesh-ancestor
6512889|NCT00696982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6512890|NCT00696982|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6512891|NCT00696982|Protease Inhibitors|protease inhibitors|mesh-ancestor
6512892|NCT00696982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6512893|NCT00696982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512894|NCT00696995|Insulin Aspart|insulin aspart|mesh-list
6512895|NCT00696995|Biphasic Insulins|biphasic insulins|mesh-list
6512896|NCT00696995|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6512897|NCT00696995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6512898|NCT00696995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512899|NCT00697021|Aspirin|aspirin|mesh-list
6512900|NCT00697021|Clopidogrel|clopidogrel|mesh-list
6512901|NCT00697021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6512902|NCT00697021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5717706|NCT03231683|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5717707|NCT03231683|Narcotics|narcotics|mesh-ancestor
5717708|NCT03231683|Antidepressive Agents|antidepressive agents|mesh-ancestor
6512903|NCT00697021|Analgesics|analgesics|mesh-ancestor
6512904|NCT00697021|Sensory System Agents|sensory system agents|mesh-ancestor
6512905|NCT00697021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6512906|NCT00697021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512907|NCT00697021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6512908|NCT00697021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6512909|NCT00697021|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6512910|NCT00697021|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6512911|NCT00697021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512912|NCT00697021|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6512913|NCT00697021|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6512914|NCT00697021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6512915|NCT00697021|Antipyretics|antipyretics|mesh-ancestor
6512916|NCT00697021|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6512917|NCT00697021|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6512918|NCT00697021|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6512919|NCT00697021|Purinergic Agents|purinergic agents|mesh-ancestor
6512920|NCT00697021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5717709|NCT03231683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5717710|NCT03231436|Bupivacaine|bupivacaine|mesh-list
5717711|NCT03231436|Anesthetics, Local|anesthetics, local|mesh-ancestor
5717712|NCT03231436|Anesthetics|anesthetics|mesh-ancestor
6512921|NCT00697034|Capsaicin|capsaicin|mesh-list
6512922|NCT00697034|Antipruritics|antipruritics|mesh-ancestor
6512923|NCT00697034|Dermatologic Agents|dermatologic agents|mesh-ancestor
6512924|NCT00697034|Sensory System Agents|sensory system agents|mesh-ancestor
6512925|NCT00697034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6512926|NCT00697034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512927|NCT00697060|Docetaxel|docetaxel|mesh-list
5717713|NCT03231436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6512928|NCT00697060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6512929|NCT00697060|Tubulin Modulators|tubulin modulators|mesh-ancestor
6512930|NCT00697060|Antimitotic Agents|antimitotic agents|mesh-ancestor
6512931|NCT00697060|Mitosis Modulators|mitosis modulators|mesh-ancestor
6512932|NCT00697060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512933|NCT00697086|Dronedarone|dronedarone|mesh-list
6512934|NCT00697086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6512935|NCT00697125|Vaccines|vaccines|mesh-list
6512936|NCT00697125|Immunologic Factors|immunologic factors|mesh-ancestor
6512937|NCT00697125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512938|NCT00697138|Amphetamine|amphetamine|mesh-list
6512939|NCT00697138|Dextroamphetamine|dextroamphetamine|mesh-list
6512940|NCT00697138|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6512941|NCT00697138|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6512942|NCT00697138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6512943|NCT00697138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6512944|NCT00697138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512945|NCT00697138|Adrenergic Agents|adrenergic agents|mesh-ancestor
6512946|NCT00697138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6512947|NCT00697138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512948|NCT00697138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6512949|NCT00697138|Sympathomimetics|sympathomimetics|mesh-ancestor
6512950|NCT00697138|Autonomic Agents|autonomic agents|mesh-ancestor
6512951|NCT00697138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6679930|NCT01600963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6679931|NCT01600963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6679932|NCT01601002|Mirtazapine|mirtazapine|mesh-list
6679933|NCT01601002|Antidepressive Agents|antidepressive agents|mesh-ancestor
6512952|NCT00697138|Dopamine Agents|dopamine agents|mesh-ancestor
5717714|NCT03231436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717715|NCT03231436|Sensory System Agents|sensory system agents|mesh-ancestor
5717716|NCT03231436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5717717|NCT03231176|Capecitabine|capecitabine|mesh-list
5717718|NCT03231176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5717719|NCT03231176|Antimetabolites|antimetabolites|mesh-ancestor
5717720|NCT03231176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717721|NCT03231176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5717722|NCT03231215|Dexamethasone|dexamethasone|mesh-list
5717723|NCT03231215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5717724|NCT03231215|Antiemetics|antiemetics|mesh-ancestor
6512953|NCT00697138|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6512954|NCT00697151|Aspirin|aspirin|mesh-list
6512955|NCT00697151|Warfarin|warfarin|mesh-list
6512956|NCT00697151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6512957|NCT00697151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6512958|NCT00697151|Analgesics|analgesics|mesh-ancestor
6512959|NCT00697151|Sensory System Agents|sensory system agents|mesh-ancestor
6679934|NCT01601002|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6679935|NCT01601002|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6679936|NCT01601002|Histamine Antagonists|histamine antagonists|mesh-ancestor
6679937|NCT01601002|Histamine Agents|histamine agents|mesh-ancestor
6679938|NCT01601002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5717725|NCT03231215|Autonomic Agents|autonomic agents|mesh-ancestor
6512960|NCT00697151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6512961|NCT00697151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512962|NCT00697151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6512963|NCT00697151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6512964|NCT00697151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6512965|NCT00697151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6512966|NCT00697151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512967|NCT00697151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6512968|NCT00697151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6512969|NCT00697151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6512970|NCT00697151|Antipyretics|antipyretics|mesh-ancestor
6512971|NCT00697151|Anticoagulants|anticoagulants|mesh-ancestor
6512972|NCT00697164|Epoetin Alfa|epoetin alfa|mesh-list
6512973|NCT00697164|Hematinics|hematinics|mesh-ancestor
6512974|NCT00697281|Indoleacetic Acids|indoleacetic acids|mesh-list
6512975|NCT00697281|Plant Growth Regulators|plant growth regulators|mesh-ancestor
6512976|NCT00697281|Growth Substances|growth substances|mesh-ancestor
6512977|NCT00697281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679939|NCT01601002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512978|NCT00697372|Sirolimus|sirolimus|mesh-list
6512979|NCT00697372|Everolimus|everolimus|mesh-list
6512980|NCT00697372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6512981|NCT00697372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6679940|NCT01601002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679941|NCT01601002|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6512982|NCT00697372|Immunologic Factors|immunologic factors|mesh-ancestor
6512983|NCT00697372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6512984|NCT00697372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6512985|NCT00697372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6512986|NCT00697372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6512987|NCT00697372|Antifungal Agents|antifungal agents|mesh-ancestor
6512988|NCT00697385|Tranexamic Acid|tranexamic acid|mesh-list
6512989|NCT00697385|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6512990|NCT00697385|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6512991|NCT00697385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6512992|NCT00697385|Hemostatics|hemostatics|mesh-ancestor
6512993|NCT00697385|Coagulants|coagulants|mesh-ancestor
6512994|NCT00697437|Ketoconazole|ketoconazole|mesh-list
6512995|NCT00697437|Docetaxel|docetaxel|mesh-list
6512996|NCT00697437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6512997|NCT00697437|Tubulin Modulators|tubulin modulators|mesh-ancestor
6679942|NCT01601002|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6679943|NCT01601002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6679944|NCT01601002|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6679945|NCT01601002|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6679946|NCT01601002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6679947|NCT01601002|Adrenergic Agents|adrenergic agents|mesh-ancestor
6679948|NCT01601002|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6512998|NCT00697437|Antimitotic Agents|antimitotic agents|mesh-ancestor
6512999|NCT00697437|Mitosis Modulators|mitosis modulators|mesh-ancestor
6513000|NCT00697437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513001|NCT00697437|Antifungal Agents|antifungal agents|mesh-ancestor
6513002|NCT00697437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6513003|NCT00697437|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6513004|NCT00697437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6513005|NCT00697437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6513006|NCT00697437|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6513007|NCT00697437|Hormone Antagonists|hormone antagonists|mesh-ancestor
6513008|NCT00697437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6513009|NCT00697437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513010|NCT00697437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6513011|NCT00697450|Insulin Detemir|insulin detemir|mesh-list
6513012|NCT00697450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6513013|NCT00697450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513014|NCT00697476|Topotecan|topotecan|mesh-list
6513015|NCT00697476|Vorinostat|vorinostat|mesh-list
6513016|NCT00697476|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6513017|NCT00697476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6513018|NCT00697476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6513019|NCT00697476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513020|NCT00697476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6513021|NCT00697476|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6513022|NCT00697502|Capecitabine|capecitabine|mesh-list
6513023|NCT00697502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6513024|NCT00697502|Antimetabolites|antimetabolites|mesh-ancestor
6513025|NCT00697502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513026|NCT00697502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6513027|NCT00697554|Vaccines|vaccines|mesh-list
6513028|NCT00697554|Immunologic Factors|immunologic factors|mesh-ancestor
6513029|NCT00697554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513030|NCT00697567|Vaccines|vaccines|mesh-list
6679949|NCT01601002|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6679950|NCT01601002|Serotonin Agents|serotonin agents|mesh-ancestor
6679951|NCT01601002|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6679952|NCT01601028|Hydroxychloroquine|hydroxychloroquine|mesh-list
6679953|NCT01601028|Antimalarials|antimalarials|mesh-ancestor
6679954|NCT01601028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6679955|NCT01601028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6679956|NCT01601028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6679957|NCT01601028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6679958|NCT01601028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679959|NCT01601028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6679960|NCT01601093|Sulbactam|sulbactam|mesh-list
6679961|NCT01601093|Cefoperazone|cefoperazone|mesh-list
6679962|NCT01601093|Sulperazone|sulperazone|mesh-list
6679963|NCT01601093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6679964|NCT01601093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6513031|NCT00697567|Immunologic Factors|immunologic factors|mesh-ancestor
6513032|NCT00697567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513033|NCT00697658|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6513034|NCT00697658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6513035|NCT00697658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6513036|NCT00697658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6513037|NCT00697658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513038|NCT00697658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6513039|NCT00697658|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6513040|NCT00697658|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6513041|NCT00697658|Serotonin Agents|serotonin agents|mesh-ancestor
6513042|NCT00697658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6679965|NCT01601093|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6513043|NCT00697658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513044|NCT00697658|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6513045|NCT00697658|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6513046|NCT00697658|Dopamine Agents|dopamine agents|mesh-ancestor
6513047|NCT00697671|Cyclophosphamide|cyclophosphamide|mesh-list
6513048|NCT00697671|Etoposide|etoposide|mesh-list
6513049|NCT00697671|Interleukin-2|interleukin-2|mesh-list
6513050|NCT00697671|Clofarabine|clofarabine|mesh-list
6513051|NCT00697671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6513052|NCT00697671|Immunologic Factors|immunologic factors|mesh-ancestor
6513053|NCT00697671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513054|NCT00697671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6513055|NCT00697671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6513056|NCT00697671|Alkylating Agents|alkylating agents|mesh-ancestor
6513057|NCT00697671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513058|NCT00697671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6513059|NCT00697671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6513060|NCT00697671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6513061|NCT00697671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6513062|NCT00697671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6513063|NCT00697671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6513064|NCT00697671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6513065|NCT00697671|Analgesics|analgesics|mesh-ancestor
6513066|NCT00697671|Sensory System Agents|sensory system agents|mesh-ancestor
6513067|NCT00697671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6513068|NCT00697671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6513069|NCT00697671|Antimetabolites|antimetabolites|mesh-ancestor
6513070|NCT00697775|Vaccines|vaccines|mesh-list
6513071|NCT00697775|Immunologic Factors|immunologic factors|mesh-ancestor
6513072|NCT00697775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513073|NCT00697814|Clomiphene|clomiphene|mesh-list
6513074|NCT00697814|Enclomiphene|enclomiphene|mesh-list
6513075|NCT00697814|Zuclomiphene|zuclomiphene|mesh-list
6513076|NCT00697814|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6513077|NCT00697814|Hormone Antagonists|hormone antagonists|mesh-ancestor
6513078|NCT00697814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6513079|NCT00697814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513080|NCT00697814|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6513081|NCT00697814|Fertility Agents|fertility agents|mesh-ancestor
6513082|NCT00697814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6513083|NCT00697814|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6513084|NCT00697814|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6513085|NCT00697866|Vaccines|vaccines|mesh-list
6513086|NCT00697866|Immunologic Factors|immunologic factors|mesh-ancestor
6513087|NCT00697866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513088|NCT00697879|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
6513089|NCT00697879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6513090|NCT00697879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513091|NCT00697892|Ritonavir|ritonavir|mesh-list
6513092|NCT00697892|Lopinavir|lopinavir|mesh-list
6513093|NCT00697892|Efavirenz|efavirenz|mesh-list
6513094|NCT00697892|Lumefantrine|lumefantrine|mesh-list
6513095|NCT00697892|Artemether|artemether|mesh-list
6513096|NCT00697892|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6513097|NCT00697892|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6513098|NCT00697892|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6513099|NCT00697892|Protease Inhibitors|protease inhibitors|mesh-ancestor
6513100|NCT00697892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6513101|NCT00697892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513102|NCT00697892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6513103|NCT00697892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6513104|NCT00697892|Antiviral Agents|antiviral agents|mesh-ancestor
6513105|NCT00697892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5717726|NCT03231215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5717727|NCT03231215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513106|NCT00697892|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6513107|NCT00697892|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6513108|NCT00697892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6513109|NCT00697892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6513110|NCT00697892|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6513111|NCT00697892|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6513112|NCT00697892|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6513113|NCT00697892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6513114|NCT00697892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6513115|NCT00697892|Antimalarials|antimalarials|mesh-ancestor
6513116|NCT00697892|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6513117|NCT00697892|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6513118|NCT00697905|Gemcitabine|gemcitabine|mesh-list
6513119|NCT00697905|Carboplatin|carboplatin|mesh-list
6513120|NCT00697905|Fluorouracil|fluorouracil|mesh-list
5717728|NCT03231215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5717729|NCT03231215|Glucocorticoids|glucocorticoids|mesh-ancestor
5717730|NCT03231215|Hormones|hormones|mesh-ancestor
6513121|NCT00697905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6513122|NCT00697905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6513123|NCT00697905|Antimetabolites|antimetabolites|mesh-ancestor
6513124|NCT00697905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513125|NCT00697905|Antiviral Agents|antiviral agents|mesh-ancestor
6513126|NCT00697905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6513127|NCT00697905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6513128|NCT00697905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6513129|NCT00697905|Immunologic Factors|immunologic factors|mesh-ancestor
6513130|NCT00697905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513131|NCT00697944|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6513132|NCT00697944|Antifungal Agents|antifungal agents|mesh-ancestor
6513133|NCT00697944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6513134|NCT00697944|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6513135|NCT00697944|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6513136|NCT00697996|Rituximab|rituximab|mesh-list
6513137|NCT00697996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6513138|NCT00697996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6513139|NCT00697996|Immunologic Factors|immunologic factors|mesh-ancestor
6513140|NCT00697996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513141|NCT00697996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6513142|NCT00698126|Insulin|insulin|mesh-list
6513143|NCT00698126|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6513144|NCT00698126|Insulin Aspart|insulin aspart|mesh-list
6513145|NCT00698126|Biphasic Insulins|biphasic insulins|mesh-list
6513146|NCT00698126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6513147|NCT00698126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513148|NCT00698269|Insulin|insulin|mesh-list
6513149|NCT00698269|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6513150|NCT00698269|Insulin Aspart|insulin aspart|mesh-list
6513151|NCT00698269|Insulin, Long-Acting|insulin, long-acting|mesh-list
6513152|NCT00698269|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6513153|NCT00698269|Insulin Detemir|insulin detemir|mesh-list
6513154|NCT00698269|Biphasic Insulins|biphasic insulins|mesh-list
6513155|NCT00698269|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6513156|NCT00698269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6513157|NCT00698269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513158|NCT00698334|Rifampin|rifampin|mesh-list
6513159|NCT00698334|Pyrazinamide|pyrazinamide|mesh-list
6513160|NCT00698334|Ethambutol|ethambutol|mesh-list
6513161|NCT00698334|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6513162|NCT00698334|Antitubercular Agents|antitubercular agents|mesh-ancestor
6513163|NCT00698334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6513164|NCT00698334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6513165|NCT00698334|Leprostatic Agents|leprostatic agents|mesh-ancestor
6513166|NCT00698334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6513167|NCT00698334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6513168|NCT00698334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513169|NCT00698334|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6513170|NCT00698334|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6513171|NCT00698334|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6679966|NCT01601093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5717731|NCT03231215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5717732|NCT03231215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6513172|NCT00698334|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6513173|NCT00698334|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6513174|NCT00698334|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6679967|NCT01601093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679968|NCT01601093|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6679969|NCT01601093|Renal Agents|renal agents|mesh-ancestor
6679970|NCT01601106|Prednisolone|prednisolone|mesh-list
6679971|NCT01601106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6679972|NCT01601106|Glucocorticoids|glucocorticoids|mesh-ancestor
6679973|NCT01601106|Hormones|hormones|mesh-ancestor
6679974|NCT01601106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6679975|NCT01601106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679976|NCT01601106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6679977|NCT01601106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6679978|NCT01601184|Temozolomide|temozolomide|mesh-list
6679979|NCT01601184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6679980|NCT01601184|Alkylating Agents|alkylating agents|mesh-ancestor
6679981|NCT01601184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679982|NCT01601184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6679983|NCT01601314|Magnesium Sulfate|magnesium sulfate|mesh-list
6679984|NCT01601314|Analgesics|analgesics|mesh-ancestor
6679985|NCT01601314|Sensory System Agents|sensory system agents|mesh-ancestor
6679986|NCT01601314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6679987|NCT01601314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6679988|NCT01601314|Anesthetics|anesthetics|mesh-ancestor
6679989|NCT01601314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6679990|NCT01601314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6679991|NCT01601314|Anticonvulsants|anticonvulsants|mesh-ancestor
6679992|NCT01601314|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6679993|NCT01601314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6679994|NCT01601314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6679995|NCT01601314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6679996|NCT01601314|Tocolytic Agents|tocolytic agents|mesh-ancestor
6679997|NCT01601314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6679998|NCT01601327|Methyltestosterone|methyltestosterone|mesh-list
6679999|NCT01601327|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6680000|NCT01601327|Testosterone|testosterone|mesh-list
6680001|NCT01601327|Testosterone undecanoate|testosterone undecanoate|mesh-list
6680002|NCT01601327|Testosterone enanthate|testosterone enanthate|mesh-list
6680003|NCT01601327|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5717733|NCT03231215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5717734|NCT03231033|Pioglitazone|pioglitazone|mesh-list
5717735|NCT03231033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5717736|NCT03231033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717737|NCT03230786|Metformin|metformin|mesh-list
5717738|NCT03230786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5717739|NCT03230786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717740|NCT03230825|Contraceptive Agents|contraceptive agents|mesh-list
5717741|NCT03230825|Contraceptives, Oral|contraceptives, oral|mesh-list
5717742|NCT03230825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5717743|NCT03230825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717744|NCT03230825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5717745|NCT03230851|Aspirin|aspirin|mesh-list
5717746|NCT03230851|Indobufen|indobufen|mesh-list
6680004|NCT01601327|Androgens|androgens|mesh-ancestor
6680005|NCT01601327|Hormones|hormones|mesh-ancestor
6680006|NCT01601327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6680007|NCT01601327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680008|NCT01601327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6680009|NCT01601327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6680010|NCT01601327|Anabolic Agents|anabolic agents|mesh-ancestor
6680011|NCT01601327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6680012|NCT01601366|Contraceptive Agents|contraceptive agents|mesh-list
6680013|NCT01601366|Contraceptives, Oral|contraceptives, oral|mesh-list
6680014|NCT01601366|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
6680015|NCT01601366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6680016|NCT01601366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680017|NCT01601366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6680018|NCT01601509|Tramazoline|tramazoline|mesh-list
6680019|NCT01601509|Sympathomimetics|sympathomimetics|mesh-ancestor
6680020|NCT01601509|Autonomic Agents|autonomic agents|mesh-ancestor
6680021|NCT01601509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6680022|NCT01601509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717747|NCT03230851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6513175|NCT00698425|Citric Acid|citric acid|mesh-list
6513176|NCT00698425|Sodium Citrate|sodium citrate|mesh-list
6513177|NCT00698425|Anticoagulants|anticoagulants|mesh-ancestor
6513178|NCT00698425|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6513179|NCT00698425|Chelating Agents|chelating agents|mesh-ancestor
6513180|NCT00698425|Sequestering Agents|sequestering agents|mesh-ancestor
6513181|NCT00698425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513182|NCT00698464|Pasireotide|pasireotide|mesh-list
6513183|NCT00698464|Hormones|hormones|mesh-ancestor
6513184|NCT00698464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6513185|NCT00698464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513186|NCT00698607|Sirolimus|sirolimus|mesh-list
6513187|NCT00698607|Everolimus|everolimus|mesh-list
6513188|NCT00698607|Clopidogrel|clopidogrel|mesh-list
6513189|NCT00698607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6513190|NCT00698607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6513191|NCT00698607|Immunologic Factors|immunologic factors|mesh-ancestor
6513192|NCT00698607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513193|NCT00698607|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6513194|NCT00698607|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6513195|NCT00698607|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6513196|NCT00698607|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6513197|NCT00698607|Purinergic Agents|purinergic agents|mesh-ancestor
6513198|NCT00698607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6513199|NCT00698607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513200|NCT00698607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6513201|NCT00698607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6513202|NCT00698607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6513203|NCT00698607|Antifungal Agents|antifungal agents|mesh-ancestor
6513204|NCT00698724|Prednisolone acetate|prednisolone acetate|mesh-list
6513205|NCT00698724|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6513206|NCT00698724|Methylprednisolone|methylprednisolone|mesh-list
6513207|NCT00698724|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6513208|NCT00698724|Prednisolone|prednisolone|mesh-list
6513209|NCT00698724|Bromfenac|bromfenac|mesh-list
6513210|NCT00698724|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6513211|NCT00698724|Prednisolone phosphate|prednisolone phosphate|mesh-list
6513212|NCT00698724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6513213|NCT00698724|Antiemetics|antiemetics|mesh-ancestor
6513214|NCT00698724|Autonomic Agents|autonomic agents|mesh-ancestor
6513215|NCT00698724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6513216|NCT00698724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513217|NCT00698724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6513218|NCT00698724|Glucocorticoids|glucocorticoids|mesh-ancestor
6513219|NCT00698724|Hormones|hormones|mesh-ancestor
6513220|NCT00698724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6513221|NCT00698724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6513222|NCT00698724|Protective Agents|protective agents|mesh-ancestor
6513223|NCT00698724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6513224|NCT00698724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6513225|NCT00698724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6513226|NCT00698724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6513227|NCT00698724|Analgesics|analgesics|mesh-ancestor
6513228|NCT00698724|Sensory System Agents|sensory system agents|mesh-ancestor
6513229|NCT00698724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6513230|NCT00698763|Simendan|simendan|mesh-list
6513231|NCT00698763|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6513232|NCT00698763|Vasodilator Agents|vasodilator agents|mesh-ancestor
6513233|NCT00698763|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6513234|NCT00698763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6513235|NCT00698763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6513236|NCT00698763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513237|NCT00698763|Protective Agents|protective agents|mesh-ancestor
6513238|NCT00698763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513239|NCT00698776|Lenalidomide|lenalidomide|mesh-list
6513240|NCT00698776|KRN 7000|krn 7000|mesh-list
6513241|NCT00698776|Immunologic Factors|immunologic factors|mesh-ancestor
6513242|NCT00698776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513243|NCT00698776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6513244|NCT00698776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6513245|NCT00698776|Growth Substances|growth substances|mesh-ancestor
6513246|NCT00698776|Growth Inhibitors|growth inhibitors|mesh-ancestor
6513247|NCT00698776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6513248|NCT00698776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6513249|NCT00698802|Insulin|insulin|mesh-list
6680023|NCT01601561|Insulin|insulin|mesh-list
6513250|NCT00698802|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6513251|NCT00698802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6513252|NCT00698802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513253|NCT00698945|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6513254|NCT00698945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6513255|NCT00698945|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6513256|NCT00698945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6513257|NCT00698945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6513258|NCT00698945|Adrenergic Agents|adrenergic agents|mesh-ancestor
6513259|NCT00698945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6513260|NCT00698945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513261|NCT00698945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513262|NCT00699023|Simvastatin|simvastatin|mesh-list
6513263|NCT00699023|Ezetimibe|ezetimibe|mesh-list
6513264|NCT00699023|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6513265|NCT00699023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6513266|NCT00699023|Antimetabolites|antimetabolites|mesh-ancestor
6513267|NCT00699023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513268|NCT00699023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6513269|NCT00699023|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6513270|NCT00699023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6513271|NCT00699036|Metformin|metformin|mesh-list
6513272|NCT00699036|Rosiglitazone|rosiglitazone|mesh-list
6513273|NCT00699036|Losartan|losartan|mesh-list
6513274|NCT00699036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6513275|NCT00699036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513276|NCT00699036|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6513277|NCT00699036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6513278|NCT00699036|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6513279|NCT00699036|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6513280|NCT00699036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513281|NCT00699049|Solifenacin Succinate|solifenacin succinate|mesh-list
6513282|NCT00699049|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
6513283|NCT00699049|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6513284|NCT00699049|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6513285|NCT00699049|Cholinergic Agents|cholinergic agents|mesh-ancestor
6513286|NCT00699049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6513287|NCT00699049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513288|NCT00699049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513289|NCT00699049|Urological Agents|urological agents|mesh-ancestor
6513290|NCT00699049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6513291|NCT00699049|Adrenergic Agents|adrenergic agents|mesh-ancestor
6513292|NCT00699062|Montelukast|montelukast|mesh-list
6513293|NCT00699062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6513294|NCT00699062|Respiratory System Agents|respiratory system agents|mesh-ancestor
6513295|NCT00699062|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6513296|NCT00699062|Hormone Antagonists|hormone antagonists|mesh-ancestor
6513297|NCT00699062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6513298|NCT00699062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513299|NCT00699062|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6513300|NCT00699062|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6513301|NCT00699062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513302|NCT00699114|Acetaminophen|acetaminophen|mesh-list
6513303|NCT00699114|Ibuprofen|ibuprofen|mesh-list
6513304|NCT00699114|Codeine|codeine|mesh-list
6513305|NCT00699114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6513306|NCT00699114|Analgesics|analgesics|mesh-ancestor
6513307|NCT00699114|Sensory System Agents|sensory system agents|mesh-ancestor
6513308|NCT00699114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6513309|NCT00699114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513310|NCT00699114|Antipyretics|antipyretics|mesh-ancestor
6513311|NCT00699114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6513312|NCT00699114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6513313|NCT00699114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6513314|NCT00699114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6513315|NCT00699114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6513316|NCT00699114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513317|NCT00699114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6513318|NCT00699114|Narcotics|narcotics|mesh-ancestor
6513319|NCT00699114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6513320|NCT00699114|Antitussive Agents|antitussive agents|mesh-ancestor
6513321|NCT00699114|Respiratory System Agents|respiratory system agents|mesh-ancestor
6513322|NCT00699179|Insulin Aspart|insulin aspart|mesh-list
6513323|NCT00699179|Biphasic Insulins|biphasic insulins|mesh-list
6513324|NCT00699179|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6513325|NCT00699179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6513326|NCT00699179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513327|NCT00699244|Anesthetics|anesthetics|mesh-list
6513328|NCT00699244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6513329|NCT00699244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513330|NCT00699296|Panobinostat|panobinostat|mesh-list
6513331|NCT00699296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5717748|NCT03230851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5717749|NCT03230851|Analgesics|analgesics|mesh-ancestor
5717750|NCT03230851|Sensory System Agents|sensory system agents|mesh-ancestor
5717751|NCT03230851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5717752|NCT03230851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717753|NCT03230851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5717754|NCT03230851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5717755|NCT03230851|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5717756|NCT03230851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5717757|NCT03230851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717758|NCT03230851|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5717759|NCT03230851|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5717760|NCT03230851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5717761|NCT03230851|Antipyretics|antipyretics|mesh-ancestor
5717762|NCT03230682|Antidepressive Agents|antidepressive agents|mesh-list
5717763|NCT03230682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5722074|NCT03201185|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5722075|NCT03201185|Protease Inhibitors|protease inhibitors|mesh-ancestor
5722076|NCT03201185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5722077|NCT03201185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722078|NCT03201185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5722079|NCT03201601|Inositol|inositol|mesh-list
5722080|NCT03201601|Vitamin B Complex|vitamin b complex|mesh-ancestor
5722081|NCT03201601|Vitamins|vitamins|mesh-ancestor
5722082|NCT03201601|Micronutrients|micronutrients|mesh-ancestor
5722083|NCT03201601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722084|NCT03201250|Dexamethasone|dexamethasone|mesh-list
5722085|NCT03201250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5722086|NCT03201250|Antiemetics|antiemetics|mesh-ancestor
5722087|NCT03201250|Autonomic Agents|autonomic agents|mesh-ancestor
5722088|NCT03201250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5722089|NCT03201250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722090|NCT03201250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5722091|NCT03201250|Glucocorticoids|glucocorticoids|mesh-ancestor
5722092|NCT03201250|Hormones|hormones|mesh-ancestor
5722093|NCT03201250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6513332|NCT00699296|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6513333|NCT00699296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6513334|NCT00699296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513335|NCT00699322|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6513336|NCT00699322|Glimepiride|glimepiride|mesh-list
6513337|NCT00699322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6513338|NCT00699322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513339|NCT00699322|Incretins|incretins|mesh-ancestor
6513340|NCT00699322|Hormones|hormones|mesh-ancestor
6513341|NCT00699322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6513342|NCT00699322|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6513343|NCT00699322|Protease Inhibitors|protease inhibitors|mesh-ancestor
6513344|NCT00699322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6513345|NCT00699322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513346|NCT00699322|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6513347|NCT00699322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6513348|NCT00699322|Immunologic Factors|immunologic factors|mesh-ancestor
6513349|NCT00699361|Pantoprazole|pantoprazole|mesh-list
6513350|NCT00699361|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6513351|NCT00699361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6513352|NCT00699361|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6513353|NCT00699361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6513354|NCT00699361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513355|NCT00699387|Benzonidazole|benzonidazole|mesh-list
6513356|NCT00699387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6513357|NCT00699387|Immunologic Factors|immunologic factors|mesh-ancestor
6513358|NCT00699387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513359|NCT00699387|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6680024|NCT01601561|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6513360|NCT00699387|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6513361|NCT00699387|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6513362|NCT00699387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6513363|NCT00699426|Esomeprazole|esomeprazole|mesh-list
6513364|NCT00699426|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6513365|NCT00699426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6513366|NCT00699426|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6513367|NCT00699426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6513368|NCT00699426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513369|NCT00699452|Candesartan|candesartan|mesh-list
6513370|NCT00699452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6513371|NCT00699452|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6513372|NCT00699452|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6513373|NCT00699452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513374|NCT00699465|Enoxaparin|enoxaparin|mesh-list
6513375|NCT00699465|Enoxaparin sodium|enoxaparin sodium|mesh-list
6513376|NCT00699465|Anticoagulants|anticoagulants|mesh-ancestor
6513377|NCT00699465|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6513378|NCT00699465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6513379|NCT00699465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717764|NCT03230630|Melatonin|melatonin|mesh-list
5717765|NCT03230630|Antioxidants|antioxidants|mesh-ancestor
5717766|NCT03230630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717767|NCT03230630|Protective Agents|protective agents|mesh-ancestor
5717768|NCT03230630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717769|NCT03230630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5717770|NCT03230734|Docetaxel|docetaxel|mesh-list
5717771|NCT03230734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5717772|NCT03230734|Tubulin Modulators|tubulin modulators|mesh-ancestor
5717773|NCT03230734|Antimitotic Agents|antimitotic agents|mesh-ancestor
5717774|NCT03230734|Mitosis Modulators|mitosis modulators|mesh-ancestor
5717775|NCT03230734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717776|NCT03230604|Z 350|z 350|mesh-list
5717777|NCT03230604|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
5717778|NCT03230604|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5717779|NCT03230604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5717780|NCT03230604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717781|NCT03230604|Hormone Antagonists|hormone antagonists|mesh-ancestor
6513380|NCT00699478|Vitamin B 12|vitamin b 12|mesh-list
6513381|NCT00699478|Vitamin B Complex|vitamin b complex|mesh-ancestor
6513382|NCT00699478|Vitamins|vitamins|mesh-ancestor
5717782|NCT03230604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5717783|NCT03230604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717784|NCT03230539|Ulipristal acetate|ulipristal acetate|mesh-list
5717785|NCT03230539|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5717786|NCT03230539|Contraceptive Agents|contraceptive agents|mesh-ancestor
5919430|NCT04982237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919431|NCT04982237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5919432|NCT04982237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5919433|NCT04982237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5919434|NCT04982237|Growth Substances|growth substances|mesh-ancestor
5919435|NCT04982237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919436|NCT04982237|Growth Inhibitors|growth inhibitors|mesh-ancestor
5919437|NCT04981886|Bimatoprost|bimatoprost|mesh-list
5919438|NCT04981886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6513383|NCT00699478|Micronutrients|micronutrients|mesh-ancestor
6513384|NCT00699478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513385|NCT00699504|Moxifloxacin|moxifloxacin|mesh-list
6513386|NCT00699504|Cangrelor|cangrelor|mesh-list
6513387|NCT00699504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6513388|NCT00699504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6513389|NCT00699504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6513390|NCT00699504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6513391|NCT00699504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6513392|NCT00699504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513393|NCT00699504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6513394|NCT00699504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513395|NCT00699504|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6513396|NCT00699504|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6513397|NCT00699504|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6513398|NCT00699504|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6513399|NCT00699504|Purinergic Agents|purinergic agents|mesh-ancestor
6513400|NCT00699504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6513401|NCT00699530|Cabergoline|cabergoline|mesh-list
6513402|NCT00699530|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6513403|NCT00699530|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6513404|NCT00699530|Dopamine Agonists|dopamine agonists|mesh-ancestor
6513405|NCT00699530|Dopamine Agents|dopamine agents|mesh-ancestor
6513406|NCT00699530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6513407|NCT00699530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513408|NCT00699530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513409|NCT00699634|Nabilone|nabilone|mesh-list
6513410|NCT00699634|Antiemetics|antiemetics|mesh-ancestor
6513411|NCT00699634|Autonomic Agents|autonomic agents|mesh-ancestor
6513412|NCT00699634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6513413|NCT00699634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513414|NCT00699634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6513415|NCT00699634|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6513416|NCT00699634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6513417|NCT00699634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6513418|NCT00699634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6513419|NCT00699686|Insulin Glargine|insulin glargine|mesh-list
5717787|NCT03230539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5717788|NCT03230539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717789|NCT03230539|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5717790|NCT03230565|Ropivacaine|ropivacaine|mesh-list
5717791|NCT03230565|Anesthetics, Local|anesthetics, local|mesh-ancestor
5717792|NCT03230565|Anesthetics|anesthetics|mesh-ancestor
5717793|NCT03230565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5717794|NCT03230565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513420|NCT00699686|Insulin Detemir|insulin detemir|mesh-list
6513421|NCT00699686|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6513422|NCT00699686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513423|NCT00699764|Vaccines|vaccines|mesh-list
6513424|NCT00699764|Immunologic Factors|immunologic factors|mesh-ancestor
6513425|NCT00699764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513426|NCT00699777|Risedronic Acid|risedronic acid|mesh-list
6513427|NCT00699777|Etidronic Acid|etidronic acid|mesh-list
6513428|NCT00699777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6513429|NCT00699777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6513430|NCT00699777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513431|NCT00699777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6513432|NCT00699777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513433|NCT00699777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6513434|NCT00699881|Cetuximab|cetuximab|mesh-list
6513435|NCT00699881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6513436|NCT00699881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6513437|NCT00699894|Ondansetron|ondansetron|mesh-list
6513438|NCT00699894|Aprepitant|aprepitant|mesh-list
6513439|NCT00699894|Antiemetics|antiemetics|mesh-ancestor
6513440|NCT00699894|Autonomic Agents|autonomic agents|mesh-ancestor
6513441|NCT00699894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6513442|NCT00699894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513443|NCT00699894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6513444|NCT00699894|Antipruritics|antipruritics|mesh-ancestor
5919439|NCT04982055|Nadroparin|nadroparin|mesh-list
5919440|NCT04982055|Anticoagulants|anticoagulants|mesh-ancestor
5919441|NCT04982055|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6513445|NCT00699894|Dermatologic Agents|dermatologic agents|mesh-ancestor
6513446|NCT00699894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6513447|NCT00699894|Serotonin Agents|serotonin agents|mesh-ancestor
6513448|NCT00699894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6513449|NCT00699894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513450|NCT00699894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6513451|NCT00699894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6513452|NCT00699894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6513453|NCT00699894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6513454|NCT00699894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6513455|NCT00699894|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6513456|NCT00699920|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6513457|NCT00699920|Antimalarials|antimalarials|mesh-ancestor
6513458|NCT00699920|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6513459|NCT00699920|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5919442|NCT04982055|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5919443|NCT04982055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919444|NCT04981743|Vitamin D|vitamin d|mesh-list
5919445|NCT04981743|Vitamins|vitamins|mesh-ancestor
5919446|NCT04981743|Micronutrients|micronutrients|mesh-ancestor
5919447|NCT04981743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513460|NCT00699920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6513461|NCT00699946|Olanzapine|olanzapine|mesh-list
6513462|NCT00699946|Antiemetics|antiemetics|mesh-ancestor
6513463|NCT00699946|Autonomic Agents|autonomic agents|mesh-ancestor
6513464|NCT00699946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6513465|NCT00699946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513466|NCT00699946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6513467|NCT00699946|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6513468|NCT00699946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6513469|NCT00699946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6513470|NCT00699946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5717795|NCT03230565|Sensory System Agents|sensory system agents|mesh-ancestor
5717796|NCT03230565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5717797|NCT03230474|Morphine|morphine|mesh-list
5717798|NCT03230474|Naloxone|naloxone|mesh-list
5717799|NCT03230474|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5717800|NCT03230474|Narcotics|narcotics|mesh-ancestor
5717801|NCT03230474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5919448|NCT04981743|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5919449|NCT04982146|Acetylcysteine|acetylcysteine|mesh-list
6513471|NCT00699946|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6513472|NCT00699946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6513473|NCT00699946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6513474|NCT00699946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513475|NCT00699946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6513476|NCT00699946|Serotonin Agents|serotonin agents|mesh-ancestor
6513477|NCT00700024|Methyltestosterone|methyltestosterone|mesh-list
6513478|NCT00700024|Testosterone|testosterone|mesh-list
6513479|NCT00700024|Testosterone undecanoate|testosterone undecanoate|mesh-list
6513480|NCT00700024|Testosterone enanthate|testosterone enanthate|mesh-list
6513481|NCT00700024|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6513482|NCT00700024|Androgens|androgens|mesh-ancestor
6513483|NCT00700024|Hormones|hormones|mesh-ancestor
6513484|NCT00700024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6513485|NCT00700024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513486|NCT00700024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5717802|NCT03230474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717803|NCT03230474|Analgesics|analgesics|mesh-ancestor
5919450|NCT04982146|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5919451|NCT04982146|Antiviral Agents|antiviral agents|mesh-ancestor
5919452|NCT04982146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6513487|NCT00700024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6513488|NCT00700024|Anabolic Agents|anabolic agents|mesh-ancestor
6513489|NCT00700037|Atorvastatin|atorvastatin|mesh-list
6513490|NCT00700037|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6513491|NCT00700037|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6513492|NCT00700037|Antimetabolites|antimetabolites|mesh-ancestor
6513493|NCT00700037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513494|NCT00700037|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6513495|NCT00700037|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6513496|NCT00700037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6513497|NCT00700076|Ketamine|ketamine|mesh-list
6513498|NCT00700076|Analgesics|analgesics|mesh-ancestor
6513499|NCT00700076|Sensory System Agents|sensory system agents|mesh-ancestor
6513500|NCT00700076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6513501|NCT00700076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513502|NCT00700076|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6513503|NCT00700076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6513504|NCT00700076|Anesthetics, General|anesthetics, general|mesh-ancestor
6513505|NCT00700076|Anesthetics|anesthetics|mesh-ancestor
6513506|NCT00700076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6513507|NCT00700076|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6513508|NCT00700076|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6513509|NCT00700076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6513510|NCT00700076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513511|NCT00700128|Frovatriptan|frovatriptan|mesh-list
6513512|NCT00700128|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6513513|NCT00700128|Serotonin Agents|serotonin agents|mesh-ancestor
6680025|NCT01601561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5717804|NCT03230474|Sensory System Agents|sensory system agents|mesh-ancestor
5717805|NCT03230474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5717806|NCT03230474|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5717807|NCT03230227|Bupivacaine|bupivacaine|mesh-list
5717808|NCT03230227|Anesthetics, Local|anesthetics, local|mesh-ancestor
5717809|NCT03230227|Anesthetics|anesthetics|mesh-ancestor
6513514|NCT00700128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6513515|NCT00700128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513516|NCT00700128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513517|NCT00700154|Insulin|insulin|mesh-list
6513518|NCT00700154|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6513519|NCT00700154|Insulin Aspart|insulin aspart|mesh-list
6513520|NCT00700154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6513521|NCT00700154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513522|NCT00700193|Vaccines|vaccines|mesh-list
6513523|NCT00700193|Immunologic Factors|immunologic factors|mesh-ancestor
6513524|NCT00700193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513525|NCT00700284|Dapivirine|dapivirine|mesh-list
6513526|NCT00700284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6513527|NCT00700284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6513528|NCT00700284|Antiviral Agents|antiviral agents|mesh-ancestor
6513529|NCT00700284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6513530|NCT00700297|Colchicine|colchicine|mesh-list
6513531|NCT00700297|Gout Suppressants|gout suppressants|mesh-ancestor
6513532|NCT00700297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6513533|NCT00700297|Tubulin Modulators|tubulin modulators|mesh-ancestor
6513534|NCT00700297|Antimitotic Agents|antimitotic agents|mesh-ancestor
6513535|NCT00700297|Mitosis Modulators|mitosis modulators|mesh-ancestor
6513536|NCT00700297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513537|NCT00700297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6513538|NCT00700362|Insulin|insulin|mesh-list
6513539|NCT00700362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6513540|NCT00700362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680026|NCT01601561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680027|NCT01601730|Dexetimide|dexetimide|mesh-list
6680028|NCT01601730|Modafinil|modafinil|mesh-list
6680029|NCT01601730|Citalopram|citalopram|mesh-list
6680030|NCT01601730|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6680031|NCT01601730|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6680032|NCT01601730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6680033|NCT01601730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6680034|NCT01601730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6680035|NCT01601730|Serotonin Agents|serotonin agents|mesh-ancestor
6680036|NCT01601730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680037|NCT01601730|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6680038|NCT01601730|Antidepressive Agents|antidepressive agents|mesh-ancestor
6680039|NCT01601730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6680040|NCT01601730|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6680041|NCT01601730|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6680042|NCT01601730|Parasympatholytics|parasympatholytics|mesh-ancestor
6680043|NCT01601730|Autonomic Agents|autonomic agents|mesh-ancestor
6680044|NCT01601730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6680045|NCT01601730|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6680046|NCT01601730|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6680047|NCT01601730|Cholinergic Agents|cholinergic agents|mesh-ancestor
6680048|NCT01601730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6680049|NCT01601730|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6680050|NCT01601730|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6680051|NCT01601730|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6680052|NCT01601795|Sevoflurane|sevoflurane|mesh-list
6680053|NCT01601795|Isoflurane|isoflurane|mesh-list
6680054|NCT01601795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6680055|NCT01601795|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6680056|NCT01601795|Anesthetics, General|anesthetics, general|mesh-ancestor
6680057|NCT01601795|Anesthetics|anesthetics|mesh-ancestor
6680058|NCT01601795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6680059|NCT01601795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680060|NCT01601899|Tenofovir|tenofovir|mesh-list
6680061|NCT01601899|Lamivudine|lamivudine|mesh-list
6680062|NCT01601899|Efavirenz|efavirenz|mesh-list
6680063|NCT01601899|Stavudine|stavudine|mesh-list
6680064|NCT01601899|Antiviral Agents|antiviral agents|mesh-ancestor
6680065|NCT01601899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6680066|NCT01601899|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6680067|NCT01601899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6680068|NCT01601899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6680069|NCT01601899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6680070|NCT01601899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6680071|NCT01601899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6680072|NCT01601899|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6680073|NCT01601899|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6680074|NCT01601899|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6513541|NCT00700466|Metoprolol|metoprolol|mesh-list
6513542|NCT00700466|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
6513543|NCT00700466|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6513544|NCT00700466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6513545|NCT00700466|Sympatholytics|sympatholytics|mesh-ancestor
6513546|NCT00700466|Autonomic Agents|autonomic agents|mesh-ancestor
6513547|NCT00700466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6513548|NCT00700466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513549|NCT00700466|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6513550|NCT00700466|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6513551|NCT00700466|Adrenergic Agents|adrenergic agents|mesh-ancestor
6513552|NCT00700466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6513553|NCT00700466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513554|NCT00700492|Progesterone|progesterone|mesh-list
6513555|NCT00700492|Progestins|progestins|mesh-ancestor
6513556|NCT00700492|Hormones|hormones|mesh-ancestor
6513557|NCT00700492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6513558|NCT00700492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513559|NCT00700518|Nitroglycerin|nitroglycerin|mesh-list
6513560|NCT00700518|Vasodilator Agents|vasodilator agents|mesh-ancestor
6513561|NCT00700544|Norethandrolone|norethandrolone|mesh-list
6513562|NCT00700544|Anabolic Agents|anabolic agents|mesh-ancestor
6513563|NCT00700544|Hormones|hormones|mesh-ancestor
6513564|NCT00700544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6513565|NCT00700544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513566|NCT00700583|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6513567|NCT00700583|Terazosin|terazosin|mesh-list
6513568|NCT00700583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6513569|NCT00700583|Diuretics|diuretics|mesh-ancestor
6513570|NCT00700583|Natriuretic Agents|natriuretic agents|mesh-ancestor
6513571|NCT00700583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513572|NCT00700583|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6513573|NCT00700583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6513574|NCT00700583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513575|NCT00700583|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6513576|NCT00700583|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6513577|NCT00700583|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6513578|NCT00700583|Adrenergic Agents|adrenergic agents|mesh-ancestor
6513579|NCT00700583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6513580|NCT00700583|Urological Agents|urological agents|mesh-ancestor
6513581|NCT00700648|Insulin Aspart|insulin aspart|mesh-list
6513582|NCT00700648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6513583|NCT00700648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513584|NCT00700687|Aspirin|aspirin|mesh-list
6513585|NCT00700687|Celecoxib|celecoxib|mesh-list
6513586|NCT00700687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6513587|NCT00700687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6513588|NCT00700687|Analgesics|analgesics|mesh-ancestor
6513589|NCT00700687|Sensory System Agents|sensory system agents|mesh-ancestor
6513590|NCT00700687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6513591|NCT00700687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513592|NCT00700687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6513593|NCT00700687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6513594|NCT00700687|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6513595|NCT00700687|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6513596|NCT00700687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513597|NCT00700687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6513598|NCT00700687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6513599|NCT00700687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6513600|NCT00700687|Antipyretics|antipyretics|mesh-ancestor
6513601|NCT00700687|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6513602|NCT00700765|Insulin Detemir|insulin detemir|mesh-list
6513603|NCT00700765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6513604|NCT00700765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513605|NCT00700830|Insulin Detemir|insulin detemir|mesh-list
6513606|NCT00700830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6513607|NCT00700830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513608|NCT00700856|Pioglitazone|pioglitazone|mesh-list
6513609|NCT00700856|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6513610|NCT00700856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513611|NCT00700895|Warfarin|warfarin|mesh-list
6513612|NCT00700895|Anticoagulants|anticoagulants|mesh-ancestor
6513613|NCT00700921|Lovastatin|lovastatin|mesh-list
6513614|NCT00700921|L 647318|l 647318|mesh-list
6513615|NCT00700921|Dihydromevinolin|dihydromevinolin|mesh-list
6513616|NCT00700921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6513617|NCT00700921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6513618|NCT00700921|Antimetabolites|antimetabolites|mesh-ancestor
6513619|NCT00700921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513620|NCT00700921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6513621|NCT00700921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6513622|NCT00700921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6513623|NCT00700947|Metoprolol|metoprolol|mesh-list
6513624|NCT00700947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
6513625|NCT00700947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6513626|NCT00700947|Adrenergic Agents|adrenergic agents|mesh-ancestor
6513627|NCT00700947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6513628|NCT00700947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513629|NCT00700947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513630|NCT00700947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6513631|NCT00700947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6513632|NCT00700947|Sympatholytics|sympatholytics|mesh-ancestor
6513633|NCT00700947|Autonomic Agents|autonomic agents|mesh-ancestor
6513634|NCT00700947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6513635|NCT00700947|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6513636|NCT00700960|Insulin Detemir|insulin detemir|mesh-list
6513637|NCT00700960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6513638|NCT00700960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513639|NCT00701155|Insulin Detemir|insulin detemir|mesh-list
6513640|NCT00701155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6513641|NCT00701155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513642|NCT00701220|Atorvastatin|atorvastatin|mesh-list
6513643|NCT00701220|Calcium|calcium|mesh-list
6513644|NCT00701220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6680075|NCT01601899|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6680076|NCT01601899|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6680077|NCT01601899|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6680078|NCT01601899|Antimetabolites|antimetabolites|mesh-ancestor
6680079|NCT01601912|Dexetimide|dexetimide|mesh-list
6513645|NCT00701220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513646|NCT00701220|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6513647|NCT00701220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6513648|NCT00701220|Antimetabolites|antimetabolites|mesh-ancestor
6513649|NCT00701220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513650|NCT00701220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6513651|NCT00701220|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6513652|NCT00701220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6513653|NCT00701233|Botulinum Toxins|botulinum toxins|mesh-list
6513654|NCT00701233|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6513655|NCT00701233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6513656|NCT00701233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6680080|NCT01601912|Citalopram|citalopram|mesh-list
6680081|NCT01601912|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6680082|NCT01601912|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6513657|NCT00701233|Cholinergic Agents|cholinergic agents|mesh-ancestor
6513658|NCT00701233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6513659|NCT00701233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513660|NCT00701246|Folic Acid|folic acid|mesh-list
6513661|NCT00701246|Vitamin B Complex|vitamin b complex|mesh-list
6513662|NCT00701246|Hematinics|hematinics|mesh-ancestor
6513663|NCT00701246|Vitamins|vitamins|mesh-ancestor
6513664|NCT00701246|Micronutrients|micronutrients|mesh-ancestor
6513665|NCT00701246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513666|NCT00701259|Lansoprazole|lansoprazole|mesh-list
6513667|NCT00701259|Dexlansoprazole|dexlansoprazole|mesh-list
6680083|NCT01601912|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6680084|NCT01601912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6680085|NCT01601912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6680086|NCT01601912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6680087|NCT01601912|Serotonin Agents|serotonin agents|mesh-ancestor
6680088|NCT01601912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513668|NCT00701259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6513669|NCT00701259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6513670|NCT00701259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6513671|NCT00701259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6513672|NCT00701259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513673|NCT00701285|Pravastatin|pravastatin|mesh-list
6513674|NCT00701285|Pitavastatin|pitavastatin|mesh-list
6513675|NCT00701285|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6513676|NCT00701285|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6513677|NCT00701285|Antimetabolites|antimetabolites|mesh-ancestor
6513678|NCT00701285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513679|NCT00701285|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6513680|NCT00701285|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6513681|NCT00701285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6513682|NCT00701298|Interferons|interferons|mesh-list
5717810|NCT03230227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5717811|NCT03230227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717812|NCT03230227|Sensory System Agents|sensory system agents|mesh-ancestor
6513683|NCT00701298|Interferon-alpha|interferon-alpha|mesh-list
5717813|NCT03230227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5717814|NCT03230162|Heparin|heparin|mesh-list
5717815|NCT03230162|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5717816|NCT03230162|Tinzaparin|tinzaparin|mesh-list
5717817|NCT03230162|Dalteparin|dalteparin|mesh-list
5717818|NCT03230162|Sildenafil Citrate|sildenafil citrate|mesh-list
5717819|NCT03230162|Anticoagulants|anticoagulants|mesh-ancestor
6513684|NCT00701298|Interferon alpha-2|interferon alpha-2|mesh-list
6513685|NCT00701298|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6513686|NCT00701298|Decitabine|decitabine|mesh-list
6513687|NCT00701298|Azacitidine|azacitidine|mesh-list
6513688|NCT00701298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6513689|NCT00701298|Antiviral Agents|antiviral agents|mesh-ancestor
6513690|NCT00701298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6513691|NCT00701298|Immunologic Factors|immunologic factors|mesh-ancestor
6513692|NCT00701298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513693|NCT00701298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6513694|NCT00701298|Antimetabolites|antimetabolites|mesh-ancestor
6513695|NCT00701298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513696|NCT00701298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6513697|NCT00701337|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6513698|NCT00701337|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6513699|NCT00701337|Estradiol|estradiol|mesh-list
6513700|NCT00701337|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6513701|NCT00701337|Estrogens|estrogens|mesh-ancestor
6513702|NCT00701337|Hormones|hormones|mesh-ancestor
6513703|NCT00701337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6513704|NCT00701337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513705|NCT00701337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6513706|NCT00701337|Contraceptive Agents|contraceptive agents|mesh-ancestor
6513707|NCT00701337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6513708|NCT00701337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6513709|NCT00701428|Losartan|losartan|mesh-list
6513710|NCT00701428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6513711|NCT00701428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6513712|NCT00701428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6513713|NCT00701428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6513714|NCT00701428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513715|NCT00701493|Topiramate|topiramate|mesh-list
6513716|NCT00701493|Anticonvulsants|anticonvulsants|mesh-ancestor
6513717|NCT00701493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6513718|NCT00701493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513719|NCT00701532|Modafinil|modafinil|mesh-list
6513720|NCT00701532|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6513721|NCT00701532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513722|NCT00701532|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6513723|NCT00701532|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6513724|NCT00701532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6513725|NCT00701532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513726|NCT00701597|Bosentan|bosentan|mesh-list
6513727|NCT00701597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6513728|NCT00701597|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6513729|NCT00701597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513730|NCT00701623|Heparin|heparin|mesh-list
6513731|NCT00701623|Calcium heparin|calcium heparin|mesh-list
6513732|NCT00701623|Anticoagulants|anticoagulants|mesh-ancestor
6513733|NCT00701623|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6513734|NCT00701623|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6513735|NCT00701623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513736|NCT00701740|Isotretinoin|isotretinoin|mesh-list
6513737|NCT00701740|Terephthalylidene dicamphor sulfonic acid|terephthalylidene dicamphor sulfonic acid|mesh-list
5717820|NCT03230162|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5717821|NCT03230162|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5717822|NCT03230162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513738|NCT00701740|Dermatologic Agents|dermatologic agents|mesh-ancestor
6513739|NCT00701740|Sunscreening Agents|sunscreening agents|mesh-ancestor
6513740|NCT00701740|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6513741|NCT00701740|Protective Agents|protective agents|mesh-ancestor
6513742|NCT00701740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717823|NCT03230162|Vasodilator Agents|vasodilator agents|mesh-ancestor
5717824|NCT03230162|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5717825|NCT03230162|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5717826|NCT03230162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5717827|NCT03230162|Urological Agents|urological agents|mesh-ancestor
6513743|NCT00701792|Liver Extracts|liver extracts|mesh-list
6513744|NCT00701792|Hematinics|hematinics|mesh-ancestor
6513745|NCT00701831|Insulin Glargine|insulin glargine|mesh-list
6513746|NCT00701831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6513747|NCT00701831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513748|NCT00701857|Pemetrexed|pemetrexed|mesh-list
6513749|NCT00701857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6513750|NCT00701857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6513751|NCT00701857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513752|NCT00701857|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6513753|NCT00701857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6513754|NCT00701909|Morphine|morphine|mesh-list
6513755|NCT00701909|Ketamine|ketamine|mesh-list
6513756|NCT00701909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6513757|NCT00701909|Narcotics|narcotics|mesh-ancestor
6513758|NCT00701909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6513759|NCT00701909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717828|NCT03229954|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
5717829|NCT03229954|Hematinics|hematinics|mesh-ancestor
5717830|NCT03230097|BI 409306|bi 409306|mesh-list
5717831|NCT03230097|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5717832|NCT03230097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5717833|NCT03230097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717834|NCT03229746|Hydroxychloroquine|hydroxychloroquine|mesh-list
5717835|NCT03229746|Vincristine|vincristine|mesh-list
5717836|NCT03229746|Azathioprine|azathioprine|mesh-list
5717837|NCT03229746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5717838|NCT03229746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6513760|NCT00701909|Analgesics|analgesics|mesh-ancestor
6513761|NCT00701909|Sensory System Agents|sensory system agents|mesh-ancestor
6513762|NCT00701909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6513763|NCT00701909|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6513764|NCT00701909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6513765|NCT00701909|Anesthetics, General|anesthetics, general|mesh-ancestor
6513766|NCT00701909|Anesthetics|anesthetics|mesh-ancestor
6513767|NCT00701909|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6513768|NCT00701909|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6513769|NCT00701909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6513770|NCT00701909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513771|NCT00701961|Artesunate|artesunate|mesh-list
6513772|NCT00701961|Mefloquine|mefloquine|mesh-list
6513773|NCT00701961|Antimalarials|antimalarials|mesh-ancestor
6513774|NCT00701961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6513775|NCT00701961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6513776|NCT00701961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6513777|NCT00701961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6513778|NCT00701961|Antiviral Agents|antiviral agents|mesh-ancestor
6513779|NCT00701961|Schistosomicides|schistosomicides|mesh-ancestor
6513780|NCT00701961|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6513781|NCT00701961|Anthelmintics|anthelmintics|mesh-ancestor
6513782|NCT00702091|Ramipril|ramipril|mesh-list
6513783|NCT00702091|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6513784|NCT00702091|Protease Inhibitors|protease inhibitors|mesh-ancestor
6513785|NCT00702091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6513786|NCT00702091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513787|NCT00702091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6513788|NCT00702117|Flecainide|flecainide|mesh-list
6513789|NCT00702117|Procainamide|procainamide|mesh-list
6513790|NCT00702117|Ajmaline|ajmaline|mesh-list
6513791|NCT00702117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6513792|NCT00702117|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6513793|NCT00702117|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6513794|NCT00702117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6513795|NCT00702117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513796|NCT00702130|Pravastatin|pravastatin|mesh-list
6513797|NCT00702130|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6513798|NCT00702130|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6513799|NCT00702130|Antimetabolites|antimetabolites|mesh-ancestor
6513800|NCT00702130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513801|NCT00702130|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6513802|NCT00702130|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6513803|NCT00702130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6513804|NCT00702156|Bisoprolol|bisoprolol|mesh-list
6513805|NCT00702156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6513806|NCT00702156|Sympatholytics|sympatholytics|mesh-ancestor
6513807|NCT00702156|Autonomic Agents|autonomic agents|mesh-ancestor
6513808|NCT00702156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6513809|NCT00702156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513810|NCT00702156|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6513811|NCT00702156|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6513812|NCT00702156|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6513813|NCT00702156|Adrenergic Agents|adrenergic agents|mesh-ancestor
6513814|NCT00702156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6513815|NCT00702156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513816|NCT00702182|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6513817|NCT00702182|Vinorelbine|vinorelbine|mesh-list
6513818|NCT00702182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6513819|NCT00702182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6513820|NCT00702182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6513821|NCT00702182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513822|NCT00702182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6513823|NCT00702182|Tubulin Modulators|tubulin modulators|mesh-ancestor
6513824|NCT00702182|Antimitotic Agents|antimitotic agents|mesh-ancestor
6513825|NCT00702182|Mitosis Modulators|mitosis modulators|mesh-ancestor
6513826|NCT00702260|Ramipril|ramipril|mesh-list
6513827|NCT00702260|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6513828|NCT00702260|Protease Inhibitors|protease inhibitors|mesh-ancestor
6513829|NCT00702260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6513830|NCT00702260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513831|NCT00702260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6513832|NCT00702416|Acetaminophen|acetaminophen|mesh-list
6513833|NCT00702416|Fentanyl|fentanyl|mesh-list
5717839|NCT03229746|Tubulin Modulators|tubulin modulators|mesh-ancestor
6513834|NCT00702416|Morphine|morphine|mesh-list
6513835|NCT00702416|Analgesics, Opioid|analgesics, opioid|mesh-list
6513836|NCT00702416|Narcotics|narcotics|mesh-list
6513837|NCT00702416|Analgesics|analgesics|mesh-list
6513838|NCT00702416|Anesthetics|anesthetics|mesh-list
6513839|NCT00702416|Ropivacaine|ropivacaine|mesh-list
6513840|NCT00702416|Anesthetics, Local|anesthetics, local|mesh-list
6513841|NCT00702416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6513842|NCT00702416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513843|NCT00702416|Sensory System Agents|sensory system agents|mesh-ancestor
6513844|NCT00702416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6513845|NCT00702416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6513846|NCT00702416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6513847|NCT00702416|Anesthetics, General|anesthetics, general|mesh-ancestor
6513848|NCT00702416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6513849|NCT00702416|Antipyretics|antipyretics|mesh-ancestor
6513850|NCT00702442|Droperidol|droperidol|mesh-list
6513851|NCT00702442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6513852|NCT00702442|Antiemetics|antiemetics|mesh-ancestor
6513853|NCT00702442|Autonomic Agents|autonomic agents|mesh-ancestor
6513854|NCT00702442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6513855|NCT00702442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513856|NCT00702442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6513857|NCT00702442|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6513858|NCT00702442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6513859|NCT00702442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6513860|NCT00702442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6513861|NCT00702442|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6513862|NCT00702442|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6513863|NCT00702442|Dopamine Agents|dopamine agents|mesh-ancestor
6513864|NCT00702442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6513865|NCT00702442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513866|NCT00702481|Nimotuzumab|nimotuzumab|mesh-list
6513867|NCT00702481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6513868|NCT00702481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6680089|NCT01601912|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6680090|NCT01601912|Antidepressive Agents|antidepressive agents|mesh-ancestor
6680091|NCT01601912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6680092|NCT01601912|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5717840|NCT03229746|Antimitotic Agents|antimitotic agents|mesh-ancestor
6513869|NCT00702572|Paclitaxel|paclitaxel|mesh-list
6513870|NCT00702572|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6513871|NCT00702572|Bevacizumab|bevacizumab|mesh-list
6513872|NCT00702572|Carboplatin|carboplatin|mesh-list
6513873|NCT00702572|Vorinostat|vorinostat|mesh-list
6513874|NCT00702572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6513875|NCT00702572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6513876|NCT00702572|Tubulin Modulators|tubulin modulators|mesh-ancestor
6513877|NCT00702572|Antimitotic Agents|antimitotic agents|mesh-ancestor
6513878|NCT00702572|Mitosis Modulators|mitosis modulators|mesh-ancestor
6513879|NCT00702572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513880|NCT00702572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6513881|NCT00702572|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6513882|NCT00702572|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6513883|NCT00702572|Growth Substances|growth substances|mesh-ancestor
6513884|NCT00702572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513885|NCT00702572|Growth Inhibitors|growth inhibitors|mesh-ancestor
6513886|NCT00702572|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6513887|NCT00702572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6513888|NCT00702637|Modafinil|modafinil|mesh-list
6513889|NCT00702637|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6513890|NCT00702637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513891|NCT00702637|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6513892|NCT00702637|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6513893|NCT00702637|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6513894|NCT00702637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513895|NCT00702676|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6513896|NCT00702676|Antidepressive Agents|antidepressive agents|mesh-ancestor
6513897|NCT00702676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6513898|NCT00702676|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6513899|NCT00702676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6513900|NCT00702676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6513901|NCT00702676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513902|NCT00702728|Furosemide|furosemide|mesh-list
6513903|NCT00702728|Diuretics|diuretics|mesh-ancestor
6513904|NCT00702728|Natriuretic Agents|natriuretic agents|mesh-ancestor
6513905|NCT00702728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513906|NCT00702728|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6513907|NCT00702728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6513908|NCT00702728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513909|NCT00702767|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6513910|NCT00702767|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6513911|NCT00702767|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6513912|NCT00702767|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6513913|NCT00702793|Varenicline|varenicline|mesh-list
6513914|NCT00702793|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6513915|NCT00702793|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6513916|NCT00702793|Cholinergic Agents|cholinergic agents|mesh-ancestor
6513917|NCT00702793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6513918|NCT00702793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513919|NCT00702793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513920|NCT00702819|Bevacizumab|bevacizumab|mesh-list
6513921|NCT00702819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6513922|NCT00702819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6513923|NCT00702819|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6513924|NCT00702819|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6513925|NCT00702819|Growth Substances|growth substances|mesh-ancestor
6513926|NCT00702819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513927|NCT00702819|Growth Inhibitors|growth inhibitors|mesh-ancestor
6513928|NCT00702871|Ranitidine|ranitidine|mesh-list
6513929|NCT00702871|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
6513930|NCT00702871|Sucralfate|sucralfate|mesh-list
6513931|NCT00702871|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6513932|NCT00702871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6513933|NCT00702871|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6513934|NCT00702871|Histamine Antagonists|histamine antagonists|mesh-ancestor
6513935|NCT00702871|Histamine Agents|histamine agents|mesh-ancestor
6513936|NCT00702871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6513937|NCT00702871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513938|NCT00702871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513939|NCT00702936|Telmisartan|telmisartan|mesh-list
6513940|NCT00702936|Ramipril|ramipril|mesh-list
6513941|NCT00702936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5717841|NCT03229746|Mitosis Modulators|mitosis modulators|mesh-ancestor
5717842|NCT03229746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717843|NCT03229746|Antimalarials|antimalarials|mesh-ancestor
5717844|NCT03229746|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5717845|NCT03229746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5717846|NCT03229746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5717847|NCT03229746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5717848|NCT03229746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6513942|NCT00702936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6513943|NCT00702936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6513944|NCT00702936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513945|NCT00702936|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6513946|NCT00702936|Protease Inhibitors|protease inhibitors|mesh-ancestor
6513947|NCT00702936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6513948|NCT00702975|Paclitaxel|paclitaxel|mesh-list
6513949|NCT00702975|Bevacizumab|bevacizumab|mesh-list
6513950|NCT00702975|Carboplatin|carboplatin|mesh-list
6680093|NCT01601912|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6680094|NCT01601912|Parasympatholytics|parasympatholytics|mesh-ancestor
6680095|NCT01601912|Autonomic Agents|autonomic agents|mesh-ancestor
6680096|NCT01601912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6680097|NCT01601912|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6680098|NCT01601912|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6680099|NCT01601912|Cholinergic Agents|cholinergic agents|mesh-ancestor
6680100|NCT01601912|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6680101|NCT01601912|Adrenergic Agents|adrenergic agents|mesh-ancestor
6680102|NCT01601938|Selenium|selenium|mesh-list
6680103|NCT01601938|Antioxidants|antioxidants|mesh-ancestor
6680104|NCT01601938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6680105|NCT01601938|Protective Agents|protective agents|mesh-ancestor
6680106|NCT01601938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680107|NCT01601938|Trace Elements|trace elements|mesh-ancestor
6680108|NCT01601938|Micronutrients|micronutrients|mesh-ancestor
6680109|NCT01602003|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6680110|NCT01602003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6680111|NCT01602003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680112|NCT01602003|Incretins|incretins|mesh-ancestor
6513951|NCT00702975|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6513952|NCT00702975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6513953|NCT00702975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6513954|NCT00702975|Tubulin Modulators|tubulin modulators|mesh-ancestor
6513955|NCT00702975|Antimitotic Agents|antimitotic agents|mesh-ancestor
6680113|NCT01602003|Hormones|hormones|mesh-ancestor
6680114|NCT01602003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6680115|NCT01602003|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6680116|NCT01602003|Protease Inhibitors|protease inhibitors|mesh-ancestor
6680117|NCT01602003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6680118|NCT01602003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6680119|NCT01602029|Ondansetron|ondansetron|mesh-list
6680120|NCT01602029|Simvastatin|simvastatin|mesh-list
6680121|NCT01602029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6680122|NCT01602029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6680123|NCT01602029|Antimetabolites|antimetabolites|mesh-ancestor
6680124|NCT01602029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6680125|NCT01602029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6680126|NCT01602029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6513956|NCT00702975|Mitosis Modulators|mitosis modulators|mesh-ancestor
6513957|NCT00702975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513958|NCT00702975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6513959|NCT00702975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6513960|NCT00702975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6513961|NCT00702975|Growth Substances|growth substances|mesh-ancestor
6513962|NCT00702975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513963|NCT00702975|Growth Inhibitors|growth inhibitors|mesh-ancestor
6513964|NCT00702975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6513965|NCT00702975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6513966|NCT00703066|Vaccines|vaccines|mesh-list
6513967|NCT00703066|Immunologic Factors|immunologic factors|mesh-ancestor
6513968|NCT00703066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513969|NCT00703079|Octreotide|octreotide|mesh-list
6513970|NCT00703079|Lanreotide|lanreotide|mesh-list
6513971|NCT00703079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6513972|NCT00703079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6513973|NCT00703079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6513974|NCT00703105|Vaccines|vaccines|mesh-list
6513975|NCT00703105|Immunologic Factors|immunologic factors|mesh-ancestor
6513976|NCT00703105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6513977|NCT00703144|Tazobactam|tazobactam|mesh-list
6513978|NCT00703144|Piperacillin|piperacillin|mesh-list
6513979|NCT00703144|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
6513980|NCT00703144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6513981|NCT00703144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6513982|NCT00703144|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6513983|NCT00703144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6513984|NCT00703144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513985|NCT00703170|Sirolimus|sirolimus|mesh-list
6513986|NCT00703170|Doxorubicin|doxorubicin|mesh-list
6513987|NCT00703170|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6513988|NCT00703170|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6513989|NCT00703170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6513990|NCT00703170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6513991|NCT00703170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6513992|NCT00703170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6513993|NCT00703170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6513994|NCT00703170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6513995|NCT00703170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6513996|NCT00703170|Antifungal Agents|antifungal agents|mesh-ancestor
6513997|NCT00703170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6513998|NCT00703170|Immunologic Factors|immunologic factors|mesh-ancestor
6513999|NCT00703170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514000|NCT00703196|Folic Acid|folic acid|mesh-list
6514001|NCT00703196|Hematinics|hematinics|mesh-ancestor
6514002|NCT00703196|Vitamin B Complex|vitamin b complex|mesh-ancestor
6514003|NCT00703196|Vitamins|vitamins|mesh-ancestor
6514004|NCT00703196|Micronutrients|micronutrients|mesh-ancestor
6514005|NCT00703196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514006|NCT00703235|Bevacizumab|bevacizumab|mesh-list
6514007|NCT00703235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6514008|NCT00703235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6514009|NCT00703235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6514010|NCT00703235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6514011|NCT00703235|Growth Substances|growth substances|mesh-ancestor
6514012|NCT00703235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514013|NCT00703235|Growth Inhibitors|growth inhibitors|mesh-ancestor
6514014|NCT00703300|Bortezomib|bortezomib|mesh-list
6514015|NCT00703300|Decitabine|decitabine|mesh-list
6514016|NCT00703300|Azacitidine|azacitidine|mesh-list
6514017|NCT00703300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6514018|NCT00703300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6514019|NCT00703300|Antimetabolites|antimetabolites|mesh-ancestor
6514020|NCT00703300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514021|NCT00703300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6514022|NCT00703313|Moxifloxacin|moxifloxacin|mesh-list
6514023|NCT00703313|Levofloxacin|levofloxacin|mesh-list
6514024|NCT00703313|Ofloxacin|ofloxacin|mesh-list
6514025|NCT00703313|Gatifloxacin|gatifloxacin|mesh-list
6514026|NCT00703313|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6514027|NCT00703313|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6514028|NCT00703313|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6514029|NCT00703313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6514030|NCT00703313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6514031|NCT00703313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6514032|NCT00703313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6514033|NCT00703313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6514034|NCT00703313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514035|NCT00703313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6514036|NCT00703313|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6514037|NCT00703313|Contraceptive Agents|contraceptive agents|mesh-ancestor
6514038|NCT00703313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6514039|NCT00703313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514040|NCT00703313|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6514041|NCT00703313|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6514042|NCT00703313|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6514043|NCT00703313|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6514044|NCT00703313|Renal Agents|renal agents|mesh-ancestor
6514045|NCT00703313|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5717849|NCT03229746|Antimetabolites|antimetabolites|mesh-ancestor
6514046|NCT00703313|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6514047|NCT00703352|Eplerenone|eplerenone|mesh-list
6514048|NCT00703352|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6514049|NCT00703352|Hormone Antagonists|hormone antagonists|mesh-ancestor
6514050|NCT00703352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6514051|NCT00703352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514052|NCT00703352|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6514053|NCT00703352|Diuretics|diuretics|mesh-ancestor
6514054|NCT00703352|Natriuretic Agents|natriuretic agents|mesh-ancestor
6514055|NCT00703352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6514056|NCT00703365|Gemcitabine|gemcitabine|mesh-list
6514057|NCT00703365|Sorafenib|sorafenib|mesh-list
6514058|NCT00703365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6514059|NCT00703365|Antimetabolites|antimetabolites|mesh-ancestor
6514060|NCT00703365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514061|NCT00703365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6514062|NCT00703365|Antiviral Agents|antiviral agents|mesh-ancestor
6514063|NCT00703365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6514064|NCT00703365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6514065|NCT00703365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6514066|NCT00703365|Immunologic Factors|immunologic factors|mesh-ancestor
6514067|NCT00703365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514068|NCT00703365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6514069|NCT00703378|Docetaxel|docetaxel|mesh-list
6514070|NCT00703378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6514071|NCT00703378|Tubulin Modulators|tubulin modulators|mesh-ancestor
6514072|NCT00703378|Antimitotic Agents|antimitotic agents|mesh-ancestor
6514073|NCT00703378|Mitosis Modulators|mitosis modulators|mesh-ancestor
6514074|NCT00703378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514075|NCT00703430|Memantine|memantine|mesh-list
6514076|NCT00703430|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6514077|NCT00703430|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6514078|NCT00703430|Dopamine Agents|dopamine agents|mesh-ancestor
6514079|NCT00703430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6514080|NCT00703430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514081|NCT00703430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514082|NCT00703430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6514083|NCT00703430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6514084|NCT00703469|Nivolumab|nivolumab|mesh-list
6514085|NCT00703469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5919453|NCT04982146|Expectorants|expectorants|mesh-ancestor
5919454|NCT04982146|Respiratory System Agents|respiratory system agents|mesh-ancestor
5919455|NCT04982146|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5919456|NCT04982146|Antioxidants|antioxidants|mesh-ancestor
5919457|NCT04982146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919458|NCT04982146|Protective Agents|protective agents|mesh-ancestor
5919459|NCT04982146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919460|NCT04982146|Antidotes|antidotes|mesh-ancestor
5919461|NCT04981457|Misoprostol|misoprostol|mesh-list
5919462|NCT04981457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5919463|NCT04981457|Abortifacient Agents|abortifacient agents|mesh-ancestor
5919464|NCT04981457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5919465|NCT04981457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919466|NCT04981457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5919467|NCT04981457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5919468|NCT04981457|Oxytocics|oxytocics|mesh-ancestor
5919469|NCT04981860|Povidone-Iodine|povidone-iodine|mesh-list
5919470|NCT04981860|Povidone|povidone|mesh-list
6514086|NCT00703469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6514087|NCT00703469|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6514088|NCT00703469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514089|NCT00703482|Coenzyme Q10|coenzyme q10|mesh-list
6514090|NCT00703482|Ubiquinone|ubiquinone|mesh-list
6514091|NCT00703482|Fenofibrate|fenofibrate|mesh-list
6514092|NCT00703482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6514093|NCT00703482|Antimetabolites|antimetabolites|mesh-ancestor
6514094|NCT00703482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514095|NCT00703482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6514096|NCT00703482|Vitamins|vitamins|mesh-ancestor
6514097|NCT00703482|Micronutrients|micronutrients|mesh-ancestor
6514098|NCT00703482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514099|NCT00703586|Maraviroc|maraviroc|mesh-list
6514100|NCT00703586|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6514101|NCT00703586|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6514102|NCT00703586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514103|NCT00703586|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6680127|NCT01602029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6680128|NCT01602029|Antiemetics|antiemetics|mesh-ancestor
5919471|NCT04981860|Plasma Substitutes|plasma substitutes|mesh-ancestor
6514104|NCT00703586|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6514105|NCT00703586|Antiviral Agents|antiviral agents|mesh-ancestor
6514106|NCT00703586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6514107|NCT00703586|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6514108|NCT00703625|Sirolimus|sirolimus|mesh-list
6514109|NCT00703625|Docetaxel|docetaxel|mesh-list
6514110|NCT00703625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5717850|NCT03229746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5717851|NCT03229746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5717852|NCT03229746|Immunologic Factors|immunologic factors|mesh-ancestor
5717853|NCT03229746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717854|NCT03229668|Pregabalin|pregabalin|mesh-list
5717855|NCT03229668|Analgesics|analgesics|mesh-ancestor
5717856|NCT03229668|Sensory System Agents|sensory system agents|mesh-ancestor
5717857|NCT03229668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5717858|NCT03229668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717859|NCT03229668|Anticonvulsants|anticonvulsants|mesh-ancestor
5717860|NCT03229668|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5717861|NCT03229668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5717862|NCT03229668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717863|NCT03229668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5717864|NCT03229668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5717865|NCT03229668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5717866|NCT03229668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5717867|NCT03229668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5717868|NCT03229850|Insulin Lispro|insulin lispro|mesh-list
5717869|NCT03229850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5717870|NCT03229850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717871|NCT03230058|Voriconazole|voriconazole|mesh-list
5717872|NCT03230058|Natamycin|natamycin|mesh-list
5717873|NCT03230058|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5717874|NCT03230058|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6514111|NCT00703625|Tubulin Modulators|tubulin modulators|mesh-ancestor
6514112|NCT00703625|Antimitotic Agents|antimitotic agents|mesh-ancestor
6514113|NCT00703625|Mitosis Modulators|mitosis modulators|mesh-ancestor
6514114|NCT00703625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514115|NCT00703625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6514116|NCT00703625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6514117|NCT00703625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6514118|NCT00703625|Antifungal Agents|antifungal agents|mesh-ancestor
6514119|NCT00703625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6514120|NCT00703625|Immunologic Factors|immunologic factors|mesh-ancestor
6514121|NCT00703625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514122|NCT00703638|Pemetrexed|pemetrexed|mesh-list
6514123|NCT00703638|Sorafenib|sorafenib|mesh-list
6514124|NCT00703638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6514125|NCT00703638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6514126|NCT00703638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514127|NCT00703638|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6514128|NCT00703638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6514129|NCT00703638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6514130|NCT00703651|Vaccines|vaccines|mesh-list
6514131|NCT00703651|Immunologic Factors|immunologic factors|mesh-ancestor
6514132|NCT00703651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514133|NCT00703690|Fenofibrate|fenofibrate|mesh-list
6514134|NCT00703690|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6514135|NCT00703690|Antimetabolites|antimetabolites|mesh-ancestor
6680129|NCT01602029|Autonomic Agents|autonomic agents|mesh-ancestor
6680130|NCT01602029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6680131|NCT01602029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680132|NCT01602029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5717875|NCT03230058|Antifungal Agents|antifungal agents|mesh-ancestor
5717876|NCT03230058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5717877|NCT03230058|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5717878|NCT03230058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5717879|NCT03230058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5717880|NCT03230058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717881|NCT03230058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5717882|NCT03230058|Hormone Antagonists|hormone antagonists|mesh-ancestor
5717883|NCT03230058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6680133|NCT01602029|Antipruritics|antipruritics|mesh-ancestor
6680134|NCT01602029|Dermatologic Agents|dermatologic agents|mesh-ancestor
6680135|NCT01602029|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6680136|NCT01602029|Serotonin Agents|serotonin agents|mesh-ancestor
5919472|NCT04981860|Blood Substitutes|blood substitutes|mesh-ancestor
5717884|NCT03230058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514136|NCT00703690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717885|NCT03230058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5717886|NCT03230058|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5717887|NCT03230058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5717888|NCT03229694|Bosentan|bosentan|mesh-list
5717889|NCT03229694|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-list
5717890|NCT03229694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5717891|NCT03229694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717892|NCT03230136|Anesthetics|anesthetics|mesh-list
5717893|NCT03230136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5717894|NCT03230136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717895|NCT03229824|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
5717896|NCT03229824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5717897|NCT03229798|Sumatriptan|sumatriptan|mesh-list
5717898|NCT03229798|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5717899|NCT03229798|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5717900|NCT03229798|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5717901|NCT03229798|Serotonin Agents|serotonin agents|mesh-ancestor
5717902|NCT03229798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5717903|NCT03229798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717904|NCT03229798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717905|NCT03229889|Tadalafil|tadalafil|mesh-list
6514137|NCT00703690|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6514138|NCT00703703|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6514139|NCT00703703|Darifenacin|darifenacin|mesh-list
6514140|NCT00703703|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6514141|NCT00703703|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6514142|NCT00703703|Cholinergic Agents|cholinergic agents|mesh-ancestor
6514143|NCT00703703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6514144|NCT00703703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514145|NCT00703703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514146|NCT00703703|Urological Agents|urological agents|mesh-ancestor
6514147|NCT00703742|Citalopram|citalopram|mesh-list
6514148|NCT00703742|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6514149|NCT00703742|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6514150|NCT00703742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6514151|NCT00703742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514152|NCT00703742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6514153|NCT00703742|Serotonin Agents|serotonin agents|mesh-ancestor
6514154|NCT00703742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514155|NCT00703742|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6514156|NCT00703742|Antidepressive Agents|antidepressive agents|mesh-ancestor
6514157|NCT00703742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6514158|NCT00703755|Metformin|metformin|mesh-list
6514159|NCT00703755|Fenofibrate|fenofibrate|mesh-list
6514160|NCT00703755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6514161|NCT00703755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514162|NCT00703755|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6514163|NCT00703755|Antimetabolites|antimetabolites|mesh-ancestor
6514164|NCT00703755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514165|NCT00703755|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6514166|NCT00703807|Everolimus|everolimus|mesh-list
6514167|NCT00703807|Topotecan|topotecan|mesh-list
6514168|NCT00703807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6514169|NCT00703807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6514170|NCT00703807|Immunologic Factors|immunologic factors|mesh-ancestor
6514171|NCT00703807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514172|NCT00703807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6514173|NCT00703807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6514174|NCT00703807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6514175|NCT00703807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514176|NCT00703872|Interferons|interferons|mesh-list
6514177|NCT00703872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6514178|NCT00703872|Antiviral Agents|antiviral agents|mesh-ancestor
6514179|NCT00703872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6514180|NCT00703898|Nevirapine|nevirapine|mesh-list
6514181|NCT00703898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6514182|NCT00703898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6514183|NCT00703898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6514184|NCT00703898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514185|NCT00703898|Antiviral Agents|antiviral agents|mesh-ancestor
6514186|NCT00703898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5717906|NCT03229889|Tamsulosin|tamsulosin|mesh-list
5717907|NCT03229889|Vasodilator Agents|vasodilator agents|mesh-ancestor
5717908|NCT03229889|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5717909|NCT03229889|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5717910|NCT03229889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5717911|NCT03229889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717912|NCT03229889|Urological Agents|urological agents|mesh-ancestor
6514187|NCT00703898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6514188|NCT00703898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6514189|NCT00703898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6514190|NCT00703898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6514191|NCT00703989|Thioctic Acid|thioctic acid|mesh-list
6514192|NCT00703989|Benphothiamine|benphothiamine|mesh-list
6680137|NCT01602029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6680138|NCT01602029|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6680139|NCT01602029|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6680140|NCT01602029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6680141|NCT01602029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6680142|NCT01602029|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6680143|NCT01602055|Azithromycin|azithromycin|mesh-list
6680144|NCT01602055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6680145|NCT01602055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6680146|NCT01602185|Memantine|memantine|mesh-list
6680147|NCT01602185|Dextromethorphan|dextromethorphan|mesh-list
6680148|NCT01602185|Antitussive Agents|antitussive agents|mesh-list
6680149|NCT01602185|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6680150|NCT01602185|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6680151|NCT01602185|Dopamine Agents|dopamine agents|mesh-ancestor
6680152|NCT01602185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6680153|NCT01602185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6680154|NCT01602185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514193|NCT00703989|Antioxidants|antioxidants|mesh-ancestor
6514194|NCT00703989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514195|NCT00703989|Protective Agents|protective agents|mesh-ancestor
6514196|NCT00703989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514197|NCT00703989|Vitamin B Complex|vitamin b complex|mesh-ancestor
6680155|NCT01602185|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6680156|NCT01602185|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6680157|NCT01602185|Respiratory System Agents|respiratory system agents|mesh-ancestor
6680158|NCT01602250|Ropivacaine|ropivacaine|mesh-list
6680159|NCT01602250|Levobupivacaine|levobupivacaine|mesh-list
6680160|NCT01602250|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6680161|NCT01602250|Anesthetics, Local|anesthetics, local|mesh-ancestor
6680162|NCT01602250|Anesthetics|anesthetics|mesh-ancestor
6680163|NCT01602250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6680164|NCT01602250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680165|NCT01602250|Sensory System Agents|sensory system agents|mesh-ancestor
6680166|NCT01602250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6680167|NCT01602250|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6680168|NCT01602250|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6680169|NCT01602250|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6680170|NCT01602289|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6680171|NCT01602289|Gefitinib|gefitinib|mesh-list
6680172|NCT01602289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6680173|NCT01602289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6680174|NCT01602289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6680175|NCT01602289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6680176|NCT01602302|Adalimumab|adalimumab|mesh-list
6680177|NCT01602302|Etanercept|etanercept|mesh-list
6680178|NCT01602302|Golimumab|golimumab|mesh-list
6680179|NCT01602302|Abatacept|abatacept|mesh-list
6680180|NCT01602302|Infliximab|infliximab|mesh-list
6680181|NCT01602302|Certolizumab Pegol|certolizumab pegol|mesh-list
6680182|NCT01602302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6680183|NCT01602302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6680184|NCT01602302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6680185|NCT01602302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6514198|NCT00703989|Vitamins|vitamins|mesh-ancestor
6514199|NCT00703989|Micronutrients|micronutrients|mesh-ancestor
6514200|NCT00703989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6514201|NCT00703989|Immunologic Factors|immunologic factors|mesh-ancestor
6514202|NCT00703989|Chelating Agents|chelating agents|mesh-ancestor
6514203|NCT00703989|Sequestering Agents|sequestering agents|mesh-ancestor
6680186|NCT01602302|Analgesics|analgesics|mesh-ancestor
6680187|NCT01602302|Sensory System Agents|sensory system agents|mesh-ancestor
6680188|NCT01602302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6514204|NCT00704080|Temozolomide|temozolomide|mesh-list
6514205|NCT00704080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6514206|NCT00704080|Alkylating Agents|alkylating agents|mesh-ancestor
6514207|NCT00704080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514208|NCT00704080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6514209|NCT00704106|Entecavir|entecavir|mesh-list
6514210|NCT00704106|Antiviral Agents|antiviral agents|mesh-ancestor
6514211|NCT00704106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6514212|NCT00704145|Paclitaxel|paclitaxel|mesh-list
6514213|NCT00704145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6514214|NCT00704145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6514215|NCT00704145|Tubulin Modulators|tubulin modulators|mesh-ancestor
6514216|NCT00704145|Antimitotic Agents|antimitotic agents|mesh-ancestor
6514217|NCT00704145|Mitosis Modulators|mitosis modulators|mesh-ancestor
6514218|NCT00704145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514219|NCT00704223|Insulin Aspart|insulin aspart|mesh-list
6514220|NCT00704223|Biphasic Insulins|biphasic insulins|mesh-list
6514221|NCT00704223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6514222|NCT00704223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514223|NCT00704249|Nevirapine|nevirapine|mesh-list
6514224|NCT00704249|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6514225|NCT00704249|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6514226|NCT00704249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6514227|NCT00704249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514228|NCT00704249|Antiviral Agents|antiviral agents|mesh-ancestor
6514229|NCT00704249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6514230|NCT00704249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6514231|NCT00704249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6514232|NCT00704249|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6514233|NCT00704249|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6514234|NCT00704275|Cyclosporine|cyclosporine|mesh-list
6514235|NCT00704275|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6514236|NCT00704275|Cyclosporins|cyclosporins|mesh-list
6514237|NCT00704275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6514238|NCT00704275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514239|NCT00704275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6514240|NCT00704275|Immunologic Factors|immunologic factors|mesh-ancestor
6514241|NCT00704275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514242|NCT00704275|Antifungal Agents|antifungal agents|mesh-ancestor
6514243|NCT00704275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6514244|NCT00704275|Dermatologic Agents|dermatologic agents|mesh-ancestor
6514245|NCT00704275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6514246|NCT00704275|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6514247|NCT00704275|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6514248|NCT00704301|Rivastigmine|rivastigmine|mesh-list
6514249|NCT00704301|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6514250|NCT00704301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6514251|NCT00704301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514252|NCT00704301|Cholinergic Agents|cholinergic agents|mesh-ancestor
6514253|NCT00704301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6514254|NCT00704301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514255|NCT00704301|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6514256|NCT00704301|Protective Agents|protective agents|mesh-ancestor
6514257|NCT00704314|Simvastatin|simvastatin|mesh-list
6514258|NCT00704314|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6514259|NCT00704314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6514260|NCT00704314|Antimetabolites|antimetabolites|mesh-ancestor
6514261|NCT00704314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514262|NCT00704314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6514263|NCT00704314|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6514264|NCT00704314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6514265|NCT00704366|Saracatinib|saracatinib|mesh-list
6514266|NCT00704366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6514267|NCT00704366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6514268|NCT00704366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514269|NCT00704392|XL647|xl647|mesh-list
6514270|NCT00704392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6514271|NCT00704392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6514272|NCT00704392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6514273|NCT00704392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514274|NCT00704431|Darapladib|darapladib|mesh-list
6514275|NCT00704431|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
6514276|NCT00704431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6514277|NCT00704431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514278|NCT00704509|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6514279|NCT00704509|Antidepressive Agents|antidepressive agents|mesh-ancestor
6514280|NCT00704509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6514281|NCT00704509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6514282|NCT00704509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6514283|NCT00704509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6514284|NCT00704509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514285|NCT00704548|Simvastatin|simvastatin|mesh-list
6680189|NCT01602302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680190|NCT01602302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6680191|NCT01602302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6680192|NCT01602302|Immunologic Factors|immunologic factors|mesh-ancestor
6680193|NCT01602302|Dermatologic Agents|dermatologic agents|mesh-ancestor
6680194|NCT01602302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6680195|NCT01602302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6680196|NCT01602302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6680197|NCT01602302|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6680198|NCT01602406|Trastuzumab|trastuzumab|mesh-list
6680199|NCT01602406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6680200|NCT01602406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6680201|NCT01602523|Budesonide|budesonide|mesh-list
6680202|NCT01602523|Formoterol Fumarate|formoterol fumarate|mesh-list
6680203|NCT01602523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6680204|NCT01602523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6514286|NCT00704548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6514287|NCT00704548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6514288|NCT00704548|Antimetabolites|antimetabolites|mesh-ancestor
6514289|NCT00704548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514290|NCT00704548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6514291|NCT00704548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6514292|NCT00704548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6514293|NCT00704574|Insulin Detemir|insulin detemir|mesh-list
6514294|NCT00704574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6514295|NCT00704574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514296|NCT00704600|Nelfinavir|nelfinavir|mesh-list
6514297|NCT00704600|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6514298|NCT00704600|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6514299|NCT00704600|Protease Inhibitors|protease inhibitors|mesh-ancestor
6514300|NCT00704600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6514301|NCT00704600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514302|NCT00704600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6514303|NCT00704600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6514304|NCT00704600|Antiviral Agents|antiviral agents|mesh-ancestor
6514305|NCT00704600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6680205|NCT01602523|Autonomic Agents|autonomic agents|mesh-ancestor
6680206|NCT01602523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6680207|NCT01602523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680208|NCT01602523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6680209|NCT01602523|Respiratory System Agents|respiratory system agents|mesh-ancestor
6680210|NCT01602523|Glucocorticoids|glucocorticoids|mesh-ancestor
6680211|NCT01602523|Hormones|hormones|mesh-ancestor
6680212|NCT01602523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6680213|NCT01602523|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6680214|NCT01602523|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6680215|NCT01602523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6680216|NCT01602523|Adrenergic Agents|adrenergic agents|mesh-ancestor
6680217|NCT01602523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6680218|NCT01602523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6680219|NCT01602588|Hydroxychloroquine|hydroxychloroquine|mesh-list
6680220|NCT01602588|Antimalarials|antimalarials|mesh-ancestor
6680221|NCT01602588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6680222|NCT01602588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6680223|NCT01602588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6680224|NCT01602588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6680225|NCT01602588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6680226|NCT01602588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6680227|NCT01602640|Fentanyl|fentanyl|mesh-list
6680228|NCT01602640|Midazolam|midazolam|mesh-list
6680229|NCT01602640|Morphine|morphine|mesh-list
6680230|NCT01602640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6680231|NCT01602640|Narcotics|narcotics|mesh-ancestor
6680232|NCT01602640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6514306|NCT00704639|Carboplatin|carboplatin|mesh-list
6514307|NCT00704639|Cetuximab|cetuximab|mesh-list
6514308|NCT00704639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6514309|NCT00704639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6514310|NCT00704665|Methocarbamol|methocarbamol|mesh-list
6514311|NCT00704665|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6514312|NCT00704665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514313|NCT00704665|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6514314|NCT00704665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6514315|NCT00704678|Sevelamer|sevelamer|mesh-list
6514316|NCT00704678|Chelating Agents|chelating agents|mesh-ancestor
6514317|NCT00704678|Sequestering Agents|sequestering agents|mesh-ancestor
6514318|NCT00704678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514319|NCT00704691|Lenalidomide|lenalidomide|mesh-list
6680233|NCT01602640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680234|NCT01602640|Analgesics|analgesics|mesh-ancestor
6680235|NCT01602640|Sensory System Agents|sensory system agents|mesh-ancestor
6680236|NCT01602640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6680237|NCT01602640|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6680238|NCT01602640|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6680239|NCT01602640|Anesthetics, General|anesthetics, general|mesh-ancestor
6680240|NCT01602640|Anesthetics|anesthetics|mesh-ancestor
6680241|NCT01602640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6680242|NCT01602640|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6680243|NCT01602640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6680244|NCT01602640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6680245|NCT01602640|GABA Modulators|gaba modulators|mesh-ancestor
6680246|NCT01602640|GABA Agents|gaba agents|mesh-ancestor
6680247|NCT01602640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6680248|NCT01602640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779863|NCT02181335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779864|NCT02181335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6779865|NCT02181335|Respiratory System Agents|respiratory system agents|mesh-ancestor
6779866|NCT02181335|Glucocorticoids|glucocorticoids|mesh-ancestor
6514320|NCT00704691|Immunologic Factors|immunologic factors|mesh-ancestor
6514321|NCT00704691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514322|NCT00704691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6514323|NCT00704691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6779867|NCT02181335|Hormones|hormones|mesh-ancestor
6514324|NCT00704691|Growth Substances|growth substances|mesh-ancestor
6514325|NCT00704691|Growth Inhibitors|growth inhibitors|mesh-ancestor
6514326|NCT00704691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6514327|NCT00704704|Thalidomide|thalidomide|mesh-list
6514328|NCT00704704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6514329|NCT00704704|Immunologic Factors|immunologic factors|mesh-ancestor
6514330|NCT00704704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514331|NCT00704704|Leprostatic Agents|leprostatic agents|mesh-ancestor
6514332|NCT00704704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6514333|NCT00704704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6514334|NCT00704704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6514335|NCT00704704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6514336|NCT00704704|Growth Substances|growth substances|mesh-ancestor
6514337|NCT00704704|Growth Inhibitors|growth inhibitors|mesh-ancestor
6514338|NCT00704704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6514339|NCT00704743|Calpastatin|calpastatin|mesh-list
6514340|NCT00704743|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
6514341|NCT00704743|Protease Inhibitors|protease inhibitors|mesh-ancestor
6514342|NCT00704743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6514343|NCT00704743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514344|NCT00704756|Ribavirin|ribavirin|mesh-list
6779868|NCT02181335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6779869|NCT02181348|Vitamin E|vitamin e|mesh-list
6779870|NCT02181348|Vitamins|vitamins|mesh-ancestor
6779871|NCT02181348|Micronutrients|micronutrients|mesh-ancestor
6779872|NCT02181348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779873|NCT02181348|Antioxidants|antioxidants|mesh-ancestor
6779874|NCT02181348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779875|NCT02181348|Protective Agents|protective agents|mesh-ancestor
6779876|NCT02181361|Aspirin|aspirin|mesh-list
6779877|NCT02181361|Hirudins|hirudins|mesh-list
6779878|NCT02181361|Warfarin|warfarin|mesh-list
6514345|NCT00704756|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6514346|NCT00704756|Interferon-alpha|interferon-alpha|mesh-list
6514347|NCT00704756|Antimetabolites|antimetabolites|mesh-ancestor
6514348|NCT00704756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514349|NCT00704756|Antiviral Agents|antiviral agents|mesh-ancestor
6514350|NCT00704756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6514351|NCT00704756|Immunologic Factors|immunologic factors|mesh-ancestor
6514352|NCT00704756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514353|NCT00704821|Docetaxel|docetaxel|mesh-list
6514354|NCT00704821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6514355|NCT00704821|Tubulin Modulators|tubulin modulators|mesh-ancestor
6514356|NCT00704821|Antimitotic Agents|antimitotic agents|mesh-ancestor
6514357|NCT00704821|Mitosis Modulators|mitosis modulators|mesh-ancestor
6514358|NCT00704821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514359|NCT00704860|Antidepressive Agents|antidepressive agents|mesh-list
6514360|NCT00704860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6514361|NCT00704899|Amitriptyline|amitriptyline|mesh-list
6514362|NCT00704899|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6514363|NCT00704899|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6514364|NCT00704899|Antidepressive Agents|antidepressive agents|mesh-ancestor
6514365|NCT00704899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6514366|NCT00704899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6514367|NCT00704899|Analgesics|analgesics|mesh-ancestor
6514368|NCT00704899|Sensory System Agents|sensory system agents|mesh-ancestor
6514369|NCT00704899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6514370|NCT00704899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514371|NCT00704899|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6514372|NCT00704899|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6514373|NCT00704899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6514374|NCT00704899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514375|NCT00704899|Adrenergic Agents|adrenergic agents|mesh-ancestor
6514376|NCT00704899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6514377|NCT00704899|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6514378|NCT00704899|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6514379|NCT00704899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6514380|NCT00704925|Amifampridine|amifampridine|mesh-list
6514381|NCT00704925|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6514382|NCT00704925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6514383|NCT00704925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514384|NCT00704925|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6514385|NCT00704925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6514386|NCT00704925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514387|NCT00704951|Posaconazole|posaconazole|mesh-list
6514388|NCT00704951|Antifungal Agents|antifungal agents|mesh-ancestor
6514389|NCT00704951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6514390|NCT00704951|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6514391|NCT00704951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6680249|NCT01602757|Lidocaine|lidocaine|mesh-list
6680250|NCT01602757|Tetracaine|tetracaine|mesh-list
6680251|NCT01602757|Anesthetics, Local|anesthetics, local|mesh-ancestor
6680252|NCT01602757|Anesthetics|anesthetics|mesh-ancestor
6680253|NCT01602757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6680254|NCT01602757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680255|NCT01602757|Sensory System Agents|sensory system agents|mesh-ancestor
6680256|NCT01602757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6680257|NCT01602757|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6680258|NCT01602757|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6680259|NCT01602757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6680260|NCT01602757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6680261|NCT01602757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6680262|NCT01602822|Ritonavir|ritonavir|mesh-list
6680263|NCT01602822|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6680264|NCT01602822|Tenofovir|tenofovir|mesh-list
6680265|NCT01602822|Emtricitabine|emtricitabine|mesh-list
6680266|NCT01602822|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6680267|NCT01602822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6680268|NCT01602822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6680269|NCT01602822|Protease Inhibitors|protease inhibitors|mesh-ancestor
6680270|NCT01602822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6680271|NCT01602822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6680272|NCT01602822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6680273|NCT01602822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6680274|NCT01602822|Antiviral Agents|antiviral agents|mesh-ancestor
6680275|NCT01602822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6514392|NCT00704951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6514393|NCT00704951|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6514394|NCT00704951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6514395|NCT00704951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6514396|NCT00704951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514397|NCT00704951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6514398|NCT00704951|Hormone Antagonists|hormone antagonists|mesh-ancestor
6514399|NCT00704951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6514400|NCT00704951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514401|NCT00704990|Vitamins|vitamins|mesh-list
6514402|NCT00704990|Ascorbic Acid|ascorbic acid|mesh-list
6514403|NCT00704990|Vitamin B 6|vitamin b 6|mesh-list
6514404|NCT00704990|Pyridoxal|pyridoxal|mesh-list
6514405|NCT00704990|Pyridoxine|pyridoxine|mesh-list
6514406|NCT00704990|Zinc|zinc|mesh-list
6514407|NCT00704990|Vitamin B Complex|vitamin b complex|mesh-list
6514408|NCT00704990|Micronutrients|micronutrients|mesh-ancestor
6514409|NCT00704990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514410|NCT00704990|Trace Elements|trace elements|mesh-ancestor
6514411|NCT00704990|Antioxidants|antioxidants|mesh-ancestor
6514412|NCT00704990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514413|NCT00704990|Protective Agents|protective agents|mesh-ancestor
6514414|NCT00705042|Etanercept|etanercept|mesh-list
6514415|NCT00705042|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6514416|NCT00705042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6514417|NCT00705042|Analgesics|analgesics|mesh-ancestor
6514418|NCT00705042|Sensory System Agents|sensory system agents|mesh-ancestor
6514419|NCT00705042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6514420|NCT00705042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514421|NCT00705042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6514422|NCT00705042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6514423|NCT00705042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6514424|NCT00705042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6514425|NCT00705042|Immunologic Factors|immunologic factors|mesh-ancestor
6514426|NCT00705120|Cyclosporine|cyclosporine|mesh-list
6514427|NCT00705120|Cyclophosphamide|cyclophosphamide|mesh-list
6514428|NCT00705120|Busulfan|busulfan|mesh-list
6514429|NCT00705120|Cyclosporins|cyclosporins|mesh-list
6514430|NCT00705120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6514431|NCT00705120|Immunologic Factors|immunologic factors|mesh-ancestor
6514432|NCT00705120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514433|NCT00705120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6514434|NCT00705120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6514435|NCT00705120|Alkylating Agents|alkylating agents|mesh-ancestor
6514436|NCT00705120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514437|NCT00705120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6514438|NCT00705120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6514439|NCT00705120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6514440|NCT00705120|Antifungal Agents|antifungal agents|mesh-ancestor
6514441|NCT00705120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6514442|NCT00705120|Dermatologic Agents|dermatologic agents|mesh-ancestor
6514443|NCT00705120|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6514444|NCT00705198|Temozolomide|temozolomide|mesh-list
6514445|NCT00705198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6514446|NCT00705198|Alkylating Agents|alkylating agents|mesh-ancestor
6514447|NCT00705198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514448|NCT00705198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6514449|NCT00705315|Bevacizumab|bevacizumab|mesh-list
6514450|NCT00705315|Docetaxel|docetaxel|mesh-list
6514451|NCT00705315|Epirubicin|epirubicin|mesh-list
6514452|NCT00705315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6514453|NCT00705315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6514454|NCT00705315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6514455|NCT00705315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6514456|NCT00705315|Growth Substances|growth substances|mesh-ancestor
6514457|NCT00705315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514458|NCT00705315|Growth Inhibitors|growth inhibitors|mesh-ancestor
6514459|NCT00705315|Tubulin Modulators|tubulin modulators|mesh-ancestor
6514460|NCT00705315|Antimitotic Agents|antimitotic agents|mesh-ancestor
6514461|NCT00705315|Mitosis Modulators|mitosis modulators|mesh-ancestor
6514462|NCT00705315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514463|NCT00705315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6514464|NCT00705315|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6514465|NCT00705315|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6514466|NCT00705315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6514467|NCT00705354|Bacitracin|bacitracin|mesh-list
6514468|NCT00705354|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6514469|NCT00705354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6514470|NCT00705354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6514471|NCT00705419|Tenofovir|tenofovir|mesh-list
6514472|NCT00705419|Emtricitabine|emtricitabine|mesh-list
6514473|NCT00705419|Maleic acid|maleic acid|mesh-list
6514474|NCT00705419|Antiviral Agents|antiviral agents|mesh-ancestor
6514475|NCT00705419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6514476|NCT00705419|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6514477|NCT00705419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6514478|NCT00705419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6514479|NCT00705419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514480|NCT00705419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6514481|NCT00705419|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6514482|NCT00705445|Zinc|zinc|mesh-list
6514483|NCT00705445|Trace Elements|trace elements|mesh-list
6514484|NCT00705445|Micronutrients|micronutrients|mesh-list
6514485|NCT00705445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514486|NCT00705471|Infliximab|infliximab|mesh-list
6514487|NCT00705471|Dermatologic Agents|dermatologic agents|mesh-ancestor
6514488|NCT00705471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6514489|NCT00705471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6514490|NCT00705510|Cyclosporine|cyclosporine|mesh-list
6514491|NCT00705510|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6514492|NCT00705510|Cyclosporins|cyclosporins|mesh-list
6514493|NCT00705510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6514494|NCT00705510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514495|NCT00705510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6514496|NCT00705510|Immunologic Factors|immunologic factors|mesh-ancestor
6514497|NCT00705510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514498|NCT00705510|Antifungal Agents|antifungal agents|mesh-ancestor
6514499|NCT00705510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6514500|NCT00705510|Dermatologic Agents|dermatologic agents|mesh-ancestor
6514501|NCT00705510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6514502|NCT00705510|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6514503|NCT00705510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6514504|NCT00705549|Gemcitabine|gemcitabine|mesh-list
6514505|NCT00705549|Cisplatin|cisplatin|mesh-list
6514506|NCT00705549|Docetaxel|docetaxel|mesh-list
6514507|NCT00705549|Vinorelbine|vinorelbine|mesh-list
6514508|NCT00705549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6514509|NCT00705549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6514510|NCT00705549|Antimetabolites|antimetabolites|mesh-ancestor
6514511|NCT00705549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514512|NCT00705549|Antiviral Agents|antiviral agents|mesh-ancestor
6514513|NCT00705549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6514514|NCT00705549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6514515|NCT00705549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6514516|NCT00705549|Immunologic Factors|immunologic factors|mesh-ancestor
6514517|NCT00705549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514518|NCT00705549|Tubulin Modulators|tubulin modulators|mesh-ancestor
6514519|NCT00705549|Antimitotic Agents|antimitotic agents|mesh-ancestor
6514520|NCT00705549|Mitosis Modulators|mitosis modulators|mesh-ancestor
6514521|NCT00705549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6514522|NCT00705562|Caseins|caseins|mesh-list
6514523|NCT00705562|Chelating Agents|chelating agents|mesh-ancestor
6514524|NCT00705562|Sequestering Agents|sequestering agents|mesh-ancestor
6514525|NCT00705562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514526|NCT00705588|Tadalafil|tadalafil|mesh-list
6514527|NCT00705588|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6514528|NCT00705588|Vasodilator Agents|vasodilator agents|mesh-ancestor
6514529|NCT00705588|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6514530|NCT00705588|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6514531|NCT00705588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6514532|NCT00705588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514533|NCT00705588|Urological Agents|urological agents|mesh-ancestor
6514534|NCT00705640|Freund's Adjuvant|freund's adjuvant|mesh-list
6514535|NCT00705640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6514536|NCT00705640|Immunologic Factors|immunologic factors|mesh-ancestor
6514537|NCT00705640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514538|NCT00705692|Levamisole|levamisole|mesh-list
6514539|NCT00705692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6514540|NCT00705692|Immunologic Factors|immunologic factors|mesh-ancestor
6514541|NCT00705692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514542|NCT00705692|Antinematodal Agents|antinematodal agents|mesh-ancestor
6514543|NCT00705692|Anthelmintics|anthelmintics|mesh-ancestor
6514544|NCT00705692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6514545|NCT00705692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6514546|NCT00705692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6514547|NCT00705770|Hydrocortisone|hydrocortisone|mesh-list
6514548|NCT00705770|Anecortave|anecortave|mesh-list
6514549|NCT00705770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6514550|NCT00705770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6514551|NCT00705770|Growth Substances|growth substances|mesh-ancestor
6514552|NCT00705770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514553|NCT00705770|Growth Inhibitors|growth inhibitors|mesh-ancestor
6514554|NCT00705770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6514555|NCT00705770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6514556|NCT00705796|Methyltestosterone|methyltestosterone|mesh-list
6514557|NCT00705796|Testosterone|testosterone|mesh-list
6514558|NCT00705796|Testosterone undecanoate|testosterone undecanoate|mesh-list
6514559|NCT00705796|Testosterone enanthate|testosterone enanthate|mesh-list
6514560|NCT00705796|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6514561|NCT00705796|Androgens|androgens|mesh-ancestor
6514562|NCT00705796|Hormones|hormones|mesh-ancestor
6514563|NCT00705796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6514564|NCT00705796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514565|NCT00705796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6514566|NCT00705796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6514567|NCT00705796|Anabolic Agents|anabolic agents|mesh-ancestor
6514568|NCT00705822|Prednisone|prednisone|mesh-list
6514569|NCT00705822|Hydrocortisone|hydrocortisone|mesh-list
6514570|NCT00705822|Docetaxel|docetaxel|mesh-list
6514571|NCT00705822|Estramustine|estramustine|mesh-list
6680276|NCT01602822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6680277|NCT01602822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6680278|NCT01602822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6680279|NCT01602822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6680280|NCT01602861|Spironolactone|spironolactone|mesh-list
6680281|NCT01602861|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6680282|NCT01602861|Hormone Antagonists|hormone antagonists|mesh-ancestor
6680283|NCT01602861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6680284|NCT01602861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680285|NCT01602861|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6680286|NCT01602861|Diuretics|diuretics|mesh-ancestor
6680287|NCT01602861|Natriuretic Agents|natriuretic agents|mesh-ancestor
6680288|NCT01602874|Metronidazole|metronidazole|mesh-list
6680289|NCT01602874|Clarithromycin|clarithromycin|mesh-list
6680290|NCT01602874|Ceftriaxone|ceftriaxone|mesh-list
6680291|NCT01602874|Tigecycline|tigecycline|mesh-list
6680292|NCT01602874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6680293|NCT01602874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6514572|NCT00705822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6514573|NCT00705822|Tubulin Modulators|tubulin modulators|mesh-ancestor
6514574|NCT00705822|Antimitotic Agents|antimitotic agents|mesh-ancestor
6514575|NCT00705822|Mitosis Modulators|mitosis modulators|mesh-ancestor
6514576|NCT00705822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514577|NCT00705822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6514578|NCT00705822|Glucocorticoids|glucocorticoids|mesh-ancestor
6514579|NCT00705822|Hormones|hormones|mesh-ancestor
6514580|NCT00705822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6514581|NCT00705822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514582|NCT00705822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6514583|NCT00705822|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6514584|NCT00705822|Alkylating Agents|alkylating agents|mesh-ancestor
6514585|NCT00705835|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6514586|NCT00705835|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6514587|NCT00705835|Immunologic Factors|immunologic factors|mesh-ancestor
6514588|NCT00705835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514589|NCT00705835|Antacids|antacids|mesh-ancestor
6514590|NCT00705835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514591|NCT00705835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6514592|NCT00705900|Calcipotriene|calcipotriene|mesh-list
6514593|NCT00705900|Dermatologic Agents|dermatologic agents|mesh-ancestor
6514594|NCT00705926|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6680294|NCT01602874|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6680295|NCT01602874|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6680296|NCT01602874|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6514595|NCT00705926|Antiviral Agents|antiviral agents|mesh-ancestor
6514596|NCT00705926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6514597|NCT00705978|Pancreatin|pancreatin|mesh-list
6514598|NCT00705978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6514599|NCT00706017|Insulin Detemir|insulin detemir|mesh-list
6514600|NCT00706017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6680297|NCT01602874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6514601|NCT00706017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514602|NCT00706069|Capecitabine|capecitabine|mesh-list
6514603|NCT00706069|Vinorelbine|vinorelbine|mesh-list
6514604|NCT00706069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6514605|NCT00706069|Antimetabolites|antimetabolites|mesh-ancestor
6514606|NCT00706069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514607|NCT00706069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6514608|NCT00706069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6514609|NCT00706069|Tubulin Modulators|tubulin modulators|mesh-ancestor
6514610|NCT00706069|Antimitotic Agents|antimitotic agents|mesh-ancestor
6514611|NCT00706069|Mitosis Modulators|mitosis modulators|mesh-ancestor
6514612|NCT00706173|Hydrocortisone|hydrocortisone|mesh-list
6514613|NCT00706173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6514614|NCT00706186|Sodium Oxybate|sodium oxybate|mesh-list
6514615|NCT00706186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6514616|NCT00706186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6514617|NCT00706186|Anesthetics, General|anesthetics, general|mesh-ancestor
6514618|NCT00706186|Anesthetics|anesthetics|mesh-ancestor
6514619|NCT00706186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6514620|NCT00706186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514621|NCT00706225|Bazedoxifene|bazedoxifene|mesh-list
6514622|NCT00706225|Estrogens|estrogens|mesh-list
6514623|NCT00706225|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6514624|NCT00706225|Hormones|hormones|mesh-ancestor
6514625|NCT00706225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6514626|NCT00706225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514627|NCT00706225|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6514628|NCT00706225|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6514629|NCT00706225|Hormone Antagonists|hormone antagonists|mesh-ancestor
6514630|NCT00706225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6514631|NCT00706277|Fentanyl|fentanyl|mesh-list
6514632|NCT00706277|Remifentanil|remifentanil|mesh-list
6680298|NCT01602874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6680299|NCT01602874|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6680300|NCT01602874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6680301|NCT01602887|Palbociclib|palbociclib|mesh-list
6680302|NCT01602887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6680303|NCT01602887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6680304|NCT01602887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6680305|NCT01602887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6680306|NCT01602900|Rolipram|rolipram|mesh-list
6680307|NCT01602900|Antidepressive Agents|antidepressive agents|mesh-ancestor
6680308|NCT01602900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6680309|NCT01602900|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6680310|NCT01602900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6680311|NCT01602900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6680312|NCT01602900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6680313|NCT01602913|Paroxetine|paroxetine|mesh-list
6680314|NCT01602913|Pravastatin|pravastatin|mesh-list
6680315|NCT01602913|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6680316|NCT01602913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6680317|NCT01602913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6680318|NCT01602913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6680319|NCT01602913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6680320|NCT01602913|Serotonin Agents|serotonin agents|mesh-ancestor
6680321|NCT01602913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680322|NCT01602913|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6680323|NCT01602913|Antidepressive Agents|antidepressive agents|mesh-ancestor
6680324|NCT01602913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6680325|NCT01602913|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6680326|NCT01602913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6514633|NCT00706277|Nitrous Oxide|nitrous oxide|mesh-list
6514634|NCT00706277|Propofol|propofol|mesh-list
6514635|NCT00706277|Sevoflurane|sevoflurane|mesh-list
6514636|NCT00706277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6514637|NCT00706277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6514638|NCT00706277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514639|NCT00706277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6514640|NCT00706277|Anesthetics, General|anesthetics, general|mesh-ancestor
6514641|NCT00706277|Anesthetics|anesthetics|mesh-ancestor
6514642|NCT00706277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6514643|NCT00706277|Narcotics|narcotics|mesh-ancestor
6514644|NCT00706277|Analgesics|analgesics|mesh-ancestor
6514645|NCT00706277|Sensory System Agents|sensory system agents|mesh-ancestor
6514646|NCT00706277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6514647|NCT00706277|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6514648|NCT00706277|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6514649|NCT00706277|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6514650|NCT00706277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6514651|NCT00706576|Mitogens|mitogens|mesh-list
6514652|NCT00706576|Enkephalin, Methionine|enkephalin, methionine|mesh-list
6514653|NCT00706576|Enkephalins|enkephalins|mesh-list
6514654|NCT00706576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514655|NCT00706576|Mitosis Modulators|mitosis modulators|mesh-ancestor
6514656|NCT00706576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514657|NCT00706576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6514658|NCT00706680|Cyclosporine|cyclosporine|mesh-list
6514659|NCT00706680|Mycophenolic Acid|mycophenolic acid|mesh-list
6514660|NCT00706680|Prednisone|prednisone|mesh-list
6514661|NCT00706680|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6514662|NCT00706680|Cyclosporins|cyclosporins|mesh-list
6514663|NCT00706680|Thymoglobulin|thymoglobulin|mesh-list
6514664|NCT00706680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6514665|NCT00706680|Glucocorticoids|glucocorticoids|mesh-ancestor
6514666|NCT00706680|Hormones|hormones|mesh-ancestor
6514667|NCT00706680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6514668|NCT00706680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514669|NCT00706680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6514670|NCT00706680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6514671|NCT00706680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6514672|NCT00706680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514673|NCT00706680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6514674|NCT00706680|Immunologic Factors|immunologic factors|mesh-ancestor
6514675|NCT00706680|Antifungal Agents|antifungal agents|mesh-ancestor
6514676|NCT00706680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6514677|NCT00706680|Dermatologic Agents|dermatologic agents|mesh-ancestor
6514678|NCT00706680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6514679|NCT00706680|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6514680|NCT00706680|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6514681|NCT00706680|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6514682|NCT00706680|Antitubercular Agents|antitubercular agents|mesh-ancestor
6514683|NCT00706680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6514684|NCT00706680|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6514685|NCT00706680|Protective Agents|protective agents|mesh-ancestor
6514686|NCT00706862|Lactoferrin|lactoferrin|mesh-list
6514687|NCT00706862|Talactoferrin alfa|talactoferrin alfa|mesh-list
6514688|NCT00706862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6680327|NCT01602913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6680328|NCT01602913|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6680329|NCT01602913|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6680330|NCT01602913|Antimetabolites|antimetabolites|mesh-ancestor
6680331|NCT01602913|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6680332|NCT01602913|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6680333|NCT01602939|Cladribine|cladribine|mesh-list
6680334|NCT01602939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6680335|NCT01602939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6680336|NCT01602939|Immunologic Factors|immunologic factors|mesh-ancestor
6680337|NCT01602939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680338|NCT01603030|Moxifloxacin|moxifloxacin|mesh-list
6680339|NCT01603030|Prednisolone|prednisolone|mesh-list
6680340|NCT01603030|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6514689|NCT00706862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6514690|NCT00706888|Vitamin B 6|vitamin b 6|mesh-list
6514691|NCT00706888|Pyridoxal|pyridoxal|mesh-list
6514692|NCT00706888|Pyridoxine|pyridoxine|mesh-list
6514693|NCT00706888|Vitamins|vitamins|mesh-ancestor
6514694|NCT00706888|Micronutrients|micronutrients|mesh-ancestor
6514695|NCT00706888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514696|NCT00706888|Vitamin B Complex|vitamin b complex|mesh-ancestor
6514697|NCT00706927|Timolol|timolol|mesh-list
6514698|NCT00706927|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6514699|NCT00706927|Latanoprost|latanoprost|mesh-list
6514700|NCT00706927|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6514701|NCT00706927|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6514702|NCT00706927|Adrenergic Agents|adrenergic agents|mesh-ancestor
6514703|NCT00706927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6514704|NCT00706927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514705|NCT00706927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514706|NCT00706927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6514707|NCT00706927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6514708|NCT00706927|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6680341|NCT01603030|Methylprednisolone|methylprednisolone|mesh-list
6514709|NCT00706927|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6514710|NCT00706927|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6514711|NCT00706927|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6514712|NCT00706927|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6514713|NCT00706953|Doxorubicin|doxorubicin|mesh-list
6514714|NCT00706953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6514715|NCT00706953|Bortezomib|bortezomib|mesh-list
6514716|NCT00706953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6514717|NCT00706953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6514718|NCT00706953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6514719|NCT00706953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6680342|NCT01603030|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6680343|NCT01603030|Prednisolone acetate|prednisolone acetate|mesh-list
6680344|NCT01603030|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6680345|NCT01603030|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6680346|NCT01603030|Prednisolone phosphate|prednisolone phosphate|mesh-list
6680347|NCT01603030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6680348|NCT01603030|Glucocorticoids|glucocorticoids|mesh-ancestor
6514720|NCT00706953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6514721|NCT00706953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6680349|NCT01603030|Hormones|hormones|mesh-ancestor
6680350|NCT01603030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6680351|NCT01603030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680352|NCT01603030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6680353|NCT01603030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6680354|NCT01603030|Antiemetics|antiemetics|mesh-ancestor
6680355|NCT01603030|Autonomic Agents|autonomic agents|mesh-ancestor
6680356|NCT01603030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6680357|NCT01603030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6680358|NCT01603030|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6680359|NCT01603030|Protective Agents|protective agents|mesh-ancestor
6680360|NCT01603030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6680361|NCT01603030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6680362|NCT01603030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6680363|NCT01603030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6680364|NCT01603030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6680365|NCT01603030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6680366|NCT01603030|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6680367|NCT01603030|Contraceptive Agents|contraceptive agents|mesh-ancestor
6680368|NCT01603030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6680369|NCT01603030|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6680370|NCT01603030|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6680371|NCT01603030|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6680372|NCT01603108|Rifaximin|rifaximin|mesh-list
6680373|NCT01603108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6680374|NCT01603108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6680375|NCT01603108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6680376|NCT01603134|Allopurinol|allopurinol|mesh-list
6680377|NCT01603134|Antimetabolites|antimetabolites|mesh-ancestor
6680378|NCT01603134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6680379|NCT01603134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6680380|NCT01603134|Gout Suppressants|gout suppressants|mesh-ancestor
6680381|NCT01603134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6680382|NCT01603134|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6680383|NCT01603134|Antioxidants|antioxidants|mesh-ancestor
6680384|NCT01603134|Protective Agents|protective agents|mesh-ancestor
6680385|NCT01603134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680386|NCT01603173|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6680387|NCT01603173|Antidepressive Agents|antidepressive agents|mesh-ancestor
6680388|NCT01603173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6680389|NCT01603173|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6680390|NCT01603173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6680391|NCT01603173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6680392|NCT01603173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680393|NCT01603186|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6680394|NCT01603186|Antidepressive Agents|antidepressive agents|mesh-ancestor
6680395|NCT01603186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6680396|NCT01603186|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6680397|NCT01603186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6680398|NCT01603186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6680399|NCT01603186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680400|NCT01603212|Interferons|interferons|mesh-list
6680401|NCT01603212|Interferon-alpha|interferon-alpha|mesh-list
6680402|NCT01603212|Interferon alpha-2|interferon alpha-2|mesh-list
6680403|NCT01603212|Aldesleukin|aldesleukin|mesh-list
6514722|NCT00707070|Acitretin|acitretin|mesh-list
6514723|NCT00707070|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6514724|NCT00707070|Immunologic Factors|immunologic factors|mesh-ancestor
6514725|NCT00707070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514726|NCT00707070|Keratolytic Agents|keratolytic agents|mesh-ancestor
6514727|NCT00707070|Dermatologic Agents|dermatologic agents|mesh-ancestor
6514728|NCT00707083|Dexamethasone|dexamethasone|mesh-list
6514729|NCT00707083|Methotrexate|methotrexate|mesh-list
6514730|NCT00707083|Vincristine|vincristine|mesh-list
6514731|NCT00707083|Mercaptopurine|mercaptopurine|mesh-list
6514732|NCT00707083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6514733|NCT00707083|Antiemetics|antiemetics|mesh-ancestor
6514734|NCT00707083|Autonomic Agents|autonomic agents|mesh-ancestor
6514735|NCT00707083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6514736|NCT00707083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514737|NCT00707083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6514738|NCT00707083|Glucocorticoids|glucocorticoids|mesh-ancestor
6514739|NCT00707083|Hormones|hormones|mesh-ancestor
6514740|NCT00707083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6514741|NCT00707083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6514742|NCT00707083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6514743|NCT00707083|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6514744|NCT00707083|Abortifacient Agents|abortifacient agents|mesh-ancestor
6514745|NCT00707083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6514746|NCT00707083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6514747|NCT00707083|Antimetabolites|antimetabolites|mesh-ancestor
6514748|NCT00707083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514749|NCT00707083|Dermatologic Agents|dermatologic agents|mesh-ancestor
6514750|NCT00707083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6514751|NCT00707083|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6514752|NCT00707083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6514753|NCT00707083|Immunologic Factors|immunologic factors|mesh-ancestor
6514754|NCT00707083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6514755|NCT00707083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6514756|NCT00707083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6514757|NCT00707083|Tubulin Modulators|tubulin modulators|mesh-ancestor
6514758|NCT00707083|Antimitotic Agents|antimitotic agents|mesh-ancestor
6514759|NCT00707083|Mitosis Modulators|mitosis modulators|mesh-ancestor
6514760|NCT00707135|Sirolimus|sirolimus|mesh-list
6514761|NCT00707135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6514762|NCT00707135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6514763|NCT00707135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6514764|NCT00707135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6514765|NCT00707135|Antifungal Agents|antifungal agents|mesh-ancestor
6514766|NCT00707135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6680404|NCT01603212|Interleukin-2|interleukin-2|mesh-list
6680405|NCT01603212|Vemurafenib|vemurafenib|mesh-list
6680406|NCT01603212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6680407|NCT01603212|Antiviral Agents|antiviral agents|mesh-ancestor
6680408|NCT01603212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6680409|NCT01603212|Immunologic Factors|immunologic factors|mesh-ancestor
6680410|NCT01603212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680411|NCT01603212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6680412|NCT01603212|Analgesics|analgesics|mesh-ancestor
6680413|NCT01603212|Sensory System Agents|sensory system agents|mesh-ancestor
6680414|NCT01603212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6680415|NCT01603212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6680416|NCT01603212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6680417|NCT01603212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6680418|NCT01603212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6680419|NCT01603212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6680420|NCT01603251|Ivermectin|ivermectin|mesh-list
6680421|NCT01603251|Lumefantrine|lumefantrine|mesh-list
6680422|NCT01603251|Artemether|artemether|mesh-list
6680423|NCT01603251|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6680424|NCT01603251|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6680425|NCT01603251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6680426|NCT01603251|Antimalarials|antimalarials|mesh-ancestor
6680427|NCT01603251|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6680428|NCT01603264|Trastuzumab|trastuzumab|mesh-list
6680429|NCT01603264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6680430|NCT01603264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6514767|NCT00707135|Immunologic Factors|immunologic factors|mesh-ancestor
6680431|NCT01603342|Clopidogrel|clopidogrel|mesh-list
6680432|NCT01603342|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6680433|NCT01603342|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6680434|NCT01603342|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6514768|NCT00707135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514769|NCT00707187|Tadalafil|tadalafil|mesh-list
6514770|NCT00707187|Vasodilator Agents|vasodilator agents|mesh-ancestor
6680435|NCT01603342|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6680436|NCT01603342|Purinergic Agents|purinergic agents|mesh-ancestor
6680437|NCT01603342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6514771|NCT00707187|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6514772|NCT00707187|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6514773|NCT00707187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6514774|NCT00707187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514775|NCT00707187|Urological Agents|urological agents|mesh-ancestor
6514776|NCT00707252|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6514777|NCT00707252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6514778|NCT00707252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6514779|NCT00707252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6514780|NCT00707252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514781|NCT00707278|Capecitabine|capecitabine|mesh-list
6514782|NCT00707278|Oxaliplatin|oxaliplatin|mesh-list
6514783|NCT00707278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6514784|NCT00707278|Antimetabolites|antimetabolites|mesh-ancestor
6514785|NCT00707278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514786|NCT00707278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6514787|NCT00707330|Clarithromycin|clarithromycin|mesh-list
6514788|NCT00707330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6514789|NCT00707330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6514790|NCT00707330|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6514791|NCT00707330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6514792|NCT00707330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514793|NCT00707330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6514794|NCT00707330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6514795|NCT00707369|Amoxicillin|amoxicillin|mesh-list
6514796|NCT00707369|Metronidazole|metronidazole|mesh-list
6514797|NCT00707369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6514798|NCT00707369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6514799|NCT00707369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6514800|NCT00707369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6514801|NCT00707408|Imatinib Mesylate|imatinib mesylate|mesh-list
6514802|NCT00707408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6514803|NCT00707408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6514804|NCT00707408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6514805|NCT00707408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514806|NCT00707421|Fluorometholone|fluorometholone|mesh-list
6514807|NCT00707421|Ketorolac|ketorolac|mesh-list
6514808|NCT00707421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6514809|NCT00707421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6514810|NCT00707421|Analgesics|analgesics|mesh-ancestor
6514811|NCT00707421|Sensory System Agents|sensory system agents|mesh-ancestor
6514812|NCT00707421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6514813|NCT00707421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514814|NCT00707421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6514815|NCT00707421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6514816|NCT00707421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6514817|NCT00707421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6514818|NCT00707421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514819|NCT00707421|Glucocorticoids|glucocorticoids|mesh-ancestor
6514820|NCT00707421|Hormones|hormones|mesh-ancestor
6514821|NCT00707421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6514822|NCT00707421|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6514823|NCT00707473|Cisplatin|cisplatin|mesh-list
6514824|NCT00707473|Carboplatin|carboplatin|mesh-list
6514825|NCT00707473|Docetaxel|docetaxel|mesh-list
6514826|NCT00707473|Fluorouracil|fluorouracil|mesh-list
6514827|NCT00707473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6514828|NCT00707473|Tubulin Modulators|tubulin modulators|mesh-ancestor
6514829|NCT00707473|Antimitotic Agents|antimitotic agents|mesh-ancestor
6514830|NCT00707473|Mitosis Modulators|mitosis modulators|mesh-ancestor
6514831|NCT00707473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514832|NCT00707473|Antimetabolites|antimetabolites|mesh-ancestor
6514833|NCT00707473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6514834|NCT00707473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6514835|NCT00707473|Immunologic Factors|immunologic factors|mesh-ancestor
6514836|NCT00707473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514837|NCT00707512|Natalizumab|natalizumab|mesh-list
6514838|NCT00707512|Immunologic Factors|immunologic factors|mesh-ancestor
6514839|NCT00707512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514840|NCT00707551|Ketoconazole|ketoconazole|mesh-list
6514841|NCT00707551|Verapamil|verapamil|mesh-list
6514842|NCT00707551|Antifungal Agents|antifungal agents|mesh-ancestor
6514843|NCT00707551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6514844|NCT00707551|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6514845|NCT00707551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6514846|NCT00707551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6514847|NCT00707551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514848|NCT00707551|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6680438|NCT01603342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514849|NCT00707551|Hormone Antagonists|hormone antagonists|mesh-ancestor
6514850|NCT00707551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6514851|NCT00707551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514852|NCT00707551|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6514853|NCT00707551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6514854|NCT00707551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6514855|NCT00707551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6514856|NCT00707551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6514857|NCT00707551|Vasodilator Agents|vasodilator agents|mesh-ancestor
6514858|NCT00707642|Vaccines|vaccines|mesh-list
6514859|NCT00707642|Immunologic Factors|immunologic factors|mesh-ancestor
6514860|NCT00707642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514861|NCT00707707|Paclitaxel|paclitaxel|mesh-list
6514862|NCT00707707|Olaparib|olaparib|mesh-list
6514863|NCT00707707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6514864|NCT00707707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6514865|NCT00707707|Tubulin Modulators|tubulin modulators|mesh-ancestor
6514866|NCT00707707|Antimitotic Agents|antimitotic agents|mesh-ancestor
6514867|NCT00707707|Mitosis Modulators|mitosis modulators|mesh-ancestor
6514868|NCT00707707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514869|NCT00707707|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6514870|NCT00707707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6514871|NCT00707772|Ribavirin|ribavirin|mesh-list
6514872|NCT00707772|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6514873|NCT00707772|Interferon-alpha|interferon-alpha|mesh-list
6514874|NCT00707772|Antimetabolites|antimetabolites|mesh-ancestor
6514875|NCT00707772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514876|NCT00707772|Antiviral Agents|antiviral agents|mesh-ancestor
6514877|NCT00707772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6514878|NCT00707772|Immunologic Factors|immunologic factors|mesh-ancestor
6514879|NCT00707772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514880|NCT00707785|Vitamin A|vitamin a|mesh-list
6514881|NCT00707785|Vitamins|vitamins|mesh-ancestor
6514882|NCT00707785|Micronutrients|micronutrients|mesh-ancestor
6514883|NCT00707785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514884|NCT00707798|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6514885|NCT00707798|Immunologic Factors|immunologic factors|mesh-ancestor
6514886|NCT00707798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514887|NCT00707824|Nalbuphine|nalbuphine|mesh-list
6514888|NCT00707824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6514889|NCT00707824|Narcotics|narcotics|mesh-ancestor
6514890|NCT00707824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6514891|NCT00707824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514892|NCT00707824|Analgesics|analgesics|mesh-ancestor
6514893|NCT00707824|Sensory System Agents|sensory system agents|mesh-ancestor
6514894|NCT00707824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6514895|NCT00707850|Ribavirin|ribavirin|mesh-list
6514896|NCT00707850|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6514897|NCT00707850|Interferon-alpha|interferon-alpha|mesh-list
6514898|NCT00707850|Antimetabolites|antimetabolites|mesh-ancestor
6514899|NCT00707850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514900|NCT00707850|Antiviral Agents|antiviral agents|mesh-ancestor
6514901|NCT00707850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6514902|NCT00707850|Immunologic Factors|immunologic factors|mesh-ancestor
6514903|NCT00707850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514904|NCT00707876|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
6514905|NCT00707876|Hematinics|hematinics|mesh-ancestor
6514906|NCT00707876|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6514907|NCT00707876|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6514908|NCT00707902|Chlorhexidine|chlorhexidine|mesh-list
6514909|NCT00707902|Lidocaine|lidocaine|mesh-list
6514910|NCT00707902|Anesthetics, Local|anesthetics, local|mesh-ancestor
6514911|NCT00707902|Anesthetics|anesthetics|mesh-ancestor
6514912|NCT00707902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6514913|NCT00707902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514914|NCT00707902|Sensory System Agents|sensory system agents|mesh-ancestor
6514915|NCT00707902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6514916|NCT00707902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6514917|NCT00707902|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6514918|NCT00707902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6514919|NCT00707902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6514920|NCT00707902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514921|NCT00707902|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6514922|NCT00707902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6514923|NCT00707902|Disinfectants|disinfectants|mesh-ancestor
6514924|NCT00707928|Nitroglycerin|nitroglycerin|mesh-list
6514925|NCT00707928|Vasodilator Agents|vasodilator agents|mesh-ancestor
6514926|NCT00707941|Oseltamivir|oseltamivir|mesh-list
6514927|NCT00707941|Antiviral Agents|antiviral agents|mesh-ancestor
6514928|NCT00707941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6514929|NCT00707941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6514930|NCT00707941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514931|NCT00708149|Lansoprazole|lansoprazole|mesh-list
6514932|NCT00708149|Dexlansoprazole|dexlansoprazole|mesh-list
6514933|NCT00708149|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6514934|NCT00708149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6514935|NCT00708149|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6514936|NCT00708149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6514937|NCT00708149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514938|NCT00708240|Citalopram|citalopram|mesh-list
6514939|NCT00708240|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6514940|NCT00708240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6514941|NCT00708240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6514942|NCT00708240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514943|NCT00708240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6514944|NCT00708240|Serotonin Agents|serotonin agents|mesh-ancestor
6514945|NCT00708240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514946|NCT00708240|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6514947|NCT00708240|Antidepressive Agents|antidepressive agents|mesh-ancestor
6514948|NCT00708240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6514949|NCT00708266|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6680439|NCT01603342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680440|NCT01603498|Dexamethasone|dexamethasone|mesh-list
6680441|NCT01603498|Methylprednisolone|methylprednisolone|mesh-list
6680442|NCT01603498|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6680443|NCT01603498|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6680444|NCT01603498|Prednisolone|prednisolone|mesh-list
6680445|NCT01603498|Prednisolone acetate|prednisolone acetate|mesh-list
6680446|NCT01603498|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6680447|NCT01603498|Prednisolone phosphate|prednisolone phosphate|mesh-list
6680448|NCT01603498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6680449|NCT01603498|Antiemetics|antiemetics|mesh-ancestor
6680450|NCT01603498|Autonomic Agents|autonomic agents|mesh-ancestor
6680451|NCT01603498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6680452|NCT01603498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680453|NCT01603498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6680454|NCT01603498|Glucocorticoids|glucocorticoids|mesh-ancestor
6680455|NCT01603498|Hormones|hormones|mesh-ancestor
6680456|NCT01603498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6680457|NCT01603498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6680458|NCT01603498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6680459|NCT01603498|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6680460|NCT01603498|Protective Agents|protective agents|mesh-ancestor
6680461|NCT01603511|Charcoal|charcoal|mesh-list
6680462|NCT01603511|Antidotes|antidotes|mesh-ancestor
6680463|NCT01603511|Protective Agents|protective agents|mesh-ancestor
6680464|NCT01603511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680465|NCT01603654|Ascorbic Acid|ascorbic acid|mesh-list
6680466|NCT01603654|Picosulfate sodium|picosulfate sodium|mesh-list
6680467|NCT01603654|Magnesium citrate|magnesium citrate|mesh-list
6680468|NCT01603654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6680469|NCT01603654|Antioxidants|antioxidants|mesh-ancestor
6680470|NCT01603654|Protective Agents|protective agents|mesh-ancestor
6680471|NCT01603654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680472|NCT01603654|Vitamins|vitamins|mesh-ancestor
6680473|NCT01603654|Micronutrients|micronutrients|mesh-ancestor
6680474|NCT01603654|Cathartics|cathartics|mesh-ancestor
6680475|NCT01603654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6680476|NCT01603680|Anesthetics|anesthetics|mesh-list
6514950|NCT00708266|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6514951|NCT00708266|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6514952|NCT00708266|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6514953|NCT00708318|Fentanyl|fentanyl|mesh-list
6514954|NCT00708318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6514955|NCT00708318|Narcotics|narcotics|mesh-ancestor
6514956|NCT00708318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6514957|NCT00708318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514958|NCT00708318|Analgesics|analgesics|mesh-ancestor
6514959|NCT00708318|Sensory System Agents|sensory system agents|mesh-ancestor
6514960|NCT00708318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6514961|NCT00708318|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6514962|NCT00708318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6514963|NCT00708318|Anesthetics, General|anesthetics, general|mesh-ancestor
6514964|NCT00708318|Anesthetics|anesthetics|mesh-ancestor
6514965|NCT00708344|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6514966|NCT00708344|Irbesartan|irbesartan|mesh-list
6514967|NCT00708344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6514968|NCT00708344|Diuretics|diuretics|mesh-ancestor
6514969|NCT00708344|Natriuretic Agents|natriuretic agents|mesh-ancestor
6514970|NCT00708344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514971|NCT00708344|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6514972|NCT00708344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6514973|NCT00708344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514974|NCT00708344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6514975|NCT00708344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6514976|NCT00708357|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
6514977|NCT00708357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6514978|NCT00708357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514979|NCT00708396|Citalopram|citalopram|mesh-list
6514980|NCT00708396|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6680477|NCT01603680|Mepivacaine|mepivacaine|mesh-list
6680478|NCT01603680|Anesthetics, Local|anesthetics, local|mesh-list
6680479|NCT01603680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6680480|NCT01603680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680481|NCT01603680|Sensory System Agents|sensory system agents|mesh-ancestor
6680482|NCT01603680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6680483|NCT01603693|Calcium|calcium|mesh-list
6680484|NCT01603693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6680485|NCT01603693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680486|NCT01603745|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
6680487|NCT01603745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6680488|NCT01603745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680489|NCT01603758|Ezetimibe|ezetimibe|mesh-list
6514981|NCT00708396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6514982|NCT00708396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6514983|NCT00708396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6514984|NCT00708396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6514985|NCT00708396|Serotonin Agents|serotonin agents|mesh-ancestor
6514986|NCT00708396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514987|NCT00708396|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6514988|NCT00708396|Antidepressive Agents|antidepressive agents|mesh-ancestor
6514989|NCT00708396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6514990|NCT00708539|Progesterone|progesterone|mesh-list
6680490|NCT01603758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6680491|NCT01603758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6680492|NCT01603758|Antimetabolites|antimetabolites|mesh-ancestor
6680493|NCT01603758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6680494|NCT01603758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6680495|NCT01604031|Lenalidomide|lenalidomide|mesh-list
6680496|NCT01604031|Immunologic Factors|immunologic factors|mesh-ancestor
6680497|NCT01604031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680498|NCT01604031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6680499|NCT01604031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6680500|NCT01604031|Growth Substances|growth substances|mesh-ancestor
6514991|NCT00708539|Progestins|progestins|mesh-ancestor
6514992|NCT00708539|Hormones|hormones|mesh-ancestor
6514993|NCT00708539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6514994|NCT00708539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6514995|NCT00708565|Iloprost|iloprost|mesh-list
6514996|NCT00708565|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6514997|NCT00708565|Vasodilator Agents|vasodilator agents|mesh-ancestor
6514998|NCT00708578|Metformin|metformin|mesh-list
6514999|NCT00708578|Insulin Glargine|insulin glargine|mesh-list
6515000|NCT00708578|Glimepiride|glimepiride|mesh-list
6515001|NCT00708578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6515002|NCT00708578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515003|NCT00708578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6515004|NCT00708578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6515005|NCT00708578|Immunologic Factors|immunologic factors|mesh-ancestor
6515006|NCT00708591|Sirolimus|sirolimus|mesh-list
6515007|NCT00708591|Ketoconazole|ketoconazole|mesh-list
6515008|NCT00708591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6515009|NCT00708591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6515010|NCT00708591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6515011|NCT00708591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6515012|NCT00708591|Antifungal Agents|antifungal agents|mesh-ancestor
6515013|NCT00708591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6515014|NCT00708591|Immunologic Factors|immunologic factors|mesh-ancestor
6515015|NCT00708591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515016|NCT00708591|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6515017|NCT00708591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6515018|NCT00708591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6515019|NCT00708591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515020|NCT00708591|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6515021|NCT00708591|Hormone Antagonists|hormone antagonists|mesh-ancestor
6515022|NCT00708591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6515023|NCT00708591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6515024|NCT00708656|Mesalamine|mesalamine|mesh-list
6515025|NCT00708656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6515026|NCT00708656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6515027|NCT00708656|Analgesics|analgesics|mesh-ancestor
6515028|NCT00708656|Sensory System Agents|sensory system agents|mesh-ancestor
6515029|NCT00708656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6515030|NCT00708656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515031|NCT00708656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6515032|NCT00708656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6515033|NCT00708747|Immunoglobulins|immunoglobulins|mesh-list
6515034|NCT00708747|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6515035|NCT00708747|Antibodies|antibodies|mesh-list
6515036|NCT00708747|Immunologic Factors|immunologic factors|mesh-ancestor
6515037|NCT00708747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515038|NCT00708773|Irinotecan|irinotecan|mesh-list
6515039|NCT00708773|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6515040|NCT00708773|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6515041|NCT00708773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6515042|NCT00708773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515043|NCT00708773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6515044|NCT00708799|Azithromycin|azithromycin|mesh-list
6680501|NCT01604031|Growth Inhibitors|growth inhibitors|mesh-ancestor
6515045|NCT00708799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6515046|NCT00708799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6515047|NCT00708812|Paclitaxel|paclitaxel|mesh-list
6515048|NCT00708812|Carboplatin|carboplatin|mesh-list
6515049|NCT00708812|Endostar protein|endostar protein|mesh-list
6515050|NCT00708812|Endostatins|endostatins|mesh-list
6515051|NCT00708812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6515052|NCT00708812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6515053|NCT00708812|Tubulin Modulators|tubulin modulators|mesh-ancestor
6515054|NCT00708812|Antimitotic Agents|antimitotic agents|mesh-ancestor
6515055|NCT00708812|Mitosis Modulators|mitosis modulators|mesh-ancestor
6515056|NCT00708812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515057|NCT00708812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6515058|NCT00708812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6515059|NCT00708812|Growth Substances|growth substances|mesh-ancestor
6515060|NCT00708812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515061|NCT00708812|Growth Inhibitors|growth inhibitors|mesh-ancestor
6515062|NCT00708903|Moxifloxacin|moxifloxacin|mesh-list
6515063|NCT00708903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6515064|NCT00708903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6515065|NCT00708903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6515066|NCT00708903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6515067|NCT00708903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6515068|NCT00708903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515069|NCT00708903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6515070|NCT00709007|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6515071|NCT00709007|Antiviral Agents|antiviral agents|mesh-ancestor
6515072|NCT00709007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6680502|NCT01604031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5717913|NCT03229889|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5717914|NCT03229889|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5717915|NCT03229889|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5717916|NCT03229889|Adrenergic Agents|adrenergic agents|mesh-ancestor
5717917|NCT03229889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6680503|NCT01604057|Teriparatide|teriparatide|mesh-list
6680504|NCT01604057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6680505|NCT01604057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680506|NCT01604057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6680507|NCT01604135|Riboflavin|riboflavin|mesh-list
6680508|NCT01604135|Dextrans|dextrans|mesh-list
6680509|NCT01604135|Vitamin B Complex|vitamin b complex|mesh-ancestor
6680510|NCT01604135|Vitamins|vitamins|mesh-ancestor
6680511|NCT01604135|Micronutrients|micronutrients|mesh-ancestor
6680512|NCT01604135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680513|NCT01604135|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6680514|NCT01604135|Dermatologic Agents|dermatologic agents|mesh-ancestor
6680515|NCT01604135|Anticoagulants|anticoagulants|mesh-ancestor
6680516|NCT01604135|Plasma Substitutes|plasma substitutes|mesh-ancestor
6680517|NCT01604135|Blood Substitutes|blood substitutes|mesh-ancestor
6680518|NCT01604187|Fentanyl|fentanyl|mesh-list
6680519|NCT01604187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6680520|NCT01604187|Narcotics|narcotics|mesh-ancestor
6680521|NCT01604187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6680522|NCT01604187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680523|NCT01604187|Analgesics|analgesics|mesh-ancestor
6680524|NCT01604187|Sensory System Agents|sensory system agents|mesh-ancestor
6680525|NCT01604187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6680526|NCT01604187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6680527|NCT01604187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6680528|NCT01604187|Anesthetics, General|anesthetics, general|mesh-ancestor
6680529|NCT01604187|Anesthetics|anesthetics|mesh-ancestor
6680530|NCT01604213|Metformin|metformin|mesh-list
6680531|NCT01604213|Vildagliptin|vildagliptin|mesh-list
6680532|NCT01604213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6680533|NCT01604213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680534|NCT01604213|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6680535|NCT01604213|Protease Inhibitors|protease inhibitors|mesh-ancestor
6680536|NCT01604213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6680537|NCT01604213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6680538|NCT01604330|Baclofen|baclofen|mesh-list
6680539|NCT01604330|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6680540|NCT01604330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680541|NCT01604330|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6680542|NCT01604330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6680543|NCT01604330|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6680544|NCT01604330|GABA Agonists|gaba agonists|mesh-ancestor
6680545|NCT01604330|GABA Agents|gaba agents|mesh-ancestor
6680546|NCT01604330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6680547|NCT01604330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779879|NCT02181361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6779880|NCT02181361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6779881|NCT02181361|Analgesics|analgesics|mesh-ancestor
6779882|NCT02181361|Sensory System Agents|sensory system agents|mesh-ancestor
6779883|NCT02181361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6779884|NCT02181361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779885|NCT02181361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6779886|NCT02181361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6779887|NCT02181361|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6779888|NCT02181361|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6779889|NCT02181361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779890|NCT02181361|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6779891|NCT02181361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6779892|NCT02181361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6779893|NCT02181361|Antipyretics|antipyretics|mesh-ancestor
6779894|NCT02181361|Anticoagulants|anticoagulants|mesh-ancestor
6779895|NCT02181361|Antithrombins|antithrombins|mesh-ancestor
6779896|NCT02181361|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6779897|NCT02181361|Protease Inhibitors|protease inhibitors|mesh-ancestor
6779898|NCT02181478|Cyclosporine|cyclosporine|mesh-list
6779899|NCT02181478|Mycophenolic Acid|mycophenolic acid|mesh-list
6779900|NCT02181478|Cyclophosphamide|cyclophosphamide|mesh-list
6779901|NCT02181478|Fludarabine|fludarabine|mesh-list
6779902|NCT02181478|Fludarabine phosphate|fludarabine phosphate|mesh-list
6779903|NCT02181478|Cyclosporins|cyclosporins|mesh-list
6515073|NCT00709046|Pantoprazole|pantoprazole|mesh-list
6515074|NCT00709046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6515075|NCT00709046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6515076|NCT00709046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6515077|NCT00709046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6515078|NCT00709046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515079|NCT00709137|Amiloride|amiloride|mesh-list
6515080|NCT00709137|Spironolactone|spironolactone|mesh-list
6515081|NCT00709137|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6515082|NCT00709137|Hormone Antagonists|hormone antagonists|mesh-ancestor
6515083|NCT00709137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6515084|NCT00709137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515085|NCT00709137|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6515086|NCT00709137|Diuretics|diuretics|mesh-ancestor
6515087|NCT00709137|Natriuretic Agents|natriuretic agents|mesh-ancestor
6515088|NCT00709137|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
6515089|NCT00709137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6515090|NCT00709137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6515091|NCT00709137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515092|NCT00709137|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
6515093|NCT00709163|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6515094|NCT00709163|Natriuretic Agents|natriuretic agents|mesh-ancestor
6515095|NCT00709163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515096|NCT00709189|Folic Acid|folic acid|mesh-list
6515097|NCT00709189|Norgestimate|norgestimate|mesh-list
6515098|NCT00709189|Estradiol|estradiol|mesh-list
6515099|NCT00709189|Estrogens|estrogens|mesh-ancestor
6515100|NCT00709189|Hormones|hormones|mesh-ancestor
6515101|NCT00709189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6515102|NCT00709189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515103|NCT00709189|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6515104|NCT00709189|Contraceptive Agents|contraceptive agents|mesh-ancestor
6515105|NCT00709189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6515106|NCT00709189|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6515107|NCT00709189|Hematinics|hematinics|mesh-ancestor
6515108|NCT00709189|Vitamin B Complex|vitamin b complex|mesh-ancestor
6515109|NCT00709189|Vitamins|vitamins|mesh-ancestor
6515110|NCT00709189|Micronutrients|micronutrients|mesh-ancestor
6515111|NCT00709189|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6515112|NCT00709189|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6515113|NCT00709215|Cordycepin|cordycepin|mesh-list
6515114|NCT00709215|Pentostatin|pentostatin|mesh-list
6515115|NCT00709215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6515116|NCT00709215|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
6515117|NCT00709215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6515118|NCT00709215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515119|NCT00709215|Antifungal Agents|antifungal agents|mesh-ancestor
6515120|NCT00709215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6515121|NCT00709254|Fentanyl|fentanyl|mesh-list
6515122|NCT00709254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6515123|NCT00709254|Narcotics|narcotics|mesh-ancestor
6515124|NCT00709254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6515125|NCT00709254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515126|NCT00709254|Analgesics|analgesics|mesh-ancestor
6515127|NCT00709254|Sensory System Agents|sensory system agents|mesh-ancestor
6515128|NCT00709254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6515129|NCT00709254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6515130|NCT00709254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6515131|NCT00709254|Anesthetics, General|anesthetics, general|mesh-ancestor
6515132|NCT00709254|Anesthetics|anesthetics|mesh-ancestor
6515133|NCT00709267|Folic Acid|folic acid|mesh-list
6515134|NCT00709267|Hematinics|hematinics|mesh-ancestor
6515135|NCT00709267|Vitamin B Complex|vitamin b complex|mesh-ancestor
6515136|NCT00709267|Vitamins|vitamins|mesh-ancestor
6515137|NCT00709267|Micronutrients|micronutrients|mesh-ancestor
6515138|NCT00709267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515139|NCT00709293|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6515140|NCT00709293|Immunologic Factors|immunologic factors|mesh-ancestor
6515141|NCT00709293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515142|NCT00709293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6515143|NCT00709332|Folic Acid|folic acid|mesh-list
6515144|NCT00709332|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6515145|NCT00709332|Norgestimate|norgestimate|mesh-list
6515146|NCT00709332|Estradiol|estradiol|mesh-list
6680548|NCT01604382|Remifentanil|remifentanil|mesh-list
6515147|NCT00709332|Estrogens|estrogens|mesh-ancestor
6515148|NCT00709332|Hormones|hormones|mesh-ancestor
6680549|NCT01604382|Bupivacaine|bupivacaine|mesh-list
5919473|NCT04981860|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5919474|NCT04981860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5919475|NCT04981327|Apixaban|apixaban|mesh-list
5919476|NCT04981327|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5919477|NCT04981327|Antithrombins|antithrombins|mesh-ancestor
5919478|NCT04981327|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5919479|NCT04981327|Protease Inhibitors|protease inhibitors|mesh-ancestor
6515149|NCT00709332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6515150|NCT00709332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515151|NCT00709332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6515152|NCT00709332|Contraceptive Agents|contraceptive agents|mesh-ancestor
6515153|NCT00709332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6515154|NCT00709332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6515155|NCT00709332|Hematinics|hematinics|mesh-ancestor
6515156|NCT00709332|Vitamin B Complex|vitamin b complex|mesh-ancestor
6515157|NCT00709332|Vitamins|vitamins|mesh-ancestor
6515158|NCT00709332|Micronutrients|micronutrients|mesh-ancestor
6515159|NCT00709332|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6515160|NCT00709332|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6515161|NCT00709332|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6515162|NCT00709423|Moxaverine|moxaverine|mesh-list
6515163|NCT00709423|Parasympatholytics|parasympatholytics|mesh-ancestor
6515164|NCT00709423|Autonomic Agents|autonomic agents|mesh-ancestor
6680550|NCT01604382|Anesthetics|anesthetics|mesh-list
6680551|NCT01604382|Propofol|propofol|mesh-list
6680552|NCT01604382|Anesthetics, Local|anesthetics, local|mesh-ancestor
6680553|NCT01604382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6680554|NCT01604382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680555|NCT01604382|Sensory System Agents|sensory system agents|mesh-ancestor
6680556|NCT01604382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6680557|NCT01604382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6680558|NCT01604382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6680559|NCT01604382|Anesthetics, General|anesthetics, general|mesh-ancestor
6680560|NCT01604382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6680561|NCT01604382|Narcotics|narcotics|mesh-ancestor
6680562|NCT01604382|Analgesics|analgesics|mesh-ancestor
6680563|NCT01604629|Adalimumab|adalimumab|mesh-list
6680564|NCT01604629|Etanercept|etanercept|mesh-list
6680565|NCT01604629|Golimumab|golimumab|mesh-list
6680566|NCT01604629|Infliximab|infliximab|mesh-list
6680567|NCT01604629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6680568|NCT01604629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6680569|NCT01604629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6680570|NCT01604629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6680571|NCT01604629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6515165|NCT00709423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6515166|NCT00709423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515167|NCT00709436|Ketamine|ketamine|mesh-list
6515168|NCT00709436|Analgesics|analgesics|mesh-ancestor
6515169|NCT00709436|Sensory System Agents|sensory system agents|mesh-ancestor
6515170|NCT00709436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6515171|NCT00709436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515172|NCT00709436|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6515173|NCT00709436|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6515174|NCT00709436|Anesthetics, General|anesthetics, general|mesh-ancestor
6515175|NCT00709436|Anesthetics|anesthetics|mesh-ancestor
6515176|NCT00709436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6515177|NCT00709436|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6680572|NCT01604629|Analgesics|analgesics|mesh-ancestor
6680573|NCT01604629|Sensory System Agents|sensory system agents|mesh-ancestor
6680574|NCT01604629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6680575|NCT01604629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680576|NCT01604629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6515178|NCT00709436|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6515179|NCT00709436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6515180|NCT00709436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515181|NCT00709449|Papaverine|papaverine|mesh-list
6515182|NCT00709449|Moxaverine|moxaverine|mesh-list
6680577|NCT01604629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5919480|NCT04981327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5919481|NCT04981327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919482|NCT04981327|Anticoagulants|anticoagulants|mesh-ancestor
5919483|NCT04981379|Hydroxychloroquine|hydroxychloroquine|mesh-list
5919484|NCT04981379|Favipiravir|favipiravir|mesh-list
5919485|NCT04981379|Antimalarials|antimalarials|mesh-ancestor
6515183|NCT00709449|Parasympatholytics|parasympatholytics|mesh-ancestor
6515184|NCT00709449|Autonomic Agents|autonomic agents|mesh-ancestor
6515185|NCT00709449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6515186|NCT00709449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515187|NCT00709449|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6515188|NCT00709449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6515189|NCT00709449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515190|NCT00709449|Vasodilator Agents|vasodilator agents|mesh-ancestor
6515191|NCT00709449|Urological Agents|urological agents|mesh-ancestor
6515192|NCT00709475|Insulin Detemir|insulin detemir|mesh-list
6515193|NCT00709475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6515194|NCT00709475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515195|NCT00709488|Talaporfin|talaporfin|mesh-list
6515196|NCT00709488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6515197|NCT00709488|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6515198|NCT00709488|Dermatologic Agents|dermatologic agents|mesh-ancestor
6515199|NCT00709553|Midazolam|midazolam|mesh-list
6515200|NCT00709553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6515201|NCT00709553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6515202|NCT00709553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6515203|NCT00709553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515204|NCT00709553|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6515205|NCT00709553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6515206|NCT00709553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6515207|NCT00709553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6515208|NCT00709553|Anesthetics, General|anesthetics, general|mesh-ancestor
6515209|NCT00709553|Anesthetics|anesthetics|mesh-ancestor
6515210|NCT00709553|GABA Modulators|gaba modulators|mesh-ancestor
6515211|NCT00709553|GABA Agents|gaba agents|mesh-ancestor
6515212|NCT00709553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6515213|NCT00709553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515214|NCT00709644|Folic Acid|folic acid|mesh-list
6515215|NCT00709644|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6515216|NCT00709644|Norgestimate|norgestimate|mesh-list
6515217|NCT00709644|Estradiol|estradiol|mesh-list
6515218|NCT00709644|Estrogens|estrogens|mesh-ancestor
6515219|NCT00709644|Hormones|hormones|mesh-ancestor
6515220|NCT00709644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6515221|NCT00709644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515222|NCT00709644|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6515223|NCT00709644|Contraceptive Agents|contraceptive agents|mesh-ancestor
6515224|NCT00709644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6515225|NCT00709644|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6515226|NCT00709644|Hematinics|hematinics|mesh-ancestor
6515227|NCT00709644|Vitamin B Complex|vitamin b complex|mesh-ancestor
6515228|NCT00709644|Vitamins|vitamins|mesh-ancestor
6515229|NCT00709644|Micronutrients|micronutrients|mesh-ancestor
6515230|NCT00709644|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6515231|NCT00709644|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6515232|NCT00709644|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6515233|NCT00709657|Bevacizumab|bevacizumab|mesh-list
6515234|NCT00709657|Ranibizumab|ranibizumab|mesh-list
6515235|NCT00709657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6515236|NCT00709657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6515237|NCT00709657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6515238|NCT00709657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6515239|NCT00709657|Growth Substances|growth substances|mesh-ancestor
6515240|NCT00709657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515241|NCT00709657|Growth Inhibitors|growth inhibitors|mesh-ancestor
6515242|NCT00709683|Insulin Aspart|insulin aspart|mesh-list
6515243|NCT00709683|Biphasic Insulins|biphasic insulins|mesh-list
6515244|NCT00709683|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6515245|NCT00709683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6515246|NCT00709683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515247|NCT00709839|Hydrocortisone|hydrocortisone|mesh-list
6515248|NCT00709839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6515249|NCT00709917|Repaglinide|repaglinide|mesh-list
6515250|NCT00709917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6515251|NCT00709917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515252|NCT00709969|Lumefantrine|lumefantrine|mesh-list
6515253|NCT00709969|Artemether|artemether|mesh-list
6515254|NCT00709969|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6515255|NCT00709969|Antimalarials|antimalarials|mesh-ancestor
6515256|NCT00709969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6515257|NCT00709969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6515258|NCT00709969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6515259|NCT00709982|Folic Acid|folic acid|mesh-list
6515260|NCT00709982|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6515261|NCT00709982|Norgestimate|norgestimate|mesh-list
6515262|NCT00709982|Estradiol|estradiol|mesh-list
6515263|NCT00709982|Estrogens|estrogens|mesh-ancestor
6515264|NCT00709982|Hormones|hormones|mesh-ancestor
6515265|NCT00709982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6515266|NCT00709982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515267|NCT00709982|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6515268|NCT00709982|Contraceptive Agents|contraceptive agents|mesh-ancestor
6515269|NCT00709982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6515270|NCT00709982|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6515271|NCT00709982|Hematinics|hematinics|mesh-ancestor
6515272|NCT00709982|Vitamin B Complex|vitamin b complex|mesh-ancestor
6515273|NCT00709982|Vitamins|vitamins|mesh-ancestor
6515274|NCT00709982|Micronutrients|micronutrients|mesh-ancestor
6515275|NCT00709982|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6515276|NCT00709982|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6515277|NCT00709982|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6515278|NCT00710086|Remifentanil|remifentanil|mesh-list
6515279|NCT00710086|Hydromorphone|hydromorphone|mesh-list
6515280|NCT00710086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6515281|NCT00710086|Narcotics|narcotics|mesh-ancestor
6515282|NCT00710086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6515283|NCT00710086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717918|NCT03229889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717919|NCT03229616|Cyclophosphamide|cyclophosphamide|mesh-list
5717920|NCT03229616|Busulfan|busulfan|mesh-list
5717921|NCT03229616|Etoposide|etoposide|mesh-list
5717922|NCT03229616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5717923|NCT03229616|Immunologic Factors|immunologic factors|mesh-ancestor
5717924|NCT03229616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717925|NCT03229616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5717926|NCT03229616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5717927|NCT03229616|Alkylating Agents|alkylating agents|mesh-ancestor
5717928|NCT03229616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717929|NCT03229616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5717930|NCT03229616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5717931|NCT03229616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5717932|NCT03229616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5717933|NCT03229616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5717934|NCT03229616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5717935|NCT03229408|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
6515284|NCT00710086|Analgesics|analgesics|mesh-ancestor
6515285|NCT00710086|Sensory System Agents|sensory system agents|mesh-ancestor
6515286|NCT00710086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6515287|NCT00710099|Sildenafil Citrate|sildenafil citrate|mesh-list
6515288|NCT00710099|Vasodilator Agents|vasodilator agents|mesh-ancestor
6515289|NCT00710099|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6515290|NCT00710099|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6515291|NCT00710099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6515292|NCT00710099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515293|NCT00710099|Urological Agents|urological agents|mesh-ancestor
6515294|NCT00710125|Doxorubicin|doxorubicin|mesh-list
6515295|NCT00710125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6515296|NCT00710125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6515297|NCT00710125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6515298|NCT00710125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6515299|NCT00710125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6515300|NCT00710125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515301|NCT00710138|Vitamins|vitamins|mesh-list
6515302|NCT00710138|Vitamin B 12|vitamin b 12|mesh-list
6515303|NCT00710138|Hydroxocobalamin|hydroxocobalamin|mesh-list
5717936|NCT03229408|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5717937|NCT03229408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5717938|NCT03229408|Analgesics|analgesics|mesh-ancestor
5717939|NCT03229408|Sensory System Agents|sensory system agents|mesh-ancestor
5919486|NCT04981379|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5919487|NCT04981379|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5919488|NCT04981379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5919489|NCT04981379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5919490|NCT04981379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919491|NCT04981379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5919492|NCT04981379|Antiviral Agents|antiviral agents|mesh-ancestor
5919493|NCT04981392|Vaccines|vaccines|mesh-list
5919494|NCT04981392|Immunologic Factors|immunologic factors|mesh-ancestor
6515304|NCT00710138|Vitamin B Complex|vitamin b complex|mesh-list
6515305|NCT00710138|Micronutrients|micronutrients|mesh-ancestor
5717940|NCT03229408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6515306|NCT00710138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515307|NCT00710138|Hematinics|hematinics|mesh-ancestor
6515308|NCT00710216|Lamivudine|lamivudine|mesh-list
6515309|NCT00710216|Telbivudine|telbivudine|mesh-list
6515310|NCT00710216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6515311|NCT00710216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6515312|NCT00710216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6515313|NCT00710216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515314|NCT00710216|Antiviral Agents|antiviral agents|mesh-ancestor
6515315|NCT00710216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6515316|NCT00710216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6515317|NCT00710216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6515318|NCT00710229|Bevacizumab|bevacizumab|mesh-list
6515319|NCT00710229|Ranibizumab|ranibizumab|mesh-list
6515320|NCT00710229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6515321|NCT00710229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6515322|NCT00710229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6515323|NCT00710229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6515324|NCT00710229|Growth Substances|growth substances|mesh-ancestor
6515325|NCT00710229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515326|NCT00710229|Growth Inhibitors|growth inhibitors|mesh-ancestor
6515327|NCT00710268|Bevacizumab|bevacizumab|mesh-list
6515328|NCT00710268|Olaparib|olaparib|mesh-list
6515329|NCT00710268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5717941|NCT03229408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717942|NCT03229408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5717943|NCT03229408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5717944|NCT03229538|Methylprednisolone|methylprednisolone|mesh-list
5717945|NCT03229538|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5717946|NCT03229538|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5717947|NCT03229538|Prednisolone|prednisolone|mesh-list
5717948|NCT03229538|Prednisolone acetate|prednisolone acetate|mesh-list
5717949|NCT03229538|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5717950|NCT03229538|Prednisolone phosphate|prednisolone phosphate|mesh-list
5717951|NCT03229538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5717952|NCT03229538|Antiemetics|antiemetics|mesh-ancestor
5717953|NCT03229538|Autonomic Agents|autonomic agents|mesh-ancestor
5717954|NCT03229538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5717955|NCT03229538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717956|NCT03229538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5717957|NCT03229538|Glucocorticoids|glucocorticoids|mesh-ancestor
5717958|NCT03229538|Hormones|hormones|mesh-ancestor
5717959|NCT03229538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6515330|NCT00710268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6515331|NCT00710268|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6515332|NCT00710268|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6515333|NCT00710268|Growth Substances|growth substances|mesh-ancestor
6515334|NCT00710268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515335|NCT00710268|Growth Inhibitors|growth inhibitors|mesh-ancestor
6515336|NCT00710268|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6515337|NCT00710268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6515338|NCT00710268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515339|NCT00710320|Anesthetics|anesthetics|mesh-list
6515340|NCT00710320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6515341|NCT00710320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515342|NCT00710359|Vitamins|vitamins|mesh-list
6515343|NCT00710359|Vitamin B 12|vitamin b 12|mesh-list
6515344|NCT00710359|Hydroxocobalamin|hydroxocobalamin|mesh-list
6515345|NCT00710359|Vitamin B Complex|vitamin b complex|mesh-list
6515346|NCT00710359|Micronutrients|micronutrients|mesh-ancestor
6515347|NCT00710359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515348|NCT00710359|Hematinics|hematinics|mesh-ancestor
6515349|NCT00710437|Dexmedetomidine|dexmedetomidine|mesh-list
6515350|NCT00710437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6515351|NCT00710437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6515352|NCT00710437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515353|NCT00710437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6515354|NCT00710437|Analgesics|analgesics|mesh-ancestor
6515355|NCT00710437|Sensory System Agents|sensory system agents|mesh-ancestor
6515356|NCT00710437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6515357|NCT00710437|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6515358|NCT00710437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6515359|NCT00710437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6515360|NCT00710437|Adrenergic Agents|adrenergic agents|mesh-ancestor
6680578|NCT01604629|Immunologic Factors|immunologic factors|mesh-ancestor
6680579|NCT01604629|Dermatologic Agents|dermatologic agents|mesh-ancestor
6515361|NCT00710437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6515362|NCT00710437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515363|NCT00710528|Idelalisib|idelalisib|mesh-list
6515364|NCT00710528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6515365|NCT00710528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6515366|NCT00710528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515367|NCT00710619|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
6515368|NCT00710619|Coagulants|coagulants|mesh-ancestor
6515369|NCT00710736|Fluorouracil|fluorouracil|mesh-list
6515370|NCT00710736|Capecitabine|capecitabine|mesh-list
6515371|NCT00710736|Antimetabolites|antimetabolites|mesh-ancestor
6515372|NCT00710736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515373|NCT00710736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6515374|NCT00710736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6515375|NCT00710736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6515376|NCT00710736|Immunologic Factors|immunologic factors|mesh-ancestor
6515377|NCT00710736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515378|NCT00710788|Calcium Carbonate|calcium carbonate|mesh-list
6515379|NCT00710788|Calcium|calcium|mesh-list
6515380|NCT00710788|Sevelamer|sevelamer|mesh-list
6515381|NCT00710788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6515382|NCT00710788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515383|NCT00710788|Antacids|antacids|mesh-ancestor
6515384|NCT00710788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515385|NCT00710788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6515386|NCT00710788|Chelating Agents|chelating agents|mesh-ancestor
6515387|NCT00710788|Sequestering Agents|sequestering agents|mesh-ancestor
6515388|NCT00710827|Testosterone undecanoate|testosterone undecanoate|mesh-list
6515389|NCT00710827|Androgens|androgens|mesh-ancestor
6515390|NCT00710827|Hormones|hormones|mesh-ancestor
6515391|NCT00710827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6515392|NCT00710827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680580|NCT01604629|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6680581|NCT01604811|Saw palmetto extract|saw palmetto extract|mesh-list
6680582|NCT01604811|Tamsulosin|tamsulosin|mesh-list
6680583|NCT01604811|Urological Agents|urological agents|mesh-ancestor
6680584|NCT01604811|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6680585|NCT01604811|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6680586|NCT01604811|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6680587|NCT01604811|Adrenergic Agents|adrenergic agents|mesh-ancestor
6680588|NCT01604811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6680589|NCT01604811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6680590|NCT01604811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680591|NCT01604863|Paclitaxel|paclitaxel|mesh-list
6680592|NCT01604863|Etoposide|etoposide|mesh-list
6680593|NCT01604863|Docetaxel|docetaxel|mesh-list
6680594|NCT01604863|Carboplatin|carboplatin|mesh-list
6680595|NCT01604863|Immunoglobulin G|immunoglobulin g|mesh-list
6680596|NCT01604863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6680597|NCT01604863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6680598|NCT01604863|Tubulin Modulators|tubulin modulators|mesh-ancestor
6680599|NCT01604863|Antimitotic Agents|antimitotic agents|mesh-ancestor
6680600|NCT01604863|Mitosis Modulators|mitosis modulators|mesh-ancestor
6680601|NCT01604863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6680602|NCT01604863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6680603|NCT01604863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6680604|NCT01604863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6680605|NCT01604863|Immunologic Factors|immunologic factors|mesh-ancestor
6680606|NCT01604863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680607|NCT01604928|Mirabegron|mirabegron|mesh-list
6680608|NCT01604928|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6680609|NCT01604928|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6680610|NCT01604928|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6680611|NCT01604928|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6680612|NCT01604928|Adrenergic Agents|adrenergic agents|mesh-ancestor
6680613|NCT01604928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6680614|NCT01604928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6680615|NCT01604928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680616|NCT01604928|Urological Agents|urological agents|mesh-ancestor
6680617|NCT01604928|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6680618|NCT01604928|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6680619|NCT01604928|Cholinergic Agents|cholinergic agents|mesh-ancestor
6680620|NCT01605084|Ritonavir|ritonavir|mesh-list
6680621|NCT01605084|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6680622|NCT01605084|Darunavir|darunavir|mesh-list
6680623|NCT01605084|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6515393|NCT00711074|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
6515394|NCT00711074|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6515395|NCT00711074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515396|NCT00711074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6515397|NCT00711074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6515398|NCT00711074|Antiviral Agents|antiviral agents|mesh-ancestor
6515399|NCT00711074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6515400|NCT00711165|Mometasone Furoate|mometasone furoate|mesh-list
6515401|NCT00711165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6515402|NCT00711165|Dermatologic Agents|dermatologic agents|mesh-ancestor
6515403|NCT00711165|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6515404|NCT00711178|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6515405|NCT00711178|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
6515406|NCT00711178|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6515407|NCT00711178|Dermatologic Agents|dermatologic agents|mesh-ancestor
6515408|NCT00711204|Donepezil|donepezil|mesh-list
6515409|NCT00711204|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6515410|NCT00711204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6515411|NCT00711204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515412|NCT00711204|Cholinergic Agents|cholinergic agents|mesh-ancestor
6515413|NCT00711204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6515414|NCT00711204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515415|NCT00711204|Nootropic Agents|nootropic agents|mesh-ancestor
6515416|NCT00711256|Sunscreening Agents|sunscreening agents|mesh-list
6515417|NCT00711256|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6515418|NCT00711256|Protective Agents|protective agents|mesh-ancestor
6515419|NCT00711256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515420|NCT00711256|Dermatologic Agents|dermatologic agents|mesh-ancestor
6515421|NCT00711295|Vaccines|vaccines|mesh-list
6515422|NCT00711295|Immunologic Factors|immunologic factors|mesh-ancestor
6515423|NCT00711295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515424|NCT00711308|Vitamin K|vitamin k|mesh-list
6515425|NCT00711308|Tinzaparin|tinzaparin|mesh-list
6515426|NCT00711308|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6515427|NCT00711308|Dalteparin|dalteparin|mesh-list
6515428|NCT00711308|Acenocoumarol|acenocoumarol|mesh-list
6515429|NCT00711308|Vitamins|vitamins|mesh-ancestor
6515430|NCT00711308|Micronutrients|micronutrients|mesh-ancestor
6515431|NCT00711308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515432|NCT00711308|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6515433|NCT00711308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6515434|NCT00711308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515435|NCT00711308|Hemostatics|hemostatics|mesh-ancestor
6515436|NCT00711308|Coagulants|coagulants|mesh-ancestor
6515437|NCT00711308|Anticoagulants|anticoagulants|mesh-ancestor
6515438|NCT00711308|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6515439|NCT00711503|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6515440|NCT00711503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6515441|NCT00711620|Thymalfasin|thymalfasin|mesh-list
6515442|NCT00711620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6515443|NCT00711620|Immunologic Factors|immunologic factors|mesh-ancestor
6515444|NCT00711620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515445|NCT00711698|Analgesics, Opioid|analgesics, opioid|mesh-list
6515446|NCT00711698|Narcotics|narcotics|mesh-ancestor
6515447|NCT00711698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6515448|NCT00711698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515449|NCT00711698|Analgesics|analgesics|mesh-ancestor
6515450|NCT00711698|Sensory System Agents|sensory system agents|mesh-ancestor
6515451|NCT00711698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6515452|NCT00711789|Angiotensin II|angiotensin ii|mesh-list
6515453|NCT00711789|Giapreza|giapreza|mesh-list
6515454|NCT00711789|Angiotensinogen|angiotensinogen|mesh-list
6515455|NCT00711789|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6515456|NCT00711789|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6515457|NCT00711789|Protease Inhibitors|protease inhibitors|mesh-ancestor
6515458|NCT00711789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6515459|NCT00711789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515460|NCT00711841|Dexamethasone|dexamethasone|mesh-list
6515461|NCT00711841|Dexamethasone acetate|dexamethasone acetate|mesh-list
6515462|NCT00711841|BB 1101|bb 1101|mesh-list
6515463|NCT00711841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6515464|NCT00711841|Antiemetics|antiemetics|mesh-ancestor
6515465|NCT00711841|Autonomic Agents|autonomic agents|mesh-ancestor
6515466|NCT00711841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6515467|NCT00711841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515468|NCT00711841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6515469|NCT00711841|Glucocorticoids|glucocorticoids|mesh-ancestor
6515470|NCT00711841|Hormones|hormones|mesh-ancestor
6515471|NCT00711841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6515472|NCT00711841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6515473|NCT00711841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6515474|NCT00711841|Protease Inhibitors|protease inhibitors|mesh-ancestor
6680624|NCT01605084|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6680625|NCT01605084|Protease Inhibitors|protease inhibitors|mesh-ancestor
6680626|NCT01605084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6680627|NCT01605084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6680628|NCT01605084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6515475|NCT00711841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6515476|NCT00711841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515477|NCT00711854|Rifampin|rifampin|mesh-list
6515478|NCT00711854|Linezolid|linezolid|mesh-list
6515479|NCT00711854|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6515480|NCT00711854|Trimethoprim|trimethoprim|mesh-list
6515481|NCT00711854|Sulfamethoxazole|sulfamethoxazole|mesh-list
6515482|NCT00711854|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6515483|NCT00711854|Antitubercular Agents|antitubercular agents|mesh-ancestor
6515484|NCT00711854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6515485|NCT00711854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6515486|NCT00711854|Leprostatic Agents|leprostatic agents|mesh-ancestor
6515487|NCT00711854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6515488|NCT00711854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6515489|NCT00711854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515490|NCT00711854|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6515491|NCT00711854|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6515492|NCT00711854|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6515493|NCT00711854|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6515494|NCT00711854|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6515495|NCT00711854|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6515496|NCT00711854|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6515497|NCT00711854|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6515498|NCT00711854|Renal Agents|renal agents|mesh-ancestor
6515499|NCT00711854|Antimalarials|antimalarials|mesh-ancestor
6515500|NCT00711854|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6515501|NCT00711854|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6515502|NCT00711854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6515503|NCT00711854|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6515504|NCT00711854|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6515505|NCT00711854|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6515506|NCT00711906|Pyrimethamine|pyrimethamine|mesh-list
6515507|NCT00711906|Sulfadoxine|sulfadoxine|mesh-list
6680629|NCT01605084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6680630|NCT01605084|Antiviral Agents|antiviral agents|mesh-ancestor
6680631|NCT01605084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6680632|NCT01605084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6515508|NCT00711906|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6680633|NCT01605084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6680634|NCT01605240|Acetaminophen|acetaminophen|mesh-list
6680635|NCT01605240|Ibuprofen|ibuprofen|mesh-list
6680636|NCT01605240|Codeine|codeine|mesh-list
6680637|NCT01605240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6680638|NCT01605240|Analgesics|analgesics|mesh-ancestor
6680639|NCT01605240|Sensory System Agents|sensory system agents|mesh-ancestor
6680640|NCT01605240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6680641|NCT01605240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680642|NCT01605240|Antipyretics|antipyretics|mesh-ancestor
6680643|NCT01605240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6680644|NCT01605240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6680645|NCT01605240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6680646|NCT01605240|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6680647|NCT01605240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6680648|NCT01605240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6680649|NCT01605240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6680650|NCT01605240|Narcotics|narcotics|mesh-ancestor
6680651|NCT01605240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6680652|NCT01605240|Antitussive Agents|antitussive agents|mesh-ancestor
6680653|NCT01605240|Respiratory System Agents|respiratory system agents|mesh-ancestor
6680654|NCT01605253|Eszopiclone|eszopiclone|mesh-list
6680655|NCT01605253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6680656|NCT01605253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6515509|NCT00711906|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6515510|NCT00711906|Antimalarials|antimalarials|mesh-ancestor
6515511|NCT00711906|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6515512|NCT00711906|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6515513|NCT00711906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6515514|NCT00711906|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6515515|NCT00711906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6515516|NCT00711906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515517|NCT00711906|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6515518|NCT00711906|Renal Agents|renal agents|mesh-ancestor
6515519|NCT00711906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6515520|NCT00711919|Pitavastatin|pitavastatin|mesh-list
6515521|NCT00711919|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6515522|NCT00711919|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6515523|NCT00711919|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6515524|NCT00711919|Antimetabolites|antimetabolites|mesh-ancestor
6515525|NCT00711919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6680657|NCT01605253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680658|NCT01605279|Dobutamine|dobutamine|mesh-list
6680659|NCT01605279|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6680660|NCT01605279|Sympathomimetics|sympathomimetics|mesh-ancestor
6680661|NCT01605279|Autonomic Agents|autonomic agents|mesh-ancestor
6680662|NCT01605279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6680663|NCT01605279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680664|NCT01605279|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6680665|NCT01605279|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6680666|NCT01605279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6680667|NCT01605279|Adrenergic Agents|adrenergic agents|mesh-ancestor
6680668|NCT01605279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6680669|NCT01605279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6680670|NCT01605279|Protective Agents|protective agents|mesh-ancestor
6680671|NCT01605318|Irinotecan|irinotecan|mesh-list
6680672|NCT01605318|Labetuzumab|labetuzumab|mesh-list
6680673|NCT01605318|Immunoconjugates|immunoconjugates|mesh-list
5717960|NCT03229538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5717961|NCT03229538|Protective Agents|protective agents|mesh-ancestor
5717962|NCT03229538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5717963|NCT03229538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5717964|NCT03229057|Metformin|metformin|mesh-list
5717965|NCT03229057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5717966|NCT03229057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722094|NCT03201250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5722095|NCT03201250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5722096|NCT03201380|Choline|choline|mesh-list
5722097|NCT03201380|Lipotropic Agents|lipotropic agents|mesh-ancestor
5722098|NCT03201380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5722099|NCT03201380|Antimetabolites|antimetabolites|mesh-ancestor
5722100|NCT03201380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722101|NCT03201380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5722102|NCT03201380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6680674|NCT01605318|Immunologic Factors|immunologic factors|mesh-ancestor
6680675|NCT01605318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680676|NCT01605318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6680677|NCT01605318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6680678|NCT01605318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6680679|NCT01605318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6680680|NCT01605318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6680681|NCT01605318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6680682|NCT01605344|Leucovorin|leucovorin|mesh-list
6680683|NCT01605344|Fluorouracil|fluorouracil|mesh-list
6680684|NCT01605344|Irinotecan|irinotecan|mesh-list
6680685|NCT01605344|Atorvastatin|atorvastatin|mesh-list
6680686|NCT01605344|Antimetabolites|antimetabolites|mesh-ancestor
6680687|NCT01605344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6680688|NCT01605344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6680689|NCT01605344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6680690|NCT01605344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6680691|NCT01605344|Immunologic Factors|immunologic factors|mesh-ancestor
6680692|NCT01605344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680693|NCT01605344|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6680694|NCT01605344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6680695|NCT01605344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6680696|NCT01605344|Antidotes|antidotes|mesh-ancestor
6515526|NCT00711919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5722103|NCT03201380|Nootropic Agents|nootropic agents|mesh-ancestor
6515527|NCT00711919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6515528|NCT00712049|Nicotinic Acids|nicotinic acids|mesh-list
6515529|NCT00712049|Niacin|niacin|mesh-list
6515530|NCT00712049|Niacinamide|niacinamide|mesh-list
6515531|NCT00712049|Simvastatin|simvastatin|mesh-list
6515532|NCT00712049|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6515533|NCT00712049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6515534|NCT00712049|Antimetabolites|antimetabolites|mesh-ancestor
6515535|NCT00712049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515536|NCT00712049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6515537|NCT00712049|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6515538|NCT00712049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6515539|NCT00712049|Vitamin B Complex|vitamin b complex|mesh-ancestor
6515540|NCT00712049|Vitamins|vitamins|mesh-ancestor
6515541|NCT00712049|Micronutrients|micronutrients|mesh-ancestor
6680697|NCT01605344|Protective Agents|protective agents|mesh-ancestor
6680698|NCT01605344|Vitamin B Complex|vitamin b complex|mesh-ancestor
6680699|NCT01605344|Vitamins|vitamins|mesh-ancestor
6680700|NCT01605344|Micronutrients|micronutrients|mesh-ancestor
6680701|NCT01605344|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6680702|NCT01605344|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6680703|NCT01605344|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6680704|NCT01605344|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6680705|NCT01605357|Mannitol|mannitol|mesh-list
6680706|NCT01605357|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6680707|NCT01605357|Diuretics|diuretics|mesh-ancestor
6680708|NCT01605357|Natriuretic Agents|natriuretic agents|mesh-ancestor
6680709|NCT01605357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680710|NCT01605487|Cyproheptadine|cyproheptadine|mesh-list
6680711|NCT01605487|Antipruritics|antipruritics|mesh-ancestor
6680712|NCT01605487|Dermatologic Agents|dermatologic agents|mesh-ancestor
6680713|NCT01605487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6680714|NCT01605487|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6680715|NCT01605487|Histamine Antagonists|histamine antagonists|mesh-ancestor
6680716|NCT01605487|Histamine Agents|histamine agents|mesh-ancestor
6680717|NCT01605487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6680718|NCT01605487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6680719|NCT01605487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680720|NCT01605487|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6680721|NCT01605487|Serotonin Agents|serotonin agents|mesh-ancestor
6680722|NCT01605487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6680723|NCT01605513|Interferons|interferons|mesh-list
6515542|NCT00712049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515543|NCT00712049|Vasodilator Agents|vasodilator agents|mesh-ancestor
6515544|NCT00712062|Pemetrexed|pemetrexed|mesh-list
6515545|NCT00712062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6515546|NCT00712062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6515547|NCT00712062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515548|NCT00712062|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6515549|NCT00712062|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6680724|NCT01605513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6680725|NCT01605513|Antiviral Agents|antiviral agents|mesh-ancestor
6680726|NCT01605513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6680727|NCT01605526|Doxorubicin|doxorubicin|mesh-list
6680728|NCT01605526|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6680729|NCT01605526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6680730|NCT01605526|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6680731|NCT01605526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6680732|NCT01605526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6680733|NCT01605526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6680734|NCT01605721|Everolimus|everolimus|mesh-list
6680735|NCT01605721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6680736|NCT01605721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6680737|NCT01605721|Immunologic Factors|immunologic factors|mesh-ancestor
6680738|NCT01605721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680739|NCT01605734|Sorafenib|sorafenib|mesh-list
6680740|NCT01605734|Chlorotrianisene|chlorotrianisene|mesh-list
6680741|NCT01605734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6680742|NCT01605734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6680743|NCT01605734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6680744|NCT01605734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6680745|NCT01605734|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6515550|NCT00712101|Abciximab|abciximab|mesh-list
6680746|NCT01605734|Estrogens|estrogens|mesh-ancestor
6680747|NCT01605734|Hormones|hormones|mesh-ancestor
6515551|NCT00712101|Anticoagulants|anticoagulants|mesh-ancestor
6680748|NCT01605734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6515552|NCT00712101|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6515553|NCT00712114|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
6515554|NCT00712114|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6515555|NCT00712114|Immunologic Factors|immunologic factors|mesh-ancestor
6515556|NCT00712114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515557|NCT00712140|Trastuzumab|trastuzumab|mesh-list
6515558|NCT00712140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6515559|NCT00712140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6515560|NCT00712205|Calcitriol|calcitriol|mesh-list
6515561|NCT00712205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6515562|NCT00712205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515563|NCT00712205|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6515564|NCT00712205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6515565|NCT00712205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515566|NCT00712205|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6515567|NCT00712205|Vitamins|vitamins|mesh-ancestor
6515568|NCT00712205|Micronutrients|micronutrients|mesh-ancestor
6515569|NCT00712205|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6515570|NCT00712257|Heparin|heparin|mesh-list
6515571|NCT00712257|Anticoagulants|anticoagulants|mesh-ancestor
6515572|NCT00712257|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6515573|NCT00712257|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6515574|NCT00712257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515575|NCT00712322|Darifenacin|darifenacin|mesh-list
6515576|NCT00712322|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6515577|NCT00712322|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6515578|NCT00712322|Cholinergic Agents|cholinergic agents|mesh-ancestor
6515579|NCT00712322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6515580|NCT00712322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515581|NCT00712322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515582|NCT00712322|Urological Agents|urological agents|mesh-ancestor
6515583|NCT00712374|Pyrimethamine|pyrimethamine|mesh-list
6515584|NCT00712374|Sulfadoxine|sulfadoxine|mesh-list
6515585|NCT00712374|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6515586|NCT00712374|Amodiaquine|amodiaquine|mesh-list
6515587|NCT00712374|Antimalarials|antimalarials|mesh-ancestor
6515588|NCT00712374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6515589|NCT00712374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6515590|NCT00712374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6515591|NCT00712374|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6515592|NCT00712374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6515593|NCT00712374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515594|NCT00712374|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6515595|NCT00712374|Renal Agents|renal agents|mesh-ancestor
6515596|NCT00712400|Latanoprost|latanoprost|mesh-list
6515597|NCT00712400|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6515598|NCT00712400|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5717967|NCT03229096|Apatinib|apatinib|mesh-list
5717968|NCT03229096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5717969|NCT03229096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5717970|NCT03229096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6515599|NCT00712439|Gabapentin|gabapentin|mesh-list
6515600|NCT00712439|Analgesics|analgesics|mesh-ancestor
5717971|NCT03229096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717972|NCT03229174|Droxidopa|droxidopa|mesh-list
5717973|NCT03229174|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5717974|NCT03229174|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5717975|NCT03229148|Anesthetics|anesthetics|mesh-list
5717976|NCT03229148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5717977|NCT03229148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717978|NCT03229135|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5717979|NCT03229135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5717980|NCT03228992|Ibuprofen|ibuprofen|mesh-list
5717981|NCT03228992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5722104|NCT03201159|Pentamidine|pentamidine|mesh-list
5919495|NCT04981392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919496|NCT04981704|Itraconazole|itraconazole|mesh-list
5919497|NCT04981704|Phenytoin|phenytoin|mesh-list
5919498|NCT04981704|Paroxetine|paroxetine|mesh-list
5919499|NCT04981704|Antifungal Agents|antifungal agents|mesh-ancestor
5919500|NCT04981704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5919501|NCT04981704|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5919502|NCT04981704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5919503|NCT04981704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5919504|NCT04981704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515601|NCT00712439|Sensory System Agents|sensory system agents|mesh-ancestor
6515602|NCT00712439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6515603|NCT00712439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515604|NCT00712439|Anticonvulsants|anticonvulsants|mesh-ancestor
6515605|NCT00712439|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6515606|NCT00712439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6515607|NCT00712439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6515608|NCT00712439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6515609|NCT00712439|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6515610|NCT00712439|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6515611|NCT00712439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6515612|NCT00712439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515613|NCT00712439|Antimanic Agents|antimanic agents|mesh-ancestor
6515614|NCT00712452|Cyclophosphamide|cyclophosphamide|mesh-list
6515615|NCT00712452|Vinblastine|vinblastine|mesh-list
6515616|NCT00712452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6515617|NCT00712452|Immunologic Factors|immunologic factors|mesh-ancestor
6515618|NCT00712452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515619|NCT00712452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6515620|NCT00712452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6515621|NCT00712452|Alkylating Agents|alkylating agents|mesh-ancestor
6515622|NCT00712452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515623|NCT00712452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6515624|NCT00712452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6515625|NCT00712452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6515626|NCT00712452|Tubulin Modulators|tubulin modulators|mesh-ancestor
6515627|NCT00712452|Antimitotic Agents|antimitotic agents|mesh-ancestor
6515628|NCT00712452|Mitosis Modulators|mitosis modulators|mesh-ancestor
6515629|NCT00712465|Digoxin|digoxin|mesh-list
6515630|NCT00712465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6515631|NCT00712465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6515632|NCT00712465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6515633|NCT00712465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515634|NCT00712465|Protective Agents|protective agents|mesh-ancestor
6515635|NCT00712465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515636|NCT00712478|Insulin|insulin|mesh-list
6515637|NCT00712478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6515638|NCT00712478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515639|NCT00712491|Sirolimus|sirolimus|mesh-list
6515640|NCT00712491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6515641|NCT00712491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6515642|NCT00712491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6515643|NCT00712491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6515644|NCT00712491|Antifungal Agents|antifungal agents|mesh-ancestor
6515645|NCT00712491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6515646|NCT00712491|Immunologic Factors|immunologic factors|mesh-ancestor
6515647|NCT00712491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515648|NCT00712504|Docetaxel|docetaxel|mesh-list
6515649|NCT00712504|Sunitinib|sunitinib|mesh-list
6515650|NCT00712504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6515651|NCT00712504|Tubulin Modulators|tubulin modulators|mesh-ancestor
6515652|NCT00712504|Antimitotic Agents|antimitotic agents|mesh-ancestor
6515653|NCT00712504|Mitosis Modulators|mitosis modulators|mesh-ancestor
6515654|NCT00712504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515655|NCT00712504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6515656|NCT00712504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6515657|NCT00712504|Growth Substances|growth substances|mesh-ancestor
5919505|NCT04981704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5919506|NCT04981704|Hormone Antagonists|hormone antagonists|mesh-ancestor
5919507|NCT04981704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6515658|NCT00712504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515659|NCT00712504|Growth Inhibitors|growth inhibitors|mesh-ancestor
6515660|NCT00712504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6515661|NCT00712504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6515662|NCT00712517|Propofol|propofol|mesh-list
5919508|NCT04981704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919509|NCT04981704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5919510|NCT04981704|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5919511|NCT04981704|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5919512|NCT04981704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5919513|NCT04981704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5919514|NCT04981704|Serotonin Agents|serotonin agents|mesh-ancestor
6515663|NCT00712517|Sevoflurane|sevoflurane|mesh-list
6515664|NCT00712517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6515665|NCT00712517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6515666|NCT00712517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515667|NCT00712517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6515668|NCT00712517|Anesthetics, General|anesthetics, general|mesh-ancestor
6515669|NCT00712517|Anesthetics|anesthetics|mesh-ancestor
6515670|NCT00712517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6515671|NCT00712517|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6515672|NCT00712556|Fluorides|fluorides|mesh-list
6515673|NCT00712556|Cariostatic Agents|cariostatic agents|mesh-ancestor
6515674|NCT00712556|Protective Agents|protective agents|mesh-ancestor
6515675|NCT00712556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515676|NCT00712582|Cyclophosphamide|cyclophosphamide|mesh-list
6515677|NCT00712582|Ifosfamide|ifosfamide|mesh-list
6515678|NCT00712582|Isophosphamide mustard|isophosphamide mustard|mesh-list
6515679|NCT00712582|Carmustine|carmustine|mesh-list
6515680|NCT00712582|Rituximab|rituximab|mesh-list
6515681|NCT00712582|Carboplatin|carboplatin|mesh-list
6515682|NCT00712582|Etoposide|etoposide|mesh-list
6515683|NCT00712582|Etoposide phosphate|etoposide phosphate|mesh-list
6515684|NCT00712582|Mitoxantrone|mitoxantrone|mesh-list
6515685|NCT00712582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6515686|NCT00712582|Immunologic Factors|immunologic factors|mesh-ancestor
6515687|NCT00712582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515688|NCT00712582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6515689|NCT00712582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6515690|NCT00712582|Alkylating Agents|alkylating agents|mesh-ancestor
6515691|NCT00712582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515692|NCT00712582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6515693|NCT00712582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6515694|NCT00712582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6515695|NCT00712582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6515696|NCT00712582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6515697|NCT00712582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6515698|NCT00712582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6515699|NCT00712582|Analgesics|analgesics|mesh-ancestor
6515700|NCT00712582|Sensory System Agents|sensory system agents|mesh-ancestor
6515701|NCT00712582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6515702|NCT00712595|Mifepristone|mifepristone|mesh-list
6515703|NCT00712595|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6515704|NCT00712595|Abortifacient Agents|abortifacient agents|mesh-ancestor
6515705|NCT00712595|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6515706|NCT00712595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515707|NCT00712595|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6515708|NCT00712595|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6515709|NCT00712595|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6515710|NCT00712595|Contraceptive Agents|contraceptive agents|mesh-ancestor
6515711|NCT00712595|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6515712|NCT00712595|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6515713|NCT00712595|Hormone Antagonists|hormone antagonists|mesh-ancestor
6515714|NCT00712595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6515715|NCT00712595|Luteolytic Agents|luteolytic agents|mesh-ancestor
6515716|NCT00712595|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6515717|NCT00712595|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6515718|NCT00712647|Beta Carotene|beta carotene|mesh-list
6515719|NCT00712647|Vitamin A|vitamin a|mesh-list
6515720|NCT00712647|Carotenoids|carotenoids|mesh-list
6515721|NCT00712647|Antioxidants|antioxidants|mesh-ancestor
6515722|NCT00712647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515723|NCT00712647|Protective Agents|protective agents|mesh-ancestor
6515724|NCT00712647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515725|NCT00712647|Provitamins|provitamins|mesh-ancestor
6515726|NCT00712647|Vitamins|vitamins|mesh-ancestor
6515727|NCT00712647|Micronutrients|micronutrients|mesh-ancestor
6515728|NCT00712660|Antipsychotic Agents|antipsychotic agents|mesh-list
6515729|NCT00712660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6515730|NCT00712660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6515731|NCT00712660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515732|NCT00712660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6515733|NCT00712686|Olanzapine|olanzapine|mesh-list
6515734|NCT00712686|Aripiprazole|aripiprazole|mesh-list
6515735|NCT00712686|Antiemetics|antiemetics|mesh-ancestor
6515736|NCT00712686|Autonomic Agents|autonomic agents|mesh-ancestor
6515737|NCT00712686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6515738|NCT00712686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515739|NCT00712686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6515740|NCT00712686|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6515741|NCT00712686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6515742|NCT00712686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6515743|NCT00712686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6515744|NCT00712686|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6515745|NCT00712686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6515746|NCT00712686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6515747|NCT00712686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515748|NCT00712686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6515749|NCT00712686|Serotonin Agents|serotonin agents|mesh-ancestor
6515750|NCT00712686|Antidepressive Agents|antidepressive agents|mesh-ancestor
6515751|NCT00712686|Dopamine Agonists|dopamine agonists|mesh-ancestor
6515752|NCT00712686|Dopamine Agents|dopamine agents|mesh-ancestor
6515753|NCT00712686|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6515754|NCT00712686|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6515755|NCT00712686|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6680749|NCT01605734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680750|NCT01605734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6680751|NCT01605773|Glyburide|glyburide|mesh-list
6680752|NCT01605773|Repaglinide|repaglinide|mesh-list
6680753|NCT01605773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6680754|NCT01605773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680755|NCT01605864|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
6680756|NCT01605864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6680757|NCT01605864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6680758|NCT01605929|Mepivacaine|mepivacaine|mesh-list
6680759|NCT01605929|Anesthetics, Local|anesthetics, local|mesh-ancestor
6680760|NCT01605929|Anesthetics|anesthetics|mesh-ancestor
6680761|NCT01605929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6680762|NCT01605929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919515|NCT04981704|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5919516|NCT04981704|Antidepressive Agents|antidepressive agents|mesh-ancestor
5919517|NCT04981704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5919518|NCT04981704|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5919519|NCT04981704|Anticonvulsants|anticonvulsants|mesh-ancestor
5919520|NCT04981704|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5919521|NCT04981704|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5919522|NCT04981704|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5919523|NCT04981704|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6515756|NCT00712686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6515757|NCT00712686|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6515758|NCT00712686|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6515759|NCT00712738|Nifedipine|nifedipine|mesh-list
6515760|NCT00712738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6515761|NCT00712738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6515762|NCT00712738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515763|NCT00712738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6515764|NCT00712738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515765|NCT00712738|Vasodilator Agents|vasodilator agents|mesh-ancestor
6515766|NCT00712738|Tocolytic Agents|tocolytic agents|mesh-ancestor
6515767|NCT00712738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6515768|NCT00712764|Adenosine|adenosine|mesh-list
6515769|NCT00712764|Analgesics|analgesics|mesh-ancestor
6515770|NCT00712764|Sensory System Agents|sensory system agents|mesh-ancestor
6515771|NCT00712764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6515772|NCT00712764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515773|NCT00712764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6515774|NCT00712764|Vasodilator Agents|vasodilator agents|mesh-ancestor
6515775|NCT00712764|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6515776|NCT00712764|Purinergic Agonists|purinergic agonists|mesh-ancestor
6515777|NCT00712764|Purinergic Agents|purinergic agents|mesh-ancestor
6515778|NCT00712764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6515779|NCT00712764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515780|NCT00712777|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6515781|NCT00712777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6515782|NCT00712777|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6515783|NCT00712777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6515784|NCT00712777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6515785|NCT00712777|Adrenergic Agents|adrenergic agents|mesh-ancestor
6515786|NCT00712777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6515787|NCT00712777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515788|NCT00712777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515789|NCT00712790|Sorafenib|sorafenib|mesh-list
6515790|NCT00712790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6515791|NCT00712790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6515792|NCT00712790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6515793|NCT00712790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515794|NCT00712855|Sorafenib|sorafenib|mesh-list
6515795|NCT00712855|Mapatumumab|mapatumumab|mesh-list
6515796|NCT00712855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6515797|NCT00712855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6515798|NCT00712855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6515799|NCT00712855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515800|NCT00712894|Verapamil|verapamil|mesh-list
6515801|NCT00712894|Diltiazem|diltiazem|mesh-list
6515802|NCT00712894|Nitroglycerin|nitroglycerin|mesh-list
6515803|NCT00712894|Vasodilator Agents|vasodilator agents|mesh-ancestor
6515804|NCT00712894|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6515805|NCT00712894|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6515806|NCT00712894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6515807|NCT00712894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515808|NCT00712894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6515809|NCT00712894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515810|NCT00712894|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6680763|NCT01605929|Sensory System Agents|sensory system agents|mesh-ancestor
6680764|NCT01605929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6680765|NCT01605968|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6680766|NCT01605968|Laxatives|laxatives|mesh-ancestor
6680767|NCT01605968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6680768|NCT01605994|Antacids|antacids|mesh-list
6680769|NCT01605994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6680770|NCT01605994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6680771|NCT01606046|Anesthetics|anesthetics|mesh-list
6680772|NCT01606046|Ethyl Chloride|ethyl chloride|mesh-list
6680773|NCT01606046|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
6680774|NCT01606046|Anesthetics, Local|anesthetics, local|mesh-list
6680775|NCT01606046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6680776|NCT01606046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680777|NCT01606046|Sensory System Agents|sensory system agents|mesh-ancestor
6680778|NCT01606046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6680779|NCT01606046|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
6680780|NCT01606059|Acetaminophen|acetaminophen|mesh-list
6680781|NCT01606059|Tramadol|tramadol|mesh-list
6680782|NCT01606059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6680783|NCT01606059|Analgesics|analgesics|mesh-ancestor
6680784|NCT01606059|Sensory System Agents|sensory system agents|mesh-ancestor
6680785|NCT01606059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6680786|NCT01606059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680787|NCT01606059|Antipyretics|antipyretics|mesh-ancestor
6680788|NCT01606059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6680789|NCT01606059|Narcotics|narcotics|mesh-ancestor
6680790|NCT01606059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6680791|NCT01606072|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
6680792|NCT01606072|Hemostatics|hemostatics|mesh-ancestor
6680793|NCT01606072|Coagulants|coagulants|mesh-ancestor
6680794|NCT01606072|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6680795|NCT01606072|Natriuretic Agents|natriuretic agents|mesh-ancestor
6680796|NCT01606072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779904|NCT02181478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6779905|NCT02181478|Immunologic Factors|immunologic factors|mesh-ancestor
6779906|NCT02181478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779907|NCT02181478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6779908|NCT02181478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6779909|NCT02181478|Alkylating Agents|alkylating agents|mesh-ancestor
6779910|NCT02181478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779911|NCT02181478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6779912|NCT02181478|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6779913|NCT02181478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6779914|NCT02181478|Antimetabolites|antimetabolites|mesh-ancestor
6779915|NCT02181478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6779916|NCT02181478|Antifungal Agents|antifungal agents|mesh-ancestor
6779917|NCT02181478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6779918|NCT02181478|Dermatologic Agents|dermatologic agents|mesh-ancestor
6779919|NCT02181478|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6779920|NCT02181478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6779921|NCT02181478|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6779922|NCT02181478|Antitubercular Agents|antitubercular agents|mesh-ancestor
6779923|NCT02181478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6779924|NCT02181543|Clonidine|clonidine|mesh-list
5717982|NCT03228992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5717983|NCT03228992|Analgesics|analgesics|mesh-ancestor
5717984|NCT03228992|Sensory System Agents|sensory system agents|mesh-ancestor
5717985|NCT03228992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5717986|NCT03228992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5717987|NCT03228992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5717988|NCT03228992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5717989|NCT03228992|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5717990|NCT03228992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5717991|NCT03228992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717992|NCT03229278|Pembrolizumab|pembrolizumab|mesh-list
6515811|NCT00712907|Ascorbic Acid|ascorbic acid|mesh-list
6515812|NCT00712907|Vitamins|vitamins|mesh-ancestor
6515813|NCT00712907|Micronutrients|micronutrients|mesh-ancestor
6515814|NCT00712907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515815|NCT00712907|Antioxidants|antioxidants|mesh-ancestor
6515816|NCT00712907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515817|NCT00712907|Protective Agents|protective agents|mesh-ancestor
6515818|NCT00712933|Belimumab|belimumab|mesh-list
6515819|NCT00712933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6515820|NCT00712933|Immunologic Factors|immunologic factors|mesh-ancestor
6515821|NCT00712933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515822|NCT00713011|Nifedipine|nifedipine|mesh-list
6515823|NCT00713011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6515824|NCT00713011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6515825|NCT00713011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515826|NCT00713011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6515827|NCT00713011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515828|NCT00713011|Vasodilator Agents|vasodilator agents|mesh-ancestor
6515829|NCT00713011|Tocolytic Agents|tocolytic agents|mesh-ancestor
6515830|NCT00713011|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6515831|NCT00713167|Grape Seed Extract|grape seed extract|mesh-list
6515832|NCT00713167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6515833|NCT00713167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5717993|NCT03229278|Nivolumab|nivolumab|mesh-list
5717994|NCT03229278|Enzyme Inhibitors|enzyme inhibitors|mesh-list
5717995|NCT03229278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5717996|NCT03229278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5717997|NCT03229278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5717998|NCT03229278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5717999|NCT03228901|Oxytocin|oxytocin|mesh-list
5718000|NCT03228901|Oxytocics|oxytocics|mesh-ancestor
5718001|NCT03228901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5718002|NCT03228901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718003|NCT03228797|Ropivacaine|ropivacaine|mesh-list
5718004|NCT03228797|Anesthetics, Local|anesthetics, local|mesh-ancestor
5718005|NCT03228797|Anesthetics|anesthetics|mesh-ancestor
5718006|NCT03228797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5718007|NCT03228797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718008|NCT03228797|Sensory System Agents|sensory system agents|mesh-ancestor
5718009|NCT03228797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5718010|NCT03228628|Nitrous Oxide|nitrous oxide|mesh-list
5718011|NCT03228628|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5718012|NCT03228628|Anesthetics, General|anesthetics, general|mesh-ancestor
5718013|NCT03228628|Anesthetics|anesthetics|mesh-ancestor
5718014|NCT03228628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5718015|NCT03228628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718016|NCT03228628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5718017|NCT03228628|Analgesics|analgesics|mesh-ancestor
5718018|NCT03228628|Sensory System Agents|sensory system agents|mesh-ancestor
5718019|NCT03228628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5718020|NCT03228823|Amiodarone|amiodarone|mesh-list
5718021|NCT03228823|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
5718022|NCT03228823|Vasodilator Agents|vasodilator agents|mesh-ancestor
5718023|NCT03228823|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5718024|NCT03228823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5718025|NCT03228823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718026|NCT03228823|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5718027|NCT03228823|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5718028|NCT03228823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5718029|NCT03228823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5718030|NCT03228823|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5718031|NCT03228823|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6515834|NCT00713167|Antioxidants|antioxidants|mesh-ancestor
6515835|NCT00713167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515836|NCT00713167|Protective Agents|protective agents|mesh-ancestor
6515837|NCT00713167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515838|NCT00713193|Cyclosporine|cyclosporine|mesh-list
6515839|NCT00713193|Prednisone|prednisone|mesh-list
6515840|NCT00713193|Cyclosporins|cyclosporins|mesh-list
6515841|NCT00713193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6515842|NCT00713193|Glucocorticoids|glucocorticoids|mesh-ancestor
6515843|NCT00713193|Hormones|hormones|mesh-ancestor
6515844|NCT00713193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6515845|NCT00713193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515846|NCT00713193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6515847|NCT00713193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6515848|NCT00713193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6515849|NCT00713193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515850|NCT00713193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6515851|NCT00713193|Immunologic Factors|immunologic factors|mesh-ancestor
6515852|NCT00713193|Antifungal Agents|antifungal agents|mesh-ancestor
6515853|NCT00713193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6515854|NCT00713193|Dermatologic Agents|dermatologic agents|mesh-ancestor
6515855|NCT00713193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6515856|NCT00713193|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6515857|NCT00713271|AZD-3199|azd-3199|mesh-list
6515858|NCT00713271|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6515859|NCT00713271|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6515860|NCT00713271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6515861|NCT00713271|Adrenergic Agents|adrenergic agents|mesh-ancestor
6680797|NCT01606098|Bevacizumab|bevacizumab|mesh-list
6680798|NCT01606098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6680799|NCT01606098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6515862|NCT00713271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6515863|NCT00713271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515864|NCT00713271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515865|NCT00713336|Moxifloxacin|moxifloxacin|mesh-list
6515866|NCT00713336|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6515867|NCT00713336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6515868|NCT00713336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6515869|NCT00713336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6515870|NCT00713336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6515871|NCT00713336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6515872|NCT00713336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515873|NCT00713336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6515874|NCT00713336|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6515875|NCT00713336|Contraceptive Agents|contraceptive agents|mesh-ancestor
6515876|NCT00713336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6515877|NCT00713336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515878|NCT00713336|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6515879|NCT00713336|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6515880|NCT00713336|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6515881|NCT00713440|Acetaminophen|acetaminophen|mesh-list
6515882|NCT00713440|Prednisolone|prednisolone|mesh-list
6515883|NCT00713440|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6515884|NCT00713440|Methylprednisolone|methylprednisolone|mesh-list
6515885|NCT00713440|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6515886|NCT00713440|Prednisolone acetate|prednisolone acetate|mesh-list
6515887|NCT00713440|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6515888|NCT00713440|Prednisolone phosphate|prednisolone phosphate|mesh-list
6515889|NCT00713440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6515890|NCT00713440|Glucocorticoids|glucocorticoids|mesh-ancestor
6515891|NCT00713440|Hormones|hormones|mesh-ancestor
6515892|NCT00713440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6515893|NCT00713440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515894|NCT00713440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6515895|NCT00713440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6515896|NCT00713440|Antiemetics|antiemetics|mesh-ancestor
6515897|NCT00713440|Autonomic Agents|autonomic agents|mesh-ancestor
6515898|NCT00713440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6515899|NCT00713440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6515900|NCT00713440|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6515901|NCT00713440|Protective Agents|protective agents|mesh-ancestor
6515902|NCT00713440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6515903|NCT00713440|Analgesics|analgesics|mesh-ancestor
6515904|NCT00713440|Sensory System Agents|sensory system agents|mesh-ancestor
6515905|NCT00713440|Antipyretics|antipyretics|mesh-ancestor
6515906|NCT00713557|Tirofiban|tirofiban|mesh-list
6515907|NCT00713557|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6515908|NCT00713557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6515909|NCT00713557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515910|NCT00713557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6515911|NCT00713622|Zonisamide|zonisamide|mesh-list
6515912|NCT00713622|Valproic Acid|valproic acid|mesh-list
6515913|NCT00713622|Anticonvulsants|anticonvulsants|mesh-ancestor
6515914|NCT00713622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6515915|NCT00713622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6680800|NCT01606098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6680801|NCT01606098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6680802|NCT01606098|Growth Substances|growth substances|mesh-ancestor
6680803|NCT01606098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680804|NCT01606098|Growth Inhibitors|growth inhibitors|mesh-ancestor
6680805|NCT01606111|Cerebrolysin|cerebrolysin|mesh-list
5718032|NCT03228823|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5718033|NCT03228732|Fluoxetine|fluoxetine|mesh-list
5718034|NCT03228732|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
5718035|NCT03228732|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5718036|NCT03228732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5718037|NCT03228732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6515916|NCT00713622|GABA Agents|gaba agents|mesh-ancestor
6515917|NCT00713622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6515918|NCT00713622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515919|NCT00713622|Antimanic Agents|antimanic agents|mesh-ancestor
6515920|NCT00713622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6515921|NCT00713622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6515922|NCT00713622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6515923|NCT00713622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6515924|NCT00713622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6515925|NCT00713622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6515926|NCT00713674|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6515927|NCT00713674|Mupirocin|mupirocin|mesh-list
6515928|NCT00713674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6515929|NCT00713674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6515930|NCT00713674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6515931|NCT00713674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718038|NCT03228732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718039|NCT03228732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5718040|NCT03228732|Serotonin Agents|serotonin agents|mesh-ancestor
5718041|NCT03228732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718042|NCT03228732|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5718043|NCT03228732|Antidepressive Agents|antidepressive agents|mesh-ancestor
5718044|NCT03228732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5718045|NCT03228732|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5718046|NCT03228732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5718047|NCT03228732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5718048|NCT03228732|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5718049|NCT03228732|Immunologic Factors|immunologic factors|mesh-ancestor
5718050|NCT03228667|Pembrolizumab|pembrolizumab|mesh-list
5718051|NCT03228667|Nivolumab|nivolumab|mesh-list
5718052|NCT03228667|Durvalumab|durvalumab|mesh-list
5718053|NCT03228667|Avelumab|avelumab|mesh-list
5718054|NCT03228667|Atezolizumab|atezolizumab|mesh-list
5718055|NCT03228667|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5718056|NCT03228667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5718057|NCT03228667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5718058|NCT03228667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5718059|NCT03228667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718060|NCT03228667|Immunologic Factors|immunologic factors|mesh-ancestor
6515932|NCT00713687|Gemcitabine|gemcitabine|mesh-list
6515933|NCT00713687|Oxaliplatin|oxaliplatin|mesh-list
6515934|NCT00713687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6515935|NCT00713687|Antimetabolites|antimetabolites|mesh-ancestor
6515936|NCT00713687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515937|NCT00713687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6515938|NCT00713687|Antiviral Agents|antiviral agents|mesh-ancestor
6515939|NCT00713687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6515940|NCT00713687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6515941|NCT00713687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6515942|NCT00713687|Immunologic Factors|immunologic factors|mesh-ancestor
6680806|NCT01606111|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6680807|NCT01606111|Protective Agents|protective agents|mesh-ancestor
6680808|NCT01606111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515943|NCT00713687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515944|NCT00713726|Fentanyl|fentanyl|mesh-list
6515945|NCT00713726|Tramadol|tramadol|mesh-list
6515946|NCT00713726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6515947|NCT00713726|Narcotics|narcotics|mesh-ancestor
6515948|NCT00713726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6515949|NCT00713726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515950|NCT00713726|Analgesics|analgesics|mesh-ancestor
6515951|NCT00713726|Sensory System Agents|sensory system agents|mesh-ancestor
6515952|NCT00713726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6515953|NCT00713726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6515954|NCT00713726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6515955|NCT00713726|Anesthetics, General|anesthetics, general|mesh-ancestor
6515956|NCT00713726|Anesthetics|anesthetics|mesh-ancestor
6515957|NCT00713739|Prazosin|prazosin|mesh-list
6515958|NCT00713739|Doxazosin|doxazosin|mesh-list
6515959|NCT00713739|Nifedipine|nifedipine|mesh-list
6515960|NCT00713739|Alfuzosin|alfuzosin|mesh-list
6515961|NCT00713739|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6515962|NCT00713739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6515963|NCT00713739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515964|NCT00713739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6515965|NCT00713739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515966|NCT00713739|Vasodilator Agents|vasodilator agents|mesh-ancestor
6515967|NCT00713739|Tocolytic Agents|tocolytic agents|mesh-ancestor
6515968|NCT00713739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6515969|NCT00713739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6515970|NCT00713739|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6515971|NCT00713739|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6515972|NCT00713739|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6515973|NCT00713739|Adrenergic Agents|adrenergic agents|mesh-ancestor
6515974|NCT00713739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6515975|NCT00713739|Urological Agents|urological agents|mesh-ancestor
6515976|NCT00713765|Donepezil|donepezil|mesh-list
6515977|NCT00713765|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6515978|NCT00713765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6515979|NCT00713765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515980|NCT00713765|Cholinergic Agents|cholinergic agents|mesh-ancestor
6515981|NCT00713765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6515982|NCT00713765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515983|NCT00713765|Nootropic Agents|nootropic agents|mesh-ancestor
6515984|NCT00713921|Fesoterodine|fesoterodine|mesh-list
6515985|NCT00713921|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6515986|NCT00713921|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6515987|NCT00713921|Cholinergic Agents|cholinergic agents|mesh-ancestor
6515988|NCT00713921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6515989|NCT00713921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6515990|NCT00713921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6515991|NCT00713921|Urological Agents|urological agents|mesh-ancestor
6515992|NCT00713947|Amoxicillin|amoxicillin|mesh-list
6515993|NCT00713947|Metronidazole|metronidazole|mesh-list
6515994|NCT00713947|Clarithromycin|clarithromycin|mesh-list
6515995|NCT00713947|Pantoprazole|pantoprazole|mesh-list
6515996|NCT00713947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6515997|NCT00713947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6515998|NCT00713947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6515999|NCT00713947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6516000|NCT00713947|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6516001|NCT00713947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6516002|NCT00713947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6516003|NCT00713947|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6516004|NCT00713947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6516005|NCT00713947|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6516006|NCT00713947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6516007|NCT00713947|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6516008|NCT00713986|Tin Fluorides|tin fluorides|mesh-list
5718061|NCT03228667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718062|NCT03228771|Atorvastatin|atorvastatin|mesh-list
5718063|NCT03228771|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5718064|NCT03228771|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5718065|NCT03228771|Antimetabolites|antimetabolites|mesh-ancestor
5718066|NCT03228771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718067|NCT03228771|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5718068|NCT03228771|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5718069|NCT03228771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5718070|NCT03228576|Everolimus|everolimus|mesh-list
6516009|NCT00713986|Cariostatic Agents|cariostatic agents|mesh-ancestor
6516010|NCT00713986|Protective Agents|protective agents|mesh-ancestor
6516011|NCT00713986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516012|NCT00713999|Praziquantel|praziquantel|mesh-list
6516013|NCT00713999|Anthelmintics|anthelmintics|mesh-ancestor
6516014|NCT00713999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6516015|NCT00713999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6516016|NCT00714025|Everolimus|everolimus|mesh-list
6516017|NCT00714025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6516018|NCT00714025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6516019|NCT00714025|Immunologic Factors|immunologic factors|mesh-ancestor
6516020|NCT00714025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516021|NCT00714064|Edetic Acid|edetic acid|mesh-list
6516022|NCT00714064|Pentetic Acid|pentetic acid|mesh-list
6516023|NCT00714064|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6516024|NCT00714064|Antidotes|antidotes|mesh-ancestor
6516025|NCT00714064|Protective Agents|protective agents|mesh-ancestor
6516026|NCT00714064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516027|NCT00714064|Chelating Agents|chelating agents|mesh-ancestor
6516028|NCT00714064|Sequestering Agents|sequestering agents|mesh-ancestor
6516029|NCT00714064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6516030|NCT00714064|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6516031|NCT00714064|Anticoagulants|anticoagulants|mesh-ancestor
6516032|NCT00714064|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5718071|NCT03228576|Tacrolimus|tacrolimus|mesh-list
5718072|NCT03228576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5718073|NCT03228576|Immunologic Factors|immunologic factors|mesh-ancestor
5718074|NCT03228576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722105|NCT03201159|Antifungal Agents|antifungal agents|mesh-ancestor
6516033|NCT00714064|Immunologic Factors|immunologic factors|mesh-ancestor
6516034|NCT00714090|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6516035|NCT00714090|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6516036|NCT00714090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5919524|NCT04982211|Propranolol|propranolol|mesh-list
5919525|NCT04982211|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5919526|NCT04982211|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5919527|NCT04982211|Adrenergic Agents|adrenergic agents|mesh-ancestor
5919528|NCT04982211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5919529|NCT04982211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919530|NCT04982211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919531|NCT04982211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5919532|NCT04982211|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5919533|NCT04982211|Vasodilator Agents|vasodilator agents|mesh-ancestor
5919534|NCT04981093|Dexamethasone|dexamethasone|mesh-list
5919535|NCT04981093|Dexamethasone acetate|dexamethasone acetate|mesh-list
5919536|NCT04981093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5919537|NCT04981093|Antiemetics|antiemetics|mesh-ancestor
5919538|NCT04981093|Autonomic Agents|autonomic agents|mesh-ancestor
5919539|NCT04981093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5919540|NCT04981093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516037|NCT00714090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6516038|NCT00714090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6516039|NCT00714090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6516040|NCT00714090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516041|NCT00714090|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6516042|NCT00714090|Antidepressive Agents|antidepressive agents|mesh-ancestor
6516043|NCT00714090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6516044|NCT00714103|Adenosine|adenosine|mesh-list
6516045|NCT00714103|Analgesics|analgesics|mesh-ancestor
6516046|NCT00714103|Sensory System Agents|sensory system agents|mesh-ancestor
6516047|NCT00714103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6516048|NCT00714103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516049|NCT00714103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6516050|NCT00714103|Vasodilator Agents|vasodilator agents|mesh-ancestor
6516051|NCT00714103|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6516052|NCT00714103|Purinergic Agonists|purinergic agonists|mesh-ancestor
6516053|NCT00714103|Purinergic Agents|purinergic agents|mesh-ancestor
6516054|NCT00714103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6680809|NCT01606111|Nootropic Agents|nootropic agents|mesh-ancestor
6680810|NCT01606241|Cyclophosphamide|cyclophosphamide|mesh-list
6680811|NCT01606241|Vaccines|vaccines|mesh-list
6680812|NCT01606241|Immunologic Factors|immunologic factors|mesh-ancestor
6680813|NCT01606241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680814|NCT01606241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6680815|NCT01606241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6680816|NCT01606241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6680817|NCT01606241|Alkylating Agents|alkylating agents|mesh-ancestor
6680818|NCT01606241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6680819|NCT01606241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6680820|NCT01606241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6680821|NCT01606345|Valrubicin|valrubicin|mesh-list
6680822|NCT01606345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6680823|NCT01606345|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6680824|NCT01606345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6680825|NCT01606345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6680826|NCT01606345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6680827|NCT01606358|Carboplatin|carboplatin|mesh-list
6680828|NCT01606358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6680829|NCT01606384|Vasopressins|vasopressins|mesh-list
6680830|NCT01606384|Arginine Vasopressin|arginine vasopressin|mesh-list
6680831|NCT01606384|Hemostatics|hemostatics|mesh-ancestor
6680832|NCT01606384|Coagulants|coagulants|mesh-ancestor
6680833|NCT01606384|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6516055|NCT00714103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6516056|NCT00714181|Hydroxychloroquine|hydroxychloroquine|mesh-list
6516057|NCT00714181|Temozolomide|temozolomide|mesh-list
6516058|NCT00714181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6516059|NCT00714181|Alkylating Agents|alkylating agents|mesh-ancestor
6516060|NCT00714181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6680834|NCT01606384|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6680835|NCT01606384|Natriuretic Agents|natriuretic agents|mesh-ancestor
6680836|NCT01606384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680837|NCT01606436|Moxifloxacin|moxifloxacin|mesh-list
6680838|NCT01606436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6680839|NCT01606436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6680840|NCT01606436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6680841|NCT01606436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6680842|NCT01606436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6680843|NCT01606436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6680844|NCT01606436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6516061|NCT00714181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6516062|NCT00714181|Antimalarials|antimalarials|mesh-ancestor
6516063|NCT00714181|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6516064|NCT00714181|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6516065|NCT00714181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6516066|NCT00714181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6516067|NCT00714181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6516068|NCT00714246|Carboplatin|carboplatin|mesh-list
6516069|NCT00714246|Docetaxel|docetaxel|mesh-list
6680845|NCT01606462|Oxytocin|oxytocin|mesh-list
6680846|NCT01606462|Oxytocics|oxytocics|mesh-ancestor
6680847|NCT01606462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6680848|NCT01606462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680849|NCT01606527|Ibuprofen|ibuprofen|mesh-list
6680850|NCT01606527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6680851|NCT01606527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6680852|NCT01606527|Analgesics|analgesics|mesh-ancestor
6680853|NCT01606527|Sensory System Agents|sensory system agents|mesh-ancestor
6516070|NCT00714246|Bortezomib|bortezomib|mesh-list
6680854|NCT01606527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6680855|NCT01606527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680856|NCT01606527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6680857|NCT01606527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6680858|NCT01606527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6680859|NCT01606527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6680860|NCT01606527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6680861|NCT01606540|Ibuprofen|ibuprofen|mesh-list
6680862|NCT01606540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6680863|NCT01606540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6516071|NCT00714246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6516072|NCT00714246|Tubulin Modulators|tubulin modulators|mesh-ancestor
6516073|NCT00714246|Antimitotic Agents|antimitotic agents|mesh-ancestor
6516074|NCT00714246|Mitosis Modulators|mitosis modulators|mesh-ancestor
6516075|NCT00714246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6516076|NCT00714376|Docetaxel|docetaxel|mesh-list
6516077|NCT00714376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6516078|NCT00714376|Tubulin Modulators|tubulin modulators|mesh-ancestor
6516079|NCT00714376|Antimitotic Agents|antimitotic agents|mesh-ancestor
6516080|NCT00714376|Mitosis Modulators|mitosis modulators|mesh-ancestor
6516081|NCT00714376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6516082|NCT00714480|Thymoglobulin|thymoglobulin|mesh-list
6516083|NCT00714480|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6516084|NCT00714480|Immunologic Factors|immunologic factors|mesh-ancestor
5919541|NCT04981093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5919542|NCT04981093|Glucocorticoids|glucocorticoids|mesh-ancestor
5919543|NCT04981093|Hormones|hormones|mesh-ancestor
5919544|NCT04981093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5919545|NCT04981093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6516085|NCT00714480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516086|NCT00714480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6516087|NCT00714519|Castor Oil|castor oil|mesh-list
6516088|NCT00714519|Cathartics|cathartics|mesh-ancestor
6516089|NCT00714519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5718075|NCT03228576|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5718076|NCT03228576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5718077|NCT03228576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718078|NCT03228576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5718079|NCT03228498|Choline|choline|mesh-list
5718080|NCT03228498|Lipotropic Agents|lipotropic agents|mesh-ancestor
5718081|NCT03228498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5718082|NCT03228498|Antimetabolites|antimetabolites|mesh-ancestor
5718083|NCT03228498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718084|NCT03228498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5718085|NCT03228498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5718086|NCT03228498|Nootropic Agents|nootropic agents|mesh-ancestor
5718087|NCT03228368|Atezolizumab|atezolizumab|mesh-list
6516090|NCT00714558|Fentanyl|fentanyl|mesh-list
6516091|NCT00714558|Naltrexone|naltrexone|mesh-list
6516092|NCT00714558|Naloxone|naloxone|mesh-list
6516093|NCT00714558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6516094|NCT00714558|Narcotics|narcotics|mesh-ancestor
6516095|NCT00714558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6516096|NCT00714558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516097|NCT00714558|Analgesics|analgesics|mesh-ancestor
6516098|NCT00714558|Sensory System Agents|sensory system agents|mesh-ancestor
6516099|NCT00714558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6516100|NCT00714558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6516101|NCT00714558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6516102|NCT00714558|Anesthetics, General|anesthetics, general|mesh-ancestor
6516103|NCT00714558|Anesthetics|anesthetics|mesh-ancestor
6516104|NCT00714558|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6516105|NCT00714558|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6516106|NCT00714584|Naltrexone|naltrexone|mesh-list
6516107|NCT00714584|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6516108|NCT00714584|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6516109|NCT00714584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680864|NCT01606540|Analgesics|analgesics|mesh-ancestor
5919546|NCT04981093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5919547|NCT04981158|Anesthetics|anesthetics|mesh-list
5919548|NCT04981158|Anesthetics, General|anesthetics, general|mesh-list
5919549|NCT04981158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5919550|NCT04981158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919551|NCT04981041|Clopidogrel|clopidogrel|mesh-list
5919552|NCT04981041|Ticagrelor|ticagrelor|mesh-list
5919553|NCT04981041|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6516110|NCT00714584|Sensory System Agents|sensory system agents|mesh-ancestor
6516111|NCT00714584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6516112|NCT00714623|Sirolimus|sirolimus|mesh-list
6516113|NCT00714623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6516114|NCT00714623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6516115|NCT00714623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6516116|NCT00714623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6516117|NCT00714623|Antifungal Agents|antifungal agents|mesh-ancestor
6516118|NCT00714623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6516119|NCT00714623|Immunologic Factors|immunologic factors|mesh-ancestor
6516120|NCT00714623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516121|NCT00714649|Cetuximab|cetuximab|mesh-list
6516122|NCT00714649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6516123|NCT00714649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6680865|NCT01606540|Sensory System Agents|sensory system agents|mesh-ancestor
6680866|NCT01606540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6680867|NCT01606540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680868|NCT01606540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6680869|NCT01606540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6680870|NCT01606540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6680871|NCT01606540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6680872|NCT01606540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6680873|NCT01606722|Ritonavir|ritonavir|mesh-list
6680874|NCT01606722|Darunavir|darunavir|mesh-list
6680875|NCT01606722|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6680876|NCT01606722|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6680877|NCT01606722|Protease Inhibitors|protease inhibitors|mesh-ancestor
6680878|NCT01606722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6680879|NCT01606722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6680880|NCT01606722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6680881|NCT01606722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6680882|NCT01606722|Antiviral Agents|antiviral agents|mesh-ancestor
6680883|NCT01606722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6680884|NCT01606722|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6680885|NCT01606722|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6680886|NCT01606878|Cyclophosphamide|cyclophosphamide|mesh-list
6680887|NCT01606878|Doxorubicin|doxorubicin|mesh-list
6680888|NCT01606878|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6680889|NCT01606878|Vincristine|vincristine|mesh-list
6680890|NCT01606878|Topotecan|topotecan|mesh-list
6680891|NCT01606878|Crizotinib|crizotinib|mesh-list
6680892|NCT01606878|Dexrazoxane|dexrazoxane|mesh-list
6680893|NCT01606878|Razoxane|razoxane|mesh-list
6680894|NCT01606878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6680895|NCT01606878|Immunologic Factors|immunologic factors|mesh-ancestor
6680896|NCT01606878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680897|NCT01606878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6680898|NCT01606878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6680899|NCT01606878|Alkylating Agents|alkylating agents|mesh-ancestor
6680900|NCT01606878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6680901|NCT01606878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6680902|NCT01606878|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6680903|NCT01606878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6680904|NCT01606878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6680905|NCT01606878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6680906|NCT01606878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6680907|NCT01606878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6680908|NCT01606878|Tubulin Modulators|tubulin modulators|mesh-ancestor
6680909|NCT01606878|Antimitotic Agents|antimitotic agents|mesh-ancestor
6680910|NCT01606878|Mitosis Modulators|mitosis modulators|mesh-ancestor
6680911|NCT01606878|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6680912|NCT01606878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6680913|NCT01606878|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6680914|NCT01606878|Protective Agents|protective agents|mesh-ancestor
6680915|NCT01606969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6680916|NCT01606995|Rivaroxaban|rivaroxaban|mesh-list
6680917|NCT01606995|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6680918|NCT01606995|Antithrombins|antithrombins|mesh-ancestor
6680919|NCT01606995|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6680920|NCT01606995|Protease Inhibitors|protease inhibitors|mesh-ancestor
6680921|NCT01606995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6680922|NCT01606995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6680923|NCT01606995|Anticoagulants|anticoagulants|mesh-ancestor
6680924|NCT01607034|Pramipexole|pramipexole|mesh-list
6680925|NCT01607034|Antioxidants|antioxidants|mesh-ancestor
6680926|NCT01607034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6680927|NCT01607034|Protective Agents|protective agents|mesh-ancestor
6516124|NCT00714740|Acetazolamide|acetazolamide|mesh-list
6516125|NCT00714740|Anticonvulsants|anticonvulsants|mesh-ancestor
6516126|NCT00714740|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6516127|NCT00714740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6516128|NCT00714740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6516129|NCT00714740|Diuretics|diuretics|mesh-ancestor
6516130|NCT00714740|Natriuretic Agents|natriuretic agents|mesh-ancestor
6516131|NCT00714740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516132|NCT00714779|Fluoxetine|fluoxetine|mesh-list
6516133|NCT00714779|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6516134|NCT00714779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6516135|NCT00714779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6516136|NCT00714779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6516137|NCT00714779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6516138|NCT00714779|Serotonin Agents|serotonin agents|mesh-ancestor
6516139|NCT00714779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516140|NCT00714779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6516141|NCT00714779|Antidepressive Agents|antidepressive agents|mesh-ancestor
6516142|NCT00714779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6516143|NCT00714779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6516144|NCT00714779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6516145|NCT00714779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6516146|NCT00714857|Dexmedetomidine|dexmedetomidine|mesh-list
6516147|NCT00714857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6516148|NCT00714857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6516149|NCT00714857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516150|NCT00714857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6516151|NCT00714857|Analgesics|analgesics|mesh-ancestor
5718088|NCT03228368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5718089|NCT03228862|Ergocalciferols|ergocalciferols|mesh-list
5718090|NCT03228862|Vitamin D|vitamin d|mesh-list
5718091|NCT03228862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5718092|NCT03228862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718093|NCT03228862|Vitamins|vitamins|mesh-ancestor
5718094|NCT03228862|Micronutrients|micronutrients|mesh-ancestor
5718095|NCT03228862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5718096|NCT03228303|Imatinib Mesylate|imatinib mesylate|mesh-list
5718097|NCT03228303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6516152|NCT00714857|Sensory System Agents|sensory system agents|mesh-ancestor
6516153|NCT00714857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6516154|NCT00714857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6516155|NCT00714857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6516156|NCT00714857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6516157|NCT00714857|Adrenergic Agents|adrenergic agents|mesh-ancestor
6516158|NCT00714857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6516159|NCT00714857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6516160|NCT00714883|Sirolimus|sirolimus|mesh-list
6516161|NCT00714883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6516162|NCT00714883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6516163|NCT00714883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6516164|NCT00714883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6516165|NCT00714883|Antifungal Agents|antifungal agents|mesh-ancestor
6516166|NCT00714883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6516167|NCT00714883|Immunologic Factors|immunologic factors|mesh-ancestor
6516168|NCT00714883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516169|NCT00714961|Clopidogrel|clopidogrel|mesh-list
6516170|NCT00714961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6516171|NCT00714961|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6516172|NCT00714961|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6516173|NCT00714961|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6516174|NCT00714961|Purinergic Agents|purinergic agents|mesh-ancestor
6516175|NCT00714961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6516176|NCT00714961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6516177|NCT00714961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516178|NCT00715013|Epothilone B|epothilone b|mesh-list
6516179|NCT00715013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6516180|NCT00715013|Tubulin Modulators|tubulin modulators|mesh-ancestor
6516181|NCT00715013|Antimitotic Agents|antimitotic agents|mesh-ancestor
6680928|NCT01607034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680929|NCT01607034|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6680930|NCT01607034|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6680931|NCT01607034|Dopamine Agonists|dopamine agonists|mesh-ancestor
5718098|NCT03228303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6516182|NCT00715013|Mitosis Modulators|mitosis modulators|mesh-ancestor
6516183|NCT00715013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6516184|NCT00715039|Lorazepam|lorazepam|mesh-list
6516185|NCT00715039|Paroxetine|paroxetine|mesh-list
6516186|NCT00715039|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6516187|NCT00715039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6516188|NCT00715039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6516189|NCT00715039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6516190|NCT00715039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6516191|NCT00715039|Serotonin Agents|serotonin agents|mesh-ancestor
6516192|NCT00715039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516193|NCT00715039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6516194|NCT00715039|Antidepressive Agents|antidepressive agents|mesh-ancestor
6516195|NCT00715039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6516196|NCT00715039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6516197|NCT00715039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6516198|NCT00715039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6516199|NCT00715039|Anticonvulsants|anticonvulsants|mesh-ancestor
6516200|NCT00715039|Antiemetics|antiemetics|mesh-ancestor
6516201|NCT00715039|Autonomic Agents|autonomic agents|mesh-ancestor
6516202|NCT00715039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6516203|NCT00715039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6516204|NCT00715039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6516205|NCT00715039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6516206|NCT00715039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6516207|NCT00715039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6516208|NCT00715039|GABA Modulators|gaba modulators|mesh-ancestor
6516209|NCT00715039|GABA Agents|gaba agents|mesh-ancestor
6516210|NCT00715091|Diclofenac|diclofenac|mesh-list
6516211|NCT00715091|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6516212|NCT00715091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6516213|NCT00715091|Analgesics|analgesics|mesh-ancestor
6516214|NCT00715091|Sensory System Agents|sensory system agents|mesh-ancestor
6516215|NCT00715091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6516216|NCT00715091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516217|NCT00715091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6516218|NCT00715091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5919554|NCT04981041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5919555|NCT04981041|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5919556|NCT04981041|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5919557|NCT04981041|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5919558|NCT04981041|Purinergic Agents|purinergic agents|mesh-ancestor
5919559|NCT04981041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5919560|NCT04981041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919561|NCT04981041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919562|NCT04981145|Hydroxychloroquine|hydroxychloroquine|mesh-list
5919563|NCT04981145|Antimalarials|antimalarials|mesh-ancestor
5919564|NCT04981145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5919565|NCT04981145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5919566|NCT04981145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5919567|NCT04981145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5919568|NCT04981145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919569|NCT04981145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5919570|NCT04980885|Azacitidine|azacitidine|mesh-list
5919571|NCT04980885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6516219|NCT00715091|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6516220|NCT00715091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6516221|NCT00715091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6516222|NCT00715273|Niacin|niacin|mesh-list
6516223|NCT00715273|Niacinamide|niacinamide|mesh-list
6516224|NCT00715273|Nicotinic Acids|nicotinic acids|mesh-list
6516225|NCT00715273|Atorvastatin|atorvastatin|mesh-list
6516226|NCT00715273|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
6516227|NCT00715273|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6516228|NCT00715273|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6516229|NCT00715273|Antimetabolites|antimetabolites|mesh-ancestor
6516230|NCT00715273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6516231|NCT00715273|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6516232|NCT00715273|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6516233|NCT00715273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6516234|NCT00715273|Vasodilator Agents|vasodilator agents|mesh-ancestor
6516235|NCT00715273|Vitamin B Complex|vitamin b complex|mesh-ancestor
6516236|NCT00715273|Vitamins|vitamins|mesh-ancestor
6516237|NCT00715273|Micronutrients|micronutrients|mesh-ancestor
6516238|NCT00715273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516239|NCT00715351|Insulin|insulin|mesh-list
6516240|NCT00715351|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6516241|NCT00715351|Insulin Detemir|insulin detemir|mesh-list
6516242|NCT00715351|Isophane Insulin, Human|isophane insulin, human|mesh-list
6516243|NCT00715351|Insulin, Isophane|insulin, isophane|mesh-list
6516244|NCT00715351|Isophane insulin, beef|isophane insulin, beef|mesh-list
6516245|NCT00715351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6516246|NCT00715351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516247|NCT00715377|Benztropine|benztropine|mesh-list
6516248|NCT00715377|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6516249|NCT00715377|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6516250|NCT00715377|Parasympatholytics|parasympatholytics|mesh-ancestor
6516251|NCT00715377|Autonomic Agents|autonomic agents|mesh-ancestor
6516252|NCT00715377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6516253|NCT00715377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718099|NCT03228303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5718100|NCT03228303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718101|NCT03228238|Vitamins|vitamins|mesh-list
5718102|NCT03228238|Ascorbic Acid|ascorbic acid|mesh-list
5718103|NCT03228238|Vitamin E|vitamin e|mesh-list
5718104|NCT03228238|Tocopherols|tocopherols|mesh-list
5718105|NCT03228238|Calcium Channel Blockers|calcium channel blockers|mesh-list
5718106|NCT03228238|Atorvastatin|atorvastatin|mesh-list
5718107|NCT03228238|Micronutrients|micronutrients|mesh-ancestor
5718108|NCT03228238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718109|NCT03228238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6516254|NCT00715377|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6516255|NCT00715377|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6516256|NCT00715377|Cholinergic Agents|cholinergic agents|mesh-ancestor
6516257|NCT00715377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6516258|NCT00715377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6516259|NCT00715377|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6516260|NCT00715377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6516261|NCT00715377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6516262|NCT00715377|Dopamine Agents|dopamine agents|mesh-ancestor
6516263|NCT00715442|Sunitinib|sunitinib|mesh-list
6516264|NCT00715442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6680932|NCT01607034|Dopamine Agents|dopamine agents|mesh-ancestor
6516265|NCT00715442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6516266|NCT00715442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6516267|NCT00715442|Growth Substances|growth substances|mesh-ancestor
6516268|NCT00715442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516269|NCT00715442|Growth Inhibitors|growth inhibitors|mesh-ancestor
6516270|NCT00715442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6516271|NCT00715442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6516272|NCT00715442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6516273|NCT00715455|Heparin|heparin|mesh-list
6516274|NCT00715455|Calcium heparin|calcium heparin|mesh-list
6516275|NCT00715455|Anticoagulants|anticoagulants|mesh-ancestor
6516276|NCT00715455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6516277|NCT00715455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6516278|NCT00715455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6516279|NCT00715637|Cytarabine|cytarabine|mesh-list
6516280|NCT00715637|Amonafide|amonafide|mesh-list
6516281|NCT00715637|Daunorubicin|daunorubicin|mesh-list
6516282|NCT00715637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6516283|NCT00715637|Antimetabolites|antimetabolites|mesh-ancestor
6516284|NCT00715637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6516285|NCT00715637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6516286|NCT00715637|Antiviral Agents|antiviral agents|mesh-ancestor
6516287|NCT00715637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6516288|NCT00715637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6516289|NCT00715637|Immunologic Factors|immunologic factors|mesh-ancestor
6516290|NCT00715637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779925|NCT02181543|Analgesics|analgesics|mesh-ancestor
6516291|NCT00715637|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6516292|NCT00715637|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6516293|NCT00715637|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6516294|NCT00715637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6516295|NCT00715663|Insulin Aspart|insulin aspart|mesh-list
6516296|NCT00715663|Biphasic Insulins|biphasic insulins|mesh-list
6516297|NCT00715663|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6516298|NCT00715663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6516299|NCT00715663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516300|NCT00715689|Hormones|hormones|mesh-list
6516301|NCT00715689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6516302|NCT00715689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516303|NCT00715702|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
6516304|NCT00715702|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6516305|NCT00715702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6516306|NCT00715702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6516307|NCT00715702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6516308|NCT00715702|Antiviral Agents|antiviral agents|mesh-ancestor
6516309|NCT00715702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6516310|NCT00715715|Prednisone|prednisone|mesh-list
6516311|NCT00715715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6516312|NCT00715715|Glucocorticoids|glucocorticoids|mesh-ancestor
6516313|NCT00715715|Hormones|hormones|mesh-ancestor
6516314|NCT00715715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6516315|NCT00715715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516316|NCT00715715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6516317|NCT00715715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6516318|NCT00715780|Insulin|insulin|mesh-list
6516319|NCT00715780|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6516320|NCT00715780|Insulin Aspart|insulin aspart|mesh-list
6516321|NCT00715780|Insulin, Long-Acting|insulin, long-acting|mesh-list
6516322|NCT00715780|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6516323|NCT00715780|Insulin Detemir|insulin detemir|mesh-list
6516324|NCT00715780|Biphasic Insulins|biphasic insulins|mesh-list
6516325|NCT00715780|Isophane Insulin, Human|isophane insulin, human|mesh-list
6516326|NCT00715780|Insulin, Isophane|insulin, isophane|mesh-list
6516327|NCT00715780|Isophane insulin, beef|isophane insulin, beef|mesh-list
6516328|NCT00715780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6516329|NCT00715780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516330|NCT00715832|Vaccines|vaccines|mesh-list
6516331|NCT00715832|Immunologic Factors|immunologic factors|mesh-ancestor
6516332|NCT00715832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516333|NCT00715858|Doxycycline|doxycycline|mesh-list
6516334|NCT00715858|Rifampin|rifampin|mesh-list
6680933|NCT01607034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6680934|NCT01607086|Lamotrigine|lamotrigine|mesh-list
6680935|NCT01607086|Anticonvulsants|anticonvulsants|mesh-ancestor
6680936|NCT01607086|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6680937|NCT01607086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6680938|NCT01607086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6680939|NCT01607086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6680940|NCT01607086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680941|NCT01607086|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6680942|NCT01607086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6516335|NCT00715858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6516336|NCT00715858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6516337|NCT00715858|Antimalarials|antimalarials|mesh-ancestor
6516338|NCT00715858|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6516339|NCT00715858|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6516340|NCT00715858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6516341|NCT00715858|Antitubercular Agents|antitubercular agents|mesh-ancestor
6516342|NCT00715858|Leprostatic Agents|leprostatic agents|mesh-ancestor
6516343|NCT00715858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6516344|NCT00715858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6516345|NCT00715858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6516346|NCT00715858|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6516347|NCT00715858|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6516348|NCT00715858|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6516349|NCT00715858|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6516350|NCT00715858|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6516351|NCT00715858|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6516352|NCT00715871|Nicotine|nicotine|mesh-list
6516353|NCT00715871|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6516354|NCT00715871|Autonomic Agents|autonomic agents|mesh-ancestor
6516355|NCT00715871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6680943|NCT01607086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6680944|NCT01607086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6680945|NCT01607086|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6680946|NCT01607125|Vortioxetine|vortioxetine|mesh-list
6680947|NCT01607125|Antidepressive Agents|antidepressive agents|mesh-ancestor
6680948|NCT01607125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6680949|NCT01607125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6680950|NCT01607125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6680951|NCT01607125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6680952|NCT01607125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680953|NCT01607125|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6680954|NCT01607125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6680955|NCT01607125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6680956|NCT01607125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6680957|NCT01607125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6680958|NCT01607125|Serotonin Agents|serotonin agents|mesh-ancestor
6680959|NCT01607125|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6680960|NCT01607125|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6680961|NCT01607125|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6680962|NCT01607125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6680963|NCT01607307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6680964|NCT01607333|Lamotrigine|lamotrigine|mesh-list
6680965|NCT01607333|Anticonvulsants|anticonvulsants|mesh-ancestor
6680966|NCT01607333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6680967|NCT01607333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6680968|NCT01607333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6680969|NCT01607333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6680970|NCT01607333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680971|NCT01607333|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6516356|NCT00715871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516357|NCT00715871|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6516358|NCT00715871|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6516359|NCT00715871|Cholinergic Agents|cholinergic agents|mesh-ancestor
6516360|NCT00715871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6516361|NCT00715871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6680972|NCT01607333|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6680973|NCT01607333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6680974|NCT01607333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6680975|NCT01607333|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6680976|NCT01607580|Methylprednisolone|methylprednisolone|mesh-list
6680977|NCT01607580|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5718110|NCT03228238|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5718111|NCT03228238|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5718112|NCT03228238|Antimetabolites|antimetabolites|mesh-ancestor
6516362|NCT00715975|Clobetasol|clobetasol|mesh-list
6516363|NCT00715975|Halobetasol|halobetasol|mesh-list
6516364|NCT00715975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6516365|NCT00715975|Glucocorticoids|glucocorticoids|mesh-ancestor
6516366|NCT00715975|Hormones|hormones|mesh-ancestor
6516367|NCT00715975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6516368|NCT00715975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516369|NCT00715975|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6516370|NCT00715988|Methadone|methadone|mesh-list
6516371|NCT00715988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6516372|NCT00715988|Narcotics|narcotics|mesh-ancestor
6516373|NCT00715988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6516374|NCT00715988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516375|NCT00715988|Analgesics|analgesics|mesh-ancestor
6516376|NCT00715988|Sensory System Agents|sensory system agents|mesh-ancestor
6516377|NCT00715988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6516378|NCT00715988|Antitussive Agents|antitussive agents|mesh-ancestor
6516379|NCT00715988|Respiratory System Agents|respiratory system agents|mesh-ancestor
6516380|NCT00716001|Acetylcysteine|acetylcysteine|mesh-list
6516381|NCT00716001|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6516382|NCT00716001|Antiviral Agents|antiviral agents|mesh-ancestor
6516383|NCT00716001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6516384|NCT00716001|Expectorants|expectorants|mesh-ancestor
6516385|NCT00716001|Respiratory System Agents|respiratory system agents|mesh-ancestor
6516386|NCT00716001|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6516387|NCT00716001|Antioxidants|antioxidants|mesh-ancestor
6516388|NCT00716001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6516389|NCT00716001|Protective Agents|protective agents|mesh-ancestor
6516390|NCT00716001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516391|NCT00716001|Antidotes|antidotes|mesh-ancestor
6516392|NCT00716066|Cytarabine|cytarabine|mesh-list
6516393|NCT00716066|Prednisone|prednisone|mesh-list
6516394|NCT00716066|Cortisone|cortisone|mesh-list
6516395|NCT00716066|Etoposide|etoposide|mesh-list
6516396|NCT00716066|Etoposide phosphate|etoposide phosphate|mesh-list
6516397|NCT00716066|Melphalan|melphalan|mesh-list
6516398|NCT00716066|Mechlorethamine|mechlorethamine|mesh-list
6516399|NCT00716066|Carmustine|carmustine|mesh-list
6516400|NCT00716066|Podophyllotoxin|podophyllotoxin|mesh-list
6516401|NCT00716066|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
6516402|NCT00716066|Thymoglobulin|thymoglobulin|mesh-list
6516403|NCT00716066|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6516404|NCT00716066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6516405|NCT00716066|Glucocorticoids|glucocorticoids|mesh-ancestor
6516406|NCT00716066|Hormones|hormones|mesh-ancestor
6516407|NCT00716066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6516408|NCT00716066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516409|NCT00716066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6516410|NCT00716066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6516411|NCT00716066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6516412|NCT00716066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6516413|NCT00716066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6516414|NCT00716066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6516415|NCT00716066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6516416|NCT00716066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6516417|NCT00716066|Antimetabolites|antimetabolites|mesh-ancestor
6516418|NCT00716066|Antiviral Agents|antiviral agents|mesh-ancestor
6516419|NCT00716066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6516420|NCT00716066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6516421|NCT00716066|Immunologic Factors|immunologic factors|mesh-ancestor
6516422|NCT00716066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6516423|NCT00716066|Alkylating Agents|alkylating agents|mesh-ancestor
6516424|NCT00716066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6516425|NCT00716066|Keratolytic Agents|keratolytic agents|mesh-ancestor
6516426|NCT00716066|Dermatologic Agents|dermatologic agents|mesh-ancestor
6516427|NCT00716066|Tubulin Modulators|tubulin modulators|mesh-ancestor
6516428|NCT00716066|Antimitotic Agents|antimitotic agents|mesh-ancestor
6516429|NCT00716066|Mitosis Modulators|mitosis modulators|mesh-ancestor
6516430|NCT00716170|Glucagon|glucagon|mesh-list
6516431|NCT00716170|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
6516432|NCT00716170|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6516433|NCT00716170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6516434|NCT00716170|Hormones|hormones|mesh-ancestor
6516435|NCT00716170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6516436|NCT00716170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516437|NCT00716170|Incretins|incretins|mesh-ancestor
6516438|NCT00716183|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6680978|NCT01607580|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6680979|NCT01607580|Prednisolone|prednisolone|mesh-list
5919572|NCT04980885|Antimetabolites|antimetabolites|mesh-ancestor
6516439|NCT00716183|Amoxicillin|amoxicillin|mesh-list
6516440|NCT00716183|Clavulanic Acids|clavulanic acids|mesh-list
6516441|NCT00716183|Clavulanic Acid|clavulanic acid|mesh-list
6516442|NCT00716183|Lactams|lactams|mesh-list
6516443|NCT00716183|beta-Lactams|beta-lactams|mesh-list
6516444|NCT00716183|Cloxacillin|cloxacillin|mesh-list
5919573|NCT04980885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919574|NCT04980885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5919575|NCT04980885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5919576|NCT04980404|Decitabine|decitabine|mesh-list
5919577|NCT04980404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5919578|NCT04980404|Antimetabolites|antimetabolites|mesh-ancestor
5919579|NCT04980404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919580|NCT04980404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5919581|NCT04980404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5964098|NCT04594772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5964099|NCT04594772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5964100|NCT04594772|Tubulin Modulators|tubulin modulators|mesh-ancestor
5964101|NCT04594772|Antimitotic Agents|antimitotic agents|mesh-ancestor
5964102|NCT04594772|Mitosis Modulators|mitosis modulators|mesh-ancestor
6516445|NCT00716183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6516446|NCT00716183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6516447|NCT00716183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6516448|NCT00716183|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6516449|NCT00716248|Bucillamine|bucillamine|mesh-list
6516450|NCT00716248|Methotrexate|methotrexate|mesh-list
6516451|NCT00716248|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6516452|NCT00716248|Abortifacient Agents|abortifacient agents|mesh-ancestor
6516453|NCT00716248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6516454|NCT00716248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516455|NCT00716248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6516456|NCT00716248|Antimetabolites|antimetabolites|mesh-ancestor
6516457|NCT00716248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6516458|NCT00716248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6516459|NCT00716248|Dermatologic Agents|dermatologic agents|mesh-ancestor
6516460|NCT00716248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6680980|NCT01607580|Prednisolone acetate|prednisolone acetate|mesh-list
6516461|NCT00716248|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6516462|NCT00716248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6516463|NCT00716248|Immunologic Factors|immunologic factors|mesh-ancestor
6516464|NCT00716248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6516465|NCT00716248|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6516466|NCT00716248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6516467|NCT00716248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6516468|NCT00716248|Analgesics|analgesics|mesh-ancestor
6516469|NCT00716248|Sensory System Agents|sensory system agents|mesh-ancestor
6516470|NCT00716248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6516471|NCT00716248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6516472|NCT00716248|Antioxidants|antioxidants|mesh-ancestor
6516473|NCT00716248|Protective Agents|protective agents|mesh-ancestor
6516474|NCT00716391|Cisplatin|cisplatin|mesh-list
6516475|NCT00716391|Cetuximab|cetuximab|mesh-list
6516476|NCT00716391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6516477|NCT00716391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6680981|NCT01607580|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6680982|NCT01607580|Prednisolone phosphate|prednisolone phosphate|mesh-list
6680983|NCT01607580|Glucocorticoids|glucocorticoids|mesh-list
6680984|NCT01607580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6680985|NCT01607580|Antiemetics|antiemetics|mesh-ancestor
6680986|NCT01607580|Autonomic Agents|autonomic agents|mesh-ancestor
6680987|NCT01607580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6680988|NCT01607580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6680989|NCT01607580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6680990|NCT01607580|Hormones|hormones|mesh-ancestor
6680991|NCT01607580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6680992|NCT01607580|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6680993|NCT01607580|Protective Agents|protective agents|mesh-ancestor
6680994|NCT01607580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6680995|NCT01607580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6680996|NCT01607671|Timolol|timolol|mesh-list
6680997|NCT01607671|Maleic acid|maleic acid|mesh-list
5919582|NCT04980170|Amoxicillin|amoxicillin|mesh-list
5919583|NCT04980170|Clindamycin|clindamycin|mesh-list
6680998|NCT01607671|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6680999|NCT01607671|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6681000|NCT01607671|Adrenergic Agents|adrenergic agents|mesh-ancestor
6681001|NCT01607671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6681002|NCT01607671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681003|NCT01607671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681004|NCT01607671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6681005|NCT01607671|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6681006|NCT01607671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6681007|NCT01607762|Olanzapine|olanzapine|mesh-list
6681008|NCT01607762|Risperidone|risperidone|mesh-list
6681009|NCT01607762|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6681010|NCT01607762|Aripiprazole|aripiprazole|mesh-list
6681011|NCT01607762|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6681012|NCT01607762|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6681013|NCT01607762|Serotonin Agents|serotonin agents|mesh-ancestor
6681014|NCT01607762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5919584|NCT04980170|Clindamycin palmitate|clindamycin palmitate|mesh-list
5919585|NCT04980170|Clindamycin phosphate|clindamycin phosphate|mesh-list
5919586|NCT04980170|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5919587|NCT04980170|Clavulanic Acids|clavulanic acids|mesh-list
5919588|NCT04980170|Clavulanic Acid|clavulanic acid|mesh-list
5919589|NCT04980170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5919590|NCT04980170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6681015|NCT01607762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681016|NCT01607762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681017|NCT01607762|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6681018|NCT01607762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6516478|NCT00716469|Talaporfin|talaporfin|mesh-list
6516479|NCT00716469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6516480|NCT00716469|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6516481|NCT00716469|Dermatologic Agents|dermatologic agents|mesh-ancestor
6516482|NCT00716521|Zolpidem|zolpidem|mesh-list
6516483|NCT00716521|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6516484|NCT00716521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6516485|NCT00716521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6516486|NCT00716521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516487|NCT00716521|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6516488|NCT00716521|GABA Agonists|gaba agonists|mesh-ancestor
6516489|NCT00716521|GABA Agents|gaba agents|mesh-ancestor
6516490|NCT00716521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6516491|NCT00716521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6516492|NCT00716547|Celecoxib|celecoxib|mesh-list
6516493|NCT00716547|Ketoprofen|ketoprofen|mesh-list
6516494|NCT00716547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6681019|NCT01607762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6516495|NCT00716547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6516496|NCT00716547|Analgesics|analgesics|mesh-ancestor
6516497|NCT00716547|Sensory System Agents|sensory system agents|mesh-ancestor
6516498|NCT00716547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6516499|NCT00716547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516500|NCT00716547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6516501|NCT00716547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6516502|NCT00716547|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6516503|NCT00716547|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6516504|NCT00716547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6516505|NCT00716547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6516506|NCT00716573|Everolimus|everolimus|mesh-list
6516507|NCT00716573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6516508|NCT00716573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6516509|NCT00716573|Immunologic Factors|immunologic factors|mesh-ancestor
6516510|NCT00716573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516511|NCT00716612|Ubiquinone|ubiquinone|mesh-list
6681020|NCT01607762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6681021|NCT01607762|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6681022|NCT01607762|Dopamine Agents|dopamine agents|mesh-ancestor
6681023|NCT01607762|Antiemetics|antiemetics|mesh-ancestor
6681024|NCT01607762|Autonomic Agents|autonomic agents|mesh-ancestor
6681025|NCT01607762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6516512|NCT00716612|Coenzyme Q10|coenzyme q10|mesh-list
6516513|NCT00716612|Micronutrients|micronutrients|mesh-ancestor
6516514|NCT00716612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516515|NCT00716612|Vitamins|vitamins|mesh-ancestor
6516516|NCT00716755|Olanzapine|olanzapine|mesh-list
6516517|NCT00716755|Risperidone|risperidone|mesh-list
6516518|NCT00716755|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6516519|NCT00716755|Serotonin Agents|serotonin agents|mesh-ancestor
6516520|NCT00716755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6516521|NCT00716755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6516522|NCT00716755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516523|NCT00716755|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6516524|NCT00716755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5919591|NCT04980170|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5919592|NCT04980170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5919593|NCT04980170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919594|NCT04980170|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5919595|NCT04980105|Methylprednisolone|methylprednisolone|mesh-list
5919596|NCT04980105|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5919597|NCT04980105|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5919598|NCT04980105|Prednisolone|prednisolone|mesh-list
5919599|NCT04980105|Prednisolone acetate|prednisolone acetate|mesh-list
5919600|NCT04980105|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5919601|NCT04980105|Prednisolone phosphate|prednisolone phosphate|mesh-list
5919602|NCT04980105|Hyaluronic Acid|hyaluronic acid|mesh-list
5919603|NCT04980105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5919604|NCT04980105|Antiemetics|antiemetics|mesh-ancestor
5919605|NCT04980105|Autonomic Agents|autonomic agents|mesh-ancestor
5919606|NCT04980105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5919607|NCT04980105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919608|NCT04980105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6516525|NCT00716755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5919609|NCT04980105|Glucocorticoids|glucocorticoids|mesh-ancestor
6516526|NCT00716755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6516527|NCT00716755|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6516528|NCT00716755|Dopamine Agents|dopamine agents|mesh-ancestor
6516529|NCT00716755|Antiemetics|antiemetics|mesh-ancestor
6516530|NCT00716755|Autonomic Agents|autonomic agents|mesh-ancestor
6516531|NCT00716755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6516532|NCT00716755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6516533|NCT00716755|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6516534|NCT00716755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6516535|NCT00716755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6516536|NCT00716846|Atorvastatin|atorvastatin|mesh-list
6516537|NCT00716846|Simvastatin|simvastatin|mesh-list
6516538|NCT00716846|Pitavastatin|pitavastatin|mesh-list
6516539|NCT00716846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6516540|NCT00716846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6516541|NCT00716846|Antimetabolites|antimetabolites|mesh-ancestor
6516542|NCT00716846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6516543|NCT00716846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6516544|NCT00716846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6516545|NCT00716846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6516546|NCT00716911|Ganciclovir|ganciclovir|mesh-list
6516547|NCT00716911|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6516548|NCT00716911|Antiviral Agents|antiviral agents|mesh-ancestor
6516549|NCT00716911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6516550|NCT00716911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6516551|NCT00716911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6516552|NCT00716911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6516553|NCT00716924|Clopidogrel|clopidogrel|mesh-list
6516554|NCT00716924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6516555|NCT00716924|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6516556|NCT00716924|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6516557|NCT00716924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6516558|NCT00716924|Purinergic Agents|purinergic agents|mesh-ancestor
6516559|NCT00716924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6516560|NCT00716924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6516561|NCT00716924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516562|NCT00716950|Losartan|losartan|mesh-list
6516563|NCT00716950|Valsartan|valsartan|mesh-list
6516564|NCT00716950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6681026|NCT01607762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6681027|NCT01607762|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6681028|NCT01607762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6681029|NCT01607762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6516565|NCT00716950|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6516566|NCT00716950|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5919610|NCT04980105|Hormones|hormones|mesh-ancestor
6516567|NCT00716950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919611|NCT04980105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5919612|NCT04980105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5919613|NCT04980105|Protective Agents|protective agents|mesh-ancestor
5919614|NCT04980105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5919615|NCT04980105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5919616|NCT04980105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5919617|NCT04980105|Immunologic Factors|immunologic factors|mesh-ancestor
5919618|NCT04980105|Viscosupplements|viscosupplements|mesh-ancestor
5919619|NCT04980040|Alogliptin|alogliptin|mesh-list
5919620|NCT04980040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5919621|NCT04980040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919622|NCT04980040|Incretins|incretins|mesh-ancestor
5919623|NCT04980040|Hormones|hormones|mesh-ancestor
5919624|NCT04980040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6516568|NCT00716950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6516569|NCT00717145|Risedronic Acid|risedronic acid|mesh-list
6516570|NCT00717145|Etidronic Acid|etidronic acid|mesh-list
6516571|NCT00717145|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6516572|NCT00717145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6516573|NCT00717145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6516574|NCT00717145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6516575|NCT00717145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516576|NCT00717145|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6516577|NCT00717210|Temozolomide|temozolomide|mesh-list
6516578|NCT00717210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6516579|NCT00717210|Alkylating Agents|alkylating agents|mesh-ancestor
6516580|NCT00717210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6516581|NCT00717210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6516582|NCT00717340|Paclitaxel|paclitaxel|mesh-list
6516583|NCT00717340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6516584|NCT00717340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6516585|NCT00717340|Tubulin Modulators|tubulin modulators|mesh-ancestor
5718113|NCT03228238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718114|NCT03228238|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5718115|NCT03228238|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5718116|NCT03228238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5718117|NCT03228238|Antioxidants|antioxidants|mesh-ancestor
5718118|NCT03228238|Protective Agents|protective agents|mesh-ancestor
5718119|NCT03228238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5718120|NCT03228355|Cromakalim|cromakalim|mesh-list
6516586|NCT00717340|Antimitotic Agents|antimitotic agents|mesh-ancestor
6516587|NCT00717340|Mitosis Modulators|mitosis modulators|mesh-ancestor
6516588|NCT00717340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6516589|NCT00717379|Mycophenolic Acid|mycophenolic acid|mesh-list
6516590|NCT00717379|Prednisone|prednisone|mesh-list
6516591|NCT00717379|Methylprednisolone|methylprednisolone|mesh-list
6516592|NCT00717379|Tacrolimus|tacrolimus|mesh-list
6516593|NCT00717379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6516594|NCT00717379|Glucocorticoids|glucocorticoids|mesh-ancestor
6516595|NCT00717379|Hormones|hormones|mesh-ancestor
6516596|NCT00717379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6516597|NCT00717379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718121|NCT03228355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5919625|NCT04980040|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5919626|NCT04980040|Protease Inhibitors|protease inhibitors|mesh-ancestor
5919627|NCT04980040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6516598|NCT00717379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6516599|NCT00717379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6516600|NCT00717379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6516601|NCT00717379|Immunologic Factors|immunologic factors|mesh-ancestor
6516602|NCT00717379|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6516603|NCT00717379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6516604|NCT00717379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6516605|NCT00717379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6516606|NCT00717379|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6516607|NCT00717379|Antitubercular Agents|antitubercular agents|mesh-ancestor
6516608|NCT00717379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6516609|NCT00717379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6516610|NCT00717379|Antiemetics|antiemetics|mesh-ancestor
6516611|NCT00717379|Autonomic Agents|autonomic agents|mesh-ancestor
6516612|NCT00717379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6516613|NCT00717379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6516614|NCT00717379|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6516615|NCT00717379|Protective Agents|protective agents|mesh-ancestor
6516616|NCT00717470|Mycophenolic Acid|mycophenolic acid|mesh-list
6516617|NCT00717470|Prednisone|prednisone|mesh-list
6516618|NCT00717470|Methylprednisolone|methylprednisolone|mesh-list
5919628|NCT04980040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919629|NCT04980144|Lubricant Eye Drops|lubricant eye drops|mesh-list
5919630|NCT04980144|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5919631|NCT04980144|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5919632|NCT04979663|Gemcitabine|gemcitabine|mesh-list
5919633|NCT04979663|Oxaliplatin|oxaliplatin|mesh-list
5919634|NCT04979663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5919635|NCT04979663|Antimetabolites|antimetabolites|mesh-ancestor
5919636|NCT04979663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919637|NCT04979663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5919638|NCT04979663|Antiviral Agents|antiviral agents|mesh-ancestor
5919639|NCT04979663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5919640|NCT04979663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5919641|NCT04979663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5919642|NCT04979663|Immunologic Factors|immunologic factors|mesh-ancestor
5919643|NCT04979663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516619|NCT00717470|Tacrolimus|tacrolimus|mesh-list
6516620|NCT00717470|Basiliximab|basiliximab|mesh-list
6516621|NCT00717470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6516622|NCT00717470|Glucocorticoids|glucocorticoids|mesh-ancestor
6516623|NCT00717470|Hormones|hormones|mesh-ancestor
6516624|NCT00717470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6516625|NCT00717470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516626|NCT00717470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6516627|NCT00717470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6516628|NCT00717470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6516629|NCT00717470|Immunologic Factors|immunologic factors|mesh-ancestor
6516630|NCT00717470|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6516631|NCT00717470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6516632|NCT00717470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6516633|NCT00717470|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6516634|NCT00717470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6516635|NCT00717470|Antitubercular Agents|antitubercular agents|mesh-ancestor
6516636|NCT00717470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6681030|NCT01607762|Antidepressive Agents|antidepressive agents|mesh-ancestor
6681031|NCT01607762|Dopamine Agonists|dopamine agonists|mesh-ancestor
5718122|NCT03228355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5718123|NCT03228355|Autonomic Agents|autonomic agents|mesh-ancestor
5718124|NCT03228355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5718125|NCT03228355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718126|NCT03228355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5718127|NCT03228355|Respiratory System Agents|respiratory system agents|mesh-ancestor
5718128|NCT03228355|Parasympatholytics|parasympatholytics|mesh-ancestor
5718129|NCT03228355|Vasodilator Agents|vasodilator agents|mesh-ancestor
5718130|NCT03228108|Amoxicillin|amoxicillin|mesh-list
5919644|NCT04979650|Methylprednisolone|methylprednisolone|mesh-list
5919645|NCT04979650|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5919646|NCT04979650|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5919647|NCT04979650|Prednisolone|prednisolone|mesh-list
5919648|NCT04979650|Prednisolone acetate|prednisolone acetate|mesh-list
5919649|NCT04979650|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5919650|NCT04979650|Prednisolone phosphate|prednisolone phosphate|mesh-list
5919651|NCT04979650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5919652|NCT04979650|Antiemetics|antiemetics|mesh-ancestor
5919653|NCT04979650|Autonomic Agents|autonomic agents|mesh-ancestor
5919654|NCT04979650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5919655|NCT04979650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516637|NCT00717470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6516638|NCT00717470|Antiemetics|antiemetics|mesh-ancestor
6516639|NCT00717470|Autonomic Agents|autonomic agents|mesh-ancestor
6516640|NCT00717470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6516641|NCT00717470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6516642|NCT00717470|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6516643|NCT00717470|Protective Agents|protective agents|mesh-ancestor
6516644|NCT00717561|Amoxicillin|amoxicillin|mesh-list
6516645|NCT00717561|Azithromycin|azithromycin|mesh-list
6516646|NCT00717561|Moxifloxacin|moxifloxacin|mesh-list
6516647|NCT00717561|Clarithromycin|clarithromycin|mesh-list
6516648|NCT00717561|Ceftriaxone|ceftriaxone|mesh-list
6516649|NCT00717561|Clavulanic Acid|clavulanic acid|mesh-list
6516650|NCT00717561|Clavulanic Acids|clavulanic acids|mesh-list
6516651|NCT00717561|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6516652|NCT00717561|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6516653|NCT00717561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6516654|NCT00717561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6516655|NCT00717561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6516656|NCT00717561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6516657|NCT00717561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6516658|NCT00717561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6516659|NCT00717561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6516660|NCT00717561|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6516661|NCT00717561|Contraceptive Agents|contraceptive agents|mesh-ancestor
6516662|NCT00717561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6516663|NCT00717561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516664|NCT00717561|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6516665|NCT00717561|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6516666|NCT00717561|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6516667|NCT00717561|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6516668|NCT00717561|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6516669|NCT00717561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6516670|NCT00717561|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6516671|NCT00717587|Sunitinib|sunitinib|mesh-list
6516672|NCT00717587|Motexafin gadolinium|motexafin gadolinium|mesh-list
6516673|NCT00717587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6516674|NCT00717587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6516675|NCT00717587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6516676|NCT00717587|Growth Substances|growth substances|mesh-ancestor
6516677|NCT00717587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516678|NCT00717587|Growth Inhibitors|growth inhibitors|mesh-ancestor
6516679|NCT00717587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6516680|NCT00717587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6516681|NCT00717587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6516682|NCT00717587|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6516683|NCT00717587|Dermatologic Agents|dermatologic agents|mesh-ancestor
6516684|NCT00717652|Triamcinolone|triamcinolone|mesh-list
6516685|NCT00717652|Tretinoin|tretinoin|mesh-list
6516686|NCT00717652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6516687|NCT00717652|Glucocorticoids|glucocorticoids|mesh-ancestor
6516688|NCT00717652|Hormones|hormones|mesh-ancestor
6516689|NCT00717652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6516690|NCT00717652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516691|NCT00717652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6516692|NCT00717652|Keratolytic Agents|keratolytic agents|mesh-ancestor
6516693|NCT00717652|Dermatologic Agents|dermatologic agents|mesh-ancestor
6516694|NCT00717678|Mycophenolic Acid|mycophenolic acid|mesh-list
6516695|NCT00717678|Tacrolimus|tacrolimus|mesh-list
6516696|NCT00717678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6516697|NCT00717678|Immunologic Factors|immunologic factors|mesh-ancestor
6516698|NCT00717678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516699|NCT00717678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6516700|NCT00717678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6516701|NCT00717678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6516702|NCT00717678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6516703|NCT00717678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6516704|NCT00717678|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6516705|NCT00717678|Antitubercular Agents|antitubercular agents|mesh-ancestor
6516706|NCT00717678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6516707|NCT00717678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6516708|NCT00717704|Dasatinib|dasatinib|mesh-list
6516709|NCT00717704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6516710|NCT00717704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6516711|NCT00717704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6516712|NCT00717704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6516713|NCT00717730|Vitamins|vitamins|mesh-list
6516714|NCT00717730|Folic Acid|folic acid|mesh-list
6516715|NCT00717730|Hydroxocobalamin|hydroxocobalamin|mesh-list
6516716|NCT00717730|Vitamin B 12|vitamin b 12|mesh-list
6516717|NCT00717730|Vitamin B Complex|vitamin b complex|mesh-list
6516718|NCT00717730|Micronutrients|micronutrients|mesh-ancestor
6516719|NCT00717730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516720|NCT00717730|Hematinics|hematinics|mesh-ancestor
6516721|NCT00717782|Botulinum Toxins|botulinum toxins|mesh-list
6516722|NCT00717782|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6516723|NCT00717782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6516724|NCT00717782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6516725|NCT00717782|Cholinergic Agents|cholinergic agents|mesh-ancestor
6516726|NCT00717782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6516727|NCT00717782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516728|NCT00717808|Tranilast|tranilast|mesh-list
5919656|NCT04979650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5919657|NCT04979650|Glucocorticoids|glucocorticoids|mesh-ancestor
5919658|NCT04979650|Hormones|hormones|mesh-ancestor
6516729|NCT00717808|Anthranilic acid|anthranilic acid|mesh-list
6516730|NCT00717808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6516731|NCT00717808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6516732|NCT00717808|Analgesics|analgesics|mesh-ancestor
6516733|NCT00717808|Sensory System Agents|sensory system agents|mesh-ancestor
6516734|NCT00717808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6516735|NCT00717808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516736|NCT00717808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6516737|NCT00717808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5919659|NCT04979650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5919660|NCT04979650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5919661|NCT04979650|Protective Agents|protective agents|mesh-ancestor
5919662|NCT04979650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5919663|NCT04979650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5919664|NCT04979611|Exenatide|exenatide|mesh-list
5919665|NCT04979611|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5919666|NCT04979611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516738|NCT00717808|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6516739|NCT00717808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5919667|NCT04979611|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6516740|NCT00717808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6516741|NCT00717808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6516742|NCT00717808|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6516743|NCT00717808|Histamine Antagonists|histamine antagonists|mesh-ancestor
6516744|NCT00717808|Histamine Agents|histamine agents|mesh-ancestor
6516745|NCT00717808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6516746|NCT00717808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6516747|NCT00717808|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6516748|NCT00717808|Anticonvulsants|anticonvulsants|mesh-ancestor
6516749|NCT00717821|Epoetin Alfa|epoetin alfa|mesh-list
6516750|NCT00717821|Darbepoetin alfa|darbepoetin alfa|mesh-list
6516751|NCT00717821|Hematinics|hematinics|mesh-ancestor
6516752|NCT00717834|Formaldehyde|formaldehyde|mesh-list
6516753|NCT00717834|Disinfectants|disinfectants|mesh-ancestor
6516754|NCT00717834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6516755|NCT00717925|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
6516756|NCT00717925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6516757|NCT00717925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6516758|NCT00717925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6516759|NCT00717938|Carboplatin|carboplatin|mesh-list
6516760|NCT00717938|Etoposide|etoposide|mesh-list
6516761|NCT00717938|Etoposide phosphate|etoposide phosphate|mesh-list
6516762|NCT00717938|Cisplatin|cisplatin|mesh-list
6516763|NCT00717938|Enoxaparin|enoxaparin|mesh-list
6516764|NCT00717938|Enoxaparin sodium|enoxaparin sodium|mesh-list
6516765|NCT00717938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6516766|NCT00717938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6516767|NCT00717938|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6516768|NCT00717938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6516769|NCT00717938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6516770|NCT00717938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6516771|NCT00717938|Anticoagulants|anticoagulants|mesh-ancestor
6516772|NCT00717938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6516773|NCT00717938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6516774|NCT00717951|Capecitabine|capecitabine|mesh-list
6516775|NCT00717951|Docetaxel|docetaxel|mesh-list
6516776|NCT00717951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6516777|NCT00717951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6516778|NCT00717951|Antimetabolites|antimetabolites|mesh-ancestor
6516779|NCT00717951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6516780|NCT00717951|Tubulin Modulators|tubulin modulators|mesh-ancestor
6516781|NCT00717951|Antimitotic Agents|antimitotic agents|mesh-ancestor
5718131|NCT03228108|Ciprofloxacin|ciprofloxacin|mesh-list
5718132|NCT03228108|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5718133|NCT03228108|Clavulanic Acids|clavulanic acids|mesh-list
5718134|NCT03228108|Clavulanic Acid|clavulanic acid|mesh-list
5919668|NCT04979611|Incretins|incretins|mesh-ancestor
5919669|NCT04979611|Hormones|hormones|mesh-ancestor
5919670|NCT04979611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5919671|NCT04979585|Paclitaxel|paclitaxel|mesh-list
5919672|NCT04979585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5919673|NCT04979585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5919674|NCT04979585|Tubulin Modulators|tubulin modulators|mesh-ancestor
5919675|NCT04979585|Antimitotic Agents|antimitotic agents|mesh-ancestor
5919676|NCT04979585|Mitosis Modulators|mitosis modulators|mesh-ancestor
5919677|NCT04979585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919678|NCT04979884|Cyclosporine|cyclosporine|mesh-list
5919679|NCT04979884|Interleukin-2|interleukin-2|mesh-list
5919680|NCT04979884|Cyclosporins|cyclosporins|mesh-list
5919681|NCT04979884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5919682|NCT04979884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919683|NCT04979884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6516782|NCT00717951|Mitosis Modulators|mitosis modulators|mesh-ancestor
6516783|NCT00717990|Bevacizumab|bevacizumab|mesh-list
5718135|NCT03228108|Fosfomycin|fosfomycin|mesh-list
5718136|NCT03228108|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
5718137|NCT03228108|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
5718138|NCT03228108|Trimethoprim|trimethoprim|mesh-list
5718139|NCT03228108|Sulfamethoxazole|sulfamethoxazole|mesh-list
5718140|NCT03228108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5718141|NCT03228108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5718142|NCT03228108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5718143|NCT03228108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5718144|NCT03228108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5919684|NCT04979884|Immunologic Factors|immunologic factors|mesh-ancestor
5919685|NCT04979884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516784|NCT00717990|Capecitabine|capecitabine|mesh-list
5718145|NCT03228108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718146|NCT03228108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5718147|NCT03228108|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5718148|NCT03228108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5718149|NCT03228108|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5718150|NCT03228108|Renal Agents|renal agents|mesh-ancestor
5718151|NCT03228108|Antimalarials|antimalarials|mesh-ancestor
5718152|NCT03228108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5718153|NCT03228108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5718154|NCT03228108|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5718155|NCT03228108|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5718156|NCT03228108|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
5718157|NCT03228108|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5718158|NCT03228030|Thiamine|thiamine|mesh-list
5718159|NCT03228030|Vitamin B Complex|vitamin b complex|mesh-ancestor
5718160|NCT03228030|Vitamins|vitamins|mesh-ancestor
6516785|NCT00717990|Irinotecan|irinotecan|mesh-list
6516786|NCT00717990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6516787|NCT00717990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6516788|NCT00717990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6516789|NCT00717990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6516790|NCT00717990|Growth Substances|growth substances|mesh-ancestor
6681032|NCT01607762|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6681033|NCT01607762|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6681034|NCT01607762|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6681035|NCT01607762|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6779926|NCT02181543|Sensory System Agents|sensory system agents|mesh-ancestor
6779927|NCT02181543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5919686|NCT04979884|Antifungal Agents|antifungal agents|mesh-ancestor
5919687|NCT04979884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5919688|NCT04979884|Dermatologic Agents|dermatologic agents|mesh-ancestor
5919689|NCT04979884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5919690|NCT04979884|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5919691|NCT04979884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5919692|NCT04979884|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5919693|NCT04979884|Analgesics|analgesics|mesh-ancestor
5919694|NCT04979884|Sensory System Agents|sensory system agents|mesh-ancestor
5919695|NCT04979884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5919696|NCT04979832|Metronidazole|metronidazole|mesh-list
5919697|NCT04979832|Fosfomycin|fosfomycin|mesh-list
5919698|NCT04979832|Molgramostim|molgramostim|mesh-list
5919699|NCT04979832|Sargramostim|sargramostim|mesh-list
5919700|NCT04979832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5919701|NCT04979832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5919702|NCT04979832|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5919703|NCT04979832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5919704|NCT04979832|Immunologic Factors|immunologic factors|mesh-ancestor
5919705|NCT04979832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779928|NCT02181543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779929|NCT02181543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6779930|NCT02181543|Sympatholytics|sympatholytics|mesh-ancestor
6779931|NCT02181543|Autonomic Agents|autonomic agents|mesh-ancestor
6779932|NCT02181543|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5919706|NCT04979832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5919707|NCT04979923|Lidocaine|lidocaine|mesh-list
5919708|NCT04979923|Anesthetics, Local|anesthetics, local|mesh-ancestor
5919709|NCT04979923|Anesthetics|anesthetics|mesh-ancestor
5919710|NCT04979923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5919711|NCT04979923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919712|NCT04979923|Sensory System Agents|sensory system agents|mesh-ancestor
5919713|NCT04979923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5919714|NCT04979923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5919715|NCT04979923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5919716|NCT04979923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5919717|NCT04979923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5919718|NCT04979923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919719|NCT04979468|Lamivudine|lamivudine|mesh-list
5919720|NCT04979468|Dolutegravir|dolutegravir|mesh-list
5919721|NCT04979468|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5919722|NCT04979468|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5919723|NCT04979468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5970636|NCT04533867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6516791|NCT00717990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516792|NCT00717990|Growth Inhibitors|growth inhibitors|mesh-ancestor
6516793|NCT00717990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6516794|NCT00717990|Antimetabolites|antimetabolites|mesh-ancestor
6516795|NCT00717990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6516796|NCT00717990|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6516797|NCT00717990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6516798|NCT00717990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6516799|NCT00718146|Vaccines|vaccines|mesh-list
6516800|NCT00718146|Immunologic Factors|immunologic factors|mesh-ancestor
6516801|NCT00718146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516802|NCT00718172|Ribavirin|ribavirin|mesh-list
6516803|NCT00718172|Antimetabolites|antimetabolites|mesh-ancestor
6516804|NCT00718172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6516805|NCT00718172|Antiviral Agents|antiviral agents|mesh-ancestor
6516806|NCT00718172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6516807|NCT00718276|Vitamin D|vitamin d|mesh-list
6516808|NCT00718276|Cholecalciferol|cholecalciferol|mesh-list
6516809|NCT00718276|Vitamins|vitamins|mesh-ancestor
6516810|NCT00718276|Micronutrients|micronutrients|mesh-ancestor
6516811|NCT00718276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516812|NCT00718276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6516813|NCT00718276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6516814|NCT00718289|Dialysis Solutions|dialysis solutions|mesh-list
6516815|NCT00718289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6681036|NCT01607879|Androgens|androgens|mesh-list
6681037|NCT01607879|Hormones|hormones|mesh-ancestor
6681038|NCT01607879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6681039|NCT01607879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681040|NCT01607918|Amoxicillin|amoxicillin|mesh-list
6681041|NCT01607918|Metronidazole|metronidazole|mesh-list
6681042|NCT01607918|Clarithromycin|clarithromycin|mesh-list
6681043|NCT01607918|Lansoprazole|lansoprazole|mesh-list
6681044|NCT01607918|Dexlansoprazole|dexlansoprazole|mesh-list
6681045|NCT01607918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6681046|NCT01607918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6681047|NCT01607918|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6681048|NCT01607918|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6681049|NCT01607918|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6681050|NCT01607918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6681051|NCT01607918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681052|NCT01607918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6681053|NCT01607918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6681054|NCT01607918|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6681055|NCT01607918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6681056|NCT01607918|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6681057|NCT01607970|Oxytocin|oxytocin|mesh-list
6681058|NCT01607970|Oxytocics|oxytocics|mesh-ancestor
6681059|NCT01607970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6681060|NCT01607970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681061|NCT01607983|Nitric Oxide|nitric oxide|mesh-list
6681062|NCT01607983|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6681063|NCT01607983|Autonomic Agents|autonomic agents|mesh-ancestor
6681064|NCT01607983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6681065|NCT01607983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681066|NCT01607983|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6681067|NCT01607983|Respiratory System Agents|respiratory system agents|mesh-ancestor
6681068|NCT01607983|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6681069|NCT01607983|Antioxidants|antioxidants|mesh-ancestor
6681070|NCT01607983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919724|NCT04979468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919725|NCT04979468|Antiviral Agents|antiviral agents|mesh-ancestor
5919726|NCT04979468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5919727|NCT04979468|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5919728|NCT04979468|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5919729|NCT04979468|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5919730|NCT04979468|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5919731|NCT04979520|Brodalumab|brodalumab|mesh-list
5919732|NCT04979520|Dermatologic Agents|dermatologic agents|mesh-ancestor
5919733|NCT04979273|Epinephrine|epinephrine|mesh-list
5919734|NCT04979273|Racepinephrine|racepinephrine|mesh-list
5919735|NCT04979273|Epinephryl borate|epinephryl borate|mesh-list
5919736|NCT04979273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5919737|NCT04979273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5919738|NCT04979273|Adrenergic Agents|adrenergic agents|mesh-ancestor
5919739|NCT04979273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6681071|NCT01607983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6681072|NCT01607983|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6681073|NCT01607983|Vasodilator Agents|vasodilator agents|mesh-ancestor
6516816|NCT00718354|Cisplatin|cisplatin|mesh-list
6516817|NCT00718354|Carboplatin|carboplatin|mesh-list
6516818|NCT00718354|Fluorouracil|fluorouracil|mesh-list
6516819|NCT00718354|Capecitabine|capecitabine|mesh-list
6516820|NCT00718354|Oxaliplatin|oxaliplatin|mesh-list
6516821|NCT00718354|Epirubicin|epirubicin|mesh-list
6516822|NCT00718354|Enoxaparin|enoxaparin|mesh-list
6516823|NCT00718354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6681074|NCT01607983|Gasotransmitters|gasotransmitters|mesh-ancestor
6681075|NCT01607983|Protective Agents|protective agents|mesh-ancestor
6681076|NCT01607996|Anesthetics|anesthetics|mesh-list
6681077|NCT01607996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6681078|NCT01607996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681079|NCT01608009|Paclitaxel|paclitaxel|mesh-list
6681080|NCT01608009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6681081|NCT01608009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6681082|NCT01608009|Tubulin Modulators|tubulin modulators|mesh-ancestor
6681083|NCT01608009|Antimitotic Agents|antimitotic agents|mesh-ancestor
6681084|NCT01608009|Mitosis Modulators|mitosis modulators|mesh-ancestor
6681085|NCT01608009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681086|NCT01608139|Curcumin|curcumin|mesh-list
6681087|NCT01608139|Sorafenib|sorafenib|mesh-list
6681088|NCT01608139|Vorinostat|vorinostat|mesh-list
6681089|NCT01608139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6681090|NCT01608139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6681091|NCT01608139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6681092|NCT01608139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681093|NCT01608139|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6681094|NCT01608139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6681095|NCT01608139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6681096|NCT01608139|Analgesics|analgesics|mesh-ancestor
6681097|NCT01608139|Sensory System Agents|sensory system agents|mesh-ancestor
6681098|NCT01608139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6681099|NCT01608139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681100|NCT01608139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5718161|NCT03228030|Micronutrients|micronutrients|mesh-ancestor
5718162|NCT03228030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718163|NCT03227731|Tenofovir|tenofovir|mesh-list
5718164|NCT03227731|Emtricitabine|emtricitabine|mesh-list
5718165|NCT03227731|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5718166|NCT03227731|Antiviral Agents|antiviral agents|mesh-ancestor
5718167|NCT03227731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5718168|NCT03227731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5718169|NCT03227731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6516824|NCT00718354|Antimetabolites|antimetabolites|mesh-ancestor
5919740|NCT04979273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919741|NCT04979273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919742|NCT04979273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5919743|NCT04979273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5919744|NCT04979273|Autonomic Agents|autonomic agents|mesh-ancestor
5919745|NCT04979273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5919746|NCT04979273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5919747|NCT04979273|Respiratory System Agents|respiratory system agents|mesh-ancestor
5919748|NCT04979273|Mydriatics|mydriatics|mesh-ancestor
5919749|NCT04979273|Sympathomimetics|sympathomimetics|mesh-ancestor
5919750|NCT04979273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5919751|NCT04979221|Cyproheptadine|cyproheptadine|mesh-list
5718170|NCT03227731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5718171|NCT03227731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919752|NCT04979221|Antipruritics|antipruritics|mesh-ancestor
5919753|NCT04979221|Dermatologic Agents|dermatologic agents|mesh-ancestor
6516825|NCT00718354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6516826|NCT00718354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6516827|NCT00718354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6516828|NCT00718354|Immunologic Factors|immunologic factors|mesh-ancestor
6516829|NCT00718354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516830|NCT00718354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6516831|NCT00718354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6516832|NCT00718354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6516833|NCT00718354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6516834|NCT00718354|Anticoagulants|anticoagulants|mesh-ancestor
6516835|NCT00718354|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5718172|NCT03227731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5919754|NCT04979221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6681101|NCT01608139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6681102|NCT01608217|Acetaminophen|acetaminophen|mesh-list
6516836|NCT00718354|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6516837|NCT00718406|Metoprolol|metoprolol|mesh-list
6516838|NCT00718406|Morphine|morphine|mesh-list
6516839|NCT00718406|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6516840|NCT00718406|Narcotics|narcotics|mesh-ancestor
6516841|NCT00718406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6516842|NCT00718406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516843|NCT00718406|Analgesics|analgesics|mesh-ancestor
6516844|NCT00718406|Sensory System Agents|sensory system agents|mesh-ancestor
6516845|NCT00718406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6516846|NCT00718406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6516847|NCT00718406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6516848|NCT00718406|Sympatholytics|sympatholytics|mesh-ancestor
6516849|NCT00718406|Autonomic Agents|autonomic agents|mesh-ancestor
6516850|NCT00718406|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6516851|NCT00718406|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6516852|NCT00718406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6516853|NCT00718406|Adrenergic Agents|adrenergic agents|mesh-ancestor
6516854|NCT00718406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6516855|NCT00718406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718173|NCT03227731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5718174|NCT03227900|Lidocaine|lidocaine|mesh-list
5718175|NCT03227900|Anesthetics, Local|anesthetics, local|mesh-ancestor
5718176|NCT03227900|Anesthetics|anesthetics|mesh-ancestor
5718177|NCT03227900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5718178|NCT03227900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718179|NCT03227900|Sensory System Agents|sensory system agents|mesh-ancestor
5718180|NCT03227900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5718181|NCT03227900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6516856|NCT00718471|Heparin|heparin|mesh-list
6516857|NCT00718471|Enoxaparin|enoxaparin|mesh-list
6516858|NCT00718471|Calcium heparin|calcium heparin|mesh-list
6516859|NCT00718471|Anticoagulants|anticoagulants|mesh-ancestor
6516860|NCT00718471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6516861|NCT00718471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6516862|NCT00718471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6516863|NCT00718484|Doxorubicin|doxorubicin|mesh-list
6516864|NCT00718484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6516865|NCT00718484|Isophosphamide mustard|isophosphamide mustard|mesh-list
6516866|NCT00718484|Ifosfamide|ifosfamide|mesh-list
6516867|NCT00718484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6516868|NCT00718484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6516869|NCT00718484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6516870|NCT00718484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6516871|NCT00718484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6516872|NCT00718484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6516873|NCT00718484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6516874|NCT00718484|Alkylating Agents|alkylating agents|mesh-ancestor
6516875|NCT00718536|Raltegravir Potassium|raltegravir potassium|mesh-list
6516876|NCT00718536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6516877|NCT00718536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6516878|NCT00718536|Antiviral Agents|antiviral agents|mesh-ancestor
6516879|NCT00718536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6516880|NCT00718536|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6516881|NCT00718536|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6516882|NCT00718536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6516883|NCT00718536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6516884|NCT00718601|Imetelstat|imetelstat|mesh-list
6516885|NCT00718601|Motesanib diphosphate|motesanib diphosphate|mesh-list
6681103|NCT01608217|Dronabinol|dronabinol|mesh-list
6681104|NCT01608217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6516886|NCT00718601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6516887|NCT00718601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919755|NCT04979221|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5919756|NCT04979221|Histamine Antagonists|histamine antagonists|mesh-ancestor
5919757|NCT04979221|Histamine Agents|histamine agents|mesh-ancestor
5919758|NCT04979221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5919759|NCT04979221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919760|NCT04979221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919761|NCT04979221|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5919762|NCT04979221|Serotonin Agents|serotonin agents|mesh-ancestor
5919763|NCT04979221|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6516888|NCT00718601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6516889|NCT00718705|Josamycin|josamycin|mesh-list
6516890|NCT00718705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6681105|NCT01608217|Analgesics|analgesics|mesh-ancestor
6516891|NCT00718705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6516892|NCT00718757|Dexamethasone|dexamethasone|mesh-list
6516893|NCT00718757|Irinotecan|irinotecan|mesh-list
6516894|NCT00718757|Vincristine|vincristine|mesh-list
6516895|NCT00718757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6516896|NCT00718757|Antiemetics|antiemetics|mesh-ancestor
6516897|NCT00718757|Autonomic Agents|autonomic agents|mesh-ancestor
6516898|NCT00718757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6516899|NCT00718757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516900|NCT00718757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6516901|NCT00718757|Glucocorticoids|glucocorticoids|mesh-ancestor
6516902|NCT00718757|Hormones|hormones|mesh-ancestor
6516903|NCT00718757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5718182|NCT03227900|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6516904|NCT00718757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6516905|NCT00718757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6516906|NCT00718757|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6516907|NCT00718757|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6516908|NCT00718757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6516909|NCT00718757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6516910|NCT00718757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6516911|NCT00718757|Tubulin Modulators|tubulin modulators|mesh-ancestor
6516912|NCT00718757|Antimitotic Agents|antimitotic agents|mesh-ancestor
6516913|NCT00718757|Mitosis Modulators|mitosis modulators|mesh-ancestor
6516914|NCT00718796|Coenzyme Q10|coenzyme q10|mesh-list
6516915|NCT00718796|Ubiquinone|ubiquinone|mesh-list
6516916|NCT00718796|Atorvastatin|atorvastatin|mesh-list
6516917|NCT00718796|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6516918|NCT00718796|Simvastatin|simvastatin|mesh-list
6516919|NCT00718796|Pravastatin|pravastatin|mesh-list
6516920|NCT00718796|Lovastatin|lovastatin|mesh-list
6516921|NCT00718796|L 647318|l 647318|mesh-list
6516922|NCT00718796|Dihydromevinolin|dihydromevinolin|mesh-list
6516923|NCT00718796|Anticholesteremic Agents|anticholesteremic agents|mesh-list
6516924|NCT00718796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6516925|NCT00718796|Antimetabolites|antimetabolites|mesh-ancestor
6516926|NCT00718796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6516927|NCT00718796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6516928|NCT00718796|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6516929|NCT00718796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6516930|NCT00718796|Vitamins|vitamins|mesh-ancestor
6516931|NCT00718796|Micronutrients|micronutrients|mesh-ancestor
6516932|NCT00718796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516933|NCT00718913|Docetaxel|docetaxel|mesh-list
6516934|NCT00718913|Capecitabine|capecitabine|mesh-list
6516935|NCT00718913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6516936|NCT00718913|Tubulin Modulators|tubulin modulators|mesh-ancestor
6516937|NCT00718913|Antimitotic Agents|antimitotic agents|mesh-ancestor
6516938|NCT00718913|Mitosis Modulators|mitosis modulators|mesh-ancestor
6516939|NCT00718913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6516940|NCT00718913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6516941|NCT00718913|Antimetabolites|antimetabolites|mesh-ancestor
6516942|NCT00718952|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6516943|NCT00718952|Vasodilator Agents|vasodilator agents|mesh-ancestor
6516944|NCT00718952|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6516945|NCT00718952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6516946|NCT00718952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5718183|NCT03227900|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5718184|NCT03227900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5718185|NCT03227900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718186|NCT03228069|Vaccines|vaccines|mesh-list
5718187|NCT03228069|Immunologic Factors|immunologic factors|mesh-ancestor
5718188|NCT03228069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718189|NCT03228043|Apatinib|apatinib|mesh-list
5718190|NCT03228043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5718191|NCT03228043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5718192|NCT03228043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5718193|NCT03228043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718194|NCT03227926|Panitumumab|panitumumab|mesh-list
6516947|NCT00718952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6516948|NCT00718952|Urological Agents|urological agents|mesh-ancestor
6516949|NCT00719056|Ciprofloxacin|ciprofloxacin|mesh-list
6516950|NCT00719056|Lactams|lactams|mesh-list
6516951|NCT00719056|Cephalosporins|cephalosporins|mesh-list
6516952|NCT00719056|Teicoplanin|teicoplanin|mesh-list
6516953|NCT00719056|beta-Lactams|beta-lactams|mesh-list
6516954|NCT00719056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6516955|NCT00719056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6516956|NCT00719056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6516957|NCT00719056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6516958|NCT00719056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6516959|NCT00719056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6516960|NCT00719056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6516961|NCT00719056|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6516962|NCT00719056|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6681106|NCT01608217|Sensory System Agents|sensory system agents|mesh-ancestor
6681107|NCT01608217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6681108|NCT01608217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681109|NCT01608217|Antipyretics|antipyretics|mesh-ancestor
6681110|NCT01608217|Hallucinogens|hallucinogens|mesh-ancestor
6681111|NCT01608217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5718195|NCT03227926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5718196|NCT03227926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5722106|NCT03201159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5919764|NCT04979091|Hormones|hormones|mesh-list
5919765|NCT04979091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5919766|NCT04979091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919767|NCT04979338|Bupivacaine|bupivacaine|mesh-list
5919768|NCT04979338|Anesthetics, Local|anesthetics, local|mesh-list
5919769|NCT04979338|Anesthetics|anesthetics|mesh-list
5722107|NCT03201159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5722108|NCT03201159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5722109|NCT03201159|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5722110|NCT03201146|Cisplatin|cisplatin|mesh-list
5722111|NCT03201146|Carboplatin|carboplatin|mesh-list
5722112|NCT03201146|Pemetrexed|pemetrexed|mesh-list
5722113|NCT03201146|Apatinib|apatinib|mesh-list
5722114|NCT03201146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5919770|NCT04979338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5919771|NCT04979338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919772|NCT04979338|Sensory System Agents|sensory system agents|mesh-ancestor
5919773|NCT04979338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5919774|NCT04979377|Insulin|insulin|mesh-list
5919775|NCT04979377|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5919776|NCT04979377|Hormones|hormones|mesh-list
5919777|NCT04979377|Testosterone|testosterone|mesh-list
5919778|NCT04979377|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
5919779|NCT04979377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5919780|NCT04979377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919781|NCT04979377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5919782|NCT04979377|Androgens|androgens|mesh-ancestor
5919783|NCT04979377|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5919784|NCT04979377|Immunologic Factors|immunologic factors|mesh-ancestor
5919785|NCT04979065|Vitamin D|vitamin d|mesh-list
5919786|NCT04979065|Vitamins|vitamins|mesh-ancestor
5919787|NCT04979065|Micronutrients|micronutrients|mesh-ancestor
5919788|NCT04979065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919789|NCT04979065|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5919790|NCT04978675|Fluorides|fluorides|mesh-list
5919791|NCT04978675|Cariostatic Agents|cariostatic agents|mesh-ancestor
5919792|NCT04978675|Protective Agents|protective agents|mesh-ancestor
5919793|NCT04978675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919794|NCT04978688|Relugolix|relugolix|mesh-list
5722115|NCT03201146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5722116|NCT03201146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722117|NCT03201146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5722118|NCT03201146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5919795|NCT04978688|Androgen Antagonists|androgen antagonists|mesh-ancestor
5919796|NCT04978688|Hormone Antagonists|hormone antagonists|mesh-ancestor
5919797|NCT04978688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5919798|NCT04978688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964103|NCT04594772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964104|NCT04594772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5964105|NCT04594772|Antimetabolites|antimetabolites|mesh-ancestor
5964106|NCT04594772|Antiviral Agents|antiviral agents|mesh-ancestor
5964107|NCT04594772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5964108|NCT04594772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5964109|NCT04594772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5964110|NCT04594772|Immunologic Factors|immunologic factors|mesh-ancestor
6516963|NCT00719095|Naltrexone|naltrexone|mesh-list
6516964|NCT00719095|Buprenorphine|buprenorphine|mesh-list
6516965|NCT00719095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6516966|NCT00719095|Narcotics|narcotics|mesh-ancestor
5919799|NCT04978649|Amlodipine|amlodipine|mesh-list
5919800|NCT04978649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5919801|NCT04978649|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5919802|NCT04978649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5919803|NCT04978649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919804|NCT04978649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5919805|NCT04978649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919806|NCT04978649|Vasodilator Agents|vasodilator agents|mesh-ancestor
5919807|NCT04978597|Opicapone|opicapone|mesh-list
5919808|NCT04978597|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
5919809|NCT04978597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5919810|NCT04978597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919811|NCT04978597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5919812|NCT04978597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5919813|NCT04978545|Chlorhexidine|chlorhexidine|mesh-list
5919814|NCT04978545|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5919815|NCT04978545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5919816|NCT04978545|Disinfectants|disinfectants|mesh-ancestor
5919817|NCT04978584|Prednisone|prednisone|mesh-list
5919818|NCT04978584|Cortisone|cortisone|mesh-list
5919819|NCT04978584|Cyclophosphamide|cyclophosphamide|mesh-list
5919820|NCT04978584|Rituximab|rituximab|mesh-list
5919821|NCT04978584|Doxorubicin|doxorubicin|mesh-list
5919822|NCT04978584|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5919823|NCT04978584|Vincristine|vincristine|mesh-list
5919824|NCT04978584|Lenalidomide|lenalidomide|mesh-list
5919825|NCT04978584|Acalabrutinib|acalabrutinib|mesh-list
5919826|NCT04978584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5919827|NCT04978584|Antibodies|antibodies|mesh-list
5919828|NCT04978584|Immunoglobulins|immunoglobulins|mesh-list
5919829|NCT04978584|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5919830|NCT04978584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5919831|NCT04978584|Immunologic Factors|immunologic factors|mesh-ancestor
5919832|NCT04978584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919833|NCT04978584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5919834|NCT04978584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5919835|NCT04978584|Alkylating Agents|alkylating agents|mesh-ancestor
5919836|NCT04978584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919837|NCT04978584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5919838|NCT04978584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5919839|NCT04978584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5919840|NCT04978584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5919841|NCT04978584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5919842|NCT04978584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5919843|NCT04978584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5919844|NCT04978584|Glucocorticoids|glucocorticoids|mesh-ancestor
5919845|NCT04978584|Hormones|hormones|mesh-ancestor
5919846|NCT04978584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5919847|NCT04978584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5919848|NCT04978584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5919849|NCT04978584|Tubulin Modulators|tubulin modulators|mesh-ancestor
5919850|NCT04978584|Antimitotic Agents|antimitotic agents|mesh-ancestor
5919851|NCT04978584|Mitosis Modulators|mitosis modulators|mesh-ancestor
5919852|NCT04978584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5919853|NCT04978584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5919854|NCT04978584|Growth Substances|growth substances|mesh-ancestor
5919855|NCT04978584|Growth Inhibitors|growth inhibitors|mesh-ancestor
5919856|NCT04978181|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5919857|NCT04978181|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5919858|NCT04978181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5919859|NCT04978181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919860|NCT04977960|Canrenone|canrenone|mesh-list
5919861|NCT04977960|Canrenoic Acid|canrenoic acid|mesh-list
5919862|NCT04977960|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5919863|NCT04977960|Hormone Antagonists|hormone antagonists|mesh-ancestor
5718197|NCT03227679|Bupropion|bupropion|mesh-list
5718198|NCT03227679|Nicotine|nicotine|mesh-list
5718199|NCT03227679|Varenicline|varenicline|mesh-list
5718200|NCT03227679|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5718201|NCT03227679|Autonomic Agents|autonomic agents|mesh-ancestor
5718202|NCT03227679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5718203|NCT03227679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718204|NCT03227679|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5919864|NCT04977960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5919865|NCT04977960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919866|NCT04977960|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5919867|NCT04977960|Diuretics|diuretics|mesh-ancestor
5919868|NCT04977960|Natriuretic Agents|natriuretic agents|mesh-ancestor
5919869|NCT04978155|Anesthetics|anesthetics|mesh-list
5919870|NCT04978155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5919871|NCT04978155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919872|NCT04978038|Vaccines|vaccines|mesh-list
5919873|NCT04978038|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5919874|NCT04978038|Immunologic Factors|immunologic factors|mesh-ancestor
5919875|NCT04978038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919876|NCT04977778|Fluorides|fluorides|mesh-list
5919877|NCT04977778|Tin Fluorides|tin fluorides|mesh-list
5919878|NCT04977778|Cariostatic Agents|cariostatic agents|mesh-ancestor
5919879|NCT04977778|Protective Agents|protective agents|mesh-ancestor
5919880|NCT04977778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919881|NCT04977674|Naltrexone|naltrexone|mesh-list
5919882|NCT04977674|Ketamine|ketamine|mesh-list
5919883|NCT04977674|Analgesics|analgesics|mesh-ancestor
5919884|NCT04977674|Sensory System Agents|sensory system agents|mesh-ancestor
5919885|NCT04977674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5919886|NCT04977674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919887|NCT04977674|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5919888|NCT04977674|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5919889|NCT04977674|Anesthetics, General|anesthetics, general|mesh-ancestor
5919890|NCT04977674|Anesthetics|anesthetics|mesh-ancestor
5919891|NCT04977674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5919892|NCT04977674|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5919893|NCT04977674|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5919894|NCT04977674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5919895|NCT04977674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919896|NCT04977674|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5919897|NCT04977674|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5919898|NCT04977908|Insulin|insulin|mesh-list
5919899|NCT04977908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5919900|NCT04977908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919901|NCT04977830|Xenon|xenon|mesh-list
5919902|NCT04977830|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5919903|NCT04977830|Anesthetics, General|anesthetics, general|mesh-ancestor
5919904|NCT04977830|Anesthetics|anesthetics|mesh-ancestor
5919905|NCT04977830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5919906|NCT04977830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919907|NCT04977661|Vitamin E|vitamin e|mesh-list
5919908|NCT04977661|Tocopherols|tocopherols|mesh-list
5919909|NCT04977661|alpha-Tocopherol|alpha-tocopherol|mesh-list
5919910|NCT04977661|Pentoxifylline|pentoxifylline|mesh-list
5919911|NCT04977661|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
5919912|NCT04977661|Vitamins|vitamins|mesh-ancestor
5919913|NCT04977661|Micronutrients|micronutrients|mesh-ancestor
5919914|NCT04977661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919915|NCT04977661|Antioxidants|antioxidants|mesh-ancestor
5919916|NCT04977661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919917|NCT04977661|Protective Agents|protective agents|mesh-ancestor
5919918|NCT04977661|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5919919|NCT04977661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5919920|NCT04977661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5919921|NCT04977661|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5919922|NCT04977661|Vasodilator Agents|vasodilator agents|mesh-ancestor
5919923|NCT04977661|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5919924|NCT04977661|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5919925|NCT04977661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5919926|NCT04977791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5919927|NCT04977791|Antibodies|antibodies|mesh-list
5919928|NCT04977791|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5919929|NCT04977791|Immunologic Factors|immunologic factors|mesh-ancestor
5919930|NCT04977791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919931|NCT04977791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919932|NCT04977791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5919933|NCT04978051|Icatibant|icatibant|mesh-list
5919934|NCT04978051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5919935|NCT04978051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5919936|NCT04978051|Analgesics|analgesics|mesh-ancestor
5919937|NCT04978051|Sensory System Agents|sensory system agents|mesh-ancestor
5919938|NCT04978051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5919939|NCT04978051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919940|NCT04978051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5919941|NCT04978051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5919942|NCT04978051|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
5970637|NCT04533867|Serotonin Agents|serotonin agents|mesh-ancestor
5919943|NCT04978051|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
5919944|NCT04978051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919945|NCT04978051|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5919946|NCT04978051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5919947|NCT04978051|Immunologic Factors|immunologic factors|mesh-ancestor
5919948|NCT04977427|Prednisolone|prednisolone|mesh-list
5919949|NCT04977427|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5919950|NCT04977427|Methylprednisolone|methylprednisolone|mesh-list
5919951|NCT04977427|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5919952|NCT04977427|Prednisolone acetate|prednisolone acetate|mesh-list
5919953|NCT04977427|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5919954|NCT04977427|Prednisolone phosphate|prednisolone phosphate|mesh-list
5919955|NCT04977427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5919956|NCT04977427|Glucocorticoids|glucocorticoids|mesh-ancestor
5919957|NCT04977427|Hormones|hormones|mesh-ancestor
5919958|NCT04977427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5919959|NCT04977427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919960|NCT04977427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5919961|NCT04977427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5718205|NCT03227679|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5718206|NCT03227679|Cholinergic Agents|cholinergic agents|mesh-ancestor
5718207|NCT03227679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5718208|NCT03227679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718209|NCT03227679|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5718210|NCT03227679|Antidepressive Agents|antidepressive agents|mesh-ancestor
5919962|NCT04977427|Antiemetics|antiemetics|mesh-ancestor
5919963|NCT04977427|Autonomic Agents|autonomic agents|mesh-ancestor
5919964|NCT04977427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5919965|NCT04977427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5919966|NCT04977427|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5919967|NCT04977427|Protective Agents|protective agents|mesh-ancestor
5919968|NCT04977375|Pembrolizumab|pembrolizumab|mesh-list
5919969|NCT04977375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5919970|NCT04977375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5919971|NCT04977336|Acetaminophen|acetaminophen|mesh-list
5919972|NCT04977336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5919973|NCT04977336|Analgesics|analgesics|mesh-ancestor
5919974|NCT04977336|Sensory System Agents|sensory system agents|mesh-ancestor
5919975|NCT04977336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5919976|NCT04977336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919977|NCT04977336|Antipyretics|antipyretics|mesh-ancestor
5919978|NCT04977544|Sertraline|sertraline|mesh-list
5919979|NCT04977544|Antidepressive Agents|antidepressive agents|mesh-ancestor
5919980|NCT04977544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5919981|NCT04977544|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5919982|NCT04977544|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5919983|NCT04977544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5919984|NCT04977544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5919985|NCT04977544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5919986|NCT04977544|Serotonin Agents|serotonin agents|mesh-ancestor
5919987|NCT04977544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919988|NCT04977401|Glycerol|glycerol|mesh-list
5919989|NCT04977401|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
5919990|NCT04977401|Protective Agents|protective agents|mesh-ancestor
5919991|NCT04977401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919992|NCT04977557|Thiamine|thiamine|mesh-list
5919993|NCT04977557|Vitamin B Complex|vitamin b complex|mesh-ancestor
5919994|NCT04977557|Vitamins|vitamins|mesh-ancestor
5919995|NCT04977557|Micronutrients|micronutrients|mesh-ancestor
5919996|NCT04977557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5919997|NCT04977167|Antibodies|antibodies|mesh-list
5919998|NCT04977167|Immunologic Factors|immunologic factors|mesh-ancestor
5919999|NCT04977167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920000|NCT04977388|Droxidopa|droxidopa|mesh-list
5920001|NCT04977388|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5718211|NCT03227679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5718212|NCT03227679|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5718213|NCT03227679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5718214|NCT03227679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5718215|NCT03227679|Dopamine Agents|dopamine agents|mesh-ancestor
5718216|NCT03227679|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5718217|NCT03227679|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5718218|NCT03227679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5920002|NCT04977388|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5920003|NCT04976816|Triamcinolone|triamcinolone|mesh-list
5718219|NCT03227705|Progesterone|progesterone|mesh-list
5718220|NCT03227705|Progestins|progestins|mesh-ancestor
5718221|NCT03227705|Hormones|hormones|mesh-ancestor
5718222|NCT03227705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5718223|NCT03227705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718224|NCT03227653|Ritonavir|ritonavir|mesh-list
5718225|NCT03227653|Lopinavir|lopinavir|mesh-list
5718226|NCT03227653|Nevirapine|nevirapine|mesh-list
5718227|NCT03227653|Efavirenz|efavirenz|mesh-list
5718228|NCT03227653|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5718229|NCT03227653|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5718230|NCT03227653|Protease Inhibitors|protease inhibitors|mesh-ancestor
5920004|NCT04976816|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5920005|NCT04976816|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5920006|NCT04976816|Betamethasone|betamethasone|mesh-list
5718231|NCT03227653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5718232|NCT03227653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718233|NCT03227653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5718234|NCT03227653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5718235|NCT03227653|Antiviral Agents|antiviral agents|mesh-ancestor
5718236|NCT03227653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5718237|NCT03227653|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5718238|NCT03227653|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5718239|NCT03227653|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5718240|NCT03227653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5718241|NCT03227653|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5718242|NCT03227653|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5718243|NCT03227653|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5718244|NCT03227653|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5718245|NCT03227653|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5718246|NCT03227484|Empagliflozin|empagliflozin|mesh-list
5718247|NCT03227484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5718248|NCT03227484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718249|NCT03227484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5718250|NCT03227484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718251|NCT03227419|Abatacept|abatacept|mesh-list
5718252|NCT03227419|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5718253|NCT03227419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718254|NCT03227419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5718255|NCT03227419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5718256|NCT03227419|Immunologic Factors|immunologic factors|mesh-ancestor
5718257|NCT03227419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718258|NCT03227419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5718259|NCT03227562|Risperidone|risperidone|mesh-list
5718260|NCT03227562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5718261|NCT03227562|Serotonin Agents|serotonin agents|mesh-ancestor
5718262|NCT03227562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5718263|NCT03227562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718264|NCT03227562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718265|NCT03227562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5718266|NCT03227562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5718267|NCT03227562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5718268|NCT03227562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5718269|NCT03227562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5718270|NCT03227562|Dopamine Agents|dopamine agents|mesh-ancestor
5718271|NCT03227432|Dexamethasone|dexamethasone|mesh-list
5718272|NCT03227432|Nivolumab|nivolumab|mesh-list
5718273|NCT03227432|Pomalidomide|pomalidomide|mesh-list
5718274|NCT03227432|Elotuzumab|elotuzumab|mesh-list
5718275|NCT03227432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5718276|NCT03227432|Antiemetics|antiemetics|mesh-ancestor
5718277|NCT03227432|Autonomic Agents|autonomic agents|mesh-ancestor
5718278|NCT03227432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5718279|NCT03227432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718280|NCT03227432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5718281|NCT03227432|Glucocorticoids|glucocorticoids|mesh-ancestor
5718282|NCT03227432|Hormones|hormones|mesh-ancestor
5718283|NCT03227432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5718284|NCT03227432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5718285|NCT03227432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5718286|NCT03227432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5718287|NCT03227432|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5718288|NCT03227432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920007|NCT04976816|Betamethasone Valerate|betamethasone valerate|mesh-list
5920008|NCT04976816|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5920009|NCT04976816|Betamethasone benzoate|betamethasone benzoate|mesh-list
5920010|NCT04976816|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
5920011|NCT04976816|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5920012|NCT04976816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5920013|NCT04976816|Glucocorticoids|glucocorticoids|mesh-ancestor
5920014|NCT04976816|Hormones|hormones|mesh-ancestor
5920015|NCT04976816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5920016|NCT04976816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920017|NCT04976816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5920018|NCT04976816|Immunologic Factors|immunologic factors|mesh-ancestor
5920019|NCT04976816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5920020|NCT04976816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920021|NCT04976816|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5920022|NCT04976816|Respiratory System Agents|respiratory system agents|mesh-ancestor
5920023|NCT04976868|Pimecrolimus|pimecrolimus|mesh-list
5920024|NCT04976868|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5920025|NCT04976868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5920026|NCT04976868|Analgesics|analgesics|mesh-ancestor
5920027|NCT04976868|Sensory System Agents|sensory system agents|mesh-ancestor
5920028|NCT04976868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5920029|NCT04976868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920030|NCT04976868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5920031|NCT04976868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5920032|NCT04976868|Dermatologic Agents|dermatologic agents|mesh-ancestor
5920033|NCT04976868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5920034|NCT04976868|Immunologic Factors|immunologic factors|mesh-ancestor
5920035|NCT04976868|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5920036|NCT04976868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5920037|NCT04976868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920038|NCT04976673|Triamcinolone|triamcinolone|mesh-list
5920039|NCT04976673|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5920040|NCT04976673|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5920041|NCT04976673|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5920042|NCT04976673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5920043|NCT04976673|Glucocorticoids|glucocorticoids|mesh-ancestor
5920044|NCT04976673|Hormones|hormones|mesh-ancestor
5920045|NCT04976673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5920046|NCT04976673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920047|NCT04976673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5920048|NCT04976673|Immunologic Factors|immunologic factors|mesh-ancestor
5920049|NCT04976673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5920050|NCT04976673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964111|NCT04594772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964112|NCT04594772|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5964113|NCT04594772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5964114|NCT04594551|Vaccines|vaccines|mesh-list
5964115|NCT04594551|Immunoglobulins|immunoglobulins|mesh-list
5964116|NCT04594551|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5964117|NCT04594551|Antibodies|antibodies|mesh-list
5964118|NCT04594551|Immunologic Factors|immunologic factors|mesh-ancestor
5964119|NCT04594551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964120|NCT04594629|Nitroglycerin|nitroglycerin|mesh-list
5964121|NCT04594629|Vasodilator Agents|vasodilator agents|mesh-ancestor
5964122|NCT04594018|Minoxidil|minoxidil|mesh-list
5964123|NCT04594018|Finasteride|finasteride|mesh-list
5964124|NCT04594018|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
5964125|NCT04594018|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5964126|NCT04594018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5964127|NCT04594018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964128|NCT04594018|Hormone Antagonists|hormone antagonists|mesh-ancestor
5964129|NCT04594018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5964130|NCT04594018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964131|NCT04594018|Urological Agents|urological agents|mesh-ancestor
5964132|NCT04594018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5964133|NCT04594018|Vasodilator Agents|vasodilator agents|mesh-ancestor
5964134|NCT04594005|Paclitaxel|paclitaxel|mesh-list
5964135|NCT04594005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5964136|NCT04594005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5964137|NCT04594005|Tubulin Modulators|tubulin modulators|mesh-ancestor
5964138|NCT04594005|Antimitotic Agents|antimitotic agents|mesh-ancestor
5964139|NCT04594005|Mitosis Modulators|mitosis modulators|mesh-ancestor
5964140|NCT04594005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920051|NCT04976543|Heparin|heparin|mesh-list
5920052|NCT04976543|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5920053|NCT04976543|Tinzaparin|tinzaparin|mesh-list
5920054|NCT04976543|Dalteparin|dalteparin|mesh-list
5920055|NCT04976543|Warfarin|warfarin|mesh-list
5920056|NCT04976543|Anticoagulants|anticoagulants|mesh-ancestor
5920057|NCT04976543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5920058|NCT04976543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5920059|NCT04976543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920060|NCT04976829|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5920061|NCT04976829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5920062|NCT04976855|Buprenorphine|buprenorphine|mesh-list
5920063|NCT04976855|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
5920064|NCT04976855|Naloxone|naloxone|mesh-list
5920065|NCT04976855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5920066|NCT04976855|Narcotics|narcotics|mesh-ancestor
5920067|NCT04976855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5920068|NCT04976855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920069|NCT04976855|Analgesics|analgesics|mesh-ancestor
5920070|NCT04976855|Sensory System Agents|sensory system agents|mesh-ancestor
5920071|NCT04976855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5920072|NCT04976855|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5920073|NCT04976478|Nimotuzumab|nimotuzumab|mesh-list
5920074|NCT04976478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5920075|NCT04976478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5920076|NCT04976088|Diclofenac|diclofenac|mesh-list
5920077|NCT04976088|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
5920078|NCT04976088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5920079|NCT04976088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5920080|NCT04976088|Analgesics|analgesics|mesh-ancestor
5920081|NCT04976088|Sensory System Agents|sensory system agents|mesh-ancestor
5920082|NCT04976088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5920083|NCT04976088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920084|NCT04976088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5920085|NCT04976088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5920086|NCT04976088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5920087|NCT04976088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5920088|NCT04976088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920089|NCT04976036|Nintedanib|nintedanib|mesh-list
5920090|NCT04976036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5920091|NCT04976036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5920092|NCT04976036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5920093|NCT04976036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920094|NCT04976283|Pioglitazone|pioglitazone|mesh-list
5920095|NCT04976283|Empagliflozin|empagliflozin|mesh-list
5920096|NCT04976283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5920097|NCT04976283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920098|NCT04976283|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5920099|NCT04976283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920100|NCT04975802|Caffeine|caffeine|mesh-list
5920101|NCT04975802|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5920102|NCT04975802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920103|NCT04975802|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5920104|NCT04975802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5920105|NCT04975802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718289|NCT03227432|Immunologic Factors|immunologic factors|mesh-ancestor
5718290|NCT03227432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5718291|NCT03227432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5718292|NCT03227432|Growth Substances|growth substances|mesh-ancestor
5718293|NCT03227432|Growth Inhibitors|growth inhibitors|mesh-ancestor
5718294|NCT03227016|Topotecan|topotecan|mesh-list
5718295|NCT03227016|Veliparib|veliparib|mesh-list
5718296|NCT03227016|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
5718297|NCT03227016|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5718298|NCT03227016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5718299|NCT03227016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5718300|NCT03227016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718301|NCT03227016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5718302|NCT03226717|Antiviral Agents|antiviral agents|mesh-list
5718303|NCT03226717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5718304|NCT03226821|Tesamorelin|tesamorelin|mesh-list
5718305|NCT03226821|Growth Substances|growth substances|mesh-ancestor
5718306|NCT03226821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964141|NCT04594343|Disulfiram|disulfiram|mesh-list
5718307|NCT03226626|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5920106|NCT04975802|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5920107|NCT04975802|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5920108|NCT04975802|Purinergic Agents|purinergic agents|mesh-ancestor
5920109|NCT04975802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5920110|NCT04975945|Ceftriaxone|ceftriaxone|mesh-list
5920111|NCT04975945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5920112|NCT04975945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5920113|NCT04975932|Chlorotrianisene|chlorotrianisene|mesh-list
5920114|NCT04975932|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
5920115|NCT04975932|Estrogens|estrogens|mesh-ancestor
5920116|NCT04975932|Hormones|hormones|mesh-ancestor
5920117|NCT04975932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5920118|NCT04975932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920119|NCT04975932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5920120|NCT04975932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5920121|NCT04975971|Dexamethasone|dexamethasone|mesh-list
5718308|NCT03226626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5718309|NCT03226431|Ascorbic Acid|ascorbic acid|mesh-list
5718310|NCT03226431|Antioxidants|antioxidants|mesh-ancestor
5718311|NCT03226431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718312|NCT03226431|Protective Agents|protective agents|mesh-ancestor
5718313|NCT03226431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718314|NCT03226431|Vitamins|vitamins|mesh-ancestor
5920122|NCT04975971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5920123|NCT04975971|Antiemetics|antiemetics|mesh-ancestor
5920124|NCT04975971|Autonomic Agents|autonomic agents|mesh-ancestor
5920125|NCT04975971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5920126|NCT04975971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920127|NCT04975971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5920128|NCT04975971|Glucocorticoids|glucocorticoids|mesh-ancestor
5920129|NCT04975971|Hormones|hormones|mesh-ancestor
5920130|NCT04975971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5920131|NCT04975971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5920132|NCT04975971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5920133|NCT04975724|Citalopram|citalopram|mesh-list
5920134|NCT04975724|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5920135|NCT04975724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5920136|NCT04975724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5920137|NCT04975724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920138|NCT04975724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5920139|NCT04975724|Serotonin Agents|serotonin agents|mesh-ancestor
5920140|NCT04975724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920141|NCT04975724|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5920142|NCT04975724|Antidepressive Agents|antidepressive agents|mesh-ancestor
5920143|NCT04975724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5920144|NCT04975269|Acetazolamide|acetazolamide|mesh-list
5920145|NCT04975269|Anticonvulsants|anticonvulsants|mesh-ancestor
5920146|NCT04975269|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5920147|NCT04975269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5920148|NCT04975269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920149|NCT04975269|Diuretics|diuretics|mesh-ancestor
5920150|NCT04975269|Natriuretic Agents|natriuretic agents|mesh-ancestor
5920151|NCT04975269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920152|NCT04975373|Hyaluronic Acid|hyaluronic acid|mesh-list
5920153|NCT04975373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5920154|NCT04975373|Immunologic Factors|immunologic factors|mesh-ancestor
5920155|NCT04975373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920156|NCT04975373|Viscosupplements|viscosupplements|mesh-ancestor
6681112|NCT01608217|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6681113|NCT01608217|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6681114|NCT01608217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5718315|NCT03226431|Micronutrients|micronutrients|mesh-ancestor
5718316|NCT03226418|Cytarabine|cytarabine|mesh-list
5718317|NCT03226418|Azacitidine|azacitidine|mesh-list
5718318|NCT03226418|Decitabine|decitabine|mesh-list
5718319|NCT03226418|Daunorubicin|daunorubicin|mesh-list
5718320|NCT03226418|Venetoclax|venetoclax|mesh-list
5718321|NCT03226418|Idarubicin|idarubicin|mesh-list
5718322|NCT03226418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6681115|NCT01608217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681116|NCT01608217|Hormones|hormones|mesh-ancestor
6681117|NCT01608217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6681118|NCT01608269|Lamivudine|lamivudine|mesh-list
6681119|NCT01608269|Abacavir|abacavir|mesh-list
5718323|NCT03226418|Antimetabolites|antimetabolites|mesh-ancestor
6681120|NCT01608269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6681121|NCT01608269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6681122|NCT01608269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6681123|NCT01608269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681124|NCT01608269|Antiviral Agents|antiviral agents|mesh-ancestor
5920157|NCT04975373|Protective Agents|protective agents|mesh-ancestor
5920158|NCT04975360|Caffeine|caffeine|mesh-list
5920159|NCT04975360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5920160|NCT04975360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920161|NCT04975360|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5920162|NCT04975360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5920163|NCT04975360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920164|NCT04975360|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5920165|NCT04975360|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5920166|NCT04975360|Purinergic Agents|purinergic agents|mesh-ancestor
5920167|NCT04975360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5920168|NCT04975022|Insulin|insulin|mesh-list
5920169|NCT04975022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5920170|NCT04975022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920171|NCT04975074|Iron|iron|mesh-list
5920172|NCT04975074|Ferrous succinate|ferrous succinate|mesh-list
5920173|NCT04975074|Trace Elements|trace elements|mesh-ancestor
5920174|NCT04975074|Micronutrients|micronutrients|mesh-ancestor
5920175|NCT04975074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920176|NCT04975074|Hematinics|hematinics|mesh-ancestor
5920177|NCT04974827|Carboplatin|carboplatin|mesh-list
5920178|NCT04974827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5920179|NCT04974723|Teriparatide|teriparatide|mesh-list
5920180|NCT04974723|Abaloparatide|abaloparatide|mesh-list
5920181|NCT04974723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5920182|NCT04974723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920183|NCT04974723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5964142|NCT04594343|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5964143|NCT04594343|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
5964144|NCT04594343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5964145|NCT04594343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964146|NCT04593706|Dexamethasone|dexamethasone|mesh-list
5718324|NCT03226418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718325|NCT03226418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5718326|NCT03226418|Antiviral Agents|antiviral agents|mesh-ancestor
5718327|NCT03226418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5718328|NCT03226418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5718329|NCT03226418|Immunologic Factors|immunologic factors|mesh-ancestor
5718330|NCT03226418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718331|NCT03226418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5718332|NCT03226418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5718333|NCT03226418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5718334|NCT03226418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5718335|NCT03226522|Bupropion|bupropion|mesh-list
5718336|NCT03226522|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5964147|NCT04593706|Methylprednisolone|methylprednisolone|mesh-list
5964148|NCT04593706|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5964149|NCT04593706|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5964150|NCT04593706|Prednisolone|prednisolone|mesh-list
5964151|NCT04593706|Prednisolone acetate|prednisolone acetate|mesh-list
5964152|NCT04593706|Triamcinolone|triamcinolone|mesh-list
5964153|NCT04593706|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5964154|NCT04593706|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5964155|NCT04593706|Betamethasone|betamethasone|mesh-list
5964156|NCT04593706|Betamethasone Valerate|betamethasone valerate|mesh-list
5964157|NCT04593706|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5964158|NCT04593706|Betamethasone benzoate|betamethasone benzoate|mesh-list
5964159|NCT04593706|Dexamethasone acetate|dexamethasone acetate|mesh-list
5964160|NCT04593706|Betamethasone acetate|betamethasone acetate|mesh-list
5964161|NCT04593706|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5964162|NCT04593706|Prednisolone phosphate|prednisolone phosphate|mesh-list
5964163|NCT04593706|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
5964164|NCT04593706|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
5964165|NCT04593706|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5964166|NCT04593706|BB 1101|bb 1101|mesh-list
5964167|NCT04593706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5964168|NCT04593706|Antiemetics|antiemetics|mesh-ancestor
5964169|NCT04593706|Autonomic Agents|autonomic agents|mesh-ancestor
5964170|NCT04593706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5964171|NCT04593706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964172|NCT04593706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5920184|NCT04974853|Complement System Proteins|complement system proteins|mesh-list
5920185|NCT04974853|Immunologic Factors|immunologic factors|mesh-ancestor
5920186|NCT04974853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920187|NCT04974944|Paclitaxel|paclitaxel|mesh-list
5920188|NCT04974944|Bevacizumab|bevacizumab|mesh-list
5920189|NCT04974944|Carboplatin|carboplatin|mesh-list
5920190|NCT04974944|Apatinib|apatinib|mesh-list
5920191|NCT04974944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5920192|NCT04974944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5920193|NCT04974944|Tubulin Modulators|tubulin modulators|mesh-ancestor
5920194|NCT04974944|Antimitotic Agents|antimitotic agents|mesh-ancestor
5920195|NCT04974944|Mitosis Modulators|mitosis modulators|mesh-ancestor
5920196|NCT04974944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920197|NCT04974944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5920198|NCT04974944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5920199|NCT04974944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5920200|NCT04974944|Growth Substances|growth substances|mesh-ancestor
5920201|NCT04974944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920202|NCT04974944|Growth Inhibitors|growth inhibitors|mesh-ancestor
5920203|NCT04974944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5920204|NCT04974944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5920205|NCT04974580|Nicotine|nicotine|mesh-list
5920206|NCT04974580|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5920207|NCT04974580|Autonomic Agents|autonomic agents|mesh-ancestor
5920208|NCT04974580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5920209|NCT04974580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920210|NCT04974580|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5920211|NCT04974580|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5920212|NCT04974580|Cholinergic Agents|cholinergic agents|mesh-ancestor
5920213|NCT04974580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5920214|NCT04974580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920215|NCT04974814|Atorvastatin|atorvastatin|mesh-list
5920216|NCT04974814|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5920217|NCT04974814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5920218|NCT04974814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5920219|NCT04974814|Antimetabolites|antimetabolites|mesh-ancestor
5920220|NCT04974814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920221|NCT04974814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5920222|NCT04974814|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5920223|NCT04974814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5920224|NCT04974684|Apixaban|apixaban|mesh-list
5920225|NCT04974684|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5920226|NCT04974684|Antithrombins|antithrombins|mesh-ancestor
5920227|NCT04974684|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5920228|NCT04974684|Protease Inhibitors|protease inhibitors|mesh-ancestor
5920229|NCT04974684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5920230|NCT04974684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920231|NCT04974684|Anticoagulants|anticoagulants|mesh-ancestor
5920232|NCT04974281|Lenvatinib|lenvatinib|mesh-list
5920233|NCT04974281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5920234|NCT04974281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5920235|NCT04974281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5920236|NCT04974281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920237|NCT04974385|Bupivacaine|bupivacaine|mesh-list
5920238|NCT04974385|Anesthetics, Local|anesthetics, local|mesh-ancestor
5920239|NCT04974385|Anesthetics|anesthetics|mesh-ancestor
5920240|NCT04974385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5920241|NCT04974385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920242|NCT04974385|Sensory System Agents|sensory system agents|mesh-ancestor
5920243|NCT04974385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5920244|NCT04974294|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5920245|NCT04974294|Immunologic Factors|immunologic factors|mesh-ancestor
5920246|NCT04974294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920247|NCT04974398|Gemcitabine|gemcitabine|mesh-list
5920248|NCT04974398|Cisplatin|cisplatin|mesh-list
5920249|NCT04974398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5920250|NCT04974398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5920251|NCT04974398|Antimetabolites|antimetabolites|mesh-ancestor
5920252|NCT04974398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920253|NCT04974398|Antiviral Agents|antiviral agents|mesh-ancestor
5920254|NCT04974398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5920255|NCT04974398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5920256|NCT04974398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5920257|NCT04974398|Immunologic Factors|immunologic factors|mesh-ancestor
5920258|NCT04974398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920259|NCT04974151|Folic Acid|folic acid|mesh-list
5920260|NCT04974151|Vitamin B Complex|vitamin b complex|mesh-list
5920261|NCT04974151|Amlodipine|amlodipine|mesh-list
5920262|NCT04974151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5920263|NCT04974151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5920264|NCT04974151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5920265|NCT04974151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920266|NCT04974151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5920267|NCT04974151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920268|NCT04974151|Vasodilator Agents|vasodilator agents|mesh-ancestor
5920269|NCT04974151|Hematinics|hematinics|mesh-ancestor
5920270|NCT04974151|Vitamins|vitamins|mesh-ancestor
5920271|NCT04974151|Micronutrients|micronutrients|mesh-ancestor
5920272|NCT04974060|Remifentanil|remifentanil|mesh-list
5920273|NCT04974060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5920274|NCT04974060|Narcotics|narcotics|mesh-ancestor
5920275|NCT04974060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5920276|NCT04974060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920277|NCT04974060|Analgesics|analgesics|mesh-ancestor
5920278|NCT04974060|Sensory System Agents|sensory system agents|mesh-ancestor
5920279|NCT04974060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5920280|NCT04974138|Folic Acid|folic acid|mesh-list
5920281|NCT04974138|Amlodipine|amlodipine|mesh-list
5920282|NCT04974138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5920283|NCT04974138|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5920284|NCT04974138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5920285|NCT04974138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920286|NCT04974138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5920287|NCT04974138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920288|NCT04974138|Vasodilator Agents|vasodilator agents|mesh-ancestor
5920289|NCT04974138|Hematinics|hematinics|mesh-ancestor
5920290|NCT04974138|Vitamin B Complex|vitamin b complex|mesh-ancestor
5920291|NCT04974138|Vitamins|vitamins|mesh-ancestor
5920292|NCT04974138|Micronutrients|micronutrients|mesh-ancestor
5920293|NCT04973982|Tacrolimus|tacrolimus|mesh-list
5920294|NCT04973982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5920295|NCT04973982|Immunologic Factors|immunologic factors|mesh-ancestor
5920296|NCT04973982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920297|NCT04973982|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5920298|NCT04973982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5920299|NCT04973982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920300|NCT04973969|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5920301|NCT04973969|Luteolytic Agents|luteolytic agents|mesh-ancestor
5920302|NCT04973969|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5920303|NCT04973969|Contraceptive Agents|contraceptive agents|mesh-ancestor
5920304|NCT04973969|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5920305|NCT04973969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920306|NCT04973969|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5920307|NCT04973969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5920308|NCT04973969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5920309|NCT04973787|Antirheumatic Agents|antirheumatic agents|mesh-list
5920310|NCT04973904|Paclitaxel|paclitaxel|mesh-list
5920311|NCT04973904|Bevacizumab|bevacizumab|mesh-list
5920312|NCT04973904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5920313|NCT04973904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5920314|NCT04973904|Tubulin Modulators|tubulin modulators|mesh-ancestor
5920315|NCT04973904|Antimitotic Agents|antimitotic agents|mesh-ancestor
5920316|NCT04973904|Mitosis Modulators|mitosis modulators|mesh-ancestor
5920317|NCT04973904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920318|NCT04973904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5920319|NCT04973904|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5920320|NCT04973904|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5920321|NCT04973904|Growth Substances|growth substances|mesh-ancestor
5920322|NCT04973904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920323|NCT04973904|Growth Inhibitors|growth inhibitors|mesh-ancestor
5920324|NCT04973605|Dexamethasone|dexamethasone|mesh-list
5920325|NCT04973605|Dexamethasone acetate|dexamethasone acetate|mesh-list
5920326|NCT04973605|BB 1101|bb 1101|mesh-list
5920327|NCT04973605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5920328|NCT04973605|Antiemetics|antiemetics|mesh-ancestor
5920329|NCT04973605|Autonomic Agents|autonomic agents|mesh-ancestor
5920330|NCT04973605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5920331|NCT04973605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920332|NCT04973605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5920333|NCT04973605|Glucocorticoids|glucocorticoids|mesh-ancestor
5920334|NCT04973605|Hormones|hormones|mesh-ancestor
5964173|NCT04593706|Glucocorticoids|glucocorticoids|mesh-ancestor
5718337|NCT03226522|Antidepressive Agents|antidepressive agents|mesh-ancestor
5718338|NCT03226522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5718339|NCT03226522|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5718340|NCT03226522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5718341|NCT03226522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5718342|NCT03226522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718343|NCT03226522|Dopamine Agents|dopamine agents|mesh-ancestor
5718344|NCT03226522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5718345|NCT03226522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718346|NCT03226522|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5718347|NCT03226522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5718348|NCT03226522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5718349|NCT03226301|Venetoclax|venetoclax|mesh-list
5920335|NCT04973605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5920336|NCT04973605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5920337|NCT04973605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5920338|NCT04973605|Protease Inhibitors|protease inhibitors|mesh-ancestor
5920339|NCT04973605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5920340|NCT04973605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920341|NCT04973462|Oseltamivir|oseltamivir|mesh-list
5920342|NCT04973462|Antiviral Agents|antiviral agents|mesh-ancestor
5920343|NCT04973462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5920344|NCT04973462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5920345|NCT04973462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920346|NCT04973722|Denosumab|denosumab|mesh-list
5920347|NCT04973722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5920348|NCT04973722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920349|NCT04973579|Anesthetics|anesthetics|mesh-list
5920350|NCT04973579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5920351|NCT04973579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920352|NCT04973033|Tofacitinib|tofacitinib|mesh-list
5920353|NCT04973033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5920354|NCT04973033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5920355|NCT04973033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920356|NCT04973319|Trastuzumab|trastuzumab|mesh-list
5920357|NCT04973319|Pertuzumab|pertuzumab|mesh-list
5920358|NCT04973319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5920359|NCT04973319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5920360|NCT04973124|Dexmedetomidine|dexmedetomidine|mesh-list
5920361|NCT04973124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5920362|NCT04973124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5920363|NCT04973124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920364|NCT04973124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5920365|NCT04973124|Analgesics|analgesics|mesh-ancestor
5920366|NCT04973124|Sensory System Agents|sensory system agents|mesh-ancestor
5920367|NCT04973124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5920368|NCT04973124|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5920369|NCT04973124|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5920370|NCT04973124|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5920371|NCT04973124|Adrenergic Agents|adrenergic agents|mesh-ancestor
5920372|NCT04973124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5920373|NCT04973124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920374|NCT04972942|Daratumumab|daratumumab|mesh-list
5920375|NCT04972942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5920376|NCT04973293|Bevacizumab|bevacizumab|mesh-list
5920377|NCT04973293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5920378|NCT04973293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5920379|NCT04973293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5920380|NCT04973293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5920381|NCT04973293|Growth Substances|growth substances|mesh-ancestor
5964174|NCT04593706|Hormones|hormones|mesh-ancestor
5718350|NCT03226301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5718351|NCT03226340|Niacin|niacin|mesh-list
5718352|NCT03226340|Amlodipine|amlodipine|mesh-list
5718353|NCT03226340|Telmisartan|telmisartan|mesh-list
5718354|NCT03226340|Chlorthalidone|chlorthalidone|mesh-list
5718355|NCT03226340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5718356|NCT03226340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5718357|NCT03226340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5718358|NCT03226340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718359|NCT03226340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5718360|NCT03226340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718361|NCT03226340|Vasodilator Agents|vasodilator agents|mesh-ancestor
5920382|NCT04973293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920383|NCT04973293|Growth Inhibitors|growth inhibitors|mesh-ancestor
5920384|NCT04972656|Ambrisentan|ambrisentan|mesh-list
5920385|NCT04972656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5964175|NCT04593706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5964176|NCT04593706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5964177|NCT04593706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5964178|NCT04593706|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5964179|NCT04593706|Protective Agents|protective agents|mesh-ancestor
5964180|NCT04593706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5964181|NCT04593706|Immunologic Factors|immunologic factors|mesh-ancestor
5964182|NCT04593706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5964183|NCT04593706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964184|NCT04593706|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5964185|NCT04593706|Respiratory System Agents|respiratory system agents|mesh-ancestor
5964186|NCT04593706|Protease Inhibitors|protease inhibitors|mesh-ancestor
5964187|NCT04593758|Hydroxychloroquine|hydroxychloroquine|mesh-list
5964188|NCT04593758|Antimalarials|antimalarials|mesh-ancestor
5964189|NCT04593758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5964190|NCT04593758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5964191|NCT04593758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5964192|NCT04593758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5964193|NCT04593758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964194|NCT04593758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5964195|NCT04593836|Peppermint oil|peppermint oil|mesh-list
5964196|NCT04593836|Menthol|menthol|mesh-list
5964197|NCT04593836|Antipruritics|antipruritics|mesh-ancestor
5964198|NCT04593836|Dermatologic Agents|dermatologic agents|mesh-ancestor
5964199|NCT04593836|Antiemetics|antiemetics|mesh-ancestor
5964200|NCT04593836|Autonomic Agents|autonomic agents|mesh-ancestor
5964201|NCT04593836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5964202|NCT04593836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964203|NCT04593836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5718362|NCT03226340|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5718363|NCT03226340|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5718364|NCT03226340|Diuretics|diuretics|mesh-ancestor
5718365|NCT03226340|Natriuretic Agents|natriuretic agents|mesh-ancestor
5718366|NCT03226340|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5718367|NCT03226340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5718368|NCT03226340|Antimetabolites|antimetabolites|mesh-ancestor
5718369|NCT03226340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5718370|NCT03226340|Vitamin B Complex|vitamin b complex|mesh-ancestor
5718371|NCT03226340|Vitamins|vitamins|mesh-ancestor
5718372|NCT03226340|Micronutrients|micronutrients|mesh-ancestor
5964204|NCT04593836|Parasympatholytics|parasympatholytics|mesh-ancestor
5964205|NCT04593654|Dalteparin|dalteparin|mesh-list
5964206|NCT04593654|Tinzaparin|tinzaparin|mesh-list
5964207|NCT04593654|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5964208|NCT04593654|Anticoagulants|anticoagulants|mesh-ancestor
5964209|NCT04593654|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5964210|NCT04593654|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5964211|NCT04593654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964212|NCT04593238|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5964213|NCT04593238|Calcium|calcium|mesh-list
5964214|NCT04593238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5964215|NCT04593238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964216|NCT04593238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5964217|NCT04593524|Vitamin D|vitamin d|mesh-list
5964218|NCT04593524|Vitamins|vitamins|mesh-ancestor
5964219|NCT04593524|Micronutrients|micronutrients|mesh-ancestor
5964220|NCT04593524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964221|NCT04593524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5964222|NCT04593329|Dipyrone|dipyrone|mesh-list
5964223|NCT04593329|Tramadol|tramadol|mesh-list
5964224|NCT04593329|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5964225|NCT04593329|Narcotics|narcotics|mesh-ancestor
5964226|NCT04593329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5964227|NCT04593329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964228|NCT04593329|Analgesics|analgesics|mesh-ancestor
5964229|NCT04593329|Sensory System Agents|sensory system agents|mesh-ancestor
5964230|NCT04593329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5964231|NCT04593329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5964232|NCT04593329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5964233|NCT04593329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5964234|NCT04593329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5964235|NCT04593329|Antipyretics|antipyretics|mesh-ancestor
5964236|NCT04593446|Picosulfate sodium|picosulfate sodium|mesh-list
5920386|NCT04972383|Hyaluronic Acid|hyaluronic acid|mesh-list
5920387|NCT04972383|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5920388|NCT04972383|Immunologic Factors|immunologic factors|mesh-ancestor
5920389|NCT04972383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920390|NCT04972383|Viscosupplements|viscosupplements|mesh-ancestor
5920391|NCT04972383|Protective Agents|protective agents|mesh-ancestor
5920392|NCT04972617|Furosemide|furosemide|mesh-list
5920393|NCT04972617|Diuretics|diuretics|mesh-ancestor
5920394|NCT04972617|Natriuretic Agents|natriuretic agents|mesh-ancestor
5920395|NCT04972617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920396|NCT04972617|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5920397|NCT04972617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5920398|NCT04972617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920399|NCT04972292|Dipyrone|dipyrone|mesh-list
5920400|NCT04972292|Codeine|codeine|mesh-list
5920401|NCT04972292|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5920402|NCT04972292|Narcotics|narcotics|mesh-ancestor
5920403|NCT04972292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5920404|NCT04972292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920405|NCT04972292|Analgesics|analgesics|mesh-ancestor
5920406|NCT04972292|Sensory System Agents|sensory system agents|mesh-ancestor
5920407|NCT04972292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5920408|NCT04972292|Antitussive Agents|antitussive agents|mesh-ancestor
5920409|NCT04972292|Respiratory System Agents|respiratory system agents|mesh-ancestor
5920410|NCT04972292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5920411|NCT04972292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5920412|NCT04972292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5920413|NCT04972292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5920414|NCT04972292|Antipyretics|antipyretics|mesh-ancestor
5920415|NCT04972123|Phenylephrine|phenylephrine|mesh-list
5920416|NCT04972123|Oxymetazoline|oxymetazoline|mesh-list
5920417|NCT04972123|Caffeine|caffeine|mesh-list
5920418|NCT04972123|Capsaicin|capsaicin|mesh-list
5920419|NCT04972123|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5920420|NCT04972123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920421|NCT04972123|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5920422|NCT04972123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5920423|NCT04972123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920424|NCT04972123|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5920425|NCT04972123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5920426|NCT04972123|Purinergic Agents|purinergic agents|mesh-ancestor
5920427|NCT04972123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5920428|NCT04972123|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5920429|NCT04972123|Mydriatics|mydriatics|mesh-ancestor
5920430|NCT04972123|Autonomic Agents|autonomic agents|mesh-ancestor
5920431|NCT04972123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5920432|NCT04972123|Sympathomimetics|sympathomimetics|mesh-ancestor
5920433|NCT04972123|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5920434|NCT04972123|Nasal Decongestants|nasal decongestants|mesh-ancestor
5920435|NCT04972123|Respiratory System Agents|respiratory system agents|mesh-ancestor
5920436|NCT04972123|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5920437|NCT04972123|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5920438|NCT04972123|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5920439|NCT04972123|Adrenergic Agents|adrenergic agents|mesh-ancestor
5920440|NCT04972123|Protective Agents|protective agents|mesh-ancestor
5920441|NCT04972123|Antipruritics|antipruritics|mesh-ancestor
5920442|NCT04972123|Dermatologic Agents|dermatologic agents|mesh-ancestor
5920443|NCT04972123|Sensory System Agents|sensory system agents|mesh-ancestor
5920444|NCT04972513|Nitric Oxide|nitric oxide|mesh-list
5920445|NCT04972513|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5920446|NCT04972513|Autonomic Agents|autonomic agents|mesh-ancestor
5920447|NCT04972513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5920448|NCT04972513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920449|NCT04972513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5920450|NCT04972513|Respiratory System Agents|respiratory system agents|mesh-ancestor
5920451|NCT04972513|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5920452|NCT04972513|Antioxidants|antioxidants|mesh-ancestor
5920453|NCT04972513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920454|NCT04972513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5920455|NCT04972513|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5920456|NCT04972513|Vasodilator Agents|vasodilator agents|mesh-ancestor
5920457|NCT04972513|Gasotransmitters|gasotransmitters|mesh-ancestor
5920458|NCT04972513|Protective Agents|protective agents|mesh-ancestor
5920459|NCT04972552|Ubiquinone|ubiquinone|mesh-list
5920460|NCT04972552|Coenzyme Q10|coenzyme q10|mesh-list
5920461|NCT04972552|Micronutrients|micronutrients|mesh-ancestor
5964237|NCT04593446|Cathartics|cathartics|mesh-ancestor
5718373|NCT03226210|Insulin|insulin|mesh-list
5718374|NCT03226210|Insulin Aspart|insulin aspart|mesh-list
5718375|NCT03226210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5718376|NCT03226210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722119|NCT03201146|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5722120|NCT03201367|Rivaroxaban|rivaroxaban|mesh-list
5722121|NCT03201367|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5722122|NCT03201367|Antithrombins|antithrombins|mesh-ancestor
5722123|NCT03201367|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5920462|NCT04972552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920463|NCT04972552|Vitamins|vitamins|mesh-ancestor
5920464|NCT04972032|Estrogens|estrogens|mesh-list
5920465|NCT04972032|Hyaluronic Acid|hyaluronic acid|mesh-list
5920466|NCT04972032|Hormones|hormones|mesh-ancestor
5920467|NCT04972032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5920468|NCT04972032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920469|NCT04972032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5920470|NCT04972032|Immunologic Factors|immunologic factors|mesh-ancestor
5920471|NCT04972032|Viscosupplements|viscosupplements|mesh-ancestor
5920472|NCT04972032|Protective Agents|protective agents|mesh-ancestor
5920473|NCT04972045|Curcumin|curcumin|mesh-list
5920474|NCT04972045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5920475|NCT04972045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5920476|NCT04972045|Analgesics|analgesics|mesh-ancestor
5920477|NCT04972045|Sensory System Agents|sensory system agents|mesh-ancestor
5920478|NCT04972045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5920479|NCT04972045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920480|NCT04972045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5920481|NCT04972045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5920482|NCT04972045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5920483|NCT04972045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5920484|NCT04972045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920485|NCT04971759|Fentanyl|fentanyl|mesh-list
5920486|NCT04971759|Dexmedetomidine|dexmedetomidine|mesh-list
5920487|NCT04971759|Levobupivacaine|levobupivacaine|mesh-list
5920488|NCT04971759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5920489|NCT04971759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5920490|NCT04971759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920491|NCT04971759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5920492|NCT04971759|Analgesics|analgesics|mesh-ancestor
5920493|NCT04971759|Sensory System Agents|sensory system agents|mesh-ancestor
5920494|NCT04971759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5920495|NCT04971759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5920496|NCT04971759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5920497|NCT04971759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5920498|NCT04971759|Adrenergic Agents|adrenergic agents|mesh-ancestor
5920499|NCT04971759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5920500|NCT04971759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920501|NCT04971759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5920502|NCT04971759|Narcotics|narcotics|mesh-ancestor
5920503|NCT04971759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5920504|NCT04971759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5920505|NCT04971759|Anesthetics, General|anesthetics, general|mesh-ancestor
5920506|NCT04971759|Anesthetics|anesthetics|mesh-ancestor
5920507|NCT04971759|Anesthetics, Local|anesthetics, local|mesh-ancestor
5920508|NCT04971343|Antibodies|antibodies|mesh-list
5920509|NCT04971343|Immunoglobulins|immunoglobulins|mesh-list
5920510|NCT04971343|Immunologic Factors|immunologic factors|mesh-ancestor
5920511|NCT04971343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920512|NCT04971356|Aspirin|aspirin|mesh-list
5920513|NCT04971356|Ticagrelor|ticagrelor|mesh-list
5920514|NCT04971356|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5920515|NCT04971356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5920516|NCT04971356|Analgesics|analgesics|mesh-ancestor
5920517|NCT04971356|Sensory System Agents|sensory system agents|mesh-ancestor
5920518|NCT04971356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5920519|NCT04971356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920520|NCT04971356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5920521|NCT04971356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5920522|NCT04971356|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5920523|NCT04971356|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5920524|NCT04971356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920525|NCT04971356|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5920526|NCT04971356|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5920527|NCT04971356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5722124|NCT03201367|Protease Inhibitors|protease inhibitors|mesh-ancestor
5722125|NCT03201367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5920528|NCT04971356|Antipyretics|antipyretics|mesh-ancestor
5920529|NCT04971356|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5920530|NCT04971356|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5920531|NCT04971356|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5920532|NCT04971356|Purinergic Agents|purinergic agents|mesh-ancestor
5920533|NCT04971356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5920534|NCT04971382|Curcumin|curcumin|mesh-list
5920535|NCT04971382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5920536|NCT04971382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5920537|NCT04971382|Analgesics|analgesics|mesh-ancestor
5920538|NCT04971382|Sensory System Agents|sensory system agents|mesh-ancestor
5920539|NCT04971382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5920540|NCT04971382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920541|NCT04971382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5920542|NCT04971382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5920543|NCT04971382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5920544|NCT04971382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5920545|NCT04971382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920546|NCT04971577|Simvastatin|simvastatin|mesh-list
5920547|NCT04971577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5920548|NCT04971577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5920549|NCT04971577|Antimetabolites|antimetabolites|mesh-ancestor
5920550|NCT04971577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920551|NCT04971577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5920552|NCT04971577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5920553|NCT04971577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5920554|NCT04971304|Sargramostim|sargramostim|mesh-list
5920555|NCT04971304|Lenograstim|lenograstim|mesh-list
5920556|NCT04971304|Immunologic Factors|immunologic factors|mesh-ancestor
5920557|NCT04971304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920558|NCT04971304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5920559|NCT04971291|Bupropion|bupropion|mesh-list
5920560|NCT04971291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5920561|NCT04971291|Antidepressive Agents|antidepressive agents|mesh-ancestor
5920562|NCT04971291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5920563|NCT04971291|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5920564|NCT04971291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5920565|NCT04971291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5920566|NCT04971291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920567|NCT04971291|Dopamine Agents|dopamine agents|mesh-ancestor
5920568|NCT04971291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5920569|NCT04971291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920570|NCT04971291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5920571|NCT04971291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5920572|NCT04971291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5920573|NCT04971005|Alemtuzumab|alemtuzumab|mesh-list
5920574|NCT04971005|Ocrelizumab|ocrelizumab|mesh-list
5920575|NCT04971005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5920576|NCT04971005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5920577|NCT04971005|Immunologic Factors|immunologic factors|mesh-ancestor
5920578|NCT04971005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920579|NCT04971239|Methotrexate|methotrexate|mesh-list
5920580|NCT04971239|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5920581|NCT04971239|Abortifacient Agents|abortifacient agents|mesh-ancestor
5920582|NCT04971239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5920583|NCT04971239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920584|NCT04971239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5920585|NCT04971239|Antimetabolites|antimetabolites|mesh-ancestor
5920586|NCT04971239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920587|NCT04971239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5920588|NCT04971239|Dermatologic Agents|dermatologic agents|mesh-ancestor
5920589|NCT04971239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5920590|NCT04971239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5920591|NCT04971239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5920592|NCT04971239|Immunologic Factors|immunologic factors|mesh-ancestor
5920593|NCT04971239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5920594|NCT04971239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5964238|NCT04593446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5964239|NCT04593459|Metformin|metformin|mesh-list
5964240|NCT04593459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5964241|NCT04593459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964242|NCT04593160|Acetaminophen|acetaminophen|mesh-list
5964243|NCT04593160|Diclofenac|diclofenac|mesh-list
5920595|NCT04970719|Remdesivir|remdesivir|mesh-list
5920596|NCT04970719|Dexamethasone|dexamethasone|mesh-list
5920597|NCT04970719|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
5718377|NCT03225937|Trastuzumab|trastuzumab|mesh-list
5718378|NCT03225937|Pertuzumab|pertuzumab|mesh-list
5718379|NCT03225937|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
5718380|NCT03225937|Lapatinib|lapatinib|mesh-list
5718381|NCT03225937|Maytansine|maytansine|mesh-list
5718382|NCT03225937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5718383|NCT03225937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5718384|NCT03225937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5718385|NCT03225937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5718386|NCT03225937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718387|NCT03225937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5718388|NCT03225937|Tubulin Modulators|tubulin modulators|mesh-ancestor
5718389|NCT03225937|Antimitotic Agents|antimitotic agents|mesh-ancestor
5718390|NCT03225937|Mitosis Modulators|mitosis modulators|mesh-ancestor
5718391|NCT03226080|Rocuronium|rocuronium|mesh-list
5718392|NCT03226080|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5718393|NCT03226080|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5920598|NCT04970719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5920599|NCT04970719|Antiemetics|antiemetics|mesh-ancestor
5920600|NCT04970719|Autonomic Agents|autonomic agents|mesh-ancestor
5920601|NCT04970719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5920602|NCT04970719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920603|NCT04970719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5920604|NCT04970719|Glucocorticoids|glucocorticoids|mesh-ancestor
5920605|NCT04970719|Hormones|hormones|mesh-ancestor
5920606|NCT04970719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5920607|NCT04970719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5920608|NCT04970719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5920609|NCT04970719|Antimetabolites|antimetabolites|mesh-ancestor
5920610|NCT04970719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920611|NCT04970719|Antiviral Agents|antiviral agents|mesh-ancestor
5920612|NCT04970719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5920613|NCT04970719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5920614|NCT04970719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5920615|NCT04970576|Warfarin|warfarin|mesh-list
5920616|NCT04970576|Rivaroxaban|rivaroxaban|mesh-list
5920617|NCT04970576|Anticoagulants|anticoagulants|mesh-ancestor
5920618|NCT04970576|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5920619|NCT04970576|Antithrombins|antithrombins|mesh-ancestor
5920620|NCT04970576|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5920621|NCT04970576|Protease Inhibitors|protease inhibitors|mesh-ancestor
5920622|NCT04970576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5920623|NCT04970576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920624|NCT04970667|Flupenthixol|flupenthixol|mesh-list
5920625|NCT04970667|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
5920626|NCT04970667|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5920627|NCT04970667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5920628|NCT04970667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5920629|NCT04970667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920630|NCT04970667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5920631|NCT04970667|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5920632|NCT04970667|Dopamine Agents|dopamine agents|mesh-ancestor
5920633|NCT04970667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5920634|NCT04970667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920635|NCT04970602|Methylene Blue|methylene blue|mesh-list
5920636|NCT04970602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5920637|NCT04970602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920638|NCT04970446|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5920639|NCT04970446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5920640|NCT04970251|Aflibercept|aflibercept|mesh-list
5920641|NCT04970251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5920642|NCT04970251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5920643|NCT04970251|Growth Substances|growth substances|mesh-ancestor
5920644|NCT04970251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920645|NCT04970251|Growth Inhibitors|growth inhibitors|mesh-ancestor
5920646|NCT04970251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5920647|NCT04970069|Analgesics|analgesics|mesh-list
5920648|NCT04970069|Sensory System Agents|sensory system agents|mesh-ancestor
5920649|NCT04970069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5920650|NCT04970069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920651|NCT04970303|Methylphenidate|methylphenidate|mesh-list
5718394|NCT03226080|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5920652|NCT04970303|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5920653|NCT04970303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920654|NCT04970303|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5920655|NCT04970303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5920656|NCT04970303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5920657|NCT04970303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920658|NCT04970303|Dopamine Agents|dopamine agents|mesh-ancestor
5920659|NCT04970303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5920660|NCT04970108|Empagliflozin|empagliflozin|mesh-list
5920661|NCT04970108|Telmisartan|telmisartan|mesh-list
5920662|NCT04970108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5920663|NCT04970108|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5920664|NCT04970108|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5920665|NCT04970108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920666|NCT04970108|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5920667|NCT04970108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5920668|NCT04970108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920669|NCT04970121|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5920670|NCT04970121|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5920671|NCT04970121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5920672|NCT04970121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5920673|NCT04970121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920674|NCT04970121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5920675|NCT04970121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920676|NCT04970121|Analgesics|analgesics|mesh-ancestor
5920677|NCT04970121|Sensory System Agents|sensory system agents|mesh-ancestor
5920678|NCT04970121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5920679|NCT04970121|Antidepressive Agents|antidepressive agents|mesh-ancestor
5920680|NCT04970121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5920681|NCT04970121|Dopamine Agents|dopamine agents|mesh-ancestor
5920682|NCT04970329|Dextrans|dextrans|mesh-list
5920683|NCT04970329|Anticoagulants|anticoagulants|mesh-ancestor
5920684|NCT04970329|Plasma Substitutes|plasma substitutes|mesh-ancestor
5920685|NCT04970329|Blood Substitutes|blood substitutes|mesh-ancestor
5920686|NCT04970238|Simendan|simendan|mesh-list
5920687|NCT04970238|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5920688|NCT04970238|Vasodilator Agents|vasodilator agents|mesh-ancestor
5920689|NCT04970238|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5920690|NCT04970238|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5920691|NCT04970238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5920692|NCT04970238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920693|NCT04970238|Protective Agents|protective agents|mesh-ancestor
5920694|NCT04970238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920695|NCT04970342|Alprazolam|alprazolam|mesh-list
5920696|NCT04970342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920697|NCT04970342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5920698|NCT04970342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5920699|NCT04970342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920700|NCT04970342|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5920701|NCT04970342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5920702|NCT04970342|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5920703|NCT04970342|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5920704|NCT04970342|GABA Modulators|gaba modulators|mesh-ancestor
5718395|NCT03226080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5718396|NCT03226080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718397|NCT03225963|Temozolomide|temozolomide|mesh-list
5718398|NCT03225963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5718399|NCT03225963|Alkylating Agents|alkylating agents|mesh-ancestor
5718400|NCT03225963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718401|NCT03225963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5718402|NCT03225924|Prednisone|prednisone|mesh-list
5920705|NCT04970342|GABA Agents|gaba agents|mesh-ancestor
5920706|NCT04970381|Rivaroxaban|rivaroxaban|mesh-list
5920707|NCT04970381|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5920708|NCT04970381|Antithrombins|antithrombins|mesh-ancestor
5920709|NCT04970381|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5920710|NCT04970381|Protease Inhibitors|protease inhibitors|mesh-ancestor
5920711|NCT04970381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5920712|NCT04970381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920713|NCT04970381|Anticoagulants|anticoagulants|mesh-ancestor
5920714|NCT04969991|Varespladib methyl|varespladib methyl|mesh-list
5920715|NCT04969991|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
5920716|NCT04969991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5920717|NCT04969991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920718|NCT04970043|Pemetrexed|pemetrexed|mesh-list
5920719|NCT04970043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5920720|NCT04970043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5920721|NCT04970043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920722|NCT04970043|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5920723|NCT04970043|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5920724|NCT04969705|Dexmedetomidine|dexmedetomidine|mesh-list
5920725|NCT04969705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5920726|NCT04969705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5920727|NCT04969705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920728|NCT04969705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5920729|NCT04969705|Analgesics|analgesics|mesh-ancestor
5920730|NCT04969705|Sensory System Agents|sensory system agents|mesh-ancestor
5920731|NCT04969705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5920732|NCT04969705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5920733|NCT04969705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5920734|NCT04969705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5920735|NCT04969705|Adrenergic Agents|adrenergic agents|mesh-ancestor
5920736|NCT04969705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5920737|NCT04969705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920738|NCT04969627|Metformin|metformin|mesh-list
5920739|NCT04969627|Exenatide|exenatide|mesh-list
5920740|NCT04969627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5920741|NCT04969627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920742|NCT04969627|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5920743|NCT04969627|Incretins|incretins|mesh-ancestor
5920744|NCT04969627|Hormones|hormones|mesh-ancestor
5920745|NCT04969627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5920746|NCT04969263|Vaccines|vaccines|mesh-list
5920747|NCT04969263|Immunologic Factors|immunologic factors|mesh-ancestor
5718403|NCT03225924|Cyclophosphamide|cyclophosphamide|mesh-list
5718404|NCT03225924|Rituximab|rituximab|mesh-list
5718405|NCT03225924|Doxorubicin|doxorubicin|mesh-list
5718406|NCT03225924|Vincristine|vincristine|mesh-list
5718407|NCT03225924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5718408|NCT03225924|Immunologic Factors|immunologic factors|mesh-ancestor
5718409|NCT03225924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516967|NCT00719095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6516968|NCT00719095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920748|NCT04969263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920749|NCT04969237|Vitamin D|vitamin d|mesh-list
5920750|NCT04969237|Vitamins|vitamins|mesh-ancestor
5920751|NCT04969237|Micronutrients|micronutrients|mesh-ancestor
5920752|NCT04969237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920753|NCT04969237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5920754|NCT04969211|Iloperidone|iloperidone|mesh-list
5920755|NCT04969211|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5920756|NCT04969211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5920757|NCT04969211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5920758|NCT04969211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920759|NCT04969211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5920760|NCT04969276|Vaccines|vaccines|mesh-list
5920761|NCT04969276|Immunologic Factors|immunologic factors|mesh-ancestor
5920762|NCT04969276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920763|NCT04969497|Zolmitriptan|zolmitriptan|mesh-list
5920764|NCT04969497|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5920765|NCT04969497|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5920766|NCT04969497|Serotonin Agents|serotonin agents|mesh-ancestor
5920767|NCT04969497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5920768|NCT04969497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920769|NCT04969497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920770|NCT04969133|Levobupivacaine|levobupivacaine|mesh-list
5920771|NCT04969133|Anesthetics, Local|anesthetics, local|mesh-ancestor
5920772|NCT04969133|Anesthetics|anesthetics|mesh-ancestor
5920773|NCT04969133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5920774|NCT04969133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920775|NCT04969133|Sensory System Agents|sensory system agents|mesh-ancestor
5920776|NCT04969133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5964244|NCT04593160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5964245|NCT04593160|Analgesics|analgesics|mesh-ancestor
5964246|NCT04593160|Sensory System Agents|sensory system agents|mesh-ancestor
5964247|NCT04593160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5718410|NCT03225924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5964248|NCT04593160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920777|NCT04968587|Dialysis Solutions|dialysis solutions|mesh-list
5920778|NCT04968587|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5920779|NCT04968613|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
5920780|NCT04968613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5920781|NCT04968613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920782|NCT04968613|Dopamine Agents|dopamine agents|mesh-ancestor
5920783|NCT04968613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5920784|NCT04968613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920785|NCT04968392|Dexmedetomidine|dexmedetomidine|mesh-list
5920786|NCT04968392|Levobupivacaine|levobupivacaine|mesh-list
5920787|NCT04968392|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5920788|NCT04968392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5920789|NCT04968392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920790|NCT04968392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5920791|NCT04968392|Analgesics|analgesics|mesh-ancestor
5920792|NCT04968392|Sensory System Agents|sensory system agents|mesh-ancestor
5920793|NCT04968392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5920794|NCT04968392|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5920795|NCT04968392|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5920796|NCT04968392|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5920797|NCT04968392|Adrenergic Agents|adrenergic agents|mesh-ancestor
5920798|NCT04968392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5920799|NCT04968392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920800|NCT04968392|Anesthetics, Local|anesthetics, local|mesh-ancestor
5920801|NCT04968392|Anesthetics|anesthetics|mesh-ancestor
5920802|NCT04968522|Methylphenidate|methylphenidate|mesh-list
5920803|NCT04968522|Dextroamphetamine|dextroamphetamine|mesh-list
5920804|NCT04968522|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5920805|NCT04968522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920806|NCT04968522|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5920807|NCT04968522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5920808|NCT04968522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5920809|NCT04968522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920810|NCT04968522|Dopamine Agents|dopamine agents|mesh-ancestor
5920811|NCT04968522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5920812|NCT04968509|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
5920813|NCT04968509|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5920814|NCT04968509|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5920815|NCT04968509|Antimetabolites|antimetabolites|mesh-ancestor
5920816|NCT04968509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920817|NCT04968509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5920818|NCT04968509|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5920819|NCT04968132|Analgesics, Opioid|analgesics, opioid|mesh-list
5920820|NCT04968132|Narcotics|narcotics|mesh-ancestor
5920821|NCT04968132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5920822|NCT04968132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920823|NCT04968132|Analgesics|analgesics|mesh-ancestor
5920824|NCT04968132|Sensory System Agents|sensory system agents|mesh-ancestor
5920825|NCT04968132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5920826|NCT04968002|Apatinib|apatinib|mesh-list
5920827|NCT04968002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5920828|NCT04968002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5920829|NCT04968002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5920830|NCT04968002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920831|NCT04967859|Gentamicins|gentamicins|mesh-list
5920832|NCT04967859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5920833|NCT04967859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5920834|NCT04967859|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5920835|NCT04967859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5920836|NCT04967859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920837|NCT04968054|Propofol|propofol|mesh-list
5920838|NCT04968054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5920839|NCT04968054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5920840|NCT04968054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718411|NCT03225924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5718412|NCT03225924|Alkylating Agents|alkylating agents|mesh-ancestor
5718413|NCT03225924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718414|NCT03225924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5718415|NCT03225924|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5718416|NCT03225924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5718417|NCT03225924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5718418|NCT03225924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5920841|NCT04968054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5920842|NCT04968054|Anesthetics, General|anesthetics, general|mesh-ancestor
5920843|NCT04968054|Anesthetics|anesthetics|mesh-ancestor
5920844|NCT04967469|Calcitriol|calcitriol|mesh-list
5920845|NCT04967469|Alfacalcidol|alfacalcidol|mesh-list
5920846|NCT04967469|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
5920847|NCT04967469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5920848|NCT04967469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920849|NCT04967469|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
5920850|NCT04967469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5920851|NCT04967469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920852|NCT04967469|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5920853|NCT04967469|Vitamins|vitamins|mesh-ancestor
5920854|NCT04967469|Micronutrients|micronutrients|mesh-ancestor
5920855|NCT04967469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5920856|NCT04967950|Methotrexate|methotrexate|mesh-list
5920857|NCT04967950|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5920858|NCT04967950|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5920859|NCT04967950|Abortifacient Agents|abortifacient agents|mesh-ancestor
5920860|NCT04967950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5920861|NCT04967950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920862|NCT04967950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5920863|NCT04967950|Antimetabolites|antimetabolites|mesh-ancestor
5920864|NCT04967950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920865|NCT04967950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5920866|NCT04967950|Dermatologic Agents|dermatologic agents|mesh-ancestor
5920867|NCT04967950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5920868|NCT04967950|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5920869|NCT04967950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5920870|NCT04967950|Immunologic Factors|immunologic factors|mesh-ancestor
5920871|NCT04967950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5920872|NCT04967950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5920873|NCT04967326|Carbamazepine|carbamazepine|mesh-list
5920874|NCT04967326|Phenytoin|phenytoin|mesh-list
5920875|NCT04967326|Valproic Acid|valproic acid|mesh-list
5920876|NCT04967326|Anticonvulsants|anticonvulsants|mesh-list
5920877|NCT04967326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5920878|NCT04967326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920879|NCT04967326|GABA Agents|gaba agents|mesh-ancestor
5920880|NCT04967326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5920881|NCT04967326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920882|NCT04967326|Antimanic Agents|antimanic agents|mesh-ancestor
5920883|NCT04967326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5920884|NCT04967326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5920885|NCT04967326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5920886|NCT04967326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5920887|NCT04967326|Analgesics|analgesics|mesh-ancestor
5920888|NCT04967326|Sensory System Agents|sensory system agents|mesh-ancestor
5920889|NCT04967326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5920890|NCT04967326|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5920891|NCT04967326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5920892|NCT04967326|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5920893|NCT04967326|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5920894|NCT04967326|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5920895|NCT04967326|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5920896|NCT04967417|Paclitaxel|paclitaxel|mesh-list
5920897|NCT04967417|Carboplatin|carboplatin|mesh-list
5920898|NCT04967417|Pembrolizumab|pembrolizumab|mesh-list
5920899|NCT04967417|Pemetrexed|pemetrexed|mesh-list
5920900|NCT04967417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5920901|NCT04967417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5920902|NCT04967417|Tubulin Modulators|tubulin modulators|mesh-ancestor
5920903|NCT04967417|Antimitotic Agents|antimitotic agents|mesh-ancestor
5920904|NCT04967417|Mitosis Modulators|mitosis modulators|mesh-ancestor
5920905|NCT04967417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920906|NCT04967417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5920907|NCT04967417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5920908|NCT04967417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5920909|NCT04967417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5920910|NCT04967196|Nivolumab|nivolumab|mesh-list
5920911|NCT04967196|Ipilimumab|ipilimumab|mesh-list
5920912|NCT04967196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5920913|NCT04967196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5920914|NCT04967196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5920915|NCT04967196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920916|NCT04967378|Psychotropic Drugs|psychotropic drugs|mesh-list
5920917|NCT04967157|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
5920918|NCT04967157|Nootropic Agents|nootropic agents|mesh-ancestor
5964249|NCT04593160|Antipyretics|antipyretics|mesh-ancestor
5964250|NCT04593160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5964251|NCT04593160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5964252|NCT04593160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5964253|NCT04593160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5964254|NCT04593160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5964255|NCT04593160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964256|NCT04593108|Letrozole|letrozole|mesh-list
5964257|NCT04593108|Misoprostol|misoprostol|mesh-list
5964258|NCT04593108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5964259|NCT04593108|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5964260|NCT04593108|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5964261|NCT04593108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5964262|NCT04593108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964263|NCT04593108|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5964264|NCT04593108|Hormone Antagonists|hormone antagonists|mesh-ancestor
5964265|NCT04593108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5964266|NCT04593108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964267|NCT04593108|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5964268|NCT04593108|Abortifacient Agents|abortifacient agents|mesh-ancestor
5964269|NCT04593108|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5964270|NCT04593108|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5964271|NCT04593108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5964272|NCT04593108|Oxytocics|oxytocics|mesh-ancestor
5964273|NCT04592952|Calcitonin|calcitonin|mesh-list
5964274|NCT04592952|Salmon calcitonin|salmon calcitonin|mesh-list
5964275|NCT04592952|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
5964276|NCT04592952|Erenumab|erenumab|mesh-list
5964277|NCT04592952|Katacalcin|katacalcin|mesh-list
5964278|NCT04592952|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
5964279|NCT04592952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964280|NCT04592952|Analgesics|analgesics|mesh-ancestor
5964281|NCT04592952|Sensory System Agents|sensory system agents|mesh-ancestor
5964282|NCT04592952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5964283|NCT04592952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964284|NCT04592952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5964285|NCT04592952|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5964286|NCT04592952|Vasodilator Agents|vasodilator agents|mesh-ancestor
5964287|NCT04593030|Warfarin|warfarin|mesh-list
5964288|NCT04593030|Apixaban|apixaban|mesh-list
5964289|NCT04593030|Anticoagulants|anticoagulants|mesh-ancestor
5964290|NCT04593030|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5964291|NCT04593030|Antithrombins|antithrombins|mesh-ancestor
5964292|NCT04593030|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5964293|NCT04593030|Protease Inhibitors|protease inhibitors|mesh-ancestor
5964294|NCT04593030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5964295|NCT04593030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964296|NCT04592991|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
5964297|NCT04592991|Chelating Agents|chelating agents|mesh-ancestor
5964298|NCT04592991|Sequestering Agents|sequestering agents|mesh-ancestor
5964299|NCT04592991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970638|NCT04533867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5970639|NCT04533867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970640|NCT04533867|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5970641|NCT04533867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5970642|NCT04533867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5970643|NCT04533867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5970644|NCT04533867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5970645|NCT04533867|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5970646|NCT04533685|Vaccines|vaccines|mesh-list
5970647|NCT04533685|Immunologic Factors|immunologic factors|mesh-ancestor
5970648|NCT04533685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970649|NCT04533906|Povidone-Iodine|povidone-iodine|mesh-list
5970650|NCT04533906|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5970651|NCT04533906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5970652|NCT04533347|Tafenoquine|tafenoquine|mesh-list
5970653|NCT04533347|Antimalarials|antimalarials|mesh-ancestor
5970654|NCT04533347|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5970655|NCT04533347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5970656|NCT04533347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5970657|NCT04533243|Fentanyl|fentanyl|mesh-list
5920919|NCT04967495|Sorafenib|sorafenib|mesh-list
5920920|NCT04967495|Chlorotrianisene|chlorotrianisene|mesh-list
5920921|NCT04967495|Lenvatinib|lenvatinib|mesh-list
5920922|NCT04967495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5920923|NCT04967495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5920924|NCT04967495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5920925|NCT04967495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920926|NCT04967495|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
5920927|NCT04967495|Estrogens|estrogens|mesh-ancestor
5920928|NCT04967495|Hormones|hormones|mesh-ancestor
5920929|NCT04967495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5920930|NCT04967495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920931|NCT04967495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5920932|NCT04966702|Ivermectin|ivermectin|mesh-list
5920933|NCT04966702|Albendazole|albendazole|mesh-list
5920934|NCT04966702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5920935|NCT04966702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5920936|NCT04966702|Anthelmintics|anthelmintics|mesh-ancestor
5920937|NCT04966702|Anticestodal Agents|anticestodal agents|mesh-ancestor
5920938|NCT04966702|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5920939|NCT04966702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5920940|NCT04966702|Tubulin Modulators|tubulin modulators|mesh-ancestor
5920941|NCT04966702|Antimitotic Agents|antimitotic agents|mesh-ancestor
5920942|NCT04966702|Mitosis Modulators|mitosis modulators|mesh-ancestor
5920943|NCT04966702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920944|NCT04966702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5920945|NCT04966676|Nivolumab|nivolumab|mesh-list
5920946|NCT04966676|Ipilimumab|ipilimumab|mesh-list
5920947|NCT04966676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5920948|NCT04966676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5920949|NCT04966676|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5920950|NCT04966676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920951|NCT04966845|Carbon Monoxide|carbon monoxide|mesh-list
5920952|NCT04966845|Antimetabolites|antimetabolites|mesh-ancestor
5920953|NCT04966845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920954|NCT04966845|Gasotransmitters|gasotransmitters|mesh-ancestor
5920955|NCT04966845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5920956|NCT04966845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920957|NCT04966884|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
5920958|NCT04966884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5920959|NCT04966884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5920960|NCT04966884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920961|NCT04966585|Posaconazole|posaconazole|mesh-list
5920962|NCT04966585|Antifungal Agents|antifungal agents|mesh-ancestor
5920963|NCT04966585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5920964|NCT04966585|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5920965|NCT04966585|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5920966|NCT04966585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5920967|NCT04966585|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5920968|NCT04966585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5920969|NCT04966585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5920970|NCT04966585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920971|NCT04966585|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5920972|NCT04966585|Hormone Antagonists|hormone antagonists|mesh-ancestor
5920973|NCT04966585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5920974|NCT04966585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920975|NCT04966546|Memantine|memantine|mesh-list
5920976|NCT04966546|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5920977|NCT04966546|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5920978|NCT04966546|Dopamine Agents|dopamine agents|mesh-ancestor
5920979|NCT04966546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5920980|NCT04966546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5920981|NCT04966546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920982|NCT04966546|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5920983|NCT04966546|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5920984|NCT04966507|Listerine|listerine|mesh-list
5920985|NCT04966507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
5920986|NCT04966507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5920987|NCT04966338|Ocrelizumab|ocrelizumab|mesh-list
5920988|NCT04966338|Immunologic Factors|immunologic factors|mesh-ancestor
5920989|NCT04966338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5920990|NCT04966299|Erythritol|erythritol|mesh-list
5920991|NCT04966299|Vasodilator Agents|vasodilator agents|mesh-ancestor
5920992|NCT04966234|Posaconazole|posaconazole|mesh-list
5920993|NCT04966234|Antifungal Agents|antifungal agents|mesh-ancestor
5920994|NCT04966234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5920995|NCT04966234|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5920996|NCT04966234|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5920997|NCT04966234|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5920998|NCT04966234|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5920999|NCT04966234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5921000|NCT04966234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5921001|NCT04966234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921002|NCT04966234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5921003|NCT04966234|Hormone Antagonists|hormone antagonists|mesh-ancestor
5921004|NCT04966234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5921005|NCT04966234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921006|NCT04966429|Maraviroc|maraviroc|mesh-list
5921007|NCT04966429|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5921008|NCT04966429|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5921009|NCT04966429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921010|NCT04966429|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5921011|NCT04966429|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5921012|NCT04966429|Antiviral Agents|antiviral agents|mesh-ancestor
5921013|NCT04966429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5921014|NCT04966429|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
5921015|NCT04965870|Trifluridine|trifluridine|mesh-list
5921016|NCT04965870|Antimetabolites|antimetabolites|mesh-ancestor
5921017|NCT04965870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921018|NCT04965870|Antiviral Agents|antiviral agents|mesh-ancestor
5921019|NCT04965870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5921020|NCT04965818|Futibatinib|futibatinib|mesh-list
5921021|NCT04965818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5921022|NCT04965831|Aflutinib|aflutinib|mesh-list
5921023|NCT04965831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5921024|NCT04965831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5921025|NCT04965831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921026|NCT04965545|Copper|copper|mesh-list
5921027|NCT04965545|Trace Elements|trace elements|mesh-ancestor
5921028|NCT04965545|Micronutrients|micronutrients|mesh-ancestor
5921029|NCT04965545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921030|NCT04965532|Anesthetics|anesthetics|mesh-list
5921031|NCT04965532|Propofol|propofol|mesh-list
5921032|NCT04965532|Sevoflurane|sevoflurane|mesh-list
5921033|NCT04965532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5921034|NCT04965532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921035|NCT04965532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5921036|NCT04965532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5921037|NCT04965532|Anesthetics, General|anesthetics, general|mesh-ancestor
5921038|NCT04965532|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5718419|NCT03225924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5718420|NCT03225924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5718421|NCT03225924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5718422|NCT03225924|Glucocorticoids|glucocorticoids|mesh-ancestor
5718423|NCT03225924|Hormones|hormones|mesh-ancestor
5718424|NCT03225924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5718425|NCT03225924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5921039|NCT04965532|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5921040|NCT04965714|Nivolumab|nivolumab|mesh-list
5921041|NCT04965714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5921042|NCT04965714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5718426|NCT03225924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5718427|NCT03225924|Tubulin Modulators|tubulin modulators|mesh-ancestor
5718428|NCT03225924|Antimitotic Agents|antimitotic agents|mesh-ancestor
5718429|NCT03225924|Mitosis Modulators|mitosis modulators|mesh-ancestor
6516969|NCT00719095|Analgesics|analgesics|mesh-ancestor
6516970|NCT00719095|Sensory System Agents|sensory system agents|mesh-ancestor
6516971|NCT00719095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6516972|NCT00719095|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6516973|NCT00719095|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6516974|NCT00719108|Insulin|insulin|mesh-list
6516975|NCT00719108|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6516976|NCT00719108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6516977|NCT00719108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516978|NCT00719121|Adapalene|adapalene|mesh-list
6516979|NCT00719121|R 115866|r 115866|mesh-list
5718430|NCT03226145|Scopolamine|scopolamine|mesh-list
5921043|NCT04965714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6516980|NCT00719121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5921044|NCT04965714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921045|NCT04965766|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
5921046|NCT04965766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5921047|NCT04965766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5921048|NCT04965701|Osimertinib|osimertinib|mesh-list
5921049|NCT04965701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5921050|NCT04965701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5921051|NCT04965701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5921052|NCT04965701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921053|NCT04965662|Tenofovir|tenofovir|mesh-list
5921054|NCT04965662|Emtricitabine|emtricitabine|mesh-list
5921055|NCT04965662|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5921056|NCT04965662|Maraviroc|maraviroc|mesh-list
5921057|NCT04965662|Antiviral Agents|antiviral agents|mesh-ancestor
5921058|NCT04965662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5921059|NCT04965662|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5921060|NCT04965662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5921061|NCT04965662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5921062|NCT04965662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921063|NCT04965662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5921064|NCT04965662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5921065|NCT04965662|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5921066|NCT04965662|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5921067|NCT04965662|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
5964300|NCT04592822|Dabigatran|dabigatran|mesh-list
5964301|NCT04592822|Antithrombins|antithrombins|mesh-ancestor
5964302|NCT04592822|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5964303|NCT04592822|Protease Inhibitors|protease inhibitors|mesh-ancestor
5964304|NCT04592822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5964305|NCT04592822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964306|NCT04592822|Anticoagulants|anticoagulants|mesh-ancestor
5964307|NCT04592744|Vasopressins|vasopressins|mesh-list
5964308|NCT04592744|Epinephrine|epinephrine|mesh-list
5964309|NCT04592744|Norepinephrine|norepinephrine|mesh-list
5964310|NCT04592744|Angiotensin II|angiotensin ii|mesh-list
5964311|NCT04592744|Giapreza|giapreza|mesh-list
5964312|NCT04592744|Angiotensinogen|angiotensinogen|mesh-list
5964313|NCT04592744|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5964314|NCT04592744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5964315|NCT04592744|Adrenergic Agents|adrenergic agents|mesh-ancestor
5964316|NCT04592744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5964317|NCT04592744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964318|NCT04592744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964319|NCT04592744|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5964320|NCT04592744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5964321|NCT04592744|Autonomic Agents|autonomic agents|mesh-ancestor
5964322|NCT04592744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5964323|NCT04592744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5964324|NCT04592744|Respiratory System Agents|respiratory system agents|mesh-ancestor
5964325|NCT04592744|Mydriatics|mydriatics|mesh-ancestor
5964326|NCT04592744|Sympathomimetics|sympathomimetics|mesh-ancestor
5964327|NCT04592744|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5964328|NCT04592744|Hemostatics|hemostatics|mesh-ancestor
5964329|NCT04592744|Coagulants|coagulants|mesh-ancestor
5964330|NCT04592744|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5964331|NCT04592744|Natriuretic Agents|natriuretic agents|mesh-ancestor
5964332|NCT04592744|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5964333|NCT04592744|Protease Inhibitors|protease inhibitors|mesh-ancestor
5964334|NCT04592744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5964335|NCT04592666|Carboplatin|carboplatin|mesh-list
5964336|NCT04592666|Pemetrexed|pemetrexed|mesh-list
5964337|NCT04592666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5964338|NCT04592666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5964339|NCT04592666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964340|NCT04592666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5964341|NCT04592666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5964342|NCT04593056|Warfarin|warfarin|mesh-list
5964343|NCT04593056|Rivaroxaban|rivaroxaban|mesh-list
5964344|NCT04593056|Anticoagulants|anticoagulants|mesh-ancestor
5964345|NCT04593056|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5964346|NCT04593056|Antithrombins|antithrombins|mesh-ancestor
5964347|NCT04593056|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5964348|NCT04593056|Protease Inhibitors|protease inhibitors|mesh-ancestor
5964349|NCT04593056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5964350|NCT04593056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964351|NCT04592653|Pembrolizumab|pembrolizumab|mesh-list
5921068|NCT04965181|Nicotine|nicotine|mesh-list
5921069|NCT04965181|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5921070|NCT04965181|Autonomic Agents|autonomic agents|mesh-ancestor
5921071|NCT04965181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5921072|NCT04965181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921073|NCT04965181|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5921074|NCT04965181|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5921075|NCT04965181|Cholinergic Agents|cholinergic agents|mesh-ancestor
5921076|NCT04965181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5921077|NCT04965181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921078|NCT04965116|Contraceptive Agents|contraceptive agents|mesh-list
5921079|NCT04965116|Progestins|progestins|mesh-list
5921080|NCT04965116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5921081|NCT04965116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921082|NCT04965116|Hormones|hormones|mesh-ancestor
5921083|NCT04965116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5921084|NCT04965298|Lansoprazole|lansoprazole|mesh-list
5921085|NCT04965298|Dexlansoprazole|dexlansoprazole|mesh-list
5921086|NCT04965298|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5921087|NCT04965298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5921088|NCT04965298|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5921089|NCT04965298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5921090|NCT04965298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921091|NCT04965324|Anesthetics|anesthetics|mesh-list
5921092|NCT04965324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5921093|NCT04965324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921094|NCT04965051|Insulin|insulin|mesh-list
5921095|NCT04965051|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5921096|NCT04965051|Insulin Aspart|insulin aspart|mesh-list
5921097|NCT04965051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5921098|NCT04965051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921099|NCT04965311|Botulinum Toxins|botulinum toxins|mesh-list
5921100|NCT04965311|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5921101|NCT04965311|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5921102|NCT04965311|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
5921103|NCT04965311|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5921104|NCT04965311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5921105|NCT04965311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921106|NCT04965311|Cholinergic Agents|cholinergic agents|mesh-ancestor
5921107|NCT04965311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5921108|NCT04965311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921109|NCT04965311|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5921110|NCT04965311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5921111|NCT04964869|Epinephrine|epinephrine|mesh-list
5921112|NCT04964869|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5921113|NCT04964869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5921114|NCT04964869|Adrenergic Agents|adrenergic agents|mesh-ancestor
5921115|NCT04964869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5921116|NCT04964869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921117|NCT04964869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921118|NCT04964869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5921119|NCT04964869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5921120|NCT04964869|Autonomic Agents|autonomic agents|mesh-ancestor
5921121|NCT04964869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5921122|NCT04964869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5921123|NCT04964869|Respiratory System Agents|respiratory system agents|mesh-ancestor
5921124|NCT04964869|Mydriatics|mydriatics|mesh-ancestor
5921125|NCT04964869|Sympathomimetics|sympathomimetics|mesh-ancestor
5921126|NCT04964869|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5921127|NCT04964583|Azithromycin|azithromycin|mesh-list
5921128|NCT04964583|Hydroxychloroquine|hydroxychloroquine|mesh-list
5921129|NCT04964583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5921130|NCT04964583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5921131|NCT04964583|Antimalarials|antimalarials|mesh-ancestor
5921132|NCT04964583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5921133|NCT04964583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5921134|NCT04964583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5921135|NCT04964583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921136|NCT04964583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5921137|NCT04964479|Pembrolizumab|pembrolizumab|mesh-list
5921138|NCT04964479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5921139|NCT04964479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5921140|NCT04964505|Azacitidine|azacitidine|mesh-list
5921141|NCT04964505|Venetoclax|venetoclax|mesh-list
5921142|NCT04964505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5921143|NCT04964505|Antimetabolites|antimetabolites|mesh-ancestor
5921144|NCT04964505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921145|NCT04964505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5921146|NCT04964505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5921147|NCT04964180|Indomethacin|indomethacin|mesh-list
5921148|NCT04964180|Lidocaine|lidocaine|mesh-list
5921149|NCT04964180|Anesthetics, Local|anesthetics, local|mesh-ancestor
5921150|NCT04964180|Anesthetics|anesthetics|mesh-ancestor
5921151|NCT04964180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5921152|NCT04964180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921153|NCT04964180|Sensory System Agents|sensory system agents|mesh-ancestor
5921154|NCT04964180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5921155|NCT04964180|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5921156|NCT04964180|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5921157|NCT04964180|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5921158|NCT04964180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5921159|NCT04964180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921160|NCT04964180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5921161|NCT04964180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5921162|NCT04964180|Analgesics|analgesics|mesh-ancestor
5921163|NCT04964180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5921164|NCT04964180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5921165|NCT04964180|Gout Suppressants|gout suppressants|mesh-ancestor
5921166|NCT04964180|Tocolytic Agents|tocolytic agents|mesh-ancestor
5921167|NCT04964180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5921168|NCT04964180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5921169|NCT04964180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5921170|NCT04964427|Methylphenidate|methylphenidate|mesh-list
5921171|NCT04964427|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5921172|NCT04964427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921173|NCT04964427|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5921174|NCT04964427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5921175|NCT04964427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5921176|NCT04964427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921177|NCT04964427|Dopamine Agents|dopamine agents|mesh-ancestor
5921178|NCT04964427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5921179|NCT04964414|Budesonide|budesonide|mesh-list
5921180|NCT04964414|Glucocorticoids|glucocorticoids|mesh-list
5921181|NCT04964414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5921182|NCT04964414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5921183|NCT04964414|Autonomic Agents|autonomic agents|mesh-ancestor
5921184|NCT04964414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5921185|NCT04964414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921186|NCT04964414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5921187|NCT04964414|Respiratory System Agents|respiratory system agents|mesh-ancestor
5921188|NCT04964414|Hormones|hormones|mesh-ancestor
5921189|NCT04964414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5921190|NCT04964219|Ketamine|ketamine|mesh-list
5921191|NCT04964219|Esketamine|esketamine|mesh-list
5921192|NCT04964219|Analgesics|analgesics|mesh-ancestor
5921193|NCT04964219|Sensory System Agents|sensory system agents|mesh-ancestor
5921194|NCT04964219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5921195|NCT04964219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921196|NCT04964219|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5921197|NCT04964219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5921198|NCT04964219|Anesthetics, General|anesthetics, general|mesh-ancestor
5921199|NCT04964219|Anesthetics|anesthetics|mesh-ancestor
5921200|NCT04964219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5921201|NCT04964219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5921202|NCT04964219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5921203|NCT04964219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5921204|NCT04964219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921205|NCT04964219|Antidepressive Agents|antidepressive agents|mesh-ancestor
5921206|NCT04964219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5921207|NCT04964089|Aflibercept|aflibercept|mesh-list
5921208|NCT04964089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5921209|NCT04964089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5921210|NCT04964089|Growth Substances|growth substances|mesh-ancestor
5921211|NCT04964089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921212|NCT04964089|Growth Inhibitors|growth inhibitors|mesh-ancestor
5921213|NCT04964089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5921214|NCT04964024|Antibodies|antibodies|mesh-list
5921215|NCT04964024|Immunologic Factors|immunologic factors|mesh-ancestor
5921216|NCT04964024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921217|NCT04963998|Copper|copper|mesh-list
5921218|NCT04963998|Trace Elements|trace elements|mesh-ancestor
5921219|NCT04963998|Micronutrients|micronutrients|mesh-ancestor
5921220|NCT04963998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921221|NCT04963673|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
5921222|NCT04963673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5921223|NCT04963673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921224|NCT04963764|Amoxicillin|amoxicillin|mesh-list
5921225|NCT04963764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5921226|NCT04963764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5921227|NCT04963712|Thymalfasin|thymalfasin|mesh-list
5921228|NCT04963712|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5921229|NCT04963712|Immunologic Factors|immunologic factors|mesh-ancestor
5921230|NCT04963712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921231|NCT04963530|Lithium Carbonate|lithium carbonate|mesh-list
5921232|NCT04963530|Antidepressive Agents|antidepressive agents|mesh-ancestor
5921233|NCT04963530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5921234|NCT04963530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5921235|NCT04963530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921236|NCT04963530|Antimanic Agents|antimanic agents|mesh-ancestor
5921237|NCT04963530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5921238|NCT04963530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5921239|NCT04963530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921240|NCT04963881|Antibodies|antibodies|mesh-list
5921241|NCT04963881|Immunologic Factors|immunologic factors|mesh-ancestor
5921242|NCT04963881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921243|NCT04963595|Vinorelbine|vinorelbine|mesh-list
5921244|NCT04963595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5921245|NCT04963595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5921246|NCT04963595|Tubulin Modulators|tubulin modulators|mesh-ancestor
5921247|NCT04963595|Antimitotic Agents|antimitotic agents|mesh-ancestor
5921248|NCT04963595|Mitosis Modulators|mitosis modulators|mesh-ancestor
5921249|NCT04963595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921250|NCT04963257|Aripiprazole|aripiprazole|mesh-list
5921251|NCT04963257|Fluvoxamine|fluvoxamine|mesh-list
5921252|NCT04963257|Sertraline|sertraline|mesh-list
5921253|NCT04963257|Antidepressive Agents|antidepressive agents|mesh-ancestor
5921254|NCT04963257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5921255|NCT04963257|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5921256|NCT04963257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5921257|NCT04963257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5921258|NCT04963257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921259|NCT04963257|Dopamine Agonists|dopamine agonists|mesh-ancestor
5921260|NCT04963257|Dopamine Agents|dopamine agents|mesh-ancestor
5921261|NCT04963257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5921262|NCT04963257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718431|NCT03226145|Bisacodyl|bisacodyl|mesh-list
5718432|NCT03226145|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
5718433|NCT03226145|Cathartics|cathartics|mesh-ancestor
5718434|NCT03226145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5718435|NCT03226145|Laxatives|laxatives|mesh-ancestor
5718436|NCT03226145|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5921263|NCT04963257|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5921264|NCT04963257|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5921265|NCT04963257|Serotonin Agents|serotonin agents|mesh-ancestor
5921266|NCT04963257|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5921267|NCT04963257|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5921268|NCT04963257|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5921269|NCT04963257|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6516981|NCT00719121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6516982|NCT00719121|Analgesics|analgesics|mesh-ancestor
6516983|NCT00719121|Sensory System Agents|sensory system agents|mesh-ancestor
6516984|NCT00719121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6516985|NCT00719121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516986|NCT00719121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5921270|NCT04963257|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5921271|NCT04963257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5718437|NCT03226145|Antiemetics|antiemetics|mesh-ancestor
5718438|NCT03226145|Autonomic Agents|autonomic agents|mesh-ancestor
5718439|NCT03226145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5718440|NCT03226145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718441|NCT03226145|Mydriatics|mydriatics|mesh-ancestor
5718442|NCT03226145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5718443|NCT03226145|Cholinergic Agents|cholinergic agents|mesh-ancestor
5718444|NCT03226145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5718445|NCT03226145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921272|NCT04963257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5921273|NCT04963257|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5921274|NCT04963257|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5921275|NCT04963257|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5921276|NCT04963257|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5921277|NCT04963257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5921278|NCT04963257|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5964352|NCT04592653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5964353|NCT04592653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5964354|NCT04593043|Warfarin|warfarin|mesh-list
5964355|NCT04593043|Dabigatran|dabigatran|mesh-list
5964356|NCT04593043|Anticoagulants|anticoagulants|mesh-ancestor
5964357|NCT04593043|Antithrombins|antithrombins|mesh-ancestor
5964358|NCT04593043|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5964359|NCT04593043|Protease Inhibitors|protease inhibitors|mesh-ancestor
5964360|NCT04593043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5964361|NCT04593043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964362|NCT04592211|Paclitaxel|paclitaxel|mesh-list
5964363|NCT04592211|Pembrolizumab|pembrolizumab|mesh-list
5964364|NCT04592211|Olaparib|olaparib|mesh-list
5964365|NCT04592211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5964366|NCT04592211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5964367|NCT04592211|Tubulin Modulators|tubulin modulators|mesh-ancestor
5964368|NCT04592211|Antimitotic Agents|antimitotic agents|mesh-ancestor
5964369|NCT04592211|Mitosis Modulators|mitosis modulators|mesh-ancestor
5964370|NCT04592211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964371|NCT04592211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5964372|NCT04592211|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5964373|NCT04592211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5964374|NCT04592159|Nabiximols|nabiximols|mesh-list
5964375|NCT04592159|Analgesics|analgesics|mesh-ancestor
5964376|NCT04592159|Sensory System Agents|sensory system agents|mesh-ancestor
5964377|NCT04592159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5964378|NCT04592159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964379|NCT04592419|Aflibercept|aflibercept|mesh-list
5964380|NCT04592419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5964381|NCT04592419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5964382|NCT04592419|Growth Substances|growth substances|mesh-ancestor
5964383|NCT04592419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964384|NCT04592419|Growth Inhibitors|growth inhibitors|mesh-ancestor
5964385|NCT04592419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5964386|NCT04592380|Clevidipine|clevidipine|mesh-list
5964387|NCT04592380|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
5964388|NCT04592380|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
5964389|NCT04592380|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5964390|NCT04592380|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5964391|NCT04592380|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5964392|NCT04592380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5964393|NCT04592380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964394|NCT04592380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5964395|NCT04592380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964396|NCT04592198|Palonosetron|palonosetron|mesh-list
5964397|NCT04592198|Antiemetics|antiemetics|mesh-ancestor
5964398|NCT04592198|Autonomic Agents|autonomic agents|mesh-ancestor
5964399|NCT04592198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5964400|NCT04592198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964401|NCT04592198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5964402|NCT04592198|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5964403|NCT04592198|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5964404|NCT04592198|Serotonin Agents|serotonin agents|mesh-ancestor
5964405|NCT04592198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5964406|NCT04592198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964407|NCT04591990|Hydrocortisone|hydrocortisone|mesh-list
5964408|NCT04591990|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
5964409|NCT04591990|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
5964410|NCT04591990|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
5964411|NCT04591990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5964412|NCT04592081|Dexamethasone|dexamethasone|mesh-list
5964413|NCT04592081|Dexamethasone acetate|dexamethasone acetate|mesh-list
5964414|NCT04592081|BB 1101|bb 1101|mesh-list
5964415|NCT04592081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5964416|NCT04592081|Antiemetics|antiemetics|mesh-ancestor
5964417|NCT04592081|Autonomic Agents|autonomic agents|mesh-ancestor
5964418|NCT04592081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5921279|NCT04963088|Capecitabine|capecitabine|mesh-list
5921280|NCT04963088|Oxaliplatin|oxaliplatin|mesh-list
5921281|NCT04963088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5921282|NCT04963088|Antimetabolites|antimetabolites|mesh-ancestor
5921283|NCT04963088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921284|NCT04963088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5921285|NCT04963036|Anesthetics|anesthetics|mesh-list
5921286|NCT04963036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5921287|NCT04963036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921288|NCT04962672|Anesthetics|anesthetics|mesh-list
5921289|NCT04962672|Propofol|propofol|mesh-list
5921290|NCT04962672|Sevoflurane|sevoflurane|mesh-list
5718446|NCT03226145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5718447|NCT03226145|Parasympatholytics|parasympatholytics|mesh-ancestor
5718448|NCT03225950|Antibodies|antibodies|mesh-list
5718449|NCT03225950|Immunologic Factors|immunologic factors|mesh-ancestor
5718450|NCT03225950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718451|NCT03225690|Morphine|morphine|mesh-list
5718452|NCT03225690|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5718453|NCT03225690|Narcotics|narcotics|mesh-ancestor
5718454|NCT03225690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5718455|NCT03225690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718456|NCT03225690|Analgesics|analgesics|mesh-ancestor
5718457|NCT03225690|Sensory System Agents|sensory system agents|mesh-ancestor
5718458|NCT03225690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5718459|NCT03225755|Hormones|hormones|mesh-list
5718460|NCT03225755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5718461|NCT03225755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718462|NCT03225664|Pembrolizumab|pembrolizumab|mesh-list
5718463|NCT03225664|Trametinib|trametinib|mesh-list
5718464|NCT03225664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5718465|NCT03225664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5718466|NCT03225664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5718467|NCT03225664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5718468|NCT03225664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718469|NCT03225781|Bleomycin|bleomycin|mesh-list
5718470|NCT03225781|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5718471|NCT03225781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5718472|NCT03225417|Sirolimus|sirolimus|mesh-list
5718473|NCT03225417|Ixazomib|ixazomib|mesh-list
5921291|NCT04962672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5921292|NCT04962672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921293|NCT04962672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5921294|NCT04962672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5921295|NCT04962672|Anesthetics, General|anesthetics, general|mesh-ancestor
5921296|NCT04962672|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5921297|NCT04962672|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5921298|NCT04962893|Vaccines|vaccines|mesh-list
5921299|NCT04962893|Immunologic Factors|immunologic factors|mesh-ancestor
5921300|NCT04962893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921301|NCT04962958|Leucovorin|leucovorin|mesh-list
5921302|NCT04962958|Fluorouracil|fluorouracil|mesh-list
5921303|NCT04962958|Oxaliplatin|oxaliplatin|mesh-list
5921304|NCT04962958|Antimetabolites|antimetabolites|mesh-ancestor
5921305|NCT04962958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921306|NCT04962958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5921307|NCT04962958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5921308|NCT04962958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5921309|NCT04962958|Immunologic Factors|immunologic factors|mesh-ancestor
5921310|NCT04962958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921311|NCT04962958|Antidotes|antidotes|mesh-ancestor
5921312|NCT04962958|Protective Agents|protective agents|mesh-ancestor
5921313|NCT04962958|Vitamin B Complex|vitamin b complex|mesh-ancestor
5921314|NCT04962958|Vitamins|vitamins|mesh-ancestor
5921315|NCT04962958|Micronutrients|micronutrients|mesh-ancestor
5921316|NCT04962841|Metformin|metformin|mesh-list
5921317|NCT04962841|Amlodipine|amlodipine|mesh-list
5921318|NCT04962841|Ramipril|ramipril|mesh-list
5921319|NCT04962841|Nebivolol|nebivolol|mesh-list
5921320|NCT04962841|Rivastigmine|rivastigmine|mesh-list
5921321|NCT04962841|Sertraline|sertraline|mesh-list
5921322|NCT04962841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5921323|NCT04962841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921324|NCT04962841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5718474|NCT03225417|Tacrolimus|tacrolimus|mesh-list
5718475|NCT03225417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5921325|NCT04962841|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5921326|NCT04962841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5921327|NCT04962841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921328|NCT04962841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5921329|NCT04962841|Vasodilator Agents|vasodilator agents|mesh-ancestor
5921330|NCT04962841|Antidepressive Agents|antidepressive agents|mesh-ancestor
5921331|NCT04962841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5921332|NCT04962841|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5921333|NCT04962841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5921334|NCT04962841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5921335|NCT04962841|Serotonin Agents|serotonin agents|mesh-ancestor
5921336|NCT04962841|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5921337|NCT04962841|Protease Inhibitors|protease inhibitors|mesh-ancestor
5921338|NCT04962841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5921339|NCT04962841|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5921340|NCT04962841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5921341|NCT04962841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5921342|NCT04962841|Adrenergic Agents|adrenergic agents|mesh-ancestor
5921343|NCT04962841|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5921344|NCT04962841|Cholinergic Agents|cholinergic agents|mesh-ancestor
5921345|NCT04962841|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5921346|NCT04962841|Protective Agents|protective agents|mesh-ancestor
5718476|NCT03225417|Immunologic Factors|immunologic factors|mesh-ancestor
5718477|NCT03225417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516987|NCT00719121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6516988|NCT00719121|Dermatologic Agents|dermatologic agents|mesh-ancestor
6516989|NCT00719121|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6516990|NCT00719121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6516991|NCT00719121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6516992|NCT00719173|Cyclophosphamide|cyclophosphamide|mesh-list
6516993|NCT00719173|Aprepitant|aprepitant|mesh-list
6516994|NCT00719173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6516995|NCT00719173|Immunologic Factors|immunologic factors|mesh-ancestor
5921347|NCT04962425|Trastuzumab|trastuzumab|mesh-list
5921348|NCT04962425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5921349|NCT04962425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5921350|NCT04962451|Ticagrelor|ticagrelor|mesh-list
5921351|NCT04962451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5921352|NCT04962451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5921353|NCT04962451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5921354|NCT04962451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5921355|NCT04962451|Purinergic Agents|purinergic agents|mesh-ancestor
5921356|NCT04962451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5921357|NCT04962451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921358|NCT04962451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921359|NCT04962386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5921360|NCT04962386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5921361|NCT04962386|Hormones|hormones|mesh-list
5921362|NCT04962386|Estradiol|estradiol|mesh-list
5921363|NCT04962386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5921364|NCT04962386|Progesterone|progesterone|mesh-list
5921365|NCT04962386|Estrogens|estrogens|mesh-list
5921366|NCT04962386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5921367|NCT04962386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921368|NCT04962386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5921369|NCT04962386|Contraceptive Agents|contraceptive agents|mesh-ancestor
5921370|NCT04962386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5921371|NCT04962386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5921372|NCT04962386|Progestins|progestins|mesh-ancestor
5921373|NCT04962308|Vaccines|vaccines|mesh-list
5921374|NCT04962308|Immunologic Factors|immunologic factors|mesh-ancestor
5921375|NCT04962308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921376|NCT04962438|Bevacizumab|bevacizumab|mesh-list
5921377|NCT04962438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5921378|NCT04962438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5921379|NCT04962438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5921380|NCT04962438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5921381|NCT04962438|Growth Substances|growth substances|mesh-ancestor
5970658|NCT04533243|Morphine|morphine|mesh-list
5718478|NCT03225417|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5718479|NCT03225417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5718480|NCT03225417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718481|NCT03225417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5718482|NCT03225417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5718483|NCT03225417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5718484|NCT03225417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5718485|NCT03225417|Antifungal Agents|antifungal agents|mesh-ancestor
5921382|NCT04962438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921383|NCT04962438|Growth Inhibitors|growth inhibitors|mesh-ancestor
5921384|NCT04962152|Nalbuphine|nalbuphine|mesh-list
5921385|NCT04962152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5921386|NCT04962152|Narcotics|narcotics|mesh-ancestor
5921387|NCT04962152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5921388|NCT04962152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921389|NCT04962152|Analgesics|analgesics|mesh-ancestor
5921390|NCT04962152|Sensory System Agents|sensory system agents|mesh-ancestor
5921391|NCT04962152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5921392|NCT04961970|Leucovorin|leucovorin|mesh-list
5921393|NCT04961970|Gemcitabine|gemcitabine|mesh-list
5921394|NCT04961970|Fluorouracil|fluorouracil|mesh-list
5921395|NCT04961970|Oxaliplatin|oxaliplatin|mesh-list
5921396|NCT04961970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5921397|NCT04961970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5921398|NCT04961970|Antimetabolites|antimetabolites|mesh-ancestor
5921399|NCT04961970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921400|NCT04961970|Antiviral Agents|antiviral agents|mesh-ancestor
5921401|NCT04961970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5921402|NCT04961970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5921403|NCT04961970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5921404|NCT04961970|Immunologic Factors|immunologic factors|mesh-ancestor
5921405|NCT04961970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921406|NCT04961970|Antidotes|antidotes|mesh-ancestor
5921407|NCT04961970|Protective Agents|protective agents|mesh-ancestor
5921408|NCT04961970|Vitamin B Complex|vitamin b complex|mesh-ancestor
5921409|NCT04961970|Vitamins|vitamins|mesh-ancestor
5921410|NCT04961970|Micronutrients|micronutrients|mesh-ancestor
5921411|NCT04961684|Amorolfine|amorolfine|mesh-list
5921412|NCT04961684|Antifungal Agents|antifungal agents|mesh-ancestor
5921413|NCT04961684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5921414|NCT04961918|Durvalumab|durvalumab|mesh-list
5921415|NCT04961918|Lenvatinib|lenvatinib|mesh-list
5921416|NCT04961918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5921417|NCT04961918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5921418|NCT04961918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5921419|NCT04961918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5921420|NCT04961918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921421|NCT04961931|Empagliflozin|empagliflozin|mesh-list
5921422|NCT04961931|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5921423|NCT04961931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921424|NCT04961931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5921425|NCT04961931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921426|NCT04961788|Antibodies|antibodies|mesh-list
5921427|NCT04961788|Immunologic Factors|immunologic factors|mesh-ancestor
5921428|NCT04961788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921429|NCT04961632|Tamoxifen|tamoxifen|mesh-list
5921430|NCT04961632|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5921431|NCT04961632|Hormone Antagonists|hormone antagonists|mesh-ancestor
5921432|NCT04961632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5921433|NCT04961632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921434|NCT04961632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5921435|NCT04961632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5921436|NCT04961632|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5921437|NCT04961632|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5921438|NCT04961632|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5921439|NCT04961359|Vaccines|vaccines|mesh-list
5921440|NCT04961359|Immunologic Factors|immunologic factors|mesh-ancestor
5921441|NCT04961359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921442|NCT04961268|Acetaminophen|acetaminophen|mesh-list
5921443|NCT04961268|Ibuprofen|ibuprofen|mesh-list
5921444|NCT04961268|Tramadol|tramadol|mesh-list
5921445|NCT04961268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5921446|NCT04961268|Analgesics|analgesics|mesh-ancestor
5921447|NCT04961268|Sensory System Agents|sensory system agents|mesh-ancestor
5921448|NCT04961268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5921449|NCT04961268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921450|NCT04961268|Antipyretics|antipyretics|mesh-ancestor
5921451|NCT04961268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5921452|NCT04961268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5921453|NCT04961268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5921454|NCT04961268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5921455|NCT04961268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5921456|NCT04961268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921457|NCT04961268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5921458|NCT04961268|Narcotics|narcotics|mesh-ancestor
5718486|NCT03225417|Protease Inhibitors|protease inhibitors|mesh-ancestor
5718487|NCT03225456|Oxytocin|oxytocin|mesh-list
5718488|NCT03225456|Oxytocics|oxytocics|mesh-ancestor
5718489|NCT03225456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5718490|NCT03225456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718491|NCT03225352|Aspirin|aspirin|mesh-list
5718492|NCT03225352|Ibuprofen|ibuprofen|mesh-list
5718493|NCT03225352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6516996|NCT00719173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516997|NCT00719173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5718494|NCT03225352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5718495|NCT03225352|Analgesics|analgesics|mesh-ancestor
5718496|NCT03225352|Sensory System Agents|sensory system agents|mesh-ancestor
5718497|NCT03225352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5718498|NCT03225352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718499|NCT03225352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5718500|NCT03225352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5718501|NCT03225352|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5718502|NCT03225352|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5718503|NCT03225352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718504|NCT03225352|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5718505|NCT03225352|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5718506|NCT03225352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5718507|NCT03225352|Antipyretics|antipyretics|mesh-ancestor
5718508|NCT03225326|Carticaine|carticaine|mesh-list
5718509|NCT03225326|Anesthetics, Local|anesthetics, local|mesh-ancestor
5718510|NCT03225326|Anesthetics|anesthetics|mesh-ancestor
5718511|NCT03225326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5718512|NCT03225326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718513|NCT03225326|Sensory System Agents|sensory system agents|mesh-ancestor
5718514|NCT03225326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5718515|NCT03224923|Aspirin|aspirin|mesh-list
5718516|NCT03224923|Clopidogrel|clopidogrel|mesh-list
5718517|NCT03224923|Ticagrelor|ticagrelor|mesh-list
5718518|NCT03224923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5921459|NCT04961268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5921460|NCT04961554|Anesthetics|anesthetics|mesh-list
5921461|NCT04961554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5921462|NCT04961554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964419|NCT04592081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964420|NCT04592081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5964421|NCT04592081|Glucocorticoids|glucocorticoids|mesh-ancestor
5964422|NCT04592081|Hormones|hormones|mesh-ancestor
5964423|NCT04592081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5964424|NCT04592081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5964425|NCT04592081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5964426|NCT04592081|Protease Inhibitors|protease inhibitors|mesh-ancestor
5964427|NCT04592081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5964428|NCT04592081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964429|NCT04591795|Diclofenac|diclofenac|mesh-list
5964430|NCT04591795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5964431|NCT04591795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5964432|NCT04591795|Analgesics|analgesics|mesh-ancestor
5964433|NCT04591795|Sensory System Agents|sensory system agents|mesh-ancestor
5964434|NCT04591795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5964435|NCT04591795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964436|NCT04591795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5964437|NCT04591795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5964438|NCT04591795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5964439|NCT04591795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5964440|NCT04591795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964441|NCT04591743|Nicotine|nicotine|mesh-list
5964442|NCT04591743|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5964443|NCT04591743|Autonomic Agents|autonomic agents|mesh-ancestor
5964444|NCT04591743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5964445|NCT04591743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964446|NCT04591743|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5964447|NCT04591743|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5964448|NCT04591743|Cholinergic Agents|cholinergic agents|mesh-ancestor
5964449|NCT04591743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5964450|NCT04591743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964451|NCT04591639|Dapagliflozin|dapagliflozin|mesh-list
5964452|NCT04591639|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5718519|NCT03224923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5921463|NCT04961502|Vaccines|vaccines|mesh-list
5921464|NCT04961502|Immunologic Factors|immunologic factors|mesh-ancestor
5921465|NCT04961502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921466|NCT04961307|Trastuzumab|trastuzumab|mesh-list
5921467|NCT04961307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5921468|NCT04961307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5921469|NCT04961528|Terlipressin|terlipressin|mesh-list
5921470|NCT04961528|Tranexamic Acid|tranexamic acid|mesh-list
5921471|NCT04961528|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5921472|NCT04961528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5921473|NCT04961528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921474|NCT04961528|Hemostatics|hemostatics|mesh-ancestor
5921475|NCT04961528|Coagulants|coagulants|mesh-ancestor
5921476|NCT04961528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5921477|NCT04961528|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5921478|NCT04961138|Lenvatinib|lenvatinib|mesh-list
5921479|NCT04961138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5921480|NCT04961138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5921481|NCT04961138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5921482|NCT04961138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921483|NCT04960943|Trastuzumab|trastuzumab|mesh-list
5921484|NCT04960943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5921485|NCT04960943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5921486|NCT04960618|Gemcitabine|gemcitabine|mesh-list
5921487|NCT04960618|Pembrolizumab|pembrolizumab|mesh-list
5921488|NCT04960618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5921489|NCT04960618|Antimetabolites|antimetabolites|mesh-ancestor
5921490|NCT04960618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921491|NCT04960618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5921492|NCT04960618|Antiviral Agents|antiviral agents|mesh-ancestor
5921493|NCT04960618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5921494|NCT04960618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5921495|NCT04960618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5921496|NCT04960618|Immunologic Factors|immunologic factors|mesh-ancestor
5921497|NCT04960618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921498|NCT04960618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5921499|NCT04960657|Glyburide|glyburide|mesh-list
5921500|NCT04960657|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
5921501|NCT04960657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5921502|NCT04960657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921503|NCT04960657|Growth Substances|growth substances|mesh-ancestor
5921504|NCT04960657|Vasodilator Agents|vasodilator agents|mesh-ancestor
5921505|NCT04960657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5921506|NCT04960657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921507|NCT04960293|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
5921508|NCT04960293|Hemostatics|hemostatics|mesh-ancestor
5921509|NCT04960293|Coagulants|coagulants|mesh-ancestor
5921510|NCT04959721|Triamcinolone|triamcinolone|mesh-list
5921511|NCT04959721|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5921512|NCT04959721|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5921513|NCT04959721|Bupivacaine|bupivacaine|mesh-list
5921514|NCT04959721|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5921515|NCT04959721|Anesthetics, Local|anesthetics, local|mesh-ancestor
5921516|NCT04959721|Anesthetics|anesthetics|mesh-ancestor
5921517|NCT04959721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5921518|NCT04959721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921519|NCT04959721|Sensory System Agents|sensory system agents|mesh-ancestor
5921520|NCT04959721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5921521|NCT04959721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5921522|NCT04959721|Glucocorticoids|glucocorticoids|mesh-ancestor
5921523|NCT04959721|Hormones|hormones|mesh-ancestor
5921524|NCT04959721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5921525|NCT04959721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5921526|NCT04959721|Immunologic Factors|immunologic factors|mesh-ancestor
5921527|NCT04959721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5921528|NCT04959721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921529|NCT04959825|Melatonin|melatonin|mesh-list
5921530|NCT04959825|Antioxidants|antioxidants|mesh-ancestor
5921531|NCT04959825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921532|NCT04959825|Protective Agents|protective agents|mesh-ancestor
5921533|NCT04959825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921534|NCT04959825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5921535|NCT04959786|Ribavirin|ribavirin|mesh-list
5921536|NCT04959786|Ivermectin|ivermectin|mesh-list
5921537|NCT04959786|Nitazoxanide|nitazoxanide|mesh-list
5921538|NCT04959786|Antimetabolites|antimetabolites|mesh-ancestor
5921539|NCT04959786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921540|NCT04959786|Antiviral Agents|antiviral agents|mesh-ancestor
5921541|NCT04959786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5921542|NCT04959786|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5921543|NCT04959799|Dalbavancin|dalbavancin|mesh-list
5921544|NCT04959799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5921545|NCT04959799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5921546|NCT04959578|Epoetin Alfa|epoetin alfa|mesh-list
5921547|NCT04959578|Darbepoetin alfa|darbepoetin alfa|mesh-list
5921548|NCT04959578|Hematinics|hematinics|mesh-ancestor
5921549|NCT04959591|Acetaminophen|acetaminophen|mesh-list
5921550|NCT04959591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5921551|NCT04959591|Analgesics|analgesics|mesh-ancestor
5921552|NCT04959591|Sensory System Agents|sensory system agents|mesh-ancestor
5921553|NCT04959591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5921554|NCT04959591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921555|NCT04959591|Antipyretics|antipyretics|mesh-ancestor
5964453|NCT04591639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964454|NCT04591639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5964455|NCT04591639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964456|NCT04592016|Diclofenac|diclofenac|mesh-list
5964457|NCT04592016|Coal Tar|coal tar|mesh-list
5964458|NCT04592016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5964459|NCT04592016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5964460|NCT04592016|Analgesics|analgesics|mesh-ancestor
5964461|NCT04592016|Sensory System Agents|sensory system agents|mesh-ancestor
5964462|NCT04592016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5964463|NCT04592016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964464|NCT04592016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5964465|NCT04592016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5964466|NCT04592016|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5964467|NCT04592016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5964468|NCT04592016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964469|NCT04592016|Keratolytic Agents|keratolytic agents|mesh-ancestor
5964470|NCT04592016|Dermatologic Agents|dermatologic agents|mesh-ancestor
5964471|NCT04592029|Bevacizumab|bevacizumab|mesh-list
5964472|NCT04592029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5964473|NCT04592029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5964474|NCT04592029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5964475|NCT04592029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5964476|NCT04592029|Growth Substances|growth substances|mesh-ancestor
5964477|NCT04592029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964478|NCT04592029|Growth Inhibitors|growth inhibitors|mesh-ancestor
5964479|NCT04591847|Vitamin D|vitamin d|mesh-list
5964480|NCT04591847|Ergocalciferols|ergocalciferols|mesh-list
5964481|NCT04591847|Vitamins|vitamins|mesh-ancestor
5964482|NCT04591847|Micronutrients|micronutrients|mesh-ancestor
5964483|NCT04591847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964484|NCT04591847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5964485|NCT04591847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5964486|NCT04591535|Levodopa|levodopa|mesh-list
5964487|NCT04591535|Carbidopa|carbidopa|mesh-list
5964488|NCT04591535|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
5964489|NCT04591535|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5964490|NCT04591535|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5964491|NCT04591535|Dopamine Agents|dopamine agents|mesh-ancestor
5964492|NCT04591535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5964493|NCT04591535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964494|NCT04591535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964495|NCT04591535|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5964496|NCT04591535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5964497|NCT04591535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5964498|NCT04591535|Immunologic Factors|immunologic factors|mesh-ancestor
5964499|NCT04591535|Dopamine Agonists|dopamine agonists|mesh-ancestor
5964500|NCT04591444|Fluorides|fluorides|mesh-list
5964501|NCT04591444|Fluorides, Topical|fluorides, topical|mesh-list
5964502|NCT04591444|Cariostatic Agents|cariostatic agents|mesh-ancestor
5964503|NCT04591444|Protective Agents|protective agents|mesh-ancestor
5964504|NCT04591444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964505|NCT04591457|Insulin|insulin|mesh-list
5964506|NCT04591457|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5964507|NCT04591457|Insulin Glargine|insulin glargine|mesh-list
5964508|NCT04591457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5964509|NCT04591457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964510|NCT04591327|Anesthetics|anesthetics|mesh-list
5964511|NCT04591327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5921556|NCT04959331|Fosfomycin|fosfomycin|mesh-list
5921557|NCT04959331|Nitrofurantoin|nitrofurantoin|mesh-list
5921558|NCT04959331|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
5921559|NCT04959331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5921560|NCT04959331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5921561|NCT04959331|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5921562|NCT04959331|Renal Agents|renal agents|mesh-ancestor
5921563|NCT04959253|Psilocybin|psilocybin|mesh-list
5921564|NCT04959253|Hallucinogens|hallucinogens|mesh-ancestor
5921565|NCT04959253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921566|NCT04959253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5921567|NCT04959500|Temozolomide|temozolomide|mesh-list
5921568|NCT04959500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5921569|NCT04959500|Alkylating Agents|alkylating agents|mesh-ancestor
5921570|NCT04959500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921571|NCT04959500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5921572|NCT04959409|Tetracaine|tetracaine|mesh-list
5921573|NCT04959409|Anesthetics, Local|anesthetics, local|mesh-ancestor
5921574|NCT04959409|Anesthetics|anesthetics|mesh-ancestor
5921575|NCT04959409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5921576|NCT04959409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921577|NCT04959409|Sensory System Agents|sensory system agents|mesh-ancestor
5921578|NCT04959409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5921579|NCT04958772|Lenograstim|lenograstim|mesh-list
5921580|NCT04958772|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5921581|NCT04958772|Immunologic Factors|immunologic factors|mesh-ancestor
5921582|NCT04958772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921583|NCT04958746|Propofol|propofol|mesh-list
5921584|NCT04958746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5921585|NCT04958746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5921586|NCT04958746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921587|NCT04958746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5921588|NCT04958746|Anesthetics, General|anesthetics, general|mesh-ancestor
5921589|NCT04958746|Anesthetics|anesthetics|mesh-ancestor
5921590|NCT04958538|Methotrexate|methotrexate|mesh-list
5921591|NCT04958538|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5921592|NCT04958538|Abortifacient Agents|abortifacient agents|mesh-ancestor
5921593|NCT04958538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5921594|NCT04958538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921595|NCT04958538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5921596|NCT04958538|Antimetabolites|antimetabolites|mesh-ancestor
5921597|NCT04958538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921598|NCT04958538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5921599|NCT04958538|Dermatologic Agents|dermatologic agents|mesh-ancestor
5921600|NCT04958538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5921601|NCT04958538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5921602|NCT04958538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5921603|NCT04958538|Immunologic Factors|immunologic factors|mesh-ancestor
5921604|NCT04958538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5921605|NCT04958538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5921606|NCT04958486|Trastuzumab|trastuzumab|mesh-list
5921607|NCT04958486|Azacitidine|azacitidine|mesh-list
5921608|NCT04958486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5921609|NCT04958486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5921610|NCT04958486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5921611|NCT04958486|Antimetabolites|antimetabolites|mesh-ancestor
5921612|NCT04958486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921613|NCT04958486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5921614|NCT04958187|Mitogens|mitogens|mesh-list
5921615|NCT04958187|Mitosis Modulators|mitosis modulators|mesh-ancestor
5921616|NCT04958187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921617|NCT04958473|Axitinib|axitinib|mesh-list
5921618|NCT04958473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5921619|NCT04958473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5921620|NCT04958473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5921621|NCT04958473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921622|NCT04957940|SMOFlipid|smoflipid|mesh-list
5921623|NCT04957940|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
5921624|NCT04957940|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5921625|NCT04957940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5921626|NCT04958122|Penicillins|penicillins|mesh-list
5921627|NCT04958122|Cefixime|cefixime|mesh-list
5921628|NCT04958122|Penicillin G Benzathine|penicillin g benzathine|mesh-list
5921629|NCT04958122|Penicillin G|penicillin g|mesh-list
5921630|NCT04958122|Penicillin G Procaine|penicillin g procaine|mesh-list
5921631|NCT04958122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5921632|NCT04958122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5921633|NCT04957927|Fluticasone|fluticasone|mesh-list
5921634|NCT04957927|Xhance|xhance|mesh-list
5921635|NCT04957927|Montelukast|montelukast|mesh-list
5921636|NCT04957927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5921637|NCT04957927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5921638|NCT04957927|Autonomic Agents|autonomic agents|mesh-ancestor
5921639|NCT04957927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5921640|NCT04957927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921641|NCT04957927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5921642|NCT04957927|Respiratory System Agents|respiratory system agents|mesh-ancestor
5921643|NCT04957927|Dermatologic Agents|dermatologic agents|mesh-ancestor
5921644|NCT04957927|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5921645|NCT04957927|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5921646|NCT04957927|Hormone Antagonists|hormone antagonists|mesh-ancestor
5921647|NCT04957927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5921648|NCT04957927|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5921649|NCT04957927|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5921650|NCT04957927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964512|NCT04591327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970659|NCT04533243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5970660|NCT04533243|Narcotics|narcotics|mesh-ancestor
5970661|NCT04533243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5970662|NCT04533243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970663|NCT04533243|Analgesics|analgesics|mesh-ancestor
5970664|NCT04533243|Sensory System Agents|sensory system agents|mesh-ancestor
5970665|NCT04533243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5970666|NCT04533243|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5970667|NCT04533243|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5970668|NCT04533243|Anesthetics, General|anesthetics, general|mesh-ancestor
5970669|NCT04533243|Anesthetics|anesthetics|mesh-ancestor
5970670|NCT04533321|Afatinib|afatinib|mesh-list
5970671|NCT04533321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5970672|NCT04533321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5970673|NCT04533321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5970674|NCT04533321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970675|NCT04532931|Acetaminophen|acetaminophen|mesh-list
5970676|NCT04532931|Sofosbuvir|sofosbuvir|mesh-list
5970677|NCT04532931|Artesunate|artesunate|mesh-list
5970678|NCT04532931|Favipiravir|favipiravir|mesh-list
5970679|NCT04532931|Amodiaquine|amodiaquine|mesh-list
5970680|NCT04532931|Nitazoxanide|nitazoxanide|mesh-list
5970681|NCT04532931|Pyronaridine|pyronaridine|mesh-list
5970682|NCT04532931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5970683|NCT04532931|Analgesics|analgesics|mesh-ancestor
5970684|NCT04532931|Sensory System Agents|sensory system agents|mesh-ancestor
5970685|NCT04532931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5970686|NCT04532931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970687|NCT04532931|Antipyretics|antipyretics|mesh-ancestor
5970688|NCT04532931|Antiviral Agents|antiviral agents|mesh-ancestor
5970689|NCT04532931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5970690|NCT04532931|Antimalarials|antimalarials|mesh-ancestor
5970691|NCT04532931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5970692|NCT04532931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5970693|NCT04532931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5970694|NCT04532931|Schistosomicides|schistosomicides|mesh-ancestor
5970695|NCT04532931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5970696|NCT04532931|Anthelmintics|anthelmintics|mesh-ancestor
5970697|NCT04532918|Cyclosporine|cyclosporine|mesh-list
5970698|NCT04532918|Rifampin|rifampin|mesh-list
5970699|NCT04532918|Allopurinol|allopurinol|mesh-list
5970700|NCT04532918|Verinurad|verinurad|mesh-list
5970701|NCT04532918|Cyclosporins|cyclosporins|mesh-list
5970702|NCT04532918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5970703|NCT04532918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970704|NCT04532918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5970705|NCT04532918|Immunologic Factors|immunologic factors|mesh-ancestor
5970706|NCT04532918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970707|NCT04532918|Antifungal Agents|antifungal agents|mesh-ancestor
5970708|NCT04532918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5970709|NCT04532918|Dermatologic Agents|dermatologic agents|mesh-ancestor
5970710|NCT04532918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5970711|NCT04532918|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5970712|NCT04532918|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5970713|NCT04532918|Antitubercular Agents|antitubercular agents|mesh-ancestor
5970714|NCT04532918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6681125|NCT01608269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5970715|NCT04532918|Leprostatic Agents|leprostatic agents|mesh-ancestor
5921651|NCT04957615|Nivolumab|nivolumab|mesh-list
5921652|NCT04957615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5921653|NCT04957615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5921654|NCT04957615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5921655|NCT04957615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921656|NCT04957420|Rotigotine|rotigotine|mesh-list
5921657|NCT04957420|Dopamine Agonists|dopamine agonists|mesh-ancestor
5921658|NCT04957420|Dopamine Agents|dopamine agents|mesh-ancestor
5921659|NCT04957420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5921660|NCT04957420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921661|NCT04957420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921662|NCT04957329|Latanoprost|latanoprost|mesh-list
5921663|NCT04957329|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5921664|NCT04957329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5921665|NCT04957212|Carboplatin|carboplatin|mesh-list
5921666|NCT04957212|Docetaxel|docetaxel|mesh-list
5921667|NCT04957212|Trastuzumab|trastuzumab|mesh-list
5921668|NCT04957212|Pertuzumab|pertuzumab|mesh-list
5921669|NCT04957212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5921670|NCT04957212|Tubulin Modulators|tubulin modulators|mesh-ancestor
5921671|NCT04957212|Antimitotic Agents|antimitotic agents|mesh-ancestor
5921672|NCT04957212|Mitosis Modulators|mitosis modulators|mesh-ancestor
5921673|NCT04957212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921674|NCT04957212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5921675|NCT04956939|Levodopa|levodopa|mesh-list
5921676|NCT04956939|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5921677|NCT04956939|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5921678|NCT04956939|Dopamine Agents|dopamine agents|mesh-ancestor
5921679|NCT04956939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5921680|NCT04956939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921681|NCT04956939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921682|NCT04956432|Allopurinol|allopurinol|mesh-list
5921683|NCT04956432|Antimetabolites|antimetabolites|mesh-ancestor
5921684|NCT04956432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921685|NCT04956432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5921686|NCT04956432|Gout Suppressants|gout suppressants|mesh-ancestor
5921687|NCT04956432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5921688|NCT04956432|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5921689|NCT04956432|Antioxidants|antioxidants|mesh-ancestor
5921690|NCT04956432|Protective Agents|protective agents|mesh-ancestor
5921691|NCT04956432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921692|NCT04956419|Fluconazole|fluconazole|mesh-list
5921693|NCT04956419|Antifungal Agents|antifungal agents|mesh-ancestor
5921694|NCT04956419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5921695|NCT04956419|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5921696|NCT04956419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5921697|NCT04956419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5921698|NCT04956419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921699|NCT04956419|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5921700|NCT04956419|Hormone Antagonists|hormone antagonists|mesh-ancestor
5921701|NCT04956419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5921702|NCT04956419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921703|NCT04956419|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5921704|NCT04956419|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5921705|NCT04956705|Vitamin D|vitamin d|mesh-list
5921706|NCT04956705|Calcium|calcium|mesh-list
5921707|NCT04956705|Vitamins|vitamins|mesh-ancestor
5921708|NCT04956705|Micronutrients|micronutrients|mesh-ancestor
5921709|NCT04956705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921710|NCT04956705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5718520|NCT03224923|Analgesics|analgesics|mesh-ancestor
5718521|NCT03224923|Sensory System Agents|sensory system agents|mesh-ancestor
5718522|NCT03224923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5718523|NCT03224923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718524|NCT03224923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5718525|NCT03224923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5718526|NCT03224923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5718527|NCT03224923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5718528|NCT03224923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718529|NCT03224923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5718530|NCT03224923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5718531|NCT03224923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5718532|NCT03224923|Antipyretics|antipyretics|mesh-ancestor
5921711|NCT04956705|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5921712|NCT04956484|Belimumab|belimumab|mesh-list
5921713|NCT04956484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5921714|NCT04956484|Immunologic Factors|immunologic factors|mesh-ancestor
5921715|NCT04956484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921716|NCT04956094|Uric Acid|uric acid|mesh-list
5921717|NCT04956094|Antioxidants|antioxidants|mesh-ancestor
5921718|NCT04956094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921719|NCT04956094|Protective Agents|protective agents|mesh-ancestor
5921720|NCT04956094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921721|NCT04956120|Dialysis Solutions|dialysis solutions|mesh-list
5921722|NCT04956120|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5921723|NCT04955678|Sorbitol|sorbitol|mesh-list
5921724|NCT04955678|Calcium|calcium|mesh-list
5921725|NCT04955678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5921726|NCT04955678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921727|NCT04955678|Cathartics|cathartics|mesh-ancestor
5921728|NCT04955678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5921729|NCT04955574|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5921730|NCT04955574|Metronidazole|metronidazole|mesh-list
5921731|NCT04955574|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5921732|NCT04955574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5921733|NCT04955574|Antitubercular Agents|antitubercular agents|mesh-ancestor
5921734|NCT04955574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5921735|NCT04955574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5921736|NCT04955834|Insulin|insulin|mesh-list
5921737|NCT04955834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5921738|NCT04955834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964513|NCT04591275|Denosumab|denosumab|mesh-list
5964514|NCT04591275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5964515|NCT04591275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964516|NCT04591600|Ivermectin|ivermectin|mesh-list
5964517|NCT04591600|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5964518|NCT04591600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5964519|NCT04591405|Vaccines|vaccines|mesh-list
5964520|NCT04591405|Immunologic Factors|immunologic factors|mesh-ancestor
5964521|NCT04591405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964522|NCT04591210|Angiotensin II|angiotensin ii|mesh-list
5964523|NCT04591210|Giapreza|giapreza|mesh-list
5964524|NCT04591210|Enzyme Inhibitors|enzyme inhibitors|mesh-list
5964525|NCT04591210|Angiotensinogen|angiotensinogen|mesh-list
5964526|NCT04591210|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
5964527|NCT04591210|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
5964528|NCT04591210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964529|NCT04591210|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5964530|NCT04591210|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5964531|NCT04591210|Protease Inhibitors|protease inhibitors|mesh-ancestor
5964532|NCT04590742|Melatonin|melatonin|mesh-list
5964533|NCT04590742|Antioxidants|antioxidants|mesh-ancestor
5964534|NCT04590742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964535|NCT04590742|Protective Agents|protective agents|mesh-ancestor
5964536|NCT04590742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964537|NCT04590742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5964538|NCT04590638|Epinephrine|epinephrine|mesh-list
5964539|NCT04590638|Racepinephrine|racepinephrine|mesh-list
5964540|NCT04590638|Epinephryl borate|epinephryl borate|mesh-list
5964541|NCT04590638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5964542|NCT04590638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5964543|NCT04590638|Adrenergic Agents|adrenergic agents|mesh-ancestor
5964544|NCT04590638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5964545|NCT04590638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964546|NCT04590638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964547|NCT04590638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5964548|NCT04590638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5964549|NCT04590638|Autonomic Agents|autonomic agents|mesh-ancestor
5964550|NCT04590638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5964551|NCT04590638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5964552|NCT04590638|Respiratory System Agents|respiratory system agents|mesh-ancestor
5964553|NCT04590638|Mydriatics|mydriatics|mesh-ancestor
5964554|NCT04590638|Sympathomimetics|sympathomimetics|mesh-ancestor
5964555|NCT04590638|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5964556|NCT04590937|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5964557|NCT04590937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5964558|NCT04590937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5964559|NCT04590937|Antimetabolites|antimetabolites|mesh-ancestor
5964560|NCT04590937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964561|NCT04590937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5964562|NCT04590937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5921739|NCT04955470|Midazolam|midazolam|mesh-list
5921740|NCT04955470|Ketamine|ketamine|mesh-list
5921741|NCT04955470|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5921742|NCT04955470|Analgesics|analgesics|mesh-ancestor
5921743|NCT04955470|Sensory System Agents|sensory system agents|mesh-ancestor
5921744|NCT04955470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5921745|NCT04955470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921746|NCT04955470|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5921747|NCT04955470|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5921748|NCT04955470|Anesthetics, General|anesthetics, general|mesh-ancestor
5921749|NCT04955470|Anesthetics|anesthetics|mesh-ancestor
5921750|NCT04955470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5921751|NCT04955470|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5921752|NCT04955470|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5921753|NCT04955470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5921754|NCT04955470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921755|NCT04955470|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5921756|NCT04955470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5921757|NCT04955470|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5921758|NCT04955470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5718533|NCT03224923|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5718534|NCT03224923|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5718535|NCT03224923|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5718536|NCT03224923|Purinergic Agents|purinergic agents|mesh-ancestor
5718537|NCT03224923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5718538|NCT03224637|Acetaminophen|acetaminophen|mesh-list
5718539|NCT03224637|Ketorolac|ketorolac|mesh-list
5718540|NCT03224637|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
5718541|NCT03224637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5718542|NCT03224637|Analgesics|analgesics|mesh-ancestor
5718543|NCT03224637|Sensory System Agents|sensory system agents|mesh-ancestor
5718544|NCT03224637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5718545|NCT03224637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718546|NCT03224637|Antipyretics|antipyretics|mesh-ancestor
5718547|NCT03224637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5718548|NCT03224637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5718549|NCT03224637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5718550|NCT03224637|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5718551|NCT03224637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5718552|NCT03224637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718553|NCT03224572|Ascorbic Acid|ascorbic acid|mesh-list
5718554|NCT03224572|Vitamins|vitamins|mesh-ancestor
5718555|NCT03224572|Micronutrients|micronutrients|mesh-ancestor
5718556|NCT03224572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718557|NCT03224572|Antioxidants|antioxidants|mesh-ancestor
5718558|NCT03224572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718559|NCT03224572|Protective Agents|protective agents|mesh-ancestor
5718560|NCT03224871|Aldesleukin|aldesleukin|mesh-list
5718561|NCT03224871|Pembrolizumab|pembrolizumab|mesh-list
5921759|NCT04955470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5921760|NCT04955470|GABA Modulators|gaba modulators|mesh-ancestor
5921761|NCT04955470|GABA Agents|gaba agents|mesh-ancestor
5921762|NCT04955262|Nivolumab|nivolumab|mesh-list
5921763|NCT04955262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5921764|NCT04955262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5921765|NCT04955262|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5921766|NCT04955262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921767|NCT04955366|Abatacept|abatacept|mesh-list
5921768|NCT04955366|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5921769|NCT04955366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921770|NCT04955366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5921771|NCT04955366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5921772|NCT04955366|Immunologic Factors|immunologic factors|mesh-ancestor
5921773|NCT04955366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921774|NCT04955366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5921775|NCT04954989|Epoetin Alfa|epoetin alfa|mesh-list
5921776|NCT04954989|Hematinics|hematinics|mesh-ancestor
5921777|NCT04954664|Dimenhydrinate|dimenhydrinate|mesh-list
5921778|NCT04954664|Antiemetics|antiemetics|mesh-ancestor
5921779|NCT04954664|Autonomic Agents|autonomic agents|mesh-ancestor
5921780|NCT04954664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5921781|NCT04954664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921782|NCT04954664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5921783|NCT04954664|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5921784|NCT04954664|Histamine Antagonists|histamine antagonists|mesh-ancestor
5718562|NCT03224871|Nivolumab|nivolumab|mesh-list
5921785|NCT04954664|Histamine Agents|histamine agents|mesh-ancestor
5921786|NCT04954664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5921787|NCT04954664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921788|NCT04954742|Riociguat|riociguat|mesh-list
5921789|NCT04954742|Enzyme Activators|enzyme activators|mesh-ancestor
5921790|NCT04954742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921791|NCT04954560|Losartan|losartan|mesh-list
5921792|NCT04954560|Eprosartan|eprosartan|mesh-list
5921793|NCT04954560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5921794|NCT04954560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5921795|NCT04954560|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5921796|NCT04954560|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5921797|NCT04954560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921798|NCT04954560|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
5921799|NCT04954599|Carboplatin|carboplatin|mesh-list
5921800|NCT04954599|Pembrolizumab|pembrolizumab|mesh-list
5921801|NCT04954599|Nivolumab|nivolumab|mesh-list
5921802|NCT04954599|Ipilimumab|ipilimumab|mesh-list
5921803|NCT04954599|Durvalumab|durvalumab|mesh-list
5921804|NCT04954599|Atezolizumab|atezolizumab|mesh-list
5921805|NCT04954599|Avelumab|avelumab|mesh-list
5921806|NCT04954599|Cemiplimab|cemiplimab|mesh-list
5921807|NCT04954599|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5921808|NCT04954599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5921809|NCT04954599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5921810|NCT04954599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921811|NCT04954638|Sodium Hypochlorite|sodium hypochlorite|mesh-list
5921812|NCT04954638|Chlorine dioxide|chlorine dioxide|mesh-list
5921813|NCT04954638|Eusol|eusol|mesh-list
5921814|NCT04954638|Disinfectants|disinfectants|mesh-ancestor
5921815|NCT04954638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5921816|NCT04954638|Dental Disinfectants|dental disinfectants|mesh-ancestor
5964563|NCT04590937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5964564|NCT04590820|Rituximab|rituximab|mesh-list
5964565|NCT04590820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5964566|NCT04590820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5964567|NCT04590820|Immunologic Factors|immunologic factors|mesh-ancestor
5964568|NCT04590820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964569|NCT04590820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5964570|NCT04590612|Levodopa|levodopa|mesh-list
5964571|NCT04590612|Carbidopa|carbidopa|mesh-list
5964572|NCT04590612|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
5964573|NCT04590612|Citalopram|citalopram|mesh-list
5964574|NCT04590612|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
5964575|NCT04590612|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5964576|NCT04590612|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5964577|NCT04590612|Dopamine Agents|dopamine agents|mesh-ancestor
5718563|NCT03224871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5718564|NCT03224871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5718565|NCT03224871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5718566|NCT03224871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718567|NCT03224871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5718568|NCT03224871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5718569|NCT03224871|Antiviral Agents|antiviral agents|mesh-ancestor
5718570|NCT03224871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5722126|NCT03201367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722127|NCT03201367|Anticoagulants|anticoagulants|mesh-ancestor
5722128|NCT03200964|Anesthetics|anesthetics|mesh-list
5722129|NCT03200964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5722130|NCT03200964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722131|NCT03200938|Zinc|zinc|mesh-list
5722132|NCT03200938|Zinc Oxide|zinc oxide|mesh-list
5722133|NCT03200938|Trace Elements|trace elements|mesh-ancestor
5722134|NCT03200938|Micronutrients|micronutrients|mesh-ancestor
5722135|NCT03200938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722136|NCT03200938|Dermatologic Agents|dermatologic agents|mesh-ancestor
5722137|NCT03200938|Sunscreening Agents|sunscreening agents|mesh-ancestor
5722138|NCT03200938|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5964578|NCT04590612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5964579|NCT04590612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964580|NCT04590612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964581|NCT04590612|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5964582|NCT04590612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5964583|NCT04590612|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5964584|NCT04590612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5964585|NCT04590612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5921817|NCT04953754|Melatonin|melatonin|mesh-list
5921818|NCT04953754|Antioxidants|antioxidants|mesh-ancestor
5921819|NCT04953754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921820|NCT04953754|Protective Agents|protective agents|mesh-ancestor
5921821|NCT04953754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921822|NCT04953754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5921823|NCT04953923|Moxifloxacin|moxifloxacin|mesh-list
5921824|NCT04953923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5921825|NCT04953923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5921826|NCT04953923|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5921827|NCT04953923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5921828|NCT04953923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5921829|NCT04953923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921830|NCT04953923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5921831|NCT04953871|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
5921832|NCT04953871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5921833|NCT04953741|Fluticasone|fluticasone|mesh-list
5921834|NCT04953741|Xhance|xhance|mesh-list
5921835|NCT04953741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5921836|NCT04953741|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5921837|NCT04953741|Autonomic Agents|autonomic agents|mesh-ancestor
5921838|NCT04953741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5921839|NCT04953741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921840|NCT04953741|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5921841|NCT04953741|Respiratory System Agents|respiratory system agents|mesh-ancestor
5921842|NCT04953741|Dermatologic Agents|dermatologic agents|mesh-ancestor
5921843|NCT04953741|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5921844|NCT04954014|Bevacizumab|bevacizumab|mesh-list
5921845|NCT04954014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5921846|NCT04954014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5921847|NCT04954014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5921848|NCT04954014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5921849|NCT04954014|Growth Substances|growth substances|mesh-ancestor
5921850|NCT04954014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921851|NCT04954014|Growth Inhibitors|growth inhibitors|mesh-ancestor
5921852|NCT04954040|Azithromycin|azithromycin|mesh-list
5921853|NCT04954040|Hydroxychloroquine|hydroxychloroquine|mesh-list
5921854|NCT04954040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5921855|NCT04954040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5921856|NCT04954040|Antimalarials|antimalarials|mesh-ancestor
5921857|NCT04954040|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5921858|NCT04954040|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5921859|NCT04954040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5921860|NCT04954040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921861|NCT04954040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5921862|NCT04953325|Vaccines|vaccines|mesh-list
5921863|NCT04953325|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5921864|NCT04953325|Immunologic Factors|immunologic factors|mesh-ancestor
5921865|NCT04953325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921866|NCT04953117|Paclitaxel|paclitaxel|mesh-list
5921867|NCT04953117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5921868|NCT04953117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5921869|NCT04953117|Tubulin Modulators|tubulin modulators|mesh-ancestor
5921870|NCT04953117|Antimitotic Agents|antimitotic agents|mesh-ancestor
5921871|NCT04953117|Mitosis Modulators|mitosis modulators|mesh-ancestor
5921872|NCT04953117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921873|NCT04953130|Vaccines|vaccines|mesh-list
5921874|NCT04953130|Immunologic Factors|immunologic factors|mesh-ancestor
5921875|NCT04953130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921876|NCT04953104|Nivolumab|nivolumab|mesh-list
5921877|NCT04953104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5921878|NCT04953104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5921879|NCT04953104|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5921880|NCT04953104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921881|NCT04953156|Nitroglycerin|nitroglycerin|mesh-list
5921882|NCT04953156|Dexmedetomidine|dexmedetomidine|mesh-list
5718571|NCT03224507|Dexamethasone|dexamethasone|mesh-list
5718572|NCT03224507|Dexamethasone acetate|dexamethasone acetate|mesh-list
5718573|NCT03224507|Lenalidomide|lenalidomide|mesh-list
5718574|NCT03224507|Daratumumab|daratumumab|mesh-list
5718575|NCT03224507|BB 1101|bb 1101|mesh-list
5718576|NCT03224507|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5718577|NCT03224507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5718578|NCT03224507|Antiemetics|antiemetics|mesh-ancestor
5718579|NCT03224507|Autonomic Agents|autonomic agents|mesh-ancestor
5718580|NCT03224507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5921883|NCT04953156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5921884|NCT04953156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5921885|NCT04953156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921886|NCT04953156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5921887|NCT04953156|Analgesics|analgesics|mesh-ancestor
5921888|NCT04953156|Sensory System Agents|sensory system agents|mesh-ancestor
5921889|NCT04953156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5921890|NCT04953156|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5921891|NCT04953156|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5921892|NCT04953156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5921893|NCT04953156|Adrenergic Agents|adrenergic agents|mesh-ancestor
5718581|NCT03224507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718582|NCT03224507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5718583|NCT03224507|Glucocorticoids|glucocorticoids|mesh-ancestor
5921894|NCT04953156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5921895|NCT04953156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921896|NCT04953156|Vasodilator Agents|vasodilator agents|mesh-ancestor
5921897|NCT04952727|Vaccines|vaccines|mesh-list
5921898|NCT04952727|Immunologic Factors|immunologic factors|mesh-ancestor
5921899|NCT04952727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921900|NCT04952792|Apixaban|apixaban|mesh-list
5921901|NCT04952792|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5921902|NCT04952792|Antithrombins|antithrombins|mesh-ancestor
5921903|NCT04952792|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5921904|NCT04952792|Protease Inhibitors|protease inhibitors|mesh-ancestor
5921905|NCT04952792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5921906|NCT04952792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921907|NCT04952792|Anticoagulants|anticoagulants|mesh-ancestor
5921908|NCT04952571|Bevacizumab|bevacizumab|mesh-list
5921909|NCT04952571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5921910|NCT04952571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5921911|NCT04952571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5921912|NCT04952571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5921913|NCT04952571|Growth Substances|growth substances|mesh-ancestor
5921914|NCT04952571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921915|NCT04952571|Growth Inhibitors|growth inhibitors|mesh-ancestor
5921916|NCT04952519|Amantadine|amantadine|mesh-list
5921917|NCT04952519|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5921918|NCT04952519|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5921919|NCT04952519|Antiviral Agents|antiviral agents|mesh-ancestor
5921920|NCT04952519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5921921|NCT04952519|Dopamine Agents|dopamine agents|mesh-ancestor
5921922|NCT04952519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5921923|NCT04952519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921924|NCT04952519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921925|NCT04952519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5921926|NCT04952519|Analgesics|analgesics|mesh-ancestor
5921927|NCT04952519|Sensory System Agents|sensory system agents|mesh-ancestor
5921928|NCT04952519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5921929|NCT04952194|Levodopa|levodopa|mesh-list
5921930|NCT04952194|Carbidopa|carbidopa|mesh-list
5921931|NCT04952194|Entacapone|entacapone|mesh-list
5921932|NCT04952194|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5921933|NCT04952194|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5718584|NCT03224507|Hormones|hormones|mesh-ancestor
5718585|NCT03224507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5718586|NCT03224507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5718587|NCT03224507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5921934|NCT04952194|Dopamine Agents|dopamine agents|mesh-ancestor
5921935|NCT04952194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5718588|NCT03224507|Protease Inhibitors|protease inhibitors|mesh-ancestor
5718589|NCT03224507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5718590|NCT03224507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718591|NCT03224507|Immunologic Factors|immunologic factors|mesh-ancestor
5718592|NCT03224507|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5718593|NCT03224507|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5718594|NCT03224507|Growth Substances|growth substances|mesh-ancestor
5718595|NCT03224507|Growth Inhibitors|growth inhibitors|mesh-ancestor
5718596|NCT03224104|Temozolomide|temozolomide|mesh-list
5718597|NCT03224104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5718598|NCT03224104|Alkylating Agents|alkylating agents|mesh-ancestor
5718599|NCT03224104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718600|NCT03224104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5718601|NCT03224208|Vemurafenib|vemurafenib|mesh-list
5964586|NCT04590612|Serotonin Agents|serotonin agents|mesh-ancestor
5921936|NCT04952194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921937|NCT04952194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921938|NCT04952194|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5921939|NCT04952194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5921940|NCT04952194|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
5921941|NCT04952207|Sofosbuvir|sofosbuvir|mesh-list
5921942|NCT04952207|Grazoprevir|grazoprevir|mesh-list
5921943|NCT04952207|Antiviral Agents|antiviral agents|mesh-list
5921944|NCT04952207|Ledipasvir|ledipasvir|mesh-list
5921945|NCT04952207|Velpatasvir|velpatasvir|mesh-list
5921946|NCT04952207|Asunaprevir|asunaprevir|mesh-list
5921947|NCT04952207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5921948|NCT04952207|Protease Inhibitors|protease inhibitors|mesh-ancestor
5921949|NCT04952207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5921950|NCT04952207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921951|NCT04952272|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
5921952|NCT04952272|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5921953|NCT04952272|Immunologic Factors|immunologic factors|mesh-ancestor
5921954|NCT04952272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964587|NCT04590612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5964588|NCT04590612|Antidepressive Agents|antidepressive agents|mesh-ancestor
5718602|NCT03224208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5718603|NCT03224208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5718604|NCT03224208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5718605|NCT03224208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718606|NCT03224338|Dolutegravir|dolutegravir|mesh-list
5718607|NCT03224338|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5718608|NCT03224338|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5718609|NCT03224338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5718610|NCT03224338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718611|NCT03224338|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5718612|NCT03224338|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5718613|NCT03224338|Antiviral Agents|antiviral agents|mesh-ancestor
5718614|NCT03224338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5718615|NCT03224377|Antibodies|antibodies|mesh-list
5718616|NCT03224377|Immunoglobulins|immunoglobulins|mesh-list
5964589|NCT04590612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5964590|NCT04590612|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5964591|NCT04590612|Immunologic Factors|immunologic factors|mesh-ancestor
5964592|NCT04590612|Dopamine Agonists|dopamine agonists|mesh-ancestor
5964593|NCT04590625|Carboplatin|carboplatin|mesh-list
5964594|NCT04590625|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5964595|NCT04590625|Apatinib|apatinib|mesh-list
5964596|NCT04590625|Cisplatin|cisplatin|mesh-list
5964597|NCT04590625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5964598|NCT04590625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964599|NCT04590625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5964600|NCT04590625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5964601|NCT04590326|Cemiplimab|cemiplimab|mesh-list
5964602|NCT04590326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5964603|NCT04590326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5964604|NCT04590183|Prednisolone|prednisolone|mesh-list
5964605|NCT04590183|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5964606|NCT04590183|Methylprednisolone|methylprednisolone|mesh-list
5964607|NCT04590183|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5964608|NCT04590183|Prednisolone acetate|prednisolone acetate|mesh-list
5964609|NCT04590183|Tacrolimus|tacrolimus|mesh-list
5964610|NCT04590183|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5964611|NCT04590183|Prednisolone phosphate|prednisolone phosphate|mesh-list
5964612|NCT04590183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5964613|NCT04590183|Immunologic Factors|immunologic factors|mesh-ancestor
5964614|NCT04590183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964615|NCT04590183|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5964616|NCT04590183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5964617|NCT04590183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964618|NCT04590183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5964619|NCT04590183|Glucocorticoids|glucocorticoids|mesh-ancestor
5964620|NCT04590183|Hormones|hormones|mesh-ancestor
5964621|NCT04590183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5964622|NCT04590183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5964623|NCT04590183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5964624|NCT04590183|Antiemetics|antiemetics|mesh-ancestor
5964625|NCT04590183|Autonomic Agents|autonomic agents|mesh-ancestor
5964626|NCT04590183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5964627|NCT04590183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5964628|NCT04590183|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5921955|NCT04951986|Levofloxacin|levofloxacin|mesh-list
5921956|NCT04951986|Ofloxacin|ofloxacin|mesh-list
5921957|NCT04951986|Rifampin|rifampin|mesh-list
5921958|NCT04951986|Isoniazid|isoniazid|mesh-list
5921959|NCT04951986|Pyrazinamide|pyrazinamide|mesh-list
5921960|NCT04951986|Ethambutol|ethambutol|mesh-list
5921961|NCT04951986|Prednisone|prednisone|mesh-list
5921962|NCT04951986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5921963|NCT04951986|Glucocorticoids|glucocorticoids|mesh-ancestor
5921964|NCT04951986|Hormones|hormones|mesh-ancestor
5921965|NCT04951986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5921966|NCT04951986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5921967|NCT04951986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5921968|NCT04951986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5921969|NCT04951986|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5921970|NCT04951986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5921971|NCT04951986|Renal Agents|renal agents|mesh-ancestor
5921972|NCT04951986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5921973|NCT04951986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5921974|NCT04951986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5921975|NCT04951986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5921976|NCT04951986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921977|NCT04951986|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5921978|NCT04951986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5921979|NCT04951986|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5921980|NCT04951986|Antitubercular Agents|antitubercular agents|mesh-ancestor
5921981|NCT04951986|Leprostatic Agents|leprostatic agents|mesh-ancestor
5921982|NCT04951986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5921983|NCT04951986|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5921984|NCT04951986|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5921985|NCT04951986|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5921986|NCT04951986|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5921987|NCT04951986|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5921988|NCT04951986|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5921989|NCT04951986|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5921990|NCT04951986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5921991|NCT04951986|Antimetabolites|antimetabolites|mesh-ancestor
5921992|NCT04951986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5921993|NCT04951947|Lenvatinib|lenvatinib|mesh-list
5921994|NCT04951947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5921995|NCT04951947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5921996|NCT04951947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5921997|NCT04951947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5921998|NCT04951856|Evolocumab|evolocumab|mesh-list
5921999|NCT04951856|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5922000|NCT04951856|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5922001|NCT04951856|Antimetabolites|antimetabolites|mesh-ancestor
5922002|NCT04951856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922003|NCT04951856|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5922004|NCT04952129|Selenium|selenium|mesh-list
5922005|NCT04952129|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
5922006|NCT04952129|Antioxidants|antioxidants|mesh-ancestor
5922007|NCT04952129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922008|NCT04952129|Protective Agents|protective agents|mesh-ancestor
5922009|NCT04952129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922010|NCT04952129|Trace Elements|trace elements|mesh-ancestor
5922011|NCT04952129|Micronutrients|micronutrients|mesh-ancestor
5922012|NCT04952129|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5922013|NCT04952129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5922014|NCT04952051|Folic Acid|folic acid|mesh-list
5922015|NCT04952051|Vitamin B Complex|vitamin b complex|mesh-list
5922016|NCT04952051|Amlodipine|amlodipine|mesh-list
5922017|NCT04952051|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5922018|NCT04952051|Enalapril|enalapril|mesh-list
5922019|NCT04952051|Enalaprilat|enalaprilat|mesh-list
5922020|NCT04952051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5922021|NCT04952051|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5922022|NCT04952051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5922023|NCT04952051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922024|NCT04952051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5922025|NCT04952051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922026|NCT04952051|Vasodilator Agents|vasodilator agents|mesh-ancestor
5922027|NCT04952051|Diuretics|diuretics|mesh-ancestor
5922028|NCT04952051|Natriuretic Agents|natriuretic agents|mesh-ancestor
5964629|NCT04590183|Protective Agents|protective agents|mesh-ancestor
5718617|NCT03224377|Immunologic Factors|immunologic factors|mesh-ancestor
5718618|NCT03224377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718619|NCT03224221|Fluorouracil|fluorouracil|mesh-list
5718620|NCT03224221|Apatinib|apatinib|mesh-list
5718621|NCT03224221|Antimetabolites|antimetabolites|mesh-ancestor
5718622|NCT03224221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718623|NCT03224221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5718624|NCT03224221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5718625|NCT03224221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5718626|NCT03224221|Immunologic Factors|immunologic factors|mesh-ancestor
5718627|NCT03224221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718628|NCT03224221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5718629|NCT03224221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5718630|NCT03224039|Sufentanil|sufentanil|mesh-list
5718631|NCT03224039|Morphine|morphine|mesh-list
5718632|NCT03224039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5718633|NCT03224039|Narcotics|narcotics|mesh-ancestor
5922029|NCT04952051|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5922030|NCT04952051|Hematinics|hematinics|mesh-ancestor
5922031|NCT04952051|Vitamins|vitamins|mesh-ancestor
5922032|NCT04952051|Micronutrients|micronutrients|mesh-ancestor
5922033|NCT04952051|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5922034|NCT04952051|Protease Inhibitors|protease inhibitors|mesh-ancestor
5922035|NCT04952051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5922036|NCT04951791|SMOFlipid|smoflipid|mesh-list
5922037|NCT04951791|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
5922038|NCT04951791|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5922039|NCT04951791|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5922040|NCT04951713|Clarithromycin|clarithromycin|mesh-list
5922041|NCT04951713|Rifampin|rifampin|mesh-list
5922042|NCT04951713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5922043|NCT04951713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5922044|NCT04951713|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5922045|NCT04951713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5922046|NCT04951713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922047|NCT04951713|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5922048|NCT04951713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5922049|NCT04951713|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5922050|NCT04951713|Antitubercular Agents|antitubercular agents|mesh-ancestor
5922051|NCT04951713|Leprostatic Agents|leprostatic agents|mesh-ancestor
5922052|NCT04951713|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5718634|NCT03224039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5718635|NCT03224039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718636|NCT03224039|Analgesics|analgesics|mesh-ancestor
5718637|NCT03224039|Sensory System Agents|sensory system agents|mesh-ancestor
5718638|NCT03224039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5718639|NCT03224039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5922053|NCT04951713|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5922054|NCT04951713|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5922055|NCT04951713|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5922056|NCT04951713|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5922057|NCT04951713|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5922058|NCT04951713|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5922059|NCT04951752|Ropivacaine|ropivacaine|mesh-list
5922060|NCT04951752|Anesthetics, Local|anesthetics, local|mesh-ancestor
5922061|NCT04951752|Anesthetics|anesthetics|mesh-ancestor
5922062|NCT04951752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5922063|NCT04951752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922064|NCT04951752|Sensory System Agents|sensory system agents|mesh-ancestor
5922065|NCT04951752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5922066|NCT04951505|Cefepime|cefepime|mesh-list
5922067|NCT04951505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5922068|NCT04951505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5922069|NCT04951362|Ivermectin|ivermectin|mesh-list
5922070|NCT04951362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5922071|NCT04951362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5922072|NCT04951726|Neostigmine|neostigmine|mesh-list
5922073|NCT04951726|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5922074|NCT04951726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5922075|NCT04951726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922076|NCT04951726|Cholinergic Agents|cholinergic agents|mesh-ancestor
5922077|NCT04951726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5922078|NCT04951726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718640|NCT03224039|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5922079|NCT04951726|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5922080|NCT04951726|Autonomic Agents|autonomic agents|mesh-ancestor
5922081|NCT04951726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5922082|NCT04951349|Petrolatum|petrolatum|mesh-list
5922083|NCT04951349|Emollients|emollients|mesh-ancestor
5922084|NCT04951349|Dermatologic Agents|dermatologic agents|mesh-ancestor
5922085|NCT04951167|Norepinephrine|norepinephrine|mesh-list
5922086|NCT04951167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5922087|NCT04951167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5922088|NCT04951167|Adrenergic Agents|adrenergic agents|mesh-ancestor
5922089|NCT04951167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5922090|NCT04951167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922091|NCT04951167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922092|NCT04951167|Sympathomimetics|sympathomimetics|mesh-ancestor
5922093|NCT04951167|Autonomic Agents|autonomic agents|mesh-ancestor
5922094|NCT04951167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5922095|NCT04951167|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5922096|NCT04950933|Riluzole|riluzole|mesh-list
5922097|NCT04950933|Anticonvulsants|anticonvulsants|mesh-ancestor
5922098|NCT04950933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5922099|NCT04950933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5922100|NCT04950933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5922101|NCT04950933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922102|NCT04950933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922103|NCT04950933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5922104|NCT04950933|Protective Agents|protective agents|mesh-ancestor
5922105|NCT04951128|Anesthetics|anesthetics|mesh-list
5922106|NCT04951128|Anesthetics, Local|anesthetics, local|mesh-list
5922107|NCT04951128|Tranexamic Acid|tranexamic acid|mesh-list
5922108|NCT04951128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5922109|NCT04951128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922110|NCT04951128|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5922111|NCT04951128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5922112|NCT04951128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922113|NCT04951128|Hemostatics|hemostatics|mesh-ancestor
5922114|NCT04951128|Coagulants|coagulants|mesh-ancestor
5922115|NCT04951128|Sensory System Agents|sensory system agents|mesh-ancestor
5922116|NCT04951128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5922117|NCT04951232|Cinepazide|cinepazide|mesh-list
5922118|NCT04951232|Vasodilator Agents|vasodilator agents|mesh-ancestor
5922119|NCT04951115|Carboplatin|carboplatin|mesh-list
5922120|NCT04951115|Etoposide|etoposide|mesh-list
5922121|NCT04951115|Durvalumab|durvalumab|mesh-list
5922122|NCT04951115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5922123|NCT04951115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5922124|NCT04951115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5922125|NCT04951115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5922126|NCT04951115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5922127|NCT04951115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922128|NCT04951115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5922129|NCT04951206|Clobetasol|clobetasol|mesh-list
5922130|NCT04951206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5922131|NCT04951206|Glucocorticoids|glucocorticoids|mesh-ancestor
5922132|NCT04951206|Hormones|hormones|mesh-ancestor
5922133|NCT04951206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5922134|NCT04951206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922135|NCT04950569|Simendan|simendan|mesh-list
5922136|NCT04950569|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5922137|NCT04950569|Vasodilator Agents|vasodilator agents|mesh-ancestor
5922138|NCT04950569|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5922139|NCT04950569|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5922140|NCT04950569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5922141|NCT04950569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922142|NCT04950569|Protective Agents|protective agents|mesh-ancestor
5922143|NCT04950569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922148|NCT04950621|Propofol|propofol|mesh-list
5922149|NCT04950621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5922150|NCT04950621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5922151|NCT04950621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922152|NCT04950621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5922153|NCT04950621|Anesthetics, General|anesthetics, general|mesh-ancestor
5922154|NCT04950621|Anesthetics|anesthetics|mesh-ancestor
5922155|NCT04950647|Nitrofurazone|nitrofurazone|mesh-list
5922156|NCT04950647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5922157|NCT04950205|Sevoflurane|sevoflurane|mesh-list
5922158|NCT04950205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5922159|NCT04950205|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5922160|NCT04950205|Anesthetics, General|anesthetics, general|mesh-ancestor
5922161|NCT04950205|Anesthetics|anesthetics|mesh-ancestor
5922162|NCT04950205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5922163|NCT04950205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964630|NCT04590495|Cannabidiol|cannabidiol|mesh-list
5964631|NCT04590495|Anticonvulsants|anticonvulsants|mesh-ancestor
5964632|NCT04590508|Xanthohumol|xanthohumol|mesh-list
5964633|NCT04590508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5964634|NCT04590508|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5964635|NCT04590508|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5964636|NCT04590508|Growth Substances|growth substances|mesh-ancestor
5964637|NCT04590508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964638|NCT04590508|Growth Inhibitors|growth inhibitors|mesh-ancestor
5964639|NCT04590482|Letrozole|letrozole|mesh-list
5964640|NCT04590482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5964641|NCT04590482|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5964642|NCT04590482|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5964643|NCT04590482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5964644|NCT04590482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964645|NCT04590482|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5964646|NCT04590482|Hormone Antagonists|hormone antagonists|mesh-ancestor
5964647|NCT04590482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5964648|NCT04590482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964649|NCT04590196|Curcumin|curcumin|mesh-list
5964650|NCT04590196|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5964651|NCT04590196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5964652|NCT04590196|Analgesics|analgesics|mesh-ancestor
5964653|NCT04590196|Sensory System Agents|sensory system agents|mesh-ancestor
5964654|NCT04590196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5964655|NCT04590196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964656|NCT04590196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5964657|NCT04590196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5964658|NCT04590196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5964659|NCT04590196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5964660|NCT04590196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964661|NCT04589819|Teriparatide|teriparatide|mesh-list
5964662|NCT04589819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5964663|NCT04589819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964664|NCT04589819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5964665|NCT04589728|Venetoclax|venetoclax|mesh-list
5964666|NCT04589728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5964667|NCT04589429|Morphine|morphine|mesh-list
5964668|NCT04589429|Nalbuphine|nalbuphine|mesh-list
5964669|NCT04589429|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5964670|NCT04589429|Narcotics|narcotics|mesh-ancestor
5964671|NCT04589429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5964672|NCT04589429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964673|NCT04589429|Analgesics|analgesics|mesh-ancestor
5964674|NCT04589429|Sensory System Agents|sensory system agents|mesh-ancestor
5964675|NCT04589429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5964676|NCT04589364|Botulinum Toxins|botulinum toxins|mesh-list
5964677|NCT04589364|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5964678|NCT04589364|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5964679|NCT04589364|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5964680|NCT04589364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5964681|NCT04589364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964682|NCT04589364|Cholinergic Agents|cholinergic agents|mesh-ancestor
5964683|NCT04589364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5964684|NCT04589364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964685|NCT04589364|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5964686|NCT04589364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5964687|NCT04589390|Selexipag|selexipag|mesh-list
5964688|NCT04589390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5964689|NCT04589546|Niacinamide|niacinamide|mesh-list
5964690|NCT04589546|Niacin|niacin|mesh-list
5964691|NCT04589546|Nicotinic Acids|nicotinic acids|mesh-list
5964692|NCT04589546|Vitamin B Complex|vitamin b complex|mesh-ancestor
5964693|NCT04589546|Vitamins|vitamins|mesh-ancestor
5964694|NCT04589546|Micronutrients|micronutrients|mesh-ancestor
5964695|NCT04589546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964696|NCT04589546|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5964697|NCT04589546|Antimetabolites|antimetabolites|mesh-ancestor
5718641|NCT03224039|Anesthetics, General|anesthetics, general|mesh-ancestor
5718642|NCT03224039|Anesthetics|anesthetics|mesh-ancestor
5718643|NCT03224416|Ethanol|ethanol|mesh-list
5922164|NCT04950049|Dexamethasone|dexamethasone|mesh-list
5922165|NCT04950049|Dexamethasone acetate|dexamethasone acetate|mesh-list
5922166|NCT04950049|BB 1101|bb 1101|mesh-list
5922167|NCT04950049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5922168|NCT04950049|Antiemetics|antiemetics|mesh-ancestor
5922169|NCT04950049|Autonomic Agents|autonomic agents|mesh-ancestor
5922170|NCT04950049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5718644|NCT03224416|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5718645|NCT03224416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5718646|NCT03224416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5718647|NCT03224416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718648|NCT03223779|Trifluridine|trifluridine|mesh-list
5718649|NCT03223779|Antimetabolites|antimetabolites|mesh-ancestor
5718650|NCT03223779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718651|NCT03223779|Antiviral Agents|antiviral agents|mesh-ancestor
5718652|NCT03223779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5718653|NCT03223844|Dextroamphetamine|dextroamphetamine|mesh-list
5718654|NCT03223844|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5718655|NCT03223844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718656|NCT03223844|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5718657|NCT03223844|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5718658|NCT03223844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5718659|NCT03223844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718660|NCT03223844|Dopamine Agents|dopamine agents|mesh-ancestor
5718661|NCT03223844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5718662|NCT03223974|Paclitaxel|paclitaxel|mesh-list
5922171|NCT04950049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922172|NCT04950049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5922173|NCT04950049|Glucocorticoids|glucocorticoids|mesh-ancestor
5922174|NCT04950049|Hormones|hormones|mesh-ancestor
5922175|NCT04950049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5922176|NCT04950049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5922177|NCT04950049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5922178|NCT04950049|Protease Inhibitors|protease inhibitors|mesh-ancestor
5922179|NCT04950049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5922180|NCT04950049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922181|NCT04950400|Apatinib|apatinib|mesh-list
5922182|NCT04950400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5922183|NCT04950400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5922184|NCT04950400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5922185|NCT04950400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922186|NCT04950530|Emtricitabine|emtricitabine|mesh-list
5922187|NCT04950530|Antiviral Agents|antiviral agents|mesh-ancestor
5922188|NCT04950530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5922189|NCT04950530|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5922190|NCT04950530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5922191|NCT04950530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5922192|NCT04950530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922193|NCT04950530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5922194|NCT04950530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5922195|NCT04950270|Arginine Vasopressin|arginine vasopressin|mesh-list
5922196|NCT04950270|Hemostatics|hemostatics|mesh-ancestor
5922197|NCT04950270|Coagulants|coagulants|mesh-ancestor
5922198|NCT04950270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5922199|NCT04950270|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5922200|NCT04950270|Natriuretic Agents|natriuretic agents|mesh-ancestor
5922201|NCT04950270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922202|NCT04949867|Glucagon|glucagon|mesh-list
5922203|NCT04949867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5922204|NCT04949867|Hormones|hormones|mesh-ancestor
5922205|NCT04949867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5922206|NCT04949867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922207|NCT04949932|Turmeric extract|turmeric extract|mesh-list
5922208|NCT04949932|Antioxidants|antioxidants|mesh-ancestor
5922209|NCT04949932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922210|NCT04949932|Protective Agents|protective agents|mesh-ancestor
5922211|NCT04949932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922212|NCT04949464|Nicotine|nicotine|mesh-list
5922213|NCT04949464|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5922214|NCT04949464|Autonomic Agents|autonomic agents|mesh-ancestor
5922215|NCT04949464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5722139|NCT03200938|Protective Agents|protective agents|mesh-ancestor
5922216|NCT04949464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922217|NCT04949464|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5922218|NCT04949464|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5922219|NCT04949464|Cholinergic Agents|cholinergic agents|mesh-ancestor
5922220|NCT04949464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5922221|NCT04949464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922222|NCT04949516|Aspirin|aspirin|mesh-list
5922223|NCT04949516|Colchicine|colchicine|mesh-list
5922224|NCT04949516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5922225|NCT04949516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5922226|NCT04949516|Analgesics|analgesics|mesh-ancestor
5922227|NCT04949516|Sensory System Agents|sensory system agents|mesh-ancestor
5922228|NCT04949516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5922229|NCT04949516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922230|NCT04949516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5922231|NCT04949516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5922232|NCT04949516|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5922233|NCT04949516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5922234|NCT04949516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922235|NCT04949516|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5922236|NCT04949516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5922237|NCT04949516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5922238|NCT04949516|Antipyretics|antipyretics|mesh-ancestor
5922239|NCT04949516|Gout Suppressants|gout suppressants|mesh-ancestor
5922240|NCT04949516|Tubulin Modulators|tubulin modulators|mesh-ancestor
5922241|NCT04949516|Antimitotic Agents|antimitotic agents|mesh-ancestor
5922242|NCT04949516|Mitosis Modulators|mitosis modulators|mesh-ancestor
5922243|NCT04949516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5922244|NCT04949503|Nimotuzumab|nimotuzumab|mesh-list
5922245|NCT04949503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5922246|NCT04949503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5922247|NCT04949282|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
5922248|NCT04949282|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5922249|NCT04949282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922250|NCT04949113|Nivolumab|nivolumab|mesh-list
5922251|NCT04949113|Ipilimumab|ipilimumab|mesh-list
5922252|NCT04949113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5922253|NCT04949113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5922254|NCT04949113|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5922255|NCT04949113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922256|NCT04949269|BMS-986165|bms-986165|mesh-list
5922257|NCT04949269|Famotidine|famotidine|mesh-list
5922258|NCT04949269|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5922259|NCT04949269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5922260|NCT04949269|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5922261|NCT04949269|Histamine Antagonists|histamine antagonists|mesh-ancestor
5922262|NCT04949269|Histamine Agents|histamine agents|mesh-ancestor
5922263|NCT04949269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5922264|NCT04949269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922265|NCT04949269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922266|NCT04949269|Dermatologic Agents|dermatologic agents|mesh-ancestor
5922267|NCT04949269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5922268|NCT04949269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5922269|NCT04949347|Glycerol|glycerol|mesh-list
5922270|NCT04949347|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
5922271|NCT04949347|Protective Agents|protective agents|mesh-ancestor
5922272|NCT04949347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922273|NCT04949477|Acetaminophen|acetaminophen|mesh-list
5922274|NCT04949477|Dexmedetomidine|dexmedetomidine|mesh-list
5922275|NCT04949477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5922276|NCT04949477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5922277|NCT04949477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922278|NCT04949477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5922279|NCT04949477|Analgesics|analgesics|mesh-ancestor
5922280|NCT04949477|Sensory System Agents|sensory system agents|mesh-ancestor
5922281|NCT04949477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5922282|NCT04949477|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5922283|NCT04949477|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5922284|NCT04949477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5922285|NCT04949477|Adrenergic Agents|adrenergic agents|mesh-ancestor
5922286|NCT04949477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5922287|NCT04949477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922288|NCT04949477|Antipyretics|antipyretics|mesh-ancestor
5922289|NCT04948814|Vancomycin|vancomycin|mesh-list
5922290|NCT04948814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5922291|NCT04948814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5922292|NCT04948749|Sirolimus|sirolimus|mesh-list
5922293|NCT04948749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5922294|NCT04948749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5922295|NCT04948749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5922296|NCT04948749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5922297|NCT04948749|Antifungal Agents|antifungal agents|mesh-ancestor
5922298|NCT04948749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5922299|NCT04948749|Immunologic Factors|immunologic factors|mesh-ancestor
5922300|NCT04948749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922301|NCT04948788|Gemcitabine|gemcitabine|mesh-list
5922302|NCT04948788|Oxaliplatin|oxaliplatin|mesh-list
5922303|NCT04948788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5922304|NCT04948788|Antimetabolites|antimetabolites|mesh-ancestor
5922305|NCT04948788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922306|NCT04948788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5922307|NCT04948788|Antiviral Agents|antiviral agents|mesh-ancestor
5922308|NCT04948788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5922309|NCT04948788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5922310|NCT04948788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5922311|NCT04948788|Immunologic Factors|immunologic factors|mesh-ancestor
5922312|NCT04948788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922313|NCT04948697|Bevacizumab|bevacizumab|mesh-list
5922314|NCT04948697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5922315|NCT04948697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5922316|NCT04948697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5922317|NCT04948697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5922318|NCT04948697|Growth Substances|growth substances|mesh-ancestor
5922319|NCT04948697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922320|NCT04948697|Growth Inhibitors|growth inhibitors|mesh-ancestor
5922321|NCT04948957|Nitroglycerin|nitroglycerin|mesh-list
5922322|NCT04948957|Esmolol|esmolol|mesh-list
5922323|NCT04948957|Vasodilator Agents|vasodilator agents|mesh-ancestor
5922324|NCT04948957|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5922325|NCT04948957|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5922326|NCT04948957|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5922327|NCT04948957|Adrenergic Agents|adrenergic agents|mesh-ancestor
5922328|NCT04948957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5922329|NCT04948957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922330|NCT04948957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922331|NCT04948801|Sofosbuvir|sofosbuvir|mesh-list
5922332|NCT04948801|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
5922333|NCT04948801|Velpatasvir|velpatasvir|mesh-list
5922334|NCT04948801|Antiviral Agents|antiviral agents|mesh-ancestor
5922335|NCT04948801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5922336|NCT04948489|Norethindrone|norethindrone|mesh-list
5922337|NCT04948489|Norethindrone Acetate|norethindrone acetate|mesh-list
5922338|NCT04948489|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5922339|NCT04948489|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5922340|NCT04948489|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5922341|NCT04948489|Contraceptive Agents|contraceptive agents|mesh-ancestor
5922342|NCT04948489|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5922343|NCT04948489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922344|NCT04948489|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5922345|NCT04948489|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5964698|NCT04589546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964699|NCT04589546|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5964700|NCT04589546|Vasodilator Agents|vasodilator agents|mesh-ancestor
5970716|NCT04532918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5970717|NCT04532918|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5970718|NCT04532918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5970719|NCT04532918|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5970720|NCT04532918|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5970721|NCT04532918|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5970722|NCT04532918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5970723|NCT04532918|Antimetabolites|antimetabolites|mesh-ancestor
5970724|NCT04532918|Gout Suppressants|gout suppressants|mesh-ancestor
5970725|NCT04532918|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5970726|NCT04532918|Antioxidants|antioxidants|mesh-ancestor
5970727|NCT04532918|Protective Agents|protective agents|mesh-ancestor
5970728|NCT04532775|Methylprednisolone|methylprednisolone|mesh-list
5970729|NCT04532775|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5970730|NCT04532775|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5970731|NCT04532775|Prednisolone|prednisolone|mesh-list
5922346|NCT04948567|Magnesium Sulfate|magnesium sulfate|mesh-list
5922347|NCT04948567|Analgesics|analgesics|mesh-ancestor
5922348|NCT04948567|Sensory System Agents|sensory system agents|mesh-ancestor
5922349|NCT04948567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5922350|NCT04948567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922351|NCT04948567|Anesthetics|anesthetics|mesh-ancestor
5922352|NCT04948567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5922353|NCT04948567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5922354|NCT04948567|Anticonvulsants|anticonvulsants|mesh-ancestor
5922355|NCT04948567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5922356|NCT04948567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5922357|NCT04948567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922358|NCT04948567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5922359|NCT04948567|Tocolytic Agents|tocolytic agents|mesh-ancestor
5922360|NCT04948567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5922361|NCT04948203|Sirolimus|sirolimus|mesh-list
5922362|NCT04948203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5922363|NCT04948203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5922364|NCT04948203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5922365|NCT04948203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5922366|NCT04948203|Antifungal Agents|antifungal agents|mesh-ancestor
5922367|NCT04948203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5922368|NCT04948203|Immunologic Factors|immunologic factors|mesh-ancestor
5922369|NCT04948203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922370|NCT04948294|Pyrithione zinc|pyrithione zinc|mesh-list
5922371|NCT04948294|Keratolytic Agents|keratolytic agents|mesh-ancestor
5922372|NCT04948294|Dermatologic Agents|dermatologic agents|mesh-ancestor
5922373|NCT04948125|Apatinib|apatinib|mesh-list
5922374|NCT04948125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5922375|NCT04948125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5922376|NCT04948125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5922377|NCT04948125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922378|NCT04948385|Propofol|propofol|mesh-list
5922379|NCT04948385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5922380|NCT04948385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5922381|NCT04948385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922382|NCT04948385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5922383|NCT04948385|Anesthetics, General|anesthetics, general|mesh-ancestor
5922384|NCT04948385|Anesthetics|anesthetics|mesh-ancestor
5922385|NCT04948372|Terlipressin|terlipressin|mesh-list
5922386|NCT04948372|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5922387|NCT04948372|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5922388|NCT04947748|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5922389|NCT04947748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5922390|NCT04948164|Naproxen|naproxen|mesh-list
5922391|NCT04948164|Sumatriptan|sumatriptan|mesh-list
5922392|NCT04948164|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5922393|NCT04948164|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5922394|NCT04948164|Analgesics|analgesics|mesh-ancestor
5922395|NCT04948164|Sensory System Agents|sensory system agents|mesh-ancestor
5922396|NCT04948164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5922397|NCT04948164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922398|NCT04948164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5922399|NCT04948164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5922400|NCT04948164|Gout Suppressants|gout suppressants|mesh-ancestor
5922401|NCT04948164|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5922402|NCT04948164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5922403|NCT04948164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922404|NCT04948164|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5922405|NCT04948164|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5922406|NCT04948164|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5922407|NCT04948164|Serotonin Agents|serotonin agents|mesh-ancestor
5922408|NCT04948164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5922409|NCT04947956|Apatinib|apatinib|mesh-list
5922410|NCT04947956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5922411|NCT04947956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5922412|NCT04947956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5922413|NCT04947956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922414|NCT04948151|Sildenafil Citrate|sildenafil citrate|mesh-list
5922415|NCT04948151|Vasodilator Agents|vasodilator agents|mesh-ancestor
5922416|NCT04948151|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5922417|NCT04948151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5922418|NCT04948151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5922419|NCT04948151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922420|NCT04948151|Urological Agents|urological agents|mesh-ancestor
5922421|NCT04947501|Cyclophosphamide|cyclophosphamide|mesh-list
5922422|NCT04947501|Ifosfamide|ifosfamide|mesh-list
5922423|NCT04947501|Carboplatin|carboplatin|mesh-list
5922424|NCT04947501|Doxorubicin|doxorubicin|mesh-list
5922425|NCT04947501|Etoposide|etoposide|mesh-list
5922426|NCT04947501|Vincristine|vincristine|mesh-list
5922427|NCT04947501|Topotecan|topotecan|mesh-list
5922428|NCT04947501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5922429|NCT04947501|Immunologic Factors|immunologic factors|mesh-ancestor
5922430|NCT04947501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922431|NCT04947501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5922432|NCT04947501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5922433|NCT04947501|Alkylating Agents|alkylating agents|mesh-ancestor
5922434|NCT04947501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922435|NCT04947501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5922436|NCT04947501|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5922437|NCT04947501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5922438|NCT04947501|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5922439|NCT04947501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5922440|NCT04947501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5718663|NCT03223974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5718664|NCT03223974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5718665|NCT03223974|Tubulin Modulators|tubulin modulators|mesh-ancestor
5718666|NCT03223974|Antimitotic Agents|antimitotic agents|mesh-ancestor
5718667|NCT03223974|Mitosis Modulators|mitosis modulators|mesh-ancestor
5718668|NCT03223974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718669|NCT03223597|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
5718670|NCT03223597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5718671|NCT03223961|Epoetin Alfa|epoetin alfa|mesh-list
5718672|NCT03223961|Hematinics|hematinics|mesh-ancestor
5718673|NCT03223506|Acetaminophen|acetaminophen|mesh-list
5718674|NCT03223506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5718675|NCT03223506|Analgesics|analgesics|mesh-ancestor
5718676|NCT03223506|Sensory System Agents|sensory system agents|mesh-ancestor
5718677|NCT03223506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5718678|NCT03223506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718679|NCT03223506|Antipyretics|antipyretics|mesh-ancestor
5718680|NCT03223896|Naloxone|naloxone|mesh-list
5922441|NCT04947501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5922442|NCT04947501|Tubulin Modulators|tubulin modulators|mesh-ancestor
5922443|NCT04947501|Antimitotic Agents|antimitotic agents|mesh-ancestor
5922444|NCT04947501|Mitosis Modulators|mitosis modulators|mesh-ancestor
5922445|NCT04947501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5922446|NCT04947826|Antibodies|antibodies|mesh-list
5922447|NCT04947826|Immunoglobulins|immunoglobulins|mesh-list
5922448|NCT04947826|Immunologic Factors|immunologic factors|mesh-ancestor
5922449|NCT04947826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922450|NCT04947566|Ibuprofen|ibuprofen|mesh-list
5922451|NCT04947566|Naproxen|naproxen|mesh-list
5922452|NCT04947566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5922453|NCT04947566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5922454|NCT04947566|Analgesics|analgesics|mesh-ancestor
5922455|NCT04947566|Sensory System Agents|sensory system agents|mesh-ancestor
5922456|NCT04947566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5922457|NCT04947566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922458|NCT04947566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5922459|NCT04947566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5922460|NCT04947566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5922461|NCT04947566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5922462|NCT04947566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922463|NCT04947566|Gout Suppressants|gout suppressants|mesh-ancestor
5922464|NCT04947423|Scopolamine|scopolamine|mesh-list
5922465|NCT04947423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5922466|NCT04947423|Antiemetics|antiemetics|mesh-ancestor
5922467|NCT04947423|Autonomic Agents|autonomic agents|mesh-ancestor
5922468|NCT04947423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5922469|NCT04947423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922470|NCT04947423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5922471|NCT04947423|Mydriatics|mydriatics|mesh-ancestor
5922472|NCT04947423|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5922473|NCT04947423|Cholinergic Agents|cholinergic agents|mesh-ancestor
5922474|NCT04947423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5922475|NCT04947423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718681|NCT03223896|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5718682|NCT03223896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922476|NCT04947423|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5922477|NCT04947267|Epinephrine|epinephrine|mesh-list
5922478|NCT04947267|Mepivacaine|mepivacaine|mesh-list
5922479|NCT04947267|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5922480|NCT04947267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5922481|NCT04947267|Adrenergic Agents|adrenergic agents|mesh-ancestor
5922482|NCT04947267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5922483|NCT04947267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922484|NCT04947267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922485|NCT04947267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5922486|NCT04947267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5922487|NCT04947267|Autonomic Agents|autonomic agents|mesh-ancestor
5922488|NCT04947267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5922489|NCT04947267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5922490|NCT04947267|Respiratory System Agents|respiratory system agents|mesh-ancestor
5922491|NCT04947267|Mydriatics|mydriatics|mesh-ancestor
5922492|NCT04947267|Sympathomimetics|sympathomimetics|mesh-ancestor
5922493|NCT04947267|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5922494|NCT04947267|Anesthetics, Local|anesthetics, local|mesh-ancestor
5922495|NCT04947267|Anesthetics|anesthetics|mesh-ancestor
5922496|NCT04947267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5922497|NCT04947267|Sensory System Agents|sensory system agents|mesh-ancestor
5922498|NCT04947111|Antibodies|antibodies|mesh-list
5922499|NCT04947111|Immunoglobulins|immunoglobulins|mesh-list
5922500|NCT04947111|Antibodies, Blocking|antibodies, blocking|mesh-list
5922501|NCT04947111|Immunologic Factors|immunologic factors|mesh-ancestor
5922502|NCT04947111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922503|NCT04946929|Heparin|heparin|mesh-list
5922504|NCT04946929|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5922505|NCT04946929|Tinzaparin|tinzaparin|mesh-list
5922506|NCT04946929|Dalteparin|dalteparin|mesh-list
5922507|NCT04946929|Ticagrelor|ticagrelor|mesh-list
5922508|NCT04946929|Anticoagulants|anticoagulants|mesh-ancestor
5922509|NCT04946929|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5922510|NCT04946929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5922511|NCT04946929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922512|NCT04946929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5922513|NCT04946929|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5922514|NCT04946929|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5922515|NCT04946929|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5922516|NCT04946929|Purinergic Agents|purinergic agents|mesh-ancestor
5922517|NCT04946929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5922518|NCT04946929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922519|NCT04947345|Propofol|propofol|mesh-list
5922520|NCT04947345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5922521|NCT04947345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5922522|NCT04947345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922523|NCT04947345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5922524|NCT04947345|Anesthetics, General|anesthetics, general|mesh-ancestor
5922525|NCT04947345|Anesthetics|anesthetics|mesh-ancestor
5922526|NCT04947189|Dexamethasone|dexamethasone|mesh-list
5922527|NCT04947189|Docetaxel|docetaxel|mesh-list
5922528|NCT04947189|Seviteronel|seviteronel|mesh-list
5922529|NCT04947189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5922530|NCT04947189|Antiemetics|antiemetics|mesh-ancestor
5922531|NCT04947189|Autonomic Agents|autonomic agents|mesh-ancestor
5922532|NCT04947189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5922533|NCT04947189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922534|NCT04947189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5922535|NCT04947189|Glucocorticoids|glucocorticoids|mesh-ancestor
5922536|NCT04947189|Hormones|hormones|mesh-ancestor
5922537|NCT04947189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5922538|NCT04947189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5922539|NCT04947189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5922540|NCT04947189|Tubulin Modulators|tubulin modulators|mesh-ancestor
5922541|NCT04947189|Antimitotic Agents|antimitotic agents|mesh-ancestor
5922542|NCT04947189|Mitosis Modulators|mitosis modulators|mesh-ancestor
5922543|NCT04947189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922544|NCT04947189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5922545|NCT04947189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5922546|NCT04947254|Ascorbic Acid|ascorbic acid|mesh-list
5922547|NCT04947254|Prednisone|prednisone|mesh-list
5922548|NCT04947254|Cortisone|cortisone|mesh-list
5922549|NCT04947254|Methyltestosterone|methyltestosterone|mesh-list
5922550|NCT04947254|Abiraterone Acetate|abiraterone acetate|mesh-list
5922551|NCT04947254|Niraparib|niraparib|mesh-list
5922552|NCT04947254|Hormones|hormones|mesh-list
5922553|NCT04947254|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
5922554|NCT04947254|Androgens|androgens|mesh-list
5922555|NCT04947254|Androgen Antagonists|androgen antagonists|mesh-list
5922556|NCT04947254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5922557|NCT04947254|Glucocorticoids|glucocorticoids|mesh-ancestor
5922558|NCT04947254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5922559|NCT04947254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922560|NCT04947254|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5922561|NCT04947254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5922562|NCT04947254|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5922563|NCT04947254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5922564|NCT04947254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922565|NCT04947254|Hormone Antagonists|hormone antagonists|mesh-ancestor
5922566|NCT04947254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5922567|NCT04947254|Antioxidants|antioxidants|mesh-ancestor
5922568|NCT04947254|Protective Agents|protective agents|mesh-ancestor
5922569|NCT04947254|Vitamins|vitamins|mesh-ancestor
5922570|NCT04947254|Micronutrients|micronutrients|mesh-ancestor
5922571|NCT04947254|Estrogens|estrogens|mesh-ancestor
5922572|NCT04947254|Anabolic Agents|anabolic agents|mesh-ancestor
5922573|NCT04947254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5922574|NCT04947241|Gemcitabine|gemcitabine|mesh-list
5922575|NCT04947241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5922576|NCT04947241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5718683|NCT03223896|Sensory System Agents|sensory system agents|mesh-ancestor
5718684|NCT03223896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5718685|NCT03223519|Ascorbic Acid|ascorbic acid|mesh-list
5718686|NCT03223519|Ibuprofen|ibuprofen|mesh-list
5718687|NCT03223519|Vitamins|vitamins|mesh-ancestor
5718688|NCT03223519|Micronutrients|micronutrients|mesh-ancestor
5718689|NCT03223519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718690|NCT03223519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5718691|NCT03223519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5718692|NCT03223519|Analgesics|analgesics|mesh-ancestor
5718693|NCT03223519|Sensory System Agents|sensory system agents|mesh-ancestor
5718694|NCT03223519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5718695|NCT03223519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5718696|NCT03223519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5718697|NCT03223519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5718698|NCT03223519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5718699|NCT03223519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718700|NCT03223519|Antioxidants|antioxidants|mesh-ancestor
5718701|NCT03223519|Protective Agents|protective agents|mesh-ancestor
5718702|NCT03223402|Lamivudine|lamivudine|mesh-list
5718703|NCT03223402|Nevirapine|nevirapine|mesh-list
5718704|NCT03223402|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5922577|NCT04947241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5922578|NCT04947241|Antimetabolites|antimetabolites|mesh-ancestor
5922579|NCT04947241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922580|NCT04947241|Antiviral Agents|antiviral agents|mesh-ancestor
5922581|NCT04947241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5922582|NCT04947241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5922583|NCT04947241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5922584|NCT04947241|Immunologic Factors|immunologic factors|mesh-ancestor
5922585|NCT04947241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922586|NCT04946825|Nicotine|nicotine|mesh-list
5922587|NCT04946825|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5922588|NCT04946825|Autonomic Agents|autonomic agents|mesh-ancestor
5922589|NCT04946825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5922590|NCT04946825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922591|NCT04946825|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5922592|NCT04946825|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5922593|NCT04946825|Cholinergic Agents|cholinergic agents|mesh-ancestor
5922594|NCT04946825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5922595|NCT04946825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922596|NCT04946864|Palbociclib|palbociclib|mesh-list
5922597|NCT04946864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5922598|NCT04946864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5922599|NCT04946864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5922600|NCT04946864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922601|NCT04946734|Aspirin|aspirin|mesh-list
5922602|NCT04946734|Clopidogrel|clopidogrel|mesh-list
5922603|NCT04946734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5922604|NCT04946734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5922605|NCT04946734|Analgesics|analgesics|mesh-ancestor
5922606|NCT04946734|Sensory System Agents|sensory system agents|mesh-ancestor
5922607|NCT04946734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5718705|NCT03223402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5718706|NCT03223402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5922608|NCT04946734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922609|NCT04946734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5922610|NCT04946734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5922611|NCT04946734|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5922612|NCT04946734|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5922613|NCT04946734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922614|NCT04946734|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5922615|NCT04946734|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5922616|NCT04946734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5922617|NCT04946734|Antipyretics|antipyretics|mesh-ancestor
5922618|NCT04946734|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5922619|NCT04946734|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5922620|NCT04946734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5718707|NCT03223402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718708|NCT03223402|Antiviral Agents|antiviral agents|mesh-ancestor
5718709|NCT03223402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5718710|NCT03223402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5718711|NCT03223402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5718712|NCT03223402|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5718713|NCT03223402|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5718714|NCT03223220|Midazolam|midazolam|mesh-list
5718715|NCT03223220|Ketamine|ketamine|mesh-list
5922621|NCT04946734|Purinergic Agents|purinergic agents|mesh-ancestor
5922622|NCT04946734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5922623|NCT04946461|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
5922624|NCT04946461|Dextroamphetamine|dextroamphetamine|mesh-list
5922625|NCT04946461|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5922626|NCT04946461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922627|NCT04946461|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5922628|NCT04946461|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5922629|NCT04946461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5922630|NCT04946461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922631|NCT04946461|Dopamine Agents|dopamine agents|mesh-ancestor
5922632|NCT04946461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5922633|NCT04946630|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
5922634|NCT04946630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5922635|NCT04946630|Autonomic Agents|autonomic agents|mesh-ancestor
5922636|NCT04946630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5922637|NCT04946630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922638|NCT04946630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5922639|NCT04946630|Respiratory System Agents|respiratory system agents|mesh-ancestor
5922640|NCT04946630|Glucocorticoids|glucocorticoids|mesh-ancestor
5922641|NCT04946630|Hormones|hormones|mesh-ancestor
5922642|NCT04946630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5922643|NCT04946630|Sympathomimetics|sympathomimetics|mesh-ancestor
5964701|NCT04589611|Amobarbital|amobarbital|mesh-list
5964702|NCT04589611|Hyaluronic Acid|hyaluronic acid|mesh-list
5964703|NCT04589611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5964704|NCT04589611|Immunologic Factors|immunologic factors|mesh-ancestor
5964705|NCT04589611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964706|NCT04589611|Viscosupplements|viscosupplements|mesh-ancestor
5964707|NCT04589611|Protective Agents|protective agents|mesh-ancestor
5964708|NCT04589611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5964709|NCT04589611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5964710|NCT04589611|GABA Modulators|gaba modulators|mesh-ancestor
5964711|NCT04589611|GABA Agents|gaba agents|mesh-ancestor
5964712|NCT04589611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5964713|NCT04589611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964714|NCT04589494|Morphine|morphine|mesh-list
5964715|NCT04589494|Tramadol|tramadol|mesh-list
5964716|NCT04589494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5964717|NCT04589494|Narcotics|narcotics|mesh-ancestor
5964718|NCT04589494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5964719|NCT04589494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964720|NCT04589494|Analgesics|analgesics|mesh-ancestor
5964721|NCT04589494|Sensory System Agents|sensory system agents|mesh-ancestor
5964722|NCT04589494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5964723|NCT04589325|Ixekizumab|ixekizumab|mesh-list
5964724|NCT04589325|Dermatologic Agents|dermatologic agents|mesh-ancestor
5964725|NCT04589299|Immunoglobulins|immunoglobulins|mesh-list
5964726|NCT04589299|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5964727|NCT04589299|Antibodies|antibodies|mesh-list
6681126|NCT01608269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6681127|NCT01608269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5964728|NCT04589299|Immunologic Factors|immunologic factors|mesh-ancestor
5922644|NCT04946669|Abatacept|abatacept|mesh-list
5922645|NCT04946669|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5922646|NCT04946669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922647|NCT04946669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5922648|NCT04946669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5922649|NCT04946669|Immunologic Factors|immunologic factors|mesh-ancestor
5922650|NCT04946669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922651|NCT04946669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5718716|NCT03223220|Analgesics|analgesics|mesh-ancestor
5718717|NCT03223220|Sensory System Agents|sensory system agents|mesh-ancestor
5718718|NCT03223220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5718719|NCT03223220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718720|NCT03223220|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5718721|NCT03223220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5718722|NCT03223220|Anesthetics, General|anesthetics, general|mesh-ancestor
5718723|NCT03223220|Anesthetics|anesthetics|mesh-ancestor
5718724|NCT03223220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5922652|NCT04946383|Dasatinib|dasatinib|mesh-list
5922653|NCT04946383|Quercetin|quercetin|mesh-list
5922654|NCT04946383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5922655|NCT04946383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5922656|NCT04946383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5922657|NCT04946383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922658|NCT04946383|Antioxidants|antioxidants|mesh-ancestor
5922659|NCT04946383|Protective Agents|protective agents|mesh-ancestor
5922660|NCT04946383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922661|NCT04946370|Pembrolizumab|pembrolizumab|mesh-list
5922662|NCT04946370|Edetic Acid|edetic acid|mesh-list
5922663|NCT04946370|Androgens|androgens|mesh-list
5922664|NCT04946370|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5922665|NCT04946370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5922666|NCT04946370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5922667|NCT04946370|Hormones|hormones|mesh-ancestor
5922668|NCT04946370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5922669|NCT04946370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922670|NCT04946370|Anticoagulants|anticoagulants|mesh-ancestor
5922671|NCT04946370|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5922672|NCT04946370|Chelating Agents|chelating agents|mesh-ancestor
5922673|NCT04946370|Sequestering Agents|sequestering agents|mesh-ancestor
5922674|NCT04946370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922675|NCT04946370|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5922676|NCT04945954|Cyclophosphamide|cyclophosphamide|mesh-list
5922677|NCT04945954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5922678|NCT04945954|Immunologic Factors|immunologic factors|mesh-ancestor
5922679|NCT04945954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922680|NCT04945954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5922681|NCT04945954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5922682|NCT04945954|Alkylating Agents|alkylating agents|mesh-ancestor
5922683|NCT04945954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922684|NCT04945954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5922685|NCT04945954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5922686|NCT04946162|Tadalafil|tadalafil|mesh-list
5922687|NCT04946162|Vasodilator Agents|vasodilator agents|mesh-ancestor
5922688|NCT04946162|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5922689|NCT04946162|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5922690|NCT04946162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5922691|NCT04946162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922692|NCT04946162|Urological Agents|urological agents|mesh-ancestor
5922693|NCT04946227|Paclitaxel|paclitaxel|mesh-list
5922694|NCT04946227|Pembrolizumab|pembrolizumab|mesh-list
5922695|NCT04946227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5922696|NCT04946227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5922697|NCT04946227|Tubulin Modulators|tubulin modulators|mesh-ancestor
5922698|NCT04946227|Antimitotic Agents|antimitotic agents|mesh-ancestor
5922699|NCT04946227|Mitosis Modulators|mitosis modulators|mesh-ancestor
5922700|NCT04946227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922701|NCT04946227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5922702|NCT04946123|Selenium|selenium|mesh-list
5922703|NCT04946123|Antioxidants|antioxidants|mesh-ancestor
5922704|NCT04946123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922705|NCT04946123|Protective Agents|protective agents|mesh-ancestor
5922706|NCT04946123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718725|NCT03223220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5922707|NCT04946123|Trace Elements|trace elements|mesh-ancestor
5922708|NCT04946123|Micronutrients|micronutrients|mesh-ancestor
5922709|NCT04945824|Dexamethasone|dexamethasone|mesh-list
5922710|NCT04945824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5922711|NCT04945824|Antiemetics|antiemetics|mesh-ancestor
5922712|NCT04945824|Autonomic Agents|autonomic agents|mesh-ancestor
5922713|NCT04945824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5922714|NCT04945824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922715|NCT04945824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5922716|NCT04945824|Glucocorticoids|glucocorticoids|mesh-ancestor
5922717|NCT04945824|Hormones|hormones|mesh-ancestor
5922718|NCT04945824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5922719|NCT04945824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5922720|NCT04945824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5922721|NCT04945681|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5922722|NCT04945681|Immunologic Factors|immunologic factors|mesh-ancestor
5922723|NCT04945681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922724|NCT04945694|Fentanyl|fentanyl|mesh-list
5922725|NCT04945694|Propofol|propofol|mesh-list
5922726|NCT04945694|Sevoflurane|sevoflurane|mesh-list
5922727|NCT04945694|Atracurium|atracurium|mesh-list
5922728|NCT04945694|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5922729|NCT04945694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5922730|NCT04945694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922731|NCT04945694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5922732|NCT04945694|Anesthetics, General|anesthetics, general|mesh-ancestor
5922733|NCT04945694|Anesthetics|anesthetics|mesh-ancestor
5922734|NCT04945694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5922735|NCT04945694|Narcotics|narcotics|mesh-ancestor
5922736|NCT04945694|Analgesics|analgesics|mesh-ancestor
5922737|NCT04945694|Sensory System Agents|sensory system agents|mesh-ancestor
5922738|NCT04945694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5922739|NCT04945694|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5922740|NCT04945694|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5922741|NCT04945694|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5922742|NCT04945694|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5922743|NCT04945694|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5922744|NCT04945694|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5922745|NCT04945694|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
5922746|NCT04945694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5922747|NCT04945694|Cholinergic Agents|cholinergic agents|mesh-ancestor
5922748|NCT04945694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5922749|NCT04945694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922750|NCT04945577|Vitamin D|vitamin d|mesh-list
5922751|NCT04945577|Vitamins|vitamins|mesh-ancestor
5922752|NCT04945577|Micronutrients|micronutrients|mesh-ancestor
5922753|NCT04945577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922754|NCT04945577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5922755|NCT04945226|Finasteride|finasteride|mesh-list
5922756|NCT04945226|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
5922757|NCT04945226|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5922758|NCT04945226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5922759|NCT04945226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922760|NCT04945226|Hormone Antagonists|hormone antagonists|mesh-ancestor
5922761|NCT04945226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5718726|NCT03223220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5718727|NCT03223220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5718728|NCT03223220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718729|NCT03223220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5718730|NCT03223220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5718731|NCT03223220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5718732|NCT03223220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5718733|NCT03223220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5718734|NCT03223220|GABA Modulators|gaba modulators|mesh-ancestor
5718735|NCT03223220|GABA Agents|gaba agents|mesh-ancestor
5718736|NCT03223376|Paclitaxel|paclitaxel|mesh-list
5718737|NCT03223376|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5718738|NCT03223376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5922762|NCT04945226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922763|NCT04945226|Urological Agents|urological agents|mesh-ancestor
5922764|NCT04945434|Methamphetamine|methamphetamine|mesh-list
5922765|NCT04945434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5922766|NCT04945434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922767|NCT04945434|Sympathomimetics|sympathomimetics|mesh-ancestor
5922768|NCT04945434|Autonomic Agents|autonomic agents|mesh-ancestor
5718739|NCT03223376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5922769|NCT04945434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5922770|NCT04945434|Dopamine Agents|dopamine agents|mesh-ancestor
5922771|NCT04945434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5922772|NCT04945434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922773|NCT04945434|Adrenergic Agents|adrenergic agents|mesh-ancestor
5922774|NCT04945434|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5922775|NCT04945434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5922776|NCT04945434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5922777|NCT04945434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5922778|NCT04945122|Atorvastatin|atorvastatin|mesh-list
5922779|NCT04945122|Pitavastatin|pitavastatin|mesh-list
5922780|NCT04945122|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5922781|NCT04945122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5922782|NCT04945122|Antimetabolites|antimetabolites|mesh-ancestor
5922783|NCT04945122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922784|NCT04945122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5922785|NCT04945122|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5922786|NCT04945122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5922787|NCT04945070|Insulin|insulin|mesh-list
5922788|NCT04945070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5922789|NCT04945070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922790|NCT04945096|Cytarabine|cytarabine|mesh-list
5922791|NCT04945096|Acetylcysteine|acetylcysteine|mesh-list
5922792|NCT04945096|Cyclosporine|cyclosporine|mesh-list
5922793|NCT04945096|Cyclophosphamide|cyclophosphamide|mesh-list
5922794|NCT04945096|Busulfan|busulfan|mesh-list
5922795|NCT04945096|Semustine|semustine|mesh-list
5922796|NCT04945096|Decitabine|decitabine|mesh-list
5922797|NCT04945096|Cyclosporins|cyclosporins|mesh-list
5922798|NCT04945096|Thymoglobulin|thymoglobulin|mesh-list
5922799|NCT04945096|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5922800|NCT04945096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5922801|NCT04945096|Immunologic Factors|immunologic factors|mesh-ancestor
5922802|NCT04945096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922803|NCT04945096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5922804|NCT04945096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5922805|NCT04945096|Alkylating Agents|alkylating agents|mesh-ancestor
5922806|NCT04945096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922807|NCT04945096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5922808|NCT04945096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5922809|NCT04945096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5922810|NCT04945096|Antimetabolites|antimetabolites|mesh-ancestor
5922811|NCT04945096|Antiviral Agents|antiviral agents|mesh-ancestor
5922812|NCT04945096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5922813|NCT04945096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5922814|NCT04945096|Antifungal Agents|antifungal agents|mesh-ancestor
5922815|NCT04945096|Dermatologic Agents|dermatologic agents|mesh-ancestor
5922816|NCT04945096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5922817|NCT04945096|Expectorants|expectorants|mesh-ancestor
5922818|NCT04945096|Respiratory System Agents|respiratory system agents|mesh-ancestor
5922819|NCT04945096|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5922820|NCT04945096|Antioxidants|antioxidants|mesh-ancestor
5922821|NCT04945096|Protective Agents|protective agents|mesh-ancestor
5922822|NCT04944836|Clomiphene|clomiphene|mesh-list
5922823|NCT04944836|Enclomiphene|enclomiphene|mesh-list
5922824|NCT04944836|Zuclomiphene|zuclomiphene|mesh-list
5922825|NCT04944836|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5922826|NCT04944836|Hormone Antagonists|hormone antagonists|mesh-ancestor
5922827|NCT04944836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5922828|NCT04944836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922829|NCT04944836|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5922830|NCT04944836|Fertility Agents|fertility agents|mesh-ancestor
5922831|NCT04944836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5922832|NCT04944836|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5922833|NCT04944836|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5922834|NCT04944966|Lumefantrine|lumefantrine|mesh-list
5922835|NCT04944966|Artemether|artemether|mesh-list
5922836|NCT04944966|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
5922837|NCT04944966|Antimalarials|antimalarials|mesh-ancestor
5922838|NCT04944966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5922839|NCT04944966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5922840|NCT04944966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5964729|NCT04589299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964730|NCT04589143|S 20098|s 20098|mesh-list
6681128|NCT01608334|Fentanyl|fentanyl|mesh-list
5964731|NCT04589143|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5964732|NCT04589143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5964733|NCT04589143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681129|NCT01608334|Sufentanil|sufentanil|mesh-list
5922841|NCT04944381|Vaccines|vaccines|mesh-list
5922842|NCT04944381|Immunologic Factors|immunologic factors|mesh-ancestor
5922843|NCT04944381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922844|NCT04944602|Omalizumab|omalizumab|mesh-list
5922845|NCT04944602|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5922846|NCT04944602|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5922847|NCT04944602|Respiratory System Agents|respiratory system agents|mesh-ancestor
5922848|NCT04944524|Methotrexate|methotrexate|mesh-list
5922849|NCT04944524|Tofacitinib|tofacitinib|mesh-list
5922850|NCT04944524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5922851|NCT04944524|Abortifacient Agents|abortifacient agents|mesh-ancestor
5922852|NCT04944524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5922853|NCT04944524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922854|NCT04944524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5922855|NCT04944524|Antimetabolites|antimetabolites|mesh-ancestor
5922856|NCT04944524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922857|NCT04944524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5922858|NCT04944524|Dermatologic Agents|dermatologic agents|mesh-ancestor
5922859|NCT04944524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5922860|NCT04944524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5922861|NCT04944524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5922862|NCT04944524|Immunologic Factors|immunologic factors|mesh-ancestor
5922863|NCT04944524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5922864|NCT04944524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5922865|NCT04944524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5922866|NCT04943952|Asparaginase|asparaginase|mesh-list
5922867|NCT04943952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5922868|NCT04944069|Bevacizumab|bevacizumab|mesh-list
5922869|NCT04944069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5922870|NCT04944069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5922871|NCT04944069|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5922872|NCT04944069|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5922873|NCT04944069|Growth Substances|growth substances|mesh-ancestor
5922874|NCT04944069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922875|NCT04944069|Growth Inhibitors|growth inhibitors|mesh-ancestor
5922876|NCT04944641|Anticonvulsants|anticonvulsants|mesh-list
5922877|NCT04944082|Ivermectin|ivermectin|mesh-list
5922878|NCT04944082|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5922879|NCT04944082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5922880|NCT04944095|Antibodies|antibodies|mesh-list
5922881|NCT04944095|Immunologic Factors|immunologic factors|mesh-ancestor
5922882|NCT04944095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922883|NCT04944212|Vitamin D|vitamin d|mesh-list
5922884|NCT04944212|Vitamins|vitamins|mesh-ancestor
5922885|NCT04944212|Micronutrients|micronutrients|mesh-ancestor
5922886|NCT04944212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922887|NCT04944212|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5922888|NCT04943692|Metformin|metformin|mesh-list
5922889|NCT04943692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5922890|NCT04943692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922891|NCT04944173|Durvalumab|durvalumab|mesh-list
5922892|NCT04944173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5922893|NCT04944173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5922894|NCT04943588|Antibodies|antibodies|mesh-list
5922895|NCT04943588|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
5922896|NCT04943588|Immunologic Factors|immunologic factors|mesh-ancestor
5922897|NCT04943588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922898|NCT04943757|Cyclophosphamide|cyclophosphamide|mesh-list
5922899|NCT04943757|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5922900|NCT04943757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5922901|NCT04943757|Immunologic Factors|immunologic factors|mesh-ancestor
5922902|NCT04943757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922903|NCT04943757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5922904|NCT04943757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5922905|NCT04943757|Alkylating Agents|alkylating agents|mesh-ancestor
5922906|NCT04943757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922907|NCT04943757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5922908|NCT04943757|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5922909|NCT04943653|Paclitaxel|paclitaxel|mesh-list
5922910|NCT04943653|Capecitabine|capecitabine|mesh-list
5922911|NCT04943653|Oxaliplatin|oxaliplatin|mesh-list
5922912|NCT04943653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5922913|NCT04943653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5922914|NCT04943653|Tubulin Modulators|tubulin modulators|mesh-ancestor
5922915|NCT04943653|Antimitotic Agents|antimitotic agents|mesh-ancestor
5922916|NCT04943653|Mitosis Modulators|mitosis modulators|mesh-ancestor
5970732|NCT04532775|Prednisolone acetate|prednisolone acetate|mesh-list
5922917|NCT04943653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922918|NCT04943653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5922919|NCT04943653|Antimetabolites|antimetabolites|mesh-ancestor
5922920|NCT04943536|Bicalutamide|bicalutamide|mesh-list
5922921|NCT04943536|Androgen Antagonists|androgen antagonists|mesh-ancestor
5922922|NCT04943536|Hormone Antagonists|hormone antagonists|mesh-ancestor
5922923|NCT04943536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5922924|NCT04943536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922925|NCT04943536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5922926|NCT04943783|Atorvastatin|atorvastatin|mesh-list
5922927|NCT04943783|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5922928|NCT04943783|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5922929|NCT04943783|Antimetabolites|antimetabolites|mesh-ancestor
5922930|NCT04943783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922931|NCT04943783|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5922932|NCT04943783|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5922933|NCT04943783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5922934|NCT04943679|Interferons|interferons|mesh-list
5922935|NCT04943679|Interferon-alpha|interferon-alpha|mesh-list
5922936|NCT04943679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5922937|NCT04943679|Antiviral Agents|antiviral agents|mesh-ancestor
5922938|NCT04943679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5922939|NCT04943679|Immunologic Factors|immunologic factors|mesh-ancestor
5922940|NCT04943679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922941|NCT04943211|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5922942|NCT04943211|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5922943|NCT04943211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922944|NCT04943237|Sulfasalazine|sulfasalazine|mesh-list
5922945|NCT04943237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
5922946|NCT04943237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5922947|NCT04943237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5922948|NCT04943237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5922949|NCT04943237|Analgesics|analgesics|mesh-ancestor
5922950|NCT04943237|Sensory System Agents|sensory system agents|mesh-ancestor
5922951|NCT04943237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5922952|NCT04943237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922953|NCT04943237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5922954|NCT04943237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5922955|NCT04943029|Paclitaxel|paclitaxel|mesh-list
5922956|NCT04943029|Carboplatin|carboplatin|mesh-list
5922957|NCT04943029|Pemetrexed|pemetrexed|mesh-list
5922958|NCT04943029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5922959|NCT04943029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5922960|NCT04943029|Tubulin Modulators|tubulin modulators|mesh-ancestor
5922961|NCT04943029|Antimitotic Agents|antimitotic agents|mesh-ancestor
5922962|NCT04943029|Mitosis Modulators|mitosis modulators|mesh-ancestor
5922963|NCT04943029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922964|NCT04943029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5922965|NCT04943029|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5922966|NCT04943029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5922967|NCT04943198|Vemurafenib|vemurafenib|mesh-list
5922968|NCT04943198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5922969|NCT04943198|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5922970|NCT04943198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5922971|NCT04943198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922972|NCT04942899|Capecitabine|capecitabine|mesh-list
5922973|NCT04942899|Letrozole|letrozole|mesh-list
5922974|NCT04942899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5922975|NCT04942899|Antimetabolites|antimetabolites|mesh-ancestor
5922976|NCT04942899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5922977|NCT04942899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5922978|NCT04942899|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5922979|NCT04942899|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5922980|NCT04942899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5922981|NCT04942899|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5922982|NCT04942899|Hormone Antagonists|hormone antagonists|mesh-ancestor
5922983|NCT04942899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5922984|NCT04942899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922985|NCT04943146|Aspirin|aspirin|mesh-list
5922986|NCT04943146|Prednisone|prednisone|mesh-list
5922987|NCT04943146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5922988|NCT04943146|Glucocorticoids|glucocorticoids|mesh-ancestor
5922989|NCT04943146|Hormones|hormones|mesh-ancestor
5922990|NCT04943146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5922991|NCT04943146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5922992|NCT04943146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5922993|NCT04943146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5922994|NCT04943146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5922995|NCT04943146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5922996|NCT04943146|Analgesics|analgesics|mesh-ancestor
5922997|NCT04943146|Sensory System Agents|sensory system agents|mesh-ancestor
5922998|NCT04943146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5922999|NCT04943146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5923000|NCT04943146|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5923001|NCT04943146|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5923002|NCT04943146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5923003|NCT04943146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5923004|NCT04943146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5923005|NCT04943146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5923006|NCT04943146|Antipyretics|antipyretics|mesh-ancestor
5923007|NCT04943224|Trametinib|trametinib|mesh-list
5923008|NCT04943224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5923009|NCT04943224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5923010|NCT04943224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5923011|NCT04943224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5923012|NCT04942886|Entecavir|entecavir|mesh-list
5923013|NCT04942886|Antiviral Agents|antiviral agents|mesh-ancestor
5923014|NCT04942886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5923015|NCT04942626|Capecitabine|capecitabine|mesh-list
5923016|NCT04942626|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5923017|NCT04942626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5923018|NCT04942626|Antimetabolites|antimetabolites|mesh-ancestor
5923019|NCT04942626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5923020|NCT04942626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5923021|NCT04942626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5964734|NCT04589130|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
5964735|NCT04589130|Naltrexone|naltrexone|mesh-list
5964736|NCT04589130|Bupropion|bupropion|mesh-list
5964737|NCT04589130|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5964738|NCT04589130|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5964739|NCT04589130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964740|NCT04589130|Sensory System Agents|sensory system agents|mesh-ancestor
5964741|NCT04589130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5964742|NCT04589130|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5964743|NCT04589130|Antidepressive Agents|antidepressive agents|mesh-ancestor
5964744|NCT04589130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5964745|NCT04589130|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5964746|NCT04589130|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5964747|NCT04589130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5964748|NCT04589130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964749|NCT04589130|Dopamine Agents|dopamine agents|mesh-ancestor
5964750|NCT04589130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5964751|NCT04589130|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5964752|NCT04589130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5964753|NCT04589130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5964754|NCT04589130|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5964755|NCT04589234|Gemcitabine|gemcitabine|mesh-list
5964756|NCT04589234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5964757|NCT04589234|Folfirinox|folfirinox|mesh-list
5964758|NCT04589234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5964759|NCT04589234|Antimetabolites|antimetabolites|mesh-ancestor
5964760|NCT04589234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964761|NCT04589234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5964762|NCT04589234|Antiviral Agents|antiviral agents|mesh-ancestor
5964763|NCT04589234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5964764|NCT04589234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5964765|NCT04589234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5964766|NCT04589234|Immunologic Factors|immunologic factors|mesh-ancestor
5964767|NCT04589234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964768|NCT04588935|Bisoprolol|bisoprolol|mesh-list
5964769|NCT04588935|Perindopril|perindopril|mesh-list
5964770|NCT04588935|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5964771|NCT04588935|Sympatholytics|sympatholytics|mesh-ancestor
5964772|NCT04588935|Autonomic Agents|autonomic agents|mesh-ancestor
5964773|NCT04588935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5964774|NCT04588935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964775|NCT04588935|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5923022|NCT04942860|Methotrexate|methotrexate|mesh-list
5923023|NCT04942860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5923024|NCT04942860|Abortifacient Agents|abortifacient agents|mesh-ancestor
5923025|NCT04942860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5923026|NCT04942860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923027|NCT04942860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5923028|NCT04942860|Antimetabolites|antimetabolites|mesh-ancestor
5923029|NCT04942860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5923030|NCT04942860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5923031|NCT04942860|Dermatologic Agents|dermatologic agents|mesh-ancestor
5923032|NCT04942860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5923033|NCT04942860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5923034|NCT04942860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5923035|NCT04942860|Immunologic Factors|immunologic factors|mesh-ancestor
5923036|NCT04942860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5923037|NCT04942860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5923038|NCT04942834|Amiodarone|amiodarone|mesh-list
5923039|NCT04942834|Sotalol|sotalol|mesh-list
5923040|NCT04942834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
5923041|NCT04942834|Dronedarone|dronedarone|mesh-list
5923042|NCT04942834|Propafenone|propafenone|mesh-list
5923043|NCT04942834|Vasodilator Agents|vasodilator agents|mesh-ancestor
5923044|NCT04942834|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5923045|NCT04942834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5923046|NCT04942834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5923047|NCT04942834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5923048|NCT04942834|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5923049|NCT04942834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5923050|NCT04942834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5923051|NCT04942834|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5923052|NCT04942834|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5923053|NCT04942834|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5923054|NCT04942834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5923055|NCT04942834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5923056|NCT04942834|Adrenergic Agents|adrenergic agents|mesh-ancestor
5923057|NCT04942834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5923058|NCT04942834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923059|NCT04942834|Sympatholytics|sympatholytics|mesh-ancestor
5923060|NCT04942834|Autonomic Agents|autonomic agents|mesh-ancestor
5923061|NCT04942834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5923062|NCT04942834|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5923063|NCT04942652|Itraconazole|itraconazole|mesh-list
5923064|NCT04942652|Esomeprazole|esomeprazole|mesh-list
5923065|NCT04942652|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5923066|NCT04942652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5923067|NCT04942652|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5923068|NCT04942652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5923069|NCT04942652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5923070|NCT04942652|Antifungal Agents|antifungal agents|mesh-ancestor
5923071|NCT04942652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5923072|NCT04942652|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5923073|NCT04942652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5923074|NCT04942652|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5923075|NCT04942652|Hormone Antagonists|hormone antagonists|mesh-ancestor
5923076|NCT04942652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5923077|NCT04942652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923078|NCT04942652|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5923079|NCT04942769|Selenium|selenium|mesh-list
5923080|NCT04942769|Antioxidants|antioxidants|mesh-ancestor
5923081|NCT04942769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5923082|NCT04942769|Protective Agents|protective agents|mesh-ancestor
5923083|NCT04942769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923084|NCT04942769|Trace Elements|trace elements|mesh-ancestor
5923085|NCT04942769|Micronutrients|micronutrients|mesh-ancestor
5923086|NCT04942730|Mycophenolic Acid|mycophenolic acid|mesh-list
5923087|NCT04942730|Cyclophosphamide|cyclophosphamide|mesh-list
5923088|NCT04942730|Busulfan|busulfan|mesh-list
5923089|NCT04942730|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5923090|NCT04942730|Fludarabine|fludarabine|mesh-list
5923091|NCT04942730|Tacrolimus|tacrolimus|mesh-list
5923092|NCT04942730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5923093|NCT04942730|Immunologic Factors|immunologic factors|mesh-ancestor
5923094|NCT04942730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6516998|NCT00719173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5923095|NCT04942730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5923096|NCT04942730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5923097|NCT04942730|Alkylating Agents|alkylating agents|mesh-ancestor
5923098|NCT04942730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5923099|NCT04942730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5923100|NCT04942730|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5923101|NCT04942730|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5923102|NCT04942730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5923103|NCT04942730|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5923104|NCT04942730|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5923105|NCT04942730|Antitubercular Agents|antitubercular agents|mesh-ancestor
5923106|NCT04942730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5923107|NCT04942730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5923108|NCT04942340|Dexmedetomidine|dexmedetomidine|mesh-list
5923109|NCT04942340|Caffeine|caffeine|mesh-list
5923110|NCT04942340|Atipamezole|atipamezole|mesh-list
5923111|NCT04942340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5923112|NCT04942340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5923113|NCT04942340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923114|NCT04942340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5923115|NCT04942340|Analgesics|analgesics|mesh-ancestor
5923116|NCT04942340|Sensory System Agents|sensory system agents|mesh-ancestor
5923117|NCT04942340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5923118|NCT04942340|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5923119|NCT04942340|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5923120|NCT04942340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5923121|NCT04942340|Adrenergic Agents|adrenergic agents|mesh-ancestor
5923122|NCT04942340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5923123|NCT04942340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5923124|NCT04942340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5923125|NCT04942340|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5923126|NCT04942340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5923127|NCT04942340|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5923128|NCT04942340|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5923129|NCT04942340|Purinergic Agents|purinergic agents|mesh-ancestor
5923130|NCT04942340|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5923131|NCT04942340|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5923132|NCT04942340|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5923133|NCT04942496|Chlorhexidine|chlorhexidine|mesh-list
5923134|NCT04942496|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5923135|NCT04942496|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5923136|NCT04942496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5923137|NCT04942496|Disinfectants|disinfectants|mesh-ancestor
5923138|NCT04942496|Dermatologic Agents|dermatologic agents|mesh-ancestor
5923139|NCT04942301|Endostar protein|endostar protein|mesh-list
5923140|NCT04942301|Endostatins|endostatins|mesh-list
5923141|NCT04942301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5923142|NCT04942301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5923143|NCT04942301|Growth Substances|growth substances|mesh-ancestor
5923144|NCT04942301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923145|NCT04942301|Growth Inhibitors|growth inhibitors|mesh-ancestor
5923146|NCT04942301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5923147|NCT04941976|Benzydamine|benzydamine|mesh-list
5923148|NCT04941976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5923149|NCT04942002|Methylprednisolone|methylprednisolone|mesh-list
5923150|NCT04942002|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5923151|NCT04942002|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5923152|NCT04942002|Prednisolone|prednisolone|mesh-list
5923153|NCT04942002|Prednisolone acetate|prednisolone acetate|mesh-list
5923154|NCT04942002|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5923155|NCT04942002|Prednisolone phosphate|prednisolone phosphate|mesh-list
5923156|NCT04942002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5923157|NCT04942002|Antiemetics|antiemetics|mesh-ancestor
5923158|NCT04942002|Autonomic Agents|autonomic agents|mesh-ancestor
5923159|NCT04942002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5923160|NCT04942002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923161|NCT04942002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5923162|NCT04942002|Glucocorticoids|glucocorticoids|mesh-ancestor
5923163|NCT04942002|Hormones|hormones|mesh-ancestor
5923164|NCT04942002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5923165|NCT04942002|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5923166|NCT04942002|Protective Agents|protective agents|mesh-ancestor
5923167|NCT04942002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5923168|NCT04942002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5923169|NCT04941872|FAPI-46|fapi-46|mesh-list
5718740|NCT03223376|Tubulin Modulators|tubulin modulators|mesh-ancestor
5718741|NCT03223376|Antimitotic Agents|antimitotic agents|mesh-ancestor
5923170|NCT04941872|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5923171|NCT04941872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5923172|NCT04941898|Factor VIII|factor viii|mesh-list
5923173|NCT04941898|BAX 855|bax 855|mesh-list
5923174|NCT04941898|Coagulants|coagulants|mesh-ancestor
5923175|NCT04941937|Thalidomide|thalidomide|mesh-list
5923176|NCT04941937|Dexamethasone|dexamethasone|mesh-list
5923177|NCT04941937|Lenalidomide|lenalidomide|mesh-list
5923178|NCT04941937|Pomalidomide|pomalidomide|mesh-list
5923179|NCT04941937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5923180|NCT04941937|Antiemetics|antiemetics|mesh-ancestor
5923181|NCT04941937|Autonomic Agents|autonomic agents|mesh-ancestor
5923182|NCT04941937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5923183|NCT04941937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923184|NCT04941937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5923185|NCT04941937|Glucocorticoids|glucocorticoids|mesh-ancestor
5923186|NCT04941937|Hormones|hormones|mesh-ancestor
5923187|NCT04941937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5923188|NCT04941937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5923189|NCT04941937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5923190|NCT04941937|Immunologic Factors|immunologic factors|mesh-ancestor
5923191|NCT04941937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5923192|NCT04941937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5923193|NCT04941937|Growth Substances|growth substances|mesh-ancestor
5923194|NCT04941937|Growth Inhibitors|growth inhibitors|mesh-ancestor
5923195|NCT04941937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5923196|NCT04941937|Leprostatic Agents|leprostatic agents|mesh-ancestor
5923197|NCT04941937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5923198|NCT04941937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5923199|NCT04941833|Desogestrel|desogestrel|mesh-list
5923200|NCT04941833|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5923201|NCT04941833|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5923202|NCT04941833|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5923203|NCT04941833|Contraceptive Agents|contraceptive agents|mesh-ancestor
5923204|NCT04941833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5923205|NCT04941833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923206|NCT04941833|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5923207|NCT04941833|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5923208|NCT04941833|Progestins|progestins|mesh-ancestor
5923209|NCT04941833|Hormones|hormones|mesh-ancestor
5923210|NCT04941833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5923211|NCT04941911|Octreotide|octreotide|mesh-list
5923212|NCT04941911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5923213|NCT04941911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5923214|NCT04941911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5923215|NCT04941885|Cyclophosphamide|cyclophosphamide|mesh-list
5923216|NCT04941885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5923217|NCT04941885|Immunologic Factors|immunologic factors|mesh-ancestor
5923218|NCT04941885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923219|NCT04941885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5923220|NCT04941885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5923221|NCT04941885|Alkylating Agents|alkylating agents|mesh-ancestor
5923222|NCT04941885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5923223|NCT04941885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5923224|NCT04941885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5923225|NCT04941846|Nimodipine|nimodipine|mesh-list
5923226|NCT04941846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5923227|NCT04941846|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5923228|NCT04941846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5923229|NCT04941846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718742|NCT03223376|Mitosis Modulators|mitosis modulators|mesh-ancestor
5718743|NCT03223376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718744|NCT03223064|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5718745|NCT03223064|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5718746|NCT03223064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718747|NCT03223103|Poly ICLC|poly iclc|mesh-list
5718748|NCT03223103|Interferon Inducers|interferon inducers|mesh-ancestor
5718749|NCT03223103|Immunologic Factors|immunologic factors|mesh-ancestor
5718750|NCT03223103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718751|NCT03223025|Hormones|hormones|mesh-list
5718752|NCT03223025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5722140|NCT03200821|Gemcitabine|gemcitabine|mesh-list
5970733|NCT04532775|Magnesium Sulfate|magnesium sulfate|mesh-list
5718753|NCT03223025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718754|NCT03222960|Propolis|propolis|mesh-list
5718755|NCT03222960|Fluorides|fluorides|mesh-list
5718756|NCT03222960|Cariostatic Agents|cariostatic agents|mesh-ancestor
5718757|NCT03222960|Protective Agents|protective agents|mesh-ancestor
5718758|NCT03222960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718759|NCT03222960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5718760|NCT03222856|Pembrolizumab|pembrolizumab|mesh-list
5718761|NCT03222856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5718762|NCT03222856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5722141|NCT03200821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5722142|NCT03200821|Antimetabolites|antimetabolites|mesh-ancestor
5722143|NCT03200821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722144|NCT03200821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5722145|NCT03200821|Antiviral Agents|antiviral agents|mesh-ancestor
5722146|NCT03200821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5722147|NCT03200821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5722148|NCT03200821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5722149|NCT03200821|Immunologic Factors|immunologic factors|mesh-ancestor
5722150|NCT03200821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722151|NCT03200782|Empagliflozin|empagliflozin|mesh-list
5722152|NCT03200782|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5722153|NCT03200782|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5722154|NCT03200782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722155|NCT03200782|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5722156|NCT03200782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722157|NCT03200782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5722158|NCT03200847|Pembrolizumab|pembrolizumab|mesh-list
5923230|NCT04941846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5923231|NCT04941846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923232|NCT04941846|Vasodilator Agents|vasodilator agents|mesh-ancestor
5923233|NCT04941521|Exenatide|exenatide|mesh-list
5923234|NCT04941521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5923235|NCT04941521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923236|NCT04941521|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5923237|NCT04941521|Incretins|incretins|mesh-ancestor
5923238|NCT04941521|Hormones|hormones|mesh-ancestor
5923239|NCT04941521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5923240|NCT04941625|Cystatins|cystatins|mesh-list
5923241|NCT04941625|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
5923242|NCT04941625|Protease Inhibitors|protease inhibitors|mesh-ancestor
5923243|NCT04941625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5923244|NCT04941625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5923245|NCT04941573|Xenon|xenon|mesh-list
5923246|NCT04941573|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5923247|NCT04941573|Anesthetics, General|anesthetics, general|mesh-ancestor
5923248|NCT04941573|Anesthetics|anesthetics|mesh-ancestor
5923249|NCT04941573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5923250|NCT04941573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923251|NCT04941417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5923252|NCT04941417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5923253|NCT04941417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5923254|NCT04941131|Chlorhexidine|chlorhexidine|mesh-list
5923255|NCT04941131|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5923256|NCT04941131|Povidone-Iodine|povidone-iodine|mesh-list
5923257|NCT04941131|Povidone|povidone|mesh-list
5923258|NCT04941131|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5923259|NCT04941131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5923260|NCT04941131|Disinfectants|disinfectants|mesh-ancestor
5923261|NCT04941131|Dermatologic Agents|dermatologic agents|mesh-ancestor
5923262|NCT04941131|Plasma Substitutes|plasma substitutes|mesh-ancestor
5923263|NCT04941131|Blood Substitutes|blood substitutes|mesh-ancestor
5923264|NCT04941196|Ticagrelor|ticagrelor|mesh-list
5923265|NCT04941196|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5923266|NCT04941196|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5923267|NCT04941196|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5923268|NCT04941196|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5923269|NCT04941196|Purinergic Agents|purinergic agents|mesh-ancestor
5923270|NCT04941196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5923271|NCT04941196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5923272|NCT04941196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923273|NCT04941105|Evolocumab|evolocumab|mesh-list
5923274|NCT04941105|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5722159|NCT03200847|Tretinoin|tretinoin|mesh-list
5923275|NCT04941105|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5923276|NCT04941105|Antimetabolites|antimetabolites|mesh-ancestor
5923277|NCT04941105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5923278|NCT04941105|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5923279|NCT04941170|Bupivacaine|bupivacaine|mesh-list
5923280|NCT04941170|Anesthetics, Local|anesthetics, local|mesh-ancestor
5923281|NCT04941170|Anesthetics|anesthetics|mesh-ancestor
5923282|NCT04941170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5923283|NCT04941170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923284|NCT04941170|Sensory System Agents|sensory system agents|mesh-ancestor
5923285|NCT04941170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5923286|NCT04941118|Anesthetics|anesthetics|mesh-list
5923287|NCT04941118|Anesthetics, Local|anesthetics, local|mesh-list
5923288|NCT04941118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5923289|NCT04941118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923290|NCT04941118|Sensory System Agents|sensory system agents|mesh-ancestor
5923291|NCT04941118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5964776|NCT04588935|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5964777|NCT04588935|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5964778|NCT04588935|Adrenergic Agents|adrenergic agents|mesh-ancestor
5964779|NCT04588935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5964780|NCT04588935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964781|NCT04588935|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5964782|NCT04588935|Protease Inhibitors|protease inhibitors|mesh-ancestor
5964783|NCT04588935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5964784|NCT04588987|Apatinib|apatinib|mesh-list
5964785|NCT04588987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5964786|NCT04588987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5964787|NCT04588987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5964788|NCT04588987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964789|NCT04588857|Dexamethasone|dexamethasone|mesh-list
5964790|NCT04588857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5964791|NCT04588857|Antiemetics|antiemetics|mesh-ancestor
5964792|NCT04588857|Autonomic Agents|autonomic agents|mesh-ancestor
5964793|NCT04588857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5964794|NCT04588857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964795|NCT04588857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5964796|NCT04588857|Glucocorticoids|glucocorticoids|mesh-ancestor
5964797|NCT04588857|Hormones|hormones|mesh-ancestor
5964798|NCT04588857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5964799|NCT04588857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5964800|NCT04588857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5964801|NCT04588948|Aflibercept|aflibercept|mesh-list
5964802|NCT04588948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5964803|NCT04588948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5964804|NCT04588948|Growth Substances|growth substances|mesh-ancestor
5964805|NCT04588948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964806|NCT04588948|Growth Inhibitors|growth inhibitors|mesh-ancestor
5964807|NCT04588948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5964808|NCT04588532|Doxepin|doxepin|mesh-list
5964809|NCT04588532|Histamine|histamine|mesh-list
5964810|NCT04588532|Histamine Agonists|histamine agonists|mesh-ancestor
5964811|NCT04588532|Histamine Agents|histamine agents|mesh-ancestor
5964812|NCT04588532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5964813|NCT04588532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964814|NCT04588532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964815|NCT04588532|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5964816|NCT04588532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5964817|NCT04588532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5964818|NCT04588532|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5964819|NCT04588532|Antidepressive Agents|antidepressive agents|mesh-ancestor
5964820|NCT04588532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5964821|NCT04588532|Histamine Antagonists|histamine antagonists|mesh-ancestor
5964822|NCT04588636|Salicylic Acid|salicylic acid|mesh-list
5964823|NCT04588636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5964824|NCT04588636|Antifungal Agents|antifungal agents|mesh-ancestor
5964825|NCT04588636|Keratolytic Agents|keratolytic agents|mesh-ancestor
5964826|NCT04588636|Dermatologic Agents|dermatologic agents|mesh-ancestor
5964827|NCT04588792|Furosemide|furosemide|mesh-list
5964828|NCT04588792|Diuretics|diuretics|mesh-ancestor
5964829|NCT04588792|Natriuretic Agents|natriuretic agents|mesh-ancestor
5964830|NCT04588792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964831|NCT04588792|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5964832|NCT04588792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5923292|NCT04940689|Lidocaine|lidocaine|mesh-list
5923293|NCT04940689|Dexmedetomidine|dexmedetomidine|mesh-list
5923294|NCT04940689|Remifentanil|remifentanil|mesh-list
5923295|NCT04940689|Anesthetics, Local|anesthetics, local|mesh-ancestor
5923296|NCT04940689|Anesthetics|anesthetics|mesh-ancestor
5923297|NCT04940689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5923298|NCT04940689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923299|NCT04940689|Sensory System Agents|sensory system agents|mesh-ancestor
5923300|NCT04940689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5923301|NCT04940689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5923302|NCT04940689|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5923303|NCT04940689|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5923304|NCT04940689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5923305|NCT04940689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5923306|NCT04940689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5923307|NCT04940689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5923308|NCT04940689|Analgesics|analgesics|mesh-ancestor
5923309|NCT04940689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5923310|NCT04940689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5923311|NCT04940689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5923312|NCT04940689|Adrenergic Agents|adrenergic agents|mesh-ancestor
5923313|NCT04940689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5923314|NCT04940689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5923315|NCT04940689|Narcotics|narcotics|mesh-ancestor
5923316|NCT04940845|Denosumab|denosumab|mesh-list
5923317|NCT04940845|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5923318|NCT04940845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923319|NCT04940871|Favipiravir|favipiravir|mesh-list
5923320|NCT04940871|Antiviral Agents|antiviral agents|mesh-ancestor
5923321|NCT04940871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5923322|NCT04940546|Bevacizumab|bevacizumab|mesh-list
5923323|NCT04940546|Capecitabine|capecitabine|mesh-list
5923324|NCT04940546|Oxaliplatin|oxaliplatin|mesh-list
5923325|NCT04940546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5923326|NCT04940546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5923327|NCT04940546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5923328|NCT04940546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5923329|NCT04940546|Growth Substances|growth substances|mesh-ancestor
5923330|NCT04940546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923331|NCT04940546|Growth Inhibitors|growth inhibitors|mesh-ancestor
5923332|NCT04940546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5923333|NCT04940546|Antimetabolites|antimetabolites|mesh-ancestor
5923334|NCT04940546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5923335|NCT04940273|Remifentanil|remifentanil|mesh-list
5923336|NCT04940273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5923337|NCT04940273|Narcotics|narcotics|mesh-ancestor
5923338|NCT04940273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5923339|NCT04940273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923340|NCT04940273|Analgesics|analgesics|mesh-ancestor
5923341|NCT04940273|Sensory System Agents|sensory system agents|mesh-ancestor
5923342|NCT04940273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5923343|NCT04940299|Nivolumab|nivolumab|mesh-list
5923344|NCT04940299|Ipilimumab|ipilimumab|mesh-list
5923345|NCT04940299|Immunoglobulins|immunoglobulins|mesh-list
5923346|NCT04940299|Immunoglobulin G|immunoglobulin g|mesh-list
5923347|NCT04940299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5923348|NCT04940299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5923349|NCT04940299|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5923350|NCT04940299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5923351|NCT04940299|Immunologic Factors|immunologic factors|mesh-ancestor
5923352|NCT04940299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923353|NCT04940143|Botulinum Toxins|botulinum toxins|mesh-list
5718763|NCT03222544|Methylene Blue|methylene blue|mesh-list
5718764|NCT03222544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5718765|NCT03222544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718766|NCT03222765|Metformin|metformin|mesh-list
5718767|NCT03222765|Linagliptin|linagliptin|mesh-list
5718768|NCT03222765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5718769|NCT03222765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718770|NCT03222765|Incretins|incretins|mesh-ancestor
5718771|NCT03222765|Hormones|hormones|mesh-ancestor
5718772|NCT03222765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5718773|NCT03222765|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5718774|NCT03222765|Protease Inhibitors|protease inhibitors|mesh-ancestor
5718775|NCT03222765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5923354|NCT04940143|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5923355|NCT04940143|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5923356|NCT04940143|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5923357|NCT04940143|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5923358|NCT04940143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5923359|NCT04940143|Cholinergic Agents|cholinergic agents|mesh-ancestor
5923360|NCT04940143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5923361|NCT04940143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923362|NCT04940143|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5923363|NCT04940143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5923364|NCT04939935|Metformin|metformin|mesh-list
5923365|NCT04939935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5923366|NCT04939935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923367|NCT04939909|Botulinum Toxins|botulinum toxins|mesh-list
5923368|NCT04939909|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5923369|NCT04939909|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5923370|NCT04939909|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5923371|NCT04939909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5923372|NCT04939909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5923373|NCT04939909|Cholinergic Agents|cholinergic agents|mesh-ancestor
5923374|NCT04939909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5923375|NCT04939909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923376|NCT04939909|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5923377|NCT04939909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5923378|NCT04939883|Carvedilol|carvedilol|mesh-list
5923379|NCT04939883|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5923380|NCT04939883|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5923381|NCT04939883|Adrenergic Agents|adrenergic agents|mesh-ancestor
5923382|NCT04939883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5923383|NCT04939883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5923384|NCT04939883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923385|NCT04939883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5718776|NCT03222765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718777|NCT03222492|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5718778|NCT03222492|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5718779|NCT03222492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5718780|NCT03222492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5718781|NCT03222492|Immunologic Factors|immunologic factors|mesh-ancestor
5718782|NCT03222492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718783|NCT03222687|Prednisone|prednisone|mesh-list
5718784|NCT03222687|Tacrolimus|tacrolimus|mesh-list
5718785|NCT03222687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5718786|NCT03222687|Glucocorticoids|glucocorticoids|mesh-ancestor
5718787|NCT03222687|Hormones|hormones|mesh-ancestor
5718788|NCT03222687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5718789|NCT03222687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718790|NCT03222687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5923386|NCT04939883|Antioxidants|antioxidants|mesh-ancestor
5923387|NCT04939883|Protective Agents|protective agents|mesh-ancestor
5923388|NCT04939883|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5923389|NCT04939883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5923390|NCT04939883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5923391|NCT04939883|Vasodilator Agents|vasodilator agents|mesh-ancestor
5923392|NCT04939883|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5923393|NCT04939883|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5923394|NCT04939844|Lenalidomide|lenalidomide|mesh-list
5923395|NCT04939844|Bortezomib|bortezomib|mesh-list
5923396|NCT04939844|Immunologic Factors|immunologic factors|mesh-ancestor
5923397|NCT04939844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923398|NCT04939844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5923399|NCT04939844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5923400|NCT04939844|Growth Substances|growth substances|mesh-ancestor
5923401|NCT04939844|Growth Inhibitors|growth inhibitors|mesh-ancestor
5923402|NCT04939844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5923403|NCT04939623|Benzoic Acid|benzoic acid|mesh-list
5923404|NCT04939623|Probenecid|probenecid|mesh-list
5923405|NCT04939623|Uricosuric Agents|uricosuric agents|mesh-ancestor
5923406|NCT04939623|Gout Suppressants|gout suppressants|mesh-ancestor
5923407|NCT04939623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5923408|NCT04939623|Renal Agents|renal agents|mesh-ancestor
5923409|NCT04939623|Antifungal Agents|antifungal agents|mesh-ancestor
5923410|NCT04939623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5923411|NCT04939662|Bevacizumab|bevacizumab|mesh-list
5923412|NCT04939662|Olaparib|olaparib|mesh-list
5970734|NCT04532775|Bupivacaine|bupivacaine|mesh-list
5923413|NCT04939662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5923414|NCT04939662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5923415|NCT04939662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5923416|NCT04939662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5923417|NCT04939662|Growth Substances|growth substances|mesh-ancestor
5923418|NCT04939662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923419|NCT04939662|Growth Inhibitors|growth inhibitors|mesh-ancestor
5923420|NCT04939662|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5923421|NCT04939662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5923422|NCT04939662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5923423|NCT04939857|Trimetazidine|trimetazidine|mesh-list
5923424|NCT04939857|Vasodilator Agents|vasodilator agents|mesh-ancestor
5923425|NCT04939779|Delpazolid|delpazolid|mesh-list
5923426|NCT04939779|Oxazolidinones|oxazolidinones|mesh-list
5923427|NCT04939779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5923428|NCT04939779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5923429|NCT04939779|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5923430|NCT04939779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5923431|NCT04939779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5923432|NCT04939675|Lamotrigine|lamotrigine|mesh-list
5923433|NCT04939675|Zonisamide|zonisamide|mesh-list
5923434|NCT04939675|Levetiracetam|levetiracetam|mesh-list
5923435|NCT04939675|Anticonvulsants|anticonvulsants|mesh-ancestor
5923436|NCT04939675|Nootropic Agents|nootropic agents|mesh-ancestor
5923437|NCT04939675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5923438|NCT04939675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5923439|NCT04939675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5923440|NCT04939675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5923441|NCT04939675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923442|NCT04939675|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5923443|NCT04939675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5923444|NCT04939675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5923445|NCT04939675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5923446|NCT04939675|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5923447|NCT04939766|Insulin|insulin|mesh-list
5923448|NCT04939766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5923449|NCT04939766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923450|NCT04939649|Midazolam|midazolam|mesh-list
5923451|NCT04939649|Ketamine|ketamine|mesh-list
5718791|NCT03222687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5718792|NCT03222687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5718793|NCT03222687|Immunologic Factors|immunologic factors|mesh-ancestor
5718794|NCT03222687|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5718795|NCT03222687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5718796|NCT03222687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718797|NCT03222518|Acetaminophen|acetaminophen|mesh-list
5718798|NCT03222518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
5718799|NCT03222518|Piroxicam|piroxicam|mesh-list
5718800|NCT03222518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5718801|NCT03222518|Analgesics|analgesics|mesh-ancestor
5718802|NCT03222518|Sensory System Agents|sensory system agents|mesh-ancestor
5718803|NCT03222518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5718804|NCT03222518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718805|NCT03222518|Antipyretics|antipyretics|mesh-ancestor
5718806|NCT03222518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5718807|NCT03222518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5718808|NCT03222518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5718809|NCT03222518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5718810|NCT03222518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718811|NCT03222206|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
5718812|NCT03222206|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5718813|NCT03222206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5718814|NCT03222206|Analgesics|analgesics|mesh-ancestor
5718815|NCT03222206|Sensory System Agents|sensory system agents|mesh-ancestor
5718816|NCT03222206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5718817|NCT03222206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718818|NCT03222206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5718819|NCT03222206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5718820|NCT03222076|Nivolumab|nivolumab|mesh-list
5718821|NCT03222076|Ipilimumab|ipilimumab|mesh-list
5718822|NCT03222076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5923452|NCT04939649|Analgesics|analgesics|mesh-ancestor
5718823|NCT03222076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5923453|NCT04939649|Sensory System Agents|sensory system agents|mesh-ancestor
5923454|NCT04939649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5923455|NCT04939649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923456|NCT04939649|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5923457|NCT04939649|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5923458|NCT04939649|Anesthetics, General|anesthetics, general|mesh-ancestor
5923459|NCT04939649|Anesthetics|anesthetics|mesh-ancestor
5923460|NCT04939649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5923461|NCT04939649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5923462|NCT04939649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5923463|NCT04939649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5923464|NCT04939649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5923465|NCT04939649|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5923466|NCT04939649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5923467|NCT04939649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5923468|NCT04939649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5923469|NCT04939649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5923470|NCT04939649|GABA Modulators|gaba modulators|mesh-ancestor
5923471|NCT04939649|GABA Agents|gaba agents|mesh-ancestor
5923472|NCT04939480|Atezolizumab|atezolizumab|mesh-list
5923473|NCT04939480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5923474|NCT04939441|Tenofovir|tenofovir|mesh-list
5923475|NCT04939441|Antiviral Agents|antiviral agents|mesh-ancestor
5923476|NCT04939441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5923477|NCT04939441|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5923478|NCT04939441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5923479|NCT04939441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5923480|NCT04939441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5923481|NCT04939441|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5923482|NCT04939441|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5964833|NCT04588792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964834|NCT04588441|Adenosine|adenosine|mesh-list
5964835|NCT04588441|Analgesics|analgesics|mesh-ancestor
5964836|NCT04588441|Sensory System Agents|sensory system agents|mesh-ancestor
5964837|NCT04588441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5964838|NCT04588441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964839|NCT04588441|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5964840|NCT04588441|Vasodilator Agents|vasodilator agents|mesh-ancestor
5964841|NCT04588441|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5964842|NCT04588441|Purinergic Agonists|purinergic agonists|mesh-ancestor
5964843|NCT04588441|Purinergic Agents|purinergic agents|mesh-ancestor
5964844|NCT04588441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5964845|NCT04588441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964846|NCT04588688|Mifepristone|mifepristone|mesh-list
5964847|NCT04588688|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5964848|NCT04588688|Abortifacient Agents|abortifacient agents|mesh-ancestor
5964849|NCT04588688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5964850|NCT04588688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964851|NCT04588688|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5964852|NCT04588688|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5964853|NCT04588688|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5964854|NCT04588688|Contraceptive Agents|contraceptive agents|mesh-ancestor
5964855|NCT04588688|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5964856|NCT04588688|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5964857|NCT04588688|Hormone Antagonists|hormone antagonists|mesh-ancestor
5964858|NCT04588688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5964859|NCT04588688|Luteolytic Agents|luteolytic agents|mesh-ancestor
5964860|NCT04588688|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5964861|NCT04588688|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5964862|NCT04588389|Lidocaine|lidocaine|mesh-list
5964863|NCT04588389|Ropivacaine|ropivacaine|mesh-list
5964864|NCT04588389|Anesthetics, Local|anesthetics, local|mesh-ancestor
5964865|NCT04588389|Anesthetics|anesthetics|mesh-ancestor
5964866|NCT04588389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5964867|NCT04588389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964868|NCT04588389|Sensory System Agents|sensory system agents|mesh-ancestor
5964869|NCT04588389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5964870|NCT04588389|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5964871|NCT04588389|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5964872|NCT04588389|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5964873|NCT04588389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5964874|NCT04588389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964875|NCT04588233|Melatonin|melatonin|mesh-list
5964876|NCT04588233|Antioxidants|antioxidants|mesh-ancestor
5923483|NCT04938583|Paclitaxel|paclitaxel|mesh-list
5923484|NCT04938583|Bevacizumab|bevacizumab|mesh-list
5923485|NCT04938583|Carboplatin|carboplatin|mesh-list
5923486|NCT04938583|Oregovomab|oregovomab|mesh-list
5923487|NCT04938583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5923488|NCT04938583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5923489|NCT04938583|Tubulin Modulators|tubulin modulators|mesh-ancestor
5923490|NCT04938583|Antimitotic Agents|antimitotic agents|mesh-ancestor
5923491|NCT04938583|Mitosis Modulators|mitosis modulators|mesh-ancestor
5923492|NCT04938583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5923493|NCT04938583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5923494|NCT04938583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5923495|NCT04938583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5923496|NCT04938583|Growth Substances|growth substances|mesh-ancestor
5923497|NCT04938583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923498|NCT04938583|Growth Inhibitors|growth inhibitors|mesh-ancestor
5923499|NCT04938713|Ketamine|ketamine|mesh-list
5923500|NCT04938713|Esketamine|esketamine|mesh-list
5923501|NCT04938713|Analgesics|analgesics|mesh-ancestor
5923502|NCT04938713|Sensory System Agents|sensory system agents|mesh-ancestor
5923503|NCT04938713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5923504|NCT04938713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923505|NCT04938713|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5923506|NCT04938713|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5923507|NCT04938713|Anesthetics, General|anesthetics, general|mesh-ancestor
5923508|NCT04938713|Anesthetics|anesthetics|mesh-ancestor
5923509|NCT04938713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5923510|NCT04938713|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5923511|NCT04938713|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5923512|NCT04938713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5923513|NCT04938713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5923514|NCT04938713|Antidepressive Agents|antidepressive agents|mesh-ancestor
5923515|NCT04938713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5923516|NCT04938856|Lamotrigine|lamotrigine|mesh-list
5923517|NCT04938856|Anticonvulsants|anticonvulsants|mesh-ancestor
5923518|NCT04938856|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5923519|NCT04938856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5923520|NCT04938856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5923521|NCT04938856|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5923522|NCT04938856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923523|NCT04938856|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5923524|NCT04938856|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5923525|NCT04938856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5923526|NCT04938856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5923527|NCT04938856|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5923528|NCT04938557|Insulin|insulin|mesh-list
5923529|NCT04938557|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5923530|NCT04938557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5923531|NCT04938557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923532|NCT04938323|BCG Vaccine|bcg vaccine|mesh-list
5923533|NCT04938323|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5923534|NCT04938323|Immunologic Factors|immunologic factors|mesh-ancestor
5923535|NCT04938323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923536|NCT04938453|Nintedanib|nintedanib|mesh-list
5923537|NCT04938453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5923538|NCT04938453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5923539|NCT04938453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5923540|NCT04938453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5923541|NCT04938232|Nivolumab|nivolumab|mesh-list
5923542|NCT04938232|Ipilimumab|ipilimumab|mesh-list
5923543|NCT04938232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5923544|NCT04938232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5923545|NCT04938232|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5923546|NCT04938232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5923547|NCT04938466|Hormones|hormones|mesh-list
5923548|NCT04938466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5923549|NCT04938466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923550|NCT04938297|Rituximab|rituximab|mesh-list
5923551|NCT04938297|Lenalidomide|lenalidomide|mesh-list
5923552|NCT04938297|Zanubrutinib|zanubrutinib|mesh-list
5923553|NCT04938297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5923554|NCT04938297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5923555|NCT04938297|Immunologic Factors|immunologic factors|mesh-ancestor
5923556|NCT04938297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923557|NCT04938297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5923558|NCT04938297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5923559|NCT04938297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5923560|NCT04938297|Growth Substances|growth substances|mesh-ancestor
5923561|NCT04938297|Growth Inhibitors|growth inhibitors|mesh-ancestor
5923562|NCT04938297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5923563|NCT04938297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5923564|NCT04938297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5923565|NCT04938011|Progesterone|progesterone|mesh-list
5923566|NCT04938011|Progestins|progestins|mesh-ancestor
5923567|NCT04938011|Hormones|hormones|mesh-ancestor
5923568|NCT04938011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5923569|NCT04938011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923570|NCT04938037|Methylprednisolone|methylprednisolone|mesh-list
5923571|NCT04938037|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5923572|NCT04938037|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5923573|NCT04938037|Prednisolone|prednisolone|mesh-list
5923574|NCT04938037|Prednisolone acetate|prednisolone acetate|mesh-list
5923575|NCT04938037|Bupivacaine|bupivacaine|mesh-list
5923576|NCT04938037|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5923577|NCT04938037|Prednisolone phosphate|prednisolone phosphate|mesh-list
5923578|NCT04938037|Anesthetics, Local|anesthetics, local|mesh-ancestor
5923579|NCT04938037|Anesthetics|anesthetics|mesh-ancestor
5923580|NCT04938037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5923581|NCT04938037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923582|NCT04938037|Sensory System Agents|sensory system agents|mesh-ancestor
5923583|NCT04938037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5923584|NCT04938037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5923585|NCT04938037|Antiemetics|antiemetics|mesh-ancestor
5923586|NCT04938037|Autonomic Agents|autonomic agents|mesh-ancestor
5923587|NCT04938037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5923588|NCT04938037|Glucocorticoids|glucocorticoids|mesh-ancestor
5923589|NCT04938037|Hormones|hormones|mesh-ancestor
5923590|NCT04938037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5923591|NCT04938037|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5923592|NCT04938037|Protective Agents|protective agents|mesh-ancestor
5923593|NCT04938037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5923594|NCT04938037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5923595|NCT04937946|Fentanyl|fentanyl|mesh-list
5923596|NCT04937946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5923597|NCT04937946|Narcotics|narcotics|mesh-ancestor
5923598|NCT04937946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5923599|NCT04937946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923600|NCT04937946|Analgesics|analgesics|mesh-ancestor
5923601|NCT04937946|Sensory System Agents|sensory system agents|mesh-ancestor
5923602|NCT04937946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5923603|NCT04937946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5923604|NCT04937946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5923605|NCT04937946|Anesthetics, General|anesthetics, general|mesh-ancestor
5923606|NCT04937946|Anesthetics|anesthetics|mesh-ancestor
5923607|NCT04938102|Botulinum Toxins|botulinum toxins|mesh-list
5923608|NCT04938102|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5923609|NCT04938102|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5923610|NCT04938102|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5923611|NCT04938102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5923612|NCT04938102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5923613|NCT04938102|Cholinergic Agents|cholinergic agents|mesh-ancestor
5923614|NCT04938102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5923615|NCT04938102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923616|NCT04938102|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5923617|NCT04938102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5923618|NCT04937907|Hydroxychloroquine|hydroxychloroquine|mesh-list
5923619|NCT04937907|Benazepril|benazepril|mesh-list
5923620|NCT04937907|Antimalarials|antimalarials|mesh-ancestor
5923621|NCT04937907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5923622|NCT04937907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5923623|NCT04937907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5923624|NCT04937907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5923625|NCT04937907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5923626|NCT04937907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5923627|NCT04937907|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5923628|NCT04937907|Protease Inhibitors|protease inhibitors|mesh-ancestor
5923629|NCT04937907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5923630|NCT04937699|Aspirin|aspirin|mesh-list
5923631|NCT04937699|Ticagrelor|ticagrelor|mesh-list
5923632|NCT04937699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5923633|NCT04937699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5923634|NCT04937699|Analgesics|analgesics|mesh-ancestor
5923635|NCT04937699|Sensory System Agents|sensory system agents|mesh-ancestor
5923636|NCT04937699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5923637|NCT04937699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923638|NCT04937699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5923639|NCT04937699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5923640|NCT04937699|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5923641|NCT04937699|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5923642|NCT04937699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5923643|NCT04937699|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5923644|NCT04937699|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5923645|NCT04937699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5923646|NCT04937699|Antipyretics|antipyretics|mesh-ancestor
5923647|NCT04937699|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5923648|NCT04937699|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5923649|NCT04937699|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5923650|NCT04937699|Purinergic Agents|purinergic agents|mesh-ancestor
5923651|NCT04937699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5923652|NCT04937673|Paclitaxel|paclitaxel|mesh-list
5923653|NCT04937673|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5923654|NCT04937673|Cisplatin|cisplatin|mesh-list
5923655|NCT04937673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5923656|NCT04937673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5923657|NCT04937673|Tubulin Modulators|tubulin modulators|mesh-ancestor
5923658|NCT04937673|Antimitotic Agents|antimitotic agents|mesh-ancestor
5923659|NCT04937673|Mitosis Modulators|mitosis modulators|mesh-ancestor
5923660|NCT04937673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5923661|NCT04937894|Tigecycline|tigecycline|mesh-list
5923662|NCT04937894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5923663|NCT04937894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5923664|NCT04937894|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5923665|NCT04937894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5923666|NCT04937894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5923667|NCT04937569|Ivermectin|ivermectin|mesh-list
5923668|NCT04937569|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5923669|NCT04937569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5923670|NCT04937634|Melphalan|melphalan|mesh-list
5923671|NCT04937634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5923672|NCT04937634|Alkylating Agents|alkylating agents|mesh-ancestor
5923673|NCT04937634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5923674|NCT04937634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5923675|NCT04937634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5923676|NCT04937634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5923677|NCT04937634|Immunologic Factors|immunologic factors|mesh-ancestor
5923678|NCT04937634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923679|NCT04937543|Beclomethasone|beclomethasone|mesh-list
5923680|NCT04937543|Glycopyrrolate|glycopyrrolate|mesh-list
5923681|NCT04937543|Formoterol Fumarate|formoterol fumarate|mesh-list
5923682|NCT04937543|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5923683|NCT04937543|Autonomic Agents|autonomic agents|mesh-ancestor
5923684|NCT04937543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5923685|NCT04937543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923686|NCT04937543|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5923687|NCT04937543|Respiratory System Agents|respiratory system agents|mesh-ancestor
5923688|NCT04937543|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5923689|NCT04937543|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5923690|NCT04937543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5923691|NCT04937543|Adrenergic Agents|adrenergic agents|mesh-ancestor
6516999|NCT00719173|Alkylating Agents|alkylating agents|mesh-ancestor
6517000|NCT00719173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517001|NCT00719173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6517002|NCT00719173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6517003|NCT00719173|Antiemetics|antiemetics|mesh-ancestor
6517004|NCT00719173|Autonomic Agents|autonomic agents|mesh-ancestor
6517005|NCT00719173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6517006|NCT00719173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6517007|NCT00719173|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6517008|NCT00719173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6517009|NCT00719199|Cetuximab|cetuximab|mesh-list
6517010|NCT00719199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6517011|NCT00719199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6517012|NCT00719290|Hyaluronic Acid|hyaluronic acid|mesh-list
6517013|NCT00719290|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6517014|NCT00719290|Immunologic Factors|immunologic factors|mesh-ancestor
5923692|NCT04937543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5923693|NCT04937543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5923694|NCT04937543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5923695|NCT04937543|Glucocorticoids|glucocorticoids|mesh-ancestor
5923696|NCT04937543|Hormones|hormones|mesh-ancestor
5923697|NCT04937543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5923698|NCT04937543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5923699|NCT04937543|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5923700|NCT04937543|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5923701|NCT04937543|Cholinergic Agents|cholinergic agents|mesh-ancestor
5923702|NCT04937881|Tenofovir|tenofovir|mesh-list
5923703|NCT04937881|Antiviral Agents|antiviral agents|mesh-ancestor
5923704|NCT04937881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5923705|NCT04937881|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5923706|NCT04937881|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5923707|NCT04937881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5923708|NCT04937881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5923709|NCT04937881|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5923710|NCT04937881|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5923711|NCT04937452|Rotigotine|rotigotine|mesh-list
5923712|NCT04937452|Dopamine Agonists|dopamine agonists|mesh-ancestor
5923713|NCT04937452|Dopamine Agents|dopamine agents|mesh-ancestor
5923714|NCT04937452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5923715|NCT04937452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517015|NCT00719290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923716|NCT04937452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923717|NCT04937140|Antibodies|antibodies|mesh-list
5923718|NCT04937140|Immunologic Factors|immunologic factors|mesh-ancestor
5923719|NCT04937140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923720|NCT04937101|Chlorpheniramine|chlorpheniramine|mesh-list
5923721|NCT04937101|Codeine|codeine|mesh-list
5923722|NCT04937101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5923723|NCT04937101|Narcotics|narcotics|mesh-ancestor
5923724|NCT04937101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5923725|NCT04937101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923726|NCT04937101|Analgesics|analgesics|mesh-ancestor
5923727|NCT04937101|Sensory System Agents|sensory system agents|mesh-ancestor
5923728|NCT04937101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5923729|NCT04937101|Antitussive Agents|antitussive agents|mesh-ancestor
5923730|NCT04937101|Respiratory System Agents|respiratory system agents|mesh-ancestor
5923731|NCT04937101|Antipruritics|antipruritics|mesh-ancestor
5923732|NCT04937101|Dermatologic Agents|dermatologic agents|mesh-ancestor
5923733|NCT04937101|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5923734|NCT04937101|Histamine Antagonists|histamine antagonists|mesh-ancestor
5923735|NCT04937101|Histamine Agents|histamine agents|mesh-ancestor
5923736|NCT04937101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5923737|NCT04937101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5923738|NCT04937101|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5923739|NCT04937023|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
5923740|NCT04937023|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5923741|NCT04937023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5923742|NCT04937062|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
5923743|NCT04937062|Glycerol|glycerol|mesh-list
5923744|NCT04937062|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
5923745|NCT04937062|Protective Agents|protective agents|mesh-ancestor
5923746|NCT04937062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923747|NCT04937062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5964877|NCT04588233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964878|NCT04588233|Protective Agents|protective agents|mesh-ancestor
5964879|NCT04588233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964880|NCT04588233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5964881|NCT04588220|Plasminogen|plasminogen|mesh-list
5964882|NCT04588220|Melatonin|melatonin|mesh-list
5964883|NCT04588220|Antioxidants|antioxidants|mesh-ancestor
5964884|NCT04588220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964885|NCT04588220|Protective Agents|protective agents|mesh-ancestor
5964886|NCT04588220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964887|NCT04588220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5964888|NCT04588220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5964889|NCT04588220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5964890|NCT04588194|Dexamethasone|dexamethasone|mesh-list
5964891|NCT04588194|Rituximab|rituximab|mesh-list
5964892|NCT04588194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5964893|NCT04588194|Antiemetics|antiemetics|mesh-ancestor
5964894|NCT04588194|Autonomic Agents|autonomic agents|mesh-ancestor
5923748|NCT04936763|Hyaluronic Acid|hyaluronic acid|mesh-list
5923749|NCT04936763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5923750|NCT04936763|Immunologic Factors|immunologic factors|mesh-ancestor
5923751|NCT04936763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923752|NCT04936763|Viscosupplements|viscosupplements|mesh-ancestor
5923753|NCT04936763|Protective Agents|protective agents|mesh-ancestor
5923754|NCT04936711|Bupivacaine|bupivacaine|mesh-list
5923755|NCT04936711|Anesthetics, Local|anesthetics, local|mesh-ancestor
5923756|NCT04936711|Anesthetics|anesthetics|mesh-ancestor
5923757|NCT04936711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5923758|NCT04936711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923759|NCT04936711|Sensory System Agents|sensory system agents|mesh-ancestor
5923760|NCT04936711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5923761|NCT04936854|Sirolimus|sirolimus|mesh-list
5923762|NCT04936854|Methylprednisolone|methylprednisolone|mesh-list
5923763|NCT04936854|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5923764|NCT04936854|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5923765|NCT04936854|Prednisolone|prednisolone|mesh-list
5923766|NCT04936854|Prednisolone acetate|prednisolone acetate|mesh-list
5923767|NCT04936854|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5923768|NCT04936854|Prednisolone phosphate|prednisolone phosphate|mesh-list
5923769|NCT04936854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5923770|NCT04936854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5923771|NCT04936854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5923772|NCT04936854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5923773|NCT04936854|Antifungal Agents|antifungal agents|mesh-ancestor
5923774|NCT04936854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5923775|NCT04936854|Immunologic Factors|immunologic factors|mesh-ancestor
5923776|NCT04936854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923777|NCT04936854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5923778|NCT04936854|Antiemetics|antiemetics|mesh-ancestor
5923779|NCT04936854|Autonomic Agents|autonomic agents|mesh-ancestor
5923780|NCT04936854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5923781|NCT04936854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5923782|NCT04936854|Glucocorticoids|glucocorticoids|mesh-ancestor
5923783|NCT04936854|Hormones|hormones|mesh-ancestor
5923784|NCT04936854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5923785|NCT04936854|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5923786|NCT04936854|Protective Agents|protective agents|mesh-ancestor
5923787|NCT04936854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5923788|NCT04936841|Pembrolizumab|pembrolizumab|mesh-list
5923789|NCT04936841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5923790|NCT04936841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5923791|NCT04936334|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5923792|NCT04936334|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5923793|NCT04936334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5923794|NCT04936971|Mycophenolic Acid|mycophenolic acid|mesh-list
5923795|NCT04936971|Everolimus|everolimus|mesh-list
5923796|NCT04936971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5923797|NCT04936971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5923798|NCT04936971|Immunologic Factors|immunologic factors|mesh-ancestor
5923799|NCT04936971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923800|NCT04936971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5923801|NCT04936971|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5923802|NCT04936971|Antitubercular Agents|antitubercular agents|mesh-ancestor
5923803|NCT04936971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5923804|NCT04936971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5923805|NCT04936971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5923806|NCT04936971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5923807|NCT04936282|Tacrolimus|tacrolimus|mesh-list
5923808|NCT04936282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5923809|NCT04936282|Immunologic Factors|immunologic factors|mesh-ancestor
5923810|NCT04936282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923811|NCT04936282|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5923812|NCT04936282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5923813|NCT04936282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5923814|NCT04936399|Nivolumab|nivolumab|mesh-list
5923815|NCT04936399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5923816|NCT04936399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5923817|NCT04936399|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5923818|NCT04936399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5923819|NCT04936295|Fulvestrant|fulvestrant|mesh-list
5923820|NCT04936295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5923821|NCT04936295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5923822|NCT04936295|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5923823|NCT04936295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5923824|NCT04936295|Hormone Antagonists|hormone antagonists|mesh-ancestor
5923825|NCT04936295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5923826|NCT04936295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923827|NCT04936204|Hyaluronic Acid|hyaluronic acid|mesh-list
5923828|NCT04936204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6517016|NCT00719290|Viscosupplements|viscosupplements|mesh-ancestor
6517017|NCT00719290|Protective Agents|protective agents|mesh-ancestor
6681130|NCT01608334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5923829|NCT04936204|Immunologic Factors|immunologic factors|mesh-ancestor
5923830|NCT04936204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923831|NCT04936204|Viscosupplements|viscosupplements|mesh-ancestor
5923832|NCT04936204|Protective Agents|protective agents|mesh-ancestor
5923833|NCT04936126|Amantadine|amantadine|mesh-list
5923834|NCT04936126|Pramipexole|pramipexole|mesh-list
5923835|NCT04936126|Quetiapine Fumarate|quetiapine fumarate|mesh-list
5923836|NCT04936126|Antidepressive Agents|antidepressive agents|mesh-ancestor
5923837|NCT04936126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5923838|NCT04936126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5923839|NCT04936126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5923840|NCT04936126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5923841|NCT04936126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923842|NCT04936126|Antioxidants|antioxidants|mesh-ancestor
5923843|NCT04936126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5923844|NCT04936126|Protective Agents|protective agents|mesh-ancestor
5923845|NCT04936126|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5923846|NCT04936126|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5923847|NCT04936126|Dopamine Agonists|dopamine agonists|mesh-ancestor
5923848|NCT04936126|Dopamine Agents|dopamine agents|mesh-ancestor
5923849|NCT04936126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5923850|NCT04936126|Antiviral Agents|antiviral agents|mesh-ancestor
5923851|NCT04936126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5923852|NCT04936126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5923853|NCT04936126|Analgesics|analgesics|mesh-ancestor
5923854|NCT04936126|Sensory System Agents|sensory system agents|mesh-ancestor
5923855|NCT04936126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5923856|NCT04935814|Vasopressins|vasopressins|mesh-list
5923857|NCT04935814|Arginine Vasopressin|arginine vasopressin|mesh-list
5923858|NCT04935814|Hemostatics|hemostatics|mesh-ancestor
5923859|NCT04935814|Coagulants|coagulants|mesh-ancestor
5923860|NCT04935814|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5923861|NCT04935814|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5923862|NCT04935814|Natriuretic Agents|natriuretic agents|mesh-ancestor
5923863|NCT04935814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923864|NCT04935931|Naltrexone|naltrexone|mesh-list
5923865|NCT04935931|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5923866|NCT04935931|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5923867|NCT04935931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923868|NCT04935931|Sensory System Agents|sensory system agents|mesh-ancestor
5923869|NCT04935931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5923870|NCT04935788|Caseins|caseins|mesh-list
5923871|NCT04935788|Chelating Agents|chelating agents|mesh-ancestor
5923872|NCT04935788|Sequestering Agents|sequestering agents|mesh-ancestor
5923873|NCT04935788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5923874|NCT04935658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
5923875|NCT04935658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5923876|NCT04935658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923877|NCT04935515|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5923878|NCT04935515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5923879|NCT04935515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
5923880|NCT04935515|Anticoagulants|anticoagulants|mesh-list
5923881|NCT04935515|Coagulants|coagulants|mesh-list
5923882|NCT04935515|Histamine Antagonists|histamine antagonists|mesh-list
5923883|NCT04935515|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
5923884|NCT04935515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5923885|NCT04935515|Antitubercular Agents|antitubercular agents|mesh-ancestor
5923886|NCT04935515|Histamine Agents|histamine agents|mesh-ancestor
5923887|NCT04935515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5923888|NCT04935515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5923889|NCT04935515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923890|NCT04935541|Dexmedetomidine|dexmedetomidine|mesh-list
5923891|NCT04935541|Remifentanil|remifentanil|mesh-list
5923892|NCT04935541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5923893|NCT04935541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5923894|NCT04935541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923895|NCT04935541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5923896|NCT04935541|Analgesics|analgesics|mesh-ancestor
5923897|NCT04935541|Sensory System Agents|sensory system agents|mesh-ancestor
5923898|NCT04935541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5923899|NCT04935541|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5923900|NCT04935541|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5923901|NCT04935541|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5923902|NCT04935541|Adrenergic Agents|adrenergic agents|mesh-ancestor
5923903|NCT04935541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5923904|NCT04935541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5923905|NCT04935541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5923906|NCT04935541|Narcotics|narcotics|mesh-ancestor
5923907|NCT04935034|Vitamin D|vitamin d|mesh-list
5923908|NCT04935034|Vitamins|vitamins|mesh-ancestor
5923909|NCT04935034|Micronutrients|micronutrients|mesh-ancestor
5923910|NCT04935034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923911|NCT04935034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5923912|NCT04934930|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5923913|NCT04934930|Obinutuzumab|obinutuzumab|mesh-list
5923914|NCT04934930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5923915|NCT04934930|Alkylating Agents|alkylating agents|mesh-ancestor
5923916|NCT04934930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5923917|NCT04934930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5923918|NCT04934930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5923919|NCT04935073|Cetrorelix|cetrorelix|mesh-list
5923920|NCT04935073|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5923921|NCT04935073|Hormones|hormones|mesh-ancestor
5923922|NCT04935073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5923923|NCT04935073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923924|NCT04935073|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5923925|NCT04935073|Fertility Agents|fertility agents|mesh-ancestor
5923926|NCT04935073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5923927|NCT04935073|Hormone Antagonists|hormone antagonists|mesh-ancestor
5964895|NCT04588194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5964896|NCT04588194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964897|NCT04588194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5964898|NCT04588194|Glucocorticoids|glucocorticoids|mesh-ancestor
5964899|NCT04588194|Hormones|hormones|mesh-ancestor
5964900|NCT04588194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5964901|NCT04588194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5964902|NCT04588194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5964903|NCT04588194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5964904|NCT04588194|Immunologic Factors|immunologic factors|mesh-ancestor
5964905|NCT04588194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5964906|NCT04588090|Cisplatin|cisplatin|mesh-list
5964907|NCT04588090|Paclitaxel|paclitaxel|mesh-list
5964908|NCT04588090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5964909|NCT04588090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5964910|NCT04588090|Tubulin Modulators|tubulin modulators|mesh-ancestor
5964911|NCT04588090|Antimitotic Agents|antimitotic agents|mesh-ancestor
5964912|NCT04588090|Mitosis Modulators|mitosis modulators|mesh-ancestor
5964913|NCT04588090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964914|NCT04588285|Ambroxol|ambroxol|mesh-list
5964915|NCT04588285|Expectorants|expectorants|mesh-ancestor
5964916|NCT04588285|Respiratory System Agents|respiratory system agents|mesh-ancestor
5964917|NCT04587947|Valsartan|valsartan|mesh-list
5964918|NCT04587947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5964919|NCT04587947|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5964920|NCT04587947|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5964921|NCT04587947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964922|NCT04587973|Dexmedetomidine|dexmedetomidine|mesh-list
5964923|NCT04587973|Ropivacaine|ropivacaine|mesh-list
5964924|NCT04587973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5964925|NCT04587973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5964926|NCT04587973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964927|NCT04587973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5964928|NCT04587973|Analgesics|analgesics|mesh-ancestor
5964929|NCT04587973|Sensory System Agents|sensory system agents|mesh-ancestor
5964930|NCT04587973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5964931|NCT04587973|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5964932|NCT04587973|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5964933|NCT04587973|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5964934|NCT04587973|Adrenergic Agents|adrenergic agents|mesh-ancestor
5964935|NCT04587973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5964936|NCT04587973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5923928|NCT04934696|Contraceptive Agents|contraceptive agents|mesh-list
5923929|NCT04934696|Contraceptives, Oral|contraceptives, oral|mesh-list
5923930|NCT04934696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5923931|NCT04934696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923932|NCT04934696|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5923933|NCT04934683|Propofol|propofol|mesh-list
5923934|NCT04934683|Etomidate|etomidate|mesh-list
5923935|NCT04934683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5923936|NCT04934683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5923937|NCT04934683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923938|NCT04934683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5923939|NCT04934683|Anesthetics, General|anesthetics, general|mesh-ancestor
5923940|NCT04934683|Anesthetics|anesthetics|mesh-ancestor
5923941|NCT04934579|Rituximab|rituximab|mesh-list
5923942|NCT04934579|Methotrexate|methotrexate|mesh-list
5923943|NCT04934579|Lenalidomide|lenalidomide|mesh-list
5923944|NCT04934579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5923945|NCT04934579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5923946|NCT04934579|Immunologic Factors|immunologic factors|mesh-ancestor
5923947|NCT04934579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923948|NCT04934579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5923949|NCT04934579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5923950|NCT04934579|Abortifacient Agents|abortifacient agents|mesh-ancestor
5923951|NCT04934579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5923952|NCT04934579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5923953|NCT04934579|Antimetabolites|antimetabolites|mesh-ancestor
5923954|NCT04934579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5923955|NCT04934579|Dermatologic Agents|dermatologic agents|mesh-ancestor
5923956|NCT04934579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5923957|NCT04934579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5923958|NCT04934579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5923959|NCT04934579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5923960|NCT04934579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5923961|NCT04934579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5923962|NCT04934579|Growth Substances|growth substances|mesh-ancestor
5923963|NCT04934579|Growth Inhibitors|growth inhibitors|mesh-ancestor
5923964|NCT04934852|Ephedrine|ephedrine|mesh-list
5923965|NCT04934852|Pseudoephedrine|pseudoephedrine|mesh-list
5923966|NCT04934852|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5923967|NCT04934852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923968|NCT04934852|Sympathomimetics|sympathomimetics|mesh-ancestor
5923969|NCT04934852|Autonomic Agents|autonomic agents|mesh-ancestor
5923970|NCT04934852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5923971|NCT04934852|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5923972|NCT04934852|Adrenergic Agents|adrenergic agents|mesh-ancestor
5923973|NCT04934852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5923974|NCT04934852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5923975|NCT04934852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5923976|NCT04934852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5923977|NCT04934852|Respiratory System Agents|respiratory system agents|mesh-ancestor
5923978|NCT04934852|Nasal Decongestants|nasal decongestants|mesh-ancestor
5923979|NCT04934618|Irinotecan|irinotecan|mesh-list
5923980|NCT04934618|Apatinib|apatinib|mesh-list
5923981|NCT04934618|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5923982|NCT04934618|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5923983|NCT04934618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5923984|NCT04934618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5923985|NCT04934618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5923986|NCT04934618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5923987|NCT04934904|Ropivacaine|ropivacaine|mesh-list
5923988|NCT04934904|Anesthetics, Local|anesthetics, local|mesh-ancestor
5923989|NCT04934904|Anesthetics|anesthetics|mesh-ancestor
5923990|NCT04934904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5923991|NCT04934904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5923992|NCT04934904|Sensory System Agents|sensory system agents|mesh-ancestor
5923993|NCT04934904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5923994|NCT04934514|Gemcitabine|gemcitabine|mesh-list
5923995|NCT04934514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5923996|NCT04934514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5923997|NCT04934514|Antimetabolites|antimetabolites|mesh-ancestor
5923998|NCT04934514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5923999|NCT04934514|Antiviral Agents|antiviral agents|mesh-ancestor
5924000|NCT04934514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5924001|NCT04934514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5924002|NCT04934514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5924003|NCT04934514|Immunologic Factors|immunologic factors|mesh-ancestor
5924004|NCT04934514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924005|NCT04934748|Phenylephrine|phenylephrine|mesh-list
5924006|NCT04934748|Oxymetazoline|oxymetazoline|mesh-list
5924007|NCT04934748|Norepinephrine|norepinephrine|mesh-list
5924008|NCT04934748|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5924009|NCT04934748|Mydriatics|mydriatics|mesh-ancestor
5924010|NCT04934748|Autonomic Agents|autonomic agents|mesh-ancestor
5924011|NCT04934748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5924012|NCT04934748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924013|NCT04934748|Sympathomimetics|sympathomimetics|mesh-ancestor
5924014|NCT04934748|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5924015|NCT04934748|Nasal Decongestants|nasal decongestants|mesh-ancestor
5924016|NCT04934748|Respiratory System Agents|respiratory system agents|mesh-ancestor
5924017|NCT04934748|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5924018|NCT04934748|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5924019|NCT04934748|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5924020|NCT04934748|Adrenergic Agents|adrenergic agents|mesh-ancestor
5924021|NCT04934748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5924022|NCT04934748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924023|NCT04934748|Protective Agents|protective agents|mesh-ancestor
5924024|NCT04934228|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5924025|NCT04934228|Clonidine|clonidine|mesh-list
5924026|NCT04934228|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5924027|NCT04934228|Diuretics|diuretics|mesh-ancestor
5924028|NCT04934228|Natriuretic Agents|natriuretic agents|mesh-ancestor
5924029|NCT04934228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924030|NCT04934228|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5924031|NCT04934228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5924032|NCT04934228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924033|NCT04934228|Analgesics|analgesics|mesh-ancestor
5924034|NCT04934228|Sensory System Agents|sensory system agents|mesh-ancestor
5924035|NCT04934228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5924036|NCT04934228|Sympatholytics|sympatholytics|mesh-ancestor
5924037|NCT04934228|Autonomic Agents|autonomic agents|mesh-ancestor
5924038|NCT04934228|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5924039|NCT04934228|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5924040|NCT04934228|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5924041|NCT04934228|Adrenergic Agents|adrenergic agents|mesh-ancestor
5924042|NCT04934228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5924043|NCT04934475|Lenalidomide|lenalidomide|mesh-list
5924044|NCT04934475|Immunologic Factors|immunologic factors|mesh-ancestor
5924045|NCT04934475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924046|NCT04934475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5924047|NCT04934475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5924048|NCT04934475|Growth Substances|growth substances|mesh-ancestor
5924049|NCT04934475|Growth Inhibitors|growth inhibitors|mesh-ancestor
5924050|NCT04934475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5924051|NCT04933942|Lomustine|lomustine|mesh-list
5924052|NCT04933942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5924053|NCT04933942|Alkylating Agents|alkylating agents|mesh-ancestor
5924054|NCT04933942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924055|NCT04933942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5924056|NCT04933630|Norepinephrine|norepinephrine|mesh-list
5924057|NCT04933630|Serotonin|serotonin|mesh-list
5924058|NCT04933630|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
5924059|NCT04933630|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5924060|NCT04933630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5924061|NCT04933630|Adrenergic Agents|adrenergic agents|mesh-ancestor
5924062|NCT04933630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5924063|NCT04933630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924064|NCT04933630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924065|NCT04933630|Sympathomimetics|sympathomimetics|mesh-ancestor
5924066|NCT04933630|Autonomic Agents|autonomic agents|mesh-ancestor
5924067|NCT04933630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5924068|NCT04933630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5924069|NCT04933630|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5924070|NCT04933630|Serotonin Agents|serotonin agents|mesh-ancestor
5924071|NCT04933630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5924072|NCT04933630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5924073|NCT04933864|Methylene Blue|methylene blue|mesh-list
5924074|NCT04933864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5924075|NCT04933864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924076|NCT04933721|Berotralstat|berotralstat|mesh-list
5924077|NCT04933721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5924078|NCT04933721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924079|NCT04933526|Dasatinib|dasatinib|mesh-list
5924080|NCT04933526|HH-GV-678|hh-gv-678|mesh-list
5924081|NCT04933526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5924082|NCT04933526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5924083|NCT04933526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5924084|NCT04933526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924085|NCT04933019|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5924086|NCT04933019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5924087|NCT04933292|Mycophenolic Acid|mycophenolic acid|mesh-list
5924088|NCT04933292|Methylprednisolone|methylprednisolone|mesh-list
5924089|NCT04933292|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5924090|NCT04933292|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5924091|NCT04933292|Prednisolone|prednisolone|mesh-list
5924092|NCT04933292|Prednisolone acetate|prednisolone acetate|mesh-list
5924093|NCT04933292|Azathioprine|azathioprine|mesh-list
5924094|NCT04933292|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5718824|NCT03222076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5718825|NCT03222076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718826|NCT03222323|Dexmedetomidine|dexmedetomidine|mesh-list
5718827|NCT03222323|Ropivacaine|ropivacaine|mesh-list
5718828|NCT03222323|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5718829|NCT03222323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5718830|NCT03222323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718831|NCT03222323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5718832|NCT03222323|Analgesics|analgesics|mesh-ancestor
5718833|NCT03222323|Sensory System Agents|sensory system agents|mesh-ancestor
5718834|NCT03222323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5718835|NCT03222323|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5718836|NCT03222323|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5718837|NCT03222323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5718838|NCT03222323|Adrenergic Agents|adrenergic agents|mesh-ancestor
5718839|NCT03222323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5718840|NCT03222323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718841|NCT03222323|Anesthetics, Local|anesthetics, local|mesh-ancestor
5718842|NCT03222323|Anesthetics|anesthetics|mesh-ancestor
5718843|NCT03222089|Leucovorin|leucovorin|mesh-list
5718844|NCT03222089|Fluorouracil|fluorouracil|mesh-list
5718845|NCT03222089|Oxaliplatin|oxaliplatin|mesh-list
5718846|NCT03222089|Irinotecan|irinotecan|mesh-list
5718847|NCT03222089|Interleukin-2|interleukin-2|mesh-list
5718848|NCT03222089|Molgramostim|molgramostim|mesh-list
5718849|NCT03222089|Sargramostim|sargramostim|mesh-list
5718850|NCT03222089|Levoleucovorin|levoleucovorin|mesh-list
5718851|NCT03222089|Antimetabolites|antimetabolites|mesh-ancestor
5718852|NCT03222089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718853|NCT03222089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5718854|NCT03222089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5718855|NCT03222089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5718856|NCT03222089|Immunologic Factors|immunologic factors|mesh-ancestor
5718857|NCT03222089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924095|NCT04933292|Prednisolone phosphate|prednisolone phosphate|mesh-list
5924096|NCT04933292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5924097|NCT04933292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5924098|NCT04933292|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5924099|NCT04933292|Antitubercular Agents|antitubercular agents|mesh-ancestor
5924100|NCT04933292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5924101|NCT04933292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5924102|NCT04933292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5924103|NCT04933292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924104|NCT04933292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5924105|NCT04933292|Antiemetics|antiemetics|mesh-ancestor
5924106|NCT04933292|Autonomic Agents|autonomic agents|mesh-ancestor
5924107|NCT04933292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5924108|NCT04933292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924109|NCT04933292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5924110|NCT04933292|Glucocorticoids|glucocorticoids|mesh-ancestor
5924111|NCT04933292|Hormones|hormones|mesh-ancestor
5924112|NCT04933292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5924113|NCT04933292|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5924114|NCT04933292|Protective Agents|protective agents|mesh-ancestor
5924115|NCT04933292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5924116|NCT04933292|Antimetabolites|antimetabolites|mesh-ancestor
5924117|NCT04933292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5924118|NCT04933292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5924119|NCT04933292|Immunologic Factors|immunologic factors|mesh-ancestor
5924120|NCT04933292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5924121|NCT04933084|Analgesics, Opioid|analgesics, opioid|mesh-list
5924122|NCT04933084|Narcotics|narcotics|mesh-ancestor
5924123|NCT04933084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5924124|NCT04933084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924125|NCT04933084|Analgesics|analgesics|mesh-ancestor
5924126|NCT04933084|Sensory System Agents|sensory system agents|mesh-ancestor
5924127|NCT04933084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5924128|NCT04933266|Levobupivacaine|levobupivacaine|mesh-list
5924129|NCT04933266|Anesthetics, Local|anesthetics, local|mesh-ancestor
5924130|NCT04933266|Anesthetics|anesthetics|mesh-ancestor
5924131|NCT04933266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5924132|NCT04933266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924133|NCT04933266|Sensory System Agents|sensory system agents|mesh-ancestor
5924134|NCT04933266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5964937|NCT04587973|Anesthetics, Local|anesthetics, local|mesh-ancestor
5964938|NCT04587973|Anesthetics|anesthetics|mesh-ancestor
5964939|NCT04588324|Antineoplastic Agents|antineoplastic agents|mesh-list
5964940|NCT04587843|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
5964941|NCT04587843|Naltrexone|naltrexone|mesh-list
5964942|NCT04587843|Bupropion|bupropion|mesh-list
5964943|NCT04587843|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5964944|NCT04587843|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5964945|NCT04587843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964946|NCT04587843|Sensory System Agents|sensory system agents|mesh-ancestor
5964947|NCT04587843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5964948|NCT04587843|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5964949|NCT04587843|Antidepressive Agents|antidepressive agents|mesh-ancestor
5964950|NCT04587843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5964951|NCT04587843|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5964952|NCT04587843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5964953|NCT04587843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5964954|NCT04587843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964955|NCT04587843|Dopamine Agents|dopamine agents|mesh-ancestor
5964956|NCT04587843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5964957|NCT04587843|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5964958|NCT04587843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5964959|NCT04587843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5964960|NCT04587843|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5964961|NCT04588311|Epoetin Alfa|epoetin alfa|mesh-list
5964962|NCT04588311|Hematinics|hematinics|mesh-ancestor
5964963|NCT04587830|Temozolomide|temozolomide|mesh-list
5964964|NCT04587830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5964965|NCT04587830|Alkylating Agents|alkylating agents|mesh-ancestor
5964966|NCT04587830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964967|NCT04587830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5964968|NCT04587791|Cannabidiol|cannabidiol|mesh-list
5964969|NCT04587791|Anticonvulsants|anticonvulsants|mesh-ancestor
5964970|NCT04587778|Ketamine|ketamine|mesh-list
5964971|NCT04587778|Esketamine|esketamine|mesh-list
5964972|NCT04587778|Analgesics|analgesics|mesh-ancestor
5964973|NCT04587778|Sensory System Agents|sensory system agents|mesh-ancestor
5964974|NCT04587778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5964975|NCT04587778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964976|NCT04587778|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5964977|NCT04587778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5964978|NCT04587778|Anesthetics, General|anesthetics, general|mesh-ancestor
5964979|NCT04587778|Anesthetics|anesthetics|mesh-ancestor
5964980|NCT04587778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5964981|NCT04587778|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5964982|NCT04587778|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5964983|NCT04587778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5964984|NCT04587778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5964985|NCT04587778|Antidepressive Agents|antidepressive agents|mesh-ancestor
5964986|NCT04587778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5970735|NCT04532775|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5970736|NCT04532775|Prednisolone phosphate|prednisolone phosphate|mesh-list
5970737|NCT04532775|Anesthetics, Local|anesthetics, local|mesh-ancestor
5970738|NCT04532775|Anesthetics|anesthetics|mesh-ancestor
5970739|NCT04532775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5970740|NCT04532775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970741|NCT04532775|Sensory System Agents|sensory system agents|mesh-ancestor
5970742|NCT04532775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5970743|NCT04532775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5924135|NCT04933279|Iodine|iodine|mesh-list
5924136|NCT04933279|Cadexomer iodine|cadexomer iodine|mesh-list
5924137|NCT04933279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5924138|NCT04933279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5924139|NCT04933279|Trace Elements|trace elements|mesh-ancestor
5924140|NCT04933279|Micronutrients|micronutrients|mesh-ancestor
5924141|NCT04933279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924142|NCT04932980|Aflibercept|aflibercept|mesh-list
5924143|NCT04932980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5924144|NCT04932980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5924145|NCT04932980|Growth Substances|growth substances|mesh-ancestor
5924146|NCT04932980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924147|NCT04932980|Growth Inhibitors|growth inhibitors|mesh-ancestor
5924148|NCT04932980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5924149|NCT04932564|Leflunomide|leflunomide|mesh-list
5924150|NCT04932564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5924151|NCT04932564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924152|NCT04932564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5924153|NCT04932564|Immunologic Factors|immunologic factors|mesh-ancestor
5924154|NCT04932564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924155|NCT04932746|Dexmedetomidine|dexmedetomidine|mesh-list
5924156|NCT04932746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5924157|NCT04932746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5924158|NCT04932746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924159|NCT04932746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5924160|NCT04932746|Analgesics|analgesics|mesh-ancestor
5924161|NCT04932746|Sensory System Agents|sensory system agents|mesh-ancestor
5924162|NCT04932746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5924163|NCT04932746|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5924164|NCT04932746|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5924165|NCT04932746|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5924166|NCT04932746|Adrenergic Agents|adrenergic agents|mesh-ancestor
5924167|NCT04932746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5924168|NCT04932746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924169|NCT04932434|Psilocybin|psilocybin|mesh-list
5924170|NCT04932434|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
5924171|NCT04932434|Hallucinogens|hallucinogens|mesh-ancestor
5924172|NCT04932434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924173|NCT04932434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5924174|NCT04932434|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5924175|NCT04932434|Serotonin Agents|serotonin agents|mesh-ancestor
5924176|NCT04932434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5924177|NCT04932434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924178|NCT04932434|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5924179|NCT04932135|Hormones|hormones|mesh-list
5924180|NCT04932135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5924181|NCT04932135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924182|NCT04932096|Melatonin|melatonin|mesh-list
5924183|NCT04932096|Antioxidants|antioxidants|mesh-ancestor
5924184|NCT04932096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924185|NCT04932096|Protective Agents|protective agents|mesh-ancestor
5924186|NCT04932096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924187|NCT04932096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5924188|NCT04932382|Misoprostol|misoprostol|mesh-list
5924189|NCT04932382|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5924190|NCT04932382|Abortifacient Agents|abortifacient agents|mesh-ancestor
5924191|NCT04932382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5924192|NCT04932382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924193|NCT04932382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5924194|NCT04932382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5924195|NCT04932382|Oxytocics|oxytocics|mesh-ancestor
5924196|NCT04932187|Capecitabine|capecitabine|mesh-list
5924197|NCT04932187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5924198|NCT04932187|Antimetabolites|antimetabolites|mesh-ancestor
5924199|NCT04932187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924200|NCT04932187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5924201|NCT04932083|Fentanyl|fentanyl|mesh-list
5924202|NCT04932083|Midazolam|midazolam|mesh-list
5924203|NCT04932083|Nalbuphine|nalbuphine|mesh-list
5924204|NCT04932083|Bupivacaine|bupivacaine|mesh-list
5924205|NCT04932083|Anesthetics, Local|anesthetics, local|mesh-ancestor
5924206|NCT04932083|Anesthetics|anesthetics|mesh-ancestor
5924207|NCT04932083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5924208|NCT04932083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924209|NCT04932083|Sensory System Agents|sensory system agents|mesh-ancestor
5924210|NCT04932083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5924211|NCT04932083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5924212|NCT04932083|Narcotics|narcotics|mesh-ancestor
5924213|NCT04932083|Analgesics|analgesics|mesh-ancestor
5924214|NCT04932083|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5924215|NCT04932083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5924216|NCT04932083|Anesthetics, General|anesthetics, general|mesh-ancestor
5924217|NCT04932083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5924218|NCT04932083|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5924219|NCT04932083|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5924220|NCT04932083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5924221|NCT04932083|GABA Modulators|gaba modulators|mesh-ancestor
5924222|NCT04932083|GABA Agents|gaba agents|mesh-ancestor
5924223|NCT04932083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5924224|NCT04932083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924225|NCT04931602|Vitamin D|vitamin d|mesh-list
5924226|NCT04931602|Vitamins|vitamins|mesh-ancestor
5924227|NCT04931602|Micronutrients|micronutrients|mesh-ancestor
5924228|NCT04931602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924229|NCT04931602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5924230|NCT04931693|Acetaminophen|acetaminophen|mesh-list
5924231|NCT04931693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5924232|NCT04931693|Analgesics|analgesics|mesh-ancestor
5924233|NCT04931693|Sensory System Agents|sensory system agents|mesh-ancestor
5924234|NCT04931693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5924235|NCT04931693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924236|NCT04931693|Antipyretics|antipyretics|mesh-ancestor
5924237|NCT04931368|Rituximab|rituximab|mesh-list
5924238|NCT04931368|Methotrexate|methotrexate|mesh-list
5924239|NCT04931368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5924240|NCT04931368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5924241|NCT04931368|Immunologic Factors|immunologic factors|mesh-ancestor
5924242|NCT04931368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924243|NCT04931368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5924244|NCT04931368|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5924245|NCT04931368|Abortifacient Agents|abortifacient agents|mesh-ancestor
5924246|NCT04931368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5924247|NCT04931368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5924248|NCT04931368|Antimetabolites|antimetabolites|mesh-ancestor
5924249|NCT04931368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924250|NCT04931368|Dermatologic Agents|dermatologic agents|mesh-ancestor
5924251|NCT04931368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5924252|NCT04931368|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5924253|NCT04931368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5924254|NCT04931368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5924255|NCT04931433|Lidocaine|lidocaine|mesh-list
5924256|NCT04931433|Anesthetics, Local|anesthetics, local|mesh-ancestor
5924257|NCT04931433|Anesthetics|anesthetics|mesh-ancestor
5924258|NCT04931433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5924259|NCT04931433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924260|NCT04931433|Sensory System Agents|sensory system agents|mesh-ancestor
5924261|NCT04931433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5924262|NCT04931433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5924263|NCT04931433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5924264|NCT04931433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5924265|NCT04931433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5924266|NCT04931433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924267|NCT04931524|Mitogens|mitogens|mesh-list
5924268|NCT04931524|Mitosis Modulators|mitosis modulators|mesh-ancestor
5924269|NCT04931524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924270|NCT04931355|Cetrorelix|cetrorelix|mesh-list
5924271|NCT04931355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5924272|NCT04931355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924273|NCT04931355|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5924274|NCT04931355|Fertility Agents|fertility agents|mesh-ancestor
5924275|NCT04931355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5924276|NCT04931355|Hormone Antagonists|hormone antagonists|mesh-ancestor
5964987|NCT04587505|Morphine|morphine|mesh-list
5964988|NCT04587505|Tramadol|tramadol|mesh-list
5964989|NCT04587505|Anesthetics|anesthetics|mesh-list
5964990|NCT04587505|Ropivacaine|ropivacaine|mesh-list
5964991|NCT04587505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5964992|NCT04587505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964993|NCT04587505|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5964994|NCT04587505|Narcotics|narcotics|mesh-ancestor
5964995|NCT04587505|Analgesics|analgesics|mesh-ancestor
5924277|NCT04930952|Ethanol|ethanol|mesh-list
5924278|NCT04930952|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5924279|NCT04930952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5924280|NCT04930952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5924281|NCT04930952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924282|NCT04931225|Landiolol|landiolol|mesh-list
5924283|NCT04931225|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5924284|NCT04931225|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5924285|NCT04931225|Adrenergic Agents|adrenergic agents|mesh-ancestor
5924286|NCT04931225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5924287|NCT04931225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924288|NCT04931225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924289|NCT04931225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5924290|NCT04931108|Atenolol|atenolol|mesh-list
5924291|NCT04931108|Nitrendipine|nitrendipine|mesh-list
5924292|NCT04931108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5924293|NCT04931108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5924294|NCT04931108|Sympatholytics|sympatholytics|mesh-ancestor
5924295|NCT04931108|Autonomic Agents|autonomic agents|mesh-ancestor
5924296|NCT04931108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5924297|NCT04931108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924298|NCT04931108|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5924299|NCT04931108|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5924300|NCT04931108|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5924301|NCT04931108|Adrenergic Agents|adrenergic agents|mesh-ancestor
5924302|NCT04931108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5924303|NCT04931108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924304|NCT04931108|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5924305|NCT04931108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5924306|NCT04931108|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5924307|NCT04931108|Vasodilator Agents|vasodilator agents|mesh-ancestor
5924308|NCT04931121|Viscosupplements|viscosupplements|mesh-list
5924309|NCT04931121|Protective Agents|protective agents|mesh-ancestor
5924310|NCT04931121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924311|NCT04930744|Metformin|metformin|mesh-list
5924312|NCT04930744|Rifampin|rifampin|mesh-list
5924313|NCT04930744|Isoniazid|isoniazid|mesh-list
5924314|NCT04930744|Pyrazinamide|pyrazinamide|mesh-list
5924315|NCT04930744|Ethambutol|ethambutol|mesh-list
5718858|NCT03222089|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5718859|NCT03222089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5718860|NCT03222089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5718861|NCT03222089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5718862|NCT03222089|Analgesics|analgesics|mesh-ancestor
5718863|NCT03222089|Sensory System Agents|sensory system agents|mesh-ancestor
5718864|NCT03222089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5718865|NCT03222089|Antidotes|antidotes|mesh-ancestor
5718866|NCT03222089|Protective Agents|protective agents|mesh-ancestor
5718867|NCT03222089|Vitamin B Complex|vitamin b complex|mesh-ancestor
5718868|NCT03222089|Vitamins|vitamins|mesh-ancestor
5718869|NCT03222089|Micronutrients|micronutrients|mesh-ancestor
5718870|NCT03222310|Itraconazole|itraconazole|mesh-list
5718871|NCT03222310|Antifungal Agents|antifungal agents|mesh-ancestor
5718872|NCT03222310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5718873|NCT03222310|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5718874|NCT03222310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5718875|NCT03222310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5718876|NCT03222310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718877|NCT03222310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5718878|NCT03222310|Hormone Antagonists|hormone antagonists|mesh-ancestor
5718879|NCT03222310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5718880|NCT03222310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718881|NCT03222310|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5718882|NCT03222167|Grazoprevir|grazoprevir|mesh-list
5718883|NCT03222167|Antiviral Agents|antiviral agents|mesh-ancestor
5718884|NCT03222167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5718885|NCT03221816|Folic Acid|folic acid|mesh-list
5718886|NCT03221816|Pyridoxine|pyridoxine|mesh-list
5718887|NCT03221816|Vitamin B 12|vitamin b 12|mesh-list
5718888|NCT03221816|Hematinics|hematinics|mesh-ancestor
5718889|NCT03221816|Vitamin B Complex|vitamin b complex|mesh-ancestor
5718890|NCT03221816|Vitamins|vitamins|mesh-ancestor
5718891|NCT03221816|Micronutrients|micronutrients|mesh-ancestor
5718892|NCT03221816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924316|NCT04930744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5718893|NCT03221855|Domperidone|domperidone|mesh-list
5924317|NCT04930744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924318|NCT04930744|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5924319|NCT04930744|Antitubercular Agents|antitubercular agents|mesh-ancestor
5924320|NCT04930744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5924321|NCT04930744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5924322|NCT04930744|Leprostatic Agents|leprostatic agents|mesh-ancestor
5924323|NCT04930744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5924324|NCT04930744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5924325|NCT04930744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924326|NCT04930744|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5924327|NCT04930744|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5924328|NCT04930744|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5924329|NCT04930744|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5924330|NCT04930744|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5924331|NCT04930744|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5924332|NCT04930744|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5924333|NCT04930744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5924334|NCT04930744|Antimetabolites|antimetabolites|mesh-ancestor
5924335|NCT04930744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5924336|NCT04930627|Empagliflozin|empagliflozin|mesh-list
5924337|NCT04930627|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5924338|NCT04930627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924339|NCT04930627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5924340|NCT04930627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924341|NCT04930887|Bupivacaine|bupivacaine|mesh-list
5924342|NCT04930887|Anesthetics, Local|anesthetics, local|mesh-ancestor
5924343|NCT04930887|Anesthetics|anesthetics|mesh-ancestor
5924344|NCT04930887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5924345|NCT04930887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924346|NCT04930887|Sensory System Agents|sensory system agents|mesh-ancestor
5924347|NCT04930887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5924348|NCT04930458|Listerine|listerine|mesh-list
5924349|NCT04930458|Calcium|calcium|mesh-list
5924350|NCT04930458|Fluorides|fluorides|mesh-list
5924351|NCT04930458|Sodium Fluoride|sodium fluoride|mesh-list
5924352|NCT04930458|Fluorides, Topical|fluorides, topical|mesh-list
5924353|NCT04930458|Caseins|caseins|mesh-list
5924354|NCT04930458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5924355|NCT04930458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924356|NCT04930458|Cariostatic Agents|cariostatic agents|mesh-ancestor
5924357|NCT04930458|Protective Agents|protective agents|mesh-ancestor
5924358|NCT04930458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5924359|NCT04930458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5924360|NCT04930458|Chelating Agents|chelating agents|mesh-ancestor
5924361|NCT04930458|Sequestering Agents|sequestering agents|mesh-ancestor
5924362|NCT04930458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924363|NCT04930471|Metformin|metformin|mesh-list
5924364|NCT04930471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5924365|NCT04930471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924366|NCT04930211|Dexamethasone|dexamethasone|mesh-list
5924367|NCT04930211|Lidocaine|lidocaine|mesh-list
5924368|NCT04930211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5924369|NCT04930211|Antiemetics|antiemetics|mesh-ancestor
5924370|NCT04930211|Autonomic Agents|autonomic agents|mesh-ancestor
5924371|NCT04930211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5718894|NCT03221855|Antiemetics|antiemetics|mesh-ancestor
5718895|NCT03221855|Autonomic Agents|autonomic agents|mesh-ancestor
5718896|NCT03221855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5718897|NCT03221855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718898|NCT03221855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5718899|NCT03221855|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5718900|NCT03221855|Dopamine Agents|dopamine agents|mesh-ancestor
5718901|NCT03221855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5718902|NCT03221855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718903|NCT03221907|Pregabalin|pregabalin|mesh-list
5718904|NCT03221907|Analgesics|analgesics|mesh-ancestor
5718905|NCT03221907|Sensory System Agents|sensory system agents|mesh-ancestor
5718906|NCT03221907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5718907|NCT03221907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718908|NCT03221907|Anticonvulsants|anticonvulsants|mesh-ancestor
5718909|NCT03221907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5718910|NCT03221907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5722160|NCT03200847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5924372|NCT04930211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924373|NCT04930211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5924374|NCT04930211|Glucocorticoids|glucocorticoids|mesh-ancestor
5924375|NCT04930211|Hormones|hormones|mesh-ancestor
5924376|NCT04930211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5924377|NCT04930211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5924378|NCT04930211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5924379|NCT04930211|Anesthetics, Local|anesthetics, local|mesh-ancestor
5924380|NCT04930211|Anesthetics|anesthetics|mesh-ancestor
5924381|NCT04930211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5924382|NCT04930211|Sensory System Agents|sensory system agents|mesh-ancestor
5924383|NCT04930211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5924384|NCT04930211|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5924385|NCT04930211|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5924386|NCT04930211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5924387|NCT04930211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924388|NCT04930185|Vaccines|vaccines|mesh-list
5924389|NCT04930185|Immunologic Factors|immunologic factors|mesh-ancestor
5924390|NCT04930185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924391|NCT04930055|Vaccines|vaccines|mesh-list
5924392|NCT04930055|Immunologic Factors|immunologic factors|mesh-ancestor
5924393|NCT04930055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924394|NCT04930133|Afatinib|afatinib|mesh-list
5924395|NCT04930133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5924396|NCT04930133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5924397|NCT04930133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5924398|NCT04930133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924399|NCT04929652|Irinotecan|irinotecan|mesh-list
5924400|NCT04929652|Molgramostim|molgramostim|mesh-list
5924401|NCT04929652|Sargramostim|sargramostim|mesh-list
5924402|NCT04929652|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5924403|NCT04929652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5924404|NCT04929652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5924405|NCT04929652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924406|NCT04929652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5924407|NCT04929652|Immunologic Factors|immunologic factors|mesh-ancestor
5924408|NCT04929652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924409|NCT04929626|Magnesium Sulfate|magnesium sulfate|mesh-list
5924410|NCT04929626|Albuterol|albuterol|mesh-list
5924411|NCT04929626|Analgesics|analgesics|mesh-ancestor
5924412|NCT04929626|Sensory System Agents|sensory system agents|mesh-ancestor
5924413|NCT04929626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5924414|NCT04929626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924415|NCT04929626|Anesthetics|anesthetics|mesh-ancestor
5924416|NCT04929626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5924417|NCT04929626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5924418|NCT04929626|Anticonvulsants|anticonvulsants|mesh-ancestor
5924419|NCT04929626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5924420|NCT04929626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5924421|NCT04929626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924422|NCT04929626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5924423|NCT04929626|Tocolytic Agents|tocolytic agents|mesh-ancestor
5924424|NCT04929626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5924425|NCT04929626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5924426|NCT04929626|Autonomic Agents|autonomic agents|mesh-ancestor
5924427|NCT04929626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5924428|NCT04929626|Respiratory System Agents|respiratory system agents|mesh-ancestor
5924429|NCT04929626|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5924430|NCT04929626|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5924431|NCT04929626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5924432|NCT04929626|Adrenergic Agents|adrenergic agents|mesh-ancestor
5924433|NCT04929626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5924434|NCT04929535|Hydrogen Peroxide|hydrogen peroxide|mesh-list
5924435|NCT04929535|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5924436|NCT04929535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5924437|NCT04929522|Anesthetics|anesthetics|mesh-list
5924438|NCT04929522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5924439|NCT04929522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5964996|NCT04587505|Sensory System Agents|sensory system agents|mesh-ancestor
5964997|NCT04587505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5964998|NCT04587505|Anesthetics, Local|anesthetics, local|mesh-ancestor
5964999|NCT04587089|Anti-Infective Agents|anti-infective agents|mesh-list
5965000|NCT04587089|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5965001|NCT04587128|Irinotecan|irinotecan|mesh-list
5965002|NCT04587128|Cetuximab|cetuximab|mesh-list
5965003|NCT04587128|Panitumumab|panitumumab|mesh-list
5924440|NCT04929509|Listerine|listerine|mesh-list
5924441|NCT04929509|Fluorides|fluorides|mesh-list
5924442|NCT04929509|Sodium Fluoride|sodium fluoride|mesh-list
5924443|NCT04929509|Fluorides, Topical|fluorides, topical|mesh-list
5924444|NCT04929509|Cariostatic Agents|cariostatic agents|mesh-ancestor
5718911|NCT03221907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718912|NCT03221907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5718913|NCT03221907|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5718914|NCT03221907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5718915|NCT03221907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5718916|NCT03221907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5718917|NCT03221881|Docetaxel|docetaxel|mesh-list
5718918|NCT03221881|Doxorubicin|doxorubicin|mesh-list
5718919|NCT03221881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5718920|NCT03221881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5718921|NCT03221881|Tubulin Modulators|tubulin modulators|mesh-ancestor
5718922|NCT03221881|Antimitotic Agents|antimitotic agents|mesh-ancestor
5718923|NCT03221881|Mitosis Modulators|mitosis modulators|mesh-ancestor
5924445|NCT04929509|Protective Agents|protective agents|mesh-ancestor
5924446|NCT04929509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924447|NCT04929509|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5924448|NCT04929509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5924449|NCT04929080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5924450|NCT04929080|Antibodies|antibodies|mesh-list
5924451|NCT04929080|Immunoglobulins|immunoglobulins|mesh-list
5924452|NCT04929080|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5924453|NCT04929080|Immunoglobulin G|immunoglobulin g|mesh-list
5924454|NCT04929080|Immunologic Factors|immunologic factors|mesh-ancestor
5924455|NCT04929080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924456|NCT04929080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5924457|NCT04928391|Dexmedetomidine|dexmedetomidine|mesh-list
5924458|NCT04928391|Nalbuphine|nalbuphine|mesh-list
5924459|NCT04928391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5924460|NCT04928391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5924461|NCT04928391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924462|NCT04928391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5924463|NCT04928391|Analgesics|analgesics|mesh-ancestor
5924464|NCT04928391|Sensory System Agents|sensory system agents|mesh-ancestor
5924465|NCT04928391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5924466|NCT04928391|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5924467|NCT04928391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5924468|NCT04928391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5924469|NCT04928391|Adrenergic Agents|adrenergic agents|mesh-ancestor
5924470|NCT04928391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5924471|NCT04928391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924472|NCT04928391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5924473|NCT04928391|Narcotics|narcotics|mesh-ancestor
5924474|NCT04928365|Antibodies|antibodies|mesh-list
5924475|NCT04928365|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5924476|NCT04928365|Immunologic Factors|immunologic factors|mesh-ancestor
5924477|NCT04928365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924478|NCT04928352|Bupivacaine|bupivacaine|mesh-list
5924479|NCT04928352|Anesthetics, Local|anesthetics, local|mesh-ancestor
5924480|NCT04928352|Anesthetics|anesthetics|mesh-ancestor
5924481|NCT04928352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5924482|NCT04928352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924483|NCT04928352|Sensory System Agents|sensory system agents|mesh-ancestor
5924484|NCT04928352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5924485|NCT04928495|Ascorbic Acid|ascorbic acid|mesh-list
5924486|NCT04928495|Acetylcysteine|acetylcysteine|mesh-list
5924487|NCT04928495|Bromhexine|bromhexine|mesh-list
5924488|NCT04928495|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5924489|NCT04928495|Vitamins|vitamins|mesh-ancestor
5924490|NCT04928495|Micronutrients|micronutrients|mesh-ancestor
5924491|NCT04928495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924492|NCT04928495|Antioxidants|antioxidants|mesh-ancestor
5924493|NCT04928495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924494|NCT04928495|Protective Agents|protective agents|mesh-ancestor
5924495|NCT04928495|Antiviral Agents|antiviral agents|mesh-ancestor
5924496|NCT04928495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5924497|NCT04928495|Expectorants|expectorants|mesh-ancestor
5924498|NCT04928495|Respiratory System Agents|respiratory system agents|mesh-ancestor
5924499|NCT04928495|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5924500|NCT04928495|Antidotes|antidotes|mesh-ancestor
5924501|NCT04928313|Glatiramer Acetate|glatiramer acetate|mesh-list
6517018|NCT00719381|Pioglitazone|pioglitazone|mesh-list
5924502|NCT04928313|(T,G)-A-L|(t,g)-a-l|mesh-list
5924503|NCT04928313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5924504|NCT04928313|Immunologic Factors|immunologic factors|mesh-ancestor
5924505|NCT04928313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924506|NCT04928313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5924507|NCT04928313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5924508|NCT04928183|Nitroprusside|nitroprusside|mesh-list
5924509|NCT04928183|Phenylephrine|phenylephrine|mesh-list
5924510|NCT04928183|Oxymetazoline|oxymetazoline|mesh-list
5924511|NCT04928183|Carbon Monoxide|carbon monoxide|mesh-list
5924512|NCT04928183|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5924513|NCT04928183|Mydriatics|mydriatics|mesh-ancestor
5924514|NCT04928183|Autonomic Agents|autonomic agents|mesh-ancestor
5924515|NCT04928183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5924516|NCT04928183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924517|NCT04928183|Sympathomimetics|sympathomimetics|mesh-ancestor
5924518|NCT04928183|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5924519|NCT04928183|Nasal Decongestants|nasal decongestants|mesh-ancestor
5924520|NCT04928183|Respiratory System Agents|respiratory system agents|mesh-ancestor
5924521|NCT04928183|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5924522|NCT04928183|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5924523|NCT04928183|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5924524|NCT04928183|Adrenergic Agents|adrenergic agents|mesh-ancestor
5924525|NCT04928183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5924526|NCT04928183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924527|NCT04928183|Protective Agents|protective agents|mesh-ancestor
5924528|NCT04928183|Antimetabolites|antimetabolites|mesh-ancestor
5924529|NCT04928183|Gasotransmitters|gasotransmitters|mesh-ancestor
5924530|NCT04928183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5924531|NCT04928183|Vasodilator Agents|vasodilator agents|mesh-ancestor
5924532|NCT04928183|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5924533|NCT04928079|Antiparkinson Agents|antiparkinson agents|mesh-list
5924534|NCT04928079|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5924535|NCT04928066|Prednisone|prednisone|mesh-list
5924536|NCT04928066|Tofacitinib|tofacitinib|mesh-list
5924537|NCT04928066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5924538|NCT04928066|Glucocorticoids|glucocorticoids|mesh-ancestor
5924539|NCT04928066|Hormones|hormones|mesh-ancestor
5924540|NCT04928066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5924541|NCT04928066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924542|NCT04928066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5924543|NCT04928066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5924544|NCT04928066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5924545|NCT04928066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5924546|NCT04928066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924547|NCT04927936|Vaccines|vaccines|mesh-list
5924548|NCT04927936|Immunologic Factors|immunologic factors|mesh-ancestor
5924549|NCT04927936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924550|NCT04927949|Cangrelor|cangrelor|mesh-list
5924551|NCT04927949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5924552|NCT04927949|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5924553|NCT04927949|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5924554|NCT04927949|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5924555|NCT04927949|Purinergic Agents|purinergic agents|mesh-ancestor
5924556|NCT04927949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5924557|NCT04927949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924558|NCT04927949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924559|NCT04928586|Pirfenidone|pirfenidone|mesh-list
5924560|NCT04928586|Analgesics|analgesics|mesh-ancestor
5924561|NCT04928586|Sensory System Agents|sensory system agents|mesh-ancestor
5924562|NCT04928586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5924563|NCT04928586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924564|NCT04928586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5924565|NCT04928586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5924566|NCT04928586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5924567|NCT04928586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5924568|NCT04928586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5924569|NCT04928651|Clonidine|clonidine|mesh-list
5924570|NCT04928651|Analgesics|analgesics|mesh-ancestor
5924571|NCT04928651|Sensory System Agents|sensory system agents|mesh-ancestor
5924572|NCT04928651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5924573|NCT04928651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924574|NCT04928651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5924575|NCT04928651|Sympatholytics|sympatholytics|mesh-ancestor
5924576|NCT04928651|Autonomic Agents|autonomic agents|mesh-ancestor
5924577|NCT04928651|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5924578|NCT04928651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5924579|NCT04928651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5924580|NCT04928651|Adrenergic Agents|adrenergic agents|mesh-ancestor
5924581|NCT04928651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5924582|NCT04928651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924583|NCT04928820|Edetic Acid|edetic acid|mesh-list
5924584|NCT04928820|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5924585|NCT04928820|Chelating Agents|chelating agents|mesh-ancestor
5924586|NCT04928820|Sequestering Agents|sequestering agents|mesh-ancestor
5924587|NCT04928820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718924|NCT03221881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718925|NCT03221881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5718926|NCT03221881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5718927|NCT03221881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5718928|NCT03221881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5718929|NCT03221946|Diclofenac|diclofenac|mesh-list
5718930|NCT03221946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5718931|NCT03221946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5718932|NCT03221946|Analgesics|analgesics|mesh-ancestor
5924588|NCT04928820|Anticoagulants|anticoagulants|mesh-ancestor
5924589|NCT04928820|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5924590|NCT04928820|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5924591|NCT04928703|Ketamine|ketamine|mesh-list
5924592|NCT04928703|Analgesics|analgesics|mesh-ancestor
5924593|NCT04928703|Sensory System Agents|sensory system agents|mesh-ancestor
5924594|NCT04928703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5924595|NCT04928703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924596|NCT04928703|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5924597|NCT04928703|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5924598|NCT04928703|Anesthetics, General|anesthetics, general|mesh-ancestor
5924599|NCT04928703|Anesthetics|anesthetics|mesh-ancestor
5924600|NCT04928703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5924601|NCT04928703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5924602|NCT04928703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5924603|NCT04928703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5924604|NCT04928703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924605|NCT04927858|Empagliflozin|empagliflozin|mesh-list
5924606|NCT04927858|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5924607|NCT04927858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924608|NCT04927858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5924609|NCT04927858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924610|NCT04927585|Vaccines|vaccines|mesh-list
5924611|NCT04927585|Immunologic Factors|immunologic factors|mesh-ancestor
5924612|NCT04927585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924613|NCT04927481|Mitoxantrone|mitoxantrone|mesh-list
5924614|NCT04927481|Analgesics|analgesics|mesh-ancestor
5924615|NCT04927481|Sensory System Agents|sensory system agents|mesh-ancestor
5924616|NCT04927481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5924617|NCT04927481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924618|NCT04927481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5924619|NCT04927481|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5924620|NCT04927481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5924621|NCT04927481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5924622|NCT04927481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965004|NCT04587128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5965005|NCT04587128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5965006|NCT04587128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5965007|NCT04587128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965008|NCT04587128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5965009|NCT04587128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5965010|NCT04587141|Ferric gluconate|ferric gluconate|mesh-list
5965011|NCT04587141|Hematinics|hematinics|mesh-ancestor
5965012|NCT04587115|Oxycodone|oxycodone|mesh-list
5965013|NCT04587115|Risperidone|risperidone|mesh-list
5965014|NCT04587115|Ziprasidone|ziprasidone|mesh-list
5965015|NCT04587115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5965016|NCT04587115|Narcotics|narcotics|mesh-ancestor
5965017|NCT04587115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5965018|NCT04587115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965019|NCT04587115|Analgesics|analgesics|mesh-ancestor
5965020|NCT04587115|Sensory System Agents|sensory system agents|mesh-ancestor
5965021|NCT04587115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5965022|NCT04587115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5965023|NCT04587115|Serotonin Agents|serotonin agents|mesh-ancestor
5965024|NCT04587115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5965025|NCT04587115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924623|NCT04927299|Losartan|losartan|mesh-list
5924624|NCT04927299|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5924625|NCT04927299|Chlorthalidone|chlorthalidone|mesh-list
5924626|NCT04927299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5924627|NCT04927299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5924628|NCT04927299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5924629|NCT04927299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5924630|NCT04927299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924631|NCT04927299|Diuretics|diuretics|mesh-ancestor
5924632|NCT04927299|Natriuretic Agents|natriuretic agents|mesh-ancestor
5924633|NCT04927299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924634|NCT04927299|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5924635|NCT04927299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5924636|NCT04926844|Midazolam|midazolam|mesh-list
5924637|NCT04926844|Levetiracetam|levetiracetam|mesh-list
5924638|NCT04926844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5924639|NCT04926844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5924640|NCT04926844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5924641|NCT04926844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924642|NCT04926844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5924643|NCT04926844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5924644|NCT04926844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5924645|NCT04926844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5924646|NCT04926844|Anesthetics, General|anesthetics, general|mesh-ancestor
5924647|NCT04926844|Anesthetics|anesthetics|mesh-ancestor
5924648|NCT04926844|GABA Modulators|gaba modulators|mesh-ancestor
5924649|NCT04926844|GABA Agents|gaba agents|mesh-ancestor
5924650|NCT04926844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5924651|NCT04926844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924652|NCT04926844|Anticonvulsants|anticonvulsants|mesh-ancestor
5924653|NCT04926844|Nootropic Agents|nootropic agents|mesh-ancestor
5924654|NCT04927000|Tofacitinib|tofacitinib|mesh-list
5924655|NCT04927000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5924656|NCT04927000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5924657|NCT04927000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924658|NCT04927052|Lidocaine|lidocaine|mesh-list
5924659|NCT04927052|Anesthetics, Local|anesthetics, local|mesh-ancestor
5924660|NCT04927052|Anesthetics|anesthetics|mesh-ancestor
5924661|NCT04927052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5924662|NCT04927052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924663|NCT04927052|Sensory System Agents|sensory system agents|mesh-ancestor
5924664|NCT04927052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5924665|NCT04927052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5924666|NCT04927052|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5924667|NCT04927052|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5924668|NCT04927052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5924669|NCT04927052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924670|NCT04926753|Fluorouracil|fluorouracil|mesh-list
5924671|NCT04926753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5924672|NCT04926753|Antimetabolites|antimetabolites|mesh-ancestor
5924673|NCT04926753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924674|NCT04926753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5924675|NCT04926753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5924676|NCT04926753|Immunologic Factors|immunologic factors|mesh-ancestor
5924677|NCT04926753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924678|NCT04926480|Anesthetics|anesthetics|mesh-list
5924679|NCT04926480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5924680|NCT04926480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924681|NCT04926467|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5924682|NCT04926467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5924683|NCT04927039|Iloprost|iloprost|mesh-list
5924684|NCT04927039|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5924685|NCT04927039|Vasodilator Agents|vasodilator agents|mesh-ancestor
5924686|NCT04926545|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
5924687|NCT04926545|Fluorouracil|fluorouracil|mesh-list
5924688|NCT04926545|Irinotecan|irinotecan|mesh-list
5924689|NCT04926545|Antimetabolites|antimetabolites|mesh-ancestor
5924690|NCT04926545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924691|NCT04926545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5924692|NCT04926545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5924693|NCT04926545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5924694|NCT04926545|Immunologic Factors|immunologic factors|mesh-ancestor
5924695|NCT04926545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924696|NCT04926545|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5924697|NCT04926545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5924698|NCT04926545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5924699|NCT04926545|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5924700|NCT04926545|Hormone Antagonists|hormone antagonists|mesh-ancestor
5924701|NCT04926545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5924702|NCT04926545|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5924703|NCT04926545|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5924704|NCT04926545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5924705|NCT04926532|Sorafenib|sorafenib|mesh-list
5924706|NCT04926532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5924707|NCT04926532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5924708|NCT04926532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5924709|NCT04926532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924710|NCT04925973|Tofacitinib|tofacitinib|mesh-list
5924711|NCT04925973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5924712|NCT04925973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5924713|NCT04925973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924714|NCT04926155|Metformin|metformin|mesh-list
5924715|NCT04926155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5924716|NCT04926155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924717|NCT04925531|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5924718|NCT04925531|Ampicillin|ampicillin|mesh-list
5924719|NCT04925531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5924720|NCT04925505|Anesthetics|anesthetics|mesh-list
5924721|NCT04925505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5924722|NCT04925505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924723|NCT04925557|Ocrelizumab|ocrelizumab|mesh-list
5924724|NCT04925557|Siponimod|siponimod|mesh-list
5924725|NCT04925557|Immunologic Factors|immunologic factors|mesh-ancestor
5924726|NCT04925557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924727|NCT04925557|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5924728|NCT04925557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924729|NCT04925557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5965026|NCT04587115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5965027|NCT04587115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5965028|NCT04587115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5965029|NCT04587115|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5965030|NCT04587115|Dopamine Agents|dopamine agents|mesh-ancestor
5965031|NCT04586543|Docetaxel|docetaxel|mesh-list
5965032|NCT04586543|Selegiline|selegiline|mesh-list
5965033|NCT04586543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5965034|NCT04586543|Tubulin Modulators|tubulin modulators|mesh-ancestor
5965035|NCT04586543|Antimitotic Agents|antimitotic agents|mesh-ancestor
5965036|NCT04586543|Mitosis Modulators|mitosis modulators|mesh-ancestor
5965037|NCT04586543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965038|NCT04586543|Antidepressive Agents|antidepressive agents|mesh-ancestor
5965039|NCT04586543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5965040|NCT04586543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5965041|NCT04586543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5965042|NCT04586543|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
5965043|NCT04586543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5965044|NCT04586543|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5965045|NCT04586543|Protective Agents|protective agents|mesh-ancestor
5965046|NCT04586543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965047|NCT04586504|Midazolam|midazolam|mesh-list
5965048|NCT04586504|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5965049|NCT04586504|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5965050|NCT04586504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5965051|NCT04586504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965052|NCT04586504|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5965053|NCT04586504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5965054|NCT04586504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5965055|NCT04586504|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5965056|NCT04586504|Anesthetics, General|anesthetics, general|mesh-ancestor
5965057|NCT04586504|Anesthetics|anesthetics|mesh-ancestor
5965058|NCT04586504|GABA Modulators|gaba modulators|mesh-ancestor
5965059|NCT04586504|GABA Agents|gaba agents|mesh-ancestor
5965060|NCT04586504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5965061|NCT04586504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965062|NCT04586790|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
5965063|NCT04586790|Epinephrine|epinephrine|mesh-list
5965064|NCT04586790|Racepinephrine|racepinephrine|mesh-list
5965065|NCT04586790|Midodrine|midodrine|mesh-list
5965066|NCT04586790|Norepinephrine|norepinephrine|mesh-list
5965067|NCT04586790|Epinephryl borate|epinephryl borate|mesh-list
5924730|NCT04925375|Abatacept|abatacept|mesh-list
5924731|NCT04925375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5924732|NCT04925375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924733|NCT04925375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5924734|NCT04925375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5924735|NCT04925375|Immunologic Factors|immunologic factors|mesh-ancestor
5924736|NCT04925375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924737|NCT04925375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5924738|NCT04925141|Dasatinib|dasatinib|mesh-list
5924739|NCT04925141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5924740|NCT04925141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5924741|NCT04925141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5924742|NCT04925141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924743|NCT04925063|Metformin|metformin|mesh-list
5924744|NCT04925063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5924745|NCT04925063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924746|NCT04925076|Ethanol|ethanol|mesh-list
5924747|NCT04925076|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5924748|NCT04925076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5924749|NCT04925076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5924750|NCT04925076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924751|NCT04925167|Heparin|heparin|mesh-list
5924752|NCT04925167|Calcium heparin|calcium heparin|mesh-list
5924753|NCT04925167|Argatroban|argatroban|mesh-list
5924754|NCT04925167|Anticoagulants|anticoagulants|mesh-ancestor
5924755|NCT04925167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5924756|NCT04925167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5924757|NCT04925167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924758|NCT04925167|Antithrombins|antithrombins|mesh-ancestor
5924759|NCT04925167|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5924760|NCT04925167|Protease Inhibitors|protease inhibitors|mesh-ancestor
5924761|NCT04925167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5924762|NCT04925167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5924763|NCT04924868|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
5924764|NCT04924868|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5924765|NCT04924868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5924766|NCT04924647|Dexamethasone|dexamethasone|mesh-list
5924767|NCT04924647|Lenalidomide|lenalidomide|mesh-list
5924768|NCT04924647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5924769|NCT04924647|Antiemetics|antiemetics|mesh-ancestor
5924770|NCT04924647|Autonomic Agents|autonomic agents|mesh-ancestor
5924771|NCT04924647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5924772|NCT04924647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924773|NCT04924647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5924774|NCT04924647|Glucocorticoids|glucocorticoids|mesh-ancestor
5924775|NCT04924647|Hormones|hormones|mesh-ancestor
5924776|NCT04924647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5924777|NCT04924647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5924778|NCT04924647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5924779|NCT04924647|Immunologic Factors|immunologic factors|mesh-ancestor
5924780|NCT04924647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5924781|NCT04924647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5924782|NCT04924647|Growth Substances|growth substances|mesh-ancestor
5924783|NCT04924647|Growth Inhibitors|growth inhibitors|mesh-ancestor
5924784|NCT04924946|Antihypertensive Agents|antihypertensive agents|mesh-list
5924785|NCT04924192|Irinotecan|irinotecan|mesh-list
5924786|NCT04924192|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5924787|NCT04924192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5924788|NCT04924192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5924789|NCT04924192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924790|NCT04924192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5924791|NCT04924257|Esketamine|esketamine|mesh-list
5924792|NCT04924257|Antidepressive Agents|antidepressive agents|mesh-ancestor
5924793|NCT04924257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5924794|NCT04923776|Carboplatin|carboplatin|mesh-list
5924795|NCT04923776|Etoposide|etoposide|mesh-list
5924796|NCT04923776|Atezolizumab|atezolizumab|mesh-list
5924797|NCT04923776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5924798|NCT04923776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5924799|NCT04923776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5924800|NCT04923776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5924801|NCT04923776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5924802|NCT04923776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924803|NCT04923659|Nimodipine|nimodipine|mesh-list
5924804|NCT04923659|Carbamazepine|carbamazepine|mesh-list
5924805|NCT04923659|Lorazepam|lorazepam|mesh-list
5924806|NCT04923659|Dextromethorphan|dextromethorphan|mesh-list
5924807|NCT04923659|Antitussive Agents|antitussive agents|mesh-ancestor
5924808|NCT04923659|Respiratory System Agents|respiratory system agents|mesh-ancestor
5924809|NCT04923659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5924810|NCT04923659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5924811|NCT04923659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5924812|NCT04923659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924813|NCT04923659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924814|NCT04923659|Anticonvulsants|anticonvulsants|mesh-ancestor
5924815|NCT04923659|Antiemetics|antiemetics|mesh-ancestor
5924816|NCT04923659|Autonomic Agents|autonomic agents|mesh-ancestor
5924817|NCT04923659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5924818|NCT04923659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5924819|NCT04923659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5924820|NCT04923659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5924821|NCT04923659|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5924822|NCT04923659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5924823|NCT04923659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5924824|NCT04923659|GABA Modulators|gaba modulators|mesh-ancestor
5924825|NCT04923659|GABA Agents|gaba agents|mesh-ancestor
5924826|NCT04923659|Antimanic Agents|antimanic agents|mesh-ancestor
5924827|NCT04923659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5924828|NCT04923659|Analgesics|analgesics|mesh-ancestor
5924829|NCT04923659|Sensory System Agents|sensory system agents|mesh-ancestor
5924830|NCT04923659|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5924831|NCT04923659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5924832|NCT04923659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5924833|NCT04923659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5924834|NCT04923659|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5924835|NCT04923659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5924836|NCT04923659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5924837|NCT04923659|Vasodilator Agents|vasodilator agents|mesh-ancestor
5924838|NCT04923737|Dexmedetomidine|dexmedetomidine|mesh-list
5924839|NCT04923737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5924840|NCT04923737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5924841|NCT04923737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924842|NCT04923737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5924843|NCT04923737|Analgesics|analgesics|mesh-ancestor
5924844|NCT04923737|Sensory System Agents|sensory system agents|mesh-ancestor
5924845|NCT04923737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5924846|NCT04923737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5924847|NCT04923737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5924848|NCT04923737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5924849|NCT04923737|Adrenergic Agents|adrenergic agents|mesh-ancestor
5924850|NCT04923737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5924851|NCT04923737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965068|NCT04586790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5965069|NCT04586790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5965070|NCT04586790|Adrenergic Agents|adrenergic agents|mesh-ancestor
5965071|NCT04586790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5965072|NCT04586790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965073|NCT04586790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965074|NCT04586790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5965075|NCT04586790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5965076|NCT04586790|Autonomic Agents|autonomic agents|mesh-ancestor
5965077|NCT04586790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5965078|NCT04586790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5965079|NCT04586790|Respiratory System Agents|respiratory system agents|mesh-ancestor
5965080|NCT04586790|Mydriatics|mydriatics|mesh-ancestor
5965081|NCT04586790|Sympathomimetics|sympathomimetics|mesh-ancestor
5965082|NCT04586790|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5965083|NCT04586790|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5965084|NCT04586790|Hemostatics|hemostatics|mesh-ancestor
5965085|NCT04586790|Coagulants|coagulants|mesh-ancestor
5965086|NCT04586790|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5965087|NCT04586790|Natriuretic Agents|natriuretic agents|mesh-ancestor
5965088|NCT04586491|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5965089|NCT04586465|Gemcitabine|gemcitabine|mesh-list
5965090|NCT04586465|Carboplatin|carboplatin|mesh-list
5965091|NCT04586465|Pembrolizumab|pembrolizumab|mesh-list
5965092|NCT04586465|Pemetrexed|pemetrexed|mesh-list
5965093|NCT04586465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5965094|NCT04586465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5965095|NCT04586465|Antimetabolites|antimetabolites|mesh-ancestor
5965096|NCT04586465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965097|NCT04586465|Antiviral Agents|antiviral agents|mesh-ancestor
5924852|NCT04923152|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
5924853|NCT04923152|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5924854|NCT04923152|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5924855|NCT04923152|Antimetabolites|antimetabolites|mesh-ancestor
5924856|NCT04923152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924857|NCT04923152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5924858|NCT04923152|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5924859|NCT04922983|Botulinum Toxins|botulinum toxins|mesh-list
5924860|NCT04922983|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5924861|NCT04922983|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5924862|NCT04922983|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5924863|NCT04922983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5924864|NCT04922983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924865|NCT04922983|Cholinergic Agents|cholinergic agents|mesh-ancestor
5924866|NCT04922983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5718933|NCT03221946|Sensory System Agents|sensory system agents|mesh-ancestor
5718934|NCT03221946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5718935|NCT03221946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718936|NCT03221946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5718937|NCT03221946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5718938|NCT03221946|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5718939|NCT03221946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5718940|NCT03221946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718941|NCT03221998|Acetaminophen|acetaminophen|mesh-list
5718942|NCT03221998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5718943|NCT03221998|Analgesics|analgesics|mesh-ancestor
5718944|NCT03221998|Sensory System Agents|sensory system agents|mesh-ancestor
5718945|NCT03221998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5718946|NCT03221998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718947|NCT03221998|Antipyretics|antipyretics|mesh-ancestor
5718948|NCT03221569|Ketorolac|ketorolac|mesh-list
5718949|NCT03221569|Ketamine|ketamine|mesh-list
5718950|NCT03221569|Analgesics|analgesics|mesh-ancestor
5718951|NCT03221569|Sensory System Agents|sensory system agents|mesh-ancestor
5718952|NCT03221569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5718953|NCT03221569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718954|NCT03221569|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5718955|NCT03221569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5718956|NCT03221569|Anesthetics, General|anesthetics, general|mesh-ancestor
5718957|NCT03221569|Anesthetics|anesthetics|mesh-ancestor
5718958|NCT03221569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5718959|NCT03221569|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5718960|NCT03221569|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5718961|NCT03221569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5718962|NCT03221569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718963|NCT03221569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5718964|NCT03221569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5718965|NCT03221569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5718966|NCT03221569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5718967|NCT03221569|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5718968|NCT03221569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5718969|NCT03221504|Oxymetazoline|oxymetazoline|mesh-list
5718970|NCT03221504|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5718971|NCT03221504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5924867|NCT04922983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924868|NCT04922983|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5924869|NCT04922983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5924870|NCT04922944|Vaccines|vaccines|mesh-list
5924871|NCT04922944|Immunologic Factors|immunologic factors|mesh-ancestor
5924872|NCT04922944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924873|NCT04922827|Infliximab|infliximab|mesh-list
5924874|NCT04922827|Dermatologic Agents|dermatologic agents|mesh-ancestor
5924875|NCT04922827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5924876|NCT04922827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5924877|NCT04922996|Calcium Dobesilate|calcium dobesilate|mesh-list
5924878|NCT04922996|Calcium|calcium|mesh-list
5924879|NCT04922996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5924880|NCT04922996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924881|NCT04922996|Hemostatics|hemostatics|mesh-ancestor
5924882|NCT04922996|Coagulants|coagulants|mesh-ancestor
5924883|NCT04923113|Amoxicillin|amoxicillin|mesh-list
5924884|NCT04923113|Minocycline|minocycline|mesh-list
5924885|NCT04923113|Rabeprazole|rabeprazole|mesh-list
5924886|NCT04923113|Bismuth|bismuth|mesh-list
5924887|NCT04923113|Antibodies|antibodies|mesh-list
5924888|NCT04923113|Immunologic Factors|immunologic factors|mesh-ancestor
5924889|NCT04923113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924890|NCT04923113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5924891|NCT04923113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5924892|NCT04923113|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5924893|NCT04923113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5924894|NCT04923113|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5924895|NCT04923113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5924896|NCT04923113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924897|NCT04923113|Antacids|antacids|mesh-ancestor
5924898|NCT04923516|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5924899|NCT04923516|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5924900|NCT04923516|Dermatologic Agents|dermatologic agents|mesh-ancestor
5924901|NCT04922359|Lidocaine|lidocaine|mesh-list
5924902|NCT04922359|Anesthetics, Local|anesthetics, local|mesh-ancestor
5924903|NCT04922359|Anesthetics|anesthetics|mesh-ancestor
5924904|NCT04922359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5924905|NCT04922359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924906|NCT04922359|Sensory System Agents|sensory system agents|mesh-ancestor
5924907|NCT04922359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5924908|NCT04922359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5924909|NCT04922359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5924910|NCT04922359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5924911|NCT04922359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5924912|NCT04922359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924913|NCT04922567|Prednisone|prednisone|mesh-list
5924914|NCT04922567|Cyclophosphamide|cyclophosphamide|mesh-list
5924915|NCT04922567|Doxorubicin|doxorubicin|mesh-list
5924916|NCT04922567|Vincristine|vincristine|mesh-list
5924917|NCT04922567|Lenalidomide|lenalidomide|mesh-list
5924918|NCT04922567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5924919|NCT04922567|Immunologic Factors|immunologic factors|mesh-ancestor
5924920|NCT04922567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924921|NCT04922567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5924922|NCT04922567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5924923|NCT04922567|Alkylating Agents|alkylating agents|mesh-ancestor
5924924|NCT04922567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924925|NCT04922567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5924926|NCT04922567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5924927|NCT04922567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5924928|NCT04922567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5924929|NCT04922567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5924930|NCT04922567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5924931|NCT04922567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5924932|NCT04922567|Glucocorticoids|glucocorticoids|mesh-ancestor
5924933|NCT04922567|Hormones|hormones|mesh-ancestor
5924934|NCT04922567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5924935|NCT04922567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5924936|NCT04922567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5924937|NCT04922567|Tubulin Modulators|tubulin modulators|mesh-ancestor
5924938|NCT04922567|Antimitotic Agents|antimitotic agents|mesh-ancestor
5924939|NCT04922567|Mitosis Modulators|mitosis modulators|mesh-ancestor
5924940|NCT04922567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5924941|NCT04922567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5924942|NCT04922567|Growth Substances|growth substances|mesh-ancestor
5924943|NCT04922567|Growth Inhibitors|growth inhibitors|mesh-ancestor
5924944|NCT04922450|Paclitaxel|paclitaxel|mesh-list
5924945|NCT04922450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5924946|NCT04922450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5924947|NCT04922450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5924948|NCT04922450|Tubulin Modulators|tubulin modulators|mesh-ancestor
5924949|NCT04922450|Antimitotic Agents|antimitotic agents|mesh-ancestor
5924950|NCT04922450|Mitosis Modulators|mitosis modulators|mesh-ancestor
5924951|NCT04922450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924952|NCT04922658|Vinorelbine|vinorelbine|mesh-list
5924953|NCT04922658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5924954|NCT04922658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5924955|NCT04922658|Tubulin Modulators|tubulin modulators|mesh-ancestor
5924956|NCT04922658|Antimitotic Agents|antimitotic agents|mesh-ancestor
5924957|NCT04922658|Mitosis Modulators|mitosis modulators|mesh-ancestor
5924958|NCT04922658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924959|NCT04922723|Daratumumab|daratumumab|mesh-list
5924960|NCT04922723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5924961|NCT04922333|Risedronic Acid|risedronic acid|mesh-list
5924962|NCT04922333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5924963|NCT04922333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5924964|NCT04922333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924965|NCT04922333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5924966|NCT04922333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924967|NCT04922333|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5924968|NCT04922541|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5924969|NCT04922541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924970|NCT04922541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5924971|NCT04922034|Amoxicillin|amoxicillin|mesh-list
5924972|NCT04922034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5924973|NCT04922034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5924974|NCT04921943|Azithromycin|azithromycin|mesh-list
5924975|NCT04921943|Rifampin|rifampin|mesh-list
5924976|NCT04921943|Ethambutol|ethambutol|mesh-list
5924977|NCT04921943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5924978|NCT04921943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5924979|NCT04921943|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5924980|NCT04921943|Antitubercular Agents|antitubercular agents|mesh-ancestor
5924981|NCT04921943|Leprostatic Agents|leprostatic agents|mesh-ancestor
5924982|NCT04921943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5924983|NCT04921943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5924984|NCT04921943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924985|NCT04921943|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5924986|NCT04921943|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5924987|NCT04921943|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5924988|NCT04921943|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5924989|NCT04921943|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5924990|NCT04921943|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5924991|NCT04922008|Capecitabine|capecitabine|mesh-list
5924992|NCT04922008|Trastuzumab|trastuzumab|mesh-list
5924993|NCT04922008|Vinorelbine|vinorelbine|mesh-list
6517019|NCT00719381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6517020|NCT00719381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5924994|NCT04922008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5924995|NCT04922008|Antimetabolites|antimetabolites|mesh-ancestor
5924996|NCT04922008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5924997|NCT04922008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5924998|NCT04922008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5924999|NCT04922008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5925000|NCT04922008|Tubulin Modulators|tubulin modulators|mesh-ancestor
5925001|NCT04922008|Antimitotic Agents|antimitotic agents|mesh-ancestor
5925002|NCT04922008|Mitosis Modulators|mitosis modulators|mesh-ancestor
5925003|NCT04922151|Ranibizumab|ranibizumab|mesh-list
5925004|NCT04922151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5925005|NCT04922151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5925006|NCT04922151|Growth Substances|growth substances|mesh-ancestor
5925007|NCT04922151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925008|NCT04922151|Growth Inhibitors|growth inhibitors|mesh-ancestor
5925009|NCT04922151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5925010|NCT04921930|Artesunate|artesunate|mesh-list
5925011|NCT04921930|Antimalarials|antimalarials|mesh-ancestor
5925012|NCT04921930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5925013|NCT04921930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5925014|NCT04921930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5925015|NCT04921930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5925016|NCT04921930|Antiviral Agents|antiviral agents|mesh-ancestor
5925017|NCT04921930|Schistosomicides|schistosomicides|mesh-ancestor
5925018|NCT04921930|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5925019|NCT04921930|Anthelmintics|anthelmintics|mesh-ancestor
5925020|NCT04921878|Mitoxantrone|mitoxantrone|mesh-list
5925021|NCT04921878|Analgesics|analgesics|mesh-ancestor
5925022|NCT04921878|Sensory System Agents|sensory system agents|mesh-ancestor
5925023|NCT04921878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5925024|NCT04921878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925025|NCT04921878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5925026|NCT04921878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5925027|NCT04921878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5925028|NCT04921878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5925029|NCT04921878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925030|NCT04921657|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5925031|NCT04921657|Simvastatin|simvastatin|mesh-list
5925032|NCT04921657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5925033|NCT04921657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6517021|NCT00719407|Epoetin Alfa|epoetin alfa|mesh-list
5925034|NCT04921657|Antimetabolites|antimetabolites|mesh-ancestor
5925035|NCT04921657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925036|NCT04921657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5925037|NCT04921657|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5925038|NCT04921657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5925039|NCT04921670|Infliximab|infliximab|mesh-list
5925040|NCT04921670|Dermatologic Agents|dermatologic agents|mesh-ancestor
5925041|NCT04921670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5925042|NCT04921670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5925043|NCT04922424|Atorvastatin|atorvastatin|mesh-list
5925044|NCT04922424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5925045|NCT04922424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5925046|NCT04922424|Antimetabolites|antimetabolites|mesh-ancestor
5925047|NCT04922424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925048|NCT04922424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5925049|NCT04922424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5925050|NCT04922424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5925051|NCT04921904|Ramucirumab|ramucirumab|mesh-list
5925052|NCT04921904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5965098|NCT04586465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5965099|NCT04586465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5965100|NCT04586465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5965101|NCT04586465|Immunologic Factors|immunologic factors|mesh-ancestor
5965102|NCT04586465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965103|NCT04586465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5965104|NCT04586465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5965105|NCT04586465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5965106|NCT04586218|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
5965107|NCT04586335|Olaparib|olaparib|mesh-list
5965108|NCT04586335|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5965109|NCT04586335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5965110|NCT04586335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965111|NCT04586335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5965112|NCT04586088|Apatinib|apatinib|mesh-list
5965113|NCT04586088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5965114|NCT04586088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5965115|NCT04586088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5965116|NCT04586088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965117|NCT04586166|Imidacloprid|imidacloprid|mesh-list
5965118|NCT04586166|Cholinergic Agents|cholinergic agents|mesh-ancestor
5965119|NCT04586166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5965120|NCT04586166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965121|NCT04586166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965122|NCT04586348|Iodine|iodine|mesh-list
5965123|NCT04586348|Cadexomer iodine|cadexomer iodine|mesh-list
5965124|NCT04586348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5965125|NCT04586348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5965126|NCT04586348|Trace Elements|trace elements|mesh-ancestor
5965127|NCT04586348|Micronutrients|micronutrients|mesh-ancestor
5965128|NCT04586348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965129|NCT04586062|Plasminogen|plasminogen|mesh-list
5965130|NCT04586062|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5965131|NCT04586062|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6517022|NCT00719407|Hematinics|hematinics|mesh-ancestor
6517023|NCT00719420|Amoxicillin|amoxicillin|mesh-list
6517024|NCT00719420|Metronidazole|metronidazole|mesh-list
6517025|NCT00719420|Clarithromycin|clarithromycin|mesh-list
6517026|NCT00719420|Omeprazole|omeprazole|mesh-list
6517027|NCT00719420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6517028|NCT00719420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6517029|NCT00719420|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6517030|NCT00719420|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6517031|NCT00719420|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6517032|NCT00719420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6517033|NCT00719420|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6517034|NCT00719420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6517035|NCT00719420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517036|NCT00719420|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6517037|NCT00719420|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6517038|NCT00719420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6517039|NCT00719433|Armin|armin|mesh-list
5965132|NCT04586062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965133|NCT04586361|Hyaluronic Acid|hyaluronic acid|mesh-list
6517040|NCT00719433|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6517041|NCT00719433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5925053|NCT04921982|Propranolol|propranolol|mesh-list
5925054|NCT04921982|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5925055|NCT04921982|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5925056|NCT04921982|Adrenergic Agents|adrenergic agents|mesh-ancestor
5925057|NCT04921982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5925058|NCT04921982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925059|NCT04921982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925060|NCT04921982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5925061|NCT04921982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5925062|NCT04921982|Vasodilator Agents|vasodilator agents|mesh-ancestor
5925063|NCT04921566|Torsemide|torsemide|mesh-list
5925064|NCT04921566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5925065|NCT04921566|Diuretics|diuretics|mesh-ancestor
5925066|NCT04921566|Natriuretic Agents|natriuretic agents|mesh-ancestor
5925067|NCT04921566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925068|NCT04921566|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5925069|NCT04921566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5925070|NCT04921566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925071|NCT04921527|Paclitaxel|paclitaxel|mesh-list
5925072|NCT04921527|Chiauranib|chiauranib|mesh-list
5925073|NCT04921527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5925074|NCT04921527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5925075|NCT04921527|Tubulin Modulators|tubulin modulators|mesh-ancestor
5925076|NCT04921527|Antimitotic Agents|antimitotic agents|mesh-ancestor
5925077|NCT04921527|Mitosis Modulators|mitosis modulators|mesh-ancestor
5925078|NCT04921527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925079|NCT04921527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5925080|NCT04921527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5925081|NCT04921306|Clenbuterol|clenbuterol|mesh-list
5925082|NCT04921306|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5925083|NCT04921306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5925084|NCT04921306|Adrenergic Agents|adrenergic agents|mesh-ancestor
5925085|NCT04921306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5925086|NCT04921306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925087|NCT04921306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925088|NCT04921306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5925089|NCT04921306|Autonomic Agents|autonomic agents|mesh-ancestor
5925090|NCT04921306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5925091|NCT04921306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5925092|NCT04921306|Respiratory System Agents|respiratory system agents|mesh-ancestor
5925093|NCT04921306|Sympathomimetics|sympathomimetics|mesh-ancestor
5925094|NCT04921111|Aluminum phosphate|aluminum phosphate|mesh-list
5925095|NCT04921111|Vaccines|vaccines|mesh-list
5925096|NCT04921111|Immunologic Factors|immunologic factors|mesh-ancestor
5925097|NCT04921111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925098|NCT04921111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5925099|NCT04921111|Antacids|antacids|mesh-ancestor
5925100|NCT04921111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925101|NCT04921111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5925102|NCT04921358|Docetaxel|docetaxel|mesh-list
5925103|NCT04921358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5925104|NCT04921358|Tubulin Modulators|tubulin modulators|mesh-ancestor
5925105|NCT04921358|Antimitotic Agents|antimitotic agents|mesh-ancestor
5925106|NCT04921358|Mitosis Modulators|mitosis modulators|mesh-ancestor
5925107|NCT04921358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925108|NCT04921371|Listerine|listerine|mesh-list
5925109|NCT04921371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5925110|NCT04921371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5925111|NCT04921124|Teriparatide|teriparatide|mesh-list
5925112|NCT04921124|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5925113|NCT04921124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925114|NCT04921124|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5925115|NCT04921046|Lidocaine|lidocaine|mesh-list
5925116|NCT04921046|Midazolam|midazolam|mesh-list
5925117|NCT04921046|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5925118|NCT04921046|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5925119|NCT04921046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5925120|NCT04921046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925121|NCT04921046|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5925122|NCT04921046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5925123|NCT04921046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5925124|NCT04921046|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5925125|NCT04921046|Anesthetics, General|anesthetics, general|mesh-ancestor
5925126|NCT04921046|Anesthetics|anesthetics|mesh-ancestor
5925127|NCT04921046|GABA Modulators|gaba modulators|mesh-ancestor
5925128|NCT04921046|GABA Agents|gaba agents|mesh-ancestor
5925129|NCT04921046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5925130|NCT04921046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925131|NCT04921046|Anesthetics, Local|anesthetics, local|mesh-ancestor
5925132|NCT04921046|Sensory System Agents|sensory system agents|mesh-ancestor
5925133|NCT04921046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5925134|NCT04921046|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5925135|NCT04921046|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5925136|NCT04921046|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5925137|NCT04921046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5925138|NCT04920968|Rituximab|rituximab|mesh-list
5925139|NCT04920968|Obinutuzumab|obinutuzumab|mesh-list
5925140|NCT04920968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5925141|NCT04920968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5925142|NCT04920968|Immunologic Factors|immunologic factors|mesh-ancestor
5925143|NCT04920968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925144|NCT04920968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5925145|NCT04920981|Atezolizumab|atezolizumab|mesh-list
5925146|NCT04920981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5925147|NCT04920838|Acetaminophen|acetaminophen|mesh-list
5925148|NCT04920838|Ciclesonide|ciclesonide|mesh-list
5925149|NCT04920838|Nitazoxanide|nitazoxanide|mesh-list
5925150|NCT04920838|Telmisartan|telmisartan|mesh-list
5925151|NCT04920838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5925152|NCT04920838|Analgesics|analgesics|mesh-ancestor
5925153|NCT04920838|Sensory System Agents|sensory system agents|mesh-ancestor
5925154|NCT04920838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5925155|NCT04920838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925156|NCT04920838|Antipyretics|antipyretics|mesh-ancestor
5925157|NCT04920838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5925158|NCT04920838|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5925159|NCT04920838|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5925160|NCT04920838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925161|NCT04920838|Glucocorticoids|glucocorticoids|mesh-ancestor
5925162|NCT04920838|Hormones|hormones|mesh-ancestor
5925163|NCT04920838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5925164|NCT04920838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5925165|NCT04920838|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5925166|NCT04920838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5925167|NCT04920747|Taxane|taxane|mesh-list
5925168|NCT04920747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5925169|NCT04920760|Vitamin A|vitamin a|mesh-list
5925170|NCT04920760|Vitamins|vitamins|mesh-ancestor
5925171|NCT04920760|Micronutrients|micronutrients|mesh-ancestor
5925172|NCT04920760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925173|NCT04920669|Dexmedetomidine|dexmedetomidine|mesh-list
5925174|NCT04920669|Bupivacaine|bupivacaine|mesh-list
5925175|NCT04920669|Anesthetics, Local|anesthetics, local|mesh-ancestor
5925176|NCT04920669|Anesthetics|anesthetics|mesh-ancestor
5925177|NCT04920669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5925178|NCT04920669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925179|NCT04920669|Sensory System Agents|sensory system agents|mesh-ancestor
5925180|NCT04920669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5925181|NCT04920669|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5925182|NCT04920669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5925183|NCT04920669|Analgesics|analgesics|mesh-ancestor
5925184|NCT04920669|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5925185|NCT04920669|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5925186|NCT04920669|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5925187|NCT04920669|Adrenergic Agents|adrenergic agents|mesh-ancestor
5925188|NCT04920669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5925189|NCT04920669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925190|NCT04920604|Anesthetics|anesthetics|mesh-list
5925191|NCT04920604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5925192|NCT04920604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925193|NCT04920695|Nitric Oxide|nitric oxide|mesh-list
5925194|NCT04920695|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5925195|NCT04920695|Autonomic Agents|autonomic agents|mesh-ancestor
5925196|NCT04920695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5925197|NCT04920695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925198|NCT04920695|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5925199|NCT04920695|Respiratory System Agents|respiratory system agents|mesh-ancestor
5925200|NCT04920695|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5925201|NCT04920695|Antioxidants|antioxidants|mesh-ancestor
5925202|NCT04920695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925203|NCT04920695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5925204|NCT04920695|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5925205|NCT04920695|Vasodilator Agents|vasodilator agents|mesh-ancestor
5925206|NCT04920695|Gasotransmitters|gasotransmitters|mesh-ancestor
5925207|NCT04920695|Protective Agents|protective agents|mesh-ancestor
6517042|NCT00719433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517043|NCT00719433|Cholinergic Agents|cholinergic agents|mesh-ancestor
6517044|NCT00719433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6517045|NCT00719433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517046|NCT00719459|Iron|iron|mesh-list
5925208|NCT04920708|Fulvestrant|fulvestrant|mesh-list
5925209|NCT04920708|Palbociclib|palbociclib|mesh-list
5925210|NCT04920708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5925211|NCT04920708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5925212|NCT04920708|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5925213|NCT04920708|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5925214|NCT04920708|Hormone Antagonists|hormone antagonists|mesh-ancestor
5925215|NCT04920708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5925216|NCT04920708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925217|NCT04920708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5925218|NCT04920708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5925219|NCT04920708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925220|NCT04920565|Polymyxins|polymyxins|mesh-list
5925221|NCT04920565|Polymyxin B|polymyxin b|mesh-list
5925222|NCT04920565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5925223|NCT04920565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5925224|NCT04920682|Iodine|iodine|mesh-list
5925225|NCT04920682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5925226|NCT04920682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5925227|NCT04920682|Trace Elements|trace elements|mesh-ancestor
5925228|NCT04920682|Micronutrients|micronutrients|mesh-ancestor
5925229|NCT04920682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925230|NCT04921033|Prednisolone|prednisolone|mesh-list
5925231|NCT04921033|Budesonide|budesonide|mesh-list
5925232|NCT04921033|Azathioprine|azathioprine|mesh-list
5925233|NCT04921033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5925234|NCT04921033|Glucocorticoids|glucocorticoids|mesh-ancestor
5925235|NCT04921033|Hormones|hormones|mesh-ancestor
5925236|NCT04921033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5925237|NCT04921033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925238|NCT04921033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5925239|NCT04921033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5925240|NCT04921033|Autonomic Agents|autonomic agents|mesh-ancestor
5925241|NCT04921033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5925242|NCT04921033|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5925243|NCT04921033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5925244|NCT04921033|Respiratory System Agents|respiratory system agents|mesh-ancestor
5925245|NCT04921033|Antimetabolites|antimetabolites|mesh-ancestor
5925246|NCT04921033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925247|NCT04921033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5925248|NCT04921033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5925249|NCT04921033|Immunologic Factors|immunologic factors|mesh-ancestor
5925250|NCT04921033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5925251|NCT04920357|Vaccines|vaccines|mesh-list
5925252|NCT04920357|Immunologic Factors|immunologic factors|mesh-ancestor
5925253|NCT04920357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925254|NCT04920448|Acetylcysteine|acetylcysteine|mesh-list
5925255|NCT04920448|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5925256|NCT04920448|Antiviral Agents|antiviral agents|mesh-ancestor
5925257|NCT04920448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5925258|NCT04920448|Expectorants|expectorants|mesh-ancestor
5925259|NCT04920448|Respiratory System Agents|respiratory system agents|mesh-ancestor
5925260|NCT04920448|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5925261|NCT04920448|Antioxidants|antioxidants|mesh-ancestor
5925262|NCT04920448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925263|NCT04920448|Protective Agents|protective agents|mesh-ancestor
5925264|NCT04920448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925265|NCT04920448|Antidotes|antidotes|mesh-ancestor
5925266|NCT04920500|Cytarabine|cytarabine|mesh-list
5925267|NCT04920500|Daunorubicin|daunorubicin|mesh-list
5925268|NCT04920500|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5925269|NCT04920500|Antimetabolites|antimetabolites|mesh-ancestor
5925270|NCT04920500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925271|NCT04920500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5925272|NCT04920500|Antiviral Agents|antiviral agents|mesh-ancestor
5925273|NCT04920500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5925274|NCT04920500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5925275|NCT04920500|Immunologic Factors|immunologic factors|mesh-ancestor
5925276|NCT04920500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925277|NCT04920500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5925278|NCT04920500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5925279|NCT04920500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5925280|NCT04920500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5925281|NCT04920032|Irinotecan|irinotecan|mesh-list
5925282|NCT04920032|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5925283|NCT04920032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5925284|NCT04920032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5925285|NCT04920032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925286|NCT04920032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5925287|NCT04920149|Mesalamine|mesalamine|mesh-list
5925288|NCT04920149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5925289|NCT04920149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5925290|NCT04920149|Analgesics|analgesics|mesh-ancestor
5925291|NCT04920149|Sensory System Agents|sensory system agents|mesh-ancestor
5925292|NCT04920149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5925293|NCT04920149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925294|NCT04920149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5925295|NCT04920149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5718972|NCT03221504|Adrenergic Agents|adrenergic agents|mesh-ancestor
5718973|NCT03221504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5718974|NCT03221504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718975|NCT03221504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5718976|NCT03221504|Sympathomimetics|sympathomimetics|mesh-ancestor
5718977|NCT03221504|Autonomic Agents|autonomic agents|mesh-ancestor
5718978|NCT03221504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5718979|NCT03221504|Nasal Decongestants|nasal decongestants|mesh-ancestor
5718980|NCT03221504|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5718981|NCT03221504|Respiratory System Agents|respiratory system agents|mesh-ancestor
5718982|NCT03221426|Leucovorin|leucovorin|mesh-list
5718983|NCT03221426|Docetaxel|docetaxel|mesh-list
5718984|NCT03221426|Fluorouracil|fluorouracil|mesh-list
5718985|NCT03221426|Pembrolizumab|pembrolizumab|mesh-list
5718986|NCT03221426|Capecitabine|capecitabine|mesh-list
5718987|NCT03221426|Oxaliplatin|oxaliplatin|mesh-list
5718988|NCT03221426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5718989|NCT03221426|Tubulin Modulators|tubulin modulators|mesh-ancestor
5718990|NCT03221426|Antimitotic Agents|antimitotic agents|mesh-ancestor
5718991|NCT03221426|Mitosis Modulators|mitosis modulators|mesh-ancestor
5718992|NCT03221426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5718993|NCT03221426|Antimetabolites|antimetabolites|mesh-ancestor
5718994|NCT03221426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5718995|NCT03221426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5718996|NCT03221426|Immunologic Factors|immunologic factors|mesh-ancestor
5718997|NCT03221426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965134|NCT04586361|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5965135|NCT04586361|Immunologic Factors|immunologic factors|mesh-ancestor
5965136|NCT04586361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965137|NCT04586361|Viscosupplements|viscosupplements|mesh-ancestor
5965138|NCT04586361|Protective Agents|protective agents|mesh-ancestor
5965139|NCT04585997|Omalizumab|omalizumab|mesh-list
5965140|NCT04585997|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5965141|NCT04585997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5965142|NCT04585997|Respiratory System Agents|respiratory system agents|mesh-ancestor
5965143|NCT04585737|Tenofovir|tenofovir|mesh-list
5965144|NCT04585737|Lamivudine|lamivudine|mesh-list
5965145|NCT04585737|Emtricitabine|emtricitabine|mesh-list
5965146|NCT04585737|Dolutegravir|dolutegravir|mesh-list
5965147|NCT04585737|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
5965148|NCT04585737|Antiviral Agents|antiviral agents|mesh-ancestor
5965149|NCT04585737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5965150|NCT04585737|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5965151|NCT04585737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5965152|NCT04585737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5965153|NCT04585737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965154|NCT04585737|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5965155|NCT04585737|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5965156|NCT04585737|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5965157|NCT04585737|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5965158|NCT04585867|Bupivacaine|bupivacaine|mesh-list
5965159|NCT04585867|Anesthetics, Local|anesthetics, local|mesh-ancestor
5718998|NCT03221426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5718999|NCT03221426|Antidotes|antidotes|mesh-ancestor
5965160|NCT04585867|Anesthetics|anesthetics|mesh-ancestor
5925296|NCT04919564|Furosemide|furosemide|mesh-list
5925297|NCT04919564|Diuretics|diuretics|mesh-ancestor
5925298|NCT04919564|Natriuretic Agents|natriuretic agents|mesh-ancestor
5925299|NCT04919564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925300|NCT04919564|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5925301|NCT04919564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5925302|NCT04919564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925303|NCT04919460|Tolonium Chloride|tolonium chloride|mesh-list
5925304|NCT04919460|Hemostatics|hemostatics|mesh-ancestor
5925305|NCT04919460|Coagulants|coagulants|mesh-ancestor
5925306|NCT04919460|Heparin Antagonists|heparin antagonists|mesh-ancestor
5925307|NCT04919460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925308|NCT04919317|Dexamethasone|dexamethasone|mesh-list
5925309|NCT04919317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5925310|NCT04919317|Antiemetics|antiemetics|mesh-ancestor
5925311|NCT04919317|Autonomic Agents|autonomic agents|mesh-ancestor
5925312|NCT04919317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5925313|NCT04919317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925314|NCT04919317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5925315|NCT04919317|Glucocorticoids|glucocorticoids|mesh-ancestor
5925316|NCT04919317|Hormones|hormones|mesh-ancestor
5925317|NCT04919317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5925318|NCT04919317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5925319|NCT04919317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5925320|NCT04919252|Vedolizumab|vedolizumab|mesh-list
5925321|NCT04919252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5925322|NCT04919096|Aflibercept|aflibercept|mesh-list
5925323|NCT04919096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5925324|NCT04919096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5925325|NCT04919096|Growth Substances|growth substances|mesh-ancestor
5925326|NCT04919096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925327|NCT04919096|Growth Inhibitors|growth inhibitors|mesh-ancestor
5925328|NCT04919096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5925329|NCT04919174|Dexmedetomidine|dexmedetomidine|mesh-list
5925330|NCT04919174|Remifentanil|remifentanil|mesh-list
5925331|NCT04919174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5925332|NCT04919174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5925333|NCT04919174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925334|NCT04919174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5925335|NCT04919174|Analgesics|analgesics|mesh-ancestor
5925336|NCT04919174|Sensory System Agents|sensory system agents|mesh-ancestor
5925337|NCT04919174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5925338|NCT04919174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5925339|NCT04919174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5925340|NCT04919174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5925341|NCT04919174|Adrenergic Agents|adrenergic agents|mesh-ancestor
5925342|NCT04919174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5925343|NCT04919174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925344|NCT04919174|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5925345|NCT04919174|Narcotics|narcotics|mesh-ancestor
5925346|NCT04918914|Dapsone|dapsone|mesh-list
5925347|NCT04918914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5925348|NCT04918914|Antimalarials|antimalarials|mesh-ancestor
5925349|NCT04918914|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5925350|NCT04918914|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5925351|NCT04918914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5925352|NCT04918914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5925353|NCT04918914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925354|NCT04918914|Leprostatic Agents|leprostatic agents|mesh-ancestor
5925355|NCT04918914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5925356|NCT04918589|Tranexamic Acid|tranexamic acid|mesh-list
5925357|NCT04918589|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5925358|NCT04918589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5925359|NCT04918589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925360|NCT04918589|Hemostatics|hemostatics|mesh-ancestor
5925361|NCT04918589|Coagulants|coagulants|mesh-ancestor
5925362|NCT04918576|Tranexamic Acid|tranexamic acid|mesh-list
5925363|NCT04918576|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5925364|NCT04918576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5925365|NCT04918576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925366|NCT04918576|Hemostatics|hemostatics|mesh-ancestor
5925367|NCT04918576|Coagulants|coagulants|mesh-ancestor
5925368|NCT04918823|Cyclosporine|cyclosporine|mesh-list
5925369|NCT04918823|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5925370|NCT04918823|Cyclosporins|cyclosporins|mesh-list
5925371|NCT04918823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5925372|NCT04918823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925373|NCT04918823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5925374|NCT04918823|Immunologic Factors|immunologic factors|mesh-ancestor
5925375|NCT04918823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925376|NCT04918823|Antifungal Agents|antifungal agents|mesh-ancestor
5925377|NCT04918823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5925378|NCT04918823|Dermatologic Agents|dermatologic agents|mesh-ancestor
5925379|NCT04918823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5925380|NCT04918823|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5925381|NCT04918823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5925382|NCT04918758|Sucralfate|sucralfate|mesh-list
5925383|NCT04918758|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5925384|NCT04918758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5925385|NCT04918524|Aspirin|aspirin|mesh-list
5925386|NCT04918524|Hydroxychloroquine|hydroxychloroquine|mesh-list
5925387|NCT04918524|Prednisone|prednisone|mesh-list
5925388|NCT04918524|Heparin|heparin|mesh-list
5925389|NCT04918524|Enoxaparin|enoxaparin|mesh-list
5925390|NCT04918524|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5925391|NCT04918524|Tinzaparin|tinzaparin|mesh-list
5925392|NCT04918524|Dalteparin|dalteparin|mesh-list
5925393|NCT04918524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5925394|NCT04918524|Glucocorticoids|glucocorticoids|mesh-ancestor
5925395|NCT04918524|Hormones|hormones|mesh-ancestor
5925396|NCT04918524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5925397|NCT04918524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925398|NCT04918524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5925399|NCT04918524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5925400|NCT04918524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5925401|NCT04918524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5925402|NCT04918524|Analgesics|analgesics|mesh-ancestor
5925403|NCT04918524|Sensory System Agents|sensory system agents|mesh-ancestor
5925404|NCT04918524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5925405|NCT04918524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5925406|NCT04918524|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5925407|NCT04918524|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5925408|NCT04918524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925409|NCT04918524|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5925410|NCT04918524|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5925411|NCT04918524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5925412|NCT04918524|Antipyretics|antipyretics|mesh-ancestor
5925413|NCT04918524|Anticoagulants|anticoagulants|mesh-ancestor
5925414|NCT04918524|Antimalarials|antimalarials|mesh-ancestor
5925415|NCT04918524|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5925416|NCT04918524|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5925417|NCT04918524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5925418|NCT04918719|Acetylcysteine|acetylcysteine|mesh-list
5925419|NCT04918719|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5925420|NCT04918719|Antiviral Agents|antiviral agents|mesh-ancestor
5925421|NCT04918719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5925422|NCT04918719|Expectorants|expectorants|mesh-ancestor
5925423|NCT04918719|Respiratory System Agents|respiratory system agents|mesh-ancestor
5925424|NCT04918719|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5925425|NCT04918719|Antioxidants|antioxidants|mesh-ancestor
5925426|NCT04918719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925427|NCT04918719|Protective Agents|protective agents|mesh-ancestor
5925428|NCT04918719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925429|NCT04918719|Antidotes|antidotes|mesh-ancestor
5925430|NCT04918563|Nitroglycerin|nitroglycerin|mesh-list
5925431|NCT04918563|Acetylcholine|acetylcholine|mesh-list
5925432|NCT04918563|Vasodilator Agents|vasodilator agents|mesh-ancestor
5925433|NCT04918563|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5925434|NCT04918563|Cholinergic Agents|cholinergic agents|mesh-ancestor
5925435|NCT04918563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5925436|NCT04918563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925437|NCT04918563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925438|NCT04918862|Granisetron|granisetron|mesh-list
5925439|NCT04918862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925440|NCT04918862|Antiemetics|antiemetics|mesh-ancestor
5925441|NCT04918862|Autonomic Agents|autonomic agents|mesh-ancestor
5925442|NCT04918862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5925443|NCT04918862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5925444|NCT04918862|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5925445|NCT04918862|Serotonin Agents|serotonin agents|mesh-ancestor
5925446|NCT04918862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5925447|NCT04918862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925448|NCT04918953|Methylprednisolone|methylprednisolone|mesh-list
5925449|NCT04918953|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5925450|NCT04918953|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5925451|NCT04918953|Prednisolone|prednisolone|mesh-list
5925452|NCT04918953|Prednisolone acetate|prednisolone acetate|mesh-list
5925453|NCT04918953|Budesonide|budesonide|mesh-list
5925454|NCT04918953|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5925455|NCT04918953|Prednisolone phosphate|prednisolone phosphate|mesh-list
5925456|NCT04918953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5925457|NCT04918953|Antiemetics|antiemetics|mesh-ancestor
5925458|NCT04918953|Autonomic Agents|autonomic agents|mesh-ancestor
5925459|NCT04918953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5925460|NCT04918953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925461|NCT04918953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5925462|NCT04918953|Glucocorticoids|glucocorticoids|mesh-ancestor
5925463|NCT04918953|Hormones|hormones|mesh-ancestor
5925464|NCT04918953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5925465|NCT04918953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5925466|NCT04918953|Protective Agents|protective agents|mesh-ancestor
5925467|NCT04918953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5925468|NCT04918953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5925469|NCT04918953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5925470|NCT04918953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5925471|NCT04918953|Respiratory System Agents|respiratory system agents|mesh-ancestor
5925472|NCT04918069|Capsaicin|capsaicin|mesh-list
5925473|NCT04918069|Antipruritics|antipruritics|mesh-ancestor
5925474|NCT04918069|Dermatologic Agents|dermatologic agents|mesh-ancestor
5925475|NCT04918069|Sensory System Agents|sensory system agents|mesh-ancestor
5925476|NCT04918069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5925477|NCT04918069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925478|NCT04918173|Antithrombin III|antithrombin iii|mesh-list
5925479|NCT04918173|Antithrombins|antithrombins|mesh-ancestor
5925480|NCT04918173|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5925481|NCT04918173|Protease Inhibitors|protease inhibitors|mesh-ancestor
5925482|NCT04918173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5925483|NCT04918173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925484|NCT04918173|Anticoagulants|anticoagulants|mesh-ancestor
5925485|NCT04918433|Anesthetics|anesthetics|mesh-list
5925486|NCT04918433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5925487|NCT04918433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925488|NCT04918264|Capecitabine|capecitabine|mesh-list
5925489|NCT04918264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5925490|NCT04918264|Antimetabolites|antimetabolites|mesh-ancestor
5925491|NCT04918264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925492|NCT04918264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5965161|NCT04585867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5965162|NCT04585867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965163|NCT04585867|Sensory System Agents|sensory system agents|mesh-ancestor
5965164|NCT04585867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5965165|NCT04585841|Cannabidiol|cannabidiol|mesh-list
5965166|NCT04585841|Anticonvulsants|anticonvulsants|mesh-ancestor
5970744|NCT04532775|Antiemetics|antiemetics|mesh-ancestor
5970745|NCT04532775|Autonomic Agents|autonomic agents|mesh-ancestor
5970746|NCT04532775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5970747|NCT04532775|Glucocorticoids|glucocorticoids|mesh-ancestor
5970748|NCT04532775|Hormones|hormones|mesh-ancestor
5970749|NCT04532775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5970750|NCT04532775|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5970751|NCT04532775|Protective Agents|protective agents|mesh-ancestor
5970752|NCT04532775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5970753|NCT04532775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5970754|NCT04532775|Analgesics|analgesics|mesh-ancestor
5970755|NCT04532775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5970756|NCT04532775|Anticonvulsants|anticonvulsants|mesh-ancestor
5970757|NCT04532775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5970758|NCT04532775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5970759|NCT04532775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970760|NCT04532775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5970761|NCT04532775|Tocolytic Agents|tocolytic agents|mesh-ancestor
5970762|NCT04532775|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5970763|NCT04532671|Ether|ether|mesh-list
5970764|NCT04532671|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5970765|NCT04532671|Anesthetics, General|anesthetics, general|mesh-ancestor
5970766|NCT04532671|Anesthetics|anesthetics|mesh-ancestor
5970767|NCT04532671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5970768|NCT04532671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925493|NCT04917679|Diacetylrhein|diacetylrhein|mesh-list
5925494|NCT04917679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5925495|NCT04917718|Tacrolimus|tacrolimus|mesh-list
5925496|NCT04917718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5925497|NCT04917718|Immunologic Factors|immunologic factors|mesh-ancestor
5925498|NCT04917718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925499|NCT04917718|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5925500|NCT04917718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5925501|NCT04917718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925502|NCT04917692|Empagliflozin|empagliflozin|mesh-list
5925503|NCT04917692|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5925504|NCT04917692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925505|NCT04917692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5925506|NCT04917692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925507|NCT04917627|Vancomycin|vancomycin|mesh-list
5925508|NCT04917627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5925509|NCT04917627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5925510|NCT04917900|Paclitaxel|paclitaxel|mesh-list
5925511|NCT04917900|Trastuzumab|trastuzumab|mesh-list
5925512|NCT04917900|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5925513|NCT04917900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5925514|NCT04917900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5925515|NCT04917900|Tubulin Modulators|tubulin modulators|mesh-ancestor
5925516|NCT04917900|Antimitotic Agents|antimitotic agents|mesh-ancestor
5925517|NCT04917900|Mitosis Modulators|mitosis modulators|mesh-ancestor
5925518|NCT04917900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925519|NCT04917900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5925520|NCT04917757|Dexamethasone|dexamethasone|mesh-list
5925521|NCT04917757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5925522|NCT04917757|Antiemetics|antiemetics|mesh-ancestor
5925523|NCT04917757|Autonomic Agents|autonomic agents|mesh-ancestor
5925524|NCT04917757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5925525|NCT04917757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925526|NCT04917757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5925527|NCT04917757|Glucocorticoids|glucocorticoids|mesh-ancestor
5925528|NCT04917757|Hormones|hormones|mesh-ancestor
5925529|NCT04917757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5925530|NCT04917757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5925531|NCT04917757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5925532|NCT04917588|Lidocaine|lidocaine|mesh-list
5925533|NCT04917588|Anesthetics, Local|anesthetics, local|mesh-ancestor
5925534|NCT04917588|Anesthetics|anesthetics|mesh-ancestor
5925535|NCT04917588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5925536|NCT04917588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925537|NCT04917588|Sensory System Agents|sensory system agents|mesh-ancestor
5925538|NCT04917588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5925539|NCT04917588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5925540|NCT04917588|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5925541|NCT04917588|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5925542|NCT04917588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5925543|NCT04917588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925544|NCT04917497|Simendan|simendan|mesh-list
5925545|NCT04917497|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5925546|NCT04917497|Vasodilator Agents|vasodilator agents|mesh-ancestor
5925547|NCT04917497|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5925548|NCT04917497|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5925549|NCT04917497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5925550|NCT04917497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925551|NCT04917497|Protective Agents|protective agents|mesh-ancestor
5925552|NCT04917497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925553|NCT04917458|Vitamin D|vitamin d|mesh-list
5925554|NCT04917458|Cholecalciferol|cholecalciferol|mesh-list
5925555|NCT04917458|Vitamins|vitamins|mesh-ancestor
5925556|NCT04917458|Micronutrients|micronutrients|mesh-ancestor
5925557|NCT04917458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925558|NCT04917458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5925559|NCT04917458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5925560|NCT04917484|Octreotide|octreotide|mesh-list
5925561|NCT04917484|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
5925562|NCT04917484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5925563|NCT04917484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5925564|NCT04917484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5925565|NCT04917484|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5925566|NCT04917484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925567|NCT04917406|Dexamethasone|dexamethasone|mesh-list
5925568|NCT04917406|Lidocaine|lidocaine|mesh-list
5925569|NCT04917406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5925570|NCT04917406|Antiemetics|antiemetics|mesh-ancestor
5925571|NCT04917406|Autonomic Agents|autonomic agents|mesh-ancestor
5925572|NCT04917406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5925573|NCT04917406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925574|NCT04917406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5925575|NCT04917406|Glucocorticoids|glucocorticoids|mesh-ancestor
5925576|NCT04917406|Hormones|hormones|mesh-ancestor
5925577|NCT04917406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5925578|NCT04917406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5925579|NCT04917406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5925580|NCT04917406|Anesthetics, Local|anesthetics, local|mesh-ancestor
5925581|NCT04917406|Anesthetics|anesthetics|mesh-ancestor
5925582|NCT04917406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5925583|NCT04917406|Sensory System Agents|sensory system agents|mesh-ancestor
5925584|NCT04917406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5925585|NCT04917406|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5925586|NCT04917406|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5925587|NCT04917406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5925588|NCT04917406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925589|NCT04917055|Dexamethasone|dexamethasone|mesh-list
5925590|NCT04917055|Epinephrine|epinephrine|mesh-list
5925591|NCT04917055|Ropivacaine|ropivacaine|mesh-list
5925592|NCT04917055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5925593|NCT04917055|Antiemetics|antiemetics|mesh-ancestor
5925594|NCT04917055|Autonomic Agents|autonomic agents|mesh-ancestor
5925595|NCT04917055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5925596|NCT04917055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925597|NCT04917055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5925598|NCT04917055|Glucocorticoids|glucocorticoids|mesh-ancestor
5925599|NCT04917055|Hormones|hormones|mesh-ancestor
5925600|NCT04917055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5925601|NCT04917055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5925602|NCT04917055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5925603|NCT04917055|Anesthetics, Local|anesthetics, local|mesh-ancestor
5925604|NCT04917055|Anesthetics|anesthetics|mesh-ancestor
5925605|NCT04917055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5925606|NCT04917055|Sensory System Agents|sensory system agents|mesh-ancestor
5925607|NCT04917055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5925608|NCT04917055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5925609|NCT04917055|Adrenergic Agents|adrenergic agents|mesh-ancestor
5925610|NCT04917055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5925611|NCT04917055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925612|NCT04917055|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5925613|NCT04917055|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5925614|NCT04917055|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5925615|NCT04917055|Respiratory System Agents|respiratory system agents|mesh-ancestor
5925616|NCT04917055|Mydriatics|mydriatics|mesh-ancestor
5925617|NCT04917055|Sympathomimetics|sympathomimetics|mesh-ancestor
5925618|NCT04917055|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5925619|NCT04917250|Gemcitabine|gemcitabine|mesh-list
5925620|NCT04917250|Dexamethasone|dexamethasone|mesh-list
5925621|NCT04917250|Etoposide|etoposide|mesh-list
5925622|NCT04917250|Pegaspargase|pegaspargase|mesh-list
5925623|NCT04917250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5925624|NCT04917250|Antiemetics|antiemetics|mesh-ancestor
5925625|NCT04917250|Autonomic Agents|autonomic agents|mesh-ancestor
5925626|NCT04917250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5925627|NCT04917250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925628|NCT04917250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5925629|NCT04917250|Glucocorticoids|glucocorticoids|mesh-ancestor
5925630|NCT04917250|Hormones|hormones|mesh-ancestor
5925631|NCT04917250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5925632|NCT04917250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5925633|NCT04917250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5925634|NCT04917250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5925635|NCT04917250|Antimetabolites|antimetabolites|mesh-ancestor
5925636|NCT04917250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925637|NCT04917250|Antiviral Agents|antiviral agents|mesh-ancestor
5925638|NCT04917250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5925639|NCT04917250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5925640|NCT04917250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5925641|NCT04917250|Immunologic Factors|immunologic factors|mesh-ancestor
5965167|NCT04585932|Leuprolide|leuprolide|mesh-list
5925642|NCT04917250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5925643|NCT04917250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5925644|NCT04917250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5925645|NCT04916925|Vitamin D|vitamin d|mesh-list
5925646|NCT04916925|Vitamins|vitamins|mesh-ancestor
5925647|NCT04916925|Micronutrients|micronutrients|mesh-ancestor
5925648|NCT04916925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925649|NCT04916925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5925650|NCT04916951|Amoxicillin|amoxicillin|mesh-list
5925651|NCT04916951|Cephalexin|cephalexin|mesh-list
5925652|NCT04916951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5925653|NCT04916951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5925654|NCT04916899|Rifampin|rifampin|mesh-list
5925655|NCT04916899|Isoniazid|isoniazid|mesh-list
5925656|NCT04916899|Pyrazinamide|pyrazinamide|mesh-list
5925657|NCT04916899|Ethambutol|ethambutol|mesh-list
5925658|NCT04916899|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5925659|NCT04916899|Antitubercular Agents|antitubercular agents|mesh-ancestor
5925660|NCT04916899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5925661|NCT04916899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5925662|NCT04916899|Leprostatic Agents|leprostatic agents|mesh-ancestor
5925663|NCT04916899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5925664|NCT04916899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5925665|NCT04916899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925666|NCT04916899|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5925667|NCT04916899|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5925668|NCT04916899|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5925669|NCT04916899|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5925670|NCT04916899|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5925671|NCT04916899|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5925672|NCT04916899|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5925673|NCT04916899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5925674|NCT04916899|Antimetabolites|antimetabolites|mesh-ancestor
5925675|NCT04916899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5925676|NCT04916886|Vaccines|vaccines|mesh-list
5925677|NCT04916886|Immunologic Factors|immunologic factors|mesh-ancestor
5925678|NCT04916886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925679|NCT04916821|Propolis|propolis|mesh-list
5925680|NCT04916821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5925681|NCT04916522|Colchicine|colchicine|mesh-list
5925682|NCT04916522|Gout Suppressants|gout suppressants|mesh-ancestor
5925683|NCT04916522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5925684|NCT04916522|Tubulin Modulators|tubulin modulators|mesh-ancestor
5925685|NCT04916522|Antimitotic Agents|antimitotic agents|mesh-ancestor
5925686|NCT04916522|Mitosis Modulators|mitosis modulators|mesh-ancestor
5925687|NCT04916522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925688|NCT04916522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5925689|NCT04916665|Teduglutide|teduglutide|mesh-list
5925690|NCT04916665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5925691|NCT04916665|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5925692|NCT04916665|Protective Agents|protective agents|mesh-ancestor
5925693|NCT04916665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925694|NCT04916509|Fulvestrant|fulvestrant|mesh-list
5925695|NCT04916509|Palbociclib|palbociclib|mesh-list
5925696|NCT04916509|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5925697|NCT04916509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5925698|NCT04916509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5925699|NCT04916509|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5925700|NCT04916509|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5925701|NCT04916509|Hormone Antagonists|hormone antagonists|mesh-ancestor
5925702|NCT04916509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5925703|NCT04916509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925704|NCT04916509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5925705|NCT04916509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5925706|NCT04916509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925707|NCT04916509|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5925708|NCT04916548|Ketamine|ketamine|mesh-list
5925709|NCT04916548|Analgesics|analgesics|mesh-ancestor
5925710|NCT04916548|Sensory System Agents|sensory system agents|mesh-ancestor
5925711|NCT04916548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5925712|NCT04916548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925713|NCT04916548|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5925714|NCT04916548|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5925715|NCT04916548|Anesthetics, General|anesthetics, general|mesh-ancestor
5925716|NCT04916548|Anesthetics|anesthetics|mesh-ancestor
5925717|NCT04916548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5925718|NCT04916548|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5925719|NCT04916548|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5925720|NCT04916548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5925721|NCT04916548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925722|NCT04916613|Androgens|androgens|mesh-list
5925723|NCT04916613|Hormones|hormones|mesh-ancestor
5925724|NCT04916613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5925725|NCT04916613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925726|NCT04916574|Antibodies|antibodies|mesh-list
5925727|NCT04916574|Immunologic Factors|immunologic factors|mesh-ancestor
5925728|NCT04916574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925729|NCT04916418|Ropivacaine|ropivacaine|mesh-list
5925730|NCT04916418|Anesthetics, Local|anesthetics, local|mesh-ancestor
5925731|NCT04916418|Anesthetics|anesthetics|mesh-ancestor
5925732|NCT04916418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5925733|NCT04916418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925734|NCT04916418|Sensory System Agents|sensory system agents|mesh-ancestor
5925735|NCT04916418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5965168|NCT04585932|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5965169|NCT04585932|Fertility Agents|fertility agents|mesh-ancestor
5965170|NCT04585932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5965171|NCT04585932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965172|NCT04585932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5965173|NCT04585932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5965174|NCT04585776|Insulin|insulin|mesh-list
5965175|NCT04585776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5965176|NCT04585776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965177|NCT04585711|Etanercept|etanercept|mesh-list
5965178|NCT04585711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5965179|NCT04585711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5965180|NCT04585711|Analgesics|analgesics|mesh-ancestor
5965181|NCT04585711|Sensory System Agents|sensory system agents|mesh-ancestor
5965182|NCT04585711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5965183|NCT04585711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965184|NCT04585711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5965185|NCT04585711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5965186|NCT04585711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5965187|NCT04585711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5965188|NCT04585711|Immunologic Factors|immunologic factors|mesh-ancestor
5965189|NCT04585893|Rituximab|rituximab|mesh-list
5965190|NCT04585893|Etoposide|etoposide|mesh-list
5965191|NCT04585893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5965192|NCT04585893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5965193|NCT04585893|Immunologic Factors|immunologic factors|mesh-ancestor
5965194|NCT04585893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965195|NCT04585893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5965196|NCT04585893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5965197|NCT04585893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5965198|NCT04585893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5965199|NCT04585893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5965200|NCT04585893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965201|NCT04585490|Paclitaxel|paclitaxel|mesh-list
5965202|NCT04585490|Cisplatin|cisplatin|mesh-list
5965203|NCT04585490|Carboplatin|carboplatin|mesh-list
5965204|NCT04585490|Pemetrexed|pemetrexed|mesh-list
5965205|NCT04585490|Durvalumab|durvalumab|mesh-list
5965206|NCT04585490|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5965207|NCT04585490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5965208|NCT04585490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5965209|NCT04585490|Tubulin Modulators|tubulin modulators|mesh-ancestor
5965210|NCT04585490|Antimitotic Agents|antimitotic agents|mesh-ancestor
5965211|NCT04585490|Mitosis Modulators|mitosis modulators|mesh-ancestor
5965212|NCT04585490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965213|NCT04585490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5965214|NCT04585490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5965215|NCT04585490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5965216|NCT04585490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5965217|NCT04585490|Immunologic Factors|immunologic factors|mesh-ancestor
5965218|NCT04585490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965219|NCT04585334|Diclofenac|diclofenac|mesh-list
5965220|NCT04585334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5965221|NCT04585334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5965222|NCT04585334|Analgesics|analgesics|mesh-ancestor
5965223|NCT04585334|Sensory System Agents|sensory system agents|mesh-ancestor
5925736|NCT04916392|Bupivacaine|bupivacaine|mesh-list
5925737|NCT04916392|Anesthetics, Local|anesthetics, local|mesh-ancestor
5925738|NCT04916392|Anesthetics|anesthetics|mesh-ancestor
5925739|NCT04916392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5925740|NCT04916392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925741|NCT04916392|Sensory System Agents|sensory system agents|mesh-ancestor
5925742|NCT04916392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5925743|NCT04916353|Triamcinolone|triamcinolone|mesh-list
5925744|NCT04916353|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5925745|NCT04916353|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5925746|NCT04916353|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5925747|NCT04916353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5925748|NCT04916353|Glucocorticoids|glucocorticoids|mesh-ancestor
5925749|NCT04916353|Hormones|hormones|mesh-ancestor
5925750|NCT04916353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5925751|NCT04916353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925752|NCT04916353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5925753|NCT04916353|Immunologic Factors|immunologic factors|mesh-ancestor
5925754|NCT04916353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5925755|NCT04916353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925756|NCT04916691|Ropivacaine|ropivacaine|mesh-list
5925757|NCT04916691|Anesthetics, Local|anesthetics, local|mesh-ancestor
5925758|NCT04916691|Anesthetics|anesthetics|mesh-ancestor
5925759|NCT04916691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5925760|NCT04916691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925761|NCT04916691|Sensory System Agents|sensory system agents|mesh-ancestor
5925762|NCT04916691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5925763|NCT04916327|Antioxidants|antioxidants|mesh-list
5925764|NCT04916327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925765|NCT04916327|Protective Agents|protective agents|mesh-ancestor
5925766|NCT04916327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925767|NCT04916093|Metformin|metformin|mesh-list
5925768|NCT04916093|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5925769|NCT04916093|Vildagliptin|vildagliptin|mesh-list
5925770|NCT04916093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5925771|NCT04916093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925772|NCT04916093|Incretins|incretins|mesh-ancestor
5925773|NCT04916093|Hormones|hormones|mesh-ancestor
5925774|NCT04916093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5925775|NCT04916093|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5925776|NCT04916093|Protease Inhibitors|protease inhibitors|mesh-ancestor
5925777|NCT04916093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5925778|NCT04916093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925779|NCT04915846|Tamoxifen|tamoxifen|mesh-list
5925780|NCT04915846|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5925781|NCT04915846|Hormone Antagonists|hormone antagonists|mesh-ancestor
5925782|NCT04915846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5925783|NCT04915846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925784|NCT04915846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5925785|NCT04915846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5925786|NCT04915846|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5925787|NCT04915846|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5925788|NCT04915846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5925789|NCT04915885|Contraceptive Agents|contraceptive agents|mesh-list
5925790|NCT04915885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5925791|NCT04915885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925792|NCT04916080|Acetylcysteine|acetylcysteine|mesh-list
5925793|NCT04916080|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5925794|NCT04916080|Antiviral Agents|antiviral agents|mesh-ancestor
5925795|NCT04916080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5925796|NCT04916080|Expectorants|expectorants|mesh-ancestor
5925797|NCT04916080|Respiratory System Agents|respiratory system agents|mesh-ancestor
5925798|NCT04916080|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5925799|NCT04916080|Antioxidants|antioxidants|mesh-ancestor
5925800|NCT04916080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925801|NCT04916080|Protective Agents|protective agents|mesh-ancestor
5925802|NCT04916080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925803|NCT04916080|Antidotes|antidotes|mesh-ancestor
5925804|NCT04915963|Vitamin D|vitamin d|mesh-list
5925805|NCT04915963|Vitamins|vitamins|mesh-ancestor
5925806|NCT04915963|Micronutrients|micronutrients|mesh-ancestor
5925807|NCT04915963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925808|NCT04915963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5925809|NCT04915807|Paclitaxel|paclitaxel|mesh-list
5925810|NCT04915807|Irinotecan|irinotecan|mesh-list
6517047|NCT00719459|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6517048|NCT00719459|Trace Elements|trace elements|mesh-ancestor
6517049|NCT00719459|Micronutrients|micronutrients|mesh-ancestor
6517050|NCT00719459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517051|NCT00719459|Hematinics|hematinics|mesh-ancestor
6517052|NCT00719602|Ritonavir|ritonavir|mesh-list
6517053|NCT00719602|Lopinavir|lopinavir|mesh-list
6517054|NCT00719602|Lamivudine|lamivudine|mesh-list
6517055|NCT00719602|Zidovudine|zidovudine|mesh-list
6517056|NCT00719602|Nevirapine|nevirapine|mesh-list
6517057|NCT00719602|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6517058|NCT00719602|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6517059|NCT00719602|Protease Inhibitors|protease inhibitors|mesh-ancestor
6517060|NCT00719602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6517061|NCT00719602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517062|NCT00719602|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6517063|NCT00719602|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6517064|NCT00719602|Antiviral Agents|antiviral agents|mesh-ancestor
6517065|NCT00719602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6517066|NCT00719602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6517067|NCT00719602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6517068|NCT00719602|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6517069|NCT00719602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6517070|NCT00719602|Antimetabolites|antimetabolites|mesh-ancestor
6517071|NCT00719602|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6517072|NCT00719602|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5925811|NCT04915807|Ramucirumab|ramucirumab|mesh-list
5925812|NCT04915807|Taxane|taxane|mesh-list
5925813|NCT04915807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5925814|NCT04915807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5925815|NCT04915807|Tubulin Modulators|tubulin modulators|mesh-ancestor
5925816|NCT04915807|Antimitotic Agents|antimitotic agents|mesh-ancestor
5925817|NCT04915807|Mitosis Modulators|mitosis modulators|mesh-ancestor
5925818|NCT04915807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925819|NCT04915807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5925820|NCT04915807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5925821|NCT04915807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5925822|NCT04915508|Hormones|hormones|mesh-list
5925823|NCT04915508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5925824|NCT04915508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925825|NCT04915612|Cytarabine|cytarabine|mesh-list
5925826|NCT04915612|Daunorubicin|daunorubicin|mesh-list
5925827|NCT04915612|Gemtuzumab|gemtuzumab|mesh-list
5925828|NCT04915612|Calicheamicins|calicheamicins|mesh-list
5925829|NCT04915612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5925830|NCT04915612|Antimetabolites|antimetabolites|mesh-ancestor
5925831|NCT04915612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925832|NCT04915612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5925833|NCT04915612|Antiviral Agents|antiviral agents|mesh-ancestor
5925834|NCT04915612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5925835|NCT04915612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5925836|NCT04915612|Immunologic Factors|immunologic factors|mesh-ancestor
5925837|NCT04915612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925838|NCT04915612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5925839|NCT04915612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5925840|NCT04915612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5925841|NCT04915612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5925842|NCT04915612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5925843|NCT04915586|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5925844|NCT04915586|Plasminogen|plasminogen|mesh-list
5925845|NCT04915586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5925846|NCT04915586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5925847|NCT04915586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925848|NCT04915482|Rituximab|rituximab|mesh-list
5925849|NCT04915482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5925850|NCT04915482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5925851|NCT04915482|Immunologic Factors|immunologic factors|mesh-ancestor
5925852|NCT04915482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925853|NCT04915482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5925854|NCT04915365|Acetazolamide|acetazolamide|mesh-list
5925855|NCT04915365|Anticonvulsants|anticonvulsants|mesh-ancestor
5925856|NCT04915365|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5925857|NCT04915365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5925858|NCT04915365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925859|NCT04915365|Diuretics|diuretics|mesh-ancestor
6517073|NCT00719693|Calcium, Dietary|calcium, dietary|mesh-list
5925860|NCT04915365|Natriuretic Agents|natriuretic agents|mesh-ancestor
5925861|NCT04915365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925862|NCT04915287|Maleic acid|maleic acid|mesh-list
5925863|NCT04915287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5925864|NCT04915287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925865|NCT04915456|Prednisolone|prednisolone|mesh-list
5925866|NCT04915456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5925867|NCT04915456|Glucocorticoids|glucocorticoids|mesh-ancestor
5925868|NCT04915456|Hormones|hormones|mesh-ancestor
5925869|NCT04915456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5925870|NCT04915456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925871|NCT04915456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5925872|NCT04915456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5925873|NCT04914962|Lithium Carbonate|lithium carbonate|mesh-list
5925874|NCT04914962|Antidepressive Agents|antidepressive agents|mesh-ancestor
5925875|NCT04914962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5925876|NCT04914962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5925877|NCT04914962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925878|NCT04914962|Antimanic Agents|antimanic agents|mesh-ancestor
5925879|NCT04914962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5925880|NCT04914962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5925881|NCT04914962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925882|NCT04914793|Anti-Infective Agents|anti-infective agents|mesh-list
5925883|NCT04914793|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5925884|NCT04914910|Insulin|insulin|mesh-list
5925885|NCT04914910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5925886|NCT04914910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925887|NCT04914936|Rifampin|rifampin|mesh-list
5925888|NCT04914936|Acalabrutinib|acalabrutinib|mesh-list
5925889|NCT04914936|Omeprazole|omeprazole|mesh-list
5925890|NCT04914936|Calcium Carbonate|calcium carbonate|mesh-list
5925891|NCT04914936|Calcium|calcium|mesh-list
5925892|NCT04914936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5925893|NCT04914936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925894|NCT04914936|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5925895|NCT04914936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5925896|NCT04914936|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5925897|NCT04914936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5925898|NCT04914936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925899|NCT04914936|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5925900|NCT04914936|Antitubercular Agents|antitubercular agents|mesh-ancestor
5925901|NCT04914936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5925902|NCT04914936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5925903|NCT04914936|Leprostatic Agents|leprostatic agents|mesh-ancestor
5925904|NCT04914936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5925905|NCT04914936|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5925906|NCT04914936|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5925907|NCT04914936|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5925908|NCT04914936|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5925909|NCT04914936|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5925910|NCT04914936|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5925911|NCT04914936|Antacids|antacids|mesh-ancestor
5925912|NCT04914936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5925913|NCT04914390|Paclitaxel|paclitaxel|mesh-list
5925914|NCT04914390|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5925915|NCT04914390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5925916|NCT04914390|Tubulin Modulators|tubulin modulators|mesh-ancestor
5925917|NCT04914390|Antimitotic Agents|antimitotic agents|mesh-ancestor
5925918|NCT04914390|Mitosis Modulators|mitosis modulators|mesh-ancestor
5925919|NCT04914390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965224|NCT04585334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5965225|NCT04585334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965226|NCT04585334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5965227|NCT04585334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5965228|NCT04585334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5965229|NCT04585334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5965230|NCT04585334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965231|NCT04585542|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
5965232|NCT04585542|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
5965233|NCT04585542|Laxatives|laxatives|mesh-ancestor
5965234|NCT04585542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5965235|NCT04585542|Chelating Agents|chelating agents|mesh-ancestor
5965236|NCT04585542|Sequestering Agents|sequestering agents|mesh-ancestor
5970769|NCT04532684|Pregabalin|pregabalin|mesh-list
5925920|NCT04914598|Cisplatin|cisplatin|mesh-list
5925921|NCT04914598|Endostar protein|endostar protein|mesh-list
5925922|NCT04914598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5925923|NCT04914598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5925924|NCT04914598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5925925|NCT04914598|Growth Substances|growth substances|mesh-ancestor
5925926|NCT04914598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925927|NCT04914598|Growth Inhibitors|growth inhibitors|mesh-ancestor
5925928|NCT04913987|Cimetidine|cimetidine|mesh-list
5925929|NCT04913987|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5925930|NCT04913987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5925931|NCT04913987|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5925932|NCT04913987|Histamine Antagonists|histamine antagonists|mesh-ancestor
5925933|NCT04913987|Histamine Agents|histamine agents|mesh-ancestor
5925934|NCT04913987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5925935|NCT04913987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925936|NCT04913987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925937|NCT04913987|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5925938|NCT04913987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5925939|NCT04913987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5925940|NCT04914247|Selexipag|selexipag|mesh-list
5925941|NCT04914247|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5925942|NCT04913896|Oxaliplatin|oxaliplatin|mesh-list
5925943|NCT04913896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5925944|NCT04913896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5925945|NCT04913896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925946|NCT04913714|Vaccines|vaccines|mesh-list
5925947|NCT04913714|Immunologic Factors|immunologic factors|mesh-ancestor
5925948|NCT04913714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925949|NCT04913831|Cerebrolysin|cerebrolysin|mesh-list
5925950|NCT04913831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5925951|NCT04913831|Protective Agents|protective agents|mesh-ancestor
5925952|NCT04913831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925953|NCT04913831|Nootropic Agents|nootropic agents|mesh-ancestor
5925954|NCT04913610|Ivermectin|ivermectin|mesh-list
5925955|NCT04913610|Albendazole|albendazole|mesh-list
5925956|NCT04913610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5925957|NCT04913610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5925958|NCT04913610|Anthelmintics|anthelmintics|mesh-ancestor
5925959|NCT04913610|Anticestodal Agents|anticestodal agents|mesh-ancestor
5925960|NCT04913610|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5925961|NCT04913610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5925962|NCT04913610|Tubulin Modulators|tubulin modulators|mesh-ancestor
5925963|NCT04913610|Antimitotic Agents|antimitotic agents|mesh-ancestor
5925964|NCT04913610|Mitosis Modulators|mitosis modulators|mesh-ancestor
5925965|NCT04913610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925966|NCT04913610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5925967|NCT04913480|Durvalumab|durvalumab|mesh-list
5925968|NCT04913480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5925969|NCT04913480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5925970|NCT04913922|Nivolumab|nivolumab|mesh-list
5925971|NCT04913922|Azacitidine|azacitidine|mesh-list
5925972|NCT04913922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5925973|NCT04913922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5925974|NCT04913922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5925975|NCT04913922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925976|NCT04913922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5925977|NCT04913922|Antimetabolites|antimetabolites|mesh-ancestor
5925978|NCT04913922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5925979|NCT04913389|Acetazolamide|acetazolamide|mesh-list
5925980|NCT04913389|Anticonvulsants|anticonvulsants|mesh-ancestor
5925981|NCT04913389|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5925982|NCT04913389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5925983|NCT04913389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5925984|NCT04913389|Diuretics|diuretics|mesh-ancestor
5925985|NCT04913389|Natriuretic Agents|natriuretic agents|mesh-ancestor
5925986|NCT04913389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925987|NCT04913402|Sufentanil|sufentanil|mesh-list
5925988|NCT04913402|Dsuvia|dsuvia|mesh-list
5925989|NCT04913402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5925990|NCT04913402|Narcotics|narcotics|mesh-ancestor
5925991|NCT04913402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5925992|NCT04913402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5925993|NCT04913402|Analgesics|analgesics|mesh-ancestor
5925994|NCT04913402|Sensory System Agents|sensory system agents|mesh-ancestor
5925995|NCT04913402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5925996|NCT04913402|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5925997|NCT04913402|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5925998|NCT04913402|Anesthetics, General|anesthetics, general|mesh-ancestor
5925999|NCT04913402|Anesthetics|anesthetics|mesh-ancestor
5926000|NCT04913103|Rituximab|rituximab|mesh-list
5926001|NCT04913103|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5926002|NCT04913103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5926003|NCT04913103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5926004|NCT04913103|Immunologic Factors|immunologic factors|mesh-ancestor
5926005|NCT04913103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926006|NCT04913103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5926007|NCT04913103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5926008|NCT04913103|Alkylating Agents|alkylating agents|mesh-ancestor
5926009|NCT04913103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681131|NCT01608334|Narcotics|narcotics|mesh-ancestor
6681132|NCT01608334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6681133|NCT01608334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926010|NCT04912934|Insulin|insulin|mesh-list
5926011|NCT04912934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5926012|NCT04912934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926013|NCT04913311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5926014|NCT04913311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926015|NCT04913311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5926016|NCT04912700|Vaccines|vaccines|mesh-list
5926017|NCT04912700|Immunologic Factors|immunologic factors|mesh-ancestor
5926018|NCT04912700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965237|NCT04585542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965238|NCT04585477|Durvalumab|durvalumab|mesh-list
5965239|NCT04585477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5965240|NCT04585477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5965241|NCT04585412|Palonosetron|palonosetron|mesh-list
5965242|NCT04585412|Antiemetics|antiemetics|mesh-ancestor
5965243|NCT04585412|Autonomic Agents|autonomic agents|mesh-ancestor
5965244|NCT04585412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5965245|NCT04585412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965246|NCT04585412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5965247|NCT04585412|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5965248|NCT04585412|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5965249|NCT04585412|Serotonin Agents|serotonin agents|mesh-ancestor
5965250|NCT04585412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5965251|NCT04585412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965252|NCT04585438|Diclofenac|diclofenac|mesh-list
5965253|NCT04585438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5965254|NCT04585438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5965255|NCT04585438|Analgesics|analgesics|mesh-ancestor
6517074|NCT00719693|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6517075|NCT00719693|Fenofibric acid|fenofibric acid|mesh-list
6517076|NCT00719693|Fenofibrate|fenofibrate|mesh-list
6517077|NCT00719693|Calcium|calcium|mesh-list
6681134|NCT01608334|Analgesics|analgesics|mesh-ancestor
6681135|NCT01608334|Sensory System Agents|sensory system agents|mesh-ancestor
6681136|NCT01608334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6681137|NCT01608334|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6681138|NCT01608334|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6681139|NCT01608334|Anesthetics, General|anesthetics, general|mesh-ancestor
6681140|NCT01608334|Anesthetics|anesthetics|mesh-ancestor
6681141|NCT01608347|Folic Acid|folic acid|mesh-list
6681142|NCT01608347|Vitamin B Complex|vitamin b complex|mesh-list
6681143|NCT01608347|Hematinics|hematinics|mesh-ancestor
6681144|NCT01608347|Vitamins|vitamins|mesh-ancestor
6681145|NCT01608347|Micronutrients|micronutrients|mesh-ancestor
6681146|NCT01608347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681147|NCT01608360|Lidocaine|lidocaine|mesh-list
6681148|NCT01608360|Anesthetics, Local|anesthetics, local|mesh-ancestor
6681149|NCT01608360|Anesthetics|anesthetics|mesh-ancestor
6681150|NCT01608360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6681151|NCT01608360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681152|NCT01608360|Sensory System Agents|sensory system agents|mesh-ancestor
6681153|NCT01608360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6681154|NCT01608360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5965256|NCT04585438|Sensory System Agents|sensory system agents|mesh-ancestor
6517078|NCT00719693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6517079|NCT00719693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517080|NCT00719693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6517081|NCT00719693|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6517082|NCT00719693|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5926019|NCT04912765|Nivolumab|nivolumab|mesh-list
5926020|NCT04912765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5926021|NCT04912765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5926022|NCT04912765|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5926023|NCT04912765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926024|NCT04912726|Sildenafil Citrate|sildenafil citrate|mesh-list
5926025|NCT04912726|Vasodilator Agents|vasodilator agents|mesh-ancestor
5926026|NCT04912726|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5926027|NCT04912726|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5926028|NCT04912726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5926029|NCT04912726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926030|NCT04912726|Urological Agents|urological agents|mesh-ancestor
5926031|NCT04912596|Albuterol|albuterol|mesh-list
5926032|NCT04912596|Procaterol|procaterol|mesh-list
5926033|NCT04912596|Methacholine Chloride|methacholine chloride|mesh-list
5926034|NCT04912596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5926035|NCT04912596|Autonomic Agents|autonomic agents|mesh-ancestor
5926036|NCT04912596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5926037|NCT04912596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926038|NCT04912596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5926039|NCT04912596|Respiratory System Agents|respiratory system agents|mesh-ancestor
5926040|NCT04912596|Tocolytic Agents|tocolytic agents|mesh-ancestor
5926041|NCT04912596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5926042|NCT04912596|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5926043|NCT04912596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5926044|NCT04912596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5926045|NCT04912596|Adrenergic Agents|adrenergic agents|mesh-ancestor
5926046|NCT04912596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5926047|NCT04912596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926048|NCT04912596|Miotics|miotics|mesh-ancestor
5926049|NCT04912596|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5926050|NCT04912596|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
5926051|NCT04912596|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
5926052|NCT04912596|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5926053|NCT04912596|Cholinergic Agents|cholinergic agents|mesh-ancestor
5926054|NCT04912596|Sympathomimetics|sympathomimetics|mesh-ancestor
5926055|NCT04912167|Valsartan|valsartan|mesh-list
5926056|NCT04912167|Enalapril|enalapril|mesh-list
5926057|NCT04912167|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5926058|NCT04912167|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5926059|NCT04912167|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5926060|NCT04912167|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5926061|NCT04912167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926062|NCT04912167|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5926063|NCT04912167|Protease Inhibitors|protease inhibitors|mesh-ancestor
5926064|NCT04912167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5926065|NCT04912271|Dexamethasone|dexamethasone|mesh-list
5926066|NCT04912271|Aprepitant|aprepitant|mesh-list
5926067|NCT04912271|Fosaprepitant|fosaprepitant|mesh-list
5926068|NCT04912271|Palonosetron|palonosetron|mesh-list
5926069|NCT04912271|Granisetron|granisetron|mesh-list
5926070|NCT04912271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5926071|NCT04912271|Antiemetics|antiemetics|mesh-ancestor
5926072|NCT04912271|Autonomic Agents|autonomic agents|mesh-ancestor
5926073|NCT04912271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5926074|NCT04912271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926075|NCT04912271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5926076|NCT04912271|Glucocorticoids|glucocorticoids|mesh-ancestor
5926077|NCT04912271|Hormones|hormones|mesh-ancestor
5926078|NCT04912271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5926079|NCT04912271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5926080|NCT04912271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5926081|NCT04912271|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5926082|NCT04912271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5926083|NCT04912271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926084|NCT04912271|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5926085|NCT04912271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5926086|NCT04912271|Serotonin Agents|serotonin agents|mesh-ancestor
5926087|NCT04912193|Antithrombins|antithrombins|mesh-list
5926088|NCT04912193|Antithrombin III|antithrombin iii|mesh-list
5926089|NCT04912193|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5926090|NCT04912193|Protease Inhibitors|protease inhibitors|mesh-ancestor
5926091|NCT04912193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5926092|NCT04912193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926093|NCT04912193|Anticoagulants|anticoagulants|mesh-ancestor
5926094|NCT04912258|Irinotecan|irinotecan|mesh-list
5926095|NCT04912258|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5926096|NCT04912258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5926097|NCT04912258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5926098|NCT04912258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926099|NCT04912258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5926100|NCT04912492|Ethanol|ethanol|mesh-list
5926101|NCT04912492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5926102|NCT04912492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5926103|NCT04912492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5926104|NCT04912492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926105|NCT04912297|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5926106|NCT04912297|Immunologic Factors|immunologic factors|mesh-ancestor
5926107|NCT04912297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926108|NCT04912128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
5926109|NCT04912128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5926110|NCT04912128|Growth Substances|growth substances|mesh-ancestor
5926111|NCT04912128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926112|NCT04912128|Growth Inhibitors|growth inhibitors|mesh-ancestor
5926113|NCT04912128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5926114|NCT04911959|Lenvatinib|lenvatinib|mesh-list
5926115|NCT04911959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5926116|NCT04911959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5926117|NCT04911959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5926118|NCT04911959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926119|NCT04912141|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
5926120|NCT04912141|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5926121|NCT04912141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5926122|NCT04912141|Immunologic Factors|immunologic factors|mesh-ancestor
5926123|NCT04912141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926124|NCT04912011|Canrenoic Acid|canrenoic acid|mesh-list
5926125|NCT04912011|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5926126|NCT04912011|Hormone Antagonists|hormone antagonists|mesh-ancestor
5926127|NCT04912011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5926128|NCT04912011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926129|NCT04912011|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5926130|NCT04912011|Diuretics|diuretics|mesh-ancestor
5926131|NCT04912011|Natriuretic Agents|natriuretic agents|mesh-ancestor
5926132|NCT04911621|Temozolomide|temozolomide|mesh-list
5926133|NCT04911621|Vaccines|vaccines|mesh-list
5926134|NCT04911621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5926135|NCT04911621|Alkylating Agents|alkylating agents|mesh-ancestor
5926136|NCT04911621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926137|NCT04911621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5926138|NCT04911621|Immunologic Factors|immunologic factors|mesh-ancestor
5926139|NCT04911621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926140|NCT04911816|Hydroxychloroquine|hydroxychloroquine|mesh-list
5926141|NCT04911816|Antimalarials|antimalarials|mesh-ancestor
5926142|NCT04911816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5926143|NCT04911816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5926144|NCT04911816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5926145|NCT04911816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5926146|NCT04911816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926147|NCT04911816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5926148|NCT04911127|Cannabidiol|cannabidiol|mesh-list
5926149|NCT04911127|Anticonvulsants|anticonvulsants|mesh-ancestor
5926150|NCT04911413|Tranexamic Acid|tranexamic acid|mesh-list
5926151|NCT04911413|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5926152|NCT04911413|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5926153|NCT04911413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926154|NCT04911413|Hemostatics|hemostatics|mesh-ancestor
5926155|NCT04911413|Coagulants|coagulants|mesh-ancestor
5965257|NCT04585438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5965258|NCT04585438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965259|NCT04585438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5965260|NCT04585438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5965261|NCT04585438|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5965262|NCT04585438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5965263|NCT04585438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965264|NCT04585321|Diclofenac|diclofenac|mesh-list
5965265|NCT04585321|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
5965266|NCT04585321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5926156|NCT04910711|Dolutegravir|dolutegravir|mesh-list
5926157|NCT04910711|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
5926158|NCT04910711|Levonorgestrel|levonorgestrel|mesh-list
5926159|NCT04910711|Medroxyprogesterone|medroxyprogesterone|mesh-list
5926160|NCT04910711|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5926161|NCT04910711|Contraceptive Agents|contraceptive agents|mesh-ancestor
5926162|NCT04910711|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5926163|NCT04910711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926164|NCT04910711|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5926165|NCT04910711|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5926166|NCT04910711|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5926167|NCT04910711|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5926168|NCT04910711|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5926169|NCT04910711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5926170|NCT04910711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926171|NCT04910711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5926172|NCT04910711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5926173|NCT04910711|Antiviral Agents|antiviral agents|mesh-ancestor
5926174|NCT04910711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5926175|NCT04910711|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5926176|NCT04910711|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5926177|NCT04910711|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5926178|NCT04910711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5926179|NCT04910815|Rifaximin|rifaximin|mesh-list
5926180|NCT04910815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5926181|NCT04910815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5926182|NCT04910815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5926183|NCT04910477|Atropine|atropine|mesh-list
5926184|NCT04910477|Dexmedetomidine|dexmedetomidine|mesh-list
5926185|NCT04910477|Neostigmine|neostigmine|mesh-list
5926186|NCT04910477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5926187|NCT04910477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5926188|NCT04910477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926189|NCT04910477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5926190|NCT04910477|Analgesics|analgesics|mesh-ancestor
5926191|NCT04910477|Sensory System Agents|sensory system agents|mesh-ancestor
5926192|NCT04910477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5926193|NCT04910477|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5926194|NCT04910477|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5719000|NCT03221426|Protective Agents|protective agents|mesh-ancestor
5719001|NCT03221426|Vitamin B Complex|vitamin b complex|mesh-ancestor
5719002|NCT03221426|Vitamins|vitamins|mesh-ancestor
5719003|NCT03221426|Micronutrients|micronutrients|mesh-ancestor
5719004|NCT03221582|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
5719005|NCT03221582|Antiviral Agents|antiviral agents|mesh-ancestor
5719006|NCT03221582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5719007|NCT03221634|Pembrolizumab|pembrolizumab|mesh-list
5719008|NCT03221634|Daratumumab|daratumumab|mesh-list
5719009|NCT03221634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5719010|NCT03221634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5719011|NCT03221140|Anti-Infective Agents|anti-infective agents|mesh-list
5719012|NCT03221140|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5719013|NCT03221166|Thalidomide|thalidomide|mesh-list
5719014|NCT03221166|Infliximab|infliximab|mesh-list
5719015|NCT03221166|Dermatologic Agents|dermatologic agents|mesh-ancestor
5719016|NCT03221166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5719017|NCT03221166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5719018|NCT03221166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5719019|NCT03221166|Immunologic Factors|immunologic factors|mesh-ancestor
5719020|NCT03221166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926195|NCT04910477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5926196|NCT04910477|Adrenergic Agents|adrenergic agents|mesh-ancestor
5926197|NCT04910477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5926198|NCT04910477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926199|NCT04910477|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5926200|NCT04910477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5926201|NCT04910477|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5926202|NCT04910477|Autonomic Agents|autonomic agents|mesh-ancestor
5926203|NCT04910477|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5926204|NCT04910477|Respiratory System Agents|respiratory system agents|mesh-ancestor
5926205|NCT04910477|Mydriatics|mydriatics|mesh-ancestor
5926206|NCT04910477|Parasympatholytics|parasympatholytics|mesh-ancestor
5926207|NCT04910477|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5926208|NCT04910477|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5926209|NCT04910477|Cholinergic Agents|cholinergic agents|mesh-ancestor
5719021|NCT03221166|Leprostatic Agents|leprostatic agents|mesh-ancestor
5719022|NCT03221166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5926210|NCT04910477|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5926211|NCT04910477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5926212|NCT04910477|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5926213|NCT04910347|Nivolumab|nivolumab|mesh-list
5926214|NCT04910347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5926215|NCT04910347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5926216|NCT04910347|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5926217|NCT04910347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926218|NCT04910386|Gemcitabine|gemcitabine|mesh-list
5926219|NCT04910386|Cisplatin|cisplatin|mesh-list
5926220|NCT04910386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5926221|NCT04910386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5926222|NCT04910386|Antimetabolites|antimetabolites|mesh-ancestor
5926223|NCT04910386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926224|NCT04910386|Antiviral Agents|antiviral agents|mesh-ancestor
5926225|NCT04910386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5926226|NCT04910386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5719023|NCT03221166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5719024|NCT03221166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5719025|NCT03221166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5719026|NCT03221166|Growth Substances|growth substances|mesh-ancestor
5719027|NCT03221166|Growth Inhibitors|growth inhibitors|mesh-ancestor
5719028|NCT03221166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5722161|NCT03200847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5722162|NCT03200847|Keratolytic Agents|keratolytic agents|mesh-ancestor
5722163|NCT03200847|Dermatologic Agents|dermatologic agents|mesh-ancestor
5722164|NCT03200808|Methylene Blue|methylene blue|mesh-list
5722165|NCT03200808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5926227|NCT04910386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5926228|NCT04910386|Immunologic Factors|immunologic factors|mesh-ancestor
5926229|NCT04910386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926230|NCT04910464|Tranexamic Acid|tranexamic acid|mesh-list
5926231|NCT04910464|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5926232|NCT04910464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5926233|NCT04910464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926234|NCT04910464|Hemostatics|hemostatics|mesh-ancestor
5926235|NCT04910464|Coagulants|coagulants|mesh-ancestor
5926236|NCT04910698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5926237|NCT04910698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5926238|NCT04910594|Epoetin Alfa|epoetin alfa|mesh-list
5926239|NCT04910594|Hematinics|hematinics|mesh-ancestor
5926240|NCT04910425|Fluorides|fluorides|mesh-list
5926241|NCT04910425|Cariostatic Agents|cariostatic agents|mesh-ancestor
5926242|NCT04910425|Protective Agents|protective agents|mesh-ancestor
5926243|NCT04910425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926244|NCT04910022|Lomustine|lomustine|mesh-list
5926245|NCT04910022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5926246|NCT04910022|Alkylating Agents|alkylating agents|mesh-ancestor
5926247|NCT04910022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926248|NCT04910022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5926249|NCT04910100|Timolol|timolol|mesh-list
5926250|NCT04910100|Nebivolol|nebivolol|mesh-list
5926251|NCT04910100|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5926252|NCT04910100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5926253|NCT04910100|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5926254|NCT04910100|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5926255|NCT04910100|Adrenergic Agents|adrenergic agents|mesh-ancestor
5926256|NCT04910100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5926257|NCT04910100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926258|NCT04910100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926259|NCT04910100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5926260|NCT04910100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5926261|NCT04910100|Vasodilator Agents|vasodilator agents|mesh-ancestor
5926262|NCT04910100|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5926263|NCT04910100|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5926264|NCT04910100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5926265|NCT04910126|Doxorubicin|doxorubicin|mesh-list
5926266|NCT04910126|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5926267|NCT04910126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5926268|NCT04910126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5926269|NCT04910126|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6681155|NCT01608360|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6681156|NCT01608360|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6681157|NCT01608360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6779933|NCT02181543|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5926270|NCT04910126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5926271|NCT04910126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5926272|NCT04910126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926273|NCT04910178|Empagliflozin|empagliflozin|mesh-list
5926274|NCT04910178|Pentoxifylline|pentoxifylline|mesh-list
5926275|NCT04910178|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
5926276|NCT04910178|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5926277|NCT04910178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926278|NCT04910178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5926279|NCT04910178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926280|NCT04910178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5926281|NCT04910178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5926282|NCT04910178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5926283|NCT04910178|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5926284|NCT04910178|Protective Agents|protective agents|mesh-ancestor
5926285|NCT04910178|Vasodilator Agents|vasodilator agents|mesh-ancestor
5926286|NCT04910178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5926287|NCT04910178|Antioxidants|antioxidants|mesh-ancestor
5926288|NCT04910178|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5926289|NCT04910178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5926290|NCT04910165|Ropivacaine|ropivacaine|mesh-list
5926291|NCT04910165|Anesthetics, Local|anesthetics, local|mesh-ancestor
5926292|NCT04910165|Anesthetics|anesthetics|mesh-ancestor
5926293|NCT04910165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5926294|NCT04910165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926295|NCT04910165|Sensory System Agents|sensory system agents|mesh-ancestor
5926296|NCT04910165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5926297|NCT04909931|Vitamin D|vitamin d|mesh-list
5926298|NCT04909931|Ergocalciferols|ergocalciferols|mesh-list
5926299|NCT04909931|Vitamins|vitamins|mesh-ancestor
5926300|NCT04909931|Micronutrients|micronutrients|mesh-ancestor
5926301|NCT04909931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926302|NCT04909931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5926303|NCT04909931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5926304|NCT04909918|Dexamethasone|dexamethasone|mesh-list
5926305|NCT04909918|Methylprednisolone|methylprednisolone|mesh-list
5926306|NCT04909918|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5926307|NCT04909918|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5926308|NCT04909918|Prednisolone|prednisolone|mesh-list
5926309|NCT04909918|Prednisolone acetate|prednisolone acetate|mesh-list
5926310|NCT04909918|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5926311|NCT04909918|Prednisolone phosphate|prednisolone phosphate|mesh-list
5926312|NCT04909918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5926313|NCT04909918|Antiemetics|antiemetics|mesh-ancestor
5926314|NCT04909918|Autonomic Agents|autonomic agents|mesh-ancestor
5926315|NCT04909918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5926316|NCT04909918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926317|NCT04909918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5926318|NCT04909918|Glucocorticoids|glucocorticoids|mesh-ancestor
5926319|NCT04909918|Hormones|hormones|mesh-ancestor
5926320|NCT04909918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5926321|NCT04909918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5926322|NCT04909918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5926323|NCT04909918|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5926324|NCT04909918|Protective Agents|protective agents|mesh-ancestor
5926325|NCT04909684|Pembrolizumab|pembrolizumab|mesh-list
5926326|NCT04909684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5926327|NCT04909684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5926328|NCT04909697|Sivelestat|sivelestat|mesh-list
5926329|NCT04909697|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5926330|NCT04909697|Protease Inhibitors|protease inhibitors|mesh-ancestor
5926331|NCT04909697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5926332|NCT04909697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926333|NCT04909619|Anesthetics|anesthetics|mesh-list
5926334|NCT04909619|Anesthetics, Local|anesthetics, local|mesh-list
5926335|NCT04909619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5926336|NCT04909619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926337|NCT04909619|Sensory System Agents|sensory system agents|mesh-ancestor
5926338|NCT04909619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5926339|NCT04909775|Gemcitabine|gemcitabine|mesh-list
5926340|NCT04909775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5926341|NCT04909775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5926342|NCT04909775|Antimetabolites|antimetabolites|mesh-ancestor
5926343|NCT04909775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926344|NCT04909775|Antiviral Agents|antiviral agents|mesh-ancestor
5926345|NCT04909775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5719029|NCT03221231|Acetylcysteine|acetylcysteine|mesh-list
5719030|NCT03221231|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5719031|NCT03221231|Antiviral Agents|antiviral agents|mesh-ancestor
5719032|NCT03221231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5719033|NCT03221231|Expectorants|expectorants|mesh-ancestor
5719034|NCT03221231|Respiratory System Agents|respiratory system agents|mesh-ancestor
5719035|NCT03221231|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5719036|NCT03221231|Antioxidants|antioxidants|mesh-ancestor
5926346|NCT04909775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5926347|NCT04909775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5926348|NCT04909775|Immunologic Factors|immunologic factors|mesh-ancestor
5926349|NCT04909775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926350|NCT04909333|Exenatide|exenatide|mesh-list
5926351|NCT04909333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5926352|NCT04909333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5926353|NCT04909333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926354|NCT04909333|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5926355|NCT04909333|Incretins|incretins|mesh-ancestor
5926356|NCT04909333|Hormones|hormones|mesh-ancestor
5926357|NCT04909333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5926358|NCT04908982|Aspirin|aspirin|mesh-list
5926359|NCT04908982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5926360|NCT04908982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5926361|NCT04908982|Analgesics|analgesics|mesh-ancestor
5926362|NCT04908982|Sensory System Agents|sensory system agents|mesh-ancestor
5926363|NCT04908982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5926364|NCT04908982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926365|NCT04908982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5926366|NCT04908982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5926367|NCT04908982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5926368|NCT04908982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5926369|NCT04908982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926370|NCT04908982|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5926371|NCT04908982|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5926372|NCT04908982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5926373|NCT04908982|Antipyretics|antipyretics|mesh-ancestor
5965267|NCT04585321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5965268|NCT04585321|Analgesics|analgesics|mesh-ancestor
5965269|NCT04585321|Sensory System Agents|sensory system agents|mesh-ancestor
5965270|NCT04585321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5965271|NCT04585321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965272|NCT04585321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5965273|NCT04585321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5965274|NCT04585321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5965275|NCT04585321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5965276|NCT04585321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965277|NCT04585230|Mineral Oil|mineral oil|mesh-list
5965278|NCT04585230|Emollients|emollients|mesh-ancestor
5965279|NCT04585230|Dermatologic Agents|dermatologic agents|mesh-ancestor
5965280|NCT04585152|Rituximab|rituximab|mesh-list
5965281|NCT04585152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5965282|NCT04585152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5965283|NCT04585152|Immunologic Factors|immunologic factors|mesh-ancestor
5965284|NCT04585152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965285|NCT04585152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5965286|NCT04584983|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
5965287|NCT04584983|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
5965288|NCT04584983|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5965289|NCT04584983|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5965290|NCT04585022|Cimetidine|cimetidine|mesh-list
5965291|NCT04585022|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5965292|NCT04585022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5965293|NCT04585022|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5965294|NCT04585022|Histamine Antagonists|histamine antagonists|mesh-ancestor
5965295|NCT04585022|Histamine Agents|histamine agents|mesh-ancestor
5965296|NCT04585022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5965297|NCT04585022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965298|NCT04585022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965299|NCT04585022|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5965300|NCT04585022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5965301|NCT04585022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5965302|NCT04584515|Itraconazole|itraconazole|mesh-list
5965303|NCT04584515|Rifampin|rifampin|mesh-list
6517083|NCT00719693|Antimetabolites|antimetabolites|mesh-ancestor
5719037|NCT03221231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719038|NCT03221231|Protective Agents|protective agents|mesh-ancestor
5719039|NCT03221231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719040|NCT03221231|Antidotes|antidotes|mesh-ancestor
5719041|NCT03221621|Adalimumab|adalimumab|mesh-list
5719042|NCT03221621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5719043|NCT03221621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5719044|NCT03221023|Vancomycin|vancomycin|mesh-list
5719045|NCT03221023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5719046|NCT03221023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5719047|NCT03220932|Bevacizumab|bevacizumab|mesh-list
5719048|NCT03220932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5719049|NCT03220932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5719050|NCT03220932|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5719051|NCT03220932|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5719052|NCT03220932|Growth Substances|growth substances|mesh-ancestor
5719053|NCT03220932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719054|NCT03220932|Growth Inhibitors|growth inhibitors|mesh-ancestor
5719055|NCT03221036|Vedolizumab|vedolizumab|mesh-list
5719056|NCT03221036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5719057|NCT03220815|Methamphetamine|methamphetamine|mesh-list
5719058|NCT03220815|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5719059|NCT03220815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719060|NCT03220815|Sympathomimetics|sympathomimetics|mesh-ancestor
5719061|NCT03220815|Autonomic Agents|autonomic agents|mesh-ancestor
5926374|NCT04909073|Afatinib|afatinib|mesh-list
5926375|NCT04909073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5926376|NCT04909073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5926377|NCT04909073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5926378|NCT04909073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926379|NCT04909255|Solifenacin Succinate|solifenacin succinate|mesh-list
5926380|NCT04909255|Mirabegron|mirabegron|mesh-list
5926381|NCT04909255|Tolterodine Tartrate|tolterodine tartrate|mesh-list
5926382|NCT04909255|Oxybutynin|oxybutynin|mesh-list
5926383|NCT04909255|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5926384|NCT04909255|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5926385|NCT04909255|Cholinergic Agents|cholinergic agents|mesh-ancestor
5926386|NCT04909255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5926387|NCT04909255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926388|NCT04909255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926389|NCT04909255|Urological Agents|urological agents|mesh-ancestor
5926390|NCT04909255|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
5926391|NCT04909255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5926392|NCT04909255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5926393|NCT04909255|Adrenergic Agents|adrenergic agents|mesh-ancestor
5926394|NCT04909255|Parasympatholytics|parasympatholytics|mesh-ancestor
5926395|NCT04909255|Autonomic Agents|autonomic agents|mesh-ancestor
5926396|NCT04909255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5926397|NCT04909151|Methamphetamine|methamphetamine|mesh-list
5926398|NCT04909151|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5926399|NCT04909151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926400|NCT04909151|Sympathomimetics|sympathomimetics|mesh-ancestor
5926401|NCT04909151|Autonomic Agents|autonomic agents|mesh-ancestor
5926402|NCT04909151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5926403|NCT04909151|Dopamine Agents|dopamine agents|mesh-ancestor
5926404|NCT04909151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5926405|NCT04909151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926406|NCT04909151|Adrenergic Agents|adrenergic agents|mesh-ancestor
5926407|NCT04909151|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5926408|NCT04909151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5926409|NCT04909151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5926410|NCT04909151|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5926411|NCT04908865|Belimumab|belimumab|mesh-list
5926412|NCT04908865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5926413|NCT04908865|Immunologic Factors|immunologic factors|mesh-ancestor
5926414|NCT04908865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926415|NCT04908566|Folfirinox|folfirinox|mesh-list
5926416|NCT04908566|Antibodies|antibodies|mesh-list
5926417|NCT04908566|Immunoglobulins|immunoglobulins|mesh-list
5926418|NCT04908566|Immunologic Factors|immunologic factors|mesh-ancestor
5926419|NCT04908566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926420|NCT04908566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5926421|NCT04908657|Sildenafil Citrate|sildenafil citrate|mesh-list
5926422|NCT04908657|Vasodilator Agents|vasodilator agents|mesh-ancestor
5719062|NCT03220815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5719063|NCT03220815|Dopamine Agents|dopamine agents|mesh-ancestor
5719064|NCT03220815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5965304|NCT04584515|Antifungal Agents|antifungal agents|mesh-ancestor
5926423|NCT04908657|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5926424|NCT04908657|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5926425|NCT04908657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5926426|NCT04908657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926427|NCT04908657|Urological Agents|urological agents|mesh-ancestor
5926428|NCT04908813|Capecitabine|capecitabine|mesh-list
5926429|NCT04908813|Oxaliplatin|oxaliplatin|mesh-list
5926430|NCT04908813|Trastuzumab|trastuzumab|mesh-list
5926431|NCT04908813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6681158|NCT01608360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681159|NCT01608373|Lidocaine|lidocaine|mesh-list
6681160|NCT01608373|Anesthetics, Local|anesthetics, local|mesh-ancestor
6681161|NCT01608373|Anesthetics|anesthetics|mesh-ancestor
6681162|NCT01608373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6681163|NCT01608373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681164|NCT01608373|Sensory System Agents|sensory system agents|mesh-ancestor
6681165|NCT01608373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5926432|NCT04908813|Antimetabolites|antimetabolites|mesh-ancestor
5926433|NCT04908813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926434|NCT04908813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5926435|NCT04908813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5926436|NCT04908228|Obinutuzumab|obinutuzumab|mesh-list
5926437|NCT04908228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5926438|NCT04908228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5926439|NCT04908345|Fentanyl|fentanyl|mesh-list
5926440|NCT04908345|Methadone|methadone|mesh-list
5926441|NCT04908345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5926442|NCT04908345|Narcotics|narcotics|mesh-ancestor
5926443|NCT04908345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5926444|NCT04908345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926445|NCT04908345|Analgesics|analgesics|mesh-ancestor
5926446|NCT04908345|Sensory System Agents|sensory system agents|mesh-ancestor
5926447|NCT04908345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5926448|NCT04908345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5926449|NCT04908345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5926450|NCT04908345|Anesthetics, General|anesthetics, general|mesh-ancestor
5926451|NCT04908345|Anesthetics|anesthetics|mesh-ancestor
5926452|NCT04908345|Antitussive Agents|antitussive agents|mesh-ancestor
5926453|NCT04908345|Respiratory System Agents|respiratory system agents|mesh-ancestor
5926454|NCT04908176|Midazolam|midazolam|mesh-list
5926455|NCT04908176|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5926456|NCT04908176|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5926457|NCT04908176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5926458|NCT04908176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926459|NCT04908176|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5926460|NCT04908176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5926461|NCT04908176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5926462|NCT04908176|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5926463|NCT04908176|Anesthetics, General|anesthetics, general|mesh-ancestor
5926464|NCT04908176|Anesthetics|anesthetics|mesh-ancestor
5926465|NCT04908176|GABA Modulators|gaba modulators|mesh-ancestor
5926466|NCT04908176|GABA Agents|gaba agents|mesh-ancestor
5926467|NCT04908176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5926468|NCT04908176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926469|NCT04907708|Metformin|metformin|mesh-list
5926470|NCT04907708|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5926471|NCT04907708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926472|NCT04907812|Tranexamic Acid|tranexamic acid|mesh-list
5926473|NCT04907812|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5926474|NCT04907812|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5926475|NCT04907812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926476|NCT04907812|Hemostatics|hemostatics|mesh-ancestor
5926477|NCT04907812|Coagulants|coagulants|mesh-ancestor
5926478|NCT04907864|Ibuprofen|ibuprofen|mesh-list
5926479|NCT04907864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5926480|NCT04907864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5926481|NCT04907864|Analgesics|analgesics|mesh-ancestor
5926482|NCT04907864|Sensory System Agents|sensory system agents|mesh-ancestor
5926483|NCT04907864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5926484|NCT04907864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926485|NCT04907864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5926486|NCT04907864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5926487|NCT04907864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5926488|NCT04907864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5926489|NCT04907864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926490|NCT04907721|Glucagon|glucagon|mesh-list
5926491|NCT04907721|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5926492|NCT04907721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5926493|NCT04907721|Hormones|hormones|mesh-ancestor
5926494|NCT04907721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5926495|NCT04907721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926496|NCT04907721|Incretins|incretins|mesh-ancestor
5926497|NCT04907825|Warfarin|warfarin|mesh-list
5926498|NCT04907825|Anticoagulants|anticoagulants|mesh-list
5926499|NCT04907682|Ribavirin|ribavirin|mesh-list
5926500|NCT04907682|Favipiravir|favipiravir|mesh-list
5926501|NCT04907682|Antimetabolites|antimetabolites|mesh-ancestor
5926502|NCT04907682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926503|NCT04907682|Antiviral Agents|antiviral agents|mesh-ancestor
5926504|NCT04907682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5926505|NCT04907838|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
5926506|NCT04907838|BQ 788|bq 788|mesh-list
5926507|NCT04907838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5926508|NCT04907838|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5926509|NCT04907838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926510|NCT04907838|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
5926511|NCT04907474|Phenylephrine|phenylephrine|mesh-list
5926512|NCT04907474|Oxymetazoline|oxymetazoline|mesh-list
5926513|NCT04907474|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5926514|NCT04907474|Tropicamide|tropicamide|mesh-list
5926515|NCT04907474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5926516|NCT04907474|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5926517|NCT04907474|Mydriatics|mydriatics|mesh-ancestor
5926518|NCT04907474|Autonomic Agents|autonomic agents|mesh-ancestor
5926519|NCT04907474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5926520|NCT04907474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926521|NCT04907474|Sympathomimetics|sympathomimetics|mesh-ancestor
5926522|NCT04907474|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5926523|NCT04907474|Nasal Decongestants|nasal decongestants|mesh-ancestor
5926524|NCT04907474|Respiratory System Agents|respiratory system agents|mesh-ancestor
5926525|NCT04907474|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5926526|NCT04907474|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5926527|NCT04907474|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5926528|NCT04907474|Adrenergic Agents|adrenergic agents|mesh-ancestor
5926529|NCT04907474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5926530|NCT04907474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926531|NCT04907474|Protective Agents|protective agents|mesh-ancestor
5926532|NCT04907474|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5926533|NCT04907474|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5926534|NCT04907474|Cholinergic Agents|cholinergic agents|mesh-ancestor
5926535|NCT04907747|Amoxicillin|amoxicillin|mesh-list
5926536|NCT04907747|Furazolidone|furazolidone|mesh-list
5926537|NCT04907747|Esomeprazole|esomeprazole|mesh-list
5926538|NCT04907747|Bismuth|bismuth|mesh-list
5926539|NCT04907747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5926540|NCT04907747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5926541|NCT04907747|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5926542|NCT04907747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5926543|NCT04907747|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5926544|NCT04907747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5926545|NCT04907747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926546|NCT04907747|Antacids|antacids|mesh-ancestor
5926547|NCT04907747|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5926548|NCT04907747|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5926549|NCT04907747|Renal Agents|renal agents|mesh-ancestor
5926550|NCT04907747|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
5926551|NCT04907747|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5926552|NCT04907747|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5926553|NCT04907747|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
5926557|NCT04907279|Aripiprazole|aripiprazole|mesh-list
5926558|NCT04907279|Antidepressive Agents|antidepressive agents|mesh-ancestor
5926559|NCT04907279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5926560|NCT04907279|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5926561|NCT04907279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5926562|NCT04907279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5926563|NCT04907279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926564|NCT04907279|Dopamine Agonists|dopamine agonists|mesh-ancestor
5926565|NCT04907279|Dopamine Agents|dopamine agents|mesh-ancestor
5926566|NCT04907279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5926567|NCT04907279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926568|NCT04907279|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5926569|NCT04907279|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5926570|NCT04907279|Serotonin Agents|serotonin agents|mesh-ancestor
5926571|NCT04907279|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5926572|NCT04907279|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5926573|NCT04907279|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5926574|NCT04907279|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5926575|NCT04907253|Quercetin|quercetin|mesh-list
5926576|NCT04907253|Antioxidants|antioxidants|mesh-ancestor
5926577|NCT04907253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926578|NCT04907253|Protective Agents|protective agents|mesh-ancestor
5926579|NCT04907253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926580|NCT04907123|Diuretics|diuretics|mesh-list
5719065|NCT03220815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719066|NCT03220815|Adrenergic Agents|adrenergic agents|mesh-ancestor
5719067|NCT03220815|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5719068|NCT03220815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5719069|NCT03220815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5719070|NCT03220815|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5719071|NCT03220841|Adalimumab|adalimumab|mesh-list
5719072|NCT03220841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5719073|NCT03220841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5719074|NCT03220880|Dexmedetomidine|dexmedetomidine|mesh-list
5719075|NCT03220880|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5719076|NCT03220880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5719077|NCT03220880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719078|NCT03220880|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5719079|NCT03220880|Analgesics|analgesics|mesh-ancestor
5719080|NCT03220880|Sensory System Agents|sensory system agents|mesh-ancestor
5719081|NCT03220880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5719082|NCT03220880|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5719083|NCT03220880|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5926581|NCT04907123|Natriuretic Agents|natriuretic agents|mesh-ancestor
5926582|NCT04907123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926583|NCT04907149|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5926584|NCT04907084|Fenofibrate|fenofibrate|mesh-list
5926585|NCT04907084|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5926586|NCT04907084|Antimetabolites|antimetabolites|mesh-ancestor
5926587|NCT04907084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926588|NCT04907084|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5926589|NCT04907370|Gemcitabine|gemcitabine|mesh-list
5926590|NCT04907370|Cisplatin|cisplatin|mesh-list
5926591|NCT04907370|Antibodies|antibodies|mesh-list
5926592|NCT04907370|Antibodies, Blocking|antibodies, blocking|mesh-list
5926593|NCT04907370|Immunologic Factors|immunologic factors|mesh-ancestor
5926594|NCT04907370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926595|NCT04907370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5926596|NCT04907370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5926597|NCT04907370|Antimetabolites|antimetabolites|mesh-ancestor
5926598|NCT04907370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926599|NCT04907370|Antiviral Agents|antiviral agents|mesh-ancestor
5926600|NCT04907370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5926601|NCT04907370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5926602|NCT04907370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5926603|NCT04907110|Niacinamide|niacinamide|mesh-list
5926604|NCT04907110|Vitamin B Complex|vitamin b complex|mesh-ancestor
5926605|NCT04907110|Vitamins|vitamins|mesh-ancestor
5926606|NCT04907110|Micronutrients|micronutrients|mesh-ancestor
5926607|NCT04907110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926608|NCT04907071|Coal Tar|coal tar|mesh-list
5926609|NCT04907071|Keratolytic Agents|keratolytic agents|mesh-ancestor
5926610|NCT04907071|Dermatologic Agents|dermatologic agents|mesh-ancestor
5965305|NCT04584515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5965306|NCT04584515|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5965307|NCT04584515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5965308|NCT04584515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5965309|NCT04584515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965310|NCT04584515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5965311|NCT04584515|Hormone Antagonists|hormone antagonists|mesh-ancestor
5965312|NCT04584515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5965313|NCT04584515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965314|NCT04584515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5965315|NCT04584515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5965316|NCT04584515|Antitubercular Agents|antitubercular agents|mesh-ancestor
5926611|NCT04907344|Paclitaxel|paclitaxel|mesh-list
5926612|NCT04907344|Carboplatin|carboplatin|mesh-list
5926613|NCT04907344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5926614|NCT04907344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5926615|NCT04907344|Tubulin Modulators|tubulin modulators|mesh-ancestor
5926616|NCT04907344|Antimitotic Agents|antimitotic agents|mesh-ancestor
5926617|NCT04907344|Mitosis Modulators|mitosis modulators|mesh-ancestor
5926618|NCT04907344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926619|NCT04907019|Rifampin|rifampin|mesh-list
5926620|NCT04907019|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5926621|NCT04907019|Antitubercular Agents|antitubercular agents|mesh-ancestor
5926622|NCT04907019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5926623|NCT04907019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5926624|NCT04907019|Leprostatic Agents|leprostatic agents|mesh-ancestor
5926625|NCT04907019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5926626|NCT04907019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5926627|NCT04907019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926628|NCT04907019|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5926629|NCT04907019|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5926630|NCT04907019|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5926631|NCT04907019|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5926632|NCT04907019|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5926633|NCT04907019|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5926634|NCT04906889|Lidocaine|lidocaine|mesh-list
5926635|NCT04906889|Dexmedetomidine|dexmedetomidine|mesh-list
5926636|NCT04906889|Remifentanil|remifentanil|mesh-list
5926637|NCT04906889|Anesthetics, Local|anesthetics, local|mesh-ancestor
5926638|NCT04906889|Anesthetics|anesthetics|mesh-ancestor
5926639|NCT04906889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5926640|NCT04906889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926641|NCT04906889|Sensory System Agents|sensory system agents|mesh-ancestor
6681166|NCT01608373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6681167|NCT01608373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6681168|NCT01608373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6681169|NCT01608373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6681170|NCT01608373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681171|NCT01608412|Everolimus|everolimus|mesh-list
5926642|NCT04906889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5926643|NCT04906889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5926644|NCT04906889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5926645|NCT04906889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5926646|NCT04906889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5926647|NCT04906889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926648|NCT04906889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5926649|NCT04906889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5926650|NCT04906889|Analgesics|analgesics|mesh-ancestor
5926651|NCT04906889|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5926652|NCT04906889|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5926653|NCT04906889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5926654|NCT04906889|Adrenergic Agents|adrenergic agents|mesh-ancestor
5926655|NCT04906889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5926656|NCT04906889|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5926657|NCT04906889|Narcotics|narcotics|mesh-ancestor
5926658|NCT04906876|Gemcitabine|gemcitabine|mesh-list
5926659|NCT04906876|Docetaxel|docetaxel|mesh-list
5926660|NCT04906876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5926661|NCT04906876|Antimetabolites|antimetabolites|mesh-ancestor
5926662|NCT04906876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926663|NCT04906876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5926664|NCT04906876|Antiviral Agents|antiviral agents|mesh-ancestor
5926665|NCT04906876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5926666|NCT04906876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5926667|NCT04906876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5926668|NCT04906876|Immunologic Factors|immunologic factors|mesh-ancestor
5926669|NCT04906876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926670|NCT04906876|Tubulin Modulators|tubulin modulators|mesh-ancestor
5926671|NCT04906876|Antimitotic Agents|antimitotic agents|mesh-ancestor
5926672|NCT04906876|Mitosis Modulators|mitosis modulators|mesh-ancestor
5926673|NCT04906772|Dexmedetomidine|dexmedetomidine|mesh-list
5926674|NCT04906772|Ketamine|ketamine|mesh-list
5926675|NCT04906772|Propofol|propofol|mesh-list
5926676|NCT04906772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5926677|NCT04906772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5926678|NCT04906772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926679|NCT04906772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5926680|NCT04906772|Anesthetics, General|anesthetics, general|mesh-ancestor
5926681|NCT04906772|Anesthetics|anesthetics|mesh-ancestor
5926682|NCT04906772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5926683|NCT04906772|Analgesics|analgesics|mesh-ancestor
5926684|NCT04906772|Sensory System Agents|sensory system agents|mesh-ancestor
5926685|NCT04906772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5926686|NCT04906772|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5926687|NCT04906772|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5926688|NCT04906772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5926689|NCT04906772|Adrenergic Agents|adrenergic agents|mesh-ancestor
5926690|NCT04906772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5926691|NCT04906772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926692|NCT04906772|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5926693|NCT04906772|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5926694|NCT04906772|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5926695|NCT04906655|Glycopyrrolate|glycopyrrolate|mesh-list
5926696|NCT04906655|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5926697|NCT04906655|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5926698|NCT04906655|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5926699|NCT04906655|Cholinergic Agents|cholinergic agents|mesh-ancestor
5926700|NCT04906655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5926701|NCT04906655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926702|NCT04906655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926703|NCT04906915|Ketamine|ketamine|mesh-list
5926704|NCT04906915|Analgesics|analgesics|mesh-ancestor
5926705|NCT04906915|Sensory System Agents|sensory system agents|mesh-ancestor
5926706|NCT04906915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5926707|NCT04906915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926708|NCT04906915|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5926709|NCT04906915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5926710|NCT04906915|Anesthetics, General|anesthetics, general|mesh-ancestor
5926711|NCT04906915|Anesthetics|anesthetics|mesh-ancestor
5926712|NCT04906915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5926713|NCT04906915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5926714|NCT04906915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5926715|NCT04906915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5926716|NCT04906915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926717|NCT04906720|Colchicine|colchicine|mesh-list
5926718|NCT04906720|Gout Suppressants|gout suppressants|mesh-ancestor
5926719|NCT04906720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5926720|NCT04906720|Tubulin Modulators|tubulin modulators|mesh-ancestor
5926721|NCT04906720|Antimitotic Agents|antimitotic agents|mesh-ancestor
5926722|NCT04906720|Mitosis Modulators|mitosis modulators|mesh-ancestor
5926723|NCT04906720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926724|NCT04906720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5926725|NCT04906317|Midazolam|midazolam|mesh-list
5926726|NCT04906317|Dezocine|dezocine|mesh-list
5926727|NCT04906317|Propofol|propofol|mesh-list
5926728|NCT04906317|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5926729|NCT04906317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5926730|NCT04906317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926731|NCT04906317|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5926732|NCT04906317|Anesthetics, General|anesthetics, general|mesh-ancestor
5926733|NCT04906317|Anesthetics|anesthetics|mesh-ancestor
5926734|NCT04906317|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5926735|NCT04906317|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5926736|NCT04906317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5926737|NCT04906317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5926738|NCT04906317|GABA Modulators|gaba modulators|mesh-ancestor
5926739|NCT04906317|GABA Agents|gaba agents|mesh-ancestor
5926740|NCT04906317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5926741|NCT04906317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926742|NCT04906317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5926743|NCT04906317|Narcotics|narcotics|mesh-ancestor
5926744|NCT04906317|Analgesics|analgesics|mesh-ancestor
5926745|NCT04906317|Sensory System Agents|sensory system agents|mesh-ancestor
5926746|NCT04906317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5926747|NCT04906031|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
5926748|NCT04906031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5926749|NCT04906031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5926750|NCT04906031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5926751|NCT04906031|Schistosomicides|schistosomicides|mesh-ancestor
5926752|NCT04906031|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5926753|NCT04906031|Anthelmintics|anthelmintics|mesh-ancestor
5926754|NCT04906304|Mycophenolic Acid|mycophenolic acid|mesh-list
5926755|NCT04906304|Cyclosporine|cyclosporine|mesh-list
5926756|NCT04906304|Everolimus|everolimus|mesh-list
5926757|NCT04906304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5926758|NCT04906304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5926759|NCT04906304|Immunologic Factors|immunologic factors|mesh-ancestor
5926760|NCT04906304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926761|NCT04906304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5926762|NCT04906304|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5926763|NCT04906304|Antitubercular Agents|antitubercular agents|mesh-ancestor
5926764|NCT04906304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5926765|NCT04906304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5926766|NCT04906304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5926767|NCT04906304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926768|NCT04906304|Antifungal Agents|antifungal agents|mesh-ancestor
5926769|NCT04906304|Dermatologic Agents|dermatologic agents|mesh-ancestor
5926770|NCT04906304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5926771|NCT04906304|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5926772|NCT04906096|GDC-0084|gdc-0084|mesh-list
5926773|NCT04906096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5926774|NCT04906096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926775|NCT04906083|Mitogens|mitogens|mesh-list
5926776|NCT04906083|Mitosis Modulators|mitosis modulators|mesh-ancestor
5926777|NCT04906083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926778|NCT04906161|Vitamin D|vitamin d|mesh-list
5926779|NCT04906161|Calcium|calcium|mesh-list
5926780|NCT04906161|Vitamins|vitamins|mesh-ancestor
5926781|NCT04906161|Micronutrients|micronutrients|mesh-ancestor
5926782|NCT04906161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926783|NCT04906161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5926784|NCT04906161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5926785|NCT04906382|Paclitaxel|paclitaxel|mesh-list
5926786|NCT04906382|Carboplatin|carboplatin|mesh-list
5926787|NCT04906382|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5926788|NCT04906382|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5926789|NCT04906382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5926790|NCT04906382|Tubulin Modulators|tubulin modulators|mesh-ancestor
5926791|NCT04906382|Antimitotic Agents|antimitotic agents|mesh-ancestor
5926792|NCT04906382|Mitosis Modulators|mitosis modulators|mesh-ancestor
5926793|NCT04906382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926794|NCT04905979|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
5926795|NCT04905979|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5926796|NCT04905979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5926797|NCT04905979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5926798|NCT04905979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926799|NCT04905979|Adrenergic Agents|adrenergic agents|mesh-ancestor
5926800|NCT04905979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5926801|NCT04905979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926802|NCT04905953|Neostigmine|neostigmine|mesh-list
5926803|NCT04905953|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5926804|NCT04905953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5926805|NCT04905953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926806|NCT04905953|Cholinergic Agents|cholinergic agents|mesh-ancestor
5926807|NCT04905953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5926808|NCT04905953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926809|NCT04905953|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5926810|NCT04905953|Autonomic Agents|autonomic agents|mesh-ancestor
5926811|NCT04905953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5926812|NCT04905667|Trastuzumab|trastuzumab|mesh-list
5926813|NCT04905667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5926814|NCT04905667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5926815|NCT04905563|Acetaminophen|acetaminophen|mesh-list
5926816|NCT04905563|Ibuprofen|ibuprofen|mesh-list
5926817|NCT04905563|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
5926818|NCT04905563|Hydrocodone|hydrocodone|mesh-list
5926819|NCT04905563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5926820|NCT04905563|Analgesics|analgesics|mesh-ancestor
5926821|NCT04905563|Sensory System Agents|sensory system agents|mesh-ancestor
5926822|NCT04905563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5926823|NCT04905563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926824|NCT04905563|Antipyretics|antipyretics|mesh-ancestor
5926825|NCT04905563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5926826|NCT04905563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5926827|NCT04905563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5926828|NCT04905563|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5926829|NCT04905563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5926830|NCT04905563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926831|NCT04905563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5926832|NCT04905563|Narcotics|narcotics|mesh-ancestor
5926833|NCT04905563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5926834|NCT04905563|Antitussive Agents|antitussive agents|mesh-ancestor
5926835|NCT04905563|Respiratory System Agents|respiratory system agents|mesh-ancestor
5965317|NCT04584515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5965318|NCT04584515|Leprostatic Agents|leprostatic agents|mesh-ancestor
5965319|NCT04584515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5965320|NCT04584515|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5965321|NCT04584515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5965322|NCT04584515|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5965323|NCT04584515|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5965324|NCT04584515|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5965325|NCT04584515|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5965326|NCT04584580|Heparin|heparin|mesh-list
5965327|NCT04584580|Enoxaparin|enoxaparin|mesh-list
5965328|NCT04584580|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5965329|NCT04584580|Tinzaparin|tinzaparin|mesh-list
5965330|NCT04584580|Dalteparin|dalteparin|mesh-list
5965331|NCT04584580|Anticoagulants|anticoagulants|mesh-ancestor
5965332|NCT04584580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5965333|NCT04584580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5965334|NCT04584580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965335|NCT04584749|Lidocaine|lidocaine|mesh-list
5965336|NCT04584749|Anesthetics, Local|anesthetics, local|mesh-ancestor
5965337|NCT04584749|Anesthetics|anesthetics|mesh-ancestor
5965338|NCT04584749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5965339|NCT04584749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965340|NCT04584749|Sensory System Agents|sensory system agents|mesh-ancestor
5965341|NCT04584749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5965342|NCT04584749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5965343|NCT04584749|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5965344|NCT04584749|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5965345|NCT04584749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5965346|NCT04584749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965347|NCT04584710|Dactolisib|dactolisib|mesh-list
5965348|NCT04584710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5965349|NCT04584671|Xenon|xenon|mesh-list
5965350|NCT04584671|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5965351|NCT04584671|Anesthetics, General|anesthetics, general|mesh-ancestor
5965352|NCT04584671|Anesthetics|anesthetics|mesh-ancestor
5965353|NCT04584671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5965354|NCT04584671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965355|NCT04584736|Ezetimibe|ezetimibe|mesh-list
5965356|NCT04584736|Pitavastatin|pitavastatin|mesh-list
5965357|NCT04584736|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5965358|NCT04584736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5965359|NCT04584736|Antimetabolites|antimetabolites|mesh-ancestor
5965360|NCT04584736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965361|NCT04584736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5965362|NCT04584736|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5965363|NCT04584736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5965364|NCT04584125|Riboflavin|riboflavin|mesh-list
5965365|NCT04584125|Flavin Mononucleotide|flavin mononucleotide|mesh-list
5965366|NCT04584125|Dextrans|dextrans|mesh-list
5965367|NCT04584125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5965368|NCT04584125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5965369|NCT04584125|Vitamin B Complex|vitamin b complex|mesh-ancestor
5965370|NCT04584125|Vitamins|vitamins|mesh-ancestor
5965371|NCT04584125|Micronutrients|micronutrients|mesh-ancestor
5719084|NCT03220880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5719085|NCT03220880|Adrenergic Agents|adrenergic agents|mesh-ancestor
5719086|NCT03220880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5719087|NCT03220880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719088|NCT03220867|Risperidone|risperidone|mesh-list
5719089|NCT03220867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5719090|NCT03220867|Serotonin Agents|serotonin agents|mesh-ancestor
5719091|NCT03220867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5719092|NCT03220867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719093|NCT03220867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719094|NCT03220867|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5719095|NCT03220867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5965372|NCT04584125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965373|NCT04584125|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5926836|NCT04905277|Atenolol|atenolol|mesh-list
5926837|NCT04905277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5926838|NCT04905277|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5926839|NCT04905277|Sympatholytics|sympatholytics|mesh-ancestor
5926840|NCT04905277|Autonomic Agents|autonomic agents|mesh-ancestor
5926841|NCT04905277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5926842|NCT04905277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926843|NCT04905277|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5926844|NCT04905277|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5926845|NCT04905277|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5926846|NCT04905277|Adrenergic Agents|adrenergic agents|mesh-ancestor
5926847|NCT04905277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5926848|NCT04905277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926849|NCT04905108|Riboflavin|riboflavin|mesh-list
5926850|NCT04905108|Vitamin B Complex|vitamin b complex|mesh-ancestor
5926851|NCT04905108|Vitamins|vitamins|mesh-ancestor
5926852|NCT04905108|Micronutrients|micronutrients|mesh-ancestor
5926853|NCT04905108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926854|NCT04905108|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5926855|NCT04905108|Dermatologic Agents|dermatologic agents|mesh-ancestor
5926856|NCT04905043|Acalabrutinib|acalabrutinib|mesh-list
5926857|NCT04905043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5926858|NCT04904965|Propofol|propofol|mesh-list
5926859|NCT04904965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5926860|NCT04904965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5926861|NCT04904965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926862|NCT04904965|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5926863|NCT04904965|Anesthetics, General|anesthetics, general|mesh-ancestor
5926864|NCT04904965|Anesthetics|anesthetics|mesh-ancestor
5926865|NCT04905147|Mosapride|mosapride|mesh-list
5926866|NCT04905147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5926867|NCT04905147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5926868|NCT04905147|Serotonin Agents|serotonin agents|mesh-ancestor
5926869|NCT04905147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5926870|NCT04905147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926871|NCT04905147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926872|NCT04904536|Atorvastatin|atorvastatin|mesh-list
5926873|NCT04904536|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5926874|NCT04904536|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5926875|NCT04904536|Antimetabolites|antimetabolites|mesh-ancestor
5926876|NCT04904536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926877|NCT04904536|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5926878|NCT04904536|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5926879|NCT04904536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5926880|NCT04904341|Cerebrolysin|cerebrolysin|mesh-list
5926881|NCT04904341|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5926882|NCT04904341|Protective Agents|protective agents|mesh-ancestor
5926883|NCT04904341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926884|NCT04904341|Nootropic Agents|nootropic agents|mesh-ancestor
5926885|NCT04904302|Nivolumab|nivolumab|mesh-list
5926886|NCT04904302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5926887|NCT04904302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5926888|NCT04904302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5926889|NCT04904302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926890|NCT04904185|Cyclophosphamide|cyclophosphamide|mesh-list
5926891|NCT04904185|Pembrolizumab|pembrolizumab|mesh-list
5926892|NCT04904185|Fludarabine|fludarabine|mesh-list
5926893|NCT04904185|Fludarabine phosphate|fludarabine phosphate|mesh-list
5926894|NCT04904185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5926895|NCT04904185|Immunologic Factors|immunologic factors|mesh-ancestor
5926896|NCT04904185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926897|NCT04904185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5926898|NCT04904185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5926899|NCT04904185|Alkylating Agents|alkylating agents|mesh-ancestor
5926900|NCT04904185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926901|NCT04904185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5926902|NCT04904185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5926903|NCT04904185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5926904|NCT04904185|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5926905|NCT04904185|Antimetabolites|antimetabolites|mesh-ancestor
5926906|NCT04904406|Lamivudine|lamivudine|mesh-list
5926907|NCT04904406|Abacavir|abacavir|mesh-list
5926908|NCT04904406|Dolutegravir|dolutegravir|mesh-list
5926909|NCT04904406|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5926910|NCT04904406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5926911|NCT04904406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5926912|NCT04904406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926913|NCT04904406|Antiviral Agents|antiviral agents|mesh-ancestor
5926914|NCT04904406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5926915|NCT04904406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5926916|NCT04904406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5926917|NCT04904406|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5926918|NCT04904406|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5926919|NCT04903899|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
5926920|NCT04903899|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5926921|NCT04903899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926922|NCT04903847|Tenofovir|tenofovir|mesh-list
5926923|NCT04903847|Lamivudine|lamivudine|mesh-list
5926924|NCT04903847|Dolutegravir|dolutegravir|mesh-list
5926925|NCT04903847|Antiviral Agents|antiviral agents|mesh-ancestor
5926926|NCT04903847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5926927|NCT04903847|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5926928|NCT04903847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5926929|NCT04903847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5926930|NCT04903847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926931|NCT04903847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5926932|NCT04903847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5926933|NCT04903847|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5926934|NCT04903847|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5926935|NCT04903808|Allyl sulfide|allyl sulfide|mesh-list
5926936|NCT04903808|Antioxidants|antioxidants|mesh-ancestor
5926937|NCT04903808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926938|NCT04903808|Protective Agents|protective agents|mesh-ancestor
5926939|NCT04903808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926940|NCT04903808|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5926941|NCT04903808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5926942|NCT04903808|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5926943|NCT04903808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5926944|NCT04903743|Magnesium Sulfate|magnesium sulfate|mesh-list
5926945|NCT04903743|Bupivacaine|bupivacaine|mesh-list
5926946|NCT04903743|Anesthetics, Local|anesthetics, local|mesh-ancestor
5926947|NCT04903743|Anesthetics|anesthetics|mesh-ancestor
5926948|NCT04903743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5926949|NCT04903743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926950|NCT04903743|Sensory System Agents|sensory system agents|mesh-ancestor
6517084|NCT00719693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517085|NCT00719693|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6517086|NCT00719693|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6517087|NCT00719693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6517088|NCT00719745|Tacrolimus|tacrolimus|mesh-list
6517089|NCT00719745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6517090|NCT00719745|Immunologic Factors|immunologic factors|mesh-ancestor
6517091|NCT00719745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517092|NCT00719745|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6517093|NCT00719745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5926951|NCT04903743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5926952|NCT04903743|Analgesics|analgesics|mesh-ancestor
5926953|NCT04903743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5926954|NCT04903743|Anticonvulsants|anticonvulsants|mesh-ancestor
5926955|NCT04903743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5926956|NCT04903743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5926957|NCT04903743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926958|NCT04903743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5926959|NCT04903743|Tocolytic Agents|tocolytic agents|mesh-ancestor
5926960|NCT04903743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5926961|NCT04903652|Vinorelbine|vinorelbine|mesh-list
5926962|NCT04903652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5926963|NCT04903652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5926964|NCT04903652|Tubulin Modulators|tubulin modulators|mesh-ancestor
5926965|NCT04903652|Antimitotic Agents|antimitotic agents|mesh-ancestor
5926966|NCT04903652|Mitosis Modulators|mitosis modulators|mesh-ancestor
5926967|NCT04903652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965374|NCT04584125|Dermatologic Agents|dermatologic agents|mesh-ancestor
5965375|NCT04584125|Anticoagulants|anticoagulants|mesh-ancestor
5965376|NCT04584125|Plasma Substitutes|plasma substitutes|mesh-ancestor
5965377|NCT04584125|Blood Substitutes|blood substitutes|mesh-ancestor
5965378|NCT04584307|Pomalidomide|pomalidomide|mesh-list
5965379|NCT04584307|Elotuzumab|elotuzumab|mesh-list
5965380|NCT04584307|Immunologic Factors|immunologic factors|mesh-ancestor
6681172|NCT01608412|Tacrolimus|tacrolimus|mesh-list
5926968|NCT04903483|Anesthetics|anesthetics|mesh-list
5926969|NCT04903483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5926970|NCT04903483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926971|NCT04903470|Bisacodyl|bisacodyl|mesh-list
5926972|NCT04903470|Cathartics|cathartics|mesh-ancestor
5926973|NCT04903470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5926974|NCT04903470|Laxatives|laxatives|mesh-ancestor
5926975|NCT04903678|Melphalan|melphalan|mesh-list
5926976|NCT04903678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5926977|NCT04903678|Alkylating Agents|alkylating agents|mesh-ancestor
5926978|NCT04903678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926979|NCT04903678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5926980|NCT04903678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5926981|NCT04903678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5926982|NCT04903678|Immunologic Factors|immunologic factors|mesh-ancestor
5926983|NCT04903678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926984|NCT04903366|Timolol|timolol|mesh-list
5926985|NCT04903366|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5926986|NCT04903366|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5926987|NCT04903366|Adrenergic Agents|adrenergic agents|mesh-ancestor
5926988|NCT04903366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5926989|NCT04903366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5926990|NCT04903366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926991|NCT04903366|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5926992|NCT04903366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5926993|NCT04903275|Fluorides|fluorides|mesh-list
5926994|NCT04903275|Fluorides, Topical|fluorides, topical|mesh-list
5926995|NCT04903275|Cariostatic Agents|cariostatic agents|mesh-ancestor
5926996|NCT04903275|Protective Agents|protective agents|mesh-ancestor
5926997|NCT04903275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5926998|NCT04903054|Mycophenolic Acid|mycophenolic acid|mesh-list
5926999|NCT04903054|Prednisone|prednisone|mesh-list
5927000|NCT04903054|Methylprednisolone|methylprednisolone|mesh-list
5927001|NCT04903054|Tacrolimus|tacrolimus|mesh-list
5927002|NCT04903054|Thymoglobulin|thymoglobulin|mesh-list
5927003|NCT04903054|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5927004|NCT04903054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5927005|NCT04903054|Glucocorticoids|glucocorticoids|mesh-ancestor
5927006|NCT04903054|Hormones|hormones|mesh-ancestor
5927007|NCT04903054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5927008|NCT04903054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927009|NCT04903054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5927010|NCT04903054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5927011|NCT04903054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5927012|NCT04903054|Immunologic Factors|immunologic factors|mesh-ancestor
5927013|NCT04903054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5927014|NCT04903054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5927015|NCT04903054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927016|NCT04903054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5927017|NCT04903054|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5927018|NCT04903054|Antitubercular Agents|antitubercular agents|mesh-ancestor
5927019|NCT04903054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5927020|NCT04903054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5927021|NCT04903054|Antiemetics|antiemetics|mesh-ancestor
5927022|NCT04903054|Autonomic Agents|autonomic agents|mesh-ancestor
5927023|NCT04903054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5927024|NCT04903054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5927025|NCT04903054|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5927026|NCT04903054|Protective Agents|protective agents|mesh-ancestor
5927027|NCT04902911|Antibodies|antibodies|mesh-list
5927028|NCT04902911|Immunoglobulin M|immunoglobulin m|mesh-list
5927029|NCT04902911|Immunologic Factors|immunologic factors|mesh-ancestor
5927030|NCT04902911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927031|NCT04902885|Carboplatin|carboplatin|mesh-list
5927032|NCT04902885|Etoposide|etoposide|mesh-list
5927033|NCT04902885|Topotecan|topotecan|mesh-list
5927034|NCT04902885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5927035|NCT04902885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5927036|NCT04902885|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5927037|NCT04902885|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5927038|NCT04902885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5927039|NCT04902885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927040|NCT04902885|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5927041|NCT04902950|Tranexamic Acid|tranexamic acid|mesh-list
5927042|NCT04902950|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5927043|NCT04902950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6779934|NCT02181543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5927044|NCT04902950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927045|NCT04902950|Hemostatics|hemostatics|mesh-ancestor
5927046|NCT04902950|Coagulants|coagulants|mesh-ancestor
5927047|NCT04903002|Oxytocin|oxytocin|mesh-list
5927048|NCT04903002|Oxytocics|oxytocics|mesh-ancestor
5927049|NCT04903002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5927050|NCT04903002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927051|NCT04902859|Clonidine|clonidine|mesh-list
5927052|NCT04902859|Analgesics|analgesics|mesh-ancestor
5927053|NCT04902859|Sensory System Agents|sensory system agents|mesh-ancestor
5927054|NCT04902859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5927055|NCT04902859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927056|NCT04902859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5927057|NCT04902859|Sympatholytics|sympatholytics|mesh-ancestor
5927058|NCT04902859|Autonomic Agents|autonomic agents|mesh-ancestor
5927059|NCT04902859|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5927060|NCT04902859|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5927061|NCT04902859|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5927062|NCT04902859|Adrenergic Agents|adrenergic agents|mesh-ancestor
5927063|NCT04902859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5927064|NCT04902859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927065|NCT04902729|Oxytocin|oxytocin|mesh-list
5927066|NCT04902729|Carbetocin|carbetocin|mesh-list
5927067|NCT04902729|Oxytocics|oxytocics|mesh-ancestor
5927068|NCT04902729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5927069|NCT04902729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927070|NCT04902638|Dexamethasone|dexamethasone|mesh-list
5927071|NCT04902638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5927072|NCT04902638|Antiemetics|antiemetics|mesh-ancestor
5927073|NCT04902638|Autonomic Agents|autonomic agents|mesh-ancestor
5927074|NCT04902638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5927075|NCT04902638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927076|NCT04902638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5927077|NCT04902638|Glucocorticoids|glucocorticoids|mesh-ancestor
5927078|NCT04902638|Hormones|hormones|mesh-ancestor
5927079|NCT04902638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5927080|NCT04902638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5927081|NCT04902638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5927082|NCT04902261|Gemcitabine|gemcitabine|mesh-list
5927083|NCT04902261|Paclitaxel|paclitaxel|mesh-list
5927084|NCT04902261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5927085|NCT04902261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5927086|NCT04902261|Tubulin Modulators|tubulin modulators|mesh-ancestor
5927087|NCT04902261|Antimitotic Agents|antimitotic agents|mesh-ancestor
5927088|NCT04902261|Mitosis Modulators|mitosis modulators|mesh-ancestor
5927089|NCT04902261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927090|NCT04902261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5927091|NCT04902261|Antimetabolites|antimetabolites|mesh-ancestor
5927092|NCT04902261|Antiviral Agents|antiviral agents|mesh-ancestor
5927093|NCT04902261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5927094|NCT04902261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5927095|NCT04902261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5927096|NCT04902261|Immunologic Factors|immunologic factors|mesh-ancestor
5927097|NCT04902261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927098|NCT04902495|Pemetrexed|pemetrexed|mesh-list
5927099|NCT04902495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5927100|NCT04902495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5927101|NCT04902495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927102|NCT04902495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5927103|NCT04902495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5927104|NCT04902222|Morphine|morphine|mesh-list
5927105|NCT04902222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5927106|NCT04902222|Narcotics|narcotics|mesh-ancestor
5927107|NCT04902222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5927108|NCT04902222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927109|NCT04902222|Analgesics|analgesics|mesh-ancestor
5927110|NCT04902222|Sensory System Agents|sensory system agents|mesh-ancestor
5927111|NCT04902222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5927112|NCT04901975|Spironolactone|spironolactone|mesh-list
5927113|NCT04901975|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5927114|NCT04901975|Hormone Antagonists|hormone antagonists|mesh-ancestor
5927115|NCT04901975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5927116|NCT04901975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927117|NCT04901975|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5927118|NCT04901975|Diuretics|diuretics|mesh-ancestor
5927119|NCT04901975|Natriuretic Agents|natriuretic agents|mesh-ancestor
5927120|NCT04902378|Insulin|insulin|mesh-list
5927121|NCT04902378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5927122|NCT04902378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927123|NCT04902027|Mitoxantrone|mitoxantrone|mesh-list
5927124|NCT04902027|Analgesics|analgesics|mesh-ancestor
5927125|NCT04902027|Sensory System Agents|sensory system agents|mesh-ancestor
5927126|NCT04902027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5927127|NCT04902027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927128|NCT04902027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5927129|NCT04902027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5927130|NCT04902027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5927131|NCT04902027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5927132|NCT04902027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927133|NCT04902105|Mefenamic Acid|mefenamic acid|mesh-list
5927134|NCT04902105|Valproic Acid|valproic acid|mesh-list
5927135|NCT04902105|Ecopipam|ecopipam|mesh-list
5927136|NCT04902105|Anticonvulsants|anticonvulsants|mesh-ancestor
5927137|NCT04902105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5927138|NCT04902105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927139|NCT04902105|GABA Agents|gaba agents|mesh-ancestor
5927140|NCT04902105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5927141|NCT04902105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927142|NCT04902105|Antimanic Agents|antimanic agents|mesh-ancestor
5927143|NCT04902105|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5927144|NCT04902105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5927145|NCT04902105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5927146|NCT04902105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5927147|NCT04902105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5927148|NCT04902105|Analgesics|analgesics|mesh-ancestor
5927149|NCT04902105|Sensory System Agents|sensory system agents|mesh-ancestor
5927150|NCT04902105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5927151|NCT04902105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5927152|NCT04902105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5927153|NCT04902105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5927154|NCT04902105|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5927155|NCT04902105|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5927156|NCT04902105|Dopamine Agents|dopamine agents|mesh-ancestor
5927157|NCT04902040|Pembrolizumab|pembrolizumab|mesh-list
5927158|NCT04902040|Nivolumab|nivolumab|mesh-list
5927159|NCT04902040|Durvalumab|durvalumab|mesh-list
5927160|NCT04902040|Avelumab|avelumab|mesh-list
5927161|NCT04902040|Atezolizumab|atezolizumab|mesh-list
5927162|NCT04902040|Immunoglobulins|immunoglobulins|mesh-list
5927163|NCT04902040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5927164|NCT04902040|Immunoglobulin G|immunoglobulin g|mesh-list
5927165|NCT04902040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5927166|NCT04902040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5927167|NCT04902040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5927168|NCT04902040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927169|NCT04902040|Immunologic Factors|immunologic factors|mesh-ancestor
5927170|NCT04902040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927171|NCT04901923|Itraconazole|itraconazole|mesh-list
5927172|NCT04901923|Acalabrutinib|acalabrutinib|mesh-list
5927173|NCT04901923|Antifungal Agents|antifungal agents|mesh-ancestor
5927174|NCT04901923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5927175|NCT04901923|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5927176|NCT04901923|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5927177|NCT04901923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5927178|NCT04901923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927179|NCT04901923|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5927180|NCT04901923|Hormone Antagonists|hormone antagonists|mesh-ancestor
5927181|NCT04901923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5927182|NCT04901923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927183|NCT04901923|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5927184|NCT04901923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5927185|NCT04901884|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5927186|NCT04901884|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5927187|NCT04901884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965381|NCT04584307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965382|NCT04584307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5965383|NCT04584307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5965384|NCT04584307|Growth Substances|growth substances|mesh-ancestor
5965385|NCT04584307|Growth Inhibitors|growth inhibitors|mesh-ancestor
5965386|NCT04584307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5965387|NCT04584034|Albuterol|albuterol|mesh-list
5927188|NCT04901494|Serotonin|serotonin|mesh-list
5927189|NCT04901494|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
5927190|NCT04901494|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5927191|NCT04901494|Serotonin Agents|serotonin agents|mesh-ancestor
5927192|NCT04901494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5927193|NCT04901494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927194|NCT04901494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927195|NCT04901494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5927196|NCT04901494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5927197|NCT04901663|Amoxicillin|amoxicillin|mesh-list
5927198|NCT04901663|Clarithromycin|clarithromycin|mesh-list
5927199|NCT04901663|Omeprazole|omeprazole|mesh-list
5927200|NCT04901663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5927201|NCT04901663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5927202|NCT04901663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5927203|NCT04901663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5927204|NCT04901663|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5927205|NCT04901663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5927206|NCT04901663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927207|NCT04901663|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5927208|NCT04901663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5927209|NCT04901663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5927210|NCT04901312|Analgesics, Opioid|analgesics, opioid|mesh-list
5927211|NCT04901312|Narcotics|narcotics|mesh-ancestor
5927212|NCT04901312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5927213|NCT04901312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927214|NCT04901312|Analgesics|analgesics|mesh-ancestor
5927215|NCT04901312|Sensory System Agents|sensory system agents|mesh-ancestor
5927216|NCT04901312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5927217|NCT04901117|Amoxicillin|amoxicillin|mesh-list
5927218|NCT04901117|Metronidazole|metronidazole|mesh-list
5927219|NCT04901117|Clarithromycin|clarithromycin|mesh-list
5927220|NCT04901117|Tetracycline|tetracycline|mesh-list
5927221|NCT04901117|Potassium Citrate|potassium citrate|mesh-list
5927222|NCT04901117|Bismuth|bismuth|mesh-list
5927223|NCT04901117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719096|NCT03220867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5719097|NCT03220867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5719098|NCT03220867|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5719099|NCT03220867|Dopamine Agents|dopamine agents|mesh-ancestor
5719100|NCT03220789|Methamphetamine|methamphetamine|mesh-list
5719101|NCT03220789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5719102|NCT03220789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719103|NCT03220789|Sympathomimetics|sympathomimetics|mesh-ancestor
5927224|NCT04901117|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5927225|NCT04901117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5927226|NCT04901117|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5927227|NCT04901117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5927228|NCT04901117|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5927229|NCT04901117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5927230|NCT04901117|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5927231|NCT04901117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5927232|NCT04901117|Antacids|antacids|mesh-ancestor
5927233|NCT04901117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5927234|NCT04901117|Diuretics|diuretics|mesh-ancestor
5927235|NCT04901117|Natriuretic Agents|natriuretic agents|mesh-ancestor
5927236|NCT04901117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927237|NCT04901117|Expectorants|expectorants|mesh-ancestor
5927238|NCT04901117|Respiratory System Agents|respiratory system agents|mesh-ancestor
5927239|NCT04901065|Lidocaine|lidocaine|mesh-list
5927240|NCT04901065|Anesthetics, Local|anesthetics, local|mesh-ancestor
5927241|NCT04901065|Anesthetics|anesthetics|mesh-ancestor
5927242|NCT04901065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5927243|NCT04901065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927244|NCT04901065|Sensory System Agents|sensory system agents|mesh-ancestor
5927245|NCT04901065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5927246|NCT04901065|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5927247|NCT04901065|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5927248|NCT04901065|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5927249|NCT04901065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5927250|NCT04901065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927251|NCT04901208|Nicotine|nicotine|mesh-list
5927252|NCT04901208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5927253|NCT04901208|Autonomic Agents|autonomic agents|mesh-ancestor
5927254|NCT04901208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5927255|NCT04901208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927256|NCT04901208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5927257|NCT04901208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5719104|NCT03220789|Autonomic Agents|autonomic agents|mesh-ancestor
5719105|NCT03220789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5719106|NCT03220789|Dopamine Agents|dopamine agents|mesh-ancestor
5719107|NCT03220789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5719108|NCT03220789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719109|NCT03220789|Adrenergic Agents|adrenergic agents|mesh-ancestor
5719110|NCT03220789|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5719111|NCT03220789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5719112|NCT03220789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5719113|NCT03220789|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5719114|NCT03220555|Lidocaine|lidocaine|mesh-list
5719115|NCT03220555|Prilocaine|prilocaine|mesh-list
5719116|NCT03220555|Anesthetics, Local|anesthetics, local|mesh-ancestor
5719117|NCT03220555|Anesthetics|anesthetics|mesh-ancestor
5927258|NCT04901208|Cholinergic Agents|cholinergic agents|mesh-ancestor
5927259|NCT04901208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5927260|NCT04901208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927261|NCT04901169|Angiotensin II|angiotensin ii|mesh-list
5927262|NCT04901169|Giapreza|giapreza|mesh-list
5927263|NCT04901169|Angiotensinogen|angiotensinogen|mesh-list
5927264|NCT04901169|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5927265|NCT04901169|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5927266|NCT04901169|Protease Inhibitors|protease inhibitors|mesh-ancestor
5927267|NCT04901169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5927268|NCT04901169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927269|NCT04900948|Methylprednisolone|methylprednisolone|mesh-list
5927270|NCT04900948|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5927271|NCT04900948|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5927272|NCT04900948|Prednisolone|prednisolone|mesh-list
5927273|NCT04900948|Prednisolone acetate|prednisolone acetate|mesh-list
5927274|NCT04900948|Pimecrolimus|pimecrolimus|mesh-list
5927275|NCT04900948|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
5927276|NCT04900948|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5927277|NCT04900948|Prednisolone phosphate|prednisolone phosphate|mesh-list
5927278|NCT04900948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5927279|NCT04900948|Antiemetics|antiemetics|mesh-ancestor
5927280|NCT04900948|Autonomic Agents|autonomic agents|mesh-ancestor
5927281|NCT04900948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5927282|NCT04900948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927283|NCT04900948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5927284|NCT04900948|Glucocorticoids|glucocorticoids|mesh-ancestor
5927285|NCT04900948|Hormones|hormones|mesh-ancestor
5927286|NCT04900948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5927287|NCT04900948|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5927288|NCT04900948|Protective Agents|protective agents|mesh-ancestor
5927289|NCT04900948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5927290|NCT04900948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5927291|NCT04900948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5927292|NCT04900948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5927293|NCT04900948|Analgesics|analgesics|mesh-ancestor
5927294|NCT04900948|Sensory System Agents|sensory system agents|mesh-ancestor
5927295|NCT04900948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5927296|NCT04900948|Dermatologic Agents|dermatologic agents|mesh-ancestor
5927297|NCT04900948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5927298|NCT04900948|Immunologic Factors|immunologic factors|mesh-ancestor
5927299|NCT04900948|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5927300|NCT04900948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5927301|NCT04900948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927302|NCT04901104|Thymalfasin|thymalfasin|mesh-list
5927303|NCT04901104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5927304|NCT04901104|Immunologic Factors|immunologic factors|mesh-ancestor
5927305|NCT04901104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927306|NCT04900792|Ascorbic Acid|ascorbic acid|mesh-list
5927307|NCT04900792|Temozolomide|temozolomide|mesh-list
5927308|NCT04900792|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
5927309|NCT04900792|Vitamins|vitamins|mesh-ancestor
5927310|NCT04900792|Micronutrients|micronutrients|mesh-ancestor
5927311|NCT04900792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927312|NCT04900792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5927313|NCT04900792|Alkylating Agents|alkylating agents|mesh-ancestor
5927314|NCT04900792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927315|NCT04900792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5927316|NCT04900792|Antioxidants|antioxidants|mesh-ancestor
5927317|NCT04900792|Protective Agents|protective agents|mesh-ancestor
5927318|NCT04900792|Hematinics|hematinics|mesh-ancestor
5927319|NCT04900792|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5927320|NCT04900792|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5927321|NCT04900532|Tocotrienols|tocotrienols|mesh-list
5927322|NCT04900532|Vitamin E|vitamin e|mesh-list
5927323|NCT04900532|Tocopherols|tocopherols|mesh-list
5927324|NCT04900532|Antioxidants|antioxidants|mesh-ancestor
5927325|NCT04900532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927326|NCT04900532|Protective Agents|protective agents|mesh-ancestor
5927327|NCT04900532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927328|NCT04900532|Vitamins|vitamins|mesh-ancestor
5927329|NCT04900532|Micronutrients|micronutrients|mesh-ancestor
5927330|NCT04900415|Vitamin A|vitamin a|mesh-list
5927331|NCT04900415|Vitamins|vitamins|mesh-ancestor
5927332|NCT04900415|Micronutrients|micronutrients|mesh-ancestor
5927333|NCT04900415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927334|NCT04900571|Nitrofurantoin|nitrofurantoin|mesh-list
5927335|NCT04900571|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5927336|NCT04900571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5927337|NCT04900571|Renal Agents|renal agents|mesh-ancestor
5927338|NCT04900571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5927339|NCT04900623|Paclitaxel|paclitaxel|mesh-list
5927340|NCT04900623|Cisplatin|cisplatin|mesh-list
5927341|NCT04900623|Carboplatin|carboplatin|mesh-list
5927342|NCT04900623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5927343|NCT04900623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5927344|NCT04900623|Tubulin Modulators|tubulin modulators|mesh-ancestor
5927345|NCT04900623|Antimitotic Agents|antimitotic agents|mesh-ancestor
5927346|NCT04900623|Mitosis Modulators|mitosis modulators|mesh-ancestor
5927347|NCT04900623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927348|NCT04900766|Mitoxantrone|mitoxantrone|mesh-list
5927349|NCT04900766|Analgesics|analgesics|mesh-ancestor
5927350|NCT04900766|Sensory System Agents|sensory system agents|mesh-ancestor
5927351|NCT04900766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5927352|NCT04900766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927353|NCT04900766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5927354|NCT04900766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5927355|NCT04900766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5927356|NCT04900766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5927357|NCT04900766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927358|NCT04900311|Paclitaxel|paclitaxel|mesh-list
5927359|NCT04900311|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5927360|NCT04900311|Trastuzumab|trastuzumab|mesh-list
5927361|NCT04900311|Pertuzumab|pertuzumab|mesh-list
5927362|NCT04900311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5927363|NCT04900311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5927364|NCT04900311|Tubulin Modulators|tubulin modulators|mesh-ancestor
5927365|NCT04900311|Antimitotic Agents|antimitotic agents|mesh-ancestor
5927366|NCT04900311|Mitosis Modulators|mitosis modulators|mesh-ancestor
5927367|NCT04900311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927368|NCT04900311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5927369|NCT04900350|Azacitidine|azacitidine|mesh-list
5927370|NCT04900350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5927371|NCT04900350|Antimetabolites|antimetabolites|mesh-ancestor
5927372|NCT04900350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927373|NCT04900350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5927374|NCT04900350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5927375|NCT04899921|Nivolumab|nivolumab|mesh-list
5927376|NCT04899921|Ipilimumab|ipilimumab|mesh-list
5927377|NCT04899921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5927378|NCT04899921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5927379|NCT04899921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5927380|NCT04899921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927381|NCT04900155|Atorvastatin|atorvastatin|mesh-list
5927382|NCT04900155|Ezetimibe|ezetimibe|mesh-list
5927383|NCT04900155|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5927384|NCT04900155|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5927385|NCT04900155|Antimetabolites|antimetabolites|mesh-ancestor
5927386|NCT04900155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927387|NCT04900155|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5927388|NCT04900155|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5927389|NCT04900155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5927390|NCT04900129|Acetylcysteine|acetylcysteine|mesh-list
5927391|NCT04900129|Diclofenac|diclofenac|mesh-list
5927392|NCT04900129|Salicylates|salicylates|mesh-list
5927393|NCT04900129|Methyl salicylate|methyl salicylate|mesh-list
5927394|NCT04900129|Menthol|menthol|mesh-list
5927395|NCT04900129|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5927396|NCT04900129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5927397|NCT04900129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5927398|NCT04900129|Analgesics|analgesics|mesh-ancestor
5927399|NCT04900129|Sensory System Agents|sensory system agents|mesh-ancestor
5927400|NCT04900129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5927401|NCT04900129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927402|NCT04900129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5927403|NCT04900129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5927404|NCT04900129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5927405|NCT04900129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5927406|NCT04900129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927407|NCT04900129|Antipruritics|antipruritics|mesh-ancestor
5927408|NCT04900129|Dermatologic Agents|dermatologic agents|mesh-ancestor
5927409|NCT04900129|Antiviral Agents|antiviral agents|mesh-ancestor
5927410|NCT04900129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5927411|NCT04900129|Expectorants|expectorants|mesh-ancestor
5927412|NCT04900129|Respiratory System Agents|respiratory system agents|mesh-ancestor
5927413|NCT04900129|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5927414|NCT04900129|Antioxidants|antioxidants|mesh-ancestor
5927415|NCT04900129|Protective Agents|protective agents|mesh-ancestor
5927416|NCT04900129|Antidotes|antidotes|mesh-ancestor
5927417|NCT04899765|Vaccines|vaccines|mesh-list
5927418|NCT04899765|BCG Vaccine|bcg vaccine|mesh-list
5927419|NCT04899765|Immunologic Factors|immunologic factors|mesh-ancestor
5927420|NCT04899765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927421|NCT04899765|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5927422|NCT04899791|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
5927423|NCT04899791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5927424|NCT04899791|Antioxidants|antioxidants|mesh-ancestor
5927425|NCT04899791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927426|NCT04899791|Protective Agents|protective agents|mesh-ancestor
5927427|NCT04899791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927428|NCT04899791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5927429|NCT04900220|Methylprednisolone|methylprednisolone|mesh-list
5927430|NCT04900220|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5927431|NCT04900220|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5927432|NCT04900220|Prednisolone|prednisolone|mesh-list
5927433|NCT04900220|Prednisolone acetate|prednisolone acetate|mesh-list
5927434|NCT04900220|Betamethasone|betamethasone|mesh-list
5927435|NCT04900220|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5927436|NCT04900220|Prednisolone phosphate|prednisolone phosphate|mesh-list
5927437|NCT04900220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5927438|NCT04900220|Antiemetics|antiemetics|mesh-ancestor
5927439|NCT04900220|Autonomic Agents|autonomic agents|mesh-ancestor
5927440|NCT04900220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5927441|NCT04900220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927442|NCT04900220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5927443|NCT04900220|Glucocorticoids|glucocorticoids|mesh-ancestor
5927444|NCT04900220|Hormones|hormones|mesh-ancestor
5927445|NCT04900220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5927446|NCT04900220|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5927447|NCT04900220|Protective Agents|protective agents|mesh-ancestor
5927448|NCT04900220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5927449|NCT04900220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5927450|NCT04900220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5927451|NCT04900220|Respiratory System Agents|respiratory system agents|mesh-ancestor
5965388|NCT04584034|Bronchodilator Agents|bronchodilator agents|mesh-list
5965389|NCT04584034|Autonomic Agents|autonomic agents|mesh-ancestor
5965390|NCT04584034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5965391|NCT04584034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965392|NCT04584034|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5965393|NCT04584034|Respiratory System Agents|respiratory system agents|mesh-ancestor
5965394|NCT04584034|Tocolytic Agents|tocolytic agents|mesh-ancestor
5965395|NCT04584034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5965396|NCT04584034|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5965397|NCT04584034|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5965398|NCT04584034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5965399|NCT04584034|Adrenergic Agents|adrenergic agents|mesh-ancestor
5965400|NCT04584034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5965401|NCT04584034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970770|NCT04532684|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5970771|NCT04532684|Analgesics|analgesics|mesh-ancestor
5970772|NCT04532684|Sensory System Agents|sensory system agents|mesh-ancestor
6517094|NCT00719745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927452|NCT04899687|Dextromethorphan|dextromethorphan|mesh-list
5927453|NCT04899687|Fluoxetine|fluoxetine|mesh-list
5927454|NCT04899687|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5927455|NCT04899687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5927456|NCT04899687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5927457|NCT04899687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927458|NCT04899687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5927459|NCT04899687|Serotonin Agents|serotonin agents|mesh-ancestor
5927460|NCT04899687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927461|NCT04899687|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5927462|NCT04899687|Antidepressive Agents|antidepressive agents|mesh-ancestor
5927463|NCT04899687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5927464|NCT04899687|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5927465|NCT04899687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5927466|NCT04899687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5927467|NCT04899687|Antitussive Agents|antitussive agents|mesh-ancestor
5927468|NCT04899687|Respiratory System Agents|respiratory system agents|mesh-ancestor
5927469|NCT04899687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5927470|NCT04899687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5927471|NCT04899570|Prednisone|prednisone|mesh-list
5927472|NCT04899570|Cyclophosphamide|cyclophosphamide|mesh-list
5927473|NCT04899570|Rituximab|rituximab|mesh-list
5927474|NCT04899570|Epirubicin|epirubicin|mesh-list
5927475|NCT04899570|Zanubrutinib|zanubrutinib|mesh-list
5927476|NCT04899570|Vindesine|vindesine|mesh-list
5927477|NCT04899570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5927478|NCT04899570|Immunologic Factors|immunologic factors|mesh-ancestor
5927479|NCT04899570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927480|NCT04899570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5927481|NCT04899570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5927482|NCT04899570|Alkylating Agents|alkylating agents|mesh-ancestor
5927483|NCT04899570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927484|NCT04899570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5927485|NCT04899570|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5927486|NCT04899570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5927487|NCT04899570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5927488|NCT04899570|Glucocorticoids|glucocorticoids|mesh-ancestor
5927489|NCT04899570|Hormones|hormones|mesh-ancestor
5927490|NCT04899570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5927491|NCT04899570|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5927492|NCT04899570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5927493|NCT04899570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5927494|NCT04899570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5927495|NCT04899570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5927496|NCT04899570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5927497|NCT04899570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5927498|NCT04899570|Tubulin Modulators|tubulin modulators|mesh-ancestor
5927499|NCT04899570|Antimitotic Agents|antimitotic agents|mesh-ancestor
5927500|NCT04899570|Mitosis Modulators|mitosis modulators|mesh-ancestor
5927501|NCT04899453|Rituximab|rituximab|mesh-list
5927502|NCT04899453|Methotrexate|methotrexate|mesh-list
5927503|NCT04899453|Zanubrutinib|zanubrutinib|mesh-list
5927504|NCT04899453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5927505|NCT04899453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5927506|NCT04899453|Immunologic Factors|immunologic factors|mesh-ancestor
5927507|NCT04899453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927508|NCT04899453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5927509|NCT04899453|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5927510|NCT04899453|Abortifacient Agents|abortifacient agents|mesh-ancestor
5927511|NCT04899453|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5927512|NCT04899453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5927513|NCT04899453|Antimetabolites|antimetabolites|mesh-ancestor
5927514|NCT04899453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927515|NCT04899453|Dermatologic Agents|dermatologic agents|mesh-ancestor
5927516|NCT04899453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5927517|NCT04899453|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5927518|NCT04899453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5927519|NCT04899453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5927520|NCT04899453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5927521|NCT04899817|Granisetron|granisetron|mesh-list
5927522|NCT04899817|Antiemetics|antiemetics|mesh-ancestor
5927523|NCT04899817|Autonomic Agents|autonomic agents|mesh-ancestor
5927524|NCT04899817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5927525|NCT04899817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927526|NCT04899817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5927527|NCT04899817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5927528|NCT04899817|Serotonin Agents|serotonin agents|mesh-ancestor
5927529|NCT04899817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5927530|NCT04899817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927531|NCT04899674|Bupropion|bupropion|mesh-list
5927532|NCT04899674|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5927533|NCT04899674|Antidepressive Agents|antidepressive agents|mesh-ancestor
5927534|NCT04899674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5927535|NCT04899674|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5927536|NCT04899674|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5927537|NCT04899674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5927538|NCT04899674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927539|NCT04899674|Dopamine Agents|dopamine agents|mesh-ancestor
5927540|NCT04899674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5927541|NCT04899674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927542|NCT04899674|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5927543|NCT04899674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5927544|NCT04899674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5927545|NCT04899479|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
5927546|NCT04899479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927547|NCT04899479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5927548|NCT04899479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927549|NCT04899414|Dexamethasone|dexamethasone|mesh-list
5927550|NCT04899414|Azacitidine|azacitidine|mesh-list
5927551|NCT04899414|Pegaspargase|pegaspargase|mesh-list
5927552|NCT04899414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5927553|NCT04899414|Antiemetics|antiemetics|mesh-ancestor
5927554|NCT04899414|Autonomic Agents|autonomic agents|mesh-ancestor
5927555|NCT04899414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5927556|NCT04899414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927557|NCT04899414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5927558|NCT04899414|Glucocorticoids|glucocorticoids|mesh-ancestor
5927559|NCT04899414|Hormones|hormones|mesh-ancestor
5927560|NCT04899414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5927561|NCT04899414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5927562|NCT04899414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5927563|NCT04899414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5927564|NCT04899414|Antimetabolites|antimetabolites|mesh-ancestor
5927565|NCT04899414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927566|NCT04899414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5927567|NCT04899778|Contraceptive Agents|contraceptive agents|mesh-list
5927568|NCT04899778|Contraceptives, Oral|contraceptives, oral|mesh-list
5927569|NCT04899778|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
5927570|NCT04899778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5927571|NCT04899778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927572|NCT04899778|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5927573|NCT04899518|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5927574|NCT04899518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5927575|NCT04899388|Fentanyl|fentanyl|mesh-list
5927576|NCT04899388|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5927577|NCT04899388|Narcotics|narcotics|mesh-ancestor
5927578|NCT04899388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5927579|NCT04899388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927580|NCT04899388|Analgesics|analgesics|mesh-ancestor
5927581|NCT04899388|Sensory System Agents|sensory system agents|mesh-ancestor
5927582|NCT04899388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5927583|NCT04899388|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5927584|NCT04899388|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5927585|NCT04899388|Anesthetics, General|anesthetics, general|mesh-ancestor
5927586|NCT04899388|Anesthetics|anesthetics|mesh-ancestor
5927587|NCT04899115|Vancomycin|vancomycin|mesh-list
5927588|NCT04899115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5927589|NCT04899115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5927590|NCT04898920|Dexamethasone|dexamethasone|mesh-list
5927591|NCT04898920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5927592|NCT04898920|Antiemetics|antiemetics|mesh-ancestor
5927593|NCT04898920|Autonomic Agents|autonomic agents|mesh-ancestor
5927594|NCT04898920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5927595|NCT04898920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927596|NCT04898920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5927597|NCT04898920|Glucocorticoids|glucocorticoids|mesh-ancestor
5927598|NCT04898920|Hormones|hormones|mesh-ancestor
5927599|NCT04898920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5927600|NCT04898920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5927601|NCT04898920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5927602|NCT04898946|Vaccines|vaccines|mesh-list
5927603|NCT04898946|Immunologic Factors|immunologic factors|mesh-ancestor
5927604|NCT04898946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927605|NCT04899050|Cannabidiol|cannabidiol|mesh-list
5927606|NCT04899050|Anticonvulsants|anticonvulsants|mesh-ancestor
5927607|NCT04898738|Hand Sanitizers|hand sanitizers|mesh-list
5927608|NCT04898738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5927609|NCT04898738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5927610|NCT04898738|Disinfectants|disinfectants|mesh-ancestor
5927611|NCT04898751|Pembrolizumab|pembrolizumab|mesh-list
5927612|NCT04898751|Nivolumab|nivolumab|mesh-list
5927613|NCT04898751|Ipilimumab|ipilimumab|mesh-list
5927614|NCT04898751|Durvalumab|durvalumab|mesh-list
5927615|NCT04898751|Avelumab|avelumab|mesh-list
5927616|NCT04898751|Cemiplimab|cemiplimab|mesh-list
5927617|NCT04898751|Atezolizumab|atezolizumab|mesh-list
5927618|NCT04898751|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5927619|NCT04898751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5927620|NCT04898751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5927621|NCT04898751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927622|NCT04898907|Moxifloxacin|moxifloxacin|mesh-list
5927623|NCT04898907|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
5927624|NCT04898907|Mitogens|mitogens|mesh-list
5927625|NCT04898907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5927626|NCT04898907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5927627|NCT04898907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5927628|NCT04898907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5927629|NCT04898907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5927630|NCT04898907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927631|NCT04898907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5927632|NCT04898907|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5927633|NCT04898907|Contraceptive Agents|contraceptive agents|mesh-ancestor
5927634|NCT04898907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5927635|NCT04898907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927636|NCT04898907|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5927637|NCT04898907|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5927638|NCT04898907|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5927639|NCT04898907|Mitosis Modulators|mitosis modulators|mesh-ancestor
5927640|NCT04898621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5927641|NCT04898699|Tenofovir|tenofovir|mesh-list
5927642|NCT04898699|Emtricitabine|emtricitabine|mesh-list
5927643|NCT04898699|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5927644|NCT04898699|Antiviral Agents|antiviral agents|mesh-ancestor
5927645|NCT04898699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5927646|NCT04898699|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5927647|NCT04898699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5927648|NCT04898699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5927649|NCT04898699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927650|NCT04898699|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5927651|NCT04898699|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5927652|NCT04898725|Vitamin D|vitamin d|mesh-list
5927653|NCT04898725|Cholecalciferol|cholecalciferol|mesh-list
5927654|NCT04898725|Vitamins|vitamins|mesh-ancestor
5927655|NCT04898725|Micronutrients|micronutrients|mesh-ancestor
5927656|NCT04898725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927657|NCT04898725|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5927658|NCT04898725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5927659|NCT04898712|Tranexamic Acid|tranexamic acid|mesh-list
5927660|NCT04898712|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5927661|NCT04898712|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5927662|NCT04898712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927663|NCT04898712|Hemostatics|hemostatics|mesh-ancestor
5927664|NCT04898712|Coagulants|coagulants|mesh-ancestor
5927665|NCT04898387|Timolol|timolol|mesh-list
5927666|NCT04898387|Bimatoprost|bimatoprost|mesh-list
5927667|NCT04898387|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5927668|NCT04898387|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5927669|NCT04898387|Adrenergic Agents|adrenergic agents|mesh-ancestor
5927670|NCT04898387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5927671|NCT04898387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927672|NCT04898387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927673|NCT04898387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5927674|NCT04898387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5927675|NCT04898374|Gemcitabine|gemcitabine|mesh-list
5927676|NCT04898374|Cisplatin|cisplatin|mesh-list
5927677|NCT04898374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5927678|NCT04898374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5927679|NCT04898374|Antimetabolites|antimetabolites|mesh-ancestor
5927680|NCT04898374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927681|NCT04898374|Antiviral Agents|antiviral agents|mesh-ancestor
5927682|NCT04898374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5927683|NCT04898374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5927684|NCT04898374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5927685|NCT04898374|Immunologic Factors|immunologic factors|mesh-ancestor
5927686|NCT04898374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927687|NCT04898348|Vancomycin|vancomycin|mesh-list
5927688|NCT04898348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5927689|NCT04898348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5927690|NCT04898101|Acalabrutinib|acalabrutinib|mesh-list
5927691|NCT04898101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5927692|NCT04898556|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
5927693|NCT04898556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5927694|NCT04898556|Immunologic Factors|immunologic factors|mesh-ancestor
5927695|NCT04898556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927696|NCT04898023|Ascorbic Acid|ascorbic acid|mesh-list
5927697|NCT04898023|Antioxidants|antioxidants|mesh-ancestor
5927698|NCT04898023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927699|NCT04898023|Protective Agents|protective agents|mesh-ancestor
5927700|NCT04898023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927701|NCT04898023|Vitamins|vitamins|mesh-ancestor
5927702|NCT04898023|Micronutrients|micronutrients|mesh-ancestor
5927703|NCT04898504|Floxuridine|floxuridine|mesh-list
5927704|NCT04898504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5927705|NCT04898504|Antimetabolites|antimetabolites|mesh-ancestor
5927706|NCT04898504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927707|NCT04898504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5927708|NCT04898075|Nicotine|nicotine|mesh-list
5927709|NCT04898075|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5927710|NCT04898075|Autonomic Agents|autonomic agents|mesh-ancestor
5927711|NCT04898075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5927712|NCT04898075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927713|NCT04898075|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5927714|NCT04898075|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5927715|NCT04898075|Cholinergic Agents|cholinergic agents|mesh-ancestor
5927716|NCT04898075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5927717|NCT04898075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927718|NCT04898478|Analgesics, Opioid|analgesics, opioid|mesh-list
5927719|NCT04898478|Narcotics|narcotics|mesh-ancestor
5927720|NCT04898478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5927721|NCT04898478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927722|NCT04898478|Analgesics|analgesics|mesh-ancestor
5927723|NCT04898478|Sensory System Agents|sensory system agents|mesh-ancestor
5927724|NCT04898478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5927725|NCT04898114|Magnesium Sulfate|magnesium sulfate|mesh-list
5927726|NCT04898114|Sildenafil Citrate|sildenafil citrate|mesh-list
5927727|NCT04898114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927728|NCT04898114|Vasodilator Agents|vasodilator agents|mesh-ancestor
5927729|NCT04898114|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5927730|NCT04898114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5927731|NCT04898114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5927732|NCT04898114|Urological Agents|urological agents|mesh-ancestor
5927733|NCT04898114|Analgesics|analgesics|mesh-ancestor
5927734|NCT04898114|Sensory System Agents|sensory system agents|mesh-ancestor
5927735|NCT04898114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5927736|NCT04898114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927737|NCT04898114|Anesthetics|anesthetics|mesh-ancestor
5927738|NCT04898114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5927739|NCT04898114|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5927740|NCT04898114|Anticonvulsants|anticonvulsants|mesh-ancestor
5927741|NCT04898114|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5927742|NCT04898114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5927743|NCT04898114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5927744|NCT04898114|Tocolytic Agents|tocolytic agents|mesh-ancestor
5927745|NCT04898114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5927746|NCT04898231|Methylprednisolone|methylprednisolone|mesh-list
5927747|NCT04898231|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5927748|NCT04898231|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5927749|NCT04898231|Prednisolone|prednisolone|mesh-list
5927750|NCT04898231|Prednisolone acetate|prednisolone acetate|mesh-list
5927751|NCT04898231|Infliximab|infliximab|mesh-list
5927752|NCT04898231|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5927753|NCT04898231|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5927754|NCT04898231|Prednisolone phosphate|prednisolone phosphate|mesh-list
5927755|NCT04898231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5927756|NCT04898231|Antiemetics|antiemetics|mesh-ancestor
5927757|NCT04898231|Autonomic Agents|autonomic agents|mesh-ancestor
5927758|NCT04898231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5927759|NCT04898231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927760|NCT04898231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5927761|NCT04898231|Glucocorticoids|glucocorticoids|mesh-ancestor
5927762|NCT04898231|Hormones|hormones|mesh-ancestor
5927763|NCT04898231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5927764|NCT04898231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5927765|NCT04898231|Protective Agents|protective agents|mesh-ancestor
5927766|NCT04898231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5927767|NCT04898231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5927768|NCT04898231|Dermatologic Agents|dermatologic agents|mesh-ancestor
5927769|NCT04898231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5965402|NCT04584008|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
5965403|NCT04584008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5965404|NCT04584008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965405|NCT04584008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5965406|NCT04583813|Empagliflozin|empagliflozin|mesh-list
5965407|NCT04583813|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5965408|NCT04583813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965409|NCT04583813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5965410|NCT04583813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965411|NCT04583410|Nicotine|nicotine|mesh-list
5965412|NCT04583410|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5965413|NCT04583410|Autonomic Agents|autonomic agents|mesh-ancestor
5965414|NCT04583410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5965415|NCT04583410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965416|NCT04583410|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5965417|NCT04583410|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5965418|NCT04583410|Cholinergic Agents|cholinergic agents|mesh-ancestor
5965419|NCT04583410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5965420|NCT04583410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965421|NCT04583501|Omalizumab|omalizumab|mesh-list
5965422|NCT04583501|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5965423|NCT04583501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5965424|NCT04583501|Respiratory System Agents|respiratory system agents|mesh-ancestor
5965425|NCT04583267|Tenofovir|tenofovir|mesh-list
5965426|NCT04583267|Emtricitabine|emtricitabine|mesh-list
5965427|NCT04583267|Antiviral Agents|antiviral agents|mesh-ancestor
5965428|NCT04583267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5965429|NCT04583267|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5965430|NCT04583267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5965431|NCT04583267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5965432|NCT04583267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965433|NCT04583267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5965434|NCT04583267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5965435|NCT04583111|Domperidone|domperidone|mesh-list
5965436|NCT04583111|Sulpiride|sulpiride|mesh-list
5965437|NCT04583111|Antiemetics|antiemetics|mesh-ancestor
5965438|NCT04583111|Autonomic Agents|autonomic agents|mesh-ancestor
5965439|NCT04583111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5965440|NCT04583111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965441|NCT04583111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5965442|NCT04583111|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5965443|NCT04583111|Dopamine Agents|dopamine agents|mesh-ancestor
5965444|NCT04583111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5965445|NCT04583111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965446|NCT04583111|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5965447|NCT04583111|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5965448|NCT04583111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5965449|NCT04583111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5965450|NCT04583111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5965451|NCT04583111|Antidepressive Agents|antidepressive agents|mesh-ancestor
5965452|NCT04582968|Capecitabine|capecitabine|mesh-list
5965453|NCT04582968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5965454|NCT04582968|Antimetabolites|antimetabolites|mesh-ancestor
5965455|NCT04582968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965456|NCT04582968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5965457|NCT04583046|Iloprost|iloprost|mesh-list
5927770|NCT04898270|Antipsychotic Agents|antipsychotic agents|mesh-list
5927771|NCT04898270|Flupenthixol|flupenthixol|mesh-list
5927772|NCT04898270|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
5927773|NCT04898270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5927774|NCT04898270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5927775|NCT04898270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927776|NCT04898270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5927777|NCT04898270|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5927778|NCT04898270|Dopamine Agents|dopamine agents|mesh-ancestor
5927779|NCT04898270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5927780|NCT04898270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927781|NCT04897984|Anti-Infective Agents|anti-infective agents|mesh-list
5927782|NCT04897984|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5927783|NCT04897971|Antibodies|antibodies|mesh-list
5927784|NCT04897971|Immunologic Factors|immunologic factors|mesh-ancestor
5927785|NCT04897971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927786|NCT04897958|Leuprolide|leuprolide|mesh-list
5927787|NCT04897958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5927788|NCT04897958|Fertility Agents|fertility agents|mesh-ancestor
5927789|NCT04897958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5927790|NCT04897958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927791|NCT04897958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5927792|NCT04897958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5927793|NCT04897854|Folfirinox|folfirinox|mesh-list
5927794|NCT04897854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5927795|NCT04897802|Exenatide|exenatide|mesh-list
5927796|NCT04897802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5927797|NCT04897802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927798|NCT04897802|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5927799|NCT04897802|Incretins|incretins|mesh-ancestor
5927800|NCT04897802|Hormones|hormones|mesh-ancestor
5927801|NCT04897802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5927802|NCT04897880|Panobinostat|panobinostat|mesh-list
5927803|NCT04897880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5927804|NCT04897880|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5927805|NCT04897880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5927806|NCT04897880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927807|NCT04897919|Piperaquine|piperaquine|mesh-list
5927808|NCT04897919|Artenimol|artenimol|mesh-list
5927809|NCT04897919|Antimalarials|antimalarials|mesh-ancestor
5927810|NCT04897919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5927811|NCT04897919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5927812|NCT04897919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5927813|NCT04897737|Tenofovir|tenofovir|mesh-list
5927814|NCT04897737|Antiviral Agents|antiviral agents|mesh-ancestor
5927815|NCT04897737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5927816|NCT04897737|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5927817|NCT04897737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5927818|NCT04897737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5927819|NCT04897737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927820|NCT04897737|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5927821|NCT04897737|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5927822|NCT04897516|Benzonidazole|benzonidazole|mesh-list
5927823|NCT04897516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5927824|NCT04897516|Immunologic Factors|immunologic factors|mesh-ancestor
5927825|NCT04897516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927826|NCT04897516|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5927827|NCT04897516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5927828|NCT04897516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5927829|NCT04897516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5927830|NCT04897503|Riboflavin|riboflavin|mesh-list
5927831|NCT04897503|Vitamin B Complex|vitamin b complex|mesh-ancestor
5927832|NCT04897503|Vitamins|vitamins|mesh-ancestor
5927833|NCT04897503|Micronutrients|micronutrients|mesh-ancestor
5927834|NCT04897503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927835|NCT04897503|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5927836|NCT04897503|Dermatologic Agents|dermatologic agents|mesh-ancestor
6517095|NCT00719758|Beraprost|beraprost|mesh-list
6517096|NCT00719758|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6517097|NCT00719758|Vasodilator Agents|vasodilator agents|mesh-ancestor
5927837|NCT04897386|Pemetrexed|pemetrexed|mesh-list
5927838|NCT04897386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5927839|NCT04897386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5927840|NCT04897386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927841|NCT04897386|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5927842|NCT04897386|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5927843|NCT04897321|Cyclophosphamide|cyclophosphamide|mesh-list
6517098|NCT00719797|Leucovorin|leucovorin|mesh-list
5927844|NCT04897321|Fludarabine|fludarabine|mesh-list
5927845|NCT04897321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5927846|NCT04897321|Immunologic Factors|immunologic factors|mesh-ancestor
5927847|NCT04897321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927848|NCT04897321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5927849|NCT04897321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5927850|NCT04897321|Alkylating Agents|alkylating agents|mesh-ancestor
5927851|NCT04897321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927852|NCT04897321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5927853|NCT04897321|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5927854|NCT04897477|Azacitidine|azacitidine|mesh-list
5927855|NCT04897477|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5927856|NCT04897477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5927857|NCT04897477|Antimetabolites|antimetabolites|mesh-ancestor
5927858|NCT04897477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927859|NCT04897477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5927860|NCT04897477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5927861|NCT04897477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5927862|NCT04897477|Alkylating Agents|alkylating agents|mesh-ancestor
5927863|NCT04897269|Progesterone|progesterone|mesh-list
5927864|NCT04897269|Progestins|progestins|mesh-ancestor
5927865|NCT04897269|Hormones|hormones|mesh-ancestor
5927866|NCT04897269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5927867|NCT04897269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927868|NCT04896359|Ascorbic Acid|ascorbic acid|mesh-list
5927869|NCT04896359|Vitamins|vitamins|mesh-ancestor
5927870|NCT04896359|Micronutrients|micronutrients|mesh-ancestor
5927871|NCT04896359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927872|NCT04896359|Antioxidants|antioxidants|mesh-ancestor
5927873|NCT04896359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927874|NCT04896359|Protective Agents|protective agents|mesh-ancestor
5927875|NCT04896489|Hydrocortisone|hydrocortisone|mesh-list
5927876|NCT04896489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5965458|NCT04583046|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5965459|NCT04583046|Vasodilator Agents|vasodilator agents|mesh-ancestor
5965460|NCT04583137|Lidocaine|lidocaine|mesh-list
5965461|NCT04583137|Anesthetics, Local|anesthetics, local|mesh-ancestor
5965462|NCT04583137|Anesthetics|anesthetics|mesh-ancestor
5965463|NCT04583137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5965464|NCT04583137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965465|NCT04583137|Sensory System Agents|sensory system agents|mesh-ancestor
5965466|NCT04583137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5965467|NCT04583137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5965468|NCT04583137|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5965469|NCT04583137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5965470|NCT04583137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5965471|NCT04583137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965472|NCT04583020|Temozolomide|temozolomide|mesh-list
5965473|NCT04583020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5965474|NCT04583020|Alkylating Agents|alkylating agents|mesh-ancestor
5965475|NCT04583020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965476|NCT04583020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5965477|NCT04582942|Lactulose|lactulose|mesh-list
5965478|NCT04582942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5965479|NCT04582929|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5965480|NCT04582929|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5965481|NCT04582929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5965482|NCT04582929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965483|NCT04582929|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5965484|NCT04582929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5965485|NCT04582929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965486|NCT04582929|Cholinergic Agents|cholinergic agents|mesh-ancestor
5965487|NCT04582929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5965488|NCT04582552|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
5965489|NCT04582552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5965490|NCT04582552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965491|NCT04582552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5965492|NCT04582604|Decitabine|decitabine|mesh-list
5965493|NCT04582604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5965494|NCT04582604|Antimetabolites|antimetabolites|mesh-ancestor
5965495|NCT04582604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517099|NCT00719797|Bevacizumab|bevacizumab|mesh-list
6517100|NCT00719797|Fluorouracil|fluorouracil|mesh-list
5927877|NCT04896177|Sirolimus|sirolimus|mesh-list
5927878|NCT04896177|Paclitaxel|paclitaxel|mesh-list
5927879|NCT04896177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5927880|NCT04896177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5927881|NCT04896177|Tubulin Modulators|tubulin modulators|mesh-ancestor
5927882|NCT04896177|Antimitotic Agents|antimitotic agents|mesh-ancestor
5927883|NCT04896177|Mitosis Modulators|mitosis modulators|mesh-ancestor
5927884|NCT04896177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927885|NCT04896177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5927886|NCT04896177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5927887|NCT04896177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5927888|NCT04896177|Antifungal Agents|antifungal agents|mesh-ancestor
5927889|NCT04896177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5927890|NCT04896177|Immunologic Factors|immunologic factors|mesh-ancestor
5927891|NCT04896177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927892|NCT04896125|Bimatoprost|bimatoprost|mesh-list
5927893|NCT04896125|Latanoprost|latanoprost|mesh-list
5927894|NCT04896125|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5927895|NCT04896125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5927896|NCT04896125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5927897|NCT04896164|Curcumin|curcumin|mesh-list
5927898|NCT04896164|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5927899|NCT04896164|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5927900|NCT04896164|Analgesics|analgesics|mesh-ancestor
5927901|NCT04896164|Sensory System Agents|sensory system agents|mesh-ancestor
5927902|NCT04896164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5927903|NCT04896164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927904|NCT04896164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5719118|NCT03220555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5719119|NCT03220555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719120|NCT03220555|Sensory System Agents|sensory system agents|mesh-ancestor
5719121|NCT03220555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5719122|NCT03220555|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5719123|NCT03220555|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5719124|NCT03220555|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5719125|NCT03220555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5719126|NCT03220555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719127|NCT03220256|Lamotrigine|lamotrigine|mesh-list
5719128|NCT03220256|Anticonvulsants|anticonvulsants|mesh-ancestor
5719129|NCT03220256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5719130|NCT03220256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5719131|NCT03220256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719132|NCT03220256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5927905|NCT04896164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5927906|NCT04896164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5927907|NCT04896164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5927908|NCT04896164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927909|NCT04895917|Daratumumab|daratumumab|mesh-list
5927910|NCT04895917|Pomalidomide|pomalidomide|mesh-list
5927911|NCT04895917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5927912|NCT04895917|Immunologic Factors|immunologic factors|mesh-ancestor
5927913|NCT04895917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927914|NCT04895917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5927915|NCT04895917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5927916|NCT04895917|Growth Substances|growth substances|mesh-ancestor
5927917|NCT04895917|Growth Inhibitors|growth inhibitors|mesh-ancestor
5927918|NCT04895657|Tazobactam|tazobactam|mesh-list
5927919|NCT04895657|Piperacillin|piperacillin|mesh-list
5927920|NCT04895657|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
5927921|NCT04895657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5927922|NCT04895657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5927923|NCT04895657|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5927924|NCT04895657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5927925|NCT04895657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927926|NCT04895423|Cyclosporine|cyclosporine|mesh-list
5927927|NCT04895423|Mycophenolic Acid|mycophenolic acid|mesh-list
5927928|NCT04895423|Methotrexate|methotrexate|mesh-list
6517101|NCT00719797|Oxaliplatin|oxaliplatin|mesh-list
6517102|NCT00719797|Irinotecan|irinotecan|mesh-list
6517103|NCT00719797|Calcium|calcium|mesh-list
6517104|NCT00719797|Levoleucovorin|levoleucovorin|mesh-list
6517105|NCT00719797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5927929|NCT04895423|Cyclosporins|cyclosporins|mesh-list
6517106|NCT00719797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6517107|NCT00719797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5927930|NCT04895423|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5927931|NCT04895423|Abortifacient Agents|abortifacient agents|mesh-ancestor
5927932|NCT04895423|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5927933|NCT04895423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927934|NCT04895423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5927935|NCT04895423|Antimetabolites|antimetabolites|mesh-ancestor
5927936|NCT04895423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927937|NCT04895423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5927938|NCT04895423|Dermatologic Agents|dermatologic agents|mesh-ancestor
5927939|NCT04895423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5927940|NCT04895423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5927941|NCT04895423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5927942|NCT04895423|Immunologic Factors|immunologic factors|mesh-ancestor
5927943|NCT04895423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5927944|NCT04895423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5927945|NCT04895423|Antifungal Agents|antifungal agents|mesh-ancestor
5927946|NCT04895423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5927947|NCT04895423|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5927948|NCT04895423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5927949|NCT04895423|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5927950|NCT04895423|Antitubercular Agents|antitubercular agents|mesh-ancestor
5927951|NCT04895423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5927952|NCT04895800|Caffeine|caffeine|mesh-list
5719133|NCT03220256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719134|NCT03220256|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5719135|NCT03220256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5719136|NCT03220256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5719137|NCT03220256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5719138|NCT03220256|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5719139|NCT03220321|Lithium Carbonate|lithium carbonate|mesh-list
5719140|NCT03220321|Antidepressive Agents|antidepressive agents|mesh-ancestor
5719141|NCT03220321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5719142|NCT03220321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5927953|NCT04895800|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5927954|NCT04895800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927955|NCT04895800|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5927956|NCT04895800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5927957|NCT04895800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927958|NCT04895800|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5927959|NCT04895800|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5927960|NCT04895800|Purinergic Agents|purinergic agents|mesh-ancestor
5927961|NCT04895800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5927962|NCT04895579|Durvalumab|durvalumab|mesh-list
5927963|NCT04895579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5927964|NCT04895579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5927965|NCT04895306|Methyltestosterone|methyltestosterone|mesh-list
5927966|NCT04895306|Testosterone|testosterone|mesh-list
5927967|NCT04895306|Testosterone undecanoate|testosterone undecanoate|mesh-list
5927968|NCT04895306|Testosterone enanthate|testosterone enanthate|mesh-list
5927969|NCT04895306|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5927970|NCT04895306|Androgens|androgens|mesh-ancestor
5927971|NCT04895306|Hormones|hormones|mesh-ancestor
5927972|NCT04895306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5927973|NCT04895306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927974|NCT04895306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5927975|NCT04895306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5927976|NCT04895306|Anabolic Agents|anabolic agents|mesh-ancestor
5927977|NCT04895592|Dexamethasone|dexamethasone|mesh-list
5927978|NCT04895592|Dexamethasone acetate|dexamethasone acetate|mesh-list
5927979|NCT04895592|Ichthammol|ichthammol|mesh-list
5927980|NCT04895592|BB 1101|bb 1101|mesh-list
5927981|NCT04895592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5927982|NCT04895592|Antiemetics|antiemetics|mesh-ancestor
5927983|NCT04895592|Autonomic Agents|autonomic agents|mesh-ancestor
5927984|NCT04895592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5927985|NCT04895592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5927986|NCT04895592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5927987|NCT04895592|Glucocorticoids|glucocorticoids|mesh-ancestor
5927988|NCT04895592|Hormones|hormones|mesh-ancestor
5927989|NCT04895592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5927990|NCT04895592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6681173|NCT01608412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5719143|NCT03220321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719144|NCT03220321|Antimanic Agents|antimanic agents|mesh-ancestor
5927991|NCT04895592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5927992|NCT04895592|Protease Inhibitors|protease inhibitors|mesh-ancestor
5927993|NCT04895592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5927994|NCT04895592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5927995|NCT04895592|Dermatologic Agents|dermatologic agents|mesh-ancestor
5927996|NCT04895566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5927997|NCT04895566|Antibodies|antibodies|mesh-list
5927998|NCT04895566|Immunoglobulins|immunoglobulins|mesh-list
5927999|NCT04895566|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5928000|NCT04895566|Immunologic Factors|immunologic factors|mesh-ancestor
5928001|NCT04895566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928002|NCT04895566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5928003|NCT04895059|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5928004|NCT04895059|Ezetimibe|ezetimibe|mesh-list
5928005|NCT04895059|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5928006|NCT04895059|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5928007|NCT04895059|Antimetabolites|antimetabolites|mesh-ancestor
5928008|NCT04895059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928009|NCT04895059|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5928010|NCT04895059|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5928011|NCT04895059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5928012|NCT04895007|Vaccines|vaccines|mesh-list
5928013|NCT04895007|Immunologic Factors|immunologic factors|mesh-ancestor
5928014|NCT04895007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928015|NCT04895137|Bevacizumab|bevacizumab|mesh-list
5928016|NCT04895137|Antibodies|antibodies|mesh-list
5928017|NCT04895137|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5928018|NCT04895137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5928019|NCT04895137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5928020|NCT04895137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5928021|NCT04895137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5928022|NCT04895137|Growth Substances|growth substances|mesh-ancestor
5928023|NCT04895137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928024|NCT04895137|Growth Inhibitors|growth inhibitors|mesh-ancestor
5928025|NCT04895137|Immunologic Factors|immunologic factors|mesh-ancestor
5928026|NCT04894994|Ipilimumab|ipilimumab|mesh-list
5928027|NCT04894994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5928028|NCT04894994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5928029|NCT04894994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5928030|NCT04894994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928031|NCT04894643|Gemcitabine|gemcitabine|mesh-list
5928032|NCT04894643|Paclitaxel|paclitaxel|mesh-list
5928033|NCT04894643|Capecitabine|capecitabine|mesh-list
5928034|NCT04894643|Pancrelipase|pancrelipase|mesh-list
5928035|NCT04894643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5928036|NCT04894643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5928037|NCT04894643|Tubulin Modulators|tubulin modulators|mesh-ancestor
5928038|NCT04894643|Antimitotic Agents|antimitotic agents|mesh-ancestor
5928039|NCT04894643|Mitosis Modulators|mitosis modulators|mesh-ancestor
5928040|NCT04894643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928041|NCT04894643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5928042|NCT04894643|Antimetabolites|antimetabolites|mesh-ancestor
5928043|NCT04894643|Antiviral Agents|antiviral agents|mesh-ancestor
5928044|NCT04894643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5928045|NCT04894643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5928046|NCT04894643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5928047|NCT04894643|Immunologic Factors|immunologic factors|mesh-ancestor
5928048|NCT04894643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928049|NCT04894643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5928050|NCT04894630|Anti-Infective Agents|anti-infective agents|mesh-list
5928051|NCT04894630|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5928052|NCT04894617|Amantadine|amantadine|mesh-list
5928053|NCT04894617|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5928054|NCT04894617|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5928055|NCT04894617|Antiviral Agents|antiviral agents|mesh-ancestor
5928056|NCT04894617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5928057|NCT04894617|Dopamine Agents|dopamine agents|mesh-ancestor
5928058|NCT04894617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5928059|NCT04894617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928060|NCT04894617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928061|NCT04894617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5928062|NCT04894617|Analgesics|analgesics|mesh-ancestor
5928063|NCT04894617|Sensory System Agents|sensory system agents|mesh-ancestor
5928064|NCT04894617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5928065|NCT04894682|Vaccines|vaccines|mesh-list
5928066|NCT04894682|Immunologic Factors|immunologic factors|mesh-ancestor
5928067|NCT04894682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928068|NCT04894253|Vaccines|vaccines|mesh-list
5928069|NCT04894253|Immunologic Factors|immunologic factors|mesh-ancestor
5928070|NCT04894253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928071|NCT04894188|Goserelin|goserelin|mesh-list
5928072|NCT04894188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5928073|NCT04894188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5965496|NCT04582604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5965497|NCT04582604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5965498|NCT04582786|Morphine|morphine|mesh-list
5965499|NCT04582786|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5965500|NCT04582786|Narcotics|narcotics|mesh-ancestor
5965501|NCT04582786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5965502|NCT04582786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965503|NCT04582786|Analgesics|analgesics|mesh-ancestor
5965504|NCT04582786|Sensory System Agents|sensory system agents|mesh-ancestor
5965505|NCT04582786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5965506|NCT04582084|Etanercept|etanercept|mesh-list
5965507|NCT04582084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5965508|NCT04582084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5965509|NCT04582084|Analgesics|analgesics|mesh-ancestor
5965510|NCT04582084|Sensory System Agents|sensory system agents|mesh-ancestor
5965511|NCT04582084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5965512|NCT04582084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965513|NCT04582084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5965514|NCT04582084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5965515|NCT04582084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5965516|NCT04582084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5965517|NCT04582084|Immunologic Factors|immunologic factors|mesh-ancestor
5970773|NCT04532684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5970774|NCT04532684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970775|NCT04532684|Anticonvulsants|anticonvulsants|mesh-ancestor
5970776|NCT04532684|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5970777|NCT04532684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5970778|NCT04532684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970779|NCT04532684|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5970780|NCT04532684|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5970781|NCT04532684|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5970782|NCT04532684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5970783|NCT04532684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5970784|NCT04532684|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5970785|NCT04532684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5970786|NCT04532684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5970787|NCT04532684|Antidepressive Agents|antidepressive agents|mesh-ancestor
5970788|NCT04532684|Dopamine Agents|dopamine agents|mesh-ancestor
5970789|NCT04532736|Mometasone Furoate|mometasone furoate|mesh-list
5970790|NCT04532736|Methylprednisolone|methylprednisolone|mesh-list
5970791|NCT04532736|Methotrexate|methotrexate|mesh-list
5970792|NCT04532736|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5970793|NCT04532736|Abortifacient Agents|abortifacient agents|mesh-ancestor
5970794|NCT04532736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5970795|NCT04532736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970796|NCT04532736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5970797|NCT04532736|Antimetabolites|antimetabolites|mesh-ancestor
5970798|NCT04532736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970799|NCT04532736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5970800|NCT04532736|Dermatologic Agents|dermatologic agents|mesh-ancestor
5970801|NCT04532736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5970802|NCT04532736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5970803|NCT04532736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5970804|NCT04532736|Immunologic Factors|immunologic factors|mesh-ancestor
5970805|NCT04532736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5970806|NCT04532736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5970807|NCT04532736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5970808|NCT04532736|Antiemetics|antiemetics|mesh-ancestor
5970809|NCT04532736|Autonomic Agents|autonomic agents|mesh-ancestor
5970810|NCT04532736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5970811|NCT04532736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5970812|NCT04532736|Glucocorticoids|glucocorticoids|mesh-ancestor
5970813|NCT04532736|Hormones|hormones|mesh-ancestor
5970814|NCT04532736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5970815|NCT04532736|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5970816|NCT04532736|Protective Agents|protective agents|mesh-ancestor
5970817|NCT04532736|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5928074|NCT04893993|Thiamine|thiamine|mesh-list
5928075|NCT04893993|Vitamin B Complex|vitamin b complex|mesh-ancestor
5928076|NCT04893993|Vitamins|vitamins|mesh-ancestor
5928077|NCT04893993|Micronutrients|micronutrients|mesh-ancestor
5928078|NCT04893993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928079|NCT04893798|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
5928080|NCT04893798|Medroxyprogesterone|medroxyprogesterone|mesh-list
5928081|NCT04893798|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5928082|NCT04893798|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5928083|NCT04893798|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5928084|NCT04893798|Contraceptive Agents|contraceptive agents|mesh-ancestor
5928085|NCT04893798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5928086|NCT04893798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928087|NCT04893798|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5928088|NCT04893798|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5928089|NCT04893798|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5928090|NCT04893798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5928091|NCT04893798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5928092|NCT04893980|Aldesleukin|aldesleukin|mesh-list
5928093|NCT04893980|Interleukin-2|interleukin-2|mesh-list
5928094|NCT04893980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5928095|NCT04893980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5928096|NCT04893980|Analgesics|analgesics|mesh-ancestor
5928097|NCT04893980|Sensory System Agents|sensory system agents|mesh-ancestor
5928098|NCT04893980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5928099|NCT04893980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681174|NCT01608412|Immunologic Factors|immunologic factors|mesh-ancestor
6681175|NCT01608412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681176|NCT01608412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6681177|NCT01608412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6681178|NCT01608412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681179|NCT01608412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6681180|NCT01608451|Cholecalciferol|cholecalciferol|mesh-list
6681181|NCT01608451|Progesterone|progesterone|mesh-list
5928100|NCT04893980|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5928101|NCT04893980|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5928102|NCT04893980|Antiviral Agents|antiviral agents|mesh-ancestor
5928103|NCT04893980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5928104|NCT04893655|Dobutamine|dobutamine|mesh-list
5928105|NCT04893655|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5928106|NCT04893655|Sympathomimetics|sympathomimetics|mesh-ancestor
5928107|NCT04893655|Autonomic Agents|autonomic agents|mesh-ancestor
5928108|NCT04893655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5928109|NCT04893655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928110|NCT04893655|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5928111|NCT04893655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5928112|NCT04893655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5928113|NCT04893655|Adrenergic Agents|adrenergic agents|mesh-ancestor
5928114|NCT04893655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5928115|NCT04893655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928116|NCT04893655|Protective Agents|protective agents|mesh-ancestor
5928117|NCT04893616|Vaccines|vaccines|mesh-list
5928118|NCT04893616|Immunologic Factors|immunologic factors|mesh-ancestor
5928119|NCT04893616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928120|NCT04893733|Folic Acid|folic acid|mesh-list
5928121|NCT04893733|Vitamin B Complex|vitamin b complex|mesh-list
5928122|NCT04893733|Vitamins|vitamins|mesh-ancestor
5928123|NCT04893733|Micronutrients|micronutrients|mesh-ancestor
5928124|NCT04893733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928125|NCT04893733|Hematinics|hematinics|mesh-ancestor
5928126|NCT04893629|Digoxin|digoxin|mesh-list
5928127|NCT04893629|Captopril|captopril|mesh-list
5928128|NCT04893629|Furosemide|furosemide|mesh-list
5928129|NCT04893629|Diuretics|diuretics|mesh-ancestor
5928130|NCT04893629|Natriuretic Agents|natriuretic agents|mesh-ancestor
5928131|NCT04893629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928132|NCT04893629|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5928133|NCT04893629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5928134|NCT04893629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928135|NCT04893629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5928136|NCT04893629|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5928137|NCT04893629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5928138|NCT04893629|Protective Agents|protective agents|mesh-ancestor
5928139|NCT04893629|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5928140|NCT04893629|Protease Inhibitors|protease inhibitors|mesh-ancestor
5928141|NCT04893629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5928142|NCT04893525|Buprenorphine|buprenorphine|mesh-list
5928143|NCT04893525|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
5928144|NCT04893525|Naloxone|naloxone|mesh-list
5928145|NCT04893525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5928146|NCT04893525|Narcotics|narcotics|mesh-ancestor
5928147|NCT04893525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5928148|NCT04893525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928149|NCT04893525|Analgesics|analgesics|mesh-ancestor
5928150|NCT04893525|Sensory System Agents|sensory system agents|mesh-ancestor
5928151|NCT04893525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5928152|NCT04893525|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5928153|NCT04893356|Dacarbazine|dacarbazine|mesh-list
5928154|NCT04893356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5928155|NCT04893356|Alkylating Agents|alkylating agents|mesh-ancestor
5928156|NCT04893356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928157|NCT04893356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5928158|NCT04893174|Hyaluronic Acid|hyaluronic acid|mesh-list
5928159|NCT04893174|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5928160|NCT04893174|Immunologic Factors|immunologic factors|mesh-ancestor
5928161|NCT04893174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928162|NCT04893174|Viscosupplements|viscosupplements|mesh-ancestor
5928163|NCT04893174|Protective Agents|protective agents|mesh-ancestor
5928164|NCT04892953|Gemcitabine|gemcitabine|mesh-list
5928165|NCT04892953|Paclitaxel|paclitaxel|mesh-list
5928166|NCT04892953|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5928167|NCT04892953|Carboplatin|carboplatin|mesh-list
5928168|NCT04892953|Pemetrexed|pemetrexed|mesh-list
5928169|NCT04892953|Durvalumab|durvalumab|mesh-list
5928170|NCT04892953|Immunoglobulins|immunoglobulins|mesh-list
5928171|NCT04892953|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5928172|NCT04892953|Immunoglobulin G|immunoglobulin g|mesh-list
5928173|NCT04892953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5928174|NCT04892953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5928175|NCT04892953|Tubulin Modulators|tubulin modulators|mesh-ancestor
5928176|NCT04892953|Antimitotic Agents|antimitotic agents|mesh-ancestor
5928177|NCT04892953|Mitosis Modulators|mitosis modulators|mesh-ancestor
5928178|NCT04892953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928179|NCT04892953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5928180|NCT04892953|Antimetabolites|antimetabolites|mesh-ancestor
5928181|NCT04892953|Antiviral Agents|antiviral agents|mesh-ancestor
5928182|NCT04892953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5928183|NCT04892953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5928184|NCT04892953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5928185|NCT04892953|Immunologic Factors|immunologic factors|mesh-ancestor
5928186|NCT04892953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928187|NCT04892953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5928188|NCT04892953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5928189|NCT04892953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5928190|NCT04892940|Analgesics|analgesics|mesh-list
5928191|NCT04892940|Sensory System Agents|sensory system agents|mesh-ancestor
5928192|NCT04892940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5928193|NCT04892940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928194|NCT04893252|Durvalumab|durvalumab|mesh-list
5928195|NCT04893252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5928196|NCT04893252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5928197|NCT04892732|Budesonide|budesonide|mesh-list
5928198|NCT04892732|Formoterol Fumarate|formoterol fumarate|mesh-list
5928199|NCT04892732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5928200|NCT04892732|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5928201|NCT04892732|Autonomic Agents|autonomic agents|mesh-ancestor
5928202|NCT04892732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5928203|NCT04892732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928204|NCT04892732|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5928205|NCT04892732|Respiratory System Agents|respiratory system agents|mesh-ancestor
5928206|NCT04892732|Glucocorticoids|glucocorticoids|mesh-ancestor
5928207|NCT04892732|Hormones|hormones|mesh-ancestor
5928208|NCT04892732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5928209|NCT04892732|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5928210|NCT04892732|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5928211|NCT04892732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5928212|NCT04892732|Adrenergic Agents|adrenergic agents|mesh-ancestor
5928213|NCT04892732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5928214|NCT04892732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928215|NCT04892758|Mometasone Furoate|mometasone furoate|mesh-list
5928216|NCT04892758|Formoterol Fumarate|formoterol fumarate|mesh-list
5928217|NCT04892758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5928218|NCT04892758|Autonomic Agents|autonomic agents|mesh-ancestor
5928219|NCT04892758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5928220|NCT04892758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928221|NCT04892758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5928222|NCT04892758|Respiratory System Agents|respiratory system agents|mesh-ancestor
5928223|NCT04892758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5928224|NCT04892758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5928225|NCT04892758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5928226|NCT04892758|Adrenergic Agents|adrenergic agents|mesh-ancestor
5928227|NCT04892758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5928228|NCT04892758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928229|NCT04892758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5928230|NCT04892758|Dermatologic Agents|dermatologic agents|mesh-ancestor
5928231|NCT04892758|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5928232|NCT04892498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5928233|NCT04892498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928234|NCT04892498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5928235|NCT04892511|Nitroprusside|nitroprusside|mesh-list
5928236|NCT04892511|Labetalol|labetalol|mesh-list
5928237|NCT04892511|Urapidil|urapidil|mesh-list
5928238|NCT04892511|Phenylephrine|phenylephrine|mesh-list
5928239|NCT04892511|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5928240|NCT04892511|Mydriatics|mydriatics|mesh-ancestor
5928241|NCT04892511|Autonomic Agents|autonomic agents|mesh-ancestor
5928242|NCT04892511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5928243|NCT04892511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928244|NCT04892511|Sympathomimetics|sympathomimetics|mesh-ancestor
5928245|NCT04892511|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5928246|NCT04892511|Nasal Decongestants|nasal decongestants|mesh-ancestor
5928247|NCT04892511|Respiratory System Agents|respiratory system agents|mesh-ancestor
5928248|NCT04892511|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5928249|NCT04892511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5928250|NCT04892511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5928251|NCT04892511|Adrenergic Agents|adrenergic agents|mesh-ancestor
5928252|NCT04892511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5928253|NCT04892511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928254|NCT04892511|Protective Agents|protective agents|mesh-ancestor
5928255|NCT04892511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5928256|NCT04892511|Vasodilator Agents|vasodilator agents|mesh-ancestor
5928257|NCT04892511|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5928258|NCT04892511|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5928259|NCT04892511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5928260|NCT04892511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5928261|NCT04892511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5928262|NCT04892511|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5928263|NCT04892511|Serotonin Agents|serotonin agents|mesh-ancestor
5928264|NCT04892693|Talazoparib|talazoparib|mesh-list
5928265|NCT04892693|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5928266|NCT04892693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5928267|NCT04892693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928268|NCT04892693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5928269|NCT04892654|Dolutegravir|dolutegravir|mesh-list
5928270|NCT04892654|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5928271|NCT04892654|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5928272|NCT04892654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5928273|NCT04892654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928274|NCT04892654|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5928275|NCT04892654|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5928276|NCT04892654|Antiviral Agents|antiviral agents|mesh-ancestor
5928277|NCT04892654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5928278|NCT04892459|Vaccines|vaccines|mesh-list
5928279|NCT04892459|Immunologic Factors|immunologic factors|mesh-ancestor
5928280|NCT04892459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928281|NCT04892563|Morphine|morphine|mesh-list
5928282|NCT04892563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5928283|NCT04892563|Narcotics|narcotics|mesh-ancestor
5928284|NCT04892563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5928285|NCT04892563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928286|NCT04892563|Analgesics|analgesics|mesh-ancestor
5928287|NCT04892563|Sensory System Agents|sensory system agents|mesh-ancestor
5928288|NCT04892563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5928289|NCT04892303|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
5928290|NCT04892303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928291|NCT04892212|Sirolimus|sirolimus|mesh-list
5928292|NCT04892212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5928293|NCT04892212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5928294|NCT04892212|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5928295|NCT04892212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5928296|NCT04892212|Antifungal Agents|antifungal agents|mesh-ancestor
5928297|NCT04892212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5928298|NCT04892212|Immunologic Factors|immunologic factors|mesh-ancestor
5928299|NCT04892212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928300|NCT04892264|Dexamethasone|dexamethasone|mesh-list
5928301|NCT04892264|Dexamethasone acetate|dexamethasone acetate|mesh-list
5928302|NCT04892264|Lenalidomide|lenalidomide|mesh-list
5928303|NCT04892264|Daratumumab|daratumumab|mesh-list
5928304|NCT04892264|Ichthammol|ichthammol|mesh-list
5928305|NCT04892264|BB 1101|bb 1101|mesh-list
5928306|NCT04892264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5928307|NCT04892264|Antiemetics|antiemetics|mesh-ancestor
5928308|NCT04892264|Autonomic Agents|autonomic agents|mesh-ancestor
5928309|NCT04892264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5928310|NCT04892264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928311|NCT04892264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5928312|NCT04892264|Glucocorticoids|glucocorticoids|mesh-ancestor
5928313|NCT04892264|Hormones|hormones|mesh-ancestor
5928314|NCT04892264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5928315|NCT04892264|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5928316|NCT04892264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5928317|NCT04892264|Protease Inhibitors|protease inhibitors|mesh-ancestor
5928318|NCT04892264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5928319|NCT04892264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928320|NCT04892264|Immunologic Factors|immunologic factors|mesh-ancestor
5928321|NCT04892264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5928322|NCT04892264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5928323|NCT04892264|Growth Substances|growth substances|mesh-ancestor
5928324|NCT04892264|Growth Inhibitors|growth inhibitors|mesh-ancestor
5928325|NCT04892264|Dermatologic Agents|dermatologic agents|mesh-ancestor
5965518|NCT04582305|Bleomycin|bleomycin|mesh-list
5965519|NCT04582305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5965520|NCT04582305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5965521|NCT04582136|Sirolimus|sirolimus|mesh-list
5965522|NCT04582136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5965523|NCT04582136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5965524|NCT04582136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5965525|NCT04582136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5965526|NCT04582136|Antifungal Agents|antifungal agents|mesh-ancestor
5965527|NCT04582136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5965528|NCT04582136|Immunologic Factors|immunologic factors|mesh-ancestor
5965529|NCT04582136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965530|NCT04582032|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
5965531|NCT04582032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5965532|NCT04582032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5965533|NCT04582032|Analgesics|analgesics|mesh-ancestor
5965534|NCT04582032|Sensory System Agents|sensory system agents|mesh-ancestor
5965535|NCT04582032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5965536|NCT04582032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965537|NCT04582032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5965538|NCT04582032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5965539|NCT04582097|Ramipril|ramipril|mesh-list
5965540|NCT04582097|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5965541|NCT04582097|Protease Inhibitors|protease inhibitors|mesh-ancestor
5965542|NCT04582097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5965543|NCT04582097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965544|NCT04582097|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5965545|NCT04581876|Paclitaxel|paclitaxel|mesh-list
5965546|NCT04581876|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5965547|NCT04581876|Raltitrexed|raltitrexed|mesh-list
5965548|NCT04581876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5965549|NCT04581876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5965550|NCT04581876|Tubulin Modulators|tubulin modulators|mesh-ancestor
5965551|NCT04581876|Antimitotic Agents|antimitotic agents|mesh-ancestor
5965552|NCT04581876|Mitosis Modulators|mitosis modulators|mesh-ancestor
5965553|NCT04581876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965554|NCT04581876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5965555|NCT04581876|Antimetabolites|antimetabolites|mesh-ancestor
5965556|NCT04581876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5965557|NCT04581876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5965558|NCT04581967|Cyclophosphamide|cyclophosphamide|mesh-list
5965559|NCT04581967|Doxorubicin|doxorubicin|mesh-list
5965560|NCT04581967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5965561|NCT04581967|Immunologic Factors|immunologic factors|mesh-ancestor
5970818|NCT04532710|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5928326|NCT04892069|Insulin|insulin|mesh-list
5928327|NCT04892069|Insulin Aspart|insulin aspart|mesh-list
5928328|NCT04892069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5928329|NCT04892069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928330|NCT04892017|Trametinib|trametinib|mesh-list
5928331|NCT04892017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5928332|NCT04892017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5928333|NCT04892017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5928334|NCT04892017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928335|NCT04892186|Inositol|inositol|mesh-list
5928336|NCT04892186|Metformin|metformin|mesh-list
5928337|NCT04892186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5928338|NCT04892186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928339|NCT04892186|Vitamin B Complex|vitamin b complex|mesh-ancestor
5928340|NCT04892186|Vitamins|vitamins|mesh-ancestor
5928341|NCT04892186|Micronutrients|micronutrients|mesh-ancestor
5928342|NCT04892173|Cetuximab|cetuximab|mesh-list
5928343|NCT04892173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5928344|NCT04892173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5928345|NCT04891861|Rivaroxaban|rivaroxaban|mesh-list
5928346|NCT04891861|Apixaban|apixaban|mesh-list
5928347|NCT04891861|Edoxaban|edoxaban|mesh-list
5928348|NCT04891861|Dabigatran|dabigatran|mesh-list
5928349|NCT04891861|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5928350|NCT04891861|Antithrombins|antithrombins|mesh-ancestor
5928351|NCT04891861|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5928352|NCT04891861|Protease Inhibitors|protease inhibitors|mesh-ancestor
5928353|NCT04891861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5928354|NCT04891861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928355|NCT04891861|Anticoagulants|anticoagulants|mesh-ancestor
5928356|NCT04891744|Thalidomide|thalidomide|mesh-list
5928357|NCT04891744|Dexamethasone|dexamethasone|mesh-list
5928358|NCT04891744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5928359|NCT04891744|Antiemetics|antiemetics|mesh-ancestor
5928360|NCT04891744|Autonomic Agents|autonomic agents|mesh-ancestor
5928361|NCT04891744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5928362|NCT04891744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928363|NCT04891744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5928364|NCT04891744|Glucocorticoids|glucocorticoids|mesh-ancestor
5928365|NCT04891744|Hormones|hormones|mesh-ancestor
5928366|NCT04891744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5928367|NCT04891744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5928368|NCT04891744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5928369|NCT04891744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5928370|NCT04891744|Immunologic Factors|immunologic factors|mesh-ancestor
5928371|NCT04891744|Leprostatic Agents|leprostatic agents|mesh-ancestor
5928372|NCT04891744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5928373|NCT04891744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5928374|NCT04891744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5928375|NCT04891744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5928376|NCT04891744|Growth Substances|growth substances|mesh-ancestor
5928377|NCT04891744|Growth Inhibitors|growth inhibitors|mesh-ancestor
5928378|NCT04891900|Capecitabine|capecitabine|mesh-list
5928379|NCT04891900|Oxaliplatin|oxaliplatin|mesh-list
5928380|NCT04891900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5928381|NCT04891900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5928382|NCT04891900|Antimetabolites|antimetabolites|mesh-ancestor
5928383|NCT04891900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928384|NCT04891900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5928385|NCT04891588|Timolol|timolol|mesh-list
5928386|NCT04891588|Latanoprost|latanoprost|mesh-list
5928387|NCT04891588|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5928388|NCT04891588|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5928389|NCT04891588|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5928390|NCT04891588|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5928391|NCT04891588|Adrenergic Agents|adrenergic agents|mesh-ancestor
5928392|NCT04891588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5928393|NCT04891588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928394|NCT04891588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928395|NCT04891588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5928396|NCT04891588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5928397|NCT04891497|Dimethyl Fumarate|dimethyl fumarate|mesh-list
5928398|NCT04891497|Dermatologic Agents|dermatologic agents|mesh-ancestor
5928399|NCT04891497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5928400|NCT04891497|Immunologic Factors|immunologic factors|mesh-ancestor
5928401|NCT04891497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928402|NCT04891679|Misoprostol|misoprostol|mesh-list
5928403|NCT04891679|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5928404|NCT04891679|Abortifacient Agents|abortifacient agents|mesh-ancestor
5928405|NCT04891679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5928406|NCT04891679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928407|NCT04891679|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5928408|NCT04891679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5928409|NCT04891679|Oxytocics|oxytocics|mesh-ancestor
5928410|NCT04891458|Dexmedetomidine|dexmedetomidine|mesh-list
5928411|NCT04891458|Anesthetics|anesthetics|mesh-list
5928412|NCT04891458|Propofol|propofol|mesh-list
5928413|NCT04891458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5928414|NCT04891458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928415|NCT04891458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5928416|NCT04891458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5928417|NCT04891458|Anesthetics, General|anesthetics, general|mesh-ancestor
5928418|NCT04891458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5928419|NCT04891458|Analgesics|analgesics|mesh-ancestor
5928420|NCT04891458|Sensory System Agents|sensory system agents|mesh-ancestor
5928421|NCT04891458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5928422|NCT04891458|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5928423|NCT04891458|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5928424|NCT04891458|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5928425|NCT04891458|Adrenergic Agents|adrenergic agents|mesh-ancestor
5928426|NCT04891458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5928427|NCT04891458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928428|NCT04891718|Nivolumab|nivolumab|mesh-list
5928429|NCT04891718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5928430|NCT04891718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5928431|NCT04891718|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5928432|NCT04891718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928433|NCT04891172|Immunoglobulins|immunoglobulins|mesh-list
5928434|NCT04891172|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5928435|NCT04891172|Antibodies|antibodies|mesh-list
5928436|NCT04891172|gamma-Globulins|gamma-globulins|mesh-list
5928437|NCT04891172|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5928438|NCT04891172|Immunologic Factors|immunologic factors|mesh-ancestor
5928439|NCT04891172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928440|NCT04891302|Clevudine|clevudine|mesh-list
5928441|NCT04891302|Antiviral Agents|antiviral agents|mesh-ancestor
5928442|NCT04891302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5928443|NCT04891211|Vitamin D|vitamin d|mesh-list
5928444|NCT04891211|Vitamins|vitamins|mesh-ancestor
5928445|NCT04891211|Micronutrients|micronutrients|mesh-ancestor
5928446|NCT04891211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928447|NCT04891211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5928448|NCT04890626|Tenofovir|tenofovir|mesh-list
5928449|NCT04890626|Emtricitabine|emtricitabine|mesh-list
5928450|NCT04890626|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5928451|NCT04890626|Dexamethasone|dexamethasone|mesh-list
5928452|NCT04890626|Dexamethasone acetate|dexamethasone acetate|mesh-list
5928453|NCT04890626|BB 1101|bb 1101|mesh-list
5928454|NCT04890626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5928455|NCT04890626|Antiemetics|antiemetics|mesh-ancestor
5928456|NCT04890626|Autonomic Agents|autonomic agents|mesh-ancestor
5928457|NCT04890626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5928458|NCT04890626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928459|NCT04890626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5928460|NCT04890626|Glucocorticoids|glucocorticoids|mesh-ancestor
5928461|NCT04890626|Hormones|hormones|mesh-ancestor
5928462|NCT04890626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5928463|NCT04890626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5928464|NCT04890626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5928465|NCT04890626|Protease Inhibitors|protease inhibitors|mesh-ancestor
5928466|NCT04890626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5928467|NCT04890626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928468|NCT04890626|Antiviral Agents|antiviral agents|mesh-ancestor
5928469|NCT04890626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5928470|NCT04890626|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5928471|NCT04890626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5928472|NCT04890626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5928473|NCT04890626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5928474|NCT04890873|Magnesium Hydroxide|magnesium hydroxide|mesh-list
5928475|NCT04890873|Antacids|antacids|mesh-ancestor
5928476|NCT04890873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928477|NCT04890873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5928478|NCT04890522|Gemcitabine|gemcitabine|mesh-list
5928479|NCT04890522|Fluorouracil|fluorouracil|mesh-list
5928480|NCT04890522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5928481|NCT04890522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5928482|NCT04890522|Antimetabolites|antimetabolites|mesh-ancestor
5928483|NCT04890522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928484|NCT04890522|Antiviral Agents|antiviral agents|mesh-ancestor
5928485|NCT04890522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5719145|NCT03220321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5719146|NCT03220321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5928486|NCT04890522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5928487|NCT04890522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5928488|NCT04890522|Immunologic Factors|immunologic factors|mesh-ancestor
5928489|NCT04890522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928490|NCT04890561|Lemborexant|lemborexant|mesh-list
5928491|NCT04890561|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
5928492|NCT04890561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5928493|NCT04890561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928494|NCT04890561|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5928495|NCT04890561|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5928496|NCT04890561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5928497|NCT04890561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928498|NCT04890353|Dimethyl Fumarate|dimethyl fumarate|mesh-list
5928499|NCT04890353|Dermatologic Agents|dermatologic agents|mesh-ancestor
5928500|NCT04890353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5928501|NCT04890353|Immunologic Factors|immunologic factors|mesh-ancestor
5928502|NCT04890353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965562|NCT04581967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965563|NCT04581967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5965564|NCT04581967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5719147|NCT03220321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719148|NCT03220425|Insulin|insulin|mesh-list
5719149|NCT03220425|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5719150|NCT03220425|Insulin Detemir|insulin detemir|mesh-list
5719151|NCT03220425|Insulin, Isophane|insulin, isophane|mesh-list
5965565|NCT04581967|Alkylating Agents|alkylating agents|mesh-ancestor
5965566|NCT04581967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965567|NCT04581967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5965568|NCT04581967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5965569|NCT04581967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5965570|NCT04581967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5965571|NCT04581967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5965572|NCT04581967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5965573|NCT04581447|Metformin|metformin|mesh-list
5965574|NCT04581447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5965575|NCT04581447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965576|NCT04581603|Topiramate|topiramate|mesh-list
5965577|NCT04581603|Anticonvulsants|anticonvulsants|mesh-ancestor
5965578|NCT04581603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5965579|NCT04581603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965580|NCT04581213|Anesthetics|anesthetics|mesh-list
5965581|NCT04581213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5965582|NCT04581213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965583|NCT04581408|Ivacaftor|ivacaftor|mesh-list
5965584|NCT04581408|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
5965585|NCT04581408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5965586|NCT04581408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965587|NCT04581265|Paclitaxel|paclitaxel|mesh-list
5965588|NCT04581265|Ifosfamide|ifosfamide|mesh-list
5965589|NCT04581265|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5965590|NCT04581265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5965591|NCT04581265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5965592|NCT04581265|Tubulin Modulators|tubulin modulators|mesh-ancestor
5965593|NCT04581265|Antimitotic Agents|antimitotic agents|mesh-ancestor
5965594|NCT04581265|Mitosis Modulators|mitosis modulators|mesh-ancestor
5965595|NCT04581265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965596|NCT04581265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5965597|NCT04581265|Alkylating Agents|alkylating agents|mesh-ancestor
5965598|NCT04581382|Pembrolizumab|pembrolizumab|mesh-list
5965599|NCT04581382|Nivolumab|nivolumab|mesh-list
5965600|NCT04581382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5965601|NCT04581382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5965602|NCT04581382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5965603|NCT04581382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965604|NCT04580797|PF-06700841|pf-06700841|mesh-list
5719152|NCT03220425|Isophane Insulin, Human|isophane insulin, human|mesh-list
5719153|NCT03220425|Isophane insulin, beef|isophane insulin, beef|mesh-list
5719154|NCT03220425|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5719155|NCT03220425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719156|NCT03220542|Amoxicillin|amoxicillin|mesh-list
5928503|NCT04890366|Dimethyl Fumarate|dimethyl fumarate|mesh-list
5928504|NCT04890366|Dermatologic Agents|dermatologic agents|mesh-ancestor
5928505|NCT04890366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5928506|NCT04890366|Immunologic Factors|immunologic factors|mesh-ancestor
5928507|NCT04890366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928508|NCT04890379|Dimethyl Fumarate|dimethyl fumarate|mesh-list
5928509|NCT04890379|Dermatologic Agents|dermatologic agents|mesh-ancestor
5928510|NCT04890379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5928511|NCT04890379|Immunologic Factors|immunologic factors|mesh-ancestor
5928512|NCT04890379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928513|NCT04890418|Ketamine|ketamine|mesh-list
5928514|NCT04890418|Analgesics|analgesics|mesh-ancestor
5928515|NCT04890418|Sensory System Agents|sensory system agents|mesh-ancestor
5928516|NCT04890418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5928517|NCT04890418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928518|NCT04890418|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5928519|NCT04890418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5928520|NCT04890418|Anesthetics, General|anesthetics, general|mesh-ancestor
5928521|NCT04890418|Anesthetics|anesthetics|mesh-ancestor
5928522|NCT04890418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5928523|NCT04890418|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5928524|NCT04890418|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5928525|NCT04890418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5928526|NCT04890418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928527|NCT04890392|Oxaliplatin|oxaliplatin|mesh-list
5928528|NCT04890392|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5928529|NCT04890392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5928530|NCT04890392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928531|NCT04890470|Vasopressins|vasopressins|mesh-list
5928532|NCT04890470|Arginine Vasopressin|arginine vasopressin|mesh-list
5928533|NCT04890470|Oxytocin|oxytocin|mesh-list
5928534|NCT04890470|Oxytocics|oxytocics|mesh-ancestor
5928535|NCT04890470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5928536|NCT04890470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928537|NCT04890470|Hemostatics|hemostatics|mesh-ancestor
5928538|NCT04890470|Coagulants|coagulants|mesh-ancestor
5928539|NCT04890470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5928540|NCT04890470|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5928541|NCT04890470|Natriuretic Agents|natriuretic agents|mesh-ancestor
5928542|NCT04889768|Antibodies|antibodies|mesh-list
5928543|NCT04889768|Immunologic Factors|immunologic factors|mesh-ancestor
5928544|NCT04889768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928545|NCT04889781|Dexamethasone|dexamethasone|mesh-list
5928546|NCT04889781|Dexamethasone acetate|dexamethasone acetate|mesh-list
5928547|NCT04889781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5928548|NCT04889781|Antiemetics|antiemetics|mesh-ancestor
5928549|NCT04889781|Autonomic Agents|autonomic agents|mesh-ancestor
5928550|NCT04889781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5928551|NCT04889781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928552|NCT04889781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5928553|NCT04889781|Glucocorticoids|glucocorticoids|mesh-ancestor
5928554|NCT04889781|Hormones|hormones|mesh-ancestor
5928555|NCT04889781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5928556|NCT04889781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5928557|NCT04889781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5928558|NCT04889651|Abiraterone Acetate|abiraterone acetate|mesh-list
5928559|NCT04889651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5928560|NCT04889651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5928561|NCT04889651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5928562|NCT04889651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928563|NCT04889651|Hormone Antagonists|hormone antagonists|mesh-ancestor
5928564|NCT04889651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5928565|NCT04889651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928566|NCT04889651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5719157|NCT03220542|Clarithromycin|clarithromycin|mesh-list
5719158|NCT03220542|Sulforaphane|sulforaphane|mesh-list
5719159|NCT03220542|Esomeprazole|esomeprazole|mesh-list
5719160|NCT03220542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5719161|NCT03220542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5719162|NCT03220542|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5928567|NCT04889664|Ketamine|ketamine|mesh-list
5719163|NCT03220542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5928568|NCT04889664|Analgesics|analgesics|mesh-ancestor
5928569|NCT04889664|Sensory System Agents|sensory system agents|mesh-ancestor
5928570|NCT04889664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5928571|NCT04889664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928572|NCT04889664|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5928573|NCT04889664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5928574|NCT04889664|Anesthetics, General|anesthetics, general|mesh-ancestor
5928575|NCT04889664|Anesthetics|anesthetics|mesh-ancestor
5928576|NCT04889664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5928577|NCT04889664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5928578|NCT04889664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5928579|NCT04889664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5928580|NCT04889664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928581|NCT04889079|Contraceptive Agents|contraceptive agents|mesh-list
5928582|NCT04889079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5928583|NCT04889079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928584|NCT04889196|Fluorides|fluorides|mesh-list
5928585|NCT04889196|Cariostatic Agents|cariostatic agents|mesh-ancestor
5928586|NCT04889196|Protective Agents|protective agents|mesh-ancestor
5928587|NCT04889196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928588|NCT04888663|Paclitaxel|paclitaxel|mesh-list
5928589|NCT04888663|Trastuzumab|trastuzumab|mesh-list
5928590|NCT04888663|Ramucirumab|ramucirumab|mesh-list
5928591|NCT04888663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5928592|NCT04888663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5928593|NCT04888663|Tubulin Modulators|tubulin modulators|mesh-ancestor
5928594|NCT04888663|Antimitotic Agents|antimitotic agents|mesh-ancestor
5928595|NCT04888663|Mitosis Modulators|mitosis modulators|mesh-ancestor
5928596|NCT04888663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928597|NCT04888663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5928598|NCT04888728|Nebivolol|nebivolol|mesh-list
5928599|NCT04888728|Paroxetine|paroxetine|mesh-list
5928600|NCT04888728|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5928601|NCT04888728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5928602|NCT04888728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5928603|NCT04888728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928604|NCT04888728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5928605|NCT04888728|Serotonin Agents|serotonin agents|mesh-ancestor
5928606|NCT04888728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928607|NCT04888728|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5928608|NCT04888728|Antidepressive Agents|antidepressive agents|mesh-ancestor
5928609|NCT04888728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6517108|NCT00719797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6517109|NCT00719797|Growth Substances|growth substances|mesh-ancestor
6517110|NCT00719797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517111|NCT00719797|Growth Inhibitors|growth inhibitors|mesh-ancestor
6517112|NCT00719797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6517113|NCT00719797|Antimetabolites|antimetabolites|mesh-ancestor
5928610|NCT04888728|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5928611|NCT04888728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5928612|NCT04888728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5928613|NCT04888728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5928614|NCT04888728|Vasodilator Agents|vasodilator agents|mesh-ancestor
5928615|NCT04888728|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5928616|NCT04888728|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5928617|NCT04888728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5928618|NCT04888728|Adrenergic Agents|adrenergic agents|mesh-ancestor
5928619|NCT04888858|Fentanyl|fentanyl|mesh-list
5928620|NCT04888858|Bupivacaine|bupivacaine|mesh-list
5928621|NCT04888858|Anesthetics, Local|anesthetics, local|mesh-ancestor
5928622|NCT04888858|Anesthetics|anesthetics|mesh-ancestor
5928623|NCT04888858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5928624|NCT04888858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928625|NCT04888858|Sensory System Agents|sensory system agents|mesh-ancestor
5928626|NCT04888858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5928627|NCT04888858|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5928628|NCT04888858|Narcotics|narcotics|mesh-ancestor
5928629|NCT04888858|Analgesics|analgesics|mesh-ancestor
5928630|NCT04888858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5928631|NCT04888858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5928632|NCT04888858|Anesthetics, General|anesthetics, general|mesh-ancestor
5928633|NCT04888741|Cyclosporine|cyclosporine|mesh-list
5928634|NCT04888741|Sirolimus|sirolimus|mesh-list
5928635|NCT04888741|Mycophenolic Acid|mycophenolic acid|mesh-list
5928636|NCT04888741|Cyclophosphamide|cyclophosphamide|mesh-list
5928637|NCT04888741|Cyclosporins|cyclosporins|mesh-list
5928638|NCT04888741|Thymoglobulin|thymoglobulin|mesh-list
5928639|NCT04888741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5928640|NCT04888741|Immunologic Factors|immunologic factors|mesh-ancestor
5928641|NCT04888741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928642|NCT04888741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5928643|NCT04888741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5928644|NCT04888741|Alkylating Agents|alkylating agents|mesh-ancestor
5928645|NCT04888741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928646|NCT04888741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5928647|NCT04888741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5928648|NCT04888741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5928649|NCT04888741|Antifungal Agents|antifungal agents|mesh-ancestor
5928650|NCT04888741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5928651|NCT04888741|Dermatologic Agents|dermatologic agents|mesh-ancestor
5928652|NCT04888741|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5928653|NCT04888741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5928654|NCT04888741|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5928655|NCT04888741|Antitubercular Agents|antitubercular agents|mesh-ancestor
5928656|NCT04888741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5928657|NCT04888715|Pirfenidone|pirfenidone|mesh-list
5928658|NCT04888715|Nintedanib|nintedanib|mesh-list
5928659|NCT04888715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5928660|NCT04888715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5928661|NCT04888715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5928662|NCT04888715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928663|NCT04888715|Analgesics|analgesics|mesh-ancestor
5928664|NCT04888715|Sensory System Agents|sensory system agents|mesh-ancestor
5928665|NCT04888715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5928666|NCT04888715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928667|NCT04888715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5928668|NCT04888715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5928669|NCT04888715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5928670|NCT04888715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5965605|NCT04580797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5965606|NCT04580797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5965607|NCT04580797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965608|NCT04580771|Cisplatin|cisplatin|mesh-list
5965609|NCT04580771|Vaccines|vaccines|mesh-list
5965610|NCT04580771|Immunologic Factors|immunologic factors|mesh-ancestor
5965611|NCT04580771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965612|NCT04580771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5970819|NCT04532710|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5970820|NCT04532606|Anesthetics|anesthetics|mesh-list
5970821|NCT04532606|Propofol|propofol|mesh-list
5970822|NCT04532606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5970823|NCT04532606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970824|NCT04532606|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5970825|NCT04532606|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5970826|NCT04532606|Anesthetics, General|anesthetics, general|mesh-ancestor
5970827|NCT04532372|Leflunomide|leflunomide|mesh-list
5970828|NCT04532372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5970829|NCT04532372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970830|NCT04532372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5970831|NCT04532372|Immunologic Factors|immunologic factors|mesh-ancestor
5970832|NCT04532372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970833|NCT04532554|Hormones|hormones|mesh-list
5970834|NCT04532554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5970835|NCT04532554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971373|NCT04528797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5971374|NCT04528797|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5971375|NCT04528797|Protective Agents|protective agents|mesh-ancestor
5971376|NCT04528797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5971377|NCT04528797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5971378|NCT04528888|Methylprednisolone|methylprednisolone|mesh-list
5971379|NCT04528888|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5971380|NCT04528888|Heparin|heparin|mesh-list
5971381|NCT04528888|Enoxaparin|enoxaparin|mesh-list
5971382|NCT04528888|Calcium heparin|calcium heparin|mesh-list
5971383|NCT04528888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5971384|NCT04528888|Antiemetics|antiemetics|mesh-ancestor
5971385|NCT04528888|Autonomic Agents|autonomic agents|mesh-ancestor
5971386|NCT04528888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5971387|NCT04528888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779935|NCT02181543|Adrenergic Agents|adrenergic agents|mesh-ancestor
5928671|NCT04888403|Paclitaxel|paclitaxel|mesh-list
5928672|NCT04888403|Nedaplatin|nedaplatin|mesh-list
5928673|NCT04888403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5928674|NCT04888403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5928675|NCT04888403|Tubulin Modulators|tubulin modulators|mesh-ancestor
5928676|NCT04888403|Antimitotic Agents|antimitotic agents|mesh-ancestor
5928677|NCT04888403|Mitosis Modulators|mitosis modulators|mesh-ancestor
5928678|NCT04888403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928679|NCT04887818|Lidocaine|lidocaine|mesh-list
5928680|NCT04887818|Diltiazem|diltiazem|mesh-list
5928681|NCT04887818|Nifedipine|nifedipine|mesh-list
5928682|NCT04887818|Anesthetics, Local|anesthetics, local|mesh-ancestor
5928683|NCT04887818|Anesthetics|anesthetics|mesh-ancestor
5928684|NCT04887818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5928685|NCT04887818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928686|NCT04887818|Sensory System Agents|sensory system agents|mesh-ancestor
5928687|NCT04887818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5928688|NCT04887818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5928689|NCT04887818|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5928690|NCT04887818|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5928691|NCT04887818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5928692|NCT04887818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928693|NCT04887818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5928694|NCT04887818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5928695|NCT04887818|Vasodilator Agents|vasodilator agents|mesh-ancestor
5928696|NCT04887818|Tocolytic Agents|tocolytic agents|mesh-ancestor
5928697|NCT04887818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5928698|NCT04887818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5928699|NCT04887961|Trabectedin|trabectedin|mesh-list
5928700|NCT04887961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5928701|NCT04887961|Alkylating Agents|alkylating agents|mesh-ancestor
5928702|NCT04887961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928703|NCT04887961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5928704|NCT04887649|Morphine|morphine|mesh-list
5928705|NCT04887649|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5928706|NCT04887649|Narcotics|narcotics|mesh-ancestor
5928707|NCT04887649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5928708|NCT04887649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928709|NCT04887649|Analgesics|analgesics|mesh-ancestor
5928710|NCT04887649|Sensory System Agents|sensory system agents|mesh-ancestor
5928711|NCT04887649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5928712|NCT04887805|Pembrolizumab|pembrolizumab|mesh-list
5928713|NCT04887805|Lenvatinib|lenvatinib|mesh-list
5928714|NCT04887805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5928715|NCT04887805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5928716|NCT04887805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5928717|NCT04887805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5928718|NCT04887805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928719|NCT04887844|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
5928720|NCT04887844|Lidocaine|lidocaine|mesh-list
5928721|NCT04887844|Anesthetics, Local|anesthetics, local|mesh-ancestor
5928722|NCT04887844|Anesthetics|anesthetics|mesh-ancestor
5928723|NCT04887844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5928724|NCT04887844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928725|NCT04887844|Sensory System Agents|sensory system agents|mesh-ancestor
5928726|NCT04887844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5928727|NCT04887844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6517114|NCT00719797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681182|NCT01608451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6681183|NCT01608451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681184|NCT01608451|Vitamins|vitamins|mesh-ancestor
6681185|NCT01608451|Micronutrients|micronutrients|mesh-ancestor
6681186|NCT01608451|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6681187|NCT01608451|Progestins|progestins|mesh-ancestor
6681188|NCT01608451|Hormones|hormones|mesh-ancestor
6681189|NCT01608451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6681190|NCT01608464|Cisplatin|cisplatin|mesh-list
6681191|NCT01608464|Docetaxel|docetaxel|mesh-list
6681192|NCT01608464|Fluorouracil|fluorouracil|mesh-list
6681193|NCT01608464|Irinotecan|irinotecan|mesh-list
6681194|NCT01608464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6681195|NCT01608464|Tubulin Modulators|tubulin modulators|mesh-ancestor
6681196|NCT01608464|Antimitotic Agents|antimitotic agents|mesh-ancestor
6517115|NCT00719797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6681197|NCT01608464|Mitosis Modulators|mitosis modulators|mesh-ancestor
6681198|NCT01608464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681199|NCT01608464|Antimetabolites|antimetabolites|mesh-ancestor
6681200|NCT01608464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5928728|NCT04887844|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5928729|NCT04887844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5928730|NCT04887844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5928731|NCT04887844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928732|NCT04887844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5928733|NCT04887844|Glucocorticoids|glucocorticoids|mesh-ancestor
5928734|NCT04887844|Hormones|hormones|mesh-ancestor
5928735|NCT04887844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5928736|NCT04887467|Apomorphine|apomorphine|mesh-list
5928737|NCT04887467|Emetics|emetics|mesh-ancestor
5928738|NCT04887467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928739|NCT04887467|Autonomic Agents|autonomic agents|mesh-ancestor
5928740|NCT04887467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5928741|NCT04887467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5928742|NCT04887467|Dopamine Agonists|dopamine agonists|mesh-ancestor
5928743|NCT04887467|Dopamine Agents|dopamine agents|mesh-ancestor
5928744|NCT04887467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5928745|NCT04887467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928746|NCT04887493|Alprostadil|alprostadil|mesh-list
5928747|NCT04887493|Misoprostol|misoprostol|mesh-list
5928748|NCT04887493|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5928749|NCT04887493|Abortifacient Agents|abortifacient agents|mesh-ancestor
5928750|NCT04887493|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5928751|NCT04887493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928752|NCT04887493|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5928753|NCT04887493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5928754|NCT04887493|Oxytocics|oxytocics|mesh-ancestor
5928755|NCT04887493|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5928756|NCT04887493|Vasodilator Agents|vasodilator agents|mesh-ancestor
5928757|NCT04887493|Urological Agents|urological agents|mesh-ancestor
5928758|NCT04887298|Annamycin|annamycin|mesh-list
5928759|NCT04887298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5928760|NCT04887298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5928761|NCT04887389|Listerine|listerine|mesh-list
5928762|NCT04887389|Fluorides|fluorides|mesh-list
5928763|NCT04887389|Sodium Fluoride|sodium fluoride|mesh-list
5928764|NCT04887389|Fluorides, Topical|fluorides, topical|mesh-list
5928765|NCT04887389|Cariostatic Agents|cariostatic agents|mesh-ancestor
5928766|NCT04887389|Protective Agents|protective agents|mesh-ancestor
5928767|NCT04887389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928768|NCT04887389|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5928769|NCT04887389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5928770|NCT04887311|Tempol|tempol|mesh-list
5928771|NCT04887311|Antioxidants|antioxidants|mesh-ancestor
5928772|NCT04887311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928773|NCT04887311|Protective Agents|protective agents|mesh-ancestor
5928774|NCT04887311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928775|NCT04887311|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5928776|NCT04887311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5928777|NCT04887311|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5928778|NCT04887311|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5928779|NCT04886986|Edetic Acid|edetic acid|mesh-list
5928780|NCT04886986|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5928781|NCT04886986|Anticoagulants|anticoagulants|mesh-ancestor
5928782|NCT04886986|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6517116|NCT00719797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6517117|NCT00719797|Immunologic Factors|immunologic factors|mesh-ancestor
6517118|NCT00719797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6517119|NCT00719797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6517120|NCT00719797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6517121|NCT00719797|Antidotes|antidotes|mesh-ancestor
6517122|NCT00719797|Protective Agents|protective agents|mesh-ancestor
6517123|NCT00719797|Vitamin B Complex|vitamin b complex|mesh-ancestor
6517124|NCT00719797|Vitamins|vitamins|mesh-ancestor
6517125|NCT00719797|Micronutrients|micronutrients|mesh-ancestor
6517126|NCT00719823|Maraviroc|maraviroc|mesh-list
6517127|NCT00719823|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6517128|NCT00719823|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6517129|NCT00719823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517130|NCT00719823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6517131|NCT00719823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5928783|NCT04886986|Chelating Agents|chelating agents|mesh-ancestor
5928784|NCT04886986|Sequestering Agents|sequestering agents|mesh-ancestor
5928785|NCT04886986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928786|NCT04886986|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5928787|NCT04886869|Caffeine|caffeine|mesh-list
5928788|NCT04886869|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5928789|NCT04886869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928790|NCT04886869|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5928791|NCT04886869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5928792|NCT04886869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928793|NCT04886869|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5928794|NCT04886869|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5928795|NCT04886869|Purinergic Agents|purinergic agents|mesh-ancestor
5928796|NCT04886869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5928797|NCT04886752|Vitamins|vitamins|mesh-list
5928798|NCT04886752|Ascorbic Acid|ascorbic acid|mesh-list
5928799|NCT04886752|Vitamin B Complex|vitamin b complex|mesh-list
5928800|NCT04886752|Micronutrients|micronutrients|mesh-ancestor
5928801|NCT04886752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928802|NCT04886752|Antioxidants|antioxidants|mesh-ancestor
5928803|NCT04886752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928804|NCT04886752|Protective Agents|protective agents|mesh-ancestor
5965613|NCT04580355|Amoxicillin|amoxicillin|mesh-list
5965614|NCT04580355|Metronidazole|metronidazole|mesh-list
5965615|NCT04580355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5965616|NCT04580355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5965617|NCT04580355|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5965618|NCT04580355|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5965619|NCT04580342|Propranolol|propranolol|mesh-list
5965620|NCT04580342|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5965621|NCT04580342|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5965622|NCT04580342|Adrenergic Agents|adrenergic agents|mesh-ancestor
5965623|NCT04580342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5965624|NCT04580342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965625|NCT04580342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965626|NCT04580342|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5965627|NCT04580342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5965628|NCT04580342|Vasodilator Agents|vasodilator agents|mesh-ancestor
5965629|NCT04580381|Natalizumab|natalizumab|mesh-list
5965630|NCT04580381|Immunologic Factors|immunologic factors|mesh-ancestor
5965631|NCT04580381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965632|NCT04580472|Clindamycin|clindamycin|mesh-list
5965633|NCT04580472|Clindamycin palmitate|clindamycin palmitate|mesh-list
5965634|NCT04580472|Clindamycin phosphate|clindamycin phosphate|mesh-list
5965635|NCT04580472|Cephalexin|cephalexin|mesh-list
5965636|NCT04580472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5965637|NCT04580472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5965638|NCT04580472|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5965639|NCT04580472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5965640|NCT04580472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965641|NCT04580394|Oxybutynin|oxybutynin|mesh-list
5965642|NCT04580394|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
5965643|NCT04580394|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5965644|NCT04580394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5719164|NCT03220542|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5719165|NCT03220542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5719166|NCT03220542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965645|NCT04580394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5965646|NCT04580394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965647|NCT04580394|Adrenergic Agents|adrenergic agents|mesh-ancestor
5965648|NCT04580394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5965649|NCT04580394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965650|NCT04580394|Parasympatholytics|parasympatholytics|mesh-ancestor
5965651|NCT04580394|Autonomic Agents|autonomic agents|mesh-ancestor
5719167|NCT03220542|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5719168|NCT03220542|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5719169|NCT03220542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5719170|NCT03220542|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5719171|NCT03220542|Protective Agents|protective agents|mesh-ancestor
5719172|NCT03220542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719173|NCT03220542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5719174|NCT03220490|Timolol|timolol|mesh-list
5719175|NCT03220490|Brimonidine Tartrate|brimonidine tartrate|mesh-list
5719176|NCT03220490|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5928805|NCT04886323|Ketoconazole|ketoconazole|mesh-list
5928806|NCT04886323|Antifungal Agents|antifungal agents|mesh-ancestor
5928807|NCT04886323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5928808|NCT04886323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5928809|NCT04886323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5928810|NCT04886323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5928811|NCT04886323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928812|NCT04886323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5928813|NCT04886323|Hormone Antagonists|hormone antagonists|mesh-ancestor
5928814|NCT04886323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5928815|NCT04886323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928816|NCT04886323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5928817|NCT04886414|Hand Sanitizers|hand sanitizers|mesh-list
5928818|NCT04886414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5928819|NCT04886414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5928820|NCT04886414|Disinfectants|disinfectants|mesh-ancestor
5928821|NCT04886297|Resveratrol|resveratrol|mesh-list
5928822|NCT04886297|Antioxidants|antioxidants|mesh-ancestor
5928823|NCT04886297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928824|NCT04886297|Protective Agents|protective agents|mesh-ancestor
5928825|NCT04886297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928826|NCT04886297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5928827|NCT04886297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5928828|NCT04886362|Ivermectin|ivermectin|mesh-list
5928829|NCT04886362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5928830|NCT04886362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5928831|NCT04886193|Leucovorin|leucovorin|mesh-list
5928832|NCT04886193|Docetaxel|docetaxel|mesh-list
5928833|NCT04886193|Oxaliplatin|oxaliplatin|mesh-list
5928834|NCT04886193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5928835|NCT04886193|Tubulin Modulators|tubulin modulators|mesh-ancestor
5928836|NCT04886193|Antimitotic Agents|antimitotic agents|mesh-ancestor
5928837|NCT04886193|Mitosis Modulators|mitosis modulators|mesh-ancestor
5928838|NCT04886193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928839|NCT04886193|Antidotes|antidotes|mesh-ancestor
5928840|NCT04886193|Protective Agents|protective agents|mesh-ancestor
5928841|NCT04886193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928842|NCT04886193|Vitamin B Complex|vitamin b complex|mesh-ancestor
5928843|NCT04886193|Vitamins|vitamins|mesh-ancestor
5928844|NCT04886193|Micronutrients|micronutrients|mesh-ancestor
5928845|NCT04886167|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5928846|NCT04886167|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5928847|NCT04886167|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5928848|NCT04886167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5928849|NCT04886167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928850|NCT04886167|Cholinergic Agents|cholinergic agents|mesh-ancestor
5928851|NCT04886167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5928852|NCT04886167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928853|NCT04886167|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5928854|NCT04886167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5928855|NCT04885972|Triamcinolone|triamcinolone|mesh-list
5928856|NCT04885972|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5928857|NCT04885972|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5928858|NCT04885972|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5928859|NCT04885972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5928860|NCT04885972|Glucocorticoids|glucocorticoids|mesh-ancestor
5928861|NCT04885972|Hormones|hormones|mesh-ancestor
5928862|NCT04885972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5928863|NCT04885972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928864|NCT04885972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5928865|NCT04885972|Immunologic Factors|immunologic factors|mesh-ancestor
5928866|NCT04885972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5928867|NCT04885972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928868|NCT04885907|Vaccines|vaccines|mesh-list
5928869|NCT04885907|Immunologic Factors|immunologic factors|mesh-ancestor
5928870|NCT04885907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928871|NCT04885764|Vaccines|vaccines|mesh-list
5928872|NCT04885764|Immunologic Factors|immunologic factors|mesh-ancestor
5928873|NCT04885764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928874|NCT04885777|Lidocaine|lidocaine|mesh-list
5928875|NCT04885777|Anesthetics, Local|anesthetics, local|mesh-ancestor
5928876|NCT04885777|Anesthetics|anesthetics|mesh-ancestor
5928877|NCT04885777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5928878|NCT04885777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928879|NCT04885777|Sensory System Agents|sensory system agents|mesh-ancestor
5928880|NCT04885777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5928881|NCT04885777|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5928882|NCT04885777|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5928883|NCT04885777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5928884|NCT04885777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5928885|NCT04885777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928886|NCT04885712|Metformin|metformin|mesh-list
5928887|NCT04885712|Pioglitazone|pioglitazone|mesh-list
5928888|NCT04885712|Dapagliflozin|dapagliflozin|mesh-list
5928889|NCT04885712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5928890|NCT04885712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928891|NCT04885712|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5928892|NCT04885712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928893|NCT04885660|Lisinopril|lisinopril|mesh-list
5928894|NCT04885660|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5928895|NCT04885660|Protease Inhibitors|protease inhibitors|mesh-ancestor
5928896|NCT04885660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5928897|NCT04885660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928898|NCT04885660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5928899|NCT04885660|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5928900|NCT04885660|Protective Agents|protective agents|mesh-ancestor
5928901|NCT04885660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928902|NCT04885686|Formaldehyde|formaldehyde|mesh-list
5928903|NCT04885686|Thymol|thymol|mesh-list
5928904|NCT04885686|Dexamethasone|dexamethasone|mesh-list
5928905|NCT04885686|Hydrocortisone|hydrocortisone|mesh-list
5928906|NCT04885686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5928907|NCT04885686|Antiemetics|antiemetics|mesh-ancestor
5928908|NCT04885686|Autonomic Agents|autonomic agents|mesh-ancestor
5928909|NCT04885686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5928910|NCT04885686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928911|NCT04885686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5928912|NCT04885686|Glucocorticoids|glucocorticoids|mesh-ancestor
5928913|NCT04885686|Hormones|hormones|mesh-ancestor
5928914|NCT04885686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5928915|NCT04885686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5928916|NCT04885686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5928917|NCT04885686|Disinfectants|disinfectants|mesh-ancestor
5928918|NCT04885686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5928919|NCT04885686|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5928920|NCT04885686|Antifungal Agents|antifungal agents|mesh-ancestor
5928921|NCT04885855|Sofosbuvir|sofosbuvir|mesh-list
5928922|NCT04885855|Antiviral Agents|antiviral agents|mesh-ancestor
5928923|NCT04885855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5928924|NCT04885751|Rebamipide|rebamipide|mesh-list
5928925|NCT04885751|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5928926|NCT04885751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5928927|NCT04885751|Antioxidants|antioxidants|mesh-ancestor
5928928|NCT04885751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928929|NCT04885751|Protective Agents|protective agents|mesh-ancestor
5928930|NCT04885751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928931|NCT04885751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5928932|NCT04885803|Vitamin D|vitamin d|mesh-list
5928933|NCT04885803|Ergocalciferols|ergocalciferols|mesh-list
5928934|NCT04885803|Cholecalciferol|cholecalciferol|mesh-list
5928935|NCT04885803|Vitamins|vitamins|mesh-list
5928936|NCT04885803|Micronutrients|micronutrients|mesh-ancestor
5928937|NCT04885803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928938|NCT04885803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5928939|NCT04885803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5928940|NCT04885270|Cisplatin|cisplatin|mesh-list
5928941|NCT04885270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5928942|NCT04885426|Metformin|metformin|mesh-list
5928943|NCT04885426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5928944|NCT04885426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928945|NCT04885413|Niraparib|niraparib|mesh-list
5928946|NCT04885413|Antibodies|antibodies|mesh-list
5928947|NCT04885413|Immunologic Factors|immunologic factors|mesh-ancestor
5928948|NCT04885413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928949|NCT04885413|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5928950|NCT04885413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5928951|NCT04885413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928952|NCT04885413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5928953|NCT04885153|Fenofibrate|fenofibrate|mesh-list
5928954|NCT04885153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5928955|NCT04885153|Antimetabolites|antimetabolites|mesh-ancestor
5970836|NCT04532229|Nimotuzumab|nimotuzumab|mesh-list
5928956|NCT04885153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928957|NCT04885153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5928958|NCT04884997|Temozolomide|temozolomide|mesh-list
5928959|NCT04884997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5928960|NCT04884997|Alkylating Agents|alkylating agents|mesh-ancestor
5928961|NCT04884997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928962|NCT04884997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5928963|NCT04884906|Paclitaxel|paclitaxel|mesh-list
5928964|NCT04884906|Cisplatin|cisplatin|mesh-list
5928965|NCT04884906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5928966|NCT04884906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5928967|NCT04884906|Tubulin Modulators|tubulin modulators|mesh-ancestor
5928968|NCT04884906|Antimitotic Agents|antimitotic agents|mesh-ancestor
5928969|NCT04884906|Mitosis Modulators|mitosis modulators|mesh-ancestor
5928970|NCT04884906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928971|NCT04885075|Midazolam|midazolam|mesh-list
5928972|NCT04885075|Diazepam|diazepam|mesh-list
5928973|NCT04885075|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5928974|NCT04885075|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5928975|NCT04885075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5928976|NCT04885075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5928977|NCT04885075|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5928978|NCT04885075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5928979|NCT04885075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5928980|NCT04885075|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5928981|NCT04885075|Anesthetics, General|anesthetics, general|mesh-ancestor
5928982|NCT04885075|Anesthetics|anesthetics|mesh-ancestor
5928983|NCT04885075|GABA Modulators|gaba modulators|mesh-ancestor
5928984|NCT04885075|GABA Agents|gaba agents|mesh-ancestor
5928985|NCT04885075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5928986|NCT04885075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928987|NCT04885075|Anticonvulsants|anticonvulsants|mesh-ancestor
5928988|NCT04885075|Antiemetics|antiemetics|mesh-ancestor
5928989|NCT04885075|Autonomic Agents|autonomic agents|mesh-ancestor
5928990|NCT04885075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5928991|NCT04885075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5928992|NCT04885075|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5928993|NCT04885075|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5928994|NCT04884919|Chitosan|chitosan|mesh-list
5928995|NCT04884919|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5928996|NCT04884919|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5928997|NCT04884919|Antimetabolites|antimetabolites|mesh-ancestor
5928998|NCT04884919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5928999|NCT04884919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5929000|NCT04884919|Chelating Agents|chelating agents|mesh-ancestor
5929001|NCT04884919|Sequestering Agents|sequestering agents|mesh-ancestor
5929002|NCT04884919|Hemostatics|hemostatics|mesh-ancestor
5929003|NCT04884919|Coagulants|coagulants|mesh-ancestor
5929004|NCT04885049|Racecadotril|racecadotril|mesh-list
5929005|NCT04885049|Antidiarrheals|antidiarrheals|mesh-ancestor
5929006|NCT04885049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5929007|NCT04885049|Protease Inhibitors|protease inhibitors|mesh-ancestor
5929008|NCT04885049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5929009|NCT04885049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965652|NCT04580394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5965653|NCT04580394|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5965654|NCT04580394|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5965655|NCT04580394|Cholinergic Agents|cholinergic agents|mesh-ancestor
5965656|NCT04580394|Urological Agents|urological agents|mesh-ancestor
5965657|NCT04580199|Ethanol|ethanol|mesh-list
5965658|NCT04580199|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5965659|NCT04580199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5965660|NCT04580199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5965661|NCT04580199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965662|NCT04580498|Paclitaxel|paclitaxel|mesh-list
5965663|NCT04580498|Carboplatin|carboplatin|mesh-list
5965664|NCT04580498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5965665|NCT04580498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5965666|NCT04580498|Tubulin Modulators|tubulin modulators|mesh-ancestor
5965667|NCT04580498|Antimitotic Agents|antimitotic agents|mesh-ancestor
5965668|NCT04580498|Mitosis Modulators|mitosis modulators|mesh-ancestor
5965669|NCT04580498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965670|NCT04579848|Folic Acid|folic acid|mesh-list
5965671|NCT04579848|Methotrexate|methotrexate|mesh-list
5965672|NCT04579848|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5965673|NCT04579848|Abortifacient Agents|abortifacient agents|mesh-ancestor
5965674|NCT04579848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5929010|NCT04884802|Phenylephrine|phenylephrine|mesh-list
5929011|NCT04884802|Norepinephrine|norepinephrine|mesh-list
5929012|NCT04884802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
5929013|NCT04884802|Propofol|propofol|mesh-list
5929014|NCT04884802|Etomidate|etomidate|mesh-list
5929015|NCT04884802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5929016|NCT04884802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5929017|NCT04884802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929018|NCT04884802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5929019|NCT04884802|Anesthetics, General|anesthetics, general|mesh-ancestor
5929020|NCT04884802|Anesthetics|anesthetics|mesh-ancestor
5929021|NCT04884802|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5929022|NCT04884802|Mydriatics|mydriatics|mesh-ancestor
5929023|NCT04884802|Autonomic Agents|autonomic agents|mesh-ancestor
5929024|NCT04884802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5929025|NCT04884802|Sympathomimetics|sympathomimetics|mesh-ancestor
5929026|NCT04884802|Nasal Decongestants|nasal decongestants|mesh-ancestor
5929027|NCT04884802|Respiratory System Agents|respiratory system agents|mesh-ancestor
5929028|NCT04884802|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5929029|NCT04884802|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5929030|NCT04884802|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5929031|NCT04884802|Adrenergic Agents|adrenergic agents|mesh-ancestor
5929032|NCT04884802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5929033|NCT04884802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929034|NCT04884802|Protective Agents|protective agents|mesh-ancestor
5929035|NCT04884750|Vaccines|vaccines|mesh-list
5929036|NCT04884750|Immunologic Factors|immunologic factors|mesh-ancestor
5929037|NCT04884750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929038|NCT04884503|Clonazepam|clonazepam|mesh-list
5929039|NCT04884503|Anticonvulsants|anticonvulsants|mesh-ancestor
5929040|NCT04884503|GABA Modulators|gaba modulators|mesh-ancestor
5929041|NCT04884503|GABA Agents|gaba agents|mesh-ancestor
5929042|NCT04884503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5929043|NCT04884503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929044|NCT04884503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929045|NCT04884516|Vitamin A|vitamin a|mesh-list
5929046|NCT04884516|Vitamins|vitamins|mesh-ancestor
5929047|NCT04884516|Micronutrients|micronutrients|mesh-ancestor
5929048|NCT04884516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929049|NCT04884490|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
5929050|NCT04884490|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5929051|NCT04884490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5929052|NCT04884490|Renal Agents|renal agents|mesh-ancestor
5929053|NCT04884490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5929054|NCT04884490|Antimalarials|antimalarials|mesh-ancestor
5929055|NCT04884490|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5929056|NCT04884490|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5929057|NCT04884399|Ranibizumab|ranibizumab|mesh-list
5929058|NCT04884399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5929059|NCT04884399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5929060|NCT04884399|Growth Substances|growth substances|mesh-ancestor
6517132|NCT00719823|Antiviral Agents|antiviral agents|mesh-ancestor
6517133|NCT00719823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6517134|NCT00719823|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6517135|NCT00719875|Vorinostat|vorinostat|mesh-list
6517136|NCT00719875|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
6517137|NCT00719875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6517138|NCT00719875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6517139|NCT00719875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517140|NCT00719888|Cyclosporine|cyclosporine|mesh-list
6517141|NCT00719888|Mycophenolic Acid|mycophenolic acid|mesh-list
6517142|NCT00719888|Cyclophosphamide|cyclophosphamide|mesh-list
6517143|NCT00719888|Thiotepa|thiotepa|mesh-list
6517144|NCT00719888|Fludarabine|fludarabine|mesh-list
6517145|NCT00719888|Cyclosporins|cyclosporins|mesh-list
6517146|NCT00719888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6517147|NCT00719888|Immunologic Factors|immunologic factors|mesh-ancestor
6517148|NCT00719888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517149|NCT00719888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5929061|NCT04884399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929062|NCT04884399|Growth Inhibitors|growth inhibitors|mesh-ancestor
5929063|NCT04884399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5929064|NCT04884139|Tenofovir|tenofovir|mesh-list
5929065|NCT04884139|Lamivudine|lamivudine|mesh-list
5929066|NCT04884139|Emtricitabine|emtricitabine|mesh-list
5929067|NCT04884139|Dolutegravir|dolutegravir|mesh-list
5929068|NCT04884139|Antiviral Agents|antiviral agents|mesh-ancestor
6517150|NCT00719888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6517151|NCT00719888|Alkylating Agents|alkylating agents|mesh-ancestor
5929069|NCT04884139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5929070|NCT04884139|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5929071|NCT04884139|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5929072|NCT04884139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5929073|NCT04884139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929074|NCT04884139|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5929075|NCT04884139|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5929076|NCT04884139|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5929077|NCT04884139|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5929078|NCT04884282|Docetaxel|docetaxel|mesh-list
5929079|NCT04884282|Nivolumab|nivolumab|mesh-list
5929080|NCT04884282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5929081|NCT04884282|Tubulin Modulators|tubulin modulators|mesh-ancestor
5929082|NCT04884282|Antimitotic Agents|antimitotic agents|mesh-ancestor
5929083|NCT04884282|Mitosis Modulators|mitosis modulators|mesh-ancestor
5929084|NCT04884282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929085|NCT04884282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5929086|NCT04884282|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5929087|NCT04883996|Pilocarpine|pilocarpine|mesh-list
5929088|NCT04883996|Miotics|miotics|mesh-ancestor
5929089|NCT04883996|Autonomic Agents|autonomic agents|mesh-ancestor
5929090|NCT04883996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5929091|NCT04883996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929092|NCT04883996|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
5929093|NCT04883996|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5929094|NCT04883996|Cholinergic Agents|cholinergic agents|mesh-ancestor
5929095|NCT04883996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5929096|NCT04883996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929097|NCT04884464|Chlorhexidine|chlorhexidine|mesh-list
5929098|NCT04884464|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5929099|NCT04884464|Hyaluronic Acid|hyaluronic acid|mesh-list
5929100|NCT04884464|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5929101|NCT04884464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5929102|NCT04884464|Disinfectants|disinfectants|mesh-ancestor
5929103|NCT04884464|Dermatologic Agents|dermatologic agents|mesh-ancestor
5929104|NCT04884464|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5929105|NCT04884464|Immunologic Factors|immunologic factors|mesh-ancestor
5929106|NCT04884464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929107|NCT04884464|Viscosupplements|viscosupplements|mesh-ancestor
5929108|NCT04884464|Protective Agents|protective agents|mesh-ancestor
5929109|NCT04883840|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5929110|NCT04883840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5929111|NCT04883840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5929112|NCT04883840|Antimetabolites|antimetabolites|mesh-ancestor
5929113|NCT04883840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929114|NCT04883840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5929115|NCT04883840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5929116|NCT04883840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5929117|NCT04883736|Tretinoin|tretinoin|mesh-list
5929118|NCT04883736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5929119|NCT04883736|Keratolytic Agents|keratolytic agents|mesh-ancestor
5929120|NCT04883736|Dermatologic Agents|dermatologic agents|mesh-ancestor
5929121|NCT04883892|Hyaluronic Acid|hyaluronic acid|mesh-list
5929122|NCT04883892|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5929123|NCT04883892|Immunologic Factors|immunologic factors|mesh-ancestor
5929124|NCT04883892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929125|NCT04883892|Viscosupplements|viscosupplements|mesh-ancestor
5929126|NCT04883892|Protective Agents|protective agents|mesh-ancestor
5929127|NCT04883528|Valsartan|valsartan|mesh-list
5719177|NCT03220490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5719178|NCT03220490|Adrenergic Agents|adrenergic agents|mesh-ancestor
5719179|NCT03220490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5719180|NCT03220490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719181|NCT03220490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719182|NCT03220490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5719183|NCT03220490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5719184|NCT03220490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5719185|NCT03220490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5719186|NCT03220490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5719187|NCT03220152|Tenofovir|tenofovir|mesh-list
5719188|NCT03220152|Emtricitabine|emtricitabine|mesh-list
5719189|NCT03220152|Antiviral Agents|antiviral agents|mesh-ancestor
5719190|NCT03220152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5929128|NCT04883528|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5719191|NCT03220152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5929129|NCT04883528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5929130|NCT04883528|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5929131|NCT04883528|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5929132|NCT04883528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929133|NCT04883632|Lidocaine|lidocaine|mesh-list
5929134|NCT04883632|Anesthetics, Local|anesthetics, local|mesh-ancestor
5929135|NCT04883632|Anesthetics|anesthetics|mesh-ancestor
5929136|NCT04883632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5929137|NCT04883632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929138|NCT04883632|Sensory System Agents|sensory system agents|mesh-ancestor
5929139|NCT04883632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5929140|NCT04883632|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5929141|NCT04883632|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5929142|NCT04883632|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5929143|NCT04883632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5929144|NCT04883632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929145|NCT04883255|Dronabinol|dronabinol|mesh-list
5929146|NCT04883255|Cannabidiol|cannabidiol|mesh-list
5929147|NCT04883255|Anticonvulsants|anticonvulsants|mesh-ancestor
5929148|NCT04883255|Hallucinogens|hallucinogens|mesh-ancestor
5929149|NCT04883255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929150|NCT04883255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5929151|NCT04883255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5929152|NCT04883255|Analgesics|analgesics|mesh-ancestor
5929153|NCT04883255|Sensory System Agents|sensory system agents|mesh-ancestor
5929154|NCT04883255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5929155|NCT04883255|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5929156|NCT04883255|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5929157|NCT04883255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5929158|NCT04883255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929159|NCT04883255|Hormones|hormones|mesh-ancestor
5929160|NCT04883255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5929161|NCT04883164|Antibodies|antibodies|mesh-list
5929162|NCT04883164|Immunologic Factors|immunologic factors|mesh-ancestor
5929163|NCT04883164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929164|NCT04883203|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5929165|NCT04883203|Plasma-lyte 148|plasma-lyte 148|mesh-list
5929166|NCT04883203|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5929167|NCT04883034|Analgesics|analgesics|mesh-list
5929168|NCT04883034|Sensory System Agents|sensory system agents|mesh-ancestor
5929169|NCT04883034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5929170|NCT04883034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929171|NCT04882839|Psilocybin|psilocybin|mesh-list
5929172|NCT04882839|Hallucinogens|hallucinogens|mesh-ancestor
5929173|NCT04882839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929174|NCT04882839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5929175|NCT04882826|Sildenafil Citrate|sildenafil citrate|mesh-list
5929176|NCT04882826|Vasodilator Agents|vasodilator agents|mesh-ancestor
5929177|NCT04882826|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5929178|NCT04882826|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5929179|NCT04882826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5929180|NCT04882826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929181|NCT04882826|Urological Agents|urological agents|mesh-ancestor
5965675|NCT04579848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965676|NCT04579848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5965677|NCT04579848|Antimetabolites|antimetabolites|mesh-ancestor
5965678|NCT04579848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965679|NCT04579848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6517152|NCT00719888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517153|NCT00719888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5965680|NCT04579848|Dermatologic Agents|dermatologic agents|mesh-ancestor
5965681|NCT04579848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5965682|NCT04579848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5965683|NCT04579848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5965684|NCT04579848|Immunologic Factors|immunologic factors|mesh-ancestor
5965685|NCT04579848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5965686|NCT04579848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5965687|NCT04579848|Hematinics|hematinics|mesh-ancestor
5965688|NCT04579848|Vitamin B Complex|vitamin b complex|mesh-ancestor
5965689|NCT04579848|Vitamins|vitamins|mesh-ancestor
5965690|NCT04579848|Micronutrients|micronutrients|mesh-ancestor
5965691|NCT04580277|Tofacitinib|tofacitinib|mesh-list
5965692|NCT04580277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5965693|NCT04580277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5929182|NCT04882813|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5929183|NCT04882813|Dapagliflozin|dapagliflozin|mesh-list
5929184|NCT04882813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5929185|NCT04882813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929186|NCT04882813|Incretins|incretins|mesh-ancestor
5929187|NCT04882813|Hormones|hormones|mesh-ancestor
5929188|NCT04882813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5929189|NCT04882813|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5929190|NCT04882813|Protease Inhibitors|protease inhibitors|mesh-ancestor
5929191|NCT04882813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5929192|NCT04882813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929193|NCT04882813|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5929194|NCT04883125|Pioglitazone|pioglitazone|mesh-list
5929195|NCT04883125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5929196|NCT04883125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929197|NCT04882774|Treprostinil|treprostinil|mesh-list
5929198|NCT04882774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5929199|NCT04882540|Brivaracetam|brivaracetam|mesh-list
5929200|NCT04882540|Anticonvulsants|anticonvulsants|mesh-ancestor
5929201|NCT04882332|Vitamin B 12|vitamin b 12|mesh-list
5929202|NCT04882332|Hydroxocobalamin|hydroxocobalamin|mesh-list
5929203|NCT04882332|Vitamins|vitamins|mesh-ancestor
5929204|NCT04882332|Micronutrients|micronutrients|mesh-ancestor
5929205|NCT04882332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929206|NCT04882332|Vitamin B Complex|vitamin b complex|mesh-ancestor
5929207|NCT04882332|Hematinics|hematinics|mesh-ancestor
5929208|NCT04882462|Nimotuzumab|nimotuzumab|mesh-list
5929209|NCT04882462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5929210|NCT04882462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5929211|NCT04882683|Prednisone|prednisone|mesh-list
5929212|NCT04882683|Adalimumab|adalimumab|mesh-list
5929213|NCT04882683|Azathioprine|azathioprine|mesh-list
5929214|NCT04882683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5929215|NCT04882683|Glucocorticoids|glucocorticoids|mesh-ancestor
5929216|NCT04882683|Hormones|hormones|mesh-ancestor
5929217|NCT04882683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5929218|NCT04882683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929219|NCT04882683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5929220|NCT04882683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5929221|NCT04882683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5929222|NCT04882683|Antimetabolites|antimetabolites|mesh-ancestor
5929223|NCT04882683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929224|NCT04882683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5929225|NCT04882683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5929226|NCT04882683|Immunologic Factors|immunologic factors|mesh-ancestor
5929227|NCT04882293|Atorvastatin|atorvastatin|mesh-list
5929228|NCT04882293|Fenofibrate|fenofibrate|mesh-list
5929229|NCT04882293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5929230|NCT04882293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5929231|NCT04882293|Antimetabolites|antimetabolites|mesh-ancestor
5929232|NCT04882293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929233|NCT04882293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5929234|NCT04882293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5929235|NCT04882293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5929236|NCT04882202|Acetaminophen|acetaminophen|mesh-list
5929237|NCT04882202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5929238|NCT04882202|Analgesics|analgesics|mesh-ancestor
5929239|NCT04882202|Sensory System Agents|sensory system agents|mesh-ancestor
5929240|NCT04882202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5929241|NCT04882202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929242|NCT04882202|Antipyretics|antipyretics|mesh-ancestor
5929243|NCT04882358|Dapagliflozin|dapagliflozin|mesh-list
5929244|NCT04882358|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
5929245|NCT04882358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929246|NCT04882358|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5929247|NCT04882358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929248|NCT04882163|Gemcitabine|gemcitabine|mesh-list
5929249|NCT04882163|Dexamethasone|dexamethasone|mesh-list
5929250|NCT04882163|Rituximab|rituximab|mesh-list
5929251|NCT04882163|Lenalidomide|lenalidomide|mesh-list
5929252|NCT04882163|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5929253|NCT04882163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5929254|NCT04882163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5929255|NCT04882163|Antiemetics|antiemetics|mesh-ancestor
5929256|NCT04882163|Autonomic Agents|autonomic agents|mesh-ancestor
5929257|NCT04882163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5929258|NCT04882163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929259|NCT04882163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5929260|NCT04882163|Glucocorticoids|glucocorticoids|mesh-ancestor
5929261|NCT04882163|Hormones|hormones|mesh-ancestor
5929262|NCT04882163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5929263|NCT04882163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5929264|NCT04882163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5929265|NCT04882163|Immunologic Factors|immunologic factors|mesh-ancestor
5929266|NCT04882163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5929267|NCT04882163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5929268|NCT04882163|Antimetabolites|antimetabolites|mesh-ancestor
5929269|NCT04882163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929270|NCT04882163|Antiviral Agents|antiviral agents|mesh-ancestor
5929271|NCT04882163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5929272|NCT04882163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5929273|NCT04882163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5929274|NCT04882163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5929275|NCT04882163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5929276|NCT04882163|Growth Substances|growth substances|mesh-ancestor
5929277|NCT04882163|Growth Inhibitors|growth inhibitors|mesh-ancestor
5929278|NCT04882163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5929279|NCT04882163|Alkylating Agents|alkylating agents|mesh-ancestor
5929280|NCT04881942|Menthol|menthol|mesh-list
5929281|NCT04881942|Nicotine|nicotine|mesh-list
5929282|NCT04881942|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5929283|NCT04881942|Autonomic Agents|autonomic agents|mesh-ancestor
5929284|NCT04881942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5929285|NCT04881942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929286|NCT04881942|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5929287|NCT04881942|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5929288|NCT04881942|Cholinergic Agents|cholinergic agents|mesh-ancestor
5929289|NCT04881942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5929290|NCT04881942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929291|NCT04881942|Antipruritics|antipruritics|mesh-ancestor
5929292|NCT04881942|Dermatologic Agents|dermatologic agents|mesh-ancestor
5929293|NCT04882020|Hydrocortisone|hydrocortisone|mesh-list
5929294|NCT04882020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5929295|NCT04881929|Docetaxel|docetaxel|mesh-list
5929296|NCT04881929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5929297|NCT04881929|Tubulin Modulators|tubulin modulators|mesh-ancestor
5929298|NCT04881929|Antimitotic Agents|antimitotic agents|mesh-ancestor
5929299|NCT04881929|Mitosis Modulators|mitosis modulators|mesh-ancestor
5929300|NCT04881929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929301|NCT04881799|Topiramate|topiramate|mesh-list
5929302|NCT04881799|Phentermine|phentermine|mesh-list
5929303|NCT04881799|Anticonvulsants|anticonvulsants|mesh-ancestor
5929304|NCT04881799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5929305|NCT04881799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929306|NCT04881799|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5929307|NCT04881799|Appetite Depressants|appetite depressants|mesh-ancestor
5929308|NCT04881799|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5929309|NCT04881799|Sympathomimetics|sympathomimetics|mesh-ancestor
5929310|NCT04881799|Autonomic Agents|autonomic agents|mesh-ancestor
5929311|NCT04881799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5929312|NCT04881799|Adrenergic Agents|adrenergic agents|mesh-ancestor
5929313|NCT04881799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5929314|NCT04881799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929315|NCT04881747|Lasmiditan|lasmiditan|mesh-list
5929316|NCT04881747|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5929317|NCT04881747|Serotonin Agents|serotonin agents|mesh-ancestor
5929318|NCT04881747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5929319|NCT04881747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929320|NCT04881747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929321|NCT04881539|Cannabidiol|cannabidiol|mesh-list
5929322|NCT04881539|Anticonvulsants|anticonvulsants|mesh-ancestor
5929323|NCT04881682|Immunoglobulins|immunoglobulins|mesh-list
5929324|NCT04881682|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5929325|NCT04881682|Antibodies|antibodies|mesh-list
5929326|NCT04881682|Immunologic Factors|immunologic factors|mesh-ancestor
5929327|NCT04881682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929328|NCT04881474|Ibuprofen|ibuprofen|mesh-list
6517154|NCT00719888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6517155|NCT00719888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6517156|NCT00719888|Antifungal Agents|antifungal agents|mesh-ancestor
5929329|NCT04881474|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5929330|NCT04881474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5929331|NCT04881474|Analgesics|analgesics|mesh-ancestor
5929332|NCT04881474|Sensory System Agents|sensory system agents|mesh-ancestor
5929333|NCT04881474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5929334|NCT04881474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929335|NCT04881474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5929336|NCT04881474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5929337|NCT04881474|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5929338|NCT04881474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5929339|NCT04881474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929340|NCT04881851|Folic Acid|folic acid|mesh-list
5929341|NCT04881851|Thioctic Acid|thioctic acid|mesh-list
5929342|NCT04881851|Inositol|inositol|mesh-list
5929343|NCT04881851|Hematinics|hematinics|mesh-ancestor
5929344|NCT04881851|Vitamin B Complex|vitamin b complex|mesh-ancestor
5929345|NCT04881851|Vitamins|vitamins|mesh-ancestor
5929346|NCT04881851|Micronutrients|micronutrients|mesh-ancestor
5929347|NCT04881851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929348|NCT04881851|Antioxidants|antioxidants|mesh-ancestor
5929349|NCT04881851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929350|NCT04881851|Protective Agents|protective agents|mesh-ancestor
5929351|NCT04881006|Dapagliflozin|dapagliflozin|mesh-list
5929352|NCT04881006|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5929353|NCT04881006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929354|NCT04881006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5929355|NCT04881006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965694|NCT04580277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965695|NCT04580147|Aflibercept|aflibercept|mesh-list
5965696|NCT04580147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5965697|NCT04580147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5965698|NCT04580147|Growth Substances|growth substances|mesh-ancestor
5965699|NCT04580147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965700|NCT04580147|Growth Inhibitors|growth inhibitors|mesh-ancestor
5965701|NCT04580147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5965702|NCT04579614|Vaccines|vaccines|mesh-list
5965703|NCT04579614|Immunologic Factors|immunologic factors|mesh-ancestor
5965704|NCT04579614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965705|NCT04579731|Lactitol|lactitol|mesh-list
5965706|NCT04579731|Cathartics|cathartics|mesh-ancestor
5965707|NCT04579731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5965708|NCT04579302|Bupivacaine|bupivacaine|mesh-list
5965709|NCT04579302|Anesthetics, Local|anesthetics, local|mesh-ancestor
5965710|NCT04579302|Anesthetics|anesthetics|mesh-ancestor
5965711|NCT04579302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5965712|NCT04579302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965713|NCT04579302|Sensory System Agents|sensory system agents|mesh-ancestor
5965714|NCT04579302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5965715|NCT04578938|Ketamine|ketamine|mesh-list
5965716|NCT04578938|Analgesics|analgesics|mesh-ancestor
5965717|NCT04578938|Sensory System Agents|sensory system agents|mesh-ancestor
5965718|NCT04578938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5965719|NCT04578938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965720|NCT04578938|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5965721|NCT04578938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5965722|NCT04578938|Anesthetics, General|anesthetics, general|mesh-ancestor
5965723|NCT04578938|Anesthetics|anesthetics|mesh-ancestor
5965724|NCT04578938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5965725|NCT04578938|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5965726|NCT04578938|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5965727|NCT04578938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5965728|NCT04578938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965729|NCT04578782|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5965730|NCT04578782|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5965731|NCT04578782|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5965732|NCT04578782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5965733|NCT04578782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965734|NCT04578782|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5965735|NCT04578782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5965736|NCT04578782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965737|NCT04578782|Cholinergic Agents|cholinergic agents|mesh-ancestor
5965738|NCT04578782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5965739|NCT04579133|Durvalumab|durvalumab|mesh-list
5965740|NCT04579133|Olaparib|olaparib|mesh-list
5965741|NCT04579133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5965742|NCT04579133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5965743|NCT04579133|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5929356|NCT04881110|Liraglutide|liraglutide|mesh-list
5929357|NCT04881110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5929358|NCT04881110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929359|NCT04881110|Incretins|incretins|mesh-ancestor
5929360|NCT04881110|Hormones|hormones|mesh-ancestor
5929361|NCT04881110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5929362|NCT04880993|Dapagliflozin|dapagliflozin|mesh-list
5929363|NCT04880993|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5929364|NCT04880993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929365|NCT04880993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5929366|NCT04880993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929367|NCT04880746|Cladribine|cladribine|mesh-list
5929368|NCT04880746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5929369|NCT04880746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5929370|NCT04880746|Immunologic Factors|immunologic factors|mesh-ancestor
5929371|NCT04880746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929372|NCT04880980|Itraconazole|itraconazole|mesh-list
5929373|NCT04880980|Terbinafine|terbinafine|mesh-list
5929374|NCT04880980|Antifungal Agents|antifungal agents|mesh-ancestor
5929375|NCT04880980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5929376|NCT04880980|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5929377|NCT04880980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5929378|NCT04880980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5929379|NCT04880980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929380|NCT04880980|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5929381|NCT04880980|Hormone Antagonists|hormone antagonists|mesh-ancestor
5929382|NCT04880980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5929383|NCT04880980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929384|NCT04880980|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5929385|NCT04880811|Afatinib|afatinib|mesh-list
5929386|NCT04880811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5929387|NCT04880811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5929388|NCT04880811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5929389|NCT04880811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929390|NCT04880785|Lamivudine|lamivudine|mesh-list
5929391|NCT04880785|Dolutegravir|dolutegravir|mesh-list
5929392|NCT04880785|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5929393|NCT04880785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5929394|NCT04880785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5929395|NCT04880785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929396|NCT04880785|Antiviral Agents|antiviral agents|mesh-ancestor
5929397|NCT04880785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5929398|NCT04880785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5929399|NCT04880785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5929400|NCT04880785|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5929401|NCT04880785|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5929402|NCT04880655|Bacitracin|bacitracin|mesh-list
5929403|NCT04880655|Petrolatum|petrolatum|mesh-list
5929404|NCT04880655|Emollients|emollients|mesh-ancestor
5929405|NCT04880655|Dermatologic Agents|dermatologic agents|mesh-ancestor
5929406|NCT04880655|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5929407|NCT04880655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5929408|NCT04880655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5929409|NCT04880499|Folic Acid|folic acid|mesh-list
5929410|NCT04880499|Riboflavin|riboflavin|mesh-list
5929411|NCT04880499|Vitamins|vitamins|mesh-ancestor
5929412|NCT04880499|Micronutrients|micronutrients|mesh-ancestor
5929413|NCT04880499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929414|NCT04880499|Hematinics|hematinics|mesh-ancestor
5929415|NCT04880499|Vitamin B Complex|vitamin b complex|mesh-ancestor
5929416|NCT04880499|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5929417|NCT04880499|Dermatologic Agents|dermatologic agents|mesh-ancestor
5929418|NCT04880395|Lamivudine|lamivudine|mesh-list
5929419|NCT04880395|Emtricitabine|emtricitabine|mesh-list
5929420|NCT04880395|Dolutegravir|dolutegravir|mesh-list
5929421|NCT04880395|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5929422|NCT04880395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5929423|NCT04880395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5929424|NCT04880395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929425|NCT04880395|Antiviral Agents|antiviral agents|mesh-ancestor
5929426|NCT04880395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5929427|NCT04880395|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5929428|NCT04880395|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5929429|NCT04880395|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5929430|NCT04880395|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5929431|NCT04879823|Acetaminophen|acetaminophen|mesh-list
5929432|NCT04879823|Dexamethasone|dexamethasone|mesh-list
5929433|NCT04879823|Ibuprofen|ibuprofen|mesh-list
5929434|NCT04879823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5929435|NCT04879823|Antiemetics|antiemetics|mesh-ancestor
5929436|NCT04879823|Autonomic Agents|autonomic agents|mesh-ancestor
5929437|NCT04879823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5929438|NCT04879823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929439|NCT04879823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5929440|NCT04879823|Glucocorticoids|glucocorticoids|mesh-ancestor
5929441|NCT04879823|Hormones|hormones|mesh-ancestor
5929442|NCT04879823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5929443|NCT04879823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5929444|NCT04879823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5929445|NCT04879823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5929446|NCT04879823|Analgesics|analgesics|mesh-ancestor
5929447|NCT04879823|Sensory System Agents|sensory system agents|mesh-ancestor
5929448|NCT04879823|Antipyretics|antipyretics|mesh-ancestor
5929449|NCT04879823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5929450|NCT04879823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5929451|NCT04879823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5929452|NCT04879823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5929453|NCT04879823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929454|NCT04879992|Amoxicillin|amoxicillin|mesh-list
5929455|NCT04879992|Metronidazole|metronidazole|mesh-list
5929456|NCT04879992|Tetracycline|tetracycline|mesh-list
5929457|NCT04879992|Rifabutin|rifabutin|mesh-list
5929458|NCT04879992|Potassium Citrate|potassium citrate|mesh-list
5929459|NCT04879992|Esomeprazole|esomeprazole|mesh-list
5929460|NCT04879992|Bismuth|bismuth|mesh-list
5929461|NCT04879992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929462|NCT04879992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5929463|NCT04879992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5929464|NCT04879992|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5929465|NCT04879992|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5929466|NCT04879992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5929467|NCT04879992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5929468|NCT04879992|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5929469|NCT04879992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5929470|NCT04879992|Antacids|antacids|mesh-ancestor
5929471|NCT04879992|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5929472|NCT04879992|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5929473|NCT04879992|Antitubercular Agents|antitubercular agents|mesh-ancestor
5929474|NCT04879992|Diuretics|diuretics|mesh-ancestor
5929475|NCT04879992|Natriuretic Agents|natriuretic agents|mesh-ancestor
5929476|NCT04879992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929477|NCT04879992|Expectorants|expectorants|mesh-ancestor
5929478|NCT04879992|Respiratory System Agents|respiratory system agents|mesh-ancestor
5929479|NCT04879966|Infliximab|infliximab|mesh-list
5929480|NCT04879966|Dermatologic Agents|dermatologic agents|mesh-ancestor
5929481|NCT04879966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5929482|NCT04879966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5929483|NCT04879446|Mitogens|mitogens|mesh-list
5929484|NCT04879446|Mitosis Modulators|mitosis modulators|mesh-ancestor
5929485|NCT04879446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929486|NCT04879511|Metformin|metformin|mesh-list
5929487|NCT04879511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5929488|NCT04879511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929489|NCT04879524|Botulinum Toxins|botulinum toxins|mesh-list
5929490|NCT04879524|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5929491|NCT04879524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5929492|NCT04879524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929493|NCT04879524|Cholinergic Agents|cholinergic agents|mesh-ancestor
5929494|NCT04879524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5929495|NCT04879524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929496|NCT04879589|Abiraterone Acetate|abiraterone acetate|mesh-list
5929497|NCT04879589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5929498|NCT04879589|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5929499|NCT04879589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5929500|NCT04879589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929501|NCT04879589|Hormone Antagonists|hormone antagonists|mesh-ancestor
5929502|NCT04879589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5929503|NCT04879589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929504|NCT04879589|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5929505|NCT04879420|Teriparatide|teriparatide|mesh-list
5929506|NCT04879420|Risedronic Acid|risedronic acid|mesh-list
5929507|NCT04879420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5965744|NCT04579133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5929508|NCT04879420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929509|NCT04879420|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5929510|NCT04879420|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5929511|NCT04879420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5929512|NCT04879420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929513|NCT04879615|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5929514|NCT04879615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5929515|NCT04879615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5929516|NCT04879615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929517|NCT04879550|Antithrombins|antithrombins|mesh-list
5929518|NCT04879550|Antithrombin III|antithrombin iii|mesh-list
5929519|NCT04879550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5929520|NCT04879550|Protease Inhibitors|protease inhibitors|mesh-ancestor
5929521|NCT04879550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5929522|NCT04879550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929523|NCT04879550|Anticoagulants|anticoagulants|mesh-ancestor
5965745|NCT04579133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965746|NCT04578847|Imatinib Mesylate|imatinib mesylate|mesh-list
5965747|NCT04578847|Dasatinib|dasatinib|mesh-list
5965748|NCT04578847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5965749|NCT04578847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5965750|NCT04578847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5965751|NCT04578847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970837|NCT04532229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5970838|NCT04532229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5970839|NCT04532060|Anti-Infective Agents|anti-infective agents|mesh-list
5970840|NCT04532060|Nystatin|nystatin|mesh-list
5970841|NCT04532060|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5970842|NCT04532060|Antifungal Agents|antifungal agents|mesh-ancestor
5970843|NCT04532060|Ionophores|ionophores|mesh-ancestor
5970844|NCT04532060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5970845|NCT04532060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970846|NCT04532281|Carbamide Peroxide|carbamide peroxide|mesh-list
5970847|NCT04532281|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5970848|NCT04532281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5970849|NCT04532164|Antifungal Agents|antifungal agents|mesh-list
5970850|NCT04532164|Clotrimazole|clotrimazole|mesh-list
5970851|NCT04532164|Miconazole|miconazole|mesh-list
5970852|NCT04532164|Butenafine|butenafine|mesh-list
5970853|NCT04532164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5970854|NCT04532164|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5970855|NCT04532164|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5970856|NCT04532164|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5970857|NCT04532164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5970858|NCT04532164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970859|NCT04532164|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5970860|NCT04532164|Hormone Antagonists|hormone antagonists|mesh-ancestor
5970861|NCT04532164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5970862|NCT04532164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970863|NCT04532164|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5970864|NCT04532164|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5970865|NCT04532099|Hydrogen Peroxide|hydrogen peroxide|mesh-list
5970866|NCT04532099|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5970867|NCT04532099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5970868|NCT04532333|Heparin|heparin|mesh-list
5970869|NCT04532333|Bivalirudin|bivalirudin|mesh-list
5970870|NCT04532333|Anticoagulants|anticoagulants|mesh-ancestor
5970871|NCT04532333|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5970872|NCT04532333|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5970873|NCT04532333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970874|NCT04532333|Antithrombins|antithrombins|mesh-ancestor
5970875|NCT04532333|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5970876|NCT04532333|Protease Inhibitors|protease inhibitors|mesh-ancestor
5970877|NCT04532333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5970878|NCT04531878|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
5970879|NCT04531878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5970880|NCT04531943|Progesterone|progesterone|mesh-list
5970881|NCT04531943|Estrogens|estrogens|mesh-list
5970882|NCT04531943|Progestins|progestins|mesh-ancestor
5970883|NCT04531943|Hormones|hormones|mesh-ancestor
5970884|NCT04531943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5970885|NCT04531943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970886|NCT04531865|Mycophenolic Acid|mycophenolic acid|mesh-list
5970887|NCT04531865|Rituximab|rituximab|mesh-list
5929524|NCT04879407|Warfarin|warfarin|mesh-list
5929525|NCT04879407|Rivaroxaban|rivaroxaban|mesh-list
5929526|NCT04879407|Anticoagulants|anticoagulants|mesh-ancestor
5929527|NCT04879407|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5929528|NCT04879407|Antithrombins|antithrombins|mesh-ancestor
5929529|NCT04879407|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5929530|NCT04879407|Protease Inhibitors|protease inhibitors|mesh-ancestor
5929531|NCT04879407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5929532|NCT04879407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929533|NCT04879225|Menthol|menthol|mesh-list
5929534|NCT04879225|Antipruritics|antipruritics|mesh-ancestor
5929535|NCT04879225|Dermatologic Agents|dermatologic agents|mesh-ancestor
5929536|NCT04879004|Ropivacaine|ropivacaine|mesh-list
5929537|NCT04879004|Anesthetics, Local|anesthetics, local|mesh-ancestor
5929538|NCT04879004|Anesthetics|anesthetics|mesh-ancestor
5929539|NCT04879004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5929540|NCT04879004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929541|NCT04879004|Sensory System Agents|sensory system agents|mesh-ancestor
5929542|NCT04879004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5929543|NCT04879134|Apomorphine|apomorphine|mesh-list
5929544|NCT04879134|Emetics|emetics|mesh-ancestor
5929545|NCT04879134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929546|NCT04879134|Autonomic Agents|autonomic agents|mesh-ancestor
5929547|NCT04879134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5929548|NCT04879134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5929549|NCT04879134|Dopamine Agonists|dopamine agonists|mesh-ancestor
5929550|NCT04879134|Dopamine Agents|dopamine agents|mesh-ancestor
5929551|NCT04879134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5929552|NCT04879134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929553|NCT04878926|Midazolam|midazolam|mesh-list
5929554|NCT04878926|Propofol|propofol|mesh-list
5929555|NCT04878926|Anesthetics|anesthetics|mesh-list
5929556|NCT04878926|Anesthetics, Local|anesthetics, local|mesh-list
5929557|NCT04878926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5929558|NCT04878926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5929559|NCT04878926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929560|NCT04878926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5929561|NCT04878926|Anesthetics, General|anesthetics, general|mesh-ancestor
5929562|NCT04878926|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5929563|NCT04878926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5929564|NCT04878926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5719192|NCT03220152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5719193|NCT03220152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5719194|NCT03220152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719195|NCT03220152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5719196|NCT03220152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5719197|NCT03220464|Interferons|interferons|mesh-list
5719198|NCT03220464|Interferon-gamma|interferon-gamma|mesh-list
5929565|NCT04878926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5929566|NCT04878926|GABA Modulators|gaba modulators|mesh-ancestor
5929567|NCT04878926|GABA Agents|gaba agents|mesh-ancestor
5929568|NCT04878926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5929569|NCT04878926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929570|NCT04878926|Sensory System Agents|sensory system agents|mesh-ancestor
5929571|NCT04878926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5929572|NCT04879030|Moxifloxacin|moxifloxacin|mesh-list
5929573|NCT04879030|Ciprofloxacin|ciprofloxacin|mesh-list
5929574|NCT04879030|Levofloxacin|levofloxacin|mesh-list
5929575|NCT04879030|Meropenem|meropenem|mesh-list
5929576|NCT04879030|Tazobactam|tazobactam|mesh-list
5929577|NCT04879030|Ceftriaxone|ceftriaxone|mesh-list
5929578|NCT04879030|Piperacillin|piperacillin|mesh-list
5929579|NCT04879030|Clavulanic Acid|clavulanic acid|mesh-list
5929580|NCT04879030|Imipenem|imipenem|mesh-list
5929581|NCT04879030|Ceftazidime|ceftazidime|mesh-list
5929582|NCT04879030|Ertapenem|ertapenem|mesh-list
5929583|NCT04879030|Lactams|lactams|mesh-list
5929584|NCT04879030|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
5929585|NCT04879030|Cefotaxime|cefotaxime|mesh-list
5929586|NCT04879030|Cefixime|cefixime|mesh-list
5929587|NCT04879030|beta-Lactams|beta-lactams|mesh-list
5929588|NCT04879030|Fluoroquinolones|fluoroquinolones|mesh-list
5929589|NCT04879030|Ticarcillin|ticarcillin|mesh-list
5929590|NCT04879030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5929591|NCT04879030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5929592|NCT04879030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5929593|NCT04879030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5929594|NCT04879030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5929595|NCT04879030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929596|NCT04879030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5929597|NCT04879030|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5929598|NCT04879030|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5929599|NCT04879030|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5929600|NCT04879030|Renal Agents|renal agents|mesh-ancestor
5929601|NCT04879030|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5929602|NCT04879030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5929603|NCT04878835|Ranibizumab|ranibizumab|mesh-list
5929604|NCT04878835|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5929605|NCT04878835|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5929606|NCT04878835|Growth Substances|growth substances|mesh-ancestor
5929607|NCT04878835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929608|NCT04878835|Growth Inhibitors|growth inhibitors|mesh-ancestor
5929609|NCT04878835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5929610|NCT04878770|Cyclosporine|cyclosporine|mesh-list
5929611|NCT04878770|Cyclosporins|cyclosporins|mesh-list
5929612|NCT04878770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5929613|NCT04878770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929614|NCT04878770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5929615|NCT04878770|Immunologic Factors|immunologic factors|mesh-ancestor
5929616|NCT04878770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929617|NCT04878770|Antifungal Agents|antifungal agents|mesh-ancestor
5929618|NCT04878770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5929619|NCT04878770|Dermatologic Agents|dermatologic agents|mesh-ancestor
5929620|NCT04878770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5929621|NCT04878770|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5929622|NCT04878510|Dexmedetomidine|dexmedetomidine|mesh-list
5929623|NCT04878510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5929624|NCT04878510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5929625|NCT04878510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929626|NCT04878510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5929627|NCT04878510|Analgesics|analgesics|mesh-ancestor
5929628|NCT04878510|Sensory System Agents|sensory system agents|mesh-ancestor
5929629|NCT04878510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5929630|NCT04878510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5929631|NCT04878510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5929632|NCT04878510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5929633|NCT04878510|Adrenergic Agents|adrenergic agents|mesh-ancestor
5929634|NCT04878510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5929635|NCT04878510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929636|NCT04878718|Vancomycin|vancomycin|mesh-list
5929637|NCT04878718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5929638|NCT04878718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5929639|NCT04878497|Warfarin|warfarin|mesh-list
5929640|NCT04878497|Rivaroxaban|rivaroxaban|mesh-list
5929641|NCT04878497|Dabigatran|dabigatran|mesh-list
5929642|NCT04878497|Apixaban|apixaban|mesh-list
5929643|NCT04878497|Edoxaban|edoxaban|mesh-list
5929644|NCT04878497|Anticoagulants|anticoagulants|mesh-ancestor
5929645|NCT04878497|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5929646|NCT04878497|Antithrombins|antithrombins|mesh-ancestor
5929647|NCT04878497|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5929648|NCT04878497|Protease Inhibitors|protease inhibitors|mesh-ancestor
5929649|NCT04878497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5929650|NCT04878497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929651|NCT04878198|Melatonin|melatonin|mesh-list
5929652|NCT04878198|Antioxidants|antioxidants|mesh-ancestor
5929653|NCT04878198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929654|NCT04878198|Protective Agents|protective agents|mesh-ancestor
5929655|NCT04878198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929656|NCT04878198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5929657|NCT04878042|Hydrogen Peroxide|hydrogen peroxide|mesh-list
5929658|NCT04878042|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5929659|NCT04878042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5929660|NCT04878029|Immunoconjugates|immunoconjugates|mesh-list
5929661|NCT04878029|Immunologic Factors|immunologic factors|mesh-ancestor
5929662|NCT04878029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929663|NCT04877639|Dexmedetomidine|dexmedetomidine|mesh-list
5929664|NCT04877639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5929665|NCT04877639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5929666|NCT04877639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929667|NCT04877639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5929668|NCT04877639|Analgesics|analgesics|mesh-ancestor
5929669|NCT04877639|Sensory System Agents|sensory system agents|mesh-ancestor
5929670|NCT04877639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5929671|NCT04877639|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5929672|NCT04877639|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5929673|NCT04877639|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5929674|NCT04877639|Adrenergic Agents|adrenergic agents|mesh-ancestor
5929675|NCT04877639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5929676|NCT04877639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929677|NCT04877613|Cyclophosphamide|cyclophosphamide|mesh-list
5929678|NCT04877613|Fludarabine|fludarabine|mesh-list
5929679|NCT04877613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5929680|NCT04877613|Immunologic Factors|immunologic factors|mesh-ancestor
5929681|NCT04877613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929682|NCT04877613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5929683|NCT04877613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5929684|NCT04877613|Alkylating Agents|alkylating agents|mesh-ancestor
5929685|NCT04877613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929686|NCT04877613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5929687|NCT04877613|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5929688|NCT04878016|Carboplatin|carboplatin|mesh-list
5929689|NCT04878016|Etoposide|etoposide|mesh-list
5929690|NCT04878016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5929691|NCT04878016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5929692|NCT04878016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5929693|NCT04878016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5929694|NCT04878016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5929695|NCT04878016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929696|NCT04877834|Dexlansoprazole|dexlansoprazole|mesh-list
5929697|NCT04877834|Lansoprazole|lansoprazole|mesh-list
5929698|NCT04877834|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5929699|NCT04877834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5929700|NCT04877834|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5929701|NCT04877834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5929702|NCT04877834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965752|NCT04578613|Rituximab|rituximab|mesh-list
5965753|NCT04578613|Chlorambucil|chlorambucil|mesh-list
5965754|NCT04578613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5965755|NCT04578613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5965756|NCT04578613|Immunologic Factors|immunologic factors|mesh-ancestor
5965757|NCT04578613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965758|NCT04578613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5965759|NCT04578613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5965760|NCT04578613|Alkylating Agents|alkylating agents|mesh-ancestor
5965761|NCT04578613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965762|NCT04578639|Rituximab|rituximab|mesh-list
5965763|NCT04578639|Ocrelizumab|ocrelizumab|mesh-list
5965764|NCT04578639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5965765|NCT04578639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5965766|NCT04578639|Immunologic Factors|immunologic factors|mesh-ancestor
5965767|NCT04578639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965768|NCT04578639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5965769|NCT04578470|Vitamin D|vitamin d|mesh-list
5965770|NCT04578470|Vitamins|vitamins|mesh-ancestor
5965771|NCT04578470|Micronutrients|micronutrients|mesh-ancestor
5965772|NCT04578470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965773|NCT04578470|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5965774|NCT04578496|Afamelanotide|afamelanotide|mesh-list
5965775|NCT04578496|Dermatologic Agents|dermatologic agents|mesh-ancestor
5965776|NCT04578691|Titanium dioxide|titanium dioxide|mesh-list
5965777|NCT04578691|Sunscreening Agents|sunscreening agents|mesh-ancestor
5965778|NCT04578691|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5965779|NCT04578691|Protective Agents|protective agents|mesh-ancestor
5965780|NCT04578691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965781|NCT04578691|Dermatologic Agents|dermatologic agents|mesh-ancestor
5965782|NCT04578691|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5965783|NCT04578236|Tretinoin|tretinoin|mesh-list
5965784|NCT04578236|Captopril|captopril|mesh-list
5965785|NCT04578236|Isotretinoin|isotretinoin|mesh-list
5965786|NCT04578236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5965787|NCT04578236|Keratolytic Agents|keratolytic agents|mesh-ancestor
5965788|NCT04578236|Dermatologic Agents|dermatologic agents|mesh-ancestor
5965789|NCT04578236|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5965790|NCT04578236|Protease Inhibitors|protease inhibitors|mesh-ancestor
5965791|NCT04578236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5965792|NCT04578236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965793|NCT04578236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5965794|NCT04578158|Quercetin|quercetin|mesh-list
5965795|NCT04578158|Antioxidants|antioxidants|mesh-ancestor
5965796|NCT04578158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929703|NCT05257993|Gemcitabine|gemcitabine|mesh-list
5929704|NCT05257993|Paclitaxel|paclitaxel|mesh-list
5929705|NCT05257993|Folfirinox|folfirinox|mesh-list
5929706|NCT05257993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5929707|NCT05257993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5929708|NCT05257993|Tubulin Modulators|tubulin modulators|mesh-ancestor
5929709|NCT05257993|Antimitotic Agents|antimitotic agents|mesh-ancestor
5929710|NCT05257993|Mitosis Modulators|mitosis modulators|mesh-ancestor
5929711|NCT05257993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929712|NCT05257993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5929713|NCT05257993|Antimetabolites|antimetabolites|mesh-ancestor
5929714|NCT05257993|Antiviral Agents|antiviral agents|mesh-ancestor
5929715|NCT05257993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5929716|NCT05257993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5929717|NCT05257993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5929718|NCT05257993|Immunologic Factors|immunologic factors|mesh-ancestor
5929719|NCT05257993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929720|NCT05257902|Choline|choline|mesh-list
5929721|NCT05257902|Lipotropic Agents|lipotropic agents|mesh-ancestor
5929722|NCT05257902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5929723|NCT05257902|Antimetabolites|antimetabolites|mesh-ancestor
5929724|NCT05257902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929725|NCT05257902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5929726|NCT05257902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5929727|NCT05257902|Nootropic Agents|nootropic agents|mesh-ancestor
5929728|NCT05257824|Aspirin|aspirin|mesh-list
5929729|NCT05257824|Clopidogrel|clopidogrel|mesh-list
5929730|NCT05257824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5929731|NCT05257824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5929732|NCT05257824|Analgesics|analgesics|mesh-ancestor
5929733|NCT05257824|Sensory System Agents|sensory system agents|mesh-ancestor
5929734|NCT05257824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5929735|NCT05257824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929736|NCT05257824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5929737|NCT05257824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5929738|NCT05257824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5929739|NCT05257824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5929740|NCT05257824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929741|NCT05257824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5929742|NCT05257824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5929743|NCT05257824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5929744|NCT05257824|Antipyretics|antipyretics|mesh-ancestor
5929745|NCT05257824|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5929746|NCT05257824|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5929747|NCT05257824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5929748|NCT05257824|Purinergic Agents|purinergic agents|mesh-ancestor
5929749|NCT05257824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5929750|NCT05257655|Analgesics, Opioid|analgesics, opioid|mesh-list
5929751|NCT05257655|Narcotics|narcotics|mesh-ancestor
5929752|NCT05257655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5929753|NCT05257655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929754|NCT05257655|Analgesics|analgesics|mesh-ancestor
5929755|NCT05257655|Sensory System Agents|sensory system agents|mesh-ancestor
5929756|NCT05257655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5929757|NCT05257629|Nicotine|nicotine|mesh-list
5929758|NCT05257629|Varenicline|varenicline|mesh-list
5929759|NCT05257629|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5929760|NCT05257629|Autonomic Agents|autonomic agents|mesh-ancestor
5929761|NCT05257629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5929762|NCT05257629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719199|NCT03220464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5719200|NCT03220464|Antiviral Agents|antiviral agents|mesh-ancestor
5719201|NCT03220464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5719202|NCT03220126|Mirikizumab|mirikizumab|mesh-list
5719203|NCT03220126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5719204|NCT03220126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5719205|NCT03220126|Analgesics|analgesics|mesh-ancestor
5719206|NCT03220126|Sensory System Agents|sensory system agents|mesh-ancestor
5719207|NCT03220126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5719208|NCT03220126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719209|NCT03220126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5719210|NCT03220126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5929763|NCT05257629|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5929764|NCT05257629|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5719211|NCT03220126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5929765|NCT05257629|Cholinergic Agents|cholinergic agents|mesh-ancestor
5929766|NCT05257629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5929767|NCT05257629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929768|NCT05257590|Nivolumab|nivolumab|mesh-list
5929769|NCT05257590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5929770|NCT05257590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5929771|NCT05257590|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5929772|NCT05257590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929773|NCT05257460|Insulin|insulin|mesh-list
5929774|NCT05257460|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5929775|NCT05257460|Insulin Lispro|insulin lispro|mesh-list
5929776|NCT05257460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5929777|NCT05257460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929789|NCT05257408|Paclitaxel|paclitaxel|mesh-list
5929790|NCT05257408|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5929791|NCT05257408|Doxorubicin|doxorubicin|mesh-list
5929792|NCT05257408|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5929793|NCT05257408|Topotecan|topotecan|mesh-list
5929794|NCT05257408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5929795|NCT05257408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5929796|NCT05257408|Tubulin Modulators|tubulin modulators|mesh-ancestor
5929797|NCT05257408|Antimitotic Agents|antimitotic agents|mesh-ancestor
5929798|NCT05257408|Mitosis Modulators|mitosis modulators|mesh-ancestor
5929799|NCT05257408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929800|NCT05257408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5929801|NCT05257408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5929802|NCT05257408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5929803|NCT05257408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5929804|NCT05257408|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5929805|NCT05257395|Letrozole|letrozole|mesh-list
5929806|NCT05257395|Anastrozole|anastrozole|mesh-list
5929807|NCT05257395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5929808|NCT05257395|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5929809|NCT05257395|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5929810|NCT05257395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5929811|NCT05257395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929812|NCT05257395|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5929813|NCT05257395|Hormone Antagonists|hormone antagonists|mesh-ancestor
5929814|NCT05257395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5929815|NCT05257395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929816|NCT05257395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5929817|NCT05257291|Melatonin|melatonin|mesh-list
5929818|NCT05257291|Antioxidants|antioxidants|mesh-ancestor
5929819|NCT05257291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929820|NCT05257291|Protective Agents|protective agents|mesh-ancestor
5929821|NCT05257291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929822|NCT05257291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5929823|NCT05257213|Heparin|heparin|mesh-list
5929824|NCT05257213|Anticoagulants|anticoagulants|mesh-ancestor
5929825|NCT05257213|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5929826|NCT05257213|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5929827|NCT05257213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965797|NCT04578158|Protective Agents|protective agents|mesh-ancestor
5929843|NCT05257083|Dexamethasone|dexamethasone|mesh-list
5929844|NCT05257083|Cyclophosphamide|cyclophosphamide|mesh-list
5929845|NCT05257083|Fludarabine|fludarabine|mesh-list
5929846|NCT05257083|Lenalidomide|lenalidomide|mesh-list
5929847|NCT05257083|Bortezomib|bortezomib|mesh-list
5929848|NCT05257083|Daratumumab|daratumumab|mesh-list
5929849|NCT05257083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5929850|NCT05257083|Immunologic Factors|immunologic factors|mesh-ancestor
5929851|NCT05257083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929852|NCT05257083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5929853|NCT05257083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5929854|NCT05257083|Alkylating Agents|alkylating agents|mesh-ancestor
5929855|NCT05257083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929856|NCT05257083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5929857|NCT05257083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5929858|NCT05257083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5929859|NCT05257083|Antiemetics|antiemetics|mesh-ancestor
5929860|NCT05257083|Autonomic Agents|autonomic agents|mesh-ancestor
5929861|NCT05257083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5929862|NCT05257083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5929863|NCT05257083|Glucocorticoids|glucocorticoids|mesh-ancestor
5929864|NCT05257083|Hormones|hormones|mesh-ancestor
5929865|NCT05257083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5929866|NCT05257083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5929867|NCT05257083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5929868|NCT05257083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5929869|NCT05257083|Growth Substances|growth substances|mesh-ancestor
5929870|NCT05257083|Growth Inhibitors|growth inhibitors|mesh-ancestor
5929871|NCT05257018|Doxorubicin|doxorubicin|mesh-list
5929872|NCT05257018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5929873|NCT05257018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5929874|NCT05257018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5929875|NCT05257018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5929876|NCT05257018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5929877|NCT05257018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929878|NCT05256953|Anesthetics|anesthetics|mesh-list
5929879|NCT05256953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5929880|NCT05256953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929881|NCT05256914|Chlorhexidine|chlorhexidine|mesh-list
5929882|NCT05256914|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5929883|NCT05256914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5929884|NCT05256914|Disinfectants|disinfectants|mesh-ancestor
5929885|NCT05256901|Glycopyrrolate|glycopyrrolate|mesh-list
5929886|NCT05256901|Neostigmine|neostigmine|mesh-list
5929887|NCT05256901|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5929888|NCT05256901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5929889|NCT05256901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929890|NCT05256901|Cholinergic Agents|cholinergic agents|mesh-ancestor
5929891|NCT05256901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5929892|NCT05256901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929893|NCT05256901|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5929894|NCT05256901|Autonomic Agents|autonomic agents|mesh-ancestor
5929895|NCT05256901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5929896|NCT05256901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5929897|NCT05256901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5929898|NCT05256901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5929899|NCT05256823|Celecoxib|celecoxib|mesh-list
5929900|NCT05256823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5929901|NCT05256823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5929902|NCT05256823|Analgesics|analgesics|mesh-ancestor
5929903|NCT05256823|Sensory System Agents|sensory system agents|mesh-ancestor
5929904|NCT05256823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5719212|NCT03220126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5719213|NCT03220191|Palbociclib|palbociclib|mesh-list
5719214|NCT03220191|Rabeprazole|rabeprazole|mesh-list
5719215|NCT03220191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5719216|NCT03220191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5719217|NCT03220191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5719218|NCT03220191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719219|NCT03220191|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5719220|NCT03220191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5719221|NCT03220191|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5719222|NCT03220113|Thiamine|thiamine|mesh-list
5929905|NCT05256823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929906|NCT05256823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5929907|NCT05256823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5929908|NCT05256823|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5929909|NCT05256823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5929910|NCT05256823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5929911|NCT05256823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929912|NCT05256797|Rivaroxaban|rivaroxaban|mesh-list
5929913|NCT05256797|Apixaban|apixaban|mesh-list
5929914|NCT05256797|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5929915|NCT05256797|Antithrombins|antithrombins|mesh-ancestor
5929916|NCT05256797|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5929917|NCT05256797|Protease Inhibitors|protease inhibitors|mesh-ancestor
5929918|NCT05256797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5929919|NCT05256797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929920|NCT05256797|Anticoagulants|anticoagulants|mesh-ancestor
5929921|NCT05256758|Fenofibrate|fenofibrate|mesh-list
5929922|NCT05256758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5929923|NCT05256758|Antimetabolites|antimetabolites|mesh-ancestor
5929924|NCT05256758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929925|NCT05256758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5929926|NCT05256745|Paclitaxel|paclitaxel|mesh-list
5929927|NCT05256745|Docetaxel|docetaxel|mesh-list
5929928|NCT05256745|Cyclophosphamide|cyclophosphamide|mesh-list
5929929|NCT05256745|Carboplatin|carboplatin|mesh-list
5929930|NCT05256745|Doxorubicin|doxorubicin|mesh-list
5929931|NCT05256745|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5929932|NCT05256745|Trastuzumab|trastuzumab|mesh-list
5929933|NCT05256745|Pertuzumab|pertuzumab|mesh-list
5929934|NCT05256745|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5929935|NCT05256745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5929936|NCT05256745|Tubulin Modulators|tubulin modulators|mesh-ancestor
5929937|NCT05256745|Antimitotic Agents|antimitotic agents|mesh-ancestor
5929938|NCT05256745|Mitosis Modulators|mitosis modulators|mesh-ancestor
5929939|NCT05256745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929940|NCT05256745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5929941|NCT05256745|Immunologic Factors|immunologic factors|mesh-ancestor
5929942|NCT05256745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929943|NCT05256745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5929944|NCT05256745|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5929945|NCT05256745|Alkylating Agents|alkylating agents|mesh-ancestor
5929946|NCT05256745|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5929947|NCT05256745|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5929948|NCT05256745|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5929949|NCT05256745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5929950|NCT05256745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5929951|NCT05256745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5929952|NCT05256719|Abatacept|abatacept|mesh-list
5929953|NCT05256719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5929954|NCT05256719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929955|NCT05256719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5929956|NCT05256719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5929957|NCT05256719|Immunologic Factors|immunologic factors|mesh-ancestor
5929958|NCT05256719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929959|NCT05256719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5929960|NCT05256693|Vancomycin|vancomycin|mesh-list
5929961|NCT05256693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5929962|NCT05256693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5929963|NCT05256641|Acalabrutinib|acalabrutinib|mesh-list
5929964|NCT05256641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5929965|NCT05256537|Mycophenolic Acid|mycophenolic acid|mesh-list
5929966|NCT05256537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5929967|NCT05256537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5929968|NCT05256537|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5929969|NCT05256537|Antitubercular Agents|antitubercular agents|mesh-ancestor
5929970|NCT05256537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5929971|NCT05256537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5929972|NCT05256537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5929973|NCT05256537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929974|NCT05256472|Axitinib|axitinib|mesh-list
5929975|NCT05256472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5929976|NCT05256472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5929977|NCT05256472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5929978|NCT05256472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929979|NCT05256381|Pembrolizumab|pembrolizumab|mesh-list
6517157|NCT00719888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5929980|NCT05256381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5929981|NCT05256381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5929982|NCT05256342|Etoricoxib|etoricoxib|mesh-list
5929983|NCT05256342|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5929984|NCT05256342|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5929985|NCT05256342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5929986|NCT05256342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5929987|NCT05256342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5929988|NCT05256342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5929989|NCT05256342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5929990|NCT05256342|Analgesics|analgesics|mesh-ancestor
5929991|NCT05256342|Sensory System Agents|sensory system agents|mesh-ancestor
5929992|NCT05256342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5929993|NCT05256342|Antidepressive Agents|antidepressive agents|mesh-ancestor
5929994|NCT05256342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5929995|NCT05256342|Dopamine Agents|dopamine agents|mesh-ancestor
5929996|NCT05256342|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5929997|NCT05256342|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5929998|NCT05256342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5929999|NCT05256342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5930000|NCT05256342|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5930001|NCT05256342|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5930002|NCT05256342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5930003|NCT05256264|Ketamine|ketamine|mesh-list
5930004|NCT05256264|Analgesics|analgesics|mesh-ancestor
5930005|NCT05256264|Sensory System Agents|sensory system agents|mesh-ancestor
5930006|NCT05256264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5930007|NCT05256264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5930008|NCT05256264|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5930009|NCT05256264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5930010|NCT05256264|Anesthetics, General|anesthetics, general|mesh-ancestor
5930011|NCT05256264|Anesthetics|anesthetics|mesh-ancestor
5930012|NCT05256264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5930013|NCT05256264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5930014|NCT05256264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5930015|NCT05256264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5930016|NCT05256264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5930017|NCT05256225|Paclitaxel|paclitaxel|mesh-list
5930018|NCT05256225|Carboplatin|carboplatin|mesh-list
5930019|NCT05256225|Trastuzumab|trastuzumab|mesh-list
5930020|NCT05256225|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5930021|NCT05256225|Pertuzumab|pertuzumab|mesh-list
5930022|NCT05256225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5930023|NCT05256225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5930024|NCT05256225|Tubulin Modulators|tubulin modulators|mesh-ancestor
5930025|NCT05256225|Antimitotic Agents|antimitotic agents|mesh-ancestor
5930026|NCT05256225|Mitosis Modulators|mitosis modulators|mesh-ancestor
5930027|NCT05256225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5930028|NCT05256225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5930029|NCT05256173|Melatonin|melatonin|mesh-list
5930030|NCT05256173|Antioxidants|antioxidants|mesh-ancestor
5930031|NCT05256173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5930032|NCT05256173|Protective Agents|protective agents|mesh-ancestor
5930033|NCT05256173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5930034|NCT05256173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5930035|NCT05256147|Ibuprofen|ibuprofen|mesh-list
5930036|NCT05256147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5930037|NCT05256147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5930038|NCT05256147|Analgesics|analgesics|mesh-ancestor
5930039|NCT05256147|Sensory System Agents|sensory system agents|mesh-ancestor
5930040|NCT05256147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5930041|NCT05256147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5930042|NCT05256147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5930043|NCT05256147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5930044|NCT05256147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5930045|NCT05256147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5930046|NCT05256147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5930047|NCT05256108|Oxycodone|oxycodone|mesh-list
5930048|NCT05256108|Tramadol|tramadol|mesh-list
5930049|NCT05256108|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5930050|NCT05256108|Narcotics|narcotics|mesh-ancestor
5930051|NCT05256108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5930052|NCT05256108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5930053|NCT05256108|Analgesics|analgesics|mesh-ancestor
5930054|NCT05256108|Sensory System Agents|sensory system agents|mesh-ancestor
5930055|NCT05256108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5930056|NCT05256069|Propranolol|propranolol|mesh-list
5930057|NCT05256069|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5930058|NCT05256069|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5930059|NCT05256069|Adrenergic Agents|adrenergic agents|mesh-ancestor
5719223|NCT03220113|Dexamethasone|dexamethasone|mesh-list
5719224|NCT03220113|Lidocaine|lidocaine|mesh-list
5719225|NCT03220113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5719226|NCT03220113|Antiemetics|antiemetics|mesh-ancestor
5719227|NCT03220113|Autonomic Agents|autonomic agents|mesh-ancestor
5719228|NCT03220113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5719229|NCT03220113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719230|NCT03220113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5719231|NCT03220113|Glucocorticoids|glucocorticoids|mesh-ancestor
5719232|NCT03220113|Hormones|hormones|mesh-ancestor
5719233|NCT03220113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5719234|NCT03220113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5719235|NCT03220113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5719236|NCT03220113|Anesthetics, Local|anesthetics, local|mesh-ancestor
5719237|NCT03220113|Anesthetics|anesthetics|mesh-ancestor
5719238|NCT03220113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5719239|NCT03220113|Sensory System Agents|sensory system agents|mesh-ancestor
5719240|NCT03220113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5719241|NCT03220113|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5719242|NCT03220113|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5719243|NCT03220113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5719244|NCT03220113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719245|NCT03220113|Vitamin B Complex|vitamin b complex|mesh-ancestor
5719246|NCT03220113|Vitamins|vitamins|mesh-ancestor
5719247|NCT03220113|Micronutrients|micronutrients|mesh-ancestor
5719248|NCT03219788|Remifentanil|remifentanil|mesh-list
5930060|NCT05256069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5930061|NCT05256069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5930062|NCT05256069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5930063|NCT05256069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5930064|NCT05256069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5930065|NCT05256069|Vasodilator Agents|vasodilator agents|mesh-ancestor
5930073|NCT05255991|Treprostinil|treprostinil|mesh-list
5930074|NCT05255991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5930075|NCT05255913|Fluorides|fluorides|mesh-list
5930076|NCT05255913|Cariostatic Agents|cariostatic agents|mesh-ancestor
5930077|NCT05255913|Protective Agents|protective agents|mesh-ancestor
5930078|NCT05255913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5930079|NCT05255900|Metyrapone|metyrapone|mesh-list
5930080|NCT05255900|Antimetabolites|antimetabolites|mesh-ancestor
5930081|NCT05255900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5930082|NCT05255900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5930083|NCT05255848|Heparin|heparin|mesh-list
5930084|NCT05255848|Calcium heparin|calcium heparin|mesh-list
5930085|NCT05255848|Anticoagulants|anticoagulants|mesh-ancestor
5930086|NCT05255848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5930087|NCT05255848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5930088|NCT05255848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5930089|NCT05255770|Benzocaine|benzocaine|mesh-list
5930090|NCT05255770|Anesthetics, Local|anesthetics, local|mesh-ancestor
5930091|NCT05255770|Anesthetics|anesthetics|mesh-ancestor
5930092|NCT05255770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5930093|NCT05255770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5930094|NCT05255770|Sensory System Agents|sensory system agents|mesh-ancestor
5930095|NCT05255770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5930096|NCT05250973|Dexamethasone|dexamethasone|mesh-list
5930097|NCT05250973|Cyclophosphamide|cyclophosphamide|mesh-list
5930098|NCT05250973|Bortezomib|bortezomib|mesh-list
5930099|NCT05250973|Daratumumab|daratumumab|mesh-list
5930100|NCT05250973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5930101|NCT05250973|Immunologic Factors|immunologic factors|mesh-ancestor
5930102|NCT05250973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719249|NCT03219788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5930103|NCT05250973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5930104|NCT05250973|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5930105|NCT05250973|Alkylating Agents|alkylating agents|mesh-ancestor
5930106|NCT05250973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5930107|NCT05250973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5930108|NCT05250973|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5930109|NCT05250973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5930110|NCT05250973|Antiemetics|antiemetics|mesh-ancestor
5930111|NCT05250973|Autonomic Agents|autonomic agents|mesh-ancestor
5930112|NCT05250973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5930113|NCT05250973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5930114|NCT05250973|Glucocorticoids|glucocorticoids|mesh-ancestor
5930115|NCT05250973|Hormones|hormones|mesh-ancestor
5930116|NCT05250973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5930117|NCT05250973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5930118|NCT05238831|Paclitaxel|paclitaxel|mesh-list
5930119|NCT05238831|Vinorelbine|vinorelbine|mesh-list
5930120|NCT05238831|Maytansine|maytansine|mesh-list
5930121|NCT05238831|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
5930122|NCT05238831|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5930123|NCT05238831|Bevacizumab|bevacizumab|mesh-list
5930124|NCT05238831|Carboplatin|carboplatin|mesh-list
5930125|NCT05238831|Capecitabine|capecitabine|mesh-list
5930126|NCT05238831|Trastuzumab|trastuzumab|mesh-list
5930127|NCT05238831|Irinotecan|irinotecan|mesh-list
5930128|NCT05238831|Letrozole|letrozole|mesh-list
5930129|NCT05238831|Atezolizumab|atezolizumab|mesh-list
5930130|NCT05238831|Olaparib|olaparib|mesh-list
5930131|NCT05238831|Fulvestrant|fulvestrant|mesh-list
5930132|NCT05238831|Palbociclib|palbociclib|mesh-list
5930133|NCT05238831|Anastrozole|anastrozole|mesh-list
5930134|NCT05238831|Pertuzumab|pertuzumab|mesh-list
5930135|NCT05238831|Niraparib|niraparib|mesh-list
5930136|NCT05238831|Vemurafenib|vemurafenib|mesh-list
5930137|NCT05238831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5930138|NCT05238831|Endothelial Growth Factors|endothelial growth factors|mesh-list
5930139|NCT05238831|Antibodies|antibodies|mesh-list
5930140|NCT05238831|Immunoglobulins|immunoglobulins|mesh-list
5930141|NCT05238831|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5930142|NCT05238831|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5930143|NCT05238831|Immunoglobulin G|immunoglobulin g|mesh-list
5930144|NCT05238831|Immunoconjugates|immunoconjugates|mesh-list
5930145|NCT05238831|Entrectinib|entrectinib|mesh-list
5930146|NCT05238831|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
5930147|NCT05238831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5930148|NCT05238831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5930149|NCT05238831|Tubulin Modulators|tubulin modulators|mesh-ancestor
5930150|NCT05238831|Antimitotic Agents|antimitotic agents|mesh-ancestor
5930151|NCT05238831|Mitosis Modulators|mitosis modulators|mesh-ancestor
5930152|NCT05238831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5930153|NCT05238831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5930154|NCT05238831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5930155|NCT05238831|Growth Substances|growth substances|mesh-ancestor
5930156|NCT05238831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5930157|NCT05238831|Growth Inhibitors|growth inhibitors|mesh-ancestor
5930158|NCT05238831|Immunologic Factors|immunologic factors|mesh-ancestor
5930159|NCT05238831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5930160|NCT05238831|Antimetabolites|antimetabolites|mesh-ancestor
5930161|NCT05238831|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5930162|NCT05238831|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5930163|NCT05238831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5930164|NCT05238831|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5930165|NCT05238831|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5930166|NCT05238831|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5930167|NCT05238831|Hormone Antagonists|hormone antagonists|mesh-ancestor
5930168|NCT05238831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5930169|NCT05238831|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5930170|NCT05238831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5930171|NCT05238831|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5930172|NCT05238831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5930173|NCT05237947|Vaccines|vaccines|mesh-list
5930174|NCT05237947|Immunologic Factors|immunologic factors|mesh-ancestor
5930175|NCT05237947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5930176|NCT05232825|Diphenhydramine|diphenhydramine|mesh-list
5930177|NCT05232825|Promethazine|promethazine|mesh-list
5930178|NCT05232825|Dexamethasone|dexamethasone|mesh-list
5930179|NCT05232825|Methylprednisolone|methylprednisolone|mesh-list
5930180|NCT05232825|Desloratadine|desloratadine|mesh-list
5930181|NCT05232825|Ocrelizumab|ocrelizumab|mesh-list
5719250|NCT03219788|Narcotics|narcotics|mesh-ancestor
5719251|NCT03219788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5719252|NCT03219788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719253|NCT03219788|Analgesics|analgesics|mesh-ancestor
5719254|NCT03219788|Sensory System Agents|sensory system agents|mesh-ancestor
5719255|NCT03219788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5719256|NCT03219853|Selenium|selenium|mesh-list
5719257|NCT03219853|Antioxidants|antioxidants|mesh-ancestor
5719258|NCT03219853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719259|NCT03219853|Protective Agents|protective agents|mesh-ancestor
5719260|NCT03219853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719261|NCT03219853|Trace Elements|trace elements|mesh-ancestor
5719262|NCT03219853|Micronutrients|micronutrients|mesh-ancestor
5719263|NCT03219762|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5719264|NCT03219762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5719265|NCT03219970|Osimertinib|osimertinib|mesh-list
5719266|NCT03219970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5719267|NCT03219970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5719268|NCT03219970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5719269|NCT03219970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719270|NCT03220009|Nivolumab|nivolumab|mesh-list
5719271|NCT03220009|Ipilimumab|ipilimumab|mesh-list
5719272|NCT03220009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5719273|NCT03220009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5719274|NCT03220009|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5719275|NCT03220009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719276|NCT03219983|Bupivacaine|bupivacaine|mesh-list
5719277|NCT03219983|Ropivacaine|ropivacaine|mesh-list
5719278|NCT03219983|Anesthetics, Local|anesthetics, local|mesh-ancestor
5719279|NCT03219983|Anesthetics|anesthetics|mesh-ancestor
5719280|NCT03219983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5719281|NCT03219983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719282|NCT03219983|Sensory System Agents|sensory system agents|mesh-ancestor
5719283|NCT03219983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5719284|NCT03220022|Prednisone|prednisone|mesh-list
5719285|NCT03220022|Cortisone|cortisone|mesh-list
5719286|NCT03220022|Cyclophosphamide|cyclophosphamide|mesh-list
5719287|NCT03220022|Rituximab|rituximab|mesh-list
5719288|NCT03220022|Doxorubicin|doxorubicin|mesh-list
5719289|NCT03220022|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5719290|NCT03220022|Etoposide|etoposide|mesh-list
5719291|NCT03220022|Vincristine|vincristine|mesh-list
5719292|NCT03220022|Etoposide phosphate|etoposide phosphate|mesh-list
5719293|NCT03220022|Podophyllotoxin|podophyllotoxin|mesh-list
5719294|NCT03220022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5719295|NCT03220022|Antibodies|antibodies|mesh-list
5719296|NCT03220022|Immunoglobulins|immunoglobulins|mesh-list
5719297|NCT03220022|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5930182|NCT05232825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5930183|NCT05232825|Antiemetics|antiemetics|mesh-ancestor
5930184|NCT05232825|Autonomic Agents|autonomic agents|mesh-ancestor
5930185|NCT05232825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5930186|NCT05232825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5930187|NCT05232825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5930188|NCT05232825|Glucocorticoids|glucocorticoids|mesh-ancestor
5930189|NCT05232825|Hormones|hormones|mesh-ancestor
5930190|NCT05232825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5930191|NCT05232825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5930192|NCT05232825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5930193|NCT05232825|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5930194|NCT05232825|Protective Agents|protective agents|mesh-ancestor
5930195|NCT05232825|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5930196|NCT05232825|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5930197|NCT05232825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5930198|NCT05232825|Anesthetics, Local|anesthetics, local|mesh-ancestor
5930199|NCT05232825|Anesthetics|anesthetics|mesh-ancestor
5930200|NCT05232825|Sensory System Agents|sensory system agents|mesh-ancestor
5930201|NCT05232825|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5930202|NCT05232825|Histamine Antagonists|histamine antagonists|mesh-ancestor
5930203|NCT05232825|Histamine Agents|histamine agents|mesh-ancestor
5930204|NCT05232825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5930205|NCT05232825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719298|NCT03220022|Lenograstim|lenograstim|mesh-list
5719299|NCT03220022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5719300|NCT03220022|Immunologic Factors|immunologic factors|mesh-ancestor
5719301|NCT03220022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719302|NCT03220022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5930206|NCT05232825|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5930207|NCT05232825|Antipruritics|antipruritics|mesh-ancestor
5930208|NCT05232825|Dermatologic Agents|dermatologic agents|mesh-ancestor
5930209|NCT05232825|Immunologic Factors|immunologic factors|mesh-ancestor
5930210|NCT05232825|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5930211|NCT05232825|Cholinergic Agents|cholinergic agents|mesh-ancestor
5930212|NCT05232825|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5930213|NCT05231941|Lidocaine|lidocaine|mesh-list
5930214|NCT05231941|Ropivacaine|ropivacaine|mesh-list
5930215|NCT05231941|Anesthetics, Local|anesthetics, local|mesh-ancestor
5930216|NCT05231941|Anesthetics|anesthetics|mesh-ancestor
5930217|NCT05231941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5930218|NCT05231941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5930219|NCT05231941|Sensory System Agents|sensory system agents|mesh-ancestor
5930220|NCT05231941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5930221|NCT05231941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5930222|NCT05231941|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5930223|NCT05231941|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5930224|NCT05231941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5930225|NCT05231941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5930226|NCT05231590|Myeloma Proteins|myeloma proteins|mesh-list
5930227|NCT05231590|Paraproteins|paraproteins|mesh-list
5930228|NCT05231590|Immunologic Factors|immunologic factors|mesh-ancestor
5930229|NCT05231590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5930230|NCT05222984|Decitabine|decitabine|mesh-list
5930231|NCT05222984|Venetoclax|venetoclax|mesh-list
5930232|NCT05222984|Navitoclax|navitoclax|mesh-list
5930233|NCT05222984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5930234|NCT05222984|Antimetabolites|antimetabolites|mesh-ancestor
5930235|NCT05222984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5930236|NCT05222984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5930237|NCT05222984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5930238|NCT05216575|Almitrine|almitrine|mesh-list
5930239|NCT05216575|Respiratory System Agents|respiratory system agents|mesh-ancestor
5930240|NCT05214417|Ketamine|ketamine|mesh-list
5930241|NCT05214417|Analgesics|analgesics|mesh-ancestor
5930242|NCT05214417|Sensory System Agents|sensory system agents|mesh-ancestor
5930243|NCT05214417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5930244|NCT05214417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5930245|NCT05214417|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5930246|NCT05214417|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5930247|NCT05214417|Anesthetics, General|anesthetics, general|mesh-ancestor
5719303|NCT03220022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5719304|NCT03220022|Alkylating Agents|alkylating agents|mesh-ancestor
5719305|NCT03220022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719306|NCT03220022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5719307|NCT03220022|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5719308|NCT03220022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5719309|NCT03220022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5719310|NCT03220022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5719311|NCT03220022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5719312|NCT03220022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5719313|NCT03220022|Glucocorticoids|glucocorticoids|mesh-ancestor
5719314|NCT03220022|Hormones|hormones|mesh-ancestor
5930248|NCT05214417|Anesthetics|anesthetics|mesh-ancestor
5930249|NCT05214417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5930250|NCT05214417|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5930251|NCT05214417|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5930252|NCT05214417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5930253|NCT05214417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5930274|NCT05205252|Dexamethasone|dexamethasone|mesh-list
5930275|NCT05205252|Dexamethasone acetate|dexamethasone acetate|mesh-list
5930276|NCT05205252|Lenalidomide|lenalidomide|mesh-list
5930277|NCT05205252|Daratumumab|daratumumab|mesh-list
5930278|NCT05205252|Pomalidomide|pomalidomide|mesh-list
5930279|NCT05205252|Acalabrutinib|acalabrutinib|mesh-list
5930280|NCT05205252|BB 1101|bb 1101|mesh-list
5930281|NCT05205252|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5930282|NCT05205252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5930283|NCT05205252|Antiemetics|antiemetics|mesh-ancestor
5930284|NCT05205252|Autonomic Agents|autonomic agents|mesh-ancestor
5930285|NCT05205252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5930286|NCT05205252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5930287|NCT05205252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5930288|NCT05205252|Glucocorticoids|glucocorticoids|mesh-ancestor
5930289|NCT05205252|Hormones|hormones|mesh-ancestor
5930290|NCT05205252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5930291|NCT05205252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5930292|NCT05205252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5930293|NCT05205252|Protease Inhibitors|protease inhibitors|mesh-ancestor
5930294|NCT05205252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5930295|NCT05205252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5930296|NCT05205252|Immunologic Factors|immunologic factors|mesh-ancestor
5930297|NCT05205252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5930298|NCT05205252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5930299|NCT05205252|Growth Substances|growth substances|mesh-ancestor
5930300|NCT05205252|Growth Inhibitors|growth inhibitors|mesh-ancestor
5930301|NCT05202262|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
5930302|NCT05202262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5930303|NCT05202262|Respiratory System Agents|respiratory system agents|mesh-ancestor
5930304|NCT05197842|Prednisone|prednisone|mesh-list
5930305|NCT05197842|Cyclophosphamide|cyclophosphamide|mesh-list
5930306|NCT05197842|Glucocorticoids|glucocorticoids|mesh-list
5930307|NCT05197842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5930308|NCT05197842|Immunologic Factors|immunologic factors|mesh-ancestor
5930309|NCT05197842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5930310|NCT05197842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5930311|NCT05197842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5930312|NCT05197842|Alkylating Agents|alkylating agents|mesh-ancestor
5930313|NCT05197842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5930314|NCT05197842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5930315|NCT05197842|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5930316|NCT05197842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5930317|NCT05197842|Hormones|hormones|mesh-ancestor
5930318|NCT05197842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5930319|NCT05197842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5930320|NCT05189730|Paclitaxel|paclitaxel|mesh-list
5930321|NCT05189730|Carboplatin|carboplatin|mesh-list
5930322|NCT05189730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5930323|NCT05189730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5930324|NCT05189730|Tubulin Modulators|tubulin modulators|mesh-ancestor
5930325|NCT05189730|Antimitotic Agents|antimitotic agents|mesh-ancestor
5930326|NCT05189730|Mitosis Modulators|mitosis modulators|mesh-ancestor
5930327|NCT05189730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5930335|NCT05182931|Trametinib|trametinib|mesh-list
5930336|NCT05182931|Dabrafenib|dabrafenib|mesh-list
5930337|NCT05182931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5930338|NCT05182931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5930339|NCT05182931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5930340|NCT05182931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5930344|NCT05168709|Vaccines|vaccines|mesh-list
5930345|NCT05168709|Immunologic Factors|immunologic factors|mesh-ancestor
5930346|NCT05168709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5930347|NCT05163106|Letrozole|letrozole|mesh-list
5930348|NCT05163106|Goserelin|goserelin|mesh-list
5930349|NCT05163106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5930350|NCT05163106|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5930351|NCT05163106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5930352|NCT05163106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5930353|NCT05163106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5930354|NCT05163106|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5930355|NCT05163106|Hormone Antagonists|hormone antagonists|mesh-ancestor
5930356|NCT05163106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5930357|NCT05163106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5930358|NCT05163106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5930367|NCT05154123|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5930368|NCT05154123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5930369|NCT05154123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5930370|NCT05154123|Antimetabolites|antimetabolites|mesh-ancestor
5930371|NCT05154123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5930372|NCT05154123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5930373|NCT05154123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5930374|NCT05154123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5930381|NCT05127590|Pembrolizumab|pembrolizumab|mesh-list
5930382|NCT05127590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5930383|NCT05127590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5930384|NCT05119855|Vaccines|vaccines|mesh-list
5930385|NCT05119855|Immunologic Factors|immunologic factors|mesh-ancestor
5930386|NCT05119855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719315|NCT03220022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5719316|NCT03220022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5719317|NCT03220022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5719318|NCT03220022|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5719319|NCT03220022|Tubulin Modulators|tubulin modulators|mesh-ancestor
5719320|NCT03220022|Antimitotic Agents|antimitotic agents|mesh-ancestor
5719321|NCT03220022|Mitosis Modulators|mitosis modulators|mesh-ancestor
5719322|NCT03220022|Keratolytic Agents|keratolytic agents|mesh-ancestor
5719323|NCT03220022|Dermatologic Agents|dermatologic agents|mesh-ancestor
5719324|NCT03219710|Dexamethasone|dexamethasone|mesh-list
5719325|NCT03219710|Ondansetron|ondansetron|mesh-list
5719326|NCT03219710|Olanzapine|olanzapine|mesh-list
5719327|NCT03219710|Aprepitant|aprepitant|mesh-list
5719328|NCT03219710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5719329|NCT03219710|Antiemetics|antiemetics|mesh-ancestor
5719330|NCT03219710|Autonomic Agents|autonomic agents|mesh-ancestor
5719331|NCT03219710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5719332|NCT03219710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719333|NCT03219710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5719334|NCT03219710|Glucocorticoids|glucocorticoids|mesh-ancestor
5719335|NCT03219710|Hormones|hormones|mesh-ancestor
5719336|NCT03219710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5719337|NCT03219710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5719338|NCT03219710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5719339|NCT03219710|Antipruritics|antipruritics|mesh-ancestor
5930387|NCT05112952|Lazertinib|lazertinib|mesh-list
5930388|NCT05112952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5930389|NCT05112952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5930390|NCT05112952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719340|NCT03219710|Dermatologic Agents|dermatologic agents|mesh-ancestor
5930395|NCT05083169|Dexamethasone|dexamethasone|mesh-list
5930396|NCT05083169|Bortezomib|bortezomib|mesh-list
5930397|NCT05083169|Daratumumab|daratumumab|mesh-list
5930398|NCT05083169|Pomalidomide|pomalidomide|mesh-list
5930399|NCT05083169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5930400|NCT05083169|Antiemetics|antiemetics|mesh-ancestor
5930401|NCT05083169|Autonomic Agents|autonomic agents|mesh-ancestor
5930402|NCT05083169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5930403|NCT05083169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5930404|NCT05083169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5930405|NCT05083169|Glucocorticoids|glucocorticoids|mesh-ancestor
5930406|NCT05083169|Hormones|hormones|mesh-ancestor
5930407|NCT05083169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5930408|NCT05083169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5930409|NCT05083169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5930410|NCT05083169|Immunologic Factors|immunologic factors|mesh-ancestor
5930411|NCT05083169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5930412|NCT05083169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5930413|NCT05083169|Growth Substances|growth substances|mesh-ancestor
5930414|NCT05083169|Growth Inhibitors|growth inhibitors|mesh-ancestor
5930415|NCT05071664|Golimumab|golimumab|mesh-list
5930416|NCT05071664|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
5930417|NCT05071664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5930418|NCT05071664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5930419|NCT05071664|Immunologic Factors|immunologic factors|mesh-ancestor
5930420|NCT05071664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5930426|NCT05050097|Lenalidomide|lenalidomide|mesh-list
5930427|NCT05050097|Pomalidomide|pomalidomide|mesh-list
5930428|NCT05050097|Daratumumab|daratumumab|mesh-list
5930429|NCT05050097|Immunologic Factors|immunologic factors|mesh-ancestor
5930430|NCT05050097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5930431|NCT05050097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5930432|NCT05050097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5930433|NCT05050097|Growth Substances|growth substances|mesh-ancestor
5930434|NCT05050097|Growth Inhibitors|growth inhibitors|mesh-ancestor
5930435|NCT05050097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5930436|NCT05048264|Dexamethasone|dexamethasone|mesh-list
5930437|NCT05048264|Methylprednisolone|methylprednisolone|mesh-list
5930438|NCT05048264|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5930439|NCT05048264|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5930440|NCT05048264|Prednisolone|prednisolone|mesh-list
5930441|NCT05048264|Prednisolone acetate|prednisolone acetate|mesh-list
5930442|NCT05048264|Triamcinolone|triamcinolone|mesh-list
5930443|NCT05048264|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5930444|NCT05048264|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5930445|NCT05048264|Betamethasone|betamethasone|mesh-list
5930446|NCT05048264|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5930447|NCT05048264|Prednisolone phosphate|prednisolone phosphate|mesh-list
5930448|NCT05048264|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5930449|NCT05048264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5930450|NCT05048264|Antiemetics|antiemetics|mesh-ancestor
5930451|NCT05048264|Autonomic Agents|autonomic agents|mesh-ancestor
5930452|NCT05048264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5930453|NCT05048264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5930454|NCT05048264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5930455|NCT05048264|Glucocorticoids|glucocorticoids|mesh-ancestor
5930456|NCT05048264|Hormones|hormones|mesh-ancestor
5930457|NCT05048264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5930458|NCT05048264|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5930459|NCT05048264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5930460|NCT05048264|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5930461|NCT05048264|Protective Agents|protective agents|mesh-ancestor
5930462|NCT05048264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5930463|NCT05048264|Immunologic Factors|immunologic factors|mesh-ancestor
5930464|NCT05048264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5930465|NCT05048264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5930466|NCT05048264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5930467|NCT05048264|Respiratory System Agents|respiratory system agents|mesh-ancestor
5930484|NCT05028608|Carbamazepine|carbamazepine|mesh-list
5930485|NCT05028608|Midazolam|midazolam|mesh-list
5930486|NCT05028608|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5930487|NCT05028608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5930488|NCT05028608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5930489|NCT05028608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5930490|NCT05028608|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5930491|NCT05028608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5930492|NCT05028608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5930493|NCT05028608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5930494|NCT05028608|Anesthetics, General|anesthetics, general|mesh-ancestor
5930495|NCT05028608|Anesthetics|anesthetics|mesh-ancestor
5930496|NCT05028608|GABA Modulators|gaba modulators|mesh-ancestor
5930497|NCT05028608|GABA Agents|gaba agents|mesh-ancestor
5930498|NCT05028608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5930499|NCT05028608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5930500|NCT05028608|Anticonvulsants|anticonvulsants|mesh-ancestor
5930501|NCT05028608|Antimanic Agents|antimanic agents|mesh-ancestor
5930502|NCT05028608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5930503|NCT05028608|Analgesics|analgesics|mesh-ancestor
5930504|NCT05028608|Sensory System Agents|sensory system agents|mesh-ancestor
5930505|NCT05028608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5930506|NCT05028608|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5930507|NCT05028608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5930508|NCT05028608|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5930509|NCT05028608|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5930510|NCT05028569|Botulinum Toxins|botulinum toxins|mesh-list
5930511|NCT05028569|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5930512|NCT05028569|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5930513|NCT05028569|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5930514|NCT05028569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5930515|NCT05028569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5930516|NCT05028569|Cholinergic Agents|cholinergic agents|mesh-ancestor
5930517|NCT05028569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5930518|NCT05028569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5930519|NCT05028569|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5930520|NCT05028569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5930542|NCT05020899|Nicotine|nicotine|mesh-list
5930543|NCT05020899|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5930544|NCT05020899|Autonomic Agents|autonomic agents|mesh-ancestor
5930545|NCT05020899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6517158|NCT00719888|Dermatologic Agents|dermatologic agents|mesh-ancestor
5719341|NCT03219710|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5719342|NCT03219710|Serotonin Agents|serotonin agents|mesh-ancestor
5719343|NCT03219710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5719344|NCT03219710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719345|NCT03219710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5719346|NCT03219710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5719347|NCT03219710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5719348|NCT03219710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5719349|NCT03219710|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5719350|NCT03219710|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5719351|NCT03219710|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5719352|NCT03219710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5719353|NCT03219710|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5930546|NCT05020899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5930547|NCT05020899|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5930548|NCT05020899|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5930549|NCT05020899|Cholinergic Agents|cholinergic agents|mesh-ancestor
5930550|NCT05020899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5930551|NCT05020899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5930555|NCT05009862|Aspirin|aspirin|mesh-list
5930556|NCT05009862|Rivaroxaban|rivaroxaban|mesh-list
5930557|NCT05009862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5930558|NCT05009862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5930559|NCT05009862|Analgesics|analgesics|mesh-ancestor
5930560|NCT05009862|Sensory System Agents|sensory system agents|mesh-ancestor
5930561|NCT05009862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5930562|NCT05009862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5930563|NCT05009862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5930564|NCT05009862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5930565|NCT05009862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5930566|NCT05009862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5930567|NCT05009862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5930568|NCT05009862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5930569|NCT05009862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5930570|NCT05009862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5930571|NCT05009862|Antipyretics|antipyretics|mesh-ancestor
5930572|NCT05009862|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5930573|NCT05009862|Antithrombins|antithrombins|mesh-ancestor
5930574|NCT05009862|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5930575|NCT05009862|Protease Inhibitors|protease inhibitors|mesh-ancestor
5930576|NCT05009862|Anticoagulants|anticoagulants|mesh-ancestor
5930577|NCT04994717|Blinatumomab|blinatumomab|mesh-list
5930578|NCT04994717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5930579|NCT04988295|Carboplatin|carboplatin|mesh-list
5930580|NCT04988295|Pemetrexed|pemetrexed|mesh-list
5930581|NCT04988295|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
5930582|NCT04988295|Lazertinib|lazertinib|mesh-list
5930583|NCT04988295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5930584|NCT04988295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5930585|NCT04988295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5930586|NCT04988295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5930587|NCT04988295|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5930588|NCT04988295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5930589|NCT04988295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5930590|NCT04984798|Vitamin E|vitamin e|mesh-list
5930591|NCT04984798|Tocopherols|tocopherols|mesh-list
5930592|NCT04984798|alpha-Tocopherol|alpha-tocopherol|mesh-list
5930593|NCT04984798|Vitamins|vitamins|mesh-ancestor
5930594|NCT04984798|Micronutrients|micronutrients|mesh-ancestor
5930595|NCT04984798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5930596|NCT04984798|Antioxidants|antioxidants|mesh-ancestor
5930597|NCT04984798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5930598|NCT04984798|Protective Agents|protective agents|mesh-ancestor
5930599|NCT04984317|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5930600|NCT04984317|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5930601|NCT04984317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5930602|NCT04984317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5930603|NCT04984317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5930604|NCT04984317|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5930605|NCT04984317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5719354|NCT03219554|Palbociclib|palbociclib|mesh-list
5965798|NCT04578158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719355|NCT03219554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5719356|NCT03219554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5719357|NCT03219554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5719358|NCT03219554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719359|NCT03219593|Apatinib|apatinib|mesh-list
5719360|NCT03219593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5719361|NCT03219593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5719362|NCT03219593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5930606|NCT04984317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5930607|NCT04984317|Cholinergic Agents|cholinergic agents|mesh-ancestor
5930608|NCT04984317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5930609|NCT04972968|Glucocorticoids|glucocorticoids|mesh-list
5930610|NCT04972968|Hormones|hormones|mesh-ancestor
5930611|NCT04972968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5930612|NCT04972968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5930613|NCT04945733|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
5930614|NCT04945733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5930615|NCT04945733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5930616|NCT04940390|Dihydroergotamine|dihydroergotamine|mesh-list
5930617|NCT04940390|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5930618|NCT04940390|Dopamine Agonists|dopamine agonists|mesh-ancestor
5930619|NCT04940390|Dopamine Agents|dopamine agents|mesh-ancestor
5930620|NCT04940390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5930621|NCT04940390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5930622|NCT04940390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5930623|NCT04940390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5930624|NCT04940390|Analgesics|analgesics|mesh-ancestor
5930625|NCT04940390|Sensory System Agents|sensory system agents|mesh-ancestor
5930626|NCT04940390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5930627|NCT04938817|Pembrolizumab|pembrolizumab|mesh-list
5930628|NCT04938817|Lenvatinib|lenvatinib|mesh-list
5930629|NCT04938817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5930630|NCT04938817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5930631|NCT04938817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5930632|NCT04938817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5930633|NCT04938817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681201|NCT01608464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6681202|NCT01608464|Immunologic Factors|immunologic factors|mesh-ancestor
6681203|NCT01608464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681204|NCT01608464|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6681205|NCT01608464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6681206|NCT01608464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6681207|NCT01608555|Tobramycin|tobramycin|mesh-list
6681208|NCT01608555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6681209|NCT01608555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6681210|NCT01608594|Ipilimumab|ipilimumab|mesh-list
6681211|NCT01608594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5930706|NCT04895709|Nivolumab|nivolumab|mesh-list
5930707|NCT04895709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5930708|NCT04895709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5930709|NCT04895709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5930710|NCT04895709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5930711|NCT04892472|Pembrolizumab|pembrolizumab|mesh-list
5930712|NCT04892472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5930713|NCT04892472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5930724|NCT04873596|Midazolam|midazolam|mesh-list
5930725|NCT04873596|Dexmedetomidine|dexmedetomidine|mesh-list
5930726|NCT04873596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5930727|NCT04873596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5930728|NCT04873596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5930729|NCT04873596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5930730|NCT04873596|Analgesics|analgesics|mesh-ancestor
5930731|NCT04873596|Sensory System Agents|sensory system agents|mesh-ancestor
5930732|NCT04873596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5930733|NCT04873596|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5930734|NCT04873596|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5930735|NCT04873596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5930736|NCT04873596|Adrenergic Agents|adrenergic agents|mesh-ancestor
5930737|NCT04873596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5930738|NCT04873596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5930739|NCT04873596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5930740|NCT04873596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5930741|NCT04873596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5930742|NCT04873596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5930743|NCT04873596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5930744|NCT04873596|Anesthetics, General|anesthetics, general|mesh-ancestor
5930745|NCT04873596|Anesthetics|anesthetics|mesh-ancestor
5930746|NCT04873596|GABA Modulators|gaba modulators|mesh-ancestor
5930747|NCT04873596|GABA Agents|gaba agents|mesh-ancestor
5930748|NCT04873362|Trastuzumab|trastuzumab|mesh-list
5930749|NCT04873362|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
5930750|NCT04873362|Atezolizumab|atezolizumab|mesh-list
5930751|NCT04873362|Maytansine|maytansine|mesh-list
5930752|NCT04873362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5930753|NCT04873362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5930754|NCT04873362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5930755|NCT04873362|Tubulin Modulators|tubulin modulators|mesh-ancestor
5930756|NCT04873362|Antimitotic Agents|antimitotic agents|mesh-ancestor
5930757|NCT04873362|Mitosis Modulators|mitosis modulators|mesh-ancestor
5930758|NCT04873362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5930759|NCT04854434|Trifluridine|trifluridine|mesh-list
5930760|NCT04854434|Pembrolizumab|pembrolizumab|mesh-list
5930761|NCT04854434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5930762|NCT04854434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5930763|NCT04854434|Antimetabolites|antimetabolites|mesh-ancestor
5930764|NCT04854434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5930765|NCT04854434|Antiviral Agents|antiviral agents|mesh-ancestor
5930766|NCT04854434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5930767|NCT04847557|Tirzepatide|tirzepatide|mesh-list
5930768|NCT04847557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5930769|NCT04847557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5930770|NCT04847557|Incretins|incretins|mesh-ancestor
5930771|NCT04847557|Hormones|hormones|mesh-ancestor
5930772|NCT04847557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5930773|NCT04840602|Rituximab|rituximab|mesh-list
5930774|NCT04840602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5930775|NCT04840602|Venetoclax|venetoclax|mesh-list
5930776|NCT04840602|Antibodies|antibodies|mesh-list
5930777|NCT04840602|Immunoglobulins|immunoglobulins|mesh-list
5930778|NCT04840602|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5930779|NCT04840602|Immunologic Factors|immunologic factors|mesh-ancestor
5930780|NCT04840602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5930781|NCT04840602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5930782|NCT04840602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5930783|NCT04829604|Immunoconjugates|immunoconjugates|mesh-list
5930784|NCT04829604|Immunologic Factors|immunologic factors|mesh-ancestor
5930785|NCT04829604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5930786|NCT04795336|Melatonin|melatonin|mesh-list
5930787|NCT04795336|Antioxidants|antioxidants|mesh-ancestor
5930788|NCT04795336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5930789|NCT04795336|Protective Agents|protective agents|mesh-ancestor
5719363|NCT03219593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719364|NCT03219580|Fluorouracil|fluorouracil|mesh-list
5719365|NCT03219580|Antimetabolites|antimetabolites|mesh-ancestor
5719366|NCT03219580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719367|NCT03219580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5719368|NCT03219580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5719369|NCT03219580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5719370|NCT03219580|Immunologic Factors|immunologic factors|mesh-ancestor
5719371|NCT03219580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722166|NCT03200808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722167|NCT03200587|Avelumab|avelumab|mesh-list
5722168|NCT03200587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5722169|NCT03200587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5722341|NCT03199924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5722342|NCT03199924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722343|NCT03199924|Sensory System Agents|sensory system agents|mesh-ancestor
5722344|NCT03199924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5930790|NCT04795336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5930791|NCT04795336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5930792|NCT04768881|Pembrolizumab|pembrolizumab|mesh-list
5930793|NCT04768881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5930794|NCT04768881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5930795|NCT04759586|Prednisone|prednisone|mesh-list
5930796|NCT04759586|Prednisolone|prednisolone|mesh-list
5930797|NCT04759586|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5930798|NCT04759586|Methylprednisolone|methylprednisolone|mesh-list
5930799|NCT04759586|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5930800|NCT04759586|Prednisolone acetate|prednisolone acetate|mesh-list
5719372|NCT03219476|Tamoxifen|tamoxifen|mesh-list
5719373|NCT03219476|Letrozole|letrozole|mesh-list
5719374|NCT03219476|Anastrozole|anastrozole|mesh-list
5719375|NCT03219476|Exemestane|exemestane|mesh-list
5719376|NCT03219476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5719377|NCT03219476|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5719378|NCT03219476|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5719379|NCT03219476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5719380|NCT03219476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719381|NCT03219476|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5719382|NCT03219476|Hormone Antagonists|hormone antagonists|mesh-ancestor
5719383|NCT03219476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5719384|NCT03219476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719385|NCT03219476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5719386|NCT03219476|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5719387|NCT03219476|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5719388|NCT03219476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5719389|NCT03219359|Methylprednisolone|methylprednisolone|mesh-list
5719390|NCT03219359|Cyclophosphamide|cyclophosphamide|mesh-list
5719391|NCT03219359|Vedolizumab|vedolizumab|mesh-list
5719392|NCT03219359|Thymoglobulin|thymoglobulin|mesh-list
5719393|NCT03219359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5719394|NCT03219359|Immunologic Factors|immunologic factors|mesh-ancestor
5719395|NCT03219359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719396|NCT03219359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5719397|NCT03219359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5719398|NCT03219359|Alkylating Agents|alkylating agents|mesh-ancestor
5719399|NCT03219359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5930801|NCT04759586|Hydrocortisone|hydrocortisone|mesh-list
5930802|NCT04759586|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
5930803|NCT04759586|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
5930804|NCT04759586|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
5930805|NCT04759586|Cortisone|cortisone|mesh-list
5930806|NCT04759586|Cyclophosphamide|cyclophosphamide|mesh-list
5930807|NCT04759586|Rituximab|rituximab|mesh-list
5930808|NCT04759586|Doxorubicin|doxorubicin|mesh-list
5930809|NCT04759586|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5930810|NCT04759586|Nivolumab|nivolumab|mesh-list
5930811|NCT04759586|Etoposide|etoposide|mesh-list
5930812|NCT04759586|Vincristine|vincristine|mesh-list
5930813|NCT04759586|Etoposide phosphate|etoposide phosphate|mesh-list
5930814|NCT04759586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5930815|NCT04759586|Antibodies|antibodies|mesh-list
5930816|NCT04759586|Immunoglobulins|immunoglobulins|mesh-list
5930817|NCT04759586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5930818|NCT04759586|Lenograstim|lenograstim|mesh-list
5930819|NCT04759586|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5930820|NCT04759586|Prednisolone phosphate|prednisolone phosphate|mesh-list
5930821|NCT04759586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5930822|NCT04759586|Immunologic Factors|immunologic factors|mesh-ancestor
5930823|NCT04759586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5930824|NCT04759586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5930825|NCT04759586|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5930826|NCT04759586|Alkylating Agents|alkylating agents|mesh-ancestor
5930827|NCT04759586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5930828|NCT04759586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5930829|NCT04759586|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5930830|NCT04759586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5930831|NCT04759586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5930832|NCT04759586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5930833|NCT04759586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5930834|NCT04759586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5930835|NCT04759586|Glucocorticoids|glucocorticoids|mesh-ancestor
5930836|NCT04759586|Hormones|hormones|mesh-ancestor
5719400|NCT03219359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5719401|NCT03219359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5930837|NCT04759586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5930838|NCT04759586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5930839|NCT04759586|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5930840|NCT04759586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5930841|NCT04759586|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5930842|NCT04759586|Tubulin Modulators|tubulin modulators|mesh-ancestor
5930843|NCT04759586|Antimitotic Agents|antimitotic agents|mesh-ancestor
5930844|NCT04759586|Mitosis Modulators|mitosis modulators|mesh-ancestor
5930845|NCT04759586|Antiemetics|antiemetics|mesh-ancestor
5930846|NCT04759586|Autonomic Agents|autonomic agents|mesh-ancestor
5930847|NCT04759586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5930848|NCT04759586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5930849|NCT04759586|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5930850|NCT04759586|Protective Agents|protective agents|mesh-ancestor
5930851|NCT04739358|Tepotinib|tepotinib|mesh-list
5930852|NCT04739358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5930853|NCT04729959|Atezolizumab|atezolizumab|mesh-list
5930854|NCT04729959|Immunoglobulins|immunoglobulins|mesh-list
5930855|NCT04729959|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5930856|NCT04729959|Immunoglobulin G|immunoglobulin g|mesh-list
5930857|NCT04729959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5930858|NCT04729959|Immunologic Factors|immunologic factors|mesh-ancestor
5930859|NCT04729959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5930860|NCT04698187|Nivolumab|nivolumab|mesh-list
5930861|NCT04698187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5930862|NCT04698187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5930863|NCT04698187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5930864|NCT04698187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5930865|NCT04685876|Bupivacaine|bupivacaine|mesh-list
5930866|NCT04685876|Anesthetics, Local|anesthetics, local|mesh-ancestor
5930867|NCT04685876|Anesthetics|anesthetics|mesh-ancestor
5930868|NCT04685876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5930869|NCT04685876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719402|NCT03219359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5719403|NCT03219359|Antiemetics|antiemetics|mesh-ancestor
5719404|NCT03219359|Autonomic Agents|autonomic agents|mesh-ancestor
5719405|NCT03219359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5719406|NCT03219359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5719407|NCT03219359|Glucocorticoids|glucocorticoids|mesh-ancestor
5719408|NCT03219359|Hormones|hormones|mesh-ancestor
5930870|NCT04685876|Sensory System Agents|sensory system agents|mesh-ancestor
5930871|NCT04685876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5930872|NCT04683029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5930873|NCT04683029|Immunologic Factors|immunologic factors|mesh-ancestor
5930874|NCT04683029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5930875|NCT04676399|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5930876|NCT04676399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5930877|NCT04676399|Diuretics|diuretics|mesh-ancestor
5930878|NCT04676399|Natriuretic Agents|natriuretic agents|mesh-ancestor
5930879|NCT04676399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5930880|NCT04676399|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5930881|NCT04676399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5930882|NCT04676399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5930883|NCT04671082|Tolperisone|tolperisone|mesh-list
5930884|NCT04671082|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5930885|NCT04671082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5930886|NCT04671082|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5930887|NCT04671082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5930888|NCT04667078|Cangrelor|cangrelor|mesh-list
5930889|NCT04667078|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5930890|NCT04667078|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5930891|NCT04667078|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5930892|NCT04667078|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5930893|NCT04667078|Purinergic Agents|purinergic agents|mesh-ancestor
5930894|NCT04667078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5930895|NCT04667078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5930896|NCT04667078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5930897|NCT04659603|Maytansine|maytansine|mesh-list
5930898|NCT04659603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5930899|NCT04659603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5930900|NCT04659603|Tubulin Modulators|tubulin modulators|mesh-ancestor
5930901|NCT04659603|Antimitotic Agents|antimitotic agents|mesh-ancestor
5930902|NCT04659603|Mitosis Modulators|mitosis modulators|mesh-ancestor
5930903|NCT04659603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5930904|NCT04658862|Gemcitabine|gemcitabine|mesh-list
5930905|NCT04658862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5719409|NCT03219359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5930906|NCT04658862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5930907|NCT04658862|Antimetabolites|antimetabolites|mesh-ancestor
5930908|NCT04658862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5930909|NCT04658862|Antiviral Agents|antiviral agents|mesh-ancestor
5930910|NCT04658862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5930911|NCT04658862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5930912|NCT04658862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5930913|NCT04658862|Immunologic Factors|immunologic factors|mesh-ancestor
5930914|NCT04658862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5930915|NCT04657289|Ranibizumab|ranibizumab|mesh-list
5930916|NCT04657289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5930917|NCT04657289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5930918|NCT04657289|Growth Substances|growth substances|mesh-ancestor
5930919|NCT04657289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5930920|NCT04657289|Growth Inhibitors|growth inhibitors|mesh-ancestor
5930921|NCT04657289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5930922|NCT04657081|Decitabine|decitabine|mesh-list
5930923|NCT04657081|Venetoclax|venetoclax|mesh-list
5930924|NCT04657081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5930925|NCT04657081|Antimetabolites|antimetabolites|mesh-ancestor
5930926|NCT04657081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5930927|NCT04657081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5930928|NCT04657081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5930929|NCT04643002|Dexamethasone|dexamethasone|mesh-list
5930930|NCT04643002|Pomalidomide|pomalidomide|mesh-list
5930931|NCT04643002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5930932|NCT04643002|Antiemetics|antiemetics|mesh-ancestor
5930933|NCT04643002|Autonomic Agents|autonomic agents|mesh-ancestor
5930934|NCT04643002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5930935|NCT04643002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5930936|NCT04643002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5930937|NCT04643002|Glucocorticoids|glucocorticoids|mesh-ancestor
5930938|NCT04643002|Hormones|hormones|mesh-ancestor
5930939|NCT04643002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5930940|NCT04643002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5930941|NCT04643002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5930942|NCT04643002|Immunologic Factors|immunologic factors|mesh-ancestor
5930943|NCT04643002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5930944|NCT04643002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5930945|NCT04643002|Growth Substances|growth substances|mesh-ancestor
5930946|NCT04643002|Growth Inhibitors|growth inhibitors|mesh-ancestor
5930947|NCT04640623|Gemcitabine|gemcitabine|mesh-list
5930948|NCT04640623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5930949|NCT04640623|Antimetabolites|antimetabolites|mesh-ancestor
5930950|NCT04640623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5930951|NCT04640623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5930952|NCT04640623|Antiviral Agents|antiviral agents|mesh-ancestor
5930953|NCT04640623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5930954|NCT04640623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5930955|NCT04640623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5930956|NCT04640623|Immunologic Factors|immunologic factors|mesh-ancestor
5930957|NCT04640623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5930970|NCT04621526|Dexmedetomidine|dexmedetomidine|mesh-list
5930971|NCT04621526|Ketamine|ketamine|mesh-list
5930972|NCT04621526|Propofol|propofol|mesh-list
5930973|NCT04621526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5930974|NCT04621526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5930975|NCT04621526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5930976|NCT04621526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5930977|NCT04621526|Anesthetics, General|anesthetics, general|mesh-ancestor
5930978|NCT04621526|Anesthetics|anesthetics|mesh-ancestor
5930979|NCT04621526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5930980|NCT04621526|Analgesics|analgesics|mesh-ancestor
5930981|NCT04621526|Sensory System Agents|sensory system agents|mesh-ancestor
5930982|NCT04621526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5930983|NCT04621526|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5930984|NCT04621526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5930985|NCT04621526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5930986|NCT04621526|Adrenergic Agents|adrenergic agents|mesh-ancestor
5930987|NCT04621526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5930988|NCT04621526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5930989|NCT04621526|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5930990|NCT04621526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5930991|NCT04621526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5930992|NCT04620733|Seladelpar|seladelpar|mesh-list
5930993|NCT04620733|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5930994|NCT04620733|Antimetabolites|antimetabolites|mesh-ancestor
5930995|NCT04620733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5930996|NCT04620733|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5930997|NCT04606381|Lazertinib|lazertinib|mesh-list
5930998|NCT04606381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5930999|NCT04606381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5931000|NCT04606381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5931001|NCT04605991|Insulin Glargine|insulin glargine|mesh-list
5931002|NCT04605991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5931003|NCT04605991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5931004|NCT04599634|Venetoclax|venetoclax|mesh-list
5931005|NCT04599634|Obinutuzumab|obinutuzumab|mesh-list
5931006|NCT04599634|Magrolimab|magrolimab|mesh-list
5931007|NCT04599634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5931008|NCT04599634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5931009|NCT04586426|Daratumumab|daratumumab|mesh-list
5931010|NCT04586426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5931011|NCT04577833|Prednisone|prednisone|mesh-list
5931012|NCT04577833|Abiraterone Acetate|abiraterone acetate|mesh-list
5931013|NCT04577833|Niraparib|niraparib|mesh-list
5931014|NCT04577833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5931015|NCT04577833|Glucocorticoids|glucocorticoids|mesh-ancestor
5931016|NCT04577833|Hormones|hormones|mesh-ancestor
5931017|NCT04577833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5931018|NCT04577833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5931019|NCT04577833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5931020|NCT04577833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5931021|NCT04577833|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5931022|NCT04577833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5931023|NCT04577833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5931024|NCT04577833|Hormone Antagonists|hormone antagonists|mesh-ancestor
5931025|NCT04577833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5931026|NCT04577833|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5931027|NCT04576962|Vaccines|vaccines|mesh-list
5931028|NCT04576962|Immunologic Factors|immunologic factors|mesh-ancestor
5931029|NCT04576962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5931030|NCT04569084|Edaravone|edaravone|mesh-list
5931031|NCT04569084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5931032|NCT04569084|Antioxidants|antioxidants|mesh-ancestor
5931033|NCT04569084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5931034|NCT04569084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5931035|NCT04569084|Protective Agents|protective agents|mesh-ancestor
5931036|NCT04569084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5931037|NCT04569045|Lidocaine|lidocaine|mesh-list
5931038|NCT04569045|Anesthetics, Local|anesthetics, local|mesh-ancestor
5931039|NCT04569045|Anesthetics|anesthetics|mesh-ancestor
5931040|NCT04569045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5931041|NCT04569045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5931042|NCT04569045|Sensory System Agents|sensory system agents|mesh-ancestor
5931043|NCT04569045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5931044|NCT04569045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5931045|NCT04569045|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5931046|NCT04569045|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5931047|NCT04569045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5931048|NCT04569045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5931049|NCT04550195|Famotidine|famotidine|mesh-list
5931050|NCT04550195|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5931051|NCT04550195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5931052|NCT04550195|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5931053|NCT04550195|Histamine Antagonists|histamine antagonists|mesh-ancestor
5931054|NCT04550195|Histamine Agents|histamine agents|mesh-ancestor
5931055|NCT04550195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5931056|NCT04550195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5931057|NCT04550195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5931058|NCT04548999|Methylprednisolone|methylprednisolone|mesh-list
5931059|NCT04548999|Ocrelizumab|ocrelizumab|mesh-list
5931060|NCT04548999|Histamine Antagonists|histamine antagonists|mesh-list
5931061|NCT04548999|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
5931062|NCT04548999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5931063|NCT04548999|Antiemetics|antiemetics|mesh-ancestor
5931064|NCT04548999|Autonomic Agents|autonomic agents|mesh-ancestor
5931065|NCT04548999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5931066|NCT04548999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5931067|NCT04548999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5931068|NCT04548999|Glucocorticoids|glucocorticoids|mesh-ancestor
5931069|NCT04548999|Hormones|hormones|mesh-ancestor
5931070|NCT04548999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5931071|NCT04548999|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5931072|NCT04548999|Protective Agents|protective agents|mesh-ancestor
5931073|NCT04548999|Immunologic Factors|immunologic factors|mesh-ancestor
5931074|NCT04548999|Histamine Agents|histamine agents|mesh-ancestor
5931075|NCT04548999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5931076|NCT04548999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5931077|NCT04537962|Listerine|listerine|mesh-list
5931078|NCT04537962|Cetylpyridinium|cetylpyridinium|mesh-list
5931079|NCT04537962|Fluorides|fluorides|mesh-list
5931080|NCT04537962|Sodium Fluoride|sodium fluoride|mesh-list
5931081|NCT04537962|Fluorophosphate|fluorophosphate|mesh-list
5931082|NCT04537962|Tin Fluorides|tin fluorides|mesh-list
5931083|NCT04537962|Cariostatic Agents|cariostatic agents|mesh-ancestor
5931084|NCT04537962|Protective Agents|protective agents|mesh-ancestor
5931085|NCT04537962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5931086|NCT04537962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5931087|NCT04537962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5931088|NCT04535882|polysaccharide-K|polysaccharide-k|mesh-list
5931089|NCT04535882|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5931090|NCT04535882|Immunologic Factors|immunologic factors|mesh-ancestor
5931091|NCT04535882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5931092|NCT04535882|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5931093|NCT04535882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5931094|NCT04535882|Antiviral Agents|antiviral agents|mesh-ancestor
5931095|NCT04535882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5931096|NCT04535882|Interferon Inducers|interferon inducers|mesh-ancestor
5931097|NCT04535882|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5931098|NCT04535882|Protective Agents|protective agents|mesh-ancestor
5931099|NCT04532645|Olaparib|olaparib|mesh-list
5931100|NCT04532645|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5931101|NCT04532645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5931102|NCT04532645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5931103|NCT04532645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5931104|NCT04525391|Durvalumab|durvalumab|mesh-list
5931105|NCT04525391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5931106|NCT04525391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5931107|NCT04523207|Relugolix|relugolix|mesh-list
5931108|NCT04523207|Androgen Antagonists|androgen antagonists|mesh-ancestor
5931109|NCT04523207|Hormone Antagonists|hormone antagonists|mesh-ancestor
5931110|NCT04523207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5931111|NCT04523207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5931112|NCT04497844|Prednisone|prednisone|mesh-list
5931113|NCT04497844|Abiraterone Acetate|abiraterone acetate|mesh-list
5931114|NCT04497844|Niraparib|niraparib|mesh-list
5931115|NCT04497844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5931116|NCT04497844|Glucocorticoids|glucocorticoids|mesh-ancestor
5931117|NCT04497844|Hormones|hormones|mesh-ancestor
5931118|NCT04497844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5931119|NCT04497844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5931120|NCT04497844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5931121|NCT04497844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5931122|NCT04497844|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5931123|NCT04497844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5931124|NCT04497844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5931125|NCT04497844|Hormone Antagonists|hormone antagonists|mesh-ancestor
5931126|NCT04497844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5931127|NCT04497844|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5931128|NCT04487080|Osimertinib|osimertinib|mesh-list
5931129|NCT04487080|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
5931130|NCT04487080|Lazertinib|lazertinib|mesh-list
5931131|NCT04487080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5931132|NCT04487080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5931133|NCT04487080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5931134|NCT04487080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5931135|NCT04487080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5931136|NCT04481048|Acetylcysteine|acetylcysteine|mesh-list
5931137|NCT04481048|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5931138|NCT04481048|Antiviral Agents|antiviral agents|mesh-ancestor
5931139|NCT04481048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5931140|NCT04481048|Expectorants|expectorants|mesh-ancestor
5931141|NCT04481048|Respiratory System Agents|respiratory system agents|mesh-ancestor
5931142|NCT04481048|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5931143|NCT04481048|Antioxidants|antioxidants|mesh-ancestor
5931144|NCT04481048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5931145|NCT04481048|Protective Agents|protective agents|mesh-ancestor
5931146|NCT04481048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5931147|NCT04481048|Antidotes|antidotes|mesh-ancestor
5931148|NCT04469530|Sirolimus|sirolimus|mesh-list
5931149|NCT04469530|Celecoxib|celecoxib|mesh-list
5931150|NCT04469530|Cyclophosphamide|cyclophosphamide|mesh-list
5931151|NCT04469530|Etoposide|etoposide|mesh-list
5931152|NCT04469530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5931153|NCT04469530|Immunologic Factors|immunologic factors|mesh-ancestor
5931154|NCT04469530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5931155|NCT04469530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5931156|NCT04469530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5931157|NCT04469530|Alkylating Agents|alkylating agents|mesh-ancestor
5931158|NCT04469530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5931159|NCT04469530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5931160|NCT04469530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5931161|NCT04469530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5931162|NCT04469530|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5931163|NCT04469530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5931164|NCT04469530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5931165|NCT04469530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5931166|NCT04469530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5931167|NCT04469530|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5931168|NCT04469530|Antifungal Agents|antifungal agents|mesh-ancestor
5931169|NCT04469530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5931170|NCT04469530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5931171|NCT04469530|Analgesics|analgesics|mesh-ancestor
5931172|NCT04469530|Sensory System Agents|sensory system agents|mesh-ancestor
5931173|NCT04469530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5931174|NCT04469530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5931175|NCT04469530|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5931176|NCT04469530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5931177|NCT04468360|Pregnanolone|pregnanolone|mesh-list
5931178|NCT04468360|Brexanolone|brexanolone|mesh-list
5931179|NCT04468360|Anesthetics|anesthetics|mesh-ancestor
5931180|NCT04468360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5931181|NCT04468360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5931182|NCT04468360|Neurosteroids|neurosteroids|mesh-ancestor
5931183|NCT04468360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5931184|NCT04468360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5931185|NCT04468360|GABA Modulators|gaba modulators|mesh-ancestor
5931186|NCT04468360|GABA Agents|gaba agents|mesh-ancestor
5931187|NCT04425291|Vaccines|vaccines|mesh-list
5931188|NCT04425291|Immunologic Factors|immunologic factors|mesh-ancestor
5931189|NCT04425291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5931190|NCT04423055|Contraceptive Agents|contraceptive agents|mesh-list
5931191|NCT04423055|Etonogestrel|etonogestrel|mesh-list
5931192|NCT04423055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5931193|NCT04423055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5931194|NCT04423055|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5931195|NCT04423055|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5931196|NCT04416633|Durvalumab|durvalumab|mesh-list
5931197|NCT04416633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5931198|NCT04416633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5931199|NCT04402788|Atezolizumab|atezolizumab|mesh-list
5931200|NCT04402788|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5931201|NCT04402788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5931202|NCT04402788|Immunologic Factors|immunologic factors|mesh-ancestor
5931203|NCT04402788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517159|NCT00719888|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5931213|NCT04389073|Cyclophosphamide|cyclophosphamide|mesh-list
5931214|NCT04389073|Bevacizumab|bevacizumab|mesh-list
5931215|NCT04389073|Capecitabine|capecitabine|mesh-list
5931216|NCT04389073|Vinorelbine|vinorelbine|mesh-list
5931217|NCT04389073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5931218|NCT04389073|Immunologic Factors|immunologic factors|mesh-ancestor
5931219|NCT04389073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5931220|NCT04389073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5931221|NCT04389073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5931222|NCT04389073|Alkylating Agents|alkylating agents|mesh-ancestor
5931223|NCT04389073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5931224|NCT04389073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5931225|NCT04389073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5931226|NCT04389073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5931227|NCT04389073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5931228|NCT04389073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5931229|NCT04389073|Growth Substances|growth substances|mesh-ancestor
5931230|NCT04389073|Growth Inhibitors|growth inhibitors|mesh-ancestor
5931231|NCT04389073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5931232|NCT04389073|Antimetabolites|antimetabolites|mesh-ancestor
5931233|NCT04389073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5931234|NCT04389073|Tubulin Modulators|tubulin modulators|mesh-ancestor
5931235|NCT04389073|Antimitotic Agents|antimitotic agents|mesh-ancestor
5931236|NCT04389073|Mitosis Modulators|mitosis modulators|mesh-ancestor
5931237|NCT04384484|Gemcitabine|gemcitabine|mesh-list
5931238|NCT04384484|Rituximab|rituximab|mesh-list
5931239|NCT04384484|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
5931240|NCT04384484|Oxaliplatin|oxaliplatin|mesh-list
5931241|NCT04384484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5931242|NCT04384484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5931243|NCT04384484|Immunologic Factors|immunologic factors|mesh-ancestor
5931244|NCT04384484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5931245|NCT04384484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5931246|NCT04384484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5931247|NCT04384484|Antimetabolites|antimetabolites|mesh-ancestor
5931248|NCT04384484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5931249|NCT04384484|Antiviral Agents|antiviral agents|mesh-ancestor
5931250|NCT04384484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5931251|NCT04384484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5931252|NCT04384484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5931253|NCT04376827|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5931254|NCT04376827|Immunologic Factors|immunologic factors|mesh-ancestor
5931255|NCT04376827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5931256|NCT04373265|Pembrolizumab|pembrolizumab|mesh-list
5931257|NCT04373265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5931258|NCT04373265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5931259|NCT04371445|Dexamethasone|dexamethasone|mesh-list
5931260|NCT04371445|Prednisolone|prednisolone|mesh-list
5931261|NCT04371445|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5931262|NCT04371445|Methylprednisolone|methylprednisolone|mesh-list
5931263|NCT04371445|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5931264|NCT04371445|Prednisolone acetate|prednisolone acetate|mesh-list
5931265|NCT04371445|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5931266|NCT04371445|Prednisolone phosphate|prednisolone phosphate|mesh-list
5931267|NCT04371445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5931268|NCT04371445|Antiemetics|antiemetics|mesh-ancestor
5931269|NCT04371445|Autonomic Agents|autonomic agents|mesh-ancestor
5931270|NCT04371445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5931271|NCT04371445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5931272|NCT04371445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5931273|NCT04371445|Glucocorticoids|glucocorticoids|mesh-ancestor
5931274|NCT04371445|Hormones|hormones|mesh-ancestor
5931275|NCT04371445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5931276|NCT04371445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5931277|NCT04371445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5931278|NCT04371445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5931279|NCT04371445|Protective Agents|protective agents|mesh-ancestor
5931294|NCT04357782|Ascorbic Acid|ascorbic acid|mesh-list
5931295|NCT04357782|Vitamins|vitamins|mesh-ancestor
5931296|NCT04357782|Micronutrients|micronutrients|mesh-ancestor
5931297|NCT04357782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5931298|NCT04357782|Antioxidants|antioxidants|mesh-ancestor
5931299|NCT04357782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5931300|NCT04357782|Protective Agents|protective agents|mesh-ancestor
5931316|NCT04339738|Paclitaxel|paclitaxel|mesh-list
5931317|NCT04339738|Nivolumab|nivolumab|mesh-list
5931318|NCT04339738|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5931319|NCT04339738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5931320|NCT04339738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5931321|NCT04339738|Tubulin Modulators|tubulin modulators|mesh-ancestor
5931322|NCT04339738|Antimitotic Agents|antimitotic agents|mesh-ancestor
5931323|NCT04339738|Mitosis Modulators|mitosis modulators|mesh-ancestor
5931324|NCT04339738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5931325|NCT04339738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5931326|NCT04339738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5931327|NCT04337073|Propofol|propofol|mesh-list
5931328|NCT04337073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5931329|NCT04337073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5931330|NCT04337073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5931331|NCT04337073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5931332|NCT04337073|Anesthetics, General|anesthetics, general|mesh-ancestor
5931333|NCT04337073|Anesthetics|anesthetics|mesh-ancestor
5931334|NCT04330248|Carbamazepine|carbamazepine|mesh-list
5931335|NCT04330248|Anticonvulsants|anticonvulsants|mesh-ancestor
5931336|NCT04330248|Antimanic Agents|antimanic agents|mesh-ancestor
5931337|NCT04330248|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5931338|NCT04330248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5931339|NCT04330248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5931340|NCT04330248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5931341|NCT04330248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5931342|NCT04330248|Analgesics|analgesics|mesh-ancestor
5931343|NCT04330248|Sensory System Agents|sensory system agents|mesh-ancestor
5931344|NCT04330248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5931345|NCT04330248|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5931346|NCT04330248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5931347|NCT04330248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5931348|NCT04330248|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5931349|NCT04330248|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5931350|NCT04316806|Rifaximin|rifaximin|mesh-list
5931351|NCT04316806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5931352|NCT04316806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5931353|NCT04316806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5931354|NCT04316117|Deoxyglucose|deoxyglucose|mesh-list
5931355|NCT04316117|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5931356|NCT04316117|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5931357|NCT04316117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5931358|NCT04316117|Antimetabolites|antimetabolites|mesh-ancestor
5931359|NCT04316117|Antiviral Agents|antiviral agents|mesh-ancestor
5931360|NCT04316117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5931361|NCT04311606|Aflibercept|aflibercept|mesh-list
5931362|NCT04311606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5931363|NCT04311606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5931364|NCT04311606|Growth Substances|growth substances|mesh-ancestor
5931365|NCT04311606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5931366|NCT04311606|Growth Inhibitors|growth inhibitors|mesh-ancestor
5931367|NCT04311606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5931368|NCT04309916|Esomeprazole|esomeprazole|mesh-list
5931369|NCT04309916|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5931370|NCT04309916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5931371|NCT04309916|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5931372|NCT04309916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5931373|NCT04309916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5931374|NCT04284774|Tipifarnib|tipifarnib|mesh-list
5931375|NCT04284774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5931376|NCT04284397|Aspirin|aspirin|mesh-list
5931377|NCT04284397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5931378|NCT04284397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5931379|NCT04284397|Analgesics|analgesics|mesh-ancestor
5931380|NCT04284397|Sensory System Agents|sensory system agents|mesh-ancestor
5931381|NCT04284397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5931382|NCT04284397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5931383|NCT04284397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5931384|NCT04284397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5931385|NCT04284397|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5931386|NCT04284397|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5931387|NCT04284397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5931388|NCT04284397|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5931389|NCT04284397|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5931390|NCT04284397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5931391|NCT04284397|Antipyretics|antipyretics|mesh-ancestor
5931392|NCT04275999|Ivermectin|ivermectin|mesh-list
5931393|NCT04275999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5931394|NCT04275999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5931395|NCT04270474|Cholinergic Antagonists|cholinergic antagonists|mesh-list
5931396|NCT04270474|Cholinergic Agents|cholinergic agents|mesh-ancestor
5931397|NCT04270474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5931398|NCT04270474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5931399|NCT04270474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5931400|NCT04267848|Gemcitabine|gemcitabine|mesh-list
5931401|NCT04267848|Paclitaxel|paclitaxel|mesh-list
5931402|NCT04267848|Cisplatin|cisplatin|mesh-list
5931403|NCT04267848|Carboplatin|carboplatin|mesh-list
5931404|NCT04267848|Pembrolizumab|pembrolizumab|mesh-list
5931405|NCT04267848|Pemetrexed|pemetrexed|mesh-list
5931406|NCT04267848|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5931407|NCT04267848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5931408|NCT04267848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5931409|NCT04267848|Tubulin Modulators|tubulin modulators|mesh-ancestor
5931410|NCT04267848|Antimitotic Agents|antimitotic agents|mesh-ancestor
5931411|NCT04267848|Mitosis Modulators|mitosis modulators|mesh-ancestor
5719410|NCT03219359|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5719411|NCT03219359|Protective Agents|protective agents|mesh-ancestor
5719412|NCT03219671|Nivolumab|nivolumab|mesh-list
5719413|NCT03219671|Ipilimumab|ipilimumab|mesh-list
5719414|NCT03219671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5719415|NCT03219671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5719416|NCT03219671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5719417|NCT03219671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719418|NCT03219450|Cyclophosphamide|cyclophosphamide|mesh-list
5719419|NCT03219450|Pembrolizumab|pembrolizumab|mesh-list
5719420|NCT03219450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5719421|NCT03219450|Immunologic Factors|immunologic factors|mesh-ancestor
5719422|NCT03219450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719423|NCT03219450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5719424|NCT03219450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5719425|NCT03219450|Alkylating Agents|alkylating agents|mesh-ancestor
5719426|NCT03219450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719427|NCT03219450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5719428|NCT03219450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5931412|NCT04267848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722170|NCT03200691|Antibodies|antibodies|mesh-list
5931413|NCT04267848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5931414|NCT04267848|Antimetabolites|antimetabolites|mesh-ancestor
5931415|NCT04267848|Antiviral Agents|antiviral agents|mesh-ancestor
5931416|NCT04267848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5931417|NCT04267848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5931418|NCT04267848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5931419|NCT04267848|Immunologic Factors|immunologic factors|mesh-ancestor
5931420|NCT04267848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5931421|NCT04267848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5931422|NCT04267848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5931423|NCT04267848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5931424|NCT04256707|Docetaxel|docetaxel|mesh-list
5931425|NCT04256707|Pembrolizumab|pembrolizumab|mesh-list
5931426|NCT04256707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5931427|NCT04256707|Tubulin Modulators|tubulin modulators|mesh-ancestor
5931428|NCT04256707|Antimitotic Agents|antimitotic agents|mesh-ancestor
5931429|NCT04256707|Mitosis Modulators|mitosis modulators|mesh-ancestor
5931430|NCT04256707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5931431|NCT04256707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5931432|NCT04252742|Erenumab|erenumab|mesh-list
5931433|NCT04252742|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
5931434|NCT04252742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5931435|NCT04252742|Analgesics|analgesics|mesh-ancestor
5931436|NCT04252742|Sensory System Agents|sensory system agents|mesh-ancestor
5931437|NCT04252742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5931438|NCT04252742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5931439|NCT04247542|Vancomycin|vancomycin|mesh-list
5931440|NCT04247542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5931441|NCT04247542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5931442|NCT04245215|Ustekinumab|ustekinumab|mesh-list
5931443|NCT04245215|Dermatologic Agents|dermatologic agents|mesh-ancestor
5931444|NCT04206319|Listerine|listerine|mesh-list
5931445|NCT04206319|Fluorides|fluorides|mesh-list
5931446|NCT04206319|Sodium Fluoride|sodium fluoride|mesh-list
5931447|NCT04206319|Cariostatic Agents|cariostatic agents|mesh-ancestor
5931448|NCT04206319|Protective Agents|protective agents|mesh-ancestor
5931449|NCT04206319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5931450|NCT04206319|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5931451|NCT04206319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5931452|NCT04196283|Paclitaxel|paclitaxel|mesh-list
5931453|NCT04196283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5931454|NCT04196283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5931455|NCT04196283|Tubulin Modulators|tubulin modulators|mesh-ancestor
5931456|NCT04196283|Antimitotic Agents|antimitotic agents|mesh-ancestor
5931457|NCT04196283|Mitosis Modulators|mitosis modulators|mesh-ancestor
5931458|NCT04196283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5931459|NCT04195555|Ivosidenib|ivosidenib|mesh-list
5931460|NCT04195555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5931461|NCT04195555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5931462|NCT04195555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5931463|NCT04189107|Dexamethasone|dexamethasone|mesh-list
5931464|NCT04189107|Dexamethasone acetate|dexamethasone acetate|mesh-list
5931465|NCT04189107|BB 1101|bb 1101|mesh-list
5931466|NCT04189107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5931467|NCT04189107|Antiemetics|antiemetics|mesh-ancestor
5931468|NCT04189107|Autonomic Agents|autonomic agents|mesh-ancestor
5931469|NCT04189107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5931470|NCT04189107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5931471|NCT04189107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5931472|NCT04189107|Glucocorticoids|glucocorticoids|mesh-ancestor
5931473|NCT04189107|Hormones|hormones|mesh-ancestor
5931474|NCT04189107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5931475|NCT04189107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5931476|NCT04189107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5931477|NCT04189107|Protease Inhibitors|protease inhibitors|mesh-ancestor
5931478|NCT04189107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5931479|NCT04189107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5931480|NCT04181827|Dexamethasone|dexamethasone|mesh-list
5931481|NCT04181827|Bortezomib|bortezomib|mesh-list
5931482|NCT04181827|Daratumumab|daratumumab|mesh-list
5931483|NCT04181827|Pomalidomide|pomalidomide|mesh-list
5931484|NCT04181827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5931485|NCT04181827|Antiemetics|antiemetics|mesh-ancestor
5931486|NCT04181827|Autonomic Agents|autonomic agents|mesh-ancestor
5931487|NCT04181827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5931488|NCT04181827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5931489|NCT04181827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5931490|NCT04181827|Glucocorticoids|glucocorticoids|mesh-ancestor
5931491|NCT04181827|Hormones|hormones|mesh-ancestor
5931492|NCT04181827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5931493|NCT04181827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5931494|NCT04181827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5931495|NCT04181827|Immunologic Factors|immunologic factors|mesh-ancestor
5931496|NCT04181827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5931497|NCT04181827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5931498|NCT04181827|Growth Substances|growth substances|mesh-ancestor
5931499|NCT04181827|Growth Inhibitors|growth inhibitors|mesh-ancestor
5931518|NCT04172675|Gemcitabine|gemcitabine|mesh-list
5931519|NCT04172675|Mitomycins|mitomycins|mesh-list
5931520|NCT04172675|Mitomycin|mitomycin|mesh-list
5931521|NCT04172675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5931522|NCT04172675|Antimetabolites|antimetabolites|mesh-ancestor
5931523|NCT04172675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5931524|NCT04172675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5931525|NCT04172675|Antiviral Agents|antiviral agents|mesh-ancestor
5931526|NCT04172675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5931527|NCT04172675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5931528|NCT04172675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5931529|NCT04172675|Immunologic Factors|immunologic factors|mesh-ancestor
5931530|NCT04172675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5931531|NCT04172675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5931532|NCT04172675|Alkylating Agents|alkylating agents|mesh-ancestor
5931533|NCT04172675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5931547|NCT04153435|Calcium|calcium|mesh-list
5931548|NCT04153435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5931549|NCT04153435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5931550|NCT04150887|Azacitidine|azacitidine|mesh-list
5931551|NCT04150887|Venetoclax|venetoclax|mesh-list
5931552|NCT04150887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5931553|NCT04150887|Antimetabolites|antimetabolites|mesh-ancestor
5931554|NCT04150887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5931555|NCT04150887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5931556|NCT04150887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5931557|NCT04121260|Daratumumab|daratumumab|mesh-list
5931558|NCT04121260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5931559|NCT04113382|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
5931560|NCT04113382|Laxatives|laxatives|mesh-ancestor
5931561|NCT04113382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5931562|NCT04112095|Norgestrel|norgestrel|mesh-list
5931563|NCT04112095|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5931564|NCT04112095|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5931565|NCT04112095|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5931566|NCT04112095|Contraceptive Agents|contraceptive agents|mesh-ancestor
5931567|NCT04112095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5931568|NCT04112095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5931569|NCT04112095|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5931570|NCT04112095|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5931571|NCT04109066|Paclitaxel|paclitaxel|mesh-list
5931572|NCT04109066|Cyclophosphamide|cyclophosphamide|mesh-list
5931573|NCT04109066|Nivolumab|nivolumab|mesh-list
5931574|NCT04109066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5931575|NCT04109066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5931576|NCT04109066|Tubulin Modulators|tubulin modulators|mesh-ancestor
5931577|NCT04109066|Antimitotic Agents|antimitotic agents|mesh-ancestor
5931578|NCT04109066|Mitosis Modulators|mitosis modulators|mesh-ancestor
5931579|NCT04109066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5931580|NCT04109066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5931581|NCT04109066|Immunologic Factors|immunologic factors|mesh-ancestor
5931582|NCT04109066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5931583|NCT04109066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5931584|NCT04109066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5931585|NCT04109066|Alkylating Agents|alkylating agents|mesh-ancestor
5931586|NCT04109066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5931587|NCT04109066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5931588|NCT04109066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5931589|NCT04108208|Androgens|androgens|mesh-list
5931590|NCT04108208|Hormones|hormones|mesh-ancestor
5931591|NCT04108208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5931592|NCT04108208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5931593|NCT04108195|Daratumumab|daratumumab|mesh-list
5931594|NCT04108195|Pomalidomide|pomalidomide|mesh-list
5931595|NCT04108195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5931596|NCT04108195|Immunologic Factors|immunologic factors|mesh-ancestor
5931597|NCT04108195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5931598|NCT04108195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5931599|NCT04108195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5931600|NCT04108195|Growth Substances|growth substances|mesh-ancestor
5931601|NCT04108195|Growth Inhibitors|growth inhibitors|mesh-ancestor
5931602|NCT04092283|Paclitaxel|paclitaxel|mesh-list
5931603|NCT04092283|Etoposide|etoposide|mesh-list
5931604|NCT04092283|Podophyllotoxin|podophyllotoxin|mesh-list
5931605|NCT04092283|Cisplatin|cisplatin|mesh-list
5931606|NCT04092283|Carboplatin|carboplatin|mesh-list
5931607|NCT04092283|Pemetrexed|pemetrexed|mesh-list
5931608|NCT04092283|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5931609|NCT04092283|Etoposide phosphate|etoposide phosphate|mesh-list
5931610|NCT04092283|Durvalumab|durvalumab|mesh-list
5931611|NCT04092283|Immunoglobulins|immunoglobulins|mesh-list
5931612|NCT04092283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5931613|NCT04092283|Immunoglobulin G|immunoglobulin g|mesh-list
5931614|NCT04092283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5931615|NCT04092283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5719429|NCT03219450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5719430|NCT03219645|Aspirin|aspirin|mesh-list
5719431|NCT03219645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5719432|NCT03219645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5719433|NCT03219645|Analgesics|analgesics|mesh-ancestor
5719434|NCT03219645|Sensory System Agents|sensory system agents|mesh-ancestor
5931616|NCT04092283|Tubulin Modulators|tubulin modulators|mesh-ancestor
5931617|NCT04092283|Antimitotic Agents|antimitotic agents|mesh-ancestor
5931618|NCT04092283|Mitosis Modulators|mitosis modulators|mesh-ancestor
5931619|NCT04092283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5931620|NCT04092283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5931621|NCT04092283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5931622|NCT04092283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5719435|NCT03219645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5719436|NCT03219645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719437|NCT03219645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5719438|NCT03219645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5719439|NCT03219645|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5719440|NCT03219645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5719441|NCT03219645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719442|NCT03219645|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5719443|NCT03219645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5931623|NCT04092283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5931624|NCT04092283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5931625|NCT04092283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5931626|NCT04092283|Immunologic Factors|immunologic factors|mesh-ancestor
5931627|NCT04092283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5931628|NCT04092283|Keratolytic Agents|keratolytic agents|mesh-ancestor
5931629|NCT04092283|Dermatologic Agents|dermatologic agents|mesh-ancestor
5931635|NCT04077463|Carboplatin|carboplatin|mesh-list
5931636|NCT04077463|Pemetrexed|pemetrexed|mesh-list
5931637|NCT04077463|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
5931638|NCT04077463|Lazertinib|lazertinib|mesh-list
5931639|NCT04077463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5931640|NCT04077463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5931641|NCT04077463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5931642|NCT04077463|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5931643|NCT04077463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5931644|NCT04077463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5931645|NCT04077463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5931657|NCT04062448|Rituximab|rituximab|mesh-list
5931658|NCT04062448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5931659|NCT04062448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5931660|NCT04062448|Immunologic Factors|immunologic factors|mesh-ancestor
5931661|NCT04062448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5931662|NCT04062448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5931670|NCT04057898|Ibudilast|ibudilast|mesh-list
5931671|NCT04057898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5931672|NCT04057898|Autonomic Agents|autonomic agents|mesh-ancestor
5931673|NCT04057898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5931674|NCT04057898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5931675|NCT04057898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5931676|NCT04057898|Respiratory System Agents|respiratory system agents|mesh-ancestor
5931677|NCT04057898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5931678|NCT04057898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5931679|NCT04057898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5931680|NCT04057898|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5931681|NCT04057898|Vasodilator Agents|vasodilator agents|mesh-ancestor
5931685|NCT04050553|Tirzepatide|tirzepatide|mesh-list
5931686|NCT04050553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5931687|NCT04050553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5931688|NCT04050553|Incretins|incretins|mesh-ancestor
5931689|NCT04050553|Hormones|hormones|mesh-ancestor
5931690|NCT04050553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5931691|NCT04049331|Methyltestosterone|methyltestosterone|mesh-list
5931692|NCT04049331|Testosterone|testosterone|mesh-list
5931693|NCT04049331|Testosterone undecanoate|testosterone undecanoate|mesh-list
5931694|NCT04049331|Testosterone enanthate|testosterone enanthate|mesh-list
5931695|NCT04049331|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5931696|NCT04049331|Androgens|androgens|mesh-ancestor
5931697|NCT04049331|Hormones|hormones|mesh-ancestor
5931698|NCT04049331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5931699|NCT04049331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5931700|NCT04049331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5931701|NCT04049331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5931702|NCT04049331|Anabolic Agents|anabolic agents|mesh-ancestor
5931703|NCT04041050|Celecoxib|celecoxib|mesh-list
5931704|NCT04041050|Navitoclax|navitoclax|mesh-list
5931705|NCT04041050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5931706|NCT04041050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5931707|NCT04041050|Analgesics|analgesics|mesh-ancestor
5931708|NCT04041050|Sensory System Agents|sensory system agents|mesh-ancestor
5931709|NCT04041050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5931710|NCT04041050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5931711|NCT04041050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5931712|NCT04041050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5931713|NCT04041050|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5931714|NCT04041050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5931715|NCT04041050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5931716|NCT04041050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5931717|NCT04041050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5931718|NCT04034095|Prednisolone|prednisolone|mesh-list
5931719|NCT04034095|Docetaxel|docetaxel|mesh-list
5931720|NCT04034095|Bicalutamide|bicalutamide|mesh-list
5931721|NCT04034095|Androgens|androgens|mesh-list
5931722|NCT04034095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5931723|NCT04034095|Tubulin Modulators|tubulin modulators|mesh-ancestor
5931724|NCT04034095|Antimitotic Agents|antimitotic agents|mesh-ancestor
5931725|NCT04034095|Mitosis Modulators|mitosis modulators|mesh-ancestor
5931726|NCT04034095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5931727|NCT04034095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5931728|NCT04034095|Glucocorticoids|glucocorticoids|mesh-ancestor
5931729|NCT04034095|Hormones|hormones|mesh-ancestor
5931730|NCT04034095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5931731|NCT04034095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5931732|NCT04034095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5931733|NCT04034095|Androgen Antagonists|androgen antagonists|mesh-ancestor
5931734|NCT04034095|Hormone Antagonists|hormone antagonists|mesh-ancestor
5931735|NCT04026412|Nivolumab|nivolumab|mesh-list
5931736|NCT04026412|Ipilimumab|ipilimumab|mesh-list
5931737|NCT04026412|Durvalumab|durvalumab|mesh-list
5931738|NCT04026412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5931739|NCT04026412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5931740|NCT04026412|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5931741|NCT04026412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5931742|NCT04023526|Azacitidine|azacitidine|mesh-list
5931743|NCT04023526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5931744|NCT04023526|Antimetabolites|antimetabolites|mesh-ancestor
5931745|NCT04023526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5931746|NCT04023526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5931747|NCT04023526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5931748|NCT04001829|Paclitaxel|paclitaxel|mesh-list
5931749|NCT04001829|Docetaxel|docetaxel|mesh-list
5931750|NCT04001829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5931751|NCT04001829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5931752|NCT04001829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5931753|NCT04001829|Tubulin Modulators|tubulin modulators|mesh-ancestor
5931754|NCT04001829|Antimitotic Agents|antimitotic agents|mesh-ancestor
5931755|NCT04001829|Mitosis Modulators|mitosis modulators|mesh-ancestor
5931756|NCT04001829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5931757|NCT03968419|Pembrolizumab|pembrolizumab|mesh-list
5931758|NCT03968419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5931759|NCT03968419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5931760|NCT03955471|Niraparib|niraparib|mesh-list
5931761|NCT03955471|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5931762|NCT03955471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5931763|NCT03955471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5931764|NCT03955471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5931765|NCT03952585|Cisplatin|cisplatin|mesh-list
5931766|NCT03952585|Nivolumab|nivolumab|mesh-list
5931767|NCT03952585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5931768|NCT03952585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5931769|NCT03952585|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5931770|NCT03952585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5931771|NCT03946891|Furosemide|furosemide|mesh-list
5931772|NCT03946891|Diuretics|diuretics|mesh-ancestor
5931773|NCT03946891|Natriuretic Agents|natriuretic agents|mesh-ancestor
5931774|NCT03946891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5931775|NCT03946891|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5931776|NCT03946891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5931777|NCT03946891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5931778|NCT03934684|Dexamethasone|dexamethasone|mesh-list
5931779|NCT03934684|Dexamethasone acetate|dexamethasone acetate|mesh-list
5931780|NCT03934684|Lenalidomide|lenalidomide|mesh-list
5931781|NCT03934684|BB 1101|bb 1101|mesh-list
5931782|NCT03934684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5931783|NCT03934684|Antiemetics|antiemetics|mesh-ancestor
5931784|NCT03934684|Autonomic Agents|autonomic agents|mesh-ancestor
5931785|NCT03934684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5931786|NCT03934684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5931787|NCT03934684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5931788|NCT03934684|Glucocorticoids|glucocorticoids|mesh-ancestor
5931789|NCT03934684|Hormones|hormones|mesh-ancestor
5931790|NCT03934684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5931791|NCT03934684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5931792|NCT03934684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5931793|NCT03934684|Protease Inhibitors|protease inhibitors|mesh-ancestor
5931794|NCT03934684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5931795|NCT03934684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5931796|NCT03934684|Immunologic Factors|immunologic factors|mesh-ancestor
5931797|NCT03934684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5931798|NCT03934684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5931799|NCT03934684|Growth Substances|growth substances|mesh-ancestor
5931800|NCT03934684|Growth Inhibitors|growth inhibitors|mesh-ancestor
5931801|NCT03924895|Pembrolizumab|pembrolizumab|mesh-list
5931802|NCT03924895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5931803|NCT03924895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5931804|NCT03914625|Calcium, Dietary|calcium, dietary|mesh-list
5931805|NCT03914625|Leucovorin|leucovorin|mesh-list
5931806|NCT03914625|Folic Acid|folic acid|mesh-list
5931807|NCT03914625|Cytarabine|cytarabine|mesh-list
5931808|NCT03914625|Dexamethasone|dexamethasone|mesh-list
5931809|NCT03914625|Dexamethasone acetate|dexamethasone acetate|mesh-list
5931810|NCT03914625|Prednisone|prednisone|mesh-list
5931811|NCT03914625|Prednisolone|prednisolone|mesh-list
5931812|NCT03914625|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5931813|NCT03914625|Methylprednisolone|methylprednisolone|mesh-list
5931814|NCT03914625|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5931815|NCT03914625|Prednisolone acetate|prednisolone acetate|mesh-list
5931816|NCT03914625|Hydrocortisone|hydrocortisone|mesh-list
5931817|NCT03914625|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
5931818|NCT03914625|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
5931819|NCT03914625|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
5931820|NCT03914625|Cortisone|cortisone|mesh-list
5931821|NCT03914625|Cyclophosphamide|cyclophosphamide|mesh-list
5931822|NCT03914625|Doxorubicin|doxorubicin|mesh-list
5931823|NCT03914625|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5931824|NCT03914625|Methotrexate|methotrexate|mesh-list
5931825|NCT03914625|Vincristine|vincristine|mesh-list
5931826|NCT03914625|Asparaginase|asparaginase|mesh-list
5931827|NCT03914625|Mercaptopurine|mercaptopurine|mesh-list
5931828|NCT03914625|Pegaspargase|pegaspargase|mesh-list
5931829|NCT03914625|Thioguanine|thioguanine|mesh-list
5931830|NCT03914625|Blinatumomab|blinatumomab|mesh-list
5931831|NCT03914625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5931832|NCT03914625|Muromonab-CD3|muromonab-cd3|mesh-list
5931833|NCT03914625|Antibodies|antibodies|mesh-list
5931834|NCT03914625|Immunoglobulins|immunoglobulins|mesh-list
5931835|NCT03914625|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5931836|NCT03914625|Antibodies, Bispecific|antibodies, bispecific|mesh-list
5931837|NCT03914625|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5931838|NCT03914625|Prednisolone phosphate|prednisolone phosphate|mesh-list
5931839|NCT03914625|BB 1101|bb 1101|mesh-list
5931840|NCT03914625|Calcium|calcium|mesh-list
5931841|NCT03914625|2-Aminopurine|2-aminopurine|mesh-list
5931842|NCT03914625|Levoleucovorin|levoleucovorin|mesh-list
5931843|NCT03914625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5931844|NCT03914625|Immunologic Factors|immunologic factors|mesh-ancestor
5931845|NCT03914625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5931846|NCT03914625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5931847|NCT03914625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5931848|NCT03914625|Alkylating Agents|alkylating agents|mesh-ancestor
5931849|NCT03914625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5931850|NCT03914625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5931851|NCT03914625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5931852|NCT03914625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5931853|NCT03914625|Antiemetics|antiemetics|mesh-ancestor
5931854|NCT03914625|Autonomic Agents|autonomic agents|mesh-ancestor
5931855|NCT03914625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5931856|NCT03914625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5931857|NCT03914625|Glucocorticoids|glucocorticoids|mesh-ancestor
5931858|NCT03914625|Hormones|hormones|mesh-ancestor
5931859|NCT03914625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5931860|NCT03914625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5931861|NCT03914625|Protease Inhibitors|protease inhibitors|mesh-ancestor
5931862|NCT03914625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5931863|NCT03914625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5931864|NCT03914625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5931865|NCT03914625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5931866|NCT03914625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5931867|NCT03914625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5931868|NCT03914625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5931869|NCT03914625|Abortifacient Agents|abortifacient agents|mesh-ancestor
5931870|NCT03914625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5931871|NCT03914625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5931872|NCT03914625|Antimetabolites|antimetabolites|mesh-ancestor
5931873|NCT03914625|Dermatologic Agents|dermatologic agents|mesh-ancestor
5931874|NCT03914625|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5931875|NCT03914625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5931876|NCT03914625|Antiviral Agents|antiviral agents|mesh-ancestor
5931877|NCT03914625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5931878|NCT03914625|Antidotes|antidotes|mesh-ancestor
5931879|NCT03914625|Protective Agents|protective agents|mesh-ancestor
5931880|NCT03914625|Vitamin B Complex|vitamin b complex|mesh-ancestor
5931881|NCT03914625|Vitamins|vitamins|mesh-ancestor
5931882|NCT03914625|Micronutrients|micronutrients|mesh-ancestor
5931883|NCT03914625|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5931884|NCT03914625|Tubulin Modulators|tubulin modulators|mesh-ancestor
5931885|NCT03914625|Antimitotic Agents|antimitotic agents|mesh-ancestor
5931886|NCT03914625|Mitosis Modulators|mitosis modulators|mesh-ancestor
5931887|NCT03914625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5931888|NCT03914625|Hematinics|hematinics|mesh-ancestor
5931900|NCT03911453|Rucaparib|rucaparib|mesh-list
5931901|NCT03911453|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5931902|NCT03911453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5931903|NCT03911453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5931904|NCT03911453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5719444|NCT03219645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5719445|NCT03219645|Antipyretics|antipyretics|mesh-ancestor
5719446|NCT03219177|Analgesics, Opioid|analgesics, opioid|mesh-list
5719447|NCT03219177|Narcotics|narcotics|mesh-ancestor
5719448|NCT03219177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5719449|NCT03219177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719450|NCT03219177|Analgesics|analgesics|mesh-ancestor
5719451|NCT03219177|Sensory System Agents|sensory system agents|mesh-ancestor
5719452|NCT03219177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5719453|NCT03218969|Ecopipam|ecopipam|mesh-list
5719454|NCT03218969|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5719455|NCT03218969|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5719456|NCT03218969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5719457|NCT03218969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719458|NCT03218969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5719459|NCT03218969|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5719460|NCT03218969|Dopamine Agents|dopamine agents|mesh-ancestor
5719461|NCT03218969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5719462|NCT03218969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5931934|NCT03901963|Lenalidomide|lenalidomide|mesh-list
5931935|NCT03901963|Daratumumab|daratumumab|mesh-list
5931936|NCT03901963|Immunologic Factors|immunologic factors|mesh-ancestor
5931937|NCT03901963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5931938|NCT03901963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5931939|NCT03901963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5931940|NCT03901963|Growth Substances|growth substances|mesh-ancestor
5931941|NCT03901963|Growth Inhibitors|growth inhibitors|mesh-ancestor
5931942|NCT03901963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5931943|NCT03895203|Adalimumab|adalimumab|mesh-list
5931944|NCT03895203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5931945|NCT03895203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5931946|NCT03871829|Dexamethasone|dexamethasone|mesh-list
5931947|NCT03871829|Dexamethasone acetate|dexamethasone acetate|mesh-list
5931948|NCT03871829|BB 1101|bb 1101|mesh-list
5931949|NCT03871829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5931950|NCT03871829|Antiemetics|antiemetics|mesh-ancestor
5931951|NCT03871829|Autonomic Agents|autonomic agents|mesh-ancestor
6517160|NCT00719888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6517161|NCT00719888|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6517162|NCT00719888|Antitubercular Agents|antitubercular agents|mesh-ancestor
6517163|NCT00719888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6517164|NCT00720018|Sumatriptan|sumatriptan|mesh-list
6517165|NCT00720018|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6517166|NCT00720018|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6517167|NCT00720018|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6517168|NCT00720018|Serotonin Agents|serotonin agents|mesh-ancestor
5719463|NCT03219008|Lithium Carbonate|lithium carbonate|mesh-list
5719464|NCT03219008|Mirtazapine|mirtazapine|mesh-list
5931952|NCT03871829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5931953|NCT03871829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5931954|NCT03871829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5931955|NCT03871829|Glucocorticoids|glucocorticoids|mesh-ancestor
5931956|NCT03871829|Hormones|hormones|mesh-ancestor
5931957|NCT03871829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5931958|NCT03871829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5931959|NCT03871829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5931960|NCT03871829|Protease Inhibitors|protease inhibitors|mesh-ancestor
5931961|NCT03871829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5931962|NCT03871829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5931963|NCT03871049|Dexamethasone|dexamethasone|mesh-list
5931964|NCT03871049|Bupivacaine|bupivacaine|mesh-list
5931965|NCT03871049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5931966|NCT03871049|Antiemetics|antiemetics|mesh-ancestor
5931967|NCT03871049|Autonomic Agents|autonomic agents|mesh-ancestor
5931968|NCT03871049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5931969|NCT03871049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5931970|NCT03871049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5931971|NCT03871049|Glucocorticoids|glucocorticoids|mesh-ancestor
5931972|NCT03871049|Hormones|hormones|mesh-ancestor
5931973|NCT03871049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5931974|NCT03871049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5931975|NCT03871049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5931976|NCT03871049|Anesthetics, Local|anesthetics, local|mesh-ancestor
5931977|NCT03871049|Anesthetics|anesthetics|mesh-ancestor
5719465|NCT03219008|Fluvoxamine|fluvoxamine|mesh-list
5931978|NCT03871049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6517169|NCT00720018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5931979|NCT03871049|Sensory System Agents|sensory system agents|mesh-ancestor
5931986|NCT03849625|Aspirin|aspirin|mesh-list
5931987|NCT03849625|Acetaminophen|acetaminophen|mesh-list
5931988|NCT03849625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5931989|NCT03849625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5931990|NCT03849625|Analgesics|analgesics|mesh-ancestor
5931991|NCT03849625|Sensory System Agents|sensory system agents|mesh-ancestor
5931992|NCT03849625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5931993|NCT03849625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5931994|NCT03849625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5931995|NCT03849625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5931996|NCT03849625|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5931997|NCT03849625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5931998|NCT03849625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5931999|NCT03849625|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5932000|NCT03849625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5932001|NCT03849625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5932002|NCT03849625|Antipyretics|antipyretics|mesh-ancestor
5932003|NCT03836040|Erenumab|erenumab|mesh-list
5932004|NCT03836040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5932005|NCT03836040|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
5932006|NCT03836040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5932007|NCT03836040|Analgesics|analgesics|mesh-ancestor
5932008|NCT03836040|Sensory System Agents|sensory system agents|mesh-ancestor
5932009|NCT03836040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5932010|NCT03836040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5932011|NCT03836040|Immunologic Factors|immunologic factors|mesh-ancestor
5932012|NCT03832998|Erenumab|erenumab|mesh-list
5932013|NCT03832998|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5932014|NCT03832998|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
5932015|NCT03832998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5932016|NCT03832998|Analgesics|analgesics|mesh-ancestor
5932017|NCT03832998|Sensory System Agents|sensory system agents|mesh-ancestor
5932018|NCT03832998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5932019|NCT03832998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5932020|NCT03832998|Immunologic Factors|immunologic factors|mesh-ancestor
5932021|NCT03811015|Cisplatin|cisplatin|mesh-list
5932022|NCT03811015|Nivolumab|nivolumab|mesh-list
5932023|NCT03811015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932024|NCT03811015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5932025|NCT03811015|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5932026|NCT03811015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5932047|NCT03793179|Carboplatin|carboplatin|mesh-list
5932048|NCT03793179|Pembrolizumab|pembrolizumab|mesh-list
5932049|NCT03793179|Pemetrexed|pemetrexed|mesh-list
5932050|NCT03793179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932051|NCT03793179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5932052|NCT03793179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5932053|NCT03793179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5932054|NCT03793179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5932055|NCT03793179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5932056|NCT03775265|Gemcitabine|gemcitabine|mesh-list
5932057|NCT03775265|Cisplatin|cisplatin|mesh-list
5932058|NCT03775265|Fluorouracil|fluorouracil|mesh-list
5932059|NCT03775265|Atezolizumab|atezolizumab|mesh-list
5932060|NCT03775265|Mitomycins|mitomycins|mesh-list
5932061|NCT03775265|Mitomycin|mitomycin|mesh-list
5932062|NCT03775265|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5932063|NCT03775265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932064|NCT03775265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5932065|NCT03775265|Antimetabolites|antimetabolites|mesh-ancestor
5932066|NCT03775265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5932067|NCT03775265|Antiviral Agents|antiviral agents|mesh-ancestor
5932068|NCT03775265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5932069|NCT03775265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5932070|NCT03775265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5932071|NCT03775265|Immunologic Factors|immunologic factors|mesh-ancestor
5932072|NCT03775265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5932073|NCT03775265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5932074|NCT03775265|Alkylating Agents|alkylating agents|mesh-ancestor
5932075|NCT03775265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5932076|NCT03769844|Molgramostim|molgramostim|mesh-list
5932077|NCT03769844|Sargramostim|sargramostim|mesh-list
5932078|NCT03769844|Immunologic Factors|immunologic factors|mesh-ancestor
5932079|NCT03769844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5932080|NCT03769844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932081|NCT03767244|Androgens|androgens|mesh-list
5932082|NCT03767244|Hormones|hormones|mesh-ancestor
5932083|NCT03767244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5932084|NCT03767244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5932085|NCT03760068|Insulin Aspart|insulin aspart|mesh-list
5932086|NCT03760068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5932087|NCT03760068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5932088|NCT03755804|Prednisone|prednisone|mesh-list
5932089|NCT03755804|Prednisolone|prednisolone|mesh-list
5932090|NCT03755804|Cyclophosphamide|cyclophosphamide|mesh-list
5932091|NCT03755804|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5932092|NCT03755804|Dacarbazine|dacarbazine|mesh-list
5932093|NCT03755804|Doxorubicin|doxorubicin|mesh-list
5932094|NCT03755804|Etoposide|etoposide|mesh-list
5932095|NCT03755804|Vincristine|vincristine|mesh-list
5932096|NCT03755804|Bleomycin|bleomycin|mesh-list
5932097|NCT03755804|Vinblastine|vinblastine|mesh-list
5932098|NCT03755804|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5932099|NCT03755804|Imidazole|imidazole|mesh-list
5932100|NCT03755804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5932101|NCT03755804|Immunologic Factors|immunologic factors|mesh-ancestor
5932102|NCT03755804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5932103|NCT03755804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6681212|NCT01608594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6681213|NCT01608594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6681214|NCT01608594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681215|NCT01608646|Oxaliplatin|oxaliplatin|mesh-list
6681216|NCT01608646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6681217|NCT01608698|Drospirenone|drospirenone|mesh-list
6681218|NCT01608698|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6681219|NCT01608698|Chlormadinone Acetate|chlormadinone acetate|mesh-list
6681220|NCT01608698|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6681221|NCT01608698|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6681222|NCT01608698|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5932104|NCT03755804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5932105|NCT03755804|Alkylating Agents|alkylating agents|mesh-ancestor
5932106|NCT03755804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5932107|NCT03755804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932108|NCT03755804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5932109|NCT03755804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5932110|NCT03755804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5932111|NCT03755804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5932112|NCT03755804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5932113|NCT03755804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5932114|NCT03755804|Glucocorticoids|glucocorticoids|mesh-ancestor
5932115|NCT03755804|Hormones|hormones|mesh-ancestor
5932116|NCT03755804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5932117|NCT03755804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5932118|NCT03755804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5932119|NCT03755804|Tubulin Modulators|tubulin modulators|mesh-ancestor
6681223|NCT01608698|Contraceptive Agents|contraceptive agents|mesh-ancestor
5719466|NCT03219008|Fluoxetine|fluoxetine|mesh-list
5719467|NCT03219008|Bupropion|bupropion|mesh-list
5719468|NCT03219008|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
5719469|NCT03219008|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5719470|NCT03219008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5932120|NCT03755804|Antimitotic Agents|antimitotic agents|mesh-ancestor
5932121|NCT03755804|Mitosis Modulators|mitosis modulators|mesh-ancestor
5932122|NCT03755804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5932123|NCT03748680|Oxaliplatin|oxaliplatin|mesh-list
5932124|NCT03748680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932125|NCT03748641|Prednisone|prednisone|mesh-list
5932126|NCT03748641|Abiraterone Acetate|abiraterone acetate|mesh-list
5932127|NCT03748641|Niraparib|niraparib|mesh-list
5932128|NCT03748641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5932129|NCT03748641|Glucocorticoids|glucocorticoids|mesh-ancestor
5932130|NCT03748641|Hormones|hormones|mesh-ancestor
5932131|NCT03748641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5932132|NCT03748641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5932133|NCT03748641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5932134|NCT03748641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932135|NCT03748641|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5932136|NCT03748641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5932137|NCT03748641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5932138|NCT03748641|Hormone Antagonists|hormone antagonists|mesh-ancestor
5932139|NCT03748641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5932140|NCT03748641|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5932141|NCT03742986|Paclitaxel|paclitaxel|mesh-list
5932142|NCT03742986|Docetaxel|docetaxel|mesh-list
5932143|NCT03742986|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5932144|NCT03742986|Cyclophosphamide|cyclophosphamide|mesh-list
5932145|NCT03742986|Doxorubicin|doxorubicin|mesh-list
5932146|NCT03742986|Nivolumab|nivolumab|mesh-list
5932147|NCT03742986|Trastuzumab|trastuzumab|mesh-list
5932148|NCT03742986|Pertuzumab|pertuzumab|mesh-list
5932149|NCT03742986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5932150|NCT03742986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932151|NCT03742986|Tubulin Modulators|tubulin modulators|mesh-ancestor
5932152|NCT03742986|Antimitotic Agents|antimitotic agents|mesh-ancestor
5932153|NCT03742986|Mitosis Modulators|mitosis modulators|mesh-ancestor
5932154|NCT03742986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5932155|NCT03742986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5932156|NCT03742986|Immunologic Factors|immunologic factors|mesh-ancestor
5932157|NCT03742986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5932158|NCT03742986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5932159|NCT03742986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5932160|NCT03742986|Alkylating Agents|alkylating agents|mesh-ancestor
5932161|NCT03742986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5932162|NCT03742986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5932163|NCT03742986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5932164|NCT03742986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5932165|NCT03742986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5932166|NCT03742986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5932167|NCT03742986|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5932180|NCT03729349|Golimumab|golimumab|mesh-list
5932181|NCT03729349|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
5932182|NCT03729349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5932183|NCT03729349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5719471|NCT03219008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5719472|NCT03219008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719473|NCT03219008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5932184|NCT03729349|Immunologic Factors|immunologic factors|mesh-ancestor
5932185|NCT03729349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719474|NCT03219008|Serotonin Agents|serotonin agents|mesh-ancestor
5932186|NCT03725007|Upadacitinib|upadacitinib|mesh-list
5932187|NCT03725007|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
5932188|NCT03725007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5932189|NCT03725007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5932190|NCT03725007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517170|NCT00720018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517171|NCT00720018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517172|NCT00720135|Rituximab|rituximab|mesh-list
5932191|NCT03725007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5932192|NCT03698019|Pembrolizumab|pembrolizumab|mesh-list
5932193|NCT03698019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5932194|NCT03698019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932195|NCT03665597|Pembrolizumab|pembrolizumab|mesh-list
5932196|NCT03665597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5932197|NCT03665597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932198|NCT03660826|Durvalumab|durvalumab|mesh-list
5932199|NCT03660826|Olaparib|olaparib|mesh-list
5932200|NCT03660826|Cediranib|cediranib|mesh-list
5932201|NCT03660826|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
5932202|NCT03660826|Immunoglobulins|immunoglobulins|mesh-list
5932203|NCT03660826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5932204|NCT03660826|Immunoglobulin G|immunoglobulin g|mesh-list
5932205|NCT03660826|Maleic acid|maleic acid|mesh-list
5932206|NCT03660826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5932207|NCT03660826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932208|NCT03660826|Immunologic Factors|immunologic factors|mesh-ancestor
5932209|NCT03660826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5932210|NCT03660826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5932211|NCT03660826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5932212|NCT03660826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5932213|NCT03653507|Capecitabine|capecitabine|mesh-list
5932214|NCT03653507|Oxaliplatin|oxaliplatin|mesh-list
5932215|NCT03653507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5932216|NCT03653507|Antimetabolites|antimetabolites|mesh-ancestor
5932217|NCT03653507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5932218|NCT03653507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932219|NCT03652064|Dexamethasone|dexamethasone|mesh-list
5719475|NCT03219008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719476|NCT03219008|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5719477|NCT03219008|Antidepressive Agents|antidepressive agents|mesh-ancestor
5719478|NCT03219008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5719479|NCT03219008|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5719480|NCT03219008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5719481|NCT03219008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5719482|NCT03219008|Antimanic Agents|antimanic agents|mesh-ancestor
5719483|NCT03219008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5719484|NCT03219008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5719485|NCT03219008|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5719486|NCT03219008|Histamine Antagonists|histamine antagonists|mesh-ancestor
5719487|NCT03219008|Histamine Agents|histamine agents|mesh-ancestor
5719488|NCT03219008|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5719489|NCT03219008|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5932220|NCT03652064|Lenalidomide|lenalidomide|mesh-list
5932221|NCT03652064|Bortezomib|bortezomib|mesh-list
5932222|NCT03652064|Daratumumab|daratumumab|mesh-list
5932223|NCT03652064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5932224|NCT03652064|Antiemetics|antiemetics|mesh-ancestor
5932225|NCT03652064|Autonomic Agents|autonomic agents|mesh-ancestor
5932226|NCT03652064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5932227|NCT03652064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5932228|NCT03652064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5932229|NCT03652064|Glucocorticoids|glucocorticoids|mesh-ancestor
5932230|NCT03652064|Hormones|hormones|mesh-ancestor
5932231|NCT03652064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5932232|NCT03652064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5932233|NCT03652064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932234|NCT03652064|Immunologic Factors|immunologic factors|mesh-ancestor
5932235|NCT03652064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5932236|NCT03652064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5932237|NCT03652064|Growth Substances|growth substances|mesh-ancestor
5932238|NCT03652064|Growth Inhibitors|growth inhibitors|mesh-ancestor
5932239|NCT03637660|Penicillins|penicillins|mesh-list
5932240|NCT03637660|Penicillin G Benzathine|penicillin g benzathine|mesh-list
5932241|NCT03637660|Penicillin G|penicillin g|mesh-list
5932242|NCT03637660|Penicillin G Procaine|penicillin g procaine|mesh-list
5932243|NCT03637660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5932244|NCT03637660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5932245|NCT03630705|Vaccines|vaccines|mesh-list
5932246|NCT03630705|Immunologic Factors|immunologic factors|mesh-ancestor
5932247|NCT03630705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5932248|NCT03625323|Pembrolizumab|pembrolizumab|mesh-list
5932249|NCT03625323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5932250|NCT03625323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932251|NCT03612973|Insulin|insulin|mesh-list
5932252|NCT03612973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5932253|NCT03612973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5932260|NCT03589014|Propranolol|propranolol|mesh-list
5932261|NCT03589014|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5932262|NCT03589014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5932263|NCT03589014|Adrenergic Agents|adrenergic agents|mesh-ancestor
5932264|NCT03589014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5932265|NCT03589014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5932266|NCT03589014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5932267|NCT03589014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5932268|NCT03589014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5932269|NCT03589014|Vasodilator Agents|vasodilator agents|mesh-ancestor
5932270|NCT03583255|Dexamethasone|dexamethasone|mesh-list
5932271|NCT03583255|Dexamethasone acetate|dexamethasone acetate|mesh-list
5932272|NCT03583255|Ichthammol|ichthammol|mesh-list
5932273|NCT03583255|BB 1101|bb 1101|mesh-list
5932274|NCT03583255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5932275|NCT03583255|Antiemetics|antiemetics|mesh-ancestor
5932276|NCT03583255|Autonomic Agents|autonomic agents|mesh-ancestor
5932277|NCT03583255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5932278|NCT03583255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5932279|NCT03583255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5932280|NCT03583255|Glucocorticoids|glucocorticoids|mesh-ancestor
5932281|NCT03583255|Hormones|hormones|mesh-ancestor
5932282|NCT03583255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5932283|NCT03583255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5932284|NCT03583255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932285|NCT03583255|Protease Inhibitors|protease inhibitors|mesh-ancestor
5932286|NCT03583255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5932287|NCT03583255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5932288|NCT03583255|Dermatologic Agents|dermatologic agents|mesh-ancestor
5932292|NCT03573310|JNJ-64619178|jnj-64619178|mesh-list
5932293|NCT03573310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5932294|NCT03573310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5932295|NCT03557918|Tremelimumab|tremelimumab|mesh-list
5932296|NCT03557918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932297|NCT03526250|Palbociclib|palbociclib|mesh-list
5932298|NCT03526250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932299|NCT03526250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5932300|NCT03526250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5932301|NCT03526250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5932305|NCT03473743|Carboplatin|carboplatin|mesh-list
5932306|NCT03473743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932307|NCT03462719|Venetoclax|venetoclax|mesh-list
5932308|NCT03462719|Obinutuzumab|obinutuzumab|mesh-list
5932309|NCT03462719|Chlorambucil|chlorambucil|mesh-list
5932310|NCT03462719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932311|NCT03462719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5932312|NCT03462719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5932313|NCT03462719|Alkylating Agents|alkylating agents|mesh-ancestor
5932314|NCT03462719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5932315|NCT03456843|Ascorbic Acid|ascorbic acid|mesh-list
5932316|NCT03456843|Docetaxel|docetaxel|mesh-list
5932317|NCT03456843|Methyltestosterone|methyltestosterone|mesh-list
5932318|NCT03456843|Hormones|hormones|mesh-list
5932319|NCT03456843|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
5932320|NCT03456843|Androgens|androgens|mesh-list
5932321|NCT03456843|Androgen Antagonists|androgen antagonists|mesh-list
5932322|NCT03456843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932323|NCT03456843|Tubulin Modulators|tubulin modulators|mesh-ancestor
5932324|NCT03456843|Antimitotic Agents|antimitotic agents|mesh-ancestor
5932325|NCT03456843|Mitosis Modulators|mitosis modulators|mesh-ancestor
5932326|NCT03456843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5932327|NCT03456843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5932328|NCT03456843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5932329|NCT03456843|Antioxidants|antioxidants|mesh-ancestor
5932330|NCT03456843|Protective Agents|protective agents|mesh-ancestor
5932331|NCT03456843|Vitamins|vitamins|mesh-ancestor
5932332|NCT03456843|Micronutrients|micronutrients|mesh-ancestor
5932333|NCT03456843|Estrogens|estrogens|mesh-ancestor
5932334|NCT03456843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5932335|NCT03456843|Anabolic Agents|anabolic agents|mesh-ancestor
5932336|NCT03456843|Hormone Antagonists|hormone antagonists|mesh-ancestor
5932337|NCT03451851|Etanercept|etanercept|mesh-list
5932338|NCT03451851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5932339|NCT03451851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5932340|NCT03451851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5932341|NCT03451851|Analgesics|analgesics|mesh-ancestor
5932342|NCT03451851|Sensory System Agents|sensory system agents|mesh-ancestor
5932343|NCT03451851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5932344|NCT03451851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5932345|NCT03451851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5932346|NCT03451851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5932347|NCT03451851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5932348|NCT03451851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5932349|NCT03451851|Immunologic Factors|immunologic factors|mesh-ancestor
5932350|NCT03442114|Hydroxyurea|hydroxyurea|mesh-list
5932351|NCT03442114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932352|NCT03442114|Antisickling Agents|antisickling agents|mesh-ancestor
5932353|NCT03442114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5932354|NCT03442114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5932355|NCT03442114|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5932356|NCT03431350|Prednisone|prednisone|mesh-list
5932357|NCT03431350|Abiraterone Acetate|abiraterone acetate|mesh-list
5932358|NCT03431350|Niraparib|niraparib|mesh-list
5932359|NCT03431350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5932360|NCT03431350|Glucocorticoids|glucocorticoids|mesh-ancestor
5932361|NCT03431350|Hormones|hormones|mesh-ancestor
5932362|NCT03431350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5932363|NCT03431350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5932364|NCT03431350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5932365|NCT03431350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932366|NCT03431350|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5932367|NCT03431350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5932368|NCT03431350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5932369|NCT03431350|Hormone Antagonists|hormone antagonists|mesh-ancestor
5932370|NCT03431350|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5932371|NCT03431350|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5932372|NCT03428126|Durvalumab|durvalumab|mesh-list
5932373|NCT03428126|Trametinib|trametinib|mesh-list
5932374|NCT03428126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5932375|NCT03428126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932376|NCT03428126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5932377|NCT03428126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5932378|NCT03428126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5932379|NCT03404791|Gemcitabine|gemcitabine|mesh-list
5932380|NCT03404791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5932381|NCT03404791|Antimetabolites|antimetabolites|mesh-ancestor
5932382|NCT03404791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5932383|NCT03404791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932384|NCT03404791|Antiviral Agents|antiviral agents|mesh-ancestor
5932385|NCT03404791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5932386|NCT03404791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5932387|NCT03404791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5932388|NCT03404791|Immunologic Factors|immunologic factors|mesh-ancestor
5932389|NCT03404791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5932390|NCT03390504|Docetaxel|docetaxel|mesh-list
5932391|NCT03390504|Pembrolizumab|pembrolizumab|mesh-list
5932392|NCT03390504|Mitogens|mitogens|mesh-list
5932393|NCT03390504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932394|NCT03390504|Tubulin Modulators|tubulin modulators|mesh-ancestor
5932395|NCT03390504|Antimitotic Agents|antimitotic agents|mesh-ancestor
5932396|NCT03390504|Mitosis Modulators|mitosis modulators|mesh-ancestor
5932397|NCT03390504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5932398|NCT03390504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5932399|NCT03384654|Cytarabine|cytarabine|mesh-list
5932400|NCT03384654|Prednisone|prednisone|mesh-list
5932401|NCT03384654|Cyclophosphamide|cyclophosphamide|mesh-list
5932402|NCT03384654|Doxorubicin|doxorubicin|mesh-list
5932403|NCT03384654|Methotrexate|methotrexate|mesh-list
5932404|NCT03384654|Vincristine|vincristine|mesh-list
5932405|NCT03384654|Asparaginase|asparaginase|mesh-list
5932406|NCT03384654|Mercaptopurine|mercaptopurine|mesh-list
5932407|NCT03384654|Daratumumab|daratumumab|mesh-list
5932408|NCT03384654|Pegaspargase|pegaspargase|mesh-list
5932409|NCT03384654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5932410|NCT03384654|Immunologic Factors|immunologic factors|mesh-ancestor
5932411|NCT03384654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5932412|NCT03384654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5932413|NCT03384654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5932414|NCT03384654|Alkylating Agents|alkylating agents|mesh-ancestor
5932415|NCT03384654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5932416|NCT03384654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932417|NCT03384654|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5932418|NCT03384654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5932419|NCT03384654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5932420|NCT03384654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5932421|NCT03384654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5932422|NCT03384654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5932423|NCT03384654|Glucocorticoids|glucocorticoids|mesh-ancestor
5932424|NCT03384654|Hormones|hormones|mesh-ancestor
5932425|NCT03384654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5932426|NCT03384654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5932427|NCT03384654|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5932428|NCT03384654|Abortifacient Agents|abortifacient agents|mesh-ancestor
5932429|NCT03384654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5932430|NCT03384654|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5932431|NCT03384654|Antimetabolites|antimetabolites|mesh-ancestor
5932432|NCT03384654|Dermatologic Agents|dermatologic agents|mesh-ancestor
5932433|NCT03384654|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5932434|NCT03384654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5932435|NCT03384654|Antiviral Agents|antiviral agents|mesh-ancestor
5932436|NCT03384654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5932437|NCT03384654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5932438|NCT03384654|Tubulin Modulators|tubulin modulators|mesh-ancestor
5932439|NCT03384654|Antimitotic Agents|antimitotic agents|mesh-ancestor
5932440|NCT03384654|Mitosis Modulators|mitosis modulators|mesh-ancestor
5932441|NCT03377491|Gemcitabine|gemcitabine|mesh-list
5932442|NCT03377491|Paclitaxel|paclitaxel|mesh-list
5932443|NCT03377491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5932444|NCT03377491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932445|NCT03377491|Tubulin Modulators|tubulin modulators|mesh-ancestor
5932446|NCT03377491|Antimitotic Agents|antimitotic agents|mesh-ancestor
5932447|NCT03377491|Mitosis Modulators|mitosis modulators|mesh-ancestor
5932448|NCT03377491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5932449|NCT03377491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5932450|NCT03377491|Antimetabolites|antimetabolites|mesh-ancestor
5932451|NCT03377491|Antiviral Agents|antiviral agents|mesh-ancestor
5932452|NCT03377491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5932453|NCT03377491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5932454|NCT03377491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5932455|NCT03377491|Immunologic Factors|immunologic factors|mesh-ancestor
5932456|NCT03377491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5932457|NCT03352934|Avelumab|avelumab|mesh-list
5932458|NCT03352934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5932459|NCT03352934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932460|NCT03341689|Psilocybin|psilocybin|mesh-list
5932461|NCT03341689|Hallucinogens|hallucinogens|mesh-ancestor
5932462|NCT03341689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5932463|NCT03341689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5932464|NCT03340766|Pembrolizumab|pembrolizumab|mesh-list
5932465|NCT03340766|Blinatumomab|blinatumomab|mesh-list
5932466|NCT03340766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5932467|NCT03340766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932468|NCT03340064|Levetiracetam|levetiracetam|mesh-list
5932469|NCT03340064|Anticonvulsants|anticonvulsants|mesh-ancestor
5932470|NCT03340064|Nootropic Agents|nootropic agents|mesh-ancestor
5932471|NCT03301415|Valganciclovir|valganciclovir|mesh-list
5932472|NCT03301415|Antiviral Agents|antiviral agents|mesh-ancestor
5932473|NCT03301415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5932474|NCT03301220|Daratumumab|daratumumab|mesh-list
5932475|NCT03301220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932476|NCT03300817|Poly ICLC|poly iclc|mesh-list
5932477|NCT03300817|Interferon Inducers|interferon inducers|mesh-ancestor
5932478|NCT03300817|Immunologic Factors|immunologic factors|mesh-ancestor
5932479|NCT03300817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5932480|NCT03298451|Sorafenib|sorafenib|mesh-list
5932481|NCT03298451|Durvalumab|durvalumab|mesh-list
5932482|NCT03298451|Tremelimumab|tremelimumab|mesh-list
5932483|NCT03298451|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5932484|NCT03298451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932485|NCT03298451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5932486|NCT03298451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5932487|NCT03298451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5932488|NCT03298451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5932489|NCT03298451|Immunologic Factors|immunologic factors|mesh-ancestor
5932490|NCT03298451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5932501|NCT03257033|Gemcitabine|gemcitabine|mesh-list
5932502|NCT03257033|Paclitaxel|paclitaxel|mesh-list
5932503|NCT03257033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5932504|NCT03257033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932505|NCT03257033|Tubulin Modulators|tubulin modulators|mesh-ancestor
5932506|NCT03257033|Antimitotic Agents|antimitotic agents|mesh-ancestor
5932507|NCT03257033|Mitosis Modulators|mitosis modulators|mesh-ancestor
5932508|NCT03257033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5932509|NCT03257033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5932510|NCT03257033|Antimetabolites|antimetabolites|mesh-ancestor
5932511|NCT03257033|Antiviral Agents|antiviral agents|mesh-ancestor
5932512|NCT03257033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5932513|NCT03257033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5932514|NCT03257033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5932515|NCT03257033|Immunologic Factors|immunologic factors|mesh-ancestor
5932516|NCT03257033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5932517|NCT03250169|Alemtuzumab|alemtuzumab|mesh-list
5932518|NCT03250169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5932519|NCT03250169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932520|NCT03239899|Pembrolizumab|pembrolizumab|mesh-list
5932521|NCT03239899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5932522|NCT03239899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932523|NCT03234972|Dexamethasone|dexamethasone|mesh-list
5932524|NCT03234972|Bortezomib|bortezomib|mesh-list
5932525|NCT03234972|Daratumumab|daratumumab|mesh-list
5932526|NCT03234972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5932527|NCT03234972|Antiemetics|antiemetics|mesh-ancestor
5932528|NCT03234972|Autonomic Agents|autonomic agents|mesh-ancestor
5932529|NCT03234972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5932530|NCT03234972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5932531|NCT03234972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5932532|NCT03234972|Glucocorticoids|glucocorticoids|mesh-ancestor
5932533|NCT03234972|Hormones|hormones|mesh-ancestor
5932534|NCT03234972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5932535|NCT03234972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5932536|NCT03234972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932537|NCT03233204|Olaparib|olaparib|mesh-list
5932538|NCT03233204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
5932539|NCT03233204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5932540|NCT03233204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5932541|NCT03233204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932542|NCT03220035|Vemurafenib|vemurafenib|mesh-list
5932543|NCT03220035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932544|NCT03220035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5932545|NCT03220035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5932546|NCT03220035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5932547|NCT03217812|Prednisone|prednisone|mesh-list
5932548|NCT03217812|Bortezomib|bortezomib|mesh-list
5932549|NCT03217812|Melphalan|melphalan|mesh-list
5932550|NCT03217812|Daratumumab|daratumumab|mesh-list
5932551|NCT03217812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5932552|NCT03217812|Glucocorticoids|glucocorticoids|mesh-ancestor
5932553|NCT03217812|Hormones|hormones|mesh-ancestor
5932554|NCT03217812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5932555|NCT03217812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5932556|NCT03217812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5932557|NCT03217812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932558|NCT03217812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5932559|NCT03217812|Alkylating Agents|alkylating agents|mesh-ancestor
5932560|NCT03217812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5932561|NCT03217812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5932562|NCT03217812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5932563|NCT03217812|Immunologic Factors|immunologic factors|mesh-ancestor
5932569|NCT03201965|Dexamethasone|dexamethasone|mesh-list
5932570|NCT03201965|Cyclophosphamide|cyclophosphamide|mesh-list
5932571|NCT03201965|Bortezomib|bortezomib|mesh-list
5932572|NCT03201965|Daratumumab|daratumumab|mesh-list
5932573|NCT03201965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5932574|NCT03201965|Immunologic Factors|immunologic factors|mesh-ancestor
5932575|NCT03201965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5932576|NCT03201965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5932577|NCT03201965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5932578|NCT03201965|Alkylating Agents|alkylating agents|mesh-ancestor
5932579|NCT03201965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5932580|NCT03201965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932581|NCT03201965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5932582|NCT03201965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5932583|NCT03201965|Antiemetics|antiemetics|mesh-ancestor
5932584|NCT03201965|Autonomic Agents|autonomic agents|mesh-ancestor
5932585|NCT03201965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5932586|NCT03201965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5932587|NCT03201965|Glucocorticoids|glucocorticoids|mesh-ancestor
5932588|NCT03201965|Hormones|hormones|mesh-ancestor
5932589|NCT03201965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5932590|NCT03201965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5932591|NCT03196427|Vedolizumab|vedolizumab|mesh-list
5932592|NCT03196427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5932593|NCT03192397|Mycophenolic Acid|mycophenolic acid|mesh-list
5932594|NCT03192397|Sirolimus|sirolimus|mesh-list
5932595|NCT03192397|Cyclophosphamide|cyclophosphamide|mesh-list
5932596|NCT03192397|Melphalan|melphalan|mesh-list
5932597|NCT03192397|Fludarabine|fludarabine|mesh-list
5932598|NCT03192397|Fludarabine phosphate|fludarabine phosphate|mesh-list
5932599|NCT03192397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5932600|NCT03192397|Immunologic Factors|immunologic factors|mesh-ancestor
5932601|NCT03192397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5932602|NCT03192397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5932603|NCT03192397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5932604|NCT03192397|Alkylating Agents|alkylating agents|mesh-ancestor
5932605|NCT03192397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5932606|NCT03192397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932607|NCT03192397|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5932608|NCT03192397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5932609|NCT03192397|Antimetabolites|antimetabolites|mesh-ancestor
5932610|NCT03192397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5932611|NCT03192397|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5932612|NCT03192397|Antitubercular Agents|antitubercular agents|mesh-ancestor
5932613|NCT03192397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5932614|NCT03192397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5932615|NCT03192397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5932616|NCT03192397|Antifungal Agents|antifungal agents|mesh-ancestor
5932617|NCT03155620|Olaparib|olaparib|mesh-list
5932618|NCT03155620|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
5932619|NCT03155620|Palbociclib|palbociclib|mesh-list
5932620|NCT03155620|Vemurafenib|vemurafenib|mesh-list
5932621|NCT03155620|Tipifarnib|tipifarnib|mesh-list
5932622|NCT03155620|Ensartinib|ensartinib|mesh-list
5932623|NCT03155620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5932624|NCT03155620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5932625|NCT03155620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932626|NCT03155620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5932627|NCT03154580|Acetylcysteine|acetylcysteine|mesh-list
5932628|NCT03154580|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5932629|NCT03154580|Antiviral Agents|antiviral agents|mesh-ancestor
5932630|NCT03154580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5932631|NCT03154580|Expectorants|expectorants|mesh-ancestor
5932632|NCT03154580|Respiratory System Agents|respiratory system agents|mesh-ancestor
5932633|NCT03154580|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5932634|NCT03154580|Antioxidants|antioxidants|mesh-ancestor
5932635|NCT03154580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5932636|NCT03154580|Protective Agents|protective agents|mesh-ancestor
5932637|NCT03154580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5932638|NCT03154580|Antidotes|antidotes|mesh-ancestor
5932639|NCT03138733|Daptomycin|daptomycin|mesh-list
5932640|NCT03138733|Ceftobiprole|ceftobiprole|mesh-list
5932641|NCT03138733|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
5932642|NCT03138733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5932643|NCT03138733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5932644|NCT03123978|Niclosamide|niclosamide|mesh-list
5932645|NCT03123978|Anticestodal Agents|anticestodal agents|mesh-ancestor
5932646|NCT03123978|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5932647|NCT03123978|Anthelmintics|anthelmintics|mesh-ancestor
5932648|NCT03123978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5932649|NCT03123978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5932650|NCT03123978|Antinematodal Agents|antinematodal agents|mesh-ancestor
5932675|NCT03092518|Sodium thiosulfate|sodium thiosulfate|mesh-list
5932676|NCT03092518|Mitomycins|mitomycins|mesh-list
5932677|NCT03092518|Mitomycin|mitomycin|mesh-list
5932678|NCT03092518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932679|NCT03092518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5932680|NCT03092518|Alkylating Agents|alkylating agents|mesh-ancestor
5932681|NCT03092518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5932682|NCT03092518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5932683|NCT03092518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5932684|NCT03092518|Antidotes|antidotes|mesh-ancestor
5932685|NCT03092518|Protective Agents|protective agents|mesh-ancestor
5932686|NCT03092518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5932687|NCT03092518|Antioxidants|antioxidants|mesh-ancestor
5932688|NCT03092518|Antitubercular Agents|antitubercular agents|mesh-ancestor
5932689|NCT03092518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5932690|NCT03092518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5932691|NCT03092518|Chelating Agents|chelating agents|mesh-ancestor
5932692|NCT03092518|Sequestering Agents|sequestering agents|mesh-ancestor
5932693|NCT03043599|Nivolumab|nivolumab|mesh-list
5932694|NCT03043599|Ipilimumab|ipilimumab|mesh-list
5932695|NCT03043599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5932696|NCT03043599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932697|NCT03043599|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5932698|NCT03043599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5932703|NCT02989402|Rivastigmine|rivastigmine|mesh-list
5932704|NCT02989402|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5932705|NCT02989402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5932706|NCT02989402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5932707|NCT02989402|Cholinergic Agents|cholinergic agents|mesh-ancestor
5932708|NCT02989402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5932709|NCT02989402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5932710|NCT02989402|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5932711|NCT02989402|Protective Agents|protective agents|mesh-ancestor
5932712|NCT02960022|Prednisone|prednisone|mesh-list
5932713|NCT02960022|Abiraterone Acetate|abiraterone acetate|mesh-list
5932714|NCT02960022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5932715|NCT02960022|Glucocorticoids|glucocorticoids|mesh-ancestor
5932716|NCT02960022|Hormones|hormones|mesh-ancestor
5932717|NCT02960022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5932718|NCT02960022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5932719|NCT02960022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5932720|NCT02960022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932721|NCT02960022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5932722|NCT02960022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5932723|NCT02960022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5932724|NCT02960022|Hormone Antagonists|hormone antagonists|mesh-ancestor
5932725|NCT02960022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5932750|NCT02877550|Venetoclax|venetoclax|mesh-list
5932751|NCT02877550|Obinutuzumab|obinutuzumab|mesh-list
5932752|NCT02877550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932753|NCT02877550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5932754|NCT02874742|Dexamethasone|dexamethasone|mesh-list
5932755|NCT02874742|Lenalidomide|lenalidomide|mesh-list
5932756|NCT02874742|Bortezomib|bortezomib|mesh-list
5932757|NCT02874742|Daratumumab|daratumumab|mesh-list
5932758|NCT02874742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5932759|NCT02874742|Antiemetics|antiemetics|mesh-ancestor
5932760|NCT02874742|Autonomic Agents|autonomic agents|mesh-ancestor
5932761|NCT02874742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5932762|NCT02874742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5932763|NCT02874742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5932764|NCT02874742|Glucocorticoids|glucocorticoids|mesh-ancestor
5932765|NCT02874742|Hormones|hormones|mesh-ancestor
5932766|NCT02874742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5932767|NCT02874742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5932768|NCT02874742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932769|NCT02874742|Immunologic Factors|immunologic factors|mesh-ancestor
5932770|NCT02874742|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5932771|NCT02874742|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5932772|NCT02874742|Growth Substances|growth substances|mesh-ancestor
5932773|NCT02874742|Growth Inhibitors|growth inhibitors|mesh-ancestor
5932774|NCT02740699|Atorvastatin|atorvastatin|mesh-list
5932775|NCT02740699|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5932776|NCT02740699|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5932777|NCT02740699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5932778|NCT02740699|Antimetabolites|antimetabolites|mesh-ancestor
5932779|NCT02740699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5932780|NCT02740699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5932781|NCT02740699|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5932782|NCT02740699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5932783|NCT02720185|Dasatinib|dasatinib|mesh-list
5932784|NCT02720185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932785|NCT02720185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5932786|NCT02720185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5932787|NCT02720185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5932788|NCT02706847|Upadacitinib|upadacitinib|mesh-list
5932789|NCT02706847|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
5932790|NCT02706847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5932791|NCT02706847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5932792|NCT02706847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5932793|NCT02706847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5932794|NCT02657434|Carboplatin|carboplatin|mesh-list
5932795|NCT02657434|Pemetrexed|pemetrexed|mesh-list
5932796|NCT02657434|Atezolizumab|atezolizumab|mesh-list
5932797|NCT02657434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932798|NCT02657434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5932799|NCT02657434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5932800|NCT02657434|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5932801|NCT02657434|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5932802|NCT02609776|Carboplatin|carboplatin|mesh-list
5932803|NCT02609776|Pemetrexed|pemetrexed|mesh-list
5932804|NCT02609776|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
5932805|NCT02609776|Lazertinib|lazertinib|mesh-list
5932806|NCT02609776|Antibodies, Bispecific|antibodies, bispecific|mesh-list
5932807|NCT02609776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932808|NCT02609776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5932809|NCT02609776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5932810|NCT02609776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5932811|NCT02609776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5932812|NCT02609776|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5932813|NCT02609776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5932814|NCT02609776|Immunologic Factors|immunologic factors|mesh-ancestor
5932815|NCT02609776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5932816|NCT02608359|Abiraterone Acetate|abiraterone acetate|mesh-list
5932817|NCT02608359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932818|NCT02608359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5932819|NCT02608359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5932820|NCT02608359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5932821|NCT02608359|Hormone Antagonists|hormone antagonists|mesh-ancestor
5932822|NCT02608359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5932823|NCT02608359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5932824|NCT02608359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5932825|NCT02592317|Pioglitazone|pioglitazone|mesh-list
5932826|NCT02592317|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5932827|NCT02592317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5932828|NCT02592317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5719490|NCT03219008|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5719491|NCT03219008|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5719492|NCT03219008|Adrenergic Agents|adrenergic agents|mesh-ancestor
5719493|NCT03219008|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5719494|NCT03219008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5719495|NCT03219008|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5719496|NCT03219008|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5719497|NCT03219008|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5719498|NCT03219008|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5719499|NCT03219008|Dopamine Agents|dopamine agents|mesh-ancestor
5719500|NCT03218930|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5719501|NCT03218930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5932829|NCT02592317|Antimetabolites|antimetabolites|mesh-ancestor
5932830|NCT02592317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5932831|NCT02592317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5932832|NCT02592317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5932833|NCT02592317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5932834|NCT02592317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5932835|NCT02592317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5932836|NCT02567435|Sirolimus|sirolimus|mesh-list
5932837|NCT02567435|Dactinomycin|dactinomycin|mesh-list
5932838|NCT02567435|Cactinomycin|cactinomycin|mesh-list
5932839|NCT02567435|Cyclophosphamide|cyclophosphamide|mesh-list
5932840|NCT02567435|Irinotecan|irinotecan|mesh-list
5932841|NCT02567435|Vincristine|vincristine|mesh-list
5932842|NCT02567435|Vinorelbine|vinorelbine|mesh-list
5932843|NCT02567435|Camptothecin|camptothecin|mesh-list
5932844|NCT02567435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5932845|NCT02567435|Immunologic Factors|immunologic factors|mesh-ancestor
5932846|NCT02567435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5932847|NCT02567435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5932848|NCT02567435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5932849|NCT02567435|Alkylating Agents|alkylating agents|mesh-ancestor
5932850|NCT02567435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5932851|NCT02567435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932852|NCT02567435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5932853|NCT02567435|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5932854|NCT02567435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5932855|NCT02567435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5932856|NCT02567435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5932857|NCT02567435|Tubulin Modulators|tubulin modulators|mesh-ancestor
5932858|NCT02567435|Antimitotic Agents|antimitotic agents|mesh-ancestor
5932859|NCT02567435|Mitosis Modulators|mitosis modulators|mesh-ancestor
5932860|NCT02567435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5932861|NCT02567435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5932862|NCT02567435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5932863|NCT02567435|Antifungal Agents|antifungal agents|mesh-ancestor
5932864|NCT02567435|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5932865|NCT02567435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5932866|NCT02564900|Camptothecin|camptothecin|mesh-list
5932867|NCT02564900|Immunoconjugates|immunoconjugates|mesh-list
5932868|NCT02564900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5932869|NCT02564900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932870|NCT02564900|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5932871|NCT02564900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5932872|NCT02564900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5932873|NCT02564900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5932874|NCT02564900|Immunologic Factors|immunologic factors|mesh-ancestor
5932875|NCT02564900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5932876|NCT02531516|Bicalutamide|bicalutamide|mesh-list
5932877|NCT02531516|Androgen Antagonists|androgen antagonists|mesh-ancestor
5932878|NCT02531516|Hormone Antagonists|hormone antagonists|mesh-ancestor
5932879|NCT02531516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5932880|NCT02531516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5932881|NCT02531516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932882|NCT02519452|Daratumumab|daratumumab|mesh-list
5932883|NCT02519452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932884|NCT02496780|Insulin|insulin|mesh-list
5932885|NCT02496780|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5932886|NCT02496780|Insulin Aspart|insulin aspart|mesh-list
5932887|NCT02496780|Insulin Detemir|insulin detemir|mesh-list
5932888|NCT02496780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5932889|NCT02496780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5932890|NCT02489318|Androgens|androgens|mesh-list
5932891|NCT02489318|Hormones|hormones|mesh-ancestor
5932892|NCT02489318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5932893|NCT02489318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5932894|NCT02488759|Nivolumab|nivolumab|mesh-list
5932895|NCT02488759|Ipilimumab|ipilimumab|mesh-list
5932896|NCT02488759|Daratumumab|daratumumab|mesh-list
5932897|NCT02488759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5932898|NCT02488759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932899|NCT02488759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5932900|NCT02488759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719502|NCT03218930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5719503|NCT03218930|Antitubercular Agents|antitubercular agents|mesh-ancestor
5719504|NCT03219086|Bupivacaine|bupivacaine|mesh-list
5719505|NCT03219086|Prilocaine|prilocaine|mesh-list
5719506|NCT03219086|Anesthetics|anesthetics|mesh-list
5719507|NCT03219086|Anesthetics, Local|anesthetics, local|mesh-ancestor
5719508|NCT03219086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5719509|NCT03219086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719510|NCT03219086|Sensory System Agents|sensory system agents|mesh-ancestor
5719511|NCT03219086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5719512|NCT03218631|Oxandrolone|oxandrolone|mesh-list
5719513|NCT03218631|Androgens|androgens|mesh-ancestor
5719514|NCT03218631|Hormones|hormones|mesh-ancestor
5719515|NCT03218631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5719516|NCT03218631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719517|NCT03218631|Anabolic Agents|anabolic agents|mesh-ancestor
5719518|NCT03218709|Vitamins|vitamins|mesh-list
5932940|NCT02443077|Cytarabine|cytarabine|mesh-list
5932941|NCT02443077|Cyclophosphamide|cyclophosphamide|mesh-list
5932942|NCT02443077|Melphalan|melphalan|mesh-list
5932943|NCT02443077|Mechlorethamine|mechlorethamine|mesh-list
5932944|NCT02443077|Carmustine|carmustine|mesh-list
5932945|NCT02443077|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
5932946|NCT02443077|Etoposide|etoposide|mesh-list
5932947|NCT02443077|Etoposide phosphate|etoposide phosphate|mesh-list
5932948|NCT02443077|Podophyllotoxin|podophyllotoxin|mesh-list
5932949|NCT02443077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5932950|NCT02443077|Immunologic Factors|immunologic factors|mesh-ancestor
5932951|NCT02443077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5932952|NCT02443077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5932953|NCT02443077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5932954|NCT02443077|Alkylating Agents|alkylating agents|mesh-ancestor
5932955|NCT02443077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5932956|NCT02443077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932957|NCT02443077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5932958|NCT02443077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5932959|NCT02443077|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5932960|NCT02443077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5932961|NCT02443077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5932962|NCT02443077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5932963|NCT02443077|Antimetabolites|antimetabolites|mesh-ancestor
5932964|NCT02443077|Antiviral Agents|antiviral agents|mesh-ancestor
5932965|NCT02443077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5932966|NCT02443077|Keratolytic Agents|keratolytic agents|mesh-ancestor
5932967|NCT02443077|Dermatologic Agents|dermatologic agents|mesh-ancestor
5932968|NCT02443077|Tubulin Modulators|tubulin modulators|mesh-ancestor
5932969|NCT02443077|Antimitotic Agents|antimitotic agents|mesh-ancestor
5932970|NCT02443077|Mitosis Modulators|mitosis modulators|mesh-ancestor
5719519|NCT03218709|Micronutrients|micronutrients|mesh-ancestor
5719520|NCT03218709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5932971|NCT02408549|Lacosamide|lacosamide|mesh-list
5932972|NCT02408549|Anticonvulsants|anticonvulsants|mesh-ancestor
5719521|NCT03218657|Cyclosporine|cyclosporine|mesh-list
5965799|NCT04577846|Cephalexin|cephalexin|mesh-list
5719522|NCT03218657|Levamisole|levamisole|mesh-list
5719523|NCT03218657|Cyclosporins|cyclosporins|mesh-list
5719524|NCT03218657|Androgens|androgens|mesh-list
5932973|NCT02408549|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5932974|NCT02408549|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5932975|NCT02408549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5932976|NCT02408549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5932977|NCT02393859|Dexamethasone|dexamethasone|mesh-list
5932978|NCT02393859|Methotrexate|methotrexate|mesh-list
5932979|NCT02393859|Daunorubicin|daunorubicin|mesh-list
5932980|NCT02393859|Asparaginase|asparaginase|mesh-list
5932981|NCT02393859|Ifosfamide|ifosfamide|mesh-list
5932982|NCT02393859|Blinatumomab|blinatumomab|mesh-list
5932983|NCT02393859|Pegaspargase|pegaspargase|mesh-list
5932984|NCT02393859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5932985|NCT02393859|Antiemetics|antiemetics|mesh-ancestor
5932986|NCT02393859|Autonomic Agents|autonomic agents|mesh-ancestor
5932987|NCT02393859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5932988|NCT02393859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5932989|NCT02393859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5932990|NCT02393859|Glucocorticoids|glucocorticoids|mesh-ancestor
5932991|NCT02393859|Hormones|hormones|mesh-ancestor
5932992|NCT02393859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5932993|NCT02393859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5932994|NCT02393859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5932995|NCT02393859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5932996|NCT02393859|Abortifacient Agents|abortifacient agents|mesh-ancestor
5932997|NCT02393859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5932998|NCT02393859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5932999|NCT02393859|Antimetabolites|antimetabolites|mesh-ancestor
5933000|NCT02393859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5933001|NCT02393859|Dermatologic Agents|dermatologic agents|mesh-ancestor
5933002|NCT02393859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5933003|NCT02393859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5933004|NCT02393859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5933005|NCT02393859|Immunologic Factors|immunologic factors|mesh-ancestor
5933006|NCT02393859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5933007|NCT02393859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5933008|NCT02393859|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5933009|NCT02393859|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5933010|NCT02393859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5933011|NCT02393859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5933012|NCT02393859|Alkylating Agents|alkylating agents|mesh-ancestor
5933013|NCT02365597|Metformin|metformin|mesh-list
5933014|NCT02365597|Midazolam|midazolam|mesh-list
5933015|NCT02365597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5933016|NCT02365597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933017|NCT02365597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5933018|NCT02365597|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5933019|NCT02365597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5933020|NCT02365597|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5933021|NCT02365597|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5933022|NCT02365597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5933023|NCT02365597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5933024|NCT02365597|Anesthetics, General|anesthetics, general|mesh-ancestor
5933025|NCT02365597|Anesthetics|anesthetics|mesh-ancestor
5933026|NCT02365597|GABA Modulators|gaba modulators|mesh-ancestor
5933027|NCT02365597|GABA Agents|gaba agents|mesh-ancestor
5933028|NCT02365597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5933029|NCT02365597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5933030|NCT02329847|Nivolumab|nivolumab|mesh-list
5719525|NCT03218657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5719526|NCT03218657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719527|NCT03218657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5719528|NCT03218657|Immunologic Factors|immunologic factors|mesh-ancestor
5719529|NCT03218657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719530|NCT03218657|Antifungal Agents|antifungal agents|mesh-ancestor
5719531|NCT03218657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5719532|NCT03218657|Dermatologic Agents|dermatologic agents|mesh-ancestor
5719533|NCT03218657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5719534|NCT03218657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5719535|NCT03218657|Hormones|hormones|mesh-ancestor
5719536|NCT03218657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5719537|NCT03218657|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5719538|NCT03218657|Antinematodal Agents|antinematodal agents|mesh-ancestor
5719539|NCT03218657|Anthelmintics|anthelmintics|mesh-ancestor
5933031|NCT02329847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5933032|NCT02329847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5933033|NCT02329847|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5933034|NCT02329847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5933035|NCT02316106|Daratumumab|daratumumab|mesh-list
5933036|NCT02316106|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5933037|NCT02316106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5933038|NCT02316106|Immunologic Factors|immunologic factors|mesh-ancestor
5933039|NCT02316106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933040|NCT02277444|Golimumab|golimumab|mesh-list
5933041|NCT02277444|Methotrexate|methotrexate|mesh-list
5933042|NCT02277444|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5933043|NCT02277444|Abortifacient Agents|abortifacient agents|mesh-ancestor
5933044|NCT02277444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5933045|NCT02277444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933046|NCT02277444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5933047|NCT02277444|Antimetabolites|antimetabolites|mesh-ancestor
5933048|NCT02277444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5933049|NCT02277444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5933050|NCT02277444|Dermatologic Agents|dermatologic agents|mesh-ancestor
5933051|NCT02277444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5933052|NCT02277444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5933053|NCT02277444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5933054|NCT02277444|Immunologic Factors|immunologic factors|mesh-ancestor
5933055|NCT02277444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5933056|NCT02277444|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5933057|NCT02277444|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
5933058|NCT02277444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5933059|NCT02273362|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5933060|NCT02273362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5933061|NCT02273362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5933062|NCT02273362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5933063|NCT02273362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5933064|NCT02257736|Prednisone|prednisone|mesh-list
5933065|NCT02257736|Abiraterone Acetate|abiraterone acetate|mesh-list
5933066|NCT02257736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5933067|NCT02257736|Glucocorticoids|glucocorticoids|mesh-ancestor
5933068|NCT02257736|Hormones|hormones|mesh-ancestor
5933069|NCT02257736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5933070|NCT02257736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933071|NCT02257736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5933072|NCT02257736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5933073|NCT02257736|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5933074|NCT02257736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5933075|NCT02257736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5933076|NCT02257736|Hormone Antagonists|hormone antagonists|mesh-ancestor
5933077|NCT02257736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5933078|NCT02252172|Dexamethasone|dexamethasone|mesh-list
5933079|NCT02252172|Lenalidomide|lenalidomide|mesh-list
5933080|NCT02252172|Daratumumab|daratumumab|mesh-list
5933081|NCT02252172|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5933082|NCT02252172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5933083|NCT02252172|Antiemetics|antiemetics|mesh-ancestor
5933084|NCT02252172|Autonomic Agents|autonomic agents|mesh-ancestor
5933085|NCT02252172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5933086|NCT02252172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933087|NCT02252172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5933088|NCT02252172|Glucocorticoids|glucocorticoids|mesh-ancestor
5933089|NCT02252172|Hormones|hormones|mesh-ancestor
5933090|NCT02252172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5933091|NCT02252172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5933092|NCT02252172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5933093|NCT02252172|Immunologic Factors|immunologic factors|mesh-ancestor
5933094|NCT02252172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5933095|NCT02252172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5933096|NCT02252172|Growth Substances|growth substances|mesh-ancestor
5933097|NCT02252172|Growth Inhibitors|growth inhibitors|mesh-ancestor
5933098|NCT02195479|Dexamethasone|dexamethasone|mesh-list
5933099|NCT02195479|Prednisone|prednisone|mesh-list
5933100|NCT02195479|Melphalan|melphalan|mesh-list
5933101|NCT02195479|Bortezomib|bortezomib|mesh-list
5933102|NCT02195479|Daratumumab|daratumumab|mesh-list
5933103|NCT02195479|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5933104|NCT02195479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6517173|NCT00720135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5933105|NCT02195479|Antiemetics|antiemetics|mesh-ancestor
5933106|NCT02195479|Autonomic Agents|autonomic agents|mesh-ancestor
5933107|NCT02195479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5933108|NCT02195479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933109|NCT02195479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5933110|NCT02195479|Glucocorticoids|glucocorticoids|mesh-ancestor
5933111|NCT02195479|Hormones|hormones|mesh-ancestor
5933112|NCT02195479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5933113|NCT02195479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5933114|NCT02195479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5933115|NCT02195479|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5933116|NCT02195479|Alkylating Agents|alkylating agents|mesh-ancestor
5933117|NCT02195479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5933118|NCT02195479|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5933119|NCT02195479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5933120|NCT02195479|Immunologic Factors|immunologic factors|mesh-ancestor
5933121|NCT02178358|Sorafenib|sorafenib|mesh-list
5933122|NCT02178358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5933123|NCT02178358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5933124|NCT02178358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5933125|NCT02178358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5933126|NCT02157610|Nicotine|nicotine|mesh-list
5933127|NCT02157610|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5933128|NCT02157610|Autonomic Agents|autonomic agents|mesh-ancestor
5719540|NCT03218657|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5719541|NCT03218553|Dexamethasone|dexamethasone|mesh-list
5719542|NCT03218553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5719543|NCT03218553|Antiemetics|antiemetics|mesh-ancestor
5719544|NCT03218553|Autonomic Agents|autonomic agents|mesh-ancestor
5719545|NCT03218553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5719546|NCT03218553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719547|NCT03218553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5719548|NCT03218553|Glucocorticoids|glucocorticoids|mesh-ancestor
5719549|NCT03218553|Hormones|hormones|mesh-ancestor
5719550|NCT03218553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5719551|NCT03218553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5719552|NCT03218553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5719553|NCT03218852|Prednisone|prednisone|mesh-list
5719554|NCT03218852|Cyclophosphamide|cyclophosphamide|mesh-list
5719555|NCT03218852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5719556|NCT03218852|Immunologic Factors|immunologic factors|mesh-ancestor
5719557|NCT03218852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719558|NCT03218852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5719559|NCT03218852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5719560|NCT03218852|Alkylating Agents|alkylating agents|mesh-ancestor
5719561|NCT03218852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5933129|NCT02157610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5933130|NCT02157610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933131|NCT02157610|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5933132|NCT02157610|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5933133|NCT02157610|Cholinergic Agents|cholinergic agents|mesh-ancestor
5933134|NCT02157610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5933135|NCT02157610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5933136|NCT02136134|Dexamethasone|dexamethasone|mesh-list
5933137|NCT02136134|Bortezomib|bortezomib|mesh-list
5933138|NCT02136134|Daratumumab|daratumumab|mesh-list
5933139|NCT02136134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5933140|NCT02136134|Antiemetics|antiemetics|mesh-ancestor
5933141|NCT02136134|Autonomic Agents|autonomic agents|mesh-ancestor
5933142|NCT02136134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5933143|NCT02136134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933144|NCT02136134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5933145|NCT02136134|Glucocorticoids|glucocorticoids|mesh-ancestor
5933146|NCT02136134|Hormones|hormones|mesh-ancestor
5933147|NCT02136134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5933148|NCT02136134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5933149|NCT02136134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5933150|NCT02123758|Prednisone|prednisone|mesh-list
5933151|NCT02123758|Abiraterone Acetate|abiraterone acetate|mesh-list
5933152|NCT02123758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5933153|NCT02123758|Glucocorticoids|glucocorticoids|mesh-ancestor
5933154|NCT02123758|Hormones|hormones|mesh-ancestor
5933155|NCT02123758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5933156|NCT02123758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517174|NCT00720135|Interleukin-2|interleukin-2|mesh-list
5933157|NCT02123758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5933158|NCT02123758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5933159|NCT02123758|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5933160|NCT02123758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5933161|NCT02123758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5933162|NCT02123758|Hormone Antagonists|hormone antagonists|mesh-ancestor
5933163|NCT02123758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5933164|NCT02076009|Dexamethasone|dexamethasone|mesh-list
5933165|NCT02076009|Lenalidomide|lenalidomide|mesh-list
5933166|NCT02076009|Daratumumab|daratumumab|mesh-list
5933167|NCT02076009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5933168|NCT02076009|Antiemetics|antiemetics|mesh-ancestor
5933169|NCT02076009|Autonomic Agents|autonomic agents|mesh-ancestor
5933170|NCT02076009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5933171|NCT02076009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933172|NCT02076009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5933173|NCT02076009|Glucocorticoids|glucocorticoids|mesh-ancestor
5933174|NCT02076009|Hormones|hormones|mesh-ancestor
5933175|NCT02076009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5933176|NCT02076009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5933177|NCT02076009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5933178|NCT02076009|Immunologic Factors|immunologic factors|mesh-ancestor
5933179|NCT02076009|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5933180|NCT02076009|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5933181|NCT02076009|Growth Substances|growth substances|mesh-ancestor
5933182|NCT02076009|Growth Inhibitors|growth inhibitors|mesh-ancestor
5933183|NCT02051933|Botulinum Toxins|botulinum toxins|mesh-list
5933184|NCT02051933|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5933185|NCT02051933|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5933186|NCT02051933|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5933187|NCT02051933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5933188|NCT02051933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5933189|NCT02051933|Cholinergic Agents|cholinergic agents|mesh-ancestor
5933190|NCT02051933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5933191|NCT02051933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933192|NCT02051933|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5933193|NCT02051933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5933194|NCT01998971|Acetaminophen|acetaminophen|mesh-list
5933195|NCT01998971|Diphenhydramine|diphenhydramine|mesh-list
5933196|NCT01998971|Promethazine|promethazine|mesh-list
5933197|NCT01998971|Thalidomide|thalidomide|mesh-list
5933198|NCT01998971|Dexamethasone|dexamethasone|mesh-list
5933199|NCT01998971|Prednisone|prednisone|mesh-list
5933200|NCT01998971|Lenalidomide|lenalidomide|mesh-list
5933201|NCT01998971|Melphalan|melphalan|mesh-list
5933202|NCT01998971|Bortezomib|bortezomib|mesh-list
5933203|NCT01998971|Daratumumab|daratumumab|mesh-list
5933204|NCT01998971|Pomalidomide|pomalidomide|mesh-list
5933205|NCT01998971|Montelukast|montelukast|mesh-list
5933206|NCT01998971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5933207|NCT01998971|Antiemetics|antiemetics|mesh-ancestor
5933208|NCT01998971|Autonomic Agents|autonomic agents|mesh-ancestor
5933209|NCT01998971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5933210|NCT01998971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933211|NCT01998971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5933212|NCT01998971|Glucocorticoids|glucocorticoids|mesh-ancestor
5933213|NCT01998971|Hormones|hormones|mesh-ancestor
5933214|NCT01998971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5933215|NCT01998971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5933216|NCT01998971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5933217|NCT01998971|Immunologic Factors|immunologic factors|mesh-ancestor
5933218|NCT01998971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5933219|NCT01998971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5933220|NCT01998971|Growth Substances|growth substances|mesh-ancestor
5933221|NCT01998971|Growth Inhibitors|growth inhibitors|mesh-ancestor
5933222|NCT01998971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5933223|NCT01998971|Analgesics|analgesics|mesh-ancestor
5933224|NCT01998971|Sensory System Agents|sensory system agents|mesh-ancestor
5933225|NCT01998971|Antipyretics|antipyretics|mesh-ancestor
5933226|NCT01998971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5933227|NCT01998971|Alkylating Agents|alkylating agents|mesh-ancestor
5933228|NCT01998971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5933229|NCT01998971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5933230|NCT01998971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5933231|NCT01998971|Leprostatic Agents|leprostatic agents|mesh-ancestor
5933232|NCT01998971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5933233|NCT01998971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5933234|NCT01998971|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5933235|NCT01998971|Respiratory System Agents|respiratory system agents|mesh-ancestor
5933236|NCT01998971|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5933237|NCT01998971|Hormone Antagonists|hormone antagonists|mesh-ancestor
5933238|NCT01998971|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5933239|NCT01998971|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5933240|NCT01998971|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5933241|NCT01998971|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5933242|NCT01998971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5933243|NCT01998971|Anesthetics, Local|anesthetics, local|mesh-ancestor
5933244|NCT01998971|Anesthetics|anesthetics|mesh-ancestor
5933245|NCT01998971|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5933246|NCT01998971|Histamine Antagonists|histamine antagonists|mesh-ancestor
5933247|NCT01998971|Histamine Agents|histamine agents|mesh-ancestor
5933248|NCT01998971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5933249|NCT01998971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5933250|NCT01998971|Antipruritics|antipruritics|mesh-ancestor
5933251|NCT01998971|Dermatologic Agents|dermatologic agents|mesh-ancestor
5933252|NCT01974440|Prednisone|prednisone|mesh-list
5933253|NCT01974440|Cyclophosphamide|cyclophosphamide|mesh-list
5933254|NCT01974440|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5933255|NCT01974440|Rituximab|rituximab|mesh-list
5933256|NCT01974440|Doxorubicin|doxorubicin|mesh-list
5933257|NCT01974440|Vincristine|vincristine|mesh-list
5933258|NCT01974440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5933259|NCT01974440|Immunologic Factors|immunologic factors|mesh-ancestor
5933260|NCT01974440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933261|NCT01974440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5933262|NCT01974440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5933263|NCT01974440|Alkylating Agents|alkylating agents|mesh-ancestor
5933264|NCT01974440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5933265|NCT01974440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5933266|NCT01974440|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5933267|NCT01974440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5933268|NCT01974440|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5933269|NCT01974440|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5933270|NCT01974440|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5933271|NCT01974440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5933272|NCT01974440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5933273|NCT01974440|Glucocorticoids|glucocorticoids|mesh-ancestor
5933274|NCT01974440|Hormones|hormones|mesh-ancestor
5933275|NCT01974440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5933276|NCT01974440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5933277|NCT01974440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5933278|NCT01974440|Tubulin Modulators|tubulin modulators|mesh-ancestor
5933279|NCT01974440|Antimitotic Agents|antimitotic agents|mesh-ancestor
5933280|NCT01974440|Mitosis Modulators|mitosis modulators|mesh-ancestor
5933281|NCT01900574|Golimumab|golimumab|mesh-list
5933282|NCT01900574|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
5933283|NCT01900574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5933284|NCT01900574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5933285|NCT01900574|Immunologic Factors|immunologic factors|mesh-ancestor
5933286|NCT01900574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933287|NCT01842386|Rituximab|rituximab|mesh-list
5933288|NCT01842386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5933289|NCT01842386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5933290|NCT01842386|Immunologic Factors|immunologic factors|mesh-ancestor
5933291|NCT01842386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933292|NCT01842386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5933293|NCT01838174|Methylprednisolone|methylprednisolone|mesh-list
5933294|NCT01838174|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5933295|NCT01838174|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5933296|NCT01838174|Prednisolone|prednisolone|mesh-list
5933297|NCT01838174|Prednisolone acetate|prednisolone acetate|mesh-list
5933298|NCT01838174|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5933299|NCT01838174|Prednisolone phosphate|prednisolone phosphate|mesh-list
5933300|NCT01838174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5933301|NCT01838174|Antiemetics|antiemetics|mesh-ancestor
5933302|NCT01838174|Autonomic Agents|autonomic agents|mesh-ancestor
5933303|NCT01838174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5933304|NCT01838174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933305|NCT01838174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5933306|NCT01838174|Glucocorticoids|glucocorticoids|mesh-ancestor
5933307|NCT01838174|Hormones|hormones|mesh-ancestor
5933308|NCT01838174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5933309|NCT01838174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5933310|NCT01838174|Protective Agents|protective agents|mesh-ancestor
5933311|NCT01838174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5933312|NCT01838174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5933328|NCT01792687|Prednisone|prednisone|mesh-list
5933329|NCT01792687|Abiraterone Acetate|abiraterone acetate|mesh-list
5933330|NCT01792687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5933331|NCT01792687|Glucocorticoids|glucocorticoids|mesh-ancestor
5933332|NCT01792687|Hormones|hormones|mesh-ancestor
5933333|NCT01792687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5933334|NCT01792687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933335|NCT01792687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5933336|NCT01792687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5933337|NCT01792687|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5933338|NCT01792687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5933339|NCT01792687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5933340|NCT01792687|Hormone Antagonists|hormone antagonists|mesh-ancestor
5933341|NCT01792687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5933342|NCT01615029|Dexamethasone|dexamethasone|mesh-list
5933343|NCT01615029|Lenalidomide|lenalidomide|mesh-list
5933344|NCT01615029|Daratumumab|daratumumab|mesh-list
5933345|NCT01615029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5933346|NCT01615029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5933347|NCT01615029|Antiemetics|antiemetics|mesh-ancestor
5933348|NCT01615029|Autonomic Agents|autonomic agents|mesh-ancestor
5933349|NCT01615029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5933350|NCT01615029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933351|NCT01615029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5933352|NCT01615029|Glucocorticoids|glucocorticoids|mesh-ancestor
5933353|NCT01615029|Hormones|hormones|mesh-ancestor
5933354|NCT01615029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5933355|NCT01615029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5933356|NCT01615029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5933357|NCT01615029|Immunologic Factors|immunologic factors|mesh-ancestor
5933358|NCT01615029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5933359|NCT01615029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5933360|NCT01615029|Growth Substances|growth substances|mesh-ancestor
5933361|NCT01615029|Growth Inhibitors|growth inhibitors|mesh-ancestor
5933362|NCT01532310|Belimumab|belimumab|mesh-list
5933363|NCT01532310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5933364|NCT01532310|Immunologic Factors|immunologic factors|mesh-ancestor
5933365|NCT01532310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933368|NCT01495637|Sargramostim|sargramostim|mesh-list
5933369|NCT01495637|Immunologic Factors|immunologic factors|mesh-ancestor
5933370|NCT01495637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933379|NCT01314118|Prednisone|prednisone|mesh-list
5933380|NCT01314118|Abiraterone Acetate|abiraterone acetate|mesh-list
5933381|NCT01314118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5933382|NCT01314118|Glucocorticoids|glucocorticoids|mesh-ancestor
5933383|NCT01314118|Hormones|hormones|mesh-ancestor
5933384|NCT01314118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5933385|NCT01314118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517175|NCT00720135|Antibodies|antibodies|mesh-list
5933386|NCT01314118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5933387|NCT01314118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5933388|NCT01314118|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5933389|NCT01314118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5933390|NCT01314118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5933391|NCT01314118|Hormone Antagonists|hormone antagonists|mesh-ancestor
5933392|NCT01314118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5933393|NCT01306019|Busulfan|busulfan|mesh-list
5933394|NCT01306019|Alkylating Agents|alkylating agents|mesh-ancestor
5933395|NCT01306019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5933396|NCT01306019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5933397|NCT01306019|Immunologic Factors|immunologic factors|mesh-ancestor
5933398|NCT01306019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933399|NCT01306019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5933400|NCT01306019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5933401|NCT01306019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5933402|NCT01243190|Ofatumumab|ofatumumab|mesh-list
5933403|NCT01243190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5933404|NCT00903110|Mecasermin|mecasermin|mesh-list
5933405|NCT00903110|Growth Substances|growth substances|mesh-ancestor
5933406|NCT00903110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933407|NCT00806390|Metoprolol|metoprolol|mesh-list
5933408|NCT00806390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5933409|NCT00806390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5933410|NCT00806390|Sympatholytics|sympatholytics|mesh-ancestor
5933411|NCT00806390|Autonomic Agents|autonomic agents|mesh-ancestor
5933412|NCT00806390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5933413|NCT00806390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933414|NCT00806390|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5933415|NCT00806390|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5933416|NCT00806390|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5933417|NCT00806390|Adrenergic Agents|adrenergic agents|mesh-ancestor
5933418|NCT00806390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5933419|NCT00806390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5933420|NCT00777036|Dasatinib|dasatinib|mesh-list
5933421|NCT00777036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5933422|NCT00777036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5933423|NCT00777036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5933424|NCT00777036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5933425|NCT00566618|Zoledronic Acid|zoledronic acid|mesh-list
5933426|NCT00566618|Dasatinib|dasatinib|mesh-list
5933427|NCT00566618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5933428|NCT00566618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5933429|NCT00566618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5933430|NCT00566618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5933431|NCT00566618|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5933432|NCT00566618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933433|NCT00442559|Montelukast|montelukast|mesh-list
5933434|NCT00442559|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5933435|NCT00442559|Respiratory System Agents|respiratory system agents|mesh-ancestor
5933436|NCT00442559|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5933437|NCT00442559|Hormone Antagonists|hormone antagonists|mesh-ancestor
5933438|NCT00442559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5933439|NCT00442559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933440|NCT00442559|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5933441|NCT00442559|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5933442|NCT00442559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5933443|NCT00117338|Montelukast|montelukast|mesh-list
5933444|NCT00117338|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5933445|NCT00117338|Respiratory System Agents|respiratory system agents|mesh-ancestor
5933446|NCT00117338|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5933447|NCT00117338|Hormone Antagonists|hormone antagonists|mesh-ancestor
5933448|NCT00117338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5933449|NCT00117338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933450|NCT00117338|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5933451|NCT00117338|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5933452|NCT00117338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5933453|NCT00001481|Estradiol|estradiol|mesh-list
5933454|NCT00001481|Progesterone|progesterone|mesh-list
5933455|NCT00001481|Estrogens|estrogens|mesh-ancestor
5933456|NCT00001481|Hormones|hormones|mesh-ancestor
5965800|NCT04577846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5933457|NCT00001481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5933458|NCT00001481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933459|NCT00001481|Progestins|progestins|mesh-ancestor
5965801|NCT04577846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5965802|NCT04577885|Rifampin|rifampin|mesh-list
5965803|NCT04577885|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5965804|NCT04577885|Antitubercular Agents|antitubercular agents|mesh-ancestor
5965805|NCT04577885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5965806|NCT04577885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5965807|NCT04577885|Leprostatic Agents|leprostatic agents|mesh-ancestor
5965808|NCT04577885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5965809|NCT04577885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5965810|NCT04577885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965811|NCT04577885|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5965812|NCT04577885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5965813|NCT04577885|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5965814|NCT04577885|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5965815|NCT04577885|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5965816|NCT04577885|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5965817|NCT04577716|Listerine|listerine|mesh-list
5965818|NCT04577716|Fluorides|fluorides|mesh-list
5965819|NCT04577716|Sodium Fluoride|sodium fluoride|mesh-list
5965820|NCT04577716|Cariostatic Agents|cariostatic agents|mesh-ancestor
5965821|NCT04577716|Protective Agents|protective agents|mesh-ancestor
5965822|NCT04577716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965823|NCT04577716|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5965824|NCT04577716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5965825|NCT04577443|Adenosine|adenosine|mesh-list
5965826|NCT04577443|Analgesics|analgesics|mesh-ancestor
5965827|NCT04577443|Sensory System Agents|sensory system agents|mesh-ancestor
5965828|NCT04577443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5965829|NCT04577443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965830|NCT04577443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5965831|NCT04577443|Vasodilator Agents|vasodilator agents|mesh-ancestor
5965832|NCT04577443|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5965833|NCT04577443|Purinergic Agonists|purinergic agonists|mesh-ancestor
5965834|NCT04577443|Purinergic Agents|purinergic agents|mesh-ancestor
5965835|NCT04577443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5965836|NCT04577443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965837|NCT04577378|Itraconazole|itraconazole|mesh-list
5965838|NCT04577378|Tretinoin|tretinoin|mesh-list
5965839|NCT04577378|Isotretinoin|isotretinoin|mesh-list
5965840|NCT04577378|Antifungal Agents|antifungal agents|mesh-ancestor
5965841|NCT04577378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5965842|NCT04577378|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5965843|NCT04577378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5965844|NCT04577378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5965845|NCT04577378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965846|NCT04577378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5965847|NCT04577378|Hormone Antagonists|hormone antagonists|mesh-ancestor
5965848|NCT04577378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5965849|NCT04577378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965850|NCT04577378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5965851|NCT04577378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5965852|NCT04577378|Keratolytic Agents|keratolytic agents|mesh-ancestor
5965853|NCT04577378|Dermatologic Agents|dermatologic agents|mesh-ancestor
5965854|NCT04577417|Methylphenidate|methylphenidate|mesh-list
5965855|NCT04577417|Amphetamine|amphetamine|mesh-list
5965856|NCT04577417|Adderall|adderall|mesh-list
5965857|NCT04577417|Dextroamphetamine|dextroamphetamine|mesh-list
5965858|NCT04577417|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
5965859|NCT04577417|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5965860|NCT04577417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965861|NCT04577417|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5965862|NCT04577417|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5965863|NCT04577417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5965864|NCT04577417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965865|NCT04577417|Dopamine Agents|dopamine agents|mesh-ancestor
5965866|NCT04577417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5965867|NCT04577417|Sympathomimetics|sympathomimetics|mesh-ancestor
5965868|NCT04577417|Autonomic Agents|autonomic agents|mesh-ancestor
5965869|NCT04577417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6517176|NCT00720135|Immunoglobulins|immunoglobulins|mesh-list
5933460|NCT04877626|Artesunate|artesunate|mesh-list
5933461|NCT04877626|Antimalarials|antimalarials|mesh-ancestor
5933462|NCT04877626|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5933463|NCT04877626|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5933464|NCT04877626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5933465|NCT04877626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5933466|NCT04877626|Antiviral Agents|antiviral agents|mesh-ancestor
5933467|NCT04877626|Schistosomicides|schistosomicides|mesh-ancestor
5933468|NCT04877626|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5933469|NCT04877626|Anthelmintics|anthelmintics|mesh-ancestor
5933470|NCT04877509|Vitamin D|vitamin d|mesh-list
5933471|NCT04877509|Vitamin A|vitamin a|mesh-list
5933472|NCT04877509|Selenium|selenium|mesh-list
5933473|NCT04877509|Copper|copper|mesh-list
5933474|NCT04877509|Vitamins|vitamins|mesh-ancestor
5933475|NCT04877509|Micronutrients|micronutrients|mesh-ancestor
5933476|NCT04877509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933477|NCT04877509|Antioxidants|antioxidants|mesh-ancestor
5933478|NCT04877509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5933479|NCT04877509|Protective Agents|protective agents|mesh-ancestor
5933480|NCT04877509|Trace Elements|trace elements|mesh-ancestor
5933481|NCT04877509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5933482|NCT04877275|Dexamethasone|dexamethasone|mesh-list
5933483|NCT04877275|Cyclophosphamide|cyclophosphamide|mesh-list
5933484|NCT04877275|Doxorubicin|doxorubicin|mesh-list
5933485|NCT04877275|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5933486|NCT04877275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5933487|NCT04877275|Immunologic Factors|immunologic factors|mesh-ancestor
5933488|NCT04877275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933489|NCT04877275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5933490|NCT04877275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5933491|NCT04877275|Alkylating Agents|alkylating agents|mesh-ancestor
5719562|NCT03218852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5719563|NCT03218852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5719564|NCT03218852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5719565|NCT03218852|Glucocorticoids|glucocorticoids|mesh-ancestor
5719566|NCT03218852|Hormones|hormones|mesh-ancestor
5719567|NCT03218852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5719568|NCT03218852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5719569|NCT03218800|Ertapenem|ertapenem|mesh-list
5933492|NCT04877275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5933493|NCT04877275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5933494|NCT04877275|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5933495|NCT04877275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5933496|NCT04877275|Antiemetics|antiemetics|mesh-ancestor
5933497|NCT04877275|Autonomic Agents|autonomic agents|mesh-ancestor
5933498|NCT04877275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5933499|NCT04877275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5933500|NCT04877275|Glucocorticoids|glucocorticoids|mesh-ancestor
5933501|NCT04877275|Hormones|hormones|mesh-ancestor
5933502|NCT04877275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5933503|NCT04877275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5933504|NCT04877275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5933505|NCT04877275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5933506|NCT04877275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5933507|NCT04877275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5933508|NCT04877210|Insulin|insulin|mesh-list
5933509|NCT04877210|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5933510|NCT04877210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5933511|NCT04877210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933512|NCT04877106|Metformin|metformin|mesh-list
5933513|NCT04877106|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5933514|NCT04877106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5933515|NCT04877106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719570|NCT03218800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5719571|NCT03218800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5719572|NCT03218722|Thrombin|thrombin|mesh-list
5719573|NCT03218722|Hemostatics|hemostatics|mesh-ancestor
5719574|NCT03218722|Coagulants|coagulants|mesh-ancestor
5719575|NCT03218514|Dalteparin|dalteparin|mesh-list
5719576|NCT03218514|Tinzaparin|tinzaparin|mesh-list
5719577|NCT03218514|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5719578|NCT03218514|Anticoagulants|anticoagulants|mesh-ancestor
5719579|NCT03218514|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5719580|NCT03218514|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5933516|NCT04877106|Incretins|incretins|mesh-ancestor
5933517|NCT04877106|Hormones|hormones|mesh-ancestor
5933518|NCT04877106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5933519|NCT04877106|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5933520|NCT04877106|Protease Inhibitors|protease inhibitors|mesh-ancestor
5933521|NCT04877106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5933522|NCT04877106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5933523|NCT04876937|Dexmedetomidine|dexmedetomidine|mesh-list
5933524|NCT04876937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5933525|NCT04876937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5933526|NCT04876937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933527|NCT04876937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5933528|NCT04876937|Analgesics|analgesics|mesh-ancestor
5933529|NCT04876937|Sensory System Agents|sensory system agents|mesh-ancestor
5933530|NCT04876937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5933531|NCT04876937|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5933532|NCT04876937|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5933533|NCT04876937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5933534|NCT04876937|Adrenergic Agents|adrenergic agents|mesh-ancestor
5933535|NCT04876937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5933536|NCT04876937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5933537|NCT04877288|Cyclosporine|cyclosporine|mesh-list
5933538|NCT04877288|Mycophenolic Acid|mycophenolic acid|mesh-list
5933539|NCT04877288|Abatacept|abatacept|mesh-list
5933540|NCT04877288|Tacrolimus|tacrolimus|mesh-list
5933541|NCT04877288|Cyclosporins|cyclosporins|mesh-list
5933542|NCT04877288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5933543|NCT04877288|Immunologic Factors|immunologic factors|mesh-ancestor
5933544|NCT04877288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933545|NCT04877288|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5933546|NCT04877288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5933547|NCT04877288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5933548|NCT04877288|Antifungal Agents|antifungal agents|mesh-ancestor
5933549|NCT04877288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5933550|NCT04877288|Dermatologic Agents|dermatologic agents|mesh-ancestor
5933551|NCT04877288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5933552|NCT04877288|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5933553|NCT04877288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5933554|NCT04877288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5933555|NCT04877288|Antitubercular Agents|antitubercular agents|mesh-ancestor
5933556|NCT04877288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5933557|NCT04877288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5933558|NCT04876781|Tofacitinib|tofacitinib|mesh-list
5933559|NCT04876781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5933560|NCT04876781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5933561|NCT04876781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5933562|NCT04876716|Voriconazole|voriconazole|mesh-list
5933563|NCT04876716|Posaconazole|posaconazole|mesh-list
5933564|NCT04876716|Isavuconazole|isavuconazole|mesh-list
5933565|NCT04876716|Anidulafungin|anidulafungin|mesh-list
5933566|NCT04876716|Antifungal Agents|antifungal agents|mesh-ancestor
5933567|NCT04876716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5933568|NCT04876716|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5933569|NCT04876716|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5933570|NCT04876716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5933571|NCT04876716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5933572|NCT04876716|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5933573|NCT04876716|Hormone Antagonists|hormone antagonists|mesh-ancestor
5933574|NCT04876716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5933575|NCT04876716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933576|NCT04876716|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5933577|NCT04876716|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5933578|NCT04876716|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5933579|NCT04876716|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5933580|NCT04876638|Minocycline|minocycline|mesh-list
5933581|NCT04876638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5933582|NCT04876638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5933583|NCT04876859|Anesthetics|anesthetics|mesh-list
5933584|NCT04876859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5933585|NCT04876859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933586|NCT04876807|Acalabrutinib|acalabrutinib|mesh-list
5933587|NCT04876807|Omeprazole|omeprazole|mesh-list
5933588|NCT04876807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5933589|NCT04876807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5933590|NCT04876807|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5933591|NCT04876807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5933592|NCT04876807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5933593|NCT04876807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5933594|NCT04876430|Meropenem|meropenem|mesh-list
5933595|NCT04876430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5933596|NCT04876430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5933597|NCT04876313|Paclitaxel|paclitaxel|mesh-list
5933598|NCT04876313|Nivolumab|nivolumab|mesh-list
5933599|NCT04876313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5933600|NCT04876313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5933601|NCT04876313|Tubulin Modulators|tubulin modulators|mesh-ancestor
5719581|NCT03218514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719582|NCT03218254|Methylphenidate|methylphenidate|mesh-list
5719583|NCT03218254|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5719584|NCT03218254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719585|NCT03218254|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5719586|NCT03218254|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5719587|NCT03218254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5933602|NCT04876313|Antimitotic Agents|antimitotic agents|mesh-ancestor
5933603|NCT04876313|Mitosis Modulators|mitosis modulators|mesh-ancestor
5933604|NCT04876313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5933605|NCT04876313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5933606|NCT04876313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5933607|NCT04876755|TEMPO|tempo|mesh-list
5933608|NCT04876755|TEMPOL-H|tempol-h|mesh-list
5933609|NCT04876755|Antioxidants|antioxidants|mesh-ancestor
5933610|NCT04876755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5933611|NCT04876755|Protective Agents|protective agents|mesh-ancestor
5933612|NCT04876755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933613|NCT04876755|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5933614|NCT04876573|Cyproheptadine|cyproheptadine|mesh-list
5933615|NCT04876573|Antipruritics|antipruritics|mesh-ancestor
5933616|NCT04876573|Dermatologic Agents|dermatologic agents|mesh-ancestor
5933617|NCT04876573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5933618|NCT04876573|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5933619|NCT04876573|Histamine Antagonists|histamine antagonists|mesh-ancestor
5933620|NCT04876573|Histamine Agents|histamine agents|mesh-ancestor
5933621|NCT04876573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5933622|NCT04876573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5933623|NCT04876573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933624|NCT04876573|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5933625|NCT04876573|Serotonin Agents|serotonin agents|mesh-ancestor
5933626|NCT04876573|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5933627|NCT04876521|Olanzapine|olanzapine|mesh-list
5933628|NCT04876521|Amisulpride|amisulpride|mesh-list
5933629|NCT04876521|Fluoxetine|fluoxetine|mesh-list
5933630|NCT04876521|Antiemetics|antiemetics|mesh-ancestor
5933631|NCT04876521|Autonomic Agents|autonomic agents|mesh-ancestor
5933632|NCT04876521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5933633|NCT04876521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933634|NCT04876521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5933635|NCT04876521|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5933636|NCT04876521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5933637|NCT04876521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5933638|NCT04876521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5933639|NCT04876521|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5933640|NCT04876521|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5933641|NCT04876521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5933642|NCT04876521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5933643|NCT04876521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5933644|NCT04876521|Serotonin Agents|serotonin agents|mesh-ancestor
5933645|NCT04876521|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5933646|NCT04876521|Antidepressive Agents|antidepressive agents|mesh-ancestor
5933647|NCT04876521|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5933648|NCT04876521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5933649|NCT04876521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5933650|NCT04876521|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5933651|NCT04876521|Dopamine Agents|dopamine agents|mesh-ancestor
5933652|NCT04876534|Methylprednisolone|methylprednisolone|mesh-list
5933653|NCT04876534|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5933654|NCT04876534|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5933655|NCT04876534|Prednisolone|prednisolone|mesh-list
5933656|NCT04876534|Prednisolone acetate|prednisolone acetate|mesh-list
5933657|NCT04876534|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5933658|NCT04876534|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5933659|NCT04876534|Prednisolone phosphate|prednisolone phosphate|mesh-list
5933660|NCT04876534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5933661|NCT04876534|Antiemetics|antiemetics|mesh-ancestor
5933662|NCT04876534|Autonomic Agents|autonomic agents|mesh-ancestor
5933663|NCT04876534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5933664|NCT04876534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933665|NCT04876534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5933666|NCT04876534|Glucocorticoids|glucocorticoids|mesh-ancestor
5933667|NCT04876534|Hormones|hormones|mesh-ancestor
5933668|NCT04876534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5933669|NCT04876534|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5933670|NCT04876534|Protective Agents|protective agents|mesh-ancestor
5933671|NCT04876534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5933672|NCT04876534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5933673|NCT04876261|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
5933674|NCT04876261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5933675|NCT04876261|Antioxidants|antioxidants|mesh-ancestor
5933676|NCT04876261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5933677|NCT04876261|Protective Agents|protective agents|mesh-ancestor
5933678|NCT04876261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933679|NCT04876261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5933680|NCT04876131|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5933681|NCT04876131|Gentamicins|gentamicins|mesh-list
5933682|NCT04876131|Cephalexin|cephalexin|mesh-list
5933683|NCT04876131|Penicillin G|penicillin g|mesh-list
5933684|NCT04876131|Penicillin G Benzathine|penicillin g benzathine|mesh-list
5933685|NCT04876131|Penicillin G Procaine|penicillin g procaine|mesh-list
5933686|NCT04876131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5933687|NCT04876131|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5933688|NCT04876131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5933689|NCT04876131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5933690|NCT04875819|Vaccines|vaccines|mesh-list
5933691|NCT04875819|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5933692|NCT04875819|Immunologic Factors|immunologic factors|mesh-ancestor
5933693|NCT04875819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933694|NCT04876066|Ketamine|ketamine|mesh-list
5933695|NCT04876066|Analgesics|analgesics|mesh-ancestor
5933696|NCT04876066|Sensory System Agents|sensory system agents|mesh-ancestor
5933697|NCT04876066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5933698|NCT04876066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933699|NCT04876066|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5933700|NCT04876066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5933701|NCT04876066|Anesthetics, General|anesthetics, general|mesh-ancestor
5933702|NCT04876066|Anesthetics|anesthetics|mesh-ancestor
5933703|NCT04876066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5933704|NCT04876066|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5933705|NCT04876066|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5933706|NCT04876066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5933707|NCT04876066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5933708|NCT04876079|Insulin|insulin|mesh-list
5933709|NCT04876079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5933710|NCT04876079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933711|NCT04876027|Dulaglutide|dulaglutide|mesh-list
5933712|NCT04876027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5933713|NCT04876027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965870|NCT04577417|Adrenergic Agents|adrenergic agents|mesh-ancestor
5965871|NCT04577417|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5965872|NCT04577326|Cyclophosphamide|cyclophosphamide|mesh-list
5965873|NCT04577326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5965874|NCT04577326|Immunologic Factors|immunologic factors|mesh-ancestor
5965875|NCT04577326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965876|NCT04577326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5965877|NCT04577326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5965878|NCT04577326|Alkylating Agents|alkylating agents|mesh-ancestor
5965879|NCT04577326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965880|NCT04577326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5965881|NCT04577326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5965882|NCT04577027|Travoprost|travoprost|mesh-list
5965883|NCT04577027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5965884|NCT04577040|Tadalafil|tadalafil|mesh-list
5965885|NCT04577040|Vasodilator Agents|vasodilator agents|mesh-ancestor
5965886|NCT04577040|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5965887|NCT04577040|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5965888|NCT04577040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5965889|NCT04577040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965890|NCT04577040|Urological Agents|urological agents|mesh-ancestor
5965891|NCT04576975|Dexmedetomidine|dexmedetomidine|mesh-list
5965892|NCT04576975|Ketamine|ketamine|mesh-list
5933714|NCT04875767|Coal Tar|coal tar|mesh-list
5933715|NCT04875767|Keratolytic Agents|keratolytic agents|mesh-ancestor
5933716|NCT04875767|Dermatologic Agents|dermatologic agents|mesh-ancestor
5933717|NCT04875728|Cefazolin|cefazolin|mesh-list
5933718|NCT04875728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5933719|NCT04875728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5933720|NCT04875702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
5933721|NCT04875702|Allopurinol|allopurinol|mesh-list
5933722|NCT04875702|Antimetabolites|antimetabolites|mesh-ancestor
5933723|NCT04875702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5933724|NCT04875702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5933725|NCT04875702|Gout Suppressants|gout suppressants|mesh-ancestor
5933726|NCT04875702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5933727|NCT04875702|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5933728|NCT04875702|Antioxidants|antioxidants|mesh-ancestor
5933729|NCT04875702|Protective Agents|protective agents|mesh-ancestor
5933730|NCT04875702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933731|NCT04875585|Pembrolizumab|pembrolizumab|mesh-list
5933732|NCT04875585|Lenvatinib|lenvatinib|mesh-list
5933733|NCT04875585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5933734|NCT04875585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5933735|NCT04875585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5933736|NCT04875585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5933737|NCT04875585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5933738|NCT04875858|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5933739|NCT04875858|Immunologic Factors|immunologic factors|mesh-ancestor
5933740|NCT04875858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933741|NCT04875611|Nivolumab|nivolumab|mesh-list
5933742|NCT04875611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5933743|NCT04875611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5933744|NCT04875611|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5933745|NCT04875611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5933746|NCT04875026|Fluorouracil|fluorouracil|mesh-list
5933747|NCT04875026|Antimetabolites|antimetabolites|mesh-ancestor
5933748|NCT04875026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5933749|NCT04875026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5933750|NCT04875026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5933751|NCT04875026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5933752|NCT04875026|Immunologic Factors|immunologic factors|mesh-ancestor
5933753|NCT04875026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933754|NCT04874844|Antibodies|antibodies|mesh-list
5933755|NCT04874844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5933756|NCT04874844|Immunologic Factors|immunologic factors|mesh-ancestor
5933757|NCT04874844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933758|NCT04875039|Dexamethasone|dexamethasone|mesh-list
5933759|NCT04875039|Dexamethasone acetate|dexamethasone acetate|mesh-list
5933760|NCT04875039|Dexmedetomidine|dexmedetomidine|mesh-list
5933761|NCT04875039|BB 1101|bb 1101|mesh-list
5933762|NCT04875039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5933763|NCT04875039|Antiemetics|antiemetics|mesh-ancestor
5933764|NCT04875039|Autonomic Agents|autonomic agents|mesh-ancestor
5933765|NCT04875039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5933766|NCT04875039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933767|NCT04875039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5933768|NCT04875039|Glucocorticoids|glucocorticoids|mesh-ancestor
5933769|NCT04875039|Hormones|hormones|mesh-ancestor
5933770|NCT04875039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5933771|NCT04875039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5933772|NCT04875039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5933773|NCT04875039|Protease Inhibitors|protease inhibitors|mesh-ancestor
5933774|NCT04875039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5933775|NCT04875039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5933776|NCT04875039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5933777|NCT04875039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5933778|NCT04875039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5933779|NCT04875039|Analgesics|analgesics|mesh-ancestor
5933780|NCT04875039|Sensory System Agents|sensory system agents|mesh-ancestor
5933781|NCT04875039|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5933782|NCT04875039|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5933783|NCT04875039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5933784|NCT04875039|Adrenergic Agents|adrenergic agents|mesh-ancestor
5933785|NCT04875039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5933786|NCT04874688|Provitamins|provitamins|mesh-list
5933787|NCT04874688|Beta Carotene|beta carotene|mesh-list
5933788|NCT04874688|Vitamins|vitamins|mesh-ancestor
5933789|NCT04874688|Micronutrients|micronutrients|mesh-ancestor
5933790|NCT04874688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933791|NCT04874610|Methylprednisolone|methylprednisolone|mesh-list
5933792|NCT04874610|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5933793|NCT04874610|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5933794|NCT04874610|Prednisolone|prednisolone|mesh-list
5933795|NCT04874610|Prednisolone acetate|prednisolone acetate|mesh-list
5933796|NCT04874610|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5933797|NCT04874610|Prednisolone phosphate|prednisolone phosphate|mesh-list
5933798|NCT04874610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5933799|NCT04874610|Antiemetics|antiemetics|mesh-ancestor
5933800|NCT04874610|Autonomic Agents|autonomic agents|mesh-ancestor
5933801|NCT04874610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5933802|NCT04874610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933803|NCT04874610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5933804|NCT04874610|Glucocorticoids|glucocorticoids|mesh-ancestor
5933805|NCT04874610|Hormones|hormones|mesh-ancestor
5933806|NCT04874610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5719588|NCT03218254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719589|NCT03218254|Dopamine Agents|dopamine agents|mesh-ancestor
5719590|NCT03218254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5719591|NCT03218280|Ascorbic Acid|ascorbic acid|mesh-list
5719592|NCT03218280|Vitamins|vitamins|mesh-ancestor
5719593|NCT03218280|Micronutrients|micronutrients|mesh-ancestor
5719594|NCT03218280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719595|NCT03218280|Antioxidants|antioxidants|mesh-ancestor
5719596|NCT03218280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719597|NCT03218280|Protective Agents|protective agents|mesh-ancestor
5719598|NCT03218059|Methotrexate|methotrexate|mesh-list
5719599|NCT03218059|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5719600|NCT03218059|Abortifacient Agents|abortifacient agents|mesh-ancestor
5719601|NCT03218059|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5719602|NCT03218059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719603|NCT03218059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5719604|NCT03218059|Antimetabolites|antimetabolites|mesh-ancestor
5719605|NCT03218059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719606|NCT03218059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5719607|NCT03218059|Dermatologic Agents|dermatologic agents|mesh-ancestor
5719608|NCT03218059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5719609|NCT03218059|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5933807|NCT04874610|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5933808|NCT04874610|Protective Agents|protective agents|mesh-ancestor
5933809|NCT04874610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5933810|NCT04874610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5933811|NCT04874675|Acetaminophen|acetaminophen|mesh-list
5933812|NCT04874675|Ibuprofen|ibuprofen|mesh-list
5933813|NCT04874675|Diclofenac|diclofenac|mesh-list
5933814|NCT04874675|Codeine|codeine|mesh-list
5933815|NCT04874675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5933816|NCT04874675|Analgesics|analgesics|mesh-ancestor
5933817|NCT04874675|Sensory System Agents|sensory system agents|mesh-ancestor
5933818|NCT04874675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5933819|NCT04874675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933820|NCT04874675|Antipyretics|antipyretics|mesh-ancestor
5933821|NCT04874675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5933822|NCT04874675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5933823|NCT04874675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5933824|NCT04874675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5933825|NCT04874675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5933826|NCT04874675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5933827|NCT04874675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5933828|NCT04874675|Narcotics|narcotics|mesh-ancestor
5933829|NCT04874675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5933830|NCT04874675|Antitussive Agents|antitussive agents|mesh-ancestor
5933831|NCT04874675|Respiratory System Agents|respiratory system agents|mesh-ancestor
5933832|NCT04874506|TEMPO|tempo|mesh-list
5933833|NCT04874506|TEMPOL-H|tempol-h|mesh-list
5933834|NCT04874506|Antioxidants|antioxidants|mesh-ancestor
5933835|NCT04874506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5933836|NCT04874506|Protective Agents|protective agents|mesh-ancestor
5933837|NCT04874506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933838|NCT04874506|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5933839|NCT04874246|Vasopressins|vasopressins|mesh-list
5719610|NCT03218059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5719611|NCT03218059|Immunologic Factors|immunologic factors|mesh-ancestor
5933840|NCT04874246|Arginine Vasopressin|arginine vasopressin|mesh-list
5933841|NCT04874246|Hemostatics|hemostatics|mesh-ancestor
5933842|NCT04874246|Coagulants|coagulants|mesh-ancestor
5933843|NCT04874246|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5933844|NCT04874246|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5933845|NCT04874246|Natriuretic Agents|natriuretic agents|mesh-ancestor
5933846|NCT04874246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933847|NCT04874428|Rivaroxaban|rivaroxaban|mesh-list
5933848|NCT04874428|Apixaban|apixaban|mesh-list
5933849|NCT04874428|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5933850|NCT04874428|Antithrombins|antithrombins|mesh-ancestor
5933851|NCT04874428|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5933852|NCT04874428|Protease Inhibitors|protease inhibitors|mesh-ancestor
5933853|NCT04874428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5933854|NCT04874428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5933855|NCT04874428|Anticoagulants|anticoagulants|mesh-ancestor
5965893|NCT04576975|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5965894|NCT04576975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5965895|NCT04576975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965896|NCT04576975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5965897|NCT04576975|Analgesics|analgesics|mesh-ancestor
5965898|NCT04576975|Sensory System Agents|sensory system agents|mesh-ancestor
5965899|NCT04576975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5965900|NCT04576975|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5965901|NCT04576975|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5965902|NCT04576975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5965903|NCT04576975|Adrenergic Agents|adrenergic agents|mesh-ancestor
5965904|NCT04576975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5965905|NCT04576975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965906|NCT04576975|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5965907|NCT04576975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5965908|NCT04576975|Anesthetics, General|anesthetics, general|mesh-ancestor
5965909|NCT04576975|Anesthetics|anesthetics|mesh-ancestor
5965910|NCT04576975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5965911|NCT04576975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5965912|NCT04577430|Dexmedetomidine|dexmedetomidine|mesh-list
5965913|NCT04577430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5965914|NCT04577430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5965915|NCT04577430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965916|NCT04577430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5965917|NCT04577430|Analgesics|analgesics|mesh-ancestor
5965918|NCT04577430|Sensory System Agents|sensory system agents|mesh-ancestor
5965919|NCT04577430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5965920|NCT04577430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5965921|NCT04577430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5965922|NCT04577430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5965923|NCT04577430|Adrenergic Agents|adrenergic agents|mesh-ancestor
5965924|NCT04577430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5965925|NCT04577430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965926|NCT04577014|Gemcitabine|gemcitabine|mesh-list
5965927|NCT04577014|Docetaxel|docetaxel|mesh-list
5965928|NCT04577014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5965929|NCT04577014|Antimetabolites|antimetabolites|mesh-ancestor
5965930|NCT04577014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965931|NCT04577014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5965932|NCT04577014|Antiviral Agents|antiviral agents|mesh-ancestor
5965933|NCT04577014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5965934|NCT04577014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5965935|NCT04577014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5965936|NCT04577014|Immunologic Factors|immunologic factors|mesh-ancestor
5965937|NCT04577014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965938|NCT04577014|Tubulin Modulators|tubulin modulators|mesh-ancestor
5965939|NCT04577014|Antimitotic Agents|antimitotic agents|mesh-ancestor
5965940|NCT04577014|Mitosis Modulators|mitosis modulators|mesh-ancestor
5965941|NCT04577404|Edaravone|edaravone|mesh-list
5965942|NCT04577404|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5965943|NCT04577404|Antioxidants|antioxidants|mesh-ancestor
5965944|NCT04577404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965945|NCT04577404|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5965946|NCT04577404|Protective Agents|protective agents|mesh-ancestor
5965947|NCT04577404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965948|NCT04577001|Letrozole|letrozole|mesh-list
5965949|NCT04577001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5965950|NCT04577001|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5965951|NCT04577001|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5965952|NCT04577001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5970888|NCT04531865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5933856|NCT04874025|Palbociclib|palbociclib|mesh-list
5933857|NCT04874025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5933858|NCT04874025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5933859|NCT04874025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5933860|NCT04874025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5933861|NCT04873895|Hydroxychloroquine|hydroxychloroquine|mesh-list
5933862|NCT04873895|Axitinib|axitinib|mesh-list
5933863|NCT04873895|Antimalarials|antimalarials|mesh-ancestor
5933864|NCT04873895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5933865|NCT04873895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5933866|NCT04873895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5933867|NCT04873895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5933868|NCT04873895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5933869|NCT04873895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5933870|NCT04873895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5933871|NCT04873895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5933872|NCT04873531|Neostigmine|neostigmine|mesh-list
5933873|NCT04873531|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5933874|NCT04873531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5933875|NCT04873531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5933876|NCT04873531|Cholinergic Agents|cholinergic agents|mesh-ancestor
5933877|NCT04873531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5933878|NCT04873531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933879|NCT04873531|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5933880|NCT04873531|Autonomic Agents|autonomic agents|mesh-ancestor
5933881|NCT04873531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5933882|NCT04874597|Ocrelizumab|ocrelizumab|mesh-list
5933883|NCT04874597|Immunologic Factors|immunologic factors|mesh-ancestor
5933884|NCT04874597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933885|NCT04873440|Manganese|manganese|mesh-list
5933886|NCT04873440|Trace Elements|trace elements|mesh-ancestor
5933887|NCT04873440|Micronutrients|micronutrients|mesh-ancestor
5933888|NCT04873440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933889|NCT04873570|Moxifloxacin|moxifloxacin|mesh-list
5933890|NCT04873570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5933891|NCT04873570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5933892|NCT04873570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5933893|NCT04873570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5933894|NCT04873570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5933895|NCT04873570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5933896|NCT04873570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5933897|NCT04873557|Copper|copper|mesh-list
5933898|NCT04873557|Trace Elements|trace elements|mesh-ancestor
5933899|NCT04873557|Micronutrients|micronutrients|mesh-ancestor
5933900|NCT04873557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933901|NCT04873479|Ketamine|ketamine|mesh-list
5933902|NCT04873479|Esketamine|esketamine|mesh-list
5933903|NCT04873479|Analgesics|analgesics|mesh-ancestor
5933904|NCT04873479|Sensory System Agents|sensory system agents|mesh-ancestor
5933905|NCT04873479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5933906|NCT04873479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933907|NCT04873479|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5933908|NCT04873479|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5933909|NCT04873479|Anesthetics, General|anesthetics, general|mesh-ancestor
5933910|NCT04873479|Anesthetics|anesthetics|mesh-ancestor
5933911|NCT04873479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5933912|NCT04873479|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5933913|NCT04873479|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5933914|NCT04873479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5933915|NCT04873479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5933916|NCT04873479|Antidepressive Agents|antidepressive agents|mesh-ancestor
5933917|NCT04873479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5933918|NCT04873349|Oleuropein|oleuropein|mesh-list
5933919|NCT04873349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5933920|NCT04873349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5933921|NCT04873349|Vasodilator Agents|vasodilator agents|mesh-ancestor
5933922|NCT04873193|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5933923|NCT04873193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5933924|NCT04873284|Dexamethasone|dexamethasone|mesh-list
5933925|NCT04873284|Aprepitant|aprepitant|mesh-list
5933926|NCT04873284|Fosaprepitant|fosaprepitant|mesh-list
5933927|NCT04873284|Granisetron|granisetron|mesh-list
5933928|NCT04873284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5933929|NCT04873284|Antiemetics|antiemetics|mesh-ancestor
5933930|NCT04873284|Autonomic Agents|autonomic agents|mesh-ancestor
5933931|NCT04873284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5933932|NCT04873284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933933|NCT04873284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5933934|NCT04873284|Glucocorticoids|glucocorticoids|mesh-ancestor
5933935|NCT04873284|Hormones|hormones|mesh-ancestor
5933936|NCT04873284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5933937|NCT04873284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5933938|NCT04873284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5933939|NCT04873284|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5933940|NCT04873284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5933941|NCT04873284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5933942|NCT04873284|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5933943|NCT04873284|Serotonin Agents|serotonin agents|mesh-ancestor
5933944|NCT04873102|Danazol|danazol|mesh-list
5933945|NCT04873102|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5933946|NCT04873102|Hormone Antagonists|hormone antagonists|mesh-ancestor
5933947|NCT04873102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5933948|NCT04873102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933949|NCT04873011|Quinine|quinine|mesh-list
5933950|NCT04873011|Antimalarials|antimalarials|mesh-ancestor
5933951|NCT04873011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5933952|NCT04873011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5933953|NCT04873011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5933954|NCT04873011|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5933955|NCT04873011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933956|NCT04873011|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5933957|NCT04873011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5933958|NCT04873011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5933959|NCT04873011|Analgesics|analgesics|mesh-ancestor
5933960|NCT04873011|Sensory System Agents|sensory system agents|mesh-ancestor
5933961|NCT04872985|Paclitaxel|paclitaxel|mesh-list
5933962|NCT04872985|Docetaxel|docetaxel|mesh-list
5933963|NCT04872985|Cyclophosphamide|cyclophosphamide|mesh-list
5933964|NCT04872985|Doxorubicin|doxorubicin|mesh-list
5933965|NCT04872985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5933966|NCT04872985|Epirubicin|epirubicin|mesh-list
5933967|NCT04872985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5933968|NCT04872985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5933969|NCT04872985|Tubulin Modulators|tubulin modulators|mesh-ancestor
5933970|NCT04872985|Antimitotic Agents|antimitotic agents|mesh-ancestor
5933971|NCT04872985|Mitosis Modulators|mitosis modulators|mesh-ancestor
5933972|NCT04872985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5933973|NCT04872985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5933974|NCT04872985|Immunologic Factors|immunologic factors|mesh-ancestor
5933975|NCT04872985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933976|NCT04872985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5933977|NCT04872985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5933978|NCT04872985|Alkylating Agents|alkylating agents|mesh-ancestor
5933979|NCT04872985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5933980|NCT04872985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5933981|NCT04872985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5933982|NCT04872985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5933983|NCT04872985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5933984|NCT04873063|Beclomethasone|beclomethasone|mesh-list
5933985|NCT04873063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5933986|NCT04873063|Glucocorticoids|glucocorticoids|mesh-ancestor
5933987|NCT04873063|Hormones|hormones|mesh-ancestor
5933988|NCT04873063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5933989|NCT04873063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933990|NCT04873063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5933991|NCT04873063|Respiratory System Agents|respiratory system agents|mesh-ancestor
5933992|NCT04872907|Fluorides|fluorides|mesh-list
5933993|NCT04872907|Fluorides, Topical|fluorides, topical|mesh-list
5933994|NCT04872907|Cariostatic Agents|cariostatic agents|mesh-ancestor
5933995|NCT04872907|Protective Agents|protective agents|mesh-ancestor
5933996|NCT04872907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5933997|NCT04872608|Letrozole|letrozole|mesh-list
5933998|NCT04872608|Palbociclib|palbociclib|mesh-list
5933999|NCT04872608|Onapristone|onapristone|mesh-list
5934000|NCT04872608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5934001|NCT04872608|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5934002|NCT04872608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5934003|NCT04872608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5934004|NCT04872608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934005|NCT04872608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5934006|NCT04872608|Hormone Antagonists|hormone antagonists|mesh-ancestor
5934007|NCT04872608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5934008|NCT04872608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934009|NCT04872608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5934010|NCT04872608|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5934011|NCT04872608|Fertility Agents|fertility agents|mesh-ancestor
5934012|NCT04872608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5934013|NCT04872881|Fentanyl|fentanyl|mesh-list
5934014|NCT04872881|Propofol|propofol|mesh-list
5934015|NCT04872881|Rocuronium|rocuronium|mesh-list
5934016|NCT04872881|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5934017|NCT04872881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5934018|NCT04872881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934019|NCT04872881|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5934020|NCT04872881|Anesthetics, General|anesthetics, general|mesh-ancestor
5934021|NCT04872881|Anesthetics|anesthetics|mesh-ancestor
5934022|NCT04872881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5934023|NCT04872881|Narcotics|narcotics|mesh-ancestor
5934024|NCT04872881|Analgesics|analgesics|mesh-ancestor
5934025|NCT04872881|Sensory System Agents|sensory system agents|mesh-ancestor
5934026|NCT04872881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5934027|NCT04872881|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5934028|NCT04872881|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5934029|NCT04872881|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5934030|NCT04872881|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5934031|NCT04872634|Cetuximab|cetuximab|mesh-list
5934032|NCT04872634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5934033|NCT04872634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5934034|NCT04872270|Caffeine|caffeine|mesh-list
5934035|NCT04872270|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5934036|NCT04872270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934037|NCT04872270|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5934038|NCT04872270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5934039|NCT04872270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934040|NCT04872270|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5934041|NCT04872270|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5934042|NCT04872270|Purinergic Agents|purinergic agents|mesh-ancestor
5934043|NCT04872270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5934044|NCT04872218|Abatacept|abatacept|mesh-list
5934045|NCT04872218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5934046|NCT04872218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934047|NCT04872218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5934048|NCT04872218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5934049|NCT04872218|Immunologic Factors|immunologic factors|mesh-ancestor
5934050|NCT04872218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934051|NCT04872218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5934052|NCT04872400|Vancomycin|vancomycin|mesh-list
5934053|NCT04872400|Tobramycin|tobramycin|mesh-list
5934054|NCT04872400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5934055|NCT04872400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5934056|NCT04872192|Anesthetics|anesthetics|mesh-list
5934057|NCT04872192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5934058|NCT04872192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934059|NCT04872231|Voriconazole|voriconazole|mesh-list
5934060|NCT04872231|Antifungal Agents|antifungal agents|mesh-ancestor
5934061|NCT04872231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5934062|NCT04872231|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5934063|NCT04872231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5934064|NCT04872231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5934065|NCT04872231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934066|NCT04872231|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5934067|NCT04872231|Hormone Antagonists|hormone antagonists|mesh-ancestor
5934068|NCT04872231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5934069|NCT04872231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934070|NCT04872231|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5965953|NCT04577001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965954|NCT04577001|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5965955|NCT04577001|Hormone Antagonists|hormone antagonists|mesh-ancestor
5965956|NCT04577001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5965957|NCT04577001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970889|NCT04531865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5970890|NCT04531865|Immunologic Factors|immunologic factors|mesh-ancestor
5970891|NCT04531865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970892|NCT04531865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5970893|NCT04531865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5934071|NCT04872283|Aspirin|aspirin|mesh-list
5934072|NCT04872283|Acetaminophen|acetaminophen|mesh-list
5934073|NCT04872283|Ketorolac|ketorolac|mesh-list
5934074|NCT04872283|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
5934075|NCT04872283|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
5934076|NCT04872283|Oxycodone|oxycodone|mesh-list
5934077|NCT04872283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5934078|NCT04872283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5934079|NCT04872283|Analgesics|analgesics|mesh-ancestor
5934080|NCT04872283|Sensory System Agents|sensory system agents|mesh-ancestor
5934081|NCT04872283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5934082|NCT04872283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934083|NCT04872283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5934084|NCT04872283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5934085|NCT04872283|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5934086|NCT04872283|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5934087|NCT04872283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934088|NCT04872283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5934089|NCT04872283|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5934090|NCT04872283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5934091|NCT04872283|Antipyretics|antipyretics|mesh-ancestor
5934092|NCT04872283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5934093|NCT04872283|Narcotics|narcotics|mesh-ancestor
5934094|NCT04872283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5934095|NCT04872257|Vitamin D|vitamin d|mesh-list
5934096|NCT04872257|Vitamins|vitamins|mesh-ancestor
5934097|NCT04872257|Micronutrients|micronutrients|mesh-ancestor
5934098|NCT04872257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934099|NCT04872257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5934100|NCT04872244|Levonorgestrel|levonorgestrel|mesh-list
5934101|NCT04872244|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5934102|NCT04872244|Contraceptive Agents|contraceptive agents|mesh-ancestor
5934103|NCT04872244|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5934104|NCT04872244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934105|NCT04872244|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5934106|NCT04872244|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5934107|NCT04872244|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5934108|NCT04872322|Ropivacaine|ropivacaine|mesh-list
5934109|NCT04872322|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5934110|NCT04872322|Anesthetics, Local|anesthetics, local|mesh-ancestor
5934111|NCT04872322|Anesthetics|anesthetics|mesh-ancestor
5934112|NCT04872322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5934113|NCT04872322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934114|NCT04872322|Sensory System Agents|sensory system agents|mesh-ancestor
5934115|NCT04872322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5934116|NCT04871958|Insulin|insulin|mesh-list
5934117|NCT04871958|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5934118|NCT04871958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934119|NCT04871828|Leukotriene Antagonists|leukotriene antagonists|mesh-list
5934120|NCT04871828|Hormone Antagonists|hormone antagonists|mesh-ancestor
5934121|NCT04871828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5934122|NCT04871828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934123|NCT04871828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5934124|NCT04871828|Respiratory System Agents|respiratory system agents|mesh-ancestor
5934125|NCT04871724|Fluconazole|fluconazole|mesh-list
5934126|NCT04871724|Antifungal Agents|antifungal agents|mesh-ancestor
5934127|NCT04871724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5934128|NCT04871724|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5934129|NCT04871724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5934130|NCT04871724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5934131|NCT04871724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934132|NCT04871724|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5934133|NCT04871724|Hormone Antagonists|hormone antagonists|mesh-ancestor
5934134|NCT04871724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5934135|NCT04871724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934136|NCT04871724|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5934137|NCT04871724|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5934138|NCT04871802|Taxifolin|taxifolin|mesh-list
5934139|NCT04871802|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5934140|NCT04871802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5934141|NCT04871802|Analgesics|analgesics|mesh-ancestor
5934142|NCT04871802|Sensory System Agents|sensory system agents|mesh-ancestor
5934143|NCT04871802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5965958|NCT04576546|Inositol|inositol|mesh-list
5934144|NCT04871802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934145|NCT04871802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5934146|NCT04871802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5934147|NCT04871633|Azithromycin|azithromycin|mesh-list
5934148|NCT04871633|Remdesivir|remdesivir|mesh-list
5934149|NCT04871633|Dexamethasone|dexamethasone|mesh-list
5934150|NCT04871633|Prednisolone|prednisolone|mesh-list
5934151|NCT04871633|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5934152|NCT04871633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5934153|NCT04871633|Antiemetics|antiemetics|mesh-ancestor
5934154|NCT04871633|Autonomic Agents|autonomic agents|mesh-ancestor
5934155|NCT04871633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5934156|NCT04871633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934157|NCT04871633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5934158|NCT04871633|Glucocorticoids|glucocorticoids|mesh-ancestor
5934159|NCT04871633|Hormones|hormones|mesh-ancestor
5934160|NCT04871633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5934161|NCT04871633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5934162|NCT04871633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5934163|NCT04871633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934164|NCT04871633|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5934165|NCT04871633|Protective Agents|protective agents|mesh-ancestor
5934166|NCT04871633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5934167|NCT04871633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5934168|NCT04871633|Antimetabolites|antimetabolites|mesh-ancestor
5934169|NCT04871633|Antiviral Agents|antiviral agents|mesh-ancestor
5934170|NCT04871750|Caseins|caseins|mesh-list
5934171|NCT04871750|Chelating Agents|chelating agents|mesh-ancestor
5934172|NCT04871750|Sequestering Agents|sequestering agents|mesh-ancestor
5934173|NCT04871750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934174|NCT04871932|Vaccines|vaccines|mesh-list
5934175|NCT04871932|Immunologic Factors|immunologic factors|mesh-ancestor
5934176|NCT04871932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934177|NCT04871594|Nivolumab|nivolumab|mesh-list
5934178|NCT04871594|Ipilimumab|ipilimumab|mesh-list
5934179|NCT04871594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5934180|NCT04871594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5934181|NCT04871594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5934182|NCT04871594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934183|NCT04871425|Fentanyl|fentanyl|mesh-list
5934184|NCT04871425|Ketamine|ketamine|mesh-list
5934185|NCT04871425|Analgesics|analgesics|mesh-ancestor
5934186|NCT04871425|Sensory System Agents|sensory system agents|mesh-ancestor
5934187|NCT04871425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5934188|NCT04871425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934189|NCT04871425|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5934190|NCT04871425|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5934191|NCT04871425|Anesthetics, General|anesthetics, general|mesh-ancestor
5719612|NCT03218059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5719613|NCT03218059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5719614|NCT03218085|Tenofovir|tenofovir|mesh-list
5719615|NCT03218085|Emtricitabine|emtricitabine|mesh-list
5719616|NCT03218085|Antiviral Agents|antiviral agents|mesh-ancestor
5719617|NCT03218085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5719618|NCT03218085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5719619|NCT03218085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5719620|NCT03218085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5934192|NCT04871425|Anesthetics|anesthetics|mesh-ancestor
5934193|NCT04871425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5965959|NCT04576546|Vitamin B Complex|vitamin b complex|mesh-ancestor
5719621|NCT03218085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719622|NCT03218085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5719623|NCT03218085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5719624|NCT03217916|polysaccharide-K|polysaccharide-k|mesh-list
5719625|NCT03217916|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5719626|NCT03217916|Immunologic Factors|immunologic factors|mesh-ancestor
5934194|NCT04871425|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5934195|NCT04871425|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5934196|NCT04871425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5934197|NCT04871425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934198|NCT04871425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5934199|NCT04871425|Narcotics|narcotics|mesh-ancestor
5934200|NCT04871425|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5934201|NCT04871321|Gemcitabine|gemcitabine|mesh-list
5934202|NCT04871321|Paclitaxel|paclitaxel|mesh-list
5934203|NCT04871321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5934204|NCT04871321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5934205|NCT04871321|Tubulin Modulators|tubulin modulators|mesh-ancestor
5934206|NCT04871321|Antimitotic Agents|antimitotic agents|mesh-ancestor
5934207|NCT04871321|Mitosis Modulators|mitosis modulators|mesh-ancestor
5934208|NCT04871321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934209|NCT04871321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5934210|NCT04871321|Antimetabolites|antimetabolites|mesh-ancestor
5934211|NCT04871321|Antiviral Agents|antiviral agents|mesh-ancestor
5934212|NCT04871321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5934213|NCT04871321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5934214|NCT04871321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5934215|NCT04871321|Immunologic Factors|immunologic factors|mesh-ancestor
5934216|NCT04871321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934217|NCT04871191|Rituximab|rituximab|mesh-list
5934218|NCT04871191|Abatacept|abatacept|mesh-list
5934219|NCT04871191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5934220|NCT04871191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5934221|NCT04871191|Immunologic Factors|immunologic factors|mesh-ancestor
5934222|NCT04871191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934223|NCT04871191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5934224|NCT04871191|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5934225|NCT04871191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934226|NCT04871191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5934227|NCT04871412|Vitamin D|vitamin d|mesh-list
5934228|NCT04871412|Ergocalciferols|ergocalciferols|mesh-list
5934229|NCT04871412|Vitamins|vitamins|mesh-list
5934230|NCT04871412|Curcumin|curcumin|mesh-list
5934231|NCT04871412|Micronutrients|micronutrients|mesh-ancestor
5934232|NCT04871412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934233|NCT04871412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5934234|NCT04871412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5719627|NCT03217916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719628|NCT03217916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5719629|NCT03217916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5719630|NCT03217916|Antiviral Agents|antiviral agents|mesh-ancestor
5719631|NCT03217916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5719632|NCT03217916|Interferon Inducers|interferon inducers|mesh-ancestor
5719633|NCT03217916|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5719634|NCT03217916|Protective Agents|protective agents|mesh-ancestor
5719635|NCT03218124|Remifentanil|remifentanil|mesh-list
5719636|NCT03218124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5719637|NCT03218124|Narcotics|narcotics|mesh-ancestor
5719638|NCT03218124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5719639|NCT03218124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719640|NCT03218124|Analgesics|analgesics|mesh-ancestor
5719641|NCT03218124|Sensory System Agents|sensory system agents|mesh-ancestor
5719642|NCT03218124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5719643|NCT03217838|Azacitidine|azacitidine|mesh-list
5719644|NCT03217838|Venetoclax|venetoclax|mesh-list
5719645|NCT03217838|Pyrazole|pyrazole|mesh-list
5719646|NCT03217838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5719647|NCT03217838|Antimetabolites|antimetabolites|mesh-ancestor
5719648|NCT03217838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719649|NCT03217838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5934235|NCT04871412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5934236|NCT04871412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5934237|NCT04871412|Analgesics|analgesics|mesh-ancestor
5934238|NCT04871412|Sensory System Agents|sensory system agents|mesh-ancestor
5719650|NCT03217838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5934239|NCT04871412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5934240|NCT04871412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5934241|NCT04871412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5934242|NCT04871412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5934243|NCT04871412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5934244|NCT04871412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934245|NCT04871308|Dexmedetomidine|dexmedetomidine|mesh-list
5934246|NCT04871308|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5934247|NCT04871308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5934248|NCT04871308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934249|NCT04871308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5934250|NCT04871308|Analgesics|analgesics|mesh-ancestor
5934251|NCT04871308|Sensory System Agents|sensory system agents|mesh-ancestor
5934252|NCT04871308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5934253|NCT04871308|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5934254|NCT04871308|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5934255|NCT04871308|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5934256|NCT04871308|Adrenergic Agents|adrenergic agents|mesh-ancestor
5934257|NCT04871308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5934258|NCT04871308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934259|NCT04871204|Octreotide|octreotide|mesh-list
5934260|NCT04871204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5934261|NCT04871204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5934262|NCT04871204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5934263|NCT04871269|Dronabinol|dronabinol|mesh-list
5934264|NCT04871269|Hallucinogens|hallucinogens|mesh-ancestor
5934265|NCT04871269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934266|NCT04871269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5934267|NCT04871269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5934268|NCT04871269|Analgesics|analgesics|mesh-ancestor
5934269|NCT04871269|Sensory System Agents|sensory system agents|mesh-ancestor
5934270|NCT04871269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5934271|NCT04871269|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5934272|NCT04871269|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5934273|NCT04871269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5934274|NCT04871269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934275|NCT04871269|Hormones|hormones|mesh-ancestor
5934276|NCT04871269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5934277|NCT04871061|Fentanyl|fentanyl|mesh-list
5934278|NCT04871061|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5934279|NCT04871061|Narcotics|narcotics|mesh-ancestor
5934280|NCT04871061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5934281|NCT04871061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934282|NCT04871061|Analgesics|analgesics|mesh-ancestor
5934283|NCT04871061|Sensory System Agents|sensory system agents|mesh-ancestor
5934284|NCT04871061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5934285|NCT04871061|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5934286|NCT04871061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5934287|NCT04871061|Anesthetics, General|anesthetics, general|mesh-ancestor
5934288|NCT04871061|Anesthetics|anesthetics|mesh-ancestor
5934289|NCT04870957|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5934290|NCT04870957|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5934291|NCT04870957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5934292|NCT04870957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5934293|NCT04870957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934294|NCT04870957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5934295|NCT04870957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934296|NCT04870957|Analgesics|analgesics|mesh-ancestor
5934297|NCT04870957|Sensory System Agents|sensory system agents|mesh-ancestor
5934298|NCT04870957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5934299|NCT04870957|Antidepressive Agents|antidepressive agents|mesh-ancestor
5934300|NCT04870957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5934301|NCT04870957|Dopamine Agents|dopamine agents|mesh-ancestor
5934302|NCT04871152|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5719651|NCT03217825|Losartan|losartan|mesh-list
5719652|NCT03217825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5719653|NCT03217825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5719654|NCT03217825|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5719655|NCT03217825|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5719656|NCT03217825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719657|NCT03217669|Sirolimus|sirolimus|mesh-list
5719658|NCT03217669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5934303|NCT04871152|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5934304|NCT04871152|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5934305|NCT04871152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5934306|NCT04871152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934307|NCT04871152|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5934308|NCT04871152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5934309|NCT04871152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934310|NCT04871152|Cholinergic Agents|cholinergic agents|mesh-ancestor
5934311|NCT04871152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5934312|NCT04870372|Selegiline|selegiline|mesh-list
5934313|NCT04870372|Antidepressive Agents|antidepressive agents|mesh-ancestor
5934314|NCT04870372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5934315|NCT04870372|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5934316|NCT04870372|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5934317|NCT04870372|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
5934318|NCT04870372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5934319|NCT04870372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934320|NCT04870372|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5934321|NCT04870372|Protective Agents|protective agents|mesh-ancestor
5934322|NCT04870372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934323|NCT04870671|Tenofovir|tenofovir|mesh-list
5934324|NCT04870671|Antiviral Agents|antiviral agents|mesh-ancestor
5934325|NCT04870671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5934326|NCT04870671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5934327|NCT04870671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5934328|NCT04870671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5934329|NCT04870671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934330|NCT04870671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5934331|NCT04870671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5934332|NCT04870866|Niacinamide|niacinamide|mesh-list
5934333|NCT04870866|Niacin|niacin|mesh-list
5934334|NCT04870866|Nicotinic Acids|nicotinic acids|mesh-list
5934335|NCT04870866|Vitamin B Complex|vitamin b complex|mesh-ancestor
5934336|NCT04870866|Vitamins|vitamins|mesh-ancestor
5934337|NCT04870866|Micronutrients|micronutrients|mesh-ancestor
5934338|NCT04870866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934339|NCT04870866|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5934340|NCT04870866|Antimetabolites|antimetabolites|mesh-ancestor
5934341|NCT04870866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934342|NCT04870866|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5934343|NCT04870866|Vasodilator Agents|vasodilator agents|mesh-ancestor
5934344|NCT04870489|Isotretinoin|isotretinoin|mesh-list
5934345|NCT04870489|Dermatologic Agents|dermatologic agents|mesh-ancestor
5934346|NCT04870541|Nefopam|nefopam|mesh-list
5934347|NCT04870541|Ondansetron|ondansetron|mesh-list
5934348|NCT04870541|Antiemetics|antiemetics|mesh-ancestor
5934349|NCT04870541|Autonomic Agents|autonomic agents|mesh-ancestor
5934350|NCT04870541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5934351|NCT04870541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934352|NCT04870541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5934353|NCT04870541|Antipruritics|antipruritics|mesh-ancestor
5934354|NCT04870541|Dermatologic Agents|dermatologic agents|mesh-ancestor
5934355|NCT04870541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5934356|NCT04870541|Serotonin Agents|serotonin agents|mesh-ancestor
5934357|NCT04870541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5934358|NCT04870541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934359|NCT04870541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5934360|NCT04870541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5934361|NCT04870541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5934362|NCT04870541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5934363|NCT04870541|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5934364|NCT04870541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5934365|NCT04870541|Analgesics|analgesics|mesh-ancestor
5934366|NCT04870541|Sensory System Agents|sensory system agents|mesh-ancestor
5965960|NCT04576546|Vitamins|vitamins|mesh-ancestor
5965961|NCT04576546|Micronutrients|micronutrients|mesh-ancestor
5965962|NCT04576546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965963|NCT04576364|Magnesium Sulfate|magnesium sulfate|mesh-list
5965964|NCT04576364|Analgesics|analgesics|mesh-ancestor
5965965|NCT04576364|Sensory System Agents|sensory system agents|mesh-ancestor
5965966|NCT04576364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5965967|NCT04576364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965968|NCT04576364|Anesthetics|anesthetics|mesh-ancestor
5965969|NCT04576364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5965970|NCT04576364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5965971|NCT04576364|Anticonvulsants|anticonvulsants|mesh-ancestor
5965972|NCT04576364|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5934367|NCT04870502|Clomiphene|clomiphene|mesh-list
5934368|NCT04870502|Enclomiphene|enclomiphene|mesh-list
5934369|NCT04870502|Zuclomiphene|zuclomiphene|mesh-list
5934370|NCT04870502|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5934371|NCT04870502|Hormone Antagonists|hormone antagonists|mesh-ancestor
5934372|NCT04870502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5934373|NCT04870502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934374|NCT04870502|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5934375|NCT04870502|Fertility Agents|fertility agents|mesh-ancestor
5934376|NCT04870502|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5934377|NCT04870502|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5934378|NCT04870502|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5934379|NCT04870359|Prednisolone|prednisolone|mesh-list
5934380|NCT04870359|Immunosuppressive Agents|immunosuppressive agents|mesh-list
5934381|NCT04870359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5934382|NCT04870359|Glucocorticoids|glucocorticoids|mesh-ancestor
5934383|NCT04870359|Hormones|hormones|mesh-ancestor
5934384|NCT04870359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5934385|NCT04870359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934386|NCT04870359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5934387|NCT04870359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5934388|NCT04870359|Immunologic Factors|immunologic factors|mesh-ancestor
5934389|NCT04870333|Niclosamide|niclosamide|mesh-list
5934390|NCT04870333|Anticestodal Agents|anticestodal agents|mesh-ancestor
5934391|NCT04870333|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5934392|NCT04870333|Anthelmintics|anthelmintics|mesh-ancestor
5934393|NCT04870333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5934394|NCT04870333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5934395|NCT04870333|Antinematodal Agents|antinematodal agents|mesh-ancestor
5934396|NCT04870203|Adalimumab|adalimumab|mesh-list
5934397|NCT04870203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5934398|NCT04870203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5934399|NCT04870190|Osimertinib|osimertinib|mesh-list
5934400|NCT04870190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5934401|NCT04870190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5934402|NCT04870190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5934403|NCT04870190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934404|NCT04870021|Vaccines|vaccines|mesh-list
5934405|NCT04870021|Immunologic Factors|immunologic factors|mesh-ancestor
5934406|NCT04870021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934407|NCT04870060|Curcumin|curcumin|mesh-list
5934408|NCT04870060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5934409|NCT04870060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5934410|NCT04870060|Analgesics|analgesics|mesh-ancestor
5934411|NCT04870060|Sensory System Agents|sensory system agents|mesh-ancestor
5934412|NCT04870060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5934413|NCT04870060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934414|NCT04870060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5934415|NCT04870060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5934416|NCT04870060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5934417|NCT04870060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5934418|NCT04870060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934419|NCT04870073|Mannitol|mannitol|mesh-list
5934420|NCT04870073|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5934421|NCT04870073|Diuretics|diuretics|mesh-ancestor
5934422|NCT04870073|Natriuretic Agents|natriuretic agents|mesh-ancestor
5934423|NCT04870073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934424|NCT04869436|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5934425|NCT04869436|Immunologic Factors|immunologic factors|mesh-ancestor
5934426|NCT04869436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934427|NCT04869592|Vaccines|vaccines|mesh-list
5934428|NCT04869592|Immunologic Factors|immunologic factors|mesh-ancestor
5934429|NCT04869592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934430|NCT04869475|Arsenic Trioxide|arsenic trioxide|mesh-list
5934431|NCT04869475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5934432|NCT04869501|Atezolizumab|atezolizumab|mesh-list
5934433|NCT04869501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5934434|NCT04869579|Selenium|selenium|mesh-list
5934435|NCT04869579|Selenious Acid|selenious acid|mesh-list
5934436|NCT04869579|Antioxidants|antioxidants|mesh-ancestor
5934437|NCT04869579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934438|NCT04869579|Protective Agents|protective agents|mesh-ancestor
5934439|NCT04869579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934440|NCT04869579|Trace Elements|trace elements|mesh-ancestor
5934441|NCT04869579|Micronutrients|micronutrients|mesh-ancestor
5934442|NCT04869709|Betamethasone|betamethasone|mesh-list
5934443|NCT04869709|Betamethasone Valerate|betamethasone valerate|mesh-list
5934444|NCT04869709|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5934445|NCT04869709|Betamethasone benzoate|betamethasone benzoate|mesh-list
5934446|NCT04869709|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
5934447|NCT04869709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5934448|NCT04869709|Glucocorticoids|glucocorticoids|mesh-ancestor
5934449|NCT04869709|Hormones|hormones|mesh-ancestor
5934450|NCT04869709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5934451|NCT04869709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934452|NCT04869709|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5934453|NCT04869709|Respiratory System Agents|respiratory system agents|mesh-ancestor
5934454|NCT04869306|Hyaluronic Acid|hyaluronic acid|mesh-list
5934455|NCT04869306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5934456|NCT04869306|Immunologic Factors|immunologic factors|mesh-ancestor
5934457|NCT04869306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934458|NCT04869306|Viscosupplements|viscosupplements|mesh-ancestor
5934459|NCT04869306|Protective Agents|protective agents|mesh-ancestor
5934460|NCT04869137|Pembrolizumab|pembrolizumab|mesh-list
5934461|NCT04869137|Lenvatinib|lenvatinib|mesh-list
5934462|NCT04869137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5934463|NCT04869137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5934464|NCT04869137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5934465|NCT04869137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5934466|NCT04869137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934467|NCT04869176|Caffeine|caffeine|mesh-list
5934468|NCT04869176|Caffeine citrate|caffeine citrate|mesh-list
5934469|NCT04869176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934470|NCT04869176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5934471|NCT04869176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934472|NCT04869176|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5934473|NCT04869176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5934474|NCT04869176|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5934475|NCT04869176|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5934476|NCT04869176|Purinergic Agents|purinergic agents|mesh-ancestor
5934477|NCT04869176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5934478|NCT04869046|Acetaminophen|acetaminophen|mesh-list
5934479|NCT04869046|Ibuprofen|ibuprofen|mesh-list
5934480|NCT04869046|Analgesics|analgesics|mesh-list
5934481|NCT04869046|Levobupivacaine|levobupivacaine|mesh-list
5934482|NCT04869046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5934483|NCT04869046|Sensory System Agents|sensory system agents|mesh-ancestor
5934484|NCT04869046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5934485|NCT04869046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934486|NCT04869046|Antipyretics|antipyretics|mesh-ancestor
5934487|NCT04869046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5934488|NCT04869046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5934489|NCT04869046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5934490|NCT04869046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5934491|NCT04869046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5934492|NCT04869046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934493|NCT04869046|Anesthetics, Local|anesthetics, local|mesh-ancestor
5934494|NCT04869046|Anesthetics|anesthetics|mesh-ancestor
5934495|NCT04869046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5934496|NCT04868903|Vitamin D|vitamin d|mesh-list
5934497|NCT04868903|Cholecalciferol|cholecalciferol|mesh-list
5934498|NCT04868903|Vitamins|vitamins|mesh-ancestor
5934499|NCT04868903|Micronutrients|micronutrients|mesh-ancestor
5934500|NCT04868903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934501|NCT04868903|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5934502|NCT04868903|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5934503|NCT04868786|Mycophenolic Acid|mycophenolic acid|mesh-list
5934504|NCT04868786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5934505|NCT04868786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5934506|NCT04868786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5934507|NCT04868786|Antitubercular Agents|antitubercular agents|mesh-ancestor
5934508|NCT04868786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5934509|NCT04868786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5934510|NCT04868786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5934511|NCT04868786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934512|NCT04868760|Ipilimumab|ipilimumab|mesh-list
5934513|NCT04868760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5934514|NCT04868760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5934515|NCT04868760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5934516|NCT04868760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934517|NCT04868747|Lidocaine|lidocaine|mesh-list
5934518|NCT04868747|Anesthetics, Local|anesthetics, local|mesh-ancestor
5934519|NCT04868747|Anesthetics|anesthetics|mesh-ancestor
5934520|NCT04868747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5934521|NCT04868747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934522|NCT04868747|Sensory System Agents|sensory system agents|mesh-ancestor
5934523|NCT04868747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5934524|NCT04868747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5934525|NCT04868747|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5934526|NCT04868747|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5934527|NCT04868747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5934528|NCT04868747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934529|NCT04868552|Naloxone|naloxone|mesh-list
5934530|NCT04868552|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5934531|NCT04868552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934532|NCT04868552|Sensory System Agents|sensory system agents|mesh-ancestor
5934533|NCT04868552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5934534|NCT04868513|Chlorhexidine|chlorhexidine|mesh-list
5934535|NCT04868513|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5934536|NCT04868513|Fluorides|fluorides|mesh-list
5934537|NCT04868513|Cariostatic Agents|cariostatic agents|mesh-ancestor
5934538|NCT04868513|Protective Agents|protective agents|mesh-ancestor
5934539|NCT04868513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934540|NCT04868513|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5934541|NCT04868513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5934542|NCT04868513|Disinfectants|disinfectants|mesh-ancestor
5934543|NCT04868513|Dermatologic Agents|dermatologic agents|mesh-ancestor
5965973|NCT04576364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5965974|NCT04576364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965975|NCT04576364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5965976|NCT04576364|Tocolytic Agents|tocolytic agents|mesh-ancestor
5965977|NCT04576364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5965978|NCT04576208|Antidiarrheals|antidiarrheals|mesh-list
5965979|NCT04576208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5965980|NCT04576143|Paclitaxel|paclitaxel|mesh-list
5965981|NCT04576143|Docetaxel|docetaxel|mesh-list
5965982|NCT04576143|Cyclophosphamide|cyclophosphamide|mesh-list
5965983|NCT04576143|Epirubicin|epirubicin|mesh-list
5965984|NCT04576143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5965985|NCT04576143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5965986|NCT04576143|Tubulin Modulators|tubulin modulators|mesh-ancestor
5965987|NCT04576143|Antimitotic Agents|antimitotic agents|mesh-ancestor
5965988|NCT04576143|Mitosis Modulators|mitosis modulators|mesh-ancestor
5965989|NCT04576143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5965990|NCT04576143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5965991|NCT04576143|Immunologic Factors|immunologic factors|mesh-ancestor
5965992|NCT04576143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5965993|NCT04576143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5965994|NCT04576143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5965995|NCT04576143|Alkylating Agents|alkylating agents|mesh-ancestor
5965996|NCT04576143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5965997|NCT04576143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5965998|NCT04576143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5965999|NCT04576143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5966000|NCT04576143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5966001|NCT04576390|Ondansetron|ondansetron|mesh-list
5966002|NCT04576390|Palonosetron|palonosetron|mesh-list
5966003|NCT04576390|Antiemetics|antiemetics|mesh-ancestor
5966004|NCT04576390|Autonomic Agents|autonomic agents|mesh-ancestor
5966005|NCT04576390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5966006|NCT04576390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966007|NCT04576390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5966008|NCT04576390|Antipruritics|antipruritics|mesh-ancestor
5966009|NCT04576390|Dermatologic Agents|dermatologic agents|mesh-ancestor
5966010|NCT04576390|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5966011|NCT04576390|Serotonin Agents|serotonin agents|mesh-ancestor
5966012|NCT04576390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5966013|NCT04576390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966014|NCT04576390|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5966015|NCT04576390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5966016|NCT04576390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5966017|NCT04576390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5966018|NCT04576390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5966019|NCT04576390|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5966020|NCT04575961|Pembrolizumab|pembrolizumab|mesh-list
5966021|NCT04575961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5934544|NCT04868838|Daratumumab|daratumumab|mesh-list
5934545|NCT04868838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5934546|NCT04868773|Trifluridine|trifluridine|mesh-list
5934547|NCT04868773|Antimetabolites|antimetabolites|mesh-ancestor
5934548|NCT04868773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517177|NCT00720135|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6517178|NCT00720135|Immunologic Factors|immunologic factors|mesh-ancestor
6517179|NCT00720135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934549|NCT04868773|Antiviral Agents|antiviral agents|mesh-ancestor
5934550|NCT04868773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5934551|NCT04868708|Paclitaxel|paclitaxel|mesh-list
5934552|NCT04868708|Bevacizumab|bevacizumab|mesh-list
5934553|NCT04868708|Carboplatin|carboplatin|mesh-list
5934554|NCT04868708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5934555|NCT04868708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5934556|NCT04868708|Tubulin Modulators|tubulin modulators|mesh-ancestor
5934557|NCT04868708|Antimitotic Agents|antimitotic agents|mesh-ancestor
5934558|NCT04868708|Mitosis Modulators|mitosis modulators|mesh-ancestor
5934559|NCT04868708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934560|NCT04868708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5934561|NCT04868708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5934562|NCT04868708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5934563|NCT04868708|Growth Substances|growth substances|mesh-ancestor
5934564|NCT04868708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934565|NCT04868708|Growth Inhibitors|growth inhibitors|mesh-ancestor
5934566|NCT04868175|Timolol|timolol|mesh-list
5934567|NCT04868175|Travoprost|travoprost|mesh-list
5934568|NCT04868175|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5934569|NCT04868175|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5934570|NCT04868175|Adrenergic Agents|adrenergic agents|mesh-ancestor
5934571|NCT04868175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5934572|NCT04868175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934573|NCT04868175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934574|NCT04868175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5934575|NCT04868175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5934576|NCT04868227|Vitamin D|vitamin d|mesh-list
5934577|NCT04868227|Cholecalciferol|cholecalciferol|mesh-list
5934578|NCT04868227|Vitamins|vitamins|mesh-ancestor
5934579|NCT04868227|Micronutrients|micronutrients|mesh-ancestor
5934580|NCT04868227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934581|NCT04868227|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5934582|NCT04868227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5934583|NCT04868461|Caseins|caseins|mesh-list
5934584|NCT04868461|Chelating Agents|chelating agents|mesh-ancestor
5934585|NCT04868461|Sequestering Agents|sequestering agents|mesh-ancestor
5934586|NCT04868461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934587|NCT04868019|Fenofibrate|fenofibrate|mesh-list
5934588|NCT04868019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5934589|NCT04868019|Antimetabolites|antimetabolites|mesh-ancestor
5934590|NCT04868019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934591|NCT04868019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5934592|NCT04867980|Moxifloxacin|moxifloxacin|mesh-list
5934593|NCT04867980|Acalabrutinib|acalabrutinib|mesh-list
5934594|NCT04867980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5934595|NCT04867980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5934596|NCT04867980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5934597|NCT04867980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5934598|NCT04867980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5934599|NCT04867980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934600|NCT04867980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5934601|NCT04868253|Oxazepam|oxazepam|mesh-list
5934602|NCT04868253|Metyrapone|metyrapone|mesh-list
5934603|NCT04868253|Antimetabolites|antimetabolites|mesh-ancestor
5934604|NCT04868253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719659|NCT03217669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5719660|NCT03217669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5719661|NCT03217669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5719662|NCT03217669|Antifungal Agents|antifungal agents|mesh-ancestor
5719663|NCT03217669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5719664|NCT03217669|Immunologic Factors|immunologic factors|mesh-ancestor
5719665|NCT03217669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719666|NCT03217942|Mitogens|mitogens|mesh-list
5719667|NCT03217942|Mitosis Modulators|mitosis modulators|mesh-ancestor
5934605|NCT04868253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5934606|NCT04868253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6517180|NCT00720135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5934607|NCT04868253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5934608|NCT04868253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934609|NCT04868253|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5934610|NCT04868253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5934611|NCT04868253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5934612|NCT04868253|GABA Modulators|gaba modulators|mesh-ancestor
5934613|NCT04868253|GABA Agents|gaba agents|mesh-ancestor
5934614|NCT04868253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5934615|NCT04867993|Amikacin|amikacin|mesh-list
5934616|NCT04867993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5934617|NCT04867993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5934618|NCT04868058|Ropivacaine|ropivacaine|mesh-list
5934619|NCT04868058|Anesthetics, Local|anesthetics, local|mesh-ancestor
5934620|NCT04868058|Anesthetics|anesthetics|mesh-ancestor
5934621|NCT04868058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5934622|NCT04868058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934623|NCT04868058|Sensory System Agents|sensory system agents|mesh-ancestor
5934624|NCT04868058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5934625|NCT04868565|Caffeine|caffeine|mesh-list
5934626|NCT04868565|Caffeine citrate|caffeine citrate|mesh-list
5934627|NCT04868565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934628|NCT04868565|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5934629|NCT04868565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934630|NCT04868565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5934631|NCT04868565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5934632|NCT04868565|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5934633|NCT04868565|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5934634|NCT04868565|Purinergic Agents|purinergic agents|mesh-ancestor
5934635|NCT04868565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5934636|NCT04868045|Hormones|hormones|mesh-list
5934637|NCT04868045|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
5934638|NCT04868045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5934639|NCT04868045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934640|NCT04867720|Everolimus|everolimus|mesh-list
5934641|NCT04867720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5934642|NCT04867720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5934643|NCT04867720|Immunologic Factors|immunologic factors|mesh-ancestor
5934644|NCT04867720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934645|NCT04867941|Acalabrutinib|acalabrutinib|mesh-list
5934646|NCT04867941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5934647|NCT04867707|Zanamivir|zanamivir|mesh-list
5934648|NCT04867707|Antiviral Agents|antiviral agents|mesh-ancestor
5934649|NCT04867707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5934650|NCT04867707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5719668|NCT03217942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719669|NCT03217760|Hydrocortisone|hydrocortisone|mesh-list
5719670|NCT03217760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5719671|NCT03217643|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5719672|NCT03217643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5719673|NCT03217643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5719674|NCT03217409|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5719675|NCT03217409|Ezetimibe|ezetimibe|mesh-list
5719676|NCT03217409|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5719677|NCT03217409|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5719678|NCT03217409|Antimetabolites|antimetabolites|mesh-ancestor
5719679|NCT03217409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934651|NCT04867707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934652|NCT04867343|Fentanyl|fentanyl|mesh-list
5934653|NCT04867343|Remifentanil|remifentanil|mesh-list
5934654|NCT04867343|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5934655|NCT04867343|Narcotics|narcotics|mesh-ancestor
5934656|NCT04867343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5934657|NCT04867343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934658|NCT04867343|Analgesics|analgesics|mesh-ancestor
5934659|NCT04867343|Sensory System Agents|sensory system agents|mesh-ancestor
5934660|NCT04867343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5934661|NCT04867343|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5934662|NCT04867343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5934663|NCT04867343|Anesthetics, General|anesthetics, general|mesh-ancestor
5934664|NCT04867343|Anesthetics|anesthetics|mesh-ancestor
5934665|NCT04867226|Colchicine|colchicine|mesh-list
5934666|NCT04867226|Gout Suppressants|gout suppressants|mesh-ancestor
5934667|NCT04867226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5934668|NCT04867226|Tubulin Modulators|tubulin modulators|mesh-ancestor
5934669|NCT04867226|Antimitotic Agents|antimitotic agents|mesh-ancestor
5934670|NCT04867226|Mitosis Modulators|mitosis modulators|mesh-ancestor
5934671|NCT04867226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934672|NCT04867226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5934673|NCT04867135|Amikacin|amikacin|mesh-list
5934674|NCT04867135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5934675|NCT04867135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5934676|NCT04867252|Inositol|inositol|mesh-list
5934677|NCT04867252|Metformin|metformin|mesh-list
5934678|NCT04867252|Pioglitazone|pioglitazone|mesh-list
5934679|NCT04867252|Resveratrol|resveratrol|mesh-list
5934680|NCT04867252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5934681|NCT04867252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934682|NCT04867252|Antioxidants|antioxidants|mesh-ancestor
5934683|NCT04867252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934684|NCT04867252|Protective Agents|protective agents|mesh-ancestor
5934685|NCT04867252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5934686|NCT04867252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5934687|NCT04867252|Vitamin B Complex|vitamin b complex|mesh-ancestor
5934688|NCT04867252|Vitamins|vitamins|mesh-ancestor
5934689|NCT04867252|Micronutrients|micronutrients|mesh-ancestor
5966022|NCT04575961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5966023|NCT04575844|Liraglutide|liraglutide|mesh-list
5966024|NCT04575844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5966025|NCT04575844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966026|NCT04575844|Incretins|incretins|mesh-ancestor
5966027|NCT04575844|Hormones|hormones|mesh-ancestor
5966028|NCT04575844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5966029|NCT04575688|Bupivacaine|bupivacaine|mesh-list
5966030|NCT04575688|Anesthetics, Local|anesthetics, local|mesh-ancestor
5966031|NCT04575688|Anesthetics|anesthetics|mesh-ancestor
5966032|NCT04575688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5966033|NCT04575688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966034|NCT04575688|Sensory System Agents|sensory system agents|mesh-ancestor
5966035|NCT04575688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5966036|NCT04575779|Cyclosporine|cyclosporine|mesh-list
5966037|NCT04575779|Cyclosporins|cyclosporins|mesh-list
5966038|NCT04575779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5966039|NCT04575779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966040|NCT04575779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5966041|NCT04575779|Immunologic Factors|immunologic factors|mesh-ancestor
5966042|NCT04575779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966043|NCT04575779|Antifungal Agents|antifungal agents|mesh-ancestor
5966044|NCT04575779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5966045|NCT04575779|Dermatologic Agents|dermatologic agents|mesh-ancestor
5966046|NCT04575779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5966047|NCT04575779|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5966048|NCT04575675|Dapagliflozin|dapagliflozin|mesh-list
5966049|NCT04575675|Valsartan|valsartan|mesh-list
5966050|NCT04575675|Carvedilol|carvedilol|mesh-list
5966051|NCT04575675|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5966052|NCT04575675|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
5966053|NCT04575675|Mineralocorticoids|mineralocorticoids|mesh-list
5966054|NCT04575675|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
5966055|NCT04575675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5966056|NCT04575675|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5966057|NCT04575675|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5966058|NCT04575675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966059|NCT04575675|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5966060|NCT04575675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5934690|NCT04866498|Analgesics|analgesics|mesh-list
5934691|NCT04866498|Sensory System Agents|sensory system agents|mesh-ancestor
5934692|NCT04866498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5934693|NCT04866498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934694|NCT04866706|Hyaluronic Acid|hyaluronic acid|mesh-list
5934695|NCT04866706|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5934696|NCT04866706|Immunologic Factors|immunologic factors|mesh-ancestor
5719680|NCT03217409|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5719681|NCT03217409|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5719682|NCT03217409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5719683|NCT03217292|Tramadol|tramadol|mesh-list
5719684|NCT03217292|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5719685|NCT03217292|Narcotics|narcotics|mesh-ancestor
5719686|NCT03217292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5719687|NCT03217292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719688|NCT03217292|Analgesics|analgesics|mesh-ancestor
5719689|NCT03217292|Sensory System Agents|sensory system agents|mesh-ancestor
5719690|NCT03217292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5719691|NCT03217448|Warfarin|warfarin|mesh-list
5719692|NCT03217448|Dabigatran|dabigatran|mesh-list
5719693|NCT03217448|Anticoagulants|anticoagulants|mesh-ancestor
5719694|NCT03217448|Antithrombins|antithrombins|mesh-ancestor
5719695|NCT03217448|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5719696|NCT03217448|Protease Inhibitors|protease inhibitors|mesh-ancestor
5719697|NCT03217448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5719698|NCT03217448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719699|NCT03217474|Ganciclovir|ganciclovir|mesh-list
5719700|NCT03217474|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
5719701|NCT03217474|Antiviral Agents|antiviral agents|mesh-ancestor
5719702|NCT03217474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5719703|NCT03217474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5719704|NCT03217474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5719705|NCT03217474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719706|NCT03217734|Adalimumab|adalimumab|mesh-list
5719707|NCT03217734|Methotrexate|methotrexate|mesh-list
5719708|NCT03217734|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5719709|NCT03217734|Abortifacient Agents|abortifacient agents|mesh-ancestor
5934697|NCT04866706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934698|NCT04866706|Viscosupplements|viscosupplements|mesh-ancestor
5934699|NCT04866706|Protective Agents|protective agents|mesh-ancestor
5934700|NCT04866654|Nivolumab|nivolumab|mesh-list
5934701|NCT04866654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5934702|NCT04866654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5719710|NCT03217734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5719711|NCT03217734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719712|NCT03217734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5719713|NCT03217734|Antimetabolites|antimetabolites|mesh-ancestor
5719714|NCT03217734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719715|NCT03217734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5719716|NCT03217734|Dermatologic Agents|dermatologic agents|mesh-ancestor
5719717|NCT03217734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5719718|NCT03217734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5719719|NCT03217734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5719720|NCT03217734|Immunologic Factors|immunologic factors|mesh-ancestor
5719721|NCT03217734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5719722|NCT03217734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5719723|NCT03217734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5719724|NCT03217227|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
5719725|NCT03217227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5719726|NCT03217227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5719727|NCT03217227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719728|NCT03217227|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5719729|NCT03217071|Pembrolizumab|pembrolizumab|mesh-list
5719730|NCT03217071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5934703|NCT04866654|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5934704|NCT04866654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934705|NCT04866355|Ibuprofen|ibuprofen|mesh-list
5934706|NCT04866355|Scopolamine|scopolamine|mesh-list
5934707|NCT04866355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5934708|NCT04866355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5934709|NCT04866355|Analgesics|analgesics|mesh-ancestor
5934710|NCT04866355|Sensory System Agents|sensory system agents|mesh-ancestor
5934711|NCT04866355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5934712|NCT04866355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934713|NCT04866355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6517181|NCT00720135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6517182|NCT00720135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6517183|NCT00720135|Analgesics|analgesics|mesh-ancestor
6517184|NCT00720135|Sensory System Agents|sensory system agents|mesh-ancestor
6517185|NCT00720135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6517186|NCT00720148|Bortezomib|bortezomib|mesh-list
6517187|NCT00720148|Sunitinib|sunitinib|mesh-list
6517188|NCT00720148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6517189|NCT00720148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6517190|NCT00720148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6517191|NCT00720148|Growth Substances|growth substances|mesh-ancestor
6517192|NCT00720148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934714|NCT04866355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5934715|NCT04866355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5934716|NCT04866355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5934717|NCT04866355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934718|NCT04866355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5934719|NCT04866355|Antiemetics|antiemetics|mesh-ancestor
5934720|NCT04866355|Autonomic Agents|autonomic agents|mesh-ancestor
5934721|NCT04866355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5934722|NCT04866355|Mydriatics|mydriatics|mesh-ancestor
5934723|NCT04866355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5934724|NCT04866355|Cholinergic Agents|cholinergic agents|mesh-ancestor
5934725|NCT04866355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5934726|NCT04866355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5934727|NCT04866485|Pembrolizumab|pembrolizumab|mesh-list
5934728|NCT04866485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5934729|NCT04866485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5934730|NCT04866108|Capecitabine|capecitabine|mesh-list
5934731|NCT04866108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5934732|NCT04866108|Antimetabolites|antimetabolites|mesh-ancestor
5934733|NCT04866108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934734|NCT04866108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5934735|NCT04866056|Azacitidine|azacitidine|mesh-list
5934736|NCT04866056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5934737|NCT04866056|Antimetabolites|antimetabolites|mesh-ancestor
5934738|NCT04866056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934739|NCT04866056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5934740|NCT04866056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5934741|NCT04865900|Antibodies|antibodies|mesh-list
5934742|NCT04865900|Immunologic Factors|immunologic factors|mesh-ancestor
5934743|NCT04865900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934744|NCT04865848|Anesthetics|anesthetics|mesh-list
5934745|NCT04865848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5934746|NCT04865848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934747|NCT04865705|Paclitaxel|paclitaxel|mesh-list
5934748|NCT04865705|Cisplatin|cisplatin|mesh-list
5934749|NCT04865705|Carboplatin|carboplatin|mesh-list
5934750|NCT04865705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5934751|NCT04865705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5934752|NCT04865705|Tubulin Modulators|tubulin modulators|mesh-ancestor
5934753|NCT04865705|Antimitotic Agents|antimitotic agents|mesh-ancestor
5934754|NCT04865705|Mitosis Modulators|mitosis modulators|mesh-ancestor
5934755|NCT04865705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934756|NCT04865991|Propofol|propofol|mesh-list
5934757|NCT04865991|Sevoflurane|sevoflurane|mesh-list
5934758|NCT04865991|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5934759|NCT04865991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5934760|NCT04865991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934761|NCT04865991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5934762|NCT04865991|Anesthetics, General|anesthetics, general|mesh-ancestor
5934763|NCT04865991|Anesthetics|anesthetics|mesh-ancestor
5934764|NCT04865991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5934765|NCT04865991|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5934766|NCT04865653|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
5934767|NCT04865653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5934768|NCT04865653|Hallucinogens|hallucinogens|mesh-ancestor
5934769|NCT04865653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934770|NCT04865653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5934771|NCT04865653|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5934772|NCT04865653|Serotonin Agents|serotonin agents|mesh-ancestor
5934773|NCT04865653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5934774|NCT04865653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934775|NCT04865653|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5934776|NCT04865510|Heparin|heparin|mesh-list
5934777|NCT04865510|Anticoagulants|anticoagulants|mesh-ancestor
6517193|NCT00720148|Growth Inhibitors|growth inhibitors|mesh-ancestor
5934778|NCT04865510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934779|NCT04865510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5934780|NCT04865510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5934781|NCT04865211|Bupivacaine|bupivacaine|mesh-list
5934782|NCT04865211|Anesthetics, Local|anesthetics, local|mesh-ancestor
5934783|NCT04865211|Anesthetics|anesthetics|mesh-ancestor
5934784|NCT04865211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5934785|NCT04865211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934786|NCT04865211|Sensory System Agents|sensory system agents|mesh-ancestor
5934787|NCT04865211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5934788|NCT04865237|Remdesivir|remdesivir|mesh-list
5934789|NCT04865237|Antimetabolites|antimetabolites|mesh-ancestor
5934790|NCT04865237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934791|NCT04865237|Antiviral Agents|antiviral agents|mesh-ancestor
5934792|NCT04865237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5934793|NCT04865445|Midazolam|midazolam|mesh-list
5934794|NCT04865445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5934795|NCT04865445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5934796|NCT04865445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5934797|NCT04865445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934798|NCT04865445|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5934799|NCT04865445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5934800|NCT04865445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5934801|NCT04865445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5934802|NCT04865445|Anesthetics, General|anesthetics, general|mesh-ancestor
5934803|NCT04865445|Anesthetics|anesthetics|mesh-ancestor
5934804|NCT04865445|GABA Modulators|gaba modulators|mesh-ancestor
5934805|NCT04865445|GABA Agents|gaba agents|mesh-ancestor
5934806|NCT04865445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5934807|NCT04865445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934808|NCT04865250|Paclitaxel|paclitaxel|mesh-list
5934809|NCT04865250|Carboplatin|carboplatin|mesh-list
5934810|NCT04865250|Atezolizumab|atezolizumab|mesh-list
5934811|NCT04865250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5934812|NCT04865250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5934813|NCT04865250|Tubulin Modulators|tubulin modulators|mesh-ancestor
5934814|NCT04865250|Antimitotic Agents|antimitotic agents|mesh-ancestor
5934815|NCT04865250|Mitosis Modulators|mitosis modulators|mesh-ancestor
5934816|NCT04865250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934817|NCT04865562|Methyltestosterone|methyltestosterone|mesh-list
5934818|NCT04865562|Testosterone|testosterone|mesh-list
5934819|NCT04865562|Testosterone undecanoate|testosterone undecanoate|mesh-list
5934820|NCT04865562|Testosterone enanthate|testosterone enanthate|mesh-list
5934821|NCT04865562|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5934822|NCT04865562|Androgens|androgens|mesh-ancestor
5934823|NCT04865562|Hormones|hormones|mesh-ancestor
5934824|NCT04865562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5934825|NCT04865562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934826|NCT04865562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5934827|NCT04865562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5934828|NCT04865562|Anabolic Agents|anabolic agents|mesh-ancestor
5934829|NCT04865380|Tranexamic Acid|tranexamic acid|mesh-list
5934830|NCT04865380|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5934831|NCT04865380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5934832|NCT04865380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934833|NCT04865380|Hemostatics|hemostatics|mesh-ancestor
5934834|NCT04865380|Coagulants|coagulants|mesh-ancestor
5934835|NCT04865185|Ethanol|ethanol|mesh-list
5934836|NCT04865185|Lidocaine|lidocaine|mesh-list
5934837|NCT04865185|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5934838|NCT04865185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5934839|NCT04865185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5934840|NCT04865185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934841|NCT04865185|Anesthetics, Local|anesthetics, local|mesh-ancestor
5934842|NCT04865185|Anesthetics|anesthetics|mesh-ancestor
5934843|NCT04865185|Sensory System Agents|sensory system agents|mesh-ancestor
5934844|NCT04865185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5934845|NCT04865185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5934846|NCT04865185|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5934847|NCT04865185|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5934848|NCT04865185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5934849|NCT04865185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934850|NCT04865159|Tipifarnib|tipifarnib|mesh-list
5934851|NCT04865159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5966061|NCT04575675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934852|NCT04864977|Insulin|insulin|mesh-list
5934853|NCT04864977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5934854|NCT04864977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934855|NCT04864782|Paclitaxel|paclitaxel|mesh-list
5934856|NCT04864782|Carboplatin|carboplatin|mesh-list
5934857|NCT04864782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5934858|NCT04864782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5934859|NCT04864782|Tubulin Modulators|tubulin modulators|mesh-ancestor
5934860|NCT04864782|Antimitotic Agents|antimitotic agents|mesh-ancestor
5934861|NCT04864782|Mitosis Modulators|mitosis modulators|mesh-ancestor
5934862|NCT04864782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934863|NCT04864717|Doxycycline|doxycycline|mesh-list
5934864|NCT04864717|Isotretinoin|isotretinoin|mesh-list
5934865|NCT04864717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5934866|NCT04864717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5934867|NCT04864717|Antimalarials|antimalarials|mesh-ancestor
5934868|NCT04864717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5934869|NCT04864717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5934870|NCT04864717|Dermatologic Agents|dermatologic agents|mesh-ancestor
5934871|NCT04865029|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5934872|NCT04865029|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5934873|NCT04865029|Estradiol|estradiol|mesh-list
5934874|NCT04865029|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5934875|NCT04865029|Progesterone|progesterone|mesh-list
5934876|NCT04865029|Estrogens|estrogens|mesh-ancestor
5934877|NCT04865029|Hormones|hormones|mesh-ancestor
5934878|NCT04865029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5934879|NCT04865029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934880|NCT04865029|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5934881|NCT04865029|Contraceptive Agents|contraceptive agents|mesh-ancestor
5934882|NCT04865029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5934883|NCT04865029|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5934884|NCT04865029|Progestins|progestins|mesh-ancestor
5934885|NCT04864379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5934886|NCT04864379|Molgramostim|molgramostim|mesh-list
5934887|NCT04864379|Sargramostim|sargramostim|mesh-list
5934888|NCT04864379|Immunologic Factors|immunologic factors|mesh-ancestor
5934889|NCT04864379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934890|NCT04864379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934891|NCT04864379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5934892|NCT04864431|Vitamin D|vitamin d|mesh-list
5934893|NCT04864431|Cholecalciferol|cholecalciferol|mesh-list
5934894|NCT04864431|Vitamins|vitamins|mesh-ancestor
5934895|NCT04864431|Micronutrients|micronutrients|mesh-ancestor
5934896|NCT04864431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934897|NCT04864431|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5934898|NCT04864431|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5934899|NCT04864210|Bupivacaine|bupivacaine|mesh-list
5934900|NCT04864210|Anesthetics, Local|anesthetics, local|mesh-ancestor
5934901|NCT04864210|Anesthetics|anesthetics|mesh-ancestor
5934902|NCT04864210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5934903|NCT04864210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934904|NCT04864210|Sensory System Agents|sensory system agents|mesh-ancestor
5934905|NCT04864210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5934906|NCT04864314|Superoxide Dismutase|superoxide dismutase|mesh-list
5934907|NCT04864314|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5934908|NCT04864314|Antioxidants|antioxidants|mesh-ancestor
5934909|NCT04864314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934910|NCT04864314|Protective Agents|protective agents|mesh-ancestor
5934911|NCT04864314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934912|NCT04864366|Tenofovir|tenofovir|mesh-list
5934913|NCT04864366|Antiviral Agents|antiviral agents|mesh-ancestor
5934914|NCT04864366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5934915|NCT04864366|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5934916|NCT04864366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5934917|NCT04864366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5934918|NCT04864366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934919|NCT04864366|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5934920|NCT04864366|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5934921|NCT04864444|Piperaquine|piperaquine|mesh-list
5934922|NCT04864444|Primaquine|primaquine|mesh-list
5934923|NCT04864444|Artenimol|artenimol|mesh-list
5934924|NCT04864444|Antimalarials|antimalarials|mesh-ancestor
5934925|NCT04864444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5934926|NCT04864444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5934927|NCT04864444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5934928|NCT04864067|Leucovorin|leucovorin|mesh-list
5934929|NCT04864067|Capecitabine|capecitabine|mesh-list
5934930|NCT04864067|Oxaliplatin|oxaliplatin|mesh-list
5934931|NCT04864067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5934932|NCT04864067|Antimetabolites|antimetabolites|mesh-ancestor
5934933|NCT04864067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934934|NCT04864067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5934935|NCT04864067|Antidotes|antidotes|mesh-ancestor
5934936|NCT04864067|Protective Agents|protective agents|mesh-ancestor
5934937|NCT04864067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934938|NCT04864067|Vitamin B Complex|vitamin b complex|mesh-ancestor
5934939|NCT04864067|Vitamins|vitamins|mesh-ancestor
5934940|NCT04864067|Micronutrients|micronutrients|mesh-ancestor
5934941|NCT04864509|Melatonin|melatonin|mesh-list
5934942|NCT04864509|Antioxidants|antioxidants|mesh-ancestor
5719731|NCT03217071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5719732|NCT03217162|Pulmonary Surfactants|pulmonary surfactants|mesh-list
5719733|NCT03217162|Respiratory System Agents|respiratory system agents|mesh-ancestor
5719734|NCT03216759|Dexmedetomidine|dexmedetomidine|mesh-list
5719735|NCT03216759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5719736|NCT03216759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5719737|NCT03216759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719738|NCT03216759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5719739|NCT03216759|Analgesics|analgesics|mesh-ancestor
5719740|NCT03216759|Sensory System Agents|sensory system agents|mesh-ancestor
5719741|NCT03216759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5719742|NCT03216759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5719743|NCT03216759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5719744|NCT03216759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5719745|NCT03216759|Adrenergic Agents|adrenergic agents|mesh-ancestor
5719746|NCT03216759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5719747|NCT03216759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719748|NCT03216733|Sirolimus|sirolimus|mesh-list
5719749|NCT03216733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5719750|NCT03216733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5719751|NCT03216733|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5719752|NCT03216733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5719753|NCT03216733|Antifungal Agents|antifungal agents|mesh-ancestor
5719754|NCT03216733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5719755|NCT03216733|Immunologic Factors|immunologic factors|mesh-ancestor
5719756|NCT03216733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719757|NCT03216967|Everolimus|everolimus|mesh-list
5719758|NCT03216967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5719759|NCT03216967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5719760|NCT03216967|Immunologic Factors|immunologic factors|mesh-ancestor
5719761|NCT03216967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719762|NCT03216915|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
5719763|NCT03216915|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5722171|NCT03200691|Immunologic Factors|immunologic factors|mesh-ancestor
5934943|NCT04864509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934944|NCT04864509|Protective Agents|protective agents|mesh-ancestor
5934945|NCT04864509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934946|NCT04864509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5934947|NCT04864496|Acetylcysteine|acetylcysteine|mesh-list
5934948|NCT04864496|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5934949|NCT04864496|Antiviral Agents|antiviral agents|mesh-ancestor
5934950|NCT04864496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5934951|NCT04864496|Expectorants|expectorants|mesh-ancestor
5934952|NCT04864496|Respiratory System Agents|respiratory system agents|mesh-ancestor
5934953|NCT04864496|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5934954|NCT04864496|Antioxidants|antioxidants|mesh-ancestor
5934955|NCT04864496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5934956|NCT04864496|Protective Agents|protective agents|mesh-ancestor
5934957|NCT04864496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934958|NCT04864496|Antidotes|antidotes|mesh-ancestor
5934959|NCT04863742|Prednisolone|prednisolone|mesh-list
5934960|NCT04863742|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5934961|NCT04863742|Methylprednisolone|methylprednisolone|mesh-list
5934962|NCT04863742|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5934963|NCT04863742|Prednisolone acetate|prednisolone acetate|mesh-list
5934964|NCT04863742|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5934965|NCT04863742|Prednisolone phosphate|prednisolone phosphate|mesh-list
5934966|NCT04863742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5934967|NCT04863742|Glucocorticoids|glucocorticoids|mesh-ancestor
5934968|NCT04863742|Hormones|hormones|mesh-ancestor
5934969|NCT04863742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5934970|NCT04863742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934971|NCT04863742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5934972|NCT04863742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5934973|NCT04863742|Antiemetics|antiemetics|mesh-ancestor
5934974|NCT04863742|Autonomic Agents|autonomic agents|mesh-ancestor
5934975|NCT04863742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5934976|NCT04863742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5934977|NCT04863742|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5934978|NCT04863742|Protective Agents|protective agents|mesh-ancestor
5934979|NCT04863716|Fentanyl|fentanyl|mesh-list
5934980|NCT04863716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5934981|NCT04863716|Narcotics|narcotics|mesh-ancestor
5934982|NCT04863716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5934983|NCT04863716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934984|NCT04863716|Analgesics|analgesics|mesh-ancestor
5934985|NCT04863716|Sensory System Agents|sensory system agents|mesh-ancestor
5934986|NCT04863716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5934987|NCT04863716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5934988|NCT04863716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5934989|NCT04863716|Anesthetics, General|anesthetics, general|mesh-ancestor
5934990|NCT04863716|Anesthetics|anesthetics|mesh-ancestor
5934991|NCT04863807|Anesthetics|anesthetics|mesh-list
5934992|NCT04863807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5934993|NCT04863807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5934994|NCT04863638|Vaccines|vaccines|mesh-list
5934995|NCT04863638|Immunologic Factors|immunologic factors|mesh-ancestor
5934996|NCT04863638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966062|NCT04575675|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5966063|NCT04575675|Adrenergic Agents|adrenergic agents|mesh-ancestor
5966064|NCT04575675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5966065|NCT04575675|Antioxidants|antioxidants|mesh-ancestor
5966066|NCT04575675|Protective Agents|protective agents|mesh-ancestor
5966067|NCT04575675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5966068|NCT04575675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5966069|NCT04575675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5966070|NCT04575675|Vasodilator Agents|vasodilator agents|mesh-ancestor
5966071|NCT04575675|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5966072|NCT04575675|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5966073|NCT04575675|Hormones|hormones|mesh-ancestor
5966074|NCT04575675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5966075|NCT04575675|Hormone Antagonists|hormone antagonists|mesh-ancestor
5966076|NCT04575675|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5966077|NCT04575675|Diuretics|diuretics|mesh-ancestor
5966078|NCT04575675|Natriuretic Agents|natriuretic agents|mesh-ancestor
5966079|NCT04575922|Nivolumab|nivolumab|mesh-list
5966080|NCT04575922|Ipilimumab|ipilimumab|mesh-list
5966081|NCT04575922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5966082|NCT04575922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5966083|NCT04575922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5966084|NCT04575922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966085|NCT04575558|Azithromycin|azithromycin|mesh-list
5966086|NCT04575558|Hydroxychloroquine|hydroxychloroquine|mesh-list
5966087|NCT04575558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5966088|NCT04575558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5966089|NCT04575558|Antimalarials|antimalarials|mesh-ancestor
5966090|NCT04575558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5966091|NCT04575558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5966092|NCT04575558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5966093|NCT04575558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966094|NCT04575558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5966095|NCT04575519|Aspirin|aspirin|mesh-list
5966096|NCT04575519|Ibuprofen|ibuprofen|mesh-list
5966097|NCT04575519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5966098|NCT04575519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5934997|NCT04863430|Oxaliplatin|oxaliplatin|mesh-list
5934998|NCT04863430|Apatinib|apatinib|mesh-list
5934999|NCT04863430|Tegafur|tegafur|mesh-list
5935000|NCT04863430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5935001|NCT04863430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5935002|NCT04863430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5935003|NCT04863430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935004|NCT04863430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5935005|NCT04863430|Antimetabolites|antimetabolites|mesh-ancestor
5935006|NCT04863339|Tranexamic Acid|tranexamic acid|mesh-list
5935007|NCT04863339|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5935008|NCT04863339|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5935009|NCT04863339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935010|NCT04863339|Hemostatics|hemostatics|mesh-ancestor
5935011|NCT04863339|Coagulants|coagulants|mesh-ancestor
5935012|NCT04863183|Triamcinolone|triamcinolone|mesh-list
5935013|NCT04863183|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5935014|NCT04863183|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5935015|NCT04863183|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5935016|NCT04863183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5935017|NCT04863183|Glucocorticoids|glucocorticoids|mesh-ancestor
5935018|NCT04863183|Hormones|hormones|mesh-ancestor
5935019|NCT04863183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5935020|NCT04863183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935021|NCT04863183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5935022|NCT04863183|Immunologic Factors|immunologic factors|mesh-ancestor
5935023|NCT04863183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5935024|NCT04863183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935025|NCT04863274|Atorvastatin|atorvastatin|mesh-list
5935026|NCT04863274|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5935027|NCT04863274|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5935028|NCT04863274|Antimetabolites|antimetabolites|mesh-ancestor
5935029|NCT04863274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935030|NCT04863274|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5935031|NCT04863274|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5935032|NCT04863274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5935033|NCT04863365|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5935034|NCT04863365|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5935035|NCT04863079|Pembrolizumab|pembrolizumab|mesh-list
5935036|NCT04863079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5935037|NCT04863079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5935038|NCT04863001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
5935039|NCT04863105|Abiraterone Acetate|abiraterone acetate|mesh-list
5935040|NCT04863105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5935041|NCT04863105|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5935042|NCT04863105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5935043|NCT04863105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935044|NCT04863105|Hormone Antagonists|hormone antagonists|mesh-ancestor
5935045|NCT04863105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5935046|NCT04863105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935047|NCT04863105|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5935048|NCT04862455|Pembrolizumab|pembrolizumab|mesh-list
5935049|NCT04862455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5935050|NCT04862455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5935051|NCT04862767|Aldesleukin|aldesleukin|mesh-list
5935052|NCT04862767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5935053|NCT04862767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5935054|NCT04862767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5935055|NCT04862767|Antiviral Agents|antiviral agents|mesh-ancestor
5935056|NCT04862767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5935057|NCT04862845|Pregabalin|pregabalin|mesh-list
5935058|NCT04862845|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5935059|NCT04862845|Analgesics|analgesics|mesh-ancestor
5935060|NCT04862845|Sensory System Agents|sensory system agents|mesh-ancestor
5935061|NCT04862845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5935062|NCT04862845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935063|NCT04862845|Anticonvulsants|anticonvulsants|mesh-ancestor
5935064|NCT04862845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5935065|NCT04862845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5935066|NCT04862845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935067|NCT04862845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5935068|NCT04862845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5935069|NCT04862845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5935070|NCT04862845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5935071|NCT04862845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5935072|NCT04862845|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5935073|NCT04862845|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5935074|NCT04862845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5935075|NCT04862845|Antidepressive Agents|antidepressive agents|mesh-ancestor
5935076|NCT04862845|Dopamine Agents|dopamine agents|mesh-ancestor
5935077|NCT04862091|Abiraterone Acetate|abiraterone acetate|mesh-list
5935078|NCT04862091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5935079|NCT04862091|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5935080|NCT04862091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5935081|NCT04862091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935082|NCT04862091|Hormone Antagonists|hormone antagonists|mesh-ancestor
5935083|NCT04862091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5935084|NCT04862091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935085|NCT04862091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5935086|NCT04862377|Budesonide|budesonide|mesh-list
5935087|NCT04862377|Poractant alfa|poractant alfa|mesh-list
5935088|NCT04862377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5935089|NCT04862377|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5935090|NCT04862377|Autonomic Agents|autonomic agents|mesh-ancestor
5935091|NCT04862377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5935092|NCT04862377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935093|NCT04862377|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5935094|NCT04862377|Respiratory System Agents|respiratory system agents|mesh-ancestor
5935095|NCT04862377|Glucocorticoids|glucocorticoids|mesh-ancestor
5935096|NCT04862377|Hormones|hormones|mesh-ancestor
5935097|NCT04862377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5935098|NCT04862377|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
5935099|NCT04862234|Dulaglutide|dulaglutide|mesh-list
5935100|NCT04862234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5935101|NCT04862234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935102|NCT04861948|Bevacizumab|bevacizumab|mesh-list
5935103|NCT04861948|Carboplatin|carboplatin|mesh-list
5935104|NCT04861948|Pemetrexed|pemetrexed|mesh-list
5935105|NCT04861948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5935106|NCT04861948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5935107|NCT04861948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5935108|NCT04861948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5935109|NCT04861948|Growth Substances|growth substances|mesh-ancestor
5935110|NCT04861948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935111|NCT04861948|Growth Inhibitors|growth inhibitors|mesh-ancestor
5935112|NCT04861948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5935113|NCT04861948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935114|NCT04861948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5935115|NCT04861948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5935116|NCT04862117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
5935117|NCT04862117|Cholinergic Agents|cholinergic agents|mesh-list
5935118|NCT04862117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5935119|NCT04862117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935120|NCT04862117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966099|NCT04575519|Analgesics|analgesics|mesh-ancestor
5966100|NCT04575519|Sensory System Agents|sensory system agents|mesh-ancestor
5966101|NCT04575519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5966102|NCT04575519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966103|NCT04575519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5966104|NCT04575519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5966105|NCT04575519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5966106|NCT04575519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5966107|NCT04575519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966108|NCT04575519|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5966109|NCT04575519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5966110|NCT04575519|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5966111|NCT04575519|Antipyretics|antipyretics|mesh-ancestor
5966112|NCT04575194|Liraglutide|liraglutide|mesh-list
5966113|NCT04575194|Naltrexone|naltrexone|mesh-list
5966114|NCT04575194|Bupropion|bupropion|mesh-list
5966115|NCT04575194|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5966116|NCT04575194|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5966117|NCT04575194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966118|NCT04575194|Sensory System Agents|sensory system agents|mesh-ancestor
5966119|NCT04575194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5966120|NCT04575194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5966121|NCT04575194|Incretins|incretins|mesh-ancestor
5935121|NCT04861922|Heparin|heparin|mesh-list
5935122|NCT04861922|Calcium heparin|calcium heparin|mesh-list
5935123|NCT04861922|Anticoagulants|anticoagulants|mesh-ancestor
5935124|NCT04861922|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5935125|NCT04861922|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5935126|NCT04861922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966122|NCT04575194|Hormones|hormones|mesh-ancestor
5966123|NCT04575194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5966124|NCT04575194|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5966125|NCT04575194|Antidepressive Agents|antidepressive agents|mesh-ancestor
5966126|NCT04575194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5966127|NCT04575194|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5966128|NCT04575194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5966129|NCT04575194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5966130|NCT04575194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966131|NCT04575194|Dopamine Agents|dopamine agents|mesh-ancestor
5966132|NCT04575194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5966133|NCT04575194|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5966134|NCT04575194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5966135|NCT04575194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5966136|NCT04575233|Ropivacaine|ropivacaine|mesh-list
5966137|NCT04575233|Anesthetics, Local|anesthetics, local|mesh-ancestor
5966138|NCT04575233|Anesthetics|anesthetics|mesh-ancestor
5966139|NCT04575233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5966140|NCT04575233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966141|NCT04575233|Sensory System Agents|sensory system agents|mesh-ancestor
5966142|NCT04575233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5966143|NCT04575415|Bevacizumab|bevacizumab|mesh-list
5966144|NCT04575415|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5966145|NCT04575415|Gefitinib|gefitinib|mesh-list
5966146|NCT04575415|Afatinib|afatinib|mesh-list
5966147|NCT04575415|Osimertinib|osimertinib|mesh-list
5966148|NCT04575415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5966149|NCT04575415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5966150|NCT04575415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5966151|NCT04575415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5966152|NCT04575415|Growth Substances|growth substances|mesh-ancestor
5966153|NCT04575415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966154|NCT04575415|Growth Inhibitors|growth inhibitors|mesh-ancestor
5966155|NCT04575415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5966156|NCT04575415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5966157|NCT04575415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966158|NCT04575389|Uric Acid|uric acid|mesh-list
5966159|NCT04575389|Antioxidants|antioxidants|mesh-ancestor
5966160|NCT04575389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966161|NCT04575389|Protective Agents|protective agents|mesh-ancestor
5966162|NCT04575389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970894|NCT04531865|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5970895|NCT04531865|Antitubercular Agents|antitubercular agents|mesh-ancestor
5970896|NCT04531865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5970897|NCT04531865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5970898|NCT04531865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5970899|NCT04531865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970900|NCT04531800|Mitogens|mitogens|mesh-list
5970901|NCT04531800|Mitosis Modulators|mitosis modulators|mesh-ancestor
5970902|NCT04531800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970903|NCT04531813|Butenafine|butenafine|mesh-list
5970904|NCT04531813|Antifungal Agents|antifungal agents|mesh-ancestor
5970905|NCT04531813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5970906|NCT04531748|Toremifene|toremifene|mesh-list
5970907|NCT04531748|Melatonin|melatonin|mesh-list
5970908|NCT04531748|Antioxidants|antioxidants|mesh-ancestor
5970909|NCT04531748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970910|NCT04531748|Protective Agents|protective agents|mesh-ancestor
5970911|NCT04531748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970912|NCT04531748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5970913|NCT04531748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5970914|NCT04531748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5970915|NCT04531748|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5970916|NCT04531748|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5970917|NCT04531748|Hormone Antagonists|hormone antagonists|mesh-ancestor
5970918|NCT04531748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5970919|NCT04531748|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5935127|NCT04861181|Niraparib|niraparib|mesh-list
5935128|NCT04861181|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5935129|NCT04861181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5935130|NCT04861181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935131|NCT04861181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5935132|NCT04861142|Denosumab|denosumab|mesh-list
5935133|NCT04861142|Alendronate|alendronate|mesh-list
5935134|NCT04861142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5935135|NCT04861142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935136|NCT04861051|Ketamine|ketamine|mesh-list
5935137|NCT04861051|Analgesics|analgesics|mesh-ancestor
5935138|NCT04861051|Sensory System Agents|sensory system agents|mesh-ancestor
5935139|NCT04861051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5935140|NCT04861051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935141|NCT04861051|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5935142|NCT04861051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5935143|NCT04861051|Anesthetics, General|anesthetics, general|mesh-ancestor
5935144|NCT04861051|Anesthetics|anesthetics|mesh-ancestor
5935145|NCT04861051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5935146|NCT04861051|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5935147|NCT04861051|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5935148|NCT04861051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5935149|NCT04861051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935150|NCT04860661|Esketamine|esketamine|mesh-list
5935151|NCT04860661|Antidepressive Agents|antidepressive agents|mesh-ancestor
5935152|NCT04860661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5935153|NCT04860739|Vaccines|vaccines|mesh-list
5935154|NCT04860739|Immunologic Factors|immunologic factors|mesh-ancestor
5935155|NCT04860739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935156|NCT04861103|Enoxaparin|enoxaparin|mesh-list
5935157|NCT04861103|Anticoagulants|anticoagulants|mesh-ancestor
5935158|NCT04861103|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5935159|NCT04861103|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5935160|NCT04861103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935161|NCT04860674|Carboplatin|carboplatin|mesh-list
5935162|NCT04860674|Etoposide|etoposide|mesh-list
5935163|NCT04860674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5935164|NCT04860674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5935165|NCT04860674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5935166|NCT04860674|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5935167|NCT04860674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5935168|NCT04860674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5935169|NCT04860674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935170|NCT04860856|Ropivacaine|ropivacaine|mesh-list
5935171|NCT04860856|Anesthetics, Local|anesthetics, local|mesh-ancestor
5935172|NCT04860856|Anesthetics|anesthetics|mesh-ancestor
5935173|NCT04860856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5935174|NCT04860856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935175|NCT04860856|Sensory System Agents|sensory system agents|mesh-ancestor
5935176|NCT04860856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5935177|NCT04860505|Doxycycline|doxycycline|mesh-list
5935178|NCT04860505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5935179|NCT04860505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5935180|NCT04860505|Antimalarials|antimalarials|mesh-ancestor
5935181|NCT04860505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5935182|NCT04860505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5935183|NCT04861207|Cladribine|cladribine|mesh-list
5935184|NCT04861207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5935185|NCT04861207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5935186|NCT04861207|Immunologic Factors|immunologic factors|mesh-ancestor
5935187|NCT04861207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935188|NCT04860531|Betamethasone|betamethasone|mesh-list
5935189|NCT04860531|Lidocaine|lidocaine|mesh-list
5935190|NCT04860531|Anesthetics, Local|anesthetics, local|mesh-ancestor
5935191|NCT04860531|Anesthetics|anesthetics|mesh-ancestor
5935192|NCT04860531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5935193|NCT04860531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935194|NCT04860531|Sensory System Agents|sensory system agents|mesh-ancestor
5935195|NCT04860531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5935196|NCT04860531|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5935197|NCT04860531|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5935198|NCT04860531|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5935199|NCT04860531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5935200|NCT04860531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935201|NCT04860531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5935202|NCT04860531|Glucocorticoids|glucocorticoids|mesh-ancestor
5935203|NCT04860531|Hormones|hormones|mesh-ancestor
5935204|NCT04860531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5935205|NCT04860531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5935206|NCT04860531|Respiratory System Agents|respiratory system agents|mesh-ancestor
5935207|NCT04860284|Hydroxychloroquine|hydroxychloroquine|mesh-list
5719764|NCT03216915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719765|NCT03216915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5719766|NCT03216915|Immunologic Factors|immunologic factors|mesh-ancestor
5719767|NCT03216915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719768|NCT03216980|Antioxidants|antioxidants|mesh-list
5719769|NCT03216980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719770|NCT03216980|Protective Agents|protective agents|mesh-ancestor
5719771|NCT03216980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719772|NCT03216876|Ursolic acid|ursolic acid|mesh-list
5719773|NCT03216876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5719774|NCT03216876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5719775|NCT03216876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5719776|NCT03216876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5719777|NCT03216876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5719778|NCT03216876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719779|NCT03216876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5719780|NCT03216876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5719781|NCT03216876|Analgesics|analgesics|mesh-ancestor
5719782|NCT03216876|Sensory System Agents|sensory system agents|mesh-ancestor
5719783|NCT03216876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5935208|NCT04860284|Antimalarials|antimalarials|mesh-ancestor
5935209|NCT04860284|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5935210|NCT04860284|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5935211|NCT04860284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5935212|NCT04860284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5935213|NCT04860284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935214|NCT04860284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5935215|NCT04860141|Gabapentin|gabapentin|mesh-list
5935216|NCT04860141|Analgesics|analgesics|mesh-ancestor
5935217|NCT04860141|Sensory System Agents|sensory system agents|mesh-ancestor
5935218|NCT04860141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5935219|NCT04860141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935220|NCT04860141|Anticonvulsants|anticonvulsants|mesh-ancestor
5935221|NCT04860141|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5935222|NCT04860141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5935223|NCT04860141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5935224|NCT04860141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5935225|NCT04860141|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5935226|NCT04860141|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5935227|NCT04860141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5935228|NCT04860141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935229|NCT04860141|Antimanic Agents|antimanic agents|mesh-ancestor
5935230|NCT04860167|Diclofenac|diclofenac|mesh-list
5935231|NCT04860167|Lidocaine|lidocaine|mesh-list
5935232|NCT04860167|Propofol|propofol|mesh-list
5935233|NCT04860167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5935234|NCT04860167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5935235|NCT04860167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935236|NCT04860167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5935237|NCT04860167|Anesthetics, General|anesthetics, general|mesh-ancestor
5935238|NCT04860167|Anesthetics|anesthetics|mesh-ancestor
5935239|NCT04860167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5935240|NCT04860167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5935241|NCT04860167|Analgesics|analgesics|mesh-ancestor
5935242|NCT04860167|Sensory System Agents|sensory system agents|mesh-ancestor
5935243|NCT04860167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5935244|NCT04860167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5935245|NCT04860167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5935246|NCT04860167|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5935247|NCT04860167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5935248|NCT04860167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935249|NCT04860167|Anesthetics, Local|anesthetics, local|mesh-ancestor
5935250|NCT04860167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5935251|NCT04860167|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5935252|NCT04860167|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5935253|NCT04860167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5935254|NCT04860076|Pembrolizumab|pembrolizumab|mesh-list
5935255|NCT04860076|Nivolumab|nivolumab|mesh-list
5935256|NCT04860076|Ipilimumab|ipilimumab|mesh-list
5935257|NCT04860076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5935258|NCT04860076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5935259|NCT04860076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5935260|NCT04860076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935261|NCT04860154|Hematoporphyrins|hematoporphyrins|mesh-list
5935262|NCT04860154|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5935263|NCT04860154|Dermatologic Agents|dermatologic agents|mesh-ancestor
5935264|NCT04860011|Dapagliflozin|dapagliflozin|mesh-list
5935265|NCT04860011|Metolazone|metolazone|mesh-list
5935266|NCT04860011|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5935267|NCT04860011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935268|NCT04860011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5935269|NCT04860011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935270|NCT04860011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5935271|NCT04860011|Diuretics|diuretics|mesh-ancestor
5935272|NCT04860011|Natriuretic Agents|natriuretic agents|mesh-ancestor
5935273|NCT04860011|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5935274|NCT04860011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5935275|NCT04859738|Lidocaine|lidocaine|mesh-list
5935276|NCT04859738|Anesthetics, Local|anesthetics, local|mesh-ancestor
5935277|NCT04859738|Anesthetics|anesthetics|mesh-ancestor
5935278|NCT04859738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5935279|NCT04859738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935280|NCT04859738|Sensory System Agents|sensory system agents|mesh-ancestor
5935281|NCT04859738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5935282|NCT04859738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5935283|NCT04859738|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5935284|NCT04859738|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5935285|NCT04859738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5935286|NCT04859738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935287|NCT04859829|Immunoglobulins|immunoglobulins|mesh-list
5935288|NCT04859829|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5935289|NCT04859829|Antibodies|antibodies|mesh-list
5935290|NCT04859829|gamma-Globulins|gamma-globulins|mesh-list
5935291|NCT04859829|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5935292|NCT04859829|Immunologic Factors|immunologic factors|mesh-ancestor
5935293|NCT04859829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935294|NCT04859777|Pembrolizumab|pembrolizumab|mesh-list
5935295|NCT04859777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5935296|NCT04859777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5966163|NCT04575493|Ciprofloxacin|ciprofloxacin|mesh-list
5966164|NCT04575493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5966165|NCT04575493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5966166|NCT04575493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5966167|NCT04575493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5966168|NCT04575493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5966169|NCT04575493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966170|NCT04575493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5966171|NCT04575493|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5966172|NCT04575493|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5966173|NCT04575103|Antipsychotic Agents|antipsychotic agents|mesh-list
5966174|NCT04575103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5966175|NCT04575103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5966176|NCT04575103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966177|NCT04575103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5966178|NCT04575038|Brequinar|brequinar|mesh-list
5966179|NCT04575038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5966180|NCT04575038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5966181|NCT04575038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966182|NCT04575038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5966183|NCT04575038|Immunologic Factors|immunologic factors|mesh-ancestor
5966184|NCT04575038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966185|NCT04574960|Gemcitabine|gemcitabine|mesh-list
5966186|NCT04574960|Carboplatin|carboplatin|mesh-list
5966187|NCT04574960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5966188|NCT04574960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5966189|NCT04574960|Antimetabolites|antimetabolites|mesh-ancestor
5966190|NCT04574960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966191|NCT04574960|Antiviral Agents|antiviral agents|mesh-ancestor
5966192|NCT04574960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5966193|NCT04574960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5966194|NCT04574960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5935297|NCT04860219|Lactoferrin|lactoferrin|mesh-list
5935298|NCT04860219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5935299|NCT04859660|Tamsulosin|tamsulosin|mesh-list
5935300|NCT04859660|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5935301|NCT04859660|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5935302|NCT04859660|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5935303|NCT04859660|Adrenergic Agents|adrenergic agents|mesh-ancestor
5935304|NCT04859660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5935305|NCT04859660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935306|NCT04859660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935307|NCT04859660|Urological Agents|urological agents|mesh-ancestor
5935308|NCT04859621|Vitamin D|vitamin d|mesh-list
5935309|NCT04859621|Ergocalciferols|ergocalciferols|mesh-list
5935310|NCT04859621|Cholecalciferol|cholecalciferol|mesh-list
5935311|NCT04859621|Vitamins|vitamins|mesh-list
5935312|NCT04859621|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5935313|NCT04859621|Micronutrients|micronutrients|mesh-ancestor
5935314|NCT04859621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935315|NCT04859621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5935316|NCT04859621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5935317|NCT04859621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5935318|NCT04859556|Dipivefrin|dipivefrin|mesh-list
5935319|NCT04859556|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5935320|NCT04859556|Adrenergic Agents|adrenergic agents|mesh-ancestor
5935321|NCT04859556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5935322|NCT04859556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935323|NCT04859556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935324|NCT04859569|Denosumab|denosumab|mesh-list
5935325|NCT04859569|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5935326|NCT04859569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935327|NCT04859530|Lugol's solution|lugol's solution|mesh-list
5935328|NCT04859530|Hemostatics|hemostatics|mesh-ancestor
5935329|NCT04859530|Coagulants|coagulants|mesh-ancestor
5935330|NCT04859283|Dexmedetomidine|dexmedetomidine|mesh-list
5935331|NCT04859283|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5935332|NCT04859283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5935333|NCT04859283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935334|NCT04859283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5935335|NCT04859283|Analgesics|analgesics|mesh-ancestor
5935336|NCT04859283|Sensory System Agents|sensory system agents|mesh-ancestor
5935337|NCT04859283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5935338|NCT04859283|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5935339|NCT04859283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5935340|NCT04859283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5935341|NCT04859283|Adrenergic Agents|adrenergic agents|mesh-ancestor
5935342|NCT04859283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5935343|NCT04859283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935344|NCT04859452|Metformin|metformin|mesh-list
5935345|NCT04859452|Glyburide|glyburide|mesh-list
5935346|NCT04859452|Valsartan|valsartan|mesh-list
5935347|NCT04859452|Simvastatin|simvastatin|mesh-list
5935348|NCT04859452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5935349|NCT04859452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935350|NCT04859452|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5935351|NCT04859452|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5935352|NCT04859452|Antimetabolites|antimetabolites|mesh-ancestor
5935353|NCT04859452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935354|NCT04859452|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5935355|NCT04859452|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5935356|NCT04859452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5935357|NCT04859452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5935358|NCT04859452|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5935359|NCT04859452|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5935360|NCT04859361|Imiquimod|imiquimod|mesh-list
5935361|NCT04859361|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5935362|NCT04859361|Immunologic Factors|immunologic factors|mesh-ancestor
5935363|NCT04859361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935364|NCT04859361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5935365|NCT04859361|Interferon Inducers|interferon inducers|mesh-ancestor
5935366|NCT04859322|Glucagon|glucagon|mesh-list
5935367|NCT04859322|Somatostatin|somatostatin|mesh-list
5935368|NCT04859322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935369|NCT04859322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5935370|NCT04859322|Hormones|hormones|mesh-ancestor
5966195|NCT04574960|Immunologic Factors|immunologic factors|mesh-ancestor
5935371|NCT04859322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5935372|NCT04859244|Remdesivir|remdesivir|mesh-list
5935373|NCT04859244|Antimetabolites|antimetabolites|mesh-ancestor
5935374|NCT04859244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935375|NCT04859244|Antiviral Agents|antiviral agents|mesh-ancestor
5935376|NCT04859244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5935377|NCT04858997|Palbociclib|palbociclib|mesh-list
5935378|NCT04858997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5935379|NCT04858997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5935380|NCT04858997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5935381|NCT04858997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935382|NCT04858841|Levetiracetam|levetiracetam|mesh-list
5935383|NCT04858841|Anticonvulsants|anticonvulsants|mesh-ancestor
5935384|NCT04858841|Nootropic Agents|nootropic agents|mesh-ancestor
5935385|NCT04858529|Carboplatin|carboplatin|mesh-list
5935386|NCT04858529|Docetaxel|docetaxel|mesh-list
5935387|NCT04858529|Trastuzumab|trastuzumab|mesh-list
5935388|NCT04858529|Pertuzumab|pertuzumab|mesh-list
5935389|NCT04858529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5935390|NCT04858529|Tubulin Modulators|tubulin modulators|mesh-ancestor
5935391|NCT04858529|Antimitotic Agents|antimitotic agents|mesh-ancestor
5935392|NCT04858529|Mitosis Modulators|mitosis modulators|mesh-ancestor
5935393|NCT04858529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935394|NCT04858529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5935395|NCT04858516|Trastuzumab|trastuzumab|mesh-list
5935396|NCT04858516|Palbociclib|palbociclib|mesh-list
5935397|NCT04858516|Exemestane|exemestane|mesh-list
5935398|NCT04858516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5935399|NCT04858516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5935400|NCT04858516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5935401|NCT04858516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5935402|NCT04858516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935403|NCT04858516|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5935404|NCT04858516|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5935405|NCT04858516|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5935406|NCT04858516|Hormone Antagonists|hormone antagonists|mesh-ancestor
5935407|NCT04858516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5935408|NCT04858516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935409|NCT04858633|Hydroxychloroquine|hydroxychloroquine|mesh-list
5935410|NCT04858633|Antimalarials|antimalarials|mesh-ancestor
5935411|NCT04858633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5935412|NCT04858633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5935413|NCT04858633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5935414|NCT04858633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5935415|NCT04858633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935416|NCT04858633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5935417|NCT04858087|Lumefantrine|lumefantrine|mesh-list
5935418|NCT04858087|Artemether|artemether|mesh-list
5935419|NCT04858087|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
5935420|NCT04858087|Antimalarials|antimalarials|mesh-ancestor
5935421|NCT04858087|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5935422|NCT04858087|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5935423|NCT04858087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5935424|NCT04858048|Anesthetics|anesthetics|mesh-list
5935425|NCT04858048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5935426|NCT04858048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935427|NCT04857983|Memantine|memantine|mesh-list
5935428|NCT04857983|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6517194|NCT00720148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6517195|NCT00720148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6517196|NCT00720148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517197|NCT00720161|Metformin|metformin|mesh-list
6517198|NCT00720161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6517199|NCT00720161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517200|NCT00720174|Doxorubicin|doxorubicin|mesh-list
6517201|NCT00720174|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5935429|NCT04857983|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5935430|NCT04857983|Dopamine Agents|dopamine agents|mesh-ancestor
5935431|NCT04857983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5935432|NCT04857983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517202|NCT00720174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5935433|NCT04857983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935434|NCT04857983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5935435|NCT04857983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5966196|NCT04574960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966197|NCT04574947|Lidocaine|lidocaine|mesh-list
5966198|NCT04574947|Anesthetics, Local|anesthetics, local|mesh-ancestor
5966199|NCT04574947|Anesthetics|anesthetics|mesh-ancestor
5966200|NCT04574947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5966201|NCT04574947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966202|NCT04574947|Sensory System Agents|sensory system agents|mesh-ancestor
5966203|NCT04574947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5966204|NCT04574947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5966205|NCT04574947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5966206|NCT04574947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5966207|NCT04574947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5966208|NCT04574947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966209|NCT04574713|Candesartan|candesartan|mesh-list
5966210|NCT04574713|Candesartan cilexetil|candesartan cilexetil|mesh-list
5966211|NCT04574713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5966212|NCT04574713|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5966213|NCT04574713|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5966214|NCT04574713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966215|NCT04574778|Acetaminophen|acetaminophen|mesh-list
5966216|NCT04574778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5966217|NCT04574778|Analgesics|analgesics|mesh-ancestor
5966218|NCT04574778|Sensory System Agents|sensory system agents|mesh-ancestor
5966219|NCT04574778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5966220|NCT04574778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966221|NCT04574778|Antipyretics|antipyretics|mesh-ancestor
5966222|NCT04574791|Tizanidine|tizanidine|mesh-list
5966223|NCT04574791|Analgesics|analgesics|mesh-ancestor
5966224|NCT04574791|Sensory System Agents|sensory system agents|mesh-ancestor
5966225|NCT04574791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5966226|NCT04574791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966227|NCT04574791|Anticonvulsants|anticonvulsants|mesh-ancestor
5966228|NCT04574791|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5966229|NCT04574791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5966230|NCT04574791|Parasympatholytics|parasympatholytics|mesh-ancestor
5966231|NCT04574791|Autonomic Agents|autonomic agents|mesh-ancestor
5966232|NCT04574791|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5966233|NCT04574791|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5966234|NCT04574791|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5966235|NCT04574791|Adrenergic Agents|adrenergic agents|mesh-ancestor
5966236|NCT04574791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5966237|NCT04574791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517203|NCT00720174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6517204|NCT00720174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5966238|NCT04575064|Remdesivir|remdesivir|mesh-list
5966239|NCT04575064|Antimetabolites|antimetabolites|mesh-ancestor
5966240|NCT04575064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966241|NCT04575064|Antiviral Agents|antiviral agents|mesh-ancestor
5966242|NCT04575064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5966243|NCT04574479|Morphine|morphine|mesh-list
5966244|NCT04574479|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5966245|NCT04574479|Narcotics|narcotics|mesh-ancestor
5966246|NCT04574479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5966247|NCT04574479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966248|NCT04574479|Analgesics|analgesics|mesh-ancestor
5966249|NCT04574479|Sensory System Agents|sensory system agents|mesh-ancestor
5966250|NCT04574479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5966251|NCT04574141|Melatonin|melatonin|mesh-list
5966252|NCT04574141|Antioxidants|antioxidants|mesh-ancestor
5935436|NCT04857671|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5935437|NCT04857671|Botulinum Toxins|botulinum toxins|mesh-list
5935438|NCT04857671|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5935439|NCT04857671|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5935440|NCT04857671|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5935441|NCT04857671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5935442|NCT04857671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935443|NCT04857671|Cholinergic Agents|cholinergic agents|mesh-ancestor
5935444|NCT04857671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5935445|NCT04857671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935446|NCT04857671|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5935447|NCT04857671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5935448|NCT04857801|Teduglutide|teduglutide|mesh-list
5935449|NCT04857801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5935450|NCT04857801|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5935451|NCT04857801|Protective Agents|protective agents|mesh-ancestor
5935452|NCT04857801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935453|NCT04857840|Firibastat|firibastat|mesh-list
5935454|NCT04857840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5935455|NCT04857320|Insulin|insulin|mesh-list
5935456|NCT04857320|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5935457|NCT04857320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5935458|NCT04857320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935459|NCT04857333|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5935460|NCT04857333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5935461|NCT04857450|Ketamine|ketamine|mesh-list
5935462|NCT04857450|Etomidate|etomidate|mesh-list
5935463|NCT04857450|Analgesics|analgesics|mesh-ancestor
5935464|NCT04857450|Sensory System Agents|sensory system agents|mesh-ancestor
5935465|NCT04857450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5935466|NCT04857450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935467|NCT04857450|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5935468|NCT04857450|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5935469|NCT04857450|Anesthetics, General|anesthetics, general|mesh-ancestor
5935470|NCT04857450|Anesthetics|anesthetics|mesh-ancestor
5935471|NCT04857450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5935472|NCT04857450|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5935473|NCT04857450|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5935474|NCT04857450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5935475|NCT04857450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935476|NCT04857450|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5935477|NCT04857177|Ranibizumab|ranibizumab|mesh-list
5935478|NCT04857177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5935479|NCT04857177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5935480|NCT04857177|Growth Substances|growth substances|mesh-ancestor
5935481|NCT04857177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935482|NCT04857177|Growth Inhibitors|growth inhibitors|mesh-ancestor
5935483|NCT04857177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5935484|NCT04857203|Vitamin D|vitamin d|mesh-list
5935485|NCT04857203|Vitamins|vitamins|mesh-ancestor
5935486|NCT04857203|Micronutrients|micronutrients|mesh-ancestor
5935487|NCT04857203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935488|NCT04857203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5935489|NCT04856761|Capecitabine|capecitabine|mesh-list
5935490|NCT04856761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5935491|NCT04856761|Antimetabolites|antimetabolites|mesh-ancestor
5935492|NCT04856761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935493|NCT04856761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5935494|NCT04856852|Iodine|iodine|mesh-list
5935495|NCT04856852|Temozolomide|temozolomide|mesh-list
5935496|NCT04856852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5935497|NCT04856852|Alkylating Agents|alkylating agents|mesh-ancestor
5935498|NCT04856852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935499|NCT04856852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5935500|NCT04856852|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5935501|NCT04856852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5935502|NCT04856852|Trace Elements|trace elements|mesh-ancestor
5935503|NCT04856852|Micronutrients|micronutrients|mesh-ancestor
5935504|NCT04856852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935505|NCT04856878|Vancomycin|vancomycin|mesh-list
5935506|NCT04856878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5935507|NCT04856878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5935508|NCT04856787|Fluorouracil|fluorouracil|mesh-list
5935509|NCT04856787|Antimetabolites|antimetabolites|mesh-ancestor
5935510|NCT04856787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935511|NCT04856787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5935512|NCT04856787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5935513|NCT04856787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5935514|NCT04856787|Immunologic Factors|immunologic factors|mesh-ancestor
5935515|NCT04856787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935516|NCT04856969|Dapagliflozin|dapagliflozin|mesh-list
5935517|NCT04856969|Olmesartan|olmesartan|mesh-list
5935518|NCT04856969|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5935519|NCT04856969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935520|NCT04856969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5935521|NCT04856969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935522|NCT04856969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5935523|NCT04856969|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5935524|NCT04856969|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5935525|NCT04856644|Moxifloxacin|moxifloxacin|mesh-list
5935526|NCT04856644|Rifapentine|rifapentine|mesh-list
5935527|NCT04856644|Rifampin|rifampin|mesh-list
5935528|NCT04856644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5935529|NCT04856644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5935530|NCT04856644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5935531|NCT04856644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5935532|NCT04856644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5935533|NCT04856644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935534|NCT04856644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5935535|NCT04856644|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5935536|NCT04856644|Antitubercular Agents|antitubercular agents|mesh-ancestor
5935537|NCT04856644|Leprostatic Agents|leprostatic agents|mesh-ancestor
5935538|NCT04856644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5935539|NCT04856644|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5935540|NCT04856644|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5935541|NCT04856644|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5935542|NCT04856644|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5935543|NCT04856644|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5935544|NCT04856644|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5935545|NCT04856631|Cetuximab|cetuximab|mesh-list
5935546|NCT04856631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5935547|NCT04856631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5935548|NCT04856371|Letrozole|letrozole|mesh-list
5719784|NCT03216876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719785|NCT03216876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5719786|NCT03216876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5719787|NCT03217084|Fluorides|fluorides|mesh-list
5719788|NCT03217084|Fluorides, Topical|fluorides, topical|mesh-list
5719789|NCT03217084|Cariostatic Agents|cariostatic agents|mesh-ancestor
5719790|NCT03217084|Protective Agents|protective agents|mesh-ancestor
5719791|NCT03217084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719792|NCT03216941|Ketamine|ketamine|mesh-list
5719793|NCT03216941|Olanzapine|olanzapine|mesh-list
5719794|NCT03216941|Analgesics|analgesics|mesh-ancestor
5719795|NCT03216941|Sensory System Agents|sensory system agents|mesh-ancestor
5719796|NCT03216941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5719797|NCT03216941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935549|NCT04856371|Fulvestrant|fulvestrant|mesh-list
5935550|NCT04856371|Palbociclib|palbociclib|mesh-list
5935551|NCT04856371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5935552|NCT04856371|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5935553|NCT04856371|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5935554|NCT04856371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5935555|NCT04856371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935556|NCT04856371|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5935557|NCT04856371|Hormone Antagonists|hormone antagonists|mesh-ancestor
5935558|NCT04856371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5935559|NCT04856371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935560|NCT04856371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5935561|NCT04856371|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5935562|NCT04856371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5935563|NCT04856137|Paclitaxel|paclitaxel|mesh-list
5935564|NCT04856137|Rituximab|rituximab|mesh-list
5935565|NCT04856137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5935566|NCT04856137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5935567|NCT04856137|Tubulin Modulators|tubulin modulators|mesh-ancestor
5935568|NCT04856137|Antimitotic Agents|antimitotic agents|mesh-ancestor
5935569|NCT04856137|Mitosis Modulators|mitosis modulators|mesh-ancestor
5935570|NCT04856137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719798|NCT03216941|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5935571|NCT04856137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5935572|NCT04856137|Immunologic Factors|immunologic factors|mesh-ancestor
5935573|NCT04856137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935574|NCT04856137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5935575|NCT04856189|Pembrolizumab|pembrolizumab|mesh-list
5935576|NCT04856189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5935577|NCT04856189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5935578|NCT04856098|Glycopyrrolate|glycopyrrolate|mesh-list
5935579|NCT04856098|Bromides|bromides|mesh-list
5935580|NCT04856098|Maleic acid|maleic acid|mesh-list
5935581|NCT04856098|Charcoal|charcoal|mesh-list
5935582|NCT04856098|Anticonvulsants|anticonvulsants|mesh-ancestor
5935583|NCT04856098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5935584|NCT04856098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935585|NCT04856098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5935586|NCT04856098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5935587|NCT04856098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5935588|NCT04856098|Cholinergic Agents|cholinergic agents|mesh-ancestor
5935589|NCT04856098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5935590|NCT04856098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935591|NCT04856098|Antidotes|antidotes|mesh-ancestor
5935592|NCT04856098|Protective Agents|protective agents|mesh-ancestor
5935593|NCT04856111|Pirfenidone|pirfenidone|mesh-list
5935594|NCT04856111|Nintedanib|nintedanib|mesh-list
5935595|NCT04856111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5935596|NCT04856111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5935597|NCT04856111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5935598|NCT04856111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935599|NCT04856111|Analgesics|analgesics|mesh-ancestor
5935600|NCT04856111|Sensory System Agents|sensory system agents|mesh-ancestor
5935601|NCT04856111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5935602|NCT04856111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935603|NCT04856111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5935604|NCT04856111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5935605|NCT04856111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5935606|NCT04856111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5935607|NCT04855968|Analgesics|analgesics|mesh-list
5935608|NCT04855968|Sensory System Agents|sensory system agents|mesh-ancestor
5935609|NCT04855968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5935610|NCT04855968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935611|NCT04856124|Ketamine|ketamine|mesh-list
5935612|NCT04856124|Esketamine|esketamine|mesh-list
5935613|NCT04856124|Analgesics|analgesics|mesh-ancestor
5935614|NCT04856124|Sensory System Agents|sensory system agents|mesh-ancestor
5935615|NCT04856124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5935616|NCT04856124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935617|NCT04856124|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5935618|NCT04856124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5935619|NCT04856124|Anesthetics, General|anesthetics, general|mesh-ancestor
5935620|NCT04856124|Anesthetics|anesthetics|mesh-ancestor
5935621|NCT04856124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5935622|NCT04856124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5935623|NCT04856124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5935624|NCT04856124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5935625|NCT04856124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935626|NCT04856124|Antidepressive Agents|antidepressive agents|mesh-ancestor
5935627|NCT04856124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5966253|NCT04574141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966254|NCT04574141|Protective Agents|protective agents|mesh-ancestor
5966255|NCT04574141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966256|NCT04574141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5966257|NCT04573855|Immunoglobulins|immunoglobulins|mesh-list
5966258|NCT04573855|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5966259|NCT04573855|Antibodies|antibodies|mesh-list
5966260|NCT04573855|Immunologic Factors|immunologic factors|mesh-ancestor
5966261|NCT04573855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966262|NCT04573920|Atrasentan|atrasentan|mesh-list
5966263|NCT04573920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5966264|NCT04573920|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
5966265|NCT04573920|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5966266|NCT04573920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966267|NCT04573803|Phenytoin|phenytoin|mesh-list
5966268|NCT04573803|Levetiracetam|levetiracetam|mesh-list
5966269|NCT04573803|Anticonvulsants|anticonvulsants|mesh-ancestor
5966270|NCT04573803|Nootropic Agents|nootropic agents|mesh-ancestor
5935628|NCT04856007|Metformin|metformin|mesh-list
5935629|NCT04856007|Dapagliflozin|dapagliflozin|mesh-list
5935630|NCT04856007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5935631|NCT04856007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935632|NCT04856007|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5935633|NCT04856007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935634|NCT04855617|Ocrelizumab|ocrelizumab|mesh-list
5935635|NCT04855617|Immunologic Factors|immunologic factors|mesh-ancestor
5935636|NCT04855617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935637|NCT04855513|Metformin|metformin|mesh-list
5935638|NCT04855513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5935639|NCT04855513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935640|NCT04855279|Listerine|listerine|mesh-list
5935641|NCT04855279|Fluorides|fluorides|mesh-list
5935642|NCT04855279|Sodium Fluoride|sodium fluoride|mesh-list
5935643|NCT04855279|Glycerol|glycerol|mesh-list
5935644|NCT04855279|Cariostatic Agents|cariostatic agents|mesh-ancestor
5935645|NCT04855279|Protective Agents|protective agents|mesh-ancestor
5935646|NCT04855279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935647|NCT04855279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5935648|NCT04855279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5935649|NCT04855279|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
5935650|NCT04855266|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
5935651|NCT04855266|Hematinics|hematinics|mesh-ancestor
5935652|NCT04855383|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5935653|NCT04855383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5935654|NCT04855383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935655|NCT04855695|Venetoclax|venetoclax|mesh-list
5935656|NCT04855695|Obinutuzumab|obinutuzumab|mesh-list
5935657|NCT04855695|Acalabrutinib|acalabrutinib|mesh-list
5935658|NCT04855695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5935659|NCT04855695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5935660|NCT04855110|Warfarin|warfarin|mesh-list
5935661|NCT04855110|Anticoagulants|anticoagulants|mesh-ancestor
5935662|NCT04854837|Remdesivir|remdesivir|mesh-list
5935663|NCT04854837|Antimetabolites|antimetabolites|mesh-ancestor
5935664|NCT04854837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935665|NCT04854837|Antiviral Agents|antiviral agents|mesh-ancestor
5935666|NCT04854837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5935667|NCT04854889|Decitabine|decitabine|mesh-list
5935668|NCT04854889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5935669|NCT04854889|Antimetabolites|antimetabolites|mesh-ancestor
5935670|NCT04854889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935671|NCT04854889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5935672|NCT04854889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5935673|NCT04854759|Amantadine|amantadine|mesh-list
5935674|NCT04854759|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5935675|NCT04854759|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5935676|NCT04854759|Antiviral Agents|antiviral agents|mesh-ancestor
5935677|NCT04854759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5935678|NCT04854759|Dopamine Agents|dopamine agents|mesh-ancestor
5935679|NCT04854759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5935680|NCT04854759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935681|NCT04854759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935682|NCT04854759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5935683|NCT04854759|Analgesics|analgesics|mesh-ancestor
5935684|NCT04854759|Sensory System Agents|sensory system agents|mesh-ancestor
5935685|NCT04854759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5935686|NCT04855136|Dexamethasone|dexamethasone|mesh-list
5935687|NCT04855136|Bortezomib|bortezomib|mesh-list
5935688|NCT04855136|Pomalidomide|pomalidomide|mesh-list
5935689|NCT04855136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5935690|NCT04855136|Antiemetics|antiemetics|mesh-ancestor
5935691|NCT04855136|Autonomic Agents|autonomic agents|mesh-ancestor
5935692|NCT04855136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5935693|NCT04855136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935694|NCT04855136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5935695|NCT04855136|Glucocorticoids|glucocorticoids|mesh-ancestor
5935696|NCT04855136|Hormones|hormones|mesh-ancestor
5935697|NCT04855136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5935698|NCT04855136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5935699|NCT04855136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5935700|NCT04855136|Immunologic Factors|immunologic factors|mesh-ancestor
5935701|NCT04855136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5935702|NCT04855136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5935703|NCT04855136|Growth Substances|growth substances|mesh-ancestor
5935704|NCT04855136|Growth Inhibitors|growth inhibitors|mesh-ancestor
5935705|NCT04854668|Bevacizumab|bevacizumab|mesh-list
5935706|NCT04854668|Capecitabine|capecitabine|mesh-list
6517205|NCT00720174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6517206|NCT00720174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6517207|NCT00720174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6517208|NCT00720174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517209|NCT00720174|Immunologic Factors|immunologic factors|mesh-ancestor
5935707|NCT04854668|Oxaliplatin|oxaliplatin|mesh-list
5935708|NCT04854668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5935709|NCT04854668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5935710|NCT04854668|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5935711|NCT04854668|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5935712|NCT04854668|Growth Substances|growth substances|mesh-ancestor
5935713|NCT04854668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935714|NCT04854668|Growth Inhibitors|growth inhibitors|mesh-ancestor
5935715|NCT04854668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5935716|NCT04854668|Antimetabolites|antimetabolites|mesh-ancestor
5935717|NCT04854668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935718|NCT04854460|Ivermectin|ivermectin|mesh-list
5935719|NCT04854460|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5935720|NCT04854460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5935721|NCT04854551|Naltrexone|naltrexone|mesh-list
5935722|NCT04854551|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5935723|NCT04854551|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5935724|NCT04854551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935725|NCT04854551|Sensory System Agents|sensory system agents|mesh-ancestor
5935726|NCT04854551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5935727|NCT04854577|Anesthetics|anesthetics|mesh-list
5935728|NCT04854577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5935729|NCT04854577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935730|NCT04854538|Budesonide|budesonide|mesh-list
5935731|NCT04854538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5935732|NCT04854538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5935733|NCT04854538|Autonomic Agents|autonomic agents|mesh-ancestor
5935734|NCT04854538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5935735|NCT04854538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935736|NCT04854538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5935737|NCT04854538|Respiratory System Agents|respiratory system agents|mesh-ancestor
5935738|NCT04854538|Glucocorticoids|glucocorticoids|mesh-ancestor
5935739|NCT04854538|Hormones|hormones|mesh-ancestor
5935740|NCT04854538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5935741|NCT04854395|Bupivacaine|bupivacaine|mesh-list
5935742|NCT04854395|Anesthetics, Local|anesthetics, local|mesh-ancestor
5935743|NCT04854395|Anesthetics|anesthetics|mesh-ancestor
5935744|NCT04854395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5935745|NCT04854395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935746|NCT04854395|Sensory System Agents|sensory system agents|mesh-ancestor
5935747|NCT04854395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5935748|NCT04854369|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5935749|NCT04854369|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5935750|NCT04854369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935751|NCT04854343|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
5935752|NCT04854343|Protease Inhibitors|protease inhibitors|mesh-list
5935753|NCT04854343|Secretory Leukocyte Peptidase Inhibitor|secretory leukocyte peptidase inhibitor|mesh-list
5935754|NCT04854343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5935755|NCT04854343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935756|NCT04854343|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5935757|NCT04854343|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5935758|NCT04854343|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5935759|NCT04854343|Antiviral Agents|antiviral agents|mesh-ancestor
5935760|NCT04854343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5935761|NCT04854343|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5935762|NCT04854044|TIC10 compound|tic10 compound|mesh-list
5935763|NCT04854044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5966271|NCT04573803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5966272|NCT04573803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5966273|NCT04573803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5966274|NCT04573803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966275|NCT04573803|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5966276|NCT04573803|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5966277|NCT04573647|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5966278|NCT04573647|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5935764|NCT04854252|Fentanyl|fentanyl|mesh-list
5935765|NCT04854252|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5935766|NCT04854252|Narcotics|narcotics|mesh-ancestor
5935767|NCT04854252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5935768|NCT04854252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935769|NCT04854252|Analgesics|analgesics|mesh-ancestor
5935770|NCT04854252|Sensory System Agents|sensory system agents|mesh-ancestor
5935771|NCT04854252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5935772|NCT04854252|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5935773|NCT04854252|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5935774|NCT04854252|Anesthetics, General|anesthetics, general|mesh-ancestor
5935775|NCT04854252|Anesthetics|anesthetics|mesh-ancestor
5935776|NCT04853758|Valsartan|valsartan|mesh-list
5935777|NCT04853758|Enalapril|enalapril|mesh-list
5935778|NCT04853758|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5935779|NCT04853758|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
5935780|NCT04853758|Enzyme Inhibitors|enzyme inhibitors|mesh-list
5935781|NCT04853758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5935782|NCT04853758|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5935783|NCT04853758|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5935784|NCT04853758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935785|NCT04853758|Protease Inhibitors|protease inhibitors|mesh-ancestor
5935786|NCT04853797|Calcium|calcium|mesh-list
5935787|NCT04853797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5935788|NCT04853797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935789|NCT04853875|Amoxicillin|amoxicillin|mesh-list
5935790|NCT04853875|Metronidazole|metronidazole|mesh-list
5935791|NCT04853875|Clarithromycin|clarithromycin|mesh-list
5935792|NCT04853875|Tetracycline|tetracycline|mesh-list
5935793|NCT04853875|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
5935794|NCT04853875|Bismuth|bismuth|mesh-list
5935795|NCT04853875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5935796|NCT04853875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5935797|NCT04853875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5935798|NCT04853875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5935799|NCT04853875|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5935800|NCT04853875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5935801|NCT04853875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935802|NCT04853875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5935803|NCT04853875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5935804|NCT04853875|Antacids|antacids|mesh-ancestor
5935805|NCT04853875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5935806|NCT04853875|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5935807|NCT04853615|Empagliflozin|empagliflozin|mesh-list
5935808|NCT04853615|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
5935809|NCT04853615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935810|NCT04853615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5935811|NCT04853615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935812|NCT04853446|Dexamethasone|dexamethasone|mesh-list
5935813|NCT04853446|Dexamethasone acetate|dexamethasone acetate|mesh-list
5935814|NCT04853446|BB 1101|bb 1101|mesh-list
5935815|NCT04853446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5935816|NCT04853446|Antiemetics|antiemetics|mesh-ancestor
5935817|NCT04853446|Autonomic Agents|autonomic agents|mesh-ancestor
5935818|NCT04853446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5935819|NCT04853446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935820|NCT04853446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5935821|NCT04853446|Glucocorticoids|glucocorticoids|mesh-ancestor
5935822|NCT04853446|Hormones|hormones|mesh-ancestor
5935823|NCT04853446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5935824|NCT04853446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5719799|NCT03216941|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5719800|NCT03216941|Anesthetics, General|anesthetics, general|mesh-ancestor
5719801|NCT03216941|Anesthetics|anesthetics|mesh-ancestor
5719802|NCT03216941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5719803|NCT03216941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5719804|NCT03216941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5719805|NCT03216941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5719806|NCT03216941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719807|NCT03216941|Antiemetics|antiemetics|mesh-ancestor
5719808|NCT03216941|Autonomic Agents|autonomic agents|mesh-ancestor
5719809|NCT03216941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5719810|NCT03216941|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5719811|NCT03216941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5935825|NCT04853446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5935826|NCT04853446|Protease Inhibitors|protease inhibitors|mesh-ancestor
5935827|NCT04853446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5935828|NCT04853446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935829|NCT04853719|Aspirin|aspirin|mesh-list
5935830|NCT04853719|Rivaroxaban|rivaroxaban|mesh-list
5935831|NCT04853719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5935832|NCT04853719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5935833|NCT04853719|Analgesics|analgesics|mesh-ancestor
5935834|NCT04853719|Sensory System Agents|sensory system agents|mesh-ancestor
5935835|NCT04853719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5935836|NCT04853719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935837|NCT04853719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5935838|NCT04853719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5935839|NCT04853719|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5935840|NCT04853719|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5935841|NCT04853719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935842|NCT04853719|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5935843|NCT04853719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5935844|NCT04853719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5935845|NCT04853719|Antipyretics|antipyretics|mesh-ancestor
5935846|NCT04853719|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5935847|NCT04853719|Antithrombins|antithrombins|mesh-ancestor
5935848|NCT04853719|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5935849|NCT04853719|Protease Inhibitors|protease inhibitors|mesh-ancestor
5935850|NCT04853719|Anticoagulants|anticoagulants|mesh-ancestor
5935851|NCT04853589|Hyaluronic Acid|hyaluronic acid|mesh-list
5935852|NCT04853589|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5935853|NCT04853589|Immunologic Factors|immunologic factors|mesh-ancestor
5935854|NCT04853589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935855|NCT04853589|Viscosupplements|viscosupplements|mesh-ancestor
5935856|NCT04853589|Protective Agents|protective agents|mesh-ancestor
5935857|NCT04853628|Ethanol|ethanol|mesh-list
5935858|NCT04853628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5935859|NCT04853628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5935860|NCT04853628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5935861|NCT04853628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935862|NCT04853524|Tenofovir|tenofovir|mesh-list
5935863|NCT04853524|Emtricitabine|emtricitabine|mesh-list
5935864|NCT04853524|Antiviral Agents|antiviral agents|mesh-ancestor
5935865|NCT04853524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5935866|NCT04853524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5935867|NCT04853524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5935868|NCT04853524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5935869|NCT04853524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935870|NCT04853524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5935871|NCT04853524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5935872|NCT04853901|Remdesivir|remdesivir|mesh-list
5935873|NCT04853901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5935874|NCT04853901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935875|NCT04853901|Antimetabolites|antimetabolites|mesh-ancestor
5935876|NCT04853901|Antiviral Agents|antiviral agents|mesh-ancestor
5935877|NCT04853511|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5935878|NCT04853511|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5935879|NCT04853511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935880|NCT04853199|Quercetin|quercetin|mesh-list
5935881|NCT04853199|Antioxidants|antioxidants|mesh-ancestor
5935882|NCT04853199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935883|NCT04853199|Protective Agents|protective agents|mesh-ancestor
5935884|NCT04853199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935885|NCT04853069|Estradiol|estradiol|mesh-list
5935886|NCT04853069|Estrogens|estrogens|mesh-ancestor
5935887|NCT04853069|Hormones|hormones|mesh-ancestor
5935888|NCT04853069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5935889|NCT04853069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935890|NCT04853030|Insulin Aspart|insulin aspart|mesh-list
5935891|NCT04853030|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5935892|NCT04853030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935893|NCT04852458|Hydrocortisone|hydrocortisone|mesh-list
5935894|NCT04852458|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
5935895|NCT04852458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5935896|NCT04852510|Metformin|metformin|mesh-list
5935897|NCT04852510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5935898|NCT04852510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935899|NCT04852315|Caffeine|caffeine|mesh-list
5935900|NCT04852315|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5935901|NCT04852315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935902|NCT04852315|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5935903|NCT04852315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5935904|NCT04852315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935905|NCT04852315|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5935906|NCT04852315|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5935907|NCT04852315|Purinergic Agents|purinergic agents|mesh-ancestor
5935908|NCT04852315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5935909|NCT04852484|Morphine|morphine|mesh-list
5935910|NCT04852484|Ketamine|ketamine|mesh-list
5935911|NCT04852484|Anesthetics|anesthetics|mesh-list
5935912|NCT04852484|Anesthetics, Local|anesthetics, local|mesh-list
5935913|NCT04852484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5935914|NCT04852484|Narcotics|narcotics|mesh-ancestor
5935915|NCT04852484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5935916|NCT04852484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935917|NCT04852484|Analgesics|analgesics|mesh-ancestor
5935918|NCT04852484|Sensory System Agents|sensory system agents|mesh-ancestor
5935919|NCT04852484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5935920|NCT04852484|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5935921|NCT04852484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5935922|NCT04852484|Anesthetics, General|anesthetics, general|mesh-ancestor
5935923|NCT04852484|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5935924|NCT04852484|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5935925|NCT04852484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5935926|NCT04852484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966279|NCT04573426|Acetaminophen|acetaminophen|mesh-list
5966280|NCT04573426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5966281|NCT04573426|Analgesics|analgesics|mesh-ancestor
5966282|NCT04573426|Sensory System Agents|sensory system agents|mesh-ancestor
5966283|NCT04573426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5966284|NCT04573426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966285|NCT04573426|Antipyretics|antipyretics|mesh-ancestor
5966286|NCT04573751|Verapamil|verapamil|mesh-list
5966287|NCT04573751|Epinephrine|epinephrine|mesh-list
5966288|NCT04573751|Racepinephrine|racepinephrine|mesh-list
5966289|NCT04573751|Epinephryl borate|epinephryl borate|mesh-list
5966290|NCT04573751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5966291|NCT04573751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5966292|NCT04573751|Adrenergic Agents|adrenergic agents|mesh-ancestor
5966293|NCT04573751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5966294|NCT04573751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966295|NCT04573751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966296|NCT04573751|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5966297|NCT04573751|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5966298|NCT04573751|Autonomic Agents|autonomic agents|mesh-ancestor
5966299|NCT04573751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5966300|NCT04573751|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5966301|NCT04573751|Respiratory System Agents|respiratory system agents|mesh-ancestor
5966302|NCT04573751|Mydriatics|mydriatics|mesh-ancestor
5966303|NCT04573751|Sympathomimetics|sympathomimetics|mesh-ancestor
5966304|NCT04573751|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5966305|NCT04573751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5966306|NCT04573751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5966307|NCT04573751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5966308|NCT04573751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5966309|NCT04573751|Vasodilator Agents|vasodilator agents|mesh-ancestor
5966310|NCT04573673|Emodin|emodin|mesh-list
5966311|NCT04573673|Cathartics|cathartics|mesh-ancestor
5966312|NCT04573673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5966313|NCT04573673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5966314|NCT04573673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5966315|NCT04573673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966316|NCT04573556|Lemborexant|lemborexant|mesh-list
5966317|NCT04573556|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
5966318|NCT04573556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5966319|NCT04573556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966320|NCT04573556|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5966321|NCT04573556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5966322|NCT04573556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5966323|NCT04573556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970920|NCT04531527|Butenafine|butenafine|mesh-list
5970921|NCT04531527|Antifungal Agents|antifungal agents|mesh-ancestor
5970922|NCT04531527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5970923|NCT04531371|Dexmedetomidine|dexmedetomidine|mesh-list
5970924|NCT04531371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5935927|NCT04852068|Vaccines|vaccines|mesh-list
5935928|NCT04852068|Immunologic Factors|immunologic factors|mesh-ancestor
5935929|NCT04852068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935930|NCT04851769|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
5935931|NCT04851769|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5935932|NCT04851769|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5935933|NCT04851769|Antimetabolites|antimetabolites|mesh-ancestor
5935934|NCT04851769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935935|NCT04851769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5935936|NCT04851769|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5935937|NCT04851821|Quercetin|quercetin|mesh-list
5935938|NCT04851821|Antioxidants|antioxidants|mesh-ancestor
5935939|NCT04851821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935940|NCT04851821|Protective Agents|protective agents|mesh-ancestor
5935941|NCT04851821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935942|NCT04851977|Vaccines|vaccines|mesh-list
5935943|NCT04851977|Immunologic Factors|immunologic factors|mesh-ancestor
5935944|NCT04851977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935945|NCT04851548|Hyaluronic Acid|hyaluronic acid|mesh-list
5935946|NCT04851548|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5935947|NCT04851548|Immunologic Factors|immunologic factors|mesh-ancestor
5935948|NCT04851548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935949|NCT04851548|Viscosupplements|viscosupplements|mesh-ancestor
5935950|NCT04851548|Protective Agents|protective agents|mesh-ancestor
5935951|NCT04851626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
5935952|NCT04851626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5935953|NCT04851626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935954|NCT04852081|Tamoxifen|tamoxifen|mesh-list
5935955|NCT04852081|Letrozole|letrozole|mesh-list
5935956|NCT04852081|Fulvestrant|fulvestrant|mesh-list
5935957|NCT04852081|Palbociclib|palbociclib|mesh-list
5935958|NCT04852081|Anastrozole|anastrozole|mesh-list
5935959|NCT04852081|Exemestane|exemestane|mesh-list
5935960|NCT04852081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5935961|NCT04852081|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5935962|NCT04852081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5935963|NCT04852081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5935964|NCT04852081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935965|NCT04852081|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5935966|NCT04852081|Hormone Antagonists|hormone antagonists|mesh-ancestor
5935967|NCT04852081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5935968|NCT04852081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935969|NCT04852081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5935970|NCT04852081|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5935971|NCT04852081|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5935972|NCT04852081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5935973|NCT04852081|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5935974|NCT04852081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5935975|NCT04851457|Tirofiban|tirofiban|mesh-list
5935976|NCT04851457|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5935977|NCT04851457|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5935978|NCT04851457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935979|NCT04851457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5935980|NCT04851392|Dronabinol|dronabinol|mesh-list
5935981|NCT04851392|Cannabidiol|cannabidiol|mesh-list
5935982|NCT04851392|Anticonvulsants|anticonvulsants|mesh-ancestor
5935983|NCT04851392|Hallucinogens|hallucinogens|mesh-ancestor
5935984|NCT04851392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5935985|NCT04851392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5935986|NCT04851392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5935987|NCT04851392|Analgesics|analgesics|mesh-ancestor
5935988|NCT04851392|Sensory System Agents|sensory system agents|mesh-ancestor
5935989|NCT04851392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5935990|NCT04851392|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5935991|NCT04851392|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5935992|NCT04851392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5935993|NCT04851392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5935994|NCT04851392|Hormones|hormones|mesh-ancestor
5935995|NCT04851392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5935996|NCT04851015|Trimethoprim|trimethoprim|mesh-list
5935997|NCT04851015|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
5935998|NCT04851015|Sulfamethoxazole|sulfamethoxazole|mesh-list
5935999|NCT04851015|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6517210|NCT00720174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517211|NCT00720265|Tacrolimus|tacrolimus|mesh-list
6517212|NCT00720265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6517213|NCT00720265|Immunologic Factors|immunologic factors|mesh-ancestor
6517214|NCT00720265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517215|NCT00720265|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6517216|NCT00720265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6517217|NCT00720265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681224|NCT01608698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6681225|NCT01608698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681226|NCT01608698|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6681227|NCT01608698|Estrogens|estrogens|mesh-ancestor
6681228|NCT01608698|Hormones|hormones|mesh-ancestor
6681229|NCT01608698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6681230|NCT01608698|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6681231|NCT01608698|Hormone Antagonists|hormone antagonists|mesh-ancestor
6681232|NCT01608698|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6681233|NCT01608698|Diuretics|diuretics|mesh-ancestor
6681234|NCT01608698|Natriuretic Agents|natriuretic agents|mesh-ancestor
6681235|NCT01608698|Androgen Antagonists|androgen antagonists|mesh-ancestor
6681236|NCT01608698|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6681237|NCT01608711|Gemcitabine|gemcitabine|mesh-list
6681238|NCT01608711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6681239|NCT01608711|Antimetabolites|antimetabolites|mesh-ancestor
5936000|NCT04851015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5936001|NCT04851015|Renal Agents|renal agents|mesh-ancestor
5936002|NCT04851015|Antimalarials|antimalarials|mesh-ancestor
5936003|NCT04851015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5936004|NCT04851015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5936005|NCT04851015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5936006|NCT04851015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5936007|NCT04851015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5936008|NCT04851015|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5936009|NCT04851015|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
5936010|NCT04851015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5936011|NCT04851015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5936012|NCT04851158|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5936013|NCT04851158|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5936014|NCT04851158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5936015|NCT04851158|Antitubercular Agents|antitubercular agents|mesh-ancestor
5936016|NCT04851002|Mitogens|mitogens|mesh-list
5936017|NCT04851002|Mitosis Modulators|mitosis modulators|mesh-ancestor
5936018|NCT04851002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5936019|NCT04850911|Ketamine|ketamine|mesh-list
5936020|NCT04850911|Analgesics|analgesics|mesh-ancestor
5936021|NCT04850911|Sensory System Agents|sensory system agents|mesh-ancestor
5936022|NCT04850911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5936023|NCT04850911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936024|NCT04850911|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5936025|NCT04850911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5936026|NCT04850911|Anesthetics, General|anesthetics, general|mesh-ancestor
5936027|NCT04850911|Anesthetics|anesthetics|mesh-ancestor
5936028|NCT04850911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5936029|NCT04850911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5936030|NCT04850911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5936031|NCT04850911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5936032|NCT04850911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5936033|NCT04851132|Durvalumab|durvalumab|mesh-list
5936034|NCT04851132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5936035|NCT04851132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5936036|NCT04850885|Dexamethasone|dexamethasone|mesh-list
5936037|NCT04850885|Lidocaine|lidocaine|mesh-list
5936038|NCT04850885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5936039|NCT04850885|Antiemetics|antiemetics|mesh-ancestor
5936040|NCT04850885|Autonomic Agents|autonomic agents|mesh-ancestor
5936041|NCT04850885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5936042|NCT04850885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936043|NCT04850885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5936044|NCT04850885|Glucocorticoids|glucocorticoids|mesh-ancestor
5936045|NCT04850885|Hormones|hormones|mesh-ancestor
5936046|NCT04850885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5936047|NCT04850885|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5966324|NCT04573686|Epoetin Alfa|epoetin alfa|mesh-list
6517218|NCT00720291|Metronidazole|metronidazole|mesh-list
5936048|NCT04850885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5936049|NCT04850885|Anesthetics, Local|anesthetics, local|mesh-ancestor
5936050|NCT04850885|Anesthetics|anesthetics|mesh-ancestor
5936051|NCT04850885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5936052|NCT04850885|Sensory System Agents|sensory system agents|mesh-ancestor
5936053|NCT04850885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5936054|NCT04850885|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5936055|NCT04850885|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5936056|NCT04850885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5936057|NCT04850885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5936058|NCT04850950|Tenofovir|tenofovir|mesh-list
5936059|NCT04850950|Antiviral Agents|antiviral agents|mesh-ancestor
5936060|NCT04850950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5936061|NCT04850950|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5936062|NCT04850950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5936063|NCT04850950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5936064|NCT04850950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5936065|NCT04850950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5936066|NCT04850950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5936067|NCT04850846|Metformin|metformin|mesh-list
5936068|NCT04850846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5936069|NCT04850846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936070|NCT04850937|Esketamine|esketamine|mesh-list
5936071|NCT04850937|Antidepressive Agents|antidepressive agents|mesh-ancestor
5936072|NCT04850937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5936073|NCT04850638|Furosemide|furosemide|mesh-list
5936074|NCT04850638|Diuretics|diuretics|mesh-ancestor
5936075|NCT04850638|Natriuretic Agents|natriuretic agents|mesh-ancestor
5936076|NCT04850638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936077|NCT04850638|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5936078|NCT04850638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5936079|NCT04850638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5936080|NCT04850755|Nivolumab|nivolumab|mesh-list
5936081|NCT04850755|Ipilimumab|ipilimumab|mesh-list
5936082|NCT04850755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5936083|NCT04850755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5936084|NCT04850755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5936085|NCT04850755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5936086|NCT04850378|Dalteparin|dalteparin|mesh-list
5936087|NCT04850378|Tinzaparin|tinzaparin|mesh-list
5936088|NCT04850378|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5936089|NCT04850378|Apixaban|apixaban|mesh-list
5936090|NCT04850378|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5936091|NCT04850378|Antithrombins|antithrombins|mesh-ancestor
5936092|NCT04850378|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5936093|NCT04850378|Protease Inhibitors|protease inhibitors|mesh-ancestor
5936094|NCT04850378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5936095|NCT04850378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5936096|NCT04850378|Anticoagulants|anticoagulants|mesh-ancestor
5936097|NCT04850378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5936098|NCT04850378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5936099|NCT04850560|Decitabine|decitabine|mesh-list
5936100|NCT04850560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5936101|NCT04850560|Antimetabolites|antimetabolites|mesh-ancestor
5936102|NCT04850560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5936103|NCT04850560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5936104|NCT04850560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5966325|NCT04573686|Hematinics|hematinics|mesh-ancestor
5966326|NCT04573153|Hydroxychloroquine|hydroxychloroquine|mesh-list
5966327|NCT04573153|Sorbitol|sorbitol|mesh-list
5966328|NCT04573153|Antimalarials|antimalarials|mesh-ancestor
5966329|NCT04573153|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5966330|NCT04573153|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5966331|NCT04573153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5966332|NCT04573153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5966333|NCT04573153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966334|NCT04573153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5966335|NCT04573153|Cathartics|cathartics|mesh-ancestor
5966336|NCT04573153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5966337|NCT04573192|Lomustine|lomustine|mesh-list
5966338|NCT04573192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5966339|NCT04573192|Alkylating Agents|alkylating agents|mesh-ancestor
5966340|NCT04573192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966341|NCT04573192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5966342|NCT04573049|Simendan|simendan|mesh-list
5966343|NCT04573049|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5936105|NCT04850404|Ropivacaine|ropivacaine|mesh-list
5936106|NCT04850404|Rocuronium|rocuronium|mesh-list
5936107|NCT04850404|Anesthetics, Local|anesthetics, local|mesh-ancestor
5936108|NCT04850404|Anesthetics|anesthetics|mesh-ancestor
5936109|NCT04850404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5936110|NCT04850404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936111|NCT04850404|Sensory System Agents|sensory system agents|mesh-ancestor
5936112|NCT04850404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5936113|NCT04850404|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5936114|NCT04850404|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5936115|NCT04850404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5936116|NCT04850417|Aspirin|aspirin|mesh-list
5936117|NCT04850417|Clopidogrel|clopidogrel|mesh-list
5936118|NCT04850417|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
5936119|NCT04850417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5936120|NCT04850417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5936121|NCT04850417|Analgesics|analgesics|mesh-ancestor
5936122|NCT04850417|Sensory System Agents|sensory system agents|mesh-ancestor
5936123|NCT04850417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5936124|NCT04850417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936125|NCT04850417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5936126|NCT04850417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5936127|NCT04850417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5936128|NCT04850417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5936129|NCT04850417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5936130|NCT04850417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5936131|NCT04850417|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5936132|NCT04850417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5936133|NCT04850417|Antipyretics|antipyretics|mesh-ancestor
5936134|NCT04850417|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5936135|NCT04850417|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5936136|NCT04850417|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5936137|NCT04850417|Purinergic Agents|purinergic agents|mesh-ancestor
5936138|NCT04850417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5936139|NCT04850417|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5936140|NCT04850417|Adrenergic Agents|adrenergic agents|mesh-ancestor
5936141|NCT04850235|Paclitaxel|paclitaxel|mesh-list
5936142|NCT04850235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5936143|NCT04850235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5936144|NCT04850235|Tubulin Modulators|tubulin modulators|mesh-ancestor
5936145|NCT04850235|Antimitotic Agents|antimitotic agents|mesh-ancestor
5936146|NCT04850235|Mitosis Modulators|mitosis modulators|mesh-ancestor
5936147|NCT04850235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5936148|NCT04850261|Nafarelin|nafarelin|mesh-list
5936149|NCT04850261|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5936150|NCT04850261|Fertility Agents|fertility agents|mesh-ancestor
5936151|NCT04850261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5936152|NCT04850261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936153|NCT04850040|Oxaliplatin|oxaliplatin|mesh-list
5936154|NCT04850040|Apatinib|apatinib|mesh-list
5936155|NCT04850040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5936156|NCT04850040|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5936157|NCT04850040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5936158|NCT04850040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5936159|NCT04850001|Aspirin|aspirin|mesh-list
5936160|NCT04850001|Clopidogrel|clopidogrel|mesh-list
5936161|NCT04850001|Atorvastatin|atorvastatin|mesh-list
5936162|NCT04850001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5936163|NCT04850001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5936164|NCT04850001|Analgesics|analgesics|mesh-ancestor
5936165|NCT04850001|Sensory System Agents|sensory system agents|mesh-ancestor
5936166|NCT04850001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5936167|NCT04850001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936168|NCT04850001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5936169|NCT04850001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5936170|NCT04850001|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5936171|NCT04850001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5936172|NCT04850001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5936173|NCT04850001|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5936174|NCT04850001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5936175|NCT04850001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5936176|NCT04850001|Antipyretics|antipyretics|mesh-ancestor
5936177|NCT04850001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5936178|NCT04850001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5936179|NCT04850001|Antimetabolites|antimetabolites|mesh-ancestor
5936180|NCT04850001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5936181|NCT04850001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5936182|NCT04850001|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5936183|NCT04850001|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5936184|NCT04850001|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5936185|NCT04850001|Purinergic Agents|purinergic agents|mesh-ancestor
5936186|NCT04850001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5936187|NCT04849845|Insulin|insulin|mesh-list
5936188|NCT04849845|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5936189|NCT04849845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5936190|NCT04849845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936191|NCT04849858|Bupivacaine|bupivacaine|mesh-list
5936192|NCT04849858|Anesthetics, Local|anesthetics, local|mesh-ancestor
5936193|NCT04849858|Anesthetics|anesthetics|mesh-ancestor
5936194|NCT04849858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5936195|NCT04849858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936196|NCT04849858|Sensory System Agents|sensory system agents|mesh-ancestor
5936197|NCT04849858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5936198|NCT04849533|Mycophenolic Acid|mycophenolic acid|mesh-list
5936199|NCT04849533|Prednisone|prednisone|mesh-list
5936200|NCT04849533|Everolimus|everolimus|mesh-list
5936201|NCT04849533|Abatacept|abatacept|mesh-list
5936202|NCT04849533|Thymoglobulin|thymoglobulin|mesh-list
5936203|NCT04849533|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5936204|NCT04849533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5936205|NCT04849533|Glucocorticoids|glucocorticoids|mesh-ancestor
5936206|NCT04849533|Hormones|hormones|mesh-ancestor
5936207|NCT04849533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5936208|NCT04849533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936209|NCT04849533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5936210|NCT04849533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5936211|NCT04849533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5936212|NCT04849533|Immunologic Factors|immunologic factors|mesh-ancestor
5936213|NCT04849533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5936214|NCT04849533|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5936215|NCT04849533|Antitubercular Agents|antitubercular agents|mesh-ancestor
5936216|NCT04849533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5936217|NCT04849533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5936218|NCT04849533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5936219|NCT04849533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5936220|NCT04849533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5936221|NCT04849533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5936222|NCT04849377|Cisplatin|cisplatin|mesh-list
5936223|NCT04849377|Carboplatin|carboplatin|mesh-list
5936224|NCT04849377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5936225|NCT04849455|Morphine|morphine|mesh-list
5936226|NCT04849455|Ropivacaine|ropivacaine|mesh-list
5936227|NCT04849455|Anesthetics, Local|anesthetics, local|mesh-list
5936228|NCT04849455|Anesthetics|anesthetics|mesh-list
5936229|NCT04849455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5936230|NCT04849455|Narcotics|narcotics|mesh-ancestor
5936231|NCT04849455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5936232|NCT04849455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936233|NCT04849455|Analgesics|analgesics|mesh-ancestor
5936234|NCT04849455|Sensory System Agents|sensory system agents|mesh-ancestor
5936235|NCT04849455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5936236|NCT04849390|Mometasone Furoate|mometasone furoate|mesh-list
5936237|NCT04849390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5936238|NCT04849390|Dermatologic Agents|dermatologic agents|mesh-ancestor
5936239|NCT04849390|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5936240|NCT04849013|Ketanserin|ketanserin|mesh-list
5936241|NCT04849013|Mescaline|mescaline|mesh-list
5936242|NCT04849013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5936243|NCT04849013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5936244|NCT04849013|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5936245|NCT04849013|Serotonin Agents|serotonin agents|mesh-ancestor
5936246|NCT04849013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5936247|NCT04849013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5936248|NCT04849013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936249|NCT04849013|Hallucinogens|hallucinogens|mesh-ancestor
5936250|NCT04849013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5936251|NCT04849013|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5936252|NCT04849026|Clozapine|clozapine|mesh-list
5936253|NCT04849026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5936254|NCT04849026|Serotonin Agents|serotonin agents|mesh-ancestor
5936255|NCT04849026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5936256|NCT04849026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5936257|NCT04849026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936258|NCT04849026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5936259|NCT04849026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5936260|NCT04849026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5936261|NCT04849026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5936262|NCT04849026|GABA Antagonists|gaba antagonists|mesh-ancestor
5936263|NCT04849026|GABA Agents|gaba agents|mesh-ancestor
5936264|NCT04849299|Cyclosporine|cyclosporine|mesh-list
5936265|NCT04849299|Cyclosporins|cyclosporins|mesh-list
5936266|NCT04849299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5936267|NCT04849299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5936268|NCT04849299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5936269|NCT04849299|Immunologic Factors|immunologic factors|mesh-ancestor
5936270|NCT04849299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936271|NCT04849299|Antifungal Agents|antifungal agents|mesh-ancestor
5936272|NCT04849299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5936273|NCT04849299|Dermatologic Agents|dermatologic agents|mesh-ancestor
5936274|NCT04849299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5936275|NCT04849299|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5936276|NCT04848974|Cytarabine|cytarabine|mesh-list
5936277|NCT04848974|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
5936278|NCT04848974|Cladribine|cladribine|mesh-list
5936279|NCT04848974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5936280|NCT04848974|Antimetabolites|antimetabolites|mesh-ancestor
5936281|NCT04848974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5936282|NCT04848974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5936283|NCT04848974|Antiviral Agents|antiviral agents|mesh-ancestor
5936284|NCT04848974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5936285|NCT04848974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5936286|NCT04848974|Immunologic Factors|immunologic factors|mesh-ancestor
5936287|NCT04848974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936288|NCT04848857|Colchicine|colchicine|mesh-list
5936289|NCT04848857|Gout Suppressants|gout suppressants|mesh-ancestor
5936290|NCT04848857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5936291|NCT04848857|Tubulin Modulators|tubulin modulators|mesh-ancestor
5936292|NCT04848857|Antimitotic Agents|antimitotic agents|mesh-ancestor
5936293|NCT04848857|Mitosis Modulators|mitosis modulators|mesh-ancestor
5936294|NCT04848857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5936295|NCT04848857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5936296|NCT04848792|Sulforaphane|sulforaphane|mesh-list
5936297|NCT04848792|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5936298|NCT04848792|Protective Agents|protective agents|mesh-ancestor
5936299|NCT04848792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936300|NCT04848792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5936301|NCT04848662|Budesonide|budesonide|mesh-list
5936302|NCT04848662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5936303|NCT04848662|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5936304|NCT04848662|Autonomic Agents|autonomic agents|mesh-ancestor
5936305|NCT04848662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5936306|NCT04848662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936307|NCT04848662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5936308|NCT04848662|Respiratory System Agents|respiratory system agents|mesh-ancestor
5936309|NCT04848662|Glucocorticoids|glucocorticoids|mesh-ancestor
5936310|NCT04848662|Hormones|hormones|mesh-ancestor
5936311|NCT04848662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5966344|NCT04573049|Vasodilator Agents|vasodilator agents|mesh-ancestor
5966345|NCT04573049|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5966346|NCT04573049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5966347|NCT04573049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5966348|NCT04573049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966349|NCT04573049|Protective Agents|protective agents|mesh-ancestor
5966350|NCT04573049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966351|NCT04572698|Endothelial Growth Factors|endothelial growth factors|mesh-list
5966352|NCT04572698|Growth Substances|growth substances|mesh-ancestor
5966353|NCT04572698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966354|NCT04572867|Diuretics|diuretics|mesh-list
5966355|NCT04572867|Natriuretic Agents|natriuretic agents|mesh-ancestor
5966356|NCT04572867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966357|NCT04572685|Paliperidone Palmitate|paliperidone palmitate|mesh-list
5966358|NCT04572685|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5966359|NCT04572685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5966360|NCT04572685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5966361|NCT04572685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966362|NCT04572685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5966363|NCT04572685|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5936312|NCT04848597|Paclitaxel|paclitaxel|mesh-list
5936313|NCT04848597|Antibodies|antibodies|mesh-list
5936314|NCT04848597|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5936315|NCT04848597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5936316|NCT04848597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5936317|NCT04848597|Tubulin Modulators|tubulin modulators|mesh-ancestor
5936318|NCT04848597|Antimitotic Agents|antimitotic agents|mesh-ancestor
5936319|NCT04848597|Mitosis Modulators|mitosis modulators|mesh-ancestor
5936320|NCT04848597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5936321|NCT04848597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936322|NCT04848597|Immunologic Factors|immunologic factors|mesh-ancestor
5936323|NCT04848467|Vaccines|vaccines|mesh-list
5936324|NCT04848467|Immunologic Factors|immunologic factors|mesh-ancestor
5936325|NCT04848467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936326|NCT04848259|Dexamethasone|dexamethasone|mesh-list
5936327|NCT04848259|Dexamethasone acetate|dexamethasone acetate|mesh-list
5936328|NCT04848259|BB 1101|bb 1101|mesh-list
5936329|NCT04848259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5936330|NCT04848259|Antiemetics|antiemetics|mesh-ancestor
5936331|NCT04848259|Autonomic Agents|autonomic agents|mesh-ancestor
5936332|NCT04848259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5936333|NCT04848259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936334|NCT04848259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5936335|NCT04848259|Glucocorticoids|glucocorticoids|mesh-ancestor
5936336|NCT04848259|Hormones|hormones|mesh-ancestor
5936337|NCT04848259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5936338|NCT04848259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5936339|NCT04848259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5936340|NCT04848259|Protease Inhibitors|protease inhibitors|mesh-ancestor
5936341|NCT04848259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5936342|NCT04848259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5936343|NCT04848519|Pembrolizumab|pembrolizumab|mesh-list
5936344|NCT04848519|Propranolol|propranolol|mesh-list
5936345|NCT04848519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5936346|NCT04848519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5936347|NCT04848519|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5936348|NCT04848519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5936349|NCT04848519|Adrenergic Agents|adrenergic agents|mesh-ancestor
5936350|NCT04848519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5936351|NCT04848519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5936352|NCT04848519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936353|NCT04848519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5936354|NCT04848519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5936355|NCT04848519|Vasodilator Agents|vasodilator agents|mesh-ancestor
5936356|NCT04848246|Bupropion|bupropion|mesh-list
5936357|NCT04848246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5936358|NCT04848246|Antidepressive Agents|antidepressive agents|mesh-ancestor
5936359|NCT04848246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5936360|NCT04848246|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5936361|NCT04848246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5936362|NCT04848246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5936363|NCT04848246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5936364|NCT04848246|Dopamine Agents|dopamine agents|mesh-ancestor
5936365|NCT04848246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5936366|NCT04848246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936367|NCT04848246|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5936368|NCT04848246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5936369|NCT04848246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5936370|NCT04848181|Cyproterone Acetate|cyproterone acetate|mesh-list
5936371|NCT04848181|Finasteride|finasteride|mesh-list
5936372|NCT04848181|Cyproterone|cyproterone|mesh-list
5936373|NCT04848181|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
5936374|NCT04848181|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5936375|NCT04848181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5936376|NCT04848181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5936377|NCT04848181|Hormone Antagonists|hormone antagonists|mesh-ancestor
5936378|NCT04848181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5936379|NCT04848181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936380|NCT04848181|Urological Agents|urological agents|mesh-ancestor
5936381|NCT04848181|Androgen Antagonists|androgen antagonists|mesh-ancestor
5936382|NCT04848181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5936383|NCT04848181|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5936384|NCT04848181|Contraceptive Agents|contraceptive agents|mesh-ancestor
5936385|NCT04848181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5936386|NCT04848116|Nivolumab|nivolumab|mesh-list
5936387|NCT04848116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5936388|NCT04848116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5936389|NCT04848116|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5936390|NCT04848116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5936391|NCT04847791|Lactoferrin|lactoferrin|mesh-list
5936392|NCT04847791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5936393|NCT04848064|Cyclophosphamide|cyclophosphamide|mesh-list
5936394|NCT04848064|Fludarabine|fludarabine|mesh-list
5936395|NCT04848064|Mogamulizumab|mogamulizumab|mesh-list
5936396|NCT04848064|Immunoglobulins|immunoglobulins|mesh-list
5936397|NCT04848064|Immunoglobulin G|immunoglobulin g|mesh-list
5936398|NCT04848064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5936399|NCT04848064|Immunologic Factors|immunologic factors|mesh-ancestor
5936400|NCT04848064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936401|NCT04848064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5936402|NCT04848064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5936403|NCT04848064|Alkylating Agents|alkylating agents|mesh-ancestor
5936404|NCT04848064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5936405|NCT04848064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5936406|NCT04848064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5936407|NCT04847921|Dalbavancin|dalbavancin|mesh-list
5936408|NCT04847921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5936409|NCT04847921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5936410|NCT04847895|Ranibizumab|ranibizumab|mesh-list
5936411|NCT04847895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5936412|NCT04847895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5936413|NCT04847895|Growth Substances|growth substances|mesh-ancestor
5936414|NCT04847895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936415|NCT04847895|Growth Inhibitors|growth inhibitors|mesh-ancestor
5936416|NCT04847895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5936417|NCT04847947|Vitamin D|vitamin d|mesh-list
5936418|NCT04847947|Cholecalciferol|cholecalciferol|mesh-list
5936419|NCT04847947|Vitamins|vitamins|mesh-ancestor
5936420|NCT04847947|Micronutrients|micronutrients|mesh-ancestor
5936421|NCT04847947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936422|NCT04847947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5936423|NCT04847947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5936424|NCT04847752|Aspirin|aspirin|mesh-list
5936425|NCT04847752|Warfarin|warfarin|mesh-list
5936426|NCT04847752|Rivaroxaban|rivaroxaban|mesh-list
5936427|NCT04847752|Dabigatran|dabigatran|mesh-list
5936428|NCT04847752|Anticoagulants|anticoagulants|mesh-list
5936429|NCT04847752|Clopidogrel|clopidogrel|mesh-list
5936430|NCT04847752|Atorvastatin|atorvastatin|mesh-list
5936431|NCT04847752|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5936432|NCT04847752|Evolocumab|evolocumab|mesh-list
5936433|NCT04847752|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
5936434|NCT04847752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5936435|NCT04847752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5936436|NCT04847752|Analgesics|analgesics|mesh-ancestor
5936437|NCT04847752|Sensory System Agents|sensory system agents|mesh-ancestor
5936438|NCT04847752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5936439|NCT04847752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936440|NCT04847752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5936441|NCT04847752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5936442|NCT04847752|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5936443|NCT04847752|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5936444|NCT04847752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5936445|NCT04847752|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5936446|NCT04847752|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5936447|NCT04847752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5936448|NCT04847752|Antipyretics|antipyretics|mesh-ancestor
5936449|NCT04847752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5936450|NCT04847752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5936451|NCT04847752|Antimetabolites|antimetabolites|mesh-ancestor
5936452|NCT04847752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5936453|NCT04847752|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5936454|NCT04847752|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5936455|NCT04847752|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5936456|NCT04847752|Purinergic Agents|purinergic agents|mesh-ancestor
5936457|NCT04847752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5936458|NCT04847752|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5936459|NCT04847752|Antithrombins|antithrombins|mesh-ancestor
5936460|NCT04847752|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5936461|NCT04847752|Protease Inhibitors|protease inhibitors|mesh-ancestor
5936462|NCT04847622|Remdesivir|remdesivir|mesh-list
5936463|NCT04847622|Antimetabolites|antimetabolites|mesh-ancestor
5936464|NCT04847622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5936465|NCT04847622|Antiviral Agents|antiviral agents|mesh-ancestor
5936466|NCT04847622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5936467|NCT04847661|Mefloquine|mefloquine|mesh-list
5936468|NCT04847661|Antimalarials|antimalarials|mesh-ancestor
5936469|NCT04847661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5936470|NCT04847661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5936471|NCT04847661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5936472|NCT04847687|Methylprednisolone|methylprednisolone|mesh-list
5936473|NCT04847687|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5936474|NCT04847687|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5936475|NCT04847687|Prednisolone|prednisolone|mesh-list
5936476|NCT04847687|Prednisolone acetate|prednisolone acetate|mesh-list
5936477|NCT04847687|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5936478|NCT04847687|Prednisolone phosphate|prednisolone phosphate|mesh-list
5936479|NCT04847687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5936480|NCT04847687|Antiemetics|antiemetics|mesh-ancestor
5936481|NCT04847687|Autonomic Agents|autonomic agents|mesh-ancestor
5936482|NCT04847687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5936483|NCT04847687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936484|NCT04847687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5936485|NCT04847687|Glucocorticoids|glucocorticoids|mesh-ancestor
5936486|NCT04847687|Hormones|hormones|mesh-ancestor
5936487|NCT04847687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5936488|NCT04847687|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5936489|NCT04847687|Protective Agents|protective agents|mesh-ancestor
5936490|NCT04847687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5936491|NCT04847687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5936492|NCT04847375|Pulmonary Surfactants|pulmonary surfactants|mesh-list
5936493|NCT04847375|Respiratory System Agents|respiratory system agents|mesh-ancestor
5936494|NCT04847024|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
5936495|NCT04847024|Parecoxib|parecoxib|mesh-list
5936496|NCT04847024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5936497|NCT04847024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5936498|NCT04847024|Analgesics|analgesics|mesh-ancestor
5936499|NCT04847024|Sensory System Agents|sensory system agents|mesh-ancestor
5936500|NCT04847024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5936501|NCT04847024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936502|NCT04847024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5936503|NCT04847024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5936504|NCT04847024|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5936505|NCT04847024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5936506|NCT04847024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5936507|NCT04847024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5936508|NCT04847245|Pregabalin|pregabalin|mesh-list
5936509|NCT04847245|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5936510|NCT04847245|Esketamine|esketamine|mesh-list
5936511|NCT04847245|Analgesics|analgesics|mesh-ancestor
5936512|NCT04847245|Sensory System Agents|sensory system agents|mesh-ancestor
6681240|NCT01608711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681241|NCT01608711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5936513|NCT04847245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5936514|NCT04847245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936515|NCT04847245|Anticonvulsants|anticonvulsants|mesh-ancestor
5936516|NCT04847245|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5936517|NCT04847245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5936518|NCT04847245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5936519|NCT04847245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5936520|NCT04847245|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5936521|NCT04847245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5936522|NCT04847245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5936523|NCT04847245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5936524|NCT04847245|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5936525|NCT04847245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5936526|NCT04847245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5936527|NCT04847245|Antidepressive Agents|antidepressive agents|mesh-ancestor
5936528|NCT04847245|Dopamine Agents|dopamine agents|mesh-ancestor
6517219|NCT00720291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6517220|NCT00720291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6517221|NCT00720291|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6517222|NCT00720291|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6517223|NCT00720304|Docetaxel|docetaxel|mesh-list
6517224|NCT00720304|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5936529|NCT04847193|Xanthohumol|xanthohumol|mesh-list
5936530|NCT04847193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5936531|NCT04847193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5936532|NCT04847193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5936533|NCT04847193|Growth Substances|growth substances|mesh-ancestor
5936534|NCT04847193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936535|NCT04847193|Growth Inhibitors|growth inhibitors|mesh-ancestor
5936536|NCT04846673|Thioctic Acid|thioctic acid|mesh-list
5936537|NCT04846673|Pregabalin|pregabalin|mesh-list
5936538|NCT04846673|Analgesics|analgesics|mesh-ancestor
5936539|NCT04846673|Sensory System Agents|sensory system agents|mesh-ancestor
5936540|NCT04846673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5936541|NCT04846673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936542|NCT04846673|Anticonvulsants|anticonvulsants|mesh-ancestor
5936543|NCT04846673|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5936544|NCT04846673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5936545|NCT04846673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5936546|NCT04846673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5936547|NCT04846673|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5936548|NCT04846673|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5936549|NCT04846673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5936550|NCT04846673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5936551|NCT04846673|Antioxidants|antioxidants|mesh-ancestor
5936552|NCT04846673|Protective Agents|protective agents|mesh-ancestor
5936553|NCT04846673|Vitamin B Complex|vitamin b complex|mesh-ancestor
5936554|NCT04846673|Vitamins|vitamins|mesh-ancestor
5936555|NCT04846673|Micronutrients|micronutrients|mesh-ancestor
5966364|NCT04572685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5966365|NCT04572685|Serotonin Agents|serotonin agents|mesh-ancestor
5966366|NCT04572685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5966367|NCT04572685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966368|NCT04572685|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5966369|NCT04572685|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5966370|NCT04572685|Dopamine Agents|dopamine agents|mesh-ancestor
5966371|NCT04572724|Valsartan|valsartan|mesh-list
5966372|NCT04572724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5966373|NCT04572724|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5966374|NCT04572724|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5966375|NCT04572724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966376|NCT04572997|Apremilast|apremilast|mesh-list
5966377|NCT04572997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5966378|NCT04572997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5966379|NCT04572997|Analgesics|analgesics|mesh-ancestor
5966380|NCT04572997|Sensory System Agents|sensory system agents|mesh-ancestor
5966381|NCT04572997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5966382|NCT04572997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966383|NCT04572997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5966384|NCT04572997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5966385|NCT04572997|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5966386|NCT04572997|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5966387|NCT04572997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5966388|NCT04572997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966389|NCT04572620|Rituximab|rituximab|mesh-list
5966390|NCT04572620|Abatacept|abatacept|mesh-list
5966391|NCT04572620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5966392|NCT04572620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5966393|NCT04572620|Immunologic Factors|immunologic factors|mesh-ancestor
5966394|NCT04572620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966395|NCT04572620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5966396|NCT04572620|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5966397|NCT04572620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966398|NCT04572620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5966399|NCT04572542|Paclitaxel|paclitaxel|mesh-list
5966400|NCT04572542|Apatinib|apatinib|mesh-list
5966401|NCT04572542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5966402|NCT04572542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5966403|NCT04572542|Tubulin Modulators|tubulin modulators|mesh-ancestor
5966404|NCT04572542|Antimitotic Agents|antimitotic agents|mesh-ancestor
5966405|NCT04572542|Mitosis Modulators|mitosis modulators|mesh-ancestor
5966406|NCT04572542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966407|NCT04572542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5966408|NCT04572542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5966409|NCT04572763|Venetoclax|venetoclax|mesh-list
5966410|NCT04572763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6681242|NCT01608711|Antiviral Agents|antiviral agents|mesh-ancestor
5936556|NCT04846621|Calcium Channel Blockers|calcium channel blockers|mesh-list
5936557|NCT04846621|Calcium|calcium|mesh-list
5936558|NCT04846621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5936559|NCT04846621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936560|NCT04846621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5936561|NCT04846621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5936562|NCT04846829|Citalopram|citalopram|mesh-list
5936563|NCT04846829|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5936564|NCT04846829|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5936565|NCT04846829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5936566|NCT04846829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5936567|NCT04846829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5936568|NCT04846829|Serotonin Agents|serotonin agents|mesh-ancestor
5936569|NCT04846829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936570|NCT04846829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5936571|NCT04846829|Antidepressive Agents|antidepressive agents|mesh-ancestor
5936572|NCT04846829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5936573|NCT04846855|Anesthetics|anesthetics|mesh-list
5936574|NCT04846855|Anesthetics, Local|anesthetics, local|mesh-list
5936575|NCT04846855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5936576|NCT04846855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936577|NCT04846855|Sensory System Agents|sensory system agents|mesh-ancestor
5936578|NCT04846855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5936579|NCT04846634|Gemcitabine|gemcitabine|mesh-list
5936580|NCT04846634|Paclitaxel|paclitaxel|mesh-list
5936581|NCT04846634|Docetaxel|docetaxel|mesh-list
5936582|NCT04846634|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5936583|NCT04846634|Cisplatin|cisplatin|mesh-list
5936584|NCT04846634|Carboplatin|carboplatin|mesh-list
5936585|NCT04846634|Pemetrexed|pemetrexed|mesh-list
5936586|NCT04846634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5936587|NCT04846634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5936588|NCT04846634|Tubulin Modulators|tubulin modulators|mesh-ancestor
5936589|NCT04846634|Antimitotic Agents|antimitotic agents|mesh-ancestor
5936590|NCT04846634|Mitosis Modulators|mitosis modulators|mesh-ancestor
5936591|NCT04846634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5936592|NCT04846634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5936593|NCT04846634|Antimetabolites|antimetabolites|mesh-ancestor
5936594|NCT04846634|Antiviral Agents|antiviral agents|mesh-ancestor
5936595|NCT04846634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5936596|NCT04846634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5936597|NCT04846634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5936598|NCT04846634|Immunologic Factors|immunologic factors|mesh-ancestor
5936599|NCT04846634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936600|NCT04846634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5936601|NCT04846634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5936602|NCT04846491|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
5936603|NCT04846491|Interferon-alpha|interferon-alpha|mesh-list
5936604|NCT04846491|Antiviral Agents|antiviral agents|mesh-ancestor
5936605|NCT04846491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5936606|NCT04846491|Immunologic Factors|immunologic factors|mesh-ancestor
5936607|NCT04846491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936608|NCT04846452|Paclitaxel|paclitaxel|mesh-list
5936609|NCT04846452|Carboplatin|carboplatin|mesh-list
5936610|NCT04846452|Pemetrexed|pemetrexed|mesh-list
5936611|NCT04846452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5936612|NCT04846452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5936613|NCT04846452|Tubulin Modulators|tubulin modulators|mesh-ancestor
5936614|NCT04846452|Antimitotic Agents|antimitotic agents|mesh-ancestor
5936615|NCT04846452|Mitosis Modulators|mitosis modulators|mesh-ancestor
5936616|NCT04846452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5936617|NCT04846452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5936618|NCT04846452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5936619|NCT04846452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5936620|NCT04846478|Talazoparib|talazoparib|mesh-list
5936621|NCT04846478|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5936622|NCT04846478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5936623|NCT04846478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5936624|NCT04846478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5936625|NCT04846335|Doxycycline|doxycycline|mesh-list
5936626|NCT04846335|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5936627|NCT04846335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5936628|NCT04846335|Antimalarials|antimalarials|mesh-ancestor
5936629|NCT04846335|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5936630|NCT04846335|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5936631|NCT04846348|Diphenhydramine|diphenhydramine|mesh-list
5936632|NCT04846348|Promethazine|promethazine|mesh-list
5936633|NCT04846348|Salicylates|salicylates|mesh-list
5936634|NCT04846348|Cromolyn Sodium|cromolyn sodium|mesh-list
5936635|NCT04846348|Emollients|emollients|mesh-list
5936636|NCT04846348|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5936637|NCT04846348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5936638|NCT04846348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5936639|NCT04846348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936640|NCT04846348|Anesthetics, Local|anesthetics, local|mesh-ancestor
5936641|NCT04846348|Anesthetics|anesthetics|mesh-ancestor
5936642|NCT04846348|Sensory System Agents|sensory system agents|mesh-ancestor
5936643|NCT04846348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5936644|NCT04846348|Antiemetics|antiemetics|mesh-ancestor
5936645|NCT04846348|Autonomic Agents|autonomic agents|mesh-ancestor
5936646|NCT04846348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5936647|NCT04846348|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5936648|NCT04846348|Histamine Antagonists|histamine antagonists|mesh-ancestor
5936649|NCT04846348|Histamine Agents|histamine agents|mesh-ancestor
5936650|NCT04846348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5936651|NCT04846348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5936652|NCT04846348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5936653|NCT04846348|Antipruritics|antipruritics|mesh-ancestor
5936654|NCT04846348|Dermatologic Agents|dermatologic agents|mesh-ancestor
5936655|NCT04846348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5936656|NCT04846348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5936657|NCT04846348|Analgesics|analgesics|mesh-ancestor
5936658|NCT04846348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5936659|NCT04846348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5936660|NCT04846348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5936661|NCT04846348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5936662|NCT04846348|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
5936663|NCT04846348|Immunologic Factors|immunologic factors|mesh-ancestor
5936664|NCT04846348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5936665|NCT04846348|Respiratory System Agents|respiratory system agents|mesh-ancestor
5936666|NCT04845880|Myeloma Proteins|myeloma proteins|mesh-list
5936667|NCT04845880|Paraproteins|paraproteins|mesh-list
5936668|NCT04845880|Immunologic Factors|immunologic factors|mesh-ancestor
5936669|NCT04845880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936670|NCT04845737|Vitamin D|vitamin d|mesh-list
5936671|NCT04845737|Vitamins|vitamins|mesh-ancestor
5936672|NCT04845737|Micronutrients|micronutrients|mesh-ancestor
5936673|NCT04845737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936674|NCT04845737|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5936675|NCT04845607|Amiodarone|amiodarone|mesh-list
5936676|NCT04845607|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5936677|NCT04845607|Vasodilator Agents|vasodilator agents|mesh-ancestor
5936678|NCT04845607|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5936679|NCT04845607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5936680|NCT04845607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5936681|NCT04845607|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5936682|NCT04845607|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5936683|NCT04845607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5936684|NCT04845607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5936685|NCT04845607|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5936686|NCT04845607|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5936687|NCT04845607|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5936688|NCT04845672|Chlorhexidine|chlorhexidine|mesh-list
5936689|NCT04845672|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5936690|NCT04845672|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5936691|NCT04845672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5936692|NCT04845672|Disinfectants|disinfectants|mesh-ancestor
5936693|NCT04845672|Dermatologic Agents|dermatologic agents|mesh-ancestor
5936694|NCT04845646|Itraconazole|itraconazole|mesh-list
5936695|NCT04845646|Phenytoin|phenytoin|mesh-list
5936696|NCT04845646|Antifungal Agents|antifungal agents|mesh-ancestor
5936697|NCT04845646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5936698|NCT04845646|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5936699|NCT04845646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5936700|NCT04845646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5936701|NCT04845646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5936702|NCT04845646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5936703|NCT04845646|Hormone Antagonists|hormone antagonists|mesh-ancestor
5936704|NCT04845646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5936705|NCT04845646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936706|NCT04845646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5936707|NCT04845646|Anticonvulsants|anticonvulsants|mesh-ancestor
5936708|NCT04845646|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5936709|NCT04845646|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5936710|NCT04845646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5936711|NCT04845646|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5936712|NCT04845646|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5936713|NCT04845399|Factor VIII|factor viii|mesh-list
5936714|NCT04845399|Coagulants|coagulants|mesh-ancestor
5936715|NCT04845217|Peppermint oil|peppermint oil|mesh-list
5936716|NCT04845217|Antiemetics|antiemetics|mesh-ancestor
5936717|NCT04845217|Autonomic Agents|autonomic agents|mesh-ancestor
5936718|NCT04845217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5936719|NCT04845217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936720|NCT04845217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5936721|NCT04845217|Parasympatholytics|parasympatholytics|mesh-ancestor
5966411|NCT04572516|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5966412|NCT04572516|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5966413|NCT04572516|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5966414|NCT04572516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6517225|NCT00720304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6517226|NCT00720304|Tubulin Modulators|tubulin modulators|mesh-ancestor
6517227|NCT00720304|Antimitotic Agents|antimitotic agents|mesh-ancestor
6517228|NCT00720304|Mitosis Modulators|mitosis modulators|mesh-ancestor
6517229|NCT00720304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517230|NCT00720304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5966415|NCT04572516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966416|NCT04572516|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5966417|NCT04572516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5966418|NCT04572516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966419|NCT04572516|Cholinergic Agents|cholinergic agents|mesh-ancestor
5966420|NCT04572516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5966421|NCT04572217|Topiramate|topiramate|mesh-list
5966422|NCT04572217|Phentermine|phentermine|mesh-list
5966423|NCT04572217|Anticonvulsants|anticonvulsants|mesh-ancestor
5966424|NCT04572217|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5966425|NCT04572217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966426|NCT04572217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5966427|NCT04572217|Appetite Depressants|appetite depressants|mesh-ancestor
5966428|NCT04572217|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5966429|NCT04572217|Sympathomimetics|sympathomimetics|mesh-ancestor
5966430|NCT04572217|Autonomic Agents|autonomic agents|mesh-ancestor
5966431|NCT04572217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5966432|NCT04572217|Adrenergic Agents|adrenergic agents|mesh-ancestor
5966433|NCT04572217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5966434|NCT04572217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966435|NCT04572373|SMOFlipid|smoflipid|mesh-list
5966436|NCT04572373|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
5966437|NCT04572373|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5966438|NCT04572373|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5966439|NCT04571879|Lidocaine|lidocaine|mesh-list
5966440|NCT04571879|Midazolam|midazolam|mesh-list
5966441|NCT04571879|Anesthetics, Local|anesthetics, local|mesh-ancestor
5966442|NCT04571879|Anesthetics|anesthetics|mesh-ancestor
5966443|NCT04571879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5966444|NCT04571879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966445|NCT04571879|Sensory System Agents|sensory system agents|mesh-ancestor
5966446|NCT04571879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5966447|NCT04571879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5966448|NCT04571879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5966449|NCT04571879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5966450|NCT04571879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5966451|NCT04571879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966452|NCT04571879|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5966453|NCT04571879|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5966454|NCT04571879|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5966455|NCT04571879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5966456|NCT04571879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5966457|NCT04571879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5966458|NCT04571879|Anesthetics, General|anesthetics, general|mesh-ancestor
5966459|NCT04571879|GABA Modulators|gaba modulators|mesh-ancestor
5966460|NCT04571879|GABA Agents|gaba agents|mesh-ancestor
5966461|NCT04571879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5966462|NCT04571437|Capecitabine|capecitabine|mesh-list
6517231|NCT00720304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5936722|NCT04845139|Nivolumab|nivolumab|mesh-list
5936723|NCT04845139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5936724|NCT04845139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5936725|NCT04845139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5936726|NCT04845139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5936727|NCT04844996|Ezetimibe|ezetimibe|mesh-list
5936728|NCT04844996|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5936729|NCT04844996|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5936730|NCT04844996|Antimetabolites|antimetabolites|mesh-ancestor
5936731|NCT04844996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5936732|NCT04844996|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5936733|NCT04845061|Nebivolol|nebivolol|mesh-list
5936734|NCT04845061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5936735|NCT04845061|Vasodilator Agents|vasodilator agents|mesh-ancestor
5936736|NCT04845061|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5936737|NCT04845061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5936738|NCT04845061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5936739|NCT04845061|Adrenergic Agents|adrenergic agents|mesh-ancestor
5936740|NCT04845061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5936741|NCT04845061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5936742|NCT04845061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936743|NCT04844814|Prednisone|prednisone|mesh-list
5936744|NCT04844814|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5936745|NCT04844814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5936746|NCT04844814|Glucocorticoids|glucocorticoids|mesh-ancestor
5936747|NCT04844814|Hormones|hormones|mesh-ancestor
5936748|NCT04844814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5936749|NCT04844814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936750|NCT04844814|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5936751|NCT04844814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5936752|NCT04844814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5936753|NCT04844957|Vitamin D|vitamin d|mesh-list
5936754|NCT04844957|Ergocalciferols|ergocalciferols|mesh-list
5936755|NCT04844957|Vitamins|vitamins|mesh-list
5936756|NCT04844957|Micronutrients|micronutrients|mesh-ancestor
5936757|NCT04844957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936758|NCT04844957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5936759|NCT04844957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5936760|NCT04844762|Menthol|menthol|mesh-list
5936761|NCT04844762|Antipruritics|antipruritics|mesh-ancestor
5936762|NCT04844762|Dermatologic Agents|dermatologic agents|mesh-ancestor
5936763|NCT04844775|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
5936764|NCT04844775|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5936765|NCT04844775|Immunologic Factors|immunologic factors|mesh-ancestor
5936766|NCT04844775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936767|NCT04844385|Paclitaxel|paclitaxel|mesh-list
5936768|NCT04844385|Capecitabine|capecitabine|mesh-list
5936769|NCT04844385|Nedaplatin|nedaplatin|mesh-list
5936770|NCT04844385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5936771|NCT04844385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5936772|NCT04844385|Tubulin Modulators|tubulin modulators|mesh-ancestor
5936773|NCT04844385|Antimitotic Agents|antimitotic agents|mesh-ancestor
5936774|NCT04844385|Mitosis Modulators|mitosis modulators|mesh-ancestor
5936775|NCT04844385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5936776|NCT04844385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5936777|NCT04844385|Antimetabolites|antimetabolites|mesh-ancestor
5936778|NCT04844489|Vaccines|vaccines|mesh-list
5936779|NCT04844489|Immunologic Factors|immunologic factors|mesh-ancestor
5936780|NCT04844489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936781|NCT04844164|Cholecalciferol|cholecalciferol|mesh-list
5936782|NCT04844164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5936783|NCT04844164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936784|NCT04844164|Vitamins|vitamins|mesh-ancestor
5936785|NCT04844164|Micronutrients|micronutrients|mesh-ancestor
5936786|NCT04844164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5936787|NCT04844333|Anesthetics|anesthetics|mesh-list
5936788|NCT04844333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5936789|NCT04844333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936790|NCT04844268|Vaccines|vaccines|mesh-list
5936791|NCT04844268|Immunologic Factors|immunologic factors|mesh-ancestor
5936792|NCT04844268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936793|NCT04844216|Lidocaine|lidocaine|mesh-list
5936794|NCT04844216|Hyaluronic Acid|hyaluronic acid|mesh-list
5936795|NCT04844216|Anesthetics, Local|anesthetics, local|mesh-ancestor
5936796|NCT04844216|Anesthetics|anesthetics|mesh-ancestor
5936797|NCT04844216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5936798|NCT04844216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936799|NCT04844216|Sensory System Agents|sensory system agents|mesh-ancestor
5936800|NCT04844216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5936801|NCT04844216|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5936802|NCT04844216|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5936803|NCT04844216|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5936804|NCT04844216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5936805|NCT04844216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5936806|NCT04844216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5936807|NCT04844216|Immunologic Factors|immunologic factors|mesh-ancestor
5936808|NCT04844216|Viscosupplements|viscosupplements|mesh-ancestor
5936809|NCT04844216|Protective Agents|protective agents|mesh-ancestor
5936810|NCT04844099|Piperaquine|piperaquine|mesh-list
5936811|NCT04844099|Artenimol|artenimol|mesh-list
5936812|NCT04844099|Antimalarials|antimalarials|mesh-ancestor
5936813|NCT04844099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5936814|NCT04844099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5936815|NCT04844099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5936816|NCT04843982|Esketamine|esketamine|mesh-list
5936817|NCT04843982|Antidepressive Agents|antidepressive agents|mesh-ancestor
5936818|NCT04843982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5936819|NCT04843943|Bevacizumab|bevacizumab|mesh-list
5936820|NCT04843943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5936821|NCT04843943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5936822|NCT04843943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5936823|NCT04843943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5936824|NCT04843943|Growth Substances|growth substances|mesh-ancestor
5936825|NCT04843943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936826|NCT04843943|Growth Inhibitors|growth inhibitors|mesh-ancestor
5936827|NCT04843917|Immunoglobulins|immunoglobulins|mesh-list
5936828|NCT04843917|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5936829|NCT04843917|Antibodies|antibodies|mesh-list
5936830|NCT04843917|Immunoglobulin G|immunoglobulin g|mesh-list
5936831|NCT04843917|Immunologic Factors|immunologic factors|mesh-ancestor
5936832|NCT04843917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936833|NCT04843904|Rituximab|rituximab|mesh-list
5936834|NCT04843904|Obinutuzumab|obinutuzumab|mesh-list
5936835|NCT04843904|Venetoclax|venetoclax|mesh-list
5936836|NCT04843904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5936837|NCT04843904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5936838|NCT04843904|Immunologic Factors|immunologic factors|mesh-ancestor
5936839|NCT04843904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936840|NCT04843904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5936841|NCT04843839|Nepafenac|nepafenac|mesh-list
5936842|NCT04843839|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
5936843|NCT04843839|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5936844|NCT04843839|Lubricant Eye Drops|lubricant eye drops|mesh-list
5936845|NCT04843839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5936846|NCT04843839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5936847|NCT04843839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5936848|NCT04843839|Analgesics|analgesics|mesh-ancestor
5936849|NCT04843839|Sensory System Agents|sensory system agents|mesh-ancestor
5936850|NCT04843839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5936851|NCT04843839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936852|NCT04843839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5936853|NCT04843839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5936854|NCT04843839|Laxatives|laxatives|mesh-ancestor
5936855|NCT04843839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5936856|NCT04843553|Niacinamide|niacinamide|mesh-list
5936857|NCT04843553|Niacin|niacin|mesh-list
5936858|NCT04843553|Nicotinic Acids|nicotinic acids|mesh-list
5936859|NCT04843553|Vitamins|vitamins|mesh-ancestor
5936860|NCT04843553|Micronutrients|micronutrients|mesh-ancestor
5936861|NCT04843553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936862|NCT04843553|Vitamin B Complex|vitamin b complex|mesh-ancestor
5936863|NCT04843553|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5936864|NCT04843553|Antimetabolites|antimetabolites|mesh-ancestor
5936865|NCT04843553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5936866|NCT04843553|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5936867|NCT04843553|Vasodilator Agents|vasodilator agents|mesh-ancestor
5936868|NCT04843462|Esketamine|esketamine|mesh-list
5936869|NCT04843462|Antidepressive Agents|antidepressive agents|mesh-ancestor
5936870|NCT04843462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5936871|NCT04843566|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5936872|NCT04843566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5936873|NCT04843631|Ustekinumab|ustekinumab|mesh-list
5936874|NCT04843631|Dermatologic Agents|dermatologic agents|mesh-ancestor
5936875|NCT04843111|Vaccines|vaccines|mesh-list
5936876|NCT04843111|Immunologic Factors|immunologic factors|mesh-ancestor
5936877|NCT04843111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936878|NCT04843449|Itraconazole|itraconazole|mesh-list
5936879|NCT04843449|Rifampin|rifampin|mesh-list
5936880|NCT04843449|Antifungal Agents|antifungal agents|mesh-ancestor
5936881|NCT04843449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5936882|NCT04843449|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5936883|NCT04843449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5936884|NCT04843449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5936885|NCT04843449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5936886|NCT04843449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5936887|NCT04843449|Hormone Antagonists|hormone antagonists|mesh-ancestor
5936888|NCT04843449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5936889|NCT04843449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936890|NCT04843449|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5936891|NCT04843449|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5936892|NCT04843449|Antitubercular Agents|antitubercular agents|mesh-ancestor
5936893|NCT04843449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5936894|NCT04843449|Leprostatic Agents|leprostatic agents|mesh-ancestor
5936895|NCT04843449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5936896|NCT04843449|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5936897|NCT04843449|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5936898|NCT04843449|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5936899|NCT04843449|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5936900|NCT04843449|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5936901|NCT04843449|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5966463|NCT04571437|Letrozole|letrozole|mesh-list
5966464|NCT04571437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5966465|NCT04571437|Antimetabolites|antimetabolites|mesh-ancestor
5966466|NCT04571437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966467|NCT04571437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5966468|NCT04571437|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5966469|NCT04571437|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5966470|NCT04571437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5966471|NCT04571437|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5966472|NCT04571437|Hormone Antagonists|hormone antagonists|mesh-ancestor
5966473|NCT04571437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5966474|NCT04571437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966475|NCT04571489|Gemcitabine|gemcitabine|mesh-list
5966476|NCT04571489|Tegafur|tegafur|mesh-list
5966477|NCT04571489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5966478|NCT04571489|Antimetabolites|antimetabolites|mesh-ancestor
5966479|NCT04571489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966480|NCT04571489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5966481|NCT04571489|Antiviral Agents|antiviral agents|mesh-ancestor
5966482|NCT04571489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5966483|NCT04571489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5966484|NCT04571489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5966485|NCT04571489|Immunologic Factors|immunologic factors|mesh-ancestor
5966486|NCT04571489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966487|NCT04571632|Pembrolizumab|pembrolizumab|mesh-list
5966488|NCT04571632|Ipilimumab|ipilimumab|mesh-list
5966489|NCT04571632|Avelumab|avelumab|mesh-list
5966490|NCT04571632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5966491|NCT04571632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5966492|NCT04571632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5966493|NCT04571632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970925|NCT04531371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5970926|NCT04531371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970927|NCT04531371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5970928|NCT04531371|Analgesics|analgesics|mesh-ancestor
5970929|NCT04531371|Sensory System Agents|sensory system agents|mesh-ancestor
5970930|NCT04531371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5970931|NCT04531371|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5970932|NCT04531371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5970933|NCT04531371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5970934|NCT04531371|Adrenergic Agents|adrenergic agents|mesh-ancestor
5970935|NCT04531371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5970936|NCT04531371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970937|NCT04531540|Butenafine|butenafine|mesh-list
5970938|NCT04531540|Antifungal Agents|antifungal agents|mesh-ancestor
5970939|NCT04531540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5970940|NCT04531423|Golimumab|golimumab|mesh-list
5719812|NCT03216941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5719813|NCT03216941|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5719814|NCT03216941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5719815|NCT03216941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5719816|NCT03216941|Serotonin Agents|serotonin agents|mesh-ancestor
5719817|NCT03216707|Capsaicin|capsaicin|mesh-list
5719818|NCT03216707|Antipruritics|antipruritics|mesh-ancestor
5719819|NCT03216707|Dermatologic Agents|dermatologic agents|mesh-ancestor
5719820|NCT03216707|Sensory System Agents|sensory system agents|mesh-ancestor
5719821|NCT03216707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5719822|NCT03216707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719823|NCT03216668|Silymarin|silymarin|mesh-list
5719824|NCT03216668|Antioxidants|antioxidants|mesh-ancestor
5719825|NCT03216668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719826|NCT03216668|Protective Agents|protective agents|mesh-ancestor
5719827|NCT03216668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936902|NCT04843644|Propolis|propolis|mesh-list
5936903|NCT04843644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5936904|NCT04843280|Coal Tar|coal tar|mesh-list
5936905|NCT04843280|Keratolytic Agents|keratolytic agents|mesh-ancestor
5936906|NCT04843280|Dermatologic Agents|dermatologic agents|mesh-ancestor
5936907|NCT04843098|Paclitaxel|paclitaxel|mesh-list
5936908|NCT04843098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5936909|NCT04843098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5936910|NCT04843098|Tubulin Modulators|tubulin modulators|mesh-ancestor
5936911|NCT04843098|Antimitotic Agents|antimitotic agents|mesh-ancestor
5936912|NCT04843098|Mitosis Modulators|mitosis modulators|mesh-ancestor
5936913|NCT04843098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5936914|NCT04842825|Cetrorelix|cetrorelix|mesh-list
5936915|NCT04842825|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5936916|NCT04842825|Hormones|hormones|mesh-ancestor
5936917|NCT04842825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5936918|NCT04842825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936919|NCT04842825|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5936920|NCT04842825|Fertility Agents|fertility agents|mesh-ancestor
5936921|NCT04842825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5936922|NCT04842825|Hormone Antagonists|hormone antagonists|mesh-ancestor
5936923|NCT04843046|Pioglitazone|pioglitazone|mesh-list
5936924|NCT04843046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5936925|NCT04843046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936926|NCT04843007|Pemetrexed|pemetrexed|mesh-list
5936927|NCT04843007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5936928|NCT04843007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5936929|NCT04843007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5936930|NCT04843007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5936931|NCT04843007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5936932|NCT04842838|Paclitaxel|paclitaxel|mesh-list
5936933|NCT04842838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5936934|NCT04842838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5936935|NCT04842838|Tubulin Modulators|tubulin modulators|mesh-ancestor
5936936|NCT04842838|Antimitotic Agents|antimitotic agents|mesh-ancestor
5936937|NCT04842838|Mitosis Modulators|mitosis modulators|mesh-ancestor
5936938|NCT04842838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517232|NCT00720408|Mycophenolic Acid|mycophenolic acid|mesh-list
6517233|NCT00720408|Tacrolimus|tacrolimus|mesh-list
6517234|NCT00720408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6517235|NCT00720408|Immunologic Factors|immunologic factors|mesh-ancestor
6517236|NCT00720408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517237|NCT00720408|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6517238|NCT00720408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6517239|NCT00720408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517240|NCT00720408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5936939|NCT04842968|Methylene Blue|methylene blue|mesh-list
5936940|NCT04842968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5936941|NCT04842968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5936942|NCT04842682|Diazepam|diazepam|mesh-list
5936943|NCT04842682|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5936944|NCT04842682|Anticonvulsants|anticonvulsants|mesh-ancestor
5936945|NCT04842682|Antiemetics|antiemetics|mesh-ancestor
5936946|NCT04842682|Autonomic Agents|autonomic agents|mesh-ancestor
5936947|NCT04842682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5936948|NCT04842682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936949|NCT04842682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5936950|NCT04842682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5936951|NCT04842682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5936952|NCT04842682|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5936953|NCT04842682|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5936954|NCT04842682|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5936955|NCT04842682|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5936956|NCT04842682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5936957|NCT04842682|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5936958|NCT04842682|Anesthetics, General|anesthetics, general|mesh-ancestor
5936959|NCT04842682|Anesthetics|anesthetics|mesh-ancestor
5936960|NCT04842682|GABA Modulators|gaba modulators|mesh-ancestor
5936961|NCT04842682|GABA Agents|gaba agents|mesh-ancestor
5936962|NCT04842682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5936963|NCT04842682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5936964|NCT04842435|Immunoglobulins|immunoglobulins|mesh-list
5936965|NCT04842435|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5936966|NCT04842435|Immunologic Factors|immunologic factors|mesh-ancestor
5936967|NCT04842435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936968|NCT04842487|Prednisone|prednisone|mesh-list
5936969|NCT04842487|Cyclophosphamide|cyclophosphamide|mesh-list
5936970|NCT04842487|Rituximab|rituximab|mesh-list
5936971|NCT04842487|Vincristine|vincristine|mesh-list
5936972|NCT04842487|Lenalidomide|lenalidomide|mesh-list
5936973|NCT04842487|Doxorubicin|doxorubicin|mesh-list
5936974|NCT04842487|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5936975|NCT04842487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5936976|NCT04842487|Immunologic Factors|immunologic factors|mesh-ancestor
5936977|NCT04842487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5936978|NCT04842487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5936979|NCT04842487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5936980|NCT04842487|Alkylating Agents|alkylating agents|mesh-ancestor
5936981|NCT04842487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5936982|NCT04842487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5936983|NCT04842487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5936984|NCT04842487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5936985|NCT04842487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5936986|NCT04842487|Glucocorticoids|glucocorticoids|mesh-ancestor
5936987|NCT04842487|Hormones|hormones|mesh-ancestor
5936988|NCT04842487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5936989|NCT04842487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5936990|NCT04842487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5936991|NCT04842487|Tubulin Modulators|tubulin modulators|mesh-ancestor
5936992|NCT04842487|Antimitotic Agents|antimitotic agents|mesh-ancestor
5936993|NCT04842487|Mitosis Modulators|mitosis modulators|mesh-ancestor
5936994|NCT04842487|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5936995|NCT04842487|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5936996|NCT04842487|Growth Substances|growth substances|mesh-ancestor
5936997|NCT04842487|Growth Inhibitors|growth inhibitors|mesh-ancestor
5936998|NCT04842487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5936999|NCT04842487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5937000|NCT04842487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5937001|NCT04842487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5937002|NCT04842292|Heparin|heparin|mesh-list
5937003|NCT04842292|Anticoagulants|anticoagulants|mesh-ancestor
5937004|NCT04842292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5937005|NCT04842292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5937006|NCT04842292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937007|NCT04842383|Peppermint oil|peppermint oil|mesh-list
5937008|NCT04842383|Antiemetics|antiemetics|mesh-ancestor
5937009|NCT04842383|Autonomic Agents|autonomic agents|mesh-ancestor
5937010|NCT04842383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5937011|NCT04842383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937012|NCT04842383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5937013|NCT04842383|Parasympatholytics|parasympatholytics|mesh-ancestor
5937014|NCT04842526|Irinotecan|irinotecan|mesh-list
5937015|NCT04842526|Temozolomide|temozolomide|mesh-list
5937016|NCT04842526|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5937017|NCT04842526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5937018|NCT04842526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5937019|NCT04842526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937020|NCT04842526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5937021|NCT04842526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5937022|NCT04842526|Alkylating Agents|alkylating agents|mesh-ancestor
5937023|NCT04842331|Nitric Oxide|nitric oxide|mesh-list
5937024|NCT04842331|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5937025|NCT04842331|Autonomic Agents|autonomic agents|mesh-ancestor
5937026|NCT04842331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5937027|NCT04842331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937028|NCT04842331|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5937029|NCT04842331|Respiratory System Agents|respiratory system agents|mesh-ancestor
5937030|NCT04842331|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5937031|NCT04842331|Antioxidants|antioxidants|mesh-ancestor
5937032|NCT04842331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937033|NCT04842331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5937034|NCT04842331|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5937035|NCT04842331|Vasodilator Agents|vasodilator agents|mesh-ancestor
5937036|NCT04842331|Gasotransmitters|gasotransmitters|mesh-ancestor
5937037|NCT04842331|Protective Agents|protective agents|mesh-ancestor
5937038|NCT04841980|Rifaximin|rifaximin|mesh-list
5937039|NCT04841980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5937040|NCT04841980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5937041|NCT04841980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5937042|NCT04841720|Metformin|metformin|mesh-list
5937043|NCT04841720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5937044|NCT04841720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937045|NCT04841668|Metformin|metformin|mesh-list
5937046|NCT04841668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5937047|NCT04841668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966494|NCT04571996|Acetaminophen|acetaminophen|mesh-list
5966495|NCT04571996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5966496|NCT04571996|Analgesics|analgesics|mesh-ancestor
5966497|NCT04571996|Sensory System Agents|sensory system agents|mesh-ancestor
5966498|NCT04571996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5966499|NCT04571996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966500|NCT04571996|Antipyretics|antipyretics|mesh-ancestor
5966501|NCT04571580|Reteplase|reteplase|mesh-list
5966502|NCT04571580|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5966503|NCT04571580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5966504|NCT04571580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5966505|NCT04571580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966506|NCT04571606|Bupivacaine|bupivacaine|mesh-list
5966507|NCT04571606|Anesthetics, Local|anesthetics, local|mesh-ancestor
5966508|NCT04571606|Anesthetics|anesthetics|mesh-ancestor
5966509|NCT04571606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5966510|NCT04571606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966511|NCT04571606|Sensory System Agents|sensory system agents|mesh-ancestor
5966512|NCT04571606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5966513|NCT04571164|Rotigotine|rotigotine|mesh-list
5966514|NCT04571164|Dopamine Agonists|dopamine agonists|mesh-ancestor
5966515|NCT04571164|Dopamine Agents|dopamine agents|mesh-ancestor
5966516|NCT04571164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5966517|NCT04571164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966518|NCT04571164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966519|NCT04571151|Halobetasol|halobetasol|mesh-list
5966520|NCT04571151|Calcipotriene|calcipotriene|mesh-list
5966521|NCT04571151|Dermatologic Agents|dermatologic agents|mesh-ancestor
5966522|NCT04571151|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5966523|NCT04571229|Mifamurtide|mifamurtide|mesh-list
5966524|NCT04571229|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5966525|NCT04571229|Immunologic Factors|immunologic factors|mesh-ancestor
5966526|NCT04571229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966527|NCT04570956|Tamoxifen|tamoxifen|mesh-list
5966528|NCT04570956|Afimoxifene|afimoxifene|mesh-list
5966529|NCT04570956|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5966530|NCT04570956|Hormone Antagonists|hormone antagonists|mesh-ancestor
5966531|NCT04570956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5966532|NCT04570956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966533|NCT04570956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5966534|NCT04570956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5966535|NCT04570956|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5966536|NCT04570956|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5966537|NCT04570956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5966538|NCT04570865|Dapagliflozin|dapagliflozin|mesh-list
5966539|NCT04570865|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5966540|NCT04570865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966541|NCT04570865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5966542|NCT04570865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966543|NCT04570631|Dexamethasone|dexamethasone|mesh-list
5966544|NCT04570631|Bortezomib|bortezomib|mesh-list
5966545|NCT04570631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5966546|NCT04570631|Antiemetics|antiemetics|mesh-ancestor
5966547|NCT04570631|Autonomic Agents|autonomic agents|mesh-ancestor
5966548|NCT04570631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6517241|NCT00720408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5937048|NCT04842071|Listerine|listerine|mesh-list
5937049|NCT04842071|Fluorides|fluorides|mesh-list
5937050|NCT04842071|Sodium Fluoride|sodium fluoride|mesh-list
5937051|NCT04842071|Cariostatic Agents|cariostatic agents|mesh-ancestor
5937052|NCT04842071|Protective Agents|protective agents|mesh-ancestor
5937053|NCT04842071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937054|NCT04842071|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5937055|NCT04842071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5937056|NCT04841551|Deoxycholic Acid|deoxycholic acid|mesh-list
5937057|NCT04841551|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5937058|NCT04841551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5937059|NCT04841096|Metformin|metformin|mesh-list
5937060|NCT04841096|Glimepiride|glimepiride|mesh-list
5937061|NCT04841096|Vildagliptin|vildagliptin|mesh-list
5937062|NCT04841096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5937063|NCT04841096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937064|NCT04841096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5937065|NCT04841096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5937066|NCT04841096|Immunologic Factors|immunologic factors|mesh-ancestor
5937067|NCT04841096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5937068|NCT04841096|Protease Inhibitors|protease inhibitors|mesh-ancestor
5937069|NCT04841096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5937070|NCT04841096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937071|NCT04841369|Vaccines|vaccines|mesh-list
5937072|NCT04841369|Immunologic Factors|immunologic factors|mesh-ancestor
5937073|NCT04841369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937074|NCT04841343|Triamcinolone|triamcinolone|mesh-list
5937075|NCT04841343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5937076|NCT04841343|Glucocorticoids|glucocorticoids|mesh-ancestor
5937077|NCT04841343|Hormones|hormones|mesh-ancestor
5937078|NCT04841343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5937079|NCT04841343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937080|NCT04841148|Hydroxychloroquine|hydroxychloroquine|mesh-list
5937081|NCT04841148|Palbociclib|palbociclib|mesh-list
5937082|NCT04841148|Avelumab|avelumab|mesh-list
5937083|NCT04841148|Antimalarials|antimalarials|mesh-ancestor
5937084|NCT04841148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5937085|NCT04841148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5937086|NCT04841148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5937087|NCT04841148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5937088|NCT04841148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937089|NCT04841148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5937090|NCT04841148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5937091|NCT04841148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5937092|NCT04841148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5937093|NCT04841434|Methotrexate|methotrexate|mesh-list
5937094|NCT04841434|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5937095|NCT04841434|Abortifacient Agents|abortifacient agents|mesh-ancestor
5937096|NCT04841434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5937097|NCT04841434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937098|NCT04841434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5937099|NCT04841434|Antimetabolites|antimetabolites|mesh-ancestor
5937100|NCT04841434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937101|NCT04841434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5937102|NCT04841434|Dermatologic Agents|dermatologic agents|mesh-ancestor
5937103|NCT04841434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5937104|NCT04841434|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5937105|NCT04841434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5937106|NCT04841434|Immunologic Factors|immunologic factors|mesh-ancestor
5937107|NCT04841434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5937108|NCT04841434|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5937109|NCT04841265|Vitamin D|vitamin d|mesh-list
5937110|NCT04841265|Cholecalciferol|cholecalciferol|mesh-list
5937111|NCT04841265|Vitamins|vitamins|mesh-ancestor
5937112|NCT04841265|Micronutrients|micronutrients|mesh-ancestor
5937113|NCT04841265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937114|NCT04841265|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5937115|NCT04841265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5937116|NCT04840862|Rifabutin|rifabutin|mesh-list
5937117|NCT04840862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5937118|NCT04840862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5937119|NCT04840862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5937120|NCT04840862|Antitubercular Agents|antitubercular agents|mesh-ancestor
5937121|NCT04841018|Dexamethasone|dexamethasone|mesh-list
5937122|NCT04841018|Dexamethasone acetate|dexamethasone acetate|mesh-list
5937123|NCT04841018|BB 1101|bb 1101|mesh-list
5937124|NCT04841018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5937125|NCT04841018|Antiemetics|antiemetics|mesh-ancestor
5937126|NCT04841018|Autonomic Agents|autonomic agents|mesh-ancestor
5937127|NCT04841018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5937128|NCT04841018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937129|NCT04841018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5937130|NCT04841018|Glucocorticoids|glucocorticoids|mesh-ancestor
5937131|NCT04841018|Hormones|hormones|mesh-ancestor
5937132|NCT04841018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5937133|NCT04841018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5937134|NCT04841018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5937135|NCT04841018|Protease Inhibitors|protease inhibitors|mesh-ancestor
5937136|NCT04841018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5937137|NCT04841018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937138|NCT04840992|Vaccines|vaccines|mesh-list
5937139|NCT04840992|Immunologic Factors|immunologic factors|mesh-ancestor
5937140|NCT04840992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937141|NCT04840550|Lansoprazole|lansoprazole|mesh-list
5937142|NCT04840550|Dexlansoprazole|dexlansoprazole|mesh-list
5937143|NCT04840550|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5937144|NCT04840550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5937145|NCT04840550|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5937146|NCT04840550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5937147|NCT04840550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937148|NCT04840394|Pembrolizumab|pembrolizumab|mesh-list
5937149|NCT04840394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5937150|NCT04840394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5937151|NCT04840511|Lidocaine|lidocaine|mesh-list
5937152|NCT04840511|Anesthetics, Local|anesthetics, local|mesh-ancestor
5937153|NCT04840511|Anesthetics|anesthetics|mesh-ancestor
5937154|NCT04840511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5937155|NCT04840511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937156|NCT04840511|Sensory System Agents|sensory system agents|mesh-ancestor
5937157|NCT04840511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5937158|NCT04840511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5937159|NCT04840511|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5937160|NCT04840511|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5937161|NCT04840511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5937162|NCT04840511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937163|NCT04840745|Leuprolide|leuprolide|mesh-list
5937164|NCT04840745|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5937165|NCT04840745|Fertility Agents|fertility agents|mesh-ancestor
5937166|NCT04840745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5937167|NCT04840745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937168|NCT04840745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5937169|NCT04840745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5937170|NCT04840238|Cholecalciferol|cholecalciferol|mesh-list
5937171|NCT04840238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5937172|NCT04840238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937173|NCT04840238|Vitamins|vitamins|mesh-ancestor
5937174|NCT04840238|Micronutrients|micronutrients|mesh-ancestor
5937175|NCT04840238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5937176|NCT04840290|Paclitaxel|paclitaxel|mesh-list
5937177|NCT04840290|Carboplatin|carboplatin|mesh-list
5937178|NCT04840290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5937179|NCT04840290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5937180|NCT04840290|Tubulin Modulators|tubulin modulators|mesh-ancestor
5937181|NCT04840290|Antimitotic Agents|antimitotic agents|mesh-ancestor
5937182|NCT04840290|Mitosis Modulators|mitosis modulators|mesh-ancestor
5937183|NCT04840290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937184|NCT04840342|Amlodipine|amlodipine|mesh-list
5937185|NCT04840342|Eplerenone|eplerenone|mesh-list
5937186|NCT04840342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5937187|NCT04840342|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5937188|NCT04840342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5937189|NCT04840342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937190|NCT04840342|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5937191|NCT04840342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937192|NCT04840342|Vasodilator Agents|vasodilator agents|mesh-ancestor
5937193|NCT04840342|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5937194|NCT04840342|Hormone Antagonists|hormone antagonists|mesh-ancestor
5937195|NCT04840342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5937196|NCT04840342|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5937197|NCT04840342|Diuretics|diuretics|mesh-ancestor
5937198|NCT04840342|Natriuretic Agents|natriuretic agents|mesh-ancestor
5937199|NCT04839913|Antibodies|antibodies|mesh-list
5937200|NCT04839913|Immunologic Factors|immunologic factors|mesh-ancestor
5937201|NCT04839913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966549|NCT04570631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966550|NCT04570631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5966551|NCT04570631|Glucocorticoids|glucocorticoids|mesh-ancestor
5966552|NCT04570631|Hormones|hormones|mesh-ancestor
5966553|NCT04570631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5966554|NCT04570631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5966555|NCT04570631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5966556|NCT04570592|Dexamethasone|dexamethasone|mesh-list
5966557|NCT04570592|Granisetron|granisetron|mesh-list
5966558|NCT04570592|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5966559|NCT04570592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5966560|NCT04570592|Antiemetics|antiemetics|mesh-ancestor
5966561|NCT04570592|Autonomic Agents|autonomic agents|mesh-ancestor
5966562|NCT04570592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5966563|NCT04570592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966564|NCT04570592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5966565|NCT04570592|Glucocorticoids|glucocorticoids|mesh-ancestor
5966566|NCT04570592|Hormones|hormones|mesh-ancestor
5966567|NCT04570592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5966568|NCT04570592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5966569|NCT04570592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5966570|NCT04570592|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5966571|NCT04570592|Serotonin Agents|serotonin agents|mesh-ancestor
5966572|NCT04570592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5966573|NCT04570592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966574|NCT04570475|Vitamin D|vitamin d|mesh-list
5966575|NCT04570475|Vitamins|vitamins|mesh-ancestor
5966576|NCT04570475|Micronutrients|micronutrients|mesh-ancestor
5966577|NCT04570475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966578|NCT04570475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5966579|NCT04570683|Nivolumab|nivolumab|mesh-list
5966580|NCT04570683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5966581|NCT04570683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5966582|NCT04570683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5966583|NCT04570683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966584|NCT04570670|Dimethyl Fumarate|dimethyl fumarate|mesh-list
5966585|NCT04570670|Dermatologic Agents|dermatologic agents|mesh-ancestor
5966586|NCT04570670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5966587|NCT04570670|Immunologic Factors|immunologic factors|mesh-ancestor
5966588|NCT04570670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966589|NCT04570449|Fluoxetine|fluoxetine|mesh-list
5966590|NCT04570449|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5966591|NCT04570449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5966592|NCT04570449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5966593|NCT04570449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966594|NCT04570449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5966595|NCT04570449|Serotonin Agents|serotonin agents|mesh-ancestor
5966596|NCT04570449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966597|NCT04570449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5966598|NCT04570449|Antidepressive Agents|antidepressive agents|mesh-ancestor
5966599|NCT04570449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5966600|NCT04570449|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5966601|NCT04570449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5966602|NCT04570449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5966603|NCT04570436|Diazepam|diazepam|mesh-list
5966604|NCT04570436|Gabapentin|gabapentin|mesh-list
5966605|NCT04570436|Analgesics|analgesics|mesh-ancestor
5966606|NCT04570436|Sensory System Agents|sensory system agents|mesh-ancestor
5966607|NCT04570436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5966608|NCT04570436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966609|NCT04570436|Anticonvulsants|anticonvulsants|mesh-ancestor
5966610|NCT04570436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5966611|NCT04570436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5966612|NCT04570436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5966613|NCT04570436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5966614|NCT04570436|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5966615|NCT04570436|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5966616|NCT04570436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5966617|NCT04570436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966618|NCT04570436|Antimanic Agents|antimanic agents|mesh-ancestor
5937202|NCT04840004|Aprepitant|aprepitant|mesh-list
5937203|NCT04840004|Antiemetics|antiemetics|mesh-ancestor
5937204|NCT04840004|Autonomic Agents|autonomic agents|mesh-ancestor
5937205|NCT04840004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5937206|NCT04840004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937207|NCT04840004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5937208|NCT04840004|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5937209|NCT04840004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5937210|NCT04840004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937211|NCT04839666|Propofol|propofol|mesh-list
5937212|NCT04839666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5937213|NCT04839666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5937214|NCT04839666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937215|NCT04839666|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5937216|NCT04839666|Anesthetics, General|anesthetics, general|mesh-ancestor
5937217|NCT04839666|Anesthetics|anesthetics|mesh-ancestor
5937218|NCT04839692|Hyaluronic Acid|hyaluronic acid|mesh-list
5937219|NCT04839692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5937220|NCT04839692|Immunologic Factors|immunologic factors|mesh-ancestor
5937221|NCT04839692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937222|NCT04839692|Viscosupplements|viscosupplements|mesh-ancestor
5937223|NCT04839692|Protective Agents|protective agents|mesh-ancestor
5937224|NCT04839731|Fluorouracil|fluorouracil|mesh-list
5937225|NCT04839731|Calcipotriene|calcipotriene|mesh-list
5937226|NCT04839731|Antimetabolites|antimetabolites|mesh-ancestor
5937227|NCT04839731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937228|NCT04839731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5937229|NCT04839731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5937230|NCT04839731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5937231|NCT04839731|Immunologic Factors|immunologic factors|mesh-ancestor
5937232|NCT04839731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937233|NCT04839731|Dermatologic Agents|dermatologic agents|mesh-ancestor
5937234|NCT04839653|Vancomycin|vancomycin|mesh-list
5937235|NCT04839653|Gentamicins|gentamicins|mesh-list
5937236|NCT04839653|Ceftriaxone|ceftriaxone|mesh-list
5937237|NCT04839653|Polymyxins|polymyxins|mesh-list
5937238|NCT04839653|Cefotaxime|cefotaxime|mesh-list
5937239|NCT04839653|Cefoxitin|cefoxitin|mesh-list
5937240|NCT04839653|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5937241|NCT04839653|Polymyxin B|polymyxin b|mesh-list
5937242|NCT04839653|Amphotericin B|amphotericin b|mesh-list
5937243|NCT04839653|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
5937244|NCT04839653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5937245|NCT04839653|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5937246|NCT04839653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5937247|NCT04839653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937248|NCT04839653|Amebicides|amebicides|mesh-ancestor
5937249|NCT04839653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5937250|NCT04839653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5937251|NCT04839653|Antifungal Agents|antifungal agents|mesh-ancestor
5937252|NCT04839536|Sevoflurane|sevoflurane|mesh-list
5937253|NCT04839536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5937254|NCT04839536|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5937255|NCT04839536|Anesthetics, General|anesthetics, general|mesh-ancestor
5937256|NCT04839536|Anesthetics|anesthetics|mesh-ancestor
5937257|NCT04839536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5937258|NCT04839536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937259|NCT04839549|Fluorometholone|fluorometholone|mesh-list
5937260|NCT04839549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5937261|NCT04839549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937262|NCT04839549|Glucocorticoids|glucocorticoids|mesh-ancestor
5937263|NCT04839549|Hormones|hormones|mesh-ancestor
5937264|NCT04839549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5937265|NCT04839549|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5937266|NCT04839627|Progesterone|progesterone|mesh-list
5937267|NCT04839627|Progestins|progestins|mesh-ancestor
5937268|NCT04839627|Hormones|hormones|mesh-ancestor
5937269|NCT04839627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5937270|NCT04839627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937271|NCT04839445|Anesthetics|anesthetics|mesh-list
5937272|NCT04839445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5937273|NCT04839445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937274|NCT04839224|Phenylephrine|phenylephrine|mesh-list
5937275|NCT04839224|Oxymetazoline|oxymetazoline|mesh-list
5937276|NCT04839224|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5937277|NCT04839224|Mydriatics|mydriatics|mesh-ancestor
5937278|NCT04839224|Autonomic Agents|autonomic agents|mesh-ancestor
5937279|NCT04839224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5937280|NCT04839224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937281|NCT04839224|Sympathomimetics|sympathomimetics|mesh-ancestor
5937282|NCT04839224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5937283|NCT04839224|Nasal Decongestants|nasal decongestants|mesh-ancestor
5937284|NCT04839224|Respiratory System Agents|respiratory system agents|mesh-ancestor
5937285|NCT04839224|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5937286|NCT04839224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5937287|NCT04839224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5937288|NCT04839224|Adrenergic Agents|adrenergic agents|mesh-ancestor
5937289|NCT04839224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5937290|NCT04839224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937291|NCT04839224|Protective Agents|protective agents|mesh-ancestor
5937292|NCT04839471|Afatinib|afatinib|mesh-list
5937293|NCT04839471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5937294|NCT04839471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5937295|NCT04839471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5937296|NCT04839471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937297|NCT04839328|Hemay005|hemay005|mesh-list
5937298|NCT04839328|Dermatologic Agents|dermatologic agents|mesh-ancestor
5937299|NCT04839328|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5937300|NCT04839328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5937301|NCT04839328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5937302|NCT04839328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937303|NCT04839198|Nicotine|nicotine|mesh-list
5937304|NCT04839198|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5937305|NCT04839198|Autonomic Agents|autonomic agents|mesh-ancestor
5937306|NCT04839198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5937307|NCT04839198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937308|NCT04839198|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5937309|NCT04839198|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5937310|NCT04839198|Cholinergic Agents|cholinergic agents|mesh-ancestor
5937311|NCT04839198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5937312|NCT04839198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937313|NCT04839237|Metformin|metformin|mesh-list
5937314|NCT04839237|Liraglutide|liraglutide|mesh-list
5937315|NCT04839237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5937316|NCT04839237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937317|NCT04839237|Incretins|incretins|mesh-ancestor
5937318|NCT04839237|Hormones|hormones|mesh-ancestor
5937319|NCT04839237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5937320|NCT04838652|Pembrolizumab|pembrolizumab|mesh-list
5937321|NCT04838652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5937322|NCT04838652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5937323|NCT04838704|Mycophenolic Acid|mycophenolic acid|mesh-list
5937324|NCT04838704|Methotrexate|methotrexate|mesh-list
5937325|NCT04838704|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5937326|NCT04838704|Abortifacient Agents|abortifacient agents|mesh-ancestor
5937327|NCT04838704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5937328|NCT04838704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937329|NCT04838704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5937330|NCT04838704|Antimetabolites|antimetabolites|mesh-ancestor
5937331|NCT04838704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937332|NCT04838704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5937333|NCT04838704|Dermatologic Agents|dermatologic agents|mesh-ancestor
5937334|NCT04838704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5937335|NCT04838704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5937336|NCT04838704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5937337|NCT04838704|Immunologic Factors|immunologic factors|mesh-ancestor
5937338|NCT04838704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5937339|NCT04838704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5937340|NCT04838704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5937341|NCT04838704|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5937342|NCT04838704|Antitubercular Agents|antitubercular agents|mesh-ancestor
5937343|NCT04838704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5937344|NCT04838704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5937345|NCT04838665|Phenylephrine|phenylephrine|mesh-list
5937346|NCT04838665|Oxymetazoline|oxymetazoline|mesh-list
5937347|NCT04838665|Tropicamide|tropicamide|mesh-list
5937348|NCT04838665|Cyclopentolate|cyclopentolate|mesh-list
5937349|NCT04838665|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5937350|NCT04838665|Mydriatics|mydriatics|mesh-ancestor
5937351|NCT04838665|Autonomic Agents|autonomic agents|mesh-ancestor
5937352|NCT04838665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5937353|NCT04838665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937354|NCT04838665|Sympathomimetics|sympathomimetics|mesh-ancestor
5937355|NCT04838665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5937356|NCT04838665|Nasal Decongestants|nasal decongestants|mesh-ancestor
5719828|NCT03216642|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5719829|NCT03216642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5719830|NCT03216525|Alvimopan|alvimopan|mesh-list
5719831|NCT03216525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5719832|NCT03216343|Chiauranib|chiauranib|mesh-list
5719833|NCT03216343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5719834|NCT03216343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5719835|NCT03216343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5719836|NCT03216343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719837|NCT03216278|Metformin|metformin|mesh-list
5719838|NCT03216278|Dapagliflozin|dapagliflozin|mesh-list
5719839|NCT03216278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5719840|NCT03216278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719841|NCT03216278|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5719842|NCT03216278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719843|NCT03216356|Cycloserine|cycloserine|mesh-list
5719844|NCT03216356|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5719845|NCT03216356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5719846|NCT03216356|Renal Agents|renal agents|mesh-ancestor
5719847|NCT03216356|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5719848|NCT03216356|Antitubercular Agents|antitubercular agents|mesh-ancestor
5719849|NCT03216356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5719850|NCT03216356|Antimetabolites|antimetabolites|mesh-ancestor
5719851|NCT03216356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719852|NCT03216473|Botulinum Toxins|botulinum toxins|mesh-list
5719853|NCT03216473|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5719854|NCT03216473|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5719855|NCT03216473|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5719856|NCT03216473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5937357|NCT04838665|Respiratory System Agents|respiratory system agents|mesh-ancestor
5937358|NCT04838665|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5937359|NCT04838665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5937360|NCT04838665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5937361|NCT04838665|Adrenergic Agents|adrenergic agents|mesh-ancestor
5937362|NCT04838665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5937363|NCT04838665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937364|NCT04838665|Protective Agents|protective agents|mesh-ancestor
5937365|NCT04838665|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5937366|NCT04838665|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5937367|NCT04838665|Cholinergic Agents|cholinergic agents|mesh-ancestor
5937368|NCT04838665|Parasympatholytics|parasympatholytics|mesh-ancestor
5937369|NCT04838808|Rivaroxaban|rivaroxaban|mesh-list
5937370|NCT04838808|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5937371|NCT04838808|Antithrombins|antithrombins|mesh-ancestor
5937372|NCT04838808|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5937373|NCT04838808|Protease Inhibitors|protease inhibitors|mesh-ancestor
5937374|NCT04838808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5937375|NCT04838808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937376|NCT04838808|Anticoagulants|anticoagulants|mesh-ancestor
5937377|NCT04838717|Doxycycline|doxycycline|mesh-list
5937378|NCT04838717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5937379|NCT04838717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5937380|NCT04838717|Antimalarials|antimalarials|mesh-ancestor
5937381|NCT04838717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5937382|NCT04838717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5937383|NCT04838860|Siltuximab|siltuximab|mesh-list
5937384|NCT04838860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5937385|NCT04838288|Tacrolimus|tacrolimus|mesh-list
5937386|NCT04838288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5937387|NCT04838288|Immunologic Factors|immunologic factors|mesh-ancestor
5937388|NCT04838288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937389|NCT04838288|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5937390|NCT04838288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5937391|NCT04838288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937392|NCT04838301|Pregnanolone|pregnanolone|mesh-list
5937393|NCT04838301|Anesthetics|anesthetics|mesh-ancestor
5937394|NCT04838301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5937395|NCT04838301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966619|NCT04570436|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5966620|NCT04570436|Antiemetics|antiemetics|mesh-ancestor
5966621|NCT04570436|Autonomic Agents|autonomic agents|mesh-ancestor
5966622|NCT04570436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5719857|NCT03216473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937396|NCT04838145|Ribavirin|ribavirin|mesh-list
5937397|NCT04838145|Pleconaril|pleconaril|mesh-list
5937398|NCT04838145|Antimetabolites|antimetabolites|mesh-ancestor
5937399|NCT04838145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937400|NCT04838145|Antiviral Agents|antiviral agents|mesh-ancestor
5937401|NCT04838145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5937402|NCT04838132|Ropivacaine|ropivacaine|mesh-list
5937403|NCT04838132|Anesthetics, Local|anesthetics, local|mesh-ancestor
5937404|NCT04838132|Anesthetics|anesthetics|mesh-ancestor
5937405|NCT04838132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5937406|NCT04838132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937407|NCT04838132|Sensory System Agents|sensory system agents|mesh-ancestor
5937408|NCT04838132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5937409|NCT04837885|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
5937410|NCT04837885|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5937411|NCT04837885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937412|NCT04837768|Progesterone|progesterone|mesh-list
5937413|NCT04837768|Progestins|progestins|mesh-ancestor
5937414|NCT04837768|Hormones|hormones|mesh-ancestor
5937415|NCT04837768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5937416|NCT04837768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937417|NCT04837924|Acetaminophen|acetaminophen|mesh-list
5937418|NCT04837924|Tramadol|tramadol|mesh-list
5937419|NCT04837924|Analgesics|analgesics|mesh-list
5937420|NCT04837924|Levobupivacaine|levobupivacaine|mesh-list
5937421|NCT04837924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5937422|NCT04837924|Sensory System Agents|sensory system agents|mesh-ancestor
5937423|NCT04837924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5937424|NCT04837924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937425|NCT04837924|Antipyretics|antipyretics|mesh-ancestor
5937426|NCT04837924|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5937427|NCT04837924|Narcotics|narcotics|mesh-ancestor
5937428|NCT04837924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5937429|NCT04837924|Anesthetics, Local|anesthetics, local|mesh-ancestor
5937430|NCT04837924|Anesthetics|anesthetics|mesh-ancestor
5937431|NCT04838080|Vaccines|vaccines|mesh-list
5937432|NCT04838080|Immunologic Factors|immunologic factors|mesh-ancestor
5937433|NCT04838080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937434|NCT04838054|Chlorine dioxide|chlorine dioxide|mesh-list
5937435|NCT04838054|Dental Disinfectants|dental disinfectants|mesh-ancestor
5719858|NCT03216473|Cholinergic Agents|cholinergic agents|mesh-ancestor
5719859|NCT03216473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5719860|NCT03216473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719861|NCT03216473|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5719862|NCT03216473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5719863|NCT03216408|Botulinum Toxins|botulinum toxins|mesh-list
5719864|NCT03216408|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5719865|NCT03216408|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5719866|NCT03216408|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5719867|NCT03216408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5719868|NCT03216408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719869|NCT03216408|Cholinergic Agents|cholinergic agents|mesh-ancestor
5719870|NCT03216408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5719871|NCT03216408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719872|NCT03216408|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5719873|NCT03216408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5719874|NCT03216564|Vitamin D|vitamin d|mesh-list
5719875|NCT03216564|Calcitriol|calcitriol|mesh-list
5719876|NCT03216564|Vitamins|vitamins|mesh-ancestor
5719877|NCT03216564|Micronutrients|micronutrients|mesh-ancestor
5937436|NCT04838054|Disinfectants|disinfectants|mesh-ancestor
5937437|NCT04838054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5937438|NCT04837664|Nystatin|nystatin|mesh-list
5937439|NCT04837664|Curcumin|curcumin|mesh-list
5937440|NCT04837664|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5937441|NCT04837664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5937442|NCT04837664|Analgesics|analgesics|mesh-ancestor
5937443|NCT04837664|Sensory System Agents|sensory system agents|mesh-ancestor
5937444|NCT04837664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5937445|NCT04837664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937446|NCT04837664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5937447|NCT04837664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5937448|NCT04837664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5937449|NCT04837664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5937450|NCT04837664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517242|NCT00720408|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5937451|NCT04837664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5937452|NCT04837664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5937453|NCT04837664|Antifungal Agents|antifungal agents|mesh-ancestor
5937454|NCT04837664|Ionophores|ionophores|mesh-ancestor
5937455|NCT04837664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5937456|NCT04837716|Bevacizumab|bevacizumab|mesh-list
5937457|NCT04837716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5937458|NCT04837716|Carboplatin|carboplatin|mesh-list
5937459|NCT04837716|Pemetrexed|pemetrexed|mesh-list
5937460|NCT04837716|Ensartinib|ensartinib|mesh-list
5937461|NCT04837716|Endothelial Growth Factors|endothelial growth factors|mesh-list
5937462|NCT04837716|Antibodies|antibodies|mesh-list
5937463|NCT04837716|Immunoglobulins|immunoglobulins|mesh-list
5937464|NCT04837716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5937465|NCT04837716|Immunoglobulin G|immunoglobulin g|mesh-list
5937466|NCT04837716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5937467|NCT04837716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5937468|NCT04837716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5937469|NCT04837716|Growth Substances|growth substances|mesh-ancestor
5937470|NCT04837716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937471|NCT04837716|Growth Inhibitors|growth inhibitors|mesh-ancestor
5937472|NCT04837716|Immunologic Factors|immunologic factors|mesh-ancestor
5937473|NCT04837716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5937474|NCT04837716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937475|NCT04837716|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5937476|NCT04837716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5937477|NCT04837716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5937478|NCT04837651|Antibodies|antibodies|mesh-list
5937479|NCT04837651|Immunologic Factors|immunologic factors|mesh-ancestor
5937480|NCT04837651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937481|NCT04837209|Niraparib|niraparib|mesh-list
5937482|NCT04837209|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5937483|NCT04837209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5937484|NCT04837209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937485|NCT04837209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5937486|NCT04837131|Ixazomib|ixazomib|mesh-list
5937487|NCT04837131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5937488|NCT04837131|Protease Inhibitors|protease inhibitors|mesh-ancestor
5937489|NCT04837131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5937490|NCT04837131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937491|NCT04837014|Acetaminophen|acetaminophen|mesh-list
5937492|NCT04837014|Naproxen|naproxen|mesh-list
5937493|NCT04837014|Hydromorphone|hydromorphone|mesh-list
5937494|NCT04837014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5937495|NCT04837014|Analgesics|analgesics|mesh-ancestor
5937496|NCT04837014|Sensory System Agents|sensory system agents|mesh-ancestor
5937497|NCT04837014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5937498|NCT04837014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937499|NCT04837014|Antipyretics|antipyretics|mesh-ancestor
5937500|NCT04837014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5937501|NCT04837014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5937502|NCT04837014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5937503|NCT04837014|Gout Suppressants|gout suppressants|mesh-ancestor
5937504|NCT04837014|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5937505|NCT04837014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5937506|NCT04837014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937507|NCT04837014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5937508|NCT04837014|Narcotics|narcotics|mesh-ancestor
5937509|NCT04837014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5937510|NCT04837170|Ketamine|ketamine|mesh-list
5937511|NCT04837170|Esketamine|esketamine|mesh-list
5937512|NCT04837170|Analgesics|analgesics|mesh-ancestor
5937513|NCT04837170|Sensory System Agents|sensory system agents|mesh-ancestor
5937514|NCT04837170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5937515|NCT04837170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937516|NCT04837170|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5937517|NCT04837170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5937518|NCT04837170|Anesthetics, General|anesthetics, general|mesh-ancestor
5937519|NCT04837170|Anesthetics|anesthetics|mesh-ancestor
5937520|NCT04837170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5937521|NCT04837170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5937522|NCT04837170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5937523|NCT04837170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5937524|NCT04837170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937525|NCT04837170|Antidepressive Agents|antidepressive agents|mesh-ancestor
5937526|NCT04837170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5937527|NCT04837066|Imidacloprid|imidacloprid|mesh-list
5937528|NCT04837066|Cholinergic Agents|cholinergic agents|mesh-ancestor
5937529|NCT04837066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5937530|NCT04837066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937531|NCT04837066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937532|NCT04837261|Propranolol|propranolol|mesh-list
5937533|NCT04837261|Amiodarone|amiodarone|mesh-list
5937534|NCT04837261|Flecainide|flecainide|mesh-list
5937535|NCT04837261|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5937536|NCT04837261|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5937537|NCT04837261|Adrenergic Agents|adrenergic agents|mesh-ancestor
5937538|NCT04837261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5937539|NCT04837261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937540|NCT04837261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937541|NCT04837261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5937542|NCT04837261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5937543|NCT04837261|Vasodilator Agents|vasodilator agents|mesh-ancestor
5937544|NCT04837261|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5937545|NCT04837261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5937546|NCT04837261|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5937547|NCT04837261|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5937548|NCT04837261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5937549|NCT04837261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5937550|NCT04837261|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5937551|NCT04837261|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5937552|NCT04837261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5937553|NCT04837261|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5937554|NCT04836962|Dexamethasone|dexamethasone|mesh-list
5937555|NCT04836962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5937556|NCT04836962|Antiemetics|antiemetics|mesh-ancestor
5937557|NCT04836962|Autonomic Agents|autonomic agents|mesh-ancestor
5937558|NCT04836962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5937559|NCT04836962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937560|NCT04836962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5937561|NCT04836962|Glucocorticoids|glucocorticoids|mesh-ancestor
5937562|NCT04836962|Hormones|hormones|mesh-ancestor
5937563|NCT04836962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5937564|NCT04836962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5937565|NCT04836962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5937566|NCT04836806|Cetirizine|cetirizine|mesh-list
5937567|NCT04836806|Famotidine|famotidine|mesh-list
5937568|NCT04836806|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5937569|NCT04836806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5937570|NCT04836806|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5937571|NCT04836806|Histamine Antagonists|histamine antagonists|mesh-ancestor
5937572|NCT04836806|Histamine Agents|histamine agents|mesh-ancestor
5937573|NCT04836806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5937574|NCT04836806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937575|NCT04836806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937576|NCT04836806|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5937577|NCT04836806|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5937578|NCT04836806|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5937579|NCT04836728|Paclitaxel|paclitaxel|mesh-list
5937580|NCT04836728|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5937581|NCT04836728|Carboplatin|carboplatin|mesh-list
5937582|NCT04836728|Pemetrexed|pemetrexed|mesh-list
5937583|NCT04836728|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5937584|NCT04836728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5937585|NCT04836728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5937586|NCT04836728|Tubulin Modulators|tubulin modulators|mesh-ancestor
5937587|NCT04836728|Antimitotic Agents|antimitotic agents|mesh-ancestor
5937588|NCT04836728|Mitosis Modulators|mitosis modulators|mesh-ancestor
5937589|NCT04836728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937590|NCT04836728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5937591|NCT04836728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5937592|NCT04836728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5937593|NCT04836533|Antidepressive Agents|antidepressive agents|mesh-list
5937594|NCT04836533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5937595|NCT04836637|Calcium, Dietary|calcium, dietary|mesh-list
5937596|NCT04836637|Calcium Carbonate|calcium carbonate|mesh-list
5937597|NCT04836637|Calcium|calcium|mesh-list
5937598|NCT04836637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5937599|NCT04836637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937600|NCT04836637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5937601|NCT04836637|Antacids|antacids|mesh-ancestor
5937602|NCT04836637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937603|NCT04836637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5937604|NCT04836819|Lidocaine|lidocaine|mesh-list
5937605|NCT04836819|Dexmedetomidine|dexmedetomidine|mesh-list
5937606|NCT04836819|Ketamine|ketamine|mesh-list
5937607|NCT04836819|Anesthetics, Local|anesthetics, local|mesh-ancestor
5937608|NCT04836819|Anesthetics|anesthetics|mesh-ancestor
5937609|NCT04836819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5937610|NCT04836819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937611|NCT04836819|Sensory System Agents|sensory system agents|mesh-ancestor
5937612|NCT04836819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5937613|NCT04836819|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5937614|NCT04836819|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5937615|NCT04836819|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5937616|NCT04836819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5937617|NCT04836819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937618|NCT04836819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5937619|NCT04836819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5937620|NCT04836819|Analgesics|analgesics|mesh-ancestor
5937621|NCT04836819|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5937622|NCT04836819|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5937623|NCT04836819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5937624|NCT04836819|Adrenergic Agents|adrenergic agents|mesh-ancestor
5937625|NCT04836819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5937626|NCT04836819|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5937627|NCT04836819|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5937628|NCT04836819|Anesthetics, General|anesthetics, general|mesh-ancestor
5937629|NCT04836819|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5937630|NCT04836819|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5966623|NCT04570436|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5966624|NCT04570436|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5966625|NCT04570436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5966626|NCT04570436|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5966627|NCT04570436|Anesthetics, General|anesthetics, general|mesh-ancestor
5966628|NCT04570436|Anesthetics|anesthetics|mesh-ancestor
5966629|NCT04570436|GABA Modulators|gaba modulators|mesh-ancestor
5966630|NCT04570436|GABA Agents|gaba agents|mesh-ancestor
5966631|NCT04570410|Gemcitabine|gemcitabine|mesh-list
5966632|NCT04570410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5966633|NCT04570410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5966634|NCT04570410|Antimetabolites|antimetabolites|mesh-ancestor
5966635|NCT04570410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966636|NCT04570410|Antiviral Agents|antiviral agents|mesh-ancestor
5966637|NCT04570410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5966638|NCT04570410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5966639|NCT04570410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5966640|NCT04570410|Immunologic Factors|immunologic factors|mesh-ancestor
5966641|NCT04570410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966642|NCT04570397|Ravulizumab|ravulizumab|mesh-list
5966643|NCT04570397|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5966644|NCT04570397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5966645|NCT04570397|Immunologic Factors|immunologic factors|mesh-ancestor
5966646|NCT04570397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966647|NCT04570345|Aspirin|aspirin|mesh-list
5966648|NCT04570345|Ticagrelor|ticagrelor|mesh-list
5966649|NCT04570345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5966650|NCT04570345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5966651|NCT04570345|Analgesics|analgesics|mesh-ancestor
5966652|NCT04570345|Sensory System Agents|sensory system agents|mesh-ancestor
5966653|NCT04570345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5966654|NCT04570345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719878|NCT03216564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719879|NCT03216564|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5719880|NCT03216564|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5719881|NCT03216564|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
5719882|NCT03216564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5719883|NCT03216564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719884|NCT03216564|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5719885|NCT03216304|Calcium, Dietary|calcium, dietary|mesh-list
5719886|NCT03216304|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5719887|NCT03216304|Calcium|calcium|mesh-list
5966655|NCT04570345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5966656|NCT04570345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5966657|NCT04570345|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5937631|NCT04836780|Dexamethasone|dexamethasone|mesh-list
5937632|NCT04836780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5937633|NCT04836780|Antiemetics|antiemetics|mesh-ancestor
5937634|NCT04836780|Autonomic Agents|autonomic agents|mesh-ancestor
5937635|NCT04836780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5937636|NCT04836780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937637|NCT04836780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5937638|NCT04836780|Glucocorticoids|glucocorticoids|mesh-ancestor
5937639|NCT04836780|Hormones|hormones|mesh-ancestor
5937640|NCT04836780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5937641|NCT04836780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5937642|NCT04836780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5937643|NCT04836507|Cyclophosphamide|cyclophosphamide|mesh-list
5937644|NCT04836507|Fludarabine|fludarabine|mesh-list
5937645|NCT04836507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5937646|NCT04836507|Immunologic Factors|immunologic factors|mesh-ancestor
5937647|NCT04836507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937648|NCT04836507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5937649|NCT04836507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5937650|NCT04836507|Alkylating Agents|alkylating agents|mesh-ancestor
5937651|NCT04836507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937652|NCT04836507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5937653|NCT04836507|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5937654|NCT04836078|Chitosan|chitosan|mesh-list
5937655|NCT04836078|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5937656|NCT04836078|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5937657|NCT04836078|Antimetabolites|antimetabolites|mesh-ancestor
5937658|NCT04836078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937659|NCT04836078|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5937660|NCT04836078|Chelating Agents|chelating agents|mesh-ancestor
5937661|NCT04836078|Sequestering Agents|sequestering agents|mesh-ancestor
5937662|NCT04836078|Hemostatics|hemostatics|mesh-ancestor
5937663|NCT04836078|Coagulants|coagulants|mesh-ancestor
5937664|NCT04836156|Cyclophosphamide|cyclophosphamide|mesh-list
5937665|NCT04836156|Carboplatin|carboplatin|mesh-list
5937666|NCT04836156|Docetaxel|docetaxel|mesh-list
5937667|NCT04836156|Epirubicin|epirubicin|mesh-list
5937668|NCT04836156|Phenobarbital|phenobarbital|mesh-list
5937669|NCT04836156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5937670|NCT04836156|Immunologic Factors|immunologic factors|mesh-ancestor
5937671|NCT04836156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937672|NCT04836156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5937673|NCT04836156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5937674|NCT04836156|Alkylating Agents|alkylating agents|mesh-ancestor
5937675|NCT04836156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937676|NCT04836156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5937677|NCT04836156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5937678|NCT04836156|Tubulin Modulators|tubulin modulators|mesh-ancestor
5937679|NCT04836156|Antimitotic Agents|antimitotic agents|mesh-ancestor
5937680|NCT04836156|Mitosis Modulators|mitosis modulators|mesh-ancestor
5937681|NCT04836156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5937682|NCT04836156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5937683|NCT04836156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5937684|NCT04836156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5937685|NCT04836156|Anticonvulsants|anticonvulsants|mesh-ancestor
5937686|NCT04836156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5937687|NCT04836156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5937688|NCT04836156|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5937689|NCT04836156|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5937690|NCT04836156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5937691|NCT04836156|GABA Modulators|gaba modulators|mesh-ancestor
5937692|NCT04836156|GABA Agents|gaba agents|mesh-ancestor
5937693|NCT04836156|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5937694|NCT04836156|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5937695|NCT04836156|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5937696|NCT04836143|Mitogens|mitogens|mesh-list
5937697|NCT04836143|Endothelial Growth Factors|endothelial growth factors|mesh-list
5937698|NCT04836143|Mitosis Modulators|mitosis modulators|mesh-ancestor
5937699|NCT04836143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937700|NCT04836143|Growth Substances|growth substances|mesh-ancestor
5937701|NCT04836143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937702|NCT04836299|Ivermectin|ivermectin|mesh-list
5937703|NCT04836299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5937704|NCT04836299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5937705|NCT04835870|Prednisone|prednisone|mesh-list
5937706|NCT04835870|Cyclophosphamide|cyclophosphamide|mesh-list
5937707|NCT04835870|Rituximab|rituximab|mesh-list
5937708|NCT04835870|Doxorubicin|doxorubicin|mesh-list
5937709|NCT04835870|Vincristine|vincristine|mesh-list
5937710|NCT04835870|Zanubrutinib|zanubrutinib|mesh-list
5937711|NCT04835870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5937712|NCT04835870|Immunologic Factors|immunologic factors|mesh-ancestor
5937713|NCT04835870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937714|NCT04835870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5937715|NCT04835870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5937716|NCT04835870|Alkylating Agents|alkylating agents|mesh-ancestor
5937717|NCT04835870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937718|NCT04835870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5937719|NCT04835870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5937720|NCT04835870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5937721|NCT04835870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5937722|NCT04835870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5937723|NCT04835870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5937724|NCT04835870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5937725|NCT04835870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5937726|NCT04835870|Glucocorticoids|glucocorticoids|mesh-ancestor
5937727|NCT04835870|Hormones|hormones|mesh-ancestor
5937728|NCT04835870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5937729|NCT04835870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5937730|NCT04835870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5937731|NCT04835870|Tubulin Modulators|tubulin modulators|mesh-ancestor
5937732|NCT04835870|Antimitotic Agents|antimitotic agents|mesh-ancestor
5937733|NCT04835870|Mitosis Modulators|mitosis modulators|mesh-ancestor
5937734|NCT04835870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5937735|NCT04835948|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5937736|NCT04835948|Immunologic Factors|immunologic factors|mesh-ancestor
5937737|NCT04835948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937738|NCT04835948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5937739|NCT04835623|Cyclosporine|cyclosporine|mesh-list
5937740|NCT04835623|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5937741|NCT04835623|Cyclosporins|cyclosporins|mesh-list
5937742|NCT04835623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5937743|NCT04835623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937744|NCT04835623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5937745|NCT04835623|Immunologic Factors|immunologic factors|mesh-ancestor
5937746|NCT04835623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937747|NCT04835623|Antifungal Agents|antifungal agents|mesh-ancestor
5937748|NCT04835623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5937749|NCT04835623|Dermatologic Agents|dermatologic agents|mesh-ancestor
5937750|NCT04835623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5937751|NCT04835623|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5937752|NCT04835623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5937753|NCT04835922|Anesthetics|anesthetics|mesh-list
5937754|NCT04835922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5937755|NCT04835922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937756|NCT04835896|Paclitaxel|paclitaxel|mesh-list
5937757|NCT04835896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5937758|NCT04835896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5937759|NCT04835896|Tubulin Modulators|tubulin modulators|mesh-ancestor
5937760|NCT04835896|Antimitotic Agents|antimitotic agents|mesh-ancestor
5937761|NCT04835896|Mitosis Modulators|mitosis modulators|mesh-ancestor
5937762|NCT04835896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937763|NCT04835350|Pancrelipase|pancrelipase|mesh-list
5937764|NCT04835350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5937765|NCT04835259|Selenium|selenium|mesh-list
5937766|NCT04835259|Antioxidants|antioxidants|mesh-ancestor
5937767|NCT04835259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937768|NCT04835259|Protective Agents|protective agents|mesh-ancestor
5937769|NCT04835259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937770|NCT04835259|Trace Elements|trace elements|mesh-ancestor
5937771|NCT04835259|Micronutrients|micronutrients|mesh-ancestor
5937772|NCT04835584|Dasatinib|dasatinib|mesh-list
5937773|NCT04835584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5937774|NCT04835584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5937775|NCT04835584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5937776|NCT04835584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937777|NCT04835402|Pembrolizumab|pembrolizumab|mesh-list
5937778|NCT04835402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5937779|NCT04835402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5937780|NCT04835506|Infliximab|infliximab|mesh-list
5937781|NCT04835506|Dermatologic Agents|dermatologic agents|mesh-ancestor
5937782|NCT04835506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5937783|NCT04835506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5937784|NCT04835233|Methyldopa|methyldopa|mesh-list
5937785|NCT04835233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5937786|NCT04835233|Sympatholytics|sympatholytics|mesh-ancestor
5937787|NCT04835233|Autonomic Agents|autonomic agents|mesh-ancestor
5937788|NCT04835233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5937789|NCT04835233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937790|NCT04835233|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5937791|NCT04835233|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5937792|NCT04835233|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5937793|NCT04835233|Adrenergic Agents|adrenergic agents|mesh-ancestor
5937794|NCT04835233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5937795|NCT04835233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937796|NCT04834973|Pembrolizumab|pembrolizumab|mesh-list
5937797|NCT04834973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5937798|NCT04834973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5937799|NCT04834986|Lenvatinib|lenvatinib|mesh-list
5937800|NCT04834986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5937801|NCT04834986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5937802|NCT04834986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5937803|NCT04834986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937804|NCT04835064|Gemcitabine|gemcitabine|mesh-list
5937805|NCT04835064|Paclitaxel|paclitaxel|mesh-list
5937806|NCT04835064|Folfirinox|folfirinox|mesh-list
5937807|NCT04835064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5937808|NCT04835064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5937809|NCT04835064|Tubulin Modulators|tubulin modulators|mesh-ancestor
5937810|NCT04835064|Antimitotic Agents|antimitotic agents|mesh-ancestor
5937811|NCT04835064|Mitosis Modulators|mitosis modulators|mesh-ancestor
5937812|NCT04835064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937813|NCT04835064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5937814|NCT04835064|Antimetabolites|antimetabolites|mesh-ancestor
5937815|NCT04835064|Antiviral Agents|antiviral agents|mesh-ancestor
5937816|NCT04835064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5937817|NCT04835064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5937818|NCT04835064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5937819|NCT04835064|Immunologic Factors|immunologic factors|mesh-ancestor
5937820|NCT04835064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937821|NCT04835116|Acetaminophen|acetaminophen|mesh-list
5937822|NCT04835116|Tramadol|tramadol|mesh-list
5937823|NCT04835116|Analgesics|analgesics|mesh-list
5937824|NCT04835116|Orphenadrine|orphenadrine|mesh-list
5937825|NCT04835116|Dimenhydrinate|dimenhydrinate|mesh-list
5937826|NCT04835116|Bupivacaine|bupivacaine|mesh-list
5937827|NCT04835116|Anesthetics, Local|anesthetics, local|mesh-ancestor
5937828|NCT04835116|Anesthetics|anesthetics|mesh-ancestor
5937829|NCT04835116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5937830|NCT04835116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937831|NCT04835116|Sensory System Agents|sensory system agents|mesh-ancestor
5937832|NCT04835116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5937833|NCT04835116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5937834|NCT04835116|Antipyretics|antipyretics|mesh-ancestor
5937835|NCT04835116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5937836|NCT04835116|Narcotics|narcotics|mesh-ancestor
5937837|NCT04835116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5937838|NCT04835116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5937839|NCT04835116|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5937840|NCT04835116|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5937841|NCT04835116|Parasympatholytics|parasympatholytics|mesh-ancestor
5937842|NCT04835116|Autonomic Agents|autonomic agents|mesh-ancestor
5937843|NCT04835116|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5937844|NCT04835116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5937845|NCT04835116|Cholinergic Agents|cholinergic agents|mesh-ancestor
5937846|NCT04835116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5937847|NCT04835116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937848|NCT04835116|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
5937849|NCT04835116|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5937850|NCT04835116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5937851|NCT04835116|Antiemetics|antiemetics|mesh-ancestor
5937852|NCT04835116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5937853|NCT04835116|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5937854|NCT04835116|Histamine Antagonists|histamine antagonists|mesh-ancestor
5937855|NCT04835116|Histamine Agents|histamine agents|mesh-ancestor
5937856|NCT04834908|Immune Sera|immune sera|mesh-list
5937857|NCT04834908|Immunologic Factors|immunologic factors|mesh-ancestor
5937858|NCT04834908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937859|NCT04834791|Letrozole|letrozole|mesh-list
5937860|NCT04834791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5937861|NCT04834791|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5937862|NCT04834791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5937863|NCT04834791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5937864|NCT04834791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937865|NCT04834791|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5937866|NCT04834791|Hormone Antagonists|hormone antagonists|mesh-ancestor
5937867|NCT04834791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5937868|NCT04834791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966658|NCT04570345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5966659|NCT04570345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966660|NCT04570345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5966661|NCT04570345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5966662|NCT04570345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5966663|NCT04570345|Antipyretics|antipyretics|mesh-ancestor
5966664|NCT04570345|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5966665|NCT04570345|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5966666|NCT04570345|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5966667|NCT04570345|Purinergic Agents|purinergic agents|mesh-ancestor
5966668|NCT04570345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5966669|NCT04570293|Lidocaine|lidocaine|mesh-list
5966670|NCT04570293|Anesthetics, Local|anesthetics, local|mesh-ancestor
5966671|NCT04570293|Anesthetics|anesthetics|mesh-ancestor
5966672|NCT04570293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5966673|NCT04570293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966674|NCT04570293|Sensory System Agents|sensory system agents|mesh-ancestor
5966675|NCT04570293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5966676|NCT04570293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5966677|NCT04570293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5966678|NCT04570293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5966679|NCT04570293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5966680|NCT04570293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966681|NCT04570254|Vitamins|vitamins|mesh-list
5966682|NCT04570254|Vitamin E|vitamin e|mesh-list
5966683|NCT04570254|Acetylcysteine|acetylcysteine|mesh-list
5966684|NCT04570254|Pentoxifylline|pentoxifylline|mesh-list
5966685|NCT04570254|Melatonin|melatonin|mesh-list
5966686|NCT04570254|Antioxidants|antioxidants|mesh-list
5966687|NCT04570254|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5966688|NCT04570254|Micronutrients|micronutrients|mesh-ancestor
5966689|NCT04570254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966690|NCT04570254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966691|NCT04570254|Protective Agents|protective agents|mesh-ancestor
5966692|NCT04570254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5966693|NCT04570254|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5966694|NCT04570254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5966695|NCT04570254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5966696|NCT04570254|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5966697|NCT04570254|Vasodilator Agents|vasodilator agents|mesh-ancestor
5966698|NCT04570254|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5966699|NCT04570254|Antiviral Agents|antiviral agents|mesh-ancestor
5966700|NCT04570254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5966701|NCT04570254|Expectorants|expectorants|mesh-ancestor
5966702|NCT04570254|Respiratory System Agents|respiratory system agents|mesh-ancestor
5966703|NCT04570254|Antidotes|antidotes|mesh-ancestor
5966704|NCT04570150|Neostigmine|neostigmine|mesh-list
5966705|NCT04570150|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5966706|NCT04570150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5966707|NCT04570150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966708|NCT04570150|Cholinergic Agents|cholinergic agents|mesh-ancestor
5966709|NCT04570150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5966710|NCT04570150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966711|NCT04570150|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5966712|NCT04570150|Autonomic Agents|autonomic agents|mesh-ancestor
5966713|NCT04570150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5966714|NCT04570306|Belimumab|belimumab|mesh-list
5966715|NCT04570306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5966716|NCT04570306|Immunologic Factors|immunologic factors|mesh-ancestor
5966717|NCT04570306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966718|NCT04570033|Parathyroid Hormone|parathyroid hormone|mesh-list
5966719|NCT04570033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6242649|NCT02654054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5966720|NCT04570033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937869|NCT04834960|Vaccines|vaccines|mesh-list
5937870|NCT04834960|Immunologic Factors|immunologic factors|mesh-ancestor
5937871|NCT04834960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937872|NCT04835129|Dexamethasone|dexamethasone|mesh-list
5937873|NCT04835129|Pomalidomide|pomalidomide|mesh-list
5937874|NCT04835129|Elotuzumab|elotuzumab|mesh-list
5937875|NCT04835129|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5937876|NCT04835129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5937877|NCT04835129|Antiemetics|antiemetics|mesh-ancestor
5937878|NCT04835129|Autonomic Agents|autonomic agents|mesh-ancestor
5937879|NCT04835129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5937880|NCT04835129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937881|NCT04835129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5937882|NCT04835129|Glucocorticoids|glucocorticoids|mesh-ancestor
5937883|NCT04835129|Hormones|hormones|mesh-ancestor
5937884|NCT04835129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5937885|NCT04835129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5937886|NCT04835129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5937887|NCT04835129|Immunologic Factors|immunologic factors|mesh-ancestor
5937888|NCT04835129|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5937889|NCT04835129|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5937890|NCT04835129|Growth Substances|growth substances|mesh-ancestor
5937891|NCT04835129|Growth Inhibitors|growth inhibitors|mesh-ancestor
5937892|NCT04835025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5937893|NCT04835025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937894|NCT04835025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5937895|NCT04834440|Ropivacaine|ropivacaine|mesh-list
5937896|NCT04834440|Anesthetics, Local|anesthetics, local|mesh-ancestor
5937897|NCT04834440|Anesthetics|anesthetics|mesh-ancestor
5937898|NCT04834440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5937899|NCT04834440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937900|NCT04834440|Sensory System Agents|sensory system agents|mesh-ancestor
5937901|NCT04834440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5937902|NCT04834557|Digoxin|digoxin|mesh-list
5937903|NCT04834557|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
5937904|NCT04834557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5937905|NCT04834557|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5937906|NCT04834557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5937907|NCT04834557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937908|NCT04834557|Protective Agents|protective agents|mesh-ancestor
5937909|NCT04834557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937910|NCT04834557|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5937911|NCT04834557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5937912|NCT04834752|Esomeprazole|esomeprazole|mesh-list
5937913|NCT04834752|Omeprazole|omeprazole|mesh-list
5937914|NCT04834752|Rabeprazole|rabeprazole|mesh-list
5937915|NCT04834752|Pantoprazole|pantoprazole|mesh-list
5937916|NCT04834752|Lansoprazole|lansoprazole|mesh-list
5937917|NCT04834752|Dexlansoprazole|dexlansoprazole|mesh-list
5937918|NCT04834752|Famotidine|famotidine|mesh-list
5937919|NCT04834752|Ranitidine|ranitidine|mesh-list
5937920|NCT04834752|Cimetidine|cimetidine|mesh-list
5937921|NCT04834752|Nizatidine|nizatidine|mesh-list
5937922|NCT04834752|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5937923|NCT04834752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5937924|NCT04834752|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5937925|NCT04834752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5937926|NCT04834752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937927|NCT04834752|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5937928|NCT04834752|Histamine Antagonists|histamine antagonists|mesh-ancestor
5937929|NCT04834752|Histamine Agents|histamine agents|mesh-ancestor
5937930|NCT04834752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5937931|NCT04834752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937932|NCT04834752|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5937933|NCT04834752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5937934|NCT04834674|Apatinib|apatinib|mesh-list
5937935|NCT04834674|Antibodies|antibodies|mesh-list
5937936|NCT04834674|Immunologic Factors|immunologic factors|mesh-ancestor
5937937|NCT04834674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937938|NCT04834674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5937939|NCT04834674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5937940|NCT04834674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5937941|NCT04834674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517243|NCT00720408|Antitubercular Agents|antitubercular agents|mesh-ancestor
5937942|NCT04834427|Ketamine|ketamine|mesh-list
5937943|NCT04834427|Esketamine|esketamine|mesh-list
5937944|NCT04834427|Analgesics|analgesics|mesh-ancestor
5937945|NCT04834427|Sensory System Agents|sensory system agents|mesh-ancestor
5937946|NCT04834427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5937947|NCT04834427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937948|NCT04834427|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5937949|NCT04834427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5937950|NCT04834427|Anesthetics, General|anesthetics, general|mesh-ancestor
5937951|NCT04834427|Anesthetics|anesthetics|mesh-ancestor
5937952|NCT04834427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5937953|NCT04834427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5937954|NCT04834427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5937955|NCT04834427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5937956|NCT04834427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937957|NCT04834427|Antidepressive Agents|antidepressive agents|mesh-ancestor
5937958|NCT04834427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5937959|NCT04834388|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5937960|NCT04834388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5937961|NCT04834375|Dexamethasone|dexamethasone|mesh-list
5937962|NCT04834375|Dexamethasone acetate|dexamethasone acetate|mesh-list
5937963|NCT04834375|BB 1101|bb 1101|mesh-list
5937964|NCT04834375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5937965|NCT04834375|Antiemetics|antiemetics|mesh-ancestor
5937966|NCT04834375|Autonomic Agents|autonomic agents|mesh-ancestor
5937967|NCT04834375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5937968|NCT04834375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5937969|NCT04834375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5937970|NCT04834375|Glucocorticoids|glucocorticoids|mesh-ancestor
5937971|NCT04834375|Hormones|hormones|mesh-ancestor
5937972|NCT04834375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5937973|NCT04834375|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5937974|NCT04834375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5937975|NCT04834375|Protease Inhibitors|protease inhibitors|mesh-ancestor
5937976|NCT04834375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5937977|NCT04834375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937978|NCT04834310|Clindamycin|clindamycin|mesh-list
5937979|NCT04834310|Clindamycin palmitate|clindamycin palmitate|mesh-list
5937980|NCT04834310|Clindamycin phosphate|clindamycin phosphate|mesh-list
5937981|NCT04834310|Cefazolin|cefazolin|mesh-list
5937982|NCT04834310|Cephalexin|cephalexin|mesh-list
5937983|NCT04834310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5937984|NCT04834310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5937985|NCT04834310|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5937986|NCT04834310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5937987|NCT04834310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5937988|NCT04833959|Panitumumab|panitumumab|mesh-list
5937989|NCT04833959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5937990|NCT04833959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5937991|NCT04834115|Ivermectin|ivermectin|mesh-list
5937992|NCT04834115|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5937993|NCT04834115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5937994|NCT04834349|Pembrolizumab|pembrolizumab|mesh-list
5937995|NCT04834349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5937996|NCT04834349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5937997|NCT04834206|Docetaxel|docetaxel|mesh-list
5937998|NCT04834206|Fluorouracil|fluorouracil|mesh-list
5937999|NCT04834206|Nedaplatin|nedaplatin|mesh-list
5938000|NCT04834206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5938001|NCT04834206|Tubulin Modulators|tubulin modulators|mesh-ancestor
5938002|NCT04834206|Antimitotic Agents|antimitotic agents|mesh-ancestor
5938003|NCT04834206|Mitosis Modulators|mitosis modulators|mesh-ancestor
5938004|NCT04834206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938005|NCT04834206|Antimetabolites|antimetabolites|mesh-ancestor
5938006|NCT04834206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5938007|NCT04834206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5938008|NCT04834206|Immunologic Factors|immunologic factors|mesh-ancestor
5938009|NCT04834206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938010|NCT04833907|Prednisolone|prednisolone|mesh-list
5938011|NCT04833907|Levetiracetam|levetiracetam|mesh-list
5938012|NCT04833907|Prednisolone phosphate|prednisolone phosphate|mesh-list
5938013|NCT04833907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5938014|NCT04833907|Glucocorticoids|glucocorticoids|mesh-ancestor
5938015|NCT04833907|Hormones|hormones|mesh-ancestor
5938016|NCT04833907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5938017|NCT04833907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938018|NCT04833907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5938019|NCT04833907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5938020|NCT04833907|Anticonvulsants|anticonvulsants|mesh-ancestor
5938021|NCT04833907|Nootropic Agents|nootropic agents|mesh-ancestor
5938022|NCT04833608|Carbon Fiber|carbon fiber|mesh-list
5938023|NCT04833608|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5938024|NCT04833608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5938025|NCT04833738|Triamcinolone|triamcinolone|mesh-list
5938026|NCT04833738|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5938027|NCT04833738|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5938028|NCT04833738|Hyaluronic Acid|hyaluronic acid|mesh-list
5938029|NCT04833738|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5938030|NCT04833738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5938031|NCT04833738|Glucocorticoids|glucocorticoids|mesh-ancestor
5938032|NCT04833738|Hormones|hormones|mesh-ancestor
5938033|NCT04833738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5938034|NCT04833738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938035|NCT04833738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5938036|NCT04833738|Immunologic Factors|immunologic factors|mesh-ancestor
5938037|NCT04833738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5938038|NCT04833738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938039|NCT04833738|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5938040|NCT04833738|Viscosupplements|viscosupplements|mesh-ancestor
5938041|NCT04833738|Protective Agents|protective agents|mesh-ancestor
5938042|NCT04833790|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5938043|NCT04833790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5938044|NCT04833777|Lidocaine|lidocaine|mesh-list
5938045|NCT04833777|Bupivacaine|bupivacaine|mesh-list
5938046|NCT04833777|Anesthetics, Local|anesthetics, local|mesh-list
5938047|NCT04833777|Anesthetics|anesthetics|mesh-list
5938048|NCT04833777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5938049|NCT04833777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938050|NCT04833777|Sensory System Agents|sensory system agents|mesh-ancestor
5938051|NCT04833777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5938052|NCT04833777|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5938053|NCT04833777|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5938054|NCT04833777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5938055|NCT04833777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5938056|NCT04833777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966721|NCT04569838|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5966722|NCT04569838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5966723|NCT04569838|Alkylating Agents|alkylating agents|mesh-ancestor
5966724|NCT04569838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966725|NCT04569838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5966726|NCT04570085|Caffeine|caffeine|mesh-list
5966727|NCT04570085|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5966728|NCT04570085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966729|NCT04570085|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5966730|NCT04570085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5966731|NCT04570085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966732|NCT04570085|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5966733|NCT04570085|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5966734|NCT04570085|Purinergic Agents|purinergic agents|mesh-ancestor
5966735|NCT04570085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5966736|NCT04569877|Molgramostim|molgramostim|mesh-list
5966737|NCT04569877|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5966738|NCT04569877|Sargramostim|sargramostim|mesh-list
5966739|NCT04569877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5966740|NCT04569877|Immunologic Factors|immunologic factors|mesh-ancestor
5966741|NCT04569877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966742|NCT04569916|Irinotecan|irinotecan|mesh-list
5966743|NCT04569916|Apatinib|apatinib|mesh-list
5966744|NCT04569916|Antibodies|antibodies|mesh-list
5966745|NCT04569916|Immunologic Factors|immunologic factors|mesh-ancestor
5966746|NCT04569916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966747|NCT04569916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5966748|NCT04569916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5966749|NCT04569916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5966750|NCT04569916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966751|NCT04569916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5966752|NCT04569916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5966753|NCT04569942|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
5966754|NCT04569890|Hydroxychloroquine|hydroxychloroquine|mesh-list
5966755|NCT04569890|Prednisone|prednisone|mesh-list
5966756|NCT04569890|Certolizumab Pegol|certolizumab pegol|mesh-list
5966757|NCT04569890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5966758|NCT04569890|Glucocorticoids|glucocorticoids|mesh-ancestor
5966759|NCT04569890|Hormones|hormones|mesh-ancestor
5938057|NCT04833205|Nimotuzumab|nimotuzumab|mesh-list
5938058|NCT04833205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5938059|NCT04833205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5938060|NCT04833218|Propranolol|propranolol|mesh-list
5938061|NCT04833218|Clonidine|clonidine|mesh-list
5938062|NCT04833218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5938063|NCT04833218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5938064|NCT04833218|Adrenergic Agents|adrenergic agents|mesh-ancestor
5938065|NCT04833218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5938066|NCT04833218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938067|NCT04833218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938068|NCT04833218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5938069|NCT04833218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5938070|NCT04833218|Vasodilator Agents|vasodilator agents|mesh-ancestor
5938071|NCT04833218|Analgesics|analgesics|mesh-ancestor
5938072|NCT04833218|Sensory System Agents|sensory system agents|mesh-ancestor
5938073|NCT04833218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5938074|NCT04833218|Sympatholytics|sympatholytics|mesh-ancestor
5938075|NCT04833218|Autonomic Agents|autonomic agents|mesh-ancestor
5938076|NCT04833218|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5938077|NCT04833218|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5938078|NCT04833218|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5938079|NCT04833114|Carboplatin|carboplatin|mesh-list
5938080|NCT04833114|Etoposide|etoposide|mesh-list
5938081|NCT04833114|Rituximab|rituximab|mesh-list
5938082|NCT04833114|Ifosfamide|ifosfamide|mesh-list
5938083|NCT04833114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5938084|NCT04833114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5938085|NCT04833114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5938086|NCT04833114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5938087|NCT04833114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5938088|NCT04833114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938089|NCT04833114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5938090|NCT04833114|Immunologic Factors|immunologic factors|mesh-ancestor
5938091|NCT04833114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938092|NCT04833114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5938093|NCT04833114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5938094|NCT04833114|Alkylating Agents|alkylating agents|mesh-ancestor
5938095|NCT04833387|Antibodies|antibodies|mesh-list
5938096|NCT04833387|Immunologic Factors|immunologic factors|mesh-ancestor
5938097|NCT04833387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938098|NCT04833374|Prednisone|prednisone|mesh-list
5938099|NCT04833374|Methylprednisolone|methylprednisolone|mesh-list
5938100|NCT04833374|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5938101|NCT04833374|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5938102|NCT04833374|Prednisolone|prednisolone|mesh-list
5938103|NCT04833374|Prednisolone acetate|prednisolone acetate|mesh-list
5938104|NCT04833374|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5938105|NCT04833374|Prednisolone phosphate|prednisolone phosphate|mesh-list
5938106|NCT04833374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5938107|NCT04833374|Glucocorticoids|glucocorticoids|mesh-ancestor
5938108|NCT04833374|Hormones|hormones|mesh-ancestor
5938109|NCT04833374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5938110|NCT04833374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938111|NCT04833374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5938112|NCT04833374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5938113|NCT04833374|Antiemetics|antiemetics|mesh-ancestor
5938114|NCT04833374|Autonomic Agents|autonomic agents|mesh-ancestor
5938115|NCT04833374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5938116|NCT04833374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5938117|NCT04833374|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5938118|NCT04833374|Protective Agents|protective agents|mesh-ancestor
5938119|NCT04833426|Testosterone|testosterone|mesh-list
5938120|NCT04833426|Androgens|androgens|mesh-ancestor
5938121|NCT04833426|Hormones|hormones|mesh-ancestor
5938122|NCT04833426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5938123|NCT04833426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938124|NCT04833101|Vaccines|vaccines|mesh-list
5938125|NCT04833101|Immunologic Factors|immunologic factors|mesh-ancestor
5938126|NCT04833101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938127|NCT04833036|Irinotecan|irinotecan|mesh-list
5938128|NCT04833036|Cetuximab|cetuximab|mesh-list
5938129|NCT04833036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5938130|NCT04833036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5938131|NCT04833036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5938132|NCT04833036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938133|NCT04833036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5938134|NCT04833036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5938135|NCT04833023|Olanzapine|olanzapine|mesh-list
5938136|NCT04833023|Antiemetics|antiemetics|mesh-ancestor
5938137|NCT04833023|Autonomic Agents|autonomic agents|mesh-ancestor
5938138|NCT04833023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5938139|NCT04833023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938140|NCT04833023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5938141|NCT04833023|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5938142|NCT04833023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5938143|NCT04833023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5938144|NCT04833023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5938145|NCT04833023|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5938146|NCT04833023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5938147|NCT04833023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5938148|NCT04833023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938149|NCT04833023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5938150|NCT04833023|Serotonin Agents|serotonin agents|mesh-ancestor
5938151|NCT04833296|Ropivacaine|ropivacaine|mesh-list
5938152|NCT04833296|Anesthetics, Local|anesthetics, local|mesh-ancestor
5938153|NCT04833296|Anesthetics|anesthetics|mesh-ancestor
5938154|NCT04833296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5938155|NCT04833296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938156|NCT04833296|Sensory System Agents|sensory system agents|mesh-ancestor
5938157|NCT04833296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5938158|NCT04832906|Ulipristal acetate|ulipristal acetate|mesh-list
5938159|NCT04832906|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5938160|NCT04832906|Contraceptive Agents|contraceptive agents|mesh-ancestor
5938161|NCT04832906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5938162|NCT04832906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938163|NCT04832906|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5938164|NCT04832880|Remdesivir|remdesivir|mesh-list
5938165|NCT04832880|Dexamethasone|dexamethasone|mesh-list
5938166|NCT04832880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5938167|NCT04832880|Antiemetics|antiemetics|mesh-ancestor
5938168|NCT04832880|Autonomic Agents|autonomic agents|mesh-ancestor
5938169|NCT04832880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5938170|NCT04832880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938171|NCT04832880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5938172|NCT04832880|Glucocorticoids|glucocorticoids|mesh-ancestor
5938173|NCT04832880|Hormones|hormones|mesh-ancestor
5938174|NCT04832880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5938175|NCT04832880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5938176|NCT04832880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5938177|NCT04832880|Antimetabolites|antimetabolites|mesh-ancestor
5938178|NCT04832880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938179|NCT04832880|Antiviral Agents|antiviral agents|mesh-ancestor
5938180|NCT04832880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5938181|NCT04832945|Ivermectin|ivermectin|mesh-list
5938182|NCT04832945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5938183|NCT04832945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5938184|NCT04832776|Bevacizumab|bevacizumab|mesh-list
5938185|NCT04832776|Cetuximab|cetuximab|mesh-list
5938186|NCT04832776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5938187|NCT04832776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5938188|NCT04832776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5938189|NCT04832776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5938190|NCT04832776|Growth Substances|growth substances|mesh-ancestor
5938191|NCT04832776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938192|NCT04832776|Growth Inhibitors|growth inhibitors|mesh-ancestor
5938193|NCT04832399|Natalizumab|natalizumab|mesh-list
5938194|NCT04832399|Immunologic Factors|immunologic factors|mesh-ancestor
5938195|NCT04832399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938196|NCT04832009|Ascorbic Acid|ascorbic acid|mesh-list
5938197|NCT04832009|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
5938198|NCT04832009|Antioxidants|antioxidants|mesh-ancestor
5938199|NCT04832009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938200|NCT04832009|Protective Agents|protective agents|mesh-ancestor
5938201|NCT04832009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938202|NCT04832009|Vitamins|vitamins|mesh-ancestor
5938203|NCT04832009|Micronutrients|micronutrients|mesh-ancestor
5938204|NCT04832009|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
5938205|NCT04832009|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5938206|NCT04832009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5938207|NCT04832269|Methylprednisolone|methylprednisolone|mesh-list
5938208|NCT04832269|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5938209|NCT04832269|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5938210|NCT04832269|Prednisolone|prednisolone|mesh-list
5938211|NCT04832269|Prednisolone acetate|prednisolone acetate|mesh-list
5938212|NCT04832269|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5938213|NCT04832269|Prednisolone phosphate|prednisolone phosphate|mesh-list
5938214|NCT04832269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5938215|NCT04832269|Antiemetics|antiemetics|mesh-ancestor
5938216|NCT04832269|Autonomic Agents|autonomic agents|mesh-ancestor
5938217|NCT04832269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5938218|NCT04832269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938219|NCT04832269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5938220|NCT04832269|Glucocorticoids|glucocorticoids|mesh-ancestor
5938221|NCT04832269|Hormones|hormones|mesh-ancestor
5938222|NCT04832269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5938223|NCT04832269|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5938224|NCT04832269|Protective Agents|protective agents|mesh-ancestor
5938225|NCT04832269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5938226|NCT04832269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5938227|NCT04832035|Psychotropic Drugs|psychotropic drugs|mesh-list
5938228|NCT04832100|Pregabalin|pregabalin|mesh-list
5938229|NCT04832100|Imipramine|imipramine|mesh-list
5938230|NCT04832100|Analgesics|analgesics|mesh-ancestor
5938231|NCT04832100|Sensory System Agents|sensory system agents|mesh-ancestor
5938232|NCT04832100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5938233|NCT04832100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938234|NCT04832100|Anticonvulsants|anticonvulsants|mesh-ancestor
5938235|NCT04832100|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5938236|NCT04832100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5938237|NCT04832100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938238|NCT04832100|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5938239|NCT04832100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5938240|NCT04832100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5938241|NCT04832100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5938242|NCT04832100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5938243|NCT04832100|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5938244|NCT04832100|Antidepressive Agents|antidepressive agents|mesh-ancestor
5938245|NCT04832100|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5938246|NCT04832100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5938247|NCT04832100|Adrenergic Agents|adrenergic agents|mesh-ancestor
5938248|NCT04832100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5938249|NCT04832204|Apatinib|apatinib|mesh-list
5938250|NCT04832204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5938251|NCT04832204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5938252|NCT04832204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5938253|NCT04832204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966760|NCT04569890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5966761|NCT04569890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966762|NCT04569890|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5966763|NCT04569890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5966764|NCT04569890|Antimalarials|antimalarials|mesh-ancestor
5966765|NCT04569890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5966766|NCT04569890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5966767|NCT04569890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5966768|NCT04569890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5966769|NCT04569890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966770|NCT04569890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5966771|NCT04569890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5966772|NCT04569890|Immunologic Factors|immunologic factors|mesh-ancestor
5966773|NCT04569994|Insulin|insulin|mesh-list
5966774|NCT04569994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5966775|NCT04569994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966776|NCT04569448|Brexpiprazole|brexpiprazole|mesh-list
5966777|NCT04569448|Serotonin Agents|serotonin agents|mesh-ancestor
5966778|NCT04569448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5966779|NCT04569448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966780|NCT04569448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966781|NCT04569448|Dopamine Agonists|dopamine agonists|mesh-ancestor
5966782|NCT04569448|Dopamine Agents|dopamine agents|mesh-ancestor
5966783|NCT04569513|Parathyroid Hormone|parathyroid hormone|mesh-list
5966784|NCT04569513|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5966785|NCT04569513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966786|NCT04569630|Hypoglycemic Agents|hypoglycemic agents|mesh-list
5938254|NCT04831619|Deoxyglucose|deoxyglucose|mesh-list
5938255|NCT04831619|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5938256|NCT04831619|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5938257|NCT04831619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938258|NCT04831619|Antimetabolites|antimetabolites|mesh-ancestor
5938259|NCT04831619|Antiviral Agents|antiviral agents|mesh-ancestor
5938260|NCT04831619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5938261|NCT04831541|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5938262|NCT04831541|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5938263|NCT04831541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938264|NCT04831593|Anesthetics|anesthetics|mesh-list
5938265|NCT04831593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5938266|NCT04831593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938267|NCT04831736|Ketamine|ketamine|mesh-list
5938268|NCT04831736|Analgesics|analgesics|mesh-ancestor
5938269|NCT04831736|Sensory System Agents|sensory system agents|mesh-ancestor
5938270|NCT04831736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5938271|NCT04831736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938272|NCT04831736|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5938273|NCT04831736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5938274|NCT04831736|Anesthetics, General|anesthetics, general|mesh-ancestor
5938275|NCT04831736|Anesthetics|anesthetics|mesh-ancestor
5938276|NCT04831736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5938277|NCT04831736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5938278|NCT04831736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5938279|NCT04831736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5938280|NCT04831736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938281|NCT04831528|Bevacizumab|bevacizumab|mesh-list
5938282|NCT04831528|Trastuzumab|trastuzumab|mesh-list
5938283|NCT04831528|Cetuximab|cetuximab|mesh-list
5938284|NCT04831528|Pertuzumab|pertuzumab|mesh-list
5938285|NCT04831528|Lapatinib|lapatinib|mesh-list
5938286|NCT04831528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5938287|NCT04831528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5938288|NCT04831528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5938289|NCT04831528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5938290|NCT04831528|Growth Substances|growth substances|mesh-ancestor
5938291|NCT04831528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938292|NCT04831528|Growth Inhibitors|growth inhibitors|mesh-ancestor
5938293|NCT04831528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5938294|NCT04831528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5938295|NCT04831528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938296|NCT04831151|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
5938297|NCT04831151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938298|NCT04831151|Androgen Antagonists|androgen antagonists|mesh-ancestor
5938299|NCT04831151|Hormone Antagonists|hormone antagonists|mesh-ancestor
5938300|NCT04831151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5938301|NCT04831320|Paclitaxel|paclitaxel|mesh-list
5938302|NCT04831320|Nivolumab|nivolumab|mesh-list
5938303|NCT04831320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5938304|NCT04831320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5938305|NCT04831320|Tubulin Modulators|tubulin modulators|mesh-ancestor
5938306|NCT04831320|Antimitotic Agents|antimitotic agents|mesh-ancestor
5938307|NCT04831320|Mitosis Modulators|mitosis modulators|mesh-ancestor
5938308|NCT04831320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938309|NCT04831320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5938310|NCT04831320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5938311|NCT04831086|Tocolytic Agents|tocolytic agents|mesh-list
5938312|NCT04831086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5938313|NCT04831086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938314|NCT04831047|Phenylephrine|phenylephrine|mesh-list
5938315|NCT04831047|Oxymetazoline|oxymetazoline|mesh-list
5938316|NCT04831047|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5938317|NCT04831047|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5938318|NCT04831047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5938319|NCT04831047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5938320|NCT04831047|Adrenergic Agents|adrenergic agents|mesh-ancestor
6517244|NCT00720408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6517245|NCT00720408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6517246|NCT00720421|Lorazepam|lorazepam|mesh-list
6517247|NCT00720421|Anticonvulsants|anticonvulsants|mesh-ancestor
6517248|NCT00720421|Antiemetics|antiemetics|mesh-ancestor
6517249|NCT00720421|Autonomic Agents|autonomic agents|mesh-ancestor
5938321|NCT04831047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6517250|NCT00720421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5938322|NCT04831047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938323|NCT04831047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938324|NCT04831047|Sympathomimetics|sympathomimetics|mesh-ancestor
5938325|NCT04831047|Autonomic Agents|autonomic agents|mesh-ancestor
5938326|NCT04831047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5938327|NCT04831047|Nasal Decongestants|nasal decongestants|mesh-ancestor
5938328|NCT04831047|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5938329|NCT04831047|Respiratory System Agents|respiratory system agents|mesh-ancestor
5938330|NCT04831047|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5938331|NCT04831047|Mydriatics|mydriatics|mesh-ancestor
5938332|NCT04831047|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5938333|NCT04831047|Protective Agents|protective agents|mesh-ancestor
5938334|NCT04831255|Triamcinolone|triamcinolone|mesh-list
5938335|NCT04831255|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5938336|NCT04831255|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5938337|NCT04831255|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5938338|NCT04831255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5938339|NCT04831255|Glucocorticoids|glucocorticoids|mesh-ancestor
5938340|NCT04831255|Hormones|hormones|mesh-ancestor
5938341|NCT04831255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5938342|NCT04831255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938343|NCT04831255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5938344|NCT04831255|Immunologic Factors|immunologic factors|mesh-ancestor
5938345|NCT04831255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5938346|NCT04831255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938347|NCT04831294|Cannabidiol|cannabidiol|mesh-list
5938348|NCT04831294|Anticonvulsants|anticonvulsants|mesh-ancestor
5938349|NCT04830982|Diazoxide|diazoxide|mesh-list
5938350|NCT04830982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5938351|NCT04830982|Vasodilator Agents|vasodilator agents|mesh-ancestor
5938352|NCT04830969|Chlorhexidine|chlorhexidine|mesh-list
5938353|NCT04830969|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5938354|NCT04830969|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5938355|NCT04830969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5938356|NCT04830969|Disinfectants|disinfectants|mesh-ancestor
5938357|NCT04830969|Dermatologic Agents|dermatologic agents|mesh-ancestor
5938358|NCT04830878|Methotrexate|methotrexate|mesh-list
5938359|NCT04830878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5938360|NCT04830878|Abortifacient Agents|abortifacient agents|mesh-ancestor
5938361|NCT04830878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5938362|NCT04830878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938363|NCT04830878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5938364|NCT04830878|Antimetabolites|antimetabolites|mesh-ancestor
5938365|NCT04830878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938366|NCT04830878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5938367|NCT04830878|Dermatologic Agents|dermatologic agents|mesh-ancestor
5938368|NCT04830878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5938369|NCT04830878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5938370|NCT04830878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5938371|NCT04830878|Immunologic Factors|immunologic factors|mesh-ancestor
5938372|NCT04830878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5938373|NCT04830878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5938374|NCT04830943|Cerebrolysin|cerebrolysin|mesh-list
5938375|NCT04830943|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5938376|NCT04830943|Protective Agents|protective agents|mesh-ancestor
5938377|NCT04830943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938378|NCT04830943|Nootropic Agents|nootropic agents|mesh-ancestor
5938379|NCT04830813|Chiauranib|chiauranib|mesh-list
5938380|NCT04830813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5938381|NCT04830813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5938382|NCT04830813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5938383|NCT04830813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938384|NCT04830579|Etoricoxib|etoricoxib|mesh-list
5938385|NCT04830579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5938386|NCT04830579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5938387|NCT04830579|Analgesics|analgesics|mesh-ancestor
5938388|NCT04830579|Sensory System Agents|sensory system agents|mesh-ancestor
5938389|NCT04830579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5938390|NCT04830579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938391|NCT04830579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5938392|NCT04830579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5938393|NCT04830579|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5938394|NCT04830579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5938395|NCT04830579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5938396|NCT04830579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938397|NCT04830462|Rifampin|rifampin|mesh-list
5938398|NCT04830462|Isoniazid|isoniazid|mesh-list
5938399|NCT04830462|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5938400|NCT04830462|Antitubercular Agents|antitubercular agents|mesh-ancestor
5938401|NCT04830462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5938402|NCT04830462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5938403|NCT04830462|Leprostatic Agents|leprostatic agents|mesh-ancestor
5938404|NCT04830462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5938405|NCT04830462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5938406|NCT04830462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938407|NCT04830462|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5938408|NCT04830462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5938409|NCT04830462|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5938410|NCT04830462|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5938411|NCT04830462|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5938412|NCT04830462|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5938413|NCT04830462|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5938414|NCT04830462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5938415|NCT04830462|Antimetabolites|antimetabolites|mesh-ancestor
5938416|NCT04830462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5938417|NCT04831099|Testosterone|testosterone|mesh-list
5938418|NCT04831099|Androgens|androgens|mesh-ancestor
5938419|NCT04831099|Hormones|hormones|mesh-ancestor
5938420|NCT04831099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5938421|NCT04831099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938422|NCT04831229|Menthol|menthol|mesh-list
5938423|NCT04831229|Antipruritics|antipruritics|mesh-ancestor
5938424|NCT04831229|Dermatologic Agents|dermatologic agents|mesh-ancestor
5938425|NCT04830358|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5938426|NCT04830358|Immunologic Factors|immunologic factors|mesh-ancestor
5938427|NCT04830358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938428|NCT04830241|Antidepressive Agents|antidepressive agents|mesh-list
5938429|NCT04830241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5938430|NCT04830410|Levan|levan|mesh-list
5938431|NCT04830410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5938432|NCT04830215|Brexpiprazole|brexpiprazole|mesh-list
5938433|NCT04830215|Serotonin Agents|serotonin agents|mesh-ancestor
5938434|NCT04830215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5938435|NCT04830215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938436|NCT04830215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938437|NCT04830215|Dopamine Agonists|dopamine agonists|mesh-ancestor
5938438|NCT04830215|Dopamine Agents|dopamine agents|mesh-ancestor
5966787|NCT04569630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966788|NCT04569214|PAZ320|paz320|mesh-list
5966789|NCT04569214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5966790|NCT04569214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966791|NCT04569279|Warfarin|warfarin|mesh-list
5966792|NCT04569279|Rivaroxaban|rivaroxaban|mesh-list
5966793|NCT04569279|Anticoagulants|anticoagulants|mesh-ancestor
5966794|NCT04569279|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5966795|NCT04569279|Antithrombins|antithrombins|mesh-ancestor
5966796|NCT04569279|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5966797|NCT04569279|Protease Inhibitors|protease inhibitors|mesh-ancestor
5966798|NCT04569279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5966799|NCT04569279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966800|NCT04568863|Melatonin|melatonin|mesh-list
5966801|NCT04568863|Antioxidants|antioxidants|mesh-ancestor
5966802|NCT04568863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966803|NCT04568863|Protective Agents|protective agents|mesh-ancestor
5966804|NCT04568863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966805|NCT04568863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5966806|NCT04568772|Atovaquone|atovaquone|mesh-list
5966807|NCT04568772|Proguanil|proguanil|mesh-list
5966808|NCT04568772|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
5966809|NCT04568772|Esomeprazole|esomeprazole|mesh-list
5966810|NCT04568772|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5966811|NCT04568772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5966812|NCT04568772|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5966813|NCT04568772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5966814|NCT04568772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966815|NCT04568772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5966816|NCT04568772|Antimalarials|antimalarials|mesh-ancestor
5966817|NCT04568772|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5966818|NCT04568772|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5966819|NCT04568772|Antimetabolites|antimetabolites|mesh-ancestor
5966820|NCT04568603|Islatravir|islatravir|mesh-list
5966821|NCT04568603|Methadone|methadone|mesh-list
5938439|NCT04829799|Ketorolac|ketorolac|mesh-list
5938440|NCT04829799|Lidocaine|lidocaine|mesh-list
5938441|NCT04829799|Phenylephrine|phenylephrine|mesh-list
5938442|NCT04829799|Oxymetazoline|oxymetazoline|mesh-list
5938443|NCT04829799|Anesthetics, Local|anesthetics, local|mesh-ancestor
5938444|NCT04829799|Anesthetics|anesthetics|mesh-ancestor
5938445|NCT04829799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5938446|NCT04829799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938447|NCT04829799|Sensory System Agents|sensory system agents|mesh-ancestor
5719888|NCT03216304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5719889|NCT03216304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719890|NCT03216304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5719891|NCT03216304|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5719892|NCT03216304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5719893|NCT03216304|Antimetabolites|antimetabolites|mesh-ancestor
5719894|NCT03216304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719895|NCT03216304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5719896|NCT03216304|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5719897|NCT03216304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5722172|NCT03200691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722173|NCT03200886|Triamcinolone|triamcinolone|mesh-list
5722174|NCT03200886|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5938448|NCT04829799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5938449|NCT04829799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5938450|NCT04829799|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5938451|NCT04829799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5938452|NCT04829799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5938453|NCT04829799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938454|NCT04829799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5938455|NCT04829799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5938456|NCT04829799|Analgesics|analgesics|mesh-ancestor
5938457|NCT04829799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5938458|NCT04829799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5938459|NCT04829799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5938460|NCT04829799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5938461|NCT04829799|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5938462|NCT04829799|Mydriatics|mydriatics|mesh-ancestor
5938463|NCT04829799|Autonomic Agents|autonomic agents|mesh-ancestor
5938464|NCT04829799|Sympathomimetics|sympathomimetics|mesh-ancestor
5938465|NCT04829799|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5938466|NCT04829799|Nasal Decongestants|nasal decongestants|mesh-ancestor
5938467|NCT04829799|Respiratory System Agents|respiratory system agents|mesh-ancestor
5938468|NCT04829799|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5938469|NCT04829799|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5938470|NCT04829799|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5938471|NCT04829799|Adrenergic Agents|adrenergic agents|mesh-ancestor
5938472|NCT04829799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5938473|NCT04829799|Protective Agents|protective agents|mesh-ancestor
5938474|NCT04829903|Liraglutide|liraglutide|mesh-list
5938475|NCT04829903|Dulaglutide|dulaglutide|mesh-list
5938476|NCT04829903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5938477|NCT04829903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938478|NCT04829903|Incretins|incretins|mesh-ancestor
5938479|NCT04829903|Hormones|hormones|mesh-ancestor
5938480|NCT04829903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5938481|NCT04829916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5938482|NCT04829773|Midazolam|midazolam|mesh-list
5938483|NCT04829773|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5938484|NCT04829773|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5938485|NCT04829773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5938486|NCT04829773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938487|NCT04829773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5938488|NCT04829773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5938489|NCT04829773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5938490|NCT04829773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5938491|NCT04829773|Anesthetics, General|anesthetics, general|mesh-ancestor
5938492|NCT04829773|Anesthetics|anesthetics|mesh-ancestor
5938493|NCT04829773|GABA Modulators|gaba modulators|mesh-ancestor
5938494|NCT04829773|GABA Agents|gaba agents|mesh-ancestor
5938495|NCT04829773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5938496|NCT04829773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938497|NCT04829760|Psyllium|psyllium|mesh-list
5938498|NCT04829760|Cathartics|cathartics|mesh-ancestor
5938499|NCT04829760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5938500|NCT04829695|Artesunate|artesunate|mesh-list
5938501|NCT04829695|Lumefantrine|lumefantrine|mesh-list
5938502|NCT04829695|Artemether|artemether|mesh-list
5938503|NCT04829695|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
5938504|NCT04829695|Amodiaquine|amodiaquine|mesh-list
5938505|NCT04829695|Antimalarials|antimalarials|mesh-ancestor
5938506|NCT04829695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5938507|NCT04829695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5938508|NCT04829695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5938509|NCT04829695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5938510|NCT04829695|Antiviral Agents|antiviral agents|mesh-ancestor
5938511|NCT04829695|Schistosomicides|schistosomicides|mesh-ancestor
5938512|NCT04829695|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5938513|NCT04829695|Anthelmintics|anthelmintics|mesh-ancestor
5938514|NCT04829435|Rasburicase|rasburicase|mesh-list
5938515|NCT04829435|Gout Suppressants|gout suppressants|mesh-ancestor
5938516|NCT04829435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5938517|NCT04829422|Lazertinib|lazertinib|mesh-list
5938518|NCT04829422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5938519|NCT04829422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5938520|NCT04829422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938521|NCT04829487|Vitamin D|vitamin d|mesh-list
5938522|NCT04829487|Ergocalciferols|ergocalciferols|mesh-list
5938523|NCT04829487|Vitamins|vitamins|mesh-ancestor
5938524|NCT04829487|Micronutrients|micronutrients|mesh-ancestor
5938525|NCT04829487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938526|NCT04829487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5938527|NCT04829487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5938528|NCT04829344|Carticaine|carticaine|mesh-list
5938529|NCT04829344|Anesthetics, Local|anesthetics, local|mesh-ancestor
5938530|NCT04829344|Anesthetics|anesthetics|mesh-ancestor
5938531|NCT04829344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5938532|NCT04829344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938533|NCT04829344|Sensory System Agents|sensory system agents|mesh-ancestor
5938534|NCT04829344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5938535|NCT04829565|Botulinum Toxins|botulinum toxins|mesh-list
5938536|NCT04829565|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5938537|NCT04829565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5938538|NCT04829565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938539|NCT04829565|Cholinergic Agents|cholinergic agents|mesh-ancestor
5938540|NCT04829565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5938541|NCT04829565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938542|NCT04829097|Temozolomide|temozolomide|mesh-list
5938543|NCT04829097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5938544|NCT04829097|Alkylating Agents|alkylating agents|mesh-ancestor
5938545|NCT04829097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938546|NCT04829097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5938547|NCT04829019|Osimertinib|osimertinib|mesh-list
5938548|NCT04829019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5938549|NCT04829019|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5938550|NCT04829019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5938551|NCT04829019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938552|NCT04828824|Moxifloxacin|moxifloxacin|mesh-list
5938553|NCT04828824|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5719898|NCT03216395|Epinephrine|epinephrine|mesh-list
5719899|NCT03216395|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5719900|NCT03216395|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5719901|NCT03216395|Adrenergic Agents|adrenergic agents|mesh-ancestor
5719902|NCT03216395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5719903|NCT03216395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938554|NCT04828824|Norgestimate|norgestimate|mesh-list
5938555|NCT04828824|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
5938556|NCT04828824|Estradiol|estradiol|mesh-list
5938557|NCT04828824|Estrogens|estrogens|mesh-ancestor
5938558|NCT04828824|Hormones|hormones|mesh-ancestor
5938559|NCT04828824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5938560|NCT04828824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938561|NCT04828824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5719904|NCT03216395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719905|NCT03216395|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5719906|NCT03216395|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5719907|NCT03216395|Autonomic Agents|autonomic agents|mesh-ancestor
5719908|NCT03216395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5719909|NCT03216395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5719910|NCT03216395|Respiratory System Agents|respiratory system agents|mesh-ancestor
5719911|NCT03216395|Mydriatics|mydriatics|mesh-ancestor
5719912|NCT03216395|Sympathomimetics|sympathomimetics|mesh-ancestor
6681243|NCT01608711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6681244|NCT01608711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6681245|NCT01608711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6681246|NCT01608711|Immunologic Factors|immunologic factors|mesh-ancestor
6681247|NCT01608711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938562|NCT04828824|Contraceptive Agents|contraceptive agents|mesh-ancestor
5938563|NCT04828824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5938564|NCT04828824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5938565|NCT04828824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5938566|NCT04828824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5938567|NCT04828824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5938568|NCT04828824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5938569|NCT04828824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5938570|NCT04828824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5938571|NCT04828824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5938572|NCT04828824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5938573|NCT04828824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938574|NCT04828824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5938575|NCT04828824|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5938576|NCT04828525|Dexamethasone|dexamethasone|mesh-list
5938577|NCT04828525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5938578|NCT04828525|Antiemetics|antiemetics|mesh-ancestor
5938579|NCT04828525|Autonomic Agents|autonomic agents|mesh-ancestor
5938580|NCT04828525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5938581|NCT04828525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938582|NCT04828525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5938583|NCT04828525|Glucocorticoids|glucocorticoids|mesh-ancestor
5938584|NCT04828525|Hormones|hormones|mesh-ancestor
5938585|NCT04828525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5938586|NCT04828525|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5938587|NCT04828525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5938588|NCT04828642|Vitamins|vitamins|mesh-list
5938589|NCT04828642|Ascorbic Acid|ascorbic acid|mesh-list
5938590|NCT04828642|Vitamin E|vitamin e|mesh-list
5938591|NCT04828642|Tocopherols|tocopherols|mesh-list
5938592|NCT04828642|Micronutrients|micronutrients|mesh-ancestor
5938593|NCT04828642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938594|NCT04828642|Antioxidants|antioxidants|mesh-ancestor
5938595|NCT04828642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938596|NCT04828642|Protective Agents|protective agents|mesh-ancestor
5938597|NCT04828694|Naltrexone|naltrexone|mesh-list
5938598|NCT04828694|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5938599|NCT04828694|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5938600|NCT04828694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938601|NCT04828694|Sensory System Agents|sensory system agents|mesh-ancestor
5938602|NCT04828694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5938603|NCT04828564|Ribavirin|ribavirin|mesh-list
5938604|NCT04828564|Favipiravir|favipiravir|mesh-list
5938605|NCT04828564|Antimetabolites|antimetabolites|mesh-ancestor
5938606|NCT04828564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938607|NCT04828564|Antiviral Agents|antiviral agents|mesh-ancestor
5938608|NCT04828564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5938609|NCT04828135|Xenon|xenon|mesh-list
5938610|NCT04828135|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5938611|NCT04828135|Anesthetics, General|anesthetics, general|mesh-ancestor
5938612|NCT04828135|Anesthetics|anesthetics|mesh-ancestor
5938613|NCT04828135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5938614|NCT04828135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938615|NCT04828031|Vitamin D|vitamin d|mesh-list
5938616|NCT04828031|Vitamins|vitamins|mesh-ancestor
5938617|NCT04828031|Micronutrients|micronutrients|mesh-ancestor
5938618|NCT04828031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938619|NCT04828031|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5966822|NCT04568603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5966823|NCT04568603|Narcotics|narcotics|mesh-ancestor
5966824|NCT04568603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5966825|NCT04568603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966826|NCT04568603|Analgesics|analgesics|mesh-ancestor
5966827|NCT04568603|Sensory System Agents|sensory system agents|mesh-ancestor
5966828|NCT04568603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5966829|NCT04568603|Antitussive Agents|antitussive agents|mesh-ancestor
5966830|NCT04568603|Respiratory System Agents|respiratory system agents|mesh-ancestor
5966831|NCT04568603|Antiviral Agents|antiviral agents|mesh-ancestor
5966832|NCT04568603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5966833|NCT04568603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5966834|NCT04568603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938620|NCT04828083|Lidocaine|lidocaine|mesh-list
5938621|NCT04828083|Anesthetics, Local|anesthetics, local|mesh-ancestor
5938622|NCT04828083|Anesthetics|anesthetics|mesh-ancestor
5938623|NCT04828083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5938624|NCT04828083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938625|NCT04828083|Sensory System Agents|sensory system agents|mesh-ancestor
5938626|NCT04828083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5938627|NCT04828083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5938628|NCT04828083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5938629|NCT04828083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5938630|NCT04828083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5938631|NCT04828083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938632|NCT04828057|Timolol|timolol|mesh-list
5938633|NCT04828057|Bimatoprost|bimatoprost|mesh-list
5938634|NCT04828057|Travoprost|travoprost|mesh-list
5938635|NCT04828057|Latanoprost|latanoprost|mesh-list
5938636|NCT04828057|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5938637|NCT04828057|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5938638|NCT04828057|Adrenergic Agents|adrenergic agents|mesh-ancestor
5938639|NCT04828057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5938640|NCT04828057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938641|NCT04828057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938642|NCT04828057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5938643|NCT04828057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5938644|NCT04828057|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5938645|NCT04828057|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5938646|NCT04828226|Clonidine|clonidine|mesh-list
5938647|NCT04828226|Analgesics|analgesics|mesh-ancestor
5938648|NCT04828226|Sensory System Agents|sensory system agents|mesh-ancestor
5938649|NCT04828226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5938650|NCT04828226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938651|NCT04828226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5938652|NCT04828226|Sympatholytics|sympatholytics|mesh-ancestor
5938653|NCT04828226|Autonomic Agents|autonomic agents|mesh-ancestor
5938654|NCT04828226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5938655|NCT04828226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5938656|NCT04828226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5938657|NCT04828226|Adrenergic Agents|adrenergic agents|mesh-ancestor
5938658|NCT04828226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5938659|NCT04828226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938660|NCT04827966|Calcium, Dietary|calcium, dietary|mesh-list
5938661|NCT04827966|Listerine|listerine|mesh-list
5938662|NCT04827966|Calcium|calcium|mesh-list
5938663|NCT04827966|Fluorides|fluorides|mesh-list
5938664|NCT04827966|Sodium Fluoride|sodium fluoride|mesh-list
5938665|NCT04827966|Caseins|caseins|mesh-list
5938666|NCT04827966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5938667|NCT04827966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938668|NCT04827966|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5938669|NCT04827966|Cariostatic Agents|cariostatic agents|mesh-ancestor
5938670|NCT04827966|Protective Agents|protective agents|mesh-ancestor
5938671|NCT04827966|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5938672|NCT04827966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5938673|NCT04827966|Chelating Agents|chelating agents|mesh-ancestor
5938674|NCT04827966|Sequestering Agents|sequestering agents|mesh-ancestor
5938675|NCT04827966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938676|NCT04828395|Paclitaxel|paclitaxel|mesh-list
5938677|NCT04828395|Etoposide|etoposide|mesh-list
5938678|NCT04828395|Cisplatin|cisplatin|mesh-list
5938679|NCT04828395|Carboplatin|carboplatin|mesh-list
5938680|NCT04828395|Pemetrexed|pemetrexed|mesh-list
5938681|NCT04828395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5938682|NCT04828395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5938683|NCT04828395|Tubulin Modulators|tubulin modulators|mesh-ancestor
5938684|NCT04828395|Antimitotic Agents|antimitotic agents|mesh-ancestor
5938685|NCT04828395|Mitosis Modulators|mitosis modulators|mesh-ancestor
5938686|NCT04828395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938687|NCT04828395|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5938688|NCT04828395|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5938689|NCT04828395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5938690|NCT04828395|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5938691|NCT04828395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5938692|NCT04827745|Blinatumomab|blinatumomab|mesh-list
5938693|NCT04827745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5938694|NCT04827784|Anesthetics|anesthetics|mesh-list
5938695|NCT04827784|Anesthetics, Local|anesthetics, local|mesh-list
5938696|NCT04827784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5938697|NCT04827784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938698|NCT04827784|Sensory System Agents|sensory system agents|mesh-ancestor
5938699|NCT04827784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5938700|NCT04827862|Pembrolizumab|pembrolizumab|mesh-list
5938701|NCT04827862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5938702|NCT04827862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5938703|NCT04827537|Metronidazole|metronidazole|mesh-list
5938704|NCT04827537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5938705|NCT04827537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5938706|NCT04827537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5938707|NCT04827537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5938708|NCT04827446|Methamphetamine|methamphetamine|mesh-list
5938709|NCT04827446|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5938710|NCT04827446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938711|NCT04827446|Sympathomimetics|sympathomimetics|mesh-ancestor
5938712|NCT04827446|Autonomic Agents|autonomic agents|mesh-ancestor
5938713|NCT04827446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5938714|NCT04827446|Dopamine Agents|dopamine agents|mesh-ancestor
5938715|NCT04827446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5938716|NCT04827446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938717|NCT04827446|Adrenergic Agents|adrenergic agents|mesh-ancestor
5938718|NCT04827446|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5938719|NCT04827446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5938720|NCT04827446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5938721|NCT04827446|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5938722|NCT04827134|Triumeq|triumeq|mesh-list
5938723|NCT04827134|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5938724|NCT04827134|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5938725|NCT04827134|Antiviral Agents|antiviral agents|mesh-ancestor
5938726|NCT04827134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5938727|NCT04827147|Methamphetamine|methamphetamine|mesh-list
5938728|NCT04827147|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5938729|NCT04827147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938730|NCT04827147|Sympathomimetics|sympathomimetics|mesh-ancestor
5938731|NCT04827147|Autonomic Agents|autonomic agents|mesh-ancestor
5938732|NCT04827147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5938733|NCT04827147|Dopamine Agents|dopamine agents|mesh-ancestor
5938734|NCT04827147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5938735|NCT04827147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938736|NCT04827147|Adrenergic Agents|adrenergic agents|mesh-ancestor
5938737|NCT04827147|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5938738|NCT04827147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5938739|NCT04827147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5938740|NCT04827147|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5938741|NCT04826822|Dexamethasone|dexamethasone|mesh-list
5938742|NCT04826822|Spironolactone|spironolactone|mesh-list
5938743|NCT04826822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5938744|NCT04826822|Antiemetics|antiemetics|mesh-ancestor
5938745|NCT04826822|Autonomic Agents|autonomic agents|mesh-ancestor
5938746|NCT04826822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5938747|NCT04826822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938748|NCT04826822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5938749|NCT04826822|Glucocorticoids|glucocorticoids|mesh-ancestor
5938750|NCT04826822|Hormones|hormones|mesh-ancestor
5938751|NCT04826822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5938752|NCT04826822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5938753|NCT04826822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5938754|NCT04826822|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5938755|NCT04826822|Hormone Antagonists|hormone antagonists|mesh-ancestor
5938756|NCT04826822|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5938757|NCT04826822|Diuretics|diuretics|mesh-ancestor
5938758|NCT04826822|Natriuretic Agents|natriuretic agents|mesh-ancestor
5938759|NCT04826900|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
5938760|NCT04826900|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5938761|NCT04826900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5938762|NCT04826900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938763|NCT04826900|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5938764|NCT04826900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5938765|NCT04826900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938766|NCT04826900|Cholinergic Agents|cholinergic agents|mesh-ancestor
5938767|NCT04826900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5938768|NCT04826679|Paclitaxel|paclitaxel|mesh-list
5938769|NCT04826679|Cisplatin|cisplatin|mesh-list
5938770|NCT04826679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5938771|NCT04826679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5938772|NCT04826679|Tubulin Modulators|tubulin modulators|mesh-ancestor
5938773|NCT04826679|Antimitotic Agents|antimitotic agents|mesh-ancestor
5938774|NCT04826679|Mitosis Modulators|mitosis modulators|mesh-ancestor
5938775|NCT04826679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938776|NCT04826692|Metformin|metformin|mesh-list
5938777|NCT04826692|Biguanides|biguanides|mesh-list
5938778|NCT04826692|Hypoglycemic Agents|hypoglycemic agents|mesh-list
5938779|NCT04826692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966835|NCT04568603|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5966836|NCT04568603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5966837|NCT04568603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5966838|NCT04568876|Palmidrol|palmidrol|mesh-list
5966839|NCT04568876|Analgesics|analgesics|mesh-ancestor
5966840|NCT04568876|Sensory System Agents|sensory system agents|mesh-ancestor
5966841|NCT04568876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5966842|NCT04568876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966843|NCT04568876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5966844|NCT04568876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5966845|NCT04568876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5966846|NCT04568876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5966847|NCT04568876|Antiviral Agents|antiviral agents|mesh-ancestor
5966848|NCT04568876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5966849|NCT04568876|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5966850|NCT04568876|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5966851|NCT04568876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5966852|NCT04568876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966853|NCT04568876|Hormones|hormones|mesh-ancestor
5966854|NCT04568876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5966855|NCT04568837|Dexamethasone|dexamethasone|mesh-list
5966856|NCT04568837|Dexamethasone acetate|dexamethasone acetate|mesh-list
5966857|NCT04568837|Prednisone|prednisone|mesh-list
5966858|NCT04568837|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
5966859|NCT04568837|BB 1101|bb 1101|mesh-list
5966860|NCT04568837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5966861|NCT04568837|Antiemetics|antiemetics|mesh-ancestor
5966862|NCT04568837|Autonomic Agents|autonomic agents|mesh-ancestor
5966863|NCT04568837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5966864|NCT04568837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966865|NCT04568837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5966866|NCT04568837|Glucocorticoids|glucocorticoids|mesh-ancestor
5966867|NCT04568837|Hormones|hormones|mesh-ancestor
5966868|NCT04568837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5966869|NCT04568837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5966870|NCT04568837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5966871|NCT04568837|Protease Inhibitors|protease inhibitors|mesh-ancestor
5966872|NCT04568837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5966873|NCT04568837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966874|NCT04568265|Entecavir|entecavir|mesh-list
5966875|NCT04568265|Antiviral Agents|antiviral agents|mesh-ancestor
5966876|NCT04568265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5966877|NCT04568421|Immunosuppressive Agents|immunosuppressive agents|mesh-list
5966878|NCT04568421|Immunologic Factors|immunologic factors|mesh-ancestor
5966879|NCT04568421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970941|NCT04531423|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
5970942|NCT04531423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5970943|NCT04531423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5970944|NCT04531423|Immunologic Factors|immunologic factors|mesh-ancestor
5970945|NCT04531423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970946|NCT04531397|Dapagliflozin|dapagliflozin|mesh-list
5970947|NCT04531397|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
5970948|NCT04531397|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5970949|NCT04531397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970950|NCT04531397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5970951|NCT04531397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970952|NCT04531397|Protease Inhibitors|protease inhibitors|mesh-ancestor
5970953|NCT04531397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5970954|NCT04531267|Calcium|calcium|mesh-list
5970955|NCT04531267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5970956|NCT04531267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970957|NCT04531475|Lansoprazole|lansoprazole|mesh-list
5970958|NCT04531475|Dexlansoprazole|dexlansoprazole|mesh-list
5970959|NCT04531475|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5970960|NCT04531475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5938780|NCT04826198|Olaparib|olaparib|mesh-list
5938781|NCT04826198|Niraparib|niraparib|mesh-list
5938782|NCT04826198|Rucaparib|rucaparib|mesh-list
5938783|NCT04826198|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5938784|NCT04826198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5938785|NCT04826198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938786|NCT04826198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5938787|NCT04826562|Lamivudine|lamivudine|mesh-list
5938788|NCT04826562|Dolutegravir|dolutegravir|mesh-list
5938789|NCT04826562|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5938790|NCT04826562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5938791|NCT04826562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5938792|NCT04826562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938793|NCT04826562|Antiviral Agents|antiviral agents|mesh-ancestor
5938794|NCT04826562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5938795|NCT04826562|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5938796|NCT04826562|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5938797|NCT04826562|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5938798|NCT04826562|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5938799|NCT04826237|Dexamethasone|dexamethasone|mesh-list
5938800|NCT04826237|Methylprednisolone|methylprednisolone|mesh-list
5938801|NCT04826237|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5938802|NCT04826237|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5938803|NCT04826237|Prednisolone|prednisolone|mesh-list
5938804|NCT04826237|Prednisolone acetate|prednisolone acetate|mesh-list
5938805|NCT04826237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
5938806|NCT04826237|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5938807|NCT04826237|Prednisolone phosphate|prednisolone phosphate|mesh-list
5938808|NCT04826237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5938809|NCT04826237|Antiemetics|antiemetics|mesh-ancestor
5938810|NCT04826237|Autonomic Agents|autonomic agents|mesh-ancestor
5938811|NCT04826237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5938812|NCT04826237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938813|NCT04826237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5938814|NCT04826237|Glucocorticoids|glucocorticoids|mesh-ancestor
5938815|NCT04826237|Hormones|hormones|mesh-ancestor
5938816|NCT04826237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5938817|NCT04826237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5938818|NCT04826237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5938819|NCT04826237|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5938820|NCT04826237|Protective Agents|protective agents|mesh-ancestor
5938821|NCT04826237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5938822|NCT04826237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5938823|NCT04826237|Antimetabolites|antimetabolites|mesh-ancestor
5938824|NCT04826237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938825|NCT04826237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5938826|NCT04826237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5938827|NCT04826406|Apatinib|apatinib|mesh-list
5938828|NCT04826406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5938829|NCT04826406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5938830|NCT04826406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5938831|NCT04826406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938832|NCT04826432|Pasireotide|pasireotide|mesh-list
5938833|NCT04826432|Hormones|hormones|mesh-ancestor
5938834|NCT04826432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5938835|NCT04826432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938836|NCT04826497|Nicorandil|nicorandil|mesh-list
5938837|NCT04826497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5938838|NCT04826497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5938839|NCT04826497|Vasodilator Agents|vasodilator agents|mesh-ancestor
5938840|NCT04826497|Vitamin B Complex|vitamin b complex|mesh-ancestor
5938841|NCT04826497|Vitamins|vitamins|mesh-ancestor
5938842|NCT04826497|Micronutrients|micronutrients|mesh-ancestor
5938843|NCT04826497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938844|NCT04826510|Lithium Carbonate|lithium carbonate|mesh-list
5938845|NCT04826510|Perospirone|perospirone|mesh-list
5938846|NCT04826510|Antidepressive Agents|antidepressive agents|mesh-ancestor
5938847|NCT04826510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5938848|NCT04826510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5938849|NCT04826510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938850|NCT04826510|Antimanic Agents|antimanic agents|mesh-ancestor
6681248|NCT01608750|Folic Acid|folic acid|mesh-list
5938851|NCT04826510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5938852|NCT04826510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5938853|NCT04826510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938854|NCT04826510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5938855|NCT04825938|Paclitaxel|paclitaxel|mesh-list
5938856|NCT04825938|Carboplatin|carboplatin|mesh-list
5938857|NCT04825938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5938858|NCT04825938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5938859|NCT04825938|Tubulin Modulators|tubulin modulators|mesh-ancestor
5938860|NCT04825938|Antimitotic Agents|antimitotic agents|mesh-ancestor
5938861|NCT04825938|Mitosis Modulators|mitosis modulators|mesh-ancestor
5938862|NCT04825938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938863|NCT04826016|Paclitaxel|paclitaxel|mesh-list
5938864|NCT04826016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5938865|NCT04826016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5938866|NCT04826016|Tubulin Modulators|tubulin modulators|mesh-ancestor
5938867|NCT04826016|Antimitotic Agents|antimitotic agents|mesh-ancestor
5938868|NCT04826016|Mitosis Modulators|mitosis modulators|mesh-ancestor
5938869|NCT04826016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938870|NCT04825795|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
5938871|NCT04825795|Protease Inhibitors|protease inhibitors|mesh-ancestor
5938872|NCT04825795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5938873|NCT04825795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938874|NCT04825795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5938875|NCT04825795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938876|NCT04826133|Calcitriol|calcitriol|mesh-list
5938877|NCT04826133|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
5938878|NCT04826133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5938879|NCT04826133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938880|NCT04826133|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
5938881|NCT04826133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5938882|NCT04826133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938883|NCT04826133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5938884|NCT04826133|Vitamins|vitamins|mesh-ancestor
5938885|NCT04826133|Micronutrients|micronutrients|mesh-ancestor
5938886|NCT04826133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5938887|NCT04825990|Pembrolizumab|pembrolizumab|mesh-list
5938888|NCT04825990|Olaparib|olaparib|mesh-list
5938889|NCT04825990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5938890|NCT04825990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5938891|NCT04825990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5938892|NCT04825990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5938893|NCT04825990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938894|NCT04825496|Cyclophosphamide|cyclophosphamide|mesh-list
5938895|NCT04825496|Fludarabine|fludarabine|mesh-list
5938896|NCT04825496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5938897|NCT04825496|Immunologic Factors|immunologic factors|mesh-ancestor
5938898|NCT04825496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938899|NCT04825496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5938900|NCT04825496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5938901|NCT04825496|Alkylating Agents|alkylating agents|mesh-ancestor
5938902|NCT04825496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938903|NCT04825496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5938904|NCT04825496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5938905|NCT04825522|Vancomycin|vancomycin|mesh-list
5938906|NCT04825522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5938907|NCT04825522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5938908|NCT04824924|Venetoclax|venetoclax|mesh-list
5938909|NCT04824924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5938910|NCT04825093|Vitamin D|vitamin d|mesh-list
5938911|NCT04825093|Vitamins|vitamins|mesh-ancestor
5938912|NCT04825093|Micronutrients|micronutrients|mesh-ancestor
5938913|NCT04825093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938914|NCT04825093|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5938915|NCT04824638|Vaccines|vaccines|mesh-list
5938916|NCT04824638|Immunologic Factors|immunologic factors|mesh-ancestor
5938917|NCT04824638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938918|NCT04824586|Insulin|insulin|mesh-list
5938919|NCT04824586|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5938920|NCT04824586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5938921|NCT04824586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938922|NCT04824599|Ropivacaine|ropivacaine|mesh-list
5938923|NCT04824599|Anesthetics, Local|anesthetics, local|mesh-list
5938924|NCT04824599|Anesthetics|anesthetics|mesh-list
5938925|NCT04824599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5938926|NCT04824599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938927|NCT04824599|Sensory System Agents|sensory system agents|mesh-ancestor
5938928|NCT04824599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6517251|NCT00720421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938929|NCT04824898|Simvastatin|simvastatin|mesh-list
5938930|NCT04824898|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5938931|NCT04824898|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5938932|NCT04824898|Antimetabolites|antimetabolites|mesh-ancestor
5938933|NCT04824898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938934|NCT04824898|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5938935|NCT04824898|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5938936|NCT04824898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5938937|NCT04824937|Talazoparib|talazoparib|mesh-list
5938938|NCT04824937|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5938939|NCT04824937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5938940|NCT04824937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938941|NCT04824937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5966880|NCT04568304|Gemcitabine|gemcitabine|mesh-list
5966881|NCT04568304|Carboplatin|carboplatin|mesh-list
5966882|NCT04568304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5966883|NCT04568304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5966884|NCT04568304|Antimetabolites|antimetabolites|mesh-ancestor
5966885|NCT04568304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966886|NCT04568304|Antiviral Agents|antiviral agents|mesh-ancestor
5966887|NCT04568304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5966888|NCT04568304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5966889|NCT04568304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5966890|NCT04568304|Immunologic Factors|immunologic factors|mesh-ancestor
5966891|NCT04568304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966892|NCT04568096|Tamoxifen|tamoxifen|mesh-list
5966893|NCT04568096|Tretinoin|tretinoin|mesh-list
5966894|NCT04568096|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5966895|NCT04568096|Hormone Antagonists|hormone antagonists|mesh-ancestor
5966896|NCT04568096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5966897|NCT04568096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966898|NCT04568096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5966899|NCT04568096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5966900|NCT04568096|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5966901|NCT04568096|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5966902|NCT04568096|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5966903|NCT04568096|Keratolytic Agents|keratolytic agents|mesh-ancestor
5966904|NCT04568096|Dermatologic Agents|dermatologic agents|mesh-ancestor
5966905|NCT04568200|Paclitaxel|paclitaxel|mesh-list
5966906|NCT04568200|Carboplatin|carboplatin|mesh-list
5966907|NCT04568200|Durvalumab|durvalumab|mesh-list
5966908|NCT04568200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5966909|NCT04568200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5966910|NCT04568200|Tubulin Modulators|tubulin modulators|mesh-ancestor
5966911|NCT04568200|Antimitotic Agents|antimitotic agents|mesh-ancestor
5966912|NCT04568200|Mitosis Modulators|mitosis modulators|mesh-ancestor
5966913|NCT04568200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966914|NCT04568200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5966915|NCT04568161|Cyclophosphamide|cyclophosphamide|mesh-list
5966916|NCT04568161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5966917|NCT04568161|Immunologic Factors|immunologic factors|mesh-ancestor
5966918|NCT04568161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966919|NCT04568161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5966920|NCT04568161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5966921|NCT04568161|Alkylating Agents|alkylating agents|mesh-ancestor
5966922|NCT04568161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966923|NCT04568161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5966924|NCT04568161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5966925|NCT04568018|Pulmonary Surfactants|pulmonary surfactants|mesh-list
5966926|NCT04568018|Respiratory System Agents|respiratory system agents|mesh-ancestor
5966927|NCT04567576|Antirheumatic Agents|antirheumatic agents|mesh-list
5966928|NCT04567433|Hydrocortisone|hydrocortisone|mesh-list
5966929|NCT04567433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5966930|NCT04567225|Insulin Glargine|insulin glargine|mesh-list
5966931|NCT04567225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5966932|NCT04567225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966933|NCT04567290|Ticagrelor|ticagrelor|mesh-list
5966934|NCT04567290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5966935|NCT04567290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5966936|NCT04567290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5966937|NCT04567290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5966938|NCT04567290|Purinergic Agents|purinergic agents|mesh-ancestor
5966939|NCT04567290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6681249|NCT01608750|Hematinics|hematinics|mesh-ancestor
5938942|NCT04824612|Triamcinolone|triamcinolone|mesh-list
5938943|NCT04824612|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5938944|NCT04824612|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5938945|NCT04824612|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5938946|NCT04824612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5938947|NCT04824612|Glucocorticoids|glucocorticoids|mesh-ancestor
5938948|NCT04824612|Hormones|hormones|mesh-ancestor
5938949|NCT04824612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5938950|NCT04824612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938951|NCT04824612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5938952|NCT04824612|Immunologic Factors|immunologic factors|mesh-ancestor
5938953|NCT04824612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5938954|NCT04824612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938955|NCT04824911|Aspirin|aspirin|mesh-list
5938956|NCT04824911|Clopidogrel|clopidogrel|mesh-list
5938957|NCT04824911|Atorvastatin|atorvastatin|mesh-list
5938958|NCT04824911|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5938959|NCT04824911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5938960|NCT04824911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5938961|NCT04824911|Analgesics|analgesics|mesh-ancestor
5938962|NCT04824911|Sensory System Agents|sensory system agents|mesh-ancestor
5938963|NCT04824911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5938964|NCT04824911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938965|NCT04824911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5938966|NCT04824911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5938967|NCT04824911|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5938968|NCT04824911|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5938969|NCT04824911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938970|NCT04824911|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5938971|NCT04824911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5938972|NCT04824911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5938973|NCT04824911|Antipyretics|antipyretics|mesh-ancestor
5938974|NCT04824911|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5938975|NCT04824911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5938976|NCT04824911|Antimetabolites|antimetabolites|mesh-ancestor
5938977|NCT04824911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5938978|NCT04824911|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5938979|NCT04824911|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5938980|NCT04824911|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5938981|NCT04824911|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5938982|NCT04824911|Purinergic Agents|purinergic agents|mesh-ancestor
5938983|NCT04824911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5938984|NCT04824352|Apatinib|apatinib|mesh-list
5938985|NCT04824352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5938986|NCT04824352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5938987|NCT04824352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5938988|NCT04824352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5938989|NCT04824404|Buprenorphine|buprenorphine|mesh-list
5938990|NCT04824404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5938991|NCT04824404|Narcotics|narcotics|mesh-ancestor
5938992|NCT04824404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5938993|NCT04824404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5938994|NCT04824404|Analgesics|analgesics|mesh-ancestor
5938995|NCT04824404|Sensory System Agents|sensory system agents|mesh-ancestor
5938996|NCT04824404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5938997|NCT04824404|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5938998|NCT04824261|Clotrimazole|clotrimazole|mesh-list
5938999|NCT04824261|Miconazole|miconazole|mesh-list
5939000|NCT04824261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5939001|NCT04824261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5939002|NCT04824261|Antifungal Agents|antifungal agents|mesh-ancestor
5939003|NCT04824261|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5939004|NCT04824261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5939005|NCT04824261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5939006|NCT04824261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5939007|NCT04824261|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5939008|NCT04824261|Hormone Antagonists|hormone antagonists|mesh-ancestor
5939009|NCT04824261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5939010|NCT04824261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939011|NCT04824261|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5939012|NCT04824261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5939013|NCT04824391|Vaccines|vaccines|mesh-list
5939014|NCT04824391|Immunologic Factors|immunologic factors|mesh-ancestor
5939015|NCT04824391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939016|NCT04823962|Molgramostim|molgramostim|mesh-list
5939017|NCT04823962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5939018|NCT04824053|Selenium|selenium|mesh-list
5939019|NCT04824053|Caseins|caseins|mesh-list
5939020|NCT04824053|Antioxidants|antioxidants|mesh-ancestor
5939021|NCT04824053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5939022|NCT04824053|Protective Agents|protective agents|mesh-ancestor
5939023|NCT04824053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939024|NCT04824053|Trace Elements|trace elements|mesh-ancestor
5939025|NCT04824053|Micronutrients|micronutrients|mesh-ancestor
5939026|NCT04824053|Chelating Agents|chelating agents|mesh-ancestor
5939027|NCT04824053|Sequestering Agents|sequestering agents|mesh-ancestor
5939028|NCT04823845|Adapalene|adapalene|mesh-list
5939029|NCT04823845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5939030|NCT04823845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5939031|NCT04823845|Analgesics|analgesics|mesh-ancestor
5939032|NCT04823845|Sensory System Agents|sensory system agents|mesh-ancestor
5939033|NCT04823845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5939034|NCT04823845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939035|NCT04823845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5939036|NCT04823845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5939037|NCT04823845|Dermatologic Agents|dermatologic agents|mesh-ancestor
5939038|NCT04823390|Fentanyl|fentanyl|mesh-list
5939039|NCT04823390|Midazolam|midazolam|mesh-list
5939040|NCT04823390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5939041|NCT04823390|Narcotics|narcotics|mesh-ancestor
5939042|NCT04823390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5939043|NCT04823390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939044|NCT04823390|Analgesics|analgesics|mesh-ancestor
5939045|NCT04823390|Sensory System Agents|sensory system agents|mesh-ancestor
5939046|NCT04823390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5939047|NCT04823390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5939048|NCT04823390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5939049|NCT04823390|Anesthetics, General|anesthetics, general|mesh-ancestor
5939050|NCT04823390|Anesthetics|anesthetics|mesh-ancestor
5939051|NCT04823390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5939052|NCT04823390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5939053|NCT04823390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5939054|NCT04823390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5939055|NCT04823390|GABA Modulators|gaba modulators|mesh-ancestor
5939056|NCT04823390|GABA Agents|gaba agents|mesh-ancestor
5939057|NCT04823390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5939058|NCT04823390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5939059|NCT04823442|Bisoprolol|bisoprolol|mesh-list
5939060|NCT04823442|Mirabegron|mirabegron|mesh-list
5939061|NCT04823442|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
5939062|NCT04823442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5939063|NCT04823442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5939064|NCT04823442|Adrenergic Agents|adrenergic agents|mesh-ancestor
5939065|NCT04823442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5939066|NCT04823442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5939067|NCT04823442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939068|NCT04823442|Urological Agents|urological agents|mesh-ancestor
5939069|NCT04823442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5939070|NCT04823442|Sympatholytics|sympatholytics|mesh-ancestor
5939071|NCT04823442|Autonomic Agents|autonomic agents|mesh-ancestor
5939072|NCT04823442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5939073|NCT04823442|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5939074|NCT04823442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5939075|NCT04823442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5939076|NCT04823468|Cisplatin|cisplatin|mesh-list
5939077|NCT04823468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5939078|NCT04823364|Neurotransmitter Agents|neurotransmitter agents|mesh-list
5939079|NCT04823364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5939080|NCT04823364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939081|NCT04823403|Nivolumab|nivolumab|mesh-list
5939082|NCT04823403|Ipilimumab|ipilimumab|mesh-list
5939083|NCT04823403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5939084|NCT04823403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5939085|NCT04823403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5939086|NCT04823403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5939087|NCT04823156|Calcium|calcium|mesh-list
5939088|NCT04823156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5939089|NCT04823156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939090|NCT04823260|Niacinamide|niacinamide|mesh-list
5939091|NCT04823260|Niacin|niacin|mesh-list
5939092|NCT04823260|Nicotinic Acids|nicotinic acids|mesh-list
5939093|NCT04823260|Vitamin B Complex|vitamin b complex|mesh-ancestor
5939094|NCT04823260|Vitamins|vitamins|mesh-ancestor
5939095|NCT04823260|Micronutrients|micronutrients|mesh-ancestor
5939096|NCT04823260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939097|NCT04823260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5939098|NCT04823260|Antimetabolites|antimetabolites|mesh-ancestor
5939099|NCT04823260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5939100|NCT04823260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5939101|NCT04823260|Vasodilator Agents|vasodilator agents|mesh-ancestor
5939102|NCT04823091|Cyclophosphamide|cyclophosphamide|mesh-list
5939103|NCT04823091|Fludarabine|fludarabine|mesh-list
5939104|NCT04823091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5939105|NCT04823091|Immunologic Factors|immunologic factors|mesh-ancestor
5939106|NCT04823091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939107|NCT04823091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5939108|NCT04823091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5939109|NCT04823091|Alkylating Agents|alkylating agents|mesh-ancestor
5939110|NCT04823091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5939111|NCT04823091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5939112|NCT04823091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5966940|NCT04567290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966941|NCT04567290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966942|NCT04567108|Benzocaine|benzocaine|mesh-list
5966943|NCT04567108|Anesthetics, Local|anesthetics, local|mesh-ancestor
5966944|NCT04567108|Anesthetics|anesthetics|mesh-ancestor
5966945|NCT04567108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5966946|NCT04567108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966947|NCT04567108|Sensory System Agents|sensory system agents|mesh-ancestor
5966948|NCT04567108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5966949|NCT04566952|Olaparib|olaparib|mesh-list
5966950|NCT04566952|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5966951|NCT04566952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5966952|NCT04566952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966953|NCT04566952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5966954|NCT04567069|Vaccines|vaccines|mesh-list
5966955|NCT04567069|Immunologic Factors|immunologic factors|mesh-ancestor
5966956|NCT04567069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966957|NCT04566887|Acalabrutinib|acalabrutinib|mesh-list
5966958|NCT04566887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5966959|NCT04566796|Neostigmine|neostigmine|mesh-list
5966960|NCT04566796|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5966961|NCT04566796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5966962|NCT04566796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966963|NCT04566796|Cholinergic Agents|cholinergic agents|mesh-ancestor
5966964|NCT04566796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5966965|NCT04566796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966966|NCT04566796|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5966967|NCT04566796|Autonomic Agents|autonomic agents|mesh-ancestor
5966968|NCT04566796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5966969|NCT04566991|Deferoxamine|deferoxamine|mesh-list
5966970|NCT04566991|Siderophores|siderophores|mesh-ancestor
5966971|NCT04566991|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5966972|NCT04566991|Chelating Agents|chelating agents|mesh-ancestor
5966973|NCT04566991|Sequestering Agents|sequestering agents|mesh-ancestor
5966974|NCT04566991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966975|NCT04567160|Propofol|propofol|mesh-list
5966976|NCT04567160|Sevoflurane|sevoflurane|mesh-list
5966977|NCT04567160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5966978|NCT04567160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5966979|NCT04567160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966980|NCT04567160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5966981|NCT04567160|Anesthetics, General|anesthetics, general|mesh-ancestor
5966982|NCT04567160|Anesthetics|anesthetics|mesh-ancestor
5966983|NCT04567160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5966984|NCT04567160|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5966985|NCT04566770|Vaccines|vaccines|mesh-list
5966986|NCT04566770|Immunologic Factors|immunologic factors|mesh-ancestor
5966987|NCT04566770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966988|NCT04566653|Calcium|calcium|mesh-list
5966989|NCT04566653|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
5966990|NCT04566653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5966991|NCT04566653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5966992|NCT04566653|Chelating Agents|chelating agents|mesh-ancestor
5966993|NCT04566653|Sequestering Agents|sequestering agents|mesh-ancestor
5939113|NCT04822909|Thalidomide|thalidomide|mesh-list
5939114|NCT04822909|Apremilast|apremilast|mesh-list
5939115|NCT04822909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5939116|NCT04822909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5939117|NCT04822909|Analgesics|analgesics|mesh-ancestor
5939118|NCT04822909|Sensory System Agents|sensory system agents|mesh-ancestor
5939119|NCT04822909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5939120|NCT04822909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939121|NCT04822909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5939122|NCT04822909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5939123|NCT04822909|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5939124|NCT04822909|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5939125|NCT04822909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5939126|NCT04822909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5939127|NCT04822909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5939128|NCT04822909|Immunologic Factors|immunologic factors|mesh-ancestor
5939129|NCT04822909|Leprostatic Agents|leprostatic agents|mesh-ancestor
5939130|NCT04822909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5939131|NCT04822909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5939132|NCT04822909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5939133|NCT04822909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5939134|NCT04822909|Growth Substances|growth substances|mesh-ancestor
6517252|NCT00720421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5939135|NCT04822909|Growth Inhibitors|growth inhibitors|mesh-ancestor
5939136|NCT04822909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5939137|NCT04823065|Scopolamine|scopolamine|mesh-list
5939138|NCT04823065|Loperamide|loperamide|mesh-list
5939139|NCT04823065|Antidiarrheals|antidiarrheals|mesh-list
5939140|NCT04823065|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
5939141|NCT04823065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5939142|NCT04823065|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5939143|NCT04823065|Antiemetics|antiemetics|mesh-ancestor
5939144|NCT04823065|Autonomic Agents|autonomic agents|mesh-ancestor
5939145|NCT04823065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5939146|NCT04823065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939147|NCT04823065|Mydriatics|mydriatics|mesh-ancestor
5939148|NCT04823065|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5939149|NCT04823065|Cholinergic Agents|cholinergic agents|mesh-ancestor
5939150|NCT04823065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5939151|NCT04823065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5939152|NCT04823065|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5939153|NCT04823065|Parasympatholytics|parasympatholytics|mesh-ancestor
5939154|NCT04822649|Adenosine|adenosine|mesh-list
5939155|NCT04822649|Analgesics|analgesics|mesh-ancestor
5939156|NCT04822649|Sensory System Agents|sensory system agents|mesh-ancestor
5939157|NCT04822649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5939158|NCT04822649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939159|NCT04822649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5939160|NCT04822649|Vasodilator Agents|vasodilator agents|mesh-ancestor
5939161|NCT04822649|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5939162|NCT04822649|Purinergic Agonists|purinergic agonists|mesh-ancestor
5939163|NCT04822649|Purinergic Agents|purinergic agents|mesh-ancestor
5939164|NCT04822649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5939165|NCT04822649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5939166|NCT04822415|Mepivacaine|mepivacaine|mesh-list
5939167|NCT04822415|Carticaine|carticaine|mesh-list
5939168|NCT04822415|Anesthetics, Local|anesthetics, local|mesh-ancestor
5939169|NCT04822415|Anesthetics|anesthetics|mesh-ancestor
5939170|NCT04822415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5939171|NCT04822415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939172|NCT04822415|Sensory System Agents|sensory system agents|mesh-ancestor
5939173|NCT04822415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5939174|NCT04822064|Dexmedetomidine|dexmedetomidine|mesh-list
5939175|NCT04822064|Ketamine|ketamine|mesh-list
5939176|NCT04822064|Chloral Hydrate|chloral hydrate|mesh-list
5939177|NCT04822064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5939178|NCT04822064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5939179|NCT04822064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939180|NCT04822064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5939181|NCT04822064|Analgesics|analgesics|mesh-ancestor
5939182|NCT04822064|Sensory System Agents|sensory system agents|mesh-ancestor
5939183|NCT04822064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5939184|NCT04822064|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5939185|NCT04822064|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5939186|NCT04822064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5939187|NCT04822064|Adrenergic Agents|adrenergic agents|mesh-ancestor
5939188|NCT04822064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5939189|NCT04822064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5939190|NCT04822064|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5939191|NCT04822064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5939192|NCT04822064|Anesthetics, General|anesthetics, general|mesh-ancestor
5939193|NCT04822064|Anesthetics|anesthetics|mesh-ancestor
5939194|NCT04822064|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5939195|NCT04822064|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5939196|NCT04822012|Antibodies|antibodies|mesh-list
5939197|NCT04822012|Immunoglobulin G|immunoglobulin g|mesh-list
5939198|NCT04822012|Progesterone|progesterone|mesh-list
5939199|NCT04822012|Estrogens|estrogens|mesh-list
5939200|NCT04822012|Immunologic Factors|immunologic factors|mesh-ancestor
5939201|NCT04822012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939202|NCT04822012|Progestins|progestins|mesh-ancestor
5939203|NCT04822012|Hormones|hormones|mesh-ancestor
5939204|NCT04822012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5939205|NCT04822363|Aspirin|aspirin|mesh-list
5939206|NCT04822363|Clopidogrel|clopidogrel|mesh-list
5939207|NCT04822363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5939208|NCT04822363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5939209|NCT04822363|Analgesics|analgesics|mesh-ancestor
5939210|NCT04822363|Sensory System Agents|sensory system agents|mesh-ancestor
5939211|NCT04822363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5939212|NCT04822363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939213|NCT04822363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5939214|NCT04822363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5939215|NCT04822363|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5939216|NCT04822363|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5939217|NCT04822363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5939218|NCT04822363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5939219|NCT04822363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5939220|NCT04822363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5939221|NCT04822363|Antipyretics|antipyretics|mesh-ancestor
5939222|NCT04822363|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5939223|NCT04822363|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5939224|NCT04822363|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5939225|NCT04822363|Purinergic Agents|purinergic agents|mesh-ancestor
5939226|NCT04822363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5939227|NCT04822038|Vitamin D|vitamin d|mesh-list
5939228|NCT04822038|Cholecalciferol|cholecalciferol|mesh-list
5939229|NCT04822038|Vitamins|vitamins|mesh-ancestor
5939230|NCT04822038|Micronutrients|micronutrients|mesh-ancestor
5939231|NCT04822038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939232|NCT04822038|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5939233|NCT04822038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5939234|NCT04821856|Cannabidiol|cannabidiol|mesh-list
5939235|NCT04821856|Anticonvulsants|anticonvulsants|mesh-ancestor
5939236|NCT04821947|Bupivacaine|bupivacaine|mesh-list
5939237|NCT04821947|Anesthetics, Local|anesthetics, local|mesh-list
5939238|NCT04821947|Anesthetics|anesthetics|mesh-list
5939239|NCT04821947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5939240|NCT04821947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939241|NCT04821947|Sensory System Agents|sensory system agents|mesh-ancestor
5939242|NCT04821947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5939243|NCT04822090|Immunoglobulins|immunoglobulins|mesh-list
5939244|NCT04822090|Antibodies|antibodies|mesh-list
5939245|NCT04822090|gamma-Globulins|gamma-globulins|mesh-list
5939246|NCT04822090|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5939247|NCT04822090|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5939248|NCT04822090|Immunologic Factors|immunologic factors|mesh-ancestor
5939249|NCT04822090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939250|NCT04821843|Paclitaxel|paclitaxel|mesh-list
5939251|NCT04821843|Nimotuzumab|nimotuzumab|mesh-list
5939252|NCT04821843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5939253|NCT04821843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5939254|NCT04821843|Tubulin Modulators|tubulin modulators|mesh-ancestor
5939255|NCT04821843|Antimitotic Agents|antimitotic agents|mesh-ancestor
5939256|NCT04821843|Mitosis Modulators|mitosis modulators|mesh-ancestor
5939257|NCT04821843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5939258|NCT04821843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5939259|NCT04821817|Rocuronium|rocuronium|mesh-list
5939260|NCT04821817|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5939261|NCT04821817|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5939262|NCT04821817|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5939263|NCT04821817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5939264|NCT04821817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939265|NCT04821778|Paclitaxel|paclitaxel|mesh-list
5939266|NCT04821778|Nimotuzumab|nimotuzumab|mesh-list
5939267|NCT04821778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5939268|NCT04821778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5939269|NCT04821778|Tubulin Modulators|tubulin modulators|mesh-ancestor
5939270|NCT04821778|Antimitotic Agents|antimitotic agents|mesh-ancestor
5939271|NCT04821778|Mitosis Modulators|mitosis modulators|mesh-ancestor
5939272|NCT04821778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5939273|NCT04821778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5939274|NCT04821583|Hydrocortisone|hydrocortisone|mesh-list
5939275|NCT04821583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5939276|NCT04821765|Paclitaxel|paclitaxel|mesh-list
5939277|NCT04821765|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5939278|NCT04821765|Antibodies|antibodies|mesh-list
5939279|NCT04821765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5939280|NCT04821765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5939281|NCT04821765|Tubulin Modulators|tubulin modulators|mesh-ancestor
5939282|NCT04821765|Antimitotic Agents|antimitotic agents|mesh-ancestor
5939283|NCT04821765|Mitosis Modulators|mitosis modulators|mesh-ancestor
5939284|NCT04821765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5939285|NCT04821765|Immunologic Factors|immunologic factors|mesh-ancestor
5939286|NCT04821765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939287|NCT04821323|Indomethacin|indomethacin|mesh-list
5939288|NCT04821323|Mannitol|mannitol|mesh-list
5939289|NCT04821323|Lactulose|lactulose|mesh-list
5939290|NCT04821323|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5939291|NCT04821323|Diuretics|diuretics|mesh-ancestor
5939292|NCT04821323|Natriuretic Agents|natriuretic agents|mesh-ancestor
5939293|NCT04821323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939294|NCT04821323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5939295|NCT04821323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5939296|NCT04821323|Analgesics|analgesics|mesh-ancestor
5939297|NCT04821323|Sensory System Agents|sensory system agents|mesh-ancestor
5939298|NCT04821323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5939299|NCT04821323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5939300|NCT04821323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5939301|NCT04821323|Gout Suppressants|gout suppressants|mesh-ancestor
5939302|NCT04821323|Tocolytic Agents|tocolytic agents|mesh-ancestor
5939303|NCT04821323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5939304|NCT04821323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5939305|NCT04821323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5939306|NCT04821323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5939307|NCT04821323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5939308|NCT04821804|Hyaluronic Acid|hyaluronic acid|mesh-list
5939309|NCT04821804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5939310|NCT04821804|Immunologic Factors|immunologic factors|mesh-ancestor
5939311|NCT04821804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939312|NCT04821804|Viscosupplements|viscosupplements|mesh-ancestor
5939313|NCT04821804|Protective Agents|protective agents|mesh-ancestor
5939314|NCT04821687|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
5939315|NCT04821687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5939316|NCT04821687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5939317|NCT04821687|Dopamine Agents|dopamine agents|mesh-ancestor
5939318|NCT04821687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5939319|NCT04821687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939320|NCT04821063|Moxifloxacin|moxifloxacin|mesh-list
5939321|NCT04821063|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
5939322|NCT04821063|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
5939323|NCT04821063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5939324|NCT04821063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5939325|NCT04821063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5939326|NCT04821063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5939327|NCT04821063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5939328|NCT04821063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5939329|NCT04821063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5939330|NCT04821063|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5939331|NCT04821063|Contraceptive Agents|contraceptive agents|mesh-ancestor
5939332|NCT04821063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5939333|NCT04821063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939334|NCT04821063|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5939335|NCT04821063|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5939336|NCT04821063|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5939337|NCT04821063|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5939338|NCT04821206|Antirheumatic Agents|antirheumatic agents|mesh-list
5939339|NCT04821206|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
5939340|NCT04821206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5939341|NCT04821206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5939342|NCT04821206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5939343|NCT04821193|Chlorhexidine|chlorhexidine|mesh-list
5939344|NCT04821193|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5939345|NCT04821193|Disinfectants|disinfectants|mesh-list
5939346|NCT04821193|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5939347|NCT04821193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5939348|NCT04821193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5939349|NCT04821193|Dermatologic Agents|dermatologic agents|mesh-ancestor
5939350|NCT04820972|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
5939351|NCT04820751|Cyproheptadine|cyproheptadine|mesh-list
5939352|NCT04820751|Antipruritics|antipruritics|mesh-ancestor
5939353|NCT04820751|Dermatologic Agents|dermatologic agents|mesh-ancestor
5939354|NCT04820751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5939355|NCT04820751|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5939356|NCT04820751|Histamine Antagonists|histamine antagonists|mesh-ancestor
5939357|NCT04820751|Histamine Agents|histamine agents|mesh-ancestor
5939358|NCT04820751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5939359|NCT04820751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5939360|NCT04820751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939361|NCT04820751|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5939362|NCT04820751|Serotonin Agents|serotonin agents|mesh-ancestor
5939363|NCT04820751|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5939364|NCT04820933|Tenofovir|tenofovir|mesh-list
5939365|NCT04820933|Emtricitabine|emtricitabine|mesh-list
5939366|NCT04820933|Antiviral Agents|antiviral agents|mesh-ancestor
5939367|NCT04820933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5939368|NCT04820933|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5939369|NCT04820933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5939370|NCT04820933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5939371|NCT04820933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5939372|NCT04820933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5939373|NCT04820933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5939374|NCT04820673|Sarecycline|sarecycline|mesh-list
5939375|NCT04820673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5939376|NCT04820673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5939377|NCT04820673|Dermatologic Agents|dermatologic agents|mesh-ancestor
5939378|NCT04820803|Cetylpyridinium|cetylpyridinium|mesh-list
5939379|NCT04820803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5939380|NCT04820803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5939381|NCT04820361|Parasympatholytics|parasympatholytics|mesh-list
5939382|NCT04820361|Autonomic Agents|autonomic agents|mesh-ancestor
5939383|NCT04820361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5939384|NCT04820361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939385|NCT04820205|Dexmedetomidine|dexmedetomidine|mesh-list
5939386|NCT04820205|Ketamine|ketamine|mesh-list
5939387|NCT04820205|Chloral Hydrate|chloral hydrate|mesh-list
5939388|NCT04820205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5939389|NCT04820205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5939390|NCT04820205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939391|NCT04820205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5939392|NCT04820205|Analgesics|analgesics|mesh-ancestor
5939393|NCT04820205|Sensory System Agents|sensory system agents|mesh-ancestor
5939394|NCT04820205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5939395|NCT04820205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5939396|NCT04820205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5939397|NCT04820205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5939398|NCT04820205|Adrenergic Agents|adrenergic agents|mesh-ancestor
5939399|NCT04820205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5939400|NCT04820205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5939401|NCT04820205|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5939402|NCT04820205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5939403|NCT04820205|Anesthetics, General|anesthetics, general|mesh-ancestor
5939404|NCT04820205|Anesthetics|anesthetics|mesh-ancestor
5939405|NCT04820205|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5939406|NCT04820205|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5939407|NCT04820439|Pertuzumab|pertuzumab|mesh-list
5939408|NCT04820439|Antibodies|antibodies|mesh-list
5939409|NCT04820439|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5939410|NCT04820439|Mitogens|mitogens|mesh-list
5939411|NCT04820439|Immunologic Factors|immunologic factors|mesh-ancestor
5939412|NCT04820439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939413|NCT04820439|Mitosis Modulators|mitosis modulators|mesh-ancestor
5939414|NCT04820439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5939415|NCT04820439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5939416|NCT04820439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5939424|NCT04820036|Insulin|insulin|mesh-list
5939425|NCT04820036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5939426|NCT04820036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939427|NCT04819971|Docetaxel|docetaxel|mesh-list
5939428|NCT04819971|Oxaliplatin|oxaliplatin|mesh-list
5939429|NCT04819971|Trastuzumab|trastuzumab|mesh-list
5939430|NCT04819971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5939431|NCT04819971|Tubulin Modulators|tubulin modulators|mesh-ancestor
5939432|NCT04819971|Antimitotic Agents|antimitotic agents|mesh-ancestor
5939433|NCT04819971|Mitosis Modulators|mitosis modulators|mesh-ancestor
5939434|NCT04819971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5939435|NCT04819971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5939436|NCT04819906|Moxifloxacin|moxifloxacin|mesh-list
5939437|NCT04819906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5939438|NCT04819906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5939439|NCT04819906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5939440|NCT04819906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5939441|NCT04819906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5939442|NCT04819906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5939443|NCT04819906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5939444|NCT04820010|Insulin|insulin|mesh-list
5939445|NCT04820010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5939446|NCT04820010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939447|NCT04819776|Iloperidone|iloperidone|mesh-list
5939448|NCT04819776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5939449|NCT04819776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5939450|NCT04819776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5939451|NCT04819776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939452|NCT04819776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5939453|NCT04820101|Dexmedetomidine|dexmedetomidine|mesh-list
5939454|NCT04820101|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5939455|NCT04820101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5939456|NCT04820101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939457|NCT04820101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5939458|NCT04820101|Analgesics|analgesics|mesh-ancestor
5939459|NCT04820101|Sensory System Agents|sensory system agents|mesh-ancestor
5939460|NCT04820101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5939461|NCT04820101|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5939462|NCT04820101|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5939463|NCT04820101|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5939464|NCT04820101|Adrenergic Agents|adrenergic agents|mesh-ancestor
5939465|NCT04820101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5939466|NCT04820101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5939467|NCT04819867|Propolis|propolis|mesh-list
5939468|NCT04819867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5939469|NCT04819503|Anesthetics|anesthetics|mesh-list
5939470|NCT04819503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5939471|NCT04819503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939472|NCT04819399|Catumaxomab|catumaxomab|mesh-list
5939473|NCT04819399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5966994|NCT04566653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5966995|NCT04566718|Metformin|metformin|mesh-list
5966996|NCT04566718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5966997|NCT04566718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970961|NCT04531475|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5970962|NCT04531475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5970963|NCT04531475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970964|NCT04531228|Lenvatinib|lenvatinib|mesh-list
5970965|NCT04531228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5970966|NCT04531228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5970967|NCT04531228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5970968|NCT04531228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970969|NCT04531332|Linezolid|linezolid|mesh-list
5970970|NCT04531332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5719913|NCT03216395|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5719914|NCT03216447|Tacrolimus|tacrolimus|mesh-list
5719915|NCT03216447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5719916|NCT03216447|Immunologic Factors|immunologic factors|mesh-ancestor
5719917|NCT03216447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719918|NCT03216447|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5719919|NCT03216447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5719920|NCT03216447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719921|NCT03216538|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
5719922|NCT03216538|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5719923|NCT03216538|Immunologic Factors|immunologic factors|mesh-ancestor
5719924|NCT03216538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939474|NCT04819438|Riluzole|riluzole|mesh-list
5939475|NCT04819438|Anticonvulsants|anticonvulsants|mesh-ancestor
5939476|NCT04819438|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5939477|NCT04819438|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5939478|NCT04819438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5939479|NCT04819438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5939480|NCT04819438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939481|NCT04819438|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5939482|NCT04819438|Protective Agents|protective agents|mesh-ancestor
5939483|NCT04819828|Diclofenac|diclofenac|mesh-list
5939484|NCT04819828|Tamsulosin|tamsulosin|mesh-list
5939485|NCT04819828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5939486|NCT04819828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5939487|NCT04819828|Analgesics|analgesics|mesh-ancestor
5939488|NCT04819828|Sensory System Agents|sensory system agents|mesh-ancestor
5939489|NCT04819828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5939490|NCT04819828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939491|NCT04819828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5939492|NCT04819828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5939493|NCT04819828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5939494|NCT04819828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5939495|NCT04819828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5939496|NCT04819828|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5939497|NCT04819828|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5939498|NCT04819828|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5939499|NCT04819828|Adrenergic Agents|adrenergic agents|mesh-ancestor
5939500|NCT04819828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5939501|NCT04819828|Urological Agents|urological agents|mesh-ancestor
5939502|NCT04818931|Cefazolin|cefazolin|mesh-list
5939503|NCT04818931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5939504|NCT04818931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5939505|NCT04819204|Cetrorelix|cetrorelix|mesh-list
5939506|NCT04819204|Testosterone|testosterone|mesh-list
5939507|NCT04819204|Androgens|androgens|mesh-ancestor
5939508|NCT04819204|Hormones|hormones|mesh-ancestor
5939509|NCT04819204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5939510|NCT04819204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939511|NCT04819204|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5939512|NCT04819204|Fertility Agents|fertility agents|mesh-ancestor
5939513|NCT04819204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5939514|NCT04819204|Hormone Antagonists|hormone antagonists|mesh-ancestor
5939515|NCT04819217|Charcoal|charcoal|mesh-list
5939516|NCT04819217|Antidotes|antidotes|mesh-ancestor
5939517|NCT04819217|Protective Agents|protective agents|mesh-ancestor
5939518|NCT04819217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939519|NCT04819269|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5939520|NCT04819269|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5939521|NCT04819243|Atezolizumab|atezolizumab|mesh-list
5939522|NCT04819243|Talazoparib|talazoparib|mesh-list
5939523|NCT04819243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5939524|NCT04819243|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5939525|NCT04819243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5939526|NCT04819243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5939527|NCT04818723|Montelukast|montelukast|mesh-list
5939528|NCT04818723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5939529|NCT04818723|Respiratory System Agents|respiratory system agents|mesh-ancestor
5939530|NCT04818723|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5939531|NCT04818723|Hormone Antagonists|hormone antagonists|mesh-ancestor
5939532|NCT04818723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5939533|NCT04818723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939534|NCT04818723|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5939535|NCT04818723|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5939536|NCT04818723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5939537|NCT04818736|Vaccines|vaccines|mesh-list
5939538|NCT04818736|Immunologic Factors|immunologic factors|mesh-ancestor
5939539|NCT04818736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939540|NCT04818450|Gabapentin|gabapentin|mesh-list
5939541|NCT04818450|Analgesics|analgesics|mesh-ancestor
5939542|NCT04818450|Sensory System Agents|sensory system agents|mesh-ancestor
5939543|NCT04818450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5939544|NCT04818450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939545|NCT04818450|Anticonvulsants|anticonvulsants|mesh-ancestor
5939546|NCT04818450|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5939547|NCT04818450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5939548|NCT04818450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5939549|NCT04818450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5939550|NCT04818450|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5939551|NCT04818450|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5939552|NCT04818450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5939553|NCT04818450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5939554|NCT04818450|Antimanic Agents|antimanic agents|mesh-ancestor
5939555|NCT04818749|Dexamethasone|dexamethasone|mesh-list
5939556|NCT04818749|Dexamethasone acetate|dexamethasone acetate|mesh-list
5939557|NCT04818749|Dexmedetomidine|dexmedetomidine|mesh-list
5939558|NCT04818749|BB 1101|bb 1101|mesh-list
5939559|NCT04818749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5939560|NCT04818749|Antiemetics|antiemetics|mesh-ancestor
5939561|NCT04818749|Autonomic Agents|autonomic agents|mesh-ancestor
5939562|NCT04818749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5939563|NCT04818749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939564|NCT04818749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5939565|NCT04818749|Glucocorticoids|glucocorticoids|mesh-ancestor
5939566|NCT04818749|Hormones|hormones|mesh-ancestor
5939567|NCT04818749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5939568|NCT04818749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5939569|NCT04818749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5939570|NCT04818749|Protease Inhibitors|protease inhibitors|mesh-ancestor
5939571|NCT04818749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5939572|NCT04818749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5939573|NCT04818749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5939574|NCT04818749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5939575|NCT04818749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5939576|NCT04818749|Analgesics|analgesics|mesh-ancestor
5939577|NCT04818749|Sensory System Agents|sensory system agents|mesh-ancestor
5939578|NCT04818749|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5939579|NCT04818749|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5939580|NCT04818749|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5939581|NCT04818749|Adrenergic Agents|adrenergic agents|mesh-ancestor
5939582|NCT04818749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5939590|NCT04818216|Niacinamide|niacinamide|mesh-list
5939591|NCT04818216|Niacin|niacin|mesh-list
5939592|NCT04818216|Nicotinic Acids|nicotinic acids|mesh-list
5939593|NCT04818216|Vitamin B Complex|vitamin b complex|mesh-ancestor
5939594|NCT04818216|Vitamins|vitamins|mesh-ancestor
5939595|NCT04818216|Micronutrients|micronutrients|mesh-ancestor
5939596|NCT04818216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939597|NCT04818216|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5939598|NCT04818216|Antimetabolites|antimetabolites|mesh-ancestor
5939599|NCT04818216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5939600|NCT04818216|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5939601|NCT04818216|Vasodilator Agents|vasodilator agents|mesh-ancestor
5939602|NCT04818034|Dapagliflozin|dapagliflozin|mesh-list
5939603|NCT04818034|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5939604|NCT04818034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5939605|NCT04818034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5939606|NCT04818034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939607|NCT04817904|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5939608|NCT04817904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5939609|NCT04817904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5939610|NCT04817904|Antimetabolites|antimetabolites|mesh-ancestor
5966998|NCT04566224|Pyrithione zinc|pyrithione zinc|mesh-list
5939611|NCT04817904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5939612|NCT04817904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5939613|NCT04817904|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5939614|NCT04817904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5939615|NCT04817826|Durvalumab|durvalumab|mesh-list
5939616|NCT04817826|Tremelimumab|tremelimumab|mesh-list
5939617|NCT04817826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5939618|NCT04817826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5939619|NCT04817865|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5939620|NCT04817865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5939621|NCT04817982|Dexamethasone|dexamethasone|mesh-list
5939622|NCT04817982|Dexamethasone acetate|dexamethasone acetate|mesh-list
5939623|NCT04817982|Lidocaine|lidocaine|mesh-list
5939624|NCT04817982|BB 1101|bb 1101|mesh-list
5939625|NCT04817982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5939626|NCT04817982|Antiemetics|antiemetics|mesh-ancestor
5939627|NCT04817982|Autonomic Agents|autonomic agents|mesh-ancestor
5939628|NCT04817982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5939629|NCT04817982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939630|NCT04817982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5939631|NCT04817982|Glucocorticoids|glucocorticoids|mesh-ancestor
5939632|NCT04817982|Hormones|hormones|mesh-ancestor
5939633|NCT04817982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5939634|NCT04817982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5939635|NCT04817982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5939636|NCT04817982|Protease Inhibitors|protease inhibitors|mesh-ancestor
5939637|NCT04817982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5939638|NCT04817982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5939639|NCT04817982|Anesthetics, Local|anesthetics, local|mesh-ancestor
5939640|NCT04817982|Anesthetics|anesthetics|mesh-ancestor
5939641|NCT04817982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5939642|NCT04817982|Sensory System Agents|sensory system agents|mesh-ancestor
5939643|NCT04817982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5939644|NCT04817982|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5939645|NCT04817982|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5939646|NCT04817982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5939647|NCT04818099|Vortioxetine|vortioxetine|mesh-list
5939648|NCT04818099|Antidepressive Agents|antidepressive agents|mesh-ancestor
5939649|NCT04818099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5939650|NCT04818099|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5939651|NCT04818099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5939652|NCT04818099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5939653|NCT04818099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939654|NCT04818099|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5939655|NCT04818099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5939656|NCT04818099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5939657|NCT04818099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5939658|NCT04818099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5939659|NCT04818099|Serotonin Agents|serotonin agents|mesh-ancestor
5939660|NCT04818099|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5939661|NCT04818099|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5939662|NCT04818099|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5939663|NCT04818099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5939664|NCT04817969|Cimetidine|cimetidine|mesh-list
5939665|NCT04817969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5939666|NCT04817969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5939667|NCT04817969|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5939668|NCT04817969|Histamine Antagonists|histamine antagonists|mesh-ancestor
5939669|NCT04817969|Histamine Agents|histamine agents|mesh-ancestor
5939670|NCT04817969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5939671|NCT04817969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5939672|NCT04817969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939673|NCT04817969|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5939674|NCT04817969|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5939675|NCT04817969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5939676|NCT04818151|Warfarin|warfarin|mesh-list
5939677|NCT04818151|Apixaban|apixaban|mesh-list
5939678|NCT04818151|Anticoagulants|anticoagulants|mesh-ancestor
5939679|NCT04818151|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5939680|NCT04818151|Antithrombins|antithrombins|mesh-ancestor
5939681|NCT04818151|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5939682|NCT04818151|Protease Inhibitors|protease inhibitors|mesh-ancestor
5939683|NCT04818151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5966999|NCT04566224|Keratolytic Agents|keratolytic agents|mesh-ancestor
5939684|NCT04818151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5939685|NCT04817800|Azelastine|azelastine|mesh-list
5939686|NCT04817800|Beclomethasone|beclomethasone|mesh-list
5939687|NCT04817800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5939688|NCT04817800|Glucocorticoids|glucocorticoids|mesh-ancestor
5939689|NCT04817800|Hormones|hormones|mesh-ancestor
5939690|NCT04817800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5939691|NCT04817800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939692|NCT04817800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5939693|NCT04817800|Respiratory System Agents|respiratory system agents|mesh-ancestor
5939694|NCT04817800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5939695|NCT04817800|Autonomic Agents|autonomic agents|mesh-ancestor
5939696|NCT04817800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5939697|NCT04817800|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
5939698|NCT04817800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5939699|NCT04817800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5939700|NCT04817800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5939701|NCT04817800|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5939702|NCT04817800|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5939703|NCT04817800|Histamine Antagonists|histamine antagonists|mesh-ancestor
5939704|NCT04817800|Histamine Agents|histamine agents|mesh-ancestor
5939705|NCT04817800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5939706|NCT04817527|Edaravone|edaravone|mesh-list
5939707|NCT04817527|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5939708|NCT04817527|Antioxidants|antioxidants|mesh-ancestor
5939709|NCT04817527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5939710|NCT04817527|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5939711|NCT04817527|Protective Agents|protective agents|mesh-ancestor
5939712|NCT04817527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939713|NCT04817501|Edetic Acid|edetic acid|mesh-list
5939714|NCT04817501|Anticoagulants|anticoagulants|mesh-ancestor
5939715|NCT04817501|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5939716|NCT04817501|Chelating Agents|chelating agents|mesh-ancestor
5939717|NCT04817501|Sequestering Agents|sequestering agents|mesh-ancestor
5939718|NCT04817501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967000|NCT04566224|Dermatologic Agents|dermatologic agents|mesh-ancestor
5967001|NCT04566250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
5967002|NCT04566250|Analgesics|analgesics|mesh-ancestor
5967003|NCT04566250|Sensory System Agents|sensory system agents|mesh-ancestor
5967004|NCT04566250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5967005|NCT04566250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967006|NCT04566380|Nivolumab|nivolumab|mesh-list
5967007|NCT04566380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5967008|NCT04566380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5967009|NCT04566380|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5967010|NCT04566380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967011|NCT04566211|Amoxicillin|amoxicillin|mesh-list
5967012|NCT04566211|Metronidazole|metronidazole|mesh-list
5967013|NCT04566211|Clarithromycin|clarithromycin|mesh-list
5967014|NCT04566211|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
5967015|NCT04566211|Pantoprazole|pantoprazole|mesh-list
5967016|NCT04566211|Bismuth|bismuth|mesh-list
5967017|NCT04566211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5967018|NCT04566211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5967019|NCT04566211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5967020|NCT04566211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5967021|NCT04566211|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5967022|NCT04566211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5967023|NCT04566211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967024|NCT04566211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5967025|NCT04566211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5967026|NCT04566211|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5967027|NCT04566211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5967028|NCT04566211|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5967029|NCT04566211|Antacids|antacids|mesh-ancestor
5967030|NCT04566016|Anesthetics|anesthetics|mesh-list
5967031|NCT04566016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5967032|NCT04566016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967033|NCT04565847|Albuterol|albuterol|mesh-list
5967034|NCT04565847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5967035|NCT04565847|Autonomic Agents|autonomic agents|mesh-ancestor
5967036|NCT04565847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6517253|NCT00720421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5967037|NCT04565847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517254|NCT00720421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5939719|NCT04817189|Dexamethasone|dexamethasone|mesh-list
5939720|NCT04817189|Ondansetron|ondansetron|mesh-list
5939721|NCT04817189|Palonosetron|palonosetron|mesh-list
5939722|NCT04817189|Granisetron|granisetron|mesh-list
5939723|NCT04817189|Tropisetron|tropisetron|mesh-list
5939724|NCT04817189|Dolasetron|dolasetron|mesh-list
5939725|NCT04817189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5939726|NCT04817189|Antiemetics|antiemetics|mesh-ancestor
5939727|NCT04817189|Autonomic Agents|autonomic agents|mesh-ancestor
5939728|NCT04817189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5939729|NCT04817189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939730|NCT04817189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5939731|NCT04817189|Glucocorticoids|glucocorticoids|mesh-ancestor
5939732|NCT04817189|Hormones|hormones|mesh-ancestor
5939733|NCT04817189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5939734|NCT04817189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5939735|NCT04817189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5939736|NCT04817189|Antipruritics|antipruritics|mesh-ancestor
5939737|NCT04817189|Dermatologic Agents|dermatologic agents|mesh-ancestor
5939738|NCT04817189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5939739|NCT04817189|Serotonin Agents|serotonin agents|mesh-ancestor
5939740|NCT04817189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5939741|NCT04817189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5939742|NCT04817189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5939743|NCT04817189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5939744|NCT04817189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5939745|NCT04817189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5939746|NCT04817189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5939747|NCT04817189|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5939748|NCT04817202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5939749|NCT04817202|Antibodies|antibodies|mesh-list
5939750|NCT04817202|Immunoglobulins|immunoglobulins|mesh-list
5939751|NCT04817202|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5939752|NCT04817202|Immunologic Factors|immunologic factors|mesh-ancestor
5939753|NCT04817202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939754|NCT04817202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5939755|NCT04816968|Vancomycin|vancomycin|mesh-list
5939756|NCT04816968|Meropenem|meropenem|mesh-list
5939757|NCT04816968|Tazobactam|tazobactam|mesh-list
5939758|NCT04816968|Piperacillin|piperacillin|mesh-list
5939759|NCT04816968|Cefepime|cefepime|mesh-list
5939760|NCT04816968|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
5939761|NCT04816968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5939762|NCT04816968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5939763|NCT04816968|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5939764|NCT04816968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5939765|NCT04816968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5939766|NCT04816877|Analgesics, Opioid|analgesics, opioid|mesh-list
5939767|NCT04816877|Narcotics|narcotics|mesh-ancestor
5939768|NCT04816877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5939769|NCT04816877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939770|NCT04816877|Analgesics|analgesics|mesh-ancestor
5939771|NCT04816877|Sensory System Agents|sensory system agents|mesh-ancestor
5939772|NCT04816877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5939773|NCT04816838|Osimertinib|osimertinib|mesh-list
5939774|NCT04816838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5939775|NCT04816838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5939776|NCT04816838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5939777|NCT04816838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5939778|NCT04817033|Midazolam|midazolam|mesh-list
5939779|NCT04817033|Dexmedetomidine|dexmedetomidine|mesh-list
5939780|NCT04817033|Anesthetics|anesthetics|mesh-list
5939781|NCT04817033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5939782|NCT04817033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939783|NCT04817033|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5939784|NCT04817033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5939785|NCT04817033|Analgesics|analgesics|mesh-ancestor
5939786|NCT04817033|Sensory System Agents|sensory system agents|mesh-ancestor
5939787|NCT04817033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5939788|NCT04817033|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5939789|NCT04817033|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5939790|NCT04817033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5939791|NCT04817033|Adrenergic Agents|adrenergic agents|mesh-ancestor
5939792|NCT04817033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5939793|NCT04817033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5939794|NCT04817033|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5939795|NCT04817033|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5939796|NCT04817033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5939797|NCT04817033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5939798|NCT04817033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5939799|NCT04817033|Anesthetics, General|anesthetics, general|mesh-ancestor
5939800|NCT04817033|GABA Modulators|gaba modulators|mesh-ancestor
5939801|NCT04817033|GABA Agents|gaba agents|mesh-ancestor
5939802|NCT04816682|Silymarin|silymarin|mesh-list
5939803|NCT04816682|Antioxidants|antioxidants|mesh-ancestor
5939804|NCT04816682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5939805|NCT04816682|Protective Agents|protective agents|mesh-ancestor
5939806|NCT04816682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939807|NCT04816890|Insulin Lispro|insulin lispro|mesh-list
5939808|NCT04816890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5939809|NCT04816890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939810|NCT04816344|Anesthetics|anesthetics|mesh-list
5939811|NCT04816344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5939812|NCT04816344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939813|NCT04816461|Piperaquine|piperaquine|mesh-list
5939814|NCT04816461|Sulfadoxine|sulfadoxine|mesh-list
5939815|NCT04816461|Amodiaquine|amodiaquine|mesh-list
5939816|NCT04816461|Artenimol|artenimol|mesh-list
5939817|NCT04816461|Antimalarials|antimalarials|mesh-ancestor
5939818|NCT04816461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5939819|NCT04816461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5939820|NCT04816461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5939821|NCT04816461|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5939822|NCT04816461|Renal Agents|renal agents|mesh-ancestor
5939823|NCT04816253|Methylprednisolone|methylprednisolone|mesh-list
5939824|NCT04816253|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5939825|NCT04816253|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5939826|NCT04816253|Prednisolone|prednisolone|mesh-list
5939827|NCT04816253|Prednisolone acetate|prednisolone acetate|mesh-list
5939828|NCT04816253|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5939829|NCT04816253|Prednisolone phosphate|prednisolone phosphate|mesh-list
5939830|NCT04816253|Hyaluronic Acid|hyaluronic acid|mesh-list
5939831|NCT04816253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5939832|NCT04816253|Antiemetics|antiemetics|mesh-ancestor
5939833|NCT04816253|Autonomic Agents|autonomic agents|mesh-ancestor
5939834|NCT04816253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5939835|NCT04816253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939836|NCT04816253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5939837|NCT04816253|Glucocorticoids|glucocorticoids|mesh-ancestor
5939838|NCT04816253|Hormones|hormones|mesh-ancestor
5939839|NCT04816253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5939840|NCT04816253|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5939841|NCT04816253|Protective Agents|protective agents|mesh-ancestor
5939842|NCT04816253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5939843|NCT04816253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5939844|NCT04816253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5939845|NCT04816253|Immunologic Factors|immunologic factors|mesh-ancestor
5939846|NCT04816253|Viscosupplements|viscosupplements|mesh-ancestor
5939847|NCT04815967|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
5939848|NCT04815967|Botulinum Toxins|botulinum toxins|mesh-list
5939849|NCT04815967|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5939850|NCT04815967|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5939851|NCT04815967|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5939852|NCT04815967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5939853|NCT04815967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5939854|NCT04815967|Cholinergic Agents|cholinergic agents|mesh-ancestor
5939855|NCT04815967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5939856|NCT04815967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939857|NCT04815967|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5939858|NCT04815967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5939859|NCT04815967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5939860|NCT04816097|Dexamethasone|dexamethasone|mesh-list
5939861|NCT04816097|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
5939862|NCT04816097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5939863|NCT04816097|Antiemetics|antiemetics|mesh-ancestor
5939864|NCT04816097|Autonomic Agents|autonomic agents|mesh-ancestor
5939865|NCT04816097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5939866|NCT04816097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939867|NCT04816097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5939868|NCT04816097|Glucocorticoids|glucocorticoids|mesh-ancestor
5939869|NCT04816097|Hormones|hormones|mesh-ancestor
5939870|NCT04816097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5939871|NCT04816097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5939872|NCT04816097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5939873|NCT04816240|Midodrine|midodrine|mesh-list
5939874|NCT04816240|Sympathomimetics|sympathomimetics|mesh-ancestor
5939875|NCT04816240|Autonomic Agents|autonomic agents|mesh-ancestor
5939876|NCT04816240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5719925|NCT03216538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5719926|NCT03216538|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5719927|NCT03216538|Protective Agents|protective agents|mesh-ancestor
5719928|NCT03216538|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5719929|NCT03216538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5719930|NCT03216538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5719931|NCT03216538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719932|NCT03216538|Antiviral Agents|antiviral agents|mesh-ancestor
5719933|NCT03216538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5719934|NCT03215927|Abatacept|abatacept|mesh-list
5719935|NCT03215927|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5719936|NCT03215927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719937|NCT03215927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5719938|NCT03215927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5719939|NCT03215927|Immunologic Factors|immunologic factors|mesh-ancestor
5719940|NCT03215927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719941|NCT03215927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5719942|NCT03215940|Dronabinol|dronabinol|mesh-list
5719943|NCT03215940|Cannabidiol|cannabidiol|mesh-list
5719944|NCT03215940|Anticonvulsants|anticonvulsants|mesh-ancestor
5719945|NCT03215940|Hallucinogens|hallucinogens|mesh-ancestor
5719946|NCT03215940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719947|NCT03215940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5719948|NCT03215940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5719949|NCT03215940|Analgesics|analgesics|mesh-ancestor
5719950|NCT03215940|Sensory System Agents|sensory system agents|mesh-ancestor
5719951|NCT03215940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5719952|NCT03215940|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5719953|NCT03215940|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5719954|NCT03215940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5719955|NCT03215940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719956|NCT03215940|Hormones|hormones|mesh-ancestor
5719957|NCT03215940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5719958|NCT03215875|Torsemide|torsemide|mesh-list
6517255|NCT00720421|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6517256|NCT00720421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6517257|NCT00720421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6517258|NCT00720421|GABA Modulators|gaba modulators|mesh-ancestor
6517259|NCT00720421|GABA Agents|gaba agents|mesh-ancestor
6517260|NCT00720421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6517261|NCT00720421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517262|NCT00720447|Cytarabine|cytarabine|mesh-list
6517263|NCT00720447|Etoposide|etoposide|mesh-list
6517264|NCT00720447|Melphalan|melphalan|mesh-list
6517265|NCT00720447|Alemtuzumab|alemtuzumab|mesh-list
6517266|NCT00720447|Carmustine|carmustine|mesh-list
6517267|NCT00720447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6517268|NCT00720447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6517269|NCT00720447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5939877|NCT04816240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939878|NCT04816240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5939879|NCT04816240|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5939880|NCT04816240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5939881|NCT04816240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5939882|NCT04816240|Adrenergic Agents|adrenergic agents|mesh-ancestor
5939883|NCT04816240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5939884|NCT04816240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967038|NCT04565847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5967039|NCT04565847|Respiratory System Agents|respiratory system agents|mesh-ancestor
5967040|NCT04565847|Tocolytic Agents|tocolytic agents|mesh-ancestor
5967041|NCT04565847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5967042|NCT04565847|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5967043|NCT04565847|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5967044|NCT04565847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5967045|NCT04565847|Adrenergic Agents|adrenergic agents|mesh-ancestor
5967046|NCT04565847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5967047|NCT04565847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967048|NCT04565496|Pembrolizumab|pembrolizumab|mesh-list
5967049|NCT04565496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6517270|NCT00720447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6517271|NCT00720447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5939885|NCT04815590|Buprenorphine|buprenorphine|mesh-list
5939886|NCT04815590|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5939887|NCT04815590|Narcotics|narcotics|mesh-ancestor
5939888|NCT04815590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5939889|NCT04815590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939890|NCT04815590|Analgesics|analgesics|mesh-ancestor
5939891|NCT04815590|Sensory System Agents|sensory system agents|mesh-ancestor
5939892|NCT04815590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5939893|NCT04815590|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5939894|NCT04815265|Dexmedetomidine|dexmedetomidine|mesh-list
5939895|NCT04815265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5939896|NCT04815265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5939897|NCT04815265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939898|NCT04815265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5939899|NCT04815265|Analgesics|analgesics|mesh-ancestor
5939900|NCT04815265|Sensory System Agents|sensory system agents|mesh-ancestor
5939901|NCT04815265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5939902|NCT04815265|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5939903|NCT04815265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5939904|NCT04815265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5939905|NCT04815265|Adrenergic Agents|adrenergic agents|mesh-ancestor
5939906|NCT04815265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5939907|NCT04815265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5939908|NCT04815408|Paclitaxel|paclitaxel|mesh-list
5939909|NCT04815408|Carboplatin|carboplatin|mesh-list
5939910|NCT04815408|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5939911|NCT04815408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5939912|NCT04815408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5939913|NCT04815408|Tubulin Modulators|tubulin modulators|mesh-ancestor
5939914|NCT04815408|Antimitotic Agents|antimitotic agents|mesh-ancestor
5939915|NCT04815408|Mitosis Modulators|mitosis modulators|mesh-ancestor
5939916|NCT04815408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5939917|NCT04815395|Oxytocin|oxytocin|mesh-list
5939918|NCT04815395|Oxytocics|oxytocics|mesh-ancestor
5939919|NCT04815395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5939920|NCT04815395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939921|NCT04815187|Montelukast|montelukast|mesh-list
5939922|NCT04815187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5939923|NCT04815187|Respiratory System Agents|respiratory system agents|mesh-ancestor
5939924|NCT04815187|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5939925|NCT04815187|Hormone Antagonists|hormone antagonists|mesh-ancestor
5939926|NCT04815187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5939927|NCT04815187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939928|NCT04815187|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5939929|NCT04815187|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5939930|NCT04815187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5939931|NCT04814927|Copper|copper|mesh-list
5939932|NCT04814927|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
5939933|NCT04814927|Levonorgestrel|levonorgestrel|mesh-list
5939934|NCT04814927|Medroxyprogesterone|medroxyprogesterone|mesh-list
5939935|NCT04814927|Etonogestrel|etonogestrel|mesh-list
5939936|NCT04814927|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5939937|NCT04814927|Contraceptive Agents|contraceptive agents|mesh-ancestor
5939938|NCT04814927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5939939|NCT04814927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939940|NCT04814927|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5939941|NCT04814927|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5939942|NCT04814927|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5939943|NCT04814927|Trace Elements|trace elements|mesh-ancestor
5939944|NCT04814927|Micronutrients|micronutrients|mesh-ancestor
5939945|NCT04814927|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5939946|NCT04814927|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5939947|NCT04814927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5939948|NCT04814927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5939949|NCT04815200|Copper|copper|mesh-list
5939950|NCT04815200|Nickel|nickel|mesh-list
5939951|NCT04815200|Trace Elements|trace elements|mesh-ancestor
5939952|NCT04815200|Micronutrients|micronutrients|mesh-ancestor
5939953|NCT04815200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939954|NCT04814875|Carboplatin|carboplatin|mesh-list
5939955|NCT04814875|Doxorubicin|doxorubicin|mesh-list
5939956|NCT04814875|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5939957|NCT04814875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5939958|NCT04814875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5939959|NCT04814875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5939960|NCT04814875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5939961|NCT04814875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5939962|NCT04814875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5939963|NCT04814537|Bupivacaine|bupivacaine|mesh-list
5939964|NCT04814537|Anesthetics, Local|anesthetics, local|mesh-ancestor
5939965|NCT04814537|Anesthetics|anesthetics|mesh-ancestor
5939966|NCT04814537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5939967|NCT04814537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939968|NCT04814537|Sensory System Agents|sensory system agents|mesh-ancestor
5939969|NCT04814537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5939970|NCT04814719|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
5939971|NCT04814719|Anticoagulants|anticoagulants|mesh-ancestor
5939972|NCT04814615|Daratumumab|daratumumab|mesh-list
5939973|NCT04814615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5939974|NCT04815083|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5939975|NCT04815083|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5939976|NCT04815083|Dermatologic Agents|dermatologic agents|mesh-ancestor
5939977|NCT04814602|Proglumide|proglumide|mesh-list
5939978|NCT04814602|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5939979|NCT04814602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5939980|NCT04814303|Morphine|morphine|mesh-list
5939981|NCT04814303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5939982|NCT04814303|Narcotics|narcotics|mesh-ancestor
5939983|NCT04814303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5939984|NCT04814303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5939985|NCT04814303|Analgesics|analgesics|mesh-ancestor
5939986|NCT04814303|Sensory System Agents|sensory system agents|mesh-ancestor
5939987|NCT04814303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5939988|NCT04814511|Permethrin|permethrin|mesh-list
5939989|NCT04814511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5939990|NCT04814511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5939991|NCT04814485|Paclitaxel|paclitaxel|mesh-list
5939992|NCT04814485|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5939993|NCT04814485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5939994|NCT04814485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5939995|NCT04814485|Tubulin Modulators|tubulin modulators|mesh-ancestor
5939996|NCT04814485|Antimitotic Agents|antimitotic agents|mesh-ancestor
5939997|NCT04814485|Mitosis Modulators|mitosis modulators|mesh-ancestor
5939998|NCT04814485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5939999|NCT04814043|Lenvatinib|lenvatinib|mesh-list
5940000|NCT04814043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
6517272|NCT00720447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517273|NCT00720447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6517274|NCT00720447|Antimetabolites|antimetabolites|mesh-ancestor
6517275|NCT00720447|Antiviral Agents|antiviral agents|mesh-ancestor
6517276|NCT00720447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6517277|NCT00720447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6517278|NCT00720447|Immunologic Factors|immunologic factors|mesh-ancestor
5940001|NCT04814043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5940002|NCT04814043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5940003|NCT04814043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5940004|NCT04814043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940005|NCT04814030|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5940006|NCT04814030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940007|NCT04814030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5967050|NCT04565496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5967051|NCT04565301|Dexamethasone|dexamethasone|mesh-list
5967052|NCT04565301|Neostigmine|neostigmine|mesh-list
5967053|NCT04565301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5967054|NCT04565301|Antiemetics|antiemetics|mesh-ancestor
5967055|NCT04565301|Autonomic Agents|autonomic agents|mesh-ancestor
5967056|NCT04565301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5967057|NCT04565301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967058|NCT04565301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5967059|NCT04565301|Glucocorticoids|glucocorticoids|mesh-ancestor
5967060|NCT04565301|Hormones|hormones|mesh-ancestor
5967061|NCT04565301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5967062|NCT04565301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5967063|NCT04565301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5967064|NCT04565301|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5967065|NCT04565301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5967066|NCT04565301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967067|NCT04565301|Cholinergic Agents|cholinergic agents|mesh-ancestor
6517279|NCT00720447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940008|NCT04814589|Ezetimibe|ezetimibe|mesh-list
5940009|NCT04814589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5940010|NCT04814589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5940011|NCT04814589|Antimetabolites|antimetabolites|mesh-ancestor
5940012|NCT04814589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940013|NCT04814589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5940014|NCT04813913|Bevacizumab|bevacizumab|mesh-list
5940015|NCT04813913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5940016|NCT04813913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5940017|NCT04813913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5940018|NCT04813913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5940019|NCT04813913|Growth Substances|growth substances|mesh-ancestor
5940020|NCT04813913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940021|NCT04813913|Growth Inhibitors|growth inhibitors|mesh-ancestor
5940022|NCT04813952|Sevoflurane|sevoflurane|mesh-list
5940023|NCT04813952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5940024|NCT04813952|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5940025|NCT04813952|Anesthetics, General|anesthetics, general|mesh-ancestor
5940026|NCT04813952|Anesthetics|anesthetics|mesh-ancestor
5940027|NCT04813952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5940028|NCT04813952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940029|NCT04814056|Afatinib|afatinib|mesh-list
5940030|NCT04814056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5940031|NCT04814056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5940032|NCT04814056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5940033|NCT04814056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940034|NCT04814381|Magnesium Sulfate|magnesium sulfate|mesh-list
5940035|NCT04814381|Ketamine|ketamine|mesh-list
5940036|NCT04814381|Analgesics|analgesics|mesh-ancestor
5940037|NCT04814381|Sensory System Agents|sensory system agents|mesh-ancestor
5940038|NCT04814381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5940039|NCT04814381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940040|NCT04814381|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5940041|NCT04814381|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5940042|NCT04814381|Anesthetics, General|anesthetics, general|mesh-ancestor
5940043|NCT04814381|Anesthetics|anesthetics|mesh-ancestor
5940044|NCT04814381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5940045|NCT04814381|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5940046|NCT04814381|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5940047|NCT04814381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5940048|NCT04814381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940049|NCT04814381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5940050|NCT04814381|Anticonvulsants|anticonvulsants|mesh-ancestor
5940051|NCT04814381|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5940052|NCT04814381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5940053|NCT04814381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5940054|NCT04814381|Tocolytic Agents|tocolytic agents|mesh-ancestor
5940055|NCT04814381|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5940056|NCT04813874|Nitrous Oxide|nitrous oxide|mesh-list
5940057|NCT04813874|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5940058|NCT04813874|Anesthetics, General|anesthetics, general|mesh-ancestor
5940059|NCT04813874|Anesthetics|anesthetics|mesh-ancestor
5940060|NCT04813874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5940061|NCT04813874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940062|NCT04813874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5940063|NCT04813874|Analgesics|analgesics|mesh-ancestor
5940064|NCT04813874|Sensory System Agents|sensory system agents|mesh-ancestor
5940065|NCT04813874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5940066|NCT04813848|Fluorides|fluorides|mesh-list
5940067|NCT04813848|Cariostatic Agents|cariostatic agents|mesh-ancestor
5940068|NCT04813848|Protective Agents|protective agents|mesh-ancestor
5940069|NCT04813848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940070|NCT04813822|Miconazole|miconazole|mesh-list
5940071|NCT04813822|Clotrimazole|clotrimazole|mesh-list
5940072|NCT04813822|Bromides|bromides|mesh-list
5940073|NCT04813822|Anticonvulsants|anticonvulsants|mesh-ancestor
5940074|NCT04813822|Antifungal Agents|antifungal agents|mesh-ancestor
5940075|NCT04813822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5940076|NCT04813822|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5940077|NCT04813822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5940078|NCT04813822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5940079|NCT04813822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940080|NCT04813822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5940081|NCT04813822|Hormone Antagonists|hormone antagonists|mesh-ancestor
5967068|NCT04565301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5940082|NCT04813822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5940083|NCT04813822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940084|NCT04813822|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5940085|NCT04813822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5940086|NCT04813822|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5940087|NCT04813614|Lidocaine|lidocaine|mesh-list
5940088|NCT04813614|Anesthetics, Local|anesthetics, local|mesh-ancestor
5940089|NCT04813614|Anesthetics|anesthetics|mesh-ancestor
5940090|NCT04813614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5940091|NCT04813614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940092|NCT04813614|Sensory System Agents|sensory system agents|mesh-ancestor
5940093|NCT04813614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5940094|NCT04813614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5940095|NCT04813614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5940096|NCT04813614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5940097|NCT04813614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5940098|NCT04813614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940099|NCT04813562|Vaccines|vaccines|mesh-list
5940100|NCT04813562|Immunologic Factors|immunologic factors|mesh-ancestor
5940101|NCT04813562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940102|NCT04813523|Cisplatin|cisplatin|mesh-list
5940103|NCT04813523|Pembrolizumab|pembrolizumab|mesh-list
5940104|NCT04813523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5940105|NCT04813523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5940106|NCT04813471|Folic Acid|folic acid|mesh-list
5940107|NCT04813471|Nicorandil|nicorandil|mesh-list
5940108|NCT04813471|Vitamin B Complex|vitamin b complex|mesh-list
5940109|NCT04813471|Atorvastatin|atorvastatin|mesh-list
5940110|NCT04813471|Vitamins|vitamins|mesh-ancestor
5940111|NCT04813471|Micronutrients|micronutrients|mesh-ancestor
5940112|NCT04813471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940113|NCT04813471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5940114|NCT04813471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5940115|NCT04813471|Antimetabolites|antimetabolites|mesh-ancestor
5940116|NCT04813471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940117|NCT04813471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5940118|NCT04813471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5940119|NCT04813471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5940120|NCT04813471|Hematinics|hematinics|mesh-ancestor
5940121|NCT04813471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5940122|NCT04813471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5940123|NCT04813471|Vasodilator Agents|vasodilator agents|mesh-ancestor
5940124|NCT04813653|Cyclosporine|cyclosporine|mesh-list
5940125|NCT04813653|Dexamethasone|dexamethasone|mesh-list
5940126|NCT04813653|Cyclosporins|cyclosporins|mesh-list
5940127|NCT04813653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5940128|NCT04813653|Antiemetics|antiemetics|mesh-ancestor
5940129|NCT04813653|Autonomic Agents|autonomic agents|mesh-ancestor
5940130|NCT04813653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5940131|NCT04813653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940132|NCT04813653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5719959|NCT03215875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5719960|NCT03215875|Diuretics|diuretics|mesh-ancestor
5719961|NCT03215875|Natriuretic Agents|natriuretic agents|mesh-ancestor
5719962|NCT03215875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5719963|NCT03215875|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5719964|NCT03215875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5719965|NCT03215875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719966|NCT03216083|Tranexamic Acid|tranexamic acid|mesh-list
5940133|NCT04813653|Glucocorticoids|glucocorticoids|mesh-ancestor
5940134|NCT04813653|Hormones|hormones|mesh-ancestor
5940135|NCT04813653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5940136|NCT04813653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5940137|NCT04813653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5940138|NCT04813653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5940139|NCT04813653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940140|NCT04813653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5940141|NCT04813653|Immunologic Factors|immunologic factors|mesh-ancestor
5940142|NCT04813653|Antifungal Agents|antifungal agents|mesh-ancestor
5940143|NCT04813653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5940144|NCT04813653|Dermatologic Agents|dermatologic agents|mesh-ancestor
5940145|NCT04813653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5940146|NCT04813653|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5940147|NCT04812912|Hormones|hormones|mesh-list
5940148|NCT04812912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5940149|NCT04812912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940150|NCT04812457|Povidone-Iodine|povidone-iodine|mesh-list
5940151|NCT04812457|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5940152|NCT04812457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5940153|NCT04812470|Melphalan|melphalan|mesh-list
5940154|NCT04812470|Interleukin-2|interleukin-2|mesh-list
5940155|NCT04812470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5940156|NCT04812470|Alkylating Agents|alkylating agents|mesh-ancestor
5940157|NCT04812470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940158|NCT04812470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5940159|NCT04812470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5940160|NCT04812470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5940161|NCT04812470|Immunologic Factors|immunologic factors|mesh-ancestor
5940162|NCT04812470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940163|NCT04812470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5940164|NCT04812470|Analgesics|analgesics|mesh-ancestor
5940165|NCT04812470|Sensory System Agents|sensory system agents|mesh-ancestor
5940166|NCT04812470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5940167|NCT04812860|Tramadol|tramadol|mesh-list
5940168|NCT04812860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5940169|NCT04812860|Narcotics|narcotics|mesh-ancestor
5940170|NCT04812860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5940171|NCT04812860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940172|NCT04812860|Analgesics|analgesics|mesh-ancestor
5940173|NCT04812860|Sensory System Agents|sensory system agents|mesh-ancestor
5940174|NCT04812860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5940175|NCT04812379|Aripiprazole|aripiprazole|mesh-list
5940176|NCT04812379|Antidepressive Agents|antidepressive agents|mesh-ancestor
5940177|NCT04812379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5940178|NCT04812379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5940179|NCT04812379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5940180|NCT04812379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5940181|NCT04812379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940182|NCT04812379|Dopamine Agonists|dopamine agonists|mesh-ancestor
5940183|NCT04812379|Dopamine Agents|dopamine agents|mesh-ancestor
5940184|NCT04812379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5940185|NCT04812379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940186|NCT04812379|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5940187|NCT04812379|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5940188|NCT04812379|Serotonin Agents|serotonin agents|mesh-ancestor
5940189|NCT04812379|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5940190|NCT04812379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5940191|NCT04812379|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5940192|NCT04812379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5940193|NCT04812535|Pembrolizumab|pembrolizumab|mesh-list
5940194|NCT04812535|Vilobelimab|vilobelimab|mesh-list
5940195|NCT04812535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5940196|NCT04812535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5940197|NCT04812535|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5940198|NCT04812535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5940199|NCT04812535|Immunologic Factors|immunologic factors|mesh-ancestor
5940200|NCT04812535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940201|NCT04812509|Denosumab|denosumab|mesh-list
5940202|NCT04812509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5940203|NCT04812509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967069|NCT04565301|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5967070|NCT04565431|Natalizumab|natalizumab|mesh-list
5967071|NCT04565431|Immunologic Factors|immunologic factors|mesh-ancestor
5967072|NCT04565431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967073|NCT04565184|Artesunate|artesunate|mesh-list
5967074|NCT04565184|Lumefantrine|lumefantrine|mesh-list
5967075|NCT04565184|Artemether|artemether|mesh-list
5967076|NCT04565184|Amodiaquine|amodiaquine|mesh-list
5967077|NCT04565184|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
5967078|NCT04565184|Amodiaquine, artesunate drug combination|amodiaquine, artesunate drug combination|mesh-list
5967079|NCT04565184|Antimalarials|antimalarials|mesh-ancestor
5967080|NCT04565184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5967081|NCT04565184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5967082|NCT04565184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5967083|NCT04565184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5967084|NCT04565184|Antiviral Agents|antiviral agents|mesh-ancestor
5967085|NCT04565184|Schistosomicides|schistosomicides|mesh-ancestor
5967086|NCT04565184|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5967087|NCT04565184|Anthelmintics|anthelmintics|mesh-ancestor
5967088|NCT04565171|Yimitasvir|yimitasvir|mesh-list
5940204|NCT04812626|Triamcinolone|triamcinolone|mesh-list
5940205|NCT04812626|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5940206|NCT04812626|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5940207|NCT04812626|Fluorouracil|fluorouracil|mesh-list
5940208|NCT04812626|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5940209|NCT04812626|Antimetabolites|antimetabolites|mesh-ancestor
5940210|NCT04812626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940211|NCT04812626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5940212|NCT04812626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5940213|NCT04812626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5940214|NCT04812626|Immunologic Factors|immunologic factors|mesh-ancestor
5940215|NCT04812626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940216|NCT04812626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5940217|NCT04812626|Glucocorticoids|glucocorticoids|mesh-ancestor
5940218|NCT04812626|Hormones|hormones|mesh-ancestor
5940219|NCT04812626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5940220|NCT04812626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5940221|NCT04812028|Magnesium Sulfate|magnesium sulfate|mesh-list
5940222|NCT04812028|Analgesics|analgesics|mesh-ancestor
5940223|NCT04812028|Sensory System Agents|sensory system agents|mesh-ancestor
5940224|NCT04812028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5940225|NCT04812028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940226|NCT04812028|Anesthetics|anesthetics|mesh-ancestor
5940227|NCT04812028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5940228|NCT04812028|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5940229|NCT04812028|Anticonvulsants|anticonvulsants|mesh-ancestor
5940230|NCT04812028|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5940231|NCT04812028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5940232|NCT04812028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940233|NCT04812028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5940234|NCT04812028|Tocolytic Agents|tocolytic agents|mesh-ancestor
5940235|NCT04812028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5940236|NCT04811573|Thalidomide|thalidomide|mesh-list
5940237|NCT04811573|Apremilast|apremilast|mesh-list
5940238|NCT04811573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5940239|NCT04811573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5940240|NCT04811573|Analgesics|analgesics|mesh-ancestor
5940241|NCT04811573|Sensory System Agents|sensory system agents|mesh-ancestor
5940242|NCT04811573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5940243|NCT04811573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940244|NCT04811573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5940245|NCT04811573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5940246|NCT04811573|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5940247|NCT04811573|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5940248|NCT04811573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5940249|NCT04811573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940250|NCT04811573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5940251|NCT04811573|Immunologic Factors|immunologic factors|mesh-ancestor
5940252|NCT04811573|Leprostatic Agents|leprostatic agents|mesh-ancestor
5940253|NCT04811573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5940254|NCT04811573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5940255|NCT04811573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5940256|NCT04811573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5940257|NCT04811573|Growth Substances|growth substances|mesh-ancestor
5940258|NCT04811573|Growth Inhibitors|growth inhibitors|mesh-ancestor
5940259|NCT04811573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5940260|NCT04811625|Aspirin|aspirin|mesh-list
5940261|NCT04811625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5940262|NCT04811625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5940263|NCT04811625|Analgesics|analgesics|mesh-ancestor
5940264|NCT04811625|Sensory System Agents|sensory system agents|mesh-ancestor
5940265|NCT04811625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5940266|NCT04811625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940267|NCT04811625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5940268|NCT04811625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5940269|NCT04811625|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5940270|NCT04811625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5940271|NCT04811625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940272|NCT04811625|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5940273|NCT04811625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5940274|NCT04811625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5940275|NCT04811625|Antipyretics|antipyretics|mesh-ancestor
5940276|NCT04811911|Methotrexate|methotrexate|mesh-list
5940277|NCT04811911|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5940278|NCT04811911|Abortifacient Agents|abortifacient agents|mesh-ancestor
5940279|NCT04811911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5940280|NCT04811911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940281|NCT04811911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5940282|NCT04811911|Antimetabolites|antimetabolites|mesh-ancestor
5940283|NCT04811911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940284|NCT04811911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5940285|NCT04811911|Dermatologic Agents|dermatologic agents|mesh-ancestor
5940286|NCT04811911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5940287|NCT04811911|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5940288|NCT04811911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5940289|NCT04811911|Immunologic Factors|immunologic factors|mesh-ancestor
5940290|NCT04811911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5940291|NCT04811911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5940292|NCT04811339|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
5940293|NCT04811339|Antidiarrheals|antidiarrheals|mesh-ancestor
5940294|NCT04811339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5940295|NCT04811326|Latanoprost|latanoprost|mesh-list
5940296|NCT04811326|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5940297|NCT04811326|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5940298|NCT04811404|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
5940299|NCT04811404|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5940300|NCT04811404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5940301|NCT04811209|Analgesics|analgesics|mesh-list
5940302|NCT04811209|Anesthetics|anesthetics|mesh-list
5940303|NCT04811209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5940304|NCT04811209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940305|NCT04811209|Sensory System Agents|sensory system agents|mesh-ancestor
5940306|NCT04811209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5940307|NCT04811313|Bupivacaine|bupivacaine|mesh-list
5940308|NCT04811313|Tranexamic Acid|tranexamic acid|mesh-list
5940309|NCT04811313|Anesthetics, Local|anesthetics, local|mesh-ancestor
5940310|NCT04811313|Anesthetics|anesthetics|mesh-ancestor
5940311|NCT04811313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5940312|NCT04811313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940313|NCT04811313|Sensory System Agents|sensory system agents|mesh-ancestor
5940314|NCT04811313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5940315|NCT04811313|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5940316|NCT04811313|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5940317|NCT04811313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940318|NCT04811313|Hemostatics|hemostatics|mesh-ancestor
5940319|NCT04811313|Coagulants|coagulants|mesh-ancestor
5940320|NCT04811014|Buprenorphine|buprenorphine|mesh-list
5940321|NCT04811014|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
5940322|NCT04811014|Naloxone|naloxone|mesh-list
5940323|NCT04811014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5940324|NCT04811014|Narcotics|narcotics|mesh-ancestor
5940325|NCT04811014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5940326|NCT04811014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940327|NCT04811014|Analgesics|analgesics|mesh-ancestor
5940328|NCT04811014|Sensory System Agents|sensory system agents|mesh-ancestor
5940329|NCT04811014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5719967|NCT03216083|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5719968|NCT03216083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5719969|NCT03216083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719970|NCT03216083|Hemostatics|hemostatics|mesh-ancestor
5719971|NCT03216083|Coagulants|coagulants|mesh-ancestor
5719972|NCT03215810|Cyclophosphamide|cyclophosphamide|mesh-list
5719973|NCT03215810|Nivolumab|nivolumab|mesh-list
6517280|NCT00720447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5719974|NCT03215810|Fludarabine|fludarabine|mesh-list
5719975|NCT03215810|Interleukin-2|interleukin-2|mesh-list
5719976|NCT03215810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5940330|NCT04811014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5940331|NCT04811001|Osimertinib|osimertinib|mesh-list
5940332|NCT04811001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5940333|NCT04811001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5940334|NCT04811001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5940335|NCT04811001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967089|NCT04565171|Antiviral Agents|antiviral agents|mesh-ancestor
5967090|NCT04565171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5967091|NCT04565015|Immunoglobulins|immunoglobulins|mesh-list
5719977|NCT03215810|Immunologic Factors|immunologic factors|mesh-ancestor
5719978|NCT03215810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967092|NCT04565015|gamma-Globulins|gamma-globulins|mesh-list
5967093|NCT04565015|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5940336|NCT04810819|Methylprednisolone|methylprednisolone|mesh-list
5940337|NCT04810819|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5940338|NCT04810819|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5940339|NCT04810819|Prednisolone|prednisolone|mesh-list
5940340|NCT04810819|Prednisolone acetate|prednisolone acetate|mesh-list
5940341|NCT04810819|Dyphylline|dyphylline|mesh-list
5940342|NCT04810819|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5940343|NCT04810819|Prednisolone phosphate|prednisolone phosphate|mesh-list
5940344|NCT04810819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5940345|NCT04810819|Antiemetics|antiemetics|mesh-ancestor
5940346|NCT04810819|Autonomic Agents|autonomic agents|mesh-ancestor
5940347|NCT04810819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5940348|NCT04810819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940349|NCT04810819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6681250|NCT01608750|Vitamin B Complex|vitamin b complex|mesh-ancestor
6681251|NCT01608750|Vitamins|vitamins|mesh-ancestor
6681252|NCT01608750|Micronutrients|micronutrients|mesh-ancestor
6681253|NCT01608750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681254|NCT01608841|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6681255|NCT01608841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6681256|NCT01608841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6681257|NCT01608841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6681258|NCT01608841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681259|NCT01608854|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6681260|NCT01608854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6681261|NCT01608880|Nitroglycerin|nitroglycerin|mesh-list
5940350|NCT04810819|Glucocorticoids|glucocorticoids|mesh-ancestor
5940351|NCT04810819|Hormones|hormones|mesh-ancestor
5940352|NCT04810819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5940353|NCT04810819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5940354|NCT04810819|Protective Agents|protective agents|mesh-ancestor
5940355|NCT04810819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5940356|NCT04810819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5940357|NCT04810819|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5940358|NCT04810819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5940359|NCT04810819|Respiratory System Agents|respiratory system agents|mesh-ancestor
5940360|NCT04810819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5940361|NCT04810819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5940362|NCT04810819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940363|NCT04810819|Vasodilator Agents|vasodilator agents|mesh-ancestor
5940364|NCT04810754|Daratumumab|daratumumab|mesh-list
5940365|NCT04810754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6517281|NCT00720447|Alkylating Agents|alkylating agents|mesh-ancestor
6517282|NCT00720447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6517283|NCT00720447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6517284|NCT00720512|Leucovorin|leucovorin|mesh-list
6517285|NCT00720512|Bevacizumab|bevacizumab|mesh-list
6517286|NCT00720512|Fluorouracil|fluorouracil|mesh-list
6517287|NCT00720512|Oxaliplatin|oxaliplatin|mesh-list
6517288|NCT00720512|Irinotecan|irinotecan|mesh-list
6517289|NCT00720512|Calcium|calcium|mesh-list
6517290|NCT00720512|Levoleucovorin|levoleucovorin|mesh-list
6517291|NCT00720512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6681262|NCT01608880|Vasodilator Agents|vasodilator agents|mesh-ancestor
6681263|NCT01608893|Metoprolol|metoprolol|mesh-list
6681264|NCT01608893|Carvedilol|carvedilol|mesh-list
6681265|NCT01608893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6681266|NCT01608893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6681267|NCT01608893|Sympatholytics|sympatholytics|mesh-ancestor
6681268|NCT01608893|Autonomic Agents|autonomic agents|mesh-ancestor
5940366|NCT04810507|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5940367|NCT04810507|Anagliptin|anagliptin|mesh-list
5940368|NCT04810507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5940369|NCT04810507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940370|NCT04810507|Incretins|incretins|mesh-ancestor
5940371|NCT04810507|Hormones|hormones|mesh-ancestor
5940372|NCT04810507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5940373|NCT04810507|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5940374|NCT04810507|Protease Inhibitors|protease inhibitors|mesh-ancestor
5940375|NCT04810507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5940376|NCT04810507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940377|NCT04810572|Silymarin|silymarin|mesh-list
5940378|NCT04810572|Antioxidants|antioxidants|mesh-ancestor
5940379|NCT04810572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517292|NCT00720512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6517293|NCT00720512|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6681269|NCT01608893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6681270|NCT01608893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940380|NCT04810572|Protective Agents|protective agents|mesh-ancestor
5940381|NCT04810572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940382|NCT04810585|Aflibercept|aflibercept|mesh-list
5940383|NCT04810585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5940384|NCT04810585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5940385|NCT04810585|Growth Substances|growth substances|mesh-ancestor
5940386|NCT04810585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940387|NCT04810585|Growth Inhibitors|growth inhibitors|mesh-ancestor
5940388|NCT04810585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5940389|NCT04809818|Aspirin|aspirin|mesh-list
5940390|NCT04809818|Dabigatran|dabigatran|mesh-list
5940391|NCT04809818|Apixaban|apixaban|mesh-list
5940392|NCT04809818|Clopidogrel|clopidogrel|mesh-list
5940393|NCT04809818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5940394|NCT04809818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5940395|NCT04809818|Analgesics|analgesics|mesh-ancestor
5940396|NCT04809818|Sensory System Agents|sensory system agents|mesh-ancestor
5940397|NCT04809818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5940398|NCT04809818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940399|NCT04809818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5940400|NCT04809818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5940401|NCT04809818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5940402|NCT04809818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5940403|NCT04809818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940404|NCT04809818|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5940405|NCT04809818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5940406|NCT04809818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5940407|NCT04809818|Antipyretics|antipyretics|mesh-ancestor
5940408|NCT04809818|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5940409|NCT04809818|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5940410|NCT04809818|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5940411|NCT04809818|Purinergic Agents|purinergic agents|mesh-ancestor
5940412|NCT04809818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5940413|NCT04809818|Antithrombins|antithrombins|mesh-ancestor
5940414|NCT04809818|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5940415|NCT04809818|Protease Inhibitors|protease inhibitors|mesh-ancestor
5940416|NCT04809818|Anticoagulants|anticoagulants|mesh-ancestor
5940417|NCT04809818|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5940418|NCT04810156|Mycophenolic Acid|mycophenolic acid|mesh-list
5940419|NCT04810156|Methylprednisolone|methylprednisolone|mesh-list
5940420|NCT04810156|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5940421|NCT04810156|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5940422|NCT04810156|Prednisolone|prednisolone|mesh-list
5940423|NCT04810156|Prednisolone acetate|prednisolone acetate|mesh-list
5940424|NCT04810156|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
5940425|NCT04810156|Tacrolimus|tacrolimus|mesh-list
5940426|NCT04810156|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5940427|NCT04810156|Prednisolone phosphate|prednisolone phosphate|mesh-list
5940428|NCT04810156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5940429|NCT04810156|Immunologic Factors|immunologic factors|mesh-ancestor
5940430|NCT04810156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940431|NCT04810156|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5940432|NCT04810156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5940433|NCT04810156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940434|NCT04810156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5940435|NCT04810156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5940436|NCT04810156|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5940437|NCT04810156|Antitubercular Agents|antitubercular agents|mesh-ancestor
5940438|NCT04810156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5940439|NCT04810156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5940440|NCT04810156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5940441|NCT04810156|Antiemetics|antiemetics|mesh-ancestor
5940442|NCT04810156|Autonomic Agents|autonomic agents|mesh-ancestor
5940443|NCT04810156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5940444|NCT04810156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5940445|NCT04810156|Glucocorticoids|glucocorticoids|mesh-ancestor
5940446|NCT04810156|Hormones|hormones|mesh-ancestor
5940447|NCT04810156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5940448|NCT04810156|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5940449|NCT04810156|Protective Agents|protective agents|mesh-ancestor
5940450|NCT04810156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5940451|NCT04810156|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5940452|NCT04809974|Niacinamide|niacinamide|mesh-list
5940453|NCT04809974|Vitamins|vitamins|mesh-ancestor
5940454|NCT04809974|Micronutrients|micronutrients|mesh-ancestor
5940455|NCT04809974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940456|NCT04809974|Vitamin B Complex|vitamin b complex|mesh-ancestor
5940457|NCT04809675|Salicylic Acid|salicylic acid|mesh-list
5940458|NCT04809675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5940459|NCT04809675|Antifungal Agents|antifungal agents|mesh-ancestor
5940460|NCT04809675|Keratolytic Agents|keratolytic agents|mesh-ancestor
5940461|NCT04809675|Dermatologic Agents|dermatologic agents|mesh-ancestor
5940462|NCT04809584|Motexafin gadolinium|motexafin gadolinium|mesh-list
5940463|NCT04809584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5940464|NCT04809584|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5940465|NCT04809584|Dermatologic Agents|dermatologic agents|mesh-ancestor
5940466|NCT04809662|Imiquimod|imiquimod|mesh-list
5940467|NCT04809662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5940468|NCT04809662|Immunologic Factors|immunologic factors|mesh-ancestor
5940469|NCT04809662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940470|NCT04809662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5940471|NCT04809662|Interferon Inducers|interferon inducers|mesh-ancestor
5940472|NCT04809649|Itraconazole|itraconazole|mesh-list
5940473|NCT04809649|Antifungal Agents|antifungal agents|mesh-ancestor
5940474|NCT04809649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5940475|NCT04809649|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5940476|NCT04809649|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5940477|NCT04809649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5940478|NCT04809649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940479|NCT04809649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5940480|NCT04809649|Hormone Antagonists|hormone antagonists|mesh-ancestor
5940481|NCT04809649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5940482|NCT04809649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940483|NCT04809649|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5940484|NCT04809532|Tramadol|tramadol|mesh-list
5940485|NCT04809532|Bupivacaine|bupivacaine|mesh-list
5940486|NCT04809532|Anesthetics, Local|anesthetics, local|mesh-ancestor
5940487|NCT04809532|Anesthetics|anesthetics|mesh-ancestor
5940488|NCT04809532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5940489|NCT04809532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940490|NCT04809532|Sensory System Agents|sensory system agents|mesh-ancestor
5940491|NCT04809532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5940492|NCT04809532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5940493|NCT04809532|Narcotics|narcotics|mesh-ancestor
5940494|NCT04809532|Analgesics|analgesics|mesh-ancestor
5940495|NCT04809233|Tipifarnib|tipifarnib|mesh-list
5940496|NCT04809233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5940497|NCT04809116|Pimavanserin|pimavanserin|mesh-list
5940498|NCT04809116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5940499|NCT04809116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5940500|NCT04809116|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5940501|NCT04809116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5940502|NCT04809116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5940503|NCT04809116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940504|NCT04809116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5940505|NCT04809116|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5940506|NCT04809116|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5940507|NCT04809116|Serotonin Agents|serotonin agents|mesh-ancestor
5940508|NCT04809116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5940509|NCT04809116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940510|NCT04809038|Magnesium Sulfate|magnesium sulfate|mesh-list
5940511|NCT04809038|Analgesics|analgesics|mesh-ancestor
5940512|NCT04809038|Sensory System Agents|sensory system agents|mesh-ancestor
5940513|NCT04809038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5940514|NCT04809038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940515|NCT04809038|Anesthetics|anesthetics|mesh-ancestor
5940516|NCT04809038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5940517|NCT04809038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5940518|NCT04809038|Anticonvulsants|anticonvulsants|mesh-ancestor
5940519|NCT04809038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5940520|NCT04809038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5940521|NCT04809038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940522|NCT04809038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5940523|NCT04809038|Tocolytic Agents|tocolytic agents|mesh-ancestor
5940524|NCT04809038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5940525|NCT04808999|Pembrolizumab|pembrolizumab|mesh-list
5940526|NCT04808999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5940527|NCT04808999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5967094|NCT04565015|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5967095|NCT04565015|Immunologic Factors|immunologic factors|mesh-ancestor
5967096|NCT04565015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940528|NCT04809103|Cisplatin|cisplatin|mesh-list
5940529|NCT04809103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5940530|NCT04808882|Tinzaparin|tinzaparin|mesh-list
5940531|NCT04808882|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5940532|NCT04808882|Dalteparin|dalteparin|mesh-list
5940533|NCT04808882|Anticoagulants|anticoagulants|mesh-ancestor
5940534|NCT04808882|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5940535|NCT04808882|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5940536|NCT04808882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940537|NCT04809142|Gemcitabine|gemcitabine|mesh-list
5940538|NCT04809142|Capecitabine|capecitabine|mesh-list
5940539|NCT04809142|Oxaliplatin|oxaliplatin|mesh-list
5940540|NCT04809142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5940541|NCT04809142|Antimetabolites|antimetabolites|mesh-ancestor
5940542|NCT04809142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940543|NCT04809142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5940544|NCT04809142|Antiviral Agents|antiviral agents|mesh-ancestor
5940545|NCT04809142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5940546|NCT04809142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5940547|NCT04809142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5940548|NCT04809142|Immunologic Factors|immunologic factors|mesh-ancestor
5940549|NCT04809142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940550|NCT04808934|Rivaroxaban|rivaroxaban|mesh-list
5940551|NCT04808934|Apixaban|apixaban|mesh-list
5940552|NCT04808934|Dabigatran|dabigatran|mesh-list
5940553|NCT04808934|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5940554|NCT04808934|Antithrombins|antithrombins|mesh-ancestor
5940555|NCT04808934|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5940556|NCT04808934|Protease Inhibitors|protease inhibitors|mesh-ancestor
5940557|NCT04808934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5940558|NCT04808934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940559|NCT04808934|Anticoagulants|anticoagulants|mesh-ancestor
5940560|NCT04809181|Azacitidine|azacitidine|mesh-list
5940561|NCT04809181|Venetoclax|venetoclax|mesh-list
5940562|NCT04809181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5940563|NCT04809181|Antimetabolites|antimetabolites|mesh-ancestor
5940564|NCT04809181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940565|NCT04809181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5940566|NCT04809181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5940567|NCT04808739|Adalimumab|adalimumab|mesh-list
5940568|NCT04808739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5940569|NCT04808739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5940570|NCT04808856|Methylprednisolone|methylprednisolone|mesh-list
5940571|NCT04808856|Hormones|hormones|mesh-list
5940572|NCT04808856|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
5940573|NCT04808856|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
5940574|NCT04808856|beta-Endorphin|beta-endorphin|mesh-list
5940575|NCT04808856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5940576|NCT04808856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517294|NCT00720512|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6517295|NCT00720512|Growth Substances|growth substances|mesh-ancestor
6517296|NCT00720512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517297|NCT00720512|Growth Inhibitors|growth inhibitors|mesh-ancestor
5940577|NCT04808856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5940578|NCT04808856|Antiemetics|antiemetics|mesh-ancestor
5940579|NCT04808856|Autonomic Agents|autonomic agents|mesh-ancestor
5940580|NCT04808856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5940581|NCT04808856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5940582|NCT04808856|Glucocorticoids|glucocorticoids|mesh-ancestor
5940583|NCT04808856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5940584|NCT04808856|Protective Agents|protective agents|mesh-ancestor
5940585|NCT04808856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5940586|NCT04808856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940587|NCT04808648|Itraconazole|itraconazole|mesh-list
5940588|NCT04808648|Rifampin|rifampin|mesh-list
5940589|NCT04808648|Antifungal Agents|antifungal agents|mesh-ancestor
5940590|NCT04808648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5940591|NCT04808648|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5940592|NCT04808648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5940593|NCT04808648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5940594|NCT04808648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940595|NCT04808648|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5940596|NCT04808648|Hormone Antagonists|hormone antagonists|mesh-ancestor
5940597|NCT04808648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5940598|NCT04808648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967097|NCT04564872|Linagliptin|linagliptin|mesh-list
5940599|NCT04808648|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5940600|NCT04808648|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5940601|NCT04808648|Antitubercular Agents|antitubercular agents|mesh-ancestor
5940602|NCT04808648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5940603|NCT04808648|Leprostatic Agents|leprostatic agents|mesh-ancestor
5940604|NCT04808648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5940605|NCT04808648|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5940606|NCT04808648|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5940607|NCT04808648|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5940608|NCT04808648|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5940609|NCT04808648|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5940610|NCT04808648|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5940611|NCT04808895|Aspirin|aspirin|mesh-list
5940612|NCT04808895|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5940613|NCT04808895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5940614|NCT04808895|Analgesics|analgesics|mesh-ancestor
5940615|NCT04808895|Sensory System Agents|sensory system agents|mesh-ancestor
5940616|NCT04808895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5940617|NCT04808895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940618|NCT04808895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5940619|NCT04808895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5940620|NCT04808895|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5940621|NCT04808895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5940622|NCT04808895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940623|NCT04808895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5940624|NCT04808895|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5940625|NCT04808895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5940626|NCT04808895|Antipyretics|antipyretics|mesh-ancestor
5940627|NCT04808791|Trifluridine|trifluridine|mesh-list
5940628|NCT04808791|Oxaliplatin|oxaliplatin|mesh-list
5940629|NCT04808791|Irinotecan|irinotecan|mesh-list
5940630|NCT04808791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5940631|NCT04808791|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5940632|NCT04808791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5940633|NCT04808791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5940634|NCT04808791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940635|NCT04808791|Antimetabolites|antimetabolites|mesh-ancestor
5940636|NCT04808791|Antiviral Agents|antiviral agents|mesh-ancestor
5940637|NCT04808791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5940638|NCT04808687|Paclitaxel|paclitaxel|mesh-list
5940639|NCT04808687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5940640|NCT04808687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5940641|NCT04808687|Tubulin Modulators|tubulin modulators|mesh-ancestor
5940642|NCT04808687|Antimitotic Agents|antimitotic agents|mesh-ancestor
5940643|NCT04808687|Mitosis Modulators|mitosis modulators|mesh-ancestor
5940644|NCT04808687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940645|NCT04808531|Oxycodone|oxycodone|mesh-list
5940646|NCT04808531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5940647|NCT04808531|Narcotics|narcotics|mesh-ancestor
5940648|NCT04808531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5940649|NCT04808531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940650|NCT04808531|Analgesics|analgesics|mesh-ancestor
5940651|NCT04808531|Sensory System Agents|sensory system agents|mesh-ancestor
5940652|NCT04808531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5940653|NCT04808622|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
5940654|NCT04808622|Antioxidants|antioxidants|mesh-ancestor
5940655|NCT04808622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940656|NCT04808622|Protective Agents|protective agents|mesh-ancestor
5940657|NCT04808622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940658|NCT04808622|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5940659|NCT04808622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5940660|NCT04808778|Hydroxyurea|hydroxyurea|mesh-list
5940661|NCT04808778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5940662|NCT04808778|Antisickling Agents|antisickling agents|mesh-ancestor
5940663|NCT04808778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5940664|NCT04808778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940665|NCT04808778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5940666|NCT04808323|Capecitabine|capecitabine|mesh-list
5940667|NCT04808323|Oxaliplatin|oxaliplatin|mesh-list
5940668|NCT04808323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5940669|NCT04808323|Antimetabolites|antimetabolites|mesh-ancestor
5940670|NCT04808323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940671|NCT04808323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5940672|NCT04807816|Gemcitabine|gemcitabine|mesh-list
5940673|NCT04807816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5940674|NCT04807816|Antimetabolites|antimetabolites|mesh-ancestor
5940675|NCT04807816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940676|NCT04807816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5940677|NCT04807816|Antiviral Agents|antiviral agents|mesh-ancestor
5940678|NCT04807816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5940679|NCT04807816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5940680|NCT04807816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5940681|NCT04807816|Immunologic Factors|immunologic factors|mesh-ancestor
5940682|NCT04807816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940683|NCT04807829|Nabilone|nabilone|mesh-list
5940684|NCT04807829|Antiemetics|antiemetics|mesh-ancestor
5940685|NCT04807829|Autonomic Agents|autonomic agents|mesh-ancestor
5940686|NCT04807829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5940687|NCT04807829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940688|NCT04807829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5940689|NCT04807829|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5940690|NCT04807829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5940691|NCT04807829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5940692|NCT04807829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5940693|NCT04807894|Testosterone|testosterone|mesh-list
5940694|NCT04807894|Androgens|androgens|mesh-ancestor
5940695|NCT04807894|Hormones|hormones|mesh-ancestor
5940696|NCT04807894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5940697|NCT04807894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940698|NCT04807569|Tamsulosin|tamsulosin|mesh-list
5940699|NCT04807569|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5940700|NCT04807569|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5940701|NCT04807569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5940702|NCT04807569|Adrenergic Agents|adrenergic agents|mesh-ancestor
5940703|NCT04807569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5940704|NCT04807569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940705|NCT04807569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940706|NCT04807569|Urological Agents|urological agents|mesh-ancestor
5940707|NCT04807634|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
5940708|NCT04807634|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
5940709|NCT04807634|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5940710|NCT04807634|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5940711|NCT04807504|Ropivacaine|ropivacaine|mesh-list
5940712|NCT04807504|Anesthetics, Local|anesthetics, local|mesh-ancestor
5940713|NCT04807504|Anesthetics|anesthetics|mesh-ancestor
5940714|NCT04807504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5940715|NCT04807504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940716|NCT04807504|Sensory System Agents|sensory system agents|mesh-ancestor
5940717|NCT04807504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5940718|NCT04807413|Nitric Oxide|nitric oxide|mesh-list
5940719|NCT04807413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5940720|NCT04807413|Autonomic Agents|autonomic agents|mesh-ancestor
5940721|NCT04807413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5940722|NCT04807413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940723|NCT04807413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5940724|NCT04807413|Respiratory System Agents|respiratory system agents|mesh-ancestor
5940725|NCT04807413|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5940726|NCT04807413|Antioxidants|antioxidants|mesh-ancestor
5940727|NCT04807413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940728|NCT04807413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5940729|NCT04807413|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5940730|NCT04807413|Vasodilator Agents|vasodilator agents|mesh-ancestor
5940731|NCT04807413|Gasotransmitters|gasotransmitters|mesh-ancestor
5940732|NCT04807413|Protective Agents|protective agents|mesh-ancestor
5940733|NCT04807673|Paclitaxel|paclitaxel|mesh-list
5940734|NCT04807673|Pembrolizumab|pembrolizumab|mesh-list
5940735|NCT04807673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5940736|NCT04807673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5940737|NCT04807673|Tubulin Modulators|tubulin modulators|mesh-ancestor
5940738|NCT04807673|Antimitotic Agents|antimitotic agents|mesh-ancestor
5940739|NCT04807673|Mitosis Modulators|mitosis modulators|mesh-ancestor
5940740|NCT04807673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940741|NCT04807673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5940742|NCT04807517|Buspirone|buspirone|mesh-list
5940743|NCT04807517|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5940744|NCT04807517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5940745|NCT04807517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5940746|NCT04807517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940747|NCT04807517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5940748|NCT04807517|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5940749|NCT04807517|Serotonin Agents|serotonin agents|mesh-ancestor
5940750|NCT04807517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5940751|NCT04807517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940752|NCT04807543|Castor Oil|castor oil|mesh-list
5940753|NCT04807543|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
5940754|NCT04807543|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
5940755|NCT04807543|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5940756|NCT04807543|Hormone Antagonists|hormone antagonists|mesh-ancestor
5940757|NCT04807543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5940758|NCT04807543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940759|NCT04807543|Progestins|progestins|mesh-ancestor
5940760|NCT04807543|Hormones|hormones|mesh-ancestor
5940761|NCT04807543|Cathartics|cathartics|mesh-ancestor
5940762|NCT04807543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5940763|NCT04807348|Metformin|metformin|mesh-list
5940764|NCT04807348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5940765|NCT04807348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940766|NCT04807140|Paclitaxel|paclitaxel|mesh-list
5940767|NCT04807140|Carboplatin|carboplatin|mesh-list
5940768|NCT04807140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5940769|NCT04807140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5940770|NCT04807140|Tubulin Modulators|tubulin modulators|mesh-ancestor
5940771|NCT04807140|Antimitotic Agents|antimitotic agents|mesh-ancestor
5940772|NCT04807140|Mitosis Modulators|mitosis modulators|mesh-ancestor
5940773|NCT04807140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967098|NCT04564872|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5967099|NCT04564872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967100|NCT04564872|Incretins|incretins|mesh-ancestor
5967101|NCT04564872|Hormones|hormones|mesh-ancestor
5967102|NCT04564872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5967103|NCT04564872|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5967104|NCT04564872|Protease Inhibitors|protease inhibitors|mesh-ancestor
5967105|NCT04564872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5967106|NCT04564872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967107|NCT04564638|Cyclosporine|cyclosporine|mesh-list
5967108|NCT04564638|Cyclosporins|cyclosporins|mesh-list
5967109|NCT04564638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5967110|NCT04564638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967111|NCT04564638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5967112|NCT04564638|Immunologic Factors|immunologic factors|mesh-ancestor
5967113|NCT04564638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967114|NCT04564638|Antifungal Agents|antifungal agents|mesh-ancestor
5967115|NCT04564638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5967116|NCT04564638|Dermatologic Agents|dermatologic agents|mesh-ancestor
5967117|NCT04564638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5967118|NCT04564638|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5967119|NCT04564521|Nitroglycerin|nitroglycerin|mesh-list
5967120|NCT04564521|Vasodilator Agents|vasodilator agents|mesh-ancestor
5967121|NCT04564326|Fentanyl|fentanyl|mesh-list
5967122|NCT04564326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5967123|NCT04564326|Narcotics|narcotics|mesh-ancestor
5967124|NCT04564326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5967125|NCT04564326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967126|NCT04564326|Analgesics|analgesics|mesh-ancestor
5967127|NCT04564326|Sensory System Agents|sensory system agents|mesh-ancestor
5967128|NCT04564326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5967129|NCT04564326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5967130|NCT04564326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5967131|NCT04564326|Anesthetics, General|anesthetics, general|mesh-ancestor
5967132|NCT04564326|Anesthetics|anesthetics|mesh-ancestor
5967133|NCT04564690|Vitamin E|vitamin e|mesh-list
5967134|NCT04564690|Selenium|selenium|mesh-list
5967135|NCT04564690|Vitamins|vitamins|mesh-ancestor
5967136|NCT04564690|Micronutrients|micronutrients|mesh-ancestor
5967137|NCT04564690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967138|NCT04564690|Antioxidants|antioxidants|mesh-ancestor
5967139|NCT04564690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967140|NCT04564690|Protective Agents|protective agents|mesh-ancestor
5967141|NCT04564690|Trace Elements|trace elements|mesh-ancestor
5967142|NCT04564469|Furosemide|furosemide|mesh-list
5967143|NCT04564469|Diuretics|diuretics|mesh-ancestor
5967144|NCT04564469|Natriuretic Agents|natriuretic agents|mesh-ancestor
5967145|NCT04564469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967146|NCT04564469|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5967147|NCT04564469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5940774|NCT04807309|Danazol|danazol|mesh-list
5940775|NCT04807309|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5940776|NCT04807309|Hormone Antagonists|hormone antagonists|mesh-ancestor
5940777|NCT04807309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5940778|NCT04807309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940779|NCT04807166|Paclitaxel|paclitaxel|mesh-list
5940780|NCT04807166|Carboplatin|carboplatin|mesh-list
5940781|NCT04807166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5940782|NCT04807166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5940783|NCT04807166|Tubulin Modulators|tubulin modulators|mesh-ancestor
5940784|NCT04807166|Antimitotic Agents|antimitotic agents|mesh-ancestor
5940785|NCT04807166|Mitosis Modulators|mitosis modulators|mesh-ancestor
5940786|NCT04807166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940787|NCT04807335|Sufentanil|sufentanil|mesh-list
5940788|NCT04807335|Ketamine|ketamine|mesh-list
5940789|NCT04807335|Analgesics|analgesics|mesh-ancestor
5940790|NCT04807335|Sensory System Agents|sensory system agents|mesh-ancestor
5940791|NCT04807335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5940792|NCT04807335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940793|NCT04807335|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5940794|NCT04807335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5940795|NCT04807335|Anesthetics, General|anesthetics, general|mesh-ancestor
5940796|NCT04807335|Anesthetics|anesthetics|mesh-ancestor
5940797|NCT04807335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5940798|NCT04807335|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5940799|NCT04807335|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5940800|NCT04807335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5940801|NCT04807335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940802|NCT04807335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5940803|NCT04807335|Narcotics|narcotics|mesh-ancestor
5940804|NCT04807335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5940805|NCT04807101|Midazolam|midazolam|mesh-list
5940806|NCT04807101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5940807|NCT04807101|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5940808|NCT04807101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5940809|NCT04807101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940810|NCT04807101|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5940811|NCT04807101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5940812|NCT04807101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5940813|NCT04807101|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5940814|NCT04807101|Anesthetics, General|anesthetics, general|mesh-ancestor
5940815|NCT04807101|Anesthetics|anesthetics|mesh-ancestor
5940816|NCT04807101|GABA Modulators|gaba modulators|mesh-ancestor
5940817|NCT04807101|GABA Agents|gaba agents|mesh-ancestor
5940818|NCT04807101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5940819|NCT04807101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940820|NCT04807127|Pembrolizumab|pembrolizumab|mesh-list
5940821|NCT04807127|Durvalumab|durvalumab|mesh-list
5940822|NCT04807127|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5940823|NCT04807127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5940824|NCT04807127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5940825|NCT04807127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940826|NCT04806945|Paclitaxel|paclitaxel|mesh-list
5940827|NCT04806945|Carboplatin|carboplatin|mesh-list
5940828|NCT04806945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5940829|NCT04806945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5940830|NCT04806945|Tubulin Modulators|tubulin modulators|mesh-ancestor
5940831|NCT04806945|Antimitotic Agents|antimitotic agents|mesh-ancestor
5940832|NCT04806945|Mitosis Modulators|mitosis modulators|mesh-ancestor
5940833|NCT04806945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940834|NCT04807114|Pembrolizumab|pembrolizumab|mesh-list
5940835|NCT04807114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5940836|NCT04807114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5940837|NCT04807114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5940838|NCT04807114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940839|NCT04806737|Teriflunomide|teriflunomide|mesh-list
5940840|NCT04806737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5940841|NCT04806737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5940842|NCT04806737|Analgesics|analgesics|mesh-ancestor
5940843|NCT04806737|Sensory System Agents|sensory system agents|mesh-ancestor
5940844|NCT04806737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5940845|NCT04806737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940846|NCT04806737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5940847|NCT04806737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5940848|NCT04806737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5940849|NCT04806737|Immunologic Factors|immunologic factors|mesh-ancestor
5940850|NCT04806633|Dapagliflozin|dapagliflozin|mesh-list
5940851|NCT04806633|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5940852|NCT04806633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940853|NCT04806633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5940854|NCT04806633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940855|NCT04806906|Azacitidine|azacitidine|mesh-list
5940856|NCT04806906|Cc-486|cc-486|mesh-list
5940857|NCT04806906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5940858|NCT04806906|Antimetabolites|antimetabolites|mesh-ancestor
5940859|NCT04806906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940860|NCT04806906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5940861|NCT04806906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5940862|NCT04806386|Psyllium|psyllium|mesh-list
5940863|NCT04806386|Cathartics|cathartics|mesh-ancestor
5940864|NCT04806386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5940865|NCT04806425|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
5940866|NCT04806425|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
5940867|NCT04806425|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5940868|NCT04806425|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5940869|NCT04806438|Lidocaine|lidocaine|mesh-list
5940870|NCT04806438|Anesthetics, Local|anesthetics, local|mesh-ancestor
5940871|NCT04806438|Anesthetics|anesthetics|mesh-ancestor
5940872|NCT04806438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5940873|NCT04806438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940874|NCT04806438|Sensory System Agents|sensory system agents|mesh-ancestor
5940875|NCT04806438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5940876|NCT04806438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5940877|NCT04806438|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5940878|NCT04806438|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5940879|NCT04806438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5940880|NCT04806438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940881|NCT04806230|Mirtazapine|mirtazapine|mesh-list
5940882|NCT04806230|Citalopram|citalopram|mesh-list
5940883|NCT04806230|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
5940884|NCT04806230|Sertraline|sertraline|mesh-list
5940885|NCT04806230|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5940886|NCT04806230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5940887|NCT04806230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5940888|NCT04806230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940889|NCT04806230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5940890|NCT04806230|Serotonin Agents|serotonin agents|mesh-ancestor
5940891|NCT04806230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940892|NCT04806230|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5940893|NCT04806230|Antidepressive Agents|antidepressive agents|mesh-ancestor
5940894|NCT04806230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5940895|NCT04806230|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5940896|NCT04806230|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5940897|NCT04806230|Histamine Antagonists|histamine antagonists|mesh-ancestor
5940898|NCT04806230|Histamine Agents|histamine agents|mesh-ancestor
5940899|NCT04806230|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5940900|NCT04806230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5940901|NCT04806230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5940902|NCT04806230|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5940903|NCT04806230|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5940904|NCT04806230|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5940905|NCT04806230|Adrenergic Agents|adrenergic agents|mesh-ancestor
5940906|NCT04806230|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5940907|NCT04806230|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5940908|NCT04806230|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5940909|NCT04806373|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5940910|NCT04806373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5940911|NCT04806373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5940912|NCT04806373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940913|NCT04806178|BCG Vaccine|bcg vaccine|mesh-list
5940914|NCT04806178|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5940915|NCT04806178|Immunologic Factors|immunologic factors|mesh-ancestor
5940916|NCT04806178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940917|NCT04805775|Propofol|propofol|mesh-list
5940918|NCT04805775|Desflurane|desflurane|mesh-list
5940919|NCT04805775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5940920|NCT04805775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5940921|NCT04805775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940922|NCT04805775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5940923|NCT04805775|Anesthetics, General|anesthetics, general|mesh-ancestor
5940924|NCT04805775|Anesthetics|anesthetics|mesh-ancestor
5940925|NCT04805775|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5940926|NCT04805801|Antibodies, Bispecific|antibodies, bispecific|mesh-list
5940927|NCT04805801|Immunologic Factors|immunologic factors|mesh-ancestor
5940928|NCT04805801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940929|NCT04805957|Sulforaphane|sulforaphane|mesh-list
5940930|NCT04805957|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5940931|NCT04805957|Protective Agents|protective agents|mesh-ancestor
5940932|NCT04805957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940933|NCT04805957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5940934|NCT04805944|Dolutegravir|dolutegravir|mesh-list
5940935|NCT04805944|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5940936|NCT04805944|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5940937|NCT04805944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5940938|NCT04805944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940939|NCT04805944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5940940|NCT04805944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5940941|NCT04805944|Antiviral Agents|antiviral agents|mesh-ancestor
5940942|NCT04805944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5940943|NCT04805827|Gabapentin|gabapentin|mesh-list
5940944|NCT04805827|Analgesics|analgesics|mesh-ancestor
5940945|NCT04805827|Sensory System Agents|sensory system agents|mesh-ancestor
5940946|NCT04805827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5940947|NCT04805827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940948|NCT04805827|Anticonvulsants|anticonvulsants|mesh-ancestor
5940949|NCT04805827|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5940950|NCT04805827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5940951|NCT04805827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5940952|NCT04805827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5940953|NCT04805827|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5940954|NCT04805827|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5940955|NCT04805827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5940956|NCT04805827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940957|NCT04805827|Antimanic Agents|antimanic agents|mesh-ancestor
5940958|NCT04805710|Rivaroxaban|rivaroxaban|mesh-list
5940959|NCT04805710|Clopidogrel|clopidogrel|mesh-list
5940960|NCT04805710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5940961|NCT04805710|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5940962|NCT04805710|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5940963|NCT04805710|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5940964|NCT04805710|Purinergic Agents|purinergic agents|mesh-ancestor
5940965|NCT04805710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5940966|NCT04805710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940967|NCT04805710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940968|NCT04805710|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5940969|NCT04805710|Antithrombins|antithrombins|mesh-ancestor
5940970|NCT04805710|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5940971|NCT04805710|Protease Inhibitors|protease inhibitors|mesh-ancestor
5940972|NCT04805710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5940973|NCT04805710|Anticoagulants|anticoagulants|mesh-ancestor
5967148|NCT04564469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970971|NCT04531332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5970972|NCT04531332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5970973|NCT04531332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5970974|NCT04531332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970975|NCT04530877|Infliximab|infliximab|mesh-list
5970976|NCT04530877|Dermatologic Agents|dermatologic agents|mesh-ancestor
5970977|NCT04530877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5970978|NCT04530877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5970979|NCT04531163|Acetylcysteine|acetylcysteine|mesh-list
5970980|NCT04531163|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5970981|NCT04531163|Antiviral Agents|antiviral agents|mesh-ancestor
5970982|NCT04531163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5970983|NCT04531163|Expectorants|expectorants|mesh-ancestor
5970984|NCT04531163|Respiratory System Agents|respiratory system agents|mesh-ancestor
5970985|NCT04531163|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5970986|NCT04531163|Antioxidants|antioxidants|mesh-ancestor
5970987|NCT04531163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970988|NCT04531163|Protective Agents|protective agents|mesh-ancestor
5970989|NCT04531163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970990|NCT04531163|Antidotes|antidotes|mesh-ancestor
5970991|NCT04531072|Ritonavir|ritonavir|mesh-list
5940974|NCT04805515|Nicotine|nicotine|mesh-list
5940975|NCT04805515|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5940976|NCT04805515|Autonomic Agents|autonomic agents|mesh-ancestor
5940977|NCT04805515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5940978|NCT04805515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940979|NCT04805515|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5940980|NCT04805515|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5940981|NCT04805515|Cholinergic Agents|cholinergic agents|mesh-ancestor
5940982|NCT04805515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5940983|NCT04805515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940984|NCT04805580|Anesthetics|anesthetics|mesh-list
5940985|NCT04805580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5940986|NCT04805580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940987|NCT04805229|Analgesics, Opioid|analgesics, opioid|mesh-list
5940988|NCT04805229|Narcotics|narcotics|mesh-ancestor
5940989|NCT04805229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5940990|NCT04805229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5940991|NCT04805229|Analgesics|analgesics|mesh-ancestor
5940992|NCT04805229|Sensory System Agents|sensory system agents|mesh-ancestor
5940993|NCT04805229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5940994|NCT04805268|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5940995|NCT04805268|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5940996|NCT04805268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5940997|NCT04805281|Lithium Carbonate|lithium carbonate|mesh-list
5940998|NCT04805281|Antidepressive Agents|antidepressive agents|mesh-ancestor
5940999|NCT04805281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5941000|NCT04805281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5941001|NCT04805281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941002|NCT04805281|Antimanic Agents|antimanic agents|mesh-ancestor
5941003|NCT04805281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5941004|NCT04805281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5941005|NCT04805281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941006|NCT04805073|Promethazine|promethazine|mesh-list
5941007|NCT04805073|Diphenhydramine|diphenhydramine|mesh-list
5941008|NCT04805073|Antipruritics|antipruritics|mesh-ancestor
5941009|NCT04805073|Dermatologic Agents|dermatologic agents|mesh-ancestor
5941010|NCT04805073|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5941011|NCT04805073|Histamine Antagonists|histamine antagonists|mesh-ancestor
5941012|NCT04805073|Histamine Agents|histamine agents|mesh-ancestor
5941013|NCT04805073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5941014|NCT04805073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941015|NCT04805073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941016|NCT04805073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5941017|NCT04805073|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5941018|NCT04805073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5941019|NCT04805073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5941020|NCT04805073|Anesthetics, Local|anesthetics, local|mesh-ancestor
5941021|NCT04805073|Anesthetics|anesthetics|mesh-ancestor
5941022|NCT04805073|Sensory System Agents|sensory system agents|mesh-ancestor
5941023|NCT04805073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5941024|NCT04805073|Antiemetics|antiemetics|mesh-ancestor
5941025|NCT04805073|Autonomic Agents|autonomic agents|mesh-ancestor
5941026|NCT04805073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5941027|NCT04805034|Antiviral Agents|antiviral agents|mesh-list
5941028|NCT04805034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5941029|NCT04804696|Paclitaxel|paclitaxel|mesh-list
5941030|NCT04804696|Cisplatin|cisplatin|mesh-list
5941031|NCT04804696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5941032|NCT04804696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5941033|NCT04804696|Tubulin Modulators|tubulin modulators|mesh-ancestor
5941034|NCT04804696|Antimitotic Agents|antimitotic agents|mesh-ancestor
5941035|NCT04804696|Mitosis Modulators|mitosis modulators|mesh-ancestor
5941036|NCT04804696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941037|NCT04804423|Listerine|listerine|mesh-list
5941038|NCT04804423|Fluorides|fluorides|mesh-list
5941039|NCT04804423|Sodium Fluoride|sodium fluoride|mesh-list
5941040|NCT04804423|Fluorides, Topical|fluorides, topical|mesh-list
5941041|NCT04804423|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
5941042|NCT04804423|Cariostatic Agents|cariostatic agents|mesh-ancestor
5941043|NCT04804423|Protective Agents|protective agents|mesh-ancestor
5941044|NCT04804423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941045|NCT04804423|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5941046|NCT04804423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5941047|NCT04804371|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5941048|NCT04804371|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5967149|NCT04564417|Pembrolizumab|pembrolizumab|mesh-list
5941049|NCT04804371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941050|NCT04804072|Analgesics, Opioid|analgesics, opioid|mesh-list
5941051|NCT04804072|Narcotics|narcotics|mesh-ancestor
5941052|NCT04804072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5941053|NCT04804072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941054|NCT04804072|Analgesics|analgesics|mesh-ancestor
5941055|NCT04804072|Sensory System Agents|sensory system agents|mesh-ancestor
5941056|NCT04804072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5941057|NCT04804267|Linaclotide|linaclotide|mesh-list
5941058|NCT04804267|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
5941059|NCT04804267|Enzyme Activators|enzyme activators|mesh-ancestor
5941060|NCT04804267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941061|NCT04804267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5941062|NCT04803539|Capecitabine|capecitabine|mesh-list
5941063|NCT04803539|Apatinib|apatinib|mesh-list
5941064|NCT04803539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5941065|NCT04803539|Antimetabolites|antimetabolites|mesh-ancestor
5941066|NCT04803539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941067|NCT04803539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5941068|NCT04803539|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5941069|NCT04803539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5941070|NCT04803734|Albuterol|albuterol|mesh-list
5941071|NCT04803734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5941072|NCT04803734|Autonomic Agents|autonomic agents|mesh-ancestor
5941073|NCT04803734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5941074|NCT04803734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941075|NCT04803734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5941076|NCT04803734|Respiratory System Agents|respiratory system agents|mesh-ancestor
5941077|NCT04803734|Tocolytic Agents|tocolytic agents|mesh-ancestor
5941078|NCT04803734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5941079|NCT04803734|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5941080|NCT04803734|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5941081|NCT04803734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5941082|NCT04803734|Adrenergic Agents|adrenergic agents|mesh-ancestor
5941083|NCT04803734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5941084|NCT04803734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967150|NCT04564417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5967151|NCT04564417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5967152|NCT04564456|Fluticasone|fluticasone|mesh-list
5967153|NCT04564456|Xhance|xhance|mesh-list
5967154|NCT04564456|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5967155|NCT04564456|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
5967156|NCT04564456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5967157|NCT04564456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5967158|NCT04564456|Autonomic Agents|autonomic agents|mesh-ancestor
5967159|NCT04564456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5967160|NCT04564456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967161|NCT04564456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5967162|NCT04564456|Respiratory System Agents|respiratory system agents|mesh-ancestor
5967163|NCT04564456|Dermatologic Agents|dermatologic agents|mesh-ancestor
5967164|NCT04564456|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5967165|NCT04564456|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5967166|NCT04564456|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5967167|NCT04564456|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5967168|NCT04564456|Adrenergic Agents|adrenergic agents|mesh-ancestor
5967169|NCT04564456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5967170|NCT04564456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967171|NCT04564456|Glucocorticoids|glucocorticoids|mesh-ancestor
5967172|NCT04564456|Hormones|hormones|mesh-ancestor
5967173|NCT04564456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5967174|NCT04564456|Sympathomimetics|sympathomimetics|mesh-ancestor
5967175|NCT04564430|Clonidine|clonidine|mesh-list
5967176|NCT04564430|Analgesics|analgesics|mesh-ancestor
5967177|NCT04564430|Sensory System Agents|sensory system agents|mesh-ancestor
5967178|NCT04564430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5967179|NCT04564430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967180|NCT04564430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5967181|NCT04564430|Sympatholytics|sympatholytics|mesh-ancestor
5967182|NCT04564430|Autonomic Agents|autonomic agents|mesh-ancestor
5967183|NCT04564430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5967184|NCT04564430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5967185|NCT04564430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5967186|NCT04564430|Adrenergic Agents|adrenergic agents|mesh-ancestor
5967187|NCT04564430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5941085|NCT04803747|Tranexamic Acid|tranexamic acid|mesh-list
5941086|NCT04803747|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5941087|NCT04803747|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5941088|NCT04803747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941089|NCT04803747|Hemostatics|hemostatics|mesh-ancestor
5941090|NCT04803747|Coagulants|coagulants|mesh-ancestor
5941091|NCT04803500|Simvastatin|simvastatin|mesh-list
5941092|NCT04803500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5941093|NCT04803500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5941094|NCT04803500|Antimetabolites|antimetabolites|mesh-ancestor
5941095|NCT04803500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941096|NCT04803500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5719979|NCT03215810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5719980|NCT03215810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5719981|NCT03215810|Alkylating Agents|alkylating agents|mesh-ancestor
5719982|NCT03215810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5719983|NCT03215810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5719984|NCT03215810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5719985|NCT03215810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5719986|NCT03215810|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5719987|NCT03215810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5719988|NCT03215810|Analgesics|analgesics|mesh-ancestor
5719989|NCT03215810|Sensory System Agents|sensory system agents|mesh-ancestor
5719990|NCT03215810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5719991|NCT03215797|Phenylephrine|phenylephrine|mesh-list
5719992|NCT03215797|Oxymetazoline|oxymetazoline|mesh-list
5719993|NCT03215797|Norepinephrine|norepinephrine|mesh-list
5941097|NCT04803500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5941098|NCT04803500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5941099|NCT04803318|Everolimus|everolimus|mesh-list
5941100|NCT04803318|Lenvatinib|lenvatinib|mesh-list
5941101|NCT04803318|Trametinib|trametinib|mesh-list
5941102|NCT04803318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5941103|NCT04803318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5941104|NCT04803318|Immunologic Factors|immunologic factors|mesh-ancestor
5941105|NCT04803318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941106|NCT04803318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5941107|NCT04803318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5941108|NCT04803318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941109|NCT04803422|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5941110|NCT04803422|Amoxicillin|amoxicillin|mesh-list
5941111|NCT04803422|Metronidazole|metronidazole|mesh-list
5941112|NCT04803422|Tazobactam|tazobactam|mesh-list
5941113|NCT04803422|Piperacillin|piperacillin|mesh-list
5941114|NCT04803422|Clavulanic Acids|clavulanic acids|mesh-list
5941115|NCT04803422|Clavulanic Acid|clavulanic acid|mesh-list
5941116|NCT04803422|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
5941117|NCT04803422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5941118|NCT04803422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5941119|NCT04803422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5941120|NCT04803422|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5941121|NCT04803422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5941122|NCT04803422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941123|NCT04803162|Omeprazole|omeprazole|mesh-list
5941124|NCT04803162|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5941125|NCT04803162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5941126|NCT04803162|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5941127|NCT04803162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5941128|NCT04803162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941129|NCT04803175|Valsartan|valsartan|mesh-list
5941130|NCT04803175|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5941131|NCT04803175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5941132|NCT04803175|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5941133|NCT04803175|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5941134|NCT04803175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941135|NCT04803084|TEMPO|tempo|mesh-list
5941136|NCT04803084|Antioxidants|antioxidants|mesh-ancestor
5941137|NCT04803084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941138|NCT04803084|Protective Agents|protective agents|mesh-ancestor
5941139|NCT04803084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941140|NCT04803240|Hyaluronic Acid|hyaluronic acid|mesh-list
5941141|NCT04803240|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5719994|NCT03215797|Adrenergic Agonists|adrenergic agonists|mesh-list
5941142|NCT04803240|Immunologic Factors|immunologic factors|mesh-ancestor
5941143|NCT04803240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941144|NCT04803240|Viscosupplements|viscosupplements|mesh-ancestor
5941145|NCT04803240|Protective Agents|protective agents|mesh-ancestor
5941146|NCT04803474|Hormones|hormones|mesh-list
5941147|NCT04803474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5941148|NCT04803474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941149|NCT04803370|Antibodies|antibodies|mesh-list
5941150|NCT04803370|Immunologic Factors|immunologic factors|mesh-ancestor
5941151|NCT04803370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941152|NCT04802616|Broncho-Vaxom|broncho-vaxom|mesh-list
5941153|NCT04802616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5941154|NCT04802616|Immunologic Factors|immunologic factors|mesh-ancestor
5941155|NCT04802616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941156|NCT04802967|Ketoprofen|ketoprofen|mesh-list
5941157|NCT04802967|Ketoprofen lysine|ketoprofen lysine|mesh-list
5941158|NCT04802967|Gabapentin|gabapentin|mesh-list
5941159|NCT04802967|Analgesics|analgesics|mesh-ancestor
5941160|NCT04802967|Sensory System Agents|sensory system agents|mesh-ancestor
5941161|NCT04802967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5941162|NCT04802967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941163|NCT04802967|Anticonvulsants|anticonvulsants|mesh-ancestor
5941164|NCT04802967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5941165|NCT04802967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5941166|NCT04802967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5941167|NCT04802967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5941168|NCT04802967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5941169|NCT04802967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5941170|NCT04802967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5941171|NCT04802967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941172|NCT04802967|Antimanic Agents|antimanic agents|mesh-ancestor
5941173|NCT04802967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5941174|NCT04802967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5941175|NCT04802967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5941176|NCT04802967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5941177|NCT04802967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5941178|NCT04802967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5941179|NCT04802928|Isoniazid|isoniazid|mesh-list
5941180|NCT04802928|Antitubercular Agents|antitubercular agents|mesh-ancestor
5941181|NCT04802928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5941182|NCT04802928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5941183|NCT04802928|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5941184|NCT04802928|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5941185|NCT04802928|Antimetabolites|antimetabolites|mesh-ancestor
5941186|NCT04802928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941187|NCT04802928|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5941188|NCT04802785|Aspirin|aspirin|mesh-list
5941189|NCT04802785|Domperidone|domperidone|mesh-list
5941190|NCT04802785|Melatonin|melatonin|mesh-list
5941191|NCT04802785|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
5941192|NCT04802785|Simethicone|simethicone|mesh-list
5941193|NCT04802785|Magnesium Hydroxide|magnesium hydroxide|mesh-list
5941194|NCT04802785|Citric Acid|citric acid|mesh-list
5941195|NCT04802785|Sodium Citrate|sodium citrate|mesh-list
5941196|NCT04802785|Anticoagulants|anticoagulants|mesh-ancestor
5941197|NCT04802785|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5941198|NCT04802785|Chelating Agents|chelating agents|mesh-ancestor
5941199|NCT04802785|Sequestering Agents|sequestering agents|mesh-ancestor
5941200|NCT04802785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941201|NCT04802785|Antioxidants|antioxidants|mesh-ancestor
5941202|NCT04802785|Protective Agents|protective agents|mesh-ancestor
5941203|NCT04802785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941204|NCT04802785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5941205|NCT04802785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5941206|NCT04802785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5941207|NCT04802785|Analgesics|analgesics|mesh-ancestor
5941208|NCT04802785|Sensory System Agents|sensory system agents|mesh-ancestor
5941209|NCT04802785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5941210|NCT04802785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5941211|NCT04802785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5941212|NCT04802785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5941213|NCT04802785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5941214|NCT04802785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5941215|NCT04802785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5941216|NCT04802785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5941217|NCT04802785|Antipyretics|antipyretics|mesh-ancestor
5941218|NCT04802785|Antiemetics|antiemetics|mesh-ancestor
5941219|NCT04802785|Autonomic Agents|autonomic agents|mesh-ancestor
5941220|NCT04802785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5941221|NCT04802785|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5941222|NCT04802785|Dopamine Agents|dopamine agents|mesh-ancestor
5941223|NCT04802785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5941224|NCT04802785|Antifoaming Agents|antifoaming agents|mesh-ancestor
5941225|NCT04802785|Emollients|emollients|mesh-ancestor
5941226|NCT04802785|Dermatologic Agents|dermatologic agents|mesh-ancestor
5941227|NCT04802785|Nootropic Agents|nootropic agents|mesh-ancestor
5941228|NCT04802785|Antacids|antacids|mesh-ancestor
5941229|NCT04802876|Spartalizumab|spartalizumab|mesh-list
5941230|NCT04802876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5941231|NCT04802876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941232|NCT04802876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5941233|NCT04802980|Gemcitabine|gemcitabine|mesh-list
5941234|NCT04802980|Paclitaxel|paclitaxel|mesh-list
5941235|NCT04802980|Carboplatin|carboplatin|mesh-list
5941236|NCT04802980|Capecitabine|capecitabine|mesh-list
5941237|NCT04802980|Oxaliplatin|oxaliplatin|mesh-list
5941238|NCT04802980|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5941239|NCT04802980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5941240|NCT04802980|Tubulin Modulators|tubulin modulators|mesh-ancestor
5941241|NCT04802980|Antimitotic Agents|antimitotic agents|mesh-ancestor
5941242|NCT04802980|Mitosis Modulators|mitosis modulators|mesh-ancestor
5941243|NCT04802980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941244|NCT04802980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5941245|NCT04802980|Antimetabolites|antimetabolites|mesh-ancestor
6681271|NCT01608893|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6681272|NCT01608893|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6681273|NCT01608893|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6681274|NCT01608893|Adrenergic Agents|adrenergic agents|mesh-ancestor
6681275|NCT01608893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6681276|NCT01608893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941246|NCT04802980|Antiviral Agents|antiviral agents|mesh-ancestor
5941247|NCT04802980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5941248|NCT04802980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5941249|NCT04802980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5941250|NCT04802980|Immunologic Factors|immunologic factors|mesh-ancestor
5941251|NCT04802980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941252|NCT04802382|Fibrin fragment D|fibrin fragment d|mesh-list
5941253|NCT04802382|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5941254|NCT04802382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5941255|NCT04802382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941256|NCT04802382|Hemostatics|hemostatics|mesh-ancestor
5941257|NCT04802382|Coagulants|coagulants|mesh-ancestor
5941258|NCT04802122|Propofol|propofol|mesh-list
5941259|NCT04802122|Sevoflurane|sevoflurane|mesh-list
5941260|NCT04802122|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5941261|NCT04802122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5941262|NCT04802122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941263|NCT04802122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5941264|NCT04802122|Anesthetics, General|anesthetics, general|mesh-ancestor
5941265|NCT04802122|Anesthetics|anesthetics|mesh-ancestor
5941266|NCT04802122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5941267|NCT04802122|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5941268|NCT04802083|Eculizumab|eculizumab|mesh-list
5941269|NCT04802083|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5941270|NCT04802083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5941271|NCT04802083|Immunologic Factors|immunologic factors|mesh-ancestor
5941272|NCT04802083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967188|NCT04564430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967189|NCT04564144|Meclizine|meclizine|mesh-list
5967190|NCT04564144|Antiemetics|antiemetics|mesh-ancestor
5967191|NCT04564144|Autonomic Agents|autonomic agents|mesh-ancestor
5967192|NCT04564144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5967193|NCT04564144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967194|NCT04564144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5967195|NCT04564144|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5967196|NCT04564144|Histamine Antagonists|histamine antagonists|mesh-ancestor
5967197|NCT04564144|Histamine Agents|histamine agents|mesh-ancestor
5967198|NCT04564144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5967199|NCT04564144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967200|NCT04564144|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5967201|NCT04564040|Acalabrutinib|acalabrutinib|mesh-list
5967202|NCT04564040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5967203|NCT04564222|Micronutrients|micronutrients|mesh-list
5967204|NCT04564222|Trace Elements|trace elements|mesh-list
5967205|NCT04564222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967206|NCT04563936|Goserelin|goserelin|mesh-list
5941273|NCT04801953|Nimodipine|nimodipine|mesh-list
5941274|NCT04801953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5941275|NCT04801953|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5941276|NCT04801953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5941277|NCT04801953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941278|NCT04801953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5941279|NCT04801953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941280|NCT04801953|Vasodilator Agents|vasodilator agents|mesh-ancestor
5941281|NCT04801888|Vaccines|vaccines|mesh-list
5941282|NCT04801888|Immunologic Factors|immunologic factors|mesh-ancestor
5941283|NCT04801888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941284|NCT04801940|Apixaban|apixaban|mesh-list
5941285|NCT04801940|Atorvastatin|atorvastatin|mesh-list
5941286|NCT04801940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5941287|NCT04801940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5941288|NCT04801940|Antimetabolites|antimetabolites|mesh-ancestor
5941289|NCT04801940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941290|NCT04801940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5941291|NCT04801940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5941292|NCT04801940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5941293|NCT04801940|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5941294|NCT04801940|Antithrombins|antithrombins|mesh-ancestor
5941295|NCT04801940|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5941296|NCT04801940|Protease Inhibitors|protease inhibitors|mesh-ancestor
5941297|NCT04801940|Anticoagulants|anticoagulants|mesh-ancestor
5941298|NCT04801966|Pembrolizumab|pembrolizumab|mesh-list
5941299|NCT04801966|Nivolumab|nivolumab|mesh-list
5941300|NCT04801966|Atezolizumab|atezolizumab|mesh-list
5941301|NCT04801966|Olaparib|olaparib|mesh-list
5941302|NCT04801966|Palbociclib|palbociclib|mesh-list
5941303|NCT04801966|Trametinib|trametinib|mesh-list
5941304|NCT04801966|Vemurafenib|vemurafenib|mesh-list
5941305|NCT04801966|Dabrafenib|dabrafenib|mesh-list
5941306|NCT04801966|Talazoparib|talazoparib|mesh-list
5941307|NCT04801966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5941308|NCT04801966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5941309|NCT04801966|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5941310|NCT04801966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941311|NCT04801966|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5941312|NCT04801966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5941313|NCT04801966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5941314|NCT04802031|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5941315|NCT04802031|Immunologic Factors|immunologic factors|mesh-ancestor
5941316|NCT04802031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941317|NCT04801511|Ascorbic Acid|ascorbic acid|mesh-list
5941318|NCT04801511|Vitamins|vitamins|mesh-ancestor
5941319|NCT04801511|Micronutrients|micronutrients|mesh-ancestor
5941320|NCT04801511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941321|NCT04801511|Antioxidants|antioxidants|mesh-ancestor
5941322|NCT04801511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941323|NCT04801511|Protective Agents|protective agents|mesh-ancestor
5941324|NCT04801303|Calcitriol|calcitriol|mesh-list
5941325|NCT04801303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5941326|NCT04801303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941327|NCT04801303|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
5941328|NCT04801303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5941329|NCT04801303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941330|NCT04801303|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5941331|NCT04801303|Vitamins|vitamins|mesh-ancestor
5941332|NCT04801303|Micronutrients|micronutrients|mesh-ancestor
5941333|NCT04801303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5941334|NCT04801589|Midazolam|midazolam|mesh-list
5941335|NCT04801589|Dexmedetomidine|dexmedetomidine|mesh-list
5941336|NCT04801589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5941337|NCT04801589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5941338|NCT04801589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941339|NCT04801589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5941340|NCT04801589|Analgesics|analgesics|mesh-ancestor
5941341|NCT04801589|Sensory System Agents|sensory system agents|mesh-ancestor
5941342|NCT04801589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5941343|NCT04801589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5941344|NCT04801589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5941345|NCT04801589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5941346|NCT04801589|Adrenergic Agents|adrenergic agents|mesh-ancestor
5941347|NCT04801589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5941348|NCT04801589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941349|NCT04801589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5941350|NCT04801589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5941351|NCT04801589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5941352|NCT04801589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5941353|NCT04801589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5941354|NCT04801589|Anesthetics, General|anesthetics, general|mesh-ancestor
5941355|NCT04801589|Anesthetics|anesthetics|mesh-ancestor
5941356|NCT04801589|GABA Modulators|gaba modulators|mesh-ancestor
5941357|NCT04801589|GABA Agents|gaba agents|mesh-ancestor
5941358|NCT04801641|Nabilone|nabilone|mesh-list
5941359|NCT04801641|Antiemetics|antiemetics|mesh-ancestor
5941360|NCT04801641|Autonomic Agents|autonomic agents|mesh-ancestor
5941361|NCT04801641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5941362|NCT04801641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941363|NCT04801641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5941364|NCT04801641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5941365|NCT04801641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5941366|NCT04801641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5941367|NCT04801641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5941368|NCT04801485|Inositol|inositol|mesh-list
5941369|NCT04801485|Vitamin B Complex|vitamin b complex|mesh-ancestor
5941370|NCT04801485|Vitamins|vitamins|mesh-ancestor
5941371|NCT04801485|Micronutrients|micronutrients|mesh-ancestor
5941372|NCT04801485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941373|NCT04801342|Memantine|memantine|mesh-list
5941374|NCT04801342|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5941375|NCT04801342|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5941376|NCT04801342|Dopamine Agents|dopamine agents|mesh-ancestor
5941377|NCT04801342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5941378|NCT04801342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941379|NCT04801342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941380|NCT04801342|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5941381|NCT04801342|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5941382|NCT04801264|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5941383|NCT04801264|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
5941384|NCT04801264|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5941385|NCT04801264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941386|NCT04800978|Durvalumab|durvalumab|mesh-list
5941387|NCT04800978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5941388|NCT04800978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5941389|NCT04801017|Artemisinins|artemisinins|mesh-list
5941390|NCT04801017|Artemisinin|artemisinin|mesh-list
5941391|NCT04801017|Trabedersen|trabedersen|mesh-list
5941392|NCT04801017|Antimalarials|antimalarials|mesh-ancestor
5941393|NCT04801017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5941394|NCT04801017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5941395|NCT04801017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5941396|NCT04801017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5941397|NCT04801199|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5941398|NCT04801199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5941399|NCT04801199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941400|NCT04801199|Incretins|incretins|mesh-ancestor
5941401|NCT04801199|Hormones|hormones|mesh-ancestor
5941402|NCT04801199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5941403|NCT04801199|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5941404|NCT04801199|Protease Inhibitors|protease inhibitors|mesh-ancestor
5941405|NCT04801199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5941406|NCT04801199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941407|NCT04800822|Cetuximab|cetuximab|mesh-list
5941408|NCT04800822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5941409|NCT04800822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5941410|NCT04800471|Insulin|insulin|mesh-list
5941411|NCT04800471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5941412|NCT04800471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941413|NCT04800367|Denosumab|denosumab|mesh-list
5941414|NCT04800367|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5941415|NCT04800367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941416|NCT04800107|Curcumin|curcumin|mesh-list
5941417|NCT04800107|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5941418|NCT04800107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5941419|NCT04800107|Analgesics|analgesics|mesh-ancestor
5941420|NCT04800107|Sensory System Agents|sensory system agents|mesh-ancestor
5941421|NCT04800107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5941422|NCT04800107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941423|NCT04800107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5941424|NCT04800107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5941425|NCT04800107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5941426|NCT04800107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5941427|NCT04800107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967207|NCT04563936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5967208|NCT04563936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5967209|NCT04563975|Paclitaxel|paclitaxel|mesh-list
5967210|NCT04563975|Docetaxel|docetaxel|mesh-list
5967211|NCT04563975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5967212|NCT04563975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5967213|NCT04563975|Tubulin Modulators|tubulin modulators|mesh-ancestor
5967214|NCT04563975|Antimitotic Agents|antimitotic agents|mesh-ancestor
5967215|NCT04563975|Mitosis Modulators|mitosis modulators|mesh-ancestor
5967216|NCT04563975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967217|NCT04563962|Methamphetamine|methamphetamine|mesh-list
5967218|NCT04563962|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5967219|NCT04563962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517298|NCT00720512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6517299|NCT00720512|Antimetabolites|antimetabolites|mesh-ancestor
6517300|NCT00720512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517301|NCT00720512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6517302|NCT00720512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6517303|NCT00720512|Immunologic Factors|immunologic factors|mesh-ancestor
6517304|NCT00720512|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6517305|NCT00720512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6517306|NCT00720512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6517307|NCT00720512|Antidotes|antidotes|mesh-ancestor
6517308|NCT00720512|Protective Agents|protective agents|mesh-ancestor
6517309|NCT00720512|Vitamin B Complex|vitamin b complex|mesh-ancestor
6517310|NCT00720512|Vitamins|vitamins|mesh-ancestor
6517311|NCT00720512|Micronutrients|micronutrients|mesh-ancestor
6517312|NCT00720538|Thalidomide|thalidomide|mesh-list
6517313|NCT00720538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5719995|NCT03215797|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5719996|NCT03215797|Mydriatics|mydriatics|mesh-ancestor
5719997|NCT03215797|Autonomic Agents|autonomic agents|mesh-ancestor
5967220|NCT04563962|Sympathomimetics|sympathomimetics|mesh-ancestor
5967221|NCT04563962|Autonomic Agents|autonomic agents|mesh-ancestor
5967222|NCT04563962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5967223|NCT04563962|Dopamine Agents|dopamine agents|mesh-ancestor
5967224|NCT04563962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5967225|NCT04563962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967226|NCT04563962|Adrenergic Agents|adrenergic agents|mesh-ancestor
5967227|NCT04563962|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5719998|NCT03215797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5719999|NCT03215797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720000|NCT03215797|Sympathomimetics|sympathomimetics|mesh-ancestor
5720001|NCT03215797|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5720002|NCT03215797|Nasal Decongestants|nasal decongestants|mesh-ancestor
5720003|NCT03215797|Respiratory System Agents|respiratory system agents|mesh-ancestor
5720004|NCT03215797|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5720005|NCT03215797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5720006|NCT03215797|Adrenergic Agents|adrenergic agents|mesh-ancestor
5720007|NCT03215797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5720008|NCT03215797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967228|NCT04563962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5967229|NCT04563962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5967230|NCT04563962|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5967231|NCT04563871|Osimertinib|osimertinib|mesh-list
5967232|NCT04563871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5967233|NCT04563871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5967234|NCT04563871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5967235|NCT04563871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967236|NCT04564001|Infliximab|infliximab|mesh-list
5967237|NCT04564001|Dermatologic Agents|dermatologic agents|mesh-ancestor
5967238|NCT04564001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5967239|NCT04564001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5967240|NCT04563780|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
5967241|NCT04563780|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5967242|NCT04563780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967243|NCT04563299|Prednisolone|prednisolone|mesh-list
5967244|NCT04563299|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5967245|NCT04563299|Methylprednisolone|methylprednisolone|mesh-list
5967246|NCT04563299|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5967247|NCT04563299|Prednisolone acetate|prednisolone acetate|mesh-list
6517314|NCT00720538|Immunologic Factors|immunologic factors|mesh-ancestor
5941428|NCT04800302|Morphine|morphine|mesh-list
5941429|NCT04800302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5941430|NCT04800302|Narcotics|narcotics|mesh-ancestor
5941431|NCT04800302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5941432|NCT04800302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941433|NCT04800302|Analgesics|analgesics|mesh-ancestor
5941434|NCT04800302|Sensory System Agents|sensory system agents|mesh-ancestor
5941435|NCT04800302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5941436|NCT04800224|Propolis|propolis|mesh-list
5941437|NCT04800224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5941438|NCT04800081|Valsartan|valsartan|mesh-list
5941439|NCT04800081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5941440|NCT04800081|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5941441|NCT04800081|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5941442|NCT04800081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941443|NCT04799847|Catumaxomab|catumaxomab|mesh-list
5941444|NCT04799847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5941445|NCT04799873|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
5941446|NCT04799873|Protein C Inhibitor|protein c inhibitor|mesh-list
5941447|NCT04799873|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5941448|NCT04799873|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5941449|NCT04799873|Protease Inhibitors|protease inhibitors|mesh-ancestor
5941450|NCT04799873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5941451|NCT04799873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941452|NCT04799925|Febuxostat|febuxostat|mesh-list
5941453|NCT04799925|Gout Suppressants|gout suppressants|mesh-ancestor
5941454|NCT04799925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5941455|NCT04799782|Mirtazapine|mirtazapine|mesh-list
5941456|NCT04799782|Antidepressive Agents|antidepressive agents|mesh-ancestor
5941457|NCT04799782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5941458|NCT04799782|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5941459|NCT04799782|Histamine Antagonists|histamine antagonists|mesh-ancestor
5941460|NCT04799782|Histamine Agents|histamine agents|mesh-ancestor
5941461|NCT04799782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5941462|NCT04799782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941463|NCT04799782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941464|NCT04799782|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5941465|NCT04799782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5941466|NCT04799782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5941467|NCT04799782|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5941468|NCT04799782|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5941469|NCT04799782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5941470|NCT04799782|Adrenergic Agents|adrenergic agents|mesh-ancestor
5941471|NCT04799782|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5941472|NCT04799782|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5941473|NCT04799782|Serotonin Agents|serotonin agents|mesh-ancestor
5941474|NCT04799782|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5941475|NCT04799743|Resveratrol|resveratrol|mesh-list
5941476|NCT04799743|Antioxidants|antioxidants|mesh-ancestor
5941477|NCT04799743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941478|NCT04799743|Protective Agents|protective agents|mesh-ancestor
5941479|NCT04799743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941480|NCT04799743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5941481|NCT04799743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5941482|NCT04799626|Meropenem|meropenem|mesh-list
5941483|NCT04799626|Tazobactam|tazobactam|mesh-list
5941484|NCT04799626|Piperacillin|piperacillin|mesh-list
5941485|NCT04799626|Tigecycline|tigecycline|mesh-list
5941486|NCT04799626|Biapenem|biapenem|mesh-list
5941487|NCT04799626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5941488|NCT04799626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5941489|NCT04799626|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5941490|NCT04799626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5941491|NCT04799626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941492|NCT04799626|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5941493|NCT04799262|Prednisone|prednisone|mesh-list
5941494|NCT04799262|Tofacitinib|tofacitinib|mesh-list
5941495|NCT04799262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5941496|NCT04799262|Glucocorticoids|glucocorticoids|mesh-ancestor
5941497|NCT04799262|Hormones|hormones|mesh-ancestor
5941498|NCT04799262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5941499|NCT04799262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941500|NCT04799262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5941501|NCT04799262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5941502|NCT04799262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5941503|NCT04799262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5941504|NCT04799262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941505|NCT04799639|Paclitaxel|paclitaxel|mesh-list
5941506|NCT04799639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5941507|NCT04799639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5941508|NCT04799639|Tubulin Modulators|tubulin modulators|mesh-ancestor
5941509|NCT04799639|Antimitotic Agents|antimitotic agents|mesh-ancestor
5941510|NCT04799639|Mitosis Modulators|mitosis modulators|mesh-ancestor
5941511|NCT04799639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941512|NCT04799314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5941513|NCT04799314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941514|NCT04799314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5941515|NCT04799002|Melphalan|melphalan|mesh-list
5941516|NCT04799002|Topotecan|topotecan|mesh-list
5941517|NCT04799002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5941518|NCT04799002|Alkylating Agents|alkylating agents|mesh-ancestor
5941519|NCT04799002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941520|NCT04799002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5941521|NCT04799002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5941522|NCT04799002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5941523|NCT04799002|Immunologic Factors|immunologic factors|mesh-ancestor
5941524|NCT04799002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941525|NCT04799002|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5941526|NCT04799002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5941527|NCT04799002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5941528|NCT04799184|Epinephrine|epinephrine|mesh-list
5941529|NCT04799184|Racepinephrine|racepinephrine|mesh-list
5941530|NCT04799184|Bupivacaine|bupivacaine|mesh-list
5941531|NCT04799184|Levobupivacaine|levobupivacaine|mesh-list
5941532|NCT04799184|Epinephryl borate|epinephryl borate|mesh-list
5941533|NCT04799184|Anesthetics, Local|anesthetics, local|mesh-ancestor
5941534|NCT04799184|Anesthetics|anesthetics|mesh-ancestor
5941535|NCT04799184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5941536|NCT04799184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941537|NCT04799184|Sensory System Agents|sensory system agents|mesh-ancestor
5941538|NCT04799184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5941539|NCT04799184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5941540|NCT04799184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5941541|NCT04799184|Adrenergic Agents|adrenergic agents|mesh-ancestor
5941542|NCT04799184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5941543|NCT04799184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941544|NCT04799184|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5941545|NCT04799184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5941546|NCT04799184|Autonomic Agents|autonomic agents|mesh-ancestor
5941547|NCT04799184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5941548|NCT04799184|Respiratory System Agents|respiratory system agents|mesh-ancestor
5941549|NCT04799184|Mydriatics|mydriatics|mesh-ancestor
5941550|NCT04799184|Sympathomimetics|sympathomimetics|mesh-ancestor
5941551|NCT04799184|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5941552|NCT04798703|Paclitaxel|paclitaxel|mesh-list
5941553|NCT04798703|Hyaluronic Acid|hyaluronic acid|mesh-list
5941554|NCT04798703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5941555|NCT04798703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5941556|NCT04798703|Tubulin Modulators|tubulin modulators|mesh-ancestor
5941557|NCT04798703|Antimitotic Agents|antimitotic agents|mesh-ancestor
5941558|NCT04798703|Mitosis Modulators|mitosis modulators|mesh-ancestor
5941559|NCT04798703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941560|NCT04798703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5941561|NCT04798703|Immunologic Factors|immunologic factors|mesh-ancestor
5720009|NCT03215797|Protective Agents|protective agents|mesh-ancestor
5720010|NCT03215693|Ensartinib|ensartinib|mesh-list
5720011|NCT03215693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5720012|NCT03215693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5720013|NCT03215693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5720014|NCT03215693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5720015|NCT03216070|Dasatinib|dasatinib|mesh-list
5720016|NCT03216070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5720017|NCT03216070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5720018|NCT03216070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5720019|NCT03216070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5720020|NCT03215602|Pyrantel|pyrantel|mesh-list
5720021|NCT03215602|Pyrantel Pamoate|pyrantel pamoate|mesh-list
5720022|NCT03215602|Antinematodal Agents|antinematodal agents|mesh-ancestor
5720023|NCT03215602|Anthelmintics|anthelmintics|mesh-ancestor
5720024|NCT03215602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5941562|NCT04798703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941563|NCT04798703|Viscosupplements|viscosupplements|mesh-ancestor
5941564|NCT04798703|Protective Agents|protective agents|mesh-ancestor
5941565|NCT04798729|Salicylic Acid|salicylic acid|mesh-list
5941566|NCT04798729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5941567|NCT04798729|Antifungal Agents|antifungal agents|mesh-ancestor
5941568|NCT04798729|Keratolytic Agents|keratolytic agents|mesh-ancestor
5941569|NCT04798729|Dermatologic Agents|dermatologic agents|mesh-ancestor
5941570|NCT04798638|Osimertinib|osimertinib|mesh-list
5941571|NCT04798638|Complement Factor H|complement factor h|mesh-list
5941572|NCT04798638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5941573|NCT04798638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5941574|NCT04798638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5941575|NCT04798638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941576|NCT04798638|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5941577|NCT04798638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5941578|NCT04798638|Immunologic Factors|immunologic factors|mesh-ancestor
5941579|NCT04798638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941580|NCT04798612|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5941581|NCT04798612|Antiviral Agents|antiviral agents|mesh-ancestor
5941582|NCT04798612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5941583|NCT04798443|Hyaluronic Acid|hyaluronic acid|mesh-list
5941584|NCT04798443|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5941585|NCT04798443|Immunologic Factors|immunologic factors|mesh-ancestor
5941586|NCT04798443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941587|NCT04798443|Viscosupplements|viscosupplements|mesh-ancestor
5941588|NCT04798443|Protective Agents|protective agents|mesh-ancestor
5967248|NCT04563299|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5967249|NCT04563299|Prednisolone phosphate|prednisolone phosphate|mesh-list
5967250|NCT04563299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5967251|NCT04563299|Glucocorticoids|glucocorticoids|mesh-ancestor
5967252|NCT04563299|Hormones|hormones|mesh-ancestor
5967253|NCT04563299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5967254|NCT04563299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967255|NCT04563299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5967256|NCT04563299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5967257|NCT04563299|Antiemetics|antiemetics|mesh-ancestor
5967258|NCT04563299|Autonomic Agents|autonomic agents|mesh-ancestor
5967259|NCT04563299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5967260|NCT04563299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5967261|NCT04563299|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5967262|NCT04563299|Protective Agents|protective agents|mesh-ancestor
5967263|NCT04563260|Palonosetron|palonosetron|mesh-list
5967264|NCT04563260|Antiemetics|antiemetics|mesh-ancestor
5967265|NCT04563260|Autonomic Agents|autonomic agents|mesh-ancestor
5967266|NCT04563260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5967267|NCT04563260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967268|NCT04563260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5967269|NCT04563260|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5967270|NCT04563260|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5967271|NCT04563260|Serotonin Agents|serotonin agents|mesh-ancestor
5967272|NCT04563260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5967273|NCT04563260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967274|NCT04563533|Vaccines|vaccines|mesh-list
5967275|NCT04563533|Immunologic Factors|immunologic factors|mesh-ancestor
5967276|NCT04563533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967277|NCT04563494|Dexamethasone|dexamethasone|mesh-list
5967278|NCT04563494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5967279|NCT04563494|Antiemetics|antiemetics|mesh-ancestor
5967280|NCT04563494|Autonomic Agents|autonomic agents|mesh-ancestor
5967281|NCT04563494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5967282|NCT04563494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967283|NCT04563494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5967284|NCT04563494|Glucocorticoids|glucocorticoids|mesh-ancestor
5967285|NCT04563494|Hormones|hormones|mesh-ancestor
5967286|NCT04563494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5967287|NCT04563494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5967288|NCT04563494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5967289|NCT04563351|Anesthetics|anesthetics|mesh-list
5967290|NCT04563351|Anesthetics, Local|anesthetics, local|mesh-list
5967291|NCT04563351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5967292|NCT04563351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967293|NCT04563351|Sensory System Agents|sensory system agents|mesh-ancestor
5967294|NCT04563351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5967295|NCT04563507|Letrozole|letrozole|mesh-list
5967296|NCT04563507|Palbociclib|palbociclib|mesh-list
5941589|NCT04798313|Denosumab|denosumab|mesh-list
5941590|NCT04798313|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5941591|NCT04798313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941592|NCT04798287|Adalimumab|adalimumab|mesh-list
5941593|NCT04798287|Etanercept|etanercept|mesh-list
5941594|NCT04798287|Golimumab|golimumab|mesh-list
5941595|NCT04798287|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
5941596|NCT04798287|Infliximab|infliximab|mesh-list
5941597|NCT04798287|Certolizumab Pegol|certolizumab pegol|mesh-list
5941598|NCT04798287|Tofacitinib|tofacitinib|mesh-list
5941599|NCT04798287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5941600|NCT04798287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5941601|NCT04798287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5941602|NCT04798287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5941603|NCT04798287|Analgesics|analgesics|mesh-ancestor
5941604|NCT04798287|Sensory System Agents|sensory system agents|mesh-ancestor
5941605|NCT04798287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5941606|NCT04798287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941607|NCT04798287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5941608|NCT04798287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5941609|NCT04798287|Immunologic Factors|immunologic factors|mesh-ancestor
5941610|NCT04798287|Dermatologic Agents|dermatologic agents|mesh-ancestor
5941611|NCT04798287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5941612|NCT04798287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5941613|NCT04798287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941614|NCT04798391|Dexamethasone|dexamethasone|mesh-list
5941615|NCT04798391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5941616|NCT04798391|Antiemetics|antiemetics|mesh-ancestor
5941617|NCT04798391|Autonomic Agents|autonomic agents|mesh-ancestor
5941618|NCT04798391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5941619|NCT04798391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941620|NCT04798391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5941621|NCT04798391|Glucocorticoids|glucocorticoids|mesh-ancestor
5941622|NCT04798391|Hormones|hormones|mesh-ancestor
5941623|NCT04798391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5941624|NCT04798391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5941625|NCT04798391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5941626|NCT04798001|Vaccines|vaccines|mesh-list
5941627|NCT04798001|Immunologic Factors|immunologic factors|mesh-ancestor
5941628|NCT04798001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941629|NCT04797949|Aspirin|aspirin|mesh-list
5941630|NCT04797949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5941631|NCT04797949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5941632|NCT04797949|Analgesics|analgesics|mesh-ancestor
5941633|NCT04797949|Sensory System Agents|sensory system agents|mesh-ancestor
5941634|NCT04797949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5941635|NCT04797949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941636|NCT04797949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5941637|NCT04797949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5941638|NCT04797949|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5941639|NCT04797949|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5941640|NCT04797949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941641|NCT04797949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5941642|NCT04797949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5941643|NCT04797949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5941644|NCT04797949|Antipyretics|antipyretics|mesh-ancestor
5941645|NCT04797832|Ferric gluconate|ferric gluconate|mesh-list
5941646|NCT04797832|Hematinics|hematinics|mesh-ancestor
5941647|NCT04797546|Morphine|morphine|mesh-list
5941648|NCT04797546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5941649|NCT04797546|Narcotics|narcotics|mesh-ancestor
5941650|NCT04797546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5941651|NCT04797546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941652|NCT04797546|Analgesics|analgesics|mesh-ancestor
5941653|NCT04797546|Sensory System Agents|sensory system agents|mesh-ancestor
5941654|NCT04797546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5941655|NCT04797793|Adapalene|adapalene|mesh-list
5941656|NCT04797793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5941657|NCT04797793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5941658|NCT04797793|Analgesics|analgesics|mesh-ancestor
5941659|NCT04797793|Sensory System Agents|sensory system agents|mesh-ancestor
5941660|NCT04797793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5941661|NCT04797793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941662|NCT04797793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5941663|NCT04797793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5941664|NCT04797793|Dermatologic Agents|dermatologic agents|mesh-ancestor
5941665|NCT04797429|Hypoglycemic Agents|hypoglycemic agents|mesh-list
5941666|NCT04797429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941667|NCT04797338|Nafarelin|nafarelin|mesh-list
5941668|NCT04797338|Progesterone|progesterone|mesh-list
5941669|NCT04797338|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
5941670|NCT04797338|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
5941671|NCT04797338|Estradiol|estradiol|mesh-list
5941672|NCT04797338|Progestins|progestins|mesh-ancestor
5941673|NCT04797338|Hormones|hormones|mesh-ancestor
5941674|NCT04797338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5941675|NCT04797338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941676|NCT04797338|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5941677|NCT04797338|Hormone Antagonists|hormone antagonists|mesh-ancestor
5941678|NCT04797338|Estrogens|estrogens|mesh-ancestor
5941679|NCT04797338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5941680|NCT04797338|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5941681|NCT04797338|Fertility Agents|fertility agents|mesh-ancestor
5941682|NCT04797156|Tranexamic Acid|tranexamic acid|mesh-list
5941683|NCT04797156|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5941684|NCT04797156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5941685|NCT04797156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941686|NCT04797156|Hemostatics|hemostatics|mesh-ancestor
5941687|NCT04797156|Coagulants|coagulants|mesh-ancestor
5941688|NCT04797286|Sildenafil Citrate|sildenafil citrate|mesh-list
5941689|NCT04797286|Vasodilator Agents|vasodilator agents|mesh-ancestor
5941690|NCT04797286|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5941691|NCT04797286|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5941692|NCT04797286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5941693|NCT04797286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941694|NCT04797286|Urological Agents|urological agents|mesh-ancestor
5941695|NCT04797013|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5941696|NCT04797013|Plasminogen|plasminogen|mesh-list
5941697|NCT04797013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5941698|NCT04797013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5941699|NCT04797013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941700|NCT04796857|Lenalidomide|lenalidomide|mesh-list
5941701|NCT04796857|Antibodies|antibodies|mesh-list
5941702|NCT04796857|Immunologic Factors|immunologic factors|mesh-ancestor
5941703|NCT04796857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941704|NCT04796857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5941705|NCT04796857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5941706|NCT04796857|Growth Substances|growth substances|mesh-ancestor
5941707|NCT04796857|Growth Inhibitors|growth inhibitors|mesh-ancestor
5941708|NCT04796857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5941709|NCT04796623|Fulvestrant|fulvestrant|mesh-list
5941710|NCT04796623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5941711|NCT04796623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5941712|NCT04796623|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5941713|NCT04796623|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5941714|NCT04796623|Hormone Antagonists|hormone antagonists|mesh-ancestor
5941715|NCT04796623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5941716|NCT04796623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941717|NCT04796688|Cyclophosphamide|cyclophosphamide|mesh-list
5941718|NCT04796688|Fludarabine|fludarabine|mesh-list
5941719|NCT04796688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5941720|NCT04796688|Immunologic Factors|immunologic factors|mesh-ancestor
5941721|NCT04796688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941722|NCT04796688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5941723|NCT04796688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5941724|NCT04796688|Alkylating Agents|alkylating agents|mesh-ancestor
5941725|NCT04796688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941726|NCT04796688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5941727|NCT04796688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5967297|NCT04563507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5967298|NCT04563507|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5967299|NCT04563507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5967300|NCT04563507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5967301|NCT04563507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967302|NCT04563507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5967303|NCT04563507|Hormone Antagonists|hormone antagonists|mesh-ancestor
5967304|NCT04563507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5967305|NCT04563507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967306|NCT04563507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5967307|NCT04563429|Vitamin A|vitamin a|mesh-list
5967308|NCT04563429|Vitamins|vitamins|mesh-ancestor
5967309|NCT04563429|Micronutrients|micronutrients|mesh-ancestor
5941728|NCT04796714|Aspirin|aspirin|mesh-list
5941729|NCT04796714|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5941730|NCT04796714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5941731|NCT04796714|Analgesics|analgesics|mesh-ancestor
5941732|NCT04796714|Sensory System Agents|sensory system agents|mesh-ancestor
5941733|NCT04796714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5941734|NCT04796714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941735|NCT04796714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5941736|NCT04796714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5941737|NCT04796714|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5941738|NCT04796714|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5941739|NCT04796714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941740|NCT04796714|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5941741|NCT04796714|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5941742|NCT04796714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5941743|NCT04796714|Antipyretics|antipyretics|mesh-ancestor
5941744|NCT04796428|Dapagliflozin|dapagliflozin|mesh-list
5941745|NCT04796428|Empagliflozin|empagliflozin|mesh-list
5941746|NCT04796428|Canagliflozin|canagliflozin|mesh-list
5941747|NCT04796428|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5941748|NCT04796428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941749|NCT04796428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5941750|NCT04796428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941751|NCT04796675|Cyclophosphamide|cyclophosphamide|mesh-list
5941752|NCT04796675|Fludarabine|fludarabine|mesh-list
5941753|NCT04796675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5941754|NCT04796675|Immunologic Factors|immunologic factors|mesh-ancestor
5941755|NCT04796675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941756|NCT04796675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5941757|NCT04796675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5941758|NCT04796675|Alkylating Agents|alkylating agents|mesh-ancestor
5941759|NCT04796675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941760|NCT04796675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5941761|NCT04796675|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5941762|NCT04796454|Gemcitabine|gemcitabine|mesh-list
5941763|NCT04796454|Oxaliplatin|oxaliplatin|mesh-list
5941764|NCT04796454|Temozolomide|temozolomide|mesh-list
5941765|NCT04796454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5941766|NCT04796454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5941767|NCT04796454|Antimetabolites|antimetabolites|mesh-ancestor
5941768|NCT04796454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941769|NCT04796454|Antiviral Agents|antiviral agents|mesh-ancestor
5941770|NCT04796454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5941771|NCT04796454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5941772|NCT04796454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5941773|NCT04796454|Immunologic Factors|immunologic factors|mesh-ancestor
5941774|NCT04796454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941775|NCT04796454|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5941776|NCT04796454|Alkylating Agents|alkylating agents|mesh-ancestor
5941777|NCT04796012|Irinotecan|irinotecan|mesh-list
5941778|NCT04796012|Vincristine|vincristine|mesh-list
5941779|NCT04796012|Temozolomide|temozolomide|mesh-list
5941780|NCT04796012|Atezolizumab|atezolizumab|mesh-list
5941781|NCT04796012|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5941782|NCT04796012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5941783|NCT04796012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5941784|NCT04796012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941785|NCT04796012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5941786|NCT04796012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5941787|NCT04796012|Tubulin Modulators|tubulin modulators|mesh-ancestor
5941788|NCT04796012|Antimitotic Agents|antimitotic agents|mesh-ancestor
5941789|NCT04796012|Mitosis Modulators|mitosis modulators|mesh-ancestor
5941790|NCT04796012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5941791|NCT04796012|Alkylating Agents|alkylating agents|mesh-ancestor
5941792|NCT04796025|Bevacizumab|bevacizumab|mesh-list
5941793|NCT04796025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5941794|NCT04796025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5941795|NCT04796025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5941796|NCT04796025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5941797|NCT04796025|Growth Substances|growth substances|mesh-ancestor
5941798|NCT04796025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941799|NCT04796025|Growth Inhibitors|growth inhibitors|mesh-ancestor
5941800|NCT04795583|Prednisone|prednisone|mesh-list
5941801|NCT04795583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5941802|NCT04795583|Glucocorticoids|glucocorticoids|mesh-ancestor
5941803|NCT04795583|Hormones|hormones|mesh-ancestor
5941804|NCT04795583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5941805|NCT04795583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941806|NCT04795583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5941807|NCT04795583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5941808|NCT04795752|Cyclosporine|cyclosporine|mesh-list
5941809|NCT04795752|Cyclosporins|cyclosporins|mesh-list
5941810|NCT04795752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5941811|NCT04795752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941812|NCT04795752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5941813|NCT04795752|Immunologic Factors|immunologic factors|mesh-ancestor
5941814|NCT04795752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941815|NCT04795752|Antifungal Agents|antifungal agents|mesh-ancestor
5941816|NCT04795752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5941817|NCT04795752|Dermatologic Agents|dermatologic agents|mesh-ancestor
5941818|NCT04795752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5941819|NCT04795752|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5941820|NCT04795479|Moxifloxacin|moxifloxacin|mesh-list
5941821|NCT04795479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5941822|NCT04795479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5941823|NCT04795479|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5941824|NCT04795479|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5941825|NCT04795479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5941826|NCT04795479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941827|NCT04795479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5941828|NCT04794738|Morphine|morphine|mesh-list
5941829|NCT04794738|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5941830|NCT04794738|Narcotics|narcotics|mesh-ancestor
5941831|NCT04794738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5941832|NCT04794738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941833|NCT04794738|Analgesics|analgesics|mesh-ancestor
5941834|NCT04794738|Sensory System Agents|sensory system agents|mesh-ancestor
5941835|NCT04794738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5941836|NCT04794842|Phenol|phenol|mesh-list
5941837|NCT04794842|Tetracaine|tetracaine|mesh-list
5941838|NCT04794842|Anesthetics, Local|anesthetics, local|mesh-ancestor
5941839|NCT04794842|Anesthetics|anesthetics|mesh-ancestor
5941840|NCT04794842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5941841|NCT04794842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941842|NCT04794842|Sensory System Agents|sensory system agents|mesh-ancestor
5941843|NCT04794842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5941844|NCT04794842|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5941845|NCT04794842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5941846|NCT04794842|Disinfectants|disinfectants|mesh-ancestor
5941847|NCT04794842|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
5941848|NCT04794842|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5967310|NCT04563429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967311|NCT04563000|Ascorbic Acid|ascorbic acid|mesh-list
5967312|NCT04563000|Vitamins|vitamins|mesh-ancestor
5967313|NCT04563000|Micronutrients|micronutrients|mesh-ancestor
5967314|NCT04563000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967315|NCT04563000|Antioxidants|antioxidants|mesh-ancestor
5967316|NCT04563000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967317|NCT04563000|Protective Agents|protective agents|mesh-ancestor
5967318|NCT04562831|Niacinamide|niacinamide|mesh-list
5967319|NCT04562831|Niacin|niacin|mesh-list
5967320|NCT04562831|Nicotinic Acids|nicotinic acids|mesh-list
5967321|NCT04562831|Vitamin B Complex|vitamin b complex|mesh-ancestor
5967322|NCT04562831|Vitamins|vitamins|mesh-ancestor
5967323|NCT04562831|Micronutrients|micronutrients|mesh-ancestor
5967324|NCT04562831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967325|NCT04562831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5967326|NCT04562831|Antimetabolites|antimetabolites|mesh-ancestor
5967327|NCT04562831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967328|NCT04562831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5967329|NCT04562831|Vasodilator Agents|vasodilator agents|mesh-ancestor
5967330|NCT04562532|Sirolimus|sirolimus|mesh-list
5967331|NCT04562532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5967332|NCT04562532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5967333|NCT04562532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5967334|NCT04562532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5967335|NCT04562532|Antifungal Agents|antifungal agents|mesh-ancestor
5967336|NCT04562532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5967337|NCT04562532|Immunologic Factors|immunologic factors|mesh-ancestor
5967338|NCT04562532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967339|NCT04562441|Avelumab|avelumab|mesh-list
5967340|NCT04562441|Axitinib|axitinib|mesh-list
5967341|NCT04562441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5941849|NCT04794426|Fluorides|fluorides|mesh-list
5941850|NCT04794426|Cariostatic Agents|cariostatic agents|mesh-ancestor
5941851|NCT04794426|Protective Agents|protective agents|mesh-ancestor
5941852|NCT04794426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941853|NCT04794231|Chlorhexidine|chlorhexidine|mesh-list
5941854|NCT04794231|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5941855|NCT04794231|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5941856|NCT04794231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5941857|NCT04794231|Disinfectants|disinfectants|mesh-ancestor
5941858|NCT04794231|Dermatologic Agents|dermatologic agents|mesh-ancestor
5941859|NCT04794413|Pimavanserin|pimavanserin|mesh-list
5941860|NCT04794413|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5941861|NCT04794413|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5941862|NCT04794413|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5941863|NCT04794413|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5941864|NCT04794413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5941865|NCT04794413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941866|NCT04794413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5941867|NCT04794413|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5941868|NCT04794413|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5941869|NCT04794413|Serotonin Agents|serotonin agents|mesh-ancestor
5941870|NCT04794413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5941871|NCT04794413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941872|NCT04794504|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5941873|NCT04794504|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5941874|NCT04794504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5941875|NCT04794504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941876|NCT04794504|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5941877|NCT04794504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5941878|NCT04794504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941879|NCT04794504|Cholinergic Agents|cholinergic agents|mesh-ancestor
5941880|NCT04794504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5941881|NCT04794049|Lactulose|lactulose|mesh-list
5941882|NCT04794049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5941883|NCT04794127|Pioglitazone|pioglitazone|mesh-list
5941884|NCT04794127|Trabectedin|trabectedin|mesh-list
5941885|NCT04794127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5941886|NCT04794127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941887|NCT04794127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5941888|NCT04794127|Alkylating Agents|alkylating agents|mesh-ancestor
5941889|NCT04794127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941890|NCT04794127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5941891|NCT04794088|Imatinib Mesylate|imatinib mesylate|mesh-list
5941892|NCT04794088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5941893|NCT04794088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5941894|NCT04794088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5941895|NCT04794088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941896|NCT04793919|Tretinoin|tretinoin|mesh-list
5941897|NCT04793919|Arsenic Trioxide|arsenic trioxide|mesh-list
5941898|NCT04793919|Gemtuzumab|gemtuzumab|mesh-list
5941899|NCT04793919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5941900|NCT04793919|Keratolytic Agents|keratolytic agents|mesh-ancestor
5941901|NCT04793919|Dermatologic Agents|dermatologic agents|mesh-ancestor
6681277|NCT01608893|Antioxidants|antioxidants|mesh-ancestor
6681278|NCT01608893|Protective Agents|protective agents|mesh-ancestor
6681279|NCT01608893|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6681280|NCT01608893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6681281|NCT01608893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6681282|NCT01608893|Vasodilator Agents|vasodilator agents|mesh-ancestor
6681283|NCT01608893|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6681284|NCT01608893|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6681285|NCT01608945|Hydrocortisone|hydrocortisone|mesh-list
6681286|NCT01608945|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6681287|NCT01608945|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6681288|NCT01608945|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6681289|NCT01608945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6681290|NCT01608958|Oxytocin|oxytocin|mesh-list
6681291|NCT01608958|Oxytocics|oxytocics|mesh-ancestor
6681292|NCT01608958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6681293|NCT01608958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681294|NCT01608984|Sufentanil|sufentanil|mesh-list
6681295|NCT01608984|Isoflurane|isoflurane|mesh-list
6681296|NCT01608984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6681297|NCT01608984|Narcotics|narcotics|mesh-ancestor
6681298|NCT01608984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6681299|NCT01608984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681300|NCT01608984|Analgesics|analgesics|mesh-ancestor
6681301|NCT01608984|Sensory System Agents|sensory system agents|mesh-ancestor
6681302|NCT01608984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6681303|NCT01608984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6681304|NCT01608984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6681305|NCT01608984|Anesthetics, General|anesthetics, general|mesh-ancestor
6681306|NCT01608984|Anesthetics|anesthetics|mesh-ancestor
6681307|NCT01608984|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5941902|NCT04793919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5941903|NCT04793711|Decanoic acid|decanoic acid|mesh-list
5941904|NCT04793711|Antifungal Agents|antifungal agents|mesh-ancestor
5941905|NCT04793711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5941906|NCT04793529|Cholecalciferol|cholecalciferol|mesh-list
5941907|NCT04793529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5941908|NCT04793529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941909|NCT04793529|Vitamins|vitamins|mesh-ancestor
5941910|NCT04793529|Micronutrients|micronutrients|mesh-ancestor
5941911|NCT04793529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5941912|NCT04793815|Pembrolizumab|pembrolizumab|mesh-list
5941913|NCT04793815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5941914|NCT04793815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5941915|NCT04793867|Xenon|xenon|mesh-list
5941916|NCT04793867|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5941917|NCT04793867|Anesthetics, General|anesthetics, general|mesh-ancestor
5941918|NCT04793867|Anesthetics|anesthetics|mesh-ancestor
5941919|NCT04793867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5941920|NCT04793867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941921|NCT04793256|Listerine|listerine|mesh-list
5941922|NCT04793256|Fluorides|fluorides|mesh-list
5941923|NCT04793256|Sodium Fluoride|sodium fluoride|mesh-list
5941924|NCT04793256|Fluorides, Topical|fluorides, topical|mesh-list
5941925|NCT04793256|Cariostatic Agents|cariostatic agents|mesh-ancestor
5941926|NCT04793256|Protective Agents|protective agents|mesh-ancestor
5941927|NCT04793256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941928|NCT04793256|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5941929|NCT04793256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5941930|NCT04793243|Vitamin D|vitamin d|mesh-list
5941931|NCT04793243|Cholecalciferol|cholecalciferol|mesh-list
5941932|NCT04793243|Vitamins|vitamins|mesh-ancestor
5941933|NCT04793243|Micronutrients|micronutrients|mesh-ancestor
5941934|NCT04793243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941935|NCT04793243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5941936|NCT04793243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5941937|NCT04793399|Atezolizumab|atezolizumab|mesh-list
5941938|NCT04793399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5941939|NCT04793152|Vancomycin|vancomycin|mesh-list
5941940|NCT04793152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5941941|NCT04793152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5967342|NCT04562441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5967343|NCT04562441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5967344|NCT04562441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5967345|NCT04562441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970992|NCT04531072|Atazanavir Sulfate|atazanavir sulfate|mesh-list
5970993|NCT04531072|Lumefantrine|lumefantrine|mesh-list
5970994|NCT04531072|Artemether|artemether|mesh-list
5970995|NCT04531072|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
5970996|NCT04531072|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5970997|NCT04531072|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5970998|NCT04531072|Protease Inhibitors|protease inhibitors|mesh-ancestor
5970999|NCT04531072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5971000|NCT04531072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971001|NCT04531072|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5971002|NCT04531072|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5971003|NCT04531072|Antiviral Agents|antiviral agents|mesh-ancestor
5971004|NCT04531072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5971005|NCT04531072|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5971006|NCT04531072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5971007|NCT04531072|Antimalarials|antimalarials|mesh-ancestor
5971008|NCT04531072|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5971009|NCT04531072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5971010|NCT04530864|Dexamethasone|dexamethasone|mesh-list
5971011|NCT04530864|Dexamethasone acetate|dexamethasone acetate|mesh-list
5971012|NCT04530864|BB 1101|bb 1101|mesh-list
5971013|NCT04530864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5971014|NCT04530864|Antiemetics|antiemetics|mesh-ancestor
5971015|NCT04530864|Autonomic Agents|autonomic agents|mesh-ancestor
5971016|NCT04530864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5941942|NCT04793022|Anesthetics|anesthetics|mesh-list
5941943|NCT04793022|Propofol|propofol|mesh-list
5941944|NCT04793022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5941945|NCT04793022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941946|NCT04793022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5941947|NCT04793022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5941948|NCT04793022|Anesthetics, General|anesthetics, general|mesh-ancestor
5941949|NCT04792723|Aspirin|aspirin|mesh-list
5941950|NCT04792723|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5941951|NCT04792723|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5941952|NCT04792723|Analgesics|analgesics|mesh-ancestor
5941953|NCT04792723|Sensory System Agents|sensory system agents|mesh-ancestor
5941954|NCT04792723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5941955|NCT04792723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941956|NCT04792723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5941957|NCT04792723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5941958|NCT04792723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5941959|NCT04792723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5941960|NCT04792723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941961|NCT04792723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5941962|NCT04792723|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5941963|NCT04792723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5941964|NCT04792723|Antipyretics|antipyretics|mesh-ancestor
5941965|NCT04792801|Choline|choline|mesh-list
5941966|NCT04792801|Lipotropic Agents|lipotropic agents|mesh-ancestor
5941967|NCT04792801|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5941968|NCT04792801|Antimetabolites|antimetabolites|mesh-ancestor
5941969|NCT04792801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941970|NCT04792801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5941971|NCT04792801|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5941972|NCT04792801|Nootropic Agents|nootropic agents|mesh-ancestor
5941973|NCT04792645|Memantine|memantine|mesh-list
5941974|NCT04792645|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5941975|NCT04792645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5941976|NCT04792645|Dopamine Agents|dopamine agents|mesh-ancestor
5941977|NCT04792645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5941978|NCT04792645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941979|NCT04792645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941980|NCT04792645|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5941981|NCT04792645|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5941982|NCT04792749|Metformin|metformin|mesh-list
5941983|NCT04792749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5941984|NCT04792749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5941985|NCT04792710|Metronidazole|metronidazole|mesh-list
5941986|NCT04792710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5941987|NCT04792710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5941988|NCT04792710|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5941989|NCT04792710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5941990|NCT04792840|Letrozole|letrozole|mesh-list
5941991|NCT04792840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5941992|NCT04792840|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5941993|NCT04792840|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5941994|NCT04792840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5941995|NCT04792840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5941996|NCT04792840|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5941997|NCT04792840|Hormone Antagonists|hormone antagonists|mesh-ancestor
5941998|NCT04792840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5941999|NCT04792840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942000|NCT04792580|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5942001|NCT04792580|Lifitegrast|lifitegrast|mesh-list
5942002|NCT04792580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5942003|NCT04792398|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
5942004|NCT04792398|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5942005|NCT04792398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5942006|NCT04792398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942007|NCT04792398|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5942008|NCT04792398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5942009|NCT04792398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942010|NCT04792398|Cholinergic Agents|cholinergic agents|mesh-ancestor
5942011|NCT04792398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5942012|NCT04792333|Firibastat|firibastat|mesh-list
5942013|NCT04792333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5942014|NCT04792385|Drospirenone|drospirenone|mesh-list
5942015|NCT04792385|Contraceptive Agents|contraceptive agents|mesh-list
5942016|NCT04792385|Contraceptives, Oral|contraceptives, oral|mesh-list
5942017|NCT04792385|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
5942018|NCT04792385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5942019|NCT04792385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942020|NCT04792385|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5942021|NCT04792385|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5942022|NCT04792385|Hormone Antagonists|hormone antagonists|mesh-ancestor
5942023|NCT04792385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5942024|NCT04792385|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5942025|NCT04792385|Diuretics|diuretics|mesh-ancestor
5942026|NCT04792385|Natriuretic Agents|natriuretic agents|mesh-ancestor
5942027|NCT04792320|Charcoal|charcoal|mesh-list
5942028|NCT04792320|Antidotes|antidotes|mesh-ancestor
5942029|NCT04792320|Protective Agents|protective agents|mesh-ancestor
5942030|NCT04792320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942031|NCT04792138|Phenobarbital|phenobarbital|mesh-list
5942032|NCT04792138|Anticonvulsants|anticonvulsants|mesh-ancestor
5942033|NCT04792138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5942034|NCT04792138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5942035|NCT04792138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942036|NCT04792138|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5942037|NCT04792138|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5942038|NCT04792138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5942039|NCT04792138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942040|NCT04792138|GABA Modulators|gaba modulators|mesh-ancestor
5942041|NCT04792138|GABA Agents|gaba agents|mesh-ancestor
5942042|NCT04792138|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5942043|NCT04792138|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5942044|NCT04792138|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5942045|NCT04792424|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5942046|NCT04792424|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
5942047|NCT04792424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5942048|NCT04792502|Lenalidomide|lenalidomide|mesh-list
5942049|NCT04792502|Immunologic Factors|immunologic factors|mesh-ancestor
5942050|NCT04792502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942051|NCT04792502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5942052|NCT04792502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5942053|NCT04792502|Growth Substances|growth substances|mesh-ancestor
5942054|NCT04792502|Growth Inhibitors|growth inhibitors|mesh-ancestor
5942055|NCT04792502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5942056|NCT04792515|Apatinib|apatinib|mesh-list
5942057|NCT04792515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5942058|NCT04792515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5942059|NCT04792515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5942060|NCT04792515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942061|NCT04792034|Cocaine|cocaine|mesh-list
5942062|NCT04792034|Anesthetics, Local|anesthetics, local|mesh-ancestor
5942063|NCT04792034|Anesthetics|anesthetics|mesh-ancestor
5942064|NCT04792034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5942065|NCT04792034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942066|NCT04792034|Sensory System Agents|sensory system agents|mesh-ancestor
5942067|NCT04792034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5942068|NCT04792034|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5942069|NCT04792034|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5942070|NCT04792034|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5942071|NCT04792034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5942072|NCT04792034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942073|NCT04792034|Dopamine Agents|dopamine agents|mesh-ancestor
5942074|NCT04792034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5942075|NCT04792021|Acetylcysteine|acetylcysteine|mesh-list
5942076|NCT04792021|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5942077|NCT04792021|Antiviral Agents|antiviral agents|mesh-ancestor
5942078|NCT04792021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5942079|NCT04792021|Expectorants|expectorants|mesh-ancestor
5942080|NCT04792021|Respiratory System Agents|respiratory system agents|mesh-ancestor
5942081|NCT04792021|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5942082|NCT04792021|Antioxidants|antioxidants|mesh-ancestor
5942083|NCT04792021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942084|NCT04792021|Protective Agents|protective agents|mesh-ancestor
5942085|NCT04792021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942086|NCT04792021|Antidotes|antidotes|mesh-ancestor
5942087|NCT04791969|Naltrexone|naltrexone|mesh-list
5942088|NCT04791969|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5942089|NCT04791969|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5942090|NCT04791969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942091|NCT04791969|Sensory System Agents|sensory system agents|mesh-ancestor
5942092|NCT04791969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5942093|NCT04791761|Acetaminophen|acetaminophen|mesh-list
5942094|NCT04791761|Ibuprofen|ibuprofen|mesh-list
5942095|NCT04791761|Oxycodone|oxycodone|mesh-list
5942096|NCT04791761|Analgesics, Opioid|analgesics, opioid|mesh-list
5942097|NCT04791761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5942098|NCT04791761|Analgesics|analgesics|mesh-ancestor
5942099|NCT04791761|Sensory System Agents|sensory system agents|mesh-ancestor
5942100|NCT04791761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5942101|NCT04791761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942102|NCT04791761|Antipyretics|antipyretics|mesh-ancestor
5942103|NCT04791761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5942104|NCT04791761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5942105|NCT04791761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5942106|NCT04791761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5942107|NCT04791761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5942108|NCT04791761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942109|NCT04791761|Narcotics|narcotics|mesh-ancestor
5942110|NCT04791761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5942111|NCT04791943|Melatonin|melatonin|mesh-list
5942112|NCT04791943|Antioxidants|antioxidants|mesh-ancestor
5942113|NCT04791943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942114|NCT04791943|Protective Agents|protective agents|mesh-ancestor
5942115|NCT04791943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942116|NCT04791943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5942117|NCT04791774|Caseins|caseins|mesh-list
5942118|NCT04791774|Chelating Agents|chelating agents|mesh-ancestor
5942119|NCT04791774|Sequestering Agents|sequestering agents|mesh-ancestor
5942120|NCT04791774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942121|NCT04791345|Dexamethasone|dexamethasone|mesh-list
5942122|NCT04791345|Dexamethasone acetate|dexamethasone acetate|mesh-list
5942123|NCT04791345|Methylprednisolone|methylprednisolone|mesh-list
5942124|NCT04791345|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5942125|NCT04791345|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5942126|NCT04791345|Prednisolone|prednisolone|mesh-list
5942127|NCT04791345|Prednisolone acetate|prednisolone acetate|mesh-list
5942128|NCT04791345|Deflazacort|deflazacort|mesh-list
5942129|NCT04791345|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5942130|NCT04791345|Prednisolone phosphate|prednisolone phosphate|mesh-list
5942131|NCT04791345|BB 1101|bb 1101|mesh-list
5942132|NCT04791345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5942133|NCT04791345|Antiemetics|antiemetics|mesh-ancestor
5942134|NCT04791345|Autonomic Agents|autonomic agents|mesh-ancestor
5942135|NCT04791345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5942136|NCT04791345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942137|NCT04791345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5942138|NCT04791345|Glucocorticoids|glucocorticoids|mesh-ancestor
5942139|NCT04791345|Hormones|hormones|mesh-ancestor
5942140|NCT04791345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5942141|NCT04791345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5942142|NCT04791345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5942143|NCT04791345|Protease Inhibitors|protease inhibitors|mesh-ancestor
5942144|NCT04791345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5942145|NCT04791345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942146|NCT04791345|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5942147|NCT04791345|Protective Agents|protective agents|mesh-ancestor
5942148|NCT04791345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5942149|NCT04791345|Immunologic Factors|immunologic factors|mesh-ancestor
5967346|NCT04562597|Acetylcysteine|acetylcysteine|mesh-list
5967347|NCT04562597|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5967348|NCT04562597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967349|NCT04562597|Antiviral Agents|antiviral agents|mesh-ancestor
5967350|NCT04562597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5967351|NCT04562597|Expectorants|expectorants|mesh-ancestor
5967352|NCT04562597|Respiratory System Agents|respiratory system agents|mesh-ancestor
5967353|NCT04562597|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5967354|NCT04562597|Antioxidants|antioxidants|mesh-ancestor
5967355|NCT04562597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967356|NCT04562597|Protective Agents|protective agents|mesh-ancestor
5967357|NCT04562597|Antidotes|antidotes|mesh-ancestor
5967358|NCT04561934|Fluorides|fluorides|mesh-list
5967359|NCT04561934|Cariostatic Agents|cariostatic agents|mesh-ancestor
5967360|NCT04561934|Protective Agents|protective agents|mesh-ancestor
5967361|NCT04561934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967362|NCT04561960|Fluorides|fluorides|mesh-list
5967363|NCT04561960|Cariostatic Agents|cariostatic agents|mesh-ancestor
5942150|NCT04791579|Ciprofloxacin|ciprofloxacin|mesh-list
5942151|NCT04791579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5942152|NCT04791579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5942153|NCT04791579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5942154|NCT04791579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5942155|NCT04791579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5942156|NCT04791579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942157|NCT04791579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5942158|NCT04791579|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5942159|NCT04791579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5942160|NCT04791566|Dexamethasone|dexamethasone|mesh-list
5942161|NCT04791566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5942162|NCT04791566|Antiemetics|antiemetics|mesh-ancestor
5942163|NCT04791566|Autonomic Agents|autonomic agents|mesh-ancestor
5942164|NCT04791566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5942165|NCT04791566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942166|NCT04791566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5942167|NCT04791566|Glucocorticoids|glucocorticoids|mesh-ancestor
5942168|NCT04791566|Hormones|hormones|mesh-ancestor
5942169|NCT04791566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5942170|NCT04791566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5942171|NCT04791566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5942172|NCT04791475|Dexamethasone|dexamethasone|mesh-list
5942173|NCT04791475|Dexmedetomidine|dexmedetomidine|mesh-list
5942174|NCT04791475|Bupivacaine|bupivacaine|mesh-list
5942175|NCT04791475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5942176|NCT04791475|Antiemetics|antiemetics|mesh-ancestor
5942177|NCT04791475|Autonomic Agents|autonomic agents|mesh-ancestor
5942178|NCT04791475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5942179|NCT04791475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942180|NCT04791475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5942181|NCT04791475|Glucocorticoids|glucocorticoids|mesh-ancestor
5942182|NCT04791475|Hormones|hormones|mesh-ancestor
5942183|NCT04791475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5942184|NCT04791475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5942185|NCT04791475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5942186|NCT04791475|Anesthetics, Local|anesthetics, local|mesh-ancestor
5942187|NCT04791475|Anesthetics|anesthetics|mesh-ancestor
5942188|NCT04791475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5942189|NCT04791475|Sensory System Agents|sensory system agents|mesh-ancestor
5942190|NCT04791475|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5942191|NCT04791475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5942192|NCT04791475|Analgesics|analgesics|mesh-ancestor
5942193|NCT04791475|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5942194|NCT04791475|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5942195|NCT04791475|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5942196|NCT04791475|Adrenergic Agents|adrenergic agents|mesh-ancestor
5942197|NCT04791475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5942198|NCT04791475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942199|NCT04791202|Methylprednisolone|methylprednisolone|mesh-list
5942200|NCT04791202|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5942201|NCT04791202|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5942202|NCT04791202|Prednisolone|prednisolone|mesh-list
5942203|NCT04791202|Prednisolone acetate|prednisolone acetate|mesh-list
5942204|NCT04791202|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5942205|NCT04791202|Prednisolone phosphate|prednisolone phosphate|mesh-list
5942206|NCT04791202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5942207|NCT04791202|Antiemetics|antiemetics|mesh-ancestor
5942208|NCT04791202|Autonomic Agents|autonomic agents|mesh-ancestor
5942209|NCT04791202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5942210|NCT04791202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942211|NCT04791202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5942212|NCT04791202|Glucocorticoids|glucocorticoids|mesh-ancestor
5942213|NCT04791202|Hormones|hormones|mesh-ancestor
5942214|NCT04791202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5942215|NCT04791202|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5942216|NCT04791202|Protective Agents|protective agents|mesh-ancestor
5942217|NCT04791202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5942218|NCT04791202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5942219|NCT04790838|Fluticasone|fluticasone|mesh-list
5942220|NCT04790838|Xhance|xhance|mesh-list
5942221|NCT04790838|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5942222|NCT04790838|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
5942223|NCT04790838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5942224|NCT04790838|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5942225|NCT04790838|Autonomic Agents|autonomic agents|mesh-ancestor
5942226|NCT04790838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5942227|NCT04790838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942228|NCT04790838|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5942229|NCT04790838|Respiratory System Agents|respiratory system agents|mesh-ancestor
5942230|NCT04790838|Dermatologic Agents|dermatologic agents|mesh-ancestor
5942231|NCT04790838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5942232|NCT04790838|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5942233|NCT04790838|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5942234|NCT04790838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5942235|NCT04790838|Adrenergic Agents|adrenergic agents|mesh-ancestor
5942236|NCT04790838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5942237|NCT04790838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942238|NCT04790838|Glucocorticoids|glucocorticoids|mesh-ancestor
5942239|NCT04790838|Hormones|hormones|mesh-ancestor
5942240|NCT04790838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5942241|NCT04790838|Sympathomimetics|sympathomimetics|mesh-ancestor
5942242|NCT04791020|Lidocaine|lidocaine|mesh-list
5942243|NCT04791020|Anesthetics, Local|anesthetics, local|mesh-ancestor
5942244|NCT04791020|Anesthetics|anesthetics|mesh-ancestor
5942245|NCT04791020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5942246|NCT04791020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942247|NCT04791020|Sensory System Agents|sensory system agents|mesh-ancestor
5942248|NCT04791020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5942249|NCT04791020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5942250|NCT04791020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5942251|NCT04791020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5942252|NCT04791020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5942253|NCT04791020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942254|NCT04791059|Sufentanil|sufentanil|mesh-list
5942255|NCT04791059|Dexmedetomidine|dexmedetomidine|mesh-list
5942256|NCT04791059|Ketamine|ketamine|mesh-list
5942257|NCT04791059|Esketamine|esketamine|mesh-list
5942258|NCT04791059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5942259|NCT04791059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5942260|NCT04791059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942261|NCT04791059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5942262|NCT04791059|Analgesics|analgesics|mesh-ancestor
5942263|NCT04791059|Sensory System Agents|sensory system agents|mesh-ancestor
5942264|NCT04791059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5942265|NCT04791059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5942266|NCT04791059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5942267|NCT04791059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5942268|NCT04791059|Adrenergic Agents|adrenergic agents|mesh-ancestor
5942269|NCT04791059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5942270|NCT04791059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942271|NCT04791059|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5942272|NCT04791059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5942273|NCT04791059|Anesthetics, General|anesthetics, general|mesh-ancestor
5942274|NCT04791059|Anesthetics|anesthetics|mesh-ancestor
5942275|NCT04791059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5942276|NCT04791059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5942277|NCT04791059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5942278|NCT04791059|Narcotics|narcotics|mesh-ancestor
5942279|NCT04791059|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5942280|NCT04791059|Antidepressive Agents|antidepressive agents|mesh-ancestor
5942281|NCT04791059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5942282|NCT04790812|Acetaminophen|acetaminophen|mesh-list
5942283|NCT04790812|Celecoxib|celecoxib|mesh-list
5942284|NCT04790812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5942285|NCT04790812|Analgesics|analgesics|mesh-ancestor
5942286|NCT04790812|Sensory System Agents|sensory system agents|mesh-ancestor
5942287|NCT04790812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5942288|NCT04790812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942289|NCT04790812|Antipyretics|antipyretics|mesh-ancestor
5942290|NCT04790812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5942291|NCT04790812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5942292|NCT04790812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5942293|NCT04790812|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5942294|NCT04790812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5942295|NCT04790812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5942296|NCT04790812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942297|NCT04791046|Antihypertensive Agents|antihypertensive agents|mesh-list
5942298|NCT04790734|Remifentanil|remifentanil|mesh-list
5942299|NCT04790734|Propofol|propofol|mesh-list
5942300|NCT04790734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5942301|NCT04790734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5942302|NCT04790734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942303|NCT04790734|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5942304|NCT04790734|Anesthetics, General|anesthetics, general|mesh-ancestor
5942305|NCT04790734|Anesthetics|anesthetics|mesh-ancestor
5942306|NCT04790734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5942307|NCT04790734|Narcotics|narcotics|mesh-ancestor
5942308|NCT04790734|Analgesics|analgesics|mesh-ancestor
5942309|NCT04790734|Sensory System Agents|sensory system agents|mesh-ancestor
5942310|NCT04790734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5942311|NCT04790383|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
5942312|NCT04790383|Vasodilator Agents|vasodilator agents|mesh-ancestor
5942313|NCT04790383|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
5942314|NCT04790383|Protective Agents|protective agents|mesh-ancestor
5942315|NCT04790383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942316|NCT04790708|Octreotide|octreotide|mesh-list
5942317|NCT04790708|Edotreotide|edotreotide|mesh-list
5942318|NCT04790708|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5942319|NCT04790708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942320|NCT04790708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5942321|NCT04790708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5942322|NCT04790708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5942323|NCT04790409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5942324|NCT04790409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942325|NCT04790409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5942326|NCT04790487|Chlorpheniramine|chlorpheniramine|mesh-list
5942327|NCT04790487|Antipruritics|antipruritics|mesh-ancestor
5942328|NCT04790487|Dermatologic Agents|dermatologic agents|mesh-ancestor
5942329|NCT04790487|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5942330|NCT04790487|Histamine Antagonists|histamine antagonists|mesh-ancestor
5942331|NCT04790487|Histamine Agents|histamine agents|mesh-ancestor
5942332|NCT04790487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5942333|NCT04790487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942334|NCT04790487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942335|NCT04790487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5942336|NCT04790448|Irinotecan|irinotecan|mesh-list
5942337|NCT04790448|Camptothecin|camptothecin|mesh-list
5942338|NCT04790448|Cetuximab|cetuximab|mesh-list
5942339|NCT04790448|Vemurafenib|vemurafenib|mesh-list
5942340|NCT04790448|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5942341|NCT04790448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5942342|NCT04790448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5942343|NCT04790448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942344|NCT04790448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5942345|NCT04790448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5942346|NCT04790448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5942347|NCT04790448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5942348|NCT04790331|Verapamil|verapamil|mesh-list
5942349|NCT04790331|Diltiazem|diltiazem|mesh-list
5942350|NCT04790331|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5942351|NCT04790331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5942352|NCT04790331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5942353|NCT04790331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942354|NCT04790331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5942355|NCT04790331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942356|NCT04790331|Vasodilator Agents|vasodilator agents|mesh-ancestor
5942357|NCT04790331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5942358|NCT04790136|Cannabidiol|cannabidiol|mesh-list
5942359|NCT04790136|Anticonvulsants|anticonvulsants|mesh-ancestor
5942360|NCT04790279|Amlodipine|amlodipine|mesh-list
5942361|NCT04790279|Nifedipine|nifedipine|mesh-list
5942362|NCT04790279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5942363|NCT04790279|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5942364|NCT04790279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5942365|NCT04790279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942366|NCT04790279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5942367|NCT04790279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942368|NCT04790279|Vasodilator Agents|vasodilator agents|mesh-ancestor
5942369|NCT04790279|Tocolytic Agents|tocolytic agents|mesh-ancestor
5942370|NCT04790279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5942371|NCT04790175|Tolvaptan|tolvaptan|mesh-list
5942372|NCT04790175|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
5967364|NCT04561960|Protective Agents|protective agents|mesh-ancestor
5942373|NCT04790175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942374|NCT04790175|Natriuretic Agents|natriuretic agents|mesh-ancestor
5942375|NCT04790175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942376|NCT04789941|Irinotecan|irinotecan|mesh-list
5942377|NCT04789941|Cisplatin|cisplatin|mesh-list
5942378|NCT04789941|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5942379|NCT04789941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5942380|NCT04789941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5942381|NCT04789941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942382|NCT04789941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5942383|NCT04790045|Venetoclax|venetoclax|mesh-list
5942384|NCT04790045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5942385|NCT04789915|Memantine|memantine|mesh-list
5942386|NCT04789915|Amisulpride|amisulpride|mesh-list
5942387|NCT04789915|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5942388|NCT04789915|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5942389|NCT04789915|Dopamine Agents|dopamine agents|mesh-ancestor
5942390|NCT04789915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5942391|NCT04789915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942392|NCT04789915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942393|NCT04789915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5942394|NCT04789915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5942395|NCT04789915|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5942396|NCT04789915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5942397|NCT04789915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5942398|NCT04789915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5942399|NCT04789915|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5942400|NCT04789915|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5942401|NCT04789915|Antidepressive Agents|antidepressive agents|mesh-ancestor
5967365|NCT04561960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967366|NCT04562103|Epinephrine|epinephrine|mesh-list
5967367|NCT04562103|Ropivacaine|ropivacaine|mesh-list
5967368|NCT04562103|Anesthetics, Local|anesthetics, local|mesh-ancestor
5967369|NCT04562103|Anesthetics|anesthetics|mesh-ancestor
5967370|NCT04562103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5967371|NCT04562103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967372|NCT04562103|Sensory System Agents|sensory system agents|mesh-ancestor
5967373|NCT04562103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5967374|NCT04562103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5967375|NCT04562103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5967376|NCT04562103|Adrenergic Agents|adrenergic agents|mesh-ancestor
5967377|NCT04562103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5967378|NCT04562103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967379|NCT04562103|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5967380|NCT04562103|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5967381|NCT04562103|Autonomic Agents|autonomic agents|mesh-ancestor
5967382|NCT04562103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5967383|NCT04562103|Respiratory System Agents|respiratory system agents|mesh-ancestor
5967384|NCT04562103|Mydriatics|mydriatics|mesh-ancestor
5967385|NCT04562103|Sympathomimetics|sympathomimetics|mesh-ancestor
5967386|NCT04562103|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5967387|NCT04561635|Micronutrients|micronutrients|mesh-list
5967388|NCT04561635|Trace Elements|trace elements|mesh-list
5967389|NCT04561635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967390|NCT04561921|Magnesium Sulfate|magnesium sulfate|mesh-list
5967391|NCT04561921|Nordefrin|nordefrin|mesh-list
5967392|NCT04561921|Mepivacaine|mepivacaine|mesh-list
5967393|NCT04561921|Analgesics|analgesics|mesh-ancestor
5967394|NCT04561921|Sensory System Agents|sensory system agents|mesh-ancestor
5967395|NCT04561921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5967396|NCT04561921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967397|NCT04561921|Anesthetics|anesthetics|mesh-ancestor
5967398|NCT04561921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5967399|NCT04561921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5967400|NCT04561921|Anticonvulsants|anticonvulsants|mesh-ancestor
5967401|NCT04561921|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5967402|NCT04561921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5967403|NCT04561921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967404|NCT04561921|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5967405|NCT04561921|Tocolytic Agents|tocolytic agents|mesh-ancestor
5967406|NCT04561921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5967407|NCT04561921|Anesthetics, Local|anesthetics, local|mesh-ancestor
5967408|NCT04561921|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5967409|NCT04561687|Azelastine|azelastine|mesh-list
5967410|NCT04561687|Budesonide|budesonide|mesh-list
5967411|NCT04561687|Montelukast|montelukast|mesh-list
5942402|NCT04789668|Atezolizumab|atezolizumab|mesh-list
5942403|NCT04789668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5942404|NCT04790032|Cangrelor|cangrelor|mesh-list
5942405|NCT04790032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5942406|NCT04790032|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5942407|NCT04790032|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5942408|NCT04790032|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5942409|NCT04790032|Purinergic Agents|purinergic agents|mesh-ancestor
5942410|NCT04790032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5942411|NCT04790032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942412|NCT04790032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942413|NCT04789837|Cilostazol|cilostazol|mesh-list
5942414|NCT04789837|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5942415|NCT04789837|Autonomic Agents|autonomic agents|mesh-ancestor
5942416|NCT04789837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5942417|NCT04789837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942418|NCT04789837|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5942419|NCT04789837|Respiratory System Agents|respiratory system agents|mesh-ancestor
5942420|NCT04789837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5942421|NCT04789837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5942422|NCT04789837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942423|NCT04789837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5942424|NCT04789837|Vasodilator Agents|vasodilator agents|mesh-ancestor
5942425|NCT04789837|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5942426|NCT04789837|Protective Agents|protective agents|mesh-ancestor
5942427|NCT04789837|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5942428|NCT04789837|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5942429|NCT04789837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5942430|NCT04789330|Phenylephrine|phenylephrine|mesh-list
5942431|NCT04789330|Oxymetazoline|oxymetazoline|mesh-list
5942432|NCT04789330|Norepinephrine|norepinephrine|mesh-list
5942433|NCT04789330|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5942434|NCT04789330|Mydriatics|mydriatics|mesh-ancestor
5942435|NCT04789330|Autonomic Agents|autonomic agents|mesh-ancestor
5942436|NCT04789330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5942437|NCT04789330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942438|NCT04789330|Sympathomimetics|sympathomimetics|mesh-ancestor
5942439|NCT04789330|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5942440|NCT04789330|Nasal Decongestants|nasal decongestants|mesh-ancestor
5942441|NCT04789330|Respiratory System Agents|respiratory system agents|mesh-ancestor
5942442|NCT04789330|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5942443|NCT04789330|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5942444|NCT04789330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5942445|NCT04789330|Adrenergic Agents|adrenergic agents|mesh-ancestor
5942446|NCT04789330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5942447|NCT04789330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942448|NCT04789330|Protective Agents|protective agents|mesh-ancestor
5942449|NCT04789005|Phenylephrine|phenylephrine|mesh-list
5942450|NCT04789005|Oxymetazoline|oxymetazoline|mesh-list
5942451|NCT04789005|Norepinephrine|norepinephrine|mesh-list
5942452|NCT04789005|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5942453|NCT04789005|Mydriatics|mydriatics|mesh-ancestor
5942454|NCT04789005|Autonomic Agents|autonomic agents|mesh-ancestor
5942455|NCT04789005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5942456|NCT04789005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942457|NCT04789005|Sympathomimetics|sympathomimetics|mesh-ancestor
5942458|NCT04789005|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5942459|NCT04789005|Nasal Decongestants|nasal decongestants|mesh-ancestor
5942460|NCT04789005|Respiratory System Agents|respiratory system agents|mesh-ancestor
5942461|NCT04789005|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5942462|NCT04789005|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5942463|NCT04789005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5942464|NCT04789005|Adrenergic Agents|adrenergic agents|mesh-ancestor
5942465|NCT04789005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5942466|NCT04789005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942467|NCT04789005|Protective Agents|protective agents|mesh-ancestor
5942468|NCT04788979|Melatonin|melatonin|mesh-list
5942469|NCT04788979|Antioxidants|antioxidants|mesh-ancestor
5942470|NCT04788979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942471|NCT04788979|Protective Agents|protective agents|mesh-ancestor
5942472|NCT04788979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942473|NCT04788979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5942474|NCT04788667|Erenumab|erenumab|mesh-list
5942475|NCT04788667|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
5942476|NCT04788667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942477|NCT04788667|Analgesics|analgesics|mesh-ancestor
5942478|NCT04788667|Sensory System Agents|sensory system agents|mesh-ancestor
5942479|NCT04788667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5942480|NCT04788667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942481|NCT04788641|Cyclosporine|cyclosporine|mesh-list
5942482|NCT04788641|Tacrolimus|tacrolimus|mesh-list
5942483|NCT04788641|Cyclosporins|cyclosporins|mesh-list
5942484|NCT04788641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5942485|NCT04788641|Immunologic Factors|immunologic factors|mesh-ancestor
5942486|NCT04788641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942487|NCT04788641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5942488|NCT04788641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5942489|NCT04788641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942490|NCT04788641|Antifungal Agents|antifungal agents|mesh-ancestor
5942491|NCT04788641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5942492|NCT04788641|Dermatologic Agents|dermatologic agents|mesh-ancestor
5942493|NCT04788641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5942494|NCT04788823|Prednisone|prednisone|mesh-list
5942495|NCT04788823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5942496|NCT04788823|Glucocorticoids|glucocorticoids|mesh-ancestor
5942497|NCT04788823|Hormones|hormones|mesh-ancestor
5942498|NCT04788823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5942499|NCT04788823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942500|NCT04788823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5942501|NCT04788823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5942502|NCT04788914|Charcoal|charcoal|mesh-list
5942503|NCT04788914|Antidotes|antidotes|mesh-ancestor
5942504|NCT04788914|Protective Agents|protective agents|mesh-ancestor
5942505|NCT04788914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942506|NCT04788654|Acetaminophen|acetaminophen|mesh-list
5942507|NCT04788654|Dexamethasone|dexamethasone|mesh-list
5942508|NCT04788654|Celecoxib|celecoxib|mesh-list
5942509|NCT04788654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5942510|NCT04788654|Antiemetics|antiemetics|mesh-ancestor
5942511|NCT04788654|Autonomic Agents|autonomic agents|mesh-ancestor
5942512|NCT04788654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5942513|NCT04788654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942514|NCT04788654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5942515|NCT04788654|Glucocorticoids|glucocorticoids|mesh-ancestor
5942516|NCT04788654|Hormones|hormones|mesh-ancestor
5942517|NCT04788654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5942518|NCT04788654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5942519|NCT04788654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5942520|NCT04788654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5942521|NCT04788654|Analgesics|analgesics|mesh-ancestor
5942522|NCT04788654|Sensory System Agents|sensory system agents|mesh-ancestor
5942523|NCT04788654|Antipyretics|antipyretics|mesh-ancestor
5942524|NCT04788654|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5942525|NCT04788654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5942526|NCT04788654|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5942527|NCT04788654|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5942528|NCT04788654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5942529|NCT04788654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942530|NCT04789096|Pembrolizumab|pembrolizumab|mesh-list
5942531|NCT04789096|Trastuzumab|trastuzumab|mesh-list
5942532|NCT04789096|Capecitabine|capecitabine|mesh-list
5942533|NCT04789096|Tucatinib|tucatinib|mesh-list
5942534|NCT04789096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5942535|NCT04789096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5942536|NCT04789096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5942537|NCT04789096|Antimetabolites|antimetabolites|mesh-ancestor
5942538|NCT04789096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942539|NCT04789096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5942540|NCT04789096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5942541|NCT04789057|Atorvastatin|atorvastatin|mesh-list
5942542|NCT04789057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5942543|NCT04789057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5942544|NCT04789057|Antimetabolites|antimetabolites|mesh-ancestor
5942545|NCT04789057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942546|NCT04789057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5942547|NCT04789057|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5942548|NCT04789057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5942549|NCT04788745|Trimetazidine|trimetazidine|mesh-list
5942550|NCT04788745|Vasodilator Agents|vasodilator agents|mesh-ancestor
5942551|NCT04788355|Hydroxychloroquine|hydroxychloroquine|mesh-list
5942552|NCT04788355|Apixaban|apixaban|mesh-list
5942553|NCT04788355|Antimalarials|antimalarials|mesh-ancestor
5942554|NCT04788355|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5942555|NCT04788355|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5942556|NCT04788355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5942557|NCT04788355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5942558|NCT04788355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942559|NCT04788355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5942560|NCT04788355|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5942561|NCT04788355|Antithrombins|antithrombins|mesh-ancestor
5942562|NCT04788355|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5942563|NCT04788355|Protease Inhibitors|protease inhibitors|mesh-ancestor
5942564|NCT04788355|Anticoagulants|anticoagulants|mesh-ancestor
5942565|NCT04788381|Bevacizumab|bevacizumab|mesh-list
5942566|NCT04788381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5942567|NCT04788381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5942568|NCT04788381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5942569|NCT04788381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5942570|NCT04788381|Growth Substances|growth substances|mesh-ancestor
5942571|NCT04788381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942572|NCT04788381|Growth Inhibitors|growth inhibitors|mesh-ancestor
5942573|NCT04788420|Sorafenib|sorafenib|mesh-list
5942574|NCT04788420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5942575|NCT04788420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5942576|NCT04788420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5942577|NCT04788420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942578|NCT04788407|Nitazoxanide|nitazoxanide|mesh-list
5942579|NCT04788407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5942580|NCT04788407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5942581|NCT04788043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5942582|NCT04788043|Pembrolizumab|pembrolizumab|mesh-list
5942583|NCT04788043|Magrolimab|magrolimab|mesh-list
5942584|NCT04788043|Antibodies|antibodies|mesh-list
5942585|NCT04788043|Immunoglobulins|immunoglobulins|mesh-list
5942586|NCT04788043|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5942587|NCT04788043|Immunologic Factors|immunologic factors|mesh-ancestor
5942588|NCT04788043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942589|NCT04788043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5942590|NCT04788121|Tranexamic Acid|tranexamic acid|mesh-list
5942591|NCT04788121|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5942592|NCT04788121|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5942593|NCT04788121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942594|NCT04788121|Hemostatics|hemostatics|mesh-ancestor
5942595|NCT04788121|Coagulants|coagulants|mesh-ancestor
5942596|NCT04788186|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
5942597|NCT04788186|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5942598|NCT04788186|Adrenergic Agents|adrenergic agents|mesh-ancestor
5942599|NCT04788186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5942600|NCT04788186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942601|NCT04788186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942602|NCT04788108|Dydrogesterone|dydrogesterone|mesh-list
5942603|NCT04788108|Progestins|progestins|mesh-ancestor
5942604|NCT04788108|Hormones|hormones|mesh-ancestor
5942605|NCT04788108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5942606|NCT04788108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967412|NCT04561687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5967413|NCT04561687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5967414|NCT04561687|Autonomic Agents|autonomic agents|mesh-ancestor
5967415|NCT04561687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5967416|NCT04561687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967417|NCT04561687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5967418|NCT04561687|Respiratory System Agents|respiratory system agents|mesh-ancestor
5967419|NCT04561687|Glucocorticoids|glucocorticoids|mesh-ancestor
5967420|NCT04561687|Hormones|hormones|mesh-ancestor
5967421|NCT04561687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5967422|NCT04561687|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5967423|NCT04561687|Hormone Antagonists|hormone antagonists|mesh-ancestor
5967424|NCT04561687|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5967425|NCT04561687|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5967426|NCT04561687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967427|NCT04561687|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
5967428|NCT04561687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5967429|NCT04561687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5967430|NCT04561687|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5967431|NCT04561687|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5942607|NCT04787848|Bromides|bromides|mesh-list
5942608|NCT04787848|Methylnaltrexone|methylnaltrexone|mesh-list
5942609|NCT04787848|Anticonvulsants|anticonvulsants|mesh-ancestor
5942610|NCT04787848|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5942611|NCT04787848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942612|NCT04787848|Sensory System Agents|sensory system agents|mesh-ancestor
5942613|NCT04787848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5942614|NCT04787510|Heparin|heparin|mesh-list
5942615|NCT04787510|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5942616|NCT04787510|Tinzaparin|tinzaparin|mesh-list
5942617|NCT04787510|Dalteparin|dalteparin|mesh-list
5942618|NCT04787510|Anticoagulants|anticoagulants|mesh-ancestor
5942619|NCT04787510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5942620|NCT04787510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5942621|NCT04787510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5720025|NCT03215602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5720026|NCT03215602|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
5720027|NCT03215602|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5720028|NCT03215602|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5720029|NCT03215602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5720030|NCT03215602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720031|NCT03215719|Cisplatin|cisplatin|mesh-list
5720032|NCT03215719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5720033|NCT03216096|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5720034|NCT03216096|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5720035|NCT03215966|Tadalafil|tadalafil|mesh-list
5720036|NCT03215966|Macitentan|macitentan|mesh-list
5720037|NCT03215966|Vasodilator Agents|vasodilator agents|mesh-ancestor
5720038|NCT03215966|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5720039|NCT03215966|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5720040|NCT03215966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5720041|NCT03215966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942622|NCT04787341|Panitumumab|panitumumab|mesh-list
5942623|NCT04787341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5942624|NCT04787341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5942625|NCT04787471|Riboflavin|riboflavin|mesh-list
5942626|NCT04787471|Vitamin B Complex|vitamin b complex|mesh-ancestor
5942627|NCT04787471|Vitamins|vitamins|mesh-ancestor
5942628|NCT04787471|Micronutrients|micronutrients|mesh-ancestor
5942629|NCT04787471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942630|NCT04787471|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5942631|NCT04787471|Dermatologic Agents|dermatologic agents|mesh-ancestor
5942632|NCT04787731|Lidocaine|lidocaine|mesh-list
5942633|NCT04787731|Bupivacaine|bupivacaine|mesh-list
5942634|NCT04787731|Anesthetics, Local|anesthetics, local|mesh-list
5942635|NCT04787731|Anesthetics|anesthetics|mesh-list
5942636|NCT04787731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5942637|NCT04787731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942638|NCT04787731|Sensory System Agents|sensory system agents|mesh-ancestor
5942639|NCT04787731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5942640|NCT04787731|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5942641|NCT04787731|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5942642|NCT04787731|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6517315|NCT00720538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517316|NCT00720538|Leprostatic Agents|leprostatic agents|mesh-ancestor
6517317|NCT00720538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6517318|NCT00720538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6517319|NCT00720538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6517320|NCT00720538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6517321|NCT00720538|Growth Substances|growth substances|mesh-ancestor
6517322|NCT00720538|Growth Inhibitors|growth inhibitors|mesh-ancestor
6517323|NCT00720538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6517324|NCT00720564|Temozolomide|temozolomide|mesh-list
6517325|NCT00720564|Arsenic Trioxide|arsenic trioxide|mesh-list
6517326|NCT00720564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6517327|NCT00720564|Alkylating Agents|alkylating agents|mesh-ancestor
6517328|NCT00720564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517329|NCT00720564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6517330|NCT00720577|Pioglitazone|pioglitazone|mesh-list
6517331|NCT00720577|Losartan|losartan|mesh-list
6517332|NCT00720577|Simvastatin|simvastatin|mesh-list
6517333|NCT00720577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6517334|NCT00720577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6517335|NCT00720577|Antimetabolites|antimetabolites|mesh-ancestor
6517336|NCT00720577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681308|NCT01609049|Ribavirin|ribavirin|mesh-list
5942643|NCT04787731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5942644|NCT04787731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942645|NCT04787289|Bevacizumab|bevacizumab|mesh-list
5942646|NCT04787289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5942647|NCT04787289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5942648|NCT04787289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5942649|NCT04787289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5942650|NCT04787289|Growth Substances|growth substances|mesh-ancestor
5942651|NCT04787289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942652|NCT04787289|Growth Inhibitors|growth inhibitors|mesh-ancestor
5942653|NCT04787276|Rifaximin|rifaximin|mesh-list
5942654|NCT04787276|Lactulose|lactulose|mesh-list
5942655|NCT04787276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5942656|NCT04787276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5942657|NCT04787276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5942658|NCT04786795|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
5942659|NCT04786795|Pancreatin|pancreatin|mesh-list
5942660|NCT04786795|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5942661|NCT04786795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5942662|NCT04786613|Hyaluronic Acid|hyaluronic acid|mesh-list
5942663|NCT04786613|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5942664|NCT04786613|Immunologic Factors|immunologic factors|mesh-ancestor
5942665|NCT04786613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942666|NCT04786613|Viscosupplements|viscosupplements|mesh-ancestor
5942667|NCT04786613|Protective Agents|protective agents|mesh-ancestor
5942668|NCT04786873|Clonidine|clonidine|mesh-list
5942669|NCT04786873|Analgesics|analgesics|mesh-ancestor
5942670|NCT04786873|Sensory System Agents|sensory system agents|mesh-ancestor
5942671|NCT04786873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5942672|NCT04786873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942673|NCT04786873|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5942674|NCT04786873|Sympatholytics|sympatholytics|mesh-ancestor
5942675|NCT04786873|Autonomic Agents|autonomic agents|mesh-ancestor
5942676|NCT04786873|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5942677|NCT04786873|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5942678|NCT04786873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5942679|NCT04786873|Adrenergic Agents|adrenergic agents|mesh-ancestor
5942680|NCT04786873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5942681|NCT04786873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942682|NCT04786574|Tolvaptan|tolvaptan|mesh-list
5942683|NCT04786574|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
5942684|NCT04786574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942685|NCT04786574|Natriuretic Agents|natriuretic agents|mesh-ancestor
5942686|NCT04786574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942687|NCT04786548|Celecoxib|celecoxib|mesh-list
5942688|NCT04786548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5942689|NCT04786548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5942690|NCT04786548|Analgesics|analgesics|mesh-ancestor
5942691|NCT04786548|Sensory System Agents|sensory system agents|mesh-ancestor
5942692|NCT04786548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5942693|NCT04786548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942694|NCT04786548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5942695|NCT04786548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5942696|NCT04786548|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5942697|NCT04786548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5942698|NCT04786548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5942699|NCT04786548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942700|NCT04786275|Fentanyl|fentanyl|mesh-list
5942701|NCT04786275|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5942702|NCT04786275|Narcotics|narcotics|mesh-ancestor
5942703|NCT04786275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5942704|NCT04786275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942705|NCT04786275|Analgesics|analgesics|mesh-ancestor
5942706|NCT04786275|Sensory System Agents|sensory system agents|mesh-ancestor
5942707|NCT04786275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5942708|NCT04786275|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5942709|NCT04786275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5942710|NCT04786275|Anesthetics, General|anesthetics, general|mesh-ancestor
5942711|NCT04786275|Anesthetics|anesthetics|mesh-ancestor
5942712|NCT04786158|Apomorphine|apomorphine|mesh-list
5942713|NCT04786158|Emetics|emetics|mesh-ancestor
5942714|NCT04786158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942715|NCT04786158|Autonomic Agents|autonomic agents|mesh-ancestor
5942716|NCT04786158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5942717|NCT04786158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5942718|NCT04786158|Dopamine Agonists|dopamine agonists|mesh-ancestor
5942719|NCT04786158|Dopamine Agents|dopamine agents|mesh-ancestor
5942720|NCT04786158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5942721|NCT04786158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942722|NCT04786340|Pirenzepine|pirenzepine|mesh-list
5942723|NCT04786340|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5942724|NCT04786340|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5942725|NCT04786340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5942726|NCT04786340|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5942727|NCT04786340|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5942728|NCT04786340|Cholinergic Agents|cholinergic agents|mesh-ancestor
5942729|NCT04786340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5942730|NCT04786340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942731|NCT04786340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942732|NCT04786327|Edetic Acid|edetic acid|mesh-list
5942733|NCT04786327|Mitogens|mitogens|mesh-list
5942734|NCT04786327|Pentetic Acid|pentetic acid|mesh-list
5942735|NCT04786327|Mitosis Modulators|mitosis modulators|mesh-ancestor
5942736|NCT04786327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942737|NCT04786327|Anticoagulants|anticoagulants|mesh-ancestor
5942738|NCT04786327|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5942739|NCT04786327|Chelating Agents|chelating agents|mesh-ancestor
5942740|NCT04786327|Sequestering Agents|sequestering agents|mesh-ancestor
5942741|NCT04786327|Antidotes|antidotes|mesh-ancestor
5942742|NCT04786327|Protective Agents|protective agents|mesh-ancestor
5942743|NCT04786327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942744|NCT04786327|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5942745|NCT04786470|Ropivacaine|ropivacaine|mesh-list
5942746|NCT04786470|Anesthetics, Local|anesthetics, local|mesh-ancestor
5942747|NCT04786470|Anesthetics|anesthetics|mesh-ancestor
5942748|NCT04786470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5942749|NCT04786470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942750|NCT04786470|Sensory System Agents|sensory system agents|mesh-ancestor
5942751|NCT04786470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5967432|NCT04561687|Histamine Antagonists|histamine antagonists|mesh-ancestor
5967433|NCT04561687|Histamine Agents|histamine agents|mesh-ancestor
5967434|NCT04561687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5967435|NCT04561947|Mitogens|mitogens|mesh-list
5967436|NCT04561947|Mitosis Modulators|mitosis modulators|mesh-ancestor
5967437|NCT04561947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967438|NCT04561739|Aspirin|aspirin|mesh-list
5967439|NCT04561739|Sirolimus|sirolimus|mesh-list
5967440|NCT04561739|Paclitaxel|paclitaxel|mesh-list
5967441|NCT04561739|Clopidogrel|clopidogrel|mesh-list
5967442|NCT04561739|Ticagrelor|ticagrelor|mesh-list
5967443|NCT04561739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5967444|NCT04561739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5967445|NCT04561739|Tubulin Modulators|tubulin modulators|mesh-ancestor
5967446|NCT04561739|Antimitotic Agents|antimitotic agents|mesh-ancestor
5967447|NCT04561739|Mitosis Modulators|mitosis modulators|mesh-ancestor
5967448|NCT04561739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967449|NCT04561739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5967450|NCT04561739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5967451|NCT04561739|Analgesics|analgesics|mesh-ancestor
5967452|NCT04561739|Sensory System Agents|sensory system agents|mesh-ancestor
5967453|NCT04561739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5967454|NCT04561739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967455|NCT04561739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5967456|NCT04561739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5967457|NCT04561739|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5967458|NCT04561739|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5967459|NCT04561739|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5967460|NCT04561739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5967461|NCT04561739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5967462|NCT04561739|Antipyretics|antipyretics|mesh-ancestor
5967463|NCT04561739|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5967464|NCT04561739|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5967465|NCT04561739|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5967466|NCT04561739|Purinergic Agents|purinergic agents|mesh-ancestor
5967467|NCT04561739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5967468|NCT04561739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5967469|NCT04561739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5967470|NCT04561739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5967471|NCT04561739|Antifungal Agents|antifungal agents|mesh-ancestor
5967472|NCT04561739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5967473|NCT04561739|Immunologic Factors|immunologic factors|mesh-ancestor
5967474|NCT04561466|Bezafibrate|bezafibrate|mesh-list
5967475|NCT04561466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5942752|NCT04786093|Durvalumab|durvalumab|mesh-list
5942753|NCT04786093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5942754|NCT04786093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5942755|NCT04785716|Niraparib|niraparib|mesh-list
5942756|NCT04785716|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5942757|NCT04785716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5942758|NCT04785716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942759|NCT04785716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5942760|NCT04785755|Etilefrine|etilefrine|mesh-list
5942761|NCT04785755|Furosemide|furosemide|mesh-list
5942762|NCT04785755|Spironolactone|spironolactone|mesh-list
5942763|NCT04785755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5942764|NCT04785755|Diuretics|diuretics|mesh-list
5942765|NCT04785755|Natriuretic Agents|natriuretic agents|mesh-ancestor
5942766|NCT04785755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942767|NCT04785755|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5942768|NCT04785755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5942769|NCT04785755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942770|NCT04785755|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5942771|NCT04785755|Hormone Antagonists|hormone antagonists|mesh-ancestor
5942772|NCT04785755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5942773|NCT04785755|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5942774|NCT04785755|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5942775|NCT04785755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5942776|NCT04785755|Adrenergic Agents|adrenergic agents|mesh-ancestor
5942777|NCT04785755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5942778|NCT04785755|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5942779|NCT04785755|Sympathomimetics|sympathomimetics|mesh-ancestor
5942780|NCT04785755|Autonomic Agents|autonomic agents|mesh-ancestor
5942781|NCT04785755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5942782|NCT04785755|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5942783|NCT04785755|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5942784|NCT04785755|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5942785|NCT04785755|Protective Agents|protective agents|mesh-ancestor
5942786|NCT04786002|Busulfan|busulfan|mesh-list
5942787|NCT04786002|Alkylating Agents|alkylating agents|mesh-ancestor
5942788|NCT04786002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942789|NCT04786002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5942790|NCT04786002|Immunologic Factors|immunologic factors|mesh-ancestor
5942791|NCT04786002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942792|NCT04786002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5942793|NCT04786002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5942794|NCT04786002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5942795|NCT04785924|Imipenem|imipenem|mesh-list
5942796|NCT04785924|Relebactam|relebactam|mesh-list
5942797|NCT04785924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5942798|NCT04785924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5942799|NCT04785924|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5942800|NCT04785924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5942801|NCT04785924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942802|NCT04785911|Antiemetics|antiemetics|mesh-list
5942803|NCT04785911|Histamine|histamine|mesh-list
5942804|NCT04785911|Histamine Agonists|histamine agonists|mesh-ancestor
5942805|NCT04785911|Histamine Agents|histamine agents|mesh-ancestor
5942806|NCT04785911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5942807|NCT04785911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942808|NCT04785911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942809|NCT04785911|Autonomic Agents|autonomic agents|mesh-ancestor
5942810|NCT04785911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5942811|NCT04785911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5942812|NCT04785768|Morphine|morphine|mesh-list
5942813|NCT04785768|Hydromorphone|hydromorphone|mesh-list
5942814|NCT04785768|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5942815|NCT04785768|Narcotics|narcotics|mesh-ancestor
5942816|NCT04785768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5720042|NCT03215966|Urological Agents|urological agents|mesh-ancestor
5720043|NCT03215966|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
5720044|NCT03215966|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5720045|NCT03215966|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
5720046|NCT03215498|Insulin|insulin|mesh-list
5720047|NCT03215498|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5720048|NCT03215498|Insulin Aspart|insulin aspart|mesh-list
5720049|NCT03215498|Insulin, Long-Acting|insulin, long-acting|mesh-list
5942817|NCT04785768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942818|NCT04785768|Analgesics|analgesics|mesh-ancestor
5942819|NCT04785768|Sensory System Agents|sensory system agents|mesh-ancestor
5942820|NCT04785768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5942821|NCT04785651|Tranexamic Acid|tranexamic acid|mesh-list
5942822|NCT04785651|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5942823|NCT04785651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5942824|NCT04785651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942825|NCT04785651|Hemostatics|hemostatics|mesh-ancestor
5942826|NCT04785651|Coagulants|coagulants|mesh-ancestor
5942827|NCT04785547|Blinatumomab|blinatumomab|mesh-list
5942828|NCT04785547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5942829|NCT04785183|Melatonin|melatonin|mesh-list
5942830|NCT04785183|Antioxidants|antioxidants|mesh-ancestor
5942831|NCT04785183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942832|NCT04785183|Protective Agents|protective agents|mesh-ancestor
5942833|NCT04785183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942834|NCT04785183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5942835|NCT04785118|Scopolamine|scopolamine|mesh-list
5942836|NCT04785118|Ondansetron|ondansetron|mesh-list
5942837|NCT04785118|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
5942838|NCT04785118|Antiemetics|antiemetics|mesh-ancestor
5942839|NCT04785118|Autonomic Agents|autonomic agents|mesh-ancestor
5942840|NCT04785118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5942841|NCT04785118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942842|NCT04785118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5942843|NCT04785118|Antipruritics|antipruritics|mesh-ancestor
5942844|NCT04785118|Dermatologic Agents|dermatologic agents|mesh-ancestor
5942845|NCT04785118|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5942846|NCT04785118|Serotonin Agents|serotonin agents|mesh-ancestor
5720050|NCT03215498|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
5720051|NCT03215498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5720052|NCT03215498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720053|NCT03215446|Anesthetics|anesthetics|mesh-list
5720054|NCT03215446|Propofol|propofol|mesh-list
5720055|NCT03215446|Sevoflurane|sevoflurane|mesh-list
5720056|NCT03215446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5720057|NCT03215446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720058|NCT03215446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5720059|NCT03215446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5720060|NCT03215446|Anesthetics, General|anesthetics, general|mesh-ancestor
5942847|NCT04785118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5942848|NCT04785118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942849|NCT04785118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5942850|NCT04785118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5942851|NCT04785118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5942852|NCT04785118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5942853|NCT04785118|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5942854|NCT04785118|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5942855|NCT04785118|Mydriatics|mydriatics|mesh-ancestor
5942856|NCT04785118|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5942857|NCT04785118|Cholinergic Agents|cholinergic agents|mesh-ancestor
5942858|NCT04785118|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5942859|NCT04785118|Parasympatholytics|parasympatholytics|mesh-ancestor
5942860|NCT04785222|Dexmedetomidine|dexmedetomidine|mesh-list
5942861|NCT04785222|Bupivacaine|bupivacaine|mesh-list
5942862|NCT04785222|Anesthetics, Local|anesthetics, local|mesh-ancestor
5942863|NCT04785222|Anesthetics|anesthetics|mesh-ancestor
5942864|NCT04785222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5942865|NCT04785222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942866|NCT04785222|Sensory System Agents|sensory system agents|mesh-ancestor
5942867|NCT04785222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5942868|NCT04785222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5942869|NCT04785222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5942870|NCT04785222|Analgesics|analgesics|mesh-ancestor
5942871|NCT04785222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5942872|NCT04785222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5942873|NCT04785222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5942874|NCT04785222|Adrenergic Agents|adrenergic agents|mesh-ancestor
5942875|NCT04785222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5942876|NCT04785222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942877|NCT04784754|Melatonin|melatonin|mesh-list
5942878|NCT04784754|Antioxidants|antioxidants|mesh-ancestor
5942879|NCT04784754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942880|NCT04784754|Protective Agents|protective agents|mesh-ancestor
5942881|NCT04784754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942882|NCT04784754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5942883|NCT04784988|BAX 855|bax 855|mesh-list
5942884|NCT04784988|Coagulants|coagulants|mesh-ancestor
5942885|NCT04784728|Lidocaine|lidocaine|mesh-list
5942886|NCT04784728|Anesthetics, Local|anesthetics, local|mesh-ancestor
5942887|NCT04784728|Anesthetics|anesthetics|mesh-ancestor
5942888|NCT04784728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5942889|NCT04784728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942890|NCT04784728|Sensory System Agents|sensory system agents|mesh-ancestor
5942891|NCT04784728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5942892|NCT04784728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5942893|NCT04784728|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5942894|NCT04784728|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5942895|NCT04784728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5942896|NCT04784728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942897|NCT04784910|Lansoprazole|lansoprazole|mesh-list
5942898|NCT04784910|Dexlansoprazole|dexlansoprazole|mesh-list
5942899|NCT04784910|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5942900|NCT04784910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5942901|NCT04784910|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5942902|NCT04784910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5942903|NCT04784910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942904|NCT04784767|Saponin QA-21V1|saponin qa-21v1|mesh-list
5942905|NCT04784767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5942906|NCT04784767|Immunologic Factors|immunologic factors|mesh-ancestor
5942907|NCT04784767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942908|NCT04784481|Ivermectin|ivermectin|mesh-list
5942909|NCT04784481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5942910|NCT04784481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5942911|NCT04784442|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
5942912|NCT04784442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5942913|NCT04784442|Antimetabolites|antimetabolites|mesh-ancestor
5942914|NCT04784442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942915|NCT04784442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5942916|NCT04784442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5942917|NCT04784442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5942918|NCT04784442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967476|NCT04561466|Antimetabolites|antimetabolites|mesh-ancestor
5967477|NCT04561466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967478|NCT04561466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5967479|NCT04561856|Dexamethasone|dexamethasone|mesh-list
5967480|NCT04561856|Dexamethasone acetate|dexamethasone acetate|mesh-list
5967481|NCT04561856|BB 1101|bb 1101|mesh-list
5967482|NCT04561856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5967483|NCT04561856|Antiemetics|antiemetics|mesh-ancestor
5967484|NCT04561856|Autonomic Agents|autonomic agents|mesh-ancestor
5967485|NCT04561856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5967486|NCT04561856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967487|NCT04561856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5967488|NCT04561856|Glucocorticoids|glucocorticoids|mesh-ancestor
5967489|NCT04561856|Hormones|hormones|mesh-ancestor
5967490|NCT04561856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5967491|NCT04561856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5967492|NCT04561856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5967493|NCT04561856|Protease Inhibitors|protease inhibitors|mesh-ancestor
5967494|NCT04561856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5967495|NCT04561856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967496|NCT04561817|Paclitaxel|paclitaxel|mesh-list
5967497|NCT04561817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5967498|NCT04561817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5967499|NCT04561817|Tubulin Modulators|tubulin modulators|mesh-ancestor
5967500|NCT04561817|Antimitotic Agents|antimitotic agents|mesh-ancestor
5967501|NCT04561817|Mitosis Modulators|mitosis modulators|mesh-ancestor
5967502|NCT04561817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967503|NCT04561648|Heparin|heparin|mesh-list
5967504|NCT04561648|Calcium heparin|calcium heparin|mesh-list
5967505|NCT04561648|Anticoagulants|anticoagulants|mesh-ancestor
5967506|NCT04561648|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5967507|NCT04561648|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5967508|NCT04561648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967509|NCT04561219|Nitazoxanide|nitazoxanide|mesh-list
5967510|NCT04561219|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5967511|NCT04561219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5967512|NCT04561375|Fentanyl|fentanyl|mesh-list
5967513|NCT04561375|Sufentanil|sufentanil|mesh-list
5967514|NCT04561375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5967515|NCT04561375|Narcotics|narcotics|mesh-ancestor
5942919|NCT04784247|Pembrolizumab|pembrolizumab|mesh-list
5942920|NCT04784247|Lenvatinib|lenvatinib|mesh-list
5942921|NCT04784247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5942922|NCT04784247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5942923|NCT04784247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5942924|NCT04784247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5942925|NCT04784247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942926|NCT04784039|Fibrin fragment D|fibrin fragment d|mesh-list
5942927|NCT04784039|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5942928|NCT04784039|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5942929|NCT04784039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942930|NCT04784039|Hemostatics|hemostatics|mesh-ancestor
5942931|NCT04784039|Coagulants|coagulants|mesh-ancestor
5942932|NCT04784104|Epinephrine|epinephrine|mesh-list
5942933|NCT04784104|Racepinephrine|racepinephrine|mesh-list
5942934|NCT04784104|Bupivacaine|bupivacaine|mesh-list
5942935|NCT04784104|Prilocaine|prilocaine|mesh-list
5942936|NCT04784104|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5942937|NCT04784104|Epinephryl borate|epinephryl borate|mesh-list
5942938|NCT04784104|Anesthetics, Local|anesthetics, local|mesh-ancestor
5942939|NCT04784104|Anesthetics|anesthetics|mesh-ancestor
5942940|NCT04784104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5942941|NCT04784104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942942|NCT04784104|Sensory System Agents|sensory system agents|mesh-ancestor
5942943|NCT04784104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5942944|NCT04784104|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5942945|NCT04784104|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5942946|NCT04784104|Adrenergic Agents|adrenergic agents|mesh-ancestor
5942947|NCT04784104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5942948|NCT04784104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942949|NCT04784104|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5942950|NCT04784104|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5942951|NCT04784104|Autonomic Agents|autonomic agents|mesh-ancestor
5942952|NCT04784104|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5942953|NCT04784104|Respiratory System Agents|respiratory system agents|mesh-ancestor
5942954|NCT04784104|Mydriatics|mydriatics|mesh-ancestor
5942955|NCT04784104|Sympathomimetics|sympathomimetics|mesh-ancestor
5942956|NCT04784104|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5942957|NCT04784000|Carbamazepine|carbamazepine|mesh-list
5942958|NCT04784000|Anticonvulsants|anticonvulsants|mesh-ancestor
5942959|NCT04784000|Antimanic Agents|antimanic agents|mesh-ancestor
5942960|NCT04784000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5942961|NCT04784000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5942962|NCT04784000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942963|NCT04784000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5942964|NCT04784000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5942965|NCT04784000|Analgesics|analgesics|mesh-ancestor
5942966|NCT04784000|Sensory System Agents|sensory system agents|mesh-ancestor
5942967|NCT04784000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5942968|NCT04784000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5942969|NCT04784000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5942970|NCT04784000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942971|NCT04784000|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5942972|NCT04784000|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5942973|NCT04783870|Dapagliflozin|dapagliflozin|mesh-list
5942974|NCT04783870|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5942975|NCT04783870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942976|NCT04783870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5942977|NCT04783870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942978|NCT04783935|Cladribine|cladribine|mesh-list
5942979|NCT04783935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5942980|NCT04783935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5942981|NCT04783935|Immunologic Factors|immunologic factors|mesh-ancestor
5942982|NCT04783935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942983|NCT04783792|Ascorbic Acid|ascorbic acid|mesh-list
5942984|NCT04783792|Antioxidants|antioxidants|mesh-ancestor
5942985|NCT04783792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942986|NCT04783792|Protective Agents|protective agents|mesh-ancestor
5942987|NCT04783792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5942988|NCT04783792|Vitamins|vitamins|mesh-ancestor
6517337|NCT00720577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6517338|NCT00720577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6517339|NCT00720577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5942989|NCT04783792|Micronutrients|micronutrients|mesh-ancestor
5942990|NCT04783753|Itraconazole|itraconazole|mesh-list
6517340|NCT00720577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6517341|NCT00720577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517342|NCT00720577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6517343|NCT00720577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6517344|NCT00720577|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5942991|NCT04783753|Quinidine|quinidine|mesh-list
5942992|NCT04783753|Carbamazepine|carbamazepine|mesh-list
5942993|NCT04783753|Antifungal Agents|antifungal agents|mesh-ancestor
5942994|NCT04783753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5942995|NCT04783753|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5942996|NCT04783753|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5942997|NCT04783753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5942998|NCT04783753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5942999|NCT04783753|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5943000|NCT04783753|Hormone Antagonists|hormone antagonists|mesh-ancestor
5943001|NCT04783753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5943002|NCT04783753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943003|NCT04783753|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5943004|NCT04783753|Anticonvulsants|anticonvulsants|mesh-ancestor
5943005|NCT04783753|Antimanic Agents|antimanic agents|mesh-ancestor
5943006|NCT04783753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5943007|NCT04783753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5943008|NCT04783753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5943009|NCT04783753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5943010|NCT04783753|Analgesics|analgesics|mesh-ancestor
5943011|NCT04783753|Sensory System Agents|sensory system agents|mesh-ancestor
5943012|NCT04783753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5943013|NCT04783753|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5943014|NCT04783753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5943015|NCT04783753|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5943016|NCT04783753|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5943017|NCT04783753|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5943018|NCT04783753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5943019|NCT04783753|Adrenergic Agents|adrenergic agents|mesh-ancestor
5943020|NCT04783753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5943021|NCT04783753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5943022|NCT04783753|Antimalarials|antimalarials|mesh-ancestor
5943023|NCT04783753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5943024|NCT04783753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5943025|NCT04783753|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5943026|NCT04783753|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5943027|NCT04783753|Cholinergic Agents|cholinergic agents|mesh-ancestor
5943028|NCT04783753|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5943029|NCT04783753|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5943030|NCT04783636|Leuprolide|leuprolide|mesh-list
5943031|NCT04783636|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5943032|NCT04783636|Fertility Agents|fertility agents|mesh-ancestor
5943033|NCT04783636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5943034|NCT04783636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943035|NCT04783636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5943036|NCT04783636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5943037|NCT04783610|Ethanol|ethanol|mesh-list
5943038|NCT04783610|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5943039|NCT04783610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5943040|NCT04783610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5943041|NCT04783610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943042|NCT04783194|Dexamethasone|dexamethasone|mesh-list
5943043|NCT04783194|Bupivacaine|bupivacaine|mesh-list
5943044|NCT04783194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5943045|NCT04783194|Antiemetics|antiemetics|mesh-ancestor
5943046|NCT04783194|Autonomic Agents|autonomic agents|mesh-ancestor
5943047|NCT04783194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5943048|NCT04783194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943049|NCT04783194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5943050|NCT04783194|Glucocorticoids|glucocorticoids|mesh-ancestor
6517345|NCT00720577|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6517346|NCT00720590|Ritonavir|ritonavir|mesh-list
6517347|NCT00720590|Lopinavir|lopinavir|mesh-list
6517348|NCT00720590|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6517349|NCT00720590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6517350|NCT00720590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6517351|NCT00720590|Protease Inhibitors|protease inhibitors|mesh-ancestor
6517352|NCT00720590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6517353|NCT00720590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5943051|NCT04783194|Hormones|hormones|mesh-ancestor
5943052|NCT04783194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5943053|NCT04783194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5943054|NCT04783194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5943055|NCT04783194|Anesthetics, Local|anesthetics, local|mesh-ancestor
5943056|NCT04783194|Anesthetics|anesthetics|mesh-ancestor
5943057|NCT04783194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5943058|NCT04783194|Sensory System Agents|sensory system agents|mesh-ancestor
5943059|NCT04783415|Acalabrutinib|acalabrutinib|mesh-list
5943060|NCT04783415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5943061|NCT04783051|Pyrimethamine|pyrimethamine|mesh-list
5943062|NCT04783051|Sulfadoxine|sulfadoxine|mesh-list
5943063|NCT04783051|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
5943064|NCT04783051|Antimalarials|antimalarials|mesh-ancestor
5943065|NCT04783051|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5943066|NCT04783051|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5943067|NCT04783051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5943068|NCT04783051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5943069|NCT04783051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5943070|NCT04783051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5943071|NCT04783051|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5943072|NCT04783051|Renal Agents|renal agents|mesh-ancestor
5943073|NCT04782622|Apatinib|apatinib|mesh-list
5943074|NCT04782622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5943075|NCT04782622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5943076|NCT04782622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5943077|NCT04782622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5943078|NCT04782830|Midodrine|midodrine|mesh-list
5943079|NCT04782830|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
5943080|NCT04782830|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5943081|NCT04782830|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5943082|NCT04782830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5943083|NCT04782830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5943084|NCT04782830|Adrenergic Agents|adrenergic agents|mesh-ancestor
5943085|NCT04782830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5943086|NCT04782830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943087|NCT04782830|Sympathomimetics|sympathomimetics|mesh-ancestor
5943088|NCT04782830|Autonomic Agents|autonomic agents|mesh-ancestor
5943089|NCT04782830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5943090|NCT04782830|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5943091|NCT04782830|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5943092|NCT04782830|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5943093|NCT04782830|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5943094|NCT04782960|Bupivacaine|bupivacaine|mesh-list
5943095|NCT04782960|Anesthetics|anesthetics|mesh-list
5943096|NCT04782960|Anesthetics, Local|anesthetics, local|mesh-ancestor
5943097|NCT04782960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5943098|NCT04782960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943099|NCT04782960|Sensory System Agents|sensory system agents|mesh-ancestor
5943100|NCT04782960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5943101|NCT04782804|Capecitabine|capecitabine|mesh-list
5943102|NCT04782804|Antibodies|antibodies|mesh-list
5943103|NCT04782804|Immunologic Factors|immunologic factors|mesh-ancestor
5943104|NCT04782804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943105|NCT04782804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5943106|NCT04782804|Antimetabolites|antimetabolites|mesh-ancestor
5943107|NCT04782804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5943108|NCT04782804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5967516|NCT04561375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5967517|NCT04561375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967518|NCT04561375|Analgesics|analgesics|mesh-ancestor
5967519|NCT04561375|Sensory System Agents|sensory system agents|mesh-ancestor
5967520|NCT04561375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5967521|NCT04561375|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5967522|NCT04561375|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5967523|NCT04561375|Anesthetics, General|anesthetics, general|mesh-ancestor
5967524|NCT04561375|Anesthetics|anesthetics|mesh-ancestor
5967525|NCT04561336|Cetuximab|cetuximab|mesh-list
5967526|NCT04561336|Avelumab|avelumab|mesh-list
5967527|NCT04561336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5967528|NCT04561336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5967529|NCT04561076|Myeloma Proteins|myeloma proteins|mesh-list
5967530|NCT04561076|Paraproteins|paraproteins|mesh-list
5967531|NCT04561076|Immunologic Factors|immunologic factors|mesh-ancestor
5967532|NCT04561076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943109|NCT04782388|Alprazolam|alprazolam|mesh-list
5943110|NCT04782388|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5943111|NCT04782388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5943112|NCT04782388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943113|NCT04782388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5943114|NCT04782388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5943115|NCT04782388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5943116|NCT04782388|GABA Modulators|gaba modulators|mesh-ancestor
5943117|NCT04782388|GABA Agents|gaba agents|mesh-ancestor
5943118|NCT04782388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5943119|NCT04782388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5943120|NCT04782076|Dabigatran|dabigatran|mesh-list
5943121|NCT04782076|Antithrombins|antithrombins|mesh-ancestor
5943122|NCT04782076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5943123|NCT04782076|Protease Inhibitors|protease inhibitors|mesh-ancestor
5943124|NCT04782076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5943125|NCT04782076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5943126|NCT04782076|Anticoagulants|anticoagulants|mesh-ancestor
5943127|NCT04782089|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
5943128|NCT04782089|Antibodies|antibodies|mesh-list
5943129|NCT04782089|Immunologic Factors|immunologic factors|mesh-ancestor
5943130|NCT04782089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943131|NCT04782089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5943132|NCT04782089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5943133|NCT04782089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5943134|NCT04782245|Dapagliflozin|dapagliflozin|mesh-list
5943135|NCT04782245|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5943136|NCT04782245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5943137|NCT04782245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5943138|NCT04782245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943139|NCT04782375|Antiviral Agents|antiviral agents|mesh-list
5943140|NCT04782375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5943141|NCT04782258|Tolvaptan|tolvaptan|mesh-list
5943142|NCT04782258|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
5943143|NCT04782258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5943144|NCT04782258|Natriuretic Agents|natriuretic agents|mesh-ancestor
5943145|NCT04782258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943146|NCT04782037|Calcium|calcium|mesh-list
5943147|NCT04782037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5943148|NCT04782037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943149|NCT04782310|Pregabalin|pregabalin|mesh-list
5943150|NCT04782310|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5943151|NCT04782310|Analgesics|analgesics|mesh-ancestor
5943152|NCT04782310|Sensory System Agents|sensory system agents|mesh-ancestor
5943153|NCT04782310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5943154|NCT04782310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943155|NCT04782310|Anticonvulsants|anticonvulsants|mesh-ancestor
5943156|NCT04782310|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5943157|NCT04782310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5943158|NCT04782310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5943159|NCT04782310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5943160|NCT04782310|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5943161|NCT04782310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5943162|NCT04782310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5943163|NCT04782310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5943164|NCT04782310|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5943165|NCT04782310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5943166|NCT04782310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5943167|NCT04782310|Antidepressive Agents|antidepressive agents|mesh-ancestor
5943168|NCT04782310|Dopamine Agents|dopamine agents|mesh-ancestor
5943169|NCT04781998|Liraglutide|liraglutide|mesh-list
5943170|NCT04781998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5943171|NCT04781998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943172|NCT04781998|Incretins|incretins|mesh-ancestor
5943173|NCT04781998|Hormones|hormones|mesh-ancestor
5943174|NCT04781998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5943175|NCT04781803|Cyclosporine|cyclosporine|mesh-list
5943176|NCT04781803|Cyclosporins|cyclosporins|mesh-list
5943177|NCT04781803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5943178|NCT04781803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5943179|NCT04781803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5943180|NCT04781803|Immunologic Factors|immunologic factors|mesh-ancestor
5943181|NCT04781803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943182|NCT04781803|Antifungal Agents|antifungal agents|mesh-ancestor
5943183|NCT04781803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5943184|NCT04781803|Dermatologic Agents|dermatologic agents|mesh-ancestor
5943185|NCT04781803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5943186|NCT04781803|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5943187|NCT04781673|Lidocaine|lidocaine|mesh-list
5943188|NCT04781673|Ketamine|ketamine|mesh-list
5943189|NCT04781673|Anesthetics, Local|anesthetics, local|mesh-ancestor
5943190|NCT04781673|Anesthetics|anesthetics|mesh-ancestor
5943191|NCT04781673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5943192|NCT04781673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943193|NCT04781673|Sensory System Agents|sensory system agents|mesh-ancestor
5943194|NCT04781673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5943195|NCT04781673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5943196|NCT04781673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5943197|NCT04781673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5943198|NCT04781673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5943199|NCT04781673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5943200|NCT04781673|Analgesics|analgesics|mesh-ancestor
5943201|NCT04781673|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5943202|NCT04781673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5943203|NCT04781673|Anesthetics, General|anesthetics, general|mesh-ancestor
5943204|NCT04781673|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5943205|NCT04781673|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5943206|NCT04781673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5943207|NCT04781959|Lenograstim|lenograstim|mesh-list
5943208|NCT04781959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5943209|NCT04781959|Immunologic Factors|immunologic factors|mesh-ancestor
5943210|NCT04781959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943211|NCT04781686|Docetaxel|docetaxel|mesh-list
5943212|NCT04781686|Apatinib|apatinib|mesh-list
5943213|NCT04781686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5943214|NCT04781686|Tubulin Modulators|tubulin modulators|mesh-ancestor
5943215|NCT04781686|Antimitotic Agents|antimitotic agents|mesh-ancestor
5943216|NCT04781686|Mitosis Modulators|mitosis modulators|mesh-ancestor
5943217|NCT04781686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5943218|NCT04781686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5943219|NCT04781686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5943220|NCT04781777|Insulin|insulin|mesh-list
5943221|NCT04781777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5943222|NCT04781777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943223|NCT04781751|Insulin|insulin|mesh-list
5943224|NCT04781751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5943225|NCT04781751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943226|NCT04781270|Bevacizumab|bevacizumab|mesh-list
5943227|NCT04781270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5943228|NCT04781270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5943229|NCT04781270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5943230|NCT04781270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5943231|NCT04781270|Growth Substances|growth substances|mesh-ancestor
5943232|NCT04781270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943233|NCT04781270|Growth Inhibitors|growth inhibitors|mesh-ancestor
5943234|NCT04781439|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5943235|NCT04781439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5943236|NCT04781075|Bupivacaine|bupivacaine|mesh-list
5943237|NCT04781075|Anesthetics, Local|anesthetics, local|mesh-ancestor
5943238|NCT04781075|Anesthetics|anesthetics|mesh-ancestor
5943239|NCT04781075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5943240|NCT04781075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943241|NCT04781075|Sensory System Agents|sensory system agents|mesh-ancestor
5943242|NCT04781075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5943243|NCT04781036|Chlorhexidine|chlorhexidine|mesh-list
5943244|NCT04781036|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5943245|NCT04781036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5943246|NCT04781036|Disinfectants|disinfectants|mesh-ancestor
5943247|NCT04781335|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5943248|NCT04781335|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5943249|NCT04781335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5943250|NCT04781335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5943251|NCT04780867|Vaccines|vaccines|mesh-list
5943252|NCT04780867|Immunologic Factors|immunologic factors|mesh-ancestor
5943253|NCT04780867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943254|NCT04780945|Olaparib|olaparib|mesh-list
5943255|NCT04780945|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5943256|NCT04780945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5943257|NCT04780945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5943258|NCT04780945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5943259|NCT04780659|Vaccines|vaccines|mesh-list
5943260|NCT04780659|Immunologic Factors|immunologic factors|mesh-ancestor
5943261|NCT04780659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967533|NCT04560894|Sorafenib|sorafenib|mesh-list
5967534|NCT04560894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5967535|NCT04560894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5967536|NCT04560894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5967537|NCT04560894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967538|NCT04561063|Sofosbuvir|sofosbuvir|mesh-list
5967539|NCT04561063|Nitazoxanide|nitazoxanide|mesh-list
5967540|NCT04561063|Antiviral Agents|antiviral agents|mesh-ancestor
5967541|NCT04561063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5967542|NCT04561063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5967543|NCT04560660|Midazolam|midazolam|mesh-list
5967544|NCT04560660|Ketamine|ketamine|mesh-list
5967545|NCT04560660|Analgesics|analgesics|mesh-ancestor
5967546|NCT04560660|Sensory System Agents|sensory system agents|mesh-ancestor
5967547|NCT04560660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5967548|NCT04560660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967549|NCT04560660|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5967550|NCT04560660|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5967551|NCT04560660|Anesthetics, General|anesthetics, general|mesh-ancestor
5967552|NCT04560660|Anesthetics|anesthetics|mesh-ancestor
5967553|NCT04560660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5967554|NCT04560660|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5967555|NCT04560660|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5967556|NCT04560660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5967557|NCT04560660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967558|NCT04560660|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5967559|NCT04560660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5967560|NCT04560660|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5967561|NCT04560660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5967562|NCT04560660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5967563|NCT04560660|GABA Modulators|gaba modulators|mesh-ancestor
5967564|NCT04560660|GABA Agents|gaba agents|mesh-ancestor
5967565|NCT04560686|Atezolizumab|atezolizumab|mesh-list
5967566|NCT04560686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5971017|NCT04530864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971018|NCT04530864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5971019|NCT04530864|Glucocorticoids|glucocorticoids|mesh-ancestor
5971020|NCT04530864|Hormones|hormones|mesh-ancestor
5971021|NCT04530864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5971022|NCT04530864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5971023|NCT04530864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5971024|NCT04530864|Protease Inhibitors|protease inhibitors|mesh-ancestor
5971025|NCT04530864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5971026|NCT04530864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971027|NCT04531098|Vaccines|vaccines|mesh-list
5971028|NCT04531098|Immunologic Factors|immunologic factors|mesh-ancestor
5971029|NCT04531098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971030|NCT04531059|Metronidazole|metronidazole|mesh-list
5971031|NCT04531059|Minocycline|minocycline|mesh-list
5971032|NCT04531059|Tetracycline|tetracycline|mesh-list
5971033|NCT04531059|Potassium Citrate|potassium citrate|mesh-list
5971034|NCT04531059|Esomeprazole|esomeprazole|mesh-list
5971035|NCT04531059|Bismuth|bismuth|mesh-list
5971036|NCT04531059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971037|NCT04531059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5971038|NCT04531059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5971039|NCT04531059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5971040|NCT04531059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5971041|NCT04531059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5971042|NCT04531059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5971043|NCT04531059|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5971044|NCT04531059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5971045|NCT04531059|Antacids|antacids|mesh-ancestor
5971046|NCT04531059|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5971047|NCT04531059|Diuretics|diuretics|mesh-ancestor
5971048|NCT04531059|Natriuretic Agents|natriuretic agents|mesh-ancestor
5971049|NCT04531059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971050|NCT04531059|Expectorants|expectorants|mesh-ancestor
5971051|NCT04531059|Respiratory System Agents|respiratory system agents|mesh-ancestor
5971052|NCT04530903|Clonidine|clonidine|mesh-list
5971053|NCT04530903|Levobupivacaine|levobupivacaine|mesh-list
6517354|NCT00720590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5971054|NCT04530903|Anesthetics, Local|anesthetics, local|mesh-ancestor
5971055|NCT04530903|Anesthetics|anesthetics|mesh-ancestor
6517355|NCT00720590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5943262|NCT04780750|Docetaxel|docetaxel|mesh-list
5943263|NCT04780750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5943264|NCT04780750|Tubulin Modulators|tubulin modulators|mesh-ancestor
5943265|NCT04780750|Antimitotic Agents|antimitotic agents|mesh-ancestor
5943266|NCT04780750|Mitosis Modulators|mitosis modulators|mesh-ancestor
5943267|NCT04780750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5943268|NCT04780854|Metformin|metformin|mesh-list
5943269|NCT04780854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5943270|NCT04780854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943271|NCT04781088|Paclitaxel|paclitaxel|mesh-list
5943272|NCT04781088|Pembrolizumab|pembrolizumab|mesh-list
5943273|NCT04781088|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5943274|NCT04781088|Lenvatinib|lenvatinib|mesh-list
5943275|NCT04781088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5943276|NCT04781088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5943277|NCT04781088|Tubulin Modulators|tubulin modulators|mesh-ancestor
5943278|NCT04781088|Antimitotic Agents|antimitotic agents|mesh-ancestor
5943279|NCT04781088|Mitosis Modulators|mitosis modulators|mesh-ancestor
5943280|NCT04781088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5943281|NCT04781088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5943282|NCT04781088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5943283|NCT04781088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5943284|NCT04780581|Dexamethasone|dexamethasone|mesh-list
5943285|NCT04780581|Methylprednisolone|methylprednisolone|mesh-list
5943286|NCT04780581|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5943287|NCT04780581|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5943288|NCT04780581|Prednisolone|prednisolone|mesh-list
5943289|NCT04780581|Prednisolone acetate|prednisolone acetate|mesh-list
5943290|NCT04780581|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5943291|NCT04780581|Prednisolone phosphate|prednisolone phosphate|mesh-list
5943292|NCT04780581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5943293|NCT04780581|Antiemetics|antiemetics|mesh-ancestor
5943294|NCT04780581|Autonomic Agents|autonomic agents|mesh-ancestor
5943295|NCT04780581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5943296|NCT04780581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943297|NCT04780581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5943298|NCT04780581|Glucocorticoids|glucocorticoids|mesh-ancestor
5943299|NCT04780581|Hormones|hormones|mesh-ancestor
5943300|NCT04780581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5943301|NCT04780581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5943302|NCT04780581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5943303|NCT04780581|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5943304|NCT04780581|Protective Agents|protective agents|mesh-ancestor
5943305|NCT04780958|Vitamin A|vitamin a|mesh-list
5943306|NCT04780958|Vitamins|vitamins|mesh-ancestor
5943307|NCT04780958|Micronutrients|micronutrients|mesh-ancestor
5943308|NCT04780958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943309|NCT04780568|Osimertinib|osimertinib|mesh-list
5943310|NCT04780568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5943311|NCT04780568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5943312|NCT04780568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5943313|NCT04780568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5943314|NCT04780984|Bromides|bromides|mesh-list
5943315|NCT04780984|Tiotropium Bromide|tiotropium bromide|mesh-list
5943316|NCT04780984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5943317|NCT04780984|Autonomic Agents|autonomic agents|mesh-ancestor
5943318|NCT04780984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5943319|NCT04780984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943320|NCT04780984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5943321|NCT04780984|Respiratory System Agents|respiratory system agents|mesh-ancestor
5943322|NCT04780984|Parasympatholytics|parasympatholytics|mesh-ancestor
5943323|NCT04780984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5943324|NCT04780984|Cholinergic Agents|cholinergic agents|mesh-ancestor
5943325|NCT04780984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5943326|NCT04780984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5943327|NCT04780984|Anticonvulsants|anticonvulsants|mesh-ancestor
5943328|NCT04780412|Alprostadil|alprostadil|mesh-list
5943329|NCT04780412|Misoprostol|misoprostol|mesh-list
5943330|NCT04780412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5943331|NCT04780412|Abortifacient Agents|abortifacient agents|mesh-ancestor
5943332|NCT04780412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5943333|NCT04780412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943334|NCT04780412|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5943335|NCT04780412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5943336|NCT04780412|Oxytocics|oxytocics|mesh-ancestor
5943337|NCT04780412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5943338|NCT04780412|Vasodilator Agents|vasodilator agents|mesh-ancestor
5943339|NCT04780412|Urological Agents|urological agents|mesh-ancestor
5943340|NCT04780347|Paclitaxel|paclitaxel|mesh-list
5943341|NCT04780347|Capecitabine|capecitabine|mesh-list
5943342|NCT04780347|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5943343|NCT04780347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5943344|NCT04780347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5943345|NCT04780347|Tubulin Modulators|tubulin modulators|mesh-ancestor
5943346|NCT04780347|Antimitotic Agents|antimitotic agents|mesh-ancestor
5943347|NCT04780347|Mitosis Modulators|mitosis modulators|mesh-ancestor
5943348|NCT04780347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5943349|NCT04780347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5943350|NCT04780347|Antimetabolites|antimetabolites|mesh-ancestor
5943351|NCT04780269|Dinoprostone|dinoprostone|mesh-list
5943352|NCT04780269|Oxytocics|oxytocics|mesh-ancestor
5943353|NCT04780269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5943354|NCT04780269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943355|NCT04780438|Dapagliflozin|dapagliflozin|mesh-list
5943356|NCT04780438|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5943357|NCT04780438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5943358|NCT04780438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5943359|NCT04780438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943360|NCT04780217|Pembrolizumab|pembrolizumab|mesh-list
5943361|NCT04780217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5943362|NCT04780217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5943363|NCT04779853|Antibodies|antibodies|mesh-list
5943364|NCT04779853|Immunologic Factors|immunologic factors|mesh-ancestor
5943365|NCT04779853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943366|NCT04779892|Infliximab|infliximab|mesh-list
5943367|NCT04779892|Dermatologic Agents|dermatologic agents|mesh-ancestor
5943368|NCT04779892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5943369|NCT04779892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5943370|NCT04780152|Fluoxetine|fluoxetine|mesh-list
5943371|NCT04780152|Antidepressive Agents|antidepressive agents|mesh-list
5943372|NCT04780152|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5943373|NCT04780152|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5943374|NCT04780152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5943375|NCT04780152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5943376|NCT04780152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5943377|NCT04780152|Serotonin Agents|serotonin agents|mesh-ancestor
5943378|NCT04780152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943379|NCT04780152|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5943380|NCT04780152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5943381|NCT04780152|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5943382|NCT04780152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5943383|NCT04780152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5943384|NCT04779762|Ustekinumab|ustekinumab|mesh-list
5943385|NCT04779762|Dermatologic Agents|dermatologic agents|mesh-ancestor
5943386|NCT04779645|Volagidemab|volagidemab|mesh-list
5943387|NCT04779645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5943388|NCT04779645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943403|NCT04779255|Acetaminophen|acetaminophen|mesh-list
5943404|NCT04779255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943405|NCT04779255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5943406|NCT04779255|Analgesics|analgesics|mesh-ancestor
5943407|NCT04779255|Sensory System Agents|sensory system agents|mesh-ancestor
5943408|NCT04779255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5943409|NCT04779255|Antipyretics|antipyretics|mesh-ancestor
5943410|NCT04779567|Acetaminophen|acetaminophen|mesh-list
5943411|NCT04779567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5943412|NCT04779567|Analgesics|analgesics|mesh-ancestor
5943413|NCT04779567|Sensory System Agents|sensory system agents|mesh-ancestor
5943414|NCT04779567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5943415|NCT04779567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943416|NCT04779567|Antipyretics|antipyretics|mesh-ancestor
5943417|NCT04779502|Chlorhexidine|chlorhexidine|mesh-list
5943418|NCT04779502|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5943419|NCT04779502|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5943420|NCT04779502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5943421|NCT04779502|Disinfectants|disinfectants|mesh-ancestor
5943422|NCT04779502|Dermatologic Agents|dermatologic agents|mesh-ancestor
5943423|NCT04779580|Anesthetics|anesthetics|mesh-list
5943424|NCT04779580|Anesthetics, Local|anesthetics, local|mesh-list
5943425|NCT04779580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5943426|NCT04779580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943427|NCT04779580|Sensory System Agents|sensory system agents|mesh-ancestor
5943428|NCT04779580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5943429|NCT04779554|Mitomycins|mitomycins|mesh-list
5943430|NCT04779554|Mitomycin|mitomycin|mesh-list
5943431|NCT04779554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5943432|NCT04779554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5943433|NCT04779554|Alkylating Agents|alkylating agents|mesh-ancestor
5943434|NCT04779554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5943435|NCT04779554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5943436|NCT04779554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5967567|NCT04560465|Tranexamic Acid|tranexamic acid|mesh-list
5967568|NCT04560465|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5967569|NCT04560465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5967570|NCT04560465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967571|NCT04560465|Hemostatics|hemostatics|mesh-ancestor
5967572|NCT04560465|Coagulants|coagulants|mesh-ancestor
5967573|NCT04560322|Venetoclax|venetoclax|mesh-list
5967574|NCT04560322|Obinutuzumab|obinutuzumab|mesh-list
5967575|NCT04560322|Acalabrutinib|acalabrutinib|mesh-list
5967576|NCT04560322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5967577|NCT04560322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5967578|NCT04560751|Lenvatinib|lenvatinib|mesh-list
5967579|NCT04560751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5967580|NCT04560751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5967581|NCT04560751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5967582|NCT04560751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967583|NCT04560816|Moxifloxacin|moxifloxacin|mesh-list
5967584|NCT04560816|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
5967585|NCT04560816|Choline|choline|mesh-list
5967586|NCT04560816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5967587|NCT04560816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5967588|NCT04560816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5967589|NCT04560816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5967590|NCT04560816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5967591|NCT04560816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967592|NCT04560816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5967593|NCT04560816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967594|NCT04560816|Lipotropic Agents|lipotropic agents|mesh-ancestor
5967595|NCT04560816|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5967596|NCT04560816|Antimetabolites|antimetabolites|mesh-ancestor
5967597|NCT04560816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5967598|NCT04560816|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5967599|NCT04560816|Nootropic Agents|nootropic agents|mesh-ancestor
5967600|NCT04560816|Chelating Agents|chelating agents|mesh-ancestor
5967601|NCT04560816|Sequestering Agents|sequestering agents|mesh-ancestor
5967602|NCT04560816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5967603|NCT04560816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5967604|NCT04560816|Growth Substances|growth substances|mesh-ancestor
5967605|NCT04560816|Growth Inhibitors|growth inhibitors|mesh-ancestor
5967606|NCT04560569|Antibodies|antibodies|mesh-list
5967607|NCT04560569|Immunologic Factors|immunologic factors|mesh-ancestor
5967608|NCT04560569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967609|NCT04560972|Carboplatin|carboplatin|mesh-list
5967610|NCT04560972|Etoposide|etoposide|mesh-list
5967611|NCT04560972|Etoposide phosphate|etoposide phosphate|mesh-list
5967612|NCT04560972|Atezolizumab|atezolizumab|mesh-list
5967613|NCT04560972|Podophyllotoxin|podophyllotoxin|mesh-list
5967614|NCT04560972|LB100|lb100|mesh-list
5967615|NCT04560972|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5967616|NCT04560972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5967617|NCT04560972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5967618|NCT04560972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5967619|NCT04560972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5967620|NCT04560972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5967621|NCT04560972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967622|NCT04560972|Immunologic Factors|immunologic factors|mesh-ancestor
5943437|NCT04778904|Nivolumab|nivolumab|mesh-list
5943438|NCT04778904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5943439|NCT04778904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5943440|NCT04778904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5943441|NCT04778904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5943442|NCT04778982|Fulvestrant|fulvestrant|mesh-list
5943443|NCT04778982|Palbociclib|palbociclib|mesh-list
5943444|NCT04778982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5943445|NCT04778982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5943446|NCT04778982|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5943447|NCT04778982|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5943448|NCT04778982|Hormone Antagonists|hormone antagonists|mesh-ancestor
5943449|NCT04778982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5943450|NCT04778982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943451|NCT04778982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5943452|NCT04778982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5943453|NCT04778982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5943454|NCT04779151|Niraparib|niraparib|mesh-list
5943455|NCT04779151|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5943456|NCT04779151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5943457|NCT04779151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5943458|NCT04779151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5943459|NCT04779060|Dexamethasone|dexamethasone|mesh-list
5943460|NCT04779060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5943461|NCT04779060|Antiemetics|antiemetics|mesh-ancestor
5943462|NCT04779060|Autonomic Agents|autonomic agents|mesh-ancestor
5943463|NCT04779060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5943464|NCT04779060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943465|NCT04779060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5943466|NCT04779060|Glucocorticoids|glucocorticoids|mesh-ancestor
5943467|NCT04779060|Hormones|hormones|mesh-ancestor
5943468|NCT04779060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5943469|NCT04779060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5943470|NCT04779060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5943471|NCT04778917|Heparin|heparin|mesh-list
5943472|NCT04778917|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5943473|NCT04778917|Tinzaparin|tinzaparin|mesh-list
5943474|NCT04778917|Dalteparin|dalteparin|mesh-list
5943475|NCT04778917|Calcium heparin|calcium heparin|mesh-list
5943476|NCT04778917|Calcium|calcium|mesh-list
5943477|NCT04778917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5943478|NCT04778917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943479|NCT04778917|Anticoagulants|anticoagulants|mesh-ancestor
5943480|NCT04778917|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5943481|NCT04778917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5943482|NCT04778917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5943483|NCT04778865|Vitamin D|vitamin d|mesh-list
5943484|NCT04778865|Ergocalciferols|ergocalciferols|mesh-list
5943485|NCT04778865|Vitamins|vitamins|mesh-list
5943486|NCT04778865|Micronutrients|micronutrients|mesh-ancestor
5943487|NCT04778865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943488|NCT04778865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5943489|NCT04778865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5943490|NCT04778839|Paclitaxel|paclitaxel|mesh-list
5943491|NCT04778839|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5943492|NCT04778839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5943493|NCT04778839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5943494|NCT04778839|Tubulin Modulators|tubulin modulators|mesh-ancestor
5943495|NCT04778839|Antimitotic Agents|antimitotic agents|mesh-ancestor
5943496|NCT04778839|Mitosis Modulators|mitosis modulators|mesh-ancestor
5943497|NCT04778839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5943498|NCT04778813|Artesunate|artesunate|mesh-list
5943499|NCT04778813|Lumefantrine|lumefantrine|mesh-list
5943500|NCT04778813|Artemether|artemether|mesh-list
5943501|NCT04778813|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
5943502|NCT04778813|Artenimol|artenimol|mesh-list
5943503|NCT04778813|Pyronaridine|pyronaridine|mesh-list
5943504|NCT04778813|Antimalarials|antimalarials|mesh-ancestor
5943505|NCT04778813|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5943506|NCT04778813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5943507|NCT04778813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5943508|NCT04778813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5943509|NCT04778813|Antiviral Agents|antiviral agents|mesh-ancestor
5943510|NCT04778813|Schistosomicides|schistosomicides|mesh-ancestor
5943511|NCT04778813|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6681309|NCT01609049|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5943512|NCT04778813|Anthelmintics|anthelmintics|mesh-ancestor
5943513|NCT04779047|Ritonavir|ritonavir|mesh-list
5943514|NCT04779047|Lopinavir|lopinavir|mesh-list
5943515|NCT04779047|Hydroxychloroquine|hydroxychloroquine|mesh-list
5943516|NCT04779047|Ivermectin|ivermectin|mesh-list
5943517|NCT04779047|Remdesivir|remdesivir|mesh-list
5943518|NCT04779047|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5943519|NCT04779047|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5943520|NCT04779047|Protease Inhibitors|protease inhibitors|mesh-ancestor
5943521|NCT04779047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5943522|NCT04779047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5943523|NCT04779047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5943524|NCT04779047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5943525|NCT04779047|Antiviral Agents|antiviral agents|mesh-ancestor
5943526|NCT04779047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5943527|NCT04779047|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5943528|NCT04779047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5943529|NCT04779047|Antimalarials|antimalarials|mesh-ancestor
5943530|NCT04779047|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5943531|NCT04779047|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5943532|NCT04779047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5943533|NCT04779047|Antimetabolites|antimetabolites|mesh-ancestor
5943534|NCT04778787|Dapagliflozin|dapagliflozin|mesh-list
5943535|NCT04778787|Digoxin|digoxin|mesh-list
5943536|NCT04778787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
5943537|NCT04778787|Vasodilator Agents|vasodilator agents|mesh-list
5943538|NCT04778787|Diuretics|diuretics|mesh-list
5943539|NCT04778787|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
5943540|NCT04778787|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5943541|NCT04778787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5943542|NCT04778787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5943543|NCT04778787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943544|NCT04778787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5943545|NCT04778787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5943546|NCT04778787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5943547|NCT04778787|Protective Agents|protective agents|mesh-ancestor
5943548|NCT04778787|Natriuretic Agents|natriuretic agents|mesh-ancestor
5943549|NCT04778787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5943550|NCT04778514|Contraceptive Agents|contraceptive agents|mesh-list
5943551|NCT04778514|Contraceptives, Oral|contraceptives, oral|mesh-list
5943552|NCT04778514|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
5943553|NCT04778514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5943554|NCT04778514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943555|NCT04778514|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5943556|NCT04778358|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5943557|NCT04778358|Hormones|hormones|mesh-ancestor
5943558|NCT04778358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5943559|NCT04778358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943560|NCT04778176|Levodopa|levodopa|mesh-list
5943561|NCT04778176|Carbidopa|carbidopa|mesh-list
5943562|NCT04778176|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5943563|NCT04778176|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5943564|NCT04778176|Dopamine Agents|dopamine agents|mesh-ancestor
5943565|NCT04778176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5943566|NCT04778176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5943567|NCT04778176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943568|NCT04778176|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5943569|NCT04778176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5943570|NCT04778072|Iron|iron|mesh-list
5943571|NCT04778072|Trace Elements|trace elements|mesh-ancestor
5943572|NCT04778072|Micronutrients|micronutrients|mesh-ancestor
5943573|NCT04778072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943574|NCT04778137|Omalizumab|omalizumab|mesh-list
5943575|NCT04778137|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5943576|NCT04778137|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5943577|NCT04778137|Respiratory System Agents|respiratory system agents|mesh-ancestor
5943578|NCT04777968|Fluorides|fluorides|mesh-list
5943579|NCT04777968|Cariostatic Agents|cariostatic agents|mesh-ancestor
5943580|NCT04777968|Protective Agents|protective agents|mesh-ancestor
5943581|NCT04777968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943582|NCT04777929|Progesterone|progesterone|mesh-list
5943583|NCT04777929|Estrogens|estrogens|mesh-list
5943584|NCT04777929|Progestins|progestins|mesh-ancestor
5943585|NCT04777929|Hormones|hormones|mesh-ancestor
5943586|NCT04777929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5943587|NCT04777929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943588|NCT04777760|Pulmonary Surfactants|pulmonary surfactants|mesh-list
5943589|NCT04777760|Respiratory System Agents|respiratory system agents|mesh-ancestor
5943590|NCT04777383|Atropine|atropine|mesh-list
5943591|NCT04777383|Phenylephrine|phenylephrine|mesh-list
5943592|NCT04777383|Oxymetazoline|oxymetazoline|mesh-list
5943593|NCT04777383|Norepinephrine|norepinephrine|mesh-list
5943594|NCT04777383|Acetylcholine|acetylcholine|mesh-list
5943595|NCT04777383|Neostigmine|neostigmine|mesh-list
5943596|NCT04777383|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5943597|NCT04777383|Mydriatics|mydriatics|mesh-ancestor
5943598|NCT04777383|Autonomic Agents|autonomic agents|mesh-ancestor
5943599|NCT04777383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5943600|NCT04777383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943601|NCT04777383|Sympathomimetics|sympathomimetics|mesh-ancestor
5943602|NCT04777383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5943603|NCT04777383|Nasal Decongestants|nasal decongestants|mesh-ancestor
5943604|NCT04777383|Respiratory System Agents|respiratory system agents|mesh-ancestor
5943605|NCT04777383|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5943606|NCT04777383|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5943607|NCT04777383|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5943608|NCT04777383|Adrenergic Agents|adrenergic agents|mesh-ancestor
5943609|NCT04777383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5943610|NCT04777383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5943611|NCT04777383|Protective Agents|protective agents|mesh-ancestor
5943612|NCT04777383|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5943613|NCT04777383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5943614|NCT04777383|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5943615|NCT04777383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5943616|NCT04777383|Parasympatholytics|parasympatholytics|mesh-ancestor
5943617|NCT04777383|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5943618|NCT04777383|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5943619|NCT04777383|Cholinergic Agents|cholinergic agents|mesh-ancestor
5943620|NCT04777383|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5943621|NCT04777383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5943622|NCT04777383|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5943623|NCT04777383|Vasodilator Agents|vasodilator agents|mesh-ancestor
5943624|NCT04777383|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5943625|NCT04777539|Natalizumab|natalizumab|mesh-list
5943626|NCT04777539|Immunologic Factors|immunologic factors|mesh-ancestor
5943627|NCT04777539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943628|NCT04777838|Amitriptyline|amitriptyline|mesh-list
5943629|NCT04777838|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
5943630|NCT04777838|Citalopram|citalopram|mesh-list
5943631|NCT04777838|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5943632|NCT04777838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5943633|NCT04777838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5943634|NCT04777838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5943635|NCT04777838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5943636|NCT04777838|Serotonin Agents|serotonin agents|mesh-ancestor
5943637|NCT04777838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943638|NCT04777838|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5943639|NCT04777838|Antidepressive Agents|antidepressive agents|mesh-ancestor
5943640|NCT04777838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5943641|NCT04777838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5943642|NCT04777838|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5943643|NCT04777838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5943644|NCT04777838|Analgesics|analgesics|mesh-ancestor
5943645|NCT04777838|Sensory System Agents|sensory system agents|mesh-ancestor
5943646|NCT04777838|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5943647|NCT04777838|Adrenergic Agents|adrenergic agents|mesh-ancestor
5943648|NCT04777838|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5943649|NCT04777838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5943650|NCT04777838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5943651|NCT04777552|Diazepam|diazepam|mesh-list
5943652|NCT04777552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5943653|NCT04777552|Anticonvulsants|anticonvulsants|mesh-ancestor
5943654|NCT04777552|Antiemetics|antiemetics|mesh-ancestor
5943655|NCT04777552|Autonomic Agents|autonomic agents|mesh-ancestor
5943656|NCT04777552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5943657|NCT04777552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943658|NCT04777552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5943659|NCT04777552|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5943660|NCT04777552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5943661|NCT04777552|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5943662|NCT04777552|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6681310|NCT01609049|Antimetabolites|antimetabolites|mesh-ancestor
5943663|NCT04777552|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5943664|NCT04777552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5943665|NCT04777552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5943666|NCT04777552|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5943667|NCT04777552|Anesthetics, General|anesthetics, general|mesh-ancestor
5943668|NCT04777552|Anesthetics|anesthetics|mesh-ancestor
5943669|NCT04777552|GABA Modulators|gaba modulators|mesh-ancestor
5943670|NCT04777552|GABA Agents|gaba agents|mesh-ancestor
5943671|NCT04777552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5943672|NCT04777552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967623|NCT04560972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967624|NCT04560972|Keratolytic Agents|keratolytic agents|mesh-ancestor
5967625|NCT04560972|Dermatologic Agents|dermatologic agents|mesh-ancestor
5967626|NCT04560972|Tubulin Modulators|tubulin modulators|mesh-ancestor
5967627|NCT04560972|Antimitotic Agents|antimitotic agents|mesh-ancestor
5967628|NCT04560972|Mitosis Modulators|mitosis modulators|mesh-ancestor
5967629|NCT04560556|Antibodies|antibodies|mesh-list
5967630|NCT04560556|Immunologic Factors|immunologic factors|mesh-ancestor
5967631|NCT04560556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967632|NCT04560426|Parathyroid Hormone|parathyroid hormone|mesh-list
5967633|NCT04560426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5967634|NCT04560426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967635|NCT04560673|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5967636|NCT04560673|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5967637|NCT04560673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5967638|NCT04560673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5967639|NCT04560673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967640|NCT04560673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5967641|NCT04560673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967642|NCT04560673|Analgesics|analgesics|mesh-ancestor
5967643|NCT04560673|Sensory System Agents|sensory system agents|mesh-ancestor
5967644|NCT04560673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5967645|NCT04560673|Antidepressive Agents|antidepressive agents|mesh-ancestor
5967646|NCT04560673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5967647|NCT04560673|Dopamine Agents|dopamine agents|mesh-ancestor
5967648|NCT04559880|Tranexamic Acid|tranexamic acid|mesh-list
5967649|NCT04559880|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5967650|NCT04559880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5967651|NCT04559880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967652|NCT04559880|Hemostatics|hemostatics|mesh-ancestor
5967653|NCT04559880|Coagulants|coagulants|mesh-ancestor
5967654|NCT04560010|Tranexamic Acid|tranexamic acid|mesh-list
5967655|NCT04560010|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5967656|NCT04560010|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5967657|NCT04560010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967658|NCT04560010|Hemostatics|hemostatics|mesh-ancestor
5967659|NCT04560010|Coagulants|coagulants|mesh-ancestor
5967660|NCT04560231|Remdesivir|remdesivir|mesh-list
5967661|NCT04560231|Antimetabolites|antimetabolites|mesh-ancestor
5967662|NCT04560231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967663|NCT04560231|Antiviral Agents|antiviral agents|mesh-ancestor
5967664|NCT04560231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5967665|NCT04560101|Botulinum Toxins|botulinum toxins|mesh-list
5967666|NCT04560101|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5967667|NCT04560101|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5967668|NCT04560101|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5967669|NCT04560101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6517356|NCT00720590|Antiviral Agents|antiviral agents|mesh-ancestor
6517357|NCT00720590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6517358|NCT00720590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5967670|NCT04560101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967671|NCT04560101|Cholinergic Agents|cholinergic agents|mesh-ancestor
5967672|NCT04560101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5967673|NCT04560101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967674|NCT04560101|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5967675|NCT04560101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5967676|NCT04560218|Misoprostol|misoprostol|mesh-list
5967677|NCT04560218|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5967678|NCT04560218|Abortifacient Agents|abortifacient agents|mesh-ancestor
5967679|NCT04560218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5967680|NCT04560218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967681|NCT04560218|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5967682|NCT04560218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5967683|NCT04560218|Oxytocics|oxytocics|mesh-ancestor
5967684|NCT04560049|Phenol|phenol|mesh-list
5967685|NCT04560049|Silver Nitrate|silver nitrate|mesh-list
5943673|NCT04777591|Bupivacaine|bupivacaine|mesh-list
5943674|NCT04777591|Anesthetics, Local|anesthetics, local|mesh-ancestor
5943675|NCT04777591|Anesthetics|anesthetics|mesh-ancestor
5943676|NCT04777591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5943677|NCT04777591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943678|NCT04777591|Sensory System Agents|sensory system agents|mesh-ancestor
5943679|NCT04777591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5943680|NCT04777045|Diltiazem|diltiazem|mesh-list
5943681|NCT04777045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5943682|NCT04777045|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5943683|NCT04777045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5943684|NCT04777045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5943685|NCT04777045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5943686|NCT04777045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943687|NCT04777045|Vasodilator Agents|vasodilator agents|mesh-ancestor
5943688|NCT04777227|Lidocaine|lidocaine|mesh-list
5943689|NCT04777227|Anesthetics, Local|anesthetics, local|mesh-ancestor
5943690|NCT04777227|Anesthetics|anesthetics|mesh-ancestor
5943691|NCT04777227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5943692|NCT04777227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943693|NCT04777227|Sensory System Agents|sensory system agents|mesh-ancestor
5943694|NCT04777227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5943695|NCT04777227|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5943696|NCT04777227|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5943697|NCT04777227|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5943698|NCT04777227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5943699|NCT04777227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5943700|NCT04777071|Edetic Acid|edetic acid|mesh-list
5943701|NCT04777071|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5943702|NCT04777071|Chelating Agents|chelating agents|mesh-ancestor
5943703|NCT04777071|Sequestering Agents|sequestering agents|mesh-ancestor
5943704|NCT04777071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5943705|NCT04777071|Anticoagulants|anticoagulants|mesh-ancestor
5943706|NCT04777071|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5943707|NCT04777071|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5943708|NCT04777110|Esketamine|esketamine|mesh-list
5943709|NCT04777110|Antidepressive Agents|antidepressive agents|mesh-ancestor
5943710|NCT04777110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5943711|NCT04776889|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5943712|NCT04776889|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5943713|NCT04776889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5943714|NCT04776889|Antimetabolites|antimetabolites|mesh-ancestor
5943715|NCT04776889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5943716|NCT04776889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5943717|NCT04776889|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5943718|NCT04776889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5943719|NCT04776850|Mycophenolic Acid|mycophenolic acid|mesh-list
5943720|NCT04776850|Dexamethasone|dexamethasone|mesh-list
5943721|NCT04776850|Dexamethasone acetate|dexamethasone acetate|mesh-list
5943722|NCT04776850|Cyclophosphamide|cyclophosphamide|mesh-list
5943723|NCT04776850|Busulfan|busulfan|mesh-list
5943724|NCT04776850|Rituximab|rituximab|mesh-list
5943725|NCT04776850|Fludarabine|fludarabine|mesh-list
5943726|NCT04776850|Fludarabine phosphate|fludarabine phosphate|mesh-list
5943727|NCT04776850|Bortezomib|bortezomib|mesh-list
5943728|NCT04776850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5943729|NCT04776850|Tacrolimus|tacrolimus|mesh-list
5943730|NCT04776850|Thymoglobulin|thymoglobulin|mesh-list
5943731|NCT04776850|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5943732|NCT04776850|Antibodies|antibodies|mesh-list
5943733|NCT04776850|Immunoglobulins|immunoglobulins|mesh-list
5943734|NCT04776850|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5943735|NCT04776850|gamma-Globulins|gamma-globulins|mesh-list
5943736|NCT04776850|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5943737|NCT04776850|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5943738|NCT04776850|BB 1101|bb 1101|mesh-list
5943739|NCT04776850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5943740|NCT04776850|Immunologic Factors|immunologic factors|mesh-ancestor
5943741|NCT04776850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943742|NCT04776850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5943743|NCT04776850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5943744|NCT04776850|Alkylating Agents|alkylating agents|mesh-ancestor
5943745|NCT04776850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5943746|NCT04776850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5943747|NCT04776850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5943748|NCT04776850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5943749|NCT04776850|Antiemetics|antiemetics|mesh-ancestor
5943750|NCT04776850|Autonomic Agents|autonomic agents|mesh-ancestor
5943751|NCT04776850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5943752|NCT04776850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5943753|NCT04776850|Glucocorticoids|glucocorticoids|mesh-ancestor
5943754|NCT04776850|Hormones|hormones|mesh-ancestor
5943755|NCT04776850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5943756|NCT04776850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5943757|NCT04776850|Protease Inhibitors|protease inhibitors|mesh-ancestor
5943758|NCT04776850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5943759|NCT04776850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5943760|NCT04776850|Antimetabolites|antimetabolites|mesh-ancestor
5943761|NCT04776850|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5943762|NCT04776850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5943763|NCT04776850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5943764|NCT04776850|Antitubercular Agents|antitubercular agents|mesh-ancestor
5943765|NCT04776850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5943766|NCT04776850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5943767|NCT04776772|Complement System Proteins|complement system proteins|mesh-list
5943768|NCT04776772|Immunologic Factors|immunologic factors|mesh-ancestor
5943769|NCT04776772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943770|NCT04776512|Bupivacaine|bupivacaine|mesh-list
5943771|NCT04776512|Anesthetics, Local|anesthetics, local|mesh-ancestor
5943772|NCT04776512|Anesthetics|anesthetics|mesh-ancestor
5943773|NCT04776512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5943774|NCT04776512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943775|NCT04776512|Sensory System Agents|sensory system agents|mesh-ancestor
5943776|NCT04776512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5943777|NCT04776525|Doxorubicin|doxorubicin|mesh-list
5943778|NCT04776525|Ifosfamide|ifosfamide|mesh-list
5943779|NCT04776525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5943780|NCT04776525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5943781|NCT04776525|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5943782|NCT04776525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5943783|NCT04776525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5943784|NCT04776525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5943785|NCT04776525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5943786|NCT04776525|Alkylating Agents|alkylating agents|mesh-ancestor
5943787|NCT04776499|Perphenazine|perphenazine|mesh-list
5943788|NCT04776499|Riociguat|riociguat|mesh-list
5943789|NCT04776499|Propylthiouracil|propylthiouracil|mesh-list
5943790|NCT04776499|Enzyme Activators|enzyme activators|mesh-ancestor
5943791|NCT04776499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5943792|NCT04776499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5943793|NCT04776499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5943794|NCT04776499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5943795|NCT04776499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943796|NCT04776499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5943797|NCT04776499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5943798|NCT04776499|Dopamine Agents|dopamine agents|mesh-ancestor
5943799|NCT04776499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5943800|NCT04776499|Antimetabolites|antimetabolites|mesh-ancestor
5943801|NCT04776499|Antithyroid Agents|antithyroid agents|mesh-ancestor
5943802|NCT04776499|Hormone Antagonists|hormone antagonists|mesh-ancestor
5943803|NCT04776499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5943804|NCT04776655|Leucovorin|leucovorin|mesh-list
5943805|NCT04776655|Bevacizumab|bevacizumab|mesh-list
5943806|NCT04776655|Cetuximab|cetuximab|mesh-list
5943807|NCT04776655|Fluorouracil|fluorouracil|mesh-list
5943808|NCT04776655|Irinotecan|irinotecan|mesh-list
5943809|NCT04776655|Calcium|calcium|mesh-list
5943810|NCT04776655|Levoleucovorin|levoleucovorin|mesh-list
5943811|NCT04776655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5943812|NCT04776655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5943813|NCT04776655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5943814|NCT04776655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5943815|NCT04776655|Growth Substances|growth substances|mesh-ancestor
5943816|NCT04776655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943817|NCT04776655|Growth Inhibitors|growth inhibitors|mesh-ancestor
5943818|NCT04776655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5943819|NCT04776655|Antimetabolites|antimetabolites|mesh-ancestor
5943820|NCT04776655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5943821|NCT04776655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5943822|NCT04776655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5943823|NCT04776655|Immunologic Factors|immunologic factors|mesh-ancestor
5943824|NCT04776655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5943825|NCT04776655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5943826|NCT04776655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5943827|NCT04776655|Antidotes|antidotes|mesh-ancestor
5943828|NCT04776655|Protective Agents|protective agents|mesh-ancestor
5943829|NCT04776655|Vitamin B Complex|vitamin b complex|mesh-ancestor
5943830|NCT04776655|Vitamins|vitamins|mesh-ancestor
5943831|NCT04776655|Micronutrients|micronutrients|mesh-ancestor
5943832|NCT04776395|Dexamethasone|dexamethasone|mesh-list
5943833|NCT04776395|Dexamethasone acetate|dexamethasone acetate|mesh-list
5943834|NCT04776395|Ichthammol|ichthammol|mesh-list
5943835|NCT04776395|BB 1101|bb 1101|mesh-list
5943836|NCT04776395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5943837|NCT04776395|Antiemetics|antiemetics|mesh-ancestor
5943838|NCT04776395|Autonomic Agents|autonomic agents|mesh-ancestor
5943839|NCT04776395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5943840|NCT04776395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943841|NCT04776395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5943842|NCT04776395|Glucocorticoids|glucocorticoids|mesh-ancestor
5943843|NCT04776395|Hormones|hormones|mesh-ancestor
5943844|NCT04776395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5943845|NCT04776395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5943846|NCT04776395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5943847|NCT04776395|Protease Inhibitors|protease inhibitors|mesh-ancestor
5943848|NCT04776395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5943849|NCT04776395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5943850|NCT04776395|Dermatologic Agents|dermatologic agents|mesh-ancestor
5943851|NCT04776408|Nitric Oxide|nitric oxide|mesh-list
5943852|NCT04776408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5943853|NCT04776408|Autonomic Agents|autonomic agents|mesh-ancestor
5943854|NCT04776408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5943855|NCT04776408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943856|NCT04776408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5943857|NCT04776408|Respiratory System Agents|respiratory system agents|mesh-ancestor
5943858|NCT04776408|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5943859|NCT04776408|Antioxidants|antioxidants|mesh-ancestor
5943860|NCT04776408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5943861|NCT04776408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5943862|NCT04776408|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5943863|NCT04776408|Vasodilator Agents|vasodilator agents|mesh-ancestor
5943864|NCT04776408|Gasotransmitters|gasotransmitters|mesh-ancestor
5943865|NCT04776408|Protective Agents|protective agents|mesh-ancestor
5943866|NCT04776369|Lidocaine|lidocaine|mesh-list
5943867|NCT04776369|Magnesium Sulfate|magnesium sulfate|mesh-list
5943868|NCT04776369|Anesthetics, Local|anesthetics, local|mesh-ancestor
5943869|NCT04776369|Anesthetics|anesthetics|mesh-ancestor
5943870|NCT04776369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5943871|NCT04776369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943872|NCT04776369|Sensory System Agents|sensory system agents|mesh-ancestor
5943873|NCT04776369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5943874|NCT04776369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5943875|NCT04776369|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5943876|NCT04776369|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5943877|NCT04776369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5943878|NCT04776369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5943879|NCT04776369|Analgesics|analgesics|mesh-ancestor
5943880|NCT04776369|Anticonvulsants|anticonvulsants|mesh-ancestor
5943881|NCT04776369|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5943882|NCT04776369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5943883|NCT04776369|Tocolytic Agents|tocolytic agents|mesh-ancestor
5943884|NCT04776369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5943885|NCT04776213|Cladribine|cladribine|mesh-list
5943886|NCT04776213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5943887|NCT04776213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5943888|NCT04776213|Immunologic Factors|immunologic factors|mesh-ancestor
5943889|NCT04776213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943890|NCT04776135|Edaravone|edaravone|mesh-list
5943891|NCT04776135|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5943892|NCT04776135|Antioxidants|antioxidants|mesh-ancestor
5943893|NCT04776135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5943894|NCT04776135|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5943895|NCT04776135|Protective Agents|protective agents|mesh-ancestor
5943896|NCT04776135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943897|NCT04776226|Citalopram|citalopram|mesh-list
5943898|NCT04776226|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5943899|NCT04776226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5943900|NCT04776226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5943901|NCT04776226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5943902|NCT04776226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5943903|NCT04776226|Serotonin Agents|serotonin agents|mesh-ancestor
5943904|NCT04776226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943905|NCT04776226|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5943906|NCT04776226|Antidepressive Agents|antidepressive agents|mesh-ancestor
5943907|NCT04776226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5943908|NCT04776096|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
5943909|NCT04776096|Bepotastine besilate|bepotastine besilate|mesh-list
5943910|NCT04776096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5943911|NCT04776096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5943912|NCT04776096|Analgesics|analgesics|mesh-ancestor
5943913|NCT04776096|Sensory System Agents|sensory system agents|mesh-ancestor
5943914|NCT04776096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5943915|NCT04776096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943916|NCT04776096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5943917|NCT04776096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5943918|NCT04776096|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5943919|NCT04776096|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5943920|NCT04776096|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5943921|NCT04776096|Histamine Antagonists|histamine antagonists|mesh-ancestor
5943922|NCT04776096|Histamine Agents|histamine agents|mesh-ancestor
5943923|NCT04776096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5943924|NCT04776096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5943925|NCT04775797|Tenofovir|tenofovir|mesh-list
5943926|NCT04775797|Antiviral Agents|antiviral agents|mesh-ancestor
5943927|NCT04775797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5943928|NCT04775797|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5943929|NCT04775797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5943930|NCT04775797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5943931|NCT04775797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5943932|NCT04775797|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5943933|NCT04775797|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5943934|NCT04775732|Infliximab|infliximab|mesh-list
5943935|NCT04775732|Dermatologic Agents|dermatologic agents|mesh-ancestor
5943936|NCT04775732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5943937|NCT04775732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5967686|NCT04560049|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5967687|NCT04560049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5967688|NCT04560049|Disinfectants|disinfectants|mesh-ancestor
5967689|NCT04560049|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
5967690|NCT04560049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5967691|NCT04559906|Ethyl Chloride|ethyl chloride|mesh-list
5967692|NCT04559906|Anesthetics, Local|anesthetics, local|mesh-ancestor
5967693|NCT04559906|Anesthetics|anesthetics|mesh-ancestor
5967694|NCT04559906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5967695|NCT04559906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967696|NCT04559906|Sensory System Agents|sensory system agents|mesh-ancestor
5967697|NCT04559906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5967698|NCT04559841|Simvastatin|simvastatin|mesh-list
5967699|NCT04559841|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5967700|NCT04559841|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5967701|NCT04559841|Antimetabolites|antimetabolites|mesh-ancestor
5967702|NCT04559841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967703|NCT04559841|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5967704|NCT04559841|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5967705|NCT04559841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5967706|NCT04559425|Dexamethasone|dexamethasone|mesh-list
5967707|NCT04559425|Dexamethasone acetate|dexamethasone acetate|mesh-list
5967708|NCT04559425|BB 1101|bb 1101|mesh-list
5967709|NCT04559425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5967710|NCT04559425|Antiemetics|antiemetics|mesh-ancestor
5967711|NCT04559425|Autonomic Agents|autonomic agents|mesh-ancestor
5967712|NCT04559425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5967713|NCT04559425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967714|NCT04559425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5967715|NCT04559425|Glucocorticoids|glucocorticoids|mesh-ancestor
5967716|NCT04559425|Hormones|hormones|mesh-ancestor
5967717|NCT04559425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5967718|NCT04559425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5967719|NCT04559425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5967720|NCT04559425|Protease Inhibitors|protease inhibitors|mesh-ancestor
5967721|NCT04559425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5967722|NCT04559425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5943938|NCT04775563|Vaccines|vaccines|mesh-list
5943939|NCT04775563|Immunologic Factors|immunologic factors|mesh-ancestor
5943940|NCT04775563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943941|NCT04775303|Cyclosporine|cyclosporine|mesh-list
5943942|NCT04775303|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5943943|NCT04775303|Cyclosporins|cyclosporins|mesh-list
5943944|NCT04775303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5943945|NCT04775303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5943946|NCT04775303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5943947|NCT04775303|Immunologic Factors|immunologic factors|mesh-ancestor
5943948|NCT04775303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943949|NCT04775303|Antifungal Agents|antifungal agents|mesh-ancestor
5943950|NCT04775303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5943951|NCT04775303|Dermatologic Agents|dermatologic agents|mesh-ancestor
5943952|NCT04775303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5943953|NCT04775303|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5943954|NCT04775303|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5943955|NCT04775576|Anesthetics|anesthetics|mesh-list
5943956|NCT04775576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5943957|NCT04775576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943958|NCT04775381|Vitamin D|vitamin d|mesh-list
5943959|NCT04775381|Vitamins|vitamins|mesh-ancestor
5943960|NCT04775381|Micronutrients|micronutrients|mesh-ancestor
5943961|NCT04775381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943962|NCT04775381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5943963|NCT04775459|Pulmonary Surfactants|pulmonary surfactants|mesh-list
5943964|NCT04775459|Respiratory System Agents|respiratory system agents|mesh-ancestor
5943965|NCT04775212|Sevoflurane|sevoflurane|mesh-list
5943966|NCT04775212|Desflurane|desflurane|mesh-list
5943967|NCT04775212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5943968|NCT04775212|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5943969|NCT04775212|Anesthetics, General|anesthetics, general|mesh-ancestor
5943970|NCT04775212|Anesthetics|anesthetics|mesh-ancestor
5943971|NCT04775212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5943972|NCT04775212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943973|NCT04775238|Copper|copper|mesh-list
5943974|NCT04775238|Trace Elements|trace elements|mesh-ancestor
5943975|NCT04775238|Micronutrients|micronutrients|mesh-ancestor
5943976|NCT04775238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943977|NCT04775173|Sirolimus|sirolimus|mesh-list
5943978|NCT04775173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5943979|NCT04775173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5943980|NCT04775173|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5943981|NCT04775173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5943982|NCT04775173|Antifungal Agents|antifungal agents|mesh-ancestor
5943983|NCT04775173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5943984|NCT04775173|Immunologic Factors|immunologic factors|mesh-ancestor
5943985|NCT04775173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943986|NCT04775225|Lidocaine|lidocaine|mesh-list
5943987|NCT04775225|Anesthetics, Local|anesthetics, local|mesh-ancestor
5943988|NCT04775225|Anesthetics|anesthetics|mesh-ancestor
5943989|NCT04775225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5943990|NCT04775225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5943991|NCT04775225|Sensory System Agents|sensory system agents|mesh-ancestor
5943992|NCT04775225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5943993|NCT04775225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5943994|NCT04775225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5943995|NCT04775225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5943996|NCT04775225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5943997|NCT04775225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5943998|NCT04774666|Antibodies|antibodies|mesh-list
5943999|NCT04774666|Immunologic Factors|immunologic factors|mesh-ancestor
5944000|NCT04774666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944001|NCT04774822|Mydriatics|mydriatics|mesh-list
5944002|NCT04774822|Autonomic Agents|autonomic agents|mesh-ancestor
5944003|NCT04774822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5944004|NCT04774822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944005|NCT04775030|Salicylic Acid|salicylic acid|mesh-list
5944006|NCT04775030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5944007|NCT04775030|Antifungal Agents|antifungal agents|mesh-ancestor
5944008|NCT04775030|Keratolytic Agents|keratolytic agents|mesh-ancestor
5944009|NCT04775030|Dermatologic Agents|dermatologic agents|mesh-ancestor
5944010|NCT04774627|Olaparib|olaparib|mesh-list
5944011|NCT04774627|Niraparib|niraparib|mesh-list
5944012|NCT04774627|Veliparib|veliparib|mesh-list
5944013|NCT04774627|Talazoparib|talazoparib|mesh-list
5944014|NCT04774627|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
5944015|NCT04774627|Rucaparib|rucaparib|mesh-list
5944016|NCT04774627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5944017|NCT04774627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944018|NCT04774627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5944019|NCT04775329|Rifaximin|rifaximin|mesh-list
5944020|NCT04775329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5944021|NCT04775329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5944022|NCT04775329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5944023|NCT04774120|Propofol|propofol|mesh-list
5944024|NCT04774120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5944025|NCT04774120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5944026|NCT04774120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944027|NCT04774120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5944028|NCT04774120|Anesthetics, General|anesthetics, general|mesh-ancestor
5944029|NCT04774120|Anesthetics|anesthetics|mesh-ancestor
5944030|NCT04774068|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5944031|NCT04774068|Romidepsin|romidepsin|mesh-list
5944032|NCT04774068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5944033|NCT04774068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5944034|NCT04774068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5944035|NCT04774029|Lidocaine|lidocaine|mesh-list
5944036|NCT04774029|Anesthetics, Local|anesthetics, local|mesh-ancestor
5944037|NCT04774029|Anesthetics|anesthetics|mesh-ancestor
5944038|NCT04774029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5944039|NCT04774029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944040|NCT04774029|Sensory System Agents|sensory system agents|mesh-ancestor
5944041|NCT04774029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5944042|NCT04774029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5944043|NCT04774029|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5944044|NCT04774029|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5944045|NCT04774029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5944046|NCT04774029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944047|NCT04773756|Sofosbuvir|sofosbuvir|mesh-list
5944048|NCT04773756|Antiviral Agents|antiviral agents|mesh-ancestor
5944049|NCT04773756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5944050|NCT04773951|Antibodies|antibodies|mesh-list
5944051|NCT04773951|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5944052|NCT04773951|Immunologic Factors|immunologic factors|mesh-ancestor
5944053|NCT04773951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944054|NCT04773873|Lithium Carbonate|lithium carbonate|mesh-list
5944055|NCT04773873|Antidepressive Agents|antidepressive agents|mesh-ancestor
5944056|NCT04773873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5944057|NCT04773873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5944058|NCT04773873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944059|NCT04773873|Antimanic Agents|antimanic agents|mesh-ancestor
5944060|NCT04773873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5944061|NCT04773873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5944062|NCT04773873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967723|NCT04559607|Apatinib|apatinib|mesh-list
5967724|NCT04559607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5967725|NCT04559607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5967726|NCT04559607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5967727|NCT04559607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967728|NCT04559412|Etanercept|etanercept|mesh-list
5967729|NCT04559412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5967730|NCT04559412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5967731|NCT04559412|Analgesics|analgesics|mesh-ancestor
5967732|NCT04559412|Sensory System Agents|sensory system agents|mesh-ancestor
5967733|NCT04559412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5967734|NCT04559412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967735|NCT04559412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5967736|NCT04559412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5967737|NCT04559412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5967738|NCT04559412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5967739|NCT04559412|Immunologic Factors|immunologic factors|mesh-ancestor
5967740|NCT04559568|Midazolam|midazolam|mesh-list
5967741|NCT04559568|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5967742|NCT04559568|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5967743|NCT04559568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5967744|NCT04559568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967745|NCT04559568|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5967746|NCT04559568|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5967747|NCT04559568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5967748|NCT04559568|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5967749|NCT04559568|Anesthetics, General|anesthetics, general|mesh-ancestor
5967750|NCT04559568|Anesthetics|anesthetics|mesh-ancestor
5967751|NCT04559568|GABA Modulators|gaba modulators|mesh-ancestor
5944063|NCT04773717|Ascorbic Acid|ascorbic acid|mesh-list
5944064|NCT04773717|Antioxidants|antioxidants|mesh-ancestor
5944065|NCT04773717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944066|NCT04773717|Protective Agents|protective agents|mesh-ancestor
5944067|NCT04773717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944068|NCT04773717|Vitamins|vitamins|mesh-ancestor
5944069|NCT04773717|Micronutrients|micronutrients|mesh-ancestor
5944070|NCT04774159|Colchicine|colchicine|mesh-list
5944071|NCT04774159|Gout Suppressants|gout suppressants|mesh-ancestor
5944072|NCT04774159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5944073|NCT04774159|Tubulin Modulators|tubulin modulators|mesh-ancestor
5944074|NCT04774159|Antimitotic Agents|antimitotic agents|mesh-ancestor
5944075|NCT04774159|Mitosis Modulators|mitosis modulators|mesh-ancestor
5944076|NCT04774159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944077|NCT04774159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5944078|NCT04774406|Olaparib|olaparib|mesh-list
5944079|NCT04774406|Niraparib|niraparib|mesh-list
5944080|NCT04774406|Veliparib|veliparib|mesh-list
5944081|NCT04774406|Talazoparib|talazoparib|mesh-list
5944082|NCT04774406|Rucaparib|rucaparib|mesh-list
5944083|NCT04774406|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5944084|NCT04774406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5944085|NCT04774406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944086|NCT04774406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5944087|NCT04773366|Cytarabine|cytarabine|mesh-list
5944088|NCT04773366|Prednisone|prednisone|mesh-list
5944089|NCT04773366|Vincristine|vincristine|mesh-list
5944090|NCT04773366|Mercaptopurine|mercaptopurine|mesh-list
5944091|NCT04773366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5944092|NCT04773366|Glucocorticoids|glucocorticoids|mesh-ancestor
5944093|NCT04773366|Hormones|hormones|mesh-ancestor
5944094|NCT04773366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5944095|NCT04773366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944096|NCT04773366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5944097|NCT04773366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5944098|NCT04773366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5944099|NCT04773366|Antimetabolites|antimetabolites|mesh-ancestor
5944100|NCT04773366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944101|NCT04773366|Antiviral Agents|antiviral agents|mesh-ancestor
5944102|NCT04773366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5944103|NCT04773366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5944104|NCT04773366|Immunologic Factors|immunologic factors|mesh-ancestor
5944105|NCT04773366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5944106|NCT04773366|Tubulin Modulators|tubulin modulators|mesh-ancestor
5944107|NCT04773366|Antimitotic Agents|antimitotic agents|mesh-ancestor
5944108|NCT04773366|Mitosis Modulators|mitosis modulators|mesh-ancestor
5944109|NCT04773366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5944110|NCT04773366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5944111|NCT04773301|Ropivacaine|ropivacaine|mesh-list
5944112|NCT04773301|Levobupivacaine|levobupivacaine|mesh-list
5944113|NCT04773301|Anesthetics, Local|anesthetics, local|mesh-ancestor
5944114|NCT04773301|Anesthetics|anesthetics|mesh-ancestor
5944115|NCT04773301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5944116|NCT04773301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944117|NCT04773301|Sensory System Agents|sensory system agents|mesh-ancestor
5944118|NCT04773301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5944119|NCT04773236|Lidocaine|lidocaine|mesh-list
5944120|NCT04773236|Anesthetics, Local|anesthetics, local|mesh-ancestor
5944121|NCT04773236|Anesthetics|anesthetics|mesh-ancestor
5944122|NCT04773236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5944123|NCT04773236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944124|NCT04773236|Sensory System Agents|sensory system agents|mesh-ancestor
5944125|NCT04773236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5944126|NCT04773236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5944127|NCT04773236|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5944128|NCT04773236|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5944129|NCT04773236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5944130|NCT04773236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944131|NCT04774393|Decitabine|decitabine|mesh-list
5944132|NCT04774393|Venetoclax|venetoclax|mesh-list
5944133|NCT04774393|Ivosidenib|ivosidenib|mesh-list
5944134|NCT04774393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5944135|NCT04774393|Antimetabolites|antimetabolites|mesh-ancestor
5944136|NCT04774393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944137|NCT04774393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5944138|NCT04774393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5944139|NCT04773392|Mycophenolic Acid|mycophenolic acid|mesh-list
5944140|NCT04773392|Prednisone|prednisone|mesh-list
5944141|NCT04773392|Methylprednisolone|methylprednisolone|mesh-list
5944142|NCT04773392|Azathioprine|azathioprine|mesh-list
5944143|NCT04773392|Tacrolimus|tacrolimus|mesh-list
5944144|NCT04773392|Thymoglobulin|thymoglobulin|mesh-list
5944145|NCT04773392|Basiliximab|basiliximab|mesh-list
5944146|NCT04773392|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5944147|NCT04773392|Antimetabolites|antimetabolites|mesh-list
5944148|NCT04773392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5944149|NCT04773392|Glucocorticoids|glucocorticoids|mesh-ancestor
5944150|NCT04773392|Hormones|hormones|mesh-ancestor
5944151|NCT04773392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5944152|NCT04773392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944153|NCT04773392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5944154|NCT04773392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5944155|NCT04773392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5944156|NCT04773392|Immunologic Factors|immunologic factors|mesh-ancestor
5944157|NCT04773392|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5944158|NCT04773392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5944159|NCT04773392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944160|NCT04773392|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5944161|NCT04773392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5944162|NCT04773392|Antitubercular Agents|antitubercular agents|mesh-ancestor
5944163|NCT04773392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5944164|NCT04773392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5944165|NCT04773392|Antiemetics|antiemetics|mesh-ancestor
5944166|NCT04773392|Autonomic Agents|autonomic agents|mesh-ancestor
5944167|NCT04773392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5944168|NCT04773392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5944169|NCT04773392|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5944170|NCT04773392|Protective Agents|protective agents|mesh-ancestor
5944171|NCT04773392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5944172|NCT04773392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5944173|NCT04773093|Lidocaine|lidocaine|mesh-list
5944174|NCT04773093|Anesthetics, Local|anesthetics, local|mesh-ancestor
5944175|NCT04773093|Anesthetics|anesthetics|mesh-ancestor
5944176|NCT04773093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5944177|NCT04773093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944178|NCT04773093|Sensory System Agents|sensory system agents|mesh-ancestor
5944179|NCT04773093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5944180|NCT04773093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5944181|NCT04773093|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5944182|NCT04773093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5944183|NCT04773093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5944184|NCT04773093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944185|NCT04772781|Ibuprofen|ibuprofen|mesh-list
5944186|NCT04772781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5944187|NCT04772781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5944188|NCT04772781|Analgesics|analgesics|mesh-ancestor
5944189|NCT04772781|Sensory System Agents|sensory system agents|mesh-ancestor
5944190|NCT04772781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5944191|NCT04772781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944192|NCT04772781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5944193|NCT04772781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5944194|NCT04772781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5944195|NCT04772781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5944196|NCT04772781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944197|NCT04773002|Anesthetics|anesthetics|mesh-list
5944198|NCT04773002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5944199|NCT04773002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944200|NCT04772729|Insulin|insulin|mesh-list
5944201|NCT04772729|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5944202|NCT04772729|Insulin Aspart|insulin aspart|mesh-list
5944203|NCT04772729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5944204|NCT04772729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944205|NCT04772521|Nicotine|nicotine|mesh-list
5944206|NCT04772521|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5944207|NCT04772521|Autonomic Agents|autonomic agents|mesh-ancestor
5944208|NCT04772521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5944209|NCT04772521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944210|NCT04772521|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5944211|NCT04772521|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5944212|NCT04772521|Cholinergic Agents|cholinergic agents|mesh-ancestor
5944213|NCT04772521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5944214|NCT04772521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944215|NCT04772287|Gemcitabine|gemcitabine|mesh-list
5944216|NCT04772287|Paclitaxel|paclitaxel|mesh-list
5944217|NCT04772287|Vinorelbine|vinorelbine|mesh-list
5944218|NCT04772287|Docetaxel|docetaxel|mesh-list
5944219|NCT04772287|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5944220|NCT04772287|Cisplatin|cisplatin|mesh-list
5944221|NCT04772287|Carboplatin|carboplatin|mesh-list
5944222|NCT04772287|Pemetrexed|pemetrexed|mesh-list
5944223|NCT04772287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5944224|NCT04772287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5944225|NCT04772287|Tubulin Modulators|tubulin modulators|mesh-ancestor
5944226|NCT04772287|Antimitotic Agents|antimitotic agents|mesh-ancestor
5944227|NCT04772287|Mitosis Modulators|mitosis modulators|mesh-ancestor
5944228|NCT04772287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944229|NCT04772287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5944230|NCT04772287|Antimetabolites|antimetabolites|mesh-ancestor
5944231|NCT04772287|Antiviral Agents|antiviral agents|mesh-ancestor
5944232|NCT04772287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5944233|NCT04772287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5944234|NCT04772287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5944235|NCT04772287|Immunologic Factors|immunologic factors|mesh-ancestor
5944236|NCT04772287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944237|NCT04772287|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5944238|NCT04772287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5944239|NCT04772196|Vitamin D|vitamin d|mesh-list
5944240|NCT04772196|Cholecalciferol|cholecalciferol|mesh-list
5944241|NCT04772196|Vitamins|vitamins|mesh-ancestor
5944242|NCT04772196|Micronutrients|micronutrients|mesh-ancestor
5944243|NCT04772196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944244|NCT04772196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5944245|NCT04772196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5967752|NCT04559568|GABA Agents|gaba agents|mesh-ancestor
5967753|NCT04559568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5967754|NCT04559568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967755|NCT04559308|Metformin|metformin|mesh-list
5967756|NCT04559308|Paclitaxel|paclitaxel|mesh-list
5967757|NCT04559308|Cyclophosphamide|cyclophosphamide|mesh-list
5967758|NCT04559308|Doxorubicin|doxorubicin|mesh-list
5967759|NCT04559308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5967760|NCT04559308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5967761|NCT04559308|Tubulin Modulators|tubulin modulators|mesh-ancestor
5967762|NCT04559308|Antimitotic Agents|antimitotic agents|mesh-ancestor
5967763|NCT04559308|Mitosis Modulators|mitosis modulators|mesh-ancestor
5967764|NCT04559308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967765|NCT04559308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5967766|NCT04559308|Immunologic Factors|immunologic factors|mesh-ancestor
5967767|NCT04559308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967768|NCT04559308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5967769|NCT04559308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5967770|NCT04559308|Alkylating Agents|alkylating agents|mesh-ancestor
5967771|NCT04559308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5967772|NCT04559308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5967773|NCT04559308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5967774|NCT04559308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5967775|NCT04559308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5967776|NCT04559308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5967777|NCT04559165|Chitosan|chitosan|mesh-list
5967778|NCT04559165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5967779|NCT04559165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5967780|NCT04559165|Antimetabolites|antimetabolites|mesh-ancestor
5967781|NCT04559165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967782|NCT04559165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5967783|NCT04559165|Chelating Agents|chelating agents|mesh-ancestor
5967784|NCT04559165|Sequestering Agents|sequestering agents|mesh-ancestor
5967785|NCT04559165|Hemostatics|hemostatics|mesh-ancestor
5967786|NCT04559165|Coagulants|coagulants|mesh-ancestor
5967787|NCT04559100|Carbon Monoxide|carbon monoxide|mesh-list
5967788|NCT04559100|Antimetabolites|antimetabolites|mesh-ancestor
5967789|NCT04559100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967790|NCT04559100|Gasotransmitters|gasotransmitters|mesh-ancestor
5967791|NCT04559100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5967792|NCT04559100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967793|NCT04559113|Methylprednisolone|methylprednisolone|mesh-list
5967794|NCT04559113|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5967795|NCT04559113|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5967796|NCT04559113|Prednisolone|prednisolone|mesh-list
5967797|NCT04559113|Prednisolone acetate|prednisolone acetate|mesh-list
5967798|NCT04559113|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5944246|NCT04772248|Adalimumab|adalimumab|mesh-list
5944247|NCT04772248|Etanercept|etanercept|mesh-list
5944248|NCT04772248|Golimumab|golimumab|mesh-list
5944249|NCT04772248|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
5944250|NCT04772248|Infliximab|infliximab|mesh-list
5944251|NCT04772248|Certolizumab Pegol|certolizumab pegol|mesh-list
5944252|NCT04772248|Tofacitinib|tofacitinib|mesh-list
5944253|NCT04772248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5944254|NCT04772248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5944255|NCT04772248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5944256|NCT04772248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5944257|NCT04772248|Analgesics|analgesics|mesh-ancestor
5944258|NCT04772248|Sensory System Agents|sensory system agents|mesh-ancestor
5944259|NCT04772248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5944260|NCT04772248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944261|NCT04772248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5944262|NCT04772248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5944263|NCT04772248|Immunologic Factors|immunologic factors|mesh-ancestor
5944264|NCT04772248|Dermatologic Agents|dermatologic agents|mesh-ancestor
5944265|NCT04772248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5944266|NCT04772248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5944267|NCT04772248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944268|NCT04772352|Febuxostat|febuxostat|mesh-list
5944269|NCT04772352|Gout Suppressants|gout suppressants|mesh-ancestor
5944270|NCT04772352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5944271|NCT04772235|Osimertinib|osimertinib|mesh-list
5944272|NCT04772235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5944273|NCT04772235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5944274|NCT04772235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5944275|NCT04772235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944276|NCT04772001|Carboplatin|carboplatin|mesh-list
5944277|NCT04772001|Cisplatin|cisplatin|mesh-list
5944278|NCT04772001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5944279|NCT04771715|Pembrolizumab|pembrolizumab|mesh-list
5944280|NCT04771715|Nivolumab|nivolumab|mesh-list
5944281|NCT04771715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5944282|NCT04771715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5944283|NCT04771715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5944284|NCT04771715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944285|NCT04771741|Acetaminophen|acetaminophen|mesh-list
5944286|NCT04771741|Ketorolac|ketorolac|mesh-list
5944287|NCT04771741|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
5944288|NCT04771741|Meloxicam|meloxicam|mesh-list
5944289|NCT04771741|Pregabalin|pregabalin|mesh-list
5944290|NCT04771741|Cyclobenzaprine|cyclobenzaprine|mesh-list
5944291|NCT04771741|Analgesics|analgesics|mesh-ancestor
5944292|NCT04771741|Sensory System Agents|sensory system agents|mesh-ancestor
5944293|NCT04771741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5944294|NCT04771741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944295|NCT04771741|Anticonvulsants|anticonvulsants|mesh-ancestor
5944296|NCT04771741|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5944297|NCT04771741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5944298|NCT04771741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944299|NCT04771741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5944300|NCT04771741|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5944301|NCT04771741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5944302|NCT04771741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5944303|NCT04771741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5944304|NCT04771741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5944305|NCT04771741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5944306|NCT04771741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5944307|NCT04771741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5944308|NCT04771741|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5944309|NCT04771741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5944310|NCT04771741|Antipyretics|antipyretics|mesh-ancestor
5944311|NCT04771741|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5944312|NCT04771741|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5944313|NCT04771741|Antidepressive Agents|antidepressive agents|mesh-ancestor
5944314|NCT04771741|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5944315|NCT04771741|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5944316|NCT04771728|Metronidazole|metronidazole|mesh-list
5944317|NCT04771728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5944318|NCT04771728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5944319|NCT04771728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5944320|NCT04771728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5944321|NCT04771884|Vancomycin|vancomycin|mesh-list
5944322|NCT04771884|Meropenem|meropenem|mesh-list
5944323|NCT04771884|Ceftriaxone|ceftriaxone|mesh-list
5944324|NCT04771884|Linezolid|linezolid|mesh-list
5944325|NCT04771884|Ceftazidime|ceftazidime|mesh-list
5944326|NCT04771884|Ceftizoxime|ceftizoxime|mesh-list
5944327|NCT04771884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5944328|NCT04771884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5944329|NCT04771884|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5944330|NCT04771884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5944331|NCT04771884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944332|NCT04771754|Dolutegravir|dolutegravir|mesh-list
5944333|NCT04771754|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5944334|NCT04771754|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5944335|NCT04771754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5944336|NCT04771754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944337|NCT04771754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5944338|NCT04771754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5944339|NCT04771754|Antiviral Agents|antiviral agents|mesh-ancestor
5944340|NCT04771754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5944341|NCT04771559|Antibodies|antibodies|mesh-list
5944342|NCT04771559|Immunologic Factors|immunologic factors|mesh-ancestor
5944343|NCT04771559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944344|NCT04771767|Ketamine|ketamine|mesh-list
5944345|NCT04771767|Analgesics|analgesics|mesh-ancestor
5944346|NCT04771767|Sensory System Agents|sensory system agents|mesh-ancestor
5944347|NCT04771767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5944348|NCT04771767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944349|NCT04771767|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5944350|NCT04771767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5944351|NCT04771767|Anesthetics, General|anesthetics, general|mesh-ancestor
5944352|NCT04771767|Anesthetics|anesthetics|mesh-ancestor
5944353|NCT04771767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5944354|NCT04771767|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5944355|NCT04771767|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5944356|NCT04771767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5944357|NCT04771767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944358|NCT04771520|Piperazine|piperazine|mesh-list
5944359|NCT04771520|Mebendazole|mebendazole|mesh-list
5944360|NCT04771520|Piperazine citrate|piperazine citrate|mesh-list
5944361|NCT04771520|DMP 777|dmp 777|mesh-list
5944362|NCT04771520|Antinematodal Agents|antinematodal agents|mesh-ancestor
5944363|NCT04771520|Anthelmintics|anthelmintics|mesh-ancestor
5944364|NCT04771520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5944365|NCT04771520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5944366|NCT04771520|Tubulin Modulators|tubulin modulators|mesh-ancestor
5944367|NCT04771520|Antimitotic Agents|antimitotic agents|mesh-ancestor
5944368|NCT04771520|Mitosis Modulators|mitosis modulators|mesh-ancestor
5944369|NCT04771520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944370|NCT04771520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5944371|NCT04771520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5944372|NCT04771390|Selitrectinib|selitrectinib|mesh-list
5944373|NCT04771390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5944374|NCT04771390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944375|NCT04771481|Metoclopramide|metoclopramide|mesh-list
5944376|NCT04771481|Antiemetics|antiemetics|mesh-ancestor
5944377|NCT04771481|Autonomic Agents|autonomic agents|mesh-ancestor
5944378|NCT04771481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5944379|NCT04771481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944380|NCT04771481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5944381|NCT04771481|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5944382|NCT04771481|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5944383|NCT04771481|Dopamine Agents|dopamine agents|mesh-ancestor
5944384|NCT04771481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5944385|NCT04771481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944386|NCT04771299|Cariprazine|cariprazine|mesh-list
5944387|NCT04771299|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5944388|NCT04771299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5944389|NCT04771299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5944390|NCT04771299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944391|NCT04771299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5944392|NCT04771026|Dexamethasone|dexamethasone|mesh-list
5944393|NCT04771026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5944394|NCT04771026|Antiemetics|antiemetics|mesh-ancestor
5944395|NCT04771026|Autonomic Agents|autonomic agents|mesh-ancestor
5944396|NCT04771026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5944397|NCT04771026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944398|NCT04771026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5944399|NCT04771026|Glucocorticoids|glucocorticoids|mesh-ancestor
5944400|NCT04771026|Hormones|hormones|mesh-ancestor
5944401|NCT04771026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5944402|NCT04771026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5944403|NCT04771026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5944404|NCT04771000|Ambrisentan|ambrisentan|mesh-list
5944405|NCT04771000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5944406|NCT04770740|Vitamin K|vitamin k|mesh-list
5944407|NCT04770740|Vitamin K 2|vitamin k 2|mesh-list
5944408|NCT04770740|Vitamin MK 7|vitamin mk 7|mesh-list
5944409|NCT04770740|Vitamins|vitamins|mesh-ancestor
5944410|NCT04770740|Micronutrients|micronutrients|mesh-ancestor
5944411|NCT04770740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944412|NCT04770740|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5944413|NCT04770740|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5944414|NCT04770740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944415|NCT04770740|Hemostatics|hemostatics|mesh-ancestor
5944416|NCT04770740|Coagulants|coagulants|mesh-ancestor
5944417|NCT04770792|Chlorhexidine|chlorhexidine|mesh-list
5944418|NCT04770792|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5944419|NCT04770792|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5944420|NCT04770792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5944421|NCT04770792|Disinfectants|disinfectants|mesh-ancestor
5944422|NCT04770792|Dermatologic Agents|dermatologic agents|mesh-ancestor
5944423|NCT04770623|Docetaxel|docetaxel|mesh-list
5944424|NCT04770623|Irinotecan|irinotecan|mesh-list
5944425|NCT04770623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5944426|NCT04770623|Tubulin Modulators|tubulin modulators|mesh-ancestor
5944427|NCT04770623|Antimitotic Agents|antimitotic agents|mesh-ancestor
5944428|NCT04770623|Mitosis Modulators|mitosis modulators|mesh-ancestor
5944429|NCT04770623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944430|NCT04770623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5944431|NCT04770623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5944432|NCT04770623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5944433|NCT04770688|Osimertinib|osimertinib|mesh-list
5944434|NCT04770688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5944435|NCT04770688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5944436|NCT04770688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5944437|NCT04770688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944438|NCT04770610|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5944439|NCT04770610|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5944440|NCT04770961|Ropivacaine|ropivacaine|mesh-list
5944441|NCT04770961|Anesthetics, Local|anesthetics, local|mesh-ancestor
5944442|NCT04770961|Anesthetics|anesthetics|mesh-ancestor
5944443|NCT04770961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5944444|NCT04770961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944445|NCT04770961|Sensory System Agents|sensory system agents|mesh-ancestor
5944446|NCT04770961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5944447|NCT04770155|Bosentan|bosentan|mesh-list
5944448|NCT04770155|Sildenafil Citrate|sildenafil citrate|mesh-list
5944449|NCT04770155|Vasodilator Agents|vasodilator agents|mesh-ancestor
5944450|NCT04770155|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5944451|NCT04770155|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5944452|NCT04770155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5944453|NCT04770155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944454|NCT04770155|Urological Agents|urological agents|mesh-ancestor
5944455|NCT04770155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5944456|NCT04770155|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5967799|NCT04559113|Prednisolone phosphate|prednisolone phosphate|mesh-list
5967800|NCT04559113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5967801|NCT04559113|Antiemetics|antiemetics|mesh-ancestor
5967802|NCT04559113|Autonomic Agents|autonomic agents|mesh-ancestor
5967803|NCT04559113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5967804|NCT04559113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967805|NCT04559113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5967806|NCT04559113|Glucocorticoids|glucocorticoids|mesh-ancestor
5967807|NCT04559113|Hormones|hormones|mesh-ancestor
5967808|NCT04559113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5967809|NCT04559113|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5967810|NCT04559113|Protective Agents|protective agents|mesh-ancestor
5967811|NCT04559113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5967812|NCT04559113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5967813|NCT04559074|Amlodipine|amlodipine|mesh-list
5967814|NCT04559074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5967815|NCT04559074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5967816|NCT04559074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5967817|NCT04559074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944457|NCT04770389|Ezetimibe|ezetimibe|mesh-list
5944458|NCT04770389|Hypolipidemic Agents|hypolipidemic agents|mesh-list
5944459|NCT04770389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5944460|NCT04770389|Antimetabolites|antimetabolites|mesh-ancestor
5944461|NCT04770389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944462|NCT04770389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5944463|NCT04769908|Lenvatinib|lenvatinib|mesh-list
5944464|NCT04769908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5944465|NCT04769908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5944466|NCT04769908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5944467|NCT04769908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944468|NCT04769557|Acetaminophen|acetaminophen|mesh-list
5944469|NCT04769557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5944470|NCT04769557|Analgesics|analgesics|mesh-ancestor
5944471|NCT04769557|Sensory System Agents|sensory system agents|mesh-ancestor
5944472|NCT04769557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5944473|NCT04769557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944474|NCT04769557|Antipyretics|antipyretics|mesh-ancestor
5944475|NCT04769713|Ropivacaine|ropivacaine|mesh-list
5944476|NCT04769713|Anesthetics, Local|anesthetics, local|mesh-ancestor
5944477|NCT04769713|Anesthetics|anesthetics|mesh-ancestor
5944478|NCT04769713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5944479|NCT04769713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944480|NCT04769713|Sensory System Agents|sensory system agents|mesh-ancestor
5944481|NCT04769713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5944482|NCT04769583|Metronidazole|metronidazole|mesh-list
5944483|NCT04769583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5944484|NCT04769583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5944485|NCT04769583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5944486|NCT04769583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5944487|NCT04769778|Valsartan|valsartan|mesh-list
5944488|NCT04769778|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5944489|NCT04769778|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5944490|NCT04769778|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5944491|NCT04769778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944492|NCT04769362|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
5944493|NCT04769362|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5944494|NCT04769362|Adrenergic Agents|adrenergic agents|mesh-ancestor
5944495|NCT04769362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5944496|NCT04769362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944497|NCT04769362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944498|NCT04769414|Gemcitabine|gemcitabine|mesh-list
5944499|NCT04769414|Fluorouracil|fluorouracil|mesh-list
5944500|NCT04769414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5944501|NCT04769414|Antimetabolites|antimetabolites|mesh-ancestor
5944502|NCT04769414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944503|NCT04769414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5944504|NCT04769414|Antiviral Agents|antiviral agents|mesh-ancestor
5944505|NCT04769414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5944506|NCT04769414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5944507|NCT04769414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5944508|NCT04769414|Immunologic Factors|immunologic factors|mesh-ancestor
5944509|NCT04769414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944510|NCT04769258|Vaccines|vaccines|mesh-list
5944511|NCT04769258|Immunologic Factors|immunologic factors|mesh-ancestor
5944512|NCT04769258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944513|NCT04769388|Carboplatin|carboplatin|mesh-list
5944514|NCT04769388|Pemetrexed|pemetrexed|mesh-list
5944515|NCT04769388|Osimertinib|osimertinib|mesh-list
5944516|NCT04769388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5944517|NCT04769388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5944518|NCT04769388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944519|NCT04769388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5944520|NCT04769388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5944521|NCT04769388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5944522|NCT04769297|Ketamine|ketamine|mesh-list
5944523|NCT04769297|Analgesics|analgesics|mesh-ancestor
5944524|NCT04769297|Sensory System Agents|sensory system agents|mesh-ancestor
5944525|NCT04769297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5944526|NCT04769297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944527|NCT04769297|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5944528|NCT04769297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5944529|NCT04769297|Anesthetics, General|anesthetics, general|mesh-ancestor
5944530|NCT04769297|Anesthetics|anesthetics|mesh-ancestor
5944531|NCT04769297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5944532|NCT04769297|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5944533|NCT04769297|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5944534|NCT04769297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5944535|NCT04769297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944536|NCT04769076|Paclitaxel|paclitaxel|mesh-list
5944537|NCT04769076|Cisplatin|cisplatin|mesh-list
5944538|NCT04769076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5944539|NCT04769076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5944540|NCT04769076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5944541|NCT04769076|Tubulin Modulators|tubulin modulators|mesh-ancestor
5944542|NCT04769076|Antimitotic Agents|antimitotic agents|mesh-ancestor
5944543|NCT04769076|Mitosis Modulators|mitosis modulators|mesh-ancestor
5944544|NCT04769076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944545|NCT04769050|Docetaxel|docetaxel|mesh-list
5944546|NCT04769050|Capecitabine|capecitabine|mesh-list
5944547|NCT04769050|Trastuzumab|trastuzumab|mesh-list
5944548|NCT04769050|Pertuzumab|pertuzumab|mesh-list
5944549|NCT04769050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5944550|NCT04769050|Tubulin Modulators|tubulin modulators|mesh-ancestor
5944551|NCT04769050|Antimitotic Agents|antimitotic agents|mesh-ancestor
5944552|NCT04769050|Mitosis Modulators|mitosis modulators|mesh-ancestor
5944553|NCT04769050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944554|NCT04769050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5944555|NCT04769050|Antimetabolites|antimetabolites|mesh-ancestor
5944556|NCT04769050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5944557|NCT04769271|Tea Tree Oil|tea tree oil|mesh-list
5944558|NCT04769271|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5944559|NCT04769271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5944560|NCT04768985|Acalabrutinib|acalabrutinib|mesh-list
5944561|NCT04768985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5944562|NCT04768764|Bupivacaine|bupivacaine|mesh-list
5944563|NCT04768764|Anesthetics|anesthetics|mesh-list
5944564|NCT04768764|Anesthetics, Local|anesthetics, local|mesh-ancestor
5944565|NCT04768764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5944566|NCT04768764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944567|NCT04768764|Sensory System Agents|sensory system agents|mesh-ancestor
5944568|NCT04768764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5967818|NCT04559074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5967819|NCT04559074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967820|NCT04559074|Vasodilator Agents|vasodilator agents|mesh-ancestor
5971056|NCT04530903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5971057|NCT04530903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971058|NCT04530903|Sensory System Agents|sensory system agents|mesh-ancestor
5971059|NCT04530903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5971060|NCT04530903|Analgesics|analgesics|mesh-ancestor
5971061|NCT04530903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5971062|NCT04530903|Sympatholytics|sympatholytics|mesh-ancestor
5971063|NCT04530903|Autonomic Agents|autonomic agents|mesh-ancestor
5971064|NCT04530903|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5971065|NCT04530903|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5971066|NCT04530903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5971067|NCT04530903|Adrenergic Agents|adrenergic agents|mesh-ancestor
5971068|NCT04530903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5971069|NCT04530903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971070|NCT04530474|Ivermectin|ivermectin|mesh-list
5971071|NCT04530474|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5971072|NCT04530474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5971073|NCT04530500|Androgens|androgens|mesh-list
5971074|NCT04530500|Hormones|hormones|mesh-ancestor
5971075|NCT04530500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5971076|NCT04530500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971077|NCT04530578|Heparin|heparin|mesh-list
5971078|NCT04530578|Calcium heparin|calcium heparin|mesh-list
5971079|NCT04530578|Enoxaparin|enoxaparin|mesh-list
5971080|NCT04530578|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5971081|NCT04530578|Tinzaparin|tinzaparin|mesh-list
5971082|NCT04530578|Dalteparin|dalteparin|mesh-list
5971083|NCT04530578|Anticoagulants|anticoagulants|mesh-ancestor
5971084|NCT04530578|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5971085|NCT04530578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5971086|NCT04530578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971388|NCT04528888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5971389|NCT04528888|Glucocorticoids|glucocorticoids|mesh-ancestor
5971390|NCT04528888|Hormones|hormones|mesh-ancestor
5971391|NCT04528888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5971392|NCT04528888|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5944569|NCT04768686|Pembrolizumab|pembrolizumab|mesh-list
5944570|NCT04768686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5944571|NCT04768686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5944572|NCT04768530|Nitazoxanide|nitazoxanide|mesh-list
5944573|NCT04768530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5944574|NCT04768530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5944575|NCT04768465|Prednisone|prednisone|mesh-list
5944576|NCT04768465|Bromides|bromides|mesh-list
5944577|NCT04768465|Tacrolimus|tacrolimus|mesh-list
5944578|NCT04768465|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
5944579|NCT04768465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5944580|NCT04768465|Glucocorticoids|glucocorticoids|mesh-ancestor
5944581|NCT04768465|Hormones|hormones|mesh-ancestor
5944582|NCT04768465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5944583|NCT04768465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944584|NCT04768465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5944585|NCT04768465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5944586|NCT04768465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5944587|NCT04768465|Immunologic Factors|immunologic factors|mesh-ancestor
5944588|NCT04768465|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5944589|NCT04768465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5944590|NCT04768465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944591|NCT04768465|Anticonvulsants|anticonvulsants|mesh-ancestor
5944592|NCT04768465|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5944593|NCT04768465|Cholinergic Agents|cholinergic agents|mesh-ancestor
5944594|NCT04768465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5944595|NCT04768166|Miglustat|miglustat|mesh-list
5944596|NCT04768166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5944597|NCT04768166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944598|NCT04768166|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5944599|NCT04768166|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5944600|NCT04768166|Antiviral Agents|antiviral agents|mesh-ancestor
5944601|NCT04768166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5944602|NCT04768166|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
5944603|NCT04768166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5944604|NCT04768166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944605|NCT04768231|Rifampin|rifampin|mesh-list
5944606|NCT04768231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5944607|NCT04768231|Antitubercular Agents|antitubercular agents|mesh-ancestor
5944608|NCT04768231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5944609|NCT04768231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5944610|NCT04768231|Leprostatic Agents|leprostatic agents|mesh-ancestor
5944611|NCT04768231|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5944612|NCT04768231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5944613|NCT04768231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944614|NCT04768231|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5944615|NCT04768231|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5944616|NCT04768231|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5944617|NCT04768231|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5944618|NCT04768231|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6681311|NCT01609049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681312|NCT01609049|Antiviral Agents|antiviral agents|mesh-ancestor
6681313|NCT01609049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6681314|NCT01609088|Erythritol|erythritol|mesh-list
6681315|NCT01609088|Vasodilator Agents|vasodilator agents|mesh-ancestor
6681316|NCT01609101|Cobalt|cobalt|mesh-list
6681317|NCT01609101|Trace Elements|trace elements|mesh-ancestor
6681318|NCT01609101|Micronutrients|micronutrients|mesh-ancestor
5944619|NCT04768231|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5944620|NCT04768075|Paclitaxel|paclitaxel|mesh-list
5944621|NCT04768075|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5944622|NCT04768075|Carboplatin|carboplatin|mesh-list
5944623|NCT04768075|Pemetrexed|pemetrexed|mesh-list
5944624|NCT04768075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5944625|NCT04768075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5944626|NCT04768075|Tubulin Modulators|tubulin modulators|mesh-ancestor
5944627|NCT04768075|Antimitotic Agents|antimitotic agents|mesh-ancestor
5944628|NCT04768075|Mitosis Modulators|mitosis modulators|mesh-ancestor
5944629|NCT04768075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944630|NCT04768075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5944631|NCT04768075|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5944632|NCT04768075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5944633|NCT04768439|Vitamin D|vitamin d|mesh-list
5944634|NCT04768439|Ergocalciferols|ergocalciferols|mesh-list
5944635|NCT04768439|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
5944636|NCT04768439|Calcitriol|calcitriol|mesh-list
5944637|NCT04768439|Vitamins|vitamins|mesh-list
5944638|NCT04768439|Micronutrients|micronutrients|mesh-ancestor
5944639|NCT04768439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944640|NCT04768439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5944641|NCT04768439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5944642|NCT04768439|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
5944643|NCT04768439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5944644|NCT04768439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944645|NCT04768439|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5944646|NCT04767841|Metformin|metformin|mesh-list
5944647|NCT04767841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5944648|NCT04767841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944649|NCT04768023|Vitamin D|vitamin d|mesh-list
5944650|NCT04768023|Vitamins|vitamins|mesh-ancestor
5944651|NCT04768023|Micronutrients|micronutrients|mesh-ancestor
5944652|NCT04768023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944653|NCT04768023|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5944654|NCT04767698|Belimumab|belimumab|mesh-list
5944655|NCT04767698|Ocrelizumab|ocrelizumab|mesh-list
5944656|NCT04767698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5944657|NCT04767698|Immunologic Factors|immunologic factors|mesh-ancestor
5944658|NCT04767698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944659|NCT04767828|Capecitabine|capecitabine|mesh-list
6517359|NCT00720590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6517360|NCT00720603|Plerixafor|plerixafor|mesh-list
6517361|NCT00720603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6517362|NCT00720603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6517363|NCT00720603|Antiviral Agents|antiviral agents|mesh-ancestor
6517364|NCT00720603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6517365|NCT00720616|Insulin|insulin|mesh-list
6517366|NCT00720616|Hormones|hormones|mesh-list
6517367|NCT00720616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6517368|NCT00720616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517369|NCT00720616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6517370|NCT00720772|Sodium thiosulfate|sodium thiosulfate|mesh-list
6517371|NCT00720772|Antidotes|antidotes|mesh-ancestor
6517372|NCT00720772|Protective Agents|protective agents|mesh-ancestor
6517373|NCT00720772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944660|NCT04767828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5944661|NCT04767828|Antimetabolites|antimetabolites|mesh-ancestor
5944662|NCT04767828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944663|NCT04767828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5944664|NCT04767711|Prednisolone|prednisolone|mesh-list
5944665|NCT04767711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5944666|NCT04767711|Glucocorticoids|glucocorticoids|mesh-ancestor
5944667|NCT04767711|Hormones|hormones|mesh-ancestor
5944668|NCT04767711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5944669|NCT04767711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944670|NCT04767711|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5944671|NCT04767711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5944672|NCT04767633|Magnesium Sulfate|magnesium sulfate|mesh-list
5944673|NCT04767633|Analgesics|analgesics|mesh-ancestor
5944674|NCT04767633|Sensory System Agents|sensory system agents|mesh-ancestor
5944675|NCT04767633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5944676|NCT04767633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944677|NCT04767633|Anesthetics|anesthetics|mesh-ancestor
5944678|NCT04767633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5944679|NCT04767633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5944680|NCT04767633|Anticonvulsants|anticonvulsants|mesh-ancestor
5944681|NCT04767633|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5944682|NCT04767633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5944683|NCT04767633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944684|NCT04767633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5944685|NCT04767633|Tocolytic Agents|tocolytic agents|mesh-ancestor
5944686|NCT04767633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5944687|NCT04767243|Methamphetamine|methamphetamine|mesh-list
5944688|NCT04767243|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5944689|NCT04767243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944690|NCT04767243|Sympathomimetics|sympathomimetics|mesh-ancestor
5944691|NCT04767243|Autonomic Agents|autonomic agents|mesh-ancestor
5944692|NCT04767243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5944693|NCT04767243|Dopamine Agents|dopamine agents|mesh-ancestor
5944694|NCT04767243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5944695|NCT04767243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944696|NCT04767243|Adrenergic Agents|adrenergic agents|mesh-ancestor
5944697|NCT04767243|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5944698|NCT04767243|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5944699|NCT04767243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5944700|NCT04767243|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5944701|NCT04767256|Dexamethasone|dexamethasone|mesh-list
5944702|NCT04767256|Dexmedetomidine|dexmedetomidine|mesh-list
5944703|NCT04767256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5944704|NCT04767256|Antiemetics|antiemetics|mesh-ancestor
5944705|NCT04767256|Autonomic Agents|autonomic agents|mesh-ancestor
5944706|NCT04767256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5944707|NCT04767256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944708|NCT04767256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5944709|NCT04767256|Glucocorticoids|glucocorticoids|mesh-ancestor
5944710|NCT04767256|Hormones|hormones|mesh-ancestor
5944711|NCT04767256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5944712|NCT04767256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5944713|NCT04767256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5944714|NCT04767256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5944715|NCT04767256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5944716|NCT04767256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5944717|NCT04767256|Analgesics|analgesics|mesh-ancestor
5944718|NCT04767256|Sensory System Agents|sensory system agents|mesh-ancestor
5944719|NCT04767256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5944720|NCT04767256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5944721|NCT04767256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5944722|NCT04767256|Adrenergic Agents|adrenergic agents|mesh-ancestor
5944723|NCT04767256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5944724|NCT04767256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944725|NCT04767295|Paclitaxel|paclitaxel|mesh-list
5944726|NCT04767295|Carboplatin|carboplatin|mesh-list
5944727|NCT04767295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5944728|NCT04767295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5944729|NCT04767295|Tubulin Modulators|tubulin modulators|mesh-ancestor
5944730|NCT04767295|Antimitotic Agents|antimitotic agents|mesh-ancestor
5944731|NCT04767295|Mitosis Modulators|mitosis modulators|mesh-ancestor
5944732|NCT04767295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944733|NCT04767503|Propofol|propofol|mesh-list
5944734|NCT04767503|Desflurane|desflurane|mesh-list
5944735|NCT04767503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5944736|NCT04767503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5944737|NCT04767503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944738|NCT04767503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5944739|NCT04767503|Anesthetics, General|anesthetics, general|mesh-ancestor
5944740|NCT04767503|Anesthetics|anesthetics|mesh-ancestor
5944741|NCT04767503|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5944742|NCT04767217|Lumefantrine|lumefantrine|mesh-list
5944743|NCT04767217|Artemether|artemether|mesh-list
5944744|NCT04767217|Piperaquine|piperaquine|mesh-list
5944745|NCT04767217|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
5944746|NCT04767217|Artenimol|artenimol|mesh-list
5944747|NCT04767217|Antimalarials|antimalarials|mesh-ancestor
6517374|NCT00720772|Antioxidants|antioxidants|mesh-ancestor
6517375|NCT00720772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944748|NCT04767217|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5944749|NCT04767217|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5944750|NCT04767217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5944751|NCT04767308|Cyclophosphamide|cyclophosphamide|mesh-list
5944752|NCT04767308|Fludarabine|fludarabine|mesh-list
5944753|NCT04767308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5944754|NCT04767308|Immunologic Factors|immunologic factors|mesh-ancestor
5944755|NCT04767308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944756|NCT04767308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5944757|NCT04767308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5944758|NCT04767308|Alkylating Agents|alkylating agents|mesh-ancestor
5944759|NCT04767308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944760|NCT04767308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5944761|NCT04767308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5944762|NCT04767594|Palbociclib|palbociclib|mesh-list
5944763|NCT04767594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5944764|NCT04767594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5944765|NCT04767594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5944766|NCT04767594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944767|NCT04767178|Acetaminophen|acetaminophen|mesh-list
6517376|NCT00720772|Antitubercular Agents|antitubercular agents|mesh-ancestor
6517377|NCT00720772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5944768|NCT04767178|Ibuprofen|ibuprofen|mesh-list
5944769|NCT04767178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5944770|NCT04767178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5944771|NCT04767178|Analgesics|analgesics|mesh-ancestor
5944772|NCT04767178|Sensory System Agents|sensory system agents|mesh-ancestor
5944773|NCT04767178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5944774|NCT04767178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944775|NCT04767178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5944776|NCT04767178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5944777|NCT04767178|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5944778|NCT04767178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5944779|NCT04767178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944780|NCT04767178|Antipyretics|antipyretics|mesh-ancestor
5944781|NCT04767542|Acetaminophen|acetaminophen|mesh-list
5944782|NCT04767542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944783|NCT04767542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5944784|NCT04767542|Analgesics|analgesics|mesh-ancestor
5944785|NCT04767542|Sensory System Agents|sensory system agents|mesh-ancestor
5944786|NCT04767542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5944787|NCT04767542|Antipyretics|antipyretics|mesh-ancestor
5944788|NCT04766853|Dexamethasone|dexamethasone|mesh-list
5944789|NCT04766853|Hyaluronic Acid|hyaluronic acid|mesh-list
5944790|NCT04766853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5944791|NCT04766853|Antiemetics|antiemetics|mesh-ancestor
5944792|NCT04766853|Autonomic Agents|autonomic agents|mesh-ancestor
5944793|NCT04766853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5944794|NCT04766853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944795|NCT04766853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5944796|NCT04766853|Glucocorticoids|glucocorticoids|mesh-ancestor
5944797|NCT04766853|Hormones|hormones|mesh-ancestor
5944798|NCT04766853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5944799|NCT04766853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5944800|NCT04766853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5944801|NCT04766853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5944802|NCT04766853|Immunologic Factors|immunologic factors|mesh-ancestor
5944803|NCT04766853|Viscosupplements|viscosupplements|mesh-ancestor
5944804|NCT04766853|Protective Agents|protective agents|mesh-ancestor
5944805|NCT04767035|Midazolam|midazolam|mesh-list
5944806|NCT04767035|Ketamine|ketamine|mesh-list
5944807|NCT04767035|Analgesics|analgesics|mesh-ancestor
5944808|NCT04767035|Sensory System Agents|sensory system agents|mesh-ancestor
5944809|NCT04767035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5944810|NCT04767035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944811|NCT04767035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5944812|NCT04767035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5944813|NCT04767035|Anesthetics, General|anesthetics, general|mesh-ancestor
5944814|NCT04767035|Anesthetics|anesthetics|mesh-ancestor
5944815|NCT04767035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5944816|NCT04767035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5944817|NCT04767035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5944818|NCT04767035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5944819|NCT04767035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944820|NCT04767035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5944821|NCT04767035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5944822|NCT04767035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5944823|NCT04767035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5944824|NCT04767035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5944825|NCT04767035|GABA Modulators|gaba modulators|mesh-ancestor
5944826|NCT04767035|GABA Agents|gaba agents|mesh-ancestor
5944827|NCT04766827|Paclitaxel|paclitaxel|mesh-list
5944828|NCT04766827|Docetaxel|docetaxel|mesh-list
5944829|NCT04766827|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5944830|NCT04766827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5944831|NCT04766827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5944832|NCT04766827|Tubulin Modulators|tubulin modulators|mesh-ancestor
5944833|NCT04766827|Antimitotic Agents|antimitotic agents|mesh-ancestor
5944834|NCT04766827|Mitosis Modulators|mitosis modulators|mesh-ancestor
5944835|NCT04766827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967821|NCT04559048|Tacrolimus|tacrolimus|mesh-list
5967822|NCT04559048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5967823|NCT04559048|Immunologic Factors|immunologic factors|mesh-ancestor
5967824|NCT04559048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967825|NCT04559048|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5967826|NCT04559048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5967827|NCT04559048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967828|NCT04558892|Enoxaparin|enoxaparin|mesh-list
5967829|NCT04558892|Anticoagulants|anticoagulants|mesh-ancestor
5944836|NCT04766918|Hyaluronic Acid|hyaluronic acid|mesh-list
5944837|NCT04766918|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5944838|NCT04766918|Immunologic Factors|immunologic factors|mesh-ancestor
5944839|NCT04766918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944840|NCT04766918|Viscosupplements|viscosupplements|mesh-ancestor
5944841|NCT04766918|Protective Agents|protective agents|mesh-ancestor
5944842|NCT04767074|Phenylpropanolamine|phenylpropanolamine|mesh-list
5944843|NCT04767074|Guaifenesin|guaifenesin|mesh-list
5944844|NCT04767074|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
5944845|NCT04767074|Expectorants|expectorants|mesh-ancestor
5944846|NCT04767074|Respiratory System Agents|respiratory system agents|mesh-ancestor
5944847|NCT04767074|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5944848|NCT04767074|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5944849|NCT04767074|Adrenergic Agents|adrenergic agents|mesh-ancestor
5944850|NCT04767074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5944851|NCT04767074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944852|NCT04767074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944853|NCT04767074|Appetite Depressants|appetite depressants|mesh-ancestor
5944854|NCT04767074|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5944855|NCT04767074|Sympathomimetics|sympathomimetics|mesh-ancestor
5944856|NCT04767074|Autonomic Agents|autonomic agents|mesh-ancestor
5944857|NCT04767074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5944858|NCT04767074|Nasal Decongestants|nasal decongestants|mesh-ancestor
5944859|NCT04767074|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5944860|NCT04767061|Propranolol|propranolol|mesh-list
5944861|NCT04767061|Metoprolol|metoprolol|mesh-list
5944862|NCT04767061|Atenolol|atenolol|mesh-list
5944863|NCT04767061|Sotalol|sotalol|mesh-list
5944864|NCT04767061|Nadolol|nadolol|mesh-list
5944865|NCT04767061|Acebutolol|acebutolol|mesh-list
5944866|NCT04767061|Carvedilol|carvedilol|mesh-list
5944867|NCT04767061|Nebivolol|nebivolol|mesh-list
5944868|NCT04767061|Bisoprolol|bisoprolol|mesh-list
5944869|NCT04767061|Labetalol|labetalol|mesh-list
5944870|NCT04767061|Pindolol|pindolol|mesh-list
5944871|NCT04767061|Betaxolol|betaxolol|mesh-list
5944872|NCT04767061|Penbutolol|penbutolol|mesh-list
5944873|NCT04767061|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
5944874|NCT04767061|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5944875|NCT04767061|Adrenergic Agents|adrenergic agents|mesh-ancestor
5944876|NCT04767061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5944877|NCT04767061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944878|NCT04767061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944879|NCT04767061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5944880|NCT04767061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5944881|NCT04767061|Vasodilator Agents|vasodilator agents|mesh-ancestor
5944882|NCT04767061|Sympatholytics|sympatholytics|mesh-ancestor
5944883|NCT04767061|Autonomic Agents|autonomic agents|mesh-ancestor
5944884|NCT04767061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5944885|NCT04767061|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5944886|NCT04767061|Antioxidants|antioxidants|mesh-ancestor
5944887|NCT04767061|Protective Agents|protective agents|mesh-ancestor
5944888|NCT04767061|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5944889|NCT04767061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5944890|NCT04767061|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5944891|NCT04767061|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5944892|NCT04767061|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5944893|NCT04767061|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5944894|NCT04767061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5944895|NCT04767061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5944896|NCT04767061|Sympathomimetics|sympathomimetics|mesh-ancestor
5944897|NCT04767061|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5944898|NCT04767061|Serotonin Agents|serotonin agents|mesh-ancestor
5944899|NCT04767113|Heparin|heparin|mesh-list
5944900|NCT04767113|Calcium heparin|calcium heparin|mesh-list
5944901|NCT04767113|Anticoagulants|anticoagulants|mesh-ancestor
5944902|NCT04767113|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5944903|NCT04767113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5944904|NCT04767113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944905|NCT04766775|Fluorides|fluorides|mesh-list
5944906|NCT04766775|Cariostatic Agents|cariostatic agents|mesh-ancestor
5944907|NCT04766775|Protective Agents|protective agents|mesh-ancestor
5944908|NCT04766775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944909|NCT04766762|Flunarizine|flunarizine|mesh-list
5944910|NCT04766762|Anticonvulsants|anticonvulsants|mesh-ancestor
5944911|NCT04766762|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5944912|NCT04766762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5944913|NCT04766762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944914|NCT04766762|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5944915|NCT04766762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944916|NCT04766762|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5944917|NCT04766762|Histamine Antagonists|histamine antagonists|mesh-ancestor
5944918|NCT04766762|Histamine Agents|histamine agents|mesh-ancestor
5944919|NCT04766762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5944920|NCT04766762|Vasodilator Agents|vasodilator agents|mesh-ancestor
5944921|NCT04766736|Antibodies|antibodies|mesh-list
5944922|NCT04766736|Immunologic Factors|immunologic factors|mesh-ancestor
5944923|NCT04766736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944924|NCT04766307|Interleukin-2|interleukin-2|mesh-list
5944925|NCT04766307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5944926|NCT04766307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5944927|NCT04766307|Analgesics|analgesics|mesh-ancestor
5944928|NCT04766307|Sensory System Agents|sensory system agents|mesh-ancestor
5944929|NCT04766307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5944930|NCT04766307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944931|NCT04766359|Paclitaxel|paclitaxel|mesh-list
5944932|NCT04766359|Cisplatin|cisplatin|mesh-list
5944933|NCT04766359|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5944934|NCT04766359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5944935|NCT04766359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5944936|NCT04766359|Tubulin Modulators|tubulin modulators|mesh-ancestor
5944937|NCT04766359|Antimitotic Agents|antimitotic agents|mesh-ancestor
5944938|NCT04766359|Mitosis Modulators|mitosis modulators|mesh-ancestor
5944939|NCT04766359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944940|NCT04766177|Bumetanide|bumetanide|mesh-list
5944941|NCT04766177|Diuretics|diuretics|mesh-ancestor
5944942|NCT04766177|Natriuretic Agents|natriuretic agents|mesh-ancestor
5944943|NCT04766177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944944|NCT04766177|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5944945|NCT04766177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5944946|NCT04766177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944947|NCT04766151|Nitroglycerin|nitroglycerin|mesh-list
5944948|NCT04766151|Vasodilator Agents|vasodilator agents|mesh-ancestor
5944949|NCT04766684|Lidocaine|lidocaine|mesh-list
5944950|NCT04766684|Anesthetics, Local|anesthetics, local|mesh-ancestor
5944951|NCT04766684|Anesthetics|anesthetics|mesh-ancestor
5944952|NCT04766684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5944953|NCT04766684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944954|NCT04766684|Sensory System Agents|sensory system agents|mesh-ancestor
5944955|NCT04766684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5944956|NCT04766684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5944957|NCT04766684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5944958|NCT04766684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5944959|NCT04766684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5944960|NCT04766684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944961|NCT04766463|Morphine|morphine|mesh-list
5944962|NCT04766463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5944963|NCT04766463|Narcotics|narcotics|mesh-ancestor
5944964|NCT04766463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5944965|NCT04766463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944966|NCT04766463|Analgesics|analgesics|mesh-ancestor
5944967|NCT04766463|Sensory System Agents|sensory system agents|mesh-ancestor
5944968|NCT04766463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5944969|NCT04766450|Acetylcysteine|acetylcysteine|mesh-list
5944970|NCT04766450|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5944971|NCT04766450|Antiviral Agents|antiviral agents|mesh-ancestor
5944972|NCT04766450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5944973|NCT04766450|Expectorants|expectorants|mesh-ancestor
5944974|NCT04766450|Respiratory System Agents|respiratory system agents|mesh-ancestor
5944975|NCT04766450|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5944976|NCT04766450|Antioxidants|antioxidants|mesh-ancestor
5944977|NCT04766450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944978|NCT04766450|Protective Agents|protective agents|mesh-ancestor
5944979|NCT04766450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944980|NCT04766450|Antidotes|antidotes|mesh-ancestor
5944981|NCT04766229|Gabapentin|gabapentin|mesh-list
5944982|NCT04766229|Citalopram|citalopram|mesh-list
5944983|NCT04766229|Analgesics|analgesics|mesh-ancestor
5944984|NCT04766229|Sensory System Agents|sensory system agents|mesh-ancestor
5944985|NCT04766229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5944986|NCT04766229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5944987|NCT04766229|Anticonvulsants|anticonvulsants|mesh-ancestor
5944988|NCT04766229|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5944989|NCT04766229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5944990|NCT04766229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5944991|NCT04766229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5944992|NCT04766229|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5944993|NCT04766229|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5944994|NCT04766229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5944995|NCT04766229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5944996|NCT04766229|Antimanic Agents|antimanic agents|mesh-ancestor
5944997|NCT04766229|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5944998|NCT04766229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5944999|NCT04766229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5945000|NCT04766229|Serotonin Agents|serotonin agents|mesh-ancestor
5945001|NCT04766229|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5945002|NCT04766229|Antidepressive Agents|antidepressive agents|mesh-ancestor
5945003|NCT04765904|Fluorides|fluorides|mesh-list
5945004|NCT04765904|Cariostatic Agents|cariostatic agents|mesh-ancestor
5945005|NCT04765904|Protective Agents|protective agents|mesh-ancestor
5945006|NCT04765904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945007|NCT04765709|Carboplatin|carboplatin|mesh-list
5945008|NCT04765709|Pemetrexed|pemetrexed|mesh-list
5945009|NCT04765709|Durvalumab|durvalumab|mesh-list
5945010|NCT04765709|Vinorelbine|vinorelbine|mesh-list
5945011|NCT04765709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5945012|NCT04765709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5945013|NCT04765709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5945014|NCT04765709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945015|NCT04765709|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5945016|NCT04765709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5945017|NCT04765709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5945018|NCT04765709|Immunologic Factors|immunologic factors|mesh-ancestor
5945019|NCT04765709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945020|NCT04765709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5945021|NCT04765709|Tubulin Modulators|tubulin modulators|mesh-ancestor
5945022|NCT04765709|Antimitotic Agents|antimitotic agents|mesh-ancestor
5945023|NCT04765709|Mitosis Modulators|mitosis modulators|mesh-ancestor
5945024|NCT04766047|Dexmedetomidine|dexmedetomidine|mesh-list
5945025|NCT04766047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5945026|NCT04766047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5945027|NCT04766047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945028|NCT04766047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5945029|NCT04766047|Analgesics|analgesics|mesh-ancestor
5945030|NCT04766047|Sensory System Agents|sensory system agents|mesh-ancestor
5945031|NCT04766047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5945032|NCT04766047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5945033|NCT04766047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5945034|NCT04766047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5945035|NCT04766047|Adrenergic Agents|adrenergic agents|mesh-ancestor
5945036|NCT04766047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5945037|NCT04766047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945038|NCT04766008|Metformin|metformin|mesh-list
5945039|NCT04766008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5945040|NCT04766008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945041|NCT04766021|Mirabegron|mirabegron|mesh-list
5945042|NCT04766021|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
5945043|NCT04766021|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5945044|NCT04766021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5945045|NCT04766021|Adrenergic Agents|adrenergic agents|mesh-ancestor
5945046|NCT04766021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5945047|NCT04766021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945048|NCT04766021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945049|NCT04766021|Urological Agents|urological agents|mesh-ancestor
5945050|NCT04765267|Vitamin D|vitamin d|mesh-list
5945051|NCT04765267|Cholecalciferol|cholecalciferol|mesh-list
5945052|NCT04765267|Zinc Sulfate|zinc sulfate|mesh-list
5945053|NCT04765267|Vitamins|vitamins|mesh-ancestor
5945054|NCT04765267|Micronutrients|micronutrients|mesh-ancestor
5945055|NCT04765267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945056|NCT04765267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5945057|NCT04765267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5945058|NCT04765267|Astringents|astringents|mesh-ancestor
5945059|NCT04765267|Dermatologic Agents|dermatologic agents|mesh-ancestor
5945060|NCT04765514|Temozolomide|temozolomide|mesh-list
5945061|NCT04765514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5945062|NCT04765514|Alkylating Agents|alkylating agents|mesh-ancestor
5945063|NCT04765514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945064|NCT04765514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5945065|NCT04765527|Turmeric extract|turmeric extract|mesh-list
5945066|NCT04765527|Antioxidants|antioxidants|mesh-ancestor
5945067|NCT04765527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945068|NCT04765527|Protective Agents|protective agents|mesh-ancestor
5945069|NCT04765527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945070|NCT04765228|Doxorubicin|doxorubicin|mesh-list
5945071|NCT04765228|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5945072|NCT04765228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5945073|NCT04765228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6517378|NCT00720772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6517379|NCT00720772|Chelating Agents|chelating agents|mesh-ancestor
6517380|NCT00720772|Sequestering Agents|sequestering agents|mesh-ancestor
6517381|NCT00720811|Acetaminophen|acetaminophen|mesh-list
6517382|NCT00720811|Amoxicillin|amoxicillin|mesh-list
6517383|NCT00720811|Lumefantrine|lumefantrine|mesh-list
6517384|NCT00720811|Artemether|artemether|mesh-list
6517385|NCT00720811|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6517386|NCT00720811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6517387|NCT00720811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6517388|NCT00720811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6517389|NCT00720811|Analgesics|analgesics|mesh-ancestor
6681319|NCT01609101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681320|NCT01609127|Capecitabine|capecitabine|mesh-list
6681321|NCT01609127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6681322|NCT01609127|Antimetabolites|antimetabolites|mesh-ancestor
6681323|NCT01609127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681324|NCT01609127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6681325|NCT01609153|Olanzapine|olanzapine|mesh-list
6681326|NCT01609153|Amisulpride|amisulpride|mesh-list
6681327|NCT01609153|Antiemetics|antiemetics|mesh-ancestor
6681328|NCT01609153|Autonomic Agents|autonomic agents|mesh-ancestor
6681329|NCT01609153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6681330|NCT01609153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681331|NCT01609153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6681332|NCT01609153|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6681333|NCT01609153|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6681334|NCT01609153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6681335|NCT01609153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6681336|NCT01609153|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6681337|NCT01609153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6681338|NCT01609153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6681339|NCT01609153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681340|NCT01609153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5945074|NCT04765228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5945075|NCT04765228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5945076|NCT04765228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5945077|NCT04765228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967830|NCT04558892|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5967831|NCT04558892|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5967832|NCT04558892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967833|NCT04558697|Tea Tree Oil|tea tree oil|mesh-list
5967834|NCT04558697|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5967835|NCT04558697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6681341|NCT01609153|Serotonin Agents|serotonin agents|mesh-ancestor
6681342|NCT01609153|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6681343|NCT01609153|Dopamine Agents|dopamine agents|mesh-ancestor
6681344|NCT01609153|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6681345|NCT01609153|Antidepressive Agents|antidepressive agents|mesh-ancestor
5967836|NCT04558736|Cyclophosphamide|cyclophosphamide|mesh-list
5967837|NCT04558736|Fludarabine|fludarabine|mesh-list
5967838|NCT04558736|Thymoglobulin|thymoglobulin|mesh-list
5967839|NCT04558736|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5967840|NCT04558736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5967841|NCT04558736|Immunologic Factors|immunologic factors|mesh-ancestor
5967842|NCT04558736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967843|NCT04558736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5967844|NCT04558736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5967845|NCT04558736|Alkylating Agents|alkylating agents|mesh-ancestor
5967846|NCT04558736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967847|NCT04558736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5967848|NCT04558736|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5967849|NCT04558580|Rufinamide|rufinamide|mesh-list
5967850|NCT04558580|Anticonvulsants|anticonvulsants|mesh-ancestor
6517390|NCT00720811|Sensory System Agents|sensory system agents|mesh-ancestor
6681346|NCT01609166|Allopurinol|allopurinol|mesh-list
5945078|NCT04765085|Aripiprazole|aripiprazole|mesh-list
5945079|NCT04765085|Antidepressive Agents|antidepressive agents|mesh-ancestor
5945080|NCT04765085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5945081|NCT04765085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5945082|NCT04765085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5945083|NCT04765085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5945084|NCT04765085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945085|NCT04765085|Dopamine Agonists|dopamine agonists|mesh-ancestor
5945086|NCT04765085|Dopamine Agents|dopamine agents|mesh-ancestor
5945087|NCT04765085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5945088|NCT04765085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945089|NCT04765085|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5945090|NCT04765085|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5945091|NCT04765085|Serotonin Agents|serotonin agents|mesh-ancestor
5945092|NCT04765085|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5945093|NCT04765085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5945094|NCT04765085|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5945095|NCT04765085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5945096|NCT04765111|Rituximab|rituximab|mesh-list
5945097|NCT04765111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5945098|NCT04765111|Acalabrutinib|acalabrutinib|mesh-list
5945099|NCT04765111|Antibodies|antibodies|mesh-list
5945100|NCT04765111|Immunoglobulins|immunoglobulins|mesh-list
5945101|NCT04765111|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5945102|NCT04765111|Immunologic Factors|immunologic factors|mesh-ancestor
5945103|NCT04765111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945104|NCT04765111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5945105|NCT04765111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5945106|NCT04764955|Vitamin D|vitamin d|mesh-list
5945107|NCT04764955|Cholecalciferol|cholecalciferol|mesh-list
5945108|NCT04764955|Vitamins|vitamins|mesh-ancestor
5945109|NCT04764955|Micronutrients|micronutrients|mesh-ancestor
5945110|NCT04764955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945111|NCT04764955|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5945112|NCT04764955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5945113|NCT04764825|Morphine|morphine|mesh-list
5945114|NCT04764825|Methadone|methadone|mesh-list
5945115|NCT04764825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5945116|NCT04764825|Narcotics|narcotics|mesh-ancestor
5945117|NCT04764825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5945118|NCT04764825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945119|NCT04764825|Analgesics|analgesics|mesh-ancestor
5945120|NCT04764825|Sensory System Agents|sensory system agents|mesh-ancestor
5945121|NCT04764825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5945122|NCT04764825|Antitussive Agents|antitussive agents|mesh-ancestor
5945123|NCT04764825|Respiratory System Agents|respiratory system agents|mesh-ancestor
5945124|NCT04765098|Tamoxifen|tamoxifen|mesh-list
5945125|NCT04765098|Etoposide|etoposide|mesh-list
5945126|NCT04765098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5945127|NCT04765098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5945128|NCT04765098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5945129|NCT04765098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5945130|NCT04765098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5945131|NCT04765098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945132|NCT04765098|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5945133|NCT04765098|Hormone Antagonists|hormone antagonists|mesh-ancestor
5945134|NCT04765098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5945135|NCT04765098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945136|NCT04765098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5945137|NCT04765098|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5945138|NCT04765098|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5945139|NCT04765098|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5945140|NCT04764916|Bupivacaine|bupivacaine|mesh-list
5945141|NCT04764916|Anesthetics, Local|anesthetics, local|mesh-ancestor
5945142|NCT04764916|Anesthetics|anesthetics|mesh-ancestor
5945143|NCT04764916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5945144|NCT04764916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945145|NCT04764916|Sensory System Agents|sensory system agents|mesh-ancestor
5945146|NCT04764916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5945147|NCT04764851|Ecopipam|ecopipam|mesh-list
5945148|NCT04764851|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5945149|NCT04764851|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5945150|NCT04764851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5945151|NCT04764851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945152|NCT04764851|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5945153|NCT04764851|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5945154|NCT04764851|Dopamine Agents|dopamine agents|mesh-ancestor
5945155|NCT04764851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5945156|NCT04764851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945157|NCT04764630|Naloxone|naloxone|mesh-list
5945158|NCT04764630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5945159|NCT04764630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945160|NCT04764630|Sensory System Agents|sensory system agents|mesh-ancestor
5945161|NCT04764630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5945162|NCT04764643|Acetylcysteine|acetylcysteine|mesh-list
5945163|NCT04764643|Sodium thiosulfate|sodium thiosulfate|mesh-list
5945164|NCT04764643|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5945165|NCT04764643|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5945166|NCT04764643|Antiviral Agents|antiviral agents|mesh-ancestor
5945167|NCT04764643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5945168|NCT04764643|Expectorants|expectorants|mesh-ancestor
5945169|NCT04764643|Respiratory System Agents|respiratory system agents|mesh-ancestor
5945170|NCT04764643|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5945171|NCT04764643|Antioxidants|antioxidants|mesh-ancestor
5945172|NCT04764643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945173|NCT04764643|Protective Agents|protective agents|mesh-ancestor
5945174|NCT04764643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945175|NCT04764643|Antidotes|antidotes|mesh-ancestor
5945176|NCT04764643|Antitubercular Agents|antitubercular agents|mesh-ancestor
5945177|NCT04764643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5945178|NCT04764643|Chelating Agents|chelating agents|mesh-ancestor
5945179|NCT04764643|Sequestering Agents|sequestering agents|mesh-ancestor
5945180|NCT04764396|Heparin|heparin|mesh-list
5945181|NCT04764396|Calcium heparin|calcium heparin|mesh-list
5945182|NCT04764396|Anticoagulants|anticoagulants|mesh-ancestor
5945183|NCT04764396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5945184|NCT04764396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5945185|NCT04764396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945186|NCT04764227|Paclitaxel|paclitaxel|mesh-list
5945187|NCT04764227|Carboplatin|carboplatin|mesh-list
5945188|NCT04764227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5945189|NCT04764227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5945190|NCT04764227|Tubulin Modulators|tubulin modulators|mesh-ancestor
5945191|NCT04764227|Antimitotic Agents|antimitotic agents|mesh-ancestor
5945192|NCT04764227|Mitosis Modulators|mitosis modulators|mesh-ancestor
5945193|NCT04764227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945194|NCT04764344|Haloperidol|haloperidol|mesh-list
5945195|NCT04764344|Ondansetron|ondansetron|mesh-list
5945196|NCT04764344|Haloperidol decanoate|haloperidol decanoate|mesh-list
5945197|NCT04764344|Antiemetics|antiemetics|mesh-ancestor
5945198|NCT04764344|Autonomic Agents|autonomic agents|mesh-ancestor
5945199|NCT04764344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5945200|NCT04764344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945201|NCT04764344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5945202|NCT04764344|Antipruritics|antipruritics|mesh-ancestor
5945203|NCT04764344|Dermatologic Agents|dermatologic agents|mesh-ancestor
5945204|NCT04764344|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5945205|NCT04764344|Serotonin Agents|serotonin agents|mesh-ancestor
5945206|NCT04764344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5945207|NCT04764344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945208|NCT04764344|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5945209|NCT04764344|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5945210|NCT04764344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5945211|NCT04764344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5945212|NCT04764344|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5945213|NCT04764344|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5945214|NCT04764344|Dopamine Agents|dopamine agents|mesh-ancestor
5945215|NCT04764344|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5945216|NCT04764383|Histamine|histamine|mesh-list
5945217|NCT04764383|Histamine Agonists|histamine agonists|mesh-ancestor
5945218|NCT04764383|Histamine Agents|histamine agents|mesh-ancestor
5945219|NCT04764383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5945220|NCT04764383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945221|NCT04764383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945222|NCT04764084|Niraparib|niraparib|mesh-list
5945223|NCT04764084|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5945224|NCT04764084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5945225|NCT04764084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945226|NCT04764084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5945227|NCT04763759|Antibodies|antibodies|mesh-list
5945228|NCT04763759|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5945229|NCT04763759|Immunologic Factors|immunologic factors|mesh-ancestor
5945230|NCT04763759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945231|NCT04764214|Osimertinib|osimertinib|mesh-list
5945232|NCT04764214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5945233|NCT04764214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5945234|NCT04764214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5945235|NCT04764214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945236|NCT04764045|Ropivacaine|ropivacaine|mesh-list
5945237|NCT04764045|Anesthetics, Local|anesthetics, local|mesh-ancestor
5945238|NCT04764045|Anesthetics|anesthetics|mesh-ancestor
5945239|NCT04764045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5945240|NCT04764045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945241|NCT04764045|Sensory System Agents|sensory system agents|mesh-ancestor
5945242|NCT04764045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5945243|NCT04763876|Ketorolac|ketorolac|mesh-list
5945244|NCT04763876|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
5945245|NCT04763876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5945246|NCT04763876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5945247|NCT04763876|Analgesics|analgesics|mesh-ancestor
5945248|NCT04763876|Sensory System Agents|sensory system agents|mesh-ancestor
5945249|NCT04763876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5945250|NCT04763876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945251|NCT04763876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5945252|NCT04763876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5945253|NCT04763876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5945254|NCT04763876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5945255|NCT04763876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945256|NCT04764058|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
5945257|NCT04764058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5945258|NCT04764058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5945259|NCT04764058|Protease Inhibitors|protease inhibitors|mesh-ancestor
5945260|NCT04764058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5945261|NCT04764058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945262|NCT04764162|Choline|choline|mesh-list
5945263|NCT04764162|Lipotropic Agents|lipotropic agents|mesh-ancestor
5945264|NCT04764162|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5945265|NCT04764162|Antimetabolites|antimetabolites|mesh-ancestor
5945266|NCT04764162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945267|NCT04764162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5945268|NCT04764162|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5945269|NCT04764162|Nootropic Agents|nootropic agents|mesh-ancestor
5945270|NCT04763434|Dexamethasone|dexamethasone|mesh-list
5945271|NCT04763434|Dexmedetomidine|dexmedetomidine|mesh-list
5945272|NCT04763434|Ropivacaine|ropivacaine|mesh-list
5945273|NCT04763434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5945274|NCT04763434|Antiemetics|antiemetics|mesh-ancestor
5945275|NCT04763434|Autonomic Agents|autonomic agents|mesh-ancestor
5945276|NCT04763434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5945277|NCT04763434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945278|NCT04763434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5945279|NCT04763434|Glucocorticoids|glucocorticoids|mesh-ancestor
5945280|NCT04763434|Hormones|hormones|mesh-ancestor
5945281|NCT04763434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5945282|NCT04763434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5945283|NCT04763434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5945284|NCT04763434|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5945285|NCT04763434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5945286|NCT04763434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5945287|NCT04763434|Analgesics|analgesics|mesh-ancestor
5945288|NCT04763434|Sensory System Agents|sensory system agents|mesh-ancestor
5945289|NCT04763434|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5945290|NCT04763434|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5945291|NCT04763434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5945292|NCT04763434|Adrenergic Agents|adrenergic agents|mesh-ancestor
5945293|NCT04763434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5945294|NCT04763434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945295|NCT04763434|Anesthetics, Local|anesthetics, local|mesh-ancestor
5945296|NCT04763434|Anesthetics|anesthetics|mesh-ancestor
5945297|NCT04763226|Furosemide|furosemide|mesh-list
5945298|NCT04763226|Diuretics|diuretics|mesh-ancestor
5945299|NCT04763226|Natriuretic Agents|natriuretic agents|mesh-ancestor
5945300|NCT04763226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945301|NCT04763226|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5945302|NCT04763226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5945303|NCT04763226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945304|NCT04763252|Coal Tar|coal tar|mesh-list
5945305|NCT04763252|Keratolytic Agents|keratolytic agents|mesh-ancestor
5945306|NCT04763252|Dermatologic Agents|dermatologic agents|mesh-ancestor
5945307|NCT04763486|Cefazolin|cefazolin|mesh-list
5945308|NCT04763486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5945309|NCT04763486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5945310|NCT04763616|Cemiplimab|cemiplimab|mesh-list
5945311|NCT04763616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5945312|NCT04763616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5945313|NCT04763135|Mirtazapine|mirtazapine|mesh-list
5945314|NCT04763135|Citalopram|citalopram|mesh-list
5945315|NCT04763135|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5945316|NCT04763135|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5945317|NCT04763135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5945318|NCT04763135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945319|NCT04763135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5945320|NCT04763135|Serotonin Agents|serotonin agents|mesh-ancestor
5945321|NCT04763135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945322|NCT04763135|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5945323|NCT04763135|Antidepressive Agents|antidepressive agents|mesh-ancestor
5945324|NCT04763135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5945325|NCT04763135|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5945326|NCT04763135|Histamine Antagonists|histamine antagonists|mesh-ancestor
5945327|NCT04763135|Histamine Agents|histamine agents|mesh-ancestor
5945328|NCT04763135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5945329|NCT04763135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5945330|NCT04763135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5945331|NCT04763135|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5945332|NCT04763135|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5945333|NCT04763135|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5945334|NCT04763135|Adrenergic Agents|adrenergic agents|mesh-ancestor
5945335|NCT04763135|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5945336|NCT04763135|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5945337|NCT04763135|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5945338|NCT04763564|Liraglutide|liraglutide|mesh-list
5945339|NCT04763564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5945340|NCT04763564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945341|NCT04763564|Incretins|incretins|mesh-ancestor
5945342|NCT04763564|Hormones|hormones|mesh-ancestor
5945343|NCT04763564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5945344|NCT04763265|Botulinum Toxins|botulinum toxins|mesh-list
5945345|NCT04763265|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5945346|NCT04763265|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5945347|NCT04763265|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5945348|NCT04763265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5945349|NCT04763265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945350|NCT04763265|Cholinergic Agents|cholinergic agents|mesh-ancestor
5945351|NCT04763265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5945352|NCT04763265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945353|NCT04763265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5945354|NCT04763265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5945355|NCT04763070|Ciprofloxacin|ciprofloxacin|mesh-list
5945356|NCT04763070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5945357|NCT04763070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5945358|NCT04763070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5945359|NCT04763070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5945360|NCT04763070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5945361|NCT04763070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945362|NCT04763070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5945363|NCT04763070|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5945364|NCT04763070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5945365|NCT04763057|Calcium|calcium|mesh-list
5945366|NCT04763057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5945367|NCT04763057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945368|NCT04763096|Tacrolimus|tacrolimus|mesh-list
5945369|NCT04763096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5945370|NCT04763096|Immunologic Factors|immunologic factors|mesh-ancestor
5945371|NCT04763096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945372|NCT04763096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5945373|NCT04763096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5945374|NCT04763096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945375|NCT04762953|Leucovorin|leucovorin|mesh-list
5945376|NCT04762953|Paclitaxel|paclitaxel|mesh-list
5945377|NCT04762953|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5945378|NCT04762953|Fluorouracil|fluorouracil|mesh-list
5945379|NCT04762953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5945380|NCT04762953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5945381|NCT04762953|Tubulin Modulators|tubulin modulators|mesh-ancestor
5945382|NCT04762953|Antimitotic Agents|antimitotic agents|mesh-ancestor
5945383|NCT04762953|Mitosis Modulators|mitosis modulators|mesh-ancestor
5945384|NCT04762953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945385|NCT04762953|Antimetabolites|antimetabolites|mesh-ancestor
5945386|NCT04762953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5945387|NCT04762953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5945388|NCT04762953|Immunologic Factors|immunologic factors|mesh-ancestor
5945389|NCT04762953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945390|NCT04762953|Antidotes|antidotes|mesh-ancestor
5945391|NCT04762953|Protective Agents|protective agents|mesh-ancestor
5945392|NCT04762953|Vitamin B Complex|vitamin b complex|mesh-ancestor
5945393|NCT04762953|Vitamins|vitamins|mesh-ancestor
5945394|NCT04762953|Micronutrients|micronutrients|mesh-ancestor
5945395|NCT04762992|Enoxaparin|enoxaparin|mesh-list
5945396|NCT04762992|Anticoagulants|anticoagulants|mesh-ancestor
5945397|NCT04762992|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5945398|NCT04762992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5945399|NCT04762992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945400|NCT04762966|Metformin|metformin|mesh-list
5945401|NCT04762966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5945402|NCT04762966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945403|NCT04762888|Edetic Acid|edetic acid|mesh-list
5945404|NCT04762888|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5945405|NCT04762888|Chelating Agents|chelating agents|mesh-ancestor
5945406|NCT04762888|Sequestering Agents|sequestering agents|mesh-ancestor
5945407|NCT04762888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945408|NCT04762888|Anticoagulants|anticoagulants|mesh-ancestor
5945409|NCT04762888|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5945410|NCT04762888|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5945411|NCT04762810|Cyclophosphamide|cyclophosphamide|mesh-list
5945412|NCT04762810|Glucocorticoids|glucocorticoids|mesh-list
5945413|NCT04762810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5945414|NCT04762810|Immunologic Factors|immunologic factors|mesh-ancestor
5945415|NCT04762810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945416|NCT04762810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5945417|NCT04762810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5945418|NCT04762810|Alkylating Agents|alkylating agents|mesh-ancestor
5945419|NCT04762810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945420|NCT04762810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5945421|NCT04762810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5945422|NCT04762810|Hormones|hormones|mesh-ancestor
5945423|NCT04762810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5945424|NCT04762745|Thalidomide|thalidomide|mesh-list
5945425|NCT04762745|Dexamethasone|dexamethasone|mesh-list
5945426|NCT04762745|Dexamethasone acetate|dexamethasone acetate|mesh-list
5945427|NCT04762745|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5945428|NCT04762745|Pomalidomide|pomalidomide|mesh-list
5945429|NCT04762745|BB 1101|bb 1101|mesh-list
5945430|NCT04762745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5945431|NCT04762745|Antiemetics|antiemetics|mesh-ancestor
5945432|NCT04762745|Autonomic Agents|autonomic agents|mesh-ancestor
5945433|NCT04762745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5945434|NCT04762745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945435|NCT04762745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5945436|NCT04762745|Glucocorticoids|glucocorticoids|mesh-ancestor
5945437|NCT04762745|Hormones|hormones|mesh-ancestor
5945438|NCT04762745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5945439|NCT04762745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5945440|NCT04762745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5945441|NCT04762745|Protease Inhibitors|protease inhibitors|mesh-ancestor
5945442|NCT04762745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5945443|NCT04762745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945444|NCT04762745|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5945445|NCT04762745|Alkylating Agents|alkylating agents|mesh-ancestor
5945446|NCT04762745|Immunologic Factors|immunologic factors|mesh-ancestor
5945447|NCT04762745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5945448|NCT04762745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5945449|NCT04762745|Growth Substances|growth substances|mesh-ancestor
5945450|NCT04762745|Growth Inhibitors|growth inhibitors|mesh-ancestor
6517391|NCT00720811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5945451|NCT04762745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5945452|NCT04762745|Leprostatic Agents|leprostatic agents|mesh-ancestor
5945453|NCT04762745|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5945454|NCT04762745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5945455|NCT04762381|Dexamethasone|dexamethasone|mesh-list
5945456|NCT04762381|Glucocorticoids|glucocorticoids|mesh-list
5945457|NCT04762381|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
5945458|NCT04762381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5945459|NCT04762381|Antiemetics|antiemetics|mesh-ancestor
5945460|NCT04762381|Autonomic Agents|autonomic agents|mesh-ancestor
5945461|NCT04762381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5945462|NCT04762381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945463|NCT04762381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5945464|NCT04762381|Hormones|hormones|mesh-ancestor
5945465|NCT04762381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5945466|NCT04762381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5945467|NCT04762381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5945468|NCT04762316|Pyridoxal|pyridoxal|mesh-list
5945469|NCT04762316|Pyridoxine|pyridoxine|mesh-list
5945470|NCT04762316|Vitamin B 6|vitamin b 6|mesh-list
5945471|NCT04762316|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
5945472|NCT04762316|Vitamin B Complex|vitamin b complex|mesh-ancestor
5945473|NCT04762316|Vitamins|vitamins|mesh-ancestor
5945474|NCT04762316|Micronutrients|micronutrients|mesh-ancestor
5945475|NCT04762316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945476|NCT04762511|Vaccines|vaccines|mesh-list
5945477|NCT04762511|Immunologic Factors|immunologic factors|mesh-ancestor
5945478|NCT04762511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945479|NCT04762498|Methotrexate|methotrexate|mesh-list
5945480|NCT04762498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5945481|NCT04762498|Abortifacient Agents|abortifacient agents|mesh-ancestor
5945482|NCT04762498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5945483|NCT04762498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945484|NCT04762498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5945485|NCT04762498|Antimetabolites|antimetabolites|mesh-ancestor
5945486|NCT04762498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945487|NCT04762498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5945488|NCT04762498|Dermatologic Agents|dermatologic agents|mesh-ancestor
5945489|NCT04762498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5945490|NCT04762498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5945491|NCT04762498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5945492|NCT04762498|Immunologic Factors|immunologic factors|mesh-ancestor
5945493|NCT04762498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5945494|NCT04762498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5945495|NCT04762472|Montelukast|montelukast|mesh-list
5945496|NCT04762472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5945497|NCT04762472|Respiratory System Agents|respiratory system agents|mesh-ancestor
5945498|NCT04762472|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5945499|NCT04762472|Hormone Antagonists|hormone antagonists|mesh-ancestor
5945500|NCT04762472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5945501|NCT04762472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945502|NCT04762472|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5945503|NCT04762472|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5945504|NCT04762472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945505|NCT04762784|Glucocorticoids|glucocorticoids|mesh-list
5945506|NCT04762784|Hormones|hormones|mesh-ancestor
5945507|NCT04762784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5945508|NCT04762784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945509|NCT04762901|Paclitaxel|paclitaxel|mesh-list
5945510|NCT04762901|Cyclophosphamide|cyclophosphamide|mesh-list
5945511|NCT04762901|Carboplatin|carboplatin|mesh-list
5945512|NCT04762901|Doxorubicin|doxorubicin|mesh-list
5945513|NCT04762901|Niraparib|niraparib|mesh-list
5945514|NCT04762901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5945515|NCT04762901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5945516|NCT04762901|Tubulin Modulators|tubulin modulators|mesh-ancestor
5945517|NCT04762901|Antimitotic Agents|antimitotic agents|mesh-ancestor
5945518|NCT04762901|Mitosis Modulators|mitosis modulators|mesh-ancestor
5945519|NCT04762901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945520|NCT04762901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5945521|NCT04762901|Immunologic Factors|immunologic factors|mesh-ancestor
5945522|NCT04762901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945523|NCT04762901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5945524|NCT04762901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5945525|NCT04762901|Alkylating Agents|alkylating agents|mesh-ancestor
5945526|NCT04762901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5945527|NCT04762901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5945528|NCT04762901|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5945529|NCT04762901|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5945530|NCT04762901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5945531|NCT04762901|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5945532|NCT04761952|Azathioprine|azathioprine|mesh-list
5945533|NCT04761952|Infliximab|infliximab|mesh-list
5945534|NCT04761952|Dermatologic Agents|dermatologic agents|mesh-ancestor
5945535|NCT04761952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5945536|NCT04761952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5945537|NCT04761952|Antimetabolites|antimetabolites|mesh-ancestor
5945538|NCT04761952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945539|NCT04761952|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5945540|NCT04761952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5945541|NCT04761952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5945542|NCT04761952|Immunologic Factors|immunologic factors|mesh-ancestor
5945543|NCT04761952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945544|NCT04761757|Antidepressive Agents|antidepressive agents|mesh-list
5945545|NCT04761757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5945546|NCT04762030|Paclitaxel|paclitaxel|mesh-list
5945547|NCT04762030|Carboplatin|carboplatin|mesh-list
5945548|NCT04762030|Durvalumab|durvalumab|mesh-list
5945549|NCT04762030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5945550|NCT04762030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5945551|NCT04762030|Tubulin Modulators|tubulin modulators|mesh-ancestor
5945552|NCT04762030|Antimitotic Agents|antimitotic agents|mesh-ancestor
5945553|NCT04762030|Mitosis Modulators|mitosis modulators|mesh-ancestor
5945554|NCT04762030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945555|NCT04762030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5945556|NCT04762134|Doxycycline|doxycycline|mesh-list
5945557|NCT04762134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5945558|NCT04762134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5945559|NCT04762134|Antimalarials|antimalarials|mesh-ancestor
5945560|NCT04762134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5945561|NCT04762134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5945562|NCT04761705|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5945563|NCT04761705|Latanoprost|latanoprost|mesh-list
5945564|NCT04761705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5945565|NCT04762082|Tadalafil|tadalafil|mesh-list
5945566|NCT04762082|Vasodilator Agents|vasodilator agents|mesh-ancestor
5945567|NCT04762082|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5945568|NCT04762082|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5945569|NCT04762082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5945570|NCT04762082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945571|NCT04762082|Urological Agents|urological agents|mesh-ancestor
5945572|NCT04762147|Acetaminophen|acetaminophen|mesh-list
5945573|NCT04762147|Fentanyl|fentanyl|mesh-list
5945574|NCT04762147|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5945575|NCT04762147|Narcotics|narcotics|mesh-ancestor
5945576|NCT04762147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5945577|NCT04762147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945578|NCT04762147|Analgesics|analgesics|mesh-ancestor
5945579|NCT04762147|Sensory System Agents|sensory system agents|mesh-ancestor
5945580|NCT04762147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5945581|NCT04762147|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5945582|NCT04762147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5945583|NCT04762147|Anesthetics, General|anesthetics, general|mesh-ancestor
5945584|NCT04762147|Anesthetics|anesthetics|mesh-ancestor
5945585|NCT04762147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5945586|NCT04762147|Antipyretics|antipyretics|mesh-ancestor
5945587|NCT04761744|Nivolumab|nivolumab|mesh-list
5945588|NCT04761744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5945589|NCT04761744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5945590|NCT04761744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5945591|NCT04761744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945592|NCT04761731|Tacrolimus|tacrolimus|mesh-list
5945593|NCT04761731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5945594|NCT04761731|Immunologic Factors|immunologic factors|mesh-ancestor
5945595|NCT04761731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945596|NCT04761731|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5945597|NCT04761731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5945598|NCT04761731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967851|NCT04558580|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5967852|NCT04558580|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5967853|NCT04558580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5971087|NCT04530422|Azithromycin|azithromycin|mesh-list
6517392|NCT00720811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945599|NCT04761601|Gemcitabine|gemcitabine|mesh-list
5945600|NCT04761601|Paclitaxel|paclitaxel|mesh-list
5945601|NCT04761601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5945602|NCT04761601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5945603|NCT04761601|Tubulin Modulators|tubulin modulators|mesh-ancestor
5945604|NCT04761601|Antimitotic Agents|antimitotic agents|mesh-ancestor
5945605|NCT04761601|Mitosis Modulators|mitosis modulators|mesh-ancestor
5945606|NCT04761601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945607|NCT04761601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5945608|NCT04761601|Antimetabolites|antimetabolites|mesh-ancestor
5945609|NCT04761601|Antiviral Agents|antiviral agents|mesh-ancestor
5945610|NCT04761601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5945611|NCT04761601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5945612|NCT04761601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5945613|NCT04761601|Immunologic Factors|immunologic factors|mesh-ancestor
5945614|NCT04761601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945615|NCT04761302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
5945616|NCT04761185|Raltitrexed|raltitrexed|mesh-list
5945617|NCT04761185|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5945618|NCT04761185|Antimetabolites|antimetabolites|mesh-ancestor
5945619|NCT04761185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945620|NCT04761185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5945621|NCT04761185|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5945622|NCT04761185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5945623|NCT04761159|Ketamine|ketamine|mesh-list
5945624|NCT04761159|Analgesics|analgesics|mesh-ancestor
5945625|NCT04761159|Sensory System Agents|sensory system agents|mesh-ancestor
5945626|NCT04761159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5945627|NCT04761159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945628|NCT04761159|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5945629|NCT04761159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5945630|NCT04761159|Anesthetics, General|anesthetics, general|mesh-ancestor
5945631|NCT04761159|Anesthetics|anesthetics|mesh-ancestor
5945632|NCT04761159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5945633|NCT04761159|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5945634|NCT04761159|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5945635|NCT04761159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5945636|NCT04761159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945637|NCT04761393|Xenon|xenon|mesh-list
5945638|NCT04761393|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5945639|NCT04761393|Anesthetics, General|anesthetics, general|mesh-ancestor
5945640|NCT04761393|Anesthetics|anesthetics|mesh-ancestor
5945641|NCT04761393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5945642|NCT04761393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945643|NCT04761133|Povidone-Iodine|povidone-iodine|mesh-list
5945644|NCT04761133|Povidone|povidone|mesh-list
5945645|NCT04761133|Plasma Substitutes|plasma substitutes|mesh-ancestor
5945646|NCT04761133|Blood Substitutes|blood substitutes|mesh-ancestor
5945647|NCT04761133|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5945648|NCT04761133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5945649|NCT04761198|Nivolumab|nivolumab|mesh-list
5945650|NCT04761198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5945651|NCT04761198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5945652|NCT04761198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5945653|NCT04761198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945654|NCT04761029|Tramadol|tramadol|mesh-list
5945655|NCT04761029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5945656|NCT04761029|Narcotics|narcotics|mesh-ancestor
5945657|NCT04761029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5945658|NCT04761029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945659|NCT04761029|Analgesics|analgesics|mesh-ancestor
5945660|NCT04761029|Sensory System Agents|sensory system agents|mesh-ancestor
5945661|NCT04761029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6242650|NCT02654054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720061|NCT03215446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5720062|NCT03215446|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5720063|NCT03215264|Hydroxychloroquine|hydroxychloroquine|mesh-list
5720064|NCT03215264|Entinostat|entinostat|mesh-list
5720065|NCT03215264|Antimalarials|antimalarials|mesh-ancestor
5720066|NCT03215264|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5720067|NCT03215264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5720068|NCT03215264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5720069|NCT03215264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5720070|NCT03215264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945662|NCT04760821|Trimetazidine|trimetazidine|mesh-list
5945663|NCT04760821|Vasodilator Agents|vasodilator agents|mesh-ancestor
5945664|NCT04760860|Prazosin|prazosin|mesh-list
5945665|NCT04760860|Terazosin|terazosin|mesh-list
5945666|NCT04760860|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5945667|NCT04760860|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5945668|NCT04760860|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5945669|NCT04760860|Adrenergic Agents|adrenergic agents|mesh-ancestor
5945670|NCT04760860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5945671|NCT04760860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945672|NCT04760860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945673|NCT04760860|Urological Agents|urological agents|mesh-ancestor
5945674|NCT04760860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5945675|NCT04760743|Aluminum sulfate|aluminum sulfate|mesh-list
5945676|NCT04760743|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5945677|NCT04760743|Immunologic Factors|immunologic factors|mesh-ancestor
5945678|NCT04760743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945679|NCT04760912|Bromides|bromides|mesh-list
5945680|NCT04760912|Anesthetics|anesthetics|mesh-list
5945681|NCT04760912|Rocuronium|rocuronium|mesh-list
5945682|NCT04760912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5945683|NCT04760912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945684|NCT04760912|Anticonvulsants|anticonvulsants|mesh-ancestor
5945685|NCT04760912|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5945686|NCT04760912|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5945687|NCT04760912|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5945688|NCT04760912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5945689|NCT04760704|Antibodies|antibodies|mesh-list
5945690|NCT04760704|Immunologic Factors|immunologic factors|mesh-ancestor
5945691|NCT04760704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945692|NCT04760691|Tenofovir|tenofovir|mesh-list
5945693|NCT04760691|Emtricitabine|emtricitabine|mesh-list
5945694|NCT04760691|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5945695|NCT04760691|Leuprolide|leuprolide|mesh-list
5945696|NCT04760691|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5945697|NCT04760691|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5945698|NCT04760691|Estradiol|estradiol|mesh-list
5945699|NCT04760691|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5945700|NCT04760691|Estrogens|estrogens|mesh-list
5945701|NCT04760691|Antiviral Agents|antiviral agents|mesh-ancestor
5945702|NCT04760691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5945703|NCT04760691|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5945704|NCT04760691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5945705|NCT04760691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5945706|NCT04760691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945707|NCT04760691|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5945708|NCT04760691|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5945709|NCT04760691|Hormones|hormones|mesh-ancestor
5945710|NCT04760691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5945711|NCT04760691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945712|NCT04760691|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5945713|NCT04760691|Contraceptive Agents|contraceptive agents|mesh-ancestor
5945714|NCT04760691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5945715|NCT04760691|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5945716|NCT04760691|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5945717|NCT04760691|Fertility Agents|fertility agents|mesh-ancestor
5945718|NCT04760691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5945719|NCT04760691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5945720|NCT04760574|Testosterone|testosterone|mesh-list
5945721|NCT04760574|Androgens|androgens|mesh-ancestor
5945722|NCT04760574|Hormones|hormones|mesh-ancestor
5945723|NCT04760574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5945724|NCT04760574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681347|NCT01609166|Antimetabolites|antimetabolites|mesh-ancestor
6681348|NCT01609166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681349|NCT01609166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6681350|NCT01609166|Gout Suppressants|gout suppressants|mesh-ancestor
6681351|NCT01609166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6681352|NCT01609166|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5945725|NCT04760327|Cisplatin|cisplatin|mesh-list
5945726|NCT04760327|Bleomycin|bleomycin|mesh-list
5945727|NCT04760327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5945728|NCT04760327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5945729|NCT04760496|Oxytocin|oxytocin|mesh-list
5945730|NCT04760496|Oxytocics|oxytocics|mesh-ancestor
5945731|NCT04760496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5945732|NCT04760496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945733|NCT04760431|Paclitaxel|paclitaxel|mesh-list
5945734|NCT04760431|Docetaxel|docetaxel|mesh-list
5945735|NCT04760431|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5945736|NCT04760431|Trastuzumab|trastuzumab|mesh-list
5945737|NCT04760431|Pertuzumab|pertuzumab|mesh-list
5945738|NCT04760431|Taxane|taxane|mesh-list
5945739|NCT04760431|Tucatinib|tucatinib|mesh-list
5945740|NCT04760431|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5945741|NCT04760431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5945742|NCT04760431|Tubulin Modulators|tubulin modulators|mesh-ancestor
5945743|NCT04760431|Antimitotic Agents|antimitotic agents|mesh-ancestor
5945744|NCT04760431|Mitosis Modulators|mitosis modulators|mesh-ancestor
5945745|NCT04760431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945746|NCT04760431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5945747|NCT04760431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5945748|NCT04760431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5945749|NCT04760301|Tranexamic Acid|tranexamic acid|mesh-list
5945750|NCT04760301|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5945751|NCT04760301|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5945752|NCT04760301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945753|NCT04760301|Hemostatics|hemostatics|mesh-ancestor
5945754|NCT04760301|Coagulants|coagulants|mesh-ancestor
5945755|NCT04760132|Vaccines|vaccines|mesh-list
5945756|NCT04760132|Immunologic Factors|immunologic factors|mesh-ancestor
5945757|NCT04760132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967854|NCT04558580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967855|NCT04558463|Oseltamivir|oseltamivir|mesh-list
5967856|NCT04558463|Favipiravir|favipiravir|mesh-list
5967857|NCT04558463|Antiviral Agents|antiviral agents|mesh-ancestor
5967858|NCT04558463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5967859|NCT04558463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5967860|NCT04558463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967861|NCT04558268|Folic Acid|folic acid|mesh-list
5967862|NCT04558268|Prednisone|prednisone|mesh-list
5967863|NCT04558268|Progesterone|progesterone|mesh-list
5967864|NCT04558268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5967865|NCT04558268|Glucocorticoids|glucocorticoids|mesh-ancestor
5967866|NCT04558268|Hormones|hormones|mesh-ancestor
5967867|NCT04558268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5967868|NCT04558268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967869|NCT04558268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5967870|NCT04558268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5967871|NCT04558268|Progestins|progestins|mesh-ancestor
5967872|NCT04558268|Hematinics|hematinics|mesh-ancestor
5967873|NCT04558268|Vitamin B Complex|vitamin b complex|mesh-ancestor
5967874|NCT04558268|Vitamins|vitamins|mesh-ancestor
5967875|NCT04558268|Micronutrients|micronutrients|mesh-ancestor
5967876|NCT04558424|Ascorbic Acid|ascorbic acid|mesh-list
5967877|NCT04558424|Antioxidants|antioxidants|mesh-ancestor
5967878|NCT04558424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967879|NCT04558424|Protective Agents|protective agents|mesh-ancestor
5967880|NCT04558424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967881|NCT04558424|Vitamins|vitamins|mesh-ancestor
5967882|NCT04558424|Micronutrients|micronutrients|mesh-ancestor
5967883|NCT04558281|Ropivacaine|ropivacaine|mesh-list
5967884|NCT04558281|Anesthetics, Local|anesthetics, local|mesh-ancestor
5967885|NCT04558281|Anesthetics|anesthetics|mesh-ancestor
5967886|NCT04558281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5967887|NCT04558281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967888|NCT04558281|Sensory System Agents|sensory system agents|mesh-ancestor
5967889|NCT04558281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5967890|NCT04558216|Rifampin|rifampin|mesh-list
5967891|NCT04558216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5720071|NCT03215264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5720072|NCT03215264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5720073|NCT03215264|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5720074|NCT03215407|Betamethasone|betamethasone|mesh-list
5720075|NCT03215407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5720076|NCT03215407|Glucocorticoids|glucocorticoids|mesh-ancestor
5720077|NCT03215407|Hormones|hormones|mesh-ancestor
5720078|NCT03215407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5720079|NCT03215407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720080|NCT03215407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5720081|NCT03215407|Respiratory System Agents|respiratory system agents|mesh-ancestor
5720082|NCT03215069|Empagliflozin|empagliflozin|mesh-list
5720083|NCT03215069|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5967892|NCT04558216|Antitubercular Agents|antitubercular agents|mesh-ancestor
5967893|NCT04558216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5945758|NCT04759703|Pramipexole|pramipexole|mesh-list
5945759|NCT04759703|Antioxidants|antioxidants|mesh-ancestor
5945760|NCT04759703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945761|NCT04759703|Protective Agents|protective agents|mesh-ancestor
5945762|NCT04759703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945763|NCT04759703|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5945764|NCT04759703|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5945765|NCT04759703|Dopamine Agonists|dopamine agonists|mesh-ancestor
5945766|NCT04759703|Dopamine Agents|dopamine agents|mesh-ancestor
5945767|NCT04759703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5945768|NCT04759729|Vitamin D|vitamin d|mesh-list
5945769|NCT04759729|Ergocalciferols|ergocalciferols|mesh-list
5945770|NCT04759729|Vitamins|vitamins|mesh-list
5945771|NCT04759729|Micronutrients|micronutrients|mesh-ancestor
5945772|NCT04759729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945773|NCT04759729|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5945774|NCT04759729|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5945775|NCT04759742|Ropivacaine|ropivacaine|mesh-list
5945776|NCT04759742|Anesthetics, Local|anesthetics, local|mesh-ancestor
5945777|NCT04759742|Anesthetics|anesthetics|mesh-ancestor
5945778|NCT04759742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5945779|NCT04759742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945780|NCT04759742|Sensory System Agents|sensory system agents|mesh-ancestor
5945781|NCT04759742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5945782|NCT04759248|Trastuzumab|trastuzumab|mesh-list
5945783|NCT04759248|Atezolizumab|atezolizumab|mesh-list
5945784|NCT04759248|Vinorelbine|vinorelbine|mesh-list
5945785|NCT04759248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5945786|NCT04759248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5945787|NCT04759248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5945788|NCT04759248|Tubulin Modulators|tubulin modulators|mesh-ancestor
5945789|NCT04759248|Antimitotic Agents|antimitotic agents|mesh-ancestor
5945790|NCT04759248|Mitosis Modulators|mitosis modulators|mesh-ancestor
5945791|NCT04759248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945792|NCT04759339|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5945793|NCT04759339|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5945794|NCT04759235|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5945795|NCT04759235|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5945796|NCT04759235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945797|NCT04760262|Remifentanil|remifentanil|mesh-list
5945798|NCT04760262|Propofol|propofol|mesh-list
5945799|NCT04760262|Sevoflurane|sevoflurane|mesh-list
5945800|NCT04760262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5945801|NCT04760262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5945802|NCT04760262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945803|NCT04760262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5945804|NCT04760262|Anesthetics, General|anesthetics, general|mesh-ancestor
5945805|NCT04760262|Anesthetics|anesthetics|mesh-ancestor
5945806|NCT04760262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5945807|NCT04760262|Narcotics|narcotics|mesh-ancestor
5945808|NCT04760262|Analgesics|analgesics|mesh-ancestor
5945809|NCT04760262|Sensory System Agents|sensory system agents|mesh-ancestor
5945810|NCT04760262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5945811|NCT04760262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5945812|NCT04760262|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5945813|NCT04758936|Clonidine|clonidine|mesh-list
5945814|NCT04758936|Dexmedetomidine|dexmedetomidine|mesh-list
5945815|NCT04758936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5945816|NCT04758936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5945817|NCT04758936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945818|NCT04758936|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5945819|NCT04758936|Analgesics|analgesics|mesh-ancestor
5945820|NCT04758936|Sensory System Agents|sensory system agents|mesh-ancestor
5945821|NCT04758936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5945822|NCT04758936|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5945823|NCT04758936|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5945824|NCT04758936|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5945825|NCT04758936|Adrenergic Agents|adrenergic agents|mesh-ancestor
5945826|NCT04758936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5945827|NCT04758936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945828|NCT04758936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5945829|NCT04758936|Sympatholytics|sympatholytics|mesh-ancestor
5945830|NCT04758936|Autonomic Agents|autonomic agents|mesh-ancestor
5945831|NCT04758871|Progesterone|progesterone|mesh-list
5945832|NCT04758871|Dydrogesterone|dydrogesterone|mesh-list
5945833|NCT04758871|Progestins|progestins|mesh-ancestor
5945834|NCT04758871|Hormones|hormones|mesh-ancestor
5945835|NCT04758871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5945836|NCT04758871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945837|NCT04758858|Glucagon|glucagon|mesh-list
5945838|NCT04758858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945839|NCT04758858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5945840|NCT04758858|Hormones|hormones|mesh-ancestor
5945841|NCT04758858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5945842|NCT04759079|Antiemetics|antiemetics|mesh-list
5945843|NCT04759079|Autonomic Agents|autonomic agents|mesh-ancestor
5945844|NCT04759079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5945845|NCT04759079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945846|NCT04759079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5945847|NCT04759196|Topiramate|topiramate|mesh-list
5945848|NCT04759196|Levetiracetam|levetiracetam|mesh-list
5945849|NCT04759196|Anticonvulsants|anticonvulsants|mesh-ancestor
5945850|NCT04759196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5945851|NCT04759196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945852|NCT04759196|Nootropic Agents|nootropic agents|mesh-ancestor
5945853|NCT04758975|Rituximab|rituximab|mesh-list
5945854|NCT04758975|Venetoclax|venetoclax|mesh-list
5945855|NCT04758975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5945856|NCT04758975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5945857|NCT04758975|Immunologic Factors|immunologic factors|mesh-ancestor
5945858|NCT04758975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945859|NCT04758975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5945860|NCT04758416|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5945861|NCT04758416|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5945862|NCT04758416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945863|NCT04758689|Methotrexate|methotrexate|mesh-list
5945864|NCT04758689|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5945865|NCT04758689|Abortifacient Agents|abortifacient agents|mesh-ancestor
5945866|NCT04758689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5945867|NCT04758689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945868|NCT04758689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5945869|NCT04758689|Antimetabolites|antimetabolites|mesh-ancestor
5945870|NCT04758689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945871|NCT04758689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5945872|NCT04758689|Dermatologic Agents|dermatologic agents|mesh-ancestor
5945873|NCT04758689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5945874|NCT04758689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5945875|NCT04758689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5945876|NCT04758689|Immunologic Factors|immunologic factors|mesh-ancestor
5945877|NCT04758689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5945878|NCT04758689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5945879|NCT04758728|Epinephrine|epinephrine|mesh-list
5945880|NCT04758728|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5945881|NCT04758728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5945882|NCT04758728|Adrenergic Agents|adrenergic agents|mesh-ancestor
5945883|NCT04758728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5945884|NCT04758728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945885|NCT04758728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945886|NCT04758728|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5945887|NCT04758728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5945888|NCT04758728|Autonomic Agents|autonomic agents|mesh-ancestor
5945889|NCT04758728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5945890|NCT04758728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5945891|NCT04758728|Respiratory System Agents|respiratory system agents|mesh-ancestor
5945892|NCT04758728|Mydriatics|mydriatics|mesh-ancestor
5945893|NCT04758728|Sympathomimetics|sympathomimetics|mesh-ancestor
5945894|NCT04758728|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5945895|NCT04758260|Antioxidants|antioxidants|mesh-list
5945896|NCT04758260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945897|NCT04758260|Protective Agents|protective agents|mesh-ancestor
5945898|NCT04758260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967894|NCT04558216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5967895|NCT04558216|Leprostatic Agents|leprostatic agents|mesh-ancestor
5967896|NCT04558216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5967897|NCT04558216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5967898|NCT04558216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967899|NCT04558216|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5967900|NCT04558216|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5967901|NCT04558216|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5967902|NCT04558216|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5945899|NCT04758286|Anesthetics|anesthetics|mesh-list
5945900|NCT04758286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5945901|NCT04758286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945902|NCT04757883|Antibodies|antibodies|mesh-list
5945903|NCT04757883|Immunologic Factors|immunologic factors|mesh-ancestor
5945904|NCT04757883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945905|NCT04758273|Vaccines|vaccines|mesh-list
5945906|NCT04758273|Immunologic Factors|immunologic factors|mesh-ancestor
5945907|NCT04758273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945908|NCT04757818|Cetylpyridinium|cetylpyridinium|mesh-list
5945909|NCT04757818|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5945910|NCT04757818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5945911|NCT04757857|Rivaroxaban|rivaroxaban|mesh-list
5945912|NCT04757857|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5945913|NCT04757857|Antithrombins|antithrombins|mesh-ancestor
5945914|NCT04757857|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5945915|NCT04757857|Protease Inhibitors|protease inhibitors|mesh-ancestor
5945916|NCT04757857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5945917|NCT04757857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945918|NCT04757857|Anticoagulants|anticoagulants|mesh-ancestor
5945919|NCT04758000|Metformin|metformin|mesh-list
5945920|NCT04758000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5945921|NCT04758000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945922|NCT04757974|Fostemsavir|fostemsavir|mesh-list
5945923|NCT04757974|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5945924|NCT04757974|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5945925|NCT04757974|Antiviral Agents|antiviral agents|mesh-ancestor
5945926|NCT04757974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5945927|NCT04757974|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5945928|NCT04757974|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5945929|NCT04757974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945930|NCT04757779|Docetaxel|docetaxel|mesh-list
5945931|NCT04757779|Irinotecan|irinotecan|mesh-list
5945932|NCT04757779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5945933|NCT04757779|Tubulin Modulators|tubulin modulators|mesh-ancestor
5945934|NCT04757779|Antimitotic Agents|antimitotic agents|mesh-ancestor
5945935|NCT04757779|Mitosis Modulators|mitosis modulators|mesh-ancestor
5945936|NCT04757779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945937|NCT04757779|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5945938|NCT04757779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5945939|NCT04757779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5945940|NCT04757740|Methylprednisolone|methylprednisolone|mesh-list
5945941|NCT04757740|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5945942|NCT04757740|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5945943|NCT04757740|Prednisolone|prednisolone|mesh-list
5945944|NCT04757740|Prednisolone acetate|prednisolone acetate|mesh-list
5945945|NCT04757740|Lidocaine|lidocaine|mesh-list
5945946|NCT04757740|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5945947|NCT04757740|Prednisolone phosphate|prednisolone phosphate|mesh-list
5945948|NCT04757740|Anesthetics, Local|anesthetics, local|mesh-ancestor
5945949|NCT04757740|Anesthetics|anesthetics|mesh-ancestor
5945950|NCT04757740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5945951|NCT04757740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945952|NCT04757740|Sensory System Agents|sensory system agents|mesh-ancestor
5945953|NCT04757740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5945954|NCT04757740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5945955|NCT04757740|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5945956|NCT04757740|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5945957|NCT04757740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5945958|NCT04757740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945959|NCT04757740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5945960|NCT04757740|Antiemetics|antiemetics|mesh-ancestor
5945961|NCT04757740|Autonomic Agents|autonomic agents|mesh-ancestor
5945962|NCT04757740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5945963|NCT04757740|Glucocorticoids|glucocorticoids|mesh-ancestor
5945964|NCT04757740|Hormones|hormones|mesh-ancestor
5945965|NCT04757740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5945966|NCT04757740|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5945967|NCT04757740|Protective Agents|protective agents|mesh-ancestor
5945968|NCT04757740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5945969|NCT04757740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5945970|NCT04757506|Naltrexone|naltrexone|mesh-list
5945971|NCT04757506|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5945972|NCT04757506|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5945973|NCT04757506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945974|NCT04757506|Sensory System Agents|sensory system agents|mesh-ancestor
5945975|NCT04757506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5945976|NCT04757675|Dexmedetomidine|dexmedetomidine|mesh-list
5945977|NCT04757675|Ketamine|ketamine|mesh-list
5945978|NCT04757675|Esketamine|esketamine|mesh-list
5945979|NCT04757675|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5945980|NCT04757675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5945981|NCT04757675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5945982|NCT04757675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5945983|NCT04757675|Analgesics|analgesics|mesh-ancestor
5945984|NCT04757675|Sensory System Agents|sensory system agents|mesh-ancestor
5945985|NCT04757675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5945986|NCT04757675|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5945987|NCT04757675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5945988|NCT04757675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5945989|NCT04757675|Adrenergic Agents|adrenergic agents|mesh-ancestor
5945990|NCT04757675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5945991|NCT04757675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5945992|NCT04757675|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5945993|NCT04757675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5945994|NCT04757675|Anesthetics, General|anesthetics, general|mesh-ancestor
5945995|NCT04757675|Anesthetics|anesthetics|mesh-ancestor
5945996|NCT04757675|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5945997|NCT04757675|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5945998|NCT04757675|Antidepressive Agents|antidepressive agents|mesh-ancestor
5945999|NCT04757675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5946000|NCT04757532|Methyltestosterone|methyltestosterone|mesh-list
5946001|NCT04757532|Anastrozole|anastrozole|mesh-list
5946002|NCT04757532|Chlorthalidone|chlorthalidone|mesh-list
5946003|NCT04757532|Bupropion|bupropion|mesh-list
5946004|NCT04757532|Testosterone|testosterone|mesh-list
5946005|NCT04757532|Testosterone undecanoate|testosterone undecanoate|mesh-list
5946006|NCT04757532|Testosterone enanthate|testosterone enanthate|mesh-list
5946007|NCT04757532|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5946008|NCT04757532|Danazol|danazol|mesh-list
5946009|NCT04757532|Androgens|androgens|mesh-ancestor
5946010|NCT04757532|Hormones|hormones|mesh-ancestor
5946011|NCT04757532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5946012|NCT04757532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946013|NCT04757532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5946014|NCT04757532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5946015|NCT04757532|Anabolic Agents|anabolic agents|mesh-ancestor
5946016|NCT04757532|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5946017|NCT04757532|Antidepressive Agents|antidepressive agents|mesh-ancestor
5946018|NCT04757532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5946019|NCT04757532|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5946020|NCT04757532|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5946021|NCT04757532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5946022|NCT04757532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5946023|NCT04757532|Dopamine Agents|dopamine agents|mesh-ancestor
5946024|NCT04757532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5946025|NCT04757532|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5946026|NCT04757532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5946027|NCT04757532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5946028|NCT04757532|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5946029|NCT04757532|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5946030|NCT04757532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5946031|NCT04757532|Hormone Antagonists|hormone antagonists|mesh-ancestor
5946032|NCT04757532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5946033|NCT04757532|Diuretics|diuretics|mesh-ancestor
5946034|NCT04757532|Natriuretic Agents|natriuretic agents|mesh-ancestor
5946035|NCT04757532|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5946036|NCT04757584|Propranolol|propranolol|mesh-list
5946037|NCT04757584|Metoprolol|metoprolol|mesh-list
5946038|NCT04757584|Atenolol|atenolol|mesh-list
5946039|NCT04757584|Sotalol|sotalol|mesh-list
5946040|NCT04757584|Nadolol|nadolol|mesh-list
5946041|NCT04757584|Acebutolol|acebutolol|mesh-list
5946042|NCT04757584|Carvedilol|carvedilol|mesh-list
5946043|NCT04757584|Nebivolol|nebivolol|mesh-list
5946044|NCT04757584|Bisoprolol|bisoprolol|mesh-list
5946045|NCT04757584|Labetalol|labetalol|mesh-list
5946046|NCT04757584|Pindolol|pindolol|mesh-list
5946047|NCT04757584|Betaxolol|betaxolol|mesh-list
5946048|NCT04757584|Penbutolol|penbutolol|mesh-list
6517393|NCT00720811|Antipyretics|antipyretics|mesh-ancestor
5946049|NCT04757584|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
5946050|NCT04757584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5946051|NCT04757584|Adrenergic Agents|adrenergic agents|mesh-ancestor
5946052|NCT04757584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5946053|NCT04757584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5946054|NCT04757584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946055|NCT04757584|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5946056|NCT04757584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5946057|NCT04757584|Vasodilator Agents|vasodilator agents|mesh-ancestor
5946058|NCT04757584|Sympatholytics|sympatholytics|mesh-ancestor
5946059|NCT04757584|Autonomic Agents|autonomic agents|mesh-ancestor
5946060|NCT04757584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5946061|NCT04757584|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5946062|NCT04757584|Antioxidants|antioxidants|mesh-ancestor
5946063|NCT04757584|Protective Agents|protective agents|mesh-ancestor
5946064|NCT04757584|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5946065|NCT04757584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5946066|NCT04757584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5946067|NCT04757584|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5946068|NCT04757584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5946069|NCT04757584|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5946070|NCT04757584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5946071|NCT04757584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5946072|NCT04757584|Sympathomimetics|sympathomimetics|mesh-ancestor
5946073|NCT04757584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5946074|NCT04757584|Serotonin Agents|serotonin agents|mesh-ancestor
5946075|NCT04757662|Tadalafil|tadalafil|mesh-list
5946076|NCT04757662|Vasodilator Agents|vasodilator agents|mesh-ancestor
5946077|NCT04757662|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5946078|NCT04757662|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5946079|NCT04757662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5946080|NCT04757662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5946081|NCT04757662|Urological Agents|urological agents|mesh-ancestor
5946082|NCT04757376|Denosumab|denosumab|mesh-list
5946083|NCT04757376|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5946084|NCT04757376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946085|NCT04757337|Cyclophosphamide|cyclophosphamide|mesh-list
5946086|NCT04757337|Doxorubicin|doxorubicin|mesh-list
5946087|NCT04757337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5946088|NCT04757337|Immunologic Factors|immunologic factors|mesh-ancestor
5946089|NCT04757337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946090|NCT04757337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5946091|NCT04757337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5946092|NCT04757337|Alkylating Agents|alkylating agents|mesh-ancestor
5946093|NCT04757337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5946094|NCT04757337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5946095|NCT04757337|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5946096|NCT04757337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5946097|NCT04757337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5946098|NCT04757337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5946099|NCT04757337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5946100|NCT04756882|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5946101|NCT04756882|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5946102|NCT04756882|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5946103|NCT04756882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5946104|NCT04756882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5946105|NCT04756882|Cholinergic Agents|cholinergic agents|mesh-ancestor
5946106|NCT04756882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5946107|NCT04756882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946108|NCT04756882|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5946109|NCT04756882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5946110|NCT04756895|Vancomycin|vancomycin|mesh-list
5946111|NCT04756895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5946112|NCT04756895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5946113|NCT04756622|Acetylcysteine|acetylcysteine|mesh-list
5946114|NCT04756622|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5946115|NCT04756622|Antiviral Agents|antiviral agents|mesh-ancestor
5946116|NCT04756622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5946117|NCT04756622|Expectorants|expectorants|mesh-ancestor
5946118|NCT04756622|Respiratory System Agents|respiratory system agents|mesh-ancestor
5946119|NCT04756622|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5946120|NCT04756622|Antioxidants|antioxidants|mesh-ancestor
5946121|NCT04756622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5946122|NCT04756622|Protective Agents|protective agents|mesh-ancestor
5946123|NCT04756622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946124|NCT04756622|Antidotes|antidotes|mesh-ancestor
5946125|NCT04756492|Cyclosporine|cyclosporine|mesh-list
5946126|NCT04756492|Antifungal Agents|antifungal agents|mesh-ancestor
5946127|NCT04756492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5946128|NCT04756492|Dermatologic Agents|dermatologic agents|mesh-ancestor
5946129|NCT04756492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5946130|NCT04756492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5946131|NCT04756492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5946132|NCT04756492|Immunologic Factors|immunologic factors|mesh-ancestor
5946133|NCT04756492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946134|NCT04756492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5946135|NCT04756492|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5946136|NCT04756661|Misoprostol|misoprostol|mesh-list
5946137|NCT04756661|Oxytocin|oxytocin|mesh-list
5946138|NCT04756661|Carbetocin|carbetocin|mesh-list
5946139|NCT04756661|Oxytocics|oxytocics|mesh-ancestor
5946140|NCT04756661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5946141|NCT04756661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946142|NCT04756661|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5946143|NCT04756661|Abortifacient Agents|abortifacient agents|mesh-ancestor
5946144|NCT04756661|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5946145|NCT04756661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5946146|NCT04756323|Vaccines|vaccines|mesh-list
5946147|NCT04756323|Immunologic Factors|immunologic factors|mesh-ancestor
5946148|NCT04756323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967903|NCT04558216|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5967904|NCT04558216|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5967905|NCT04558021|Niclosamide|niclosamide|mesh-list
5967906|NCT04558021|Anticestodal Agents|anticestodal agents|mesh-ancestor
5967907|NCT04558021|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5967908|NCT04558021|Anthelmintics|anthelmintics|mesh-ancestor
5967909|NCT04558021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5967910|NCT04558021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5967911|NCT04558021|Antinematodal Agents|antinematodal agents|mesh-ancestor
5967912|NCT04557878|Mitogens|mitogens|mesh-list
5967913|NCT04557878|Mitosis Modulators|mitosis modulators|mesh-ancestor
5967914|NCT04557878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967915|NCT04557735|Ravulizumab|ravulizumab|mesh-list
5967916|NCT04557735|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5967917|NCT04557735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5967918|NCT04557735|Immunologic Factors|immunologic factors|mesh-ancestor
5967919|NCT04557735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967920|NCT04557943|Hyaluronic Acid|hyaluronic acid|mesh-list
5967921|NCT04557943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5967922|NCT04557943|Immunologic Factors|immunologic factors|mesh-ancestor
5967923|NCT04557943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967924|NCT04557943|Viscosupplements|viscosupplements|mesh-ancestor
5967925|NCT04557943|Protective Agents|protective agents|mesh-ancestor
5967926|NCT04557527|Hyaluronic Acid|hyaluronic acid|mesh-list
5967927|NCT04557527|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5967928|NCT04557527|Immunologic Factors|immunologic factors|mesh-ancestor
5967929|NCT04557527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967930|NCT04557527|Viscosupplements|viscosupplements|mesh-ancestor
5967931|NCT04557527|Protective Agents|protective agents|mesh-ancestor
5967932|NCT04557475|Aspirin|aspirin|mesh-list
5967933|NCT04557475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5967934|NCT04557475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5967935|NCT04557475|Analgesics|analgesics|mesh-ancestor
5967936|NCT04557475|Sensory System Agents|sensory system agents|mesh-ancestor
5967937|NCT04557475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5967938|NCT04557475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967939|NCT04557475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5967940|NCT04557475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5967941|NCT04557475|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5967942|NCT04557475|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5967943|NCT04557475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967944|NCT04557475|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5967945|NCT04557475|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5967946|NCT04557475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5967947|NCT04557475|Antipyretics|antipyretics|mesh-ancestor
5967948|NCT04557397|Itraconazole|itraconazole|mesh-list
5967949|NCT04557397|Rifampin|rifampin|mesh-list
5967950|NCT04557397|Antifungal Agents|antifungal agents|mesh-ancestor
5967951|NCT04557397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5967952|NCT04557397|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5967953|NCT04557397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5967954|NCT04557397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5967955|NCT04557397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967956|NCT04557397|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5946149|NCT04756557|Fluorides|fluorides|mesh-list
5946150|NCT04756557|Sodium Fluoride|sodium fluoride|mesh-list
5946151|NCT04756557|Cariostatic Agents|cariostatic agents|mesh-ancestor
5946152|NCT04756557|Protective Agents|protective agents|mesh-ancestor
5946153|NCT04756557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946154|NCT04756206|Dutasteride|dutasteride|mesh-list
5946155|NCT04756206|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
5946156|NCT04756206|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5946157|NCT04756206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5946158|NCT04756206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5946159|NCT04756206|Hormone Antagonists|hormone antagonists|mesh-ancestor
5946160|NCT04756206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5946161|NCT04756206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946162|NCT04756128|Colchicine|colchicine|mesh-list
5946163|NCT04756128|Naltrexone|naltrexone|mesh-list
5946164|NCT04756128|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5946165|NCT04756128|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5946166|NCT04756128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946167|NCT04756128|Sensory System Agents|sensory system agents|mesh-ancestor
5946168|NCT04756128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5946169|NCT04756128|Gout Suppressants|gout suppressants|mesh-ancestor
5946170|NCT04756128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5946171|NCT04756128|Tubulin Modulators|tubulin modulators|mesh-ancestor
5946172|NCT04756128|Antimitotic Agents|antimitotic agents|mesh-ancestor
5946173|NCT04756128|Mitosis Modulators|mitosis modulators|mesh-ancestor
5946174|NCT04756128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5946175|NCT04756128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5946176|NCT04756089|Oxytocin|oxytocin|mesh-list
5946177|NCT04756089|Oxytocics|oxytocics|mesh-ancestor
5946178|NCT04756089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5946179|NCT04756089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946180|NCT04755998|Vaccines|vaccines|mesh-list
5946181|NCT04755998|Immunologic Factors|immunologic factors|mesh-ancestor
5946182|NCT04755998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946183|NCT04755868|Talazoparib|talazoparib|mesh-list
5946184|NCT04755868|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5946185|NCT04755868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5946186|NCT04755868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5946187|NCT04755868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5946188|NCT04755712|Sufentanil|sufentanil|mesh-list
5946189|NCT04755712|Morphine|morphine|mesh-list
5946190|NCT04755712|Bupivacaine|bupivacaine|mesh-list
5946191|NCT04755712|Anesthetics, Local|anesthetics, local|mesh-ancestor
5946192|NCT04755712|Anesthetics|anesthetics|mesh-ancestor
5946193|NCT04755712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5946194|NCT04755712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946195|NCT04755712|Sensory System Agents|sensory system agents|mesh-ancestor
5946196|NCT04755712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5946197|NCT04755712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5946198|NCT04755712|Narcotics|narcotics|mesh-ancestor
5946199|NCT04755712|Analgesics|analgesics|mesh-ancestor
5946200|NCT04755712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5946201|NCT04755712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5946202|NCT04755712|Anesthetics, General|anesthetics, general|mesh-ancestor
5946203|NCT04756050|Epinephrine|epinephrine|mesh-list
5946204|NCT04756050|Racepinephrine|racepinephrine|mesh-list
5946205|NCT04756050|Bupivacaine|bupivacaine|mesh-list
5946206|NCT04756050|Prilocaine|prilocaine|mesh-list
5946207|NCT04756050|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5946208|NCT04756050|Epinephryl borate|epinephryl borate|mesh-list
5946209|NCT04756050|Anesthetics, Local|anesthetics, local|mesh-ancestor
5946210|NCT04756050|Anesthetics|anesthetics|mesh-ancestor
5946211|NCT04756050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5946212|NCT04756050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946213|NCT04756050|Sensory System Agents|sensory system agents|mesh-ancestor
5946214|NCT04756050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5946215|NCT04756050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5946216|NCT04756050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5946217|NCT04756050|Adrenergic Agents|adrenergic agents|mesh-ancestor
5946218|NCT04756050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5946219|NCT04756050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5946220|NCT04756050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5946221|NCT04756050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5946222|NCT04756050|Autonomic Agents|autonomic agents|mesh-ancestor
5946223|NCT04756050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5946224|NCT04756050|Respiratory System Agents|respiratory system agents|mesh-ancestor
5946225|NCT04756050|Mydriatics|mydriatics|mesh-ancestor
5946226|NCT04756050|Sympathomimetics|sympathomimetics|mesh-ancestor
5946227|NCT04756050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5946228|NCT04755595|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5946229|NCT04755595|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5946230|NCT04755595|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5946231|NCT04755595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5946232|NCT04755595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946233|NCT04755595|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5946234|NCT04755595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5946235|NCT04755595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5946236|NCT04755595|Cholinergic Agents|cholinergic agents|mesh-ancestor
5946237|NCT04755595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5946238|NCT04755647|Nitric Oxide|nitric oxide|mesh-list
5946239|NCT04755647|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5946240|NCT04755647|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5946241|NCT04755647|Autonomic Agents|autonomic agents|mesh-ancestor
5946242|NCT04755647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5946243|NCT04755647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946244|NCT04755647|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5946245|NCT04755647|Respiratory System Agents|respiratory system agents|mesh-ancestor
5946246|NCT04755647|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5946247|NCT04755647|Antioxidants|antioxidants|mesh-ancestor
5946248|NCT04755647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5946249|NCT04755647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5946250|NCT04755647|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5946251|NCT04755647|Vasodilator Agents|vasodilator agents|mesh-ancestor
5946252|NCT04755647|Gasotransmitters|gasotransmitters|mesh-ancestor
5946253|NCT04755647|Protective Agents|protective agents|mesh-ancestor
5946254|NCT04755634|Hyaluronic Acid|hyaluronic acid|mesh-list
5946255|NCT04755634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5946256|NCT04755634|Immunologic Factors|immunologic factors|mesh-ancestor
5946257|NCT04755634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946258|NCT04755634|Viscosupplements|viscosupplements|mesh-ancestor
5946259|NCT04755634|Protective Agents|protective agents|mesh-ancestor
5946260|NCT04755764|Atenolol|atenolol|mesh-list
5946261|NCT04755764|Labetalol|labetalol|mesh-list
5946262|NCT04755764|Nifedipine|nifedipine|mesh-list
5946263|NCT04755764|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5946264|NCT04755764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5946265|NCT04755764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5946266|NCT04755764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5946267|NCT04755764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946268|NCT04755764|Vasodilator Agents|vasodilator agents|mesh-ancestor
5946269|NCT04755764|Tocolytic Agents|tocolytic agents|mesh-ancestor
5946270|NCT04755764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5946271|NCT04755764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5946272|NCT04755764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5946273|NCT04755764|Sympatholytics|sympatholytics|mesh-ancestor
5946274|NCT04755764|Autonomic Agents|autonomic agents|mesh-ancestor
5946275|NCT04755764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5946276|NCT04755764|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5946277|NCT04755764|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5946278|NCT04755764|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5946279|NCT04755764|Adrenergic Agents|adrenergic agents|mesh-ancestor
5946280|NCT04755764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5946281|NCT04755764|Sympathomimetics|sympathomimetics|mesh-ancestor
5946282|NCT04755764|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5946283|NCT04755764|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5720084|NCT03215069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5720085|NCT03215069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5720086|NCT03215069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720087|NCT03215056|Methoxyflurane|methoxyflurane|mesh-list
5720088|NCT03215056|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5720089|NCT03215056|Anesthetics, General|anesthetics, general|mesh-ancestor
5720090|NCT03215056|Anesthetics|anesthetics|mesh-ancestor
5720091|NCT03215056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5720092|NCT03215056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720093|NCT03215017|Loperamide|loperamide|mesh-list
5720094|NCT03215017|Sorbitol|sorbitol|mesh-list
5720095|NCT03215017|Antidiarrheals|antidiarrheals|mesh-ancestor
5720096|NCT03215017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5720097|NCT03215017|Cathartics|cathartics|mesh-ancestor
5720098|NCT03214874|Torsemide|torsemide|mesh-list
5720099|NCT03214874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5720100|NCT03214874|Diuretics|diuretics|mesh-ancestor
5946284|NCT04755543|Fluorouracil|fluorouracil|mesh-list
5946285|NCT04755543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5946286|NCT04755543|Antimetabolites|antimetabolites|mesh-ancestor
5946287|NCT04755543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5946288|NCT04755543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5946289|NCT04755543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5946290|NCT04755543|Immunologic Factors|immunologic factors|mesh-ancestor
5946291|NCT04755543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946292|NCT04755322|Aspirin|aspirin|mesh-list
5946293|NCT04755322|Folic Acid|folic acid|mesh-list
5946294|NCT04755322|Hydroxychloroquine|hydroxychloroquine|mesh-list
5946295|NCT04755322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5946296|NCT04755322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5946297|NCT04755322|Analgesics|analgesics|mesh-ancestor
5946298|NCT04755322|Sensory System Agents|sensory system agents|mesh-ancestor
5946299|NCT04755322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5946300|NCT04755322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946301|NCT04755322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5946302|NCT04755322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5946303|NCT04755322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5946304|NCT04755322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5946305|NCT04755322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5946306|NCT04755322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5946307|NCT04755322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5946308|NCT04755322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5946309|NCT04755322|Antipyretics|antipyretics|mesh-ancestor
5946310|NCT04755322|Antimalarials|antimalarials|mesh-ancestor
5946311|NCT04755322|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5946312|NCT04755322|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5946313|NCT04755322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5946314|NCT04755322|Hematinics|hematinics|mesh-ancestor
5946315|NCT04755322|Vitamin B Complex|vitamin b complex|mesh-ancestor
5946316|NCT04755322|Vitamins|vitamins|mesh-ancestor
5946317|NCT04755322|Micronutrients|micronutrients|mesh-ancestor
5946318|NCT04755387|Ticagrelor|ticagrelor|mesh-list
5946319|NCT04755387|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5946320|NCT04755387|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5946321|NCT04755387|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5946322|NCT04755387|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5946323|NCT04755387|Purinergic Agents|purinergic agents|mesh-ancestor
5946324|NCT04755387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5946325|NCT04755387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5946326|NCT04755387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946327|NCT04755062|Micronutrients|micronutrients|mesh-list
5946328|NCT04755062|Trace Elements|trace elements|mesh-list
5946329|NCT04755062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946330|NCT04755218|Misoprostol|misoprostol|mesh-list
5946331|NCT04755218|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5946332|NCT04755218|Abortifacient Agents|abortifacient agents|mesh-ancestor
5946333|NCT04755218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5946334|NCT04755218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946335|NCT04755218|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5946336|NCT04755218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5946337|NCT04755218|Oxytocics|oxytocics|mesh-ancestor
5946338|NCT04754815|Paclitaxel|paclitaxel|mesh-list
5946339|NCT04754815|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5946340|NCT04754815|Pembrolizumab|pembrolizumab|mesh-list
5946341|NCT04754815|Pemetrexed|pemetrexed|mesh-list
5946342|NCT04754815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5720101|NCT03214874|Natriuretic Agents|natriuretic agents|mesh-ancestor
5720102|NCT03214874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720103|NCT03214874|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5720104|NCT03214874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5720105|NCT03214874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5720106|NCT03214848|Contraceptive Agents|contraceptive agents|mesh-list
5720107|NCT03214848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5720108|NCT03214848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720109|NCT03214731|Artesunate|artesunate|mesh-list
5720110|NCT03214731|Antimalarials|antimalarials|mesh-ancestor
5720111|NCT03214731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5720112|NCT03214731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5946343|NCT04754815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5946344|NCT04754815|Tubulin Modulators|tubulin modulators|mesh-ancestor
5946345|NCT04754815|Antimitotic Agents|antimitotic agents|mesh-ancestor
5946346|NCT04754815|Mitosis Modulators|mitosis modulators|mesh-ancestor
5967957|NCT04557397|Hormone Antagonists|hormone antagonists|mesh-ancestor
5946347|NCT04754815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5946348|NCT04754815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5946349|NCT04754815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5946350|NCT04754815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5946351|NCT04754815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5946352|NCT04754945|Dexamethasone|dexamethasone|mesh-list
5946353|NCT04754945|Dexamethasone acetate|dexamethasone acetate|mesh-list
5946354|NCT04754945|Cyclophosphamide|cyclophosphamide|mesh-list
5946355|NCT04754945|Bortezomib|bortezomib|mesh-list
5946356|NCT04754945|Ichthammol|ichthammol|mesh-list
5946357|NCT04754945|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5946358|NCT04754945|BB 1101|bb 1101|mesh-list
5946359|NCT04754945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5946360|NCT04754945|Immunologic Factors|immunologic factors|mesh-ancestor
5946361|NCT04754945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946362|NCT04754945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5946363|NCT04754945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5946364|NCT04754945|Alkylating Agents|alkylating agents|mesh-ancestor
5946365|NCT04754945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5946366|NCT04754945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5946367|NCT04754945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5946368|NCT04754945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5946369|NCT04754945|Antiemetics|antiemetics|mesh-ancestor
5946370|NCT04754945|Autonomic Agents|autonomic agents|mesh-ancestor
5946371|NCT04754945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5946372|NCT04754945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5946373|NCT04754945|Glucocorticoids|glucocorticoids|mesh-ancestor
5946374|NCT04754945|Hormones|hormones|mesh-ancestor
5946375|NCT04754945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6517394|NCT00720811|Antimalarials|antimalarials|mesh-ancestor
6517395|NCT00720811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6517396|NCT00720811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5946376|NCT04754945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5946377|NCT04754945|Protease Inhibitors|protease inhibitors|mesh-ancestor
5946378|NCT04754945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5946379|NCT04754945|Dermatologic Agents|dermatologic agents|mesh-ancestor
5967958|NCT04557397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5967959|NCT04557397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967960|NCT04557397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5967961|NCT04557397|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5967962|NCT04557397|Antitubercular Agents|antitubercular agents|mesh-ancestor
5967963|NCT04557397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5967964|NCT04557397|Leprostatic Agents|leprostatic agents|mesh-ancestor
5967965|NCT04557397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5967966|NCT04557397|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5967967|NCT04557397|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5967968|NCT04557397|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5967969|NCT04557397|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5967970|NCT04557397|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5967971|NCT04557397|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5967972|NCT04557384|Ramucirumab|ramucirumab|mesh-list
5967973|NCT04557384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5967974|NCT04557163|Itraconazole|itraconazole|mesh-list
5967975|NCT04557163|Antifungal Agents|antifungal agents|mesh-ancestor
5967976|NCT04557163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5967977|NCT04557163|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5967978|NCT04557163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5967979|NCT04557163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5967980|NCT04557163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967981|NCT04557163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5967982|NCT04557163|Hormone Antagonists|hormone antagonists|mesh-ancestor
5967983|NCT04557163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5967984|NCT04557163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967985|NCT04557163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5971088|NCT04530422|Hydroxychloroquine|hydroxychloroquine|mesh-list
5971089|NCT04530422|Sofosbuvir|sofosbuvir|mesh-list
5971090|NCT04530422|Oseltamivir|oseltamivir|mesh-list
5971091|NCT04530422|Ledipasvir|ledipasvir|mesh-list
5971092|NCT04530422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5971093|NCT04530422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5971094|NCT04530422|Antimalarials|antimalarials|mesh-ancestor
5971095|NCT04530422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6517397|NCT00720824|Anesthetics|anesthetics|mesh-list
6681353|NCT01609166|Antioxidants|antioxidants|mesh-ancestor
5946380|NCT04754737|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5946381|NCT04754737|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5946382|NCT04754737|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5946383|NCT04754737|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5946384|NCT04754737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5946385|NCT04754737|Antitubercular Agents|antitubercular agents|mesh-ancestor
5946386|NCT04754737|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5946387|NCT04754737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5946388|NCT04754737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946389|NCT04754737|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5946390|NCT04754737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5946391|NCT04754737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5946392|NCT04754737|Cholinergic Agents|cholinergic agents|mesh-ancestor
5946393|NCT04754737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5946394|NCT04754763|Propolis|propolis|mesh-list
5946395|NCT04754763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5946396|NCT04754750|Paliperidone Palmitate|paliperidone palmitate|mesh-list
5946397|NCT04754750|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5946398|NCT04754750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5946399|NCT04754750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5946400|NCT04754750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946401|NCT04754750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5946402|NCT04754750|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5946403|NCT04754750|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5946404|NCT04754750|Serotonin Agents|serotonin agents|mesh-ancestor
5946405|NCT04754750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5946406|NCT04754750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5946407|NCT04754750|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5946408|NCT04754750|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5946409|NCT04754750|Dopamine Agents|dopamine agents|mesh-ancestor
5946410|NCT04754789|Aspirin|aspirin|mesh-list
5946411|NCT04754789|Ticagrelor|ticagrelor|mesh-list
5946412|NCT04754789|Atorvastatin|atorvastatin|mesh-list
5946413|NCT04754789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5946414|NCT04754789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5946415|NCT04754789|Analgesics|analgesics|mesh-ancestor
5946416|NCT04754789|Sensory System Agents|sensory system agents|mesh-ancestor
5946417|NCT04754789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5946418|NCT04754789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946419|NCT04754789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5946420|NCT04754789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5946421|NCT04754789|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5946422|NCT04754789|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5946423|NCT04754789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5946424|NCT04754789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5946425|NCT04754789|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5946426|NCT04754789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5946427|NCT04754789|Antipyretics|antipyretics|mesh-ancestor
5946428|NCT04754789|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5946429|NCT04754789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5946430|NCT04754789|Antimetabolites|antimetabolites|mesh-ancestor
5946431|NCT04754789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5946432|NCT04754789|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5946433|NCT04754789|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5946434|NCT04754789|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5946435|NCT04754789|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5946436|NCT04754789|Purinergic Agents|purinergic agents|mesh-ancestor
5946437|NCT04754789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5946438|NCT04754334|Insulin|insulin|mesh-list
5946439|NCT04754334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5946440|NCT04754334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946444|NCT04754399|Cannabidiol|cannabidiol|mesh-list
5946445|NCT04754399|Anticonvulsants|anticonvulsants|mesh-ancestor
5946446|NCT04753918|Ethiodized Oil|ethiodized oil|mesh-list
5946447|NCT04753918|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
5946448|NCT04753918|Trioxsalen|trioxsalen|mesh-list
5946449|NCT04753918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5946450|NCT04753918|Dermatologic Agents|dermatologic agents|mesh-ancestor
5946451|NCT04753918|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5946452|NCT04754035|Venetoclax|venetoclax|mesh-list
5946453|NCT04754035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5946454|NCT04753840|Antihypertensive Agents|antihypertensive agents|mesh-list
5946455|NCT04753723|Gentamicins|gentamicins|mesh-list
5946456|NCT04753723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5946457|NCT04753723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5946458|NCT04753723|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5946459|NCT04753723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5946460|NCT04753723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5946461|NCT04753515|Midazolam|midazolam|mesh-list
5946462|NCT04753515|Dexmedetomidine|dexmedetomidine|mesh-list
5946463|NCT04753515|Remifentanil|remifentanil|mesh-list
5946464|NCT04753515|Propofol|propofol|mesh-list
5946465|NCT04753515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5946466|NCT04753515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5946467|NCT04753515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946468|NCT04753515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5946469|NCT04753515|Anesthetics, General|anesthetics, general|mesh-ancestor
5946470|NCT04753515|Anesthetics|anesthetics|mesh-ancestor
5946471|NCT04753515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5946472|NCT04753515|Analgesics|analgesics|mesh-ancestor
5946473|NCT04753515|Sensory System Agents|sensory system agents|mesh-ancestor
5946474|NCT04753515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5946475|NCT04753515|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5946476|NCT04753515|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5946477|NCT04753515|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5946478|NCT04753515|Adrenergic Agents|adrenergic agents|mesh-ancestor
5946479|NCT04753515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5946480|NCT04753515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5946481|NCT04753515|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5946482|NCT04753515|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5946483|NCT04753515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5946484|NCT04753515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5946485|NCT04753515|GABA Modulators|gaba modulators|mesh-ancestor
5946486|NCT04753515|GABA Agents|gaba agents|mesh-ancestor
5946487|NCT04753515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5946488|NCT04753515|Narcotics|narcotics|mesh-ancestor
5946489|NCT04753749|Aspirin|aspirin|mesh-list
5946490|NCT04753749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5946491|NCT04753749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5946492|NCT04753749|Analgesics|analgesics|mesh-ancestor
5946493|NCT04753749|Sensory System Agents|sensory system agents|mesh-ancestor
5946494|NCT04753749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5946495|NCT04753749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946496|NCT04753749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5946497|NCT04753749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5946498|NCT04753749|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5946499|NCT04753749|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5946500|NCT04753749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5946501|NCT04753749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5946502|NCT04753749|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5946503|NCT04753749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5946504|NCT04753749|Antipyretics|antipyretics|mesh-ancestor
5946505|NCT04753489|Rivaroxaban|rivaroxaban|mesh-list
5946506|NCT04753489|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5946507|NCT04753489|Antithrombins|antithrombins|mesh-ancestor
5946508|NCT04753489|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5946509|NCT04753489|Protease Inhibitors|protease inhibitors|mesh-ancestor
5720113|NCT03214731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5720114|NCT03214731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5720115|NCT03214731|Antiviral Agents|antiviral agents|mesh-ancestor
5720116|NCT03214731|Schistosomicides|schistosomicides|mesh-ancestor
5946510|NCT04753489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5946511|NCT04753489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5946512|NCT04753489|Anticoagulants|anticoagulants|mesh-ancestor
5946513|NCT04753619|Niclosamide|niclosamide|mesh-list
5946514|NCT04753619|Anticestodal Agents|anticestodal agents|mesh-ancestor
5946515|NCT04753619|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5720117|NCT03214731|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5720118|NCT03214731|Anthelmintics|anthelmintics|mesh-ancestor
5722175|NCT03200886|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5722176|NCT03200886|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5722177|NCT03200886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5722178|NCT03200886|Glucocorticoids|glucocorticoids|mesh-ancestor
5946516|NCT04753619|Anthelmintics|anthelmintics|mesh-ancestor
5946517|NCT04753619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5946518|NCT04753619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6681354|NCT01609166|Protective Agents|protective agents|mesh-ancestor
5722179|NCT03200886|Hormones|hormones|mesh-ancestor
5722180|NCT03200886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5946519|NCT04753619|Antinematodal Agents|antinematodal agents|mesh-ancestor
5946520|NCT04753372|Aspirin|aspirin|mesh-list
5946521|NCT04753372|Rivaroxaban|rivaroxaban|mesh-list
5946522|NCT04753372|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5946523|NCT04753372|Antithrombins|antithrombins|mesh-ancestor
5946524|NCT04753372|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5946525|NCT04753372|Protease Inhibitors|protease inhibitors|mesh-ancestor
5946526|NCT04753372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5946527|NCT04753372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5946528|NCT04753372|Anticoagulants|anticoagulants|mesh-ancestor
5946529|NCT04753372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5946530|NCT04753372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5946531|NCT04753372|Analgesics|analgesics|mesh-ancestor
5946532|NCT04753372|Sensory System Agents|sensory system agents|mesh-ancestor
5946533|NCT04753372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5946534|NCT04753372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946535|NCT04753372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5946536|NCT04753372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5946537|NCT04753372|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5946538|NCT04753372|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5946539|NCT04753372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5946540|NCT04753372|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5946541|NCT04753372|Antipyretics|antipyretics|mesh-ancestor
5946542|NCT04753151|Tranexamic Acid|tranexamic acid|mesh-list
5946543|NCT04753151|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5946544|NCT04753151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5946545|NCT04753151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5946546|NCT04753151|Hemostatics|hemostatics|mesh-ancestor
5946547|NCT04753151|Coagulants|coagulants|mesh-ancestor
5946548|NCT04753112|Valsartan|valsartan|mesh-list
5946549|NCT04753112|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5946550|NCT04753112|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5946551|NCT04753112|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5946552|NCT04753112|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5946553|NCT04753112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5946554|NCT04753203|Capecitabine|capecitabine|mesh-list
5946555|NCT04753203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5946556|NCT04753203|Antimetabolites|antimetabolites|mesh-ancestor
5946557|NCT04753203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5946558|NCT04753203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5946559|NCT04753177|Paclitaxel|paclitaxel|mesh-list
5946560|NCT04753177|Cyclophosphamide|cyclophosphamide|mesh-list
5946561|NCT04753177|Doxorubicin|doxorubicin|mesh-list
5946562|NCT04753177|Fulvestrant|fulvestrant|mesh-list
5946563|NCT04753177|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5946564|NCT04753177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5946565|NCT04753177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5946566|NCT04753177|Tubulin Modulators|tubulin modulators|mesh-ancestor
5946567|NCT04753177|Antimitotic Agents|antimitotic agents|mesh-ancestor
5946568|NCT04753177|Mitosis Modulators|mitosis modulators|mesh-ancestor
5946569|NCT04753177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5946570|NCT04753177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5946571|NCT04753177|Immunologic Factors|immunologic factors|mesh-ancestor
5946572|NCT04753177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946573|NCT04753177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5946574|NCT04753177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5946575|NCT04753177|Alkylating Agents|alkylating agents|mesh-ancestor
5946576|NCT04753177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5946577|NCT04753177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5946578|NCT04753177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5946579|NCT04753177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5946580|NCT04753177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5946581|NCT04753177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5946582|NCT04753177|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5946583|NCT04753177|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5946584|NCT04753177|Hormone Antagonists|hormone antagonists|mesh-ancestor
5967986|NCT04557137|Somatostatin|somatostatin|mesh-list
6517398|NCT00720824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
6517399|NCT00720824|Anesthetics, Local|anesthetics, local|mesh-list
6517400|NCT00720824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6517401|NCT00720824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517402|NCT00720824|Sensory System Agents|sensory system agents|mesh-ancestor
6517403|NCT00720824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6517404|NCT00720850|Lenalidomide|lenalidomide|mesh-list
5946585|NCT04753177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5946586|NCT04753177|Luteolytic Agents|luteolytic agents|mesh-ancestor
5946587|NCT04753177|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5946588|NCT04753177|Contraceptive Agents|contraceptive agents|mesh-ancestor
5946589|NCT04753177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5946590|NCT04753177|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5946591|NCT04753008|Dopamine|dopamine|mesh-list
5946592|NCT04753008|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5946593|NCT04753008|Sympathomimetics|sympathomimetics|mesh-ancestor
5946594|NCT04753008|Autonomic Agents|autonomic agents|mesh-ancestor
5946595|NCT04753008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5946596|NCT04753008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946597|NCT04753008|Dopamine Agents|dopamine agents|mesh-ancestor
5946598|NCT04753008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5946599|NCT04753008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5946600|NCT04753008|Protective Agents|protective agents|mesh-ancestor
5946601|NCT04753216|Bevacizumab|bevacizumab|mesh-list
5946602|NCT04753216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5946603|NCT04753216|Irinotecan|irinotecan|mesh-list
5946604|NCT04753216|Endothelial Growth Factors|endothelial growth factors|mesh-list
5946605|NCT04753216|Antibodies|antibodies|mesh-list
5946606|NCT04753216|Immunoglobulins|immunoglobulins|mesh-list
5946607|NCT04753216|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5946608|NCT04753216|Immunoglobulin G|immunoglobulin g|mesh-list
5946609|NCT04753216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5946610|NCT04753216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5946611|NCT04753216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5946612|NCT04753216|Growth Substances|growth substances|mesh-ancestor
5946613|NCT04753216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946614|NCT04753216|Growth Inhibitors|growth inhibitors|mesh-ancestor
5946615|NCT04753216|Immunologic Factors|immunologic factors|mesh-ancestor
5946616|NCT04753216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5946617|NCT04753216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5946618|NCT04753216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5946619|NCT04753216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5946620|NCT04753294|Diazepam|diazepam|mesh-list
5946621|NCT04753294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5946622|NCT04753294|Anticonvulsants|anticonvulsants|mesh-ancestor
5946623|NCT04753294|Antiemetics|antiemetics|mesh-ancestor
5946624|NCT04753294|Autonomic Agents|autonomic agents|mesh-ancestor
5946625|NCT04753294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5946626|NCT04753294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946627|NCT04753294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5946628|NCT04753294|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5946629|NCT04753294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5946630|NCT04753294|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5946631|NCT04753294|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5946632|NCT04753294|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5946633|NCT04753294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5946634|NCT04753294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5946635|NCT04753294|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5946636|NCT04753294|Anesthetics, General|anesthetics, general|mesh-ancestor
5946637|NCT04753294|Anesthetics|anesthetics|mesh-ancestor
5946638|NCT04753294|GABA Modulators|gaba modulators|mesh-ancestor
5946639|NCT04753294|GABA Agents|gaba agents|mesh-ancestor
5946640|NCT04753294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5946641|NCT04753294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967987|NCT04557137|Hormones|hormones|mesh-ancestor
5967988|NCT04557137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5967989|NCT04557137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967990|NCT04557202|Tamsulosin|tamsulosin|mesh-list
5967991|NCT04557202|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5967992|NCT04557202|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5967993|NCT04557202|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5967994|NCT04557202|Adrenergic Agents|adrenergic agents|mesh-ancestor
5967995|NCT04557202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5967996|NCT04557202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5967997|NCT04557202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5967998|NCT04557202|Urological Agents|urological agents|mesh-ancestor
5967999|NCT04557020|Gemcitabine|gemcitabine|mesh-list
5968000|NCT04557020|Cisplatin|cisplatin|mesh-list
5968001|NCT04557020|Antibodies|antibodies|mesh-list
5968002|NCT04557020|Immunologic Factors|immunologic factors|mesh-ancestor
5968003|NCT04557020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968004|NCT04557020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5946642|NCT04752852|Dexamethasone|dexamethasone|mesh-list
5946643|NCT04752852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5946644|NCT04752852|Antiemetics|antiemetics|mesh-ancestor
5946645|NCT04752852|Autonomic Agents|autonomic agents|mesh-ancestor
5946646|NCT04752852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5946647|NCT04752852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946648|NCT04752852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6517405|NCT00720850|Immunologic Factors|immunologic factors|mesh-ancestor
6517406|NCT00720850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517407|NCT00720850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6517408|NCT00720850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6517409|NCT00720850|Growth Substances|growth substances|mesh-ancestor
6517410|NCT00720850|Growth Inhibitors|growth inhibitors|mesh-ancestor
6517411|NCT00720850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6517412|NCT00720902|Hormones|hormones|mesh-list
6517413|NCT00720902|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
6517414|NCT00720902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6517415|NCT00720902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517416|NCT00720915|Anticoagulants|anticoagulants|mesh-list
6517417|NCT00720915|Fibrin fragment D|fibrin fragment d|mesh-list
5946649|NCT04752852|Glucocorticoids|glucocorticoids|mesh-ancestor
5946650|NCT04752852|Hormones|hormones|mesh-ancestor
5946651|NCT04752852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5720119|NCT03214536|Ropivacaine|ropivacaine|mesh-list
5720120|NCT03214536|Anesthetics|anesthetics|mesh-ancestor
5720121|NCT03214536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5720122|NCT03214536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720123|NCT03214536|Anesthetics, Local|anesthetics, local|mesh-ancestor
5720124|NCT03214536|Sensory System Agents|sensory system agents|mesh-ancestor
5720125|NCT03214536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5720126|NCT03214770|Calcium, Dietary|calcium, dietary|mesh-list
5720127|NCT03214770|Calcium|calcium|mesh-list
5720128|NCT03214770|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5720129|NCT03214770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720130|NCT03214770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5720131|NCT03214653|Propofol|propofol|mesh-list
5946652|NCT04752852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5946653|NCT04752852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5946654|NCT04752813|Vitamin K|vitamin k|mesh-list
5946655|NCT04752813|Vitamin K 1|vitamin k 1|mesh-list
5946656|NCT04752813|Temozolomide|temozolomide|mesh-list
5946657|NCT04752813|Vitamins|vitamins|mesh-ancestor
5946658|NCT04752813|Micronutrients|micronutrients|mesh-ancestor
5946659|NCT04752813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946660|NCT04752813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5946661|NCT04752813|Alkylating Agents|alkylating agents|mesh-ancestor
5946662|NCT04752813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5946663|NCT04752813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5946664|NCT04752813|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5946665|NCT04752813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5946666|NCT04752813|Hemostatics|hemostatics|mesh-ancestor
5946667|NCT04752813|Coagulants|coagulants|mesh-ancestor
5946668|NCT04752631|Tenecteplase|tenecteplase|mesh-list
5946669|NCT04752631|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5946670|NCT04752631|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5946671|NCT04752631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5946672|NCT04752540|Olorofim|olorofim|mesh-list
5946673|NCT04752540|Antifungal Agents|antifungal agents|mesh-ancestor
5946674|NCT04752540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5946675|NCT04752267|Clevudine|clevudine|mesh-list
5946676|NCT04752267|Antiviral Agents|antiviral agents|mesh-ancestor
5946677|NCT04752267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5946678|NCT04752384|Buprenorphine|buprenorphine|mesh-list
5946679|NCT04752384|Tramadol|tramadol|mesh-list
5946680|NCT04752384|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5946681|NCT04752384|Narcotics|narcotics|mesh-ancestor
5946682|NCT04752384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5946683|NCT04752384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946684|NCT04752384|Analgesics|analgesics|mesh-ancestor
5946685|NCT04752384|Sensory System Agents|sensory system agents|mesh-ancestor
5946686|NCT04752384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5946687|NCT04752384|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5946688|NCT04752163|Leucovorin|leucovorin|mesh-list
5946689|NCT04752163|Cytarabine|cytarabine|mesh-list
6517418|NCT00720915|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5720132|NCT03214653|Sevoflurane|sevoflurane|mesh-list
5946690|NCT04752163|Voriconazole|voriconazole|mesh-list
5946691|NCT04752163|Posaconazole|posaconazole|mesh-list
5946692|NCT04752163|Dexamethasone|dexamethasone|mesh-list
5946693|NCT04752163|Dexamethasone acetate|dexamethasone acetate|mesh-list
5946694|NCT04752163|Prednisone|prednisone|mesh-list
5946695|NCT04752163|Cortisone|cortisone|mesh-list
5946696|NCT04752163|Cyclophosphamide|cyclophosphamide|mesh-list
5946697|NCT04752163|Rituximab|rituximab|mesh-list
5946698|NCT04752163|Methotrexate|methotrexate|mesh-list
5946699|NCT04752163|Vincristine|vincristine|mesh-list
5946700|NCT04752163|Azacitidine|azacitidine|mesh-list
5946701|NCT04752163|Venetoclax|venetoclax|mesh-list
5946702|NCT04752163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5946703|NCT04752163|Antibodies|antibodies|mesh-list
5946704|NCT04752163|Immunoglobulins|immunoglobulins|mesh-list
5946705|NCT04752163|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5946706|NCT04752163|Lenograstim|lenograstim|mesh-list
5946707|NCT04752163|BB 1101|bb 1101|mesh-list
5946708|NCT04752163|Mesna|mesna|mesh-list
5946709|NCT04752163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5946710|NCT04752163|Immunologic Factors|immunologic factors|mesh-ancestor
5946711|NCT04752163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946712|NCT04752163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5946713|NCT04752163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5946714|NCT04752163|Alkylating Agents|alkylating agents|mesh-ancestor
5946715|NCT04752163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5946716|NCT04752163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5946717|NCT04752163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5946718|NCT04752163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5946719|NCT04752163|Antiemetics|antiemetics|mesh-ancestor
5946720|NCT04752163|Autonomic Agents|autonomic agents|mesh-ancestor
5946721|NCT04752163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5946722|NCT04752163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5946723|NCT04752163|Glucocorticoids|glucocorticoids|mesh-ancestor
5946724|NCT04752163|Hormones|hormones|mesh-ancestor
5946725|NCT04752163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5946726|NCT04752163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5946727|NCT04752163|Protease Inhibitors|protease inhibitors|mesh-ancestor
5946728|NCT04752163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5946729|NCT04752163|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5946730|NCT04752163|Abortifacient Agents|abortifacient agents|mesh-ancestor
5946731|NCT04752163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5946732|NCT04752163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5946733|NCT04752163|Antimetabolites|antimetabolites|mesh-ancestor
5946734|NCT04752163|Dermatologic Agents|dermatologic agents|mesh-ancestor
5946735|NCT04752163|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5946736|NCT04752163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5946737|NCT04752163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5946738|NCT04752163|Antiviral Agents|antiviral agents|mesh-ancestor
5946739|NCT04752163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5946740|NCT04752163|Antidotes|antidotes|mesh-ancestor
5946741|NCT04752163|Protective Agents|protective agents|mesh-ancestor
5946742|NCT04752163|Vitamin B Complex|vitamin b complex|mesh-ancestor
5946743|NCT04752163|Vitamins|vitamins|mesh-ancestor
5946744|NCT04752163|Micronutrients|micronutrients|mesh-ancestor
5946745|NCT04752163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5946746|NCT04752163|Tubulin Modulators|tubulin modulators|mesh-ancestor
5946747|NCT04752163|Antimitotic Agents|antimitotic agents|mesh-ancestor
5946748|NCT04752163|Mitosis Modulators|mitosis modulators|mesh-ancestor
5946749|NCT04752163|Antifungal Agents|antifungal agents|mesh-ancestor
5946750|NCT04752163|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5946751|NCT04752163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5946752|NCT04752163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5946753|NCT04752163|Hormone Antagonists|hormone antagonists|mesh-ancestor
5946754|NCT04752163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5946755|NCT04752163|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5946756|NCT04752163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5946757|NCT04752163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5946758|NCT04752059|Trastuzumab|trastuzumab|mesh-list
5946759|NCT04752059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5946760|NCT04752059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5946761|NCT04752111|Esmolol|esmolol|mesh-list
5946762|NCT04752111|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5946763|NCT04752111|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5946764|NCT04752111|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5946765|NCT04752111|Adrenergic Agents|adrenergic agents|mesh-ancestor
5946766|NCT04752111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5946767|NCT04752111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5946768|NCT04752111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946769|NCT04751994|Sorbitol|sorbitol|mesh-list
5946770|NCT04751994|Cathartics|cathartics|mesh-ancestor
5946771|NCT04751994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5946772|NCT04751955|Capecitabine|capecitabine|mesh-list
5946773|NCT04751955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5946774|NCT04751955|Antimetabolites|antimetabolites|mesh-ancestor
5946775|NCT04751955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5946776|NCT04751955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5946777|NCT04751851|Oxymetazoline|oxymetazoline|mesh-list
5946778|NCT04751851|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5946779|NCT04751851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5946780|NCT04751851|Adrenergic Agents|adrenergic agents|mesh-ancestor
5946781|NCT04751851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5946782|NCT04751851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5946783|NCT04751851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946784|NCT04751851|Sympathomimetics|sympathomimetics|mesh-ancestor
5946785|NCT04751851|Autonomic Agents|autonomic agents|mesh-ancestor
5946786|NCT04751851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5946787|NCT04751851|Nasal Decongestants|nasal decongestants|mesh-ancestor
5946788|NCT04751851|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5946789|NCT04751851|Respiratory System Agents|respiratory system agents|mesh-ancestor
5946790|NCT04752033|Morphine|morphine|mesh-list
5946791|NCT04752033|Hydromorphone|hydromorphone|mesh-list
5946792|NCT04752033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5946793|NCT04752033|Narcotics|narcotics|mesh-ancestor
5946794|NCT04752033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5946795|NCT04752033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946796|NCT04752033|Analgesics|analgesics|mesh-ancestor
5946797|NCT04752033|Sensory System Agents|sensory system agents|mesh-ancestor
5946798|NCT04752033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5946799|NCT04751929|Atezolizumab|atezolizumab|mesh-list
5946800|NCT04751929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5946801|NCT04751500|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5946802|NCT04751500|Metronidazole|metronidazole|mesh-list
5946803|NCT04751500|Clindamycin|clindamycin|mesh-list
5946804|NCT04751500|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5946805|NCT04751500|Misoprostol|misoprostol|mesh-list
5946806|NCT04751500|Mifepristone|mifepristone|mesh-list
5946807|NCT04751500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5946808|NCT04751500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5946809|NCT04751500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5946810|NCT04751500|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5946811|NCT04751500|Abortifacient Agents|abortifacient agents|mesh-ancestor
5946812|NCT04751500|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5720133|NCT03214653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5720134|NCT03214653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5720135|NCT03214653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946813|NCT04751500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946814|NCT04751500|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5946815|NCT04751500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5946816|NCT04751500|Oxytocics|oxytocics|mesh-ancestor
5946817|NCT04751500|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5946818|NCT04751500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5946819|NCT04751500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5946820|NCT04751500|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5946821|NCT04751500|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5946822|NCT04751500|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5946823|NCT04751500|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5946824|NCT04751500|Contraceptive Agents|contraceptive agents|mesh-ancestor
5946825|NCT04751500|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5946826|NCT04751500|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5946827|NCT04751500|Hormone Antagonists|hormone antagonists|mesh-ancestor
5946828|NCT04751500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5946829|NCT04751500|Luteolytic Agents|luteolytic agents|mesh-ancestor
5946830|NCT04751500|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5946831|NCT04751500|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5946832|NCT04751500|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5946833|NCT04751812|Analgesics, Opioid|analgesics, opioid|mesh-list
5946834|NCT04751812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6517419|NCT00720915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5720136|NCT03214653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5720137|NCT03214653|Anesthetics, General|anesthetics, general|mesh-ancestor
5720138|NCT03214653|Anesthetics|anesthetics|mesh-ancestor
5720139|NCT03214653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5720140|NCT03214653|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5720141|NCT03214627|Iron|iron|mesh-list
5946835|NCT04751812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946836|NCT04751812|Narcotics|narcotics|mesh-ancestor
5946837|NCT04751812|Analgesics|analgesics|mesh-ancestor
5946838|NCT04751812|Sensory System Agents|sensory system agents|mesh-ancestor
5946839|NCT04751812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5946840|NCT04751669|Trace Elements|trace elements|mesh-list
5946841|NCT04751669|Micronutrients|micronutrients|mesh-list
5946842|NCT04751669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946843|NCT04751344|Bupivacaine|bupivacaine|mesh-list
5946844|NCT04751344|Anesthetics, Local|anesthetics, local|mesh-ancestor
5946845|NCT04751344|Anesthetics|anesthetics|mesh-ancestor
5946846|NCT04751344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5946847|NCT04751344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946848|NCT04751344|Sensory System Agents|sensory system agents|mesh-ancestor
5946849|NCT04751344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5946850|NCT04751227|Modafinil|modafinil|mesh-list
5946851|NCT04751227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5946852|NCT04751227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946853|NCT04751227|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
5946854|NCT04751227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5946855|NCT04751227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5946856|NCT04751227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5946857|NCT04751318|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5946858|NCT04751318|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5946859|NCT04751318|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5946860|NCT04751318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5946861|NCT04751318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5946862|NCT04751318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5946863|NCT04751318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720142|NCT03214627|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
5720143|NCT03214627|Hematinics|hematinics|mesh-list
5720144|NCT03214627|Trace Elements|trace elements|mesh-ancestor
5720145|NCT03214627|Micronutrients|micronutrients|mesh-ancestor
5720146|NCT03214627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720147|NCT03214562|Cytarabine|cytarabine|mesh-list
5946864|NCT04751318|Analgesics|analgesics|mesh-ancestor
5946865|NCT04751318|Sensory System Agents|sensory system agents|mesh-ancestor
5946866|NCT04751318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5946867|NCT04751318|Antidepressive Agents|antidepressive agents|mesh-ancestor
5946868|NCT04751318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5946869|NCT04751318|Dopamine Agents|dopamine agents|mesh-ancestor
5946870|NCT04751604|Niacinamide|niacinamide|mesh-list
5946871|NCT04751604|Niacin|niacin|mesh-list
5946872|NCT04751604|Nicotinic Acids|nicotinic acids|mesh-list
5946873|NCT04751604|Vitamin B Complex|vitamin b complex|mesh-ancestor
5946874|NCT04751604|Vitamins|vitamins|mesh-ancestor
5946875|NCT04751604|Micronutrients|micronutrients|mesh-ancestor
5946876|NCT04751604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946877|NCT04751604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5946878|NCT04751604|Antimetabolites|antimetabolites|mesh-ancestor
5946879|NCT04751604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5946880|NCT04751604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5946881|NCT04751604|Vasodilator Agents|vasodilator agents|mesh-ancestor
5946882|NCT04751175|Dexamethasone|dexamethasone|mesh-list
5946883|NCT04751175|Ketamine|ketamine|mesh-list
5946884|NCT04751175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5946885|NCT04751175|Antiemetics|antiemetics|mesh-ancestor
5946886|NCT04751175|Autonomic Agents|autonomic agents|mesh-ancestor
5946887|NCT04751175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5946888|NCT04751175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946889|NCT04751175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5946890|NCT04751175|Glucocorticoids|glucocorticoids|mesh-ancestor
5946891|NCT04751175|Hormones|hormones|mesh-ancestor
5946892|NCT04751175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5946893|NCT04751175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5946894|NCT04751175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5946895|NCT04751175|Analgesics|analgesics|mesh-ancestor
5720148|NCT03214562|Fludarabine|fludarabine|mesh-list
5720149|NCT03214562|Venetoclax|venetoclax|mesh-list
5720150|NCT03214562|Idarubicin|idarubicin|mesh-list
5720151|NCT03214562|Lenograstim|lenograstim|mesh-list
5720152|NCT03214562|Sargramostim|sargramostim|mesh-list
5720153|NCT03214562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5720154|NCT03214562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5720155|NCT03214562|Antimetabolites|antimetabolites|mesh-ancestor
5946896|NCT04751175|Sensory System Agents|sensory system agents|mesh-ancestor
5722181|NCT03200886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946897|NCT04751175|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5946898|NCT04751175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5946899|NCT04751175|Anesthetics, General|anesthetics, general|mesh-ancestor
5946900|NCT04751175|Anesthetics|anesthetics|mesh-ancestor
5946901|NCT04751175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5946902|NCT04751175|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5946903|NCT04751175|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5946904|NCT04751175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5946905|NCT04751175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968005|NCT04557020|Antimetabolites|antimetabolites|mesh-ancestor
5968006|NCT04557020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968007|NCT04557020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5968008|NCT04557020|Antiviral Agents|antiviral agents|mesh-ancestor
5968009|NCT04557020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5968010|NCT04557020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5968011|NCT04557020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5968012|NCT04556929|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5968013|NCT04556929|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5968014|NCT04556929|Dermatologic Agents|dermatologic agents|mesh-ancestor
5968015|NCT04557007|Pembrolizumab|pembrolizumab|mesh-list
5968016|NCT04557007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5968017|NCT04557007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5968018|NCT04556760|Prednisolone|prednisolone|mesh-list
5968019|NCT04556760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5968020|NCT04556760|Glucocorticoids|glucocorticoids|mesh-ancestor
5968021|NCT04556760|Hormones|hormones|mesh-ancestor
5968022|NCT04556760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5968023|NCT04556760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968024|NCT04556760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5968025|NCT04556760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5968026|NCT04556708|Chlorhexidine|chlorhexidine|mesh-list
5968027|NCT04556708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5968028|NCT04556708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5968029|NCT04556708|Disinfectants|disinfectants|mesh-ancestor
5968030|NCT04556617|Prednisone|prednisone|mesh-list
5968031|NCT04556617|Olaparib|olaparib|mesh-list
5968032|NCT04556617|Abiraterone Acetate|abiraterone acetate|mesh-list
5968033|NCT04556617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5968034|NCT04556617|Glucocorticoids|glucocorticoids|mesh-ancestor
5968035|NCT04556617|Hormones|hormones|mesh-ancestor
5968036|NCT04556617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5968037|NCT04556617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968038|NCT04556617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5968039|NCT04556617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5968040|NCT04556617|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5968041|NCT04556617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5968042|NCT04556617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968043|NCT04556617|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5968044|NCT04556617|Hormone Antagonists|hormone antagonists|mesh-ancestor
5968045|NCT04556617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5968046|NCT04556110|Perindopril|perindopril|mesh-list
5968047|NCT04556110|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5968048|NCT04556110|Protease Inhibitors|protease inhibitors|mesh-ancestor
5968049|NCT04556110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5968050|NCT04556110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968051|NCT04556110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5968052|NCT04556136|Vitamin D|vitamin d|mesh-list
5968053|NCT04556136|Vitamins|vitamins|mesh-ancestor
5968054|NCT04556136|Micronutrients|micronutrients|mesh-ancestor
5968055|NCT04556136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968056|NCT04556136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5968057|NCT04556084|Blinatumomab|blinatumomab|mesh-list
5968058|NCT04556084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5968059|NCT04556058|Perindopril|perindopril|mesh-list
5968060|NCT04556058|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5968061|NCT04556058|Protease Inhibitors|protease inhibitors|mesh-ancestor
5968062|NCT04556058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5968063|NCT04556058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968064|NCT04556058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5968065|NCT04556279|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
5968066|NCT04556279|Hormone Antagonists|hormone antagonists|mesh-ancestor
5968067|NCT04556279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5968068|NCT04556279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946906|NCT04751188|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
5946907|NCT04751188|Bezafibrate|bezafibrate|mesh-list
5946908|NCT04751188|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5946909|NCT04751188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5946910|NCT04751188|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5946911|NCT04751188|Antimetabolites|antimetabolites|mesh-ancestor
5946912|NCT04751188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517420|NCT00720915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517421|NCT00720915|Hemostatics|hemostatics|mesh-ancestor
6517422|NCT00720915|Coagulants|coagulants|mesh-ancestor
6517423|NCT00721032|Amiodarone|amiodarone|mesh-list
6517424|NCT00721032|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5946913|NCT04751188|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5946914|NCT04751084|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
5946915|NCT04751084|Parasympatholytics|parasympatholytics|mesh-ancestor
5946916|NCT04751084|Autonomic Agents|autonomic agents|mesh-ancestor
5946917|NCT04751084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5946918|NCT04751084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946919|NCT04751084|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5946920|NCT04751084|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5946921|NCT04751084|Cholinergic Agents|cholinergic agents|mesh-ancestor
5946922|NCT04751084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5946923|NCT04751084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5946924|NCT04751136|Cerebrolysin|cerebrolysin|mesh-list
5946925|NCT04751136|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5946926|NCT04751136|Protective Agents|protective agents|mesh-ancestor
5946927|NCT04751136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946928|NCT04751136|Nootropic Agents|nootropic agents|mesh-ancestor
5946929|NCT04750902|Listerine|listerine|mesh-list
5946930|NCT04750902|Fluorides|fluorides|mesh-list
5946931|NCT04750902|Sodium Fluoride|sodium fluoride|mesh-list
5946932|NCT04750902|Cariostatic Agents|cariostatic agents|mesh-ancestor
5946933|NCT04750902|Protective Agents|protective agents|mesh-ancestor
5946934|NCT04750902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946935|NCT04750902|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5946936|NCT04750902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5946937|NCT04750772|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5946938|NCT04750772|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5946939|NCT04750772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5946940|NCT04750967|Lidocaine|lidocaine|mesh-list
5946941|NCT04750967|Amitriptyline|amitriptyline|mesh-list
5946942|NCT04750967|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
5946943|NCT04750967|Anesthetics, Local|anesthetics, local|mesh-ancestor
5946944|NCT04750967|Anesthetics|anesthetics|mesh-ancestor
5946945|NCT04750967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5946946|NCT04750967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946947|NCT04750967|Sensory System Agents|sensory system agents|mesh-ancestor
5946948|NCT04750967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5946949|NCT04750967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5946950|NCT04750967|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5946951|NCT04750967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5946952|NCT04750967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5946953|NCT04750967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5946954|NCT04750967|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5946955|NCT04750967|Antidepressive Agents|antidepressive agents|mesh-ancestor
5946956|NCT04750967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5946957|NCT04750967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5946958|NCT04750967|Analgesics|analgesics|mesh-ancestor
5946959|NCT04750967|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5946960|NCT04750967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5946961|NCT04750967|Adrenergic Agents|adrenergic agents|mesh-ancestor
5946962|NCT04750967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5946963|NCT04750967|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5946964|NCT04750967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5946965|NCT04750655|Moxifloxacin|moxifloxacin|mesh-list
5946966|NCT04750655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5946967|NCT04750655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5946968|NCT04750655|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5946969|NCT04750655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5946970|NCT04750655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5946971|NCT04750655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5946972|NCT04750655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5946973|NCT04750707|Hydroxyurea|hydroxyurea|mesh-list
5946974|NCT04750707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6517425|NCT00721032|Vasodilator Agents|vasodilator agents|mesh-ancestor
5946975|NCT04750707|Antisickling Agents|antisickling agents|mesh-ancestor
5946976|NCT04750707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5946977|NCT04750707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5946978|NCT04750707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5946979|NCT04750603|Fluticasone|fluticasone|mesh-list
5946980|NCT04750603|Xhance|xhance|mesh-list
5946981|NCT04750603|Albuterol|albuterol|mesh-list
5946982|NCT04750603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5946983|NCT04750603|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5946984|NCT04750603|Autonomic Agents|autonomic agents|mesh-ancestor
5946985|NCT04750603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5946986|NCT04750603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5946987|NCT04750603|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5946988|NCT04750603|Respiratory System Agents|respiratory system agents|mesh-ancestor
5946989|NCT04750603|Dermatologic Agents|dermatologic agents|mesh-ancestor
5946990|NCT04750603|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5946991|NCT04750603|Tocolytic Agents|tocolytic agents|mesh-ancestor
5946992|NCT04750603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5946993|NCT04750603|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5946994|NCT04750603|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5946995|NCT04750603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5946996|NCT04750603|Adrenergic Agents|adrenergic agents|mesh-ancestor
5946997|NCT04750603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5946998|NCT04750603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5946999|NCT04750473|Edetic Acid|edetic acid|mesh-list
5947000|NCT04750473|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5947001|NCT04750473|Chelating Agents|chelating agents|mesh-ancestor
5947002|NCT04750473|Sequestering Agents|sequestering agents|mesh-ancestor
5947003|NCT04750473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947004|NCT04750473|Anticoagulants|anticoagulants|mesh-ancestor
5947005|NCT04750473|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5947006|NCT04750473|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5947007|NCT04750460|Teriparatide|teriparatide|mesh-list
5947008|NCT04750460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5947009|NCT04750460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947010|NCT04750460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5947011|NCT04750616|Niacinamide|niacinamide|mesh-list
5947012|NCT04750616|Niacin|niacin|mesh-list
5947013|NCT04750616|Nicotinic Acids|nicotinic acids|mesh-list
5947014|NCT04750616|Vitamin B Complex|vitamin b complex|mesh-ancestor
5947015|NCT04750616|Vitamins|vitamins|mesh-ancestor
5947016|NCT04750616|Micronutrients|micronutrients|mesh-ancestor
5947017|NCT04750616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947018|NCT04750616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5947019|NCT04750616|Antimetabolites|antimetabolites|mesh-ancestor
5947020|NCT04750616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947021|NCT04750616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5947022|NCT04750616|Vasodilator Agents|vasodilator agents|mesh-ancestor
5947023|NCT04750317|Tofacitinib|tofacitinib|mesh-list
5947024|NCT04750317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5947025|NCT04750317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5947026|NCT04750317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5720156|NCT03214562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5720157|NCT03214562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5720158|NCT03214562|Immunologic Factors|immunologic factors|mesh-ancestor
5720159|NCT03214562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720160|NCT03214562|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5720161|NCT03214562|Antiviral Agents|antiviral agents|mesh-ancestor
5720162|NCT03214562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5720163|NCT03214562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5720164|NCT03214562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5720165|NCT03214562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5720166|NCT03214562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5720167|NCT03214510|Fentanyl|fentanyl|mesh-list
5947027|NCT04750382|Gemcitabine|gemcitabine|mesh-list
5947028|NCT04750382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5947029|NCT04750382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5947030|NCT04750382|Antimetabolites|antimetabolites|mesh-ancestor
5947031|NCT04750382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947032|NCT04750382|Antiviral Agents|antiviral agents|mesh-ancestor
5947033|NCT04750382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5947034|NCT04750382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5947035|NCT04750382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5947036|NCT04750382|Immunologic Factors|immunologic factors|mesh-ancestor
5947037|NCT04750382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720168|NCT03214510|Hydromorphone|hydromorphone|mesh-list
5720169|NCT03214510|Bupivacaine|bupivacaine|mesh-list
5720170|NCT03214510|Anesthetics, Local|anesthetics, local|mesh-ancestor
5720171|NCT03214510|Anesthetics|anesthetics|mesh-ancestor
5720172|NCT03214510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5720173|NCT03214510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720174|NCT03214510|Sensory System Agents|sensory system agents|mesh-ancestor
5720175|NCT03214510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5720176|NCT03214510|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5720177|NCT03214510|Narcotics|narcotics|mesh-ancestor
5720178|NCT03214510|Analgesics|analgesics|mesh-ancestor
5720179|NCT03214510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5720180|NCT03214510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5720181|NCT03214510|Anesthetics, General|anesthetics, general|mesh-ancestor
5720182|NCT03214354|Sirolimus|sirolimus|mesh-list
5720183|NCT03214354|Alemtuzumab|alemtuzumab|mesh-list
5720184|NCT03214354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5720185|NCT03214354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5720186|NCT03214354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5720187|NCT03214354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5720188|NCT03214354|Antifungal Agents|antifungal agents|mesh-ancestor
5720189|NCT03214354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5720190|NCT03214354|Immunologic Factors|immunologic factors|mesh-ancestor
5720191|NCT03214354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720192|NCT03214354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5720193|NCT03214393|Antibodies|antibodies|mesh-list
5720194|NCT03214393|Immunologic Factors|immunologic factors|mesh-ancestor
5720195|NCT03214393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720196|NCT03214172|Rivaroxaban|rivaroxaban|mesh-list
5720197|NCT03214172|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5720198|NCT03214172|Antithrombins|antithrombins|mesh-ancestor
5720199|NCT03214172|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5720200|NCT03214172|Protease Inhibitors|protease inhibitors|mesh-ancestor
5720201|NCT03214172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5720202|NCT03214172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5720203|NCT03214172|Anticoagulants|anticoagulants|mesh-ancestor
5720204|NCT03214003|Cisplatin|cisplatin|mesh-list
5720205|NCT03214003|Etoposide|etoposide|mesh-list
5720206|NCT03214003|Etoposide phosphate|etoposide phosphate|mesh-list
5720207|NCT03214003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5720208|NCT03214003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5720209|NCT03214003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5720210|NCT03214003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5720211|NCT03214003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5720212|NCT03214003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5720213|NCT03214159|Ritonavir|ritonavir|mesh-list
5720214|NCT03214159|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5720215|NCT03214159|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5720216|NCT03214159|Protease Inhibitors|protease inhibitors|mesh-ancestor
5720217|NCT03214159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5720218|NCT03214159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5720219|NCT03214159|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5720220|NCT03214159|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5720221|NCT03214159|Antiviral Agents|antiviral agents|mesh-ancestor
5720222|NCT03214159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5720223|NCT03214159|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5720224|NCT03214159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5720225|NCT03214302|Tenofovir|tenofovir|mesh-list
5720226|NCT03214302|Antiviral Agents|antiviral agents|mesh-ancestor
5720227|NCT03214302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5720228|NCT03214302|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5720229|NCT03214302|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5720230|NCT03214302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5720231|NCT03214302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5720232|NCT03214302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5720233|NCT03214302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5720234|NCT03214055|Mannitol|mannitol|mesh-list
5720235|NCT03214055|Diuretics|diuretics|mesh-list
5720236|NCT03214055|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5720237|NCT03214055|Natriuretic Agents|natriuretic agents|mesh-ancestor
5720238|NCT03214055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720239|NCT03213964|Interleukin-2|interleukin-2|mesh-list
5720240|NCT03213964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5720241|NCT03213964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5720242|NCT03213964|Analgesics|analgesics|mesh-ancestor
5720243|NCT03213964|Sensory System Agents|sensory system agents|mesh-ancestor
5720244|NCT03213964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5720245|NCT03213964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720246|NCT03213977|Prednisone|prednisone|mesh-list
5720247|NCT03213977|Cyclophosphamide|cyclophosphamide|mesh-list
5720248|NCT03213977|Doxorubicin|doxorubicin|mesh-list
5720249|NCT03213977|Etoposide|etoposide|mesh-list
5720250|NCT03213977|Vincristine|vincristine|mesh-list
5720251|NCT03213977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5720252|NCT03213977|Immunologic Factors|immunologic factors|mesh-ancestor
5720253|NCT03213977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720254|NCT03213977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5720255|NCT03213977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5720256|NCT03213977|Alkylating Agents|alkylating agents|mesh-ancestor
5720257|NCT03213977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5720258|NCT03213977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5720259|NCT03213977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5720260|NCT03213977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5720261|NCT03213977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5720262|NCT03213977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5720263|NCT03213977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5720264|NCT03213977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5720265|NCT03213977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5720266|NCT03213977|Glucocorticoids|glucocorticoids|mesh-ancestor
5720267|NCT03213977|Hormones|hormones|mesh-ancestor
5720268|NCT03213977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5720269|NCT03213977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5720270|NCT03213977|Tubulin Modulators|tubulin modulators|mesh-ancestor
5720271|NCT03213977|Antimitotic Agents|antimitotic agents|mesh-ancestor
5720272|NCT03213977|Mitosis Modulators|mitosis modulators|mesh-ancestor
5720273|NCT03213834|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5720274|NCT03213834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5720275|NCT03213834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5720276|NCT03213834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5720277|NCT03213886|Vitamin D|vitamin d|mesh-list
5720278|NCT03213886|Calcifediol|calcifediol|mesh-list
5720279|NCT03213886|Vitamins|vitamins|mesh-ancestor
5720280|NCT03213886|Micronutrients|micronutrients|mesh-ancestor
5720281|NCT03213886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720282|NCT03213886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5720283|NCT03213769|Ubiquinone|ubiquinone|mesh-list
5720284|NCT03213769|Coenzyme Q10|coenzyme q10|mesh-list
5720285|NCT03213769|Micronutrients|micronutrients|mesh-ancestor
5720286|NCT03213769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720287|NCT03213769|Vitamins|vitamins|mesh-ancestor
5720288|NCT03213743|Dexmedetomidine|dexmedetomidine|mesh-list
5720289|NCT03213743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5720290|NCT03213743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5720291|NCT03213743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720292|NCT03213743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5720293|NCT03213743|Analgesics|analgesics|mesh-ancestor
5720294|NCT03213743|Sensory System Agents|sensory system agents|mesh-ancestor
5720295|NCT03213743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5720296|NCT03213743|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5720297|NCT03213743|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5720298|NCT03213743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5720299|NCT03213743|Adrenergic Agents|adrenergic agents|mesh-ancestor
5720300|NCT03213743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5720301|NCT03213743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5720302|NCT03213444|Oxaliplatin|oxaliplatin|mesh-list
5720303|NCT03213444|Fluorouracil|fluorouracil|mesh-list
5720304|NCT03213444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5720305|NCT03213444|Antimetabolites|antimetabolites|mesh-ancestor
5720306|NCT03213444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5720307|NCT03213444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5720308|NCT03213444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5720309|NCT03213444|Immunologic Factors|immunologic factors|mesh-ancestor
5720310|NCT03213444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720311|NCT03213639|Esomeprazole|esomeprazole|mesh-list
5720312|NCT03213639|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5720313|NCT03213639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5720314|NCT03213639|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5720315|NCT03213639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5720316|NCT03213639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5720317|NCT03213548|Daminozide|daminozide|mesh-list
5720318|NCT03213548|Plant Growth Regulators|plant growth regulators|mesh-ancestor
5720319|NCT03213548|Growth Substances|growth substances|mesh-ancestor
5720320|NCT03213548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720321|NCT03213587|Apatinib|apatinib|mesh-list
5720322|NCT03213587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5720323|NCT03213587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5720324|NCT03213587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5720325|NCT03213587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5720326|NCT03213392|Anesthetics|anesthetics|mesh-list
5720327|NCT03213392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5720328|NCT03213392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720329|NCT03213353|Acetaminophen|acetaminophen|mesh-list
5720330|NCT03213353|Phenylpropanolamine|phenylpropanolamine|mesh-list
5720331|NCT03213353|Phenylephrine|phenylephrine|mesh-list
5720332|NCT03213353|Oxymetazoline|oxymetazoline|mesh-list
5720333|NCT03213353|Guaifenesin|guaifenesin|mesh-list
5720334|NCT03213353|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
5720335|NCT03213353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5720336|NCT03213353|Analgesics|analgesics|mesh-ancestor
5720337|NCT03213353|Sensory System Agents|sensory system agents|mesh-ancestor
5720338|NCT03213353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5720339|NCT03213353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720340|NCT03213353|Antipyretics|antipyretics|mesh-ancestor
5720341|NCT03213353|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5720342|NCT03213353|Mydriatics|mydriatics|mesh-ancestor
5720343|NCT03213353|Autonomic Agents|autonomic agents|mesh-ancestor
5720344|NCT03213353|Sympathomimetics|sympathomimetics|mesh-ancestor
5720345|NCT03213353|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5720346|NCT03213353|Nasal Decongestants|nasal decongestants|mesh-ancestor
5720347|NCT03213353|Respiratory System Agents|respiratory system agents|mesh-ancestor
5720348|NCT03213353|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5720349|NCT03213353|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5720350|NCT03213353|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5720351|NCT03213353|Adrenergic Agents|adrenergic agents|mesh-ancestor
5720352|NCT03213353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5720353|NCT03213353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5720354|NCT03213353|Protective Agents|protective agents|mesh-ancestor
5720355|NCT03213353|Expectorants|expectorants|mesh-ancestor
5720356|NCT03213353|Appetite Depressants|appetite depressants|mesh-ancestor
5720357|NCT03213353|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5720358|NCT03213249|Gentamicins|gentamicins|mesh-list
5720359|NCT03213249|Cefazolin|cefazolin|mesh-list
5720360|NCT03213249|Bacitracin|bacitracin|mesh-list
5720361|NCT03213249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5720362|NCT03213249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5720363|NCT03213249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5720364|NCT03213249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5720365|NCT03213249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5720366|NCT03213249|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5720367|NCT03213158|Ixazomib|ixazomib|mesh-list
5720368|NCT03213158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5720369|NCT03213158|Protease Inhibitors|protease inhibitors|mesh-ancestor
5720370|NCT03213158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5720371|NCT03213158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5720372|NCT03213145|Rifampin|rifampin|mesh-list
5720373|NCT03213145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5720374|NCT03213145|Antitubercular Agents|antitubercular agents|mesh-ancestor
5720375|NCT03213145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5720376|NCT03213145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5720377|NCT03213145|Leprostatic Agents|leprostatic agents|mesh-ancestor
5720378|NCT03213145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5720379|NCT03213145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5720380|NCT03213145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5720381|NCT03213145|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5720382|NCT03213145|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5720383|NCT03213145|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5720384|NCT03213145|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5720385|NCT03213145|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5720386|NCT03213145|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5722182|NCT03200886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5722183|NCT03200886|Immunologic Factors|immunologic factors|mesh-ancestor
5722184|NCT03200886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5722185|NCT03200886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5720387|NCT03213041|Carboplatin|carboplatin|mesh-list
5720388|NCT03213041|Pembrolizumab|pembrolizumab|mesh-list
5720389|NCT03213041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5720390|NCT03213041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5720391|NCT03212729|Anti-Infective Agents|anti-infective agents|mesh-list
5720392|NCT03212729|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5720393|NCT03212716|Oseltamivir|oseltamivir|mesh-list
5720394|NCT03212716|Diltiazem|diltiazem|mesh-list
5720395|NCT03212716|Antiviral Agents|antiviral agents|mesh-ancestor
5720396|NCT03212716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5720397|NCT03212716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5720398|NCT03212716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5720399|NCT03212716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5720400|NCT03212716|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5720401|NCT03212716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5720402|NCT03212716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5720403|NCT03212716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720404|NCT03212716|Vasodilator Agents|vasodilator agents|mesh-ancestor
5720405|NCT03212807|Lenalidomide|lenalidomide|mesh-list
5720406|NCT03212807|Durvalumab|durvalumab|mesh-list
5720407|NCT03212807|Immunologic Factors|immunologic factors|mesh-ancestor
5720408|NCT03212807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720409|NCT03212807|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5720410|NCT03212807|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5720411|NCT03212807|Growth Substances|growth substances|mesh-ancestor
5720412|NCT03212807|Growth Inhibitors|growth inhibitors|mesh-ancestor
5720413|NCT03212807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5720414|NCT03212807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5720415|NCT03213002|Capecitabine|capecitabine|mesh-list
5720416|NCT03213002|Temozolomide|temozolomide|mesh-list
5720417|NCT03213002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5720418|NCT03213002|Antimetabolites|antimetabolites|mesh-ancestor
5720419|NCT03213002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5720420|NCT03213002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5720421|NCT03213002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5720422|NCT03213002|Alkylating Agents|alkylating agents|mesh-ancestor
5720423|NCT03212651|Pembrolizumab|pembrolizumab|mesh-list
5720424|NCT03212651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5720425|NCT03212651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5720426|NCT03212742|Temozolomide|temozolomide|mesh-list
5720427|NCT03212742|Olaparib|olaparib|mesh-list
5720428|NCT03212742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5720429|NCT03212742|Alkylating Agents|alkylating agents|mesh-ancestor
5720430|NCT03212742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5720431|NCT03212742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5720432|NCT03212742|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5720433|NCT03212742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5720434|NCT03212820|Methamphetamine|methamphetamine|mesh-list
5720435|NCT03212820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5720436|NCT03212820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720437|NCT03212820|Sympathomimetics|sympathomimetics|mesh-ancestor
5720438|NCT03212820|Autonomic Agents|autonomic agents|mesh-ancestor
5720439|NCT03212820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5720440|NCT03212820|Dopamine Agents|dopamine agents|mesh-ancestor
5720441|NCT03212820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5720442|NCT03212820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5720443|NCT03212820|Adrenergic Agents|adrenergic agents|mesh-ancestor
5720444|NCT03212820|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5720445|NCT03212820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5720446|NCT03212820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5720447|NCT03212820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5720448|NCT03212833|Insulin|insulin|mesh-list
5720449|NCT03212833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5720450|NCT03212833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720451|NCT03212677|Iron|iron|mesh-list
5720452|NCT03212677|Trace Elements|trace elements|mesh-ancestor
5720453|NCT03212677|Micronutrients|micronutrients|mesh-ancestor
5720454|NCT03212677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720455|NCT03212989|Vorinostat|vorinostat|mesh-list
5720456|NCT03212989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5720457|NCT03212989|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5720458|NCT03212989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5722186|NCT03200600|Dexamethasone|dexamethasone|mesh-list
5947038|NCT04749940|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
5720459|NCT03212989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5720460|NCT03212950|Insulin|insulin|mesh-list
5720461|NCT03212950|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5720462|NCT03212950|Insulin Aspart|insulin aspart|mesh-list
5720463|NCT03212950|Insulin, Long-Acting|insulin, long-acting|mesh-list
5720464|NCT03212950|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
5720465|NCT03212950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5720466|NCT03212950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720467|NCT03212781|Ferrous fumarate|ferrous fumarate|mesh-list
5720468|NCT03212781|Dextrans|dextrans|mesh-list
5720469|NCT03212781|Iron-Dextran Complex|iron-dextran complex|mesh-list
5720470|NCT03212781|Anticoagulants|anticoagulants|mesh-ancestor
5720471|NCT03212781|Plasma Substitutes|plasma substitutes|mesh-ancestor
5720472|NCT03212781|Blood Substitutes|blood substitutes|mesh-ancestor
5720473|NCT03212781|Trace Elements|trace elements|mesh-ancestor
5720474|NCT03212781|Micronutrients|micronutrients|mesh-ancestor
5720475|NCT03212781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720476|NCT03212781|Hematinics|hematinics|mesh-ancestor
5720477|NCT03212937|Carboplatin|carboplatin|mesh-list
5720478|NCT03212937|Etoposide|etoposide|mesh-list
5720479|NCT03212937|Ifosfamide|ifosfamide|mesh-list
5720480|NCT03212937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5720481|NCT03212937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5720482|NCT03212937|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5720483|NCT03212937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5720484|NCT03212937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5720485|NCT03212937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5720486|NCT03212937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5720487|NCT03212937|Alkylating Agents|alkylating agents|mesh-ancestor
5720488|NCT03212755|Immunoglobulins|immunoglobulins|mesh-list
5720489|NCT03212755|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5720490|NCT03212755|Antibodies|antibodies|mesh-list
5720491|NCT03212755|Immunoglobulin G|immunoglobulin g|mesh-list
5720492|NCT03212755|Immunologic Factors|immunologic factors|mesh-ancestor
5720493|NCT03212755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720494|NCT03212599|Disulfiram|disulfiram|mesh-list
5720495|NCT03212599|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5720496|NCT03212599|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
5720497|NCT03212599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5720498|NCT03212599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5720499|NCT03212352|Misoprostol|misoprostol|mesh-list
5720500|NCT03212352|Mifepristone|mifepristone|mesh-list
5720501|NCT03212352|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5720502|NCT03212352|Abortifacient Agents|abortifacient agents|mesh-ancestor
5720503|NCT03212352|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5720504|NCT03212352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720505|NCT03212352|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5720506|NCT03212352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5720507|NCT03212352|Oxytocics|oxytocics|mesh-ancestor
5720508|NCT03212352|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5720509|NCT03212352|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5720510|NCT03212352|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5720511|NCT03212352|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5720512|NCT03212352|Contraceptive Agents|contraceptive agents|mesh-ancestor
5720513|NCT03212352|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5720514|NCT03212352|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5720515|NCT03212352|Hormone Antagonists|hormone antagonists|mesh-ancestor
5720516|NCT03212352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5720517|NCT03212352|Luteolytic Agents|luteolytic agents|mesh-ancestor
5720518|NCT03212352|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5720519|NCT03212352|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5720520|NCT03212456|Analgesics, Opioid|analgesics, opioid|mesh-list
5720521|NCT03212456|Ropivacaine|ropivacaine|mesh-list
5720522|NCT03212456|Anesthetics, Local|anesthetics, local|mesh-ancestor
5720523|NCT03212456|Anesthetics|anesthetics|mesh-ancestor
5720524|NCT03212456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5720525|NCT03212456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720526|NCT03212456|Sensory System Agents|sensory system agents|mesh-ancestor
5720527|NCT03212456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5720528|NCT03212456|Narcotics|narcotics|mesh-ancestor
5720529|NCT03212456|Analgesics|analgesics|mesh-ancestor
5720530|NCT03212495|Neostigmine|neostigmine|mesh-list
5720531|NCT03212495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720532|NCT03212495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5720533|NCT03212495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5720534|NCT03212495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5720535|NCT03212495|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5720536|NCT03212495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5720537|NCT03212495|Cholinergic Agents|cholinergic agents|mesh-ancestor
5720538|NCT03212495|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5720539|NCT03212495|Autonomic Agents|autonomic agents|mesh-ancestor
5720540|NCT03212469|Durvalumab|durvalumab|mesh-list
5720541|NCT03212469|Tremelimumab|tremelimumab|mesh-list
5720542|NCT03212469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5720543|NCT03212469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5720544|NCT03212053|Hemostatics|hemostatics|mesh-list
5720545|NCT03212053|Coagulants|coagulants|mesh-ancestor
5720546|NCT03211949|Mepivacaine|mepivacaine|mesh-list
5720547|NCT03211949|Anesthetics, Local|anesthetics, local|mesh-ancestor
5720548|NCT03211949|Anesthetics|anesthetics|mesh-ancestor
5720549|NCT03211949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5720550|NCT03211949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720551|NCT03211949|Sensory System Agents|sensory system agents|mesh-ancestor
5720552|NCT03211949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5720553|NCT03211871|Dexmedetomidine|dexmedetomidine|mesh-list
5720554|NCT03211871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5720555|NCT03211871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5720556|NCT03211871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720557|NCT03211871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5720558|NCT03211871|Analgesics|analgesics|mesh-ancestor
5720559|NCT03211871|Sensory System Agents|sensory system agents|mesh-ancestor
5720560|NCT03211871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5720561|NCT03211871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5720562|NCT03211871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5720563|NCT03211871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5720564|NCT03211871|Adrenergic Agents|adrenergic agents|mesh-ancestor
5720565|NCT03211871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5720566|NCT03211871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5720567|NCT03211897|Midazolam|midazolam|mesh-list
5720568|NCT03211897|Haloperidol|haloperidol|mesh-list
5720569|NCT03211897|Olanzapine|olanzapine|mesh-list
5720570|NCT03211897|Haloperidol decanoate|haloperidol decanoate|mesh-list
5720571|NCT03211897|Ziprasidone|ziprasidone|mesh-list
5720572|NCT03211897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5720573|NCT03211897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5720574|NCT03211897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5720575|NCT03211897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720576|NCT03211897|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5720577|NCT03211897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5720578|NCT03211897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5720579|NCT03211897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5720580|NCT03211897|Anesthetics, General|anesthetics, general|mesh-ancestor
5720581|NCT03211897|Anesthetics|anesthetics|mesh-ancestor
5720582|NCT03211897|GABA Modulators|gaba modulators|mesh-ancestor
5720583|NCT03211897|GABA Agents|gaba agents|mesh-ancestor
5720584|NCT03211897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5720585|NCT03211897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5720586|NCT03211897|Antiemetics|antiemetics|mesh-ancestor
5720587|NCT03211897|Autonomic Agents|autonomic agents|mesh-ancestor
5720588|NCT03211897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5720589|NCT03211897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5720590|NCT03211897|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5720591|NCT03211897|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5720592|NCT03211897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5720593|NCT03211897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5720594|NCT03211897|Serotonin Agents|serotonin agents|mesh-ancestor
5720595|NCT03211897|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5720596|NCT03211897|Dopamine Agents|dopamine agents|mesh-ancestor
5720597|NCT03211897|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5720598|NCT03211897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5720599|NCT03211988|Entinostat|entinostat|mesh-list
5720600|NCT03211988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5720601|NCT03211988|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5720602|NCT03211988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5720603|NCT03211988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5720604|NCT03211728|Pregabalin|pregabalin|mesh-list
5720605|NCT03211728|Analgesics|analgesics|mesh-ancestor
5720606|NCT03211728|Sensory System Agents|sensory system agents|mesh-ancestor
5720607|NCT03211728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5720608|NCT03211728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720609|NCT03211728|Anticonvulsants|anticonvulsants|mesh-ancestor
5720610|NCT03211728|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5720611|NCT03211728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5720612|NCT03211728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5720613|NCT03211728|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5720614|NCT03211728|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5720615|NCT03211728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5720616|NCT03211728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5720617|NCT03211728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5720618|NCT03211741|Bevacizumab|bevacizumab|mesh-list
5720619|NCT03211741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5720620|NCT03211741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5720621|NCT03211741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5720622|NCT03211741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5720623|NCT03211741|Growth Substances|growth substances|mesh-ancestor
5720624|NCT03211741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720625|NCT03211741|Growth Inhibitors|growth inhibitors|mesh-ancestor
5720626|NCT03211572|Tamoxifen|tamoxifen|mesh-list
5720627|NCT03211572|Anastrozole|anastrozole|mesh-list
5720628|NCT03211572|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5720629|NCT03211572|Hormone Antagonists|hormone antagonists|mesh-ancestor
5720630|NCT03211572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5720631|NCT03211572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720632|NCT03211572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5720633|NCT03211572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5720634|NCT03211572|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5720635|NCT03211572|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5720636|NCT03211572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5720637|NCT03211572|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5720638|NCT03211572|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5720639|NCT03211572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5720640|NCT03211572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722187|NCT03200600|Dexamethasone acetate|dexamethasone acetate|mesh-list
5722188|NCT03200600|Flurbiprofen|flurbiprofen|mesh-list
5722189|NCT03200600|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
5722190|NCT03200600|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
5722191|NCT03200600|BB 1101|bb 1101|mesh-list
5722192|NCT03200600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5722193|NCT03200600|Antiemetics|antiemetics|mesh-ancestor
5722194|NCT03200600|Autonomic Agents|autonomic agents|mesh-ancestor
5722195|NCT03200600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5722196|NCT03200600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722197|NCT03200600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5722198|NCT03200600|Glucocorticoids|glucocorticoids|mesh-ancestor
5722199|NCT03200600|Hormones|hormones|mesh-ancestor
5722200|NCT03200600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5722201|NCT03200600|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5722202|NCT03200600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5722203|NCT03200600|Protease Inhibitors|protease inhibitors|mesh-ancestor
5722204|NCT03200600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5722205|NCT03200600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722206|NCT03200600|Analgesics|analgesics|mesh-ancestor
5722207|NCT03200600|Sensory System Agents|sensory system agents|mesh-ancestor
5722208|NCT03200600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5722209|NCT03200600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5722210|NCT03200600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5722211|NCT03200600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5722212|NCT03200561|Prednisolone|prednisolone|mesh-list
5722213|NCT03200561|Immunoglobulins|immunoglobulins|mesh-list
5722214|NCT03200561|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5722215|NCT03200561|Antibodies|antibodies|mesh-list
5722216|NCT03200561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5722217|NCT03200561|Glucocorticoids|glucocorticoids|mesh-ancestor
5722218|NCT03200561|Hormones|hormones|mesh-ancestor
5722219|NCT03200561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5722220|NCT03200561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722221|NCT03200561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5722222|NCT03200561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5947039|NCT04749940|Laxatives|laxatives|mesh-ancestor
5947040|NCT04749940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5947041|NCT04749979|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5947042|NCT04749979|Luteolytic Agents|luteolytic agents|mesh-ancestor
5947043|NCT04749979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5947044|NCT04749979|Contraceptive Agents|contraceptive agents|mesh-ancestor
5947045|NCT04749979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5947046|NCT04749979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947047|NCT04749979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5947048|NCT04749979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5947049|NCT04749979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5947050|NCT04749914|Dabigatran|dabigatran|mesh-list
5947051|NCT04749914|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5947052|NCT04749914|Lasmiditan|lasmiditan|mesh-list
5947053|NCT04749914|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5947054|NCT04749914|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5947055|NCT04749914|Antimetabolites|antimetabolites|mesh-ancestor
5947056|NCT04749914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947057|NCT04749914|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5947058|NCT04749914|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5947059|NCT04749914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5947060|NCT04749914|Antithrombins|antithrombins|mesh-ancestor
5947061|NCT04749914|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5947062|NCT04749914|Protease Inhibitors|protease inhibitors|mesh-ancestor
5947063|NCT04749914|Anticoagulants|anticoagulants|mesh-ancestor
5947064|NCT04749914|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5947065|NCT04749914|Serotonin Agents|serotonin agents|mesh-ancestor
5947066|NCT04749914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5947067|NCT04749914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947068|NCT04750122|Carboplatin|carboplatin|mesh-list
5947069|NCT04750122|Docetaxel|docetaxel|mesh-list
5947070|NCT04750122|Trastuzumab|trastuzumab|mesh-list
5947071|NCT04750122|Pertuzumab|pertuzumab|mesh-list
5947072|NCT04750122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5947073|NCT04750122|Tubulin Modulators|tubulin modulators|mesh-ancestor
5947074|NCT04750122|Antimitotic Agents|antimitotic agents|mesh-ancestor
5947075|NCT04750122|Mitosis Modulators|mitosis modulators|mesh-ancestor
5947076|NCT04750122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947077|NCT04750122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5947078|NCT04750135|Metformin|metformin|mesh-list
5947079|NCT04750135|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5947080|NCT04750135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947081|NCT04750083|Carboplatin|carboplatin|mesh-list
5947082|NCT04750083|Pembrolizumab|pembrolizumab|mesh-list
5947083|NCT04750083|Pemetrexed|pemetrexed|mesh-list
5947084|NCT04750083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5947085|NCT04750083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5947086|NCT04750083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5947087|NCT04750083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947088|NCT04750083|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5947089|NCT04750083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5720641|NCT03211650|Hyaluronic Acid|hyaluronic acid|mesh-list
5720642|NCT03211650|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5720643|NCT03211650|Immunologic Factors|immunologic factors|mesh-ancestor
5720644|NCT03211650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720645|NCT03211650|Viscosupplements|viscosupplements|mesh-ancestor
5720646|NCT03211650|Protective Agents|protective agents|mesh-ancestor
5720647|NCT03211455|Lidocaine|lidocaine|mesh-list
5720648|NCT03211455|Anesthetics, Local|anesthetics, local|mesh-ancestor
5720649|NCT03211455|Anesthetics|anesthetics|mesh-ancestor
5720650|NCT03211455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5720651|NCT03211455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947090|NCT04749797|Bupivacaine|bupivacaine|mesh-list
5947091|NCT04749797|Anesthetics, Local|anesthetics, local|mesh-ancestor
5947092|NCT04749797|Anesthetics|anesthetics|mesh-ancestor
5947093|NCT04749797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5947094|NCT04749797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947095|NCT04749797|Sensory System Agents|sensory system agents|mesh-ancestor
5947096|NCT04749797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5947097|NCT04749810|Eculizumab|eculizumab|mesh-list
5947098|NCT04749810|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5947099|NCT04749810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5947100|NCT04749810|Immunologic Factors|immunologic factors|mesh-ancestor
5947101|NCT04749810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947102|NCT04749641|Vaccines|vaccines|mesh-list
5947103|NCT04749641|Immunologic Factors|immunologic factors|mesh-ancestor
5947104|NCT04749641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947105|NCT04749394|Apatinib|apatinib|mesh-list
5947106|NCT04749394|Antibodies|antibodies|mesh-list
5947107|NCT04749394|Immunoglobulins|immunoglobulins|mesh-list
5947108|NCT04749394|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5947109|NCT04749394|Immunologic Factors|immunologic factors|mesh-ancestor
5947110|NCT04749394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947111|NCT04749394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5947112|NCT04749394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5947113|NCT04749394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5947114|NCT04749394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947115|NCT04749459|Sunscreening Agents|sunscreening agents|mesh-list
5947116|NCT04749459|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5947117|NCT04749459|Protective Agents|protective agents|mesh-ancestor
5947118|NCT04749459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947119|NCT04749459|Dermatologic Agents|dermatologic agents|mesh-ancestor
5968069|NCT04556279|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5968070|NCT04556279|Diuretics|diuretics|mesh-ancestor
5968071|NCT04556279|Natriuretic Agents|natriuretic agents|mesh-ancestor
5968072|NCT04556032|Ergothioneine|ergothioneine|mesh-list
5968073|NCT04556032|Antioxidants|antioxidants|mesh-ancestor
5968074|NCT04556032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968075|NCT04556032|Protective Agents|protective agents|mesh-ancestor
5968076|NCT04556032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968077|NCT04556071|Bevacizumab|bevacizumab|mesh-list
5968078|NCT04556071|Niraparib|niraparib|mesh-list
5968079|NCT04556071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5968080|NCT04556071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5968081|NCT04556071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5968082|NCT04556071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5968083|NCT04556071|Growth Substances|growth substances|mesh-ancestor
5968084|NCT04556071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968085|NCT04556071|Growth Inhibitors|growth inhibitors|mesh-ancestor
5968086|NCT04556071|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5968087|NCT04556071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5968088|NCT04556071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968089|NCT04555837|Pembrolizumab|pembrolizumab|mesh-list
5968090|NCT04555837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5968091|NCT04555837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5968092|NCT04555798|Meropenem|meropenem|mesh-list
5968093|NCT04555798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5968094|NCT04555798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5968095|NCT04555694|Loteprednol Etabonate|loteprednol etabonate|mesh-list
5968096|NCT04555694|Cyclosporine|cyclosporine|mesh-list
5968097|NCT04555694|Dexamethasone|dexamethasone|mesh-list
5968098|NCT04555694|Cyclosporins|cyclosporins|mesh-list
5968099|NCT04555694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5968100|NCT04555694|Antiemetics|antiemetics|mesh-ancestor
5968101|NCT04555694|Autonomic Agents|autonomic agents|mesh-ancestor
5968102|NCT04555694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5968103|NCT04555694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968104|NCT04555694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5968105|NCT04555694|Glucocorticoids|glucocorticoids|mesh-ancestor
5968106|NCT04555694|Hormones|hormones|mesh-ancestor
5968107|NCT04555694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5968108|NCT04555694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5968109|NCT04555694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5968110|NCT04555694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5968111|NCT04555694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968112|NCT04555694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5968113|NCT04555694|Immunologic Factors|immunologic factors|mesh-ancestor
5968114|NCT04555694|Antifungal Agents|antifungal agents|mesh-ancestor
5947120|NCT04749602|Nivolumab|nivolumab|mesh-list
5947121|NCT04749602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5947122|NCT04749602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5947123|NCT04749602|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5947124|NCT04749602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947125|NCT04749628|Cannabidiol|cannabidiol|mesh-list
5947126|NCT04749628|Anticonvulsants|anticonvulsants|mesh-ancestor
5947127|NCT04749212|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
5947128|NCT04749212|Natriuretic Agents|natriuretic agents|mesh-ancestor
5947129|NCT04749212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947130|NCT04748991|Amiodarone|amiodarone|mesh-list
5947131|NCT04748991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5947132|NCT04748991|Vasodilator Agents|vasodilator agents|mesh-ancestor
5947133|NCT04748991|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5947134|NCT04748991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5947135|NCT04748991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947136|NCT04748991|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5947137|NCT04748991|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5947138|NCT04748991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5947139|NCT04748991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5947140|NCT04748991|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5947141|NCT04748991|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5947142|NCT04748991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5947143|NCT04749043|Nitrous Oxide|nitrous oxide|mesh-list
5947144|NCT04749043|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5947145|NCT04749043|Anesthetics, General|anesthetics, general|mesh-ancestor
5947146|NCT04749043|Anesthetics|anesthetics|mesh-ancestor
5947147|NCT04749043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5947148|NCT04749043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947149|NCT04749043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5947150|NCT04749043|Analgesics|analgesics|mesh-ancestor
5947151|NCT04749043|Sensory System Agents|sensory system agents|mesh-ancestor
5947152|NCT04749043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5947153|NCT04749069|Remifentanil|remifentanil|mesh-list
5947154|NCT04749069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5947155|NCT04749069|Narcotics|narcotics|mesh-ancestor
5947156|NCT04749069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5947157|NCT04749069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947158|NCT04749069|Analgesics|analgesics|mesh-ancestor
5947159|NCT04749069|Sensory System Agents|sensory system agents|mesh-ancestor
5947160|NCT04749069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5947161|NCT04748887|Superoxide Dismutase|superoxide dismutase|mesh-list
5947162|NCT04748887|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5947163|NCT04748887|Antioxidants|antioxidants|mesh-ancestor
5947164|NCT04748887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947165|NCT04748887|Protective Agents|protective agents|mesh-ancestor
5947166|NCT04748887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947167|NCT04748562|Progesterone|progesterone|mesh-list
5947168|NCT04748562|Progestins|progestins|mesh-ancestor
5947169|NCT04748562|Hormones|hormones|mesh-ancestor
5947170|NCT04748562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5947171|NCT04748562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947172|NCT04748809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
5947173|NCT04748822|Ethanol|ethanol|mesh-list
5947174|NCT04748822|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5947175|NCT04748822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5947176|NCT04748822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5947177|NCT04748822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947178|NCT04748757|Annexin A5|annexin a5|mesh-list
5947179|NCT04748757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5947180|NCT04748757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947181|NCT04748523|Mirtazapine|mirtazapine|mesh-list
5947182|NCT04748523|Antidepressive Agents|antidepressive agents|mesh-ancestor
5947183|NCT04748523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5947184|NCT04748523|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5947185|NCT04748523|Histamine Antagonists|histamine antagonists|mesh-ancestor
5947186|NCT04748523|Histamine Agents|histamine agents|mesh-ancestor
5947187|NCT04748523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5947188|NCT04748523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947189|NCT04748523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947190|NCT04748523|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5947191|NCT04748523|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5947192|NCT04748523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5947193|NCT04748523|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5947194|NCT04748523|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5947195|NCT04748523|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5947196|NCT04748523|Adrenergic Agents|adrenergic agents|mesh-ancestor
5947197|NCT04748523|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5947198|NCT04748523|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5947199|NCT04748523|Serotonin Agents|serotonin agents|mesh-ancestor
5947200|NCT04748523|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5947201|NCT04748796|Landiolol|landiolol|mesh-list
5947202|NCT04748796|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5947203|NCT04748796|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5947204|NCT04748796|Adrenergic Agents|adrenergic agents|mesh-ancestor
5947205|NCT04748796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5947206|NCT04748796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947207|NCT04748796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947208|NCT04748796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5947209|NCT04748276|Norepinephrine|norepinephrine|mesh-list
5947210|NCT04748276|Serotonin|serotonin|mesh-list
5947211|NCT04748276|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
5947212|NCT04748276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5947213|NCT04748276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5947214|NCT04748276|Adrenergic Agents|adrenergic agents|mesh-ancestor
5947215|NCT04748276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5947216|NCT04748276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947217|NCT04748276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947218|NCT04748276|Sympathomimetics|sympathomimetics|mesh-ancestor
5947219|NCT04748276|Autonomic Agents|autonomic agents|mesh-ancestor
5947220|NCT04748276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5947221|NCT04748276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5947222|NCT04748276|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5947223|NCT04748276|Serotonin Agents|serotonin agents|mesh-ancestor
5947224|NCT04748276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5947225|NCT04748276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5947226|NCT04748341|Benzocaine|benzocaine|mesh-list
5947227|NCT04748341|Anesthetics, Local|anesthetics, local|mesh-ancestor
5947228|NCT04748341|Anesthetics|anesthetics|mesh-ancestor
5947229|NCT04748341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5947230|NCT04748341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947231|NCT04748341|Sensory System Agents|sensory system agents|mesh-ancestor
5947232|NCT04748341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5947233|NCT04748419|Durvalumab|durvalumab|mesh-list
5947234|NCT04748419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5947235|NCT04748419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5947236|NCT04748042|Prednisone|prednisone|mesh-list
5947237|NCT04748042|Olaparib|olaparib|mesh-list
5947238|NCT04748042|Androgens|androgens|mesh-list
5947239|NCT04748042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5947240|NCT04748042|Glucocorticoids|glucocorticoids|mesh-ancestor
5947241|NCT04748042|Hormones|hormones|mesh-ancestor
5947242|NCT04748042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5947243|NCT04748042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947244|NCT04748042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5947245|NCT04748042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5947246|NCT04748042|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5947247|NCT04748042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5947248|NCT04748042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947249|NCT04747847|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5947250|NCT04747847|Atorvastatin|atorvastatin|mesh-list
5947251|NCT04747847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5947252|NCT04747847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5947253|NCT04747847|Antimetabolites|antimetabolites|mesh-ancestor
5947254|NCT04747847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947255|NCT04747847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5947256|NCT04747847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5947257|NCT04747847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5947258|NCT04747847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5968115|NCT04555694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5968116|NCT04555694|Dermatologic Agents|dermatologic agents|mesh-ancestor
5968117|NCT04555694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5968118|NCT04555694|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5968119|NCT04555694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5968120|NCT04555733|Lemborexant|lemborexant|mesh-list
5968121|NCT04555733|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
5968122|NCT04555733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5947259|NCT04747912|Dexamethasone|dexamethasone|mesh-list
5947260|NCT04747912|Dexamethasone acetate|dexamethasone acetate|mesh-list
5947261|NCT04747912|Methotrexate|methotrexate|mesh-list
5947262|NCT04747912|Vincristine|vincristine|mesh-list
5947263|NCT04747912|Dasatinib|dasatinib|mesh-list
5947264|NCT04747912|Ponatinib|ponatinib|mesh-list
5947265|NCT04747912|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
5947266|NCT04747912|BB 1101|bb 1101|mesh-list
5947267|NCT04747912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5947268|NCT04747912|Antiemetics|antiemetics|mesh-ancestor
5947269|NCT04747912|Autonomic Agents|autonomic agents|mesh-ancestor
5947270|NCT04747912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5947271|NCT04747912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947272|NCT04747912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5947273|NCT04747912|Glucocorticoids|glucocorticoids|mesh-ancestor
5947274|NCT04747912|Hormones|hormones|mesh-ancestor
5947275|NCT04747912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5947276|NCT04747912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5947277|NCT04747912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5947278|NCT04747912|Protease Inhibitors|protease inhibitors|mesh-ancestor
5947279|NCT04747912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5947280|NCT04747912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947281|NCT04747912|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5947282|NCT04747912|Abortifacient Agents|abortifacient agents|mesh-ancestor
5947283|NCT04747912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5947284|NCT04747912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5947285|NCT04747912|Antimetabolites|antimetabolites|mesh-ancestor
5947286|NCT04747912|Dermatologic Agents|dermatologic agents|mesh-ancestor
5947287|NCT04747912|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5947288|NCT04747912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5947289|NCT04747912|Immunologic Factors|immunologic factors|mesh-ancestor
5947290|NCT04747912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5947291|NCT04747912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5947292|NCT04747912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5947293|NCT04747912|Tubulin Modulators|tubulin modulators|mesh-ancestor
5947294|NCT04747912|Antimitotic Agents|antimitotic agents|mesh-ancestor
5947295|NCT04747912|Mitosis Modulators|mitosis modulators|mesh-ancestor
5947296|NCT04747912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5947297|NCT04747912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5947298|NCT04747912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5947299|NCT04747678|Ivermectin|ivermectin|mesh-list
5947300|NCT04747678|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5947301|NCT04747678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5947302|NCT04747795|Ascorbic Acid|ascorbic acid|mesh-list
5947303|NCT04747795|Vitamins|vitamins|mesh-ancestor
5947304|NCT04747795|Micronutrients|micronutrients|mesh-ancestor
5947305|NCT04747795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947306|NCT04747795|Antioxidants|antioxidants|mesh-ancestor
5947307|NCT04747795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947308|NCT04747795|Protective Agents|protective agents|mesh-ancestor
5947309|NCT04747392|Teriparatide|teriparatide|mesh-list
5947310|NCT04747392|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5947311|NCT04747392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947312|NCT04747392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5947313|NCT04747301|Dinoprostone|dinoprostone|mesh-list
5947314|NCT04747301|Oxytocics|oxytocics|mesh-ancestor
5947315|NCT04747301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5947316|NCT04747301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947317|NCT04747236|Gemcitabine|gemcitabine|mesh-list
5947318|NCT04747236|Azacitidine|azacitidine|mesh-list
5947319|NCT04747236|Romidepsin|romidepsin|mesh-list
5947320|NCT04747236|Belinostat|belinostat|mesh-list
5947321|NCT04747236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5947322|NCT04747236|Antimetabolites|antimetabolites|mesh-ancestor
5947323|NCT04747236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947324|NCT04747236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5722223|NCT03200561|Immunologic Factors|immunologic factors|mesh-ancestor
5722224|NCT03200613|Heparin|heparin|mesh-list
5722225|NCT03200613|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5722226|NCT03200613|Tinzaparin|tinzaparin|mesh-list
5722227|NCT03200613|Dalteparin|dalteparin|mesh-list
5722228|NCT03200613|Apixaban|apixaban|mesh-list
5722229|NCT03200613|Anticoagulants|anticoagulants|mesh-ancestor
5722230|NCT03200613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5722231|NCT03200613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5722232|NCT03200613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722233|NCT03200613|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5722234|NCT03200613|Antithrombins|antithrombins|mesh-ancestor
5947325|NCT04747236|Antiviral Agents|antiviral agents|mesh-ancestor
5947326|NCT04747236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5947327|NCT04747236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5947328|NCT04747236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5947329|NCT04747236|Immunologic Factors|immunologic factors|mesh-ancestor
5947330|NCT04747236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947331|NCT04747236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5947332|NCT04747236|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5947333|NCT04747015|Oxytocin|oxytocin|mesh-list
5947334|NCT04747015|Oxytocics|oxytocics|mesh-ancestor
5947335|NCT04747015|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5947336|NCT04747015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947337|NCT04746937|Nitazoxanide|nitazoxanide|mesh-list
5947338|NCT04746937|Norfloxacin|norfloxacin|mesh-list
5947339|NCT04746937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5947340|NCT04746937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5947341|NCT04746937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5947342|NCT04746937|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5947343|NCT04746937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5947344|NCT04746937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5947345|NCT04746937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947346|NCT04746937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5947347|NCT04746937|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5947348|NCT04746937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5947349|NCT04747080|Dexamethasone|dexamethasone|mesh-list
5947350|NCT04747080|Dexamethasone acetate|dexamethasone acetate|mesh-list
5947351|NCT04747080|BB 1101|bb 1101|mesh-list
5947352|NCT04747080|Tacrolimus|tacrolimus|mesh-list
5947353|NCT04747080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5947354|NCT04747080|Antiemetics|antiemetics|mesh-ancestor
5947355|NCT04747080|Autonomic Agents|autonomic agents|mesh-ancestor
5947356|NCT04747080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5947357|NCT04747080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947358|NCT04747080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5947359|NCT04747080|Glucocorticoids|glucocorticoids|mesh-ancestor
5947360|NCT04747080|Hormones|hormones|mesh-ancestor
5947361|NCT04747080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5947362|NCT04747080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5947363|NCT04747080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5947364|NCT04747080|Protease Inhibitors|protease inhibitors|mesh-ancestor
5947365|NCT04747080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5947366|NCT04747080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947367|NCT04747080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5947368|NCT04747080|Immunologic Factors|immunologic factors|mesh-ancestor
5947369|NCT04747080|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5947370|NCT04747171|Dexmedetomidine|dexmedetomidine|mesh-list
5947371|NCT04747171|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5947372|NCT04747171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5947373|NCT04747171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947374|NCT04747171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5947375|NCT04747171|Analgesics|analgesics|mesh-ancestor
5947376|NCT04747171|Sensory System Agents|sensory system agents|mesh-ancestor
5947377|NCT04747171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5947378|NCT04747171|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5947379|NCT04747171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5947380|NCT04747171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5947381|NCT04747171|Adrenergic Agents|adrenergic agents|mesh-ancestor
5947382|NCT04747171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5947383|NCT04747171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947384|NCT04747145|Temozolomide|temozolomide|mesh-list
5947385|NCT04747145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5947386|NCT04747145|Alkylating Agents|alkylating agents|mesh-ancestor
5947387|NCT04747145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947388|NCT04747145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5947389|NCT04746430|Dexamethasone|dexamethasone|mesh-list
5947390|NCT04746430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5947391|NCT04746430|Antiemetics|antiemetics|mesh-ancestor
5947392|NCT04746430|Autonomic Agents|autonomic agents|mesh-ancestor
5947393|NCT04746430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5947394|NCT04746430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947395|NCT04746430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5947396|NCT04746430|Glucocorticoids|glucocorticoids|mesh-ancestor
5947397|NCT04746430|Hormones|hormones|mesh-ancestor
5947398|NCT04746430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5947399|NCT04746430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5947400|NCT04746430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5947401|NCT04746365|Hydroxychloroquine|hydroxychloroquine|mesh-list
5947402|NCT04746365|Ivermectin|ivermectin|mesh-list
5947403|NCT04746365|Antimalarials|antimalarials|mesh-ancestor
5947404|NCT04746365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5947405|NCT04746365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5947406|NCT04746365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5947407|NCT04746365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5947408|NCT04746365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947409|NCT04746365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5947410|NCT04746339|Apixaban|apixaban|mesh-list
5947411|NCT04746339|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5947412|NCT04746339|Antithrombins|antithrombins|mesh-ancestor
5947413|NCT04746339|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5947414|NCT04746339|Protease Inhibitors|protease inhibitors|mesh-ancestor
5947415|NCT04746339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5947416|NCT04746339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947417|NCT04746339|Anticoagulants|anticoagulants|mesh-ancestor
5947418|NCT04746235|Decitabine|decitabine|mesh-list
5947419|NCT04746235|Venetoclax|venetoclax|mesh-list
5947420|NCT04746235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5947421|NCT04746235|Antimetabolites|antimetabolites|mesh-ancestor
5947422|NCT04746235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947423|NCT04746235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5947424|NCT04746235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5947425|NCT04746209|Blinatumomab|blinatumomab|mesh-list
5947426|NCT04746209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5947427|NCT04746183|Nitazoxanide|nitazoxanide|mesh-list
5947428|NCT04746183|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5947429|NCT04746183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5968123|NCT04555733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968124|NCT04555733|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5968125|NCT04555733|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5968126|NCT04555733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5968127|NCT04555733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968128|NCT04555707|Betamethasone|betamethasone|mesh-list
5968129|NCT04555707|Betamethasone Valerate|betamethasone valerate|mesh-list
5968130|NCT04555707|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5968131|NCT04555707|Betamethasone benzoate|betamethasone benzoate|mesh-list
5968132|NCT04555707|Apremilast|apremilast|mesh-list
5968133|NCT04555707|Calcipotriene|calcipotriene|mesh-list
5968134|NCT04555707|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
5968135|NCT04555707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5968136|NCT04555707|Glucocorticoids|glucocorticoids|mesh-ancestor
5968137|NCT04555707|Hormones|hormones|mesh-ancestor
5968138|NCT04555707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5968139|NCT04555707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968140|NCT04555707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5968141|NCT04555707|Respiratory System Agents|respiratory system agents|mesh-ancestor
5968142|NCT04555707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5968143|NCT04555707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5968144|NCT04555707|Analgesics|analgesics|mesh-ancestor
5968145|NCT04555707|Sensory System Agents|sensory system agents|mesh-ancestor
5968146|NCT04555707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5968147|NCT04555707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5968148|NCT04555707|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5968149|NCT04555707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5968150|NCT04555707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5968151|NCT04555707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968152|NCT04555707|Dermatologic Agents|dermatologic agents|mesh-ancestor
5968153|NCT04555603|Pembrolizumab|pembrolizumab|mesh-list
5968154|NCT04555603|Avelumab|avelumab|mesh-list
5968155|NCT04555603|Axitinib|axitinib|mesh-list
5968156|NCT04555603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5968157|NCT04555603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5968158|NCT04555603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5968159|NCT04555603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5968160|NCT04555603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968161|NCT04555525|Sarecycline|sarecycline|mesh-list
5968162|NCT04555525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5968163|NCT04555525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5968164|NCT04555525|Dermatologic Agents|dermatologic agents|mesh-ancestor
5971096|NCT04530422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5971097|NCT04530422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5971393|NCT04528888|Protective Agents|protective agents|mesh-ancestor
5947430|NCT04746040|Fluticasone|fluticasone|mesh-list
5947431|NCT04746040|Xhance|xhance|mesh-list
5947432|NCT04746040|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5947433|NCT04746040|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
5947434|NCT04746040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5947435|NCT04746040|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5947436|NCT04746040|Autonomic Agents|autonomic agents|mesh-ancestor
5947437|NCT04746040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5947438|NCT04746040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947439|NCT04746040|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5947440|NCT04746040|Respiratory System Agents|respiratory system agents|mesh-ancestor
5947441|NCT04746040|Dermatologic Agents|dermatologic agents|mesh-ancestor
5947442|NCT04746040|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5947443|NCT04746040|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5947444|NCT04746040|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5947445|NCT04746040|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5947446|NCT04746040|Adrenergic Agents|adrenergic agents|mesh-ancestor
5947447|NCT04746040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5947448|NCT04746040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947449|NCT04746040|Glucocorticoids|glucocorticoids|mesh-ancestor
5947450|NCT04746040|Hormones|hormones|mesh-ancestor
5947451|NCT04746040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5947452|NCT04746040|Sympathomimetics|sympathomimetics|mesh-ancestor
5947453|NCT04745780|Inositol|inositol|mesh-list
5947454|NCT04745780|Vitamin B Complex|vitamin b complex|mesh-ancestor
5947455|NCT04745780|Vitamins|vitamins|mesh-ancestor
5947456|NCT04745780|Micronutrients|micronutrients|mesh-ancestor
5947457|NCT04745780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947458|NCT04745728|Prednisone|prednisone|mesh-list
5947459|NCT04745728|Cyclophosphamide|cyclophosphamide|mesh-list
5947460|NCT04745728|Rituximab|rituximab|mesh-list
5947461|NCT04745728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5947462|NCT04745728|Immunologic Factors|immunologic factors|mesh-ancestor
5947463|NCT04745728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947464|NCT04745728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5947465|NCT04745728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5947466|NCT04745728|Alkylating Agents|alkylating agents|mesh-ancestor
5947467|NCT04745728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947468|NCT04745728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5947469|NCT04745728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5947470|NCT04745728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5947471|NCT04745728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5947472|NCT04745728|Glucocorticoids|glucocorticoids|mesh-ancestor
5947473|NCT04745728|Hormones|hormones|mesh-ancestor
5947474|NCT04745728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5947475|NCT04745728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5947476|NCT04745663|Iodine|iodine|mesh-list
5947477|NCT04745663|Cadexomer iodine|cadexomer iodine|mesh-list
5947478|NCT04745663|Povidone-Iodine|povidone-iodine|mesh-list
5947479|NCT04745663|Povidone|povidone|mesh-list
5947480|NCT04745663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5947481|NCT04745663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5947482|NCT04745663|Trace Elements|trace elements|mesh-ancestor
5947483|NCT04745663|Micronutrients|micronutrients|mesh-ancestor
5947484|NCT04745663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947485|NCT04745663|Plasma Substitutes|plasma substitutes|mesh-ancestor
5947486|NCT04745663|Blood Substitutes|blood substitutes|mesh-ancestor
5947487|NCT04745260|Fentanyl|fentanyl|mesh-list
5947488|NCT04745260|Midazolam|midazolam|mesh-list
5947489|NCT04745260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5947490|NCT04745260|Narcotics|narcotics|mesh-ancestor
5947491|NCT04745260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5947492|NCT04745260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947493|NCT04745260|Analgesics|analgesics|mesh-ancestor
5947494|NCT04745260|Sensory System Agents|sensory system agents|mesh-ancestor
5947495|NCT04745260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5947496|NCT04745260|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5947497|NCT04745260|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5947498|NCT04745260|Anesthetics, General|anesthetics, general|mesh-ancestor
5947499|NCT04745260|Anesthetics|anesthetics|mesh-ancestor
5947500|NCT04745260|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5947501|NCT04745260|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5947502|NCT04745260|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5947503|NCT04745260|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5947504|NCT04745260|GABA Modulators|gaba modulators|mesh-ancestor
5947505|NCT04745260|GABA Agents|gaba agents|mesh-ancestor
5947506|NCT04745260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5968165|NCT04555304|Paclitaxel|paclitaxel|mesh-list
5947507|NCT04745260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947508|NCT04745234|Mogamulizumab|mogamulizumab|mesh-list
5947509|NCT04745234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5947510|NCT04745286|Ketamine|ketamine|mesh-list
5947511|NCT04745286|Esketamine|esketamine|mesh-list
5947512|NCT04745286|Analgesics|analgesics|mesh-ancestor
5947513|NCT04745286|Sensory System Agents|sensory system agents|mesh-ancestor
5947514|NCT04745286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5947515|NCT04745286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947516|NCT04745286|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5947517|NCT04745286|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5947518|NCT04745286|Anesthetics, General|anesthetics, general|mesh-ancestor
5947519|NCT04745286|Anesthetics|anesthetics|mesh-ancestor
5947520|NCT04745286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5947521|NCT04745286|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5947522|NCT04745286|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5947523|NCT04745286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5947524|NCT04745286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947525|NCT04745286|Antidepressive Agents|antidepressive agents|mesh-ancestor
5947526|NCT04745286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5947527|NCT04745299|Riluzole|riluzole|mesh-list
5947528|NCT04745299|Anticonvulsants|anticonvulsants|mesh-ancestor
5947529|NCT04745299|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5947530|NCT04745299|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5947531|NCT04745299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5947532|NCT04745299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947533|NCT04745299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947534|NCT04745299|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5947535|NCT04745299|Protective Agents|protective agents|mesh-ancestor
5947536|NCT04745273|Ondansetron|ondansetron|mesh-list
5947537|NCT04745273|Antiemetics|antiemetics|mesh-ancestor
5947538|NCT04745273|Autonomic Agents|autonomic agents|mesh-ancestor
5947539|NCT04745273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5947540|NCT04745273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947541|NCT04745273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5947542|NCT04745273|Antipruritics|antipruritics|mesh-ancestor
5947543|NCT04745273|Dermatologic Agents|dermatologic agents|mesh-ancestor
5947544|NCT04745273|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5947545|NCT04745273|Serotonin Agents|serotonin agents|mesh-ancestor
5947546|NCT04745273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5947547|NCT04745273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947548|NCT04745273|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5947549|NCT04745273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5947550|NCT04745273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5947551|NCT04745273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5947552|NCT04745273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5947553|NCT04745442|Antithrombins|antithrombins|mesh-list
5947554|NCT04745442|Antithrombin III|antithrombin iii|mesh-list
5947555|NCT04745442|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5947556|NCT04745442|Protease Inhibitors|protease inhibitors|mesh-ancestor
5947557|NCT04745442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5947558|NCT04745442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947559|NCT04745442|Anticoagulants|anticoagulants|mesh-ancestor
5947560|NCT04745377|Antibodies|antibodies|mesh-list
5947561|NCT04745377|Immunologic Factors|immunologic factors|mesh-ancestor
5947562|NCT04745377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947563|NCT04744883|Naloxone|naloxone|mesh-list
5947564|NCT04744883|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5947565|NCT04744883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947566|NCT04744883|Sensory System Agents|sensory system agents|mesh-ancestor
5947567|NCT04744883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5947568|NCT04745130|Cetuximab|cetuximab|mesh-list
5947569|NCT04745130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5947570|NCT04745130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5947571|NCT04744753|Calcium|calcium|mesh-list
5947572|NCT04744753|Ionophores|ionophores|mesh-list
5947573|NCT04744753|Calcium Ionophores|calcium ionophores|mesh-list
5947574|NCT04744753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5947575|NCT04744753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947576|NCT04744753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5947577|NCT04744753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947578|NCT04744727|Acetaminophen|acetaminophen|mesh-list
5947579|NCT04744727|Meperidine|meperidine|mesh-list
5947580|NCT04744727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5947581|NCT04744727|Analgesics|analgesics|mesh-ancestor
5947582|NCT04744727|Sensory System Agents|sensory system agents|mesh-ancestor
5947583|NCT04744727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5947584|NCT04744727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947585|NCT04744727|Antipyretics|antipyretics|mesh-ancestor
5947586|NCT04744727|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5947587|NCT04744727|Narcotics|narcotics|mesh-ancestor
5947588|NCT04744727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5947589|NCT04744727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5947590|NCT04744649|Fluorouracil|fluorouracil|mesh-list
5947591|NCT04744649|Antimetabolites|antimetabolites|mesh-ancestor
5947592|NCT04744649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947593|NCT04744649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5947594|NCT04744649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5947595|NCT04744649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5947596|NCT04744649|Immunologic Factors|immunologic factors|mesh-ancestor
5947597|NCT04744649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947598|NCT04744675|Triamcinolone|triamcinolone|mesh-list
5947599|NCT04744675|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5947600|NCT04744675|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5947601|NCT04744675|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5947602|NCT04744675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5947603|NCT04744675|Glucocorticoids|glucocorticoids|mesh-ancestor
5947604|NCT04744675|Hormones|hormones|mesh-ancestor
5947605|NCT04744675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5947606|NCT04744675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947607|NCT04744675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5947608|NCT04744675|Immunologic Factors|immunologic factors|mesh-ancestor
5947609|NCT04744675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5947610|NCT04744675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947611|NCT04744480|Anesthetics|anesthetics|mesh-list
5947612|NCT04744480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5947613|NCT04744480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947614|NCT04744545|Curcumin|curcumin|mesh-list
5947615|NCT04744545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5947616|NCT04744545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5947617|NCT04744545|Analgesics|analgesics|mesh-ancestor
5947618|NCT04744545|Sensory System Agents|sensory system agents|mesh-ancestor
5947619|NCT04744545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5947620|NCT04744545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947621|NCT04744545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5947622|NCT04744545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5947623|NCT04744545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5947624|NCT04744545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5947625|NCT04744545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947626|NCT04744441|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5947627|NCT04744441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5947628|NCT04744623|Mycophenolic Acid|mycophenolic acid|mesh-list
5947629|NCT04744623|Dapsone|dapsone|mesh-list
5947630|NCT04744623|Prednisolone|prednisolone|mesh-list
5947631|NCT04744623|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5947632|NCT04744623|Methylprednisolone|methylprednisolone|mesh-list
5947633|NCT04744623|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5947634|NCT04744623|Prednisolone acetate|prednisolone acetate|mesh-list
5947635|NCT04744623|Triamcinolone|triamcinolone|mesh-list
5947636|NCT04744623|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5947637|NCT04744623|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5947638|NCT04744623|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5947639|NCT04744623|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5947640|NCT04744623|Prednisolone phosphate|prednisolone phosphate|mesh-list
5947641|NCT04744623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5947642|NCT04744623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5947643|NCT04744623|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5947644|NCT04744623|Antitubercular Agents|antitubercular agents|mesh-ancestor
5947645|NCT04744623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5947646|NCT04744623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5947647|NCT04744623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5947648|NCT04744623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947649|NCT04744623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5947650|NCT04744623|Glucocorticoids|glucocorticoids|mesh-ancestor
5947651|NCT04744623|Hormones|hormones|mesh-ancestor
5947652|NCT04744623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5947653|NCT04744623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947654|NCT04744623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5947655|NCT04744623|Antiemetics|antiemetics|mesh-ancestor
5947656|NCT04744623|Autonomic Agents|autonomic agents|mesh-ancestor
5947657|NCT04744623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5947658|NCT04744623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5947659|NCT04744623|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5947660|NCT04744623|Protective Agents|protective agents|mesh-ancestor
5947661|NCT04744623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5947662|NCT04744623|Immunologic Factors|immunologic factors|mesh-ancestor
5947663|NCT04744623|Antimalarials|antimalarials|mesh-ancestor
5947664|NCT04744623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5947665|NCT04744623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5947666|NCT04744623|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5947667|NCT04744623|Leprostatic Agents|leprostatic agents|mesh-ancestor
5947668|NCT04744662|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5947669|NCT04744662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5947670|NCT04744571|Aspirin|aspirin|mesh-list
5947671|NCT04744571|Metoprolol|metoprolol|mesh-list
5947672|NCT04744571|Clopidogrel|clopidogrel|mesh-list
5947673|NCT04744571|Ticagrelor|ticagrelor|mesh-list
5947674|NCT04744571|Atorvastatin|atorvastatin|mesh-list
5947675|NCT04744571|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5947676|NCT04744571|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5947677|NCT04744571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5947678|NCT04744571|Analgesics|analgesics|mesh-ancestor
5947679|NCT04744571|Sensory System Agents|sensory system agents|mesh-ancestor
5947680|NCT04744571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5947681|NCT04744571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947682|NCT04744571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5947683|NCT04744571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5947684|NCT04744571|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5947685|NCT04744571|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5947686|NCT04744571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947687|NCT04744571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5947688|NCT04744571|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5947689|NCT04744571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5947690|NCT04744571|Antipyretics|antipyretics|mesh-ancestor
5947691|NCT04744571|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5947692|NCT04744571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5947693|NCT04744571|Antimetabolites|antimetabolites|mesh-ancestor
5947694|NCT04744571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5947695|NCT04744571|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5947696|NCT04744571|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5947697|NCT04744571|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5947698|NCT04744571|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5947699|NCT04744571|Purinergic Agents|purinergic agents|mesh-ancestor
5947700|NCT04744571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5947701|NCT04744571|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5947702|NCT04744571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5947703|NCT04744571|Sympatholytics|sympatholytics|mesh-ancestor
5947704|NCT04744571|Autonomic Agents|autonomic agents|mesh-ancestor
5947705|NCT04744571|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5947706|NCT04744571|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5947707|NCT04744571|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5947708|NCT04744571|Adrenergic Agents|adrenergic agents|mesh-ancestor
5968166|NCT04555304|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5968167|NCT04555304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5968168|NCT04555304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5968169|NCT04555304|Tubulin Modulators|tubulin modulators|mesh-ancestor
5968170|NCT04555304|Antimitotic Agents|antimitotic agents|mesh-ancestor
5968171|NCT04555304|Mitosis Modulators|mitosis modulators|mesh-ancestor
5968172|NCT04555304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968173|NCT04555291|Ropivacaine|ropivacaine|mesh-list
5968174|NCT04555291|Anesthetics, Local|anesthetics, local|mesh-ancestor
5968175|NCT04555291|Anesthetics|anesthetics|mesh-ancestor
5968176|NCT04555291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5968177|NCT04555291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968178|NCT04555291|Sensory System Agents|sensory system agents|mesh-ancestor
5968179|NCT04555291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5968180|NCT04555096|Avasopasem manganese|avasopasem manganese|mesh-list
5968181|NCT04555096|Antioxidants|antioxidants|mesh-ancestor
5968182|NCT04555096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968183|NCT04555096|Protective Agents|protective agents|mesh-ancestor
5968184|NCT04555096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968185|NCT04554979|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5968186|NCT04554979|Hydroxychloroquine|hydroxychloroquine|mesh-list
5968187|NCT04554979|Anticoagulants|anticoagulants|mesh-list
5968188|NCT04554979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5968189|NCT04554979|Antimalarials|antimalarials|mesh-ancestor
5947709|NCT04743934|Androgens|androgens|mesh-list
5947710|NCT04743934|Hormones|hormones|mesh-ancestor
5947711|NCT04743934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5947712|NCT04743934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947713|NCT04743739|Cyclosporine|cyclosporine|mesh-list
5947714|NCT04743739|Rituximab|rituximab|mesh-list
5947715|NCT04743739|Cyclosporins|cyclosporins|mesh-list
5947716|NCT04743739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5947717|NCT04743739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5947718|NCT04743739|Immunologic Factors|immunologic factors|mesh-ancestor
5947719|NCT04743739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947720|NCT04743739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5947721|NCT04743739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5947722|NCT04743739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947723|NCT04743739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5947724|NCT04743739|Antifungal Agents|antifungal agents|mesh-ancestor
5947725|NCT04743739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5947726|NCT04743739|Dermatologic Agents|dermatologic agents|mesh-ancestor
5947727|NCT04743739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5947728|NCT04743687|Zanubrutinib|zanubrutinib|mesh-list
5947729|NCT04743687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5947730|NCT04743687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5947731|NCT04743687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5947732|NCT04743687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947733|NCT04743544|Voriconazole|voriconazole|mesh-list
5947734|NCT04743544|Antifungal Agents|antifungal agents|mesh-ancestor
5947735|NCT04743544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5947736|NCT04743544|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5947737|NCT04743544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5947738|NCT04743544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5947739|NCT04743544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947740|NCT04743544|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5947741|NCT04743544|Hormone Antagonists|hormone antagonists|mesh-ancestor
5947742|NCT04743544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5947743|NCT04743544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947744|NCT04743544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5947745|NCT04743622|Latanoprost|latanoprost|mesh-list
5947746|NCT04743622|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5947747|NCT04743622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5947748|NCT04743180|Paclitaxel|paclitaxel|mesh-list
5947749|NCT04743180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5947750|NCT04743180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5947751|NCT04743180|Tubulin Modulators|tubulin modulators|mesh-ancestor
5947752|NCT04743180|Antimitotic Agents|antimitotic agents|mesh-ancestor
5947753|NCT04743180|Mitosis Modulators|mitosis modulators|mesh-ancestor
5947754|NCT04743180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947755|NCT04743011|Heparin|heparin|mesh-list
5947756|NCT04743011|Calcium heparin|calcium heparin|mesh-list
5947757|NCT04743011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5947758|NCT04743011|Anticoagulants|anticoagulants|mesh-ancestor
5947759|NCT04743011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5947760|NCT04743011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5947761|NCT04743011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947762|NCT04743297|Dinoprostone|dinoprostone|mesh-list
5947763|NCT04743297|Oxytocics|oxytocics|mesh-ancestor
5947764|NCT04743297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5947765|NCT04743297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947766|NCT04743063|Losartan|losartan|mesh-list
5947767|NCT04743063|Valsartan|valsartan|mesh-list
5947768|NCT04743063|Telmisartan|telmisartan|mesh-list
5947769|NCT04743063|Candesartan|candesartan|mesh-list
5947770|NCT04743063|Olmesartan|olmesartan|mesh-list
5947771|NCT04743063|Irbesartan|irbesartan|mesh-list
5947772|NCT04743063|Eprosartan|eprosartan|mesh-list
5947773|NCT04743063|Angiotensin II|angiotensin ii|mesh-list
5947774|NCT04743063|Giapreza|giapreza|mesh-list
5947775|NCT04743063|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
5947776|NCT04743063|Angiotensinogen|angiotensinogen|mesh-list
5947777|NCT04743063|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5947778|NCT04743063|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5947779|NCT04743063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947780|NCT04743063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5947781|NCT04743063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5947782|NCT04743063|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5947783|NCT04743063|Protease Inhibitors|protease inhibitors|mesh-ancestor
5947784|NCT04743063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5947785|NCT04743063|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
5947786|NCT04743193|Sevoflurane|sevoflurane|mesh-list
5947787|NCT04743193|Anesthetics|anesthetics|mesh-ancestor
5947788|NCT04743193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5947789|NCT04743193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947790|NCT04743193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5947791|NCT04743193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5947792|NCT04743193|Anesthetics, General|anesthetics, general|mesh-ancestor
5947793|NCT04742504|Benralizumab|benralizumab|mesh-list
5947794|NCT04742504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5947795|NCT04742504|Respiratory System Agents|respiratory system agents|mesh-ancestor
5947796|NCT04742699|Lemborexant|lemborexant|mesh-list
5947797|NCT04742699|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
5947798|NCT04742699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5947799|NCT04742699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947800|NCT04742699|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5947801|NCT04742699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5947802|NCT04742699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5947803|NCT04742699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968190|NCT04554979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5968191|NCT04554979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5968192|NCT04554979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5968193|NCT04554979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968194|NCT04554979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5968195|NCT04554654|Progesterone|progesterone|mesh-list
5968196|NCT04554654|Progestins|progestins|mesh-ancestor
5968197|NCT04554654|Hormones|hormones|mesh-ancestor
5968198|NCT04554654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5968199|NCT04554654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968200|NCT04554680|Trametinib|trametinib|mesh-list
5968201|NCT04554680|Dabrafenib|dabrafenib|mesh-list
5968202|NCT04554680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5968203|NCT04554680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5968204|NCT04554680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5968205|NCT04554680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968206|NCT04554615|Insulin|insulin|mesh-list
5968207|NCT04554615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5968208|NCT04554615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968209|NCT04554693|Metronidazole|metronidazole|mesh-list
5968210|NCT04554693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5968211|NCT04554693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5968212|NCT04554693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5968213|NCT04554693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5968214|NCT04554862|Ketorolac|ketorolac|mesh-list
5968215|NCT04554862|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
5968216|NCT04554862|Magnesium Sulfate|magnesium sulfate|mesh-list
5968217|NCT04554862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5968218|NCT04554862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5968219|NCT04554862|Analgesics|analgesics|mesh-ancestor
5968220|NCT04554862|Sensory System Agents|sensory system agents|mesh-ancestor
5968221|NCT04554862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5968222|NCT04554862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968223|NCT04554862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5968224|NCT04554862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5968225|NCT04554862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5968226|NCT04554862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5968227|NCT04554862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968228|NCT04554862|Anesthetics|anesthetics|mesh-ancestor
5968229|NCT04554862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5968230|NCT04554862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5968231|NCT04554862|Anticonvulsants|anticonvulsants|mesh-ancestor
5968232|NCT04554862|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5968233|NCT04554862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5968234|NCT04554862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5968235|NCT04554862|Tocolytic Agents|tocolytic agents|mesh-ancestor
5968236|NCT04554862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5968237|NCT04554589|Glycopyrrolate|glycopyrrolate|mesh-list
5968238|NCT04554589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5968239|NCT04554589|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5968240|NCT04554589|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5968241|NCT04554589|Cholinergic Agents|cholinergic agents|mesh-ancestor
5968242|NCT04554589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5968243|NCT04554589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968244|NCT04554589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947804|NCT04742660|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
5947805|NCT04742660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5947806|NCT04742491|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5947807|NCT04742491|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
5947808|NCT04742491|Emtricitabine|emtricitabine|mesh-list
5947809|NCT04742491|Tenofovir|tenofovir|mesh-list
5947810|NCT04742491|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5947811|NCT04742491|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5947812|NCT04742491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5947813|NCT04742491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947814|NCT04742491|Antiviral Agents|antiviral agents|mesh-ancestor
5947815|NCT04742491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5947816|NCT04742491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5947817|NCT04742491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5947818|NCT04742101|Azacitidine|azacitidine|mesh-list
5947819|NCT04742101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5947820|NCT04742101|Antimetabolites|antimetabolites|mesh-ancestor
5947821|NCT04742101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947822|NCT04742101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5947823|NCT04742101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5947824|NCT04742348|Levodopa|levodopa|mesh-list
5947825|NCT04742348|Carbidopa|carbidopa|mesh-list
5947826|NCT04742348|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
5947827|NCT04742348|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5947828|NCT04742348|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5947829|NCT04742348|Dopamine Agents|dopamine agents|mesh-ancestor
5947830|NCT04742348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5947831|NCT04742348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947832|NCT04742348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947833|NCT04742348|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5947834|NCT04742348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5947835|NCT04742348|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5947836|NCT04742348|Immunologic Factors|immunologic factors|mesh-ancestor
5947837|NCT04742348|Dopamine Agonists|dopamine agonists|mesh-ancestor
5947838|NCT04742205|Tranexamic Acid|tranexamic acid|mesh-list
5947839|NCT04742205|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5947840|NCT04742205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5947841|NCT04742205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947842|NCT04742205|Hemostatics|hemostatics|mesh-ancestor
5947843|NCT04742205|Coagulants|coagulants|mesh-ancestor
5947844|NCT04741880|Lidocaine|lidocaine|mesh-list
5947845|NCT04741880|Anesthetics, Local|anesthetics, local|mesh-ancestor
5947846|NCT04741880|Anesthetics|anesthetics|mesh-ancestor
5947847|NCT04741880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5947848|NCT04741880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947849|NCT04741880|Sensory System Agents|sensory system agents|mesh-ancestor
5947850|NCT04741880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5947851|NCT04741880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5947852|NCT04741880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5947853|NCT04741880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5947854|NCT04741880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5947855|NCT04741880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947856|NCT04741620|Cinnamaldehyde|cinnamaldehyde|mesh-list
5947857|NCT04741620|Capsaicin|capsaicin|mesh-list
5947858|NCT04741620|Sodium Citrate|sodium citrate|mesh-list
5947859|NCT04741620|Citric Acid|citric acid|mesh-list
5947860|NCT04741620|Piperine|piperine|mesh-list
5947861|NCT04741620|Antipruritics|antipruritics|mesh-ancestor
5947862|NCT04741620|Dermatologic Agents|dermatologic agents|mesh-ancestor
5947863|NCT04741620|Sensory System Agents|sensory system agents|mesh-ancestor
5947864|NCT04741620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5947865|NCT04741620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947866|NCT04741620|Anticoagulants|anticoagulants|mesh-ancestor
5947867|NCT04741620|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5947868|NCT04741620|Chelating Agents|chelating agents|mesh-ancestor
5947869|NCT04741620|Sequestering Agents|sequestering agents|mesh-ancestor
5947870|NCT04741620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947871|NCT04741620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5947872|NCT04741620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5947873|NCT04741620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5947874|NCT04741620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5947875|NCT04741620|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
5947876|NCT04741620|Protective Agents|protective agents|mesh-ancestor
5947877|NCT04741464|Tinzaparin|tinzaparin|mesh-list
5947878|NCT04741464|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5947879|NCT04741464|Dalteparin|dalteparin|mesh-list
5947880|NCT04741464|Anticoagulants|anticoagulants|mesh-ancestor
5947881|NCT04741464|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5947882|NCT04741464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5947883|NCT04741464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947884|NCT04741815|Carbon Fiber|carbon fiber|mesh-list
5947885|NCT04741815|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5947886|NCT04741815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5947887|NCT04741334|Anticoagulants|anticoagulants|mesh-list
5947888|NCT04741334|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
5947889|NCT04741386|Vaccines|vaccines|mesh-list
5947890|NCT04741386|Immunologic Factors|immunologic factors|mesh-ancestor
5947891|NCT04741386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947892|NCT04741438|Nivolumab|nivolumab|mesh-list
5947893|NCT04741438|Ipilimumab|ipilimumab|mesh-list
5947894|NCT04741438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5947895|NCT04741438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5947896|NCT04741438|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5947897|NCT04741438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947898|NCT04741295|Heparin|heparin|mesh-list
5947899|NCT04741295|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5947900|NCT04741295|Tinzaparin|tinzaparin|mesh-list
5947901|NCT04741295|Dalteparin|dalteparin|mesh-list
5947902|NCT04741295|Anticoagulants|anticoagulants|mesh-ancestor
5947903|NCT04741295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5947904|NCT04741295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5947905|NCT04741295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947906|NCT04741165|Bevacizumab|bevacizumab|mesh-list
5947907|NCT04741165|Lenvatinib|lenvatinib|mesh-list
5947908|NCT04741165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5947909|NCT04741165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5947910|NCT04741165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5947911|NCT04741165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5947912|NCT04741165|Growth Substances|growth substances|mesh-ancestor
5947913|NCT04741165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947914|NCT04741165|Growth Inhibitors|growth inhibitors|mesh-ancestor
5947915|NCT04741165|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5947916|NCT04741165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5947917|NCT04741165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947918|NCT04740840|Amlodipine|amlodipine|mesh-list
5947919|NCT04740840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5947920|NCT04740840|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5947921|NCT04740840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5947922|NCT04740840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947923|NCT04740840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5947924|NCT04740840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947925|NCT04740840|Vasodilator Agents|vasodilator agents|mesh-ancestor
5947926|NCT04740593|Methamphetamine|methamphetamine|mesh-list
5947927|NCT04740593|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5947928|NCT04740593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947929|NCT04740593|Sympathomimetics|sympathomimetics|mesh-ancestor
5947930|NCT04740593|Autonomic Agents|autonomic agents|mesh-ancestor
5947931|NCT04740593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5947932|NCT04740593|Dopamine Agents|dopamine agents|mesh-ancestor
5947933|NCT04740593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5947934|NCT04740593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947935|NCT04740593|Adrenergic Agents|adrenergic agents|mesh-ancestor
5947936|NCT04740593|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5947937|NCT04740593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5947938|NCT04740593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5947939|NCT04740593|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5968245|NCT04554485|Blinatumomab|blinatumomab|mesh-list
5968246|NCT04554485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5968247|NCT04554433|Ethanol|ethanol|mesh-list
5968248|NCT04554433|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5968249|NCT04554433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5968250|NCT04554433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5968251|NCT04554433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968252|NCT04554459|Ponatinib|ponatinib|mesh-list
5968253|NCT04554459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5968254|NCT04554459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5968255|NCT04554459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5968256|NCT04554459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968257|NCT04554524|Paclitaxel|paclitaxel|mesh-list
5968258|NCT04554524|Pembrolizumab|pembrolizumab|mesh-list
5947940|NCT04740697|Tamoxifen|tamoxifen|mesh-list
5947941|NCT04740697|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5947942|NCT04740697|Hormone Antagonists|hormone antagonists|mesh-ancestor
5947943|NCT04740697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5947944|NCT04740697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947945|NCT04740697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5947946|NCT04740697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5947947|NCT04740697|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5947948|NCT04740697|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5947949|NCT04740697|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5947950|NCT04740554|Prednisone|prednisone|mesh-list
5947951|NCT04740554|Deflazacort|deflazacort|mesh-list
5947952|NCT04740554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5947953|NCT04740554|Glucocorticoids|glucocorticoids|mesh-ancestor
5947954|NCT04740554|Hormones|hormones|mesh-ancestor
5947955|NCT04740554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5947956|NCT04740554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947957|NCT04740554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5947958|NCT04740554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5947959|NCT04740554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5947960|NCT04740554|Immunologic Factors|immunologic factors|mesh-ancestor
5947961|NCT04740190|Carboplatin|carboplatin|mesh-list
5947962|NCT04740190|Talazoparib|talazoparib|mesh-list
5947963|NCT04740190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5947964|NCT04740190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5947965|NCT04740190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5947966|NCT04740190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947967|NCT04740021|Carboplatin|carboplatin|mesh-list
5947968|NCT04740021|Etoposide|etoposide|mesh-list
5947969|NCT04740021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5947970|NCT04740021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5947971|NCT04740021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5947972|NCT04740021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5947973|NCT04740021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5947974|NCT04740021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947975|NCT04740099|Naloxone|naloxone|mesh-list
5947976|NCT04740099|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5947977|NCT04740099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947978|NCT04740099|Sensory System Agents|sensory system agents|mesh-ancestor
5947979|NCT04740099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5947980|NCT04740008|Nicotine|nicotine|mesh-list
5947981|NCT04740008|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5947982|NCT04740008|Autonomic Agents|autonomic agents|mesh-ancestor
5947983|NCT04740008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5947984|NCT04740008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5947985|NCT04740008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5947986|NCT04740008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5947987|NCT04740008|Cholinergic Agents|cholinergic agents|mesh-ancestor
5947988|NCT04740008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5947989|NCT04740008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947990|NCT04739826|HH-GV-678|hh-gv-678|mesh-list
5947991|NCT04739826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5947992|NCT04739826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5947993|NCT04739826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5947994|NCT04739774|Itraconazole|itraconazole|mesh-list
5947995|NCT04739774|Antifungal Agents|antifungal agents|mesh-ancestor
5947996|NCT04739774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5947997|NCT04739774|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5947998|NCT04739774|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5947999|NCT04739774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5948000|NCT04739774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948001|NCT04739774|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5948002|NCT04739774|Hormone Antagonists|hormone antagonists|mesh-ancestor
5948003|NCT04739774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5948004|NCT04739774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948005|NCT04739774|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5948006|NCT04740086|Calcium|calcium|mesh-list
5948007|NCT04740086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5948008|NCT04740086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948009|NCT04739670|Gemcitabine|gemcitabine|mesh-list
5948010|NCT04739670|Bevacizumab|bevacizumab|mesh-list
5948011|NCT04739670|Carboplatin|carboplatin|mesh-list
5948012|NCT04739670|Atezolizumab|atezolizumab|mesh-list
5948013|NCT04739670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5948014|NCT04739670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5948015|NCT04739670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5948016|NCT04739670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5948017|NCT04739670|Growth Substances|growth substances|mesh-ancestor
5948018|NCT04739670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948019|NCT04739670|Growth Inhibitors|growth inhibitors|mesh-ancestor
5948020|NCT04739670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5948021|NCT04739670|Antimetabolites|antimetabolites|mesh-ancestor
5948022|NCT04739670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948023|NCT04739670|Antiviral Agents|antiviral agents|mesh-ancestor
5948024|NCT04739670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5948025|NCT04739670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5948026|NCT04739670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5948027|NCT04739670|Immunologic Factors|immunologic factors|mesh-ancestor
5948028|NCT04739618|Pembrolizumab|pembrolizumab|mesh-list
5948029|NCT04739618|Ipilimumab|ipilimumab|mesh-list
5948030|NCT04739618|Sargramostim|sargramostim|mesh-list
5948031|NCT04739618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5948032|NCT04739618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5948033|NCT04739618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5948034|NCT04739618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948035|NCT04739618|Immunologic Factors|immunologic factors|mesh-ancestor
5948036|NCT04739618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948037|NCT04739566|Trametinib|trametinib|mesh-list
5948038|NCT04739566|Dabrafenib|dabrafenib|mesh-list
5948039|NCT04739566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5948040|NCT04739566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5948041|NCT04739566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5948042|NCT04739566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948043|NCT04739592|Vitamin D|vitamin d|mesh-list
5948044|NCT04739592|Cholecalciferol|cholecalciferol|mesh-list
5948045|NCT04739592|Alendronate|alendronate|mesh-list
5948046|NCT04739592|Vitamins|vitamins|mesh-ancestor
5948047|NCT04739592|Micronutrients|micronutrients|mesh-ancestor
5948048|NCT04739592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948049|NCT04739592|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5948050|NCT04739592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5948051|NCT04739410|Ivermectin|ivermectin|mesh-list
5948052|NCT04739410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5948053|NCT04739410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5948054|NCT04739241|Insulin|insulin|mesh-list
5948055|NCT04739241|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5948056|NCT04739241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5948057|NCT04739241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948058|NCT04739202|Bevacizumab|bevacizumab|mesh-list
5948059|NCT04739202|Atezolizumab|atezolizumab|mesh-list
5948060|NCT04739202|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5948061|NCT04739202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5948062|NCT04739202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5948063|NCT04739202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5948064|NCT04739202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5948065|NCT04739202|Growth Substances|growth substances|mesh-ancestor
5948066|NCT04739202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948067|NCT04739202|Growth Inhibitors|growth inhibitors|mesh-ancestor
5948068|NCT04739202|Immunologic Factors|immunologic factors|mesh-ancestor
5948069|NCT04739215|Dapagliflozin|dapagliflozin|mesh-list
5948070|NCT04739215|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5948071|NCT04739215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948072|NCT04739215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5948073|NCT04739215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948074|NCT04738955|Micafungin|micafungin|mesh-list
5948075|NCT04738955|Antifungal Agents|antifungal agents|mesh-ancestor
5948076|NCT04738955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5948077|NCT04739111|Antibodies|antibodies|mesh-list
5948078|NCT04739111|Immunoglobulins|immunoglobulins|mesh-list
5948079|NCT04739111|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5948080|NCT04739111|Immunologic Factors|immunologic factors|mesh-ancestor
5948081|NCT04739111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948082|NCT04738981|Basiliximab|basiliximab|mesh-list
5948083|NCT04738981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5948084|NCT04738981|Immunologic Factors|immunologic factors|mesh-ancestor
5948085|NCT04738981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948086|NCT04738695|Antibodies|antibodies|mesh-list
5948087|NCT04738695|Immunologic Factors|immunologic factors|mesh-ancestor
5948088|NCT04738695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948089|NCT04738838|Oxytocin|oxytocin|mesh-list
5948090|NCT04738838|Oxytocics|oxytocics|mesh-ancestor
5948091|NCT04738838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5948092|NCT04738838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948093|NCT04738773|Naltrexone|naltrexone|mesh-list
5948094|NCT04738773|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5948095|NCT04738773|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5948096|NCT04738773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948097|NCT04738773|Sensory System Agents|sensory system agents|mesh-ancestor
5948098|NCT04738773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5948099|NCT04738526|Lithium Carbonate|lithium carbonate|mesh-list
5948100|NCT04738526|Antidepressive Agents|antidepressive agents|mesh-ancestor
5948101|NCT04738526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5948102|NCT04738526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5948103|NCT04738526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948104|NCT04738526|Antimanic Agents|antimanic agents|mesh-ancestor
5948105|NCT04738526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5948106|NCT04738526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5948107|NCT04738526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948108|NCT04738058|Lactoferrin|lactoferrin|mesh-list
5948109|NCT04738058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5948110|NCT04738188|Epirubicin|epirubicin|mesh-list
5948111|NCT04738188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5948112|NCT04738188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5948113|NCT04738188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5948114|NCT04738188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5948115|NCT04738188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5948116|NCT04738188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948117|NCT04738097|Clopidogrel|clopidogrel|mesh-list
5948118|NCT04738097|Ticagrelor|ticagrelor|mesh-list
5948119|NCT04738097|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5948120|NCT04738097|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5948121|NCT04738097|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5948122|NCT04738097|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5948123|NCT04738097|Purinergic Agents|purinergic agents|mesh-ancestor
5948124|NCT04738097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5948125|NCT04738097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948126|NCT04738097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948127|NCT04738045|Ritonavir|ritonavir|mesh-list
5948128|NCT04738045|Lopinavir|lopinavir|mesh-list
5948129|NCT04738045|Remdesivir|remdesivir|mesh-list
5948130|NCT04738045|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5948131|NCT04738045|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5948132|NCT04738045|Protease Inhibitors|protease inhibitors|mesh-ancestor
5948133|NCT04738045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5948134|NCT04738045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948135|NCT04738045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5948136|NCT04738045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5948137|NCT04738045|Antiviral Agents|antiviral agents|mesh-ancestor
5948138|NCT04738045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5948139|NCT04738045|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5948140|NCT04738045|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5948141|NCT04738045|Antimetabolites|antimetabolites|mesh-ancestor
5948142|NCT04738162|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5948143|NCT04738162|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5948144|NCT04738162|Dermatologic Agents|dermatologic agents|mesh-ancestor
5948145|NCT04737889|Rituximab|rituximab|mesh-list
5948146|NCT04737889|Methotrexate|methotrexate|mesh-list
5948147|NCT04737889|Lenalidomide|lenalidomide|mesh-list
5948148|NCT04737889|Temozolomide|temozolomide|mesh-list
5948149|NCT04737889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5948150|NCT04737889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5948151|NCT04737889|Immunologic Factors|immunologic factors|mesh-ancestor
5948152|NCT04737889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948153|NCT04737889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5948154|NCT04737889|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5948155|NCT04737889|Abortifacient Agents|abortifacient agents|mesh-ancestor
5948156|NCT04737889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5948157|NCT04737889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5948158|NCT04737889|Antimetabolites|antimetabolites|mesh-ancestor
5948159|NCT04737889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948160|NCT04737889|Dermatologic Agents|dermatologic agents|mesh-ancestor
5948161|NCT04737889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5948162|NCT04737889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5948163|NCT04737889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5948164|NCT04737889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5948165|NCT04737889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5948166|NCT04737889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5948167|NCT04737889|Growth Substances|growth substances|mesh-ancestor
5948168|NCT04737889|Growth Inhibitors|growth inhibitors|mesh-ancestor
5948169|NCT04737889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5948170|NCT04737889|Alkylating Agents|alkylating agents|mesh-ancestor
5948171|NCT04737928|Latanoprost|latanoprost|mesh-list
5948172|NCT04737928|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5948173|NCT04737928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5948174|NCT04737980|Dexamethasone|dexamethasone|mesh-list
5948175|NCT04737980|Bupivacaine|bupivacaine|mesh-list
5948176|NCT04737980|Ropivacaine|ropivacaine|mesh-list
5948177|NCT04737980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5948178|NCT04737980|Antiemetics|antiemetics|mesh-ancestor
5948179|NCT04737980|Autonomic Agents|autonomic agents|mesh-ancestor
5948180|NCT04737980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5948181|NCT04737980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948182|NCT04737980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5948183|NCT04737980|Glucocorticoids|glucocorticoids|mesh-ancestor
5948184|NCT04737980|Hormones|hormones|mesh-ancestor
5948185|NCT04737980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5948186|NCT04737980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5948187|NCT04737980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5948188|NCT04737980|Anesthetics, Local|anesthetics, local|mesh-ancestor
5948189|NCT04737980|Anesthetics|anesthetics|mesh-ancestor
5948190|NCT04737980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5948191|NCT04737980|Sensory System Agents|sensory system agents|mesh-ancestor
5948192|NCT04737967|Memantine|memantine|mesh-list
5948193|NCT04737967|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
5948194|NCT04737967|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5948195|NCT04737967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5948196|NCT04737967|Dopamine Agents|dopamine agents|mesh-ancestor
5948197|NCT04737967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5948198|NCT04737967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948199|NCT04737967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948200|NCT04737967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5948201|NCT04737967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5948202|NCT04737967|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5948203|NCT04737967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5948204|NCT04737967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5948205|NCT04737967|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5948206|NCT04737967|Antidepressive Agents|antidepressive agents|mesh-ancestor
5948207|NCT04737967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5948208|NCT04737837|Lacosamide|lacosamide|mesh-list
5948209|NCT04737837|Anticonvulsants|anticonvulsants|mesh-ancestor
5948210|NCT04737837|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5948211|NCT04737837|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5948212|NCT04737837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5948213|NCT04737837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948214|NCT04737655|Beclomethasone|beclomethasone|mesh-list
5948215|NCT04737655|Glycopyrrolate|glycopyrrolate|mesh-list
5948216|NCT04737655|Formoterol Fumarate|formoterol fumarate|mesh-list
5948217|NCT04737655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5948218|NCT04737655|Autonomic Agents|autonomic agents|mesh-ancestor
5948219|NCT04737655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5948220|NCT04737655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948221|NCT04737655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5948222|NCT04737655|Respiratory System Agents|respiratory system agents|mesh-ancestor
5948223|NCT04737655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5948224|NCT04737655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5948225|NCT04737655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5948226|NCT04737655|Adrenergic Agents|adrenergic agents|mesh-ancestor
5948227|NCT04737655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5948228|NCT04737655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948229|NCT04737655|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5948230|NCT04737655|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5948231|NCT04737655|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5948232|NCT04737655|Cholinergic Agents|cholinergic agents|mesh-ancestor
5948233|NCT04737655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5948234|NCT04737655|Glucocorticoids|glucocorticoids|mesh-ancestor
5948235|NCT04737655|Hormones|hormones|mesh-ancestor
5948236|NCT04737655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5948237|NCT04737408|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5948238|NCT04737408|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5948239|NCT04737408|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5948240|NCT04737408|Antimetabolites|antimetabolites|mesh-ancestor
5948241|NCT04737408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948242|NCT04737408|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5948243|NCT04737408|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5948244|NCT04737408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5948245|NCT04737278|Nicotinic Acids|nicotinic acids|mesh-list
5948246|NCT04737278|Niacin|niacin|mesh-list
5948247|NCT04737278|Vitamin B Complex|vitamin b complex|mesh-ancestor
5948248|NCT04737278|Vitamins|vitamins|mesh-ancestor
5948249|NCT04737278|Micronutrients|micronutrients|mesh-ancestor
5948250|NCT04737278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948251|NCT04737278|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5948252|NCT04737278|Antimetabolites|antimetabolites|mesh-ancestor
5948253|NCT04737278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948254|NCT04737278|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5948255|NCT04737278|Vasodilator Agents|vasodilator agents|mesh-ancestor
5948256|NCT04737473|Anesthetics|anesthetics|mesh-list
5948257|NCT04737473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5948258|NCT04737473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968259|NCT04554524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5968260|NCT04554524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5968261|NCT04554524|Tubulin Modulators|tubulin modulators|mesh-ancestor
5968262|NCT04554524|Antimitotic Agents|antimitotic agents|mesh-ancestor
5968263|NCT04554524|Mitosis Modulators|mitosis modulators|mesh-ancestor
5968264|NCT04554524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968265|NCT04554524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5968266|NCT04554303|Amlodipine|amlodipine|mesh-list
5968267|NCT04554303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5968268|NCT04554303|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5968269|NCT04554303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5968270|NCT04554303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968271|NCT04554303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5968272|NCT04554303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968273|NCT04554303|Vasodilator Agents|vasodilator agents|mesh-ancestor
5968274|NCT04554771|Paclitaxel|paclitaxel|mesh-list
5968275|NCT04554771|Carboplatin|carboplatin|mesh-list
5968276|NCT04554771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5968277|NCT04554771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5968278|NCT04554771|Tubulin Modulators|tubulin modulators|mesh-ancestor
5968279|NCT04554771|Antimitotic Agents|antimitotic agents|mesh-ancestor
5968280|NCT04554771|Mitosis Modulators|mitosis modulators|mesh-ancestor
5968281|NCT04554771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968282|NCT04553770|Trastuzumab|trastuzumab|mesh-list
5968283|NCT04553770|Anastrozole|anastrozole|mesh-list
5968284|NCT04553770|Camptothecin|camptothecin|mesh-list
5968285|NCT04553770|Immunoconjugates|immunoconjugates|mesh-list
5968286|NCT04553770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5968287|NCT04553770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5968288|NCT04553770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5968289|NCT04553770|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5968290|NCT04553770|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5968291|NCT04553770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5968292|NCT04553770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968293|NCT04553770|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5968294|NCT04553770|Hormone Antagonists|hormone antagonists|mesh-ancestor
5968295|NCT04553770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5968296|NCT04553770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968297|NCT04553770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5968298|NCT04553770|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5968299|NCT04553770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5968300|NCT04553770|Immunologic Factors|immunologic factors|mesh-ancestor
5971098|NCT04530422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971099|NCT04530422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5971100|NCT04530422|Antiviral Agents|antiviral agents|mesh-ancestor
5971101|NCT04530617|Camostat|camostat|mesh-list
5971102|NCT04530617|Protease Inhibitors|protease inhibitors|mesh-ancestor
5971103|NCT04530617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5971104|NCT04530617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971105|NCT04530617|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5971106|NCT04530617|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5948259|NCT04736953|Sirolimus|sirolimus|mesh-list
5948260|NCT04736953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5948261|NCT04736953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5948262|NCT04736953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5948263|NCT04736953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5948264|NCT04736953|Antifungal Agents|antifungal agents|mesh-ancestor
5948265|NCT04736953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5948266|NCT04736953|Immunologic Factors|immunologic factors|mesh-ancestor
5948267|NCT04736953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948268|NCT04737057|Fluorides|fluorides|mesh-list
5948269|NCT04737057|Cariostatic Agents|cariostatic agents|mesh-ancestor
5948270|NCT04737057|Protective Agents|protective agents|mesh-ancestor
5948271|NCT04737057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948272|NCT04736836|Rifaximin|rifaximin|mesh-list
5948273|NCT04736836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5948274|NCT04736836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5948275|NCT04736836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5948276|NCT04736823|Paclitaxel|paclitaxel|mesh-list
5948277|NCT04736823|Docetaxel|docetaxel|mesh-list
5948278|NCT04736823|Carboplatin|carboplatin|mesh-list
5948279|NCT04736823|Pemetrexed|pemetrexed|mesh-list
5948280|NCT04736823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5948281|NCT04736823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5948282|NCT04736823|Tubulin Modulators|tubulin modulators|mesh-ancestor
5948283|NCT04736823|Antimitotic Agents|antimitotic agents|mesh-ancestor
5948284|NCT04736823|Mitosis Modulators|mitosis modulators|mesh-ancestor
5948285|NCT04736823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948286|NCT04736823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5948287|NCT04736823|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5948288|NCT04736823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5948289|NCT04736914|Zanubrutinib|zanubrutinib|mesh-list
5948290|NCT04736914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5948291|NCT04736914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5948292|NCT04736914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5948293|NCT04736914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948294|NCT04736966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5948295|NCT04736966|Immunologic Factors|immunologic factors|mesh-ancestor
5948296|NCT04736966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948297|NCT04736901|Enoxaparin|enoxaparin|mesh-list
5948298|NCT04736901|Rivaroxaban|rivaroxaban|mesh-list
5948299|NCT04736901|Apixaban|apixaban|mesh-list
5948300|NCT04736901|Enoxaparin sodium|enoxaparin sodium|mesh-list
5948301|NCT04736901|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5948302|NCT04736901|Antithrombins|antithrombins|mesh-ancestor
5948303|NCT04736901|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5948304|NCT04736901|Protease Inhibitors|protease inhibitors|mesh-ancestor
5948305|NCT04736901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5948306|NCT04736901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948307|NCT04736901|Anticoagulants|anticoagulants|mesh-ancestor
5948308|NCT04736901|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5948309|NCT04736901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5948310|NCT04736927|Midazolam|midazolam|mesh-list
5948311|NCT04736927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5948312|NCT04736927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5948313|NCT04736927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5948314|NCT04736927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948315|NCT04736927|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5948316|NCT04736927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5948317|NCT04736927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5948318|NCT04736927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5948319|NCT04736927|Anesthetics, General|anesthetics, general|mesh-ancestor
5948320|NCT04736927|Anesthetics|anesthetics|mesh-ancestor
5948321|NCT04736927|GABA Modulators|gaba modulators|mesh-ancestor
5948322|NCT04736927|GABA Agents|gaba agents|mesh-ancestor
5948323|NCT04736927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5948324|NCT04736927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948325|NCT04736979|Amoxicillin|amoxicillin|mesh-list
5948326|NCT04736979|Clavulanic Acid|clavulanic acid|mesh-list
5948327|NCT04736979|Clavulanic Acids|clavulanic acids|mesh-list
5948328|NCT04736979|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5948329|NCT04736979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5948330|NCT04736979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5948331|NCT04736979|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5948332|NCT04736979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5948333|NCT04736979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948334|NCT04736524|Antibodies|antibodies|mesh-list
5948335|NCT04736524|Immunologic Factors|immunologic factors|mesh-ancestor
5948336|NCT04736524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948337|NCT04736810|Gemcitabine|gemcitabine|mesh-list
5948338|NCT04736810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5948339|NCT04736810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5948340|NCT04736810|Antimetabolites|antimetabolites|mesh-ancestor
5948341|NCT04736810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948342|NCT04736810|Antiviral Agents|antiviral agents|mesh-ancestor
5948343|NCT04736810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5948344|NCT04736810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5948345|NCT04736810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5948346|NCT04736810|Immunologic Factors|immunologic factors|mesh-ancestor
5948347|NCT04736810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948348|NCT04736693|Zoledronic Acid|zoledronic acid|mesh-list
5948349|NCT04736693|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
5948350|NCT04736693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5948351|NCT04736693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948352|NCT04736693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5948353|NCT04736693|Hormone Antagonists|hormone antagonists|mesh-ancestor
5948354|NCT04736693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5948355|NCT04736693|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5948356|NCT04736693|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5948357|NCT04736719|Warfarin|warfarin|mesh-list
5948358|NCT04736719|Apixaban|apixaban|mesh-list
5948359|NCT04736719|Anticoagulants|anticoagulants|mesh-ancestor
5948360|NCT04736719|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5948361|NCT04736719|Antithrombins|antithrombins|mesh-ancestor
5948362|NCT04736719|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5948363|NCT04736719|Protease Inhibitors|protease inhibitors|mesh-ancestor
5948364|NCT04736719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5948365|NCT04736719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948366|NCT04736433|Valsartan|valsartan|mesh-list
5948367|NCT04736433|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
5948368|NCT04736433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5948369|NCT04736433|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5948370|NCT04736433|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5948371|NCT04736433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948372|NCT04736433|Protease Inhibitors|protease inhibitors|mesh-ancestor
5948373|NCT04736433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5948374|NCT04736420|Warfarin|warfarin|mesh-list
5948375|NCT04736420|Rivaroxaban|rivaroxaban|mesh-list
5948376|NCT04736420|Anticoagulants|anticoagulants|mesh-ancestor
5948377|NCT04736420|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5948378|NCT04736420|Antithrombins|antithrombins|mesh-ancestor
5948379|NCT04736420|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5948380|NCT04736420|Protease Inhibitors|protease inhibitors|mesh-ancestor
5948381|NCT04736420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5948382|NCT04736420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948383|NCT04736589|Sirolimus|sirolimus|mesh-list
5948384|NCT04736589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5948385|NCT04736589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5948386|NCT04736589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5948387|NCT04736589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5948388|NCT04736589|Antifungal Agents|antifungal agents|mesh-ancestor
5948389|NCT04736589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5948390|NCT04736589|Immunologic Factors|immunologic factors|mesh-ancestor
5948391|NCT04736589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948392|NCT04736329|Telmisartan|telmisartan|mesh-list
5948393|NCT04736329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5948394|NCT04736329|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5948395|NCT04736329|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5948396|NCT04736329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948397|NCT04736381|Mycophenolic Acid|mycophenolic acid|mesh-list
5948398|NCT04736381|Abatacept|abatacept|mesh-list
5948399|NCT04736381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5948400|NCT04736381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5948401|NCT04736381|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5948402|NCT04736381|Antitubercular Agents|antitubercular agents|mesh-ancestor
5948403|NCT04736381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5948404|NCT04736381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5948405|NCT04736381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5948406|NCT04736381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948407|NCT04736381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5948408|NCT04736381|Immunologic Factors|immunologic factors|mesh-ancestor
5948409|NCT04736381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948410|NCT04736381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5948411|NCT04736381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5948412|NCT04736108|Prednisolone|prednisolone|mesh-list
5948413|NCT04736108|Goserelin|goserelin|mesh-list
5948414|NCT04736108|Abiraterone Acetate|abiraterone acetate|mesh-list
5948415|NCT04736108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5948416|NCT04736108|Glucocorticoids|glucocorticoids|mesh-ancestor
5948417|NCT04736108|Hormones|hormones|mesh-ancestor
5948418|NCT04736108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5948419|NCT04736108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948420|NCT04736108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5948421|NCT04736108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5948422|NCT04736108|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5948423|NCT04736108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5948424|NCT04736108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948425|NCT04736108|Hormone Antagonists|hormone antagonists|mesh-ancestor
5948426|NCT04736108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5948427|NCT04736225|Insulin|insulin|mesh-list
5948428|NCT04736225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5948429|NCT04736225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948430|NCT04736186|Loperamide|loperamide|mesh-list
5948431|NCT04736186|Antidiarrheals|antidiarrheals|mesh-list
5948432|NCT04736186|Bentonite|bentonite|mesh-list
5948433|NCT04736186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5948434|NCT04736186|Antidotes|antidotes|mesh-ancestor
5948435|NCT04736186|Protective Agents|protective agents|mesh-ancestor
5948436|NCT04736186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948437|NCT04735978|Antibodies|antibodies|mesh-list
5948438|NCT04735978|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5948439|NCT04735978|Immunologic Factors|immunologic factors|mesh-ancestor
5948440|NCT04735978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948441|NCT04735926|Calcifediol|calcifediol|mesh-list
5948442|NCT04735926|Vitamins|vitamins|mesh-ancestor
5948443|NCT04735926|Micronutrients|micronutrients|mesh-ancestor
5948444|NCT04735926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948445|NCT04735926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5948446|NCT04735523|Warfarin|warfarin|mesh-list
5948447|NCT04735523|Dabigatran|dabigatran|mesh-list
5948448|NCT04735523|Anticoagulants|anticoagulants|mesh-ancestor
5948449|NCT04735523|Antithrombins|antithrombins|mesh-ancestor
5948450|NCT04735523|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5948451|NCT04735523|Protease Inhibitors|protease inhibitors|mesh-ancestor
5948452|NCT04735523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5948453|NCT04735523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948454|NCT04735445|Liver Extracts|liver extracts|mesh-list
5948455|NCT04735445|Hematinics|hematinics|mesh-ancestor
5948456|NCT04735770|Levobupivacaine|levobupivacaine|mesh-list
5948457|NCT04735770|Anesthetics|anesthetics|mesh-ancestor
5948458|NCT04735770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5948459|NCT04735770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948460|NCT04735770|Anesthetics, Local|anesthetics, local|mesh-ancestor
5948461|NCT04735770|Sensory System Agents|sensory system agents|mesh-ancestor
5948462|NCT04735770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5948463|NCT04735510|Cyclosporine|cyclosporine|mesh-list
5948464|NCT04735510|Cyclosporins|cyclosporins|mesh-list
5948465|NCT04735510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5948466|NCT04735510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948467|NCT04735510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5948468|NCT04735510|Immunologic Factors|immunologic factors|mesh-ancestor
5948469|NCT04735510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948470|NCT04735510|Antifungal Agents|antifungal agents|mesh-ancestor
5948471|NCT04735510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5948472|NCT04735510|Dermatologic Agents|dermatologic agents|mesh-ancestor
5948473|NCT04735510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5948474|NCT04735510|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5948475|NCT04735549|Hormones|hormones|mesh-list
5948476|NCT04735549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5948477|NCT04735549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681355|NCT01609166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681356|NCT01609192|Hydroxyurea|hydroxyurea|mesh-list
6681357|NCT01609192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6681358|NCT01609192|Antisickling Agents|antisickling agents|mesh-ancestor
6681359|NCT01609192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6681360|NCT01609192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681361|NCT01609192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5948478|NCT04735471|Cyclophosphamide|cyclophosphamide|mesh-list
5948479|NCT04735471|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6517426|NCT00721032|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5948480|NCT04735471|Fludarabine|fludarabine|mesh-list
5948481|NCT04735471|Interleukin-2|interleukin-2|mesh-list
5948482|NCT04735471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5948483|NCT04735471|Immunologic Factors|immunologic factors|mesh-ancestor
5948484|NCT04735471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948485|NCT04735471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5948486|NCT04735471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5948487|NCT04735471|Alkylating Agents|alkylating agents|mesh-ancestor
5948488|NCT04735471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948489|NCT04735471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5948490|NCT04735471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5948491|NCT04735471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5948492|NCT04735471|Analgesics|analgesics|mesh-ancestor
5948493|NCT04735471|Sensory System Agents|sensory system agents|mesh-ancestor
5948494|NCT04735471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5968301|NCT04553705|Quinine|quinine|mesh-list
5968302|NCT04553705|Antimalarials|antimalarials|mesh-ancestor
5968303|NCT04553705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5968304|NCT04553705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5968305|NCT04553705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5968306|NCT04553705|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5968307|NCT04553705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968308|NCT04553705|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5968309|NCT04553705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5968310|NCT04553705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5968311|NCT04553705|Analgesics|analgesics|mesh-ancestor
5968312|NCT04553705|Sensory System Agents|sensory system agents|mesh-ancestor
5968313|NCT04553601|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5968314|NCT04553601|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5968315|NCT04553601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968316|NCT04553263|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
5968317|NCT04553263|Naltrexone|naltrexone|mesh-list
5968318|NCT04553263|Bupropion|bupropion|mesh-list
5968319|NCT04553263|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5968320|NCT04553263|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5968321|NCT04553263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968322|NCT04553263|Sensory System Agents|sensory system agents|mesh-ancestor
5968323|NCT04553263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5968324|NCT04553263|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5968325|NCT04553263|Antidepressive Agents|antidepressive agents|mesh-ancestor
5968326|NCT04553263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5968327|NCT04553263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5968328|NCT04553263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5968329|NCT04553263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5968330|NCT04553263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968331|NCT04553263|Dopamine Agents|dopamine agents|mesh-ancestor
5968332|NCT04553263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5968333|NCT04553263|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5968334|NCT04553263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5968335|NCT04553263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5968336|NCT04553263|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5968337|NCT04553380|Insulin|insulin|mesh-list
5968338|NCT04553380|Insulin Glargine|insulin glargine|mesh-list
5968339|NCT04553380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5968340|NCT04553380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968341|NCT04553393|Decitabine|decitabine|mesh-list
5968342|NCT04553393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5968343|NCT04553393|Antimetabolites|antimetabolites|mesh-ancestor
5968344|NCT04553393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968345|NCT04553393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5968346|NCT04553393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5968347|NCT04553510|Bevacizumab|bevacizumab|mesh-list
5968348|NCT04553510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5968349|NCT04553510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5968350|NCT04553510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5968351|NCT04553510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5968352|NCT04553510|Growth Substances|growth substances|mesh-ancestor
5968353|NCT04553510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968354|NCT04553510|Growth Inhibitors|growth inhibitors|mesh-ancestor
5968355|NCT04553458|Ethanol|ethanol|mesh-list
5968356|NCT04553458|Sorafenib|sorafenib|mesh-list
5968357|NCT04553458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5968358|NCT04553458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6517427|NCT00721032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6517428|NCT00721032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517429|NCT00721032|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6517430|NCT00721032|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6517431|NCT00721032|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6517432|NCT00721032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6517433|NCT00721032|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6517434|NCT00721032|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6681362|NCT01609205|Adalimumab|adalimumab|mesh-list
5948495|NCT04735042|Dapagliflozin|dapagliflozin|mesh-list
5948496|NCT04735042|Empagliflozin|empagliflozin|mesh-list
5948497|NCT04735042|Linagliptin|linagliptin|mesh-list
5948498|NCT04735042|Saxagliptin|saxagliptin|mesh-list
5948499|NCT04735042|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5948500|NCT04735042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948501|NCT04735042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5948502|NCT04735042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948503|NCT04735042|Incretins|incretins|mesh-ancestor
5948504|NCT04735042|Hormones|hormones|mesh-ancestor
5948505|NCT04735042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5948506|NCT04735042|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5948507|NCT04735042|Protease Inhibitors|protease inhibitors|mesh-ancestor
5948508|NCT04735042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5948509|NCT04735068|Hydroxychloroquine|hydroxychloroquine|mesh-list
5948510|NCT04735068|Antimalarials|antimalarials|mesh-ancestor
5948511|NCT04735068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5948512|NCT04735068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5948513|NCT04735068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5948514|NCT04735068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5948515|NCT04735068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948516|NCT04735068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5948517|NCT04734639|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
5948518|NCT04734639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5948519|NCT04734639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948520|NCT04734678|Infliximab|infliximab|mesh-list
5948521|NCT04734678|Dermatologic Agents|dermatologic agents|mesh-ancestor
5948522|NCT04734678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5948523|NCT04734678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5948524|NCT04734730|Prednisone|prednisone|mesh-list
5948525|NCT04734730|Cortisone|cortisone|mesh-list
5948526|NCT04734730|Leuprolide|leuprolide|mesh-list
5948527|NCT04734730|Goserelin|goserelin|mesh-list
5948528|NCT04734730|Abiraterone Acetate|abiraterone acetate|mesh-list
5948529|NCT04734730|Bicalutamide|bicalutamide|mesh-list
5948530|NCT04734730|Talazoparib|talazoparib|mesh-list
5948531|NCT04734730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5948532|NCT04734730|Glucocorticoids|glucocorticoids|mesh-ancestor
5948533|NCT04734730|Hormones|hormones|mesh-ancestor
5948534|NCT04734730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5948535|NCT04734730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948536|NCT04734730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5948537|NCT04734730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5948538|NCT04734730|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5948539|NCT04734730|Fertility Agents|fertility agents|mesh-ancestor
5948540|NCT04734730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5948541|NCT04734730|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5948542|NCT04734730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5948543|NCT04734730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948544|NCT04734730|Hormone Antagonists|hormone antagonists|mesh-ancestor
5948545|NCT04734730|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5948546|NCT04734730|Androgen Antagonists|androgen antagonists|mesh-ancestor
5948547|NCT04734730|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5948548|NCT04734782|Antibodies|antibodies|mesh-list
5948549|NCT04734782|Immunologic Factors|immunologic factors|mesh-ancestor
5948550|NCT04734782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948551|NCT04734665|Bevacizumab|bevacizumab|mesh-list
5948552|NCT04734665|Niraparib|niraparib|mesh-list
5948553|NCT04734665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5948554|NCT04734665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5948555|NCT04734665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5948556|NCT04734665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5948557|NCT04734665|Growth Substances|growth substances|mesh-ancestor
5948558|NCT04734665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948559|NCT04734665|Growth Inhibitors|growth inhibitors|mesh-ancestor
5968359|NCT04553458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5948560|NCT04734665|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5948561|NCT04734665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5948562|NCT04734665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948563|NCT04734418|Dexmedetomidine|dexmedetomidine|mesh-list
5948564|NCT04734418|Remifentanil|remifentanil|mesh-list
5948565|NCT04734418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5948566|NCT04734418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5948567|NCT04734418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948568|NCT04734418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5948569|NCT04734418|Analgesics|analgesics|mesh-ancestor
5948570|NCT04734418|Sensory System Agents|sensory system agents|mesh-ancestor
5948571|NCT04734418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5948572|NCT04734418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5948573|NCT04734418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5948574|NCT04734418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5948575|NCT04734418|Adrenergic Agents|adrenergic agents|mesh-ancestor
5948576|NCT04734418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5948577|NCT04734418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948578|NCT04734418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5948579|NCT04734418|Narcotics|narcotics|mesh-ancestor
5948580|NCT04734210|Betamethasone|betamethasone|mesh-list
5948581|NCT04734210|Betamethasone Valerate|betamethasone valerate|mesh-list
5948582|NCT04734210|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5948583|NCT04734210|Betamethasone benzoate|betamethasone benzoate|mesh-list
5948584|NCT04734210|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
5948585|NCT04734210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5948586|NCT04734210|Glucocorticoids|glucocorticoids|mesh-ancestor
5948587|NCT04734210|Hormones|hormones|mesh-ancestor
5948588|NCT04734210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5948589|NCT04734210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948590|NCT04734210|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5948591|NCT04734210|Respiratory System Agents|respiratory system agents|mesh-ancestor
5948592|NCT04734405|Fluconazole|fluconazole|mesh-list
5948593|NCT04734405|Antifungal Agents|antifungal agents|mesh-ancestor
5948594|NCT04734405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5948595|NCT04734405|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5948596|NCT04734405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5948597|NCT04734405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5948598|NCT04734405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948599|NCT04734405|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5948600|NCT04734405|Hormone Antagonists|hormone antagonists|mesh-ancestor
5948601|NCT04734405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5948602|NCT04734405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948603|NCT04734405|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5948604|NCT04734405|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5948605|NCT04734028|Aspirin|aspirin|mesh-list
5948606|NCT04734028|Clopidogrel|clopidogrel|mesh-list
5948607|NCT04734028|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5948608|NCT04734028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5948609|NCT04734028|Analgesics|analgesics|mesh-ancestor
5948610|NCT04734028|Sensory System Agents|sensory system agents|mesh-ancestor
5948611|NCT04734028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5948612|NCT04734028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948613|NCT04734028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5948614|NCT04734028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5948615|NCT04734028|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5948616|NCT04734028|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5948617|NCT04734028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948618|NCT04734028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5948619|NCT04734028|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5948620|NCT04734028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5948621|NCT04734028|Antipyretics|antipyretics|mesh-ancestor
5948622|NCT04734028|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5948623|NCT04734028|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5948624|NCT04734028|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5948625|NCT04734028|Purinergic Agents|purinergic agents|mesh-ancestor
5948626|NCT04734028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5948627|NCT04734067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5948628|NCT04734067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948629|NCT04734067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5948630|NCT04734353|Ticagrelor|ticagrelor|mesh-list
5948631|NCT04734353|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
5948632|NCT04734353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5948633|NCT04734353|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5948634|NCT04734353|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5948635|NCT04734353|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5948636|NCT04734353|Purinergic Agents|purinergic agents|mesh-ancestor
5948637|NCT04734353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5948638|NCT04734353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948639|NCT04734353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948640|NCT04734119|Anesthetics|anesthetics|mesh-list
5948641|NCT04734119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5948642|NCT04734119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948643|NCT04734080|Dronabinol|dronabinol|mesh-list
5948644|NCT04734080|Hallucinogens|hallucinogens|mesh-ancestor
5948645|NCT04734080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948646|NCT04734080|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5948647|NCT04734080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5948648|NCT04734080|Analgesics|analgesics|mesh-ancestor
5948649|NCT04734080|Sensory System Agents|sensory system agents|mesh-ancestor
5948650|NCT04734080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5948651|NCT04734080|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5948652|NCT04734080|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5948653|NCT04734080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5948654|NCT04734080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948655|NCT04734080|Hormones|hormones|mesh-ancestor
5948656|NCT04734080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5948657|NCT04734041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
5948658|NCT04733781|Lidocaine|lidocaine|mesh-list
5948659|NCT04733781|Epinephrine|epinephrine|mesh-list
5948660|NCT04733781|Anesthetics, Local|anesthetics, local|mesh-ancestor
5948661|NCT04733781|Anesthetics|anesthetics|mesh-ancestor
5948662|NCT04733781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5948663|NCT04733781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948664|NCT04733781|Sensory System Agents|sensory system agents|mesh-ancestor
5948665|NCT04733781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5948666|NCT04733781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5948667|NCT04733781|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5948668|NCT04733781|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5948669|NCT04733781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5948670|NCT04733781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948671|NCT04733781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5948672|NCT04733781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5948673|NCT04733781|Adrenergic Agents|adrenergic agents|mesh-ancestor
5948674|NCT04733781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5948675|NCT04733781|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5948676|NCT04733781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5948677|NCT04733781|Autonomic Agents|autonomic agents|mesh-ancestor
5948678|NCT04733781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5948679|NCT04733781|Respiratory System Agents|respiratory system agents|mesh-ancestor
5948680|NCT04733781|Mydriatics|mydriatics|mesh-ancestor
5948681|NCT04733781|Sympathomimetics|sympathomimetics|mesh-ancestor
5948682|NCT04733781|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5968360|NCT04553458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968361|NCT04553458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5968362|NCT04553458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5968363|NCT04553458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5968364|NCT04553458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968365|NCT04553536|Sufentanil|sufentanil|mesh-list
5968366|NCT04553536|Remifentanil|remifentanil|mesh-list
5968367|NCT04553536|Dsuvia|dsuvia|mesh-list
5968368|NCT04553536|Bromides|bromides|mesh-list
5968369|NCT04553536|Propofol|propofol|mesh-list
5968370|NCT04553536|Esketamine|esketamine|mesh-list
5968371|NCT04553536|Rocuronium|rocuronium|mesh-list
5968372|NCT04553536|Cisatracurium|cisatracurium|mesh-list
5968373|NCT04553536|Atracurium|atracurium|mesh-list
5968374|NCT04553536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5968375|NCT04553536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5968376|NCT04553536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968377|NCT04553536|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5968378|NCT04553536|Anesthetics, General|anesthetics, general|mesh-ancestor
5968379|NCT04553536|Anesthetics|anesthetics|mesh-ancestor
5968380|NCT04553536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5968381|NCT04553536|Narcotics|narcotics|mesh-ancestor
5968382|NCT04553536|Analgesics|analgesics|mesh-ancestor
5948683|NCT04733625|Vitamin D|vitamin d|mesh-list
5948684|NCT04733625|Cholecalciferol|cholecalciferol|mesh-list
5948685|NCT04733625|Vitamins|vitamins|mesh-ancestor
5948686|NCT04733625|Micronutrients|micronutrients|mesh-ancestor
5948687|NCT04733625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948688|NCT04733625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5948689|NCT04733625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5948690|NCT04733326|Ketorolac|ketorolac|mesh-list
5948691|NCT04733326|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
5948692|NCT04733326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5948693|NCT04733326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5948694|NCT04733326|Analgesics|analgesics|mesh-ancestor
5948695|NCT04733326|Sensory System Agents|sensory system agents|mesh-ancestor
5948696|NCT04733326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5948697|NCT04733326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948698|NCT04733326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5948699|NCT04733326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5948700|NCT04733326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5948701|NCT04733326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5948702|NCT04733326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948703|NCT04733963|Bevacizumab|bevacizumab|mesh-list
5948704|NCT04733963|Capecitabine|capecitabine|mesh-list
5948705|NCT04733963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5948706|NCT04733963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5948707|NCT04733963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5948708|NCT04733963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5948709|NCT04733963|Growth Substances|growth substances|mesh-ancestor
5948710|NCT04733963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948711|NCT04733963|Growth Inhibitors|growth inhibitors|mesh-ancestor
5948712|NCT04733963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5948713|NCT04733963|Antimetabolites|antimetabolites|mesh-ancestor
5948714|NCT04733963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948715|NCT04733521|Cisplatin|cisplatin|mesh-list
5948716|NCT04733521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5948717|NCT04733508|Exenatide|exenatide|mesh-list
5948718|NCT04733508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5948719|NCT04733508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948720|NCT04733508|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5948721|NCT04733508|Incretins|incretins|mesh-ancestor
5948722|NCT04733508|Hormones|hormones|mesh-ancestor
5948723|NCT04733508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5948724|NCT04733235|Progesterone|progesterone|mesh-list
5948725|NCT04733235|Hormones|hormones|mesh-ancestor
5948726|NCT04733235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5948727|NCT04733235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948728|NCT04733235|Progestins|progestins|mesh-ancestor
5948729|NCT04733144|Dexamethasone|dexamethasone|mesh-list
5948730|NCT04733144|Prednisolone|prednisolone|mesh-list
5948731|NCT04733144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5948732|NCT04733144|Antiemetics|antiemetics|mesh-ancestor
5948733|NCT04733144|Autonomic Agents|autonomic agents|mesh-ancestor
5948734|NCT04733144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5948735|NCT04733144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948736|NCT04733144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5948737|NCT04733144|Glucocorticoids|glucocorticoids|mesh-ancestor
5948738|NCT04733144|Hormones|hormones|mesh-ancestor
5948739|NCT04733144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5948740|NCT04733144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5948741|NCT04733144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5948742|NCT04733131|Abatacept|abatacept|mesh-list
5948743|NCT04733131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5948744|NCT04733131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948745|NCT04733131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5948746|NCT04733131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5948747|NCT04733131|Immunologic Factors|immunologic factors|mesh-ancestor
5948748|NCT04733131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948749|NCT04733131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5948750|NCT04733066|Teduglutide|teduglutide|mesh-list
5948751|NCT04733066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5948752|NCT04733066|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5948753|NCT04733066|Protective Agents|protective agents|mesh-ancestor
5948754|NCT04733066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948755|NCT04733573|Salicylic Acid|salicylic acid|mesh-list
5948756|NCT04733573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5948757|NCT04733573|Antifungal Agents|antifungal agents|mesh-ancestor
5948758|NCT04733573|Keratolytic Agents|keratolytic agents|mesh-ancestor
5948759|NCT04733573|Dermatologic Agents|dermatologic agents|mesh-ancestor
5948760|NCT04733547|Furosemide|furosemide|mesh-list
5948761|NCT04733547|Diuretics|diuretics|mesh-ancestor
5948762|NCT04733547|Natriuretic Agents|natriuretic agents|mesh-ancestor
5948763|NCT04733547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948764|NCT04733547|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5948765|NCT04733547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5948766|NCT04733547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948767|NCT04732910|Ivacaftor|ivacaftor|mesh-list
5948768|NCT04732910|Elexacaftor|elexacaftor|mesh-list
5948769|NCT04732910|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
5948770|NCT04732910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5948771|NCT04732910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948772|NCT04733092|Ethiodized Oil|ethiodized oil|mesh-list
5948773|NCT04733092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5948774|NCT04732845|Cyclophosphamide|cyclophosphamide|mesh-list
5948775|NCT04732845|Fludarabine|fludarabine|mesh-list
5948776|NCT04732845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5948777|NCT04732845|Immunologic Factors|immunologic factors|mesh-ancestor
5948778|NCT04732845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948779|NCT04732845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5948780|NCT04732845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5948781|NCT04732845|Alkylating Agents|alkylating agents|mesh-ancestor
5948782|NCT04732845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948783|NCT04732845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5948784|NCT04732845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5948785|NCT04733183|Dacarbazine|dacarbazine|mesh-list
5948786|NCT04733183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5948787|NCT04733183|Alkylating Agents|alkylating agents|mesh-ancestor
5948788|NCT04733183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948789|NCT04733183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5948790|NCT04733118|Trastuzumab|trastuzumab|mesh-list
5948791|NCT04733118|Pertuzumab|pertuzumab|mesh-list
5948792|NCT04733118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5948793|NCT04733118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5948794|NCT04733196|Chlorhexidine|chlorhexidine|mesh-list
5948795|NCT04733196|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5948796|NCT04733196|Hydrogen Peroxide|hydrogen peroxide|mesh-list
5948797|NCT04733196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5948798|NCT04733196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5948799|NCT04733196|Disinfectants|disinfectants|mesh-ancestor
5948800|NCT04733196|Dermatologic Agents|dermatologic agents|mesh-ancestor
5948801|NCT04732390|Magnesium Sulfate|magnesium sulfate|mesh-list
5948802|NCT04732390|Bupivacaine|bupivacaine|mesh-list
5948803|NCT04732390|Anesthetics, Local|anesthetics, local|mesh-ancestor
5948804|NCT04732390|Anesthetics|anesthetics|mesh-ancestor
5948805|NCT04732390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5948806|NCT04732390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948807|NCT04732390|Sensory System Agents|sensory system agents|mesh-ancestor
5948808|NCT04732390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5948809|NCT04732390|Analgesics|analgesics|mesh-ancestor
5948810|NCT04732390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5948811|NCT04732390|Anticonvulsants|anticonvulsants|mesh-ancestor
5948812|NCT04732390|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5948813|NCT04732390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5948814|NCT04732390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948815|NCT04732390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5948816|NCT04732390|Tocolytic Agents|tocolytic agents|mesh-ancestor
5948817|NCT04732390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5948818|NCT04732377|Dexmedetomidine|dexmedetomidine|mesh-list
5948819|NCT04732377|Bupivacaine|bupivacaine|mesh-list
5948820|NCT04732377|Anesthetics, Local|anesthetics, local|mesh-ancestor
5948821|NCT04732377|Anesthetics|anesthetics|mesh-ancestor
5948822|NCT04732377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5948823|NCT04732377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948824|NCT04732377|Sensory System Agents|sensory system agents|mesh-ancestor
5948825|NCT04732377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5948826|NCT04732377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5948827|NCT04732377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5948828|NCT04732377|Analgesics|analgesics|mesh-ancestor
5948829|NCT04732377|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5948830|NCT04732377|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5948831|NCT04732377|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5948832|NCT04732377|Adrenergic Agents|adrenergic agents|mesh-ancestor
5948833|NCT04732377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5948834|NCT04732377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948835|NCT04732455|Lidocaine|lidocaine|mesh-list
5948836|NCT04732455|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5948837|NCT04732455|Anesthetics, Local|anesthetics, local|mesh-ancestor
5948838|NCT04732455|Anesthetics|anesthetics|mesh-ancestor
5948839|NCT04732455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5948840|NCT04732455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948841|NCT04732455|Sensory System Agents|sensory system agents|mesh-ancestor
5948842|NCT04732455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5948843|NCT04732455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5948844|NCT04732455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5948845|NCT04732455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5948846|NCT04732455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5948847|NCT04732455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948848|NCT04732455|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5948849|NCT04732455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5948850|NCT04732455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5948851|NCT04732455|Analgesics|analgesics|mesh-ancestor
5948852|NCT04732455|Antidepressive Agents|antidepressive agents|mesh-ancestor
5948853|NCT04732455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5948854|NCT04732455|Dopamine Agents|dopamine agents|mesh-ancestor
5948855|NCT04732364|Bupivacaine|bupivacaine|mesh-list
5948856|NCT04732364|Anesthetics, Local|anesthetics, local|mesh-ancestor
5948857|NCT04732364|Anesthetics|anesthetics|mesh-ancestor
5948858|NCT04732364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5948859|NCT04732364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948860|NCT04732364|Sensory System Agents|sensory system agents|mesh-ancestor
5948861|NCT04732364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5948862|NCT04732598|Paclitaxel|paclitaxel|mesh-list
5948863|NCT04732598|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5948864|NCT04732598|Bevacizumab|bevacizumab|mesh-list
5948865|NCT04732598|Atezolizumab|atezolizumab|mesh-list
5948866|NCT04732598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5948867|NCT04732598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5948868|NCT04732598|Tubulin Modulators|tubulin modulators|mesh-ancestor
5948869|NCT04732598|Antimitotic Agents|antimitotic agents|mesh-ancestor
5948870|NCT04732598|Mitosis Modulators|mitosis modulators|mesh-ancestor
5948871|NCT04732598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948872|NCT04732598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5948873|NCT04732598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5948874|NCT04732598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5948875|NCT04732598|Growth Substances|growth substances|mesh-ancestor
5948876|NCT04732598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948877|NCT04732598|Growth Inhibitors|growth inhibitors|mesh-ancestor
5948878|NCT04732507|Lidocaine|lidocaine|mesh-list
5948879|NCT04732507|Bupivacaine|bupivacaine|mesh-list
5948880|NCT04732507|Anesthetics, Local|anesthetics, local|mesh-ancestor
5948881|NCT04732507|Anesthetics|anesthetics|mesh-ancestor
5948882|NCT04732507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5948883|NCT04732507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948884|NCT04732507|Sensory System Agents|sensory system agents|mesh-ancestor
5948885|NCT04732507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5948886|NCT04732507|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5948887|NCT04732507|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5948888|NCT04732507|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5948889|NCT04732507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5948890|NCT04732507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948891|NCT04732247|Oxytocin|oxytocin|mesh-list
5948892|NCT04732247|Oxytocics|oxytocics|mesh-ancestor
5948893|NCT04732247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5948894|NCT04732247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948895|NCT04731961|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5948896|NCT04731961|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5948897|NCT04731961|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5948898|NCT04731961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5948899|NCT04731961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948900|NCT04731961|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5948901|NCT04731961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5948902|NCT04731961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948903|NCT04731961|Cholinergic Agents|cholinergic agents|mesh-ancestor
5948904|NCT04731961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5948905|NCT04732104|Lidocaine|lidocaine|mesh-list
5948906|NCT04732104|Xylometazoline|xylometazoline|mesh-list
5948907|NCT04732104|Nasal Decongestants|nasal decongestants|mesh-list
5948908|NCT04732104|Anesthetics, Local|anesthetics, local|mesh-ancestor
5948909|NCT04732104|Anesthetics|anesthetics|mesh-ancestor
5948910|NCT04732104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5948911|NCT04732104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948912|NCT04732104|Sensory System Agents|sensory system agents|mesh-ancestor
5948913|NCT04732104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5948914|NCT04732104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5948915|NCT04732104|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5948916|NCT04732104|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5948917|NCT04732104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5948918|NCT04732104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948919|NCT04732104|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5948920|NCT04732104|Respiratory System Agents|respiratory system agents|mesh-ancestor
5948921|NCT04732000|Acetylcysteine|acetylcysteine|mesh-list
5948922|NCT04732000|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5948923|NCT04732000|Antiviral Agents|antiviral agents|mesh-ancestor
5948924|NCT04732000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5948925|NCT04732000|Expectorants|expectorants|mesh-ancestor
5948926|NCT04732000|Respiratory System Agents|respiratory system agents|mesh-ancestor
5948927|NCT04732000|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5948928|NCT04732000|Antioxidants|antioxidants|mesh-ancestor
5948929|NCT04732000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948930|NCT04732000|Protective Agents|protective agents|mesh-ancestor
5948931|NCT04732000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948932|NCT04732000|Antidotes|antidotes|mesh-ancestor
5948933|NCT04731727|Riboflavin|riboflavin|mesh-list
5948934|NCT04731727|Vitamin B Complex|vitamin b complex|mesh-ancestor
5948935|NCT04731727|Vitamins|vitamins|mesh-ancestor
5948936|NCT04731727|Micronutrients|micronutrients|mesh-ancestor
5948937|NCT04731727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948938|NCT04731727|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5948939|NCT04731727|Dermatologic Agents|dermatologic agents|mesh-ancestor
5948940|NCT04731740|Pembrolizumab|pembrolizumab|mesh-list
5948941|NCT04731740|Lenvatinib|lenvatinib|mesh-list
5948942|NCT04731740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5948943|NCT04731740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5948944|NCT04731740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5948945|NCT04731740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5948946|NCT04731740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968383|NCT04553536|Sensory System Agents|sensory system agents|mesh-ancestor
5968384|NCT04553536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5968385|NCT04553536|Anticonvulsants|anticonvulsants|mesh-ancestor
5968386|NCT04553536|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5968387|NCT04553536|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5968388|NCT04553536|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5968389|NCT04553536|Antidepressive Agents|antidepressive agents|mesh-ancestor
5968390|NCT04553536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5968391|NCT04553536|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
5968392|NCT04553536|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5968393|NCT04553536|Cholinergic Agents|cholinergic agents|mesh-ancestor
5968394|NCT04553536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5968395|NCT04553536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968396|NCT04553536|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5968397|NCT04553328|Bupivacaine|bupivacaine|mesh-list
5968398|NCT04553328|Anesthetics, Local|anesthetics, local|mesh-ancestor
5968399|NCT04553328|Anesthetics|anesthetics|mesh-ancestor
5968400|NCT04553328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5968401|NCT04553328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968402|NCT04553328|Sensory System Agents|sensory system agents|mesh-ancestor
5968403|NCT04553328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5968404|NCT04552782|Ethanol|ethanol|mesh-list
5968405|NCT04552782|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5968406|NCT04552782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5968407|NCT04552782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5968408|NCT04552782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968409|NCT04552795|Lamivudine|lamivudine|mesh-list
5968410|NCT04552795|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5968411|NCT04552795|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5968412|NCT04552795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5968413|NCT04552795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968414|NCT04552795|Antiviral Agents|antiviral agents|mesh-ancestor
5968415|NCT04552795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5968416|NCT04552795|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5948947|NCT04731948|Vitamins|vitamins|mesh-list
5948948|NCT04731948|Folic Acid|folic acid|mesh-list
5948949|NCT04731948|Hydroxocobalamin|hydroxocobalamin|mesh-list
5948950|NCT04731948|Vitamin B 12|vitamin b 12|mesh-list
5948951|NCT04731948|Vitamin B Complex|vitamin b complex|mesh-list
5948952|NCT04731948|Micronutrients|micronutrients|mesh-ancestor
5948953|NCT04731948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948954|NCT04731948|Hematinics|hematinics|mesh-ancestor
5948955|NCT04731909|Cisplatin|cisplatin|mesh-list
5948956|NCT04731909|Carboplatin|carboplatin|mesh-list
5948957|NCT04731909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5948958|NCT04731766|Listerine|listerine|mesh-list
5948959|NCT04731766|Fluorides|fluorides|mesh-list
5948960|NCT04731766|Sodium Fluoride|sodium fluoride|mesh-list
5948961|NCT04731766|Cariostatic Agents|cariostatic agents|mesh-ancestor
5948962|NCT04731766|Protective Agents|protective agents|mesh-ancestor
5948963|NCT04731766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948964|NCT04731766|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5948965|NCT04731766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5948966|NCT04731558|Enoxaparin|enoxaparin|mesh-list
5948967|NCT04731558|Dalteparin|dalteparin|mesh-list
5948968|NCT04731558|Tinzaparin|tinzaparin|mesh-list
5948969|NCT04731558|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5948970|NCT04731558|Anticoagulants|anticoagulants|mesh-ancestor
5948971|NCT04731558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5948972|NCT04731558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5948973|NCT04731558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5948974|NCT04731363|Erythritol|erythritol|mesh-list
5948975|NCT04731363|Vasodilator Agents|vasodilator agents|mesh-ancestor
5948976|NCT04731376|Methyltestosterone|methyltestosterone|mesh-list
5948977|NCT04731376|Testosterone|testosterone|mesh-list
5948978|NCT04731376|Testosterone undecanoate|testosterone undecanoate|mesh-list
5948979|NCT04731376|Testosterone enanthate|testosterone enanthate|mesh-list
5948980|NCT04731376|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5948981|NCT04731376|Androgens|androgens|mesh-ancestor
5948982|NCT04731376|Hormones|hormones|mesh-ancestor
5948983|NCT04731376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5948984|NCT04731376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948985|NCT04731376|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5948986|NCT04731376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5948987|NCT04731376|Anabolic Agents|anabolic agents|mesh-ancestor
5948988|NCT04731480|Propofol|propofol|mesh-list
5948989|NCT04731480|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5948990|NCT04731480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5948991|NCT04731480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5948992|NCT04731480|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5948993|NCT04731480|Anesthetics, General|anesthetics, general|mesh-ancestor
5948994|NCT04731480|Anesthetics|anesthetics|mesh-ancestor
5948995|NCT04731116|Cannabidiol|cannabidiol|mesh-list
5948996|NCT04731116|Anticonvulsants|anticonvulsants|mesh-ancestor
5948997|NCT04731038|Paclitaxel|paclitaxel|mesh-list
5948998|NCT04731038|Carboplatin|carboplatin|mesh-list
5948999|NCT04731038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5949000|NCT04731038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5949001|NCT04731038|Tubulin Modulators|tubulin modulators|mesh-ancestor
5949002|NCT04731038|Antimitotic Agents|antimitotic agents|mesh-ancestor
5949003|NCT04731038|Mitosis Modulators|mitosis modulators|mesh-ancestor
5949004|NCT04731038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949005|NCT04731090|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5949006|NCT04731090|Fluoroquinolones|fluoroquinolones|mesh-list
5949007|NCT04731090|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5949008|NCT04731090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5949009|NCT04731090|Antitubercular Agents|antitubercular agents|mesh-ancestor
5949010|NCT04731090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5949011|NCT04731090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5949012|NCT04731090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949013|NCT04730973|Evolocumab|evolocumab|mesh-list
5949014|NCT04730973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5949015|NCT04730973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5949016|NCT04730973|Antimetabolites|antimetabolites|mesh-ancestor
5949017|NCT04730973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949018|NCT04730973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5949019|NCT04730856|Tinzaparin|tinzaparin|mesh-list
5949020|NCT04730856|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5949021|NCT04730856|Dalteparin|dalteparin|mesh-list
5949022|NCT04730856|Anticoagulants|anticoagulants|mesh-ancestor
5949023|NCT04730856|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5949024|NCT04730856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5949025|NCT04730856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949026|NCT04730765|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5949027|NCT04730765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5949028|NCT04730895|Tretinoin|tretinoin|mesh-list
5949029|NCT04730895|Isotretinoin|isotretinoin|mesh-list
5949030|NCT04730895|Vaccines|vaccines|mesh-list
5949031|NCT04730895|Myeloma Proteins|myeloma proteins|mesh-list
5949032|NCT04730895|Paraproteins|paraproteins|mesh-list
5949033|NCT04730895|Immunologic Factors|immunologic factors|mesh-ancestor
5949034|NCT04730895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949035|NCT04730895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5949036|NCT04730895|Keratolytic Agents|keratolytic agents|mesh-ancestor
5949037|NCT04730895|Dermatologic Agents|dermatologic agents|mesh-ancestor
5949038|NCT04730999|Bevacizumab|bevacizumab|mesh-list
5949039|NCT04730999|Carboplatin|carboplatin|mesh-list
5949040|NCT04730999|Etoposide|etoposide|mesh-list
5949041|NCT04730999|Atezolizumab|atezolizumab|mesh-list
5949042|NCT04730999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5949043|NCT04730999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5949044|NCT04730999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5949045|NCT04730999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5949046|NCT04730999|Growth Substances|growth substances|mesh-ancestor
5949047|NCT04730999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949048|NCT04730999|Growth Inhibitors|growth inhibitors|mesh-ancestor
5949049|NCT04730999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5949050|NCT04730999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5949051|NCT04730999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5949052|NCT04730999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5949053|NCT04730999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949054|NCT04730947|Dapagliflozin|dapagliflozin|mesh-list
5949055|NCT04730947|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5949056|NCT04730947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949057|NCT04730947|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5949058|NCT04730947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949059|NCT04730362|Propofol|propofol|mesh-list
5949060|NCT04730362|Sevoflurane|sevoflurane|mesh-list
5949061|NCT04730362|Anesthetics|anesthetics|mesh-ancestor
5949062|NCT04730362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5949063|NCT04730362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949064|NCT04730362|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5949065|NCT04730362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5949066|NCT04730362|Anesthetics, General|anesthetics, general|mesh-ancestor
5949067|NCT04730362|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5949068|NCT04730362|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5949069|NCT04730622|Mitogens|mitogens|mesh-list
5949070|NCT04730622|Mitosis Modulators|mitosis modulators|mesh-ancestor
5949071|NCT04730622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949072|NCT04730609|Dexmedetomidine|dexmedetomidine|mesh-list
5949073|NCT04730609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5949074|NCT04730609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5949075|NCT04730609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949076|NCT04730609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5949077|NCT04730609|Analgesics|analgesics|mesh-ancestor
5949078|NCT04730609|Sensory System Agents|sensory system agents|mesh-ancestor
5949079|NCT04730609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5949080|NCT04730609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5949081|NCT04730609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5949082|NCT04730609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5949083|NCT04730609|Adrenergic Agents|adrenergic agents|mesh-ancestor
5949084|NCT04730609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5949085|NCT04730609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949086|NCT04730544|Nivolumab|nivolumab|mesh-list
5949087|NCT04730544|Ipilimumab|ipilimumab|mesh-list
5949088|NCT04730544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5949089|NCT04730544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5949090|NCT04730544|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5949091|NCT04730544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949092|NCT04730531|Epinephrine|epinephrine|mesh-list
5949093|NCT04730531|Bupivacaine|bupivacaine|mesh-list
5949094|NCT04730531|Anesthetics, Local|anesthetics, local|mesh-ancestor
5949095|NCT04730531|Anesthetics|anesthetics|mesh-ancestor
5949096|NCT04730531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5949097|NCT04730531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949098|NCT04730531|Sensory System Agents|sensory system agents|mesh-ancestor
5949099|NCT04730531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5949100|NCT04730531|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5949101|NCT04730531|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5949102|NCT04730531|Adrenergic Agents|adrenergic agents|mesh-ancestor
5949103|NCT04730531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5949104|NCT04730531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949105|NCT04730531|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5949106|NCT04730531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5949107|NCT04730531|Autonomic Agents|autonomic agents|mesh-ancestor
5949108|NCT04730531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5949109|NCT04730531|Respiratory System Agents|respiratory system agents|mesh-ancestor
5949110|NCT04730531|Mydriatics|mydriatics|mesh-ancestor
5949111|NCT04730531|Sympathomimetics|sympathomimetics|mesh-ancestor
5949112|NCT04730531|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5949113|NCT04730596|Dexmedetomidine|dexmedetomidine|mesh-list
5949114|NCT04730596|Ketamine|ketamine|mesh-list
5949115|NCT04730596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5949116|NCT04730596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5949117|NCT04730596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949118|NCT04730596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5949119|NCT04730596|Analgesics|analgesics|mesh-ancestor
5949120|NCT04730596|Sensory System Agents|sensory system agents|mesh-ancestor
5949121|NCT04730596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5949122|NCT04730596|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5949123|NCT04730596|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5949124|NCT04730596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5949125|NCT04730596|Adrenergic Agents|adrenergic agents|mesh-ancestor
5949126|NCT04730596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5949127|NCT04730596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949128|NCT04730596|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5949129|NCT04730596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5949130|NCT04730596|Anesthetics, General|anesthetics, general|mesh-ancestor
5949131|NCT04730596|Anesthetics|anesthetics|mesh-ancestor
5949132|NCT04730596|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5949133|NCT04730596|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5949134|NCT04730674|Tetracycline|tetracycline|mesh-list
5949135|NCT04730674|Lidocaine|lidocaine|mesh-list
5949136|NCT04730674|Anesthetics, Local|anesthetics, local|mesh-ancestor
5949137|NCT04730674|Anesthetics|anesthetics|mesh-ancestor
5949138|NCT04730674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5949139|NCT04730674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949140|NCT04730674|Sensory System Agents|sensory system agents|mesh-ancestor
5949141|NCT04730674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5949142|NCT04730674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5949143|NCT04730674|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5949144|NCT04730674|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5949145|NCT04730674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5949146|NCT04730674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949147|NCT04730674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5949148|NCT04730674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5949149|NCT04730674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5949150|NCT04730674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5949151|NCT04730583|Deoxycholic Acid|deoxycholic acid|mesh-list
5949152|NCT04730583|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5949153|NCT04730583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5949154|NCT04730375|Dexmedetomidine|dexmedetomidine|mesh-list
5949155|NCT04730375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5949156|NCT04730375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5949157|NCT04730375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949158|NCT04730375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5949159|NCT04730375|Analgesics|analgesics|mesh-ancestor
5949160|NCT04730375|Sensory System Agents|sensory system agents|mesh-ancestor
5949161|NCT04730375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5949162|NCT04730375|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5949163|NCT04730375|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5949164|NCT04730375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5949165|NCT04730375|Adrenergic Agents|adrenergic agents|mesh-ancestor
5949166|NCT04730375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5949167|NCT04730375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949168|NCT04730245|Rifaximin|rifaximin|mesh-list
5949169|NCT04730245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5949170|NCT04730245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5949171|NCT04730245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5949172|NCT04730219|Paclitaxel|paclitaxel|mesh-list
5949173|NCT04730219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5949174|NCT04730219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5949175|NCT04730219|Tubulin Modulators|tubulin modulators|mesh-ancestor
5949176|NCT04730219|Antimitotic Agents|antimitotic agents|mesh-ancestor
5949177|NCT04730219|Mitosis Modulators|mitosis modulators|mesh-ancestor
5949178|NCT04730219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949179|NCT04730297|Acetaminophen|acetaminophen|mesh-list
5949180|NCT04730297|Ibuprofen|ibuprofen|mesh-list
5949181|NCT04730297|Codeine|codeine|mesh-list
5949182|NCT04730297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5949183|NCT04730297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5949184|NCT04730297|Analgesics|analgesics|mesh-ancestor
5949185|NCT04730297|Sensory System Agents|sensory system agents|mesh-ancestor
5949186|NCT04730297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5949187|NCT04730297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949188|NCT04730297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5949189|NCT04730297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5949190|NCT04730297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5949191|NCT04730297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5949192|NCT04730297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949193|NCT04730297|Antipyretics|antipyretics|mesh-ancestor
5949194|NCT04730297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5949195|NCT04730297|Narcotics|narcotics|mesh-ancestor
5949196|NCT04730297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5949197|NCT04730297|Antitussive Agents|antitussive agents|mesh-ancestor
5949198|NCT04730297|Respiratory System Agents|respiratory system agents|mesh-ancestor
5949199|NCT04730258|Azacitidine|azacitidine|mesh-list
5949200|NCT04730258|Decitabine|decitabine|mesh-list
5949201|NCT04730258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5949202|NCT04730258|Antimetabolites|antimetabolites|mesh-ancestor
5949203|NCT04730258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949204|NCT04730258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5949205|NCT04730258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5968417|NCT04552795|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5968418|NCT04552977|Temozolomide|temozolomide|mesh-list
5968419|NCT04552977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5968420|NCT04552977|Alkylating Agents|alkylating agents|mesh-ancestor
5968421|NCT04552977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968422|NCT04552977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5968423|NCT04553003|Prednisone|prednisone|mesh-list
5968424|NCT04553003|Methylprednisolone|methylprednisolone|mesh-list
5968425|NCT04553003|Choline|choline|mesh-list
5968426|NCT04553003|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
5968427|NCT04553003|Glucocorticoids|glucocorticoids|mesh-list
5968428|NCT04553003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5968429|NCT04553003|Hormones|hormones|mesh-ancestor
5968430|NCT04553003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5968431|NCT04553003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968432|NCT04553003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5968433|NCT04553003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5968434|NCT04553003|Antiemetics|antiemetics|mesh-ancestor
5968435|NCT04553003|Autonomic Agents|autonomic agents|mesh-ancestor
5968436|NCT04553003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5968437|NCT04553003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5968438|NCT04553003|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5968439|NCT04553003|Protective Agents|protective agents|mesh-ancestor
5968440|NCT04553003|Lipotropic Agents|lipotropic agents|mesh-ancestor
5968441|NCT04553003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5968442|NCT04553003|Antimetabolites|antimetabolites|mesh-ancestor
5968443|NCT04553003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968444|NCT04553003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5968445|NCT04553003|Nootropic Agents|nootropic agents|mesh-ancestor
5968446|NCT04552951|Vitamin D|vitamin d|mesh-list
5968447|NCT04552951|Cholecalciferol|cholecalciferol|mesh-list
5968448|NCT04552951|Vitamins|vitamins|mesh-ancestor
5968449|NCT04552951|Micronutrients|micronutrients|mesh-ancestor
5968450|NCT04552951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968451|NCT04552951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5968452|NCT04552951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5968453|NCT04552808|Yimitasvir|yimitasvir|mesh-list
5968454|NCT04552808|Antiviral Agents|antiviral agents|mesh-ancestor
5968455|NCT04552808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6517435|NCT00721032|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6517436|NCT00721201|Mifepristone|mifepristone|mesh-list
6517437|NCT00721201|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6517438|NCT00721201|Abortifacient Agents|abortifacient agents|mesh-ancestor
6517439|NCT00721201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5968456|NCT04552743|Plerixafor|plerixafor|mesh-list
6517440|NCT00721201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517441|NCT00721201|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6517442|NCT00721201|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6517443|NCT00721201|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6517444|NCT00721201|Contraceptive Agents|contraceptive agents|mesh-ancestor
6517445|NCT00721201|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5949206|NCT04729998|Rivaroxaban|rivaroxaban|mesh-list
5949207|NCT04729998|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5949208|NCT04729998|Antithrombins|antithrombins|mesh-ancestor
5949209|NCT04729998|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5949210|NCT04729998|Protease Inhibitors|protease inhibitors|mesh-ancestor
5949211|NCT04729998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5949212|NCT04729998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949213|NCT04729998|Anticoagulants|anticoagulants|mesh-ancestor
5949214|NCT04729556|Chitosan|chitosan|mesh-list
5949215|NCT04729556|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5949216|NCT04729556|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5949217|NCT04729556|Antimetabolites|antimetabolites|mesh-ancestor
5949218|NCT04729556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949219|NCT04729556|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5949220|NCT04729556|Chelating Agents|chelating agents|mesh-ancestor
5949221|NCT04729556|Sequestering Agents|sequestering agents|mesh-ancestor
5949222|NCT04729556|Hemostatics|hemostatics|mesh-ancestor
5949223|NCT04729556|Coagulants|coagulants|mesh-ancestor
5949224|NCT04729543|Azacitidine|azacitidine|mesh-list
5949225|NCT04729543|Interleukin-2|interleukin-2|mesh-list
5949226|NCT04729543|Valproic Acid|valproic acid|mesh-list
5949227|NCT04729543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5949228|NCT04729543|Antimetabolites|antimetabolites|mesh-ancestor
5949229|NCT04729543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949230|NCT04729543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5949231|NCT04729543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5949232|NCT04729543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5949233|NCT04729543|Analgesics|analgesics|mesh-ancestor
5949234|NCT04729543|Sensory System Agents|sensory system agents|mesh-ancestor
5949235|NCT04729543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5949236|NCT04729543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949237|NCT04729543|Anticonvulsants|anticonvulsants|mesh-ancestor
5949238|NCT04729543|GABA Agents|gaba agents|mesh-ancestor
5949239|NCT04729543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5949240|NCT04729543|Antimanic Agents|antimanic agents|mesh-ancestor
5949241|NCT04729543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5949242|NCT04729543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5949243|NCT04729543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5949244|NCT04729868|Dexmedetomidine|dexmedetomidine|mesh-list
5949245|NCT04729868|Bupivacaine|bupivacaine|mesh-list
5949246|NCT04729868|Levobupivacaine|levobupivacaine|mesh-list
5949247|NCT04729868|Anesthetics, Local|anesthetics, local|mesh-ancestor
5949248|NCT04729868|Anesthetics|anesthetics|mesh-ancestor
5949249|NCT04729868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5949250|NCT04729868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949251|NCT04729868|Sensory System Agents|sensory system agents|mesh-ancestor
5949252|NCT04729868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5949253|NCT04729868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5949254|NCT04729868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5949255|NCT04729868|Analgesics|analgesics|mesh-ancestor
5949256|NCT04729868|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5949257|NCT04729868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5949258|NCT04729868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5949259|NCT04729868|Adrenergic Agents|adrenergic agents|mesh-ancestor
5949260|NCT04729868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5949261|NCT04729868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949262|NCT04729465|Propofol|propofol|mesh-list
5949263|NCT04729465|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5949264|NCT04729465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5949265|NCT04729465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949266|NCT04729465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5949267|NCT04729465|Anesthetics, General|anesthetics, general|mesh-ancestor
5949268|NCT04729465|Anesthetics|anesthetics|mesh-ancestor
5949269|NCT04729491|Azithromycin|azithromycin|mesh-list
5949270|NCT04729491|Nitazoxanide|nitazoxanide|mesh-list
5949271|NCT04729491|Dutasteride|dutasteride|mesh-list
5949272|NCT04729491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6517446|NCT00721201|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5949273|NCT04729491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5949274|NCT04729491|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
5949275|NCT04729491|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5949276|NCT04729491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5949277|NCT04729491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949278|NCT04729491|Hormone Antagonists|hormone antagonists|mesh-ancestor
5949279|NCT04729491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5949280|NCT04729491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949281|NCT04729491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5949282|NCT04729322|Metronidazole|metronidazole|mesh-list
5949283|NCT04729322|Vancomycin|vancomycin|mesh-list
5949284|NCT04729322|Neomycin|neomycin|mesh-list
5949285|NCT04729322|Pembrolizumab|pembrolizumab|mesh-list
5949286|NCT04729322|Nivolumab|nivolumab|mesh-list
5949287|NCT04729322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5949288|NCT04729322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5949289|NCT04729322|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5949290|NCT04729322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949291|NCT04729322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5949292|NCT04729322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5949293|NCT04729322|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5949294|NCT04729322|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5949295|NCT04729322|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5949296|NCT04729322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5949297|NCT04729517|Azelastine|azelastine|mesh-list
5949298|NCT04729517|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5949299|NCT04729517|Autonomic Agents|autonomic agents|mesh-ancestor
5949300|NCT04729517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5949301|NCT04729517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949302|NCT04729517|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5949303|NCT04729517|Respiratory System Agents|respiratory system agents|mesh-ancestor
5949304|NCT04729517|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
5949305|NCT04729517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5949306|NCT04729517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949307|NCT04729517|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5949308|NCT04729517|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5949309|NCT04729517|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5949310|NCT04729517|Histamine Antagonists|histamine antagonists|mesh-ancestor
5949311|NCT04729517|Histamine Agents|histamine agents|mesh-ancestor
5949312|NCT04729517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5949313|NCT04729179|Cannabidiol|cannabidiol|mesh-list
5949314|NCT04729179|Anticonvulsants|anticonvulsants|mesh-ancestor
5949315|NCT04729348|Pembrolizumab|pembrolizumab|mesh-list
5949316|NCT04729348|Lenvatinib|lenvatinib|mesh-list
5949317|NCT04729348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5949318|NCT04729348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5949319|NCT04729348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5949320|NCT04729348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5949321|NCT04729348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949322|NCT04729101|Lansoprazole|lansoprazole|mesh-list
5949323|NCT04729101|Dexlansoprazole|dexlansoprazole|mesh-list
5949324|NCT04729101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5949325|NCT04729101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5949326|NCT04729101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5949327|NCT04729101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5949328|NCT04729101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949329|NCT04728932|Simendan|simendan|mesh-list
5949330|NCT04728932|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5949331|NCT04728932|Vasodilator Agents|vasodilator agents|mesh-ancestor
5949332|NCT04728932|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5949333|NCT04728932|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5949334|NCT04728932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5949335|NCT04728932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949336|NCT04728932|Protective Agents|protective agents|mesh-ancestor
5949337|NCT04728932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949338|NCT04728880|Remdesivir|remdesivir|mesh-list
5949339|NCT04728880|Antimetabolites|antimetabolites|mesh-ancestor
5949340|NCT04728880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949341|NCT04728880|Antiviral Agents|antiviral agents|mesh-ancestor
5949342|NCT04728880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5949343|NCT04728971|Caspofungin|caspofungin|mesh-list
5949344|NCT04728971|Micafungin|micafungin|mesh-list
5949345|NCT04728971|Antifungal Agents|antifungal agents|mesh-ancestor
5949346|NCT04728971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5949347|NCT04728971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5949348|NCT04728971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949349|NCT04728750|Pancrelipase|pancrelipase|mesh-list
5949350|NCT04728750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5949351|NCT04728516|Amoxicillin|amoxicillin|mesh-list
5949352|NCT04728516|Pantoprazole|pantoprazole|mesh-list
5949353|NCT04728516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5949354|NCT04728516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5949355|NCT04728516|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5949356|NCT04728516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5949357|NCT04728516|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5949358|NCT04728516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5949359|NCT04728516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949360|NCT04728581|Quetiapine Fumarate|quetiapine fumarate|mesh-list
5949361|NCT04728581|Mirtazapine|mirtazapine|mesh-list
5949362|NCT04728581|Antidepressive Agents|antidepressive agents|mesh-ancestor
5949363|NCT04728581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5949364|NCT04728581|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5949365|NCT04728581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5949366|NCT04728581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5949367|NCT04728581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949368|NCT04728581|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5949369|NCT04728581|Histamine Antagonists|histamine antagonists|mesh-ancestor
5949370|NCT04728581|Histamine Agents|histamine agents|mesh-ancestor
5949371|NCT04728581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5949372|NCT04728581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949373|NCT04728581|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5949374|NCT04728581|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5949375|NCT04728581|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5949376|NCT04728581|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5949377|NCT04728581|Adrenergic Agents|adrenergic agents|mesh-ancestor
5949378|NCT04728581|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5949379|NCT04728581|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5949380|NCT04728581|Serotonin Agents|serotonin agents|mesh-ancestor
5949381|NCT04728581|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5949382|NCT04728659|Desogestrel|desogestrel|mesh-list
5949383|NCT04728659|Ganirelix|ganirelix|mesh-list
5949384|NCT04728659|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5949385|NCT04728659|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5949386|NCT04728659|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5949387|NCT04728659|Contraceptive Agents|contraceptive agents|mesh-ancestor
5949388|NCT04728659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5949389|NCT04728659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949390|NCT04728659|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5949391|NCT04728659|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5949392|NCT04728659|Progestins|progestins|mesh-ancestor
5949393|NCT04728659|Hormones|hormones|mesh-ancestor
5949394|NCT04728659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5949395|NCT04728659|Hormone Antagonists|hormone antagonists|mesh-ancestor
5949396|NCT04728386|Sodium Hypochlorite|sodium hypochlorite|mesh-list
5949397|NCT04728386|Eusol|eusol|mesh-list
5949398|NCT04728386|Curcumin|curcumin|mesh-list
5949399|NCT04728386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5949400|NCT04728386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5949401|NCT04728386|Analgesics|analgesics|mesh-ancestor
5949402|NCT04728386|Sensory System Agents|sensory system agents|mesh-ancestor
5949403|NCT04728386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5949404|NCT04728386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949405|NCT04728386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5949406|NCT04728386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5949407|NCT04728386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5949408|NCT04728386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5949409|NCT04728386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949410|NCT04728386|Disinfectants|disinfectants|mesh-ancestor
5949411|NCT04728386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5949412|NCT04729088|Isosorbide|isosorbide|mesh-list
5949413|NCT04729088|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
5949414|NCT04729088|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
5949415|NCT04729088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5949416|NCT04729088|Diuretics|diuretics|mesh-ancestor
5949417|NCT04729088|Natriuretic Agents|natriuretic agents|mesh-ancestor
5949418|NCT04729088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949419|NCT04729088|Vasodilator Agents|vasodilator agents|mesh-ancestor
5949420|NCT04729088|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5949421|NCT04729088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968457|NCT04552743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5968458|NCT04552743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5968459|NCT04552743|Antiviral Agents|antiviral agents|mesh-ancestor
5949422|NCT04729205|Mitomycins|mitomycins|mesh-list
5949423|NCT04729205|Mitomycin|mitomycin|mesh-list
5949424|NCT04729205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5949425|NCT04729205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5949426|NCT04729205|Alkylating Agents|alkylating agents|mesh-ancestor
5949427|NCT04729205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949428|NCT04729205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5949429|NCT04729205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5949430|NCT04729140|Doxycycline|doxycycline|mesh-list
5949431|NCT04729140|Ivermectin|ivermectin|mesh-list
5949432|NCT04729140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5949433|NCT04729140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5949434|NCT04729140|Antimalarials|antimalarials|mesh-ancestor
5949435|NCT04729140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5949436|NCT04729140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5949437|NCT04728425|Immunoglobulins|immunoglobulins|mesh-list
5949438|NCT04728425|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5949439|NCT04728425|Antibodies|antibodies|mesh-list
5949440|NCT04728425|gamma-Globulins|gamma-globulins|mesh-list
5949441|NCT04728425|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5949442|NCT04728425|Immunoglobulin G|immunoglobulin g|mesh-list
5949443|NCT04728425|Immunologic Factors|immunologic factors|mesh-ancestor
5949444|NCT04728425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949445|NCT04728178|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5949446|NCT04728321|Lenvatinib|lenvatinib|mesh-list
5949447|NCT04728321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5949448|NCT04728321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5949449|NCT04728321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5949450|NCT04728321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949451|NCT04728087|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
5949452|NCT04728087|Hemostatics|hemostatics|mesh-ancestor
5949453|NCT04728087|Coagulants|coagulants|mesh-ancestor
5949454|NCT04728360|Ustekinumab|ustekinumab|mesh-list
5949455|NCT04728360|Dermatologic Agents|dermatologic agents|mesh-ancestor
5949456|NCT04728308|Bupivacaine|bupivacaine|mesh-list
5949457|NCT04728308|Anesthetics, Local|anesthetics, local|mesh-ancestor
5949458|NCT04728308|Anesthetics|anesthetics|mesh-ancestor
5949459|NCT04728308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5949460|NCT04728308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949461|NCT04728308|Sensory System Agents|sensory system agents|mesh-ancestor
5949462|NCT04728308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5949463|NCT04728217|Factor VIII|factor viii|mesh-list
5949464|NCT04728217|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
5949465|NCT04728217|Coagulants|coagulants|mesh-ancestor
5949466|NCT04728217|Immunologic Factors|immunologic factors|mesh-ancestor
5949467|NCT04728217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949468|NCT04728230|Carboplatin|carboplatin|mesh-list
5949469|NCT04728230|Etoposide|etoposide|mesh-list
5949470|NCT04728230|Etoposide phosphate|etoposide phosphate|mesh-list
5949471|NCT04728230|Durvalumab|durvalumab|mesh-list
5949472|NCT04728230|Olaparib|olaparib|mesh-list
5949473|NCT04728230|Podophyllotoxin|podophyllotoxin|mesh-list
5949474|NCT04728230|Immunoglobulins|immunoglobulins|mesh-list
5949475|NCT04728230|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5949476|NCT04728230|Immunoglobulin G|immunoglobulin g|mesh-list
5949477|NCT04728230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5949478|NCT04728230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5949479|NCT04728230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5949480|NCT04728230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5949481|NCT04728230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5949482|NCT04728230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949483|NCT04728230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5949484|NCT04728230|Immunologic Factors|immunologic factors|mesh-ancestor
5949485|NCT04728230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949486|NCT04728230|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5949487|NCT04728230|Keratolytic Agents|keratolytic agents|mesh-ancestor
5949488|NCT04728230|Dermatologic Agents|dermatologic agents|mesh-ancestor
5949489|NCT04728230|Tubulin Modulators|tubulin modulators|mesh-ancestor
5949490|NCT04728230|Antimitotic Agents|antimitotic agents|mesh-ancestor
5949491|NCT04728230|Mitosis Modulators|mitosis modulators|mesh-ancestor
5949492|NCT04728035|Irinotecan|irinotecan|mesh-list
5949493|NCT04728035|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5949494|NCT04728035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5949495|NCT04728035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5949496|NCT04728035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949497|NCT04728035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5949498|NCT04727723|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
5949499|NCT04727723|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5949500|NCT04727723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949501|NCT04727671|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5949502|NCT04727671|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5949503|NCT04727671|Cetrorelix|cetrorelix|mesh-list
5949504|NCT04727671|Menotropins|menotropins|mesh-list
5949505|NCT04727671|Luteolytic Agents|luteolytic agents|mesh-ancestor
5949506|NCT04727671|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5949507|NCT04727671|Contraceptive Agents|contraceptive agents|mesh-ancestor
5949508|NCT04727671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5949509|NCT04727671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949510|NCT04727671|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5949511|NCT04727671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5949512|NCT04727671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5949513|NCT04727671|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5949514|NCT04727671|Fertility Agents|fertility agents|mesh-ancestor
5949515|NCT04727671|Hormone Antagonists|hormone antagonists|mesh-ancestor
5949516|NCT04727671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5949517|NCT04727684|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5949518|NCT04727684|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5949519|NCT04727684|Cetrorelix|cetrorelix|mesh-list
5949520|NCT04727684|Menotropins|menotropins|mesh-list
5949521|NCT04727684|Luteolytic Agents|luteolytic agents|mesh-ancestor
5949522|NCT04727684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5949523|NCT04727684|Contraceptive Agents|contraceptive agents|mesh-ancestor
5949524|NCT04727684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5949525|NCT04727684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949526|NCT04727684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5949527|NCT04727684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5949528|NCT04727684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5949529|NCT04727684|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5949530|NCT04727684|Fertility Agents|fertility agents|mesh-ancestor
5949531|NCT04727684|Hormone Antagonists|hormone antagonists|mesh-ancestor
5949532|NCT04727684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5949533|NCT04727515|Fentanyl|fentanyl|mesh-list
5949534|NCT04727515|Isoflurane|isoflurane|mesh-list
5949535|NCT04727515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5949536|NCT04727515|Narcotics|narcotics|mesh-ancestor
5949537|NCT04727515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5949538|NCT04727515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949539|NCT04727515|Analgesics|analgesics|mesh-ancestor
5949540|NCT04727515|Sensory System Agents|sensory system agents|mesh-ancestor
5949541|NCT04727515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5949542|NCT04727515|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5949543|NCT04727515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5949544|NCT04727515|Anesthetics, General|anesthetics, general|mesh-ancestor
5949545|NCT04727515|Anesthetics|anesthetics|mesh-ancestor
5949546|NCT04727515|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5949547|NCT04727775|Remdesivir|remdesivir|mesh-list
5949548|NCT04727775|Favipiravir|favipiravir|mesh-list
5949549|NCT04727775|Antimetabolites|antimetabolites|mesh-ancestor
5949550|NCT04727775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949551|NCT04727775|Antiviral Agents|antiviral agents|mesh-ancestor
5949552|NCT04727775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5949553|NCT04727853|Irinotecan|irinotecan|mesh-list
5949554|NCT04727853|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5949555|NCT04727853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5949556|NCT04727853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5949557|NCT04727853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949558|NCT04727853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5949559|NCT04727437|Heparin|heparin|mesh-list
5949560|NCT04727437|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5949561|NCT04727437|Tinzaparin|tinzaparin|mesh-list
5949562|NCT04727437|Dalteparin|dalteparin|mesh-list
5949563|NCT04727437|Warfarin|warfarin|mesh-list
5949564|NCT04727437|Anticoagulants|anticoagulants|mesh-list
5949565|NCT04727437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5949566|NCT04727437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5949567|NCT04727437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949568|NCT04727320|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
5949569|NCT04727320|Antiviral Agents|antiviral agents|mesh-ancestor
5949570|NCT04727320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5949571|NCT04727320|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5949572|NCT04727320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5949573|NCT04727502|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5949574|NCT04727502|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5949575|NCT04727502|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5949576|NCT04727502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5949577|NCT04727502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949578|NCT04727502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5949579|NCT04727502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949580|NCT04727502|Analgesics|analgesics|mesh-ancestor
5949581|NCT04727502|Sensory System Agents|sensory system agents|mesh-ancestor
5949582|NCT04727502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5949583|NCT04727502|Antidepressive Agents|antidepressive agents|mesh-ancestor
5949584|NCT04727502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5949585|NCT04727502|Dopamine Agents|dopamine agents|mesh-ancestor
5949586|NCT04727476|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
5949587|NCT04727476|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5949588|NCT04727476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949589|NCT04727476|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5949590|NCT04727476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5949591|NCT04727476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5949592|NCT04727476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949593|NCT04727476|Dopamine Agents|dopamine agents|mesh-ancestor
5949594|NCT04727476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5949595|NCT04727229|Bupivacaine|bupivacaine|mesh-list
5949596|NCT04727229|Anesthetics, Local|anesthetics, local|mesh-ancestor
5949597|NCT04727229|Anesthetics|anesthetics|mesh-ancestor
5949598|NCT04727229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5949599|NCT04727229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949600|NCT04727229|Sensory System Agents|sensory system agents|mesh-ancestor
5949601|NCT04727229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5949602|NCT04727034|Propofol|propofol|mesh-list
5949603|NCT04727034|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5949604|NCT04727034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5949605|NCT04727034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949606|NCT04727034|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5949607|NCT04727034|Anesthetics, General|anesthetics, general|mesh-ancestor
5949608|NCT04727034|Anesthetics|anesthetics|mesh-ancestor
5949609|NCT04726982|Acetazolamide|acetazolamide|mesh-list
5949610|NCT04726982|Anticonvulsants|anticonvulsants|mesh-ancestor
5949611|NCT04726982|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5949612|NCT04726982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5949613|NCT04726982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949614|NCT04726982|Diuretics|diuretics|mesh-ancestor
5949615|NCT04726982|Natriuretic Agents|natriuretic agents|mesh-ancestor
5949616|NCT04726982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949617|NCT04726657|Insulin|insulin|mesh-list
5949618|NCT04726657|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5949619|NCT04726657|Insulin, Isophane|insulin, isophane|mesh-list
5949620|NCT04726657|Isophane Insulin, Human|isophane insulin, human|mesh-list
5949621|NCT04726657|Isophane insulin, beef|isophane insulin, beef|mesh-list
5949622|NCT04726657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5949623|NCT04726657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949624|NCT04727073|Spironolactone|spironolactone|mesh-list
5949625|NCT04727073|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5949626|NCT04727073|Hormone Antagonists|hormone antagonists|mesh-ancestor
5949627|NCT04727073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5949628|NCT04727073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949629|NCT04727073|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5949630|NCT04727073|Diuretics|diuretics|mesh-ancestor
5949631|NCT04727073|Natriuretic Agents|natriuretic agents|mesh-ancestor
5949632|NCT04726631|Insulin|insulin|mesh-list
5949633|NCT04726631|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5949634|NCT04726631|Insulin, Short-Acting|insulin, short-acting|mesh-list
5949635|NCT04726631|Protamines|protamines|mesh-list
5949636|NCT04726631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5949637|NCT04726631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949638|NCT04726631|Heparin Antagonists|heparin antagonists|mesh-ancestor
5949639|NCT04726631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949640|NCT04726631|Coagulants|coagulants|mesh-ancestor
5968460|NCT04552743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5968461|NCT04552483|Nitazoxanide|nitazoxanide|mesh-list
5968462|NCT04552483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5968463|NCT04552483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5968464|NCT04552444|Biapenem|biapenem|mesh-list
5968465|NCT04552444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5968466|NCT04552613|Carboplatin|carboplatin|mesh-list
5968467|NCT04552613|Pemetrexed|pemetrexed|mesh-list
5968468|NCT04552613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5968469|NCT04552613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5949641|NCT04727021|Rivaroxaban|rivaroxaban|mesh-list
5949642|NCT04727021|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5949643|NCT04727021|Antithrombins|antithrombins|mesh-ancestor
5949644|NCT04727021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5949645|NCT04727021|Protease Inhibitors|protease inhibitors|mesh-ancestor
5949646|NCT04727021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5949647|NCT04727021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949648|NCT04727021|Anticoagulants|anticoagulants|mesh-ancestor
5949649|NCT04726592|Ketoprofen|ketoprofen|mesh-list
5949650|NCT04726592|Clorazepate Dipotassium|clorazepate dipotassium|mesh-list
5949651|NCT04726592|Metoclopramide|metoclopramide|mesh-list
5949652|NCT04726592|Antiemetics|antiemetics|mesh-ancestor
5949653|NCT04726592|Autonomic Agents|autonomic agents|mesh-ancestor
5949654|NCT04726592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5949655|NCT04726592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949656|NCT04726592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5949657|NCT04726592|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5949658|NCT04726592|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5949659|NCT04726592|Dopamine Agents|dopamine agents|mesh-ancestor
5949660|NCT04726592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5949661|NCT04726592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949662|NCT04726592|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5949663|NCT04726592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5949664|NCT04726592|Analgesics|analgesics|mesh-ancestor
5949665|NCT04726592|Sensory System Agents|sensory system agents|mesh-ancestor
5949666|NCT04726592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5949667|NCT04726592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5949668|NCT04726592|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5949669|NCT04726592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5949670|NCT04726592|Anticonvulsants|anticonvulsants|mesh-ancestor
5949671|NCT04726592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5949672|NCT04726592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5949673|NCT04726592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5949674|NCT04726592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5949675|NCT04726592|GABA Modulators|gaba modulators|mesh-ancestor
5949676|NCT04726592|GABA Agents|gaba agents|mesh-ancestor
5949677|NCT04726332|Prednisone|prednisone|mesh-list
5949678|NCT04726332|Fulvestrant|fulvestrant|mesh-list
5949679|NCT04726332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5949680|NCT04726332|Glucocorticoids|glucocorticoids|mesh-ancestor
5949681|NCT04726332|Hormones|hormones|mesh-ancestor
5949682|NCT04726332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5949683|NCT04726332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949684|NCT04726332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5949685|NCT04726332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5949686|NCT04726332|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5949687|NCT04726332|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5949688|NCT04726332|Hormone Antagonists|hormone antagonists|mesh-ancestor
5949689|NCT04726345|Fexofenadine|fexofenadine|mesh-list
5949690|NCT04726345|Terfenadine|terfenadine|mesh-list
5949691|NCT04726345|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5949692|NCT04726345|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5949693|NCT04726345|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5949694|NCT04726345|Histamine Antagonists|histamine antagonists|mesh-ancestor
5949695|NCT04726345|Histamine Agents|histamine agents|mesh-ancestor
5949696|NCT04726345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5949697|NCT04726345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949698|NCT04726345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949699|NCT04726280|Ropivacaine|ropivacaine|mesh-list
5949700|NCT04726280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5949701|NCT04726280|Anesthetics, Local|anesthetics, local|mesh-ancestor
5949702|NCT04726280|Anesthetics|anesthetics|mesh-ancestor
5949703|NCT04726280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5949704|NCT04726280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949705|NCT04726280|Sensory System Agents|sensory system agents|mesh-ancestor
5949706|NCT04726280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5949707|NCT04726553|Mycophenolic Acid|mycophenolic acid|mesh-list
5949708|NCT04726553|Antimalarials|antimalarials|mesh-list
5949709|NCT04726553|Methotrexate|methotrexate|mesh-list
5949710|NCT04726553|Azathioprine|azathioprine|mesh-list
5949711|NCT04726553|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5949712|NCT04726553|Abortifacient Agents|abortifacient agents|mesh-ancestor
5949713|NCT04726553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5949714|NCT04726553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949715|NCT04726553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5949716|NCT04726553|Antimetabolites|antimetabolites|mesh-ancestor
5949717|NCT04726553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949718|NCT04726553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5949719|NCT04726553|Dermatologic Agents|dermatologic agents|mesh-ancestor
5949720|NCT04726553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5949721|NCT04726553|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5949722|NCT04726553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5949723|NCT04726553|Immunologic Factors|immunologic factors|mesh-ancestor
5949724|NCT04726553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5949725|NCT04726553|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5949726|NCT04726553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5949727|NCT04726553|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5949728|NCT04726553|Antitubercular Agents|antitubercular agents|mesh-ancestor
5949729|NCT04726553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5949730|NCT04726553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5949731|NCT04726553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5949732|NCT04726553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5949733|NCT04726046|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5949734|NCT04726046|Cefotetan|cefotetan|mesh-list
5949735|NCT04726046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5949736|NCT04725747|Midazolam|midazolam|mesh-list
5949737|NCT04725747|Ketamine|ketamine|mesh-list
5949738|NCT04725747|Analgesics|analgesics|mesh-ancestor
5949739|NCT04725747|Sensory System Agents|sensory system agents|mesh-ancestor
5949740|NCT04725747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5949741|NCT04725747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949742|NCT04725747|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5949743|NCT04725747|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5949744|NCT04725747|Anesthetics, General|anesthetics, general|mesh-ancestor
5949745|NCT04725747|Anesthetics|anesthetics|mesh-ancestor
5949746|NCT04725747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5949747|NCT04725747|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5949748|NCT04725747|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5949749|NCT04725747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5949750|NCT04725747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949751|NCT04725747|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5949752|NCT04725747|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5949753|NCT04725747|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5949754|NCT04725747|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5949755|NCT04725747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5949756|NCT04725747|GABA Modulators|gaba modulators|mesh-ancestor
5949757|NCT04725747|GABA Agents|gaba agents|mesh-ancestor
5949758|NCT04726007|Fibrinolytic Agents|fibrinolytic agents|mesh-list
5949759|NCT04726007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5949760|NCT04726007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949761|NCT04725812|Eculizumab|eculizumab|mesh-list
5949762|NCT04725812|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5949763|NCT04725812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5949764|NCT04725812|Immunologic Factors|immunologic factors|mesh-ancestor
5949765|NCT04725812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949766|NCT04725942|Posaconazole|posaconazole|mesh-list
5949767|NCT04725942|Antifungal Agents|antifungal agents|mesh-ancestor
5949768|NCT04725942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5949769|NCT04725942|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5949770|NCT04725942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5949771|NCT04725942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5949772|NCT04725942|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5949773|NCT04725942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5949774|NCT04725942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5949775|NCT04725942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949776|NCT04725942|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5949777|NCT04725942|Hormone Antagonists|hormone antagonists|mesh-ancestor
5949778|NCT04725942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5949779|NCT04725942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949780|NCT04726085|Ibuprofen|ibuprofen|mesh-list
5949781|NCT04726085|Indomethacin|indomethacin|mesh-list
5949782|NCT04726085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5949783|NCT04726085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5949784|NCT04726085|Analgesics|analgesics|mesh-ancestor
5949785|NCT04726085|Sensory System Agents|sensory system agents|mesh-ancestor
5949786|NCT04726085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5949787|NCT04726085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949788|NCT04726085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5949789|NCT04726085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5949790|NCT04726085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5949791|NCT04726085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5949792|NCT04726085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949793|NCT04726085|Gout Suppressants|gout suppressants|mesh-ancestor
5949794|NCT04726085|Tocolytic Agents|tocolytic agents|mesh-ancestor
5949795|NCT04726085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5949796|NCT04725591|Insulin|insulin|mesh-list
5949797|NCT04725591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5949798|NCT04725591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949799|NCT04725695|Lidocaine|lidocaine|mesh-list
5949800|NCT04725695|Anesthetics, Local|anesthetics, local|mesh-ancestor
5949801|NCT04725695|Anesthetics|anesthetics|mesh-ancestor
5949802|NCT04725695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5949803|NCT04725695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949804|NCT04725695|Sensory System Agents|sensory system agents|mesh-ancestor
5949805|NCT04725695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5949806|NCT04725695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5949807|NCT04725695|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5949808|NCT04725695|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5949809|NCT04725695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5949810|NCT04725695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949811|NCT04725682|Tacrolimus|tacrolimus|mesh-list
5949812|NCT04725682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5949813|NCT04725682|Immunologic Factors|immunologic factors|mesh-ancestor
5949814|NCT04725682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949815|NCT04725682|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5949816|NCT04725682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6517447|NCT00721201|Hormone Antagonists|hormone antagonists|mesh-ancestor
6681363|NCT01609205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5949817|NCT04725682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949818|NCT04725617|Varenicline|varenicline|mesh-list
5949819|NCT04725617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5949820|NCT04725617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5949821|NCT04725617|Cholinergic Agents|cholinergic agents|mesh-ancestor
5949822|NCT04725617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5949823|NCT04725617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949824|NCT04725617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949825|NCT04725448|Paclitaxel|paclitaxel|mesh-list
5949826|NCT04725448|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5949827|NCT04725448|Bevacizumab|bevacizumab|mesh-list
5949828|NCT04725448|Carboplatin|carboplatin|mesh-list
5949829|NCT04725448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5949830|NCT04725448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5949831|NCT04725448|Tubulin Modulators|tubulin modulators|mesh-ancestor
5949832|NCT04725448|Antimitotic Agents|antimitotic agents|mesh-ancestor
5949833|NCT04725448|Mitosis Modulators|mitosis modulators|mesh-ancestor
5949834|NCT04725448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949835|NCT04725448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5949836|NCT04725448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5949837|NCT04725448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5949838|NCT04725448|Growth Substances|growth substances|mesh-ancestor
5949839|NCT04725448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949840|NCT04725448|Growth Inhibitors|growth inhibitors|mesh-ancestor
5949841|NCT04725656|Nicotine|nicotine|mesh-list
5949842|NCT04725656|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5949843|NCT04725656|Autonomic Agents|autonomic agents|mesh-ancestor
5949844|NCT04725656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5949845|NCT04725656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949846|NCT04725656|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5949847|NCT04725656|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5949848|NCT04725656|Cholinergic Agents|cholinergic agents|mesh-ancestor
5949849|NCT04725656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5949850|NCT04725656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949851|NCT04725253|Niacinamide|niacinamide|mesh-list
5949852|NCT04725253|Niacin|niacin|mesh-list
5949853|NCT04725253|Nicotinic Acids|nicotinic acids|mesh-list
5949854|NCT04725253|Vitamin B Complex|vitamin b complex|mesh-ancestor
5949855|NCT04725253|Vitamins|vitamins|mesh-ancestor
5949856|NCT04725253|Micronutrients|micronutrients|mesh-ancestor
5949857|NCT04725253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949858|NCT04725253|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5949859|NCT04725253|Antimetabolites|antimetabolites|mesh-ancestor
5949860|NCT04725253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949861|NCT04725253|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5949862|NCT04725253|Vasodilator Agents|vasodilator agents|mesh-ancestor
5949863|NCT04725383|Amitriptyline|amitriptyline|mesh-list
5949864|NCT04725383|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
5949865|NCT04725383|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5949866|NCT04725383|Antidepressive Agents|antidepressive agents|mesh-ancestor
5949867|NCT04725383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5949868|NCT04725383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5949869|NCT04725383|Analgesics|analgesics|mesh-ancestor
5949870|NCT04725383|Sensory System Agents|sensory system agents|mesh-ancestor
5949871|NCT04725383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5949872|NCT04725383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949873|NCT04725383|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5949874|NCT04725383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5949875|NCT04725383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5949876|NCT04725383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949877|NCT04725383|Adrenergic Agents|adrenergic agents|mesh-ancestor
5949878|NCT04725383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5949879|NCT04725383|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5949880|NCT04725383|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5949881|NCT04725383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5949882|NCT04725149|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5949883|NCT04725162|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5949884|NCT04725162|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5949885|NCT04725162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949886|NCT04725357|Meloxicam|meloxicam|mesh-list
5949887|NCT04725357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5949888|NCT04725357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5949889|NCT04725357|Analgesics|analgesics|mesh-ancestor
5949890|NCT04725357|Sensory System Agents|sensory system agents|mesh-ancestor
5949891|NCT04725357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5949892|NCT04725357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949893|NCT04725357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5949894|NCT04725357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5949895|NCT04725357|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5949896|NCT04725357|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5949897|NCT04725357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5949898|NCT04725357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949899|NCT04725422|Zoledronic Acid|zoledronic acid|mesh-list
5949900|NCT04725422|Pamidronate|pamidronate|mesh-list
5949901|NCT04725422|Sulfasalazine|sulfasalazine|mesh-list
5949902|NCT04725422|Adalimumab|adalimumab|mesh-list
5949903|NCT04725422|Etanercept|etanercept|mesh-list
5949904|NCT04725422|Golimumab|golimumab|mesh-list
5949905|NCT04725422|Methotrexate|methotrexate|mesh-list
5949906|NCT04725422|Infliximab|infliximab|mesh-list
5949907|NCT04725422|Certolizumab Pegol|certolizumab pegol|mesh-list
5949908|NCT04725422|Leflunomide|leflunomide|mesh-list
5949909|NCT04725422|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5949910|NCT04725422|Abortifacient Agents|abortifacient agents|mesh-ancestor
5949911|NCT04725422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5949912|NCT04725422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949913|NCT04725422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5949914|NCT04725422|Antimetabolites|antimetabolites|mesh-ancestor
5949915|NCT04725422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949916|NCT04725422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5949917|NCT04725422|Dermatologic Agents|dermatologic agents|mesh-ancestor
5949918|NCT04725422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5949919|NCT04725422|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5949920|NCT04725422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5949921|NCT04725422|Immunologic Factors|immunologic factors|mesh-ancestor
5949922|NCT04725422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5949923|NCT04725422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5949924|NCT04725422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5949925|NCT04725422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5949926|NCT04725422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5949927|NCT04725422|Analgesics|analgesics|mesh-ancestor
5949928|NCT04725422|Sensory System Agents|sensory system agents|mesh-ancestor
5949929|NCT04725422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5949930|NCT04725422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5949931|NCT04725422|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5949932|NCT04725422|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
5949933|NCT04725422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5949934|NCT04725214|Temozolomide|temozolomide|mesh-list
5949935|NCT04725214|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5949936|NCT04725214|Alkylating Agents|alkylating agents|mesh-ancestor
5949937|NCT04725214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949938|NCT04725214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5968470|NCT04552613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968471|NCT04552613|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5968472|NCT04552613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5968473|NCT04552405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
5968474|NCT04552431|Ciprofloxacin|ciprofloxacin|mesh-list
5968475|NCT04552431|Tamsulosin|tamsulosin|mesh-list
5968476|NCT04552431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5968477|NCT04552431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5968478|NCT04552431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5968479|NCT04552431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5968480|NCT04552431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5968481|NCT04552431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968482|NCT04552431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5968483|NCT04552431|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5968484|NCT04552431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5968485|NCT04552431|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5968486|NCT04552431|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5968487|NCT04552431|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5968488|NCT04552431|Adrenergic Agents|adrenergic agents|mesh-ancestor
5968489|NCT04552431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5968490|NCT04552431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968491|NCT04552431|Urological Agents|urological agents|mesh-ancestor
5968492|NCT04552093|Floxuridine|floxuridine|mesh-list
5968493|NCT04552093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5968494|NCT04552093|Antimetabolites|antimetabolites|mesh-ancestor
5968495|NCT04552093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968496|NCT04552093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5968497|NCT04551924|Ropivacaine|ropivacaine|mesh-list
5968498|NCT04551924|Anesthetics, Local|anesthetics, local|mesh-ancestor
5968499|NCT04551924|Anesthetics|anesthetics|mesh-ancestor
5968500|NCT04551924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5968501|NCT04551924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968502|NCT04551924|Sensory System Agents|sensory system agents|mesh-ancestor
5968503|NCT04551924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5971107|NCT04530656|Vaccines|vaccines|mesh-list
5971108|NCT04530656|Immunologic Factors|immunologic factors|mesh-ancestor
5971109|NCT04530656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971110|NCT04530487|Cyclosporine|cyclosporine|mesh-list
5971111|NCT04530487|Mycophenolic Acid|mycophenolic acid|mesh-list
6517448|NCT00721201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6517449|NCT00721201|Luteolytic Agents|luteolytic agents|mesh-ancestor
6517450|NCT00721201|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5971112|NCT04530487|Fludarabine|fludarabine|mesh-list
5971113|NCT04530487|Fludarabine phosphate|fludarabine phosphate|mesh-list
5971114|NCT04530487|Etoposide|etoposide|mesh-list
5971115|NCT04530487|Etoposide phosphate|etoposide phosphate|mesh-list
5971116|NCT04530487|Melphalan|melphalan|mesh-list
5971117|NCT04530487|Mechlorethamine|mechlorethamine|mesh-list
5971118|NCT04530487|Thiotepa|thiotepa|mesh-list
5971119|NCT04530487|Podophyllotoxin|podophyllotoxin|mesh-list
5971120|NCT04530487|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
5971121|NCT04530487|Tacrolimus|tacrolimus|mesh-list
5971122|NCT04530487|Cyclosporins|cyclosporins|mesh-list
5971123|NCT04530487|Thymoglobulin|thymoglobulin|mesh-list
5971124|NCT04530487|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5971125|NCT04530487|Immunoglobulins|immunoglobulins|mesh-list
5971126|NCT04530487|Antibodies|antibodies|mesh-list
5971127|NCT04530487|gamma-Globulins|gamma-globulins|mesh-list
5971128|NCT04530487|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5971129|NCT04530487|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5971130|NCT04530487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5971131|NCT04530487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5971132|NCT04530487|Antimetabolites|antimetabolites|mesh-ancestor
5971133|NCT04530487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971134|NCT04530487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5971135|NCT04530487|Immunologic Factors|immunologic factors|mesh-ancestor
5971136|NCT04530487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971137|NCT04530487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5971138|NCT04530487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5971139|NCT04530487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5971140|NCT04530487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5971141|NCT04530487|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5971142|NCT04530487|Antifungal Agents|antifungal agents|mesh-ancestor
5949939|NCT04725201|Heparin|heparin|mesh-list
5949940|NCT04725201|Calcium heparin|calcium heparin|mesh-list
5949941|NCT04725201|Anticoagulants|anticoagulants|mesh-ancestor
5949942|NCT04725201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5949943|NCT04725201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5949944|NCT04725201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949945|NCT04724720|Famotidine|famotidine|mesh-list
5949946|NCT04724720|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5949947|NCT04724720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5949948|NCT04724720|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5949949|NCT04724720|Histamine Antagonists|histamine antagonists|mesh-ancestor
5949950|NCT04724720|Histamine Agents|histamine agents|mesh-ancestor
5949951|NCT04724720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5949952|NCT04724720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949953|NCT04724720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949954|NCT04724655|Mineral Oil|mineral oil|mesh-list
5949955|NCT04724655|Emollients|emollients|mesh-ancestor
5949956|NCT04724655|Dermatologic Agents|dermatologic agents|mesh-ancestor
5949957|NCT04724759|Lidocaine|lidocaine|mesh-list
5949958|NCT04724759|Dexmedetomidine|dexmedetomidine|mesh-list
5949959|NCT04724759|Ketamine|ketamine|mesh-list
5949960|NCT04724759|Anesthetics, Local|anesthetics, local|mesh-ancestor
5949961|NCT04724759|Anesthetics|anesthetics|mesh-ancestor
5949962|NCT04724759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5949963|NCT04724759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5949964|NCT04724759|Sensory System Agents|sensory system agents|mesh-ancestor
5949965|NCT04724759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5949966|NCT04724759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5949967|NCT04724759|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5949968|NCT04724759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5949969|NCT04724759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5949970|NCT04724759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949971|NCT04724759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5949972|NCT04724759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5949973|NCT04724759|Analgesics|analgesics|mesh-ancestor
5949974|NCT04724759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5949975|NCT04724759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5949976|NCT04724759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5949977|NCT04724759|Adrenergic Agents|adrenergic agents|mesh-ancestor
5949978|NCT04724759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5949979|NCT04724759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5949980|NCT04724759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5949981|NCT04724759|Anesthetics, General|anesthetics, general|mesh-ancestor
5949982|NCT04724759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5949983|NCT04724759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5949984|NCT04724772|Tranexamic Acid|tranexamic acid|mesh-list
5949985|NCT04724772|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5949986|NCT04724772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5949987|NCT04724772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5949988|NCT04724772|Hemostatics|hemostatics|mesh-ancestor
5949989|NCT04724772|Coagulants|coagulants|mesh-ancestor
5949990|NCT04724629|Aldesleukin|aldesleukin|mesh-list
5949991|NCT04724629|Colchicine|colchicine|mesh-list
5949992|NCT04724629|Ixekizumab|ixekizumab|mesh-list
5949993|NCT04724629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5949994|NCT04724629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5949995|NCT04724629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5949996|NCT04724629|Antiviral Agents|antiviral agents|mesh-ancestor
5949997|NCT04724629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5949998|NCT04724629|Gout Suppressants|gout suppressants|mesh-ancestor
5949999|NCT04724629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5950000|NCT04724629|Tubulin Modulators|tubulin modulators|mesh-ancestor
5950001|NCT04724629|Antimitotic Agents|antimitotic agents|mesh-ancestor
5950002|NCT04724629|Mitosis Modulators|mitosis modulators|mesh-ancestor
5950003|NCT04724629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950004|NCT04724629|Dermatologic Agents|dermatologic agents|mesh-ancestor
5950005|NCT04724486|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5950006|NCT04724486|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5950007|NCT04724486|Cetrorelix|cetrorelix|mesh-list
5950008|NCT04724486|Menotropins|menotropins|mesh-list
5950009|NCT04724486|Luteolytic Agents|luteolytic agents|mesh-ancestor
5950010|NCT04724486|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5950011|NCT04724486|Contraceptive Agents|contraceptive agents|mesh-ancestor
5950012|NCT04724486|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5950013|NCT04724486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950014|NCT04724486|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5950015|NCT04724486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5950016|NCT04724486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5950017|NCT04724486|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5950018|NCT04724486|Fertility Agents|fertility agents|mesh-ancestor
5950019|NCT04724486|Hormone Antagonists|hormone antagonists|mesh-ancestor
5950020|NCT04724486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5950021|NCT04724473|Tretinoin|tretinoin|mesh-list
5950022|NCT04724473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5950023|NCT04724473|Keratolytic Agents|keratolytic agents|mesh-ancestor
5950024|NCT04724473|Dermatologic Agents|dermatologic agents|mesh-ancestor
5950025|NCT04724538|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
5950026|NCT04724538|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5950027|NCT04724538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950028|NCT04724187|Misoprostol|misoprostol|mesh-list
5950029|NCT04724187|Oxytocin|oxytocin|mesh-list
5950030|NCT04724187|Oxytocics|oxytocics|mesh-ancestor
5950031|NCT04724187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5950032|NCT04724187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950033|NCT04724187|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5950034|NCT04724187|Abortifacient Agents|abortifacient agents|mesh-ancestor
5950035|NCT04724187|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5950036|NCT04724187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5950037|NCT04724226|Apatinib|apatinib|mesh-list
5950038|NCT04724226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5950039|NCT04724226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5950040|NCT04724226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5950041|NCT04724226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950042|NCT04724343|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5950043|NCT04724343|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5950044|NCT04724343|Cetrorelix|cetrorelix|mesh-list
5950045|NCT04724343|Menotropins|menotropins|mesh-list
5950046|NCT04724343|Luteolytic Agents|luteolytic agents|mesh-ancestor
5950047|NCT04724343|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5950048|NCT04724343|Contraceptive Agents|contraceptive agents|mesh-ancestor
5950049|NCT04724343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5950050|NCT04724343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950051|NCT04724343|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5950052|NCT04724343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5950053|NCT04724343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5950054|NCT04724343|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5950055|NCT04724343|Fertility Agents|fertility agents|mesh-ancestor
5950056|NCT04724343|Hormone Antagonists|hormone antagonists|mesh-ancestor
5950057|NCT04724343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5950058|NCT04724148|Fentanyl|fentanyl|mesh-list
5950059|NCT04724148|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5950060|NCT04724148|Narcotics|narcotics|mesh-ancestor
5950061|NCT04724148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5950062|NCT04724148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950063|NCT04724148|Analgesics|analgesics|mesh-ancestor
5950064|NCT04724148|Sensory System Agents|sensory system agents|mesh-ancestor
5950065|NCT04724148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5950066|NCT04724148|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5950067|NCT04724148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5950068|NCT04724148|Anesthetics, General|anesthetics, general|mesh-ancestor
5950069|NCT04724148|Anesthetics|anesthetics|mesh-ancestor
5950070|NCT04724044|Moxifloxacin|moxifloxacin|mesh-list
5950071|NCT04724044|Clarithromycin|clarithromycin|mesh-list
5950072|NCT04724044|Ceftriaxone|ceftriaxone|mesh-list
5950073|NCT04724044|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
5950074|NCT04724044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5950075|NCT04724044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5950076|NCT04724044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5950077|NCT04724044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5950078|NCT04724044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5950079|NCT04724044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950080|NCT04724044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5950081|NCT04724044|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5950082|NCT04724044|Contraceptive Agents|contraceptive agents|mesh-ancestor
5950083|NCT04724044|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5950084|NCT04724044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950085|NCT04724044|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5950086|NCT04724044|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5950087|NCT04724044|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5950088|NCT04724044|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5950089|NCT04724044|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5968504|NCT04552067|Enoxaparin|enoxaparin|mesh-list
5950090|NCT04724044|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5950091|NCT04724031|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
5950092|NCT04724031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5950093|NCT04724031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950094|NCT04724031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5950095|NCT04723836|Riboflavin|riboflavin|mesh-list
5950096|NCT04723836|Vitamins|vitamins|mesh-ancestor
5950097|NCT04723836|Micronutrients|micronutrients|mesh-ancestor
5950098|NCT04723836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950099|NCT04723836|Vitamin B Complex|vitamin b complex|mesh-ancestor
5950100|NCT04723836|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5950101|NCT04723836|Dermatologic Agents|dermatologic agents|mesh-ancestor
5950102|NCT04723940|Doxycycline|doxycycline|mesh-list
5950103|NCT04723940|Clindamycin|clindamycin|mesh-list
5950104|NCT04723940|Clindamycin palmitate|clindamycin palmitate|mesh-list
5950105|NCT04723940|Clindamycin phosphate|clindamycin phosphate|mesh-list
5950106|NCT04723940|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
5950107|NCT04723940|Cefadroxil|cefadroxil|mesh-list
5950108|NCT04723940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5950109|NCT04723940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5950110|NCT04723940|Antimalarials|antimalarials|mesh-ancestor
5950111|NCT04723940|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5950112|NCT04723940|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5950113|NCT04723940|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5950114|NCT04723940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5950115|NCT04723940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950116|NCT04723940|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5950117|NCT04723940|Renal Agents|renal agents|mesh-ancestor
5950118|NCT04723732|Chlorhexidine|chlorhexidine|mesh-list
5950119|NCT04723732|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5950120|NCT04723732|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5950121|NCT04723732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5950122|NCT04723732|Disinfectants|disinfectants|mesh-ancestor
5950123|NCT04723732|Dermatologic Agents|dermatologic agents|mesh-ancestor
5950124|NCT04723875|Paclitaxel|paclitaxel|mesh-list
5950125|NCT04723875|Docetaxel|docetaxel|mesh-list
5950126|NCT04723875|Carboplatin|carboplatin|mesh-list
5950127|NCT04723875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5950128|NCT04723875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5950129|NCT04723875|Tubulin Modulators|tubulin modulators|mesh-ancestor
5950130|NCT04723875|Antimitotic Agents|antimitotic agents|mesh-ancestor
5950131|NCT04723875|Mitosis Modulators|mitosis modulators|mesh-ancestor
5950132|NCT04723875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950133|NCT04723862|Spironolactone|spironolactone|mesh-list
5950134|NCT04723862|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5950135|NCT04723862|Hormone Antagonists|hormone antagonists|mesh-ancestor
5950136|NCT04723862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5950137|NCT04723862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950138|NCT04723862|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5950139|NCT04723862|Diuretics|diuretics|mesh-ancestor
5950140|NCT04723862|Natriuretic Agents|natriuretic agents|mesh-ancestor
5950141|NCT04723563|Heparin|heparin|mesh-list
5950142|NCT04723563|Anticoagulants|anticoagulants|mesh-ancestor
5950143|NCT04723563|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5950144|NCT04723563|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5950145|NCT04723563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950146|NCT04723472|Cefuroxime|cefuroxime|mesh-list
5950147|NCT04723472|Cefuroxime axetil|cefuroxime axetil|mesh-list
5950148|NCT04723472|Bismuth|bismuth|mesh-list
5950149|NCT04723472|Antacids|antacids|mesh-ancestor
5950150|NCT04723472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950151|NCT04723472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5950152|NCT04723472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5950153|NCT04723472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5950154|NCT04723147|Levodopa|levodopa|mesh-list
5950155|NCT04723147|Carbidopa|carbidopa|mesh-list
5950156|NCT04723147|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
5950157|NCT04723147|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5950158|NCT04723147|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5950159|NCT04723147|Dopamine Agents|dopamine agents|mesh-ancestor
5950160|NCT04723147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5950161|NCT04723147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950162|NCT04723147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950163|NCT04723147|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5950164|NCT04723147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5950165|NCT04723147|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5950166|NCT04723147|Immunologic Factors|immunologic factors|mesh-ancestor
5950167|NCT04723147|Dopamine Agonists|dopamine agonists|mesh-ancestor
5950168|NCT04723342|Blinatumomab|blinatumomab|mesh-list
5950169|NCT04723342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5968505|NCT04552067|Anticoagulants|anticoagulants|mesh-ancestor
5968506|NCT04552067|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5968507|NCT04552067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5968508|NCT04552067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968509|NCT04551833|Levobupivacaine|levobupivacaine|mesh-list
5968510|NCT04551833|Anesthetics, Local|anesthetics, local|mesh-ancestor
5968511|NCT04551833|Anesthetics|anesthetics|mesh-ancestor
5968512|NCT04551833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5968513|NCT04551833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968514|NCT04551833|Sensory System Agents|sensory system agents|mesh-ancestor
5968515|NCT04551833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5968516|NCT04551963|Clarithromycin|clarithromycin|mesh-list
5968517|NCT04551963|Fluconazole|fluconazole|mesh-list
5968518|NCT04551963|Voriconazole|voriconazole|mesh-list
5968519|NCT04551963|Zanubrutinib|zanubrutinib|mesh-list
5968520|NCT04551963|Diltiazem|diltiazem|mesh-list
5968521|NCT04551963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5968522|NCT04551963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5968523|NCT04551963|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5968524|NCT04551963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5968525|NCT04551963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968526|NCT04551963|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5968527|NCT04551963|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5968528|NCT04551963|Antifungal Agents|antifungal agents|mesh-ancestor
5968529|NCT04551963|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5968530|NCT04551963|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5968531|NCT04551963|Hormone Antagonists|hormone antagonists|mesh-ancestor
5968532|NCT04551963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5968533|NCT04551963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968534|NCT04551963|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5968535|NCT04551963|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5968536|NCT04551963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5968537|NCT04551963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5968538|NCT04551963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5968539|NCT04551963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5968540|NCT04551963|Vasodilator Agents|vasodilator agents|mesh-ancestor
5968541|NCT04551963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5968542|NCT04551963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5968543|NCT04551755|Doxycycline|doxycycline|mesh-list
5968544|NCT04551755|Ivermectin|ivermectin|mesh-list
5968545|NCT04551755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5968546|NCT04551755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5968547|NCT04551755|Antimalarials|antimalarials|mesh-ancestor
5968548|NCT04551755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5968549|NCT04551755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5968550|NCT04551703|Epinephrine|epinephrine|mesh-list
5968551|NCT04551703|Racepinephrine|racepinephrine|mesh-list
5968552|NCT04551703|Epinephryl borate|epinephryl borate|mesh-list
5968553|NCT04551703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5968554|NCT04551703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5968555|NCT04551703|Adrenergic Agents|adrenergic agents|mesh-ancestor
5968556|NCT04551703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5968557|NCT04551703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968558|NCT04551703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968559|NCT04551703|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5968560|NCT04551703|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5968561|NCT04551703|Autonomic Agents|autonomic agents|mesh-ancestor
5968562|NCT04551703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5968563|NCT04551703|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5968564|NCT04551703|Respiratory System Agents|respiratory system agents|mesh-ancestor
5968565|NCT04551703|Mydriatics|mydriatics|mesh-ancestor
5968566|NCT04551703|Sympathomimetics|sympathomimetics|mesh-ancestor
5968567|NCT04551703|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5968568|NCT04551950|Paclitaxel|paclitaxel|mesh-list
5968569|NCT04551950|Bevacizumab|bevacizumab|mesh-list
5968570|NCT04551950|Carboplatin|carboplatin|mesh-list
5968571|NCT04551950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5968572|NCT04551950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5968573|NCT04551950|Tubulin Modulators|tubulin modulators|mesh-ancestor
5968574|NCT04551950|Antimitotic Agents|antimitotic agents|mesh-ancestor
5968575|NCT04551950|Mitosis Modulators|mitosis modulators|mesh-ancestor
6681364|NCT01609205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5950170|NCT04723459|Ivermectin|ivermectin|mesh-list
5950171|NCT04723459|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5950172|NCT04723459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5950173|NCT04723238|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5950174|NCT04723238|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5950175|NCT04723238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5950176|NCT04723238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5950177|NCT04723238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950178|NCT04723238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5950179|NCT04723238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950180|NCT04723238|Analgesics|analgesics|mesh-ancestor
5950181|NCT04723238|Sensory System Agents|sensory system agents|mesh-ancestor
5950182|NCT04723238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5950183|NCT04723238|Antidepressive Agents|antidepressive agents|mesh-ancestor
5950184|NCT04723238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5950185|NCT04723238|Dopamine Agents|dopamine agents|mesh-ancestor
5950186|NCT04723069|Metronidazole|metronidazole|mesh-list
5950187|NCT04723069|Doxycycline|doxycycline|mesh-list
5950188|NCT04723069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5950189|NCT04723069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5950190|NCT04723069|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5950191|NCT04723069|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5950192|NCT04723069|Antimalarials|antimalarials|mesh-ancestor
5950193|NCT04722796|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5950194|NCT04722822|Vaccines|vaccines|mesh-list
5950195|NCT04722822|Immunologic Factors|immunologic factors|mesh-ancestor
5950196|NCT04722822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950197|NCT04722718|Paclitaxel|paclitaxel|mesh-list
5950198|NCT04722718|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5950199|NCT04722718|Carboplatin|carboplatin|mesh-list
5950200|NCT04722718|Apatinib|apatinib|mesh-list
5950201|NCT04722718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5950202|NCT04722718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5950203|NCT04722718|Tubulin Modulators|tubulin modulators|mesh-ancestor
5950204|NCT04722718|Antimitotic Agents|antimitotic agents|mesh-ancestor
5950205|NCT04722718|Mitosis Modulators|mitosis modulators|mesh-ancestor
5950206|NCT04722718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950207|NCT04722718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5950208|NCT04722718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5950209|NCT04723030|Paclitaxel|paclitaxel|mesh-list
5950210|NCT04723030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5950211|NCT04723030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5950212|NCT04723030|Tubulin Modulators|tubulin modulators|mesh-ancestor
5950213|NCT04723030|Antimitotic Agents|antimitotic agents|mesh-ancestor
5950214|NCT04723030|Mitosis Modulators|mitosis modulators|mesh-ancestor
5950215|NCT04723030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950216|NCT04722835|Albuterol|albuterol|mesh-list
5950217|NCT04722835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5950218|NCT04722835|Autonomic Agents|autonomic agents|mesh-ancestor
5950219|NCT04722835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5950220|NCT04722835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950221|NCT04722835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5950222|NCT04722835|Respiratory System Agents|respiratory system agents|mesh-ancestor
5950223|NCT04722835|Tocolytic Agents|tocolytic agents|mesh-ancestor
5950224|NCT04722835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5950225|NCT04722835|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5950226|NCT04722835|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5950227|NCT04722835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5950228|NCT04722835|Adrenergic Agents|adrenergic agents|mesh-ancestor
5950229|NCT04722835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5950230|NCT04722835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950231|NCT04723004|Bevacizumab|bevacizumab|mesh-list
5950232|NCT04723004|Sorafenib|sorafenib|mesh-list
5950233|NCT04723004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5950234|NCT04723004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5950235|NCT04723004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5950236|NCT04723004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5950237|NCT04723004|Growth Substances|growth substances|mesh-ancestor
5950238|NCT04723004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950239|NCT04723004|Growth Inhibitors|growth inhibitors|mesh-ancestor
5950240|NCT04723004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5950241|NCT04723004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5950242|NCT04723004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950243|NCT04722809|Botulinum Toxins|botulinum toxins|mesh-list
5950244|NCT04722809|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5950245|NCT04722809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5950246|NCT04722809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950247|NCT04722809|Cholinergic Agents|cholinergic agents|mesh-ancestor
5950248|NCT04722809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5950249|NCT04722809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950250|NCT04722523|Carboplatin|carboplatin|mesh-list
5950251|NCT04722523|Docetaxel|docetaxel|mesh-list
5950252|NCT04722523|Cetuximab|cetuximab|mesh-list
5950253|NCT04722523|Cemiplimab|cemiplimab|mesh-list
5950254|NCT04722523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5950255|NCT04722523|Tubulin Modulators|tubulin modulators|mesh-ancestor
5950256|NCT04722523|Antimitotic Agents|antimitotic agents|mesh-ancestor
5950257|NCT04722523|Mitosis Modulators|mitosis modulators|mesh-ancestor
5950258|NCT04722523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950259|NCT04722523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5950260|NCT04722354|Abscisic Acid|abscisic acid|mesh-list
5950261|NCT04722354|Plant Growth Regulators|plant growth regulators|mesh-ancestor
5950262|NCT04722354|Growth Substances|growth substances|mesh-ancestor
5950263|NCT04722354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950264|NCT04722471|Progesterone|progesterone|mesh-list
5950265|NCT04722471|Progestins|progestins|mesh-ancestor
5950266|NCT04722471|Hormones|hormones|mesh-ancestor
5950267|NCT04722471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5950268|NCT04722471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950269|NCT04722172|Obinutuzumab|obinutuzumab|mesh-list
5950270|NCT04722172|Acalabrutinib|acalabrutinib|mesh-list
5950271|NCT04722172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5950272|NCT04722172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5950273|NCT04721873|Topiramate|topiramate|mesh-list
5950274|NCT04721873|Phentermine|phentermine|mesh-list
5950275|NCT04721873|Anticonvulsants|anticonvulsants|mesh-ancestor
5950276|NCT04721873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5950277|NCT04721873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950278|NCT04721873|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5950279|NCT04721873|Appetite Depressants|appetite depressants|mesh-ancestor
5950280|NCT04721873|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5950281|NCT04721873|Sympathomimetics|sympathomimetics|mesh-ancestor
5950282|NCT04721873|Autonomic Agents|autonomic agents|mesh-ancestor
5950283|NCT04721873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5950284|NCT04721873|Adrenergic Agents|adrenergic agents|mesh-ancestor
5950285|NCT04721873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5950286|NCT04721873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950287|NCT04721899|Vitamin D|vitamin d|mesh-list
5950288|NCT04721899|Vitamins|vitamins|mesh-ancestor
5950289|NCT04721899|Micronutrients|micronutrients|mesh-ancestor
5950290|NCT04721899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950291|NCT04721899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5950292|NCT04721964|Ferrous fumarate|ferrous fumarate|mesh-list
5950293|NCT04721964|Trace Elements|trace elements|mesh-ancestor
5950294|NCT04721964|Micronutrients|micronutrients|mesh-ancestor
5950295|NCT04721964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950296|NCT04721548|Minoxidil|minoxidil|mesh-list
5950297|NCT04721548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5950298|NCT04721548|Vasodilator Agents|vasodilator agents|mesh-ancestor
5968576|NCT04551950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968577|NCT04551950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5968578|NCT04551950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5968579|NCT04551950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5968580|NCT04551950|Growth Substances|growth substances|mesh-ancestor
5968581|NCT04551950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968582|NCT04551950|Growth Inhibitors|growth inhibitors|mesh-ancestor
5968583|NCT04551677|Vaccines|vaccines|mesh-list
5968584|NCT04551677|Immunologic Factors|immunologic factors|mesh-ancestor
5968585|NCT04551677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968586|NCT04551768|Ribavirin|ribavirin|mesh-list
5968587|NCT04551768|Antimetabolites|antimetabolites|mesh-ancestor
5968588|NCT04551768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968589|NCT04551768|Antiviral Agents|antiviral agents|mesh-ancestor
5968590|NCT04551768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5968591|NCT04551781|Prednisone|prednisone|mesh-list
5968592|NCT04551781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5968593|NCT04551781|Glucocorticoids|glucocorticoids|mesh-ancestor
5968594|NCT04551781|Hormones|hormones|mesh-ancestor
5968595|NCT04551781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5968596|NCT04551781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968597|NCT04551781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5950299|NCT04721795|Antitubercular Agents|antitubercular agents|mesh-list
5950300|NCT04721795|Atorvastatin|atorvastatin|mesh-list
5950301|NCT04721795|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5950302|NCT04721795|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5950303|NCT04721795|Antimetabolites|antimetabolites|mesh-ancestor
5950304|NCT04721795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950305|NCT04721795|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5950306|NCT04721795|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5950307|NCT04721795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5950308|NCT04721795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5950309|NCT04721795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5950310|NCT04721704|Amoxicillin|amoxicillin|mesh-list
5950311|NCT04721704|Metronidazole|metronidazole|mesh-list
5950312|NCT04721704|Clarithromycin|clarithromycin|mesh-list
5950313|NCT04721704|Omeprazole|omeprazole|mesh-list
5950314|NCT04721704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5950315|NCT04721704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5950316|NCT04721704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5950317|NCT04721704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5950318|NCT04721704|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5950319|NCT04721704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5950320|NCT04721704|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5950321|NCT04721704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5950322|NCT04721704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950323|NCT04721704|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5950324|NCT04721704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5950325|NCT04721704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5950326|NCT04721223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5950327|NCT04721223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950328|NCT04721223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5950329|NCT04721054|Lidocaine|lidocaine|mesh-list
5950330|NCT04721054|Bupivacaine|bupivacaine|mesh-list
5950331|NCT04721054|Anesthetics|anesthetics|mesh-list
5950332|NCT04721054|Anesthetics, Local|anesthetics, local|mesh-ancestor
5950333|NCT04721054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5950334|NCT04721054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950335|NCT04721054|Sensory System Agents|sensory system agents|mesh-ancestor
5950336|NCT04721054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5950337|NCT04721054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5950338|NCT04721054|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5950339|NCT04721054|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5950340|NCT04721054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5950341|NCT04721054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950342|NCT04721691|Cannabidiol|cannabidiol|mesh-list
5950343|NCT04721691|Anticonvulsants|anticonvulsants|mesh-ancestor
5950344|NCT04721119|Anesthetics|anesthetics|mesh-list
5950345|NCT04721119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5950346|NCT04721119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950347|NCT04721301|Maraviroc|maraviroc|mesh-list
5950348|NCT04721301|Nivolumab|nivolumab|mesh-list
5950349|NCT04721301|Ipilimumab|ipilimumab|mesh-list
5950350|NCT04721301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5950351|NCT04721301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5950352|NCT04721301|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5950353|NCT04721301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950354|NCT04721301|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5950355|NCT04721301|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5950356|NCT04721301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5950357|NCT04721301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5950358|NCT04721301|Antiviral Agents|antiviral agents|mesh-ancestor
5950359|NCT04721301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5950360|NCT04721301|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
5950361|NCT04720807|Letrozole|letrozole|mesh-list
5950362|NCT04720807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5950363|NCT04720807|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5950364|NCT04720807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5950365|NCT04720807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5950366|NCT04720807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950367|NCT04720807|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5950368|NCT04720807|Hormone Antagonists|hormone antagonists|mesh-ancestor
5950369|NCT04720807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5950370|NCT04720807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950371|NCT04720768|Palbociclib|palbociclib|mesh-list
5950372|NCT04720768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5950373|NCT04720768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5950374|NCT04720768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5950375|NCT04720768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950376|NCT04720833|Vitamin D|vitamin d|mesh-list
5950377|NCT04720833|Calcium|calcium|mesh-list
5950378|NCT04720833|Vitamins|vitamins|mesh-ancestor
5950379|NCT04720833|Micronutrients|micronutrients|mesh-ancestor
5950380|NCT04720833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950381|NCT04720833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5950382|NCT04720833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5950383|NCT04720859|Canagliflozin|canagliflozin|mesh-list
5950384|NCT04720859|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5950385|NCT04720859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950386|NCT04720859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5950387|NCT04720859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950388|NCT04720326|Tacrolimus|tacrolimus|mesh-list
5950389|NCT04720326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5950390|NCT04720326|Immunologic Factors|immunologic factors|mesh-ancestor
5950391|NCT04720326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950392|NCT04720326|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5950393|NCT04720326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5950394|NCT04720326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950395|NCT04720573|Neostigmine|neostigmine|mesh-list
5950396|NCT04720573|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5950397|NCT04720573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5950398|NCT04720573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950399|NCT04720573|Cholinergic Agents|cholinergic agents|mesh-ancestor
5950400|NCT04720573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5950401|NCT04720573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950402|NCT04720573|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5950403|NCT04720573|Autonomic Agents|autonomic agents|mesh-ancestor
5950404|NCT04720573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5950405|NCT04720287|Bupivacaine|bupivacaine|mesh-list
5950406|NCT04720287|Neostigmine|neostigmine|mesh-list
5950407|NCT04720287|Anesthetics, Local|anesthetics, local|mesh-ancestor
5950408|NCT04720287|Anesthetics|anesthetics|mesh-ancestor
5950409|NCT04720287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5950410|NCT04720287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950411|NCT04720287|Sensory System Agents|sensory system agents|mesh-ancestor
5950412|NCT04720287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5950413|NCT04720287|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5950414|NCT04720287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5950415|NCT04720287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950416|NCT04720287|Cholinergic Agents|cholinergic agents|mesh-ancestor
5950417|NCT04720287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5950418|NCT04720287|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5950419|NCT04720287|Autonomic Agents|autonomic agents|mesh-ancestor
5950420|NCT04720547|Zolpidem|zolpidem|mesh-list
5950421|NCT04720547|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5950422|NCT04720547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5950423|NCT04720547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5950424|NCT04720547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950425|NCT04720547|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
5950426|NCT04720547|GABA Agonists|gaba agonists|mesh-ancestor
5950427|NCT04720547|GABA Agents|gaba agents|mesh-ancestor
5950428|NCT04720547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5950429|NCT04720547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950430|NCT04720248|Dipyrone|dipyrone|mesh-list
5950431|NCT04720248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5950432|NCT04720248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5950433|NCT04720248|Analgesics|analgesics|mesh-ancestor
5950434|NCT04720248|Sensory System Agents|sensory system agents|mesh-ancestor
5950435|NCT04720248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5950436|NCT04720248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950437|NCT04720248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5950438|NCT04720248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5950439|NCT04720248|Antipyretics|antipyretics|mesh-ancestor
5950440|NCT04720183|Sulfasalazine|sulfasalazine|mesh-list
5950441|NCT04720183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5950442|NCT04720183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5950443|NCT04720183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5950444|NCT04720183|Analgesics|analgesics|mesh-ancestor
5950445|NCT04720183|Sensory System Agents|sensory system agents|mesh-ancestor
5950446|NCT04720183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5950447|NCT04720183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950448|NCT04720183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5950449|NCT04720183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5950450|NCT04720183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5950451|NCT04720131|Capecitabine|capecitabine|mesh-list
5950452|NCT04720131|Apatinib|apatinib|mesh-list
5950453|NCT04720131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5950454|NCT04720131|Antimetabolites|antimetabolites|mesh-ancestor
5950455|NCT04720131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950456|NCT04720131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5950457|NCT04720131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5950458|NCT04720131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5950459|NCT04720105|Halobetasol|halobetasol|mesh-list
5950460|NCT04720105|Tazarotene|tazarotene|mesh-list
5950461|NCT04720105|Dermatologic Agents|dermatologic agents|mesh-ancestor
5950462|NCT04720105|Keratolytic Agents|keratolytic agents|mesh-ancestor
5950463|NCT04720105|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5950464|NCT04720092|Rivaroxaban|rivaroxaban|mesh-list
5950465|NCT04720092|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5950466|NCT04720092|Antithrombins|antithrombins|mesh-ancestor
5950467|NCT04720092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5950468|NCT04720092|Protease Inhibitors|protease inhibitors|mesh-ancestor
5950469|NCT04720092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5950470|NCT04720092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950471|NCT04720092|Anticoagulants|anticoagulants|mesh-ancestor
5950472|NCT04719819|Anesthetics|anesthetics|mesh-list
5950473|NCT04719819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5950474|NCT04719819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950475|NCT04719650|Zoledronic Acid|zoledronic acid|mesh-list
5950476|NCT04719650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5950477|NCT04719650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950478|NCT04719507|Meperidine|meperidine|mesh-list
5950479|NCT04719507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5950480|NCT04719507|Narcotics|narcotics|mesh-ancestor
5950481|NCT04719507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5950482|NCT04719507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950483|NCT04719507|Analgesics|analgesics|mesh-ancestor
5950484|NCT04719507|Sensory System Agents|sensory system agents|mesh-ancestor
5950485|NCT04719507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5950486|NCT04719507|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5968598|NCT04551781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5968599|NCT04551573|Rifapentine|rifapentine|mesh-list
5968600|NCT04551573|Rifampin|rifampin|mesh-list
5968601|NCT04551573|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5968602|NCT04551573|Antitubercular Agents|antitubercular agents|mesh-ancestor
5968603|NCT04551573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5968604|NCT04551573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5968605|NCT04551573|Leprostatic Agents|leprostatic agents|mesh-ancestor
5968606|NCT04551573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5968607|NCT04551573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5968608|NCT04551573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968609|NCT04551573|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5968610|NCT04551573|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5968611|NCT04551573|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5968612|NCT04551573|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5968613|NCT04551573|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5968614|NCT04551573|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5968615|NCT04551170|Theophylline|theophylline|mesh-list
5968616|NCT04551170|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5968617|NCT04551170|Autonomic Agents|autonomic agents|mesh-ancestor
5968618|NCT04551170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5968619|NCT04551170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968620|NCT04551170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5968621|NCT04551170|Respiratory System Agents|respiratory system agents|mesh-ancestor
5968622|NCT04551170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5968623|NCT04551170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5968624|NCT04551170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968625|NCT04551170|Vasodilator Agents|vasodilator agents|mesh-ancestor
5968626|NCT04551170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5968627|NCT04551170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5968628|NCT04551170|Purinergic Agents|purinergic agents|mesh-ancestor
5968629|NCT04551170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5968630|NCT04551261|Ritonavir|ritonavir|mesh-list
5968631|NCT04551261|Tenofovir|tenofovir|mesh-list
6242651|NCT02654054|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5950487|NCT04719715|Antibodies|antibodies|mesh-list
5950488|NCT04719715|Immunologic Factors|immunologic factors|mesh-ancestor
5950489|NCT04719715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950490|NCT04719585|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5950491|NCT04719585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950492|NCT04719585|Analgesics|analgesics|mesh-ancestor
5950493|NCT04719585|Sensory System Agents|sensory system agents|mesh-ancestor
5950494|NCT04719585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5950495|NCT04719585|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5950496|NCT04719585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5950497|NCT04719585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5950498|NCT04719585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950499|NCT04719585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5950500|NCT04719585|Antidepressive Agents|antidepressive agents|mesh-ancestor
5950501|NCT04719585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5950502|NCT04719585|Dopamine Agents|dopamine agents|mesh-ancestor
5950503|NCT04719481|Pravastatin|pravastatin|mesh-list
5950504|NCT04719481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5950505|NCT04719481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5950506|NCT04719481|Antimetabolites|antimetabolites|mesh-ancestor
5950507|NCT04719481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950508|NCT04719481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5950509|NCT04719481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5950510|NCT04719481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5950511|NCT04719104|Bilirubin|bilirubin|mesh-list
5950512|NCT04719104|Antioxidants|antioxidants|mesh-ancestor
5950513|NCT04719104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950514|NCT04719104|Protective Agents|protective agents|mesh-ancestor
5950515|NCT04719104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950516|NCT04719221|Evolocumab|evolocumab|mesh-list
5950517|NCT04719221|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5950518|NCT04719221|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5950519|NCT04719221|Antimetabolites|antimetabolites|mesh-ancestor
5950520|NCT04719221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950521|NCT04719221|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5950522|NCT04719273|Anastrozole|anastrozole|mesh-list
5950523|NCT04719273|Onapristone|onapristone|mesh-list
5950524|NCT04719273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5950525|NCT04719273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5950526|NCT04719273|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5950527|NCT04719273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5950528|NCT04719273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5950529|NCT04719273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950530|NCT04719273|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5950531|NCT04719273|Hormone Antagonists|hormone antagonists|mesh-ancestor
5950532|NCT04719273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5950533|NCT04719273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950534|NCT04719273|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5950535|NCT04719273|Fertility Agents|fertility agents|mesh-ancestor
5950536|NCT04719273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5950537|NCT04718792|Psilocybin|psilocybin|mesh-list
5950538|NCT04718792|Hallucinogens|hallucinogens|mesh-ancestor
5950539|NCT04718792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950540|NCT04718792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5950541|NCT04718805|Darunavir|darunavir|mesh-list
5950542|NCT04718805|Cobicistat|cobicistat|mesh-list
5950543|NCT04718805|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5950544|NCT04718805|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5950545|NCT04718805|Protease Inhibitors|protease inhibitors|mesh-ancestor
5950546|NCT04718805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5950547|NCT04718805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950548|NCT04718805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5950549|NCT04718805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5950550|NCT04718805|Antiviral Agents|antiviral agents|mesh-ancestor
5950551|NCT04718805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5950552|NCT04718805|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5950553|NCT04718805|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5950554|NCT04718740|Vitamin K|vitamin k|mesh-list
5950555|NCT04718740|Repaglinide|repaglinide|mesh-list
5950556|NCT04718740|Midazolam|midazolam|mesh-list
5950557|NCT04718740|Caffeine|caffeine|mesh-list
5950558|NCT04718740|Bupropion|bupropion|mesh-list
5950559|NCT04718740|Omeprazole|omeprazole|mesh-list
5950560|NCT04718740|Warfarin|warfarin|mesh-list
5950561|NCT04718740|Vitamins|vitamins|mesh-ancestor
5950562|NCT04718740|Micronutrients|micronutrients|mesh-ancestor
5950563|NCT04718740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950564|NCT04718740|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5950565|NCT04718740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5950566|NCT04718740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5950567|NCT04718740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5950568|NCT04718740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5950569|NCT04718740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5950570|NCT04718740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5950571|NCT04718740|Anesthetics, General|anesthetics, general|mesh-ancestor
5950572|NCT04718740|Anesthetics|anesthetics|mesh-ancestor
5950573|NCT04718740|GABA Modulators|gaba modulators|mesh-ancestor
5950574|NCT04718740|GABA Agents|gaba agents|mesh-ancestor
5950575|NCT04718740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5950576|NCT04718740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950577|NCT04718740|Anticoagulants|anticoagulants|mesh-ancestor
5950578|NCT04718740|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5950579|NCT04718740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5950580|NCT04718740|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5950581|NCT04718740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5950582|NCT04718740|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5950583|NCT04718740|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5950584|NCT04718740|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5950585|NCT04718740|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5950586|NCT04718740|Purinergic Agents|purinergic agents|mesh-ancestor
5950587|NCT04718740|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5950588|NCT04718740|Antidepressive Agents|antidepressive agents|mesh-ancestor
5950589|NCT04718740|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5950590|NCT04718740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5950591|NCT04718740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5950592|NCT04718740|Dopamine Agents|dopamine agents|mesh-ancestor
5950593|NCT04718740|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5950594|NCT04718740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5950595|NCT04718740|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5950596|NCT04718740|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5950597|NCT04718740|Hemostatics|hemostatics|mesh-ancestor
5950598|NCT04718740|Coagulants|coagulants|mesh-ancestor
5950599|NCT04718740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5950600|NCT04718701|Paclitaxel|paclitaxel|mesh-list
5950601|NCT04718701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5950602|NCT04718701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5950603|NCT04718701|Tubulin Modulators|tubulin modulators|mesh-ancestor
5950604|NCT04718701|Antimitotic Agents|antimitotic agents|mesh-ancestor
5950605|NCT04718701|Mitosis Modulators|mitosis modulators|mesh-ancestor
5950606|NCT04718701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950607|NCT04718389|Benralizumab|benralizumab|mesh-list
5950608|NCT04718389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5950609|NCT04718389|Respiratory System Agents|respiratory system agents|mesh-ancestor
5950610|NCT04718402|Mitoxantrone|mitoxantrone|mesh-list
5950611|NCT04718402|Analgesics|analgesics|mesh-ancestor
5950612|NCT04718402|Sensory System Agents|sensory system agents|mesh-ancestor
5950613|NCT04718402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5950614|NCT04718402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950615|NCT04718402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5950616|NCT04718402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5950617|NCT04718402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5950618|NCT04718402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5950619|NCT04718402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950620|NCT04718285|Favipiravir|favipiravir|mesh-list
5950621|NCT04718285|Montelukast|montelukast|mesh-list
5950622|NCT04718285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5950623|NCT04718285|Respiratory System Agents|respiratory system agents|mesh-ancestor
5950624|NCT04718285|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5950625|NCT04718285|Hormone Antagonists|hormone antagonists|mesh-ancestor
5950626|NCT04718285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5950627|NCT04718285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950628|NCT04718285|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5950629|NCT04718285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5950630|NCT04718285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950631|NCT04718285|Antiviral Agents|antiviral agents|mesh-ancestor
5950632|NCT04718285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5950633|NCT04718311|Tacrolimus|tacrolimus|mesh-list
5950634|NCT04718311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5950635|NCT04718311|Immunologic Factors|immunologic factors|mesh-ancestor
6681365|NCT01609335|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5950636|NCT04718311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950637|NCT04718311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5950638|NCT04718311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5950639|NCT04718311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950640|NCT04718376|Mitoxantrone|mitoxantrone|mesh-list
5950641|NCT04718376|Analgesics|analgesics|mesh-ancestor
5950642|NCT04718376|Sensory System Agents|sensory system agents|mesh-ancestor
5950643|NCT04718376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5950644|NCT04718376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950645|NCT04718376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5950646|NCT04718376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5950647|NCT04718376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5950648|NCT04718376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5950649|NCT04718376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950650|NCT04718584|Antibodies|antibodies|mesh-list
5950651|NCT04718584|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5950652|NCT04718584|Immunologic Factors|immunologic factors|mesh-ancestor
5950653|NCT04718584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950654|NCT04718649|Celecoxib|celecoxib|mesh-list
5950655|NCT04718649|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5950656|NCT04718649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5950657|NCT04718649|Analgesics|analgesics|mesh-ancestor
5950658|NCT04718649|Sensory System Agents|sensory system agents|mesh-ancestor
5950659|NCT04718649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5950660|NCT04718649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950661|NCT04718649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5950662|NCT04718649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5950663|NCT04718649|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5950664|NCT04718649|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5950665|NCT04718649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5950666|NCT04718649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950667|NCT04718714|Midazolam|midazolam|mesh-list
5950668|NCT04718714|Dexmedetomidine|dexmedetomidine|mesh-list
5950669|NCT04718714|Propofol|propofol|mesh-list
5950670|NCT04718714|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5950671|NCT04718714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5950672|NCT04718714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950673|NCT04718714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5950674|NCT04718714|Anesthetics, General|anesthetics, general|mesh-ancestor
5950675|NCT04718714|Anesthetics|anesthetics|mesh-ancestor
5950676|NCT04718714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5950677|NCT04718714|Analgesics|analgesics|mesh-ancestor
5950678|NCT04718714|Sensory System Agents|sensory system agents|mesh-ancestor
5950679|NCT04718714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5950680|NCT04718714|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5950681|NCT04718714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5950682|NCT04718714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5950683|NCT04718714|Adrenergic Agents|adrenergic agents|mesh-ancestor
5950684|NCT04718714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5950685|NCT04718714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950686|NCT04718714|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5950687|NCT04718714|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5950688|NCT04718714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5950689|NCT04718714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5950690|NCT04718714|GABA Modulators|gaba modulators|mesh-ancestor
5950691|NCT04718714|GABA Agents|gaba agents|mesh-ancestor
5950692|NCT04718480|Fluvoxamine|fluvoxamine|mesh-list
5950693|NCT04718480|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5950694|NCT04718480|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6681366|NCT01609335|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6681367|NCT01609335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681368|NCT01609387|Tocopherols|tocopherols|mesh-list
6681369|NCT01609387|Antioxidants|antioxidants|mesh-ancestor
6681370|NCT01609387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681371|NCT01609387|Protective Agents|protective agents|mesh-ancestor
6681372|NCT01609387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681373|NCT01609387|Vitamins|vitamins|mesh-ancestor
6681374|NCT01609387|Micronutrients|micronutrients|mesh-ancestor
6681375|NCT01609413|Calcium Carbonate|calcium carbonate|mesh-list
6681376|NCT01609413|Antacids|antacids|mesh-ancestor
6681377|NCT01609413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681378|NCT01609413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6681379|NCT01609439|Vitamin D|vitamin d|mesh-list
6681380|NCT01609439|Vitamins|vitamins|mesh-ancestor
5950695|NCT04718480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6681381|NCT01609439|Micronutrients|micronutrients|mesh-ancestor
5950696|NCT04718480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950697|NCT04718480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5950698|NCT04718480|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5950699|NCT04718480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5950700|NCT04718480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5950701|NCT04718480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950702|NCT04718480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5950703|NCT04718480|Serotonin Agents|serotonin agents|mesh-ancestor
5950704|NCT04718480|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5950705|NCT04718480|Antidepressive Agents|antidepressive agents|mesh-ancestor
5950706|NCT04718480|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5950707|NCT04718480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5950708|NCT04718480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5950709|NCT04718480|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5950710|NCT04718038|Cetuximab|cetuximab|mesh-list
5950711|NCT04718038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5950712|NCT04718038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5950713|NCT04718233|Sildenafil Citrate|sildenafil citrate|mesh-list
5950714|NCT04718233|Vasodilator Agents|vasodilator agents|mesh-ancestor
5950715|NCT04718233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5950716|NCT04718233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5950717|NCT04718233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5950718|NCT04718233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950719|NCT04718233|Urological Agents|urological agents|mesh-ancestor
5950720|NCT04718064|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
5950721|NCT04718064|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5950722|NCT04718064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950723|NCT04718064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5950724|NCT04718064|Immunologic Factors|immunologic factors|mesh-ancestor
5950725|NCT04718064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950726|NCT04718259|Midazolam|midazolam|mesh-list
5950727|NCT04718259|Bupivacaine|bupivacaine|mesh-list
5950728|NCT04718259|Anesthetics, Local|anesthetics, local|mesh-ancestor
5950729|NCT04718259|Anesthetics|anesthetics|mesh-ancestor
5950730|NCT04718259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5950731|NCT04718259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950732|NCT04718259|Sensory System Agents|sensory system agents|mesh-ancestor
5950733|NCT04718259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5950734|NCT04718259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5950735|NCT04718259|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5950736|NCT04718259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5950737|NCT04718259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5950738|NCT04718259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5950739|NCT04718259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5950740|NCT04718259|Anesthetics, General|anesthetics, general|mesh-ancestor
5950741|NCT04718259|GABA Modulators|gaba modulators|mesh-ancestor
5950742|NCT04718259|GABA Agents|gaba agents|mesh-ancestor
5950743|NCT04718259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5950744|NCT04718259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968632|NCT04551261|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5968633|NCT04551261|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5968634|NCT04551261|Protease Inhibitors|protease inhibitors|mesh-ancestor
5968635|NCT04551261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5968636|NCT04551261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968637|NCT04551261|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5968638|NCT04551261|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5968639|NCT04551261|Antiviral Agents|antiviral agents|mesh-ancestor
5968640|NCT04551261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5968641|NCT04551261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5968642|NCT04551261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5968643|NCT04551261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5968644|NCT04551261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5968645|NCT04551248|Vaccines|vaccines|mesh-list
5968646|NCT04551248|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5968647|NCT04551248|Immunologic Factors|immunologic factors|mesh-ancestor
5968648|NCT04551248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968649|NCT04551547|Vaccines|vaccines|mesh-list
5968650|NCT04551547|Immunologic Factors|immunologic factors|mesh-ancestor
5968651|NCT04551547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968652|NCT04551040|Terazosin|terazosin|mesh-list
5968653|NCT04551040|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5968654|NCT04551040|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5950745|NCT04717973|Vitamin D|vitamin d|mesh-list
5950746|NCT04717973|Vitamins|vitamins|mesh-list
5950747|NCT04717973|Vitamin B 12|vitamin b 12|mesh-list
5950748|NCT04717973|Hydroxocobalamin|hydroxocobalamin|mesh-list
5950749|NCT04717973|Micronutrients|micronutrients|mesh-ancestor
5950750|NCT04717973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950751|NCT04717973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5950752|NCT04717973|Vitamin B Complex|vitamin b complex|mesh-ancestor
5950753|NCT04717973|Hematinics|hematinics|mesh-ancestor
5950754|NCT04717908|Cycloserine|cycloserine|mesh-list
5950755|NCT04717908|Linezolid|linezolid|mesh-list
5950756|NCT04717908|Pyrazinamide|pyrazinamide|mesh-list
5950757|NCT04717908|Bedaquiline|bedaquiline|mesh-list
5950758|NCT04717908|Clofazimine|clofazimine|mesh-list
5950759|NCT04717908|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5950760|NCT04717908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5950761|NCT04717908|Renal Agents|renal agents|mesh-ancestor
5950762|NCT04717908|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5950763|NCT04717908|Antitubercular Agents|antitubercular agents|mesh-ancestor
5950764|NCT04717908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5950765|NCT04717908|Antimetabolites|antimetabolites|mesh-ancestor
5950766|NCT04717908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950767|NCT04717908|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5950768|NCT04717908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5950769|NCT04717908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5950770|NCT04717908|Leprostatic Agents|leprostatic agents|mesh-ancestor
5950771|NCT04717986|Dapagliflozin|dapagliflozin|mesh-list
5950772|NCT04717986|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5950773|NCT04717986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950774|NCT04717986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5950775|NCT04717986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950776|NCT04718220|Antibodies|antibodies|mesh-list
5950777|NCT04718220|Immunologic Factors|immunologic factors|mesh-ancestor
5950778|NCT04718220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950779|NCT04717752|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5950780|NCT04717752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5950781|NCT04717752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950782|NCT04717531|Cyclophosphamide|cyclophosphamide|mesh-list
5950783|NCT04717531|Docetaxel|docetaxel|mesh-list
5950784|NCT04717531|Trastuzumab|trastuzumab|mesh-list
5950785|NCT04717531|Epirubicin|epirubicin|mesh-list
5950786|NCT04717531|Pertuzumab|pertuzumab|mesh-list
5950787|NCT04717531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5950788|NCT04717531|Immunologic Factors|immunologic factors|mesh-ancestor
5950789|NCT04717531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950790|NCT04717531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5950791|NCT04717531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5950792|NCT04717531|Alkylating Agents|alkylating agents|mesh-ancestor
5950793|NCT04717531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950794|NCT04717531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5950795|NCT04717531|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5950796|NCT04717531|Tubulin Modulators|tubulin modulators|mesh-ancestor
5950797|NCT04717531|Antimitotic Agents|antimitotic agents|mesh-ancestor
5950798|NCT04717531|Mitosis Modulators|mitosis modulators|mesh-ancestor
5950799|NCT04717531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5950800|NCT04717531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5950801|NCT04717531|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5950802|NCT04717531|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5950803|NCT04717531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5950804|NCT04717700|Dexamethasone|dexamethasone|mesh-list
5950805|NCT04717700|Lenalidomide|lenalidomide|mesh-list
5950806|NCT04717700|Bortezomib|bortezomib|mesh-list
5950807|NCT04717700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5950808|NCT04717700|Antiemetics|antiemetics|mesh-ancestor
5950809|NCT04717700|Autonomic Agents|autonomic agents|mesh-ancestor
5950810|NCT04717700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5950811|NCT04717700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950812|NCT04717700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6517451|NCT00721201|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6517452|NCT00721240|Montelukast|montelukast|mesh-list
6517453|NCT00721240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6517454|NCT00721240|Respiratory System Agents|respiratory system agents|mesh-ancestor
5950813|NCT04717700|Glucocorticoids|glucocorticoids|mesh-ancestor
5950814|NCT04717700|Hormones|hormones|mesh-ancestor
5950815|NCT04717700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5950816|NCT04717700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5950817|NCT04717700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5950818|NCT04717700|Immunologic Factors|immunologic factors|mesh-ancestor
5950819|NCT04717700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5950820|NCT04717700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5950821|NCT04717700|Growth Substances|growth substances|mesh-ancestor
5950822|NCT04717700|Growth Inhibitors|growth inhibitors|mesh-ancestor
5950823|NCT04717609|Ropivacaine|ropivacaine|mesh-list
5950824|NCT04717609|Anesthetics, Local|anesthetics, local|mesh-ancestor
5950825|NCT04717609|Anesthetics|anesthetics|mesh-ancestor
5950826|NCT04717609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5950827|NCT04717609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950828|NCT04717609|Sensory System Agents|sensory system agents|mesh-ancestor
5950829|NCT04717609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5950830|NCT04717102|Desflurane|desflurane|mesh-list
5950831|NCT04717102|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5950832|NCT04717102|Anesthetics, General|anesthetics, general|mesh-ancestor
5950833|NCT04717102|Anesthetics|anesthetics|mesh-ancestor
5950834|NCT04717102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5950835|NCT04717102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950836|NCT04717089|Anesthetics|anesthetics|mesh-list
5950837|NCT04717089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5950838|NCT04717089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950839|NCT04716894|Itraconazole|itraconazole|mesh-list
5950840|NCT04716894|Antifungal Agents|antifungal agents|mesh-ancestor
5950841|NCT04716894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5950842|NCT04716894|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5950843|NCT04716894|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5950844|NCT04716894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5950845|NCT04716894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950846|NCT04716894|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5950847|NCT04716894|Hormone Antagonists|hormone antagonists|mesh-ancestor
5950848|NCT04716894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5950849|NCT04716894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950850|NCT04716894|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5950851|NCT04717063|Hydrogen Peroxide|hydrogen peroxide|mesh-list
5950852|NCT04717063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5950853|NCT04717063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5950854|NCT04716881|Naltrexone|naltrexone|mesh-list
5950855|NCT04716881|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5950856|NCT04716881|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5950857|NCT04716881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950858|NCT04716881|Sensory System Agents|sensory system agents|mesh-ancestor
5950859|NCT04716881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5950860|NCT04717193|Epinephrine|epinephrine|mesh-list
5950861|NCT04717193|Racepinephrine|racepinephrine|mesh-list
5950862|NCT04717193|Bupivacaine|bupivacaine|mesh-list
5950863|NCT04717193|Anesthetics, Local|anesthetics, local|mesh-list
5950864|NCT04717193|Anesthetics|anesthetics|mesh-list
5950865|NCT04717193|Epinephryl borate|epinephryl borate|mesh-list
5950866|NCT04717193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5950867|NCT04717193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950868|NCT04717193|Sensory System Agents|sensory system agents|mesh-ancestor
5950869|NCT04717193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5950870|NCT04717193|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5950871|NCT04717193|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5950872|NCT04717193|Adrenergic Agents|adrenergic agents|mesh-ancestor
5950873|NCT04717193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5950874|NCT04717193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950875|NCT04717193|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5950876|NCT04717193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5950877|NCT04717193|Autonomic Agents|autonomic agents|mesh-ancestor
5950878|NCT04717193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5950879|NCT04717193|Respiratory System Agents|respiratory system agents|mesh-ancestor
5950880|NCT04717193|Mydriatics|mydriatics|mesh-ancestor
5950881|NCT04717193|Sympathomimetics|sympathomimetics|mesh-ancestor
5950882|NCT04717193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5950883|NCT04716569|Ivermectin|ivermectin|mesh-list
5950884|NCT04716569|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5950885|NCT04716569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5950886|NCT04716868|Levan|levan|mesh-list
5950887|NCT04716868|Psyllium|psyllium|mesh-list
5950888|NCT04716868|Cathartics|cathartics|mesh-ancestor
5950889|NCT04716868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5950890|NCT04716868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5950891|NCT04716712|Azithromycin|azithromycin|mesh-list
5950892|NCT04716712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5950893|NCT04716712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5950894|NCT04716751|Paclitaxel|paclitaxel|mesh-list
5950895|NCT04716751|Carboplatin|carboplatin|mesh-list
5950896|NCT04716751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5950897|NCT04716751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5950898|NCT04716751|Tubulin Modulators|tubulin modulators|mesh-ancestor
5950899|NCT04716751|Antimitotic Agents|antimitotic agents|mesh-ancestor
5950900|NCT04716751|Mitosis Modulators|mitosis modulators|mesh-ancestor
5950901|NCT04716751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950902|NCT04716686|Niraparib|niraparib|mesh-list
5950903|NCT04716686|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5950904|NCT04716686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5950905|NCT04716686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950906|NCT04716686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5950907|NCT04716725|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5950908|NCT04716725|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5950909|NCT04716725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950910|NCT04716296|Ketamine|ketamine|mesh-list
5950911|NCT04716296|Analgesics|analgesics|mesh-ancestor
5950912|NCT04716296|Sensory System Agents|sensory system agents|mesh-ancestor
5950913|NCT04716296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5950914|NCT04716296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950915|NCT04716296|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5950916|NCT04716296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5950917|NCT04716296|Anesthetics, General|anesthetics, general|mesh-ancestor
5950918|NCT04716296|Anesthetics|anesthetics|mesh-ancestor
5950919|NCT04716296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5950920|NCT04716296|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5950921|NCT04716296|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5950922|NCT04716296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5950923|NCT04716296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950924|NCT04716413|Dsuvia|dsuvia|mesh-list
5950925|NCT04716413|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5950926|NCT04716413|Narcotics|narcotics|mesh-ancestor
5950927|NCT04716413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5950928|NCT04716413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950929|NCT04716413|Analgesics|analgesics|mesh-ancestor
5950930|NCT04716413|Sensory System Agents|sensory system agents|mesh-ancestor
5950931|NCT04716413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5968655|NCT04551040|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5968656|NCT04551040|Adrenergic Agents|adrenergic agents|mesh-ancestor
5968657|NCT04551040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5968658|NCT04551040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968659|NCT04551040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968660|NCT04551040|Urological Agents|urological agents|mesh-ancestor
5968661|NCT04550936|Isavuconazole|isavuconazole|mesh-list
5968662|NCT04550936|Antifungal Agents|antifungal agents|mesh-ancestor
5968663|NCT04550936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5968664|NCT04550949|Denosumab|denosumab|mesh-list
5968665|NCT04550949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5968666|NCT04550949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968667|NCT04550793|Botulinum Toxins|botulinum toxins|mesh-list
5968668|NCT04550793|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5968669|NCT04550793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5968670|NCT04550793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968671|NCT04550793|Cholinergic Agents|cholinergic agents|mesh-ancestor
5968672|NCT04550793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5968673|NCT04550793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968674|NCT04550858|Rebamipide|rebamipide|mesh-list
5968675|NCT04550858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5968676|NCT04550858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5968677|NCT04550858|Antioxidants|antioxidants|mesh-ancestor
5968678|NCT04550858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968679|NCT04550858|Protective Agents|protective agents|mesh-ancestor
5968680|NCT04550858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968681|NCT04550858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5968682|NCT04551196|Acetaminophen|acetaminophen|mesh-list
5968683|NCT04551196|Ibuprofen|ibuprofen|mesh-list
5968684|NCT04551196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5968685|NCT04551196|Analgesics|analgesics|mesh-ancestor
5968686|NCT04551196|Sensory System Agents|sensory system agents|mesh-ancestor
5968687|NCT04551196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5968688|NCT04551196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968689|NCT04551196|Antipyretics|antipyretics|mesh-ancestor
5968690|NCT04551196|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5968691|NCT04551196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5968692|NCT04551196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5950932|NCT04716426|Tetracycline|tetracycline|mesh-list
5950933|NCT04716426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5950934|NCT04716426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5950935|NCT04716426|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5950936|NCT04716426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5950937|NCT04716426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950938|NCT04716179|Hormones|hormones|mesh-list
5950939|NCT04716179|Testosterone|testosterone|mesh-list
5950940|NCT04716179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5950941|NCT04716179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950942|NCT04716179|Androgens|androgens|mesh-ancestor
5950943|NCT04715763|Telmisartan|telmisartan|mesh-list
5950944|NCT04715763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5950945|NCT04715763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5950946|NCT04715763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5950947|NCT04715763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950948|NCT04715737|Vasopressins|vasopressins|mesh-list
5950949|NCT04715737|Arginine Vasopressin|arginine vasopressin|mesh-list
5950950|NCT04715737|Oxytocin|oxytocin|mesh-list
5950951|NCT04715737|Oxytocics|oxytocics|mesh-ancestor
5950952|NCT04715737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5950953|NCT04715737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950954|NCT04715737|Hemostatics|hemostatics|mesh-ancestor
5950955|NCT04715737|Coagulants|coagulants|mesh-ancestor
5950956|NCT04715737|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5950957|NCT04715737|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5950958|NCT04715737|Natriuretic Agents|natriuretic agents|mesh-ancestor
5950959|NCT04715633|Apatinib|apatinib|mesh-list
5950960|NCT04715633|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5950961|NCT04715633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5950962|NCT04715633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5950963|NCT04715633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5950964|NCT04715633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950965|NCT04715620|Niraparib|niraparib|mesh-list
5950966|NCT04715620|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5950967|NCT04715620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5950968|NCT04715620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950969|NCT04715620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5950970|NCT04715568|Losartan|losartan|mesh-list
5950971|NCT04715568|Antihypertensive Agents|antihypertensive agents|mesh-list
5950972|NCT04715568|Angiotensin II|angiotensin ii|mesh-list
5950973|NCT04715568|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
5950974|NCT04715568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5950975|NCT04715568|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5950976|NCT04715568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950977|NCT04715568|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5950978|NCT04715217|Cyclophosphamide|cyclophosphamide|mesh-list
5950979|NCT04715217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5950980|NCT04715217|Immunologic Factors|immunologic factors|mesh-ancestor
5950981|NCT04715217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950982|NCT04715217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5950983|NCT04715217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5950984|NCT04715217|Alkylating Agents|alkylating agents|mesh-ancestor
5950985|NCT04715217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950986|NCT04715217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5950987|NCT04715217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5950988|NCT04715269|Alprazolam|alprazolam|mesh-list
5950989|NCT04715269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5950990|NCT04715269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5950991|NCT04715269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5950992|NCT04715269|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5950993|NCT04715269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5950994|NCT04715269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5950995|NCT04715269|GABA Modulators|gaba modulators|mesh-ancestor
5950996|NCT04715269|GABA Agents|gaba agents|mesh-ancestor
5950997|NCT04715269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5950998|NCT04715269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5950999|NCT04715152|Dexamethasone|dexamethasone|mesh-list
5951000|NCT04715152|Dexamethasone acetate|dexamethasone acetate|mesh-list
5951001|NCT04715152|Levobupivacaine|levobupivacaine|mesh-list
5951002|NCT04715152|BB 1101|bb 1101|mesh-list
5951003|NCT04715152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5951004|NCT04715152|Antiemetics|antiemetics|mesh-ancestor
5951005|NCT04715152|Autonomic Agents|autonomic agents|mesh-ancestor
5951006|NCT04715152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5951007|NCT04715152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951008|NCT04715152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5951009|NCT04715152|Glucocorticoids|glucocorticoids|mesh-ancestor
5951010|NCT04715152|Hormones|hormones|mesh-ancestor
5951011|NCT04715152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5951012|NCT04715152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5951013|NCT04715152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5951014|NCT04715152|Protease Inhibitors|protease inhibitors|mesh-ancestor
5951015|NCT04715152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5951016|NCT04715152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951017|NCT04715152|Anesthetics, Local|anesthetics, local|mesh-ancestor
5951018|NCT04715152|Anesthetics|anesthetics|mesh-ancestor
5951019|NCT04715152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5951020|NCT04715152|Sensory System Agents|sensory system agents|mesh-ancestor
5951021|NCT04715360|Favipiravir|favipiravir|mesh-list
5951022|NCT04715360|Antiviral Agents|antiviral agents|mesh-ancestor
5951023|NCT04715360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5951024|NCT04715295|Azithromycin|azithromycin|mesh-list
5951025|NCT04715295|Doxycycline|doxycycline|mesh-list
5951026|NCT04715295|Hydroxychloroquine|hydroxychloroquine|mesh-list
5951027|NCT04715295|Rivaroxaban|rivaroxaban|mesh-list
5951028|NCT04715295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5951029|NCT04715295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5951030|NCT04715295|Antimalarials|antimalarials|mesh-ancestor
5951031|NCT04715295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5951032|NCT04715295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5951033|NCT04715295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5951034|NCT04715295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951035|NCT04715295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6517455|NCT00721240|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6517456|NCT00721240|Hormone Antagonists|hormone antagonists|mesh-ancestor
6517457|NCT00721240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6517458|NCT00721240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517459|NCT00721240|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6517460|NCT00721240|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6517461|NCT00721240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517462|NCT00721305|Lovastatin|lovastatin|mesh-list
5951036|NCT04715295|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5951037|NCT04715295|Antithrombins|antithrombins|mesh-ancestor
5951038|NCT04715295|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5951039|NCT04715295|Protease Inhibitors|protease inhibitors|mesh-ancestor
5951040|NCT04715295|Anticoagulants|anticoagulants|mesh-ancestor
5951041|NCT04715503|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5951042|NCT04715503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5951043|NCT04715503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951044|NCT04715165|Dexmedetomidine|dexmedetomidine|mesh-list
5951045|NCT04715165|Bupivacaine|bupivacaine|mesh-list
5951046|NCT04715165|Anesthetics, Local|anesthetics, local|mesh-ancestor
5951047|NCT04715165|Anesthetics|anesthetics|mesh-ancestor
5951048|NCT04715165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5951049|NCT04715165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951050|NCT04715165|Sensory System Agents|sensory system agents|mesh-ancestor
5951051|NCT04715165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5951052|NCT04715165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5951053|NCT04715165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5951054|NCT04715165|Analgesics|analgesics|mesh-ancestor
5951055|NCT04715165|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5951056|NCT04715165|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5951057|NCT04715165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5951058|NCT04715165|Adrenergic Agents|adrenergic agents|mesh-ancestor
5951059|NCT04715165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5951060|NCT04715165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951061|NCT04715022|Ascorbic Acid|ascorbic acid|mesh-list
5951062|NCT04715022|Antioxidants|antioxidants|mesh-ancestor
5951063|NCT04715022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951064|NCT04715022|Protective Agents|protective agents|mesh-ancestor
5951065|NCT04715022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951066|NCT04715022|Vitamins|vitamins|mesh-ancestor
5951067|NCT04715022|Micronutrients|micronutrients|mesh-ancestor
5951068|NCT04715113|Sildenafil Citrate|sildenafil citrate|mesh-list
5951069|NCT04715113|Vasodilator Agents|vasodilator agents|mesh-ancestor
5951070|NCT04715113|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5951071|NCT04715113|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5951072|NCT04715113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6242652|NCT02654054|Contraceptive Agents|contraceptive agents|mesh-ancestor
5951073|NCT04715113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951074|NCT04715113|Urological Agents|urological agents|mesh-ancestor
5951075|NCT04714827|Cyclophosphamide|cyclophosphamide|mesh-list
5951076|NCT04714827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5951077|NCT04714827|Immunologic Factors|immunologic factors|mesh-ancestor
5951078|NCT04714827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951079|NCT04714827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5951080|NCT04714827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5951081|NCT04714827|Alkylating Agents|alkylating agents|mesh-ancestor
5951082|NCT04714827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951083|NCT04714827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5951084|NCT04714827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5968693|NCT04551196|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5968694|NCT04551196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5968695|NCT04551196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968696|NCT04550702|Mirabegron|mirabegron|mesh-list
5968697|NCT04550702|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
5968698|NCT04550702|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5968699|NCT04550702|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5968700|NCT04550702|Adrenergic Agents|adrenergic agents|mesh-ancestor
5968701|NCT04550702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5968702|NCT04550702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968703|NCT04550702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968704|NCT04550702|Urological Agents|urological agents|mesh-ancestor
5968705|NCT04550442|Azacitidine|azacitidine|mesh-list
5968706|NCT04550442|Venetoclax|venetoclax|mesh-list
5968707|NCT04550442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5968708|NCT04550442|Antimetabolites|antimetabolites|mesh-ancestor
5968709|NCT04550442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968710|NCT04550442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5968711|NCT04550442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5968712|NCT04550351|Vaccines|vaccines|mesh-list
5968713|NCT04550351|Immunologic Factors|immunologic factors|mesh-ancestor
5968714|NCT04550351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968715|NCT04550637|Apixaban|apixaban|mesh-list
5968716|NCT04550637|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5968717|NCT04550637|Antithrombins|antithrombins|mesh-ancestor
5968718|NCT04550637|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5968719|NCT04550637|Protease Inhibitors|protease inhibitors|mesh-ancestor
5968720|NCT04550637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5968721|NCT04550637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968722|NCT04550637|Anticoagulants|anticoagulants|mesh-ancestor
5968723|NCT04550338|Tranexamic Acid|tranexamic acid|mesh-list
5968724|NCT04550338|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5968725|NCT04550338|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5968726|NCT04550338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968727|NCT04550338|Hemostatics|hemostatics|mesh-ancestor
5968728|NCT04550338|Coagulants|coagulants|mesh-ancestor
5968729|NCT04550377|Cannabidiol|cannabidiol|mesh-list
5968730|NCT04550377|Anticonvulsants|anticonvulsants|mesh-ancestor
5968731|NCT04550520|Glucagon|glucagon|mesh-list
5968732|NCT04550520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5968733|NCT04550520|Hormones|hormones|mesh-ancestor
5968734|NCT04550520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5968735|NCT04550520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968736|NCT04550494|Talazoparib|talazoparib|mesh-list
5968737|NCT04550494|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5968738|NCT04550494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5968739|NCT04550494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968740|NCT04550494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5968741|NCT04550234|Allopurinol|allopurinol|mesh-list
5968742|NCT04550234|Verinurad|verinurad|mesh-list
5968743|NCT04550234|Antimetabolites|antimetabolites|mesh-ancestor
5968744|NCT04550234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968745|NCT04550234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5968746|NCT04550234|Gout Suppressants|gout suppressants|mesh-ancestor
5968747|NCT04550234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5968748|NCT04550234|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5968749|NCT04550234|Antioxidants|antioxidants|mesh-ancestor
5968750|NCT04550234|Protective Agents|protective agents|mesh-ancestor
5968751|NCT04550234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968752|NCT04550585|Insulin|insulin|mesh-list
5968753|NCT04550585|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5968754|NCT04550585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5968755|NCT04550585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951085|NCT04714554|Erythromycin|erythromycin|mesh-list
5951086|NCT04714554|Erythromycin Estolate|erythromycin estolate|mesh-list
5951087|NCT04714554|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
5951088|NCT04714554|Erythromycin stearate|erythromycin stearate|mesh-list
5951089|NCT04714554|Relugolix|relugolix|mesh-list
5951090|NCT04714554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5951091|NCT04714554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5951092|NCT04714554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5951093|NCT04714554|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5951094|NCT04714554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5951095|NCT04714554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951096|NCT04714554|Androgen Antagonists|androgen antagonists|mesh-ancestor
5951097|NCT04714554|Hormone Antagonists|hormone antagonists|mesh-ancestor
5951098|NCT04714554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5951099|NCT04714554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951100|NCT04714593|Cyclophosphamide|cyclophosphamide|mesh-list
5951101|NCT04714593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5951102|NCT04714593|Immunologic Factors|immunologic factors|mesh-ancestor
5951103|NCT04714593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951104|NCT04714593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5951105|NCT04714593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5951106|NCT04714593|Alkylating Agents|alkylating agents|mesh-ancestor
5951107|NCT04714593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951108|NCT04714593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5951109|NCT04714593|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5951110|NCT04714242|Ranibizumab|ranibizumab|mesh-list
5951111|NCT04714242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5951112|NCT04714242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5951113|NCT04714242|Growth Substances|growth substances|mesh-ancestor
5951114|NCT04714242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951115|NCT04714242|Growth Inhibitors|growth inhibitors|mesh-ancestor
5951116|NCT04714242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5951117|NCT04714229|Vaccines|vaccines|mesh-list
5951118|NCT04714229|Immunologic Factors|immunologic factors|mesh-ancestor
5951119|NCT04714229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951120|NCT04714515|Hydroxychloroquine|hydroxychloroquine|mesh-list
5951121|NCT04714515|Ivermectin|ivermectin|mesh-list
5951122|NCT04714515|Montelukast|montelukast|mesh-list
5951123|NCT04714515|Antimalarials|antimalarials|mesh-ancestor
5951124|NCT04714515|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5951125|NCT04714515|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5951126|NCT04714515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5951127|NCT04714515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5951128|NCT04714515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951129|NCT04714515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5951130|NCT04714515|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5951131|NCT04714515|Respiratory System Agents|respiratory system agents|mesh-ancestor
5951132|NCT04714515|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5951133|NCT04714515|Hormone Antagonists|hormone antagonists|mesh-ancestor
5951134|NCT04714515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5951135|NCT04714515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951136|NCT04714515|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5951137|NCT04714515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5951138|NCT04714541|Ketamine|ketamine|mesh-list
5951139|NCT04714541|Analgesics|analgesics|mesh-ancestor
5951140|NCT04714541|Sensory System Agents|sensory system agents|mesh-ancestor
5951141|NCT04714541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5951142|NCT04714541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951143|NCT04714541|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5951144|NCT04714541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5951145|NCT04714541|Anesthetics, General|anesthetics, general|mesh-ancestor
5951146|NCT04714541|Anesthetics|anesthetics|mesh-ancestor
5951147|NCT04714541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5951148|NCT04714541|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5951149|NCT04714541|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5951150|NCT04714541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5951151|NCT04714541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951152|NCT04713969|Pantoprazole|pantoprazole|mesh-list
5951153|NCT04713969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5951154|NCT04713969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5951155|NCT04713969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5951156|NCT04713969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5951157|NCT04713969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951158|NCT04714073|Itraconazole|itraconazole|mesh-list
5951159|NCT04714073|Antifungal Agents|antifungal agents|mesh-ancestor
5951160|NCT04714073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5951161|NCT04714073|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5951162|NCT04714073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5951163|NCT04714073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5951164|NCT04714073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951165|NCT04714073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5951166|NCT04714073|Hormone Antagonists|hormone antagonists|mesh-ancestor
5951167|NCT04714073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5951168|NCT04714073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951169|NCT04714073|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5951170|NCT04714112|Dexamethasone|dexamethasone|mesh-list
5951171|NCT04714112|Dexamethasone acetate|dexamethasone acetate|mesh-list
5951172|NCT04714112|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
5951173|NCT04714112|BB 1101|bb 1101|mesh-list
5951174|NCT04714112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5951175|NCT04714112|Antiemetics|antiemetics|mesh-ancestor
5951176|NCT04714112|Autonomic Agents|autonomic agents|mesh-ancestor
5951177|NCT04714112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5951178|NCT04714112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951179|NCT04714112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5951180|NCT04714112|Glucocorticoids|glucocorticoids|mesh-ancestor
5951181|NCT04714112|Hormones|hormones|mesh-ancestor
5951182|NCT04714112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5951183|NCT04714112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5951184|NCT04714112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5951185|NCT04714112|Protease Inhibitors|protease inhibitors|mesh-ancestor
5951186|NCT04714112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5951187|NCT04714112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951188|NCT04714099|Cyclosporine|cyclosporine|mesh-list
5951189|NCT04714099|Cyclosporins|cyclosporins|mesh-list
5951190|NCT04714099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5951191|NCT04714099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951192|NCT04714099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5951193|NCT04714099|Immunologic Factors|immunologic factors|mesh-ancestor
5951194|NCT04714099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951195|NCT04714099|Antifungal Agents|antifungal agents|mesh-ancestor
5951196|NCT04714099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5951197|NCT04714099|Dermatologic Agents|dermatologic agents|mesh-ancestor
5951198|NCT04714099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5951199|NCT04714099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5951200|NCT04713956|Cyclophosphamide|cyclophosphamide|mesh-list
5951201|NCT04713956|Busulfan|busulfan|mesh-list
5951202|NCT04713956|Fludarabine|fludarabine|mesh-list
5951203|NCT04713956|Decitabine|decitabine|mesh-list
5951204|NCT04713956|Sargramostim|sargramostim|mesh-list
5951205|NCT04713956|Lenograstim|lenograstim|mesh-list
5951206|NCT04713956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5951207|NCT04713956|Immunologic Factors|immunologic factors|mesh-ancestor
5951208|NCT04713956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951209|NCT04713956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5951210|NCT04713956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5951211|NCT04713956|Alkylating Agents|alkylating agents|mesh-ancestor
5951212|NCT04713956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951213|NCT04713956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5951214|NCT04713956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5951215|NCT04713956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5951216|NCT04713956|Antimetabolites|antimetabolites|mesh-ancestor
5951217|NCT04713956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5951218|NCT04713956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5951219|NCT04714177|Edaravone|edaravone|mesh-list
5951220|NCT04714177|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5951221|NCT04714177|Antioxidants|antioxidants|mesh-ancestor
5951222|NCT04714177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951223|NCT04714177|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5951224|NCT04714177|Protective Agents|protective agents|mesh-ancestor
5951225|NCT04714177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951226|NCT04713904|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5951227|NCT04713904|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5951228|NCT04713904|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5951229|NCT04713904|Estradiol|estradiol|mesh-list
5951230|NCT04713904|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5951231|NCT04713904|Estrogens|estrogens|mesh-ancestor
5951232|NCT04713904|Hormones|hormones|mesh-ancestor
6517463|NCT00721305|L 647318|l 647318|mesh-list
6517464|NCT00721305|Dihydromevinolin|dihydromevinolin|mesh-list
5951233|NCT04713904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5951234|NCT04713904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951235|NCT04713904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5951236|NCT04713904|Contraceptive Agents|contraceptive agents|mesh-ancestor
5951237|NCT04713904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5951238|NCT04713904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5951239|NCT04713904|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5951240|NCT04713904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5951241|NCT04713891|Atezolizumab|atezolizumab|mesh-list
5951242|NCT04713891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5951243|NCT04713891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5951244|NCT04713891|Immunologic Factors|immunologic factors|mesh-ancestor
5951245|NCT04713891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951246|NCT04713527|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5951247|NCT04713527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5951248|NCT04713787|Albendazole|albendazole|mesh-list
5951249|NCT04713787|Oxfendazole|oxfendazole|mesh-list
5951250|NCT04713787|Anthelmintics|anthelmintics|mesh-ancestor
5951251|NCT04713787|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5951252|NCT04713787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5951253|NCT04713787|Anticestodal Agents|anticestodal agents|mesh-ancestor
5951254|NCT04713787|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5951255|NCT04713787|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5951256|NCT04713787|Tubulin Modulators|tubulin modulators|mesh-ancestor
5951257|NCT04713787|Antimitotic Agents|antimitotic agents|mesh-ancestor
5951258|NCT04713787|Mitosis Modulators|mitosis modulators|mesh-ancestor
5951259|NCT04713787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951260|NCT04713787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5951261|NCT04713787|Antinematodal Agents|antinematodal agents|mesh-ancestor
5951262|NCT04713644|Propofol|propofol|mesh-list
5951263|NCT04713644|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5951264|NCT04713644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5951265|NCT04713644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951266|NCT04713644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5951267|NCT04713644|Anesthetics, General|anesthetics, general|mesh-ancestor
5951268|NCT04713644|Anesthetics|anesthetics|mesh-ancestor
5951269|NCT04713488|Vaccines|vaccines|mesh-list
5951270|NCT04713488|Immunologic Factors|immunologic factors|mesh-ancestor
5951271|NCT04713488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951272|NCT04713735|Lactoferrin|lactoferrin|mesh-list
5951273|NCT04713735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5951274|NCT04713761|Carboplatin|carboplatin|mesh-list
5951275|NCT04713761|Pemetrexed|pemetrexed|mesh-list
5951276|NCT04713761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5951277|NCT04713761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5951278|NCT04713761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951279|NCT04713761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5951280|NCT04713761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5951281|NCT04713631|Artesunate|artesunate|mesh-list
5951282|NCT04713631|Curcumin|curcumin|mesh-list
5951283|NCT04713631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5951284|NCT04713631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5951285|NCT04713631|Analgesics|analgesics|mesh-ancestor
5951286|NCT04713631|Sensory System Agents|sensory system agents|mesh-ancestor
5951287|NCT04713631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5951288|NCT04713631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951289|NCT04713631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5951290|NCT04713631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5951291|NCT04713631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5951292|NCT04713631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5951293|NCT04713631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951294|NCT04713631|Antimalarials|antimalarials|mesh-ancestor
5951295|NCT04713631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5951296|NCT04713631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5951297|NCT04713631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5951298|NCT04713631|Antiviral Agents|antiviral agents|mesh-ancestor
5951299|NCT04713631|Schistosomicides|schistosomicides|mesh-ancestor
5951300|NCT04713631|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5951301|NCT04713631|Anthelmintics|anthelmintics|mesh-ancestor
5951302|NCT04713254|Metoprolol|metoprolol|mesh-list
5951303|NCT04713254|Midazolam|midazolam|mesh-list
5951304|NCT04713254|Bupropion|bupropion|mesh-list
5951305|NCT04713254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5951306|NCT04713254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5951307|NCT04713254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5951308|NCT04713254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951309|NCT04713254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5951310|NCT04713254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5951311|NCT04713254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5951312|NCT04713254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5951313|NCT04713254|Anesthetics, General|anesthetics, general|mesh-ancestor
5951314|NCT04713254|Anesthetics|anesthetics|mesh-ancestor
5951315|NCT04713254|GABA Modulators|gaba modulators|mesh-ancestor
5951316|NCT04713254|GABA Agents|gaba agents|mesh-ancestor
5951317|NCT04713254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5951318|NCT04713254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951319|NCT04713254|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5951320|NCT04713254|Antidepressive Agents|antidepressive agents|mesh-ancestor
5951321|NCT04713254|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5951322|NCT04713254|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5951323|NCT04713254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5951324|NCT04713254|Dopamine Agents|dopamine agents|mesh-ancestor
5951325|NCT04713254|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5951326|NCT04713254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5951327|NCT04713254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5951328|NCT04713254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5951329|NCT04713254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5951330|NCT04713254|Sympatholytics|sympatholytics|mesh-ancestor
5951331|NCT04713254|Autonomic Agents|autonomic agents|mesh-ancestor
5951332|NCT04713254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5951333|NCT04713254|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5951334|NCT04713254|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5951335|NCT04713254|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5951336|NCT04713254|Adrenergic Agents|adrenergic agents|mesh-ancestor
5951337|NCT04713176|Remdesivir|remdesivir|mesh-list
5951338|NCT04713176|Antimetabolites|antimetabolites|mesh-ancestor
5951339|NCT04713176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951340|NCT04713176|Antiviral Agents|antiviral agents|mesh-ancestor
5951341|NCT04713176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5951342|NCT04713371|Cyclophosphamide|cyclophosphamide|mesh-list
5951343|NCT04713371|Pembrolizumab|pembrolizumab|mesh-list
5951344|NCT04713371|Ipilimumab|ipilimumab|mesh-list
5951345|NCT04713371|Sargramostim|sargramostim|mesh-list
5951346|NCT04713371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5951347|NCT04713371|Immunologic Factors|immunologic factors|mesh-ancestor
5951348|NCT04713371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951349|NCT04713371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5951350|NCT04713371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5951351|NCT04713371|Alkylating Agents|alkylating agents|mesh-ancestor
5951352|NCT04713371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951353|NCT04713371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5951354|NCT04713371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5951355|NCT04713371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5951356|NCT04713371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5951357|NCT04713410|Prednisolone|prednisolone|mesh-list
5951358|NCT04713410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5951359|NCT04713410|Glucocorticoids|glucocorticoids|mesh-ancestor
5951360|NCT04713410|Hormones|hormones|mesh-ancestor
5951361|NCT04713410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5951362|NCT04713410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951363|NCT04713410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5951364|NCT04713410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5951365|NCT04713189|Fentanyl|fentanyl|mesh-list
5951366|NCT04713189|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5951367|NCT04713189|Narcotics|narcotics|mesh-ancestor
5951368|NCT04713189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5951369|NCT04713189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951370|NCT04713189|Analgesics|analgesics|mesh-ancestor
5951371|NCT04713189|Sensory System Agents|sensory system agents|mesh-ancestor
5951372|NCT04713189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5951373|NCT04713189|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5951374|NCT04713189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5951375|NCT04713189|Anesthetics, General|anesthetics, general|mesh-ancestor
5951376|NCT04713189|Anesthetics|anesthetics|mesh-ancestor
5951377|NCT04713163|Vaccines|vaccines|mesh-list
5951378|NCT04713163|Immunologic Factors|immunologic factors|mesh-ancestor
5951379|NCT04713163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951380|NCT04713332|Vitamin E|vitamin e|mesh-list
5951381|NCT04713332|Tocopherols|tocopherols|mesh-list
5951382|NCT04713332|alpha-Tocopherol|alpha-tocopherol|mesh-list
5951383|NCT04713332|Vitamins|vitamins|mesh-ancestor
5951384|NCT04713332|Micronutrients|micronutrients|mesh-ancestor
5951385|NCT04713332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951386|NCT04713332|Antioxidants|antioxidants|mesh-ancestor
5951387|NCT04713332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951388|NCT04713332|Protective Agents|protective agents|mesh-ancestor
5951389|NCT04712929|Fluconazole|fluconazole|mesh-list
5951390|NCT04712929|Antifungal Agents|antifungal agents|mesh-ancestor
5951391|NCT04712929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5951392|NCT04712929|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5951393|NCT04712929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5951394|NCT04712929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5951395|NCT04712929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951396|NCT04712929|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5951397|NCT04712929|Hormone Antagonists|hormone antagonists|mesh-ancestor
5951398|NCT04712929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5951399|NCT04712929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951400|NCT04712929|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5951401|NCT04712929|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5951402|NCT04712734|Iloperidone|iloperidone|mesh-list
5951403|NCT04712734|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5951404|NCT04712734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5951405|NCT04712734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5951406|NCT04712734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951407|NCT04712734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5968756|NCT04550611|Immunoglobulins|immunoglobulins|mesh-list
5968757|NCT04550611|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5968758|NCT04550611|Antibodies|antibodies|mesh-list
5968759|NCT04550611|gamma-Globulins|gamma-globulins|mesh-list
5968760|NCT04550611|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5968761|NCT04550611|Immunologic Factors|immunologic factors|mesh-ancestor
5968762|NCT04550611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968763|NCT04550624|Pembrolizumab|pembrolizumab|mesh-list
5968764|NCT04550624|Lenvatinib|lenvatinib|mesh-list
5968765|NCT04550624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5968766|NCT04550624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5968767|NCT04550624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5968768|NCT04550624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5968769|NCT04550624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968770|NCT04550104|Olaparib|olaparib|mesh-list
5968771|NCT04550104|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5968772|NCT04550104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5968773|NCT04550104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968774|NCT04550104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5968775|NCT04549935|Prednisolone|prednisolone|mesh-list
5968776|NCT04549935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5968777|NCT04549935|Glucocorticoids|glucocorticoids|mesh-ancestor
5968778|NCT04549935|Hormones|hormones|mesh-ancestor
5968779|NCT04549935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5968780|NCT04549935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968781|NCT04549935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5968782|NCT04549935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5971143|NCT04530487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5971144|NCT04530487|Dermatologic Agents|dermatologic agents|mesh-ancestor
5971145|NCT04530487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5971146|NCT04530487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5971147|NCT04530487|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5971148|NCT04530487|Antitubercular Agents|antitubercular agents|mesh-ancestor
5971149|NCT04530487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5971150|NCT04530487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5971151|NCT04530487|Alkylating Agents|alkylating agents|mesh-ancestor
5971152|NCT04530487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5971153|NCT04530487|Keratolytic Agents|keratolytic agents|mesh-ancestor
5971154|NCT04530487|Tubulin Modulators|tubulin modulators|mesh-ancestor
5971155|NCT04530487|Antimitotic Agents|antimitotic agents|mesh-ancestor
5971156|NCT04530487|Mitosis Modulators|mitosis modulators|mesh-ancestor
5971157|NCT04530058|Metformin|metformin|mesh-list
5971158|NCT04530058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5971159|NCT04530058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971160|NCT04529954|Valproic Acid|valproic acid|mesh-list
5971161|NCT04529954|Anticonvulsants|anticonvulsants|mesh-ancestor
5971162|NCT04529954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5971163|NCT04529954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971164|NCT04529954|GABA Agents|gaba agents|mesh-ancestor
5971165|NCT04529954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5971166|NCT04529954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971167|NCT04529954|Antimanic Agents|antimanic agents|mesh-ancestor
5951408|NCT04712539|Oseltamivir|oseltamivir|mesh-list
5951409|NCT04712539|Baloxavir|baloxavir|mesh-list
5951410|NCT04712539|Antiviral Agents|antiviral agents|mesh-ancestor
5951411|NCT04712539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5951412|NCT04712539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5951413|NCT04712539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951414|NCT04712799|Xylometazoline|xylometazoline|mesh-list
5951415|NCT04712799|Nasal Decongestants|nasal decongestants|mesh-ancestor
5951416|NCT04712799|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5951417|NCT04712799|Respiratory System Agents|respiratory system agents|mesh-ancestor
5951418|NCT04712435|Acetylcysteine|acetylcysteine|mesh-list
5951419|NCT04712435|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5951420|NCT04712435|Antiviral Agents|antiviral agents|mesh-ancestor
5951421|NCT04712435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5951422|NCT04712435|Expectorants|expectorants|mesh-ancestor
5951423|NCT04712435|Respiratory System Agents|respiratory system agents|mesh-ancestor
5951424|NCT04712435|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5951425|NCT04712435|Antioxidants|antioxidants|mesh-ancestor
5951426|NCT04712435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951427|NCT04712435|Protective Agents|protective agents|mesh-ancestor
5951428|NCT04712435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951429|NCT04712435|Antidotes|antidotes|mesh-ancestor
5951430|NCT04712071|Ketamine|ketamine|mesh-list
5951431|NCT04712071|Analgesics|analgesics|mesh-ancestor
5951432|NCT04712071|Sensory System Agents|sensory system agents|mesh-ancestor
5951433|NCT04712071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5951434|NCT04712071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951435|NCT04712071|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5951436|NCT04712071|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5951437|NCT04712071|Anesthetics, General|anesthetics, general|mesh-ancestor
5951438|NCT04712071|Anesthetics|anesthetics|mesh-ancestor
5951439|NCT04712071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5951440|NCT04712071|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5951441|NCT04712071|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5951442|NCT04712071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5951443|NCT04712071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951444|NCT04712357|Ascorbic Acid|ascorbic acid|mesh-list
5951445|NCT04712357|Tenofovir|tenofovir|mesh-list
5951446|NCT04712357|Emtricitabine|emtricitabine|mesh-list
5951447|NCT04712357|Vitamins|vitamins|mesh-ancestor
5951448|NCT04712357|Micronutrients|micronutrients|mesh-ancestor
5951449|NCT04712357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951450|NCT04712357|Antiviral Agents|antiviral agents|mesh-ancestor
5951451|NCT04712357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5951452|NCT04712357|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5951453|NCT04712357|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5951454|NCT04712357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5951455|NCT04712357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951456|NCT04712357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5951457|NCT04712357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5951458|NCT04712357|Antioxidants|antioxidants|mesh-ancestor
5951459|NCT04712357|Protective Agents|protective agents|mesh-ancestor
5951460|NCT04712396|Itraconazole|itraconazole|mesh-list
5951461|NCT04712396|Antifungal Agents|antifungal agents|mesh-ancestor
5951462|NCT04712396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5951463|NCT04712396|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5951464|NCT04712396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5951465|NCT04712396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5951466|NCT04712396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951467|NCT04712396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5951468|NCT04712396|Hormone Antagonists|hormone antagonists|mesh-ancestor
5951469|NCT04712396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5951470|NCT04712396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951471|NCT04712396|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5951472|NCT04712266|Insulin|insulin|mesh-list
5951473|NCT04712266|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5951474|NCT04712266|Glucagon|glucagon|mesh-list
5951475|NCT04712266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5951476|NCT04712266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951477|NCT04712266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5951478|NCT04712266|Hormones|hormones|mesh-ancestor
5951479|NCT04712266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5951480|NCT04712279|Hydroxychloroquine|hydroxychloroquine|mesh-list
5951481|NCT04712279|Ivermectin|ivermectin|mesh-list
5951482|NCT04712279|Antimalarials|antimalarials|mesh-ancestor
5951483|NCT04712279|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5951484|NCT04712279|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5951485|NCT04712279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5951486|NCT04712279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5951487|NCT04712279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951488|NCT04712279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5951489|NCT04711889|Urinastatin|urinastatin|mesh-list
5951490|NCT04711889|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5951491|NCT04711889|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5951492|NCT04711889|Protease Inhibitors|protease inhibitors|mesh-ancestor
5951493|NCT04711889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5951494|NCT04711889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951495|NCT04711863|Fluvoxamine|fluvoxamine|mesh-list
5951496|NCT04711863|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5951497|NCT04711863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5951498|NCT04711863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5951499|NCT04711863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951500|NCT04711863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5951501|NCT04711863|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5951502|NCT04711863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5951503|NCT04711863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5951504|NCT04711863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951505|NCT04711863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5951506|NCT04711863|Serotonin Agents|serotonin agents|mesh-ancestor
5951507|NCT04711863|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5951508|NCT04711863|Antidepressive Agents|antidepressive agents|mesh-ancestor
5951509|NCT04711863|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5951510|NCT04711863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5951511|NCT04711863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5951512|NCT04711863|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5951513|NCT04712058|Tenofovir|tenofovir|mesh-list
5951514|NCT04712058|Emtricitabine|emtricitabine|mesh-list
5951515|NCT04712058|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
5951516|NCT04712058|Antiviral Agents|antiviral agents|mesh-ancestor
5951517|NCT04712058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5951518|NCT04712058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5951519|NCT04712058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5951520|NCT04712058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5951521|NCT04712058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951522|NCT04712058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5951523|NCT04712058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5951524|NCT04711668|Lidocaine|lidocaine|mesh-list
5951525|NCT04711668|Ketamine|ketamine|mesh-list
5951526|NCT04711668|Anesthetics, Local|anesthetics, local|mesh-ancestor
5951527|NCT04711668|Anesthetics|anesthetics|mesh-ancestor
5951528|NCT04711668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5951529|NCT04711668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951530|NCT04711668|Sensory System Agents|sensory system agents|mesh-ancestor
5951531|NCT04711668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5951532|NCT04711668|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5951533|NCT04711668|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5951534|NCT04711668|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5951535|NCT04711668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5951536|NCT04711668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951537|NCT04711668|Analgesics|analgesics|mesh-ancestor
5951538|NCT04711668|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5951539|NCT04711668|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5951540|NCT04711668|Anesthetics, General|anesthetics, general|mesh-ancestor
5951541|NCT04711668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5951542|NCT04711668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5951543|NCT04711668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5951544|NCT04711642|Hyaluronic Acid|hyaluronic acid|mesh-list
5951545|NCT04711642|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5951546|NCT04711642|Immunologic Factors|immunologic factors|mesh-ancestor
5951547|NCT04711642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951548|NCT04711642|Viscosupplements|viscosupplements|mesh-ancestor
5951549|NCT04711642|Protective Agents|protective agents|mesh-ancestor
5951550|NCT04711564|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
5951551|NCT04711564|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
5951552|NCT04711564|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5951553|NCT04711564|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6517465|NCT00721305|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6517466|NCT00721305|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6517467|NCT00721305|Antimetabolites|antimetabolites|mesh-ancestor
5951554|NCT04711291|Tacrolimus|tacrolimus|mesh-list
5951555|NCT04711291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5951556|NCT04711291|Immunologic Factors|immunologic factors|mesh-ancestor
5951557|NCT04711291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951558|NCT04711291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5951559|NCT04711291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5951560|NCT04711291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951561|NCT04711304|Hyaluronic Acid|hyaluronic acid|mesh-list
5951562|NCT04711304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5951563|NCT04711304|Immunologic Factors|immunologic factors|mesh-ancestor
5951564|NCT04711304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951565|NCT04711304|Viscosupplements|viscosupplements|mesh-ancestor
5951566|NCT04711304|Protective Agents|protective agents|mesh-ancestor
5951567|NCT04711343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5951568|NCT04711343|Immunologic Factors|immunologic factors|mesh-ancestor
5951569|NCT04711343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951570|NCT04711265|Vaccines|vaccines|mesh-list
5951571|NCT04711265|Immunologic Factors|immunologic factors|mesh-ancestor
5951572|NCT04711265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951573|NCT04711434|Antibodies|antibodies|mesh-list
5951574|NCT04711434|Immunologic Factors|immunologic factors|mesh-ancestor
5951575|NCT04711434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951576|NCT04711213|Dexamethasone|dexamethasone|mesh-list
5951577|NCT04711213|Dexamethasone acetate|dexamethasone acetate|mesh-list
5951578|NCT04711213|BB 1101|bb 1101|mesh-list
5951579|NCT04711213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5951580|NCT04711213|Antiemetics|antiemetics|mesh-ancestor
5951581|NCT04711213|Autonomic Agents|autonomic agents|mesh-ancestor
5951582|NCT04711213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5951583|NCT04711213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951584|NCT04711213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5951585|NCT04711213|Glucocorticoids|glucocorticoids|mesh-ancestor
5951586|NCT04711213|Hormones|hormones|mesh-ancestor
5951587|NCT04711213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5951588|NCT04711213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5951589|NCT04711213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5951590|NCT04711213|Protease Inhibitors|protease inhibitors|mesh-ancestor
5951591|NCT04711213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5951592|NCT04711213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951593|NCT04711161|Paclitaxel|paclitaxel|mesh-list
5951594|NCT04711161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5951595|NCT04711161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5951596|NCT04711161|Tubulin Modulators|tubulin modulators|mesh-ancestor
5951597|NCT04711161|Antimitotic Agents|antimitotic agents|mesh-ancestor
5951598|NCT04711161|Mitosis Modulators|mitosis modulators|mesh-ancestor
5951599|NCT04711161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951600|NCT04711122|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5951601|NCT04711122|Cephalosporins|cephalosporins|mesh-list
5951602|NCT04711122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5951603|NCT04711096|Bupivacaine|bupivacaine|mesh-list
5951604|NCT04711096|Anesthetics, Local|anesthetics, local|mesh-ancestor
5951605|NCT04711096|Anesthetics|anesthetics|mesh-ancestor
5951606|NCT04711096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5951607|NCT04711096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951608|NCT04711096|Sensory System Agents|sensory system agents|mesh-ancestor
5951609|NCT04711096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5968783|NCT04550078|Calcium, Dietary|calcium, dietary|mesh-list
5968784|NCT04550078|Calcium Carbonate|calcium carbonate|mesh-list
5968785|NCT04550078|Calcium|calcium|mesh-list
5968786|NCT04550078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5968787|NCT04550078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968788|NCT04550078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5968789|NCT04550078|Antacids|antacids|mesh-ancestor
5968790|NCT04550078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968791|NCT04550078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5968792|NCT04549844|Bupivacaine|bupivacaine|mesh-list
5968793|NCT04549844|Anesthetics, Local|anesthetics, local|mesh-ancestor
5968794|NCT04549844|Anesthetics|anesthetics|mesh-ancestor
5968795|NCT04549844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5968796|NCT04549844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968797|NCT04549844|Sensory System Agents|sensory system agents|mesh-ancestor
5968798|NCT04549844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5968799|NCT04549792|Ustekinumab|ustekinumab|mesh-list
5968800|NCT04549792|Dermatologic Agents|dermatologic agents|mesh-ancestor
5968801|NCT04549467|Tenofovir|tenofovir|mesh-list
5968802|NCT04549467|Lamivudine|lamivudine|mesh-list
5968803|NCT04549467|Emtricitabine|emtricitabine|mesh-list
5951610|NCT04710927|Fluorides|fluorides|mesh-list
5951611|NCT04710927|Cariostatic Agents|cariostatic agents|mesh-ancestor
5951612|NCT04710927|Protective Agents|protective agents|mesh-ancestor
5951613|NCT04710927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951614|NCT04711109|Denosumab|denosumab|mesh-list
5951615|NCT04711109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5951616|NCT04711109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951617|NCT04710914|Midazolam|midazolam|mesh-list
5951618|NCT04710914|Isoflurane|isoflurane|mesh-list
5951619|NCT04710914|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5951620|NCT04710914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5951621|NCT04710914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6517468|NCT00721305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951622|NCT04710914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951623|NCT04710914|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5951624|NCT04710914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5951625|NCT04710914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5951626|NCT04710914|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5951627|NCT04710914|Anesthetics, General|anesthetics, general|mesh-ancestor
5951628|NCT04710914|Anesthetics|anesthetics|mesh-ancestor
5951629|NCT04710914|GABA Modulators|gaba modulators|mesh-ancestor
5951630|NCT04710914|GABA Agents|gaba agents|mesh-ancestor
5951631|NCT04710914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5951632|NCT04710914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951633|NCT04710914|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5951634|NCT04710888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
5951635|NCT04711044|Menthol|menthol|mesh-list
5951636|NCT04711044|Histamine|histamine|mesh-list
5951637|NCT04711044|Antipruritics|antipruritics|mesh-ancestor
5951638|NCT04711044|Dermatologic Agents|dermatologic agents|mesh-ancestor
5951639|NCT04711044|Histamine Agonists|histamine agonists|mesh-ancestor
5951640|NCT04711044|Histamine Agents|histamine agents|mesh-ancestor
5951641|NCT04711044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5951642|NCT04711044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951643|NCT04711044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951644|NCT04710719|Triamcinolone|triamcinolone|mesh-list
5951645|NCT04710719|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5951646|NCT04710719|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5951647|NCT04710719|Fluorouracil|fluorouracil|mesh-list
5951648|NCT04710719|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5951649|NCT04710719|Antimetabolites|antimetabolites|mesh-ancestor
5951650|NCT04710719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951651|NCT04710719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5951652|NCT04710719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5951653|NCT04710719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5951654|NCT04710719|Immunologic Factors|immunologic factors|mesh-ancestor
5951655|NCT04710719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951656|NCT04710719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5951657|NCT04710719|Glucocorticoids|glucocorticoids|mesh-ancestor
5951658|NCT04710719|Hormones|hormones|mesh-ancestor
5951659|NCT04710719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5951660|NCT04710719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5951661|NCT04710368|Evolocumab|evolocumab|mesh-list
5951662|NCT04710368|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5951663|NCT04710368|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5951664|NCT04710368|Antimetabolites|antimetabolites|mesh-ancestor
5951665|NCT04710368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951666|NCT04710368|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5951667|NCT04710329|Ascorbic Acid|ascorbic acid|mesh-list
5951668|NCT04710329|Antioxidants|antioxidants|mesh-ancestor
5951669|NCT04710329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951670|NCT04710329|Protective Agents|protective agents|mesh-ancestor
5951671|NCT04710329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951672|NCT04710329|Vitamins|vitamins|mesh-ancestor
5951673|NCT04710329|Micronutrients|micronutrients|mesh-ancestor
5951674|NCT04710498|Atezolizumab|atezolizumab|mesh-list
5951675|NCT04710498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5951676|NCT04710277|Analgesics, Opioid|analgesics, opioid|mesh-list
5951677|NCT04710277|Narcotics|narcotics|mesh-ancestor
5951678|NCT04710277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5951679|NCT04710277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517469|NCT00721305|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6517470|NCT00721305|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6517471|NCT00721305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6517472|NCT00721331|Mometasone Furoate|mometasone furoate|mesh-list
6517473|NCT00721331|Loratadine|loratadine|mesh-list
5951680|NCT04710277|Analgesics|analgesics|mesh-ancestor
5951681|NCT04710277|Sensory System Agents|sensory system agents|mesh-ancestor
5951682|NCT04710277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5951683|NCT04710134|Reslizumab|reslizumab|mesh-list
5951684|NCT04710134|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5951685|NCT04710134|Respiratory System Agents|respiratory system agents|mesh-ancestor
5951686|NCT04710017|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
5951687|NCT04710017|Tranexamic Acid|tranexamic acid|mesh-list
5951688|NCT04710017|Medroxyprogesterone|medroxyprogesterone|mesh-list
5951689|NCT04710017|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5951690|NCT04710017|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5951691|NCT04710017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951692|NCT04710017|Hemostatics|hemostatics|mesh-ancestor
5951693|NCT04710017|Coagulants|coagulants|mesh-ancestor
5951694|NCT04710017|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5951695|NCT04710017|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5951696|NCT04710017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5951697|NCT04710017|Contraceptive Agents|contraceptive agents|mesh-ancestor
5951698|NCT04710017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5951699|NCT04710017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951700|NCT04710017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5951701|NCT04710017|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5951702|NCT04710017|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5951703|NCT04710017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5951704|NCT04710017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5951705|NCT04710160|Calcium|calcium|mesh-list
5951706|NCT04710160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5951707|NCT04710160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951708|NCT04709770|Simethicone|simethicone|mesh-list
5951709|NCT04709770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951710|NCT04709770|Antifoaming Agents|antifoaming agents|mesh-ancestor
5951711|NCT04709770|Emollients|emollients|mesh-ancestor
5951712|NCT04709770|Dermatologic Agents|dermatologic agents|mesh-ancestor
5951713|NCT04709731|Ponatinib|ponatinib|mesh-list
5951714|NCT04709731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5951715|NCT04709731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5951716|NCT04709731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5951717|NCT04709731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951718|NCT04709471|Nicotine|nicotine|mesh-list
5951719|NCT04709471|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5951720|NCT04709471|Autonomic Agents|autonomic agents|mesh-ancestor
5951721|NCT04709471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5951722|NCT04709471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951723|NCT04709471|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5951724|NCT04709471|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5951725|NCT04709471|Cholinergic Agents|cholinergic agents|mesh-ancestor
5951726|NCT04709471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5951727|NCT04709471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951728|NCT04709744|Vitamin D|vitamin d|mesh-list
5951729|NCT04709744|Ergocalciferols|ergocalciferols|mesh-list
5951730|NCT04709744|Vitamins|vitamins|mesh-list
5951731|NCT04709744|Micronutrients|micronutrients|mesh-ancestor
5951732|NCT04709744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951733|NCT04709744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5951734|NCT04709744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5951735|NCT04709380|Sorafenib|sorafenib|mesh-list
5951736|NCT04709380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5951737|NCT04709380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5951738|NCT04709380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5951739|NCT04709380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951740|NCT04709185|Dexamethasone|dexamethasone|mesh-list
5951741|NCT04709185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5951742|NCT04709185|Antiemetics|antiemetics|mesh-ancestor
5951743|NCT04709185|Autonomic Agents|autonomic agents|mesh-ancestor
5951744|NCT04709185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5951745|NCT04709185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951746|NCT04709185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5951747|NCT04709185|Glucocorticoids|glucocorticoids|mesh-ancestor
5951748|NCT04709185|Hormones|hormones|mesh-ancestor
5951749|NCT04709185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5951750|NCT04709185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5951751|NCT04709185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5951752|NCT04709172|Cefditoren pivoxil|cefditoren pivoxil|mesh-list
5951753|NCT04709172|Cefditoren|cefditoren|mesh-list
5951754|NCT04709172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5951755|NCT04709172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5968804|NCT04549467|Dolutegravir|dolutegravir|mesh-list
5968805|NCT04549467|Antiviral Agents|antiviral agents|mesh-ancestor
5968806|NCT04549467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5968807|NCT04549467|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5968808|NCT04549467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5968809|NCT04549467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5968810|NCT04549467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968811|NCT04549467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5968812|NCT04549467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5968813|NCT04549467|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5968814|NCT04549467|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5968815|NCT04549428|Atezolizumab|atezolizumab|mesh-list
5968816|NCT04549428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5968817|NCT04549415|Metformin|metformin|mesh-list
5968818|NCT04549415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5968819|NCT04549415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968820|NCT04549207|Denosumab|denosumab|mesh-list
5968821|NCT04549207|Zoledronic Acid|zoledronic acid|mesh-list
5968822|NCT04549207|Pamidronate|pamidronate|mesh-list
5968823|NCT04549207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5968824|NCT04549207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968825|NCT04549012|Tranexamic Acid|tranexamic acid|mesh-list
5968826|NCT04549012|Oxytocin|oxytocin|mesh-list
5968827|NCT04549012|Oxytocics|oxytocics|mesh-ancestor
5968828|NCT04549012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5968829|NCT04549012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968830|NCT04549012|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5968831|NCT04549012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5968832|NCT04549012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968833|NCT04549012|Hemostatics|hemostatics|mesh-ancestor
5968834|NCT04549012|Coagulants|coagulants|mesh-ancestor
5968835|NCT04549116|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5968836|NCT04549116|Progesterone|progesterone|mesh-list
5968837|NCT04549116|Progestins|progestins|mesh-ancestor
5968838|NCT04549116|Hormones|hormones|mesh-ancestor
5968839|NCT04549116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5968840|NCT04549116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968841|NCT04548700|Prednisone|prednisone|mesh-list
5968842|NCT04548700|Cyclophosphamide|cyclophosphamide|mesh-list
5968843|NCT04548700|Vincristine|vincristine|mesh-list
5968844|NCT04548700|Mitoxantrone|mitoxantrone|mesh-list
5968845|NCT04548700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5968846|NCT04548700|Immunologic Factors|immunologic factors|mesh-ancestor
5968847|NCT04548700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968848|NCT04548700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5968849|NCT04548700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5968850|NCT04548700|Alkylating Agents|alkylating agents|mesh-ancestor
5968851|NCT04548700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968852|NCT04548700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5968853|NCT04548700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5968854|NCT04548700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5968855|NCT04548700|Glucocorticoids|glucocorticoids|mesh-ancestor
5968856|NCT04548700|Hormones|hormones|mesh-ancestor
5968857|NCT04548700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5968858|NCT04548700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5968859|NCT04548700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5968860|NCT04548700|Tubulin Modulators|tubulin modulators|mesh-ancestor
5968861|NCT04548700|Antimitotic Agents|antimitotic agents|mesh-ancestor
5968862|NCT04548700|Mitosis Modulators|mitosis modulators|mesh-ancestor
5968863|NCT04548700|Analgesics|analgesics|mesh-ancestor
5968864|NCT04548700|Sensory System Agents|sensory system agents|mesh-ancestor
5968865|NCT04548700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5968866|NCT04548700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5968867|NCT04548700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5968868|NCT04548700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5968869|NCT04548583|Remestemcel-l|remestemcel-l|mesh-list
5968870|NCT04548583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5968871|NCT04548583|Antiviral Agents|antiviral agents|mesh-ancestor
5968872|NCT04548583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5968873|NCT04548557|Immunoglobulins|immunoglobulins|mesh-list
5968874|NCT04548557|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5968875|NCT04548557|Antibodies|antibodies|mesh-list
5968876|NCT04548557|gamma-Globulins|gamma-globulins|mesh-list
5968877|NCT04548557|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5968878|NCT04548557|Immunologic Factors|immunologic factors|mesh-ancestor
5968879|NCT04548557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951756|NCT04709315|Choline|choline|mesh-list
5951757|NCT04709315|Rocuronium|rocuronium|mesh-list
5951758|NCT04709315|Succinylcholine|succinylcholine|mesh-list
5951759|NCT04709315|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5951760|NCT04709315|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5951761|NCT04709315|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5951762|NCT04709315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5951763|NCT04709315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951764|NCT04709315|Lipotropic Agents|lipotropic agents|mesh-ancestor
5951765|NCT04709315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5951766|NCT04709315|Antimetabolites|antimetabolites|mesh-ancestor
5951767|NCT04709315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951768|NCT04709315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5951769|NCT04709315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5951770|NCT04709315|Nootropic Agents|nootropic agents|mesh-ancestor
5951771|NCT04709315|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
5951772|NCT04709094|Bupropion|bupropion|mesh-list
5951773|NCT04709094|Warfarin|warfarin|mesh-list
5951774|NCT04709094|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5951775|NCT04709094|Norethindrone|norethindrone|mesh-list
5951776|NCT04709094|Norethindrone Acetate|norethindrone acetate|mesh-list
5951777|NCT04709094|Norinyl|norinyl|mesh-list
5951778|NCT04709094|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
5951779|NCT04709094|Estradiol|estradiol|mesh-list
5951780|NCT04709094|Estrogens|estrogens|mesh-ancestor
5951781|NCT04709094|Hormones|hormones|mesh-ancestor
5951782|NCT04709094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5951783|NCT04709094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951784|NCT04709094|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5951785|NCT04709094|Contraceptive Agents|contraceptive agents|mesh-ancestor
5951786|NCT04709094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5951787|NCT04709094|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5951788|NCT04709094|Anticoagulants|anticoagulants|mesh-ancestor
5951789|NCT04709094|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5951790|NCT04709094|Antidepressive Agents|antidepressive agents|mesh-ancestor
5951791|NCT04709094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5951792|NCT04709094|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5951793|NCT04709094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5951794|NCT04709094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5951795|NCT04709094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951796|NCT04709094|Dopamine Agents|dopamine agents|mesh-ancestor
5951797|NCT04709094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5951798|NCT04709094|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5951799|NCT04709094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5951800|NCT04709094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5951801|NCT04709094|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5951802|NCT04709094|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5951803|NCT04709094|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5951804|NCT04709094|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5951805|NCT04709094|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
5951806|NCT04709211|Bupivacaine|bupivacaine|mesh-list
5951807|NCT04709211|Anesthetics, Local|anesthetics, local|mesh-ancestor
5951808|NCT04709211|Anesthetics|anesthetics|mesh-ancestor
5951809|NCT04709211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5951810|NCT04709211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951811|NCT04709211|Sensory System Agents|sensory system agents|mesh-ancestor
5951812|NCT04709211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5951813|NCT04709289|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5951814|NCT04709289|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5951815|NCT04709289|Dermatologic Agents|dermatologic agents|mesh-ancestor
5951816|NCT04709081|Itraconazole|itraconazole|mesh-list
5951817|NCT04709081|Digoxin|digoxin|mesh-list
5951818|NCT04709081|Midazolam|midazolam|mesh-list
5951819|NCT04709081|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5951820|NCT04709081|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5951821|NCT04709081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5951822|NCT04709081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951823|NCT04709081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5951824|NCT04709081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5951825|NCT04709081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5951826|NCT04709081|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5951827|NCT04709081|Anesthetics, General|anesthetics, general|mesh-ancestor
5951828|NCT04709081|Anesthetics|anesthetics|mesh-ancestor
5951829|NCT04709081|GABA Modulators|gaba modulators|mesh-ancestor
5951830|NCT04709081|GABA Agents|gaba agents|mesh-ancestor
5951831|NCT04709081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5951832|NCT04709081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951833|NCT04709081|Antifungal Agents|antifungal agents|mesh-ancestor
5951834|NCT04709081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5951835|NCT04709081|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5951836|NCT04709081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5951837|NCT04709081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5951838|NCT04709081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5951839|NCT04709081|Hormone Antagonists|hormone antagonists|mesh-ancestor
5951840|NCT04709081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5951841|NCT04709081|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5951842|NCT04709081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5951843|NCT04709081|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5951844|NCT04709081|Protective Agents|protective agents|mesh-ancestor
5951845|NCT04709276|Carboplatin|carboplatin|mesh-list
5951846|NCT04709276|Nivolumab|nivolumab|mesh-list
5951847|NCT04709276|Ipilimumab|ipilimumab|mesh-list
5951848|NCT04709276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5951849|NCT04709276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5951850|NCT04709276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5951851|NCT04709276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951852|NCT04709029|Dexamethasone|dexamethasone|mesh-list
5951853|NCT04709029|Dexamethasone acetate|dexamethasone acetate|mesh-list
5951854|NCT04709029|BB 1101|bb 1101|mesh-list
5951855|NCT04709029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5951856|NCT04709029|Antiemetics|antiemetics|mesh-ancestor
5951857|NCT04709029|Autonomic Agents|autonomic agents|mesh-ancestor
5951858|NCT04709029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5951859|NCT04709029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951860|NCT04709029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5951861|NCT04709029|Glucocorticoids|glucocorticoids|mesh-ancestor
5951862|NCT04709029|Hormones|hormones|mesh-ancestor
5951863|NCT04709029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5951864|NCT04709029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5951865|NCT04709029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5951866|NCT04709029|Protease Inhibitors|protease inhibitors|mesh-ancestor
5951867|NCT04709029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5951868|NCT04709029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951869|NCT04708821|Loteprednol Etabonate|loteprednol etabonate|mesh-list
5951870|NCT04708821|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
5951871|NCT04708821|Dexamethasone|dexamethasone|mesh-list
5951872|NCT04708821|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5951873|NCT04708821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5951874|NCT04708821|Antiemetics|antiemetics|mesh-ancestor
5951875|NCT04708821|Autonomic Agents|autonomic agents|mesh-ancestor
5951876|NCT04708821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5951877|NCT04708821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951878|NCT04708821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5951879|NCT04708821|Glucocorticoids|glucocorticoids|mesh-ancestor
5951880|NCT04708821|Hormones|hormones|mesh-ancestor
5951881|NCT04708821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5951882|NCT04708821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5951883|NCT04708821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5951884|NCT04708821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5951885|NCT04708821|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5951886|NCT04708821|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5951887|NCT04708821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5951888|NCT04708821|Analgesics|analgesics|mesh-ancestor
5951889|NCT04708821|Sensory System Agents|sensory system agents|mesh-ancestor
5951890|NCT04708821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5951891|NCT04708821|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5951892|NCT04708821|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5951893|NCT04708821|Histamine Antagonists|histamine antagonists|mesh-ancestor
5951894|NCT04708821|Histamine Agents|histamine agents|mesh-ancestor
5951895|NCT04708821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5951896|NCT04708821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951897|NCT04708964|Flurbiprofen|flurbiprofen|mesh-list
5951898|NCT04708964|Analgesics|analgesics|mesh-ancestor
5951899|NCT04708964|Sensory System Agents|sensory system agents|mesh-ancestor
5951900|NCT04708964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5951901|NCT04708964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951902|NCT04708964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5951903|NCT04708964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5951904|NCT04708964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5951905|NCT04708964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5951906|NCT04708964|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5951907|NCT04708964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5951908|NCT04708964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951909|NCT04708496|Efavirenz|efavirenz|mesh-list
5951910|NCT04708496|Lumefantrine|lumefantrine|mesh-list
5951911|NCT04708496|Dolutegravir|dolutegravir|mesh-list
5951912|NCT04708496|Artemether|artemether|mesh-list
5951913|NCT04708496|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
5951914|NCT04708496|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5951915|NCT04708496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5951916|NCT04708496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5951917|NCT04708496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951918|NCT04708496|Antiviral Agents|antiviral agents|mesh-ancestor
5951919|NCT04708496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5951920|NCT04708496|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5951921|NCT04708496|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5951922|NCT04708496|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5951923|NCT04708496|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5951924|NCT04708496|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5951925|NCT04708496|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5951926|NCT04708496|Antimalarials|antimalarials|mesh-ancestor
5951927|NCT04708496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5951928|NCT04708496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5951929|NCT04708496|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5951930|NCT04708496|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5951931|NCT04708496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5951932|NCT04708496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5951933|NCT04708249|Inositol|inositol|mesh-list
5951934|NCT04708249|Vitamin B Complex|vitamin b complex|mesh-ancestor
5951935|NCT04708249|Vitamins|vitamins|mesh-ancestor
5951936|NCT04708249|Micronutrients|micronutrients|mesh-ancestor
5951937|NCT04708249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951938|NCT04708353|Ascorbic Acid|ascorbic acid|mesh-list
5951939|NCT04708353|Pregabalin|pregabalin|mesh-list
5951940|NCT04708353|Vitamins|vitamins|mesh-ancestor
5951941|NCT04708353|Micronutrients|micronutrients|mesh-ancestor
5951942|NCT04708353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951943|NCT04708353|Analgesics|analgesics|mesh-ancestor
5951944|NCT04708353|Sensory System Agents|sensory system agents|mesh-ancestor
5951945|NCT04708353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5951946|NCT04708353|Anticonvulsants|anticonvulsants|mesh-ancestor
5951947|NCT04708353|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5951948|NCT04708353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5951949|NCT04708353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951950|NCT04708353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5951951|NCT04708353|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5951952|NCT04708353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5951953|NCT04708353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5951954|NCT04708353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5951955|NCT04708353|Antioxidants|antioxidants|mesh-ancestor
5951956|NCT04708353|Protective Agents|protective agents|mesh-ancestor
5951957|NCT04707950|Tranexamic Acid|tranexamic acid|mesh-list
5951958|NCT04707950|Oxytocin|oxytocin|mesh-list
5951959|NCT04707950|Oxytocics|oxytocics|mesh-ancestor
5951960|NCT04707950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5951961|NCT04707950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951962|NCT04707950|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5951963|NCT04707950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5951964|NCT04707950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5951965|NCT04707950|Hemostatics|hemostatics|mesh-ancestor
5951966|NCT04707950|Coagulants|coagulants|mesh-ancestor
5951967|NCT04708106|Menthol|menthol|mesh-list
5951968|NCT04708106|Antipruritics|antipruritics|mesh-ancestor
5951969|NCT04708106|Dermatologic Agents|dermatologic agents|mesh-ancestor
5951970|NCT04708171|Anesthetics|anesthetics|mesh-list
5951971|NCT04708171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5951972|NCT04708171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951973|NCT04707794|Sevoflurane|sevoflurane|mesh-list
5951974|NCT04707794|Desflurane|desflurane|mesh-list
5951975|NCT04707794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5951976|NCT04707794|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5951977|NCT04707794|Anesthetics, General|anesthetics, general|mesh-ancestor
5951978|NCT04707794|Anesthetics|anesthetics|mesh-ancestor
5951979|NCT04707794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5951980|NCT04707794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951981|NCT04707742|Povidone-Iodine|povidone-iodine|mesh-list
5951982|NCT04707742|Hydrogen Peroxide|hydrogen peroxide|mesh-list
5951983|NCT04707742|Cetylpyridinium|cetylpyridinium|mesh-list
5951984|NCT04707742|Povidone|povidone|mesh-list
5951985|NCT04707742|Plasma Substitutes|plasma substitutes|mesh-ancestor
5951986|NCT04707742|Blood Substitutes|blood substitutes|mesh-ancestor
5951987|NCT04707742|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5951988|NCT04707742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5951989|NCT04707534|Dexamethasone|dexamethasone|mesh-list
5951990|NCT04707534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5951991|NCT04707534|Antiemetics|antiemetics|mesh-ancestor
5951992|NCT04707534|Autonomic Agents|autonomic agents|mesh-ancestor
5951993|NCT04707534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5951994|NCT04707534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5951995|NCT04707534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5951996|NCT04707534|Glucocorticoids|glucocorticoids|mesh-ancestor
5951997|NCT04707534|Hormones|hormones|mesh-ancestor
5951998|NCT04707534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5951999|NCT04707534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5952000|NCT04707534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5952001|NCT04707560|Heparin|heparin|mesh-list
5952002|NCT04707560|Anticoagulants|anticoagulants|mesh-ancestor
5952003|NCT04707560|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5952004|NCT04707560|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5952005|NCT04707560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952006|NCT04707547|Nivolumab|nivolumab|mesh-list
5952007|NCT04707547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5952008|NCT04707547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5952009|NCT04707547|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5952010|NCT04707547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952011|NCT04707508|Metformin|metformin|mesh-list
5952012|NCT04707508|Valsartan|valsartan|mesh-list
5952013|NCT04707508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5952014|NCT04707508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952015|NCT04707508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5952016|NCT04707508|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5952017|NCT04707508|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5952018|NCT04707508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952019|NCT04707703|Isavuconazole|isavuconazole|mesh-list
5952020|NCT04707703|Antifungal Agents|antifungal agents|mesh-ancestor
5952021|NCT04707703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5968880|NCT04548440|Paclitaxel|paclitaxel|mesh-list
5968881|NCT04548440|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5968882|NCT04548440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5968883|NCT04548440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5968884|NCT04548440|Tubulin Modulators|tubulin modulators|mesh-ancestor
5968885|NCT04548440|Antimitotic Agents|antimitotic agents|mesh-ancestor
5968886|NCT04548440|Mitosis Modulators|mitosis modulators|mesh-ancestor
5968887|NCT04548440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968888|NCT04548401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
5968889|NCT04548518|Vaccines|vaccines|mesh-list
5968890|NCT04548518|Immunologic Factors|immunologic factors|mesh-ancestor
5968891|NCT04548518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968892|NCT04548349|Benzoyl Peroxide|benzoyl peroxide|mesh-list
5968893|NCT04548349|Dermatologic Agents|dermatologic agents|mesh-ancestor
5968894|NCT04548284|Glucocorticoids|glucocorticoids|mesh-list
5968895|NCT04548284|Hormones|hormones|mesh-ancestor
5968896|NCT04548284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5968897|NCT04548284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968898|NCT04548271|Apatinib|apatinib|mesh-list
5968899|NCT04548271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5968900|NCT04548271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5968901|NCT04548271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5968902|NCT04548271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968903|NCT04548219|Mirikizumab|mirikizumab|mesh-list
5968904|NCT04548219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5968905|NCT04548219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5968906|NCT04548219|Analgesics|analgesics|mesh-ancestor
5968907|NCT04548219|Sensory System Agents|sensory system agents|mesh-ancestor
5968908|NCT04548219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5968909|NCT04548219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968910|NCT04548219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5968911|NCT04548219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5968912|NCT04548219|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5968913|NCT04548219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5952022|NCT04707430|Progesterone|progesterone|mesh-list
5952023|NCT04707430|Progestins|progestins|mesh-ancestor
5952024|NCT04707430|Hormones|hormones|mesh-ancestor
5952025|NCT04707430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5952026|NCT04707430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952027|NCT04707209|Sirolimus|sirolimus|mesh-list
5952028|NCT04707209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5952029|NCT04707209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5952030|NCT04707209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5952031|NCT04707209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5952032|NCT04707209|Antifungal Agents|antifungal agents|mesh-ancestor
5952033|NCT04707209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5952034|NCT04707209|Immunologic Factors|immunologic factors|mesh-ancestor
5952035|NCT04707209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952036|NCT04707092|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5952037|NCT04707092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5952038|NCT04707235|Hydroxyurea|hydroxyurea|mesh-list
5952039|NCT04707235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5952040|NCT04707235|Antisickling Agents|antisickling agents|mesh-ancestor
5952041|NCT04707235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5952042|NCT04707235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952043|NCT04707235|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5952044|NCT04707352|Dapagliflozin|dapagliflozin|mesh-list
5952045|NCT04707352|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5952046|NCT04707352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952047|NCT04707352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5952048|NCT04707352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952049|NCT04707118|Paclitaxel|paclitaxel|mesh-list
5952050|NCT04707118|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5952051|NCT04707118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5952052|NCT04707118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5952053|NCT04707118|Tubulin Modulators|tubulin modulators|mesh-ancestor
5952054|NCT04707118|Antimitotic Agents|antimitotic agents|mesh-ancestor
5952055|NCT04707118|Mitosis Modulators|mitosis modulators|mesh-ancestor
5952056|NCT04707118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952057|NCT04707027|Aflibercept|aflibercept|mesh-list
5952058|NCT04707027|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5952059|NCT04707027|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5952060|NCT04707027|Growth Substances|growth substances|mesh-ancestor
5952061|NCT04707027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952062|NCT04707027|Growth Inhibitors|growth inhibitors|mesh-ancestor
5952063|NCT04707027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5952064|NCT04706767|Lidocaine|lidocaine|mesh-list
5952065|NCT04706767|Dexmedetomidine|dexmedetomidine|mesh-list
5952066|NCT04706767|Anesthetics, Local|anesthetics, local|mesh-ancestor
5952067|NCT04706767|Anesthetics|anesthetics|mesh-ancestor
5952068|NCT04706767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5952069|NCT04706767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952070|NCT04706767|Sensory System Agents|sensory system agents|mesh-ancestor
5952071|NCT04706767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5952072|NCT04706767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5952073|NCT04706767|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5952074|NCT04706767|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5952075|NCT04706767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5952076|NCT04706767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952077|NCT04706767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5952078|NCT04706767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5952079|NCT04706767|Analgesics|analgesics|mesh-ancestor
5952080|NCT04706767|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5952081|NCT04706767|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5952082|NCT04706767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5952083|NCT04706767|Adrenergic Agents|adrenergic agents|mesh-ancestor
5952084|NCT04706767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5952085|NCT04706936|Cyclophosphamide|cyclophosphamide|mesh-list
5952086|NCT04706936|Fludarabine|fludarabine|mesh-list
5952087|NCT04706936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5952088|NCT04706936|Immunologic Factors|immunologic factors|mesh-ancestor
5952089|NCT04706936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952090|NCT04706936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5952091|NCT04706936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5952092|NCT04706936|Alkylating Agents|alkylating agents|mesh-ancestor
5952093|NCT04706936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952094|NCT04706936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5952095|NCT04706936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5952096|NCT04706806|Acetic Acid|acetic acid|mesh-list
5952097|NCT04706806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5952098|NCT04706806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5952099|NCT04706637|Dapagliflozin|dapagliflozin|mesh-list
5952100|NCT04706637|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5952101|NCT04706637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952102|NCT04706637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5952103|NCT04706637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952104|NCT04706910|Furosemide|furosemide|mesh-list
5952105|NCT04706910|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
5952106|NCT04706910|Diuretics|diuretics|mesh-ancestor
5952107|NCT04706910|Natriuretic Agents|natriuretic agents|mesh-ancestor
5952108|NCT04706910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952109|NCT04706910|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5952110|NCT04706910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5952111|NCT04706910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952112|NCT04706910|Dopamine Agents|dopamine agents|mesh-ancestor
5952113|NCT04706910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5952114|NCT04706949|Carboplatin|carboplatin|mesh-list
5952115|NCT04706949|Pemetrexed|pemetrexed|mesh-list
5952116|NCT04706949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5952117|NCT04706949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5952118|NCT04706949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952119|NCT04706949|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5952120|NCT04706949|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5952121|NCT04706897|Lidocaine|lidocaine|mesh-list
5952122|NCT04706897|Dexmedetomidine|dexmedetomidine|mesh-list
5952123|NCT04706897|Ketamine|ketamine|mesh-list
5952124|NCT04706897|Anesthetics, Local|anesthetics, local|mesh-ancestor
5952125|NCT04706897|Anesthetics|anesthetics|mesh-ancestor
5952126|NCT04706897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5952127|NCT04706897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952128|NCT04706897|Sensory System Agents|sensory system agents|mesh-ancestor
5952129|NCT04706897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5952130|NCT04706897|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5952131|NCT04706897|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5952132|NCT04706897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5952133|NCT04706897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5952134|NCT04706897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952135|NCT04706897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5952136|NCT04706897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5952137|NCT04706897|Analgesics|analgesics|mesh-ancestor
5952138|NCT04706897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5952139|NCT04706897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5952140|NCT04706897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5952141|NCT04706897|Adrenergic Agents|adrenergic agents|mesh-ancestor
5952142|NCT04706897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5952143|NCT04706897|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5952144|NCT04706897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5952145|NCT04706897|Anesthetics, General|anesthetics, general|mesh-ancestor
5952146|NCT04706897|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5952147|NCT04706897|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5952148|NCT04706455|Hyaluronic Acid|hyaluronic acid|mesh-list
5952149|NCT04706455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5952150|NCT04706455|Immunologic Factors|immunologic factors|mesh-ancestor
5952151|NCT04706455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952152|NCT04706455|Viscosupplements|viscosupplements|mesh-ancestor
5952153|NCT04706455|Protective Agents|protective agents|mesh-ancestor
5952154|NCT04706429|Trientine|trientine|mesh-list
5952155|NCT04706429|Chelating Agents|chelating agents|mesh-ancestor
5952156|NCT04706429|Sequestering Agents|sequestering agents|mesh-ancestor
5952157|NCT04706429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952158|NCT04706247|Anesthetics|anesthetics|mesh-list
5952159|NCT04706247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5952160|NCT04706247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952161|NCT04706130|Artesunate|artesunate|mesh-list
5952162|NCT04706130|Primaquine|primaquine|mesh-list
5952163|NCT04706130|Antimalarials|antimalarials|mesh-ancestor
5952164|NCT04706130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5952165|NCT04706130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5952166|NCT04706130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5952167|NCT04706130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5952168|NCT04706130|Antiviral Agents|antiviral agents|mesh-ancestor
5952169|NCT04706130|Schistosomicides|schistosomicides|mesh-ancestor
5952170|NCT04706130|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5952171|NCT04706130|Anthelmintics|anthelmintics|mesh-ancestor
5952172|NCT04706546|Sildenafil Citrate|sildenafil citrate|mesh-list
5952173|NCT04706546|Vasodilator Agents|vasodilator agents|mesh-ancestor
5952174|NCT04706546|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5952175|NCT04706546|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5952176|NCT04706546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5952177|NCT04706546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952178|NCT04706546|Urological Agents|urological agents|mesh-ancestor
5952179|NCT04706377|Vitamin B 12|vitamin b 12|mesh-list
5952180|NCT04706377|Vitamins|vitamins|mesh-ancestor
5952181|NCT04706377|Micronutrients|micronutrients|mesh-ancestor
5952182|NCT04706377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952183|NCT04706377|Vitamin B Complex|vitamin b complex|mesh-ancestor
5952184|NCT04706013|Pyridoxal|pyridoxal|mesh-list
5952185|NCT04706013|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
5952186|NCT04706013|Vitamin B Complex|vitamin b complex|mesh-ancestor
5952187|NCT04706013|Vitamins|vitamins|mesh-ancestor
5952188|NCT04706013|Micronutrients|micronutrients|mesh-ancestor
5952189|NCT04706013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952190|NCT04706091|Suvorexant|suvorexant|mesh-list
5952191|NCT04706091|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5952192|NCT04706091|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5952193|NCT04706091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5952194|NCT04706091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952195|NCT04706091|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
5952196|NCT04706091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5952197|NCT04706091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952198|NCT04705844|Adalimumab|adalimumab|mesh-list
5952199|NCT04705844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5952200|NCT04705844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5952201|NCT04705948|Magnesium Sulfate|magnesium sulfate|mesh-list
5952202|NCT04705948|Ketamine|ketamine|mesh-list
5952203|NCT04705948|Analgesics|analgesics|mesh-ancestor
5952204|NCT04705948|Sensory System Agents|sensory system agents|mesh-ancestor
5952205|NCT04705948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5952206|NCT04705948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952207|NCT04705948|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5952208|NCT04705948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5952209|NCT04705948|Anesthetics, General|anesthetics, general|mesh-ancestor
5952210|NCT04705948|Anesthetics|anesthetics|mesh-ancestor
5952211|NCT04705948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5952212|NCT04705948|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5952213|NCT04705948|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5952214|NCT04705948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5952215|NCT04705948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952216|NCT04705948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5952217|NCT04705948|Anticonvulsants|anticonvulsants|mesh-ancestor
5952218|NCT04705948|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5952219|NCT04705948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5952220|NCT04705948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5952221|NCT04705948|Tocolytic Agents|tocolytic agents|mesh-ancestor
5952222|NCT04705948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5952223|NCT04705831|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
5952224|NCT04705831|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5952225|NCT04705831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5952226|NCT04705831|Immunologic Factors|immunologic factors|mesh-ancestor
5952227|NCT04705831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952228|NCT04705987|Colchicine|colchicine|mesh-list
5952229|NCT04705987|Gout Suppressants|gout suppressants|mesh-ancestor
5952230|NCT04705987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5952231|NCT04705987|Tubulin Modulators|tubulin modulators|mesh-ancestor
5952232|NCT04705987|Antimitotic Agents|antimitotic agents|mesh-ancestor
5952233|NCT04705987|Mitosis Modulators|mitosis modulators|mesh-ancestor
5952234|NCT04705987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952235|NCT04705987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5952236|NCT04705909|Pitavastatin|pitavastatin|mesh-list
5952237|NCT04705909|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
5952238|NCT04705909|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5952239|NCT04705909|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5952240|NCT04705909|Antimetabolites|antimetabolites|mesh-ancestor
5952241|NCT04705909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952242|NCT04705909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5952243|NCT04705909|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5952244|NCT04706026|Anesthetics|anesthetics|mesh-list
5952245|NCT04706026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5952246|NCT04706026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952247|NCT04705727|Budesonide|budesonide|mesh-list
5952248|NCT04705727|Terbutaline|terbutaline|mesh-list
5952249|NCT04705727|Formoterol Fumarate|formoterol fumarate|mesh-list
5952250|NCT04705727|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
5952251|NCT04705727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5952252|NCT04705727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5952253|NCT04705727|Autonomic Agents|autonomic agents|mesh-ancestor
5952254|NCT04705727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5952255|NCT04705727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952256|NCT04705727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5952257|NCT04705727|Respiratory System Agents|respiratory system agents|mesh-ancestor
5952258|NCT04705727|Glucocorticoids|glucocorticoids|mesh-ancestor
5952259|NCT04705727|Hormones|hormones|mesh-ancestor
5952260|NCT04705727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5952261|NCT04705727|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5952262|NCT04705727|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5952263|NCT04705727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5952264|NCT04705727|Adrenergic Agents|adrenergic agents|mesh-ancestor
5952265|NCT04705727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5952266|NCT04705727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952267|NCT04705727|Sympathomimetics|sympathomimetics|mesh-ancestor
5952268|NCT04705727|Tocolytic Agents|tocolytic agents|mesh-ancestor
5952269|NCT04705727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5952270|NCT04705584|Cyclosporine|cyclosporine|mesh-list
5952271|NCT04705584|Prednisolone|prednisolone|mesh-list
5952272|NCT04705584|Cyclosporins|cyclosporins|mesh-list
5952273|NCT04705584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5952274|NCT04705584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952275|NCT04705584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5952276|NCT04705584|Immunologic Factors|immunologic factors|mesh-ancestor
5952277|NCT04705584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952278|NCT04705584|Antifungal Agents|antifungal agents|mesh-ancestor
5952279|NCT04705584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5952280|NCT04705584|Dermatologic Agents|dermatologic agents|mesh-ancestor
5952281|NCT04705584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5952282|NCT04705584|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5952283|NCT04705584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5952284|NCT04705584|Glucocorticoids|glucocorticoids|mesh-ancestor
5952285|NCT04705584|Hormones|hormones|mesh-ancestor
5952286|NCT04705584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5952287|NCT04705584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5952288|NCT04705584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5968914|NCT04547829|Sargramostim|sargramostim|mesh-list
5968915|NCT04547829|Lenograstim|lenograstim|mesh-list
5968916|NCT04547829|Immunologic Factors|immunologic factors|mesh-ancestor
5968917|NCT04547829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968918|NCT04547829|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5968919|NCT04547764|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5968920|NCT04547764|Calcium|calcium|mesh-list
5968921|NCT04547764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5968922|NCT04547764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968923|NCT04547764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5968924|NCT04547907|Paclitaxel|paclitaxel|mesh-list
5968925|NCT04547907|Docetaxel|docetaxel|mesh-list
5968926|NCT04547907|Carboplatin|carboplatin|mesh-list
5968927|NCT04547907|Trastuzumab|trastuzumab|mesh-list
5968928|NCT04547907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5968929|NCT04547907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5968930|NCT04547907|Tubulin Modulators|tubulin modulators|mesh-ancestor
5968931|NCT04547907|Antimitotic Agents|antimitotic agents|mesh-ancestor
5968932|NCT04547907|Mitosis Modulators|mitosis modulators|mesh-ancestor
5968933|NCT04547907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968934|NCT04547907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5968935|NCT04547855|Temozolomide|temozolomide|mesh-list
5968936|NCT04547855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5968937|NCT04547855|Alkylating Agents|alkylating agents|mesh-ancestor
5968938|NCT04547855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968939|NCT04547855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5968940|NCT04547842|Dexamethasone|dexamethasone|mesh-list
5968941|NCT04547842|Mirtazapine|mirtazapine|mesh-list
5968942|NCT04547842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5968943|NCT04547842|Antiemetics|antiemetics|mesh-ancestor
5968944|NCT04547842|Autonomic Agents|autonomic agents|mesh-ancestor
5971168|NCT04529954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5952289|NCT04705454|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
5952290|NCT04705454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5952291|NCT04705454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5952292|NCT04705337|Simendan|simendan|mesh-list
5952293|NCT04705337|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5952294|NCT04705337|Vasodilator Agents|vasodilator agents|mesh-ancestor
5952295|NCT04705337|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5952296|NCT04705337|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5952297|NCT04705337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5952298|NCT04705337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952299|NCT04705337|Protective Agents|protective agents|mesh-ancestor
5952300|NCT04705337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952301|NCT04705480|Pregabalin|pregabalin|mesh-list
5952302|NCT04705480|Gabapentin|gabapentin|mesh-list
5952303|NCT04705480|Analgesics|analgesics|mesh-ancestor
5952304|NCT04705480|Sensory System Agents|sensory system agents|mesh-ancestor
5952305|NCT04705480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5952306|NCT04705480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952307|NCT04705480|Anticonvulsants|anticonvulsants|mesh-ancestor
5952308|NCT04705480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5952309|NCT04705480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5952310|NCT04705480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952311|NCT04705480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5952312|NCT04705480|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5952313|NCT04705480|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5952314|NCT04705480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5952315|NCT04705480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5952316|NCT04705480|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5952317|NCT04705480|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5952318|NCT04705480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5952319|NCT04705480|Antimanic Agents|antimanic agents|mesh-ancestor
5952320|NCT04705402|Mannitol|mannitol|mesh-list
5952321|NCT04705402|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5952322|NCT04705402|Diuretics|diuretics|mesh-ancestor
5952323|NCT04705402|Natriuretic Agents|natriuretic agents|mesh-ancestor
5952324|NCT04705402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952325|NCT04705519|Paclitaxel|paclitaxel|mesh-list
5952326|NCT04705519|Bevacizumab|bevacizumab|mesh-list
5952327|NCT04705519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5952328|NCT04705519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5952329|NCT04705519|Tubulin Modulators|tubulin modulators|mesh-ancestor
5952330|NCT04705519|Antimitotic Agents|antimitotic agents|mesh-ancestor
5952331|NCT04705519|Mitosis Modulators|mitosis modulators|mesh-ancestor
5952332|NCT04705519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952333|NCT04705519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5952334|NCT04705519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5952335|NCT04705519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5952336|NCT04705519|Growth Substances|growth substances|mesh-ancestor
5952337|NCT04705519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952338|NCT04705519|Growth Inhibitors|growth inhibitors|mesh-ancestor
5952339|NCT04705428|Fluorides|fluorides|mesh-list
5952340|NCT04705428|Cariostatic Agents|cariostatic agents|mesh-ancestor
5952341|NCT04705428|Protective Agents|protective agents|mesh-ancestor
5952342|NCT04705428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952343|NCT04705415|Niclosamide|niclosamide|mesh-list
5952344|NCT04705415|Anticestodal Agents|anticestodal agents|mesh-ancestor
5952345|NCT04705415|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5952346|NCT04705415|Anthelmintics|anthelmintics|mesh-ancestor
5952347|NCT04705415|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5952348|NCT04705415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5952349|NCT04705415|Antinematodal Agents|antinematodal agents|mesh-ancestor
5952350|NCT04705129|Zanubrutinib|zanubrutinib|mesh-list
5952351|NCT04705129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5952352|NCT04705129|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5952353|NCT04705129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5952354|NCT04705129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952355|NCT04704921|Ranibizumab|ranibizumab|mesh-list
5952356|NCT04704921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5952357|NCT04704921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5952358|NCT04704921|Growth Substances|growth substances|mesh-ancestor
5952359|NCT04704921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952360|NCT04704921|Growth Inhibitors|growth inhibitors|mesh-ancestor
5952361|NCT04704921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5952362|NCT04704947|Alendronate|alendronate|mesh-list
5952363|NCT04704947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
5952364|NCT04704947|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-list
6517474|NCT00721331|Nortriptyline|nortriptyline|mesh-list
6517475|NCT00721331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6517476|NCT00721331|Dermatologic Agents|dermatologic agents|mesh-ancestor
6517477|NCT00721331|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6517478|NCT00721331|Antipruritics|antipruritics|mesh-ancestor
6517479|NCT00721331|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6517480|NCT00721331|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6517481|NCT00721331|Histamine Antagonists|histamine antagonists|mesh-ancestor
6517482|NCT00721331|Histamine Agents|histamine agents|mesh-ancestor
6517483|NCT00721331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5952365|NCT04704947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5952366|NCT04704947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952367|NCT04704947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5952368|NCT04704947|Adrenergic Agents|adrenergic agents|mesh-ancestor
5952369|NCT04704947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5952370|NCT04704947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952371|NCT04704622|Midazolam|midazolam|mesh-list
5952372|NCT04704622|Dexmedetomidine|dexmedetomidine|mesh-list
5952373|NCT04704622|Ketamine|ketamine|mesh-list
5952374|NCT04704622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5952375|NCT04704622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5952376|NCT04704622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952377|NCT04704622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5952378|NCT04704622|Analgesics|analgesics|mesh-ancestor
5952379|NCT04704622|Sensory System Agents|sensory system agents|mesh-ancestor
5952380|NCT04704622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5952381|NCT04704622|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5952382|NCT04704622|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5952383|NCT04704622|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5952384|NCT04704622|Adrenergic Agents|adrenergic agents|mesh-ancestor
5952385|NCT04704622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5952386|NCT04704622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952387|NCT04704622|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5952388|NCT04704622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5952389|NCT04704622|Anesthetics, General|anesthetics, general|mesh-ancestor
5952390|NCT04704622|Anesthetics|anesthetics|mesh-ancestor
5952391|NCT04704622|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5952392|NCT04704622|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5952393|NCT04704622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5952394|NCT04704622|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5952395|NCT04704622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5952396|NCT04704622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5952397|NCT04704622|GABA Modulators|gaba modulators|mesh-ancestor
5952398|NCT04704622|GABA Agents|gaba agents|mesh-ancestor
5952399|NCT04704596|Anesthetics|anesthetics|mesh-list
5952400|NCT04704596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5952401|NCT04704596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952402|NCT04704440|Sildenafil Citrate|sildenafil citrate|mesh-list
5952403|NCT04704440|Vasodilator Agents|vasodilator agents|mesh-ancestor
5952404|NCT04704440|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5952405|NCT04704440|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5952406|NCT04704440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5952407|NCT04704440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952408|NCT04704440|Urological Agents|urological agents|mesh-ancestor
5952409|NCT04704713|Afamelanotide|afamelanotide|mesh-list
5952410|NCT04704713|Dermatologic Agents|dermatologic agents|mesh-ancestor
5952411|NCT04704297|Acetaminophen|acetaminophen|mesh-list
5952412|NCT04704297|Ibuprofen|ibuprofen|mesh-list
5952413|NCT04704297|Ketorolac|ketorolac|mesh-list
5952414|NCT04704297|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
5952415|NCT04704297|Amitriptyline|amitriptyline|mesh-list
5952416|NCT04704297|Bupivacaine|bupivacaine|mesh-list
5952417|NCT04704297|Cyclobenzaprine|cyclobenzaprine|mesh-list
5952418|NCT04704297|Anesthetics, Local|anesthetics, local|mesh-ancestor
5952419|NCT04704297|Anesthetics|anesthetics|mesh-ancestor
5952420|NCT04704297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5952421|NCT04704297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952422|NCT04704297|Sensory System Agents|sensory system agents|mesh-ancestor
5952423|NCT04704297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5952424|NCT04704297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5952425|NCT04704297|Analgesics|analgesics|mesh-ancestor
5952426|NCT04704297|Antipyretics|antipyretics|mesh-ancestor
5952427|NCT04704297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5952428|NCT04704297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6517484|NCT00721331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952429|NCT04704297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5952430|NCT04704297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5952431|NCT04704297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5952432|NCT04704297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952433|NCT04704297|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5952434|NCT04704297|Antidepressive Agents|antidepressive agents|mesh-ancestor
5952435|NCT04704297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5952436|NCT04704297|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5952437|NCT04704297|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5952438|NCT04704297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5952439|NCT04704297|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5952440|NCT04704297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5952441|NCT04704297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5952442|NCT04704297|Adrenergic Agents|adrenergic agents|mesh-ancestor
5952443|NCT04704297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5952444|NCT04704453|Amitriptyline|amitriptyline|mesh-list
5952445|NCT04704453|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
5952446|NCT04704453|Capsaicin|capsaicin|mesh-list
5952447|NCT04704453|Antipruritics|antipruritics|mesh-ancestor
5952448|NCT04704453|Dermatologic Agents|dermatologic agents|mesh-ancestor
5952449|NCT04704453|Sensory System Agents|sensory system agents|mesh-ancestor
5952450|NCT04704453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5952451|NCT04704453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952452|NCT04704453|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5952453|NCT04704453|Antidepressive Agents|antidepressive agents|mesh-ancestor
5952454|NCT04704453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5952455|NCT04704453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5952456|NCT04704453|Analgesics|analgesics|mesh-ancestor
5952457|NCT04704453|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5952458|NCT04704453|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5952459|NCT04704453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5952460|NCT04704453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952461|NCT04704453|Adrenergic Agents|adrenergic agents|mesh-ancestor
5952462|NCT04704453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5952463|NCT04704453|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5952464|NCT04704453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5952465|NCT04704453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5952466|NCT04704245|Petrolatum|petrolatum|mesh-list
5952467|NCT04704245|Mitogens|mitogens|mesh-list
5952468|NCT04704245|Mitosis Modulators|mitosis modulators|mesh-ancestor
5952469|NCT04704245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952470|NCT04704245|Emollients|emollients|mesh-ancestor
5952471|NCT04704245|Dermatologic Agents|dermatologic agents|mesh-ancestor
5952472|NCT04704141|Hormones|hormones|mesh-list
5952473|NCT04704141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5952474|NCT04704141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952475|NCT04703868|Rabeprazole|rabeprazole|mesh-list
5952476|NCT04703868|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5952477|NCT04703868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5952478|NCT04703868|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5952479|NCT04703868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5952480|NCT04703868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952481|NCT04704024|Tenofovir|tenofovir|mesh-list
5952482|NCT04704024|Lamivudine|lamivudine|mesh-list
5952483|NCT04704024|Antiviral Agents|antiviral agents|mesh-ancestor
5952484|NCT04704024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5952485|NCT04704024|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5952486|NCT04704024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5952487|NCT04704024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5952488|NCT04704024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952489|NCT04704024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5952490|NCT04704024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5952491|NCT04703803|Lidocaine|lidocaine|mesh-list
5952492|NCT04703803|Anesthetics, Local|anesthetics, local|mesh-ancestor
5952493|NCT04703803|Anesthetics|anesthetics|mesh-ancestor
5952494|NCT04703803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5952495|NCT04703803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952496|NCT04703803|Sensory System Agents|sensory system agents|mesh-ancestor
5952497|NCT04703803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5952498|NCT04703803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5952499|NCT04703803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5952500|NCT04703803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5952501|NCT04703803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5952502|NCT04703803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968945|NCT04547842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5968946|NCT04547842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968947|NCT04547842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5968948|NCT04547842|Glucocorticoids|glucocorticoids|mesh-ancestor
5968949|NCT04547842|Hormones|hormones|mesh-ancestor
5968950|NCT04547842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5968951|NCT04547842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5968952|NCT04547842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5968953|NCT04547842|Antidepressive Agents|antidepressive agents|mesh-ancestor
5968954|NCT04547842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5968955|NCT04547842|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5968956|NCT04547842|Histamine Antagonists|histamine antagonists|mesh-ancestor
5968957|NCT04547842|Histamine Agents|histamine agents|mesh-ancestor
5968958|NCT04547842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5968959|NCT04547842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968960|NCT04547842|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5968961|NCT04547842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5968962|NCT04547842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5968963|NCT04547842|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5968964|NCT04547842|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5968965|NCT04547842|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5968966|NCT04547842|Adrenergic Agents|adrenergic agents|mesh-ancestor
5968967|NCT04547842|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5968968|NCT04547842|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5968969|NCT04547842|Serotonin Agents|serotonin agents|mesh-ancestor
5968970|NCT04547842|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5968971|NCT04547621|Temozolomide|temozolomide|mesh-list
5968972|NCT04547621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5968973|NCT04547621|Alkylating Agents|alkylating agents|mesh-ancestor
5968974|NCT04547621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5968975|NCT04547621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5968976|NCT04547608|Propofol|propofol|mesh-list
5968977|NCT04547608|Rocuronium|rocuronium|mesh-list
5968978|NCT04547608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5968979|NCT04547608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5968980|NCT04547608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968981|NCT04547608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5968982|NCT04547608|Anesthetics, General|anesthetics, general|mesh-ancestor
5968983|NCT04547608|Anesthetics|anesthetics|mesh-ancestor
5968984|NCT04547608|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5968985|NCT04547608|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5968986|NCT04547608|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5968987|NCT04547608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5968988|NCT04547348|Denosumab|denosumab|mesh-list
5968989|NCT04547348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5968990|NCT04547348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968991|NCT04547426|Nicotine|nicotine|mesh-list
5968992|NCT04547426|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5968993|NCT04547426|Autonomic Agents|autonomic agents|mesh-ancestor
5968994|NCT04547426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5968995|NCT04547426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5968996|NCT04547426|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5968997|NCT04547426|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5968998|NCT04547426|Cholinergic Agents|cholinergic agents|mesh-ancestor
5968999|NCT04547426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5969000|NCT04547426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969001|NCT04547452|Antibodies|antibodies|mesh-list
5969002|NCT04547452|Immunologic Factors|immunologic factors|mesh-ancestor
5969003|NCT04547452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969004|NCT04547335|Voriconazole|voriconazole|mesh-list
5969005|NCT04547335|Antifungal Agents|antifungal agents|mesh-ancestor
5969006|NCT04547335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5969007|NCT04547335|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5969008|NCT04547335|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5969009|NCT04547335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5969010|NCT04547335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969011|NCT04547335|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5969012|NCT04547335|Hormone Antagonists|hormone antagonists|mesh-ancestor
5969013|NCT04547335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5969014|NCT04547335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952503|NCT04703920|Talazoparib|talazoparib|mesh-list
5952504|NCT04703920|Belinostat|belinostat|mesh-list
5952505|NCT04703920|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5952506|NCT04703920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5952507|NCT04703920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952508|NCT04703920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5952509|NCT04703920|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5952510|NCT04704063|Vitamin E|vitamin e|mesh-list
5952511|NCT04704063|Tocopherols|tocopherols|mesh-list
5952512|NCT04704063|Tocotrienols|tocotrienols|mesh-list
5952513|NCT04704063|Tocovid|tocovid|mesh-list
5952514|NCT04704063|Vitamins|vitamins|mesh-ancestor
5952515|NCT04704063|Micronutrients|micronutrients|mesh-ancestor
5952516|NCT04704063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952517|NCT04704063|Antioxidants|antioxidants|mesh-ancestor
5952518|NCT04704063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952519|NCT04704063|Protective Agents|protective agents|mesh-ancestor
5952520|NCT04704050|Dronedarone|dronedarone|mesh-list
5952521|NCT04704050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5952522|NCT04703751|Nitroglycerin|nitroglycerin|mesh-list
5952523|NCT04703751|Vasodilator Agents|vasodilator agents|mesh-ancestor
5952524|NCT04703465|Tenofovir|tenofovir|mesh-list
5952525|NCT04703465|Antiviral Agents|antiviral agents|mesh-ancestor
5952526|NCT04703465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5952527|NCT04703465|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5952528|NCT04703465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5952529|NCT04703465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5952530|NCT04703465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952531|NCT04703465|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5952532|NCT04703465|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5952533|NCT04703608|Ivermectin|ivermectin|mesh-list
5952534|NCT04703608|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5952535|NCT04703608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5952536|NCT04703673|Nasal Decongestants|nasal decongestants|mesh-list
5952537|NCT04703673|Pseudoephedrine|pseudoephedrine|mesh-list
5952538|NCT04703673|Ephedrine|ephedrine|mesh-list
5952539|NCT04703673|Sympathomimetics|sympathomimetics|mesh-list
5952540|NCT04703673|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5952541|NCT04703673|Respiratory System Agents|respiratory system agents|mesh-ancestor
5952542|NCT04703673|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5952543|NCT04703673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952544|NCT04703673|Autonomic Agents|autonomic agents|mesh-ancestor
5952545|NCT04703673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5952546|NCT04703673|Adrenergic Agents|adrenergic agents|mesh-ancestor
5952547|NCT04703673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5952548|NCT04703673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952549|NCT04703673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5952550|NCT04703673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5952551|NCT04703426|Pembrolizumab|pembrolizumab|mesh-list
5952552|NCT04703426|Sargramostim|sargramostim|mesh-list
5952553|NCT04703426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5952554|NCT04703426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5952555|NCT04703426|Immunologic Factors|immunologic factors|mesh-ancestor
5952556|NCT04703426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952557|NCT04703686|Obinutuzumab|obinutuzumab|mesh-list
5952558|NCT04703686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5952559|NCT04703686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5952560|NCT04703257|Dipyrone|dipyrone|mesh-list
5952561|NCT04703257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5952562|NCT04703257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5952563|NCT04703257|Analgesics|analgesics|mesh-ancestor
5952564|NCT04703257|Sensory System Agents|sensory system agents|mesh-ancestor
5952565|NCT04703257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5952566|NCT04703257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952567|NCT04703257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5952568|NCT04703257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5952569|NCT04703257|Antipyretics|antipyretics|mesh-ancestor
5952570|NCT04702906|Trimetazidine|trimetazidine|mesh-list
5952571|NCT04702906|Vasodilator Agents|vasodilator agents|mesh-ancestor
5952572|NCT04703127|Lidocaine|lidocaine|mesh-list
5952573|NCT04703127|Tadalafil|tadalafil|mesh-list
5952574|NCT04703127|Anesthetics, Local|anesthetics, local|mesh-ancestor
5952575|NCT04703127|Anesthetics|anesthetics|mesh-ancestor
5952576|NCT04703127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5952577|NCT04703127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952578|NCT04703127|Sensory System Agents|sensory system agents|mesh-ancestor
5952579|NCT04703127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5952580|NCT04703127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5952581|NCT04703127|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5952582|NCT04703127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5952583|NCT04703127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5952584|NCT04703127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952585|NCT04703127|Vasodilator Agents|vasodilator agents|mesh-ancestor
5952586|NCT04703127|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5952587|NCT04703127|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5952588|NCT04703127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5952589|NCT04703127|Urological Agents|urological agents|mesh-ancestor
5952590|NCT04702971|Flunarizine|flunarizine|mesh-list
5952591|NCT04702971|Anticonvulsants|anticonvulsants|mesh-ancestor
5952592|NCT04702971|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5952593|NCT04702971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5952594|NCT04702971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952595|NCT04702971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5952596|NCT04702971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952597|NCT04702971|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5952598|NCT04702971|Histamine Antagonists|histamine antagonists|mesh-ancestor
5952599|NCT04702971|Histamine Agents|histamine agents|mesh-ancestor
5952600|NCT04702971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5952601|NCT04702971|Vasodilator Agents|vasodilator agents|mesh-ancestor
5952602|NCT04703088|Ondansetron|ondansetron|mesh-list
5952603|NCT04703088|Antiemetics|antiemetics|mesh-ancestor
5952604|NCT04703088|Autonomic Agents|autonomic agents|mesh-ancestor
5952605|NCT04703088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5952606|NCT04703088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952607|NCT04703088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5952608|NCT04703088|Antipruritics|antipruritics|mesh-ancestor
5952609|NCT04703088|Dermatologic Agents|dermatologic agents|mesh-ancestor
5952610|NCT04703088|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5952611|NCT04703088|Serotonin Agents|serotonin agents|mesh-ancestor
5952612|NCT04703088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5952613|NCT04703088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952614|NCT04703088|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5952615|NCT04703088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5952616|NCT04703088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5952617|NCT04703088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5952618|NCT04703088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5952619|NCT04702698|Peposertib|peposertib|mesh-list
5952620|NCT04702698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5952621|NCT04702698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5952622|NCT04702698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952623|NCT04702685|Ropivacaine|ropivacaine|mesh-list
5952624|NCT04702685|Anesthetics, Local|anesthetics, local|mesh-ancestor
5952625|NCT04702685|Anesthetics|anesthetics|mesh-ancestor
5952626|NCT04702685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5952627|NCT04702685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952628|NCT04702685|Sensory System Agents|sensory system agents|mesh-ancestor
5952629|NCT04702685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5952630|NCT04702490|Empagliflozin|empagliflozin|mesh-list
5952631|NCT04702490|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5952632|NCT04702490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952633|NCT04702490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5952634|NCT04702490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952635|NCT04702048|Aflibercept|aflibercept|mesh-list
5952636|NCT04702048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5952637|NCT04702048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5952638|NCT04702048|Growth Substances|growth substances|mesh-ancestor
5952639|NCT04702048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952640|NCT04702048|Growth Inhibitors|growth inhibitors|mesh-ancestor
5952641|NCT04702048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5952642|NCT04702061|Anesthetics|anesthetics|mesh-list
5952643|NCT04702061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5952644|NCT04702061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952645|NCT04702334|Lidocaine|lidocaine|mesh-list
5952646|NCT04702334|Hyaluronic Acid|hyaluronic acid|mesh-list
5952647|NCT04702334|Anesthetics, Local|anesthetics, local|mesh-ancestor
5952648|NCT04702334|Anesthetics|anesthetics|mesh-ancestor
5952649|NCT04702334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5952650|NCT04702334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952651|NCT04702334|Sensory System Agents|sensory system agents|mesh-ancestor
5952652|NCT04702334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5952653|NCT04702334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5952654|NCT04702334|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5952655|NCT04702334|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5952656|NCT04702334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5952657|NCT04702334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952658|NCT04702334|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5952659|NCT04702334|Immunologic Factors|immunologic factors|mesh-ancestor
5952660|NCT04702334|Viscosupplements|viscosupplements|mesh-ancestor
5952661|NCT04702334|Protective Agents|protective agents|mesh-ancestor
5952662|NCT04702360|Ivacaftor|ivacaftor|mesh-list
5952663|NCT04702360|Elexacaftor|elexacaftor|mesh-list
5952664|NCT04702360|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
5952665|NCT04702360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5952666|NCT04702360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969015|NCT04547335|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5969016|NCT04547439|Melatonin|melatonin|mesh-list
5969017|NCT04547439|Antioxidants|antioxidants|mesh-ancestor
5969018|NCT04547439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969019|NCT04547439|Protective Agents|protective agents|mesh-ancestor
5969020|NCT04547439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969021|NCT04547439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5969022|NCT04547296|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5969023|NCT04547504|Pembrolizumab|pembrolizumab|mesh-list
5969024|NCT04547504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5969025|NCT04547504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5969026|NCT04547530|Vitamin D|vitamin d|mesh-list
5969027|NCT04547530|Vitamins|vitamins|mesh-ancestor
5969028|NCT04547530|Micronutrients|micronutrients|mesh-ancestor
5969029|NCT04547530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969030|NCT04547530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5969031|NCT04546802|Grazoprevir|grazoprevir|mesh-list
5969032|NCT04546802|Antiviral Agents|antiviral agents|mesh-ancestor
5969033|NCT04546802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5969034|NCT04547153|Docetaxel|docetaxel|mesh-list
5969035|NCT04547153|Fluorouracil|fluorouracil|mesh-list
5969036|NCT04547153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5969037|NCT04547153|Tubulin Modulators|tubulin modulators|mesh-ancestor
5969038|NCT04547153|Antimitotic Agents|antimitotic agents|mesh-ancestor
5969039|NCT04547153|Mitosis Modulators|mitosis modulators|mesh-ancestor
5969040|NCT04547153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969041|NCT04547153|Antimetabolites|antimetabolites|mesh-ancestor
5969042|NCT04547153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5969043|NCT04547153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5969044|NCT04547153|Immunologic Factors|immunologic factors|mesh-ancestor
5969045|NCT04547153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969046|NCT04546815|Daptomycin|daptomycin|mesh-list
5969047|NCT04546815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5969048|NCT04546815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5969049|NCT04547088|Apatinib|apatinib|mesh-list
5969050|NCT04547088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5969051|NCT04547088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5969052|NCT04547088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5969053|NCT04547088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969054|NCT04547179|Erenumab|erenumab|mesh-list
5969055|NCT04547179|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
5969056|NCT04547179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969057|NCT04547179|Analgesics|analgesics|mesh-ancestor
5969058|NCT04547179|Sensory System Agents|sensory system agents|mesh-ancestor
5969059|NCT04547179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5969060|NCT04547179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969061|NCT04546828|Gemcitabine|gemcitabine|mesh-list
5969062|NCT04546828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5969063|NCT04546828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5969064|NCT04546828|Antimetabolites|antimetabolites|mesh-ancestor
5969065|NCT04546828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969066|NCT04546828|Antiviral Agents|antiviral agents|mesh-ancestor
5969067|NCT04546828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5969068|NCT04546828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5969069|NCT04546828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5969070|NCT04546828|Immunologic Factors|immunologic factors|mesh-ancestor
5969071|NCT04546828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969072|NCT04547049|Cytarabine|cytarabine|mesh-list
5969073|NCT04547049|Cyclosporine|cyclosporine|mesh-list
5969074|NCT04547049|Mycophenolic Acid|mycophenolic acid|mesh-list
5969075|NCT04547049|Cyclophosphamide|cyclophosphamide|mesh-list
5969076|NCT04547049|Busulfan|busulfan|mesh-list
5969077|NCT04547049|Cyclosporins|cyclosporins|mesh-list
5952667|NCT04702204|Denosumab|denosumab|mesh-list
5952668|NCT04702204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5952669|NCT04702204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952670|NCT04702009|Antibodies|antibodies|mesh-list
5952671|NCT04702009|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5952672|NCT04702009|Immunologic Factors|immunologic factors|mesh-ancestor
5952673|NCT04702009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952674|NCT04701606|Artesunate|artesunate|mesh-list
5952675|NCT04701606|Pyronaridine|pyronaridine|mesh-list
5952676|NCT04701606|Antimalarials|antimalarials|mesh-ancestor
5952677|NCT04701606|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5952678|NCT04701606|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5952679|NCT04701606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5952680|NCT04701606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5952681|NCT04701606|Antiviral Agents|antiviral agents|mesh-ancestor
5952682|NCT04701606|Schistosomicides|schistosomicides|mesh-ancestor
5952683|NCT04701606|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5952684|NCT04701606|Anthelmintics|anthelmintics|mesh-ancestor
5952685|NCT04701710|Ivermectin|ivermectin|mesh-list
5952686|NCT04701710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5952687|NCT04701710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5952688|NCT04701528|Tacrolimus|tacrolimus|mesh-list
5952689|NCT04701528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5952690|NCT04701528|Immunologic Factors|immunologic factors|mesh-ancestor
5952691|NCT04701528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952692|NCT04701528|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5952693|NCT04701528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5952694|NCT04701528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952695|NCT04701476|Pembrolizumab|pembrolizumab|mesh-list
5952696|NCT04701476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5952697|NCT04701476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5952698|NCT04701463|Calcium|calcium|mesh-list
5952699|NCT04701463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5952700|NCT04701463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952701|NCT04701580|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5952702|NCT04701580|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5952703|NCT04701580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952704|NCT04701307|Niraparib|niraparib|mesh-list
5952705|NCT04701307|Immunoglobulins|immunoglobulins|mesh-list
5952706|NCT04701307|Immunoglobulin G|immunoglobulin g|mesh-list
5952707|NCT04701307|Immunologic Factors|immunologic factors|mesh-ancestor
5952708|NCT04701307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952709|NCT04701307|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5952710|NCT04701307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5952711|NCT04701307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952712|NCT04701307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5952713|NCT04701333|Cabergoline|cabergoline|mesh-list
5952714|NCT04701333|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5952715|NCT04701333|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5952716|NCT04701333|Dopamine Agonists|dopamine agonists|mesh-ancestor
5952717|NCT04701333|Dopamine Agents|dopamine agents|mesh-ancestor
5952718|NCT04701333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5952719|NCT04701333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952720|NCT04701333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952721|NCT04701242|Ezetimibe|ezetimibe|mesh-list
5952722|NCT04701242|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5952723|NCT04701242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5952724|NCT04701242|Antimetabolites|antimetabolites|mesh-ancestor
5952725|NCT04701242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952726|NCT04701242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5952727|NCT04701320|Methamphetamine|methamphetamine|mesh-list
5952728|NCT04701320|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5952729|NCT04701320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952730|NCT04701320|Sympathomimetics|sympathomimetics|mesh-ancestor
5952731|NCT04701320|Autonomic Agents|autonomic agents|mesh-ancestor
5952732|NCT04701320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5952733|NCT04701320|Dopamine Agents|dopamine agents|mesh-ancestor
5952734|NCT04701320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5952735|NCT04701320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952736|NCT04701320|Adrenergic Agents|adrenergic agents|mesh-ancestor
5952737|NCT04701320|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5952738|NCT04701320|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5952739|NCT04701320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5952740|NCT04701320|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5952741|NCT04701151|BCG Vaccine|bcg vaccine|mesh-list
5952742|NCT04701151|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5952743|NCT04701151|Immunologic Factors|immunologic factors|mesh-ancestor
5952744|NCT04701151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952745|NCT04701034|Prednisolone|prednisolone|mesh-list
5952746|NCT04701034|Immunoglobulins|immunoglobulins|mesh-list
5952747|NCT04701034|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5952748|NCT04701034|Antibodies|antibodies|mesh-list
5952749|NCT04701034|gamma-Globulins|gamma-globulins|mesh-list
5952750|NCT04701034|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5952751|NCT04701034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5952752|NCT04701034|Glucocorticoids|glucocorticoids|mesh-ancestor
5952753|NCT04701034|Hormones|hormones|mesh-ancestor
5952754|NCT04701034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5952755|NCT04701034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952756|NCT04701034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5952757|NCT04701034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5952758|NCT04701034|Immunologic Factors|immunologic factors|mesh-ancestor
5952759|NCT04701008|Ketamine|ketamine|mesh-list
5952760|NCT04701008|Analgesics|analgesics|mesh-ancestor
5952761|NCT04701008|Sensory System Agents|sensory system agents|mesh-ancestor
5952762|NCT04701008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5952763|NCT04701008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952764|NCT04701008|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5952765|NCT04701008|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5952766|NCT04701008|Anesthetics, General|anesthetics, general|mesh-ancestor
5952767|NCT04701008|Anesthetics|anesthetics|mesh-ancestor
5952768|NCT04701008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5952769|NCT04701008|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5952770|NCT04701008|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5952771|NCT04701008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5952772|NCT04701008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952773|NCT04700826|Rivaroxaban|rivaroxaban|mesh-list
5952774|NCT04700826|Apixaban|apixaban|mesh-list
5952775|NCT04700826|Edoxaban|edoxaban|mesh-list
5952776|NCT04700826|Dabigatran|dabigatran|mesh-list
5952777|NCT04700826|Anticoagulants|anticoagulants|mesh-list
5952778|NCT04700826|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5952779|NCT04700826|Antithrombins|antithrombins|mesh-ancestor
5952780|NCT04700826|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5952781|NCT04700826|Protease Inhibitors|protease inhibitors|mesh-ancestor
5952782|NCT04700826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5952783|NCT04700826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952784|NCT04700670|Platelet Factor 4|platelet factor 4|mesh-list
5952785|NCT04700670|Coagulants|coagulants|mesh-ancestor
5952786|NCT04700592|Ketamine|ketamine|mesh-list
5952787|NCT04700592|Gabapentin|gabapentin|mesh-list
5952788|NCT04700592|Analgesics|analgesics|mesh-ancestor
5952789|NCT04700592|Sensory System Agents|sensory system agents|mesh-ancestor
5952790|NCT04700592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5952791|NCT04700592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952792|NCT04700592|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5952793|NCT04700592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5952794|NCT04700592|Anesthetics, General|anesthetics, general|mesh-ancestor
5952795|NCT04700592|Anesthetics|anesthetics|mesh-ancestor
5952796|NCT04700592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5952797|NCT04700592|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5952798|NCT04700592|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5952799|NCT04700592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5952800|NCT04700592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952801|NCT04700592|Anticonvulsants|anticonvulsants|mesh-ancestor
5952802|NCT04700592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5952803|NCT04700592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5952804|NCT04700592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5952805|NCT04700592|Antimanic Agents|antimanic agents|mesh-ancestor
5952806|NCT04700943|Anesthetics|anesthetics|mesh-list
5952807|NCT04700943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5952808|NCT04700943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952809|NCT04700696|Analgesics, Opioid|analgesics, opioid|mesh-list
5952810|NCT04700696|Narcotics|narcotics|mesh-ancestor
5952811|NCT04700696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5952812|NCT04700696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952813|NCT04700696|Analgesics|analgesics|mesh-ancestor
5952814|NCT04700696|Sensory System Agents|sensory system agents|mesh-ancestor
5952815|NCT04700696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5952816|NCT04700709|Mycophenolic Acid|mycophenolic acid|mesh-list
5952817|NCT04700709|Sirolimus|sirolimus|mesh-list
5952818|NCT04700709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5952819|NCT04700709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5952820|NCT04700709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5952821|NCT04700709|Antitubercular Agents|antitubercular agents|mesh-ancestor
5952822|NCT04700709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5952823|NCT04700709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5952824|NCT04700709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5952825|NCT04700709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952826|NCT04700709|Antifungal Agents|antifungal agents|mesh-ancestor
5952827|NCT04700709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5952828|NCT04700709|Immunologic Factors|immunologic factors|mesh-ancestor
5952829|NCT04700709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952830|NCT04700761|Analgesics, Opioid|analgesics, opioid|mesh-list
5952831|NCT04700761|Anesthetics|anesthetics|mesh-list
5952832|NCT04700761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5952833|NCT04700761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952834|NCT04700761|Narcotics|narcotics|mesh-ancestor
5952835|NCT04700761|Analgesics|analgesics|mesh-ancestor
5952836|NCT04700761|Sensory System Agents|sensory system agents|mesh-ancestor
5952837|NCT04700761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5952838|NCT04700839|Metformin|metformin|mesh-list
5952839|NCT04700839|Canagliflozin|canagliflozin|mesh-list
5952840|NCT04700839|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
5952841|NCT04700839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5952842|NCT04700839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952843|NCT04700839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952844|NCT04700475|Citric Acid|citric acid|mesh-list
5952845|NCT04700475|Sodium Citrate|sodium citrate|mesh-list
5952846|NCT04700475|Anticoagulants|anticoagulants|mesh-ancestor
5952847|NCT04700475|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5952848|NCT04700475|Chelating Agents|chelating agents|mesh-ancestor
5952849|NCT04700475|Sequestering Agents|sequestering agents|mesh-ancestor
5952850|NCT04700475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952851|NCT04700436|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5952852|NCT04700436|Ezetimibe|ezetimibe|mesh-list
5952853|NCT04700436|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5952854|NCT04700436|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5952855|NCT04700436|Antimetabolites|antimetabolites|mesh-ancestor
5952856|NCT04700436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952857|NCT04700436|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5952858|NCT04700436|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5952859|NCT04700436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5952860|NCT04700228|Dexmedetomidine|dexmedetomidine|mesh-list
5952861|NCT04700228|Bupivacaine|bupivacaine|mesh-list
5952862|NCT04700228|Anesthetics, Local|anesthetics, local|mesh-ancestor
5952863|NCT04700228|Anesthetics|anesthetics|mesh-ancestor
5952864|NCT04700228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5952865|NCT04700228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952866|NCT04700228|Sensory System Agents|sensory system agents|mesh-ancestor
5952867|NCT04700228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5952868|NCT04700228|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5952869|NCT04700228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5952870|NCT04700228|Analgesics|analgesics|mesh-ancestor
5952871|NCT04700228|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5952872|NCT04700228|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5952873|NCT04700228|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5952874|NCT04700228|Adrenergic Agents|adrenergic agents|mesh-ancestor
5952875|NCT04700228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5952876|NCT04700228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969078|NCT04547049|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5969079|NCT04547049|Thymoglobulin|thymoglobulin|mesh-list
5969080|NCT04547049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5969081|NCT04547049|Immunologic Factors|immunologic factors|mesh-ancestor
5969082|NCT04547049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969083|NCT04547049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5969084|NCT04547049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5969085|NCT04547049|Alkylating Agents|alkylating agents|mesh-ancestor
5969086|NCT04547049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969087|NCT04547049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5969088|NCT04547049|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5969089|NCT04547049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5969090|NCT04547049|Antimetabolites|antimetabolites|mesh-ancestor
5969091|NCT04547049|Antiviral Agents|antiviral agents|mesh-ancestor
5969092|NCT04547049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5969093|NCT04547049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5969094|NCT04547049|Antifungal Agents|antifungal agents|mesh-ancestor
5952877|NCT04700397|Nitroglycerin|nitroglycerin|mesh-list
5952878|NCT04700397|Vasodilator Agents|vasodilator agents|mesh-ancestor
5952879|NCT04700046|Mexiletine|mexiletine|mesh-list
5952880|NCT04700046|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5952881|NCT04700046|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5952882|NCT04700046|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5952883|NCT04700046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5952884|NCT04700046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952885|NCT04699981|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5952886|NCT04699981|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5952887|NCT04699981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5952888|NCT04699981|Antitubercular Agents|antitubercular agents|mesh-ancestor
5952889|NCT04699643|Pembrolizumab|pembrolizumab|mesh-list
5952890|NCT04699643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5952891|NCT04699643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5952892|NCT04699903|Antibodies|antibodies|mesh-list
5952893|NCT04699903|Immunoglobulin G|immunoglobulin g|mesh-list
5952894|NCT04699903|Immunologic Factors|immunologic factors|mesh-ancestor
5952895|NCT04699903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952896|NCT04699734|Lidocaine|lidocaine|mesh-list
5952897|NCT04699734|Anesthetics, Local|anesthetics, local|mesh-ancestor
5952898|NCT04699734|Anesthetics|anesthetics|mesh-ancestor
5952899|NCT04699734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5952900|NCT04699734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952901|NCT04699734|Sensory System Agents|sensory system agents|mesh-ancestor
5952902|NCT04699734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5952903|NCT04699734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5952904|NCT04699734|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5952905|NCT04699734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5952906|NCT04699734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5952907|NCT04699734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952908|NCT04699721|Paclitaxel|paclitaxel|mesh-list
5952909|NCT04699721|Carboplatin|carboplatin|mesh-list
5952910|NCT04699721|Nivolumab|nivolumab|mesh-list
5952911|NCT04699721|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5952912|NCT04699721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5952913|NCT04699721|Tubulin Modulators|tubulin modulators|mesh-ancestor
5952914|NCT04699721|Antimitotic Agents|antimitotic agents|mesh-ancestor
5952915|NCT04699721|Mitosis Modulators|mitosis modulators|mesh-ancestor
5952916|NCT04699721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952917|NCT04699721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5952918|NCT04699721|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5952919|NCT04699591|Domperidone|domperidone|mesh-list
5952920|NCT04699591|Antiemetics|antiemetics|mesh-ancestor
5952921|NCT04699591|Autonomic Agents|autonomic agents|mesh-ancestor
5952922|NCT04699591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5952923|NCT04699591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952924|NCT04699591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5952925|NCT04699591|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5952926|NCT04699591|Dopamine Agents|dopamine agents|mesh-ancestor
5952927|NCT04699591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5952928|NCT04699591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952929|NCT04699214|Endostar protein|endostar protein|mesh-list
5952930|NCT04699214|Endostatins|endostatins|mesh-list
5952931|NCT04699214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5952932|NCT04699214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5952933|NCT04699214|Growth Substances|growth substances|mesh-ancestor
5952934|NCT04699214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952935|NCT04699214|Growth Inhibitors|growth inhibitors|mesh-ancestor
5952936|NCT04699214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5952937|NCT04699383|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
5952938|NCT04699383|Allopurinol|allopurinol|mesh-list
5952939|NCT04699383|Antimetabolites|antimetabolites|mesh-ancestor
5952940|NCT04699383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952941|NCT04699383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5952942|NCT04699383|Gout Suppressants|gout suppressants|mesh-ancestor
5952943|NCT04699383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5952944|NCT04699383|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5952945|NCT04699383|Antioxidants|antioxidants|mesh-ancestor
5952946|NCT04699383|Protective Agents|protective agents|mesh-ancestor
5952947|NCT04699383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952948|NCT04699383|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5952949|NCT04699383|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5952950|NCT04699383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5952951|NCT04699383|Schistosomicides|schistosomicides|mesh-ancestor
5952952|NCT04699383|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5952953|NCT04699383|Anthelmintics|anthelmintics|mesh-ancestor
5952954|NCT04699240|Clotrimazole|clotrimazole|mesh-list
5952955|NCT04699240|Miconazole|miconazole|mesh-list
5952956|NCT04699240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5952957|NCT04699240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5952958|NCT04699240|Antifungal Agents|antifungal agents|mesh-ancestor
5952959|NCT04699240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5952960|NCT04699240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5952961|NCT04699240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5952962|NCT04699240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952963|NCT04699240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5952964|NCT04699240|Hormone Antagonists|hormone antagonists|mesh-ancestor
5952965|NCT04699240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5952966|NCT04699240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952967|NCT04699240|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5952968|NCT04699240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5952969|NCT04698850|Ranibizumab|ranibizumab|mesh-list
5952970|NCT04698850|Aflibercept|aflibercept|mesh-list
5952971|NCT04698850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5952972|NCT04698850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5952973|NCT04698850|Growth Substances|growth substances|mesh-ancestor
5952974|NCT04698850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952975|NCT04698850|Growth Inhibitors|growth inhibitors|mesh-ancestor
5952976|NCT04698850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5952977|NCT04698941|Paclitaxel|paclitaxel|mesh-list
5952978|NCT04698941|Simvastatin|simvastatin|mesh-list
5952979|NCT04698941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5952980|NCT04698941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5952981|NCT04698941|Tubulin Modulators|tubulin modulators|mesh-ancestor
5952982|NCT04698941|Antimitotic Agents|antimitotic agents|mesh-ancestor
5952983|NCT04698941|Mitosis Modulators|mitosis modulators|mesh-ancestor
5952984|NCT04698941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5952985|NCT04698941|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5952986|NCT04698941|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5952987|NCT04698941|Antimetabolites|antimetabolites|mesh-ancestor
5952988|NCT04698941|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5952989|NCT04698941|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5952990|NCT04698941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5952991|NCT04699058|Antibodies|antibodies|mesh-list
5952992|NCT04699058|Immunologic Factors|immunologic factors|mesh-ancestor
5952993|NCT04699058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5952994|NCT04699110|Adenosine|adenosine|mesh-list
5952995|NCT04699110|Epinephrine|epinephrine|mesh-list
5952996|NCT04699110|Racepinephrine|racepinephrine|mesh-list
5952997|NCT04699110|Epinephryl borate|epinephryl borate|mesh-list
5952998|NCT04699110|Analgesics|analgesics|mesh-ancestor
5952999|NCT04699110|Sensory System Agents|sensory system agents|mesh-ancestor
5953000|NCT04699110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5953001|NCT04699110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953002|NCT04699110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5953003|NCT04699110|Vasodilator Agents|vasodilator agents|mesh-ancestor
5953004|NCT04699110|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5953005|NCT04699110|Purinergic Agonists|purinergic agonists|mesh-ancestor
5953006|NCT04699110|Purinergic Agents|purinergic agents|mesh-ancestor
5953007|NCT04699110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5953008|NCT04699110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953009|NCT04699110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5953010|NCT04699110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5953011|NCT04699110|Adrenergic Agents|adrenergic agents|mesh-ancestor
5953012|NCT04699110|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5953013|NCT04699110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5953014|NCT04699110|Autonomic Agents|autonomic agents|mesh-ancestor
5953015|NCT04699110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5953016|NCT04699110|Respiratory System Agents|respiratory system agents|mesh-ancestor
5953017|NCT04699110|Mydriatics|mydriatics|mesh-ancestor
5953018|NCT04699110|Sympathomimetics|sympathomimetics|mesh-ancestor
5953019|NCT04699110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5953020|NCT04699097|Azithromycin|azithromycin|mesh-list
5953021|NCT04699097|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5953022|NCT04699097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5953023|NCT04699279|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5953024|NCT04699279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5953025|NCT04699279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5953026|NCT04699279|Antimetabolites|antimetabolites|mesh-ancestor
5969095|NCT04547049|Dermatologic Agents|dermatologic agents|mesh-ancestor
5953027|NCT04699279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953028|NCT04699279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5953029|NCT04699279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5953030|NCT04699279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5953031|NCT04698746|Anesthetics|anesthetics|mesh-list
5953032|NCT04698746|Anesthetics, Local|anesthetics, local|mesh-list
5953033|NCT04698746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5953034|NCT04698746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953035|NCT04698746|Sensory System Agents|sensory system agents|mesh-ancestor
5953036|NCT04698746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5953037|NCT04698772|Morphine|morphine|mesh-list
5953038|NCT04698772|Ketamine|ketamine|mesh-list
5953039|NCT04698772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5953040|NCT04698772|Narcotics|narcotics|mesh-ancestor
5953041|NCT04698772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5953042|NCT04698772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953043|NCT04698772|Analgesics|analgesics|mesh-ancestor
5953044|NCT04698772|Sensory System Agents|sensory system agents|mesh-ancestor
5953045|NCT04698772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5953046|NCT04698772|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5953047|NCT04698772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5953048|NCT04698772|Anesthetics, General|anesthetics, general|mesh-ancestor
5953049|NCT04698772|Anesthetics|anesthetics|mesh-ancestor
5953050|NCT04698772|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5953051|NCT04698772|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5953052|NCT04698772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5953053|NCT04698772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969096|NCT04547049|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5969097|NCT04547049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5969098|NCT04547049|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5969099|NCT04547049|Antitubercular Agents|antitubercular agents|mesh-ancestor
5969100|NCT04547049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5971169|NCT04529954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5971170|NCT04529954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6681382|NCT01609439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681383|NCT01609439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6681384|NCT01609491|Phenylephrine|phenylephrine|mesh-list
6681385|NCT01609491|Oxymetazoline|oxymetazoline|mesh-list
6681386|NCT01609491|Norepinephrine|norepinephrine|mesh-list
6681387|NCT01609491|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6681388|NCT01609491|Mydriatics|mydriatics|mesh-ancestor
6681389|NCT01609491|Autonomic Agents|autonomic agents|mesh-ancestor
6681390|NCT01609491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6681391|NCT01609491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681392|NCT01609491|Sympathomimetics|sympathomimetics|mesh-ancestor
6681393|NCT01609491|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6681394|NCT01609491|Nasal Decongestants|nasal decongestants|mesh-ancestor
5971171|NCT04530045|Piperacillin|piperacillin|mesh-list
5971172|NCT04530045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5971173|NCT04530045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5971174|NCT04530136|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
5971175|NCT04530136|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5971176|NCT04530136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5971177|NCT04530136|Immunologic Factors|immunologic factors|mesh-ancestor
5971178|NCT04530136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971179|NCT04530006|Amantadine|amantadine|mesh-list
5971180|NCT04530006|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5971181|NCT04530006|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5971182|NCT04530006|Antiviral Agents|antiviral agents|mesh-ancestor
5971183|NCT04530006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5971184|NCT04530006|Dopamine Agents|dopamine agents|mesh-ancestor
5971185|NCT04530006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5971186|NCT04530006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971187|NCT04530006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971188|NCT04530006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6681395|NCT01609491|Respiratory System Agents|respiratory system agents|mesh-ancestor
5953054|NCT04698512|Sirolimus|sirolimus|mesh-list
5953055|NCT04698512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5953056|NCT04698512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5953057|NCT04698512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5953058|NCT04698512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5953059|NCT04698512|Antifungal Agents|antifungal agents|mesh-ancestor
5953060|NCT04698512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5953061|NCT04698512|Immunologic Factors|immunologic factors|mesh-ancestor
5953062|NCT04698512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953063|NCT04698226|Temazepam|temazepam|mesh-list
5953064|NCT04698226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5953065|NCT04698226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5953066|NCT04698226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953067|NCT04698226|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5953068|NCT04698226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5953069|NCT04698226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5953070|NCT04698226|GABA Modulators|gaba modulators|mesh-ancestor
5953071|NCT04698226|GABA Agents|gaba agents|mesh-ancestor
5953072|NCT04698226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5953073|NCT04698226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953074|NCT04698213|Avelumab|avelumab|mesh-list
5953075|NCT04698213|Axitinib|axitinib|mesh-list
5953076|NCT04698213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5953077|NCT04698213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5953078|NCT04698213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5953079|NCT04698213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5953080|NCT04698213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953081|NCT04698317|Mitogens|mitogens|mesh-list
5953082|NCT04698317|Mitosis Modulators|mitosis modulators|mesh-ancestor
5953083|NCT04698317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953084|NCT04697992|Vitamins|vitamins|mesh-list
5953085|NCT04697992|Ascorbic Acid|ascorbic acid|mesh-list
5953086|NCT04697992|Tranexamic Acid|tranexamic acid|mesh-list
5953087|NCT04697992|Micronutrients|micronutrients|mesh-ancestor
5953088|NCT04697992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953089|NCT04697992|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5953090|NCT04697992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5953091|NCT04697992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953092|NCT04697992|Hemostatics|hemostatics|mesh-ancestor
5953093|NCT04697992|Coagulants|coagulants|mesh-ancestor
5953094|NCT04697992|Antioxidants|antioxidants|mesh-ancestor
5953095|NCT04697992|Protective Agents|protective agents|mesh-ancestor
5953096|NCT04697940|Decitabine|decitabine|mesh-list
5953097|NCT04697940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5953098|NCT04697940|Antimetabolites|antimetabolites|mesh-ancestor
5953099|NCT04697940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953100|NCT04697940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5953101|NCT04697940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5953102|NCT04697862|Sildenafil Citrate|sildenafil citrate|mesh-list
5953103|NCT04697862|Vasodilator Agents|vasodilator agents|mesh-ancestor
5953104|NCT04697862|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5953105|NCT04697862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5953106|NCT04697862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5953107|NCT04697862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953108|NCT04697862|Urological Agents|urological agents|mesh-ancestor
5953109|NCT04697823|Hyaluronic Acid|hyaluronic acid|mesh-list
5953110|NCT04697823|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5953111|NCT04697823|Immunologic Factors|immunologic factors|mesh-ancestor
5953112|NCT04697823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953113|NCT04697823|Viscosupplements|viscosupplements|mesh-ancestor
5953114|NCT04697823|Protective Agents|protective agents|mesh-ancestor
5953115|NCT04697602|Colchicine|colchicine|mesh-list
5953116|NCT04697602|Febuxostat|febuxostat|mesh-list
5953117|NCT04697602|Gout Suppressants|gout suppressants|mesh-ancestor
5953118|NCT04697602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5953119|NCT04697602|Tubulin Modulators|tubulin modulators|mesh-ancestor
5953120|NCT04697602|Antimitotic Agents|antimitotic agents|mesh-ancestor
5953121|NCT04697602|Mitosis Modulators|mitosis modulators|mesh-ancestor
5953122|NCT04697602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953123|NCT04697602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5953124|NCT04697498|Anesthetics|anesthetics|mesh-list
5953125|NCT04697498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5953126|NCT04697498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953127|NCT04697641|Amoxicillin|amoxicillin|mesh-list
5953128|NCT04697641|Clarithromycin|clarithromycin|mesh-list
5953129|NCT04697641|Pantoprazole|pantoprazole|mesh-list
5953130|NCT04697641|Z 338|z 338|mesh-list
5953131|NCT04697641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5953132|NCT04697641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5953133|NCT04697641|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5953134|NCT04697641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5953135|NCT04697641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953136|NCT04697641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5953137|NCT04697641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5953138|NCT04697641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5953139|NCT04697641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5953140|NCT04697641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5953141|NCT04697641|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5953142|NCT04697641|Cholinergic Agents|cholinergic agents|mesh-ancestor
5953143|NCT04697641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5953144|NCT04697641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953145|NCT04697693|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5953146|NCT04697693|Citalopram|citalopram|mesh-list
5953147|NCT04697693|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5953148|NCT04697693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5953149|NCT04697693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5953150|NCT04697693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953151|NCT04697693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5953152|NCT04697693|Serotonin Agents|serotonin agents|mesh-ancestor
5953153|NCT04697693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953154|NCT04697693|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5953155|NCT04697693|Antidepressive Agents|antidepressive agents|mesh-ancestor
5953156|NCT04697693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5953157|NCT04697693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5953158|NCT04697693|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5953159|NCT04697693|Analgesics|analgesics|mesh-ancestor
5953160|NCT04697693|Sensory System Agents|sensory system agents|mesh-ancestor
5953161|NCT04697693|Dopamine Agents|dopamine agents|mesh-ancestor
5953162|NCT04697732|Anesthetics|anesthetics|mesh-list
5953163|NCT04697732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5953164|NCT04697732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953165|NCT04697576|Pembrolizumab|pembrolizumab|mesh-list
5953166|NCT04697576|Nivolumab|nivolumab|mesh-list
5953167|NCT04697576|Ipilimumab|ipilimumab|mesh-list
5953168|NCT04697576|Vaccines|vaccines|mesh-list
5953169|NCT04697576|Immunologic Factors|immunologic factors|mesh-ancestor
5953170|NCT04697576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953171|NCT04697576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5953172|NCT04697576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5953173|NCT04697576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5953174|NCT04697576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953175|NCT04697537|Dexmedetomidine|dexmedetomidine|mesh-list
5953176|NCT04697537|Ropivacaine|ropivacaine|mesh-list
5953177|NCT04697537|Anesthetics|anesthetics|mesh-ancestor
5953178|NCT04697537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6681396|NCT01609491|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6681397|NCT01609491|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6681398|NCT01609491|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6681399|NCT01609491|Adrenergic Agents|adrenergic agents|mesh-ancestor
6681400|NCT01609491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6681401|NCT01609491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681402|NCT01609491|Protective Agents|protective agents|mesh-ancestor
6779936|NCT02181543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6779937|NCT02181543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779938|NCT02181621|Cadexomer iodine|cadexomer iodine|mesh-list
6779939|NCT02181621|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6779940|NCT02181621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6779941|NCT02181920|Dipyrone|dipyrone|mesh-list
6779942|NCT02181920|Diclofenac|diclofenac|mesh-list
6779943|NCT02181920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6779944|NCT02181920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6779945|NCT02181920|Analgesics|analgesics|mesh-ancestor
6779946|NCT02181920|Sensory System Agents|sensory system agents|mesh-ancestor
6779947|NCT02181920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6779948|NCT02181920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779949|NCT02181920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6779950|NCT02181920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6779951|NCT02181920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6779952|NCT02181920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5953179|NCT04697537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953180|NCT04697537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5953181|NCT04697537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5953182|NCT04697537|Analgesics|analgesics|mesh-ancestor
5953183|NCT04697537|Sensory System Agents|sensory system agents|mesh-ancestor
5953184|NCT04697537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5953185|NCT04697537|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5953186|NCT04697537|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5953187|NCT04697537|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5953188|NCT04697537|Adrenergic Agents|adrenergic agents|mesh-ancestor
5953189|NCT04697537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5953190|NCT04697537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953191|NCT04697537|Anesthetics, Local|anesthetics, local|mesh-ancestor
5953192|NCT04697719|Aspirin|aspirin|mesh-list
5953193|NCT04697719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5953194|NCT04697719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5953195|NCT04697719|Analgesics|analgesics|mesh-ancestor
5953196|NCT04697719|Sensory System Agents|sensory system agents|mesh-ancestor
5953197|NCT04697719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5953198|NCT04697719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953199|NCT04697719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5953200|NCT04697719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5953201|NCT04697719|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5953202|NCT04697719|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5953203|NCT04697719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953204|NCT04697719|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5953205|NCT04697719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5953206|NCT04697719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5953207|NCT04697719|Antipyretics|antipyretics|mesh-ancestor
5953208|NCT04697485|Eplerenone|eplerenone|mesh-list
5953209|NCT04697485|Bumetanide|bumetanide|mesh-list
5953210|NCT04697485|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5953211|NCT04697485|Hormone Antagonists|hormone antagonists|mesh-ancestor
5953212|NCT04697485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5953213|NCT04697485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953214|NCT04697485|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5953215|NCT04697485|Diuretics|diuretics|mesh-ancestor
5953216|NCT04697485|Natriuretic Agents|natriuretic agents|mesh-ancestor
5953217|NCT04697485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5953218|NCT04697485|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5953219|NCT04697485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5953220|NCT04697485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953221|NCT04697745|Dexamethasone|dexamethasone|mesh-list
5953222|NCT04697745|Dexmedetomidine|dexmedetomidine|mesh-list
5953223|NCT04697745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5953224|NCT04697745|Antiemetics|antiemetics|mesh-ancestor
5953225|NCT04697745|Autonomic Agents|autonomic agents|mesh-ancestor
5953226|NCT04697745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5953227|NCT04697745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953228|NCT04697745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5953229|NCT04697745|Glucocorticoids|glucocorticoids|mesh-ancestor
5953230|NCT04697745|Hormones|hormones|mesh-ancestor
5953231|NCT04697745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5953232|NCT04697745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5953233|NCT04697745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5953234|NCT04697745|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5953235|NCT04697745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5953236|NCT04697745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5953237|NCT04697745|Analgesics|analgesics|mesh-ancestor
5953238|NCT04697745|Sensory System Agents|sensory system agents|mesh-ancestor
5953239|NCT04697745|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5953240|NCT04697745|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5953241|NCT04697745|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5953242|NCT04697745|Adrenergic Agents|adrenergic agents|mesh-ancestor
5953243|NCT04697745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5953244|NCT04697745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953245|NCT04697511|Midazolam|midazolam|mesh-list
5953246|NCT04697511|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5953247|NCT04697511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5953248|NCT04697511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5953249|NCT04697511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953250|NCT04697511|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5953251|NCT04697511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6681403|NCT01609517|Bupivacaine|bupivacaine|mesh-list
5953252|NCT04697511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5953253|NCT04697511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5953254|NCT04697511|Anesthetics, General|anesthetics, general|mesh-ancestor
5953255|NCT04697511|Anesthetics|anesthetics|mesh-ancestor
5953256|NCT04697511|GABA Modulators|gaba modulators|mesh-ancestor
5953257|NCT04697511|GABA Agents|gaba agents|mesh-ancestor
5953258|NCT04697511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5953259|NCT04697511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953260|NCT04697355|Beta Carotene|beta carotene|mesh-list
5953261|NCT04697355|Naringenin|naringenin|mesh-list
5953262|NCT04697355|Carotenoids|carotenoids|mesh-list
5953263|NCT04697355|Antioxidants|antioxidants|mesh-ancestor
5953264|NCT04697355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953265|NCT04697355|Protective Agents|protective agents|mesh-ancestor
5953266|NCT04697355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953267|NCT04697355|Provitamins|provitamins|mesh-ancestor
5953268|NCT04697355|Vitamins|vitamins|mesh-ancestor
5953269|NCT04697355|Micronutrients|micronutrients|mesh-ancestor
5953270|NCT04697355|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5953271|NCT04697355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5953272|NCT04697355|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5953273|NCT04697355|Hormone Antagonists|hormone antagonists|mesh-ancestor
5953274|NCT04697355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5953275|NCT04697277|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5953276|NCT04697277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5953277|NCT04697329|Levobupivacaine|levobupivacaine|mesh-list
5953278|NCT04697329|Anesthetics, Local|anesthetics, local|mesh-ancestor
5953279|NCT04697329|Anesthetics|anesthetics|mesh-ancestor
5953280|NCT04697329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5953281|NCT04697329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953282|NCT04697329|Sensory System Agents|sensory system agents|mesh-ancestor
5953283|NCT04697329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5953284|NCT04697017|Salicylic Acid|salicylic acid|mesh-list
5953285|NCT04697017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5953286|NCT04697017|Antifungal Agents|antifungal agents|mesh-ancestor
5953287|NCT04697017|Keratolytic Agents|keratolytic agents|mesh-ancestor
5953288|NCT04697017|Dermatologic Agents|dermatologic agents|mesh-ancestor
5953289|NCT04696939|Carboplatin|carboplatin|mesh-list
5953290|NCT04696939|Etoposide|etoposide|mesh-list
5953291|NCT04696939|Atezolizumab|atezolizumab|mesh-list
5953292|NCT04696939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5953293|NCT04696939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5953294|NCT04696939|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5953295|NCT04696939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5953296|NCT04696939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5953297|NCT04696939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953298|NCT04697186|Amoxicillin|amoxicillin|mesh-list
5953299|NCT04697186|Clarithromycin|clarithromycin|mesh-list
5953300|NCT04697186|Rabeprazole|rabeprazole|mesh-list
5953301|NCT04697186|Bismuth|bismuth|mesh-list
5953302|NCT04697186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5953303|NCT04697186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5953304|NCT04697186|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5953305|NCT04697186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5953306|NCT04697186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953307|NCT04697186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5953308|NCT04697186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5953309|NCT04697186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5953310|NCT04697186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5953311|NCT04697186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5953312|NCT04697186|Antacids|antacids|mesh-ancestor
5953313|NCT04696848|Durvalumab|durvalumab|mesh-list
5953314|NCT04696848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5953315|NCT04696848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5953316|NCT04696666|Hyaluronic Acid|hyaluronic acid|mesh-list
5953317|NCT04696666|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5953318|NCT04696666|Immunologic Factors|immunologic factors|mesh-ancestor
5953319|NCT04696666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953320|NCT04696666|Viscosupplements|viscosupplements|mesh-ancestor
5953321|NCT04696666|Protective Agents|protective agents|mesh-ancestor
5969101|NCT04546672|Neostigmine|neostigmine|mesh-list
5969102|NCT04546672|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5969103|NCT04546672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5969104|NCT04546672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969105|NCT04546672|Cholinergic Agents|cholinergic agents|mesh-ancestor
5969106|NCT04546672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5969107|NCT04546672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953322|NCT04696783|Esomeprazole|esomeprazole|mesh-list
5953323|NCT04696783|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5953324|NCT04696783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5953325|NCT04696783|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5953326|NCT04696783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5953327|NCT04696783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953328|NCT04696523|Xenon|xenon|mesh-list
5953329|NCT04696523|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5953330|NCT04696523|Anesthetics, General|anesthetics, general|mesh-ancestor
5953331|NCT04696523|Anesthetics|anesthetics|mesh-ancestor
5953332|NCT04696523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5953333|NCT04696523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953334|NCT04696757|Capecitabine|capecitabine|mesh-list
5953335|NCT04696757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5953336|NCT04696757|Antimetabolites|antimetabolites|mesh-ancestor
5953337|NCT04696757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953338|NCT04696757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5953339|NCT04696224|Tranexamic Acid|tranexamic acid|mesh-list
5953340|NCT04696224|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5953341|NCT04696224|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5953342|NCT04696224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953343|NCT04696224|Hemostatics|hemostatics|mesh-ancestor
5953344|NCT04696224|Coagulants|coagulants|mesh-ancestor
5953345|NCT04696380|Nicotine|nicotine|mesh-list
5953346|NCT04696380|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5953347|NCT04696380|Autonomic Agents|autonomic agents|mesh-ancestor
5953348|NCT04696380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5953349|NCT04696380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953350|NCT04696380|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5953351|NCT04696380|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5953352|NCT04696380|Cholinergic Agents|cholinergic agents|mesh-ancestor
5953353|NCT04696380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5953354|NCT04696380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953355|NCT04696250|Antineoplastic Agents|antineoplastic agents|mesh-list
5953356|NCT04696536|Listerine|listerine|mesh-list
5953357|NCT04696536|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5953358|NCT04696536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5953359|NCT04696185|Dapagliflozin|dapagliflozin|mesh-list
5953360|NCT04696185|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5953361|NCT04696185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953362|NCT04696185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5953363|NCT04696185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953364|NCT04696042|Lanreotide|lanreotide|mesh-list
5953365|NCT04696042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5953366|NCT04696029|Eflornithine|eflornithine|mesh-list
5953367|NCT04696029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5953368|NCT04696029|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5953369|NCT04696029|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5953370|NCT04696029|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5953371|NCT04696029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5953372|NCT04696029|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
5953373|NCT04696029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5953374|NCT04696029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953375|NCT04695925|Carboplatin|carboplatin|mesh-list
5953376|NCT04695925|Pemetrexed|pemetrexed|mesh-list
5953377|NCT04695925|Osimertinib|osimertinib|mesh-list
5953378|NCT04695925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5953379|NCT04695925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5953380|NCT04695925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953381|NCT04695925|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5953382|NCT04695925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5953383|NCT04695925|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5953384|NCT04696120|Apixaban|apixaban|mesh-list
5953385|NCT04696120|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5953386|NCT04696120|Antithrombins|antithrombins|mesh-ancestor
5953387|NCT04696120|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5953388|NCT04696120|Protease Inhibitors|protease inhibitors|mesh-ancestor
5953389|NCT04696120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5953390|NCT04696120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953391|NCT04696120|Anticoagulants|anticoagulants|mesh-ancestor
5953392|NCT04695613|Magnesium Sulfate|magnesium sulfate|mesh-list
5953393|NCT04695613|Analgesics|analgesics|mesh-ancestor
5953394|NCT04695613|Sensory System Agents|sensory system agents|mesh-ancestor
5953395|NCT04695613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5953396|NCT04695613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953397|NCT04695613|Anesthetics|anesthetics|mesh-ancestor
5953398|NCT04695613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5953399|NCT04695613|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5953400|NCT04695613|Anticonvulsants|anticonvulsants|mesh-ancestor
5953401|NCT04695613|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5953402|NCT04695613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5953403|NCT04695613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953404|NCT04695613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5953405|NCT04695613|Tocolytic Agents|tocolytic agents|mesh-ancestor
5953406|NCT04695613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5953407|NCT04695600|Botulinum Toxins|botulinum toxins|mesh-list
5953408|NCT04695600|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5953409|NCT04695600|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5953410|NCT04695600|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5953411|NCT04695600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5953412|NCT04695600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953413|NCT04695600|Cholinergic Agents|cholinergic agents|mesh-ancestor
5953414|NCT04695600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5953415|NCT04695600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953416|NCT04695600|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5953417|NCT04695600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5953418|NCT04695483|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5953419|NCT04695483|Hormones|hormones|mesh-ancestor
5953420|NCT04695483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5953421|NCT04695483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953422|NCT04695509|Propofol|propofol|mesh-list
5953423|NCT04695509|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5953424|NCT04695509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5953425|NCT04695509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953426|NCT04695509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5953427|NCT04695509|Anesthetics, General|anesthetics, general|mesh-ancestor
5953428|NCT04695509|Anesthetics|anesthetics|mesh-ancestor
5953429|NCT04695769|Ribavirin|ribavirin|mesh-list
5953430|NCT04695769|Sofosbuvir|sofosbuvir|mesh-list
5953431|NCT04695769|Velpatasvir|velpatasvir|mesh-list
5953432|NCT04695769|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
5953433|NCT04695769|Antimetabolites|antimetabolites|mesh-ancestor
5953434|NCT04695769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953435|NCT04695769|Antiviral Agents|antiviral agents|mesh-ancestor
5953436|NCT04695769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5953437|NCT04695704|Montelukast|montelukast|mesh-list
5953438|NCT04695704|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5953439|NCT04695704|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5953440|NCT04695704|Respiratory System Agents|respiratory system agents|mesh-ancestor
5953441|NCT04695704|Hormone Antagonists|hormone antagonists|mesh-ancestor
5953442|NCT04695704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5953443|NCT04695704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953444|NCT04695704|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5953445|NCT04695704|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5953446|NCT04695704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953447|NCT04695197|Artesunate|artesunate|mesh-list
5953448|NCT04695197|Lumefantrine|lumefantrine|mesh-list
5953449|NCT04695197|Artemether|artemether|mesh-list
5953450|NCT04695197|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
5953451|NCT04695197|Pyronaridine|pyronaridine|mesh-list
5953452|NCT04695197|Antimalarials|antimalarials|mesh-ancestor
5953453|NCT04695197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5953454|NCT04695197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5953455|NCT04695197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5953456|NCT04695197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5953457|NCT04695197|Antiviral Agents|antiviral agents|mesh-ancestor
5953458|NCT04695197|Schistosomicides|schistosomicides|mesh-ancestor
5953459|NCT04695197|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5953460|NCT04695197|Anthelmintics|anthelmintics|mesh-ancestor
5953461|NCT04695080|Cladribine|cladribine|mesh-list
5953462|NCT04695080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5953463|NCT04695080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5953464|NCT04695080|Immunologic Factors|immunologic factors|mesh-ancestor
5953465|NCT04695080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953466|NCT04695340|Psyllium|psyllium|mesh-list
5953467|NCT04695340|Cathartics|cathartics|mesh-ancestor
5953468|NCT04695340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5969108|NCT04546672|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5969109|NCT04546672|Autonomic Agents|autonomic agents|mesh-ancestor
5969110|NCT04546672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6681404|NCT01609517|Anesthetics|anesthetics|mesh-list
5953469|NCT04695223|Arsenic Trioxide|arsenic trioxide|mesh-list
5953470|NCT04695223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5953471|NCT04694612|Remdesivir|remdesivir|mesh-list
5953472|NCT04694612|Favipiravir|favipiravir|mesh-list
5953473|NCT04694612|Antimetabolites|antimetabolites|mesh-ancestor
5953474|NCT04694612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953475|NCT04694612|Antiviral Agents|antiviral agents|mesh-ancestor
5953476|NCT04694612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5953477|NCT04694586|Rifampin|rifampin|mesh-list
5953478|NCT04694586|Isoniazid|isoniazid|mesh-list
5953479|NCT04694586|Pyrazinamide|pyrazinamide|mesh-list
5953480|NCT04694586|Ethambutol|ethambutol|mesh-list
5953481|NCT04694586|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5953482|NCT04694586|Antitubercular Agents|antitubercular agents|mesh-ancestor
5953483|NCT04694586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5953484|NCT04694586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5953485|NCT04694586|Leprostatic Agents|leprostatic agents|mesh-ancestor
5953486|NCT04694586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5953487|NCT04694586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5953488|NCT04694586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953489|NCT04694586|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5953490|NCT04694586|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5953491|NCT04694586|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5953492|NCT04694586|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5953493|NCT04694586|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5953494|NCT04694586|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5953495|NCT04694586|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5953496|NCT04694586|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5953497|NCT04694586|Antimetabolites|antimetabolites|mesh-ancestor
5953498|NCT04694586|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5953499|NCT04694846|Bupropion|bupropion|mesh-list
5953500|NCT04694846|Nicotine|nicotine|mesh-list
5953501|NCT04694846|Varenicline|varenicline|mesh-list
5953502|NCT04694846|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5953503|NCT04694846|Autonomic Agents|autonomic agents|mesh-ancestor
5953504|NCT04694846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5953505|NCT04694846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953506|NCT04694846|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5953507|NCT04694846|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5953508|NCT04694846|Cholinergic Agents|cholinergic agents|mesh-ancestor
5953509|NCT04694846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5953510|NCT04694846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953511|NCT04694846|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5953512|NCT04694846|Antidepressive Agents|antidepressive agents|mesh-ancestor
5953513|NCT04694846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5953514|NCT04694846|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5953515|NCT04694846|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5953516|NCT04694846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5953517|NCT04694846|Dopamine Agents|dopamine agents|mesh-ancestor
5953518|NCT04694846|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5953519|NCT04694846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5953520|NCT04694846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5953521|NCT04694677|Misoprostol|misoprostol|mesh-list
5953522|NCT04694677|Tranexamic Acid|tranexamic acid|mesh-list
5953523|NCT04694677|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5953524|NCT04694677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5953525|NCT04694677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953526|NCT04694677|Hemostatics|hemostatics|mesh-ancestor
5953527|NCT04694677|Coagulants|coagulants|mesh-ancestor
5953528|NCT04694677|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5953529|NCT04694677|Abortifacient Agents|abortifacient agents|mesh-ancestor
5953530|NCT04694677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5953531|NCT04694677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953532|NCT04694677|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5953533|NCT04694677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5953534|NCT04694677|Oxytocics|oxytocics|mesh-ancestor
5953535|NCT04694183|Paclitaxel|paclitaxel|mesh-list
5953536|NCT04694183|Antibodies|antibodies|mesh-list
5953537|NCT04694183|Immunoglobulins|immunoglobulins|mesh-list
5953538|NCT04694183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5953539|NCT04694183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5953540|NCT04694183|Tubulin Modulators|tubulin modulators|mesh-ancestor
5953541|NCT04694183|Antimitotic Agents|antimitotic agents|mesh-ancestor
5953542|NCT04694183|Mitosis Modulators|mitosis modulators|mesh-ancestor
5953543|NCT04694183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953544|NCT04694183|Immunologic Factors|immunologic factors|mesh-ancestor
5953545|NCT04694183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953546|NCT04694404|Oxaliplatin|oxaliplatin|mesh-list
5953547|NCT04694404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5953548|NCT04694092|Landiolol|landiolol|mesh-list
5953549|NCT04694092|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5953550|NCT04694092|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5953551|NCT04694092|Adrenergic Agents|adrenergic agents|mesh-ancestor
5953552|NCT04694092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5953553|NCT04694092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953554|NCT04694092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953555|NCT04694092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5953556|NCT04694300|Acetaminophen|acetaminophen|mesh-list
5953557|NCT04694300|Naproxen|naproxen|mesh-list
5953558|NCT04694300|Tramadol|tramadol|mesh-list
5953559|NCT04694300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5953560|NCT04694300|Analgesics|analgesics|mesh-ancestor
5953561|NCT04694300|Sensory System Agents|sensory system agents|mesh-ancestor
5953562|NCT04694300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5953563|NCT04694300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953564|NCT04694300|Antipyretics|antipyretics|mesh-ancestor
5953565|NCT04694300|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5953566|NCT04694300|Narcotics|narcotics|mesh-ancestor
5953567|NCT04694300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5953568|NCT04694300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5953569|NCT04694300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5953570|NCT04694300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5953571|NCT04694300|Gout Suppressants|gout suppressants|mesh-ancestor
5953572|NCT04694300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5953573|NCT04694300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5953574|NCT04694300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953575|NCT04694105|Dexamethasone|dexamethasone|mesh-list
5953576|NCT04694105|Dexmedetomidine|dexmedetomidine|mesh-list
5953577|NCT04694105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5953578|NCT04694105|Antiemetics|antiemetics|mesh-ancestor
5953579|NCT04694105|Autonomic Agents|autonomic agents|mesh-ancestor
5953580|NCT04694105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5953581|NCT04694105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953582|NCT04694105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5953583|NCT04694105|Glucocorticoids|glucocorticoids|mesh-ancestor
5953584|NCT04694105|Hormones|hormones|mesh-ancestor
5953585|NCT04694105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5953586|NCT04694105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5953587|NCT04694105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5953588|NCT04694105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5953589|NCT04694105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5953590|NCT04694105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5953591|NCT04694105|Analgesics|analgesics|mesh-ancestor
5953592|NCT04694105|Sensory System Agents|sensory system agents|mesh-ancestor
5953593|NCT04694105|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5953594|NCT04694105|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5953595|NCT04694105|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5953596|NCT04694105|Adrenergic Agents|adrenergic agents|mesh-ancestor
5953597|NCT04694105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5953598|NCT04694105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953599|NCT04693715|RNS60|rns60|mesh-list
5953600|NCT04693715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5953601|NCT04693715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5953602|NCT04693715|Analgesics|analgesics|mesh-ancestor
5953603|NCT04693715|Sensory System Agents|sensory system agents|mesh-ancestor
5953604|NCT04693715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5953605|NCT04693715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953606|NCT04693715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5953607|NCT04693715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5953608|NCT04693715|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5953609|NCT04693910|Hormones|hormones|mesh-list
5953610|NCT04693910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5953611|NCT04693910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953612|NCT04693897|Solifenacin Succinate|solifenacin succinate|mesh-list
5953613|NCT04693897|Mirabegron|mirabegron|mesh-list
5953614|NCT04693897|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5953615|NCT04693897|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5953616|NCT04693897|Cholinergic Agents|cholinergic agents|mesh-ancestor
5953617|NCT04693897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5953618|NCT04693897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969111|NCT04546373|Niraparib|niraparib|mesh-list
5953619|NCT04693897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953620|NCT04693897|Urological Agents|urological agents|mesh-ancestor
5953621|NCT04693897|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
5953622|NCT04693897|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5953623|NCT04693897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5953624|NCT04693897|Adrenergic Agents|adrenergic agents|mesh-ancestor
5953625|NCT04693962|Mitogens|mitogens|mesh-list
5953626|NCT04693962|Mitosis Modulators|mitosis modulators|mesh-ancestor
5953627|NCT04693962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953628|NCT04693169|Choline|choline|mesh-list
5953629|NCT04693169|Lipotropic Agents|lipotropic agents|mesh-ancestor
5953630|NCT04693169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5953631|NCT04693169|Antimetabolites|antimetabolites|mesh-ancestor
5953632|NCT04693169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953633|NCT04693169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5953634|NCT04693169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5953635|NCT04693169|Nootropic Agents|nootropic agents|mesh-ancestor
5969112|NCT04546373|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5969113|NCT04546373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5969114|NCT04546373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969115|NCT04546373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5969116|NCT04546282|Osimertinib|osimertinib|mesh-list
5969117|NCT04546282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5969118|NCT04546282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5969119|NCT04546282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5969120|NCT04546282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969121|NCT04546347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5969122|NCT04546334|Magnesium Sulfate|magnesium sulfate|mesh-list
5969123|NCT04546334|Analgesics|analgesics|mesh-ancestor
5969124|NCT04546334|Sensory System Agents|sensory system agents|mesh-ancestor
5969125|NCT04546334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5969126|NCT04546334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969127|NCT04546334|Anesthetics|anesthetics|mesh-ancestor
5969128|NCT04546334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5969129|NCT04546334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5969130|NCT04546334|Anticonvulsants|anticonvulsants|mesh-ancestor
5969131|NCT04546334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5969132|NCT04546334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5969133|NCT04546334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969134|NCT04546334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5969135|NCT04546334|Tocolytic Agents|tocolytic agents|mesh-ancestor
5969136|NCT04546334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5969137|NCT04546256|Fluticasone|fluticasone|mesh-list
5969138|NCT04546256|Xhance|xhance|mesh-list
5969139|NCT04546256|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
5969140|NCT04546256|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
5969141|NCT04546256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5969142|NCT04546256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5969143|NCT04546256|Autonomic Agents|autonomic agents|mesh-ancestor
5969144|NCT04546256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5969145|NCT04546256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969146|NCT04546256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5969147|NCT04546256|Respiratory System Agents|respiratory system agents|mesh-ancestor
5969148|NCT04546256|Dermatologic Agents|dermatologic agents|mesh-ancestor
5969149|NCT04546256|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5969150|NCT04546256|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5969151|NCT04546256|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5969152|NCT04546256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5969153|NCT04546256|Adrenergic Agents|adrenergic agents|mesh-ancestor
5969154|NCT04546256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5969155|NCT04546256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969156|NCT04546256|Glucocorticoids|glucocorticoids|mesh-ancestor
5969157|NCT04546256|Hormones|hormones|mesh-ancestor
5969158|NCT04546256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5969159|NCT04546256|Sympathomimetics|sympathomimetics|mesh-ancestor
5969160|NCT04546074|Pembrolizumab|pembrolizumab|mesh-list
5969161|NCT04546074|Imatinib Mesylate|imatinib mesylate|mesh-list
5969162|NCT04546074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5969163|NCT04546074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5969164|NCT04546074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5969165|NCT04546074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5969166|NCT04546074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969167|NCT04546113|Ropivacaine|ropivacaine|mesh-list
5953636|NCT04693156|Bupivacaine|bupivacaine|mesh-list
5953637|NCT04693156|Prilocaine|prilocaine|mesh-list
5953638|NCT04693156|Anesthetics, Local|anesthetics, local|mesh-ancestor
5953639|NCT04693156|Anesthetics|anesthetics|mesh-ancestor
5953640|NCT04693156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5953641|NCT04693156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953642|NCT04693156|Sensory System Agents|sensory system agents|mesh-ancestor
5953643|NCT04693156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5953644|NCT04693312|Methylprednisolone|methylprednisolone|mesh-list
5953645|NCT04693312|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5953646|NCT04693312|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5953647|NCT04693312|Prednisolone|prednisolone|mesh-list
5953648|NCT04693312|Prednisolone acetate|prednisolone acetate|mesh-list
5953649|NCT04693312|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5953650|NCT04693312|Prednisolone phosphate|prednisolone phosphate|mesh-list
5953651|NCT04693312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5953652|NCT04693312|Antiemetics|antiemetics|mesh-ancestor
5953653|NCT04693312|Autonomic Agents|autonomic agents|mesh-ancestor
5953654|NCT04693312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5953655|NCT04693312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953656|NCT04693312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5953657|NCT04693312|Glucocorticoids|glucocorticoids|mesh-ancestor
5953658|NCT04693312|Hormones|hormones|mesh-ancestor
5953659|NCT04693312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5953660|NCT04693312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5953661|NCT04693312|Protective Agents|protective agents|mesh-ancestor
5953662|NCT04693312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5953663|NCT04693312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5953664|NCT04693026|Remdesivir|remdesivir|mesh-list
5953665|NCT04693026|Antimetabolites|antimetabolites|mesh-ancestor
5953666|NCT04693026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953667|NCT04693026|Antiviral Agents|antiviral agents|mesh-ancestor
5953668|NCT04693026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5953669|NCT04692831|Pertuzumab|pertuzumab|mesh-list
5953670|NCT04692831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5953671|NCT04692831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5953672|NCT04692623|Insulin|insulin|mesh-list
5953673|NCT04692623|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5953674|NCT04692623|Moxifloxacin|moxifloxacin|mesh-list
5953675|NCT04692623|Gemifloxacin|gemifloxacin|mesh-list
5953676|NCT04692623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5953677|NCT04692623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953678|NCT04692623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5953679|NCT04692623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5953680|NCT04692623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5953681|NCT04692623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5953682|NCT04692623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5953683|NCT04692623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953684|NCT04692623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5953685|NCT04692558|Hyaluronic Acid|hyaluronic acid|mesh-list
5953686|NCT04692558|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5953687|NCT04692558|Immunologic Factors|immunologic factors|mesh-ancestor
5953688|NCT04692558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953689|NCT04692558|Viscosupplements|viscosupplements|mesh-ancestor
5953690|NCT04692558|Protective Agents|protective agents|mesh-ancestor
5953691|NCT04692844|Propranolol|propranolol|mesh-list
5953692|NCT04692844|Primidone|primidone|mesh-list
5953693|NCT04692844|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5953694|NCT04692844|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5953695|NCT04692844|Adrenergic Agents|adrenergic agents|mesh-ancestor
5953696|NCT04692844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5953697|NCT04692844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953698|NCT04692844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953699|NCT04692844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5953700|NCT04692844|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5953701|NCT04692844|Vasodilator Agents|vasodilator agents|mesh-ancestor
5953702|NCT04692844|Anticonvulsants|anticonvulsants|mesh-ancestor
5953703|NCT04692844|GABA Modulators|gaba modulators|mesh-ancestor
5953704|NCT04692844|GABA Agents|gaba agents|mesh-ancestor
5953705|NCT04692896|Lidocaine|lidocaine|mesh-list
5953706|NCT04692896|Anesthetics, Local|anesthetics, local|mesh-ancestor
5953707|NCT04692896|Anesthetics|anesthetics|mesh-ancestor
5953708|NCT04692896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5953709|NCT04692896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953710|NCT04692896|Sensory System Agents|sensory system agents|mesh-ancestor
5953711|NCT04692896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5953712|NCT04692896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5953713|NCT04692896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5953714|NCT04692896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5953715|NCT04692896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5953716|NCT04692896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953717|NCT04692740|Chlorambucil|chlorambucil|mesh-list
5953718|NCT04692740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5953719|NCT04692740|Alkylating Agents|alkylating agents|mesh-ancestor
5953720|NCT04692740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953721|NCT04692740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5953722|NCT04692285|Zolpidem|zolpidem|mesh-list
5953723|NCT04692285|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5953724|NCT04692285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5953725|NCT04692285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5953726|NCT04692285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953727|NCT04692285|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
5953728|NCT04692285|GABA Agonists|gaba agonists|mesh-ancestor
5953729|NCT04692285|GABA Agents|gaba agents|mesh-ancestor
5953730|NCT04692285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5953731|NCT04692285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953732|NCT04692376|Cyclosporine|cyclosporine|mesh-list
5953733|NCT04692376|Cyclosporins|cyclosporins|mesh-list
5953734|NCT04692376|Glucocorticoids|glucocorticoids|mesh-list
5953735|NCT04692376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5953736|NCT04692376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953737|NCT04692376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5953738|NCT04692376|Immunologic Factors|immunologic factors|mesh-ancestor
5953739|NCT04692376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953740|NCT04692376|Antifungal Agents|antifungal agents|mesh-ancestor
5953741|NCT04692376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5953742|NCT04692376|Dermatologic Agents|dermatologic agents|mesh-ancestor
5953743|NCT04692376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5953744|NCT04692376|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5953745|NCT04692376|Hormones|hormones|mesh-ancestor
5953746|NCT04692376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5953747|NCT04692415|Insulin Glargine|insulin glargine|mesh-list
5953748|NCT04692415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5953749|NCT04692415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953750|NCT04692051|Gemcitabine|gemcitabine|mesh-list
5953751|NCT04692051|Paclitaxel|paclitaxel|mesh-list
5953752|NCT04692051|Cisplatin|cisplatin|mesh-list
5953753|NCT04692051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5953754|NCT04692051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5953755|NCT04692051|Tubulin Modulators|tubulin modulators|mesh-ancestor
5953756|NCT04692051|Antimitotic Agents|antimitotic agents|mesh-ancestor
5953757|NCT04692051|Mitosis Modulators|mitosis modulators|mesh-ancestor
5953758|NCT04692051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953759|NCT04692051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5953760|NCT04692051|Antimetabolites|antimetabolites|mesh-ancestor
5953761|NCT04692051|Antiviral Agents|antiviral agents|mesh-ancestor
5953762|NCT04692051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5953763|NCT04692051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5953764|NCT04692051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5953765|NCT04692051|Immunologic Factors|immunologic factors|mesh-ancestor
5953766|NCT04692051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953767|NCT04691765|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5953768|NCT04691765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5953769|NCT04691687|Furosemide|furosemide|mesh-list
5953770|NCT04691687|Diuretics|diuretics|mesh-ancestor
5953771|NCT04691687|Natriuretic Agents|natriuretic agents|mesh-ancestor
5953772|NCT04691687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953773|NCT04691687|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5953774|NCT04691687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5953775|NCT04691687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953776|NCT04691726|Dipyrone|dipyrone|mesh-list
5953777|NCT04691726|Lidocaine|lidocaine|mesh-list
5953778|NCT04691726|Morphine|morphine|mesh-list
5953779|NCT04691726|Anesthetics, Local|anesthetics, local|mesh-ancestor
5953780|NCT04691726|Anesthetics|anesthetics|mesh-ancestor
5953781|NCT04691726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5953782|NCT04691726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953783|NCT04691726|Sensory System Agents|sensory system agents|mesh-ancestor
5953784|NCT04691726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5953785|NCT04691726|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5953786|NCT04691726|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5953787|NCT04691726|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5953788|NCT04691726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5953789|NCT04691726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953790|NCT04691726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5953791|NCT04691726|Narcotics|narcotics|mesh-ancestor
5953792|NCT04691726|Analgesics|analgesics|mesh-ancestor
5953793|NCT04691726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5953794|NCT04691726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5953795|NCT04691726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5953796|NCT04691726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5953797|NCT04691726|Antipyretics|antipyretics|mesh-ancestor
5953798|NCT04691817|Atezolizumab|atezolizumab|mesh-list
5953799|NCT04691817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5953800|NCT04691856|Acetaminophen|acetaminophen|mesh-list
5953801|NCT04691856|Ibuprofen|ibuprofen|mesh-list
5953802|NCT04691856|Morphine|morphine|mesh-list
5953803|NCT04691856|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5953804|NCT04691856|Narcotics|narcotics|mesh-ancestor
5953805|NCT04691856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5953806|NCT04691856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953807|NCT04691856|Analgesics|analgesics|mesh-ancestor
5953808|NCT04691856|Sensory System Agents|sensory system agents|mesh-ancestor
5953809|NCT04691856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5953810|NCT04691856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5953811|NCT04691856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5953812|NCT04691856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5953813|NCT04691856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5953814|NCT04691856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5953815|NCT04691856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5953816|NCT04691856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953817|NCT04691856|Antipyretics|antipyretics|mesh-ancestor
5953818|NCT04691934|Anesthetics|anesthetics|mesh-list
5953819|NCT04691934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5953820|NCT04691934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969168|NCT04546113|Anesthetics, Local|anesthetics, local|mesh-ancestor
5969169|NCT04546113|Anesthetics|anesthetics|mesh-ancestor
5969170|NCT04546113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5969171|NCT04546113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969172|NCT04546113|Sensory System Agents|sensory system agents|mesh-ancestor
5969173|NCT04546113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5969174|NCT04546022|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5969175|NCT04545970|Sunscreening Agents|sunscreening agents|mesh-list
5969176|NCT04545970|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5969177|NCT04545970|Protective Agents|protective agents|mesh-ancestor
5969178|NCT04545970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969179|NCT04545970|Dermatologic Agents|dermatologic agents|mesh-ancestor
5969180|NCT04545931|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
5969181|NCT04545931|Hemostatics|hemostatics|mesh-ancestor
5969182|NCT04545931|Coagulants|coagulants|mesh-ancestor
5969183|NCT04545931|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5969184|NCT04545931|Natriuretic Agents|natriuretic agents|mesh-ancestor
5969185|NCT04545931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969186|NCT04545944|Midazolam|midazolam|mesh-list
5969187|NCT04545944|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5969188|NCT04545944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5969189|NCT04545944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5969190|NCT04545944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969191|NCT04545944|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5969192|NCT04545944|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5969193|NCT04545944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5969194|NCT04545944|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5969195|NCT04545944|Anesthetics, General|anesthetics, general|mesh-ancestor
5969196|NCT04545944|Anesthetics|anesthetics|mesh-ancestor
5969197|NCT04545944|GABA Modulators|gaba modulators|mesh-ancestor
5969198|NCT04545944|GABA Agents|gaba agents|mesh-ancestor
5969199|NCT04545944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5969200|NCT04545944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969201|NCT04545879|Allicin|allicin|mesh-list
5969202|NCT04545879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5969203|NCT04545879|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5969204|NCT04545879|Antimetabolites|antimetabolites|mesh-ancestor
5969205|NCT04545879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969206|NCT04545879|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5969207|NCT04545879|Antioxidants|antioxidants|mesh-ancestor
5969208|NCT04545879|Protective Agents|protective agents|mesh-ancestor
5969209|NCT04545879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953821|NCT04691375|Pembrolizumab|pembrolizumab|mesh-list
5953822|NCT04691375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5953823|NCT04691375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5953824|NCT04691362|Tranexamic Acid|tranexamic acid|mesh-list
5953825|NCT04691362|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5953826|NCT04691362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5953827|NCT04691362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953828|NCT04691362|Hemostatics|hemostatics|mesh-ancestor
5953829|NCT04691362|Coagulants|coagulants|mesh-ancestor
5953830|NCT04690920|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5953831|NCT04690920|Remdesivir|remdesivir|mesh-list
5953832|NCT04690920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5953833|NCT04690920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953834|NCT04690920|Antimetabolites|antimetabolites|mesh-ancestor
5953835|NCT04690920|Antiviral Agents|antiviral agents|mesh-ancestor
5953836|NCT04691076|Fentanyl|fentanyl|mesh-list
5953837|NCT04691076|Propofol|propofol|mesh-list
5953838|NCT04691076|Esketamine|esketamine|mesh-list
5953839|NCT04691076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5953840|NCT04691076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5953841|NCT04691076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953842|NCT04691076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5953843|NCT04691076|Anesthetics, General|anesthetics, general|mesh-ancestor
5953844|NCT04691076|Anesthetics|anesthetics|mesh-ancestor
5953845|NCT04691076|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5953846|NCT04691076|Narcotics|narcotics|mesh-ancestor
5953847|NCT04691076|Analgesics|analgesics|mesh-ancestor
5953848|NCT04691076|Sensory System Agents|sensory system agents|mesh-ancestor
5953849|NCT04691076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5953850|NCT04691076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5953851|NCT04691076|Antidepressive Agents|antidepressive agents|mesh-ancestor
5953852|NCT04691076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5953853|NCT04691063|Carboplatin|carboplatin|mesh-list
5953854|NCT04691063|Etoposide|etoposide|mesh-list
5953855|NCT04691063|Etoposide phosphate|etoposide phosphate|mesh-list
5953856|NCT04691063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5953857|NCT04691063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5953858|NCT04691063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5953859|NCT04691063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5953860|NCT04691063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5953861|NCT04691063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953862|NCT04690855|Atezolizumab|atezolizumab|mesh-list
5953863|NCT04690855|Talazoparib|talazoparib|mesh-list
5953864|NCT04690855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5953865|NCT04690855|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5953866|NCT04690855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5953867|NCT04690855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953868|NCT04690608|Triamcinolone|triamcinolone|mesh-list
5953869|NCT04690608|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5953870|NCT04690608|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5953871|NCT04690608|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5953872|NCT04690608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5953873|NCT04690608|Glucocorticoids|glucocorticoids|mesh-ancestor
5953874|NCT04690608|Hormones|hormones|mesh-ancestor
5953875|NCT04690608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5953876|NCT04690608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953877|NCT04690608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5953878|NCT04690608|Immunologic Factors|immunologic factors|mesh-ancestor
5953879|NCT04690608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5953880|NCT04690608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953881|NCT04690686|Paclitaxel|paclitaxel|mesh-list
5953882|NCT04690686|Atezolizumab|atezolizumab|mesh-list
5953883|NCT04690686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5953884|NCT04690686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5953885|NCT04690686|Tubulin Modulators|tubulin modulators|mesh-ancestor
5953886|NCT04690686|Antimitotic Agents|antimitotic agents|mesh-ancestor
5953887|NCT04690686|Mitosis Modulators|mitosis modulators|mesh-ancestor
5953888|NCT04690686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953889|NCT04690647|Dexamethasone|dexamethasone|mesh-list
5953890|NCT04690647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
5953891|NCT04690647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5953892|NCT04690647|Antiemetics|antiemetics|mesh-ancestor
5953893|NCT04690647|Autonomic Agents|autonomic agents|mesh-ancestor
5953894|NCT04690647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5953895|NCT04690647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953896|NCT04690647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5953897|NCT04690647|Glucocorticoids|glucocorticoids|mesh-ancestor
5953898|NCT04690647|Hormones|hormones|mesh-ancestor
5953899|NCT04690647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5953900|NCT04690647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5953901|NCT04690647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5953902|NCT04690647|Analgesics|analgesics|mesh-ancestor
5953903|NCT04690647|Sensory System Agents|sensory system agents|mesh-ancestor
5953904|NCT04690751|Cenobamate|cenobamate|mesh-list
5953905|NCT04690751|Anticonvulsants|anticonvulsants|mesh-ancestor
5953906|NCT04690556|Ranibizumab|ranibizumab|mesh-list
5953907|NCT04690556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5953908|NCT04690556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5953909|NCT04690556|Growth Substances|growth substances|mesh-ancestor
5953910|NCT04690556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953911|NCT04690556|Growth Inhibitors|growth inhibitors|mesh-ancestor
5953912|NCT04690556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5953913|NCT04690270|Sumatriptan|sumatriptan|mesh-list
5953914|NCT04690270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5953915|NCT04690270|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5953916|NCT04690270|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5953917|NCT04690270|Serotonin Agents|serotonin agents|mesh-ancestor
5953918|NCT04690270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5953919|NCT04690270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953920|NCT04690270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953921|NCT04690322|Factor VIII|factor viii|mesh-list
5953922|NCT04690322|BAX 855|bax 855|mesh-list
5953923|NCT04690322|Antibodies, Bispecific|antibodies, bispecific|mesh-list
5953924|NCT04690322|Coagulants|coagulants|mesh-ancestor
5953925|NCT04690322|Immunologic Factors|immunologic factors|mesh-ancestor
5953926|NCT04690322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953927|NCT04689958|Vitamin D|vitamin d|mesh-list
5953928|NCT04689958|Vitamins|vitamins|mesh-ancestor
5953929|NCT04689958|Micronutrients|micronutrients|mesh-ancestor
5953930|NCT04689958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953931|NCT04689958|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5953932|NCT04689919|Rivaroxaban|rivaroxaban|mesh-list
5953933|NCT04689919|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5953934|NCT04689919|Antithrombins|antithrombins|mesh-ancestor
5953935|NCT04689919|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5953936|NCT04689919|Protease Inhibitors|protease inhibitors|mesh-ancestor
5953937|NCT04689919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5953938|NCT04689919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953939|NCT04689919|Anticoagulants|anticoagulants|mesh-ancestor
5953940|NCT04690231|Etoposide|etoposide|mesh-list
5953941|NCT04690231|Etoposide phosphate|etoposide phosphate|mesh-list
5953942|NCT04690231|Apatinib|apatinib|mesh-list
5953943|NCT04690231|Ifosfamide|ifosfamide|mesh-list
5953944|NCT04690231|Isophosphamide mustard|isophosphamide mustard|mesh-list
5953945|NCT04690231|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5953946|NCT04690231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5953947|NCT04690231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5953948|NCT04690231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5953949|NCT04690231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5953950|NCT04690231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953951|NCT04690231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5953952|NCT04690231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5953953|NCT04690231|Alkylating Agents|alkylating agents|mesh-ancestor
5953954|NCT04689971|Vitamins|vitamins|mesh-list
5953955|NCT04689971|Vitamin B Complex|vitamin b complex|mesh-list
5953956|NCT04689971|Micronutrients|micronutrients|mesh-ancestor
5953957|NCT04689971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953958|NCT04690309|Insulin|insulin|mesh-list
5953959|NCT04690309|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5953960|NCT04690309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5953961|NCT04690309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969210|NCT04545879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5969211|NCT04545879|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5969212|NCT04545892|Capsaicin|capsaicin|mesh-list
5969213|NCT04545892|Antipruritics|antipruritics|mesh-ancestor
5969214|NCT04545892|Dermatologic Agents|dermatologic agents|mesh-ancestor
5969215|NCT04545892|Sensory System Agents|sensory system agents|mesh-ancestor
5969216|NCT04545892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5969217|NCT04545892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969218|NCT04545866|Budesonide|budesonide|mesh-list
5969219|NCT04545866|Poractant alfa|poractant alfa|mesh-list
5969220|NCT04545866|Pulmonary Surfactants|pulmonary surfactants|mesh-list
5969221|NCT04545866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5969222|NCT04545866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5969223|NCT04545866|Autonomic Agents|autonomic agents|mesh-ancestor
5953962|NCT04689815|Arsenic Trioxide|arsenic trioxide|mesh-list
5953963|NCT04689815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5953964|NCT04689893|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
5953965|NCT04689893|Chelating Agents|chelating agents|mesh-ancestor
5953966|NCT04689893|Sequestering Agents|sequestering agents|mesh-ancestor
5953967|NCT04689893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953968|NCT04689412|Resveratrol|resveratrol|mesh-list
5953969|NCT04689412|Antioxidants|antioxidants|mesh-ancestor
5953970|NCT04689412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953971|NCT04689412|Protective Agents|protective agents|mesh-ancestor
5953972|NCT04689412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953973|NCT04689412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5953974|NCT04689412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5953975|NCT04689191|Vaccines|vaccines|mesh-list
5953976|NCT04689191|Immunologic Factors|immunologic factors|mesh-ancestor
5953977|NCT04689191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953978|NCT04689347|Leucovorin|leucovorin|mesh-list
5953979|NCT04689347|Bevacizumab|bevacizumab|mesh-list
5953980|NCT04689347|Fluorouracil|fluorouracil|mesh-list
5953981|NCT04689347|Irinotecan|irinotecan|mesh-list
5953982|NCT04689347|Temozolomide|temozolomide|mesh-list
5953983|NCT04689347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5953984|NCT04689347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5953985|NCT04689347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5953986|NCT04689347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5953987|NCT04689347|Growth Substances|growth substances|mesh-ancestor
5953988|NCT04689347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5953989|NCT04689347|Growth Inhibitors|growth inhibitors|mesh-ancestor
5953990|NCT04689347|Antimetabolites|antimetabolites|mesh-ancestor
5953991|NCT04689347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5953992|NCT04689347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5953993|NCT04689347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5953994|NCT04689347|Immunologic Factors|immunologic factors|mesh-ancestor
5953995|NCT04689347|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5953996|NCT04689347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5953997|NCT04689347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5953998|NCT04689347|Antidotes|antidotes|mesh-ancestor
5953999|NCT04689347|Protective Agents|protective agents|mesh-ancestor
5954000|NCT04689347|Vitamin B Complex|vitamin b complex|mesh-ancestor
5954001|NCT04689347|Vitamins|vitamins|mesh-ancestor
5954002|NCT04689347|Micronutrients|micronutrients|mesh-ancestor
5954003|NCT04689347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5954004|NCT04689347|Alkylating Agents|alkylating agents|mesh-ancestor
5954005|NCT04689100|Leucovorin|leucovorin|mesh-list
5954006|NCT04689100|Fluorouracil|fluorouracil|mesh-list
5954007|NCT04689100|Oxaliplatin|oxaliplatin|mesh-list
5954008|NCT04689100|Irinotecan|irinotecan|mesh-list
5954009|NCT04689100|Calcium|calcium|mesh-list
5954010|NCT04689100|Levoleucovorin|levoleucovorin|mesh-list
5954011|NCT04689100|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5954012|NCT04689100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954013|NCT04689100|Antimetabolites|antimetabolites|mesh-ancestor
5954014|NCT04689100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954015|NCT04689100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5954016|NCT04689100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5954017|NCT04689100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5954018|NCT04689100|Immunologic Factors|immunologic factors|mesh-ancestor
5954019|NCT04689100|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5954020|NCT04689100|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5954021|NCT04689100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5954022|NCT04689100|Antidotes|antidotes|mesh-ancestor
5954023|NCT04689100|Protective Agents|protective agents|mesh-ancestor
5954024|NCT04689100|Vitamin B Complex|vitamin b complex|mesh-ancestor
5954025|NCT04689100|Vitamins|vitamins|mesh-ancestor
5954026|NCT04689100|Micronutrients|micronutrients|mesh-ancestor
5954027|NCT04689165|Vaccines|vaccines|mesh-list
5954028|NCT04689165|Immunologic Factors|immunologic factors|mesh-ancestor
5954029|NCT04689165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954030|NCT04688983|Imatinib Mesylate|imatinib mesylate|mesh-list
5954031|NCT04688983|Blinatumomab|blinatumomab|mesh-list
5954032|NCT04688983|Ponatinib|ponatinib|mesh-list
5954033|NCT04688983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5954034|NCT04688983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5954035|NCT04688983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5954036|NCT04688983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954037|NCT04688801|Antineoplastic Agents|antineoplastic agents|mesh-list
5954038|NCT04688736|Chlorpheniramine|chlorpheniramine|mesh-list
5954039|NCT04688736|Antipruritics|antipruritics|mesh-ancestor
5954040|NCT04688736|Dermatologic Agents|dermatologic agents|mesh-ancestor
5954041|NCT04688736|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5954042|NCT04688736|Histamine Antagonists|histamine antagonists|mesh-ancestor
5954043|NCT04688736|Histamine Agents|histamine agents|mesh-ancestor
5954044|NCT04688736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5954045|NCT04688736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954046|NCT04688736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954047|NCT04688736|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5954048|NCT04688723|Dabigatran|dabigatran|mesh-list
5954049|NCT04688723|Clopidogrel|clopidogrel|mesh-list
5954050|NCT04688723|Ticagrelor|ticagrelor|mesh-list
5954051|NCT04688723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5954052|NCT04688723|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5954053|NCT04688723|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5954054|NCT04688723|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5954055|NCT04688723|Purinergic Agents|purinergic agents|mesh-ancestor
5954056|NCT04688723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5954057|NCT04688723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954058|NCT04688723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954059|NCT04688723|Antithrombins|antithrombins|mesh-ancestor
5954060|NCT04688723|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5954061|NCT04688723|Protease Inhibitors|protease inhibitors|mesh-ancestor
5954062|NCT04688723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5954063|NCT04688723|Anticoagulants|anticoagulants|mesh-ancestor
5954064|NCT04688645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5954065|NCT04688658|Nivolumab|nivolumab|mesh-list
5954066|NCT04688658|Axitinib|axitinib|mesh-list
5954067|NCT04688658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5954068|NCT04688658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5954069|NCT04688658|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5954070|NCT04688658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954071|NCT04688658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5954072|NCT04688658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5954073|NCT04688632|Moxifloxacin|moxifloxacin|mesh-list
5954074|NCT04688632|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
5954075|NCT04688632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5954076|NCT04688632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5954077|NCT04688632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5954078|NCT04688632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5954079|NCT04688632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5954080|NCT04688632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954081|NCT04688632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5954082|NCT04688632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5954083|NCT04688632|Contraceptive Agents|contraceptive agents|mesh-ancestor
5954084|NCT04688632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5954085|NCT04688632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954086|NCT04688632|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5954087|NCT04688632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5954088|NCT04688632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5954089|NCT04688346|Epinephrine|epinephrine|mesh-list
5954090|NCT04688346|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5954091|NCT04688346|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5954092|NCT04688346|Adrenergic Agents|adrenergic agents|mesh-ancestor
5954093|NCT04688346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5954094|NCT04688346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954095|NCT04688346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954096|NCT04688346|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5954097|NCT04688346|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5954098|NCT04688346|Autonomic Agents|autonomic agents|mesh-ancestor
5954099|NCT04688346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5954100|NCT04688346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5954101|NCT04688346|Respiratory System Agents|respiratory system agents|mesh-ancestor
5954102|NCT04688346|Mydriatics|mydriatics|mesh-ancestor
5954103|NCT04688346|Sympathomimetics|sympathomimetics|mesh-ancestor
5954104|NCT04688346|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5954105|NCT04688021|Cytarabine|cytarabine|mesh-list
5954106|NCT04688021|Cyclosporine|cyclosporine|mesh-list
5954107|NCT04688021|Mycophenolic Acid|mycophenolic acid|mesh-list
5954108|NCT04688021|Cyclophosphamide|cyclophosphamide|mesh-list
5954109|NCT04688021|Busulfan|busulfan|mesh-list
5954110|NCT04688021|Cyclosporins|cyclosporins|mesh-list
5954111|NCT04688021|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5954112|NCT04688021|Thymoglobulin|thymoglobulin|mesh-list
5954113|NCT04688021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5954114|NCT04688021|Immunologic Factors|immunologic factors|mesh-ancestor
5954115|NCT04688021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954116|NCT04688021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5954117|NCT04688021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5954118|NCT04688021|Alkylating Agents|alkylating agents|mesh-ancestor
5954119|NCT04688021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954120|NCT04688021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5954121|NCT04688021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5954122|NCT04688021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5954123|NCT04688021|Antimetabolites|antimetabolites|mesh-ancestor
5954124|NCT04688021|Antiviral Agents|antiviral agents|mesh-ancestor
5954125|NCT04688021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5954126|NCT04688021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5954127|NCT04688021|Antifungal Agents|antifungal agents|mesh-ancestor
5954128|NCT04688021|Dermatologic Agents|dermatologic agents|mesh-ancestor
5954129|NCT04688021|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5954130|NCT04688021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5954131|NCT04688021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5954132|NCT04688021|Antitubercular Agents|antitubercular agents|mesh-ancestor
5954133|NCT04688021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5954134|NCT04688151|Rituximab|rituximab|mesh-list
5954135|NCT04688151|Durvalumab|durvalumab|mesh-list
5954136|NCT04688151|Acalabrutinib|acalabrutinib|mesh-list
5954137|NCT04688151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5954138|NCT04688151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5954139|NCT04688151|Immunologic Factors|immunologic factors|mesh-ancestor
5954140|NCT04688151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954141|NCT04688151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5969224|NCT04545866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5969225|NCT04545866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969226|NCT04545866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5969227|NCT04545866|Respiratory System Agents|respiratory system agents|mesh-ancestor
5969228|NCT04545866|Glucocorticoids|glucocorticoids|mesh-ancestor
5969229|NCT04545866|Hormones|hormones|mesh-ancestor
5969230|NCT04545866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5969231|NCT04545801|Ketamine|ketamine|mesh-list
5969232|NCT04545801|Analgesics|analgesics|mesh-ancestor
5969233|NCT04545801|Sensory System Agents|sensory system agents|mesh-ancestor
5969234|NCT04545801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5969235|NCT04545801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969236|NCT04545801|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5969237|NCT04545801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5969238|NCT04545801|Anesthetics, General|anesthetics, general|mesh-ancestor
5969239|NCT04545801|Anesthetics|anesthetics|mesh-ancestor
5969240|NCT04545801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5969241|NCT04545801|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5969242|NCT04545801|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5969243|NCT04545801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5969244|NCT04545801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969245|NCT04545762|Vidarabine|vidarabine|mesh-list
5969246|NCT04545762|Cyclophosphamide|cyclophosphamide|mesh-list
5969247|NCT04545762|Fludarabine|fludarabine|mesh-list
5969248|NCT04545762|Fludarabine phosphate|fludarabine phosphate|mesh-list
5969249|NCT04545762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5969250|NCT04545762|Immunologic Factors|immunologic factors|mesh-ancestor
5969251|NCT04545762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969252|NCT04545762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5969253|NCT04545762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5969254|NCT04545762|Alkylating Agents|alkylating agents|mesh-ancestor
5969255|NCT04545762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969256|NCT04545762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5969257|NCT04545762|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5969258|NCT04545762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5969259|NCT04545762|Antimetabolites|antimetabolites|mesh-ancestor
5969260|NCT04545762|Antiviral Agents|antiviral agents|mesh-ancestor
5969261|NCT04545762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5969262|NCT04545788|Cycloserine|cycloserine|mesh-list
5969263|NCT04545788|Linezolid|linezolid|mesh-list
5969264|NCT04545788|Bedaquiline|bedaquiline|mesh-list
5969265|NCT04545788|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5969266|NCT04545788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5969267|NCT04545788|Renal Agents|renal agents|mesh-ancestor
5969268|NCT04545788|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5969269|NCT04545788|Antitubercular Agents|antitubercular agents|mesh-ancestor
5969270|NCT04545788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5969271|NCT04545788|Antimetabolites|antimetabolites|mesh-ancestor
5954142|NCT04687878|Insulin|insulin|mesh-list
5954143|NCT04687878|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5954144|NCT04687878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5954145|NCT04687878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954146|NCT04687800|Dexamethasone|dexamethasone|mesh-list
5954147|NCT04687800|Difluprednate|difluprednate|mesh-list
5954148|NCT04687800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5954149|NCT04687800|Antiemetics|antiemetics|mesh-ancestor
5954150|NCT04687800|Autonomic Agents|autonomic agents|mesh-ancestor
5954151|NCT04687800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5954152|NCT04687800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954153|NCT04687800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5954154|NCT04687800|Glucocorticoids|glucocorticoids|mesh-ancestor
5954155|NCT04687800|Hormones|hormones|mesh-ancestor
5954156|NCT04687800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5954157|NCT04687800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5954158|NCT04687800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5954159|NCT04687566|Memantine|memantine|mesh-list
5954160|NCT04687566|Dextromethorphan|dextromethorphan|mesh-list
5954161|NCT04687566|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5954162|NCT04687566|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5954163|NCT04687566|Dopamine Agents|dopamine agents|mesh-ancestor
6681405|NCT01609517|Anesthetics, Local|anesthetics, local|mesh-ancestor
6681406|NCT01609517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6681407|NCT01609517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681408|NCT01609517|Sensory System Agents|sensory system agents|mesh-ancestor
6681409|NCT01609517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6681410|NCT01609647|Clopidogrel|clopidogrel|mesh-list
6681411|NCT01609647|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6681412|NCT01609647|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6681413|NCT01609647|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6681414|NCT01609647|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6681415|NCT01609647|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6681416|NCT01609647|Purinergic Agents|purinergic agents|mesh-ancestor
6681417|NCT01609647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6681418|NCT01609647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681419|NCT01609647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681420|NCT01609673|Everolimus|everolimus|mesh-list
5954164|NCT04687566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5954165|NCT04687566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954166|NCT04687566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954167|NCT04687566|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5954168|NCT04687566|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5954169|NCT04687566|Antitussive Agents|antitussive agents|mesh-ancestor
5954170|NCT04687566|Respiratory System Agents|respiratory system agents|mesh-ancestor
5954171|NCT04687631|Bevacizumab|bevacizumab|mesh-list
5954172|NCT04687631|Cetuximab|cetuximab|mesh-list
5954173|NCT04687631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5954174|NCT04687631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5954175|NCT04687631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5954176|NCT04687631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5954177|NCT04687631|Growth Substances|growth substances|mesh-ancestor
5954178|NCT04687631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954179|NCT04687631|Growth Inhibitors|growth inhibitors|mesh-ancestor
5954180|NCT04687761|Cytarabine|cytarabine|mesh-list
5954181|NCT04687761|Azacitidine|azacitidine|mesh-list
5954182|NCT04687761|Venetoclax|venetoclax|mesh-list
5954183|NCT04687761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5954184|NCT04687761|Antimetabolites|antimetabolites|mesh-ancestor
5954185|NCT04687761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954186|NCT04687761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5954187|NCT04687761|Antiviral Agents|antiviral agents|mesh-ancestor
5954188|NCT04687761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5954189|NCT04687761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5954190|NCT04687761|Immunologic Factors|immunologic factors|mesh-ancestor
5954191|NCT04687761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954192|NCT04687761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5954193|NCT04687514|Dulaglutide|dulaglutide|mesh-list
5954194|NCT04687514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5954195|NCT04687514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954196|NCT04687332|Tryptophan|tryptophan|mesh-list
5954197|NCT04687332|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5954198|NCT04687332|Antidepressive Agents|antidepressive agents|mesh-ancestor
5954199|NCT04687332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5954200|NCT04687449|Curcumin|curcumin|mesh-list
5954201|NCT04687449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5954202|NCT04687449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5954203|NCT04687449|Analgesics|analgesics|mesh-ancestor
5954204|NCT04687449|Sensory System Agents|sensory system agents|mesh-ancestor
5954205|NCT04687449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5954206|NCT04687449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954207|NCT04687449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5954208|NCT04687449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5954209|NCT04687449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5954210|NCT04687449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5954211|NCT04687449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954212|NCT04687111|Valsartan|valsartan|mesh-list
5954213|NCT04687111|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5954214|NCT04687111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5954215|NCT04687111|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5954216|NCT04687111|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5954217|NCT04687111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954218|NCT04686890|Acetaminophen|acetaminophen|mesh-list
5954219|NCT04686890|Tramadol|tramadol|mesh-list
5954220|NCT04686890|Analgesics|analgesics|mesh-list
5954221|NCT04686890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5954222|NCT04686890|Sensory System Agents|sensory system agents|mesh-ancestor
5954223|NCT04686890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5954224|NCT04686890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954225|NCT04686890|Antipyretics|antipyretics|mesh-ancestor
5954226|NCT04686890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5954227|NCT04686890|Narcotics|narcotics|mesh-ancestor
5954228|NCT04686890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5954229|NCT04687176|Arsenic Trioxide|arsenic trioxide|mesh-list
5954230|NCT04687176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5954231|NCT04687163|Oxaliplatin|oxaliplatin|mesh-list
5954232|NCT04687163|Fluorouracil|fluorouracil|mesh-list
5954233|NCT04687163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5954234|NCT04687163|Antimetabolites|antimetabolites|mesh-ancestor
5954235|NCT04687163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954236|NCT04687163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5954237|NCT04687163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5954238|NCT04687163|Immunologic Factors|immunologic factors|mesh-ancestor
5954239|NCT04687163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954240|NCT04686929|Abatacept|abatacept|mesh-list
5954241|NCT04686929|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5954242|NCT04686929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954243|NCT04686929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5954244|NCT04686929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5954245|NCT04686929|Immunologic Factors|immunologic factors|mesh-ancestor
5954246|NCT04686929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954247|NCT04686929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5954248|NCT04687098|Idarubicin|idarubicin|mesh-list
5954249|NCT04687098|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5954250|NCT04687098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5954251|NCT04687098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5954252|NCT04687098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5954253|NCT04687098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5954254|NCT04687098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954255|NCT04686760|Nitroglycerin|nitroglycerin|mesh-list
5954256|NCT04686760|Vasodilator Agents|vasodilator agents|mesh-ancestor
5954257|NCT04686448|Fentanyl|fentanyl|mesh-list
5954258|NCT04686448|Ketamine|ketamine|mesh-list
5954259|NCT04686448|Propofol|propofol|mesh-list
5954260|NCT04686448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5954261|NCT04686448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5954262|NCT04686448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954263|NCT04686448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5954264|NCT04686448|Anesthetics, General|anesthetics, general|mesh-ancestor
5954265|NCT04686448|Anesthetics|anesthetics|mesh-ancestor
5954266|NCT04686448|Analgesics|analgesics|mesh-ancestor
5954267|NCT04686448|Sensory System Agents|sensory system agents|mesh-ancestor
5954268|NCT04686448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5954269|NCT04686448|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5954270|NCT04686448|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5954271|NCT04686448|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5954272|NCT04686448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5954273|NCT04686448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954274|NCT04686448|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5954275|NCT04686448|Narcotics|narcotics|mesh-ancestor
5954276|NCT04686448|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5954277|NCT04686825|DA-8010|da-8010|mesh-list
5954278|NCT04686825|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5954279|NCT04686825|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5954280|NCT04686825|Cholinergic Agents|cholinergic agents|mesh-ancestor
5954281|NCT04686825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5954282|NCT04686825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954283|NCT04686825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954284|NCT04686643|Niacin|niacin|mesh-list
5954285|NCT04686643|Amlodipine|amlodipine|mesh-list
5954286|NCT04686643|Valsartan|valsartan|mesh-list
5954287|NCT04686643|Indapamide|indapamide|mesh-list
5954288|NCT04686643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5954289|NCT04686643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5954290|NCT04686643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5954291|NCT04686643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954292|NCT04686643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5954293|NCT04686643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954294|NCT04686643|Vasodilator Agents|vasodilator agents|mesh-ancestor
5954295|NCT04686643|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5954296|NCT04686643|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5954297|NCT04686643|Diuretics|diuretics|mesh-ancestor
5954298|NCT04686643|Natriuretic Agents|natriuretic agents|mesh-ancestor
5954299|NCT04686643|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5954300|NCT04686643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5954301|NCT04686643|Antimetabolites|antimetabolites|mesh-ancestor
5954302|NCT04686643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5954303|NCT04686643|Vitamin B Complex|vitamin b complex|mesh-ancestor
5954304|NCT04686643|Vitamins|vitamins|mesh-ancestor
5954305|NCT04686643|Micronutrients|micronutrients|mesh-ancestor
5969272|NCT04545788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969273|NCT04545788|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5969274|NCT04545788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5969275|NCT04545463|Psyllium|psyllium|mesh-list
5969276|NCT04545463|Cathartics|cathartics|mesh-ancestor
5969277|NCT04545463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5969278|NCT04545450|Methyltestosterone|methyltestosterone|mesh-list
5969279|NCT04545450|Testosterone|testosterone|mesh-list
5969280|NCT04545450|Testosterone undecanoate|testosterone undecanoate|mesh-list
5969281|NCT04545450|Testosterone enanthate|testosterone enanthate|mesh-list
5969282|NCT04545450|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5969283|NCT04545450|Dutasteride|dutasteride|mesh-list
5969284|NCT04545450|Androgens|androgens|mesh-ancestor
5969285|NCT04545450|Hormones|hormones|mesh-ancestor
5969286|NCT04545450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5969287|NCT04545450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969288|NCT04545450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5969289|NCT04545450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5969290|NCT04545450|Anabolic Agents|anabolic agents|mesh-ancestor
5969291|NCT04545450|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
5969292|NCT04545450|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5969293|NCT04545450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5969294|NCT04545450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969295|NCT04545450|Hormone Antagonists|hormone antagonists|mesh-ancestor
5969296|NCT04545710|Osimertinib|osimertinib|mesh-list
5969297|NCT04545710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5969298|NCT04545710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5969299|NCT04545710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5969300|NCT04545710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969301|NCT04545242|Dexamethasone|dexamethasone|mesh-list
5969302|NCT04545242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5969303|NCT04545242|Antiemetics|antiemetics|mesh-ancestor
5969304|NCT04545242|Autonomic Agents|autonomic agents|mesh-ancestor
5969305|NCT04545242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5969306|NCT04545242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969307|NCT04545242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5969308|NCT04545242|Glucocorticoids|glucocorticoids|mesh-ancestor
5969309|NCT04545242|Hormones|hormones|mesh-ancestor
5969310|NCT04545242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5969311|NCT04545242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5969312|NCT04545242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5969313|NCT04544995|Niraparib|niraparib|mesh-list
5969314|NCT04544995|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5969315|NCT04544995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5971189|NCT04530006|Analgesics|analgesics|mesh-ancestor
5954306|NCT04686279|Tenofovir|tenofovir|mesh-list
5954307|NCT04686279|Antiviral Agents|antiviral agents|mesh-ancestor
5954308|NCT04686279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5954309|NCT04686279|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5954310|NCT04686279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5954311|NCT04686279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5954312|NCT04686279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954313|NCT04686279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5954314|NCT04686279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5954315|NCT04685980|Morphine|morphine|mesh-list
5954316|NCT04685980|Anesthetics|anesthetics|mesh-list
5954317|NCT04685980|Anesthetics, Local|anesthetics, local|mesh-list
5954318|NCT04685980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5954319|NCT04685980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954320|NCT04685980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5954321|NCT04685980|Narcotics|narcotics|mesh-ancestor
5954322|NCT04685980|Analgesics|analgesics|mesh-ancestor
5954323|NCT04685980|Sensory System Agents|sensory system agents|mesh-ancestor
5954324|NCT04685980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5954325|NCT04686058|Midazolam|midazolam|mesh-list
5954326|NCT04686058|Meperidine|meperidine|mesh-list
5954327|NCT04686058|Propofol|propofol|mesh-list
5954328|NCT04686058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5954329|NCT04686058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5954330|NCT04686058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954331|NCT04686058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5954332|NCT04686058|Anesthetics, General|anesthetics, general|mesh-ancestor
5954333|NCT04686058|Anesthetics|anesthetics|mesh-ancestor
5954334|NCT04686058|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5954335|NCT04686058|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5954336|NCT04686058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5954337|NCT04686058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5954338|NCT04686058|GABA Modulators|gaba modulators|mesh-ancestor
5954339|NCT04686058|GABA Agents|gaba agents|mesh-ancestor
5954340|NCT04686058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5954341|NCT04686058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954342|NCT04686058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5954343|NCT04686058|Narcotics|narcotics|mesh-ancestor
5954344|NCT04686058|Analgesics|analgesics|mesh-ancestor
5954345|NCT04686058|Sensory System Agents|sensory system agents|mesh-ancestor
5954346|NCT04686058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5954347|NCT04686097|Sclerosing Solutions|sclerosing solutions|mesh-list
5954348|NCT04686097|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5954349|NCT04685512|Tenofovir|tenofovir|mesh-list
5954350|NCT04685512|Emtricitabine|emtricitabine|mesh-list
5954351|NCT04685512|Antiviral Agents|antiviral agents|mesh-ancestor
5954352|NCT04685512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5954353|NCT04685512|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5954354|NCT04685512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5954355|NCT04685512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5954356|NCT04685512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954357|NCT04685512|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5954358|NCT04685512|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5954359|NCT04685642|Aspirin|aspirin|mesh-list
5954360|NCT04685642|Atorvastatin|atorvastatin|mesh-list
5954361|NCT04685642|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5954362|NCT04685642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5954363|NCT04685642|Analgesics|analgesics|mesh-ancestor
5954364|NCT04685642|Sensory System Agents|sensory system agents|mesh-ancestor
5954365|NCT04685642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5954366|NCT04685642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954367|NCT04685642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5954368|NCT04685642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5954369|NCT04685642|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5954370|NCT04685642|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5954371|NCT04685642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954372|NCT04685642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5954373|NCT04685642|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5954374|NCT04685642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5954375|NCT04685642|Antipyretics|antipyretics|mesh-ancestor
5954376|NCT04685642|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5954377|NCT04685642|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5954378|NCT04685642|Antimetabolites|antimetabolites|mesh-ancestor
5954379|NCT04685642|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5954380|NCT04685642|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5954381|NCT04685499|Pembrolizumab|pembrolizumab|mesh-list
5954382|NCT04685499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5954383|NCT04685499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5954384|NCT04685616|Doxorubicin|doxorubicin|mesh-list
5954385|NCT04685616|Bleomycin|bleomycin|mesh-list
5954386|NCT04685616|Dacarbazine|dacarbazine|mesh-list
5954387|NCT04685616|Vinblastine|vinblastine|mesh-list
5954388|NCT04685616|Brentuximab Vedotin|brentuximab vedotin|mesh-list
5954389|NCT04685616|Mitogens|mitogens|mesh-list
5954390|NCT04685616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5954391|NCT04685616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5954392|NCT04685616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5954393|NCT04685616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5954394|NCT04685616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5954395|NCT04685616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954396|NCT04685616|Mitosis Modulators|mitosis modulators|mesh-ancestor
5954397|NCT04685616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5954398|NCT04685616|Alkylating Agents|alkylating agents|mesh-ancestor
5954399|NCT04685616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5954400|NCT04685616|Tubulin Modulators|tubulin modulators|mesh-ancestor
5954401|NCT04685616|Antimitotic Agents|antimitotic agents|mesh-ancestor
5954402|NCT04685616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5954403|NCT04685694|Misoprostol|misoprostol|mesh-list
5954404|NCT04685694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5954405|NCT04685694|Abortifacient Agents|abortifacient agents|mesh-ancestor
5954406|NCT04685694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5954407|NCT04685694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954408|NCT04685694|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5954409|NCT04685694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5954410|NCT04685694|Oxytocics|oxytocics|mesh-ancestor
5954411|NCT04685538|Tetracaine|tetracaine|mesh-list
5954412|NCT04685538|Chloroprocaine|chloroprocaine|mesh-list
5954413|NCT04685538|Anesthetics, Local|anesthetics, local|mesh-ancestor
5954414|NCT04685538|Anesthetics|anesthetics|mesh-ancestor
5954415|NCT04685538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5954416|NCT04685538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954417|NCT04685538|Sensory System Agents|sensory system agents|mesh-ancestor
5954418|NCT04685538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5954419|NCT04685421|Bupivacaine|bupivacaine|mesh-list
5954420|NCT04685421|Anesthetics, Local|anesthetics, local|mesh-ancestor
5954421|NCT04685421|Anesthetics|anesthetics|mesh-ancestor
5954422|NCT04685421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5954423|NCT04685421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954424|NCT04685421|Sensory System Agents|sensory system agents|mesh-ancestor
5954425|NCT04685421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5954426|NCT04685577|Nefopam|nefopam|mesh-list
5954427|NCT04685577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5954428|NCT04685577|Analgesics|analgesics|mesh-ancestor
5954429|NCT04685577|Sensory System Agents|sensory system agents|mesh-ancestor
5954430|NCT04685577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5954431|NCT04685577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954432|NCT04685148|Estradiol|estradiol|mesh-list
5954433|NCT04685148|Estrogens|estrogens|mesh-ancestor
5954434|NCT04685148|Hormones|hormones|mesh-ancestor
5954435|NCT04685148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5954436|NCT04685148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954437|NCT04685031|Clobetasol|clobetasol|mesh-list
5954438|NCT04685031|Nitroglycerin|nitroglycerin|mesh-list
5954439|NCT04685031|Vasodilator Agents|vasodilator agents|mesh-ancestor
5954440|NCT04685031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5954441|NCT04685031|Glucocorticoids|glucocorticoids|mesh-ancestor
5954442|NCT04685031|Hormones|hormones|mesh-ancestor
5954443|NCT04685031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5954444|NCT04685031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954445|NCT04685005|Caffeine|caffeine|mesh-list
5954446|NCT04685005|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5954447|NCT04685005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954448|NCT04685005|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5954449|NCT04685005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5954450|NCT04685005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954451|NCT04685005|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5954452|NCT04685005|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5954453|NCT04685005|Purinergic Agents|purinergic agents|mesh-ancestor
5954454|NCT04685005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5954455|NCT04684589|Tadalafil|tadalafil|mesh-list
5954456|NCT04684589|Vasodilator Agents|vasodilator agents|mesh-ancestor
5954457|NCT04684589|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5954458|NCT04684589|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5954459|NCT04684589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5954460|NCT04684589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954461|NCT04684589|Urological Agents|urological agents|mesh-ancestor
5954462|NCT04684667|Propranolol|propranolol|mesh-list
5954463|NCT04684667|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5954464|NCT04684667|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5954465|NCT04684667|Adrenergic Agents|adrenergic agents|mesh-ancestor
5954466|NCT04684667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5954467|NCT04684667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954468|NCT04684667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954469|NCT04684667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5954470|NCT04684667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5954471|NCT04684667|Vasodilator Agents|vasodilator agents|mesh-ancestor
5969316|NCT04544995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969317|NCT04544995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5969318|NCT04545099|Neostigmine|neostigmine|mesh-list
5969319|NCT04545099|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5969320|NCT04545099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5969321|NCT04545099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969322|NCT04545099|Cholinergic Agents|cholinergic agents|mesh-ancestor
5969323|NCT04545099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5969324|NCT04545099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969325|NCT04545099|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5969326|NCT04545099|Autonomic Agents|autonomic agents|mesh-ancestor
5969327|NCT04545099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5969328|NCT04544943|Gentamicins|gentamicins|mesh-list
5969329|NCT04544943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5969330|NCT04544943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5969331|NCT04544943|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5969332|NCT04544943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5969333|NCT04544943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969334|NCT04544969|Gemcitabine|gemcitabine|mesh-list
5969335|NCT04544969|Cisplatin|cisplatin|mesh-list
5969336|NCT04544969|Docetaxel|docetaxel|mesh-list
5969337|NCT04544969|Fluorouracil|fluorouracil|mesh-list
5969338|NCT04544969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5969339|NCT04544969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5969340|NCT04544969|Antimetabolites|antimetabolites|mesh-ancestor
5969341|NCT04544969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969342|NCT04544969|Antiviral Agents|antiviral agents|mesh-ancestor
5969343|NCT04544969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5969344|NCT04544969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5969345|NCT04544969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5969346|NCT04544969|Immunologic Factors|immunologic factors|mesh-ancestor
5969347|NCT04544969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969348|NCT04544969|Tubulin Modulators|tubulin modulators|mesh-ancestor
5969349|NCT04544969|Antimitotic Agents|antimitotic agents|mesh-ancestor
5969350|NCT04544969|Mitosis Modulators|mitosis modulators|mesh-ancestor
5971190|NCT04530006|Sensory System Agents|sensory system agents|mesh-ancestor
5971191|NCT04530006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5971192|NCT04530188|Propofol|propofol|mesh-list
5971193|NCT04530188|Sevoflurane|sevoflurane|mesh-list
5971194|NCT04530188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5971195|NCT04530188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5971196|NCT04530188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971197|NCT04530188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5971198|NCT04530188|Anesthetics, General|anesthetics, general|mesh-ancestor
5971199|NCT04530188|Anesthetics|anesthetics|mesh-ancestor
5971200|NCT04530188|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5971201|NCT04530188|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5971202|NCT04530227|Paclitaxel|paclitaxel|mesh-list
5971203|NCT04530227|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5971204|NCT04530227|Pemetrexed|pemetrexed|mesh-list
5971205|NCT04530227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5971206|NCT04530227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5971207|NCT04530227|Tubulin Modulators|tubulin modulators|mesh-ancestor
5971208|NCT04530227|Antimitotic Agents|antimitotic agents|mesh-ancestor
5971209|NCT04530227|Mitosis Modulators|mitosis modulators|mesh-ancestor
5971210|NCT04530227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971211|NCT04530227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5971212|NCT04530227|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5971213|NCT04530227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5971214|NCT04529811|Rifaximin|rifaximin|mesh-list
5971215|NCT04529811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5954472|NCT04684628|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5954473|NCT04684628|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5954474|NCT04684628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954475|NCT04684199|Melatonin|melatonin|mesh-list
5954476|NCT04684199|Antioxidants|antioxidants|mesh-ancestor
5954477|NCT04684199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954478|NCT04684199|Protective Agents|protective agents|mesh-ancestor
5954479|NCT04684199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954480|NCT04684199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5954481|NCT04684277|Antidepressive Agents|antidepressive agents|mesh-list
5954482|NCT04684277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5954483|NCT04684498|Oseltamivir|oseltamivir|mesh-list
5954484|NCT04684498|Antiviral Agents|antiviral agents|mesh-ancestor
5954485|NCT04684498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5954486|NCT04684498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5954487|NCT04684498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954488|NCT04683965|Bevacizumab|bevacizumab|mesh-list
5954489|NCT04683965|Pemetrexed|pemetrexed|mesh-list
5954490|NCT04683965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5954491|NCT04683965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5954492|NCT04683965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5954493|NCT04683965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5954494|NCT04683965|Growth Substances|growth substances|mesh-ancestor
5954495|NCT04683965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954496|NCT04683965|Growth Inhibitors|growth inhibitors|mesh-ancestor
5954497|NCT04683965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5954498|NCT04683965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954499|NCT04683965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5954500|NCT04683965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5954501|NCT04684017|Carboplatin|carboplatin|mesh-list
5954502|NCT04684017|Etoposide|etoposide|mesh-list
5954503|NCT04684017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5954504|NCT04684017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5954505|NCT04684017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5954506|NCT04684017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5954507|NCT04684017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5954508|NCT04684017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954509|NCT04683458|Paclitaxel|paclitaxel|mesh-list
5954510|NCT04683458|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5954511|NCT04683458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5954512|NCT04683458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5954513|NCT04683458|Tubulin Modulators|tubulin modulators|mesh-ancestor
5954514|NCT04683458|Antimitotic Agents|antimitotic agents|mesh-ancestor
5954515|NCT04683458|Mitosis Modulators|mitosis modulators|mesh-ancestor
5954516|NCT04683458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954517|NCT04683640|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
5954518|NCT04683640|GABA Agents|gaba agents|mesh-ancestor
5954519|NCT04683640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5954520|NCT04683640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954521|NCT04683640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954522|NCT04683445|Pembrolizumab|pembrolizumab|mesh-list
5954523|NCT04683445|Trastuzumab|trastuzumab|mesh-list
5954524|NCT04683445|Pertuzumab|pertuzumab|mesh-list
5954525|NCT04683445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5954526|NCT04683445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5954527|NCT04683627|Diclofenac|diclofenac|mesh-list
5954528|NCT04683627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5954529|NCT04683627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5954530|NCT04683627|Analgesics|analgesics|mesh-ancestor
5954531|NCT04683627|Sensory System Agents|sensory system agents|mesh-ancestor
5954532|NCT04683627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5954533|NCT04683627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954534|NCT04683627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5954535|NCT04683627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5954536|NCT04683627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5954537|NCT04683627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5954538|NCT04683627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954539|NCT04683406|Oseltamivir|oseltamivir|mesh-list
5954540|NCT04683406|Antiviral Agents|antiviral agents|mesh-ancestor
5954541|NCT04683406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5954542|NCT04683406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5954543|NCT04683406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954544|NCT04683341|Tenofovir|tenofovir|mesh-list
5954545|NCT04683341|Antiviral Agents|antiviral agents|mesh-ancestor
5954546|NCT04683341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5954547|NCT04683341|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5954548|NCT04683341|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5954549|NCT04683341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5954550|NCT04683341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954551|NCT04683341|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5954552|NCT04683341|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5954553|NCT04683315|Gemcitabine|gemcitabine|mesh-list
5954554|NCT04683315|Paclitaxel|paclitaxel|mesh-list
5954555|NCT04683315|Fluorouracil|fluorouracil|mesh-list
5954556|NCT04683315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5954557|NCT04683315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5954558|NCT04683315|Tubulin Modulators|tubulin modulators|mesh-ancestor
5954559|NCT04683315|Antimitotic Agents|antimitotic agents|mesh-ancestor
5954560|NCT04683315|Mitosis Modulators|mitosis modulators|mesh-ancestor
5954561|NCT04683315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954562|NCT04683315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5954563|NCT04683315|Antimetabolites|antimetabolites|mesh-ancestor
5954564|NCT04683315|Antiviral Agents|antiviral agents|mesh-ancestor
5954565|NCT04683315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5954566|NCT04683315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5954567|NCT04683315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5954568|NCT04683315|Immunologic Factors|immunologic factors|mesh-ancestor
5954569|NCT04683315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954570|NCT04683198|Carboplatin|carboplatin|mesh-list
5954571|NCT04683198|Etoposide|etoposide|mesh-list
5954572|NCT04683198|Apatinib|apatinib|mesh-list
5954573|NCT04683198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5954574|NCT04683198|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5954575|NCT04683198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5954576|NCT04683198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5954577|NCT04683198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5954578|NCT04683198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954579|NCT04683198|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5954580|NCT04683159|Brimonidine Tartrate|brimonidine tartrate|mesh-list
5954581|NCT04683159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5954582|NCT04683159|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5954583|NCT04683159|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5954584|NCT04683159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5954585|NCT04683159|Adrenergic Agents|adrenergic agents|mesh-ancestor
5954586|NCT04683159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5954587|NCT04683159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954588|NCT04683159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954589|NCT04683146|Chlorhexidine|chlorhexidine|mesh-list
5954590|NCT04683146|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5954591|NCT04683146|Propranolol|propranolol|mesh-list
5954592|NCT04683146|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5954593|NCT04683146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5954594|NCT04683146|Disinfectants|disinfectants|mesh-ancestor
5954595|NCT04683146|Dermatologic Agents|dermatologic agents|mesh-ancestor
5954596|NCT04683146|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5954597|NCT04683146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5954598|NCT04683146|Adrenergic Agents|adrenergic agents|mesh-ancestor
5954599|NCT04683146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5954600|NCT04683146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954601|NCT04683146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954602|NCT04683146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5954603|NCT04683146|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5954604|NCT04683146|Vasodilator Agents|vasodilator agents|mesh-ancestor
5954605|NCT04683237|Liraglutide|liraglutide|mesh-list
5954606|NCT04683237|Megestrol|megestrol|mesh-list
5954607|NCT04683237|Megestrol Acetate|megestrol acetate|mesh-list
5954608|NCT04683237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5954609|NCT04683237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954610|NCT04683237|Incretins|incretins|mesh-ancestor
5954611|NCT04683237|Hormones|hormones|mesh-ancestor
5954612|NCT04683237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5954613|NCT04683237|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5954614|NCT04683237|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5954615|NCT04683237|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5954616|NCT04683237|Contraceptive Agents|contraceptive agents|mesh-ancestor
5954617|NCT04683237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5954618|NCT04683237|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5954619|NCT04683237|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5954620|NCT04683237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5954621|NCT04683237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5954622|NCT04683237|Appetite Stimulants|appetite stimulants|mesh-ancestor
5954623|NCT04683237|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5954624|NCT04683679|Pembrolizumab|pembrolizumab|mesh-list
5954625|NCT04683679|Olaparib|olaparib|mesh-list
5954626|NCT04683679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5954627|NCT04683679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5954628|NCT04683679|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5954629|NCT04683679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5954630|NCT04683679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954631|NCT04682782|Esketamine|esketamine|mesh-list
5954632|NCT04682782|Antidepressive Agents|antidepressive agents|mesh-ancestor
5954633|NCT04682782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5969351|NCT04544813|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5969352|NCT04544813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5969353|NCT04544683|Dexamethasone|dexamethasone|mesh-list
5969354|NCT04544683|Dexamethasone acetate|dexamethasone acetate|mesh-list
5969355|NCT04544683|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
5969356|NCT04544683|BB 1101|bb 1101|mesh-list
5969357|NCT04544683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5969358|NCT04544683|Antiemetics|antiemetics|mesh-ancestor
5969359|NCT04544683|Autonomic Agents|autonomic agents|mesh-ancestor
5969360|NCT04544683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5969361|NCT04544683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969362|NCT04544683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5969363|NCT04544683|Glucocorticoids|glucocorticoids|mesh-ancestor
5969364|NCT04544683|Hormones|hormones|mesh-ancestor
5969365|NCT04544683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5969366|NCT04544683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5969367|NCT04544683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5969368|NCT04544683|Protease Inhibitors|protease inhibitors|mesh-ancestor
5969369|NCT04544683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5969370|NCT04544683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969371|NCT04544306|Anti-Infective Agents|anti-infective agents|mesh-list
5969372|NCT04544306|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5969373|NCT04544228|Ketamine|ketamine|mesh-list
5969374|NCT04544228|Bupivacaine|bupivacaine|mesh-list
5969375|NCT04544228|Neostigmine|neostigmine|mesh-list
5969376|NCT04544228|Anesthetics, Local|anesthetics, local|mesh-ancestor
5969377|NCT04544228|Anesthetics|anesthetics|mesh-ancestor
5969378|NCT04544228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5969379|NCT04544228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969380|NCT04544228|Sensory System Agents|sensory system agents|mesh-ancestor
5969381|NCT04544228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5969382|NCT04544228|Analgesics|analgesics|mesh-ancestor
5969383|NCT04544228|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5969384|NCT04544228|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5969385|NCT04544228|Anesthetics, General|anesthetics, general|mesh-ancestor
5969386|NCT04544228|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5969387|NCT04544228|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5969388|NCT04544228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5969389|NCT04544228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969390|NCT04544228|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5969391|NCT04544228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5969392|NCT04544228|Cholinergic Agents|cholinergic agents|mesh-ancestor
5969393|NCT04544228|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5969394|NCT04544228|Autonomic Agents|autonomic agents|mesh-ancestor
5969395|NCT04544475|Estrogens|estrogens|mesh-list
5969396|NCT04544475|Estradiol|estradiol|mesh-list
5969397|NCT04544475|Hormones|hormones|mesh-ancestor
5969398|NCT04544475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5969399|NCT04544475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969400|NCT04544319|Dapagliflozin|dapagliflozin|mesh-list
5969401|NCT04544319|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5969402|NCT04544319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969403|NCT04544319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5969404|NCT04544319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969405|NCT04544202|Trametinib|trametinib|mesh-list
5969406|NCT04544202|Dabrafenib|dabrafenib|mesh-list
5969407|NCT04544202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5969408|NCT04544202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5969409|NCT04544202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5969410|NCT04544202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969411|NCT04544059|Lenalidomide|lenalidomide|mesh-list
5954634|NCT04682665|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
5954635|NCT04682665|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5954636|NCT04682665|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5954637|NCT04682691|Erythromycin|erythromycin|mesh-list
5954638|NCT04682691|Erythromycin Estolate|erythromycin estolate|mesh-list
5954639|NCT04682691|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
5954640|NCT04682691|Erythromycin stearate|erythromycin stearate|mesh-list
5954641|NCT04682691|Metoclopramide|metoclopramide|mesh-list
5954642|NCT04682691|Antiemetics|antiemetics|mesh-ancestor
5954643|NCT04682691|Autonomic Agents|autonomic agents|mesh-ancestor
5954644|NCT04682691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5954645|NCT04682691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954646|NCT04682691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5954647|NCT04682691|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5954648|NCT04682691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5954649|NCT04682691|Dopamine Agents|dopamine agents|mesh-ancestor
5954650|NCT04682691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5954651|NCT04682691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954652|NCT04682691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5954653|NCT04682691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5954654|NCT04682691|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5954655|NCT04682691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5954656|NCT04682834|Probenecid|probenecid|mesh-list
5954657|NCT04682834|Uricosuric Agents|uricosuric agents|mesh-ancestor
5954658|NCT04682834|Gout Suppressants|gout suppressants|mesh-ancestor
5954659|NCT04682834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5954660|NCT04682834|Renal Agents|renal agents|mesh-ancestor
5954661|NCT04682795|Insulin|insulin|mesh-list
5954662|NCT04682795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5954663|NCT04682795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954664|NCT04682626|Cholecalciferol|cholecalciferol|mesh-list
5954665|NCT04682626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5954666|NCT04682626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954667|NCT04682626|Vitamins|vitamins|mesh-ancestor
5954668|NCT04682626|Micronutrients|micronutrients|mesh-ancestor
5954669|NCT04682626|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5954670|NCT04682899|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5954671|NCT04682899|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5954672|NCT04682899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5954673|NCT04682899|Antitubercular Agents|antitubercular agents|mesh-ancestor
5954674|NCT04682431|Pembrolizumab|pembrolizumab|mesh-list
5954675|NCT04682431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5954676|NCT04682431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5954677|NCT04682743|Acetaminophen|acetaminophen|mesh-list
5954678|NCT04682743|Ondansetron|ondansetron|mesh-list
5954679|NCT04682743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5954680|NCT04682743|Analgesics|analgesics|mesh-ancestor
5954681|NCT04682743|Sensory System Agents|sensory system agents|mesh-ancestor
5954682|NCT04682743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5954683|NCT04682743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954684|NCT04682743|Antipyretics|antipyretics|mesh-ancestor
5954685|NCT04682743|Antiemetics|antiemetics|mesh-ancestor
5954686|NCT04682743|Autonomic Agents|autonomic agents|mesh-ancestor
5954687|NCT04682743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5954688|NCT04682743|Antipruritics|antipruritics|mesh-ancestor
5954689|NCT04682743|Dermatologic Agents|dermatologic agents|mesh-ancestor
5954690|NCT04682743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5954691|NCT04682743|Serotonin Agents|serotonin agents|mesh-ancestor
5954692|NCT04682743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5954693|NCT04682743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954694|NCT04682743|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5954695|NCT04682743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5954696|NCT04682743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5954697|NCT04682743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5954698|NCT04682743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5954699|NCT04682587|Pembrolizumab|pembrolizumab|mesh-list
5954700|NCT04682587|Avelumab|avelumab|mesh-list
5954701|NCT04682587|Axitinib|axitinib|mesh-list
5954702|NCT04682587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5954703|NCT04682587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5954704|NCT04682587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5954705|NCT04682587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5954706|NCT04682587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954707|NCT04682574|Ascorbic Acid|ascorbic acid|mesh-list
5954708|NCT04682574|Vitamins|vitamins|mesh-ancestor
5954709|NCT04682574|Micronutrients|micronutrients|mesh-ancestor
5954710|NCT04682574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954711|NCT04682574|Antioxidants|antioxidants|mesh-ancestor
5954712|NCT04682574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954713|NCT04682574|Protective Agents|protective agents|mesh-ancestor
5954714|NCT04681937|Methylprednisolone|methylprednisolone|mesh-list
5954715|NCT04681937|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5954716|NCT04681937|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5954717|NCT04681937|Prednisolone|prednisolone|mesh-list
5954718|NCT04681937|Prednisolone acetate|prednisolone acetate|mesh-list
5954719|NCT04681937|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5954720|NCT04681937|Prednisolone phosphate|prednisolone phosphate|mesh-list
5954721|NCT04681937|Hyaluronic Acid|hyaluronic acid|mesh-list
5954722|NCT04681937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5954723|NCT04681937|Antiemetics|antiemetics|mesh-ancestor
5954724|NCT04681937|Autonomic Agents|autonomic agents|mesh-ancestor
5954725|NCT04681937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5954726|NCT04681937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954727|NCT04681937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5954728|NCT04681937|Glucocorticoids|glucocorticoids|mesh-ancestor
5954729|NCT04681937|Hormones|hormones|mesh-ancestor
5954730|NCT04681937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5954731|NCT04681937|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5954732|NCT04681937|Protective Agents|protective agents|mesh-ancestor
5954733|NCT04681937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5954734|NCT04681937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5954735|NCT04681937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5954736|NCT04681937|Immunologic Factors|immunologic factors|mesh-ancestor
5954737|NCT04681937|Viscosupplements|viscosupplements|mesh-ancestor
5954738|NCT04681846|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5954739|NCT04681846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5954740|NCT04682249|Apatinib|apatinib|mesh-list
5954741|NCT04682249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5954742|NCT04682249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5954743|NCT04682249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5954744|NCT04682249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954745|NCT04682184|Propranolol|propranolol|mesh-list
5954746|NCT04682184|Pseudoephedrine|pseudoephedrine|mesh-list
5954747|NCT04682184|Ephedrine|ephedrine|mesh-list
5954748|NCT04682184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5954749|NCT04682184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5954750|NCT04682184|Adrenergic Agents|adrenergic agents|mesh-ancestor
5954751|NCT04682184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5954752|NCT04682184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954753|NCT04682184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954754|NCT04682184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5954755|NCT04682184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5954756|NCT04682184|Vasodilator Agents|vasodilator agents|mesh-ancestor
5954757|NCT04682184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5954758|NCT04682184|Autonomic Agents|autonomic agents|mesh-ancestor
5954759|NCT04682184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5954760|NCT04682184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5954761|NCT04682184|Respiratory System Agents|respiratory system agents|mesh-ancestor
5954762|NCT04682184|Nasal Decongestants|nasal decongestants|mesh-ancestor
5954763|NCT04682184|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5954764|NCT04682184|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5954765|NCT04682184|Sympathomimetics|sympathomimetics|mesh-ancestor
5954766|NCT04682210|Bevacizumab|bevacizumab|mesh-list
5954767|NCT04682210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5954768|NCT04682210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5954769|NCT04682210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5954770|NCT04682210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5954771|NCT04682210|Growth Substances|growth substances|mesh-ancestor
5954772|NCT04682210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954773|NCT04682210|Growth Inhibitors|growth inhibitors|mesh-ancestor
5954774|NCT04682132|Antibodies|antibodies|mesh-list
5954775|NCT04682132|Immunologic Factors|immunologic factors|mesh-ancestor
5954776|NCT04682132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954777|NCT04681820|HH-GV-678|hh-gv-678|mesh-list
5954778|NCT04681820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5954779|NCT04681820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5954780|NCT04681820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954781|NCT04681911|Gemcitabine|gemcitabine|mesh-list
5954782|NCT04681911|Paclitaxel|paclitaxel|mesh-list
5954783|NCT04681911|Vinorelbine|vinorelbine|mesh-list
5954784|NCT04681911|Carboplatin|carboplatin|mesh-list
5954785|NCT04681911|Capecitabine|capecitabine|mesh-list
5954786|NCT04681911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5969412|NCT04544059|Immunologic Factors|immunologic factors|mesh-ancestor
5954787|NCT04681911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5954788|NCT04681911|Tubulin Modulators|tubulin modulators|mesh-ancestor
5954789|NCT04681911|Antimitotic Agents|antimitotic agents|mesh-ancestor
5954790|NCT04681911|Mitosis Modulators|mitosis modulators|mesh-ancestor
5954791|NCT04681911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954792|NCT04681911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5954793|NCT04681911|Antimetabolites|antimetabolites|mesh-ancestor
5954794|NCT04681911|Antiviral Agents|antiviral agents|mesh-ancestor
5954795|NCT04681911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5954796|NCT04681911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5954797|NCT04681911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5954798|NCT04681911|Immunologic Factors|immunologic factors|mesh-ancestor
5954799|NCT04681911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954800|NCT04682041|Immunoglobulins|immunoglobulins|mesh-list
5954801|NCT04682041|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5954802|NCT04682041|Antibodies|antibodies|mesh-list
5954803|NCT04682041|Immunologic Factors|immunologic factors|mesh-ancestor
5954804|NCT04682041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954805|NCT04681443|Phenol|phenol|mesh-list
5954806|NCT04681443|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5954807|NCT04681443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5954808|NCT04681443|Disinfectants|disinfectants|mesh-ancestor
5954809|NCT04681443|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
5954810|NCT04681443|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5954811|NCT04681469|Niraparib|niraparib|mesh-list
5954812|NCT04681469|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5954813|NCT04681469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5954814|NCT04681469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954815|NCT04681469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5954816|NCT04681833|Vaccines|vaccines|mesh-list
5954817|NCT04681833|Immunologic Factors|immunologic factors|mesh-ancestor
5954818|NCT04681833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954819|NCT04680884|Antifungal Agents|antifungal agents|mesh-list
5954820|NCT04680884|Clotrimazole|clotrimazole|mesh-list
5954821|NCT04680884|Miconazole|miconazole|mesh-list
5954822|NCT04680884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5954823|NCT04680884|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5954824|NCT04680884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5954825|NCT04680884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5954826|NCT04680884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5954827|NCT04680884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954828|NCT04680884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5954829|NCT04680884|Hormone Antagonists|hormone antagonists|mesh-ancestor
5954830|NCT04680884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5954831|NCT04680884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954832|NCT04680884|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5954833|NCT04680884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5954834|NCT04680962|Rituximab|rituximab|mesh-list
5954835|NCT04680962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5954836|NCT04680962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5954837|NCT04680962|Immunologic Factors|immunologic factors|mesh-ancestor
5954838|NCT04680962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954839|NCT04680962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5969413|NCT04544059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969414|NCT04544059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5969415|NCT04544059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5969416|NCT04544059|Growth Substances|growth substances|mesh-ancestor
5969417|NCT04544059|Growth Inhibitors|growth inhibitors|mesh-ancestor
5969418|NCT04544059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5969419|NCT04544163|Lidocaine|lidocaine|mesh-list
5969420|NCT04544163|Magnesium Sulfate|magnesium sulfate|mesh-list
5969421|NCT04544163|Fentanyl|fentanyl|mesh-list
5969422|NCT04544163|Anesthetics, Local|anesthetics, local|mesh-ancestor
5969423|NCT04544163|Anesthetics|anesthetics|mesh-ancestor
5969424|NCT04544163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5969425|NCT04544163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969426|NCT04544163|Sensory System Agents|sensory system agents|mesh-ancestor
5969427|NCT04544163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5969428|NCT04544163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5969429|NCT04544163|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5969430|NCT04544163|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5969431|NCT04544163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5969432|NCT04544163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969433|NCT04544163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5954840|NCT04681027|Oxymorphone|oxymorphone|mesh-list
5954841|NCT04681027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5954842|NCT04681027|Narcotics|narcotics|mesh-ancestor
5954843|NCT04681027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5954844|NCT04681027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954845|NCT04681027|Analgesics|analgesics|mesh-ancestor
5954846|NCT04681027|Sensory System Agents|sensory system agents|mesh-ancestor
5954847|NCT04681027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5954848|NCT04681027|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5954849|NCT04681287|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5954850|NCT04681287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954851|NCT04681287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5954852|NCT04681053|Ivermectin|ivermectin|mesh-list
5954853|NCT04681053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5954854|NCT04681053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5954855|NCT04681131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5954856|NCT04681131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954857|NCT04681131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5954858|NCT04680923|Bupivacaine|bupivacaine|mesh-list
5954859|NCT04680923|Anesthetics, Local|anesthetics, local|mesh-ancestor
5954860|NCT04680923|Anesthetics|anesthetics|mesh-ancestor
5954861|NCT04680923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5954862|NCT04680923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954863|NCT04680923|Sensory System Agents|sensory system agents|mesh-ancestor
5954864|NCT04680923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5954865|NCT04680949|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5954866|NCT04680949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5954867|NCT04680819|Propolis|propolis|mesh-list
5954868|NCT04680819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5954869|NCT04680650|Anesthetics|anesthetics|mesh-list
5954870|NCT04680650|Propofol|propofol|mesh-list
5954871|NCT04680650|Sevoflurane|sevoflurane|mesh-list
5954872|NCT04680650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5954873|NCT04680650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954874|NCT04680650|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5954875|NCT04680650|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5954876|NCT04680650|Anesthetics, General|anesthetics, general|mesh-ancestor
5954877|NCT04680650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5954878|NCT04680650|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5954879|NCT04680442|Trastuzumab|trastuzumab|mesh-list
5954880|NCT04680442|Pertuzumab|pertuzumab|mesh-list
5954881|NCT04680442|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
5954882|NCT04680442|Maytansine|maytansine|mesh-list
5954883|NCT04680442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5954884|NCT04680442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5954885|NCT04680442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5954886|NCT04680442|Tubulin Modulators|tubulin modulators|mesh-ancestor
5954887|NCT04680442|Antimitotic Agents|antimitotic agents|mesh-ancestor
5954888|NCT04680442|Mitosis Modulators|mitosis modulators|mesh-ancestor
5954889|NCT04680442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954890|NCT04680221|Bupivacaine|bupivacaine|mesh-list
5954891|NCT04680221|Anesthetics, Local|anesthetics, local|mesh-ancestor
5954892|NCT04680221|Anesthetics|anesthetics|mesh-ancestor
5954893|NCT04680221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5954894|NCT04680221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954895|NCT04680221|Sensory System Agents|sensory system agents|mesh-ancestor
5954896|NCT04680221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5954897|NCT04680091|Efavirenz|efavirenz|mesh-list
5954898|NCT04680091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5954899|NCT04680091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5954900|NCT04680091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5954901|NCT04680091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954902|NCT04680091|Antiviral Agents|antiviral agents|mesh-ancestor
5954903|NCT04680091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5954904|NCT04680091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5954905|NCT04680091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5954906|NCT04680091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5954907|NCT04680091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5954908|NCT04680091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5954909|NCT04680091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5954910|NCT04680143|Epoetin Alfa|epoetin alfa|mesh-list
5954911|NCT04680143|Hematinics|hematinics|mesh-ancestor
5954912|NCT04680208|Anesthetics|anesthetics|mesh-list
5954913|NCT04680208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5954914|NCT04680208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954915|NCT04679948|Midazolam|midazolam|mesh-list
5954916|NCT04679948|Caffeine|caffeine|mesh-list
5954917|NCT04679948|Omeprazole|omeprazole|mesh-list
5954918|NCT04679948|Warfarin|warfarin|mesh-list
5954919|NCT04679948|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5954920|NCT04679948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5954921|NCT04679948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5954922|NCT04679948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954923|NCT04679948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5954924|NCT04679948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5954925|NCT04679948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5954926|NCT04679948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5954927|NCT04679948|Anesthetics, General|anesthetics, general|mesh-ancestor
5954928|NCT04679948|Anesthetics|anesthetics|mesh-ancestor
5954929|NCT04679948|GABA Modulators|gaba modulators|mesh-ancestor
5954930|NCT04679948|GABA Agents|gaba agents|mesh-ancestor
5954931|NCT04679948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5954932|NCT04679948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954933|NCT04679948|Anticoagulants|anticoagulants|mesh-ancestor
5954934|NCT04679948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5954935|NCT04679948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5954936|NCT04679948|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5954937|NCT04679948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5954938|NCT04679948|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5954939|NCT04679948|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5954940|NCT04679948|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5954941|NCT04679948|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5954942|NCT04679948|Purinergic Agents|purinergic agents|mesh-ancestor
5954943|NCT04680286|Methadone|methadone|mesh-list
5954944|NCT04680286|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5954945|NCT04680286|Narcotics|narcotics|mesh-ancestor
5954946|NCT04680286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5954947|NCT04680286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954948|NCT04680286|Analgesics|analgesics|mesh-ancestor
5954949|NCT04680286|Sensory System Agents|sensory system agents|mesh-ancestor
5954950|NCT04680286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5954951|NCT04680286|Antitussive Agents|antitussive agents|mesh-ancestor
5954952|NCT04680286|Respiratory System Agents|respiratory system agents|mesh-ancestor
5954953|NCT04679831|Praziquantel|praziquantel|mesh-list
5954954|NCT04679831|Anthelmintics|anthelmintics|mesh-ancestor
5954955|NCT04679831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5954956|NCT04679831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5954957|NCT04679740|Sirolimus|sirolimus|mesh-list
5954958|NCT04679740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5954959|NCT04679740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5954960|NCT04679740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5954961|NCT04679740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5954962|NCT04679740|Antifungal Agents|antifungal agents|mesh-ancestor
5954963|NCT04679740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5954964|NCT04679740|Immunologic Factors|immunologic factors|mesh-ancestor
5954965|NCT04679740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954966|NCT04679558|Chlorhexidine|chlorhexidine|mesh-list
5954967|NCT04679558|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5954968|NCT04679558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5954969|NCT04679558|Disinfectants|disinfectants|mesh-ancestor
5954970|NCT04679389|Acetazolamide|acetazolamide|mesh-list
5954971|NCT04679389|Anticonvulsants|anticonvulsants|mesh-ancestor
5954972|NCT04679389|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5954973|NCT04679389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5954974|NCT04679389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5954975|NCT04679389|Diuretics|diuretics|mesh-ancestor
5954976|NCT04679389|Natriuretic Agents|natriuretic agents|mesh-ancestor
5954977|NCT04679389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954978|NCT04680195|Thalidomide|thalidomide|mesh-list
5954979|NCT04680195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5954980|NCT04680195|Immunologic Factors|immunologic factors|mesh-ancestor
5954981|NCT04680195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954982|NCT04680195|Leprostatic Agents|leprostatic agents|mesh-ancestor
5954983|NCT04680195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5954984|NCT04680195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5954985|NCT04680195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5954986|NCT04680195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5954987|NCT04680195|Growth Substances|growth substances|mesh-ancestor
5954988|NCT04680195|Growth Inhibitors|growth inhibitors|mesh-ancestor
5954989|NCT04680195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5954990|NCT04679623|Midazolam|midazolam|mesh-list
5954991|NCT04679623|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5954992|NCT04679623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5954993|NCT04679623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5954994|NCT04679623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5954995|NCT04679623|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5954996|NCT04679623|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5954997|NCT04679623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5954998|NCT04679623|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5954999|NCT04679623|Anesthetics, General|anesthetics, general|mesh-ancestor
5955000|NCT04679623|Anesthetics|anesthetics|mesh-ancestor
5955001|NCT04679623|GABA Modulators|gaba modulators|mesh-ancestor
5955002|NCT04679623|GABA Agents|gaba agents|mesh-ancestor
5955003|NCT04679623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5955004|NCT04679623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955005|NCT04679818|Fentanyl|fentanyl|mesh-list
5955006|NCT04679818|Analgesics, Opioid|analgesics, opioid|mesh-list
6681421|NCT01609673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6681422|NCT01609673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6681423|NCT01609673|Immunologic Factors|immunologic factors|mesh-ancestor
6681424|NCT01609673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681425|NCT01609816|Dasatinib|dasatinib|mesh-list
6681426|NCT01609816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6681427|NCT01609816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6681428|NCT01609816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6681429|NCT01609816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955007|NCT04679818|Narcotics|narcotics|mesh-ancestor
5955008|NCT04679818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5955009|NCT04679818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955010|NCT04679818|Analgesics|analgesics|mesh-ancestor
5955011|NCT04679818|Sensory System Agents|sensory system agents|mesh-ancestor
5955012|NCT04679818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5955013|NCT04679818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5955014|NCT04679818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5955015|NCT04679818|Anesthetics, General|anesthetics, general|mesh-ancestor
5955016|NCT04679818|Anesthetics|anesthetics|mesh-ancestor
5955017|NCT04679597|Capecitabine|capecitabine|mesh-list
5955018|NCT04679597|Oxaliplatin|oxaliplatin|mesh-list
5955019|NCT04679597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5955020|NCT04679597|Antimetabolites|antimetabolites|mesh-ancestor
5955021|NCT04679597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955022|NCT04679597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5969434|NCT04544163|Narcotics|narcotics|mesh-ancestor
5969435|NCT04544163|Analgesics|analgesics|mesh-ancestor
5969436|NCT04544163|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5969437|NCT04544163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5969438|NCT04544163|Anesthetics, General|anesthetics, general|mesh-ancestor
5969439|NCT04544163|Anticonvulsants|anticonvulsants|mesh-ancestor
5969440|NCT04544163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5969441|NCT04544163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5969442|NCT04544163|Tocolytic Agents|tocolytic agents|mesh-ancestor
5969443|NCT04544163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5969444|NCT04543851|Carbon Fiber|carbon fiber|mesh-list
5969445|NCT04543851|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6517485|NCT00721331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517486|NCT00721331|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6517487|NCT00721331|Antidepressive Agents|antidepressive agents|mesh-ancestor
6517488|NCT00721331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6517489|NCT00721331|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6517490|NCT00721331|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6517491|NCT00721331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6517492|NCT00721331|Adrenergic Agents|adrenergic agents|mesh-ancestor
6517493|NCT00721344|Moxifloxacin|moxifloxacin|mesh-list
6517494|NCT00721344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6517495|NCT00721344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6517496|NCT00721344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6517497|NCT00721344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6517498|NCT00721344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6517499|NCT00721344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681430|NCT01609855|Scopolamine|scopolamine|mesh-list
5969446|NCT04543851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5969447|NCT04543916|Irinotecan|irinotecan|mesh-list
5969448|NCT04543916|Venetoclax|venetoclax|mesh-list
5969449|NCT04543916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5969450|NCT04543916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5969451|NCT04543916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5969452|NCT04543916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969453|NCT04543916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5955023|NCT04679506|Cytarabine|cytarabine|mesh-list
5955024|NCT04679506|Etoposide|etoposide|mesh-list
5955025|NCT04679506|Cladribine|cladribine|mesh-list
5955026|NCT04679506|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5955027|NCT04679506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5955028|NCT04679506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5955029|NCT04679506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5955030|NCT04679506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5955031|NCT04679506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955032|NCT04679506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5955033|NCT04679506|Antimetabolites|antimetabolites|mesh-ancestor
5955034|NCT04679506|Antiviral Agents|antiviral agents|mesh-ancestor
5955035|NCT04679506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5955036|NCT04679506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5955037|NCT04679506|Immunologic Factors|immunologic factors|mesh-ancestor
5955038|NCT04679506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955039|NCT04679480|Cemiplimab|cemiplimab|mesh-list
5955040|NCT04679480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5955041|NCT04679480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5955042|NCT04679376|Atorvastatin|atorvastatin|mesh-list
5955043|NCT04679376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5955044|NCT04679376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5955045|NCT04679376|Antimetabolites|antimetabolites|mesh-ancestor
5955046|NCT04679376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955047|NCT04679376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5955048|NCT04679376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5955049|NCT04679376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5955050|NCT04678869|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5955051|NCT04678869|Ciprofloxacin|ciprofloxacin|mesh-list
5955052|NCT04678869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5955053|NCT04678869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5955054|NCT04678869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5955055|NCT04678869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5955056|NCT04678869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955057|NCT04678869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5955058|NCT04678869|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5955059|NCT04678869|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5955060|NCT04679142|Baclofen|baclofen|mesh-list
5955061|NCT04679142|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5955062|NCT04679142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955063|NCT04679142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5955064|NCT04679142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5955065|NCT04679142|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
5955066|NCT04679142|GABA Agonists|gaba agonists|mesh-ancestor
5955067|NCT04679142|GABA Agents|gaba agents|mesh-ancestor
5955068|NCT04679142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5955069|NCT04679142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955070|NCT04679064|Gemcitabine|gemcitabine|mesh-list
5955071|NCT04679064|Paclitaxel|paclitaxel|mesh-list
5955072|NCT04679064|Bevacizumab|bevacizumab|mesh-list
5955073|NCT04679064|Doxorubicin|doxorubicin|mesh-list
5955074|NCT04679064|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5955075|NCT04679064|Topotecan|topotecan|mesh-list
5955076|NCT04679064|Niraparib|niraparib|mesh-list
5955077|NCT04679064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5955078|NCT04679064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5955079|NCT04679064|Tubulin Modulators|tubulin modulators|mesh-ancestor
5955080|NCT04679064|Antimitotic Agents|antimitotic agents|mesh-ancestor
5955081|NCT04679064|Mitosis Modulators|mitosis modulators|mesh-ancestor
5955082|NCT04679064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955083|NCT04679064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5955084|NCT04679064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5955085|NCT04679064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5955086|NCT04679064|Growth Substances|growth substances|mesh-ancestor
5955087|NCT04679064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955088|NCT04679064|Growth Inhibitors|growth inhibitors|mesh-ancestor
5955089|NCT04679064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5955090|NCT04679064|Antimetabolites|antimetabolites|mesh-ancestor
5955091|NCT04679064|Antiviral Agents|antiviral agents|mesh-ancestor
5955092|NCT04679064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5955093|NCT04679064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5955094|NCT04679064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5955095|NCT04679064|Immunologic Factors|immunologic factors|mesh-ancestor
5955096|NCT04679064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5955097|NCT04679064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5969454|NCT04543994|Remestemcel-l|remestemcel-l|mesh-list
5955098|NCT04679064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5955099|NCT04679064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5955100|NCT04679064|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5955101|NCT04679103|Eculizumab|eculizumab|mesh-list
5955102|NCT04679103|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5955103|NCT04679103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5955104|NCT04679103|Immunologic Factors|immunologic factors|mesh-ancestor
5955105|NCT04679103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955106|NCT04678830|Leronlimab|leronlimab|mesh-list
5955107|NCT04678830|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5955108|NCT04678830|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5955109|NCT04678830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955110|NCT04678830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5955111|NCT04678830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5955112|NCT04678830|Antiviral Agents|antiviral agents|mesh-ancestor
5955113|NCT04678830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5955114|NCT04678791|Cisplatin|cisplatin|mesh-list
5955115|NCT04678791|Nimotuzumab|nimotuzumab|mesh-list
5955116|NCT04678791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5955117|NCT04678791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5955118|NCT04678739|Remdesivir|remdesivir|mesh-list
5955119|NCT04678739|Antimetabolites|antimetabolites|mesh-ancestor
5720652|NCT03211455|Sensory System Agents|sensory system agents|mesh-ancestor
5720653|NCT03211455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5720654|NCT03211455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5720655|NCT03211455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5720656|NCT03211455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5720657|NCT03211455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5720658|NCT03211455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5720659|NCT03211338|Progesterone|progesterone|mesh-list
5955120|NCT04678739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955121|NCT04678739|Antiviral Agents|antiviral agents|mesh-ancestor
5955122|NCT04678739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5955123|NCT04678492|Amoxicillin|amoxicillin|mesh-list
5955124|NCT04678492|Tetracycline|tetracycline|mesh-list
5955125|NCT04678492|Furazolidone|furazolidone|mesh-list
5955126|NCT04678492|Esomeprazole|esomeprazole|mesh-list
5955127|NCT04678492|Bismuth|bismuth|mesh-list
5955128|NCT04678492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5955129|NCT04678492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5955130|NCT04678492|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5955131|NCT04678492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5955132|NCT04678492|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5955133|NCT04678492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5955134|NCT04678492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955135|NCT04678492|Antacids|antacids|mesh-ancestor
5955136|NCT04678492|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5955137|NCT04678492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5955138|NCT04678492|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5955139|NCT04678492|Renal Agents|renal agents|mesh-ancestor
5955140|NCT04678492|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
5955141|NCT04678492|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5955142|NCT04678492|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5955143|NCT04678492|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
5955144|NCT04678531|Tea Tree Oil|tea tree oil|mesh-list
5955145|NCT04678531|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5955146|NCT04678531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5955147|NCT04678336|Cyclophosphamide|cyclophosphamide|mesh-list
5955148|NCT04678336|Fludarabine|fludarabine|mesh-list
5955149|NCT04678336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5955150|NCT04678336|Immunologic Factors|immunologic factors|mesh-ancestor
5955151|NCT04678336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955152|NCT04678336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5955153|NCT04678336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5955154|NCT04678336|Alkylating Agents|alkylating agents|mesh-ancestor
5955155|NCT04678336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955156|NCT04678336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5955157|NCT04678336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5955158|NCT04678154|Vancomycin|vancomycin|mesh-list
5955159|NCT04678154|Tobramycin|tobramycin|mesh-list
5955160|NCT04678154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5955161|NCT04678154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5955162|NCT04678076|Ketoprofen|ketoprofen|mesh-list
5955163|NCT04678076|Ketoprofen lysine|ketoprofen lysine|mesh-list
5955164|NCT04678076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5955165|NCT04678076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5955166|NCT04678076|Analgesics|analgesics|mesh-ancestor
5955167|NCT04678076|Sensory System Agents|sensory system agents|mesh-ancestor
5955168|NCT04678076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5955169|NCT04678076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955170|NCT04678076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5955171|NCT04678076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5955172|NCT04678076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5955173|NCT04678076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5955174|NCT04678076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955175|NCT04678089|Bortezomib|bortezomib|mesh-list
5955176|NCT04678089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5955177|NCT04678050|Dexmedetomidine|dexmedetomidine|mesh-list
5955178|NCT04678050|Ketamine|ketamine|mesh-list
5955179|NCT04678050|Propofol|propofol|mesh-list
5955180|NCT04678050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5955181|NCT04678050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5955182|NCT04678050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955183|NCT04678050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5955184|NCT04678050|Anesthetics, General|anesthetics, general|mesh-ancestor
5955185|NCT04678050|Anesthetics|anesthetics|mesh-ancestor
5955186|NCT04678050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5955187|NCT04678050|Analgesics|analgesics|mesh-ancestor
5955188|NCT04678050|Sensory System Agents|sensory system agents|mesh-ancestor
5955189|NCT04678050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5955190|NCT04678050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5955191|NCT04678050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5955192|NCT04678050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5955193|NCT04678050|Adrenergic Agents|adrenergic agents|mesh-ancestor
5955194|NCT04678050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5955195|NCT04678050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955196|NCT04678050|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5955197|NCT04678050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5955198|NCT04678050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5955199|NCT04678479|Ganaxolone|ganaxolone|mesh-list
5955200|NCT04678479|Neurosteroids|neurosteroids|mesh-ancestor
5955201|NCT04678479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5955202|NCT04678479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955203|NCT04678479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955204|NCT04678479|GABA Modulators|gaba modulators|mesh-ancestor
5955205|NCT04678479|GABA Agents|gaba agents|mesh-ancestor
5955206|NCT04678661|Insulin|insulin|mesh-list
5955207|NCT04678661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5955208|NCT04678661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955209|NCT04677985|Analgesics|analgesics|mesh-list
5955210|NCT04677985|Menthol|menthol|mesh-list
5955211|NCT04677985|Sensory System Agents|sensory system agents|mesh-ancestor
5955212|NCT04677985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5955213|NCT04677985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955214|NCT04677985|Antipruritics|antipruritics|mesh-ancestor
5955215|NCT04677985|Dermatologic Agents|dermatologic agents|mesh-ancestor
5955216|NCT04677972|Ebselen|ebselen|mesh-list
5955217|NCT04677972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5955218|NCT04677972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5955219|NCT04677972|Analgesics|analgesics|mesh-ancestor
5955220|NCT04677972|Sensory System Agents|sensory system agents|mesh-ancestor
5955221|NCT04677972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5955222|NCT04677972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955223|NCT04677972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5955224|NCT04677972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5955225|NCT04677972|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5955226|NCT04677972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5955227|NCT04677972|Antioxidants|antioxidants|mesh-ancestor
5955228|NCT04677972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955229|NCT04677972|Protective Agents|protective agents|mesh-ancestor
5955230|NCT04677972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5955231|NCT04677972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5955232|NCT04677972|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5955233|NCT04677868|Methotrexate|methotrexate|mesh-list
5955234|NCT04677868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5955235|NCT04677868|Abortifacient Agents|abortifacient agents|mesh-ancestor
5955236|NCT04677868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5955237|NCT04677868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955238|NCT04677868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5955239|NCT04677868|Antimetabolites|antimetabolites|mesh-ancestor
5955240|NCT04677868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955241|NCT04677868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5955242|NCT04677868|Dermatologic Agents|dermatologic agents|mesh-ancestor
5955243|NCT04677868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5955244|NCT04677868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5955245|NCT04677868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5955246|NCT04677868|Immunologic Factors|immunologic factors|mesh-ancestor
5955247|NCT04677868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5955248|NCT04677868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5969455|NCT04543994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5969456|NCT04543994|Antiviral Agents|antiviral agents|mesh-ancestor
5969457|NCT04543994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5969458|NCT04543890|Etoposide|etoposide|mesh-list
5969459|NCT04543890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5969460|NCT04543890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5969461|NCT04543890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5969462|NCT04543890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5969463|NCT04543890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5969464|NCT04543890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969465|NCT04543682|Iloprost|iloprost|mesh-list
5969466|NCT04543682|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5969467|NCT04543682|Vasodilator Agents|vasodilator agents|mesh-ancestor
5969468|NCT04543942|Ethanol|ethanol|mesh-list
5969469|NCT04543942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5969470|NCT04543942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5969471|NCT04543942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5969472|NCT04543942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969473|NCT04543565|Tenofovir|tenofovir|mesh-list
5969474|NCT04543565|Pradefovir|pradefovir|mesh-list
5969475|NCT04543565|Antiviral Agents|antiviral agents|mesh-ancestor
5969476|NCT04543565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5969477|NCT04543565|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5969478|NCT04543565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5969479|NCT04543565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5969480|NCT04543565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969481|NCT04543565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5969482|NCT04543565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5969483|NCT04543591|Ravulizumab|ravulizumab|mesh-list
5969484|NCT04543591|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5969485|NCT04543591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5969486|NCT04543591|Immunologic Factors|immunologic factors|mesh-ancestor
5969487|NCT04543591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969488|NCT04543370|Deflazacort|deflazacort|mesh-list
5969489|NCT04543370|Midazolam|midazolam|mesh-list
5969490|NCT04543370|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5969491|NCT04543370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5969492|NCT04543370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5969493|NCT04543370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969494|NCT04543370|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5969495|NCT04543370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5969496|NCT04543370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5969497|NCT04543370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5969498|NCT04543370|Anesthetics, General|anesthetics, general|mesh-ancestor
5969499|NCT04543370|Anesthetics|anesthetics|mesh-ancestor
5969500|NCT04543370|GABA Modulators|gaba modulators|mesh-ancestor
5969501|NCT04543370|GABA Agents|gaba agents|mesh-ancestor
5969502|NCT04543370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5969503|NCT04543370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969504|NCT04543370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5969505|NCT04543370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5969506|NCT04543370|Immunologic Factors|immunologic factors|mesh-ancestor
5969507|NCT04543110|Durvalumab|durvalumab|mesh-list
5969508|NCT04543110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5969509|NCT04543110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5969510|NCT04543227|Analgesics, Opioid|analgesics, opioid|mesh-list
5969511|NCT04543227|Narcotics|narcotics|mesh-ancestor
5969512|NCT04543227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5969513|NCT04543227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969514|NCT04543227|Analgesics|analgesics|mesh-ancestor
5969515|NCT04543227|Sensory System Agents|sensory system agents|mesh-ancestor
5969516|NCT04543227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5969517|NCT04543188|Midazolam|midazolam|mesh-list
5969518|NCT04543188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5969519|NCT04543188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5969520|NCT04543188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5969521|NCT04543188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969522|NCT04543188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5969523|NCT04543188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5955249|NCT04678362|Avelumab|avelumab|mesh-list
5955250|NCT04678362|Talazoparib|talazoparib|mesh-list
5955251|NCT04678362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5955252|NCT04678362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5955253|NCT04678362|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5955254|NCT04678362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5955255|NCT04678362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955256|NCT04677855|Prednisone|prednisone|mesh-list
5955257|NCT04677855|Dutasteride|dutasteride|mesh-list
5955258|NCT04677855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5955259|NCT04677855|Glucocorticoids|glucocorticoids|mesh-ancestor
5955260|NCT04677855|Hormones|hormones|mesh-ancestor
5955261|NCT04677855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5955262|NCT04677855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955263|NCT04677855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5955264|NCT04677855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5955265|NCT04677855|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
5955266|NCT04677855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5955267|NCT04677855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5955268|NCT04677855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955269|NCT04677855|Hormone Antagonists|hormone antagonists|mesh-ancestor
5955270|NCT04677439|HH-GV-678|hh-gv-678|mesh-list
5955271|NCT04677439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5955272|NCT04677439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5955273|NCT04677439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955274|NCT04677335|Lovastatin|lovastatin|mesh-list
5955275|NCT04677335|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5955276|NCT04677335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5955277|NCT04677335|Antimetabolites|antimetabolites|mesh-ancestor
5955278|NCT04677335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955279|NCT04677335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5955280|NCT04677335|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5955281|NCT04677335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5955282|NCT04677361|Pembrolizumab|pembrolizumab|mesh-list
5955283|NCT04677361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5955284|NCT04677361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5955285|NCT04676958|Vitamin K|vitamin k|mesh-list
5955286|NCT04676958|Vitamin K 2|vitamin k 2|mesh-list
5955287|NCT04676958|Vitamins|vitamins|mesh-ancestor
5955288|NCT04676958|Micronutrients|micronutrients|mesh-ancestor
5955289|NCT04676958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955290|NCT04676958|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5955291|NCT04676958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5955292|NCT04676958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955293|NCT04676958|Hemostatics|hemostatics|mesh-ancestor
5955294|NCT04676958|Coagulants|coagulants|mesh-ancestor
5955295|NCT04677114|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5955296|NCT04677114|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5955297|NCT04677114|Buprenorphine|buprenorphine|mesh-list
5955298|NCT04677114|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
5955299|NCT04677114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5955300|NCT04677114|Antitubercular Agents|antitubercular agents|mesh-ancestor
5955301|NCT04677114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5955302|NCT04677114|Narcotics|narcotics|mesh-ancestor
5955303|NCT04677114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5955304|NCT04677114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955305|NCT04677114|Analgesics|analgesics|mesh-ancestor
5955306|NCT04677114|Sensory System Agents|sensory system agents|mesh-ancestor
5955307|NCT04677114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5955308|NCT04677114|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5955309|NCT04677049|Niacin|niacin|mesh-list
5955310|NCT04677049|Nicotinic Acids|nicotinic acids|mesh-list
5955311|NCT04677049|Vitamins|vitamins|mesh-ancestor
5955312|NCT04677049|Micronutrients|micronutrients|mesh-ancestor
5955313|NCT04677049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955314|NCT04677049|Vitamin B Complex|vitamin b complex|mesh-ancestor
5955315|NCT04677049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5955316|NCT04677049|Antimetabolites|antimetabolites|mesh-ancestor
5955317|NCT04677049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955318|NCT04677049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5955319|NCT04677049|Vasodilator Agents|vasodilator agents|mesh-ancestor
5955320|NCT04676867|Dalcetrapib|dalcetrapib|mesh-list
5955321|NCT04676867|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5955322|NCT04676867|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5955323|NCT04676867|Antimetabolites|antimetabolites|mesh-ancestor
5969524|NCT04543188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5955324|NCT04676867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955325|NCT04676867|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5955326|NCT04676997|Paclitaxel|paclitaxel|mesh-list
5955327|NCT04676997|Cyclophosphamide|cyclophosphamide|mesh-list
5955328|NCT04676997|Epirubicin|epirubicin|mesh-list
5955329|NCT04676997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5955330|NCT04676997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5955331|NCT04676997|Tubulin Modulators|tubulin modulators|mesh-ancestor
5955332|NCT04676997|Antimitotic Agents|antimitotic agents|mesh-ancestor
5955333|NCT04676997|Mitosis Modulators|mitosis modulators|mesh-ancestor
5955334|NCT04676997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955335|NCT04676997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5955336|NCT04676997|Immunologic Factors|immunologic factors|mesh-ancestor
5955337|NCT04676997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955338|NCT04676997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5955339|NCT04676997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5955340|NCT04676997|Alkylating Agents|alkylating agents|mesh-ancestor
5955341|NCT04676997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5955342|NCT04676997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5955343|NCT04676997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5955344|NCT04676997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5955345|NCT04676997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5955346|NCT04676763|Histamine|histamine|mesh-list
5955347|NCT04676763|Substance P|substance p|mesh-list
5955348|NCT04676763|Neurokinin A|neurokinin a|mesh-list
5955349|NCT04676763|Histamine Agonists|histamine agonists|mesh-ancestor
5955350|NCT04676763|Histamine Agents|histamine agents|mesh-ancestor
5955351|NCT04676763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5955352|NCT04676763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955353|NCT04676763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955354|NCT04676789|Pegaspargase|pegaspargase|mesh-list
5955355|NCT04676789|Antibodies|antibodies|mesh-list
5955356|NCT04676789|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5955357|NCT04676789|Immunologic Factors|immunologic factors|mesh-ancestor
5955358|NCT04676789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955359|NCT04676789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5955360|NCT04676555|Ofatumumab|ofatumumab|mesh-list
5955361|NCT04676555|Ocrelizumab|ocrelizumab|mesh-list
5955362|NCT04676555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5955363|NCT04676555|Immunologic Factors|immunologic factors|mesh-ancestor
5955364|NCT04676555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955365|NCT04676659|Tenecteplase|tenecteplase|mesh-list
5955366|NCT04676659|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5955367|NCT04676659|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5955368|NCT04676659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955369|NCT04676516|GSK-3326595|gsk-3326595|mesh-list
5955370|NCT04676516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5955371|NCT04676516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955372|NCT04676204|Teriflunomide|teriflunomide|mesh-list
5955373|NCT04676204|Cladribine|cladribine|mesh-list
5955374|NCT04676204|Dimethyl Fumarate|dimethyl fumarate|mesh-list
5955375|NCT04676204|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
5955376|NCT04676204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5955377|NCT04676204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5955378|NCT04676204|Immunologic Factors|immunologic factors|mesh-ancestor
5955379|NCT04676204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955380|NCT04676204|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5955381|NCT04676204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955382|NCT04676204|Dermatologic Agents|dermatologic agents|mesh-ancestor
5955383|NCT04676204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5955384|NCT04676204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5955385|NCT04676204|Analgesics|analgesics|mesh-ancestor
5955386|NCT04676204|Sensory System Agents|sensory system agents|mesh-ancestor
5955387|NCT04676204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5955388|NCT04676204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5955389|NCT04676204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5955390|NCT04676776|Levonorgestrel|levonorgestrel|mesh-list
5955391|NCT04676776|Mifepristone|mifepristone|mesh-list
5955392|NCT04676776|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5955393|NCT04676776|Contraceptive Agents|contraceptive agents|mesh-ancestor
5955394|NCT04676776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5955395|NCT04676776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955396|NCT04676776|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5955397|NCT04676776|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5955398|NCT04676776|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6681431|NCT01609855|Bromides|bromides|mesh-list
5955399|NCT04676776|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5955400|NCT04676776|Abortifacient Agents|abortifacient agents|mesh-ancestor
5955401|NCT04676776|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5955402|NCT04676776|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5955403|NCT04676776|Hormone Antagonists|hormone antagonists|mesh-ancestor
5955404|NCT04676776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5955405|NCT04676776|Luteolytic Agents|luteolytic agents|mesh-ancestor
5955406|NCT04676776|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5955407|NCT04676139|Fluoxetine|fluoxetine|mesh-list
5955408|NCT04676139|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5955409|NCT04676139|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5955410|NCT04676139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5955411|NCT04676139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955412|NCT04676139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5955413|NCT04676139|Serotonin Agents|serotonin agents|mesh-ancestor
5955414|NCT04676139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955415|NCT04676139|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5955416|NCT04676139|Antidepressive Agents|antidepressive agents|mesh-ancestor
5955417|NCT04676139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5955418|NCT04676139|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5955419|NCT04676139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5955420|NCT04676139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5955421|NCT04676061|Norethindrone|norethindrone|mesh-list
5955422|NCT04676061|Norethindrone Acetate|norethindrone acetate|mesh-list
5955423|NCT04676061|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5955424|NCT04676061|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5955425|NCT04676061|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5955426|NCT04676061|Contraceptive Agents|contraceptive agents|mesh-ancestor
5955427|NCT04676061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5955428|NCT04676061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955429|NCT04676061|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5955430|NCT04676061|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5955431|NCT04676035|Vitamin K|vitamin k|mesh-list
5955432|NCT04676035|Vitamin K 1|vitamin k 1|mesh-list
5955433|NCT04676035|Midazolam|midazolam|mesh-list
5955434|NCT04676035|Omeprazole|omeprazole|mesh-list
5955435|NCT04676035|Warfarin|warfarin|mesh-list
5955436|NCT04676035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5955437|NCT04676035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5955438|NCT04676035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5955439|NCT04676035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955440|NCT04676035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5955441|NCT04676035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5955442|NCT04676035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5955443|NCT04676035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5955444|NCT04676035|Anesthetics, General|anesthetics, general|mesh-ancestor
5955445|NCT04676035|Anesthetics|anesthetics|mesh-ancestor
5955446|NCT04676035|GABA Modulators|gaba modulators|mesh-ancestor
5955447|NCT04676035|GABA Agents|gaba agents|mesh-ancestor
5955448|NCT04676035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5955449|NCT04676035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955450|NCT04676035|Anticoagulants|anticoagulants|mesh-ancestor
5955451|NCT04676035|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5955452|NCT04676035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5955453|NCT04676035|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5955454|NCT04676035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5955455|NCT04676035|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5955456|NCT04676035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5955457|NCT04676035|Hemostatics|hemostatics|mesh-ancestor
5955458|NCT04676035|Coagulants|coagulants|mesh-ancestor
5955459|NCT04676035|Vitamins|vitamins|mesh-ancestor
5955460|NCT04676035|Micronutrients|micronutrients|mesh-ancestor
5955461|NCT04675944|Treprostinil|treprostinil|mesh-list
5955462|NCT04675944|Zamicastat|zamicastat|mesh-list
5955463|NCT04675944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5955464|NCT04675944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5955465|NCT04675944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955466|NCT04675697|Etoposide|etoposide|mesh-list
5955467|NCT04675697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5955468|NCT04675697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5955469|NCT04675697|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5955470|NCT04675697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5955471|NCT04675697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5955472|NCT04675697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955473|NCT04676126|Dorzolamide|dorzolamide|mesh-list
5955474|NCT04676126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5955475|NCT04676126|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5955476|NCT04676126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5955477|NCT04676126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969525|NCT04543188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5969526|NCT04543188|Anesthetics, General|anesthetics, general|mesh-ancestor
5969527|NCT04543188|Anesthetics|anesthetics|mesh-ancestor
5969528|NCT04543188|GABA Modulators|gaba modulators|mesh-ancestor
5969529|NCT04543188|GABA Agents|gaba agents|mesh-ancestor
5969530|NCT04543188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5969531|NCT04543188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971216|NCT04529811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5971217|NCT04529811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5971218|NCT04529785|Ethanol|ethanol|mesh-list
5971219|NCT04529785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5971220|NCT04529785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5971221|NCT04529785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5971222|NCT04529785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971223|NCT04529668|Vitamin D|vitamin d|mesh-list
5971224|NCT04529668|Vitamins|vitamins|mesh-ancestor
5971225|NCT04529668|Micronutrients|micronutrients|mesh-ancestor
5971226|NCT04529668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971227|NCT04529668|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5971228|NCT04529525|Ivermectin|ivermectin|mesh-list
5971229|NCT04529525|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5971230|NCT04529525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5971231|NCT04529512|Dexamethasone|dexamethasone|mesh-list
5971232|NCT04529512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5971233|NCT04529512|Antiemetics|antiemetics|mesh-ancestor
5971234|NCT04529512|Autonomic Agents|autonomic agents|mesh-ancestor
5971235|NCT04529512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5971236|NCT04529512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971237|NCT04529512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5971238|NCT04529512|Glucocorticoids|glucocorticoids|mesh-ancestor
5971239|NCT04529512|Hormones|hormones|mesh-ancestor
5971240|NCT04529512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5971241|NCT04529512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5971242|NCT04529512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5971243|NCT04529356|Acetaminophen|acetaminophen|mesh-list
5971244|NCT04529356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5971245|NCT04529356|Analgesics|analgesics|mesh-ancestor
5971246|NCT04529356|Sensory System Agents|sensory system agents|mesh-ancestor
5971247|NCT04529356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5971248|NCT04529356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971249|NCT04529356|Antipyretics|antipyretics|mesh-ancestor
5971250|NCT04529044|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
5971251|NCT04529044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971252|NCT04529044|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5971253|NCT04529135|Dexmedetomidine|dexmedetomidine|mesh-list
5971254|NCT04529135|Remifentanil|remifentanil|mesh-list
5971255|NCT04529135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5971256|NCT04529135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5971257|NCT04529135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971258|NCT04529135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5971259|NCT04529135|Analgesics|analgesics|mesh-ancestor
5971260|NCT04529135|Sensory System Agents|sensory system agents|mesh-ancestor
5971261|NCT04529135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5971262|NCT04529135|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5971263|NCT04529135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5971264|NCT04529135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5971265|NCT04529135|Adrenergic Agents|adrenergic agents|mesh-ancestor
5971266|NCT04529135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5971267|NCT04529135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971268|NCT04529135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5971269|NCT04529135|Narcotics|narcotics|mesh-ancestor
5971270|NCT04529187|Midazolam|midazolam|mesh-list
5971271|NCT04529187|Dexmedetomidine|dexmedetomidine|mesh-list
5971272|NCT04529187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5971273|NCT04529187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5971274|NCT04529187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971275|NCT04529187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5971276|NCT04529187|Analgesics|analgesics|mesh-ancestor
5971277|NCT04529187|Sensory System Agents|sensory system agents|mesh-ancestor
5971278|NCT04529187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5971279|NCT04529187|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5955478|NCT04675619|Pirfenidone|pirfenidone|mesh-list
5955479|NCT04675619|Analgesics|analgesics|mesh-ancestor
5955480|NCT04675619|Sensory System Agents|sensory system agents|mesh-ancestor
5955481|NCT04675619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5955482|NCT04675619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955483|NCT04675619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5955484|NCT04675619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5955485|NCT04675619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5955486|NCT04675619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5955487|NCT04675619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5955488|NCT04676087|Mogamulizumab|mogamulizumab|mesh-list
5955489|NCT04676087|Immunoglobulins|immunoglobulins|mesh-list
5955490|NCT04676087|Immunoglobulin G|immunoglobulin g|mesh-list
5955491|NCT04676087|Immunologic Factors|immunologic factors|mesh-ancestor
5955492|NCT04676087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955493|NCT04676087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5955494|NCT04675827|Trastuzumab|trastuzumab|mesh-list
5955495|NCT04675827|Pertuzumab|pertuzumab|mesh-list
5955496|NCT04675827|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
5955497|NCT04675827|Maytansine|maytansine|mesh-list
5955498|NCT04675827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5955499|NCT04675827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5955500|NCT04675827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5955501|NCT04675827|Tubulin Modulators|tubulin modulators|mesh-ancestor
5955502|NCT04675827|Antimitotic Agents|antimitotic agents|mesh-ancestor
5955503|NCT04675827|Mitosis Modulators|mitosis modulators|mesh-ancestor
5955504|NCT04675827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955505|NCT04675762|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
5955506|NCT04675762|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5955507|NCT04675762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955508|NCT04675762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5955509|NCT04675762|Immunologic Factors|immunologic factors|mesh-ancestor
5955510|NCT04675762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955511|NCT04675710|Pembrolizumab|pembrolizumab|mesh-list
5955512|NCT04675710|Trametinib|trametinib|mesh-list
5955513|NCT04675710|Dabrafenib|dabrafenib|mesh-list
5955514|NCT04675710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5955515|NCT04675710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5955516|NCT04675710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5955517|NCT04675710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5955518|NCT04675710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955519|NCT04675528|Paclitaxel|paclitaxel|mesh-list
5955520|NCT04675528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5955521|NCT04675528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5955522|NCT04675528|Tubulin Modulators|tubulin modulators|mesh-ancestor
5955523|NCT04675528|Antimitotic Agents|antimitotic agents|mesh-ancestor
5955524|NCT04675528|Mitosis Modulators|mitosis modulators|mesh-ancestor
5955525|NCT04675528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955526|NCT04675983|Fluorouracil|fluorouracil|mesh-list
5955527|NCT04675983|Capecitabine|capecitabine|mesh-list
5955528|NCT04675983|Oxaliplatin|oxaliplatin|mesh-list
5955529|NCT04675983|Ramucirumab|ramucirumab|mesh-list
5955530|NCT04675983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5955531|NCT04675983|Antimetabolites|antimetabolites|mesh-ancestor
5955532|NCT04675983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955533|NCT04675983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5955534|NCT04675983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5955535|NCT04675983|Immunologic Factors|immunologic factors|mesh-ancestor
5955536|NCT04675983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955537|NCT04675177|Polidocanol|polidocanol|mesh-list
5955538|NCT04675177|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
5955539|NCT04675177|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5955540|NCT04675385|Hyaluronic Acid|hyaluronic acid|mesh-list
5955541|NCT04675385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5955542|NCT04675385|Immunologic Factors|immunologic factors|mesh-ancestor
5955543|NCT04675385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955544|NCT04675385|Viscosupplements|viscosupplements|mesh-ancestor
5955545|NCT04675385|Protective Agents|protective agents|mesh-ancestor
5955546|NCT04675086|Antiviral Agents|antiviral agents|mesh-list
5955547|NCT04675086|Remdesivir|remdesivir|mesh-list
5955548|NCT04675086|Protease Inhibitors|protease inhibitors|mesh-list
5955549|NCT04675086|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
5955550|NCT04675086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5955551|NCT04675086|Antimetabolites|antimetabolites|mesh-ancestor
5955552|NCT04675086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955553|NCT04675086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5955554|NCT04675086|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5955555|NCT04675086|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5955556|NCT04675372|Midazolam|midazolam|mesh-list
5955557|NCT04675372|Dexmedetomidine|dexmedetomidine|mesh-list
5955558|NCT04675372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5955559|NCT04675372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5955560|NCT04675372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955561|NCT04675372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5955562|NCT04675372|Analgesics|analgesics|mesh-ancestor
5955563|NCT04675372|Sensory System Agents|sensory system agents|mesh-ancestor
5955564|NCT04675372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5955565|NCT04675372|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5955566|NCT04675372|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5955567|NCT04675372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5955568|NCT04675372|Adrenergic Agents|adrenergic agents|mesh-ancestor
5955569|NCT04675372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5955570|NCT04675372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955571|NCT04675372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5955572|NCT04675372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5955573|NCT04675372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5955574|NCT04675372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5955575|NCT04675372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5955576|NCT04675372|Anesthetics, General|anesthetics, general|mesh-ancestor
5955577|NCT04675372|Anesthetics|anesthetics|mesh-ancestor
5955578|NCT04675372|GABA Modulators|gaba modulators|mesh-ancestor
5955579|NCT04675372|GABA Agents|gaba agents|mesh-ancestor
5955580|NCT04674956|Gemcitabine|gemcitabine|mesh-list
5955581|NCT04674956|Paclitaxel|paclitaxel|mesh-list
5955582|NCT04674956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5955583|NCT04674956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5955584|NCT04674956|Tubulin Modulators|tubulin modulators|mesh-ancestor
5955585|NCT04674956|Antimitotic Agents|antimitotic agents|mesh-ancestor
5955586|NCT04674956|Mitosis Modulators|mitosis modulators|mesh-ancestor
5955587|NCT04674956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955588|NCT04674956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5955589|NCT04674956|Antimetabolites|antimetabolites|mesh-ancestor
5955590|NCT04674956|Antiviral Agents|antiviral agents|mesh-ancestor
5955591|NCT04674956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5955592|NCT04674956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5955593|NCT04674956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5955594|NCT04674956|Immunologic Factors|immunologic factors|mesh-ancestor
5955595|NCT04674956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955596|NCT04675021|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5955597|NCT04674813|Cyclophosphamide|cyclophosphamide|mesh-list
5955598|NCT04674813|Fludarabine|fludarabine|mesh-list
5955599|NCT04674813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5955600|NCT04674813|Immunologic Factors|immunologic factors|mesh-ancestor
5955601|NCT04674813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955602|NCT04674813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5955603|NCT04674813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5955604|NCT04674813|Alkylating Agents|alkylating agents|mesh-ancestor
5955605|NCT04674813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955606|NCT04674813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5955607|NCT04674813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5955608|NCT04674423|Tenofovir|tenofovir|mesh-list
5955609|NCT04674423|Antiviral Agents|antiviral agents|mesh-ancestor
5955610|NCT04674423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5955611|NCT04674423|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5955612|NCT04674423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5955613|NCT04674423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5720660|NCT03211338|Mitogens|mitogens|mesh-list
5720661|NCT03211338|Progestins|progestins|mesh-ancestor
5720662|NCT03211338|Hormones|hormones|mesh-ancestor
5720663|NCT03211338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5720664|NCT03211338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720665|NCT03211338|Mitosis Modulators|mitosis modulators|mesh-ancestor
5720666|NCT03211338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5720667|NCT03211065|Immunoglobulins|immunoglobulins|mesh-list
5955614|NCT04674423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955615|NCT04674423|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5955616|NCT04674423|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5955617|NCT04674358|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5955618|NCT04674358|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5955619|NCT04674332|Insulin, Long-Acting|insulin, long-acting|mesh-list
5955620|NCT04674332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5969532|NCT04543123|Citalopram|citalopram|mesh-list
5955621|NCT04674332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955622|NCT04674176|Rifaximin|rifaximin|mesh-list
5955623|NCT04674176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5955624|NCT04674176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5955625|NCT04674176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5955626|NCT04674254|Bevacizumab|bevacizumab|mesh-list
5955627|NCT04674254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5955628|NCT04674254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5955629|NCT04674254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5955630|NCT04674254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5955631|NCT04674254|Growth Substances|growth substances|mesh-ancestor
5955632|NCT04674254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955633|NCT04674254|Growth Inhibitors|growth inhibitors|mesh-ancestor
5955634|NCT04674527|Temozolomide|temozolomide|mesh-list
5955635|NCT04674527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5955636|NCT04674527|Alkylating Agents|alkylating agents|mesh-ancestor
5955637|NCT04674527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955638|NCT04674527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5955639|NCT04674514|Dexamethasone|dexamethasone|mesh-list
5955640|NCT04674514|Lenalidomide|lenalidomide|mesh-list
5955641|NCT04674514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5955642|NCT04674514|Antiemetics|antiemetics|mesh-ancestor
5955643|NCT04674514|Autonomic Agents|autonomic agents|mesh-ancestor
5955644|NCT04674514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5955645|NCT04674514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955646|NCT04674514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5955647|NCT04674514|Glucocorticoids|glucocorticoids|mesh-ancestor
5955648|NCT04674514|Hormones|hormones|mesh-ancestor
5955649|NCT04674514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5955650|NCT04674514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5955651|NCT04674514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5955652|NCT04674514|Immunologic Factors|immunologic factors|mesh-ancestor
5955653|NCT04674514|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5955654|NCT04674514|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5955655|NCT04674514|Growth Substances|growth substances|mesh-ancestor
5955656|NCT04674514|Growth Inhibitors|growth inhibitors|mesh-ancestor
5955657|NCT04673877|Vancomycin|vancomycin|mesh-list
5955658|NCT04673877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5955659|NCT04673877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5955660|NCT04673955|Cetuximab|cetuximab|mesh-list
5955661|NCT04673955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5955662|NCT04673955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5969533|NCT04543123|Antidepressive Agents|antidepressive agents|mesh-list
5969534|NCT04543123|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5969535|NCT04543123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6681432|NCT01609855|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
6681433|NCT01609855|Anticonvulsants|anticonvulsants|mesh-ancestor
6681434|NCT01609855|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6681435|NCT01609855|Antiemetics|antiemetics|mesh-ancestor
6681436|NCT01609855|Autonomic Agents|autonomic agents|mesh-ancestor
6681437|NCT01609855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6681438|NCT01609855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681439|NCT01609855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6681440|NCT01609855|Mydriatics|mydriatics|mesh-ancestor
6681441|NCT01609855|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6681442|NCT01609855|Cholinergic Agents|cholinergic agents|mesh-ancestor
6681443|NCT01609855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6681444|NCT01609855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681445|NCT01609855|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6681446|NCT01609855|Parasympatholytics|parasympatholytics|mesh-ancestor
6681447|NCT01609881|Ketorolac|ketorolac|mesh-list
6681448|NCT01609881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6681449|NCT01609881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6681450|NCT01609881|Analgesics|analgesics|mesh-ancestor
6681451|NCT01609881|Sensory System Agents|sensory system agents|mesh-ancestor
6681452|NCT01609881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6681453|NCT01609881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681454|NCT01609881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6681455|NCT01609881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6681456|NCT01609881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6681457|NCT01609881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6681458|NCT01609881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681459|NCT01609907|Valsartan|valsartan|mesh-list
6681460|NCT01609907|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6517500|NCT00721344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6517501|NCT00721448|Ticagrelor|ticagrelor|mesh-list
6517502|NCT00721448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6517503|NCT00721448|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6517504|NCT00721448|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6517505|NCT00721448|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6517506|NCT00721448|Purinergic Agents|purinergic agents|mesh-ancestor
6517507|NCT00721448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6517508|NCT00721448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955663|NCT04673799|Denosumab|denosumab|mesh-list
5955664|NCT04673799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5955665|NCT04673799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955666|NCT04673812|Fentanyl|fentanyl|mesh-list
5955667|NCT04673812|Bupivacaine|bupivacaine|mesh-list
5955668|NCT04673812|Naloxone|naloxone|mesh-list
5955669|NCT04673812|Anesthetics, Local|anesthetics, local|mesh-ancestor
5955670|NCT04673812|Anesthetics|anesthetics|mesh-ancestor
5955671|NCT04673812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5955672|NCT04673812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955673|NCT04673812|Sensory System Agents|sensory system agents|mesh-ancestor
5955674|NCT04673812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5955675|NCT04673812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5955676|NCT04673812|Narcotics|narcotics|mesh-ancestor
5955677|NCT04673812|Analgesics|analgesics|mesh-ancestor
5955678|NCT04673812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5955679|NCT04673812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5955680|NCT04673812|Anesthetics, General|anesthetics, general|mesh-ancestor
5955681|NCT04673812|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5955682|NCT04674137|Histamine|histamine|mesh-list
5955683|NCT04674137|Glutarimide|glutarimide|mesh-list
5955684|NCT04674137|Histamine Agonists|histamine agonists|mesh-ancestor
5955685|NCT04674137|Histamine Agents|histamine agents|mesh-ancestor
5955686|NCT04674137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5955687|NCT04674137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955688|NCT04674137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955689|NCT04674137|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5955690|NCT04674137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5955691|NCT04673487|Immunoglobulin G|immunoglobulin g|mesh-list
5955692|NCT04673487|Immunoglobulin M|immunoglobulin m|mesh-list
5955693|NCT04673487|Immunologic Factors|immunologic factors|mesh-ancestor
5955694|NCT04673487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955695|NCT04673461|Xylometazoline|xylometazoline|mesh-list
5955696|NCT04673461|Nasal Decongestants|nasal decongestants|mesh-ancestor
5955697|NCT04673461|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5955698|NCT04673461|Respiratory System Agents|respiratory system agents|mesh-ancestor
5955699|NCT04673500|Lidocaine|lidocaine|mesh-list
5955700|NCT04673500|Propofol|propofol|mesh-list
5955701|NCT04673500|Anesthetics, Local|anesthetics, local|mesh-ancestor
5955702|NCT04673500|Anesthetics|anesthetics|mesh-ancestor
5955703|NCT04673500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5955704|NCT04673500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955705|NCT04673500|Sensory System Agents|sensory system agents|mesh-ancestor
5955706|NCT04673500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5955707|NCT04673500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5955708|NCT04673500|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5955709|NCT04673500|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5955710|NCT04673500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5955711|NCT04673500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955712|NCT04673500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5955713|NCT04673500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5955714|NCT04673500|Anesthetics, General|anesthetics, general|mesh-ancestor
5955715|NCT04673578|Celecoxib|celecoxib|mesh-list
5955716|NCT04673578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5955717|NCT04673578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5955718|NCT04673578|Analgesics|analgesics|mesh-ancestor
5955719|NCT04673578|Sensory System Agents|sensory system agents|mesh-ancestor
5955720|NCT04673578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5955721|NCT04673578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955722|NCT04673578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5955723|NCT04673578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5955724|NCT04673578|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5955725|NCT04673578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5955726|NCT04673578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5955727|NCT04673578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955728|NCT04673396|Norcantharidin|norcantharidin|mesh-list
5955729|NCT04673396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5955730|NCT04673396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5955731|NCT04673396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955732|NCT04673422|Montelukast|montelukast|mesh-list
5955733|NCT04673422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5955734|NCT04673422|Respiratory System Agents|respiratory system agents|mesh-ancestor
5955735|NCT04673422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5955736|NCT04673422|Hormone Antagonists|hormone antagonists|mesh-ancestor
5955737|NCT04673422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5955738|NCT04673422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955739|NCT04673422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5955740|NCT04673422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5955741|NCT04673422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955742|NCT04672928|Paclitaxel|paclitaxel|mesh-list
5955743|NCT04672928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5955744|NCT04672928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5955745|NCT04672928|Tubulin Modulators|tubulin modulators|mesh-ancestor
5955746|NCT04672928|Antimitotic Agents|antimitotic agents|mesh-ancestor
5955747|NCT04672928|Mitosis Modulators|mitosis modulators|mesh-ancestor
5955748|NCT04672928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955749|NCT04673162|Methylprednisolone|methylprednisolone|mesh-list
5955750|NCT04673162|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5955751|NCT04673162|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5955752|NCT04673162|Prednisolone|prednisolone|mesh-list
5955753|NCT04673162|Prednisolone acetate|prednisolone acetate|mesh-list
5955754|NCT04673162|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5955755|NCT04673162|Prednisolone phosphate|prednisolone phosphate|mesh-list
5955756|NCT04673162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5955757|NCT04673162|Antiemetics|antiemetics|mesh-ancestor
5955758|NCT04673162|Autonomic Agents|autonomic agents|mesh-ancestor
5955759|NCT04673162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5955760|NCT04673162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955761|NCT04673162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5955762|NCT04673162|Glucocorticoids|glucocorticoids|mesh-ancestor
5955763|NCT04673162|Hormones|hormones|mesh-ancestor
5955764|NCT04673162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5955765|NCT04673162|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5955766|NCT04673162|Protective Agents|protective agents|mesh-ancestor
5955767|NCT04673162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5955768|NCT04673162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5955769|NCT04673240|Botulinum Toxins|botulinum toxins|mesh-list
5955770|NCT04673240|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5955771|NCT04673240|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5955772|NCT04673240|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5955773|NCT04673240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5955774|NCT04673240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955775|NCT04673240|Cholinergic Agents|cholinergic agents|mesh-ancestor
5955776|NCT04673240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5955777|NCT04673240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955778|NCT04673240|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5955779|NCT04673240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5955780|NCT04673214|Acetaminophen|acetaminophen|mesh-list
5955781|NCT04673214|Azithromycin|azithromycin|mesh-list
5955782|NCT04673214|Ivermectin|ivermectin|mesh-list
5955783|NCT04673214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5955784|NCT04673214|Analgesics|analgesics|mesh-ancestor
5955785|NCT04673214|Sensory System Agents|sensory system agents|mesh-ancestor
5955786|NCT04673214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5955787|NCT04673214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955788|NCT04673214|Antipyretics|antipyretics|mesh-ancestor
5955789|NCT04673214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5955790|NCT04673214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5955791|NCT04673214|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5955792|NCT04672772|Paclitaxel|paclitaxel|mesh-list
5955793|NCT04672772|Cetuximab|cetuximab|mesh-list
5955794|NCT04672772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5955795|NCT04672772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5955796|NCT04672772|Tubulin Modulators|tubulin modulators|mesh-ancestor
5955797|NCT04672772|Antimitotic Agents|antimitotic agents|mesh-ancestor
5955798|NCT04672772|Mitosis Modulators|mitosis modulators|mesh-ancestor
5955799|NCT04672772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955800|NCT04672772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5955801|NCT04672759|Durvalumab|durvalumab|mesh-list
5955802|NCT04672759|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5955803|NCT04672759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5955804|NCT04672759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5955805|NCT04672759|Immunologic Factors|immunologic factors|mesh-ancestor
5955806|NCT04672759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955807|NCT04672499|Cortisone|cortisone|mesh-list
5955808|NCT04672499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5955809|NCT04672525|Rifampin|rifampin|mesh-list
5955810|NCT04672525|Rifabutin|rifabutin|mesh-list
5955811|NCT04672525|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5955812|NCT04672525|Antitubercular Agents|antitubercular agents|mesh-ancestor
5955813|NCT04672525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5955814|NCT04672525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5955815|NCT04672525|Leprostatic Agents|leprostatic agents|mesh-ancestor
5955816|NCT04672525|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5955817|NCT04672525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5955818|NCT04672525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955819|NCT04672525|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5955820|NCT04672525|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6517509|NCT00721448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517510|NCT00721487|Fluconazole|fluconazole|mesh-list
6517511|NCT00721487|Antifungal Agents|antifungal agents|mesh-ancestor
6517512|NCT00721487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5955821|NCT04672525|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5955822|NCT04672525|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5955823|NCT04672525|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5955824|NCT04672525|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5955825|NCT04672707|Bromhexine|bromhexine|mesh-list
5955826|NCT04672707|Expectorants|expectorants|mesh-ancestor
5955827|NCT04672707|Respiratory System Agents|respiratory system agents|mesh-ancestor
5955828|NCT04672213|Tranexamic Acid|tranexamic acid|mesh-list
5955829|NCT04672213|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5955830|NCT04672213|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5955831|NCT04672213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955832|NCT04672213|Hemostatics|hemostatics|mesh-ancestor
5955833|NCT04672213|Coagulants|coagulants|mesh-ancestor
5969536|NCT04543123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5969537|NCT04543123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969538|NCT04543123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5969539|NCT04543123|Serotonin Agents|serotonin agents|mesh-ancestor
5969540|NCT04543123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969541|NCT04543123|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5969542|NCT04543123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5969543|NCT04542980|Autoantibodies|autoantibodies|mesh-list
5969544|NCT04542980|Immunologic Factors|immunologic factors|mesh-ancestor
5969545|NCT04542980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969546|NCT04542694|Favipiravir|favipiravir|mesh-list
5969547|NCT04542694|Antiviral Agents|antiviral agents|mesh-ancestor
5969548|NCT04542694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5969549|NCT04542993|Zinc|zinc|mesh-list
5969550|NCT04542993|Resveratrol|resveratrol|mesh-list
5969551|NCT04542993|Picolinic acid|picolinic acid|mesh-list
5969552|NCT04542993|Trace Elements|trace elements|mesh-ancestor
5969553|NCT04542993|Micronutrients|micronutrients|mesh-ancestor
5969554|NCT04542993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969555|NCT04542993|Antioxidants|antioxidants|mesh-ancestor
5969556|NCT04542993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969557|NCT04542993|Protective Agents|protective agents|mesh-ancestor
5969558|NCT04542993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5969559|NCT04542993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5969560|NCT04542993|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5969561|NCT04542993|Chelating Agents|chelating agents|mesh-ancestor
5969562|NCT04542993|Sequestering Agents|sequestering agents|mesh-ancestor
5969563|NCT04542837|Lenvatinib|lenvatinib|mesh-list
5969564|NCT04542837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5969565|NCT04542837|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5969566|NCT04542837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5969567|NCT04542837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969568|NCT04542629|Trace Elements|trace elements|mesh-list
5969569|NCT04542629|Rituximab|rituximab|mesh-list
6517513|NCT00721487|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5969570|NCT04542629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5969571|NCT04542629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5969572|NCT04542629|Immunologic Factors|immunologic factors|mesh-ancestor
5969573|NCT04542629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955834|NCT04672291|Poly I-C|poly i-c|mesh-list
5955835|NCT04672291|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
5955836|NCT04672291|Poly ICLC|poly iclc|mesh-list
5955837|NCT04672291|Interferon Inducers|interferon inducers|mesh-ancestor
5955838|NCT04672291|Immunologic Factors|immunologic factors|mesh-ancestor
5955839|NCT04672291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955840|NCT04672291|Laxatives|laxatives|mesh-ancestor
5955841|NCT04672291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5955842|NCT04672291|Antiviral Agents|antiviral agents|mesh-ancestor
5955843|NCT04672291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5955844|NCT04672005|Leucovorin|leucovorin|mesh-list
5955845|NCT04672005|Gemcitabine|gemcitabine|mesh-list
5955846|NCT04672005|Paclitaxel|paclitaxel|mesh-list
5955847|NCT04672005|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5955848|NCT04672005|Oxaliplatin|oxaliplatin|mesh-list
5955849|NCT04672005|Irinotecan|irinotecan|mesh-list
5955850|NCT04672005|Folfirinox|folfirinox|mesh-list
5955851|NCT04672005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5955852|NCT04672005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5955853|NCT04672005|Tubulin Modulators|tubulin modulators|mesh-ancestor
5955854|NCT04672005|Antimitotic Agents|antimitotic agents|mesh-ancestor
5955855|NCT04672005|Mitosis Modulators|mitosis modulators|mesh-ancestor
5955856|NCT04672005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955857|NCT04672005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5955858|NCT04672005|Antimetabolites|antimetabolites|mesh-ancestor
5955859|NCT04672005|Antiviral Agents|antiviral agents|mesh-ancestor
5955860|NCT04672005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5955861|NCT04672005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5955862|NCT04672005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5955863|NCT04672005|Immunologic Factors|immunologic factors|mesh-ancestor
5955864|NCT04672005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955865|NCT04672005|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5955866|NCT04672005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5955867|NCT04672005|Antidotes|antidotes|mesh-ancestor
5955868|NCT04672005|Protective Agents|protective agents|mesh-ancestor
5955869|NCT04672005|Vitamin B Complex|vitamin b complex|mesh-ancestor
5955870|NCT04672005|Vitamins|vitamins|mesh-ancestor
5955871|NCT04672005|Micronutrients|micronutrients|mesh-ancestor
5955872|NCT04671914|Hyaluronic Acid|hyaluronic acid|mesh-list
5955873|NCT04671914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5955874|NCT04671914|Immunologic Factors|immunologic factors|mesh-ancestor
5955875|NCT04671914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955876|NCT04671914|Viscosupplements|viscosupplements|mesh-ancestor
5955877|NCT04671914|Protective Agents|protective agents|mesh-ancestor
5955878|NCT04671836|Lorazepam|lorazepam|mesh-list
5955879|NCT04671836|Anticonvulsants|anticonvulsants|mesh-ancestor
5955880|NCT04671836|Antiemetics|antiemetics|mesh-ancestor
5955881|NCT04671836|Autonomic Agents|autonomic agents|mesh-ancestor
5955882|NCT04671836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5955883|NCT04671836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955884|NCT04671836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5955885|NCT04671836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5955886|NCT04671836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5955887|NCT04671836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5955888|NCT04671836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5955889|NCT04671836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5955890|NCT04671836|GABA Modulators|gaba modulators|mesh-ancestor
5955891|NCT04671836|GABA Agents|gaba agents|mesh-ancestor
5955892|NCT04671836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5955893|NCT04671836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955894|NCT04671966|Cetrorelix|cetrorelix|mesh-list
5955895|NCT04671966|Estradiol|estradiol|mesh-list
5955896|NCT04671966|Estrogens|estrogens|mesh-ancestor
5955897|NCT04671966|Hormones|hormones|mesh-ancestor
5955898|NCT04671966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5955899|NCT04671966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955900|NCT04671966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5955901|NCT04671966|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5955902|NCT04671966|Fertility Agents|fertility agents|mesh-ancestor
5955903|NCT04671966|Hormone Antagonists|hormone antagonists|mesh-ancestor
5955904|NCT04671589|Meropenem|meropenem|mesh-list
5955905|NCT04671589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5955906|NCT04671589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5955907|NCT04671563|Tenofovir|tenofovir|mesh-list
5955908|NCT04671563|Antiviral Agents|antiviral agents|mesh-ancestor
5955909|NCT04671563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5955910|NCT04671563|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5955911|NCT04671563|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5955912|NCT04671563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5969574|NCT04542629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5955913|NCT04671563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955914|NCT04671563|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5955915|NCT04671563|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5955916|NCT04671446|Autoantibodies|autoantibodies|mesh-list
5955917|NCT04671446|Immunologic Factors|immunologic factors|mesh-ancestor
5955918|NCT04671446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955919|NCT04671160|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5955920|NCT04671160|Dalteparin|dalteparin|mesh-list
5955921|NCT04671160|Anticoagulants|anticoagulants|mesh-ancestor
5955922|NCT04671160|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5955923|NCT04671160|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5955924|NCT04671160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955925|NCT04671394|Photosensitizing Agents|photosensitizing agents|mesh-list
5955926|NCT04671394|Dermatologic Agents|dermatologic agents|mesh-ancestor
5955927|NCT04671420|Rituximab|rituximab|mesh-list
5955928|NCT04671420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5955929|NCT04671420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5955930|NCT04671420|Immunologic Factors|immunologic factors|mesh-ancestor
5955931|NCT04671420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955932|NCT04671420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5955933|NCT04671108|Hyaluronic Acid|hyaluronic acid|mesh-list
5955934|NCT04671108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5955935|NCT04671108|Immunologic Factors|immunologic factors|mesh-ancestor
5955936|NCT04671108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955937|NCT04671108|Viscosupplements|viscosupplements|mesh-ancestor
5955938|NCT04671108|Protective Agents|protective agents|mesh-ancestor
5955939|NCT04670978|Bevacizumab|bevacizumab|mesh-list
5955940|NCT04670978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5955941|NCT04670978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5955942|NCT04670978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5955943|NCT04670978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5955944|NCT04670978|Growth Substances|growth substances|mesh-ancestor
5955945|NCT04670978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955946|NCT04670978|Growth Inhibitors|growth inhibitors|mesh-ancestor
5955947|NCT04671056|Pioglitazone|pioglitazone|mesh-list
5955948|NCT04671056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5955949|NCT04671056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955950|NCT04670653|Mometasone Furoate|mometasone furoate|mesh-list
5955951|NCT04670653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5955952|NCT04670653|Dermatologic Agents|dermatologic agents|mesh-ancestor
5955953|NCT04670653|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5955954|NCT04670601|Flurbiprofen|flurbiprofen|mesh-list
5955955|NCT04670601|Analgesics|analgesics|mesh-ancestor
5955956|NCT04670601|Sensory System Agents|sensory system agents|mesh-ancestor
5955957|NCT04670601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5955958|NCT04670601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955959|NCT04670601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5955960|NCT04670601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5955961|NCT04670601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5955962|NCT04670601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5955963|NCT04670601|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5955964|NCT04670601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5955965|NCT04670601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955966|NCT04670913|Apatinib|apatinib|mesh-list
5955967|NCT04670913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5955968|NCT04670913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5955969|NCT04670913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5955970|NCT04670913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955971|NCT04671069|Clopidogrel|clopidogrel|mesh-list
5955972|NCT04671069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5955973|NCT04671069|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5955974|NCT04671069|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5955975|NCT04671069|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5955976|NCT04671069|Purinergic Agents|purinergic agents|mesh-ancestor
5955977|NCT04671069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5955978|NCT04671069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955979|NCT04671069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955980|NCT04670796|Trastuzumab|trastuzumab|mesh-list
5955981|NCT04670796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5955982|NCT04670796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5955983|NCT04670809|Clevidipine|clevidipine|mesh-list
5955984|NCT04670809|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5955985|NCT04670809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5955986|NCT04670809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955987|NCT04670809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5955988|NCT04670809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955989|NCT04670666|Metformin|metformin|mesh-list
5955990|NCT04670666|Empagliflozin|empagliflozin|mesh-list
5955991|NCT04670666|Linagliptin|linagliptin|mesh-list
5955992|NCT04670666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5955993|NCT04670666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5955994|NCT04670666|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5955995|NCT04670666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5955996|NCT04670666|Incretins|incretins|mesh-ancestor
5955997|NCT04670666|Hormones|hormones|mesh-ancestor
5955998|NCT04670666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5955999|NCT04670666|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5956000|NCT04670666|Protease Inhibitors|protease inhibitors|mesh-ancestor
5956001|NCT04670666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5956002|NCT04670471|Remifentanil|remifentanil|mesh-list
5956003|NCT04670471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5956004|NCT04670471|Narcotics|narcotics|mesh-ancestor
5956005|NCT04670471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5956006|NCT04670471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956007|NCT04670471|Analgesics|analgesics|mesh-ancestor
5956008|NCT04670471|Sensory System Agents|sensory system agents|mesh-ancestor
5956009|NCT04670471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5969575|NCT04542629|Micronutrients|micronutrients|mesh-ancestor
5969576|NCT04542759|Besifloxacin|besifloxacin|mesh-list
5969577|NCT04542759|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5969578|NCT04542759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5969579|NCT04542759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5969580|NCT04542759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5969581|NCT04542759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5969582|NCT04542759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5969583|NCT04542759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5969584|NCT04542759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969585|NCT04542759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5969586|NCT04542733|Everolimus|everolimus|mesh-list
5969587|NCT04542733|Tacrolimus|tacrolimus|mesh-list
5969588|NCT04542733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5969589|NCT04542733|Immunologic Factors|immunologic factors|mesh-ancestor
5969590|NCT04542733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969591|NCT04542733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5969592|NCT04542733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5969593|NCT04542733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969594|NCT04542733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5969595|NCT04542395|Vaccines|vaccines|mesh-list
5969596|NCT04542395|Immunologic Factors|immunologic factors|mesh-ancestor
5969597|NCT04542395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969598|NCT04542473|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
5969599|NCT04542473|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5969600|NCT04542473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5969601|NCT04542226|Bromides|bromides|mesh-list
5969602|NCT04542226|Anticonvulsants|anticonvulsants|mesh-ancestor
5969603|NCT04542213|Insulin|insulin|mesh-list
5969604|NCT04542213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5969605|NCT04542213|Linagliptin|linagliptin|mesh-list
5969606|NCT04542213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5969607|NCT04542213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969608|NCT04542213|Incretins|incretins|mesh-ancestor
5969609|NCT04542213|Hormones|hormones|mesh-ancestor
5969610|NCT04542213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5969611|NCT04542213|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5969612|NCT04542213|Protease Inhibitors|protease inhibitors|mesh-ancestor
5969613|NCT04542213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5969614|NCT04542213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969615|NCT04542382|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5969616|NCT04542382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5969617|NCT04542382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5969618|NCT04542382|Antimetabolites|antimetabolites|mesh-ancestor
5969619|NCT04542382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969620|NCT04542382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5969621|NCT04542382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5969622|NCT04542382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5969623|NCT04542369|Etoposide|etoposide|mesh-list
5969624|NCT04542369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5969625|NCT04542369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5969626|NCT04542369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5956010|NCT04670432|Troxerutin|troxerutin|mesh-list
5956011|NCT04670432|Anticoagulants|anticoagulants|mesh-ancestor
5956012|NCT04670497|Epinephrine|epinephrine|mesh-list
5956013|NCT04670497|Racepinephrine|racepinephrine|mesh-list
5956014|NCT04670497|Bupivacaine|bupivacaine|mesh-list
5956015|NCT04670497|Epinephryl borate|epinephryl borate|mesh-list
5956016|NCT04670497|Anesthetics, Local|anesthetics, local|mesh-ancestor
5956017|NCT04670497|Anesthetics|anesthetics|mesh-ancestor
5956018|NCT04670497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5956019|NCT04670497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956020|NCT04670497|Sensory System Agents|sensory system agents|mesh-ancestor
5956021|NCT04670497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5956022|NCT04670497|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5956023|NCT04670497|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5956024|NCT04670497|Adrenergic Agents|adrenergic agents|mesh-ancestor
5956025|NCT04670497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5956026|NCT04670497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5956027|NCT04670497|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5956028|NCT04670497|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5956029|NCT04670497|Autonomic Agents|autonomic agents|mesh-ancestor
5956030|NCT04670497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5956031|NCT04670497|Respiratory System Agents|respiratory system agents|mesh-ancestor
5956032|NCT04670497|Mydriatics|mydriatics|mesh-ancestor
5956033|NCT04670497|Sympathomimetics|sympathomimetics|mesh-ancestor
5956034|NCT04670497|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5956035|NCT04670107|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5956036|NCT04670107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5956037|NCT04670107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5956038|NCT04670224|Anesthetics|anesthetics|mesh-list
5956039|NCT04670224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5956040|NCT04670224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956041|NCT04669821|Propofol|propofol|mesh-list
5956042|NCT04669821|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5956043|NCT04669821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5956044|NCT04669821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956045|NCT04669821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5956046|NCT04669821|Anesthetics, General|anesthetics, general|mesh-ancestor
5956047|NCT04669821|Anesthetics|anesthetics|mesh-ancestor
5956048|NCT04670081|Niacinamide|niacinamide|mesh-list
5956049|NCT04670081|Niacin|niacin|mesh-list
5956050|NCT04670081|Nicotinic Acids|nicotinic acids|mesh-list
5956051|NCT04670081|Psilocybin|psilocybin|mesh-list
5956052|NCT04670081|Vitamin B Complex|vitamin b complex|mesh-ancestor
5956053|NCT04670081|Vitamins|vitamins|mesh-ancestor
5956054|NCT04670081|Micronutrients|micronutrients|mesh-ancestor
5956055|NCT04670081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956056|NCT04670081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5956057|NCT04670081|Antimetabolites|antimetabolites|mesh-ancestor
5956058|NCT04670081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5956059|NCT04670081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5956060|NCT04670081|Vasodilator Agents|vasodilator agents|mesh-ancestor
5956061|NCT04670081|Hallucinogens|hallucinogens|mesh-ancestor
5956062|NCT04670081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5956063|NCT04669938|Immunologic Factors|immunologic factors|mesh-list
5956064|NCT04669938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956065|NCT04669717|Amoxicillin|amoxicillin|mesh-list
5956066|NCT04669717|Azithromycin|azithromycin|mesh-list
5956067|NCT04669717|Metronidazole|metronidazole|mesh-list
5956068|NCT04669717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5956069|NCT04669717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5956070|NCT04669717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5956071|NCT04669717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5956072|NCT04669782|Teriparatide|teriparatide|mesh-list
5956073|NCT04669782|Vitamin K|vitamin k|mesh-list
5956074|NCT04669782|Vitamins|vitamins|mesh-ancestor
5956075|NCT04669782|Micronutrients|micronutrients|mesh-ancestor
5956076|NCT04669782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956077|NCT04669782|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5956078|NCT04669782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5956079|NCT04669782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5956080|NCT04669782|Hemostatics|hemostatics|mesh-ancestor
5956081|NCT04669782|Coagulants|coagulants|mesh-ancestor
5956082|NCT04669782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5956083|NCT04669782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5956084|NCT04669990|Remdesivir|remdesivir|mesh-list
5956085|NCT04669990|Antimetabolites|antimetabolites|mesh-ancestor
5956086|NCT04669990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5956087|NCT04669990|Antiviral Agents|antiviral agents|mesh-ancestor
5956088|NCT04669990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5956089|NCT04669392|Ethanol|ethanol|mesh-list
5956090|NCT04669392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5956091|NCT04669392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5956092|NCT04669392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5956093|NCT04669392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681461|NCT01609907|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6681462|NCT01609907|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6681463|NCT01609907|Antimetabolites|antimetabolites|mesh-ancestor
6681464|NCT01609907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681465|NCT01609907|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6681466|NCT01609907|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6681467|NCT01609907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6681468|NCT01609907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6681469|NCT01609907|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6681470|NCT01609907|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6681471|NCT01609959|Valsartan|valsartan|mesh-list
6681472|NCT01609959|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
6681473|NCT01609959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6681474|NCT01609959|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6681475|NCT01609959|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6681476|NCT01609959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681477|NCT01609998|Vaccines|vaccines|mesh-list
6681478|NCT01609998|Immunologic Factors|immunologic factors|mesh-ancestor
6681479|NCT01609998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681480|NCT01610141|Warfarin|warfarin|mesh-list
5956094|NCT04669457|Midazolam|midazolam|mesh-list
5956095|NCT04669457|Dexmedetomidine|dexmedetomidine|mesh-list
5956096|NCT04669457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5956097|NCT04669457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5956098|NCT04669457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956099|NCT04669457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5956100|NCT04669457|Analgesics|analgesics|mesh-ancestor
5956101|NCT04669457|Sensory System Agents|sensory system agents|mesh-ancestor
5956102|NCT04669457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5956103|NCT04669457|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5956104|NCT04669457|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5956105|NCT04669457|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5956106|NCT04669457|Adrenergic Agents|adrenergic agents|mesh-ancestor
5956107|NCT04669457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5956108|NCT04669457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5956109|NCT04669457|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5956110|NCT04669457|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5956111|NCT04669457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5956112|NCT04669457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5956113|NCT04669457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5956114|NCT04669457|Anesthetics, General|anesthetics, general|mesh-ancestor
5956115|NCT04669457|Anesthetics|anesthetics|mesh-ancestor
5956116|NCT04669457|GABA Modulators|gaba modulators|mesh-ancestor
5956117|NCT04669457|GABA Agents|gaba agents|mesh-ancestor
5956118|NCT04669587|Palbociclib|palbociclib|mesh-list
5956119|NCT04669587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5956120|NCT04669587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5956121|NCT04669587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5956122|NCT04669587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5956123|NCT04669678|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
5956124|NCT04669678|Medroxyprogesterone|medroxyprogesterone|mesh-list
5956125|NCT04669678|Etonogestrel|etonogestrel|mesh-list
5956126|NCT04669678|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5956127|NCT04669678|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5956128|NCT04669678|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5956129|NCT04669678|Contraceptive Agents|contraceptive agents|mesh-ancestor
5956130|NCT04669678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5956131|NCT04669678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956132|NCT04669678|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5956133|NCT04669678|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5956134|NCT04669678|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5956135|NCT04669678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5956136|NCT04669678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5956137|NCT04669158|Idebenone|idebenone|mesh-list
5956138|NCT04669158|Antioxidants|antioxidants|mesh-ancestor
5956139|NCT04669158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5956140|NCT04669158|Protective Agents|protective agents|mesh-ancestor
6681481|NCT01610141|Anticoagulants|anticoagulants|mesh-ancestor
5956141|NCT04669158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956142|NCT04669171|Rituximab|rituximab|mesh-list
5956143|NCT04669171|Lenalidomide|lenalidomide|mesh-list
5956144|NCT04669171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5956145|NCT04669171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5956146|NCT04669171|Immunologic Factors|immunologic factors|mesh-ancestor
6681482|NCT01610310|Interferon-beta|interferon-beta|mesh-list
6681483|NCT01610310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6681484|NCT01610310|Antiviral Agents|antiviral agents|mesh-ancestor
6681485|NCT01610310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6681486|NCT01610310|Immunologic Factors|immunologic factors|mesh-ancestor
6681487|NCT01610310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681488|NCT01610362|Immunoglobulins|immunoglobulins|mesh-list
6681489|NCT01610362|Antibodies|antibodies|mesh-list
6681490|NCT01610362|gamma-Globulins|gamma-globulins|mesh-list
6681491|NCT01610362|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6681492|NCT01610362|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6681493|NCT01610362|Immunoglobulin G|immunoglobulin g|mesh-list
6681494|NCT01610362|Immunologic Factors|immunologic factors|mesh-ancestor
6681495|NCT01610362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681496|NCT01610401|Metformin|metformin|mesh-list
6681497|NCT01610401|Caffeine|caffeine|mesh-list
6681498|NCT01610401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6681499|NCT01610401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681500|NCT01610401|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6681501|NCT01610401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6681502|NCT01610401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6681503|NCT01610401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681504|NCT01610401|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6681505|NCT01610401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6681506|NCT01610401|Purinergic Agents|purinergic agents|mesh-ancestor
6681507|NCT01610401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6681508|NCT01610765|Antiviral Agents|antiviral agents|mesh-list
6681509|NCT01610765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6681510|NCT01610778|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6681511|NCT01610778|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6681512|NCT01610778|Dermatologic Agents|dermatologic agents|mesh-ancestor
6681513|NCT01610869|Nintedanib|nintedanib|mesh-list
6681514|NCT01610869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6681515|NCT01610869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6681516|NCT01610869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6681517|NCT01610869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681518|NCT01610921|Adenosine|adenosine|mesh-list
6681519|NCT01610921|Analgesics|analgesics|mesh-ancestor
6681520|NCT01610921|Sensory System Agents|sensory system agents|mesh-ancestor
6517514|NCT00721487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6517515|NCT00721487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6517516|NCT00721487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517517|NCT00721487|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6517518|NCT00721487|Hormone Antagonists|hormone antagonists|mesh-ancestor
6517519|NCT00721487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6517520|NCT00721487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517521|NCT00721487|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6517522|NCT00721487|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6681521|NCT01610921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6681522|NCT01610921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681523|NCT01610921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6681524|NCT01610921|Vasodilator Agents|vasodilator agents|mesh-ancestor
6681525|NCT01610921|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6681526|NCT01610921|Purinergic Agonists|purinergic agonists|mesh-ancestor
6681527|NCT01610921|Purinergic Agents|purinergic agents|mesh-ancestor
6681528|NCT01610921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6681529|NCT01610921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681530|NCT01610934|Liraglutide|liraglutide|mesh-list
5956147|NCT04669171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956148|NCT04669171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5956149|NCT04669171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5956150|NCT04669171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5956151|NCT04669171|Growth Substances|growth substances|mesh-ancestor
6681531|NCT01610934|Glimepiride|glimepiride|mesh-list
6681532|NCT01610934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6681533|NCT01610934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681534|NCT01610934|Incretins|incretins|mesh-ancestor
6681535|NCT01610934|Hormones|hormones|mesh-ancestor
5956152|NCT04669171|Growth Inhibitors|growth inhibitors|mesh-ancestor
6681536|NCT01610934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6681537|NCT01610934|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6681538|NCT01610934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6681539|NCT01610934|Immunologic Factors|immunologic factors|mesh-ancestor
6681540|NCT01610947|Adalimumab|adalimumab|mesh-list
6681541|NCT01610947|Etanercept|etanercept|mesh-list
6681542|NCT01610947|Golimumab|golimumab|mesh-list
6681543|NCT01610947|Infliximab|infliximab|mesh-list
6681544|NCT01610947|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6681545|NCT01610947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6681546|NCT01610947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6681547|NCT01610947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6681548|NCT01610947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6681549|NCT01610947|Analgesics|analgesics|mesh-ancestor
5956153|NCT04669210|Mycophenolic Acid|mycophenolic acid|mesh-list
5956154|NCT04669210|Tacrolimus|tacrolimus|mesh-list
5956155|NCT04669210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5956156|NCT04669210|Immunologic Factors|immunologic factors|mesh-ancestor
5956157|NCT04669210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956158|NCT04669210|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5956159|NCT04669210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5956160|NCT04669210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5956161|NCT04669210|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5956162|NCT04669210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5956163|NCT04669210|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5956164|NCT04669210|Antitubercular Agents|antitubercular agents|mesh-ancestor
5956165|NCT04669210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5956166|NCT04669210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5956167|NCT04669145|Ropivacaine|ropivacaine|mesh-list
6517523|NCT00721526|Disulfiram|disulfiram|mesh-list
6517524|NCT00721526|Lorazepam|lorazepam|mesh-list
6517525|NCT00721526|Anticonvulsants|anticonvulsants|mesh-ancestor
5956168|NCT04669145|Anesthetics, Local|anesthetics, local|mesh-ancestor
5956169|NCT04669145|Anesthetics|anesthetics|mesh-ancestor
5956170|NCT04669145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5956171|NCT04669145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956172|NCT04669145|Sensory System Agents|sensory system agents|mesh-ancestor
5956173|NCT04669145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5956174|NCT04668976|Gemcitabine|gemcitabine|mesh-list
5956175|NCT04668976|Fluorouracil|fluorouracil|mesh-list
5956176|NCT04668976|Floxuridine|floxuridine|mesh-list
5956177|NCT04668976|Oxaliplatin|oxaliplatin|mesh-list
5956178|NCT04668976|Irinotecan|irinotecan|mesh-list
5956179|NCT04668976|Cetuximab|cetuximab|mesh-list
5956180|NCT04668976|Panitumumab|panitumumab|mesh-list
5956181|NCT04668976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5956182|NCT04668976|Antimetabolites|antimetabolites|mesh-ancestor
5956183|NCT04668976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5956184|NCT04668976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5956185|NCT04668976|Antiviral Agents|antiviral agents|mesh-ancestor
5956186|NCT04668976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5956187|NCT04668976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5956188|NCT04668976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5956189|NCT04668976|Immunologic Factors|immunologic factors|mesh-ancestor
5956190|NCT04668976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956191|NCT04668976|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5956192|NCT04668976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5956193|NCT04668976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5956194|NCT04669366|Sunitinib|sunitinib|mesh-list
5956195|NCT04669366|Axitinib|axitinib|mesh-list
5956196|NCT04669366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6517526|NCT00721526|Antiemetics|antiemetics|mesh-ancestor
6517527|NCT00721526|Autonomic Agents|autonomic agents|mesh-ancestor
6517528|NCT00721526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6517529|NCT00721526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517530|NCT00721526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6517531|NCT00721526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6517532|NCT00721526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6517533|NCT00721526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6517534|NCT00721526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6517535|NCT00721526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6517536|NCT00721526|GABA Modulators|gaba modulators|mesh-ancestor
6517537|NCT00721526|GABA Agents|gaba agents|mesh-ancestor
6517538|NCT00721526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6517539|NCT00721526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517540|NCT00721526|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6517541|NCT00721526|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
5956197|NCT04669366|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5956198|NCT04669366|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5956199|NCT04669366|Growth Substances|growth substances|mesh-ancestor
5956200|NCT04669366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956201|NCT04669366|Growth Inhibitors|growth inhibitors|mesh-ancestor
5956202|NCT04669366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5956203|NCT04669366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5956204|NCT04669366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5956205|NCT04669197|Gemcitabine|gemcitabine|mesh-list
5956206|NCT04669197|Hydroxychloroquine|hydroxychloroquine|mesh-list
5956207|NCT04669197|Paclitaxel|paclitaxel|mesh-list
5956208|NCT04669197|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5956209|NCT04669197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5956210|NCT04669197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5956211|NCT04669197|Tubulin Modulators|tubulin modulators|mesh-ancestor
5956212|NCT04669197|Antimitotic Agents|antimitotic agents|mesh-ancestor
5956213|NCT04669197|Mitosis Modulators|mitosis modulators|mesh-ancestor
5956214|NCT04669197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5956215|NCT04669197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6681550|NCT01610947|Sensory System Agents|sensory system agents|mesh-ancestor
6681551|NCT01610947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5956216|NCT04669197|Antimetabolites|antimetabolites|mesh-ancestor
5956217|NCT04669197|Antiviral Agents|antiviral agents|mesh-ancestor
5956218|NCT04669197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5956219|NCT04669197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5956220|NCT04669197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5956221|NCT04669197|Immunologic Factors|immunologic factors|mesh-ancestor
5956222|NCT04669197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956223|NCT04669197|Antimalarials|antimalarials|mesh-ancestor
5956224|NCT04669197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5956225|NCT04669197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5956226|NCT04669197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5956227|NCT04668859|Midodrine|midodrine|mesh-list
5956228|NCT04668859|Sympathomimetics|sympathomimetics|mesh-ancestor
5956229|NCT04668859|Autonomic Agents|autonomic agents|mesh-ancestor
5956230|NCT04668859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5956231|NCT04668859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956232|NCT04668859|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5956233|NCT04668859|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5956234|NCT04668859|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5956235|NCT04668859|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5956236|NCT04668859|Adrenergic Agents|adrenergic agents|mesh-ancestor
5956237|NCT04668859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5956238|NCT04668859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969627|NCT04542369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5969628|NCT04542369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5969629|NCT04542369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969630|NCT04542070|Rilpivirine|rilpivirine|mesh-list
5969631|NCT04542070|Cabotegravir|cabotegravir|mesh-list
5969632|NCT04542070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5969633|NCT04542070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5969634|NCT04542070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5969635|NCT04542070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969636|NCT04542070|Antiviral Agents|antiviral agents|mesh-ancestor
5969637|NCT04542070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5969638|NCT04542070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5969639|NCT04542070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5969640|NCT04542070|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5969641|NCT04542070|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5969642|NCT04542278|Prednisone|prednisone|mesh-list
5969643|NCT04542278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5969644|NCT04542278|Glucocorticoids|glucocorticoids|mesh-ancestor
5969645|NCT04542278|Hormones|hormones|mesh-ancestor
5969646|NCT04542278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6517542|NCT00721526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6517543|NCT00721552|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6517544|NCT00721552|Prednisolone|prednisolone|mesh-list
6517545|NCT00721552|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6517546|NCT00721552|Methylprednisolone|methylprednisolone|mesh-list
6517547|NCT00721552|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6517548|NCT00721552|Prednisolone acetate|prednisolone acetate|mesh-list
6517549|NCT00721552|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6517550|NCT00721552|Prednisolone phosphate|prednisolone phosphate|mesh-list
6517551|NCT00721552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6517552|NCT00721552|Glucocorticoids|glucocorticoids|mesh-ancestor
5956239|NCT04668456|Lidocaine|lidocaine|mesh-list
5956240|NCT04668456|Dexmedetomidine|dexmedetomidine|mesh-list
5956241|NCT04668456|Anesthetics, Local|anesthetics, local|mesh-ancestor
6681552|NCT01610947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681553|NCT01610947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6681554|NCT01610947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6681555|NCT01610947|Immunologic Factors|immunologic factors|mesh-ancestor
6681556|NCT01610947|Dermatologic Agents|dermatologic agents|mesh-ancestor
6681557|NCT01610947|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
5956242|NCT04668456|Anesthetics|anesthetics|mesh-ancestor
5956243|NCT04668456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5956244|NCT04668456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956245|NCT04668456|Sensory System Agents|sensory system agents|mesh-ancestor
5956246|NCT04668456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6517553|NCT00721552|Hormones|hormones|mesh-ancestor
6517554|NCT00721552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6517555|NCT00721552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517556|NCT00721552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6517557|NCT00721552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6517558|NCT00721552|Antiemetics|antiemetics|mesh-ancestor
6517559|NCT00721552|Autonomic Agents|autonomic agents|mesh-ancestor
6681558|NCT01610999|Plerixafor|plerixafor|mesh-list
6681559|NCT01610999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6681560|NCT01610999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6681561|NCT01610999|Antiviral Agents|antiviral agents|mesh-ancestor
6681562|NCT01610999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6681563|NCT01611038|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
5956247|NCT04668456|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5956248|NCT04668456|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5956249|NCT04668456|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5956250|NCT04668456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5956251|NCT04668456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517560|NCT00721552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6517561|NCT00721552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6517562|NCT00721552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6517563|NCT00721552|Protective Agents|protective agents|mesh-ancestor
6517564|NCT00721552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6517565|NCT00721552|Incretins|incretins|mesh-ancestor
6517566|NCT00721552|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6517567|NCT00721552|Protease Inhibitors|protease inhibitors|mesh-ancestor
5956252|NCT04668456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5956253|NCT04668456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5956254|NCT04668456|Analgesics|analgesics|mesh-ancestor
5956255|NCT04668456|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5956256|NCT04668456|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5956257|NCT04668456|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5956258|NCT04668456|Adrenergic Agents|adrenergic agents|mesh-ancestor
5956259|NCT04668456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5956260|NCT04668417|Vaccines|vaccines|mesh-list
5956261|NCT04668417|Immunologic Factors|immunologic factors|mesh-ancestor
5956262|NCT04668417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956263|NCT04668690|Mitoxantrone|mitoxantrone|mesh-list
5956264|NCT04668690|Analgesics|analgesics|mesh-ancestor
5956265|NCT04668690|Sensory System Agents|sensory system agents|mesh-ancestor
5956266|NCT04668690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5956267|NCT04668690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681564|NCT01611038|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6681565|NCT01611038|Protective Agents|protective agents|mesh-ancestor
6681566|NCT01611038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681567|NCT01611038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6681568|NCT01611077|Amlodipine|amlodipine|mesh-list
5956268|NCT04668690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5956269|NCT04668690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5956270|NCT04668690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5956271|NCT04668690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5956272|NCT04668690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5956273|NCT04668469|Acetaminophen|acetaminophen|mesh-list
5956274|NCT04668469|Vitamins|vitamins|mesh-list
5956275|NCT04668469|Ascorbic Acid|ascorbic acid|mesh-list
5956276|NCT04668469|Zinc|zinc|mesh-list
5956277|NCT04668469|Azithromycin|azithromycin|mesh-list
5956278|NCT04668469|Hydroxychloroquine|hydroxychloroquine|mesh-list
5956279|NCT04668469|Ivermectin|ivermectin|mesh-list
6517568|NCT00721552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6517569|NCT00721552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517570|NCT00721604|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
5956280|NCT04668469|Lactoferrin|lactoferrin|mesh-list
5956281|NCT04668469|Fibrin fragment D|fibrin fragment d|mesh-list
5956282|NCT04668469|Micronutrients|micronutrients|mesh-ancestor
5956283|NCT04668469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956284|NCT04668469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5956285|NCT04668469|Analgesics|analgesics|mesh-ancestor
5956286|NCT04668469|Sensory System Agents|sensory system agents|mesh-ancestor
5956287|NCT04668469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5956288|NCT04668469|Antipyretics|antipyretics|mesh-ancestor
5956289|NCT04668469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5956290|NCT04668469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5956291|NCT04668469|Antimalarials|antimalarials|mesh-ancestor
5956292|NCT04668469|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5956293|NCT04668469|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5956294|NCT04668469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5956295|NCT04668469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5956296|NCT04668469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5956297|NCT04668469|Trace Elements|trace elements|mesh-ancestor
5956298|NCT04668469|Antioxidants|antioxidants|mesh-ancestor
5956299|NCT04668469|Protective Agents|protective agents|mesh-ancestor
5956300|NCT04668469|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5956301|NCT04668469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5956302|NCT04668469|Hemostatics|hemostatics|mesh-ancestor
5956303|NCT04668469|Coagulants|coagulants|mesh-ancestor
5956304|NCT04668352|Dactolisib|dactolisib|mesh-list
5956305|NCT04668352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5956306|NCT04668300|Durvalumab|durvalumab|mesh-list
5956307|NCT04668300|Immunoglobulins|immunoglobulins|mesh-list
5956308|NCT04668300|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5956309|NCT04668300|Immunoglobulin G|immunoglobulin g|mesh-list
5956310|NCT04668300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5956311|NCT04668300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5956312|NCT04668300|Immunologic Factors|immunologic factors|mesh-ancestor
5956313|NCT04668300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956314|NCT04668274|Resveratrol|resveratrol|mesh-list
5956315|NCT04668274|Antioxidants|antioxidants|mesh-ancestor
5956316|NCT04668274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5956317|NCT04668274|Protective Agents|protective agents|mesh-ancestor
5956318|NCT04668274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956319|NCT04668274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5956320|NCT04668274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5956321|NCT04668131|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5956322|NCT04668131|Hyaluronic Acid|hyaluronic acid|mesh-list
5956323|NCT04668131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5956324|NCT04668131|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5956325|NCT04668131|Immunologic Factors|immunologic factors|mesh-ancestor
5956326|NCT04668131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956327|NCT04668131|Viscosupplements|viscosupplements|mesh-ancestor
5956328|NCT04668131|Protective Agents|protective agents|mesh-ancestor
5956329|NCT04668144|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
5956330|NCT04668144|Cangrelor|cangrelor|mesh-list
5956331|NCT04668144|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5956332|NCT04668144|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5956333|NCT04668144|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5956334|NCT04668144|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5956335|NCT04668144|Purinergic Agents|purinergic agents|mesh-ancestor
5956336|NCT04668144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5956337|NCT04668144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5956338|NCT04668144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956339|NCT04668118|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5956340|NCT04668118|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5956341|NCT04667663|Dexamethasone|dexamethasone|mesh-list
5956342|NCT04667663|Cyclophosphamide|cyclophosphamide|mesh-list
5956343|NCT04667663|Daratumumab|daratumumab|mesh-list
5956344|NCT04667663|Pomalidomide|pomalidomide|mesh-list
5956345|NCT04667663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5956346|NCT04667663|Immunologic Factors|immunologic factors|mesh-ancestor
5956347|NCT04667663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956348|NCT04667663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5956349|NCT04667663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5956350|NCT04667663|Alkylating Agents|alkylating agents|mesh-ancestor
5956351|NCT04667663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5956352|NCT04667663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5956353|NCT04667663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5956354|NCT04667663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5956355|NCT04667663|Antiemetics|antiemetics|mesh-ancestor
5956356|NCT04667663|Autonomic Agents|autonomic agents|mesh-ancestor
5956357|NCT04667663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5956358|NCT04667663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5956359|NCT04667663|Glucocorticoids|glucocorticoids|mesh-ancestor
5956360|NCT04667663|Hormones|hormones|mesh-ancestor
5956361|NCT04667663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5956362|NCT04667663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5956363|NCT04667663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5956364|NCT04667663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5956365|NCT04667663|Growth Substances|growth substances|mesh-ancestor
5956366|NCT04667663|Growth Inhibitors|growth inhibitors|mesh-ancestor
5956367|NCT04667910|Ranibizumab|ranibizumab|mesh-list
5956368|NCT04667910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5956369|NCT04667910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5956370|NCT04667910|Growth Substances|growth substances|mesh-ancestor
5956371|NCT04667910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956372|NCT04667910|Growth Inhibitors|growth inhibitors|mesh-ancestor
5956373|NCT04667910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6681569|NCT01611077|Candesartan|candesartan|mesh-list
6681570|NCT01611077|Candesartan cilexetil|candesartan cilexetil|mesh-list
6681571|NCT01611077|Olmesartan|olmesartan|mesh-list
6681572|NCT01611077|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6681573|NCT01611077|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6681574|NCT01611077|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6681575|NCT01611077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6681576|NCT01611077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681577|NCT01611077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6681578|NCT01611077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681579|NCT01611077|Vasodilator Agents|vasodilator agents|mesh-ancestor
6681580|NCT01611077|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6681581|NCT01611077|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6681582|NCT01611142|Mogamulizumab|mogamulizumab|mesh-list
6681583|NCT01611142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6779953|NCT02181920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779954|NCT02181920|Antipyretics|antipyretics|mesh-ancestor
5956374|NCT04667897|Ranibizumab|ranibizumab|mesh-list
5956375|NCT04667897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5956376|NCT04667897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5956377|NCT04667897|Growth Substances|growth substances|mesh-ancestor
5956378|NCT04667897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956379|NCT04667897|Growth Inhibitors|growth inhibitors|mesh-ancestor
5956380|NCT04667897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5956381|NCT04667819|Hyaluronic Acid|hyaluronic acid|mesh-list
5956382|NCT04667819|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5956383|NCT04667819|Immunologic Factors|immunologic factors|mesh-ancestor
5956384|NCT04667819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956385|NCT04667819|Viscosupplements|viscosupplements|mesh-ancestor
5956386|NCT04667819|Protective Agents|protective agents|mesh-ancestor
5956387|NCT04667624|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
5956388|NCT04667624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5956389|NCT04667624|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5956390|NCT04667624|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5956391|NCT04667624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5956392|NCT04667572|Riboflavin|riboflavin|mesh-list
5956393|NCT04667572|Vitamin B Complex|vitamin b complex|mesh-ancestor
5956394|NCT04667572|Vitamins|vitamins|mesh-ancestor
5956395|NCT04667572|Micronutrients|micronutrients|mesh-ancestor
5956396|NCT04667572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956397|NCT04667572|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5956398|NCT04667572|Dermatologic Agents|dermatologic agents|mesh-ancestor
5956399|NCT04667351|Fluorouracil|fluorouracil|mesh-list
5956400|NCT04667351|Antimetabolites|antimetabolites|mesh-ancestor
5956401|NCT04667351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5956402|NCT04667351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5956403|NCT04667351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5956404|NCT04667351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5956405|NCT04667351|Immunologic Factors|immunologic factors|mesh-ancestor
5956406|NCT04667351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956407|NCT04667507|Dexamethasone|dexamethasone|mesh-list
5956408|NCT04667507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5956409|NCT04667507|Antiemetics|antiemetics|mesh-ancestor
5956410|NCT04667507|Autonomic Agents|autonomic agents|mesh-ancestor
5956411|NCT04667507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5956412|NCT04667507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956413|NCT04667507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5956414|NCT04667507|Glucocorticoids|glucocorticoids|mesh-ancestor
5956415|NCT04667507|Hormones|hormones|mesh-ancestor
5956416|NCT04667507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5956417|NCT04667507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6681584|NCT01611311|BI 409306|bi 409306|mesh-list
6681585|NCT01611311|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6681586|NCT01611311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6681587|NCT01611311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681588|NCT01611324|Epinephrine|epinephrine|mesh-list
6681589|NCT01611324|Mepivacaine|mepivacaine|mesh-list
6681590|NCT01611324|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6681591|NCT01611324|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6681592|NCT01611324|Adrenergic Agents|adrenergic agents|mesh-ancestor
6681593|NCT01611324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6681594|NCT01611324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5956418|NCT04667507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5956419|NCT04667299|Amoxicillin|amoxicillin|mesh-list
5956420|NCT04667299|Metronidazole|metronidazole|mesh-list
5956421|NCT04667299|Potassium Citrate|potassium citrate|mesh-list
5956422|NCT04667299|Rabeprazole|rabeprazole|mesh-list
5956423|NCT04667299|Bismuth|bismuth|mesh-list
5956424|NCT04667299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5956425|NCT04667299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5956426|NCT04667299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5956427|NCT04667299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5956428|NCT04667299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5956429|NCT04667299|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5956430|NCT04667299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5956431|NCT04667299|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5956432|NCT04667299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5956433|NCT04667299|Antacids|antacids|mesh-ancestor
5956434|NCT04667299|Diuretics|diuretics|mesh-ancestor
5956435|NCT04667299|Natriuretic Agents|natriuretic agents|mesh-ancestor
5956436|NCT04667299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956437|NCT04667299|Expectorants|expectorants|mesh-ancestor
5956438|NCT04667299|Respiratory System Agents|respiratory system agents|mesh-ancestor
5956439|NCT04667013|Tetramethylpyrazine|tetramethylpyrazine|mesh-list
5956440|NCT04667013|Vasodilator Agents|vasodilator agents|mesh-ancestor
5956441|NCT04667143|Metformin|metformin|mesh-list
5956442|NCT04667143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5956443|NCT04667143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969647|NCT04542278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969648|NCT04542278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5969649|NCT04542278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5969650|NCT04542304|Metolazone|metolazone|mesh-list
5969651|NCT04542304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5969652|NCT04542304|Diuretics|diuretics|mesh-ancestor
5969653|NCT04542304|Natriuretic Agents|natriuretic agents|mesh-ancestor
5969654|NCT04542304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969655|NCT04542304|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5969656|NCT04542304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5969657|NCT04542304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969658|NCT04542252|Cyclosporine|cyclosporine|mesh-list
5969659|NCT04542252|Cyclosporins|cyclosporins|mesh-list
5969660|NCT04542252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5969661|NCT04542252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969662|NCT04542252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5969663|NCT04542252|Immunologic Factors|immunologic factors|mesh-ancestor
5969664|NCT04542252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969665|NCT04542252|Antifungal Agents|antifungal agents|mesh-ancestor
5969666|NCT04542252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5969667|NCT04542252|Dermatologic Agents|dermatologic agents|mesh-ancestor
5969668|NCT04542252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5969669|NCT04542252|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5969670|NCT04541719|Remifentanil|remifentanil|mesh-list
5969671|NCT04541719|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5969672|NCT04541719|Narcotics|narcotics|mesh-ancestor
5969673|NCT04541719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5969674|NCT04541719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969675|NCT04541719|Analgesics|analgesics|mesh-ancestor
5969676|NCT04541719|Sensory System Agents|sensory system agents|mesh-ancestor
5969677|NCT04541719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6681595|NCT01611324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969678|NCT04541732|Anesthetics|anesthetics|mesh-list
5969679|NCT04541732|Propofol|propofol|mesh-list
5969680|NCT04541732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5956444|NCT04666948|Vancomycin|vancomycin|mesh-list
5956445|NCT04666948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5956446|NCT04666948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5956447|NCT04666987|Liraglutide|liraglutide|mesh-list
5956448|NCT04666987|Xultophy|xultophy|mesh-list
5956449|NCT04666987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5956450|NCT04666987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956451|NCT04666987|Incretins|incretins|mesh-ancestor
5956452|NCT04666987|Hormones|hormones|mesh-ancestor
5956453|NCT04666987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5956454|NCT04666805|Tamoxifen|tamoxifen|mesh-list
5956455|NCT04666805|Toremifene|toremifene|mesh-list
5956456|NCT04666805|Letrozole|letrozole|mesh-list
5956457|NCT04666805|Anastrozole|anastrozole|mesh-list
5956458|NCT04666805|Exemestane|exemestane|mesh-list
5956459|NCT04666805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5956460|NCT04666805|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5956461|NCT04666805|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5956462|NCT04666805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5956463|NCT04666805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5956464|NCT04666805|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5956465|NCT04666805|Hormone Antagonists|hormone antagonists|mesh-ancestor
5956466|NCT04666805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5956467|NCT04666805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681596|NCT01611324|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6681597|NCT01611324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6681598|NCT01611324|Autonomic Agents|autonomic agents|mesh-ancestor
6681599|NCT01611324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6681600|NCT01611324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5956468|NCT04666805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5956469|NCT04666805|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5956470|NCT04666805|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5956471|NCT04666805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5956472|NCT04667117|Ofatumumab|ofatumumab|mesh-list
5956473|NCT04667117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5956474|NCT04666675|Upadacitinib|upadacitinib|mesh-list
5956475|NCT04666675|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
5956476|NCT04666675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5956477|NCT04666675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5956478|NCT04666675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5956479|NCT04666675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5956480|NCT04666688|Gemcitabine|gemcitabine|mesh-list
5956481|NCT04666688|Paclitaxel|paclitaxel|mesh-list
5956482|NCT04666688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5956483|NCT04666688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5956484|NCT04666688|Tubulin Modulators|tubulin modulators|mesh-ancestor
5956485|NCT04666688|Antimitotic Agents|antimitotic agents|mesh-ancestor
5956486|NCT04666688|Mitosis Modulators|mitosis modulators|mesh-ancestor
5956487|NCT04666688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5956488|NCT04666688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5956489|NCT04666688|Antimetabolites|antimetabolites|mesh-ancestor
5956490|NCT04666688|Antiviral Agents|antiviral agents|mesh-ancestor
5956491|NCT04666688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5956492|NCT04666688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5956493|NCT04666688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5956494|NCT04666688|Immunologic Factors|immunologic factors|mesh-ancestor
5956495|NCT04666688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956496|NCT04666701|Ketorolac|ketorolac|mesh-list
5956497|NCT04666701|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
5956498|NCT04666701|Scopolamine|scopolamine|mesh-list
5956499|NCT04666701|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
5956500|NCT04666701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5956501|NCT04666701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6517571|NCT00721604|Plasma Substitutes|plasma substitutes|mesh-ancestor
6517572|NCT00721604|Blood Substitutes|blood substitutes|mesh-ancestor
6517573|NCT00721747|Cyclophosphamide|cyclophosphamide|mesh-list
6517574|NCT00721747|Docetaxel|docetaxel|mesh-list
6517575|NCT00721747|Doxorubicin|doxorubicin|mesh-list
6517576|NCT00721747|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6517577|NCT00721747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6517578|NCT00721747|Immunologic Factors|immunologic factors|mesh-ancestor
6517579|NCT00721747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517580|NCT00721747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5956502|NCT04666701|Analgesics|analgesics|mesh-ancestor
5956503|NCT04666701|Sensory System Agents|sensory system agents|mesh-ancestor
6517581|NCT00721747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6517582|NCT00721747|Alkylating Agents|alkylating agents|mesh-ancestor
6517583|NCT00721747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517584|NCT00721747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6517585|NCT00721747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6517586|NCT00721747|Tubulin Modulators|tubulin modulators|mesh-ancestor
6517587|NCT00721747|Antimitotic Agents|antimitotic agents|mesh-ancestor
6517588|NCT00721747|Mitosis Modulators|mitosis modulators|mesh-ancestor
6517589|NCT00721747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6517590|NCT00721747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5956504|NCT04666701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5956505|NCT04666701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956506|NCT04666701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5956507|NCT04666701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5956508|NCT04666701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5956509|NCT04666701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5956510|NCT04666701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5956511|NCT04666701|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5956512|NCT04666701|Antiemetics|antiemetics|mesh-ancestor
5956513|NCT04666701|Autonomic Agents|autonomic agents|mesh-ancestor
5956514|NCT04666701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5956515|NCT04666701|Mydriatics|mydriatics|mesh-ancestor
5956516|NCT04666701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5956517|NCT04666701|Cholinergic Agents|cholinergic agents|mesh-ancestor
5956518|NCT04666701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5956519|NCT04666701|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6681601|NCT01611324|Respiratory System Agents|respiratory system agents|mesh-ancestor
6681602|NCT01611324|Mydriatics|mydriatics|mesh-ancestor
6681603|NCT01611324|Sympathomimetics|sympathomimetics|mesh-ancestor
6681604|NCT01611324|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6681605|NCT01611324|Anesthetics, Local|anesthetics, local|mesh-ancestor
6681606|NCT01611324|Anesthetics|anesthetics|mesh-ancestor
6681607|NCT01611324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5956520|NCT04666701|Parasympatholytics|parasympatholytics|mesh-ancestor
5956521|NCT04666623|Esketamine|esketamine|mesh-list
5956522|NCT04666623|Antidepressive Agents|antidepressive agents|mesh-ancestor
5956523|NCT04666623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5956524|NCT04666714|Pregabalin|pregabalin|mesh-list
5956525|NCT04666714|Analgesics|analgesics|mesh-ancestor
5956526|NCT04666714|Sensory System Agents|sensory system agents|mesh-ancestor
5956527|NCT04666714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5956528|NCT04666714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956529|NCT04666714|Anticonvulsants|anticonvulsants|mesh-ancestor
5956530|NCT04666714|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5956531|NCT04666714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5956532|NCT04666714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5956533|NCT04666714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5956534|NCT04666714|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5956535|NCT04666714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5956536|NCT04666714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5956537|NCT04666714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5956538|NCT04666324|Simethicone|simethicone|mesh-list
5956539|NCT04666324|Antifoaming Agents|antifoaming agents|mesh-ancestor
6681608|NCT01611324|Sensory System Agents|sensory system agents|mesh-ancestor
6681609|NCT01611363|Ipragliflozin|ipragliflozin|mesh-list
6681610|NCT01611363|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6681611|NCT01611363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681612|NCT01611363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6681613|NCT01611363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681614|NCT01611415|Ipragliflozin|ipragliflozin|mesh-list
6681615|NCT01611415|Furosemide|furosemide|mesh-list
6517591|NCT00721747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6517592|NCT00721747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6517593|NCT00721773|Valsartan|valsartan|mesh-list
6517594|NCT00721773|Benazepril|benazepril|mesh-list
6517595|NCT00721773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6517596|NCT00721773|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6517597|NCT00721773|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6517598|NCT00721773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517599|NCT00721773|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6517600|NCT00721773|Protease Inhibitors|protease inhibitors|mesh-ancestor
6517601|NCT00721773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6517602|NCT00721877|Resveratrol|resveratrol|mesh-list
6517603|NCT00721877|Antioxidants|antioxidants|mesh-ancestor
6517604|NCT00721877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517605|NCT00721877|Protective Agents|protective agents|mesh-ancestor
6681616|NCT01611415|Diuretics|diuretics|mesh-ancestor
6517606|NCT00721877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517607|NCT00721877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6517608|NCT00721877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6517609|NCT00721916|Leucovorin|leucovorin|mesh-list
6517610|NCT00721916|Oxaliplatin|oxaliplatin|mesh-list
6517611|NCT00721916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6517612|NCT00721916|Antidotes|antidotes|mesh-ancestor
6517613|NCT00721916|Protective Agents|protective agents|mesh-ancestor
6517614|NCT00721916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517615|NCT00721916|Vitamin B Complex|vitamin b complex|mesh-ancestor
6517616|NCT00721916|Vitamins|vitamins|mesh-ancestor
6517617|NCT00721916|Micronutrients|micronutrients|mesh-ancestor
6517618|NCT00722033|Indomethacin|indomethacin|mesh-list
6517619|NCT00722033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6517620|NCT00722033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6517621|NCT00722033|Analgesics|analgesics|mesh-ancestor
6517622|NCT00722033|Sensory System Agents|sensory system agents|mesh-ancestor
6517623|NCT00722033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6517624|NCT00722033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517625|NCT00722033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6517626|NCT00722033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6517627|NCT00722033|Gout Suppressants|gout suppressants|mesh-ancestor
6517628|NCT00722033|Tocolytic Agents|tocolytic agents|mesh-ancestor
5956540|NCT04666324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5956541|NCT04666324|Emollients|emollients|mesh-ancestor
5956542|NCT04666324|Dermatologic Agents|dermatologic agents|mesh-ancestor
5956543|NCT04666649|Venetoclax|venetoclax|mesh-list
5956544|NCT04666649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6681617|NCT01611415|Natriuretic Agents|natriuretic agents|mesh-ancestor
6681618|NCT01611415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681619|NCT01611415|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6681620|NCT01611415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6681621|NCT01611415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681622|NCT01611415|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6681623|NCT01611415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6681624|NCT01611428|Ipragliflozin|ipragliflozin|mesh-list
6681625|NCT01611428|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6681626|NCT01611428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681627|NCT01611428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6681628|NCT01611428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681629|NCT01611480|Imiquimod|imiquimod|mesh-list
6681630|NCT01611480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6681631|NCT01611480|Immunologic Factors|immunologic factors|mesh-ancestor
6681632|NCT01611480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681633|NCT01611480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6681634|NCT01611480|Interferon Inducers|interferon inducers|mesh-ancestor
6681635|NCT01611506|Capecitabine|capecitabine|mesh-list
6681636|NCT01611506|Cetuximab|cetuximab|mesh-list
6681637|NCT01611506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6681638|NCT01611506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6681639|NCT01611506|Antimetabolites|antimetabolites|mesh-ancestor
6681640|NCT01611506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681641|NCT01611506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6681642|NCT01611675|Vemurafenib|vemurafenib|mesh-list
6681643|NCT01611675|Leflunomide|leflunomide|mesh-list
6681644|NCT01611675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6681645|NCT01611675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6681646|NCT01611675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6681647|NCT01611675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681648|NCT01611675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6681649|NCT01611675|Immunologic Factors|immunologic factors|mesh-ancestor
6681650|NCT01611675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956545|NCT04666051|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
5956546|NCT04666051|Hemostatics|hemostatics|mesh-ancestor
5956547|NCT04666051|Coagulants|coagulants|mesh-ancestor
5956548|NCT04666168|Cyclophosphamide|cyclophosphamide|mesh-list
5956549|NCT04666168|Fludarabine|fludarabine|mesh-list
5956550|NCT04666168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5956551|NCT04666168|Immunologic Factors|immunologic factors|mesh-ancestor
5956552|NCT04666168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956553|NCT04666168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6517629|NCT00722033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5956554|NCT04666168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5956555|NCT04666168|Alkylating Agents|alkylating agents|mesh-ancestor
6517630|NCT00722033|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5956556|NCT04666168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5956557|NCT04666168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5956558|NCT04666168|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5956559|NCT04665947|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
5956560|NCT04665947|Chelating Agents|chelating agents|mesh-ancestor
5956561|NCT04665947|Sequestering Agents|sequestering agents|mesh-ancestor
5956562|NCT04665947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5956563|NCT04665895|Fluticasone|fluticasone|mesh-list
5956564|NCT04665895|Xhance|xhance|mesh-list
5956565|NCT04665895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5956566|NCT04665895|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5956567|NCT04665895|Autonomic Agents|autonomic agents|mesh-ancestor
5956568|NCT04665895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5956569|NCT04665895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956570|NCT04665895|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5956571|NCT04665895|Respiratory System Agents|respiratory system agents|mesh-ancestor
5956572|NCT04665895|Dermatologic Agents|dermatologic agents|mesh-ancestor
5956573|NCT04665895|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5956574|NCT04665986|Docetaxel|docetaxel|mesh-list
5956575|NCT04665986|Vinorelbine|vinorelbine|mesh-list
5956576|NCT04665986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5956577|NCT04665986|Tubulin Modulators|tubulin modulators|mesh-ancestor
5956578|NCT04665986|Antimitotic Agents|antimitotic agents|mesh-ancestor
5956579|NCT04665986|Mitosis Modulators|mitosis modulators|mesh-ancestor
5956580|NCT04665986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681651|NCT01611688|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6681652|NCT01611688|Immunologic Factors|immunologic factors|mesh-ancestor
6681653|NCT01611688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681654|NCT01611727|Cisplatin|cisplatin|mesh-list
6681655|NCT01611727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6681656|NCT01611896|Selenium|selenium|mesh-list
6681657|NCT01611896|Antioxidants|antioxidants|mesh-ancestor
6681658|NCT01611896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681659|NCT01611896|Protective Agents|protective agents|mesh-ancestor
6681660|NCT01611896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681661|NCT01611896|Trace Elements|trace elements|mesh-ancestor
6681662|NCT01611896|Micronutrients|micronutrients|mesh-ancestor
6681663|NCT01611909|Terpin|terpin|mesh-list
6681664|NCT01611909|Expectorants|expectorants|mesh-ancestor
6681665|NCT01611909|Respiratory System Agents|respiratory system agents|mesh-ancestor
6681666|NCT01611961|Docetaxel|docetaxel|mesh-list
5956581|NCT04665986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5956582|NCT04666129|Prednisone|prednisone|mesh-list
5956583|NCT04666129|Methylprednisolone|methylprednisolone|mesh-list
5956584|NCT04666129|Docetaxel|docetaxel|mesh-list
5956585|NCT04666129|Relugolix|relugolix|mesh-list
5956586|NCT04666129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5956587|NCT04666129|Tubulin Modulators|tubulin modulators|mesh-ancestor
5956588|NCT04666129|Antimitotic Agents|antimitotic agents|mesh-ancestor
5956589|NCT04666129|Mitosis Modulators|mitosis modulators|mesh-ancestor
5956590|NCT04666129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5956591|NCT04666129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5956592|NCT04666129|Glucocorticoids|glucocorticoids|mesh-ancestor
5956593|NCT04666129|Hormones|hormones|mesh-ancestor
5956594|NCT04666129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5956595|NCT04666129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956596|NCT04666129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6681667|NCT01611961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6681668|NCT01611961|Tubulin Modulators|tubulin modulators|mesh-ancestor
6681669|NCT01611961|Antimitotic Agents|antimitotic agents|mesh-ancestor
6681670|NCT01611961|Mitosis Modulators|mitosis modulators|mesh-ancestor
6681671|NCT01611961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681672|NCT01612052|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6681673|NCT01612052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6681674|NCT01612065|Misoprostol|misoprostol|mesh-list
6681675|NCT01612065|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6681676|NCT01612065|Abortifacient Agents|abortifacient agents|mesh-ancestor
6681677|NCT01612065|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6681678|NCT01612065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681679|NCT01612065|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5956597|NCT04666129|Antiemetics|antiemetics|mesh-ancestor
5956598|NCT04666129|Autonomic Agents|autonomic agents|mesh-ancestor
5956599|NCT04666129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5956600|NCT04666129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6681680|NCT01612065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6681681|NCT01612065|Oxytocics|oxytocics|mesh-ancestor
6681682|NCT01612078|Droxidopa|droxidopa|mesh-list
5956601|NCT04666129|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5956602|NCT04666129|Protective Agents|protective agents|mesh-ancestor
5956603|NCT04666129|Androgen Antagonists|androgen antagonists|mesh-ancestor
5956604|NCT04666129|Hormone Antagonists|hormone antagonists|mesh-ancestor
5956605|NCT04665830|Evolocumab|evolocumab|mesh-list
5956606|NCT04665830|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5956607|NCT04665830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5956608|NCT04665830|Antimetabolites|antimetabolites|mesh-ancestor
5956609|NCT04665830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5956610|NCT04665830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5956611|NCT04665791|Vaccines|vaccines|mesh-list
5956612|NCT04665791|Immunologic Factors|immunologic factors|mesh-ancestor
5956613|NCT04665791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956614|NCT04665531|Ropivacaine|ropivacaine|mesh-list
5956615|NCT04665531|Anesthetics, Local|anesthetics, local|mesh-ancestor
5956616|NCT04665531|Anesthetics|anesthetics|mesh-ancestor
5956617|NCT04665531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5956618|NCT04665531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956619|NCT04665531|Sensory System Agents|sensory system agents|mesh-ancestor
5956620|NCT04665531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5956621|NCT04665765|Rituximab|rituximab|mesh-list
5956622|NCT04665765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5956623|NCT04665765|Carboplatin|carboplatin|mesh-list
5956624|NCT04665765|Etoposide|etoposide|mesh-list
5956625|NCT04665765|Etoposide phosphate|etoposide phosphate|mesh-list
5956626|NCT04665765|Ifosfamide|ifosfamide|mesh-list
5956627|NCT04665765|Isophosphamide mustard|isophosphamide mustard|mesh-list
5956628|NCT04665765|Podophyllotoxin|podophyllotoxin|mesh-list
5956629|NCT04665765|Antibodies|antibodies|mesh-list
5956630|NCT04665765|Immunoglobulins|immunoglobulins|mesh-list
5956631|NCT04665765|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5956632|NCT04665765|Immunoconjugates|immunoconjugates|mesh-list
5956633|NCT04665765|Immunologic Factors|immunologic factors|mesh-ancestor
5956634|NCT04665765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956635|NCT04665765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5956636|NCT04665765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5956637|NCT04665765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5956638|NCT04665765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5956639|NCT04665765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5956640|NCT04665765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5956641|NCT04665765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5956642|NCT04665765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5956643|NCT04665765|Alkylating Agents|alkylating agents|mesh-ancestor
5956644|NCT04665765|Keratolytic Agents|keratolytic agents|mesh-ancestor
5956645|NCT04665765|Dermatologic Agents|dermatologic agents|mesh-ancestor
5956646|NCT04665765|Tubulin Modulators|tubulin modulators|mesh-ancestor
5956647|NCT04665765|Antimitotic Agents|antimitotic agents|mesh-ancestor
5956648|NCT04665765|Mitosis Modulators|mitosis modulators|mesh-ancestor
5956649|NCT04665609|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5956650|NCT04665453|Dexmedetomidine|dexmedetomidine|mesh-list
5956651|NCT04665453|Melatonin|melatonin|mesh-list
5956652|NCT04665453|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5956653|NCT04665453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5956654|NCT04665453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956655|NCT04665453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5956656|NCT04665453|Analgesics|analgesics|mesh-ancestor
5956657|NCT04665453|Sensory System Agents|sensory system agents|mesh-ancestor
5956658|NCT04665453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5956659|NCT04665453|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6517631|NCT00722033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6517632|NCT00722033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517633|NCT00722098|Cyclophosphamide|cyclophosphamide|mesh-list
6517634|NCT00722098|Vaccines|vaccines|mesh-list
6517635|NCT00722098|Immunologic Factors|immunologic factors|mesh-ancestor
6681683|NCT01612078|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6681684|NCT01612078|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6681685|NCT01612247|Aspirin|aspirin|mesh-list
6681686|NCT01612247|Cyclophosphamide|cyclophosphamide|mesh-list
6681687|NCT01612247|Methotrexate|methotrexate|mesh-list
6681688|NCT01612247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6681689|NCT01612247|Immunologic Factors|immunologic factors|mesh-ancestor
5956660|NCT04665453|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5956661|NCT04665453|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5956662|NCT04665453|Adrenergic Agents|adrenergic agents|mesh-ancestor
6517636|NCT00722098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517637|NCT00722098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5956663|NCT04665453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6517638|NCT00722098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5956664|NCT04665453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5956665|NCT04665453|Antioxidants|antioxidants|mesh-ancestor
5956666|NCT04665453|Protective Agents|protective agents|mesh-ancestor
5956667|NCT04665362|Apatinib|apatinib|mesh-list
5956668|NCT04665362|Antibodies|antibodies|mesh-list
5956669|NCT04665362|Immunologic Factors|immunologic factors|mesh-ancestor
5956670|NCT04665362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956671|NCT04665362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5956672|NCT04665362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5956673|NCT04665362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5956674|NCT04665362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5956675|NCT04665648|Nicorandil|nicorandil|mesh-list
5956676|NCT04665648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5956677|NCT04665648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5956678|NCT04665648|Vasodilator Agents|vasodilator agents|mesh-ancestor
5956679|NCT04665648|Vitamin B Complex|vitamin b complex|mesh-ancestor
6681690|NCT01612247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681691|NCT01612247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6681692|NCT01612247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6681693|NCT01612247|Alkylating Agents|alkylating agents|mesh-ancestor
6681694|NCT01612247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681695|NCT01612247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6681696|NCT01612247|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6681697|NCT01612247|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6681698|NCT01612247|Abortifacient Agents|abortifacient agents|mesh-ancestor
5956680|NCT04665648|Vitamins|vitamins|mesh-ancestor
5956681|NCT04665648|Micronutrients|micronutrients|mesh-ancestor
5956682|NCT04665648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956683|NCT04665232|Progesterone|progesterone|mesh-list
5956684|NCT04665232|Progestins|progestins|mesh-ancestor
5956685|NCT04665232|Hormones|hormones|mesh-ancestor
5956686|NCT04665232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5956687|NCT04665232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956688|NCT04665141|Omalizumab|omalizumab|mesh-list
5956689|NCT04665141|Benralizumab|benralizumab|mesh-list
5956690|NCT04665141|Reslizumab|reslizumab|mesh-list
5956691|NCT04665141|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5956692|NCT04665141|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5956693|NCT04665141|Respiratory System Agents|respiratory system agents|mesh-ancestor
5969681|NCT04541732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969682|NCT04541732|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5969683|NCT04541732|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5969684|NCT04541732|Anesthetics, General|anesthetics, general|mesh-ancestor
6681699|NCT01612247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6681700|NCT01612247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6681701|NCT01612247|Antimetabolites|antimetabolites|mesh-ancestor
6681702|NCT01612247|Dermatologic Agents|dermatologic agents|mesh-ancestor
6681703|NCT01612247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6681704|NCT01612247|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6681705|NCT01612247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6681706|NCT01612247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5969685|NCT04541823|Propofol|propofol|mesh-list
5969686|NCT04541823|Desflurane|desflurane|mesh-list
5969687|NCT04541823|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5969688|NCT04541823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5969689|NCT04541823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969690|NCT04541823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5969691|NCT04541823|Anesthetics, General|anesthetics, general|mesh-ancestor
5969692|NCT04541823|Anesthetics|anesthetics|mesh-ancestor
6681707|NCT01612247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6681708|NCT01612247|Analgesics|analgesics|mesh-ancestor
6681709|NCT01612247|Sensory System Agents|sensory system agents|mesh-ancestor
6681710|NCT01612247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6681711|NCT01612247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6681712|NCT01612247|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6681713|NCT01612247|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6681714|NCT01612247|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6681715|NCT01612247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6681716|NCT01612247|Antipyretics|antipyretics|mesh-ancestor
6681717|NCT01612273|Aspirin|aspirin|mesh-list
6681718|NCT01612273|Triflusal|triflusal|mesh-list
6681719|NCT01612273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6681720|NCT01612273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6681721|NCT01612273|Analgesics|analgesics|mesh-ancestor
6681722|NCT01612273|Sensory System Agents|sensory system agents|mesh-ancestor
5969693|NCT04541823|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5969694|NCT04541888|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6681723|NCT01612273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6681724|NCT01612273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681725|NCT01612273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5956694|NCT04665063|Cyclophosphamide|cyclophosphamide|mesh-list
5956695|NCT04665063|Fludarabine|fludarabine|mesh-list
5956696|NCT04665063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5956697|NCT04665063|Immunologic Factors|immunologic factors|mesh-ancestor
5956698|NCT04665063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956699|NCT04665063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5956700|NCT04665063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5956701|NCT04665063|Alkylating Agents|alkylating agents|mesh-ancestor
5956702|NCT04665063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5956703|NCT04665063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5956704|NCT04665063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5956705|NCT04665076|Cyclophosphamide|cyclophosphamide|mesh-list
5956706|NCT04665076|Fludarabine|fludarabine|mesh-list
5956707|NCT04665076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5956708|NCT04665076|Immunologic Factors|immunologic factors|mesh-ancestor
5956709|NCT04665076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956710|NCT04665076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5956711|NCT04665076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5956712|NCT04665076|Alkylating Agents|alkylating agents|mesh-ancestor
5956713|NCT04665076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5956714|NCT04665076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5956715|NCT04665076|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5956716|NCT04665050|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5956717|NCT04665050|Immunologic Factors|immunologic factors|mesh-ancestor
5956718|NCT04665050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956719|NCT04665284|Empagliflozin|empagliflozin|mesh-list
5956720|NCT04665284|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5956721|NCT04665284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5956722|NCT04665284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5956723|NCT04665284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956724|NCT04665089|Erythromycin|erythromycin|mesh-list
5956725|NCT04665089|Erythromycin Estolate|erythromycin estolate|mesh-list
5956726|NCT04665089|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
5956727|NCT04665089|Erythromycin stearate|erythromycin stearate|mesh-list
5956728|NCT04665089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5956729|NCT04665089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5956730|NCT04665089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5956731|NCT04665089|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5956732|NCT04665089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5956733|NCT04665089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5956734|NCT04665310|Tacrolimus|tacrolimus|mesh-list
5956735|NCT04665310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5956736|NCT04665310|Immunologic Factors|immunologic factors|mesh-ancestor
5956737|NCT04665310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956738|NCT04665310|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5956739|NCT04665310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5956740|NCT04665310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517639|NCT00722098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6517640|NCT00722098|Alkylating Agents|alkylating agents|mesh-ancestor
6517641|NCT00722098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5956741|NCT04664894|Ribavirin|ribavirin|mesh-list
5956742|NCT04664894|Sofosbuvir|sofosbuvir|mesh-list
5956743|NCT04664894|Velpatasvir|velpatasvir|mesh-list
5956744|NCT04664894|Antimetabolites|antimetabolites|mesh-ancestor
5956745|NCT04664894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5956746|NCT04664894|Antiviral Agents|antiviral agents|mesh-ancestor
6517642|NCT00722098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6517643|NCT00722098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6517644|NCT00722150|Artesunate|artesunate|mesh-list
6517645|NCT00722150|Antimalarials|antimalarials|mesh-ancestor
6517646|NCT00722150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6517647|NCT00722150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6517648|NCT00722150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6517649|NCT00722150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6517650|NCT00722150|Antiviral Agents|antiviral agents|mesh-ancestor
6517651|NCT00722150|Schistosomicides|schistosomicides|mesh-ancestor
6517652|NCT00722150|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6517653|NCT00722150|Anthelmintics|anthelmintics|mesh-ancestor
6517654|NCT00722176|Risperidone|risperidone|mesh-list
6517655|NCT00722176|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6517656|NCT00722176|Serotonin Agents|serotonin agents|mesh-ancestor
5956747|NCT04664894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5956748|NCT04664803|Cefdinir|cefdinir|mesh-list
5956749|NCT04664803|Cefetamet|cefetamet|mesh-list
5956750|NCT04664803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5956751|NCT04664803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5956752|NCT04664725|Repaglinide|repaglinide|mesh-list
5956753|NCT04664725|Bupropion|bupropion|mesh-list
5956754|NCT04664725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5956755|NCT04664725|Antidepressive Agents|antidepressive agents|mesh-ancestor
5956756|NCT04664725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5956757|NCT04664725|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5956758|NCT04664725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5956759|NCT04664725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5956760|NCT04664725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5956761|NCT04664725|Dopamine Agents|dopamine agents|mesh-ancestor
5956762|NCT04664725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6681726|NCT01612273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6681727|NCT01612273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6681728|NCT01612273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6517657|NCT00722176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6517658|NCT00722176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517659|NCT00722176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517660|NCT00722176|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5956763|NCT04664725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956764|NCT04664725|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5956765|NCT04664725|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5956766|NCT04664725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5956767|NCT04664725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5956768|NCT04664829|Capecitabine|capecitabine|mesh-list
5956769|NCT04664829|Bexarotene|bexarotene|mesh-list
5956770|NCT04664829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5956771|NCT04664829|Antimetabolites|antimetabolites|mesh-ancestor
5956772|NCT04664829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5956773|NCT04664829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5956774|NCT04664764|Insulin, Isophane|insulin, isophane|mesh-list
5956775|NCT04664764|Isophane Insulin, Human|isophane insulin, human|mesh-list
5956776|NCT04664764|Isophane insulin, beef|isophane insulin, beef|mesh-list
5956777|NCT04664764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5956778|NCT04664764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956779|NCT04664595|Propofol|propofol|mesh-list
5956780|NCT04664595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5956781|NCT04664595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5956782|NCT04664595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956783|NCT04664595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5956784|NCT04664595|Anesthetics, General|anesthetics, general|mesh-ancestor
5956785|NCT04664595|Anesthetics|anesthetics|mesh-ancestor
5956786|NCT04664530|Esketamine|esketamine|mesh-list
5956787|NCT04664530|Antidepressive Agents|antidepressive agents|mesh-ancestor
5956788|NCT04664530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5956789|NCT04664361|Niacinamide|niacinamide|mesh-list
5956790|NCT04664361|Niacin|niacin|mesh-list
5956791|NCT04664361|Nicotinic Acids|nicotinic acids|mesh-list
5956792|NCT04664361|Vitamin B Complex|vitamin b complex|mesh-ancestor
5956793|NCT04664361|Vitamins|vitamins|mesh-ancestor
5956794|NCT04664361|Micronutrients|micronutrients|mesh-ancestor
5956795|NCT04664361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956796|NCT04664361|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5956797|NCT04664361|Antimetabolites|antimetabolites|mesh-ancestor
5956798|NCT04664361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5956799|NCT04664361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5956800|NCT04664361|Vasodilator Agents|vasodilator agents|mesh-ancestor
5956801|NCT04664517|Anesthetics|anesthetics|mesh-list
5956802|NCT04664517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5956803|NCT04664517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956804|NCT04664010|Vitamins|vitamins|mesh-list
5956805|NCT04664010|Ascorbic Acid|ascorbic acid|mesh-list
5956806|NCT04664010|Interferons|interferons|mesh-list
5956807|NCT04664010|Ribavirin|ribavirin|mesh-list
5956808|NCT04664010|Interferon-alpha|interferon-alpha|mesh-list
5956809|NCT04664010|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
5956810|NCT04664010|Micronutrients|micronutrients|mesh-ancestor
5956811|NCT04664010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517661|NCT00722176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6517662|NCT00722176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6517663|NCT00722176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6779955|NCT02181933|Lamivudine|lamivudine|mesh-list
5956812|NCT04664010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5956813|NCT04664010|Antiviral Agents|antiviral agents|mesh-ancestor
5956814|NCT04664010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5956815|NCT04664010|Antimetabolites|antimetabolites|mesh-ancestor
5956816|NCT04664010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5956817|NCT04664010|Immunologic Factors|immunologic factors|mesh-ancestor
5956818|NCT04664010|Antioxidants|antioxidants|mesh-ancestor
5956819|NCT04664010|Protective Agents|protective agents|mesh-ancestor
5956820|NCT04664127|Valacyclovir|valacyclovir|mesh-list
5956821|NCT04664127|Antiviral Agents|antiviral agents|mesh-ancestor
5956822|NCT04664127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5956823|NCT04664088|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
5956824|NCT04664088|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5956825|NCT04664088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5956826|NCT04664088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5956827|NCT04664088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5956828|NCT04664088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5956829|NCT04664088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956830|NCT04664088|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5956831|NCT04664088|Antidepressive Agents|antidepressive agents|mesh-ancestor
5956832|NCT04664088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5956833|NCT04663763|Capecitabine|capecitabine|mesh-list
5956834|NCT04663763|Oxaliplatin|oxaliplatin|mesh-list
6681729|NCT01612273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681730|NCT01612273|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6681731|NCT01612273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6681732|NCT01612273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6681733|NCT01612273|Antipyretics|antipyretics|mesh-ancestor
6681734|NCT01612286|Endostatins|endostatins|mesh-list
6681735|NCT01612286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6681736|NCT01612286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6681737|NCT01612286|Growth Substances|growth substances|mesh-ancestor
6681738|NCT01612286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681739|NCT01612286|Growth Inhibitors|growth inhibitors|mesh-ancestor
6681740|NCT01612286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6681741|NCT01612299|Everolimus|everolimus|mesh-list
6681742|NCT01612299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6681743|NCT01612299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6681744|NCT01612299|Immunologic Factors|immunologic factors|mesh-ancestor
6681745|NCT01612299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956835|NCT04663763|Antibodies|antibodies|mesh-list
5956836|NCT04663763|Immunologic Factors|immunologic factors|mesh-ancestor
5956837|NCT04663763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956838|NCT04663763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5956839|NCT04663763|Antimetabolites|antimetabolites|mesh-ancestor
5956840|NCT04663763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681746|NCT01612377|Prednisone|prednisone|mesh-list
6681747|NCT01612377|Prednisolone|prednisolone|mesh-list
6681748|NCT01612377|Dipyridamole|dipyridamole|mesh-list
6681749|NCT01612377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6681750|NCT01612377|Glucocorticoids|glucocorticoids|mesh-ancestor
6681751|NCT01612377|Hormones|hormones|mesh-ancestor
6681752|NCT01612377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6681753|NCT01612377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681754|NCT01612377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6681755|NCT01612377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6681756|NCT01612377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6681757|NCT01612377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6681758|NCT01612377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681759|NCT01612377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6681760|NCT01612377|Vasodilator Agents|vasodilator agents|mesh-ancestor
6681761|NCT01612403|Zinc Sulfate|zinc sulfate|mesh-list
6681762|NCT01612403|Astringents|astringents|mesh-ancestor
6681763|NCT01612403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681764|NCT01612403|Dermatologic Agents|dermatologic agents|mesh-ancestor
6681765|NCT01612468|Liraglutide|liraglutide|mesh-list
6681766|NCT01612468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6681767|NCT01612468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681768|NCT01612468|Incretins|incretins|mesh-ancestor
6681769|NCT01612468|Hormones|hormones|mesh-ancestor
6681770|NCT01612468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6681771|NCT01612507|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
6681772|NCT01612507|Cephalosporins|cephalosporins|mesh-list
6681773|NCT01612507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6681774|NCT01612507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5956841|NCT04663763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5956842|NCT04664244|Nimotuzumab|nimotuzumab|mesh-list
5956843|NCT04664244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6517664|NCT00722176|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6517665|NCT00722176|Dopamine Agents|dopamine agents|mesh-ancestor
6517666|NCT00722215|Nifedipine|nifedipine|mesh-list
6517667|NCT00722215|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-list
6517668|NCT00722215|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6517669|NCT00722215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6517670|NCT00722215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517671|NCT00722215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6517672|NCT00722215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681775|NCT01612728|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5956844|NCT04664244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5956845|NCT04663750|Aflibercept|aflibercept|mesh-list
5956846|NCT04663750|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5956847|NCT04663750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5956848|NCT04663750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5956849|NCT04663750|Growth Substances|growth substances|mesh-ancestor
5956850|NCT04663750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956851|NCT04663750|Growth Inhibitors|growth inhibitors|mesh-ancestor
6681776|NCT01612728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6681777|NCT01612728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6681778|NCT01612728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681779|NCT01612728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6681780|NCT01612728|Hormone Antagonists|hormone antagonists|mesh-ancestor
6681781|NCT01612728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5956852|NCT04663750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5956853|NCT04663750|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5956854|NCT04663750|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5956855|NCT04663750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5956856|NCT04664023|Vaccines|vaccines|mesh-list
5956857|NCT04664023|Immunologic Factors|immunologic factors|mesh-ancestor
5956858|NCT04664023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969695|NCT04541888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5969696|NCT04541680|Nintedanib|nintedanib|mesh-list
5969697|NCT04541680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5969698|NCT04541680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5969699|NCT04541680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5969700|NCT04541680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969701|NCT04542005|Albuterol|albuterol|mesh-list
5969702|NCT04542005|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5969703|NCT04542005|Autonomic Agents|autonomic agents|mesh-ancestor
5969704|NCT04542005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5969705|NCT04542005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969706|NCT04542005|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5969707|NCT04542005|Respiratory System Agents|respiratory system agents|mesh-ancestor
5969708|NCT04542005|Tocolytic Agents|tocolytic agents|mesh-ancestor
5969709|NCT04542005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5969710|NCT04542005|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5969711|NCT04542005|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5969712|NCT04542005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5969713|NCT04542005|Adrenergic Agents|adrenergic agents|mesh-ancestor
5969714|NCT04542005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5969715|NCT04542005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681782|NCT01612728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681783|NCT01612741|Acarbose|acarbose|mesh-list
6681784|NCT01612741|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6681785|NCT01612741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6681786|NCT01612741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681787|NCT01612741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6681788|NCT01612741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681789|NCT01612832|Pregabalin|pregabalin|mesh-list
6681790|NCT01612832|Analgesics|analgesics|mesh-ancestor
6681791|NCT01612832|Sensory System Agents|sensory system agents|mesh-ancestor
5969716|NCT04541173|Bevacizumab|bevacizumab|mesh-list
5969717|NCT04541173|Atezolizumab|atezolizumab|mesh-list
5969718|NCT04541173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5969719|NCT04541173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5969720|NCT04541173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5969721|NCT04541173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5969722|NCT04541173|Growth Substances|growth substances|mesh-ancestor
5969723|NCT04541173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681792|NCT01612832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6779956|NCT02181933|Zidovudine|zidovudine|mesh-list
6681793|NCT01612832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681794|NCT01612832|Anticonvulsants|anticonvulsants|mesh-ancestor
6681795|NCT01612832|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6681796|NCT01612832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6681797|NCT01612832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681798|NCT01612832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6681799|NCT01612832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6681800|NCT01612832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5956859|NCT04663555|Dexamethasone|dexamethasone|mesh-list
5956860|NCT04663555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5956861|NCT04663555|Antiemetics|antiemetics|mesh-ancestor
5956862|NCT04663555|Autonomic Agents|autonomic agents|mesh-ancestor
5956863|NCT04663555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5956864|NCT04663555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956865|NCT04663555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5956866|NCT04663555|Glucocorticoids|glucocorticoids|mesh-ancestor
5956867|NCT04663555|Hormones|hormones|mesh-ancestor
5956868|NCT04663555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5956869|NCT04663555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5956870|NCT04663555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5956871|NCT04663386|Budesonide|budesonide|mesh-list
5956872|NCT04663386|Formoterol Fumarate|formoterol fumarate|mesh-list
6681801|NCT01612832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6681802|NCT01612832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6681803|NCT01612871|Tamoxifen|tamoxifen|mesh-list
6681804|NCT01612871|Letrozole|letrozole|mesh-list
6681805|NCT01612871|Anastrozole|anastrozole|mesh-list
5956873|NCT04663386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5956874|NCT04663386|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5956875|NCT04663386|Autonomic Agents|autonomic agents|mesh-ancestor
5956876|NCT04663386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5956877|NCT04663386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956878|NCT04663386|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5956879|NCT04663386|Respiratory System Agents|respiratory system agents|mesh-ancestor
5956880|NCT04663386|Glucocorticoids|glucocorticoids|mesh-ancestor
5956881|NCT04663386|Hormones|hormones|mesh-ancestor
5956882|NCT04663386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5956883|NCT04663386|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5956884|NCT04663386|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5956885|NCT04663386|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5956886|NCT04663386|Adrenergic Agents|adrenergic agents|mesh-ancestor
5956887|NCT04663386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5956888|NCT04663386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5956889|NCT04663438|Antineoplastic Agents|antineoplastic agents|mesh-list
5956890|NCT04663568|Levonorgestrel|levonorgestrel|mesh-list
5956891|NCT04663568|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5956892|NCT04663568|Contraceptive Agents|contraceptive agents|mesh-ancestor
5956893|NCT04663568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5956894|NCT04663568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956895|NCT04663568|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5956896|NCT04663568|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5956897|NCT04663568|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5956898|NCT04663295|Insulin|insulin|mesh-list
5956899|NCT04663295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5956900|NCT04663295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956901|NCT04663269|Dexamethasone|dexamethasone|mesh-list
5956902|NCT04663269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5956903|NCT04663269|Antiemetics|antiemetics|mesh-ancestor
5956904|NCT04663269|Autonomic Agents|autonomic agents|mesh-ancestor
5956905|NCT04663269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5956906|NCT04663269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956907|NCT04663269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5956908|NCT04663269|Glucocorticoids|glucocorticoids|mesh-ancestor
5956909|NCT04663269|Hormones|hormones|mesh-ancestor
5956910|NCT04663269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5956911|NCT04663269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5956912|NCT04663269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5956913|NCT04662788|Antibodies|antibodies|mesh-list
5956914|NCT04662788|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6681806|NCT01612871|Exemestane|exemestane|mesh-list
6681807|NCT01612871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5956915|NCT04662788|Immunologic Factors|immunologic factors|mesh-ancestor
5956916|NCT04662788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956917|NCT04662736|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5956918|NCT04662736|Tedizolid|tedizolid|mesh-list
5956919|NCT04662736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5956920|NCT04662840|Anesthetics|anesthetics|mesh-list
5956921|NCT04662840|Anesthetics, Local|anesthetics, local|mesh-list
5956922|NCT04662840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5956923|NCT04662840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956924|NCT04662840|Sensory System Agents|sensory system agents|mesh-ancestor
5956925|NCT04662840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5956926|NCT04662866|Metformin|metformin|mesh-list
5956927|NCT04662866|Pioglitazone|pioglitazone|mesh-list
5956928|NCT04662866|Empagliflozin|empagliflozin|mesh-list
5956929|NCT04662866|Linagliptin|linagliptin|mesh-list
6681808|NCT01612871|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6681809|NCT01612871|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6681810|NCT01612871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6681811|NCT01612871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681812|NCT01612871|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6681813|NCT01612871|Hormone Antagonists|hormone antagonists|mesh-ancestor
6681814|NCT01612871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6681815|NCT01612871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681816|NCT01612871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6681817|NCT01612871|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6681818|NCT01612871|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6681819|NCT01612871|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6779957|NCT02181933|Nevirapine|nevirapine|mesh-list
6779958|NCT02181933|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6779959|NCT02181933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6779960|NCT02181933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6779961|NCT02181933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779962|NCT02181933|Antiviral Agents|antiviral agents|mesh-ancestor
6779963|NCT02181933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6779964|NCT02181933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6779965|NCT02181933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5956930|NCT04662866|Biguanides|biguanides|mesh-list
5956931|NCT04662866|Protease Inhibitors|protease inhibitors|mesh-list
5956932|NCT04662866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5956933|NCT04662866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956934|NCT04662866|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5956935|NCT04662866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5956936|NCT04662866|Incretins|incretins|mesh-ancestor
5956937|NCT04662866|Hormones|hormones|mesh-ancestor
5956938|NCT04662866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5956939|NCT04662866|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5956940|NCT04662866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5956941|NCT04662684|Rivaroxaban|rivaroxaban|mesh-list
5956942|NCT04662684|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5956943|NCT04662684|Antithrombins|antithrombins|mesh-ancestor
5956944|NCT04662684|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5956945|NCT04662684|Protease Inhibitors|protease inhibitors|mesh-ancestor
5956946|NCT04662684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5956947|NCT04662684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5956948|NCT04662684|Anticoagulants|anticoagulants|mesh-ancestor
5956949|NCT04662476|Vitamin D|vitamin d|mesh-list
5956950|NCT04662476|Cholecalciferol|cholecalciferol|mesh-list
5956951|NCT04662476|Vitamins|vitamins|mesh-ancestor
5956952|NCT04662476|Micronutrients|micronutrients|mesh-ancestor
5956953|NCT04662476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956954|NCT04662476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5956955|NCT04662476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5956956|NCT04662567|Acetaminophen|acetaminophen|mesh-list
5956957|NCT04662567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5956958|NCT04662567|Analgesics|analgesics|mesh-ancestor
5956959|NCT04662567|Sensory System Agents|sensory system agents|mesh-ancestor
5956960|NCT04662567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5956961|NCT04662567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956962|NCT04662567|Antipyretics|antipyretics|mesh-ancestor
5956963|NCT04662658|Xenon|xenon|mesh-list
5956964|NCT04662658|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5956965|NCT04662658|Anesthetics, General|anesthetics, general|mesh-ancestor
5956966|NCT04662658|Anesthetics|anesthetics|mesh-ancestor
5956967|NCT04662658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5956968|NCT04662658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956969|NCT04662515|Warfarin|warfarin|mesh-list
5956970|NCT04662515|Rivaroxaban|rivaroxaban|mesh-list
5956971|NCT04662515|Dabigatran|dabigatran|mesh-list
5956972|NCT04662515|Apixaban|apixaban|mesh-list
5956973|NCT04662515|Edoxaban|edoxaban|mesh-list
5956974|NCT04662515|Anticoagulants|anticoagulants|mesh-ancestor
5956975|NCT04662515|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5956976|NCT04662515|Antithrombins|antithrombins|mesh-ancestor
5956977|NCT04662515|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5956978|NCT04662515|Protease Inhibitors|protease inhibitors|mesh-ancestor
5956979|NCT04662515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5956980|NCT04662515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5956981|NCT04662385|Listerine|listerine|mesh-list
5956982|NCT04662385|Sodium Fluoride|sodium fluoride|mesh-list
5956983|NCT04662385|Cariostatic Agents|cariostatic agents|mesh-ancestor
5956984|NCT04662385|Protective Agents|protective agents|mesh-ancestor
5956985|NCT04662385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956986|NCT04662385|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5956987|NCT04662385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5956988|NCT04662177|Dexmedetomidine|dexmedetomidine|mesh-list
5956989|NCT04662177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5956990|NCT04662177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5956991|NCT04662177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5956992|NCT04662177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5956993|NCT04662177|Analgesics|analgesics|mesh-ancestor
5956994|NCT04662177|Sensory System Agents|sensory system agents|mesh-ancestor
5956995|NCT04662177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5956996|NCT04662177|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5956997|NCT04662177|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5956998|NCT04662177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5956999|NCT04662177|Adrenergic Agents|adrenergic agents|mesh-ancestor
5957000|NCT04662177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5957001|NCT04662177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5957002|NCT04662125|Acetaminophen|acetaminophen|mesh-list
5957003|NCT04662125|Prednisolone|prednisolone|mesh-list
5957004|NCT04662125|Pregabalin|pregabalin|mesh-list
5957005|NCT04662125|Caffeine|caffeine|mesh-list
5957006|NCT04662125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5957007|NCT04662125|Glucocorticoids|glucocorticoids|mesh-ancestor
5957008|NCT04662125|Hormones|hormones|mesh-ancestor
5957009|NCT04662125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5957010|NCT04662125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957011|NCT04662125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5957012|NCT04662125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5957013|NCT04662125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5957014|NCT04662125|Analgesics|analgesics|mesh-ancestor
5957015|NCT04662125|Sensory System Agents|sensory system agents|mesh-ancestor
5957016|NCT04662125|Anticonvulsants|anticonvulsants|mesh-ancestor
5957017|NCT04662125|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5957018|NCT04662125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5957019|NCT04662125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5957020|NCT04662125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5957021|NCT04662125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5957022|NCT04662125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5957023|NCT04662125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5957024|NCT04662125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5957025|NCT04662125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5957026|NCT04662125|Antipyretics|antipyretics|mesh-ancestor
5957027|NCT04662125|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5957028|NCT04662125|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5957029|NCT04662125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5957030|NCT04662125|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5957031|NCT04662125|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5957032|NCT04662125|Purinergic Agents|purinergic agents|mesh-ancestor
6517673|NCT00722215|Vasodilator Agents|vasodilator agents|mesh-ancestor
6517674|NCT00722215|Tocolytic Agents|tocolytic agents|mesh-ancestor
6517675|NCT00722215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6517676|NCT00722215|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6681820|NCT01612910|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
6681821|NCT01612910|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6681822|NCT01612910|Protective Agents|protective agents|mesh-ancestor
6681823|NCT01612910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681824|NCT01612910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6681825|NCT01612936|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6681826|NCT01612936|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6681827|NCT01612936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681828|NCT01612975|Naproxen|naproxen|mesh-list
6681829|NCT01612975|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5957033|NCT04662125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5957034|NCT04661930|Fenofibrate|fenofibrate|mesh-list
6681830|NCT01612975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6681831|NCT01612975|Analgesics|analgesics|mesh-ancestor
6681832|NCT01612975|Sensory System Agents|sensory system agents|mesh-ancestor
6681833|NCT01612975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6681834|NCT01612975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681835|NCT01612975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6681836|NCT01612975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6681837|NCT01612975|Gout Suppressants|gout suppressants|mesh-ancestor
6681838|NCT01612975|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6681839|NCT01612975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5957035|NCT04661930|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5957036|NCT04661930|Antimetabolites|antimetabolites|mesh-ancestor
5957037|NCT04661930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5957038|NCT04661930|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5957039|NCT04662138|Antiviral Agents|antiviral agents|mesh-list
5957040|NCT04662138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5957041|NCT04662242|Selenium|selenium|mesh-list
5957042|NCT04662242|Antioxidants|antioxidants|mesh-ancestor
5957043|NCT04662242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5957044|NCT04662242|Protective Agents|protective agents|mesh-ancestor
5957045|NCT04662242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957046|NCT04662242|Trace Elements|trace elements|mesh-ancestor
5957047|NCT04662242|Micronutrients|micronutrients|mesh-ancestor
5957048|NCT04661670|Salicylic Acid|salicylic acid|mesh-list
5957049|NCT04661670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5957050|NCT04661670|Antifungal Agents|antifungal agents|mesh-ancestor
5957051|NCT04661670|Keratolytic Agents|keratolytic agents|mesh-ancestor
6681840|NCT01612975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681841|NCT01613040|Moxifloxacin|moxifloxacin|mesh-list
6681842|NCT01613040|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6681843|NCT01613040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6681844|NCT01613040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6681845|NCT01613040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6681846|NCT01613040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6681847|NCT01613040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6681848|NCT01613040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681849|NCT01613040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5957052|NCT04661670|Dermatologic Agents|dermatologic agents|mesh-ancestor
5969724|NCT04541173|Growth Inhibitors|growth inhibitors|mesh-ancestor
5969725|NCT04541147|Dexamethasone|dexamethasone|mesh-list
5969726|NCT04541147|Analgesics|analgesics|mesh-list
5969727|NCT04541147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5969728|NCT04541147|Antiemetics|antiemetics|mesh-ancestor
5969729|NCT04541147|Autonomic Agents|autonomic agents|mesh-ancestor
5969730|NCT04541147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6681850|NCT01613040|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6681851|NCT01613040|Contraceptive Agents|contraceptive agents|mesh-ancestor
6681852|NCT01613040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5969731|NCT04541147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969732|NCT04541147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5969733|NCT04541147|Glucocorticoids|glucocorticoids|mesh-ancestor
5969734|NCT04541147|Hormones|hormones|mesh-ancestor
5969735|NCT04541147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5969736|NCT04541147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5969737|NCT04541147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5969738|NCT04541147|Sensory System Agents|sensory system agents|mesh-ancestor
6517677|NCT00722293|Doxorubicin|doxorubicin|mesh-list
6517678|NCT00722293|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6517679|NCT00722293|Epirubicin|epirubicin|mesh-list
6517680|NCT00722293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6517681|NCT00722293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6517682|NCT00722293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6517683|NCT00722293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6517684|NCT00722293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6517685|NCT00722293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517686|NCT00722475|Immunoglobulins|immunoglobulins|mesh-list
6681853|NCT01613040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681854|NCT01613040|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6681855|NCT01613040|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6681856|NCT01613040|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6681857|NCT01613053|Imatinib Mesylate|imatinib mesylate|mesh-list
6681858|NCT01613053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6681859|NCT01613053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6681860|NCT01613053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6681861|NCT01613053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681862|NCT01613079|Methotrexate|methotrexate|mesh-list
6681863|NCT01613079|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6681864|NCT01613079|Abortifacient Agents|abortifacient agents|mesh-ancestor
6681865|NCT01613079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6681866|NCT01613079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681867|NCT01613079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6681868|NCT01613079|Antimetabolites|antimetabolites|mesh-ancestor
6681869|NCT01613079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681870|NCT01613079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5969739|NCT04541303|Tranexamic Acid|tranexamic acid|mesh-list
5969740|NCT04541303|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5969741|NCT04541303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5969742|NCT04541303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969743|NCT04541303|Hemostatics|hemostatics|mesh-ancestor
5969744|NCT04541303|Coagulants|coagulants|mesh-ancestor
6681871|NCT01613079|Dermatologic Agents|dermatologic agents|mesh-ancestor
6681872|NCT01613079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6681873|NCT01613079|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6681874|NCT01613079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6681875|NCT01613079|Immunologic Factors|immunologic factors|mesh-ancestor
6681876|NCT01613079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6681877|NCT01613079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5969745|NCT04541355|Sodium thiosulfate|sodium thiosulfate|mesh-list
5969746|NCT04541355|Cisplatin|cisplatin|mesh-list
5969747|NCT04541355|Antidotes|antidotes|mesh-list
5969748|NCT04541355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5969749|NCT04541355|Protective Agents|protective agents|mesh-ancestor
5969750|NCT04541355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957053|NCT04661709|Aspirin|aspirin|mesh-list
5957054|NCT04661709|Metoprolol|metoprolol|mesh-list
5957055|NCT04661709|Isosorbide|isosorbide|mesh-list
5957056|NCT04661709|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
5957057|NCT04661709|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
5957058|NCT04661709|Nitroglycerin|nitroglycerin|mesh-list
5957059|NCT04661709|Trimetazidine|trimetazidine|mesh-list
5957060|NCT04661709|Clopidogrel|clopidogrel|mesh-list
5957061|NCT04661709|Atorvastatin|atorvastatin|mesh-list
5957062|NCT04661709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957063|NCT04661709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5957064|NCT04661709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5957065|NCT04661709|Analgesics|analgesics|mesh-ancestor
5957066|NCT04661709|Sensory System Agents|sensory system agents|mesh-ancestor
5957067|NCT04661709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5957068|NCT04661709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5957069|NCT04661709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5957070|NCT04661709|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5957071|NCT04661709|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5957072|NCT04661709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5957073|NCT04661709|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5957074|NCT04661709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5957075|NCT04661709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5957076|NCT04661709|Antipyretics|antipyretics|mesh-ancestor
5957077|NCT04661709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5957078|NCT04661709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5957079|NCT04661709|Antimetabolites|antimetabolites|mesh-ancestor
5957080|NCT04661709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5957081|NCT04661709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5957082|NCT04661709|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5957083|NCT04661709|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5957084|NCT04661709|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5957085|NCT04661709|Purinergic Agents|purinergic agents|mesh-ancestor
5957086|NCT04661709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5957087|NCT04661709|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5957088|NCT04661709|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5957089|NCT04661709|Sympatholytics|sympatholytics|mesh-ancestor
5957090|NCT04661709|Autonomic Agents|autonomic agents|mesh-ancestor
5957091|NCT04661709|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5957092|NCT04661709|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5957093|NCT04661709|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5957094|NCT04661709|Adrenergic Agents|adrenergic agents|mesh-ancestor
5957095|NCT04661709|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5957096|NCT04661709|Diuretics|diuretics|mesh-ancestor
5957097|NCT04661709|Natriuretic Agents|natriuretic agents|mesh-ancestor
5957098|NCT04661709|Vasodilator Agents|vasodilator agents|mesh-ancestor
5957099|NCT04661709|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5957100|NCT04661696|Paclitaxel|paclitaxel|mesh-list
5957101|NCT04661696|Carboplatin|carboplatin|mesh-list
5957102|NCT04661696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5957103|NCT04661696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5957104|NCT04661696|Tubulin Modulators|tubulin modulators|mesh-ancestor
5957105|NCT04661696|Antimitotic Agents|antimitotic agents|mesh-ancestor
5957106|NCT04661696|Mitosis Modulators|mitosis modulators|mesh-ancestor
5957107|NCT04661696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5957108|NCT04661475|Dexmedetomidine|dexmedetomidine|mesh-list
5957109|NCT04661475|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6517687|NCT00722475|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6517688|NCT00722475|Antibodies|antibodies|mesh-list
6517689|NCT00722475|gamma-Globulins|gamma-globulins|mesh-list
5957110|NCT04661475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5957111|NCT04661475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957112|NCT04661475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5957113|NCT04661475|Analgesics|analgesics|mesh-ancestor
5957114|NCT04661475|Sensory System Agents|sensory system agents|mesh-ancestor
6681878|NCT01613092|Vancomycin|vancomycin|mesh-list
6681879|NCT01613092|Clindamycin|clindamycin|mesh-list
6681880|NCT01613092|Cefazolin|cefazolin|mesh-list
6681881|NCT01613092|Cephalexin|cephalexin|mesh-list
6681882|NCT01613092|Bacitracin|bacitracin|mesh-list
6681883|NCT01613092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6681884|NCT01613092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6681885|NCT01613092|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6681886|NCT01613092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6681887|NCT01613092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5957115|NCT04661475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6517690|NCT00722475|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6681888|NCT01613092|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6681889|NCT01613105|Acarbose|acarbose|mesh-list
6681890|NCT01613105|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6681891|NCT01613105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6517691|NCT00722475|Immunologic Factors|immunologic factors|mesh-ancestor
6517692|NCT00722475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517693|NCT00722488|Pevonedistat|pevonedistat|mesh-list
6517694|NCT00722488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6517695|NCT00722488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517696|NCT00722579|Cobalt|cobalt|mesh-list
5957116|NCT04661475|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5957117|NCT04661475|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5957118|NCT04661475|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5957119|NCT04661475|Adrenergic Agents|adrenergic agents|mesh-ancestor
5957120|NCT04661475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5957121|NCT04661475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5957122|NCT04661852|Cyclophosphamide|cyclophosphamide|mesh-list
5957123|NCT04661852|Topotecan|topotecan|mesh-list
5957124|NCT04661852|Mitogens|mitogens|mesh-list
5957125|NCT04661852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5957126|NCT04661852|Immunologic Factors|immunologic factors|mesh-ancestor
5957127|NCT04661852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957128|NCT04661852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5957129|NCT04661852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5957130|NCT04661852|Alkylating Agents|alkylating agents|mesh-ancestor
5957131|NCT04661852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5957132|NCT04661852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5957133|NCT04661852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5957134|NCT04661852|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5957135|NCT04661852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5957136|NCT04661852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5957137|NCT04661852|Mitosis Modulators|mitosis modulators|mesh-ancestor
6681892|NCT01613105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681893|NCT01613105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5957138|NCT04661345|Coagulase|coagulase|mesh-list
5957139|NCT04661345|Coagulants|coagulants|mesh-ancestor
5957140|NCT04661397|Tenofovir|tenofovir|mesh-list
5957141|NCT04661397|Emtricitabine|emtricitabine|mesh-list
5957142|NCT04661397|Darunavir|darunavir|mesh-list
5957143|NCT04661397|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5957144|NCT04661397|Cobicistat|cobicistat|mesh-list
5957145|NCT04661397|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
5957146|NCT04661397|Antiviral Agents|antiviral agents|mesh-ancestor
5957147|NCT04661397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5957148|NCT04661397|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5957149|NCT04661397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6681894|NCT01613105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681895|NCT01613170|Estrogens|estrogens|mesh-list
6681896|NCT01613170|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6681897|NCT01613170|Hormones|hormones|mesh-ancestor
6681898|NCT01613170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6681899|NCT01613170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681900|NCT01613196|Deoxyglucose|deoxyglucose|mesh-list
6681901|NCT01613196|Antimetabolites|antimetabolites|mesh-ancestor
6681902|NCT01613196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681903|NCT01613196|Antiviral Agents|antiviral agents|mesh-ancestor
6681904|NCT01613196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6681905|NCT01613209|Candesartan|candesartan|mesh-list
6681906|NCT01613209|Candesartan cilexetil|candesartan cilexetil|mesh-list
6681907|NCT01613209|Olmesartan|olmesartan|mesh-list
6681908|NCT01613209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6681909|NCT01613209|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6681910|NCT01613209|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6681911|NCT01613209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681912|NCT01613300|Ofatumumab|ofatumumab|mesh-list
6681913|NCT01613300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6681914|NCT01613365|Chlorhexidine|chlorhexidine|mesh-list
6681915|NCT01613365|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5957150|NCT04661397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5957151|NCT04661397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5957152|NCT04661397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5957153|NCT04661397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6517697|NCT00722579|Chromium|chromium|mesh-list
6517698|NCT00722579|Trace Elements|trace elements|mesh-ancestor
6517699|NCT00722579|Micronutrients|micronutrients|mesh-ancestor
6517700|NCT00722579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681916|NCT01613365|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5957154|NCT04661397|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5957155|NCT04661397|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5957156|NCT04661397|Protease Inhibitors|protease inhibitors|mesh-ancestor
5957157|NCT04661397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5957158|NCT04661397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5957159|NCT04660773|Pregabalin|pregabalin|mesh-list
5957160|NCT04660773|Analgesics|analgesics|mesh-ancestor
5957161|NCT04660773|Sensory System Agents|sensory system agents|mesh-ancestor
6681917|NCT01613365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6681918|NCT01613365|Disinfectants|disinfectants|mesh-ancestor
6681919|NCT01613365|Dermatologic Agents|dermatologic agents|mesh-ancestor
6681920|NCT01613469|Leucovorin|leucovorin|mesh-list
6681921|NCT01613469|Antidotes|antidotes|mesh-ancestor
6681922|NCT01613469|Protective Agents|protective agents|mesh-ancestor
6681923|NCT01613469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681924|NCT01613469|Vitamin B Complex|vitamin b complex|mesh-ancestor
6681925|NCT01613469|Vitamins|vitamins|mesh-ancestor
6681926|NCT01613469|Micronutrients|micronutrients|mesh-ancestor
6681927|NCT01613482|Trastuzumab|trastuzumab|mesh-list
6681928|NCT01613482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6681929|NCT01613482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6681930|NCT01613495|Octreotide|octreotide|mesh-list
6517701|NCT00722631|Pioglitazone|pioglitazone|mesh-list
6517702|NCT00722631|Glimepiride|glimepiride|mesh-list
6517703|NCT00722631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6681931|NCT01613495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6681932|NCT01613495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6681933|NCT01613495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6681934|NCT01613534|Sucralfate|sucralfate|mesh-list
6681935|NCT01613534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6681936|NCT01613534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6681937|NCT01613547|Amoxicillin|amoxicillin|mesh-list
6681938|NCT01613547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6681939|NCT01613547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6681940|NCT01613573|Hormones|hormones|mesh-list
6681941|NCT01613573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6681942|NCT01613573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681943|NCT01613664|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6681944|NCT01613664|Hemostatics|hemostatics|mesh-ancestor
6681945|NCT01613664|Coagulants|coagulants|mesh-ancestor
6681946|NCT01613690|Glycopyrrolate|glycopyrrolate|mesh-list
6681947|NCT01613690|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6681948|NCT01613690|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6681949|NCT01613690|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6681950|NCT01613690|Cholinergic Agents|cholinergic agents|mesh-ancestor
6681951|NCT01613690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6681952|NCT01613690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681953|NCT01613690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681954|NCT01613729|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6681955|NCT01613729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5957162|NCT04660773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5957163|NCT04660773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957164|NCT04660773|Anticonvulsants|anticonvulsants|mesh-ancestor
5957165|NCT04660773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5957166|NCT04660773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5957167|NCT04660773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5957168|NCT04660773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5957169|NCT04660773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5957170|NCT04660773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5957171|NCT04660773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5957172|NCT04660773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5957173|NCT04660916|Isotretinoin|isotretinoin|mesh-list
5957174|NCT04660916|Dermatologic Agents|dermatologic agents|mesh-ancestor
5957176|NCT04660786|Vitamin D|vitamin d|mesh-list
5957177|NCT04660786|Triamcinolone|triamcinolone|mesh-list
5969751|NCT04541355|Antioxidants|antioxidants|mesh-ancestor
6517704|NCT00722631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681956|NCT01613729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6517705|NCT00722631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6517706|NCT00722631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6517707|NCT00722631|Immunologic Factors|immunologic factors|mesh-ancestor
6517708|NCT00722709|Ropivacaine|ropivacaine|mesh-list
6517709|NCT00722709|Anesthetics, Local|anesthetics, local|mesh-ancestor
6517710|NCT00722709|Anesthetics|anesthetics|mesh-ancestor
6517711|NCT00722709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6681957|NCT01613729|Antimetabolites|antimetabolites|mesh-ancestor
5957178|NCT04660786|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5957179|NCT04660786|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5957180|NCT04660786|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5957181|NCT04660786|Vitamins|vitamins|mesh-ancestor
5957182|NCT04660786|Micronutrients|micronutrients|mesh-ancestor
5957183|NCT04660786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957184|NCT04660786|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5957185|NCT04660786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5957186|NCT04660786|Glucocorticoids|glucocorticoids|mesh-ancestor
5957187|NCT04660786|Hormones|hormones|mesh-ancestor
5957188|NCT04660786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5957189|NCT04660786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5957190|NCT04660786|Immunologic Factors|immunologic factors|mesh-ancestor
5957191|NCT04660786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5957192|NCT04660786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5957193|NCT04660643|Tirzepatide|tirzepatide|mesh-list
5957194|NCT04660643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5957195|NCT04660643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957196|NCT04660643|Incretins|incretins|mesh-ancestor
5957197|NCT04660643|Hormones|hormones|mesh-ancestor
5957198|NCT04660643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5957199|NCT04660240|Sirolimus|sirolimus|mesh-list
5957200|NCT04660240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5957201|NCT04660240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5957202|NCT04660240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5957203|NCT04660240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5957204|NCT04660240|Antifungal Agents|antifungal agents|mesh-ancestor
5957205|NCT04660240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5957206|NCT04660240|Immunologic Factors|immunologic factors|mesh-ancestor
5957207|NCT04660240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957208|NCT04660461|Lansoprazole|lansoprazole|mesh-list
5957209|NCT04660461|Dexlansoprazole|dexlansoprazole|mesh-list
5957210|NCT04660461|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5957211|NCT04660461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5957212|NCT04660461|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5957213|NCT04660461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5957214|NCT04660461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5957215|NCT04660305|Insulin Aspart|insulin aspart|mesh-list
5957216|NCT04660305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5957217|NCT04660305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957218|NCT04660565|Prednisone|prednisone|mesh-list
5957219|NCT04660565|Belimumab|belimumab|mesh-list
5957220|NCT04660565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5957221|NCT04660565|Glucocorticoids|glucocorticoids|mesh-ancestor
5957222|NCT04660565|Hormones|hormones|mesh-ancestor
5957223|NCT04660565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5957224|NCT04660565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957225|NCT04660565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5957226|NCT04660565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5957227|NCT04660565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5957228|NCT04660565|Immunologic Factors|immunologic factors|mesh-ancestor
5957229|NCT04660097|Etoposide|etoposide|mesh-list
5957230|NCT04660097|Etoposide phosphate|etoposide phosphate|mesh-list
5957231|NCT04660097|Durvalumab|durvalumab|mesh-list
5957232|NCT04660097|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5957233|NCT04660097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5957234|NCT04660097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5957235|NCT04660097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5957236|NCT04660097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5957237|NCT04660097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5957238|NCT04660097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681958|NCT01613729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681959|NCT01613729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6681960|NCT01613729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5957239|NCT04660097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5957240|NCT04660097|Immunologic Factors|immunologic factors|mesh-ancestor
5957241|NCT04660097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957242|NCT04660110|Piperaquine|piperaquine|mesh-list
5957243|NCT04660110|Artenimol|artenimol|mesh-list
5957244|NCT04660110|Antimalarials|antimalarials|mesh-ancestor
5957245|NCT04660110|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5957246|NCT04660110|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5957247|NCT04660110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5969752|NCT04541355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5957248|NCT04659928|Hydrogen Peroxide|hydrogen peroxide|mesh-list
5957249|NCT04659928|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5957250|NCT04659928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5957251|NCT04659941|BCG Vaccine|bcg vaccine|mesh-list
5957252|NCT04659941|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5957253|NCT04659941|Immunologic Factors|immunologic factors|mesh-ancestor
5957254|NCT04659941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957255|NCT04659915|Metformin|metformin|mesh-list
6517712|NCT00722709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517713|NCT00722709|Sensory System Agents|sensory system agents|mesh-ancestor
6517714|NCT00722709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6517715|NCT00722735|Ciprofloxacin|ciprofloxacin|mesh-list
6517716|NCT00722735|Finafloxacin|finafloxacin|mesh-list
6517717|NCT00722735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6681961|NCT01613729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6681962|NCT01613755|Metformin|metformin|mesh-list
6681963|NCT01613755|Dipyridamole|dipyridamole|mesh-list
6681964|NCT01613755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6681965|NCT01613755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681966|NCT01613755|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6681967|NCT01613755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6681968|NCT01613755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681969|NCT01613755|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6681970|NCT01613755|Vasodilator Agents|vasodilator agents|mesh-ancestor
6681971|NCT01613794|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6681972|NCT01613794|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6681973|NCT01613794|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6681974|NCT01613794|Antimetabolites|antimetabolites|mesh-ancestor
6681975|NCT01613794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6681976|NCT01613794|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6681977|NCT01613794|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6681978|NCT01613794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6681979|NCT01613807|Insulin|insulin|mesh-list
6681980|NCT01613807|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6681981|NCT01613807|Insulin Lispro|insulin lispro|mesh-list
6681982|NCT01613807|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
6681983|NCT01613807|Insulin, Long-Acting|insulin, long-acting|mesh-list
6681984|NCT01613807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6681985|NCT01613807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957256|NCT04659915|Prednisone|prednisone|mesh-list
5957257|NCT04659915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5957258|NCT04659915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957259|NCT04659915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5957260|NCT04659915|Glucocorticoids|glucocorticoids|mesh-ancestor
5957261|NCT04659915|Hormones|hormones|mesh-ancestor
5957262|NCT04659915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5957263|NCT04659915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5957264|NCT04659915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5957265|NCT04660123|Bismuth|bismuth|mesh-list
5957266|NCT04660123|Antacids|antacids|mesh-ancestor
5957267|NCT04660123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5957268|NCT04660123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5957269|NCT04659785|Apatinib|apatinib|mesh-list
5957270|NCT04659785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5957271|NCT04659785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5957272|NCT04659785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5957273|NCT04659785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5957274|NCT04659369|Nivolumab|nivolumab|mesh-list
5957275|NCT04659369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5957276|NCT04659369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5957277|NCT04659369|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5957278|NCT04659369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5957279|NCT04659525|Ezetimibe|ezetimibe|mesh-list
5957280|NCT04659525|Evolocumab|evolocumab|mesh-list
5957281|NCT04659525|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5957282|NCT04659525|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6681986|NCT01613820|Scopolamine|scopolamine|mesh-list
5957283|NCT04659525|Antimetabolites|antimetabolites|mesh-ancestor
5957284|NCT04659525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517718|NCT00722735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6517719|NCT00722735|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6517720|NCT00722735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6517721|NCT00722735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6517722|NCT00722735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517723|NCT00722735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6681987|NCT01613820|Ketamine|ketamine|mesh-list
6681988|NCT01613820|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
6681989|NCT01613820|Analgesics|analgesics|mesh-ancestor
6681990|NCT01613820|Sensory System Agents|sensory system agents|mesh-ancestor
6681991|NCT01613820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6681992|NCT01613820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6681993|NCT01613820|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6681994|NCT01613820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6681995|NCT01613820|Anesthetics, General|anesthetics, general|mesh-ancestor
6681996|NCT01613820|Anesthetics|anesthetics|mesh-ancestor
6681997|NCT01613820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6681998|NCT01613820|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6681999|NCT01613820|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6682000|NCT01613820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6682001|NCT01613820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682002|NCT01613820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5957285|NCT04659525|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5957286|NCT04659382|Bevacizumab|bevacizumab|mesh-list
5957287|NCT04659382|Atezolizumab|atezolizumab|mesh-list
5957288|NCT04659382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5957289|NCT04659382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5957290|NCT04659382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5957291|NCT04659382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5957292|NCT04659382|Growth Substances|growth substances|mesh-ancestor
5957293|NCT04659382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957294|NCT04659382|Growth Inhibitors|growth inhibitors|mesh-ancestor
5957295|NCT04659551|Cyclophosphamide|cyclophosphamide|mesh-list
5957296|NCT04659551|Nivolumab|nivolumab|mesh-list
5957297|NCT04659551|Epirubicin|epirubicin|mesh-list
5957298|NCT04659551|Exemestane|exemestane|mesh-list
5957299|NCT04659551|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5957300|NCT04659551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5957301|NCT04659551|Immunologic Factors|immunologic factors|mesh-ancestor
5957302|NCT04659551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957303|NCT04659551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5957304|NCT04659551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5957305|NCT04659551|Alkylating Agents|alkylating agents|mesh-ancestor
5957306|NCT04659551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682003|NCT01613820|Antiemetics|antiemetics|mesh-ancestor
6682004|NCT01613820|Autonomic Agents|autonomic agents|mesh-ancestor
6682005|NCT01613820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6682006|NCT01613820|Mydriatics|mydriatics|mesh-ancestor
6682007|NCT01613820|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6682008|NCT01613820|Cholinergic Agents|cholinergic agents|mesh-ancestor
6682009|NCT01613820|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6682010|NCT01613820|Parasympatholytics|parasympatholytics|mesh-ancestor
6682011|NCT01613846|Sorafenib|sorafenib|mesh-list
6682012|NCT01613846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6682013|NCT01613846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6682014|NCT01613846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6682015|NCT01613846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682016|NCT01613924|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6682017|NCT01613924|Dermatologic Agents|dermatologic agents|mesh-ancestor
6682018|NCT01613963|Cyclosporine|cyclosporine|mesh-list
6682019|NCT01613963|Mycophenolic Acid|mycophenolic acid|mesh-list
6682020|NCT01613963|Prednisolone|prednisolone|mesh-list
6682021|NCT01613963|Adalimumab|adalimumab|mesh-list
6682022|NCT01613963|Etanercept|etanercept|mesh-list
6682023|NCT01613963|Methotrexate|methotrexate|mesh-list
6682024|NCT01613963|Azathioprine|azathioprine|mesh-list
5957307|NCT04659551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5957308|NCT04659551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5957309|NCT04659551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5957310|NCT04659551|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5957311|NCT04659551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5957312|NCT04659551|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5957313|NCT04659551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5957314|NCT04659551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5957315|NCT04659551|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6682025|NCT01613963|Infliximab|infliximab|mesh-list
6682026|NCT01613963|Cyclosporins|cyclosporins|mesh-list
6682027|NCT01613963|Immunosuppressive Agents|immunosuppressive agents|mesh-list
6682028|NCT01613963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6682029|NCT01613963|Immunologic Factors|immunologic factors|mesh-ancestor
6682030|NCT01613963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682031|NCT01613963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6682032|NCT01613963|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6682033|NCT01613963|Abortifacient Agents|abortifacient agents|mesh-ancestor
6682034|NCT01613963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6682035|NCT01613963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6682036|NCT01613963|Antimetabolites|antimetabolites|mesh-ancestor
6682037|NCT01613963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682038|NCT01613963|Dermatologic Agents|dermatologic agents|mesh-ancestor
6682039|NCT01613963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6682040|NCT01613963|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6682041|NCT01613963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6682042|NCT01613963|Antifungal Agents|antifungal agents|mesh-ancestor
6682043|NCT01613963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6682044|NCT01613963|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6682045|NCT01613963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6682046|NCT01613963|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6682047|NCT01613963|Antitubercular Agents|antitubercular agents|mesh-ancestor
6682048|NCT01613963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6682049|NCT01613963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6682050|NCT01613963|Glucocorticoids|glucocorticoids|mesh-ancestor
6682051|NCT01613963|Hormones|hormones|mesh-ancestor
6682052|NCT01613963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6682053|NCT01613963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6682054|NCT01613963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6682055|NCT01613963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6682056|NCT01613963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6682057|NCT01613963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6682058|NCT01613963|Analgesics|analgesics|mesh-ancestor
6682059|NCT01613963|Sensory System Agents|sensory system agents|mesh-ancestor
6682060|NCT01613976|Panobinostat|panobinostat|mesh-list
6682061|NCT01613976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6682062|NCT01613976|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6682063|NCT01613976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6682064|NCT01613976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682065|NCT01614041|Tandospirone|tandospirone|mesh-list
6682066|NCT01614041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6682067|NCT01614041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6682068|NCT01614041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6682069|NCT01614041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682070|NCT01614041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6517724|NCT00722735|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6517725|NCT00722735|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6517726|NCT00722735|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6517727|NCT00722735|Renal Agents|renal agents|mesh-ancestor
6517728|NCT00722839|Vaccines|vaccines|mesh-list
6517729|NCT00722839|Immunologic Factors|immunologic factors|mesh-ancestor
6517730|NCT00722839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517731|NCT00722852|Ketoprofen|ketoprofen|mesh-list
6682071|NCT01614041|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5957316|NCT04659551|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5957317|NCT04659551|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5957318|NCT04659551|Hormone Antagonists|hormone antagonists|mesh-ancestor
5957319|NCT04659551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5957320|NCT04659551|Luteolytic Agents|luteolytic agents|mesh-ancestor
5957321|NCT04659551|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5957322|NCT04659551|Contraceptive Agents|contraceptive agents|mesh-ancestor
6682072|NCT01614041|Serotonin Agents|serotonin agents|mesh-ancestor
6682073|NCT01614041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6682074|NCT01614041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682075|NCT01614132|Cisplatin|cisplatin|mesh-list
6682076|NCT01614132|Vincristine|vincristine|mesh-list
6682077|NCT01614132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6682078|NCT01614132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682079|NCT01614132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6682080|NCT01614132|Tubulin Modulators|tubulin modulators|mesh-ancestor
6682081|NCT01614132|Antimitotic Agents|antimitotic agents|mesh-ancestor
6682082|NCT01614132|Mitosis Modulators|mitosis modulators|mesh-ancestor
5957323|NCT04659551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5957324|NCT04659551|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5957325|NCT04659551|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5957326|NCT04659616|Cytarabine|cytarabine|mesh-list
5957327|NCT04659616|Daunorubicin|daunorubicin|mesh-list
5957328|NCT04659616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5957329|NCT04659616|Antimetabolites|antimetabolites|mesh-ancestor
5957330|NCT04659616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5957331|NCT04659616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5957332|NCT04659616|Antiviral Agents|antiviral agents|mesh-ancestor
5957333|NCT04659616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5957334|NCT04659616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5957335|NCT04659616|Immunologic Factors|immunologic factors|mesh-ancestor
5957336|NCT04659616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957337|NCT04659616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5957338|NCT04659616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5957339|NCT04659616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5957340|NCT04659616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5957341|NCT04659499|Paclitaxel|paclitaxel|mesh-list
5957342|NCT04659499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5957343|NCT04659499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5957344|NCT04659499|Tubulin Modulators|tubulin modulators|mesh-ancestor
5957345|NCT04659499|Antimitotic Agents|antimitotic agents|mesh-ancestor
5957346|NCT04659499|Mitosis Modulators|mitosis modulators|mesh-ancestor
5957347|NCT04659499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5957348|NCT04659642|Fentanyl|fentanyl|mesh-list
5957349|NCT04659642|Dexmedetomidine|dexmedetomidine|mesh-list
5957350|NCT04659642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5957351|NCT04659642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5957352|NCT04659642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957353|NCT04659642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5957354|NCT04659642|Analgesics|analgesics|mesh-ancestor
6682083|NCT01614171|Hormones|hormones|mesh-list
6682084|NCT01614171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6682085|NCT01614171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682086|NCT01614197|Cytarabine|cytarabine|mesh-list
6682087|NCT01614197|Hydrocortisone|hydrocortisone|mesh-list
5957355|NCT04659642|Sensory System Agents|sensory system agents|mesh-ancestor
5957356|NCT04659642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5957357|NCT04659642|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5957358|NCT04659642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5957359|NCT04659642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5957360|NCT04659642|Adrenergic Agents|adrenergic agents|mesh-ancestor
5957361|NCT04659642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5957362|NCT04659642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5957363|NCT04659642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5957364|NCT04659642|Narcotics|narcotics|mesh-ancestor
5957365|NCT04659642|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5957366|NCT04659642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5957367|NCT04659642|Anesthetics, General|anesthetics, general|mesh-ancestor
5957368|NCT04659642|Anesthetics|anesthetics|mesh-ancestor
5957369|NCT04659278|Peppermint oil|peppermint oil|mesh-list
5957370|NCT04659278|Antiemetics|antiemetics|mesh-ancestor
5957371|NCT04659278|Autonomic Agents|autonomic agents|mesh-ancestor
5957372|NCT04659278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5957373|NCT04659278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957374|NCT04659278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5957375|NCT04659278|Parasympatholytics|parasympatholytics|mesh-ancestor
5957376|NCT04659109|Glenzocimab|glenzocimab|mesh-list
5957377|NCT04659109|Anticoagulants|anticoagulants|mesh-ancestor
5957378|NCT04659070|Telmisartan|telmisartan|mesh-list
5957379|NCT04659070|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5957380|NCT04659070|Ezetimibe|ezetimibe|mesh-list
5957381|NCT04659070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5957382|NCT04659070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5957383|NCT04659070|Antimetabolites|antimetabolites|mesh-ancestor
5957384|NCT04659070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5957385|NCT04659070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5957386|NCT04659070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5957387|NCT04659070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5957388|NCT04659070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5957389|NCT04659070|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5957390|NCT04659070|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5957391|NCT04658927|Dexamethasone|dexamethasone|mesh-list
5957392|NCT04658927|Prednisone|prednisone|mesh-list
5957393|NCT04658927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5957394|NCT04658927|Antiemetics|antiemetics|mesh-ancestor
5957395|NCT04658927|Autonomic Agents|autonomic agents|mesh-ancestor
5957396|NCT04658927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5957397|NCT04658927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957398|NCT04658927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5957399|NCT04658927|Glucocorticoids|glucocorticoids|mesh-ancestor
5957400|NCT04658927|Hormones|hormones|mesh-ancestor
5957401|NCT04658927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5957402|NCT04658927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5957403|NCT04658927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5957404|NCT04659057|Lidocaine|lidocaine|mesh-list
5957405|NCT04659057|Dexmedetomidine|dexmedetomidine|mesh-list
5957406|NCT04659057|Anesthetics, Local|anesthetics, local|mesh-ancestor
5957407|NCT04659057|Anesthetics|anesthetics|mesh-ancestor
5957408|NCT04659057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5957409|NCT04659057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682088|NCT01614197|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6682089|NCT01614197|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6682090|NCT01614197|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6682091|NCT01614197|Cyclophosphamide|cyclophosphamide|mesh-list
6682092|NCT01614197|Methotrexate|methotrexate|mesh-list
6682093|NCT01614197|Etoposide|etoposide|mesh-list
6682094|NCT01614197|Etoposide phosphate|etoposide phosphate|mesh-list
6682095|NCT01614197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6682096|NCT01614197|Immunologic Factors|immunologic factors|mesh-ancestor
6682097|NCT01614197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682098|NCT01614197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5957410|NCT04659057|Sensory System Agents|sensory system agents|mesh-ancestor
5957411|NCT04659057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5957412|NCT04659057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5957413|NCT04659057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5957414|NCT04659057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5957415|NCT04659057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5957416|NCT04659057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5957417|NCT04659057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5957418|NCT04659057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5957419|NCT04659057|Analgesics|analgesics|mesh-ancestor
5957420|NCT04659057|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5957421|NCT04659057|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5957422|NCT04659057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5957423|NCT04659057|Adrenergic Agents|adrenergic agents|mesh-ancestor
5957424|NCT04659057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5957425|NCT04658823|Vitamin E|vitamin e|mesh-list
5957426|NCT04658823|Tocopherols|tocopherols|mesh-list
5957427|NCT04658823|Tocotrienols|tocotrienols|mesh-list
5957428|NCT04658823|Tocovid|tocovid|mesh-list
6682099|NCT01614197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6682100|NCT01614197|Alkylating Agents|alkylating agents|mesh-ancestor
6682101|NCT01614197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682102|NCT01614197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6682103|NCT01614197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6682104|NCT01614197|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6682105|NCT01614197|Abortifacient Agents|abortifacient agents|mesh-ancestor
6682106|NCT01614197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5957429|NCT04658823|Vitamins|vitamins|mesh-ancestor
5957430|NCT04658823|Micronutrients|micronutrients|mesh-ancestor
5957431|NCT04658823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957432|NCT04658823|Antioxidants|antioxidants|mesh-ancestor
5957433|NCT04658823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5957434|NCT04658823|Protective Agents|protective agents|mesh-ancestor
5957435|NCT04658836|Triamcinolone|triamcinolone|mesh-list
5957436|NCT04658836|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5957437|NCT04658836|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5957438|NCT04658836|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5957439|NCT04658836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5957440|NCT04658836|Glucocorticoids|glucocorticoids|mesh-ancestor
5957441|NCT04658836|Hormones|hormones|mesh-ancestor
5957442|NCT04658836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5957443|NCT04658836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957444|NCT04658836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5957445|NCT04658836|Immunologic Factors|immunologic factors|mesh-ancestor
5957446|NCT04658836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5957447|NCT04658836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5957448|NCT04658654|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-list
5957449|NCT04658654|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5957450|NCT04658654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5957451|NCT04658654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5957452|NCT04658680|Vaccines|vaccines|mesh-list
5957453|NCT04658680|Immunologic Factors|immunologic factors|mesh-ancestor
5957454|NCT04658680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957455|NCT04658732|Dexmedetomidine|dexmedetomidine|mesh-list
5957456|NCT04658732|Gabapentin|gabapentin|mesh-list
5957457|NCT04658732|Alprazolam|alprazolam|mesh-list
5957458|NCT04658732|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5957459|NCT04658732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5957460|NCT04658732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682107|NCT01614197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6682108|NCT01614197|Antimetabolites|antimetabolites|mesh-ancestor
6682109|NCT01614197|Dermatologic Agents|dermatologic agents|mesh-ancestor
6682110|NCT01614197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6682111|NCT01614197|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6682112|NCT01614197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6682113|NCT01614197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6682114|NCT01614197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6682115|NCT01614197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6682116|NCT01614197|Antiviral Agents|antiviral agents|mesh-ancestor
6682117|NCT01614197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6682118|NCT01614197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6682119|NCT01614223|Betamethasone|betamethasone|mesh-list
6682120|NCT01614223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6682121|NCT01614223|Glucocorticoids|glucocorticoids|mesh-ancestor
6682122|NCT01614223|Hormones|hormones|mesh-ancestor
6682123|NCT01614223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6682124|NCT01614223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682125|NCT01614223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6682126|NCT01614223|Respiratory System Agents|respiratory system agents|mesh-ancestor
6682127|NCT01614236|Pregabalin|pregabalin|mesh-list
6682128|NCT01614236|Analgesics|analgesics|mesh-ancestor
6682129|NCT01614236|Sensory System Agents|sensory system agents|mesh-ancestor
6682130|NCT01614236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6682131|NCT01614236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682132|NCT01614236|Anticonvulsants|anticonvulsants|mesh-ancestor
6682133|NCT01614236|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6682134|NCT01614236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6682135|NCT01614236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682136|NCT01614236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6682137|NCT01614236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6682138|NCT01614236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6682139|NCT01614236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6682140|NCT01614236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6682141|NCT01614301|Pioglitazone|pioglitazone|mesh-list
6682142|NCT01614301|Sirolimus|sirolimus|mesh-list
6682143|NCT01614301|Etoricoxib|etoricoxib|mesh-list
6682144|NCT01614301|Dacarbazine|dacarbazine|mesh-list
6682145|NCT01614301|Trofosfamide|trofosfamide|mesh-list
6682146|NCT01614301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6682147|NCT01614301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682148|NCT01614301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6682149|NCT01614301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6682150|NCT01614301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6682151|NCT01614301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6682152|NCT01614301|Antifungal Agents|antifungal agents|mesh-ancestor
6682153|NCT01614301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6682154|NCT01614301|Immunologic Factors|immunologic factors|mesh-ancestor
6682155|NCT01614301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5957461|NCT04658732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5957462|NCT04658732|Analgesics|analgesics|mesh-ancestor
5957463|NCT04658732|Sensory System Agents|sensory system agents|mesh-ancestor
5957464|NCT04658732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5957465|NCT04658732|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5957466|NCT04658732|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5957467|NCT04658732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5957468|NCT04658732|Adrenergic Agents|adrenergic agents|mesh-ancestor
5957469|NCT04658732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5957470|NCT04658732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5957471|NCT04658732|Anticonvulsants|anticonvulsants|mesh-ancestor
5957472|NCT04658732|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5957473|NCT04658732|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5957474|NCT04658732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5957475|NCT04658732|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5957476|NCT04658732|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5957477|NCT04658732|Antimanic Agents|antimanic agents|mesh-ancestor
5957478|NCT04658732|GABA Modulators|gaba modulators|mesh-ancestor
5957479|NCT04658732|GABA Agents|gaba agents|mesh-ancestor
5957480|NCT04658420|Ketamine|ketamine|mesh-list
5957481|NCT04658420|Analgesics|analgesics|mesh-ancestor
5957482|NCT04658420|Sensory System Agents|sensory system agents|mesh-ancestor
5957483|NCT04658420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5957484|NCT04658420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957485|NCT04658420|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5957486|NCT04658420|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5957487|NCT04658420|Anesthetics, General|anesthetics, general|mesh-ancestor
5957488|NCT04658420|Anesthetics|anesthetics|mesh-ancestor
5957489|NCT04658420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5957490|NCT04658420|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5957491|NCT04658420|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5957492|NCT04658420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5957493|NCT04658420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5957494|NCT04658329|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
5957495|NCT04658329|Antiviral Agents|antiviral agents|mesh-ancestor
5957496|NCT04658329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5969753|NCT04541355|Antitubercular Agents|antitubercular agents|mesh-ancestor
5969754|NCT04541355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5969755|NCT04541355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5969756|NCT04541355|Chelating Agents|chelating agents|mesh-ancestor
5969757|NCT04541355|Sequestering Agents|sequestering agents|mesh-ancestor
5969758|NCT04541277|Cytarabine|cytarabine|mesh-list
5969759|NCT04541277|Azacitidine|azacitidine|mesh-list
5969760|NCT04541277|Decitabine|decitabine|mesh-list
5969761|NCT04541277|Idarubicin|idarubicin|mesh-list
5969762|NCT04541277|Sargramostim|sargramostim|mesh-list
5969763|NCT04541277|Lenograstim|lenograstim|mesh-list
5969764|NCT04541277|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5969765|NCT04541277|Antimetabolites|antimetabolites|mesh-ancestor
5969766|NCT04541277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969767|NCT04541277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5969768|NCT04541277|Antiviral Agents|antiviral agents|mesh-ancestor
5969769|NCT04541277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5969770|NCT04541277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5969771|NCT04541277|Immunologic Factors|immunologic factors|mesh-ancestor
6682156|NCT01614301|Alkylating Agents|alkylating agents|mesh-ancestor
6682157|NCT01614301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682158|NCT01614301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6682159|NCT01614301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6682160|NCT01614301|Analgesics|analgesics|mesh-ancestor
6682161|NCT01614301|Sensory System Agents|sensory system agents|mesh-ancestor
5969772|NCT04541277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969773|NCT04541277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5969774|NCT04541277|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5969775|NCT04541277|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5969776|NCT04541277|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5969777|NCT04541277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5971280|NCT04529187|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5971281|NCT04529187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5971282|NCT04529187|Adrenergic Agents|adrenergic agents|mesh-ancestor
5971283|NCT04529187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5971284|NCT04529187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971285|NCT04529187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5971286|NCT04529187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5971287|NCT04529187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5971288|NCT04529187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5971289|NCT04529187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5971290|NCT04529187|Anesthetics, General|anesthetics, general|mesh-ancestor
5971291|NCT04529187|Anesthetics|anesthetics|mesh-ancestor
5971292|NCT04529187|GABA Modulators|gaba modulators|mesh-ancestor
5971293|NCT04529187|GABA Agents|gaba agents|mesh-ancestor
5971294|NCT04529005|Angiotensin II|angiotensin ii|mesh-list
5971295|NCT04529005|Giapreza|giapreza|mesh-list
5971296|NCT04529005|Angiotensinogen|angiotensinogen|mesh-list
6517732|NCT00722852|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5971297|NCT04529005|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5971298|NCT04529005|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6517733|NCT00722852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6517734|NCT00722852|Analgesics|analgesics|mesh-ancestor
6517735|NCT00722852|Sensory System Agents|sensory system agents|mesh-ancestor
6517736|NCT00722852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6517737|NCT00722852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517738|NCT00722852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6517739|NCT00722852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6517740|NCT00722852|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6517741|NCT00722852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6517742|NCT00722852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517743|NCT00722930|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5957497|NCT04658355|Chlorhexidine|chlorhexidine|mesh-list
5957498|NCT04658355|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5957499|NCT04658355|Povidone-Iodine|povidone-iodine|mesh-list
5957500|NCT04658355|Povidone|povidone|mesh-list
5957501|NCT04658355|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5957502|NCT04658355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5957503|NCT04658355|Disinfectants|disinfectants|mesh-ancestor
5957504|NCT04658355|Dermatologic Agents|dermatologic agents|mesh-ancestor
5957505|NCT04658355|Plasma Substitutes|plasma substitutes|mesh-ancestor
5957506|NCT04658355|Blood Substitutes|blood substitutes|mesh-ancestor
5957507|NCT04658160|Imidacloprid|imidacloprid|mesh-list
5957508|NCT04658160|Cholinergic Agents|cholinergic agents|mesh-ancestor
5957509|NCT04658160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5957510|NCT04658160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5957511|NCT04658160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957512|NCT04658134|Glycine|glycine|mesh-list
5957513|NCT04658134|Glycine Agents|glycine agents|mesh-ancestor
5957514|NCT04658134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5957515|NCT04658134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5957516|NCT04658134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957517|NCT04657939|Pioglitazone|pioglitazone|mesh-list
5957518|NCT04657939|Liraglutide|liraglutide|mesh-list
5957519|NCT04657939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5957520|NCT04657939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957521|NCT04657939|Incretins|incretins|mesh-ancestor
5957522|NCT04657939|Hormones|hormones|mesh-ancestor
5957523|NCT04657939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5957524|NCT04658225|Chlorhexidine|chlorhexidine|mesh-list
5957525|NCT04658225|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5957526|NCT04658225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5957527|NCT04658225|Disinfectants|disinfectants|mesh-ancestor
5957528|NCT04657744|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
5957529|NCT04657744|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5957530|NCT04657744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5957531|NCT04657744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5957532|NCT04657744|Immunologic Factors|immunologic factors|mesh-ancestor
5957533|NCT04657744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957534|NCT04657497|Camostat|camostat|mesh-list
5957535|NCT04657497|Protease Inhibitors|protease inhibitors|mesh-ancestor
5957536|NCT04657497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5957537|NCT04657497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5957538|NCT04657497|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5957539|NCT04657497|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5957540|NCT04657692|Anesthetics|anesthetics|mesh-list
5957541|NCT04657692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5957542|NCT04657692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957543|NCT04657484|Prednisolone|prednisolone|mesh-list
5957544|NCT04657484|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5957545|NCT04657484|Methylprednisolone|methylprednisolone|mesh-list
5957546|NCT04657484|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5957547|NCT04657484|Prednisolone acetate|prednisolone acetate|mesh-list
5957548|NCT04657484|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5957549|NCT04657484|Prednisolone phosphate|prednisolone phosphate|mesh-list
5957550|NCT04657484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5957551|NCT04657484|Glucocorticoids|glucocorticoids|mesh-ancestor
5957552|NCT04657484|Hormones|hormones|mesh-ancestor
5957553|NCT04657484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5957554|NCT04657484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957555|NCT04657484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5957556|NCT04657484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5957557|NCT04657484|Antiemetics|antiemetics|mesh-ancestor
5957558|NCT04657484|Autonomic Agents|autonomic agents|mesh-ancestor
5957559|NCT04657484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5957560|NCT04657484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5957561|NCT04657484|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5957562|NCT04657484|Protective Agents|protective agents|mesh-ancestor
5957563|NCT04657562|Tacrolimus|tacrolimus|mesh-list
5957564|NCT04657562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5957565|NCT04657562|Immunologic Factors|immunologic factors|mesh-ancestor
5957566|NCT04657562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957567|NCT04657562|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5957568|NCT04657562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5957569|NCT04657562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5957570|NCT04657068|Gemcitabine|gemcitabine|mesh-list
5957571|NCT04657068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5957572|NCT04657068|Antimetabolites|antimetabolites|mesh-ancestor
5957573|NCT04657068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5957574|NCT04657068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6682162|NCT01614301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6682163|NCT01614301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6682164|NCT01614301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6682165|NCT01614301|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6682166|NCT01614301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6682167|NCT01614301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6682168|NCT01614366|Amlodipine|amlodipine|mesh-list
6682169|NCT01614366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6682170|NCT01614366|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6682171|NCT01614366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6682172|NCT01614366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682173|NCT01614366|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6682174|NCT01614366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682175|NCT01614366|Vasodilator Agents|vasodilator agents|mesh-ancestor
6682176|NCT01614405|Ritonavir|ritonavir|mesh-list
6682177|NCT01614405|Lopinavir|lopinavir|mesh-list
6682178|NCT01614405|Tenofovir|tenofovir|mesh-list
6682179|NCT01614405|Emtricitabine|emtricitabine|mesh-list
6682180|NCT01614405|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6682181|NCT01614405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6682182|NCT01614405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6682183|NCT01614405|Protease Inhibitors|protease inhibitors|mesh-ancestor
5957575|NCT04657068|Antiviral Agents|antiviral agents|mesh-ancestor
5957576|NCT04657068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5957577|NCT04657068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5957578|NCT04657068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5957579|NCT04657068|Immunologic Factors|immunologic factors|mesh-ancestor
5957580|NCT04657068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957581|NCT04656951|Daratumumab|daratumumab|mesh-list
5957582|NCT04656951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5957583|NCT04657094|Acalabrutinib|acalabrutinib|mesh-list
5957584|NCT04657094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5957585|NCT04657107|Ketamine|ketamine|mesh-list
5957586|NCT04657107|Esketamine|esketamine|mesh-list
5957587|NCT04657107|Analgesics|analgesics|mesh-ancestor
5957588|NCT04657107|Sensory System Agents|sensory system agents|mesh-ancestor
5957589|NCT04657107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5957590|NCT04657107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957591|NCT04657107|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5957592|NCT04657107|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5957593|NCT04657107|Anesthetics, General|anesthetics, general|mesh-ancestor
5957594|NCT04657107|Anesthetics|anesthetics|mesh-ancestor
5957595|NCT04657107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5957596|NCT04657107|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5957597|NCT04657107|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5957598|NCT04657107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5957599|NCT04657107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682184|NCT01614405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6682185|NCT01614405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682186|NCT01614405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6682187|NCT01614405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6682188|NCT01614405|Antiviral Agents|antiviral agents|mesh-ancestor
6682189|NCT01614405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6682190|NCT01614405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6682191|NCT01614405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6682192|NCT01614405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6682193|NCT01614405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6682194|NCT01614431|Acetylcysteine|acetylcysteine|mesh-list
6682195|NCT01614431|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6682196|NCT01614431|Antiviral Agents|antiviral agents|mesh-ancestor
6682197|NCT01614431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6682198|NCT01614431|Expectorants|expectorants|mesh-ancestor
6682199|NCT01614431|Respiratory System Agents|respiratory system agents|mesh-ancestor
6682200|NCT01614431|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6682201|NCT01614431|Antioxidants|antioxidants|mesh-ancestor
6682202|NCT01614431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682203|NCT01614431|Protective Agents|protective agents|mesh-ancestor
6682204|NCT01614431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682205|NCT01614431|Antidotes|antidotes|mesh-ancestor
6682206|NCT01614496|Insulin|insulin|mesh-list
6682207|NCT01614496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6682208|NCT01614496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779966|NCT02181933|Antimetabolites|antimetabolites|mesh-ancestor
6779967|NCT02181933|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6779968|NCT02181933|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6779969|NCT02181946|Nevirapine|nevirapine|mesh-list
6779970|NCT02181946|Fluconazole|fluconazole|mesh-list
6779971|NCT02181946|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6779972|NCT02181946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6779973|NCT02181946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6779974|NCT02181946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779975|NCT02181946|Antiviral Agents|antiviral agents|mesh-ancestor
6779976|NCT02181946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6779977|NCT02181946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6779978|NCT02181946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5957600|NCT04657107|Antidepressive Agents|antidepressive agents|mesh-ancestor
5957601|NCT04657107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6517744|NCT00722930|Immunologic Factors|immunologic factors|mesh-ancestor
6517745|NCT00722930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517746|NCT00722956|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
6517747|NCT00722956|Atorvastatin|atorvastatin|mesh-list
6517748|NCT00722956|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6517749|NCT00722956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6517750|NCT00722956|Antimetabolites|antimetabolites|mesh-ancestor
6517751|NCT00722956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517752|NCT00722956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6517753|NCT00722956|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6517754|NCT00722956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6517755|NCT00722956|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6517756|NCT00722956|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6517757|NCT00722956|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6517758|NCT00722956|Antiviral Agents|antiviral agents|mesh-ancestor
6517759|NCT00722956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6517760|NCT00722969|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6517761|NCT00722969|Sorafenib|sorafenib|mesh-list
6517762|NCT00722969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6517763|NCT00722969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6517764|NCT00722969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6517765|NCT00722969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517766|NCT00723047|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6517767|NCT00723047|Hemostatics|hemostatics|mesh-ancestor
6517768|NCT00723047|Coagulants|coagulants|mesh-ancestor
6517769|NCT00723060|Citalopram|citalopram|mesh-list
6517770|NCT00723060|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6517771|NCT00723060|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6517772|NCT00723060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6517773|NCT00723060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517774|NCT00723060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6517775|NCT00723060|Serotonin Agents|serotonin agents|mesh-ancestor
6517776|NCT00723060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517777|NCT00723060|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6517778|NCT00723060|Antidepressive Agents|antidepressive agents|mesh-ancestor
6517779|NCT00723060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5957602|NCT04657016|Tirzepatide|tirzepatide|mesh-list
5957603|NCT04657016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5957604|NCT04657016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957605|NCT04657016|Incretins|incretins|mesh-ancestor
5957606|NCT04657016|Hormones|hormones|mesh-ancestor
5957607|NCT04657016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5957608|NCT04657172|Pilocarpine|pilocarpine|mesh-list
5957609|NCT04657172|Miotics|miotics|mesh-ancestor
5957610|NCT04657172|Autonomic Agents|autonomic agents|mesh-ancestor
5957611|NCT04657172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5957612|NCT04657172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957613|NCT04657172|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
5957614|NCT04657172|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5957615|NCT04657172|Cholinergic Agents|cholinergic agents|mesh-ancestor
5957616|NCT04657172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5957617|NCT04657172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969778|NCT04541407|Temozolomide|temozolomide|mesh-list
5969779|NCT04541407|Osimertinib|osimertinib|mesh-list
5969780|NCT04541407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5969781|NCT04541407|Alkylating Agents|alkylating agents|mesh-ancestor
5969782|NCT04541407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969783|NCT04541407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5969784|NCT04541407|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5969785|NCT04541407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5969786|NCT04540926|Cyclosporine|cyclosporine|mesh-list
5969787|NCT04540926|Cyclosporins|cyclosporins|mesh-list
5969788|NCT04540926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5969789|NCT04540926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969790|NCT04540926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5969791|NCT04540926|Immunologic Factors|immunologic factors|mesh-ancestor
5969792|NCT04540926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969793|NCT04540926|Antifungal Agents|antifungal agents|mesh-ancestor
5969794|NCT04540926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5969795|NCT04540926|Dermatologic Agents|dermatologic agents|mesh-ancestor
5969796|NCT04540926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5969797|NCT04540926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5969798|NCT04541251|Paclitaxel|paclitaxel|mesh-list
5969799|NCT04541251|Carboplatin|carboplatin|mesh-list
5969800|NCT04541251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5969801|NCT04541251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5969802|NCT04541251|Tubulin Modulators|tubulin modulators|mesh-ancestor
5969803|NCT04541251|Antimitotic Agents|antimitotic agents|mesh-ancestor
5969804|NCT04541251|Mitosis Modulators|mitosis modulators|mesh-ancestor
5969805|NCT04541251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969806|NCT04540861|Siponimod|siponimod|mesh-list
5969807|NCT04540861|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6517780|NCT00723086|Docetaxel|docetaxel|mesh-list
6517781|NCT00723086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6517782|NCT00723086|Tubulin Modulators|tubulin modulators|mesh-ancestor
6517783|NCT00723086|Antimitotic Agents|antimitotic agents|mesh-ancestor
6517784|NCT00723086|Mitosis Modulators|mitosis modulators|mesh-ancestor
6517785|NCT00723086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517786|NCT00723164|Fentanyl|fentanyl|mesh-list
6517787|NCT00723164|Midazolam|midazolam|mesh-list
6517788|NCT00723164|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6517789|NCT00723164|Narcotics|narcotics|mesh-ancestor
6517790|NCT00723164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6517791|NCT00723164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517792|NCT00723164|Analgesics|analgesics|mesh-ancestor
6517793|NCT00723164|Sensory System Agents|sensory system agents|mesh-ancestor
6517794|NCT00723164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6517795|NCT00723164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6517796|NCT00723164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6517797|NCT00723164|Anesthetics, General|anesthetics, general|mesh-ancestor
6517798|NCT00723164|Anesthetics|anesthetics|mesh-ancestor
6517799|NCT00723164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6517800|NCT00723164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6517801|NCT00723164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6517802|NCT00723164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6517803|NCT00723164|GABA Modulators|gaba modulators|mesh-ancestor
6517804|NCT00723164|GABA Agents|gaba agents|mesh-ancestor
6517805|NCT00723164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6517806|NCT00723164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517807|NCT00723216|Enoxaparin|enoxaparin|mesh-list
6517808|NCT00723216|Anticoagulants|anticoagulants|mesh-ancestor
6517809|NCT00723216|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6517810|NCT00723216|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6517811|NCT00723216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517812|NCT00723242|Ribavirin|ribavirin|mesh-list
6517813|NCT00723242|Antimetabolites|antimetabolites|mesh-ancestor
6517814|NCT00723242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517815|NCT00723242|Antiviral Agents|antiviral agents|mesh-ancestor
6517816|NCT00723242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6517817|NCT00723268|Prednisolone|prednisolone|mesh-list
6517818|NCT00723268|Colchicine|colchicine|mesh-list
6517819|NCT00723268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6517820|NCT00723268|Glucocorticoids|glucocorticoids|mesh-ancestor
6517821|NCT00723268|Hormones|hormones|mesh-ancestor
6517822|NCT00723268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6517823|NCT00723268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517824|NCT00723268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6517825|NCT00723268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6517826|NCT00723268|Gout Suppressants|gout suppressants|mesh-ancestor
6517827|NCT00723268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6517828|NCT00723268|Tubulin Modulators|tubulin modulators|mesh-ancestor
6517829|NCT00723268|Antimitotic Agents|antimitotic agents|mesh-ancestor
6517830|NCT00723268|Mitosis Modulators|mitosis modulators|mesh-ancestor
6517831|NCT00723268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517832|NCT00723307|Metformin|metformin|mesh-list
6517833|NCT00723307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6517834|NCT00723307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517835|NCT00723320|Atorvastatin|atorvastatin|mesh-list
6517836|NCT00723320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6517837|NCT00723320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6517838|NCT00723320|Antimetabolites|antimetabolites|mesh-ancestor
6517839|NCT00723320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517840|NCT00723320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6517841|NCT00723320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6517842|NCT00723320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6517843|NCT00723346|Asparaginase|asparaginase|mesh-list
6517844|NCT00723346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6517845|NCT00723385|Vitamin D|vitamin d|mesh-list
6517846|NCT00723385|Cholecalciferol|cholecalciferol|mesh-list
6517847|NCT00723385|Vitamins|vitamins|mesh-ancestor
6517848|NCT00723385|Micronutrients|micronutrients|mesh-ancestor
6517849|NCT00723385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517850|NCT00723385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6517851|NCT00723385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6517852|NCT00723411|Aluminum sulfate|aluminum sulfate|mesh-list
6517853|NCT00723411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6517854|NCT00723411|Immunologic Factors|immunologic factors|mesh-ancestor
6517855|NCT00723411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517856|NCT00723424|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
6517857|NCT00723424|Digoxin|digoxin|mesh-list
5957618|NCT04656470|Dexmedetomidine|dexmedetomidine|mesh-list
5957619|NCT04656470|Ketamine|ketamine|mesh-list
5957620|NCT04656470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5957621|NCT04656470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5957622|NCT04656470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957623|NCT04656470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5957624|NCT04656470|Analgesics|analgesics|mesh-ancestor
5957625|NCT04656470|Sensory System Agents|sensory system agents|mesh-ancestor
5957626|NCT04656470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5957627|NCT04656470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5957628|NCT04656470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6517858|NCT00723424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6517859|NCT00723424|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6517860|NCT00723424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6517861|NCT00723424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517862|NCT00723424|Protective Agents|protective agents|mesh-ancestor
5957629|NCT04656470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5957630|NCT04656470|Adrenergic Agents|adrenergic agents|mesh-ancestor
5957631|NCT04656470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5957632|NCT04656470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5957633|NCT04656470|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5957634|NCT04656470|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5957635|NCT04656470|Anesthetics, General|anesthetics, general|mesh-ancestor
5957636|NCT04656470|Anesthetics|anesthetics|mesh-ancestor
5957637|NCT04656470|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5957638|NCT04656470|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5957639|NCT04656665|Aspirin|aspirin|mesh-list
5957640|NCT04656665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5957641|NCT04656665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5957642|NCT04656665|Analgesics|analgesics|mesh-ancestor
5957643|NCT04656665|Sensory System Agents|sensory system agents|mesh-ancestor
5957644|NCT04656665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5957645|NCT04656665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957646|NCT04656665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5957647|NCT04656665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5957648|NCT04656665|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5957649|NCT04656665|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5957650|NCT04656665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5957651|NCT04656665|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5957652|NCT04656665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5957653|NCT04656665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5957654|NCT04656665|Antipyretics|antipyretics|mesh-ancestor
5957655|NCT04656301|Psilocybin|psilocybin|mesh-list
5957656|NCT04656301|Hallucinogens|hallucinogens|mesh-ancestor
5957657|NCT04656301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957658|NCT04656301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5957659|NCT04656145|Chlorhexidine|chlorhexidine|mesh-list
6517863|NCT00723424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517864|NCT00723424|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6517865|NCT00723424|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6517866|NCT00723424|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6517867|NCT00723424|Antiviral Agents|antiviral agents|mesh-ancestor
6517868|NCT00723424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6517869|NCT00723437|Acitretin|acitretin|mesh-list
6517870|NCT00723437|Keratolytic Agents|keratolytic agents|mesh-ancestor
6517871|NCT00723437|Dermatologic Agents|dermatologic agents|mesh-ancestor
6517872|NCT00723502|Amoxicillin|amoxicillin|mesh-list
6517873|NCT00723502|Finafloxacin|finafloxacin|mesh-list
6517874|NCT00723502|Fluoroquinolones|fluoroquinolones|mesh-list
6517875|NCT00723502|Esomeprazole|esomeprazole|mesh-list
5957660|NCT04656145|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5957661|NCT04656145|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5957662|NCT04656145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5957663|NCT04656145|Disinfectants|disinfectants|mesh-ancestor
5957664|NCT04656145|Dermatologic Agents|dermatologic agents|mesh-ancestor
5957665|NCT04656041|Paclitaxel|paclitaxel|mesh-list
5957666|NCT04656041|Carboplatin|carboplatin|mesh-list
5957667|NCT04656041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5957668|NCT04656041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5957669|NCT04656041|Tubulin Modulators|tubulin modulators|mesh-ancestor
5957670|NCT04656041|Antimitotic Agents|antimitotic agents|mesh-ancestor
5957671|NCT04656041|Mitosis Modulators|mitosis modulators|mesh-ancestor
5957672|NCT04656041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5957673|NCT04656106|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
5957674|NCT04656106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6517876|NCT00723502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6517877|NCT00723502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6517878|NCT00723502|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6517879|NCT00723502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6517880|NCT00723502|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6517881|NCT00723502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6517882|NCT00723502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517883|NCT00723502|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6517884|NCT00723502|Renal Agents|renal agents|mesh-ancestor
6517885|NCT00723502|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6517886|NCT00723502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6517887|NCT00723502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5957675|NCT04656106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957676|NCT04656262|Cyclophosphamide|cyclophosphamide|mesh-list
5957677|NCT04656262|Doxorubicin|doxorubicin|mesh-list
5957678|NCT04656262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5957679|NCT04656262|Immunologic Factors|immunologic factors|mesh-ancestor
5957680|NCT04656262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517888|NCT00723502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6517889|NCT00723515|Listerine|listerine|mesh-list
5957681|NCT04656262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5957682|NCT04656262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5957683|NCT04656262|Alkylating Agents|alkylating agents|mesh-ancestor
5957684|NCT04656262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5957685|NCT04656262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5957686|NCT04656262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5957687|NCT04656262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5957688|NCT04656262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5957689|NCT04656262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5957690|NCT04656262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5957691|NCT04656067|Tranexamic Acid|tranexamic acid|mesh-list
5957692|NCT04656067|Ethamsylate|ethamsylate|mesh-list
6517890|NCT00723515|Calcium|calcium|mesh-list
6517891|NCT00723515|Fluorides|fluorides|mesh-list
5957693|NCT04656067|Oxytocin|oxytocin|mesh-list
5957694|NCT04656067|Oxytocics|oxytocics|mesh-ancestor
6517892|NCT00723515|Sodium Fluoride|sodium fluoride|mesh-list
6517893|NCT00723515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5957695|NCT04656067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5957696|NCT04656067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957697|NCT04656067|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5957698|NCT04656067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5957699|NCT04656067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5957700|NCT04656067|Hemostatics|hemostatics|mesh-ancestor
5957701|NCT04656067|Coagulants|coagulants|mesh-ancestor
5957702|NCT04656184|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5957703|NCT04656184|Immunoglobulins|immunoglobulins|mesh-list
5957704|NCT04656184|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5957705|NCT04656184|Antibodies|antibodies|mesh-list
5957706|NCT04656184|gamma-Globulins|gamma-globulins|mesh-list
6517894|NCT00723515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517895|NCT00723515|Cariostatic Agents|cariostatic agents|mesh-ancestor
6517896|NCT00723515|Protective Agents|protective agents|mesh-ancestor
6517897|NCT00723515|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6517898|NCT00723515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6517899|NCT00723658|Cytarabine|cytarabine|mesh-list
6517900|NCT00723658|Thalidomide|thalidomide|mesh-list
6517901|NCT00723658|Dexamethasone|dexamethasone|mesh-list
6517902|NCT00723658|Cyclophosphamide|cyclophosphamide|mesh-list
6517903|NCT00723658|Melphalan|melphalan|mesh-list
6517904|NCT00723658|Carmustine|carmustine|mesh-list
6517905|NCT00723658|Rituximab|rituximab|mesh-list
6517906|NCT00723658|Doxorubicin|doxorubicin|mesh-list
6517907|NCT00723658|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6517908|NCT00723658|Etoposide|etoposide|mesh-list
6517909|NCT00723658|Bortezomib|bortezomib|mesh-list
6517910|NCT00723658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6517911|NCT00723658|Immunologic Factors|immunologic factors|mesh-ancestor
6517912|NCT00723658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517913|NCT00723658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6517914|NCT00723658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6517915|NCT00723658|Alkylating Agents|alkylating agents|mesh-ancestor
6517916|NCT00723658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517917|NCT00723658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6517918|NCT00723658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6517919|NCT00723658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6517920|NCT00723658|Antiemetics|antiemetics|mesh-ancestor
6517921|NCT00723658|Autonomic Agents|autonomic agents|mesh-ancestor
6517922|NCT00723658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6517923|NCT00723658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6517924|NCT00723658|Glucocorticoids|glucocorticoids|mesh-ancestor
6517925|NCT00723658|Hormones|hormones|mesh-ancestor
6517926|NCT00723658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6517927|NCT00723658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6517928|NCT00723658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6517929|NCT00723658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6517930|NCT00723658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6517931|NCT00723658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6517932|NCT00723658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6517933|NCT00723658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6517934|NCT00723658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6517935|NCT00723658|Antimetabolites|antimetabolites|mesh-ancestor
6517936|NCT00723658|Antiviral Agents|antiviral agents|mesh-ancestor
5957707|NCT04656184|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5957708|NCT04656184|Immunologic Factors|immunologic factors|mesh-ancestor
5957709|NCT04656184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957710|NCT04656184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5957711|NCT04656249|Lenvatinib|lenvatinib|mesh-list
5957712|NCT04656249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5957713|NCT04656249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5957714|NCT04656249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5957715|NCT04656249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5957716|NCT04655482|Aflibercept|aflibercept|mesh-list
5957717|NCT04655482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5957718|NCT04655482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5957719|NCT04655482|Growth Substances|growth substances|mesh-ancestor
5957720|NCT04655482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957721|NCT04655482|Growth Inhibitors|growth inhibitors|mesh-ancestor
5957722|NCT04655482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5957723|NCT04655807|Adalimumab|adalimumab|mesh-list
5957724|NCT04655807|Ustekinumab|ustekinumab|mesh-list
5957725|NCT04655807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5957726|NCT04655807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6517937|NCT00723658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6517938|NCT00723658|Leprostatic Agents|leprostatic agents|mesh-ancestor
5957727|NCT04655807|Dermatologic Agents|dermatologic agents|mesh-ancestor
5957728|NCT04655664|Vitamin D|vitamin d|mesh-list
5957729|NCT04655664|Ergocalciferols|ergocalciferols|mesh-list
5957730|NCT04655664|Vitamins|vitamins|mesh-list
5957731|NCT04655664|Micronutrients|micronutrients|mesh-ancestor
5957732|NCT04655664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957733|NCT04655664|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5957734|NCT04655664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5957735|NCT04655417|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
5957736|NCT04655417|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
5957737|NCT04655417|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5957738|NCT04655508|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
5957739|NCT04655508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5957740|NCT04655508|Autonomic Agents|autonomic agents|mesh-ancestor
5957741|NCT04655508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5957742|NCT04655508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957743|NCT04655508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5957744|NCT04655508|Respiratory System Agents|respiratory system agents|mesh-ancestor
5957745|NCT04655508|Glucocorticoids|glucocorticoids|mesh-ancestor
5957746|NCT04655508|Hormones|hormones|mesh-ancestor
5957747|NCT04655508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5957748|NCT04655508|Sympathomimetics|sympathomimetics|mesh-ancestor
5957749|NCT04655729|Infliximab|infliximab|mesh-list
5957750|NCT04655729|Dermatologic Agents|dermatologic agents|mesh-ancestor
5957751|NCT04655729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5957752|NCT04655729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5957753|NCT04655391|Decitabine|decitabine|mesh-list
5957754|NCT04655391|Venetoclax|venetoclax|mesh-list
5957755|NCT04655391|Ivosidenib|ivosidenib|mesh-list
5957756|NCT04655391|Maleic acid|maleic acid|mesh-list
5957757|NCT04655391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5957758|NCT04655391|Antimetabolites|antimetabolites|mesh-ancestor
5957759|NCT04655391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5957760|NCT04655391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5957761|NCT04655391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5957762|NCT04655157|Nivolumab|nivolumab|mesh-list
5957763|NCT04655157|Ipilimumab|ipilimumab|mesh-list
5957764|NCT04655157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5957765|NCT04655157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5957766|NCT04655157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5957767|NCT04655157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5957768|NCT04655144|Dexamethasone|dexamethasone|mesh-list
5957769|NCT04655144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5957770|NCT04655144|Antiemetics|antiemetics|mesh-ancestor
5957771|NCT04655144|Autonomic Agents|autonomic agents|mesh-ancestor
5957772|NCT04655144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6517939|NCT00723658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6517940|NCT00723658|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6517941|NCT00723658|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6517942|NCT00723658|Growth Substances|growth substances|mesh-ancestor
6517943|NCT00723658|Growth Inhibitors|growth inhibitors|mesh-ancestor
6517944|NCT00723775|Lopinavir|lopinavir|mesh-list
6517945|NCT00723775|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6517946|NCT00723775|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6517947|NCT00723775|Protease Inhibitors|protease inhibitors|mesh-ancestor
6517948|NCT00723775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6517949|NCT00723775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517950|NCT00723775|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6517951|NCT00723775|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6517952|NCT00723775|Antiviral Agents|antiviral agents|mesh-ancestor
6517953|NCT00723775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6517954|NCT00723775|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6517955|NCT00723775|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6517956|NCT00723866|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6517957|NCT00723866|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6517958|NCT00723866|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6517959|NCT00723866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6517960|NCT00723866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517961|NCT00723866|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6517962|NCT00723866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6517963|NCT00723866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517964|NCT00723866|Cholinergic Agents|cholinergic agents|mesh-ancestor
6682209|NCT01614535|Remifentanil|remifentanil|mesh-list
5957773|NCT04655144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957774|NCT04655144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5957775|NCT04655144|Glucocorticoids|glucocorticoids|mesh-ancestor
6517965|NCT00723866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5957776|NCT04655144|Hormones|hormones|mesh-ancestor
5957777|NCT04655144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5957778|NCT04655144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5957779|NCT04655144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5957780|NCT04655170|Albuterol|albuterol|mesh-list
5957781|NCT04655170|Formoterol Fumarate|formoterol fumarate|mesh-list
6517966|NCT00723879|Ribavirin|ribavirin|mesh-list
6517967|NCT00723879|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6517968|NCT00723879|Antimetabolites|antimetabolites|mesh-ancestor
5957782|NCT04655170|Ipratropium|ipratropium|mesh-list
5957783|NCT04655170|Cholinergic Antagonists|cholinergic antagonists|mesh-list
5957784|NCT04655170|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5957785|NCT04655170|Autonomic Agents|autonomic agents|mesh-ancestor
5957786|NCT04655170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5957787|NCT04655170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957788|NCT04655170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5957789|NCT04655170|Respiratory System Agents|respiratory system agents|mesh-ancestor
5957790|NCT04655170|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5957791|NCT04655170|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5957792|NCT04655170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6517969|NCT00723879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517970|NCT00723879|Antiviral Agents|antiviral agents|mesh-ancestor
6517971|NCT00723879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6517972|NCT00723918|Methadone|methadone|mesh-list
6517973|NCT00723918|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6517974|NCT00723918|Narcotics|narcotics|mesh-ancestor
6517975|NCT00723918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6517976|NCT00723918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517977|NCT00723918|Analgesics|analgesics|mesh-ancestor
6517978|NCT00723918|Sensory System Agents|sensory system agents|mesh-ancestor
6517979|NCT00723918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6682210|NCT01614535|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6682211|NCT01614535|Narcotics|narcotics|mesh-ancestor
6682212|NCT01614535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6682213|NCT01614535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682214|NCT01614535|Analgesics|analgesics|mesh-ancestor
6682215|NCT01614535|Sensory System Agents|sensory system agents|mesh-ancestor
6682216|NCT01614535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6682217|NCT01614665|Tacrolimus|tacrolimus|mesh-list
6682218|NCT01614665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6517980|NCT00723918|Antitussive Agents|antitussive agents|mesh-ancestor
6517981|NCT00723918|Respiratory System Agents|respiratory system agents|mesh-ancestor
6517982|NCT00723970|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6517983|NCT00723970|Antidepressive Agents|antidepressive agents|mesh-ancestor
6517984|NCT00723970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6517985|NCT00723970|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6517986|NCT00723970|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6682219|NCT01614665|Immunologic Factors|immunologic factors|mesh-ancestor
6682220|NCT01614665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682221|NCT01614665|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6682222|NCT01614665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6682223|NCT01614665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682224|NCT01614938|Cisplatin|cisplatin|mesh-list
6682225|NCT01614938|Docetaxel|docetaxel|mesh-list
6682226|NCT01614938|Cetuximab|cetuximab|mesh-list
6682227|NCT01614938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6682228|NCT01614938|Tubulin Modulators|tubulin modulators|mesh-ancestor
6682229|NCT01614938|Antimitotic Agents|antimitotic agents|mesh-ancestor
6682230|NCT01614938|Mitosis Modulators|mitosis modulators|mesh-ancestor
6682231|NCT01614938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682232|NCT01614938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6682233|NCT01614964|Lumefantrine|lumefantrine|mesh-list
6682234|NCT01614964|Artemether|artemether|mesh-list
6682235|NCT01614964|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6682236|NCT01614964|Antimalarials|antimalarials|mesh-ancestor
6682237|NCT01614964|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6682238|NCT01614964|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6517987|NCT00723970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6517988|NCT00723970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517989|NCT00723983|Sumatriptan|sumatriptan|mesh-list
6517990|NCT00723983|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6517991|NCT00723983|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6517992|NCT00723983|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6517993|NCT00723983|Serotonin Agents|serotonin agents|mesh-ancestor
6517994|NCT00723983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6682239|NCT01614964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6682240|NCT01615016|Pulmonary Surfactants|pulmonary surfactants|mesh-list
6682241|NCT01615016|Respiratory System Agents|respiratory system agents|mesh-ancestor
6682242|NCT01615042|Lenalidomide|lenalidomide|mesh-list
6682243|NCT01615042|Immunologic Factors|immunologic factors|mesh-ancestor
6682244|NCT01615042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682245|NCT01615042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6682246|NCT01615042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6682247|NCT01615042|Growth Substances|growth substances|mesh-ancestor
6682248|NCT01615042|Growth Inhibitors|growth inhibitors|mesh-ancestor
6682249|NCT01615042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6682250|NCT01615055|Fluoxetine|fluoxetine|mesh-list
6682251|NCT01615055|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6682252|NCT01615055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6682253|NCT01615055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6682254|NCT01615055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682255|NCT01615055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6682256|NCT01615055|Serotonin Agents|serotonin agents|mesh-ancestor
6682257|NCT01615055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682258|NCT01615055|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6682259|NCT01615055|Antidepressive Agents|antidepressive agents|mesh-ancestor
6682260|NCT01615055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6682261|NCT01615055|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6682262|NCT01615055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6682263|NCT01615055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6682264|NCT01615081|Insulin|insulin|mesh-list
5957793|NCT04655170|Adrenergic Agents|adrenergic agents|mesh-ancestor
5957794|NCT04655170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5957795|NCT04655170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5957796|NCT04655170|Tocolytic Agents|tocolytic agents|mesh-ancestor
5957797|NCT04655170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5957798|NCT04655170|Cholinergic Agents|cholinergic agents|mesh-ancestor
5957799|NCT04655183|Niraparib|niraparib|mesh-list
5957800|NCT04655183|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5957801|NCT04655183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5957802|NCT04655183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5957803|NCT04655183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5957804|NCT04655040|Caffeine|caffeine|mesh-list
5957805|NCT04655040|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5957806|NCT04655040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957807|NCT04655040|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5957808|NCT04655040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5957809|NCT04655040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5957810|NCT04655040|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5957811|NCT04655040|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5957812|NCT04655040|Purinergic Agents|purinergic agents|mesh-ancestor
5957813|NCT04655040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5957814|NCT04654988|Prednisone|prednisone|mesh-list
5957815|NCT04654988|Azathioprine|azathioprine|mesh-list
6682265|NCT01615081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6682266|NCT01615081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682267|NCT01615107|Oxytocin|oxytocin|mesh-list
6682268|NCT01615107|Oxytocics|oxytocics|mesh-ancestor
6682269|NCT01615107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6682270|NCT01615107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682271|NCT01615185|Amisulpride|amisulpride|mesh-list
6682272|NCT01615185|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6682273|NCT01615185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6682274|NCT01615185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6682275|NCT01615185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682276|NCT01615185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6682277|NCT01615185|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6682278|NCT01615185|Dopamine Agents|dopamine agents|mesh-ancestor
6682279|NCT01615185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6682280|NCT01615185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682281|NCT01615185|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6682282|NCT01615185|Antidepressive Agents|antidepressive agents|mesh-ancestor
6682283|NCT01615211|Letrozole|letrozole|mesh-list
6682284|NCT01615211|Trilostane|trilostane|mesh-list
6682285|NCT01615211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6682286|NCT01615211|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6682287|NCT01615211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6682288|NCT01615211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6779979|NCT02181946|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6682289|NCT01615211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682290|NCT01615211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6682291|NCT01615211|Hormone Antagonists|hormone antagonists|mesh-ancestor
6682292|NCT01615211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6682293|NCT01615211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682294|NCT01615211|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6682295|NCT01615211|Abortifacient Agents|abortifacient agents|mesh-ancestor
6682296|NCT01615211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6682297|NCT01615224|Misoprostol|misoprostol|mesh-list
5957816|NCT04654988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5957817|NCT04654988|Glucocorticoids|glucocorticoids|mesh-ancestor
5957818|NCT04654988|Hormones|hormones|mesh-ancestor
5957819|NCT04654988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5957820|NCT04654988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957821|NCT04654988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5957822|NCT04654988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5957823|NCT04654988|Antimetabolites|antimetabolites|mesh-ancestor
5957824|NCT04654988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5957825|NCT04654988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5957826|NCT04654988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5957827|NCT04654988|Immunologic Factors|immunologic factors|mesh-ancestor
6682298|NCT01615224|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6682299|NCT01615224|Abortifacient Agents|abortifacient agents|mesh-ancestor
6682300|NCT01615224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5957828|NCT04654988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5957829|NCT04654962|Anesthetics|anesthetics|mesh-list
5957830|NCT04654962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5957831|NCT04654962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969808|NCT04540861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969809|NCT04540861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5969810|NCT04540861|Immunologic Factors|immunologic factors|mesh-ancestor
5969811|NCT04540861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969812|NCT04540965|Famotidine|famotidine|mesh-list
5969813|NCT04540965|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5969814|NCT04540965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5969815|NCT04540965|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5969816|NCT04540965|Histamine Antagonists|histamine antagonists|mesh-ancestor
5969817|NCT04540965|Histamine Agents|histamine agents|mesh-ancestor
6682301|NCT01615224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682302|NCT01615224|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6682303|NCT01615224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6682304|NCT01615224|Oxytocics|oxytocics|mesh-ancestor
6682305|NCT01615289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6682306|NCT01615354|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
6682307|NCT01615354|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
6682308|NCT01615354|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6682309|NCT01615354|Contraceptive Agents|contraceptive agents|mesh-ancestor
6682310|NCT01615354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6682311|NCT01615354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682312|NCT01615354|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6682313|NCT01615354|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6682314|NCT01615354|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6682315|NCT01615354|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6682316|NCT01615354|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5969818|NCT04540965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5969819|NCT04540965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969820|NCT04540965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969821|NCT04540653|Vaccines|vaccines|mesh-list
5969822|NCT04540653|Immunologic Factors|immunologic factors|mesh-ancestor
5969823|NCT04540653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969824|NCT04540666|Propofol|propofol|mesh-list
5969825|NCT04540666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5969826|NCT04540666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5969827|NCT04540666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969828|NCT04540666|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5969829|NCT04540666|Anesthetics, General|anesthetics, general|mesh-ancestor
5969830|NCT04540666|Anesthetics|anesthetics|mesh-ancestor
5969831|NCT04540744|Tadalafil|tadalafil|mesh-list
5969832|NCT04540744|Macitentan|macitentan|mesh-list
5969833|NCT04540744|Vasodilator Agents|vasodilator agents|mesh-ancestor
5969834|NCT04540744|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5969835|NCT04540744|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6517995|NCT00723983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6517996|NCT00723983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6517997|NCT00724022|Mycophenolic Acid|mycophenolic acid|mesh-list
6517998|NCT00724022|Prednisolone|prednisolone|mesh-list
6517999|NCT00724022|Tacrolimus|tacrolimus|mesh-list
6518000|NCT00724022|Thymoglobulin|thymoglobulin|mesh-list
6518001|NCT00724022|Basiliximab|basiliximab|mesh-list
6518002|NCT00724022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6518003|NCT00724022|Immunologic Factors|immunologic factors|mesh-ancestor
6518004|NCT00724022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518005|NCT00724022|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6518006|NCT00724022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6518007|NCT00724022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518008|NCT00724022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6518009|NCT00724022|Glucocorticoids|glucocorticoids|mesh-ancestor
6518010|NCT00724022|Hormones|hormones|mesh-ancestor
6518011|NCT00724022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6682317|NCT01615354|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
5957832|NCT04654507|Dexamethasone|dexamethasone|mesh-list
5957833|NCT04654507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5957834|NCT04654507|Antiemetics|antiemetics|mesh-ancestor
5957835|NCT04654507|Autonomic Agents|autonomic agents|mesh-ancestor
5957836|NCT04654507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5957837|NCT04654507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957838|NCT04654507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5957839|NCT04654507|Glucocorticoids|glucocorticoids|mesh-ancestor
5957840|NCT04654507|Hormones|hormones|mesh-ancestor
5957841|NCT04654507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5957842|NCT04654507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5957843|NCT04654507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5957844|NCT04654416|Colchicine|colchicine|mesh-list
5957845|NCT04654416|Gout Suppressants|gout suppressants|mesh-ancestor
5957846|NCT04654416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5957847|NCT04654416|Tubulin Modulators|tubulin modulators|mesh-ancestor
5957848|NCT04654416|Antimitotic Agents|antimitotic agents|mesh-ancestor
5957849|NCT04654416|Mitosis Modulators|mitosis modulators|mesh-ancestor
5957850|NCT04654416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5957851|NCT04654416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5957852|NCT04654676|Vildagliptin|vildagliptin|mesh-list
5957853|NCT04654676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5957854|NCT04654676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957855|NCT04654676|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5957856|NCT04654676|Protease Inhibitors|protease inhibitors|mesh-ancestor
5957857|NCT04654676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5957858|NCT04654676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5957859|NCT04654819|Anesthetics|anesthetics|mesh-list
5957860|NCT04654819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5957861|NCT04654819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957862|NCT04654741|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
5957863|NCT04654741|Medroxyprogesterone|medroxyprogesterone|mesh-list
5957864|NCT04654741|Ganirelix|ganirelix|mesh-list
5957865|NCT04654741|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5957866|NCT04654741|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6682318|NCT01615354|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6682319|NCT01615354|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6682320|NCT01615393|Ribavirin|ribavirin|mesh-list
6682321|NCT01615393|Antimetabolites|antimetabolites|mesh-ancestor
6682322|NCT01615393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682323|NCT01615393|Antiviral Agents|antiviral agents|mesh-ancestor
6682324|NCT01615393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6682325|NCT01615445|Resveratrol|resveratrol|mesh-list
6682326|NCT01615445|Antioxidants|antioxidants|mesh-ancestor
6682327|NCT01615445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682328|NCT01615445|Protective Agents|protective agents|mesh-ancestor
6682329|NCT01615445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682330|NCT01615445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6682331|NCT01615445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6682332|NCT01615510|Tapentadol|tapentadol|mesh-list
6682333|NCT01615510|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6682334|NCT01615510|Narcotics|narcotics|mesh-ancestor
6682335|NCT01615510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6682336|NCT01615510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682337|NCT01615510|Analgesics|analgesics|mesh-ancestor
6682338|NCT01615510|Sensory System Agents|sensory system agents|mesh-ancestor
5957867|NCT04654741|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5957868|NCT04654741|Contraceptive Agents|contraceptive agents|mesh-ancestor
5957869|NCT04654741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5957870|NCT04654741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957871|NCT04654741|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5957872|NCT04654741|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5957873|NCT04654741|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5957874|NCT04654741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5957875|NCT04654741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5957876|NCT04654741|Hormone Antagonists|hormone antagonists|mesh-ancestor
5957877|NCT04654741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6682339|NCT01615510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6682340|NCT01615510|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6682341|NCT01615510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6682342|NCT01615510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6682343|NCT01615510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682344|NCT01615510|Adrenergic Agents|adrenergic agents|mesh-ancestor
6682345|NCT01615510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6682346|NCT01615601|Ritonavir|ritonavir|mesh-list
6682347|NCT01615601|Darunavir|darunavir|mesh-list
6682348|NCT01615601|Etravirine|etravirine|mesh-list
6682349|NCT01615601|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6682350|NCT01615601|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6682351|NCT01615601|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6682352|NCT01615601|Protease Inhibitors|protease inhibitors|mesh-ancestor
6682353|NCT01615601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6682354|NCT01615601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682355|NCT01615601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6682356|NCT01615601|Antiviral Agents|antiviral agents|mesh-ancestor
6682357|NCT01615601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6682358|NCT01615601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5957878|NCT04654195|Cyclophosphamide|cyclophosphamide|mesh-list
5957879|NCT04654195|Doxorubicin|doxorubicin|mesh-list
5957880|NCT04654195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5957881|NCT04654195|Immunologic Factors|immunologic factors|mesh-ancestor
5957882|NCT04654195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957883|NCT04654195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5957884|NCT04654195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5957885|NCT04654195|Alkylating Agents|alkylating agents|mesh-ancestor
5957886|NCT04654195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5957887|NCT04654195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5957888|NCT04654195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5957889|NCT04654195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5957890|NCT04654195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5957891|NCT04654195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5957892|NCT04654195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6682359|NCT01615601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6682360|NCT01615601|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6682361|NCT01615601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6682362|NCT01615614|Rilpivirine|rilpivirine|mesh-list
6682363|NCT01615614|Rifabutin|rifabutin|mesh-list
6682364|NCT01615614|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6682365|NCT01615614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6682366|NCT01615614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6682367|NCT01615614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682368|NCT01615614|Antiviral Agents|antiviral agents|mesh-ancestor
6682369|NCT01615614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6682370|NCT01615614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6682371|NCT01615614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6682372|NCT01615614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6682373|NCT01615614|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6682374|NCT01615614|Antitubercular Agents|antitubercular agents|mesh-ancestor
5957893|NCT04654351|Icatibant|icatibant|mesh-list
6518012|NCT00724022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6518013|NCT00724022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6518014|NCT00724022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6518015|NCT00724022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6518016|NCT00724022|Antitubercular Agents|antitubercular agents|mesh-ancestor
6518017|NCT00724022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6518018|NCT00724022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6518019|NCT00724035|Fentanyl|fentanyl|mesh-list
6518020|NCT00724035|Midazolam|midazolam|mesh-list
6518021|NCT00724035|Analgesics|analgesics|mesh-list
6518022|NCT00724035|Anesthetics|anesthetics|mesh-list
6518023|NCT00724035|Ropivacaine|ropivacaine|mesh-list
6518024|NCT00724035|Anesthetics, Local|anesthetics, local|mesh-list
5957894|NCT04654351|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5957895|NCT04654351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5957896|NCT04654351|Analgesics|analgesics|mesh-ancestor
5957897|NCT04654351|Sensory System Agents|sensory system agents|mesh-ancestor
5957898|NCT04654351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5957899|NCT04654351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957900|NCT04654351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5957901|NCT04654351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5957902|NCT04654351|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
5957903|NCT04654351|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
6518025|NCT00724035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6518026|NCT00724035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518027|NCT00724035|Sensory System Agents|sensory system agents|mesh-ancestor
6518028|NCT00724035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6518029|NCT00724035|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6518030|NCT00724035|Narcotics|narcotics|mesh-ancestor
6518031|NCT00724035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6518032|NCT00724035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6518033|NCT00724035|Anesthetics, General|anesthetics, general|mesh-ancestor
6518034|NCT00724035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6518035|NCT00724035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6518036|NCT00724035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6518037|NCT00724035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6682375|NCT01615627|Treprostinil|treprostinil|mesh-list
6682376|NCT01615627|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6682377|NCT01615627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6682378|NCT01615757|Cytarabine|cytarabine|mesh-list
6682379|NCT01615757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6682380|NCT01615757|Antimetabolites|antimetabolites|mesh-ancestor
6682381|NCT01615757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682382|NCT01615757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6682383|NCT01615757|Antiviral Agents|antiviral agents|mesh-ancestor
6682384|NCT01615757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6682385|NCT01615757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6682386|NCT01615757|Immunologic Factors|immunologic factors|mesh-ancestor
6682387|NCT01615757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957904|NCT04654351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5957905|NCT04654351|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6518038|NCT00724035|GABA Modulators|gaba modulators|mesh-ancestor
6518039|NCT00724035|GABA Agents|gaba agents|mesh-ancestor
6518040|NCT00724035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6518041|NCT00724035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518042|NCT00724074|Bupivacaine|bupivacaine|mesh-list
6518043|NCT00724074|Anesthetics, Local|anesthetics, local|mesh-ancestor
6518044|NCT00724074|Anesthetics|anesthetics|mesh-ancestor
6518045|NCT00724074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6518046|NCT00724074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518047|NCT00724074|Sensory System Agents|sensory system agents|mesh-ancestor
6518048|NCT00724074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6518049|NCT00724113|Lidocaine|lidocaine|mesh-list
6518050|NCT00724113|Anesthetics, Local|anesthetics, local|mesh-ancestor
6518051|NCT00724113|Anesthetics|anesthetics|mesh-ancestor
6518052|NCT00724113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6518053|NCT00724113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518054|NCT00724113|Sensory System Agents|sensory system agents|mesh-ancestor
6518055|NCT00724113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6518056|NCT00724113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6518057|NCT00724113|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6518058|NCT00724113|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6518059|NCT00724113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6518060|NCT00724113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518061|NCT00724178|Vitamin D|vitamin d|mesh-list
6518062|NCT00724178|Cholecalciferol|cholecalciferol|mesh-list
6518063|NCT00724178|Calcium Carbonate|calcium carbonate|mesh-list
6518064|NCT00724178|Calcium|calcium|mesh-list
6518065|NCT00724178|Vitamins|vitamins|mesh-ancestor
6518066|NCT00724178|Micronutrients|micronutrients|mesh-ancestor
6518067|NCT00724178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518068|NCT00724178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6518069|NCT00724178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6518070|NCT00724178|Antacids|antacids|mesh-ancestor
6682388|NCT01615887|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6518071|NCT00724178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518072|NCT00724178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6518073|NCT00724230|Ribavirin|ribavirin|mesh-list
6518074|NCT00724230|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6518075|NCT00724230|Interferon-alpha|interferon-alpha|mesh-list
6518076|NCT00724230|Antimetabolites|antimetabolites|mesh-ancestor
5957906|NCT04654351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5957907|NCT04654351|Immunologic Factors|immunologic factors|mesh-ancestor
5957908|NCT04654208|Palbociclib|palbociclib|mesh-list
5957909|NCT04654208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5957910|NCT04654208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5957911|NCT04654208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5957912|NCT04654208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518077|NCT00724230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518078|NCT00724230|Antiviral Agents|antiviral agents|mesh-ancestor
6518079|NCT00724230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6518080|NCT00724230|Immunologic Factors|immunologic factors|mesh-ancestor
6518081|NCT00724230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518082|NCT00724256|Ceftibuten|ceftibuten|mesh-list
6518083|NCT00724256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6518084|NCT00724256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6518085|NCT00724295|Ribavirin|ribavirin|mesh-list
6518086|NCT00724295|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6518087|NCT00724295|Antimetabolites|antimetabolites|mesh-ancestor
5957913|NCT04654182|Chlorhexidine|chlorhexidine|mesh-list
5957914|NCT04654182|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5957915|NCT04654182|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5957916|NCT04654182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5957917|NCT04654182|Disinfectants|disinfectants|mesh-ancestor
6682389|NCT01615887|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6682390|NCT01615887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682391|NCT01615887|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6682392|NCT01615887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6682393|NCT01615887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6682394|NCT01615887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682395|NCT01615887|Dopamine Agents|dopamine agents|mesh-ancestor
5957918|NCT04654182|Dermatologic Agents|dermatologic agents|mesh-ancestor
5957919|NCT04654026|Aspirin|aspirin|mesh-list
5957920|NCT04654026|Clopidogrel|clopidogrel|mesh-list
5957921|NCT04654026|Ticagrelor|ticagrelor|mesh-list
5957922|NCT04654026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5957923|NCT04654026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5957924|NCT04654026|Analgesics|analgesics|mesh-ancestor
5957925|NCT04654026|Sensory System Agents|sensory system agents|mesh-ancestor
5957926|NCT04654026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6518088|NCT00724295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518089|NCT00724295|Antiviral Agents|antiviral agents|mesh-ancestor
6518090|NCT00724295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6518091|NCT00724321|Iloprost|iloprost|mesh-list
6518092|NCT00724321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6518093|NCT00724321|Vasodilator Agents|vasodilator agents|mesh-ancestor
5957927|NCT04654026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957928|NCT04654026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5957929|NCT04654026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5957930|NCT04654026|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5957931|NCT04654026|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5957932|NCT04654026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5957933|NCT04654026|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5957934|NCT04654026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5957935|NCT04654026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5957936|NCT04654026|Antipyretics|antipyretics|mesh-ancestor
6682396|NCT01615887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6682397|NCT01615913|Ketoconazole|ketoconazole|mesh-list
6682398|NCT01615913|Terbinafine|terbinafine|mesh-list
6682399|NCT01615913|Antifungal Agents|antifungal agents|mesh-ancestor
6682400|NCT01615913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6682401|NCT01615913|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6682402|NCT01615913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6682403|NCT01615913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6682404|NCT01615913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682405|NCT01615913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6682406|NCT01615913|Hormone Antagonists|hormone antagonists|mesh-ancestor
5957937|NCT04654026|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6779980|NCT02181946|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6682407|NCT01615913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6682408|NCT01615913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682409|NCT01615913|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6682410|NCT01615978|Liraglutide|liraglutide|mesh-list
6682411|NCT01615978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6682412|NCT01615978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682413|NCT01615978|Incretins|incretins|mesh-ancestor
6682414|NCT01615978|Hormones|hormones|mesh-ancestor
6682415|NCT01615978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6682416|NCT01616004|Nitrous Oxide|nitrous oxide|mesh-list
5957938|NCT04654026|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5957939|NCT04654026|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5957940|NCT04654026|Purinergic Agents|purinergic agents|mesh-ancestor
5957941|NCT04654026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5957942|NCT04653831|Pirfenidone|pirfenidone|mesh-list
5957943|NCT04653831|Analgesics|analgesics|mesh-ancestor
5957944|NCT04653831|Sensory System Agents|sensory system agents|mesh-ancestor
5957945|NCT04653831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5957946|NCT04653831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957947|NCT04653831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5957948|NCT04653831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5957949|NCT04653831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6682417|NCT01616004|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6682418|NCT01616004|Anesthetics, General|anesthetics, general|mesh-ancestor
6682419|NCT01616004|Anesthetics|anesthetics|mesh-ancestor
6682420|NCT01616004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6682421|NCT01616004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682422|NCT01616004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6682423|NCT01616004|Analgesics|analgesics|mesh-ancestor
6682424|NCT01616004|Sensory System Agents|sensory system agents|mesh-ancestor
5957950|NCT04653831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6518094|NCT00724360|Trastuzumab|trastuzumab|mesh-list
6518095|NCT00724360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6518096|NCT00724360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6518097|NCT00724386|Paclitaxel|paclitaxel|mesh-list
6518098|NCT00724386|Vinorelbine|vinorelbine|mesh-list
6518099|NCT00724386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6518100|NCT00724386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6518101|NCT00724386|Tubulin Modulators|tubulin modulators|mesh-ancestor
6518102|NCT00724386|Antimitotic Agents|antimitotic agents|mesh-ancestor
6518103|NCT00724386|Mitosis Modulators|mitosis modulators|mesh-ancestor
6518104|NCT00724386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518105|NCT00724529|Infliximab|infliximab|mesh-list
6518106|NCT00724529|Dermatologic Agents|dermatologic agents|mesh-ancestor
6518107|NCT00724529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6518108|NCT00724529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6518109|NCT00724542|Voglibose|voglibose|mesh-list
6518110|NCT00724542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6518111|NCT00724542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518112|NCT00724542|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6518113|NCT00724542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6518114|NCT00724542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518115|NCT00724581|Amiodarone|amiodarone|mesh-list
6518116|NCT00724581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6518117|NCT00724581|Vasodilator Agents|vasodilator agents|mesh-ancestor
6518118|NCT00724581|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6518119|NCT00724581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6518120|NCT00724581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518121|NCT00724581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5957951|NCT04653831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5957952|NCT04653506|Acetaminophen|acetaminophen|mesh-list
5957953|NCT04653506|Ibuprofen|ibuprofen|mesh-list
5957954|NCT04653506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5957955|NCT04653506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5957956|NCT04653506|Analgesics|analgesics|mesh-ancestor
5957957|NCT04653506|Sensory System Agents|sensory system agents|mesh-ancestor
5957958|NCT04653506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5957959|NCT04653506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957960|NCT04653506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5957961|NCT04653506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5957962|NCT04653506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6518122|NCT00724581|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6682425|NCT01616004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5957963|NCT04653506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5957964|NCT04653506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682426|NCT01616069|Simendan|simendan|mesh-list
6682427|NCT01616069|Epinephrine|epinephrine|mesh-list
6682428|NCT01616069|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6682429|NCT01616069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6682430|NCT01616069|Adrenergic Agents|adrenergic agents|mesh-ancestor
6682431|NCT01616069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6682432|NCT01616069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682433|NCT01616069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682434|NCT01616069|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6682435|NCT01616069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6682436|NCT01616069|Autonomic Agents|autonomic agents|mesh-ancestor
6682437|NCT01616069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6682438|NCT01616069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6682439|NCT01616069|Respiratory System Agents|respiratory system agents|mesh-ancestor
6682440|NCT01616069|Mydriatics|mydriatics|mesh-ancestor
6682441|NCT01616069|Sympathomimetics|sympathomimetics|mesh-ancestor
6682442|NCT01616069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6682443|NCT01616069|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6682444|NCT01616069|Vasodilator Agents|vasodilator agents|mesh-ancestor
6682445|NCT01616069|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6682446|NCT01616069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6682447|NCT01616069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6682448|NCT01616069|Protective Agents|protective agents|mesh-ancestor
5957965|NCT04653506|Antipyretics|antipyretics|mesh-ancestor
5957966|NCT04653623|Tranexamic Acid|tranexamic acid|mesh-list
5957967|NCT04653623|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6518123|NCT00724581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6518124|NCT00724581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6682449|NCT01616108|Bupivacaine|bupivacaine|mesh-list
6682450|NCT01616108|Anesthetics, Local|anesthetics, local|mesh-ancestor
6682451|NCT01616108|Anesthetics|anesthetics|mesh-ancestor
6682452|NCT01616108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6682453|NCT01616108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957968|NCT04653623|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6518125|NCT00724581|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6682454|NCT01616108|Sensory System Agents|sensory system agents|mesh-ancestor
6682455|NCT01616108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6682456|NCT01616186|Everolimus|everolimus|mesh-list
6682457|NCT01616186|Sorafenib|sorafenib|mesh-list
6682458|NCT01616186|Sunitinib|sunitinib|mesh-list
6682459|NCT01616186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6682460|NCT01616186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6682461|NCT01616186|Immunologic Factors|immunologic factors|mesh-ancestor
6682462|NCT01616186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682463|NCT01616186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6682464|NCT01616186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6682465|NCT01616186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682466|NCT01616186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6682467|NCT01616186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6682468|NCT01616186|Growth Substances|growth substances|mesh-ancestor
6682469|NCT01616186|Growth Inhibitors|growth inhibitors|mesh-ancestor
6779981|NCT02181946|Antifungal Agents|antifungal agents|mesh-ancestor
6779982|NCT02181946|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6779983|NCT02181946|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6779984|NCT02181946|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6779985|NCT02181946|Hormone Antagonists|hormone antagonists|mesh-ancestor
6779986|NCT02181946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6779987|NCT02181946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779988|NCT02181946|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6779989|NCT02181946|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6779990|NCT02181985|Heparin|heparin|mesh-list
6779991|NCT02181985|Enoxaparin|enoxaparin|mesh-list
6779992|NCT02181985|Tenecteplase|tenecteplase|mesh-list
6779993|NCT02181985|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6779994|NCT02181985|Abciximab|abciximab|mesh-list
6779995|NCT02181985|Anticoagulants|anticoagulants|mesh-ancestor
5969836|NCT04540744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6518126|NCT00724581|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6518127|NCT00724581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6518128|NCT00724620|Ribavirin|ribavirin|mesh-list
6518129|NCT00724620|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6518130|NCT00724620|Antimetabolites|antimetabolites|mesh-ancestor
6779996|NCT02181985|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6682470|NCT01616225|Hormones|hormones|mesh-list
6682471|NCT01616225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6682472|NCT01616225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682473|NCT01616355|Sodium Hypochlorite|sodium hypochlorite|mesh-list
6682474|NCT01616355|Eusol|eusol|mesh-list
6682475|NCT01616355|Disinfectants|disinfectants|mesh-ancestor
6682476|NCT01616355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6682477|NCT01616381|Sildenafil Citrate|sildenafil citrate|mesh-list
6682478|NCT01616381|Vasodilator Agents|vasodilator agents|mesh-ancestor
6518131|NCT00724620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518132|NCT00724620|Antiviral Agents|antiviral agents|mesh-ancestor
6518133|NCT00724620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6518134|NCT00724633|Dialysis Solutions|dialysis solutions|mesh-list
6518135|NCT00724633|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6518136|NCT00724672|Adalimumab|adalimumab|mesh-list
6518137|NCT00724672|Etanercept|etanercept|mesh-list
6518138|NCT00724672|Infliximab|infliximab|mesh-list
6518139|NCT00724672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6518140|NCT00724672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6682479|NCT01616381|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6682480|NCT01616381|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6682481|NCT01616381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6682482|NCT01616381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682483|NCT01616381|Urological Agents|urological agents|mesh-ancestor
6682484|NCT01616407|Methylphenidate|methylphenidate|mesh-list
5957969|NCT04653623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5957970|NCT04653623|Hemostatics|hemostatics|mesh-ancestor
5957971|NCT04653623|Coagulants|coagulants|mesh-ancestor
5957972|NCT04653662|Carbamide Peroxide|carbamide peroxide|mesh-list
5957973|NCT04653662|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6682485|NCT01616407|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
6682486|NCT01616407|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6682487|NCT01616407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682488|NCT01616407|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6682489|NCT01616407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6682490|NCT01616407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6682491|NCT01616407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682492|NCT01616407|Dopamine Agents|dopamine agents|mesh-ancestor
6682493|NCT01616407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6682494|NCT01616407|Hallucinogens|hallucinogens|mesh-ancestor
6682495|NCT01616407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6682496|NCT01616407|Serotonin Agents|serotonin agents|mesh-ancestor
6682497|NCT01616407|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6682498|NCT01616407|Adrenergic Agents|adrenergic agents|mesh-ancestor
6682499|NCT01616485|Sildenafil Citrate|sildenafil citrate|mesh-list
6682500|NCT01616485|Nitroglycerin|nitroglycerin|mesh-list
6682501|NCT01616485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682502|NCT01616485|Vasodilator Agents|vasodilator agents|mesh-ancestor
6682503|NCT01616485|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6682504|NCT01616485|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6682505|NCT01616485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6682506|NCT01616485|Urological Agents|urological agents|mesh-ancestor
6682507|NCT01616615|Aspirin|aspirin|mesh-list
6682508|NCT01616615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6682509|NCT01616615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6682510|NCT01616615|Analgesics|analgesics|mesh-ancestor
6682511|NCT01616615|Sensory System Agents|sensory system agents|mesh-ancestor
6682512|NCT01616615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6682513|NCT01616615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682514|NCT01616615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6682515|NCT01616615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6682516|NCT01616615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6682517|NCT01616615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6682518|NCT01616615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682519|NCT01616615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6682520|NCT01616615|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6682521|NCT01616615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6682522|NCT01616615|Antipyretics|antipyretics|mesh-ancestor
6682523|NCT01616680|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6682524|NCT01616680|Antibodies|antibodies|mesh-list
6682525|NCT01616680|Immunoglobulins|immunoglobulins|mesh-list
6682526|NCT01616680|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5957974|NCT04653662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6682527|NCT01616680|Immunoconjugates|immunoconjugates|mesh-list
6682528|NCT01616680|Immunologic Factors|immunologic factors|mesh-ancestor
6682529|NCT01616680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682530|NCT01616680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6682531|NCT01616680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6682532|NCT01616732|Testosterone|testosterone|mesh-list
6682533|NCT01616732|Androgens|androgens|mesh-ancestor
6682534|NCT01616732|Hormones|hormones|mesh-ancestor
6682535|NCT01616732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6682536|NCT01616732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682537|NCT01616784|Insulin|insulin|mesh-list
6682538|NCT01616784|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6682539|NCT01616784|Insulin Detemir|insulin detemir|mesh-list
6682540|NCT01616784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6682541|NCT01616784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682542|NCT01616849|Nimotuzumab|nimotuzumab|mesh-list
6682543|NCT01616849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6682544|NCT01616849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6682545|NCT01616875|Cisplatin|cisplatin|mesh-list
6682546|NCT01616875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6518141|NCT00724672|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6518142|NCT00724672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6518143|NCT00724672|Analgesics|analgesics|mesh-ancestor
6518144|NCT00724672|Sensory System Agents|sensory system agents|mesh-ancestor
6518145|NCT00724672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6518146|NCT00724672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518147|NCT00724672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6682547|NCT01616888|Paclitaxel|paclitaxel|mesh-list
6682548|NCT01616888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6682549|NCT01616888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6682550|NCT01616888|Tubulin Modulators|tubulin modulators|mesh-ancestor
6682551|NCT01616888|Antimitotic Agents|antimitotic agents|mesh-ancestor
6682552|NCT01616888|Mitosis Modulators|mitosis modulators|mesh-ancestor
6682553|NCT01616888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682554|NCT01616927|Lanreotide|lanreotide|mesh-list
6682555|NCT01616927|Somatostatin|somatostatin|mesh-list
6682556|NCT01616927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6682557|NCT01616927|Hormones|hormones|mesh-ancestor
6682558|NCT01616927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6682559|NCT01616927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682560|NCT01616966|Remifentanil|remifentanil|mesh-list
6682561|NCT01616966|Propofol|propofol|mesh-list
6682562|NCT01616966|Sevoflurane|sevoflurane|mesh-list
6682563|NCT01616966|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5957975|NCT04653792|Pregabalin|pregabalin|mesh-list
5957976|NCT04653792|Analgesics|analgesics|mesh-ancestor
5957977|NCT04653792|Sensory System Agents|sensory system agents|mesh-ancestor
5957978|NCT04653792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5957979|NCT04653792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957980|NCT04653792|Anticonvulsants|anticonvulsants|mesh-ancestor
5957981|NCT04653792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5957982|NCT04653792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5957983|NCT04653792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5957984|NCT04653792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5957985|NCT04653792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5957986|NCT04653792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5971299|NCT04529005|Protease Inhibitors|protease inhibitors|mesh-ancestor
6518148|NCT00724672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6518149|NCT00724672|Immunologic Factors|immunologic factors|mesh-ancestor
6518150|NCT00724672|Dermatologic Agents|dermatologic agents|mesh-ancestor
6518151|NCT00724685|Ropivacaine|ropivacaine|mesh-list
6518152|NCT00724685|Anesthetics, Local|anesthetics, local|mesh-ancestor
6518153|NCT00724685|Anesthetics|anesthetics|mesh-ancestor
6518154|NCT00724685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6518155|NCT00724685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518156|NCT00724685|Sensory System Agents|sensory system agents|mesh-ancestor
6518157|NCT00724685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6518158|NCT00724724|Aspirin|aspirin|mesh-list
6518159|NCT00724724|3-n-butylphthalide|3-n-butylphthalide|mesh-list
6518160|NCT00724724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6518161|NCT00724724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6518162|NCT00724724|Analgesics|analgesics|mesh-ancestor
6518163|NCT00724724|Sensory System Agents|sensory system agents|mesh-ancestor
6518164|NCT00724724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6518165|NCT00724724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518166|NCT00724724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6518167|NCT00724724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5957987|NCT04653792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5957988|NCT04653792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5957989|NCT04653779|Metformin|metformin|mesh-list
5957990|NCT04653779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5957991|NCT04653779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5957992|NCT04653493|Cyclophosphamide|cyclophosphamide|mesh-list
5957993|NCT04653493|Fludarabine|fludarabine|mesh-list
5957994|NCT04653493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5957995|NCT04653493|Immunologic Factors|immunologic factors|mesh-ancestor
5957996|NCT04653493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518168|NCT00724724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6518169|NCT00724724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6682564|NCT01616966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5957997|NCT04653493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5957998|NCT04653493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5957999|NCT04653493|Alkylating Agents|alkylating agents|mesh-ancestor
5958000|NCT04653493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958001|NCT04653493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5958002|NCT04653493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5958003|NCT04653415|Methylprednisolone|methylprednisolone|mesh-list
5958004|NCT04653415|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5958005|NCT04653415|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5958006|NCT04653415|Prednisolone|prednisolone|mesh-list
5958007|NCT04653415|Prednisolone acetate|prednisolone acetate|mesh-list
5958008|NCT04653415|Gabapentin|gabapentin|mesh-list
5958009|NCT04653415|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5958010|NCT04653415|Prednisolone phosphate|prednisolone phosphate|mesh-list
5958011|NCT04653415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5958012|NCT04653415|Antiemetics|antiemetics|mesh-ancestor
5958013|NCT04653415|Autonomic Agents|autonomic agents|mesh-ancestor
5958014|NCT04653415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5958015|NCT04653415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958016|NCT04653415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5958017|NCT04653415|Glucocorticoids|glucocorticoids|mesh-ancestor
5958018|NCT04653415|Hormones|hormones|mesh-ancestor
5958019|NCT04653415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5958020|NCT04653415|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5958021|NCT04653415|Protective Agents|protective agents|mesh-ancestor
5958022|NCT04653415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5958023|NCT04653415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5958024|NCT04653415|Analgesics|analgesics|mesh-ancestor
5958025|NCT04653415|Sensory System Agents|sensory system agents|mesh-ancestor
6682565|NCT01616966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682566|NCT01616966|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6682567|NCT01616966|Anesthetics, General|anesthetics, general|mesh-ancestor
6682568|NCT01616966|Anesthetics|anesthetics|mesh-ancestor
6682569|NCT01616966|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5958026|NCT04653415|Anticonvulsants|anticonvulsants|mesh-ancestor
5958027|NCT04653415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5958028|NCT04653415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5958029|NCT04653415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5958030|NCT04653415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5958031|NCT04653415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5958032|NCT04653415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5958033|NCT04653415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5958034|NCT04653415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958035|NCT04653415|Antimanic Agents|antimanic agents|mesh-ancestor
5958036|NCT04653246|Dexamethasone|dexamethasone|mesh-list
5958037|NCT04653246|Lenalidomide|lenalidomide|mesh-list
5958038|NCT04653246|Bortezomib|bortezomib|mesh-list
5958039|NCT04653246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5958040|NCT04653246|Antiemetics|antiemetics|mesh-ancestor
5958041|NCT04653246|Autonomic Agents|autonomic agents|mesh-ancestor
5958042|NCT04653246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5958043|NCT04653246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958044|NCT04653246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5958045|NCT04653246|Glucocorticoids|glucocorticoids|mesh-ancestor
5958046|NCT04653246|Hormones|hormones|mesh-ancestor
5958047|NCT04653246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5958048|NCT04653246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5958049|NCT04653246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5958050|NCT04653246|Immunologic Factors|immunologic factors|mesh-ancestor
5958051|NCT04653246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6682570|NCT01616966|Narcotics|narcotics|mesh-ancestor
5958052|NCT04653246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5958053|NCT04653246|Growth Substances|growth substances|mesh-ancestor
6682571|NCT01616966|Analgesics|analgesics|mesh-ancestor
5958054|NCT04653246|Growth Inhibitors|growth inhibitors|mesh-ancestor
5958055|NCT04653337|Norepinephrine|norepinephrine|mesh-list
5958056|NCT04653337|Serotonin|serotonin|mesh-list
5958057|NCT04653337|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
5958058|NCT04653337|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5958059|NCT04653337|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5958060|NCT04653337|Adrenergic Agents|adrenergic agents|mesh-ancestor
5958061|NCT04653337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5958062|NCT04653337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958063|NCT04653337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958064|NCT04653337|Sympathomimetics|sympathomimetics|mesh-ancestor
5958065|NCT04653337|Autonomic Agents|autonomic agents|mesh-ancestor
5958066|NCT04653337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5958067|NCT04653337|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5958068|NCT04653337|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5958069|NCT04653337|Serotonin Agents|serotonin agents|mesh-ancestor
5958070|NCT04653337|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5958071|NCT04653337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5969837|NCT04540744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969838|NCT04540744|Urological Agents|urological agents|mesh-ancestor
5969839|NCT04540744|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
5969840|NCT04540744|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5969841|NCT04540744|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
5969842|NCT04540692|Paclitaxel|paclitaxel|mesh-list
5969843|NCT04540692|Docetaxel|docetaxel|mesh-list
5969844|NCT04540692|Cyclophosphamide|cyclophosphamide|mesh-list
5969845|NCT04540692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5969846|NCT04540692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5969847|NCT04540692|Tubulin Modulators|tubulin modulators|mesh-ancestor
5969848|NCT04540692|Antimitotic Agents|antimitotic agents|mesh-ancestor
5969849|NCT04540692|Mitosis Modulators|mitosis modulators|mesh-ancestor
5969850|NCT04540692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969851|NCT04540692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5969852|NCT04540692|Immunologic Factors|immunologic factors|mesh-ancestor
5969853|NCT04540692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969854|NCT04540692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5969855|NCT04540692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6682572|NCT01616966|Sensory System Agents|sensory system agents|mesh-ancestor
6682573|NCT01616966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6682574|NCT01616966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6682575|NCT01616966|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6682576|NCT01616992|Bupivacaine|bupivacaine|mesh-list
6682577|NCT01616992|Anesthetics, Local|anesthetics, local|mesh-ancestor
6682578|NCT01616992|Anesthetics|anesthetics|mesh-ancestor
6518170|NCT00724724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682579|NCT01616992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5969856|NCT04540692|Alkylating Agents|alkylating agents|mesh-ancestor
5969857|NCT04540692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5969858|NCT04540627|Palivizumab|palivizumab|mesh-list
5969859|NCT04540627|Antiviral Agents|antiviral agents|mesh-ancestor
5969860|NCT04540627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5969861|NCT04540133|Dexamethasone|dexamethasone|mesh-list
5969862|NCT04540133|Dexamethasone acetate|dexamethasone acetate|mesh-list
5969863|NCT04540133|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5969864|NCT04540133|BB 1101|bb 1101|mesh-list
5969865|NCT04540133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5969866|NCT04540133|Antiemetics|antiemetics|mesh-ancestor
6682580|NCT01616992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682581|NCT01616992|Sensory System Agents|sensory system agents|mesh-ancestor
6682582|NCT01616992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6682583|NCT01617057|Tiludronic acid|tiludronic acid|mesh-list
6682584|NCT01617057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6682585|NCT01617057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682586|NCT01617135|Levodopa|levodopa|mesh-list
6682587|NCT01617135|Carbidopa|carbidopa|mesh-list
6682588|NCT01617135|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
6682589|NCT01617135|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6682590|NCT01617135|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5969867|NCT04540133|Autonomic Agents|autonomic agents|mesh-ancestor
5969868|NCT04540133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5969869|NCT04540133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969870|NCT04540133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5969871|NCT04540133|Glucocorticoids|glucocorticoids|mesh-ancestor
5969872|NCT04540133|Hormones|hormones|mesh-ancestor
5958072|NCT04652648|Hydroxychloroquine|hydroxychloroquine|mesh-list
5958073|NCT04652648|Antimalarials|antimalarials|mesh-ancestor
5958074|NCT04652648|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5958075|NCT04652648|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5958076|NCT04652648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5958077|NCT04652648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5958078|NCT04652648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958079|NCT04652648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5958080|NCT04652739|Prednisolone|prednisolone|mesh-list
5958081|NCT04652739|Lycopene|lycopene|mesh-list
5958082|NCT04652739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5958083|NCT04652739|Glucocorticoids|glucocorticoids|mesh-ancestor
5958084|NCT04652739|Hormones|hormones|mesh-ancestor
5958085|NCT04652739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5958086|NCT04652739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958087|NCT04652739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5958088|NCT04652739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5958089|NCT04652739|Protective Agents|protective agents|mesh-ancestor
6682591|NCT01617135|Dopamine Agents|dopamine agents|mesh-ancestor
6682592|NCT01617135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6682593|NCT01617135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682594|NCT01617135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682595|NCT01617135|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6682596|NCT01617135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6682597|NCT01617135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6682598|NCT01617135|Immunologic Factors|immunologic factors|mesh-ancestor
6682599|NCT01617135|Dopamine Agonists|dopamine agonists|mesh-ancestor
6682600|NCT01617200|Olanzapine|olanzapine|mesh-list
6682601|NCT01617200|Asenapine|asenapine|mesh-list
6682602|NCT01617200|Antiemetics|antiemetics|mesh-ancestor
6682603|NCT01617200|Autonomic Agents|autonomic agents|mesh-ancestor
6682604|NCT01617200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6682605|NCT01617200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682606|NCT01617200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6682607|NCT01617200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6682608|NCT01617200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6682609|NCT01617200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6682610|NCT01617200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6682611|NCT01617200|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6682612|NCT01617200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6682613|NCT01617200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6779997|NCT02181985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5958090|NCT04652739|Antioxidants|antioxidants|mesh-ancestor
5958091|NCT04652739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958092|NCT04652739|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5958093|NCT04652739|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5958094|NCT04652661|Midazolam|midazolam|mesh-list
5958095|NCT04652661|Dexmedetomidine|dexmedetomidine|mesh-list
5958096|NCT04652661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6518171|NCT00724724|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6518172|NCT00724724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6518173|NCT00724724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6518174|NCT00724724|Antipyretics|antipyretics|mesh-ancestor
6518175|NCT00724724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6518176|NCT00724724|Protective Agents|protective agents|mesh-ancestor
6518177|NCT00724802|Triacetin|triacetin|mesh-list
6518178|NCT00724802|Antifungal Agents|antifungal agents|mesh-ancestor
6518179|NCT00724802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6518180|NCT00724880|Clopidogrel|clopidogrel|mesh-list
6518181|NCT00724880|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6518182|NCT00724880|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6518183|NCT00724880|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6518184|NCT00724880|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6518185|NCT00724880|Purinergic Agents|purinergic agents|mesh-ancestor
6518186|NCT00724880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6518187|NCT00724880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518188|NCT00724880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518189|NCT00725036|Insulin|insulin|mesh-list
6518190|NCT00725036|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6518191|NCT00725036|Insulin Aspart|insulin aspart|mesh-list
6518192|NCT00725036|Isophane Insulin, Human|isophane insulin, human|mesh-list
6518193|NCT00725036|Insulin, Isophane|insulin, isophane|mesh-list
6518194|NCT00725036|Isophane insulin, beef|isophane insulin, beef|mesh-list
6518195|NCT00725036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6518196|NCT00725036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518197|NCT00725114|Tetrodotoxin|tetrodotoxin|mesh-list
6518198|NCT00725114|Anesthetics, Local|anesthetics, local|mesh-ancestor
6518199|NCT00725114|Anesthetics|anesthetics|mesh-ancestor
6518200|NCT00725114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6518201|NCT00725114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518202|NCT00725114|Sensory System Agents|sensory system agents|mesh-ancestor
6518203|NCT00725114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5958097|NCT04652661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5958098|NCT04652661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958099|NCT04652661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5958100|NCT04652661|Analgesics|analgesics|mesh-ancestor
5958101|NCT04652661|Sensory System Agents|sensory system agents|mesh-ancestor
6682614|NCT01617200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682615|NCT01617200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6682616|NCT01617200|Serotonin Agents|serotonin agents|mesh-ancestor
6682617|NCT01617213|Lenalidomide|lenalidomide|mesh-list
6682618|NCT01617213|Melphalan|melphalan|mesh-list
6682619|NCT01617213|Immunologic Factors|immunologic factors|mesh-ancestor
6682620|NCT01617213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682621|NCT01617213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6682622|NCT01617213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6682623|NCT01617213|Growth Substances|growth substances|mesh-ancestor
6682624|NCT01617213|Growth Inhibitors|growth inhibitors|mesh-ancestor
6682625|NCT01617213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6682626|NCT01617213|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6682627|NCT01617213|Alkylating Agents|alkylating agents|mesh-ancestor
6682628|NCT01617213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682629|NCT01617213|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5958102|NCT04652661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5958103|NCT04652661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5958104|NCT04652661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5958105|NCT04652661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5958106|NCT04652661|Adrenergic Agents|adrenergic agents|mesh-ancestor
5958107|NCT04652661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5958108|NCT04652661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958109|NCT04652661|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5958110|NCT04652661|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5958111|NCT04652661|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5958112|NCT04652661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5958113|NCT04652661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5958114|NCT04652661|Anesthetics, General|anesthetics, general|mesh-ancestor
6518204|NCT00725114|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6518205|NCT00725114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6518206|NCT00725114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518207|NCT00725218|Flurbiprofen|flurbiprofen|mesh-list
6518208|NCT00725218|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
5958115|NCT04652661|Anesthetics|anesthetics|mesh-ancestor
5958116|NCT04652661|GABA Modulators|gaba modulators|mesh-ancestor
5958117|NCT04652661|GABA Agents|gaba agents|mesh-ancestor
5958118|NCT04652414|Prednisone|prednisone|mesh-list
5958119|NCT04652414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5958120|NCT04652414|Glucocorticoids|glucocorticoids|mesh-ancestor
5958121|NCT04652414|Hormones|hormones|mesh-ancestor
5958122|NCT04652414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5958123|NCT04652414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958124|NCT04652414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5958125|NCT04652414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6518209|NCT00725218|Analgesics|analgesics|mesh-ancestor
6518210|NCT00725218|Sensory System Agents|sensory system agents|mesh-ancestor
6518211|NCT00725218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6518212|NCT00725218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518213|NCT00725218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6518214|NCT00725218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6518215|NCT00725218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6518216|NCT00725218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6518217|NCT00725218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6518218|NCT00725218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6518219|NCT00725218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518220|NCT00725231|Alemtuzumab|alemtuzumab|mesh-list
6518221|NCT00725231|Doxorubicin|doxorubicin|mesh-list
6518222|NCT00725231|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6518223|NCT00725231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6518224|NCT00725231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6518225|NCT00725231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6518226|NCT00725231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6518227|NCT00725231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6518228|NCT00725231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5958126|NCT04652765|Bicalutamide|bicalutamide|mesh-list
5958127|NCT04652765|Camostat|camostat|mesh-list
5958128|NCT04652765|Androgen Antagonists|androgen antagonists|mesh-ancestor
5958129|NCT04652765|Hormone Antagonists|hormone antagonists|mesh-ancestor
5958130|NCT04652765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5958131|NCT04652765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958132|NCT04652765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5958133|NCT04652765|Protease Inhibitors|protease inhibitors|mesh-ancestor
5958134|NCT04652765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5958135|NCT04652765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958136|NCT04652765|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5958137|NCT04652765|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5958138|NCT04652427|Dexmedetomidine|dexmedetomidine|mesh-list
5958139|NCT04652427|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5958140|NCT04652427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5958141|NCT04652427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958142|NCT04652427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5958143|NCT04652427|Analgesics|analgesics|mesh-ancestor
5958144|NCT04652427|Sensory System Agents|sensory system agents|mesh-ancestor
5958145|NCT04652427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5958146|NCT04652427|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5958147|NCT04652427|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5958148|NCT04652427|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5958149|NCT04652427|Adrenergic Agents|adrenergic agents|mesh-ancestor
5958150|NCT04652427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5958151|NCT04652427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958152|NCT04652440|Antibodies|antibodies|mesh-list
5958153|NCT04652440|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5958154|NCT04652440|Immunologic Factors|immunologic factors|mesh-ancestor
5958155|NCT04652440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958156|NCT04652284|Amoxicillin|amoxicillin|mesh-list
5958157|NCT04652284|Clarithromycin|clarithromycin|mesh-list
5958158|NCT04652284|Rifabutin|rifabutin|mesh-list
5958159|NCT04652284|Tinidazole|tinidazole|mesh-list
5958160|NCT04652284|Esomeprazole|esomeprazole|mesh-list
5958161|NCT04652284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5958162|NCT04652284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5958163|NCT04652284|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5958164|NCT04652284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5958165|NCT04652284|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5958166|NCT04652284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5958167|NCT04652284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958168|NCT04652284|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5958169|NCT04652284|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5958170|NCT04652284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5958171|NCT04652284|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5958172|NCT04652284|Antitubercular Agents|antitubercular agents|mesh-ancestor
5958173|NCT04652284|Alkylating Agents|alkylating agents|mesh-ancestor
5958174|NCT04652284|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
5958175|NCT04652284|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5958176|NCT04652284|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5958177|NCT04652323|Calcium|calcium|mesh-list
5958178|NCT04652323|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5958179|NCT04652323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958180|NCT04651959|Favipiravir|favipiravir|mesh-list
5958181|NCT04651959|Antiviral Agents|antiviral agents|mesh-ancestor
5958182|NCT04651959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5958183|NCT04652011|Analgesics|analgesics|mesh-list
5958184|NCT04652011|Sensory System Agents|sensory system agents|mesh-ancestor
5958185|NCT04652011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5971300|NCT04529005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6518229|NCT00725231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518230|NCT00725348|R 115866|r 115866|mesh-list
6518231|NCT00725348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6518232|NCT00725348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6518233|NCT00725348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518234|NCT00725400|Cetuximab|cetuximab|mesh-list
6518235|NCT00725400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6518236|NCT00725400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6518237|NCT00725439|R 115866|r 115866|mesh-list
6518238|NCT00725439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6518239|NCT00725439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6518240|NCT00725439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518241|NCT00725478|Piribedil|piribedil|mesh-list
6518242|NCT00725478|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6518243|NCT00725478|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6518244|NCT00725478|Dopamine Agonists|dopamine agonists|mesh-ancestor
6682630|NCT01617213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6682631|NCT01617226|Azacitidine|azacitidine|mesh-list
6682632|NCT01617226|Vorinostat|vorinostat|mesh-list
6682633|NCT01617226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5958186|NCT04652011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958187|NCT04652193|Anesthetics|anesthetics|mesh-list
5958188|NCT04652193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5958189|NCT04652193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958190|NCT04652128|Zoledronic Acid|zoledronic acid|mesh-list
5958191|NCT04652128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5958192|NCT04652128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958193|NCT04652115|Defibrotide|defibrotide|mesh-list
5958194|NCT04652115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5958195|NCT04652115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5958196|NCT04652115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958197|NCT04652115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5958198|NCT04652076|Paclitaxel|paclitaxel|mesh-list
5958199|NCT04652076|Carboplatin|carboplatin|mesh-list
5958200|NCT04652076|Pembrolizumab|pembrolizumab|mesh-list
5958201|NCT04652076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5958202|NCT04652076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5958203|NCT04652076|Tubulin Modulators|tubulin modulators|mesh-ancestor
5958204|NCT04652076|Antimitotic Agents|antimitotic agents|mesh-ancestor
5958205|NCT04652076|Mitosis Modulators|mitosis modulators|mesh-ancestor
5958206|NCT04652076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958207|NCT04652076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5958208|NCT04651842|Insulin|insulin|mesh-list
5958209|NCT04651842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5958210|NCT04651842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958211|NCT04652089|Simvastatin|simvastatin|mesh-list
5958212|NCT04652089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5958213|NCT04652089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5958214|NCT04652089|Antimetabolites|antimetabolites|mesh-ancestor
5958215|NCT04652089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958216|NCT04652089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5958217|NCT04652089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5958218|NCT04652089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5958219|NCT04651595|Morphine|morphine|mesh-list
5958220|NCT04651595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5958221|NCT04651595|Narcotics|narcotics|mesh-ancestor
5958222|NCT04651595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5958223|NCT04651595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958224|NCT04651595|Analgesics|analgesics|mesh-ancestor
5958225|NCT04651595|Sensory System Agents|sensory system agents|mesh-ancestor
5958226|NCT04651595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5958227|NCT04651556|Acetaminophen|acetaminophen|mesh-list
5958228|NCT04651556|Ketorolac|ketorolac|mesh-list
6518245|NCT00725478|Dopamine Agents|dopamine agents|mesh-ancestor
6518246|NCT00725478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6518247|NCT00725478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518248|NCT00725478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518249|NCT00725517|Icodextrin|icodextrin|mesh-list
6518250|NCT00725517|Dialysis Solutions|dialysis solutions|mesh-ancestor
6518251|NCT00725517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6518252|NCT00725634|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6518253|NCT00725634|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6682634|NCT01617226|Antimetabolites|antimetabolites|mesh-ancestor
6682635|NCT01617226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682636|NCT01617226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6682637|NCT01617226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6518254|NCT00725634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6518255|NCT00725634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6518256|NCT00725634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6518257|NCT00725634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958229|NCT04651556|Magnesium Sulfate|magnesium sulfate|mesh-list
5958230|NCT04651556|Bupivacaine|bupivacaine|mesh-list
5958231|NCT04651556|Anesthetics, Local|anesthetics, local|mesh-ancestor
5958232|NCT04651556|Anesthetics|anesthetics|mesh-ancestor
6518258|NCT00725634|Immunologic Factors|immunologic factors|mesh-ancestor
5958233|NCT04651556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5958234|NCT04651556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958235|NCT04651556|Sensory System Agents|sensory system agents|mesh-ancestor
5958236|NCT04651556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5958237|NCT04651556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5958238|NCT04651556|Analgesics|analgesics|mesh-ancestor
5958239|NCT04651556|Antipyretics|antipyretics|mesh-ancestor
5958240|NCT04651556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5958241|NCT04651556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5958242|NCT04651556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5958243|NCT04651556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5958244|NCT04651556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5958245|NCT04651556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958246|NCT04651556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5958247|NCT04651556|Anticonvulsants|anticonvulsants|mesh-ancestor
5958248|NCT04651556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5958249|NCT04651556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5958250|NCT04651556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5958251|NCT04651556|Tocolytic Agents|tocolytic agents|mesh-ancestor
5958252|NCT04651556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5969873|NCT04540133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5969874|NCT04540133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5969875|NCT04540133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5969876|NCT04540133|Protease Inhibitors|protease inhibitors|mesh-ancestor
5969877|NCT04540133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5969878|NCT04540133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969879|NCT04539977|Cisplatin|cisplatin|mesh-list
5969880|NCT04539977|Etoposide|etoposide|mesh-list
5969881|NCT04539977|Etoposide phosphate|etoposide phosphate|mesh-list
5969882|NCT04539977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5969883|NCT04539977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5969884|NCT04539977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5969885|NCT04539977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5969886|NCT04539977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5969887|NCT04539977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969888|NCT04540055|Anesthetics|anesthetics|mesh-list
5969889|NCT04540055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5969890|NCT04540055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969891|NCT04540185|Neuroprotective Agents|neuroprotective agents|mesh-list
5969892|NCT04540185|Vaccines|vaccines|mesh-list
5969893|NCT04540185|Immunologic Factors|immunologic factors|mesh-ancestor
5969894|NCT04540185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969895|NCT04540185|Protective Agents|protective agents|mesh-ancestor
5969896|NCT04539951|Memantine|memantine|mesh-list
5969897|NCT04539951|Aripiprazole|aripiprazole|mesh-list
5969898|NCT04539951|Fluvoxamine|fluvoxamine|mesh-list
5969899|NCT04539951|Sertraline|sertraline|mesh-list
5969900|NCT04539951|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
5969901|NCT04539951|Antidepressive Agents|antidepressive agents|mesh-ancestor
5969902|NCT04539951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5969903|NCT04539951|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5969904|NCT04539951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5969905|NCT04539951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5969906|NCT04539951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969907|NCT04539951|Dopamine Agonists|dopamine agonists|mesh-ancestor
5969908|NCT04539951|Dopamine Agents|dopamine agents|mesh-ancestor
5969909|NCT04539951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5969910|NCT04539951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969911|NCT04539951|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5969912|NCT04539951|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5969913|NCT04539951|Serotonin Agents|serotonin agents|mesh-ancestor
5969914|NCT04539951|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5969915|NCT04539951|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5969916|NCT04539951|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5969917|NCT04539951|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5969918|NCT04539951|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5969919|NCT04539951|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5969920|NCT04539951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5969921|NCT04539951|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5969922|NCT04539951|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5969923|NCT04539951|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5969924|NCT04539951|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5958253|NCT04650984|Doxorubicin|doxorubicin|mesh-list
5958254|NCT04650984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5958255|NCT04650984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5958256|NCT04650984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5958257|NCT04650984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5958258|NCT04650984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5958259|NCT04650984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958260|NCT04651049|Propranolol|propranolol|mesh-list
5958261|NCT04651049|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5958262|NCT04651049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5958263|NCT04651049|Adrenergic Agents|adrenergic agents|mesh-ancestor
5958264|NCT04651049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5958265|NCT04651049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958266|NCT04651049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958267|NCT04651049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5958268|NCT04651049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5958269|NCT04651049|Vasodilator Agents|vasodilator agents|mesh-ancestor
5958270|NCT04651205|Thiamine|thiamine|mesh-list
6518259|NCT00725634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518260|NCT00725777|Lumefantrine|lumefantrine|mesh-list
6518261|NCT00725777|Artemether|artemether|mesh-list
6518262|NCT00725777|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6518263|NCT00725777|Antimalarials|antimalarials|mesh-ancestor
6518264|NCT00725777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6518265|NCT00725777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6518266|NCT00725777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6518267|NCT00725790|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6518268|NCT00725790|Vasodilator Agents|vasodilator agents|mesh-ancestor
5958271|NCT04651205|Vitamins|vitamins|mesh-ancestor
5958272|NCT04651205|Micronutrients|micronutrients|mesh-ancestor
5958273|NCT04651205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958274|NCT04651205|Vitamin B Complex|vitamin b complex|mesh-ancestor
5958275|NCT04650893|Dexamethasone|dexamethasone|mesh-list
6682638|NCT01617226|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6682639|NCT01617317|Immunoglobulins|immunoglobulins|mesh-list
6682640|NCT01617317|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6682641|NCT01617317|Antibodies|antibodies|mesh-list
6682642|NCT01617317|gamma-Globulins|gamma-globulins|mesh-list
6682643|NCT01617317|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6682644|NCT01617317|Immunologic Factors|immunologic factors|mesh-ancestor
6682645|NCT01617317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682646|NCT01617356|Lidocaine|lidocaine|mesh-list
6682647|NCT01617356|Anesthetics, Local|anesthetics, local|mesh-ancestor
6682648|NCT01617356|Anesthetics|anesthetics|mesh-ancestor
6682649|NCT01617356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6682650|NCT01617356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682651|NCT01617356|Sensory System Agents|sensory system agents|mesh-ancestor
6682652|NCT01617356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6682653|NCT01617356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6682654|NCT01617356|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6682655|NCT01617356|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6682656|NCT01617356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6682657|NCT01617356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682658|NCT01617538|Atorvastatin|atorvastatin|mesh-list
5958276|NCT04650893|Ketorolac|ketorolac|mesh-list
5958277|NCT04650893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5958278|NCT04650893|Antiemetics|antiemetics|mesh-ancestor
5958279|NCT04650893|Autonomic Agents|autonomic agents|mesh-ancestor
5958280|NCT04650893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5958281|NCT04650893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958282|NCT04650893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5958283|NCT04650893|Glucocorticoids|glucocorticoids|mesh-ancestor
5958284|NCT04650893|Hormones|hormones|mesh-ancestor
5958285|NCT04650893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5958286|NCT04650893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5958287|NCT04650893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5958288|NCT04650893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5958289|NCT04650893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5958290|NCT04650893|Analgesics|analgesics|mesh-ancestor
5958291|NCT04650893|Sensory System Agents|sensory system agents|mesh-ancestor
5958292|NCT04650893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5958293|NCT04650893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5958294|NCT04650893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6518269|NCT00725790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6682659|NCT01617538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5958295|NCT04650893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958296|NCT04650841|Naloxone|naloxone|mesh-list
5958297|NCT04650841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5958298|NCT04650841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958299|NCT04650841|Sensory System Agents|sensory system agents|mesh-ancestor
5958300|NCT04650841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6518270|NCT00725790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6518271|NCT00725790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6518272|NCT00725790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518273|NCT00725790|Urological Agents|urological agents|mesh-ancestor
6518274|NCT00725829|Simvastatin|simvastatin|mesh-list
6518275|NCT00725829|Ezetimibe|ezetimibe|mesh-list
6518276|NCT00725829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6518277|NCT00725829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6518278|NCT00725829|Antimetabolites|antimetabolites|mesh-ancestor
6518279|NCT00725829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518280|NCT00725829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6518281|NCT00725829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6518282|NCT00725829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6518283|NCT00725946|Iodine|iodine|mesh-list
6518284|NCT00725946|Cadexomer iodine|cadexomer iodine|mesh-list
6518285|NCT00725946|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6518286|NCT00725946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6518287|NCT00725946|Trace Elements|trace elements|mesh-ancestor
6518288|NCT00725946|Micronutrients|micronutrients|mesh-ancestor
6518289|NCT00725946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518290|NCT00725985|Cladribine|cladribine|mesh-list
6518291|NCT00725985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6518292|NCT00725985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6518293|NCT00725985|Immunologic Factors|immunologic factors|mesh-ancestor
6518294|NCT00725985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518295|NCT00726011|Tetrodotoxin|tetrodotoxin|mesh-list
6518296|NCT00726011|Anesthetics, Local|anesthetics, local|mesh-ancestor
6518297|NCT00726011|Anesthetics|anesthetics|mesh-ancestor
6518298|NCT00726011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6518299|NCT00726011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518300|NCT00726011|Sensory System Agents|sensory system agents|mesh-ancestor
6518301|NCT00726011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6518302|NCT00726011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6518303|NCT00726011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6518304|NCT00726011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518305|NCT00726258|Ketamine|ketamine|mesh-list
6518306|NCT00726258|Analgesics|analgesics|mesh-ancestor
6518307|NCT00726258|Sensory System Agents|sensory system agents|mesh-ancestor
6518308|NCT00726258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6518309|NCT00726258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518310|NCT00726258|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6518311|NCT00726258|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6682660|NCT01617538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6682661|NCT01617538|Antimetabolites|antimetabolites|mesh-ancestor
6682662|NCT01617538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682663|NCT01617538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6682664|NCT01617538|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5958301|NCT04650880|Vitamin D|vitamin d|mesh-list
5958302|NCT04650880|Vitamins|vitamins|mesh-ancestor
5958303|NCT04650880|Micronutrients|micronutrients|mesh-ancestor
5958304|NCT04650880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958305|NCT04650880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5958306|NCT04650828|Tenofovir|tenofovir|mesh-list
5958307|NCT04650828|Antiviral Agents|antiviral agents|mesh-ancestor
5958308|NCT04650828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6682665|NCT01617538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6682666|NCT01617551|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
5958309|NCT04650828|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5958310|NCT04650828|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5958311|NCT04650828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5958312|NCT04650828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958313|NCT04650828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5958314|NCT04650828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5958315|NCT04650555|Genistein|genistein|mesh-list
5958316|NCT04650555|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5958317|NCT04650555|Protective Agents|protective agents|mesh-ancestor
5958318|NCT04650555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518312|NCT00726258|Anesthetics, General|anesthetics, general|mesh-ancestor
6518313|NCT00726258|Anesthetics|anesthetics|mesh-ancestor
5958319|NCT04650555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5958320|NCT04650555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5958321|NCT04650555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5958322|NCT04650555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958323|NCT04650555|Phytoestrogens|phytoestrogens|mesh-ancestor
5958324|NCT04650555|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
5958325|NCT04650555|Estrogens|estrogens|mesh-ancestor
5958326|NCT04650555|Hormones|hormones|mesh-ancestor
5958327|NCT04650555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5958328|NCT04650542|Paroxetine|paroxetine|mesh-list
5958329|NCT04650542|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5958330|NCT04650542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5958331|NCT04650542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6518314|NCT00726258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6518315|NCT00726258|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6518316|NCT00726258|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6518317|NCT00726258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6518318|NCT00726258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682667|NCT01617551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6682668|NCT01617551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682669|NCT01617564|Bupivacaine|bupivacaine|mesh-list
6682670|NCT01617564|Anesthetics, Local|anesthetics, local|mesh-ancestor
6682671|NCT01617564|Anesthetics|anesthetics|mesh-ancestor
5958332|NCT04650542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958333|NCT04650542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5958334|NCT04650542|Serotonin Agents|serotonin agents|mesh-ancestor
5958335|NCT04650542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958336|NCT04650542|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5958337|NCT04650542|Antidepressive Agents|antidepressive agents|mesh-ancestor
5958338|NCT04650542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5958339|NCT04650542|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5958340|NCT04650542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5958341|NCT04650542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5958342|NCT04650269|Emtricitabine|emtricitabine|mesh-list
5958343|NCT04650269|Antiviral Agents|antiviral agents|mesh-ancestor
5958344|NCT04650269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6682672|NCT01617564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6682673|NCT01617564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682674|NCT01617564|Sensory System Agents|sensory system agents|mesh-ancestor
6682675|NCT01617564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6682676|NCT01617590|Methotrexate|methotrexate|mesh-list
6682677|NCT01617590|Leflunomide|leflunomide|mesh-list
6682678|NCT01617590|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6682679|NCT01617590|Abortifacient Agents|abortifacient agents|mesh-ancestor
5958345|NCT04650269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5958346|NCT04650269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5958347|NCT04650269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5958348|NCT04650269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958349|NCT04650269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5958350|NCT04650269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5958351|NCT04650243|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
5958352|NCT04650243|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5958353|NCT04650243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5958354|NCT04650321|Ocrelizumab|ocrelizumab|mesh-list
5958355|NCT04650321|Immunologic Factors|immunologic factors|mesh-ancestor
5958356|NCT04650321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958357|NCT04649892|Naltrexone|naltrexone|mesh-list
5958358|NCT04649892|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5958359|NCT04649892|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5958360|NCT04649892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958361|NCT04649892|Sensory System Agents|sensory system agents|mesh-ancestor
5958362|NCT04649892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5958363|NCT04649723|Rifampin|rifampin|mesh-list
5958364|NCT04649723|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5958365|NCT04649723|Antitubercular Agents|antitubercular agents|mesh-ancestor
5958366|NCT04649723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5958367|NCT04649723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5958368|NCT04649723|Leprostatic Agents|leprostatic agents|mesh-ancestor
5958369|NCT04649723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5958370|NCT04649723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5958371|NCT04649723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958372|NCT04649723|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5958373|NCT04649723|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5958374|NCT04649723|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5958375|NCT04649723|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5958376|NCT04649723|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5958377|NCT04649723|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5958378|NCT04649645|Nicotine|nicotine|mesh-list
5958379|NCT04649645|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5958380|NCT04649645|Autonomic Agents|autonomic agents|mesh-ancestor
5958381|NCT04649645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5958382|NCT04649645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958383|NCT04649645|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5958384|NCT04649645|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5958385|NCT04649645|Cholinergic Agents|cholinergic agents|mesh-ancestor
5958386|NCT04649645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5958387|NCT04649645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682680|NCT01617590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6682681|NCT01617590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682682|NCT01617590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6682683|NCT01617590|Antimetabolites|antimetabolites|mesh-ancestor
5958388|NCT04649229|Aprepitant|aprepitant|mesh-list
5958389|NCT04649229|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5958390|NCT04649229|Antiemetics|antiemetics|mesh-ancestor
5958391|NCT04649229|Autonomic Agents|autonomic agents|mesh-ancestor
5958392|NCT04649229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5958393|NCT04649229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958394|NCT04649229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5958395|NCT04649229|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5958396|NCT04649229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5958397|NCT04649229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958398|NCT04649229|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5969925|NCT04539951|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5969926|NCT04539951|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5969927|NCT04539951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5969928|NCT04539951|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5969929|NCT04539951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5969930|NCT04539951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5969931|NCT04539951|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5969932|NCT04539626|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5969933|NCT04539626|Estradiol|estradiol|mesh-list
5969934|NCT04539626|Estrogens|estrogens|mesh-list
5969935|NCT04539626|Hormones|hormones|mesh-ancestor
5969936|NCT04539626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5969937|NCT04539626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969938|NCT04539626|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5969939|NCT04539626|Contraceptive Agents|contraceptive agents|mesh-ancestor
5969940|NCT04539626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5969941|NCT04539626|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5969942|NCT04539626|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5969943|NCT04539626|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5971301|NCT04529005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971302|NCT04529278|Liraglutide|liraglutide|mesh-list
5971303|NCT04529278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5971304|NCT04529278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971305|NCT04529278|Incretins|incretins|mesh-ancestor
5971306|NCT04529278|Hormones|hormones|mesh-ancestor
5971307|NCT04529278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5971308|NCT04529226|Haloperidol|haloperidol|mesh-list
5971309|NCT04529226|Pimozide|pimozide|mesh-list
5971310|NCT04529226|Olanzapine|olanzapine|mesh-list
5971311|NCT04529226|Risperidone|risperidone|mesh-list
5971312|NCT04529226|Haloperidol decanoate|haloperidol decanoate|mesh-list
5971313|NCT04529226|Clozapine|clozapine|mesh-list
5971314|NCT04529226|Amisulpride|amisulpride|mesh-list
5971315|NCT04529226|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5971316|NCT04529226|Serotonin Agents|serotonin agents|mesh-ancestor
5971317|NCT04529226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5971318|NCT04529226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971319|NCT04529226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971320|NCT04529226|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5971321|NCT04529226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5971322|NCT04529226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5971323|NCT04529226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5958399|NCT04649697|Clobetasol|clobetasol|mesh-list
5958400|NCT04649697|Rebamipide|rebamipide|mesh-list
5958401|NCT04649697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5720668|NCT03211065|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5720669|NCT03211065|Antibodies|antibodies|mesh-list
5720670|NCT03211065|Immunologic Factors|immunologic factors|mesh-ancestor
5720671|NCT03211065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5720672|NCT03211286|Tranexamic Acid|tranexamic acid|mesh-list
5958402|NCT04649697|Glucocorticoids|glucocorticoids|mesh-ancestor
6682684|NCT01617590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682685|NCT01617590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6682686|NCT01617590|Dermatologic Agents|dermatologic agents|mesh-ancestor
6682687|NCT01617590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6682688|NCT01617590|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6682689|NCT01617590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6682690|NCT01617590|Immunologic Factors|immunologic factors|mesh-ancestor
6682691|NCT01617590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6682692|NCT01617590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6682693|NCT01617694|Dexmedetomidine|dexmedetomidine|mesh-list
6682694|NCT01617694|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6682695|NCT01617694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6682696|NCT01617694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682697|NCT01617694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6682698|NCT01617694|Analgesics|analgesics|mesh-ancestor
6682699|NCT01617694|Sensory System Agents|sensory system agents|mesh-ancestor
6682700|NCT01617694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6682701|NCT01617694|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6682702|NCT01617694|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6682703|NCT01617694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6682704|NCT01617694|Adrenergic Agents|adrenergic agents|mesh-ancestor
5958403|NCT04649697|Hormones|hormones|mesh-ancestor
5958404|NCT04649697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5958405|NCT04649697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958406|NCT04649697|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5958407|NCT04649697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5958408|NCT04649697|Antioxidants|antioxidants|mesh-ancestor
5958409|NCT04649697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958410|NCT04649697|Protective Agents|protective agents|mesh-ancestor
5958411|NCT04649697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5958412|NCT04649502|Metformin|metformin|mesh-list
5958413|NCT04649502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5958414|NCT04649502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958415|NCT04649476|Cisplatin|cisplatin|mesh-list
5958416|NCT04649476|Docetaxel|docetaxel|mesh-list
5958417|NCT04649476|Fluorouracil|fluorouracil|mesh-list
5958418|NCT04649476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5958419|NCT04649476|Tubulin Modulators|tubulin modulators|mesh-ancestor
5720673|NCT03211286|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5720674|NCT03211286|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5720675|NCT03211286|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5958420|NCT04649476|Antimitotic Agents|antimitotic agents|mesh-ancestor
5958421|NCT04649476|Mitosis Modulators|mitosis modulators|mesh-ancestor
5958422|NCT04649476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958423|NCT04649476|Antimetabolites|antimetabolites|mesh-ancestor
5958424|NCT04649476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5958425|NCT04649476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5958426|NCT04649476|Immunologic Factors|immunologic factors|mesh-ancestor
5958427|NCT04649476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958428|NCT04649398|Nimodipine|nimodipine|mesh-list
6518319|NCT00726466|Ranibizumab|ranibizumab|mesh-list
6518320|NCT00726466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6518321|NCT00726466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6518322|NCT00726466|Growth Substances|growth substances|mesh-ancestor
6518323|NCT00726466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518324|NCT00726466|Growth Inhibitors|growth inhibitors|mesh-ancestor
6518325|NCT00726466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6518326|NCT00726505|Dapagliflozin|dapagliflozin|mesh-list
6518327|NCT00726505|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6518328|NCT00726505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518329|NCT00726505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6518330|NCT00726505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518331|NCT00726570|Heparin|heparin|mesh-list
6518332|NCT00726570|Calcium heparin|calcium heparin|mesh-list
6682705|NCT01617694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5722235|NCT03200613|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6518333|NCT00726570|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6518334|NCT00726570|Tinzaparin|tinzaparin|mesh-list
6518335|NCT00726570|Dalteparin|dalteparin|mesh-list
6518336|NCT00726570|Anticoagulants|anticoagulants|mesh-list
6518337|NCT00726570|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6518338|NCT00726570|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6518339|NCT00726570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682706|NCT01617694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682707|NCT01617707|Midazolam|midazolam|mesh-list
6682708|NCT01617707|Propofol|propofol|mesh-list
6682709|NCT01617707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6682710|NCT01617707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6682711|NCT01617707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682712|NCT01617707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5958429|NCT04649398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5958430|NCT04649398|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5958431|NCT04649398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5958432|NCT04649398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958433|NCT04649398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5958434|NCT04649398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958435|NCT04649398|Vasodilator Agents|vasodilator agents|mesh-ancestor
5958436|NCT04649489|Bevacizumab|bevacizumab|mesh-list
5958437|NCT04649489|Atezolizumab|atezolizumab|mesh-list
5958438|NCT04649489|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5958439|NCT04649489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5958440|NCT04649489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6682713|NCT01617707|Anesthetics, General|anesthetics, general|mesh-ancestor
6682714|NCT01617707|Anesthetics|anesthetics|mesh-ancestor
6682715|NCT01617707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6682716|NCT01617707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6682717|NCT01617707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6682718|NCT01617707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6682719|NCT01617707|GABA Modulators|gaba modulators|mesh-ancestor
6682720|NCT01617707|GABA Agents|gaba agents|mesh-ancestor
6682721|NCT01617707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6682722|NCT01617707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682723|NCT01617733|Pasireotide|pasireotide|mesh-list
6682724|NCT01617733|Hormones|hormones|mesh-ancestor
6682725|NCT01617733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6682726|NCT01617733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958441|NCT04649489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5958442|NCT04649489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5958443|NCT04649489|Growth Substances|growth substances|mesh-ancestor
5958444|NCT04649489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958445|NCT04649489|Growth Inhibitors|growth inhibitors|mesh-ancestor
5958446|NCT04649489|Immunologic Factors|immunologic factors|mesh-ancestor
6682727|NCT01617746|Bosentan|bosentan|mesh-list
6682728|NCT01617746|Ambrisentan|ambrisentan|mesh-list
6682729|NCT01617746|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6682730|NCT01617746|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6682731|NCT01617746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682732|NCT01617772|Atorvastatin|atorvastatin|mesh-list
6682733|NCT01617772|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6682734|NCT01617772|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6682735|NCT01617772|Antimetabolites|antimetabolites|mesh-ancestor
6682736|NCT01617772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682737|NCT01617772|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6682738|NCT01617772|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6682739|NCT01617772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5958447|NCT04648891|Lidocaine|lidocaine|mesh-list
5958448|NCT04648891|Anesthetics, Local|anesthetics, local|mesh-ancestor
5958449|NCT04648891|Anesthetics|anesthetics|mesh-ancestor
5958450|NCT04648891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5958451|NCT04648891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958452|NCT04648891|Sensory System Agents|sensory system agents|mesh-ancestor
5958453|NCT04648891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5958454|NCT04648891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5958455|NCT04648891|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5958456|NCT04648891|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5958457|NCT04648891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5958458|NCT04648891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518340|NCT00726596|Hydroxychloroquine|hydroxychloroquine|mesh-list
6518341|NCT00726596|Antimalarials|antimalarials|mesh-ancestor
6682740|NCT01617798|Metolazone|metolazone|mesh-list
5958459|NCT04648969|Hormones|hormones|mesh-list
5958460|NCT04648969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5958461|NCT04648969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958462|NCT04648813|Bromides|bromides|mesh-list
5958463|NCT04648813|Tiotropium Bromide|tiotropium bromide|mesh-list
5958464|NCT04648813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5958465|NCT04648813|Autonomic Agents|autonomic agents|mesh-ancestor
5958466|NCT04648813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5958467|NCT04648813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958468|NCT04648813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5958469|NCT04648813|Respiratory System Agents|respiratory system agents|mesh-ancestor
5958470|NCT04648813|Parasympatholytics|parasympatholytics|mesh-ancestor
5958471|NCT04648813|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5958472|NCT04648813|Cholinergic Agents|cholinergic agents|mesh-ancestor
5958473|NCT04648813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5958474|NCT04648813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958475|NCT04648813|Anticonvulsants|anticonvulsants|mesh-ancestor
5958476|NCT04648358|Dexamethasone|dexamethasone|mesh-list
5958477|NCT04648358|Bupivacaine|bupivacaine|mesh-list
5958478|NCT04648358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5958479|NCT04648358|Antiemetics|antiemetics|mesh-ancestor
5958480|NCT04648358|Autonomic Agents|autonomic agents|mesh-ancestor
5958481|NCT04648358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5958482|NCT04648358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958483|NCT04648358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5958484|NCT04648358|Glucocorticoids|glucocorticoids|mesh-ancestor
5958485|NCT04648358|Hormones|hormones|mesh-ancestor
5958486|NCT04648358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5958487|NCT04648358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5958488|NCT04648358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5958489|NCT04648358|Anesthetics, Local|anesthetics, local|mesh-ancestor
5958490|NCT04648358|Anesthetics|anesthetics|mesh-ancestor
6518342|NCT00726596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6518343|NCT00726596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6518344|NCT00726596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6518345|NCT00726596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6518346|NCT00726596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518347|NCT00726596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6518348|NCT00726687|Capecitabine|capecitabine|mesh-list
6518349|NCT00726687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6518350|NCT00726687|Antimetabolites|antimetabolites|mesh-ancestor
6518351|NCT00726687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682741|NCT01617798|Furosemide|furosemide|mesh-list
6682742|NCT01617798|Diuretics|diuretics|mesh-ancestor
6682743|NCT01617798|Natriuretic Agents|natriuretic agents|mesh-ancestor
6682744|NCT01617798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682745|NCT01617798|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6682746|NCT01617798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6682747|NCT01617798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682748|NCT01617798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6682749|NCT01617798|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6682750|NCT01617811|Anesthetics|anesthetics|mesh-list
6682751|NCT01617811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5958491|NCT04648358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5958492|NCT04648358|Sensory System Agents|sensory system agents|mesh-ancestor
5958493|NCT04648423|Sodium Oxybate|sodium oxybate|mesh-list
5958494|NCT04648423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5958495|NCT04648423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5958496|NCT04648423|Anesthetics, General|anesthetics, general|mesh-ancestor
5958497|NCT04648423|Anesthetics|anesthetics|mesh-ancestor
5958498|NCT04648423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5958499|NCT04648423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958500|NCT04648540|Acetaminophen|acetaminophen|mesh-list
5958501|NCT04648540|Celecoxib|celecoxib|mesh-list
5958502|NCT04648540|Ketorolac|ketorolac|mesh-list
5958503|NCT04648540|Lidocaine|lidocaine|mesh-list
5958504|NCT04648540|Pregabalin|pregabalin|mesh-list
5958505|NCT04648540|Fentanyl|fentanyl|mesh-list
5958506|NCT04648540|Dexmedetomidine|dexmedetomidine|mesh-list
5958507|NCT04648540|Morphine|morphine|mesh-list
5958508|NCT04648540|Anesthetics, Local|anesthetics, local|mesh-ancestor
5958509|NCT04648540|Anesthetics|anesthetics|mesh-ancestor
5958510|NCT04648540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5958511|NCT04648540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958512|NCT04648540|Sensory System Agents|sensory system agents|mesh-ancestor
6518352|NCT00726687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5958513|NCT04648540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5958514|NCT04648540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5958515|NCT04648540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5958516|NCT04648540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5958517|NCT04648540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5958518|NCT04648540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958519|NCT04648540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5958520|NCT04648540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5958521|NCT04648540|Analgesics|analgesics|mesh-ancestor
5958522|NCT04648540|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5958523|NCT04648540|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5958524|NCT04648540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5958525|NCT04648540|Adrenergic Agents|adrenergic agents|mesh-ancestor
5958526|NCT04648540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5958527|NCT04648540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5958528|NCT04648540|Narcotics|narcotics|mesh-ancestor
5958529|NCT04648540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5958530|NCT04648540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5958531|NCT04648540|Anesthetics, General|anesthetics, general|mesh-ancestor
5958532|NCT04648540|Antipyretics|antipyretics|mesh-ancestor
5958533|NCT04648540|Anticonvulsants|anticonvulsants|mesh-ancestor
5958534|NCT04648540|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5958535|NCT04648540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5958536|NCT04648540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5958537|NCT04648540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5958538|NCT04648540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5958539|NCT04648540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5958540|NCT04648540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5958541|NCT04648540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5958542|NCT04648540|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5958543|NCT04648540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5958544|NCT04648540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5958545|NCT04648917|Caffeic acid|caffeic acid|mesh-list
5958546|NCT04648917|Antioxidants|antioxidants|mesh-ancestor
5958547|NCT04648917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958548|NCT04648917|Protective Agents|protective agents|mesh-ancestor
5958549|NCT04648917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958550|NCT04648631|Pulmonary Surfactants|pulmonary surfactants|mesh-list
5958551|NCT04648631|Respiratory System Agents|respiratory system agents|mesh-ancestor
5958552|NCT04648137|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
5958553|NCT04648137|Hallucinogens|hallucinogens|mesh-ancestor
5958554|NCT04648137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958555|NCT04648137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5958556|NCT04648137|Serotonin Agents|serotonin agents|mesh-ancestor
5958557|NCT04648137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5958558|NCT04648137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958559|NCT04648137|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5958560|NCT04648137|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5958561|NCT04648137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5958562|NCT04648137|Adrenergic Agents|adrenergic agents|mesh-ancestor
5958563|NCT04648332|Bupivacaine|bupivacaine|mesh-list
5958564|NCT04648332|Anesthetics, Local|anesthetics, local|mesh-ancestor
5958565|NCT04648332|Anesthetics|anesthetics|mesh-ancestor
5958566|NCT04648332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5958567|NCT04648332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958568|NCT04648332|Sensory System Agents|sensory system agents|mesh-ancestor
5958569|NCT04648332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5958570|NCT04648020|Clonidine|clonidine|mesh-list
5958571|NCT04648020|Analgesics|analgesics|mesh-ancestor
5958572|NCT04648020|Sensory System Agents|sensory system agents|mesh-ancestor
5958573|NCT04648020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5958574|NCT04648020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958575|NCT04648020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5958576|NCT04648020|Sympatholytics|sympatholytics|mesh-ancestor
5958577|NCT04648020|Autonomic Agents|autonomic agents|mesh-ancestor
5958578|NCT04648020|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5958579|NCT04648020|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6682752|NCT01617811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682753|NCT01617824|Linagliptin|linagliptin|mesh-list
6682754|NCT01617824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6682755|NCT01617824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682756|NCT01617824|Incretins|incretins|mesh-ancestor
6682757|NCT01617824|Hormones|hormones|mesh-ancestor
5958580|NCT04648020|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5958581|NCT04648020|Adrenergic Agents|adrenergic agents|mesh-ancestor
5958582|NCT04648020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5958583|NCT04648020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958584|NCT04648280|Fostemsavir|fostemsavir|mesh-list
5958585|NCT04648280|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5958586|NCT04648280|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6682758|NCT01617824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6682759|NCT01617824|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5958587|NCT04648280|Antiviral Agents|antiviral agents|mesh-ancestor
5958588|NCT04648280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6682760|NCT01617824|Protease Inhibitors|protease inhibitors|mesh-ancestor
6682761|NCT01617824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6682762|NCT01617824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779998|NCT02181985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779999|NCT02181985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6780000|NCT02181998|Heparin|heparin|mesh-list
6780001|NCT02181998|Enoxaparin|enoxaparin|mesh-list
6780002|NCT02181998|Tenecteplase|tenecteplase|mesh-list
6780003|NCT02181998|Anticoagulants|anticoagulants|mesh-ancestor
6780004|NCT02181998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6780005|NCT02181998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6780006|NCT02181998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780007|NCT02182011|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6780008|NCT02182011|Tenecteplase|tenecteplase|mesh-list
6780009|NCT02182011|Streptokinase|streptokinase|mesh-list
6780010|NCT02182011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6780011|NCT02182011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6780012|NCT02182011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780013|NCT02182024|Dabigatran|dabigatran|mesh-list
6780014|NCT02182024|Antithrombins|antithrombins|mesh-ancestor
6780015|NCT02182024|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6780016|NCT02182024|Protease Inhibitors|protease inhibitors|mesh-ancestor
6780017|NCT02182024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5958589|NCT04648280|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5958590|NCT04648280|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5958591|NCT04648280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958592|NCT04648046|Cyclophosphamide|cyclophosphamide|mesh-list
5958593|NCT04648046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5958594|NCT04648046|Immunologic Factors|immunologic factors|mesh-ancestor
5958595|NCT04648046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958596|NCT04648046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5958597|NCT04648046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5958598|NCT04648046|Alkylating Agents|alkylating agents|mesh-ancestor
5958599|NCT04648046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958600|NCT04648046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5958601|NCT04648046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5958602|NCT04648241|Vaccines|vaccines|mesh-list
5958603|NCT04648241|Immunologic Factors|immunologic factors|mesh-ancestor
5958604|NCT04648241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958605|NCT04647669|Interferons|interferons|mesh-list
5958606|NCT04647669|Interferon-beta|interferon-beta|mesh-list
5958607|NCT04647669|Interferon beta-1a|interferon beta-1a|mesh-list
5958608|NCT04647669|Remdesivir|remdesivir|mesh-list
5958609|NCT04647669|Acalabrutinib|acalabrutinib|mesh-list
5958610|NCT04647669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5958611|NCT04647669|Antiviral Agents|antiviral agents|mesh-ancestor
5958612|NCT04647669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5958613|NCT04647669|Immunologic Factors|immunologic factors|mesh-ancestor
5958614|NCT04647669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780018|NCT02182024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780019|NCT02182024|Anticoagulants|anticoagulants|mesh-ancestor
6780020|NCT02182050|Nintedanib|nintedanib|mesh-list
6780021|NCT02182050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6780022|NCT02182050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6780023|NCT02182050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780024|NCT02182050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780025|NCT02182063|Nintedanib|nintedanib|mesh-list
6780026|NCT02182063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6780027|NCT02182063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6780028|NCT02182063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780029|NCT02182063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780030|NCT02182076|Nintedanib|nintedanib|mesh-list
6780031|NCT02182076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5958615|NCT04647669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5958616|NCT04647669|Antimetabolites|antimetabolites|mesh-ancestor
6682763|NCT01617928|Paclitaxel|paclitaxel|mesh-list
6682764|NCT01617928|Carboplatin|carboplatin|mesh-list
6682765|NCT01617928|Veliparib|veliparib|mesh-list
6682766|NCT01617928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6682767|NCT01617928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5958617|NCT04647669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969944|NCT04539301|Anticoagulants|anticoagulants|mesh-list
5969945|NCT04539314|Dexmedetomidine|dexmedetomidine|mesh-list
5969946|NCT04539314|Bupivacaine|bupivacaine|mesh-list
5969947|NCT04539314|Anesthetics, Local|anesthetics, local|mesh-ancestor
5969948|NCT04539314|Anesthetics|anesthetics|mesh-ancestor
5969949|NCT04539314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5969950|NCT04539314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969951|NCT04539314|Sensory System Agents|sensory system agents|mesh-ancestor
5969952|NCT04539314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5969953|NCT04539314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5969954|NCT04539314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5969955|NCT04539314|Analgesics|analgesics|mesh-ancestor
5969956|NCT04539314|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5969957|NCT04539314|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5969958|NCT04539314|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5969959|NCT04539314|Adrenergic Agents|adrenergic agents|mesh-ancestor
6518353|NCT00726700|Prednisone|prednisone|mesh-list
6518354|NCT00726700|Cyclophosphamide|cyclophosphamide|mesh-list
6682768|NCT01617928|Tubulin Modulators|tubulin modulators|mesh-ancestor
6682769|NCT01617928|Antimitotic Agents|antimitotic agents|mesh-ancestor
6682770|NCT01617928|Mitosis Modulators|mitosis modulators|mesh-ancestor
6682771|NCT01617928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682772|NCT01617928|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6682773|NCT01617928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6682774|NCT01618006|Aspirin|aspirin|mesh-list
6682775|NCT01618006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6682776|NCT01618006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6682777|NCT01618006|Analgesics|analgesics|mesh-ancestor
6682778|NCT01618006|Sensory System Agents|sensory system agents|mesh-ancestor
5969960|NCT04539314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5969961|NCT04539314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969962|NCT04539405|Sevoflurane|sevoflurane|mesh-list
5969963|NCT04539405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5969964|NCT04539405|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5969965|NCT04539405|Anesthetics, General|anesthetics, general|mesh-ancestor
5969966|NCT04539405|Anesthetics|anesthetics|mesh-ancestor
5969967|NCT04539405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5969968|NCT04539405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969969|NCT04539262|Remdesivir|remdesivir|mesh-list
5969970|NCT04539262|Antimetabolites|antimetabolites|mesh-ancestor
5969971|NCT04539262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969972|NCT04539262|Antiviral Agents|antiviral agents|mesh-ancestor
6682779|NCT01618006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6682780|NCT01618006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969973|NCT04539262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5969974|NCT04539327|Rucaparib|rucaparib|mesh-list
5969975|NCT04539327|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5969976|NCT04539327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5969977|NCT04539327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969978|NCT04539327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5969979|NCT04539223|Evolocumab|evolocumab|mesh-list
6518355|NCT00726700|Rituximab|rituximab|mesh-list
6518356|NCT00726700|Doxorubicin|doxorubicin|mesh-list
6518357|NCT00726700|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6518358|NCT00726700|Vincristine|vincristine|mesh-list
6518359|NCT00726700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6518360|NCT00726700|Immunologic Factors|immunologic factors|mesh-ancestor
6518361|NCT00726700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518362|NCT00726700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6518363|NCT00726700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6518364|NCT00726700|Alkylating Agents|alkylating agents|mesh-ancestor
6518365|NCT00726700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518366|NCT00726700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6518367|NCT00726700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6518368|NCT00726700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6518369|NCT00726700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6518370|NCT00726700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6518371|NCT00726700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6518372|NCT00726700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6682781|NCT01618006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6682782|NCT01618006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6682783|NCT01618006|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6682784|NCT01618006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6682785|NCT01618006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682786|NCT01618006|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6682787|NCT01618006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6682788|NCT01618006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6682789|NCT01618006|Antipyretics|antipyretics|mesh-ancestor
6682790|NCT01618136|Paclitaxel|paclitaxel|mesh-list
6682791|NCT01618136|Carboplatin|carboplatin|mesh-list
6682792|NCT01618136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6682793|NCT01618136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6682794|NCT01618136|Tubulin Modulators|tubulin modulators|mesh-ancestor
6682795|NCT01618136|Antimitotic Agents|antimitotic agents|mesh-ancestor
6682796|NCT01618136|Mitosis Modulators|mitosis modulators|mesh-ancestor
6682797|NCT01618136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682798|NCT01618188|Insulin|insulin|mesh-list
6682799|NCT01618188|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6682800|NCT01618188|Insulin Aspart|insulin aspart|mesh-list
6682801|NCT01618188|Insulin, Long-Acting|insulin, long-acting|mesh-list
6682802|NCT01618188|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6682803|NCT01618188|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6682804|NCT01618188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682805|NCT01618253|Sorafenib|sorafenib|mesh-list
6682806|NCT01618253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6682807|NCT01618253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6682808|NCT01618253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6682809|NCT01618253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682810|NCT01618357|Veliparib|veliparib|mesh-list
5958618|NCT04647877|Phenytoin|phenytoin|mesh-list
5958619|NCT04647877|Anticonvulsants|anticonvulsants|mesh-ancestor
5958620|NCT04647877|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5958621|NCT04647877|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5958622|NCT04647877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5958623|NCT04647877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958624|NCT04647877|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5958625|NCT04647877|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5958626|NCT04647838|Tepotinib|tepotinib|mesh-list
5958627|NCT04647838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5958628|NCT04647773|Pregabalin|pregabalin|mesh-list
5958629|NCT04647773|Analgesics|analgesics|mesh-ancestor
5958630|NCT04647773|Sensory System Agents|sensory system agents|mesh-ancestor
5958631|NCT04647773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5958632|NCT04647773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958633|NCT04647773|Anticonvulsants|anticonvulsants|mesh-ancestor
5958634|NCT04647773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5958635|NCT04647773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5958636|NCT04647773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958637|NCT04647773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6518373|NCT00726700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6518374|NCT00726700|Glucocorticoids|glucocorticoids|mesh-ancestor
6518375|NCT00726700|Hormones|hormones|mesh-ancestor
6518376|NCT00726700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6518377|NCT00726700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6518378|NCT00726700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6518379|NCT00726700|Tubulin Modulators|tubulin modulators|mesh-ancestor
6518380|NCT00726700|Antimitotic Agents|antimitotic agents|mesh-ancestor
6518381|NCT00726700|Mitosis Modulators|mitosis modulators|mesh-ancestor
6518382|NCT00726726|Vitamin K|vitamin k|mesh-list
6518383|NCT00726726|Midazolam|midazolam|mesh-list
6518384|NCT00726726|Dextromethorphan|dextromethorphan|mesh-list
6518385|NCT00726726|Caffeine|caffeine|mesh-list
6518386|NCT00726726|Omeprazole|omeprazole|mesh-list
6518387|NCT00726726|Warfarin|warfarin|mesh-list
6518388|NCT00726726|Vitamins|vitamins|mesh-ancestor
6518389|NCT00726726|Micronutrients|micronutrients|mesh-ancestor
6518390|NCT00726726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958638|NCT04647773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5958639|NCT04647773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5958640|NCT04647773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5958641|NCT04647773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5958642|NCT04647461|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6518391|NCT00726726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6518392|NCT00726726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6682811|NCT01618357|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5958643|NCT04647461|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5958644|NCT04647461|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5958645|NCT04647461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6682812|NCT01618357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6682813|NCT01618357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682814|NCT01618357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6682815|NCT01618370|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
6682816|NCT01618370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6682817|NCT01618396|Midazolam|midazolam|mesh-list
6682818|NCT01618396|Propofol|propofol|mesh-list
6682819|NCT01618396|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6682820|NCT01618396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6682821|NCT01618396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682822|NCT01618396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6682823|NCT01618396|Anesthetics, General|anesthetics, general|mesh-ancestor
6682824|NCT01618396|Anesthetics|anesthetics|mesh-ancestor
6682825|NCT01618396|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6682826|NCT01618396|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6682827|NCT01618396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6682828|NCT01618396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6682829|NCT01618396|GABA Modulators|gaba modulators|mesh-ancestor
6682830|NCT01618396|GABA Agents|gaba agents|mesh-ancestor
6682831|NCT01618396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6682832|NCT01618396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682833|NCT01618448|Tolvaptan|tolvaptan|mesh-list
6682834|NCT01618448|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
5958646|NCT04647461|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5958647|NCT04647461|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5958648|NCT04647461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5958649|NCT04647461|Adrenergic Agents|adrenergic agents|mesh-ancestor
5958650|NCT04647461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5958651|NCT04647461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958652|NCT04647461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958653|NCT04647695|Interferons|interferons|mesh-list
5958654|NCT04647695|Interferon-beta|interferon-beta|mesh-list
5958655|NCT04647695|Remdesivir|remdesivir|mesh-list
5958656|NCT04647695|Interferon beta-1b|interferon beta-1b|mesh-list
5958657|NCT04647695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5958658|NCT04647695|Antiviral Agents|antiviral agents|mesh-ancestor
5958659|NCT04647695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5958660|NCT04647695|Immunologic Factors|immunologic factors|mesh-ancestor
5958661|NCT04647695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958662|NCT04647695|Antimetabolites|antimetabolites|mesh-ancestor
5958663|NCT04647695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958664|NCT04647695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6780032|NCT02182076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5722236|NCT03200613|Protease Inhibitors|protease inhibitors|mesh-ancestor
5722237|NCT03200613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5722238|NCT03200392|Chromium|chromium|mesh-list
5722239|NCT03200392|Trace Elements|trace elements|mesh-ancestor
5722240|NCT03200392|Micronutrients|micronutrients|mesh-ancestor
5722241|NCT03200392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722242|NCT03200093|Vancomycin|vancomycin|mesh-list
5722243|NCT03200093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5722244|NCT03200093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5722245|NCT03200197|Menthol|menthol|mesh-list
5722246|NCT03200197|Antipruritics|antipruritics|mesh-ancestor
5722247|NCT03200197|Dermatologic Agents|dermatologic agents|mesh-ancestor
5722248|NCT03200379|Antiviral Agents|antiviral agents|mesh-list
5722249|NCT03200379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5722250|NCT03200210|Febuxostat|febuxostat|mesh-list
5722251|NCT03200210|Gout Suppressants|gout suppressants|mesh-ancestor
5722252|NCT03200210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5722253|NCT03200080|Amphetamine|amphetamine|mesh-list
5722254|NCT03200080|Dextroamphetamine|dextroamphetamine|mesh-list
5722255|NCT03200080|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5722256|NCT03200080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722257|NCT03200080|Sympathomimetics|sympathomimetics|mesh-ancestor
5722258|NCT03200080|Autonomic Agents|autonomic agents|mesh-ancestor
5722259|NCT03200080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5722260|NCT03200080|Dopamine Agents|dopamine agents|mesh-ancestor
5722261|NCT03200080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5722262|NCT03200080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722263|NCT03200080|Adrenergic Agents|adrenergic agents|mesh-ancestor
5722264|NCT03200080|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5722265|NCT03200080|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6682835|NCT01618448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682836|NCT01618448|Natriuretic Agents|natriuretic agents|mesh-ancestor
6682837|NCT01618448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682838|NCT01618474|Docetaxel|docetaxel|mesh-list
6682839|NCT01618474|Capecitabine|capecitabine|mesh-list
5958665|NCT04647500|Methylphenidate|methylphenidate|mesh-list
5958666|NCT04647500|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5958667|NCT04647500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958668|NCT04647500|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5958669|NCT04647500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5958670|NCT04647500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5958671|NCT04647500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958672|NCT04647500|Dopamine Agents|dopamine agents|mesh-ancestor
5958673|NCT04647500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5958674|NCT04647435|Tramadol|tramadol|mesh-list
5958675|NCT04647435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5958676|NCT04647435|Narcotics|narcotics|mesh-ancestor
5958677|NCT04647435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5958678|NCT04647435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958679|NCT04647435|Analgesics|analgesics|mesh-ancestor
5958680|NCT04647435|Sensory System Agents|sensory system agents|mesh-ancestor
5958681|NCT04647435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5958682|NCT04647552|Hydrocortisone|hydrocortisone|mesh-list
5958683|NCT04647552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5958684|NCT04647344|Paclitaxel|paclitaxel|mesh-list
5958685|NCT04647344|Carboplatin|carboplatin|mesh-list
5958686|NCT04647344|Pemetrexed|pemetrexed|mesh-list
6682840|NCT01618474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6682841|NCT01618474|Tubulin Modulators|tubulin modulators|mesh-ancestor
6682842|NCT01618474|Antimitotic Agents|antimitotic agents|mesh-ancestor
6682843|NCT01618474|Mitosis Modulators|mitosis modulators|mesh-ancestor
6682844|NCT01618474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682845|NCT01618474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6682846|NCT01618474|Antimetabolites|antimetabolites|mesh-ancestor
6682847|NCT01618513|Octreotide|octreotide|mesh-list
6682848|NCT01618513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6682849|NCT01618513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6682850|NCT01618513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6682851|NCT01618539|Propofol|propofol|mesh-list
6682852|NCT01618539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6682853|NCT01618539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6682854|NCT01618539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682855|NCT01618539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6682856|NCT01618539|Anesthetics, General|anesthetics, general|mesh-ancestor
6682857|NCT01618539|Anesthetics|anesthetics|mesh-ancestor
6682858|NCT01618591|Azithromycin|azithromycin|mesh-list
6682859|NCT01618591|Levofloxacin|levofloxacin|mesh-list
6682860|NCT01618591|Ofloxacin|ofloxacin|mesh-list
6682861|NCT01618591|Rifaximin|rifaximin|mesh-list
5958687|NCT04647344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5958688|NCT04647344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5958689|NCT04647344|Tubulin Modulators|tubulin modulators|mesh-ancestor
5958690|NCT04647344|Antimitotic Agents|antimitotic agents|mesh-ancestor
5958691|NCT04647344|Mitosis Modulators|mitosis modulators|mesh-ancestor
5958692|NCT04647344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958693|NCT04647344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5958694|NCT04647344|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5958695|NCT04647344|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5958696|NCT04647292|Antihypertensive Agents|antihypertensive agents|mesh-list
5958697|NCT04646837|Paclitaxel|paclitaxel|mesh-list
5958698|NCT04646837|Carboplatin|carboplatin|mesh-list
5958699|NCT04646837|Durvalumab|durvalumab|mesh-list
6682862|NCT01618591|Loperamide|loperamide|mesh-list
6682863|NCT01618591|Antidiarrheals|antidiarrheals|mesh-list
6682864|NCT01618591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5958700|NCT04646837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5958701|NCT04646837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5958702|NCT04646837|Tubulin Modulators|tubulin modulators|mesh-ancestor
5958703|NCT04646837|Antimitotic Agents|antimitotic agents|mesh-ancestor
5958704|NCT04646837|Mitosis Modulators|mitosis modulators|mesh-ancestor
5958705|NCT04646837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958706|NCT04646837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6682865|NCT01618591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6682866|NCT01618591|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6682867|NCT01618591|Renal Agents|renal agents|mesh-ancestor
6682868|NCT01618591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6682869|NCT01618591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6682870|NCT01618591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6682871|NCT01618591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958707|NCT04646876|Magnesium Sulfate|magnesium sulfate|mesh-list
5958708|NCT04646876|Analgesics|analgesics|mesh-ancestor
5958709|NCT04646876|Sensory System Agents|sensory system agents|mesh-ancestor
5958710|NCT04646876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5958711|NCT04646876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682872|NCT01618591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6682873|NCT01618591|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6682874|NCT01618591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6682875|NCT01618591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6682876|NCT01618643|Acetic Acid|acetic acid|mesh-list
6682877|NCT01618643|Retinol acetate|retinol acetate|mesh-list
6682878|NCT01618643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6682879|NCT01618643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6682880|NCT01618643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6682881|NCT01618643|Immunologic Factors|immunologic factors|mesh-ancestor
6682882|NCT01618643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682883|NCT01618643|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6682884|NCT01618643|Protective Agents|protective agents|mesh-ancestor
6682885|NCT01618643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6682886|NCT01618760|Risperidone|risperidone|mesh-list
6682887|NCT01618760|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6682888|NCT01618760|Serotonin Agents|serotonin agents|mesh-ancestor
5958712|NCT04646876|Anesthetics|anesthetics|mesh-ancestor
5958713|NCT04646876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5958714|NCT04646876|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5958715|NCT04646876|Anticonvulsants|anticonvulsants|mesh-ancestor
5958716|NCT04646876|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5958717|NCT04646876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5958718|NCT04646876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958719|NCT04646876|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5958720|NCT04646876|Tocolytic Agents|tocolytic agents|mesh-ancestor
5958721|NCT04646876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5958722|NCT04647110|Crizotinib|crizotinib|mesh-list
5958723|NCT04647110|Ceritinib|ceritinib|mesh-list
5958724|NCT04647110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5958725|NCT04647110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5958726|NCT04647110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5958727|NCT04647110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958728|NCT04646824|Pemetrexed|pemetrexed|mesh-list
5958729|NCT04646824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5958730|NCT04646824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5958731|NCT04646824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958732|NCT04646824|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5958733|NCT04646824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5958734|NCT04646707|Lidocaine|lidocaine|mesh-list
5958735|NCT04646707|Bupivacaine|bupivacaine|mesh-list
5958736|NCT04646707|Anesthetics, Local|anesthetics, local|mesh-ancestor
5958737|NCT04646707|Anesthetics|anesthetics|mesh-ancestor
5958738|NCT04646707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5958739|NCT04646707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958740|NCT04646707|Sensory System Agents|sensory system agents|mesh-ancestor
5958741|NCT04646707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5958742|NCT04646707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5958743|NCT04646707|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5958744|NCT04646707|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5958745|NCT04646707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5958746|NCT04646707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958747|NCT04646759|Capecitabine|capecitabine|mesh-list
5958748|NCT04646759|Fulvestrant|fulvestrant|mesh-list
5958749|NCT04646759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5958750|NCT04646759|Antimetabolites|antimetabolites|mesh-ancestor
5958751|NCT04646759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958752|NCT04646759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5958753|NCT04646759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5958754|NCT04646759|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5958755|NCT04646759|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5958756|NCT04646759|Hormone Antagonists|hormone antagonists|mesh-ancestor
5958757|NCT04646759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5958758|NCT04646759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958759|NCT04646694|Ketamine|ketamine|mesh-list
6682889|NCT01618760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5958760|NCT04646694|Analgesics|analgesics|mesh-ancestor
5958761|NCT04646694|Sensory System Agents|sensory system agents|mesh-ancestor
5958762|NCT04646694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5958763|NCT04646694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958764|NCT04646694|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5958765|NCT04646694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5958766|NCT04646694|Anesthetics, General|anesthetics, general|mesh-ancestor
5958767|NCT04646694|Anesthetics|anesthetics|mesh-ancestor
5958768|NCT04646694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5958769|NCT04646694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5958770|NCT04646694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5958771|NCT04646694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5958772|NCT04646694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958773|NCT04646317|Dexmedetomidine|dexmedetomidine|mesh-list
5958774|NCT04646317|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5958775|NCT04646317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5958776|NCT04646317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958777|NCT04646317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5958778|NCT04646317|Analgesics|analgesics|mesh-ancestor
5958779|NCT04646317|Sensory System Agents|sensory system agents|mesh-ancestor
5958780|NCT04646317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6682890|NCT01618760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682891|NCT01618760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958781|NCT04646317|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5958782|NCT04646317|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5958783|NCT04646317|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5958784|NCT04646317|Adrenergic Agents|adrenergic agents|mesh-ancestor
5958785|NCT04646317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5958786|NCT04646317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958787|NCT04646161|Misoprostol|misoprostol|mesh-list
5958788|NCT04646161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5958789|NCT04646161|Abortifacient Agents|abortifacient agents|mesh-ancestor
5958790|NCT04646161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5958791|NCT04646161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958792|NCT04646161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5958793|NCT04646161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5958794|NCT04646161|Oxytocics|oxytocics|mesh-ancestor
5958795|NCT04646135|Lorazepam|lorazepam|mesh-list
5958796|NCT04646135|Anticonvulsants|anticonvulsants|mesh-ancestor
5958797|NCT04646135|Antiemetics|antiemetics|mesh-ancestor
6682892|NCT01618760|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6682893|NCT01618760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6682894|NCT01618760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6682895|NCT01618760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6682896|NCT01618760|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6682897|NCT01618760|Dopamine Agents|dopamine agents|mesh-ancestor
6682898|NCT01618773|Adapalene|adapalene|mesh-list
5958798|NCT04646135|Autonomic Agents|autonomic agents|mesh-ancestor
5958799|NCT04646135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5958800|NCT04646135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958801|NCT04646135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5958802|NCT04646135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5958803|NCT04646135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5958804|NCT04646135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5958805|NCT04646135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5958806|NCT04646135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5958807|NCT04646135|GABA Modulators|gaba modulators|mesh-ancestor
5958808|NCT04646135|GABA Agents|gaba agents|mesh-ancestor
5958809|NCT04646135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5958810|NCT04646135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958811|NCT04645914|Nicotine|nicotine|mesh-list
5958812|NCT04645914|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5958813|NCT04645914|Autonomic Agents|autonomic agents|mesh-ancestor
5958814|NCT04645914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5958815|NCT04645914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958816|NCT04645914|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5958817|NCT04645914|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6518393|NCT00726726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6518394|NCT00726726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6518395|NCT00726726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6518396|NCT00726726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6518397|NCT00726726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6518398|NCT00726726|Anesthetics, General|anesthetics, general|mesh-ancestor
6518399|NCT00726726|Anesthetics|anesthetics|mesh-ancestor
5958818|NCT04645914|Cholinergic Agents|cholinergic agents|mesh-ancestor
5958819|NCT04645914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5958820|NCT04645914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969980|NCT04539223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5969981|NCT04539223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5969982|NCT04539223|Antimetabolites|antimetabolites|mesh-ancestor
5969983|NCT04539223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969984|NCT04539223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5969985|NCT04539249|Magnesium Sulfate|magnesium sulfate|mesh-list
5969986|NCT04539249|Pentazocine|pentazocine|mesh-list
5969987|NCT04539249|Analgesics|analgesics|mesh-ancestor
5969988|NCT04539249|Sensory System Agents|sensory system agents|mesh-ancestor
5969989|NCT04539249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5969990|NCT04539249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5969991|NCT04539249|Anesthetics|anesthetics|mesh-ancestor
5969992|NCT04539249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5969993|NCT04539249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5969994|NCT04539249|Anticonvulsants|anticonvulsants|mesh-ancestor
5969995|NCT04539249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5969996|NCT04539249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5969997|NCT04539249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5969998|NCT04539249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5969999|NCT04539249|Tocolytic Agents|tocolytic agents|mesh-ancestor
5970000|NCT04539249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5970001|NCT04539249|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5970002|NCT04539249|Narcotics|narcotics|mesh-ancestor
5970003|NCT04539249|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5970004|NCT04539249|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5970005|NCT04539119|Tenofovir|tenofovir|mesh-list
5970006|NCT04539119|Entecavir|entecavir|mesh-list
5970007|NCT04539119|Antiviral Agents|antiviral agents|mesh-ancestor
5970008|NCT04539119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5970009|NCT04539119|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5970010|NCT04539119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6518400|NCT00726726|GABA Modulators|gaba modulators|mesh-ancestor
6518401|NCT00726726|GABA Agents|gaba agents|mesh-ancestor
6518402|NCT00726726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6518403|NCT00726726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682899|NCT01618773|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6682900|NCT01618773|Dermatologic Agents|dermatologic agents|mesh-ancestor
6682901|NCT01618773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6682902|NCT01618773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6682903|NCT01618773|Analgesics|analgesics|mesh-ancestor
6682904|NCT01618773|Sensory System Agents|sensory system agents|mesh-ancestor
6682905|NCT01618773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6682906|NCT01618773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682907|NCT01618773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6682908|NCT01618773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6682909|NCT01618799|Lamotrigine|lamotrigine|mesh-list
6682910|NCT01618799|Anticonvulsants|anticonvulsants|mesh-list
6682911|NCT01618799|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6682912|NCT01618799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6682913|NCT01618799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682914|NCT01618799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6682915|NCT01618799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970011|NCT04539119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5970012|NCT04539119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970013|NCT04539119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5970014|NCT04539119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5970015|NCT04539379|Magnesium Sulfate|magnesium sulfate|mesh-list
5970016|NCT04539379|Analgesics|analgesics|mesh-ancestor
5970017|NCT04539379|Sensory System Agents|sensory system agents|mesh-ancestor
5970018|NCT04539379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5970019|NCT04539379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970020|NCT04539379|Anesthetics|anesthetics|mesh-ancestor
6518404|NCT00726726|Anticoagulants|anticoagulants|mesh-ancestor
6518405|NCT00726726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6518406|NCT00726726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6518407|NCT00726726|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6518408|NCT00726726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6518409|NCT00726726|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6518410|NCT00726726|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6518411|NCT00726726|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6518412|NCT00726726|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5958821|NCT04645823|Lidocaine|lidocaine|mesh-list
5958822|NCT04645823|Fentanyl|fentanyl|mesh-list
5958823|NCT04645823|Citric Acid|citric acid|mesh-list
5958824|NCT04645823|Sodium Citrate|sodium citrate|mesh-list
5958825|NCT04645823|Anesthetics, Local|anesthetics, local|mesh-ancestor
5958826|NCT04645823|Anesthetics|anesthetics|mesh-ancestor
5958827|NCT04645823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5958828|NCT04645823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518413|NCT00726726|Purinergic Agents|purinergic agents|mesh-ancestor
6518414|NCT00726726|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6518415|NCT00726726|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6518416|NCT00726726|Hemostatics|hemostatics|mesh-ancestor
6518417|NCT00726726|Coagulants|coagulants|mesh-ancestor
6518418|NCT00726726|Antitussive Agents|antitussive agents|mesh-ancestor
6518419|NCT00726726|Respiratory System Agents|respiratory system agents|mesh-ancestor
5958829|NCT04645823|Sensory System Agents|sensory system agents|mesh-ancestor
6518420|NCT00726726|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6518421|NCT00726726|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6518422|NCT00726804|Adalimumab|adalimumab|mesh-list
6518423|NCT00726804|Etanercept|etanercept|mesh-list
6518424|NCT00726804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6518425|NCT00726804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6518426|NCT00726804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6518427|NCT00726804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5958830|NCT04645823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5958831|NCT04645823|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5958832|NCT04645823|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5958833|NCT04645823|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5958834|NCT04645823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5958835|NCT04645823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958836|NCT04645823|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5958837|NCT04645823|Narcotics|narcotics|mesh-ancestor
5958838|NCT04645823|Analgesics|analgesics|mesh-ancestor
5958839|NCT04645823|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5958840|NCT04645823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5958841|NCT04645823|Anesthetics, General|anesthetics, general|mesh-ancestor
5958842|NCT04645823|Anticoagulants|anticoagulants|mesh-ancestor
5958843|NCT04645823|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5958844|NCT04645823|Chelating Agents|chelating agents|mesh-ancestor
5958845|NCT04645823|Sequestering Agents|sequestering agents|mesh-ancestor
5958846|NCT04646109|Azithromycin|azithromycin|mesh-list
5958847|NCT04646109|Hydroxychloroquine|hydroxychloroquine|mesh-list
5958848|NCT04646109|Ivermectin|ivermectin|mesh-list
5958849|NCT04646109|Favipiravir|favipiravir|mesh-list
5958850|NCT04646109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5958851|NCT04646109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5958852|NCT04646109|Antimalarials|antimalarials|mesh-ancestor
5958853|NCT04646109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5958854|NCT04646109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5958855|NCT04646109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5958856|NCT04646109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958857|NCT04646109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5958858|NCT04646109|Antiviral Agents|antiviral agents|mesh-ancestor
5958859|NCT04645940|Rabeprazole|rabeprazole|mesh-list
5958860|NCT04645940|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5958861|NCT04645940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5958862|NCT04645940|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5958863|NCT04645940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5958864|NCT04645940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958865|NCT04646187|Adalimumab|adalimumab|mesh-list
5958866|NCT04646187|Infliximab|infliximab|mesh-list
6518428|NCT00726804|Analgesics|analgesics|mesh-ancestor
6518429|NCT00726804|Sensory System Agents|sensory system agents|mesh-ancestor
6518430|NCT00726804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6518431|NCT00726804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518432|NCT00726804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6518433|NCT00726804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6518434|NCT00726804|Immunologic Factors|immunologic factors|mesh-ancestor
6518435|NCT00726869|Elotuzumab|elotuzumab|mesh-list
6518436|NCT00726869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6518437|NCT00726960|Buprenorphine|buprenorphine|mesh-list
6518438|NCT00726960|Aprepitant|aprepitant|mesh-list
6518439|NCT00726960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6518440|NCT00726960|Narcotics|narcotics|mesh-ancestor
6518441|NCT00726960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6518442|NCT00726960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958867|NCT04646187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5958868|NCT04646187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5958869|NCT04646187|Dermatologic Agents|dermatologic agents|mesh-ancestor
5958870|NCT04646187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5958871|NCT04645589|Mycophenolic Acid|mycophenolic acid|mesh-list
5958872|NCT04645589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5958873|NCT04645589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5958874|NCT04645589|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5958875|NCT04645589|Antitubercular Agents|antitubercular agents|mesh-ancestor
5958876|NCT04645589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5958877|NCT04645589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6682916|NCT01618799|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6682917|NCT01618799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6682918|NCT01618799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6682919|NCT01618799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6518443|NCT00726960|Analgesics|analgesics|mesh-ancestor
6518444|NCT00726960|Sensory System Agents|sensory system agents|mesh-ancestor
6518445|NCT00726960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5958878|NCT04645589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5958879|NCT04645589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958880|NCT04645745|Folic Acid|folic acid|mesh-list
5958881|NCT04645745|Inositol|inositol|mesh-list
5958882|NCT04645745|Hematinics|hematinics|mesh-ancestor
5958883|NCT04645745|Vitamin B Complex|vitamin b complex|mesh-ancestor
5958884|NCT04645745|Vitamins|vitamins|mesh-ancestor
5958885|NCT04645745|Micronutrients|micronutrients|mesh-ancestor
5958886|NCT04645745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958887|NCT04645719|Magnesium Sulfate|magnesium sulfate|mesh-list
5958888|NCT04645719|Analgesics|analgesics|mesh-ancestor
5958889|NCT04645719|Sensory System Agents|sensory system agents|mesh-ancestor
5958890|NCT04645719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5958891|NCT04645719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958892|NCT04645719|Anesthetics|anesthetics|mesh-ancestor
5958893|NCT04645719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5958894|NCT04645719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5958895|NCT04645719|Anticonvulsants|anticonvulsants|mesh-ancestor
5958896|NCT04645719|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5958897|NCT04645719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5958898|NCT04645719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958899|NCT04645719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5958900|NCT04645719|Tocolytic Agents|tocolytic agents|mesh-ancestor
5958901|NCT04645719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5958902|NCT04645004|Aspirin|aspirin|mesh-list
5958903|NCT04645004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5958904|NCT04645004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5958905|NCT04645004|Analgesics|analgesics|mesh-ancestor
5958906|NCT04645004|Sensory System Agents|sensory system agents|mesh-ancestor
5958907|NCT04645004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5958908|NCT04645004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958909|NCT04645004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5958910|NCT04645004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5958911|NCT04645004|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5958912|NCT04645004|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5958913|NCT04645004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958914|NCT04645004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5958915|NCT04645004|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5958916|NCT04645004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5958917|NCT04645004|Antipyretics|antipyretics|mesh-ancestor
5958918|NCT04645303|Triamcinolone|triamcinolone|mesh-list
5958919|NCT04645303|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5958920|NCT04645303|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5958921|NCT04645303|Hyaluronic Acid|hyaluronic acid|mesh-list
5958922|NCT04645303|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5958923|NCT04645303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5958924|NCT04645303|Glucocorticoids|glucocorticoids|mesh-ancestor
5958925|NCT04645303|Hormones|hormones|mesh-ancestor
5958926|NCT04645303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5958927|NCT04645303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958928|NCT04645303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5958929|NCT04645303|Immunologic Factors|immunologic factors|mesh-ancestor
5958930|NCT04645303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5958931|NCT04645303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958932|NCT04645303|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5958933|NCT04645303|Viscosupplements|viscosupplements|mesh-ancestor
5958934|NCT04645303|Protective Agents|protective agents|mesh-ancestor
5958935|NCT04644627|Gentamicins|gentamicins|mesh-list
5958936|NCT04644627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5958937|NCT04644627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5958938|NCT04644627|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5958939|NCT04644627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5958940|NCT04644627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958941|NCT04644341|Respiratory System Agents|respiratory system agents|mesh-list
5958942|NCT04644484|Vaccines|vaccines|mesh-list
6682920|NCT01618799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6682921|NCT01618825|Lamotrigine|lamotrigine|mesh-list
6682922|NCT01618825|Anticonvulsants|anticonvulsants|mesh-list
6682923|NCT01618825|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6682924|NCT01618825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6682925|NCT01618825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958943|NCT04644484|Immunoglobulins|immunoglobulins|mesh-list
5958944|NCT04644484|Immunologic Factors|immunologic factors|mesh-ancestor
5958945|NCT04644484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958946|NCT04644354|Nifedipine|nifedipine|mesh-list
5958947|NCT04644354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5958948|NCT04644354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5958949|NCT04644354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5958950|NCT04644354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5958951|NCT04644354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682926|NCT01618825|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6682927|NCT01618825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682928|NCT01618825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6682929|NCT01618825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6682930|NCT01618825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6682931|NCT01618825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6682932|NCT01618825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6682933|NCT01618877|Levetiracetam|levetiracetam|mesh-list
6682934|NCT01618877|Anticonvulsants|anticonvulsants|mesh-ancestor
5958952|NCT04644354|Vasodilator Agents|vasodilator agents|mesh-ancestor
6682935|NCT01618877|Nootropic Agents|nootropic agents|mesh-ancestor
6682936|NCT01618890|Propranolol|propranolol|mesh-list
6682937|NCT01618890|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6682938|NCT01618890|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6682939|NCT01618890|Adrenergic Agents|adrenergic agents|mesh-ancestor
6682940|NCT01618890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6682941|NCT01618890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682942|NCT01618890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958953|NCT04644354|Tocolytic Agents|tocolytic agents|mesh-ancestor
5958954|NCT04644354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5958955|NCT04644250|Paclitaxel|paclitaxel|mesh-list
5958956|NCT04644250|Carboplatin|carboplatin|mesh-list
5958957|NCT04644250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6682943|NCT01618890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6682944|NCT01618890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6682945|NCT01618890|Vasodilator Agents|vasodilator agents|mesh-ancestor
6682946|NCT01618903|Levetiracetam|levetiracetam|mesh-list
6682947|NCT01618903|Anticonvulsants|anticonvulsants|mesh-ancestor
6682948|NCT01618903|Nootropic Agents|nootropic agents|mesh-ancestor
6682949|NCT01618929|Montelukast|montelukast|mesh-list
6682950|NCT01618929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6682951|NCT01618929|Respiratory System Agents|respiratory system agents|mesh-ancestor
6682952|NCT01618929|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6682953|NCT01618929|Hormone Antagonists|hormone antagonists|mesh-ancestor
6682954|NCT01618929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6682955|NCT01618929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682956|NCT01618929|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6682957|NCT01618929|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5958958|NCT04644250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5958959|NCT04644250|Tubulin Modulators|tubulin modulators|mesh-ancestor
5958960|NCT04644250|Antimitotic Agents|antimitotic agents|mesh-ancestor
5958961|NCT04644250|Mitosis Modulators|mitosis modulators|mesh-ancestor
5958962|NCT04644250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970021|NCT04539379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5970022|NCT04539379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5970023|NCT04539379|Anticonvulsants|anticonvulsants|mesh-ancestor
5970024|NCT04539379|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5970025|NCT04539379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5970026|NCT04539379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970027|NCT04539379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5970028|NCT04539379|Tocolytic Agents|tocolytic agents|mesh-ancestor
5970029|NCT04539379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5970030|NCT04539106|Ranibizumab|ranibizumab|mesh-list
5958963|NCT04644289|Durvalumab|durvalumab|mesh-list
5958964|NCT04644289|Olaparib|olaparib|mesh-list
5958965|NCT04644289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5958966|NCT04644289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5958967|NCT04644289|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5958968|NCT04644289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5958969|NCT04644289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518446|NCT00726960|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6518447|NCT00726960|Antiemetics|antiemetics|mesh-ancestor
6518448|NCT00726960|Autonomic Agents|autonomic agents|mesh-ancestor
6518449|NCT00726960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6518450|NCT00726960|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6518451|NCT00726960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6518452|NCT00726960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518453|NCT00726973|Ranibizumab|ranibizumab|mesh-list
6518454|NCT00726973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6518455|NCT00726973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6518456|NCT00726973|Growth Substances|growth substances|mesh-ancestor
6518457|NCT00726973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518458|NCT00726973|Growth Inhibitors|growth inhibitors|mesh-ancestor
6518459|NCT00726973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6518460|NCT00727038|Ranibizumab|ranibizumab|mesh-list
6518461|NCT00727038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6518462|NCT00727038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6518463|NCT00727038|Growth Substances|growth substances|mesh-ancestor
6518464|NCT00727038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518465|NCT00727038|Growth Inhibitors|growth inhibitors|mesh-ancestor
6518466|NCT00727038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6518467|NCT00727077|Interferons|interferons|mesh-list
6682958|NCT01618929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682959|NCT01619007|Rivaroxaban|rivaroxaban|mesh-list
6682960|NCT01619007|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6682961|NCT01619007|Antithrombins|antithrombins|mesh-ancestor
6682962|NCT01619007|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6682963|NCT01619007|Protease Inhibitors|protease inhibitors|mesh-ancestor
6682964|NCT01619007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6682965|NCT01619007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682966|NCT01619007|Anticoagulants|anticoagulants|mesh-ancestor
6682967|NCT01619046|Factor VIII|factor viii|mesh-list
6682968|NCT01619046|Coagulants|coagulants|mesh-ancestor
6682969|NCT01619072|Misoprostol|misoprostol|mesh-list
5958970|NCT04644094|Dexamethasone|dexamethasone|mesh-list
5958971|NCT04644094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5958972|NCT04644094|Antiemetics|antiemetics|mesh-ancestor
5958973|NCT04644094|Autonomic Agents|autonomic agents|mesh-ancestor
5958974|NCT04644094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5958975|NCT04644094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958976|NCT04644094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5958977|NCT04644094|Glucocorticoids|glucocorticoids|mesh-ancestor
5958978|NCT04644094|Hormones|hormones|mesh-ancestor
6682970|NCT01619072|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6682971|NCT01619072|Abortifacient Agents|abortifacient agents|mesh-ancestor
6682972|NCT01619072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6682973|NCT01619072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682974|NCT01619072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6682975|NCT01619072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6682976|NCT01619072|Oxytocics|oxytocics|mesh-ancestor
6682977|NCT01619111|Lapatinib|lapatinib|mesh-list
6682978|NCT01619111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6682979|NCT01619111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6682980|NCT01619111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6682981|NCT01619111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6682982|NCT01619137|Povidone-Iodine|povidone-iodine|mesh-list
6682983|NCT01619137|Povidone|povidone|mesh-list
6682984|NCT01619137|Plasma Substitutes|plasma substitutes|mesh-ancestor
6682985|NCT01619137|Blood Substitutes|blood substitutes|mesh-ancestor
6682986|NCT01619137|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6682987|NCT01619137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6682988|NCT01619150|Etoricoxib|etoricoxib|mesh-list
5958979|NCT04644094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5958980|NCT04644094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5958981|NCT04644094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5958982|NCT04643925|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
5958983|NCT04643925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6682989|NCT01619150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6682990|NCT01619150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5958984|NCT04643925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958985|NCT04644185|Myeloma Proteins|myeloma proteins|mesh-list
5958986|NCT04644185|Paraproteins|paraproteins|mesh-list
5958987|NCT04644185|Immunologic Factors|immunologic factors|mesh-ancestor
5958988|NCT04644185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5958989|NCT04644406|Trastuzumab|trastuzumab|mesh-list
5958990|NCT04644406|Pertuzumab|pertuzumab|mesh-list
5958991|NCT04644406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5958992|NCT04644406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5958993|NCT04643821|Calcitriol|calcitriol|mesh-list
5958994|NCT04643821|Acetylcysteine|acetylcysteine|mesh-list
5958995|NCT04643821|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5958996|NCT04643821|Antiviral Agents|antiviral agents|mesh-ancestor
5958997|NCT04643821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5958998|NCT04643821|Expectorants|expectorants|mesh-ancestor
5958999|NCT04643821|Respiratory System Agents|respiratory system agents|mesh-ancestor
6682991|NCT01619150|Analgesics|analgesics|mesh-ancestor
6682992|NCT01619150|Sensory System Agents|sensory system agents|mesh-ancestor
6682993|NCT01619150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6682994|NCT01619150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6682995|NCT01619150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6682996|NCT01619150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6682997|NCT01619150|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6682998|NCT01619150|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6682999|NCT01619150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6683000|NCT01619150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683001|NCT01619163|Prednisolone|prednisolone|mesh-list
5959000|NCT04643821|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5959001|NCT04643821|Antioxidants|antioxidants|mesh-ancestor
6683002|NCT01619163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6683003|NCT01619163|Glucocorticoids|glucocorticoids|mesh-ancestor
6683004|NCT01619163|Hormones|hormones|mesh-ancestor
6683005|NCT01619163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6683006|NCT01619163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683007|NCT01619163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6683008|NCT01619163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6683009|NCT01619176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
5959002|NCT04643821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959003|NCT04643821|Protective Agents|protective agents|mesh-ancestor
5959004|NCT04643821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959005|NCT04643821|Antidotes|antidotes|mesh-ancestor
5959006|NCT04643821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5959007|NCT04643821|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
5959008|NCT04643821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5959009|NCT04643821|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5959010|NCT04643821|Vitamins|vitamins|mesh-ancestor
5959011|NCT04643821|Micronutrients|micronutrients|mesh-ancestor
5959012|NCT04643821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5959013|NCT04644016|Cyclosporine|cyclosporine|mesh-list
5959014|NCT04644016|Mycophenolic Acid|mycophenolic acid|mesh-list
5959015|NCT04644016|Fludarabine|fludarabine|mesh-list
5959016|NCT04644016|Busulfan|busulfan|mesh-list
5959017|NCT04644016|Clofarabine|clofarabine|mesh-list
5959018|NCT04644016|Cyclosporins|cyclosporins|mesh-list
5959019|NCT04644016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5959020|NCT04644016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5959021|NCT04644016|Antimetabolites|antimetabolites|mesh-ancestor
5959022|NCT04644016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959023|NCT04644016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5959024|NCT04644016|Immunologic Factors|immunologic factors|mesh-ancestor
5959025|NCT04644016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959026|NCT04644016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6518468|NCT00727077|Ribavirin|ribavirin|mesh-list
6518469|NCT00727077|Interferon-alpha|interferon-alpha|mesh-list
6518470|NCT00727077|Interferon alpha-2|interferon alpha-2|mesh-list
6518471|NCT00727077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6518472|NCT00727077|Antiviral Agents|antiviral agents|mesh-ancestor
6518473|NCT00727077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6518474|NCT00727077|Antimetabolites|antimetabolites|mesh-ancestor
6518475|NCT00727077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518476|NCT00727077|Immunologic Factors|immunologic factors|mesh-ancestor
6518477|NCT00727077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959027|NCT04644016|Antifungal Agents|antifungal agents|mesh-ancestor
5959028|NCT04644016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5959029|NCT04644016|Dermatologic Agents|dermatologic agents|mesh-ancestor
6518478|NCT00727103|Varenicline|varenicline|mesh-list
6518479|NCT00727103|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5959030|NCT04644016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5959031|NCT04644016|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5959032|NCT04644016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5959033|NCT04644016|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5959034|NCT04644016|Antitubercular Agents|antitubercular agents|mesh-ancestor
5959035|NCT04644016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5959036|NCT04644016|Alkylating Agents|alkylating agents|mesh-ancestor
5959037|NCT04644016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5959038|NCT04644016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5959039|NCT04643470|Zanubrutinib|zanubrutinib|mesh-list
5959040|NCT04643470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5959041|NCT04643470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5959042|NCT04643470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5959043|NCT04643470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959044|NCT04643678|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5959045|NCT04643678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5959046|NCT04643691|Losartan|losartan|mesh-list
5959047|NCT04643691|Spironolactone|spironolactone|mesh-list
5959048|NCT04643691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5959049|NCT04643691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5959050|NCT04643691|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5959051|NCT04643691|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5959052|NCT04643691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959053|NCT04643691|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5959054|NCT04643691|Hormone Antagonists|hormone antagonists|mesh-ancestor
5959055|NCT04643691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5959056|NCT04643691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959057|NCT04643691|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5959058|NCT04643691|Diuretics|diuretics|mesh-ancestor
5959059|NCT04643691|Natriuretic Agents|natriuretic agents|mesh-ancestor
5959060|NCT04643483|Adalimumab|adalimumab|mesh-list
5959061|NCT04643483|Certolizumab Pegol|certolizumab pegol|mesh-list
5959062|NCT04643483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5959063|NCT04643483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5959064|NCT04643483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5959065|NCT04643483|Immunologic Factors|immunologic factors|mesh-ancestor
5959066|NCT04643483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959067|NCT04643327|Levetiracetam|levetiracetam|mesh-list
5959068|NCT04643327|Anticonvulsants|anticonvulsants|mesh-ancestor
5959069|NCT04643327|Nootropic Agents|nootropic agents|mesh-ancestor
5959070|NCT04643132|Ketamine|ketamine|mesh-list
5959071|NCT04643132|Esketamine|esketamine|mesh-list
5959072|NCT04643132|Analgesics|analgesics|mesh-ancestor
5959073|NCT04643132|Sensory System Agents|sensory system agents|mesh-ancestor
5959074|NCT04643132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5959075|NCT04643132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959076|NCT04643132|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5959077|NCT04643132|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5959078|NCT04643132|Anesthetics, General|anesthetics, general|mesh-ancestor
5959079|NCT04643132|Anesthetics|anesthetics|mesh-ancestor
5959080|NCT04643132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5959081|NCT04643132|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5959082|NCT04643132|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5959083|NCT04643132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5959084|NCT04643132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959085|NCT04643132|Antidepressive Agents|antidepressive agents|mesh-ancestor
5959086|NCT04643132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5959087|NCT04643301|Liraglutide|liraglutide|mesh-list
5959088|NCT04643301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5959089|NCT04643301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959090|NCT04643301|Incretins|incretins|mesh-ancestor
5959091|NCT04643301|Hormones|hormones|mesh-ancestor
5959092|NCT04643301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5959093|NCT04642989|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5959094|NCT04642989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5959095|NCT04643093|Ezetimibe|ezetimibe|mesh-list
5959096|NCT04643093|Pitavastatin|pitavastatin|mesh-list
5959097|NCT04643093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5959098|NCT04643093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5959099|NCT04643093|Antimetabolites|antimetabolites|mesh-ancestor
5959100|NCT04643093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518480|NCT00727103|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6518481|NCT00727103|Cholinergic Agents|cholinergic agents|mesh-ancestor
5959101|NCT04643093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5971324|NCT04529226|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6518482|NCT00727103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6683010|NCT01619176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
6683011|NCT01619176|Methotrexate|methotrexate|mesh-list
6683012|NCT01619176|Leflunomide|leflunomide|mesh-list
5959102|NCT04643093|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5959103|NCT04643093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5959104|NCT04643106|Hemostatics|hemostatics|mesh-list
5959105|NCT04643106|Coagulants|coagulants|mesh-ancestor
5959106|NCT04642846|Fluorides|fluorides|mesh-list
5959107|NCT04642846|Cariostatic Agents|cariostatic agents|mesh-ancestor
5959108|NCT04642846|Protective Agents|protective agents|mesh-ancestor
5959109|NCT04642846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959110|NCT04642664|Apatinib|apatinib|mesh-list
5959111|NCT04642664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5959112|NCT04642664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5959113|NCT04642664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5959114|NCT04642664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683013|NCT01619176|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6683014|NCT01619176|Abortifacient Agents|abortifacient agents|mesh-ancestor
6683015|NCT01619176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5959115|NCT04642807|Calpastatin|calpastatin|mesh-list
5959116|NCT04642807|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
5959117|NCT04642807|Protease Inhibitors|protease inhibitors|mesh-ancestor
5959118|NCT04642807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5959119|NCT04642807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959120|NCT04642651|Dexmedetomidine|dexmedetomidine|mesh-list
5959121|NCT04642651|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5959122|NCT04642651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5959123|NCT04642651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959124|NCT04642651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5959125|NCT04642651|Analgesics|analgesics|mesh-ancestor
5959126|NCT04642651|Sensory System Agents|sensory system agents|mesh-ancestor
5959127|NCT04642651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5959128|NCT04642651|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5959129|NCT04642651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5959130|NCT04642651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5959131|NCT04642651|Adrenergic Agents|adrenergic agents|mesh-ancestor
5959132|NCT04642651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5959133|NCT04642651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959134|NCT04642547|Gefitinib|gefitinib|mesh-list
5959135|NCT04642547|Lenvatinib|lenvatinib|mesh-list
5959136|NCT04642547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5959137|NCT04642547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5959138|NCT04642547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5959139|NCT04642547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970031|NCT04539106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5970032|NCT04539106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5970033|NCT04539106|Growth Substances|growth substances|mesh-ancestor
5970034|NCT04539106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970035|NCT04539106|Growth Inhibitors|growth inhibitors|mesh-ancestor
5970036|NCT04539106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5970037|NCT04538820|Dexamethasone|dexamethasone|mesh-list
5970038|NCT04538820|Dexamethasone acetate|dexamethasone acetate|mesh-list
5970039|NCT04538820|BB 1101|bb 1101|mesh-list
5970040|NCT04538820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5970041|NCT04538820|Antiemetics|antiemetics|mesh-ancestor
5970042|NCT04538820|Autonomic Agents|autonomic agents|mesh-ancestor
6518483|NCT00727103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970043|NCT04538820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6518484|NCT00727103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518485|NCT00727129|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6518486|NCT00727129|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6518487|NCT00727129|Estradiol|estradiol|mesh-list
6518488|NCT00727129|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6518489|NCT00727129|Estrogens|estrogens|mesh-ancestor
6518490|NCT00727129|Hormones|hormones|mesh-ancestor
6518491|NCT00727129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6518492|NCT00727129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518493|NCT00727129|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6518494|NCT00727129|Contraceptive Agents|contraceptive agents|mesh-ancestor
6518495|NCT00727129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6518496|NCT00727129|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6518497|NCT00727207|Everolimus|everolimus|mesh-list
6518498|NCT00727207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5959140|NCT04642287|Fluorouracil|fluorouracil|mesh-list
5959141|NCT04642287|Calcipotriene|calcipotriene|mesh-list
5959142|NCT04642287|Petrolatum|petrolatum|mesh-list
5959143|NCT04642287|Antimetabolites|antimetabolites|mesh-ancestor
5959144|NCT04642287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959145|NCT04642287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5959146|NCT04642287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5959147|NCT04642287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5959148|NCT04642287|Immunologic Factors|immunologic factors|mesh-ancestor
5959149|NCT04642287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959150|NCT04642287|Dermatologic Agents|dermatologic agents|mesh-ancestor
5959151|NCT04642287|Emollients|emollients|mesh-ancestor
6683016|NCT01619176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683017|NCT01619176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6683018|NCT01619176|Antimetabolites|antimetabolites|mesh-ancestor
6683019|NCT01619176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683020|NCT01619176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6683021|NCT01619176|Dermatologic Agents|dermatologic agents|mesh-ancestor
6683022|NCT01619176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6683023|NCT01619176|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6683024|NCT01619176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6683025|NCT01619176|Immunologic Factors|immunologic factors|mesh-ancestor
6683026|NCT01619176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6683027|NCT01619176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6683028|NCT01619176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6683029|NCT01619176|Analgesics|analgesics|mesh-ancestor
6683030|NCT01619176|Sensory System Agents|sensory system agents|mesh-ancestor
6683031|NCT01619176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5959152|NCT04642261|Empagliflozin|empagliflozin|mesh-list
5959153|NCT04642261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5959154|NCT04642261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959155|NCT04642261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5959156|NCT04642261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959157|NCT04642391|Cosyntropin|cosyntropin|mesh-list
5959158|NCT04642391|Hormones|hormones|mesh-ancestor
5959159|NCT04642391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5959160|NCT04642391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959161|NCT04642404|Cannabidiol|cannabidiol|mesh-list
5959162|NCT04642404|Anticonvulsants|anticonvulsants|mesh-ancestor
5959163|NCT04642131|Caffeine|caffeine|mesh-list
5959164|NCT04642131|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5959165|NCT04642131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959166|NCT04642131|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5959167|NCT04642131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5959168|NCT04642131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959169|NCT04642131|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5959170|NCT04642131|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6518499|NCT00727207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6683032|NCT01619280|Nitroprusside|nitroprusside|mesh-list
6683033|NCT01619280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6683034|NCT01619280|Vasodilator Agents|vasodilator agents|mesh-ancestor
6683035|NCT01619280|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6683036|NCT01619280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683037|NCT01619436|Clonidine|clonidine|mesh-list
6683038|NCT01619436|Analgesics|analgesics|mesh-ancestor
6683039|NCT01619436|Sensory System Agents|sensory system agents|mesh-ancestor
6683040|NCT01619436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6683041|NCT01619436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683042|NCT01619436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6683043|NCT01619436|Sympatholytics|sympatholytics|mesh-ancestor
6683044|NCT01619436|Autonomic Agents|autonomic agents|mesh-ancestor
6683045|NCT01619436|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5959171|NCT04642131|Purinergic Agents|purinergic agents|mesh-ancestor
6518500|NCT00727207|Immunologic Factors|immunologic factors|mesh-ancestor
6518501|NCT00727207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518502|NCT00727233|Sorafenib|sorafenib|mesh-list
6518503|NCT00727233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6518504|NCT00727233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6518505|NCT00727233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6518506|NCT00727233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518507|NCT00727493|Alendronate|alendronate|mesh-list
6518508|NCT00727493|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6518509|NCT00727493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518510|NCT00727545|Chelating Agents|chelating agents|mesh-list
6518511|NCT00727545|Sequestering Agents|sequestering agents|mesh-ancestor
6518512|NCT00727545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518513|NCT00727727|Piribedil|piribedil|mesh-list
5959172|NCT04642131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5959173|NCT04642001|Listerine|listerine|mesh-list
6683046|NCT01619436|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6683047|NCT01619436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6683048|NCT01619436|Adrenergic Agents|adrenergic agents|mesh-ancestor
6683049|NCT01619436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6683050|NCT01619436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683051|NCT01619462|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6683052|NCT01619462|Immunologic Factors|immunologic factors|mesh-ancestor
6683053|NCT01619462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780033|NCT02182076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780034|NCT02182076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780035|NCT02182102|Pemetrexed|pemetrexed|mesh-list
6780036|NCT02182102|Nintedanib|nintedanib|mesh-list
5959174|NCT04642001|Sodium Fluoride|sodium fluoride|mesh-list
5959175|NCT04642001|Cariostatic Agents|cariostatic agents|mesh-ancestor
5959176|NCT04642001|Protective Agents|protective agents|mesh-ancestor
5959177|NCT04642001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959178|NCT04642001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5959179|NCT04642001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5959180|NCT04641780|Brexpiprazole|brexpiprazole|mesh-list
5959181|NCT04641780|Serotonin Agents|serotonin agents|mesh-ancestor
5959182|NCT04641780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5959183|NCT04641780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959184|NCT04641780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959185|NCT04641780|Dopamine Agonists|dopamine agonists|mesh-ancestor
5959186|NCT04641780|Dopamine Agents|dopamine agents|mesh-ancestor
5959187|NCT04641507|Tadalafil|tadalafil|mesh-list
5959188|NCT04641507|Tamsulosin|tamsulosin|mesh-list
5959189|NCT04641507|Vasodilator Agents|vasodilator agents|mesh-ancestor
5959190|NCT04641507|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5959191|NCT04641507|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5959192|NCT04641507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5959193|NCT04641507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959194|NCT04641507|Urological Agents|urological agents|mesh-ancestor
5959195|NCT04641507|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5959196|NCT04641507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5959197|NCT04641507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5959198|NCT04641507|Adrenergic Agents|adrenergic agents|mesh-ancestor
5959199|NCT04641507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5959200|NCT04641507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959201|NCT04641104|Thiamine|thiamine|mesh-list
5959202|NCT04641104|Vitamin B Complex|vitamin b complex|mesh-ancestor
5959203|NCT04641104|Vitamins|vitamins|mesh-ancestor
5959204|NCT04641104|Micronutrients|micronutrients|mesh-ancestor
5959205|NCT04641104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959206|NCT04641338|Dipyrone|dipyrone|mesh-list
5959207|NCT04641338|Codeine|codeine|mesh-list
5959208|NCT04641338|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5959209|NCT04641338|Narcotics|narcotics|mesh-ancestor
5959210|NCT04641338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5959211|NCT04641338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959212|NCT04641338|Analgesics|analgesics|mesh-ancestor
5959213|NCT04641338|Sensory System Agents|sensory system agents|mesh-ancestor
5959214|NCT04641338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5959215|NCT04641338|Antitussive Agents|antitussive agents|mesh-ancestor
5959216|NCT04641338|Respiratory System Agents|respiratory system agents|mesh-ancestor
5959217|NCT04641338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5959218|NCT04641338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6518514|NCT00727727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6518515|NCT00727727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6518516|NCT00727727|Dopamine Agonists|dopamine agonists|mesh-ancestor
6518517|NCT00727727|Dopamine Agents|dopamine agents|mesh-ancestor
6518518|NCT00727727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5959219|NCT04641338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6780037|NCT02182102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6780038|NCT02182102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780039|NCT02182102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780040|NCT02182102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6518519|NCT00727727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518520|NCT00727727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518521|NCT00727753|Bevacizumab|bevacizumab|mesh-list
6518522|NCT00727753|Ranibizumab|ranibizumab|mesh-list
6518523|NCT00727753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6518524|NCT00727753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5959220|NCT04641338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5959221|NCT04641338|Antipyretics|antipyretics|mesh-ancestor
5959222|NCT04641026|Deuterium Oxide|deuterium oxide|mesh-list
6518525|NCT00727753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6518526|NCT00727753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5959223|NCT04641026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5959224|NCT04641026|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5959225|NCT04641026|Protective Agents|protective agents|mesh-ancestor
5959226|NCT04641026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959227|NCT04641234|Aflibercept|aflibercept|mesh-list
5959228|NCT04641234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5959229|NCT04641234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5959230|NCT04641234|Growth Substances|growth substances|mesh-ancestor
5959231|NCT04641234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959232|NCT04641234|Growth Inhibitors|growth inhibitors|mesh-ancestor
5959233|NCT04641234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5959234|NCT04641351|Triamcinolone|triamcinolone|mesh-list
5959235|NCT04641351|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5959236|NCT04641351|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5959237|NCT04641351|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5959238|NCT04641351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5959239|NCT04641351|Glucocorticoids|glucocorticoids|mesh-ancestor
5959240|NCT04641351|Hormones|hormones|mesh-ancestor
5959241|NCT04641351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5959242|NCT04641351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959243|NCT04641351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5959244|NCT04641351|Immunologic Factors|immunologic factors|mesh-ancestor
5959245|NCT04641351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5959246|NCT04641351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959247|NCT04641247|Niraparib|niraparib|mesh-list
5959248|NCT04641247|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5959249|NCT04641247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5959250|NCT04641247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959251|NCT04641247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5959252|NCT04640870|Afatinib|afatinib|mesh-list
5959253|NCT04640870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5959254|NCT04640870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5959255|NCT04640870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5959256|NCT04640870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959257|NCT04640896|Lidocaine|lidocaine|mesh-list
5959258|NCT04640896|Bupivacaine|bupivacaine|mesh-list
5959259|NCT04640896|Anesthetics, Local|anesthetics, local|mesh-ancestor
6518527|NCT00727753|Growth Substances|growth substances|mesh-ancestor
6518528|NCT00727753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518529|NCT00727753|Growth Inhibitors|growth inhibitors|mesh-ancestor
6518530|NCT00727766|Clofarabine|clofarabine|mesh-list
6518531|NCT00727766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6518532|NCT00727766|Antimetabolites|antimetabolites|mesh-ancestor
6518533|NCT00727766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518534|NCT00727766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5959260|NCT04640896|Anesthetics|anesthetics|mesh-ancestor
5959261|NCT04640896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5959262|NCT04640896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959263|NCT04640896|Sensory System Agents|sensory system agents|mesh-ancestor
5959264|NCT04640896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5959265|NCT04640896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5959266|NCT04640896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5959267|NCT04640896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5959268|NCT04640896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5959269|NCT04640896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959270|NCT04640883|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
5959271|NCT04640883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5959272|NCT04640883|Immunologic Factors|immunologic factors|mesh-ancestor
5959273|NCT04640883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518535|NCT00727831|Leucovorin|leucovorin|mesh-list
6518536|NCT00727831|Methotrexate|methotrexate|mesh-list
6518537|NCT00727831|Calcium|calcium|mesh-list
6518538|NCT00727831|Levoleucovorin|levoleucovorin|mesh-list
5959274|NCT04640831|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
5959275|NCT04640831|Hallucinogens|hallucinogens|mesh-ancestor
6683054|NCT01619527|Darunavir|darunavir|mesh-list
6683055|NCT01619527|Cobicistat|cobicistat|mesh-list
6683056|NCT01619527|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6683057|NCT01619527|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6683058|NCT01619527|Protease Inhibitors|protease inhibitors|mesh-ancestor
6683059|NCT01619527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6683060|NCT01619527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683061|NCT01619527|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6683062|NCT01619527|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6683063|NCT01619527|Antiviral Agents|antiviral agents|mesh-ancestor
6683064|NCT01619527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6683065|NCT01619527|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5959276|NCT04640831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959277|NCT04640831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5959278|NCT04640831|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5959279|NCT04640831|Serotonin Agents|serotonin agents|mesh-ancestor
5959280|NCT04640831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5959281|NCT04640831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959282|NCT04640831|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5970044|NCT04538820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970045|NCT04538820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5970046|NCT04538820|Glucocorticoids|glucocorticoids|mesh-ancestor
5970047|NCT04538820|Hormones|hormones|mesh-ancestor
5970048|NCT04538820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5970049|NCT04538820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5970050|NCT04538820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5970051|NCT04538820|Protease Inhibitors|protease inhibitors|mesh-ancestor
5970052|NCT04538820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5970053|NCT04538820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970054|NCT04539054|Caffeine|caffeine|mesh-list
5970055|NCT04539054|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5970056|NCT04539054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970057|NCT04539054|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5970058|NCT04539054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5970059|NCT04539054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970060|NCT04539054|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5970061|NCT04539054|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5970062|NCT04539054|Purinergic Agents|purinergic agents|mesh-ancestor
5970063|NCT04539054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5970064|NCT04539444|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5970065|NCT04539444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970066|NCT04539444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5970067|NCT04539418|Vitamin K|vitamin k|mesh-list
5970068|NCT04539418|Vitamin K 2|vitamin k 2|mesh-list
5970069|NCT04539418|Vitamins|vitamins|mesh-ancestor
5970070|NCT04539418|Micronutrients|micronutrients|mesh-ancestor
6683066|NCT01619527|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6683067|NCT01619566|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6683068|NCT01619566|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6683069|NCT01619566|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6683070|NCT01619566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6683071|NCT01619566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683072|NCT01619566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6683073|NCT01619566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683074|NCT01619566|Analgesics|analgesics|mesh-ancestor
6683075|NCT01619566|Sensory System Agents|sensory system agents|mesh-ancestor
6683076|NCT01619566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6683077|NCT01619566|Antidepressive Agents|antidepressive agents|mesh-ancestor
5970071|NCT04539418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970072|NCT04539418|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5970073|NCT04539418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5970074|NCT04539418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970075|NCT04539418|Hemostatics|hemostatics|mesh-ancestor
5970076|NCT04539418|Coagulants|coagulants|mesh-ancestor
5970077|NCT04538521|Niacin|niacin|mesh-list
5970078|NCT04538521|Nicotinic Acids|nicotinic acids|mesh-list
5970079|NCT04538521|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5970080|NCT04538521|Antimetabolites|antimetabolites|mesh-ancestor
5970081|NCT04538521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970082|NCT04538521|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5970083|NCT04538521|Vasodilator Agents|vasodilator agents|mesh-ancestor
5959283|NCT04640636|Midazolam|midazolam|mesh-list
5959284|NCT04640636|Ketamine|ketamine|mesh-list
5959285|NCT04640636|Analgesics|analgesics|mesh-ancestor
5959286|NCT04640636|Sensory System Agents|sensory system agents|mesh-ancestor
5959287|NCT04640636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5959288|NCT04640636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959289|NCT04640636|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5959290|NCT04640636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5959291|NCT04640636|Anesthetics, General|anesthetics, general|mesh-ancestor
5959292|NCT04640636|Anesthetics|anesthetics|mesh-ancestor
5959293|NCT04640636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5959294|NCT04640636|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5959295|NCT04640636|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5959296|NCT04640636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5959297|NCT04640636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959298|NCT04640636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5959299|NCT04640636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5959300|NCT04640636|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5959301|NCT04640636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5959302|NCT04640636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5959303|NCT04640636|GABA Modulators|gaba modulators|mesh-ancestor
5959304|NCT04640636|GABA Agents|gaba agents|mesh-ancestor
5959305|NCT04640779|Salicylates|salicylates|mesh-list
5959306|NCT04640779|Choline|choline|mesh-list
5959307|NCT04640779|Lipotropic Agents|lipotropic agents|mesh-ancestor
5959308|NCT04640779|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5959309|NCT04640779|Antimetabolites|antimetabolites|mesh-ancestor
5959310|NCT04640779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959311|NCT04640779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5959312|NCT04640779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5959313|NCT04640779|Nootropic Agents|nootropic agents|mesh-ancestor
5959314|NCT04640779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5959315|NCT04640779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5959316|NCT04640779|Analgesics|analgesics|mesh-ancestor
5959317|NCT04640779|Sensory System Agents|sensory system agents|mesh-ancestor
5959318|NCT04640779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5959319|NCT04640779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959320|NCT04640779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5959321|NCT04640779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5959322|NCT04640779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5959323|NCT04640779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5959324|NCT04640818|Rituximab|rituximab|mesh-list
5959325|NCT04640818|Cladribine|cladribine|mesh-list
5959326|NCT04640818|Ocrelizumab|ocrelizumab|mesh-list
5959327|NCT04640818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5959328|NCT04640818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5959329|NCT04640818|Immunologic Factors|immunologic factors|mesh-ancestor
5959330|NCT04640818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959331|NCT04640818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5959332|NCT04640818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6683078|NCT01619566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6683079|NCT01619566|Dopamine Agents|dopamine agents|mesh-ancestor
6683080|NCT01619644|Valproic Acid|valproic acid|mesh-list
6683081|NCT01619644|Anticonvulsants|anticonvulsants|mesh-ancestor
6683082|NCT01619644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5959333|NCT04640493|Dapagliflozin|dapagliflozin|mesh-list
5959334|NCT04640493|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5959335|NCT04640493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959336|NCT04640493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5959337|NCT04640493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959338|NCT04640376|Acetaminophen|acetaminophen|mesh-list
5959339|NCT04640376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5959340|NCT04640376|Analgesics|analgesics|mesh-ancestor
5959341|NCT04640376|Sensory System Agents|sensory system agents|mesh-ancestor
5959342|NCT04640376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5959343|NCT04640376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959344|NCT04640376|Antipyretics|antipyretics|mesh-ancestor
5959345|NCT04640181|Enoxaparin|enoxaparin|mesh-list
5959346|NCT04640181|Rivaroxaban|rivaroxaban|mesh-list
5959347|NCT04640181|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5959348|NCT04640181|Antithrombins|antithrombins|mesh-ancestor
5959349|NCT04640181|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5959350|NCT04640181|Protease Inhibitors|protease inhibitors|mesh-ancestor
5959351|NCT04640181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5959352|NCT04640181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959353|NCT04640181|Anticoagulants|anticoagulants|mesh-ancestor
6683083|NCT01619644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959354|NCT04640181|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5959355|NCT04640181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5959356|NCT04639986|Gemcitabine|gemcitabine|mesh-list
5959357|NCT04639986|Capecitabine|capecitabine|mesh-list
5959358|NCT04639986|Vinorelbine|vinorelbine|mesh-list
5959359|NCT04639986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5959360|NCT04639986|Antimetabolites|antimetabolites|mesh-ancestor
5959361|NCT04639986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683084|NCT01619644|GABA Agents|gaba agents|mesh-ancestor
6683085|NCT01619644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6683086|NCT01619644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683087|NCT01619644|Antimanic Agents|antimanic agents|mesh-ancestor
6683088|NCT01619644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6683089|NCT01619644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6683090|NCT01619644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6683091|NCT01619683|Enclomiphene|enclomiphene|mesh-list
6683092|NCT01619683|Clomiphene|clomiphene|mesh-list
6683093|NCT01619683|Zuclomiphene|zuclomiphene|mesh-list
6683094|NCT01619683|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6683095|NCT01619683|Hormone Antagonists|hormone antagonists|mesh-ancestor
6683096|NCT01619683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6683097|NCT01619683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683098|NCT01619683|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6683099|NCT01619683|Fertility Agents|fertility agents|mesh-ancestor
6683100|NCT01619683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6683101|NCT01619683|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6683102|NCT01619683|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6683103|NCT01619761|Mycophenolic Acid|mycophenolic acid|mesh-list
6683104|NCT01619761|Cyclophosphamide|cyclophosphamide|mesh-list
6683105|NCT01619761|Melphalan|melphalan|mesh-list
6683106|NCT01619761|Mechlorethamine|mechlorethamine|mesh-list
6683107|NCT01619761|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
6683108|NCT01619761|Rituximab|rituximab|mesh-list
6683109|NCT01619761|Fludarabine|fludarabine|mesh-list
6683110|NCT01619761|Fludarabine phosphate|fludarabine phosphate|mesh-list
6683111|NCT01619761|Lenalidomide|lenalidomide|mesh-list
6683112|NCT01619761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6683113|NCT01619761|Tacrolimus|tacrolimus|mesh-list
6683114|NCT01619761|Antibodies|antibodies|mesh-list
6683115|NCT01619761|Immunoglobulins|immunoglobulins|mesh-list
6683116|NCT01619761|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6683117|NCT01619761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5959362|NCT04639986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5959363|NCT04639986|Antiviral Agents|antiviral agents|mesh-ancestor
5959364|NCT04639986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5959365|NCT04639986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5959366|NCT04639986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5959367|NCT04639986|Immunologic Factors|immunologic factors|mesh-ancestor
5959368|NCT04639986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959369|NCT04639986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5959370|NCT04639986|Tubulin Modulators|tubulin modulators|mesh-ancestor
6683118|NCT01619761|Immunologic Factors|immunologic factors|mesh-ancestor
6683119|NCT01619761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683120|NCT01619761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6683121|NCT01619761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6683122|NCT01619761|Alkylating Agents|alkylating agents|mesh-ancestor
6683123|NCT01619761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683124|NCT01619761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6683125|NCT01619761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6683126|NCT01619761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6683127|NCT01619761|Antimetabolites|antimetabolites|mesh-ancestor
6683128|NCT01619761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6683129|NCT01619761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6683130|NCT01619761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6683131|NCT01619761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6683132|NCT01619761|Growth Substances|growth substances|mesh-ancestor
6683133|NCT01619761|Growth Inhibitors|growth inhibitors|mesh-ancestor
6683134|NCT01619761|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6683135|NCT01619761|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6683136|NCT01619761|Antitubercular Agents|antitubercular agents|mesh-ancestor
6683137|NCT01619761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6683138|NCT01619761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6683139|NCT01619813|Prednisone|prednisone|mesh-list
6683140|NCT01619813|Docetaxel|docetaxel|mesh-list
5959371|NCT04639986|Antimitotic Agents|antimitotic agents|mesh-ancestor
6683141|NCT01619813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6683142|NCT01619813|Tubulin Modulators|tubulin modulators|mesh-ancestor
6683143|NCT01619813|Antimitotic Agents|antimitotic agents|mesh-ancestor
5959372|NCT04639986|Mitosis Modulators|mitosis modulators|mesh-ancestor
5959373|NCT04640129|Interferons|interferons|mesh-list
5959374|NCT04640129|Tenofovir|tenofovir|mesh-list
5959375|NCT04640129|Interferon-alpha|interferon-alpha|mesh-list
5959376|NCT04640129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5959377|NCT04640129|Antiviral Agents|antiviral agents|mesh-ancestor
5959378|NCT04640129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5959379|NCT04640129|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5959380|NCT04640129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5959381|NCT04640129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5959382|NCT04640129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959383|NCT04640129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5959384|NCT04640129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5959385|NCT04640129|Immunologic Factors|immunologic factors|mesh-ancestor
5959386|NCT04640129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959387|NCT04640324|Vitamin D|vitamin d|mesh-list
5959388|NCT04640324|Vitamins|vitamins|mesh-list
5959389|NCT04640324|Vitamin E|vitamin e|mesh-list
5959390|NCT04640324|Silybin|silybin|mesh-list
5959391|NCT04640324|Micronutrients|micronutrients|mesh-ancestor
5959392|NCT04640324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959393|NCT04640324|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6683144|NCT01619813|Mitosis Modulators|mitosis modulators|mesh-ancestor
6683145|NCT01619813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683146|NCT01619813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6683147|NCT01619813|Glucocorticoids|glucocorticoids|mesh-ancestor
6683148|NCT01619813|Hormones|hormones|mesh-ancestor
6683149|NCT01619813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6683150|NCT01619813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683151|NCT01619813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6683152|NCT01619891|Vitamin D|vitamin d|mesh-list
6683153|NCT01619891|Vitamins|vitamins|mesh-ancestor
6683154|NCT01619891|Micronutrients|micronutrients|mesh-ancestor
6683155|NCT01619891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683156|NCT01619891|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6683157|NCT01620112|Lidocaine|lidocaine|mesh-list
6683158|NCT01620112|Clonidine|clonidine|mesh-list
6683159|NCT01620112|Anesthetics, Local|anesthetics, local|mesh-ancestor
6683160|NCT01620112|Anesthetics|anesthetics|mesh-ancestor
6683161|NCT01620112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6683162|NCT01620112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683163|NCT01620112|Sensory System Agents|sensory system agents|mesh-ancestor
6683164|NCT01620112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6683165|NCT01620112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6683166|NCT01620112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5959394|NCT04640324|Antioxidants|antioxidants|mesh-ancestor
5959395|NCT04640324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959396|NCT04640324|Protective Agents|protective agents|mesh-ancestor
5959397|NCT04640324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5959398|NCT04640324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5959399|NCT04640285|Menthol|menthol|mesh-list
5959400|NCT04640285|Nicotine|nicotine|mesh-list
5959401|NCT04640285|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5959402|NCT04640285|Autonomic Agents|autonomic agents|mesh-ancestor
5959403|NCT04640285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5959404|NCT04640285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959405|NCT04640285|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5959406|NCT04640285|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5959407|NCT04640285|Cholinergic Agents|cholinergic agents|mesh-ancestor
5959408|NCT04640285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5959409|NCT04640285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959410|NCT04640285|Antipruritics|antipruritics|mesh-ancestor
5959411|NCT04640285|Dermatologic Agents|dermatologic agents|mesh-ancestor
6518539|NCT00727831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6518540|NCT00727831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518541|NCT00727831|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6518542|NCT00727831|Abortifacient Agents|abortifacient agents|mesh-ancestor
6518543|NCT00727831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6518544|NCT00727831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6518545|NCT00727831|Antimetabolites|antimetabolites|mesh-ancestor
6683167|NCT01620112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5959412|NCT04640402|Vaccines|vaccines|mesh-list
5959413|NCT04640402|Immunologic Factors|immunologic factors|mesh-ancestor
5959414|NCT04640402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959415|NCT04639960|Risperidone|risperidone|mesh-list
6683168|NCT01620112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6683169|NCT01620112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683170|NCT01620112|Analgesics|analgesics|mesh-ancestor
6683171|NCT01620112|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6683172|NCT01620112|Sympatholytics|sympatholytics|mesh-ancestor
6683173|NCT01620112|Autonomic Agents|autonomic agents|mesh-ancestor
6683174|NCT01620112|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6683175|NCT01620112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6683176|NCT01620112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5959416|NCT04639960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5959417|NCT04639960|Serotonin Agents|serotonin agents|mesh-ancestor
5959418|NCT04639960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5959419|NCT04639960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959420|NCT04639960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959421|NCT04639960|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5959422|NCT04639960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5959423|NCT04639960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5959424|NCT04639960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5959425|NCT04639960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5959426|NCT04639960|Dopamine Agents|dopamine agents|mesh-ancestor
5959427|NCT04639817|Levofloxacin|levofloxacin|mesh-list
5959428|NCT04639817|Ofloxacin|ofloxacin|mesh-list
5959429|NCT04639817|Trimethoprim|trimethoprim|mesh-list
5959430|NCT04639817|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
5959431|NCT04639817|Sulfamethoxazole|sulfamethoxazole|mesh-list
5959432|NCT04639817|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5959433|NCT04639817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5959434|NCT04639817|Renal Agents|renal agents|mesh-ancestor
5959435|NCT04639817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5959436|NCT04639817|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5959437|NCT04639817|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5959438|NCT04639817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5959439|NCT04639817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959440|NCT04639817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5959441|NCT04639817|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5959442|NCT04639817|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5959443|NCT04639817|Antimalarials|antimalarials|mesh-ancestor
5959444|NCT04639817|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5959445|NCT04639817|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5959446|NCT04639817|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5959447|NCT04639817|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5959448|NCT04639817|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6683177|NCT01620112|Adrenergic Agents|adrenergic agents|mesh-ancestor
6683178|NCT01620112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6683179|NCT01620229|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6683180|NCT01620229|Antibodies|antibodies|mesh-list
6683181|NCT01620229|Immunoglobulins|immunoglobulins|mesh-list
6683182|NCT01620229|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6683183|NCT01620229|Immunoconjugates|immunoconjugates|mesh-list
6683184|NCT01620229|Immunologic Factors|immunologic factors|mesh-ancestor
6683185|NCT01620229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683186|NCT01620229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6683187|NCT01620229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6518546|NCT00727831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518547|NCT00727831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6518548|NCT00727831|Dermatologic Agents|dermatologic agents|mesh-ancestor
6518549|NCT00727831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6518550|NCT00727831|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6518551|NCT00727831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6518552|NCT00727831|Immunologic Factors|immunologic factors|mesh-ancestor
6518553|NCT00727831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6518554|NCT00727831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6518555|NCT00727831|Antidotes|antidotes|mesh-ancestor
6518556|NCT00727831|Protective Agents|protective agents|mesh-ancestor
6683188|NCT01620268|Leflunomide|leflunomide|mesh-list
6683189|NCT01620268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6683190|NCT01620268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959449|NCT04639804|Celecoxib|celecoxib|mesh-list
5959450|NCT04639804|Naproxen|naproxen|mesh-list
5959451|NCT04639804|Aceclofenac|aceclofenac|mesh-list
5959452|NCT04639804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5959453|NCT04639804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5959454|NCT04639804|Analgesics|analgesics|mesh-ancestor
5959455|NCT04639804|Sensory System Agents|sensory system agents|mesh-ancestor
5970084|NCT04538521|Vitamin B Complex|vitamin b complex|mesh-ancestor
5959456|NCT04639804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5959457|NCT04639804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959458|NCT04639804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5959459|NCT04639804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5959460|NCT04639804|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5959461|NCT04639804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5959462|NCT04639804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5959463|NCT04639804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959464|NCT04639804|Gout Suppressants|gout suppressants|mesh-ancestor
5959465|NCT04639362|Venetoclax|venetoclax|mesh-list
5959466|NCT04639362|Obinutuzumab|obinutuzumab|mesh-list
5959467|NCT04639362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5959468|NCT04639362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6683191|NCT01620268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6683192|NCT01620268|Immunologic Factors|immunologic factors|mesh-ancestor
6683193|NCT01620268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683194|NCT01620307|Sirolimus|sirolimus|mesh-list
6683195|NCT01620307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6683196|NCT01620307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6683197|NCT01620307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6683198|NCT01620307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6683199|NCT01620307|Antifungal Agents|antifungal agents|mesh-ancestor
6683200|NCT01620307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6683201|NCT01620307|Immunologic Factors|immunologic factors|mesh-ancestor
6683202|NCT01620307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683203|NCT01620320|Dobutamine|dobutamine|mesh-list
6683204|NCT01620320|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6683205|NCT01620320|Sympathomimetics|sympathomimetics|mesh-ancestor
6683206|NCT01620320|Autonomic Agents|autonomic agents|mesh-ancestor
6683207|NCT01620320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6683208|NCT01620320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683209|NCT01620320|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6683210|NCT01620320|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6683211|NCT01620320|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6683212|NCT01620320|Adrenergic Agents|adrenergic agents|mesh-ancestor
6683213|NCT01620320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6683214|NCT01620320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683215|NCT01620320|Protective Agents|protective agents|mesh-ancestor
6683216|NCT01620333|Insulin|insulin|mesh-list
6683217|NCT01620333|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6683218|NCT01620333|Insulin Aspart|insulin aspart|mesh-list
6683219|NCT01620333|Insulin, Long-Acting|insulin, long-acting|mesh-list
6683220|NCT01620333|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6683221|NCT01620333|Biphasic Insulins|biphasic insulins|mesh-list
6683222|NCT01620333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6683223|NCT01620333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683224|NCT01620424|Insulin|insulin|mesh-list
6683225|NCT01620424|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6683226|NCT01620424|Insulin Aspart|insulin aspart|mesh-list
6683227|NCT01620424|Insulin, Long-Acting|insulin, long-acting|mesh-list
6683228|NCT01620424|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6683229|NCT01620424|Biphasic Insulins|biphasic insulins|mesh-list
6683230|NCT01620424|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
5959469|NCT04639232|Probenecid|probenecid|mesh-list
6518557|NCT00727831|Vitamin B Complex|vitamin b complex|mesh-ancestor
6518558|NCT00727831|Vitamins|vitamins|mesh-ancestor
6518559|NCT00727831|Micronutrients|micronutrients|mesh-ancestor
6518560|NCT00727870|Glycerol|glycerol|mesh-list
6518561|NCT00727870|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6518562|NCT00727870|Protective Agents|protective agents|mesh-ancestor
6518563|NCT00727870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518564|NCT00727935|Lidocaine|lidocaine|mesh-list
6518565|NCT00727935|Ropivacaine|ropivacaine|mesh-list
5959470|NCT04639232|Uricosuric Agents|uricosuric agents|mesh-ancestor
5959471|NCT04639232|Gout Suppressants|gout suppressants|mesh-ancestor
5959472|NCT04639232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5959473|NCT04639232|Renal Agents|renal agents|mesh-ancestor
5959474|NCT04639284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
5959475|NCT04639284|Antibodies|antibodies|mesh-list
5959476|NCT04639284|Immunologic Factors|immunologic factors|mesh-ancestor
5959477|NCT04639284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959478|NCT04639284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5959479|NCT04639284|Growth Substances|growth substances|mesh-ancestor
5959480|NCT04639284|Growth Inhibitors|growth inhibitors|mesh-ancestor
6518566|NCT00727935|Anesthetics, Local|anesthetics, local|mesh-ancestor
6518567|NCT00727935|Anesthetics|anesthetics|mesh-ancestor
6683231|NCT01620424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5959481|NCT04639284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5959482|NCT04639271|Trastuzumab|trastuzumab|mesh-list
5959483|NCT04639271|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5959484|NCT04639271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5959485|NCT04639271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5959486|NCT04639180|Apatinib|apatinib|mesh-list
5959487|NCT04639180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5959488|NCT04639180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5959489|NCT04639180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5959490|NCT04639180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959491|NCT04638816|Lidocaine|lidocaine|mesh-list
5959492|NCT04638816|Hyaluronic Acid|hyaluronic acid|mesh-list
5959493|NCT04638816|Anesthetics, Local|anesthetics, local|mesh-ancestor
6683232|NCT01620424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683233|NCT01620437|Insulin Aspart|insulin aspart|mesh-list
6683234|NCT01620437|Biphasic Insulins|biphasic insulins|mesh-list
6683235|NCT01620437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6683236|NCT01620437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683237|NCT01620450|Insulin|insulin|mesh-list
6683238|NCT01620450|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6683239|NCT01620450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6683240|NCT01620450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683241|NCT01620463|Liraglutide|liraglutide|mesh-list
6683242|NCT01620463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6683243|NCT01620463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683244|NCT01620463|Incretins|incretins|mesh-ancestor
6683245|NCT01620463|Hormones|hormones|mesh-ancestor
6683246|NCT01620463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6683247|NCT01620476|Liraglutide|liraglutide|mesh-list
6683248|NCT01620476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5959494|NCT04638816|Anesthetics|anesthetics|mesh-ancestor
5959495|NCT04638816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5959496|NCT04638816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959497|NCT04638816|Sensory System Agents|sensory system agents|mesh-ancestor
5959498|NCT04638816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5959499|NCT04638816|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5959500|NCT04638816|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5959501|NCT04638816|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5959502|NCT04638816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5959503|NCT04638816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959504|NCT04638816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5959505|NCT04638816|Immunologic Factors|immunologic factors|mesh-ancestor
5959506|NCT04638816|Viscosupplements|viscosupplements|mesh-ancestor
6518568|NCT00727935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6518569|NCT00727935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518570|NCT00727935|Sensory System Agents|sensory system agents|mesh-ancestor
6518571|NCT00727935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6518572|NCT00727935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6518573|NCT00727935|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6518574|NCT00727935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6518575|NCT00727935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6518576|NCT00727935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518577|NCT00727948|Aspirin|aspirin|mesh-list
6518578|NCT00727948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6518579|NCT00727948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6518580|NCT00727948|Analgesics|analgesics|mesh-ancestor
6518581|NCT00727948|Sensory System Agents|sensory system agents|mesh-ancestor
6518582|NCT00727948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6518583|NCT00727948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518584|NCT00727948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6518585|NCT00727948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6518586|NCT00727948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6518587|NCT00727948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6518588|NCT00727948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518589|NCT00727948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6518590|NCT00727948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6518591|NCT00727948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6518592|NCT00727948|Antipyretics|antipyretics|mesh-ancestor
6518593|NCT00727987|Golimumab|golimumab|mesh-list
6518594|NCT00727987|Methotrexate|methotrexate|mesh-list
6518595|NCT00727987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6683249|NCT01620476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683250|NCT01620476|Incretins|incretins|mesh-ancestor
6683251|NCT01620476|Hormones|hormones|mesh-ancestor
6683252|NCT01620476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6683253|NCT01620684|Metyrapone|metyrapone|mesh-list
6683254|NCT01620684|Antimetabolites|antimetabolites|mesh-ancestor
6683255|NCT01620684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683256|NCT01620684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6683257|NCT01620736|Raltegravir Potassium|raltegravir potassium|mesh-list
6683258|NCT01620736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6683259|NCT01620736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6683260|NCT01620736|Antiviral Agents|antiviral agents|mesh-ancestor
5959507|NCT04638816|Protective Agents|protective agents|mesh-ancestor
5959508|NCT04639037|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
5959509|NCT04639193|Acetazolamide|acetazolamide|mesh-list
5959510|NCT04639193|Eszopiclone|eszopiclone|mesh-list
5959511|NCT04639193|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
5959512|NCT04639193|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5959513|NCT04639193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5959514|NCT04639193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5959515|NCT04639193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959516|NCT04639193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5959517|NCT04639193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959518|NCT04639193|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5959519|NCT04639193|Antidepressive Agents|antidepressive agents|mesh-ancestor
5959520|NCT04639193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5959521|NCT04639193|Anticonvulsants|anticonvulsants|mesh-ancestor
5959522|NCT04639193|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5959523|NCT04639193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5959524|NCT04639193|Diuretics|diuretics|mesh-ancestor
5959525|NCT04639193|Natriuretic Agents|natriuretic agents|mesh-ancestor
5959526|NCT04639193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5959527|NCT04639193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5959528|NCT04638686|Lamivudine|lamivudine|mesh-list
5959529|NCT04638686|Dolutegravir|dolutegravir|mesh-list
5959530|NCT04638686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5959531|NCT04638686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5959532|NCT04638686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5959533|NCT04638686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959534|NCT04638686|Antiviral Agents|antiviral agents|mesh-ancestor
5959535|NCT04638686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5959536|NCT04638686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5959537|NCT04638686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5959538|NCT04638686|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5959539|NCT04638686|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5959540|NCT04638790|Dexamethasone|dexamethasone|mesh-list
5959541|NCT04638790|Cyclophosphamide|cyclophosphamide|mesh-list
5959542|NCT04638790|Dacarbazine|dacarbazine|mesh-list
5959543|NCT04638790|Doxorubicin|doxorubicin|mesh-list
5959544|NCT04638790|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6518596|NCT00727987|Abortifacient Agents|abortifacient agents|mesh-ancestor
6518597|NCT00727987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6518598|NCT00727987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518599|NCT00727987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6518600|NCT00727987|Antimetabolites|antimetabolites|mesh-ancestor
6518601|NCT00727987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518602|NCT00727987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6683261|NCT01620736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6683262|NCT01620736|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6683263|NCT01620736|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6683264|NCT01620736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6683265|NCT01620736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683266|NCT01620788|Losartan|losartan|mesh-list
6683267|NCT01620788|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6683268|NCT01620788|Indapamide|indapamide|mesh-list
6683269|NCT01620788|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6683270|NCT01620788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6683271|NCT01620788|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6683272|NCT01620788|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6683273|NCT01620788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683274|NCT01620788|Diuretics|diuretics|mesh-ancestor
6683275|NCT01620788|Natriuretic Agents|natriuretic agents|mesh-ancestor
6683276|NCT01620788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959545|NCT04638790|Etoposide|etoposide|mesh-list
5959546|NCT04638790|Vincristine|vincristine|mesh-list
6518603|NCT00727987|Dermatologic Agents|dermatologic agents|mesh-ancestor
6518604|NCT00727987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6683277|NCT01620788|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6683278|NCT01620788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6683279|NCT01620814|Misoprostol|misoprostol|mesh-list
6683280|NCT01620814|Dinoprostone|dinoprostone|mesh-list
6683281|NCT01620814|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6683282|NCT01620814|Abortifacient Agents|abortifacient agents|mesh-ancestor
6683283|NCT01620814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6683284|NCT01620814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683285|NCT01620814|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6683286|NCT01620814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6683287|NCT01620814|Oxytocics|oxytocics|mesh-ancestor
6683288|NCT01620840|Lacosamide|lacosamide|mesh-list
6683289|NCT01620840|Anticonvulsants|anticonvulsants|mesh-ancestor
6683290|NCT01620840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6683291|NCT01620840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5959547|NCT04638790|Bleomycin|bleomycin|mesh-list
5959548|NCT04638790|Vinblastine|vinblastine|mesh-list
5959549|NCT04638790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5959550|NCT04638790|Immunologic Factors|immunologic factors|mesh-ancestor
5959551|NCT04638790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959552|NCT04638790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5959553|NCT04638790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5959554|NCT04638790|Alkylating Agents|alkylating agents|mesh-ancestor
5959555|NCT04638790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959556|NCT04638790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5959557|NCT04638790|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5959558|NCT04638790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6683292|NCT01620840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6683293|NCT01620840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683294|NCT01620944|Ritonavir|ritonavir|mesh-list
6683295|NCT01620944|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6683296|NCT01620944|Tenofovir|tenofovir|mesh-list
6683297|NCT01620944|Lamivudine|lamivudine|mesh-list
6683298|NCT01620944|Emtricitabine|emtricitabine|mesh-list
6683299|NCT01620944|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6683300|NCT01620944|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6683301|NCT01620944|Protease Inhibitors|protease inhibitors|mesh-ancestor
6683302|NCT01620944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6683303|NCT01620944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683304|NCT01620944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6683305|NCT01620944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6683306|NCT01620944|Antiviral Agents|antiviral agents|mesh-ancestor
6683307|NCT01620944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6683308|NCT01620944|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6683309|NCT01620944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6683310|NCT01620944|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6683311|NCT01620944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6683312|NCT01621022|Bupropion|bupropion|mesh-list
6683313|NCT01621022|Nicotine|nicotine|mesh-list
6683314|NCT01621022|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6683315|NCT01621022|Autonomic Agents|autonomic agents|mesh-ancestor
6683316|NCT01621022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6683317|NCT01621022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683318|NCT01621022|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6683319|NCT01621022|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6683320|NCT01621022|Cholinergic Agents|cholinergic agents|mesh-ancestor
6683321|NCT01621022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6683322|NCT01621022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683323|NCT01621022|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6683324|NCT01621022|Antidepressive Agents|antidepressive agents|mesh-ancestor
6683325|NCT01621022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6683326|NCT01621022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6683327|NCT01621022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6683328|NCT01621022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6683329|NCT01621022|Dopamine Agents|dopamine agents|mesh-ancestor
6683330|NCT01621022|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6683331|NCT01621022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6683332|NCT01621022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6683333|NCT01621100|Hydromorphone|hydromorphone|mesh-list
6683334|NCT01621100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6683335|NCT01621100|Narcotics|narcotics|mesh-ancestor
5959559|NCT04638790|Antiemetics|antiemetics|mesh-ancestor
5959560|NCT04638790|Autonomic Agents|autonomic agents|mesh-ancestor
6683336|NCT01621100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6683337|NCT01621100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683338|NCT01621100|Analgesics|analgesics|mesh-ancestor
6683339|NCT01621100|Sensory System Agents|sensory system agents|mesh-ancestor
6683340|NCT01621100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6683341|NCT01621113|4-Aminopyridine|4-aminopyridine|mesh-list
6683342|NCT01621113|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6683343|NCT01621113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6683344|NCT01621113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683345|NCT01621165|Prazosin|prazosin|mesh-list
6683346|NCT01621165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6683347|NCT01621165|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6683348|NCT01621165|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5959561|NCT04638790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5959562|NCT04638790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5959563|NCT04638790|Glucocorticoids|glucocorticoids|mesh-ancestor
5959564|NCT04638790|Hormones|hormones|mesh-ancestor
5959565|NCT04638790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5959566|NCT04638790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5959567|NCT04638790|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5959568|NCT04638790|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6518605|NCT00727987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6683349|NCT01621165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6683350|NCT01621165|Adrenergic Agents|adrenergic agents|mesh-ancestor
6683351|NCT01621165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6683352|NCT01621165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683353|NCT01621165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683354|NCT01621204|Immunoglobulins|immunoglobulins|mesh-list
6683355|NCT01621204|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6683356|NCT01621204|gamma-Globulins|gamma-globulins|mesh-list
6683357|NCT01621204|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6683358|NCT01621204|Immunologic Factors|immunologic factors|mesh-ancestor
6683359|NCT01621204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683360|NCT01621217|Cetuximab|cetuximab|mesh-list
6683361|NCT01621217|Mitomycins|mitomycins|mesh-list
6683362|NCT01621217|Mitomycin|mitomycin|mesh-list
6683363|NCT01621217|Fluorouracil|fluorouracil|mesh-list
6683364|NCT01621217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6683365|NCT01621217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6683366|NCT01621217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6683367|NCT01621217|Alkylating Agents|alkylating agents|mesh-ancestor
6683368|NCT01621217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683369|NCT01621217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6683370|NCT01621217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6683371|NCT01621217|Antimetabolites|antimetabolites|mesh-ancestor
6683372|NCT01621217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6683373|NCT01621217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6683374|NCT01621217|Immunologic Factors|immunologic factors|mesh-ancestor
6683375|NCT01621217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683376|NCT01621256|Ancrod|ancrod|mesh-list
6683377|NCT01621256|Anticoagulants|anticoagulants|mesh-ancestor
6683378|NCT01621256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6683379|NCT01621256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6683380|NCT01621256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518606|NCT00727987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6518607|NCT00727987|Immunologic Factors|immunologic factors|mesh-ancestor
6518608|NCT00727987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6518609|NCT00727987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6518610|NCT00727987|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6518611|NCT00727987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6683381|NCT01621269|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6683382|NCT01621269|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6518612|NCT00728000|Gemcitabine|gemcitabine|mesh-list
6518613|NCT00728000|Oxaliplatin|oxaliplatin|mesh-list
6518614|NCT00728000|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6518615|NCT00728000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6518616|NCT00728000|Antimetabolites|antimetabolites|mesh-ancestor
6518617|NCT00728000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683383|NCT01621269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683384|NCT01621269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6683385|NCT01621269|Immunologic Factors|immunologic factors|mesh-ancestor
6683386|NCT01621269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780041|NCT02182102|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6780042|NCT02182102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6780043|NCT02182128|Nintedanib|nintedanib|mesh-list
5959569|NCT04638790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5959570|NCT04638790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5959571|NCT04638790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5959572|NCT04638790|Tubulin Modulators|tubulin modulators|mesh-ancestor
5959573|NCT04638790|Antimitotic Agents|antimitotic agents|mesh-ancestor
5959574|NCT04638790|Mitosis Modulators|mitosis modulators|mesh-ancestor
5970085|NCT04538521|Vitamins|vitamins|mesh-ancestor
5970086|NCT04538521|Micronutrients|micronutrients|mesh-ancestor
5970087|NCT04538521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970088|NCT04538391|Bupivacaine|bupivacaine|mesh-list
5970089|NCT04538391|Anesthetics, Local|anesthetics, local|mesh-ancestor
5970090|NCT04538391|Anesthetics|anesthetics|mesh-ancestor
5970091|NCT04538391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5970092|NCT04538391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970093|NCT04538391|Sensory System Agents|sensory system agents|mesh-ancestor
5970094|NCT04538391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5970095|NCT04538365|Triclosan|triclosan|mesh-list
5970096|NCT04538365|Propranolol|propranolol|mesh-list
5970097|NCT04538365|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5970098|NCT04538365|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5970099|NCT04538365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6780044|NCT02182128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6780045|NCT02182128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6780046|NCT02182128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780047|NCT02182128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780048|NCT02182141|Nintedanib|nintedanib|mesh-list
6780049|NCT02182141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6780050|NCT02182141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6780051|NCT02182141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780052|NCT02182141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780053|NCT02182154|Nintedanib|nintedanib|mesh-list
6780054|NCT02182154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6780055|NCT02182154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6780056|NCT02182154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780057|NCT02182154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970100|NCT04538365|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5970101|NCT04538365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5970102|NCT04538365|Antimetabolites|antimetabolites|mesh-ancestor
5970103|NCT04538365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970104|NCT04538365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5970105|NCT04538365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5970106|NCT04538365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5970107|NCT04538365|Adrenergic Agents|adrenergic agents|mesh-ancestor
5970108|NCT04538365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5970109|NCT04538365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780058|NCT02182167|Acetylcysteine|acetylcysteine|mesh-list
6780059|NCT02182167|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5970110|NCT04538365|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5970111|NCT04538365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5970112|NCT04538365|Vasodilator Agents|vasodilator agents|mesh-ancestor
5970113|NCT04538976|Sildenafil Citrate|sildenafil citrate|mesh-list
5970114|NCT04538976|Vasodilator Agents|vasodilator agents|mesh-ancestor
5970115|NCT04538976|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5970116|NCT04538976|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5970117|NCT04538976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5970118|NCT04538976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970119|NCT04538976|Urological Agents|urological agents|mesh-ancestor
5970120|NCT04538053|Cefazolin|cefazolin|mesh-list
5970121|NCT04538053|Cephalexin|cephalexin|mesh-list
5970122|NCT04538053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5970123|NCT04538053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5970124|NCT04538066|Bryostatin 1|bryostatin 1|mesh-list
5970125|NCT04538066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5970126|NCT04538066|Immunologic Factors|immunologic factors|mesh-ancestor
5970127|NCT04538066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970128|NCT04538066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5970129|NCT04537780|Montelukast|montelukast|mesh-list
5970130|NCT04537780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5959575|NCT04639115|Ozanimod|ozanimod|mesh-list
5959576|NCT04639115|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5959577|NCT04639115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959578|NCT04639115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5959579|NCT04639115|Immunologic Factors|immunologic factors|mesh-ancestor
5959580|NCT04639115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959581|NCT04638582|Paclitaxel|paclitaxel|mesh-list
5959582|NCT04638582|Carboplatin|carboplatin|mesh-list
5959583|NCT04638582|Pembrolizumab|pembrolizumab|mesh-list
5959584|NCT04638582|Pemetrexed|pemetrexed|mesh-list
5959585|NCT04638582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5959586|NCT04638582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5959587|NCT04638582|Tubulin Modulators|tubulin modulators|mesh-ancestor
5959588|NCT04638582|Antimitotic Agents|antimitotic agents|mesh-ancestor
5959589|NCT04638582|Mitosis Modulators|mitosis modulators|mesh-ancestor
5959590|NCT04638582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959591|NCT04638582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5959592|NCT04638582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5959593|NCT04638582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5959594|NCT04638582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5959595|NCT04638751|Pembrolizumab|pembrolizumab|mesh-list
5959596|NCT04638751|Nivolumab|nivolumab|mesh-list
5959597|NCT04638751|Ipilimumab|ipilimumab|mesh-list
5959598|NCT04638751|Durvalumab|durvalumab|mesh-list
5959599|NCT04638751|Avelumab|avelumab|mesh-list
5959600|NCT04638751|Cemiplimab|cemiplimab|mesh-list
5959601|NCT04638751|Atezolizumab|atezolizumab|mesh-list
5959602|NCT04638751|Antineoplastic Agents|antineoplastic agents|mesh-list
5959603|NCT04638751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5959604|NCT04638751|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5959605|NCT04638751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959606|NCT04638517|Danazol|danazol|mesh-list
5959607|NCT04638517|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5959608|NCT04638517|Hormone Antagonists|hormone antagonists|mesh-ancestor
5959609|NCT04638517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5959610|NCT04638517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959611|NCT04638400|Simvastatin|simvastatin|mesh-list
5959612|NCT04638400|Ezetimibe|ezetimibe|mesh-list
5959613|NCT04638400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5959614|NCT04638400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5959615|NCT04638400|Antimetabolites|antimetabolites|mesh-ancestor
5959616|NCT04638400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959617|NCT04638400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5959618|NCT04638400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5959619|NCT04638400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5959620|NCT04638439|Entecavir|entecavir|mesh-list
5959621|NCT04638439|Nivolumab|nivolumab|mesh-list
5959622|NCT04638439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5959623|NCT04638439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5959624|NCT04638439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5959625|NCT04638439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959626|NCT04638439|Antiviral Agents|antiviral agents|mesh-ancestor
5959627|NCT04638439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5959628|NCT04638036|Cetuximab|cetuximab|mesh-list
5959629|NCT04638036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5959630|NCT04638036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5959631|NCT04637633|Lubricant Eye Drops|lubricant eye drops|mesh-list
5959632|NCT04637633|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5959633|NCT04637633|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5959634|NCT04637425|Broncho-Vaxom|broncho-vaxom|mesh-list
6683387|NCT01621308|Insulin|insulin|mesh-list
6683388|NCT01621308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6683389|NCT01621308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683390|NCT01621321|Voriconazole|voriconazole|mesh-list
6683391|NCT01621321|Prednisolone|prednisolone|mesh-list
6683392|NCT01621321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6683393|NCT01621321|Glucocorticoids|glucocorticoids|mesh-ancestor
6683394|NCT01621321|Hormones|hormones|mesh-ancestor
6683395|NCT01621321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6683396|NCT01621321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683397|NCT01621321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6683398|NCT01621321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6683399|NCT01621321|Antifungal Agents|antifungal agents|mesh-ancestor
5959635|NCT04637425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5959636|NCT04637425|Immunologic Factors|immunologic factors|mesh-ancestor
6683400|NCT01621321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6780060|NCT02182167|Antiviral Agents|antiviral agents|mesh-ancestor
5959637|NCT04637425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959638|NCT04637464|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5959639|NCT04637464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5959640|NCT04637152|Valsartan|valsartan|mesh-list
5959641|NCT04637152|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
6683401|NCT01621321|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6683402|NCT01621321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6683403|NCT01621321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6683404|NCT01621321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683405|NCT01621321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6683406|NCT01621321|Hormone Antagonists|hormone antagonists|mesh-ancestor
6683407|NCT01621321|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6683408|NCT01621373|Propofol|propofol|mesh-list
6683409|NCT01621373|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6683410|NCT01621373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6683411|NCT01621373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683412|NCT01621373|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6683413|NCT01621373|Anesthetics, General|anesthetics, general|mesh-ancestor
6683414|NCT01621373|Anesthetics|anesthetics|mesh-ancestor
6683415|NCT01621386|Prednisone|prednisone|mesh-list
6683416|NCT01621386|Montelukast|montelukast|mesh-list
5959642|NCT04637152|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5959643|NCT04637152|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5959644|NCT04637152|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5959645|NCT04637152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959646|NCT04636918|Cyclosporine|cyclosporine|mesh-list
5959647|NCT04636918|Cyclosporins|cyclosporins|mesh-list
5959648|NCT04636918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5959649|NCT04636918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959650|NCT04636918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5959651|NCT04636918|Immunologic Factors|immunologic factors|mesh-ancestor
5959652|NCT04636918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959653|NCT04636918|Antifungal Agents|antifungal agents|mesh-ancestor
5959654|NCT04636918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5959655|NCT04636918|Dermatologic Agents|dermatologic agents|mesh-ancestor
5959656|NCT04636918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5959657|NCT04636918|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5959658|NCT04637204|Axitinib|axitinib|mesh-list
5959659|NCT04637204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5959660|NCT04637204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6683417|NCT01621386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6683418|NCT01621386|Glucocorticoids|glucocorticoids|mesh-ancestor
6683419|NCT01621386|Hormones|hormones|mesh-ancestor
6683420|NCT01621386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6683421|NCT01621386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683422|NCT01621386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6683423|NCT01621386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6683424|NCT01621386|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6683425|NCT01621386|Respiratory System Agents|respiratory system agents|mesh-ancestor
6683426|NCT01621386|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6683427|NCT01621386|Hormone Antagonists|hormone antagonists|mesh-ancestor
6683428|NCT01621386|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6683429|NCT01621386|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6683430|NCT01621386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959661|NCT04637204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5959662|NCT04637204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959663|NCT04637529|Ibuprofen|ibuprofen|mesh-list
5959664|NCT04637529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5959665|NCT04637529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5959666|NCT04637529|Analgesics|analgesics|mesh-ancestor
5959667|NCT04637529|Sensory System Agents|sensory system agents|mesh-ancestor
5959668|NCT04637529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5959669|NCT04637529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959670|NCT04637529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5959671|NCT04637529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5959672|NCT04637529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5959673|NCT04637529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5959674|NCT04637529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959675|NCT04636957|Ciprofloxacin|ciprofloxacin|mesh-list
5959676|NCT04636957|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
5959677|NCT04636957|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5959678|NCT04636957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5959679|NCT04636957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6683431|NCT01621451|Aspirin|aspirin|mesh-list
6683432|NCT01621451|Clopidogrel|clopidogrel|mesh-list
6683433|NCT01621451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6683434|NCT01621451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6683435|NCT01621451|Analgesics|analgesics|mesh-ancestor
6683436|NCT01621451|Sensory System Agents|sensory system agents|mesh-ancestor
6683437|NCT01621451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6683438|NCT01621451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683439|NCT01621451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6683440|NCT01621451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6683441|NCT01621451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6683442|NCT01621451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6683443|NCT01621451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683444|NCT01621451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6518618|NCT00728000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6518619|NCT00728000|Antiviral Agents|antiviral agents|mesh-ancestor
6518620|NCT00728000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6518621|NCT00728000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6518622|NCT00728000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6518623|NCT00728000|Immunologic Factors|immunologic factors|mesh-ancestor
6518624|NCT00728000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518625|NCT00728000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5959680|NCT04636957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5959681|NCT04636957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5959682|NCT04636957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5959683|NCT04636957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959684|NCT04636957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6683445|NCT01621451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6683446|NCT01621451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6683447|NCT01621451|Antipyretics|antipyretics|mesh-ancestor
6683448|NCT01621451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6683449|NCT01621451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6683450|NCT01621451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6683451|NCT01621451|Purinergic Agents|purinergic agents|mesh-ancestor
6683452|NCT01621451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6683453|NCT01621568|Sunitinib|sunitinib|mesh-list
6683454|NCT01621568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6683455|NCT01621568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6683456|NCT01621568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6683457|NCT01621568|Growth Substances|growth substances|mesh-ancestor
6683458|NCT01621568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683459|NCT01621568|Growth Inhibitors|growth inhibitors|mesh-ancestor
6683460|NCT01621568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6683461|NCT01621568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5959685|NCT04636957|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5959686|NCT04636957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5959687|NCT04636957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5959688|NCT04636957|Glucocorticoids|glucocorticoids|mesh-ancestor
5959689|NCT04636957|Hormones|hormones|mesh-ancestor
5959690|NCT04636957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5959691|NCT04636957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970131|NCT04537780|Respiratory System Agents|respiratory system agents|mesh-ancestor
5970132|NCT04537780|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5970133|NCT04537780|Hormone Antagonists|hormone antagonists|mesh-ancestor
5970134|NCT04537780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5970135|NCT04537780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970136|NCT04537780|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5970137|NCT04537780|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5970138|NCT04537780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970139|NCT04537767|Esmolol|esmolol|mesh-list
5970140|NCT04537767|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5970141|NCT04537767|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5970142|NCT04537767|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5970143|NCT04537767|Adrenergic Agents|adrenergic agents|mesh-ancestor
5970144|NCT04537767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5970145|NCT04537767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518626|NCT00728013|Atorvastatin|atorvastatin|mesh-list
6518627|NCT00728013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6518628|NCT00728013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6683462|NCT01621568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683463|NCT01621620|Yohimbine|yohimbine|mesh-list
6518629|NCT00728013|Antimetabolites|antimetabolites|mesh-ancestor
6518630|NCT00728013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518631|NCT00728013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6518632|NCT00728013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6683464|NCT01621620|Mydriatics|mydriatics|mesh-ancestor
6683465|NCT01621620|Autonomic Agents|autonomic agents|mesh-ancestor
5959692|NCT04637282|Gemfibrozil|gemfibrozil|mesh-list
5959693|NCT04637282|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5959694|NCT04637282|Antimetabolites|antimetabolites|mesh-ancestor
5959695|NCT04637282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959696|NCT04637282|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5959697|NCT04637282|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
5959698|NCT04637282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5959699|NCT04637282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5959700|NCT04637360|Calcitriol|calcitriol|mesh-list
5959701|NCT04637360|Cinacalcet|cinacalcet|mesh-list
5959702|NCT04637360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5959703|NCT04637360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959704|NCT04637360|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
5959705|NCT04637360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5959706|NCT04637360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959707|NCT04637360|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5959708|NCT04637360|Vitamins|vitamins|mesh-ancestor
5959709|NCT04637360|Micronutrients|micronutrients|mesh-ancestor
5959710|NCT04637360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5959711|NCT04637360|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
5959712|NCT04637360|Hormone Antagonists|hormone antagonists|mesh-ancestor
5959713|NCT04637360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6683466|NCT01621620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6683467|NCT01621620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683468|NCT01621620|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6683469|NCT01621620|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6683470|NCT01621620|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6683471|NCT01621620|Adrenergic Agents|adrenergic agents|mesh-ancestor
6683472|NCT01621620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6683473|NCT01621620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683474|NCT01621620|Urological Agents|urological agents|mesh-ancestor
6683475|NCT01621698|Fentanyl|fentanyl|mesh-list
5959714|NCT04636632|Fosaprepitant|fosaprepitant|mesh-list
5959715|NCT04636632|Aprepitant|aprepitant|mesh-list
6683476|NCT01621698|Bupivacaine|bupivacaine|mesh-list
6683477|NCT01621698|Propofol|propofol|mesh-list
6683478|NCT01621698|Atracurium|atracurium|mesh-list
6683479|NCT01621698|Anesthetics, Local|anesthetics, local|mesh-ancestor
5959716|NCT04636632|Antiemetics|antiemetics|mesh-ancestor
5959717|NCT04636632|Autonomic Agents|autonomic agents|mesh-ancestor
5959718|NCT04636632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5959719|NCT04636632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959720|NCT04636632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5959721|NCT04636632|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5959722|NCT04636632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5959723|NCT04636632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959724|NCT04636671|Dexamethasone|dexamethasone|mesh-list
5959725|NCT04636671|Methylprednisolone|methylprednisolone|mesh-list
5959726|NCT04636671|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5959727|NCT04636671|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5959728|NCT04636671|Prednisolone|prednisolone|mesh-list
5959729|NCT04636671|Prednisolone acetate|prednisolone acetate|mesh-list
5959730|NCT04636671|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5959731|NCT04636671|Prednisolone phosphate|prednisolone phosphate|mesh-list
5959732|NCT04636671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5959733|NCT04636671|Antiemetics|antiemetics|mesh-ancestor
5959734|NCT04636671|Autonomic Agents|autonomic agents|mesh-ancestor
5959735|NCT04636671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5959736|NCT04636671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959737|NCT04636671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5959738|NCT04636671|Glucocorticoids|glucocorticoids|mesh-ancestor
5959739|NCT04636671|Hormones|hormones|mesh-ancestor
5959740|NCT04636671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5959741|NCT04636671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5959742|NCT04636671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5959743|NCT04636671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6518633|NCT00728013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6518634|NCT00728078|Thalidomide|thalidomide|mesh-list
6683480|NCT01621698|Anesthetics|anesthetics|mesh-ancestor
5959744|NCT04636671|Protective Agents|protective agents|mesh-ancestor
5959745|NCT04636125|Doxycycline|doxycycline|mesh-list
5959746|NCT04636125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5959747|NCT04636125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5959748|NCT04636125|Antimalarials|antimalarials|mesh-ancestor
5959749|NCT04636125|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5959750|NCT04636125|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5959751|NCT04636242|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5959752|NCT04636242|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6683481|NCT01621698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6683482|NCT01621698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683483|NCT01621698|Sensory System Agents|sensory system agents|mesh-ancestor
6683484|NCT01621698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6683485|NCT01621698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6683486|NCT01621698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6683487|NCT01621698|Anesthetics, General|anesthetics, general|mesh-ancestor
6683488|NCT01621698|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6683489|NCT01621698|Narcotics|narcotics|mesh-ancestor
6683490|NCT01621698|Analgesics|analgesics|mesh-ancestor
6683491|NCT01621698|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6683492|NCT01621698|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6683493|NCT01621698|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6683494|NCT01621698|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6683495|NCT01621698|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
6683496|NCT01621698|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6683497|NCT01621698|Cholinergic Agents|cholinergic agents|mesh-ancestor
6683498|NCT01621698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5959753|NCT04636242|Dermatologic Agents|dermatologic agents|mesh-ancestor
5959754|NCT04636255|Calcium|calcium|mesh-list
5959755|NCT04636255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5959756|NCT04636255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959757|NCT04636333|Vaccines|vaccines|mesh-list
5959758|NCT04636333|Immunologic Factors|immunologic factors|mesh-ancestor
5959759|NCT04636333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959760|NCT04635774|Insulin|insulin|mesh-list
5959761|NCT04635774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5959762|NCT04635774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959763|NCT04635852|Fentanyl|fentanyl|mesh-list
5959764|NCT04635852|Morphine|morphine|mesh-list
5959765|NCT04635852|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5959766|NCT04635852|Narcotics|narcotics|mesh-ancestor
5959767|NCT04635852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5959768|NCT04635852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959769|NCT04635852|Analgesics|analgesics|mesh-ancestor
5959770|NCT04635852|Sensory System Agents|sensory system agents|mesh-ancestor
5959771|NCT04635852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5959772|NCT04635852|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5959773|NCT04635852|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5959774|NCT04635852|Anesthetics, General|anesthetics, general|mesh-ancestor
5959775|NCT04635852|Anesthetics|anesthetics|mesh-ancestor
5959776|NCT04635839|Heparin|heparin|mesh-list
5959777|NCT04635839|Calcium heparin|calcium heparin|mesh-list
5959778|NCT04635839|Anticoagulants|anticoagulants|mesh-ancestor
5959779|NCT04635839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5959780|NCT04635839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6518635|NCT00728078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6518636|NCT00728078|Immunologic Factors|immunologic factors|mesh-ancestor
6518637|NCT00728078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518638|NCT00728078|Leprostatic Agents|leprostatic agents|mesh-ancestor
6518639|NCT00728078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6518640|NCT00728078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6518641|NCT00728078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6518642|NCT00728078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6518643|NCT00728078|Growth Substances|growth substances|mesh-ancestor
6518644|NCT00728078|Growth Inhibitors|growth inhibitors|mesh-ancestor
6518645|NCT00728078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6518646|NCT00728156|Clopidogrel|clopidogrel|mesh-list
6518647|NCT00728156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6518648|NCT00728156|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6518649|NCT00728156|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6518650|NCT00728156|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6518651|NCT00728156|Purinergic Agents|purinergic agents|mesh-ancestor
6518652|NCT00728156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6518653|NCT00728156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683499|NCT01621698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683500|NCT01621750|Clopidogrel|clopidogrel|mesh-list
6518654|NCT00728156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518655|NCT00728195|Olanzapine|olanzapine|mesh-list
6518656|NCT00728195|N-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|n-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|mesh-list
5959781|NCT04635839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959782|NCT04635696|Ethyl Chloride|ethyl chloride|mesh-list
5959783|NCT04635696|Anesthetics, Local|anesthetics, local|mesh-ancestor
6518657|NCT00728195|Antiemetics|antiemetics|mesh-ancestor
6518658|NCT00728195|Autonomic Agents|autonomic agents|mesh-ancestor
6518659|NCT00728195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6518660|NCT00728195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518661|NCT00728195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6518662|NCT00728195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6518663|NCT00728195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5959784|NCT04635696|Anesthetics|anesthetics|mesh-ancestor
5959785|NCT04635696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5959786|NCT04635696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959787|NCT04635696|Sensory System Agents|sensory system agents|mesh-ancestor
5959788|NCT04635696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5959789|NCT04635605|Methylene Blue|methylene blue|mesh-list
5959790|NCT04635605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5959791|NCT04635605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959792|NCT04635280|Pancrelipase|pancrelipase|mesh-list
5959793|NCT04635280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5959794|NCT04635176|Dexamethasone|dexamethasone|mesh-list
5959795|NCT04635176|Epinephrine|epinephrine|mesh-list
5959796|NCT04635176|Bupivacaine|bupivacaine|mesh-list
5959797|NCT04635176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5959798|NCT04635176|Antiemetics|antiemetics|mesh-ancestor
5959799|NCT04635176|Autonomic Agents|autonomic agents|mesh-ancestor
5959800|NCT04635176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5959801|NCT04635176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959802|NCT04635176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5959803|NCT04635176|Glucocorticoids|glucocorticoids|mesh-ancestor
5959804|NCT04635176|Hormones|hormones|mesh-ancestor
5959805|NCT04635176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6683501|NCT01621750|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6683502|NCT01621750|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6683503|NCT01621750|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5959806|NCT04635176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5959807|NCT04635176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5959808|NCT04635176|Anesthetics, Local|anesthetics, local|mesh-ancestor
6683504|NCT01621750|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6683505|NCT01621750|Purinergic Agents|purinergic agents|mesh-ancestor
6683506|NCT01621750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5959809|NCT04635176|Anesthetics|anesthetics|mesh-ancestor
5959810|NCT04635176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5959811|NCT04635176|Sensory System Agents|sensory system agents|mesh-ancestor
5959812|NCT04635176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5959813|NCT04635176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5959814|NCT04635176|Adrenergic Agents|adrenergic agents|mesh-ancestor
6683507|NCT01621750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683508|NCT01621750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683509|NCT01621763|Clopidogrel|clopidogrel|mesh-list
6683510|NCT01621763|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6683511|NCT01621763|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6683512|NCT01621763|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6683513|NCT01621763|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6683514|NCT01621763|Purinergic Agents|purinergic agents|mesh-ancestor
6683515|NCT01621763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6683516|NCT01621763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683517|NCT01621763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683518|NCT01621789|Diminazene aceturate|diminazene aceturate|mesh-list
6683519|NCT01621789|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6683520|NCT01621789|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6683521|NCT01621789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6683522|NCT01621789|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6683523|NCT01621893|Calcium|calcium|mesh-list
6683524|NCT01621893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6683525|NCT01621893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683526|NCT01621906|Alovudine|alovudine|mesh-list
6683527|NCT01621906|Antiviral Agents|antiviral agents|mesh-ancestor
6683528|NCT01621906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6683529|NCT01621971|Milrinone|milrinone|mesh-list
5959815|NCT04635176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6683530|NCT01621971|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6683531|NCT01621971|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6683532|NCT01621971|Vasodilator Agents|vasodilator agents|mesh-ancestor
5959816|NCT04635176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959817|NCT04635176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5959818|NCT04635176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5959819|NCT04635176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5959820|NCT04635176|Respiratory System Agents|respiratory system agents|mesh-ancestor
5959821|NCT04635176|Mydriatics|mydriatics|mesh-ancestor
5959822|NCT04635176|Sympathomimetics|sympathomimetics|mesh-ancestor
5959823|NCT04635176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5959824|NCT04635566|Mebeverine|mebeverine|mesh-list
5959825|NCT04635566|Alverine|alverine|mesh-list
5959826|NCT04635566|Anticonvulsants|anticonvulsants|mesh-ancestor
5959827|NCT04635566|Parasympatholytics|parasympatholytics|mesh-ancestor
5959828|NCT04635566|Autonomic Agents|autonomic agents|mesh-ancestor
5959829|NCT04635566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5959830|NCT04635566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959831|NCT04635293|Simendan|simendan|mesh-list
5959832|NCT04635293|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5959833|NCT04635293|Vasodilator Agents|vasodilator agents|mesh-ancestor
5959834|NCT04635293|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5959835|NCT04635293|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5959836|NCT04635293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5959837|NCT04635293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959838|NCT04635293|Protective Agents|protective agents|mesh-ancestor
5959839|NCT04635293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970146|NCT04537767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971325|NCT04529226|Dopamine Agents|dopamine agents|mesh-ancestor
5971326|NCT04529226|Antiemetics|antiemetics|mesh-ancestor
5971327|NCT04529226|Autonomic Agents|autonomic agents|mesh-ancestor
5971328|NCT04529226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5971329|NCT04529226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5971330|NCT04529226|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5971331|NCT04529226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5971332|NCT04529226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5971333|NCT04529226|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5971334|NCT04529226|GABA Antagonists|gaba antagonists|mesh-ancestor
6683533|NCT01621971|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5971335|NCT04529226|GABA Agents|gaba agents|mesh-ancestor
5971336|NCT04529226|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5971337|NCT04529226|Antidepressive Agents|antidepressive agents|mesh-ancestor
5971338|NCT04528628|Norepinephrine|norepinephrine|mesh-list
5971339|NCT04528628|Serotonin|serotonin|mesh-list
5971340|NCT04528628|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
5971341|NCT04528628|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
5971342|NCT04528628|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5971343|NCT04528628|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5971344|NCT04528628|Adrenergic Agents|adrenergic agents|mesh-ancestor
5971345|NCT04528628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5971346|NCT04528628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971347|NCT04528628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971348|NCT04528628|Sympathomimetics|sympathomimetics|mesh-ancestor
5971349|NCT04528628|Autonomic Agents|autonomic agents|mesh-ancestor
5971350|NCT04528628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5971351|NCT04528628|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5971352|NCT04528628|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5971353|NCT04528628|Serotonin Agents|serotonin agents|mesh-ancestor
5971354|NCT04528628|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6518664|NCT00728195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6518665|NCT00728195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6518666|NCT00728195|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6518667|NCT00728195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6518668|NCT00728195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6518669|NCT00728195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518670|NCT00728195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6518671|NCT00728195|Serotonin Agents|serotonin agents|mesh-ancestor
6518672|NCT00728195|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6518673|NCT00728195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6518674|NCT00728195|Dopamine Agents|dopamine agents|mesh-ancestor
6518675|NCT00728273|Micronutrients|micronutrients|mesh-list
6518676|NCT00728273|Trace Elements|trace elements|mesh-list
6518677|NCT00728273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518678|NCT00728312|Aripiprazole|aripiprazole|mesh-list
6683534|NCT01621971|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6683535|NCT01621971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6683536|NCT01621971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683537|NCT01621971|Protective Agents|protective agents|mesh-ancestor
6683538|NCT01621971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683539|NCT01622075|Paclitaxel|paclitaxel|mesh-list
6683540|NCT01622075|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6683541|NCT01622075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6683542|NCT01622075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6683543|NCT01622075|Tubulin Modulators|tubulin modulators|mesh-ancestor
6683544|NCT01622075|Antimitotic Agents|antimitotic agents|mesh-ancestor
6518679|NCT00728312|Antidepressive Agents|antidepressive agents|mesh-ancestor
6518680|NCT00728312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6518681|NCT00728312|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6518682|NCT00728312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6518683|NCT00728312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6518684|NCT00728312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518685|NCT00728312|Dopamine Agonists|dopamine agonists|mesh-ancestor
6518686|NCT00728312|Dopamine Agents|dopamine agents|mesh-ancestor
6518687|NCT00728312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6518688|NCT00728312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518689|NCT00728312|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6518690|NCT00728312|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6518691|NCT00728312|Serotonin Agents|serotonin agents|mesh-ancestor
6518692|NCT00728312|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6518693|NCT00728312|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6518694|NCT00728312|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6518695|NCT00728312|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6683545|NCT01622075|Mitosis Modulators|mitosis modulators|mesh-ancestor
6683546|NCT01622075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683547|NCT01622283|Cetirizine|cetirizine|mesh-list
6683548|NCT01622283|Levocetirizine|levocetirizine|mesh-list
6683549|NCT01622283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6683550|NCT01622283|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6683551|NCT01622283|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6683552|NCT01622283|Histamine Antagonists|histamine antagonists|mesh-ancestor
6683553|NCT01622283|Histamine Agents|histamine agents|mesh-ancestor
6683554|NCT01622283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6683555|NCT01622283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683556|NCT01622283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683557|NCT01622322|Nitrous Oxide|nitrous oxide|mesh-list
6683558|NCT01622322|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6683559|NCT01622322|Anesthetics, General|anesthetics, general|mesh-ancestor
6683560|NCT01622322|Anesthetics|anesthetics|mesh-ancestor
5959840|NCT04635007|Misoprostol|misoprostol|mesh-list
5959841|NCT04635007|Tranexamic Acid|tranexamic acid|mesh-list
5959842|NCT04635007|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5959843|NCT04635007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5959844|NCT04635007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959845|NCT04635007|Hemostatics|hemostatics|mesh-ancestor
5959846|NCT04635007|Coagulants|coagulants|mesh-ancestor
5959847|NCT04635007|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5959848|NCT04635007|Abortifacient Agents|abortifacient agents|mesh-ancestor
5959849|NCT04635007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5959850|NCT04635007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959851|NCT04635007|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5959852|NCT04635007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6683561|NCT01622322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6683562|NCT01622322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683563|NCT01622322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6683564|NCT01622322|Analgesics|analgesics|mesh-ancestor
6683565|NCT01622322|Sensory System Agents|sensory system agents|mesh-ancestor
6683566|NCT01622322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6683567|NCT01622361|Tamoxifen|tamoxifen|mesh-list
6683568|NCT01622361|Cyclophosphamide|cyclophosphamide|mesh-list
6683569|NCT01622361|Docetaxel|docetaxel|mesh-list
6683570|NCT01622361|Doxorubicin|doxorubicin|mesh-list
6683571|NCT01622361|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5959853|NCT04635007|Oxytocics|oxytocics|mesh-ancestor
5959854|NCT04635098|Dexmedetomidine|dexmedetomidine|mesh-list
5959855|NCT04635098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5959856|NCT04635098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5959857|NCT04635098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959858|NCT04635098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5959859|NCT04635098|Analgesics|analgesics|mesh-ancestor
6683572|NCT01622361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6683573|NCT01622361|Immunologic Factors|immunologic factors|mesh-ancestor
6683574|NCT01622361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683575|NCT01622361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6683576|NCT01622361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6683577|NCT01622361|Alkylating Agents|alkylating agents|mesh-ancestor
6683578|NCT01622361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683579|NCT01622361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6683580|NCT01622361|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6683581|NCT01622361|Tubulin Modulators|tubulin modulators|mesh-ancestor
6683582|NCT01622361|Antimitotic Agents|antimitotic agents|mesh-ancestor
6518696|NCT00728520|Azacitidine|azacitidine|mesh-list
6518697|NCT00728520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6518698|NCT00728520|Antimetabolites|antimetabolites|mesh-ancestor
6518699|NCT00728520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518700|NCT00728520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6683583|NCT01622361|Mitosis Modulators|mitosis modulators|mesh-ancestor
6683584|NCT01622361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6683585|NCT01622361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6683586|NCT01622361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6683587|NCT01622361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6683588|NCT01622361|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6683589|NCT01622361|Hormone Antagonists|hormone antagonists|mesh-ancestor
6683590|NCT01622361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6683591|NCT01622361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6683592|NCT01622361|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6683593|NCT01622361|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6683594|NCT01622361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6683595|NCT01622439|Prednisone|prednisone|mesh-list
6683596|NCT01622439|Cyclophosphamide|cyclophosphamide|mesh-list
6683597|NCT01622439|Rituximab|rituximab|mesh-list
6683598|NCT01622439|Doxorubicin|doxorubicin|mesh-list
6683599|NCT01622439|Vincristine|vincristine|mesh-list
5959860|NCT04635098|Sensory System Agents|sensory system agents|mesh-ancestor
5959861|NCT04635098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5959862|NCT04635098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5959863|NCT04635098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5959864|NCT04635098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5959865|NCT04635098|Adrenergic Agents|adrenergic agents|mesh-ancestor
5959866|NCT04635098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5959867|NCT04635098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959868|NCT04635553|Praziquantel|praziquantel|mesh-list
5959869|NCT04635553|Anthelmintics|anthelmintics|mesh-ancestor
5959870|NCT04635553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5959871|NCT04635553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5959872|NCT04635189|Dexamethasone|dexamethasone|mesh-list
5959873|NCT04635189|Lenalidomide|lenalidomide|mesh-list
5959874|NCT04635189|Daratumumab|daratumumab|mesh-list
5959875|NCT04635189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5959876|NCT04635189|Antiemetics|antiemetics|mesh-ancestor
5959877|NCT04635189|Autonomic Agents|autonomic agents|mesh-ancestor
5959878|NCT04635189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6518701|NCT00728520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6518702|NCT00728546|Isoniazid|isoniazid|mesh-list
6518703|NCT00728546|Antitubercular Agents|antitubercular agents|mesh-ancestor
6518704|NCT00728546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6683600|NCT01622439|Valproic Acid|valproic acid|mesh-list
6683601|NCT01622439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6683602|NCT01622439|Immunologic Factors|immunologic factors|mesh-ancestor
6683603|NCT01622439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683604|NCT01622439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6683605|NCT01622439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6683606|NCT01622439|Alkylating Agents|alkylating agents|mesh-ancestor
5959879|NCT04635189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959880|NCT04635189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5959881|NCT04635189|Glucocorticoids|glucocorticoids|mesh-ancestor
6683607|NCT01622439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683608|NCT01622439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6683609|NCT01622439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6683610|NCT01622439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6683611|NCT01622439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6683612|NCT01622439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5959882|NCT04635189|Hormones|hormones|mesh-ancestor
6242653|NCT02654054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6518705|NCT00728546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5959883|NCT04635189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5959884|NCT04635189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5959885|NCT04635189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6683613|NCT01622439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6683614|NCT01622439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6683615|NCT01622439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6683616|NCT01622439|Glucocorticoids|glucocorticoids|mesh-ancestor
6683617|NCT01622439|Hormones|hormones|mesh-ancestor
6683618|NCT01622439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6683619|NCT01622439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6683620|NCT01622439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6683621|NCT01622439|Tubulin Modulators|tubulin modulators|mesh-ancestor
6683622|NCT01622439|Antimitotic Agents|antimitotic agents|mesh-ancestor
5959886|NCT04635189|Immunologic Factors|immunologic factors|mesh-ancestor
5959887|NCT04635189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5959888|NCT04635189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5959889|NCT04635189|Growth Substances|growth substances|mesh-ancestor
5959890|NCT04635189|Growth Inhibitors|growth inhibitors|mesh-ancestor
5959891|NCT04634838|Copper|copper|mesh-list
5959892|NCT04634838|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6683623|NCT01622439|Mitosis Modulators|mitosis modulators|mesh-ancestor
6683624|NCT01622439|Anticonvulsants|anticonvulsants|mesh-ancestor
6683625|NCT01622439|GABA Agents|gaba agents|mesh-ancestor
6683626|NCT01622439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6683627|NCT01622439|Antimanic Agents|antimanic agents|mesh-ancestor
6683628|NCT01622439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6683629|NCT01622439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6683630|NCT01622439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6683631|NCT01622504|Naloxone|naloxone|mesh-list
6683632|NCT01622504|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6683633|NCT01622504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683634|NCT01622504|Sensory System Agents|sensory system agents|mesh-ancestor
6683635|NCT01622504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6683636|NCT01622556|Fludarabine|fludarabine|mesh-list
6683637|NCT01622556|Busulfan|busulfan|mesh-list
6683638|NCT01622556|Thymoglobulin|thymoglobulin|mesh-list
6683639|NCT01622556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6683640|NCT01622556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683641|NCT01622556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6683642|NCT01622556|Immunologic Factors|immunologic factors|mesh-ancestor
6683643|NCT01622556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683644|NCT01622556|Alkylating Agents|alkylating agents|mesh-ancestor
6683645|NCT01622556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6683646|NCT01622556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6683647|NCT01622777|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6683648|NCT01622777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6683649|NCT01622777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6683650|NCT01622777|Antimetabolites|antimetabolites|mesh-ancestor
6683651|NCT01622777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683652|NCT01622777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6683653|NCT01622777|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5959893|NCT04634838|Trace Elements|trace elements|mesh-ancestor
5959894|NCT04634838|Micronutrients|micronutrients|mesh-ancestor
5959895|NCT04634838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959896|NCT04634838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5959897|NCT04634981|Anesthetics|anesthetics|mesh-list
5959898|NCT04634981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5959899|NCT04634981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959900|NCT04634656|Lidocaine|lidocaine|mesh-list
5959901|NCT04634656|Anesthetics, Local|anesthetics, local|mesh-ancestor
5959902|NCT04634656|Anesthetics|anesthetics|mesh-ancestor
5959903|NCT04634656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5959904|NCT04634656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959905|NCT04634656|Sensory System Agents|sensory system agents|mesh-ancestor
5959906|NCT04634656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5959907|NCT04634656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5959908|NCT04634656|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5959909|NCT04634656|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5959910|NCT04634656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5959911|NCT04634656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959912|NCT04634500|Dapagliflozin|dapagliflozin|mesh-list
6683654|NCT01622777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6683655|NCT01622790|Lamivudine|lamivudine|mesh-list
6683656|NCT01622790|Abacavir|abacavir|mesh-list
6683657|NCT01622790|Dideoxynucleosides|dideoxynucleosides|mesh-list
5959913|NCT04634500|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5959914|NCT04634500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959915|NCT04634500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5959916|NCT04634500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959917|NCT04634721|Bupivacaine|bupivacaine|mesh-list
5959918|NCT04634721|Anesthetics, Local|anesthetics, local|mesh-ancestor
5959919|NCT04634721|Anesthetics|anesthetics|mesh-ancestor
5959920|NCT04634721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5959921|NCT04634721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959922|NCT04634721|Sensory System Agents|sensory system agents|mesh-ancestor
5959923|NCT04634721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5959924|NCT04634669|Dextromethorphan|dextromethorphan|mesh-list
5959925|NCT04634669|Bupropion|bupropion|mesh-list
5959926|NCT04634669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5959927|NCT04634669|Antidepressive Agents|antidepressive agents|mesh-ancestor
5959928|NCT04634669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5959929|NCT04634669|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5959930|NCT04634669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5959931|NCT04634669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5959932|NCT04634669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959933|NCT04634669|Dopamine Agents|dopamine agents|mesh-ancestor
5959934|NCT04634669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5959935|NCT04634669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959936|NCT04634669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5959937|NCT04634669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5959938|NCT04634669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5959939|NCT04634669|Antitussive Agents|antitussive agents|mesh-ancestor
5959940|NCT04634669|Respiratory System Agents|respiratory system agents|mesh-ancestor
5959941|NCT04634669|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5959942|NCT04634669|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5959943|NCT04633967|Alemtuzumab|alemtuzumab|mesh-list
5959944|NCT04633967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5959945|NCT04633967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5959946|NCT04633954|Brimonidine Tartrate|brimonidine tartrate|mesh-list
5959947|NCT04633954|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5959948|NCT04633954|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5959949|NCT04633954|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5959950|NCT04633954|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5959951|NCT04633954|Adrenergic Agents|adrenergic agents|mesh-ancestor
5959952|NCT04633954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5959953|NCT04633954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959954|NCT04633954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959955|NCT04634058|Antibodies|antibodies|mesh-list
5959956|NCT04634058|Immunoglobulins|immunoglobulins|mesh-list
5959957|NCT04634058|Immunologic Factors|immunologic factors|mesh-ancestor
5959958|NCT04634058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959959|NCT04633902|Pembrolizumab|pembrolizumab|mesh-list
5959960|NCT04633902|Olaparib|olaparib|mesh-list
5959961|NCT04633902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5959962|NCT04633902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5959963|NCT04633902|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5959964|NCT04633902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5959965|NCT04633902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959966|NCT04633850|Dexamethasone|dexamethasone|mesh-list
5959967|NCT04633850|Bupivacaine|bupivacaine|mesh-list
6518706|NCT00728546|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6518707|NCT00728546|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6683658|NCT01622790|Dolutegravir|dolutegravir|mesh-list
5959968|NCT04633850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5959969|NCT04633850|Antiemetics|antiemetics|mesh-ancestor
5959970|NCT04633850|Autonomic Agents|autonomic agents|mesh-ancestor
5959971|NCT04633850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6518708|NCT00728546|Antimetabolites|antimetabolites|mesh-ancestor
6518709|NCT00728546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518710|NCT00728546|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6518711|NCT00728559|Bupivacaine|bupivacaine|mesh-list
6518712|NCT00728559|Anesthetics, Local|anesthetics, local|mesh-ancestor
6518713|NCT00728559|Anesthetics|anesthetics|mesh-ancestor
6518714|NCT00728559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6518715|NCT00728559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518716|NCT00728559|Sensory System Agents|sensory system agents|mesh-ancestor
6518717|NCT00728559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6683659|NCT01622790|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6683660|NCT01622790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6683661|NCT01622790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6683662|NCT01622790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683663|NCT01622790|Antiviral Agents|antiviral agents|mesh-ancestor
6683664|NCT01622790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6683665|NCT01622790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6683666|NCT01622790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5959972|NCT04633850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959973|NCT04633850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5959974|NCT04633850|Glucocorticoids|glucocorticoids|mesh-ancestor
5959975|NCT04633850|Hormones|hormones|mesh-ancestor
5959976|NCT04633850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5959977|NCT04633850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5959978|NCT04633850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5959979|NCT04633850|Anesthetics, Local|anesthetics, local|mesh-ancestor
5959980|NCT04633850|Anesthetics|anesthetics|mesh-ancestor
5959981|NCT04633850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5959982|NCT04633850|Sensory System Agents|sensory system agents|mesh-ancestor
5959983|NCT04633746|Endostatins|endostatins|mesh-list
5959984|NCT04633746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5959985|NCT04633746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5959986|NCT04633746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5959987|NCT04633746|Growth Substances|growth substances|mesh-ancestor
5959988|NCT04633746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959989|NCT04633746|Growth Inhibitors|growth inhibitors|mesh-ancestor
5959990|NCT04633733|Tacrolimus|tacrolimus|mesh-list
5959991|NCT04633733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5959992|NCT04633733|Immunologic Factors|immunologic factors|mesh-ancestor
5959993|NCT04633733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5959994|NCT04633733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5959995|NCT04633733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5959996|NCT04633733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5959997|NCT04633577|Lidocaine|lidocaine|mesh-list
5959998|NCT04633577|Anesthetics, Local|anesthetics, local|mesh-ancestor
5959999|NCT04633577|Anesthetics|anesthetics|mesh-ancestor
5960000|NCT04633577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5960001|NCT04633577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960002|NCT04633577|Sensory System Agents|sensory system agents|mesh-ancestor
5960003|NCT04633577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5960004|NCT04633577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5960005|NCT04633577|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5960006|NCT04633577|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5960007|NCT04633577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5960008|NCT04633577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970147|NCT04537689|Cyclosporine|cyclosporine|mesh-list
5970148|NCT04537689|Methotrexate|methotrexate|mesh-list
5970149|NCT04537689|Ixekizumab|ixekizumab|mesh-list
5970150|NCT04537689|Acitretin|acitretin|mesh-list
5970151|NCT04537689|Cyclosporins|cyclosporins|mesh-list
5970152|NCT04537689|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5970153|NCT04537689|Abortifacient Agents|abortifacient agents|mesh-ancestor
5970154|NCT04537689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5970155|NCT04537689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970156|NCT04537689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5970157|NCT04537689|Antimetabolites|antimetabolites|mesh-ancestor
5970158|NCT04537689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970159|NCT04537689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5970160|NCT04537689|Dermatologic Agents|dermatologic agents|mesh-ancestor
5970161|NCT04537689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5970162|NCT04537689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5970163|NCT04537689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5970164|NCT04537689|Immunologic Factors|immunologic factors|mesh-ancestor
5970165|NCT04537689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5970166|NCT04537689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6518718|NCT00728585|Mitogens|mitogens|mesh-list
6518719|NCT00728585|Mitosis Modulators|mitosis modulators|mesh-ancestor
6518720|NCT00728585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518721|NCT00728611|Hyaluronic Acid|hyaluronic acid|mesh-list
6518722|NCT00728611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6518723|NCT00728611|Immunologic Factors|immunologic factors|mesh-ancestor
6518724|NCT00728611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683667|NCT01622790|Antimetabolites|antimetabolites|mesh-ancestor
6518725|NCT00728611|Viscosupplements|viscosupplements|mesh-ancestor
6518726|NCT00728611|Protective Agents|protective agents|mesh-ancestor
6518727|NCT00728663|Docetaxel|docetaxel|mesh-list
6518728|NCT00728663|Cetuximab|cetuximab|mesh-list
6518729|NCT00728663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6518730|NCT00728663|Tubulin Modulators|tubulin modulators|mesh-ancestor
6518731|NCT00728663|Antimitotic Agents|antimitotic agents|mesh-ancestor
6518732|NCT00728663|Mitosis Modulators|mitosis modulators|mesh-ancestor
6518733|NCT00728663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960009|NCT04633564|Bevacizumab|bevacizumab|mesh-list
5960010|NCT04633564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5960011|NCT04633564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5960012|NCT04633564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5960013|NCT04633564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5960014|NCT04633564|Growth Substances|growth substances|mesh-ancestor
5960015|NCT04633564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960016|NCT04633564|Growth Inhibitors|growth inhibitors|mesh-ancestor
5960017|NCT04633551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
5960018|NCT04633213|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5960019|NCT04633213|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5960020|NCT04633044|Betaine|betaine|mesh-list
5960021|NCT04633044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5960022|NCT04633044|Lipotropic Agents|lipotropic agents|mesh-ancestor
6683668|NCT01622790|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6683669|NCT01622790|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6683670|NCT01622881|Nefopam|nefopam|mesh-list
6683671|NCT01622881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5960023|NCT04633044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5960024|NCT04633044|Antimetabolites|antimetabolites|mesh-ancestor
6683672|NCT01622881|Analgesics|analgesics|mesh-ancestor
6683673|NCT01622881|Sensory System Agents|sensory system agents|mesh-ancestor
6683674|NCT01622881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6683675|NCT01622881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780061|NCT02182167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6780062|NCT02182167|Expectorants|expectorants|mesh-ancestor
6780063|NCT02182167|Respiratory System Agents|respiratory system agents|mesh-ancestor
6780064|NCT02182167|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6780065|NCT02182167|Antioxidants|antioxidants|mesh-ancestor
6780066|NCT02182167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780067|NCT02182167|Protective Agents|protective agents|mesh-ancestor
6780068|NCT02182167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780069|NCT02182167|Antidotes|antidotes|mesh-ancestor
6780070|NCT02182193|Nintedanib|nintedanib|mesh-list
6780071|NCT02182193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6780072|NCT02182193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6780073|NCT02182193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780074|NCT02182193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780075|NCT02182206|Nintedanib|nintedanib|mesh-list
6780076|NCT02182206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6780077|NCT02182206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6780078|NCT02182206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780079|NCT02182206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780080|NCT02182219|Nintedanib|nintedanib|mesh-list
6780081|NCT02182219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6780082|NCT02182219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6780083|NCT02182219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780084|NCT02182219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780085|NCT02182232|Paclitaxel|paclitaxel|mesh-list
6780086|NCT02182232|Carboplatin|carboplatin|mesh-list
6780087|NCT02182232|Nintedanib|nintedanib|mesh-list
6780088|NCT02182232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6780089|NCT02182232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6780090|NCT02182232|Tubulin Modulators|tubulin modulators|mesh-ancestor
6780091|NCT02182232|Antimitotic Agents|antimitotic agents|mesh-ancestor
6780092|NCT02182232|Mitosis Modulators|mitosis modulators|mesh-ancestor
5960025|NCT04633044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960026|NCT04633044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6518734|NCT00728663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6518735|NCT00728715|Budesonide|budesonide|mesh-list
6780093|NCT02182232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960027|NCT04633122|Sunitinib|sunitinib|mesh-list
6518736|NCT00728715|Formoterol Fumarate|formoterol fumarate|mesh-list
6518737|NCT00728715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6518738|NCT00728715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6518739|NCT00728715|Autonomic Agents|autonomic agents|mesh-ancestor
6518740|NCT00728715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6518741|NCT00728715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518742|NCT00728715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6518743|NCT00728715|Respiratory System Agents|respiratory system agents|mesh-ancestor
5960028|NCT04633122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5960029|NCT04633122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5960030|NCT04633122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5960031|NCT04633122|Growth Substances|growth substances|mesh-ancestor
5960032|NCT04633122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960033|NCT04633122|Growth Inhibitors|growth inhibitors|mesh-ancestor
5960034|NCT04633122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5960035|NCT04633122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5960036|NCT04633122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960037|NCT04632693|Ascorbic Acid|ascorbic acid|mesh-list
5960038|NCT04632693|Vitamins|vitamins|mesh-ancestor
5960039|NCT04632693|Micronutrients|micronutrients|mesh-ancestor
5960040|NCT04632693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960041|NCT04632693|Antioxidants|antioxidants|mesh-ancestor
5960042|NCT04632693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960043|NCT04632693|Protective Agents|protective agents|mesh-ancestor
5960044|NCT04632589|Losartan|losartan|mesh-list
5960045|NCT04632589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5960046|NCT04632589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5960047|NCT04632589|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5960048|NCT04632589|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5960049|NCT04632589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960050|NCT04632758|Crizotinib|crizotinib|mesh-list
5960051|NCT04632758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5960052|NCT04632758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5960053|NCT04632758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5960054|NCT04632758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960055|NCT04632316|Cyclophosphamide|cyclophosphamide|mesh-list
5960056|NCT04632316|Fludarabine|fludarabine|mesh-list
5960057|NCT04632316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5960058|NCT04632316|Immunologic Factors|immunologic factors|mesh-ancestor
5960059|NCT04632316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960060|NCT04632316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5960061|NCT04632316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5960062|NCT04632316|Alkylating Agents|alkylating agents|mesh-ancestor
5960063|NCT04632316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960064|NCT04632316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6683676|NCT01622933|Interferons|interferons|mesh-list
6683677|NCT01622933|Interferon-alpha|interferon-alpha|mesh-list
6683678|NCT01622933|Vaccines|vaccines|mesh-list
6683679|NCT01622933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6683680|NCT01622933|Antiviral Agents|antiviral agents|mesh-ancestor
6683681|NCT01622933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5970167|NCT04537689|Antifungal Agents|antifungal agents|mesh-ancestor
6518744|NCT00728715|Glucocorticoids|glucocorticoids|mesh-ancestor
6518745|NCT00728715|Hormones|hormones|mesh-ancestor
6683682|NCT01622933|Immunologic Factors|immunologic factors|mesh-ancestor
6683683|NCT01622933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683684|NCT01622946|Tranexamic Acid|tranexamic acid|mesh-list
6683685|NCT01622946|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6683686|NCT01622946|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6683687|NCT01622946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683688|NCT01622946|Hemostatics|hemostatics|mesh-ancestor
6683689|NCT01622946|Coagulants|coagulants|mesh-ancestor
6683690|NCT01622972|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
6683691|NCT01622972|Laxatives|laxatives|mesh-ancestor
6683692|NCT01622972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6683693|NCT01622998|Nicotine|nicotine|mesh-list
6683694|NCT01622998|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6683695|NCT01622998|Autonomic Agents|autonomic agents|mesh-ancestor
6683696|NCT01622998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6683697|NCT01622998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683698|NCT01622998|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6683699|NCT01622998|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6683700|NCT01622998|Cholinergic Agents|cholinergic agents|mesh-ancestor
6683701|NCT01622998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6683702|NCT01622998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683703|NCT01623024|Vitamin D|vitamin d|mesh-list
6518746|NCT00728715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6518747|NCT00728715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6518748|NCT00728715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6683704|NCT01623024|Vitamins|vitamins|mesh-ancestor
6683705|NCT01623024|Micronutrients|micronutrients|mesh-ancestor
6683706|NCT01623024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683707|NCT01623024|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6683708|NCT01623102|Gemcitabine|gemcitabine|mesh-list
6683709|NCT01623102|Bevacizumab|bevacizumab|mesh-list
6683710|NCT01623102|Cisplatin|cisplatin|mesh-list
6683711|NCT01623102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6683712|NCT01623102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6683713|NCT01623102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6683714|NCT01623102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6683715|NCT01623102|Growth Substances|growth substances|mesh-ancestor
6683716|NCT01623102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683717|NCT01623102|Growth Inhibitors|growth inhibitors|mesh-ancestor
6683718|NCT01623102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6683719|NCT01623102|Antimetabolites|antimetabolites|mesh-ancestor
6683720|NCT01623102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518749|NCT00728715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6518750|NCT00728715|Adrenergic Agents|adrenergic agents|mesh-ancestor
6518751|NCT00728715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6518752|NCT00728715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960065|NCT04632316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5960066|NCT04632459|Pembrolizumab|pembrolizumab|mesh-list
5960067|NCT04632459|Ramucirumab|ramucirumab|mesh-list
5960068|NCT04632459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5960069|NCT04632459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5960070|NCT04632537|BCG Vaccine|bcg vaccine|mesh-list
5960071|NCT04632537|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5960072|NCT04632537|Immunologic Factors|immunologic factors|mesh-ancestor
5960073|NCT04632537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960074|NCT04632433|Cemiplimab|cemiplimab|mesh-list
5960075|NCT04632433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5960076|NCT04632433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5960077|NCT04632238|Metronidazole|metronidazole|mesh-list
5960078|NCT04632238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5960079|NCT04632238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5960080|NCT04632238|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5960081|NCT04632238|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5960082|NCT04632121|Nicorandil|nicorandil|mesh-list
5960083|NCT04632121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5960084|NCT04632121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5960085|NCT04632121|Vasodilator Agents|vasodilator agents|mesh-ancestor
5960086|NCT04632121|Vitamin B Complex|vitamin b complex|mesh-ancestor
5960087|NCT04632121|Vitamins|vitamins|mesh-ancestor
5960088|NCT04632121|Micronutrients|micronutrients|mesh-ancestor
5960089|NCT04632121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960090|NCT04631874|Varenicline|varenicline|mesh-list
5960091|NCT04631874|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5960092|NCT04631874|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5960093|NCT04631874|Cholinergic Agents|cholinergic agents|mesh-ancestor
5960094|NCT04631874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5960095|NCT04631874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960096|NCT04631874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960097|NCT04631822|Dexamethasone|dexamethasone|mesh-list
5960098|NCT04631822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5960099|NCT04631822|Antiemetics|antiemetics|mesh-ancestor
5960100|NCT04631822|Autonomic Agents|autonomic agents|mesh-ancestor
5960101|NCT04631822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5960102|NCT04631822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960103|NCT04631822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5960104|NCT04631822|Glucocorticoids|glucocorticoids|mesh-ancestor
5960105|NCT04631822|Hormones|hormones|mesh-ancestor
5960106|NCT04631822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5960107|NCT04631822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5960108|NCT04631822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5970168|NCT04537689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5970169|NCT04537689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5970170|NCT04537689|Keratolytic Agents|keratolytic agents|mesh-ancestor
5970171|NCT04537533|Tranexamic Acid|tranexamic acid|mesh-list
5970172|NCT04537533|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5970173|NCT04537533|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5970174|NCT04537533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970175|NCT04537533|Hemostatics|hemostatics|mesh-ancestor
5970176|NCT04537533|Coagulants|coagulants|mesh-ancestor
6518753|NCT00728780|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6518754|NCT00728780|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6518755|NCT00728780|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6518756|NCT00728780|Antimetabolites|antimetabolites|mesh-ancestor
5960109|NCT04631627|Aspirin|aspirin|mesh-list
5960110|NCT04631627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5960111|NCT04631627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5960112|NCT04631627|Analgesics|analgesics|mesh-ancestor
5960113|NCT04631627|Sensory System Agents|sensory system agents|mesh-ancestor
5960114|NCT04631627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5960115|NCT04631627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960116|NCT04631627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5960117|NCT04631627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5960118|NCT04631627|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5960119|NCT04631627|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5960120|NCT04631627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960121|NCT04631627|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5960122|NCT04631627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5960123|NCT04631627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5960124|NCT04631627|Antipyretics|antipyretics|mesh-ancestor
5960125|NCT04631315|Prednisolone|prednisolone|mesh-list
5960126|NCT04631315|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5960127|NCT04631315|Methylprednisolone|methylprednisolone|mesh-list
5960128|NCT04631315|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5960129|NCT04631315|Prednisolone acetate|prednisolone acetate|mesh-list
5960130|NCT04631315|Phenylephrine|phenylephrine|mesh-list
5960131|NCT04631315|Oxymetazoline|oxymetazoline|mesh-list
5960132|NCT04631315|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5960133|NCT04631315|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5960134|NCT04631315|Prednisolone phosphate|prednisolone phosphate|mesh-list
5960135|NCT04631315|Difluprednate|difluprednate|mesh-list
5960136|NCT04631315|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5960137|NCT04631315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5960138|NCT04631315|Glucocorticoids|glucocorticoids|mesh-ancestor
5960139|NCT04631315|Hormones|hormones|mesh-ancestor
5960140|NCT04631315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5960141|NCT04631315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960142|NCT04631315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5960143|NCT04631315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5960144|NCT04631315|Antiemetics|antiemetics|mesh-ancestor
5960145|NCT04631315|Autonomic Agents|autonomic agents|mesh-ancestor
5960146|NCT04631315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5960147|NCT04631315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5960148|NCT04631315|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5960149|NCT04631315|Protective Agents|protective agents|mesh-ancestor
5960150|NCT04631315|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5960151|NCT04631315|Mydriatics|mydriatics|mesh-ancestor
5960152|NCT04631315|Sympathomimetics|sympathomimetics|mesh-ancestor
6683721|NCT01623102|Antiviral Agents|antiviral agents|mesh-ancestor
6683722|NCT01623102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6683723|NCT01623102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6683724|NCT01623102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6683725|NCT01623102|Immunologic Factors|immunologic factors|mesh-ancestor
6683726|NCT01623206|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
6683727|NCT01623206|Hemostatics|hemostatics|mesh-ancestor
6683728|NCT01623206|Coagulants|coagulants|mesh-ancestor
6683729|NCT01623206|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6683730|NCT01623206|Natriuretic Agents|natriuretic agents|mesh-ancestor
6683731|NCT01623206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683732|NCT01623284|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6683733|NCT01623284|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6683734|NCT01623284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683735|NCT01623336|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6683736|NCT01623336|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6683737|NCT01623336|Interferon-alpha|interferon-alpha|mesh-list
6683738|NCT01623336|Antiviral Agents|antiviral agents|mesh-ancestor
6683739|NCT01623336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6683740|NCT01623336|Immunologic Factors|immunologic factors|mesh-ancestor
6683741|NCT01623336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683742|NCT01623349|Olaparib|olaparib|mesh-list
6683743|NCT01623349|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6683744|NCT01623349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6683745|NCT01623349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683746|NCT01623349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6683747|NCT01623362|Fluorides|fluorides|mesh-list
6683748|NCT01623362|Cariostatic Agents|cariostatic agents|mesh-ancestor
6683749|NCT01623362|Protective Agents|protective agents|mesh-ancestor
6683750|NCT01623362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683751|NCT01623375|Insulin|insulin|mesh-list
5960153|NCT04631315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6683752|NCT01623375|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6683753|NCT01623375|Insulin, Long-Acting|insulin, long-acting|mesh-list
6683754|NCT01623375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6683755|NCT01623375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683756|NCT01623401|Tedizolid phosphate|tedizolid phosphate|mesh-list
6683757|NCT01623401|Tedizolid|tedizolid|mesh-list
6683758|NCT01623401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6683759|NCT01623401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6683760|NCT01623440|Naltrexone|naltrexone|mesh-list
6683761|NCT01623440|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6683762|NCT01623440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6683763|NCT01623440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683764|NCT01623440|Sensory System Agents|sensory system agents|mesh-ancestor
6683765|NCT01623440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6683766|NCT01623505|Varenicline|varenicline|mesh-list
6683767|NCT01623505|Nicotine|nicotine|mesh-list
6683768|NCT01623505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6683769|NCT01623505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6683770|NCT01623505|Cholinergic Agents|cholinergic agents|mesh-ancestor
6683771|NCT01623505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6683772|NCT01623505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960154|NCT04631315|Nasal Decongestants|nasal decongestants|mesh-ancestor
5960155|NCT04631315|Respiratory System Agents|respiratory system agents|mesh-ancestor
5960156|NCT04631315|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5960157|NCT04631315|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5960158|NCT04631315|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5960159|NCT04631315|Adrenergic Agents|adrenergic agents|mesh-ancestor
5960160|NCT04631315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5960161|NCT04631315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960162|NCT04631341|Melatonin|melatonin|mesh-list
5960163|NCT04631341|Antioxidants|antioxidants|mesh-ancestor
5960164|NCT04631341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960165|NCT04631341|Protective Agents|protective agents|mesh-ancestor
5960166|NCT04631341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960167|NCT04631341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5960168|NCT04631484|Riboflavin|riboflavin|mesh-list
5960169|NCT04631484|Niacinamide|niacinamide|mesh-list
5960170|NCT04631484|Niacin|niacin|mesh-list
5960171|NCT04631484|Nicotinic Acids|nicotinic acids|mesh-list
5960172|NCT04631484|Vitamin B Complex|vitamin b complex|mesh-ancestor
5960173|NCT04631484|Vitamins|vitamins|mesh-ancestor
5960174|NCT04631484|Micronutrients|micronutrients|mesh-ancestor
5960175|NCT04631484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960176|NCT04631484|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5960177|NCT04631484|Dermatologic Agents|dermatologic agents|mesh-ancestor
5960178|NCT04631484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5960179|NCT04631484|Antimetabolites|antimetabolites|mesh-ancestor
5960180|NCT04631484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960181|NCT04631484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5960182|NCT04631484|Vasodilator Agents|vasodilator agents|mesh-ancestor
5960183|NCT04631250|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5960184|NCT04631250|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5960185|NCT04631250|Dermatologic Agents|dermatologic agents|mesh-ancestor
5960186|NCT04631263|Hyaluronic Acid|hyaluronic acid|mesh-list
5960187|NCT04631263|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5960188|NCT04631263|Immunologic Factors|immunologic factors|mesh-ancestor
5960189|NCT04631263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960190|NCT04631263|Viscosupplements|viscosupplements|mesh-ancestor
5960191|NCT04631263|Protective Agents|protective agents|mesh-ancestor
5960192|NCT04630808|Latanoprost|latanoprost|mesh-list
5960193|NCT04630808|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5960194|NCT04630808|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5960195|NCT04630769|Interleukin-2|interleukin-2|mesh-list
5960196|NCT04630769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5960197|NCT04630769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5960198|NCT04630769|Analgesics|analgesics|mesh-ancestor
5960199|NCT04630769|Sensory System Agents|sensory system agents|mesh-ancestor
5960200|NCT04630769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5960201|NCT04630769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960202|NCT04630821|Sodium Hypochlorite|sodium hypochlorite|mesh-list
5960203|NCT04630821|Eusol|eusol|mesh-list
5960204|NCT04630821|Disinfectants|disinfectants|mesh-ancestor
5960205|NCT04630821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5960206|NCT04630873|Botulinum Toxins|botulinum toxins|mesh-list
5960207|NCT04630873|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5960208|NCT04630873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5960209|NCT04630873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960210|NCT04630873|Cholinergic Agents|cholinergic agents|mesh-ancestor
5960211|NCT04630873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5960212|NCT04630873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960213|NCT04630834|Acetaminophen|acetaminophen|mesh-list
5960214|NCT04630834|Ibuprofen|ibuprofen|mesh-list
5960215|NCT04630834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6518757|NCT00728780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518758|NCT00728780|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6518759|NCT00728780|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6518760|NCT00728780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6518761|NCT00728832|Morphine|morphine|mesh-list
6518762|NCT00728832|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6518763|NCT00728832|Narcotics|narcotics|mesh-ancestor
6518764|NCT00728832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6518765|NCT00728832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518766|NCT00728832|Analgesics|analgesics|mesh-ancestor
6518767|NCT00728832|Sensory System Agents|sensory system agents|mesh-ancestor
6518768|NCT00728832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6518769|NCT00729001|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6518770|NCT00729001|Immunologic Factors|immunologic factors|mesh-ancestor
6518771|NCT00729001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518772|NCT00729118|Lenalidomide|lenalidomide|mesh-list
6518773|NCT00729118|Vorinostat|vorinostat|mesh-list
6518774|NCT00729118|Immunologic Factors|immunologic factors|mesh-ancestor
6518775|NCT00729118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960216|NCT04630834|Analgesics|analgesics|mesh-ancestor
5960217|NCT04630834|Sensory System Agents|sensory system agents|mesh-ancestor
5960218|NCT04630834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5960219|NCT04630834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960220|NCT04630834|Antipyretics|antipyretics|mesh-ancestor
5960221|NCT04630834|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5960222|NCT04630834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5960223|NCT04630834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5960224|NCT04630834|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5960225|NCT04630834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5960226|NCT04630834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960227|NCT04630886|Lidocaine|lidocaine|mesh-list
5960228|NCT04630886|Epinephrine|epinephrine|mesh-list
5960229|NCT04630886|Tranexamic Acid|tranexamic acid|mesh-list
5960230|NCT04630886|Anesthetics, Local|anesthetics, local|mesh-ancestor
5960231|NCT04630886|Anesthetics|anesthetics|mesh-ancestor
5960232|NCT04630886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5960233|NCT04630886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960234|NCT04630886|Sensory System Agents|sensory system agents|mesh-ancestor
5960235|NCT04630886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5960236|NCT04630886|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5960237|NCT04630886|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5960238|NCT04630886|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5960239|NCT04630886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5960240|NCT04630886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960241|NCT04630886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5960242|NCT04630886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5960243|NCT04630886|Adrenergic Agents|adrenergic agents|mesh-ancestor
5960244|NCT04630886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5960245|NCT04630886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5960246|NCT04630886|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5960247|NCT04630886|Autonomic Agents|autonomic agents|mesh-ancestor
5960248|NCT04630886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5960249|NCT04630886|Respiratory System Agents|respiratory system agents|mesh-ancestor
5960250|NCT04630886|Mydriatics|mydriatics|mesh-ancestor
5960251|NCT04630886|Sympathomimetics|sympathomimetics|mesh-ancestor
5960252|NCT04630886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5960253|NCT04630886|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5960254|NCT04630886|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5960255|NCT04630886|Hemostatics|hemostatics|mesh-ancestor
5960256|NCT04630886|Coagulants|coagulants|mesh-ancestor
5960257|NCT04631185|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5960258|NCT04631185|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5960259|NCT04631185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6683773|NCT01623505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683774|NCT01623505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6683775|NCT01623505|Autonomic Agents|autonomic agents|mesh-ancestor
6683776|NCT01623505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6683777|NCT01623570|Menotropins|menotropins|mesh-list
6683778|NCT01623570|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5960260|NCT04631185|Antitubercular Agents|antitubercular agents|mesh-ancestor
6518776|NCT00729118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6518777|NCT00729118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6518778|NCT00729118|Growth Substances|growth substances|mesh-ancestor
6518779|NCT00729118|Growth Inhibitors|growth inhibitors|mesh-ancestor
6518780|NCT00729118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6518781|NCT00729118|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6518782|NCT00729118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6518783|NCT00729118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518784|NCT00729131|Etanercept|etanercept|mesh-list
6518785|NCT00729131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6518786|NCT00729131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6683779|NCT01623570|Fertility Agents|fertility agents|mesh-ancestor
6683780|NCT01623570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6683781|NCT01623570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960261|NCT04630522|Vitamin D|vitamin d|mesh-list
5960262|NCT04630522|Calcium, Dietary|calcium, dietary|mesh-list
5960263|NCT04630522|Calcium|calcium|mesh-list
5960264|NCT04630522|Vitamins|vitamins|mesh-ancestor
5960265|NCT04630522|Micronutrients|micronutrients|mesh-ancestor
5960266|NCT04630522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960267|NCT04630522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5960268|NCT04630522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5960269|NCT04630444|Riluzole|riluzole|mesh-list
5960270|NCT04630444|Anticonvulsants|anticonvulsants|mesh-ancestor
6683782|NCT01623609|Naloxegol|naloxegol|mesh-list
6683783|NCT01623609|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6683784|NCT01623609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960271|NCT04630444|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5960272|NCT04630444|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5960273|NCT04630444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5960274|NCT04630444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960275|NCT04630444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683785|NCT01623609|Sensory System Agents|sensory system agents|mesh-ancestor
6683786|NCT01623609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6683787|NCT01623635|Ropivacaine|ropivacaine|mesh-list
5960276|NCT04630444|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5960277|NCT04630444|Protective Agents|protective agents|mesh-ancestor
5960278|NCT04630548|Copper|copper|mesh-list
5960279|NCT04630548|Trace Elements|trace elements|mesh-ancestor
5960280|NCT04630548|Micronutrients|micronutrients|mesh-ancestor
6518787|NCT00729131|Analgesics|analgesics|mesh-ancestor
6518788|NCT00729131|Sensory System Agents|sensory system agents|mesh-ancestor
6683788|NCT01623635|Anesthetics, Local|anesthetics, local|mesh-ancestor
6683789|NCT01623635|Anesthetics|anesthetics|mesh-ancestor
6683790|NCT01623635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6683791|NCT01623635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683792|NCT01623635|Sensory System Agents|sensory system agents|mesh-ancestor
6683793|NCT01623635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6683794|NCT01623713|Risperidone|risperidone|mesh-list
6518789|NCT00729131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6518790|NCT00729131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518791|NCT00729131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6518792|NCT00729131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6518793|NCT00729131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6518794|NCT00729131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6518795|NCT00729131|Immunologic Factors|immunologic factors|mesh-ancestor
6518796|NCT00729170|Calcium|calcium|mesh-list
6518797|NCT00729170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6518798|NCT00729170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960281|NCT04630548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960282|NCT04630288|Clopidogrel|clopidogrel|mesh-list
5960283|NCT04630288|Ticagrelor|ticagrelor|mesh-list
6518799|NCT00729222|Rolofylline|rolofylline|mesh-list
6518800|NCT00729222|Diuretics|diuretics|mesh-ancestor
6518801|NCT00729222|Natriuretic Agents|natriuretic agents|mesh-ancestor
6683795|NCT01623713|Iloperidone|iloperidone|mesh-list
6683796|NCT01623713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6683797|NCT01623713|Serotonin Agents|serotonin agents|mesh-ancestor
6683798|NCT01623713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6683799|NCT01623713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683800|NCT01623713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683801|NCT01623713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5960284|NCT04630288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5960285|NCT04630288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5960286|NCT04630288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5960287|NCT04630288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5960288|NCT04630288|Purinergic Agents|purinergic agents|mesh-ancestor
5960289|NCT04630288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5960290|NCT04630288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960291|NCT04630288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960292|NCT04630171|Anesthetics|anesthetics|mesh-list
5960293|NCT04630171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5960294|NCT04630171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960295|NCT04629885|Oxytocin|oxytocin|mesh-list
5960296|NCT04629885|Oxytocics|oxytocics|mesh-ancestor
5960297|NCT04629885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5960298|NCT04629885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960299|NCT04629976|Tenofovir|tenofovir|mesh-list
5960300|NCT04629976|Antiviral Agents|antiviral agents|mesh-ancestor
5960301|NCT04629976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5960302|NCT04629976|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6683802|NCT01623713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6683803|NCT01623713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6683804|NCT01623713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6683805|NCT01623713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6683806|NCT01623713|Dopamine Agents|dopamine agents|mesh-ancestor
6683807|NCT01623778|Interferons|interferons|mesh-list
6683808|NCT01623778|Interferon-alpha|interferon-alpha|mesh-list
6683809|NCT01623778|Interferon alpha-2|interferon alpha-2|mesh-list
6683810|NCT01623778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6683811|NCT01623778|Antiviral Agents|antiviral agents|mesh-ancestor
6683812|NCT01623778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6683813|NCT01623778|Immunologic Factors|immunologic factors|mesh-ancestor
6683814|NCT01623778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683815|NCT01623817|Vancomycin|vancomycin|mesh-list
6683816|NCT01623817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6683817|NCT01623817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6683818|NCT01623908|Zoledronic Acid|zoledronic acid|mesh-list
5960303|NCT04629976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5960304|NCT04629976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5960305|NCT04629976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960306|NCT04629976|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5960307|NCT04629976|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5970177|NCT04537403|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
5970178|NCT04537403|Chelating Agents|chelating agents|mesh-ancestor
5970179|NCT04537403|Sequestering Agents|sequestering agents|mesh-ancestor
5970180|NCT04537403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970181|NCT04537065|Mydriatics|mydriatics|mesh-list
5970182|NCT04537065|Autonomic Agents|autonomic agents|mesh-ancestor
5970183|NCT04537065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5970184|NCT04537065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970185|NCT04536922|Aldesleukin|aldesleukin|mesh-list
5970186|NCT04536922|Cyclophosphamide|cyclophosphamide|mesh-list
6518802|NCT00729222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518803|NCT00729274|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6518804|NCT00729287|Selenium|selenium|mesh-list
6518805|NCT00729287|Antioxidants|antioxidants|mesh-ancestor
6518806|NCT00729287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518807|NCT00729287|Protective Agents|protective agents|mesh-ancestor
6518808|NCT00729287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518809|NCT00729287|Trace Elements|trace elements|mesh-ancestor
6518810|NCT00729287|Micronutrients|micronutrients|mesh-ancestor
6518811|NCT00729300|Disulfiram|disulfiram|mesh-list
6518812|NCT00729300|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6518813|NCT00729300|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
6518814|NCT00729300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6683819|NCT01623908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5960308|NCT04630210|Letrozole|letrozole|mesh-list
5960309|NCT04630210|Atezolizumab|atezolizumab|mesh-list
5960310|NCT04630210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5960311|NCT04630210|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5960312|NCT04630210|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5960313|NCT04630210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5960314|NCT04630210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960315|NCT04630210|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5960316|NCT04630210|Hormone Antagonists|hormone antagonists|mesh-ancestor
5960317|NCT04630210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5960318|NCT04630210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960319|NCT04629495|Sirolimus|sirolimus|mesh-list
5960320|NCT04629495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5960321|NCT04629495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5960322|NCT04629495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5960323|NCT04629495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5960324|NCT04629495|Antifungal Agents|antifungal agents|mesh-ancestor
5960325|NCT04629495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5960326|NCT04629495|Immunologic Factors|immunologic factors|mesh-ancestor
5960327|NCT04629495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960328|NCT04629846|Docetaxel|docetaxel|mesh-list
5960329|NCT04629846|Trastuzumab|trastuzumab|mesh-list
5960330|NCT04629846|Pertuzumab|pertuzumab|mesh-list
5960331|NCT04629846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5960332|NCT04629846|Tubulin Modulators|tubulin modulators|mesh-ancestor
5960333|NCT04629846|Antimitotic Agents|antimitotic agents|mesh-ancestor
5960334|NCT04629846|Mitosis Modulators|mitosis modulators|mesh-ancestor
5960335|NCT04629846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960336|NCT04629846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5960337|NCT04629573|Anesthetics|anesthetics|mesh-list
5960338|NCT04629573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5960339|NCT04629573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960340|NCT04629443|Azacitidine|azacitidine|mesh-list
5960341|NCT04629443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5960342|NCT04629443|Antimetabolites|antimetabolites|mesh-ancestor
5960343|NCT04629443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960344|NCT04629443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6683820|NCT01623908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683821|NCT01623921|Celecoxib|celecoxib|mesh-list
6683822|NCT01623921|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6683823|NCT01623921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6683824|NCT01623921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6683825|NCT01623921|Antimetabolites|antimetabolites|mesh-ancestor
6683826|NCT01623921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683827|NCT01623921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6683828|NCT01623921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6683829|NCT01623921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6683830|NCT01623921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6683831|NCT01623921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6683832|NCT01623921|Analgesics|analgesics|mesh-ancestor
6683833|NCT01623921|Sensory System Agents|sensory system agents|mesh-ancestor
6683834|NCT01623921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6683835|NCT01623921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683836|NCT01623921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6683837|NCT01623921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6683838|NCT01623921|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6683839|NCT01623921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6683840|NCT01624025|Docetaxel|docetaxel|mesh-list
6683841|NCT01624025|Epirubicin|epirubicin|mesh-list
6683842|NCT01624025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6683843|NCT01624025|Tubulin Modulators|tubulin modulators|mesh-ancestor
6683844|NCT01624025|Antimitotic Agents|antimitotic agents|mesh-ancestor
6683845|NCT01624025|Mitosis Modulators|mitosis modulators|mesh-ancestor
6683846|NCT01624025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683847|NCT01624025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6683848|NCT01624025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5960345|NCT04629443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5960346|NCT04629612|Anesthetics|anesthetics|mesh-list
5960347|NCT04629612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5960348|NCT04629612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960349|NCT04629144|Belimumab|belimumab|mesh-list
5960350|NCT04629144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5960351|NCT04629144|Immunologic Factors|immunologic factors|mesh-ancestor
5960352|NCT04629144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960353|NCT04629209|TIC10 compound|tic10 compound|mesh-list
5960354|NCT04629209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5960355|NCT04629196|Ustekinumab|ustekinumab|mesh-list
5960356|NCT04629196|Dermatologic Agents|dermatologic agents|mesh-ancestor
5960357|NCT04628884|Heparin|heparin|mesh-list
5960358|NCT04628884|Anticoagulants|anticoagulants|mesh-ancestor
5960359|NCT04628884|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5960360|NCT04628884|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5960361|NCT04628884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960362|NCT04629027|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5960363|NCT04629027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960364|NCT04629027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5960365|NCT04629118|Sirolimus|sirolimus|mesh-list
6683849|NCT01624025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6683850|NCT01624025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6683851|NCT01624038|Hydroxyurea|hydroxyurea|mesh-list
6683852|NCT01624038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6683853|NCT01624038|Antisickling Agents|antisickling agents|mesh-ancestor
6683854|NCT01624038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6683855|NCT01624038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683856|NCT01624038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6683857|NCT01624051|Cisplatin|cisplatin|mesh-list
6683858|NCT01624051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6518815|NCT00729300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518816|NCT00729313|Lanreotide|lanreotide|mesh-list
6518817|NCT00729313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6518818|NCT00729339|Mosapride|mosapride|mesh-list
6518819|NCT00729339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6518820|NCT00729339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6683859|NCT01624064|Calcium, Dietary|calcium, dietary|mesh-list
6683860|NCT01624064|Enalapril|enalapril|mesh-list
6683861|NCT01624064|Calcium|calcium|mesh-list
6683862|NCT01624064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6683863|NCT01624064|Enzyme Inhibitors|enzyme inhibitors|mesh-list
6683864|NCT01624064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6683865|NCT01624064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683866|NCT01624064|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6683867|NCT01624064|Protease Inhibitors|protease inhibitors|mesh-ancestor
6683868|NCT01624064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683869|NCT01624064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6683870|NCT01624103|Lidocaine|lidocaine|mesh-list
6683871|NCT01624103|Levobupivacaine|levobupivacaine|mesh-list
6683872|NCT01624103|Anesthetics, Local|anesthetics, local|mesh-ancestor
6683873|NCT01624103|Anesthetics|anesthetics|mesh-ancestor
6683874|NCT01624103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6683875|NCT01624103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683876|NCT01624103|Sensory System Agents|sensory system agents|mesh-ancestor
6683877|NCT01624103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6683878|NCT01624103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6683879|NCT01624103|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5960366|NCT04629118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5960367|NCT04629118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5960368|NCT04629118|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5960369|NCT04629118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5960370|NCT04629118|Antifungal Agents|antifungal agents|mesh-ancestor
5960371|NCT04629118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5960372|NCT04629118|Immunologic Factors|immunologic factors|mesh-ancestor
5960373|NCT04629118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960374|NCT04628559|Dexmedetomidine|dexmedetomidine|mesh-list
5960375|NCT04628559|Ketamine|ketamine|mesh-list
5960376|NCT04628559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5960377|NCT04628559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5960378|NCT04628559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960379|NCT04628559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5960380|NCT04628559|Analgesics|analgesics|mesh-ancestor
5960381|NCT04628559|Sensory System Agents|sensory system agents|mesh-ancestor
5960382|NCT04628559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5960383|NCT04628559|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5960384|NCT04628559|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5960385|NCT04628559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5960386|NCT04628559|Adrenergic Agents|adrenergic agents|mesh-ancestor
6518821|NCT00729339|Serotonin Agents|serotonin agents|mesh-ancestor
6518822|NCT00729339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5960387|NCT04628559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5960388|NCT04628559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960389|NCT04628559|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5960390|NCT04628559|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5960391|NCT04628559|Anesthetics, General|anesthetics, general|mesh-ancestor
6518823|NCT00729339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518824|NCT00729339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518825|NCT00729404|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6518826|NCT00729404|Gestodene|gestodene|mesh-list
6518827|NCT00729404|Femovan|femovan|mesh-list
6518828|NCT00729404|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6518829|NCT00729404|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6518830|NCT00729404|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6518831|NCT00729404|Contraceptive Agents|contraceptive agents|mesh-ancestor
6518832|NCT00729404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6518833|NCT00729404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518834|NCT00729404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6518835|NCT00729404|Estrogens|estrogens|mesh-ancestor
6518836|NCT00729404|Hormones|hormones|mesh-ancestor
6518837|NCT00729404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6518838|NCT00729404|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6518839|NCT00729404|Progestins|progestins|mesh-ancestor
6518840|NCT00729404|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6518841|NCT00729495|Celecoxib|celecoxib|mesh-list
5960392|NCT04628559|Anesthetics|anesthetics|mesh-ancestor
5960393|NCT04628559|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5960394|NCT04628559|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5960395|NCT04628676|Epinephrine|epinephrine|mesh-list
5960396|NCT04628676|Tranylcypromine|tranylcypromine|mesh-list
5960397|NCT04628676|Tranexamic Acid|tranexamic acid|mesh-list
5960398|NCT04628676|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5960399|NCT04628676|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5960400|NCT04628676|Adrenergic Agents|adrenergic agents|mesh-ancestor
5960401|NCT04628676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5960402|NCT04628676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960403|NCT04628676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960404|NCT04628676|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5960405|NCT04628676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5960406|NCT04628676|Autonomic Agents|autonomic agents|mesh-ancestor
5960407|NCT04628676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5960408|NCT04628676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5960409|NCT04628676|Respiratory System Agents|respiratory system agents|mesh-ancestor
5960410|NCT04628676|Mydriatics|mydriatics|mesh-ancestor
5960411|NCT04628676|Sympathomimetics|sympathomimetics|mesh-ancestor
5960412|NCT04628676|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5960413|NCT04628676|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5960414|NCT04628676|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5960415|NCT04628676|Hemostatics|hemostatics|mesh-ancestor
5960416|NCT04628676|Coagulants|coagulants|mesh-ancestor
5960417|NCT04628676|Antidepressive Agents|antidepressive agents|mesh-ancestor
5960418|NCT04628676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5960419|NCT04628676|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
5960420|NCT04628676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5960421|NCT04628676|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5960422|NCT04628676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5960423|NCT04628676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5960424|NCT04628429|Erenumab|erenumab|mesh-list
5960425|NCT04628429|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
5960426|NCT04628429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960427|NCT04628429|Analgesics|analgesics|mesh-ancestor
5960428|NCT04628429|Sensory System Agents|sensory system agents|mesh-ancestor
5960429|NCT04628429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5960430|NCT04628429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960431|NCT04628325|Furosemide|furosemide|mesh-list
5960432|NCT04628325|Diuretics|diuretics|mesh-ancestor
5960433|NCT04628325|Natriuretic Agents|natriuretic agents|mesh-ancestor
5960434|NCT04628325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960435|NCT04628325|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5960436|NCT04628325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5960437|NCT04628325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960438|NCT04628533|Oxymetazoline|oxymetazoline|mesh-list
5960439|NCT04628533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5960440|NCT04628533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6518842|NCT00729495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5960441|NCT04628533|Adrenergic Agents|adrenergic agents|mesh-ancestor
5960442|NCT04628533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5960443|NCT04628533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960444|NCT04628533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960445|NCT04628533|Sympathomimetics|sympathomimetics|mesh-ancestor
5960446|NCT04628533|Autonomic Agents|autonomic agents|mesh-ancestor
5960447|NCT04628533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5960448|NCT04628533|Nasal Decongestants|nasal decongestants|mesh-ancestor
5960449|NCT04628533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5960450|NCT04628533|Respiratory System Agents|respiratory system agents|mesh-ancestor
5960451|NCT04628624|Antioxidants|antioxidants|mesh-list
5960452|NCT04628624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683880|NCT01624103|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6683881|NCT01624103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6683882|NCT01624103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960453|NCT04628624|Protective Agents|protective agents|mesh-ancestor
5960454|NCT04628624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970187|NCT04536922|Pembrolizumab|pembrolizumab|mesh-list
5970188|NCT04536922|Fludarabine|fludarabine|mesh-list
5970189|NCT04536922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5970190|NCT04536922|Immunologic Factors|immunologic factors|mesh-ancestor
5970191|NCT04536922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683883|NCT01624116|Metformin|metformin|mesh-list
6683884|NCT01624116|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6683885|NCT01624116|Acarbose|acarbose|mesh-list
6683886|NCT01624116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5970192|NCT04536922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5970193|NCT04536922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5970194|NCT04536922|Alkylating Agents|alkylating agents|mesh-ancestor
5970195|NCT04536922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970196|NCT04536922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5970197|NCT04536922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5970198|NCT04536922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5970199|NCT04536922|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5970200|NCT04536922|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5970201|NCT04536922|Antiviral Agents|antiviral agents|mesh-ancestor
5970202|NCT04536922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5970203|NCT04536961|BMS-986165|bms-986165|mesh-list
5970204|NCT04536961|Famotidine|famotidine|mesh-list
5970205|NCT04536961|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5970206|NCT04536961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5970207|NCT04536961|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5970208|NCT04536961|Histamine Antagonists|histamine antagonists|mesh-ancestor
5970209|NCT04536961|Histamine Agents|histamine agents|mesh-ancestor
6518843|NCT00729495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6518844|NCT00729495|Analgesics|analgesics|mesh-ancestor
6518845|NCT00729495|Sensory System Agents|sensory system agents|mesh-ancestor
6518846|NCT00729495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6518847|NCT00729495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518848|NCT00729495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6518849|NCT00729495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6518850|NCT00729495|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6518851|NCT00729495|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6518852|NCT00729495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6518853|NCT00729495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518854|NCT00729573|Tenofovir|tenofovir|mesh-list
6518855|NCT00729573|Emtricitabine|emtricitabine|mesh-list
6518856|NCT00729573|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6518857|NCT00729573|Antiviral Agents|antiviral agents|mesh-ancestor
6518858|NCT00729573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6518859|NCT00729573|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6683887|NCT01624116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683888|NCT01624116|Incretins|incretins|mesh-ancestor
6683889|NCT01624116|Hormones|hormones|mesh-ancestor
6780094|NCT02182232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5970210|NCT04536961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5970211|NCT04536961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970212|NCT04536961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970213|NCT04536961|Dermatologic Agents|dermatologic agents|mesh-ancestor
5970214|NCT04536961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5970215|NCT04536961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5970216|NCT04536948|Methyl salicylate|methyl salicylate|mesh-list
5970217|NCT04536948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5970218|NCT04536805|Metformin|metformin|mesh-list
5970219|NCT04536805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5960455|NCT04628000|Vitamin D|vitamin d|mesh-list
5960456|NCT04628000|Ergocalciferols|ergocalciferols|mesh-list
5960457|NCT04628000|Vitamins|vitamins|mesh-list
5960458|NCT04628000|Micronutrients|micronutrients|mesh-ancestor
5960459|NCT04628000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960460|NCT04628000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5960461|NCT04628000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5960462|NCT04628026|Venetoclax|venetoclax|mesh-list
5960463|NCT04628026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5960464|NCT04627870|Paclitaxel|paclitaxel|mesh-list
5960465|NCT04627870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5960466|NCT04627870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6518860|NCT00729573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6518861|NCT00729573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6518862|NCT00729573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518863|NCT00729573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6683890|NCT01624116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6683891|NCT01624116|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5960467|NCT04627870|Tubulin Modulators|tubulin modulators|mesh-ancestor
5960468|NCT04627870|Antimitotic Agents|antimitotic agents|mesh-ancestor
5960469|NCT04627870|Mitosis Modulators|mitosis modulators|mesh-ancestor
5960470|NCT04627870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960471|NCT04628143|Nafamostat|nafamostat|mesh-list
5960472|NCT04628143|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5960473|NCT04628143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5960474|NCT04628143|Analgesics|analgesics|mesh-ancestor
5960475|NCT04628143|Sensory System Agents|sensory system agents|mesh-ancestor
5960476|NCT04628143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5960477|NCT04628143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960478|NCT04628143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5960479|NCT04628143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5960480|NCT04628143|Anticoagulants|anticoagulants|mesh-ancestor
5960481|NCT04628143|Protease Inhibitors|protease inhibitors|mesh-ancestor
5960482|NCT04628143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5960483|NCT04628143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960484|NCT04628143|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5960485|NCT04628143|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5960486|NCT04628143|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5960487|NCT04628143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5960488|NCT04628143|Immunologic Factors|immunologic factors|mesh-ancestor
5960489|NCT04627779|Flurbiprofen|flurbiprofen|mesh-list
5960490|NCT04627779|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
5960491|NCT04627779|Analgesics|analgesics|mesh-ancestor
5960492|NCT04627779|Sensory System Agents|sensory system agents|mesh-ancestor
5960493|NCT04627779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5960494|NCT04627779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960495|NCT04627779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5960496|NCT04627779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5960497|NCT04627779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5960498|NCT04627779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5960499|NCT04627779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5960500|NCT04627779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5960501|NCT04627779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960502|NCT04627571|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5960503|NCT04627571|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5960504|NCT04627467|Chloroquine|chloroquine|mesh-list
5960505|NCT04627467|Amebicides|amebicides|mesh-ancestor
5960506|NCT04627467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5960507|NCT04627467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5960508|NCT04627467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5960509|NCT04627467|Antimalarials|antimalarials|mesh-ancestor
5960510|NCT04627467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5960511|NCT04627623|Antibodies|antibodies|mesh-list
5960512|NCT04627623|Immunoglobulin G|immunoglobulin g|mesh-list
5960513|NCT04627623|Immunologic Factors|immunologic factors|mesh-ancestor
5960514|NCT04627623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960515|NCT04627363|Bevacizumab|bevacizumab|mesh-list
5960516|NCT04627363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5960517|NCT04627363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5960518|NCT04627363|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6518864|NCT00729573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6518865|NCT00729599|Cetylpyridinium|cetylpyridinium|mesh-list
6518866|NCT00729599|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6518867|NCT00729599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6518868|NCT00729638|Lenalidomide|lenalidomide|mesh-list
5960519|NCT04627363|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5960520|NCT04627363|Growth Substances|growth substances|mesh-ancestor
5960521|NCT04627363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960522|NCT04627363|Growth Inhibitors|growth inhibitors|mesh-ancestor
6518869|NCT00729638|Everolimus|everolimus|mesh-list
6518870|NCT00729638|Immunologic Factors|immunologic factors|mesh-ancestor
6518871|NCT00729638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518872|NCT00729638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6518873|NCT00729638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6518874|NCT00729638|Growth Substances|growth substances|mesh-ancestor
6518875|NCT00729638|Growth Inhibitors|growth inhibitors|mesh-ancestor
6518876|NCT00729638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6518877|NCT00729638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6518878|NCT00729664|Atezolizumab|atezolizumab|mesh-list
6518879|NCT00729664|BMS-936559|bms-936559|mesh-list
6518880|NCT00729664|Antibodies|antibodies|mesh-list
6518881|NCT00729664|Immunoglobulins|immunoglobulins|mesh-list
5960523|NCT04627298|Vaccines|vaccines|mesh-list
5960524|NCT04627298|Immunologic Factors|immunologic factors|mesh-ancestor
5960525|NCT04627298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960526|NCT04627181|Hydroxocobalamin|hydroxocobalamin|mesh-list
6683892|NCT01624116|Protease Inhibitors|protease inhibitors|mesh-ancestor
6683893|NCT01624116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6683894|NCT01624116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683895|NCT01624116|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6683896|NCT01624129|Fluticasone|fluticasone|mesh-list
6683897|NCT01624129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6683898|NCT01624129|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6683899|NCT01624129|Autonomic Agents|autonomic agents|mesh-ancestor
6683900|NCT01624129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6683901|NCT01624129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683902|NCT01624129|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6683903|NCT01624129|Respiratory System Agents|respiratory system agents|mesh-ancestor
6683904|NCT01624129|Dermatologic Agents|dermatologic agents|mesh-ancestor
6683905|NCT01624129|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5960527|NCT04627181|Vitamin B 12|vitamin b 12|mesh-list
5960528|NCT04627181|Hematinics|hematinics|mesh-ancestor
5960529|NCT04627181|Vitamin B Complex|vitamin b complex|mesh-ancestor
5960530|NCT04627181|Vitamins|vitamins|mesh-ancestor
5960531|NCT04627181|Micronutrients|micronutrients|mesh-ancestor
5960532|NCT04627181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960533|NCT04627012|Pembrolizumab|pembrolizumab|mesh-list
5960534|NCT04627012|Lenvatinib|lenvatinib|mesh-list
5960535|NCT04627012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5960536|NCT04627012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5960537|NCT04627012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960538|NCT04627012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5960539|NCT04627012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5960540|NCT04626739|Cyclophosphamide|cyclophosphamide|mesh-list
5960541|NCT04626739|Fludarabine|fludarabine|mesh-list
5960542|NCT04626739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5960543|NCT04626739|Immunologic Factors|immunologic factors|mesh-ancestor
5960544|NCT04626739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960545|NCT04626739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5960546|NCT04626739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5960547|NCT04626739|Alkylating Agents|alkylating agents|mesh-ancestor
5960548|NCT04626739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960549|NCT04626739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5960550|NCT04626739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5960551|NCT04627129|Itraconazole|itraconazole|mesh-list
5960552|NCT04627129|Antifungal Agents|antifungal agents|mesh-ancestor
5960553|NCT04627129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5960554|NCT04627129|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5960555|NCT04627129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5960556|NCT04627129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5960557|NCT04627129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960558|NCT04627129|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5960559|NCT04627129|Hormone Antagonists|hormone antagonists|mesh-ancestor
6683906|NCT01624207|Atorvastatin|atorvastatin|mesh-list
6683907|NCT01624207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6683908|NCT01624207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6683909|NCT01624207|Antimetabolites|antimetabolites|mesh-ancestor
5960560|NCT04627129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6518882|NCT00729664|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6518883|NCT00729664|Immunologic Factors|immunologic factors|mesh-ancestor
6683910|NCT01624207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683911|NCT01624207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6683912|NCT01624207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6683913|NCT01624207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6683914|NCT01624246|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
6683915|NCT01624246|Avibactam|avibactam|mesh-list
6683916|NCT01624246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6683917|NCT01624246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6683918|NCT01624246|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6683919|NCT01624246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6683920|NCT01624246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683921|NCT01624285|Sorafenib|sorafenib|mesh-list
6683922|NCT01624285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6683923|NCT01624285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6683924|NCT01624285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6683925|NCT01624285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683926|NCT01624337|Piperaquine|piperaquine|mesh-list
6683927|NCT01624337|Antimalarials|antimalarials|mesh-ancestor
6683928|NCT01624337|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6683929|NCT01624337|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6683930|NCT01624337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6683931|NCT01624428|Varenicline|varenicline|mesh-list
6683932|NCT01624428|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6683933|NCT01624428|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6683934|NCT01624428|Cholinergic Agents|cholinergic agents|mesh-ancestor
6683935|NCT01624428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6683936|NCT01624428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683937|NCT01624428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683938|NCT01624441|Epirubicin|epirubicin|mesh-list
6683939|NCT01624441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6683940|NCT01624441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6683941|NCT01624441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6683942|NCT01624441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6683943|NCT01624441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6683944|NCT01624441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683945|NCT01624493|Gemcitabine|gemcitabine|mesh-list
6683946|NCT01624493|Carboplatin|carboplatin|mesh-list
6683947|NCT01624493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6683948|NCT01624493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6683949|NCT01624493|Antimetabolites|antimetabolites|mesh-ancestor
6683950|NCT01624493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683951|NCT01624493|Antiviral Agents|antiviral agents|mesh-ancestor
6683952|NCT01624493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6683953|NCT01624493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6683954|NCT01624493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6683955|NCT01624493|Immunologic Factors|immunologic factors|mesh-ancestor
6683956|NCT01624493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780095|NCT02182232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780096|NCT02182245|Paclitaxel|paclitaxel|mesh-list
6780097|NCT02182245|Carboplatin|carboplatin|mesh-list
6780098|NCT02182245|Nintedanib|nintedanib|mesh-list
6780099|NCT02182245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6780100|NCT02182245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6780101|NCT02182245|Tubulin Modulators|tubulin modulators|mesh-ancestor
6518884|NCT00729664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518885|NCT00729664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6518886|NCT00729664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6518887|NCT00729742|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6780102|NCT02182245|Antimitotic Agents|antimitotic agents|mesh-ancestor
6780103|NCT02182245|Mitosis Modulators|mitosis modulators|mesh-ancestor
6518888|NCT00729742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6518889|NCT00729742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6518890|NCT00729742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6518891|NCT00729742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518892|NCT00729768|Cyclosporine|cyclosporine|mesh-list
6518893|NCT00729768|Mycophenolic Acid|mycophenolic acid|mesh-list
6518894|NCT00729768|Cyclosporins|cyclosporins|mesh-list
6518895|NCT00729768|Basiliximab|basiliximab|mesh-list
6518896|NCT00729768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6518897|NCT00729768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518898|NCT00729768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6518899|NCT00729768|Immunologic Factors|immunologic factors|mesh-ancestor
6518900|NCT00729768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518901|NCT00729768|Antifungal Agents|antifungal agents|mesh-ancestor
6518902|NCT00729768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5960561|NCT04627129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960562|NCT04627129|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5960563|NCT04626778|Hydrogen Peroxide|hydrogen peroxide|mesh-list
5960564|NCT04626778|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5960565|NCT04626778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5960566|NCT04626765|Cyclophosphamide|cyclophosphamide|mesh-list
5960567|NCT04626765|Fludarabine|fludarabine|mesh-list
5960568|NCT04626765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5960569|NCT04626765|Immunologic Factors|immunologic factors|mesh-ancestor
5960570|NCT04626765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960571|NCT04626765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5960572|NCT04626765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5960573|NCT04626765|Alkylating Agents|alkylating agents|mesh-ancestor
5960574|NCT04626765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960575|NCT04626765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5960576|NCT04626765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6518903|NCT00729768|Dermatologic Agents|dermatologic agents|mesh-ancestor
6518904|NCT00729768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6518905|NCT00729768|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6518906|NCT00729768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5960577|NCT04626973|Ezetimibe|ezetimibe|mesh-list
5960578|NCT04626973|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
5960579|NCT04626973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5960580|NCT04626973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5960581|NCT04626973|Antimetabolites|antimetabolites|mesh-ancestor
5960582|NCT04626973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960583|NCT04626973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5960584|NCT04626973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5960585|NCT04626752|Cyclophosphamide|cyclophosphamide|mesh-list
5960586|NCT04626752|Fludarabine|fludarabine|mesh-list
5960587|NCT04626752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5960588|NCT04626752|Immunologic Factors|immunologic factors|mesh-ancestor
5960589|NCT04626752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960590|NCT04626752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5960591|NCT04626752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5960592|NCT04626752|Alkylating Agents|alkylating agents|mesh-ancestor
5960593|NCT04626752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960594|NCT04626752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5960595|NCT04626752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5960596|NCT04626726|Cyclophosphamide|cyclophosphamide|mesh-list
5960597|NCT04626726|Fludarabine|fludarabine|mesh-list
5960598|NCT04626726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5960599|NCT04626726|Immunologic Factors|immunologic factors|mesh-ancestor
5960600|NCT04626726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960601|NCT04626726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5960602|NCT04626726|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5960603|NCT04626726|Alkylating Agents|alkylating agents|mesh-ancestor
5960604|NCT04626726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960605|NCT04626726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5960606|NCT04626726|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5960607|NCT04626414|Ferric maltol|ferric maltol|mesh-list
5960608|NCT04626414|Ferric Compounds|ferric compounds|mesh-list
5960609|NCT04626414|Hematinics|hematinics|mesh-ancestor
5970220|NCT04536805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970221|NCT04536831|Vitamin D|vitamin d|mesh-list
5970222|NCT04536831|Ergocalciferols|ergocalciferols|mesh-list
5970223|NCT04536831|Vitamins|vitamins|mesh-list
5970224|NCT04536831|Micronutrients|micronutrients|mesh-ancestor
5970225|NCT04536831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970226|NCT04536831|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5970227|NCT04536831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5970228|NCT04536558|Olanzapine|olanzapine|mesh-list
5970229|NCT04536558|Fosaprepitant|fosaprepitant|mesh-list
5970230|NCT04536558|Aprepitant|aprepitant|mesh-list
5970231|NCT04536558|Antiemetics|antiemetics|mesh-ancestor
5970232|NCT04536558|Autonomic Agents|autonomic agents|mesh-ancestor
5970233|NCT04536558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5970234|NCT04536558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970235|NCT04536558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5970236|NCT04536558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6242654|NCT02654054|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6242655|NCT02654054|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6242656|NCT02654054|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6242657|NCT02654054|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6242658|NCT02654145|Omalizumab|omalizumab|mesh-list
6242659|NCT02654145|Albuterol|albuterol|mesh-list
5960610|NCT04626089|Metformin|metformin|mesh-list
5960611|NCT04626089|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5960612|NCT04626089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960613|NCT04626193|Amoxicillin|amoxicillin|mesh-list
5960614|NCT04626193|Doxycycline|doxycycline|mesh-list
5960615|NCT04626193|Levofloxacin|levofloxacin|mesh-list
5960616|NCT04626193|Ofloxacin|ofloxacin|mesh-list
5960617|NCT04626193|Esomeprazole|esomeprazole|mesh-list
5960618|NCT04626193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5960619|NCT04626193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5960620|NCT04626193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5960621|NCT04626193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5960622|NCT04626193|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5960623|NCT04626193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5960624|NCT04626193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960625|NCT04626193|Antimalarials|antimalarials|mesh-ancestor
5960626|NCT04626193|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5960627|NCT04626193|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5960628|NCT04626193|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5960629|NCT04626193|Renal Agents|renal agents|mesh-ancestor
5960630|NCT04626193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5960631|NCT04626193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5960632|NCT04626193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5960633|NCT04626193|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5960634|NCT04626193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6518907|NCT00729768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6518908|NCT00729768|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6518909|NCT00729768|Antitubercular Agents|antitubercular agents|mesh-ancestor
6518910|NCT00729768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5960635|NCT04626258|Fluconazole|fluconazole|mesh-list
5960636|NCT04626258|Antifungal Agents|antifungal agents|mesh-ancestor
5960637|NCT04626258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5960638|NCT04626258|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6518911|NCT00729794|Methylprednisolone|methylprednisolone|mesh-list
6518912|NCT00729794|Hydrocortisone|hydrocortisone|mesh-list
6518913|NCT00729794|Vasopressins|vasopressins|mesh-list
6518914|NCT00729794|Arginine Vasopressin|arginine vasopressin|mesh-list
6518915|NCT00729794|Epinephrine|epinephrine|mesh-list
6518916|NCT00729794|Racepinephrine|racepinephrine|mesh-list
6518917|NCT00729794|Epinephryl borate|epinephryl borate|mesh-list
6518918|NCT00729794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6518919|NCT00729794|Antiemetics|antiemetics|mesh-ancestor
6518920|NCT00729794|Autonomic Agents|autonomic agents|mesh-ancestor
6518921|NCT00729794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6518922|NCT00729794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518923|NCT00729794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6518924|NCT00729794|Glucocorticoids|glucocorticoids|mesh-ancestor
6518925|NCT00729794|Hormones|hormones|mesh-ancestor
6518926|NCT00729794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5960639|NCT04626258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5960640|NCT04626258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5960641|NCT04626258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960642|NCT04626258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5960643|NCT04626258|Hormone Antagonists|hormone antagonists|mesh-ancestor
5960644|NCT04626258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5960645|NCT04626258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960646|NCT04626258|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5960647|NCT04626258|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5960648|NCT04626063|Acetaminophen|acetaminophen|mesh-list
5960649|NCT04626063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
5960650|NCT04626063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
5960651|NCT04626063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5960652|NCT04626063|Analgesics|analgesics|mesh-ancestor
5960653|NCT04626063|Sensory System Agents|sensory system agents|mesh-ancestor
5960654|NCT04626063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6518927|NCT00729794|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6518928|NCT00729794|Protective Agents|protective agents|mesh-ancestor
6518929|NCT00729794|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6518930|NCT00729794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6518931|NCT00729794|Adrenergic Agents|adrenergic agents|mesh-ancestor
6518932|NCT00729794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6518933|NCT00729794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518934|NCT00729794|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6518935|NCT00729794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6518936|NCT00729794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6518937|NCT00729794|Respiratory System Agents|respiratory system agents|mesh-ancestor
6518938|NCT00729794|Mydriatics|mydriatics|mesh-ancestor
5960655|NCT04626063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960656|NCT04626063|Antipyretics|antipyretics|mesh-ancestor
5960657|NCT04626063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5960658|NCT04625985|Metformin|metformin|mesh-list
5960659|NCT04625985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5960660|NCT04625985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960661|NCT04625777|Vaccines|vaccines|mesh-list
5960662|NCT04625777|Immunologic Factors|immunologic factors|mesh-ancestor
5960663|NCT04625777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960664|NCT04625907|Dactinomycin|dactinomycin|mesh-list
5960665|NCT04625907|Cyclophosphamide|cyclophosphamide|mesh-list
5960666|NCT04625907|Temozolomide|temozolomide|mesh-list
5960667|NCT04625907|Ifosfamide|ifosfamide|mesh-list
5960668|NCT04625907|Doxorubicin|doxorubicin|mesh-list
5960669|NCT04625907|Irinotecan|irinotecan|mesh-list
5960670|NCT04625907|Vincristine|vincristine|mesh-list
5960671|NCT04625907|Vinorelbine|vinorelbine|mesh-list
5960672|NCT04625907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5960673|NCT04625907|Immunologic Factors|immunologic factors|mesh-ancestor
5960674|NCT04625907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960675|NCT04625907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5960676|NCT04625907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5960677|NCT04625907|Alkylating Agents|alkylating agents|mesh-ancestor
5960678|NCT04625907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960679|NCT04625907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5960680|NCT04625907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5960681|NCT04625907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5960682|NCT04625907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5960683|NCT04625907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6518939|NCT00729794|Sympathomimetics|sympathomimetics|mesh-ancestor
6518940|NCT00729794|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6518941|NCT00729794|Hemostatics|hemostatics|mesh-ancestor
6518942|NCT00729794|Coagulants|coagulants|mesh-ancestor
6518943|NCT00729794|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6518944|NCT00729794|Natriuretic Agents|natriuretic agents|mesh-ancestor
5960684|NCT04625907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5960685|NCT04625907|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5960686|NCT04625907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5960687|NCT04625907|Tubulin Modulators|tubulin modulators|mesh-ancestor
5960688|NCT04625907|Antimitotic Agents|antimitotic agents|mesh-ancestor
5960689|NCT04625907|Mitosis Modulators|mitosis modulators|mesh-ancestor
5960690|NCT04625907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5960691|NCT04625907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5960692|NCT04625907|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5960693|NCT04625907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5960694|NCT04625699|Durvalumab|durvalumab|mesh-list
5960695|NCT04625699|Tremelimumab|tremelimumab|mesh-list
5960696|NCT04625699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5960697|NCT04625699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5960698|NCT04625608|Acetaminophen|acetaminophen|mesh-list
5960699|NCT04625608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5960700|NCT04625608|Analgesics|analgesics|mesh-ancestor
5960701|NCT04625608|Sensory System Agents|sensory system agents|mesh-ancestor
5960702|NCT04625608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5960703|NCT04625608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960704|NCT04625608|Antipyretics|antipyretics|mesh-ancestor
5960705|NCT04625595|Methyldopa|methyldopa|mesh-list
5960706|NCT04625595|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5960707|NCT04625595|Sympatholytics|sympatholytics|mesh-ancestor
5960708|NCT04625595|Autonomic Agents|autonomic agents|mesh-ancestor
5960709|NCT04625595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5960710|NCT04625595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960711|NCT04625595|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5960712|NCT04625595|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5960713|NCT04625595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5960714|NCT04625595|Adrenergic Agents|adrenergic agents|mesh-ancestor
5960715|NCT04625595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5960716|NCT04625595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960717|NCT04625283|Ketamine|ketamine|mesh-list
5960718|NCT04625283|Analgesics|analgesics|mesh-ancestor
5960719|NCT04625283|Sensory System Agents|sensory system agents|mesh-ancestor
5960720|NCT04625283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6518945|NCT00729898|Insulin Aspart|insulin aspart|mesh-list
5960721|NCT04625283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960722|NCT04625283|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6518946|NCT00729898|Biphasic Insulins|biphasic insulins|mesh-list
5960723|NCT04625283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5960724|NCT04625283|Anesthetics, General|anesthetics, general|mesh-ancestor
5960725|NCT04625283|Anesthetics|anesthetics|mesh-ancestor
6518947|NCT00729898|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6518948|NCT00729898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6518949|NCT00729898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960726|NCT04625283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5960727|NCT04625283|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5960728|NCT04625283|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5960729|NCT04625283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5960730|NCT04625283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960731|NCT04625257|Antibodies|antibodies|mesh-list
5960732|NCT04625257|Immunologic Factors|immunologic factors|mesh-ancestor
5960733|NCT04625257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960734|NCT04625543|Paclitaxel|paclitaxel|mesh-list
5960735|NCT04625543|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6518950|NCT00729911|Amiodarone|amiodarone|mesh-list
6518951|NCT00729911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6518952|NCT00729911|Vasodilator Agents|vasodilator agents|mesh-ancestor
6518953|NCT00729911|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6518954|NCT00729911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6518955|NCT00729911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518956|NCT00729911|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6518957|NCT00729911|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6518958|NCT00729911|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6518959|NCT00729911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6518960|NCT00729911|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6518961|NCT00729911|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6518962|NCT00729911|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6518963|NCT00729950|Ipilimumab|ipilimumab|mesh-list
6518964|NCT00729950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6518965|NCT00729950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6518966|NCT00729950|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6518967|NCT00729950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518968|NCT00729963|Sibutramine|sibutramine|mesh-list
5960736|NCT04625543|Cisplatin|cisplatin|mesh-list
5960737|NCT04625543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5960738|NCT04625543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5960739|NCT04625543|Tubulin Modulators|tubulin modulators|mesh-ancestor
5960740|NCT04625543|Antimitotic Agents|antimitotic agents|mesh-ancestor
5960741|NCT04625543|Mitosis Modulators|mitosis modulators|mesh-ancestor
5960742|NCT04625543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960743|NCT04625426|Protective Agents|protective agents|mesh-list
5960744|NCT04625426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960745|NCT04625179|Melatonin|melatonin|mesh-list
6518969|NCT00729963|Antidepressive Agents|antidepressive agents|mesh-ancestor
5960746|NCT04625179|Hyaluronic Acid|hyaluronic acid|mesh-list
5960747|NCT04625179|Antioxidants|antioxidants|mesh-ancestor
5960748|NCT04625179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960749|NCT04625179|Protective Agents|protective agents|mesh-ancestor
5960750|NCT04625179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960751|NCT04625179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5960752|NCT04625179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5960753|NCT04625179|Immunologic Factors|immunologic factors|mesh-ancestor
5960754|NCT04625179|Viscosupplements|viscosupplements|mesh-ancestor
5960755|NCT04624893|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5960756|NCT04624893|Immunoconjugates|immunoconjugates|mesh-list
5960757|NCT04624893|Immunologic Factors|immunologic factors|mesh-ancestor
5960758|NCT04624893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960759|NCT04624958|Rituximab|rituximab|mesh-list
5960760|NCT04624958|Zanubrutinib|zanubrutinib|mesh-list
5960761|NCT04624958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5960762|NCT04624958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5960763|NCT04624958|Immunologic Factors|immunologic factors|mesh-ancestor
5960764|NCT04624958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960765|NCT04624958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5960766|NCT04624958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5960767|NCT04624958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5960768|NCT04624958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960769|NCT04624984|Gemcitabine|gemcitabine|mesh-list
5960770|NCT04624984|Doxorubicin|doxorubicin|mesh-list
5960771|NCT04624984|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5960772|NCT04624984|Vinorelbine|vinorelbine|mesh-list
5960773|NCT04624984|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5960774|NCT04624984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5960775|NCT04624984|Antimetabolites|antimetabolites|mesh-ancestor
5960776|NCT04624984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960777|NCT04624984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5960778|NCT04624984|Antiviral Agents|antiviral agents|mesh-ancestor
5960779|NCT04624984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5960780|NCT04624984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5960781|NCT04624984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5960782|NCT04624984|Immunologic Factors|immunologic factors|mesh-ancestor
5960783|NCT04624984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960784|NCT04624984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5960785|NCT04624984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5960786|NCT04624984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5960787|NCT04624984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5960788|NCT04624984|Tubulin Modulators|tubulin modulators|mesh-ancestor
5960789|NCT04624984|Antimitotic Agents|antimitotic agents|mesh-ancestor
5960790|NCT04624984|Mitosis Modulators|mitosis modulators|mesh-ancestor
5960791|NCT04624906|Rituximab|rituximab|mesh-list
5960792|NCT04624906|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5960793|NCT04624906|Acalabrutinib|acalabrutinib|mesh-list
5960794|NCT04624906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5960795|NCT04624906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5960796|NCT04624906|Immunologic Factors|immunologic factors|mesh-ancestor
5960797|NCT04624906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518970|NCT00729963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6518971|NCT00729963|Appetite Depressants|appetite depressants|mesh-ancestor
6518972|NCT00729963|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6518973|NCT00729976|Ibuprofen|ibuprofen|mesh-list
6518974|NCT00729976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5960798|NCT04624906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5960799|NCT04624906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5960800|NCT04624906|Alkylating Agents|alkylating agents|mesh-ancestor
5960801|NCT04624906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960802|NCT04625114|Gabexate|gabexate|mesh-list
5960803|NCT04625114|Camostat|camostat|mesh-list
5960804|NCT04625114|Protease Inhibitors|protease inhibitors|mesh-ancestor
5960805|NCT04625114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5960806|NCT04625114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960807|NCT04625114|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5960808|NCT04625114|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5960809|NCT04625114|Anticoagulants|anticoagulants|mesh-ancestor
5960810|NCT04624776|Methylprednisolone|methylprednisolone|mesh-list
5960811|NCT04624776|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5960812|NCT04624776|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5960813|NCT04624776|Prednisolone|prednisolone|mesh-list
5960814|NCT04624776|Prednisolone acetate|prednisolone acetate|mesh-list
5960815|NCT04624776|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5960816|NCT04624776|Prednisolone phosphate|prednisolone phosphate|mesh-list
5960817|NCT04624776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6518975|NCT00729976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6518976|NCT00729976|Analgesics|analgesics|mesh-ancestor
6518977|NCT00729976|Sensory System Agents|sensory system agents|mesh-ancestor
6518978|NCT00729976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6518979|NCT00729976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518980|NCT00729976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6518981|NCT00729976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6518982|NCT00729976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6518983|NCT00729976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6518984|NCT00729976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6518985|NCT00730054|Clonidine|clonidine|mesh-list
6518986|NCT00730054|Remifentanil|remifentanil|mesh-list
6518987|NCT00730054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6518988|NCT00730054|Narcotics|narcotics|mesh-ancestor
6518989|NCT00730054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5960818|NCT04624776|Antiemetics|antiemetics|mesh-ancestor
5960819|NCT04624776|Autonomic Agents|autonomic agents|mesh-ancestor
5960820|NCT04624776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5960821|NCT04624776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960822|NCT04624776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5960823|NCT04624776|Glucocorticoids|glucocorticoids|mesh-ancestor
5960824|NCT04624776|Hormones|hormones|mesh-ancestor
5960825|NCT04624776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5960826|NCT04624776|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5960827|NCT04624776|Protective Agents|protective agents|mesh-ancestor
6683957|NCT01624649|Methylphenidate|methylphenidate|mesh-list
5960828|NCT04624776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5960829|NCT04624776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5960830|NCT04624633|Acalabrutinib|acalabrutinib|mesh-list
5960831|NCT04624633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5960832|NCT04624750|Mexiletine|mexiletine|mesh-list
5960833|NCT04624750|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5960834|NCT04624750|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5960835|NCT04624750|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5960836|NCT04624750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5960837|NCT04624750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960838|NCT04624828|Androgens|androgens|mesh-list
5960839|NCT04624828|Hormones|hormones|mesh-ancestor
5960840|NCT04624828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5960841|NCT04624828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970237|NCT04536558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5970238|NCT04536558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5970239|NCT04536558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5970240|NCT04536558|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5970241|NCT04536558|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5970242|NCT04536558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5970243|NCT04536558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970244|NCT04536558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5970245|NCT04536558|Serotonin Agents|serotonin agents|mesh-ancestor
5970246|NCT04536558|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5970247|NCT04536662|Dexamethasone|dexamethasone|mesh-list
5970248|NCT04536662|Prednisone|prednisone|mesh-list
5970249|NCT04536662|Hydrocortisone|hydrocortisone|mesh-list
5970250|NCT04536662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5970251|NCT04536662|Antiemetics|antiemetics|mesh-ancestor
5970252|NCT04536662|Autonomic Agents|autonomic agents|mesh-ancestor
5970253|NCT04536662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5970254|NCT04536662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970255|NCT04536662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5970256|NCT04536662|Glucocorticoids|glucocorticoids|mesh-ancestor
5970257|NCT04536662|Hormones|hormones|mesh-ancestor
5970258|NCT04536662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5970259|NCT04536662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5970260|NCT04536662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5970261|NCT04536675|Bromides|bromides|mesh-list
5970262|NCT04536675|Anticonvulsants|anticonvulsants|mesh-ancestor
6518990|NCT00730054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6518991|NCT00730054|Analgesics|analgesics|mesh-ancestor
6518992|NCT00730054|Sensory System Agents|sensory system agents|mesh-ancestor
5970263|NCT04536363|Alprostadil|alprostadil|mesh-list
5970264|NCT04536363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5970265|NCT04536363|Vasodilator Agents|vasodilator agents|mesh-ancestor
5970266|NCT04536363|Urological Agents|urological agents|mesh-ancestor
5970267|NCT04536532|Entecavir|entecavir|mesh-list
5970268|NCT04536532|Antiviral Agents|antiviral agents|mesh-ancestor
5970269|NCT04536532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5970270|NCT04536415|Oseltamivir|oseltamivir|mesh-list
5970271|NCT04536415|Antiviral Agents|antiviral agents|mesh-ancestor
5970272|NCT04536415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5970273|NCT04536415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5970274|NCT04536415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970275|NCT04536129|Hydrocortisone|hydrocortisone|mesh-list
5970276|NCT04536129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5970277|NCT04536298|Vitamin D|vitamin d|mesh-list
5970278|NCT04536298|Ergocalciferols|ergocalciferols|mesh-list
5970279|NCT04536298|Cholecalciferol|cholecalciferol|mesh-list
5970280|NCT04536298|Vitamins|vitamins|mesh-list
6518993|NCT00730054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6518994|NCT00730054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6518995|NCT00730054|Sympatholytics|sympatholytics|mesh-ancestor
5970281|NCT04536298|Micronutrients|micronutrients|mesh-ancestor
6518996|NCT00730054|Autonomic Agents|autonomic agents|mesh-ancestor
6518997|NCT00730054|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6518998|NCT00730054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6518999|NCT00730054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5970282|NCT04536298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970283|NCT04536298|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5970284|NCT04536298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6519000|NCT00730054|Adrenergic Agents|adrenergic agents|mesh-ancestor
6519001|NCT00730054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6519002|NCT00730054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519003|NCT00730067|Sildenafil Citrate|sildenafil citrate|mesh-list
6519004|NCT00730067|Vasodilator Agents|vasodilator agents|mesh-ancestor
6519005|NCT00730067|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6519006|NCT00730067|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6519007|NCT00730067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6519008|NCT00730067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519009|NCT00730067|Urological Agents|urological agents|mesh-ancestor
6519010|NCT00730093|Vitamin B 12|vitamin b 12|mesh-list
6519011|NCT00730093|Hydroxocobalamin|hydroxocobalamin|mesh-list
6519012|NCT00730093|Vitamins|vitamins|mesh-ancestor
6519013|NCT00730093|Micronutrients|micronutrients|mesh-ancestor
6519014|NCT00730093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519015|NCT00730093|Vitamin B Complex|vitamin b complex|mesh-ancestor
6519016|NCT00730093|Hematinics|hematinics|mesh-ancestor
6519017|NCT00730197|Albuterol|albuterol|mesh-list
6519018|NCT00730197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6519019|NCT00730197|Autonomic Agents|autonomic agents|mesh-ancestor
6519020|NCT00730197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6519021|NCT00730197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519022|NCT00730197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6519023|NCT00730197|Respiratory System Agents|respiratory system agents|mesh-ancestor
6519024|NCT00730197|Tocolytic Agents|tocolytic agents|mesh-ancestor
5960842|NCT04624295|Aspirin|aspirin|mesh-list
5960843|NCT04624295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5960844|NCT04624295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5960845|NCT04624295|Analgesics|analgesics|mesh-ancestor
5960846|NCT04624295|Sensory System Agents|sensory system agents|mesh-ancestor
5960847|NCT04624295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5960848|NCT04624295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960849|NCT04624295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5960850|NCT04624295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5960851|NCT04624295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6519025|NCT00730197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5960852|NCT04624295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5960853|NCT04624295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960854|NCT04624295|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5960855|NCT04624295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5960856|NCT04624295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5960857|NCT04624295|Antipyretics|antipyretics|mesh-ancestor
5960858|NCT04624399|Atezolizumab|atezolizumab|mesh-list
5960859|NCT04624399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5960860|NCT04624178|Nivolumab|nivolumab|mesh-list
5960861|NCT04624178|Rucaparib|rucaparib|mesh-list
5960862|NCT04624178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5960863|NCT04624178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5960864|NCT04624178|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5960865|NCT04624178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960866|NCT04624178|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5960867|NCT04624178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5960868|NCT04624269|Hydroxychloroquine|hydroxychloroquine|mesh-list
5960869|NCT04624269|Antimalarials|antimalarials|mesh-ancestor
5960870|NCT04624269|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5960871|NCT04624269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5960872|NCT04624269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5960873|NCT04624269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5960874|NCT04624269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960875|NCT04624269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5960876|NCT04624360|Dexamethasone|dexamethasone|mesh-list
5960877|NCT04624360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5960878|NCT04624360|Antiemetics|antiemetics|mesh-ancestor
5960879|NCT04624360|Autonomic Agents|autonomic agents|mesh-ancestor
5960880|NCT04624360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5960881|NCT04624360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960882|NCT04624360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6242660|NCT02654145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6242661|NCT02654145|Autonomic Agents|autonomic agents|mesh-ancestor
6242662|NCT02654145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6242663|NCT02654145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6242664|NCT02654145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6242665|NCT02654145|Respiratory System Agents|respiratory system agents|mesh-ancestor
6242666|NCT02654145|Tocolytic Agents|tocolytic agents|mesh-ancestor
6242667|NCT02654145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6242668|NCT02654145|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6519026|NCT00730197|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6519027|NCT00730197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5960883|NCT04624360|Glucocorticoids|glucocorticoids|mesh-ancestor
5960884|NCT04624360|Hormones|hormones|mesh-ancestor
5960885|NCT04624360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5960886|NCT04624360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5960887|NCT04624360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5960888|NCT04623879|Ivacaftor|ivacaftor|mesh-list
5960889|NCT04623879|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
5960890|NCT04623879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6519028|NCT00730197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6519029|NCT00730197|Adrenergic Agents|adrenergic agents|mesh-ancestor
5960891|NCT04623879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960892|NCT04624113|Pembrolizumab|pembrolizumab|mesh-list
5960893|NCT04624113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5960894|NCT04624113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5960895|NCT04624217|Gemcitabine|gemcitabine|mesh-list
5960896|NCT04624217|Paclitaxel|paclitaxel|mesh-list
5960897|NCT04624217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5960898|NCT04624217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5960899|NCT04624217|Tubulin Modulators|tubulin modulators|mesh-ancestor
5960900|NCT04624217|Antimitotic Agents|antimitotic agents|mesh-ancestor
5960901|NCT04624217|Mitosis Modulators|mitosis modulators|mesh-ancestor
6519030|NCT00730197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6519031|NCT00730197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519032|NCT00730210|Parathyroid Hormone|parathyroid hormone|mesh-list
5960902|NCT04624217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960903|NCT04624217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5960904|NCT04624217|Antimetabolites|antimetabolites|mesh-ancestor
5960905|NCT04624217|Antiviral Agents|antiviral agents|mesh-ancestor
5960906|NCT04624217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5960907|NCT04624217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5960908|NCT04624217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5960909|NCT04624217|Immunologic Factors|immunologic factors|mesh-ancestor
5960910|NCT04624217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960911|NCT04623866|Valsartan|valsartan|mesh-list
5960912|NCT04623866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6519033|NCT00730210|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6519034|NCT00730210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519035|NCT00730223|Efavirenz|efavirenz|mesh-list
6519036|NCT00730223|Nevirapine|nevirapine|mesh-list
6519037|NCT00730223|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6519038|NCT00730223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6519039|NCT00730223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6519040|NCT00730223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519041|NCT00730223|Antiviral Agents|antiviral agents|mesh-ancestor
6519042|NCT00730223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6519043|NCT00730223|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5960913|NCT04623866|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5960914|NCT04623866|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5960915|NCT04623866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960916|NCT04623619|Acetylcarnitine|acetylcarnitine|mesh-list
5960917|NCT04623619|Vitamin B Complex|vitamin b complex|mesh-ancestor
6519044|NCT00730223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6519045|NCT00730223|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6519046|NCT00730223|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6519047|NCT00730223|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6519048|NCT00730223|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6519049|NCT00730223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6519050|NCT00730223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5960918|NCT04623619|Vitamins|vitamins|mesh-ancestor
5960919|NCT04623619|Micronutrients|micronutrients|mesh-ancestor
5960920|NCT04623619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960921|NCT04623619|Nootropic Agents|nootropic agents|mesh-ancestor
5960922|NCT04623684|Phenylephrine|phenylephrine|mesh-list
5960923|NCT04623684|Oxymetazoline|oxymetazoline|mesh-list
5960924|NCT04623684|Tropicamide|tropicamide|mesh-list
5960925|NCT04623684|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5960926|NCT04623684|Mydriatics|mydriatics|mesh-ancestor
5960927|NCT04623684|Autonomic Agents|autonomic agents|mesh-ancestor
5960928|NCT04623684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5960929|NCT04623684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519051|NCT00730249|Methylphenidate|methylphenidate|mesh-list
6519052|NCT00730249|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6519053|NCT00730249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960930|NCT04623684|Sympathomimetics|sympathomimetics|mesh-ancestor
5960931|NCT04623684|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5960932|NCT04623684|Nasal Decongestants|nasal decongestants|mesh-ancestor
5960933|NCT04623684|Respiratory System Agents|respiratory system agents|mesh-ancestor
5960934|NCT04623684|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5960935|NCT04623684|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5960936|NCT04623684|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5960937|NCT04623684|Adrenergic Agents|adrenergic agents|mesh-ancestor
5960938|NCT04623684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5960939|NCT04623684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960940|NCT04623684|Protective Agents|protective agents|mesh-ancestor
5960941|NCT04623684|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5960942|NCT04623684|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5960943|NCT04623684|Cholinergic Agents|cholinergic agents|mesh-ancestor
5960944|NCT04623840|Tadalafil|tadalafil|mesh-list
5960945|NCT04623840|Vasodilator Agents|vasodilator agents|mesh-ancestor
5960946|NCT04623840|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5960947|NCT04623840|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5960948|NCT04623840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5960949|NCT04623840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960950|NCT04623840|Urological Agents|urological agents|mesh-ancestor
5960951|NCT04623086|Insulin|insulin|mesh-list
5960952|NCT04623086|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5960953|NCT04623086|Insulin Glargine|insulin glargine|mesh-list
5960954|NCT04623086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5960955|NCT04623086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960956|NCT04623385|Tretinoin|tretinoin|mesh-list
5960957|NCT04623385|Isotretinoin|isotretinoin|mesh-list
5960958|NCT04623385|Testosterone|testosterone|mesh-list
5960959|NCT04623385|Androgens|androgens|mesh-ancestor
5960960|NCT04623385|Hormones|hormones|mesh-ancestor
5960961|NCT04623385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5960962|NCT04623385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960963|NCT04623385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5960964|NCT04623385|Keratolytic Agents|keratolytic agents|mesh-ancestor
5960965|NCT04623385|Dermatologic Agents|dermatologic agents|mesh-ancestor
5960966|NCT04623021|Nafamostat|nafamostat|mesh-list
5960967|NCT04623021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5960968|NCT04623021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5960969|NCT04623021|Analgesics|analgesics|mesh-ancestor
5960970|NCT04623021|Sensory System Agents|sensory system agents|mesh-ancestor
5960971|NCT04623021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5960972|NCT04623021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960973|NCT04623021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5960974|NCT04623021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5960975|NCT04623021|Anticoagulants|anticoagulants|mesh-ancestor
5960976|NCT04623021|Protease Inhibitors|protease inhibitors|mesh-ancestor
5960977|NCT04623021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5960978|NCT04623021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960979|NCT04623021|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5960980|NCT04623021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5960981|NCT04623021|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5960982|NCT04623021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5960983|NCT04623021|Immunologic Factors|immunologic factors|mesh-ancestor
5970285|NCT04535973|Hormones|hormones|mesh-list
5970286|NCT04535973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5970287|NCT04535973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970288|NCT04536051|Acetaminophen|acetaminophen|mesh-list
5970289|NCT04536051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5970290|NCT04536051|Analgesics|analgesics|mesh-ancestor
5970291|NCT04536051|Sensory System Agents|sensory system agents|mesh-ancestor
5970292|NCT04536051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5970293|NCT04536051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970294|NCT04536051|Antipyretics|antipyretics|mesh-ancestor
5970295|NCT04536493|Lidocaine|lidocaine|mesh-list
5970296|NCT04536493|Epinephrine|epinephrine|mesh-list
6683958|NCT01624649|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6683959|NCT01624649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6683960|NCT01624649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683961|NCT01624649|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6683962|NCT01624649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6683963|NCT01624649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6683964|NCT01624649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683965|NCT01624649|Dopamine Agents|dopamine agents|mesh-ancestor
5970297|NCT04536493|Racepinephrine|racepinephrine|mesh-list
6683966|NCT01624649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6683967|NCT01624649|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6683968|NCT01624649|Adrenergic Agents|adrenergic agents|mesh-ancestor
6683969|NCT01624675|Risperidone|risperidone|mesh-list
6683970|NCT01624675|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6683971|NCT01624675|Serotonin Agents|serotonin agents|mesh-ancestor
6683972|NCT01624675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6683973|NCT01624675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683974|NCT01624675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683975|NCT01624675|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6683976|NCT01624675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6683977|NCT01624675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6683978|NCT01624675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6683979|NCT01624675|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6683980|NCT01624675|Dopamine Agents|dopamine agents|mesh-ancestor
6683981|NCT01624714|Alemtuzumab|alemtuzumab|mesh-list
6683982|NCT01624714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6683983|NCT01624714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6683984|NCT01624766|Denosumab|denosumab|mesh-list
5960984|NCT04622618|Gabapentin|gabapentin|mesh-list
5960985|NCT04622618|Analgesics|analgesics|mesh-ancestor
5960986|NCT04622618|Sensory System Agents|sensory system agents|mesh-ancestor
6683985|NCT01624766|Everolimus|everolimus|mesh-list
5960987|NCT04622618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5960988|NCT04622618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5960989|NCT04622618|Anticonvulsants|anticonvulsants|mesh-ancestor
5960990|NCT04622618|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5960991|NCT04622618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5960992|NCT04622618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5960993|NCT04622618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5960994|NCT04622618|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5960995|NCT04622618|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5960996|NCT04622618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5960997|NCT04622618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5960998|NCT04622618|Antimanic Agents|antimanic agents|mesh-ancestor
5960999|NCT04622865|Quercetin|quercetin|mesh-list
5961000|NCT04622865|Antioxidants|antioxidants|mesh-ancestor
5961001|NCT04622865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961002|NCT04622865|Protective Agents|protective agents|mesh-ancestor
5961003|NCT04622865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961004|NCT04622995|Diazepam|diazepam|mesh-list
5961005|NCT04622995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5961006|NCT04622995|Anticonvulsants|anticonvulsants|mesh-ancestor
5961007|NCT04622995|Antiemetics|antiemetics|mesh-ancestor
5961008|NCT04622995|Autonomic Agents|autonomic agents|mesh-ancestor
5961009|NCT04622995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5961010|NCT04622995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961011|NCT04622995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5961012|NCT04622995|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5961013|NCT04622995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5961014|NCT04622995|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
5961015|NCT04622995|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6519054|NCT00730249|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6519055|NCT00730249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6519056|NCT00730249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6519057|NCT00730249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519058|NCT00730249|Dopamine Agents|dopamine agents|mesh-ancestor
6519059|NCT00730249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6519060|NCT00730288|Vaccines|vaccines|mesh-list
6519061|NCT00730288|Immunologic Factors|immunologic factors|mesh-ancestor
6519062|NCT00730288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519063|NCT00730366|Chloroquine|chloroquine|mesh-list
6519064|NCT00730366|Pyrimethamine|pyrimethamine|mesh-list
6519065|NCT00730366|Sulfadoxine|sulfadoxine|mesh-list
6519066|NCT00730366|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6519067|NCT00730366|Amebicides|amebicides|mesh-ancestor
6519068|NCT00730366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6519069|NCT00730366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6519070|NCT00730366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6519071|NCT00730366|Antimalarials|antimalarials|mesh-ancestor
6519072|NCT00730366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6519073|NCT00730366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6519074|NCT00730366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6519075|NCT00730366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6683986|NCT01624766|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6683987|NCT01624766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6683988|NCT01624766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6519076|NCT00730366|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6519077|NCT00730366|Renal Agents|renal agents|mesh-ancestor
6683989|NCT01624766|Immunologic Factors|immunologic factors|mesh-ancestor
6683990|NCT01624766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6683991|NCT01624766|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5961016|NCT04622995|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5961017|NCT04622995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5961018|NCT04622995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5961019|NCT04622995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5961020|NCT04622995|Anesthetics, General|anesthetics, general|mesh-ancestor
5961021|NCT04622995|Anesthetics|anesthetics|mesh-ancestor
5961022|NCT04622995|GABA Modulators|gaba modulators|mesh-ancestor
5961023|NCT04622995|GABA Agents|gaba agents|mesh-ancestor
5961024|NCT04622995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5961025|NCT04622995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961026|NCT04622904|Lidocaine|lidocaine|mesh-list
5961027|NCT04622904|Ketamine|ketamine|mesh-list
5961028|NCT04622904|Anesthetics, Local|anesthetics, local|mesh-ancestor
5961029|NCT04622904|Anesthetics|anesthetics|mesh-ancestor
5961030|NCT04622904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5961031|NCT04622904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961032|NCT04622904|Sensory System Agents|sensory system agents|mesh-ancestor
5961033|NCT04622904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5961034|NCT04622904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5961035|NCT04622904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5961036|NCT04622904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5961037|NCT04622904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5961038|NCT04622904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961039|NCT04622904|Analgesics|analgesics|mesh-ancestor
5961040|NCT04622904|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5961041|NCT04622904|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6683992|NCT01624766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6683993|NCT01624805|Cyclosporine|cyclosporine|mesh-list
6683994|NCT01624805|Methylprednisolone|methylprednisolone|mesh-list
6683995|NCT01624805|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6683996|NCT01624805|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6683997|NCT01624805|Prednisolone|prednisolone|mesh-list
6683998|NCT01624805|Prednisolone acetate|prednisolone acetate|mesh-list
6683999|NCT01624805|Lenograstim|lenograstim|mesh-list
6684000|NCT01624805|Cyclosporins|cyclosporins|mesh-list
6684001|NCT01624805|Thymoglobulin|thymoglobulin|mesh-list
6684002|NCT01624805|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6684003|NCT01624805|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6684004|NCT01624805|Prednisolone phosphate|prednisolone phosphate|mesh-list
6684005|NCT01624805|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6684006|NCT01624805|Immunologic Factors|immunologic factors|mesh-ancestor
6684007|NCT01624805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684008|NCT01624805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6684009|NCT01624805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684010|NCT01624805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6684011|NCT01624805|Antifungal Agents|antifungal agents|mesh-ancestor
6684012|NCT01624805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6684013|NCT01624805|Dermatologic Agents|dermatologic agents|mesh-ancestor
6684014|NCT01624805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6684015|NCT01624805|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6684016|NCT01624805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6684017|NCT01624805|Antiemetics|antiemetics|mesh-ancestor
6684018|NCT01624805|Autonomic Agents|autonomic agents|mesh-ancestor
6684019|NCT01624805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6684020|NCT01624805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6684021|NCT01624805|Glucocorticoids|glucocorticoids|mesh-ancestor
6684022|NCT01624805|Hormones|hormones|mesh-ancestor
6684023|NCT01624805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6684024|NCT01624805|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6684025|NCT01624805|Protective Agents|protective agents|mesh-ancestor
6684026|NCT01624805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5961042|NCT04622904|Anesthetics, General|anesthetics, general|mesh-ancestor
5961043|NCT04622904|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5961044|NCT04622904|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5961045|NCT04622904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6684027|NCT01624805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6684028|NCT01624857|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6684029|NCT01624857|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6684030|NCT01624857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6684031|NCT01624857|Antimetabolites|antimetabolites|mesh-ancestor
6684032|NCT01624857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684033|NCT01624857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6684034|NCT01624857|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6684035|NCT01624857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6684036|NCT01625026|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
5961046|NCT04622709|Furosemide|furosemide|mesh-list
5961047|NCT04622709|Diuretics|diuretics|mesh-list
5961048|NCT04622709|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
5961049|NCT04622709|Natriuretic Agents|natriuretic agents|mesh-ancestor
5961050|NCT04622709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684037|NCT01625026|Cathartics|cathartics|mesh-ancestor
6684038|NCT01625026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6684039|NCT01625156|Sirolimus|sirolimus|mesh-list
6684040|NCT01625156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6684041|NCT01625156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6684042|NCT01625156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6684043|NCT01625156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6519078|NCT00730392|Etanercept|etanercept|mesh-list
6519079|NCT00730392|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6519080|NCT00730392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6519081|NCT00730392|Analgesics|analgesics|mesh-ancestor
6519082|NCT00730392|Sensory System Agents|sensory system agents|mesh-ancestor
6519083|NCT00730392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6519084|NCT00730392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961051|NCT04622709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5961052|NCT04622709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961053|NCT04622956|Methotrexate|methotrexate|mesh-list
5961054|NCT04622956|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5961055|NCT04622956|Abortifacient Agents|abortifacient agents|mesh-ancestor
5961056|NCT04622956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5961057|NCT04622956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961058|NCT04622956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5961059|NCT04622956|Antimetabolites|antimetabolites|mesh-ancestor
5961060|NCT04622956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961061|NCT04622956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5961062|NCT04622956|Dermatologic Agents|dermatologic agents|mesh-ancestor
5961063|NCT04622956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5961064|NCT04622956|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5961065|NCT04622956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5961066|NCT04622956|Immunologic Factors|immunologic factors|mesh-ancestor
6684044|NCT01625156|Antifungal Agents|antifungal agents|mesh-ancestor
6684045|NCT01625156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6684046|NCT01625156|Immunologic Factors|immunologic factors|mesh-ancestor
5961067|NCT04622956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5961068|NCT04622956|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5961069|NCT04622891|Azithromycin|azithromycin|mesh-list
5961070|NCT04622891|Clarithromycin|clarithromycin|mesh-list
5961071|NCT04622891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5961072|NCT04622891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5961073|NCT04622891|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5961074|NCT04622891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5961075|NCT04622891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961076|NCT04622891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5961077|NCT04622891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5961078|NCT04622566|Pembrolizumab|pembrolizumab|mesh-list
5961079|NCT04622566|Lenvatinib|lenvatinib|mesh-list
6519085|NCT00730392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6519086|NCT00730392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6519087|NCT00730392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6519088|NCT00730392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6519089|NCT00730392|Immunologic Factors|immunologic factors|mesh-ancestor
6519090|NCT00730418|Doxazosin|doxazosin|mesh-list
6519091|NCT00730418|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6519092|NCT00730418|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6519093|NCT00730418|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6519094|NCT00730418|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6519095|NCT00730418|Adrenergic Agents|adrenergic agents|mesh-ancestor
6519096|NCT00730418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6519097|NCT00730418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519098|NCT00730418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519099|NCT00730444|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
6519100|NCT00730444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6519101|NCT00730444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6519102|NCT00730444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519103|NCT00730444|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6684047|NCT01625156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684048|NCT01625260|Gemcitabine|gemcitabine|mesh-list
6684049|NCT01625260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5961080|NCT04622566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5961081|NCT04622566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5961082|NCT04622566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5961083|NCT04622566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5961084|NCT04622566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961085|NCT04622813|Acetaminophen|acetaminophen|mesh-list
5961086|NCT04622813|Ketoprofen|ketoprofen|mesh-list
5961087|NCT04622813|Nefopam|nefopam|mesh-list
5961088|NCT04622813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5961089|NCT04622813|Analgesics|analgesics|mesh-ancestor
5961090|NCT04622813|Sensory System Agents|sensory system agents|mesh-ancestor
5961091|NCT04622813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5961092|NCT04622813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961093|NCT04622813|Antipyretics|antipyretics|mesh-ancestor
5961094|NCT04622813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5961095|NCT04622813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5961096|NCT04622813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5961097|NCT04622813|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5961098|NCT04622813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5961099|NCT04622813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961100|NCT04622579|Rituximab|rituximab|mesh-list
5961101|NCT04622579|Lenalidomide|lenalidomide|mesh-list
5961102|NCT04622579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5961103|NCT04622579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5961104|NCT04622579|Immunologic Factors|immunologic factors|mesh-ancestor
5961105|NCT04622579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961106|NCT04622579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5961107|NCT04622579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5961108|NCT04622579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5961109|NCT04622579|Growth Substances|growth substances|mesh-ancestor
5961110|NCT04622579|Growth Inhibitors|growth inhibitors|mesh-ancestor
5961111|NCT04622917|Methylprednisolone|methylprednisolone|mesh-list
5961112|NCT04622917|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5961113|NCT04622917|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5961114|NCT04622917|Prednisolone|prednisolone|mesh-list
5961115|NCT04622917|Prednisolone acetate|prednisolone acetate|mesh-list
6519104|NCT00730509|Vitamin B 12|vitamin b 12|mesh-list
5961116|NCT04622917|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5961117|NCT04622917|Prednisolone phosphate|prednisolone phosphate|mesh-list
5961118|NCT04622917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5961119|NCT04622917|Antiemetics|antiemetics|mesh-ancestor
6519105|NCT00730509|Hydroxocobalamin|hydroxocobalamin|mesh-list
6519106|NCT00730509|Vitamins|vitamins|mesh-ancestor
6519107|NCT00730509|Micronutrients|micronutrients|mesh-ancestor
6519108|NCT00730509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519109|NCT00730509|Vitamin B Complex|vitamin b complex|mesh-ancestor
6519110|NCT00730509|Hematinics|hematinics|mesh-ancestor
6519111|NCT00730535|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6519112|NCT00730535|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6519113|NCT00730535|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6519114|NCT00730535|Cholinergic Agents|cholinergic agents|mesh-ancestor
6519115|NCT00730535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6519116|NCT00730535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519117|NCT00730535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519118|NCT00730535|Urological Agents|urological agents|mesh-ancestor
6519119|NCT00730574|Vitamins|vitamins|mesh-list
6519120|NCT00730574|Folic Acid|folic acid|mesh-list
6519121|NCT00730574|Vitamin B 12|vitamin b 12|mesh-list
6519122|NCT00730574|Hydroxocobalamin|hydroxocobalamin|mesh-list
6519123|NCT00730574|Vitamin B Complex|vitamin b complex|mesh-list
6519124|NCT00730574|Micronutrients|micronutrients|mesh-ancestor
6519125|NCT00730574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519126|NCT00730574|Hematinics|hematinics|mesh-ancestor
6519127|NCT00730769|Valganciclovir|valganciclovir|mesh-list
6519128|NCT00730769|Ganciclovir|ganciclovir|mesh-list
6519129|NCT00730769|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6519130|NCT00730769|Antiviral Agents|antiviral agents|mesh-ancestor
6519131|NCT00730769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6519132|NCT00730769|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6519133|NCT00730769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6684050|NCT01625260|Antimetabolites|antimetabolites|mesh-ancestor
6684051|NCT01625260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684052|NCT01625260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6684053|NCT01625260|Antiviral Agents|antiviral agents|mesh-ancestor
6684054|NCT01625260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6684055|NCT01625260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6684056|NCT01625260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6684057|NCT01625260|Immunologic Factors|immunologic factors|mesh-ancestor
6684058|NCT01625260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684059|NCT01625351|Sirolimus|sirolimus|mesh-list
6684060|NCT01625351|Fludarabine|fludarabine|mesh-list
6684061|NCT01625351|Melphalan|melphalan|mesh-list
5961120|NCT04622917|Autonomic Agents|autonomic agents|mesh-ancestor
5961121|NCT04622917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5961122|NCT04622917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961123|NCT04622917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5961124|NCT04622917|Glucocorticoids|glucocorticoids|mesh-ancestor
6684062|NCT01625351|Busulfan|busulfan|mesh-list
6684063|NCT01625351|Mechlorethamine|mechlorethamine|mesh-list
6684064|NCT01625351|Alemtuzumab|alemtuzumab|mesh-list
6684065|NCT01625351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6684066|NCT01625351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684067|NCT01625351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5961125|NCT04622917|Hormones|hormones|mesh-ancestor
5961126|NCT04622917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5961127|NCT04622917|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5961128|NCT04622917|Protective Agents|protective agents|mesh-ancestor
5961129|NCT04622917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5961130|NCT04622917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5961131|NCT04622982|Vitamin D|vitamin d|mesh-list
5961132|NCT04622982|Vitamins|vitamins|mesh-ancestor
5961133|NCT04622982|Micronutrients|micronutrients|mesh-ancestor
5961134|NCT04622982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961135|NCT04622982|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5961136|NCT04622488|Diclofenac|diclofenac|mesh-list
5961137|NCT04622488|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5961138|NCT04622488|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5961139|NCT04622488|Analgesics|analgesics|mesh-ancestor
5961140|NCT04622488|Sensory System Agents|sensory system agents|mesh-ancestor
5961141|NCT04622488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5961142|NCT04622488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961143|NCT04622488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5961144|NCT04622488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5961145|NCT04622488|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5961146|NCT04622488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5961147|NCT04622488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961148|NCT04622202|Pregabalin|pregabalin|mesh-list
5961149|NCT04622202|Analgesics|analgesics|mesh-ancestor
5961150|NCT04622202|Sensory System Agents|sensory system agents|mesh-ancestor
5961151|NCT04622202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5961152|NCT04622202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961153|NCT04622202|Anticonvulsants|anticonvulsants|mesh-ancestor
5961154|NCT04622202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5961155|NCT04622202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5961156|NCT04622202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961157|NCT04622202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5961158|NCT04622202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5961159|NCT04622202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5961160|NCT04622202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5961161|NCT04622202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5961162|NCT04622358|Rabeprazole|rabeprazole|mesh-list
5961163|NCT04622358|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5961164|NCT04622358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5961165|NCT04622358|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5961166|NCT04622358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5961167|NCT04622358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961168|NCT04622397|Tranexamic Acid|tranexamic acid|mesh-list
5961169|NCT04622397|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5961170|NCT04622397|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5961171|NCT04622397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961172|NCT04622397|Hemostatics|hemostatics|mesh-ancestor
5961173|NCT04622397|Coagulants|coagulants|mesh-ancestor
5961174|NCT04622111|Metformin|metformin|mesh-list
5961175|NCT04622111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6684068|NCT01625351|Immunologic Factors|immunologic factors|mesh-ancestor
5961176|NCT04622111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961177|NCT04621929|Topiramate|topiramate|mesh-list
5961178|NCT04621929|Phentermine|phentermine|mesh-list
5961179|NCT04621929|Allopurinol|allopurinol|mesh-list
5961180|NCT04621929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961181|NCT04621929|Anticonvulsants|anticonvulsants|mesh-ancestor
5961182|NCT04621929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5961183|NCT04621929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961184|NCT04621929|Antimetabolites|antimetabolites|mesh-ancestor
5961185|NCT04621929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5961186|NCT04621929|Gout Suppressants|gout suppressants|mesh-ancestor
5961187|NCT04621929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5961188|NCT04621929|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5961189|NCT04621929|Antioxidants|antioxidants|mesh-ancestor
5961190|NCT04621929|Protective Agents|protective agents|mesh-ancestor
5961191|NCT04621929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5961192|NCT04621929|Appetite Depressants|appetite depressants|mesh-ancestor
5961193|NCT04621929|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5961194|NCT04621929|Sympathomimetics|sympathomimetics|mesh-ancestor
5961195|NCT04621929|Autonomic Agents|autonomic agents|mesh-ancestor
5961196|NCT04621929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5961197|NCT04621929|Adrenergic Agents|adrenergic agents|mesh-ancestor
6519134|NCT00730769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519135|NCT00730821|Nintedanib|nintedanib|mesh-list
6519136|NCT00730821|Afatinib|afatinib|mesh-list
6519137|NCT00730821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6519138|NCT00730821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6519139|NCT00730821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6519140|NCT00730821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684069|NCT01625351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961198|NCT04621929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5961199|NCT04621981|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5961200|NCT04622020|Anesthetics|anesthetics|mesh-list
5961201|NCT04622020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5961202|NCT04622020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961203|NCT04622033|Brodalumab|brodalumab|mesh-list
5961204|NCT04622033|Dermatologic Agents|dermatologic agents|mesh-ancestor
5961205|NCT04621799|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
5961206|NCT04621799|Hemostatics|hemostatics|mesh-ancestor
5961207|NCT04621799|Coagulants|coagulants|mesh-ancestor
6684070|NCT01625351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6684071|NCT01625351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5961208|NCT04621370|Capecitabine|capecitabine|mesh-list
5961209|NCT04621370|Durvalumab|durvalumab|mesh-list
5961210|NCT04621370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5961211|NCT04621370|Antimetabolites|antimetabolites|mesh-ancestor
5961212|NCT04621370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961213|NCT04621370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5961214|NCT04621370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5961215|NCT04621461|Zinc Sulfate|zinc sulfate|mesh-list
5961216|NCT04621461|Astringents|astringents|mesh-ancestor
5961217|NCT04621461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961218|NCT04621461|Dermatologic Agents|dermatologic agents|mesh-ancestor
5961219|NCT04621487|Amoxicillin|amoxicillin|mesh-list
5961220|NCT04621487|Metronidazole|metronidazole|mesh-list
5961221|NCT04621487|Clarithromycin|clarithromycin|mesh-list
6684072|NCT01625351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6684073|NCT01625351|Antifungal Agents|antifungal agents|mesh-ancestor
6684074|NCT01625351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6684075|NCT01625351|Alkylating Agents|alkylating agents|mesh-ancestor
6684076|NCT01625351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6684077|NCT01625351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6684078|NCT01625429|Paclitaxel|paclitaxel|mesh-list
6684079|NCT01625429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6684080|NCT01625429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6684081|NCT01625429|Tubulin Modulators|tubulin modulators|mesh-ancestor
6684082|NCT01625429|Antimitotic Agents|antimitotic agents|mesh-ancestor
6684083|NCT01625429|Mitosis Modulators|mitosis modulators|mesh-ancestor
6684084|NCT01625429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684085|NCT01625494|Amlodipine|amlodipine|mesh-list
5961222|NCT04621487|Pantoprazole|pantoprazole|mesh-list
5961223|NCT04621487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5961224|NCT04621487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5961225|NCT04621487|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5961226|NCT04621487|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5961227|NCT04621487|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6684086|NCT01625494|Irbesartan|irbesartan|mesh-list
6684087|NCT01625494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5961228|NCT04621487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5961229|NCT04621487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961230|NCT04621487|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5961231|NCT04621487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5961232|NCT04621487|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5961233|NCT04621487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5961234|NCT04621487|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5961235|NCT04621565|Hydrocortisone|hydrocortisone|mesh-list
5961236|NCT04621565|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
5961237|NCT04621565|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
5961238|NCT04621565|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
5961239|NCT04621565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5961240|NCT04621617|Midodrine|midodrine|mesh-list
5961241|NCT04621617|Sympathomimetics|sympathomimetics|mesh-ancestor
5961242|NCT04621617|Autonomic Agents|autonomic agents|mesh-ancestor
5961243|NCT04621617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5961244|NCT04621617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961245|NCT04621617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5961246|NCT04621617|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5961247|NCT04621617|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5961248|NCT04621617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5961249|NCT04621617|Adrenergic Agents|adrenergic agents|mesh-ancestor
5961250|NCT04621617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5961251|NCT04621617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961252|NCT04621669|Metformin|metformin|mesh-list
5961253|NCT04621669|Digoxin|digoxin|mesh-list
6519141|NCT00730938|Cefuroxime|cefuroxime|mesh-list
6684088|NCT01625494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6684089|NCT01625494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6684090|NCT01625494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684091|NCT01625494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6684092|NCT01625494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684093|NCT01625494|Vasodilator Agents|vasodilator agents|mesh-ancestor
6684094|NCT01625494|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6684095|NCT01625494|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6684096|NCT01625520|Everolimus|everolimus|mesh-list
6684097|NCT01625520|Pasireotide|pasireotide|mesh-list
6684098|NCT01625520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6684099|NCT01625520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6684100|NCT01625520|Immunologic Factors|immunologic factors|mesh-ancestor
6684101|NCT01625520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684102|NCT01625520|Hormones|hormones|mesh-ancestor
6684103|NCT01625520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6684104|NCT01625572|Morphine|morphine|mesh-list
6684105|NCT01625572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6684106|NCT01625572|Narcotics|narcotics|mesh-ancestor
6684107|NCT01625572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6684108|NCT01625572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684109|NCT01625572|Analgesics|analgesics|mesh-ancestor
6684110|NCT01625572|Sensory System Agents|sensory system agents|mesh-ancestor
6684111|NCT01625572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6684112|NCT01625715|Ketotifen|ketotifen|mesh-list
6684113|NCT01625715|Antipruritics|antipruritics|mesh-ancestor
6684114|NCT01625715|Dermatologic Agents|dermatologic agents|mesh-ancestor
6684115|NCT01625715|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6519142|NCT00730938|Cefuroxime axetil|cefuroxime axetil|mesh-list
6519143|NCT00730938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6519144|NCT00730938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6519145|NCT00730977|Mannitol|mannitol|mesh-list
6519146|NCT00730977|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6519147|NCT00730977|Diuretics|diuretics|mesh-ancestor
6519148|NCT00730977|Natriuretic Agents|natriuretic agents|mesh-ancestor
6519149|NCT00730977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519150|NCT00731003|Tryptophan|tryptophan|mesh-list
6519151|NCT00731003|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
6519152|NCT00731003|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6519153|NCT00731003|Antidepressive Agents|antidepressive agents|mesh-ancestor
6519154|NCT00731003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6519155|NCT00731016|Zoledronic Acid|zoledronic acid|mesh-list
6519156|NCT00731016|Pravastatin|pravastatin|mesh-list
6519157|NCT00731016|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6519158|NCT00731016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519159|NCT00731016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6519160|NCT00731016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6519161|NCT00731016|Antimetabolites|antimetabolites|mesh-ancestor
6519162|NCT00731016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519163|NCT00731016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6519164|NCT00731016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6519165|NCT00731016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6519166|NCT00731068|Mitogens|mitogens|mesh-list
6519167|NCT00731068|Mitosis Modulators|mitosis modulators|mesh-ancestor
6519168|NCT00731068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519169|NCT00731146|Anesthetics|anesthetics|mesh-list
6519170|NCT00731146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6519171|NCT00731146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519172|NCT00731172|Glatiramer Acetate|glatiramer acetate|mesh-list
6519173|NCT00731172|(T,G)-A-L|(t,g)-a-l|mesh-list
6519174|NCT00731172|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6519175|NCT00731172|Immunologic Factors|immunologic factors|mesh-ancestor
6519176|NCT00731172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519177|NCT00731172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6519178|NCT00731172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6519179|NCT00731224|Rivastigmine|rivastigmine|mesh-list
6519180|NCT00731224|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5961254|NCT04621669|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5961255|NCT04621669|Calcium|calcium|mesh-list
5961256|NCT04621669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5961257|NCT04621669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961258|NCT04621669|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5961259|NCT04621669|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5961260|NCT04621669|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5961261|NCT04621669|Antimetabolites|antimetabolites|mesh-ancestor
5961262|NCT04621669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961263|NCT04621669|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5961264|NCT04621669|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5961265|NCT04621669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5961266|NCT04621669|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5961267|NCT04621669|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5961268|NCT04621669|Protective Agents|protective agents|mesh-ancestor
5961269|NCT04621409|Anti-Infective Agents|anti-infective agents|mesh-list
5961270|NCT04621409|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5961271|NCT04621318|Denosumab|denosumab|mesh-list
5961272|NCT04621318|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6519181|NCT00731224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6519182|NCT00731224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519183|NCT00731224|Cholinergic Agents|cholinergic agents|mesh-ancestor
6519184|NCT00731224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6519185|NCT00731224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519186|NCT00731224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6519187|NCT00731224|Protective Agents|protective agents|mesh-ancestor
6519188|NCT00731276|Irinotecan|irinotecan|mesh-list
6519189|NCT00731276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6519190|NCT00731276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6519191|NCT00731276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6684116|NCT01625715|Histamine Antagonists|histamine antagonists|mesh-ancestor
6684117|NCT01625715|Histamine Agents|histamine agents|mesh-ancestor
5961273|NCT04621318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970298|NCT04536493|Tetracaine|tetracaine|mesh-list
5970299|NCT04536493|Epinephryl borate|epinephryl borate|mesh-list
5970300|NCT04536493|Anesthetics, Local|anesthetics, local|mesh-ancestor
5970301|NCT04536493|Anesthetics|anesthetics|mesh-ancestor
5970302|NCT04536493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5970303|NCT04536493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970304|NCT04536493|Sensory System Agents|sensory system agents|mesh-ancestor
5970305|NCT04536493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5970306|NCT04536493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5970307|NCT04536493|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5970308|NCT04536493|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5970309|NCT04536493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5970310|NCT04536493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970311|NCT04536493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5970312|NCT04536493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5970313|NCT04536493|Adrenergic Agents|adrenergic agents|mesh-ancestor
5970314|NCT04536493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5970315|NCT04536493|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6519192|NCT00731276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519193|NCT00731276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6519194|NCT00731289|Triamcinolone|triamcinolone|mesh-list
5961274|NCT04621227|Midazolam|midazolam|mesh-list
5961275|NCT04621227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5961276|NCT04621227|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5961277|NCT04621227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5961278|NCT04621227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5961279|NCT04621227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961280|NCT04621227|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5961281|NCT04621227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5961282|NCT04621227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5961283|NCT04621227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5961284|NCT04621227|Anesthetics, General|anesthetics, general|mesh-ancestor
5961285|NCT04621227|Anesthetics|anesthetics|mesh-ancestor
5961286|NCT04621227|GABA Modulators|gaba modulators|mesh-ancestor
5961287|NCT04621227|GABA Agents|gaba agents|mesh-ancestor
5961288|NCT04621227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5961289|NCT04621227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961290|NCT04621227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5961291|NCT04621227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5961292|NCT04621227|Antimetabolites|antimetabolites|mesh-ancestor
5961293|NCT04621227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5961294|NCT04621227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5961295|NCT04621227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5961296|NCT04621513|Montelukast|montelukast|mesh-list
5961297|NCT04621513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5961298|NCT04621513|Respiratory System Agents|respiratory system agents|mesh-ancestor
5961299|NCT04621513|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5961300|NCT04621513|Hormone Antagonists|hormone antagonists|mesh-ancestor
5961301|NCT04621513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5961302|NCT04621513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961303|NCT04621513|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5961304|NCT04621513|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5961305|NCT04621513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961306|NCT04621149|Lactoferrin|lactoferrin|mesh-list
5961307|NCT04621149|Chlorine dioxide|chlorine dioxide|mesh-list
5961308|NCT04621149|Famotidine|famotidine|mesh-list
5961309|NCT04621149|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5961310|NCT04621149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5961311|NCT04621149|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5961312|NCT04621149|Histamine Antagonists|histamine antagonists|mesh-ancestor
5961313|NCT04621149|Histamine Agents|histamine agents|mesh-ancestor
5961314|NCT04621149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5961315|NCT04621149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961316|NCT04621149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961317|NCT04621149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5961318|NCT04621149|Dental Disinfectants|dental disinfectants|mesh-ancestor
5961319|NCT04621149|Disinfectants|disinfectants|mesh-ancestor
5961320|NCT04620954|Nivolumab|nivolumab|mesh-list
5961321|NCT04620954|Oregovomab|oregovomab|mesh-list
5961322|NCT04620954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5961323|NCT04620954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5961324|NCT04620954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5961325|NCT04620954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961326|NCT04621253|Dipyrone|dipyrone|mesh-list
5961327|NCT04621253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5961328|NCT04621253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5961329|NCT04621253|Analgesics|analgesics|mesh-ancestor
5961330|NCT04621253|Sensory System Agents|sensory system agents|mesh-ancestor
5961331|NCT04621253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5961332|NCT04621253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684118|NCT01625715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6684119|NCT01625715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684120|NCT01625715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684121|NCT01625715|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6684122|NCT01625741|Rituximab|rituximab|mesh-list
6684123|NCT01625741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6684124|NCT01625741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6684125|NCT01625741|Immunologic Factors|immunologic factors|mesh-ancestor
6684126|NCT01625741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684127|NCT01625741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6684128|NCT01625793|Interferons|interferons|mesh-list
6684129|NCT01625793|Interferon-alpha|interferon-alpha|mesh-list
6684130|NCT01625793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6684131|NCT01625793|Antiviral Agents|antiviral agents|mesh-ancestor
6684132|NCT01625793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6684133|NCT01625793|Immunologic Factors|immunologic factors|mesh-ancestor
6684134|NCT01625793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684135|NCT01625806|Ketoconazole|ketoconazole|mesh-list
6684136|NCT01625806|Antifungal Agents|antifungal agents|mesh-ancestor
6684137|NCT01625806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6684138|NCT01625806|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6684139|NCT01625806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5961333|NCT04621253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5961334|NCT04621253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5961335|NCT04621253|Antipyretics|antipyretics|mesh-ancestor
5961336|NCT04621058|Vitamin D|vitamin d|mesh-list
5961337|NCT04621058|Vitamins|vitamins|mesh-list
5961338|NCT04621058|Micronutrients|micronutrients|mesh-ancestor
5961339|NCT04621058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961340|NCT04621058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5961341|NCT04621110|Fentanyl|fentanyl|mesh-list
5961342|NCT04621110|Midazolam|midazolam|mesh-list
5961343|NCT04621110|Dexmedetomidine|dexmedetomidine|mesh-list
5961344|NCT04621110|Ketamine|ketamine|mesh-list
5961345|NCT04621110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5961346|NCT04621110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5961347|NCT04621110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961348|NCT04621110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5961349|NCT04621110|Analgesics|analgesics|mesh-ancestor
5961350|NCT04621110|Sensory System Agents|sensory system agents|mesh-ancestor
5961351|NCT04621110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5961352|NCT04621110|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5961353|NCT04621110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5961354|NCT04621110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5961355|NCT04621110|Adrenergic Agents|adrenergic agents|mesh-ancestor
5961356|NCT04621110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6684140|NCT01625806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6684141|NCT01625806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684142|NCT01625806|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6684143|NCT01625806|Hormone Antagonists|hormone antagonists|mesh-ancestor
6684144|NCT01625806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6684145|NCT01625806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684146|NCT01625806|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6684147|NCT01625871|Lumefantrine|lumefantrine|mesh-list
6684148|NCT01625871|Artemether|artemether|mesh-list
6684149|NCT01625871|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6684150|NCT01625871|Antimalarials|antimalarials|mesh-ancestor
6684151|NCT01625871|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6684152|NCT01625871|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6684153|NCT01625871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6684154|NCT01625936|Bevacizumab|bevacizumab|mesh-list
6684155|NCT01625936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6684156|NCT01625936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6684157|NCT01625936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5961357|NCT04621110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961358|NCT04621110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5961359|NCT04621110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5961360|NCT04621110|Anesthetics, General|anesthetics, general|mesh-ancestor
5961361|NCT04621110|Anesthetics|anesthetics|mesh-ancestor
5961362|NCT04621110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5961363|NCT04621110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5961364|NCT04621110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5961365|NCT04621110|Narcotics|narcotics|mesh-ancestor
5961366|NCT04621110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5961367|NCT04621110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5961368|NCT04621110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5961369|NCT04621110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5961370|NCT04621110|GABA Modulators|gaba modulators|mesh-ancestor
5961371|NCT04621110|GABA Agents|gaba agents|mesh-ancestor
5961372|NCT04621136|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5961373|NCT04621136|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5961374|NCT04620967|Insulin|insulin|mesh-list
5961375|NCT04620967|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5961376|NCT04620967|Insulin Aspart|insulin aspart|mesh-list
5961377|NCT04620967|Insulin, Long-Acting|insulin, long-acting|mesh-list
5961378|NCT04620967|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
5961379|NCT04620967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5961380|NCT04620967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961381|NCT04620785|Methylene Blue|methylene blue|mesh-list
6684158|NCT01625936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5961382|NCT04620785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5961383|NCT04620785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961384|NCT04620720|Gabapentin|gabapentin|mesh-list
5961385|NCT04620720|Analgesics|analgesics|mesh-ancestor
5961386|NCT04620720|Sensory System Agents|sensory system agents|mesh-ancestor
5961387|NCT04620720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5961388|NCT04620720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961389|NCT04620720|Anticonvulsants|anticonvulsants|mesh-ancestor
5961390|NCT04620720|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5961391|NCT04620720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5961392|NCT04620720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5961393|NCT04620720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5961394|NCT04620720|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5961395|NCT04620720|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5961396|NCT04620720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5961397|NCT04620720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961398|NCT04620720|Antimanic Agents|antimanic agents|mesh-ancestor
5961399|NCT04620590|Dapagliflozin|dapagliflozin|mesh-list
5961400|NCT04620590|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5961401|NCT04620590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961402|NCT04620590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5961403|NCT04620590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961404|NCT04620603|Nivolumab|nivolumab|mesh-list
5961405|NCT04620603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5961406|NCT04620603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5961407|NCT04620603|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5961408|NCT04620603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961409|NCT04620616|Menthol|menthol|mesh-list
5961410|NCT04620616|Antipruritics|antipruritics|mesh-ancestor
5961411|NCT04620616|Dermatologic Agents|dermatologic agents|mesh-ancestor
5961412|NCT04620473|Oxaliplatin|oxaliplatin|mesh-list
5961413|NCT04620473|Capecitabine|capecitabine|mesh-list
5961414|NCT04620473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5961415|NCT04620473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5961416|NCT04620473|Antimetabolites|antimetabolites|mesh-ancestor
5961417|NCT04620473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961418|NCT04620759|Psilocybin|psilocybin|mesh-list
5961419|NCT04620759|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
5961420|NCT04620759|Hallucinogens|hallucinogens|mesh-ancestor
5961421|NCT04620759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961422|NCT04620759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5961423|NCT04620759|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5961424|NCT04620759|Serotonin Agents|serotonin agents|mesh-ancestor
5961425|NCT04620759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5961426|NCT04620759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961427|NCT04620759|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5961428|NCT04620772|Cyclophosphamide|cyclophosphamide|mesh-list
5961429|NCT04620772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5961430|NCT04620772|Immunologic Factors|immunologic factors|mesh-ancestor
5961431|NCT04620772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961432|NCT04620772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5961433|NCT04620772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5961434|NCT04620772|Alkylating Agents|alkylating agents|mesh-ancestor
5961435|NCT04620772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961436|NCT04620772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5961437|NCT04620772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5961438|NCT04620577|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5961439|NCT04620577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5961440|NCT04620018|Amoxicillin|amoxicillin|mesh-list
5961441|NCT04620018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5961442|NCT04620018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5961443|NCT04620031|Propofol|propofol|mesh-list
5961444|NCT04620031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5961445|NCT04620031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6519195|NCT00731289|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6519196|NCT00731289|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6519197|NCT00731289|Hyaluronic Acid|hyaluronic acid|mesh-list
6519198|NCT00731289|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6519199|NCT00731289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6519200|NCT00731289|Glucocorticoids|glucocorticoids|mesh-ancestor
6519201|NCT00731289|Hormones|hormones|mesh-ancestor
6519202|NCT00731289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6519203|NCT00731289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519204|NCT00731289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6519205|NCT00731289|Immunologic Factors|immunologic factors|mesh-ancestor
5961446|NCT04620031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961447|NCT04620031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5961448|NCT04620031|Anesthetics, General|anesthetics, general|mesh-ancestor
5961449|NCT04620031|Anesthetics|anesthetics|mesh-ancestor
5961450|NCT04620109|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5961451|NCT04620109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5961452|NCT04620200|Nivolumab|nivolumab|mesh-list
6684159|NCT01625936|Growth Substances|growth substances|mesh-ancestor
6684160|NCT01625936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684161|NCT01625936|Growth Inhibitors|growth inhibitors|mesh-ancestor
6684162|NCT01626222|Everolimus|everolimus|mesh-list
6684163|NCT01626222|Exemestane|exemestane|mesh-list
5961453|NCT04620200|Ipilimumab|ipilimumab|mesh-list
5961454|NCT04620200|Immunologic Factors|immunologic factors|mesh-list
5961455|NCT04620200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5961456|NCT04620200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5961457|NCT04620200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5961458|NCT04620200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961459|NCT04620200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961460|NCT04620135|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5961461|NCT04620135|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5961462|NCT04620343|Anesthetics|anesthetics|mesh-list
5961463|NCT04620343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5961464|NCT04620343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961465|NCT04620291|UB-421|ub-421|mesh-list
5961466|NCT04620291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5961467|NCT04620291|Antiviral Agents|antiviral agents|mesh-ancestor
5961468|NCT04620291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5961469|NCT04620304|UB-421|ub-421|mesh-list
5961470|NCT04620304|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5961471|NCT04620304|Antiviral Agents|antiviral agents|mesh-ancestor
5961472|NCT04620304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5961473|NCT04620213|Phentolamine|phentolamine|mesh-list
5961474|NCT04620213|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5961475|NCT04620213|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5961476|NCT04620213|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5961477|NCT04620213|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5961478|NCT04620213|Adrenergic Agents|adrenergic agents|mesh-ancestor
5961479|NCT04620213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5961480|NCT04620213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961481|NCT04620213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961482|NCT04620213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5961483|NCT04619758|Emollients|emollients|mesh-list
5961484|NCT04619758|Dermatologic Agents|dermatologic agents|mesh-ancestor
5961485|NCT04619706|Palmidrol|palmidrol|mesh-list
5961486|NCT04619706|Analgesics|analgesics|mesh-ancestor
6684164|NCT01626222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6684165|NCT01626222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6684166|NCT01626222|Immunologic Factors|immunologic factors|mesh-ancestor
6684167|NCT01626222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684168|NCT01626222|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6684169|NCT01626222|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6684170|NCT01626222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6684171|NCT01626222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961487|NCT04619706|Sensory System Agents|sensory system agents|mesh-ancestor
5961488|NCT04619706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5961489|NCT04619706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961490|NCT04619706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6684172|NCT01626222|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5961491|NCT04619706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5961492|NCT04619706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5961493|NCT04619706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5961494|NCT04619706|Antiviral Agents|antiviral agents|mesh-ancestor
5961495|NCT04619706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5961496|NCT04619706|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6519206|NCT00731289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6519207|NCT00731289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519208|NCT00731289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6519209|NCT00731289|Viscosupplements|viscosupplements|mesh-ancestor
6519210|NCT00731289|Protective Agents|protective agents|mesh-ancestor
6519211|NCT00731302|Aspirin|aspirin|mesh-list
6519212|NCT00731302|Meloxicam|meloxicam|mesh-list
6519213|NCT00731302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6519214|NCT00731302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6519215|NCT00731302|Analgesics|analgesics|mesh-ancestor
6519216|NCT00731302|Sensory System Agents|sensory system agents|mesh-ancestor
6684173|NCT01626222|Hormone Antagonists|hormone antagonists|mesh-ancestor
6519217|NCT00731302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6519218|NCT00731302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519219|NCT00731302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6519220|NCT00731302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6519221|NCT00731302|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6519222|NCT00731302|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6519223|NCT00731302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519224|NCT00731302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6519225|NCT00731302|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6519226|NCT00731302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6519227|NCT00731302|Antipyretics|antipyretics|mesh-ancestor
6684174|NCT01626222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6780104|NCT02182245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780105|NCT02182245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6780106|NCT02182245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780107|NCT02182258|Nintedanib|nintedanib|mesh-list
6780108|NCT02182258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6780109|NCT02182258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6780110|NCT02182258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780111|NCT02182258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780112|NCT02182310|Moxifloxacin|moxifloxacin|mesh-list
6780113|NCT02182310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6780114|NCT02182310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6780115|NCT02182310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6780116|NCT02182310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6780117|NCT02182310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780118|NCT02182310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780119|NCT02182310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6780120|NCT02182336|Vitamin K|vitamin k|mesh-list
5961497|NCT04619706|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5961498|NCT04619706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5961499|NCT04619706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961500|NCT04619706|Hormones|hormones|mesh-ancestor
5961501|NCT04619706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5961502|NCT04619914|Letrozole|letrozole|mesh-list
5961503|NCT04619914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6780121|NCT02182336|Digoxin|digoxin|mesh-list
6780122|NCT02182336|Midazolam|midazolam|mesh-list
6780123|NCT02182336|Dextromethorphan|dextromethorphan|mesh-list
6780124|NCT02182336|Caffeine|caffeine|mesh-list
6780125|NCT02182336|Omeprazole|omeprazole|mesh-list
6780126|NCT02182336|Warfarin|warfarin|mesh-list
6780127|NCT02182336|Vitamins|vitamins|mesh-ancestor
6780128|NCT02182336|Micronutrients|micronutrients|mesh-ancestor
5961504|NCT04619914|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5961505|NCT04619914|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5961506|NCT04619914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5961507|NCT04619914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961508|NCT04619914|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5961509|NCT04619914|Hormone Antagonists|hormone antagonists|mesh-ancestor
5961510|NCT04619914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5961511|NCT04619914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519228|NCT00731302|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6519229|NCT00731367|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6519230|NCT00731367|Laxatives|laxatives|mesh-ancestor
5970316|NCT04536493|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5970317|NCT04536493|Autonomic Agents|autonomic agents|mesh-ancestor
5970318|NCT04536493|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5970319|NCT04536493|Respiratory System Agents|respiratory system agents|mesh-ancestor
5970320|NCT04536493|Mydriatics|mydriatics|mesh-ancestor
5970321|NCT04536493|Sympathomimetics|sympathomimetics|mesh-ancestor
5970322|NCT04536493|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5970323|NCT04535960|Liraglutide|liraglutide|mesh-list
5970324|NCT04535960|Empagliflozin|empagliflozin|mesh-list
5970325|NCT04535960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5970326|NCT04535960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970327|NCT04535960|Incretins|incretins|mesh-ancestor
5970328|NCT04535960|Hormones|hormones|mesh-ancestor
5971355|NCT04528628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6519231|NCT00731367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6519232|NCT00731380|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6519233|NCT00731380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6519234|NCT00731393|Vaccines|vaccines|mesh-list
6519235|NCT00731393|Immunologic Factors|immunologic factors|mesh-ancestor
6780129|NCT02182336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519236|NCT00731393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961512|NCT04619875|Lactulose|lactulose|mesh-list
5961513|NCT04619875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5961514|NCT04619862|Gabapentin|gabapentin|mesh-list
5961515|NCT04619862|Analgesics|analgesics|mesh-ancestor
5961516|NCT04619862|Sensory System Agents|sensory system agents|mesh-ancestor
5961517|NCT04619862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5961518|NCT04619862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961519|NCT04619862|Anticonvulsants|anticonvulsants|mesh-ancestor
5961520|NCT04619862|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5961521|NCT04619862|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5961522|NCT04619862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5961523|NCT04619862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5961524|NCT04619862|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5961525|NCT04619862|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5961526|NCT04619862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5961527|NCT04619862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961528|NCT04619862|Antimanic Agents|antimanic agents|mesh-ancestor
5961529|NCT04619290|Methylene Blue|methylene blue|mesh-list
6519237|NCT00731523|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6519238|NCT00731523|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6519239|NCT00731523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519240|NCT00731523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6519241|NCT00731523|Immunologic Factors|immunologic factors|mesh-ancestor
6519242|NCT00731523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519243|NCT00731562|Varenicline|varenicline|mesh-list
6519244|NCT00731562|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6519245|NCT00731562|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6684175|NCT01626339|Bevacizumab|bevacizumab|mesh-list
6684176|NCT01626339|Ranibizumab|ranibizumab|mesh-list
6684177|NCT01626339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6684178|NCT01626339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6684179|NCT01626339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6684180|NCT01626339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6684181|NCT01626339|Growth Substances|growth substances|mesh-ancestor
6684182|NCT01626339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684183|NCT01626339|Growth Inhibitors|growth inhibitors|mesh-ancestor
6684184|NCT01626443|Folic Acid|folic acid|mesh-list
6684185|NCT01626443|Vitamin B Complex|vitamin b complex|mesh-list
6684186|NCT01626443|Inositol|inositol|mesh-list
6684187|NCT01626443|Hematinics|hematinics|mesh-ancestor
6684188|NCT01626443|Vitamins|vitamins|mesh-ancestor
5961530|NCT04619290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5961531|NCT04619290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961532|NCT04619303|Dexamethasone|dexamethasone|mesh-list
5961533|NCT04619303|Bevacizumab|bevacizumab|mesh-list
5961534|NCT04619303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5961535|NCT04619303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5961536|NCT04619303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5961537|NCT04619303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5961538|NCT04619303|Growth Substances|growth substances|mesh-ancestor
5961539|NCT04619303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684189|NCT01626443|Micronutrients|micronutrients|mesh-ancestor
6684190|NCT01626443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684191|NCT01626469|Captopril|captopril|mesh-list
6684192|NCT01626469|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6684193|NCT01626469|Protease Inhibitors|protease inhibitors|mesh-ancestor
5961540|NCT04619303|Growth Inhibitors|growth inhibitors|mesh-ancestor
5961541|NCT04619303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5961542|NCT04619303|Antiemetics|antiemetics|mesh-ancestor
5961543|NCT04619303|Autonomic Agents|autonomic agents|mesh-ancestor
5961544|NCT04619303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5961545|NCT04619303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5961546|NCT04619303|Glucocorticoids|glucocorticoids|mesh-ancestor
5961547|NCT04619303|Hormones|hormones|mesh-ancestor
6684194|NCT01626469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6684195|NCT01626469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684196|NCT01626469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6684197|NCT01626534|Clopidogrel|clopidogrel|mesh-list
6684198|NCT01626534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6684199|NCT01626534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6684200|NCT01626534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6684201|NCT01626534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6684202|NCT01626534|Purinergic Agents|purinergic agents|mesh-ancestor
5961548|NCT04619303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6684203|NCT01626534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6684204|NCT01626534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684205|NCT01626534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684206|NCT01626560|Vancomycin|vancomycin|mesh-list
6684207|NCT01626560|Daptomycin|daptomycin|mesh-list
6684208|NCT01626560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6684209|NCT01626560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6684210|NCT01626612|Anti-Infective Agents|anti-infective agents|mesh-list
6684211|NCT01626612|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5961549|NCT04619303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5961550|NCT04619537|Docetaxel|docetaxel|mesh-list
5961551|NCT04619537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5961552|NCT04619537|Tubulin Modulators|tubulin modulators|mesh-ancestor
5961553|NCT04619537|Antimitotic Agents|antimitotic agents|mesh-ancestor
5961554|NCT04619537|Mitosis Modulators|mitosis modulators|mesh-ancestor
5961555|NCT04619537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961556|NCT04619563|Docetaxel|docetaxel|mesh-list
5961557|NCT04619563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5961558|NCT04619563|Tubulin Modulators|tubulin modulators|mesh-ancestor
5961559|NCT04619563|Antimitotic Agents|antimitotic agents|mesh-ancestor
5961560|NCT04619563|Mitosis Modulators|mitosis modulators|mesh-ancestor
5961561|NCT04619563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961562|NCT04619316|Trametinib|trametinib|mesh-list
5961563|NCT04619316|Dabrafenib|dabrafenib|mesh-list
5961564|NCT04619316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5961565|NCT04619316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5961566|NCT04619316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5961567|NCT04619316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961568|NCT04619251|Itraconazole|itraconazole|mesh-list
5961569|NCT04619251|Antifungal Agents|antifungal agents|mesh-ancestor
5961570|NCT04619251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5961571|NCT04619251|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5961572|NCT04619251|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5961573|NCT04619251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5961574|NCT04619251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519246|NCT00731562|Cholinergic Agents|cholinergic agents|mesh-ancestor
6519247|NCT00731562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6684212|NCT01626651|Ketoconazole|ketoconazole|mesh-list
6684213|NCT01626651|Antifungal Agents|antifungal agents|mesh-ancestor
6684214|NCT01626651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6684215|NCT01626651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6684216|NCT01626651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6684217|NCT01626651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6684218|NCT01626651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684219|NCT01626651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6684220|NCT01626651|Hormone Antagonists|hormone antagonists|mesh-ancestor
6684221|NCT01626651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6684222|NCT01626651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684223|NCT01626651|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6684224|NCT01626911|Heparin|heparin|mesh-list
6684225|NCT01626911|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6684226|NCT01626911|Tinzaparin|tinzaparin|mesh-list
6684227|NCT01626911|Dalteparin|dalteparin|mesh-list
6684228|NCT01626911|Anticoagulants|anticoagulants|mesh-ancestor
5961575|NCT04619251|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5961576|NCT04619251|Hormone Antagonists|hormone antagonists|mesh-ancestor
5961577|NCT04619251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5961578|NCT04619251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961579|NCT04619251|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6519248|NCT00731562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684229|NCT01626911|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6684230|NCT01626911|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6684231|NCT01626911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684232|NCT01627041|Cytarabine|cytarabine|mesh-list
6684233|NCT01627041|Decitabine|decitabine|mesh-list
6684234|NCT01627041|Daunorubicin|daunorubicin|mesh-list
6684235|NCT01627041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6684236|NCT01627041|Antimetabolites|antimetabolites|mesh-ancestor
6519249|NCT00731562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519250|NCT00731575|Prednisolone|prednisolone|mesh-list
6519251|NCT00731575|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6519252|NCT00731575|Methylprednisolone|methylprednisolone|mesh-list
6519253|NCT00731575|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6684237|NCT01627041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684238|NCT01627041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6684239|NCT01627041|Antiviral Agents|antiviral agents|mesh-ancestor
6684240|NCT01627041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6684241|NCT01627041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6684242|NCT01627041|Immunologic Factors|immunologic factors|mesh-ancestor
5961580|NCT04619381|Clopidogrel|clopidogrel|mesh-list
5961581|NCT04619381|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5961582|NCT04619381|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5961583|NCT04619381|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5961584|NCT04619381|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5961585|NCT04619381|Purinergic Agents|purinergic agents|mesh-ancestor
5961586|NCT04619381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5961587|NCT04619381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961588|NCT04619381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961589|NCT04618965|Dexmedetomidine|dexmedetomidine|mesh-list
5961590|NCT04618965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5961591|NCT04618965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5961592|NCT04618965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961593|NCT04618965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5961594|NCT04618965|Analgesics|analgesics|mesh-ancestor
5961595|NCT04618965|Sensory System Agents|sensory system agents|mesh-ancestor
5961596|NCT04618965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5961597|NCT04618965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5961598|NCT04618965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5961599|NCT04618965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5961600|NCT04618965|Adrenergic Agents|adrenergic agents|mesh-ancestor
5961601|NCT04618965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5961602|NCT04618965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961603|NCT04619095|Psyllium|psyllium|mesh-list
5961604|NCT04619095|Cathartics|cathartics|mesh-ancestor
5961605|NCT04619095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5961606|NCT04619082|Tenofovir|tenofovir|mesh-list
5961607|NCT04619082|Antiviral Agents|antiviral agents|mesh-ancestor
5961608|NCT04619082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5961609|NCT04619082|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5961610|NCT04619082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5961611|NCT04619082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6242669|NCT02654145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6684243|NCT01627041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684244|NCT01627041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6684245|NCT01627041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6684246|NCT01627041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6684247|NCT01627041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6684248|NCT01627106|Amiodarone|amiodarone|mesh-list
6684249|NCT01627106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6519254|NCT00731575|Prednisolone acetate|prednisolone acetate|mesh-list
6519255|NCT00731575|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6519256|NCT00731575|Prednisolone phosphate|prednisolone phosphate|mesh-list
6519257|NCT00731575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6519258|NCT00731575|Glucocorticoids|glucocorticoids|mesh-ancestor
6519259|NCT00731575|Hormones|hormones|mesh-ancestor
6519260|NCT00731575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6519261|NCT00731575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519262|NCT00731575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6519263|NCT00731575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6519264|NCT00731575|Antiemetics|antiemetics|mesh-ancestor
6519265|NCT00731575|Autonomic Agents|autonomic agents|mesh-ancestor
6519266|NCT00731575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6519267|NCT00731575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6519268|NCT00731575|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6519269|NCT00731575|Protective Agents|protective agents|mesh-ancestor
6519270|NCT00731601|Pantoprazole|pantoprazole|mesh-list
6684250|NCT01627106|Vasodilator Agents|vasodilator agents|mesh-ancestor
6684251|NCT01627106|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6684252|NCT01627106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6684253|NCT01627106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684254|NCT01627106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6684255|NCT01627106|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6684256|NCT01627106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6519271|NCT00731601|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5961612|NCT04619082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961613|NCT04619082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5961614|NCT04619082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5961615|NCT04618913|Rivaroxaban|rivaroxaban|mesh-list
5961616|NCT04618913|Apixaban|apixaban|mesh-list
5961617|NCT04618913|Edoxaban|edoxaban|mesh-list
5961618|NCT04618913|Dabigatran|dabigatran|mesh-list
5961619|NCT04618913|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5961620|NCT04618913|Antithrombins|antithrombins|mesh-ancestor
5961621|NCT04618913|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5961622|NCT04618913|Protease Inhibitors|protease inhibitors|mesh-ancestor
5961623|NCT04618913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5961624|NCT04618913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961625|NCT04618913|Anticoagulants|anticoagulants|mesh-ancestor
5961626|NCT04618952|Calcium|calcium|mesh-list
5961627|NCT04618952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5961628|NCT04618952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961629|NCT04619433|Carboplatin|carboplatin|mesh-list
5961630|NCT04619433|Pemetrexed|pemetrexed|mesh-list
5961631|NCT04619433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5961632|NCT04619433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5961633|NCT04619433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961634|NCT04619433|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5961635|NCT04619433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5961636|NCT04619160|Propofol|propofol|mesh-list
5961637|NCT04619160|Sevoflurane|sevoflurane|mesh-list
5961638|NCT04619160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5961639|NCT04619160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5961640|NCT04619160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961641|NCT04619160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5961642|NCT04619160|Anesthetics, General|anesthetics, general|mesh-ancestor
5961643|NCT04619160|Anesthetics|anesthetics|mesh-ancestor
6519272|NCT00731601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6519273|NCT00731601|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6519274|NCT00731601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6519275|NCT00731601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519276|NCT00731627|Simvastatin|simvastatin|mesh-list
6519277|NCT00731627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6519278|NCT00731627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6519279|NCT00731627|Antimetabolites|antimetabolites|mesh-ancestor
6519280|NCT00731627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519281|NCT00731627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5961644|NCT04619160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6519282|NCT00731627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6519283|NCT00731627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6519284|NCT00731861|Paclitaxel|paclitaxel|mesh-list
6519285|NCT00731861|Vatalanib|vatalanib|mesh-list
6519286|NCT00731861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6684257|NCT01627106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6684258|NCT01627106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6684259|NCT01627106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6684260|NCT01627106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5961645|NCT04619160|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5961646|NCT04619069|Hormones|hormones|mesh-list
5961647|NCT04619069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5961648|NCT04619069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961649|NCT04618497|Ketorolac|ketorolac|mesh-list
5961650|NCT04618497|Methoxyflurane|methoxyflurane|mesh-list
5961651|NCT04618497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5961652|NCT04618497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5961653|NCT04618497|Analgesics|analgesics|mesh-ancestor
5961654|NCT04618497|Sensory System Agents|sensory system agents|mesh-ancestor
5961655|NCT04618497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5961656|NCT04618497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961657|NCT04618497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5961658|NCT04618497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5961659|NCT04618497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5961660|NCT04618497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5961661|NCT04618497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961662|NCT04618497|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5961663|NCT04618497|Anesthetics, General|anesthetics, general|mesh-ancestor
5961664|NCT04618497|Anesthetics|anesthetics|mesh-ancestor
5961665|NCT04618497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5961666|NCT04618367|Lenvatinib|lenvatinib|mesh-list
5961667|NCT04618367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6684261|NCT01627132|Dasatinib|dasatinib|mesh-list
6684262|NCT01627132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6519287|NCT00731861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6519288|NCT00731861|Tubulin Modulators|tubulin modulators|mesh-ancestor
6519289|NCT00731861|Antimitotic Agents|antimitotic agents|mesh-ancestor
6519290|NCT00731861|Mitosis Modulators|mitosis modulators|mesh-ancestor
6519291|NCT00731861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519292|NCT00731861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6519293|NCT00731861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6519294|NCT00731926|Vitamins|vitamins|mesh-list
6519295|NCT00731926|Ascorbic Acid|ascorbic acid|mesh-list
6684263|NCT01627132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6684264|NCT01627132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6684265|NCT01627132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684266|NCT01627145|Solifenacin Succinate|solifenacin succinate|mesh-list
6684267|NCT01627145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6684268|NCT01627145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6684269|NCT01627145|Cholinergic Agents|cholinergic agents|mesh-ancestor
6684270|NCT01627145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6684271|NCT01627145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684272|NCT01627145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684273|NCT01627145|Urological Agents|urological agents|mesh-ancestor
6684274|NCT01627158|Budesonide|budesonide|mesh-list
6684275|NCT01627158|Formoterol Fumarate|formoterol fumarate|mesh-list
5961668|NCT04618367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5961669|NCT04618367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5961670|NCT04618367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961671|NCT04618575|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
5961672|NCT04618575|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5961673|NCT04618575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5961674|NCT04618536|Sunscreening Agents|sunscreening agents|mesh-list
5961675|NCT04618536|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5961676|NCT04618536|Protective Agents|protective agents|mesh-ancestor
5961677|NCT04618536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961678|NCT04618536|Dermatologic Agents|dermatologic agents|mesh-ancestor
6519296|NCT00731926|Vitamin E|vitamin e|mesh-list
6519297|NCT00731926|Micronutrients|micronutrients|mesh-ancestor
6519298|NCT00731926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519299|NCT00731926|Antioxidants|antioxidants|mesh-ancestor
6519300|NCT00731926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519301|NCT00731926|Protective Agents|protective agents|mesh-ancestor
6519302|NCT00731952|Bortezomib|bortezomib|mesh-list
6519303|NCT00731952|Vorinostat|vorinostat|mesh-list
6519304|NCT00731952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6519305|NCT00731952|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6519306|NCT00731952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6519307|NCT00731952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519308|NCT00731965|Vaccines|vaccines|mesh-list
6519309|NCT00731965|Immunologic Factors|immunologic factors|mesh-ancestor
6519310|NCT00731965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519311|NCT00732082|Gemcitabine|gemcitabine|mesh-list
6519312|NCT00732082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6519313|NCT00732082|Antimetabolites|antimetabolites|mesh-ancestor
6519314|NCT00732082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519315|NCT00732082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6519316|NCT00732082|Antiviral Agents|antiviral agents|mesh-ancestor
6519317|NCT00732082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6519318|NCT00732082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6684276|NCT01627158|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6684277|NCT01627158|Charcoal|charcoal|mesh-list
5961679|NCT04618601|Spironolactone|spironolactone|mesh-list
5961680|NCT04618601|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5961681|NCT04618601|Hormone Antagonists|hormone antagonists|mesh-ancestor
5961682|NCT04618601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5961683|NCT04618601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961684|NCT04618601|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5961685|NCT04618601|Diuretics|diuretics|mesh-ancestor
5961686|NCT04618601|Natriuretic Agents|natriuretic agents|mesh-ancestor
5961687|NCT04618107|Anesthetics|anesthetics|mesh-list
5961688|NCT04618107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5961689|NCT04618107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961690|NCT04618146|Morphine|morphine|mesh-list
5961691|NCT04618146|Bupivacaine|bupivacaine|mesh-list
5961692|NCT04618146|Anesthetics, Local|anesthetics, local|mesh-ancestor
5961693|NCT04618146|Anesthetics|anesthetics|mesh-ancestor
5961694|NCT04618146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5961695|NCT04618146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961696|NCT04618146|Sensory System Agents|sensory system agents|mesh-ancestor
5961697|NCT04618146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5961698|NCT04618146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5961699|NCT04618146|Narcotics|narcotics|mesh-ancestor
5961700|NCT04618146|Analgesics|analgesics|mesh-ancestor
5970329|NCT04535960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5970330|NCT04535960|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5970331|NCT04535960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970332|NCT04536181|Prednisone|prednisone|mesh-list
5970333|NCT04536181|Prednisolone|prednisolone|mesh-list
5970334|NCT04536181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5970335|NCT04536181|Glucocorticoids|glucocorticoids|mesh-ancestor
5970336|NCT04536181|Hormones|hormones|mesh-ancestor
5970337|NCT04536181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5970338|NCT04536181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970339|NCT04536181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5970340|NCT04536181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5970341|NCT04536428|Hemostatics|hemostatics|mesh-list
5970342|NCT04536428|Coagulants|coagulants|mesh-ancestor
5970343|NCT04535947|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5970344|NCT04535947|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5971356|NCT04528758|Rhodamine 6G|rhodamine 6g|mesh-list
5971357|NCT04528758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5971394|NCT04528888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5971395|NCT04528888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5971396|NCT04528888|Anticoagulants|anticoagulants|mesh-ancestor
5971397|NCT04528888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5971398|NCT04528888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5971399|NCT04528888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971400|NCT04528927|Azithromycin|azithromycin|mesh-list
5971401|NCT04528927|Doxycycline|doxycycline|mesh-list
5971402|NCT04528927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5971403|NCT04528927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5971404|NCT04528927|Antimalarials|antimalarials|mesh-ancestor
5971405|NCT04528927|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5971406|NCT04528927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5971407|NCT04528563|Ketorolac|ketorolac|mesh-list
5971408|NCT04528563|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
5971409|NCT04528563|Morphine|morphine|mesh-list
6519319|NCT00732082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5961701|NCT04618289|Vitamin D|vitamin d|mesh-list
5961702|NCT04618289|Cholecalciferol|cholecalciferol|mesh-list
5961703|NCT04618289|Vitamins|vitamins|mesh-ancestor
5961704|NCT04618289|Micronutrients|micronutrients|mesh-ancestor
5961705|NCT04618289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684278|NCT01627158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6684279|NCT01627158|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6684280|NCT01627158|Autonomic Agents|autonomic agents|mesh-ancestor
6684281|NCT01627158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6684282|NCT01627158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684283|NCT01627158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6684284|NCT01627158|Respiratory System Agents|respiratory system agents|mesh-ancestor
6684285|NCT01627158|Glucocorticoids|glucocorticoids|mesh-ancestor
6684286|NCT01627158|Hormones|hormones|mesh-ancestor
6684287|NCT01627158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6684288|NCT01627158|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5961706|NCT04618289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5961707|NCT04618289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5961708|NCT04618328|Tretinoin|tretinoin|mesh-list
5961709|NCT04618328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5961710|NCT04618328|Keratolytic Agents|keratolytic agents|mesh-ancestor
5961711|NCT04618328|Dermatologic Agents|dermatologic agents|mesh-ancestor
5961712|NCT04617782|Donepezil|donepezil|mesh-list
5961713|NCT04617782|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5961714|NCT04617782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5961715|NCT04617782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961716|NCT04617782|Cholinergic Agents|cholinergic agents|mesh-ancestor
5961717|NCT04617782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5961718|NCT04617782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961719|NCT04617782|Nootropic Agents|nootropic agents|mesh-ancestor
5961720|NCT04617938|Analgesics, Opioid|analgesics, opioid|mesh-list
5961721|NCT04617938|Narcotics|narcotics|mesh-ancestor
5961722|NCT04617938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5961723|NCT04617938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961724|NCT04617938|Analgesics|analgesics|mesh-ancestor
5961725|NCT04617938|Sensory System Agents|sensory system agents|mesh-ancestor
5961726|NCT04617938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5961727|NCT04617613|Amoxicillin|amoxicillin|mesh-list
5961728|NCT04617613|Metronidazole|metronidazole|mesh-list
5961729|NCT04617613|Clarithromycin|clarithromycin|mesh-list
5961730|NCT04617613|Omeprazole|omeprazole|mesh-list
5961731|NCT04617613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6519320|NCT00732082|Immunologic Factors|immunologic factors|mesh-ancestor
6519321|NCT00732082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519322|NCT00732108|Topiramate|topiramate|mesh-list
6519323|NCT00732108|Lactulose|lactulose|mesh-list
6519324|NCT00732108|Anticonvulsants|anticonvulsants|mesh-ancestor
6519325|NCT00732108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6519326|NCT00732108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519327|NCT00732108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6519328|NCT00732121|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6519329|NCT00732121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6519330|NCT00732121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961732|NCT04617613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5961733|NCT04617613|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5961734|NCT04617613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5961735|NCT04617613|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5961736|NCT04617613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5961737|NCT04617613|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5961738|NCT04617613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5961739|NCT04617613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519331|NCT00732121|Incretins|incretins|mesh-ancestor
6519332|NCT00732121|Hormones|hormones|mesh-ancestor
6519333|NCT00732121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6519334|NCT00732121|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6519335|NCT00732121|Protease Inhibitors|protease inhibitors|mesh-ancestor
6519336|NCT00732121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6519337|NCT00732121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519338|NCT00732147|Pramlintide|pramlintide|mesh-list
6519339|NCT00732147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6519340|NCT00732147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519341|NCT00732186|Ipilimumab|ipilimumab|mesh-list
6519342|NCT00732186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5961740|NCT04617613|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6519343|NCT00732186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5961741|NCT04617613|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5961742|NCT04617613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5961743|NCT04617626|Azithromycin|azithromycin|mesh-list
5961744|NCT04617626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5961745|NCT04617626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5961746|NCT04617652|Magnesium Sulfate|magnesium sulfate|mesh-list
5961747|NCT04617652|Analgesics|analgesics|mesh-ancestor
5961748|NCT04617652|Sensory System Agents|sensory system agents|mesh-ancestor
5961749|NCT04617652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5961750|NCT04617652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961751|NCT04617652|Anesthetics|anesthetics|mesh-ancestor
5961752|NCT04617652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5961753|NCT04617652|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5961754|NCT04617652|Anticonvulsants|anticonvulsants|mesh-ancestor
5961755|NCT04617652|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5961756|NCT04617652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5961757|NCT04617652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961758|NCT04617652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5961759|NCT04617652|Tocolytic Agents|tocolytic agents|mesh-ancestor
5961760|NCT04617652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5961761|NCT04617795|Insulin|insulin|mesh-list
5961762|NCT04617795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5961763|NCT04617795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961764|NCT04617561|Methylprednisolone|methylprednisolone|mesh-list
5961765|NCT04617561|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5961766|NCT04617561|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5961767|NCT04617561|Prednisolone|prednisolone|mesh-list
5961768|NCT04617561|Prednisolone acetate|prednisolone acetate|mesh-list
5961769|NCT04617561|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
5961770|NCT04617561|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5961771|NCT04617561|Prednisolone phosphate|prednisolone phosphate|mesh-list
5961772|NCT04617561|Glucocorticoids|glucocorticoids|mesh-list
5961773|NCT04617561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5961774|NCT04617561|Antiemetics|antiemetics|mesh-ancestor
5961775|NCT04617561|Autonomic Agents|autonomic agents|mesh-ancestor
5961776|NCT04617561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5961777|NCT04617561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961778|NCT04617561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5961779|NCT04617561|Hormones|hormones|mesh-ancestor
5961780|NCT04617561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5961781|NCT04617561|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5961782|NCT04617561|Protective Agents|protective agents|mesh-ancestor
5961783|NCT04617561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5961784|NCT04617561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5961785|NCT04617561|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5961786|NCT04617483|Vaccines|vaccines|mesh-list
5961787|NCT04617483|Immunologic Factors|immunologic factors|mesh-ancestor
5961788|NCT04617483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961789|NCT04617249|Anesthetics|anesthetics|mesh-list
5961790|NCT04617249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5961791|NCT04617249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961792|NCT04617171|Benralizumab|benralizumab|mesh-list
5961793|NCT04617171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5961794|NCT04617171|Respiratory System Agents|respiratory system agents|mesh-ancestor
5961795|NCT04616872|Methotrexate|methotrexate|mesh-list
5961796|NCT04616872|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5961797|NCT04616872|Abortifacient Agents|abortifacient agents|mesh-ancestor
5961798|NCT04616872|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5961799|NCT04616872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961800|NCT04616872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5961801|NCT04616872|Antimetabolites|antimetabolites|mesh-ancestor
5961802|NCT04616872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961803|NCT04616872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5961804|NCT04616872|Dermatologic Agents|dermatologic agents|mesh-ancestor
5961805|NCT04616872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5961806|NCT04616872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5961807|NCT04616872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5961808|NCT04616872|Immunologic Factors|immunologic factors|mesh-ancestor
5961809|NCT04616872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5961810|NCT04616872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5961811|NCT04616729|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6242670|NCT02654145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5961812|NCT04616729|Luteolytic Agents|luteolytic agents|mesh-ancestor
5961813|NCT04616729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5961814|NCT04616729|Contraceptive Agents|contraceptive agents|mesh-ancestor
5961815|NCT04616729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5961816|NCT04616729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961817|NCT04616729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5961818|NCT04616729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5961819|NCT04616729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6519344|NCT00732186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6519345|NCT00732186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519346|NCT00732277|Hydrocortisone|hydrocortisone|mesh-list
6519347|NCT00732277|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6519348|NCT00732277|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6519349|NCT00732277|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6519350|NCT00732277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6519351|NCT00732290|Fluoxetine|fluoxetine|mesh-list
6684289|NCT01627158|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6684290|NCT01627158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5961820|NCT04616807|Mexiletine|mexiletine|mesh-list
5961821|NCT04616807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5961822|NCT04616807|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5961823|NCT04616807|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5961824|NCT04616807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5961825|NCT04616807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961826|NCT04617015|Bromides|bromides|mesh-list
5961827|NCT04617015|Ipratropium|ipratropium|mesh-list
5961828|NCT04617015|Anticonvulsants|anticonvulsants|mesh-ancestor
5961829|NCT04617015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5961830|NCT04617015|Autonomic Agents|autonomic agents|mesh-ancestor
5961831|NCT04617015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5961832|NCT04617015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519352|NCT00732290|Clopidogrel|clopidogrel|mesh-list
6519353|NCT00732290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6519354|NCT00732290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6519355|NCT00732290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6519356|NCT00732290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6519357|NCT00732290|Purinergic Agents|purinergic agents|mesh-ancestor
6519358|NCT00732290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6519359|NCT00732290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519360|NCT00732290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684291|NCT01627158|Adrenergic Agents|adrenergic agents|mesh-ancestor
5961833|NCT04617015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5961834|NCT04617015|Respiratory System Agents|respiratory system agents|mesh-ancestor
6684292|NCT01627158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6684293|NCT01627158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684294|NCT01627158|Antidotes|antidotes|mesh-ancestor
6684295|NCT01627158|Protective Agents|protective agents|mesh-ancestor
6684296|NCT01627171|Bisacodyl|bisacodyl|mesh-list
6684297|NCT01627171|Picosulfate sodium|picosulfate sodium|mesh-list
5961835|NCT04617015|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5961836|NCT04617015|Cholinergic Agents|cholinergic agents|mesh-ancestor
5961837|NCT04617015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5961838|NCT04617015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961839|NCT04617028|Hydroxyurea|hydroxyurea|mesh-list
5961840|NCT04617028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5961841|NCT04617028|Antisickling Agents|antisickling agents|mesh-ancestor
6684298|NCT01627171|Cathartics|cathartics|mesh-ancestor
6684299|NCT01627171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6684300|NCT01627171|Laxatives|laxatives|mesh-ancestor
6684301|NCT01627223|Lamivudine|lamivudine|mesh-list
6684302|NCT01627223|Entecavir|entecavir|mesh-list
6684303|NCT01627223|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6684304|NCT01627223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6684305|NCT01627223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6684306|NCT01627223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684307|NCT01627223|Antiviral Agents|antiviral agents|mesh-ancestor
6684308|NCT01627223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6684309|NCT01627223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6684310|NCT01627223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6684311|NCT01627236|Methylprednisolone|methylprednisolone|mesh-list
6684312|NCT01627236|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6684313|NCT01627236|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6684314|NCT01627236|Prednisolone|prednisolone|mesh-list
6684315|NCT01627236|Prednisolone acetate|prednisolone acetate|mesh-list
6684316|NCT01627236|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6684317|NCT01627236|Prednisolone phosphate|prednisolone phosphate|mesh-list
6684318|NCT01627236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6684319|NCT01627236|Antiemetics|antiemetics|mesh-ancestor
6519361|NCT00732290|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6519362|NCT00732290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6519363|NCT00732290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6519364|NCT00732290|Serotonin Agents|serotonin agents|mesh-ancestor
6519365|NCT00732290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6684320|NCT01627236|Autonomic Agents|autonomic agents|mesh-ancestor
6684321|NCT01627236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6684322|NCT01627236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684323|NCT01627236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6684324|NCT01627236|Glucocorticoids|glucocorticoids|mesh-ancestor
6684325|NCT01627236|Hormones|hormones|mesh-ancestor
5961842|NCT04617028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5961843|NCT04617028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961844|NCT04617028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5961845|NCT04616859|Ethanol|ethanol|mesh-list
5961846|NCT04616859|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5961847|NCT04616859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5961848|NCT04616859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5961849|NCT04616859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961850|NCT04616586|Siltuximab|siltuximab|mesh-list
5961851|NCT04616586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5961852|NCT04616261|Formoterol Fumarate|formoterol fumarate|mesh-list
5961853|NCT04616261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5961854|NCT04616261|Autonomic Agents|autonomic agents|mesh-ancestor
5961855|NCT04616261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5961856|NCT04616261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961857|NCT04616261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5961858|NCT04616261|Respiratory System Agents|respiratory system agents|mesh-ancestor
5961859|NCT04616261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5961860|NCT04616261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6684326|NCT01627236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6684327|NCT01627236|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6684328|NCT01627236|Protective Agents|protective agents|mesh-ancestor
6519366|NCT00732290|Antidepressive Agents|antidepressive agents|mesh-ancestor
6519367|NCT00732290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6519368|NCT00732290|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6519369|NCT00732290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6519370|NCT00732290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6684329|NCT01627236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6684330|NCT01627236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6684331|NCT01627262|Mesalamine|mesalamine|mesh-list
6684332|NCT01627262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6684333|NCT01627262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5961861|NCT04616261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5961862|NCT04616261|Adrenergic Agents|adrenergic agents|mesh-ancestor
5961863|NCT04616261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5961864|NCT04616261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961865|NCT04616352|Cefuroxime|cefuroxime|mesh-list
5961866|NCT04616352|Cefuroxime axetil|cefuroxime axetil|mesh-list
5961867|NCT04616352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5961868|NCT04616352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5961869|NCT04616313|Xenon|xenon|mesh-list
5961870|NCT04616313|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5961871|NCT04616313|Anesthetics, General|anesthetics, general|mesh-ancestor
5961872|NCT04616313|Anesthetics|anesthetics|mesh-ancestor
5961873|NCT04616313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5961874|NCT04616313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970345|NCT04535869|Sofosbuvir|sofosbuvir|mesh-list
5970346|NCT04535869|Antiviral Agents|antiviral agents|mesh-ancestor
5970347|NCT04535869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5970348|NCT04535817|Omalizumab|omalizumab|mesh-list
5970349|NCT04535817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5970350|NCT04535817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6684334|NCT01627262|Analgesics|analgesics|mesh-ancestor
6684335|NCT01627262|Sensory System Agents|sensory system agents|mesh-ancestor
6684336|NCT01627262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6684337|NCT01627262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684338|NCT01627262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6684339|NCT01627262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6684340|NCT01627353|Dexamethasone|dexamethasone|mesh-list
6684341|NCT01627353|Lidocaine|lidocaine|mesh-list
6684342|NCT01627353|Magnesium Sulfate|magnesium sulfate|mesh-list
6684343|NCT01627353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6684344|NCT01627353|Antiemetics|antiemetics|mesh-ancestor
6684345|NCT01627353|Autonomic Agents|autonomic agents|mesh-ancestor
6684346|NCT01627353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6684347|NCT01627353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684348|NCT01627353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6684349|NCT01627353|Glucocorticoids|glucocorticoids|mesh-ancestor
6684350|NCT01627353|Hormones|hormones|mesh-ancestor
6684351|NCT01627353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6684352|NCT01627353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5961875|NCT04616391|Insulin|insulin|mesh-list
5961876|NCT04616391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5961877|NCT04616391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961878|NCT04615910|Exenatide|exenatide|mesh-list
5961879|NCT04615910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5961880|NCT04615910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961881|NCT04615910|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6684353|NCT01627353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6684354|NCT01627353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684355|NCT01627353|Anesthetics, Local|anesthetics, local|mesh-ancestor
6684356|NCT01627353|Anesthetics|anesthetics|mesh-ancestor
6684357|NCT01627353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6684358|NCT01627353|Sensory System Agents|sensory system agents|mesh-ancestor
6684359|NCT01627353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6684360|NCT01627353|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6684361|NCT01627353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6684362|NCT01627353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6684363|NCT01627353|Analgesics|analgesics|mesh-ancestor
6684364|NCT01627353|Anticonvulsants|anticonvulsants|mesh-ancestor
6684365|NCT01627353|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6684366|NCT01627353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6684367|NCT01627353|Tocolytic Agents|tocolytic agents|mesh-ancestor
6684368|NCT01627353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6684369|NCT01627379|Panitumumab|panitumumab|mesh-list
6684370|NCT01627379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6684371|NCT01627379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6684372|NCT01627431|Aspirin|aspirin|mesh-list
6684373|NCT01627431|Clopidogrel|clopidogrel|mesh-list
6684374|NCT01627431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5961882|NCT04615910|Incretins|incretins|mesh-ancestor
5961883|NCT04615910|Hormones|hormones|mesh-ancestor
5961884|NCT04615910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5961885|NCT04615962|Mometasone Furoate|mometasone furoate|mesh-list
5961886|NCT04615962|Hydrocortisone|hydrocortisone|mesh-list
5961887|NCT04615962|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
5961888|NCT04615962|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
5961889|NCT04615962|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
5961890|NCT04615962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5961891|NCT04615962|Dermatologic Agents|dermatologic agents|mesh-ancestor
5961892|NCT04615962|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5961893|NCT04615767|Inositol|inositol|mesh-list
5961894|NCT04615767|Vitamin B Complex|vitamin b complex|mesh-ancestor
5961895|NCT04615767|Vitamins|vitamins|mesh-ancestor
5961896|NCT04615767|Micronutrients|micronutrients|mesh-ancestor
5961897|NCT04615767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961898|NCT04615702|Acetaminophen|acetaminophen|mesh-list
5961899|NCT04615702|Metronidazole|metronidazole|mesh-list
5961900|NCT04615702|Ciprofloxacin|ciprofloxacin|mesh-list
5961901|NCT04615702|Imipenem|imipenem|mesh-list
5961902|NCT04615702|Diclofenac|diclofenac|mesh-list
5961903|NCT04615702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
5961904|NCT04615702|Opiate Alkaloids|opiate alkaloids|mesh-list
5961905|NCT04615702|Secretin|secretin|mesh-list
5961906|NCT04615702|Bilirubin|bilirubin|mesh-list
5961907|NCT04615702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961908|NCT04615702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5961909|NCT04615702|Analgesics|analgesics|mesh-ancestor
5961910|NCT04615702|Sensory System Agents|sensory system agents|mesh-ancestor
5961911|NCT04615702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5961912|NCT04615702|Antipyretics|antipyretics|mesh-ancestor
5961913|NCT04615702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5961914|NCT04615702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5961915|NCT04615702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5961916|NCT04615702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5961917|NCT04615702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5961918|NCT04615702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5961919|NCT04615702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5961920|NCT04615702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5961921|NCT04615702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961922|NCT04615702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5961923|NCT04615702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5961924|NCT04615702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5961925|NCT04615702|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5961926|NCT04615702|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5961927|NCT04615702|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5961928|NCT04615702|Narcotics|narcotics|mesh-ancestor
5961929|NCT04615702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5961930|NCT04615702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6684375|NCT01627431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6684376|NCT01627431|Analgesics|analgesics|mesh-ancestor
6684377|NCT01627431|Sensory System Agents|sensory system agents|mesh-ancestor
6684378|NCT01627431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6684379|NCT01627431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684380|NCT01627431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6684381|NCT01627431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6684382|NCT01627431|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5961931|NCT04615702|Hormones|hormones|mesh-ancestor
5961932|NCT04615702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5961933|NCT04615702|Antioxidants|antioxidants|mesh-ancestor
5961934|NCT04615702|Protective Agents|protective agents|mesh-ancestor
5961935|NCT04615611|Albuterol|albuterol|mesh-list
5961936|NCT04615611|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6684383|NCT01627431|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6684384|NCT01627431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684385|NCT01627431|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6684386|NCT01627431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6684387|NCT01627431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6684388|NCT01627431|Antipyretics|antipyretics|mesh-ancestor
6684389|NCT01627431|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6684390|NCT01627431|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6684391|NCT01627431|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6684392|NCT01627431|Purinergic Agents|purinergic agents|mesh-ancestor
5961937|NCT04615611|Autonomic Agents|autonomic agents|mesh-ancestor
5961938|NCT04615611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5961939|NCT04615611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961940|NCT04615611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5961941|NCT04615611|Respiratory System Agents|respiratory system agents|mesh-ancestor
5961942|NCT04615611|Tocolytic Agents|tocolytic agents|mesh-ancestor
5961943|NCT04615611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5961944|NCT04615611|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5961945|NCT04615611|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5961946|NCT04615611|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5961947|NCT04615611|Adrenergic Agents|adrenergic agents|mesh-ancestor
5961948|NCT04615611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5961949|NCT04615611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961950|NCT04615728|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5961951|NCT04615728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5961952|NCT04615481|Metronidazole|metronidazole|mesh-list
5961953|NCT04615481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5961954|NCT04615481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5961955|NCT04615481|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5961956|NCT04615481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5961957|NCT04615403|Travoprost|travoprost|mesh-list
5961958|NCT04615403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5961959|NCT04615351|Metformin|metformin|mesh-list
5961960|NCT04615351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5961961|NCT04615351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684393|NCT01627431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6684394|NCT01627587|Ketoconazole|ketoconazole|mesh-list
6684395|NCT01627587|Antifungal Agents|antifungal agents|mesh-ancestor
6684396|NCT01627587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6684397|NCT01627587|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6684398|NCT01627587|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6684399|NCT01627587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6684400|NCT01627587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684401|NCT01627587|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6684402|NCT01627587|Hormone Antagonists|hormone antagonists|mesh-ancestor
6684403|NCT01627587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6684404|NCT01627587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684405|NCT01627587|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6684406|NCT01627626|Pilocarpine|pilocarpine|mesh-list
6684407|NCT01627626|Miotics|miotics|mesh-ancestor
6684408|NCT01627626|Autonomic Agents|autonomic agents|mesh-ancestor
6684409|NCT01627626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6684410|NCT01627626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684411|NCT01627626|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6684412|NCT01627626|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5961962|NCT04615013|Leucovorin|leucovorin|mesh-list
5961963|NCT04615013|Paclitaxel|paclitaxel|mesh-list
5961964|NCT04615013|Docetaxel|docetaxel|mesh-list
5961965|NCT04615013|Carboplatin|carboplatin|mesh-list
5961966|NCT04615013|Fluorouracil|fluorouracil|mesh-list
5961967|NCT04615013|Capecitabine|capecitabine|mesh-list
5961968|NCT04615013|Oxaliplatin|oxaliplatin|mesh-list
5961969|NCT04615013|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5961970|NCT04615013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5961971|NCT04615013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5961972|NCT04615013|Tubulin Modulators|tubulin modulators|mesh-ancestor
5961973|NCT04615013|Antimitotic Agents|antimitotic agents|mesh-ancestor
6519371|NCT00732407|Losartan|losartan|mesh-list
6519372|NCT00732407|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6684413|NCT01627626|Cholinergic Agents|cholinergic agents|mesh-ancestor
5961974|NCT04615013|Mitosis Modulators|mitosis modulators|mesh-ancestor
5961975|NCT04615013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961976|NCT04615013|Antimetabolites|antimetabolites|mesh-ancestor
5961977|NCT04615013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5961978|NCT04615013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5961979|NCT04615013|Immunologic Factors|immunologic factors|mesh-ancestor
5961980|NCT04615013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5961981|NCT04615013|Antidotes|antidotes|mesh-ancestor
5961982|NCT04615013|Protective Agents|protective agents|mesh-ancestor
5961983|NCT04615013|Vitamin B Complex|vitamin b complex|mesh-ancestor
5961984|NCT04615013|Vitamins|vitamins|mesh-ancestor
5961985|NCT04615013|Micronutrients|micronutrients|mesh-ancestor
5961986|NCT04615156|Deoxyglucose|deoxyglucose|mesh-list
5961987|NCT04615156|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5961988|NCT04615156|Antimetabolites|antimetabolites|mesh-ancestor
5961989|NCT04615156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961990|NCT04615156|Antiviral Agents|antiviral agents|mesh-ancestor
5961991|NCT04615156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5961992|NCT04615156|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6684414|NCT01627626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6684415|NCT01627626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684416|NCT01627639|Acetazolamide|acetazolamide|mesh-list
6684417|NCT01627639|Anticonvulsants|anticonvulsants|mesh-ancestor
5961993|NCT04614766|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
5961994|NCT04614766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5961995|NCT04614766|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5961996|NCT04614727|Calcium|calcium|mesh-list
5961997|NCT04614727|Fluorides|fluorides|mesh-list
5961998|NCT04614727|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5961999|NCT04614727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962000|NCT04614727|Cariostatic Agents|cariostatic agents|mesh-ancestor
5962001|NCT04614727|Protective Agents|protective agents|mesh-ancestor
5962002|NCT04614714|Niacinamide|niacinamide|mesh-list
5962003|NCT04614714|Niacin|niacin|mesh-list
5962004|NCT04614714|Nicotinic Acids|nicotinic acids|mesh-list
5962005|NCT04614714|Vitamin B Complex|vitamin b complex|mesh-ancestor
5962006|NCT04614714|Vitamins|vitamins|mesh-ancestor
5962007|NCT04614714|Micronutrients|micronutrients|mesh-ancestor
5962008|NCT04614714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962009|NCT04614714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5962010|NCT04614714|Antimetabolites|antimetabolites|mesh-ancestor
5962011|NCT04614714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962012|NCT04614714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5962013|NCT04614714|Vasodilator Agents|vasodilator agents|mesh-ancestor
5962014|NCT04614636|Cyclophosphamide|cyclophosphamide|mesh-list
5962015|NCT04614636|Fludarabine|fludarabine|mesh-list
5962016|NCT04614636|Daratumumab|daratumumab|mesh-list
5962017|NCT04614636|Elotuzumab|elotuzumab|mesh-list
5962018|NCT04614636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5962019|NCT04614636|Immunologic Factors|immunologic factors|mesh-ancestor
5962020|NCT04614636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962021|NCT04614636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5962022|NCT04614636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5962023|NCT04614636|Alkylating Agents|alkylating agents|mesh-ancestor
5962024|NCT04614636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519373|NCT00732407|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5962025|NCT04614636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5962026|NCT04614636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5962027|NCT04614493|Temozolomide|temozolomide|mesh-list
5962028|NCT04614493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5962029|NCT04614493|Alkylating Agents|alkylating agents|mesh-ancestor
5962030|NCT04614493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962031|NCT04614493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5962032|NCT04614610|Lidocaine|lidocaine|mesh-list
5962033|NCT04614610|Anesthetics, Local|anesthetics, local|mesh-ancestor
5962034|NCT04614610|Anesthetics|anesthetics|mesh-ancestor
5962035|NCT04614610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5962036|NCT04614610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962037|NCT04614610|Sensory System Agents|sensory system agents|mesh-ancestor
5962038|NCT04614610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5962039|NCT04614610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5962040|NCT04614610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5962041|NCT04614610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5962042|NCT04614610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5962043|NCT04614610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962044|NCT04614584|Mirtazapine|mirtazapine|mesh-list
5962045|NCT04614584|Methamphetamine|methamphetamine|mesh-list
5962046|NCT04614584|Antidepressive Agents|antidepressive agents|mesh-ancestor
5962047|NCT04614584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5962048|NCT04614584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5962049|NCT04614584|Histamine Antagonists|histamine antagonists|mesh-ancestor
5962050|NCT04614584|Histamine Agents|histamine agents|mesh-ancestor
5962051|NCT04614584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5962052|NCT04614584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962053|NCT04614584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962054|NCT04614584|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5962055|NCT04614584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5962056|NCT04614584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5962057|NCT04614584|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5962058|NCT04614584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5962059|NCT04614584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5962060|NCT04614584|Adrenergic Agents|adrenergic agents|mesh-ancestor
5962061|NCT04614584|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5962062|NCT04614584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5962063|NCT04614584|Serotonin Agents|serotonin agents|mesh-ancestor
5962064|NCT04614584|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5962065|NCT04614584|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5962066|NCT04614584|Sympathomimetics|sympathomimetics|mesh-ancestor
5962067|NCT04614584|Autonomic Agents|autonomic agents|mesh-ancestor
5962068|NCT04614584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5962069|NCT04614584|Dopamine Agents|dopamine agents|mesh-ancestor
5962070|NCT04614584|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6684418|NCT01627639|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6684419|NCT01627639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6684420|NCT01627639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684421|NCT01627639|Diuretics|diuretics|mesh-ancestor
6684422|NCT01627639|Natriuretic Agents|natriuretic agents|mesh-ancestor
6684423|NCT01627639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684424|NCT01627678|Molgramostim|molgramostim|mesh-list
6684425|NCT01627678|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6684426|NCT01627678|Sargramostim|sargramostim|mesh-list
6684427|NCT01627678|Immunologic Factors|immunologic factors|mesh-ancestor
6684428|NCT01627678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684429|NCT01627678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5962071|NCT04614584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5962072|NCT04614584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5962073|NCT04614584|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5962074|NCT04614311|Triamcinolone|triamcinolone|mesh-list
5962075|NCT04614311|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5962076|NCT04614311|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5962077|NCT04614311|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5962078|NCT04614311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5962079|NCT04614311|Glucocorticoids|glucocorticoids|mesh-ancestor
5962080|NCT04614311|Hormones|hormones|mesh-ancestor
5962081|NCT04614311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5962082|NCT04614311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962083|NCT04614311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5962084|NCT04614311|Immunologic Factors|immunologic factors|mesh-ancestor
5962085|NCT04614311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5962086|NCT04614311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962087|NCT04614298|Brodalumab|brodalumab|mesh-list
5962088|NCT04614298|Dermatologic Agents|dermatologic agents|mesh-ancestor
5962089|NCT04614259|Bupivacaine|bupivacaine|mesh-list
5962090|NCT04614259|Anesthetics, Local|anesthetics, local|mesh-ancestor
5962091|NCT04614259|Anesthetics|anesthetics|mesh-ancestor
5962092|NCT04614259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5962093|NCT04614259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962094|NCT04614259|Sensory System Agents|sensory system agents|mesh-ancestor
5962095|NCT04614259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5970351|NCT04535817|Respiratory System Agents|respiratory system agents|mesh-ancestor
5970352|NCT04535804|Aspirin|aspirin|mesh-list
5970353|NCT04535804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5970354|NCT04535804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5970355|NCT04535804|Analgesics|analgesics|mesh-ancestor
5970356|NCT04535804|Sensory System Agents|sensory system agents|mesh-ancestor
5970357|NCT04535804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6684430|NCT01627678|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6684431|NCT01627678|Antacids|antacids|mesh-ancestor
6684432|NCT01627678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684433|NCT01627678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6684434|NCT01627717|Maraviroc|maraviroc|mesh-list
6684435|NCT01627717|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6684436|NCT01627717|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6684437|NCT01627717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684438|NCT01627717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6684439|NCT01627717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6684440|NCT01627717|Antiviral Agents|antiviral agents|mesh-ancestor
6684441|NCT01627717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6684442|NCT01627717|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6684443|NCT01627834|Ropinirole|ropinirole|mesh-list
6684444|NCT01627834|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6684445|NCT01627834|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6684446|NCT01627834|Dopamine Agonists|dopamine agonists|mesh-ancestor
6684447|NCT01627834|Dopamine Agents|dopamine agents|mesh-ancestor
6684448|NCT01627834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6684449|NCT01627834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684450|NCT01627834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684451|NCT01627847|Ropinirole|ropinirole|mesh-list
6684452|NCT01627847|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5970358|NCT04535804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970359|NCT04535804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5970360|NCT04535804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6684453|NCT01627847|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6684454|NCT01627847|Dopamine Agonists|dopamine agonists|mesh-ancestor
6684455|NCT01627847|Dopamine Agents|dopamine agents|mesh-ancestor
6684456|NCT01627847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6684457|NCT01627847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684458|NCT01627847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684459|NCT01627873|Fentanyl|fentanyl|mesh-list
6684460|NCT01627873|Remifentanil|remifentanil|mesh-list
6684461|NCT01627873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6684462|NCT01627873|Narcotics|narcotics|mesh-ancestor
6684463|NCT01627873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6684464|NCT01627873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684465|NCT01627873|Analgesics|analgesics|mesh-ancestor
6684466|NCT01627873|Sensory System Agents|sensory system agents|mesh-ancestor
6684467|NCT01627873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6684468|NCT01627873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6684469|NCT01627873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6684470|NCT01627873|Anesthetics, General|anesthetics, general|mesh-ancestor
6684471|NCT01627873|Anesthetics|anesthetics|mesh-ancestor
6684472|NCT01627886|Ibandronic Acid|ibandronic acid|mesh-list
6684473|NCT01627886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6684474|NCT01627886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684475|NCT01627938|Mitoxantrone|mitoxantrone|mesh-list
6684476|NCT01627938|Dexrazoxane|dexrazoxane|mesh-list
6684477|NCT01627938|Razoxane|razoxane|mesh-list
6684478|NCT01627938|Analgesics|analgesics|mesh-ancestor
6684479|NCT01627938|Sensory System Agents|sensory system agents|mesh-ancestor
6684480|NCT01627938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6684481|NCT01627938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684482|NCT01627938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6684483|NCT01627938|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6684484|NCT01627938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5970361|NCT04535804|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6684485|NCT01627938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6684486|NCT01627938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684487|NCT01627938|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6684488|NCT01627938|Protective Agents|protective agents|mesh-ancestor
6684489|NCT01627938|Antimitotic Agents|antimitotic agents|mesh-ancestor
6684490|NCT01627938|Mitosis Modulators|mitosis modulators|mesh-ancestor
6780130|NCT02182336|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6780131|NCT02182336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6780132|NCT02182336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6780133|NCT02182336|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6780134|NCT02182336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6780135|NCT02182336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5962096|NCT04614194|Letrozole|letrozole|mesh-list
5962097|NCT04614194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5962098|NCT04614194|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6519374|NCT00732407|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6519375|NCT00732407|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6519376|NCT00732407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519377|NCT00732420|Topotecan|topotecan|mesh-list
6519378|NCT00732420|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6519379|NCT00732420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6519380|NCT00732420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6519381|NCT00732420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780136|NCT02182336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5962099|NCT04614194|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5962100|NCT04614194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5962101|NCT04614194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962102|NCT04614194|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5962103|NCT04614194|Hormone Antagonists|hormone antagonists|mesh-ancestor
5962104|NCT04614194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5962105|NCT04614194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962106|NCT04613960|Magnesium Sulfate|magnesium sulfate|mesh-list
5962107|NCT04613960|Analgesics|analgesics|mesh-ancestor
5962108|NCT04613960|Sensory System Agents|sensory system agents|mesh-ancestor
5962109|NCT04613960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5962110|NCT04613960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962111|NCT04613960|Anesthetics|anesthetics|mesh-ancestor
5962112|NCT04613960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5962113|NCT04613960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5962114|NCT04613960|Anticonvulsants|anticonvulsants|mesh-ancestor
5962115|NCT04613960|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5962116|NCT04613960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5962117|NCT04613960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962118|NCT04613960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5962119|NCT04613960|Tocolytic Agents|tocolytic agents|mesh-ancestor
6780137|NCT02182336|Anesthetics, General|anesthetics, general|mesh-ancestor
6780138|NCT02182336|Anesthetics|anesthetics|mesh-ancestor
6780139|NCT02182336|GABA Modulators|gaba modulators|mesh-ancestor
6780140|NCT02182336|GABA Agents|gaba agents|mesh-ancestor
6780141|NCT02182336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6780142|NCT02182336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780143|NCT02182336|Anticoagulants|anticoagulants|mesh-ancestor
6780144|NCT02182336|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6780145|NCT02182336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6780146|NCT02182336|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6780147|NCT02182336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780148|NCT02182336|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6780149|NCT02182336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6780150|NCT02182336|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6780151|NCT02182336|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6780152|NCT02182336|Purinergic Agents|purinergic agents|mesh-ancestor
6780153|NCT02182336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6780154|NCT02182336|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6780155|NCT02182336|Protective Agents|protective agents|mesh-ancestor
6780156|NCT02182336|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6780157|NCT02182336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6780158|NCT02182336|Hemostatics|hemostatics|mesh-ancestor
6780159|NCT02182336|Coagulants|coagulants|mesh-ancestor
6780160|NCT02182336|Antitussive Agents|antitussive agents|mesh-ancestor
6780161|NCT02182336|Respiratory System Agents|respiratory system agents|mesh-ancestor
6780162|NCT02182336|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6780163|NCT02182336|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6780164|NCT02182375|Raltegravir Potassium|raltegravir potassium|mesh-list
6780165|NCT02182375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6780166|NCT02182375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6780167|NCT02182375|Antiviral Agents|antiviral agents|mesh-ancestor
6780168|NCT02182375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6684491|NCT01628029|Melatonin|melatonin|mesh-list
6684492|NCT01628029|Methylphenidate|methylphenidate|mesh-list
5962120|NCT04613960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5962121|NCT04613609|Nicotine|nicotine|mesh-list
5962122|NCT04613609|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5962123|NCT04613609|Autonomic Agents|autonomic agents|mesh-ancestor
5962124|NCT04613609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5962125|NCT04613609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684493|NCT01628029|Antioxidants|antioxidants|mesh-ancestor
6684494|NCT01628029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684495|NCT01628029|Protective Agents|protective agents|mesh-ancestor
5962126|NCT04613609|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5962127|NCT04613609|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5962128|NCT04613609|Cholinergic Agents|cholinergic agents|mesh-ancestor
5962129|NCT04613609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5962130|NCT04613609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962131|NCT04613700|Secretin|secretin|mesh-list
5962132|NCT04613700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5962133|NCT04613700|Hormones|hormones|mesh-ancestor
5962134|NCT04613700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5962135|NCT04613700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962136|NCT04613869|Hydromorphone|hydromorphone|mesh-list
5962137|NCT04613869|Esketamine|esketamine|mesh-list
5962138|NCT04613869|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5962139|NCT04613869|Narcotics|narcotics|mesh-ancestor
5962140|NCT04613869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5962141|NCT04613869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962142|NCT04613869|Analgesics|analgesics|mesh-ancestor
5962143|NCT04613869|Sensory System Agents|sensory system agents|mesh-ancestor
6684496|NCT01628029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684497|NCT01628029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6684498|NCT01628029|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5962144|NCT04613869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5962145|NCT04613869|Antidepressive Agents|antidepressive agents|mesh-ancestor
5962146|NCT04613869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5962147|NCT04613726|Ondansetron|ondansetron|mesh-list
5962148|NCT04613726|Granisetron|granisetron|mesh-list
5962149|NCT04613726|Antiemetics|antiemetics|mesh-ancestor
5962150|NCT04613726|Autonomic Agents|autonomic agents|mesh-ancestor
5962151|NCT04613726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5962152|NCT04613726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962153|NCT04613726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5962154|NCT04613726|Antipruritics|antipruritics|mesh-ancestor
5962155|NCT04613726|Dermatologic Agents|dermatologic agents|mesh-ancestor
5962156|NCT04613726|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5962157|NCT04613726|Serotonin Agents|serotonin agents|mesh-ancestor
5962158|NCT04613726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5962159|NCT04613726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962160|NCT04613726|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5962161|NCT04613726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5962162|NCT04613726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5962163|NCT04613726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5962164|NCT04613726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5962165|NCT04613557|Cyclophosphamide|cyclophosphamide|mesh-list
5962166|NCT04613557|Fludarabine|fludarabine|mesh-list
5962167|NCT04613557|Fludarabine phosphate|fludarabine phosphate|mesh-list
5962168|NCT04613557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5962169|NCT04613557|Immunologic Factors|immunologic factors|mesh-ancestor
5962170|NCT04613557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962171|NCT04613557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5962172|NCT04613557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6519382|NCT00732420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6519383|NCT00732446|Moxifloxacin|moxifloxacin|mesh-list
6519384|NCT00732446|Dexamethasone|dexamethasone|mesh-list
6519385|NCT00732446|Dexamethasone acetate|dexamethasone acetate|mesh-list
6519386|NCT00732446|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6519387|NCT00732446|BB 1101|bb 1101|mesh-list
6519388|NCT00732446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6519389|NCT00732446|Antiemetics|antiemetics|mesh-ancestor
6519390|NCT00732446|Autonomic Agents|autonomic agents|mesh-ancestor
6519391|NCT00732446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6519392|NCT00732446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519393|NCT00732446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5962173|NCT04613557|Alkylating Agents|alkylating agents|mesh-ancestor
5962174|NCT04613557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519394|NCT00732446|Glucocorticoids|glucocorticoids|mesh-ancestor
6519395|NCT00732446|Hormones|hormones|mesh-ancestor
6519396|NCT00732446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6519397|NCT00732446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6519398|NCT00732446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6519399|NCT00732446|Protease Inhibitors|protease inhibitors|mesh-ancestor
6519400|NCT00732446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6519401|NCT00732446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519402|NCT00732446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6519403|NCT00732446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6519404|NCT00732446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6684499|NCT01628029|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6684500|NCT01628029|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6684501|NCT01628029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6684502|NCT01628029|Dopamine Agents|dopamine agents|mesh-ancestor
6684503|NCT01628029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6684504|NCT01628055|Immunoglobulins|immunoglobulins|mesh-list
5962175|NCT04613557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5962176|NCT04613557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5962177|NCT04613557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5962178|NCT04613557|Antimetabolites|antimetabolites|mesh-ancestor
5962179|NCT04613804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5962180|NCT04613804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962181|NCT04613804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5962182|NCT04613830|Tramadol|tramadol|mesh-list
5962183|NCT04613830|Bupivacaine|bupivacaine|mesh-list
5962184|NCT04613830|Anesthetics, Local|anesthetics, local|mesh-ancestor
5962185|NCT04613830|Anesthetics|anesthetics|mesh-ancestor
5962186|NCT04613830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5962187|NCT04613830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962188|NCT04613830|Sensory System Agents|sensory system agents|mesh-ancestor
5962189|NCT04613830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5962190|NCT04613830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5962191|NCT04613830|Narcotics|narcotics|mesh-ancestor
6684505|NCT01628055|Antibodies|antibodies|mesh-list
6684506|NCT01628055|gamma-Globulins|gamma-globulins|mesh-list
5962192|NCT04613830|Analgesics|analgesics|mesh-ancestor
5962193|NCT04613102|Cannabidiol|cannabidiol|mesh-list
5962194|NCT04613102|Anticonvulsants|anticonvulsants|mesh-ancestor
5962195|NCT04613219|Tofacitinib|tofacitinib|mesh-list
5962196|NCT04613219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5962197|NCT04613219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5962198|NCT04613219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962199|NCT04613167|Evolocumab|evolocumab|mesh-list
5962200|NCT04613167|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5962201|NCT04613167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5962202|NCT04613167|Antimetabolites|antimetabolites|mesh-ancestor
5962203|NCT04613167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962204|NCT04613167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5962205|NCT04613271|Azithromycin|azithromycin|mesh-list
5962206|NCT04613271|Favipiravir|favipiravir|mesh-list
5962207|NCT04613271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5962208|NCT04613271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5962209|NCT04613271|Antiviral Agents|antiviral agents|mesh-ancestor
5962210|NCT04613206|Vaccines|vaccines|mesh-list
5962211|NCT04613206|Immunologic Factors|immunologic factors|mesh-ancestor
5962212|NCT04613206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962213|NCT04613284|Durvalumab|durvalumab|mesh-list
5962214|NCT04613284|Endostar protein|endostar protein|mesh-list
5962215|NCT04613284|Endostatins|endostatins|mesh-list
6684507|NCT01628055|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6684508|NCT01628055|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6684509|NCT01628055|Immunoglobulin G|immunoglobulin g|mesh-list
6684510|NCT01628055|Immunologic Factors|immunologic factors|mesh-ancestor
6684511|NCT01628055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684512|NCT01628211|Leucovorin|leucovorin|mesh-list
6684513|NCT01628211|Folic Acid|folic acid|mesh-list
5962216|NCT04613284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5962217|NCT04613284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5962218|NCT04613284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5962219|NCT04613284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5962220|NCT04613284|Growth Substances|growth substances|mesh-ancestor
5962221|NCT04613284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519405|NCT00732446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5962222|NCT04613284|Growth Inhibitors|growth inhibitors|mesh-ancestor
6684514|NCT01628211|Fluorouracil|fluorouracil|mesh-list
6684515|NCT01628211|Oxaliplatin|oxaliplatin|mesh-list
6684516|NCT01628211|Levoleucovorin|levoleucovorin|mesh-list
5962223|NCT04613024|Topiramate|topiramate|mesh-list
5962224|NCT04613024|Gabapentin|gabapentin|mesh-list
5962225|NCT04613024|Analgesics|analgesics|mesh-ancestor
5962226|NCT04613024|Sensory System Agents|sensory system agents|mesh-ancestor
5962227|NCT04613024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5962228|NCT04613024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962229|NCT04613024|Anticonvulsants|anticonvulsants|mesh-ancestor
5962230|NCT04613024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5962231|NCT04613024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5962232|NCT04613024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5962233|NCT04613024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5962234|NCT04613024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5962235|NCT04613024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5962236|NCT04613024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5962237|NCT04613024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962238|NCT04613024|Antimanic Agents|antimanic agents|mesh-ancestor
5962239|NCT04613024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5962240|NCT04612998|Atropine|atropine|mesh-list
5962241|NCT04612998|Ephedrine|ephedrine|mesh-list
5962242|NCT04612998|Metoclopramide|metoclopramide|mesh-list
5962243|NCT04612998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5962244|NCT04612998|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5962245|NCT04612998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6684517|NCT01628211|Antimetabolites|antimetabolites|mesh-ancestor
6684518|NCT01628211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684519|NCT01628211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6684520|NCT01628211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6684521|NCT01628211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6684522|NCT01628211|Immunologic Factors|immunologic factors|mesh-ancestor
6684523|NCT01628211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684524|NCT01628211|Antidotes|antidotes|mesh-ancestor
6684525|NCT01628211|Protective Agents|protective agents|mesh-ancestor
6684526|NCT01628211|Vitamin B Complex|vitamin b complex|mesh-ancestor
6684527|NCT01628211|Vitamins|vitamins|mesh-ancestor
6684528|NCT01628211|Micronutrients|micronutrients|mesh-ancestor
5962246|NCT04612998|Autonomic Agents|autonomic agents|mesh-ancestor
5962247|NCT04612998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5962248|NCT04612998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962249|NCT04612998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5962250|NCT04612998|Respiratory System Agents|respiratory system agents|mesh-ancestor
5962251|NCT04612998|Mydriatics|mydriatics|mesh-ancestor
5962252|NCT04612998|Parasympatholytics|parasympatholytics|mesh-ancestor
5962253|NCT04612998|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5962254|NCT04612998|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5962255|NCT04612998|Cholinergic Agents|cholinergic agents|mesh-ancestor
5962256|NCT04612998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5962257|NCT04612998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962258|NCT04612998|Antiemetics|antiemetics|mesh-ancestor
5962259|NCT04612998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6684529|NCT01628211|Hematinics|hematinics|mesh-ancestor
6684530|NCT01628341|Insulin|insulin|mesh-list
6684531|NCT01628341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6684532|NCT01628341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684533|NCT01628354|Ranibizumab|ranibizumab|mesh-list
6684534|NCT01628354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6684535|NCT01628354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6684536|NCT01628354|Growth Substances|growth substances|mesh-ancestor
6684537|NCT01628354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684538|NCT01628354|Growth Inhibitors|growth inhibitors|mesh-ancestor
6684539|NCT01628354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6684540|NCT01628445|Liraglutide|liraglutide|mesh-list
6684541|NCT01628445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6684542|NCT01628445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684543|NCT01628445|Incretins|incretins|mesh-ancestor
6684544|NCT01628445|Hormones|hormones|mesh-ancestor
6684545|NCT01628445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6684546|NCT01628471|Decitabine|decitabine|mesh-list
6684547|NCT01628471|Genistein|genistein|mesh-list
6684548|NCT01628471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6684549|NCT01628471|Antimetabolites|antimetabolites|mesh-ancestor
6684550|NCT01628471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684551|NCT01628471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6684552|NCT01628471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5962260|NCT04612998|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5962261|NCT04612998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6684553|NCT01628471|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6684554|NCT01628471|Protective Agents|protective agents|mesh-ancestor
6684555|NCT01628471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684556|NCT01628471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6684557|NCT01628471|Phytoestrogens|phytoestrogens|mesh-ancestor
6684558|NCT01628471|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6684559|NCT01628471|Estrogens|estrogens|mesh-ancestor
6684560|NCT01628471|Hormones|hormones|mesh-ancestor
6684561|NCT01628471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6684562|NCT01628562|Remifentanil|remifentanil|mesh-list
6684563|NCT01628562|Esmolol|esmolol|mesh-list
6684564|NCT01628562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6684565|NCT01628562|Narcotics|narcotics|mesh-ancestor
6684566|NCT01628562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6684567|NCT01628562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684568|NCT01628562|Analgesics|analgesics|mesh-ancestor
6684569|NCT01628562|Sensory System Agents|sensory system agents|mesh-ancestor
6684570|NCT01628562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6684571|NCT01628562|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6684572|NCT01628562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6684573|NCT01628562|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6684574|NCT01628562|Adrenergic Agents|adrenergic agents|mesh-ancestor
6684575|NCT01628562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6684576|NCT01628562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684577|NCT01628640|Interferons|interferons|mesh-list
6684578|NCT01628640|Interferon-beta|interferon-beta|mesh-list
5962262|NCT04612998|Dopamine Agents|dopamine agents|mesh-ancestor
5962263|NCT04612998|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5962264|NCT04612998|Sympathomimetics|sympathomimetics|mesh-ancestor
5962265|NCT04612998|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5962266|NCT04612998|Adrenergic Agents|adrenergic agents|mesh-ancestor
5962267|NCT04612920|Acetaminophen|acetaminophen|mesh-list
5962268|NCT04612920|Ibuprofen|ibuprofen|mesh-list
5962269|NCT04612920|Oxycodone|oxycodone|mesh-list
5962270|NCT04612920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5962271|NCT04612920|Analgesics|analgesics|mesh-ancestor
5962272|NCT04612920|Sensory System Agents|sensory system agents|mesh-ancestor
5962273|NCT04612920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5962274|NCT04612920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962275|NCT04612920|Antipyretics|antipyretics|mesh-ancestor
5962276|NCT04612920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5962277|NCT04612920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5962278|NCT04612920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5962279|NCT04612920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6684579|NCT01628640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6684580|NCT01628640|Antiviral Agents|antiviral agents|mesh-ancestor
6684581|NCT01628640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6684582|NCT01628640|Immunologic Factors|immunologic factors|mesh-ancestor
6684583|NCT01628640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684584|NCT01628666|Vancomycin|vancomycin|mesh-list
6684585|NCT01628666|Cefazolin|cefazolin|mesh-list
6684586|NCT01628666|Cephalexin|cephalexin|mesh-list
6684587|NCT01628666|Bacitracin|bacitracin|mesh-list
6684588|NCT01628666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6684589|NCT01628666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6684590|NCT01628666|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6684591|NCT01628731|Furosemide|furosemide|mesh-list
5962280|NCT04612920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5962281|NCT04612920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962282|NCT04612920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5962283|NCT04612920|Narcotics|narcotics|mesh-ancestor
5962284|NCT04612920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5962285|NCT04613180|Montelukast|montelukast|mesh-list
5962286|NCT04613180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6519406|NCT00732446|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6519407|NCT00732446|Contraceptive Agents|contraceptive agents|mesh-ancestor
6519408|NCT00732446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6519409|NCT00732446|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6519410|NCT00732446|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6519411|NCT00732446|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6519412|NCT00732485|Fenofibrate|fenofibrate|mesh-list
6519413|NCT00732485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6519414|NCT00732485|Antimetabolites|antimetabolites|mesh-ancestor
6519415|NCT00732485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519416|NCT00732485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5962287|NCT04613180|Respiratory System Agents|respiratory system agents|mesh-ancestor
5962288|NCT04613180|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6684592|NCT01628731|Ethacrynic Acid|ethacrynic acid|mesh-list
6684593|NCT01628731|Diuretics|diuretics|mesh-ancestor
6519417|NCT00732511|Metoprolol|metoprolol|mesh-list
6519418|NCT00732511|Carvedilol|carvedilol|mesh-list
6684594|NCT01628731|Natriuretic Agents|natriuretic agents|mesh-ancestor
6684595|NCT01628731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684596|NCT01628731|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6684597|NCT01628731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6684598|NCT01628731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684599|NCT01628731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6684600|NCT01628770|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
6684601|NCT01628770|Hematinics|hematinics|mesh-ancestor
6684602|NCT01628783|Citalopram|citalopram|mesh-list
6684603|NCT01628783|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6684604|NCT01628783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6684605|NCT01628783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6684606|NCT01628783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684607|NCT01628783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5962289|NCT04613180|Hormone Antagonists|hormone antagonists|mesh-ancestor
5962290|NCT04613180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5962291|NCT04613180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962292|NCT04613180|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5962293|NCT04613180|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6684608|NCT01628783|Serotonin Agents|serotonin agents|mesh-ancestor
6684609|NCT01628783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684610|NCT01628783|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6684611|NCT01628783|Antidepressive Agents|antidepressive agents|mesh-ancestor
5962294|NCT04613180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962295|NCT04612894|Apatinib|apatinib|mesh-list
5962296|NCT04612894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5962297|NCT04612894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5962298|NCT04612894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5962299|NCT04612894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962300|NCT04612634|Vaccines|vaccines|mesh-list
5962301|NCT04612634|Immunologic Factors|immunologic factors|mesh-ancestor
5962302|NCT04612634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962303|NCT04612803|Histamine Antagonists|histamine antagonists|mesh-list
5962304|NCT04612803|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
5962305|NCT04612803|Histamine Agents|histamine agents|mesh-ancestor
5962306|NCT04612803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5962307|NCT04612803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962308|NCT04612803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962309|NCT04612556|Vaccines|vaccines|mesh-list
5962310|NCT04612556|Immunologic Factors|immunologic factors|mesh-ancestor
5962311|NCT04612556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962312|NCT04612582|Thalidomide|thalidomide|mesh-list
5962313|NCT04612582|Cyclophosphamide|cyclophosphamide|mesh-list
5962314|NCT04612582|Bortezomib|bortezomib|mesh-list
5962315|NCT04612582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5962316|NCT04612582|Immunologic Factors|immunologic factors|mesh-ancestor
5962317|NCT04612582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962318|NCT04612582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5962319|NCT04612582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5962320|NCT04612582|Alkylating Agents|alkylating agents|mesh-ancestor
5962321|NCT04612582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962322|NCT04612582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5962323|NCT04612582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5962324|NCT04612582|Leprostatic Agents|leprostatic agents|mesh-ancestor
5962325|NCT04612582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6519419|NCT00732511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6519420|NCT00732511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6519421|NCT00732511|Sympatholytics|sympatholytics|mesh-ancestor
6519422|NCT00732511|Autonomic Agents|autonomic agents|mesh-ancestor
6519423|NCT00732511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6519424|NCT00732511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519425|NCT00732511|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6519426|NCT00732511|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6519427|NCT00732511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6519428|NCT00732511|Adrenergic Agents|adrenergic agents|mesh-ancestor
6519429|NCT00732511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6519430|NCT00732511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519431|NCT00732511|Antioxidants|antioxidants|mesh-ancestor
6519432|NCT00732511|Protective Agents|protective agents|mesh-ancestor
6519433|NCT00732511|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5962326|NCT04612582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5962327|NCT04612582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5962328|NCT04612582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5962329|NCT04612582|Growth Substances|growth substances|mesh-ancestor
5962330|NCT04612582|Growth Inhibitors|growth inhibitors|mesh-ancestor
6519434|NCT00732511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6519435|NCT00732511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6519436|NCT00732511|Vasodilator Agents|vasodilator agents|mesh-ancestor
6519437|NCT00732511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6519438|NCT00732511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6519439|NCT00732524|Glipizide|glipizide|mesh-list
6519440|NCT00732524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6519441|NCT00732524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519442|NCT00732537|Nitric Oxide|nitric oxide|mesh-list
6519443|NCT00732537|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6519444|NCT00732537|Autonomic Agents|autonomic agents|mesh-ancestor
6684612|NCT01628783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6684613|NCT01628952|Curare|curare|mesh-list
6684614|NCT01628952|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6684615|NCT01628952|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6684616|NCT01628952|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6684617|NCT01628952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6684618|NCT01628952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962331|NCT04612530|Nivolumab|nivolumab|mesh-list
6519445|NCT00732537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5962332|NCT04612530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5962333|NCT04612530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5962334|NCT04612530|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5962335|NCT04612530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970362|NCT04535804|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5970363|NCT04535804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970364|NCT04535804|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5970365|NCT04535804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5970366|NCT04535804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5970367|NCT04535804|Antipyretics|antipyretics|mesh-ancestor
5970368|NCT04535713|Gemcitabine|gemcitabine|mesh-list
5970369|NCT04535713|Docetaxel|docetaxel|mesh-list
5970370|NCT04535713|Doxorubicin|doxorubicin|mesh-list
5970371|NCT04535713|Nivolumab|nivolumab|mesh-list
5970372|NCT04535713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5970373|NCT04535713|Antimetabolites|antimetabolites|mesh-ancestor
5970374|NCT04535713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970375|NCT04535713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5970376|NCT04535713|Antiviral Agents|antiviral agents|mesh-ancestor
5970377|NCT04535713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5970378|NCT04535713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5970379|NCT04535713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5970380|NCT04535713|Immunologic Factors|immunologic factors|mesh-ancestor
5970381|NCT04535713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970382|NCT04535713|Tubulin Modulators|tubulin modulators|mesh-ancestor
5970383|NCT04535713|Antimitotic Agents|antimitotic agents|mesh-ancestor
5970384|NCT04535713|Mitosis Modulators|mitosis modulators|mesh-ancestor
5970385|NCT04535713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6519446|NCT00732537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519447|NCT00732537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5970386|NCT04535713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5970387|NCT04535713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5970388|NCT04535713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5970389|NCT04535713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5970390|NCT04535518|Aspirin|aspirin|mesh-list
5970391|NCT04535518|Infliximab|infliximab|mesh-list
5970392|NCT04535518|Immunoglobulins|immunoglobulins|mesh-list
6519448|NCT00732537|Respiratory System Agents|respiratory system agents|mesh-ancestor
6519449|NCT00732537|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6519450|NCT00732537|Antioxidants|antioxidants|mesh-ancestor
6519451|NCT00732537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519452|NCT00732537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6519453|NCT00732537|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6519454|NCT00732537|Vasodilator Agents|vasodilator agents|mesh-ancestor
6519455|NCT00732537|Gasotransmitters|gasotransmitters|mesh-ancestor
6519456|NCT00732537|Protective Agents|protective agents|mesh-ancestor
6519457|NCT00732563|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6519458|NCT00732563|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6519459|NCT00732563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962336|NCT04612504|Atezolizumab|atezolizumab|mesh-list
6519460|NCT00732576|Vitamin K 2|vitamin k 2|mesh-list
6519461|NCT00732576|Vitamin K|vitamin k|mesh-list
6519462|NCT00732576|Vitamin MK 7|vitamin mk 7|mesh-list
6519463|NCT00732576|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6519464|NCT00732576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6519465|NCT00732576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519466|NCT00732576|Hemostatics|hemostatics|mesh-ancestor
6519467|NCT00732576|Coagulants|coagulants|mesh-ancestor
6519468|NCT00732576|Vitamins|vitamins|mesh-ancestor
6519469|NCT00732576|Micronutrients|micronutrients|mesh-ancestor
6519470|NCT00732576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962337|NCT04612504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5962338|NCT04612179|Sirolimus|sirolimus|mesh-list
5962339|NCT04612179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5962340|NCT04612179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5962341|NCT04612179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5962342|NCT04612179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5962343|NCT04612179|Antifungal Agents|antifungal agents|mesh-ancestor
5962344|NCT04612179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5962345|NCT04612179|Immunologic Factors|immunologic factors|mesh-ancestor
5962346|NCT04612179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962347|NCT04612257|Insulin|insulin|mesh-list
5962348|NCT04612257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5962349|NCT04612257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962350|NCT04611958|Bupivacaine|bupivacaine|mesh-list
5962351|NCT04611958|Anesthetics, Local|anesthetics, local|mesh-ancestor
6519471|NCT00732589|Lidocaine|lidocaine|mesh-list
6519472|NCT00732589|Anesthetics, Local|anesthetics, local|mesh-ancestor
6519473|NCT00732589|Anesthetics|anesthetics|mesh-ancestor
6519474|NCT00732589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6519475|NCT00732589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519476|NCT00732589|Sensory System Agents|sensory system agents|mesh-ancestor
6519477|NCT00732589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6519478|NCT00732589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6519479|NCT00732589|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6519480|NCT00732589|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6519481|NCT00732589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6519482|NCT00732589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519483|NCT00732693|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5962352|NCT04611958|Anesthetics|anesthetics|mesh-ancestor
5962353|NCT04611958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5962354|NCT04611958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962355|NCT04611958|Sensory System Agents|sensory system agents|mesh-ancestor
5962356|NCT04611958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5962357|NCT04611971|Belimumab|belimumab|mesh-list
5962358|NCT04611971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5962359|NCT04611971|Immunologic Factors|immunologic factors|mesh-ancestor
5962360|NCT04611971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962361|NCT04611724|Folfirinox|folfirinox|mesh-list
5962362|NCT04611724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5962363|NCT04611438|Cannabidiol|cannabidiol|mesh-list
5962364|NCT04611438|Anticonvulsants|anticonvulsants|mesh-ancestor
5962365|NCT04611711|Decitabine|decitabine|mesh-list
5962366|NCT04611711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5962367|NCT04611711|Antimetabolites|antimetabolites|mesh-ancestor
5962368|NCT04611711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962369|NCT04611711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5962370|NCT04611711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5962371|NCT04611685|Parecoxib|parecoxib|mesh-list
6519484|NCT00732693|Norethindrone|norethindrone|mesh-list
6519485|NCT00732693|Norethindrone Acetate|norethindrone acetate|mesh-list
5962372|NCT04611685|Loxoprofen|loxoprofen|mesh-list
5962373|NCT04611685|Tramadol|tramadol|mesh-list
5962374|NCT04611685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5962375|NCT04611685|Narcotics|narcotics|mesh-ancestor
5962376|NCT04611685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5962377|NCT04611685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962378|NCT04611685|Analgesics|analgesics|mesh-ancestor
5962379|NCT04611685|Sensory System Agents|sensory system agents|mesh-ancestor
5962380|NCT04611685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5962381|NCT04611685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6519486|NCT00732693|Estradiol|estradiol|mesh-list
5962382|NCT04611685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5962383|NCT04611685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5962384|NCT04611685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962385|NCT04611685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6519487|NCT00732693|Progesterone|progesterone|mesh-list
5962386|NCT04611685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5962387|NCT04611685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5962388|NCT04611685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5962389|NCT04611373|Levamisole|levamisole|mesh-list
5962390|NCT04611373|Acetazolamide|acetazolamide|mesh-list
5962391|NCT04611373|Anticonvulsants|anticonvulsants|mesh-ancestor
5962392|NCT04611373|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5962393|NCT04611373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6519488|NCT00732693|Estrogens|estrogens|mesh-ancestor
6519489|NCT00732693|Hormones|hormones|mesh-ancestor
6519490|NCT00732693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6519491|NCT00732693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519492|NCT00732693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6519493|NCT00732693|Contraceptive Agents|contraceptive agents|mesh-ancestor
6519494|NCT00732693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6519495|NCT00732693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6519496|NCT00732693|Progestins|progestins|mesh-ancestor
6519497|NCT00732693|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6519498|NCT00732693|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6519499|NCT00732693|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6519500|NCT00732745|Docetaxel|docetaxel|mesh-list
6519501|NCT00732745|Oxaliplatin|oxaliplatin|mesh-list
6519502|NCT00732745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6519503|NCT00732745|Tubulin Modulators|tubulin modulators|mesh-ancestor
6519504|NCT00732745|Antimitotic Agents|antimitotic agents|mesh-ancestor
6519505|NCT00732745|Mitosis Modulators|mitosis modulators|mesh-ancestor
6519506|NCT00732745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519507|NCT00732784|Imatinib Mesylate|imatinib mesylate|mesh-list
6519508|NCT00732784|Calcium Carbonate|calcium carbonate|mesh-list
6519509|NCT00732784|Calcium|calcium|mesh-list
6519510|NCT00732784|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6519511|NCT00732784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519512|NCT00732784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6519513|NCT00732784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6519514|NCT00732784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6519515|NCT00732784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519516|NCT00732784|Antacids|antacids|mesh-ancestor
6519517|NCT00732784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6519518|NCT00732810|Capecitabine|capecitabine|mesh-list
6519519|NCT00732810|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6519520|NCT00732810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6519521|NCT00732810|Antimetabolites|antimetabolites|mesh-ancestor
6519522|NCT00732810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519523|NCT00732810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6519524|NCT00732810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6519525|NCT00732810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6519526|NCT00732836|Paclitaxel|paclitaxel|mesh-list
6519527|NCT00732836|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6519528|NCT00732836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6519529|NCT00732836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6519530|NCT00732836|Tubulin Modulators|tubulin modulators|mesh-ancestor
6519531|NCT00732836|Antimitotic Agents|antimitotic agents|mesh-ancestor
5962394|NCT04611373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962395|NCT04611373|Diuretics|diuretics|mesh-ancestor
5962396|NCT04611373|Natriuretic Agents|natriuretic agents|mesh-ancestor
5962397|NCT04611373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962398|NCT04611373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5962399|NCT04611373|Immunologic Factors|immunologic factors|mesh-ancestor
5962400|NCT04611373|Antinematodal Agents|antinematodal agents|mesh-ancestor
5962401|NCT04611373|Anthelmintics|anthelmintics|mesh-ancestor
5962402|NCT04611373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5962403|NCT04611373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6519532|NCT00732836|Mitosis Modulators|mitosis modulators|mesh-ancestor
6519533|NCT00732836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519534|NCT00732888|Calcium Carbonate|calcium carbonate|mesh-list
6519535|NCT00732888|Calcium|calcium|mesh-list
5962404|NCT04611373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5962405|NCT04611464|Misoprostol|misoprostol|mesh-list
6519536|NCT00732888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6519537|NCT00732888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519538|NCT00732888|Antacids|antacids|mesh-ancestor
6519539|NCT00732888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519540|NCT00732888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5962406|NCT04611464|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5962407|NCT04611464|Abortifacient Agents|abortifacient agents|mesh-ancestor
6519541|NCT00732914|Sorafenib|sorafenib|mesh-list
6519542|NCT00732914|Sunitinib|sunitinib|mesh-list
6519543|NCT00732914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5962408|NCT04611464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5962409|NCT04611464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962410|NCT04611464|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5962411|NCT04611464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5962412|NCT04611464|Oxytocics|oxytocics|mesh-ancestor
5962413|NCT04611776|Gemcitabine|gemcitabine|mesh-list
5962414|NCT04611776|Paclitaxel|paclitaxel|mesh-list
5962415|NCT04611776|Carboplatin|carboplatin|mesh-list
5962416|NCT04611776|Pemetrexed|pemetrexed|mesh-list
5962417|NCT04611776|Atezolizumab|atezolizumab|mesh-list
5962418|NCT04611776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5962419|NCT04611776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5962420|NCT04611776|Tubulin Modulators|tubulin modulators|mesh-ancestor
5962421|NCT04611776|Antimitotic Agents|antimitotic agents|mesh-ancestor
5962422|NCT04611776|Mitosis Modulators|mitosis modulators|mesh-ancestor
5962423|NCT04611776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962424|NCT04611776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5962425|NCT04611776|Antimetabolites|antimetabolites|mesh-ancestor
5962426|NCT04611776|Antiviral Agents|antiviral agents|mesh-ancestor
5962427|NCT04611776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5962428|NCT04611776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5962429|NCT04611776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5962430|NCT04611776|Immunologic Factors|immunologic factors|mesh-ancestor
5962431|NCT04611776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962432|NCT04611776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5962433|NCT04611776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5962434|NCT04611126|Cyclophosphamide|cyclophosphamide|mesh-list
5962435|NCT04611126|Nivolumab|nivolumab|mesh-list
5962436|NCT04611126|Fludarabine|fludarabine|mesh-list
5962437|NCT04611126|Fludarabine phosphate|fludarabine phosphate|mesh-list
5962438|NCT04611126|Ipilimumab|ipilimumab|mesh-list
5962439|NCT04611126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6519544|NCT00732914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6519545|NCT00732914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6519546|NCT00732914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519547|NCT00732914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6519548|NCT00732914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6519549|NCT00732914|Growth Substances|growth substances|mesh-ancestor
6519550|NCT00732914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519551|NCT00732914|Growth Inhibitors|growth inhibitors|mesh-ancestor
6519552|NCT00732927|Aspirin|aspirin|mesh-list
6519553|NCT00732927|Parnaparin|parnaparin|mesh-list
6519554|NCT00732927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6519555|NCT00732927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6519556|NCT00732927|Analgesics|analgesics|mesh-ancestor
6519557|NCT00732927|Sensory System Agents|sensory system agents|mesh-ancestor
6519558|NCT00732927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6519559|NCT00732927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519560|NCT00732927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6519561|NCT00732927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6519562|NCT00732927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6519563|NCT00732927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6519564|NCT00732927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519565|NCT00732927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6519566|NCT00732927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6519567|NCT00732927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6519568|NCT00732927|Antipyretics|antipyretics|mesh-ancestor
6519569|NCT00732927|Anticoagulants|anticoagulants|mesh-ancestor
6519570|NCT00732953|Paclitaxel|paclitaxel|mesh-list
6519571|NCT00732953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6519572|NCT00732953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6519573|NCT00732953|Tubulin Modulators|tubulin modulators|mesh-ancestor
6519574|NCT00732953|Antimitotic Agents|antimitotic agents|mesh-ancestor
6519575|NCT00732953|Mitosis Modulators|mitosis modulators|mesh-ancestor
6519576|NCT00732953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519577|NCT00732966|Losartan|losartan|mesh-list
6519578|NCT00732966|Valsartan|valsartan|mesh-list
6519579|NCT00732966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6519580|NCT00732966|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6519581|NCT00732966|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5962440|NCT04611126|Immunologic Factors|immunologic factors|mesh-ancestor
5962441|NCT04611126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962442|NCT04611126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6519582|NCT00732966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962443|NCT04611126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5962444|NCT04611126|Alkylating Agents|alkylating agents|mesh-ancestor
5962445|NCT04611126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962446|NCT04611126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5962447|NCT04611126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5962448|NCT04611126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5962449|NCT04611126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5962450|NCT04611126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5962451|NCT04611126|Antimetabolites|antimetabolites|mesh-ancestor
5962452|NCT04611152|Aflibercept|aflibercept|mesh-list
5962453|NCT04611152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5962454|NCT04611152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5962455|NCT04611152|Growth Substances|growth substances|mesh-ancestor
6519583|NCT00732966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6519584|NCT00733031|Gemcitabine|gemcitabine|mesh-list
6519585|NCT00733031|Pemetrexed|pemetrexed|mesh-list
6519586|NCT00733031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6519587|NCT00733031|Antimetabolites|antimetabolites|mesh-ancestor
6519588|NCT00733031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519589|NCT00733031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5962456|NCT04611152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962457|NCT04611152|Growth Inhibitors|growth inhibitors|mesh-ancestor
6519590|NCT00733031|Antiviral Agents|antiviral agents|mesh-ancestor
6519591|NCT00733031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6519592|NCT00733031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5962458|NCT04611152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5962459|NCT04611165|Nivolumab|nivolumab|mesh-list
5962460|NCT04611165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5962461|NCT04611165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5962462|NCT04611165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5962463|NCT04611165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962464|NCT04610879|Carbamazepine|carbamazepine|mesh-list
5962465|NCT04610879|Levetiracetam|levetiracetam|mesh-list
5962466|NCT04610879|Anticonvulsants|anticonvulsants|mesh-ancestor
5962467|NCT04610879|Nootropic Agents|nootropic agents|mesh-ancestor
5962468|NCT04610879|Antimanic Agents|antimanic agents|mesh-ancestor
5962469|NCT04610879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5962470|NCT04610879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5962471|NCT04610879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962472|NCT04610879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5962473|NCT04610879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5962474|NCT04610879|Analgesics|analgesics|mesh-ancestor
5962475|NCT04610879|Sensory System Agents|sensory system agents|mesh-ancestor
5962476|NCT04610879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5962477|NCT04610879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5962478|NCT04610879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5962479|NCT04610879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962480|NCT04610879|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6519593|NCT00733031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6519594|NCT00733031|Immunologic Factors|immunologic factors|mesh-ancestor
6519595|NCT00733031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962481|NCT04610879|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5970393|NCT04535518|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5970394|NCT04535518|gamma-Globulins|gamma-globulins|mesh-list
5970395|NCT04535518|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5970396|NCT04535518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5970397|NCT04535518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5970398|NCT04535518|Analgesics|analgesics|mesh-ancestor
5970399|NCT04535518|Sensory System Agents|sensory system agents|mesh-ancestor
5970400|NCT04535518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5970401|NCT04535518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970402|NCT04535518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5970403|NCT04535518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5970404|NCT04535518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6519596|NCT00733031|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6519597|NCT00733031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6519598|NCT00733057|Minocycline|minocycline|mesh-list
6519599|NCT00733057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6519600|NCT00733057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6519601|NCT00733083|Dexamethasone|dexamethasone|mesh-list
6519602|NCT00733083|Morphine|morphine|mesh-list
6519603|NCT00733083|Oxycodone|oxycodone|mesh-list
6519604|NCT00733083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6519605|NCT00733083|Antiemetics|antiemetics|mesh-ancestor
6519606|NCT00733083|Autonomic Agents|autonomic agents|mesh-ancestor
5962482|NCT04611243|Vaccines|vaccines|mesh-list
5962483|NCT04611243|Immunologic Factors|immunologic factors|mesh-ancestor
5962484|NCT04611243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962485|NCT04610736|Temozolomide|temozolomide|mesh-list
5962486|NCT04610736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5962487|NCT04610736|Alkylating Agents|alkylating agents|mesh-ancestor
5962488|NCT04610736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962489|NCT04610736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5962490|NCT04610567|Methotrexate|methotrexate|mesh-list
5962491|NCT04610567|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5962492|NCT04610567|Abortifacient Agents|abortifacient agents|mesh-ancestor
5962493|NCT04610567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5962494|NCT04610567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962495|NCT04610567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5962496|NCT04610567|Antimetabolites|antimetabolites|mesh-ancestor
5962497|NCT04610567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962498|NCT04610567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5962499|NCT04610567|Dermatologic Agents|dermatologic agents|mesh-ancestor
5962500|NCT04610567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5962501|NCT04610567|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5962502|NCT04610567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5962503|NCT04610567|Immunologic Factors|immunologic factors|mesh-ancestor
5962504|NCT04610567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5962505|NCT04610567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5962506|NCT04610541|Remdesivir|remdesivir|mesh-list
5962507|NCT04610541|Antimetabolites|antimetabolites|mesh-ancestor
5962508|NCT04610541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962509|NCT04610541|Antiviral Agents|antiviral agents|mesh-ancestor
5962510|NCT04610541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5962511|NCT04610320|Daratumumab|daratumumab|mesh-list
5962512|NCT04610320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5962513|NCT04610164|Tranexamic Acid|tranexamic acid|mesh-list
5962514|NCT04610164|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5962515|NCT04610164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5962516|NCT04610164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962517|NCT04610164|Hemostatics|hemostatics|mesh-ancestor
5962518|NCT04610164|Coagulants|coagulants|mesh-ancestor
5962519|NCT04610307|Anesthetics|anesthetics|mesh-list
5962520|NCT04610307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5962521|NCT04610307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962522|NCT04610502|Immunoglobulins|immunoglobulins|mesh-list
5962523|NCT04610502|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5962524|NCT04610502|Antibodies|antibodies|mesh-list
5962525|NCT04610502|Immunologic Factors|immunologic factors|mesh-ancestor
5962526|NCT04610502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962527|NCT04610398|Dexamethasone|dexamethasone|mesh-list
5962528|NCT04610398|Dexamethasone acetate|dexamethasone acetate|mesh-list
5962529|NCT04610398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5962530|NCT04610398|Antiemetics|antiemetics|mesh-ancestor
5962531|NCT04610398|Autonomic Agents|autonomic agents|mesh-ancestor
5962532|NCT04610398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5962533|NCT04610398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962534|NCT04610398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5962535|NCT04610398|Glucocorticoids|glucocorticoids|mesh-ancestor
5962536|NCT04610398|Hormones|hormones|mesh-ancestor
5962537|NCT04610398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5962538|NCT04610398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5962539|NCT04610398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5962540|NCT04610125|Cyclophosphamide|cyclophosphamide|mesh-list
5962541|NCT04610125|Fludarabine|fludarabine|mesh-list
5962542|NCT04610125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5962543|NCT04610125|Immunologic Factors|immunologic factors|mesh-ancestor
5962544|NCT04610125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962545|NCT04610125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5962546|NCT04610125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5962547|NCT04610125|Alkylating Agents|alkylating agents|mesh-ancestor
5962548|NCT04610125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962549|NCT04610125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5962550|NCT04610125|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5962551|NCT04609865|Lidocaine|lidocaine|mesh-list
5962552|NCT04609865|Anesthetics, Local|anesthetics, local|mesh-ancestor
5962553|NCT04609865|Anesthetics|anesthetics|mesh-ancestor
5962554|NCT04609865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5962555|NCT04609865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962556|NCT04609865|Sensory System Agents|sensory system agents|mesh-ancestor
5962557|NCT04609865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5962558|NCT04609865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5962559|NCT04609865|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5962560|NCT04609865|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5962561|NCT04609865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5962562|NCT04609865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962563|NCT04609748|Nimesulide|nimesulide|mesh-list
5962564|NCT04609748|Cannabidiol|cannabidiol|mesh-list
5962565|NCT04609748|Anticonvulsants|anticonvulsants|mesh-ancestor
5962566|NCT04609748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5962567|NCT04609748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5962568|NCT04609748|Analgesics|analgesics|mesh-ancestor
5962569|NCT04609748|Sensory System Agents|sensory system agents|mesh-ancestor
5962570|NCT04609748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5962571|NCT04609748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962572|NCT04609748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5962573|NCT04609748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5962574|NCT04609748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5962575|NCT04609748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5962576|NCT04609748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962577|NCT04609579|Pembrolizumab|pembrolizumab|mesh-list
5962578|NCT04609579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5962579|NCT04609579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5962580|NCT04609592|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
5962581|NCT04609592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962582|NCT04609592|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5962583|NCT04609761|Immunoglobulins|immunoglobulins|mesh-list
5962584|NCT04609761|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5962585|NCT04609761|Antibodies|antibodies|mesh-list
5962586|NCT04609761|gamma-Globulins|gamma-globulins|mesh-list
5962587|NCT04609761|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5962588|NCT04609761|Immunologic Factors|immunologic factors|mesh-ancestor
5962589|NCT04609761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962590|NCT04609540|Trastuzumab|trastuzumab|mesh-list
5962591|NCT04609540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5962592|NCT04609540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5962593|NCT04609488|Pulmonary Surfactants|pulmonary surfactants|mesh-list
5962594|NCT04609488|Respiratory System Agents|respiratory system agents|mesh-ancestor
5962595|NCT04609306|Hydrogen Peroxide|hydrogen peroxide|mesh-list
5962596|NCT04609306|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5962597|NCT04609306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5962598|NCT04609254|Acetaminophen|acetaminophen|mesh-list
5962599|NCT04609254|Ibuprofen|ibuprofen|mesh-list
5962600|NCT04609254|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
5962601|NCT04609254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5962602|NCT04609254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5962603|NCT04609254|Analgesics|analgesics|mesh-ancestor
5962604|NCT04609254|Sensory System Agents|sensory system agents|mesh-ancestor
5962605|NCT04609254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5962606|NCT04609254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962607|NCT04609254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5962608|NCT04609254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5962609|NCT04609254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5962610|NCT04609254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5962611|NCT04609254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962612|NCT04609254|Antipyretics|antipyretics|mesh-ancestor
5962613|NCT04609293|Apatinib|apatinib|mesh-list
5962614|NCT04609293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5962615|NCT04609293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5962616|NCT04609293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5962617|NCT04609293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962618|NCT04609189|Vitamin D|vitamin d|mesh-list
5962619|NCT04609189|Cholecalciferol|cholecalciferol|mesh-list
5962620|NCT04609189|Calcium Carbonate|calcium carbonate|mesh-list
5962621|NCT04609189|Calcium|calcium|mesh-list
5962622|NCT04609189|Vitamins|vitamins|mesh-ancestor
5962623|NCT04609189|Micronutrients|micronutrients|mesh-ancestor
5962624|NCT04609189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962625|NCT04609189|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5962626|NCT04609189|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5962627|NCT04609189|Antacids|antacids|mesh-ancestor
5962628|NCT04609189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962629|NCT04609189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5962630|NCT04609111|Aspirin|aspirin|mesh-list
5962631|NCT04609111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5962632|NCT04609111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5962633|NCT04609111|Analgesics|analgesics|mesh-ancestor
5962634|NCT04609111|Sensory System Agents|sensory system agents|mesh-ancestor
5962635|NCT04609111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5962636|NCT04609111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962637|NCT04609111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5962638|NCT04609111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5962639|NCT04609111|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5962640|NCT04609111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5962641|NCT04609111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962642|NCT04609111|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5962643|NCT04609111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5962644|NCT04609111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5962645|NCT04609111|Antipyretics|antipyretics|mesh-ancestor
5962646|NCT04609176|Apatinib|apatinib|mesh-list
5962647|NCT04609176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5962648|NCT04609176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5962649|NCT04609176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5962650|NCT04609176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970405|NCT04535518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5970406|NCT04535518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970407|NCT04535518|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5970408|NCT04535518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5970409|NCT04535518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5970410|NCT04535518|Antipyretics|antipyretics|mesh-ancestor
5970411|NCT04535518|Immunologic Factors|immunologic factors|mesh-ancestor
5970412|NCT04535518|Dermatologic Agents|dermatologic agents|mesh-ancestor
5970413|NCT04535518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5970414|NCT04535700|Pioglitazone|pioglitazone|mesh-list
5970415|NCT04535700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5970416|NCT04535700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970417|NCT04535362|Nicotine|nicotine|mesh-list
5970418|NCT04535362|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5970419|NCT04535362|Autonomic Agents|autonomic agents|mesh-ancestor
6519607|NCT00733083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6519608|NCT00733083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519609|NCT00733083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6519610|NCT00733083|Glucocorticoids|glucocorticoids|mesh-ancestor
6519611|NCT00733083|Hormones|hormones|mesh-ancestor
6519612|NCT00733083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6519613|NCT00733083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6519614|NCT00733083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6519615|NCT00733083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6519616|NCT00733083|Narcotics|narcotics|mesh-ancestor
6519617|NCT00733083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6519618|NCT00733083|Analgesics|analgesics|mesh-ancestor
6519619|NCT00733083|Sensory System Agents|sensory system agents|mesh-ancestor
6684619|NCT01628952|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
6684620|NCT01628952|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6684621|NCT01628952|Cholinergic Agents|cholinergic agents|mesh-ancestor
6684622|NCT01628952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6684623|NCT01628952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684624|NCT01629082|Lenalidomide|lenalidomide|mesh-list
5970420|NCT04535362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5970421|NCT04535362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5970422|NCT04535362|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5970423|NCT04535362|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5970424|NCT04535362|Cholinergic Agents|cholinergic agents|mesh-ancestor
5970425|NCT04535362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5970426|NCT04535362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5970427|NCT04535271|Gemcitabine|gemcitabine|mesh-list
5970428|NCT04535271|Dacarbazine|dacarbazine|mesh-list
6684625|NCT01629082|Clofarabine|clofarabine|mesh-list
6684626|NCT01629082|Immunologic Factors|immunologic factors|mesh-ancestor
6684627|NCT01629082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684628|NCT01629082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6519620|NCT00733148|Insulin|insulin|mesh-list
6519621|NCT00733148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6519622|NCT00733148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519623|NCT00733174|Rosiglitazone|rosiglitazone|mesh-list
6519624|NCT00733174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6519625|NCT00733174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684629|NCT01629082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6684630|NCT01629082|Growth Substances|growth substances|mesh-ancestor
6684631|NCT01629082|Growth Inhibitors|growth inhibitors|mesh-ancestor
5962651|NCT04609397|Hemay005|hemay005|mesh-list
5962652|NCT04609397|Dermatologic Agents|dermatologic agents|mesh-ancestor
5962653|NCT04609397|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5962654|NCT04609397|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5962655|NCT04609397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5962656|NCT04609397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962657|NCT04609098|Piperaquine|piperaquine|mesh-list
6684632|NCT01629082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6684633|NCT01629082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6684634|NCT01629082|Antimetabolites|antimetabolites|mesh-ancestor
6684635|NCT01629082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684636|NCT01629173|Ethylene|ethylene|mesh-list
6684637|NCT01629173|Plant Growth Regulators|plant growth regulators|mesh-ancestor
6684638|NCT01629173|Growth Substances|growth substances|mesh-ancestor
6684639|NCT01629173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684640|NCT01629199|Mitogens|mitogens|mesh-list
6684641|NCT01629199|Mitosis Modulators|mitosis modulators|mesh-ancestor
6684642|NCT01629199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684643|NCT01629212|Octylonium|octylonium|mesh-list
6684644|NCT01629212|Bromides|bromides|mesh-list
6684645|NCT01629212|Tiropramide|tiropramide|mesh-list
6684646|NCT01629212|Anticonvulsants|anticonvulsants|mesh-ancestor
6684647|NCT01629212|Parasympatholytics|parasympatholytics|mesh-ancestor
6684648|NCT01629212|Autonomic Agents|autonomic agents|mesh-ancestor
6684649|NCT01629212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6684650|NCT01629212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684651|NCT01629212|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6684652|NCT01629212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6684653|NCT01629212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684654|NCT01629212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6684655|NCT01629212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6684656|NCT01629212|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6684657|NCT01629212|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6684658|NCT01629212|Cholinergic Agents|cholinergic agents|mesh-ancestor
6684659|NCT01629212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6684660|NCT01629225|Candesartan|candesartan|mesh-list
6684661|NCT01629225|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6684662|NCT01629225|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6684663|NCT01629225|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5962658|NCT04609098|Artenimol|artenimol|mesh-list
5962659|NCT04609098|Tafenoquine|tafenoquine|mesh-list
5962660|NCT04609098|Antimalarials|antimalarials|mesh-ancestor
5962661|NCT04609098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5962662|NCT04609098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5962663|NCT04609098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5962664|NCT04608734|Midazolam|midazolam|mesh-list
5962665|NCT04608734|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6684664|NCT01629225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684665|NCT01629251|Insulin|insulin|mesh-list
6684666|NCT01629251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6684667|NCT01629251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519626|NCT00733239|Cycloserine|cycloserine|mesh-list
6519627|NCT00733239|Verapamil|verapamil|mesh-list
6519628|NCT00733239|Diltiazem|diltiazem|mesh-list
5962666|NCT04608734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5962667|NCT04608734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5962668|NCT04608734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962669|NCT04608734|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5962670|NCT04608734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5962671|NCT04608734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5962672|NCT04608734|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5962673|NCT04608734|Anesthetics, General|anesthetics, general|mesh-ancestor
5962674|NCT04608734|Anesthetics|anesthetics|mesh-ancestor
5962675|NCT04608734|GABA Modulators|gaba modulators|mesh-ancestor
5962676|NCT04608734|GABA Agents|gaba agents|mesh-ancestor
6684668|NCT01629277|Insulin|insulin|mesh-list
6684669|NCT01629277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6684670|NCT01629277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684671|NCT01629368|Carbamazepine|carbamazepine|mesh-list
6684672|NCT01629368|Anticonvulsants|anticonvulsants|mesh-ancestor
6684673|NCT01629368|Antimanic Agents|antimanic agents|mesh-ancestor
5962677|NCT04608734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5970429|NCT04535271|Trabectedin|trabectedin|mesh-list
6519629|NCT00733239|Isradipine|isradipine|mesh-list
6519630|NCT00733239|Nifedipine|nifedipine|mesh-list
6684674|NCT01629368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6684675|NCT01629368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5962678|NCT04608734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962679|NCT04609033|Morphine|morphine|mesh-list
5962680|NCT04609033|Ketamine|ketamine|mesh-list
5962681|NCT04609033|Bupivacaine|bupivacaine|mesh-list
5962682|NCT04609033|Anesthetics, Local|anesthetics, local|mesh-ancestor
5962683|NCT04609033|Anesthetics|anesthetics|mesh-ancestor
5962684|NCT04609033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5962685|NCT04609033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962686|NCT04609033|Sensory System Agents|sensory system agents|mesh-ancestor
5962687|NCT04609033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5962688|NCT04609033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5962689|NCT04609033|Narcotics|narcotics|mesh-ancestor
6519631|NCT00733239|Gabapentin|gabapentin|mesh-list
6519632|NCT00733239|Naloxone|naloxone|mesh-list
6519633|NCT00733239|Analgesics|analgesics|mesh-ancestor
6519634|NCT00733239|Sensory System Agents|sensory system agents|mesh-ancestor
6519635|NCT00733239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6519636|NCT00733239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519637|NCT00733239|Anticonvulsants|anticonvulsants|mesh-ancestor
6519638|NCT00733239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6519639|NCT00733239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6519640|NCT00733239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6519641|NCT00733239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6519642|NCT00733239|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6519643|NCT00733239|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6519644|NCT00733239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6684676|NCT01629368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684677|NCT01629368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6684678|NCT01629368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6684679|NCT01629368|Analgesics|analgesics|mesh-ancestor
6684680|NCT01629368|Sensory System Agents|sensory system agents|mesh-ancestor
6684681|NCT01629368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6684682|NCT01629368|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6684683|NCT01629368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6684684|NCT01629368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684685|NCT01629368|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6684686|NCT01629368|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6684687|NCT01629394|Neostigmine|neostigmine|mesh-list
6684688|NCT01629394|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6684689|NCT01629394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6684690|NCT01629394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684691|NCT01629394|Cholinergic Agents|cholinergic agents|mesh-ancestor
5962690|NCT04609033|Analgesics|analgesics|mesh-ancestor
5962691|NCT04609033|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5962692|NCT04609033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5962693|NCT04609033|Anesthetics, General|anesthetics, general|mesh-ancestor
5962694|NCT04609033|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5962695|NCT04609033|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5962696|NCT04609033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5962697|NCT04609033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962698|NCT04608981|Prednisolone|prednisolone|mesh-list
5962699|NCT04608981|Diclofenac|diclofenac|mesh-list
5962700|NCT04608981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5962701|NCT04608981|Glucocorticoids|glucocorticoids|mesh-ancestor
5962702|NCT04608981|Hormones|hormones|mesh-ancestor
5962703|NCT04608981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5962704|NCT04608981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962705|NCT04608981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5962706|NCT04608981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5962707|NCT04608981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6684692|NCT01629394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6684693|NCT01629394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684694|NCT01629394|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6684695|NCT01629394|Autonomic Agents|autonomic agents|mesh-ancestor
6684696|NCT01629394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6684697|NCT01629446|Lofexidine|lofexidine|mesh-list
6684698|NCT01629446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6684699|NCT01629446|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6684700|NCT01629446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684701|NCT01629446|Sensory System Agents|sensory system agents|mesh-ancestor
6684702|NCT01629446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6684703|NCT01629446|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6684704|NCT01629446|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6684705|NCT01629446|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6684706|NCT01629446|Adrenergic Agents|adrenergic agents|mesh-ancestor
6684707|NCT01629446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6684708|NCT01629446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684709|NCT01629511|Gemcitabine|gemcitabine|mesh-list
6684710|NCT01629511|Methotrexate|methotrexate|mesh-list
6684711|NCT01629511|Clofarabine|clofarabine|mesh-list
6684712|NCT01629511|Busulfan|busulfan|mesh-list
6684713|NCT01629511|Tacrolimus|tacrolimus|mesh-list
6684714|NCT01629511|Thymoglobulin|thymoglobulin|mesh-list
6684715|NCT01629511|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6684716|NCT01629511|Lenograstim|lenograstim|mesh-list
6684717|NCT01629511|Sargramostim|sargramostim|mesh-list
6684718|NCT01629511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6684719|NCT01629511|Antimetabolites|antimetabolites|mesh-ancestor
6684720|NCT01629511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684721|NCT01629511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6684722|NCT01629511|Antiviral Agents|antiviral agents|mesh-ancestor
6684723|NCT01629511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6684724|NCT01629511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6684725|NCT01629511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6684726|NCT01629511|Immunologic Factors|immunologic factors|mesh-ancestor
6684727|NCT01629511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684728|NCT01629511|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6684729|NCT01629511|Abortifacient Agents|abortifacient agents|mesh-ancestor
6684730|NCT01629511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6684731|NCT01629511|Dermatologic Agents|dermatologic agents|mesh-ancestor
6684732|NCT01629511|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6684733|NCT01629511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6684734|NCT01629511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6684735|NCT01629511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6684736|NCT01629511|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6684737|NCT01629511|Alkylating Agents|alkylating agents|mesh-ancestor
6684738|NCT01629511|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6684739|NCT01629511|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6684740|NCT01629628|Adalimumab|adalimumab|mesh-list
6684741|NCT01629628|Mercaptopurine|mercaptopurine|mesh-list
6684742|NCT01629628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6684743|NCT01629628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6684744|NCT01629628|Antimetabolites|antimetabolites|mesh-ancestor
6684745|NCT01629628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962708|NCT04608981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5962709|NCT04608981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5962710|NCT04608981|Analgesics|analgesics|mesh-ancestor
5962711|NCT04608981|Sensory System Agents|sensory system agents|mesh-ancestor
5962712|NCT04608981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5962713|NCT04608981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5962714|NCT04608981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5962715|NCT04608981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962716|NCT04608669|Acetaminophen|acetaminophen|mesh-list
5962717|NCT04608669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5962718|NCT04608669|Analgesics|analgesics|mesh-ancestor
5962719|NCT04608669|Sensory System Agents|sensory system agents|mesh-ancestor
5962720|NCT04608669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5962721|NCT04608669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962722|NCT04608669|Antipyretics|antipyretics|mesh-ancestor
5962723|NCT04608448|Sirolimus|sirolimus|mesh-list
6684746|NCT01629628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6684747|NCT01629628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6684748|NCT01629628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6684749|NCT01629628|Immunologic Factors|immunologic factors|mesh-ancestor
6684750|NCT01629628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684751|NCT01629628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6684752|NCT01629628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780169|NCT02182375|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6780170|NCT02182375|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5962724|NCT04608448|Petrolatum|petrolatum|mesh-list
5962725|NCT04608448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5962726|NCT04608448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5962727|NCT04608448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5962728|NCT04608448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5962729|NCT04608448|Antifungal Agents|antifungal agents|mesh-ancestor
5962730|NCT04608448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5962731|NCT04608448|Immunologic Factors|immunologic factors|mesh-ancestor
5962732|NCT04608448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780171|NCT02182375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5962733|NCT04608448|Emollients|emollients|mesh-ancestor
5962734|NCT04608448|Dermatologic Agents|dermatologic agents|mesh-ancestor
6684753|NCT01629680|Moxaverine|moxaverine|mesh-list
6684754|NCT01629680|Parasympatholytics|parasympatholytics|mesh-ancestor
6684755|NCT01629680|Autonomic Agents|autonomic agents|mesh-ancestor
6684756|NCT01629680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6684757|NCT01629680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684758|NCT01629732|Ribavirin|ribavirin|mesh-list
6684759|NCT01629732|Antimetabolites|antimetabolites|mesh-ancestor
6684760|NCT01629732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684761|NCT01629732|Antiviral Agents|antiviral agents|mesh-ancestor
6684762|NCT01629732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6684763|NCT01629758|Nivolumab|nivolumab|mesh-list
6684764|NCT01629758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6684765|NCT01629758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6684766|NCT01629758|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5962735|NCT04608474|Evolocumab|evolocumab|mesh-list
5962736|NCT04608474|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
5962737|NCT04608474|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5962738|NCT04608474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5962739|NCT04608474|Antimetabolites|antimetabolites|mesh-ancestor
5962740|NCT04608474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962741|NCT04608474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5962742|NCT04608474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5962743|NCT04608630|Zoledronic Acid|zoledronic acid|mesh-list
5962744|NCT04608630|Denosumab|denosumab|mesh-list
5962745|NCT04608630|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5962746|NCT04608630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962747|NCT04608539|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
5962748|NCT04608539|Hematinics|hematinics|mesh-ancestor
5962749|NCT04608253|Choline|choline|mesh-list
5962750|NCT04608253|Lipotropic Agents|lipotropic agents|mesh-ancestor
5962751|NCT04608253|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5962752|NCT04608253|Antimetabolites|antimetabolites|mesh-ancestor
5962753|NCT04608253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962754|NCT04608253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5962755|NCT04608253|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5962756|NCT04608253|Nootropic Agents|nootropic agents|mesh-ancestor
6684767|NCT01629758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684768|NCT01629875|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6684769|NCT01629875|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6684770|NCT01629875|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5962757|NCT04608500|Minocycline|minocycline|mesh-list
5962758|NCT04608500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5962759|NCT04608500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5962760|NCT04608084|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5962761|NCT04608084|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6519645|NCT00733239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684771|NCT01629875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6684772|NCT01629875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684773|NCT01629875|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6684774|NCT01629875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6684775|NCT01629875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684776|NCT01629875|Cholinergic Agents|cholinergic agents|mesh-ancestor
6684777|NCT01629875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6684778|NCT01630018|Topotecan|topotecan|mesh-list
6684779|NCT01630018|Belotecan|belotecan|mesh-list
6684780|NCT01630018|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6684781|NCT01630018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6684782|NCT01630018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6684783|NCT01630018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684784|NCT01630018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6684785|NCT01630057|Zonisamide|zonisamide|mesh-list
6684786|NCT01630057|Anticonvulsants|anticonvulsants|mesh-ancestor
6684787|NCT01630057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6684788|NCT01630057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6519646|NCT00733239|Antimanic Agents|antimanic agents|mesh-ancestor
6519647|NCT00733239|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6519648|NCT00733239|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6684789|NCT01630057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684790|NCT01630057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6684791|NCT01630057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684792|NCT01630070|Paclitaxel|paclitaxel|mesh-list
6684793|NCT01630070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6684794|NCT01630070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5962762|NCT04607772|Gemcitabine|gemcitabine|mesh-list
6684795|NCT01630070|Tubulin Modulators|tubulin modulators|mesh-ancestor
6684796|NCT01630070|Antimitotic Agents|antimitotic agents|mesh-ancestor
6519649|NCT00733239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6519650|NCT00733239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6519651|NCT00733239|Vasodilator Agents|vasodilator agents|mesh-ancestor
6684797|NCT01630070|Mitosis Modulators|mitosis modulators|mesh-ancestor
6684798|NCT01630070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684799|NCT01630083|Capecitabine|capecitabine|mesh-list
6684800|NCT01630083|Oxaliplatin|oxaliplatin|mesh-list
6684801|NCT01630083|Epirubicin|epirubicin|mesh-list
6684802|NCT01630083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6684803|NCT01630083|Antimetabolites|antimetabolites|mesh-ancestor
5962763|NCT04607772|Rituximab|rituximab|mesh-list
5962764|NCT04607772|Oxaliplatin|oxaliplatin|mesh-list
5962765|NCT04607772|Lenalidomide|lenalidomide|mesh-list
5962766|NCT04607772|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5962767|NCT04607772|Venetoclax|venetoclax|mesh-list
5962768|NCT04607772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5962769|NCT04607772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5962770|NCT04607772|Immunologic Factors|immunologic factors|mesh-ancestor
5962771|NCT04607772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962772|NCT04607772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5962773|NCT04607772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5962774|NCT04607772|Antimetabolites|antimetabolites|mesh-ancestor
5962775|NCT04607772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962776|NCT04607772|Antiviral Agents|antiviral agents|mesh-ancestor
5962777|NCT04607772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5962778|NCT04607772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5962779|NCT04607772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6684804|NCT01630083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684805|NCT01630083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6684806|NCT01630083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6519652|NCT00733239|Tocolytic Agents|tocolytic agents|mesh-ancestor
6684807|NCT01630083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6684808|NCT01630083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6684809|NCT01630083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6684810|NCT01630096|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
6684811|NCT01630096|Laxatives|laxatives|mesh-ancestor
6684812|NCT01630096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5962780|NCT04607772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5962781|NCT04607772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5962782|NCT04607772|Growth Substances|growth substances|mesh-ancestor
5962783|NCT04607772|Growth Inhibitors|growth inhibitors|mesh-ancestor
5962784|NCT04607772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5962785|NCT04607772|Alkylating Agents|alkylating agents|mesh-ancestor
5962786|NCT04608331|Dexmedetomidine|dexmedetomidine|mesh-list
5962787|NCT04608331|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5962788|NCT04608331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5962789|NCT04608331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962790|NCT04608331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5962791|NCT04608331|Analgesics|analgesics|mesh-ancestor
5962792|NCT04608331|Sensory System Agents|sensory system agents|mesh-ancestor
5962793|NCT04608331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5971358|NCT04528797|Methylprednisolone|methylprednisolone|mesh-list
6519653|NCT00733239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6519654|NCT00733239|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6519655|NCT00733239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6519656|NCT00733239|Renal Agents|renal agents|mesh-ancestor
6519657|NCT00733239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6519658|NCT00733239|Antitubercular Agents|antitubercular agents|mesh-ancestor
6519659|NCT00733239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6519660|NCT00733239|Antimetabolites|antimetabolites|mesh-ancestor
6519661|NCT00733239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6519662|NCT00733239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6519663|NCT00733265|Ticagrelor|ticagrelor|mesh-list
6519664|NCT00733265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6519665|NCT00733265|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6519666|NCT00733265|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6519667|NCT00733265|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6519668|NCT00733265|Purinergic Agents|purinergic agents|mesh-ancestor
6519669|NCT00733265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6684813|NCT01630148|Bemiparin|bemiparin|mesh-list
6519670|NCT00733265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519671|NCT00733265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519672|NCT00733317|Budesonide|budesonide|mesh-list
6519673|NCT00733317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6519674|NCT00733317|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6519675|NCT00733317|Autonomic Agents|autonomic agents|mesh-ancestor
6519676|NCT00733317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6519677|NCT00733317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519678|NCT00733317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6519679|NCT00733317|Respiratory System Agents|respiratory system agents|mesh-ancestor
6519680|NCT00733317|Glucocorticoids|glucocorticoids|mesh-ancestor
5962794|NCT04608331|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5962795|NCT04608331|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5962796|NCT04608331|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5962797|NCT04608331|Adrenergic Agents|adrenergic agents|mesh-ancestor
5962798|NCT04608331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5962799|NCT04608331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5962800|NCT04608006|Fentanyl|fentanyl|mesh-list
5962801|NCT04608006|Bupivacaine|bupivacaine|mesh-list
5962802|NCT04608006|Anesthetics, Local|anesthetics, local|mesh-ancestor
5962803|NCT04608006|Anesthetics|anesthetics|mesh-ancestor
5962804|NCT04608006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5962805|NCT04608006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962806|NCT04608006|Sensory System Agents|sensory system agents|mesh-ancestor
5962807|NCT04608006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5962808|NCT04608006|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5962809|NCT04608006|Narcotics|narcotics|mesh-ancestor
5962810|NCT04608006|Analgesics|analgesics|mesh-ancestor
5962811|NCT04608006|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6519681|NCT00733317|Hormones|hormones|mesh-ancestor
6519682|NCT00733317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6519683|NCT00733434|Alprostadil|alprostadil|mesh-list
6684814|NCT01630148|Anticoagulants|anticoagulants|mesh-ancestor
6684815|NCT01630187|Carbetocin|carbetocin|mesh-list
6684816|NCT01630187|Oxytocin|oxytocin|mesh-list
6684817|NCT01630187|Oxytocics|oxytocics|mesh-ancestor
6684818|NCT01630187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6684819|NCT01630187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684820|NCT01630213|Vitamin D|vitamin d|mesh-list
6684821|NCT01630213|Ergocalciferols|ergocalciferols|mesh-list
6684822|NCT01630213|Cholecalciferol|cholecalciferol|mesh-list
6684823|NCT01630213|Vitamins|vitamins|mesh-list
6684824|NCT01630213|Micronutrients|micronutrients|mesh-ancestor
6684825|NCT01630213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684826|NCT01630213|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6684827|NCT01630213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6684828|NCT01630226|Cisplatin|cisplatin|mesh-list
6684829|NCT01630226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6684830|NCT01630278|Ibuprofen|ibuprofen|mesh-list
6684831|NCT01630278|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6684832|NCT01630278|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6684833|NCT01630278|Analgesics|analgesics|mesh-ancestor
6684834|NCT01630278|Sensory System Agents|sensory system agents|mesh-ancestor
6684835|NCT01630278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6519684|NCT00733434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6519685|NCT00733434|Vasodilator Agents|vasodilator agents|mesh-ancestor
6519686|NCT00733434|Urological Agents|urological agents|mesh-ancestor
6684836|NCT01630278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684837|NCT01630278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6684838|NCT01630278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6684839|NCT01630278|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6684840|NCT01630278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6684841|NCT01630278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684842|NCT01630343|Acetaminophen|acetaminophen|mesh-list
6684843|NCT01630343|Tramadol|tramadol|mesh-list
6519687|NCT00733473|Budesonide|budesonide|mesh-list
6519688|NCT00733473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6519689|NCT00733473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6519690|NCT00733473|Autonomic Agents|autonomic agents|mesh-ancestor
6519691|NCT00733473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6519692|NCT00733473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519693|NCT00733473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6519694|NCT00733473|Respiratory System Agents|respiratory system agents|mesh-ancestor
6519695|NCT00733473|Glucocorticoids|glucocorticoids|mesh-ancestor
6684844|NCT01630343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6684845|NCT01630343|Analgesics|analgesics|mesh-ancestor
6684846|NCT01630343|Sensory System Agents|sensory system agents|mesh-ancestor
6684847|NCT01630343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6684848|NCT01630343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684849|NCT01630343|Antipyretics|antipyretics|mesh-ancestor
6519696|NCT00733473|Hormones|hormones|mesh-ancestor
6519697|NCT00733473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6519698|NCT00733525|Fluoxetine|fluoxetine|mesh-list
6519699|NCT00733525|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6519700|NCT00733525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6519701|NCT00733525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6519702|NCT00733525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519703|NCT00733525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6519704|NCT00733525|Serotonin Agents|serotonin agents|mesh-ancestor
6519705|NCT00733525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519706|NCT00733525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6519707|NCT00733525|Antidepressive Agents|antidepressive agents|mesh-ancestor
6519708|NCT00733525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6519709|NCT00733525|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6519710|NCT00733525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6519711|NCT00733525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6519712|NCT00733538|Zoledronic Acid|zoledronic acid|mesh-list
6684850|NCT01630343|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6684851|NCT01630343|Narcotics|narcotics|mesh-ancestor
6684852|NCT01630343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6684853|NCT01630369|Insulin|insulin|mesh-list
6684854|NCT01630369|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6684855|NCT01630369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6684856|NCT01630369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684857|NCT01630538|Cyclophosphamide|cyclophosphamide|mesh-list
6684858|NCT01630538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6684859|NCT01630538|Immunologic Factors|immunologic factors|mesh-ancestor
6684860|NCT01630538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684861|NCT01630538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6684862|NCT01630538|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6684863|NCT01630538|Alkylating Agents|alkylating agents|mesh-ancestor
6684864|NCT01630538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684865|NCT01630538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6684866|NCT01630538|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6684867|NCT01630564|Aldesleukin|aldesleukin|mesh-list
6684868|NCT01630564|Interleukin-2|interleukin-2|mesh-list
6684869|NCT01630564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6684870|NCT01630564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6684871|NCT01630564|Analgesics|analgesics|mesh-ancestor
6684872|NCT01630564|Sensory System Agents|sensory system agents|mesh-ancestor
6684873|NCT01630564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6684874|NCT01630564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684875|NCT01630564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6684876|NCT01630564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6684877|NCT01630564|Antiviral Agents|antiviral agents|mesh-ancestor
6684878|NCT01630564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6684879|NCT01630590|Androgens|androgens|mesh-list
6684880|NCT01630590|Hormones|hormones|mesh-ancestor
6684881|NCT01630590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6684882|NCT01630590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684883|NCT01630642|Clopidogrel|clopidogrel|mesh-list
6684884|NCT01630642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6684885|NCT01630642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6684886|NCT01630642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6684887|NCT01630642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6684888|NCT01630642|Purinergic Agents|purinergic agents|mesh-ancestor
6684889|NCT01630642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6684890|NCT01630642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684891|NCT01630642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684892|NCT01630655|Felodipine|felodipine|mesh-list
6684893|NCT01630655|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6684894|NCT01630655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6684895|NCT01630655|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6684896|NCT01630655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6684897|NCT01630655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519713|NCT00733538|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6519714|NCT00733538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519715|NCT00733564|Lidocaine|lidocaine|mesh-list
6519716|NCT00733564|Propofol|propofol|mesh-list
6519717|NCT00733564|Sevoflurane|sevoflurane|mesh-list
6519718|NCT00733564|Anesthetics, Local|anesthetics, local|mesh-ancestor
6519719|NCT00733564|Anesthetics|anesthetics|mesh-ancestor
6519720|NCT00733564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6519721|NCT00733564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519722|NCT00733564|Sensory System Agents|sensory system agents|mesh-ancestor
6519723|NCT00733564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6684898|NCT01630655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6684899|NCT01630655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684900|NCT01630655|Vasodilator Agents|vasodilator agents|mesh-ancestor
6684901|NCT01630720|Vitamin D|vitamin d|mesh-list
6684902|NCT01630720|Vitamins|vitamins|mesh-list
6684903|NCT01630720|Ascorbic Acid|ascorbic acid|mesh-list
6684904|NCT01630720|Micronutrients|micronutrients|mesh-ancestor
6684905|NCT01630720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684906|NCT01630720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6684907|NCT01630720|Antioxidants|antioxidants|mesh-ancestor
6684908|NCT01630720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684909|NCT01630720|Protective Agents|protective agents|mesh-ancestor
6684910|NCT01630733|Docetaxel|docetaxel|mesh-list
6684911|NCT01630733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6684912|NCT01630733|Tubulin Modulators|tubulin modulators|mesh-ancestor
6684913|NCT01630733|Antimitotic Agents|antimitotic agents|mesh-ancestor
6519724|NCT00733564|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6519725|NCT00733564|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6519726|NCT00733564|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6519727|NCT00733564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6519728|NCT00733564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519729|NCT00733564|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6519730|NCT00733564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6684914|NCT01630733|Mitosis Modulators|mitosis modulators|mesh-ancestor
6684915|NCT01630733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684916|NCT01630902|Felodipine|felodipine|mesh-list
6684917|NCT01630902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6684918|NCT01630902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6684919|NCT01630902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6684920|NCT01630902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6684921|NCT01630902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684922|NCT01630902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6684923|NCT01630902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684924|NCT01630902|Vasodilator Agents|vasodilator agents|mesh-ancestor
6684925|NCT01630915|Clopidogrel|clopidogrel|mesh-list
6684926|NCT01630915|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6684927|NCT01630915|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6684928|NCT01630915|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6684929|NCT01630915|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6684930|NCT01630915|Purinergic Agents|purinergic agents|mesh-ancestor
6684931|NCT01630915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6684932|NCT01630915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684933|NCT01630915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684934|NCT01630941|Denosumab|denosumab|mesh-list
6684935|NCT01630941|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6684936|NCT01630941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684937|NCT01631058|Prednisone|prednisone|mesh-list
6684938|NCT01631058|Everolimus|everolimus|mesh-list
6684939|NCT01631058|Lactitol|lactitol|mesh-list
6684940|NCT01631058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6684941|NCT01631058|Glucocorticoids|glucocorticoids|mesh-ancestor
6684942|NCT01631058|Hormones|hormones|mesh-ancestor
6684943|NCT01631058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6684944|NCT01631058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684945|NCT01631058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6684946|NCT01631058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6684947|NCT01631058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6684948|NCT01631058|Immunologic Factors|immunologic factors|mesh-ancestor
6684949|NCT01631058|Cathartics|cathartics|mesh-ancestor
6684950|NCT01631058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6684951|NCT01631136|Gemcitabine|gemcitabine|mesh-list
6684952|NCT01631136|Cisplatin|cisplatin|mesh-list
6684953|NCT01631136|Pemetrexed|pemetrexed|mesh-list
6684954|NCT01631136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6684955|NCT01631136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6684956|NCT01631136|Antimetabolites|antimetabolites|mesh-ancestor
6684957|NCT01631136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684958|NCT01631136|Antiviral Agents|antiviral agents|mesh-ancestor
6684959|NCT01631136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6684960|NCT01631136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6684961|NCT01631136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6684962|NCT01631136|Immunologic Factors|immunologic factors|mesh-ancestor
6684963|NCT01631136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684964|NCT01631136|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6684965|NCT01631136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6684966|NCT01631201|Azithromycin|azithromycin|mesh-list
6684967|NCT01631201|KRM 1648|krm 1648|mesh-list
6684968|NCT01631201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6684969|NCT01631201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6684970|NCT01631201|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6684971|NCT01631201|Antitubercular Agents|antitubercular agents|mesh-ancestor
6684972|NCT01631201|Leprostatic Agents|leprostatic agents|mesh-ancestor
6684973|NCT01631305|Magnesium Oxide|magnesium oxide|mesh-list
6684974|NCT01631305|Calcium|calcium|mesh-list
6684975|NCT01631305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6684976|NCT01631305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684977|NCT01631305|Antacids|antacids|mesh-ancestor
6684978|NCT01631305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684979|NCT01631305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6519731|NCT00733564|Anesthetics, General|anesthetics, general|mesh-ancestor
6519732|NCT00733564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6684980|NCT01631357|Gemcitabine|gemcitabine|mesh-list
6684981|NCT01631357|Cisplatin|cisplatin|mesh-list
6684982|NCT01631357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6684983|NCT01631357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6684984|NCT01631357|Antimetabolites|antimetabolites|mesh-ancestor
6684985|NCT01631357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684986|NCT01631357|Antiviral Agents|antiviral agents|mesh-ancestor
6684987|NCT01631357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6684988|NCT01631357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6684989|NCT01631357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6684990|NCT01631357|Immunologic Factors|immunologic factors|mesh-ancestor
6684991|NCT01631357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6684992|NCT01631383|Tetrahydropalmatine|tetrahydropalmatine|mesh-list
6684993|NCT01631383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6684994|NCT01631383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6684995|NCT01631383|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6684996|NCT01631383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6684997|NCT01631383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6684998|NCT01631383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6684999|NCT01631383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685000|NCT01631383|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6519733|NCT00733564|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6519734|NCT00733616|Docetaxel|docetaxel|mesh-list
6519735|NCT00733616|Capecitabine|capecitabine|mesh-list
6685001|NCT01631383|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6685002|NCT01631383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6685003|NCT01631383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6685004|NCT01631383|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6685005|NCT01631383|Dopamine Agents|dopamine agents|mesh-ancestor
6685006|NCT01631383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6685007|NCT01631383|Adrenergic Agents|adrenergic agents|mesh-ancestor
6685008|NCT01631383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6685009|NCT01631383|Analgesics|analgesics|mesh-ancestor
6685010|NCT01631383|Sensory System Agents|sensory system agents|mesh-ancestor
6685011|NCT01631383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6685012|NCT01631396|Neostigmine|neostigmine|mesh-list
6685013|NCT01631396|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6685014|NCT01631396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6685015|NCT01631396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685016|NCT01631396|Cholinergic Agents|cholinergic agents|mesh-ancestor
6685017|NCT01631396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6685018|NCT01631396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519736|NCT00733616|Oxaliplatin|oxaliplatin|mesh-list
6519737|NCT00733616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6519738|NCT00733616|Tubulin Modulators|tubulin modulators|mesh-ancestor
6519739|NCT00733616|Antimitotic Agents|antimitotic agents|mesh-ancestor
6519740|NCT00733616|Mitosis Modulators|mitosis modulators|mesh-ancestor
6519741|NCT00733616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519742|NCT00733616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6519743|NCT00733616|Antimetabolites|antimetabolites|mesh-ancestor
6519744|NCT00733668|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6519745|NCT00733668|Antidepressive Agents|antidepressive agents|mesh-ancestor
6519746|NCT00733668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6519747|NCT00733668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6519748|NCT00733668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6519749|NCT00733668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6519750|NCT00733668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519751|NCT00733720|Naltrexone|naltrexone|mesh-list
6519752|NCT00733720|Buprenorphine|buprenorphine|mesh-list
6519753|NCT00733720|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6519754|NCT00733720|Naloxone|naloxone|mesh-list
6519755|NCT00733720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6519756|NCT00733720|Narcotics|narcotics|mesh-ancestor
6519757|NCT00733720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6519758|NCT00733720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519759|NCT00733720|Analgesics|analgesics|mesh-ancestor
6519760|NCT00733720|Sensory System Agents|sensory system agents|mesh-ancestor
6519761|NCT00733720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6519762|NCT00733720|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6519763|NCT00733720|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6519764|NCT00733785|Rosiglitazone|rosiglitazone|mesh-list
6519765|NCT00733785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6685019|NCT01631396|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6519766|NCT00733785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519767|NCT00733811|Deferiprone|deferiprone|mesh-list
6519768|NCT00733811|Deferoxamine|deferoxamine|mesh-list
6519769|NCT00733811|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6519770|NCT00733811|Chelating Agents|chelating agents|mesh-ancestor
6519771|NCT00733811|Sequestering Agents|sequestering agents|mesh-ancestor
6519772|NCT00733811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519773|NCT00733811|Siderophores|siderophores|mesh-ancestor
6519774|NCT00733850|Gemcitabine|gemcitabine|mesh-list
6519775|NCT00733850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6519776|NCT00733850|Antimetabolites|antimetabolites|mesh-ancestor
6685020|NCT01631396|Autonomic Agents|autonomic agents|mesh-ancestor
6685021|NCT01631396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6685022|NCT01631409|Aspirin|aspirin|mesh-list
6519777|NCT00733850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519778|NCT00733850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6519779|NCT00733850|Antiviral Agents|antiviral agents|mesh-ancestor
6685023|NCT01631409|Atenolol|atenolol|mesh-list
6685024|NCT01631409|Enalapril|enalapril|mesh-list
6685025|NCT01631409|Enalaprilat|enalaprilat|mesh-list
6685026|NCT01631409|Amlodipine|amlodipine|mesh-list
6685027|NCT01631409|Isosorbide|isosorbide|mesh-list
6519780|NCT00733850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6519781|NCT00733850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6519782|NCT00733850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6519783|NCT00733850|Immunologic Factors|immunologic factors|mesh-ancestor
6519784|NCT00733850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519785|NCT00733889|Docetaxel|docetaxel|mesh-list
6519786|NCT00733889|Fluorouracil|fluorouracil|mesh-list
6519787|NCT00733889|Cetuximab|cetuximab|mesh-list
6519788|NCT00733889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6519789|NCT00733889|Tubulin Modulators|tubulin modulators|mesh-ancestor
6519790|NCT00733889|Antimitotic Agents|antimitotic agents|mesh-ancestor
6519791|NCT00733889|Mitosis Modulators|mitosis modulators|mesh-ancestor
6519792|NCT00733889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685028|NCT01631409|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
6685029|NCT01631409|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
6685030|NCT01631409|Nitroglycerin|nitroglycerin|mesh-list
6685031|NCT01631409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6519793|NCT00733889|Antimetabolites|antimetabolites|mesh-ancestor
6519794|NCT00733889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6519795|NCT00733889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6519796|NCT00733889|Immunologic Factors|immunologic factors|mesh-ancestor
6519797|NCT00733889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519798|NCT00733889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6519799|NCT00733967|Varenicline|varenicline|mesh-list
6685032|NCT01631409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6685033|NCT01631409|Analgesics|analgesics|mesh-ancestor
6685034|NCT01631409|Sensory System Agents|sensory system agents|mesh-ancestor
6685035|NCT01631409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6685036|NCT01631409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685037|NCT01631409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6685038|NCT01631409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6685039|NCT01631409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6685040|NCT01631409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6685041|NCT01631409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685042|NCT01631409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6685043|NCT01631409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6685044|NCT01631409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6685045|NCT01631409|Antipyretics|antipyretics|mesh-ancestor
6685046|NCT01631409|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6519800|NCT00733967|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6519801|NCT00733967|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6519802|NCT00733967|Cholinergic Agents|cholinergic agents|mesh-ancestor
6519803|NCT00733967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6519804|NCT00733967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519805|NCT00733967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685047|NCT01631409|Protease Inhibitors|protease inhibitors|mesh-ancestor
6685048|NCT01631409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6685049|NCT01631409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6685050|NCT01631409|Sympatholytics|sympatholytics|mesh-ancestor
6685051|NCT01631409|Autonomic Agents|autonomic agents|mesh-ancestor
6685052|NCT01631409|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6685053|NCT01631409|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6685054|NCT01631409|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6685055|NCT01631409|Adrenergic Agents|adrenergic agents|mesh-ancestor
6685056|NCT01631409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6519806|NCT00734123|Aspirin|aspirin|mesh-list
6519807|NCT00734123|Rimonabant|rimonabant|mesh-list
6685057|NCT01631409|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6685058|NCT01631409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6519808|NCT00734123|Enalapril|enalapril|mesh-list
6519809|NCT00734123|Clopidogrel|clopidogrel|mesh-list
6519810|NCT00734123|Atorvastatin|atorvastatin|mesh-list
6685059|NCT01631409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6685060|NCT01631409|Vasodilator Agents|vasodilator agents|mesh-ancestor
6685061|NCT01631409|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6685062|NCT01631409|Diuretics|diuretics|mesh-ancestor
6685063|NCT01631409|Natriuretic Agents|natriuretic agents|mesh-ancestor
6685064|NCT01631409|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6685065|NCT01631448|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6685066|NCT01631448|Hemostatics|hemostatics|mesh-ancestor
6685067|NCT01631448|Coagulants|coagulants|mesh-ancestor
6685068|NCT01631513|Tapentadol|tapentadol|mesh-list
6685069|NCT01631513|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6685070|NCT01631513|Narcotics|narcotics|mesh-ancestor
6685071|NCT01631513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6685072|NCT01631513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685073|NCT01631513|Analgesics|analgesics|mesh-ancestor
6685074|NCT01631513|Sensory System Agents|sensory system agents|mesh-ancestor
6685075|NCT01631513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6685076|NCT01631513|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6685077|NCT01631513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6685078|NCT01631513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6685079|NCT01631513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685080|NCT01631513|Adrenergic Agents|adrenergic agents|mesh-ancestor
6685081|NCT01631513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6685082|NCT01631526|Vitamin D|vitamin d|mesh-list
6685083|NCT01631526|Vitamins|vitamins|mesh-ancestor
6685084|NCT01631526|Micronutrients|micronutrients|mesh-ancestor
6685085|NCT01631526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685086|NCT01631526|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6685087|NCT01631539|Irinotecan|irinotecan|mesh-list
6685088|NCT01631539|Cetuximab|cetuximab|mesh-list
6685089|NCT01631539|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6685090|NCT01631539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6685091|NCT01631539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6685092|NCT01631539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685093|NCT01631539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6685094|NCT01631539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6685095|NCT01631604|Botulinum Toxins|botulinum toxins|mesh-list
6519811|NCT00734123|Simvastatin|simvastatin|mesh-list
6519812|NCT00734123|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6519813|NCT00734123|Diuretics|diuretics|mesh-list
6519814|NCT00734123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6519815|NCT00734123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6519816|NCT00734123|Analgesics|analgesics|mesh-ancestor
6519817|NCT00734123|Sensory System Agents|sensory system agents|mesh-ancestor
6519818|NCT00734123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6685096|NCT01631604|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6685097|NCT01631604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6685098|NCT01631604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685099|NCT01631604|Cholinergic Agents|cholinergic agents|mesh-ancestor
6685100|NCT01631604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6685101|NCT01631604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685102|NCT01631669|Celecoxib|celecoxib|mesh-list
6685103|NCT01631669|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6685104|NCT01631669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6685105|NCT01631669|Analgesics|analgesics|mesh-ancestor
6685106|NCT01631669|Sensory System Agents|sensory system agents|mesh-ancestor
6685107|NCT01631669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6685108|NCT01631669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685109|NCT01631669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6685110|NCT01631669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6685111|NCT01631669|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6685112|NCT01631669|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6519819|NCT00734123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519820|NCT00734123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6519821|NCT00734123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6519822|NCT00734123|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6519823|NCT00734123|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6685113|NCT01631669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6685114|NCT01631669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685115|NCT01631838|Tocotrienols|tocotrienols|mesh-list
6685116|NCT01631838|Vitamin E|vitamin e|mesh-list
6685117|NCT01631838|Tocopherols|tocopherols|mesh-list
6685118|NCT01631838|Tocovid|tocovid|mesh-list
6685119|NCT01631838|Antioxidants|antioxidants|mesh-ancestor
6685120|NCT01631838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685121|NCT01631838|Protective Agents|protective agents|mesh-ancestor
6685122|NCT01631838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685123|NCT01631838|Vitamins|vitamins|mesh-ancestor
6685124|NCT01631838|Micronutrients|micronutrients|mesh-ancestor
6685125|NCT01631877|Enoxaparin|enoxaparin|mesh-list
6519824|NCT00734123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519825|NCT00734123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6685126|NCT01631877|Acenocoumarol|acenocoumarol|mesh-list
6685127|NCT01631877|Anticoagulants|anticoagulants|mesh-ancestor
6685128|NCT01631877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6685129|NCT01631877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6685130|NCT01631877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685131|NCT01631968|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6685132|NCT01631968|Colistin|colistin|mesh-list
6685133|NCT01631968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6685134|NCT01631994|Metoclopramide|metoclopramide|mesh-list
6685135|NCT01631994|Antiemetics|antiemetics|mesh-ancestor
6685136|NCT01631994|Autonomic Agents|autonomic agents|mesh-ancestor
6519826|NCT00734123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6519827|NCT00734123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6519828|NCT00734123|Antipyretics|antipyretics|mesh-ancestor
6519829|NCT00734123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6519830|NCT00734123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6519831|NCT00734123|Antimetabolites|antimetabolites|mesh-ancestor
6519832|NCT00734123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6519833|NCT00734123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6519834|NCT00734123|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6519835|NCT00734123|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6519836|NCT00734123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6519837|NCT00734123|Purinergic Agents|purinergic agents|mesh-ancestor
6519838|NCT00734123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6519839|NCT00734123|Protease Inhibitors|protease inhibitors|mesh-ancestor
6519840|NCT00734123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6519841|NCT00734123|Natriuretic Agents|natriuretic agents|mesh-ancestor
6519842|NCT00734123|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6519843|NCT00734123|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
6519844|NCT00734123|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6519845|NCT00734123|Hormones|hormones|mesh-ancestor
6519846|NCT00734123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6685137|NCT01631994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6685138|NCT01631994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685139|NCT01631994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6685140|NCT01631994|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6685141|NCT01631994|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6685142|NCT01631994|Dopamine Agents|dopamine agents|mesh-ancestor
6685143|NCT01631994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6685144|NCT01631994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685145|NCT01632007|Alogliptin|alogliptin|mesh-list
6685146|NCT01632007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6685147|NCT01632007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685148|NCT01632007|Incretins|incretins|mesh-ancestor
6685149|NCT01632007|Hormones|hormones|mesh-ancestor
6685150|NCT01632007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6685151|NCT01632007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6685152|NCT01632007|Protease Inhibitors|protease inhibitors|mesh-ancestor
6685153|NCT01632007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6685154|NCT01632007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685155|NCT01632046|Dialysis Solutions|dialysis solutions|mesh-list
6685156|NCT01632046|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6685157|NCT01632163|Lixisenatide|lixisenatide|mesh-list
6685158|NCT01632163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6685159|NCT01632163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685160|NCT01632189|Varenicline|varenicline|mesh-list
6685161|NCT01632189|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6685162|NCT01632189|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6519847|NCT00734279|Leuprolide|leuprolide|mesh-list
6519848|NCT00734279|Ganirelix|ganirelix|mesh-list
6519849|NCT00734279|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6685163|NCT01632189|Cholinergic Agents|cholinergic agents|mesh-ancestor
6685164|NCT01632189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6685165|NCT01632189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685166|NCT01632189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685167|NCT01632371|Paclitaxel|paclitaxel|mesh-list
6685168|NCT01632371|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6685169|NCT01632371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6685170|NCT01632371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6685171|NCT01632371|Tubulin Modulators|tubulin modulators|mesh-ancestor
6685172|NCT01632371|Antimitotic Agents|antimitotic agents|mesh-ancestor
6685173|NCT01632371|Mitosis Modulators|mitosis modulators|mesh-ancestor
6685174|NCT01632371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685175|NCT01632436|Pixantrone|pixantrone|mesh-list
6685176|NCT01632436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6685177|NCT01632436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6685178|NCT01632436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6685179|NCT01632436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685180|NCT01632436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6685181|NCT01632514|Cholecalciferol|cholecalciferol|mesh-list
6685182|NCT01632514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6685183|NCT01632514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685184|NCT01632514|Vitamins|vitamins|mesh-ancestor
6685185|NCT01632514|Micronutrients|micronutrients|mesh-ancestor
6685186|NCT01632514|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6519850|NCT00734279|Fertility Agents|fertility agents|mesh-ancestor
6519851|NCT00734279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6519852|NCT00734279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519853|NCT00734279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6519854|NCT00734279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6519855|NCT00734279|Hormone Antagonists|hormone antagonists|mesh-ancestor
6519856|NCT00734279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6519857|NCT00734318|Fluticasone|fluticasone|mesh-list
6519858|NCT00734318|Xhance|xhance|mesh-list
6519859|NCT00734318|Formoterol Fumarate|formoterol fumarate|mesh-list
6519860|NCT00734318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6519861|NCT00734318|Autonomic Agents|autonomic agents|mesh-ancestor
6685187|NCT01632540|Beclomethasone|beclomethasone|mesh-list
6519862|NCT00734318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6519863|NCT00734318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519864|NCT00734318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6519865|NCT00734318|Respiratory System Agents|respiratory system agents|mesh-ancestor
6519866|NCT00734318|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6519867|NCT00734318|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6519868|NCT00734318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6519869|NCT00734318|Adrenergic Agents|adrenergic agents|mesh-ancestor
6519870|NCT00734318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6519871|NCT00734318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519872|NCT00734318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6519873|NCT00734318|Dermatologic Agents|dermatologic agents|mesh-ancestor
6519874|NCT00734318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6519875|NCT00734383|Propofol|propofol|mesh-list
6519876|NCT00734383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6519877|NCT00734383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6519878|NCT00734383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519879|NCT00734383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6519880|NCT00734383|Anesthetics, General|anesthetics, general|mesh-ancestor
6519881|NCT00734383|Anesthetics|anesthetics|mesh-ancestor
6519882|NCT00734448|Inositol|inositol|mesh-list
6519883|NCT00734448|Vitamin B Complex|vitamin b complex|mesh-ancestor
6519884|NCT00734448|Vitamins|vitamins|mesh-ancestor
6519885|NCT00734448|Micronutrients|micronutrients|mesh-ancestor
6519886|NCT00734448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519887|NCT00734526|Temozolomide|temozolomide|mesh-list
6519888|NCT00734526|Sorafenib|sorafenib|mesh-list
6519889|NCT00734526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6519890|NCT00734526|Alkylating Agents|alkylating agents|mesh-ancestor
6519891|NCT00734526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519892|NCT00734526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6519893|NCT00734526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6685188|NCT01632540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6685189|NCT01632540|Glucocorticoids|glucocorticoids|mesh-ancestor
6685190|NCT01632540|Hormones|hormones|mesh-ancestor
6685191|NCT01632540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6685192|NCT01632540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685193|NCT01632540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6685194|NCT01632540|Respiratory System Agents|respiratory system agents|mesh-ancestor
6685195|NCT01632592|Tesamorelin|tesamorelin|mesh-list
6519894|NCT00734526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6519895|NCT00734669|Glyburide|glyburide|mesh-list
6519896|NCT00734669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6519897|NCT00734669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519898|NCT00734682|Irinotecan|irinotecan|mesh-list
6519899|NCT00734682|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6519900|NCT00734682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6519901|NCT00734682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6519902|NCT00734682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519903|NCT00734682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6519904|NCT00734695|Vitamins|vitamins|mesh-list
6685196|NCT01632592|Growth Substances|growth substances|mesh-ancestor
6685197|NCT01632592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685198|NCT01632605|Sirolimus|sirolimus|mesh-list
6685199|NCT01632605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6685200|NCT01632605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6685201|NCT01632605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6685202|NCT01632605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6685203|NCT01632605|Antifungal Agents|antifungal agents|mesh-ancestor
6685204|NCT01632605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6685205|NCT01632605|Immunologic Factors|immunologic factors|mesh-ancestor
6519905|NCT00734695|Ascorbic Acid|ascorbic acid|mesh-list
6519906|NCT00734695|Micronutrients|micronutrients|mesh-ancestor
6519907|NCT00734695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519908|NCT00734695|Antioxidants|antioxidants|mesh-ancestor
6519909|NCT00734695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519910|NCT00734695|Protective Agents|protective agents|mesh-ancestor
6519911|NCT00734773|Cytarabine|cytarabine|mesh-list
6519912|NCT00734773|Rituximab|rituximab|mesh-list
6519913|NCT00734773|Methotrexate|methotrexate|mesh-list
6519914|NCT00734773|Vincristine|vincristine|mesh-list
6519915|NCT00734773|Procarbazine|procarbazine|mesh-list
6685206|NCT01632605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685207|NCT01632657|Sumatriptan|sumatriptan|mesh-list
6519916|NCT00734773|Motexafin gadolinium|motexafin gadolinium|mesh-list
6519917|NCT00734773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6519918|NCT00734773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6519919|NCT00734773|Immunologic Factors|immunologic factors|mesh-ancestor
6519920|NCT00734773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519921|NCT00734773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6519922|NCT00734773|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6519923|NCT00734773|Abortifacient Agents|abortifacient agents|mesh-ancestor
6519924|NCT00734773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6519925|NCT00734773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6519926|NCT00734773|Antimetabolites|antimetabolites|mesh-ancestor
6519927|NCT00734773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519928|NCT00734773|Dermatologic Agents|dermatologic agents|mesh-ancestor
6685208|NCT01632657|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6685209|NCT01632657|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6685210|NCT01632657|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6685211|NCT01632657|Serotonin Agents|serotonin agents|mesh-ancestor
6519929|NCT00734773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6519930|NCT00734773|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6519931|NCT00734773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6519932|NCT00734773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6519933|NCT00734773|Antiviral Agents|antiviral agents|mesh-ancestor
6519934|NCT00734773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6519935|NCT00734773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6519936|NCT00734773|Tubulin Modulators|tubulin modulators|mesh-ancestor
6519937|NCT00734773|Antimitotic Agents|antimitotic agents|mesh-ancestor
6519938|NCT00734773|Mitosis Modulators|mitosis modulators|mesh-ancestor
6519939|NCT00734773|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6519940|NCT00734864|Anticonvulsants|anticonvulsants|mesh-list
6519941|NCT00734877|Thalidomide|thalidomide|mesh-list
6519942|NCT00734877|Dexamethasone|dexamethasone|mesh-list
6519943|NCT00734877|Dexamethasone acetate|dexamethasone acetate|mesh-list
6519944|NCT00734877|Cyclophosphamide|cyclophosphamide|mesh-list
6519945|NCT00734877|Melphalan|melphalan|mesh-list
6519946|NCT00734877|Cisplatin|cisplatin|mesh-list
6519947|NCT00734877|Etoposide|etoposide|mesh-list
6519948|NCT00734877|Etoposide phosphate|etoposide phosphate|mesh-list
6519949|NCT00734877|Doxorubicin|doxorubicin|mesh-list
6519950|NCT00734877|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6519951|NCT00734877|Bortezomib|bortezomib|mesh-list
6519952|NCT00734877|BB 1101|bb 1101|mesh-list
6519953|NCT00734877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6519954|NCT00734877|Immunologic Factors|immunologic factors|mesh-ancestor
6519955|NCT00734877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519956|NCT00734877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6519957|NCT00734877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6519958|NCT00734877|Alkylating Agents|alkylating agents|mesh-ancestor
6519959|NCT00734877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6519960|NCT00734877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6519961|NCT00734877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6519962|NCT00734877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6519963|NCT00734877|Antiemetics|antiemetics|mesh-ancestor
6519964|NCT00734877|Autonomic Agents|autonomic agents|mesh-ancestor
6685212|NCT01632657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6685213|NCT01632657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685214|NCT01632657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685215|NCT01632722|Bevacizumab|bevacizumab|mesh-list
6685216|NCT01632722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6519965|NCT00734877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6519966|NCT00734877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6519967|NCT00734877|Glucocorticoids|glucocorticoids|mesh-ancestor
6519968|NCT00734877|Hormones|hormones|mesh-ancestor
6519969|NCT00734877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6519970|NCT00734877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6519971|NCT00734877|Protease Inhibitors|protease inhibitors|mesh-ancestor
6519972|NCT00734877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6519973|NCT00734877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6519974|NCT00734877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6685217|NCT01632722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6685218|NCT01632722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6685219|NCT01632722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6685220|NCT01632722|Growth Substances|growth substances|mesh-ancestor
6685221|NCT01632722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685222|NCT01632722|Growth Inhibitors|growth inhibitors|mesh-ancestor
6685223|NCT01632761|Vitamin D|vitamin d|mesh-list
6685224|NCT01632761|Ergocalciferols|ergocalciferols|mesh-list
6685225|NCT01632761|Cholecalciferol|cholecalciferol|mesh-list
6685226|NCT01632761|Vitamins|vitamins|mesh-list
6685227|NCT01632761|Micronutrients|micronutrients|mesh-ancestor
6519975|NCT00734877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6519976|NCT00734877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6519977|NCT00734877|Leprostatic Agents|leprostatic agents|mesh-ancestor
6519978|NCT00734877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6519979|NCT00734877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6519980|NCT00734877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6519981|NCT00734877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6685228|NCT01632761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685229|NCT01632761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6685230|NCT01632761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6685231|NCT01632826|Pomalidomide|pomalidomide|mesh-list
6685232|NCT01632826|Immunologic Factors|immunologic factors|mesh-ancestor
6685233|NCT01632826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685234|NCT01632826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6685235|NCT01632826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6685236|NCT01632826|Growth Substances|growth substances|mesh-ancestor
6685237|NCT01632826|Growth Inhibitors|growth inhibitors|mesh-ancestor
6685238|NCT01632826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6685239|NCT01633086|Nitric Oxide|nitric oxide|mesh-list
6519982|NCT00734877|Growth Substances|growth substances|mesh-ancestor
6519983|NCT00734877|Growth Inhibitors|growth inhibitors|mesh-ancestor
6519984|NCT00734890|Bevacizumab|bevacizumab|mesh-list
6685240|NCT01633086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6685241|NCT01633086|Autonomic Agents|autonomic agents|mesh-ancestor
6685242|NCT01633086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6685243|NCT01633086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685244|NCT01633086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6685245|NCT01633086|Respiratory System Agents|respiratory system agents|mesh-ancestor
6685246|NCT01633086|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6685247|NCT01633086|Antioxidants|antioxidants|mesh-ancestor
6685248|NCT01633086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685249|NCT01633086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6685250|NCT01633086|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6685251|NCT01633086|Vasodilator Agents|vasodilator agents|mesh-ancestor
6685252|NCT01633086|Gasotransmitters|gasotransmitters|mesh-ancestor
6685253|NCT01633086|Protective Agents|protective agents|mesh-ancestor
6685254|NCT01633099|Decitabine|decitabine|mesh-list
6685255|NCT01633099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6685256|NCT01633099|Antimetabolites|antimetabolites|mesh-ancestor
6685257|NCT01633099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685258|NCT01633099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6685259|NCT01633099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780172|NCT02182375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780173|NCT02182401|Tolbutamide|tolbutamide|mesh-list
6780174|NCT02182401|Midazolam|midazolam|mesh-list
6780175|NCT02182401|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6519985|NCT00734890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6519986|NCT00734890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6519987|NCT00734890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6519988|NCT00734890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6519989|NCT00734890|Growth Substances|growth substances|mesh-ancestor
6519990|NCT00734890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519991|NCT00734890|Growth Inhibitors|growth inhibitors|mesh-ancestor
6519992|NCT00734916|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6519993|NCT00734916|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6519994|NCT00734916|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6519995|NCT00734916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6519996|NCT00735020|Vaccines|vaccines|mesh-list
6519997|NCT00735020|Immunologic Factors|immunologic factors|mesh-ancestor
6519998|NCT00735020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6519999|NCT00735124|Gabapentin|gabapentin|mesh-list
6520000|NCT00735124|Analgesics|analgesics|mesh-ancestor
6520001|NCT00735124|Sensory System Agents|sensory system agents|mesh-ancestor
6520002|NCT00735124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6520003|NCT00735124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6520004|NCT00735124|Anticonvulsants|anticonvulsants|mesh-ancestor
6520005|NCT00735124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6520006|NCT00735124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6520007|NCT00735124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6520008|NCT00735124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6520009|NCT00735124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6520010|NCT00735124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6520011|NCT00735124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6520012|NCT00735124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520013|NCT00735124|Antimanic Agents|antimanic agents|mesh-ancestor
6520014|NCT00735228|Pancrelipase|pancrelipase|mesh-list
6520015|NCT00735228|Pancreatin|pancreatin|mesh-list
6520016|NCT00735228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6520017|NCT00735241|Leucovorin|leucovorin|mesh-list
6520018|NCT00735241|Folic Acid|folic acid|mesh-list
6520019|NCT00735241|Bevacizumab|bevacizumab|mesh-list
6520020|NCT00735241|Fluorouracil|fluorouracil|mesh-list
6520021|NCT00735241|Oxaliplatin|oxaliplatin|mesh-list
6780176|NCT02182401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6780177|NCT02182401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6780178|NCT02182401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780179|NCT02182401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6780180|NCT02182401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6780181|NCT02182401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6780182|NCT02182401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6780183|NCT02182401|Anesthetics, General|anesthetics, general|mesh-ancestor
6780184|NCT02182401|Anesthetics|anesthetics|mesh-ancestor
6520022|NCT00735241|Levoleucovorin|levoleucovorin|mesh-list
6520023|NCT00735241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6520024|NCT00735241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6520025|NCT00735241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6520026|NCT00735241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6780185|NCT02182401|GABA Modulators|gaba modulators|mesh-ancestor
6520027|NCT00735241|Growth Substances|growth substances|mesh-ancestor
6520028|NCT00735241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6520029|NCT00735241|Growth Inhibitors|growth inhibitors|mesh-ancestor
6520030|NCT00735241|Antimetabolites|antimetabolites|mesh-ancestor
6520031|NCT00735241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520032|NCT00735241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6520033|NCT00735241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6520034|NCT00735241|Immunologic Factors|immunologic factors|mesh-ancestor
6520035|NCT00735241|Antidotes|antidotes|mesh-ancestor
6520036|NCT00735241|Protective Agents|protective agents|mesh-ancestor
6520037|NCT00735241|Vitamin B Complex|vitamin b complex|mesh-ancestor
6520038|NCT00735241|Vitamins|vitamins|mesh-ancestor
6520039|NCT00735241|Micronutrients|micronutrients|mesh-ancestor
6520040|NCT00735241|Hematinics|hematinics|mesh-ancestor
6520041|NCT00735280|Heparin|heparin|mesh-list
6685260|NCT01633177|Vitamin D|vitamin d|mesh-list
6685261|NCT01633177|Ergocalciferols|ergocalciferols|mesh-list
6685262|NCT01633177|Cholecalciferol|cholecalciferol|mesh-list
6685263|NCT01633177|Vitamins|vitamins|mesh-list
6685264|NCT01633177|Micronutrients|micronutrients|mesh-ancestor
6685265|NCT01633177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685266|NCT01633177|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6685267|NCT01633177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6520042|NCT00735280|Calcium heparin|calcium heparin|mesh-list
6520043|NCT00735280|Anticoagulants|anticoagulants|mesh-ancestor
6520044|NCT00735280|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6520045|NCT00735280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6520046|NCT00735280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520047|NCT00735345|Docetaxel|docetaxel|mesh-list
6520048|NCT00735345|Cetuximab|cetuximab|mesh-list
6520049|NCT00735345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6520050|NCT00735345|Tubulin Modulators|tubulin modulators|mesh-ancestor
6520051|NCT00735345|Antimitotic Agents|antimitotic agents|mesh-ancestor
6520052|NCT00735345|Mitosis Modulators|mitosis modulators|mesh-ancestor
6520053|NCT00735345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520054|NCT00735345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6685268|NCT01633203|Capecitabine|capecitabine|mesh-list
6685269|NCT01633203|Epirubicin|epirubicin|mesh-list
6685270|NCT01633203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6685271|NCT01633203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6685272|NCT01633203|Antimetabolites|antimetabolites|mesh-ancestor
6685273|NCT01633203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685274|NCT01633203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6685275|NCT01633203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6685276|NCT01633203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6685277|NCT01633203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6685278|NCT01633294|Gentamicins|gentamicins|mesh-list
6685279|NCT01633294|Ampicillin|ampicillin|mesh-list
6685280|NCT01633294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6685281|NCT01633294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6685282|NCT01633294|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6520055|NCT00735501|Insulin Detemir|insulin detemir|mesh-list
6520056|NCT00735501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6520057|NCT00735501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6520058|NCT00735527|Lorazepam|lorazepam|mesh-list
6520059|NCT00735527|Anticonvulsants|anticonvulsants|mesh-ancestor
6520060|NCT00735527|Antiemetics|antiemetics|mesh-ancestor
6520061|NCT00735527|Autonomic Agents|autonomic agents|mesh-ancestor
6520062|NCT00735527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6520063|NCT00735527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6520064|NCT00735527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6520065|NCT00735527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6520066|NCT00735527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6520067|NCT00735527|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6520068|NCT00735527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6520069|NCT00735527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6520070|NCT00735527|GABA Modulators|gaba modulators|mesh-ancestor
6520071|NCT00735527|GABA Agents|gaba agents|mesh-ancestor
6685283|NCT01633294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6685284|NCT01633294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685285|NCT01633359|Atorvastatin|atorvastatin|mesh-list
6685286|NCT01633359|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
6685287|NCT01633359|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6685288|NCT01633359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6685289|NCT01633359|Antimetabolites|antimetabolites|mesh-ancestor
6685290|NCT01633359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520072|NCT00735527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6685291|NCT01633359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6685292|NCT01633359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6685293|NCT01633450|Zinc|zinc|mesh-list
6685294|NCT01633450|Trace Elements|trace elements|mesh-ancestor
6685295|NCT01633450|Micronutrients|micronutrients|mesh-ancestor
6520073|NCT00735527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520074|NCT00735748|Tramadol|tramadol|mesh-list
6520075|NCT00735748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6520076|NCT00735748|Narcotics|narcotics|mesh-ancestor
6520077|NCT00735748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6520078|NCT00735748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6520079|NCT00735748|Analgesics|analgesics|mesh-ancestor
6520080|NCT00735748|Sensory System Agents|sensory system agents|mesh-ancestor
6520081|NCT00735748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6520082|NCT00735761|Acyclovir|acyclovir|mesh-list
6520083|NCT00735761|Hydrocortisone|hydrocortisone|mesh-list
6520084|NCT00735761|Antiviral Agents|antiviral agents|mesh-ancestor
6685296|NCT01633450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685297|NCT01633476|Valacyclovir|valacyclovir|mesh-list
6685298|NCT01633476|Antiviral Agents|antiviral agents|mesh-ancestor
6685299|NCT01633476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6520085|NCT00735761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6520086|NCT00735761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6520087|NCT00735813|Heparin|heparin|mesh-list
6520088|NCT00735813|Anticoagulants|anticoagulants|mesh-ancestor
6520089|NCT00735813|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6520090|NCT00735813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6520091|NCT00735813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520092|NCT00735852|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6520093|NCT00735852|Luteolytic Agents|luteolytic agents|mesh-ancestor
6520094|NCT00735852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6520095|NCT00735852|Contraceptive Agents|contraceptive agents|mesh-ancestor
6520096|NCT00735852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6520097|NCT00735852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6520098|NCT00735852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6520099|NCT00735852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6520100|NCT00735852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6520101|NCT00735930|Lenalidomide|lenalidomide|mesh-list
6520102|NCT00735930|Alvocidib|alvocidib|mesh-list
6520103|NCT00735930|Immunologic Factors|immunologic factors|mesh-ancestor
6520104|NCT00735930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6520105|NCT00735930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6520106|NCT00735930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6520107|NCT00735930|Growth Substances|growth substances|mesh-ancestor
6520108|NCT00735930|Growth Inhibitors|growth inhibitors|mesh-ancestor
6520109|NCT00735930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6520110|NCT00735930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6520111|NCT00735930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6520112|NCT00735930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520113|NCT00736021|Citalopram|citalopram|mesh-list
6520114|NCT00736021|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6520115|NCT00736021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6520116|NCT00736021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6520117|NCT00736021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520118|NCT00736021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6520119|NCT00736021|Serotonin Agents|serotonin agents|mesh-ancestor
6520120|NCT00736021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6520121|NCT00736021|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6520122|NCT00736021|Antidepressive Agents|antidepressive agents|mesh-ancestor
6520123|NCT00736021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6520124|NCT00736164|Selenium|selenium|mesh-list
6520125|NCT00736164|Antioxidants|antioxidants|mesh-ancestor
6520126|NCT00736164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520127|NCT00736164|Protective Agents|protective agents|mesh-ancestor
6520128|NCT00736164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6520129|NCT00736164|Trace Elements|trace elements|mesh-ancestor
6520130|NCT00736164|Micronutrients|micronutrients|mesh-ancestor
6520131|NCT00736294|Ramipril|ramipril|mesh-list
6520132|NCT00736294|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6520133|NCT00736294|Protease Inhibitors|protease inhibitors|mesh-ancestor
6520134|NCT00736294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6520135|NCT00736294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520136|NCT00736294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6685300|NCT01633593|Donepezil|donepezil|mesh-list
6685301|NCT01633593|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6520137|NCT00736320|Vincristine|vincristine|mesh-list
6520138|NCT00736320|Doxorubicin|doxorubicin|mesh-list
6520139|NCT00736320|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6520140|NCT00736320|Dacarbazine|dacarbazine|mesh-list
6520141|NCT00736320|Bleomycin|bleomycin|mesh-list
6520142|NCT00736320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6520143|NCT00736320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6520144|NCT00736320|Tubulin Modulators|tubulin modulators|mesh-ancestor
6520145|NCT00736320|Antimitotic Agents|antimitotic agents|mesh-ancestor
6520146|NCT00736320|Mitosis Modulators|mitosis modulators|mesh-ancestor
6520147|NCT00736320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520148|NCT00736320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6520149|NCT00736320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6520150|NCT00736320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6520151|NCT00736320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6520152|NCT00736320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6520153|NCT00736320|Alkylating Agents|alkylating agents|mesh-ancestor
6520154|NCT00736346|Paroxetine|paroxetine|mesh-list
6520155|NCT00736346|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6520156|NCT00736346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6520157|NCT00736346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6520158|NCT00736346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520159|NCT00736346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6520160|NCT00736346|Serotonin Agents|serotonin agents|mesh-ancestor
6520161|NCT00736346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6520162|NCT00736346|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6520163|NCT00736346|Antidepressive Agents|antidepressive agents|mesh-ancestor
6520164|NCT00736346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6520165|NCT00736346|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6520166|NCT00736346|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6520167|NCT00736346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6685302|NCT01633593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6685303|NCT01633593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685304|NCT01633593|Cholinergic Agents|cholinergic agents|mesh-ancestor
6685305|NCT01633593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6685306|NCT01633593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685307|NCT01633593|Nootropic Agents|nootropic agents|mesh-ancestor
6685308|NCT01633645|Gemcitabine|gemcitabine|mesh-list
6685309|NCT01633645|Bortezomib|bortezomib|mesh-list
6685310|NCT01633645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6520168|NCT00736463|Atorvastatin|atorvastatin|mesh-list
6520169|NCT00736463|Simvastatin|simvastatin|mesh-list
6520170|NCT00736463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6685311|NCT01633645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6685312|NCT01633645|Antimetabolites|antimetabolites|mesh-ancestor
6685313|NCT01633645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685314|NCT01633645|Antiviral Agents|antiviral agents|mesh-ancestor
6685315|NCT01633645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6685316|NCT01633645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6685317|NCT01633645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6685318|NCT01633645|Immunologic Factors|immunologic factors|mesh-ancestor
6685319|NCT01633645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685320|NCT01633658|Cholecalciferol|cholecalciferol|mesh-list
6685321|NCT01633658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6685322|NCT01633658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685323|NCT01633658|Vitamins|vitamins|mesh-ancestor
6685324|NCT01633658|Micronutrients|micronutrients|mesh-ancestor
6685325|NCT01633658|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6685326|NCT01633749|Vaccines|vaccines|mesh-list
6685327|NCT01633749|Immunologic Factors|immunologic factors|mesh-ancestor
6685328|NCT01633749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685329|NCT01633762|Vancomycin|vancomycin|mesh-list
6685330|NCT01633762|Gentamicins|gentamicins|mesh-list
6685331|NCT01633762|Meropenem|meropenem|mesh-list
6685332|NCT01633762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6685333|NCT01633762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6520171|NCT00736463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6520172|NCT00736463|Antimetabolites|antimetabolites|mesh-ancestor
6520173|NCT00736463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520174|NCT00736463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6520175|NCT00736463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6520176|NCT00736463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6520177|NCT00736515|Insulin|insulin|mesh-list
6685334|NCT01633762|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6685335|NCT01633762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6520178|NCT00736515|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6520179|NCT00736515|Insulin Glargine|insulin glargine|mesh-list
6520180|NCT00736515|Gliclazide|gliclazide|mesh-list
6520181|NCT00736515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6520182|NCT00736515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6520183|NCT00736541|Acetylcysteine|acetylcysteine|mesh-list
6520184|NCT00736541|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6520185|NCT00736541|Cystatins|cystatins|mesh-list
6520186|NCT00736541|Antiviral Agents|antiviral agents|mesh-ancestor
6520187|NCT00736541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6685336|NCT01633762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520188|NCT00736541|Expectorants|expectorants|mesh-ancestor
6520189|NCT00736541|Respiratory System Agents|respiratory system agents|mesh-ancestor
6520190|NCT00736541|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6520191|NCT00736541|Antioxidants|antioxidants|mesh-ancestor
6520192|NCT00736541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520193|NCT00736541|Protective Agents|protective agents|mesh-ancestor
6520194|NCT00736541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6520195|NCT00736541|Antidotes|antidotes|mesh-ancestor
6520196|NCT00736541|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
6520197|NCT00736541|Protease Inhibitors|protease inhibitors|mesh-ancestor
6520198|NCT00736541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6520199|NCT00736606|Simvastatin|simvastatin|mesh-list
6520200|NCT00736606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6520201|NCT00736606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6520202|NCT00736606|Antimetabolites|antimetabolites|mesh-ancestor
6520203|NCT00736606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520204|NCT00736606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6520205|NCT00736606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6520206|NCT00736606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6520207|NCT00736619|Paclitaxel|paclitaxel|mesh-list
6520208|NCT00736619|Cetuximab|cetuximab|mesh-list
6520209|NCT00736619|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6520210|NCT00736619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6520211|NCT00736619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6520212|NCT00736619|Tubulin Modulators|tubulin modulators|mesh-ancestor
6520213|NCT00736619|Antimitotic Agents|antimitotic agents|mesh-ancestor
6520214|NCT00736619|Mitosis Modulators|mitosis modulators|mesh-ancestor
6520215|NCT00736619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520216|NCT00736619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6520217|NCT00736697|Moxidectin|moxidectin|mesh-list
6520218|NCT00736697|Anthelmintics|anthelmintics|mesh-ancestor
6520219|NCT00736697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6520220|NCT00736697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6520221|NCT00736697|Antinematodal Agents|antinematodal agents|mesh-ancestor
6520222|NCT00736801|Fluticasone|fluticasone|mesh-list
6520223|NCT00736801|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6520224|NCT00736801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6520225|NCT00736801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6520226|NCT00736801|Autonomic Agents|autonomic agents|mesh-ancestor
6520227|NCT00736801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6520228|NCT00736801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6520229|NCT00736801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6520230|NCT00736801|Respiratory System Agents|respiratory system agents|mesh-ancestor
6685337|NCT01633957|Warfarin|warfarin|mesh-list
6685338|NCT01633957|Anticoagulants|anticoagulants|mesh-ancestor
6685339|NCT01633970|Leucovorin|leucovorin|mesh-list
6685340|NCT01633970|Paclitaxel|paclitaxel|mesh-list
6685341|NCT01633970|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6685342|NCT01633970|Bevacizumab|bevacizumab|mesh-list
6685343|NCT01633970|Carboplatin|carboplatin|mesh-list
6685344|NCT01633970|Oxaliplatin|oxaliplatin|mesh-list
6685345|NCT01633970|Pemetrexed|pemetrexed|mesh-list
6685346|NCT01633970|Atezolizumab|atezolizumab|mesh-list
6685347|NCT01633970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6685348|NCT01633970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6685349|NCT01633970|Tubulin Modulators|tubulin modulators|mesh-ancestor
6685350|NCT01633970|Antimitotic Agents|antimitotic agents|mesh-ancestor
6685351|NCT01633970|Mitosis Modulators|mitosis modulators|mesh-ancestor
6685352|NCT01633970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685353|NCT01633970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6685354|NCT01633970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6685355|NCT01633970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6520231|NCT00736801|Dermatologic Agents|dermatologic agents|mesh-ancestor
6520232|NCT00736801|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6685356|NCT01633970|Growth Substances|growth substances|mesh-ancestor
6780186|NCT02182401|GABA Agents|gaba agents|mesh-ancestor
6520233|NCT00736801|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6520234|NCT00736801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6520235|NCT00736801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6520236|NCT00736801|Adrenergic Agents|adrenergic agents|mesh-ancestor
6520237|NCT00736801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6520238|NCT00736801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520239|NCT00736814|Gemcitabine|gemcitabine|mesh-list
6520240|NCT00736814|Carboplatin|carboplatin|mesh-list
6520241|NCT00736814|Docetaxel|docetaxel|mesh-list
6520242|NCT00736814|Vinorelbine|vinorelbine|mesh-list
6520243|NCT00736814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6520244|NCT00736814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6520245|NCT00736814|Antimetabolites|antimetabolites|mesh-ancestor
6520246|NCT00736814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520247|NCT00736814|Antiviral Agents|antiviral agents|mesh-ancestor
6520248|NCT00736814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6520249|NCT00736814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6520250|NCT00736814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6520251|NCT00736814|Immunologic Factors|immunologic factors|mesh-ancestor
6520252|NCT00736814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6520253|NCT00736814|Tubulin Modulators|tubulin modulators|mesh-ancestor
6520254|NCT00736814|Antimitotic Agents|antimitotic agents|mesh-ancestor
6520255|NCT00736814|Mitosis Modulators|mitosis modulators|mesh-ancestor
6520256|NCT00736814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6520257|NCT00736866|Acetylcysteine|acetylcysteine|mesh-list
6520258|NCT00736866|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6520259|NCT00736866|Antiviral Agents|antiviral agents|mesh-ancestor
6520260|NCT00736866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6520261|NCT00736866|Expectorants|expectorants|mesh-ancestor
6520262|NCT00736866|Respiratory System Agents|respiratory system agents|mesh-ancestor
6520263|NCT00736866|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6520264|NCT00736866|Antioxidants|antioxidants|mesh-ancestor
6520265|NCT00736866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520266|NCT00736866|Protective Agents|protective agents|mesh-ancestor
6520267|NCT00736866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6520268|NCT00736866|Antidotes|antidotes|mesh-ancestor
6520269|NCT00736905|Rilpivirine|rilpivirine|mesh-list
6520270|NCT00736905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6520271|NCT00736905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6520272|NCT00736905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6520273|NCT00736905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520274|NCT00736905|Antiviral Agents|antiviral agents|mesh-ancestor
6520275|NCT00736905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6520276|NCT00736905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6520277|NCT00736905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6520278|NCT00736931|Levetiracetam|levetiracetam|mesh-list
6520279|NCT00736931|Lorazepam|lorazepam|mesh-list
6520280|NCT00736931|Brivaracetam|brivaracetam|mesh-list
6520281|NCT00736931|Anticonvulsants|anticonvulsants|mesh-ancestor
6520282|NCT00736931|Nootropic Agents|nootropic agents|mesh-ancestor
6520283|NCT00736931|Antiemetics|antiemetics|mesh-ancestor
6520284|NCT00736931|Autonomic Agents|autonomic agents|mesh-ancestor
6520285|NCT00736931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6685357|NCT01633970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685358|NCT01633970|Growth Inhibitors|growth inhibitors|mesh-ancestor
6685359|NCT01633970|Antidotes|antidotes|mesh-ancestor
6685360|NCT01633970|Protective Agents|protective agents|mesh-ancestor
6685361|NCT01633970|Vitamin B Complex|vitamin b complex|mesh-ancestor
6685362|NCT01633970|Vitamins|vitamins|mesh-ancestor
6685363|NCT01633970|Micronutrients|micronutrients|mesh-ancestor
6685364|NCT01633970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6685365|NCT01633970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6685366|NCT01633970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6685367|NCT01633983|Methotrexate|methotrexate|mesh-list
6685368|NCT01633983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6685369|NCT01633983|Abortifacient Agents|abortifacient agents|mesh-ancestor
6685370|NCT01633983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6685371|NCT01633983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685372|NCT01633983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6685373|NCT01633983|Antimetabolites|antimetabolites|mesh-ancestor
6685374|NCT01633983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685375|NCT01633983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6685376|NCT01633983|Dermatologic Agents|dermatologic agents|mesh-ancestor
6685377|NCT01633983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6520286|NCT00736931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6520287|NCT00736931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6685378|NCT01633983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6685379|NCT01633983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6685380|NCT01633983|Immunologic Factors|immunologic factors|mesh-ancestor
6685381|NCT01633983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6685382|NCT01633983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6685383|NCT01634061|Dactolisib|dactolisib|mesh-list
6685384|NCT01634061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6685385|NCT01634230|Phenylacetic acid|phenylacetic acid|mesh-list
6685386|NCT01634230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6685387|NCT01634230|Antimetabolites|antimetabolites|mesh-ancestor
6685388|NCT01634230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685389|NCT01634230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6685390|NCT01634295|Niacin|niacin|mesh-list
6685391|NCT01634295|Amlodipine|amlodipine|mesh-list
6520288|NCT00736931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6520289|NCT00736931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6520290|NCT00736931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6520291|NCT00736931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6520292|NCT00736931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6520293|NCT00736931|GABA Modulators|gaba modulators|mesh-ancestor
6520294|NCT00736931|GABA Agents|gaba agents|mesh-ancestor
6520295|NCT00736931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6520296|NCT00736931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520297|NCT00736970|Sirolimus|sirolimus|mesh-list
6520298|NCT00736970|Trastuzumab|trastuzumab|mesh-list
6520299|NCT00736970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6520300|NCT00736970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6520301|NCT00736970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6520302|NCT00736970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6520303|NCT00736970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6520304|NCT00736970|Antifungal Agents|antifungal agents|mesh-ancestor
6520305|NCT00736970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6520306|NCT00736970|Immunologic Factors|immunologic factors|mesh-ancestor
6520307|NCT00736970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6520308|NCT00736983|Ciprofloxacin|ciprofloxacin|mesh-list
6520309|NCT00736983|Adalimumab|adalimumab|mesh-list
6520310|NCT00736983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6520311|NCT00736983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6520312|NCT00736983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6520313|NCT00736983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6520314|NCT00736983|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6520315|NCT00736983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6520316|NCT00736983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6520317|NCT00736983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520318|NCT00736983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6685392|NCT01634295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6520319|NCT00736983|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6520320|NCT00736983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6520321|NCT00737113|Hormones|hormones|mesh-list
6520322|NCT00737113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6520323|NCT00737113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6520324|NCT00737126|Folic Acid|folic acid|mesh-list
6520325|NCT00737126|Hematinics|hematinics|mesh-ancestor
6520326|NCT00737126|Vitamin B Complex|vitamin b complex|mesh-ancestor
6685393|NCT01634295|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6685394|NCT01634295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6685395|NCT01634295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685396|NCT01634295|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6685397|NCT01634295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685398|NCT01634295|Vasodilator Agents|vasodilator agents|mesh-ancestor
6685399|NCT01634295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6685400|NCT01634295|Antimetabolites|antimetabolites|mesh-ancestor
6685401|NCT01634295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6685402|NCT01634295|Vitamin B Complex|vitamin b complex|mesh-ancestor
6685403|NCT01634295|Vitamins|vitamins|mesh-ancestor
6685404|NCT01634295|Micronutrients|micronutrients|mesh-ancestor
6685405|NCT01634321|Leuprolide|leuprolide|mesh-list
6685406|NCT01634321|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6685407|NCT01634321|Fertility Agents|fertility agents|mesh-ancestor
6685408|NCT01634321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6685409|NCT01634321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685410|NCT01634321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6685411|NCT01634321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6520327|NCT00737126|Vitamins|vitamins|mesh-ancestor
6520328|NCT00737126|Micronutrients|micronutrients|mesh-ancestor
6520329|NCT00737126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6520330|NCT00737139|Epinephrine|epinephrine|mesh-list
6520331|NCT00737139|Bupivacaine|bupivacaine|mesh-list
6520332|NCT00737139|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6520333|NCT00737139|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6520334|NCT00737139|Adrenergic Agents|adrenergic agents|mesh-ancestor
6520335|NCT00737139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6520336|NCT00737139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520337|NCT00737139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6520338|NCT00737139|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6520339|NCT00737139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6685412|NCT01634347|Propranolol|propranolol|mesh-list
6685413|NCT01634347|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6685414|NCT01634347|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6685415|NCT01634347|Adrenergic Agents|adrenergic agents|mesh-ancestor
6685416|NCT01634347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6685417|NCT01634347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685418|NCT01634347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685419|NCT01634347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6685420|NCT01634347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6685421|NCT01634347|Vasodilator Agents|vasodilator agents|mesh-ancestor
6685422|NCT01634373|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6685423|NCT01634373|Antidepressive Agents|antidepressive agents|mesh-ancestor
6685424|NCT01634373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6685425|NCT01634373|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6685426|NCT01634373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6685427|NCT01634373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6685428|NCT01634373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685429|NCT01634386|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6685430|NCT01634386|Antidepressive Agents|antidepressive agents|mesh-ancestor
6520340|NCT00737139|Autonomic Agents|autonomic agents|mesh-ancestor
6520341|NCT00737139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6520342|NCT00737139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6520343|NCT00737139|Respiratory System Agents|respiratory system agents|mesh-ancestor
6520344|NCT00737139|Mydriatics|mydriatics|mesh-ancestor
6520345|NCT00737139|Sympathomimetics|sympathomimetics|mesh-ancestor
6520346|NCT00737139|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6520347|NCT00737139|Anesthetics, Local|anesthetics, local|mesh-ancestor
6520348|NCT00737139|Anesthetics|anesthetics|mesh-ancestor
6520349|NCT00737139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6520350|NCT00737139|Sensory System Agents|sensory system agents|mesh-ancestor
6520351|NCT00737191|Olanzapine|olanzapine|mesh-list
6520352|NCT00737191|Antiemetics|antiemetics|mesh-ancestor
6520353|NCT00737191|Autonomic Agents|autonomic agents|mesh-ancestor
6520354|NCT00737191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6685431|NCT01634386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6685432|NCT01634386|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6685433|NCT01634386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6685434|NCT01634386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6685435|NCT01634386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685436|NCT01634399|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6685437|NCT01634399|Antidepressive Agents|antidepressive agents|mesh-ancestor
6685438|NCT01634399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6685439|NCT01634399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6685440|NCT01634399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6520355|NCT00737191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6520356|NCT00737191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6520357|NCT00737191|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6520358|NCT00737191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6520359|NCT00737191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6520360|NCT00737191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6520361|NCT00737191|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6520362|NCT00737191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6520363|NCT00737191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6520364|NCT00737191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520365|NCT00737191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6520366|NCT00737191|Serotonin Agents|serotonin agents|mesh-ancestor
6520367|NCT00737256|Aripiprazole|aripiprazole|mesh-list
6520368|NCT00737256|Perphenazine|perphenazine|mesh-list
6520369|NCT00737256|Antidepressive Agents|antidepressive agents|mesh-ancestor
6520370|NCT00737256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6685441|NCT01634399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6685442|NCT01634399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685443|NCT01634412|Amitriptyline|amitriptyline|mesh-list
6685444|NCT01634412|Cyclobenzaprine|cyclobenzaprine|mesh-list
6685445|NCT01634412|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6685446|NCT01634412|Antidepressive Agents|antidepressive agents|mesh-ancestor
6685447|NCT01634412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6685448|NCT01634412|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6685449|NCT01634412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685450|NCT01634412|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6520371|NCT00737256|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6520372|NCT00737256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6520373|NCT00737256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6520374|NCT00737256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6520375|NCT00737256|Dopamine Agonists|dopamine agonists|mesh-ancestor
6520376|NCT00737256|Dopamine Agents|dopamine agents|mesh-ancestor
6685451|NCT01634412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6685452|NCT01634412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6685453|NCT01634412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6520377|NCT00737256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6520378|NCT00737256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520379|NCT00737256|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6520380|NCT00737256|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6520381|NCT00737256|Serotonin Agents|serotonin agents|mesh-ancestor
6520382|NCT00737256|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6520383|NCT00737256|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6520384|NCT00737256|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6520385|NCT00737256|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6520386|NCT00737373|Leucovorin|leucovorin|mesh-list
6520387|NCT00737373|Folic Acid|folic acid|mesh-list
6520388|NCT00737373|Docetaxel|docetaxel|mesh-list
6520389|NCT00737373|Fluorouracil|fluorouracil|mesh-list
6520390|NCT00737373|Oxaliplatin|oxaliplatin|mesh-list
6520391|NCT00737373|Levoleucovorin|levoleucovorin|mesh-list
6520392|NCT00737373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6520393|NCT00737373|Tubulin Modulators|tubulin modulators|mesh-ancestor
6520394|NCT00737373|Antimitotic Agents|antimitotic agents|mesh-ancestor
6520395|NCT00737373|Mitosis Modulators|mitosis modulators|mesh-ancestor
6520396|NCT00737373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520397|NCT00737373|Antimetabolites|antimetabolites|mesh-ancestor
6520398|NCT00737373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6520399|NCT00737373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6520400|NCT00737373|Immunologic Factors|immunologic factors|mesh-ancestor
6520401|NCT00737373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6520402|NCT00737373|Antidotes|antidotes|mesh-ancestor
6520403|NCT00737373|Protective Agents|protective agents|mesh-ancestor
6520404|NCT00737373|Vitamin B Complex|vitamin b complex|mesh-ancestor
6685454|NCT01634412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6685455|NCT01634412|Analgesics|analgesics|mesh-ancestor
6520405|NCT00737373|Vitamins|vitamins|mesh-ancestor
6520406|NCT00737373|Micronutrients|micronutrients|mesh-ancestor
6520407|NCT00737373|Hematinics|hematinics|mesh-ancestor
6520408|NCT00737542|Lidocaine|lidocaine|mesh-list
6520409|NCT00737542|Anesthetics, Local|anesthetics, local|mesh-ancestor
6520410|NCT00737542|Anesthetics|anesthetics|mesh-ancestor
6520411|NCT00737542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6520412|NCT00737542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6520413|NCT00737542|Sensory System Agents|sensory system agents|mesh-ancestor
6520414|NCT00737542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6520415|NCT00737542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6520416|NCT00737542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6520417|NCT00737542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6520418|NCT00737542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6520419|NCT00737542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520420|NCT00737555|Tosedostat|tosedostat|mesh-list
6520421|NCT00737555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6520422|NCT00737555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520423|NCT00737659|Mycophenolic Acid|mycophenolic acid|mesh-list
6520424|NCT00737659|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6520425|NCT00737659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6520426|NCT00737659|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6520427|NCT00737659|Antitubercular Agents|antitubercular agents|mesh-ancestor
6520428|NCT00737659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6520429|NCT00737659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6520430|NCT00737659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6520431|NCT00737659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520432|NCT00737685|Cyclophosphamide|cyclophosphamide|mesh-list
6520433|NCT00737685|Fludarabine|fludarabine|mesh-list
6520434|NCT00737685|Thymoglobulin|thymoglobulin|mesh-list
6520435|NCT00737685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6520436|NCT00737685|Immunologic Factors|immunologic factors|mesh-ancestor
6520437|NCT00737685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6520438|NCT00737685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6520439|NCT00737685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6520440|NCT00737685|Alkylating Agents|alkylating agents|mesh-ancestor
6520441|NCT00737685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520442|NCT00737685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6520443|NCT00737685|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6520444|NCT00737724|Efavirenz|efavirenz|mesh-list
6520445|NCT00737724|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6520446|NCT00737724|Isoniazid|isoniazid|mesh-list
6520447|NCT00737724|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6685456|NCT01634412|Sensory System Agents|sensory system agents|mesh-ancestor
6685457|NCT01634412|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6685458|NCT01634412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6685459|NCT01634412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6685460|NCT01634412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520448|NCT00737724|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6520449|NCT00737724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6520450|NCT00737724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520451|NCT00737724|Antiviral Agents|antiviral agents|mesh-ancestor
6520452|NCT00737724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6520453|NCT00737724|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6520454|NCT00737724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6520455|NCT00737724|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6520456|NCT00737724|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6520457|NCT00737724|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6520458|NCT00737724|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6520459|NCT00737724|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6520460|NCT00737724|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6520461|NCT00737724|Antitubercular Agents|antitubercular agents|mesh-ancestor
6520462|NCT00737724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6520463|NCT00737724|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6520464|NCT00737724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6520465|NCT00737724|Antimetabolites|antimetabolites|mesh-ancestor
6520466|NCT00737724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6520467|NCT00737776|Insulin Aspart|insulin aspart|mesh-list
6520468|NCT00737776|Biphasic Insulins|biphasic insulins|mesh-list
6520469|NCT00737776|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6520470|NCT00737776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6520471|NCT00737776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685461|NCT01634412|Adrenergic Agents|adrenergic agents|mesh-ancestor
6685462|NCT01634412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6685463|NCT01634438|Heparin|heparin|mesh-list
6685464|NCT01634438|Calcium heparin|calcium heparin|mesh-list
6520472|NCT00737789|Mesalamine|mesalamine|mesh-list
6520473|NCT00737789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6520474|NCT00737789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6520475|NCT00737789|Analgesics|analgesics|mesh-ancestor
6520476|NCT00737789|Sensory System Agents|sensory system agents|mesh-ancestor
6520477|NCT00737789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6520478|NCT00737789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6520479|NCT00737789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6520480|NCT00737789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6520481|NCT00737815|Magnesium citrate|magnesium citrate|mesh-list
6520482|NCT00737815|Cathartics|cathartics|mesh-ancestor
6520483|NCT00737815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6520484|NCT00737867|Gemcitabine|gemcitabine|mesh-list
6685465|NCT01634438|Anticoagulants|anticoagulants|mesh-ancestor
6685466|NCT01634438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6685467|NCT01634438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6685468|NCT01634438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685469|NCT01634594|Nicardipine|nicardipine|mesh-list
6685470|NCT01634594|Dexmedetomidine|dexmedetomidine|mesh-list
6685471|NCT01634594|Remifentanil|remifentanil|mesh-list
6685472|NCT01634594|Sevoflurane|sevoflurane|mesh-list
6685473|NCT01634594|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6685474|NCT01634594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6685475|NCT01634594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685476|NCT01634594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6685477|NCT01634594|Analgesics|analgesics|mesh-ancestor
6685478|NCT01634594|Sensory System Agents|sensory system agents|mesh-ancestor
6685479|NCT01634594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6685480|NCT01634594|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6685481|NCT01634594|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6685482|NCT01634594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6685483|NCT01634594|Adrenergic Agents|adrenergic agents|mesh-ancestor
6685484|NCT01634594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6685485|NCT01634594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685486|NCT01634594|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6685487|NCT01634594|Narcotics|narcotics|mesh-ancestor
6685488|NCT01634594|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6685489|NCT01634594|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6685490|NCT01634594|Anesthetics, General|anesthetics, general|mesh-ancestor
6685491|NCT01634594|Anesthetics|anesthetics|mesh-ancestor
6685492|NCT01634594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6685493|NCT01634594|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6685494|NCT01634594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6685495|NCT01634594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6685496|NCT01634594|Vasodilator Agents|vasodilator agents|mesh-ancestor
6685497|NCT01634685|Capecitabine|capecitabine|mesh-list
6685498|NCT01634685|Bavituximab|bavituximab|mesh-list
6685499|NCT01634685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6685500|NCT01634685|Antimetabolites|antimetabolites|mesh-ancestor
6685501|NCT01634685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685502|NCT01634685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6685503|NCT01634685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6685504|NCT01634698|Vitamin A|vitamin a|mesh-list
6685505|NCT01634698|Retinol palmitate|retinol palmitate|mesh-list
6685506|NCT01634698|Vitamins|vitamins|mesh-ancestor
6685507|NCT01634698|Micronutrients|micronutrients|mesh-ancestor
6685508|NCT01634698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685509|NCT01634698|Antioxidants|antioxidants|mesh-ancestor
6685510|NCT01634698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685511|NCT01634698|Protective Agents|protective agents|mesh-ancestor
6685512|NCT01634698|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6685513|NCT01634698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6520485|NCT00737867|Carboplatin|carboplatin|mesh-list
6520486|NCT00737867|Vinorelbine|vinorelbine|mesh-list
6520487|NCT00737867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6520488|NCT00737867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6520489|NCT00737867|Antimetabolites|antimetabolites|mesh-ancestor
6520490|NCT00737867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520491|NCT00737867|Antiviral Agents|antiviral agents|mesh-ancestor
6520492|NCT00737867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6520493|NCT00737867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6685514|NCT01634763|Ceritinib|ceritinib|mesh-list
6685515|NCT01634763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6520494|NCT00737867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6520495|NCT00737867|Immunologic Factors|immunologic factors|mesh-ancestor
6520496|NCT00737867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6520497|NCT00737867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6520498|NCT00737867|Tubulin Modulators|tubulin modulators|mesh-ancestor
6520499|NCT00737867|Antimitotic Agents|antimitotic agents|mesh-ancestor
6520500|NCT00737867|Mitosis Modulators|mitosis modulators|mesh-ancestor
6520501|NCT00737880|Pancrelipase|pancrelipase|mesh-list
6520502|NCT00737880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6520503|NCT00737971|Triamcinolone|triamcinolone|mesh-list
6520504|NCT00737971|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6520505|NCT00737971|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6520506|NCT00737971|Bevacizumab|bevacizumab|mesh-list
6520507|NCT00737971|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6520508|NCT00737971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6520509|NCT00737971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6520510|NCT00737971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6520511|NCT00737971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6520512|NCT00737971|Growth Substances|growth substances|mesh-ancestor
6520513|NCT00737971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6520514|NCT00737971|Growth Inhibitors|growth inhibitors|mesh-ancestor
6520515|NCT00737971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6520516|NCT00737971|Glucocorticoids|glucocorticoids|mesh-ancestor
6520517|NCT00737971|Hormones|hormones|mesh-ancestor
6520518|NCT00737971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6520519|NCT00737971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6520520|NCT00737971|Immunologic Factors|immunologic factors|mesh-ancestor
6520521|NCT00737971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6520522|NCT00737971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520523|NCT00737997|Morphine|morphine|mesh-list
6520524|NCT00737997|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6520525|NCT00737997|Narcotics|narcotics|mesh-ancestor
6520526|NCT00737997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6520527|NCT00737997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6520528|NCT00737997|Analgesics|analgesics|mesh-ancestor
6520529|NCT00737997|Sensory System Agents|sensory system agents|mesh-ancestor
6520530|NCT00737997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6520531|NCT00738088|Gliclazide|gliclazide|mesh-list
6520532|NCT00738088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6520533|NCT00738088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6520534|NCT00738153|Insulin Detemir|insulin detemir|mesh-list
6520535|NCT00738153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6520536|NCT00738153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685516|NCT01634763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6685517|NCT01634763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6685518|NCT01634763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685519|NCT01634789|Bazedoxifene|bazedoxifene|mesh-list
6685520|NCT01634789|Estrogens|estrogens|mesh-list
6685521|NCT01634789|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6685522|NCT01634789|Hormones|hormones|mesh-ancestor
6685523|NCT01634789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6685524|NCT01634789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685525|NCT01634789|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6685526|NCT01634789|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6685527|NCT01634789|Hormone Antagonists|hormone antagonists|mesh-ancestor
6685528|NCT01634789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6780187|NCT02182401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6780188|NCT02182401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780189|NCT02182401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6780190|NCT02182453|Empagliflozin|empagliflozin|mesh-list
6780191|NCT02182453|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6780192|NCT02182453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780193|NCT02182453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6780194|NCT02182453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780195|NCT02182479|Fenoterol|fenoterol|mesh-list
6780196|NCT02182479|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
6780197|NCT02182479|Ipratropium|ipratropium|mesh-list
6780198|NCT02182479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6780199|NCT02182479|Autonomic Agents|autonomic agents|mesh-ancestor
6780200|NCT02182479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6780201|NCT02182479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780202|NCT02182479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6780203|NCT02182479|Respiratory System Agents|respiratory system agents|mesh-ancestor
6780204|NCT02182479|Sympathomimetics|sympathomimetics|mesh-ancestor
6520537|NCT00738192|Fentanyl|fentanyl|mesh-list
6520538|NCT00738192|Sufentanil|sufentanil|mesh-list
6520539|NCT00738192|Dsuvia|dsuvia|mesh-list
6520540|NCT00738192|Butorphanol|butorphanol|mesh-list
6520541|NCT00738192|Citric Acid|citric acid|mesh-list
6520542|NCT00738192|Sodium Citrate|sodium citrate|mesh-list
6520543|NCT00738192|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6520544|NCT00738192|Narcotics|narcotics|mesh-ancestor
6520545|NCT00738192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6520546|NCT00738192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685529|NCT01634880|Panitumumab|panitumumab|mesh-list
6685530|NCT01634880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6685531|NCT01634880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6685532|NCT01634893|Hydroxychloroquine|hydroxychloroquine|mesh-list
6685533|NCT01634893|Sorafenib|sorafenib|mesh-list
6685534|NCT01634893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6685535|NCT01634893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6685536|NCT01634893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6685537|NCT01634893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520547|NCT00738192|Analgesics|analgesics|mesh-ancestor
6520548|NCT00738192|Sensory System Agents|sensory system agents|mesh-ancestor
6520549|NCT00738192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6685538|NCT01634893|Antimalarials|antimalarials|mesh-ancestor
6685539|NCT01634893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6685540|NCT01634893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6685541|NCT01634893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6685542|NCT01634893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6685543|NCT01634906|Atorvastatin|atorvastatin|mesh-list
6685544|NCT01634906|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6685545|NCT01634906|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6685546|NCT01634906|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6685547|NCT01634906|Antimetabolites|antimetabolites|mesh-ancestor
6520550|NCT00738192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6520551|NCT00738192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6520552|NCT00738192|Anesthetics, General|anesthetics, general|mesh-ancestor
6520553|NCT00738192|Anesthetics|anesthetics|mesh-ancestor
6520554|NCT00738192|Anticoagulants|anticoagulants|mesh-ancestor
6520555|NCT00738192|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6520556|NCT00738192|Chelating Agents|chelating agents|mesh-ancestor
6520557|NCT00738192|Sequestering Agents|sequestering agents|mesh-ancestor
6685548|NCT01634906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685549|NCT01634906|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6685550|NCT01634906|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6685551|NCT01634906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6685552|NCT01634932|Iron|iron|mesh-list
6685553|NCT01634932|Trace Elements|trace elements|mesh-ancestor
6685554|NCT01634932|Micronutrients|micronutrients|mesh-ancestor
6685555|NCT01634932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685556|NCT01634945|Amodiaquine|amodiaquine|mesh-list
6685557|NCT01634945|Antimalarials|antimalarials|mesh-ancestor
6685558|NCT01634945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6685559|NCT01634945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6685560|NCT01634945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6685561|NCT01634958|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6685562|NCT01634958|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6685563|NCT01634958|Immunologic Factors|immunologic factors|mesh-ancestor
6685564|NCT01634958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685565|NCT01634958|Antacids|antacids|mesh-ancestor
6520558|NCT00738192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520559|NCT00738192|Antitussive Agents|antitussive agents|mesh-ancestor
6520560|NCT00738192|Respiratory System Agents|respiratory system agents|mesh-ancestor
6520561|NCT00738192|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6520562|NCT00738257|Pamidronate|pamidronate|mesh-list
6520563|NCT00738257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6520564|NCT00738257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6520565|NCT00738296|Simvastatin|simvastatin|mesh-list
6520566|NCT00738296|Ezetimibe|ezetimibe|mesh-list
6685566|NCT01634958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685567|NCT01634958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6685568|NCT01635088|Mometasone Furoate|mometasone furoate|mesh-list
6685569|NCT01635088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6685570|NCT01635088|Dermatologic Agents|dermatologic agents|mesh-ancestor
6685571|NCT01635088|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6520567|NCT00738296|Pravastatin|pravastatin|mesh-list
6520568|NCT00738296|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6520569|NCT00738296|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6685572|NCT01635114|Resveratrol|resveratrol|mesh-list
6685573|NCT01635114|Antioxidants|antioxidants|mesh-ancestor
6685574|NCT01635114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520570|NCT00738296|Antimetabolites|antimetabolites|mesh-ancestor
6520571|NCT00738296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520572|NCT00738296|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6520573|NCT00738296|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6520574|NCT00738296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6520575|NCT00738335|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6520576|NCT00738335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6520577|NCT00738335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6520578|NCT00738335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6520579|NCT00738335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685575|NCT01635114|Protective Agents|protective agents|mesh-ancestor
6685576|NCT01635114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685577|NCT01635114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6520580|NCT00738413|Deferasirox|deferasirox|mesh-list
6520581|NCT00738413|Deferoxamine|deferoxamine|mesh-list
6520582|NCT00738413|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6520583|NCT00738413|Chelating Agents|chelating agents|mesh-ancestor
6520584|NCT00738413|Sequestering Agents|sequestering agents|mesh-ancestor
6520585|NCT00738413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520586|NCT00738413|Siderophores|siderophores|mesh-ancestor
6520587|NCT00738452|Antibodies|antibodies|mesh-list
6520588|NCT00738452|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6685578|NCT01635114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6685579|NCT01635205|Anesthetics|anesthetics|mesh-list
6685580|NCT01635205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6685581|NCT01635205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685582|NCT01635296|Cytarabine|cytarabine|mesh-list
6685583|NCT01635296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6685584|NCT01635296|Antimetabolites|antimetabolites|mesh-ancestor
6685585|NCT01635296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685586|NCT01635296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6685587|NCT01635296|Antiviral Agents|antiviral agents|mesh-ancestor
6685588|NCT01635296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6685589|NCT01635296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6685590|NCT01635296|Immunologic Factors|immunologic factors|mesh-ancestor
6685591|NCT01635296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685592|NCT01635400|Irinotecan|irinotecan|mesh-list
6685593|NCT01635400|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6685594|NCT01635400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6685595|NCT01635400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6685596|NCT01635400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685597|NCT01635400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6685598|NCT01635426|Aspirin|aspirin|mesh-list
6685599|NCT01635426|Clopidogrel|clopidogrel|mesh-list
6685600|NCT01635426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6685601|NCT01635426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6685602|NCT01635426|Analgesics|analgesics|mesh-ancestor
6685603|NCT01635426|Sensory System Agents|sensory system agents|mesh-ancestor
6685604|NCT01635426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6685605|NCT01635426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685606|NCT01635426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6685607|NCT01635426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6520589|NCT00738452|Immunologic Factors|immunologic factors|mesh-ancestor
6520590|NCT00738452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6520591|NCT00738517|Immunoglobulins|immunoglobulins|mesh-list
6520592|NCT00738517|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6520593|NCT00738517|Antibodies|antibodies|mesh-list
6520594|NCT00738517|Immunologic Factors|immunologic factors|mesh-ancestor
6520595|NCT00738517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6520596|NCT00738556|Sirolimus|sirolimus|mesh-list
6520597|NCT00738556|Paclitaxel|paclitaxel|mesh-list
6520598|NCT00738556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6520599|NCT00738556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6520600|NCT00738556|Tubulin Modulators|tubulin modulators|mesh-ancestor
6520601|NCT00738556|Antimitotic Agents|antimitotic agents|mesh-ancestor
6520602|NCT00738556|Mitosis Modulators|mitosis modulators|mesh-ancestor
6520603|NCT00738556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520604|NCT00738556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6520605|NCT00738556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6685608|NCT01635426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6685609|NCT01635426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6685610|NCT01635426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685611|NCT01635426|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6520606|NCT00738556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6685612|NCT01635426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6685613|NCT01635426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6685614|NCT01635426|Antipyretics|antipyretics|mesh-ancestor
6685615|NCT01635426|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6685616|NCT01635426|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6685617|NCT01635426|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6520607|NCT00738556|Antifungal Agents|antifungal agents|mesh-ancestor
6520608|NCT00738556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6520609|NCT00738556|Immunologic Factors|immunologic factors|mesh-ancestor
6520610|NCT00738556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6520611|NCT00738569|Raltegravir Potassium|raltegravir potassium|mesh-list
6520612|NCT00738569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6520613|NCT00738569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6520614|NCT00738569|Antiviral Agents|antiviral agents|mesh-ancestor
6520615|NCT00738569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6520616|NCT00738569|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6520617|NCT00738569|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6520618|NCT00738569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6520619|NCT00738569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520620|NCT00738595|Nicotine|nicotine|mesh-list
6685618|NCT01635426|Purinergic Agents|purinergic agents|mesh-ancestor
6685619|NCT01635426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6685620|NCT01635530|Doxycycline|doxycycline|mesh-list
6685621|NCT01635530|Ceftriaxone|ceftriaxone|mesh-list
6685622|NCT01635530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6685623|NCT01635530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6685624|NCT01635530|Antimalarials|antimalarials|mesh-ancestor
6685625|NCT01635530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6685626|NCT01635530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6685627|NCT01635608|Acetaminophen|acetaminophen|mesh-list
6685628|NCT01635608|Amoxicillin|amoxicillin|mesh-list
6685629|NCT01635608|Talinolol|talinolol|mesh-list
6520621|NCT00738595|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6520622|NCT00738595|Autonomic Agents|autonomic agents|mesh-ancestor
6520623|NCT00738595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6520624|NCT00738595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6520625|NCT00738595|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6520626|NCT00738595|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6520627|NCT00738595|Cholinergic Agents|cholinergic agents|mesh-ancestor
6520628|NCT00738595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6520629|NCT00738595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520630|NCT00738621|Dexamethasone|dexamethasone|mesh-list
6520631|NCT00738621|Dexamethasone acetate|dexamethasone acetate|mesh-list
6685630|NCT01635608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6685631|NCT01635608|Analgesics|analgesics|mesh-ancestor
6685632|NCT01635608|Sensory System Agents|sensory system agents|mesh-ancestor
6685633|NCT01635608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6685634|NCT01635608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685635|NCT01635608|Antipyretics|antipyretics|mesh-ancestor
6685636|NCT01635608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6685637|NCT01635608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6685638|NCT01635608|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6685639|NCT01635608|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6685640|NCT01635608|Adrenergic Agents|adrenergic agents|mesh-ancestor
6685641|NCT01635608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6685642|NCT01635608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685643|NCT01635608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6685644|NCT01635608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6685645|NCT01635686|Etanercept|etanercept|mesh-list
6685646|NCT01635686|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6685647|NCT01635686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6685648|NCT01635686|Analgesics|analgesics|mesh-ancestor
6685649|NCT01635686|Sensory System Agents|sensory system agents|mesh-ancestor
6685650|NCT01635686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6685651|NCT01635686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685652|NCT01635686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6520632|NCT00738621|Ondansetron|ondansetron|mesh-list
6520633|NCT00738621|Aprepitant|aprepitant|mesh-list
6520634|NCT00738621|Fosaprepitant|fosaprepitant|mesh-list
6520635|NCT00738621|BB 1101|bb 1101|mesh-list
6520636|NCT00738621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6520637|NCT00738621|Antiemetics|antiemetics|mesh-ancestor
6520638|NCT00738621|Autonomic Agents|autonomic agents|mesh-ancestor
6520639|NCT00738621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6520640|NCT00738621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685653|NCT01635686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6685654|NCT01635686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6685655|NCT01635686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6520641|NCT00738621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6520642|NCT00738621|Glucocorticoids|glucocorticoids|mesh-ancestor
6520643|NCT00738621|Hormones|hormones|mesh-ancestor
6520644|NCT00738621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6520645|NCT00738621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6520646|NCT00738621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6520647|NCT00738621|Protease Inhibitors|protease inhibitors|mesh-ancestor
6520648|NCT00738621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6520649|NCT00738621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520650|NCT00738621|Antipruritics|antipruritics|mesh-ancestor
6520651|NCT00738621|Dermatologic Agents|dermatologic agents|mesh-ancestor
6520652|NCT00738621|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6520653|NCT00738621|Serotonin Agents|serotonin agents|mesh-ancestor
6520654|NCT00738621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6520655|NCT00738621|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6520656|NCT00738621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6520657|NCT00738621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6520658|NCT00738621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6520659|NCT00738621|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6520660|NCT00738621|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6520661|NCT00738660|Telmisartan|telmisartan|mesh-list
6520662|NCT00738660|Ramipril|ramipril|mesh-list
6520663|NCT00738660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6520664|NCT00738660|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6520665|NCT00738660|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6520666|NCT00738660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520667|NCT00738660|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6520668|NCT00738660|Protease Inhibitors|protease inhibitors|mesh-ancestor
6520669|NCT00738660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6520670|NCT00738751|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6520671|NCT00738751|Panobinostat|panobinostat|mesh-list
6520672|NCT00738751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
6520673|NCT00738751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6520674|NCT00738751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6520675|NCT00738751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6520676|NCT00738751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520677|NCT00738777|Tamoxifen|tamoxifen|mesh-list
6520678|NCT00738777|Fulvestrant|fulvestrant|mesh-list
6520679|NCT00738777|Anastrozole|anastrozole|mesh-list
6520680|NCT00738777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6520681|NCT00738777|Hormone Antagonists|hormone antagonists|mesh-ancestor
6520682|NCT00738777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6520683|NCT00738777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6520684|NCT00738777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6520685|NCT00738777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6520686|NCT00738777|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6685656|NCT01635686|Immunologic Factors|immunologic factors|mesh-ancestor
6685657|NCT01635751|Pregabalin|pregabalin|mesh-list
6685658|NCT01635751|Analgesics|analgesics|mesh-ancestor
6685659|NCT01635751|Sensory System Agents|sensory system agents|mesh-ancestor
6685660|NCT01635751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6685661|NCT01635751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685662|NCT01635751|Anticonvulsants|anticonvulsants|mesh-ancestor
6685663|NCT01635751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6685664|NCT01635751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6685665|NCT01635751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685666|NCT01635751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6685667|NCT01635751|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6685668|NCT01635751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6685669|NCT01635751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6520687|NCT00738777|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6520688|NCT00738777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6520689|NCT00738777|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6520690|NCT00738777|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6520691|NCT00738777|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6520692|NCT00738777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6520693|NCT00738777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520694|NCT00738829|Vidarabine|vidarabine|mesh-list
6520695|NCT00738829|Rituximab|rituximab|mesh-list
6520696|NCT00738829|Fludarabine|fludarabine|mesh-list
6520697|NCT00738829|Fludarabine phosphate|fludarabine phosphate|mesh-list
6520698|NCT00738829|Lenalidomide|lenalidomide|mesh-list
6520699|NCT00738829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6520700|NCT00738829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6520701|NCT00738829|Immunologic Factors|immunologic factors|mesh-ancestor
6520702|NCT00738829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6520703|NCT00738829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6520704|NCT00738829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6520705|NCT00738829|Antimetabolites|antimetabolites|mesh-ancestor
6520706|NCT00738829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685670|NCT01635751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6685671|NCT01635777|Miltefosine|miltefosine|mesh-list
6685672|NCT01635777|Antifungal Agents|antifungal agents|mesh-ancestor
6685673|NCT01635777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6685674|NCT01635777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6685675|NCT01635777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6685676|NCT01635777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6520707|NCT00738829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6520708|NCT00738829|Antiviral Agents|antiviral agents|mesh-ancestor
6520709|NCT00738829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6520710|NCT00738829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6520711|NCT00738829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6520712|NCT00738829|Growth Substances|growth substances|mesh-ancestor
6520713|NCT00738829|Growth Inhibitors|growth inhibitors|mesh-ancestor
6520714|NCT00738842|Ticagrelor|ticagrelor|mesh-list
6520715|NCT00738842|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6520716|NCT00738842|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6520717|NCT00738842|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6520718|NCT00738842|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6520719|NCT00738842|Purinergic Agents|purinergic agents|mesh-ancestor
6520720|NCT00738842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6520721|NCT00738842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520722|NCT00738842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6520723|NCT00738868|Cetuximab|cetuximab|mesh-list
6520724|NCT00738868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6685677|NCT01635790|Bevacizumab|bevacizumab|mesh-list
6685678|NCT01635790|Ranibizumab|ranibizumab|mesh-list
6685679|NCT01635790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6685680|NCT01635790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6685681|NCT01635790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6685682|NCT01635790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6685683|NCT01635790|Growth Substances|growth substances|mesh-ancestor
6685684|NCT01635790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685685|NCT01635790|Growth Inhibitors|growth inhibitors|mesh-ancestor
6685686|NCT01635803|Bevacizumab|bevacizumab|mesh-list
6520725|NCT00738868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6520726|NCT00738985|Simvastatin|simvastatin|mesh-list
6520727|NCT00738985|Ezetimibe|ezetimibe|mesh-list
6520728|NCT00738985|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
6520729|NCT00738985|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6520730|NCT00738985|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6520731|NCT00738985|Antimetabolites|antimetabolites|mesh-ancestor
6520732|NCT00738985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520733|NCT00738985|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6520734|NCT00738985|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6520735|NCT00738985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6520736|NCT00739128|Vaccines|vaccines|mesh-list
6520737|NCT00739128|Immunologic Factors|immunologic factors|mesh-ancestor
6520738|NCT00739128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6520739|NCT00739141|Cyclophosphamide|cyclophosphamide|mesh-list
6520740|NCT00739141|Thiotepa|thiotepa|mesh-list
6520741|NCT00739141|Fludarabine|fludarabine|mesh-list
6520742|NCT00739141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6520743|NCT00739141|Immunologic Factors|immunologic factors|mesh-ancestor
6520744|NCT00739141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6520745|NCT00739141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6520746|NCT00739141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6520747|NCT00739141|Alkylating Agents|alkylating agents|mesh-ancestor
6520748|NCT00739141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520749|NCT00739141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6520750|NCT00739141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6520751|NCT00739193|Amiodarone|amiodarone|mesh-list
6520752|NCT00739193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6520753|NCT00739193|Vasodilator Agents|vasodilator agents|mesh-ancestor
6520754|NCT00739193|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6520755|NCT00739193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6685687|NCT01635803|Ranibizumab|ranibizumab|mesh-list
6685688|NCT01635803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6685689|NCT01635803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6685690|NCT01635803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6685691|NCT01635803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6685692|NCT01635803|Growth Substances|growth substances|mesh-ancestor
6685693|NCT01635803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685694|NCT01635803|Growth Inhibitors|growth inhibitors|mesh-ancestor
6685695|NCT01635816|Vaccines|vaccines|mesh-list
6685696|NCT01635816|Immunologic Factors|immunologic factors|mesh-ancestor
6685697|NCT01635816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685698|NCT01635829|Carbamazepine|carbamazepine|mesh-list
6685699|NCT01635829|Phenytoin|phenytoin|mesh-list
6685700|NCT01635829|Anticonvulsants|anticonvulsants|mesh-ancestor
6685701|NCT01635829|Antimanic Agents|antimanic agents|mesh-ancestor
6685702|NCT01635829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6520756|NCT00739193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520757|NCT00739193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6520758|NCT00739193|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6520759|NCT00739193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6520760|NCT00739193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6520761|NCT00739193|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6520762|NCT00739193|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6685703|NCT01635829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6685704|NCT01635829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685705|NCT01635829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6520763|NCT00739193|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6520764|NCT00739388|Azacitidine|azacitidine|mesh-list
6520765|NCT00739388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6520766|NCT00739388|Antimetabolites|antimetabolites|mesh-ancestor
6520767|NCT00739388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520768|NCT00739388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6520769|NCT00739388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6520770|NCT00739414|Panobinostat|panobinostat|mesh-list
6520771|NCT00739414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6520772|NCT00739414|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6520773|NCT00739414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6520774|NCT00739414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520775|NCT00739453|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6520776|NCT00739453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6520777|NCT00739453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6520778|NCT00739453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6520779|NCT00739453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520780|NCT00739466|Alendronate|alendronate|mesh-list
6685706|NCT01635829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6685707|NCT01635829|Analgesics|analgesics|mesh-ancestor
6685708|NCT01635829|Sensory System Agents|sensory system agents|mesh-ancestor
6685709|NCT01635829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6685710|NCT01635829|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6685711|NCT01635829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6685712|NCT01635829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685713|NCT01635829|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6685714|NCT01635829|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6520781|NCT00739466|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6520782|NCT00739466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6520783|NCT00739505|Immunoglobulin G|immunoglobulin g|mesh-list
6520784|NCT00739505|Immunologic Factors|immunologic factors|mesh-ancestor
6520785|NCT00739505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6520786|NCT00739531|Nitric Oxide|nitric oxide|mesh-list
6520787|NCT00739531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6520788|NCT00739531|Autonomic Agents|autonomic agents|mesh-ancestor
6520789|NCT00739531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6520790|NCT00739531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6520791|NCT00739531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6520792|NCT00739531|Respiratory System Agents|respiratory system agents|mesh-ancestor
6520793|NCT00739531|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6520794|NCT00739531|Antioxidants|antioxidants|mesh-ancestor
6520795|NCT00739531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685715|NCT01635829|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6685716|NCT01635829|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6685717|NCT01635946|Isavuconazole|isavuconazole|mesh-list
6685718|NCT01635946|Atorvastatin|atorvastatin|mesh-list
6685719|NCT01635946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6520796|NCT00739531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6520797|NCT00739531|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6520798|NCT00739531|Vasodilator Agents|vasodilator agents|mesh-ancestor
6520799|NCT00739531|Gasotransmitters|gasotransmitters|mesh-ancestor
6520800|NCT00739531|Protective Agents|protective agents|mesh-ancestor
6520801|NCT00739609|Tryptophan|tryptophan|mesh-list
6520802|NCT00739609|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6520803|NCT00739609|Antidepressive Agents|antidepressive agents|mesh-ancestor
6520804|NCT00739609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6520805|NCT00739622|Rilpivirine|rilpivirine|mesh-list
6520806|NCT00739622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6520807|NCT00739622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6685720|NCT01635946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6685721|NCT01635946|Antimetabolites|antimetabolites|mesh-ancestor
6685722|NCT01635946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685723|NCT01635946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6685724|NCT01635946|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6685725|NCT01635946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6685726|NCT01635946|Antifungal Agents|antifungal agents|mesh-ancestor
6520808|NCT00739622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6520809|NCT00739622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520810|NCT00739622|Antiviral Agents|antiviral agents|mesh-ancestor
6520811|NCT00739622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6520812|NCT00739622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6520813|NCT00739622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6520814|NCT00739830|Sirolimus|sirolimus|mesh-list
6520815|NCT00739830|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6520816|NCT00739830|Megestrol|megestrol|mesh-list
6520817|NCT00739830|Megestrol Acetate|megestrol acetate|mesh-list
6520818|NCT00739830|Medroxyprogesterone|medroxyprogesterone|mesh-list
6520819|NCT00739830|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6520820|NCT00739830|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6520821|NCT00739830|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6520822|NCT00739830|Contraceptive Agents|contraceptive agents|mesh-ancestor
6520823|NCT00739830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6520824|NCT00739830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6520825|NCT00739830|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6520826|NCT00739830|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6520827|NCT00739830|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6520828|NCT00739830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6520829|NCT00739830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6520830|NCT00739830|Appetite Stimulants|appetite stimulants|mesh-ancestor
6520831|NCT00739830|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6520832|NCT00739830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6520833|NCT00739830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6520834|NCT00739830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6520835|NCT00739830|Antifungal Agents|antifungal agents|mesh-ancestor
6520836|NCT00739830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6520837|NCT00739830|Immunologic Factors|immunologic factors|mesh-ancestor
6520838|NCT00739986|Semapimod|semapimod|mesh-list
6520839|NCT00739986|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6520840|NCT00739986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6520841|NCT00739986|Analgesics|analgesics|mesh-ancestor
6520842|NCT00739986|Sensory System Agents|sensory system agents|mesh-ancestor
6520843|NCT00739986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6520844|NCT00739986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685727|NCT01635946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6520845|NCT00739986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6520846|NCT00739986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6520847|NCT00739986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6520848|NCT00739986|Immunologic Factors|immunologic factors|mesh-ancestor
6685728|NCT01635972|Isavuconazole|isavuconazole|mesh-list
6685729|NCT01635972|Bupropion|bupropion|mesh-list
6685730|NCT01635972|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6685731|NCT01635972|Antidepressive Agents|antidepressive agents|mesh-ancestor
6685732|NCT01635972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6685733|NCT01635972|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6685734|NCT01635972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6685735|NCT01635972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6685736|NCT01635972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685737|NCT01635972|Dopamine Agents|dopamine agents|mesh-ancestor
6685738|NCT01635972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6685739|NCT01635972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780205|NCT02182479|Tocolytic Agents|tocolytic agents|mesh-ancestor
6520849|NCT00740064|Lamivudine|lamivudine|mesh-list
6520850|NCT00740064|Abacavir|abacavir|mesh-list
6520851|NCT00740064|Raltegravir Potassium|raltegravir potassium|mesh-list
6520852|NCT00740064|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6520853|NCT00740064|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6520854|NCT00740064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6520855|NCT00740064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520856|NCT00740064|Antiviral Agents|antiviral agents|mesh-ancestor
6520857|NCT00740064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6520858|NCT00740064|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6520859|NCT00740064|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6520860|NCT00740064|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6520861|NCT00740064|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6520862|NCT00740090|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6520863|NCT00740090|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6685740|NCT01635972|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6685741|NCT01635972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6685742|NCT01635972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6685743|NCT01635972|Antifungal Agents|antifungal agents|mesh-ancestor
6685744|NCT01635972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6685745|NCT01636037|Levodopa|levodopa|mesh-list
6685746|NCT01636037|Carbidopa|carbidopa|mesh-list
6685747|NCT01636037|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
6685748|NCT01636037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6685749|NCT01636037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6685750|NCT01636037|Dopamine Agents|dopamine agents|mesh-ancestor
6685751|NCT01636037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6520864|NCT00740090|Immunologic Factors|immunologic factors|mesh-ancestor
6520865|NCT00740090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6520866|NCT00740090|Antacids|antacids|mesh-ancestor
6520867|NCT00740090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520868|NCT00740090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6520869|NCT00740103|Semapimod|semapimod|mesh-list
6520870|NCT00740103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6520871|NCT00740103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6520872|NCT00740103|Analgesics|analgesics|mesh-ancestor
6520873|NCT00740103|Sensory System Agents|sensory system agents|mesh-ancestor
6520874|NCT00740103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6520875|NCT00740103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6520876|NCT00740103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6685752|NCT01636037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685753|NCT01636037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6520877|NCT00740103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6520878|NCT00740103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6520879|NCT00740103|Immunologic Factors|immunologic factors|mesh-ancestor
6520880|NCT00740116|Tranexamic Acid|tranexamic acid|mesh-list
6520881|NCT00740116|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6520882|NCT00740116|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6520883|NCT00740116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520884|NCT00740116|Hemostatics|hemostatics|mesh-ancestor
6520885|NCT00740116|Coagulants|coagulants|mesh-ancestor
6520886|NCT00740142|Lactulose|lactulose|mesh-list
6520887|NCT00740142|N-Methylaspartate|n-methylaspartate|mesh-list
6520888|NCT00740142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6520889|NCT00740142|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
6520890|NCT00740142|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6520891|NCT00740142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6520892|NCT00740142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520893|NCT00740142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6520894|NCT00740168|Bevacizumab|bevacizumab|mesh-list
6520895|NCT00740168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6520896|NCT00740168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6520897|NCT00740168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6520898|NCT00740168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6520899|NCT00740168|Growth Substances|growth substances|mesh-ancestor
6520900|NCT00740168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6520901|NCT00740168|Growth Inhibitors|growth inhibitors|mesh-ancestor
6520902|NCT00740194|Estradiol|estradiol|mesh-list
6520903|NCT00740194|Estrogens|estrogens|mesh-ancestor
6520904|NCT00740194|Hormones|hormones|mesh-ancestor
6520905|NCT00740194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6520906|NCT00740194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6520907|NCT00740259|Flunarizine|flunarizine|mesh-list
6520908|NCT00740259|Anticonvulsants|anticonvulsants|mesh-ancestor
6520909|NCT00740259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6685754|NCT01636037|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6685755|NCT01636037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6685756|NCT01636037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6685757|NCT01636037|Immunologic Factors|immunologic factors|mesh-ancestor
6520910|NCT00740259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6685758|NCT01636037|Dopamine Agonists|dopamine agonists|mesh-ancestor
6685759|NCT01636128|Eflornithine|eflornithine|mesh-list
6685760|NCT01636128|Sulindac|sulindac|mesh-list
6685761|NCT01636128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6685762|NCT01636128|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6685763|NCT01636128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6685764|NCT01636128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6685765|NCT01636128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6685766|NCT01636128|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
6685767|NCT01636128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6685768|NCT01636128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685769|NCT01636128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6685770|NCT01636128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6685771|NCT01636128|Analgesics|analgesics|mesh-ancestor
6685772|NCT01636128|Sensory System Agents|sensory system agents|mesh-ancestor
6685773|NCT01636128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6685774|NCT01636128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685775|NCT01636128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6685776|NCT01636128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6685777|NCT01636128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6685778|NCT01636141|Dapansutrile|dapansutrile|mesh-list
6685779|NCT01636141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6685780|NCT01636180|Clopidogrel|clopidogrel|mesh-list
6685781|NCT01636180|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6685782|NCT01636180|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6685783|NCT01636180|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6685784|NCT01636180|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6685785|NCT01636180|Purinergic Agents|purinergic agents|mesh-ancestor
6685786|NCT01636180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6685787|NCT01636180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685788|NCT01636180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685789|NCT01636245|Vaccines|vaccines|mesh-list
6685790|NCT01636245|Immunologic Factors|immunologic factors|mesh-ancestor
6685791|NCT01636245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685792|NCT01636271|Darapladib|darapladib|mesh-list
6685793|NCT01636271|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
6685794|NCT01636271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6685795|NCT01636271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685796|NCT01636310|Nicotine|nicotine|mesh-list
6685797|NCT01636310|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6685798|NCT01636310|Autonomic Agents|autonomic agents|mesh-ancestor
6685799|NCT01636310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6685800|NCT01636310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685801|NCT01636310|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6685802|NCT01636310|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6685803|NCT01636310|Cholinergic Agents|cholinergic agents|mesh-ancestor
6685804|NCT01636310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6685805|NCT01636310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685806|NCT01636323|Nicotine|nicotine|mesh-list
6685807|NCT01636323|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6685808|NCT01636323|Autonomic Agents|autonomic agents|mesh-ancestor
6685809|NCT01636323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6685810|NCT01636323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685811|NCT01636323|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6520911|NCT00740259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520912|NCT00740259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6520913|NCT00740259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6520914|NCT00740259|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6520915|NCT00740259|Histamine Antagonists|histamine antagonists|mesh-ancestor
6520916|NCT00740259|Histamine Agents|histamine agents|mesh-ancestor
6520917|NCT00740259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6520918|NCT00740259|Vasodilator Agents|vasodilator agents|mesh-ancestor
6520919|NCT00740285|Lidocaine|lidocaine|mesh-list
6520920|NCT00740285|Anesthetics, Local|anesthetics, local|mesh-ancestor
6520921|NCT00740285|Anesthetics|anesthetics|mesh-ancestor
6520922|NCT00740285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6520923|NCT00740285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6520924|NCT00740285|Sensory System Agents|sensory system agents|mesh-ancestor
6520925|NCT00740285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6520926|NCT00740285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6520927|NCT00740285|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6520928|NCT00740285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6520929|NCT00740285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6520930|NCT00740285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520931|NCT00740363|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6520932|NCT00740363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6520933|NCT00740363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6520934|NCT00740363|Incretins|incretins|mesh-ancestor
6520935|NCT00740363|Hormones|hormones|mesh-ancestor
6520936|NCT00740363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6520937|NCT00740363|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6520938|NCT00740363|Protease Inhibitors|protease inhibitors|mesh-ancestor
6520939|NCT00740363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6520940|NCT00740363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520941|NCT00740389|Etravirine|etravirine|mesh-list
6520942|NCT00740389|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6520943|NCT00740389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6520944|NCT00740389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6685812|NCT01636323|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6685813|NCT01636323|Cholinergic Agents|cholinergic agents|mesh-ancestor
6685814|NCT01636323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6685815|NCT01636323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685816|NCT01636336|Nicotine|nicotine|mesh-list
6685817|NCT01636336|Progesterone|progesterone|mesh-list
6685818|NCT01636336|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6685819|NCT01636336|Autonomic Agents|autonomic agents|mesh-ancestor
6520945|NCT00740389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520946|NCT00740389|Antiviral Agents|antiviral agents|mesh-ancestor
6520947|NCT00740389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6685820|NCT01636336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6685821|NCT01636336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685822|NCT01636336|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6685823|NCT01636336|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6685824|NCT01636336|Cholinergic Agents|cholinergic agents|mesh-ancestor
6685825|NCT01636336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6685826|NCT01636336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685827|NCT01636336|Progestins|progestins|mesh-ancestor
6685828|NCT01636336|Hormones|hormones|mesh-ancestor
6520948|NCT00740415|Dexamethasone|dexamethasone|mesh-list
6520949|NCT00740415|Rituximab|rituximab|mesh-list
6520950|NCT00740415|Bortezomib|bortezomib|mesh-list
6520951|NCT00740415|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6520952|NCT00740415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6520953|NCT00740415|Antiemetics|antiemetics|mesh-ancestor
6520954|NCT00740415|Autonomic Agents|autonomic agents|mesh-ancestor
6520955|NCT00740415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6520956|NCT00740415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6520957|NCT00740415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6520958|NCT00740415|Glucocorticoids|glucocorticoids|mesh-ancestor
6520959|NCT00740415|Hormones|hormones|mesh-ancestor
6520960|NCT00740415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6520961|NCT00740415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6520962|NCT00740415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6520963|NCT00740415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6520964|NCT00740415|Immunologic Factors|immunologic factors|mesh-ancestor
6520965|NCT00740415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6685829|NCT01636336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6685830|NCT01636401|Bromides|bromides|mesh-list
6520966|NCT00740415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6520967|NCT00740415|Alkylating Agents|alkylating agents|mesh-ancestor
6520968|NCT00740415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520969|NCT00740467|Cyclosporine|cyclosporine|mesh-list
6520970|NCT00740467|Mycophenolic Acid|mycophenolic acid|mesh-list
6685831|NCT01636401|Anticonvulsants|anticonvulsants|mesh-ancestor
6780206|NCT02182479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6780207|NCT02182479|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6780208|NCT02182479|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6780209|NCT02182479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6780210|NCT02182479|Adrenergic Agents|adrenergic agents|mesh-ancestor
6780211|NCT02182479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6780212|NCT02182479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780213|NCT02182479|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6780214|NCT02182479|Cholinergic Agents|cholinergic agents|mesh-ancestor
6520971|NCT00740467|Cyclophosphamide|cyclophosphamide|mesh-list
6520972|NCT00740467|Busulfan|busulfan|mesh-list
6520973|NCT00740467|Fludarabine|fludarabine|mesh-list
6520974|NCT00740467|Fludarabine phosphate|fludarabine phosphate|mesh-list
6520975|NCT00740467|Cyclosporins|cyclosporins|mesh-list
6520976|NCT00740467|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6520977|NCT00740467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6520978|NCT00740467|Immunologic Factors|immunologic factors|mesh-ancestor
6520979|NCT00740467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6520980|NCT00740467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6520981|NCT00740467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6520982|NCT00740467|Alkylating Agents|alkylating agents|mesh-ancestor
6520983|NCT00740467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6520984|NCT00740467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6520985|NCT00740467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6520986|NCT00740467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6520987|NCT00740467|Antimetabolites|antimetabolites|mesh-ancestor
6520988|NCT00740467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6520989|NCT00740467|Antifungal Agents|antifungal agents|mesh-ancestor
6520990|NCT00740467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6520991|NCT00740467|Dermatologic Agents|dermatologic agents|mesh-ancestor
6520992|NCT00740467|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6520993|NCT00740467|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6520994|NCT00740467|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6520995|NCT00740467|Antitubercular Agents|antitubercular agents|mesh-ancestor
6520996|NCT00740467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6520997|NCT00740493|Warfarin|warfarin|mesh-list
6520998|NCT00740493|Anticoagulants|anticoagulants|mesh-ancestor
6520999|NCT00740519|Insulin Detemir|insulin detemir|mesh-list
6521000|NCT00740519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6521001|NCT00740519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521002|NCT00740545|Enoxaparin|enoxaparin|mesh-list
6521003|NCT00740545|Anticoagulants|anticoagulants|mesh-ancestor
6521004|NCT00740545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6521005|NCT00740545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6521006|NCT00740545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521007|NCT00740571|Pregabalin|pregabalin|mesh-list
6521008|NCT00740571|Amitriptyline|amitriptyline|mesh-list
6521009|NCT00740571|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6521010|NCT00740571|Analgesics|analgesics|mesh-ancestor
6521011|NCT00740571|Sensory System Agents|sensory system agents|mesh-ancestor
6521012|NCT00740571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6521013|NCT00740571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521014|NCT00740571|Anticonvulsants|anticonvulsants|mesh-ancestor
6780215|NCT02182505|Fenoterol|fenoterol|mesh-list
6780216|NCT02182505|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
6780217|NCT02182505|Ipratropium|ipratropium|mesh-list
6780218|NCT02182505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6780219|NCT02182505|Autonomic Agents|autonomic agents|mesh-ancestor
6780220|NCT02182505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6780221|NCT02182505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780222|NCT02182505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6521015|NCT00740571|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6521016|NCT00740571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6685832|NCT01636505|Cetrorelix|cetrorelix|mesh-list
6685833|NCT01636505|Buserelin|buserelin|mesh-list
6685834|NCT01636505|Ganirelix|ganirelix|mesh-list
6685835|NCT01636505|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6521017|NCT00740571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521018|NCT00740571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6521019|NCT00740571|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6521020|NCT00740571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6521021|NCT00740571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6685836|NCT01636505|Fertility Agents|fertility agents|mesh-ancestor
6685837|NCT01636505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6685838|NCT01636505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685839|NCT01636505|Hormone Antagonists|hormone antagonists|mesh-ancestor
6685840|NCT01636505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6685841|NCT01636531|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6521022|NCT00740571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6521023|NCT00740571|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6521024|NCT00740571|Antidepressive Agents|antidepressive agents|mesh-ancestor
6521025|NCT00740571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6521026|NCT00740571|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6521027|NCT00740571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6521028|NCT00740571|Adrenergic Agents|adrenergic agents|mesh-ancestor
6521029|NCT00740571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6521030|NCT00740571|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6521031|NCT00740805|Cyclophosphamide|cyclophosphamide|mesh-list
6521032|NCT00740805|Doxorubicin|doxorubicin|mesh-list
6521033|NCT00740805|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6521034|NCT00740805|Veliparib|veliparib|mesh-list
6521035|NCT00740805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6521036|NCT00740805|Immunologic Factors|immunologic factors|mesh-ancestor
6521037|NCT00740805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521038|NCT00740805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6521039|NCT00740805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6685842|NCT01636531|Immunologic Factors|immunologic factors|mesh-ancestor
6685843|NCT01636531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685844|NCT01636557|Vitamin K|vitamin k|mesh-list
6521040|NCT00740805|Alkylating Agents|alkylating agents|mesh-ancestor
6521041|NCT00740805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521042|NCT00740805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6521043|NCT00740805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6521044|NCT00740805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6521045|NCT00740805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6521046|NCT00740805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6521047|NCT00740805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6521048|NCT00740805|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6521049|NCT00740883|Warfarin|warfarin|mesh-list
6521050|NCT00740883|Anticoagulants|anticoagulants|mesh-ancestor
6521051|NCT00740922|Becaplermin|becaplermin|mesh-list
6685845|NCT01636557|Midazolam|midazolam|mesh-list
6685846|NCT01636557|Caffeine|caffeine|mesh-list
6685847|NCT01636557|Omeprazole|omeprazole|mesh-list
6685848|NCT01636557|Warfarin|warfarin|mesh-list
6685849|NCT01636557|Vitamins|vitamins|mesh-ancestor
6685850|NCT01636557|Micronutrients|micronutrients|mesh-ancestor
6685851|NCT01636557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685852|NCT01636557|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6685853|NCT01636557|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6685854|NCT01636557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6685855|NCT01636557|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6685856|NCT01636557|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6685857|NCT01636557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6685858|NCT01636557|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6685859|NCT01636557|Anesthetics, General|anesthetics, general|mesh-ancestor
6521052|NCT00740922|Anticoagulants|anticoagulants|mesh-ancestor
6521053|NCT00740922|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
6521054|NCT00740922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6521055|NCT00740922|Growth Substances|growth substances|mesh-ancestor
6521056|NCT00740922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521057|NCT00740948|Rituximab|rituximab|mesh-list
6521058|NCT00740948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6521059|NCT00740948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6521060|NCT00740948|Immunologic Factors|immunologic factors|mesh-ancestor
6521061|NCT00740948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521062|NCT00740948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6521063|NCT00741052|Azithromycin|azithromycin|mesh-list
6685860|NCT01636557|Anesthetics|anesthetics|mesh-ancestor
6685861|NCT01636557|GABA Modulators|gaba modulators|mesh-ancestor
6521064|NCT00741052|Ciprofloxacin|ciprofloxacin|mesh-list
6521065|NCT00741052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6521066|NCT00741052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6521067|NCT00741052|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6521068|NCT00741052|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6521069|NCT00741052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6521070|NCT00741052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521071|NCT00741052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6521072|NCT00741052|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6521073|NCT00741052|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6521074|NCT00741078|Amlodipine|amlodipine|mesh-list
6521075|NCT00741078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6521076|NCT00741078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6521077|NCT00741078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6521078|NCT00741078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521079|NCT00741078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6521080|NCT00741078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521081|NCT00741078|Vasodilator Agents|vasodilator agents|mesh-ancestor
6521082|NCT00741117|Bilirubin|bilirubin|mesh-list
6521083|NCT00741117|Antioxidants|antioxidants|mesh-ancestor
6521084|NCT00741117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521085|NCT00741117|Protective Agents|protective agents|mesh-ancestor
6521086|NCT00741117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521087|NCT00741143|Fe(III)-EDTA|fe(iii)-edta|mesh-list
6521088|NCT00741143|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6521089|NCT00741143|Chelating Agents|chelating agents|mesh-ancestor
6521090|NCT00741143|Sequestering Agents|sequestering agents|mesh-ancestor
6521091|NCT00741143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521092|NCT00741169|Rifampin|rifampin|mesh-list
6521093|NCT00741169|Simeprevir|simeprevir|mesh-list
6521094|NCT00741169|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6521095|NCT00741169|Antitubercular Agents|antitubercular agents|mesh-ancestor
6521096|NCT00741169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6521097|NCT00741169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6521098|NCT00741169|Leprostatic Agents|leprostatic agents|mesh-ancestor
6521099|NCT00741169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6521100|NCT00741169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6521101|NCT00741169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521102|NCT00741169|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6521103|NCT00741169|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6521104|NCT00741169|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6521105|NCT00741169|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6521106|NCT00741169|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6521107|NCT00741169|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6521108|NCT00741169|Antiviral Agents|antiviral agents|mesh-ancestor
6521109|NCT00741169|Protease Inhibitors|protease inhibitors|mesh-ancestor
6521110|NCT00741182|Teriparatide|teriparatide|mesh-list
6521111|NCT00741182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6521112|NCT00741182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521113|NCT00741182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6521114|NCT00741195|Bevacizumab|bevacizumab|mesh-list
6521115|NCT00741195|Docetaxel|docetaxel|mesh-list
6521116|NCT00741195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6521117|NCT00741195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6521118|NCT00741195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6521119|NCT00741195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6521120|NCT00741195|Growth Substances|growth substances|mesh-ancestor
6521121|NCT00741195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521122|NCT00741195|Growth Inhibitors|growth inhibitors|mesh-ancestor
6521123|NCT00741195|Tubulin Modulators|tubulin modulators|mesh-ancestor
6521124|NCT00741195|Antimitotic Agents|antimitotic agents|mesh-ancestor
6521125|NCT00741195|Mitosis Modulators|mitosis modulators|mesh-ancestor
6521126|NCT00741195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521127|NCT00741221|Bevacizumab|bevacizumab|mesh-list
6521128|NCT00741221|Pemetrexed|pemetrexed|mesh-list
6521129|NCT00741221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6521130|NCT00741221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6521131|NCT00741221|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6521132|NCT00741221|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6685862|NCT01636557|GABA Agents|gaba agents|mesh-ancestor
6685863|NCT01636557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6685864|NCT01636557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685865|NCT01636557|Anticoagulants|anticoagulants|mesh-ancestor
6685866|NCT01636557|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6685867|NCT01636557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6685868|NCT01636557|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6685869|NCT01636557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6685870|NCT01636557|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6685871|NCT01636557|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6685872|NCT01636557|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6685873|NCT01636557|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6685874|NCT01636557|Purinergic Agents|purinergic agents|mesh-ancestor
6685875|NCT01636557|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6685876|NCT01636557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6685877|NCT01636557|Hemostatics|hemostatics|mesh-ancestor
6685878|NCT01636557|Coagulants|coagulants|mesh-ancestor
6685879|NCT01636570|Vitamin D|vitamin d|mesh-list
6685880|NCT01636570|Cholecalciferol|cholecalciferol|mesh-list
6685881|NCT01636570|Vitamins|vitamins|mesh-ancestor
6685882|NCT01636570|Micronutrients|micronutrients|mesh-ancestor
6685883|NCT01636570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685884|NCT01636570|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6685885|NCT01636570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6685886|NCT01636596|Insulin Lispro|insulin lispro|mesh-list
6685887|NCT01636596|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6685888|NCT01636596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685889|NCT01636609|Cytarabine|cytarabine|mesh-list
6685890|NCT01636609|Azacitidine|azacitidine|mesh-list
6685891|NCT01636609|Tosedostat|tosedostat|mesh-list
6685892|NCT01636609|Glycine|glycine|mesh-list
6685893|NCT01636609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6685894|NCT01636609|Antimetabolites|antimetabolites|mesh-ancestor
6685895|NCT01636609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685896|NCT01636609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6685897|NCT01636609|Antiviral Agents|antiviral agents|mesh-ancestor
6685898|NCT01636609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6685899|NCT01636609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6521133|NCT00741221|Growth Substances|growth substances|mesh-ancestor
6521134|NCT00741221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521135|NCT00741221|Growth Inhibitors|growth inhibitors|mesh-ancestor
6521136|NCT00741221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6521137|NCT00741221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521138|NCT00741221|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6521139|NCT00741221|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6521140|NCT00741234|Azacitidine|azacitidine|mesh-list
6521141|NCT00741234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6685900|NCT01636609|Immunologic Factors|immunologic factors|mesh-ancestor
6685901|NCT01636609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685902|NCT01636609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6521142|NCT00741234|Antimetabolites|antimetabolites|mesh-ancestor
6521143|NCT00741234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521144|NCT00741234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6521145|NCT00741234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6521146|NCT00741325|Plerixafor|plerixafor|mesh-list
6521147|NCT00741325|Sargramostim|sargramostim|mesh-list
6521148|NCT00741325|Lenograstim|lenograstim|mesh-list
6521149|NCT00741325|Immunologic Factors|immunologic factors|mesh-ancestor
6521150|NCT00741325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521151|NCT00741325|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6521152|NCT00741325|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6521153|NCT00741325|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6521154|NCT00741325|Antiviral Agents|antiviral agents|mesh-ancestor
6521155|NCT00741325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6521156|NCT00741351|Fentanyl|fentanyl|mesh-list
6521157|NCT00741351|Remifentanil|remifentanil|mesh-list
6521158|NCT00741351|Propofol|propofol|mesh-list
6521159|NCT00741351|Sevoflurane|sevoflurane|mesh-list
6521160|NCT00741351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6521161|NCT00741351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6521162|NCT00741351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521163|NCT00741351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6521164|NCT00741351|Anesthetics, General|anesthetics, general|mesh-ancestor
6521165|NCT00741351|Anesthetics|anesthetics|mesh-ancestor
6521166|NCT00741351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6685903|NCT01636609|Glycine Agents|glycine agents|mesh-ancestor
6685904|NCT01636609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6685905|NCT01636622|Paclitaxel|paclitaxel|mesh-list
6521167|NCT00741351|Narcotics|narcotics|mesh-ancestor
6521168|NCT00741351|Analgesics|analgesics|mesh-ancestor
6521169|NCT00741351|Sensory System Agents|sensory system agents|mesh-ancestor
6521170|NCT00741351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6521171|NCT00741351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6521172|NCT00741351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6521173|NCT00741351|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6521174|NCT00741364|Vitamin D|vitamin d|mesh-list
6521175|NCT00741364|Cholecalciferol|cholecalciferol|mesh-list
6521176|NCT00741364|Vitamins|vitamins|mesh-ancestor
6521177|NCT00741364|Micronutrients|micronutrients|mesh-ancestor
6521178|NCT00741364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521179|NCT00741364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6521180|NCT00741364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6521181|NCT00741377|Zoledronic Acid|zoledronic acid|mesh-list
6521182|NCT00741377|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6521183|NCT00741377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521184|NCT00741429|Insulin|insulin|mesh-list
6521185|NCT00741429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6521186|NCT00741429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521187|NCT00741507|Ethanol|ethanol|mesh-list
6521188|NCT00741507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6521189|NCT00741507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6521190|NCT00741507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6521191|NCT00741507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521192|NCT00741585|Atenolol|atenolol|mesh-list
6521193|NCT00741585|Amlodipine|amlodipine|mesh-list
6521194|NCT00741585|Valsartan|valsartan|mesh-list
6521195|NCT00741585|Telmisartan|telmisartan|mesh-list
6521196|NCT00741585|Carvedilol|carvedilol|mesh-list
6521197|NCT00741585|Candesartan|candesartan|mesh-list
6521198|NCT00741585|Candesartan cilexetil|candesartan cilexetil|mesh-list
6521199|NCT00741585|Ramipril|ramipril|mesh-list
6521200|NCT00741585|Olmesartan|olmesartan|mesh-list
6521201|NCT00741585|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6521202|NCT00741585|Enalapril|enalapril|mesh-list
6521203|NCT00741585|Enalaprilat|enalaprilat|mesh-list
6521204|NCT00741585|Lisinopril|lisinopril|mesh-list
6521205|NCT00741585|Irbesartan|irbesartan|mesh-list
6521206|NCT00741585|Antihypertensive Agents|antihypertensive agents|mesh-list
6521207|NCT00741585|Quinapril|quinapril|mesh-list
6521208|NCT00741585|Lercanidipine|lercanidipine|mesh-list
6521209|NCT00741585|Manidipine|manidipine|mesh-list
6521210|NCT00741585|Doxazosin|doxazosin|mesh-list
6521211|NCT00741585|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6521212|NCT00741585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6521213|NCT00741585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521214|NCT00741585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6521215|NCT00741585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685906|NCT01636622|Carboplatin|carboplatin|mesh-list
6685907|NCT01636622|Vemurafenib|vemurafenib|mesh-list
6685908|NCT01636622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6685909|NCT01636622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6521216|NCT00741585|Vasodilator Agents|vasodilator agents|mesh-ancestor
6521217|NCT00741585|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6521218|NCT00741585|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6521219|NCT00741585|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6521220|NCT00741585|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6521221|NCT00741585|Adrenergic Agents|adrenergic agents|mesh-ancestor
6685910|NCT01636622|Tubulin Modulators|tubulin modulators|mesh-ancestor
6685911|NCT01636622|Antimitotic Agents|antimitotic agents|mesh-ancestor
6685912|NCT01636622|Mitosis Modulators|mitosis modulators|mesh-ancestor
6521222|NCT00741585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6521223|NCT00741585|Antioxidants|antioxidants|mesh-ancestor
6521224|NCT00741585|Protective Agents|protective agents|mesh-ancestor
6521225|NCT00741585|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6521226|NCT00741585|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6521227|NCT00741585|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6521228|NCT00741585|Protease Inhibitors|protease inhibitors|mesh-ancestor
6521229|NCT00741585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6521230|NCT00741585|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6521231|NCT00741585|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6521232|NCT00741585|Sympatholytics|sympatholytics|mesh-ancestor
6521233|NCT00741585|Autonomic Agents|autonomic agents|mesh-ancestor
6521234|NCT00741585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6521235|NCT00741585|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6521236|NCT00741663|Furosemide|furosemide|mesh-list
6521237|NCT00741663|Spironolactone|spironolactone|mesh-list
6521238|NCT00741663|Diuretics|diuretics|mesh-ancestor
6521239|NCT00741663|Natriuretic Agents|natriuretic agents|mesh-ancestor
6521240|NCT00741663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521241|NCT00741663|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6521242|NCT00741663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6521243|NCT00741663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521244|NCT00741663|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6521245|NCT00741663|Hormone Antagonists|hormone antagonists|mesh-ancestor
6521246|NCT00741663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6521247|NCT00741663|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6521248|NCT00741741|Rilpivirine|rilpivirine|mesh-list
6521249|NCT00741741|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6521250|NCT00741741|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6521251|NCT00741741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6521252|NCT00741741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521253|NCT00741741|Antiviral Agents|antiviral agents|mesh-ancestor
6521254|NCT00741741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6521255|NCT00741741|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6521256|NCT00741741|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6521257|NCT00741767|Fluticasone|fluticasone|mesh-list
6521258|NCT00741767|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6521259|NCT00741767|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6521260|NCT00741767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6521261|NCT00741767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6521262|NCT00741767|Autonomic Agents|autonomic agents|mesh-ancestor
6521263|NCT00741767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6521264|NCT00741767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521265|NCT00741767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6521266|NCT00741767|Respiratory System Agents|respiratory system agents|mesh-ancestor
6521267|NCT00741767|Dermatologic Agents|dermatologic agents|mesh-ancestor
6521268|NCT00741767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6521269|NCT00741767|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6521270|NCT00741767|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6521271|NCT00741767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6521272|NCT00741767|Adrenergic Agents|adrenergic agents|mesh-ancestor
6521273|NCT00741767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6521274|NCT00741767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521275|NCT00741767|Glucocorticoids|glucocorticoids|mesh-ancestor
6521276|NCT00741767|Hormones|hormones|mesh-ancestor
6521277|NCT00741767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6521278|NCT00741767|Sympathomimetics|sympathomimetics|mesh-ancestor
6521279|NCT00741780|Plerixafor|plerixafor|mesh-list
6521280|NCT00741780|Sargramostim|sargramostim|mesh-list
6521281|NCT00741780|Lenograstim|lenograstim|mesh-list
6521282|NCT00741780|Immunologic Factors|immunologic factors|mesh-ancestor
6521283|NCT00741780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521284|NCT00741780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6521285|NCT00741780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6521286|NCT00741780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6521287|NCT00741780|Antiviral Agents|antiviral agents|mesh-ancestor
6521288|NCT00741780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6685913|NCT01636622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685914|NCT01636622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6685915|NCT01636622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6685916|NCT01636700|Tramadol|tramadol|mesh-list
6685917|NCT01636700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6685918|NCT01636700|Narcotics|narcotics|mesh-ancestor
6685919|NCT01636700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6685920|NCT01636700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685921|NCT01636700|Analgesics|analgesics|mesh-ancestor
6685922|NCT01636700|Sensory System Agents|sensory system agents|mesh-ancestor
6685923|NCT01636700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6685924|NCT01636869|Bupivacaine|bupivacaine|mesh-list
6685925|NCT01636869|Anesthetics, Local|anesthetics, local|mesh-ancestor
6685926|NCT01636869|Anesthetics|anesthetics|mesh-ancestor
6685927|NCT01636869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6685928|NCT01636869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685929|NCT01636869|Sensory System Agents|sensory system agents|mesh-ancestor
6685930|NCT01636869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6685931|NCT01636895|Pyrimethamine|pyrimethamine|mesh-list
6685932|NCT01636895|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6685933|NCT01636895|Sulfadoxine|sulfadoxine|mesh-list
6685934|NCT01636895|Antimalarials|antimalarials|mesh-ancestor
6685935|NCT01636895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6685936|NCT01636895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6685937|NCT01636895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6685938|NCT01636895|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6685939|NCT01636895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6685940|NCT01636895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685941|NCT01636895|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6685942|NCT01636895|Renal Agents|renal agents|mesh-ancestor
6685943|NCT01636908|Everolimus|everolimus|mesh-list
6685944|NCT01636908|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6685945|NCT01636908|Sorafenib|sorafenib|mesh-list
6685946|NCT01636908|Sunitinib|sunitinib|mesh-list
6685947|NCT01636908|Dasatinib|dasatinib|mesh-list
6685948|NCT01636908|Lapatinib|lapatinib|mesh-list
6685949|NCT01636908|Vemurafenib|vemurafenib|mesh-list
6685950|NCT01636908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6685951|NCT01636908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6685952|NCT01636908|Immunologic Factors|immunologic factors|mesh-ancestor
6685953|NCT01636908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685954|NCT01636908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6685955|NCT01636908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6685956|NCT01636908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6685957|NCT01636908|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6685958|NCT01636908|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6685959|NCT01636908|Growth Substances|growth substances|mesh-ancestor
6685960|NCT01636908|Growth Inhibitors|growth inhibitors|mesh-ancestor
6685961|NCT01636999|Nitrous Oxide|nitrous oxide|mesh-list
6685962|NCT01636999|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6521289|NCT00741845|Metronidazole|metronidazole|mesh-list
6521290|NCT00741845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6521291|NCT00741845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6521292|NCT00741845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6521293|NCT00741845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6521294|NCT00741884|Varenicline|varenicline|mesh-list
6521295|NCT00741884|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6521296|NCT00741884|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6521297|NCT00741884|Cholinergic Agents|cholinergic agents|mesh-ancestor
6521298|NCT00741884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6521299|NCT00741884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521300|NCT00741884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521301|NCT00741897|Fexofenadine|fexofenadine|mesh-list
6521302|NCT00741897|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6521303|NCT00741897|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6521304|NCT00741897|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6521305|NCT00741897|Histamine Antagonists|histamine antagonists|mesh-ancestor
6521306|NCT00741897|Histamine Agents|histamine agents|mesh-ancestor
6521307|NCT00741897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6521308|NCT00741897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521309|NCT00741897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521310|NCT00741910|Semapimod|semapimod|mesh-list
6521311|NCT00741910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6521312|NCT00741910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6521313|NCT00741910|Analgesics|analgesics|mesh-ancestor
6521314|NCT00741910|Sensory System Agents|sensory system agents|mesh-ancestor
6521315|NCT00741910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6521316|NCT00741910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521317|NCT00741910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6521318|NCT00741910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6521319|NCT00741910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6521320|NCT00741910|Immunologic Factors|immunologic factors|mesh-ancestor
6521321|NCT00741949|Propofol|propofol|mesh-list
6521322|NCT00741949|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6521323|NCT00741949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6521324|NCT00741949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521325|NCT00741949|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6521326|NCT00741949|Anesthetics, General|anesthetics, general|mesh-ancestor
6521327|NCT00741949|Anesthetics|anesthetics|mesh-ancestor
6521328|NCT00742014|Sildenafil Citrate|sildenafil citrate|mesh-list
6521329|NCT00742014|Vasodilator Agents|vasodilator agents|mesh-ancestor
6521330|NCT00742014|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6521331|NCT00742014|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6521332|NCT00742014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6521333|NCT00742014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521334|NCT00742014|Urological Agents|urological agents|mesh-ancestor
6685963|NCT01636999|Anesthetics, General|anesthetics, general|mesh-ancestor
6685964|NCT01636999|Anesthetics|anesthetics|mesh-ancestor
6521335|NCT00742040|Captopril|captopril|mesh-list
6521336|NCT00742040|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6521337|NCT00742040|Protease Inhibitors|protease inhibitors|mesh-ancestor
6521338|NCT00742040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6521339|NCT00742040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521340|NCT00742040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6521341|NCT00742066|Felodipine|felodipine|mesh-list
6521342|NCT00742066|Irbesartan|irbesartan|mesh-list
6521343|NCT00742066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6521344|NCT00742066|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6521345|NCT00742066|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6521346|NCT00742066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521347|NCT00742066|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6521348|NCT00742066|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6521349|NCT00742066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6521350|NCT00742066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6521351|NCT00742066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521352|NCT00742066|Vasodilator Agents|vasodilator agents|mesh-ancestor
6521353|NCT00742092|Miglustat|miglustat|mesh-list
6521354|NCT00742092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6521355|NCT00742092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521356|NCT00742092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6521357|NCT00742092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6521358|NCT00742092|Antiviral Agents|antiviral agents|mesh-ancestor
6521359|NCT00742092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6521360|NCT00742092|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6521361|NCT00742092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6521362|NCT00742092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521363|NCT00742144|Ofatumumab|ofatumumab|mesh-list
6521364|NCT00742144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6521365|NCT00742157|Hormones|hormones|mesh-list
6521366|NCT00742157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6521367|NCT00742157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521368|NCT00742248|Formoterol Fumarate|formoterol fumarate|mesh-list
6521369|NCT00742248|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6521370|NCT00742248|Autonomic Agents|autonomic agents|mesh-ancestor
6521371|NCT00742248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6521372|NCT00742248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521373|NCT00742248|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6521374|NCT00742248|Respiratory System Agents|respiratory system agents|mesh-ancestor
6521375|NCT00742248|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6521376|NCT00742248|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6521377|NCT00742248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6521378|NCT00742248|Adrenergic Agents|adrenergic agents|mesh-ancestor
6521379|NCT00742248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6521380|NCT00742248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521381|NCT00742287|Proanthocyanidin|proanthocyanidin|mesh-list
6521382|NCT00742287|Procyanidin|procyanidin|mesh-list
6521383|NCT00742287|Antioxidants|antioxidants|mesh-ancestor
6521384|NCT00742287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521385|NCT00742287|Protective Agents|protective agents|mesh-ancestor
6521386|NCT00742287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521387|NCT00742287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6521388|NCT00742287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6521389|NCT00742287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6521390|NCT00742300|Cyclophosphamide|cyclophosphamide|mesh-list
6521391|NCT00742300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6521392|NCT00742300|Immunologic Factors|immunologic factors|mesh-ancestor
6521393|NCT00742300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521394|NCT00742300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6521395|NCT00742300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6521396|NCT00742300|Alkylating Agents|alkylating agents|mesh-ancestor
6521397|NCT00742300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521398|NCT00742300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6521399|NCT00742300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6521400|NCT00742339|Octreotide|octreotide|mesh-list
6521401|NCT00742339|Terlipressin|terlipressin|mesh-list
6521402|NCT00742339|Midodrine|midodrine|mesh-list
6521403|NCT00742339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6521404|NCT00742339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6521405|NCT00742339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6521406|NCT00742339|Sympathomimetics|sympathomimetics|mesh-ancestor
6685965|NCT01636999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6521407|NCT00742339|Autonomic Agents|autonomic agents|mesh-ancestor
6521408|NCT00742339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6521409|NCT00742339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521410|NCT00742339|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6521411|NCT00742339|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6242671|NCT02654145|Adrenergic Agents|adrenergic agents|mesh-ancestor
6242672|NCT02654145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6242673|NCT02654145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242674|NCT02654145|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6242675|NCT02654314|Melatonin|melatonin|mesh-list
6242676|NCT02654314|Antioxidants|antioxidants|mesh-ancestor
6242677|NCT02654314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242678|NCT02654314|Protective Agents|protective agents|mesh-ancestor
6242679|NCT02654314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6242680|NCT02654314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6242681|NCT02654483|Serlopitant|serlopitant|mesh-list
6242682|NCT02654483|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6242683|NCT02654483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6242684|NCT02654483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242685|NCT02654483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6242686|NCT02654860|Acetaminophen|acetaminophen|mesh-list
6242687|NCT02654860|Bupivacaine|bupivacaine|mesh-list
6521412|NCT00742339|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6521413|NCT00742339|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6521414|NCT00742339|Adrenergic Agents|adrenergic agents|mesh-ancestor
6521415|NCT00742339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6521416|NCT00742339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521417|NCT00742339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6521418|NCT00742404|Dexamethasone|dexamethasone|mesh-list
6521419|NCT00742404|Doxorubicin|doxorubicin|mesh-list
6242688|NCT02654860|Anesthetics, Local|anesthetics, local|mesh-ancestor
6242689|NCT02654860|Anesthetics|anesthetics|mesh-ancestor
6242690|NCT02654860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6242691|NCT02654860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6242692|NCT02654860|Sensory System Agents|sensory system agents|mesh-ancestor
6242693|NCT02654860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6242694|NCT02654860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6242695|NCT02654860|Analgesics|analgesics|mesh-ancestor
6242696|NCT02654860|Antipyretics|antipyretics|mesh-ancestor
6242697|NCT02655224|Relugolix|relugolix|mesh-list
6242698|NCT02655224|Androgen Antagonists|androgen antagonists|mesh-ancestor
6242699|NCT02655224|Hormone Antagonists|hormone antagonists|mesh-ancestor
6521420|NCT00742404|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6521421|NCT00742404|Bortezomib|bortezomib|mesh-list
6521422|NCT00742404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6521423|NCT00742404|Antiemetics|antiemetics|mesh-ancestor
6521424|NCT00742404|Autonomic Agents|autonomic agents|mesh-ancestor
6521425|NCT00742404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6521426|NCT00742404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521427|NCT00742404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6521428|NCT00742404|Glucocorticoids|glucocorticoids|mesh-ancestor
6521429|NCT00742404|Hormones|hormones|mesh-ancestor
6521430|NCT00742404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6521431|NCT00742404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6521432|NCT00742404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6521433|NCT00742404|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6521434|NCT00742404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6521435|NCT00742404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6521436|NCT00742404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6521437|NCT00742404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521438|NCT00742638|Valproic Acid|valproic acid|mesh-list
6521439|NCT00742638|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6521440|NCT00742638|Antidepressive Agents|antidepressive agents|mesh-ancestor
6521441|NCT00742638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6521442|NCT00742638|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6521443|NCT00742638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6521444|NCT00742638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6521445|NCT00742638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521446|NCT00742638|Anticonvulsants|anticonvulsants|mesh-ancestor
6521447|NCT00742638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6521448|NCT00742638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521449|NCT00742638|GABA Agents|gaba agents|mesh-ancestor
6521450|NCT00742638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6521451|NCT00742638|Antimanic Agents|antimanic agents|mesh-ancestor
6521452|NCT00742690|Terlipressin|terlipressin|mesh-list
6521453|NCT00742690|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6521454|NCT00742690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6521455|NCT00742768|Vitamins|vitamins|mesh-list
6521456|NCT00742768|Vitamin K|vitamin k|mesh-list
6521457|NCT00742768|Vitamin K 2|vitamin k 2|mesh-list
6521458|NCT00742768|Micronutrients|micronutrients|mesh-ancestor
6521459|NCT00742768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521460|NCT00742768|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6521461|NCT00742768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6521462|NCT00742768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521463|NCT00742768|Hemostatics|hemostatics|mesh-ancestor
6521464|NCT00742768|Coagulants|coagulants|mesh-ancestor
6521465|NCT00742807|Alfentanil|alfentanil|mesh-list
6521466|NCT00742807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6521467|NCT00742807|Narcotics|narcotics|mesh-ancestor
6521468|NCT00742807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6521469|NCT00742807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521470|NCT00742807|Analgesics|analgesics|mesh-ancestor
6521471|NCT00742807|Sensory System Agents|sensory system agents|mesh-ancestor
6521472|NCT00742807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6521473|NCT00742807|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6521474|NCT00742807|Anesthetics, General|anesthetics, general|mesh-ancestor
6521475|NCT00742807|Anesthetics|anesthetics|mesh-ancestor
6521476|NCT00742820|Calcium, Dietary|calcium, dietary|mesh-list
6521477|NCT00742820|Calcium|calcium|mesh-list
6521478|NCT00742820|Calcium acetate|calcium acetate|mesh-list
6521479|NCT00742820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6521480|NCT00742820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521481|NCT00742820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6521482|NCT00742820|Chelating Agents|chelating agents|mesh-ancestor
6521483|NCT00742820|Sequestering Agents|sequestering agents|mesh-ancestor
6521484|NCT00742820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521485|NCT00742846|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6521486|NCT00742846|Triamcinolone|triamcinolone|mesh-list
6521487|NCT00742846|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6521488|NCT00742846|Lidocaine|lidocaine|mesh-list
6521489|NCT00742846|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6521490|NCT00742846|Anesthetics, Local|anesthetics, local|mesh-ancestor
6521491|NCT00742846|Anesthetics|anesthetics|mesh-ancestor
6521492|NCT00742846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6521493|NCT00742846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521494|NCT00742846|Sensory System Agents|sensory system agents|mesh-ancestor
6521495|NCT00742846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6521496|NCT00742846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6521497|NCT00742846|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6521498|NCT00742846|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6521499|NCT00742846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6521500|NCT00742846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521501|NCT00742846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6521502|NCT00742846|Glucocorticoids|glucocorticoids|mesh-ancestor
6521503|NCT00742846|Hormones|hormones|mesh-ancestor
6521504|NCT00742846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6521505|NCT00742846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6521506|NCT00742846|Immunologic Factors|immunologic factors|mesh-ancestor
6521507|NCT00742846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6521508|NCT00742911|Copper|copper|mesh-list
6521509|NCT00742911|Disulfiram|disulfiram|mesh-list
6521510|NCT00742911|Trace Elements|trace elements|mesh-ancestor
6521511|NCT00742911|Micronutrients|micronutrients|mesh-ancestor
6521512|NCT00742911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521513|NCT00742911|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6521514|NCT00742911|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
6521515|NCT00742911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6521516|NCT00742911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521517|NCT00742937|Vitamin A|vitamin a|mesh-list
6521518|NCT00742937|Vitamins|vitamins|mesh-ancestor
6521519|NCT00742937|Micronutrients|micronutrients|mesh-ancestor
6521520|NCT00742937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521521|NCT00742976|Insulin|insulin|mesh-list
6521522|NCT00742976|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6521523|NCT00742976|Insulin Detemir|insulin detemir|mesh-list
6521524|NCT00742976|Isophane Insulin, Human|isophane insulin, human|mesh-list
6521525|NCT00742976|Insulin, Isophane|insulin, isophane|mesh-list
6521526|NCT00742976|Isophane insulin, beef|isophane insulin, beef|mesh-list
6521527|NCT00742976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6521528|NCT00742976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521529|NCT00743028|Navitoclax|navitoclax|mesh-list
6521530|NCT00743028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6521531|NCT00743314|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
6521532|NCT00743314|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6521533|NCT00743314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521534|NCT00743327|Pioglitazone|pioglitazone|mesh-list
6521535|NCT00743327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6521536|NCT00743327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521537|NCT00743470|Ritonavir|ritonavir|mesh-list
6521538|NCT00743470|Lopinavir|lopinavir|mesh-list
6521539|NCT00743470|Rifabutin|rifabutin|mesh-list
6521540|NCT00743470|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6521541|NCT00743470|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6521542|NCT00743470|Protease Inhibitors|protease inhibitors|mesh-ancestor
6521543|NCT00743470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6685966|NCT01636999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521544|NCT00743470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521545|NCT00743470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6521546|NCT00743470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6521547|NCT00743470|Antiviral Agents|antiviral agents|mesh-ancestor
6521548|NCT00743470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6521549|NCT00743470|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6521550|NCT00743470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6521551|NCT00743470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6521552|NCT00743470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6685967|NCT01636999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6685968|NCT01636999|Analgesics|analgesics|mesh-ancestor
6685969|NCT01636999|Sensory System Agents|sensory system agents|mesh-ancestor
6685970|NCT01636999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6685971|NCT01637025|Cellulose, Oxidized|cellulose, oxidized|mesh-list
6685972|NCT01637025|Hemostatics|hemostatics|mesh-ancestor
6521553|NCT00743470|Antitubercular Agents|antitubercular agents|mesh-ancestor
6521554|NCT00743496|Antibodies|antibodies|mesh-list
6521555|NCT00743496|Immunologic Factors|immunologic factors|mesh-ancestor
6685973|NCT01637025|Coagulants|coagulants|mesh-ancestor
6685974|NCT01637155|Vitamin D|vitamin d|mesh-list
6685975|NCT01637155|Cholecalciferol|cholecalciferol|mesh-list
6685976|NCT01637155|Vitamins|vitamins|mesh-ancestor
6685977|NCT01637155|Micronutrients|micronutrients|mesh-ancestor
6685978|NCT01637155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685979|NCT01637155|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6521556|NCT00743496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521557|NCT00743587|Naproxen|naproxen|mesh-list
6521558|NCT00743587|Oxycodone|oxycodone|mesh-list
6521559|NCT00743587|Tramadol|tramadol|mesh-list
6521560|NCT00743587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6521561|NCT00743587|Narcotics|narcotics|mesh-ancestor
6521562|NCT00743587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6521563|NCT00743587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521564|NCT00743587|Analgesics|analgesics|mesh-ancestor
6521565|NCT00743587|Sensory System Agents|sensory system agents|mesh-ancestor
6521566|NCT00743587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6521567|NCT00743587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6521568|NCT00743587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6521569|NCT00743587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6521570|NCT00743587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6521571|NCT00743587|Gout Suppressants|gout suppressants|mesh-ancestor
6521572|NCT00743587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6521573|NCT00743587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6521574|NCT00743587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521575|NCT00743678|Cetuximab|cetuximab|mesh-list
6521576|NCT00743678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6521577|NCT00743678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6521578|NCT00743743|Resveratrol|resveratrol|mesh-list
6521579|NCT00743743|Antioxidants|antioxidants|mesh-ancestor
6521580|NCT00743743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521581|NCT00743743|Protective Agents|protective agents|mesh-ancestor
6521582|NCT00743743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521583|NCT00743743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6521584|NCT00743743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6685980|NCT01637155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6685981|NCT01637194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6685982|NCT01637194|Cetuximab|cetuximab|mesh-list
6685983|NCT01637194|Everolimus|everolimus|mesh-list
6685984|NCT01637194|Antibodies|antibodies|mesh-list
6685985|NCT01637194|Immunoglobulins|immunoglobulins|mesh-list
6685986|NCT01637194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6685987|NCT01637194|Immunologic Factors|immunologic factors|mesh-ancestor
6521585|NCT00743782|Hormones|hormones|mesh-list
6521586|NCT00743782|Parathyroid Hormone|parathyroid hormone|mesh-list
6521587|NCT00743782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6521588|NCT00743782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521589|NCT00743782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6521590|NCT00743834|Fluvoxamine|fluvoxamine|mesh-list
6521591|NCT00743834|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6521592|NCT00743834|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6521593|NCT00743834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6521594|NCT00743834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521595|NCT00743834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6521596|NCT00743834|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6521597|NCT00743834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6521598|NCT00743834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6521599|NCT00743834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521600|NCT00743834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6521601|NCT00743834|Serotonin Agents|serotonin agents|mesh-ancestor
6521602|NCT00743834|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6521603|NCT00743834|Antidepressive Agents|antidepressive agents|mesh-ancestor
6521604|NCT00743834|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6521605|NCT00743834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6521606|NCT00743834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6521607|NCT00743834|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6521608|NCT00743847|Varenicline|varenicline|mesh-list
6521609|NCT00743847|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6521610|NCT00743847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6521611|NCT00743847|Cholinergic Agents|cholinergic agents|mesh-ancestor
6521612|NCT00743847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6521613|NCT00743847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521614|NCT00743847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521615|NCT00743860|Darapladib|darapladib|mesh-list
6521616|NCT00743860|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
6521617|NCT00743860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6521618|NCT00743860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521619|NCT00743873|Mitogens|mitogens|mesh-list
6521620|NCT00743873|Mitosis Modulators|mitosis modulators|mesh-ancestor
6521621|NCT00743873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521622|NCT00743886|Mitogens|mitogens|mesh-list
6521623|NCT00743886|Mitosis Modulators|mitosis modulators|mesh-ancestor
6521624|NCT00743886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521625|NCT00743912|Rifaximin|rifaximin|mesh-list
6521626|NCT00743912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6521627|NCT00743912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6521628|NCT00743912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6521629|NCT00743964|Capecitabine|capecitabine|mesh-list
6521630|NCT00743964|Epirubicin|epirubicin|mesh-list
6521631|NCT00743964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6521632|NCT00743964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6521633|NCT00743964|Antimetabolites|antimetabolites|mesh-ancestor
6521634|NCT00743964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521635|NCT00743964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6521636|NCT00743964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6521637|NCT00743964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6521638|NCT00743964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6521639|NCT00743990|Camphor|camphor|mesh-list
6521640|NCT00743990|Menthol|menthol|mesh-list
6521641|NCT00743990|Petrolatum|petrolatum|mesh-list
6521642|NCT00743990|Antipruritics|antipruritics|mesh-ancestor
6521643|NCT00743990|Dermatologic Agents|dermatologic agents|mesh-ancestor
6685988|NCT01637194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6685989|NCT01637194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6521644|NCT00743990|Emollients|emollients|mesh-ancestor
6521645|NCT00743990|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6521646|NCT00743990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6521647|NCT00744016|Mesalamine|mesalamine|mesh-list
6521648|NCT00744016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6521649|NCT00744016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6521650|NCT00744016|Analgesics|analgesics|mesh-ancestor
6521651|NCT00744016|Sensory System Agents|sensory system agents|mesh-ancestor
6521652|NCT00744016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6521653|NCT00744016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521654|NCT00744016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6521655|NCT00744016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6521656|NCT00744081|Topotecan|topotecan|mesh-list
6521657|NCT00744081|Mitoxantrone|mitoxantrone|mesh-list
6685990|NCT01637194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6685991|NCT01637233|Ritonavir|ritonavir|mesh-list
6685992|NCT01637233|Lopinavir|lopinavir|mesh-list
6685993|NCT01637233|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6685994|NCT01637233|Darunavir|darunavir|mesh-list
6685995|NCT01637233|Fosamprenavir|fosamprenavir|mesh-list
6685996|NCT01637233|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
6685997|NCT01637233|Tenofovir|tenofovir|mesh-list
6685998|NCT01637233|Lamivudine|lamivudine|mesh-list
6685999|NCT01637233|Zidovudine|zidovudine|mesh-list
6686000|NCT01637233|Emtricitabine|emtricitabine|mesh-list
6686001|NCT01637233|Maraviroc|maraviroc|mesh-list
6686002|NCT01637233|Abacavir|abacavir|mesh-list
6686003|NCT01637233|Dideoxynucleosides|dideoxynucleosides|mesh-list
6686004|NCT01637233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
6686005|NCT01637233|Protease Inhibitors|protease inhibitors|mesh-list
6686006|NCT01637233|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6686007|NCT01637233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5971410|NCT04528563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6521658|NCT00744081|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6521659|NCT00744081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6521660|NCT00744081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6521661|NCT00744081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521662|NCT00744081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6521663|NCT00744081|Analgesics|analgesics|mesh-ancestor
6521664|NCT00744081|Sensory System Agents|sensory system agents|mesh-ancestor
6521665|NCT00744081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6521666|NCT00744081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521667|NCT00744081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6521668|NCT00744107|Cobalt|cobalt|mesh-list
6521669|NCT00744107|Trace Elements|trace elements|mesh-ancestor
6521670|NCT00744107|Micronutrients|micronutrients|mesh-ancestor
6521671|NCT00744107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521672|NCT00744185|Propranolol|propranolol|mesh-list
6521673|NCT00744185|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6521674|NCT00744185|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6521675|NCT00744185|Adrenergic Agents|adrenergic agents|mesh-ancestor
6521676|NCT00744185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6521677|NCT00744185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521678|NCT00744185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521679|NCT00744185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6521680|NCT00744185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6521681|NCT00744185|Vasodilator Agents|vasodilator agents|mesh-ancestor
6521682|NCT00744224|Exenatide|exenatide|mesh-list
6521683|NCT00744224|Prednisolone|prednisolone|mesh-list
6521684|NCT00744224|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6521685|NCT00744224|Methylprednisolone|methylprednisolone|mesh-list
6521686|NCT00744224|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6521687|NCT00744224|Prednisolone acetate|prednisolone acetate|mesh-list
6521688|NCT00744224|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6521689|NCT00744224|Prednisolone phosphate|prednisolone phosphate|mesh-list
6521690|NCT00744224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6521691|NCT00744224|Glucocorticoids|glucocorticoids|mesh-ancestor
6521692|NCT00744224|Hormones|hormones|mesh-ancestor
6521693|NCT00744224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6521694|NCT00744224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521695|NCT00744224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6521696|NCT00744224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6521697|NCT00744224|Antiemetics|antiemetics|mesh-ancestor
6521698|NCT00744224|Autonomic Agents|autonomic agents|mesh-ancestor
6521699|NCT00744224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6521700|NCT00744224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6521701|NCT00744224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6521702|NCT00744224|Protective Agents|protective agents|mesh-ancestor
6521703|NCT00744224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6521704|NCT00744224|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6521705|NCT00744224|Incretins|incretins|mesh-ancestor
6521706|NCT00744250|Pancrelipase|pancrelipase|mesh-list
6521707|NCT00744250|Pancreatin|pancreatin|mesh-list
6521708|NCT00744250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6521709|NCT00744302|Dialysis Solutions|dialysis solutions|mesh-list
6521710|NCT00744302|Calcium|calcium|mesh-list
6521711|NCT00744302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6521712|NCT00744302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686008|NCT01637233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686009|NCT01637233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6686010|NCT01637233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6686011|NCT01637233|Antiviral Agents|antiviral agents|mesh-ancestor
6521713|NCT00744302|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6521714|NCT00744354|Doxorubicin|doxorubicin|mesh-list
6521715|NCT00744354|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6521716|NCT00744354|Bortezomib|bortezomib|mesh-list
6521717|NCT00744354|Vorinostat|vorinostat|mesh-list
6521718|NCT00744354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6521719|NCT00744354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6521720|NCT00744354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6521721|NCT00744354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6521722|NCT00744354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6521723|NCT00744354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521724|NCT00744354|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6521725|NCT00744393|Sodium Oxybate|sodium oxybate|mesh-list
6521726|NCT00744393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6521727|NCT00744393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6521728|NCT00744393|Anesthetics, General|anesthetics, general|mesh-ancestor
6521729|NCT00744393|Anesthetics|anesthetics|mesh-ancestor
6521730|NCT00744393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6521731|NCT00744393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521732|NCT00744406|Sertraline|sertraline|mesh-list
6521733|NCT00744406|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6521734|NCT00744406|Antidepressive Agents|antidepressive agents|mesh-list
6521735|NCT00744406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6521736|NCT00744406|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6521737|NCT00744406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6521738|NCT00744406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6521739|NCT00744406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521740|NCT00744406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6521741|NCT00744406|Serotonin Agents|serotonin agents|mesh-ancestor
6521742|NCT00744406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521743|NCT00744406|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6521744|NCT00744406|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6521745|NCT00744419|Pantoprazole|pantoprazole|mesh-list
6521746|NCT00744419|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6521747|NCT00744419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6521748|NCT00744419|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6521749|NCT00744419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6521750|NCT00744419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521751|NCT00744445|Epoetin Alfa|epoetin alfa|mesh-list
6521752|NCT00744445|Hematinics|hematinics|mesh-ancestor
6521753|NCT00744536|Lenalidomide|lenalidomide|mesh-list
6521754|NCT00744536|Melphalan|melphalan|mesh-list
6521755|NCT00744536|Immunologic Factors|immunologic factors|mesh-ancestor
6521756|NCT00744536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521757|NCT00744536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6521758|NCT00744536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6521759|NCT00744536|Growth Substances|growth substances|mesh-ancestor
6521760|NCT00744536|Growth Inhibitors|growth inhibitors|mesh-ancestor
6521761|NCT00744536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6521762|NCT00744536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6521763|NCT00744536|Alkylating Agents|alkylating agents|mesh-ancestor
6521764|NCT00744536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521765|NCT00744536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6521766|NCT00744536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6521767|NCT00744549|Vitamin D|vitamin d|mesh-list
6521768|NCT00744549|Cholecalciferol|cholecalciferol|mesh-list
6521769|NCT00744549|Vitamins|vitamins|mesh-list
6521770|NCT00744549|Vitamin E|vitamin e|mesh-list
6521771|NCT00744549|Selenium|selenium|mesh-list
6521772|NCT00744549|Lycopene|lycopene|mesh-list
6521773|NCT00744549|Micronutrients|micronutrients|mesh-ancestor
6521774|NCT00744549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521775|NCT00744549|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6521776|NCT00744549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6521777|NCT00744549|Antioxidants|antioxidants|mesh-ancestor
6521778|NCT00744549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521779|NCT00744549|Protective Agents|protective agents|mesh-ancestor
6521780|NCT00744549|Trace Elements|trace elements|mesh-ancestor
6521781|NCT00744549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6521782|NCT00744549|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6521783|NCT00744549|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6521784|NCT00744549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6521785|NCT00744640|Gemcitabine|gemcitabine|mesh-list
6521786|NCT00744640|Capecitabine|capecitabine|mesh-list
6521787|NCT00744640|Oxaliplatin|oxaliplatin|mesh-list
6521788|NCT00744640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6521789|NCT00744640|Antimetabolites|antimetabolites|mesh-ancestor
6521790|NCT00744640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521791|NCT00744640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6521792|NCT00744640|Antiviral Agents|antiviral agents|mesh-ancestor
6521793|NCT00744640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6521794|NCT00744640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6521795|NCT00744640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6521796|NCT00744640|Immunologic Factors|immunologic factors|mesh-ancestor
6521797|NCT00744640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521798|NCT00744666|Prednisolone|prednisolone|mesh-list
6521799|NCT00744666|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6521800|NCT00744666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6521801|NCT00744666|Glucocorticoids|glucocorticoids|mesh-ancestor
6521802|NCT00744666|Hormones|hormones|mesh-ancestor
6521803|NCT00744666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6521804|NCT00744666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521805|NCT00744666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6521806|NCT00744666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6521807|NCT00744666|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6521808|NCT00744679|Natalizumab|natalizumab|mesh-list
6521809|NCT00744679|Immunologic Factors|immunologic factors|mesh-ancestor
6521810|NCT00744679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521811|NCT00744718|Bevacizumab|bevacizumab|mesh-list
6521812|NCT00744718|Carboplatin|carboplatin|mesh-list
6521813|NCT00744718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6521814|NCT00744718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6521815|NCT00744718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6521816|NCT00744718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6521817|NCT00744718|Growth Substances|growth substances|mesh-ancestor
6521818|NCT00744718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521819|NCT00744718|Growth Inhibitors|growth inhibitors|mesh-ancestor
6521820|NCT00744770|Rilpivirine|rilpivirine|mesh-list
6521821|NCT00744770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6521822|NCT00744770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6521823|NCT00744770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6521824|NCT00744770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521825|NCT00744770|Antiviral Agents|antiviral agents|mesh-ancestor
6521826|NCT00744770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6521827|NCT00744770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6521828|NCT00744770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6521829|NCT00744809|Moxifloxacin|moxifloxacin|mesh-list
6521830|NCT00744809|Efavirenz|efavirenz|mesh-list
6521831|NCT00744809|Rilpivirine|rilpivirine|mesh-list
6521832|NCT00744809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6521833|NCT00744809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6521834|NCT00744809|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6521835|NCT00744809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6521836|NCT00744809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6521837|NCT00744809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521838|NCT00744809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6521839|NCT00744809|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6521840|NCT00744809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6521841|NCT00744809|Antiviral Agents|antiviral agents|mesh-ancestor
6521842|NCT00744809|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6686012|NCT01637233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6686013|NCT01637233|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6686014|NCT01637233|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6686015|NCT01637233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6686016|NCT01637233|Antimetabolites|antimetabolites|mesh-ancestor
6686017|NCT01637233|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6686018|NCT01637233|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6686019|NCT01637233|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6686020|NCT01637259|Ritonavir|ritonavir|mesh-list
6686021|NCT01637259|Lopinavir|lopinavir|mesh-list
6686022|NCT01637259|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6686023|NCT01637259|Darunavir|darunavir|mesh-list
6686024|NCT01637259|Fosamprenavir|fosamprenavir|mesh-list
6686025|NCT01637259|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
6686026|NCT01637259|Tenofovir|tenofovir|mesh-list
6686027|NCT01637259|Lamivudine|lamivudine|mesh-list
6686028|NCT01637259|Zidovudine|zidovudine|mesh-list
6686029|NCT01637259|Emtricitabine|emtricitabine|mesh-list
6686030|NCT01637259|Maraviroc|maraviroc|mesh-list
6686031|NCT01637259|Abacavir|abacavir|mesh-list
6686032|NCT01637259|Dideoxynucleosides|dideoxynucleosides|mesh-list
6686033|NCT01637259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
6521843|NCT00744809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6521844|NCT00744809|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6521845|NCT00744809|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6521846|NCT00744809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6521847|NCT00744809|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6521848|NCT00744809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6521849|NCT00744809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6521850|NCT00744887|Darunavir|darunavir|mesh-list
6521851|NCT00744887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6521852|NCT00744887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6521853|NCT00744887|Protease Inhibitors|protease inhibitors|mesh-ancestor
6521854|NCT00744887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6521855|NCT00744887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521856|NCT00744887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6521857|NCT00744887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6521858|NCT00744887|Antiviral Agents|antiviral agents|mesh-ancestor
6521859|NCT00744887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6521860|NCT00744900|Pemetrexed|pemetrexed|mesh-list
6521861|NCT00744900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6521862|NCT00744900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6521863|NCT00744900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521864|NCT00744900|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6521865|NCT00744900|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6521866|NCT00744913|Nicotine|nicotine|mesh-list
6521867|NCT00744913|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6521868|NCT00744913|Autonomic Agents|autonomic agents|mesh-ancestor
6521869|NCT00744913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6521870|NCT00744913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521871|NCT00744913|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6521872|NCT00744913|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6521873|NCT00744913|Cholinergic Agents|cholinergic agents|mesh-ancestor
6521874|NCT00744913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6521875|NCT00744913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521876|NCT00745004|Ondansetron|ondansetron|mesh-list
6521877|NCT00745004|Antiemetics|antiemetics|mesh-ancestor
6521878|NCT00745004|Autonomic Agents|autonomic agents|mesh-ancestor
6521879|NCT00745004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6521880|NCT00745004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521881|NCT00745004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6521882|NCT00745004|Antipruritics|antipruritics|mesh-ancestor
6521883|NCT00745004|Dermatologic Agents|dermatologic agents|mesh-ancestor
6521884|NCT00745004|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6521885|NCT00745004|Serotonin Agents|serotonin agents|mesh-ancestor
6521886|NCT00745004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6521887|NCT00745004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521888|NCT00745004|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6521889|NCT00745004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6521890|NCT00745004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6521891|NCT00745004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6521892|NCT00745004|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6521893|NCT00745017|Antidepressive Agents|antidepressive agents|mesh-list
6521894|NCT00745017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6521895|NCT00745043|Bronchodilator Agents|bronchodilator agents|mesh-list
6521896|NCT00745043|Autonomic Agents|autonomic agents|mesh-ancestor
6521897|NCT00745043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6521898|NCT00745043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521899|NCT00745043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6521900|NCT00745043|Respiratory System Agents|respiratory system agents|mesh-ancestor
6521901|NCT00745069|Tapentadol|tapentadol|mesh-list
6521902|NCT00745069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6521903|NCT00745069|Narcotics|narcotics|mesh-ancestor
6521904|NCT00745069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6521905|NCT00745069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521906|NCT00745069|Analgesics|analgesics|mesh-ancestor
6521907|NCT00745069|Sensory System Agents|sensory system agents|mesh-ancestor
6521908|NCT00745069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6521909|NCT00745069|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6521910|NCT00745069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6521911|NCT00745069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6521912|NCT00745069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521913|NCT00745069|Adrenergic Agents|adrenergic agents|mesh-ancestor
6521914|NCT00745069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6521915|NCT00745134|Curcumin|curcumin|mesh-list
6521916|NCT00745134|Capecitabine|capecitabine|mesh-list
6521917|NCT00745134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6521918|NCT00745134|Antimetabolites|antimetabolites|mesh-ancestor
6521919|NCT00745134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521920|NCT00745134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6521921|NCT00745134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6521922|NCT00745134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6521923|NCT00745134|Analgesics|analgesics|mesh-ancestor
6521924|NCT00745134|Sensory System Agents|sensory system agents|mesh-ancestor
6521925|NCT00745134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6521926|NCT00745134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521927|NCT00745134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6521928|NCT00745134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6521929|NCT00745134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6521930|NCT00745147|Laxatives|laxatives|mesh-list
6521931|NCT00745147|Lactulose|lactulose|mesh-list
6521932|NCT00745147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6521933|NCT00745173|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6521934|NCT00745173|Estrogens|estrogens|mesh-ancestor
6521935|NCT00745173|Hormones|hormones|mesh-ancestor
6521936|NCT00745173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6521937|NCT00745173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521938|NCT00745186|Glucagon|glucagon|mesh-list
6521939|NCT00745186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6521940|NCT00745186|Hormones|hormones|mesh-ancestor
6521941|NCT00745186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6521942|NCT00745186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521943|NCT00745199|Cromolyn Sodium|cromolyn sodium|mesh-list
6521944|NCT00745199|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
6521945|NCT00745199|Immunologic Factors|immunologic factors|mesh-ancestor
6521946|NCT00745199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521947|NCT00745199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6521948|NCT00745199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6521949|NCT00745199|Respiratory System Agents|respiratory system agents|mesh-ancestor
6521950|NCT00745225|Pioglitazone|pioglitazone|mesh-list
6521951|NCT00745225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6521952|NCT00745225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521953|NCT00745407|Fenofibrate|fenofibrate|mesh-list
6521954|NCT00745407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6521955|NCT00745407|Antimetabolites|antimetabolites|mesh-ancestor
6686034|NCT01637259|Protease Inhibitors|protease inhibitors|mesh-list
6686035|NCT01637259|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6686036|NCT01637259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6686037|NCT01637259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686038|NCT01637259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6686039|NCT01637259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6686040|NCT01637259|Antiviral Agents|antiviral agents|mesh-ancestor
6686041|NCT01637259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6686042|NCT01637259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6686043|NCT01637259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6686044|NCT01637259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6686045|NCT01637259|Antimetabolites|antimetabolites|mesh-ancestor
6686046|NCT01637259|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6686047|NCT01637259|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6686048|NCT01637259|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6686049|NCT01637376|Temoporfin|temoporfin|mesh-list
6686050|NCT01637376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6686051|NCT01637376|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6686052|NCT01637376|Dermatologic Agents|dermatologic agents|mesh-ancestor
6686053|NCT01637454|Terlipressin|terlipressin|mesh-list
6686054|NCT01637454|Norepinephrine|norepinephrine|mesh-list
6686055|NCT01637454|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6686056|NCT01637454|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6686057|NCT01637454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6686058|NCT01637454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6686059|NCT01637454|Adrenergic Agents|adrenergic agents|mesh-ancestor
6521956|NCT00745407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521957|NCT00745407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6521958|NCT00745433|Metformin|metformin|mesh-list
6521959|NCT00745433|Repaglinide|repaglinide|mesh-list
6521960|NCT00745433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6521961|NCT00745433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521962|NCT00745485|Zoledronic Acid|zoledronic acid|mesh-list
6521963|NCT00745485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6521964|NCT00745485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521965|NCT00745511|Bevacizumab|bevacizumab|mesh-list
6521966|NCT00745511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6521967|NCT00745511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6521968|NCT00745511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6521969|NCT00745511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6521970|NCT00745511|Growth Substances|growth substances|mesh-ancestor
6521971|NCT00745511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521972|NCT00745511|Growth Inhibitors|growth inhibitors|mesh-ancestor
6521973|NCT00745589|Sevelamer|sevelamer|mesh-list
6686060|NCT01637454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6686061|NCT01637454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686062|NCT01637454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686063|NCT01637454|Sympathomimetics|sympathomimetics|mesh-ancestor
6521974|NCT00745589|Chelating Agents|chelating agents|mesh-ancestor
6521975|NCT00745589|Sequestering Agents|sequestering agents|mesh-ancestor
6521976|NCT00745589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686064|NCT01637454|Autonomic Agents|autonomic agents|mesh-ancestor
6686065|NCT01637454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6686066|NCT01637532|Interferons|interferons|mesh-list
6686067|NCT01637532|Interferon-alpha|interferon-alpha|mesh-list
6686068|NCT01637532|Interferon alpha-2|interferon alpha-2|mesh-list
6686069|NCT01637532|Carboplatin|carboplatin|mesh-list
6686070|NCT01637532|Doxorubicin|doxorubicin|mesh-list
6686071|NCT01637532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6686072|NCT01637532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6686073|NCT01637532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6686074|NCT01637532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6686075|NCT01637532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6686076|NCT01637532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686077|NCT01637532|Antiviral Agents|antiviral agents|mesh-ancestor
6686078|NCT01637532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6686079|NCT01637532|Immunologic Factors|immunologic factors|mesh-ancestor
6686080|NCT01637532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686081|NCT01637545|Ramosetron|ramosetron|mesh-list
6686082|NCT01637545|Antiemetics|antiemetics|mesh-ancestor
6686083|NCT01637545|Autonomic Agents|autonomic agents|mesh-ancestor
6686084|NCT01637545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6686085|NCT01637545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686086|NCT01637545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6686087|NCT01637545|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6686088|NCT01637545|Serotonin Agents|serotonin agents|mesh-ancestor
6686089|NCT01637545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6686090|NCT01637545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686091|NCT01637558|Ritonavir|ritonavir|mesh-list
6686092|NCT01637558|Lopinavir|lopinavir|mesh-list
6686093|NCT01637558|Nevirapine|nevirapine|mesh-list
6686094|NCT01637558|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6686095|NCT01637558|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6686096|NCT01637558|Protease Inhibitors|protease inhibitors|mesh-ancestor
6686097|NCT01637558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6686098|NCT01637558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686099|NCT01637558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6686100|NCT01637558|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6686101|NCT01637558|Antiviral Agents|antiviral agents|mesh-ancestor
6686102|NCT01637558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6686103|NCT01637558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6686104|NCT01637558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6686105|NCT01637558|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6686106|NCT01637558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6686107|NCT01637558|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6686108|NCT01637558|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6686109|NCT01637571|Dexlansoprazole|dexlansoprazole|mesh-list
6686110|NCT01637571|Lansoprazole|lansoprazole|mesh-list
6686111|NCT01637571|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6686112|NCT01637571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6686113|NCT01637571|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6686114|NCT01637571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6686115|NCT01637571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686116|NCT01637636|Rifampin|rifampin|mesh-list
6686117|NCT01637636|Ketoconazole|ketoconazole|mesh-list
6686118|NCT01637636|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6686119|NCT01637636|Antitubercular Agents|antitubercular agents|mesh-ancestor
6686120|NCT01637636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6686121|NCT01637636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6686122|NCT01637636|Leprostatic Agents|leprostatic agents|mesh-ancestor
6521977|NCT00745693|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
6521978|NCT00745693|BQ 788|bq 788|mesh-list
6686123|NCT01637636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6686124|NCT01637636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6686125|NCT01637636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686126|NCT01637636|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6686127|NCT01637636|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6686128|NCT01637636|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6686129|NCT01637636|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6686130|NCT01637636|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6686131|NCT01637636|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6686132|NCT01637636|Antifungal Agents|antifungal agents|mesh-ancestor
6686133|NCT01637636|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6686134|NCT01637636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6686135|NCT01637636|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6686136|NCT01637636|Hormone Antagonists|hormone antagonists|mesh-ancestor
6686137|NCT01637636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6686138|NCT01637636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686139|NCT01637636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6686140|NCT01637675|Tanshinone|tanshinone|mesh-list
6686141|NCT01637675|Sildenafil Citrate|sildenafil citrate|mesh-list
6686142|NCT01637675|Citric Acid|citric acid|mesh-list
6686143|NCT01637675|Sodium Citrate|sodium citrate|mesh-list
6686144|NCT01637675|Anticoagulants|anticoagulants|mesh-ancestor
6686145|NCT01637675|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6686146|NCT01637675|Chelating Agents|chelating agents|mesh-ancestor
6686147|NCT01637675|Sequestering Agents|sequestering agents|mesh-ancestor
6686148|NCT01637675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686149|NCT01637675|Vasodilator Agents|vasodilator agents|mesh-ancestor
6686150|NCT01637675|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6686151|NCT01637675|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6686152|NCT01637675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6686153|NCT01637675|Urological Agents|urological agents|mesh-ancestor
6686154|NCT01637675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6686155|NCT01637675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6686156|NCT01637675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6686157|NCT01637675|Analgesics|analgesics|mesh-ancestor
6686158|NCT01637675|Sensory System Agents|sensory system agents|mesh-ancestor
6686159|NCT01637675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6686160|NCT01637675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686161|NCT01637675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6686162|NCT01637675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6686163|NCT01637675|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6686164|NCT01637675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6686165|NCT01637675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6686166|NCT01637675|Immunologic Factors|immunologic factors|mesh-ancestor
6686167|NCT01637753|Carmustine|carmustine|mesh-list
6686168|NCT01637753|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6686169|NCT01637753|Alkylating Agents|alkylating agents|mesh-ancestor
6686170|NCT01637753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686171|NCT01637753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6686172|NCT01637766|Melphalan|melphalan|mesh-list
6686173|NCT01637766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6686174|NCT01637766|Alkylating Agents|alkylating agents|mesh-ancestor
6686175|NCT01637766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686176|NCT01637766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6686177|NCT01637766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6686178|NCT01637766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6686179|NCT01637766|Immunologic Factors|immunologic factors|mesh-ancestor
6686180|NCT01637766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686181|NCT01637818|Acetaminophen|acetaminophen|mesh-list
6686182|NCT01637818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
6686183|NCT01637818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
6521979|NCT00745693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6521980|NCT00745693|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6521981|NCT00745693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521982|NCT00745693|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
6521983|NCT00745810|Complement System Proteins|complement system proteins|mesh-list
6521984|NCT00745810|Immunologic Factors|immunologic factors|mesh-ancestor
6521985|NCT00745810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521986|NCT00745914|Pioglitazone|pioglitazone|mesh-list
6521987|NCT00745914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6521988|NCT00745914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521989|NCT00745953|Valsartan|valsartan|mesh-list
6521990|NCT00745953|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6521991|NCT00745953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6521992|NCT00745953|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6521993|NCT00745953|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6521994|NCT00745953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686184|NCT01637818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6686185|NCT01637818|Analgesics|analgesics|mesh-ancestor
6686186|NCT01637818|Sensory System Agents|sensory system agents|mesh-ancestor
6686187|NCT01637818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6686188|NCT01637818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686189|NCT01637818|Antipyretics|antipyretics|mesh-ancestor
6686190|NCT01637818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6686191|NCT01637844|Telbivudine|telbivudine|mesh-list
6686192|NCT01637844|Antiviral Agents|antiviral agents|mesh-ancestor
6686193|NCT01637844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6686194|NCT01637844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6686195|NCT01637844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6686196|NCT01637844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6521995|NCT00745953|Diuretics|diuretics|mesh-ancestor
6521996|NCT00745953|Natriuretic Agents|natriuretic agents|mesh-ancestor
6521997|NCT00745953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6521998|NCT00745953|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6521999|NCT00745953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6522000|NCT00746031|Goserelin|goserelin|mesh-list
6686197|NCT01637883|Benzydamine|benzydamine|mesh-list
6686198|NCT01637883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6686199|NCT01637948|Listerine|listerine|mesh-list
6686200|NCT01637948|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6686201|NCT01637948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6686202|NCT01638026|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6686203|NCT01638026|Luteolytic Agents|luteolytic agents|mesh-ancestor
6686204|NCT01638026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6686205|NCT01638026|Contraceptive Agents|contraceptive agents|mesh-ancestor
6686206|NCT01638026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6686207|NCT01638026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686208|NCT01638026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6686209|NCT01638026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6686210|NCT01638026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6522001|NCT00746031|Cetrorelix|cetrorelix|mesh-list
6686211|NCT01638078|Thalidomide|thalidomide|mesh-list
6686212|NCT01638078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6686213|NCT01638078|Immunologic Factors|immunologic factors|mesh-ancestor
6686214|NCT01638078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686215|NCT01638078|Leprostatic Agents|leprostatic agents|mesh-ancestor
6686216|NCT01638078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6686217|NCT01638078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6686218|NCT01638078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6686219|NCT01638078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6686220|NCT01638078|Growth Substances|growth substances|mesh-ancestor
6686221|NCT01638078|Growth Inhibitors|growth inhibitors|mesh-ancestor
6686222|NCT01638078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6780223|NCT02182505|Respiratory System Agents|respiratory system agents|mesh-ancestor
6780224|NCT02182505|Sympathomimetics|sympathomimetics|mesh-ancestor
6780225|NCT02182505|Tocolytic Agents|tocolytic agents|mesh-ancestor
6780226|NCT02182505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6780227|NCT02182505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6780228|NCT02182505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6780229|NCT02182505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6780230|NCT02182505|Adrenergic Agents|adrenergic agents|mesh-ancestor
6780231|NCT02182505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6780232|NCT02182505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780233|NCT02182505|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6780234|NCT02182505|Cholinergic Agents|cholinergic agents|mesh-ancestor
6780235|NCT02182518|Pseudoephedrine|pseudoephedrine|mesh-list
6780236|NCT02182518|Ephedrine|ephedrine|mesh-list
6780237|NCT02182518|Epinastine|epinastine|mesh-list
6780238|NCT02182518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6780239|NCT02182518|Autonomic Agents|autonomic agents|mesh-ancestor
6780240|NCT02182518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6780241|NCT02182518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780242|NCT02182518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6780243|NCT02182518|Respiratory System Agents|respiratory system agents|mesh-ancestor
6686223|NCT01638182|Vitamins|vitamins|mesh-list
6686224|NCT01638182|Vitamin K|vitamin k|mesh-list
6686225|NCT01638182|Vitamin K 2|vitamin k 2|mesh-list
6686226|NCT01638182|Vitamin K 1|vitamin k 1|mesh-list
6686227|NCT01638182|Micronutrients|micronutrients|mesh-ancestor
6522002|NCT00746031|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
6522003|NCT00746031|Hormones|hormones|mesh-ancestor
6522004|NCT00746031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6522005|NCT00746031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522006|NCT00746031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6522007|NCT00746031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6522008|NCT00746031|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6522009|NCT00746031|Fertility Agents|fertility agents|mesh-ancestor
6522010|NCT00746031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6522011|NCT00746031|Hormone Antagonists|hormone antagonists|mesh-ancestor
6522012|NCT00746070|Spironolactone|spironolactone|mesh-list
6522013|NCT00746070|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6522014|NCT00746070|Hormone Antagonists|hormone antagonists|mesh-ancestor
6522015|NCT00746070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6522016|NCT00746070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522017|NCT00746070|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6522018|NCT00746070|Diuretics|diuretics|mesh-ancestor
6522019|NCT00746070|Natriuretic Agents|natriuretic agents|mesh-ancestor
6522020|NCT00746174|Rosiglitazone|rosiglitazone|mesh-list
6522021|NCT00746174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6522022|NCT00746174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522023|NCT00746447|Mesalamine|mesalamine|mesh-list
6686228|NCT01638182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686229|NCT01638182|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6686230|NCT01638182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6686231|NCT01638182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686232|NCT01638182|Hemostatics|hemostatics|mesh-ancestor
6686233|NCT01638182|Coagulants|coagulants|mesh-ancestor
6686234|NCT01638234|Melatonin|melatonin|mesh-list
6686235|NCT01638234|Antioxidants|antioxidants|mesh-ancestor
6686236|NCT01638234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686237|NCT01638234|Protective Agents|protective agents|mesh-ancestor
6686238|NCT01638234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686239|NCT01638234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6686240|NCT01638247|Tamoxifen|tamoxifen|mesh-list
6522024|NCT00746447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6522025|NCT00746447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6522026|NCT00746447|Analgesics|analgesics|mesh-ancestor
6686241|NCT01638247|Goserelin|goserelin|mesh-list
6686242|NCT01638247|Exemestane|exemestane|mesh-list
6686243|NCT01638247|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
6686244|NCT01638247|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6686245|NCT01638247|Hormone Antagonists|hormone antagonists|mesh-ancestor
6686246|NCT01638247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6686247|NCT01638247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686248|NCT01638247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6686249|NCT01638247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6686250|NCT01638247|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6686251|NCT01638247|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6686252|NCT01638247|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6686253|NCT01638247|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6686254|NCT01638247|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6686255|NCT01638247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6686256|NCT01638247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686257|NCT01638247|Hormones|hormones|mesh-ancestor
6686258|NCT01638260|Liraglutide|liraglutide|mesh-list
6686259|NCT01638260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6686260|NCT01638260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686261|NCT01638260|Incretins|incretins|mesh-ancestor
6686262|NCT01638260|Hormones|hormones|mesh-ancestor
6686263|NCT01638260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6686264|NCT01638273|Pregabalin|pregabalin|mesh-list
6686265|NCT01638273|Analgesics|analgesics|mesh-ancestor
6522027|NCT00746447|Sensory System Agents|sensory system agents|mesh-ancestor
6522028|NCT00746447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6522029|NCT00746447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522030|NCT00746447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6522031|NCT00746447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6686266|NCT01638273|Sensory System Agents|sensory system agents|mesh-ancestor
6780244|NCT02182518|Nasal Decongestants|nasal decongestants|mesh-ancestor
6522032|NCT00746486|Budesonide|budesonide|mesh-list
6522033|NCT00746486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6522034|NCT00746486|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6522035|NCT00746486|Autonomic Agents|autonomic agents|mesh-ancestor
6522036|NCT00746486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6686267|NCT01638273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6686268|NCT01638273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686269|NCT01638273|Anticonvulsants|anticonvulsants|mesh-ancestor
6686270|NCT01638273|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6686271|NCT01638273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6686272|NCT01638273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686273|NCT01638273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6686274|NCT01638273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6522037|NCT00746486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522038|NCT00746486|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6522039|NCT00746486|Respiratory System Agents|respiratory system agents|mesh-ancestor
6522040|NCT00746486|Glucocorticoids|glucocorticoids|mesh-ancestor
6522041|NCT00746486|Hormones|hormones|mesh-ancestor
6522042|NCT00746486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6522043|NCT00746499|Raltegravir Potassium|raltegravir potassium|mesh-list
6522044|NCT00746499|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6522045|NCT00746499|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6686275|NCT01638273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6686276|NCT01638273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6686277|NCT01638273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6686278|NCT01638299|Insulin|insulin|mesh-list
6686279|NCT01638299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6686280|NCT01638299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686281|NCT01638325|Insulin|insulin|mesh-list
6686282|NCT01638325|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6686283|NCT01638325|Insulin Lispro|insulin lispro|mesh-list
6686284|NCT01638325|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6686285|NCT01638325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686286|NCT01638364|Ethanol|ethanol|mesh-list
6686287|NCT01638364|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6686288|NCT01638364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6686289|NCT01638364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6686290|NCT01638364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686291|NCT01638377|Naltrexone|naltrexone|mesh-list
6686292|NCT01638377|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6686293|NCT01638377|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6686294|NCT01638377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686295|NCT01638377|Sensory System Agents|sensory system agents|mesh-ancestor
6686296|NCT01638377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6686297|NCT01638403|Modafinil|modafinil|mesh-list
6686298|NCT01638403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6686299|NCT01638403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686300|NCT01638403|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6686301|NCT01638403|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6686302|NCT01638403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6686303|NCT01638403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522046|NCT00746499|Antiviral Agents|antiviral agents|mesh-ancestor
6522047|NCT00746499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6522048|NCT00746499|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6522049|NCT00746499|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6686304|NCT01638442|Tosedostat|tosedostat|mesh-list
6686305|NCT01638442|Glycine|glycine|mesh-list
6686306|NCT01638442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6686307|NCT01638442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686308|NCT01638442|Glycine Agents|glycine agents|mesh-ancestor
6686309|NCT01638442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6686310|NCT01638442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686311|NCT01638624|Propofol|propofol|mesh-list
6522050|NCT00746499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6522051|NCT00746499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522052|NCT00746655|Cisplatin|cisplatin|mesh-list
6522053|NCT00746655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6522054|NCT00746681|Pregabalin|pregabalin|mesh-list
6522055|NCT00746681|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6522056|NCT00746681|Analgesics|analgesics|mesh-ancestor
6522057|NCT00746681|Sensory System Agents|sensory system agents|mesh-ancestor
6522058|NCT00746681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6522059|NCT00746681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522060|NCT00746681|Anticonvulsants|anticonvulsants|mesh-ancestor
6522061|NCT00746681|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6522062|NCT00746681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6522063|NCT00746681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522064|NCT00746681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6522065|NCT00746681|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6522066|NCT00746681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6522067|NCT00746681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6522068|NCT00746681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6522069|NCT00746681|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6522070|NCT00746681|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6522071|NCT00746681|Cholinergic Agents|cholinergic agents|mesh-ancestor
6522072|NCT00746681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6522073|NCT00746681|Urological Agents|urological agents|mesh-ancestor
6522074|NCT00746720|Etoricoxib|etoricoxib|mesh-list
6522075|NCT00746720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6522076|NCT00746720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6522077|NCT00746720|Analgesics|analgesics|mesh-ancestor
6522078|NCT00746720|Sensory System Agents|sensory system agents|mesh-ancestor
6522079|NCT00746720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6522080|NCT00746720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686312|NCT01638624|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6686313|NCT01638624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6686314|NCT01638624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686315|NCT01638624|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6686316|NCT01638624|Anesthetics, General|anesthetics, general|mesh-ancestor
6686317|NCT01638624|Anesthetics|anesthetics|mesh-ancestor
6522081|NCT00746720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6522082|NCT00746720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6522083|NCT00746720|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6522084|NCT00746720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6522085|NCT00746720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6522086|NCT00746720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522087|NCT00746746|Interferons|interferons|mesh-list
6522088|NCT00746746|Interferon-alpha|interferon-alpha|mesh-list
6522089|NCT00746746|Interferon alpha-2|interferon alpha-2|mesh-list
6522090|NCT00746746|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6522091|NCT00746746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6522092|NCT00746746|Antiviral Agents|antiviral agents|mesh-ancestor
6522093|NCT00746746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6522094|NCT00746746|Immunologic Factors|immunologic factors|mesh-ancestor
6522095|NCT00746746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522096|NCT00746837|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
6522097|NCT00746837|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6522098|NCT00746837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522099|NCT00746837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6522100|NCT00746837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6522101|NCT00746837|Antiviral Agents|antiviral agents|mesh-ancestor
6522102|NCT00746837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6522103|NCT00746967|Sildenafil Citrate|sildenafil citrate|mesh-list
6522104|NCT00746967|Vasodilator Agents|vasodilator agents|mesh-ancestor
6522105|NCT00746967|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6686318|NCT01638650|Ritonavir|ritonavir|mesh-list
6522106|NCT00746967|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6522107|NCT00746967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6522108|NCT00746967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522109|NCT00746967|Urological Agents|urological agents|mesh-ancestor
6522110|NCT00746993|Contraceptive Agents|contraceptive agents|mesh-list
6522111|NCT00746993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6522112|NCT00746993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522113|NCT00747097|Gemcitabine|gemcitabine|mesh-list
6522114|NCT00747097|Cetuximab|cetuximab|mesh-list
6522115|NCT00747097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6522116|NCT00747097|Antimetabolites|antimetabolites|mesh-ancestor
6522117|NCT00747097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522118|NCT00747097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6522119|NCT00747097|Antiviral Agents|antiviral agents|mesh-ancestor
6522120|NCT00747097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6522121|NCT00747097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6522122|NCT00747097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6522123|NCT00747097|Immunologic Factors|immunologic factors|mesh-ancestor
6522124|NCT00747097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522125|NCT00747097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6522126|NCT00747110|Budesonide|budesonide|mesh-list
6522127|NCT00747110|Mesalamine|mesalamine|mesh-list
6522128|NCT00747110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6522129|NCT00747110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6522130|NCT00747110|Autonomic Agents|autonomic agents|mesh-ancestor
6522131|NCT00747110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6522132|NCT00747110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522133|NCT00747110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6522134|NCT00747110|Respiratory System Agents|respiratory system agents|mesh-ancestor
6522135|NCT00747110|Glucocorticoids|glucocorticoids|mesh-ancestor
6522136|NCT00747110|Hormones|hormones|mesh-ancestor
6522137|NCT00747110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6522138|NCT00747110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6522139|NCT00747110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6522140|NCT00747110|Analgesics|analgesics|mesh-ancestor
6522141|NCT00747110|Sensory System Agents|sensory system agents|mesh-ancestor
6522142|NCT00747110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6522143|NCT00747279|Insulin|insulin|mesh-list
6522144|NCT00747279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6522145|NCT00747279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522146|NCT00747305|Sunitinib|sunitinib|mesh-list
6522147|NCT00747305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6522148|NCT00747305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6522149|NCT00747305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6522150|NCT00747305|Growth Substances|growth substances|mesh-ancestor
6522151|NCT00747305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522152|NCT00747305|Growth Inhibitors|growth inhibitors|mesh-ancestor
6522153|NCT00747305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6522154|NCT00747305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6522155|NCT00747305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522156|NCT00747331|Fenoldopam|fenoldopam|mesh-list
6522157|NCT00747331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6522158|NCT00747331|Vasodilator Agents|vasodilator agents|mesh-ancestor
6522159|NCT00747331|Dopamine Agonists|dopamine agonists|mesh-ancestor
6522160|NCT00747331|Dopamine Agents|dopamine agents|mesh-ancestor
6522161|NCT00747331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6522162|NCT00747331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522163|NCT00747331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522164|NCT00747383|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6522165|NCT00747383|Glimepiride|glimepiride|mesh-list
6522166|NCT00747383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6522167|NCT00747383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522168|NCT00747383|Incretins|incretins|mesh-ancestor
6522169|NCT00747383|Hormones|hormones|mesh-ancestor
6522170|NCT00747383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6522171|NCT00747383|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6522172|NCT00747383|Protease Inhibitors|protease inhibitors|mesh-ancestor
6522173|NCT00747383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6522174|NCT00747383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522175|NCT00747383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6522176|NCT00747383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6522177|NCT00747383|Immunologic Factors|immunologic factors|mesh-ancestor
6522178|NCT00747409|Insulin|insulin|mesh-list
6522179|NCT00747409|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6522180|NCT00747409|Insulin Aspart|insulin aspart|mesh-list
6522181|NCT00747409|Insulin Detemir|insulin detemir|mesh-list
6522182|NCT00747409|Insulin, Long-Acting|insulin, long-acting|mesh-list
6522183|NCT00747409|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6522184|NCT00747409|Insulin, Isophane|insulin, isophane|mesh-list
6522185|NCT00747409|Isophane Insulin, Human|isophane insulin, human|mesh-list
6522186|NCT00747409|Isophane insulin, beef|isophane insulin, beef|mesh-list
6522187|NCT00747409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6522188|NCT00747409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522189|NCT00747487|Idebenone|idebenone|mesh-list
6522190|NCT00747487|Antioxidants|antioxidants|mesh-ancestor
6522191|NCT00747487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522192|NCT00747487|Protective Agents|protective agents|mesh-ancestor
6522193|NCT00747487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686319|NCT01638650|Saquinavir|saquinavir|mesh-list
6686320|NCT01638650|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
6686321|NCT01638650|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6686322|NCT01638650|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6686323|NCT01638650|Protease Inhibitors|protease inhibitors|mesh-ancestor
6686324|NCT01638650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6686325|NCT01638650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686326|NCT01638650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6686327|NCT01638650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6686328|NCT01638650|Antiviral Agents|antiviral agents|mesh-ancestor
6686329|NCT01638650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6686330|NCT01638650|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6686331|NCT01638650|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6686332|NCT01638650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6686333|NCT01638663|Tolvaptan|tolvaptan|mesh-list
6686334|NCT01638663|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6686335|NCT01638663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686336|NCT01638663|Natriuretic Agents|natriuretic agents|mesh-ancestor
6686337|NCT01638663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686338|NCT01638676|Metformin|metformin|mesh-list
6686339|NCT01638676|Vemurafenib|vemurafenib|mesh-list
6686340|NCT01638676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6686341|NCT01638676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686342|NCT01638676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6686343|NCT01638676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6686344|NCT01638676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6686345|NCT01638676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686346|NCT01638689|Citalopram|citalopram|mesh-list
6686347|NCT01638689|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6686348|NCT01638689|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6686349|NCT01638689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6686350|NCT01638689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686351|NCT01638689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6686352|NCT01638689|Serotonin Agents|serotonin agents|mesh-ancestor
6686353|NCT01638689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686354|NCT01638689|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6686355|NCT01638689|Antidepressive Agents|antidepressive agents|mesh-ancestor
6686356|NCT01638689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6686357|NCT01638715|Rituximab|rituximab|mesh-list
6686358|NCT01638715|Abatacept|abatacept|mesh-list
6686359|NCT01638715|Infliximab|infliximab|mesh-list
6686360|NCT01638715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6686361|NCT01638715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6686362|NCT01638715|Immunologic Factors|immunologic factors|mesh-ancestor
6686363|NCT01638715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686364|NCT01638715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6686365|NCT01638715|Dermatologic Agents|dermatologic agents|mesh-ancestor
6686366|NCT01638715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6686367|NCT01638715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6686368|NCT01638715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686369|NCT01638715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6686370|NCT01638767|Contraceptive Agents|contraceptive agents|mesh-list
6686371|NCT01638767|NuvaRing|nuvaring|mesh-list
6686372|NCT01638767|Contraceptives, Oral|contraceptives, oral|mesh-list
6686373|NCT01638767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6686374|NCT01638767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686375|NCT01638767|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6686376|NCT01638767|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6522194|NCT00747526|Rabeprazole|rabeprazole|mesh-list
6522195|NCT00747526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6522196|NCT00747526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6522197|NCT00747526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6522198|NCT00747526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6686377|NCT01638780|Resveratrol|resveratrol|mesh-list
6686378|NCT01638780|Antioxidants|antioxidants|mesh-ancestor
6522199|NCT00747526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522200|NCT00747539|Interferons|interferons|mesh-list
6522201|NCT00747539|Ribavirin|ribavirin|mesh-list
6522202|NCT00747539|Interferon-alpha|interferon-alpha|mesh-list
6686379|NCT01638780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686380|NCT01638780|Protective Agents|protective agents|mesh-ancestor
6686381|NCT01638780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686382|NCT01638780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6686383|NCT01638780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6686384|NCT01638858|Ranibizumab|ranibizumab|mesh-list
6686385|NCT01638858|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6686386|NCT01638858|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6686387|NCT01638858|Growth Substances|growth substances|mesh-ancestor
6686388|NCT01638858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686389|NCT01638858|Growth Inhibitors|growth inhibitors|mesh-ancestor
6686390|NCT01638858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6522203|NCT00747539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6522204|NCT00747539|Antiviral Agents|antiviral agents|mesh-ancestor
6522205|NCT00747539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6522206|NCT00747539|Antimetabolites|antimetabolites|mesh-ancestor
6522207|NCT00747539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522208|NCT00747539|Immunologic Factors|immunologic factors|mesh-ancestor
6522209|NCT00747539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686391|NCT01638936|Maytansine|maytansine|mesh-list
6686392|NCT01638936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6686393|NCT01638936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6686394|NCT01638936|Tubulin Modulators|tubulin modulators|mesh-ancestor
6686395|NCT01638936|Antimitotic Agents|antimitotic agents|mesh-ancestor
6686396|NCT01638936|Mitosis Modulators|mitosis modulators|mesh-ancestor
6686397|NCT01638936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686398|NCT01638962|Acetaminophen|acetaminophen|mesh-list
6686399|NCT01638962|Aspirin|aspirin|mesh-list
6686400|NCT01638962|Ibuprofen|ibuprofen|mesh-list
6686401|NCT01638962|Celecoxib|celecoxib|mesh-list
6686402|NCT01638962|Diclofenac|diclofenac|mesh-list
6686403|NCT01638962|Naproxen|naproxen|mesh-list
6686404|NCT01638962|Indomethacin|indomethacin|mesh-list
6686405|NCT01638962|Etoricoxib|etoricoxib|mesh-list
6686406|NCT01638962|Meloxicam|meloxicam|mesh-list
6686407|NCT01638962|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
6522210|NCT00747604|Mecasermin|mecasermin|mesh-list
6522211|NCT00747604|Growth Substances|growth substances|mesh-ancestor
6522212|NCT00747604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522213|NCT00747669|Lidocaine|lidocaine|mesh-list
6522214|NCT00747669|Tetracaine|tetracaine|mesh-list
6522215|NCT00747669|Anesthetics, Local|anesthetics, local|mesh-ancestor
6522216|NCT00747669|Anesthetics|anesthetics|mesh-ancestor
6522217|NCT00747669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6522218|NCT00747669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522219|NCT00747669|Sensory System Agents|sensory system agents|mesh-ancestor
6522220|NCT00747669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6522221|NCT00747669|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6522222|NCT00747669|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6522223|NCT00747669|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6522224|NCT00747669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6522225|NCT00747669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522226|NCT00747695|Rabeprazole|rabeprazole|mesh-list
6522227|NCT00747695|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6522228|NCT00747695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6522229|NCT00747695|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6522230|NCT00747695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6522231|NCT00747695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522232|NCT00747708|Sargramostim|sargramostim|mesh-list
6522233|NCT00747708|Lenograstim|lenograstim|mesh-list
6522234|NCT00747708|Immunologic Factors|immunologic factors|mesh-ancestor
6522235|NCT00747708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522236|NCT00747708|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6522237|NCT00747721|Dexmedetomidine|dexmedetomidine|mesh-list
6686408|NCT01638962|Etodolac|etodolac|mesh-list
6686409|NCT01638962|Lornoxicam|lornoxicam|mesh-list
6686410|NCT01638962|Nabumetone|nabumetone|mesh-list
6686411|NCT01638962|Tenoxicam|tenoxicam|mesh-list
6686412|NCT01638962|Tiaprofenic acid|tiaprofenic acid|mesh-list
6686413|NCT01638962|Analgesics|analgesics|mesh-list
6686414|NCT01638962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6686415|NCT01638962|Sensory System Agents|sensory system agents|mesh-ancestor
6686416|NCT01638962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6522238|NCT00747721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6522239|NCT00747721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6522240|NCT00747721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522241|NCT00747721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6522242|NCT00747721|Analgesics|analgesics|mesh-ancestor
6522243|NCT00747721|Sensory System Agents|sensory system agents|mesh-ancestor
6522244|NCT00747721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6522245|NCT00747721|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6522246|NCT00747721|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6522247|NCT00747721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6522248|NCT00747721|Adrenergic Agents|adrenergic agents|mesh-ancestor
6522249|NCT00747721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6522250|NCT00747721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522251|NCT00747799|Fluorouracil|fluorouracil|mesh-list
6522252|NCT00747799|Sorafenib|sorafenib|mesh-list
6522253|NCT00747799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6522254|NCT00747799|Antimetabolites|antimetabolites|mesh-ancestor
6522255|NCT00747799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522256|NCT00747799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6522257|NCT00747799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6522258|NCT00747799|Immunologic Factors|immunologic factors|mesh-ancestor
6522259|NCT00747799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522260|NCT00747799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6522261|NCT00747799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6522262|NCT00747877|Cyclophosphamide|cyclophosphamide|mesh-list
6522263|NCT00747877|Melphalan|melphalan|mesh-list
6522264|NCT00747877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6522265|NCT00747877|Immunologic Factors|immunologic factors|mesh-ancestor
6522266|NCT00747877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522267|NCT00747877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6522268|NCT00747877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6522269|NCT00747877|Alkylating Agents|alkylating agents|mesh-ancestor
6522270|NCT00747877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522271|NCT00747877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6522272|NCT00747877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6522273|NCT00747903|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6522274|NCT00747903|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6522275|NCT00747903|Dermatologic Agents|dermatologic agents|mesh-ancestor
6522276|NCT00747968|Exenatide|exenatide|mesh-list
6522277|NCT00747968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6522278|NCT00747968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522279|NCT00747968|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6522280|NCT00747968|Incretins|incretins|mesh-ancestor
6522281|NCT00747968|Hormones|hormones|mesh-ancestor
6522282|NCT00747968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6522283|NCT00748007|Rivastigmine|rivastigmine|mesh-list
6522284|NCT00748007|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
6522285|NCT00748007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6522286|NCT00748007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522287|NCT00748007|Cholinergic Agents|cholinergic agents|mesh-ancestor
6522288|NCT00748007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6522289|NCT00748007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522290|NCT00748007|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6522291|NCT00748007|Protective Agents|protective agents|mesh-ancestor
6522292|NCT00748046|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
6522293|NCT00748046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6522294|NCT00748059|Propranolol|propranolol|mesh-list
6522295|NCT00748059|Atropine|atropine|mesh-list
6522296|NCT00748059|Clonidine|clonidine|mesh-list
6522297|NCT00748059|Nitroprusside|nitroprusside|mesh-list
6522298|NCT00748059|Methyldopa|methyldopa|mesh-list
6522299|NCT00748059|Phenylephrine|phenylephrine|mesh-list
6522300|NCT00748059|Isoproterenol|isoproterenol|mesh-list
6522301|NCT00748059|Metoclopramide|metoclopramide|mesh-list
6522302|NCT00748059|Yohimbine|yohimbine|mesh-list
6522303|NCT00748059|Tyramine|tyramine|mesh-list
6522304|NCT00748059|Edrophonium|edrophonium|mesh-list
6522305|NCT00748059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6522306|NCT00748059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6686417|NCT01638962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522307|NCT00748059|Adrenergic Agents|adrenergic agents|mesh-ancestor
6522308|NCT00748059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6522309|NCT00748059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522310|NCT00748059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522311|NCT00748059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6522312|NCT00748059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6522313|NCT00748059|Vasodilator Agents|vasodilator agents|mesh-ancestor
6522314|NCT00748059|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6522315|NCT00748059|Mydriatics|mydriatics|mesh-ancestor
6522316|NCT00748059|Autonomic Agents|autonomic agents|mesh-ancestor
6522317|NCT00748059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6522318|NCT00748059|Sympathomimetics|sympathomimetics|mesh-ancestor
6522319|NCT00748059|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6522320|NCT00748059|Nasal Decongestants|nasal decongestants|mesh-ancestor
6522321|NCT00748059|Respiratory System Agents|respiratory system agents|mesh-ancestor
6522322|NCT00748059|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6522323|NCT00748059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6522324|NCT00748059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6522325|NCT00748059|Protective Agents|protective agents|mesh-ancestor
6522326|NCT00748059|Analgesics|analgesics|mesh-ancestor
6522327|NCT00748059|Sensory System Agents|sensory system agents|mesh-ancestor
6686418|NCT01638962|Antipyretics|antipyretics|mesh-ancestor
6686419|NCT01638962|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6522328|NCT00748059|Sympatholytics|sympatholytics|mesh-ancestor
6522329|NCT00748059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6522330|NCT00748059|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6522331|NCT00748059|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6522332|NCT00748059|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6522333|NCT00748059|Parasympatholytics|parasympatholytics|mesh-ancestor
6686420|NCT01638962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6686421|NCT01638962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6686422|NCT01638962|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6686423|NCT01638962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6686424|NCT01638962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686425|NCT01638962|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6686426|NCT01638962|Gout Suppressants|gout suppressants|mesh-ancestor
6686427|NCT01638962|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6686428|NCT01638962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6686429|NCT01638962|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6686430|NCT01638962|Tocolytic Agents|tocolytic agents|mesh-ancestor
6686431|NCT01638962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6686432|NCT01638988|Metformin|metformin|mesh-list
6686433|NCT01638988|Clomiphene|clomiphene|mesh-list
6686434|NCT01638988|Enclomiphene|enclomiphene|mesh-list
6686435|NCT01638988|Zuclomiphene|zuclomiphene|mesh-list
6686436|NCT01638988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6686437|NCT01638988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686438|NCT01638988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6686439|NCT01638988|Hormone Antagonists|hormone antagonists|mesh-ancestor
6686440|NCT01638988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6686441|NCT01638988|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6686442|NCT01638988|Fertility Agents|fertility agents|mesh-ancestor
6686443|NCT01638988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6686444|NCT01638988|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6686445|NCT01638988|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6686446|NCT01639027|Drotaverin|drotaverin|mesh-list
6686447|NCT01639027|Analgesics|analgesics|mesh-ancestor
6686448|NCT01639027|Sensory System Agents|sensory system agents|mesh-ancestor
6686449|NCT01639027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6686450|NCT01639027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686451|NCT01639027|Parasympatholytics|parasympatholytics|mesh-ancestor
6686452|NCT01639027|Autonomic Agents|autonomic agents|mesh-ancestor
6686453|NCT01639027|Vasodilator Agents|vasodilator agents|mesh-ancestor
6686454|NCT01639066|Tenofovir|tenofovir|mesh-list
6686455|NCT01639066|Entecavir|entecavir|mesh-list
6686456|NCT01639066|Antiviral Agents|antiviral agents|mesh-ancestor
6522334|NCT00748059|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6522335|NCT00748059|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6522336|NCT00748059|Cholinergic Agents|cholinergic agents|mesh-ancestor
6522337|NCT00748059|Antiemetics|antiemetics|mesh-ancestor
6686457|NCT01639066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6686458|NCT01639066|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6522338|NCT00748059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6522339|NCT00748059|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6522340|NCT00748059|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6686459|NCT01639066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6686460|NCT01639066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6522341|NCT00748059|Dopamine Agents|dopamine agents|mesh-ancestor
6522342|NCT00748059|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6522343|NCT00748059|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6522344|NCT00748059|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6522345|NCT00748059|Urological Agents|urological agents|mesh-ancestor
6522346|NCT00748059|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6522347|NCT00748059|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6522348|NCT00748059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6522349|NCT00748059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6522350|NCT00748059|Antidotes|antidotes|mesh-ancestor
6522351|NCT00748059|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6522352|NCT00748059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6522353|NCT00748150|Vaccines|vaccines|mesh-list
6522354|NCT00748150|Immunologic Factors|immunologic factors|mesh-ancestor
6522355|NCT00748150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522356|NCT00748163|Paclitaxel|paclitaxel|mesh-list
6522357|NCT00748163|Sunitinib|sunitinib|mesh-list
6522358|NCT00748163|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6522359|NCT00748163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6686461|NCT01639066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686462|NCT01639066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6686463|NCT01639066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6686464|NCT01639092|Tenofovir|tenofovir|mesh-list
6686465|NCT01639092|Entecavir|entecavir|mesh-list
6686466|NCT01639092|Antiviral Agents|antiviral agents|mesh-ancestor
6686467|NCT01639092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6686468|NCT01639092|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6686469|NCT01639092|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6686470|NCT01639092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6686471|NCT01639092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686472|NCT01639092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6686473|NCT01639092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6686474|NCT01639131|Gemcitabine|gemcitabine|mesh-list
6686475|NCT01639131|Docetaxel|docetaxel|mesh-list
6686476|NCT01639131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6686477|NCT01639131|Antimetabolites|antimetabolites|mesh-ancestor
6686478|NCT01639131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686479|NCT01639131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6686480|NCT01639131|Antiviral Agents|antiviral agents|mesh-ancestor
6686481|NCT01639131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6686482|NCT01639131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6686483|NCT01639131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6686484|NCT01639131|Immunologic Factors|immunologic factors|mesh-ancestor
6686485|NCT01639131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686486|NCT01639131|Tubulin Modulators|tubulin modulators|mesh-ancestor
6686487|NCT01639131|Antimitotic Agents|antimitotic agents|mesh-ancestor
6686488|NCT01639131|Mitosis Modulators|mitosis modulators|mesh-ancestor
6686489|NCT01639261|Interferons|interferons|mesh-list
6686490|NCT01639261|Interferon-gamma|interferon-gamma|mesh-list
6686491|NCT01639261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6686492|NCT01639261|Antiviral Agents|antiviral agents|mesh-ancestor
6686493|NCT01639261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6686494|NCT01639326|Irinotecan|irinotecan|mesh-list
6686495|NCT01639326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6686496|NCT01639326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6686497|NCT01639326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6686498|NCT01639326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686499|NCT01639326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6686500|NCT01639456|Aldesleukin|aldesleukin|mesh-list
6686501|NCT01639456|Cyclophosphamide|cyclophosphamide|mesh-list
6686502|NCT01639456|Fludarabine|fludarabine|mesh-list
6686503|NCT01639456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6522360|NCT00748163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6522361|NCT00748163|Tubulin Modulators|tubulin modulators|mesh-ancestor
6522362|NCT00748163|Antimitotic Agents|antimitotic agents|mesh-ancestor
6522363|NCT00748163|Mitosis Modulators|mitosis modulators|mesh-ancestor
6686504|NCT01639456|Immunologic Factors|immunologic factors|mesh-ancestor
6686505|NCT01639456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686506|NCT01639456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6522364|NCT00748163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522365|NCT00748163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6522366|NCT00748163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6686507|NCT01639456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6686508|NCT01639456|Alkylating Agents|alkylating agents|mesh-ancestor
6686509|NCT01639456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686510|NCT01639456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6686511|NCT01639456|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6686512|NCT01639456|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6686513|NCT01639456|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6686514|NCT01639456|Antiviral Agents|antiviral agents|mesh-ancestor
6686515|NCT01639456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6522367|NCT00748163|Growth Substances|growth substances|mesh-ancestor
6522368|NCT00748163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522369|NCT00748163|Growth Inhibitors|growth inhibitors|mesh-ancestor
6522370|NCT00748163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6522371|NCT00748163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6522372|NCT00748176|Anesthetics|anesthetics|mesh-list
6522373|NCT00748176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6522374|NCT00748176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522375|NCT00748202|Complement C1s|complement c1s|mesh-list
6522376|NCT00748202|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
6522377|NCT00748202|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
6522378|NCT00748202|Immunologic Factors|immunologic factors|mesh-ancestor
6522379|NCT00748202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522380|NCT00748202|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6522381|NCT00748202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6522382|NCT00748345|Caspofungin|caspofungin|mesh-list
6522383|NCT00748345|Antifungal Agents|antifungal agents|mesh-ancestor
6522384|NCT00748345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6686516|NCT01639521|Gemcitabine|gemcitabine|mesh-list
6686517|NCT01639521|Doxorubicin|doxorubicin|mesh-list
6686518|NCT01639521|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6686519|NCT01639521|Methotrexate|methotrexate|mesh-list
6686520|NCT01639521|Vinblastine|vinblastine|mesh-list
6686521|NCT01639521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6686522|NCT01639521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6686523|NCT01639521|Antimetabolites|antimetabolites|mesh-ancestor
6686524|NCT01639521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686525|NCT01639521|Antiviral Agents|antiviral agents|mesh-ancestor
6686526|NCT01639521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6686527|NCT01639521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6686528|NCT01639521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6686529|NCT01639521|Immunologic Factors|immunologic factors|mesh-ancestor
6522385|NCT00748345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6522386|NCT00748345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522387|NCT00748358|Sunitinib|sunitinib|mesh-list
6686530|NCT01639521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686531|NCT01639521|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6686532|NCT01639521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6686533|NCT01639521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6686534|NCT01639521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6686535|NCT01639521|Abortifacient Agents|abortifacient agents|mesh-ancestor
6686536|NCT01639521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6686537|NCT01639521|Dermatologic Agents|dermatologic agents|mesh-ancestor
6686538|NCT01639521|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6686539|NCT01639521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6522388|NCT00748358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6522389|NCT00748358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6522390|NCT00748358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6522391|NCT00748358|Growth Substances|growth substances|mesh-ancestor
6522392|NCT00748358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522393|NCT00748358|Growth Inhibitors|growth inhibitors|mesh-ancestor
6522394|NCT00748358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6522395|NCT00748358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6522396|NCT00748358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522397|NCT00748371|Aspirin|aspirin|mesh-list
6522398|NCT00748371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6522399|NCT00748371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6522400|NCT00748371|Analgesics|analgesics|mesh-ancestor
6522401|NCT00748371|Sensory System Agents|sensory system agents|mesh-ancestor
6522402|NCT00748371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6522403|NCT00748371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522404|NCT00748371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6522405|NCT00748371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6522406|NCT00748371|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6522407|NCT00748371|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6686540|NCT01639521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6686541|NCT01639521|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6686542|NCT01639521|Tubulin Modulators|tubulin modulators|mesh-ancestor
6686543|NCT01639521|Antimitotic Agents|antimitotic agents|mesh-ancestor
6522408|NCT00748371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522409|NCT00748371|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6522410|NCT00748371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6522411|NCT00748371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6522412|NCT00748371|Antipyretics|antipyretics|mesh-ancestor
6522413|NCT00748423|Nitric Oxide|nitric oxide|mesh-list
6522414|NCT00748423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6522415|NCT00748423|Autonomic Agents|autonomic agents|mesh-ancestor
6522416|NCT00748423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6522417|NCT00748423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522418|NCT00748423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6522419|NCT00748423|Respiratory System Agents|respiratory system agents|mesh-ancestor
6522420|NCT00748423|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6522421|NCT00748423|Antioxidants|antioxidants|mesh-ancestor
6522422|NCT00748423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522423|NCT00748423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6522424|NCT00748423|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6522425|NCT00748423|Vasodilator Agents|vasodilator agents|mesh-ancestor
6522426|NCT00748423|Gasotransmitters|gasotransmitters|mesh-ancestor
6522427|NCT00748423|Protective Agents|protective agents|mesh-ancestor
6522428|NCT00748436|Betahistine|betahistine|mesh-list
6522429|NCT00748436|Vasodilator Agents|vasodilator agents|mesh-ancestor
6522430|NCT00748436|Histamine Agonists|histamine agonists|mesh-ancestor
6522431|NCT00748436|Histamine Agents|histamine agents|mesh-ancestor
6522432|NCT00748436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6522433|NCT00748436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686544|NCT01639521|Mitosis Modulators|mitosis modulators|mesh-ancestor
6686545|NCT01639547|Ribavirin|ribavirin|mesh-list
6522434|NCT00748436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522435|NCT00748527|Carboplatin|carboplatin|mesh-list
6522436|NCT00748527|Decitabine|decitabine|mesh-list
6686546|NCT01639547|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6686547|NCT01639547|Antimetabolites|antimetabolites|mesh-ancestor
6686548|NCT01639547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686549|NCT01639547|Antiviral Agents|antiviral agents|mesh-ancestor
6686550|NCT01639547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6686551|NCT01639573|Alemtuzumab|alemtuzumab|mesh-list
6686552|NCT01639573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6686553|NCT01639573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6686554|NCT01639794|Solifenacin Succinate|solifenacin succinate|mesh-list
6686555|NCT01639794|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6686556|NCT01639794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6686557|NCT01639794|Cholinergic Agents|cholinergic agents|mesh-ancestor
6686558|NCT01639794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6686559|NCT01639794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686560|NCT01639794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686561|NCT01639794|Urological Agents|urological agents|mesh-ancestor
6686562|NCT01639807|Latanoprost|latanoprost|mesh-list
6686563|NCT01639807|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6522437|NCT00748527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6686564|NCT01639807|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6780245|NCT02182518|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6780246|NCT02182518|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6780247|NCT02182518|Sympathomimetics|sympathomimetics|mesh-ancestor
6780248|NCT02182518|Adrenergic Agents|adrenergic agents|mesh-ancestor
6780249|NCT02182518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6780250|NCT02182518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780251|NCT02182518|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6780252|NCT02182518|Histamine Antagonists|histamine antagonists|mesh-ancestor
6522438|NCT00748527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6522439|NCT00748527|Antimetabolites|antimetabolites|mesh-ancestor
6522440|NCT00748527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522441|NCT00748527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6522442|NCT00748618|Vitamin D|vitamin d|mesh-list
6522443|NCT00748618|Ergocalciferols|ergocalciferols|mesh-list
6522444|NCT00748618|Cholecalciferol|cholecalciferol|mesh-list
6522445|NCT00748618|Vitamins|vitamins|mesh-list
6522446|NCT00748618|Micronutrients|micronutrients|mesh-ancestor
6522447|NCT00748618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522448|NCT00748618|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6522449|NCT00748618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6522450|NCT00748644|Rituximab|rituximab|mesh-list
6522451|NCT00748644|Azathioprine|azathioprine|mesh-list
6522452|NCT00748644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6522453|NCT00748644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6522454|NCT00748644|Immunologic Factors|immunologic factors|mesh-ancestor
6522455|NCT00748644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522456|NCT00748644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6522457|NCT00748644|Antimetabolites|antimetabolites|mesh-ancestor
6686565|NCT01639885|Interferons|interferons|mesh-list
6686566|NCT01639885|Interferon-alpha|interferon-alpha|mesh-list
6686567|NCT01639885|Interferon alpha-2|interferon alpha-2|mesh-list
6686568|NCT01639885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6686569|NCT01639885|Antiviral Agents|antiviral agents|mesh-ancestor
6522458|NCT00748644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522459|NCT00748644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6522460|NCT00748644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6686570|NCT01639885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6686571|NCT01639885|Immunologic Factors|immunologic factors|mesh-ancestor
6686572|NCT01639885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686573|NCT01639898|Dexamethasone|dexamethasone|mesh-list
6686574|NCT01639898|Dexamethasone acetate|dexamethasone acetate|mesh-list
6686575|NCT01639898|Lenalidomide|lenalidomide|mesh-list
6522461|NCT00748787|Psyllium|psyllium|mesh-list
6522462|NCT00748787|Calcium polycarbophil|calcium polycarbophil|mesh-list
6522463|NCT00748787|Cathartics|cathartics|mesh-ancestor
6522464|NCT00748787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6686576|NCT01639898|BB 1101|bb 1101|mesh-list
6522465|NCT00748787|Antidiarrheals|antidiarrheals|mesh-ancestor
6522466|NCT00748891|Cediranib|cediranib|mesh-list
6522467|NCT00748891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6522468|NCT00748891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6522469|NCT00748891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6522470|NCT00748891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522471|NCT00748943|Chlorine dioxide|chlorine dioxide|mesh-list
6522472|NCT00748943|Dental Disinfectants|dental disinfectants|mesh-ancestor
6522473|NCT00748943|Disinfectants|disinfectants|mesh-ancestor
6522474|NCT00748943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6522475|NCT00749021|Ranibizumab|ranibizumab|mesh-list
6522476|NCT00749021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6522477|NCT00749021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6522478|NCT00749021|Growth Substances|growth substances|mesh-ancestor
6522479|NCT00749021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522480|NCT00749021|Growth Inhibitors|growth inhibitors|mesh-ancestor
6522481|NCT00749021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6522482|NCT00749047|Pioglitazone|pioglitazone|mesh-list
6522483|NCT00749047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6522484|NCT00749047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522485|NCT00749099|Pancrelipase|pancrelipase|mesh-list
6522486|NCT00749099|Pancreatin|pancreatin|mesh-list
6522487|NCT00749099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6522488|NCT00749112|Rituximab|rituximab|mesh-list
6522489|NCT00749112|Alemtuzumab|alemtuzumab|mesh-list
6522490|NCT00749112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6522491|NCT00749112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6522492|NCT00749112|Immunologic Factors|immunologic factors|mesh-ancestor
6522493|NCT00749112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522494|NCT00749112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6522495|NCT00749138|Tamoxifen|tamoxifen|mesh-list
6522496|NCT00749138|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6522497|NCT00749138|Hormone Antagonists|hormone antagonists|mesh-ancestor
6522498|NCT00749138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6522499|NCT00749138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522500|NCT00749138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6522501|NCT00749138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6686577|NCT01639898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6686578|NCT01639898|Antiemetics|antiemetics|mesh-ancestor
6522502|NCT00749138|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6522503|NCT00749138|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6522504|NCT00749138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6686579|NCT01639898|Autonomic Agents|autonomic agents|mesh-ancestor
6686580|NCT01639898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6686581|NCT01639898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686582|NCT01639898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6686583|NCT01639898|Glucocorticoids|glucocorticoids|mesh-ancestor
6686584|NCT01639898|Hormones|hormones|mesh-ancestor
6686585|NCT01639898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6686586|NCT01639898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6686587|NCT01639898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6686588|NCT01639898|Protease Inhibitors|protease inhibitors|mesh-ancestor
6686589|NCT01639898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6686590|NCT01639898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686591|NCT01639898|Immunologic Factors|immunologic factors|mesh-ancestor
6686592|NCT01639898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6686593|NCT01639898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6686594|NCT01639898|Growth Substances|growth substances|mesh-ancestor
6686595|NCT01639898|Growth Inhibitors|growth inhibitors|mesh-ancestor
6686596|NCT01640002|Bromides|bromides|mesh-list
6686597|NCT01640002|Propantheline|propantheline|mesh-list
6686598|NCT01640002|Anticonvulsants|anticonvulsants|mesh-ancestor
6686599|NCT01640002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6686600|NCT01640002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6686601|NCT01640002|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6686602|NCT01640002|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6686603|NCT01640002|Cholinergic Agents|cholinergic agents|mesh-ancestor
6686604|NCT01640002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6686605|NCT01640002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686606|NCT01640002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686607|NCT01640093|Abiraterone Acetate|abiraterone acetate|mesh-list
6686608|NCT01640093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6686609|NCT01640093|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6686610|NCT01640093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6686611|NCT01640093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686612|NCT01640093|Hormone Antagonists|hormone antagonists|mesh-ancestor
6686613|NCT01640093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6686614|NCT01640093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686615|NCT01640093|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6686616|NCT01640210|Insulin|insulin|mesh-list
6686617|NCT01640210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6686618|NCT01640210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686619|NCT01640275|Propofol|propofol|mesh-list
6686620|NCT01640275|Isoflurane|isoflurane|mesh-list
6686621|NCT01640275|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6686622|NCT01640275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6686623|NCT01640275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686624|NCT01640275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6686625|NCT01640275|Anesthetics, General|anesthetics, general|mesh-ancestor
6686626|NCT01640275|Anesthetics|anesthetics|mesh-ancestor
6686627|NCT01640275|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6686628|NCT01640301|Aldesleukin|aldesleukin|mesh-list
6686629|NCT01640301|Cyclophosphamide|cyclophosphamide|mesh-list
6686630|NCT01640301|Fludarabine|fludarabine|mesh-list
6686631|NCT01640301|Fludarabine phosphate|fludarabine phosphate|mesh-list
6686632|NCT01640301|Interleukin-2|interleukin-2|mesh-list
6686633|NCT01640301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6686634|NCT01640301|Immunologic Factors|immunologic factors|mesh-ancestor
6686635|NCT01640301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686636|NCT01640301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6686637|NCT01640301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6686638|NCT01640301|Alkylating Agents|alkylating agents|mesh-ancestor
6686639|NCT01640301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686640|NCT01640301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6686641|NCT01640301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6686642|NCT01640301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6686643|NCT01640301|Antimetabolites|antimetabolites|mesh-ancestor
6686644|NCT01640301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6686645|NCT01640301|Analgesics|analgesics|mesh-ancestor
6686646|NCT01640301|Sensory System Agents|sensory system agents|mesh-ancestor
6686647|NCT01640301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6686648|NCT01640301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6686649|NCT01640301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6522505|NCT00749346|Pemetrexed|pemetrexed|mesh-list
6522506|NCT00749346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6522507|NCT00749346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6522508|NCT00749346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522509|NCT00749346|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6522510|NCT00749346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6522511|NCT00749359|Paroxetine|paroxetine|mesh-list
6522512|NCT00749359|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6522513|NCT00749359|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6522514|NCT00749359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6522515|NCT00749359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522516|NCT00749359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6522517|NCT00749359|Serotonin Agents|serotonin agents|mesh-ancestor
6522518|NCT00749359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522519|NCT00749359|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6522520|NCT00749359|Antidepressive Agents|antidepressive agents|mesh-ancestor
6522521|NCT00749359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6522522|NCT00749359|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6522523|NCT00749359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6522524|NCT00749359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6522525|NCT00749385|Naproxen|naproxen|mesh-list
6522526|NCT00749385|Esomeprazole|esomeprazole|mesh-list
6686650|NCT01640301|Antiviral Agents|antiviral agents|mesh-ancestor
6686651|NCT01640301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6686652|NCT01640405|Bevacizumab|bevacizumab|mesh-list
6686653|NCT01640405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6686654|NCT01640405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6686655|NCT01640405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6686656|NCT01640405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6686657|NCT01640405|Growth Substances|growth substances|mesh-ancestor
6686658|NCT01640405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686659|NCT01640405|Growth Inhibitors|growth inhibitors|mesh-ancestor
6686660|NCT01640444|Bevacizumab|bevacizumab|mesh-list
6686661|NCT01640444|Cetuximab|cetuximab|mesh-list
6686662|NCT01640444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6686663|NCT01640444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6686664|NCT01640444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6686665|NCT01640444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6686666|NCT01640444|Growth Substances|growth substances|mesh-ancestor
6686667|NCT01640444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686668|NCT01640444|Growth Inhibitors|growth inhibitors|mesh-ancestor
6686669|NCT01640496|Vitamin D|vitamin d|mesh-list
6686670|NCT01640496|Cholecalciferol|cholecalciferol|mesh-list
6686671|NCT01640496|Vitamins|vitamins|mesh-ancestor
6686672|NCT01640496|Micronutrients|micronutrients|mesh-ancestor
6686673|NCT01640496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522527|NCT00749385|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6522528|NCT00749385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6522529|NCT00749385|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6522530|NCT00749385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6522531|NCT00749385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522532|NCT00749385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6522533|NCT00749385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6522534|NCT00749385|Analgesics|analgesics|mesh-ancestor
6522535|NCT00749385|Sensory System Agents|sensory system agents|mesh-ancestor
6522536|NCT00749385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6522537|NCT00749385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522538|NCT00749385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6522539|NCT00749385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6522540|NCT00749385|Gout Suppressants|gout suppressants|mesh-ancestor
6522541|NCT00749385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6522542|NCT00749450|Fluorouracil|fluorouracil|mesh-list
6522543|NCT00749450|Capecitabine|capecitabine|mesh-list
6522544|NCT00749450|Oxaliplatin|oxaliplatin|mesh-list
6522545|NCT00749450|Antimetabolites|antimetabolites|mesh-ancestor
6686674|NCT01640496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6686675|NCT01640496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6686676|NCT01640535|Cetirizine|cetirizine|mesh-list
6686677|NCT01640535|Montelukast|montelukast|mesh-list
6686678|NCT01640535|Levocetirizine|levocetirizine|mesh-list
6686679|NCT01640535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6686680|NCT01640535|Respiratory System Agents|respiratory system agents|mesh-ancestor
6686681|NCT01640535|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6686682|NCT01640535|Hormone Antagonists|hormone antagonists|mesh-ancestor
6780253|NCT02182518|Histamine Agents|histamine agents|mesh-ancestor
6686683|NCT01640535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6686684|NCT01640535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686685|NCT01640535|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6686686|NCT01640535|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6686687|NCT01640535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686688|NCT01640535|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6522546|NCT00749450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522547|NCT00749450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6522548|NCT00749450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6522549|NCT00749450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6522550|NCT00749450|Immunologic Factors|immunologic factors|mesh-ancestor
6522551|NCT00749450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522552|NCT00749502|Niraparib|niraparib|mesh-list
6522553|NCT00749502|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6522554|NCT00749502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6522555|NCT00749502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522556|NCT00749502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6522557|NCT00749567|Bevacizumab|bevacizumab|mesh-list
6522558|NCT00749567|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6522559|NCT00749567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6522560|NCT00749567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6686689|NCT01640535|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6686690|NCT01640535|Histamine Antagonists|histamine antagonists|mesh-ancestor
6686691|NCT01640535|Histamine Agents|histamine agents|mesh-ancestor
6686692|NCT01640535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6686693|NCT01640535|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6686694|NCT01640574|Chloroquine|chloroquine|mesh-list
6686695|NCT01640574|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
6686696|NCT01640574|Piperaquine|piperaquine|mesh-list
6686697|NCT01640574|Artenimol|artenimol|mesh-list
6686698|NCT01640574|Artemisinins|artemisinins|mesh-list
6686699|NCT01640574|Amebicides|amebicides|mesh-ancestor
6686700|NCT01640574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6686701|NCT01640574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6686702|NCT01640574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6686703|NCT01640574|Antimalarials|antimalarials|mesh-ancestor
6686704|NCT01640574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6686705|NCT01640574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6686706|NCT01640574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6686707|NCT01640574|Analgesics|analgesics|mesh-ancestor
6686708|NCT01640574|Sensory System Agents|sensory system agents|mesh-ancestor
6686709|NCT01640574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6522561|NCT00749567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6522562|NCT00749567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6522563|NCT00749567|Growth Substances|growth substances|mesh-ancestor
6522564|NCT00749567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522565|NCT00749567|Growth Inhibitors|growth inhibitors|mesh-ancestor
6522566|NCT00749567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6522567|NCT00749567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6522568|NCT00749567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522569|NCT00749619|Taurolidine|taurolidine|mesh-list
6522570|NCT00749619|Heparin|heparin|mesh-list
6522571|NCT00749619|Calcium heparin|calcium heparin|mesh-list
6522572|NCT00749619|Citric Acid|citric acid|mesh-list
6522573|NCT00749619|Sodium Citrate|sodium citrate|mesh-list
6522574|NCT00749619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6522575|NCT00749619|Anticoagulants|anticoagulants|mesh-ancestor
6522576|NCT00749619|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6522577|NCT00749619|Chelating Agents|chelating agents|mesh-ancestor
6522578|NCT00749619|Sequestering Agents|sequestering agents|mesh-ancestor
6522579|NCT00749619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522580|NCT00749619|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6522581|NCT00749619|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6522582|NCT00749619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6522583|NCT00749619|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6522584|NCT00749619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6522585|NCT00749710|Clopidogrel|clopidogrel|mesh-list
6522586|NCT00749710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6522587|NCT00749710|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6522588|NCT00749710|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6522589|NCT00749710|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6522590|NCT00749710|Purinergic Agents|purinergic agents|mesh-ancestor
6522591|NCT00749710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6686710|NCT01640574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686711|NCT01640574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6686712|NCT01640574|Filaricides|filaricides|mesh-ancestor
6686713|NCT01640574|Antinematodal Agents|antinematodal agents|mesh-ancestor
6686714|NCT01640574|Anthelmintics|anthelmintics|mesh-ancestor
6686715|NCT01640587|Artesunate|artesunate|mesh-list
6686716|NCT01640587|Piperaquine|piperaquine|mesh-list
6686717|NCT01640587|Artenimol|artenimol|mesh-list
6686718|NCT01640587|Mefloquine|mefloquine|mesh-list
6686719|NCT01640587|Antimalarials|antimalarials|mesh-ancestor
6686720|NCT01640587|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6686721|NCT01640587|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6686722|NCT01640587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6686723|NCT01640587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6686724|NCT01640587|Antiviral Agents|antiviral agents|mesh-ancestor
6686725|NCT01640587|Schistosomicides|schistosomicides|mesh-ancestor
6686726|NCT01640587|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6686727|NCT01640587|Anthelmintics|anthelmintics|mesh-ancestor
6522592|NCT00749710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522593|NCT00749710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686728|NCT01640639|Thalidomide|thalidomide|mesh-list
6686729|NCT01640639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6686730|NCT01640639|Immunologic Factors|immunologic factors|mesh-ancestor
6686731|NCT01640639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686732|NCT01640639|Leprostatic Agents|leprostatic agents|mesh-ancestor
6686733|NCT01640639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6686734|NCT01640639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6686735|NCT01640639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6686736|NCT01640639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6686737|NCT01640639|Growth Substances|growth substances|mesh-ancestor
6686738|NCT01640639|Growth Inhibitors|growth inhibitors|mesh-ancestor
6686739|NCT01640639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6686740|NCT01640665|Capecitabine|capecitabine|mesh-list
6686741|NCT01640665|Sorafenib|sorafenib|mesh-list
6686742|NCT01640665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6686743|NCT01640665|Antimetabolites|antimetabolites|mesh-ancestor
6686744|NCT01640665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686745|NCT01640665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6686746|NCT01640665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6686747|NCT01640665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6686748|NCT01640691|Vaccines|vaccines|mesh-list
6686749|NCT01640691|Immunologic Factors|immunologic factors|mesh-ancestor
6686750|NCT01640691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686751|NCT01640743|Methylprednisolone|methylprednisolone|mesh-list
6686752|NCT01640743|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6686753|NCT01640743|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6686754|NCT01640743|Prednisolone|prednisolone|mesh-list
6686755|NCT01640743|Prednisolone acetate|prednisolone acetate|mesh-list
6686756|NCT01640743|Everolimus|everolimus|mesh-list
6686757|NCT01640743|Tacrolimus|tacrolimus|mesh-list
6686758|NCT01640743|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6686759|NCT01640743|Prednisolone phosphate|prednisolone phosphate|mesh-list
6686760|NCT01640743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6686761|NCT01640743|Immunologic Factors|immunologic factors|mesh-ancestor
6686762|NCT01640743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686763|NCT01640743|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6686764|NCT01640743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6686765|NCT01640743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686766|NCT01640743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6686767|NCT01640743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6686768|NCT01640743|Antiemetics|antiemetics|mesh-ancestor
6686769|NCT01640743|Autonomic Agents|autonomic agents|mesh-ancestor
6686770|NCT01640743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6686771|NCT01640743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6686772|NCT01640743|Glucocorticoids|glucocorticoids|mesh-ancestor
6686773|NCT01640743|Hormones|hormones|mesh-ancestor
6686774|NCT01640743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6686775|NCT01640743|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6522594|NCT00749723|Carboplatin|carboplatin|mesh-list
6522595|NCT00749723|Etoposide|etoposide|mesh-list
6522596|NCT00749723|Etoposide phosphate|etoposide phosphate|mesh-list
6522597|NCT00749723|Temozolomide|temozolomide|mesh-list
6522598|NCT00749723|Thiotepa|thiotepa|mesh-list
6522599|NCT00749723|Trofosfamide|trofosfamide|mesh-list
6522600|NCT00749723|Cyclophosphamide|cyclophosphamide|mesh-list
6522601|NCT00749723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6522602|NCT00749723|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6522603|NCT00749723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6522604|NCT00749723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6686776|NCT01640743|Protective Agents|protective agents|mesh-ancestor
6686777|NCT01640743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6686778|NCT01640782|Leucovorin|leucovorin|mesh-list
6686779|NCT01640782|Docetaxel|docetaxel|mesh-list
6686780|NCT01640782|Fluorouracil|fluorouracil|mesh-list
6686781|NCT01640782|Irinotecan|irinotecan|mesh-list
6686782|NCT01640782|Levoleucovorin|levoleucovorin|mesh-list
6686783|NCT01640782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6686784|NCT01640782|Tubulin Modulators|tubulin modulators|mesh-ancestor
6686785|NCT01640782|Antimitotic Agents|antimitotic agents|mesh-ancestor
6686786|NCT01640782|Mitosis Modulators|mitosis modulators|mesh-ancestor
6522605|NCT00749723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6522606|NCT00749723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522607|NCT00749723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6522608|NCT00749723|Alkylating Agents|alkylating agents|mesh-ancestor
6522609|NCT00749723|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6522610|NCT00749723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6522611|NCT00749723|Immunologic Factors|immunologic factors|mesh-ancestor
6242700|NCT02655224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6242701|NCT02655224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244246|NCT02691494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6244247|NCT02691494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244248|NCT02691494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6244249|NCT02691494|Contraceptive Agents|contraceptive agents|mesh-ancestor
6522612|NCT00749723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522613|NCT00749723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6522614|NCT00749736|Cholecalciferol|cholecalciferol|mesh-list
6522615|NCT00749736|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
6522616|NCT00749736|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6522617|NCT00749736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522618|NCT00749736|Vitamins|vitamins|mesh-ancestor
6522619|NCT00749736|Micronutrients|micronutrients|mesh-ancestor
6522620|NCT00749736|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6522621|NCT00749814|Melatonin|melatonin|mesh-list
6522622|NCT00749814|Antioxidants|antioxidants|mesh-ancestor
6522623|NCT00749814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522624|NCT00749814|Protective Agents|protective agents|mesh-ancestor
6686787|NCT01640782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686788|NCT01640782|Antimetabolites|antimetabolites|mesh-ancestor
6686789|NCT01640782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6686790|NCT01640782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6686791|NCT01640782|Immunologic Factors|immunologic factors|mesh-ancestor
6686792|NCT01640782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522625|NCT00749814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522626|NCT00749814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6522627|NCT00749853|Buserelin|buserelin|mesh-list
6522628|NCT00749853|Hormones|hormones|mesh-list
6522629|NCT00749853|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6522630|NCT00749853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6522631|NCT00749853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244250|NCT02691494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6244251|NCT02691494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6244252|NCT02691494|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6522632|NCT00749853|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6522633|NCT00749853|Fertility Agents|fertility agents|mesh-ancestor
6522634|NCT00749853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6522635|NCT00749866|Gentamicins|gentamicins|mesh-list
6522636|NCT00749866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6522637|NCT00749866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6522638|NCT00749866|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6522639|NCT00749866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6522640|NCT00749866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522641|NCT00749918|Vitamin D|vitamin d|mesh-list
6522642|NCT00749918|Cholecalciferol|cholecalciferol|mesh-list
6522643|NCT00749918|Vitamins|vitamins|mesh-ancestor
6522644|NCT00749918|Micronutrients|micronutrients|mesh-ancestor
6522645|NCT00749918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522646|NCT00749918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6522647|NCT00749918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6522648|NCT00750048|Acetaminophen|acetaminophen|mesh-list
6686793|NCT01640782|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6686794|NCT01640782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6686795|NCT01640782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6686796|NCT01640782|Antidotes|antidotes|mesh-ancestor
6522649|NCT00750048|Naloxone|naloxone|mesh-list
6522650|NCT00750048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6522651|NCT00750048|Analgesics|analgesics|mesh-ancestor
6522652|NCT00750048|Sensory System Agents|sensory system agents|mesh-ancestor
6522653|NCT00750048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6522654|NCT00750048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522655|NCT00750048|Antipyretics|antipyretics|mesh-ancestor
6522656|NCT00750048|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6522657|NCT00750100|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6522658|NCT00750100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6522659|NCT00750100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522660|NCT00750113|Telmisartan|telmisartan|mesh-list
6522661|NCT00750113|Nifedipine|nifedipine|mesh-list
6522662|NCT00750113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6522663|NCT00750113|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6522664|NCT00750113|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6522665|NCT00750113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522666|NCT00750113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6522667|NCT00750113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6522668|NCT00750113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6522669|NCT00750113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522670|NCT00750113|Vasodilator Agents|vasodilator agents|mesh-ancestor
6522671|NCT00750113|Tocolytic Agents|tocolytic agents|mesh-ancestor
6522672|NCT00750113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6522673|NCT00750126|Fludarabine|fludarabine|mesh-list
6522674|NCT00750126|Busulfan|busulfan|mesh-list
6522675|NCT00750126|Thymoglobulin|thymoglobulin|mesh-list
6522676|NCT00750126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6522677|NCT00750126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522678|NCT00750126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6522679|NCT00750126|Immunologic Factors|immunologic factors|mesh-ancestor
6522680|NCT00750126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522681|NCT00750126|Alkylating Agents|alkylating agents|mesh-ancestor
6686797|NCT01640782|Protective Agents|protective agents|mesh-ancestor
6686798|NCT01640782|Vitamin B Complex|vitamin b complex|mesh-ancestor
6686799|NCT01640782|Vitamins|vitamins|mesh-ancestor
6686800|NCT01640782|Micronutrients|micronutrients|mesh-ancestor
6686801|NCT01640990|GW 328267|gw 328267|mesh-list
6686802|NCT01640990|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
6686803|NCT01640990|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6686804|NCT01640990|Purinergic Agonists|purinergic agonists|mesh-ancestor
6686805|NCT01640990|Purinergic Agents|purinergic agents|mesh-ancestor
6686806|NCT01640990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6686807|NCT01640990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686808|NCT01640990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522682|NCT00750126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6522683|NCT00750126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6522684|NCT00750178|Vorinostat|vorinostat|mesh-list
6522685|NCT00750178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6522686|NCT00750178|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6522687|NCT00750178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6522688|NCT00750178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522689|NCT00750217|Buprenorphine|buprenorphine|mesh-list
6522690|NCT00750217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6522691|NCT00750217|Narcotics|narcotics|mesh-ancestor
6522692|NCT00750217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6522693|NCT00750217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522694|NCT00750217|Analgesics|analgesics|mesh-ancestor
6522695|NCT00750217|Sensory System Agents|sensory system agents|mesh-ancestor
6522696|NCT00750217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6522697|NCT00750217|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6522698|NCT00750334|Clofarabine|clofarabine|mesh-list
6522699|NCT00750334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6522700|NCT00750334|Antimetabolites|antimetabolites|mesh-ancestor
6522701|NCT00750334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522702|NCT00750334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6522703|NCT00750347|Acetaminophen|acetaminophen|mesh-list
6686809|NCT01641016|Efavirenz|efavirenz|mesh-list
6686810|NCT01641016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6686811|NCT01641016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6686812|NCT01641016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780254|NCT02182531|Pseudoephedrine|pseudoephedrine|mesh-list
6522704|NCT00750347|Rimonabant|rimonabant|mesh-list
5971411|NCT04528563|Narcotics|narcotics|mesh-ancestor
6522705|NCT00750347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6522706|NCT00750347|Analgesics|analgesics|mesh-ancestor
6686813|NCT01641016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686814|NCT01641016|Antiviral Agents|antiviral agents|mesh-ancestor
6686815|NCT01641016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6686816|NCT01641016|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6686817|NCT01641016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6686818|NCT01641016|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6686819|NCT01641016|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6686820|NCT01641016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6686821|NCT01641016|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6686822|NCT01641055|Caseins|caseins|mesh-list
6686823|NCT01641055|Chelating Agents|chelating agents|mesh-ancestor
6686824|NCT01641055|Sequestering Agents|sequestering agents|mesh-ancestor
6686825|NCT01641055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686826|NCT01641224|Pinaverium|pinaverium|mesh-list
6686827|NCT01641224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6686828|NCT01641224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6686829|NCT01641224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686830|NCT01641224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6686831|NCT01641224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686832|NCT01641224|Parasympatholytics|parasympatholytics|mesh-ancestor
6686833|NCT01641224|Autonomic Agents|autonomic agents|mesh-ancestor
6686834|NCT01641224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6686835|NCT01641250|Cytarabine|cytarabine|mesh-list
6686836|NCT01641250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6686837|NCT01641250|Antimetabolites|antimetabolites|mesh-ancestor
6686838|NCT01641250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686839|NCT01641250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6686840|NCT01641250|Antiviral Agents|antiviral agents|mesh-ancestor
6686841|NCT01641250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6686842|NCT01641250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6686843|NCT01641250|Immunologic Factors|immunologic factors|mesh-ancestor
6522707|NCT00750347|Sensory System Agents|sensory system agents|mesh-ancestor
6522708|NCT00750347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6522709|NCT00750347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522710|NCT00750347|Antipyretics|antipyretics|mesh-ancestor
6522711|NCT00750347|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6522712|NCT00750347|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
6522713|NCT00750347|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6522714|NCT00750347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6522715|NCT00750347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522716|NCT00750347|Hormones|hormones|mesh-ancestor
6522717|NCT00750347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6522718|NCT00750386|Paclitaxel|paclitaxel|mesh-list
6522719|NCT00750386|Carboplatin|carboplatin|mesh-list
6522720|NCT00750386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6522721|NCT00750386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6522722|NCT00750386|Tubulin Modulators|tubulin modulators|mesh-ancestor
6522723|NCT00750386|Antimitotic Agents|antimitotic agents|mesh-ancestor
6522724|NCT00750386|Mitosis Modulators|mitosis modulators|mesh-ancestor
6522725|NCT00750386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522726|NCT00750399|Ranibizumab|ranibizumab|mesh-list
6522727|NCT00750399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6522728|NCT00750399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6522729|NCT00750399|Growth Substances|growth substances|mesh-ancestor
6522730|NCT00750399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522731|NCT00750399|Growth Inhibitors|growth inhibitors|mesh-ancestor
6522732|NCT00750399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6522733|NCT00750425|Cediranib|cediranib|mesh-list
6522734|NCT00750425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6522735|NCT00750425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6522736|NCT00750425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6522737|NCT00750425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522738|NCT00750451|Heparin|heparin|mesh-list
6522739|NCT00750451|Enoxaparin|enoxaparin|mesh-list
6522740|NCT00750451|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6522741|NCT00750451|Tinzaparin|tinzaparin|mesh-list
6522742|NCT00750451|Dalteparin|dalteparin|mesh-list
6522743|NCT00750451|Enoxaparin sodium|enoxaparin sodium|mesh-list
6522744|NCT00750451|Anticoagulants|anticoagulants|mesh-ancestor
6522745|NCT00750451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6522746|NCT00750451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6522747|NCT00750451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522748|NCT00750529|Donepezil|donepezil|mesh-list
6522749|NCT00750529|Galantamine|galantamine|mesh-list
6522750|NCT00750529|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6686844|NCT01641250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686845|NCT01641289|Acetaminophen|acetaminophen|mesh-list
6686846|NCT01641289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6686847|NCT01641289|Analgesics|analgesics|mesh-ancestor
6522751|NCT00750529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6522752|NCT00750529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522753|NCT00750529|Cholinergic Agents|cholinergic agents|mesh-ancestor
6686848|NCT01641289|Sensory System Agents|sensory system agents|mesh-ancestor
6686849|NCT01641289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6686850|NCT01641289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686851|NCT01641289|Antipyretics|antipyretics|mesh-ancestor
6686852|NCT01641315|Immunoglobulins|immunoglobulins|mesh-list
6686853|NCT01641315|Immunologic Factors|immunologic factors|mesh-ancestor
6686854|NCT01641315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686855|NCT01641341|Nitazoxanide|nitazoxanide|mesh-list
6686856|NCT01641341|Pancrelipase|pancrelipase|mesh-list
6686857|NCT01641341|Pancreatin|pancreatin|mesh-list
6686858|NCT01641341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6686859|NCT01641341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6686860|NCT01641341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6686861|NCT01641406|Cyclophosphamide|cyclophosphamide|mesh-list
6686862|NCT01641406|Bevacizumab|bevacizumab|mesh-list
6686863|NCT01641406|Docetaxel|docetaxel|mesh-list
6686864|NCT01641406|Capecitabine|capecitabine|mesh-list
6686865|NCT01641406|Trastuzumab|trastuzumab|mesh-list
6686866|NCT01641406|Epirubicin|epirubicin|mesh-list
6686867|NCT01641406|Vinorelbine|vinorelbine|mesh-list
6686868|NCT01641406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6686869|NCT01641406|Immunologic Factors|immunologic factors|mesh-ancestor
6686870|NCT01641406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686871|NCT01641406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6686872|NCT01641406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6686873|NCT01641406|Alkylating Agents|alkylating agents|mesh-ancestor
6686874|NCT01641406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686875|NCT01641406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6686876|NCT01641406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6686877|NCT01641406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6686878|NCT01641406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6686879|NCT01641406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6522754|NCT00750529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6522755|NCT00750529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522756|NCT00750529|Nootropic Agents|nootropic agents|mesh-ancestor
6522757|NCT00750529|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6522758|NCT00750529|Autonomic Agents|autonomic agents|mesh-ancestor
6522759|NCT00750529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6522760|NCT00750581|Indomethacin|indomethacin|mesh-list
6522761|NCT00750581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6522762|NCT00750581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6522763|NCT00750581|Analgesics|analgesics|mesh-ancestor
6522764|NCT00750581|Sensory System Agents|sensory system agents|mesh-ancestor
6522765|NCT00750581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6522766|NCT00750581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522767|NCT00750581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6522768|NCT00750581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6522769|NCT00750581|Gout Suppressants|gout suppressants|mesh-ancestor
6522770|NCT00750581|Tocolytic Agents|tocolytic agents|mesh-ancestor
6522771|NCT00750581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6522772|NCT00750581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6522773|NCT00750581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6522774|NCT00750581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522775|NCT00750620|Mirabegron|mirabegron|mesh-list
6686880|NCT01641406|Growth Substances|growth substances|mesh-ancestor
6686881|NCT01641406|Growth Inhibitors|growth inhibitors|mesh-ancestor
6686882|NCT01641406|Tubulin Modulators|tubulin modulators|mesh-ancestor
6686883|NCT01641406|Antimitotic Agents|antimitotic agents|mesh-ancestor
6686884|NCT01641406|Mitosis Modulators|mitosis modulators|mesh-ancestor
6686885|NCT01641406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6522776|NCT00750620|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6522777|NCT00750620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6522778|NCT00750620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6522779|NCT00750620|Adrenergic Agents|adrenergic agents|mesh-ancestor
6522780|NCT00750620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6522781|NCT00750620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522782|NCT00750620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522783|NCT00750620|Urological Agents|urological agents|mesh-ancestor
6522784|NCT00750698|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6522785|NCT00750698|Entinostat|entinostat|mesh-list
6686886|NCT01641406|Antimetabolites|antimetabolites|mesh-ancestor
6686887|NCT01641406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6522786|NCT00750698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6522787|NCT00750698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6522788|NCT00750698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6522789|NCT00750698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522790|NCT00750698|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6522791|NCT00750724|Hyaluronic Acid|hyaluronic acid|mesh-list
6522792|NCT00750724|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6686888|NCT01641406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6686889|NCT01641406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6686890|NCT01641406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6686891|NCT01641406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6686892|NCT01641419|Dexamethasone|dexamethasone|mesh-list
6686893|NCT01641419|Dexamethasone acetate|dexamethasone acetate|mesh-list
6686894|NCT01641419|BB 1101|bb 1101|mesh-list
6686895|NCT01641419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6686896|NCT01641419|Antiemetics|antiemetics|mesh-ancestor
6686897|NCT01641419|Autonomic Agents|autonomic agents|mesh-ancestor
6686898|NCT01641419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6686899|NCT01641419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686900|NCT01641419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6686901|NCT01641419|Glucocorticoids|glucocorticoids|mesh-ancestor
6686902|NCT01641419|Hormones|hormones|mesh-ancestor
6686903|NCT01641419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6686904|NCT01641419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6686905|NCT01641419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6686906|NCT01641419|Protease Inhibitors|protease inhibitors|mesh-ancestor
6686907|NCT01641419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6686908|NCT01641419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686909|NCT01641458|Capecitabine|capecitabine|mesh-list
6686910|NCT01641458|Fluorouracil|fluorouracil|mesh-list
6686911|NCT01641458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6686912|NCT01641458|Antimetabolites|antimetabolites|mesh-ancestor
6686913|NCT01641458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686914|NCT01641458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6686915|NCT01641458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6686916|NCT01641458|Immunologic Factors|immunologic factors|mesh-ancestor
6686917|NCT01641458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686918|NCT01641510|Clopidogrel|clopidogrel|mesh-list
6686919|NCT01641510|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6522793|NCT00750724|Immunologic Factors|immunologic factors|mesh-ancestor
6522794|NCT00750724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522795|NCT00750724|Viscosupplements|viscosupplements|mesh-ancestor
6522796|NCT00750724|Protective Agents|protective agents|mesh-ancestor
6522797|NCT00750763|Picosulfate sodium|picosulfate sodium|mesh-list
6522798|NCT00750763|Cathartics|cathartics|mesh-ancestor
6522799|NCT00750763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6522800|NCT00750802|Lorazepam|lorazepam|mesh-list
6522801|NCT00750802|Anticonvulsants|anticonvulsants|mesh-ancestor
6522802|NCT00750802|Antiemetics|antiemetics|mesh-ancestor
6522803|NCT00750802|Autonomic Agents|autonomic agents|mesh-ancestor
6522804|NCT00750802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6522805|NCT00750802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522806|NCT00750802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6522807|NCT00750802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6522808|NCT00750802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6522809|NCT00750802|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6522810|NCT00750802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6522811|NCT00750802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6522812|NCT00750802|GABA Modulators|gaba modulators|mesh-ancestor
6522813|NCT00750802|GABA Agents|gaba agents|mesh-ancestor
6522814|NCT00750802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6522815|NCT00750802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522816|NCT00750997|Dextrans|dextrans|mesh-list
6686920|NCT01641510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6780255|NCT02182531|Ephedrine|ephedrine|mesh-list
6686921|NCT01641510|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6686922|NCT01641510|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6686923|NCT01641510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6686924|NCT01641510|Purinergic Agents|purinergic agents|mesh-ancestor
6686925|NCT01641510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6686926|NCT01641510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686927|NCT01641510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686928|NCT01641523|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
6686929|NCT01641523|Vasodilator Agents|vasodilator agents|mesh-ancestor
6522817|NCT00750997|Anticoagulants|anticoagulants|mesh-ancestor
6522818|NCT00750997|Plasma Substitutes|plasma substitutes|mesh-ancestor
6522819|NCT00750997|Blood Substitutes|blood substitutes|mesh-ancestor
6522820|NCT00751049|Timolol|timolol|mesh-list
6522821|NCT00751049|Latanoprost|latanoprost|mesh-list
6686930|NCT01641523|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
6686931|NCT01641523|Protective Agents|protective agents|mesh-ancestor
6686932|NCT01641523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522822|NCT00751049|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6522823|NCT00751049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6686933|NCT01641536|Entecavir|entecavir|mesh-list
6522824|NCT00751049|Adrenergic Agents|adrenergic agents|mesh-ancestor
6522825|NCT00751049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6522826|NCT00751049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522827|NCT00751049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522828|NCT00751049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6522829|NCT00751049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6522830|NCT00751049|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6522831|NCT00751049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6522832|NCT00751062|Timolol|timolol|mesh-list
6522833|NCT00751062|Latanoprost|latanoprost|mesh-list
6522834|NCT00751062|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6522835|NCT00751062|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6522836|NCT00751062|Adrenergic Agents|adrenergic agents|mesh-ancestor
6522837|NCT00751062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6522838|NCT00751062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522839|NCT00751062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522840|NCT00751062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6522841|NCT00751062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6522842|NCT00751062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6522843|NCT00751062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6522844|NCT00751127|Timolol|timolol|mesh-list
6522845|NCT00751127|Latanoprost|latanoprost|mesh-list
6522846|NCT00751127|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6522847|NCT00751127|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6522848|NCT00751127|Adrenergic Agents|adrenergic agents|mesh-ancestor
6522849|NCT00751127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6522850|NCT00751127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522851|NCT00751127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522852|NCT00751127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6522853|NCT00751127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6522854|NCT00751127|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6522855|NCT00751127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6522856|NCT00751153|Raltegravir Potassium|raltegravir potassium|mesh-list
6522857|NCT00751153|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6522858|NCT00751153|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6522859|NCT00751153|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6522860|NCT00751153|Antiviral Agents|antiviral agents|mesh-ancestor
6522861|NCT00751153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6522862|NCT00751153|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6522863|NCT00751153|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6522864|NCT00751153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6522865|NCT00751153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522866|NCT00751153|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6522867|NCT00751153|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6522868|NCT00751153|Protease Inhibitors|protease inhibitors|mesh-ancestor
6522869|NCT00751205|Acetylcarnitine|acetylcarnitine|mesh-list
6522870|NCT00751205|Prednisone|prednisone|mesh-list
6522871|NCT00751205|Prednisolone|prednisolone|mesh-list
6522872|NCT00751205|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6522873|NCT00751205|Methylprednisolone|methylprednisolone|mesh-list
6522874|NCT00751205|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6522875|NCT00751205|Prednisolone acetate|prednisolone acetate|mesh-list
6522876|NCT00751205|Sagopilone|sagopilone|mesh-list
6522877|NCT00751205|Epothilones|epothilones|mesh-list
6522878|NCT00751205|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6522879|NCT00751205|Prednisolone phosphate|prednisolone phosphate|mesh-list
6522880|NCT00751205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6522881|NCT00751205|Glucocorticoids|glucocorticoids|mesh-ancestor
6522882|NCT00751205|Hormones|hormones|mesh-ancestor
6522883|NCT00751205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6522884|NCT00751205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686934|NCT01641536|Antiviral Agents|antiviral agents|mesh-ancestor
6686935|NCT01641536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6686936|NCT01641549|Fibrinolytic Agents|fibrinolytic agents|mesh-list
6522885|NCT00751205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6522886|NCT00751205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6686937|NCT01641549|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6686938|NCT01641549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686939|NCT01641575|Gemcitabine|gemcitabine|mesh-list
6686940|NCT01641575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6686941|NCT01641575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6686942|NCT01641575|Antimetabolites|antimetabolites|mesh-ancestor
6686943|NCT01641575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686944|NCT01641575|Antiviral Agents|antiviral agents|mesh-ancestor
6522887|NCT00751205|Antiemetics|antiemetics|mesh-ancestor
6522888|NCT00751205|Autonomic Agents|autonomic agents|mesh-ancestor
6522889|NCT00751205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6522890|NCT00751205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6522891|NCT00751205|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6522892|NCT00751205|Protective Agents|protective agents|mesh-ancestor
6522893|NCT00751205|Vitamin B Complex|vitamin b complex|mesh-ancestor
6522894|NCT00751205|Vitamins|vitamins|mesh-ancestor
6522895|NCT00751205|Micronutrients|micronutrients|mesh-ancestor
6522896|NCT00751205|Nootropic Agents|nootropic agents|mesh-ancestor
6522897|NCT00751205|Tubulin Modulators|tubulin modulators|mesh-ancestor
6522898|NCT00751205|Antimitotic Agents|antimitotic agents|mesh-ancestor
6522899|NCT00751205|Mitosis Modulators|mitosis modulators|mesh-ancestor
6522900|NCT00751205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522901|NCT00751257|Acetylcysteine|acetylcysteine|mesh-list
6522902|NCT00751257|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6522903|NCT00751257|Antiviral Agents|antiviral agents|mesh-ancestor
6522904|NCT00751257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6686945|NCT01641575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6686946|NCT01641575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6686947|NCT01641575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6686948|NCT01641575|Immunologic Factors|immunologic factors|mesh-ancestor
6686949|NCT01641575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686950|NCT01641666|Ribavirin|ribavirin|mesh-list
6686951|NCT01641666|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6686952|NCT01641666|Interferon-alpha|interferon-alpha|mesh-list
6686953|NCT01641666|Antimetabolites|antimetabolites|mesh-ancestor
6686954|NCT01641666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686955|NCT01641666|Antiviral Agents|antiviral agents|mesh-ancestor
6686956|NCT01641666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6686957|NCT01641666|Immunologic Factors|immunologic factors|mesh-ancestor
6686958|NCT01641666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686959|NCT01641718|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6686960|NCT01641718|Hemostatics|hemostatics|mesh-ancestor
6686961|NCT01641718|Coagulants|coagulants|mesh-ancestor
6780256|NCT02182531|Epinastine|epinastine|mesh-list
6780257|NCT02182531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6780258|NCT02182531|Autonomic Agents|autonomic agents|mesh-ancestor
6780259|NCT02182531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6780260|NCT02182531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780261|NCT02182531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6780262|NCT02182531|Respiratory System Agents|respiratory system agents|mesh-ancestor
6780263|NCT02182531|Nasal Decongestants|nasal decongestants|mesh-ancestor
6780264|NCT02182531|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6780265|NCT02182531|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6780266|NCT02182531|Sympathomimetics|sympathomimetics|mesh-ancestor
6780267|NCT02182531|Adrenergic Agents|adrenergic agents|mesh-ancestor
6780268|NCT02182531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6780269|NCT02182531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780270|NCT02182531|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6780271|NCT02182531|Histamine Antagonists|histamine antagonists|mesh-ancestor
6780272|NCT02182531|Histamine Agents|histamine agents|mesh-ancestor
6780273|NCT02182544|Ketotifen|ketotifen|mesh-list
6780274|NCT02182544|Epinastine|epinastine|mesh-list
6780275|NCT02182544|Antipruritics|antipruritics|mesh-ancestor
6686962|NCT01641783|Paclitaxel|paclitaxel|mesh-list
6686963|NCT01641783|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6686964|NCT01641783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6522905|NCT00751257|Expectorants|expectorants|mesh-ancestor
6522906|NCT00751257|Respiratory System Agents|respiratory system agents|mesh-ancestor
6522907|NCT00751257|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6522908|NCT00751257|Antioxidants|antioxidants|mesh-ancestor
6522909|NCT00751257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522910|NCT00751257|Protective Agents|protective agents|mesh-ancestor
6522911|NCT00751257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522912|NCT00751257|Antidotes|antidotes|mesh-ancestor
6522913|NCT00751270|Valacyclovir|valacyclovir|mesh-list
6522914|NCT00751270|Antiviral Agents|antiviral agents|mesh-ancestor
6522915|NCT00751270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6522916|NCT00751374|Gentamicins|gentamicins|mesh-list
6522917|NCT00751374|Mupirocin|mupirocin|mesh-list
6522918|NCT00751374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6522919|NCT00751374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6522920|NCT00751374|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6522921|NCT00751374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6522922|NCT00751374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686965|NCT01641783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6686966|NCT01641783|Tubulin Modulators|tubulin modulators|mesh-ancestor
6686967|NCT01641783|Antimitotic Agents|antimitotic agents|mesh-ancestor
6686968|NCT01641783|Mitosis Modulators|mitosis modulators|mesh-ancestor
6686969|NCT01641783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686970|NCT01641796|Paromomycin|paromomycin|mesh-list
6686971|NCT01641796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6686972|NCT01641796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6686973|NCT01641796|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6686974|NCT01641796|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6686975|NCT01642030|Buprenorphine|buprenorphine|mesh-list
6686976|NCT01642030|Hydromorphone|hydromorphone|mesh-list
6686977|NCT01642030|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6686978|NCT01642030|Narcotics|narcotics|mesh-ancestor
6686979|NCT01642030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6686980|NCT01642030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686981|NCT01642030|Analgesics|analgesics|mesh-ancestor
6686982|NCT01642030|Sensory System Agents|sensory system agents|mesh-ancestor
6686983|NCT01642030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6686984|NCT01642030|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6686985|NCT01642108|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6686986|NCT01642108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6686987|NCT01642108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6686988|NCT01642108|Incretins|incretins|mesh-ancestor
6686989|NCT01642108|Hormones|hormones|mesh-ancestor
6686990|NCT01642108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6686991|NCT01642108|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6686992|NCT01642108|Protease Inhibitors|protease inhibitors|mesh-ancestor
6686993|NCT01642108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6686994|NCT01642108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6686995|NCT01642134|Aspirin|aspirin|mesh-list
6686996|NCT01642134|Clopidogrel|clopidogrel|mesh-list
6686997|NCT01642134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6686998|NCT01642134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6686999|NCT01642134|Analgesics|analgesics|mesh-ancestor
6687000|NCT01642134|Sensory System Agents|sensory system agents|mesh-ancestor
6687001|NCT01642134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6687002|NCT01642134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687003|NCT01642134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6687004|NCT01642134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6687005|NCT01642134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6687006|NCT01642134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6687007|NCT01642134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687008|NCT01642134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6687009|NCT01642134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6687010|NCT01642134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6687011|NCT01642134|Antipyretics|antipyretics|mesh-ancestor
6687012|NCT01642134|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6687013|NCT01642134|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6687014|NCT01642134|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6687015|NCT01642134|Purinergic Agents|purinergic agents|mesh-ancestor
6687016|NCT01642134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6687017|NCT01642186|Everolimus|everolimus|mesh-list
6687018|NCT01642186|Letrozole|letrozole|mesh-list
6687019|NCT01642186|Leuprolide|leuprolide|mesh-list
6687020|NCT01642186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6687021|NCT01642186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6687022|NCT01642186|Immunologic Factors|immunologic factors|mesh-ancestor
6687023|NCT01642186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687024|NCT01642186|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6687025|NCT01642186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6687026|NCT01642186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6687027|NCT01642186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687028|NCT01642186|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6522923|NCT00751478|Naltrexone|naltrexone|mesh-list
6522924|NCT00751478|Morphine|morphine|mesh-list
6522925|NCT00751478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6522926|NCT00751478|Narcotics|narcotics|mesh-ancestor
6522927|NCT00751478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6522928|NCT00751478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522929|NCT00751478|Analgesics|analgesics|mesh-ancestor
6687029|NCT01642186|Hormone Antagonists|hormone antagonists|mesh-ancestor
6687030|NCT01642186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6687031|NCT01642186|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6687032|NCT01642186|Fertility Agents|fertility agents|mesh-ancestor
6687033|NCT01642186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6687034|NCT01642186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6687035|NCT01642433|Prazosin|prazosin|mesh-list
6687036|NCT01642433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6687037|NCT01642433|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6687038|NCT01642433|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6687039|NCT01642433|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6687040|NCT01642433|Adrenergic Agents|adrenergic agents|mesh-ancestor
6687041|NCT01642433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6687042|NCT01642433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687043|NCT01642433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687044|NCT01642472|Ulipristal acetate|ulipristal acetate|mesh-list
6687045|NCT01642472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6687046|NCT01642472|Contraceptive Agents|contraceptive agents|mesh-ancestor
6687047|NCT01642472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6687048|NCT01642472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687049|NCT01642472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6687050|NCT01642524|Dextrans|dextrans|mesh-list
6687051|NCT01642524|Anticoagulants|anticoagulants|mesh-ancestor
6687052|NCT01642524|Plasma Substitutes|plasma substitutes|mesh-ancestor
6687053|NCT01642524|Blood Substitutes|blood substitutes|mesh-ancestor
6522930|NCT00751478|Sensory System Agents|sensory system agents|mesh-ancestor
6522931|NCT00751478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6522932|NCT00751478|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6522933|NCT00751478|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6687054|NCT01642667|Saruplase|saruplase|mesh-list
6687055|NCT01642667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6687056|NCT01642667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6687057|NCT01642667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687058|NCT01642745|Mannitol|mannitol|mesh-list
6687059|NCT01642745|Methacholine Chloride|methacholine chloride|mesh-list
6687060|NCT01642745|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6687061|NCT01642745|Diuretics|diuretics|mesh-ancestor
6687062|NCT01642745|Natriuretic Agents|natriuretic agents|mesh-ancestor
6687063|NCT01642745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687064|NCT01642745|Miotics|miotics|mesh-ancestor
6687065|NCT01642745|Autonomic Agents|autonomic agents|mesh-ancestor
6687066|NCT01642745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6687067|NCT01642745|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6687068|NCT01642745|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
6522934|NCT00751491|Clopidogrel|clopidogrel|mesh-list
6522935|NCT00751491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6522936|NCT00751491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6522937|NCT00751491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6522938|NCT00751491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6522939|NCT00751491|Purinergic Agents|purinergic agents|mesh-ancestor
6687069|NCT01642745|Respiratory System Agents|respiratory system agents|mesh-ancestor
6687070|NCT01642745|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6687071|NCT01642745|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6687072|NCT01642745|Cholinergic Agents|cholinergic agents|mesh-ancestor
6522940|NCT00751491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6687073|NCT01642745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6687074|NCT01642745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687075|NCT01642771|Docetaxel|docetaxel|mesh-list
6687076|NCT01642771|Fluorouracil|fluorouracil|mesh-list
6687077|NCT01642771|Capecitabine|capecitabine|mesh-list
6687078|NCT01642771|Epirubicin|epirubicin|mesh-list
6687079|NCT01642771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6687080|NCT01642771|Tubulin Modulators|tubulin modulators|mesh-ancestor
6687081|NCT01642771|Antimitotic Agents|antimitotic agents|mesh-ancestor
6687082|NCT01642771|Mitosis Modulators|mitosis modulators|mesh-ancestor
6687083|NCT01642771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687084|NCT01642771|Antimetabolites|antimetabolites|mesh-ancestor
6687085|NCT01642771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6687086|NCT01642771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6687087|NCT01642771|Immunologic Factors|immunologic factors|mesh-ancestor
6687088|NCT01642771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687089|NCT01642771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6687090|NCT01642771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6687091|NCT01642771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6687092|NCT01642771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6687093|NCT01642862|Simvastatin|simvastatin|mesh-list
6687094|NCT01642862|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6687095|NCT01642862|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6687096|NCT01642862|Antimetabolites|antimetabolites|mesh-ancestor
6687097|NCT01642862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687098|NCT01642862|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6687099|NCT01642862|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6687100|NCT01642862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6687101|NCT01642901|Zoledronic Acid|zoledronic acid|mesh-list
6687102|NCT01642901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6687103|NCT01642901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687104|NCT01642940|Ticagrelor|ticagrelor|mesh-list
6687105|NCT01642940|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6522941|NCT00751491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522942|NCT00751491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522943|NCT00751504|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6522944|NCT00751504|Antidepressive Agents|antidepressive agents|mesh-ancestor
6522945|NCT00751504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6522946|NCT00751504|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6522947|NCT00751504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6687106|NCT01642940|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6687107|NCT01642940|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6687108|NCT01642940|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6687109|NCT01642940|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6687110|NCT01642940|Purinergic Agents|purinergic agents|mesh-ancestor
6687111|NCT01642940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6687112|NCT01642940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687113|NCT01642940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687114|NCT01642966|Ticagrelor|ticagrelor|mesh-list
6687115|NCT01642966|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6687116|NCT01642966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6687117|NCT01642966|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6687118|NCT01642966|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6687119|NCT01642966|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6687120|NCT01642966|Purinergic Agents|purinergic agents|mesh-ancestor
6687121|NCT01642966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6687122|NCT01642966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687123|NCT01642966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687124|NCT01642979|Cyclosporine|cyclosporine|mesh-list
6687125|NCT01642979|Levamisole|levamisole|mesh-list
6687126|NCT01642979|Cyclosporins|cyclosporins|mesh-list
6687127|NCT01642979|Glucocorticoids|glucocorticoids|mesh-list
6687128|NCT01642979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6687129|NCT01642979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687130|NCT01642979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6687131|NCT01642979|Immunologic Factors|immunologic factors|mesh-ancestor
6687132|NCT01642979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687133|NCT01642979|Antifungal Agents|antifungal agents|mesh-ancestor
6687134|NCT01642979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6687135|NCT01642979|Dermatologic Agents|dermatologic agents|mesh-ancestor
6687136|NCT01642979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6687137|NCT01642979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6687138|NCT01642979|Hormones|hormones|mesh-ancestor
6780276|NCT02182544|Dermatologic Agents|dermatologic agents|mesh-ancestor
6687139|NCT01642979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6687140|NCT01642979|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6687141|NCT01642979|Antinematodal Agents|antinematodal agents|mesh-ancestor
6687142|NCT01642979|Anthelmintics|anthelmintics|mesh-ancestor
6687143|NCT01642979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6687144|NCT01643031|Clopidogrel|clopidogrel|mesh-list
6687145|NCT01643031|Ticagrelor|ticagrelor|mesh-list
6687146|NCT01643031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6687147|NCT01643031|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6687148|NCT01643031|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6687149|NCT01643031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6522948|NCT00751504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6522949|NCT00751504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522950|NCT00751517|Cyclophosphamide|cyclophosphamide|mesh-list
6522951|NCT00751517|Methotrexate|methotrexate|mesh-list
6687150|NCT01643031|Purinergic Agents|purinergic agents|mesh-ancestor
6687151|NCT01643031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6687152|NCT01643031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687153|NCT01643031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687154|NCT01643070|Capecitabine|capecitabine|mesh-list
6522952|NCT00751517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6522953|NCT00751517|Immunologic Factors|immunologic factors|mesh-ancestor
6522954|NCT00751517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522955|NCT00751517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6522956|NCT00751517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6522957|NCT00751517|Alkylating Agents|alkylating agents|mesh-ancestor
6522958|NCT00751517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522959|NCT00751517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6687155|NCT01643070|Oxaliplatin|oxaliplatin|mesh-list
6687156|NCT01643070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6687157|NCT01643070|Antimetabolites|antimetabolites|mesh-ancestor
6687158|NCT01643070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687159|NCT01643070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6687160|NCT01643083|Rifaximin|rifaximin|mesh-list
6687161|NCT01643083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6687162|NCT01643083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6687163|NCT01643083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6687164|NCT01643135|Tranylcypromine|tranylcypromine|mesh-list
6687165|NCT01643135|Tranexamic Acid|tranexamic acid|mesh-list
6687166|NCT01643135|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6687167|NCT01643135|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6687168|NCT01643135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687169|NCT01643135|Hemostatics|hemostatics|mesh-ancestor
6687170|NCT01643135|Coagulants|coagulants|mesh-ancestor
6687171|NCT01643135|Antidepressive Agents|antidepressive agents|mesh-ancestor
6687172|NCT01643135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6687173|NCT01643135|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6687174|NCT01643135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6687175|NCT01643135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6687176|NCT01643135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6687177|NCT01643135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6522960|NCT00751517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6522961|NCT00751517|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6522962|NCT00751517|Abortifacient Agents|abortifacient agents|mesh-ancestor
6522963|NCT00751517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6522964|NCT00751517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6522965|NCT00751517|Antimetabolites|antimetabolites|mesh-ancestor
6522966|NCT00751517|Dermatologic Agents|dermatologic agents|mesh-ancestor
6522967|NCT00751517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6522968|NCT00751517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6522969|NCT00751517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6522970|NCT00751556|Naproxen|naproxen|mesh-list
6522971|NCT00751556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6687178|NCT01643135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687179|NCT01643187|Vitamins|vitamins|mesh-list
6687180|NCT01643187|Micronutrients|micronutrients|mesh-ancestor
6687181|NCT01643187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687182|NCT01643252|Riboflavin|riboflavin|mesh-list
6687183|NCT01643252|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6687184|NCT01643252|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6687185|NCT01643252|Vitamin B Complex|vitamin b complex|mesh-ancestor
6687186|NCT01643252|Vitamins|vitamins|mesh-ancestor
6687187|NCT01643252|Micronutrients|micronutrients|mesh-ancestor
6522972|NCT00751556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6687188|NCT01643252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687189|NCT01643252|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6687190|NCT01643252|Dermatologic Agents|dermatologic agents|mesh-ancestor
6687191|NCT01643265|Caseins|caseins|mesh-list
6687192|NCT01643265|Chelating Agents|chelating agents|mesh-ancestor
6687193|NCT01643265|Sequestering Agents|sequestering agents|mesh-ancestor
6687194|NCT01643265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687195|NCT01643278|Ipilimumab|ipilimumab|mesh-list
6687196|NCT01643278|Dasatinib|dasatinib|mesh-list
6687197|NCT01643278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6687198|NCT01643278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6687199|NCT01643278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6687200|NCT01643278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6522973|NCT00751556|Analgesics|analgesics|mesh-ancestor
6522974|NCT00751556|Sensory System Agents|sensory system agents|mesh-ancestor
6522975|NCT00751556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6522976|NCT00751556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522977|NCT00751556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6522978|NCT00751556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6522979|NCT00751556|Gout Suppressants|gout suppressants|mesh-ancestor
6522980|NCT00751556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6522981|NCT00751556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6522982|NCT00751556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687201|NCT01643278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6687202|NCT01643278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6687203|NCT01643434|Clonidine|clonidine|mesh-list
6687204|NCT01643434|Spironolactone|spironolactone|mesh-list
6687205|NCT01643434|Analgesics|analgesics|mesh-ancestor
6687206|NCT01643434|Sensory System Agents|sensory system agents|mesh-ancestor
6687207|NCT01643434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6687208|NCT01643434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687209|NCT01643434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6687210|NCT01643434|Sympatholytics|sympatholytics|mesh-ancestor
6687211|NCT01643434|Autonomic Agents|autonomic agents|mesh-ancestor
6687212|NCT01643434|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6522983|NCT00751699|Mesalamine|mesalamine|mesh-list
6687213|NCT01643434|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6687214|NCT01643434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6687215|NCT01643434|Adrenergic Agents|adrenergic agents|mesh-ancestor
6687216|NCT01643434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6687217|NCT01643434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687218|NCT01643434|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6687219|NCT01643434|Hormone Antagonists|hormone antagonists|mesh-ancestor
6687220|NCT01643434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6687221|NCT01643434|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6687222|NCT01643434|Diuretics|diuretics|mesh-ancestor
6687223|NCT01643434|Natriuretic Agents|natriuretic agents|mesh-ancestor
6687224|NCT01643447|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
6687225|NCT01643447|Urinastatin|urinastatin|mesh-list
6687226|NCT01643447|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6687227|NCT01643447|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6687228|NCT01643447|Protease Inhibitors|protease inhibitors|mesh-ancestor
6687229|NCT01643447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6687230|NCT01643447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687231|NCT01643447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6687232|NCT01643499|Leucovorin|leucovorin|mesh-list
6687233|NCT01643499|Fluorouracil|fluorouracil|mesh-list
6687234|NCT01643499|Oxaliplatin|oxaliplatin|mesh-list
6687235|NCT01643499|Irinotecan|irinotecan|mesh-list
6687236|NCT01643499|Calcium|calcium|mesh-list
6687237|NCT01643499|Levoleucovorin|levoleucovorin|mesh-list
6687238|NCT01643499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6687239|NCT01643499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687240|NCT01643499|Antimetabolites|antimetabolites|mesh-ancestor
6687241|NCT01643499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687242|NCT01643499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6687243|NCT01643499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6687244|NCT01643499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6687245|NCT01643499|Immunologic Factors|immunologic factors|mesh-ancestor
6687246|NCT01643499|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6687247|NCT01643499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6687248|NCT01643499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6687249|NCT01643499|Antidotes|antidotes|mesh-ancestor
6687250|NCT01643499|Protective Agents|protective agents|mesh-ancestor
6687251|NCT01643499|Vitamin B Complex|vitamin b complex|mesh-ancestor
6687252|NCT01643499|Vitamins|vitamins|mesh-ancestor
6687253|NCT01643499|Micronutrients|micronutrients|mesh-ancestor
6780277|NCT02182544|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6780278|NCT02182544|Histamine Antagonists|histamine antagonists|mesh-ancestor
6780279|NCT02182544|Histamine Agents|histamine agents|mesh-ancestor
6780280|NCT02182544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6780281|NCT02182544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780282|NCT02182544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780283|NCT02182544|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6780284|NCT02182557|Ketotifen|ketotifen|mesh-list
6780285|NCT02182557|Epinastine|epinastine|mesh-list
6780286|NCT02182557|Antipruritics|antipruritics|mesh-ancestor
6780287|NCT02182557|Dermatologic Agents|dermatologic agents|mesh-ancestor
6780288|NCT02182557|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6780289|NCT02182557|Histamine Antagonists|histamine antagonists|mesh-ancestor
6780290|NCT02182557|Histamine Agents|histamine agents|mesh-ancestor
6780291|NCT02182557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6780292|NCT02182557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780293|NCT02182557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780294|NCT02182557|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6522984|NCT00751699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6522985|NCT00751699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6522986|NCT00751699|Analgesics|analgesics|mesh-ancestor
6522987|NCT00751699|Sensory System Agents|sensory system agents|mesh-ancestor
6522988|NCT00751699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6780295|NCT02182570|Epinastine|epinastine|mesh-list
6780296|NCT02182570|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6780297|NCT02182570|Histamine Antagonists|histamine antagonists|mesh-ancestor
6780298|NCT02182570|Histamine Agents|histamine agents|mesh-ancestor
6780299|NCT02182570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6780300|NCT02182570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780301|NCT02182570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522989|NCT00751699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522990|NCT00751699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6522991|NCT00751699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6522992|NCT00751738|Azimilide|azimilide|mesh-list
6522993|NCT00751738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6522994|NCT00751738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6522995|NCT00751738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6522996|NCT00751738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780302|NCT02182583|Oxitropium|oxitropium|mesh-list
6780303|NCT02182583|Parasympatholytics|parasympatholytics|mesh-ancestor
6780304|NCT02182583|Autonomic Agents|autonomic agents|mesh-ancestor
6780305|NCT02182583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6780306|NCT02182583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780307|NCT02182596|Gemtuzumab|gemtuzumab|mesh-list
6780308|NCT02182596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6522997|NCT00751738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6522998|NCT00751738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6522999|NCT00751751|Losartan|losartan|mesh-list
6523000|NCT00751751|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6523001|NCT00751751|Olmesartan|olmesartan|mesh-list
6780309|NCT02182596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6780310|NCT02182622|Prednisone|prednisone|mesh-list
6780311|NCT02182622|Docetaxel|docetaxel|mesh-list
6780312|NCT02182622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6780313|NCT02182622|Tubulin Modulators|tubulin modulators|mesh-ancestor
6780314|NCT02182622|Antimitotic Agents|antimitotic agents|mesh-ancestor
6780315|NCT02182622|Mitosis Modulators|mitosis modulators|mesh-ancestor
6780316|NCT02182622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780317|NCT02182622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6780318|NCT02182622|Glucocorticoids|glucocorticoids|mesh-ancestor
6780319|NCT02182622|Hormones|hormones|mesh-ancestor
6523002|NCT00751751|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6523003|NCT00751751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6523004|NCT00751751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6523005|NCT00751751|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6523006|NCT00751751|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6780320|NCT02182622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6780321|NCT02182622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523007|NCT00751751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523008|NCT00751751|Diuretics|diuretics|mesh-ancestor
6523009|NCT00751751|Natriuretic Agents|natriuretic agents|mesh-ancestor
6780322|NCT02182622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6780323|NCT02182635|Oxitropium|oxitropium|mesh-list
6780324|NCT02182635|Parasympatholytics|parasympatholytics|mesh-ancestor
6687254|NCT01643603|Dasatinib|dasatinib|mesh-list
6687255|NCT01643603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6687256|NCT01643603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6687257|NCT01643603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6687258|NCT01643603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687259|NCT01643629|Minoxidil|minoxidil|mesh-list
6687260|NCT01643629|Finasteride|finasteride|mesh-list
6687261|NCT01643629|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6687262|NCT01643629|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6687263|NCT01643629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6687264|NCT01643629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687265|NCT01643629|Hormone Antagonists|hormone antagonists|mesh-ancestor
6687266|NCT01643629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6687267|NCT01643629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687268|NCT01643629|Urological Agents|urological agents|mesh-ancestor
6687269|NCT01643629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6687270|NCT01643629|Vasodilator Agents|vasodilator agents|mesh-ancestor
6687271|NCT01643759|Buprenorphine|buprenorphine|mesh-list
6687272|NCT01643759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6687273|NCT01643759|Narcotics|narcotics|mesh-ancestor
6687274|NCT01643759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6687275|NCT01643759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687276|NCT01643759|Analgesics|analgesics|mesh-ancestor
6687277|NCT01643759|Sensory System Agents|sensory system agents|mesh-ancestor
6523010|NCT00751751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523011|NCT00751751|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6523012|NCT00751751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6523013|NCT00751764|Moxidectin|moxidectin|mesh-list
6523014|NCT00751764|Anthelmintics|anthelmintics|mesh-ancestor
6523015|NCT00751764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6523016|NCT00751764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6523017|NCT00751764|Antinematodal Agents|antinematodal agents|mesh-ancestor
6523018|NCT00751829|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6687278|NCT01643759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6687279|NCT01643759|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6687280|NCT01643889|Moxifloxacin|moxifloxacin|mesh-list
6687281|NCT01643889|Domperidone|domperidone|mesh-list
6687282|NCT01643889|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6687283|NCT01643889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6687284|NCT01643889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6687285|NCT01643889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6687286|NCT01643889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6687287|NCT01643889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687288|NCT01643889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6687289|NCT01643889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687290|NCT01643889|Antiemetics|antiemetics|mesh-ancestor
6687291|NCT01643889|Autonomic Agents|autonomic agents|mesh-ancestor
6687292|NCT01643889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6687293|NCT01643889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6687294|NCT01643889|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6687295|NCT01643889|Dopamine Agents|dopamine agents|mesh-ancestor
6687296|NCT01643889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6687297|NCT01643941|Vaccines|vaccines|mesh-list
6687298|NCT01643941|Immunologic Factors|immunologic factors|mesh-ancestor
6687299|NCT01643941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687300|NCT01643980|Progesterone|progesterone|mesh-list
6687301|NCT01643980|Progestins|progestins|mesh-ancestor
6687302|NCT01643980|Hormones|hormones|mesh-ancestor
6687303|NCT01643980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6687304|NCT01643980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687305|NCT01644071|Dexetimide|dexetimide|mesh-list
6687306|NCT01644071|Citalopram|citalopram|mesh-list
6687307|NCT01644071|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6687308|NCT01644071|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6687309|NCT01644071|Parasympatholytics|parasympatholytics|mesh-ancestor
6687310|NCT01644071|Autonomic Agents|autonomic agents|mesh-ancestor
6687311|NCT01644071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6687312|NCT01644071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687313|NCT01644071|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6687314|NCT01644071|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6687315|NCT01644071|Cholinergic Agents|cholinergic agents|mesh-ancestor
6687316|NCT01644071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6687317|NCT01644071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687318|NCT01644071|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6523019|NCT00751829|Olmesartan|olmesartan|mesh-list
6687319|NCT01644071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6523020|NCT00751829|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6523021|NCT00751829|Nitrendipine|nitrendipine|mesh-list
6523022|NCT00751829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6523023|NCT00751829|Diuretics|diuretics|mesh-ancestor
6523024|NCT00751829|Natriuretic Agents|natriuretic agents|mesh-ancestor
6523025|NCT00751829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523026|NCT00751829|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6523027|NCT00751829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6523028|NCT00751829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523029|NCT00751829|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6523030|NCT00751829|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6523031|NCT00751829|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6523032|NCT00751829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6523033|NCT00751829|Vasodilator Agents|vasodilator agents|mesh-ancestor
6523034|NCT00751855|Hydrocortisone|hydrocortisone|mesh-list
6523035|NCT00751855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6523036|NCT00751907|Atorvastatin|atorvastatin|mesh-list
6523037|NCT00751907|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6523038|NCT00751907|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6523039|NCT00751907|Antimetabolites|antimetabolites|mesh-ancestor
6687320|NCT01644071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6687321|NCT01644071|Serotonin Agents|serotonin agents|mesh-ancestor
6687322|NCT01644071|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6687323|NCT01644071|Antidepressive Agents|antidepressive agents|mesh-ancestor
6687324|NCT01644071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6687325|NCT01644084|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
6523040|NCT00751907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523041|NCT00751907|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6523042|NCT00751907|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6523043|NCT00751907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6523044|NCT00751959|Poractant alfa|poractant alfa|mesh-list
6523045|NCT00751959|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
6523046|NCT00751959|Respiratory System Agents|respiratory system agents|mesh-ancestor
6523047|NCT00752011|Carboplatin|carboplatin|mesh-list
6523048|NCT00752011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6523049|NCT00752024|Hemostatics|hemostatics|mesh-list
6523050|NCT00752024|Coagulants|coagulants|mesh-ancestor
6523051|NCT00752037|Ritonavir|ritonavir|mesh-list
6523052|NCT00752037|Lopinavir|lopinavir|mesh-list
6687326|NCT01644084|Plasma Substitutes|plasma substitutes|mesh-ancestor
6687327|NCT01644084|Blood Substitutes|blood substitutes|mesh-ancestor
6687328|NCT01644110|Pomalidomide|pomalidomide|mesh-list
6687329|NCT01644110|Immunologic Factors|immunologic factors|mesh-ancestor
6687330|NCT01644110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687331|NCT01644110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6687332|NCT01644110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6687333|NCT01644110|Growth Substances|growth substances|mesh-ancestor
6687334|NCT01644110|Growth Inhibitors|growth inhibitors|mesh-ancestor
6687335|NCT01644110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6687336|NCT01644253|Rituximab|rituximab|mesh-list
6687337|NCT01644253|Obinutuzumab|obinutuzumab|mesh-list
6687338|NCT01644253|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6687339|NCT01644253|Idelalisib|idelalisib|mesh-list
6687340|NCT01644253|Immunoglobulin G|immunoglobulin g|mesh-list
6687341|NCT01644253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6687342|NCT01644253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6687343|NCT01644253|Immunologic Factors|immunologic factors|mesh-ancestor
6687344|NCT01644253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687345|NCT01644253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6687346|NCT01644253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6687347|NCT01644253|Alkylating Agents|alkylating agents|mesh-ancestor
6687348|NCT01644253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687349|NCT01644253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6687350|NCT01644773|Dasatinib|dasatinib|mesh-list
6687351|NCT01644773|Crizotinib|crizotinib|mesh-list
6687352|NCT01644773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6687353|NCT01644773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6687354|NCT01644773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6687355|NCT01644773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687356|NCT01644799|Lenalidomide|lenalidomide|mesh-list
6687357|NCT01644799|Idelalisib|idelalisib|mesh-list
6687358|NCT01644799|Immunologic Factors|immunologic factors|mesh-ancestor
6687359|NCT01644799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687360|NCT01644799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6687361|NCT01644799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6687362|NCT01644799|Growth Substances|growth substances|mesh-ancestor
6687363|NCT01644799|Growth Inhibitors|growth inhibitors|mesh-ancestor
6687364|NCT01644799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6687365|NCT01644799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6687366|NCT01644799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687367|NCT01644825|Paclitaxel|paclitaxel|mesh-list
6687368|NCT01644825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6687369|NCT01644825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6687370|NCT01644825|Tubulin Modulators|tubulin modulators|mesh-ancestor
6687371|NCT01644825|Antimitotic Agents|antimitotic agents|mesh-ancestor
6687372|NCT01644825|Mitosis Modulators|mitosis modulators|mesh-ancestor
6687373|NCT01644825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523053|NCT00752037|Raltegravir Potassium|raltegravir potassium|mesh-list
6523054|NCT00752037|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6523055|NCT00752037|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6523056|NCT00752037|Protease Inhibitors|protease inhibitors|mesh-ancestor
6523057|NCT00752037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6687374|NCT01644838|Promethazine|promethazine|mesh-list
6687375|NCT01644838|Diphenhydramine|diphenhydramine|mesh-list
6687376|NCT01644838|Scopolamine|scopolamine|mesh-list
6687377|NCT01644838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6687378|NCT01644838|Antiemetics|antiemetics|mesh-ancestor
6523058|NCT00752037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523059|NCT00752037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6523060|NCT00752037|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6523061|NCT00752037|Antiviral Agents|antiviral agents|mesh-ancestor
6523062|NCT00752037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6687379|NCT01644838|Autonomic Agents|autonomic agents|mesh-ancestor
6687380|NCT01644838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6687381|NCT01644838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687382|NCT01644838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6687383|NCT01644838|Mydriatics|mydriatics|mesh-ancestor
6687384|NCT01644838|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6687385|NCT01644838|Cholinergic Agents|cholinergic agents|mesh-ancestor
6523063|NCT00752037|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6523064|NCT00752037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6523065|NCT00752037|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6523066|NCT00752037|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6523067|NCT00752063|Capecitabine|capecitabine|mesh-list
6523068|NCT00752063|Oxaliplatin|oxaliplatin|mesh-list
6687386|NCT01644838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6687387|NCT01644838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687388|NCT01644838|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6687389|NCT01644838|Antipruritics|antipruritics|mesh-ancestor
6687390|NCT01644838|Dermatologic Agents|dermatologic agents|mesh-ancestor
6687391|NCT01644838|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6687392|NCT01644838|Histamine Antagonists|histamine antagonists|mesh-ancestor
6687393|NCT01644838|Histamine Agents|histamine agents|mesh-ancestor
6687394|NCT01644838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6687395|NCT01644838|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6687396|NCT01644838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6523069|NCT00752063|Sorafenib|sorafenib|mesh-list
6523070|NCT00752063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6523071|NCT00752063|Antimetabolites|antimetabolites|mesh-ancestor
6523072|NCT00752063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523073|NCT00752063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6523074|NCT00752063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6687397|NCT01644838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6687398|NCT01644838|Anesthetics, Local|anesthetics, local|mesh-ancestor
6523075|NCT00752063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6523076|NCT00752115|Paclitaxel|paclitaxel|mesh-list
6687399|NCT01644838|Anesthetics|anesthetics|mesh-ancestor
6687400|NCT01644838|Sensory System Agents|sensory system agents|mesh-ancestor
6687401|NCT01644864|Ropivacaine|ropivacaine|mesh-list
6687402|NCT01644864|Anesthetics, Local|anesthetics, local|mesh-ancestor
6687403|NCT01644864|Anesthetics|anesthetics|mesh-ancestor
6687404|NCT01644864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6687405|NCT01644864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523077|NCT00752115|Carboplatin|carboplatin|mesh-list
6523078|NCT00752115|Sildenafil Citrate|sildenafil citrate|mesh-list
6523079|NCT00752115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6523080|NCT00752115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6523081|NCT00752115|Tubulin Modulators|tubulin modulators|mesh-ancestor
6687406|NCT01644864|Sensory System Agents|sensory system agents|mesh-ancestor
6687407|NCT01644864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6687408|NCT01644955|Carboplatin|carboplatin|mesh-list
6687409|NCT01644955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6687410|NCT01644994|Cisplatin|cisplatin|mesh-list
6687411|NCT01644994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6687412|NCT01645085|Mannitol|mannitol|mesh-list
6687413|NCT01645085|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6687414|NCT01645085|Diuretics|diuretics|mesh-ancestor
6687415|NCT01645085|Natriuretic Agents|natriuretic agents|mesh-ancestor
6687416|NCT01645085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687417|NCT01645124|Hydroxyurea|hydroxyurea|mesh-list
6687418|NCT01645124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6687419|NCT01645124|Antisickling Agents|antisickling agents|mesh-ancestor
6687420|NCT01645124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6687421|NCT01645124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687422|NCT01645124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6687423|NCT01645228|Calcium|calcium|mesh-list
6687424|NCT01645228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6687425|NCT01645228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687426|NCT01645241|Ganirelix|ganirelix|mesh-list
6687427|NCT01645241|Hormone Antagonists|hormone antagonists|mesh-ancestor
6687428|NCT01645241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6687429|NCT01645241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780325|NCT02182635|Autonomic Agents|autonomic agents|mesh-ancestor
6780326|NCT02182635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6780327|NCT02182635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780328|NCT02182648|Propofol|propofol|mesh-list
6780329|NCT02182648|Etomidate|etomidate|mesh-list
6780330|NCT02182648|Sevoflurane|sevoflurane|mesh-list
6780331|NCT02182648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6780332|NCT02182648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6780333|NCT02182648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780334|NCT02182648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6780335|NCT02182648|Anesthetics, General|anesthetics, general|mesh-ancestor
6780336|NCT02182648|Anesthetics|anesthetics|mesh-ancestor
6780337|NCT02182648|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6780338|NCT02182648|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6242702|NCT02655237|Leuprolide|leuprolide|mesh-list
6780339|NCT02182661|Oxitropium|oxitropium|mesh-list
6523082|NCT00752115|Antimitotic Agents|antimitotic agents|mesh-ancestor
6523083|NCT00752115|Mitosis Modulators|mitosis modulators|mesh-ancestor
6523084|NCT00752115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523085|NCT00752115|Vasodilator Agents|vasodilator agents|mesh-ancestor
6523086|NCT00752115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6523087|NCT00752115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6523088|NCT00752115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6523089|NCT00752115|Urological Agents|urological agents|mesh-ancestor
6523090|NCT00752141|Mandelic Acids|mandelic acids|mesh-list
6523091|NCT00752141|Oxybutynin|oxybutynin|mesh-list
6523092|NCT00752141|Parasympatholytics|parasympatholytics|mesh-ancestor
6523093|NCT00752141|Autonomic Agents|autonomic agents|mesh-ancestor
6523094|NCT00752141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6523095|NCT00752141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523096|NCT00752141|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6523097|NCT00752141|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6523098|NCT00752141|Cholinergic Agents|cholinergic agents|mesh-ancestor
6523099|NCT00752141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6523100|NCT00752141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523101|NCT00752141|Urological Agents|urological agents|mesh-ancestor
6523102|NCT00752141|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6523103|NCT00752141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6523104|NCT00752141|Renal Agents|renal agents|mesh-ancestor
6523105|NCT00752154|Curcumin|curcumin|mesh-list
6523106|NCT00752154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6780340|NCT02182661|Parasympatholytics|parasympatholytics|mesh-ancestor
6780341|NCT02182661|Autonomic Agents|autonomic agents|mesh-ancestor
6780342|NCT02182661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6242703|NCT02655237|Relugolix|relugolix|mesh-list
6242704|NCT02655237|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6242705|NCT02655237|Fertility Agents|fertility agents|mesh-ancestor
6242706|NCT02655237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6242707|NCT02655237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6242708|NCT02655237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6242709|NCT02655237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6242710|NCT02655237|Androgen Antagonists|androgen antagonists|mesh-ancestor
6242711|NCT02655237|Hormone Antagonists|hormone antagonists|mesh-ancestor
6242712|NCT02655237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6242713|NCT02655354|Diphenhydramine|diphenhydramine|mesh-list
6687430|NCT01645254|Antimalarials|antimalarials|mesh-list
6687431|NCT01645254|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6687432|NCT01645254|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6687433|NCT01645254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6687434|NCT01645384|Atorvastatin|atorvastatin|mesh-list
6687435|NCT01645384|Calcium|calcium|mesh-list
6687436|NCT01645384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6687437|NCT01645384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687438|NCT01645384|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6687439|NCT01645384|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6687440|NCT01645384|Antimetabolites|antimetabolites|mesh-ancestor
6687441|NCT01645384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687442|NCT01645384|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6687443|NCT01645384|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6687444|NCT01645384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6687445|NCT01645410|Atorvastatin|atorvastatin|mesh-list
6687446|NCT01645410|Calcium|calcium|mesh-list
6687447|NCT01645410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6687448|NCT01645410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687449|NCT01645410|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6687450|NCT01645410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6687451|NCT01645410|Antimetabolites|antimetabolites|mesh-ancestor
6687452|NCT01645410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687453|NCT01645410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6687454|NCT01645410|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6687455|NCT01645410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6687456|NCT01645423|Atorvastatin|atorvastatin|mesh-list
6687457|NCT01645423|Calcium|calcium|mesh-list
6687458|NCT01645423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6687459|NCT01645423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687460|NCT01645423|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6687461|NCT01645423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6687462|NCT01645423|Antimetabolites|antimetabolites|mesh-ancestor
6687463|NCT01645423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687464|NCT01645423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6687465|NCT01645423|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6687466|NCT01645423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6687467|NCT01645449|Atorvastatin|atorvastatin|mesh-list
6687468|NCT01645449|Calcium|calcium|mesh-list
6687469|NCT01645449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6687470|NCT01645449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687471|NCT01645449|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6687472|NCT01645449|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6687473|NCT01645449|Antimetabolites|antimetabolites|mesh-ancestor
6687474|NCT01645449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687475|NCT01645449|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6687476|NCT01645449|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6687477|NCT01645449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6687478|NCT01645475|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
6687479|NCT01645475|Hemostatics|hemostatics|mesh-ancestor
6687480|NCT01645475|Coagulants|coagulants|mesh-ancestor
6687481|NCT01645475|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6687482|NCT01645475|Natriuretic Agents|natriuretic agents|mesh-ancestor
6687483|NCT01645475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687484|NCT01645748|Cisplatin|cisplatin|mesh-list
6687485|NCT01645748|Docetaxel|docetaxel|mesh-list
6687486|NCT01645748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6687487|NCT01645748|Tubulin Modulators|tubulin modulators|mesh-ancestor
6687488|NCT01645748|Antimitotic Agents|antimitotic agents|mesh-ancestor
6687489|NCT01645748|Mitosis Modulators|mitosis modulators|mesh-ancestor
6687490|NCT01645748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687491|NCT01645774|Oxymetazoline|oxymetazoline|mesh-list
6687492|NCT01645774|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6687493|NCT01645774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6687494|NCT01645774|Adrenergic Agents|adrenergic agents|mesh-ancestor
6687495|NCT01645774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6687496|NCT01645774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687497|NCT01645774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687498|NCT01645774|Sympathomimetics|sympathomimetics|mesh-ancestor
6687499|NCT01645774|Autonomic Agents|autonomic agents|mesh-ancestor
6687500|NCT01645774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6687501|NCT01645774|Nasal Decongestants|nasal decongestants|mesh-ancestor
6687502|NCT01645774|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6687503|NCT01645774|Respiratory System Agents|respiratory system agents|mesh-ancestor
6687504|NCT01645787|4-Aminopyridine|4-aminopyridine|mesh-list
6687505|NCT01645787|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6687506|NCT01645787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6687507|NCT01645787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687508|NCT01645800|Muramidase|muramidase|mesh-list
6687509|NCT01645800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6687510|NCT01645826|Diltiazem|diltiazem|mesh-list
6687511|NCT01645826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6687512|NCT01645826|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6687513|NCT01645826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6687514|NCT01645826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687515|NCT01645826|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6687516|NCT01645826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687517|NCT01645826|Vasodilator Agents|vasodilator agents|mesh-ancestor
6687518|NCT01645839|Cytarabine|cytarabine|mesh-list
6687519|NCT01645839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6687520|NCT01645839|Antimetabolites|antimetabolites|mesh-ancestor
6687521|NCT01645839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687522|NCT01645839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6687523|NCT01645839|Antiviral Agents|antiviral agents|mesh-ancestor
6687524|NCT01645839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6687525|NCT01645839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6687526|NCT01645839|Immunologic Factors|immunologic factors|mesh-ancestor
6687527|NCT01645839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687528|NCT01646034|Gemcitabine|gemcitabine|mesh-list
6523107|NCT00752154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6523108|NCT00752154|Analgesics|analgesics|mesh-ancestor
6523109|NCT00752154|Sensory System Agents|sensory system agents|mesh-ancestor
6523110|NCT00752154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6523111|NCT00752154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523112|NCT00752154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6523113|NCT00752154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6523114|NCT00752154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6523115|NCT00752154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6523116|NCT00752154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523117|NCT00752180|Insulin|insulin|mesh-list
6523118|NCT00752180|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6523119|NCT00752180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6523120|NCT00752180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523121|NCT00752310|Darunavir|darunavir|mesh-list
6523122|NCT00752310|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6523123|NCT00752310|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6523124|NCT00752310|Protease Inhibitors|protease inhibitors|mesh-ancestor
6523125|NCT00752310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6523126|NCT00752310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523127|NCT00752310|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6523128|NCT00752310|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6523129|NCT00752310|Antiviral Agents|antiviral agents|mesh-ancestor
6523130|NCT00752310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6523131|NCT00752323|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6523132|NCT00752323|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6523133|NCT00752323|Dermatologic Agents|dermatologic agents|mesh-ancestor
6523134|NCT00752375|Trimethoprim|trimethoprim|mesh-list
6523135|NCT00752375|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6523136|NCT00752375|Sulfamethoxazole|sulfamethoxazole|mesh-list
6687529|NCT01646034|Paclitaxel|paclitaxel|mesh-list
6687530|NCT01646034|Docetaxel|docetaxel|mesh-list
6687531|NCT01646034|Cyclophosphamide|cyclophosphamide|mesh-list
6687532|NCT01646034|Carboplatin|carboplatin|mesh-list
6687533|NCT01646034|Doxorubicin|doxorubicin|mesh-list
6687534|NCT01646034|Thiotepa|thiotepa|mesh-list
6687535|NCT01646034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6687536|NCT01646034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6687537|NCT01646034|Tubulin Modulators|tubulin modulators|mesh-ancestor
6687538|NCT01646034|Antimitotic Agents|antimitotic agents|mesh-ancestor
6687539|NCT01646034|Mitosis Modulators|mitosis modulators|mesh-ancestor
6687540|NCT01646034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687541|NCT01646034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6687542|NCT01646034|Immunologic Factors|immunologic factors|mesh-ancestor
6687543|NCT01646034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687544|NCT01646034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6687545|NCT01646034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6687546|NCT01646034|Alkylating Agents|alkylating agents|mesh-ancestor
6687547|NCT01646034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6687548|NCT01646034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6687549|NCT01646034|Antimetabolites|antimetabolites|mesh-ancestor
6687550|NCT01646034|Antiviral Agents|antiviral agents|mesh-ancestor
6687551|NCT01646034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6687552|NCT01646034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6687553|NCT01646034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6687554|NCT01646034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6687555|NCT01646034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6687556|NCT01646229|Polymyxins|polymyxins|mesh-list
6687557|NCT01646229|Polymyxin B|polymyxin b|mesh-list
6687558|NCT01646229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6687559|NCT01646229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6687560|NCT01646281|Flecainide|flecainide|mesh-list
6687561|NCT01646281|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6687562|NCT01646281|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6687563|NCT01646281|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6687564|NCT01646281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6687565|NCT01646281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687566|NCT01646294|Mirabegron|mirabegron|mesh-list
6687567|NCT01646294|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6687568|NCT01646294|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6687569|NCT01646294|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6687570|NCT01646294|Adrenergic Agents|adrenergic agents|mesh-ancestor
6687571|NCT01646294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6687572|NCT01646294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687573|NCT01646294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687574|NCT01646294|Urological Agents|urological agents|mesh-ancestor
6687575|NCT01646307|Atorvastatin|atorvastatin|mesh-list
6687576|NCT01646307|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6687577|NCT01646307|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6523137|NCT00752375|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6523138|NCT00752375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6523139|NCT00752375|Renal Agents|renal agents|mesh-ancestor
6523140|NCT00752375|Antimalarials|antimalarials|mesh-ancestor
6523141|NCT00752375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6523142|NCT00752375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6523143|NCT00752375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6523144|NCT00752375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6687578|NCT01646307|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6687579|NCT01646307|Antimetabolites|antimetabolites|mesh-ancestor
6687580|NCT01646307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687581|NCT01646307|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6687582|NCT01646307|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6687583|NCT01646307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6687584|NCT01646437|Aspirin|aspirin|mesh-list
6687585|NCT01646437|Vitamin D|vitamin d|mesh-list
6687586|NCT01646437|Cholecalciferol|cholecalciferol|mesh-list
6687587|NCT01646437|Vitamins|vitamins|mesh-ancestor
6687588|NCT01646437|Micronutrients|micronutrients|mesh-ancestor
6687589|NCT01646437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687590|NCT01646437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6687591|NCT01646437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6687592|NCT01646437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6687593|NCT01646437|Analgesics|analgesics|mesh-ancestor
6687594|NCT01646437|Sensory System Agents|sensory system agents|mesh-ancestor
6687595|NCT01646437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6687596|NCT01646437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6687597|NCT01646437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6687598|NCT01646437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6687599|NCT01646437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6687600|NCT01646437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687601|NCT01646437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6687602|NCT01646437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6687603|NCT01646437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6687604|NCT01646437|Antipyretics|antipyretics|mesh-ancestor
6687605|NCT01646437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6687606|NCT01646515|Udenafil|udenafil|mesh-list
6687607|NCT01646515|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6687608|NCT01646515|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6687609|NCT01646515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6687610|NCT01646515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687611|NCT01646554|Oxaliplatin|oxaliplatin|mesh-list
6687612|NCT01646554|Aflibercept|aflibercept|mesh-list
6687613|NCT01646554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6687614|NCT01646554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6523145|NCT00752375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687615|NCT01646554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6687616|NCT01646554|Growth Substances|growth substances|mesh-ancestor
6687617|NCT01646554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687618|NCT01646554|Growth Inhibitors|growth inhibitors|mesh-ancestor
6687619|NCT01646567|Betamethasone|betamethasone|mesh-list
6687620|NCT01646567|Betamethasone Valerate|betamethasone valerate|mesh-list
6687621|NCT01646567|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
6687622|NCT01646567|Betamethasone benzoate|betamethasone benzoate|mesh-list
6687623|NCT01646567|Calcipotriene|calcipotriene|mesh-list
6687624|NCT01646567|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
6687625|NCT01646567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6687626|NCT01646567|Glucocorticoids|glucocorticoids|mesh-ancestor
6687627|NCT01646567|Hormones|hormones|mesh-ancestor
6687628|NCT01646567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6687629|NCT01646567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687630|NCT01646567|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6687631|NCT01646567|Respiratory System Agents|respiratory system agents|mesh-ancestor
6523146|NCT00752375|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6523147|NCT00752375|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6523148|NCT00752375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6523149|NCT00752375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6523150|NCT00752401|Vitamin D|vitamin d|mesh-list
6523151|NCT00752401|Cholecalciferol|cholecalciferol|mesh-list
6523152|NCT00752401|Vitamins|vitamins|mesh-ancestor
6523153|NCT00752401|Micronutrients|micronutrients|mesh-ancestor
6523154|NCT00752401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523155|NCT00752401|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6523156|NCT00752401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6523157|NCT00752414|Levofloxacin|levofloxacin|mesh-list
6523158|NCT00752414|Ofloxacin|ofloxacin|mesh-list
6523159|NCT00752414|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6523160|NCT00752414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6523161|NCT00752414|Renal Agents|renal agents|mesh-ancestor
6523162|NCT00752414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6523163|NCT00752414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6523164|NCT00752414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6523165|NCT00752414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6523166|NCT00752414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523167|NCT00752414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6523168|NCT00752414|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6523169|NCT00752414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6523170|NCT00752427|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6523171|NCT00752427|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6523172|NCT00752427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6523173|NCT00752427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6523174|NCT00752427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523175|NCT00752427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6523176|NCT00752427|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6523177|NCT00752427|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6523178|NCT00752427|Serotonin Agents|serotonin agents|mesh-ancestor
6523179|NCT00752427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6523180|NCT00752427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523181|NCT00752427|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6523182|NCT00752427|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6523183|NCT00752427|Dopamine Agents|dopamine agents|mesh-ancestor
6523184|NCT00752466|Topiramate|topiramate|mesh-list
6523185|NCT00752466|Flunarizine|flunarizine|mesh-list
6523186|NCT00752466|Anticonvulsants|anticonvulsants|mesh-ancestor
6523187|NCT00752466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6523188|NCT00752466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523189|NCT00752466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6523190|NCT00752466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6523191|NCT00752466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523192|NCT00752466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6523193|NCT00752466|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6523194|NCT00752466|Histamine Antagonists|histamine antagonists|mesh-ancestor
6523195|NCT00752466|Histamine Agents|histamine agents|mesh-ancestor
6523196|NCT00752466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6687632|NCT01646567|Dermatologic Agents|dermatologic agents|mesh-ancestor
6687633|NCT01646580|Ciclopirox|ciclopirox|mesh-list
6687634|NCT01646580|Antifungal Agents|antifungal agents|mesh-ancestor
6687635|NCT01646580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6687636|NCT01646619|Magnesium Sulfate|magnesium sulfate|mesh-list
6687637|NCT01646619|Analgesics|analgesics|mesh-ancestor
6687638|NCT01646619|Sensory System Agents|sensory system agents|mesh-ancestor
6687639|NCT01646619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6687640|NCT01646619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687641|NCT01646619|Anesthetics|anesthetics|mesh-ancestor
6687642|NCT01646619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6687643|NCT01646619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6687644|NCT01646619|Anticonvulsants|anticonvulsants|mesh-ancestor
6687645|NCT01646619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6687646|NCT01646619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6687647|NCT01646619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687648|NCT01646619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6687649|NCT01646619|Tocolytic Agents|tocolytic agents|mesh-ancestor
6687650|NCT01646619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6687651|NCT01646684|Pasireotide|pasireotide|mesh-list
6687652|NCT01646684|Hormones|hormones|mesh-ancestor
6687653|NCT01646684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6687654|NCT01646684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687655|NCT01646736|Cyclophosphamide|cyclophosphamide|mesh-list
6687656|NCT01646736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6687657|NCT01646736|Immunologic Factors|immunologic factors|mesh-ancestor
6687658|NCT01646736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687659|NCT01646736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6687660|NCT01646736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6687661|NCT01646736|Alkylating Agents|alkylating agents|mesh-ancestor
6687662|NCT01646736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687663|NCT01646736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6687664|NCT01646736|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6687665|NCT01646775|Fentanyl|fentanyl|mesh-list
6687666|NCT01646775|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6687667|NCT01646775|Narcotics|narcotics|mesh-ancestor
6687668|NCT01646775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6687669|NCT01646775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687670|NCT01646775|Analgesics|analgesics|mesh-ancestor
6687671|NCT01646775|Sensory System Agents|sensory system agents|mesh-ancestor
6687672|NCT01646775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6687673|NCT01646775|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6687674|NCT01646775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6687675|NCT01646775|Anesthetics, General|anesthetics, general|mesh-ancestor
6687676|NCT01646775|Anesthetics|anesthetics|mesh-ancestor
6687677|NCT01646788|Paclitaxel|paclitaxel|mesh-list
6687678|NCT01646788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6687679|NCT01646788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6687680|NCT01646788|Tubulin Modulators|tubulin modulators|mesh-ancestor
6687681|NCT01646788|Antimitotic Agents|antimitotic agents|mesh-ancestor
6687682|NCT01646788|Mitosis Modulators|mitosis modulators|mesh-ancestor
6687683|NCT01646788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687684|NCT01646853|Fluorouracil|fluorouracil|mesh-list
6687685|NCT01646853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6523197|NCT00752466|Vasodilator Agents|vasodilator agents|mesh-ancestor
6523198|NCT00752479|Cyclosporine|cyclosporine|mesh-list
6523199|NCT00752479|Mycophenolic Acid|mycophenolic acid|mesh-list
6523200|NCT00752479|Methylprednisolone|methylprednisolone|mesh-list
6523201|NCT00752479|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6687686|NCT01646853|Antimetabolites|antimetabolites|mesh-ancestor
6687687|NCT01646853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687688|NCT01646853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6687689|NCT01646853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6687690|NCT01646853|Immunologic Factors|immunologic factors|mesh-ancestor
6687691|NCT01646853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523202|NCT00752479|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6523203|NCT00752479|Prednisolone|prednisolone|mesh-list
6523204|NCT00752479|Prednisolone acetate|prednisolone acetate|mesh-list
6523205|NCT00752479|Cyclosporins|cyclosporins|mesh-list
6523206|NCT00752479|Basiliximab|basiliximab|mesh-list
6687692|NCT01647152|Ustekinumab|ustekinumab|mesh-list
6687693|NCT01647152|Dermatologic Agents|dermatologic agents|mesh-ancestor
6687694|NCT01647165|Dexamethasone|dexamethasone|mesh-list
6687695|NCT01647165|Lenalidomide|lenalidomide|mesh-list
6687696|NCT01647165|Bortezomib|bortezomib|mesh-list
6687697|NCT01647165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6687698|NCT01647165|Antiemetics|antiemetics|mesh-ancestor
6687699|NCT01647165|Autonomic Agents|autonomic agents|mesh-ancestor
6687700|NCT01647165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6687701|NCT01647165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687702|NCT01647165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6687703|NCT01647165|Glucocorticoids|glucocorticoids|mesh-ancestor
6687704|NCT01647165|Hormones|hormones|mesh-ancestor
6687705|NCT01647165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6687706|NCT01647165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6687707|NCT01647165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6687708|NCT01647165|Immunologic Factors|immunologic factors|mesh-ancestor
6687709|NCT01647165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6687710|NCT01647165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6687711|NCT01647165|Growth Substances|growth substances|mesh-ancestor
6687712|NCT01647165|Growth Inhibitors|growth inhibitors|mesh-ancestor
6687713|NCT01647256|Nikkomycin|nikkomycin|mesh-list
6687714|NCT01647256|Antifungal Agents|antifungal agents|mesh-ancestor
6687715|NCT01647256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6687716|NCT01647256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6687717|NCT01647256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523207|NCT00752479|Thymoglobulin|thymoglobulin|mesh-list
6523208|NCT00752479|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6523209|NCT00752479|Prednisolone phosphate|prednisolone phosphate|mesh-list
6523210|NCT00752479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6687718|NCT01647347|Povidone-Iodine|povidone-iodine|mesh-list
6687719|NCT01647347|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6687720|NCT01647347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6687721|NCT01647412|Curcumin|curcumin|mesh-list
6687722|NCT01647412|Hormones|hormones|mesh-list
6687723|NCT01647412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6687724|NCT01647412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523211|NCT00752479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523212|NCT00752479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6523213|NCT00752479|Immunologic Factors|immunologic factors|mesh-ancestor
6523214|NCT00752479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523215|NCT00752479|Antifungal Agents|antifungal agents|mesh-ancestor
6523216|NCT00752479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6523217|NCT00752479|Dermatologic Agents|dermatologic agents|mesh-ancestor
6687725|NCT01647412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6687726|NCT01647412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6687727|NCT01647412|Analgesics|analgesics|mesh-ancestor
6687728|NCT01647412|Sensory System Agents|sensory system agents|mesh-ancestor
6687729|NCT01647412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6687730|NCT01647412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6687731|NCT01647412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6687732|NCT01647412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6687733|NCT01647412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6687734|NCT01647412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780343|NCT02182661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523218|NCT00752479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6523219|NCT00752479|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6523220|NCT00752479|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6523221|NCT00752479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6523222|NCT00752479|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6523223|NCT00752479|Antitubercular Agents|antitubercular agents|mesh-ancestor
6523224|NCT00752479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6523225|NCT00752479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6523226|NCT00752479|Antiemetics|antiemetics|mesh-ancestor
6523227|NCT00752479|Autonomic Agents|autonomic agents|mesh-ancestor
6523228|NCT00752479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6687735|NCT01647529|Ganciclovir|ganciclovir|mesh-list
6687736|NCT01647529|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6687737|NCT01647529|Antiviral Agents|antiviral agents|mesh-ancestor
6687738|NCT01647529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6687739|NCT01647529|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6687740|NCT01647529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6687741|NCT01647529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687742|NCT01647555|Cetuximab|cetuximab|mesh-list
6687743|NCT01647555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6687744|NCT01647555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6687745|NCT01647633|Calcium|calcium|mesh-list
6687746|NCT01647633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6687747|NCT01647633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687748|NCT01647646|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6687749|NCT01647646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6687750|NCT01647646|Respiratory System Agents|respiratory system agents|mesh-ancestor
6687751|NCT01647646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6687752|NCT01647646|Autonomic Agents|autonomic agents|mesh-ancestor
6687753|NCT01647646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6687754|NCT01647646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687755|NCT01647646|Glucocorticoids|glucocorticoids|mesh-ancestor
6687756|NCT01647646|Hormones|hormones|mesh-ancestor
6687757|NCT01647646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6687758|NCT01647646|Sympathomimetics|sympathomimetics|mesh-ancestor
6687759|NCT01647659|Trametinib|trametinib|mesh-list
6687760|NCT01647659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6687761|NCT01647659|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6687762|NCT01647659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6687763|NCT01647659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687764|NCT01647672|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6687765|NCT01647672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6687766|NCT01647685|Methylprednisolone|methylprednisolone|mesh-list
6687767|NCT01647685|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6687768|NCT01647685|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6687769|NCT01647685|Prednisolone|prednisolone|mesh-list
6523229|NCT00752479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6523230|NCT00752479|Glucocorticoids|glucocorticoids|mesh-ancestor
6523231|NCT00752479|Hormones|hormones|mesh-ancestor
6523232|NCT00752479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6523233|NCT00752479|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6523234|NCT00752479|Protective Agents|protective agents|mesh-ancestor
6687770|NCT01647685|Prednisolone acetate|prednisolone acetate|mesh-list
6687771|NCT01647685|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6687772|NCT01647685|Prednisolone phosphate|prednisolone phosphate|mesh-list
6687773|NCT01647685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6687774|NCT01647685|Antiemetics|antiemetics|mesh-ancestor
6687775|NCT01647685|Autonomic Agents|autonomic agents|mesh-ancestor
6687776|NCT01647685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6687777|NCT01647685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687778|NCT01647685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6687779|NCT01647685|Glucocorticoids|glucocorticoids|mesh-ancestor
6687780|NCT01647685|Hormones|hormones|mesh-ancestor
6687781|NCT01647685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6687782|NCT01647685|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6687783|NCT01647685|Protective Agents|protective agents|mesh-ancestor
6687784|NCT01647685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6687785|NCT01647685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6687786|NCT01647828|Gemcitabine|gemcitabine|mesh-list
6687787|NCT01647828|Paclitaxel|paclitaxel|mesh-list
6687788|NCT01647828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6687789|NCT01647828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6687790|NCT01647828|Tubulin Modulators|tubulin modulators|mesh-ancestor
6687791|NCT01647828|Antimitotic Agents|antimitotic agents|mesh-ancestor
6687792|NCT01647828|Mitosis Modulators|mitosis modulators|mesh-ancestor
6687793|NCT01647828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687794|NCT01647828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6687795|NCT01647828|Antimetabolites|antimetabolites|mesh-ancestor
6687796|NCT01647828|Antiviral Agents|antiviral agents|mesh-ancestor
6687797|NCT01647828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6687798|NCT01647828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6687799|NCT01647828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6687800|NCT01647828|Immunologic Factors|immunologic factors|mesh-ancestor
6687801|NCT01647828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687802|NCT01647880|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6687803|NCT01647880|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6687804|NCT01647880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687805|NCT01647880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6687806|NCT01647880|Immunologic Factors|immunologic factors|mesh-ancestor
6687807|NCT01647880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687808|NCT01647893|Bivalirudin|bivalirudin|mesh-list
6687809|NCT01647893|Antithrombins|antithrombins|mesh-ancestor
6687810|NCT01647893|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6687811|NCT01647893|Protease Inhibitors|protease inhibitors|mesh-ancestor
6687812|NCT01647893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6687813|NCT01647893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687814|NCT01647893|Anticoagulants|anticoagulants|mesh-ancestor
6687815|NCT01647932|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6687816|NCT01647932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6523235|NCT00752479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6523236|NCT00752518|Bortezomib|bortezomib|mesh-list
6523237|NCT00752518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6523238|NCT00752544|Simeprevir|simeprevir|mesh-list
6523239|NCT00752544|Antiviral Agents|antiviral agents|mesh-ancestor
6687817|NCT01647932|Diuretics|diuretics|mesh-ancestor
6687818|NCT01647932|Natriuretic Agents|natriuretic agents|mesh-ancestor
6687819|NCT01647932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687820|NCT01647932|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6687821|NCT01647932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6687822|NCT01647932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687823|NCT01647984|Vitamins|vitamins|mesh-list
6687824|NCT01647984|Vitamin E|vitamin e|mesh-list
6687825|NCT01647984|Vitamin B Complex|vitamin b complex|mesh-list
6687826|NCT01647984|Micronutrients|micronutrients|mesh-ancestor
6687827|NCT01647984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687828|NCT01647984|Antioxidants|antioxidants|mesh-ancestor
6687829|NCT01647984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687830|NCT01647984|Protective Agents|protective agents|mesh-ancestor
6687831|NCT01648010|Mitomycins|mitomycins|mesh-list
6687832|NCT01648010|Mitomycin|mitomycin|mesh-list
6687833|NCT01648010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6523240|NCT00752544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6523241|NCT00752544|Protease Inhibitors|protease inhibitors|mesh-ancestor
6523242|NCT00752544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6523243|NCT00752544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523244|NCT00752596|Azimilide|azimilide|mesh-list
6523245|NCT00752596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6523246|NCT00752596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6523247|NCT00752596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6687834|NCT01648010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6687835|NCT01648010|Alkylating Agents|alkylating agents|mesh-ancestor
6687836|NCT01648010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687837|NCT01648010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6687838|NCT01648010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6687839|NCT01648036|Heparin|heparin|mesh-list
6687840|NCT01648036|Calcium heparin|calcium heparin|mesh-list
6687841|NCT01648036|Dalteparin|dalteparin|mesh-list
6687842|NCT01648036|Tinzaparin|tinzaparin|mesh-list
6687843|NCT01648036|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6687844|NCT01648036|Anticoagulants|anticoagulants|mesh-ancestor
6687845|NCT01648036|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6687846|NCT01648036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6687847|NCT01648036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687848|NCT01648127|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
6687849|NCT01648127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6687850|NCT01648127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6687851|NCT01648205|Ranolazine|ranolazine|mesh-list
6687852|NCT01648205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6687853|NCT01648205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6687854|NCT01648205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687855|NCT01648218|Insulin|insulin|mesh-list
6687856|NCT01648218|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6687857|NCT01648218|Insulin Glargine|insulin glargine|mesh-list
6687858|NCT01648218|Insulin Aspart|insulin aspart|mesh-list
6687859|NCT01648218|Insulin, Isophane|insulin, isophane|mesh-list
6687860|NCT01648218|Isophane Insulin, Human|isophane insulin, human|mesh-list
6687861|NCT01648218|Protamines|protamines|mesh-list
6687862|NCT01648218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6687863|NCT01648218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687864|NCT01648218|Heparin Antagonists|heparin antagonists|mesh-ancestor
6687865|NCT01648218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687866|NCT01648218|Coagulants|coagulants|mesh-ancestor
6687867|NCT01648231|Losartan|losartan|mesh-list
6523248|NCT00752596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523249|NCT00752596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6523250|NCT00752596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523251|NCT00752635|Moxifloxacin|moxifloxacin|mesh-list
6523252|NCT00752635|Cyproterone Acetate|cyproterone acetate|mesh-list
6523253|NCT00752635|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6523254|NCT00752635|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6523255|NCT00752635|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6687868|NCT01648231|Amlodipine|amlodipine|mesh-list
6687869|NCT01648231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6687870|NCT01648231|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6687871|NCT01648231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6687872|NCT01648231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687873|NCT01648231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6687874|NCT01648231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523256|NCT00752635|Norgestimate|norgestimate|mesh-list
6523257|NCT00752635|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6523258|NCT00752635|Estradiol|estradiol|mesh-list
6523259|NCT00752635|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6523260|NCT00752635|Cyproterone|cyproterone|mesh-list
6523261|NCT00752635|Estrogens|estrogens|mesh-ancestor
6523262|NCT00752635|Hormones|hormones|mesh-ancestor
6523263|NCT00752635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6523264|NCT00752635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687875|NCT01648231|Vasodilator Agents|vasodilator agents|mesh-ancestor
6687876|NCT01648231|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6687877|NCT01648231|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6687878|NCT01648231|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6687879|NCT01648257|Cabotegravir|cabotegravir|mesh-list
6523265|NCT00752635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6687880|NCT01648257|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6687881|NCT01648257|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6687882|NCT01648257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6687883|NCT01648257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687884|NCT01648257|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6523266|NCT00752635|Contraceptive Agents|contraceptive agents|mesh-ancestor
6523267|NCT00752635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6523268|NCT00752635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6523269|NCT00752635|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6523270|NCT00752635|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6523271|NCT00752635|Androgen Antagonists|androgen antagonists|mesh-ancestor
6523272|NCT00752635|Hormone Antagonists|hormone antagonists|mesh-ancestor
6523273|NCT00752635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6523274|NCT00752635|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6523275|NCT00752635|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6523276|NCT00752635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6523277|NCT00752635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6523278|NCT00752635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6523279|NCT00752635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6523280|NCT00752635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6523281|NCT00752635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523282|NCT00752635|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6523283|NCT00752648|Simeprevir|simeprevir|mesh-list
6523284|NCT00752648|Antiviral Agents|antiviral agents|mesh-ancestor
6523285|NCT00752648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6523286|NCT00752648|Protease Inhibitors|protease inhibitors|mesh-ancestor
6523287|NCT00752648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6523288|NCT00752648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523289|NCT00752661|Tramadol|tramadol|mesh-list
6523290|NCT00752661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6523291|NCT00752661|Narcotics|narcotics|mesh-ancestor
6523292|NCT00752661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6687885|NCT01648257|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6687886|NCT01648257|Antiviral Agents|antiviral agents|mesh-ancestor
6523293|NCT00752661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523294|NCT00752661|Analgesics|analgesics|mesh-ancestor
6523295|NCT00752661|Sensory System Agents|sensory system agents|mesh-ancestor
6523296|NCT00752661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6523297|NCT00752739|Selenium|selenium|mesh-list
6523298|NCT00752739|Antioxidants|antioxidants|mesh-ancestor
6523299|NCT00752739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523300|NCT00752739|Protective Agents|protective agents|mesh-ancestor
6523301|NCT00752739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523302|NCT00752739|Trace Elements|trace elements|mesh-ancestor
6523303|NCT00752739|Micronutrients|micronutrients|mesh-ancestor
6523304|NCT00752843|Mifepristone|mifepristone|mesh-list
6523305|NCT00752843|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6523306|NCT00752843|Abortifacient Agents|abortifacient agents|mesh-ancestor
6523307|NCT00752843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6523308|NCT00752843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523309|NCT00752843|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6523310|NCT00752843|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6523311|NCT00752843|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6523312|NCT00752843|Contraceptive Agents|contraceptive agents|mesh-ancestor
6523313|NCT00752843|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6523314|NCT00752843|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6523315|NCT00752843|Hormone Antagonists|hormone antagonists|mesh-ancestor
6523316|NCT00752843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6523317|NCT00752843|Luteolytic Agents|luteolytic agents|mesh-ancestor
6523318|NCT00752843|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6523319|NCT00752843|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6523320|NCT00752869|Dutasteride|dutasteride|mesh-list
6523321|NCT00752869|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6523322|NCT00752869|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6523323|NCT00752869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6523324|NCT00752869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523325|NCT00752869|Hormone Antagonists|hormone antagonists|mesh-ancestor
6523326|NCT00752869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6687887|NCT01648257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6687888|NCT01648465|Everolimus|everolimus|mesh-list
6687889|NCT01648465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6687890|NCT01648465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6687891|NCT01648465|Immunologic Factors|immunologic factors|mesh-ancestor
6523327|NCT00752869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687892|NCT01648465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687893|NCT01648517|Gemcitabine|gemcitabine|mesh-list
6687894|NCT01648517|Carboplatin|carboplatin|mesh-list
6687895|NCT01648517|Docetaxel|docetaxel|mesh-list
6687896|NCT01648517|Vinorelbine|vinorelbine|mesh-list
6687897|NCT01648517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6687898|NCT01648517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6687899|NCT01648517|Antimetabolites|antimetabolites|mesh-ancestor
6687900|NCT01648517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687901|NCT01648517|Antiviral Agents|antiviral agents|mesh-ancestor
6687902|NCT01648517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6687903|NCT01648517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6687904|NCT01648517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6687905|NCT01648517|Immunologic Factors|immunologic factors|mesh-ancestor
6687906|NCT01648517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687907|NCT01648517|Tubulin Modulators|tubulin modulators|mesh-ancestor
6687908|NCT01648517|Antimitotic Agents|antimitotic agents|mesh-ancestor
6687909|NCT01648517|Mitosis Modulators|mitosis modulators|mesh-ancestor
6687910|NCT01648517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6687911|NCT01648556|Prednisone|prednisone|mesh-list
6687912|NCT01648556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6687913|NCT01648556|Glucocorticoids|glucocorticoids|mesh-ancestor
6687914|NCT01648556|Hormones|hormones|mesh-ancestor
6687915|NCT01648556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6687916|NCT01648556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687917|NCT01648556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6687918|NCT01648556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6687919|NCT01648595|Fentanyl|fentanyl|mesh-list
6687920|NCT01648595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6687921|NCT01648595|Narcotics|narcotics|mesh-ancestor
6687922|NCT01648595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6687923|NCT01648595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687924|NCT01648595|Analgesics|analgesics|mesh-ancestor
6687925|NCT01648595|Sensory System Agents|sensory system agents|mesh-ancestor
6687926|NCT01648595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6687927|NCT01648595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6687928|NCT01648595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6687929|NCT01648595|Anesthetics, General|anesthetics, general|mesh-ancestor
6687930|NCT01648595|Anesthetics|anesthetics|mesh-ancestor
6687931|NCT01648608|Exemestane|exemestane|mesh-list
6687932|NCT01648608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6687933|NCT01648608|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6687934|NCT01648608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6687935|NCT01648608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6687936|NCT01648608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687937|NCT01648608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6687938|NCT01648608|Hormone Antagonists|hormone antagonists|mesh-ancestor
6687939|NCT01648608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6687940|NCT01648608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687941|NCT01648634|Nebivolol|nebivolol|mesh-list
6687942|NCT01648634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6687943|NCT01648634|Vasodilator Agents|vasodilator agents|mesh-ancestor
6523328|NCT00752882|Ceftazidime|ceftazidime|mesh-list
6523329|NCT00752882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6523330|NCT00752882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6523331|NCT00752921|Etoricoxib|etoricoxib|mesh-list
6523332|NCT00752921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6523333|NCT00752921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6523334|NCT00752921|Analgesics|analgesics|mesh-ancestor
6523335|NCT00752921|Sensory System Agents|sensory system agents|mesh-ancestor
6523336|NCT00752921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6523337|NCT00752921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523338|NCT00752921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6523339|NCT00752921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6523340|NCT00752921|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6687944|NCT01648634|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6687945|NCT01648634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6687946|NCT01648634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6687947|NCT01648634|Adrenergic Agents|adrenergic agents|mesh-ancestor
6687948|NCT01648634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6687949|NCT01648634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687950|NCT01648634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687951|NCT01648712|Heparin|heparin|mesh-list
6687952|NCT01648712|Anticoagulants|anticoagulants|mesh-ancestor
6687953|NCT01648712|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6687954|NCT01648712|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6687955|NCT01648712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687956|NCT01648777|Bupivacaine|bupivacaine|mesh-list
6687957|NCT01648777|Anesthetics, Local|anesthetics, local|mesh-ancestor
6687958|NCT01648777|Anesthetics|anesthetics|mesh-ancestor
6523341|NCT00752921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6523342|NCT00752921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6523343|NCT00752921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523344|NCT00752934|Baclofen|baclofen|mesh-list
6523345|NCT00752934|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6523346|NCT00752934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523347|NCT00752934|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6523348|NCT00752934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6523349|NCT00752934|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6523350|NCT00752934|GABA Agonists|gaba agonists|mesh-ancestor
6523351|NCT00752934|GABA Agents|gaba agents|mesh-ancestor
6523352|NCT00752934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6523353|NCT00752934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523354|NCT00752947|Moxifloxacin|moxifloxacin|mesh-list
6523355|NCT00752947|Metronidazole|metronidazole|mesh-list
6523356|NCT00752947|Levofloxacin|levofloxacin|mesh-list
6523357|NCT00752947|Ofloxacin|ofloxacin|mesh-list
6523358|NCT00752947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6523359|NCT00752947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6523360|NCT00752947|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6523361|NCT00752947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6523362|NCT00752947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6687959|NCT01648777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6687960|NCT01648777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687961|NCT01648777|Sensory System Agents|sensory system agents|mesh-ancestor
6687962|NCT01648777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6687963|NCT01648829|Atorvastatin|atorvastatin|mesh-list
6687964|NCT01648829|Pitavastatin|pitavastatin|mesh-list
6687965|NCT01648829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6687966|NCT01648829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6687967|NCT01648829|Antimetabolites|antimetabolites|mesh-ancestor
6687968|NCT01648829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687969|NCT01648829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6687970|NCT01648829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6687971|NCT01648829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6687972|NCT01648881|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6687973|NCT01648881|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6687974|NCT01648881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687975|NCT01648998|Fludrocortisone|fludrocortisone|mesh-list
6687976|NCT01648998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6687977|NCT01649024|Tremelimumab|tremelimumab|mesh-list
6687978|NCT01649024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6687979|NCT01649037|Terlipressin|terlipressin|mesh-list
6687980|NCT01649037|Epinephrine|epinephrine|mesh-list
6687981|NCT01649037|Racepinephrine|racepinephrine|mesh-list
6687982|NCT01649037|Norepinephrine|norepinephrine|mesh-list
6687983|NCT01649037|Epinephryl borate|epinephryl borate|mesh-list
6687984|NCT01649037|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6687985|NCT01649037|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6523363|NCT00752947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523364|NCT00752947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6523365|NCT00752947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6523366|NCT00752947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6523367|NCT00752947|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6523368|NCT00752947|Renal Agents|renal agents|mesh-ancestor
6523369|NCT00752947|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6523370|NCT00752947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6523371|NCT00753038|Paclitaxel|paclitaxel|mesh-list
6523372|NCT00753038|Carboplatin|carboplatin|mesh-list
6523373|NCT00753038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6523374|NCT00753038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6523375|NCT00753038|Tubulin Modulators|tubulin modulators|mesh-ancestor
6523376|NCT00753038|Antimitotic Agents|antimitotic agents|mesh-ancestor
6523377|NCT00753038|Mitosis Modulators|mitosis modulators|mesh-ancestor
6523378|NCT00753038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523379|NCT00753051|Haloperidol|haloperidol|mesh-list
6523380|NCT00753051|Haloperidol decanoate|haloperidol decanoate|mesh-list
6523381|NCT00753051|Clozapine|clozapine|mesh-list
6523382|NCT00753051|Antiemetics|antiemetics|mesh-ancestor
6523383|NCT00753051|Autonomic Agents|autonomic agents|mesh-ancestor
6523384|NCT00753051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6523385|NCT00753051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523386|NCT00753051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6523387|NCT00753051|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6523388|NCT00753051|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6523389|NCT00753051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6523390|NCT00753051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6523391|NCT00753051|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6523392|NCT00753051|Dopamine Agents|dopamine agents|mesh-ancestor
6523393|NCT00753051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6523394|NCT00753051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687986|NCT01649037|Adrenergic Agents|adrenergic agents|mesh-ancestor
6523395|NCT00753051|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6523396|NCT00753051|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6523397|NCT00753051|Serotonin Agents|serotonin agents|mesh-ancestor
6687987|NCT01649037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6687988|NCT01649037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6687989|NCT01649037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6687990|NCT01649037|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6687991|NCT01649037|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6687992|NCT01649037|Autonomic Agents|autonomic agents|mesh-ancestor
6687993|NCT01649037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6687994|NCT01649037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6687995|NCT01649037|Respiratory System Agents|respiratory system agents|mesh-ancestor
6687996|NCT01649037|Mydriatics|mydriatics|mesh-ancestor
6687997|NCT01649037|Sympathomimetics|sympathomimetics|mesh-ancestor
6687998|NCT01649037|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6687999|NCT01649037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6780344|NCT02182700|Bromides|bromides|mesh-list
6780345|NCT02182700|Albuterol|albuterol|mesh-list
6780346|NCT02182700|Ipratropium|ipratropium|mesh-list
6780347|NCT02182700|Anticonvulsants|anticonvulsants|mesh-ancestor
6780348|NCT02182700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6780349|NCT02182700|Autonomic Agents|autonomic agents|mesh-ancestor
6688000|NCT01649245|Interferons|interferons|mesh-list
6688001|NCT01649245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6688002|NCT01649245|Antiviral Agents|antiviral agents|mesh-ancestor
6688003|NCT01649245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6688004|NCT01649258|Granisetron|granisetron|mesh-list
6688005|NCT01649258|Fosaprepitant|fosaprepitant|mesh-list
6688006|NCT01649258|Aprepitant|aprepitant|mesh-list
6688007|NCT01649258|Antiemetics|antiemetics|mesh-ancestor
6688008|NCT01649258|Autonomic Agents|autonomic agents|mesh-ancestor
6688009|NCT01649258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6688010|NCT01649258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688011|NCT01649258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6688012|NCT01649258|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6688013|NCT01649258|Serotonin Agents|serotonin agents|mesh-ancestor
6688014|NCT01649258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6688015|NCT01649258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688016|NCT01649258|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6688017|NCT01649284|Afatinib|afatinib|mesh-list
6688018|NCT01649284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6688019|NCT01649284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6688020|NCT01649284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6688021|NCT01649284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688022|NCT01649336|Paclitaxel|paclitaxel|mesh-list
6688023|NCT01649336|Antimitotic Agents|antimitotic agents|mesh-list
6688024|NCT01649336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6688025|NCT01649336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6688026|NCT01649336|Tubulin Modulators|tubulin modulators|mesh-ancestor
6688027|NCT01649336|Mitosis Modulators|mitosis modulators|mesh-ancestor
6688028|NCT01649336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688029|NCT01649466|Insulin|insulin|mesh-list
6688030|NCT01649466|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6688031|NCT01649466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6688032|NCT01649466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688033|NCT01649479|Antibodies|antibodies|mesh-list
6523398|NCT00753051|GABA Antagonists|gaba antagonists|mesh-ancestor
6523399|NCT00753051|GABA Agents|gaba agents|mesh-ancestor
6523400|NCT00753064|Prazosin|prazosin|mesh-list
6523401|NCT00753064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6523402|NCT00753064|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6523403|NCT00753064|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6523404|NCT00753064|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6523405|NCT00753064|Adrenergic Agents|adrenergic agents|mesh-ancestor
6523406|NCT00753064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6523407|NCT00753064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523408|NCT00753064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688034|NCT01649479|Antibodies, Antiphospholipid|antibodies, antiphospholipid|mesh-list
6688035|NCT01649479|Immunologic Factors|immunologic factors|mesh-ancestor
6688036|NCT01649479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688037|NCT01649544|Amiodarone|amiodarone|mesh-list
6688038|NCT01649544|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6688039|NCT01649544|Vasodilator Agents|vasodilator agents|mesh-ancestor
6688040|NCT01649544|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6688041|NCT01649544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6688042|NCT01649544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688043|NCT01649544|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6688044|NCT01649544|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6688045|NCT01649544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6688046|NCT01649544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6688047|NCT01649544|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6688048|NCT01649544|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6688049|NCT01649544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6688050|NCT01649570|Insulin Aspart|insulin aspart|mesh-list
6688051|NCT01649570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6688052|NCT01649570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688053|NCT01649622|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6688054|NCT01649622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6688055|NCT01649622|Alkylating Agents|alkylating agents|mesh-ancestor
6688056|NCT01649622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688057|NCT01649622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6688058|NCT01649635|Ciprofloxacin|ciprofloxacin|mesh-list
6688059|NCT01649635|Prednisone|prednisone|mesh-list
6688060|NCT01649635|Sargramostim|sargramostim|mesh-list
6688061|NCT01649635|Lenograstim|lenograstim|mesh-list
6688062|NCT01649635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6688063|NCT01649635|Glucocorticoids|glucocorticoids|mesh-ancestor
6688064|NCT01649635|Hormones|hormones|mesh-ancestor
6688065|NCT01649635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6688066|NCT01649635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688067|NCT01649635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6688068|NCT01649635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6688069|NCT01649635|Immunologic Factors|immunologic factors|mesh-ancestor
6688070|NCT01649635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6688071|NCT01649635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6688072|NCT01649635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6688073|NCT01649635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6688074|NCT01649635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6688075|NCT01649635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688076|NCT01649635|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6688077|NCT01649635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6688078|NCT01649635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6688079|NCT01649674|Picosulfate sodium|picosulfate sodium|mesh-list
6688080|NCT01649674|Magnesium citrate|magnesium citrate|mesh-list
6688081|NCT01649674|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6688082|NCT01649674|Cathartics|cathartics|mesh-ancestor
6688083|NCT01649674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6688084|NCT01649713|Vaccines|vaccines|mesh-list
6688085|NCT01649713|Immunologic Factors|immunologic factors|mesh-ancestor
6688086|NCT01649713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688087|NCT01649739|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6688088|NCT01649739|Vasodilator Agents|vasodilator agents|mesh-ancestor
6688089|NCT01649739|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6688090|NCT01649739|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6688091|NCT01649739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6523409|NCT00753103|Mycophenolic Acid|mycophenolic acid|mesh-list
6523410|NCT00753103|Methylprednisolone|methylprednisolone|mesh-list
6523411|NCT00753103|Prednisolone|prednisolone|mesh-list
6688092|NCT01649739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688093|NCT01649739|Urological Agents|urological agents|mesh-ancestor
6688094|NCT01649830|Temozolomide|temozolomide|mesh-list
6688095|NCT01649830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6688096|NCT01649830|Alkylating Agents|alkylating agents|mesh-ancestor
6688097|NCT01649830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688098|NCT01649830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6688099|NCT01649895|Cycloserine|cycloserine|mesh-list
6688100|NCT01649895|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6688101|NCT01649895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6688102|NCT01649895|Renal Agents|renal agents|mesh-ancestor
6523412|NCT00753103|Cyclophosphamide|cyclophosphamide|mesh-list
6523413|NCT00753103|Azathioprine|azathioprine|mesh-list
6523414|NCT00753103|Infliximab|infliximab|mesh-list
6523415|NCT00753103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6523416|NCT00753103|Immunologic Factors|immunologic factors|mesh-ancestor
6523417|NCT00753103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523418|NCT00753103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6523419|NCT00753103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6523420|NCT00753103|Alkylating Agents|alkylating agents|mesh-ancestor
6523421|NCT00753103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523422|NCT00753103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6523423|NCT00753103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6523424|NCT00753103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6523425|NCT00753103|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6523426|NCT00753103|Antitubercular Agents|antitubercular agents|mesh-ancestor
6523427|NCT00753103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6523428|NCT00753103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6523429|NCT00753103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6523430|NCT00753103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6523431|NCT00753103|Antiemetics|antiemetics|mesh-ancestor
6523432|NCT00753103|Autonomic Agents|autonomic agents|mesh-ancestor
6523433|NCT00753103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6523434|NCT00753103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6523435|NCT00753103|Glucocorticoids|glucocorticoids|mesh-ancestor
6523436|NCT00753103|Hormones|hormones|mesh-ancestor
6523437|NCT00753103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6523438|NCT00753103|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6688103|NCT01649895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6688104|NCT01649895|Antitubercular Agents|antitubercular agents|mesh-ancestor
6688105|NCT01649895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6688106|NCT01649895|Antimetabolites|antimetabolites|mesh-ancestor
6523439|NCT00753103|Protective Agents|protective agents|mesh-ancestor
6523440|NCT00753103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6523441|NCT00753103|Dermatologic Agents|dermatologic agents|mesh-ancestor
6523442|NCT00753103|Antimetabolites|antimetabolites|mesh-ancestor
6523443|NCT00753103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6688107|NCT01649895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688108|NCT01649921|Interferons|interferons|mesh-list
6688109|NCT01649921|Interferon-gamma|interferon-gamma|mesh-list
6688110|NCT01649921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6688111|NCT01649921|Antiviral Agents|antiviral agents|mesh-ancestor
6688112|NCT01649921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6688113|NCT01649960|Sirolimus|sirolimus|mesh-list
6688114|NCT01649960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6688115|NCT01649960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6688116|NCT01649960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6688117|NCT01649960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6688118|NCT01649960|Antifungal Agents|antifungal agents|mesh-ancestor
6688119|NCT01649960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6688120|NCT01649960|Immunologic Factors|immunologic factors|mesh-ancestor
6688121|NCT01649960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688122|NCT01650012|Eplerenone|eplerenone|mesh-list
6688123|NCT01650012|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6688124|NCT01650012|Hormone Antagonists|hormone antagonists|mesh-ancestor
6688125|NCT01650012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6688126|NCT01650012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688127|NCT01650012|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6688128|NCT01650012|Diuretics|diuretics|mesh-ancestor
6688129|NCT01650012|Natriuretic Agents|natriuretic agents|mesh-ancestor
6688130|NCT01650012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6688131|NCT01650090|Cisplatin|cisplatin|mesh-list
6688132|NCT01650090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6688133|NCT01650129|Insulin|insulin|mesh-list
6688134|NCT01650129|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6688135|NCT01650129|Insulin Aspart|insulin aspart|mesh-list
6688136|NCT01650129|Biphasic Insulins|biphasic insulins|mesh-list
6688137|NCT01650129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6688138|NCT01650129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688139|NCT01650181|Selenium|selenium|mesh-list
6688140|NCT01650181|Thioctic Acid|thioctic acid|mesh-list
6688141|NCT01650181|Metformin|metformin|mesh-list
6688142|NCT01650181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6688143|NCT01650181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688144|NCT01650181|Antioxidants|antioxidants|mesh-ancestor
6688145|NCT01650181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688146|NCT01650181|Protective Agents|protective agents|mesh-ancestor
6688147|NCT01650181|Trace Elements|trace elements|mesh-ancestor
6688148|NCT01650181|Micronutrients|micronutrients|mesh-ancestor
6688149|NCT01650181|Vitamin B Complex|vitamin b complex|mesh-ancestor
6688150|NCT01650181|Vitamins|vitamins|mesh-ancestor
6688151|NCT01650272|Minoxidil|minoxidil|mesh-list
6688152|NCT01650272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6688153|NCT01650272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6688154|NCT01650272|Vasodilator Agents|vasodilator agents|mesh-ancestor
6688155|NCT01650376|Paclitaxel|paclitaxel|mesh-list
6688156|NCT01650376|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6688157|NCT01650376|Carboplatin|carboplatin|mesh-list
6688158|NCT01650376|Olaparib|olaparib|mesh-list
6688159|NCT01650376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6688160|NCT01650376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6688161|NCT01650376|Tubulin Modulators|tubulin modulators|mesh-ancestor
6688162|NCT01650376|Antimitotic Agents|antimitotic agents|mesh-ancestor
6688163|NCT01650376|Mitosis Modulators|mitosis modulators|mesh-ancestor
6688164|NCT01650376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688165|NCT01650376|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6688166|NCT01650376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6688167|NCT01650389|BCG Vaccine|bcg vaccine|mesh-list
6688168|NCT01650389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6688169|NCT01650389|Immunologic Factors|immunologic factors|mesh-ancestor
6688170|NCT01650389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688171|NCT01650415|Epoetin Alfa|epoetin alfa|mesh-list
6688172|NCT01650415|Hematinics|hematinics|mesh-ancestor
6688173|NCT01650428|Bevacizumab|bevacizumab|mesh-list
6688174|NCT01650428|Fluorouracil|fluorouracil|mesh-list
6688175|NCT01650428|Oxaliplatin|oxaliplatin|mesh-list
6688176|NCT01650428|Irinotecan|irinotecan|mesh-list
6688177|NCT01650428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6688178|NCT01650428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6688179|NCT01650428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6688180|NCT01650428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6523444|NCT00753168|Timolol|timolol|mesh-list
6523445|NCT00753168|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6523446|NCT00753168|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6523447|NCT00753168|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6523448|NCT00753168|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6523449|NCT00753168|Adrenergic Agents|adrenergic agents|mesh-ancestor
6688181|NCT01650428|Growth Substances|growth substances|mesh-ancestor
6688182|NCT01650428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688183|NCT01650428|Growth Inhibitors|growth inhibitors|mesh-ancestor
6688184|NCT01650428|Antimetabolites|antimetabolites|mesh-ancestor
6688185|NCT01650428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688186|NCT01650428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6688187|NCT01650428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6688188|NCT01650428|Immunologic Factors|immunologic factors|mesh-ancestor
6688189|NCT01650428|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6688190|NCT01650428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6688191|NCT01650428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6688192|NCT01650441|Beclomethasone|beclomethasone|mesh-list
6688193|NCT01650441|Formoterol Fumarate|formoterol fumarate|mesh-list
6688194|NCT01650441|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6688195|NCT01650441|Autonomic Agents|autonomic agents|mesh-ancestor
6688196|NCT01650441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6688197|NCT01650441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688198|NCT01650441|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6688199|NCT01650441|Respiratory System Agents|respiratory system agents|mesh-ancestor
6688200|NCT01650441|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6688201|NCT01650441|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6688202|NCT01650441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6688203|NCT01650441|Adrenergic Agents|adrenergic agents|mesh-ancestor
6688204|NCT01650441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6688205|NCT01650441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688206|NCT01650441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6688207|NCT01650441|Glucocorticoids|glucocorticoids|mesh-ancestor
6688208|NCT01650441|Hormones|hormones|mesh-ancestor
6688209|NCT01650441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6688210|NCT01650493|Listerine|listerine|mesh-list
6688211|NCT01650493|Sodium Fluoride|sodium fluoride|mesh-list
6523450|NCT00753168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6523451|NCT00753168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523452|NCT00753168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523453|NCT00753168|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6523454|NCT00753168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6523455|NCT00753207|Epirubicin|epirubicin|mesh-list
6523456|NCT00753207|Lapatinib|lapatinib|mesh-list
6688212|NCT01650493|Cariostatic Agents|cariostatic agents|mesh-ancestor
6688213|NCT01650493|Protective Agents|protective agents|mesh-ancestor
6688214|NCT01650493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523457|NCT00753207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6523458|NCT00753207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6523459|NCT00753207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6523460|NCT00753207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6523461|NCT00753207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6523462|NCT00753207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523463|NCT00753207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6523464|NCT00753246|Nimotuzumab|nimotuzumab|mesh-list
6688215|NCT01650493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6523465|NCT00753246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6523466|NCT00753246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6523467|NCT00753311|Rizatriptan|rizatriptan|mesh-list
6523468|NCT00753311|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6523469|NCT00753311|Serotonin Agents|serotonin agents|mesh-ancestor
6523470|NCT00753311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6523471|NCT00753311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523472|NCT00753311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523473|NCT00753324|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6523474|NCT00753324|Antiviral Agents|antiviral agents|mesh-ancestor
6523475|NCT00753324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6688216|NCT01650493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6688217|NCT01650506|Metformin|metformin|mesh-list
6688218|NCT01650506|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6688219|NCT01650506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6688220|NCT01650506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523476|NCT00753389|Anesthetics|anesthetics|mesh-list
6523477|NCT00753389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6523478|NCT00753389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523479|NCT00753402|Epinephrine|epinephrine|mesh-list
6523480|NCT00753402|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6523481|NCT00753402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6523482|NCT00753402|Adrenergic Agents|adrenergic agents|mesh-ancestor
6688221|NCT01650506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6688222|NCT01650506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6688223|NCT01650506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6688224|NCT01650506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688225|NCT01650597|JNJ-42165279|jnj-42165279|mesh-list
6688226|NCT01650597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6688227|NCT01650597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688228|NCT01650649|Lofexidine|lofexidine|mesh-list
6523483|NCT00753402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6523484|NCT00753402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523485|NCT00753402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523486|NCT00753402|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6523487|NCT00753402|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6523488|NCT00753402|Autonomic Agents|autonomic agents|mesh-ancestor
6523489|NCT00753402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6688229|NCT01650649|Clonidine|clonidine|mesh-list
6688230|NCT01650649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6688231|NCT01650649|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6523490|NCT00753402|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6523491|NCT00753402|Respiratory System Agents|respiratory system agents|mesh-ancestor
6523492|NCT00753402|Mydriatics|mydriatics|mesh-ancestor
6523493|NCT00753402|Sympathomimetics|sympathomimetics|mesh-ancestor
6523494|NCT00753402|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6523495|NCT00753467|Interferons|interferons|mesh-list
6523496|NCT00753467|Adefovir|adefovir|mesh-list
6523497|NCT00753467|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6523498|NCT00753467|Interferon-gamma|interferon-gamma|mesh-list
6688232|NCT01650649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688233|NCT01650649|Sensory System Agents|sensory system agents|mesh-ancestor
6688234|NCT01650649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6688235|NCT01650649|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6688236|NCT01650649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6688237|NCT01650649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6688238|NCT01650649|Adrenergic Agents|adrenergic agents|mesh-ancestor
6688239|NCT01650649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6688240|NCT01650649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523499|NCT00753467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6523500|NCT00753467|Antiviral Agents|antiviral agents|mesh-ancestor
6523501|NCT00753467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6688241|NCT01650649|Analgesics|analgesics|mesh-ancestor
6688242|NCT01650649|Sympatholytics|sympatholytics|mesh-ancestor
6688243|NCT01650649|Autonomic Agents|autonomic agents|mesh-ancestor
6688244|NCT01650662|Cyclosporine|cyclosporine|mesh-list
6688245|NCT01650662|Cyclosporins|cyclosporins|mesh-list
6688246|NCT01650662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6688247|NCT01650662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688248|NCT01650662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6523502|NCT00753467|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6523503|NCT00753467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6523504|NCT00753467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6523505|NCT00753467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523506|NCT00753493|Topiramate|topiramate|mesh-list
6523507|NCT00753493|Anticonvulsants|anticonvulsants|mesh-ancestor
6523508|NCT00753493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6523509|NCT00753493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523510|NCT00753532|Vitamin E|vitamin e|mesh-list
6523511|NCT00753532|Tocopherols|tocopherols|mesh-list
6523512|NCT00753532|Tocotrienols|tocotrienols|mesh-list
6523513|NCT00753532|Tocovid|tocovid|mesh-list
6523514|NCT00753532|Vitamins|vitamins|mesh-ancestor
6523515|NCT00753532|Micronutrients|micronutrients|mesh-ancestor
6523516|NCT00753532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523517|NCT00753532|Antioxidants|antioxidants|mesh-ancestor
6523518|NCT00753532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523519|NCT00753532|Protective Agents|protective agents|mesh-ancestor
6523520|NCT00753558|Gentamicins|gentamicins|mesh-list
6523521|NCT00753558|Polymyxins|polymyxins|mesh-list
6688249|NCT01650662|Immunologic Factors|immunologic factors|mesh-ancestor
6688250|NCT01650662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688251|NCT01650662|Antifungal Agents|antifungal agents|mesh-ancestor
6688252|NCT01650662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6688253|NCT01650662|Dermatologic Agents|dermatologic agents|mesh-ancestor
6523522|NCT00753558|Colistin|colistin|mesh-list
6523523|NCT00753558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6523524|NCT00753558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6688254|NCT01650662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6688255|NCT01650662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6688256|NCT01650701|Rituximab|rituximab|mesh-list
6688257|NCT01650701|Lenalidomide|lenalidomide|mesh-list
6523525|NCT00753558|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6523526|NCT00753558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6523527|NCT00753558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523528|NCT00753571|Cardiac Glycosides|cardiac glycosides|mesh-list
6523529|NCT00753571|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6523530|NCT00753571|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6523531|NCT00753571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6523532|NCT00753571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523533|NCT00753571|Protective Agents|protective agents|mesh-ancestor
6523534|NCT00753571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523535|NCT00753597|Rituximab|rituximab|mesh-list
6523536|NCT00753597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6523537|NCT00753597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6523538|NCT00753597|Immunologic Factors|immunologic factors|mesh-ancestor
6523539|NCT00753597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523540|NCT00753597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6523541|NCT00753727|Sunitinib|sunitinib|mesh-list
6523542|NCT00753727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6523543|NCT00753727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6523544|NCT00753727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6523545|NCT00753727|Growth Substances|growth substances|mesh-ancestor
6523546|NCT00753727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523547|NCT00753727|Growth Inhibitors|growth inhibitors|mesh-ancestor
6523548|NCT00753727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6523549|NCT00753727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6688258|NCT01650701|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6688259|NCT01650701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6688260|NCT01650701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6688261|NCT01650701|Immunologic Factors|immunologic factors|mesh-ancestor
6688262|NCT01650701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688263|NCT01650701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6688264|NCT01650701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6688265|NCT01650701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6688266|NCT01650701|Growth Substances|growth substances|mesh-ancestor
6688267|NCT01650701|Growth Inhibitors|growth inhibitors|mesh-ancestor
6688268|NCT01650701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6688269|NCT01650701|Alkylating Agents|alkylating agents|mesh-ancestor
6688270|NCT01650701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688271|NCT01650727|Rituximab|rituximab|mesh-list
6688272|NCT01650727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6688273|NCT01650727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6688274|NCT01650727|Immunologic Factors|immunologic factors|mesh-ancestor
6523550|NCT00753727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523551|NCT00753740|Camptothecin|camptothecin|mesh-list
6523552|NCT00753740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6523553|NCT00753740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6523554|NCT00753740|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6523555|NCT00753740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6523556|NCT00753740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6523557|NCT00753740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523558|NCT00753779|Simvastatin|simvastatin|mesh-list
6523559|NCT00753779|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
6523560|NCT00753779|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6688275|NCT01650727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688276|NCT01650727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6688277|NCT01650740|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6688278|NCT01650740|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6688279|NCT01650740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6688280|NCT01650740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6688281|NCT01650740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688282|NCT01650740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6688283|NCT01650740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688284|NCT01650740|Analgesics|analgesics|mesh-ancestor
6688285|NCT01650740|Sensory System Agents|sensory system agents|mesh-ancestor
6688286|NCT01650740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6523561|NCT00753779|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6523562|NCT00753779|Antimetabolites|antimetabolites|mesh-ancestor
6523563|NCT00753779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523564|NCT00753779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6523565|NCT00753779|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6523566|NCT00753779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6688287|NCT01650740|Antidepressive Agents|antidepressive agents|mesh-ancestor
6688288|NCT01650740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6688289|NCT01650740|Dopamine Agents|dopamine agents|mesh-ancestor
6688290|NCT01650792|Aspirin|aspirin|mesh-list
6688291|NCT01650792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6688292|NCT01650792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6523567|NCT00753792|Methylprednisolone|methylprednisolone|mesh-list
6523568|NCT00753792|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6523569|NCT00753792|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6523570|NCT00753792|Prednisolone|prednisolone|mesh-list
6523571|NCT00753792|Prednisolone acetate|prednisolone acetate|mesh-list
6688293|NCT01650792|Analgesics|analgesics|mesh-ancestor
6688294|NCT01650792|Sensory System Agents|sensory system agents|mesh-ancestor
6688295|NCT01650792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6523572|NCT00753792|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6688296|NCT01650792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688297|NCT01650792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6688298|NCT01650792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6688299|NCT01650792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6688300|NCT01650792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6688301|NCT01650792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688302|NCT01650792|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6688303|NCT01650792|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6688304|NCT01650792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6688305|NCT01650792|Antipyretics|antipyretics|mesh-ancestor
6688306|NCT01650870|Lactulose|lactulose|mesh-list
6688307|NCT01650870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6688308|NCT01650883|Vitamin D|vitamin d|mesh-list
6688309|NCT01650883|Ergocalciferols|ergocalciferols|mesh-list
6688310|NCT01650883|Cholecalciferol|cholecalciferol|mesh-list
6688311|NCT01650883|Vitamins|vitamins|mesh-list
6688312|NCT01650883|Micronutrients|micronutrients|mesh-ancestor
6688313|NCT01650883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688314|NCT01650883|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6688315|NCT01650883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6688316|NCT01650961|Palonosetron|palonosetron|mesh-list
6688317|NCT01650961|Antiemetics|antiemetics|mesh-ancestor
6688318|NCT01650961|Autonomic Agents|autonomic agents|mesh-ancestor
6688319|NCT01650961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6688320|NCT01650961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688321|NCT01650961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6688322|NCT01650961|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6688323|NCT01650961|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6688324|NCT01650961|Serotonin Agents|serotonin agents|mesh-ancestor
6688325|NCT01650961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6688326|NCT01650961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780350|NCT02182700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6780351|NCT02182700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780352|NCT02182700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6780353|NCT02182700|Respiratory System Agents|respiratory system agents|mesh-ancestor
6780354|NCT02182700|Tocolytic Agents|tocolytic agents|mesh-ancestor
6780355|NCT02182700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6780356|NCT02182700|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6780357|NCT02182700|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6780358|NCT02182700|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6780359|NCT02182700|Adrenergic Agents|adrenergic agents|mesh-ancestor
6780360|NCT02182700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6780361|NCT02182700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780362|NCT02182700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6780363|NCT02182700|Cholinergic Agents|cholinergic agents|mesh-ancestor
6780364|NCT02182713|Bromides|bromides|mesh-list
6780365|NCT02182713|Albuterol|albuterol|mesh-list
6780366|NCT02182713|Ipratropium|ipratropium|mesh-list
6780367|NCT02182713|Anticonvulsants|anticonvulsants|mesh-ancestor
6780368|NCT02182713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6780369|NCT02182713|Autonomic Agents|autonomic agents|mesh-ancestor
6780370|NCT02182713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6780371|NCT02182713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780372|NCT02182713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6780373|NCT02182713|Respiratory System Agents|respiratory system agents|mesh-ancestor
6780374|NCT02182713|Tocolytic Agents|tocolytic agents|mesh-ancestor
6780375|NCT02182713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6780376|NCT02182713|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6780377|NCT02182713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6780378|NCT02182713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6780379|NCT02182713|Adrenergic Agents|adrenergic agents|mesh-ancestor
6523573|NCT00753792|Prednisolone phosphate|prednisolone phosphate|mesh-list
6523574|NCT00753792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6523575|NCT00753792|Antiemetics|antiemetics|mesh-ancestor
6523576|NCT00753792|Autonomic Agents|autonomic agents|mesh-ancestor
6523577|NCT00753792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6523578|NCT00753792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523579|NCT00753792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6523580|NCT00753792|Glucocorticoids|glucocorticoids|mesh-ancestor
6523581|NCT00753792|Hormones|hormones|mesh-ancestor
6523582|NCT00753792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6523583|NCT00753792|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6523584|NCT00753792|Protective Agents|protective agents|mesh-ancestor
6523585|NCT00753792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6523586|NCT00753792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6523587|NCT00753883|Simvastatin|simvastatin|mesh-list
6523588|NCT00753883|Ezetimibe|ezetimibe|mesh-list
6523589|NCT00753883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6523590|NCT00753883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6523591|NCT00753883|Antimetabolites|antimetabolites|mesh-ancestor
6523592|NCT00753883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523593|NCT00753883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6523594|NCT00753883|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6523595|NCT00753883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780380|NCT02182713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6780381|NCT02182713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780382|NCT02182713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6780383|NCT02182713|Cholinergic Agents|cholinergic agents|mesh-ancestor
6780384|NCT02182739|Meloxicam|meloxicam|mesh-list
6780385|NCT02182739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6780386|NCT02182739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6780387|NCT02182739|Analgesics|analgesics|mesh-ancestor
6780388|NCT02182739|Sensory System Agents|sensory system agents|mesh-ancestor
6780389|NCT02182739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6780390|NCT02182739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780391|NCT02182739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6780392|NCT02182739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6780393|NCT02182739|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6780394|NCT02182739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6780395|NCT02182739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780396|NCT02182739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780397|NCT02182752|Tramadol|tramadol|mesh-list
6780398|NCT02182752|Ropivacaine|ropivacaine|mesh-list
6780399|NCT02182752|Anesthetics, Local|anesthetics, local|mesh-ancestor
6688327|NCT01651130|Carbetocin|carbetocin|mesh-list
6688328|NCT01651130|Oxytocics|oxytocics|mesh-ancestor
6688329|NCT01651130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6688330|NCT01651130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688331|NCT01651156|Tolvaptan|tolvaptan|mesh-list
6688332|NCT01651156|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6688333|NCT01651156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688334|NCT01651156|Natriuretic Agents|natriuretic agents|mesh-ancestor
6688335|NCT01651156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688336|NCT01651169|Methylphenidate|methylphenidate|mesh-list
6688337|NCT01651169|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6688338|NCT01651169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688339|NCT01651169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6688340|NCT01651169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6688341|NCT01651169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6688342|NCT01651169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688343|NCT01651169|Dopamine Agents|dopamine agents|mesh-ancestor
6688344|NCT01651169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6688345|NCT01651182|Tranexamic Acid|tranexamic acid|mesh-list
6688346|NCT01651182|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6688347|NCT01651182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6688348|NCT01651182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688349|NCT01651182|Hemostatics|hemostatics|mesh-ancestor
6523596|NCT00753909|Paclitaxel|paclitaxel|mesh-list
6523597|NCT00753909|Bevacizumab|bevacizumab|mesh-list
6523598|NCT00753909|Carboplatin|carboplatin|mesh-list
6523599|NCT00753909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6523600|NCT00753909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6523601|NCT00753909|Tubulin Modulators|tubulin modulators|mesh-ancestor
6523602|NCT00753909|Antimitotic Agents|antimitotic agents|mesh-ancestor
6523603|NCT00753909|Mitosis Modulators|mitosis modulators|mesh-ancestor
6523604|NCT00753909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523605|NCT00753909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6523606|NCT00753909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6523607|NCT00753909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6523608|NCT00753909|Growth Substances|growth substances|mesh-ancestor
6523609|NCT00753909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523610|NCT00753909|Growth Inhibitors|growth inhibitors|mesh-ancestor
6523611|NCT00754039|Fenofibrate|fenofibrate|mesh-list
6523612|NCT00754039|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
6523613|NCT00754039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6523614|NCT00754039|Antimetabolites|antimetabolites|mesh-ancestor
6523615|NCT00754039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523616|NCT00754039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6523617|NCT00754039|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6523618|NCT00754104|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6523619|NCT00754104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6523620|NCT00754104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6523621|NCT00754104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6523622|NCT00754104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523623|NCT00754143|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6523624|NCT00754143|Immunologic Factors|immunologic factors|mesh-ancestor
6523625|NCT00754143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523626|NCT00754260|Caffeine|caffeine|mesh-list
6523627|NCT00754260|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6523628|NCT00754260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523629|NCT00754260|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6523630|NCT00754260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6523631|NCT00754260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523632|NCT00754260|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6688350|NCT01651182|Coagulants|coagulants|mesh-ancestor
6688351|NCT01651312|Mirabegron|mirabegron|mesh-list
6688352|NCT01651312|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6688353|NCT01651312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6523633|NCT00754260|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6523634|NCT00754260|Purinergic Agents|purinergic agents|mesh-ancestor
6523635|NCT00754260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6523636|NCT00754312|Entinostat|entinostat|mesh-list
6523637|NCT00754312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6523638|NCT00754312|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6523639|NCT00754312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6523640|NCT00754312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523641|NCT00754351|Gemcitabine|gemcitabine|mesh-list
6523642|NCT00754351|Bevacizumab|bevacizumab|mesh-list
6523643|NCT00754351|Docetaxel|docetaxel|mesh-list
6523644|NCT00754351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6523645|NCT00754351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6523646|NCT00754351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6523647|NCT00754351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6523648|NCT00754351|Growth Substances|growth substances|mesh-ancestor
6523649|NCT00754351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688354|NCT01651312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6688355|NCT01651312|Adrenergic Agents|adrenergic agents|mesh-ancestor
6688356|NCT01651312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6688357|NCT01651312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688358|NCT01651312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688359|NCT01651312|Urological Agents|urological agents|mesh-ancestor
6688360|NCT01651325|Isavuconazole|isavuconazole|mesh-list
6688361|NCT01651325|Dextromethorphan|dextromethorphan|mesh-list
6688362|NCT01651325|Antitussive Agents|antitussive agents|mesh-ancestor
6688363|NCT01651325|Respiratory System Agents|respiratory system agents|mesh-ancestor
6688364|NCT01651325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6523650|NCT00754351|Growth Inhibitors|growth inhibitors|mesh-ancestor
6523651|NCT00754351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6523652|NCT00754351|Antimetabolites|antimetabolites|mesh-ancestor
6688365|NCT01651325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6688366|NCT01651325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6688367|NCT01651325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688368|NCT01651325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688369|NCT01651325|Antifungal Agents|antifungal agents|mesh-ancestor
6688370|NCT01651325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6688371|NCT01651364|Cabergoline|cabergoline|mesh-list
6688372|NCT01651364|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6688373|NCT01651364|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6688374|NCT01651364|Dopamine Agonists|dopamine agonists|mesh-ancestor
6688375|NCT01651364|Dopamine Agents|dopamine agents|mesh-ancestor
6688376|NCT01651364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6688377|NCT01651364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688378|NCT01651364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688379|NCT01651377|Pramipexole|pramipexole|mesh-list
6688380|NCT01651377|Antioxidants|antioxidants|mesh-ancestor
6688381|NCT01651377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688382|NCT01651377|Protective Agents|protective agents|mesh-ancestor
6688383|NCT01651377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688384|NCT01651377|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6688385|NCT01651377|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6688386|NCT01651377|Dopamine Agonists|dopamine agonists|mesh-ancestor
6688387|NCT01651377|Dopamine Agents|dopamine agents|mesh-ancestor
6688388|NCT01651377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6688389|NCT01651390|Sirolimus|sirolimus|mesh-list
6688390|NCT01651390|Paclitaxel|paclitaxel|mesh-list
6688391|NCT01651390|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6688392|NCT01651390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6688393|NCT01651390|Tubulin Modulators|tubulin modulators|mesh-ancestor
6688394|NCT01651390|Antimitotic Agents|antimitotic agents|mesh-ancestor
6688395|NCT01651390|Mitosis Modulators|mitosis modulators|mesh-ancestor
6688396|NCT01651390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688397|NCT01651390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6688398|NCT01651390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6688399|NCT01651390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6688400|NCT01651390|Antifungal Agents|antifungal agents|mesh-ancestor
6688401|NCT01651390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6688402|NCT01651390|Immunologic Factors|immunologic factors|mesh-ancestor
6688403|NCT01651390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688404|NCT01651416|Lumefantrine|lumefantrine|mesh-list
6523653|NCT00754351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523654|NCT00754351|Antiviral Agents|antiviral agents|mesh-ancestor
6523655|NCT00754351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6523656|NCT00754351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6523657|NCT00754351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6523658|NCT00754351|Immunologic Factors|immunologic factors|mesh-ancestor
6523659|NCT00754351|Tubulin Modulators|tubulin modulators|mesh-ancestor
6523660|NCT00754351|Antimitotic Agents|antimitotic agents|mesh-ancestor
6523661|NCT00754351|Mitosis Modulators|mitosis modulators|mesh-ancestor
6523662|NCT00754364|Gemcitabine|gemcitabine|mesh-list
6523663|NCT00754364|Carboplatin|carboplatin|mesh-list
6688405|NCT01651416|Artemether|artemether|mesh-list
6688406|NCT01651416|Pyrimethamine|pyrimethamine|mesh-list
6523664|NCT00754364|Pemetrexed|pemetrexed|mesh-list
6523665|NCT00754364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6523666|NCT00754364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6523667|NCT00754364|Antimetabolites|antimetabolites|mesh-ancestor
6523668|NCT00754364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523669|NCT00754364|Antiviral Agents|antiviral agents|mesh-ancestor
6523670|NCT00754364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6523671|NCT00754364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6523672|NCT00754364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6523673|NCT00754364|Immunologic Factors|immunologic factors|mesh-ancestor
6523674|NCT00754364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523675|NCT00754364|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6523676|NCT00754364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6523677|NCT00754403|Metformin|metformin|mesh-list
6523678|NCT00754403|Pioglitazone|pioglitazone|mesh-list
6523679|NCT00754403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6523680|NCT00754403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523681|NCT00754429|Losartan|losartan|mesh-list
6523682|NCT00754429|Amlodipine|amlodipine|mesh-list
6523683|NCT00754429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6523684|NCT00754429|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6523685|NCT00754429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6523686|NCT00754429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523687|NCT00754429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6523688|NCT00754429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523689|NCT00754429|Vasodilator Agents|vasodilator agents|mesh-ancestor
6523690|NCT00754429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6523691|NCT00754429|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6523692|NCT00754429|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6523693|NCT00754507|Atorvastatin|atorvastatin|mesh-list
6523694|NCT00754507|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
6523695|NCT00754507|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6523696|NCT00754507|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6523697|NCT00754507|Antimetabolites|antimetabolites|mesh-ancestor
6523698|NCT00754507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523699|NCT00754507|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6523700|NCT00754507|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6688407|NCT01651416|Piperaquine|piperaquine|mesh-list
6688408|NCT01651416|Sulfadoxine|sulfadoxine|mesh-list
6688409|NCT01651416|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6688410|NCT01651416|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6688411|NCT01651416|Amodiaquine|amodiaquine|mesh-list
6688412|NCT01651416|Artenimol|artenimol|mesh-list
6688413|NCT01651416|Antimalarials|antimalarials|mesh-ancestor
6688414|NCT01651416|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6523701|NCT00754507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6523702|NCT00754689|Metformin|metformin|mesh-list
6688415|NCT01651416|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6688416|NCT01651416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6688417|NCT01651416|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6688418|NCT01651416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6688419|NCT01651416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688420|NCT01651416|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6688421|NCT01651416|Renal Agents|renal agents|mesh-ancestor
6688422|NCT01651481|Montelukast|montelukast|mesh-list
6688423|NCT01651481|Levocetirizine|levocetirizine|mesh-list
6688424|NCT01651481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6688425|NCT01651481|Respiratory System Agents|respiratory system agents|mesh-ancestor
6688426|NCT01651481|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6688427|NCT01651481|Hormone Antagonists|hormone antagonists|mesh-ancestor
6688428|NCT01651481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6688429|NCT01651481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523703|NCT00754689|Rimonabant|rimonabant|mesh-list
6523704|NCT00754689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6523705|NCT00754689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523706|NCT00754689|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6523707|NCT00754689|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
6523708|NCT00754689|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6523709|NCT00754689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6523710|NCT00754689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523711|NCT00754689|Hormones|hormones|mesh-ancestor
6523712|NCT00754689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6523713|NCT00754702|Vinorelbine|vinorelbine|mesh-list
6523714|NCT00754702|Lapatinib|lapatinib|mesh-list
6523715|NCT00754702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6523716|NCT00754702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6523717|NCT00754702|Tubulin Modulators|tubulin modulators|mesh-ancestor
6523718|NCT00754702|Antimitotic Agents|antimitotic agents|mesh-ancestor
6523719|NCT00754702|Mitosis Modulators|mitosis modulators|mesh-ancestor
6523720|NCT00754702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523721|NCT00754702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6523722|NCT00754702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6523723|NCT00754780|Pirfenidone|pirfenidone|mesh-list
6523724|NCT00754780|Analgesics|analgesics|mesh-ancestor
6523725|NCT00754780|Sensory System Agents|sensory system agents|mesh-ancestor
6523726|NCT00754780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6523727|NCT00754780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523728|NCT00754780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6523729|NCT00754780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6523730|NCT00754780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6523731|NCT00754780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6523732|NCT00754780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6523733|NCT00754819|Colchicine|colchicine|mesh-list
6523734|NCT00754819|Gout Suppressants|gout suppressants|mesh-ancestor
6523735|NCT00754819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6523736|NCT00754819|Tubulin Modulators|tubulin modulators|mesh-ancestor
6523737|NCT00754819|Antimitotic Agents|antimitotic agents|mesh-ancestor
6523738|NCT00754819|Mitosis Modulators|mitosis modulators|mesh-ancestor
6523739|NCT00754819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523740|NCT00754819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6523741|NCT00754858|Belotecan|belotecan|mesh-list
6523742|NCT00754858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6688430|NCT01651481|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6688431|NCT01651481|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6688432|NCT01651481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688433|NCT01651481|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6688434|NCT01651481|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6688435|NCT01651481|Histamine Antagonists|histamine antagonists|mesh-ancestor
6523743|NCT00754858|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6523744|NCT00754858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6523745|NCT00754858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6523746|NCT00754858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523747|NCT00754871|Dienogest|dienogest|mesh-list
6523748|NCT00754871|Nandrolone|nandrolone|mesh-list
6523749|NCT00754871|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6523750|NCT00754871|Contraceptive Agents|contraceptive agents|mesh-ancestor
6688436|NCT01651481|Histamine Agents|histamine agents|mesh-ancestor
6688437|NCT01651481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6688438|NCT01651520|Flumazenil|flumazenil|mesh-list
6523751|NCT00754871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6523752|NCT00754871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523753|NCT00754871|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6523754|NCT00754871|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6523755|NCT00754871|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6523756|NCT00754871|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6523757|NCT00754871|Hormone Antagonists|hormone antagonists|mesh-ancestor
6523758|NCT00754871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6688439|NCT01651520|Antidotes|antidotes|mesh-ancestor
6688440|NCT01651520|Protective Agents|protective agents|mesh-ancestor
6688441|NCT01651520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688442|NCT01651520|GABA Modulators|gaba modulators|mesh-ancestor
6688443|NCT01651520|GABA Agents|gaba agents|mesh-ancestor
6688444|NCT01651520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6688445|NCT01651520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688446|NCT01651572|Rocuronium|rocuronium|mesh-list
6688447|NCT01651572|Cisatracurium|cisatracurium|mesh-list
6688448|NCT01651572|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6688449|NCT01651572|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6688450|NCT01651572|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6688451|NCT01651572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6688452|NCT01651572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688453|NCT01651585|Valacyclovir|valacyclovir|mesh-list
6688454|NCT01651585|Antiviral Agents|antiviral agents|mesh-ancestor
6688455|NCT01651585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6688456|NCT01651637|Pulmonary Surfactants|pulmonary surfactants|mesh-list
6688457|NCT01651637|Respiratory System Agents|respiratory system agents|mesh-ancestor
6523759|NCT00754871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6523760|NCT00754871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6688458|NCT01651715|Antibodies|antibodies|mesh-list
6523761|NCT00754871|Androgens|androgens|mesh-ancestor
6523762|NCT00754871|Hormones|hormones|mesh-ancestor
6523763|NCT00754871|Anabolic Agents|anabolic agents|mesh-ancestor
6523764|NCT00754884|Calcitonin|calcitonin|mesh-list
6523765|NCT00754884|Salmon calcitonin|salmon calcitonin|mesh-list
6523766|NCT00754884|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
6523767|NCT00754884|Glycerol|glycerol|mesh-list
6523768|NCT00754884|Katacalcin|katacalcin|mesh-list
6523769|NCT00754884|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6523770|NCT00754884|Protective Agents|protective agents|mesh-ancestor
6523771|NCT00754884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523772|NCT00754884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6523773|NCT00754884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6523774|NCT00754884|Vasodilator Agents|vasodilator agents|mesh-ancestor
6523775|NCT00754910|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
6523776|NCT00754910|Trioxsalen|trioxsalen|mesh-list
6688459|NCT01651715|Immunologic Factors|immunologic factors|mesh-ancestor
6688460|NCT01651715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688461|NCT01651728|Simvastatin|simvastatin|mesh-list
6688462|NCT01651728|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6688463|NCT01651728|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6688464|NCT01651728|Antimetabolites|antimetabolites|mesh-ancestor
6688465|NCT01651728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688466|NCT01651728|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6688467|NCT01651728|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6688468|NCT01651728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6688469|NCT01651754|Vaccines|vaccines|mesh-list
6688470|NCT01651754|Immunologic Factors|immunologic factors|mesh-ancestor
6688471|NCT01651754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688472|NCT01651923|Heparin|heparin|mesh-list
6688473|NCT01651923|Calcium heparin|calcium heparin|mesh-list
6688474|NCT01651923|Anticoagulants|anticoagulants|mesh-ancestor
6688475|NCT01651923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6688476|NCT01651923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6688477|NCT01651923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688478|NCT01651962|Fentanyl|fentanyl|mesh-list
6688479|NCT01651962|Terbutaline|terbutaline|mesh-list
6688480|NCT01651962|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6688481|NCT01651962|Narcotics|narcotics|mesh-ancestor
6688482|NCT01651962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6688483|NCT01651962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688484|NCT01651962|Analgesics|analgesics|mesh-ancestor
6688485|NCT01651962|Sensory System Agents|sensory system agents|mesh-ancestor
6688486|NCT01651962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6688487|NCT01651962|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6688488|NCT01651962|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6688489|NCT01651962|Anesthetics, General|anesthetics, general|mesh-ancestor
6688490|NCT01651962|Anesthetics|anesthetics|mesh-ancestor
6688491|NCT01651962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6688492|NCT01651962|Autonomic Agents|autonomic agents|mesh-ancestor
6688493|NCT01651962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6688494|NCT01651962|Respiratory System Agents|respiratory system agents|mesh-ancestor
6688495|NCT01651962|Sympathomimetics|sympathomimetics|mesh-ancestor
6688496|NCT01651962|Tocolytic Agents|tocolytic agents|mesh-ancestor
6688497|NCT01651962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6688498|NCT01651962|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6688499|NCT01651962|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6688500|NCT01651962|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6688501|NCT01651962|Adrenergic Agents|adrenergic agents|mesh-ancestor
6688502|NCT01651962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6688503|NCT01651962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688504|NCT01651988|Propofol|propofol|mesh-list
6688505|NCT01651988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6688506|NCT01651988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6688507|NCT01651988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688508|NCT01651988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6688509|NCT01651988|Anesthetics, General|anesthetics, general|mesh-ancestor
6688510|NCT01651988|Anesthetics|anesthetics|mesh-ancestor
6688511|NCT01652014|Mycophenolic Acid|mycophenolic acid|mesh-list
6688512|NCT01652014|Cyclophosphamide|cyclophosphamide|mesh-list
6688513|NCT01652014|Fludarabine|fludarabine|mesh-list
6688514|NCT01652014|Fludarabine phosphate|fludarabine phosphate|mesh-list
6523777|NCT00754910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6523778|NCT00754910|Dermatologic Agents|dermatologic agents|mesh-ancestor
6688515|NCT01652014|Tacrolimus|tacrolimus|mesh-list
6688516|NCT01652014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6688517|NCT01652014|Immunologic Factors|immunologic factors|mesh-ancestor
6688518|NCT01652014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688519|NCT01652014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6688520|NCT01652014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6688521|NCT01652014|Alkylating Agents|alkylating agents|mesh-ancestor
6688522|NCT01652014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688523|NCT01652014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6688524|NCT01652014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6688525|NCT01652014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6688526|NCT01652014|Antimetabolites|antimetabolites|mesh-ancestor
6523779|NCT00754910|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6523780|NCT00754962|Protriptyline|protriptyline|mesh-list
6523781|NCT00754962|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6523782|NCT00754962|Antidepressive Agents|antidepressive agents|mesh-ancestor
6523783|NCT00754962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6523784|NCT00754962|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6523785|NCT00754962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6523786|NCT00754962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6523787|NCT00754962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523788|NCT00754962|Adrenergic Agents|adrenergic agents|mesh-ancestor
6523789|NCT00754962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6523790|NCT00754962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523791|NCT00755014|Ethanol|ethanol|mesh-list
6688527|NCT01652014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6688528|NCT01652014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6688529|NCT01652014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6688530|NCT01652014|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6688531|NCT01652014|Antitubercular Agents|antitubercular agents|mesh-ancestor
6688532|NCT01652014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6688533|NCT01652014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6688534|NCT01652092|Vidarabine|vidarabine|mesh-list
6688535|NCT01652092|Cyclophosphamide|cyclophosphamide|mesh-list
6688536|NCT01652092|Melphalan|melphalan|mesh-list
6688537|NCT01652092|Busulfan|busulfan|mesh-list
6688538|NCT01652092|Fludarabine|fludarabine|mesh-list
6688539|NCT01652092|Fludarabine phosphate|fludarabine phosphate|mesh-list
6688540|NCT01652092|Alemtuzumab|alemtuzumab|mesh-list
6688541|NCT01652092|Mesna|mesna|mesh-list
6688542|NCT01652092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6688543|NCT01652092|Immunologic Factors|immunologic factors|mesh-ancestor
6688544|NCT01652092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688545|NCT01652092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6688546|NCT01652092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6688547|NCT01652092|Alkylating Agents|alkylating agents|mesh-ancestor
6688548|NCT01652092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688549|NCT01652092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6688550|NCT01652092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6688551|NCT01652092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6688552|NCT01652092|Antimetabolites|antimetabolites|mesh-ancestor
6688553|NCT01652092|Antiviral Agents|antiviral agents|mesh-ancestor
6688554|NCT01652092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6688555|NCT01652092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6688556|NCT01652092|Protective Agents|protective agents|mesh-ancestor
6688557|NCT01652118|Clarithromycin|clarithromycin|mesh-list
6688558|NCT01652118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6688559|NCT01652118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6688560|NCT01652118|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6688561|NCT01652118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6688562|NCT01652118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242714|NCT02655354|Promethazine|promethazine|mesh-list
6242715|NCT02655354|Prazosin|prazosin|mesh-list
6242716|NCT02655354|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6242717|NCT02655354|Mirtazapine|mirtazapine|mesh-list
6242718|NCT02655354|Trazodone|trazodone|mesh-list
6242719|NCT02655354|Fluvoxamine|fluvoxamine|mesh-list
6242720|NCT02655354|Sertraline|sertraline|mesh-list
6242721|NCT02655354|Fluoxetine|fluoxetine|mesh-list
6242722|NCT02655354|Paroxetine|paroxetine|mesh-list
6242723|NCT02655354|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6242724|NCT02655354|Citalopram|citalopram|mesh-list
6242725|NCT02655354|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6242726|NCT02655354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6242727|NCT02655354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6242728|NCT02655354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242729|NCT02655354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6242730|NCT02655354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6242731|NCT02655354|Analgesics|analgesics|mesh-ancestor
6242732|NCT02655354|Sensory System Agents|sensory system agents|mesh-ancestor
6688563|NCT01652118|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6688564|NCT01652118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6688565|NCT01652157|Pancrelipase|pancrelipase|mesh-list
6688566|NCT01652157|Pancreatin|pancreatin|mesh-list
6688567|NCT01652157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6688568|NCT01652183|Acetaminophen|acetaminophen|mesh-list
6523792|NCT00755014|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6523793|NCT00755014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6523794|NCT00755014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6523795|NCT00755014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523796|NCT00755027|Rasagiline|rasagiline|mesh-list
6523797|NCT00755027|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6523798|NCT00755027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6523799|NCT00755027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523800|NCT00755027|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6523801|NCT00755027|Protective Agents|protective agents|mesh-ancestor
6688569|NCT01652183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6688570|NCT01652183|Analgesics|analgesics|mesh-ancestor
6688571|NCT01652183|Sensory System Agents|sensory system agents|mesh-ancestor
6688572|NCT01652183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6688573|NCT01652183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523802|NCT00755027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523803|NCT00755053|Clotrimazole|clotrimazole|mesh-list
6523804|NCT00755053|Miconazole|miconazole|mesh-list
6523805|NCT00755053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6523806|NCT00755053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6523807|NCT00755053|Antifungal Agents|antifungal agents|mesh-ancestor
6523808|NCT00755053|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6523809|NCT00755053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6523810|NCT00755053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6523811|NCT00755053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523812|NCT00755053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6523813|NCT00755053|Hormone Antagonists|hormone antagonists|mesh-ancestor
6688574|NCT01652183|Antipyretics|antipyretics|mesh-ancestor
6688575|NCT01652196|Leucovorin|leucovorin|mesh-list
6688576|NCT01652196|Fluorouracil|fluorouracil|mesh-list
6688577|NCT01652196|Oxaliplatin|oxaliplatin|mesh-list
6688578|NCT01652196|Aflibercept|aflibercept|mesh-list
6688579|NCT01652196|Endothelial Growth Factors|endothelial growth factors|mesh-list
6688580|NCT01652196|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6688581|NCT01652196|Antimetabolites|antimetabolites|mesh-ancestor
6688582|NCT01652196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688583|NCT01652196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6688584|NCT01652196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6688585|NCT01652196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6688586|NCT01652196|Immunologic Factors|immunologic factors|mesh-ancestor
6688587|NCT01652196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688588|NCT01652196|Antidotes|antidotes|mesh-ancestor
6688589|NCT01652196|Protective Agents|protective agents|mesh-ancestor
6688590|NCT01652196|Vitamin B Complex|vitamin b complex|mesh-ancestor
6688591|NCT01652196|Vitamins|vitamins|mesh-ancestor
6688592|NCT01652196|Micronutrients|micronutrients|mesh-ancestor
6688593|NCT01652196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6688594|NCT01652196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6688595|NCT01652196|Growth Substances|growth substances|mesh-ancestor
6688596|NCT01652196|Growth Inhibitors|growth inhibitors|mesh-ancestor
6688597|NCT01652196|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6688598|NCT01652313|Rasagiline|rasagiline|mesh-list
6688599|NCT01652313|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6688600|NCT01652313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6688601|NCT01652313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523814|NCT00755053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6688602|NCT01652313|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6688603|NCT01652313|Protective Agents|protective agents|mesh-ancestor
6688604|NCT01652313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688605|NCT01652326|Diazepam|diazepam|mesh-list
6688606|NCT01652326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6688607|NCT01652326|Anticonvulsants|anticonvulsants|mesh-ancestor
6688608|NCT01652326|Antiemetics|antiemetics|mesh-ancestor
6688609|NCT01652326|Autonomic Agents|autonomic agents|mesh-ancestor
6688610|NCT01652326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6688611|NCT01652326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688612|NCT01652326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6688613|NCT01652326|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6688614|NCT01652326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6780400|NCT02182752|Anesthetics|anesthetics|mesh-ancestor
6688615|NCT01652326|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6688616|NCT01652326|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6688617|NCT01652326|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6688618|NCT01652326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6688619|NCT01652326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6688620|NCT01652326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6688621|NCT01652326|Anesthetics, General|anesthetics, general|mesh-ancestor
6688622|NCT01652326|Anesthetics|anesthetics|mesh-ancestor
6688623|NCT01652326|GABA Modulators|gaba modulators|mesh-ancestor
6688624|NCT01652326|GABA Agents|gaba agents|mesh-ancestor
6688625|NCT01652326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6688626|NCT01652326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688627|NCT01652339|Amlodipine|amlodipine|mesh-list
6688628|NCT01652339|Valsartan|valsartan|mesh-list
6688629|NCT01652339|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
6688630|NCT01652339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6688631|NCT01652339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6688632|NCT01652339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6688633|NCT01652339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688634|NCT01652339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6688635|NCT01652339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688636|NCT01652339|Vasodilator Agents|vasodilator agents|mesh-ancestor
6688637|NCT01652339|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6688638|NCT01652339|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6688639|NCT01652378|Lidocaine|lidocaine|mesh-list
6688640|NCT01652378|Ondansetron|ondansetron|mesh-list
6688641|NCT01652378|Anesthetics, Local|anesthetics, local|mesh-ancestor
6688642|NCT01652378|Anesthetics|anesthetics|mesh-ancestor
6688643|NCT01652378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6688644|NCT01652378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688645|NCT01652378|Sensory System Agents|sensory system agents|mesh-ancestor
6688646|NCT01652378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6688647|NCT01652378|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6688648|NCT01652378|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6688649|NCT01652378|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6688650|NCT01652378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6688651|NCT01652378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688652|NCT01652378|Antiemetics|antiemetics|mesh-ancestor
6688653|NCT01652378|Autonomic Agents|autonomic agents|mesh-ancestor
6688654|NCT01652378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6688655|NCT01652378|Antipruritics|antipruritics|mesh-ancestor
6688656|NCT01652378|Dermatologic Agents|dermatologic agents|mesh-ancestor
6688657|NCT01652378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6688658|NCT01652378|Serotonin Agents|serotonin agents|mesh-ancestor
6688659|NCT01652378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6688660|NCT01652378|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6688661|NCT01652378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6688662|NCT01652378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6688663|NCT01652378|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6688664|NCT01652417|Methylprednisolone|methylprednisolone|mesh-list
6688665|NCT01652417|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6688666|NCT01652417|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6688667|NCT01652417|Prednisolone|prednisolone|mesh-list
6688668|NCT01652417|Prednisolone acetate|prednisolone acetate|mesh-list
6688669|NCT01652417|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6688670|NCT01652417|Prednisolone phosphate|prednisolone phosphate|mesh-list
6688671|NCT01652417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6688672|NCT01652417|Antiemetics|antiemetics|mesh-ancestor
6688673|NCT01652417|Autonomic Agents|autonomic agents|mesh-ancestor
6688674|NCT01652417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6688675|NCT01652417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688676|NCT01652417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6688677|NCT01652417|Glucocorticoids|glucocorticoids|mesh-ancestor
6688678|NCT01652417|Hormones|hormones|mesh-ancestor
6688679|NCT01652417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6688680|NCT01652417|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6688681|NCT01652417|Protective Agents|protective agents|mesh-ancestor
6688682|NCT01652417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6688683|NCT01652417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6688684|NCT01652534|Amantadine|amantadine|mesh-list
6688685|NCT01652534|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6688686|NCT01652534|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6688687|NCT01652534|Antiviral Agents|antiviral agents|mesh-ancestor
6688688|NCT01652534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6688689|NCT01652534|Dopamine Agents|dopamine agents|mesh-ancestor
6688690|NCT01652534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6688691|NCT01652534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688692|NCT01652534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688693|NCT01652534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6688694|NCT01652534|Analgesics|analgesics|mesh-ancestor
6688695|NCT01652534|Sensory System Agents|sensory system agents|mesh-ancestor
6688696|NCT01652534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6688697|NCT01652547|Pasireotide|pasireotide|mesh-list
6688698|NCT01652547|Somatostatin|somatostatin|mesh-list
6688699|NCT01652547|Hormones|hormones|mesh-ancestor
6688700|NCT01652547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6688701|NCT01652547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688702|NCT01652560|Bevacizumab|bevacizumab|mesh-list
6688703|NCT01652560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6523815|NCT00755053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523816|NCT00755053|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6523817|NCT00755053|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6523818|NCT00755066|Fluticasone|fluticasone|mesh-list
6523819|NCT00755066|Xhance|xhance|mesh-list
6523820|NCT00755066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6523821|NCT00755066|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6523822|NCT00755066|Autonomic Agents|autonomic agents|mesh-ancestor
6523823|NCT00755066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6523824|NCT00755066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523825|NCT00755066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6523826|NCT00755066|Respiratory System Agents|respiratory system agents|mesh-ancestor
6523827|NCT00755066|Dermatologic Agents|dermatologic agents|mesh-ancestor
6523828|NCT00755066|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6523829|NCT00755118|Leucovorin|leucovorin|mesh-list
6523830|NCT00755118|Bevacizumab|bevacizumab|mesh-list
6523831|NCT00755118|Cetuximab|cetuximab|mesh-list
6688704|NCT01652560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6688705|NCT01652560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6688706|NCT01652560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6688707|NCT01652560|Growth Substances|growth substances|mesh-ancestor
6688708|NCT01652560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688709|NCT01652560|Growth Inhibitors|growth inhibitors|mesh-ancestor
6688710|NCT01652586|Midazolam|midazolam|mesh-list
6688711|NCT01652586|Dexmedetomidine|dexmedetomidine|mesh-list
6688712|NCT01652586|Remifentanil|remifentanil|mesh-list
6688713|NCT01652586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6688714|NCT01652586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6688715|NCT01652586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688716|NCT01652586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6688717|NCT01652586|Analgesics|analgesics|mesh-ancestor
6688718|NCT01652586|Sensory System Agents|sensory system agents|mesh-ancestor
6688719|NCT01652586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6688720|NCT01652586|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6688721|NCT01652586|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6688722|NCT01652586|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6688723|NCT01652586|Adrenergic Agents|adrenergic agents|mesh-ancestor
6688724|NCT01652586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6688725|NCT01652586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688726|NCT01652586|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6688727|NCT01652586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6688728|NCT01652586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6688729|NCT01652586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6688730|NCT01652586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6688731|NCT01652586|Anesthetics, General|anesthetics, general|mesh-ancestor
6688732|NCT01652586|Anesthetics|anesthetics|mesh-ancestor
6688733|NCT01652586|GABA Modulators|gaba modulators|mesh-ancestor
6688734|NCT01652586|GABA Agents|gaba agents|mesh-ancestor
6523832|NCT00755118|Fluorouracil|fluorouracil|mesh-list
6523833|NCT00755118|Oxaliplatin|oxaliplatin|mesh-list
6523834|NCT00755118|Irinotecan|irinotecan|mesh-list
6523835|NCT00755118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6523836|NCT00755118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6523837|NCT00755118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6523838|NCT00755118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6523839|NCT00755118|Growth Substances|growth substances|mesh-ancestor
6523840|NCT00755118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523841|NCT00755118|Growth Inhibitors|growth inhibitors|mesh-ancestor
6688735|NCT01652586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6688736|NCT01652586|Narcotics|narcotics|mesh-ancestor
6688737|NCT01652599|Dexamethasone|dexamethasone|mesh-list
6688738|NCT01652599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6523842|NCT00755118|Antimetabolites|antimetabolites|mesh-ancestor
6688739|NCT01652599|Antiemetics|antiemetics|mesh-ancestor
6688740|NCT01652599|Autonomic Agents|autonomic agents|mesh-ancestor
6688741|NCT01652599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6688742|NCT01652599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688743|NCT01652599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6688744|NCT01652599|Glucocorticoids|glucocorticoids|mesh-ancestor
6688745|NCT01652599|Hormones|hormones|mesh-ancestor
6688746|NCT01652599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6688747|NCT01652599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6688748|NCT01652599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6688749|NCT01652638|Heparin|heparin|mesh-list
6688750|NCT01652638|Calcium heparin|calcium heparin|mesh-list
6688751|NCT01652638|Anticoagulants|anticoagulants|mesh-ancestor
6688752|NCT01652638|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6688753|NCT01652638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6523843|NCT00755118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523844|NCT00755118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6523845|NCT00755118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6688754|NCT01652638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780401|NCT02182752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6780402|NCT02182752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780403|NCT02182752|Sensory System Agents|sensory system agents|mesh-ancestor
6780404|NCT02182752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6780405|NCT02182752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6780406|NCT02182752|Narcotics|narcotics|mesh-ancestor
6780407|NCT02182752|Analgesics|analgesics|mesh-ancestor
6780408|NCT02182765|Nevirapine|nevirapine|mesh-list
6523846|NCT00755118|Immunologic Factors|immunologic factors|mesh-ancestor
6523847|NCT00755118|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6523848|NCT00755118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6523849|NCT00755118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6523850|NCT00755118|Antidotes|antidotes|mesh-ancestor
6523851|NCT00755118|Protective Agents|protective agents|mesh-ancestor
6523852|NCT00755118|Vitamin B Complex|vitamin b complex|mesh-ancestor
6523853|NCT00755118|Vitamins|vitamins|mesh-ancestor
6523854|NCT00755118|Micronutrients|micronutrients|mesh-ancestor
6780409|NCT02182765|Abacavir|abacavir|mesh-list
6780410|NCT02182765|Amprenavir|amprenavir|mesh-list
6780411|NCT02182765|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6780412|NCT02182765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6780413|NCT02182765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780414|NCT02182765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780415|NCT02182765|Antiviral Agents|antiviral agents|mesh-ancestor
6780416|NCT02182765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6780417|NCT02182765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6780418|NCT02182765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6780419|NCT02182765|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6780420|NCT02182765|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6780421|NCT02182765|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6780422|NCT02182765|Antitubercular Agents|antitubercular agents|mesh-ancestor
6780423|NCT02182765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6780424|NCT02182765|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6780425|NCT02182765|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6780426|NCT02182765|Protease Inhibitors|protease inhibitors|mesh-ancestor
6780427|NCT02182778|Gemcitabine|gemcitabine|mesh-list
6780428|NCT02182778|Cisplatin|cisplatin|mesh-list
6780429|NCT02182778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6780430|NCT02182778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6780431|NCT02182778|Antimetabolites|antimetabolites|mesh-ancestor
6780432|NCT02182778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780433|NCT02182778|Antiviral Agents|antiviral agents|mesh-ancestor
6780434|NCT02182778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6780435|NCT02182778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780436|NCT02182778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6780437|NCT02182778|Immunologic Factors|immunologic factors|mesh-ancestor
6780438|NCT02182778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780439|NCT02182791|Nevirapine|nevirapine|mesh-list
6780440|NCT02182791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6780441|NCT02182791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6780442|NCT02182791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780443|NCT02182791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780444|NCT02182791|Antiviral Agents|antiviral agents|mesh-ancestor
6780445|NCT02182791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6780446|NCT02182791|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6780447|NCT02182791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6523855|NCT00755157|Bevacizumab|bevacizumab|mesh-list
6688755|NCT01652781|Azacitidine|azacitidine|mesh-list
6688756|NCT01652781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6688757|NCT01652781|Antimetabolites|antimetabolites|mesh-ancestor
6688758|NCT01652781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688759|NCT01652781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6688760|NCT01652781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6688761|NCT01652794|Gemcitabine|gemcitabine|mesh-list
6688762|NCT01652794|Carboplatin|carboplatin|mesh-list
6688763|NCT01652794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6688764|NCT01652794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6688765|NCT01652794|Antimetabolites|antimetabolites|mesh-ancestor
6688766|NCT01652794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688767|NCT01652794|Antiviral Agents|antiviral agents|mesh-ancestor
6688768|NCT01652794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6523856|NCT00755157|Docetaxel|docetaxel|mesh-list
6523857|NCT00755157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6523858|NCT00755157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6523859|NCT00755157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6523860|NCT00755157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6523861|NCT00755157|Growth Substances|growth substances|mesh-ancestor
6688769|NCT01652794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6523862|NCT00755157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523863|NCT00755157|Growth Inhibitors|growth inhibitors|mesh-ancestor
6523864|NCT00755157|Tubulin Modulators|tubulin modulators|mesh-ancestor
6688770|NCT01652794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6688771|NCT01652794|Immunologic Factors|immunologic factors|mesh-ancestor
6688772|NCT01652794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688773|NCT01652820|Gemcitabine|gemcitabine|mesh-list
6688774|NCT01652820|Carboplatin|carboplatin|mesh-list
6688775|NCT01652820|Docetaxel|docetaxel|mesh-list
6688776|NCT01652820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6688777|NCT01652820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6688778|NCT01652820|Antimetabolites|antimetabolites|mesh-ancestor
6688779|NCT01652820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688780|NCT01652820|Antiviral Agents|antiviral agents|mesh-ancestor
6688781|NCT01652820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6688782|NCT01652820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6688783|NCT01652820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6688784|NCT01652820|Immunologic Factors|immunologic factors|mesh-ancestor
6688785|NCT01652820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688786|NCT01652820|Tubulin Modulators|tubulin modulators|mesh-ancestor
6688787|NCT01652820|Antimitotic Agents|antimitotic agents|mesh-ancestor
6688788|NCT01652820|Mitosis Modulators|mitosis modulators|mesh-ancestor
6688789|NCT01652859|Amphotericin B|amphotericin b|mesh-list
6688790|NCT01652859|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6688791|NCT01652859|Amebicides|amebicides|mesh-ancestor
6688792|NCT01652859|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6688793|NCT01652859|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6688794|NCT01652859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6688795|NCT01652859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6688796|NCT01652859|Antifungal Agents|antifungal agents|mesh-ancestor
6688797|NCT01652898|Esmolol|esmolol|mesh-list
6688798|NCT01652898|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6688799|NCT01652898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6688800|NCT01652898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6688801|NCT01652898|Adrenergic Agents|adrenergic agents|mesh-ancestor
6688802|NCT01652898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6688803|NCT01652898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688804|NCT01652898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688805|NCT01652924|Anesthetics|anesthetics|mesh-list
6523865|NCT00755157|Antimitotic Agents|antimitotic agents|mesh-ancestor
6688806|NCT01652924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6688807|NCT01652924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688808|NCT01653015|Vaccines|vaccines|mesh-list
6688809|NCT01653015|Immunologic Factors|immunologic factors|mesh-ancestor
6688810|NCT01653015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688811|NCT01653041|Everolimus|everolimus|mesh-list
6688812|NCT01653041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6688813|NCT01653041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6688814|NCT01653041|Immunologic Factors|immunologic factors|mesh-ancestor
6523866|NCT00755157|Mitosis Modulators|mitosis modulators|mesh-ancestor
6523867|NCT00755157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688815|NCT01653041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688816|NCT01653067|Cytarabine|cytarabine|mesh-list
6688817|NCT01653067|Sirolimus|sirolimus|mesh-list
6523868|NCT00755170|Bevacizumab|bevacizumab|mesh-list
6688818|NCT01653067|Dexamethasone|dexamethasone|mesh-list
6688819|NCT01653067|Dexamethasone acetate|dexamethasone acetate|mesh-list
6688820|NCT01653067|Rituximab|rituximab|mesh-list
6688821|NCT01653067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6688822|NCT01653067|Antiemetics|antiemetics|mesh-ancestor
6688823|NCT01653067|Autonomic Agents|autonomic agents|mesh-ancestor
6523869|NCT00755170|Vinorelbine|vinorelbine|mesh-list
6523870|NCT00755170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6523871|NCT00755170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6523872|NCT00755170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6523873|NCT00755170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6523874|NCT00755170|Growth Substances|growth substances|mesh-ancestor
6523875|NCT00755170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688824|NCT01653067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6688825|NCT01653067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688826|NCT01653067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6688827|NCT01653067|Glucocorticoids|glucocorticoids|mesh-ancestor
6688828|NCT01653067|Hormones|hormones|mesh-ancestor
6688829|NCT01653067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6688830|NCT01653067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6523876|NCT00755170|Growth Inhibitors|growth inhibitors|mesh-ancestor
6523877|NCT00755170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6523878|NCT00755170|Tubulin Modulators|tubulin modulators|mesh-ancestor
6523879|NCT00755170|Antimitotic Agents|antimitotic agents|mesh-ancestor
6523880|NCT00755170|Mitosis Modulators|mitosis modulators|mesh-ancestor
6523881|NCT00755170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523882|NCT00755209|Tranexamic Acid|tranexamic acid|mesh-list
6523883|NCT00755209|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6523884|NCT00755209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6523885|NCT00755209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523886|NCT00755209|Hemostatics|hemostatics|mesh-ancestor
6523887|NCT00755209|Coagulants|coagulants|mesh-ancestor
6688831|NCT01653067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6688832|NCT01653067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688833|NCT01653067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6688834|NCT01653067|Immunologic Factors|immunologic factors|mesh-ancestor
6688835|NCT01653067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6688836|NCT01653067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6688837|NCT01653067|Antimetabolites|antimetabolites|mesh-ancestor
6688838|NCT01653067|Antiviral Agents|antiviral agents|mesh-ancestor
6688839|NCT01653067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6688840|NCT01653067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6688841|NCT01653067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6688842|NCT01653067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6688843|NCT01653067|Antifungal Agents|antifungal agents|mesh-ancestor
6688844|NCT01653119|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6688845|NCT01653119|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6688846|NCT01653119|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6688847|NCT01653119|Antimetabolites|antimetabolites|mesh-ancestor
6688848|NCT01653119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688849|NCT01653119|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6688850|NCT01653119|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6688851|NCT01653119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6688852|NCT01653171|Acetylcysteine|acetylcysteine|mesh-list
6688853|NCT01653171|Simethicone|simethicone|mesh-list
6688854|NCT01653171|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6523888|NCT00755313|Cyclophosphamide|cyclophosphamide|mesh-list
6523889|NCT00755313|Carboplatin|carboplatin|mesh-list
6523890|NCT00755313|Docetaxel|docetaxel|mesh-list
6523891|NCT00755313|Doxorubicin|doxorubicin|mesh-list
6523892|NCT00755313|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6523893|NCT00755313|Trastuzumab|trastuzumab|mesh-list
6523894|NCT00755313|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6523895|NCT00755313|Aromatase Inhibitors|aromatase inhibitors|mesh-list
6523896|NCT00755313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6523897|NCT00755313|Immunologic Factors|immunologic factors|mesh-ancestor
6523898|NCT00755313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523899|NCT00755313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6523900|NCT00755313|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6523901|NCT00755313|Alkylating Agents|alkylating agents|mesh-ancestor
6523902|NCT00755313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523903|NCT00755313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6523904|NCT00755313|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6523905|NCT00755313|Tubulin Modulators|tubulin modulators|mesh-ancestor
6523906|NCT00755313|Antimitotic Agents|antimitotic agents|mesh-ancestor
6523907|NCT00755313|Mitosis Modulators|mitosis modulators|mesh-ancestor
6688855|NCT01653171|Antiviral Agents|antiviral agents|mesh-ancestor
6688856|NCT01653171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6688857|NCT01653171|Expectorants|expectorants|mesh-ancestor
6688858|NCT01653171|Respiratory System Agents|respiratory system agents|mesh-ancestor
6688859|NCT01653171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6688860|NCT01653171|Antioxidants|antioxidants|mesh-ancestor
6688861|NCT01653171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688862|NCT01653171|Protective Agents|protective agents|mesh-ancestor
6688863|NCT01653171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688864|NCT01653171|Antidotes|antidotes|mesh-ancestor
6688865|NCT01653171|Antifoaming Agents|antifoaming agents|mesh-ancestor
6688866|NCT01653171|Emollients|emollients|mesh-ancestor
6688867|NCT01653171|Dermatologic Agents|dermatologic agents|mesh-ancestor
6688868|NCT01653223|Simvastatin|simvastatin|mesh-list
6688869|NCT01653223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6688870|NCT01653223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6688871|NCT01653223|Antimetabolites|antimetabolites|mesh-ancestor
6688872|NCT01653223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688873|NCT01653223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6523908|NCT00755313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6523909|NCT00755313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6523910|NCT00755313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6523911|NCT00755313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6523912|NCT00755313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6523913|NCT00755313|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6523914|NCT00755313|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6523915|NCT00755313|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6688874|NCT01653223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6688875|NCT01653223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6688876|NCT01653236|Ribavirin|ribavirin|mesh-list
6688877|NCT01653236|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6688878|NCT01653236|Antimetabolites|antimetabolites|mesh-ancestor
6688879|NCT01653236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688880|NCT01653236|Antiviral Agents|antiviral agents|mesh-ancestor
6688881|NCT01653236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6523916|NCT00755313|Hormone Antagonists|hormone antagonists|mesh-ancestor
6523917|NCT00755313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6523918|NCT00755352|Pravastatin|pravastatin|mesh-list
6523919|NCT00755352|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
6523920|NCT00755352|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6523921|NCT00755352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6523922|NCT00755352|Antimetabolites|antimetabolites|mesh-ancestor
6523923|NCT00755352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523924|NCT00755352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6523925|NCT00755352|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6523926|NCT00755352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6688882|NCT01653314|Imatinib Mesylate|imatinib mesylate|mesh-list
6688883|NCT01653314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6688884|NCT01653314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6688885|NCT01653314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6688886|NCT01653314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688887|NCT01653457|Memantine|memantine|mesh-list
6688888|NCT01653457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6688889|NCT01653457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6688890|NCT01653457|Dopamine Agents|dopamine agents|mesh-ancestor
6688891|NCT01653457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6688892|NCT01653457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688893|NCT01653457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688894|NCT01653457|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6688895|NCT01653457|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6688896|NCT01653470|Leucovorin|leucovorin|mesh-list
6523927|NCT00755404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6523928|NCT00755456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6523929|NCT00755495|Doxepin|doxepin|mesh-list
6523930|NCT00755495|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6523931|NCT00755495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6523932|NCT00755495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6523933|NCT00755495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688897|NCT01653470|Paclitaxel|paclitaxel|mesh-list
6688898|NCT01653470|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6688899|NCT01653470|Carboplatin|carboplatin|mesh-list
6523934|NCT00755495|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6523935|NCT00755495|Antidepressive Agents|antidepressive agents|mesh-ancestor
6523936|NCT00755495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6523937|NCT00755495|Histamine Antagonists|histamine antagonists|mesh-ancestor
6523938|NCT00755495|Histamine Agents|histamine agents|mesh-ancestor
6523939|NCT00755495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6523940|NCT00755495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523941|NCT00755508|Gabapentin|gabapentin|mesh-list
6523942|NCT00755508|Analgesics|analgesics|mesh-ancestor
6523943|NCT00755508|Sensory System Agents|sensory system agents|mesh-ancestor
6688900|NCT01653470|Fluorouracil|fluorouracil|mesh-list
6688901|NCT01653470|Irinotecan|irinotecan|mesh-list
6688902|NCT01653470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6688903|NCT01653470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6688904|NCT01653470|Tubulin Modulators|tubulin modulators|mesh-ancestor
6688905|NCT01653470|Antimitotic Agents|antimitotic agents|mesh-ancestor
6688906|NCT01653470|Mitosis Modulators|mitosis modulators|mesh-ancestor
6688907|NCT01653470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688908|NCT01653470|Antimetabolites|antimetabolites|mesh-ancestor
6688909|NCT01653470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6688910|NCT01653470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6688911|NCT01653470|Immunologic Factors|immunologic factors|mesh-ancestor
6688912|NCT01653470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688913|NCT01653470|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6688914|NCT01653470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6688915|NCT01653470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6688916|NCT01653470|Antidotes|antidotes|mesh-ancestor
6688917|NCT01653470|Protective Agents|protective agents|mesh-ancestor
6688918|NCT01653470|Vitamin B Complex|vitamin b complex|mesh-ancestor
6688919|NCT01653470|Vitamins|vitamins|mesh-ancestor
6688920|NCT01653470|Micronutrients|micronutrients|mesh-ancestor
6523944|NCT00755508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6523945|NCT00755508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523946|NCT00755508|Anticonvulsants|anticonvulsants|mesh-ancestor
6523947|NCT00755508|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6523948|NCT00755508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6523949|NCT00755508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6523950|NCT00755508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6523951|NCT00755508|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6523952|NCT00755508|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6523953|NCT00755508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6523954|NCT00755508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523955|NCT00755508|Antimanic Agents|antimanic agents|mesh-ancestor
6523956|NCT00755521|Etoricoxib|etoricoxib|mesh-list
6523957|NCT00755521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6523958|NCT00755521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6523959|NCT00755521|Analgesics|analgesics|mesh-ancestor
6523960|NCT00755521|Sensory System Agents|sensory system agents|mesh-ancestor
6523961|NCT00755521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6523962|NCT00755521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688921|NCT01653522|Doxycycline|doxycycline|mesh-list
6688922|NCT01653522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6523963|NCT00755521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6523964|NCT00755521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6523965|NCT00755521|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6523966|NCT00755521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6523967|NCT00755521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6523968|NCT00755521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523969|NCT00755534|Capecitabine|capecitabine|mesh-list
6523970|NCT00755534|Oxaliplatin|oxaliplatin|mesh-list
6523971|NCT00755534|Irinotecan|irinotecan|mesh-list
6523972|NCT00755534|Cetuximab|cetuximab|mesh-list
6523973|NCT00755534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6523974|NCT00755534|Antimetabolites|antimetabolites|mesh-ancestor
6523975|NCT00755534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523976|NCT00755534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6523977|NCT00755534|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6523978|NCT00755534|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6523979|NCT00755534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6523980|NCT00755534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6523981|NCT00755560|Albendazole|albendazole|mesh-list
6523982|NCT00755560|Anthelmintics|anthelmintics|mesh-ancestor
6523983|NCT00755560|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6523984|NCT00755560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6523985|NCT00755560|Anticestodal Agents|anticestodal agents|mesh-ancestor
6523986|NCT00755560|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6523987|NCT00755560|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6523988|NCT00755560|Tubulin Modulators|tubulin modulators|mesh-ancestor
6523989|NCT00755560|Antimitotic Agents|antimitotic agents|mesh-ancestor
6523990|NCT00755560|Mitosis Modulators|mitosis modulators|mesh-ancestor
6523991|NCT00755560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6523992|NCT00755560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6523993|NCT00755573|Pregabalin|pregabalin|mesh-list
6523994|NCT00755573|Analgesics|analgesics|mesh-ancestor
6523995|NCT00755573|Sensory System Agents|sensory system agents|mesh-ancestor
6523996|NCT00755573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6523997|NCT00755573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6523998|NCT00755573|Anticonvulsants|anticonvulsants|mesh-ancestor
6523999|NCT00755573|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6524000|NCT00755573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6524001|NCT00755573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524002|NCT00755573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6524003|NCT00755573|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6524004|NCT00755573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6524005|NCT00755573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6524006|NCT00755573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6524007|NCT00755664|Vitamins|vitamins|mesh-list
6524008|NCT00755664|Vitamin B Complex|vitamin b complex|mesh-list
6524009|NCT00755664|Micronutrients|micronutrients|mesh-ancestor
6524010|NCT00755664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524011|NCT00755781|Cyclosporine|cyclosporine|mesh-list
6524012|NCT00755781|Cyclosporins|cyclosporins|mesh-list
6524013|NCT00755781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6524014|NCT00755781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524015|NCT00755781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6524016|NCT00755781|Immunologic Factors|immunologic factors|mesh-ancestor
6524017|NCT00755781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524018|NCT00755781|Antifungal Agents|antifungal agents|mesh-ancestor
6524019|NCT00755781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6524020|NCT00755781|Dermatologic Agents|dermatologic agents|mesh-ancestor
6524021|NCT00755781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6524022|NCT00755781|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6524023|NCT00755820|Cycloserine|cycloserine|mesh-list
6524024|NCT00755820|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6524025|NCT00755820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6524026|NCT00755820|Renal Agents|renal agents|mesh-ancestor
6524027|NCT00755820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6524028|NCT00755820|Antitubercular Agents|antitubercular agents|mesh-ancestor
6524029|NCT00755820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6524030|NCT00755820|Antimetabolites|antimetabolites|mesh-ancestor
6524031|NCT00755820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524032|NCT00755833|Insulin Aspart|insulin aspart|mesh-list
6524033|NCT00755833|Biphasic Insulins|biphasic insulins|mesh-list
6524034|NCT00755833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6524035|NCT00755833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524036|NCT00755859|Prednisone|prednisone|mesh-list
6524037|NCT00755859|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6524038|NCT00755859|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6688923|NCT01653522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6688924|NCT01653522|Antimalarials|antimalarials|mesh-ancestor
6688925|NCT01653522|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6688926|NCT01653522|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6688927|NCT01653561|Apatinib|apatinib|mesh-list
6688928|NCT01653561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6688929|NCT01653561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6688930|NCT01653561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6524039|NCT00755859|Methylprednisolone|methylprednisolone|mesh-list
6524040|NCT00755859|Prednisolone|prednisolone|mesh-list
6524041|NCT00755859|Prednisolone acetate|prednisolone acetate|mesh-list
6524042|NCT00755859|Azathioprine|azathioprine|mesh-list
6524043|NCT00755859|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6524044|NCT00755859|Prednisolone phosphate|prednisolone phosphate|mesh-list
6524045|NCT00755859|Antimetabolites|antimetabolites|mesh-ancestor
6524046|NCT00755859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524047|NCT00755859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6524048|NCT00755859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6688931|NCT01653561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688932|NCT01653639|Factor VIII|factor viii|mesh-list
6524049|NCT00755859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6524050|NCT00755859|Immunologic Factors|immunologic factors|mesh-ancestor
6524051|NCT00755859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524052|NCT00755859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6524053|NCT00755859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6524054|NCT00755859|Glucocorticoids|glucocorticoids|mesh-ancestor
6524055|NCT00755859|Hormones|hormones|mesh-ancestor
6524056|NCT00755859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6524057|NCT00755859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6524058|NCT00755859|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6524059|NCT00755859|Protective Agents|protective agents|mesh-ancestor
6524060|NCT00755859|Antiemetics|antiemetics|mesh-ancestor
6524061|NCT00755859|Autonomic Agents|autonomic agents|mesh-ancestor
6524062|NCT00755859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6524063|NCT00755859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6524064|NCT00755872|Risedronic Acid|risedronic acid|mesh-list
6524065|NCT00755872|Etidronic Acid|etidronic acid|mesh-list
6524066|NCT00755872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6524067|NCT00755872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6524068|NCT00755872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524069|NCT00755872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6524070|NCT00755872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524071|NCT00755872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6524072|NCT00755885|Abiraterone Acetate|abiraterone acetate|mesh-list
6524073|NCT00755885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6524074|NCT00755885|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6524075|NCT00755885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6524076|NCT00755885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524077|NCT00755885|Hormone Antagonists|hormone antagonists|mesh-ancestor
6524078|NCT00755885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6524079|NCT00755885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524080|NCT00755885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6524081|NCT00755898|Amantadine|amantadine|mesh-list
6524082|NCT00755898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6524083|NCT00755898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6524084|NCT00755898|Antiviral Agents|antiviral agents|mesh-ancestor
6524085|NCT00755898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6688933|NCT01653639|Coagulants|coagulants|mesh-ancestor
6688934|NCT01653665|Sargramostim|sargramostim|mesh-list
6688935|NCT01653665|Immunologic Factors|immunologic factors|mesh-ancestor
6688936|NCT01653665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688937|NCT01653678|Vitamin D|vitamin d|mesh-list
6688938|NCT01653678|Ergocalciferols|ergocalciferols|mesh-list
6688939|NCT01653678|Cholecalciferol|cholecalciferol|mesh-list
6688940|NCT01653678|Vitamins|vitamins|mesh-list
6688941|NCT01653678|Micronutrients|micronutrients|mesh-ancestor
6688942|NCT01653678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688943|NCT01653678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6688944|NCT01653678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6688945|NCT01653717|Vidarabine|vidarabine|mesh-list
6688946|NCT01653717|Cyclophosphamide|cyclophosphamide|mesh-list
6688947|NCT01653717|Fludarabine|fludarabine|mesh-list
6688948|NCT01653717|Fludarabine phosphate|fludarabine phosphate|mesh-list
6688949|NCT01653717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6688950|NCT01653717|Immunologic Factors|immunologic factors|mesh-ancestor
6688951|NCT01653717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688952|NCT01653717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6688953|NCT01653717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6688954|NCT01653717|Alkylating Agents|alkylating agents|mesh-ancestor
6688955|NCT01653717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688956|NCT01653717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6688957|NCT01653717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6688958|NCT01653717|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6688959|NCT01653717|Antimetabolites|antimetabolites|mesh-ancestor
6688960|NCT01653717|Antiviral Agents|antiviral agents|mesh-ancestor
6688961|NCT01653717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6688962|NCT01653925|Dutasteride|dutasteride|mesh-list
6688963|NCT01653925|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6688964|NCT01653925|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6524086|NCT00755898|Dopamine Agents|dopamine agents|mesh-ancestor
6524087|NCT00755898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6524088|NCT00755898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524089|NCT00755898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524090|NCT00755898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6524091|NCT00755898|Analgesics|analgesics|mesh-ancestor
6524092|NCT00755898|Sensory System Agents|sensory system agents|mesh-ancestor
6688965|NCT01653925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6688966|NCT01653925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688967|NCT01653925|Hormone Antagonists|hormone antagonists|mesh-ancestor
6688968|NCT01653925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6688969|NCT01653925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688970|NCT01653977|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
6688971|NCT01653990|Moxifloxacin|moxifloxacin|mesh-list
6688972|NCT01653990|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6688973|NCT01653990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6688974|NCT01653990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6688975|NCT01653990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6688976|NCT01653990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6524093|NCT00755898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6524094|NCT00755924|Acetic Acid|acetic acid|mesh-list
6524095|NCT00755924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6524096|NCT00755924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6524097|NCT00755950|Silymarin|silymarin|mesh-list
6524098|NCT00755950|Antioxidants|antioxidants|mesh-ancestor
6688977|NCT01653990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6688978|NCT01653990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688979|NCT01653990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6688980|NCT01653990|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6688981|NCT01653990|Contraceptive Agents|contraceptive agents|mesh-ancestor
6688982|NCT01653990|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6688983|NCT01653990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688984|NCT01653990|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6688985|NCT01653990|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6688986|NCT01653990|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6688987|NCT01654003|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
6688988|NCT01654081|Irinotecan|irinotecan|mesh-list
6688989|NCT01654081|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6688990|NCT01654081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6688991|NCT01654081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6688992|NCT01654081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6688993|NCT01654081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6688994|NCT01654120|Liraglutide|liraglutide|mesh-list
6688995|NCT01654120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6688996|NCT01654120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6688997|NCT01654120|Incretins|incretins|mesh-ancestor
6688998|NCT01654120|Hormones|hormones|mesh-ancestor
6688999|NCT01654120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6689000|NCT01654146|Paclitaxel|paclitaxel|mesh-list
6524099|NCT00755950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524100|NCT00755950|Protective Agents|protective agents|mesh-ancestor
6524101|NCT00755950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524102|NCT00755963|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6524103|NCT00755963|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6524104|NCT00755963|Estradiol|estradiol|mesh-list
6524105|NCT00755963|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6524106|NCT00755963|Progesterone|progesterone|mesh-list
6524107|NCT00755963|Estrogens|estrogens|mesh-ancestor
6689001|NCT01654146|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6689002|NCT01654146|Carboplatin|carboplatin|mesh-list
6689003|NCT01654146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6689004|NCT01654146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6689005|NCT01654146|Tubulin Modulators|tubulin modulators|mesh-ancestor
6689006|NCT01654146|Antimitotic Agents|antimitotic agents|mesh-ancestor
6689007|NCT01654146|Mitosis Modulators|mitosis modulators|mesh-ancestor
6689008|NCT01654146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689009|NCT01654185|Letrozole|letrozole|mesh-list
6689010|NCT01654185|Exemestane|exemestane|mesh-list
6689011|NCT01654185|Aromatase Inhibitors|aromatase inhibitors|mesh-list
6689012|NCT01654185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6689013|NCT01654185|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6689014|NCT01654185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6524108|NCT00755963|Hormones|hormones|mesh-ancestor
6524109|NCT00755963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6524110|NCT00755963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524111|NCT00755963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6524112|NCT00755963|Contraceptive Agents|contraceptive agents|mesh-ancestor
6524113|NCT00755963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6524114|NCT00755963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6524115|NCT00755963|Progestins|progestins|mesh-ancestor
6524116|NCT00755976|Sulindac|sulindac|mesh-list
6524117|NCT00755976|Epirubicin|epirubicin|mesh-list
6524118|NCT00755976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6524119|NCT00755976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6524120|NCT00755976|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6524121|NCT00755976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6524122|NCT00755976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6524123|NCT00755976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524124|NCT00755976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6524125|NCT00755976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6524126|NCT00755976|Analgesics|analgesics|mesh-ancestor
6524127|NCT00755976|Sensory System Agents|sensory system agents|mesh-ancestor
6524128|NCT00755976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6524129|NCT00755976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524130|NCT00755976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6689015|NCT01654185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689016|NCT01654185|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6689017|NCT01654185|Hormone Antagonists|hormone antagonists|mesh-ancestor
6689018|NCT01654185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6689019|NCT01654185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524131|NCT00755976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6524132|NCT00755976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6524133|NCT00755989|Morphine|morphine|mesh-list
6524134|NCT00755989|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6524135|NCT00755989|Narcotics|narcotics|mesh-ancestor
6524136|NCT00755989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6524137|NCT00755989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524138|NCT00755989|Analgesics|analgesics|mesh-ancestor
6524139|NCT00755989|Sensory System Agents|sensory system agents|mesh-ancestor
6524140|NCT00755989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6524141|NCT00756067|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6524142|NCT00756067|Immunologic Factors|immunologic factors|mesh-ancestor
6524143|NCT00756067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524144|NCT00756171|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
6524145|NCT00756171|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6524146|NCT00756171|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6524147|NCT00756171|Antimetabolites|antimetabolites|mesh-ancestor
6524148|NCT00756171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524149|NCT00756171|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6524150|NCT00756184|Travoprost|travoprost|mesh-list
6524151|NCT00756184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6524152|NCT00756301|Lidocaine|lidocaine|mesh-list
6524153|NCT00756301|Anesthetics, Local|anesthetics, local|mesh-ancestor
6524154|NCT00756301|Anesthetics|anesthetics|mesh-ancestor
6524155|NCT00756301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6524156|NCT00756301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524157|NCT00756301|Sensory System Agents|sensory system agents|mesh-ancestor
6524158|NCT00756301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6524159|NCT00756301|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6524160|NCT00756301|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6524161|NCT00756301|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6524162|NCT00756301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6524163|NCT00756301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524164|NCT00756340|Bevacizumab|bevacizumab|mesh-list
6524165|NCT00756340|Everolimus|everolimus|mesh-list
6524166|NCT00756340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6524167|NCT00756340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6689020|NCT01654211|Ritonavir|ritonavir|mesh-list
6689021|NCT01654211|Lactams|lactams|mesh-list
6689022|NCT01654211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6689023|NCT01654211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6689024|NCT01654211|Protease Inhibitors|protease inhibitors|mesh-ancestor
6689025|NCT01654211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6689026|NCT01654211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689027|NCT01654211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6689028|NCT01654211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6689029|NCT01654211|Antiviral Agents|antiviral agents|mesh-ancestor
6689030|NCT01654211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6689031|NCT01654211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6689032|NCT01654211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6689033|NCT01654211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6689034|NCT01654367|Zoledronic Acid|zoledronic acid|mesh-list
6689035|NCT01654367|Aromatase Inhibitors|aromatase inhibitors|mesh-list
6689036|NCT01654367|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6689037|NCT01654367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524168|NCT00756340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6524169|NCT00756340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6689038|NCT01654367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6689039|NCT01654367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6689040|NCT01654367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689041|NCT01654367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6689042|NCT01654367|Hormone Antagonists|hormone antagonists|mesh-ancestor
6689043|NCT01654367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6780448|NCT02182791|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6780449|NCT02182791|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6780450|NCT02182856|Bromides|bromides|mesh-list
6780451|NCT02182856|Albuterol|albuterol|mesh-list
6780452|NCT02182856|Ipratropium|ipratropium|mesh-list
6780453|NCT02182856|Anticonvulsants|anticonvulsants|mesh-ancestor
6780454|NCT02182856|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6780455|NCT02182856|Autonomic Agents|autonomic agents|mesh-ancestor
6780456|NCT02182856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6780457|NCT02182856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780458|NCT02182856|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6780459|NCT02182856|Respiratory System Agents|respiratory system agents|mesh-ancestor
6780460|NCT02182856|Tocolytic Agents|tocolytic agents|mesh-ancestor
6780461|NCT02182856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6780462|NCT02182856|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6780463|NCT02182856|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6780464|NCT02182856|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6780465|NCT02182856|Adrenergic Agents|adrenergic agents|mesh-ancestor
6780466|NCT02182856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6780467|NCT02182856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780468|NCT02182856|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6780469|NCT02182856|Cholinergic Agents|cholinergic agents|mesh-ancestor
6780470|NCT02182960|Ibuprofen|ibuprofen|mesh-list
6780471|NCT02182960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6780472|NCT02182960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6780473|NCT02182960|Analgesics|analgesics|mesh-ancestor
6780474|NCT02182960|Sensory System Agents|sensory system agents|mesh-ancestor
6780475|NCT02182960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6780476|NCT02182960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780477|NCT02182960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6780478|NCT02182960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6780479|NCT02182960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6780480|NCT02182960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6524170|NCT00756340|Growth Substances|growth substances|mesh-ancestor
6524171|NCT00756340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524172|NCT00756340|Growth Inhibitors|growth inhibitors|mesh-ancestor
6524173|NCT00756340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6780481|NCT02182960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780482|NCT02182986|Immunosuppressive Agents|immunosuppressive agents|mesh-list
6780483|NCT02182986|Immunologic Factors|immunologic factors|mesh-ancestor
6780484|NCT02182986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689044|NCT01654497|HU 211|hu 211|mesh-list
6689045|NCT01654497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6689046|NCT01654497|Antiemetics|antiemetics|mesh-ancestor
6689047|NCT01654497|Autonomic Agents|autonomic agents|mesh-ancestor
6689048|NCT01654497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6689049|NCT01654497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689050|NCT01654497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6689051|NCT01654497|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6689052|NCT01654497|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6689053|NCT01654497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6689054|NCT01654497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689055|NCT01654497|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6689056|NCT01654497|Protective Agents|protective agents|mesh-ancestor
6689057|NCT01654562|Simvastatin|simvastatin|mesh-list
6689058|NCT01654562|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6689059|NCT01654562|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6689060|NCT01654562|Antimetabolites|antimetabolites|mesh-ancestor
6689061|NCT01654562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780485|NCT02183012|Ibuprofen|ibuprofen|mesh-list
6524174|NCT00756340|Immunologic Factors|immunologic factors|mesh-ancestor
6524175|NCT00756405|Antioxidants|antioxidants|mesh-list
6524176|NCT00756405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524177|NCT00756405|Protective Agents|protective agents|mesh-ancestor
6524178|NCT00756405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524179|NCT00756691|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
6524180|NCT00756691|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6524181|NCT00756691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524182|NCT00756847|Paclitaxel|paclitaxel|mesh-list
6524183|NCT00756847|Carboplatin|carboplatin|mesh-list
6524184|NCT00756847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6524185|NCT00756847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6524186|NCT00756847|Tubulin Modulators|tubulin modulators|mesh-ancestor
6524187|NCT00756847|Antimitotic Agents|antimitotic agents|mesh-ancestor
6524188|NCT00756847|Mitosis Modulators|mitosis modulators|mesh-ancestor
6524189|NCT00756847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524190|NCT00756860|Sevelamer|sevelamer|mesh-list
6524191|NCT00756860|Chelating Agents|chelating agents|mesh-ancestor
6524192|NCT00756860|Sequestering Agents|sequestering agents|mesh-ancestor
6524193|NCT00756860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524194|NCT00756873|Etoricoxib|etoricoxib|mesh-list
6524195|NCT00756873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6524196|NCT00756873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6524197|NCT00756873|Analgesics|analgesics|mesh-ancestor
6524198|NCT00756873|Sensory System Agents|sensory system agents|mesh-ancestor
6524199|NCT00756873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6524200|NCT00756873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524201|NCT00756873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6524202|NCT00756873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6524203|NCT00756873|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6524204|NCT00756873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6524205|NCT00756873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6524206|NCT00756873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524207|NCT00756990|Naltrexone|naltrexone|mesh-list
6524208|NCT00756990|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6524209|NCT00756990|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6524210|NCT00756990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524211|NCT00756990|Sensory System Agents|sensory system agents|mesh-ancestor
6524212|NCT00756990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6524213|NCT00757016|Triamcinolone|triamcinolone|mesh-list
6524214|NCT00757016|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6524215|NCT00757016|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6524216|NCT00757016|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6524217|NCT00757016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6524218|NCT00757016|Glucocorticoids|glucocorticoids|mesh-ancestor
6524219|NCT00757016|Hormones|hormones|mesh-ancestor
6524220|NCT00757016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6524221|NCT00757016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524222|NCT00757016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6524223|NCT00757016|Immunologic Factors|immunologic factors|mesh-ancestor
6524224|NCT00757016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6524225|NCT00757016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524226|NCT00757029|Norepinephrine|norepinephrine|mesh-list
6524227|NCT00757029|Methylphenidate|methylphenidate|mesh-list
6524228|NCT00757029|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6524229|NCT00757029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524230|NCT00757029|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6524231|NCT00757029|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6524232|NCT00757029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6524233|NCT00757029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524234|NCT00757029|Dopamine Agents|dopamine agents|mesh-ancestor
6524235|NCT00757029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6524236|NCT00757029|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6524237|NCT00757029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6524238|NCT00757029|Adrenergic Agents|adrenergic agents|mesh-ancestor
6524239|NCT00757029|Sympathomimetics|sympathomimetics|mesh-ancestor
6524240|NCT00757029|Autonomic Agents|autonomic agents|mesh-ancestor
6524241|NCT00757029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6524242|NCT00757029|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6524243|NCT00757081|Deoxycholic Acid|deoxycholic acid|mesh-list
6689062|NCT01654562|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6689063|NCT01654562|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6689064|NCT01654562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6689065|NCT01654575|Methotrexate|methotrexate|mesh-list
6689066|NCT01654575|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6689067|NCT01654575|Abortifacient Agents|abortifacient agents|mesh-ancestor
6689068|NCT01654575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6689069|NCT01654575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689070|NCT01654575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6689071|NCT01654575|Antimetabolites|antimetabolites|mesh-ancestor
6689072|NCT01654575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689073|NCT01654575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6689074|NCT01654575|Dermatologic Agents|dermatologic agents|mesh-ancestor
6689075|NCT01654575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6689076|NCT01654575|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6524244|NCT00757081|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6524245|NCT00757081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6524246|NCT00757185|Methyltestosterone|methyltestosterone|mesh-list
6524247|NCT00757185|Testosterone|testosterone|mesh-list
6524248|NCT00757185|Testosterone undecanoate|testosterone undecanoate|mesh-list
6524249|NCT00757185|Testosterone enanthate|testosterone enanthate|mesh-list
6524250|NCT00757185|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6524251|NCT00757185|Ganirelix|ganirelix|mesh-list
6524252|NCT00757185|Androgens|androgens|mesh-ancestor
6524253|NCT00757185|Hormones|hormones|mesh-ancestor
6524254|NCT00757185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6524255|NCT00757185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524256|NCT00757185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6524257|NCT00757185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6689077|NCT01654575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6689078|NCT01654575|Immunologic Factors|immunologic factors|mesh-ancestor
6689079|NCT01654575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6689080|NCT01654575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6689081|NCT01654640|Metformin|metformin|mesh-list
6689082|NCT01654640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6689083|NCT01654640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689084|NCT01654692|Ipilimumab|ipilimumab|mesh-list
6689085|NCT01654692|Fotemustine|fotemustine|mesh-list
6689086|NCT01654692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6689087|NCT01654692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6689088|NCT01654692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6689089|NCT01654692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689090|NCT01654705|Pantoprazole|pantoprazole|mesh-list
6689091|NCT01654705|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6689092|NCT01654705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6689093|NCT01654705|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6689094|NCT01654705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6689095|NCT01654705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689096|NCT01654718|Pantoprazole|pantoprazole|mesh-list
6524258|NCT00757185|Anabolic Agents|anabolic agents|mesh-ancestor
6524259|NCT00757185|Hormone Antagonists|hormone antagonists|mesh-ancestor
6689097|NCT01654718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6689098|NCT01654718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6689099|NCT01654718|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6689100|NCT01654718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6689101|NCT01654718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689102|NCT01654731|Bezafibrate|bezafibrate|mesh-list
6689103|NCT01654731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6689104|NCT01654731|Antimetabolites|antimetabolites|mesh-ancestor
6689105|NCT01654731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689106|NCT01654731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6689107|NCT01654809|Vaccines|vaccines|mesh-list
6689108|NCT01654809|Immunologic Factors|immunologic factors|mesh-ancestor
6689109|NCT01654809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689110|NCT01654939|Rifaximin|rifaximin|mesh-list
6689111|NCT01654939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6689112|NCT01654939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6689113|NCT01654939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6689114|NCT01654965|Topotecan|topotecan|mesh-list
6689115|NCT01654965|Lenograstim|lenograstim|mesh-list
6689116|NCT01654965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6689117|NCT01654965|Immunologic Factors|immunologic factors|mesh-ancestor
6689118|NCT01654965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689119|NCT01654965|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6689120|NCT01654965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6689121|NCT01654965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6689122|NCT01654965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689123|NCT01654965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6689124|NCT01655004|Exemestane|exemestane|mesh-list
6689125|NCT01655004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6689126|NCT01655004|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6689127|NCT01655004|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6689128|NCT01655004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6689129|NCT01655004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689130|NCT01655004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6689131|NCT01655004|Hormone Antagonists|hormone antagonists|mesh-ancestor
6689132|NCT01655004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6689133|NCT01655004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689134|NCT01655056|Darexaban|darexaban|mesh-list
6689135|NCT01655056|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6689136|NCT01655056|Antithrombins|antithrombins|mesh-ancestor
6689137|NCT01655056|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6689138|NCT01655056|Protease Inhibitors|protease inhibitors|mesh-ancestor
6689139|NCT01655056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6689140|NCT01655056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689141|NCT01655056|Anticoagulants|anticoagulants|mesh-ancestor
6689142|NCT01655082|Nicotine|nicotine|mesh-list
6689143|NCT01655082|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6689144|NCT01655082|Autonomic Agents|autonomic agents|mesh-ancestor
6689145|NCT01655082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6689146|NCT01655082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689147|NCT01655082|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6689148|NCT01655082|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6689149|NCT01655082|Cholinergic Agents|cholinergic agents|mesh-ancestor
6689150|NCT01655082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6689151|NCT01655082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689152|NCT01655095|Prucalopride|prucalopride|mesh-list
6689153|NCT01655095|Bisacodyl|bisacodyl|mesh-list
6689154|NCT01655095|Laxatives|laxatives|mesh-ancestor
6689155|NCT01655095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6689156|NCT01655095|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
6689157|NCT01655095|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6689158|NCT01655095|Serotonin Agents|serotonin agents|mesh-ancestor
6689159|NCT01655095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6689160|NCT01655095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689161|NCT01655095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689162|NCT01655095|Cathartics|cathartics|mesh-ancestor
6689163|NCT01655108|Minoxidil|minoxidil|mesh-list
6689164|NCT01655108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6689165|NCT01655108|Vasodilator Agents|vasodilator agents|mesh-ancestor
6689166|NCT01655147|Rifampin|rifampin|mesh-list
6689167|NCT01655147|Abiraterone Acetate|abiraterone acetate|mesh-list
6689168|NCT01655147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6689169|NCT01655147|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6689170|NCT01655147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6689171|NCT01655147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689172|NCT01655147|Hormone Antagonists|hormone antagonists|mesh-ancestor
6689173|NCT01655147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6524260|NCT00757198|Remifentanil|remifentanil|mesh-list
6524261|NCT00757198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6524262|NCT00757198|Narcotics|narcotics|mesh-ancestor
6524263|NCT00757198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6524264|NCT00757198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524265|NCT00757198|Analgesics|analgesics|mesh-ancestor
6524266|NCT00757198|Sensory System Agents|sensory system agents|mesh-ancestor
6524267|NCT00757198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6524268|NCT00757250|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
6524269|NCT00757250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6524270|NCT00757250|Vasodilator Agents|vasodilator agents|mesh-ancestor
6524271|NCT00757315|Triamcinolone|triamcinolone|mesh-list
6524272|NCT00757315|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6524273|NCT00757315|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6524274|NCT00757315|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6524275|NCT00757315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6524276|NCT00757315|Glucocorticoids|glucocorticoids|mesh-ancestor
6524277|NCT00757315|Hormones|hormones|mesh-ancestor
6524278|NCT00757315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6524279|NCT00757315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689174|NCT01655147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689175|NCT01655147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6689176|NCT01655147|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6689177|NCT01655147|Antitubercular Agents|antitubercular agents|mesh-ancestor
6689178|NCT01655147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6689179|NCT01655147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6689180|NCT01655147|Leprostatic Agents|leprostatic agents|mesh-ancestor
6689181|NCT01655147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6689182|NCT01655147|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6689183|NCT01655147|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6689184|NCT01655147|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6689185|NCT01655147|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6689186|NCT01655147|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6689187|NCT01655147|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6689188|NCT01655199|Albuterol|albuterol|mesh-list
6689189|NCT01655199|Ipratropium|ipratropium|mesh-list
6689190|NCT01655199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6689191|NCT01655199|Autonomic Agents|autonomic agents|mesh-ancestor
6689192|NCT01655199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6689193|NCT01655199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689194|NCT01655199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6689195|NCT01655199|Respiratory System Agents|respiratory system agents|mesh-ancestor
6689196|NCT01655199|Tocolytic Agents|tocolytic agents|mesh-ancestor
6689197|NCT01655199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6689198|NCT01655199|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6689199|NCT01655199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6689200|NCT01655199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6689201|NCT01655199|Adrenergic Agents|adrenergic agents|mesh-ancestor
6689202|NCT01655199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6689203|NCT01655199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689204|NCT01655199|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6689205|NCT01655199|Cholinergic Agents|cholinergic agents|mesh-ancestor
6689206|NCT01655212|Valganciclovir|valganciclovir|mesh-list
6689207|NCT01655212|Antiviral Agents|antiviral agents|mesh-ancestor
6689208|NCT01655212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6689209|NCT01655303|Propranolol|propranolol|mesh-list
6689210|NCT01655303|Metoprolol|metoprolol|mesh-list
6689211|NCT01655303|Verapamil|verapamil|mesh-list
6689212|NCT01655303|Diltiazem|diltiazem|mesh-list
6689213|NCT01655303|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6689214|NCT01655303|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6689215|NCT01655303|Adrenergic Agents|adrenergic agents|mesh-ancestor
6689216|NCT01655303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6689217|NCT01655303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689218|NCT01655303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689219|NCT01655303|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6689220|NCT01655303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6689221|NCT01655303|Vasodilator Agents|vasodilator agents|mesh-ancestor
6689222|NCT01655303|Sympatholytics|sympatholytics|mesh-ancestor
6689223|NCT01655303|Autonomic Agents|autonomic agents|mesh-ancestor
6689224|NCT01655303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6689225|NCT01655303|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6689226|NCT01655303|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6524280|NCT00757315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6689227|NCT01655303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6689228|NCT01655303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6689229|NCT01655316|Verapamil|verapamil|mesh-list
6689230|NCT01655316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6689231|NCT01655316|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6689232|NCT01655316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6689233|NCT01655316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689234|NCT01655316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6689235|NCT01655316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689236|NCT01655316|Vasodilator Agents|vasodilator agents|mesh-ancestor
6689237|NCT01655368|Psychotropic Drugs|psychotropic drugs|mesh-list
6689238|NCT01655524|Aminophylline|aminophylline|mesh-list
6689239|NCT01655524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6689240|NCT01655524|Autonomic Agents|autonomic agents|mesh-ancestor
6689241|NCT01655524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6689242|NCT01655524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689243|NCT01655524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6689244|NCT01655524|Respiratory System Agents|respiratory system agents|mesh-ancestor
6689245|NCT01655524|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6689246|NCT01655524|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6689247|NCT01655524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6689248|NCT01655524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689249|NCT01655524|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6689250|NCT01655524|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6689251|NCT01655524|Purinergic Agents|purinergic agents|mesh-ancestor
6689252|NCT01655524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6689253|NCT01655524|Protective Agents|protective agents|mesh-ancestor
6242733|NCT02655354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6242734|NCT02655354|Antidepressive Agents|antidepressive agents|mesh-ancestor
6242735|NCT02655354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6242736|NCT02655354|Dopamine Agents|dopamine agents|mesh-ancestor
6242737|NCT02655354|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6242738|NCT02655354|Serotonin Agents|serotonin agents|mesh-ancestor
6242739|NCT02655354|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6242740|NCT02655354|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6242741|NCT02655354|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6242742|NCT02655354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6242743|NCT02655354|Autonomic Agents|autonomic agents|mesh-ancestor
6242744|NCT02655354|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6689254|NCT01655628|Gemcitabine|gemcitabine|mesh-list
6689255|NCT01655628|Cisplatin|cisplatin|mesh-list
6689256|NCT01655628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6689257|NCT01655628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6689258|NCT01655628|Antimetabolites|antimetabolites|mesh-ancestor
6689259|NCT01655628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689260|NCT01655628|Antiviral Agents|antiviral agents|mesh-ancestor
6689261|NCT01655628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6689262|NCT01655628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6689263|NCT01655628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6689264|NCT01655628|Immunologic Factors|immunologic factors|mesh-ancestor
6689265|NCT01655628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689266|NCT01655641|Tranexamic Acid|tranexamic acid|mesh-list
6689267|NCT01655641|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6689268|NCT01655641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6689269|NCT01655641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689270|NCT01655641|Hemostatics|hemostatics|mesh-ancestor
6689271|NCT01655641|Coagulants|coagulants|mesh-ancestor
6689272|NCT01655706|Aripiprazole|aripiprazole|mesh-list
6689273|NCT01655706|Citalopram|citalopram|mesh-list
6689274|NCT01655706|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6689275|NCT01655706|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6689276|NCT01655706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6689277|NCT01655706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689278|NCT01655706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6689279|NCT01655706|Serotonin Agents|serotonin agents|mesh-ancestor
6689280|NCT01655706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689281|NCT01655706|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6689282|NCT01655706|Antidepressive Agents|antidepressive agents|mesh-ancestor
6689283|NCT01655706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6689284|NCT01655706|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6689285|NCT01655706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6689286|NCT01655706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6689287|NCT01655706|Dopamine Agonists|dopamine agonists|mesh-ancestor
6689288|NCT01655706|Dopamine Agents|dopamine agents|mesh-ancestor
6689289|NCT01655706|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6689290|NCT01655706|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6689291|NCT01655706|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6689292|NCT01655706|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6689293|NCT01655706|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6689294|NCT01655706|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6689295|NCT01655745|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6689296|NCT01655745|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6689297|NCT01655745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689298|NCT01655758|Timolol|timolol|mesh-list
6689299|NCT01655758|Bimatoprost|bimatoprost|mesh-list
6689300|NCT01655758|Travoprost|travoprost|mesh-list
6689301|NCT01655758|Dorzolamide|dorzolamide|mesh-list
6689302|NCT01655758|Latanoprost|latanoprost|mesh-list
6689303|NCT01655758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6689304|NCT01655758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6689305|NCT01655758|Adrenergic Agents|adrenergic agents|mesh-ancestor
6689306|NCT01655758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6689307|NCT01655758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689308|NCT01655758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689309|NCT01655758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6689310|NCT01655758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6689311|NCT01655758|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6689312|NCT01655758|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6689313|NCT01655758|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6689314|NCT01655758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6689315|NCT01655810|Vitamin D|vitamin d|mesh-list
6689316|NCT01655810|Ergocalciferols|ergocalciferols|mesh-list
6689317|NCT01655810|Cholecalciferol|cholecalciferol|mesh-list
6689318|NCT01655810|Vitamins|vitamins|mesh-list
6689319|NCT01655810|Calcium Carbonate|calcium carbonate|mesh-list
6689320|NCT01655810|Micronutrients|micronutrients|mesh-ancestor
6689321|NCT01655810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689322|NCT01655810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6689323|NCT01655810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6689324|NCT01655810|Antacids|antacids|mesh-ancestor
6689325|NCT01655810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689326|NCT01655810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6689327|NCT01655862|Botulinum Toxins|botulinum toxins|mesh-list
6689328|NCT01655862|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6689329|NCT01655862|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6689330|NCT01655862|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6689331|NCT01655862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6689332|NCT01655862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689333|NCT01655862|Cholinergic Agents|cholinergic agents|mesh-ancestor
6689334|NCT01655862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6689335|NCT01655862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689336|NCT01655862|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6689337|NCT01655862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6689338|NCT01655875|Plerixafor|plerixafor|mesh-list
6689339|NCT01655875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6689340|NCT01655875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6689341|NCT01655875|Antiviral Agents|antiviral agents|mesh-ancestor
6689342|NCT01655875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6689343|NCT01655888|Tremelimumab|tremelimumab|mesh-list
6689344|NCT01655888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6689345|NCT01655914|Flumazenil|flumazenil|mesh-list
6689346|NCT01655914|Antidotes|antidotes|mesh-ancestor
6689347|NCT01655914|Protective Agents|protective agents|mesh-ancestor
6689348|NCT01655914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689349|NCT01655914|GABA Modulators|gaba modulators|mesh-ancestor
6689350|NCT01655914|GABA Agents|gaba agents|mesh-ancestor
6689351|NCT01655914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6689352|NCT01655914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689353|NCT01655927|Tranexamic Acid|tranexamic acid|mesh-list
6689354|NCT01655927|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6689355|NCT01655927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6689356|NCT01655927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689357|NCT01655927|Hemostatics|hemostatics|mesh-ancestor
6689358|NCT01655927|Coagulants|coagulants|mesh-ancestor
6689359|NCT01655966|Vitamin D|vitamin d|mesh-list
6689360|NCT01655966|Interferons|interferons|mesh-list
6689361|NCT01655966|Ribavirin|ribavirin|mesh-list
6689362|NCT01655966|Vitamins|vitamins|mesh-ancestor
6689363|NCT01655966|Micronutrients|micronutrients|mesh-ancestor
6689364|NCT01655966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689365|NCT01655966|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6689366|NCT01655966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6689367|NCT01655966|Antiviral Agents|antiviral agents|mesh-ancestor
6689368|NCT01655966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6689369|NCT01655966|Antimetabolites|antimetabolites|mesh-ancestor
6689370|NCT01655966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689371|NCT01655992|Capecitabine|capecitabine|mesh-list
6689372|NCT01655992|Tegafur|tegafur|mesh-list
6689373|NCT01655992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6689374|NCT01655992|Antimetabolites|antimetabolites|mesh-ancestor
6689375|NCT01655992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689376|NCT01655992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6689377|NCT01656005|Beclomethasone|beclomethasone|mesh-list
6689378|NCT01656005|Carvedilol|carvedilol|mesh-list
6689379|NCT01656005|Bisoprolol|bisoprolol|mesh-list
6689380|NCT01656005|Formoterol Fumarate|formoterol fumarate|mesh-list
6689381|NCT01656005|Tiotropium Bromide|tiotropium bromide|mesh-list
6689382|NCT01656005|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6689383|NCT01656005|Autonomic Agents|autonomic agents|mesh-ancestor
6689384|NCT01656005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6689385|NCT01656005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689386|NCT01656005|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6689387|NCT01656005|Respiratory System Agents|respiratory system agents|mesh-ancestor
6689388|NCT01656005|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6689389|NCT01656005|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6689390|NCT01656005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6689391|NCT01656005|Adrenergic Agents|adrenergic agents|mesh-ancestor
6689392|NCT01656005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6689393|NCT01656005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689394|NCT01656005|Parasympatholytics|parasympatholytics|mesh-ancestor
6689395|NCT01656005|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6689396|NCT01656005|Cholinergic Agents|cholinergic agents|mesh-ancestor
6689397|NCT01656005|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6689398|NCT01656005|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6689399|NCT01656005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6689400|NCT01656005|Antioxidants|antioxidants|mesh-ancestor
6689401|NCT01656005|Protective Agents|protective agents|mesh-ancestor
6689402|NCT01656005|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6689403|NCT01656005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6689404|NCT01656005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6689405|NCT01656005|Vasodilator Agents|vasodilator agents|mesh-ancestor
6689406|NCT01656005|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6689407|NCT01656005|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6689408|NCT01656005|Sympatholytics|sympatholytics|mesh-ancestor
6689409|NCT01656005|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6689410|NCT01656005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6689411|NCT01656005|Glucocorticoids|glucocorticoids|mesh-ancestor
6689412|NCT01656005|Hormones|hormones|mesh-ancestor
6689413|NCT01656005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6689414|NCT01656018|Rilpivirine|rilpivirine|mesh-list
6689415|NCT01656018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6689416|NCT01656018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6689417|NCT01656018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6689418|NCT01656018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689419|NCT01656018|Antiviral Agents|antiviral agents|mesh-ancestor
6689420|NCT01656018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6689421|NCT01656018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6689422|NCT01656018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6689423|NCT01656057|Acetaminophen|acetaminophen|mesh-list
6689424|NCT01656057|Metformin|metformin|mesh-list
6689425|NCT01656057|Cholecystokinin|cholecystokinin|mesh-list
6689426|NCT01656057|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
6689427|NCT01656057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6689428|NCT01656057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689429|NCT01656057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6689430|NCT01656057|Analgesics|analgesics|mesh-ancestor
6689431|NCT01656057|Sensory System Agents|sensory system agents|mesh-ancestor
6689432|NCT01656057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6689433|NCT01656057|Antipyretics|antipyretics|mesh-ancestor
6689434|NCT01656057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6689435|NCT01656057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6689436|NCT01656057|Antimetabolites|antimetabolites|mesh-ancestor
6689437|NCT01656057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689438|NCT01656057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6689439|NCT01656057|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6689440|NCT01656057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6689441|NCT01656070|Vitamin D|vitamin d|mesh-list
6689442|NCT01656070|Cholecalciferol|cholecalciferol|mesh-list
6689443|NCT01656070|Vitamins|vitamins|mesh-ancestor
6689444|NCT01656070|Micronutrients|micronutrients|mesh-ancestor
6689445|NCT01656070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689446|NCT01656070|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6689447|NCT01656070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6689448|NCT01656109|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6689449|NCT01656109|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6689450|NCT01656109|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6689451|NCT01656109|Protease Inhibitors|protease inhibitors|mesh-ancestor
6689452|NCT01656109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6689453|NCT01656109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689454|NCT01656109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6689455|NCT01656109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6689456|NCT01656109|Antiviral Agents|antiviral agents|mesh-ancestor
6689457|NCT01656109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6780486|NCT02183012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6780487|NCT02183012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6780488|NCT02183012|Analgesics|analgesics|mesh-ancestor
6780489|NCT02183012|Sensory System Agents|sensory system agents|mesh-ancestor
6780490|NCT02183012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6780491|NCT02183012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780492|NCT02183012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6780493|NCT02183012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6780494|NCT02183012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6780495|NCT02183012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780496|NCT02183012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780497|NCT02183025|Meloxicam|meloxicam|mesh-list
6780498|NCT02183025|Mefenamic Acid|mefenamic acid|mesh-list
6780499|NCT02183025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6780500|NCT02183025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6780501|NCT02183025|Analgesics|analgesics|mesh-ancestor
6780502|NCT02183025|Sensory System Agents|sensory system agents|mesh-ancestor
6780503|NCT02183025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6780504|NCT02183025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780505|NCT02183025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6780506|NCT02183025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6780507|NCT02183025|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6780508|NCT02183025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6780509|NCT02183025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780510|NCT02183025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780511|NCT02183038|Naproxen|naproxen|mesh-list
6780512|NCT02183038|Meloxicam|meloxicam|mesh-list
6780513|NCT02183038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6780514|NCT02183038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6780515|NCT02183038|Analgesics|analgesics|mesh-ancestor
6780516|NCT02183038|Sensory System Agents|sensory system agents|mesh-ancestor
6780517|NCT02183038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6780518|NCT02183038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780519|NCT02183038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6780520|NCT02183038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6780521|NCT02183038|Gout Suppressants|gout suppressants|mesh-ancestor
6780522|NCT02183038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6780523|NCT02183038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780524|NCT02183038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780525|NCT02183038|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6780526|NCT02183051|Ibuprofen|ibuprofen|mesh-list
6780527|NCT02183051|Meloxicam|meloxicam|mesh-list
6780528|NCT02183051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6780529|NCT02183051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6780530|NCT02183051|Analgesics|analgesics|mesh-ancestor
6780531|NCT02183051|Sensory System Agents|sensory system agents|mesh-ancestor
6780532|NCT02183051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6780533|NCT02183051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780534|NCT02183051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6780535|NCT02183051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6780536|NCT02183051|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6780537|NCT02183051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780538|NCT02183051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780539|NCT02183051|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6780540|NCT02183064|Meloxicam|meloxicam|mesh-list
6689458|NCT01656122|Abacavir|abacavir|mesh-list
6689459|NCT01656122|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6689460|NCT01656122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6689461|NCT01656122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6689462|NCT01656122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689463|NCT01656122|Antiviral Agents|antiviral agents|mesh-ancestor
6689464|NCT01656122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6689465|NCT01656122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6689466|NCT01656122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6689467|NCT01656148|4-Aminopyridine|4-aminopyridine|mesh-list
6689468|NCT01656148|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6689469|NCT01656148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6689470|NCT01656148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689471|NCT01656226|Sunscreening Agents|sunscreening agents|mesh-list
6689472|NCT01656226|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6689473|NCT01656226|Protective Agents|protective agents|mesh-ancestor
6689474|NCT01656226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689475|NCT01656226|Dermatologic Agents|dermatologic agents|mesh-ancestor
6689476|NCT01656330|Rivaroxaban|rivaroxaban|mesh-list
6689477|NCT01656330|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6689478|NCT01656330|Antithrombins|antithrombins|mesh-ancestor
6689479|NCT01656330|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6689480|NCT01656330|Protease Inhibitors|protease inhibitors|mesh-ancestor
6689481|NCT01656330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6689482|NCT01656330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689483|NCT01656330|Anticoagulants|anticoagulants|mesh-ancestor
6689484|NCT01656343|Abatacept|abatacept|mesh-list
6689485|NCT01656343|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
6689486|NCT01656343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6689487|NCT01656343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689488|NCT01656343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6689489|NCT01656343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6689490|NCT01656343|Immunologic Factors|immunologic factors|mesh-ancestor
6689491|NCT01656343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689492|NCT01656343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6689493|NCT01656343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6689494|NCT01656512|Vitamin D|vitamin d|mesh-list
6689495|NCT01656512|Diphosphonates|diphosphonates|mesh-list
6689496|NCT01656512|Calcium|calcium|mesh-list
6689497|NCT01656512|Vitamins|vitamins|mesh-ancestor
6689498|NCT01656512|Micronutrients|micronutrients|mesh-ancestor
6689499|NCT01656512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689500|NCT01656512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6689501|NCT01656512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6689502|NCT01656525|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6689503|NCT01656525|Immunologic Factors|immunologic factors|mesh-ancestor
6689504|NCT01656525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689505|NCT01656538|Paclitaxel|paclitaxel|mesh-list
6689506|NCT01656538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6689507|NCT01656538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6689508|NCT01656538|Tubulin Modulators|tubulin modulators|mesh-ancestor
6689509|NCT01656538|Antimitotic Agents|antimitotic agents|mesh-ancestor
6689510|NCT01656538|Mitosis Modulators|mitosis modulators|mesh-ancestor
6689511|NCT01656538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689512|NCT01656551|Gemcitabine|gemcitabine|mesh-list
6244253|NCT02691494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6689513|NCT01656551|Pemetrexed|pemetrexed|mesh-list
6689514|NCT01656551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6689515|NCT01656551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6689516|NCT01656551|Antimetabolites|antimetabolites|mesh-ancestor
6689517|NCT01656551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689518|NCT01656551|Antiviral Agents|antiviral agents|mesh-ancestor
6689519|NCT01656551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6689520|NCT01656551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6689521|NCT01656551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6689522|NCT01656551|Immunologic Factors|immunologic factors|mesh-ancestor
6689523|NCT01656551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689524|NCT01656551|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6689525|NCT01656551|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6689526|NCT01656616|Antidotes|antidotes|mesh-list
6689527|NCT01656616|Protective Agents|protective agents|mesh-ancestor
6689528|NCT01656616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689529|NCT01656642|Atezolizumab|atezolizumab|mesh-list
6689530|NCT01656642|Vemurafenib|vemurafenib|mesh-list
6689531|NCT01656642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6689532|NCT01656642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6689533|NCT01656642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6689534|NCT01656642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689535|NCT01656668|Theobromine|theobromine|mesh-list
6689536|NCT01656668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6689537|NCT01656668|Autonomic Agents|autonomic agents|mesh-ancestor
6689538|NCT01656668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6689539|NCT01656668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689540|NCT01656668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6689541|NCT01656668|Respiratory System Agents|respiratory system agents|mesh-ancestor
6689542|NCT01656668|Vasodilator Agents|vasodilator agents|mesh-ancestor
6689543|NCT01656720|Methoxamine|methoxamine|mesh-list
6689544|NCT01656720|Sympathomimetics|sympathomimetics|mesh-ancestor
6689545|NCT01656720|Autonomic Agents|autonomic agents|mesh-ancestor
6689546|NCT01656720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6689547|NCT01656720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689548|NCT01656720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6689549|NCT01656720|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6689550|NCT01656720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6689551|NCT01656720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6689552|NCT01656720|Adrenergic Agents|adrenergic agents|mesh-ancestor
6689553|NCT01656720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6689554|NCT01656720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689555|NCT01656798|Sildenafil Citrate|sildenafil citrate|mesh-list
6689556|NCT01656798|Citric Acid|citric acid|mesh-list
6689557|NCT01656798|Sodium Citrate|sodium citrate|mesh-list
6689558|NCT01656798|Anticoagulants|anticoagulants|mesh-ancestor
6689559|NCT01656798|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6689560|NCT01656798|Chelating Agents|chelating agents|mesh-ancestor
6689561|NCT01656798|Sequestering Agents|sequestering agents|mesh-ancestor
6689562|NCT01656798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689563|NCT01656798|Vasodilator Agents|vasodilator agents|mesh-ancestor
6689564|NCT01656798|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6689565|NCT01656798|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6689566|NCT01656798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6689567|NCT01656798|Urological Agents|urological agents|mesh-ancestor
6689568|NCT01656811|Albuterol|albuterol|mesh-list
6689569|NCT01656811|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6689570|NCT01656811|Autonomic Agents|autonomic agents|mesh-ancestor
6689571|NCT01656811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6689572|NCT01656811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689573|NCT01656811|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6689574|NCT01656811|Respiratory System Agents|respiratory system agents|mesh-ancestor
6689575|NCT01656811|Tocolytic Agents|tocolytic agents|mesh-ancestor
6689576|NCT01656811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6689577|NCT01656811|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6689578|NCT01656811|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6689579|NCT01656811|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6689580|NCT01656811|Adrenergic Agents|adrenergic agents|mesh-ancestor
6689581|NCT01656811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6689582|NCT01656811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689583|NCT01656980|Carmustine|carmustine|mesh-list
6689584|NCT01656980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6689585|NCT01656980|Alkylating Agents|alkylating agents|mesh-ancestor
6689586|NCT01656980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689587|NCT01656980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6689588|NCT01657058|Dimenhydrinate|dimenhydrinate|mesh-list
6689589|NCT01657058|Antiemetics|antiemetics|mesh-ancestor
6689590|NCT01657058|Autonomic Agents|autonomic agents|mesh-ancestor
6689591|NCT01657058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6689592|NCT01657058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689593|NCT01657058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6689594|NCT01657058|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6689595|NCT01657058|Histamine Antagonists|histamine antagonists|mesh-ancestor
6689596|NCT01657058|Histamine Agents|histamine agents|mesh-ancestor
6689597|NCT01657058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6689598|NCT01657058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689599|NCT01657071|Aspirin|aspirin|mesh-list
6689600|NCT01657071|Clopidogrel|clopidogrel|mesh-list
6689601|NCT01657071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6689602|NCT01657071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6689603|NCT01657071|Analgesics|analgesics|mesh-ancestor
6689604|NCT01657071|Sensory System Agents|sensory system agents|mesh-ancestor
6689605|NCT01657071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6689606|NCT01657071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689607|NCT01657071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6689608|NCT01657071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6689609|NCT01657071|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6689610|NCT01657071|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6689611|NCT01657071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689612|NCT01657071|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6689613|NCT01657071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6689614|NCT01657071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6689615|NCT01657071|Antipyretics|antipyretics|mesh-ancestor
6689616|NCT01657071|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6689617|NCT01657071|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6689618|NCT01657071|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6689619|NCT01657071|Purinergic Agents|purinergic agents|mesh-ancestor
6689620|NCT01657071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6689621|NCT01657110|Tea Tree Oil|tea tree oil|mesh-list
6689622|NCT01657110|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6689623|NCT01657110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6689624|NCT01657136|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
6689625|NCT01657136|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6524281|NCT00757315|Immunologic Factors|immunologic factors|mesh-ancestor
6524282|NCT00757315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6524283|NCT00757315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524284|NCT00757380|Diminazene aceturate|diminazene aceturate|mesh-list
6524285|NCT00757380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6524286|NCT00757380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6524287|NCT00757380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6524288|NCT00757380|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6524289|NCT00757393|Calcium, Dietary|calcium, dietary|mesh-list
6524290|NCT00757393|Vitamin D|vitamin d|mesh-list
6524291|NCT00757393|Ergocalciferols|ergocalciferols|mesh-list
6524292|NCT00757393|Vitamins|vitamins|mesh-list
6524293|NCT00757393|Calcium|calcium|mesh-list
6524294|NCT00757393|Micronutrients|micronutrients|mesh-ancestor
6524295|NCT00757393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524296|NCT00757393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6524297|NCT00757393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6524298|NCT00757419|Lesogaberan|lesogaberan|mesh-list
6524299|NCT00757419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6524300|NCT00757419|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6524301|NCT00757419|GABA Agonists|gaba agonists|mesh-ancestor
6524302|NCT00757419|GABA Agents|gaba agents|mesh-ancestor
6524303|NCT00757419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6524304|NCT00757419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524305|NCT00757419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524306|NCT00757458|Propofol|propofol|mesh-list
6524307|NCT00757458|Edetic Acid|edetic acid|mesh-list
6524308|NCT00757458|Pentetic Acid|pentetic acid|mesh-list
6524309|NCT00757458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6524310|NCT00757458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6524311|NCT00757458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524312|NCT00757458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6524313|NCT00757458|Anesthetics, General|anesthetics, general|mesh-ancestor
6524314|NCT00757458|Anesthetics|anesthetics|mesh-ancestor
6524315|NCT00757458|Anticoagulants|anticoagulants|mesh-ancestor
6524316|NCT00757458|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6524317|NCT00757458|Chelating Agents|chelating agents|mesh-ancestor
6689626|NCT01657136|Adrenergic Agents|adrenergic agents|mesh-ancestor
6689627|NCT01657136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6689628|NCT01657136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689629|NCT01657136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689630|NCT01657201|Voriconazole|voriconazole|mesh-list
6689631|NCT01657201|Antifungal Agents|antifungal agents|mesh-ancestor
6689632|NCT01657201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6689633|NCT01657201|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6689634|NCT01657201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6689635|NCT01657201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6689636|NCT01657201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689637|NCT01657201|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6689638|NCT01657201|Hormone Antagonists|hormone antagonists|mesh-ancestor
6689639|NCT01657201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6689640|NCT01657201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689641|NCT01657201|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6689642|NCT01657240|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
6689643|NCT01657240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6689644|NCT01657240|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6689645|NCT01657240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6689646|NCT01657240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6689647|NCT01657240|Analgesics|analgesics|mesh-ancestor
6689648|NCT01657240|Sensory System Agents|sensory system agents|mesh-ancestor
6689649|NCT01657240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6689650|NCT01657240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689651|NCT01657240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6689652|NCT01657240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6689653|NCT01657240|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6689654|NCT01657240|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6689655|NCT01657240|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6689656|NCT01657240|Histamine Antagonists|histamine antagonists|mesh-ancestor
6689657|NCT01657240|Histamine Agents|histamine agents|mesh-ancestor
6689658|NCT01657240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6689659|NCT01657240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689660|NCT01657318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
6689661|NCT01657318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6689662|NCT01657331|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6689663|NCT01657331|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6689664|NCT01657331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6689665|NCT01657331|Alkylating Agents|alkylating agents|mesh-ancestor
6689666|NCT01657331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689667|NCT01657331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6689668|NCT01657331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6689669|NCT01657396|Chlorhexidine|chlorhexidine|mesh-list
6689670|NCT01657396|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6689671|NCT01657396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6689672|NCT01657396|Disinfectants|disinfectants|mesh-ancestor
6689673|NCT01657409|Botulinum Toxins|botulinum toxins|mesh-list
6689674|NCT01657409|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6689675|NCT01657409|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6689676|NCT01657409|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
6689677|NCT01657409|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6689678|NCT01657409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6689679|NCT01657409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689680|NCT01657409|Cholinergic Agents|cholinergic agents|mesh-ancestor
6689681|NCT01657409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6689682|NCT01657409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689683|NCT01657409|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6689684|NCT01657409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6689685|NCT01657448|Methenamine|methenamine|mesh-list
6689686|NCT01657448|Methenamine hippurate|methenamine hippurate|mesh-list
6689687|NCT01657448|Methenamine mandelate|methenamine mandelate|mesh-list
6689688|NCT01657448|Methylene Blue|methylene blue|mesh-list
6689689|NCT01657448|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6689690|NCT01657448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6689691|NCT01657448|Renal Agents|renal agents|mesh-ancestor
6689692|NCT01657448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6689693|NCT01657448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6689694|NCT01657448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689695|NCT01657487|Fluticasone|fluticasone|mesh-list
6689696|NCT01657487|Xhance|xhance|mesh-list
6689697|NCT01657487|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6689698|NCT01657487|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6689699|NCT01657487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6689700|NCT01657487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6689701|NCT01657487|Autonomic Agents|autonomic agents|mesh-ancestor
6689702|NCT01657487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6689703|NCT01657487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689704|NCT01657487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6689705|NCT01657487|Respiratory System Agents|respiratory system agents|mesh-ancestor
6689706|NCT01657487|Dermatologic Agents|dermatologic agents|mesh-ancestor
6689707|NCT01657487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6689708|NCT01657487|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6689709|NCT01657487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6689710|NCT01657487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6689711|NCT01657487|Adrenergic Agents|adrenergic agents|mesh-ancestor
6689712|NCT01657487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6689713|NCT01657487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689714|NCT01657487|Glucocorticoids|glucocorticoids|mesh-ancestor
6689715|NCT01657487|Hormones|hormones|mesh-ancestor
6689716|NCT01657487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6689717|NCT01657487|Sympathomimetics|sympathomimetics|mesh-ancestor
6689718|NCT01657500|Gentamicins|gentamicins|mesh-list
6689719|NCT01657500|Dextrans|dextrans|mesh-list
6689720|NCT01657500|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6689721|NCT01657500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6689722|NCT01657500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6689723|NCT01657500|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6689724|NCT01657500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6689725|NCT01657500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689726|NCT01657500|Anticoagulants|anticoagulants|mesh-ancestor
6689727|NCT01657500|Plasma Substitutes|plasma substitutes|mesh-ancestor
6689728|NCT01657500|Blood Substitutes|blood substitutes|mesh-ancestor
6689729|NCT01657513|Adalimumab|adalimumab|mesh-list
6689730|NCT01657513|Etanercept|etanercept|mesh-list
6689731|NCT01657513|Infliximab|infliximab|mesh-list
6689732|NCT01657513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6689733|NCT01657513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6689734|NCT01657513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6689735|NCT01657513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6689736|NCT01657513|Analgesics|analgesics|mesh-ancestor
6689737|NCT01657513|Sensory System Agents|sensory system agents|mesh-ancestor
6689738|NCT01657513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6689739|NCT01657513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689740|NCT01657513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6689741|NCT01657513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6689742|NCT01657513|Immunologic Factors|immunologic factors|mesh-ancestor
6689743|NCT01657513|Dermatologic Agents|dermatologic agents|mesh-ancestor
6689744|NCT01657578|Omeprazole|omeprazole|mesh-list
6689745|NCT01657578|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6689746|NCT01657578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6689747|NCT01657578|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6689748|NCT01657578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6689749|NCT01657578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689750|NCT01657591|Vemurafenib|vemurafenib|mesh-list
6689751|NCT01657591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6689752|NCT01657591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6689753|NCT01657591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6689754|NCT01657591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689755|NCT01657656|Vitamin D|vitamin d|mesh-list
6689756|NCT01657656|Vitamins|vitamins|mesh-ancestor
6689757|NCT01657656|Micronutrients|micronutrients|mesh-ancestor
6689758|NCT01657656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689759|NCT01657656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6689760|NCT01657669|Aflibercept|aflibercept|mesh-list
6689761|NCT01657669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6689762|NCT01657669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6689763|NCT01657669|Growth Substances|growth substances|mesh-ancestor
6689764|NCT01657669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689765|NCT01657669|Growth Inhibitors|growth inhibitors|mesh-ancestor
6689766|NCT01657669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6689767|NCT01657682|Crenolanib|crenolanib|mesh-list
6689768|NCT01657682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6689769|NCT01657747|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
6689770|NCT01657747|Parasympatholytics|parasympatholytics|mesh-ancestor
6689771|NCT01657747|Autonomic Agents|autonomic agents|mesh-ancestor
6689772|NCT01657747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6689773|NCT01657747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689774|NCT01657747|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6689775|NCT01657747|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6689776|NCT01657747|Cholinergic Agents|cholinergic agents|mesh-ancestor
6689777|NCT01657747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6689778|NCT01657747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689779|NCT01657812|Dexmedetomidine|dexmedetomidine|mesh-list
6689780|NCT01657812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6689781|NCT01657812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6689782|NCT01657812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689783|NCT01657812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6689784|NCT01657812|Analgesics|analgesics|mesh-ancestor
6689785|NCT01657812|Sensory System Agents|sensory system agents|mesh-ancestor
6689786|NCT01657812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6689787|NCT01657812|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6689788|NCT01657812|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6689789|NCT01657812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6689790|NCT01657812|Adrenergic Agents|adrenergic agents|mesh-ancestor
6689791|NCT01657812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6689792|NCT01657812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689793|NCT01657825|Isavuconazole|isavuconazole|mesh-list
6689794|NCT01657825|Warfarin|warfarin|mesh-list
6689795|NCT01657825|Anticoagulants|anticoagulants|mesh-ancestor
6689796|NCT01657825|Antifungal Agents|antifungal agents|mesh-ancestor
6689797|NCT01657825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6689798|NCT01657838|Ketoconazole|ketoconazole|mesh-list
6689799|NCT01657838|Isavuconazole|isavuconazole|mesh-list
6689800|NCT01657838|Antifungal Agents|antifungal agents|mesh-ancestor
6689801|NCT01657838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6689802|NCT01657838|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6689803|NCT01657838|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6689804|NCT01657838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6689805|NCT01657838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689806|NCT01657838|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6689807|NCT01657838|Hormone Antagonists|hormone antagonists|mesh-ancestor
6689808|NCT01657838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6689809|NCT01657838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689810|NCT01657838|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6780541|NCT02183064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6780542|NCT02183064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6780543|NCT02183064|Analgesics|analgesics|mesh-ancestor
6780544|NCT02183064|Sensory System Agents|sensory system agents|mesh-ancestor
6780545|NCT02183064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6780546|NCT02183064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780547|NCT02183064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6780548|NCT02183064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6780549|NCT02183064|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6780550|NCT02183064|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6780551|NCT02183064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780552|NCT02183064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780553|NCT02183077|Meloxicam|meloxicam|mesh-list
6780554|NCT02183077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6780555|NCT02183077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6780556|NCT02183077|Analgesics|analgesics|mesh-ancestor
6780557|NCT02183077|Sensory System Agents|sensory system agents|mesh-ancestor
6780558|NCT02183077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6780559|NCT02183077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780560|NCT02183077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6780561|NCT02183077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6780562|NCT02183077|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6780563|NCT02183077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6780564|NCT02183077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780565|NCT02183077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780566|NCT02183090|Meloxicam|meloxicam|mesh-list
6780567|NCT02183090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6780568|NCT02183090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6780569|NCT02183090|Analgesics|analgesics|mesh-ancestor
6780570|NCT02183090|Sensory System Agents|sensory system agents|mesh-ancestor
6780571|NCT02183090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6780572|NCT02183090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780573|NCT02183090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6780574|NCT02183090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6780575|NCT02183090|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6689811|NCT01657851|Tamsulosin|tamsulosin|mesh-list
6689812|NCT01657851|Dutasteride|dutasteride|mesh-list
6689813|NCT01657851|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6689814|NCT01657851|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6689815|NCT01657851|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6689816|NCT01657851|Adrenergic Agents|adrenergic agents|mesh-ancestor
6689817|NCT01657851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6689818|NCT01657851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689819|NCT01657851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689820|NCT01657851|Urological Agents|urological agents|mesh-ancestor
6689821|NCT01657851|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6689822|NCT01657851|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6689823|NCT01657851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6689824|NCT01657851|Hormone Antagonists|hormone antagonists|mesh-ancestor
6689825|NCT01657851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6689826|NCT01657864|Lamotrigine|lamotrigine|mesh-list
6689827|NCT01657864|Anticonvulsants|anticonvulsants|mesh-ancestor
6689828|NCT01657864|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6689829|NCT01657864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6689830|NCT01657864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689831|NCT01657864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6689832|NCT01657864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689833|NCT01657864|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6689834|NCT01657864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6689835|NCT01657864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6689836|NCT01657864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6689837|NCT01657864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6689838|NCT01657890|Isavuconazole|isavuconazole|mesh-list
6689839|NCT01657890|Antifungal Agents|antifungal agents|mesh-ancestor
6689840|NCT01657890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6689841|NCT01657929|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6689842|NCT01657929|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6689843|NCT01657929|Immunologic Factors|immunologic factors|mesh-ancestor
6689844|NCT01657929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689845|NCT01657929|Antacids|antacids|mesh-ancestor
6689846|NCT01657929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689847|NCT01657929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6689848|NCT01657955|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6689849|NCT01657955|Chlorambucil|chlorambucil|mesh-list
6689850|NCT01657955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6689851|NCT01657955|Alkylating Agents|alkylating agents|mesh-ancestor
6689852|NCT01657955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689853|NCT01657955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6689854|NCT01657981|Darexaban|darexaban|mesh-list
6689855|NCT01657981|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6689856|NCT01657981|Antithrombins|antithrombins|mesh-ancestor
6689857|NCT01657981|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6689858|NCT01657981|Protease Inhibitors|protease inhibitors|mesh-ancestor
6689859|NCT01657981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6689860|NCT01657981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689861|NCT01657981|Anticoagulants|anticoagulants|mesh-ancestor
6689862|NCT01658007|Sirolimus|sirolimus|mesh-list
6689863|NCT01658007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6689864|NCT01658007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6689865|NCT01658007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6689866|NCT01658007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6689867|NCT01658007|Antifungal Agents|antifungal agents|mesh-ancestor
6689868|NCT01658007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6689869|NCT01658007|Immunologic Factors|immunologic factors|mesh-ancestor
6689870|NCT01658007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689871|NCT01658033|Leucovorin|leucovorin|mesh-list
6689872|NCT01658033|Oxaliplatin|oxaliplatin|mesh-list
6689873|NCT01658033|Bevacizumab|bevacizumab|mesh-list
6689874|NCT01658033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6689875|NCT01658033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6689876|NCT01658033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6689877|NCT01658033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6689878|NCT01658033|Growth Substances|growth substances|mesh-ancestor
6689879|NCT01658033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689880|NCT01658033|Growth Inhibitors|growth inhibitors|mesh-ancestor
6689881|NCT01658033|Antidotes|antidotes|mesh-ancestor
6689882|NCT01658033|Protective Agents|protective agents|mesh-ancestor
6689883|NCT01658033|Vitamin B Complex|vitamin b complex|mesh-ancestor
6689884|NCT01658033|Vitamins|vitamins|mesh-ancestor
6689885|NCT01658033|Micronutrients|micronutrients|mesh-ancestor
6689886|NCT01658124|Tranexamic Acid|tranexamic acid|mesh-list
6689887|NCT01658124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6689888|NCT01658124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6689889|NCT01658124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689890|NCT01658124|Hemostatics|hemostatics|mesh-ancestor
6689891|NCT01658124|Coagulants|coagulants|mesh-ancestor
6689892|NCT01658176|Exemestane|exemestane|mesh-list
6689893|NCT01658176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6689894|NCT01658176|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6689895|NCT01658176|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6689896|NCT01658176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6689897|NCT01658176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689898|NCT01658176|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6689899|NCT01658176|Hormone Antagonists|hormone antagonists|mesh-ancestor
6689900|NCT01658176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6689901|NCT01658176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689902|NCT01658202|Nicotine|nicotine|mesh-list
6689903|NCT01658202|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6689904|NCT01658202|Autonomic Agents|autonomic agents|mesh-ancestor
6689905|NCT01658202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6689906|NCT01658202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689907|NCT01658202|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6689908|NCT01658202|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6689909|NCT01658202|Cholinergic Agents|cholinergic agents|mesh-ancestor
6689910|NCT01658202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6689911|NCT01658202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689912|NCT01658215|Nicotine|nicotine|mesh-list
6689913|NCT01658215|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6689914|NCT01658215|Autonomic Agents|autonomic agents|mesh-ancestor
6689915|NCT01658215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6689916|NCT01658215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689917|NCT01658215|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6689918|NCT01658215|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6689919|NCT01658215|Cholinergic Agents|cholinergic agents|mesh-ancestor
6689920|NCT01658215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6689921|NCT01658215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689922|NCT01658241|Panobinostat|panobinostat|mesh-list
6689923|NCT01658241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6689924|NCT01658241|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6689925|NCT01658241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6689926|NCT01658241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689927|NCT01658319|Fludarabine|fludarabine|mesh-list
6689928|NCT01658319|Fludarabine phosphate|fludarabine phosphate|mesh-list
6689929|NCT01658319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6689930|NCT01658319|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6689931|NCT01658319|Antimetabolites|antimetabolites|mesh-ancestor
6689932|NCT01658319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689933|NCT01658319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6689934|NCT01658319|Immunologic Factors|immunologic factors|mesh-ancestor
6689935|NCT01658319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689936|NCT01658358|Doxorubicin|doxorubicin|mesh-list
6689937|NCT01658358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6689938|NCT01658358|Lapatinib|lapatinib|mesh-list
6689939|NCT01658358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6689940|NCT01658358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6689941|NCT01658358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6689942|NCT01658358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6689943|NCT01658358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6689944|NCT01658358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689945|NCT01658358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6689946|NCT01658410|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
6689947|NCT01658410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6689948|NCT01658410|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6689949|NCT01658410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689950|NCT01658449|Hyaluronic Acid|hyaluronic acid|mesh-list
6689951|NCT01658449|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6689952|NCT01658449|Immunologic Factors|immunologic factors|mesh-ancestor
6689953|NCT01658449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689954|NCT01658449|Viscosupplements|viscosupplements|mesh-ancestor
6689955|NCT01658449|Protective Agents|protective agents|mesh-ancestor
6689956|NCT01658462|Docetaxel|docetaxel|mesh-list
6689957|NCT01658462|Nintedanib|nintedanib|mesh-list
6689958|NCT01658462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6689959|NCT01658462|Tubulin Modulators|tubulin modulators|mesh-ancestor
6689960|NCT01658462|Antimitotic Agents|antimitotic agents|mesh-ancestor
6689961|NCT01658462|Mitosis Modulators|mitosis modulators|mesh-ancestor
6689962|NCT01658462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689963|NCT01658462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6689964|NCT01658462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6689965|NCT01658527|Bicalutamide|bicalutamide|mesh-list
6689966|NCT01658527|Androgen Antagonists|androgen antagonists|mesh-ancestor
6689967|NCT01658527|Hormone Antagonists|hormone antagonists|mesh-ancestor
6689968|NCT01658527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6689969|NCT01658527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689970|NCT01658527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6689971|NCT01658553|Trametinib|trametinib|mesh-list
6689972|NCT01658553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6689973|NCT01658553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6689974|NCT01658553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6689975|NCT01658553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689976|NCT01658774|Ascorbic Acid|ascorbic acid|mesh-list
6689977|NCT01658774|Albendazole|albendazole|mesh-list
6689978|NCT01658774|Vitamins|vitamins|mesh-ancestor
6689979|NCT01658774|Micronutrients|micronutrients|mesh-ancestor
6689980|NCT01658774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6689981|NCT01658774|Antioxidants|antioxidants|mesh-ancestor
6689982|NCT01658774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6689983|NCT01658774|Protective Agents|protective agents|mesh-ancestor
6689984|NCT01658774|Anthelmintics|anthelmintics|mesh-ancestor
6689985|NCT01658774|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6689986|NCT01658774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6689987|NCT01658774|Anticestodal Agents|anticestodal agents|mesh-ancestor
6689988|NCT01658774|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6689989|NCT01658774|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6689990|NCT01658774|Tubulin Modulators|tubulin modulators|mesh-ancestor
6689991|NCT01658774|Antimitotic Agents|antimitotic agents|mesh-ancestor
6689992|NCT01658774|Mitosis Modulators|mitosis modulators|mesh-ancestor
6689993|NCT01658774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6689994|NCT01658852|Metronidazole|metronidazole|mesh-list
6689995|NCT01658852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6689996|NCT01658852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6689997|NCT01658852|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6689998|NCT01658852|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6689999|NCT01658878|Nivolumab|nivolumab|mesh-list
6690000|NCT01658878|Ipilimumab|ipilimumab|mesh-list
6690001|NCT01658878|Sorafenib|sorafenib|mesh-list
6690002|NCT01658878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6690003|NCT01658878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6690004|NCT01658878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6690005|NCT01658878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690006|NCT01658878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6690007|NCT01658878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6690008|NCT01658891|Beclomethasone|beclomethasone|mesh-list
6690009|NCT01658891|Formoterol Fumarate|formoterol fumarate|mesh-list
6690010|NCT01658891|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6690011|NCT01658891|Autonomic Agents|autonomic agents|mesh-ancestor
6690012|NCT01658891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6690013|NCT01658891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690014|NCT01658891|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6690015|NCT01658891|Respiratory System Agents|respiratory system agents|mesh-ancestor
6690016|NCT01658891|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6690017|NCT01658891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6690018|NCT01658891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6690019|NCT01658891|Adrenergic Agents|adrenergic agents|mesh-ancestor
6690020|NCT01658891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6690021|NCT01658891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690022|NCT01658891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6690023|NCT01658891|Glucocorticoids|glucocorticoids|mesh-ancestor
6690024|NCT01658891|Hormones|hormones|mesh-ancestor
6690025|NCT01658891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6690026|NCT01659008|Estradiol|estradiol|mesh-list
6690027|NCT01659008|Estrogens|estrogens|mesh-ancestor
6690028|NCT01659008|Hormones|hormones|mesh-ancestor
6690029|NCT01659008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6690030|NCT01659008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690031|NCT01659047|Idelalisib|idelalisib|mesh-list
6690032|NCT01659047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6690033|NCT01659047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6690034|NCT01659047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690035|NCT01659086|Vaccines|vaccines|mesh-list
6690036|NCT01659086|Immunologic Factors|immunologic factors|mesh-ancestor
6690037|NCT01659086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690038|NCT01659099|Prednisone|prednisone|mesh-list
6690039|NCT01659099|Cyclophosphamide|cyclophosphamide|mesh-list
6690040|NCT01659099|Rituximab|rituximab|mesh-list
6690041|NCT01659099|Doxorubicin|doxorubicin|mesh-list
6690042|NCT01659099|Vincristine|vincristine|mesh-list
6690043|NCT01659099|Obinutuzumab|obinutuzumab|mesh-list
6690044|NCT01659099|Bleomycin|bleomycin|mesh-list
6690045|NCT01659099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6690046|NCT01659099|Immunologic Factors|immunologic factors|mesh-ancestor
6690047|NCT01659099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690048|NCT01659099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6690049|NCT01659099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6690050|NCT01659099|Alkylating Agents|alkylating agents|mesh-ancestor
6690051|NCT01659099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690052|NCT01659099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6690053|NCT01659099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6690054|NCT01659099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6690055|NCT01659099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6690056|NCT01659099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6690057|NCT01659099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6690058|NCT01659099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6690059|NCT01659099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6690060|NCT01659099|Glucocorticoids|glucocorticoids|mesh-ancestor
6690061|NCT01659099|Hormones|hormones|mesh-ancestor
6690062|NCT01659099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6690063|NCT01659099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6690064|NCT01659099|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6690065|NCT01659099|Tubulin Modulators|tubulin modulators|mesh-ancestor
6690066|NCT01659099|Antimitotic Agents|antimitotic agents|mesh-ancestor
6690067|NCT01659099|Mitosis Modulators|mitosis modulators|mesh-ancestor
6690068|NCT01659190|Calcium Carbonate|calcium carbonate|mesh-list
6690069|NCT01659190|Antacids|antacids|mesh-ancestor
6690070|NCT01659190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690071|NCT01659190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6690072|NCT01659242|Sulfasalazine|sulfasalazine|mesh-list
6690073|NCT01659242|Methotrexate|methotrexate|mesh-list
6690074|NCT01659242|Leflunomide|leflunomide|mesh-list
6690075|NCT01659242|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6690076|NCT01659242|Abortifacient Agents|abortifacient agents|mesh-ancestor
6690077|NCT01659242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6690078|NCT01659242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690079|NCT01659242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6690080|NCT01659242|Antimetabolites|antimetabolites|mesh-ancestor
6690081|NCT01659242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690082|NCT01659242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6690083|NCT01659242|Dermatologic Agents|dermatologic agents|mesh-ancestor
6690084|NCT01659242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6690085|NCT01659242|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6690086|NCT01659242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6690087|NCT01659242|Immunologic Factors|immunologic factors|mesh-ancestor
6690088|NCT01659242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6690089|NCT01659242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6690090|NCT01659242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6690091|NCT01659242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6690092|NCT01659242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6690093|NCT01659242|Analgesics|analgesics|mesh-ancestor
6690094|NCT01659242|Sensory System Agents|sensory system agents|mesh-ancestor
6690095|NCT01659242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6690096|NCT01659242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6690097|NCT01659242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6690098|NCT01659281|Artesunate|artesunate|mesh-list
6690099|NCT01659281|Mefloquine|mefloquine|mesh-list
6690100|NCT01659281|Antimalarials|antimalarials|mesh-ancestor
6690101|NCT01659281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6690102|NCT01659281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6690103|NCT01659281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6690104|NCT01659281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6690105|NCT01659281|Antiviral Agents|antiviral agents|mesh-ancestor
6690106|NCT01659281|Schistosomicides|schistosomicides|mesh-ancestor
6690107|NCT01659281|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6690108|NCT01659281|Anthelmintics|anthelmintics|mesh-ancestor
6690109|NCT01659307|Aspirin|aspirin|mesh-list
6690110|NCT01659307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6690111|NCT01659307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6690112|NCT01659307|Analgesics|analgesics|mesh-ancestor
6690113|NCT01659307|Sensory System Agents|sensory system agents|mesh-ancestor
6690114|NCT01659307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6690115|NCT01659307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690116|NCT01659307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6690117|NCT01659307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6690118|NCT01659307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6690119|NCT01659307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6690120|NCT01659307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690121|NCT01659307|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6690122|NCT01659307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6690123|NCT01659307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6690124|NCT01659307|Antipyretics|antipyretics|mesh-ancestor
6690125|NCT01659346|Carvedilol|carvedilol|mesh-list
6690126|NCT01659346|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6690127|NCT01659346|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6690128|NCT01659346|Adrenergic Agents|adrenergic agents|mesh-ancestor
6690129|NCT01659346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6690130|NCT01659346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690131|NCT01659346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690132|NCT01659346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6690133|NCT01659346|Antioxidants|antioxidants|mesh-ancestor
6690134|NCT01659346|Protective Agents|protective agents|mesh-ancestor
6690135|NCT01659346|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6690136|NCT01659346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6690137|NCT01659346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6690138|NCT01659346|Vasodilator Agents|vasodilator agents|mesh-ancestor
6690139|NCT01659346|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6690140|NCT01659346|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6690141|NCT01659359|Lidocaine|lidocaine|mesh-list
6690142|NCT01659359|Anesthetics, Local|anesthetics, local|mesh-ancestor
6690143|NCT01659359|Anesthetics|anesthetics|mesh-ancestor
6690144|NCT01659359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6690145|NCT01659359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690146|NCT01659359|Sensory System Agents|sensory system agents|mesh-ancestor
6690147|NCT01659359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6690148|NCT01659359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6690149|NCT01659359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6690150|NCT01659359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6690151|NCT01659359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6690152|NCT01659359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690153|NCT01659372|Naproxen|naproxen|mesh-list
6690154|NCT01659372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6690155|NCT01659372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6690156|NCT01659372|Analgesics|analgesics|mesh-ancestor
6690157|NCT01659372|Sensory System Agents|sensory system agents|mesh-ancestor
6690158|NCT01659372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6690159|NCT01659372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690160|NCT01659372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6690161|NCT01659372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6690162|NCT01659372|Gout Suppressants|gout suppressants|mesh-ancestor
6690163|NCT01659372|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6690164|NCT01659372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6690165|NCT01659372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690166|NCT01659437|Clarithromycin|clarithromycin|mesh-list
6690167|NCT01659437|Streptomycin|streptomycin|mesh-list
6690168|NCT01659437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6690169|NCT01659437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6690170|NCT01659437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6690171|NCT01659437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6690172|NCT01659437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690173|NCT01659437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6690174|NCT01659437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6690175|NCT01659476|Methacholine Chloride|methacholine chloride|mesh-list
6690176|NCT01659476|Miotics|miotics|mesh-ancestor
6690177|NCT01659476|Autonomic Agents|autonomic agents|mesh-ancestor
6690178|NCT01659476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6690179|NCT01659476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690180|NCT01659476|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6690181|NCT01659476|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
6690182|NCT01659476|Respiratory System Agents|respiratory system agents|mesh-ancestor
6690183|NCT01659476|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6690184|NCT01659476|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6690185|NCT01659476|Cholinergic Agents|cholinergic agents|mesh-ancestor
6690186|NCT01659476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6690187|NCT01659476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690188|NCT01659515|Arbekacin|arbekacin|mesh-list
6690189|NCT01659515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6780576|NCT02183090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6780577|NCT02183090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780578|NCT02183090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780579|NCT02183103|Meloxicam|meloxicam|mesh-list
6780580|NCT02183103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6780581|NCT02183103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6780582|NCT02183103|Analgesics|analgesics|mesh-ancestor
6780583|NCT02183103|Sensory System Agents|sensory system agents|mesh-ancestor
6780584|NCT02183103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6780585|NCT02183103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780586|NCT02183103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6780587|NCT02183103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6780588|NCT02183103|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6780589|NCT02183103|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6780590|NCT02183103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780591|NCT02183103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780592|NCT02183116|Meloxicam|meloxicam|mesh-list
6780593|NCT02183116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6780594|NCT02183116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6780595|NCT02183116|Analgesics|analgesics|mesh-ancestor
6780596|NCT02183116|Sensory System Agents|sensory system agents|mesh-ancestor
6780597|NCT02183116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6780598|NCT02183116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780599|NCT02183116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6780600|NCT02183116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6780601|NCT02183116|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6780602|NCT02183116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6780603|NCT02183116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780604|NCT02183116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780605|NCT02183129|Diclofenac|diclofenac|mesh-list
6780606|NCT02183129|Meloxicam|meloxicam|mesh-list
6780607|NCT02183129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6780608|NCT02183129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6780609|NCT02183129|Analgesics|analgesics|mesh-ancestor
6780610|NCT02183129|Sensory System Agents|sensory system agents|mesh-ancestor
6780611|NCT02183129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6780612|NCT02183129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780613|NCT02183129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6780614|NCT02183129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6780615|NCT02183129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6780616|NCT02183129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780617|NCT02183129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780618|NCT02183129|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6780619|NCT02183142|Meloxicam|meloxicam|mesh-list
6780620|NCT02183142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6780621|NCT02183142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6780622|NCT02183142|Analgesics|analgesics|mesh-ancestor
6780623|NCT02183142|Sensory System Agents|sensory system agents|mesh-ancestor
6780624|NCT02183142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6780625|NCT02183142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780626|NCT02183142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6780627|NCT02183142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6780628|NCT02183142|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6780629|NCT02183142|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6780630|NCT02183142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780631|NCT02183142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780632|NCT02183155|Indomethacin|indomethacin|mesh-list
6780633|NCT02183155|Meloxicam|meloxicam|mesh-list
6780634|NCT02183155|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6780635|NCT02183155|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6780636|NCT02183155|Analgesics|analgesics|mesh-ancestor
6780637|NCT02183155|Sensory System Agents|sensory system agents|mesh-ancestor
6780638|NCT02183155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6780639|NCT02183155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780640|NCT02183155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6690190|NCT01659619|Erythromycin|erythromycin|mesh-list
6690191|NCT01659619|Erythromycin Estolate|erythromycin estolate|mesh-list
6690192|NCT01659619|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
6690193|NCT01659619|Erythromycin stearate|erythromycin stearate|mesh-list
6690194|NCT01659619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6690195|NCT01659619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6690196|NCT01659619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6690197|NCT01659619|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6690198|NCT01659619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6690199|NCT01659619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690200|NCT01659658|Thalidomide|thalidomide|mesh-list
6690201|NCT01659658|Dexamethasone|dexamethasone|mesh-list
6690202|NCT01659658|Cyclophosphamide|cyclophosphamide|mesh-list
6690203|NCT01659658|Melphalan|melphalan|mesh-list
6690204|NCT01659658|Lenalidomide|lenalidomide|mesh-list
6690205|NCT01659658|Ixazomib|ixazomib|mesh-list
6690206|NCT01659658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6690207|NCT01659658|Immunologic Factors|immunologic factors|mesh-ancestor
6690208|NCT01659658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690209|NCT01659658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6690210|NCT01659658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6690211|NCT01659658|Alkylating Agents|alkylating agents|mesh-ancestor
6690212|NCT01659658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690213|NCT01659658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6690214|NCT01659658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6690215|NCT01659658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6690216|NCT01659658|Antiemetics|antiemetics|mesh-ancestor
6690217|NCT01659658|Autonomic Agents|autonomic agents|mesh-ancestor
6690218|NCT01659658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6690219|NCT01659658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6690220|NCT01659658|Glucocorticoids|glucocorticoids|mesh-ancestor
6690221|NCT01659658|Hormones|hormones|mesh-ancestor
6690222|NCT01659658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6690223|NCT01659658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6690224|NCT01659658|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6690225|NCT01659658|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6690226|NCT01659658|Growth Substances|growth substances|mesh-ancestor
6690227|NCT01659658|Growth Inhibitors|growth inhibitors|mesh-ancestor
6690228|NCT01659658|Leprostatic Agents|leprostatic agents|mesh-ancestor
6690229|NCT01659658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6690230|NCT01659658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6690231|NCT01659658|Protease Inhibitors|protease inhibitors|mesh-ancestor
6690232|NCT01659658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6690233|NCT01659684|Immunoglobulins|immunoglobulins|mesh-list
6690234|NCT01659684|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6690235|NCT01659684|Antibodies|antibodies|mesh-list
6690236|NCT01659684|gamma-Globulins|gamma-globulins|mesh-list
6690237|NCT01659684|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6690238|NCT01659684|Immunologic Factors|immunologic factors|mesh-ancestor
6690239|NCT01659684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690240|NCT01659775|Ondansetron|ondansetron|mesh-list
6690241|NCT01659775|Antiemetics|antiemetics|mesh-ancestor
6690242|NCT01659775|Autonomic Agents|autonomic agents|mesh-ancestor
6690243|NCT01659775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6690244|NCT01659775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690245|NCT01659775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6690246|NCT01659775|Antipruritics|antipruritics|mesh-ancestor
6690247|NCT01659775|Dermatologic Agents|dermatologic agents|mesh-ancestor
6690248|NCT01659775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6690249|NCT01659775|Serotonin Agents|serotonin agents|mesh-ancestor
6690250|NCT01659775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6690251|NCT01659775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690252|NCT01659775|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6690253|NCT01659775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6690254|NCT01659775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6690255|NCT01659775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6690256|NCT01659775|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6690257|NCT01659788|Ubiquinone|ubiquinone|mesh-list
6690258|NCT01659788|Coenzyme Q10|coenzyme q10|mesh-list
6690259|NCT01659788|Micronutrients|micronutrients|mesh-ancestor
6690260|NCT01659788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690261|NCT01659788|Vitamins|vitamins|mesh-ancestor
6690262|NCT01659827|Bupivacaine|bupivacaine|mesh-list
6690263|NCT01659827|Anesthetics, Local|anesthetics, local|mesh-ancestor
6690264|NCT01659827|Anesthetics|anesthetics|mesh-ancestor
6690265|NCT01659827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6690266|NCT01659827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690267|NCT01659827|Sensory System Agents|sensory system agents|mesh-ancestor
6690268|NCT01659827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6690269|NCT01659892|Montelukast|montelukast|mesh-list
6690270|NCT01659892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6690271|NCT01659892|Respiratory System Agents|respiratory system agents|mesh-ancestor
6690272|NCT01659892|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6690273|NCT01659892|Hormone Antagonists|hormone antagonists|mesh-ancestor
6690274|NCT01659892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6690275|NCT01659892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690276|NCT01659892|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6690277|NCT01659892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6690278|NCT01659892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690279|NCT01659905|Montelukast|montelukast|mesh-list
6690280|NCT01659905|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6690281|NCT01659905|Respiratory System Agents|respiratory system agents|mesh-ancestor
6690282|NCT01659905|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6690283|NCT01659905|Hormone Antagonists|hormone antagonists|mesh-ancestor
6690284|NCT01659905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6690285|NCT01659905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690286|NCT01659905|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6690287|NCT01659905|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6690288|NCT01659905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690289|NCT01659918|Montelukast|montelukast|mesh-list
6690290|NCT01659918|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6690291|NCT01659918|Respiratory System Agents|respiratory system agents|mesh-ancestor
6690292|NCT01659918|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6690293|NCT01659918|Hormone Antagonists|hormone antagonists|mesh-ancestor
6690294|NCT01659918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6690295|NCT01659918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690296|NCT01659918|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6690297|NCT01659918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6690298|NCT01659918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690299|NCT01659931|Montelukast|montelukast|mesh-list
6690300|NCT01659931|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6690301|NCT01659931|Respiratory System Agents|respiratory system agents|mesh-ancestor
6690302|NCT01659931|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6690303|NCT01659931|Hormone Antagonists|hormone antagonists|mesh-ancestor
6690304|NCT01659931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6690305|NCT01659931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690306|NCT01659931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6690307|NCT01659931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6690308|NCT01659931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690309|NCT01659944|Metoprolol|metoprolol|mesh-list
6690310|NCT01659944|Eliglustat|eliglustat|mesh-list
6690311|NCT01659944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6690312|NCT01659944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6690313|NCT01659944|Sympatholytics|sympatholytics|mesh-ancestor
6690314|NCT01659944|Autonomic Agents|autonomic agents|mesh-ancestor
6690315|NCT01659944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6690316|NCT01659944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690317|NCT01659944|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6690318|NCT01659944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6690319|NCT01659944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6690320|NCT01659944|Adrenergic Agents|adrenergic agents|mesh-ancestor
6690321|NCT01659944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6690322|NCT01659944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690323|NCT01659944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6690324|NCT01660295|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6690325|NCT01660295|Dihydroergotamine|dihydroergotamine|mesh-list
6690326|NCT01660295|Certoparin|certoparin|mesh-list
6690327|NCT01660295|Anticoagulants|anticoagulants|mesh-ancestor
6690328|NCT01660295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6690329|NCT01660295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6690330|NCT01660295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690331|NCT01660295|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6690332|NCT01660295|Dopamine Agonists|dopamine agonists|mesh-ancestor
6690333|NCT01660295|Dopamine Agents|dopamine agents|mesh-ancestor
6690334|NCT01660295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6690335|NCT01660295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690336|NCT01660295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6690337|NCT01660295|Analgesics|analgesics|mesh-ancestor
6690338|NCT01660295|Sensory System Agents|sensory system agents|mesh-ancestor
6690339|NCT01660295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6690340|NCT01660373|Tirofiban|tirofiban|mesh-list
6690341|NCT01660373|Ticagrelor|ticagrelor|mesh-list
6690342|NCT01660373|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6690343|NCT01660373|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6690344|NCT01660373|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6690345|NCT01660373|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6690346|NCT01660373|Purinergic Agents|purinergic agents|mesh-ancestor
6690347|NCT01660373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6690348|NCT01660373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690349|NCT01660373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690350|NCT01660373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6690351|NCT01660373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6690352|NCT01660386|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6690353|NCT01660386|Glimepiride|glimepiride|mesh-list
6690354|NCT01660386|Saxagliptin|saxagliptin|mesh-list
6690355|NCT01660386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6690356|NCT01660386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690357|NCT01660386|Incretins|incretins|mesh-ancestor
6690358|NCT01660386|Hormones|hormones|mesh-ancestor
6690359|NCT01660386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6690360|NCT01660386|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6690361|NCT01660386|Protease Inhibitors|protease inhibitors|mesh-ancestor
6690362|NCT01660386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6690363|NCT01660386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690364|NCT01660386|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6690365|NCT01660386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6690366|NCT01660386|Immunologic Factors|immunologic factors|mesh-ancestor
6690367|NCT01660399|Docetaxel|docetaxel|mesh-list
6690368|NCT01660399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6690369|NCT01660399|Tubulin Modulators|tubulin modulators|mesh-ancestor
6690370|NCT01660399|Antimitotic Agents|antimitotic agents|mesh-ancestor
6690371|NCT01660399|Mitosis Modulators|mitosis modulators|mesh-ancestor
6690372|NCT01660399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690373|NCT01660477|Ritonavir|ritonavir|mesh-list
6690374|NCT01660477|Lopinavir|lopinavir|mesh-list
6690375|NCT01660477|Isavuconazole|isavuconazole|mesh-list
6690376|NCT01660477|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6690377|NCT01660477|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6690378|NCT01660477|Protease Inhibitors|protease inhibitors|mesh-ancestor
6690379|NCT01660477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6690380|NCT01660477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690381|NCT01660477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6690382|NCT01660477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6690383|NCT01660477|Antiviral Agents|antiviral agents|mesh-ancestor
6690384|NCT01660477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6690385|NCT01660477|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6690386|NCT01660477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6690387|NCT01660477|Antifungal Agents|antifungal agents|mesh-ancestor
6690388|NCT01660542|Docetaxel|docetaxel|mesh-list
6690389|NCT01660542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6690390|NCT01660542|Tubulin Modulators|tubulin modulators|mesh-ancestor
6690391|NCT01660542|Antimitotic Agents|antimitotic agents|mesh-ancestor
6690392|NCT01660542|Mitosis Modulators|mitosis modulators|mesh-ancestor
6690393|NCT01660542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690394|NCT01660594|Calcium|calcium|mesh-list
6690395|NCT01660594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6690396|NCT01660594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690397|NCT01660620|Betaxolol|betaxolol|mesh-list
6690398|NCT01660620|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6690399|NCT01660620|Sympatholytics|sympatholytics|mesh-ancestor
6690400|NCT01660620|Autonomic Agents|autonomic agents|mesh-ancestor
6690401|NCT01660620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6690402|NCT01660620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690403|NCT01660620|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6690404|NCT01660620|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6690405|NCT01660620|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6690406|NCT01660620|Adrenergic Agents|adrenergic agents|mesh-ancestor
6690407|NCT01660620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6690408|NCT01660620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690409|NCT01660750|Dexamethasone|dexamethasone|mesh-list
6690410|NCT01660750|Cyclophosphamide|cyclophosphamide|mesh-list
6690411|NCT01660750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6690412|NCT01660750|Immunologic Factors|immunologic factors|mesh-ancestor
6690413|NCT01660750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690414|NCT01660750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6690415|NCT01660750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6690416|NCT01660750|Alkylating Agents|alkylating agents|mesh-ancestor
6690417|NCT01660750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690418|NCT01660750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6690419|NCT01660750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6690420|NCT01660750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6690421|NCT01660750|Antiemetics|antiemetics|mesh-ancestor
6690422|NCT01660750|Autonomic Agents|autonomic agents|mesh-ancestor
6690423|NCT01660750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6690424|NCT01660750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6690425|NCT01660750|Glucocorticoids|glucocorticoids|mesh-ancestor
6690426|NCT01660750|Hormones|hormones|mesh-ancestor
6690427|NCT01660750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6690428|NCT01660750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6690429|NCT01660854|Proguanil|proguanil|mesh-list
6690430|NCT01660854|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
6690431|NCT01660854|Antimalarials|antimalarials|mesh-ancestor
6690432|NCT01660854|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6690433|NCT01660854|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6690434|NCT01660854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6690435|NCT01660854|Antimetabolites|antimetabolites|mesh-ancestor
6690436|NCT01660854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690437|NCT01660867|Dexamethasone|dexamethasone|mesh-list
6690438|NCT01660867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6690439|NCT01660867|Antiemetics|antiemetics|mesh-ancestor
6690440|NCT01660867|Autonomic Agents|autonomic agents|mesh-ancestor
6690441|NCT01660867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6690442|NCT01660867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690443|NCT01660867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6690444|NCT01660867|Glucocorticoids|glucocorticoids|mesh-ancestor
6690445|NCT01660867|Hormones|hormones|mesh-ancestor
6690446|NCT01660867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6690447|NCT01660867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6690448|NCT01660867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6690449|NCT01660919|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6690450|NCT01660919|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6690451|NCT01660919|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6690452|NCT01660919|Antimetabolites|antimetabolites|mesh-ancestor
6690453|NCT01660919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690454|NCT01660919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6690455|NCT01660919|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6690456|NCT01660919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6690457|NCT01660945|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
6690458|NCT01660945|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6690459|NCT01660945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6690460|NCT01660945|Antimetabolites|antimetabolites|mesh-ancestor
6690461|NCT01660945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690462|NCT01660945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6690463|NCT01660997|Dexamethasone|dexamethasone|mesh-list
6690464|NCT01660997|Ixazomib|ixazomib|mesh-list
6690465|NCT01660997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6690466|NCT01660997|Antiemetics|antiemetics|mesh-ancestor
6690467|NCT01660997|Autonomic Agents|autonomic agents|mesh-ancestor
6690468|NCT01660997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6690469|NCT01660997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690470|NCT01660997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6690471|NCT01660997|Glucocorticoids|glucocorticoids|mesh-ancestor
6690472|NCT01660997|Hormones|hormones|mesh-ancestor
6690473|NCT01660997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6690474|NCT01660997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6690475|NCT01660997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6690476|NCT01660997|Protease Inhibitors|protease inhibitors|mesh-ancestor
6690477|NCT01660997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6690478|NCT01660997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690479|NCT01661101|Omeprazole|omeprazole|mesh-list
6690480|NCT01661101|Dabigatran|dabigatran|mesh-list
6690481|NCT01661101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6690482|NCT01661101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6690483|NCT01661101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6690484|NCT01661101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780641|NCT02183155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6690485|NCT01661101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690486|NCT01661101|Antithrombins|antithrombins|mesh-ancestor
6690487|NCT01661101|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6690488|NCT01661101|Protease Inhibitors|protease inhibitors|mesh-ancestor
6690489|NCT01661101|Anticoagulants|anticoagulants|mesh-ancestor
6690490|NCT01661192|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
6690491|NCT01661192|Protein C Inhibitor|protein c inhibitor|mesh-list
6690492|NCT01661192|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6690493|NCT01661192|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6690494|NCT01661192|Protease Inhibitors|protease inhibitors|mesh-ancestor
6690495|NCT01661192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6690496|NCT01661192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690497|NCT01661257|Infliximab|infliximab|mesh-list
6690498|NCT01661257|Dermatologic Agents|dermatologic agents|mesh-ancestor
6690499|NCT01661257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6690500|NCT01661257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6690501|NCT01661296|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
6690502|NCT01661296|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6690503|NCT01661296|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6690504|NCT01661296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6690505|NCT01661296|Schistosomicides|schistosomicides|mesh-ancestor
6690506|NCT01661296|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6690507|NCT01661296|Anthelmintics|anthelmintics|mesh-ancestor
6690508|NCT01661309|Vitamin B 12|vitamin b 12|mesh-list
6690509|NCT01661309|Vitamins|vitamins|mesh-ancestor
6690510|NCT01661309|Micronutrients|micronutrients|mesh-ancestor
6690511|NCT01661309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690512|NCT01661309|Vitamin B Complex|vitamin b complex|mesh-ancestor
6690513|NCT01661322|Aspirin|aspirin|mesh-list
6690514|NCT01661322|Clopidogrel|clopidogrel|mesh-list
6690515|NCT01661322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6690516|NCT01661322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6690517|NCT01661322|Analgesics|analgesics|mesh-ancestor
6690518|NCT01661322|Sensory System Agents|sensory system agents|mesh-ancestor
6690519|NCT01661322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6690520|NCT01661322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690521|NCT01661322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6690522|NCT01661322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6690523|NCT01661322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6690524|NCT01661322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6690525|NCT01661322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690526|NCT01661322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6690527|NCT01661322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6690528|NCT01661322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6690529|NCT01661322|Antipyretics|antipyretics|mesh-ancestor
6690530|NCT01661322|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6690531|NCT01661322|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6690532|NCT01661322|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6690533|NCT01661322|Purinergic Agents|purinergic agents|mesh-ancestor
6690534|NCT01661322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6690535|NCT01661335|Dexamethasone|dexamethasone|mesh-list
6690536|NCT01661335|Dexamethasone acetate|dexamethasone acetate|mesh-list
6690537|NCT01661335|Ondansetron|ondansetron|mesh-list
6690538|NCT01661335|Aprepitant|aprepitant|mesh-list
6690539|NCT01661335|Fosaprepitant|fosaprepitant|mesh-list
6690540|NCT01661335|BB 1101|bb 1101|mesh-list
6690541|NCT01661335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6690542|NCT01661335|Antiemetics|antiemetics|mesh-ancestor
6690543|NCT01661335|Autonomic Agents|autonomic agents|mesh-ancestor
6690544|NCT01661335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6690545|NCT01661335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690546|NCT01661335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6690547|NCT01661335|Glucocorticoids|glucocorticoids|mesh-ancestor
6690548|NCT01661335|Hormones|hormones|mesh-ancestor
6690549|NCT01661335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6690550|NCT01661335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6690551|NCT01661335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6690552|NCT01661335|Protease Inhibitors|protease inhibitors|mesh-ancestor
6690553|NCT01661335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6690554|NCT01661335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690555|NCT01661335|Antipruritics|antipruritics|mesh-ancestor
6690556|NCT01661335|Dermatologic Agents|dermatologic agents|mesh-ancestor
6690557|NCT01661335|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6690558|NCT01661335|Serotonin Agents|serotonin agents|mesh-ancestor
6690559|NCT01661335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6690560|NCT01661335|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6690561|NCT01661335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6690562|NCT01661335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6690563|NCT01661335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6690564|NCT01661335|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6690565|NCT01661335|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6780642|NCT02183155|Gout Suppressants|gout suppressants|mesh-ancestor
6780643|NCT02183155|Tocolytic Agents|tocolytic agents|mesh-ancestor
6780644|NCT02183155|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6780645|NCT02183155|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6780646|NCT02183155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780647|NCT02183155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780648|NCT02183155|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6780649|NCT02183168|Indomethacin|indomethacin|mesh-list
6780650|NCT02183168|Meloxicam|meloxicam|mesh-list
6780651|NCT02183168|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6780652|NCT02183168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6780653|NCT02183168|Analgesics|analgesics|mesh-ancestor
6780654|NCT02183168|Sensory System Agents|sensory system agents|mesh-ancestor
6780655|NCT02183168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6780656|NCT02183168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780657|NCT02183168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6780658|NCT02183168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6780659|NCT02183168|Gout Suppressants|gout suppressants|mesh-ancestor
6780660|NCT02183168|Tocolytic Agents|tocolytic agents|mesh-ancestor
6780661|NCT02183168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6780662|NCT02183168|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6780663|NCT02183168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780664|NCT02183168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780665|NCT02183168|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6780666|NCT02183181|Meloxicam|meloxicam|mesh-list
6780667|NCT02183181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6780668|NCT02183181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6780669|NCT02183181|Analgesics|analgesics|mesh-ancestor
6780670|NCT02183181|Sensory System Agents|sensory system agents|mesh-ancestor
6780671|NCT02183181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6780672|NCT02183181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780673|NCT02183181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6780674|NCT02183181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6780675|NCT02183181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6780676|NCT02183181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6780677|NCT02183181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780678|NCT02183181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780679|NCT02183194|Paclitaxel|paclitaxel|mesh-list
6780680|NCT02183194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6780681|NCT02183194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6780682|NCT02183194|Tubulin Modulators|tubulin modulators|mesh-ancestor
6780683|NCT02183194|Antimitotic Agents|antimitotic agents|mesh-ancestor
6780684|NCT02183194|Mitosis Modulators|mitosis modulators|mesh-ancestor
6780685|NCT02183194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780686|NCT02183220|Aspirin|aspirin|mesh-list
6780687|NCT02183220|Dipyrone|dipyrone|mesh-list
6780688|NCT02183220|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6780689|NCT02183220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6780690|NCT02183220|Analgesics|analgesics|mesh-ancestor
6780691|NCT02183220|Sensory System Agents|sensory system agents|mesh-ancestor
6780692|NCT02183220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6780693|NCT02183220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780694|NCT02183220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6780695|NCT02183220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6780696|NCT02183220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6780697|NCT02183220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6780698|NCT02183220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780699|NCT02183220|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6780700|NCT02183220|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6780701|NCT02183220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780702|NCT02183220|Antipyretics|antipyretics|mesh-ancestor
6780703|NCT02183246|Porfiromycin|porfiromycin|mesh-list
6780704|NCT02183246|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6780705|NCT02183246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6780706|NCT02183272|Ketamine|ketamine|mesh-list
6780707|NCT02183272|Analgesics|analgesics|mesh-ancestor
6780708|NCT02183272|Sensory System Agents|sensory system agents|mesh-ancestor
6780709|NCT02183272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6780710|NCT02183272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780711|NCT02183272|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6690566|NCT01661400|Thalidomide|thalidomide|mesh-list
6690567|NCT01661400|Cyclophosphamide|cyclophosphamide|mesh-list
6690568|NCT01661400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6690569|NCT01661400|Immunologic Factors|immunologic factors|mesh-ancestor
6690570|NCT01661400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690571|NCT01661400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6690572|NCT01661400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6690573|NCT01661400|Alkylating Agents|alkylating agents|mesh-ancestor
6690574|NCT01661400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690575|NCT01661400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6690576|NCT01661400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6690577|NCT01661400|Leprostatic Agents|leprostatic agents|mesh-ancestor
6690578|NCT01661400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6690579|NCT01661400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6690580|NCT01661400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6690581|NCT01661400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6690582|NCT01661400|Growth Substances|growth substances|mesh-ancestor
6690583|NCT01661400|Growth Inhibitors|growth inhibitors|mesh-ancestor
6690584|NCT01661439|Heparin|heparin|mesh-list
6690585|NCT01661439|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6690586|NCT01661439|Tinzaparin|tinzaparin|mesh-list
6690587|NCT01661439|Dalteparin|dalteparin|mesh-list
6690588|NCT01661439|Anticoagulants|anticoagulants|mesh-ancestor
6690589|NCT01661439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6690590|NCT01661439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6690591|NCT01661439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690592|NCT01661530|Vitamin E|vitamin e|mesh-list
6690593|NCT01661530|Vitamins|vitamins|mesh-ancestor
6690594|NCT01661530|Micronutrients|micronutrients|mesh-ancestor
6690595|NCT01661530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690596|NCT01661530|Antioxidants|antioxidants|mesh-ancestor
6690597|NCT01661530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690598|NCT01661530|Protective Agents|protective agents|mesh-ancestor
6690599|NCT01661556|Miconazole|miconazole|mesh-list
6690600|NCT01661556|Hydroquinone|hydroquinone|mesh-list
6690601|NCT01661556|Antifungal Agents|antifungal agents|mesh-ancestor
6690602|NCT01661556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6690603|NCT01661556|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6690604|NCT01661556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6690605|NCT01661556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6690606|NCT01661556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690607|NCT01661556|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6690608|NCT01661556|Hormone Antagonists|hormone antagonists|mesh-ancestor
6690609|NCT01661556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6690610|NCT01661556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690611|NCT01661556|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6690612|NCT01661556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6690613|NCT01661556|Antioxidants|antioxidants|mesh-ancestor
6690614|NCT01661556|Protective Agents|protective agents|mesh-ancestor
6690615|NCT01661556|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6690616|NCT01661647|Anesthetics|anesthetics|mesh-list
6690617|NCT01661647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6690618|NCT01661647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690619|NCT01661751|Vaccines|vaccines|mesh-list
6690620|NCT01661751|Immunologic Factors|immunologic factors|mesh-ancestor
6690621|NCT01661751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690622|NCT01661777|Diuretics|diuretics|mesh-list
6690623|NCT01661777|Histamine Antagonists|histamine antagonists|mesh-list
6690624|NCT01661777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
6690625|NCT01661777|Natriuretic Agents|natriuretic agents|mesh-ancestor
6690626|NCT01661777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690627|NCT01661777|Histamine Agents|histamine agents|mesh-ancestor
6690628|NCT01661777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6690629|NCT01661777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690630|NCT01661855|Riluzole|riluzole|mesh-list
6690631|NCT01661855|Anticonvulsants|anticonvulsants|mesh-ancestor
6690632|NCT01661855|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6690633|NCT01661855|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6690634|NCT01661855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6690635|NCT01661855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690636|NCT01661855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690637|NCT01661855|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6690638|NCT01661855|Protective Agents|protective agents|mesh-ancestor
6690639|NCT01661868|Olaparib|olaparib|mesh-list
6780712|NCT02183272|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6690640|NCT01661868|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6690641|NCT01661868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6690642|NCT01661868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690643|NCT01661868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6690644|NCT01661985|Azithromycin|azithromycin|mesh-list
6690645|NCT01661985|Doxycycline|doxycycline|mesh-list
6690646|NCT01661985|Lymecycline|lymecycline|mesh-list
6690647|NCT01661985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6690648|NCT01661985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6690649|NCT01661985|Antimalarials|antimalarials|mesh-ancestor
6690650|NCT01661985|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6690651|NCT01661985|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6690652|NCT01662037|Bosentan|bosentan|mesh-list
6690653|NCT01662037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6690654|NCT01662037|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6690655|NCT01662037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690656|NCT01662050|Cytarabine|cytarabine|mesh-list
6690657|NCT01662050|Rituximab|rituximab|mesh-list
6690658|NCT01662050|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6690659|NCT01662050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6690660|NCT01662050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6690661|NCT01662050|Immunologic Factors|immunologic factors|mesh-ancestor
6690662|NCT01662050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690663|NCT01662050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6690664|NCT01662050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6690665|NCT01662050|Antimetabolites|antimetabolites|mesh-ancestor
6690666|NCT01662050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690667|NCT01662050|Antiviral Agents|antiviral agents|mesh-ancestor
6690668|NCT01662050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6690669|NCT01662050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6690670|NCT01662050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6690671|NCT01662050|Alkylating Agents|alkylating agents|mesh-ancestor
6690672|NCT01662089|Zinc|zinc|mesh-list
6690673|NCT01662089|Trace Elements|trace elements|mesh-ancestor
6690674|NCT01662089|Micronutrients|micronutrients|mesh-ancestor
6690675|NCT01662089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690676|NCT01662128|Capecitabine|capecitabine|mesh-list
6690677|NCT01662128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6690678|NCT01662128|Antimetabolites|antimetabolites|mesh-ancestor
6690679|NCT01662128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690680|NCT01662128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6690681|NCT01662180|Hormones|hormones|mesh-list
6690682|NCT01662180|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6690683|NCT01662180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6690684|NCT01662180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690685|NCT01662193|Calcium, Dietary|calcium, dietary|mesh-list
6690686|NCT01662193|Vitamin D|vitamin d|mesh-list
6690687|NCT01662193|Ergocalciferols|ergocalciferols|mesh-list
6690688|NCT01662193|Cholecalciferol|cholecalciferol|mesh-list
6690689|NCT01662193|Vitamins|vitamins|mesh-list
6690690|NCT01662193|Calcium Carbonate|calcium carbonate|mesh-list
6690691|NCT01662193|Calcium|calcium|mesh-list
6690692|NCT01662193|Micronutrients|micronutrients|mesh-ancestor
6690693|NCT01662193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690694|NCT01662193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6690695|NCT01662193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6690696|NCT01662193|Antacids|antacids|mesh-ancestor
6690697|NCT01662193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690698|NCT01662193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6690699|NCT01662349|Anti-Infective Agents|anti-infective agents|mesh-list
6690700|NCT01662349|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6690701|NCT01662401|Bupivacaine|bupivacaine|mesh-list
6690702|NCT01662401|Anesthetics, Local|anesthetics, local|mesh-ancestor
6690703|NCT01662401|Anesthetics|anesthetics|mesh-ancestor
6690704|NCT01662401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6690705|NCT01662401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690706|NCT01662401|Sensory System Agents|sensory system agents|mesh-ancestor
6690707|NCT01662401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6690708|NCT01662466|Methyltestosterone|methyltestosterone|mesh-list
6690709|NCT01662466|Testosterone|testosterone|mesh-list
6690710|NCT01662466|Testosterone undecanoate|testosterone undecanoate|mesh-list
6690711|NCT01662466|Testosterone enanthate|testosterone enanthate|mesh-list
6690712|NCT01662466|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6690713|NCT01662466|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
6690714|NCT01662466|Androgens|androgens|mesh-ancestor
6690715|NCT01662466|Hormones|hormones|mesh-ancestor
6780713|NCT02183272|Anesthetics, General|anesthetics, general|mesh-ancestor
6690716|NCT01662466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6690717|NCT01662466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690718|NCT01662466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6690719|NCT01662466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6690720|NCT01662466|Anabolic Agents|anabolic agents|mesh-ancestor
6690721|NCT01662466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6690722|NCT01662466|Immunologic Factors|immunologic factors|mesh-ancestor
6690723|NCT01662518|Dexamethasone|dexamethasone|mesh-list
6690724|NCT01662518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6690725|NCT01662518|Antiemetics|antiemetics|mesh-ancestor
6690726|NCT01662518|Autonomic Agents|autonomic agents|mesh-ancestor
6690727|NCT01662518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6690728|NCT01662518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690729|NCT01662518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6690730|NCT01662518|Glucocorticoids|glucocorticoids|mesh-ancestor
6690731|NCT01662518|Hormones|hormones|mesh-ancestor
6690732|NCT01662518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6690733|NCT01662518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6690734|NCT01662518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6690735|NCT01662622|Sevoflurane|sevoflurane|mesh-list
6690736|NCT01662622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6690737|NCT01662622|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6690738|NCT01662622|Anesthetics, General|anesthetics, general|mesh-ancestor
6690739|NCT01662622|Anesthetics|anesthetics|mesh-ancestor
6690740|NCT01662622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6690741|NCT01662622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690742|NCT01662674|Metformin|metformin|mesh-list
6690743|NCT01662674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6690744|NCT01662674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690745|NCT01662687|Granisetron|granisetron|mesh-list
6690746|NCT01662687|Antiemetics|antiemetics|mesh-ancestor
6690747|NCT01662687|Autonomic Agents|autonomic agents|mesh-ancestor
6690748|NCT01662687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6690749|NCT01662687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690750|NCT01662687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6690751|NCT01662687|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6690752|NCT01662687|Serotonin Agents|serotonin agents|mesh-ancestor
6690753|NCT01662687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6690754|NCT01662687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690755|NCT01662700|Artesunate|artesunate|mesh-list
6690756|NCT01662700|Chloroquine|chloroquine|mesh-list
6690757|NCT01662700|Antimalarials|antimalarials|mesh-ancestor
6690758|NCT01662700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6690759|NCT01662700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6690760|NCT01662700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6690761|NCT01662700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6690762|NCT01662700|Antiviral Agents|antiviral agents|mesh-ancestor
6690763|NCT01662700|Schistosomicides|schistosomicides|mesh-ancestor
6690764|NCT01662700|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6690765|NCT01662700|Anthelmintics|anthelmintics|mesh-ancestor
6690766|NCT01662700|Amebicides|amebicides|mesh-ancestor
6690767|NCT01662700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6690768|NCT01662804|Interleukin-2|interleukin-2|mesh-list
6690769|NCT01662804|Antibodies|antibodies|mesh-list
6690770|NCT01662804|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6690771|NCT01662804|Immunologic Factors|immunologic factors|mesh-ancestor
6690772|NCT01662804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690773|NCT01662804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6690774|NCT01662804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6690775|NCT01662804|Analgesics|analgesics|mesh-ancestor
6690776|NCT01662804|Sensory System Agents|sensory system agents|mesh-ancestor
6690777|NCT01662804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6690778|NCT01662869|Leucovorin|leucovorin|mesh-list
6690779|NCT01662869|Folic Acid|folic acid|mesh-list
6690780|NCT01662869|Oxaliplatin|oxaliplatin|mesh-list
6690781|NCT01662869|Fluorouracil|fluorouracil|mesh-list
6690782|NCT01662869|Levoleucovorin|levoleucovorin|mesh-list
6690783|NCT01662869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6690784|NCT01662869|Antidotes|antidotes|mesh-ancestor
6690785|NCT01662869|Protective Agents|protective agents|mesh-ancestor
6690786|NCT01662869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690787|NCT01662869|Vitamin B Complex|vitamin b complex|mesh-ancestor
6690788|NCT01662869|Vitamins|vitamins|mesh-ancestor
6690789|NCT01662869|Micronutrients|micronutrients|mesh-ancestor
6690790|NCT01662869|Hematinics|hematinics|mesh-ancestor
6690791|NCT01662869|Antimetabolites|antimetabolites|mesh-ancestor
6690792|NCT01662869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690793|NCT01662869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6780714|NCT02183272|Anesthetics|anesthetics|mesh-ancestor
6690794|NCT01662869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6690795|NCT01662869|Immunologic Factors|immunologic factors|mesh-ancestor
6690796|NCT01662921|Insulin|insulin|mesh-list
6690797|NCT01662921|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6690798|NCT01662921|Insulin Lispro|insulin lispro|mesh-list
6690799|NCT01662921|Insulin glulisine|insulin glulisine|mesh-list
6690800|NCT01662921|Isophane Insulin, Human|isophane insulin, human|mesh-list
6690801|NCT01662921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6690802|NCT01662921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690803|NCT01663038|Aspirin|aspirin|mesh-list
6690804|NCT01663038|Clopidogrel|clopidogrel|mesh-list
6690805|NCT01663038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6690806|NCT01663038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6690807|NCT01663038|Analgesics|analgesics|mesh-ancestor
6690808|NCT01663038|Sensory System Agents|sensory system agents|mesh-ancestor
6690809|NCT01663038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6690810|NCT01663038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690811|NCT01663038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6690812|NCT01663038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6690813|NCT01663038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6690814|NCT01663038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6690815|NCT01663038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690816|NCT01663038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6690817|NCT01663038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6690818|NCT01663038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6690819|NCT01663038|Antipyretics|antipyretics|mesh-ancestor
6690820|NCT01663038|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6690821|NCT01663038|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6690822|NCT01663038|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6690823|NCT01663038|Purinergic Agents|purinergic agents|mesh-ancestor
6690824|NCT01663038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6690825|NCT01663077|Clozapine|clozapine|mesh-list
6690826|NCT01663077|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6690827|NCT01663077|Serotonin Agents|serotonin agents|mesh-ancestor
6690828|NCT01663077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6690829|NCT01663077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690830|NCT01663077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690831|NCT01663077|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6690832|NCT01663077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6690833|NCT01663077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6690834|NCT01663077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6690835|NCT01663077|GABA Antagonists|gaba antagonists|mesh-ancestor
6690836|NCT01663077|GABA Agents|gaba agents|mesh-ancestor
6690837|NCT01663090|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
6690838|NCT01663090|Hematinics|hematinics|mesh-ancestor
6690839|NCT01663090|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6690840|NCT01663090|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6690841|NCT01663168|Rifabutin|rifabutin|mesh-list
6690842|NCT01663168|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6690843|NCT01663168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6690844|NCT01663168|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6690845|NCT01663168|Antitubercular Agents|antitubercular agents|mesh-ancestor
6780715|NCT02183272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6780716|NCT02183272|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6780717|NCT02183272|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6780718|NCT02183272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6780719|NCT02183272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780720|NCT02183298|Linagliptin|linagliptin|mesh-list
6780721|NCT02183298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6780722|NCT02183298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780723|NCT02183298|Incretins|incretins|mesh-ancestor
6780724|NCT02183298|Hormones|hormones|mesh-ancestor
6780725|NCT02183298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6780726|NCT02183298|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6780727|NCT02183298|Protease Inhibitors|protease inhibitors|mesh-ancestor
6780728|NCT02183298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780729|NCT02183298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780730|NCT02183311|Linagliptin|linagliptin|mesh-list
6780731|NCT02183311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6780732|NCT02183311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780733|NCT02183311|Incretins|incretins|mesh-ancestor
6780734|NCT02183311|Hormones|hormones|mesh-ancestor
6780735|NCT02183311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6780736|NCT02183311|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6690846|NCT01663441|Oprelvekin|oprelvekin|mesh-list
6690847|NCT01663441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6690848|NCT01663558|Imiquimod|imiquimod|mesh-list
6690849|NCT01663558|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6690850|NCT01663558|Immunologic Factors|immunologic factors|mesh-ancestor
6690851|NCT01663558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690852|NCT01663558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6690853|NCT01663558|Interferon Inducers|interferon inducers|mesh-ancestor
6690854|NCT01663662|Tolvaptan|tolvaptan|mesh-list
6690855|NCT01663662|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6690856|NCT01663662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690857|NCT01663662|Natriuretic Agents|natriuretic agents|mesh-ancestor
6690858|NCT01663662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690859|NCT01663753|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6690860|NCT01663753|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6690861|NCT01663753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690862|NCT01663805|Everolimus|everolimus|mesh-list
6690863|NCT01663805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6690864|NCT01663805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6690865|NCT01663805|Immunologic Factors|immunologic factors|mesh-ancestor
6690866|NCT01663805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690867|NCT01663961|Digoxin|digoxin|mesh-list
6690868|NCT01663961|Mirabegron|mirabegron|mesh-list
6690869|NCT01663961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6690870|NCT01663961|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6690871|NCT01663961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6690872|NCT01663961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690873|NCT01663961|Protective Agents|protective agents|mesh-ancestor
6690874|NCT01663961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690875|NCT01663961|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6690876|NCT01663961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6690877|NCT01663961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6690878|NCT01663961|Adrenergic Agents|adrenergic agents|mesh-ancestor
6690879|NCT01663961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6690880|NCT01663961|Urological Agents|urological agents|mesh-ancestor
6690881|NCT01664013|Botulinum Toxins|botulinum toxins|mesh-list
6690882|NCT01664013|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6690883|NCT01664013|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6690884|NCT01664013|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6690885|NCT01664013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6690886|NCT01664013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690887|NCT01664013|Cholinergic Agents|cholinergic agents|mesh-ancestor
6690888|NCT01664013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6690889|NCT01664013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690890|NCT01664013|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6690891|NCT01664013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6690892|NCT01664065|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
6690893|NCT01664065|Cephalosporins|cephalosporins|mesh-list
6690894|NCT01664065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6690895|NCT01664065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6690896|NCT01664182|Bevacizumab|bevacizumab|mesh-list
6690897|NCT01664182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6690898|NCT01664182|Sunitinib|sunitinib|mesh-list
6690899|NCT01664182|Trebananib|trebananib|mesh-list
6690900|NCT01664182|Sorafenib|sorafenib|mesh-list
6690901|NCT01664182|Endothelial Growth Factors|endothelial growth factors|mesh-list
6690902|NCT01664182|Antibodies|antibodies|mesh-list
6690903|NCT01664182|Immunoglobulins|immunoglobulins|mesh-list
6690904|NCT01664182|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6690905|NCT01664182|Immunoglobulin G|immunoglobulin g|mesh-list
6690906|NCT01664182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6690907|NCT01664182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6690908|NCT01664182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6690909|NCT01664182|Growth Substances|growth substances|mesh-ancestor
6690910|NCT01664182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690911|NCT01664182|Growth Inhibitors|growth inhibitors|mesh-ancestor
6690912|NCT01664182|Immunologic Factors|immunologic factors|mesh-ancestor
6690913|NCT01664182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6690914|NCT01664182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6690915|NCT01664182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690916|NCT01664195|Epoetin Alfa|epoetin alfa|mesh-list
6690917|NCT01664195|Hematinics|hematinics|mesh-ancestor
6690918|NCT01664221|Epoetin Alfa|epoetin alfa|mesh-list
6690919|NCT01664221|Hematinics|hematinics|mesh-ancestor
6690920|NCT01664260|Acetylcysteine|acetylcysteine|mesh-list
6690921|NCT01664260|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6690922|NCT01664260|Antiviral Agents|antiviral agents|mesh-ancestor
6690923|NCT01664260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6690924|NCT01664260|Expectorants|expectorants|mesh-ancestor
6690925|NCT01664260|Respiratory System Agents|respiratory system agents|mesh-ancestor
6690926|NCT01664260|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6690927|NCT01664260|Antioxidants|antioxidants|mesh-ancestor
6690928|NCT01664260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690929|NCT01664260|Protective Agents|protective agents|mesh-ancestor
6690930|NCT01664260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690931|NCT01664260|Antidotes|antidotes|mesh-ancestor
6690932|NCT01664507|Epinephrine|epinephrine|mesh-list
6690933|NCT01664507|Racepinephrine|racepinephrine|mesh-list
6690934|NCT01664507|Epinephryl borate|epinephryl borate|mesh-list
6690935|NCT01664507|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6690936|NCT01664507|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6690937|NCT01664507|Adrenergic Agents|adrenergic agents|mesh-ancestor
6690938|NCT01664507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6690939|NCT01664507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690940|NCT01664507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690941|NCT01664507|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6690942|NCT01664507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6690943|NCT01664507|Autonomic Agents|autonomic agents|mesh-ancestor
6690944|NCT01664507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6690945|NCT01664507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6690946|NCT01664507|Respiratory System Agents|respiratory system agents|mesh-ancestor
6690947|NCT01664507|Mydriatics|mydriatics|mesh-ancestor
6690948|NCT01664507|Sympathomimetics|sympathomimetics|mesh-ancestor
6690949|NCT01664507|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6690950|NCT01664520|Dexmedetomidine|dexmedetomidine|mesh-list
6690951|NCT01664520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6690952|NCT01664520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6690953|NCT01664520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690954|NCT01664520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6690955|NCT01664520|Analgesics|analgesics|mesh-ancestor
6690956|NCT01664520|Sensory System Agents|sensory system agents|mesh-ancestor
6690957|NCT01664520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6690958|NCT01664520|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6690959|NCT01664520|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6690960|NCT01664520|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6690961|NCT01664520|Adrenergic Agents|adrenergic agents|mesh-ancestor
6690962|NCT01664520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6690963|NCT01664520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690964|NCT01664650|Genistein|genistein|mesh-list
6690965|NCT01664650|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6690966|NCT01664650|Protective Agents|protective agents|mesh-ancestor
6690967|NCT01664650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690968|NCT01664650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6690969|NCT01664650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6690970|NCT01664650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6690971|NCT01664650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690972|NCT01664650|Phytoestrogens|phytoestrogens|mesh-ancestor
6690973|NCT01664650|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6690974|NCT01664650|Estrogens|estrogens|mesh-ancestor
6690975|NCT01664650|Hormones|hormones|mesh-ancestor
6690976|NCT01664650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6690977|NCT01664676|Liraglutide|liraglutide|mesh-list
6690978|NCT01664676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6690979|NCT01664676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690980|NCT01664676|Incretins|incretins|mesh-ancestor
6690981|NCT01664676|Hormones|hormones|mesh-ancestor
6690982|NCT01664676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6690983|NCT01664728|Abiraterone Acetate|abiraterone acetate|mesh-list
6690984|NCT01664728|Glucocorticoids|glucocorticoids|mesh-list
6690985|NCT01664728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6690986|NCT01664728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6690987|NCT01664728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6690988|NCT01664728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6690989|NCT01664728|Hormone Antagonists|hormone antagonists|mesh-ancestor
6690990|NCT01664728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6690991|NCT01664728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6690992|NCT01664728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6690993|NCT01664728|Hormones|hormones|mesh-ancestor
6690994|NCT01664754|Carboplatin|carboplatin|mesh-list
6690995|NCT01664754|Pemetrexed|pemetrexed|mesh-list
6690996|NCT01664754|Exemestane|exemestane|mesh-list
6690997|NCT01664754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6690998|NCT01664754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6690999|NCT01664754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691000|NCT01664754|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6691001|NCT01664754|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6691002|NCT01664754|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6691003|NCT01664754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6691004|NCT01664754|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6691005|NCT01664754|Hormone Antagonists|hormone antagonists|mesh-ancestor
6691006|NCT01664754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6691007|NCT01664754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691008|NCT01664819|Antioxidants|antioxidants|mesh-list
6691009|NCT01664819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691010|NCT01664819|Protective Agents|protective agents|mesh-ancestor
6691011|NCT01664819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691012|NCT01664845|Metformin|metformin|mesh-list
6691013|NCT01664845|Ribavirin|ribavirin|mesh-list
6691014|NCT01664845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6691015|NCT01664845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691016|NCT01664845|Antimetabolites|antimetabolites|mesh-ancestor
6691017|NCT01664845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691018|NCT01664845|Antiviral Agents|antiviral agents|mesh-ancestor
6691019|NCT01664845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6691020|NCT01664871|Fluorides|fluorides|mesh-list
6691021|NCT01664871|Cariostatic Agents|cariostatic agents|mesh-ancestor
6691022|NCT01664871|Protective Agents|protective agents|mesh-ancestor
6691023|NCT01664871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691024|NCT01664910|Rituximab|rituximab|mesh-list
6691025|NCT01664910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6691026|NCT01664910|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
6691027|NCT01664910|Methotrexate|methotrexate|mesh-list
6691028|NCT01664910|Fludarabine|fludarabine|mesh-list
6691029|NCT01664910|Fludarabine phosphate|fludarabine phosphate|mesh-list
6691030|NCT01664910|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6691031|NCT01664910|Antibodies|antibodies|mesh-list
6691032|NCT01664910|Immunoglobulins|immunoglobulins|mesh-list
6691033|NCT01664910|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6691034|NCT01664910|Tacrolimus|tacrolimus|mesh-list
6691035|NCT01664910|Thymoglobulin|thymoglobulin|mesh-list
6691036|NCT01664910|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6691037|NCT01664910|Immunologic Factors|immunologic factors|mesh-ancestor
6691038|NCT01664910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691039|NCT01664910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6691040|NCT01664910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6691041|NCT01664910|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6691042|NCT01664910|Abortifacient Agents|abortifacient agents|mesh-ancestor
6691043|NCT01664910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6691044|NCT01664910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6691045|NCT01664910|Antimetabolites|antimetabolites|mesh-ancestor
6691046|NCT01664910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691047|NCT01664910|Dermatologic Agents|dermatologic agents|mesh-ancestor
6691048|NCT01664910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6691049|NCT01664910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6691050|NCT01664910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6691051|NCT01664910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6691052|NCT01664910|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6691053|NCT01664910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6691054|NCT01664910|Alkylating Agents|alkylating agents|mesh-ancestor
6691055|NCT01664910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6691056|NCT01664936|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6691057|NCT01664936|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6691058|NCT01664936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691059|NCT01665066|Nicotine|nicotine|mesh-list
6691060|NCT01665066|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6691061|NCT01665066|Autonomic Agents|autonomic agents|mesh-ancestor
6691062|NCT01665066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6691063|NCT01665066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691064|NCT01665066|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6691065|NCT01665066|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6691066|NCT01665066|Cholinergic Agents|cholinergic agents|mesh-ancestor
6691067|NCT01665066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6691068|NCT01665066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691069|NCT01665079|Propofol|propofol|mesh-list
6691070|NCT01665079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6691071|NCT01665079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6691072|NCT01665079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691073|NCT01665079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6691074|NCT01665079|Anesthetics, General|anesthetics, general|mesh-ancestor
6691075|NCT01665079|Anesthetics|anesthetics|mesh-ancestor
6691076|NCT01665196|Deoxyglucose|deoxyglucose|mesh-list
6691077|NCT01665196|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6691078|NCT01665196|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6691079|NCT01665196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691080|NCT01665196|Antimetabolites|antimetabolites|mesh-ancestor
6691081|NCT01665196|Antiviral Agents|antiviral agents|mesh-ancestor
6691082|NCT01665196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6691083|NCT01665209|Morphine|morphine|mesh-list
6691084|NCT01665209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6691085|NCT01665209|Narcotics|narcotics|mesh-ancestor
6691086|NCT01665209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6691087|NCT01665209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691088|NCT01665209|Analgesics|analgesics|mesh-ancestor
6691089|NCT01665209|Sensory System Agents|sensory system agents|mesh-ancestor
6691090|NCT01665209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6691091|NCT01665222|Morphine|morphine|mesh-list
6691092|NCT01665222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6691093|NCT01665222|Narcotics|narcotics|mesh-ancestor
6691094|NCT01665222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6691095|NCT01665222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691096|NCT01665222|Analgesics|analgesics|mesh-ancestor
6691097|NCT01665222|Sensory System Agents|sensory system agents|mesh-ancestor
6691098|NCT01665222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6691099|NCT01665235|Aspirin|aspirin|mesh-list
6691100|NCT01665235|Amlodipine|amlodipine|mesh-list
6691101|NCT01665235|Clopidogrel|clopidogrel|mesh-list
6691102|NCT01665235|Atorvastatin|atorvastatin|mesh-list
6691103|NCT01665235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6691104|NCT01665235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6691105|NCT01665235|Analgesics|analgesics|mesh-ancestor
6691106|NCT01665235|Sensory System Agents|sensory system agents|mesh-ancestor
6691107|NCT01665235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6691108|NCT01665235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691109|NCT01665235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6691110|NCT01665235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6691111|NCT01665235|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6691112|NCT01665235|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6691113|NCT01665235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691114|NCT01665235|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6691115|NCT01665235|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6691116|NCT01665235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6691117|NCT01665235|Antipyretics|antipyretics|mesh-ancestor
6691118|NCT01665235|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6691119|NCT01665235|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6691120|NCT01665235|Antimetabolites|antimetabolites|mesh-ancestor
6691121|NCT01665235|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6691122|NCT01665235|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6691123|NCT01665235|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6691124|NCT01665235|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6691125|NCT01665235|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6691126|NCT01665235|Purinergic Agents|purinergic agents|mesh-ancestor
6691127|NCT01665235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6691128|NCT01665235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6691129|NCT01665235|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6691130|NCT01665235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6691131|NCT01665235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6691132|NCT01665235|Vasodilator Agents|vasodilator agents|mesh-ancestor
6691133|NCT01665248|Listerine|listerine|mesh-list
6691134|NCT01665248|Fluorides|fluorides|mesh-list
6691135|NCT01665248|Sodium Fluoride|sodium fluoride|mesh-list
6691136|NCT01665248|Cariostatic Agents|cariostatic agents|mesh-ancestor
6691137|NCT01665248|Protective Agents|protective agents|mesh-ancestor
6691138|NCT01665248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691139|NCT01665248|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6691140|NCT01665248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6691141|NCT01665274|Capecitabine|capecitabine|mesh-list
6691142|NCT01665274|Oxaliplatin|oxaliplatin|mesh-list
6691143|NCT01665274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6691144|NCT01665274|Antimetabolites|antimetabolites|mesh-ancestor
6691145|NCT01665274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691146|NCT01665274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6780737|NCT02183311|Protease Inhibitors|protease inhibitors|mesh-ancestor
6780738|NCT02183311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780739|NCT02183311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780740|NCT02183324|Linagliptin|linagliptin|mesh-list
6780741|NCT02183324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6780742|NCT02183324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780743|NCT02183324|Incretins|incretins|mesh-ancestor
6780744|NCT02183324|Hormones|hormones|mesh-ancestor
6780745|NCT02183324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6780746|NCT02183324|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6780747|NCT02183324|Protease Inhibitors|protease inhibitors|mesh-ancestor
6780748|NCT02183324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780749|NCT02183324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780750|NCT02183337|Pioglitazone|pioglitazone|mesh-list
6780751|NCT02183337|Linagliptin|linagliptin|mesh-list
6780752|NCT02183337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6780753|NCT02183337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780754|NCT02183337|Incretins|incretins|mesh-ancestor
6780755|NCT02183337|Hormones|hormones|mesh-ancestor
6780756|NCT02183337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6780757|NCT02183337|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6780758|NCT02183337|Protease Inhibitors|protease inhibitors|mesh-ancestor
6780759|NCT02183337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780760|NCT02183337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780761|NCT02183350|Linagliptin|linagliptin|mesh-list
6780762|NCT02183350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6780763|NCT02183350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780764|NCT02183350|Incretins|incretins|mesh-ancestor
6780765|NCT02183350|Hormones|hormones|mesh-ancestor
6780766|NCT02183350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6780767|NCT02183350|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6780768|NCT02183350|Protease Inhibitors|protease inhibitors|mesh-ancestor
6780769|NCT02183350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780770|NCT02183350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780771|NCT02183363|Linagliptin|linagliptin|mesh-list
6780772|NCT02183363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6691147|NCT01665378|Folic Acid|folic acid|mesh-list
6691148|NCT01665378|Vitamin B Complex|vitamin b complex|mesh-list
6691149|NCT01665378|Micronutrients|micronutrients|mesh-list
6691150|NCT01665378|Trace Elements|trace elements|mesh-list
6691151|NCT01665378|Hematinics|hematinics|mesh-ancestor
6691152|NCT01665378|Vitamins|vitamins|mesh-ancestor
6691153|NCT01665378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691154|NCT01665404|Fluvoxamine|fluvoxamine|mesh-list
6691155|NCT01665404|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6691156|NCT01665404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6691157|NCT01665404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6691158|NCT01665404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691159|NCT01665404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6691160|NCT01665404|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6691161|NCT01665404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6691162|NCT01665404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6691163|NCT01665404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691164|NCT01665404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6691165|NCT01665404|Serotonin Agents|serotonin agents|mesh-ancestor
6691166|NCT01665404|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6691167|NCT01665404|Antidepressive Agents|antidepressive agents|mesh-ancestor
6691168|NCT01665404|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6691169|NCT01665404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6691170|NCT01665404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6691171|NCT01665404|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6691172|NCT01665417|Docetaxel|docetaxel|mesh-list
6691173|NCT01665417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6691174|NCT01665417|Tubulin Modulators|tubulin modulators|mesh-ancestor
6691175|NCT01665417|Antimitotic Agents|antimitotic agents|mesh-ancestor
6691176|NCT01665417|Mitosis Modulators|mitosis modulators|mesh-ancestor
6691177|NCT01665417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691178|NCT01665469|Lycopene|lycopene|mesh-list
6691179|NCT01665469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6691180|NCT01665469|Antioxidants|antioxidants|mesh-ancestor
6691181|NCT01665469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691182|NCT01665469|Protective Agents|protective agents|mesh-ancestor
6691183|NCT01665469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691184|NCT01665469|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6691185|NCT01665469|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6691186|NCT01665469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6691187|NCT01665586|Dexmedetomidine|dexmedetomidine|mesh-list
6691188|NCT01665586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6691189|NCT01665586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6691190|NCT01665586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691191|NCT01665586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6691192|NCT01665586|Analgesics|analgesics|mesh-ancestor
6691193|NCT01665586|Sensory System Agents|sensory system agents|mesh-ancestor
6691194|NCT01665586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6691195|NCT01665586|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6691196|NCT01665586|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6691197|NCT01665586|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6691198|NCT01665586|Adrenergic Agents|adrenergic agents|mesh-ancestor
6691199|NCT01665586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6691200|NCT01665586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691201|NCT01665638|Canagliflozin|canagliflozin|mesh-list
6691202|NCT01665638|Somatostatin|somatostatin|mesh-list
6691203|NCT01665638|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6691204|NCT01665638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691205|NCT01665638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6691206|NCT01665638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691207|NCT01665638|Hormones|hormones|mesh-ancestor
6691208|NCT01665638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6691209|NCT01665677|Atorvastatin|atorvastatin|mesh-list
6691210|NCT01665677|Calcium|calcium|mesh-list
6691211|NCT01665677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6691212|NCT01665677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691213|NCT01665677|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6691214|NCT01665677|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6691215|NCT01665677|Antimetabolites|antimetabolites|mesh-ancestor
6691216|NCT01665677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691217|NCT01665677|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6691218|NCT01665677|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6691219|NCT01665677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6691220|NCT01665703|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6691221|NCT01665703|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6691222|NCT01665703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691223|NCT01665742|Tocopherols|tocopherols|mesh-list
6691224|NCT01665742|Vitamin E|vitamin e|mesh-list
6691225|NCT01665742|alpha-Tocopherol|alpha-tocopherol|mesh-list
6691226|NCT01665742|Lycopene|lycopene|mesh-list
6691227|NCT01665742|Vitamins|vitamins|mesh-ancestor
6691228|NCT01665742|Micronutrients|micronutrients|mesh-ancestor
6691229|NCT01665742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691230|NCT01665742|Antioxidants|antioxidants|mesh-ancestor
6691231|NCT01665742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691232|NCT01665742|Protective Agents|protective agents|mesh-ancestor
6691233|NCT01665742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6691234|NCT01665742|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6691235|NCT01665742|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6691236|NCT01665742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6691237|NCT01665781|Epoetin Alfa|epoetin alfa|mesh-list
6691238|NCT01665781|Hematinics|hematinics|mesh-ancestor
6691239|NCT01665846|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
6691240|NCT01665846|Hematinics|hematinics|mesh-ancestor
6691241|NCT01665846|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6691242|NCT01665846|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6691243|NCT01666041|Fenofibrate|fenofibrate|mesh-list
6691244|NCT01666041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6691245|NCT01666041|Antimetabolites|antimetabolites|mesh-ancestor
6691246|NCT01666041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691247|NCT01666041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6691248|NCT01666067|Simvastatin|simvastatin|mesh-list
6691249|NCT01666067|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
6691250|NCT01666067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6691251|NCT01666067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6691252|NCT01666067|Antimetabolites|antimetabolites|mesh-ancestor
6691253|NCT01666067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691254|NCT01666067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6691255|NCT01666067|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6691256|NCT01666067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6691257|NCT01666080|Fludarabine|fludarabine|mesh-list
6691258|NCT01666080|Busulfan|busulfan|mesh-list
6691259|NCT01666080|Levetiracetam|levetiracetam|mesh-list
6691260|NCT01666080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6691261|NCT01666080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691262|NCT01666080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6691263|NCT01666080|Immunologic Factors|immunologic factors|mesh-ancestor
6691264|NCT01666080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691265|NCT01666080|Alkylating Agents|alkylating agents|mesh-ancestor
6691266|NCT01666080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6691267|NCT01666080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6691268|NCT01666080|Anticonvulsants|anticonvulsants|mesh-ancestor
6691269|NCT01666080|Nootropic Agents|nootropic agents|mesh-ancestor
6691270|NCT01666171|Metformin|metformin|mesh-list
6691271|NCT01666171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6691272|NCT01666171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691273|NCT01666223|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
6691274|NCT01666223|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
6691275|NCT01666223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6691276|NCT01666223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6691277|NCT01666223|Antimetabolites|antimetabolites|mesh-ancestor
6691278|NCT01666223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691279|NCT01666223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6691280|NCT01666223|Cathartics|cathartics|mesh-ancestor
6524318|NCT00757458|Sequestering Agents|sequestering agents|mesh-ancestor
6524319|NCT00757458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524320|NCT00757458|Antidotes|antidotes|mesh-ancestor
6524321|NCT00757458|Protective Agents|protective agents|mesh-ancestor
6524322|NCT00757458|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6524323|NCT00757523|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
6524324|NCT00757523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6524325|NCT00757523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6524326|NCT00757523|Analgesics|analgesics|mesh-ancestor
6524327|NCT00757523|Sensory System Agents|sensory system agents|mesh-ancestor
6524328|NCT00757523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6524329|NCT00757523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524330|NCT00757523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6524331|NCT00757523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6691281|NCT01666223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6691282|NCT01666236|Triamcinolone|triamcinolone|mesh-list
6691283|NCT01666236|Ranibizumab|ranibizumab|mesh-list
6691284|NCT01666236|Verteporfin|verteporfin|mesh-list
6691285|NCT01666236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6691286|NCT01666236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6691287|NCT01666236|Growth Substances|growth substances|mesh-ancestor
6691288|NCT01666236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691289|NCT01666236|Growth Inhibitors|growth inhibitors|mesh-ancestor
6691290|NCT01666236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6691291|NCT01666236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6691292|NCT01666236|Glucocorticoids|glucocorticoids|mesh-ancestor
6691293|NCT01666236|Hormones|hormones|mesh-ancestor
6691294|NCT01666236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6691295|NCT01666236|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6691296|NCT01666236|Dermatologic Agents|dermatologic agents|mesh-ancestor
6691297|NCT01666249|Immunoglobulins|immunoglobulins|mesh-list
6691298|NCT01666249|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6691299|NCT01666249|Antibodies|antibodies|mesh-list
6691300|NCT01666249|Immunologic Factors|immunologic factors|mesh-ancestor
6691301|NCT01666249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691302|NCT01666262|Vaccines|vaccines|mesh-list
6691303|NCT01666262|Immunologic Factors|immunologic factors|mesh-ancestor
6691304|NCT01666262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691305|NCT01666301|Darbepoetin alfa|darbepoetin alfa|mesh-list
6691306|NCT01666301|Hematinics|hematinics|mesh-ancestor
6691307|NCT01666353|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6691308|NCT01666353|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6691309|NCT01666353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691310|NCT01666379|Fentanyl|fentanyl|mesh-list
6691311|NCT01666379|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6691312|NCT01666379|Narcotics|narcotics|mesh-ancestor
6691313|NCT01666379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6691314|NCT01666379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691315|NCT01666379|Analgesics|analgesics|mesh-ancestor
6691316|NCT01666379|Sensory System Agents|sensory system agents|mesh-ancestor
6691317|NCT01666379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6691318|NCT01666379|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6691319|NCT01666379|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6691320|NCT01666379|Anesthetics, General|anesthetics, general|mesh-ancestor
6691321|NCT01666379|Anesthetics|anesthetics|mesh-ancestor
6691322|NCT01666418|Paclitaxel|paclitaxel|mesh-list
6691323|NCT01666418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6691324|NCT01666418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6691325|NCT01666418|Tubulin Modulators|tubulin modulators|mesh-ancestor
6691326|NCT01666418|Antimitotic Agents|antimitotic agents|mesh-ancestor
6691327|NCT01666418|Mitosis Modulators|mitosis modulators|mesh-ancestor
6691328|NCT01666418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691329|NCT01666431|Lapatinib|lapatinib|mesh-list
6691330|NCT01666431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6691331|NCT01666431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6691332|NCT01666431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6691333|NCT01666431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691334|NCT01666522|Vitamin D|vitamin d|mesh-list
6691335|NCT01666522|Cholecalciferol|cholecalciferol|mesh-list
6691336|NCT01666522|Vitamins|vitamins|mesh-ancestor
6691337|NCT01666522|Micronutrients|micronutrients|mesh-ancestor
6691338|NCT01666522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691339|NCT01666522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6691340|NCT01666522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6691341|NCT01666535|Vaccines|vaccines|mesh-list
6691342|NCT01666535|Immunologic Factors|immunologic factors|mesh-ancestor
6691343|NCT01666535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691344|NCT01666587|Ibuprofen|ibuprofen|mesh-list
6691345|NCT01666587|Antioxidants|antioxidants|mesh-list
6691346|NCT01666587|Prostaglandin Antagonists|prostaglandin antagonists|mesh-list
6691347|NCT01666587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6691348|NCT01666587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6691349|NCT01666587|Analgesics|analgesics|mesh-ancestor
6691350|NCT01666587|Sensory System Agents|sensory system agents|mesh-ancestor
6691351|NCT01666587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6691352|NCT01666587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691353|NCT01666587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6691354|NCT01666587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6691355|NCT01666587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6691356|NCT01666587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780773|NCT02183363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691357|NCT01666587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691358|NCT01666587|Protective Agents|protective agents|mesh-ancestor
6691359|NCT01666587|Hormone Antagonists|hormone antagonists|mesh-ancestor
6691360|NCT01666587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6691361|NCT01666600|Nintedanib|nintedanib|mesh-list
6691362|NCT01666600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6691363|NCT01666600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6691364|NCT01666600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6691365|NCT01666600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691366|NCT01666665|Metformin|metformin|mesh-list
6691367|NCT01666665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6691368|NCT01666665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691369|NCT01666678|Diphenhydramine|diphenhydramine|mesh-list
6691370|NCT01666678|Promethazine|promethazine|mesh-list
6691371|NCT01666678|Naproxen|naproxen|mesh-list
6691372|NCT01666678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6691373|NCT01666678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6691374|NCT01666678|Analgesics|analgesics|mesh-ancestor
6691375|NCT01666678|Sensory System Agents|sensory system agents|mesh-ancestor
6691376|NCT01666678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6691377|NCT01666678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691378|NCT01666678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6691379|NCT01666678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6691380|NCT01666678|Gout Suppressants|gout suppressants|mesh-ancestor
6691381|NCT01666678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6691382|NCT01666678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6691383|NCT01666678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691384|NCT01666678|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6691385|NCT01666678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6691386|NCT01666678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6691387|NCT01666678|Anesthetics, Local|anesthetics, local|mesh-ancestor
6691388|NCT01666678|Anesthetics|anesthetics|mesh-ancestor
6691389|NCT01666678|Antiemetics|antiemetics|mesh-ancestor
6691390|NCT01666678|Autonomic Agents|autonomic agents|mesh-ancestor
6691391|NCT01666678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6691392|NCT01666678|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6691393|NCT01666678|Histamine Antagonists|histamine antagonists|mesh-ancestor
6691394|NCT01666678|Histamine Agents|histamine agents|mesh-ancestor
6691395|NCT01666678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6691396|NCT01666678|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6691397|NCT01666678|Antipruritics|antipruritics|mesh-ancestor
6691398|NCT01666678|Dermatologic Agents|dermatologic agents|mesh-ancestor
6691399|NCT01666691|CKD732|ckd732|mesh-list
6691400|NCT01666691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6691401|NCT01666691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6691402|NCT01666691|Growth Substances|growth substances|mesh-ancestor
6691403|NCT01666691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691404|NCT01666691|Growth Inhibitors|growth inhibitors|mesh-ancestor
6691405|NCT01666691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6691406|NCT01666743|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
6691407|NCT01666743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6691408|NCT01666743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6691409|NCT01666756|Sorafenib|sorafenib|mesh-list
6691410|NCT01666756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6691411|NCT01666756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6691412|NCT01666756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6691413|NCT01666756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691414|NCT01666769|Micafungin|micafungin|mesh-list
6691415|NCT01666769|Antifungal Agents|antifungal agents|mesh-ancestor
6691416|NCT01666769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6691417|NCT01666925|Vaccines|vaccines|mesh-list
6691418|NCT01666925|Immunologic Factors|immunologic factors|mesh-ancestor
6691419|NCT01666925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780774|NCT02183363|Incretins|incretins|mesh-ancestor
6780775|NCT02183363|Hormones|hormones|mesh-ancestor
6780776|NCT02183363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6780777|NCT02183363|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6780778|NCT02183363|Protease Inhibitors|protease inhibitors|mesh-ancestor
6780779|NCT02183363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780780|NCT02183363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780781|NCT02183376|Linagliptin|linagliptin|mesh-list
6780782|NCT02183376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6780783|NCT02183376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780784|NCT02183376|Incretins|incretins|mesh-ancestor
6780785|NCT02183376|Hormones|hormones|mesh-ancestor
6691420|NCT01667081|Grazoprevir|grazoprevir|mesh-list
6691421|NCT01667081|Antiviral Agents|antiviral agents|mesh-ancestor
6691422|NCT01667081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6691423|NCT01667094|Meropenem|meropenem|mesh-list
6691424|NCT01667094|Tazobactam|tazobactam|mesh-list
6691425|NCT01667094|Piperacillin|piperacillin|mesh-list
6691426|NCT01667094|Clavulanic Acid|clavulanic acid|mesh-list
6691427|NCT01667094|Clavulanic Acids|clavulanic acids|mesh-list
6691428|NCT01667094|Ceftazidime|ceftazidime|mesh-list
6691429|NCT01667094|Cefepime|cefepime|mesh-list
6691430|NCT01667094|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
6691431|NCT01667094|Ticarcillin|ticarcillin|mesh-list
6691432|NCT01667094|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
6691433|NCT01667094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6691434|NCT01667094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6691435|NCT01667094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6691436|NCT01667094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6691437|NCT01667094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691438|NCT01667120|Ketorolac|ketorolac|mesh-list
6691439|NCT01667120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6691440|NCT01667120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6691441|NCT01667120|Analgesics|analgesics|mesh-ancestor
6691442|NCT01667120|Sensory System Agents|sensory system agents|mesh-ancestor
6691443|NCT01667120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6691444|NCT01667120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691445|NCT01667120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6691446|NCT01667120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6691447|NCT01667120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6691448|NCT01667120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6691449|NCT01667120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691450|NCT01667133|Ponatinib|ponatinib|mesh-list
6691451|NCT01667133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6691452|NCT01667133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6691453|NCT01667133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6691454|NCT01667133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691455|NCT01667211|Paclitaxel|paclitaxel|mesh-list
6691456|NCT01667211|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6691457|NCT01667211|Nedaplatin|nedaplatin|mesh-list
6691458|NCT01667211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6691459|NCT01667211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6691460|NCT01667211|Tubulin Modulators|tubulin modulators|mesh-ancestor
6691461|NCT01667211|Antimitotic Agents|antimitotic agents|mesh-ancestor
6691462|NCT01667211|Mitosis Modulators|mitosis modulators|mesh-ancestor
6691463|NCT01667211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691464|NCT01667263|Tretinoin|tretinoin|mesh-list
6691465|NCT01667263|Danazol|danazol|mesh-list
6691466|NCT01667263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6691467|NCT01667263|Keratolytic Agents|keratolytic agents|mesh-ancestor
6691468|NCT01667263|Dermatologic Agents|dermatologic agents|mesh-ancestor
6691469|NCT01667263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6691470|NCT01667263|Hormone Antagonists|hormone antagonists|mesh-ancestor
6691471|NCT01667263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6691472|NCT01667263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691473|NCT01667315|Bupivacaine|bupivacaine|mesh-list
6691474|NCT01667315|Anesthetics, Local|anesthetics, local|mesh-ancestor
6691475|NCT01667315|Anesthetics|anesthetics|mesh-ancestor
6691476|NCT01667315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6691477|NCT01667315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691478|NCT01667315|Sensory System Agents|sensory system agents|mesh-ancestor
6691479|NCT01667315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6691480|NCT01667445|Morphine|morphine|mesh-list
6691481|NCT01667445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6691482|NCT01667445|Narcotics|narcotics|mesh-ancestor
6691483|NCT01667445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6691484|NCT01667445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691485|NCT01667445|Analgesics|analgesics|mesh-ancestor
6691486|NCT01667445|Sensory System Agents|sensory system agents|mesh-ancestor
6691487|NCT01667445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6691488|NCT01667484|Adderall|adderall|mesh-list
6691489|NCT01667484|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6691490|NCT01667484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691491|NCT01667497|4-Aminopyridine|4-aminopyridine|mesh-list
6691492|NCT01667497|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6691493|NCT01667497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6691494|NCT01667497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691495|NCT01667523|Cinnamaldehyde|cinnamaldehyde|mesh-list
6691496|NCT01667523|Capsaicin|capsaicin|mesh-list
6691497|NCT01667523|Antipruritics|antipruritics|mesh-ancestor
6691498|NCT01667523|Dermatologic Agents|dermatologic agents|mesh-ancestor
6691499|NCT01667523|Sensory System Agents|sensory system agents|mesh-ancestor
6691500|NCT01667523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6691501|NCT01667523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691502|NCT01667523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6691503|NCT01667523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6691504|NCT01667523|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
6691505|NCT01667523|Protective Agents|protective agents|mesh-ancestor
6691506|NCT01667575|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6691507|NCT01667575|Amoxicillin|amoxicillin|mesh-list
6691508|NCT01667575|Clarithromycin|clarithromycin|mesh-list
6691509|NCT01667575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6691510|NCT01667575|Potassium Citrate|potassium citrate|mesh-list
6691511|NCT01667575|Esomeprazole|esomeprazole|mesh-list
6691512|NCT01667575|Bismuth|bismuth|mesh-list
6691513|NCT01667575|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
6691514|NCT01667575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691515|NCT01667575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6691516|NCT01667575|Antitubercular Agents|antitubercular agents|mesh-ancestor
6691517|NCT01667575|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6691518|NCT01667575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6691519|NCT01667575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6691520|NCT01667575|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6691521|NCT01667575|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6691522|NCT01667575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6691523|NCT01667575|Antacids|antacids|mesh-ancestor
6691524|NCT01667575|Diuretics|diuretics|mesh-ancestor
6691525|NCT01667575|Natriuretic Agents|natriuretic agents|mesh-ancestor
6691526|NCT01667575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691527|NCT01667575|Expectorants|expectorants|mesh-ancestor
6691528|NCT01667575|Respiratory System Agents|respiratory system agents|mesh-ancestor
6691529|NCT01667614|Losartan|losartan|mesh-list
6691530|NCT01667614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6691531|NCT01667614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6691532|NCT01667614|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6691533|NCT01667614|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6691534|NCT01667614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691535|NCT01667692|Azithromycin|azithromycin|mesh-list
6691536|NCT01667692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6691537|NCT01667692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6691538|NCT01667718|Amoxicillin|amoxicillin|mesh-list
6691539|NCT01667718|Levofloxacin|levofloxacin|mesh-list
6691540|NCT01667718|Ofloxacin|ofloxacin|mesh-list
6691541|NCT01667718|Potassium Citrate|potassium citrate|mesh-list
6691542|NCT01667718|Lansoprazole|lansoprazole|mesh-list
6691543|NCT01667718|Dexlansoprazole|dexlansoprazole|mesh-list
6691544|NCT01667718|Bismuth|bismuth|mesh-list
6691545|NCT01667718|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
6691546|NCT01667718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691547|NCT01667718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6691548|NCT01667718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6691549|NCT01667718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6691550|NCT01667718|Renal Agents|renal agents|mesh-ancestor
6691551|NCT01667718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6691552|NCT01667718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6691553|NCT01667718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6691554|NCT01667718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6691555|NCT01667718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6691556|NCT01667718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6691557|NCT01667718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6691558|NCT01667718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6691559|NCT01667718|Antacids|antacids|mesh-ancestor
6691560|NCT01667718|Diuretics|diuretics|mesh-ancestor
6691561|NCT01667718|Natriuretic Agents|natriuretic agents|mesh-ancestor
6691562|NCT01667718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691563|NCT01667718|Expectorants|expectorants|mesh-ancestor
6691564|NCT01667718|Respiratory System Agents|respiratory system agents|mesh-ancestor
6691565|NCT01667744|Citalopram|citalopram|mesh-list
6691566|NCT01667744|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6691567|NCT01667744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6691568|NCT01667744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6691569|NCT01667744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691570|NCT01667744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6691571|NCT01667744|Serotonin Agents|serotonin agents|mesh-ancestor
6691572|NCT01667744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524332|NCT00757523|Dermatologic Agents|dermatologic agents|mesh-ancestor
6524333|NCT00757549|Cetuximab|cetuximab|mesh-list
6524334|NCT00757549|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6524335|NCT00757549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6524336|NCT00757549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6524337|NCT00757549|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6524338|NCT00757549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524339|NCT00757679|Milnacipran|milnacipran|mesh-list
6524340|NCT00757679|Levomilnacipran|levomilnacipran|mesh-list
6524341|NCT00757679|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6524342|NCT00757679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6524343|NCT00757679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6524344|NCT00757679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524345|NCT00757679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6524346|NCT00757679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524347|NCT00757679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6524348|NCT00757679|Analgesics|analgesics|mesh-ancestor
6524349|NCT00757679|Sensory System Agents|sensory system agents|mesh-ancestor
6524350|NCT00757679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6524351|NCT00757679|Antidepressive Agents|antidepressive agents|mesh-ancestor
6524352|NCT00757679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6524353|NCT00757692|Bicalutamide|bicalutamide|mesh-list
6524354|NCT00757692|Androgen Antagonists|androgen antagonists|mesh-ancestor
6524355|NCT00757692|Hormone Antagonists|hormone antagonists|mesh-ancestor
6524356|NCT00757692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6524357|NCT00757692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524358|NCT00757692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6524359|NCT00757731|Milnacipran|milnacipran|mesh-list
6524360|NCT00757731|Levomilnacipran|levomilnacipran|mesh-list
6524361|NCT00757731|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6524362|NCT00757731|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6524363|NCT00757731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6524364|NCT00757731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524365|NCT00757731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6524366|NCT00757731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524367|NCT00757731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6524368|NCT00757731|Analgesics|analgesics|mesh-ancestor
6524369|NCT00757731|Sensory System Agents|sensory system agents|mesh-ancestor
6524370|NCT00757731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6524371|NCT00757731|Antidepressive Agents|antidepressive agents|mesh-ancestor
6524372|NCT00757731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6524373|NCT00757835|Timolol|timolol|mesh-list
6524374|NCT00757835|Latanoprost|latanoprost|mesh-list
6524375|NCT00757835|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6524376|NCT00757835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6524377|NCT00757835|Adrenergic Agents|adrenergic agents|mesh-ancestor
6524378|NCT00757835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6524379|NCT00757835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524380|NCT00757835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524381|NCT00757835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6524382|NCT00757835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6524383|NCT00757835|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6524384|NCT00757835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6524385|NCT00757874|Clobetasol|clobetasol|mesh-list
6524386|NCT00757874|Tacrolimus|tacrolimus|mesh-list
6524387|NCT00757874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6524388|NCT00757874|Immunologic Factors|immunologic factors|mesh-ancestor
6524389|NCT00757874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6524390|NCT00757874|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6524391|NCT00757874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6524392|NCT00757874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6524393|NCT00757874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6524394|NCT00757874|Glucocorticoids|glucocorticoids|mesh-ancestor
6524395|NCT00757874|Hormones|hormones|mesh-ancestor
6524396|NCT00757874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6524397|NCT00757978|Memantine|memantine|mesh-list
6524398|NCT00757978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6524399|NCT00757978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6524400|NCT00757978|Dopamine Agents|dopamine agents|mesh-ancestor
6524401|NCT00757978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6691573|NCT01667744|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6691574|NCT01667744|Antidepressive Agents|antidepressive agents|mesh-ancestor
6691575|NCT01667744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6691576|NCT01667874|Gentamicins|gentamicins|mesh-list
6691577|NCT01667874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6691578|NCT01667874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6691579|NCT01667874|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6691580|NCT01667874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6691581|NCT01667874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691582|NCT01668043|UB-421|ub-421|mesh-list
6691583|NCT01668043|Antibodies|antibodies|mesh-list
6691584|NCT01668043|Immunologic Factors|immunologic factors|mesh-ancestor
6691585|NCT01668043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691586|NCT01668043|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6691587|NCT01668043|Antiviral Agents|antiviral agents|mesh-ancestor
6691588|NCT01668043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6691589|NCT01668056|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6691590|NCT01668056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6691591|NCT01668056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691592|NCT01668069|Ondansetron|ondansetron|mesh-list
6691593|NCT01668069|Antiemetics|antiemetics|mesh-ancestor
6691594|NCT01668069|Autonomic Agents|autonomic agents|mesh-ancestor
6691595|NCT01668069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6691596|NCT01668069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691597|NCT01668069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6691598|NCT01668069|Antipruritics|antipruritics|mesh-ancestor
6691599|NCT01668069|Dermatologic Agents|dermatologic agents|mesh-ancestor
6691600|NCT01668069|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6691601|NCT01668069|Serotonin Agents|serotonin agents|mesh-ancestor
6691602|NCT01668069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6691603|NCT01668069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691604|NCT01668069|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6691605|NCT01668069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6691606|NCT01668069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6691607|NCT01668069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6691608|NCT01668069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6691609|NCT01668121|Budesonide|budesonide|mesh-list
6691610|NCT01668121|Formoterol Fumarate|formoterol fumarate|mesh-list
6691611|NCT01668121|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6691612|NCT01668121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6691613|NCT01668121|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6691614|NCT01668121|Autonomic Agents|autonomic agents|mesh-ancestor
6691615|NCT01668121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6691616|NCT01668121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691617|NCT01668121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6691618|NCT01668121|Respiratory System Agents|respiratory system agents|mesh-ancestor
6691619|NCT01668121|Glucocorticoids|glucocorticoids|mesh-ancestor
6691620|NCT01668121|Hormones|hormones|mesh-ancestor
6691621|NCT01668121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6691622|NCT01668121|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6691623|NCT01668121|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6691624|NCT01668121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6691625|NCT01668121|Adrenergic Agents|adrenergic agents|mesh-ancestor
6691626|NCT01668121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6691627|NCT01668121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691628|NCT01668433|Primaquine|primaquine|mesh-list
6691629|NCT01668433|Methylene Blue|methylene blue|mesh-list
6691630|NCT01668433|Antimalarials|antimalarials|mesh-ancestor
6691631|NCT01668433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6691632|NCT01668433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6691633|NCT01668433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6691634|NCT01668433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6691635|NCT01668433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691636|NCT01668446|Sildenafil Citrate|sildenafil citrate|mesh-list
6691637|NCT01668446|Estradiol|estradiol|mesh-list
6691638|NCT01668446|Estrogens|estrogens|mesh-ancestor
6691639|NCT01668446|Hormones|hormones|mesh-ancestor
6691640|NCT01668446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6691641|NCT01668446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691642|NCT01668446|Vasodilator Agents|vasodilator agents|mesh-ancestor
6691643|NCT01668446|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6691644|NCT01668446|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6691645|NCT01668446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6691646|NCT01668446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691647|NCT01668446|Urological Agents|urological agents|mesh-ancestor
6691648|NCT01668485|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6691649|NCT01668485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691650|NCT01668498|Doxycycline|doxycycline|mesh-list
6691651|NCT01668498|Erythromycin|erythromycin|mesh-list
6691652|NCT01668498|Erythromycin Estolate|erythromycin estolate|mesh-list
6691653|NCT01668498|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
6691654|NCT01668498|Erythromycin stearate|erythromycin stearate|mesh-list
6691655|NCT01668498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6691656|NCT01668498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6691657|NCT01668498|Antimalarials|antimalarials|mesh-ancestor
6691658|NCT01668498|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6691659|NCT01668498|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6691660|NCT01668498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6691661|NCT01668498|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6691662|NCT01668498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6691663|NCT01668498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691664|NCT01668550|AZD-0424|azd-0424|mesh-list
6691665|NCT01668550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6691666|NCT01668550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6691667|NCT01668550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691668|NCT01668615|Tretinoin|tretinoin|mesh-list
6691669|NCT01668615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6691670|NCT01668615|Keratolytic Agents|keratolytic agents|mesh-ancestor
6691671|NCT01668615|Dermatologic Agents|dermatologic agents|mesh-ancestor
6691672|NCT01668680|Celecoxib|celecoxib|mesh-list
6691673|NCT01668680|Capecitabine|capecitabine|mesh-list
6691674|NCT01668680|Methotrexate|methotrexate|mesh-list
6691675|NCT01668680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6691676|NCT01668680|Antimetabolites|antimetabolites|mesh-ancestor
6691677|NCT01668680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691678|NCT01668680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6691679|NCT01668680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6691680|NCT01668680|Abortifacient Agents|abortifacient agents|mesh-ancestor
6691681|NCT01668680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6691682|NCT01668680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691683|NCT01668680|Dermatologic Agents|dermatologic agents|mesh-ancestor
6691684|NCT01668680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6691685|NCT01668680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6691686|NCT01668680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6691687|NCT01668680|Immunologic Factors|immunologic factors|mesh-ancestor
6691688|NCT01668680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6691689|NCT01668680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6691690|NCT01668680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6691691|NCT01668680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6691692|NCT01668680|Analgesics|analgesics|mesh-ancestor
6691693|NCT01668680|Sensory System Agents|sensory system agents|mesh-ancestor
6691694|NCT01668680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6691695|NCT01668680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6691696|NCT01668680|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6691697|NCT01668680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6780786|NCT02183376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6780787|NCT02183376|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6780788|NCT02183376|Protease Inhibitors|protease inhibitors|mesh-ancestor
6780789|NCT02183376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780790|NCT02183376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780791|NCT02183389|Linagliptin|linagliptin|mesh-list
6780792|NCT02183389|Warfarin|warfarin|mesh-list
6780793|NCT02183389|Anticoagulants|anticoagulants|mesh-ancestor
6780794|NCT02183389|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6780795|NCT02183389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780796|NCT02183389|Incretins|incretins|mesh-ancestor
6780797|NCT02183389|Hormones|hormones|mesh-ancestor
6780798|NCT02183389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6780799|NCT02183389|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6780800|NCT02183389|Protease Inhibitors|protease inhibitors|mesh-ancestor
6780801|NCT02183389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780802|NCT02183389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780803|NCT02183402|Linagliptin|linagliptin|mesh-list
6780804|NCT02183402|Digoxin|digoxin|mesh-list
6780805|NCT02183402|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6780806|NCT02183402|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6780807|NCT02183402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780808|NCT02183402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780809|NCT02183402|Protective Agents|protective agents|mesh-ancestor
6691698|NCT01668849|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
6691699|NCT01668849|Fentanyl|fentanyl|mesh-list
6691700|NCT01668849|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6691701|NCT01668849|Narcotics|narcotics|mesh-ancestor
6691702|NCT01668849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6691703|NCT01668849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691704|NCT01668849|Analgesics|analgesics|mesh-ancestor
6691705|NCT01668849|Sensory System Agents|sensory system agents|mesh-ancestor
6691706|NCT01668849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6691707|NCT01668849|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6691708|NCT01668849|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6691709|NCT01668849|Anesthetics, General|anesthetics, general|mesh-ancestor
6691710|NCT01668849|Anesthetics|anesthetics|mesh-ancestor
6691711|NCT01668849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6691712|NCT01668849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6691713|NCT01668849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6691714|NCT01668849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6691715|NCT01668901|Aspirin|aspirin|mesh-list
6691716|NCT01668901|Warfarin|warfarin|mesh-list
6691717|NCT01668901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6691718|NCT01668901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6691719|NCT01668901|Analgesics|analgesics|mesh-ancestor
6691720|NCT01668901|Sensory System Agents|sensory system agents|mesh-ancestor
6691721|NCT01668901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6691722|NCT01668901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691723|NCT01668901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6691724|NCT01668901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6691725|NCT01668901|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6691726|NCT01668901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6691727|NCT01668901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691728|NCT01668901|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6691729|NCT01668901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6691730|NCT01668901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6691731|NCT01668901|Antipyretics|antipyretics|mesh-ancestor
6691732|NCT01668901|Anticoagulants|anticoagulants|mesh-ancestor
6691733|NCT01668927|Amoxicillin|amoxicillin|mesh-list
6691734|NCT01668927|Metronidazole|metronidazole|mesh-list
6691735|NCT01668927|Tetracycline|tetracycline|mesh-list
6691736|NCT01668927|Furazolidone|furazolidone|mesh-list
6691737|NCT01668927|Potassium Citrate|potassium citrate|mesh-list
6691738|NCT01668927|Lansoprazole|lansoprazole|mesh-list
6691739|NCT01668927|Bismuth|bismuth|mesh-list
6691740|NCT01668927|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
6691741|NCT01668927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691742|NCT01668927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6691743|NCT01668927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6691744|NCT01668927|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6691745|NCT01668927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6691746|NCT01668927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6691747|NCT01668927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6691748|NCT01668927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6691749|NCT01668927|Antacids|antacids|mesh-ancestor
6691750|NCT01668927|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6691751|NCT01668927|Diuretics|diuretics|mesh-ancestor
6691752|NCT01668927|Natriuretic Agents|natriuretic agents|mesh-ancestor
6691753|NCT01668927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691754|NCT01668927|Expectorants|expectorants|mesh-ancestor
6691755|NCT01668927|Respiratory System Agents|respiratory system agents|mesh-ancestor
6691756|NCT01668927|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6691757|NCT01668927|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6691758|NCT01668927|Renal Agents|renal agents|mesh-ancestor
6691759|NCT01668927|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
6691760|NCT01668927|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6691761|NCT01669044|Dexmedetomidine|dexmedetomidine|mesh-list
6691762|NCT01669044|Propofol|propofol|mesh-list
6691763|NCT01669044|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6691764|NCT01669044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6691765|NCT01669044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691766|NCT01669044|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6691767|NCT01669044|Anesthetics, General|anesthetics, general|mesh-ancestor
6691768|NCT01669044|Anesthetics|anesthetics|mesh-ancestor
6691769|NCT01669044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6691770|NCT01669044|Analgesics|analgesics|mesh-ancestor
6691771|NCT01669044|Sensory System Agents|sensory system agents|mesh-ancestor
6691772|NCT01669044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6691773|NCT01669044|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6691774|NCT01669044|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6691775|NCT01669044|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6691776|NCT01669044|Adrenergic Agents|adrenergic agents|mesh-ancestor
6691777|NCT01669044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6691778|NCT01669044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691779|NCT01669083|Diketopiperazines|diketopiperazines|mesh-list
6691780|NCT01669083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6691781|NCT01669083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6691782|NCT01669135|Anesthetics|anesthetics|mesh-list
6691783|NCT01669135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6691784|NCT01669135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691785|NCT01669213|Ondansetron|ondansetron|mesh-list
6691786|NCT01669213|Ramosetron|ramosetron|mesh-list
6691787|NCT01669213|Antiemetics|antiemetics|mesh-ancestor
6691788|NCT01669213|Autonomic Agents|autonomic agents|mesh-ancestor
6691789|NCT01669213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6691790|NCT01669213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691791|NCT01669213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6691792|NCT01669213|Antipruritics|antipruritics|mesh-ancestor
6691793|NCT01669213|Dermatologic Agents|dermatologic agents|mesh-ancestor
6691794|NCT01669213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6691795|NCT01669213|Serotonin Agents|serotonin agents|mesh-ancestor
6691796|NCT01669213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6691797|NCT01669213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691798|NCT01669213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6691799|NCT01669213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6691800|NCT01669213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6691801|NCT01669213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6691802|NCT01669213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6691803|NCT01669226|Taxane|taxane|mesh-list
6691804|NCT01669226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6691805|NCT01669239|Doxorubicin|doxorubicin|mesh-list
6691806|NCT01669239|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6691807|NCT01669239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6691808|NCT01669239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6691809|NCT01669239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6691810|NCT01669239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6691811|NCT01669239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6691812|NCT01669239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691813|NCT01669291|Leuprolide|leuprolide|mesh-list
6691814|NCT01669291|Cetrorelix|cetrorelix|mesh-list
6691815|NCT01669291|Menotropins|menotropins|mesh-list
6691816|NCT01669291|Ganirelix|ganirelix|mesh-list
6691817|NCT01669291|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6691818|NCT01669291|Fertility Agents|fertility agents|mesh-ancestor
6691819|NCT01669291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6691820|NCT01669291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691821|NCT01669291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6691822|NCT01669291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6691823|NCT01669291|Hormone Antagonists|hormone antagonists|mesh-ancestor
6691824|NCT01669291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6691825|NCT01669304|Verapamil|verapamil|mesh-list
6691826|NCT01669304|Sertraline|sertraline|mesh-list
6691827|NCT01669304|Antidepressive Agents|antidepressive agents|mesh-ancestor
6691828|NCT01669304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6691829|NCT01669304|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6691830|NCT01669304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6691831|NCT01669304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6691832|NCT01669304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691833|NCT01669304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6691834|NCT01669304|Serotonin Agents|serotonin agents|mesh-ancestor
6691835|NCT01669304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691836|NCT01669304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6691837|NCT01669304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6691838|NCT01669304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6691839|NCT01669304|Vasodilator Agents|vasodilator agents|mesh-ancestor
6691840|NCT01669369|Lithium Carbonate|lithium carbonate|mesh-list
6691841|NCT01669369|Antidepressive Agents|antidepressive agents|mesh-ancestor
6691842|NCT01669369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6691843|NCT01669369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6691844|NCT01669369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691845|NCT01669369|Antimanic Agents|antimanic agents|mesh-ancestor
6691846|NCT01669369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6691847|NCT01669369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6691848|NCT01669369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691849|NCT01669447|Ranibizumab|ranibizumab|mesh-list
6691850|NCT01669447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6691851|NCT01669447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6691852|NCT01669447|Growth Substances|growth substances|mesh-ancestor
6691853|NCT01669447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691854|NCT01669447|Growth Inhibitors|growth inhibitors|mesh-ancestor
6691855|NCT01669447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6691856|NCT01669499|Dexamethasone|dexamethasone|mesh-list
6691857|NCT01669499|Dexamethasone acetate|dexamethasone acetate|mesh-list
6691858|NCT01669499|BB 1101|bb 1101|mesh-list
6691859|NCT01669499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6691860|NCT01669499|Antiemetics|antiemetics|mesh-ancestor
6691861|NCT01669499|Autonomic Agents|autonomic agents|mesh-ancestor
6691862|NCT01669499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6691863|NCT01669499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691864|NCT01669499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6691865|NCT01669499|Glucocorticoids|glucocorticoids|mesh-ancestor
6691866|NCT01669499|Hormones|hormones|mesh-ancestor
6691867|NCT01669499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6691868|NCT01669499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6691869|NCT01669499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6691870|NCT01669499|Protease Inhibitors|protease inhibitors|mesh-ancestor
6691871|NCT01669499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6691872|NCT01669499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691873|NCT01669707|Endostar protein|endostar protein|mesh-list
6691874|NCT01669707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6691875|NCT01669707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6691876|NCT01669707|Growth Substances|growth substances|mesh-ancestor
6691877|NCT01669707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691878|NCT01669707|Growth Inhibitors|growth inhibitors|mesh-ancestor
6691879|NCT01669707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6691880|NCT01669824|Aspirin|aspirin|mesh-list
6691881|NCT01669824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6691882|NCT01669824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6691883|NCT01669824|Analgesics|analgesics|mesh-ancestor
6691884|NCT01669824|Sensory System Agents|sensory system agents|mesh-ancestor
6691885|NCT01669824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6691886|NCT01669824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691887|NCT01669824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6691888|NCT01669824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6691889|NCT01669824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6691890|NCT01669824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6691891|NCT01669824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691892|NCT01669824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6691893|NCT01669824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6691894|NCT01669824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6691895|NCT01669824|Antipyretics|antipyretics|mesh-ancestor
6691896|NCT01669941|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6691897|NCT01669941|Antimalarials|antimalarials|mesh-ancestor
6691898|NCT01669941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6691899|NCT01669941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6691900|NCT01669941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6691901|NCT01669967|Diphenhydramine|diphenhydramine|mesh-list
6691902|NCT01669967|Promethazine|promethazine|mesh-list
6691903|NCT01669967|Lidocaine|lidocaine|mesh-list
6691904|NCT01669967|Anesthetics, Local|anesthetics, local|mesh-ancestor
6691905|NCT01669967|Anesthetics|anesthetics|mesh-ancestor
6691906|NCT01669967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6691907|NCT01669967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691908|NCT01669967|Sensory System Agents|sensory system agents|mesh-ancestor
6691909|NCT01669967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6691910|NCT01669967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6691911|NCT01669967|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6691912|NCT01669967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6691913|NCT01669967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6691914|NCT01669967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691915|NCT01669967|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6691916|NCT01669967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6691917|NCT01669967|Antiemetics|antiemetics|mesh-ancestor
6691918|NCT01669967|Autonomic Agents|autonomic agents|mesh-ancestor
6691919|NCT01669967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6691920|NCT01669967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6691921|NCT01669967|Histamine Antagonists|histamine antagonists|mesh-ancestor
6691922|NCT01669967|Histamine Agents|histamine agents|mesh-ancestor
6691923|NCT01669967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6691924|NCT01669967|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6691925|NCT01669967|Antipruritics|antipruritics|mesh-ancestor
6691926|NCT01669967|Dermatologic Agents|dermatologic agents|mesh-ancestor
6691927|NCT01670071|Risperidone|risperidone|mesh-list
6691928|NCT01670071|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6691929|NCT01670071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6691930|NCT01670071|Serotonin Agents|serotonin agents|mesh-ancestor
6691931|NCT01670071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6691932|NCT01670071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691933|NCT01670071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691934|NCT01670071|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6691935|NCT01670071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6691936|NCT01670071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6691937|NCT01670071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6691938|NCT01670071|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6691939|NCT01670071|Dopamine Agents|dopamine agents|mesh-ancestor
6691940|NCT01670071|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6691941|NCT01670071|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6691942|NCT01670084|Leucovorin|leucovorin|mesh-list
6691943|NCT01670084|Cytarabine|cytarabine|mesh-list
6691944|NCT01670084|Dexamethasone|dexamethasone|mesh-list
6691945|NCT01670084|Prednisone|prednisone|mesh-list
6691946|NCT01670084|Cyclophosphamide|cyclophosphamide|mesh-list
6691947|NCT01670084|Rituximab|rituximab|mesh-list
6691948|NCT01670084|Doxorubicin|doxorubicin|mesh-list
6691949|NCT01670084|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6691950|NCT01670084|Methotrexate|methotrexate|mesh-list
6691951|NCT01670084|Vincristine|vincristine|mesh-list
6691952|NCT01670084|Levoleucovorin|levoleucovorin|mesh-list
6691953|NCT01670084|Mesna|mesna|mesh-list
6691954|NCT01670084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6691955|NCT01670084|Immunologic Factors|immunologic factors|mesh-ancestor
6691956|NCT01670084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6691957|NCT01670084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6691958|NCT01670084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6691959|NCT01670084|Alkylating Agents|alkylating agents|mesh-ancestor
6691960|NCT01670084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6691961|NCT01670084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6691962|NCT01670084|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6691963|NCT01670084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6691964|NCT01670084|Antiemetics|antiemetics|mesh-ancestor
6691965|NCT01670084|Autonomic Agents|autonomic agents|mesh-ancestor
6691966|NCT01670084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6691967|NCT01670084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6691968|NCT01670084|Glucocorticoids|glucocorticoids|mesh-ancestor
6691969|NCT01670084|Hormones|hormones|mesh-ancestor
6691970|NCT01670084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6691971|NCT01670084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6691972|NCT01670084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6691973|NCT01670084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6691974|NCT01670084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6691975|NCT01670084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6691976|NCT01670084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6691977|NCT01670084|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6691978|NCT01670084|Abortifacient Agents|abortifacient agents|mesh-ancestor
6691979|NCT01670084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6691980|NCT01670084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6691981|NCT01670084|Antimetabolites|antimetabolites|mesh-ancestor
6691982|NCT01670084|Dermatologic Agents|dermatologic agents|mesh-ancestor
6691983|NCT01670084|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6691984|NCT01670084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6691985|NCT01670084|Antiviral Agents|antiviral agents|mesh-ancestor
6691986|NCT01670084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6691987|NCT01670084|Antidotes|antidotes|mesh-ancestor
6691988|NCT01670084|Protective Agents|protective agents|mesh-ancestor
6691989|NCT01670084|Vitamin B Complex|vitamin b complex|mesh-ancestor
6691990|NCT01670084|Vitamins|vitamins|mesh-ancestor
6691991|NCT01670084|Micronutrients|micronutrients|mesh-ancestor
6691992|NCT01670084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6691993|NCT01670084|Tubulin Modulators|tubulin modulators|mesh-ancestor
6691994|NCT01670084|Antimitotic Agents|antimitotic agents|mesh-ancestor
6691995|NCT01670084|Mitosis Modulators|mitosis modulators|mesh-ancestor
6691996|NCT01670136|Sildenafil Citrate|sildenafil citrate|mesh-list
6691997|NCT01670136|Vasodilator Agents|vasodilator agents|mesh-ancestor
6691998|NCT01670136|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6691999|NCT01670136|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6692000|NCT01670136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780810|NCT02183402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692001|NCT01670136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692002|NCT01670136|Urological Agents|urological agents|mesh-ancestor
6692003|NCT01670149|Rifaximin|rifaximin|mesh-list
6692004|NCT01670149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6692005|NCT01670149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6692006|NCT01670149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6692007|NCT01670162|Aflibercept|aflibercept|mesh-list
6692008|NCT01670162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6692009|NCT01670162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6692010|NCT01670162|Growth Substances|growth substances|mesh-ancestor
6692011|NCT01670162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692012|NCT01670162|Growth Inhibitors|growth inhibitors|mesh-ancestor
6692013|NCT01670162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6692014|NCT01670175|Sirolimus|sirolimus|mesh-list
6692015|NCT01670175|Cyclophosphamide|cyclophosphamide|mesh-list
6692016|NCT01670175|Topotecan|topotecan|mesh-list
6692017|NCT01670175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6692018|NCT01670175|Immunologic Factors|immunologic factors|mesh-ancestor
6692019|NCT01670175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692020|NCT01670175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6692021|NCT01670175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6692022|NCT01670175|Alkylating Agents|alkylating agents|mesh-ancestor
6692023|NCT01670175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692024|NCT01670175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6692025|NCT01670175|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6692026|NCT01670175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6692027|NCT01670175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6692028|NCT01670175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6692029|NCT01670175|Antifungal Agents|antifungal agents|mesh-ancestor
6692030|NCT01670175|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6692031|NCT01670175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6692032|NCT01670175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6692033|NCT01670240|Adalimumab|adalimumab|mesh-list
6692034|NCT01670240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6692035|NCT01670240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6692036|NCT01670305|Photosensitizing Agents|photosensitizing agents|mesh-list
6692037|NCT01670305|Dermatologic Agents|dermatologic agents|mesh-ancestor
6692038|NCT01670318|Chromium|chromium|mesh-list
6692039|NCT01670318|Everolimus|everolimus|mesh-list
6692040|NCT01670318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6692041|NCT01670318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6692042|NCT01670318|Immunologic Factors|immunologic factors|mesh-ancestor
6692043|NCT01670318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692044|NCT01670318|Trace Elements|trace elements|mesh-ancestor
6692045|NCT01670318|Micronutrients|micronutrients|mesh-ancestor
6692046|NCT01670370|Gemcitabine|gemcitabine|mesh-list
6692047|NCT01670370|Oxaliplatin|oxaliplatin|mesh-list
6692048|NCT01670370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6692049|NCT01670370|Immunologic Factors|immunologic factors|mesh-ancestor
6692050|NCT01670370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692051|NCT01670370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6692052|NCT01670370|Antimetabolites|antimetabolites|mesh-ancestor
6692053|NCT01670370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692054|NCT01670370|Antiviral Agents|antiviral agents|mesh-ancestor
6692055|NCT01670370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6692056|NCT01670370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6692057|NCT01670370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6692058|NCT01670435|Ciprofloxacin|ciprofloxacin|mesh-list
6692059|NCT01670435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6692060|NCT01670435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6692061|NCT01670435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6692062|NCT01670435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6692063|NCT01670435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6692064|NCT01670435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692065|NCT01670435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6692066|NCT01670435|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6692067|NCT01670435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6692068|NCT01670474|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6692069|NCT01670474|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6692070|NCT01670474|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6692071|NCT01670474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780811|NCT02183402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6780812|NCT02183402|Incretins|incretins|mesh-ancestor
6780813|NCT02183402|Hormones|hormones|mesh-ancestor
6780814|NCT02183402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6692072|NCT01670552|Naproxen|naproxen|mesh-list
6692073|NCT01670552|Nimesulide|nimesulide|mesh-list
6692074|NCT01670552|Esomeprazole|esomeprazole|mesh-list
6692075|NCT01670552|Pantoprazole|pantoprazole|mesh-list
6692076|NCT01670552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6692077|NCT01670552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6692078|NCT01670552|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6692079|NCT01670552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6692080|NCT01670552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692081|NCT01670552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6692082|NCT01670552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6692083|NCT01670552|Analgesics|analgesics|mesh-ancestor
6692084|NCT01670552|Sensory System Agents|sensory system agents|mesh-ancestor
6692085|NCT01670552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6692086|NCT01670552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692087|NCT01670552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6692088|NCT01670552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6692089|NCT01670552|Gout Suppressants|gout suppressants|mesh-ancestor
6692090|NCT01670552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6692091|NCT01670565|Belimumab|belimumab|mesh-list
6692092|NCT01670565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6692093|NCT01670565|Immunologic Factors|immunologic factors|mesh-ancestor
6692094|NCT01670565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692095|NCT01670578|Hyaluronic Acid|hyaluronic acid|mesh-list
6692096|NCT01670578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6692097|NCT01670578|Immunologic Factors|immunologic factors|mesh-ancestor
6692098|NCT01670578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692099|NCT01670578|Viscosupplements|viscosupplements|mesh-ancestor
6692100|NCT01670578|Protective Agents|protective agents|mesh-ancestor
6692101|NCT01670669|Prucalopride|prucalopride|mesh-list
6692102|NCT01670669|Laxatives|laxatives|mesh-ancestor
6692103|NCT01670669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6692104|NCT01670669|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
6692105|NCT01670669|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6692106|NCT01670669|Serotonin Agents|serotonin agents|mesh-ancestor
6692107|NCT01670669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6692108|NCT01670669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692109|NCT01670669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692110|NCT01670773|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
6692111|NCT01670773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6692112|NCT01670773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6692113|NCT01670773|Analgesics|analgesics|mesh-ancestor
6692114|NCT01670773|Sensory System Agents|sensory system agents|mesh-ancestor
6692115|NCT01670773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6692116|NCT01670773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692117|NCT01670773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6692118|NCT01670773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6692119|NCT01670799|Ketorolac|ketorolac|mesh-list
6692120|NCT01670799|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6692121|NCT01670799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6692122|NCT01670799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6692123|NCT01670799|Analgesics|analgesics|mesh-ancestor
6692124|NCT01670799|Sensory System Agents|sensory system agents|mesh-ancestor
6692125|NCT01670799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6692126|NCT01670799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692127|NCT01670799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6692128|NCT01670799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6692129|NCT01670799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6692130|NCT01670799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6692131|NCT01670799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692132|NCT01670812|Methylprednisolone|methylprednisolone|mesh-list
6692133|NCT01670812|Rituximab|rituximab|mesh-list
6692134|NCT01670812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6692135|NCT01670812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6692136|NCT01670812|Immunologic Factors|immunologic factors|mesh-ancestor
6692137|NCT01670812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692138|NCT01670812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6692139|NCT01670812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6692140|NCT01670812|Antiemetics|antiemetics|mesh-ancestor
6692141|NCT01670812|Autonomic Agents|autonomic agents|mesh-ancestor
6692142|NCT01670812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6692143|NCT01670812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6692144|NCT01670812|Glucocorticoids|glucocorticoids|mesh-ancestor
6692145|NCT01670812|Hormones|hormones|mesh-ancestor
6692146|NCT01670812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6692147|NCT01670812|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6692148|NCT01670812|Protective Agents|protective agents|mesh-ancestor
6692149|NCT01670877|Trastuzumab|trastuzumab|mesh-list
6692150|NCT01670877|Fulvestrant|fulvestrant|mesh-list
6692151|NCT01670877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6692152|NCT01670877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6692153|NCT01670877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6692154|NCT01670877|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6692155|NCT01670877|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6692156|NCT01670877|Hormone Antagonists|hormone antagonists|mesh-ancestor
6692157|NCT01670877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6692158|NCT01670877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692159|NCT01670890|Cisplatin|cisplatin|mesh-list
6692160|NCT01670890|Temozolomide|temozolomide|mesh-list
6692161|NCT01670890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6692162|NCT01670890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6692163|NCT01670890|Alkylating Agents|alkylating agents|mesh-ancestor
6692164|NCT01670890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692165|NCT01670929|Progesterone|progesterone|mesh-list
6692166|NCT01670929|Progestins|progestins|mesh-ancestor
6692167|NCT01670929|Hormones|hormones|mesh-ancestor
6692168|NCT01670929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6692169|NCT01670929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692170|NCT01670955|Folic Acid|folic acid|mesh-list
6692171|NCT01670955|Hematinics|hematinics|mesh-ancestor
6692172|NCT01670955|Vitamin B Complex|vitamin b complex|mesh-ancestor
6692173|NCT01670955|Vitamins|vitamins|mesh-ancestor
6692174|NCT01670955|Micronutrients|micronutrients|mesh-ancestor
6692175|NCT01670955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692176|NCT01671384|Valproic Acid|valproic acid|mesh-list
6692177|NCT01671384|Anticonvulsants|anticonvulsants|mesh-ancestor
6692178|NCT01671384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6692179|NCT01671384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692180|NCT01671384|GABA Agents|gaba agents|mesh-ancestor
6692181|NCT01671384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6692182|NCT01671384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692183|NCT01671384|Antimanic Agents|antimanic agents|mesh-ancestor
6692184|NCT01671384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6692185|NCT01671384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6692186|NCT01671384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6692187|NCT01671410|Morphine|morphine|mesh-list
6692188|NCT01671410|Buprenorphine|buprenorphine|mesh-list
6692189|NCT01671410|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6692190|NCT01671410|Narcotics|narcotics|mesh-ancestor
6692191|NCT01671410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6692192|NCT01671410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692193|NCT01671410|Analgesics|analgesics|mesh-ancestor
6692194|NCT01671410|Sensory System Agents|sensory system agents|mesh-ancestor
6692195|NCT01671410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6692196|NCT01671410|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6692197|NCT01671449|Oxaliplatin|oxaliplatin|mesh-list
6692198|NCT01671449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6692199|NCT01671709|Montelukast|montelukast|mesh-list
6692200|NCT01671709|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6692201|NCT01671709|Respiratory System Agents|respiratory system agents|mesh-ancestor
6692202|NCT01671709|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6692203|NCT01671709|Hormone Antagonists|hormone antagonists|mesh-ancestor
6692204|NCT01671709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6692205|NCT01671709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692206|NCT01671709|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6692207|NCT01671709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6692208|NCT01671709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692209|NCT01671722|Montelukast|montelukast|mesh-list
6692210|NCT01671722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6692211|NCT01671722|Respiratory System Agents|respiratory system agents|mesh-ancestor
6692212|NCT01671722|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6692213|NCT01671722|Hormone Antagonists|hormone antagonists|mesh-ancestor
6692214|NCT01671722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6692215|NCT01671722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692216|NCT01671722|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6692217|NCT01671722|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6692218|NCT01671722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692219|NCT01671774|Zoledronic Acid|zoledronic acid|mesh-list
6692220|NCT01671774|Interleukin-2|interleukin-2|mesh-list
6692221|NCT01671774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6692222|NCT01671774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6692223|NCT01671774|Analgesics|analgesics|mesh-ancestor
6692224|NCT01671774|Sensory System Agents|sensory system agents|mesh-ancestor
6692225|NCT01671774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6692226|NCT01671774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692227|NCT01671774|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6692228|NCT01671787|Tenofovir|tenofovir|mesh-list
6692229|NCT01671787|Antiviral Agents|antiviral agents|mesh-ancestor
6692230|NCT01671787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6692231|NCT01671787|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6692232|NCT01671787|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6692233|NCT01671787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6692234|NCT01671787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692235|NCT01671787|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6692236|NCT01671787|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6692237|NCT01671800|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
6692238|NCT01671800|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6692239|NCT01671800|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6692240|NCT01671800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6692241|NCT01671800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692242|NCT01671800|Cholinergic Agents|cholinergic agents|mesh-ancestor
6692243|NCT01671800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6692244|NCT01671800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692245|NCT01671813|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6692246|NCT01671813|Immunoconjugates|immunoconjugates|mesh-list
6692247|NCT01671813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6692248|NCT01671813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6692249|NCT01671813|Immunologic Factors|immunologic factors|mesh-ancestor
6692250|NCT01671813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692251|NCT01671852|Mometasone Furoate|mometasone furoate|mesh-list
6692252|NCT01671852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6692253|NCT01671852|Dermatologic Agents|dermatologic agents|mesh-ancestor
6692254|NCT01671852|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6692255|NCT01671891|Capecitabine|capecitabine|mesh-list
6692256|NCT01671891|Oxaliplatin|oxaliplatin|mesh-list
6692257|NCT01671891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6692258|NCT01671891|Antimetabolites|antimetabolites|mesh-ancestor
6692259|NCT01671891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692260|NCT01671891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6692261|NCT01671904|Rituximab|rituximab|mesh-list
6692262|NCT01671904|Obinutuzumab|obinutuzumab|mesh-list
6692263|NCT01671904|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6692264|NCT01671904|Venetoclax|venetoclax|mesh-list
6692265|NCT01671904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6692266|NCT01671904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6692267|NCT01671904|Immunologic Factors|immunologic factors|mesh-ancestor
6692268|NCT01671904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692269|NCT01671904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6692270|NCT01671904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6692271|NCT01671904|Alkylating Agents|alkylating agents|mesh-ancestor
6692272|NCT01671904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692273|NCT01671982|Tenofovir|tenofovir|mesh-list
6692274|NCT01671982|Antiviral Agents|antiviral agents|mesh-ancestor
6692275|NCT01671982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6692276|NCT01671982|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6692277|NCT01671982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6692278|NCT01671982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6692279|NCT01671982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692280|NCT01671982|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6692281|NCT01671982|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6692282|NCT01672047|Vitamin D|vitamin d|mesh-list
6692283|NCT01672047|Ergocalciferols|ergocalciferols|mesh-list
6692284|NCT01672047|Vitamins|vitamins|mesh-ancestor
6692285|NCT01672047|Micronutrients|micronutrients|mesh-ancestor
6692286|NCT01672047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692287|NCT01672047|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6692288|NCT01672047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6692289|NCT01672086|Calcium Carbonate|calcium carbonate|mesh-list
6692290|NCT01672086|Antacids|antacids|mesh-ancestor
6692291|NCT01672086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692292|NCT01672086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6692293|NCT01672112|Oxycodone|oxycodone|mesh-list
6692294|NCT01672112|Codeine|codeine|mesh-list
6692295|NCT01672112|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6692296|NCT01672112|Narcotics|narcotics|mesh-ancestor
6692297|NCT01672112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6692298|NCT01672112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692299|NCT01672112|Analgesics|analgesics|mesh-ancestor
6692300|NCT01672112|Sensory System Agents|sensory system agents|mesh-ancestor
6692301|NCT01672112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6692302|NCT01672112|Antitussive Agents|antitussive agents|mesh-ancestor
6692303|NCT01672112|Respiratory System Agents|respiratory system agents|mesh-ancestor
6780815|NCT02183402|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6780816|NCT02183402|Protease Inhibitors|protease inhibitors|mesh-ancestor
6780817|NCT02183415|Linagliptin|linagliptin|mesh-list
6780818|NCT02183415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6780819|NCT02183415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780820|NCT02183415|Incretins|incretins|mesh-ancestor
6780821|NCT02183415|Hormones|hormones|mesh-ancestor
6780822|NCT02183415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6780823|NCT02183415|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6780824|NCT02183415|Protease Inhibitors|protease inhibitors|mesh-ancestor
6780825|NCT02183415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780826|NCT02183415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780827|NCT02183428|Glyburide|glyburide|mesh-list
6780828|NCT02183428|Linagliptin|linagliptin|mesh-list
6780829|NCT02183428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6780830|NCT02183428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780831|NCT02183428|Incretins|incretins|mesh-ancestor
6780832|NCT02183428|Hormones|hormones|mesh-ancestor
6780833|NCT02183428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6780834|NCT02183428|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6780835|NCT02183428|Protease Inhibitors|protease inhibitors|mesh-ancestor
6780836|NCT02183428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780837|NCT02183428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780838|NCT02183441|Linagliptin|linagliptin|mesh-list
6780839|NCT02183441|Ritonavir|ritonavir|mesh-list
6780840|NCT02183441|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6780841|NCT02183441|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6780842|NCT02183441|Protease Inhibitors|protease inhibitors|mesh-ancestor
6780843|NCT02183441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780844|NCT02183441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780845|NCT02183441|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6780846|NCT02183441|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6780847|NCT02183441|Antiviral Agents|antiviral agents|mesh-ancestor
6780848|NCT02183441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6780849|NCT02183441|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6780850|NCT02183441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6780851|NCT02183441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6780852|NCT02183441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780853|NCT02183441|Incretins|incretins|mesh-ancestor
6780854|NCT02183441|Hormones|hormones|mesh-ancestor
6780855|NCT02183441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6780856|NCT02183441|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6780857|NCT02183467|Linagliptin|linagliptin|mesh-list
6780858|NCT02183467|Moxifloxacin|moxifloxacin|mesh-list
6780859|NCT02183467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6780860|NCT02183467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6780861|NCT02183467|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6780862|NCT02183467|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6780863|NCT02183467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780864|NCT02183467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780865|NCT02183467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6780866|NCT02183467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780867|NCT02183467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6780868|NCT02183467|Incretins|incretins|mesh-ancestor
6780869|NCT02183467|Hormones|hormones|mesh-ancestor
6780870|NCT02183467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6780871|NCT02183467|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6692304|NCT01672151|Sirolimus|sirolimus|mesh-list
6692305|NCT01672151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6692306|NCT01672151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6692307|NCT01672151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6692308|NCT01672151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6692309|NCT01672151|Antifungal Agents|antifungal agents|mesh-ancestor
6692310|NCT01672151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6692311|NCT01672151|Immunologic Factors|immunologic factors|mesh-ancestor
6692312|NCT01672151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692313|NCT01672229|Bortezomib|bortezomib|mesh-list
6692314|NCT01672229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6692315|NCT01672255|Fluoxetine|fluoxetine|mesh-list
6692316|NCT01672255|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6692317|NCT01672255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6692318|NCT01672255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6692319|NCT01672255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692320|NCT01672255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6692321|NCT01672255|Serotonin Agents|serotonin agents|mesh-ancestor
6692322|NCT01672255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692323|NCT01672255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6692324|NCT01672255|Antidepressive Agents|antidepressive agents|mesh-ancestor
6692325|NCT01672255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6692326|NCT01672255|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6692327|NCT01672255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6692328|NCT01672255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6692329|NCT01672307|Minoxidil|minoxidil|mesh-list
6692330|NCT01672307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6692331|NCT01672307|Vasodilator Agents|vasodilator agents|mesh-ancestor
6692332|NCT01672346|Adenosine|adenosine|mesh-list
6692333|NCT01672346|Analgesics|analgesics|mesh-ancestor
6692334|NCT01672346|Sensory System Agents|sensory system agents|mesh-ancestor
6692335|NCT01672346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6692336|NCT01672346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692337|NCT01672346|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6692338|NCT01672346|Vasodilator Agents|vasodilator agents|mesh-ancestor
6692339|NCT01672346|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6692340|NCT01672346|Purinergic Agonists|purinergic agonists|mesh-ancestor
6692341|NCT01672346|Purinergic Agents|purinergic agents|mesh-ancestor
6692342|NCT01672346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6692343|NCT01672346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692344|NCT01672359|Choline|choline|mesh-list
6692345|NCT01672359|Lipotropic Agents|lipotropic agents|mesh-ancestor
6692346|NCT01672359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6692347|NCT01672359|Antimetabolites|antimetabolites|mesh-ancestor
6692348|NCT01672359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692349|NCT01672359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6692350|NCT01672359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6692351|NCT01672359|Nootropic Agents|nootropic agents|mesh-ancestor
6692352|NCT01672450|Ipilimumab|ipilimumab|mesh-list
6692353|NCT01672450|Interleukin-2|interleukin-2|mesh-list
6692354|NCT01672450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6692355|NCT01672450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6692356|NCT01672450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6692357|NCT01672450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692358|NCT01672450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6692359|NCT01672450|Analgesics|analgesics|mesh-ancestor
6692360|NCT01672450|Sensory System Agents|sensory system agents|mesh-ancestor
6692361|NCT01672450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6692362|NCT01672450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692363|NCT01672476|Valsartan|valsartan|mesh-list
6692364|NCT01672476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6692365|NCT01672476|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6692366|NCT01672476|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6692367|NCT01672476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692368|NCT01672554|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6692369|NCT01672554|Antidepressive Agents|antidepressive agents|mesh-ancestor
6692370|NCT01672554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6692371|NCT01672554|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6692372|NCT01672554|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6692373|NCT01672554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6692374|NCT01672554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692375|NCT01672580|Vitamins|vitamins|mesh-list
6692376|NCT01672580|Micronutrients|micronutrients|mesh-ancestor
6692377|NCT01672580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692378|NCT01672593|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6692379|NCT01672593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6692380|NCT01672606|Rocuronium|rocuronium|mesh-list
6692381|NCT01672606|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6692382|NCT01672606|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6692383|NCT01672606|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6692384|NCT01672606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6692385|NCT01672606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692386|NCT01672671|Paclitaxel|paclitaxel|mesh-list
6692387|NCT01672671|Doxorubicin|doxorubicin|mesh-list
6692388|NCT01672671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6692389|NCT01672671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6692390|NCT01672671|Tubulin Modulators|tubulin modulators|mesh-ancestor
6692391|NCT01672671|Antimitotic Agents|antimitotic agents|mesh-ancestor
6692392|NCT01672671|Mitosis Modulators|mitosis modulators|mesh-ancestor
6692393|NCT01672671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692394|NCT01672671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6692395|NCT01672671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6692396|NCT01672671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6692397|NCT01672671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6692398|NCT01672762|Ipragliflozin|ipragliflozin|mesh-list
6692399|NCT01672762|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6692400|NCT01672762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692401|NCT01672762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6692402|NCT01672762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692403|NCT01672814|Riboflavin|riboflavin|mesh-list
6692404|NCT01672814|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6692405|NCT01672814|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6692406|NCT01672814|Vitamin B Complex|vitamin b complex|mesh-ancestor
6692407|NCT01672814|Vitamins|vitamins|mesh-ancestor
6692408|NCT01672814|Micronutrients|micronutrients|mesh-ancestor
6692409|NCT01672814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692410|NCT01672814|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6692411|NCT01672814|Dermatologic Agents|dermatologic agents|mesh-ancestor
6692412|NCT01673087|Dexamethasone|dexamethasone|mesh-list
6692413|NCT01673087|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6692414|NCT01673087|Cosyntropin|cosyntropin|mesh-list
6692415|NCT01673087|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
6692416|NCT01673087|Metyrapone|metyrapone|mesh-list
6692417|NCT01673087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6692418|NCT01673087|Antiemetics|antiemetics|mesh-ancestor
6692419|NCT01673087|Autonomic Agents|autonomic agents|mesh-ancestor
6692420|NCT01673087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6692421|NCT01673087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692422|NCT01673087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6692423|NCT01673087|Glucocorticoids|glucocorticoids|mesh-ancestor
6692424|NCT01673087|Hormones|hormones|mesh-ancestor
6692425|NCT01673087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6692426|NCT01673087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6692427|NCT01673087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6692428|NCT01673087|Antimetabolites|antimetabolites|mesh-ancestor
6692429|NCT01673087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692430|NCT01673087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6692431|NCT01673204|Calcitriol|calcitriol|mesh-list
6692432|NCT01673204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6692433|NCT01673204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692434|NCT01673204|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6692435|NCT01673204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6692436|NCT01673204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692437|NCT01673204|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6692438|NCT01673204|Vitamins|vitamins|mesh-ancestor
6692439|NCT01673204|Micronutrients|micronutrients|mesh-ancestor
6692440|NCT01673204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6692441|NCT01673217|Doxorubicin|doxorubicin|mesh-list
6692442|NCT01673217|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6692443|NCT01673217|Decitabine|decitabine|mesh-list
6692444|NCT01673217|Azacitidine|azacitidine|mesh-list
6692445|NCT01673217|Vaccines|vaccines|mesh-list
6692446|NCT01673217|Sargramostim|sargramostim|mesh-list
6692447|NCT01673217|Freund's Adjuvant|freund's adjuvant|mesh-list
6692448|NCT01673217|Immunologic Factors|immunologic factors|mesh-ancestor
6692449|NCT01673217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692450|NCT01673217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6692451|NCT01673217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6692452|NCT01673217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6692453|NCT01673217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6692454|NCT01673217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6692455|NCT01673217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692456|NCT01673217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6692457|NCT01673217|Antimetabolites|antimetabolites|mesh-ancestor
6692458|NCT01673217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6692459|NCT01673308|Lenalidomide|lenalidomide|mesh-list
6692460|NCT01673308|Immunologic Factors|immunologic factors|mesh-ancestor
6692461|NCT01673308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692462|NCT01673308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6692463|NCT01673308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6692464|NCT01673308|Growth Substances|growth substances|mesh-ancestor
6692465|NCT01673308|Growth Inhibitors|growth inhibitors|mesh-ancestor
6692466|NCT01673308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6692467|NCT01673399|Atosiban|atosiban|mesh-list
6692468|NCT01673399|Hormone Antagonists|hormone antagonists|mesh-ancestor
6692469|NCT01673399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6692470|NCT01673399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692471|NCT01673399|Tocolytic Agents|tocolytic agents|mesh-ancestor
6692472|NCT01673399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6692473|NCT01673542|Lidocaine|lidocaine|mesh-list
6692474|NCT01673542|Prilocaine|prilocaine|mesh-list
6692475|NCT01673542|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
6692476|NCT01673542|Anesthetics, Local|anesthetics, local|mesh-ancestor
6692477|NCT01673542|Anesthetics|anesthetics|mesh-ancestor
6692478|NCT01673542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6692479|NCT01673542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692480|NCT01673542|Sensory System Agents|sensory system agents|mesh-ancestor
6692481|NCT01673542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6692482|NCT01673542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6692483|NCT01673542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6692484|NCT01673542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6692485|NCT01673542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6692486|NCT01673542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692487|NCT01673542|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
6692488|NCT01673724|Pramipexole|pramipexole|mesh-list
6692489|NCT01673724|Bromocriptine|bromocriptine|mesh-list
6692490|NCT01673724|Antioxidants|antioxidants|mesh-ancestor
6692491|NCT01673724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692492|NCT01673724|Protective Agents|protective agents|mesh-ancestor
6692493|NCT01673724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692494|NCT01673724|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6692495|NCT01673724|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6692496|NCT01673724|Dopamine Agonists|dopamine agonists|mesh-ancestor
6692497|NCT01673724|Dopamine Agents|dopamine agents|mesh-ancestor
6692498|NCT01673724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6692499|NCT01673724|Hormone Antagonists|hormone antagonists|mesh-ancestor
6692500|NCT01673724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6692501|NCT01673737|Vemurafenib|vemurafenib|mesh-list
6692502|NCT01673737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6692503|NCT01673737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6692504|NCT01673737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6692505|NCT01673737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692506|NCT01673997|Metoprolol|metoprolol|mesh-list
6692507|NCT01673997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6692508|NCT01673997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6692509|NCT01673997|Sympatholytics|sympatholytics|mesh-ancestor
6692510|NCT01673997|Autonomic Agents|autonomic agents|mesh-ancestor
6692511|NCT01673997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6692512|NCT01673997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692513|NCT01673997|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6692514|NCT01673997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6692515|NCT01673997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6692516|NCT01673997|Adrenergic Agents|adrenergic agents|mesh-ancestor
6692517|NCT01673997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6692518|NCT01673997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780872|NCT02183467|Protease Inhibitors|protease inhibitors|mesh-ancestor
6780873|NCT02183480|Linagliptin|linagliptin|mesh-list
6780874|NCT02183480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6780875|NCT02183480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780876|NCT02183480|Incretins|incretins|mesh-ancestor
6780877|NCT02183480|Hormones|hormones|mesh-ancestor
6780878|NCT02183480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6780879|NCT02183480|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6692519|NCT01674127|Methyldopa|methyldopa|mesh-list
6692520|NCT01674127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6692521|NCT01674127|Sympatholytics|sympatholytics|mesh-ancestor
6692522|NCT01674127|Autonomic Agents|autonomic agents|mesh-ancestor
6692523|NCT01674127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6692524|NCT01674127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692525|NCT01674127|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6692526|NCT01674127|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6692527|NCT01674127|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6692528|NCT01674127|Adrenergic Agents|adrenergic agents|mesh-ancestor
6692529|NCT01674127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6692530|NCT01674127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692531|NCT01674140|Tamoxifen|tamoxifen|mesh-list
6692532|NCT01674140|Everolimus|everolimus|mesh-list
6692533|NCT01674140|Letrozole|letrozole|mesh-list
6692534|NCT01674140|Anastrozole|anastrozole|mesh-list
6692535|NCT01674140|Leuprolide|leuprolide|mesh-list
6692536|NCT01674140|Exemestane|exemestane|mesh-list
6692537|NCT01674140|Goserelin|goserelin|mesh-list
6692538|NCT01674140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692539|NCT01674140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6692540|NCT01674140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6692541|NCT01674140|Immunologic Factors|immunologic factors|mesh-ancestor
6692542|NCT01674140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692543|NCT01674140|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6692544|NCT01674140|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6692545|NCT01674140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6692546|NCT01674140|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6692547|NCT01674140|Hormone Antagonists|hormone antagonists|mesh-ancestor
6692548|NCT01674140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6692549|NCT01674140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6692550|NCT01674140|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6692551|NCT01674140|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6692552|NCT01674140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6692553|NCT01674140|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6692554|NCT01674140|Fertility Agents|fertility agents|mesh-ancestor
6692555|NCT01674140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6692556|NCT01674166|Prucalopride|prucalopride|mesh-list
6692557|NCT01674166|Laxatives|laxatives|mesh-ancestor
6692558|NCT01674166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6692559|NCT01674166|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
6692560|NCT01674166|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6692561|NCT01674166|Serotonin Agents|serotonin agents|mesh-ancestor
6692562|NCT01674166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6692563|NCT01674166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692564|NCT01674166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692565|NCT01674192|Prucalopride|prucalopride|mesh-list
6692566|NCT01674192|Laxatives|laxatives|mesh-ancestor
6692567|NCT01674192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6692568|NCT01674192|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
6692569|NCT01674192|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6692570|NCT01674192|Serotonin Agents|serotonin agents|mesh-ancestor
6692571|NCT01674192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6692572|NCT01674192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692573|NCT01674192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692574|NCT01674205|Vaccines|vaccines|mesh-list
6692575|NCT01674205|Immunologic Factors|immunologic factors|mesh-ancestor
6692576|NCT01674205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692577|NCT01674218|Moxifloxacin|moxifloxacin|mesh-list
6692578|NCT01674218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6692579|NCT01674218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6692580|NCT01674218|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6692581|NCT01674218|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6692582|NCT01674218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6692583|NCT01674218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692584|NCT01674218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6692585|NCT01674257|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
6692586|NCT01674257|Fluorides|fluorides|mesh-list
6692587|NCT01674257|Cariostatic Agents|cariostatic agents|mesh-ancestor
6692588|NCT01674257|Protective Agents|protective agents|mesh-ancestor
6692589|NCT01674257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692590|NCT01674257|Hematinics|hematinics|mesh-ancestor
6692591|NCT01674257|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6692592|NCT01674257|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6692593|NCT01674270|Bicalutamide|bicalutamide|mesh-list
6692594|NCT01674270|Androgen Antagonists|androgen antagonists|mesh-ancestor
6692595|NCT01674270|Hormone Antagonists|hormone antagonists|mesh-ancestor
6692596|NCT01674270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6692597|NCT01674270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692598|NCT01674270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6692599|NCT01674283|Glucagon|glucagon|mesh-list
6692600|NCT01674283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6692601|NCT01674283|Hormones|hormones|mesh-ancestor
6692602|NCT01674283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6692603|NCT01674283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692604|NCT01674413|Adalimumab|adalimumab|mesh-list
6692605|NCT01674413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6692606|NCT01674413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6692607|NCT01674504|Montelukast|montelukast|mesh-list
6692608|NCT01674504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6692609|NCT01674504|Respiratory System Agents|respiratory system agents|mesh-ancestor
6692610|NCT01674504|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6692611|NCT01674504|Hormone Antagonists|hormone antagonists|mesh-ancestor
6692612|NCT01674504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6692613|NCT01674504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692614|NCT01674504|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6692615|NCT01674504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6692616|NCT01674504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692617|NCT01674517|Montelukast|montelukast|mesh-list
6692618|NCT01674517|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6692619|NCT01674517|Respiratory System Agents|respiratory system agents|mesh-ancestor
6692620|NCT01674517|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6692621|NCT01674517|Hormone Antagonists|hormone antagonists|mesh-ancestor
6692622|NCT01674517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6692623|NCT01674517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692624|NCT01674517|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6692625|NCT01674517|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6692626|NCT01674517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692627|NCT01674530|Lubiprostone|lubiprostone|mesh-list
6692628|NCT01674530|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6692629|NCT01674530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6692630|NCT01674530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692631|NCT01674556|Gemcitabine|gemcitabine|mesh-list
6692632|NCT01674556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6692633|NCT01674556|Antimetabolites|antimetabolites|mesh-ancestor
6692634|NCT01674556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692635|NCT01674556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6692636|NCT01674556|Antiviral Agents|antiviral agents|mesh-ancestor
6692637|NCT01674556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6692638|NCT01674556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6692639|NCT01674556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6692640|NCT01674556|Immunologic Factors|immunologic factors|mesh-ancestor
6692641|NCT01674556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692642|NCT01674686|Sarpogrelate|sarpogrelate|mesh-list
6692643|NCT01674686|Atorvastatin|atorvastatin|mesh-list
6692644|NCT01674686|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6692645|NCT01674686|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6692646|NCT01674686|Antimetabolites|antimetabolites|mesh-ancestor
6692647|NCT01674686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692648|NCT01674686|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6692649|NCT01674686|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6692650|NCT01674686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6692651|NCT01674686|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6692652|NCT01674686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6692653|NCT01674686|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6692654|NCT01674686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6692655|NCT01674686|Serotonin Agents|serotonin agents|mesh-ancestor
6692656|NCT01674686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6692657|NCT01674686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692658|NCT01674738|Bevacizumab|bevacizumab|mesh-list
6692659|NCT01674738|Pemetrexed|pemetrexed|mesh-list
6692660|NCT01674738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6692661|NCT01674738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6692662|NCT01674738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6692663|NCT01674738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6692664|NCT01674738|Growth Substances|growth substances|mesh-ancestor
6780880|NCT02183480|Protease Inhibitors|protease inhibitors|mesh-ancestor
6692665|NCT01674738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692666|NCT01674738|Growth Inhibitors|growth inhibitors|mesh-ancestor
6692667|NCT01674738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6692668|NCT01674738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692669|NCT01674738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6692670|NCT01674738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6692671|NCT01674777|Ipragliflozin|ipragliflozin|mesh-list
6692672|NCT01674777|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6692673|NCT01674777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692674|NCT01674777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6692675|NCT01674777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692676|NCT01674842|Cisplatin|cisplatin|mesh-list
6692677|NCT01674842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6692678|NCT01674855|Lenograstim|lenograstim|mesh-list
6692679|NCT01674855|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6692680|NCT01674855|Immunologic Factors|immunologic factors|mesh-ancestor
6692681|NCT01674855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692682|NCT01674868|Fluoxetine|fluoxetine|mesh-list
6692683|NCT01674868|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6692684|NCT01674868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6692685|NCT01674868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6692686|NCT01674868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692687|NCT01674868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6692688|NCT01674868|Serotonin Agents|serotonin agents|mesh-ancestor
6692689|NCT01674868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692690|NCT01674868|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6692691|NCT01674868|Antidepressive Agents|antidepressive agents|mesh-ancestor
6692692|NCT01674868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6692693|NCT01674868|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6692694|NCT01674868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6692695|NCT01674868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6692696|NCT01674933|Listerine|listerine|mesh-list
6692697|NCT01674933|Fluorides|fluorides|mesh-list
6692698|NCT01674933|Fluorides, Topical|fluorides, topical|mesh-list
6692699|NCT01674933|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
6692700|NCT01674933|Sodium Fluoride|sodium fluoride|mesh-list
6692701|NCT01674933|Cariostatic Agents|cariostatic agents|mesh-ancestor
6692702|NCT01674933|Protective Agents|protective agents|mesh-ancestor
6692703|NCT01674933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692704|NCT01674933|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6692705|NCT01674933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6692706|NCT01674946|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
6692707|NCT01674946|Bile Acids and Salts|bile acids and salts|mesh-list
6692708|NCT01674946|Cathartics|cathartics|mesh-ancestor
6692709|NCT01674946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6692710|NCT01675024|Rotigotine|rotigotine|mesh-list
6692711|NCT01675024|Dopamine Agonists|dopamine agonists|mesh-ancestor
6692712|NCT01675024|Dopamine Agents|dopamine agents|mesh-ancestor
6692713|NCT01675024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6692714|NCT01675024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692715|NCT01675024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692716|NCT01675076|Rivaroxaban|rivaroxaban|mesh-list
6692717|NCT01675076|Apixaban|apixaban|mesh-list
6692718|NCT01675076|Dabigatran|dabigatran|mesh-list
6692719|NCT01675076|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6692720|NCT01675076|Antithrombins|antithrombins|mesh-ancestor
6692721|NCT01675076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6692722|NCT01675076|Protease Inhibitors|protease inhibitors|mesh-ancestor
6692723|NCT01675076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6692724|NCT01675076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692725|NCT01675076|Anticoagulants|anticoagulants|mesh-ancestor
6692726|NCT01675089|Zoledronic Acid|zoledronic acid|mesh-list
6692727|NCT01675089|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6692728|NCT01675089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692729|NCT01675115|Aspirin|aspirin|mesh-list
6692730|NCT01675115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6692731|NCT01675115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6692732|NCT01675115|Analgesics|analgesics|mesh-ancestor
6692733|NCT01675115|Sensory System Agents|sensory system agents|mesh-ancestor
6692734|NCT01675115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6692735|NCT01675115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692736|NCT01675115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6692737|NCT01675115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6692738|NCT01675115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6692739|NCT01675115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6692740|NCT01675115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692741|NCT01675115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6692742|NCT01675115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6692743|NCT01675115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6692744|NCT01675115|Antipyretics|antipyretics|mesh-ancestor
6692745|NCT01675206|Vitamin K|vitamin k|mesh-list
6692746|NCT01675206|Vitamin K 2|vitamin k 2|mesh-list
6692747|NCT01675206|Vitamins|vitamins|mesh-ancestor
6692748|NCT01675206|Micronutrients|micronutrients|mesh-ancestor
6692749|NCT01675206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692750|NCT01675206|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6692751|NCT01675206|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6692752|NCT01675206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692753|NCT01675206|Hemostatics|hemostatics|mesh-ancestor
6692754|NCT01675206|Coagulants|coagulants|mesh-ancestor
6692755|NCT01675219|Mitomycins|mitomycins|mesh-list
6692756|NCT01675219|Mitomycin|mitomycin|mesh-list
6692757|NCT01675219|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6692758|NCT01675219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6692759|NCT01675219|Alkylating Agents|alkylating agents|mesh-ancestor
6692760|NCT01675219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692761|NCT01675219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6692762|NCT01675219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6692763|NCT01675310|Metformin|metformin|mesh-list
6692764|NCT01675310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6692765|NCT01675310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692766|NCT01675362|Selenium|selenium|mesh-list
6692767|NCT01675362|Losartan|losartan|mesh-list
6692768|NCT01675362|Verapamil|verapamil|mesh-list
6692769|NCT01675362|Calcium Channel Blockers|calcium channel blockers|mesh-list
6692770|NCT01675362|Calcium|calcium|mesh-list
6692771|NCT01675362|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
6692772|NCT01675362|Antioxidants|antioxidants|mesh-list
6692773|NCT01675362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6692774|NCT01675362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692775|NCT01675362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6692776|NCT01675362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6692777|NCT01675362|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6692778|NCT01675362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692779|NCT01675362|Protective Agents|protective agents|mesh-ancestor
6692780|NCT01675362|Trace Elements|trace elements|mesh-ancestor
6692781|NCT01675362|Micronutrients|micronutrients|mesh-ancestor
6692782|NCT01675362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6692783|NCT01675362|Vasodilator Agents|vasodilator agents|mesh-ancestor
6692784|NCT01675466|Anesthetics|anesthetics|mesh-list
6692785|NCT01675466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6692786|NCT01675466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692787|NCT01675518|ASP7991|asp7991|mesh-list
6692788|NCT01675518|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6692789|NCT01675518|Hormone Antagonists|hormone antagonists|mesh-ancestor
6692790|NCT01675518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6692791|NCT01675518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692792|NCT01675557|Vitamin D|vitamin d|mesh-list
6692793|NCT01675557|Ergocalciferols|ergocalciferols|mesh-list
6692794|NCT01675557|Cholecalciferol|cholecalciferol|mesh-list
6692795|NCT01675557|Vitamins|vitamins|mesh-list
6692796|NCT01675557|Micronutrients|micronutrients|mesh-ancestor
6692797|NCT01675557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692798|NCT01675557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6692799|NCT01675557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6692800|NCT01675648|Lofexidine|lofexidine|mesh-list
6692801|NCT01675648|Clonidine|clonidine|mesh-list
6692802|NCT01675648|Diazepam|diazepam|mesh-list
6692803|NCT01675648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6692804|NCT01675648|Anticonvulsants|anticonvulsants|mesh-ancestor
6692805|NCT01675648|Antiemetics|antiemetics|mesh-ancestor
6692806|NCT01675648|Autonomic Agents|autonomic agents|mesh-ancestor
6692807|NCT01675648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6692808|NCT01675648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692809|NCT01675648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6692810|NCT01675648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6692811|NCT01675648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6692812|NCT01675648|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6692813|NCT01675648|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6692814|NCT01675648|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6692815|NCT01675648|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6692816|NCT01675648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6692817|NCT01675648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6692818|NCT01675648|Anesthetics, General|anesthetics, general|mesh-ancestor
6692819|NCT01675648|Anesthetics|anesthetics|mesh-ancestor
6692820|NCT01675648|GABA Modulators|gaba modulators|mesh-ancestor
6692821|NCT01675648|GABA Agents|gaba agents|mesh-ancestor
6692822|NCT01675648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6692823|NCT01675648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692824|NCT01675648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6692825|NCT01675648|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6692826|NCT01675648|Sensory System Agents|sensory system agents|mesh-ancestor
6692827|NCT01675648|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6692828|NCT01675648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6692829|NCT01675648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6692830|NCT01675648|Adrenergic Agents|adrenergic agents|mesh-ancestor
6692831|NCT01675648|Analgesics|analgesics|mesh-ancestor
6692832|NCT01675648|Sympatholytics|sympatholytics|mesh-ancestor
6692833|NCT01675700|Nitroglycerin|nitroglycerin|mesh-list
6692834|NCT01675700|Vasodilator Agents|vasodilator agents|mesh-ancestor
6780881|NCT02183480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780882|NCT02183480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780883|NCT02183493|Linagliptin|linagliptin|mesh-list
6780884|NCT02183493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6780885|NCT02183493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780886|NCT02183493|Incretins|incretins|mesh-ancestor
6780887|NCT02183493|Hormones|hormones|mesh-ancestor
6780888|NCT02183493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6780889|NCT02183493|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6780890|NCT02183493|Protease Inhibitors|protease inhibitors|mesh-ancestor
6780891|NCT02183493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780892|NCT02183493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780893|NCT02183506|Metformin|metformin|mesh-list
6780894|NCT02183506|Linagliptin|linagliptin|mesh-list
6780895|NCT02183506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6780896|NCT02183506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780897|NCT02183506|Incretins|incretins|mesh-ancestor
6780898|NCT02183506|Hormones|hormones|mesh-ancestor
6780899|NCT02183506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6780900|NCT02183506|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6780901|NCT02183506|Protease Inhibitors|protease inhibitors|mesh-ancestor
6780902|NCT02183506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780903|NCT02183506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780904|NCT02183532|Linagliptin|linagliptin|mesh-list
6780905|NCT02183532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6780906|NCT02183532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780907|NCT02183532|Incretins|incretins|mesh-ancestor
6780908|NCT02183532|Hormones|hormones|mesh-ancestor
6780909|NCT02183532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6780910|NCT02183532|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6780911|NCT02183532|Protease Inhibitors|protease inhibitors|mesh-ancestor
6780912|NCT02183532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780913|NCT02183532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780914|NCT02183571|Metformin|metformin|mesh-list
6780915|NCT02183571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6780916|NCT02183571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780917|NCT02183584|Linagliptin|linagliptin|mesh-list
6780918|NCT02183584|Rifampin|rifampin|mesh-list
6780919|NCT02183584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6780920|NCT02183584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780921|NCT02183584|Incretins|incretins|mesh-ancestor
6780922|NCT02183584|Hormones|hormones|mesh-ancestor
6780923|NCT02183584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6780924|NCT02183584|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6780925|NCT02183584|Protease Inhibitors|protease inhibitors|mesh-ancestor
6780926|NCT02183584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780927|NCT02183584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780928|NCT02183584|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6780929|NCT02183584|Antitubercular Agents|antitubercular agents|mesh-ancestor
6780930|NCT02183584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6780931|NCT02183584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6780932|NCT02183584|Leprostatic Agents|leprostatic agents|mesh-ancestor
6780933|NCT02183584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6780934|NCT02183584|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6780935|NCT02183584|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6780936|NCT02183584|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6692835|NCT01675804|Methylphenidate|methylphenidate|mesh-list
6692836|NCT01675804|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6692837|NCT01675804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692838|NCT01675804|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6692839|NCT01675804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6692840|NCT01675804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6692841|NCT01675804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692842|NCT01675804|Dopamine Agents|dopamine agents|mesh-ancestor
6692843|NCT01675804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6692844|NCT01675895|Lidocaine|lidocaine|mesh-list
6692845|NCT01675895|Levobupivacaine|levobupivacaine|mesh-list
6692846|NCT01675895|Anesthetics|anesthetics|mesh-list
6692847|NCT01675895|Anesthetics, Local|anesthetics, local|mesh-ancestor
6692848|NCT01675895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6692849|NCT01675895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692850|NCT01675895|Sensory System Agents|sensory system agents|mesh-ancestor
6692851|NCT01675895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6692852|NCT01675895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6692853|NCT01675895|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6692854|NCT01675895|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6692855|NCT01675895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6692856|NCT01675895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692857|NCT01675947|Sirolimus|sirolimus|mesh-list
6692858|NCT01675947|Lidocaine|lidocaine|mesh-list
6692859|NCT01675947|Anesthetics, Local|anesthetics, local|mesh-ancestor
6692860|NCT01675947|Anesthetics|anesthetics|mesh-ancestor
6692861|NCT01675947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6692862|NCT01675947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692863|NCT01675947|Sensory System Agents|sensory system agents|mesh-ancestor
6692864|NCT01675947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6692865|NCT01675947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6692866|NCT01675947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6692867|NCT01675947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6692868|NCT01675947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6692869|NCT01675947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692870|NCT01675947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6692871|NCT01675947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6692872|NCT01675947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6692873|NCT01675947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6692874|NCT01675947|Antifungal Agents|antifungal agents|mesh-ancestor
6692875|NCT01675947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6692876|NCT01675947|Immunologic Factors|immunologic factors|mesh-ancestor
6692877|NCT01675973|Ranolazine|ranolazine|mesh-list
6692878|NCT01675973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6692879|NCT01675973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6692880|NCT01675973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692881|NCT01675986|Pregabalin|pregabalin|mesh-list
6692882|NCT01675986|Hydroxyzine|hydroxyzine|mesh-list
6692883|NCT01675986|Analgesics|analgesics|mesh-ancestor
6692884|NCT01675986|Sensory System Agents|sensory system agents|mesh-ancestor
6692885|NCT01675986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6692886|NCT01675986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692887|NCT01675986|Anticonvulsants|anticonvulsants|mesh-ancestor
6692888|NCT01675986|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6692889|NCT01675986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6692890|NCT01675986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692891|NCT01675986|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6692892|NCT01675986|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6692893|NCT01675986|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6692894|NCT01675986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6692895|NCT01675986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6692896|NCT01675986|Antipruritics|antipruritics|mesh-ancestor
6692897|NCT01675986|Dermatologic Agents|dermatologic agents|mesh-ancestor
6692898|NCT01675986|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6692899|NCT01675986|Histamine Antagonists|histamine antagonists|mesh-ancestor
6692900|NCT01675986|Histamine Agents|histamine agents|mesh-ancestor
6692901|NCT01675986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6692902|NCT01675999|Leucovorin|leucovorin|mesh-list
6692903|NCT01675999|Cetuximab|cetuximab|mesh-list
6692904|NCT01675999|Fluorouracil|fluorouracil|mesh-list
6692905|NCT01675999|Oxaliplatin|oxaliplatin|mesh-list
6692906|NCT01675999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6692907|NCT01675999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6692908|NCT01675999|Antimetabolites|antimetabolites|mesh-ancestor
6692909|NCT01675999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692910|NCT01675999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6692911|NCT01675999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6692912|NCT01675999|Immunologic Factors|immunologic factors|mesh-ancestor
6692913|NCT01675999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692914|NCT01675999|Antidotes|antidotes|mesh-ancestor
6692915|NCT01675999|Protective Agents|protective agents|mesh-ancestor
6692916|NCT01675999|Vitamin B Complex|vitamin b complex|mesh-ancestor
6692917|NCT01675999|Vitamins|vitamins|mesh-ancestor
6692918|NCT01675999|Micronutrients|micronutrients|mesh-ancestor
6692919|NCT01676233|Insulin|insulin|mesh-list
6692920|NCT01676233|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6692921|NCT01676233|Insulin Glargine|insulin glargine|mesh-list
6692922|NCT01676233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6692923|NCT01676233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692924|NCT01676246|Flupirtine|flupirtine|mesh-list
6692925|NCT01676246|Analgesics|analgesics|mesh-ancestor
6692926|NCT01676246|Sensory System Agents|sensory system agents|mesh-ancestor
6692927|NCT01676246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6692928|NCT01676246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692929|NCT01676259|Gemcitabine|gemcitabine|mesh-list
6692930|NCT01676259|Paclitaxel|paclitaxel|mesh-list
6692931|NCT01676259|Folfirinox|folfirinox|mesh-list
6692932|NCT01676259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6692933|NCT01676259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6692934|NCT01676259|Tubulin Modulators|tubulin modulators|mesh-ancestor
6692935|NCT01676259|Antimitotic Agents|antimitotic agents|mesh-ancestor
6692936|NCT01676259|Mitosis Modulators|mitosis modulators|mesh-ancestor
6692937|NCT01676259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692938|NCT01676259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6692939|NCT01676259|Antimetabolites|antimetabolites|mesh-ancestor
6692940|NCT01676259|Antiviral Agents|antiviral agents|mesh-ancestor
6692941|NCT01676259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6692942|NCT01676259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6692943|NCT01676259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6692944|NCT01676259|Immunologic Factors|immunologic factors|mesh-ancestor
6692945|NCT01676259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692946|NCT01676285|Metoprolol|metoprolol|mesh-list
6692947|NCT01676285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6692948|NCT01676285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6692949|NCT01676285|Sympatholytics|sympatholytics|mesh-ancestor
6692950|NCT01676285|Autonomic Agents|autonomic agents|mesh-ancestor
6692951|NCT01676285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6692952|NCT01676285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692953|NCT01676285|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6692954|NCT01676285|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6692955|NCT01676285|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6692956|NCT01676285|Adrenergic Agents|adrenergic agents|mesh-ancestor
6692957|NCT01676285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6692958|NCT01676285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692959|NCT01676363|Diflunisal|diflunisal|mesh-list
6692960|NCT01676363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6692961|NCT01676363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6692962|NCT01676363|Analgesics|analgesics|mesh-ancestor
6692963|NCT01676363|Sensory System Agents|sensory system agents|mesh-ancestor
6692964|NCT01676363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6692965|NCT01676363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692966|NCT01676363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6692967|NCT01676363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6692968|NCT01676363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6692969|NCT01676363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6692970|NCT01676363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6692971|NCT01676402|Vaccines|vaccines|mesh-list
6692972|NCT01676402|Immunologic Factors|immunologic factors|mesh-ancestor
6692973|NCT01676402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692974|NCT01676493|Codeine|codeine|mesh-list
6692975|NCT01676493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6692976|NCT01676493|Narcotics|narcotics|mesh-ancestor
6692977|NCT01676493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6692978|NCT01676493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692979|NCT01676493|Analgesics|analgesics|mesh-ancestor
6692980|NCT01676493|Sensory System Agents|sensory system agents|mesh-ancestor
6692981|NCT01676493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6692982|NCT01676493|Antitussive Agents|antitussive agents|mesh-ancestor
6692983|NCT01676493|Respiratory System Agents|respiratory system agents|mesh-ancestor
6692984|NCT01676506|Ranibizumab|ranibizumab|mesh-list
6692985|NCT01676506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6692986|NCT01676506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6692987|NCT01676506|Growth Substances|growth substances|mesh-ancestor
6692988|NCT01676506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692989|NCT01676506|Growth Inhibitors|growth inhibitors|mesh-ancestor
6692990|NCT01676506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6692991|NCT01676558|Rituximab|rituximab|mesh-list
6692992|NCT01676558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6692993|NCT01676558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6692994|NCT01676558|Immunologic Factors|immunologic factors|mesh-ancestor
6692995|NCT01676558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6692996|NCT01676558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6692997|NCT01676571|Vortioxetine|vortioxetine|mesh-list
6692998|NCT01676571|Antidepressive Agents|antidepressive agents|mesh-ancestor
6692999|NCT01676571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6693000|NCT01676571|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6693001|NCT01676571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6693002|NCT01676571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6693003|NCT01676571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693004|NCT01676571|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6693005|NCT01676571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6693006|NCT01676571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6693007|NCT01676571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6693008|NCT01676571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6693009|NCT01676571|Serotonin Agents|serotonin agents|mesh-ancestor
6693010|NCT01676571|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6693011|NCT01676571|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6693012|NCT01676571|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6693013|NCT01676571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6693014|NCT01676597|Rifaximin|rifaximin|mesh-list
6693015|NCT01676597|Pentoxifylline|pentoxifylline|mesh-list
6693016|NCT01676597|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6693017|NCT01676597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6693018|NCT01676597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6693019|NCT01676597|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6693020|NCT01676597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6693021|NCT01676597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6693022|NCT01676597|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6693023|NCT01676597|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6693024|NCT01676597|Protective Agents|protective agents|mesh-ancestor
6693025|NCT01676597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693026|NCT01676597|Vasodilator Agents|vasodilator agents|mesh-ancestor
6693027|NCT01676597|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6693028|NCT01676597|Antioxidants|antioxidants|mesh-ancestor
6693029|NCT01676649|Paclitaxel|paclitaxel|mesh-list
6693030|NCT01676649|Carboplatin|carboplatin|mesh-list
6693031|NCT01676649|Ipilimumab|ipilimumab|mesh-list
6693032|NCT01676649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6693033|NCT01676649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6693034|NCT01676649|Tubulin Modulators|tubulin modulators|mesh-ancestor
6693035|NCT01676649|Antimitotic Agents|antimitotic agents|mesh-ancestor
6693036|NCT01676649|Mitosis Modulators|mitosis modulators|mesh-ancestor
6693037|NCT01676649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6693038|NCT01676649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6693039|NCT01676649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6693040|NCT01676753|Pembrolizumab|pembrolizumab|mesh-list
6693041|NCT01676753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6693042|NCT01676753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6693043|NCT01676844|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6693044|NCT01676844|Potassium phosphate|potassium phosphate|mesh-list
6693045|NCT01676844|Cariostatic Agents|cariostatic agents|mesh-ancestor
6693046|NCT01676844|Protective Agents|protective agents|mesh-ancestor
6693047|NCT01676844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693048|NCT01676948|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6693049|NCT01676948|Immunologic Factors|immunologic factors|mesh-ancestor
6693050|NCT01676948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693051|NCT01676987|Budesonide|budesonide|mesh-list
6693052|NCT01676987|Formoterol Fumarate|formoterol fumarate|mesh-list
6693053|NCT01676987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6693054|NCT01676987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6693055|NCT01676987|Autonomic Agents|autonomic agents|mesh-ancestor
6693056|NCT01676987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6693057|NCT01676987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693058|NCT01676987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6693059|NCT01676987|Respiratory System Agents|respiratory system agents|mesh-ancestor
6693060|NCT01676987|Glucocorticoids|glucocorticoids|mesh-ancestor
6693061|NCT01676987|Hormones|hormones|mesh-ancestor
6693062|NCT01676987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6693063|NCT01676987|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6693064|NCT01676987|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6693065|NCT01676987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6693066|NCT01676987|Adrenergic Agents|adrenergic agents|mesh-ancestor
6693067|NCT01676987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6693068|NCT01676987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6693069|NCT01677039|Ethanol|ethanol|mesh-list
6693070|NCT01677039|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6693071|NCT01677039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6693072|NCT01677039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6693073|NCT01677039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693074|NCT01677065|Oxycodone|oxycodone|mesh-list
6693075|NCT01677065|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6693076|NCT01677065|Narcotics|narcotics|mesh-ancestor
6693077|NCT01677065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6693078|NCT01677065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693079|NCT01677065|Analgesics|analgesics|mesh-ancestor
6693080|NCT01677065|Sensory System Agents|sensory system agents|mesh-ancestor
6693081|NCT01677065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6693082|NCT01677104|Liraglutide|liraglutide|mesh-list
6693083|NCT01677104|Exenatide|exenatide|mesh-list
6693084|NCT01677104|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6693085|NCT01677104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6693086|NCT01677104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693087|NCT01677104|Incretins|incretins|mesh-ancestor
6693088|NCT01677104|Hormones|hormones|mesh-ancestor
6693089|NCT01677104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6693090|NCT01677104|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6693091|NCT01677143|Bupivacaine|bupivacaine|mesh-list
6693092|NCT01677143|Anesthetics, Local|anesthetics, local|mesh-ancestor
6693093|NCT01677143|Anesthetics|anesthetics|mesh-ancestor
6693094|NCT01677143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6693095|NCT01677143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693096|NCT01677143|Sensory System Agents|sensory system agents|mesh-ancestor
6693097|NCT01677143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6693098|NCT01677221|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6693099|NCT01677221|Dermatologic Agents|dermatologic agents|mesh-ancestor
6693100|NCT01677247|Glimepiride|glimepiride|mesh-list
6693101|NCT01677247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6693102|NCT01677247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6693103|NCT01677247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693104|NCT01677247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6693105|NCT01677247|Immunologic Factors|immunologic factors|mesh-ancestor
6693106|NCT01677260|Metformin|metformin|mesh-list
6693107|NCT01677260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6693108|NCT01677260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693109|NCT01677273|Caseins|caseins|mesh-list
6693110|NCT01677273|Chelating Agents|chelating agents|mesh-ancestor
6693111|NCT01677273|Sequestering Agents|sequestering agents|mesh-ancestor
6693112|NCT01677273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6693113|NCT01677351|Clonidine|clonidine|mesh-list
6693114|NCT01677351|Analgesics|analgesics|mesh-ancestor
6693115|NCT01677351|Sensory System Agents|sensory system agents|mesh-ancestor
6693116|NCT01677351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6693117|NCT01677351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693118|NCT01677351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6693119|NCT01677351|Sympatholytics|sympatholytics|mesh-ancestor
6693120|NCT01677351|Autonomic Agents|autonomic agents|mesh-ancestor
6693121|NCT01677351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6693122|NCT01677351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6693123|NCT01677351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6693124|NCT01677351|Adrenergic Agents|adrenergic agents|mesh-ancestor
6693125|NCT01677351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6693126|NCT01677351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780937|NCT02183584|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6780938|NCT02183584|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6780939|NCT02183584|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6780940|NCT02183610|Linagliptin|linagliptin|mesh-list
6780941|NCT02183610|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6780942|NCT02183610|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6780943|NCT02183610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693127|NCT01677364|Oxytocin|oxytocin|mesh-list
6693128|NCT01677364|Oxytocics|oxytocics|mesh-ancestor
6693129|NCT01677364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6693130|NCT01677364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693131|NCT01677390|Everolimus|everolimus|mesh-list
6693132|NCT01677390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6693133|NCT01677390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6693134|NCT01677390|Immunologic Factors|immunologic factors|mesh-ancestor
6693135|NCT01677390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693136|NCT01677403|Tobramycin|tobramycin|mesh-list
6693137|NCT01677403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6693138|NCT01677403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6693139|NCT01677442|Anesthetics|anesthetics|mesh-list
6693140|NCT01677442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6693141|NCT01677442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693142|NCT01677468|Doxorubicin|doxorubicin|mesh-list
6693143|NCT01677468|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6693144|NCT01677468|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
6693145|NCT01677468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6693146|NCT01677468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6693147|NCT01677468|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6693148|NCT01677468|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6693149|NCT01677468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6693150|NCT01677468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6693151|NCT01677468|Hemostatics|hemostatics|mesh-ancestor
6693152|NCT01677468|Coagulants|coagulants|mesh-ancestor
6693153|NCT01677546|Insulin|insulin|mesh-list
6693154|NCT01677546|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6693155|NCT01677546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6693156|NCT01677546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693157|NCT01677559|Paclitaxel|paclitaxel|mesh-list
6693158|NCT01677559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6693159|NCT01677559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6693160|NCT01677559|Tubulin Modulators|tubulin modulators|mesh-ancestor
6693161|NCT01677559|Antimitotic Agents|antimitotic agents|mesh-ancestor
6693162|NCT01677559|Mitosis Modulators|mitosis modulators|mesh-ancestor
6693163|NCT01677559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6693164|NCT01677572|Immunoglobulin G|immunoglobulin g|mesh-list
6693165|NCT01677572|Immunologic Factors|immunologic factors|mesh-ancestor
6693166|NCT01677572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693167|NCT01677598|Ustekinumab|ustekinumab|mesh-list
6693168|NCT01677598|Dermatologic Agents|dermatologic agents|mesh-ancestor
6693169|NCT01677611|Resveratrol|resveratrol|mesh-list
6693170|NCT01677611|Antioxidants|antioxidants|mesh-ancestor
6693171|NCT01677611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6693172|NCT01677611|Protective Agents|protective agents|mesh-ancestor
6693173|NCT01677611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693174|NCT01677611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6693175|NCT01677611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6693176|NCT01677650|Methadone|methadone|mesh-list
6693177|NCT01677650|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6693178|NCT01677650|Narcotics|narcotics|mesh-ancestor
6693179|NCT01677650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6693180|NCT01677650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693181|NCT01677650|Analgesics|analgesics|mesh-ancestor
6693182|NCT01677650|Sensory System Agents|sensory system agents|mesh-ancestor
6693183|NCT01677650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6693184|NCT01677650|Antitussive Agents|antitussive agents|mesh-ancestor
6693185|NCT01677650|Respiratory System Agents|respiratory system agents|mesh-ancestor
6693186|NCT01677702|Lactoferrin|lactoferrin|mesh-list
6693187|NCT01677702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6693188|NCT01677884|Bevacizumab|bevacizumab|mesh-list
6693189|NCT01677884|Capecitabine|capecitabine|mesh-list
6693190|NCT01677884|Irinotecan|irinotecan|mesh-list
6693191|NCT01677884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6693192|NCT01677884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6693193|NCT01677884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6693194|NCT01677884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6693195|NCT01677884|Growth Substances|growth substances|mesh-ancestor
6693196|NCT01677884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693197|NCT01677884|Growth Inhibitors|growth inhibitors|mesh-ancestor
6693198|NCT01677884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6693199|NCT01677884|Antimetabolites|antimetabolites|mesh-ancestor
6693200|NCT01677884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6693201|NCT01677884|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6693202|NCT01677884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6693203|NCT01677884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6693204|NCT01677897|Metformin|metformin|mesh-list
6693205|NCT01677897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6693206|NCT01677897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693207|NCT01677923|Metformin|metformin|mesh-list
6693208|NCT01677923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6693209|NCT01677923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693210|NCT01677949|Cyclophosphamide|cyclophosphamide|mesh-list
6693211|NCT01677949|Etoposide|etoposide|mesh-list
6693212|NCT01677949|Clofarabine|clofarabine|mesh-list
6693213|NCT01677949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6693214|NCT01677949|Immunologic Factors|immunologic factors|mesh-ancestor
6693215|NCT01677949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693216|NCT01677949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6693217|NCT01677949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6693218|NCT01677949|Alkylating Agents|alkylating agents|mesh-ancestor
6693219|NCT01677949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6693220|NCT01677949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6693221|NCT01677949|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6693222|NCT01677949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6693223|NCT01677949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6693224|NCT01677949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6693225|NCT01677949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6693226|NCT01677949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6693227|NCT01677949|Antimetabolites|antimetabolites|mesh-ancestor
6693228|NCT01677962|Poly ICLC|poly iclc|mesh-list
6693229|NCT01677962|Interferon Inducers|interferon inducers|mesh-ancestor
6693230|NCT01677962|Immunologic Factors|immunologic factors|mesh-ancestor
6693231|NCT01677962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693232|NCT01678001|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
6693233|NCT01678001|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6693234|NCT01678001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6693235|NCT01678001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693236|NCT01678001|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6693237|NCT01678001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6693238|NCT01678001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6693239|NCT01678001|Cholinergic Agents|cholinergic agents|mesh-ancestor
6693240|NCT01678001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6693241|NCT01678027|Clarithromycin|clarithromycin|mesh-list
6693242|NCT01678027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6693243|NCT01678027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6693244|NCT01678027|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6693245|NCT01678027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6693246|NCT01678027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6693247|NCT01678027|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6693248|NCT01678027|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6693249|NCT01678053|Omeprazole|omeprazole|mesh-list
6693250|NCT01678053|Botulinum Toxins|botulinum toxins|mesh-list
6693251|NCT01678053|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6693252|NCT01678053|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6693253|NCT01678053|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
6693254|NCT01678053|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6693255|NCT01678053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6693256|NCT01678053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6693257|NCT01678053|Cholinergic Agents|cholinergic agents|mesh-ancestor
6693258|NCT01678053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6693259|NCT01678053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693260|NCT01678053|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6693261|NCT01678053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6693262|NCT01678053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6693263|NCT01678053|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6693264|NCT01678053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6693265|NCT01678079|Calcium, Dietary|calcium, dietary|mesh-list
6693266|NCT01678079|Calcium|calcium|mesh-list
6693267|NCT01678079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6693268|NCT01678079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693269|NCT01678079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6693270|NCT01678092|Omalizumab|omalizumab|mesh-list
6693271|NCT01678092|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6693272|NCT01678092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6693273|NCT01678092|Respiratory System Agents|respiratory system agents|mesh-ancestor
6693274|NCT01678235|Insulin|insulin|mesh-list
6693275|NCT01678235|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6693276|NCT01678235|Insulin Aspart|insulin aspart|mesh-list
6693277|NCT01678235|Insulin glulisine|insulin glulisine|mesh-list
6693278|NCT01678235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6693279|NCT01678235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693280|NCT01678287|Ipragliflozin|ipragliflozin|mesh-list
6693281|NCT01678287|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6693282|NCT01678287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6693283|NCT01678287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6693284|NCT01678287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693285|NCT01678352|Imiquimod|imiquimod|mesh-list
6693286|NCT01678352|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6693287|NCT01678352|Immunologic Factors|immunologic factors|mesh-ancestor
6693288|NCT01678352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693289|NCT01678352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6693290|NCT01678352|Interferon Inducers|interferon inducers|mesh-ancestor
6693291|NCT01678365|Metronidazole|metronidazole|mesh-list
6693292|NCT01678365|Gentamicins|gentamicins|mesh-list
6693293|NCT01678365|Ceftriaxone|ceftriaxone|mesh-list
6693294|NCT01678365|Ampicillin|ampicillin|mesh-list
6693295|NCT01678365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6693296|NCT01678365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6693297|NCT01678365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6693298|NCT01678365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6693299|NCT01678365|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6693300|NCT01678365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6693301|NCT01678365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6693302|NCT01678404|Rituximab|rituximab|mesh-list
6693303|NCT01678404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6693304|NCT01678404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6693305|NCT01678404|Immunologic Factors|immunologic factors|mesh-ancestor
6693306|NCT01678404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693307|NCT01678404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6693308|NCT01678417|Rituximab|rituximab|mesh-list
6693309|NCT01678417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6693310|NCT01678417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6693311|NCT01678417|Immunologic Factors|immunologic factors|mesh-ancestor
6693312|NCT01678417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693313|NCT01678417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6693314|NCT01678430|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6693315|NCT01678430|Chlorambucil|chlorambucil|mesh-list
6693316|NCT01678430|Ofatumumab|ofatumumab|mesh-list
6693317|NCT01678430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6693318|NCT01678430|Alkylating Agents|alkylating agents|mesh-ancestor
6693319|NCT01678430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6693320|NCT01678430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6693321|NCT01678495|Plasminogen|plasminogen|mesh-list
6693322|NCT01678495|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6693323|NCT01678495|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6693324|NCT01678495|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6693325|NCT01678495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6693326|NCT01678573|Abiraterone Acetate|abiraterone acetate|mesh-list
6693327|NCT01678573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6693328|NCT01678573|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6693329|NCT01678573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6693330|NCT01678573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6693331|NCT01678573|Hormone Antagonists|hormone antagonists|mesh-ancestor
6693332|NCT01678573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6693333|NCT01678573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693334|NCT01678573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6693335|NCT01678586|Diphenhydramine|diphenhydramine|mesh-list
6693336|NCT01678586|Gabapentin|gabapentin|mesh-list
6693337|NCT01678586|Analgesics|analgesics|mesh-ancestor
6693338|NCT01678586|Sensory System Agents|sensory system agents|mesh-ancestor
6693339|NCT01678586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6693340|NCT01678586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693341|NCT01678586|Anticonvulsants|anticonvulsants|mesh-ancestor
6693342|NCT01678586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6693343|NCT01678586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6693344|NCT01678586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6693345|NCT01678586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6693346|NCT01678586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6693347|NCT01678586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6693348|NCT01678586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6693349|NCT01678586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6693350|NCT01678586|Antimanic Agents|antimanic agents|mesh-ancestor
6693351|NCT01678586|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6780944|NCT02183610|Incretins|incretins|mesh-ancestor
6693352|NCT01678586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6693353|NCT01678586|Anesthetics, Local|anesthetics, local|mesh-ancestor
6693354|NCT01678586|Anesthetics|anesthetics|mesh-ancestor
6693355|NCT01678586|Antiemetics|antiemetics|mesh-ancestor
6693356|NCT01678586|Autonomic Agents|autonomic agents|mesh-ancestor
6693357|NCT01678586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6693358|NCT01678586|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6693359|NCT01678586|Histamine Antagonists|histamine antagonists|mesh-ancestor
6693360|NCT01678586|Histamine Agents|histamine agents|mesh-ancestor
6693361|NCT01678586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6693362|NCT01678599|Benzonidazole|benzonidazole|mesh-list
6693363|NCT01678599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6693364|NCT01678599|Immunologic Factors|immunologic factors|mesh-ancestor
6693365|NCT01678599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693366|NCT01678599|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6693367|NCT01678599|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6693368|NCT01678599|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6693369|NCT01678599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6693370|NCT01678612|Copper|copper|mesh-list
6693371|NCT01678612|Trace Elements|trace elements|mesh-ancestor
6693372|NCT01678612|Micronutrients|micronutrients|mesh-ancestor
6693373|NCT01678612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693374|NCT01678664|Doxorubicin|doxorubicin|mesh-list
6693375|NCT01678664|Everolimus|everolimus|mesh-list
6693376|NCT01678664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6693377|NCT01678664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6693378|NCT01678664|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6693379|NCT01678664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6693380|NCT01678664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6693381|NCT01678664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6693382|NCT01678664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6693383|NCT01678664|Immunologic Factors|immunologic factors|mesh-ancestor
6693384|NCT01678664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693385|NCT01678677|Vaccines|vaccines|mesh-list
6693386|NCT01678677|Immunologic Factors|immunologic factors|mesh-ancestor
6693387|NCT01678677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693388|NCT01678690|Gemcitabine|gemcitabine|mesh-list
6693389|NCT01678690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6693390|NCT01678690|Antimetabolites|antimetabolites|mesh-ancestor
6693391|NCT01678690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6693392|NCT01678690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6693393|NCT01678690|Antiviral Agents|antiviral agents|mesh-ancestor
6693394|NCT01678690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6693395|NCT01678690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6693396|NCT01678690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6693397|NCT01678690|Immunologic Factors|immunologic factors|mesh-ancestor
6693398|NCT01678690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693399|NCT01678703|Misoprostol|misoprostol|mesh-list
6693400|NCT01678703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6693401|NCT01678703|Abortifacient Agents|abortifacient agents|mesh-ancestor
6693402|NCT01678703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6693403|NCT01678703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693404|NCT01678703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6693405|NCT01678703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6693406|NCT01678703|Oxytocics|oxytocics|mesh-ancestor
6693407|NCT01678716|Micronutrients|micronutrients|mesh-list
6693408|NCT01678716|Trace Elements|trace elements|mesh-list
6693409|NCT01678716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693410|NCT01678937|Cyclosporine|cyclosporine|mesh-list
6693411|NCT01678937|Sirolimus|sirolimus|mesh-list
6693412|NCT01678937|Mycophenolic Acid|mycophenolic acid|mesh-list
6693413|NCT01678937|Tacrolimus|tacrolimus|mesh-list
6693414|NCT01678937|Cyclosporins|cyclosporins|mesh-list
6693415|NCT01678937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6693416|NCT01678937|Immunologic Factors|immunologic factors|mesh-ancestor
6693417|NCT01678937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693418|NCT01678937|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6693419|NCT01678937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6693420|NCT01678937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6693421|NCT01678937|Antifungal Agents|antifungal agents|mesh-ancestor
6693422|NCT01678937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6693423|NCT01678937|Dermatologic Agents|dermatologic agents|mesh-ancestor
6693424|NCT01678937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6693425|NCT01678937|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6693426|NCT01678937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6693427|NCT01678937|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6693428|NCT01678937|Antitubercular Agents|antitubercular agents|mesh-ancestor
6693429|NCT01678937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6693430|NCT01678963|Squalamine|squalamine|mesh-list
6693431|NCT01678963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6693432|NCT01678963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6693433|NCT01678963|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6693434|NCT01678963|Protective Agents|protective agents|mesh-ancestor
6693435|NCT01678963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693436|NCT01678963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6693437|NCT01678963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6693438|NCT01678963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6693439|NCT01678963|Growth Substances|growth substances|mesh-ancestor
6693440|NCT01678963|Growth Inhibitors|growth inhibitors|mesh-ancestor
6693441|NCT01679041|Cyclophosphamide|cyclophosphamide|mesh-list
6693442|NCT01679041|Fludarabine|fludarabine|mesh-list
6693443|NCT01679041|Alemtuzumab|alemtuzumab|mesh-list
6693444|NCT01679041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6693445|NCT01679041|Immunologic Factors|immunologic factors|mesh-ancestor
6693446|NCT01679041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693447|NCT01679041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6693448|NCT01679041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6693449|NCT01679041|Alkylating Agents|alkylating agents|mesh-ancestor
6693450|NCT01679041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6693451|NCT01679041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6693452|NCT01679041|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6693453|NCT01679041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6780945|NCT02183610|Hormones|hormones|mesh-ancestor
6780946|NCT02183610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6780947|NCT02183610|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6780948|NCT02183610|Protease Inhibitors|protease inhibitors|mesh-ancestor
6780949|NCT02183610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780950|NCT02183610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780951|NCT02183623|Linagliptin|linagliptin|mesh-list
6780952|NCT02183623|Simvastatin|simvastatin|mesh-list
6780953|NCT02183623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6780954|NCT02183623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6780955|NCT02183623|Antimetabolites|antimetabolites|mesh-ancestor
6780956|NCT02183623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780957|NCT02183623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6780958|NCT02183623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6780959|NCT02183623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780960|NCT02183623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6780961|NCT02183623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780962|NCT02183623|Incretins|incretins|mesh-ancestor
6780963|NCT02183623|Hormones|hormones|mesh-ancestor
6780964|NCT02183623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6780965|NCT02183623|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6780966|NCT02183623|Protease Inhibitors|protease inhibitors|mesh-ancestor
6780967|NCT02183636|Pioglitazone|pioglitazone|mesh-list
6780968|NCT02183636|Linagliptin|linagliptin|mesh-list
6780969|NCT02183636|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6780970|NCT02183636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780971|NCT02183636|Incretins|incretins|mesh-ancestor
6780972|NCT02183636|Hormones|hormones|mesh-ancestor
6693454|NCT01679080|Zoledronic Acid|zoledronic acid|mesh-list
6693455|NCT01679080|Teriparatide|teriparatide|mesh-list
6693456|NCT01679080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6693457|NCT01679080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693458|NCT01679080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6693459|NCT01679093|Dexamethasone|dexamethasone|mesh-list
6693460|NCT01679093|Droperidol|droperidol|mesh-list
6693461|NCT01679093|Ondansetron|ondansetron|mesh-list
6693462|NCT01679093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6693463|NCT01679093|Antiemetics|antiemetics|mesh-ancestor
6693464|NCT01679093|Autonomic Agents|autonomic agents|mesh-ancestor
6693465|NCT01679093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6693466|NCT01679093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693467|NCT01679093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6693468|NCT01679093|Glucocorticoids|glucocorticoids|mesh-ancestor
6693469|NCT01679093|Hormones|hormones|mesh-ancestor
6693470|NCT01679093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6693471|NCT01679093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6693472|NCT01679093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6693473|NCT01679093|Antipruritics|antipruritics|mesh-ancestor
6693474|NCT01679093|Dermatologic Agents|dermatologic agents|mesh-ancestor
6693475|NCT01679093|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6693476|NCT01679093|Serotonin Agents|serotonin agents|mesh-ancestor
6693477|NCT01679093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6693478|NCT01679093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6693479|NCT01679093|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6693480|NCT01679093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6693481|NCT01679093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6693482|NCT01679093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6693483|NCT01679093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6693484|NCT01679093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6693485|NCT01679093|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6693486|NCT01679093|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6693487|NCT01679093|Dopamine Agents|dopamine agents|mesh-ancestor
6693488|NCT01679106|Fentanyl|fentanyl|mesh-list
6693489|NCT01679106|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6693490|NCT01679106|Narcotics|narcotics|mesh-ancestor
6693491|NCT01679106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6693492|NCT01679106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693493|NCT01679106|Analgesics|analgesics|mesh-ancestor
6693494|NCT01679106|Sensory System Agents|sensory system agents|mesh-ancestor
6693495|NCT01679106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6693496|NCT01679106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6693497|NCT01679106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6693498|NCT01679106|Anesthetics, General|anesthetics, general|mesh-ancestor
6693499|NCT01679106|Anesthetics|anesthetics|mesh-ancestor
6693500|NCT01679119|Gemcitabine|gemcitabine|mesh-list
6693501|NCT01679119|Prednisolone|prednisolone|mesh-list
6693502|NCT01679119|Cyclophosphamide|cyclophosphamide|mesh-list
6693503|NCT01679119|Rituximab|rituximab|mesh-list
6693504|NCT01679119|Vincristine|vincristine|mesh-list
6693505|NCT01679119|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
6693506|NCT01679119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6693507|NCT01679119|Immunologic Factors|immunologic factors|mesh-ancestor
6693508|NCT01679119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693509|NCT01679119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6693510|NCT01679119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6693511|NCT01679119|Alkylating Agents|alkylating agents|mesh-ancestor
6693512|NCT01679119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6693513|NCT01679119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6693514|NCT01679119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6693515|NCT01679119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6693516|NCT01679119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6693517|NCT01679119|Antimetabolites|antimetabolites|mesh-ancestor
6693518|NCT01679119|Antiviral Agents|antiviral agents|mesh-ancestor
6693519|NCT01679119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6693520|NCT01679119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6693521|NCT01679119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6693522|NCT01679119|Tubulin Modulators|tubulin modulators|mesh-ancestor
6693523|NCT01679119|Antimitotic Agents|antimitotic agents|mesh-ancestor
6693524|NCT01679119|Mitosis Modulators|mitosis modulators|mesh-ancestor
6693525|NCT01679119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6693526|NCT01679119|Glucocorticoids|glucocorticoids|mesh-ancestor
6693527|NCT01679119|Hormones|hormones|mesh-ancestor
6693528|NCT01679119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6693529|NCT01679119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6693530|NCT01679119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6693531|NCT01679327|Calcium, Dietary|calcium, dietary|mesh-list
6693532|NCT01679327|Leucovorin|leucovorin|mesh-list
6693533|NCT01679327|Bevacizumab|bevacizumab|mesh-list
6693534|NCT01679327|Oxaliplatin|oxaliplatin|mesh-list
6693535|NCT01679327|Calcium|calcium|mesh-list
6693536|NCT01679327|Levoleucovorin|levoleucovorin|mesh-list
6693537|NCT01679327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6693538|NCT01679327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6693539|NCT01679327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6693540|NCT01679327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6693541|NCT01679327|Growth Substances|growth substances|mesh-ancestor
6693542|NCT01679327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693543|NCT01679327|Growth Inhibitors|growth inhibitors|mesh-ancestor
6693544|NCT01679327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6693545|NCT01679327|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6693546|NCT01679327|Antidotes|antidotes|mesh-ancestor
6693547|NCT01679327|Protective Agents|protective agents|mesh-ancestor
6693548|NCT01679327|Vitamin B Complex|vitamin b complex|mesh-ancestor
6693549|NCT01679327|Vitamins|vitamins|mesh-ancestor
6693550|NCT01679327|Micronutrients|micronutrients|mesh-ancestor
6693551|NCT01679340|Oxaliplatin|oxaliplatin|mesh-list
6693552|NCT01679340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6693553|NCT01679392|Ropivacaine|ropivacaine|mesh-list
6693554|NCT01679392|Anesthetics, Local|anesthetics, local|mesh-ancestor
6693555|NCT01679392|Anesthetics|anesthetics|mesh-ancestor
6693556|NCT01679392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6693557|NCT01679392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693558|NCT01679392|Sensory System Agents|sensory system agents|mesh-ancestor
6693559|NCT01679392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6693560|NCT01679561|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6693561|NCT01679561|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6693562|NCT01679561|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6693563|NCT01679561|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6693564|NCT01679574|Metformin|metformin|mesh-list
6693565|NCT01679574|Letrozole|letrozole|mesh-list
6693566|NCT01679574|Clomiphene|clomiphene|mesh-list
6693567|NCT01679574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6693568|NCT01679574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693569|NCT01679574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6693570|NCT01679574|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6693571|NCT01679574|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6693572|NCT01679574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6693573|NCT01679574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6693574|NCT01679574|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6693575|NCT01679574|Hormone Antagonists|hormone antagonists|mesh-ancestor
6693576|NCT01679574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6693577|NCT01679574|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6693578|NCT01679574|Fertility Agents|fertility agents|mesh-ancestor
6693579|NCT01679574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6693580|NCT01679574|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6693581|NCT01679574|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6693582|NCT01679639|Rifampin|rifampin|mesh-list
6693583|NCT01679639|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6693584|NCT01679639|Antitubercular Agents|antitubercular agents|mesh-ancestor
6693585|NCT01679639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6693586|NCT01679639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6693587|NCT01679639|Leprostatic Agents|leprostatic agents|mesh-ancestor
6693588|NCT01679639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6693589|NCT01679639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6693590|NCT01679639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6693591|NCT01679639|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6693592|NCT01679639|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6693593|NCT01679639|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6693594|NCT01679639|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6693595|NCT01679639|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6693596|NCT01679639|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6693597|NCT01679652|Nebivolol|nebivolol|mesh-list
6693598|NCT01679652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6693599|NCT01679652|Vasodilator Agents|vasodilator agents|mesh-ancestor
6693600|NCT01679652|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6693601|NCT01679652|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6693602|NCT01679652|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6693603|NCT01679652|Adrenergic Agents|adrenergic agents|mesh-ancestor
6693604|NCT01679652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6693605|NCT01679652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6693606|NCT01679652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693607|NCT01679691|Anesthetics|anesthetics|mesh-list
6693608|NCT01679691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6693609|NCT01679691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693610|NCT01679743|Trastuzumab|trastuzumab|mesh-list
6693611|NCT01679743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6693612|NCT01679743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6693613|NCT01679795|Tibolone|tibolone|mesh-list
6693614|NCT01679795|Androgen Antagonists|androgen antagonists|mesh-ancestor
6693615|NCT01679795|Hormone Antagonists|hormone antagonists|mesh-ancestor
6693616|NCT01679795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6693617|NCT01679795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693618|NCT01679795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6693619|NCT01679795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6693620|NCT01679795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6693621|NCT01679795|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6693622|NCT01679795|Anabolic Agents|anabolic agents|mesh-ancestor
6693623|NCT01679795|Hormones|hormones|mesh-ancestor
6693624|NCT01679860|Alemtuzumab|alemtuzumab|mesh-list
6693625|NCT01679860|Immunologic Factors|immunologic factors|mesh-list
6693626|NCT01679860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693627|NCT01679860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6693628|NCT01679860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6693629|NCT01679899|Vildagliptin|vildagliptin|mesh-list
6693630|NCT01679899|Gliclazide|gliclazide|mesh-list
6693631|NCT01679899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6693632|NCT01679899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693633|NCT01679899|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6693634|NCT01679899|Protease Inhibitors|protease inhibitors|mesh-ancestor
6693635|NCT01679899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6693636|NCT01679899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6693637|NCT01679964|Raltegravir Potassium|raltegravir potassium|mesh-list
6693638|NCT01679964|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6693639|NCT01679964|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6693640|NCT01679964|Antiviral Agents|antiviral agents|mesh-ancestor
6693641|NCT01679964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6693642|NCT01679964|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6693643|NCT01679964|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6693644|NCT01679964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6693645|NCT01679964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6693646|NCT01680042|Phenytoin|phenytoin|mesh-list
6693647|NCT01680042|Anticonvulsants|anticonvulsants|mesh-ancestor
6693648|NCT01680042|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6693649|NCT01680042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6693650|NCT01680042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6693651|NCT01680042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6693652|NCT01680042|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6693653|NCT01680042|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6693654|NCT01680081|Adenosine|adenosine|mesh-list
6693655|NCT01680081|Analgesics|analgesics|mesh-ancestor
6693656|NCT01680081|Sensory System Agents|sensory system agents|mesh-ancestor
6693657|NCT01680081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6693658|NCT01680081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693659|NCT01680081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6693660|NCT01680081|Vasodilator Agents|vasodilator agents|mesh-ancestor
6693661|NCT01680081|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6693662|NCT01680081|Purinergic Agonists|purinergic agonists|mesh-ancestor
6693663|NCT01680081|Purinergic Agents|purinergic agents|mesh-ancestor
6693664|NCT01680081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6693665|NCT01680081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6693666|NCT01680094|Panobinostat|panobinostat|mesh-list
6693667|NCT01680094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6693668|NCT01680094|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6693669|NCT01680094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6693670|NCT01680094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6693671|NCT01680107|Cycloserine|cycloserine|mesh-list
6693672|NCT01680107|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6693673|NCT01680107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6693674|NCT01680107|Renal Agents|renal agents|mesh-ancestor
6693675|NCT01680107|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6693676|NCT01680107|Antitubercular Agents|antitubercular agents|mesh-ancestor
6693677|NCT01680107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6693678|NCT01680107|Antimetabolites|antimetabolites|mesh-ancestor
6693679|NCT01680107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6693680|NCT01680120|Anesthetics|anesthetics|mesh-list
6693681|NCT01680120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6693682|NCT01680120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693683|NCT01680146|Caseins|caseins|mesh-list
6693684|NCT01680146|Chelating Agents|chelating agents|mesh-ancestor
6693685|NCT01680146|Sequestering Agents|sequestering agents|mesh-ancestor
6693686|NCT01680146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6693687|NCT01680185|Insulin|insulin|mesh-list
6693688|NCT01680185|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6693689|NCT01680185|Insulin Lispro|insulin lispro|mesh-list
6693690|NCT01680185|Isophane Insulin, Human|isophane insulin, human|mesh-list
6693691|NCT01680185|Insulin, Isophane|insulin, isophane|mesh-list
6693692|NCT01680185|Isophane insulin, beef|isophane insulin, beef|mesh-list
6693693|NCT01680185|Insulin, Short-Acting|insulin, short-acting|mesh-list
6693694|NCT01680185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6693695|NCT01680185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693696|NCT01680198|Vitamin D|vitamin d|mesh-list
6693697|NCT01680198|Vitamins|vitamins|mesh-ancestor
6693698|NCT01680198|Micronutrients|micronutrients|mesh-ancestor
6693699|NCT01680198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693700|NCT01680198|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6693701|NCT01680250|Sirolimus|sirolimus|mesh-list
6693702|NCT01680250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6693703|NCT01680250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6693704|NCT01680250|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6693705|NCT01680250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6693706|NCT01680250|Antifungal Agents|antifungal agents|mesh-ancestor
6693707|NCT01680250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6693708|NCT01680250|Immunologic Factors|immunologic factors|mesh-ancestor
6693709|NCT01680250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693710|NCT01680263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
6693711|NCT01680263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
6693712|NCT01680263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6693713|NCT01680263|Analgesics|analgesics|mesh-ancestor
6693714|NCT01680263|Sensory System Agents|sensory system agents|mesh-ancestor
6693715|NCT01680263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6693716|NCT01680263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693717|NCT01680263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6693718|NCT01680406|Chloroquine|chloroquine|mesh-list
6693719|NCT01680406|Lumefantrine|lumefantrine|mesh-list
6693720|NCT01680406|Artemether|artemether|mesh-list
6693721|NCT01680406|Primaquine|primaquine|mesh-list
6693722|NCT01680406|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6693723|NCT01680406|Amebicides|amebicides|mesh-ancestor
6693724|NCT01680406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6693725|NCT01680406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6693726|NCT01680406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6693727|NCT01680406|Antimalarials|antimalarials|mesh-ancestor
6693728|NCT01680406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6693729|NCT01680471|Midazolam|midazolam|mesh-list
6693730|NCT01680471|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6693731|NCT01680471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6693732|NCT01680471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6693733|NCT01680471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693734|NCT01680471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6693735|NCT01680471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6693736|NCT01680471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6693737|NCT01680471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6693738|NCT01680471|Anesthetics, General|anesthetics, general|mesh-ancestor
6693739|NCT01680471|Anesthetics|anesthetics|mesh-ancestor
6693740|NCT01680471|GABA Modulators|gaba modulators|mesh-ancestor
6693741|NCT01680471|GABA Agents|gaba agents|mesh-ancestor
6693742|NCT01680471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6693743|NCT01680471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6693744|NCT01680536|Maraviroc|maraviroc|mesh-list
6693745|NCT01680536|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6693746|NCT01680536|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6693747|NCT01680536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6693748|NCT01680536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6693749|NCT01680536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6693750|NCT01680536|Antiviral Agents|antiviral agents|mesh-ancestor
6693751|NCT01680536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6693752|NCT01680536|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6780973|NCT02183636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6780974|NCT02183636|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6693753|NCT01680679|Vaccines|vaccines|mesh-list
6693754|NCT01680679|Immunologic Factors|immunologic factors|mesh-ancestor
6693755|NCT01680679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693756|NCT01680718|Vasopressins|vasopressins|mesh-list
6693757|NCT01680718|Arginine Vasopressin|arginine vasopressin|mesh-list
6693758|NCT01680718|Oxytocin|oxytocin|mesh-list
6693759|NCT01680718|Oxytocics|oxytocics|mesh-ancestor
6693760|NCT01680718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6693761|NCT01680718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693762|NCT01680718|Hemostatics|hemostatics|mesh-ancestor
6693763|NCT01680718|Coagulants|coagulants|mesh-ancestor
6693764|NCT01680718|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6693765|NCT01680718|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6693766|NCT01680718|Natriuretic Agents|natriuretic agents|mesh-ancestor
6693767|NCT01680796|Dexamethasone|dexamethasone|mesh-list
6693768|NCT01680796|Bortezomib|bortezomib|mesh-list
6693769|NCT01680796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6693770|NCT01680796|Antiemetics|antiemetics|mesh-ancestor
6693771|NCT01680796|Autonomic Agents|autonomic agents|mesh-ancestor
6693772|NCT01680796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6693773|NCT01680796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693774|NCT01680796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6693775|NCT01680796|Glucocorticoids|glucocorticoids|mesh-ancestor
6693776|NCT01680796|Hormones|hormones|mesh-ancestor
6693777|NCT01680796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6693778|NCT01680796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6693779|NCT01680796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6693780|NCT01680913|Anesthetics|anesthetics|mesh-list
6693781|NCT01680913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6693782|NCT01680913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693783|NCT01680939|Ibuprofen|ibuprofen|mesh-list
6693784|NCT01680939|Morphine|morphine|mesh-list
6693785|NCT01680939|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6693786|NCT01680939|Narcotics|narcotics|mesh-ancestor
6693787|NCT01680939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6693788|NCT01680939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693789|NCT01680939|Analgesics|analgesics|mesh-ancestor
6693790|NCT01680939|Sensory System Agents|sensory system agents|mesh-ancestor
6693791|NCT01680939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6693792|NCT01680939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6693793|NCT01680939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6693794|NCT01680939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6693795|NCT01680939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6693796|NCT01680939|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6693797|NCT01680939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6693798|NCT01680939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6693799|NCT01680952|Mycophenolic Acid|mycophenolic acid|mesh-list
6693800|NCT01680952|Sirolimus|sirolimus|mesh-list
6693801|NCT01680952|Tacrolimus|tacrolimus|mesh-list
6693802|NCT01680952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6693803|NCT01680952|Immunologic Factors|immunologic factors|mesh-ancestor
6693804|NCT01680952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693805|NCT01680952|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6693806|NCT01680952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6693807|NCT01680952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6693808|NCT01680952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6693809|NCT01680952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6693810|NCT01680952|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6693811|NCT01680952|Antitubercular Agents|antitubercular agents|mesh-ancestor
6693812|NCT01680952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6693813|NCT01680952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6693814|NCT01680952|Antifungal Agents|antifungal agents|mesh-ancestor
6693815|NCT01681134|Tacrolimus|tacrolimus|mesh-list
6693816|NCT01681134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6693817|NCT01681134|Immunologic Factors|immunologic factors|mesh-ancestor
6693818|NCT01681134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693819|NCT01681134|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6693820|NCT01681134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6693821|NCT01681134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6693822|NCT01681264|Guanfacine|guanfacine|mesh-list
6693823|NCT01681264|Morphine|morphine|mesh-list
6693824|NCT01681264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6693825|NCT01681264|Narcotics|narcotics|mesh-ancestor
6693826|NCT01681264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6693827|NCT01681264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693828|NCT01681264|Analgesics|analgesics|mesh-ancestor
6693829|NCT01681264|Sensory System Agents|sensory system agents|mesh-ancestor
6780975|NCT02183636|Protease Inhibitors|protease inhibitors|mesh-ancestor
6693830|NCT01681264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6693831|NCT01681264|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6693832|NCT01681264|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6693833|NCT01681264|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6693834|NCT01681264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6693835|NCT01681264|Adrenergic Agents|adrenergic agents|mesh-ancestor
6693836|NCT01681264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6693837|NCT01681264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6693838|NCT01681446|Interferons|interferons|mesh-list
6693839|NCT01681446|Interferon-alpha|interferon-alpha|mesh-list
6693840|NCT01681446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6693841|NCT01681446|Antiviral Agents|antiviral agents|mesh-ancestor
6693842|NCT01681446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6693843|NCT01681446|Immunologic Factors|immunologic factors|mesh-ancestor
6693844|NCT01681446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693845|NCT01681537|Cytarabine|cytarabine|mesh-list
6693846|NCT01681537|Etoposide|etoposide|mesh-list
6693847|NCT01681537|Mitoxantrone|mitoxantrone|mesh-list
6693848|NCT01681537|Lenalidomide|lenalidomide|mesh-list
6693849|NCT01681537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6693850|NCT01681537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6693851|NCT01681537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6693852|NCT01681537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6693853|NCT01681537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6693854|NCT01681537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6693855|NCT01681537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6693856|NCT01681537|Antimetabolites|antimetabolites|mesh-ancestor
6693857|NCT01681537|Antiviral Agents|antiviral agents|mesh-ancestor
6693858|NCT01681537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6693859|NCT01681537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6693860|NCT01681537|Immunologic Factors|immunologic factors|mesh-ancestor
6693861|NCT01681537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693862|NCT01681537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6693863|NCT01681537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6693864|NCT01681537|Growth Substances|growth substances|mesh-ancestor
6693865|NCT01681537|Growth Inhibitors|growth inhibitors|mesh-ancestor
6693866|NCT01681537|Analgesics|analgesics|mesh-ancestor
6693867|NCT01681537|Sensory System Agents|sensory system agents|mesh-ancestor
6693868|NCT01681537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6693869|NCT01681550|Incretins|incretins|mesh-list
6693870|NCT01681550|Hormones|hormones|mesh-ancestor
6693871|NCT01681550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6693872|NCT01681550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693873|NCT01681563|Cyclophosphamide|cyclophosphamide|mesh-list
6693874|NCT01681563|Ofatumumab|ofatumumab|mesh-list
6693875|NCT01681563|Pentostatin|pentostatin|mesh-list
6693876|NCT01681563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6693877|NCT01681563|Immunologic Factors|immunologic factors|mesh-ancestor
6693878|NCT01681563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693879|NCT01681563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6693880|NCT01681563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6693881|NCT01681563|Alkylating Agents|alkylating agents|mesh-ancestor
6693882|NCT01681563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6693883|NCT01681563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6693884|NCT01681563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6693885|NCT01681563|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
6693886|NCT01681563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6693887|NCT01681667|Ibuprofen|ibuprofen|mesh-list
6693888|NCT01681667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6693889|NCT01681667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6693890|NCT01681667|Analgesics|analgesics|mesh-ancestor
6693891|NCT01681667|Sensory System Agents|sensory system agents|mesh-ancestor
6693892|NCT01681667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6693893|NCT01681667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693894|NCT01681667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6693895|NCT01681667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6693896|NCT01681667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6693897|NCT01681667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6693898|NCT01681667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6693899|NCT01681680|Metformin|metformin|mesh-list
6693900|NCT01681680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6693901|NCT01681680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693902|NCT01681693|Metformin|metformin|mesh-list
6693903|NCT01681693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6780976|NCT02183636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6693904|NCT01681693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693905|NCT01681875|Nicotine|nicotine|mesh-list
6693906|NCT01681875|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6693907|NCT01681875|Autonomic Agents|autonomic agents|mesh-ancestor
6693908|NCT01681875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6693909|NCT01681875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693910|NCT01681875|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6693911|NCT01681875|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6693912|NCT01681875|Cholinergic Agents|cholinergic agents|mesh-ancestor
6693913|NCT01681875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6693914|NCT01681875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6693915|NCT01681966|Ropivacaine|ropivacaine|mesh-list
6693916|NCT01681966|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6693917|NCT01681966|Anesthetics, Local|anesthetics, local|mesh-ancestor
6693918|NCT01681966|Anesthetics|anesthetics|mesh-ancestor
6693919|NCT01681966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6693920|NCT01681966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693921|NCT01681966|Sensory System Agents|sensory system agents|mesh-ancestor
6693922|NCT01681966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6693923|NCT01681979|Fluticasone|fluticasone|mesh-list
6693924|NCT01681979|Xhance|xhance|mesh-list
6693925|NCT01681979|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6693926|NCT01681979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6693927|NCT01681979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6693928|NCT01681979|Autonomic Agents|autonomic agents|mesh-ancestor
6693929|NCT01681979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6693930|NCT01681979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693931|NCT01681979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6693932|NCT01681979|Respiratory System Agents|respiratory system agents|mesh-ancestor
6693933|NCT01681979|Dermatologic Agents|dermatologic agents|mesh-ancestor
6693934|NCT01681979|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6693935|NCT01681979|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6693936|NCT01681979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6693937|NCT01681979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6693938|NCT01681979|Adrenergic Agents|adrenergic agents|mesh-ancestor
6693939|NCT01681979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6693940|NCT01681979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6693941|NCT01682109|Valacyclovir|valacyclovir|mesh-list
6693942|NCT01682109|Antiviral Agents|antiviral agents|mesh-ancestor
6693943|NCT01682109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6693944|NCT01682161|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6693945|NCT01682161|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6693946|NCT01682161|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6693947|NCT01682161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6693948|NCT01682161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693949|NCT01682161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6693950|NCT01682161|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6693951|NCT01682161|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6693952|NCT01682161|Serotonin Agents|serotonin agents|mesh-ancestor
6693953|NCT01682161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6693954|NCT01682161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6693955|NCT01682161|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6693956|NCT01682161|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6693957|NCT01682161|Dopamine Agents|dopamine agents|mesh-ancestor
6693958|NCT01682187|Lomustine|lomustine|mesh-list
6693959|NCT01682187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6693960|NCT01682187|Alkylating Agents|alkylating agents|mesh-ancestor
6693961|NCT01682187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6693962|NCT01682187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6693963|NCT01682343|Calcium|calcium|mesh-list
6693964|NCT01682343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6693965|NCT01682343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780977|NCT02183636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780978|NCT02183649|Carbetapentane|carbetapentane|mesh-list
6780979|NCT02183649|Antitussive Agents|antitussive agents|mesh-ancestor
6780980|NCT02183649|Respiratory System Agents|respiratory system agents|mesh-ancestor
6780981|NCT02183688|Acetaminophen|acetaminophen|mesh-list
6780982|NCT02183688|Caffeine|caffeine|mesh-list
6780983|NCT02183688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6780984|NCT02183688|Analgesics|analgesics|mesh-ancestor
6780985|NCT02183688|Sensory System Agents|sensory system agents|mesh-ancestor
6780986|NCT02183688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6780987|NCT02183688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6780988|NCT02183688|Antipyretics|antipyretics|mesh-ancestor
6780989|NCT02183688|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6693966|NCT01682408|Mannitol|mannitol|mesh-list
6693967|NCT01682408|Ranitidine|ranitidine|mesh-list
6693968|NCT01682408|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
6693969|NCT01682408|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6693970|NCT01682408|Diuretics|diuretics|mesh-ancestor
6693971|NCT01682408|Natriuretic Agents|natriuretic agents|mesh-ancestor
6693972|NCT01682408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693973|NCT01682408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6693974|NCT01682408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6693975|NCT01682408|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6693976|NCT01682408|Histamine Antagonists|histamine antagonists|mesh-ancestor
6693977|NCT01682408|Histamine Agents|histamine agents|mesh-ancestor
6693978|NCT01682408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6693979|NCT01682408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6693980|NCT01682421|Dexamethasone|dexamethasone|mesh-list
6693981|NCT01682421|Dexamethasone acetate|dexamethasone acetate|mesh-list
6693982|NCT01682421|BB 1101|bb 1101|mesh-list
6693983|NCT01682421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6693984|NCT01682421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6693985|NCT01682421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6693986|NCT01682421|Antiemetics|antiemetics|mesh-ancestor
6693987|NCT01682421|Autonomic Agents|autonomic agents|mesh-ancestor
6693988|NCT01682421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6693989|NCT01682421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6693990|NCT01682421|Glucocorticoids|glucocorticoids|mesh-ancestor
6693991|NCT01682421|Hormones|hormones|mesh-ancestor
6693992|NCT01682421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6693993|NCT01682421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6693994|NCT01682421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6693995|NCT01682421|Protease Inhibitors|protease inhibitors|mesh-ancestor
6693996|NCT01682421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6693997|NCT01682499|Calcium, Dietary|calcium, dietary|mesh-list
6693998|NCT01682499|Magnesium Sulfate|magnesium sulfate|mesh-list
6693999|NCT01682499|Calcium|calcium|mesh-list
6694000|NCT01682499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6694001|NCT01682499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694002|NCT01682499|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6694003|NCT01682499|Analgesics|analgesics|mesh-ancestor
6694004|NCT01682499|Sensory System Agents|sensory system agents|mesh-ancestor
6694005|NCT01682499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6694006|NCT01682499|Anesthetics|anesthetics|mesh-ancestor
6694007|NCT01682499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6694008|NCT01682499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6694009|NCT01682499|Anticonvulsants|anticonvulsants|mesh-ancestor
6694010|NCT01682499|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6694011|NCT01682499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6694012|NCT01682499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694013|NCT01682499|Tocolytic Agents|tocolytic agents|mesh-ancestor
6694014|NCT01682499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6694015|NCT01682564|Candesartan cilexetil|candesartan cilexetil|mesh-list
6694016|NCT01682564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6694017|NCT01682564|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6694018|NCT01682564|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6694019|NCT01682564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694020|NCT01682577|Perindopril|perindopril|mesh-list
6694021|NCT01682577|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6694022|NCT01682577|Protease Inhibitors|protease inhibitors|mesh-ancestor
6694023|NCT01682577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6694024|NCT01682577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694025|NCT01682577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6694026|NCT01682616|Rituximab|rituximab|mesh-list
6694027|NCT01682616|Venetoclax|venetoclax|mesh-list
6694028|NCT01682616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6694029|NCT01682616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6694030|NCT01682616|Immunologic Factors|immunologic factors|mesh-ancestor
6694031|NCT01682616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694032|NCT01682616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6694033|NCT01682733|Botulinum Toxins|botulinum toxins|mesh-list
6694034|NCT01682733|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6694035|NCT01682733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6694036|NCT01682733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694037|NCT01682733|Cholinergic Agents|cholinergic agents|mesh-ancestor
6694038|NCT01682733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6694039|NCT01682733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694040|NCT01682746|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
6694041|NCT01682746|Trioxsalen|trioxsalen|mesh-list
6694042|NCT01682746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6694043|NCT01682746|Dermatologic Agents|dermatologic agents|mesh-ancestor
6694044|NCT01682746|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6694045|NCT01682772|Olaparib|olaparib|mesh-list
6694046|NCT01682772|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6694047|NCT01682772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6694048|NCT01682772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694049|NCT01682772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6694050|NCT01682902|Insulin|insulin|mesh-list
6694051|NCT01682902|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6694052|NCT01682902|Insulin Aspart|insulin aspart|mesh-list
6694053|NCT01682902|Insulin, Long-Acting|insulin, long-acting|mesh-list
6694054|NCT01682902|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6694055|NCT01682902|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6694056|NCT01682902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694057|NCT01682941|Phytoestrogens|phytoestrogens|mesh-list
6694058|NCT01682941|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6694059|NCT01682941|Estrogens|estrogens|mesh-ancestor
6694060|NCT01682941|Hormones|hormones|mesh-ancestor
6694061|NCT01682941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6694062|NCT01682941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694063|NCT01683006|Rocuronium|rocuronium|mesh-list
6694064|NCT01683006|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6694065|NCT01683006|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6694066|NCT01683006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6694067|NCT01683006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6694068|NCT01683006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694069|NCT01683032|Methylphenidate|methylphenidate|mesh-list
6694070|NCT01683032|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6694071|NCT01683032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694072|NCT01683032|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6694073|NCT01683032|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6694074|NCT01683032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6694075|NCT01683032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694076|NCT01683032|Dopamine Agents|dopamine agents|mesh-ancestor
6694077|NCT01683032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6694078|NCT01683149|Sorafenib|sorafenib|mesh-list
6694079|NCT01683149|Topotecan|topotecan|mesh-list
6694080|NCT01683149|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
6694081|NCT01683149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6694082|NCT01683149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6694083|NCT01683149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6694084|NCT01683149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694085|NCT01683149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6694086|NCT01683162|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6694087|NCT01683162|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6694088|NCT01683162|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6694089|NCT01683162|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6694090|NCT01683175|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6694091|NCT01683175|Cisplatin|cisplatin|mesh-list
6694092|NCT01683175|Vinorelbine|vinorelbine|mesh-list
6694093|NCT01683175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6694094|NCT01683175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6694095|NCT01683175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6694096|NCT01683175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694097|NCT01683175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6694098|NCT01683175|Tubulin Modulators|tubulin modulators|mesh-ancestor
6694099|NCT01683175|Antimitotic Agents|antimitotic agents|mesh-ancestor
6694100|NCT01683175|Mitosis Modulators|mitosis modulators|mesh-ancestor
6694101|NCT01683188|Vemurafenib|vemurafenib|mesh-list
6694102|NCT01683188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6694103|NCT01683188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6694104|NCT01683188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6694105|NCT01683188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694106|NCT01683253|Dopamine|dopamine|mesh-list
6694107|NCT01683253|Levodopa|levodopa|mesh-list
6694108|NCT01683253|Carbidopa|carbidopa|mesh-list
6694109|NCT01683253|Dopamine Agonists|dopamine agonists|mesh-list
6694110|NCT01683253|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6694111|NCT01683253|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6694112|NCT01683253|Dopamine Agents|dopamine agents|mesh-ancestor
6694113|NCT01683253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6780990|NCT02183688|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6694114|NCT01683253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694115|NCT01683253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694116|NCT01683253|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6694117|NCT01683253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6694118|NCT01683253|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6694119|NCT01683253|Sympathomimetics|sympathomimetics|mesh-ancestor
6694120|NCT01683253|Autonomic Agents|autonomic agents|mesh-ancestor
6694121|NCT01683253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6694122|NCT01683253|Protective Agents|protective agents|mesh-ancestor
6694123|NCT01683292|Apomorphine|apomorphine|mesh-list
6694124|NCT01683292|Emetics|emetics|mesh-ancestor
6694125|NCT01683292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694126|NCT01683292|Autonomic Agents|autonomic agents|mesh-ancestor
6694127|NCT01683292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6694128|NCT01683292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6694129|NCT01683292|Dopamine Agonists|dopamine agonists|mesh-ancestor
6694130|NCT01683292|Dopamine Agents|dopamine agents|mesh-ancestor
6694131|NCT01683292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6694132|NCT01683292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694133|NCT01683552|Fexofenadine|fexofenadine|mesh-list
6694134|NCT01683552|Prednisone|prednisone|mesh-list
6694135|NCT01683552|Aprepitant|aprepitant|mesh-list
6694136|NCT01683552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6694137|NCT01683552|Glucocorticoids|glucocorticoids|mesh-ancestor
6694138|NCT01683552|Hormones|hormones|mesh-ancestor
6694139|NCT01683552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6694140|NCT01683552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694141|NCT01683552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6694142|NCT01683552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6694143|NCT01683552|Antiemetics|antiemetics|mesh-ancestor
6694144|NCT01683552|Autonomic Agents|autonomic agents|mesh-ancestor
6694145|NCT01683552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6694146|NCT01683552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6694147|NCT01683552|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6694148|NCT01683552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6694149|NCT01683552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694150|NCT01683552|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6694151|NCT01683552|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6694152|NCT01683552|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6694153|NCT01683552|Histamine Antagonists|histamine antagonists|mesh-ancestor
6694154|NCT01683552|Histamine Agents|histamine agents|mesh-ancestor
6694155|NCT01683656|Niacin|niacin|mesh-list
6694156|NCT01683656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6694157|NCT01683656|Antimetabolites|antimetabolites|mesh-ancestor
6694158|NCT01683656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694159|NCT01683656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6694160|NCT01683656|Vasodilator Agents|vasodilator agents|mesh-ancestor
6694161|NCT01683656|Vitamin B Complex|vitamin b complex|mesh-ancestor
6694162|NCT01683656|Vitamins|vitamins|mesh-ancestor
6694163|NCT01683656|Micronutrients|micronutrients|mesh-ancestor
6694164|NCT01683656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694165|NCT01683682|Carboplatin|carboplatin|mesh-list
6694166|NCT01683682|Vinorelbine|vinorelbine|mesh-list
6694167|NCT01683682|Nintedanib|nintedanib|mesh-list
6694168|NCT01683682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6694169|NCT01683682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6694170|NCT01683682|Tubulin Modulators|tubulin modulators|mesh-ancestor
6694171|NCT01683682|Antimitotic Agents|antimitotic agents|mesh-ancestor
6694172|NCT01683682|Mitosis Modulators|mitosis modulators|mesh-ancestor
6694173|NCT01683682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694174|NCT01683682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6694175|NCT01683682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6694176|NCT01683747|Tranexamic Acid|tranexamic acid|mesh-list
6694177|NCT01683747|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6694178|NCT01683747|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6694179|NCT01683747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694180|NCT01683747|Hemostatics|hemostatics|mesh-ancestor
6694181|NCT01683747|Coagulants|coagulants|mesh-ancestor
6694182|NCT01683760|Fluconazole|fluconazole|mesh-list
6694183|NCT01683760|Antifungal Agents|antifungal agents|mesh-ancestor
6694184|NCT01683760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6694185|NCT01683760|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6694186|NCT01683760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6694187|NCT01683760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6694188|NCT01683760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694189|NCT01683760|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6694190|NCT01683760|Hormone Antagonists|hormone antagonists|mesh-ancestor
6694191|NCT01683760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6694192|NCT01683760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694193|NCT01683760|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6694194|NCT01683760|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6694195|NCT01683786|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6694196|NCT01683786|Antiviral Agents|antiviral agents|mesh-ancestor
6694197|NCT01683786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6694198|NCT01683955|Tranexamic Acid|tranexamic acid|mesh-list
6694199|NCT01683955|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6694200|NCT01683955|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6694201|NCT01683955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694202|NCT01683955|Hemostatics|hemostatics|mesh-ancestor
6694203|NCT01683955|Coagulants|coagulants|mesh-ancestor
6694204|NCT01684059|Zinc Sulfate|zinc sulfate|mesh-list
6694205|NCT01684059|Astringents|astringents|mesh-ancestor
6694206|NCT01684059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694207|NCT01684059|Dermatologic Agents|dermatologic agents|mesh-ancestor
6694208|NCT01684072|Vaccines|vaccines|mesh-list
6694209|NCT01684072|Immunologic Factors|immunologic factors|mesh-ancestor
6694210|NCT01684072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694211|NCT01684085|Lorazepam|lorazepam|mesh-list
6694212|NCT01684085|Anticonvulsants|anticonvulsants|mesh-ancestor
6694213|NCT01684085|Antiemetics|antiemetics|mesh-ancestor
6694214|NCT01684085|Autonomic Agents|autonomic agents|mesh-ancestor
6694215|NCT01684085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6694216|NCT01684085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694217|NCT01684085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6694218|NCT01684085|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6694219|NCT01684085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6694220|NCT01684085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6694221|NCT01684085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6694222|NCT01684085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6694223|NCT01684085|GABA Modulators|gaba modulators|mesh-ancestor
6694224|NCT01684085|GABA Agents|gaba agents|mesh-ancestor
6694225|NCT01684085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6694226|NCT01684085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694227|NCT01684098|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
6694228|NCT01684098|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6694229|NCT01684098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694230|NCT01684111|Vinorelbine|vinorelbine|mesh-list
6694231|NCT01684111|Nintedanib|nintedanib|mesh-list
6694232|NCT01684111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6694233|NCT01684111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6694234|NCT01684111|Tubulin Modulators|tubulin modulators|mesh-ancestor
6694235|NCT01684111|Antimitotic Agents|antimitotic agents|mesh-ancestor
6694236|NCT01684111|Mitosis Modulators|mitosis modulators|mesh-ancestor
6694237|NCT01684111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694238|NCT01684111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6694239|NCT01684111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780991|NCT02183688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6780992|NCT02183688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6780993|NCT02183688|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6780994|NCT02183688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6780995|NCT02183688|Purinergic Agents|purinergic agents|mesh-ancestor
6780996|NCT02183688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6780997|NCT02183701|Losartan|losartan|mesh-list
6780998|NCT02183701|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6780999|NCT02183701|Telmisartan|telmisartan|mesh-list
6781000|NCT02183701|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6781001|NCT02183701|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6781002|NCT02183701|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6781003|NCT02183701|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6781004|NCT02183701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781005|NCT02183701|Diuretics|diuretics|mesh-ancestor
6781006|NCT02183701|Natriuretic Agents|natriuretic agents|mesh-ancestor
6781007|NCT02183701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781008|NCT02183701|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6781009|NCT02183701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6781010|NCT02183779|Fluconazole|fluconazole|mesh-list
6781011|NCT02183779|Antifungal Agents|antifungal agents|mesh-ancestor
6781012|NCT02183779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6781013|NCT02183779|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6694240|NCT01684241|Vaccines|vaccines|mesh-list
6694241|NCT01684241|Immunologic Factors|immunologic factors|mesh-ancestor
6694242|NCT01684241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694243|NCT01684306|Modafinil|modafinil|mesh-list
6694244|NCT01684306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6694245|NCT01684306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694246|NCT01684306|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6694247|NCT01684306|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6694248|NCT01684306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6694249|NCT01684306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694250|NCT01684319|Caseins|caseins|mesh-list
6694251|NCT01684319|Chelating Agents|chelating agents|mesh-ancestor
6694252|NCT01684319|Sequestering Agents|sequestering agents|mesh-ancestor
6694253|NCT01684319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694254|NCT01684371|Tea Tree Oil|tea tree oil|mesh-list
6694255|NCT01684371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6694256|NCT01684371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6694257|NCT01684371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6694258|NCT01684397|Bevacizumab|bevacizumab|mesh-list
6694259|NCT01684397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6694260|NCT01684397|Endothelial Growth Factors|endothelial growth factors|mesh-list
6694261|NCT01684397|Antibodies|antibodies|mesh-list
6694262|NCT01684397|Immunoglobulins|immunoglobulins|mesh-list
6694263|NCT01684397|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6694264|NCT01684397|Immunoglobulin G|immunoglobulin g|mesh-list
6694265|NCT01684397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6694266|NCT01684397|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6694267|NCT01684397|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6694268|NCT01684397|Growth Substances|growth substances|mesh-ancestor
6694269|NCT01684397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694270|NCT01684397|Growth Inhibitors|growth inhibitors|mesh-ancestor
6694271|NCT01684397|Immunologic Factors|immunologic factors|mesh-ancestor
6694272|NCT01684449|Gemcitabine|gemcitabine|mesh-list
6694273|NCT01684449|Sirolimus|sirolimus|mesh-list
6694274|NCT01684449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6694275|NCT01684449|Antimetabolites|antimetabolites|mesh-ancestor
6694276|NCT01684449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694277|NCT01684449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6694278|NCT01684449|Antiviral Agents|antiviral agents|mesh-ancestor
6694279|NCT01684449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6694280|NCT01684449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6694281|NCT01684449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6694282|NCT01684449|Immunologic Factors|immunologic factors|mesh-ancestor
6694283|NCT01684449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694284|NCT01684449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6694285|NCT01684449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6694286|NCT01684449|Antifungal Agents|antifungal agents|mesh-ancestor
6694287|NCT01684657|Asenapine|asenapine|mesh-list
6694288|NCT01684657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6694289|NCT01684657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6694290|NCT01684657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6694291|NCT01684657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694292|NCT01684657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6694293|NCT01684683|Theophylline|theophylline|mesh-list
6694294|NCT01684683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6694295|NCT01684683|Autonomic Agents|autonomic agents|mesh-ancestor
6694296|NCT01684683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6694297|NCT01684683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694298|NCT01684683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6694299|NCT01684683|Respiratory System Agents|respiratory system agents|mesh-ancestor
6694300|NCT01684683|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6694301|NCT01684683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6694302|NCT01684683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694303|NCT01684683|Vasodilator Agents|vasodilator agents|mesh-ancestor
6694304|NCT01684683|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6694305|NCT01684683|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6694306|NCT01684683|Purinergic Agents|purinergic agents|mesh-ancestor
6694307|NCT01684683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6694308|NCT01684774|Bupivacaine|bupivacaine|mesh-list
6694309|NCT01684774|Anesthetics, Local|anesthetics, local|mesh-ancestor
6694310|NCT01684774|Anesthetics|anesthetics|mesh-ancestor
6694311|NCT01684774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6694312|NCT01684774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694313|NCT01684774|Sensory System Agents|sensory system agents|mesh-ancestor
6694314|NCT01684774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6694315|NCT01684787|Ribavirin|ribavirin|mesh-list
6694316|NCT01684787|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6694317|NCT01684787|Interferon-alpha|interferon-alpha|mesh-list
6694318|NCT01684787|Antimetabolites|antimetabolites|mesh-ancestor
6694319|NCT01684787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694320|NCT01684787|Antiviral Agents|antiviral agents|mesh-ancestor
6694321|NCT01684787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6694322|NCT01684787|Immunologic Factors|immunologic factors|mesh-ancestor
6694323|NCT01684787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694324|NCT01684800|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
6694325|NCT01684800|Hemostatics|hemostatics|mesh-ancestor
6694326|NCT01684800|Coagulants|coagulants|mesh-ancestor
6694327|NCT01684800|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6694328|NCT01684800|Natriuretic Agents|natriuretic agents|mesh-ancestor
6694329|NCT01684800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694330|NCT01684813|Clopidogrel|clopidogrel|mesh-list
6694331|NCT01684813|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6694332|NCT01684813|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6694333|NCT01684813|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6694334|NCT01684813|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6694335|NCT01684813|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6694336|NCT01684813|Purinergic Agents|purinergic agents|mesh-ancestor
6694337|NCT01684813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6694338|NCT01684813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694339|NCT01684813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694340|NCT01684865|Rituximab|rituximab|mesh-list
6694341|NCT01684865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6694342|NCT01684865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6694343|NCT01684865|Immunologic Factors|immunologic factors|mesh-ancestor
6694344|NCT01684865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694345|NCT01684865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6694346|NCT01684969|Haloperidol|haloperidol|mesh-list
6694347|NCT01684969|Haloperidol decanoate|haloperidol decanoate|mesh-list
6694348|NCT01684969|Antiemetics|antiemetics|mesh-ancestor
6694349|NCT01684969|Autonomic Agents|autonomic agents|mesh-ancestor
6694350|NCT01684969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6694351|NCT01684969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694352|NCT01684969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6694353|NCT01684969|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6694354|NCT01684969|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6694355|NCT01684969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6694356|NCT01684969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6694357|NCT01684969|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6694358|NCT01684969|Dopamine Agents|dopamine agents|mesh-ancestor
6694359|NCT01684969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6694360|NCT01684969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694361|NCT01684969|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6694362|NCT01684982|Sirolimus|sirolimus|mesh-list
6694363|NCT01684982|Everolimus|everolimus|mesh-list
6694364|NCT01684982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6694365|NCT01684982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6694366|NCT01684982|Immunologic Factors|immunologic factors|mesh-ancestor
6694367|NCT01684982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694368|NCT01684982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6694369|NCT01684982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6694370|NCT01684982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6694371|NCT01684982|Antifungal Agents|antifungal agents|mesh-ancestor
6694372|NCT01684995|Nicotine|nicotine|mesh-list
6694373|NCT01684995|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6694374|NCT01684995|Autonomic Agents|autonomic agents|mesh-ancestor
6694375|NCT01684995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6694376|NCT01684995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694377|NCT01684995|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6694378|NCT01684995|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6694379|NCT01684995|Cholinergic Agents|cholinergic agents|mesh-ancestor
6694380|NCT01684995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6694381|NCT01684995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694382|NCT01685125|Prednisone|prednisone|mesh-list
6694383|NCT01685125|Dasatinib|dasatinib|mesh-list
6694384|NCT01685125|Abiraterone Acetate|abiraterone acetate|mesh-list
6694385|NCT01685125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6694386|NCT01685125|Glucocorticoids|glucocorticoids|mesh-ancestor
6694387|NCT01685125|Hormones|hormones|mesh-ancestor
6694388|NCT01685125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6694389|NCT01685125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694390|NCT01685125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6694391|NCT01685125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6694392|NCT01685125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6694393|NCT01685125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6694394|NCT01685125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694395|NCT01685125|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6694396|NCT01685125|Hormone Antagonists|hormone antagonists|mesh-ancestor
6694397|NCT01685125|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6694398|NCT01685281|Metadoxine|metadoxine|mesh-list
6694399|NCT01685281|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6694400|NCT01685333|Epoetin Alfa|epoetin alfa|mesh-list
6694401|NCT01685333|Hematinics|hematinics|mesh-ancestor
6694402|NCT01685359|Epoetin Alfa|epoetin alfa|mesh-list
6694403|NCT01685359|Hematinics|hematinics|mesh-ancestor
6694404|NCT01685398|Timolol|timolol|mesh-list
6694405|NCT01685398|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6694406|NCT01685398|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6694407|NCT01685398|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6694408|NCT01685398|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6694409|NCT01685398|Adrenergic Agents|adrenergic agents|mesh-ancestor
6694410|NCT01685398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6694411|NCT01685398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694412|NCT01685398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694413|NCT01685398|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6694414|NCT01685398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6694415|NCT01685489|polysaccharide-K|polysaccharide-k|mesh-list
6694416|NCT01685489|Docetaxel|docetaxel|mesh-list
6694417|NCT01685489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6694418|NCT01685489|Tubulin Modulators|tubulin modulators|mesh-ancestor
6694419|NCT01685489|Antimitotic Agents|antimitotic agents|mesh-ancestor
6694420|NCT01685489|Mitosis Modulators|mitosis modulators|mesh-ancestor
6694421|NCT01685489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694422|NCT01685489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6694423|NCT01685489|Immunologic Factors|immunologic factors|mesh-ancestor
6694424|NCT01685489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694425|NCT01685489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6694426|NCT01685489|Antiviral Agents|antiviral agents|mesh-ancestor
6694427|NCT01685489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6694428|NCT01685489|Interferon Inducers|interferon inducers|mesh-ancestor
6694429|NCT01685489|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6694430|NCT01685489|Protective Agents|protective agents|mesh-ancestor
6694431|NCT01685502|Acarbose|acarbose|mesh-list
6694432|NCT01685502|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6694433|NCT01685502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6694434|NCT01685502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694435|NCT01685502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6694436|NCT01685502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694437|NCT01685515|Decitabine|decitabine|mesh-list
6694438|NCT01685515|Tetrahydrouridine|tetrahydrouridine|mesh-list
6694439|NCT01685515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6694440|NCT01685515|Antimetabolites|antimetabolites|mesh-ancestor
6694441|NCT01685515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694442|NCT01685515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6694443|NCT01685515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6694444|NCT01685658|Acetaminophen|acetaminophen|mesh-list
6694445|NCT01685658|Ketoprofen|ketoprofen|mesh-list
6694446|NCT01685658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6694447|NCT01685658|Analgesics|analgesics|mesh-ancestor
6694448|NCT01685658|Sensory System Agents|sensory system agents|mesh-ancestor
6694449|NCT01685658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6694450|NCT01685658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694451|NCT01685658|Antipyretics|antipyretics|mesh-ancestor
6694452|NCT01685658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6694453|NCT01685658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6694454|NCT01685658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6694455|NCT01685658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6694456|NCT01685658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6694457|NCT01685658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694458|NCT01685762|Metformin|metformin|mesh-list
6694459|NCT01685762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6694460|NCT01685762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694461|NCT01685814|Lenalidomide|lenalidomide|mesh-list
6694462|NCT01685814|Bortezomib|bortezomib|mesh-list
6694463|NCT01685814|Immunologic Factors|immunologic factors|mesh-ancestor
6694464|NCT01685814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694465|NCT01685814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6694466|NCT01685814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6694467|NCT01685814|Growth Substances|growth substances|mesh-ancestor
6694468|NCT01685814|Growth Inhibitors|growth inhibitors|mesh-ancestor
6694469|NCT01685814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6694470|NCT01685827|Eflornithine|eflornithine|mesh-list
6694471|NCT01685827|Nifurtimox|nifurtimox|mesh-list
6694472|NCT01685827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6694473|NCT01685827|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6694474|NCT01685827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6694475|NCT01685827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6694476|NCT01685827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6694477|NCT01685827|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
6694478|NCT01685827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6694479|NCT01685827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694480|NCT01685853|Bisacodyl|bisacodyl|mesh-list
6694481|NCT01685853|Cathartics|cathartics|mesh-ancestor
6694482|NCT01685853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6694483|NCT01685853|Laxatives|laxatives|mesh-ancestor
6694484|NCT01685892|Venetoclax|venetoclax|mesh-list
6694485|NCT01685892|Obinutuzumab|obinutuzumab|mesh-list
6694486|NCT01685892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6694487|NCT01685892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6694488|NCT01685931|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6694489|NCT01685931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6694490|NCT01685931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6694491|NCT01685931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6694492|NCT01685931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694493|NCT01685931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6694494|NCT01685931|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6694495|NCT01685931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6694496|NCT01685931|Serotonin Agents|serotonin agents|mesh-ancestor
6694497|NCT01685931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6694498|NCT01685931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694499|NCT01685931|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6694500|NCT01685931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6694501|NCT01685931|Dopamine Agents|dopamine agents|mesh-ancestor
6694502|NCT01685970|Picosulfate sodium|picosulfate sodium|mesh-list
6694503|NCT01685970|Cathartics|cathartics|mesh-ancestor
6694504|NCT01685970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6694505|NCT01686009|Ketamine|ketamine|mesh-list
6694506|NCT01686009|Analgesics|analgesics|mesh-ancestor
6694507|NCT01686009|Sensory System Agents|sensory system agents|mesh-ancestor
6694508|NCT01686009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6694509|NCT01686009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694510|NCT01686009|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6694511|NCT01686009|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6694512|NCT01686009|Anesthetics, General|anesthetics, general|mesh-ancestor
6694513|NCT01686009|Anesthetics|anesthetics|mesh-ancestor
6694514|NCT01686009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6694515|NCT01686009|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6694516|NCT01686009|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6694517|NCT01686009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6694518|NCT01686009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781014|NCT02183779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6781015|NCT02183779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6781016|NCT02183779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781017|NCT02183779|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6781018|NCT02183779|Hormone Antagonists|hormone antagonists|mesh-ancestor
6781019|NCT02183779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6781020|NCT02183779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781021|NCT02183779|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6781022|NCT02183779|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6781023|NCT02183805|Cyclophosphamide|cyclophosphamide|mesh-list
6781024|NCT02183805|Carboplatin|carboplatin|mesh-list
6781025|NCT02183805|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6781026|NCT02183805|Paclitaxel|paclitaxel|mesh-list
6781027|NCT02183805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6781028|NCT02183805|Immunologic Factors|immunologic factors|mesh-ancestor
6781029|NCT02183805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781030|NCT02183805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6781031|NCT02183805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6781032|NCT02183805|Alkylating Agents|alkylating agents|mesh-ancestor
6781033|NCT02183805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781034|NCT02183805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6781035|NCT02183805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6694519|NCT01686126|Metformin|metformin|mesh-list
6694520|NCT01686126|Levonorgestrel|levonorgestrel|mesh-list
6694521|NCT01686126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6694522|NCT01686126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694523|NCT01686126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6694524|NCT01686126|Contraceptive Agents|contraceptive agents|mesh-ancestor
6694525|NCT01686126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6694526|NCT01686126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6694527|NCT01686126|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6694528|NCT01686126|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6694529|NCT01686217|Niacinamide|niacinamide|mesh-list
6694530|NCT01686217|Peficitinib|peficitinib|mesh-list
6694531|NCT01686217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6694532|NCT01686217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694533|NCT01686217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6694534|NCT01686217|Immunologic Factors|immunologic factors|mesh-ancestor
6694535|NCT01686217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694536|NCT01686217|Vitamin B Complex|vitamin b complex|mesh-ancestor
6694537|NCT01686217|Vitamins|vitamins|mesh-ancestor
6694538|NCT01686217|Micronutrients|micronutrients|mesh-ancestor
6694539|NCT01686256|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
6694540|NCT01686256|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6694541|NCT01686256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694542|NCT01686321|Rituximab|rituximab|mesh-list
6694543|NCT01686321|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6694544|NCT01686321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6694545|NCT01686321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6694546|NCT01686321|Immunologic Factors|immunologic factors|mesh-ancestor
6694547|NCT01686321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694548|NCT01686321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6694549|NCT01686321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6694550|NCT01686321|Alkylating Agents|alkylating agents|mesh-ancestor
6694551|NCT01686321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694552|NCT01686347|Ropivacaine|ropivacaine|mesh-list
6694553|NCT01686347|Anesthetics, Local|anesthetics, local|mesh-ancestor
6694554|NCT01686347|Anesthetics|anesthetics|mesh-ancestor
6694555|NCT01686347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6694556|NCT01686347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694557|NCT01686347|Sensory System Agents|sensory system agents|mesh-ancestor
6694558|NCT01686347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6694559|NCT01686386|Dexamethasone|dexamethasone|mesh-list
6694560|NCT01686386|Lenalidomide|lenalidomide|mesh-list
6694561|NCT01686386|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6694562|NCT01686386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6694563|NCT01686386|Antiemetics|antiemetics|mesh-ancestor
6694564|NCT01686386|Autonomic Agents|autonomic agents|mesh-ancestor
6694565|NCT01686386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6694566|NCT01686386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694567|NCT01686386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6694568|NCT01686386|Glucocorticoids|glucocorticoids|mesh-ancestor
6694569|NCT01686386|Hormones|hormones|mesh-ancestor
6694570|NCT01686386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6694571|NCT01686386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6694572|NCT01686386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6694573|NCT01686386|Immunologic Factors|immunologic factors|mesh-ancestor
6694574|NCT01686386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6694575|NCT01686386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6694576|NCT01686386|Growth Substances|growth substances|mesh-ancestor
6694577|NCT01686386|Growth Inhibitors|growth inhibitors|mesh-ancestor
6694578|NCT01686386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6694579|NCT01686386|Alkylating Agents|alkylating agents|mesh-ancestor
6694580|NCT01686386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694581|NCT01686464|Valacyclovir|valacyclovir|mesh-list
6694582|NCT01686464|Prednisone|prednisone|mesh-list
6694583|NCT01686464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6694584|NCT01686464|Glucocorticoids|glucocorticoids|mesh-ancestor
6694585|NCT01686464|Hormones|hormones|mesh-ancestor
6694586|NCT01686464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6694587|NCT01686464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694588|NCT01686464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6694589|NCT01686464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6694590|NCT01686464|Antiviral Agents|antiviral agents|mesh-ancestor
6694591|NCT01686464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6694592|NCT01686529|Bevacizumab|bevacizumab|mesh-list
6694593|NCT01686529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6694594|NCT01686529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6694595|NCT01686529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6694596|NCT01686529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6694597|NCT01686529|Growth Substances|growth substances|mesh-ancestor
6694598|NCT01686529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694599|NCT01686529|Growth Inhibitors|growth inhibitors|mesh-ancestor
6694600|NCT01686555|Venetoclax|venetoclax|mesh-list
6694601|NCT01686555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6694602|NCT01686594|Methoxsalen|methoxsalen|mesh-list
6694603|NCT01686594|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6694604|NCT01686594|Dermatologic Agents|dermatologic agents|mesh-ancestor
6694605|NCT01686607|Itraconazole|itraconazole|mesh-list
6694606|NCT01686607|Fluconazole|fluconazole|mesh-list
6694607|NCT01686607|Voriconazole|voriconazole|mesh-list
6694608|NCT01686607|Amphotericin B|amphotericin b|mesh-list
6694609|NCT01686607|Caspofungin|caspofungin|mesh-list
6694610|NCT01686607|Micafungin|micafungin|mesh-list
6694611|NCT01686607|Antifungal Agents|antifungal agents|mesh-list
6694612|NCT01686607|Clotrimazole|clotrimazole|mesh-list
6694613|NCT01686607|Miconazole|miconazole|mesh-list
6694614|NCT01686607|Anidulafungin|anidulafungin|mesh-list
6694615|NCT01686607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6694616|NCT01686607|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6694617|NCT01686607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6694618|NCT01686607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6694619|NCT01686607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694620|NCT01686607|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6694621|NCT01686607|Hormone Antagonists|hormone antagonists|mesh-ancestor
6694622|NCT01686607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6694623|NCT01686607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694624|NCT01686607|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6694625|NCT01686607|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6694626|NCT01686607|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6694627|NCT01686607|Amebicides|amebicides|mesh-ancestor
6694628|NCT01686607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6694629|NCT01686607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6694630|NCT01686607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6694631|NCT01686607|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6694632|NCT01686711|Pioglitazone|pioglitazone|mesh-list
6694633|NCT01686711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6694634|NCT01686711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694635|NCT01686789|Interferons|interferons|mesh-list
6694636|NCT01686789|Interferon-alpha|interferon-alpha|mesh-list
6694637|NCT01686789|Interferon alpha-2|interferon alpha-2|mesh-list
6694638|NCT01686789|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6694639|NCT01686789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6694640|NCT01686789|Antiviral Agents|antiviral agents|mesh-ancestor
6694641|NCT01686789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6694642|NCT01686789|Immunologic Factors|immunologic factors|mesh-ancestor
6694643|NCT01686789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694644|NCT01686802|Ibuprofen|ibuprofen|mesh-list
6694645|NCT01686802|Morphine|morphine|mesh-list
6694646|NCT01686802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6694647|NCT01686802|Narcotics|narcotics|mesh-ancestor
6694648|NCT01686802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6694649|NCT01686802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694650|NCT01686802|Analgesics|analgesics|mesh-ancestor
6694651|NCT01686802|Sensory System Agents|sensory system agents|mesh-ancestor
6694652|NCT01686802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6694653|NCT01686802|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6694654|NCT01686802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6694655|NCT01686802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6694656|NCT01686802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6694657|NCT01686802|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6694658|NCT01686802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6694659|NCT01686802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694660|NCT01687049|Red yeast rice|red yeast rice|mesh-list
6694661|NCT01687049|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6694662|NCT01687049|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6694663|NCT01687049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6694664|NCT01687049|Antimetabolites|antimetabolites|mesh-ancestor
6694665|NCT01687049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694666|NCT01687049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6694667|NCT01687049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6694668|NCT01687062|Fe(III)-EDTA|fe(iii)-edta|mesh-list
6694669|NCT01687062|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6694670|NCT01687062|Chelating Agents|chelating agents|mesh-ancestor
6694671|NCT01687062|Sequestering Agents|sequestering agents|mesh-ancestor
6694672|NCT01687062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694673|NCT01687127|Folic Acid|folic acid|mesh-list
6694674|NCT01687127|Vitamin B Complex|vitamin b complex|mesh-list
6694675|NCT01687127|Calcium|calcium|mesh-list
6694676|NCT01687127|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6694677|NCT01687127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694678|NCT01687127|Hematinics|hematinics|mesh-ancestor
6694679|NCT01687127|Vitamins|vitamins|mesh-ancestor
6694680|NCT01687127|Micronutrients|micronutrients|mesh-ancestor
6694681|NCT01687140|Cycloserine|cycloserine|mesh-list
6694682|NCT01687140|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6694683|NCT01687140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6694684|NCT01687140|Renal Agents|renal agents|mesh-ancestor
6694685|NCT01687140|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6694686|NCT01687140|Antitubercular Agents|antitubercular agents|mesh-ancestor
6694687|NCT01687140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6694688|NCT01687140|Antimetabolites|antimetabolites|mesh-ancestor
6694689|NCT01687140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694690|NCT01687205|Tenofovir|tenofovir|mesh-list
6694691|NCT01687205|Antiviral Agents|antiviral agents|mesh-ancestor
6694692|NCT01687205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6694693|NCT01687205|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6694694|NCT01687205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6694695|NCT01687205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6694696|NCT01687205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694697|NCT01687205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6694698|NCT01687205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6694699|NCT01687348|Lidocaine|lidocaine|mesh-list
6694700|NCT01687348|Anesthetics, Local|anesthetics, local|mesh-ancestor
6694701|NCT01687348|Anesthetics|anesthetics|mesh-ancestor
6694702|NCT01687348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6694703|NCT01687348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694704|NCT01687348|Sensory System Agents|sensory system agents|mesh-ancestor
6694705|NCT01687348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6694706|NCT01687348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6694707|NCT01687348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6694708|NCT01687348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6694709|NCT01687348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6694710|NCT01687348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694711|NCT01687374|Hormones|hormones|mesh-list
6694712|NCT01687374|Parathyroid Hormone|parathyroid hormone|mesh-list
6694713|NCT01687374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6694714|NCT01687374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694715|NCT01687374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6694716|NCT01687426|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6694717|NCT01687426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6694718|NCT01687426|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6694719|NCT01687426|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6694720|NCT01687426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6694721|NCT01687426|Adrenergic Agents|adrenergic agents|mesh-ancestor
6694722|NCT01687426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6694723|NCT01687426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694724|NCT01687426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694725|NCT01687439|Vinorelbine|vinorelbine|mesh-list
6694726|NCT01687439|Endostar protein|endostar protein|mesh-list
6694727|NCT01687439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6694728|NCT01687439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6694729|NCT01687439|Tubulin Modulators|tubulin modulators|mesh-ancestor
6694730|NCT01687439|Antimitotic Agents|antimitotic agents|mesh-ancestor
6694731|NCT01687439|Mitosis Modulators|mitosis modulators|mesh-ancestor
6694732|NCT01687439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694733|NCT01687439|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6694734|NCT01687439|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6694735|NCT01687439|Growth Substances|growth substances|mesh-ancestor
6694736|NCT01687439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694737|NCT01687439|Growth Inhibitors|growth inhibitors|mesh-ancestor
6694738|NCT01687491|Enoxaparin|enoxaparin|mesh-list
6694739|NCT01687491|Anticoagulants|anticoagulants|mesh-ancestor
6694740|NCT01687491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6694741|NCT01687491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6694742|NCT01687491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694743|NCT01687517|Vaccines|vaccines|mesh-list
6694744|NCT01687517|Immunologic Factors|immunologic factors|mesh-ancestor
6694745|NCT01687517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694746|NCT01687582|Liraglutide|liraglutide|mesh-list
6694747|NCT01687582|Exenatide|exenatide|mesh-list
6694748|NCT01687582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6694749|NCT01687582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694750|NCT01687582|Incretins|incretins|mesh-ancestor
6694751|NCT01687582|Hormones|hormones|mesh-ancestor
6694752|NCT01687582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6694753|NCT01687582|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6694754|NCT01687699|Spironolactone|spironolactone|mesh-list
6694755|NCT01687699|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6694756|NCT01687699|Hormone Antagonists|hormone antagonists|mesh-ancestor
6694757|NCT01687699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6694758|NCT01687699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694759|NCT01687699|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6694760|NCT01687699|Diuretics|diuretics|mesh-ancestor
6694761|NCT01687699|Natriuretic Agents|natriuretic agents|mesh-ancestor
6694762|NCT01687751|Midazolam|midazolam|mesh-list
6694763|NCT01687751|Dexmedetomidine|dexmedetomidine|mesh-list
6694764|NCT01687751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6694765|NCT01687751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6694766|NCT01687751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694767|NCT01687751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6694768|NCT01687751|Analgesics|analgesics|mesh-ancestor
6694769|NCT01687751|Sensory System Agents|sensory system agents|mesh-ancestor
6694770|NCT01687751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6694771|NCT01687751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6694772|NCT01687751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6694773|NCT01687751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6694774|NCT01687751|Adrenergic Agents|adrenergic agents|mesh-ancestor
6694775|NCT01687751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6694776|NCT01687751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694777|NCT01687751|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6694778|NCT01687751|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6694779|NCT01687751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6694780|NCT01687751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6694781|NCT01687751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6694782|NCT01687751|Anesthetics, General|anesthetics, general|mesh-ancestor
6694783|NCT01687751|Anesthetics|anesthetics|mesh-ancestor
6694784|NCT01687751|GABA Modulators|gaba modulators|mesh-ancestor
6694785|NCT01687751|GABA Agents|gaba agents|mesh-ancestor
6781036|NCT02183805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6781037|NCT02183805|Tubulin Modulators|tubulin modulators|mesh-ancestor
6781038|NCT02183805|Antimitotic Agents|antimitotic agents|mesh-ancestor
6781039|NCT02183805|Mitosis Modulators|mitosis modulators|mesh-ancestor
6781040|NCT02183870|Crizotinib|crizotinib|mesh-list
6694786|NCT01687868|Dexmedetomidine|dexmedetomidine|mesh-list
6694787|NCT01687868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6694788|NCT01687868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6694789|NCT01687868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694790|NCT01687868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6694791|NCT01687868|Analgesics|analgesics|mesh-ancestor
6694792|NCT01687868|Sensory System Agents|sensory system agents|mesh-ancestor
6694793|NCT01687868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6694794|NCT01687868|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6694795|NCT01687868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6694796|NCT01687868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6694797|NCT01687868|Adrenergic Agents|adrenergic agents|mesh-ancestor
6694798|NCT01687868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6694799|NCT01687868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694800|NCT01687894|Vasopressins|vasopressins|mesh-list
6694801|NCT01687894|Arginine Vasopressin|arginine vasopressin|mesh-list
6694802|NCT01687894|Propofol|propofol|mesh-list
6694803|NCT01687894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
6694804|NCT01687894|Sevoflurane|sevoflurane|mesh-list
6694805|NCT01687894|Anesthetics|anesthetics|mesh-list
6694806|NCT01687894|Anesthetics, General|anesthetics, general|mesh-list
6694807|NCT01687894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6694808|NCT01687894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6694809|NCT01687894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694810|NCT01687894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6694811|NCT01687894|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6694812|NCT01687894|Hemostatics|hemostatics|mesh-ancestor
6694813|NCT01687894|Coagulants|coagulants|mesh-ancestor
6694814|NCT01687894|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6694815|NCT01687894|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6694816|NCT01687894|Natriuretic Agents|natriuretic agents|mesh-ancestor
6694817|NCT01688024|Mitomycins|mitomycins|mesh-list
6694818|NCT01688024|Mitomycin|mitomycin|mesh-list
6694819|NCT01688024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6694820|NCT01688024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6694821|NCT01688024|Alkylating Agents|alkylating agents|mesh-ancestor
6694822|NCT01688024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694823|NCT01688024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6694824|NCT01688024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6694825|NCT01688089|Levodopa|levodopa|mesh-list
6694826|NCT01688089|Carbidopa|carbidopa|mesh-list
6694827|NCT01688089|Entacapone|entacapone|mesh-list
6694828|NCT01688089|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6694829|NCT01688089|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6694830|NCT01688089|Dopamine Agents|dopamine agents|mesh-ancestor
6694831|NCT01688089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6694832|NCT01688089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694833|NCT01688089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694834|NCT01688089|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6694835|NCT01688089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6694836|NCT01688089|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6694837|NCT01688154|Proanthocyanidin|proanthocyanidin|mesh-list
6694838|NCT01688154|Procyanidin|procyanidin|mesh-list
6694839|NCT01688154|Antioxidants|antioxidants|mesh-ancestor
6694840|NCT01688154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694841|NCT01688154|Protective Agents|protective agents|mesh-ancestor
6694842|NCT01688154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694843|NCT01688154|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6694844|NCT01688154|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6694845|NCT01688154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6694846|NCT01688206|Atezolizumab|atezolizumab|mesh-list
6694847|NCT01688206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6694848|NCT01688349|Glucocorticoids|glucocorticoids|mesh-list
6694849|NCT01688349|Hormones|hormones|mesh-ancestor
6694850|NCT01688349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6694851|NCT01688349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694852|NCT01688362|Dexamethasone|dexamethasone|mesh-list
6694853|NCT01688362|Bupivacaine|bupivacaine|mesh-list
6694854|NCT01688362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6694855|NCT01688362|Antiemetics|antiemetics|mesh-ancestor
6694856|NCT01688362|Autonomic Agents|autonomic agents|mesh-ancestor
6694857|NCT01688362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6694858|NCT01688362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694859|NCT01688362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6694860|NCT01688362|Glucocorticoids|glucocorticoids|mesh-ancestor
6694861|NCT01688362|Hormones|hormones|mesh-ancestor
6694862|NCT01688362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6694863|NCT01688362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6694864|NCT01688362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6694865|NCT01688362|Anesthetics, Local|anesthetics, local|mesh-ancestor
6694866|NCT01688362|Anesthetics|anesthetics|mesh-ancestor
6694867|NCT01688362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6694868|NCT01688362|Sensory System Agents|sensory system agents|mesh-ancestor
6694869|NCT01688375|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
6694870|NCT01688375|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6694871|NCT01688375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6694872|NCT01688401|Melphalan|melphalan|mesh-list
6694873|NCT01688401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6694874|NCT01688401|Alkylating Agents|alkylating agents|mesh-ancestor
6694875|NCT01688401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694876|NCT01688401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6694877|NCT01688401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6694878|NCT01688401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6694879|NCT01688401|Immunologic Factors|immunologic factors|mesh-ancestor
6694880|NCT01688401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694881|NCT01688492|Ipilimumab|ipilimumab|mesh-list
6694882|NCT01688492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6694883|NCT01688492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6694884|NCT01688492|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6694885|NCT01688492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694886|NCT01688518|Lidocaine|lidocaine|mesh-list
6694887|NCT01688518|Tetracaine|tetracaine|mesh-list
6694888|NCT01688518|Anesthetics, Local|anesthetics, local|mesh-ancestor
6694889|NCT01688518|Anesthetics|anesthetics|mesh-ancestor
6694890|NCT01688518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6694891|NCT01688518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694892|NCT01688518|Sensory System Agents|sensory system agents|mesh-ancestor
6694893|NCT01688518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6694894|NCT01688518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6694895|NCT01688518|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6694896|NCT01688518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6694897|NCT01688518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6694898|NCT01688518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694899|NCT01688544|Benzimidazole|benzimidazole|mesh-list
6694900|NCT01688544|Anthelmintics|anthelmintics|mesh-ancestor
6694901|NCT01688544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6694902|NCT01688544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6694903|NCT01688570|Cyproheptadine|cyproheptadine|mesh-list
6694904|NCT01688570|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6694905|NCT01688570|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6694906|NCT01688570|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6694907|NCT01688570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6694908|NCT01688570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694909|NCT01688570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6694910|NCT01688570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694911|NCT01688570|Analgesics|analgesics|mesh-ancestor
6694912|NCT01688570|Sensory System Agents|sensory system agents|mesh-ancestor
6694913|NCT01688570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6694914|NCT01688570|Antidepressive Agents|antidepressive agents|mesh-ancestor
6694915|NCT01688570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6694916|NCT01688570|Dopamine Agents|dopamine agents|mesh-ancestor
6694917|NCT01688570|Antipruritics|antipruritics|mesh-ancestor
6694918|NCT01688570|Dermatologic Agents|dermatologic agents|mesh-ancestor
6694919|NCT01688570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6694920|NCT01688570|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6694921|NCT01688570|Histamine Antagonists|histamine antagonists|mesh-ancestor
6694922|NCT01688570|Histamine Agents|histamine agents|mesh-ancestor
6694923|NCT01688570|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6694924|NCT01688570|Serotonin Agents|serotonin agents|mesh-ancestor
6694925|NCT01688570|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6694926|NCT01688583|Fentanyl|fentanyl|mesh-list
6694927|NCT01688583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6694928|NCT01688583|Narcotics|narcotics|mesh-ancestor
6694929|NCT01688583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6694930|NCT01688583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694931|NCT01688583|Analgesics|analgesics|mesh-ancestor
6694932|NCT01688583|Sensory System Agents|sensory system agents|mesh-ancestor
6694933|NCT01688583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6694934|NCT01688583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6694935|NCT01688583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6694936|NCT01688583|Anesthetics, General|anesthetics, general|mesh-ancestor
6694937|NCT01688583|Anesthetics|anesthetics|mesh-ancestor
6694938|NCT01688648|Lidocaine|lidocaine|mesh-list
6694939|NCT01688648|Dexmedetomidine|dexmedetomidine|mesh-list
6694940|NCT01688648|Anesthetics, Local|anesthetics, local|mesh-ancestor
6694941|NCT01688648|Anesthetics|anesthetics|mesh-ancestor
6694942|NCT01688648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6694943|NCT01688648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694944|NCT01688648|Sensory System Agents|sensory system agents|mesh-ancestor
6694945|NCT01688648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6694946|NCT01688648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6694947|NCT01688648|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6694948|NCT01688648|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6694949|NCT01688648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6694950|NCT01688648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694951|NCT01688648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6694952|NCT01688648|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6694953|NCT01688648|Analgesics|analgesics|mesh-ancestor
6694954|NCT01688648|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6694955|NCT01688648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6694956|NCT01688648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6694957|NCT01688648|Adrenergic Agents|adrenergic agents|mesh-ancestor
6694958|NCT01688648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6694959|NCT01688700|Paclitaxel|paclitaxel|mesh-list
6694960|NCT01688700|Nimotuzumab|nimotuzumab|mesh-list
6694961|NCT01688700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6694962|NCT01688700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6694963|NCT01688700|Tubulin Modulators|tubulin modulators|mesh-ancestor
6694964|NCT01688700|Antimitotic Agents|antimitotic agents|mesh-ancestor
6694965|NCT01688700|Mitosis Modulators|mitosis modulators|mesh-ancestor
6694966|NCT01688700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694967|NCT01688700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6694968|NCT01688791|Paclitaxel|paclitaxel|mesh-list
6694969|NCT01688791|Carboplatin|carboplatin|mesh-list
6694970|NCT01688791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6694971|NCT01688791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6694972|NCT01688791|Tubulin Modulators|tubulin modulators|mesh-ancestor
6694973|NCT01688791|Antimitotic Agents|antimitotic agents|mesh-ancestor
6694974|NCT01688791|Mitosis Modulators|mitosis modulators|mesh-ancestor
6694975|NCT01688791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694976|NCT01688934|Naproxen|naproxen|mesh-list
6694977|NCT01688934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6694978|NCT01688934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6694979|NCT01688934|Analgesics|analgesics|mesh-ancestor
6694980|NCT01688934|Sensory System Agents|sensory system agents|mesh-ancestor
6694981|NCT01688934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6694982|NCT01688934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694983|NCT01688934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6694984|NCT01688934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6694985|NCT01688934|Gout Suppressants|gout suppressants|mesh-ancestor
6694986|NCT01688934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6694987|NCT01688934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6694988|NCT01688934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694989|NCT01688947|Pregabalin|pregabalin|mesh-list
6694990|NCT01688947|Analgesics|analgesics|mesh-ancestor
6694991|NCT01688947|Sensory System Agents|sensory system agents|mesh-ancestor
6694992|NCT01688947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6694993|NCT01688947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6694994|NCT01688947|Anticonvulsants|anticonvulsants|mesh-ancestor
6694995|NCT01688947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6694996|NCT01688947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6694997|NCT01688947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6694998|NCT01688947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6694999|NCT01688947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6695000|NCT01688947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6695001|NCT01688947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6695002|NCT01688947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6695003|NCT01688960|Aflibercept|aflibercept|mesh-list
6695004|NCT01688960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6695005|NCT01688960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6695006|NCT01688960|Growth Substances|growth substances|mesh-ancestor
6695007|NCT01688960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695008|NCT01688960|Growth Inhibitors|growth inhibitors|mesh-ancestor
6695009|NCT01688960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6695010|NCT01689051|Glucagon|glucagon|mesh-list
6695011|NCT01689051|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6695012|NCT01689051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6695013|NCT01689051|Hormones|hormones|mesh-ancestor
6695014|NCT01689051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6695015|NCT01689051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695016|NCT01689051|Incretins|incretins|mesh-ancestor
6695017|NCT01689090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
6695018|NCT01689090|Citric Acid|citric acid|mesh-list
6695019|NCT01689090|Sodium Citrate|sodium citrate|mesh-list
6695020|NCT01689090|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
6695021|NCT01689090|Anticoagulants|anticoagulants|mesh-ancestor
6695022|NCT01689090|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6695023|NCT01689090|Chelating Agents|chelating agents|mesh-ancestor
6695024|NCT01689090|Sequestering Agents|sequestering agents|mesh-ancestor
6695025|NCT01689090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695026|NCT01689090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6695027|NCT01689090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6695028|NCT01689090|Analgesics|analgesics|mesh-ancestor
6695029|NCT01689090|Sensory System Agents|sensory system agents|mesh-ancestor
6695030|NCT01689090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6695031|NCT01689090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695032|NCT01689090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6695033|NCT01689090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6695034|NCT01689090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6695035|NCT01689116|Moxifloxacin|moxifloxacin|mesh-list
6695036|NCT01689116|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6695037|NCT01689116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6695038|NCT01689116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6695039|NCT01689116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6695040|NCT01689116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6695041|NCT01689116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6695042|NCT01689116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695043|NCT01689116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6695044|NCT01689116|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6695045|NCT01689116|Contraceptive Agents|contraceptive agents|mesh-ancestor
6695046|NCT01689116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6695047|NCT01689116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695048|NCT01689116|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6695049|NCT01689116|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6695050|NCT01689116|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6695051|NCT01689129|Insulin|insulin|mesh-list
6695052|NCT01689129|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6695053|NCT01689129|Insulin Glargine|insulin glargine|mesh-list
6695054|NCT01689129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6695055|NCT01689129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695056|NCT01689142|Insulin|insulin|mesh-list
6695057|NCT01689142|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6695058|NCT01689142|Insulin Glargine|insulin glargine|mesh-list
6695059|NCT01689142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6695060|NCT01689142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695061|NCT01689194|Cisplatin|cisplatin|mesh-list
6695062|NCT01689194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6695063|NCT01689259|Cyclobenzaprine|cyclobenzaprine|mesh-list
6695064|NCT01689259|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6695065|NCT01689259|Antidepressive Agents|antidepressive agents|mesh-ancestor
6695066|NCT01689259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6695067|NCT01689259|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6695068|NCT01689259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695069|NCT01689259|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6695070|NCT01689259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6695071|NCT01689259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6695072|NCT01689259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6695073|NCT01689285|Valacyclovir|valacyclovir|mesh-list
6695074|NCT01689285|Antiviral Agents|antiviral agents|mesh-ancestor
6695075|NCT01689285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6695076|NCT01689298|Oxytocin|oxytocin|mesh-list
6695077|NCT01689298|Carbetocin|carbetocin|mesh-list
6695078|NCT01689298|Oxytocics|oxytocics|mesh-ancestor
6695079|NCT01689298|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6695080|NCT01689298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695081|NCT01689311|Alprostadil|alprostadil|mesh-list
6695082|NCT01689311|Misoprostol|misoprostol|mesh-list
6695083|NCT01689311|Oxytocin|oxytocin|mesh-list
6695084|NCT01689311|Ergonovine|ergonovine|mesh-list
6695085|NCT01689311|Dinoprost|dinoprost|mesh-list
6695086|NCT01689311|Dinoprost tromethamine|dinoprost tromethamine|mesh-list
6695087|NCT01689311|Oxytocics|oxytocics|mesh-ancestor
6695088|NCT01689311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6695089|NCT01689311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695090|NCT01689311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6695091|NCT01689311|Abortifacient Agents|abortifacient agents|mesh-ancestor
6695092|NCT01689311|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6695093|NCT01689311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6695094|NCT01689311|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6695095|NCT01689311|Vasodilator Agents|vasodilator agents|mesh-ancestor
6695096|NCT01689311|Urological Agents|urological agents|mesh-ancestor
6695097|NCT01689558|Endostatins|endostatins|mesh-list
6695098|NCT01689558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6695099|NCT01689558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6695100|NCT01689558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6695101|NCT01689558|Growth Substances|growth substances|mesh-ancestor
6695102|NCT01689558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695103|NCT01689558|Growth Inhibitors|growth inhibitors|mesh-ancestor
6695104|NCT01689597|Morphine|morphine|mesh-list
6695105|NCT01689597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6695106|NCT01689597|Narcotics|narcotics|mesh-ancestor
6695107|NCT01689597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6695108|NCT01689597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695109|NCT01689597|Analgesics|analgesics|mesh-ancestor
6695110|NCT01689597|Sensory System Agents|sensory system agents|mesh-ancestor
6695111|NCT01689597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6781041|NCT02183870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6781042|NCT02183870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6781043|NCT02183870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6781044|NCT02183870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781045|NCT02183883|Afatinib|afatinib|mesh-list
6781046|NCT02183883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6781047|NCT02183883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6781048|NCT02183883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6781049|NCT02183883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781050|NCT02183909|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6781051|NCT02183909|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6781052|NCT02183909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6781053|NCT02183909|Antiviral Agents|antiviral agents|mesh-ancestor
6781054|NCT02183909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6781055|NCT02183948|Oxytocin|oxytocin|mesh-list
6781056|NCT02183948|Oxytocics|oxytocics|mesh-ancestor
6781057|NCT02183948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6781058|NCT02183948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781059|NCT02184052|Meloxicam|meloxicam|mesh-list
6781060|NCT02184052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6781061|NCT02184052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6781062|NCT02184052|Analgesics|analgesics|mesh-ancestor
6781063|NCT02184052|Sensory System Agents|sensory system agents|mesh-ancestor
6781064|NCT02184052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6781065|NCT02184052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781066|NCT02184052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6781067|NCT02184052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6781068|NCT02184052|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6781069|NCT02184052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6781070|NCT02184052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6781071|NCT02184052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781072|NCT02184065|Meloxicam|meloxicam|mesh-list
6781073|NCT02184065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6781074|NCT02184065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6781075|NCT02184065|Analgesics|analgesics|mesh-ancestor
6781076|NCT02184065|Sensory System Agents|sensory system agents|mesh-ancestor
6781077|NCT02184065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6781078|NCT02184065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781079|NCT02184065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6781080|NCT02184065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6781081|NCT02184065|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6781082|NCT02184065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6781083|NCT02184065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6781084|NCT02184065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781085|NCT02184078|Nevirapine|nevirapine|mesh-list
6781086|NCT02184078|Rifabutin|rifabutin|mesh-list
6781087|NCT02184078|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6781088|NCT02184078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6781089|NCT02184078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6695112|NCT01689623|Simeprevir|simeprevir|mesh-list
6695113|NCT01689623|Atorvastatin|atorvastatin|mesh-list
6695114|NCT01689623|Simvastatin|simvastatin|mesh-list
6695115|NCT01689623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6695116|NCT01689623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6695117|NCT01689623|Antimetabolites|antimetabolites|mesh-ancestor
6695118|NCT01689623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695119|NCT01689623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6695120|NCT01689623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6695121|NCT01689623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6695122|NCT01689623|Antiviral Agents|antiviral agents|mesh-ancestor
6695123|NCT01689623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6695124|NCT01689623|Protease Inhibitors|protease inhibitors|mesh-ancestor
6695125|NCT01689636|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
6695126|NCT01689636|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6695127|NCT01689636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695128|NCT01689662|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
6695129|NCT01689662|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6695130|NCT01689662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695131|NCT01689714|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
6695132|NCT01689714|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6695133|NCT01689714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695134|NCT01689727|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
6695135|NCT01689727|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6695136|NCT01689727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695137|NCT01689753|Citric Acid|citric acid|mesh-list
6695138|NCT01689753|Sodium Citrate|sodium citrate|mesh-list
6695139|NCT01689753|Anticoagulants|anticoagulants|mesh-ancestor
6695140|NCT01689753|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6695141|NCT01689753|Chelating Agents|chelating agents|mesh-ancestor
6695142|NCT01689753|Sequestering Agents|sequestering agents|mesh-ancestor
6695143|NCT01689753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695144|NCT01689766|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
6695145|NCT01689766|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6695146|NCT01689766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695147|NCT01689870|Ipilimumab|ipilimumab|mesh-list
6695148|NCT01689870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6695149|NCT01689870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6695150|NCT01689870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6695151|NCT01689870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695152|NCT01689896|Testosterone|testosterone|mesh-list
6695153|NCT01689896|Androgens|androgens|mesh-ancestor
6695154|NCT01689896|Hormones|hormones|mesh-ancestor
6695155|NCT01689896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6695156|NCT01689896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695157|NCT01689935|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6695158|NCT01689935|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6695159|NCT01689935|Dermatologic Agents|dermatologic agents|mesh-ancestor
6695160|NCT01689987|Sirolimus|sirolimus|mesh-list
6695161|NCT01689987|Hydroxychloroquine|hydroxychloroquine|mesh-list
6695162|NCT01689987|Dexamethasone|dexamethasone|mesh-list
6695163|NCT01689987|Dexamethasone acetate|dexamethasone acetate|mesh-list
6695164|NCT01689987|Cyclophosphamide|cyclophosphamide|mesh-list
6695165|NCT01689987|Ichthammol|ichthammol|mesh-list
6695166|NCT01689987|BB 1101|bb 1101|mesh-list
6695167|NCT01689987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6695168|NCT01689987|Immunologic Factors|immunologic factors|mesh-ancestor
6695169|NCT01689987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695170|NCT01689987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6695171|NCT01689987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6695172|NCT01689987|Alkylating Agents|alkylating agents|mesh-ancestor
6695173|NCT01689987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695174|NCT01689987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6695175|NCT01689987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6695176|NCT01689987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6695177|NCT01689987|Antiemetics|antiemetics|mesh-ancestor
6695178|NCT01689987|Autonomic Agents|autonomic agents|mesh-ancestor
6695179|NCT01689987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6695180|NCT01689987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6695181|NCT01689987|Glucocorticoids|glucocorticoids|mesh-ancestor
6695182|NCT01689987|Hormones|hormones|mesh-ancestor
6695183|NCT01689987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6695184|NCT01689987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6695185|NCT01689987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6695186|NCT01689987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6695187|NCT01689987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6695188|NCT01689987|Antifungal Agents|antifungal agents|mesh-ancestor
6695189|NCT01689987|Antimalarials|antimalarials|mesh-ancestor
6695190|NCT01689987|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6695191|NCT01689987|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6695192|NCT01689987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6695193|NCT01689987|Protease Inhibitors|protease inhibitors|mesh-ancestor
6695194|NCT01689987|Dermatologic Agents|dermatologic agents|mesh-ancestor
6695195|NCT01690039|Fludrocortisone|fludrocortisone|mesh-list
6695196|NCT01690039|Furosemide|furosemide|mesh-list
6695197|NCT01690039|Diuretics|diuretics|mesh-ancestor
6695198|NCT01690039|Natriuretic Agents|natriuretic agents|mesh-ancestor
6695199|NCT01690039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695200|NCT01690039|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6695201|NCT01690039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6695202|NCT01690039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695203|NCT01690039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6695204|NCT01690091|Metformin|metformin|mesh-list
6695205|NCT01690091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6695206|NCT01690091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695207|NCT01690104|Rifampin|rifampin|mesh-list
6695208|NCT01690104|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6695209|NCT01690104|Antitubercular Agents|antitubercular agents|mesh-ancestor
6695210|NCT01690104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6695211|NCT01690104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6695212|NCT01690104|Leprostatic Agents|leprostatic agents|mesh-ancestor
6695213|NCT01690104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6695214|NCT01690104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6695215|NCT01690104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695216|NCT01690104|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6695217|NCT01690104|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6695218|NCT01690104|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6695219|NCT01690104|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6695220|NCT01690104|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6695221|NCT01690104|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6695222|NCT01690221|Diltiazem|diltiazem|mesh-list
6695223|NCT01690221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6695224|NCT01690221|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6695225|NCT01690221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6695226|NCT01690221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695227|NCT01690221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6695228|NCT01690221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695229|NCT01690221|Vasodilator Agents|vasodilator agents|mesh-ancestor
6695230|NCT01690247|Immunosuppressive Agents|immunosuppressive agents|mesh-list
6695231|NCT01690247|Immunologic Factors|immunologic factors|mesh-ancestor
6695232|NCT01690247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695233|NCT01690286|Ketoconazole|ketoconazole|mesh-list
6695234|NCT01690286|Antifungal Agents|antifungal agents|mesh-ancestor
6695235|NCT01690286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6695236|NCT01690286|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6695237|NCT01690286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6695238|NCT01690286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6695239|NCT01690286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695240|NCT01690286|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6695241|NCT01690286|Hormone Antagonists|hormone antagonists|mesh-ancestor
6695242|NCT01690286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6695243|NCT01690286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695244|NCT01690286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6695245|NCT01690325|Cyclophosphamide|cyclophosphamide|mesh-list
6695246|NCT01690325|Bevacizumab|bevacizumab|mesh-list
6695247|NCT01690325|Docetaxel|docetaxel|mesh-list
6695248|NCT01690325|Trastuzumab|trastuzumab|mesh-list
6695249|NCT01690325|Epirubicin|epirubicin|mesh-list
6695250|NCT01690325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6695251|NCT01690325|Immunologic Factors|immunologic factors|mesh-ancestor
6695252|NCT01690325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695253|NCT01690325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6695254|NCT01690325|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6695255|NCT01690325|Alkylating Agents|alkylating agents|mesh-ancestor
6695256|NCT01690325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695257|NCT01690325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6695258|NCT01690325|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6695259|NCT01690325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6695260|NCT01690325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6695261|NCT01690325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6695262|NCT01690325|Growth Substances|growth substances|mesh-ancestor
6695263|NCT01690325|Growth Inhibitors|growth inhibitors|mesh-ancestor
6695264|NCT01690325|Tubulin Modulators|tubulin modulators|mesh-ancestor
6695265|NCT01690325|Antimitotic Agents|antimitotic agents|mesh-ancestor
6695266|NCT01690325|Mitosis Modulators|mitosis modulators|mesh-ancestor
6695267|NCT01690325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6695268|NCT01690325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6695269|NCT01690325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6695270|NCT01690325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6695271|NCT01690338|Bromides|bromides|mesh-list
6695272|NCT01690338|Rocuronium|rocuronium|mesh-list
6695273|NCT01690338|Vecuronium Bromide|vecuronium bromide|mesh-list
6695274|NCT01690338|Cisatracurium|cisatracurium|mesh-list
6695275|NCT01690338|Anticonvulsants|anticonvulsants|mesh-ancestor
6695276|NCT01690338|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6695277|NCT01690338|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6695278|NCT01690338|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6695279|NCT01690338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6695280|NCT01690338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695281|NCT01690338|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
6695282|NCT01690338|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6695283|NCT01690338|Cholinergic Agents|cholinergic agents|mesh-ancestor
6695284|NCT01690338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6695285|NCT01690338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695286|NCT01690364|Anesthetics|anesthetics|mesh-list
6695287|NCT01690364|Cisatracurium|cisatracurium|mesh-list
6695288|NCT01690364|Vecuronium Bromide|vecuronium bromide|mesh-list
6695289|NCT01690364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6695290|NCT01690364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695291|NCT01690364|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6695292|NCT01690364|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6695293|NCT01690364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6695294|NCT01690364|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6695295|NCT01690364|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
6695296|NCT01690364|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6695297|NCT01690364|Cholinergic Agents|cholinergic agents|mesh-ancestor
6695298|NCT01690364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6695299|NCT01690364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695300|NCT01690403|Rifapentine|rifapentine|mesh-list
6695301|NCT01690403|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6695302|NCT01690403|Antitubercular Agents|antitubercular agents|mesh-ancestor
6695303|NCT01690403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6695304|NCT01690403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6695305|NCT01690403|Leprostatic Agents|leprostatic agents|mesh-ancestor
6695306|NCT01690468|Carboplatin|carboplatin|mesh-list
6695307|NCT01690468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6695308|NCT01690507|Cytarabine|cytarabine|mesh-list
6695309|NCT01690507|Decitabine|decitabine|mesh-list
6695310|NCT01690507|Aclacinomycins|aclacinomycins|mesh-list
6695311|NCT01690507|Sargramostim|sargramostim|mesh-list
6695312|NCT01690507|Lenograstim|lenograstim|mesh-list
6695313|NCT01690507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6695314|NCT01690507|Antimetabolites|antimetabolites|mesh-ancestor
6695315|NCT01690507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695316|NCT01690507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6695317|NCT01690507|Antiviral Agents|antiviral agents|mesh-ancestor
6695318|NCT01690507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6695319|NCT01690507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6695320|NCT01690507|Immunologic Factors|immunologic factors|mesh-ancestor
6695321|NCT01690507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695322|NCT01690507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6695323|NCT01690507|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6695324|NCT01690507|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6695325|NCT01690533|Moxifloxacin|moxifloxacin|mesh-list
6695326|NCT01690533|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6695327|NCT01690533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6695328|NCT01690533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6695329|NCT01690533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6695330|NCT01690533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6695331|NCT01690533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6695332|NCT01690533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695333|NCT01690533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6695334|NCT01690533|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6695335|NCT01690533|Contraceptive Agents|contraceptive agents|mesh-ancestor
6695336|NCT01690533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6695337|NCT01690533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695338|NCT01690533|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6695339|NCT01690533|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6695340|NCT01690533|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6695341|NCT01690559|Ciprofloxacin|ciprofloxacin|mesh-list
6695342|NCT01690559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6695343|NCT01690559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6695344|NCT01690559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6695345|NCT01690559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6695346|NCT01690559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6695347|NCT01690559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695348|NCT01690559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6695349|NCT01690559|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6695350|NCT01690559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6695351|NCT01690572|Paclitaxel|paclitaxel|mesh-list
6695352|NCT01690572|Hyaluronic Acid|hyaluronic acid|mesh-list
6695353|NCT01690572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6695354|NCT01690572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6695355|NCT01690572|Tubulin Modulators|tubulin modulators|mesh-ancestor
6695356|NCT01690572|Antimitotic Agents|antimitotic agents|mesh-ancestor
6695357|NCT01690572|Mitosis Modulators|mitosis modulators|mesh-ancestor
6695358|NCT01690572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695359|NCT01690572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6695360|NCT01690572|Immunologic Factors|immunologic factors|mesh-ancestor
6695361|NCT01690572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695362|NCT01690572|Viscosupplements|viscosupplements|mesh-ancestor
6695363|NCT01690572|Protective Agents|protective agents|mesh-ancestor
6695364|NCT01690598|Topotecan|topotecan|mesh-list
6695365|NCT01690598|Veliparib|veliparib|mesh-list
6695366|NCT01690598|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6695367|NCT01690598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6695368|NCT01690598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6695369|NCT01690598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695370|NCT01690598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6695371|NCT01690598|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6695372|NCT01690637|Oseltamivir|oseltamivir|mesh-list
6695373|NCT01690637|Antiviral Agents|antiviral agents|mesh-ancestor
6695374|NCT01690637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6695375|NCT01690637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6695376|NCT01690637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695377|NCT01690702|Paclitaxel|paclitaxel|mesh-list
6695378|NCT01690702|Docetaxel|docetaxel|mesh-list
6695379|NCT01690702|Cyclophosphamide|cyclophosphamide|mesh-list
6695380|NCT01690702|Epirubicin|epirubicin|mesh-list
6695381|NCT01690702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6695382|NCT01690702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6695383|NCT01690702|Tubulin Modulators|tubulin modulators|mesh-ancestor
6695384|NCT01690702|Antimitotic Agents|antimitotic agents|mesh-ancestor
6695385|NCT01690702|Mitosis Modulators|mitosis modulators|mesh-ancestor
6695386|NCT01690702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695387|NCT01690702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6695388|NCT01690702|Immunologic Factors|immunologic factors|mesh-ancestor
6695389|NCT01690702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695390|NCT01690702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6695391|NCT01690702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6695392|NCT01690702|Alkylating Agents|alkylating agents|mesh-ancestor
6695393|NCT01690702|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6695394|NCT01690702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6695395|NCT01690702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6695396|NCT01690702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6695397|NCT01690702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6695398|NCT01690767|Lidocaine|lidocaine|mesh-list
6695399|NCT01690767|Anesthetics, Local|anesthetics, local|mesh-ancestor
6695400|NCT01690767|Anesthetics|anesthetics|mesh-ancestor
6695401|NCT01690767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6695402|NCT01690767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695403|NCT01690767|Sensory System Agents|sensory system agents|mesh-ancestor
6695404|NCT01690767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6695405|NCT01690767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6695406|NCT01690767|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6695407|NCT01690767|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6695408|NCT01690767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6695409|NCT01690767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695410|NCT01690780|Ibuprofen|ibuprofen|mesh-list
6695411|NCT01690780|Morphine|morphine|mesh-list
6695412|NCT01690780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6695413|NCT01690780|Narcotics|narcotics|mesh-ancestor
6695414|NCT01690780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6695415|NCT01690780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695416|NCT01690780|Analgesics|analgesics|mesh-ancestor
6695417|NCT01690780|Sensory System Agents|sensory system agents|mesh-ancestor
6695418|NCT01690780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6695419|NCT01690780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6695420|NCT01690780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6695421|NCT01690780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6695422|NCT01690780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6695423|NCT01690780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6695424|NCT01690780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6695425|NCT01690780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695426|NCT01690832|Fenoldopam|fenoldopam|mesh-list
6695427|NCT01690832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6695428|NCT01690832|Vasodilator Agents|vasodilator agents|mesh-ancestor
6695429|NCT01690832|Dopamine Agonists|dopamine agonists|mesh-ancestor
6695430|NCT01690832|Dopamine Agents|dopamine agents|mesh-ancestor
6695431|NCT01690832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6695432|NCT01690832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695433|NCT01690832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695434|NCT01690871|Dactolisib|dactolisib|mesh-list
6695435|NCT01690871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6695436|NCT01690884|Adenosine|adenosine|mesh-list
6695437|NCT01690884|Analgesics|analgesics|mesh-ancestor
6695438|NCT01690884|Sensory System Agents|sensory system agents|mesh-ancestor
6695439|NCT01690884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6695440|NCT01690884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695441|NCT01690884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6695442|NCT01690884|Vasodilator Agents|vasodilator agents|mesh-ancestor
6695443|NCT01690884|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6695444|NCT01690884|Purinergic Agonists|purinergic agonists|mesh-ancestor
6695445|NCT01690884|Purinergic Agents|purinergic agents|mesh-ancestor
6695446|NCT01690884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6695447|NCT01690884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695448|NCT01690962|Vitamins|vitamins|mesh-list
6695449|NCT01690962|Hydroxocobalamin|hydroxocobalamin|mesh-list
6695450|NCT01690962|Vitamin B 12|vitamin b 12|mesh-list
6695451|NCT01690962|Vitamin B Complex|vitamin b complex|mesh-list
6695452|NCT01690962|Micronutrients|micronutrients|mesh-ancestor
6695453|NCT01690962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695454|NCT01690962|Hematinics|hematinics|mesh-ancestor
6695455|NCT01690975|Benzonatate|benzonatate|mesh-list
6695456|NCT01690975|Antitussive Agents|antitussive agents|mesh-ancestor
6695457|NCT01690975|Respiratory System Agents|respiratory system agents|mesh-ancestor
6695458|NCT01691001|Dexmedetomidine|dexmedetomidine|mesh-list
6695459|NCT01691001|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6695460|NCT01691001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6695461|NCT01691001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695462|NCT01691001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6695463|NCT01691001|Analgesics|analgesics|mesh-ancestor
6695464|NCT01691001|Sensory System Agents|sensory system agents|mesh-ancestor
6695465|NCT01691001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6695466|NCT01691001|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6695467|NCT01691001|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6695468|NCT01691001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6695469|NCT01691001|Adrenergic Agents|adrenergic agents|mesh-ancestor
6695470|NCT01691001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6695471|NCT01691001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695472|NCT01691053|Spironolactone|spironolactone|mesh-list
6695473|NCT01691053|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6695474|NCT01691053|Hormone Antagonists|hormone antagonists|mesh-ancestor
6695475|NCT01691053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6695476|NCT01691053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695477|NCT01691053|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6695478|NCT01691053|Diuretics|diuretics|mesh-ancestor
6695479|NCT01691053|Natriuretic Agents|natriuretic agents|mesh-ancestor
6695480|NCT01691118|Antihypertensive Agents|antihypertensive agents|mesh-list
6695481|NCT01691209|Hydrocortisone|hydrocortisone|mesh-list
6695482|NCT01691209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6781090|NCT02184078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781091|NCT02184078|Antiviral Agents|antiviral agents|mesh-ancestor
6781092|NCT02184078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6781093|NCT02184078|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6781094|NCT02184078|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6781095|NCT02184078|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6781096|NCT02184078|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6781097|NCT02184078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6781098|NCT02184078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6781099|NCT02184078|Antitubercular Agents|antitubercular agents|mesh-ancestor
6781100|NCT02184091|Nevirapine|nevirapine|mesh-list
6781101|NCT02184091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6781102|NCT02184091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6781103|NCT02184091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6781104|NCT02184091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781105|NCT02184091|Antiviral Agents|antiviral agents|mesh-ancestor
6781106|NCT02184091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6781107|NCT02184091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6781108|NCT02184091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6781109|NCT02184091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6781110|NCT02184091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6781111|NCT02184104|Caffeine|caffeine|mesh-list
6781112|NCT02184104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6781113|NCT02184104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781114|NCT02184104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6781115|NCT02184104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6781116|NCT02184104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781117|NCT02184104|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6781118|NCT02184104|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6781119|NCT02184104|Purinergic Agents|purinergic agents|mesh-ancestor
6781120|NCT02184104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6781121|NCT02184117|Adenosine|adenosine|mesh-list
6781122|NCT02184117|Analgesics|analgesics|mesh-ancestor
6781123|NCT02184117|Sensory System Agents|sensory system agents|mesh-ancestor
6781124|NCT02184117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6781125|NCT02184117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781126|NCT02184117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6781127|NCT02184117|Vasodilator Agents|vasodilator agents|mesh-ancestor
6781128|NCT02184117|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6781129|NCT02184117|Purinergic Agonists|purinergic agonists|mesh-ancestor
6781130|NCT02184117|Purinergic Agents|purinergic agents|mesh-ancestor
6781131|NCT02184117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6781132|NCT02184117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695483|NCT01691365|Vitamins|vitamins|mesh-list
6695484|NCT01691365|Vitamin B Complex|vitamin b complex|mesh-list
6695485|NCT01691365|Antioxidants|antioxidants|mesh-list
6695486|NCT01691365|Micronutrients|micronutrients|mesh-ancestor
6695487|NCT01691365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695488|NCT01691365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695489|NCT01691365|Protective Agents|protective agents|mesh-ancestor
6695490|NCT01691404|Quercetin|quercetin|mesh-list
6695491|NCT01691404|Antioxidants|antioxidants|mesh-ancestor
6695492|NCT01691404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695493|NCT01691404|Protective Agents|protective agents|mesh-ancestor
6695494|NCT01691404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695495|NCT01691456|Montelukast|montelukast|mesh-list
6695496|NCT01691456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6695497|NCT01691456|Respiratory System Agents|respiratory system agents|mesh-ancestor
6695498|NCT01691456|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6695499|NCT01691456|Hormone Antagonists|hormone antagonists|mesh-ancestor
6695500|NCT01691456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6695501|NCT01691456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695502|NCT01691456|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6695503|NCT01691456|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6695504|NCT01691456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695505|NCT01691469|Montelukast|montelukast|mesh-list
6695506|NCT01691469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6695507|NCT01691469|Respiratory System Agents|respiratory system agents|mesh-ancestor
6695508|NCT01691469|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6695509|NCT01691469|Hormone Antagonists|hormone antagonists|mesh-ancestor
6695510|NCT01691469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6695511|NCT01691469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695512|NCT01691469|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6695513|NCT01691469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6695514|NCT01691469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695515|NCT01691495|PENTA|penta|mesh-list
6695516|NCT01691495|Fondaparinux|fondaparinux|mesh-list
6695517|NCT01691495|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6695518|NCT01691495|Antithrombins|antithrombins|mesh-ancestor
6695519|NCT01691495|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6695520|NCT01691495|Protease Inhibitors|protease inhibitors|mesh-ancestor
6695521|NCT01691495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6695522|NCT01691495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695523|NCT01691495|Anticoagulants|anticoagulants|mesh-ancestor
6695524|NCT01691495|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6695525|NCT01691495|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6695526|NCT01691651|Botulinum Toxins|botulinum toxins|mesh-list
6695527|NCT01691651|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6695528|NCT01691651|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6695529|NCT01691651|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6695530|NCT01691651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6695531|NCT01691651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695532|NCT01691651|Cholinergic Agents|cholinergic agents|mesh-ancestor
6695533|NCT01691651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6695534|NCT01691651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695535|NCT01691651|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6695536|NCT01691651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6695537|NCT01691677|Beclomethasone|beclomethasone|mesh-list
6695538|NCT01691677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6695539|NCT01691677|Glucocorticoids|glucocorticoids|mesh-ancestor
6695540|NCT01691677|Hormones|hormones|mesh-ancestor
6695541|NCT01691677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6695542|NCT01691677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695543|NCT01691677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6695544|NCT01691677|Respiratory System Agents|respiratory system agents|mesh-ancestor
6695545|NCT01691742|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
6695546|NCT01691742|Laxatives|laxatives|mesh-list
6695547|NCT01691742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6695548|NCT01691807|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6695549|NCT01691807|Ofatumumab|ofatumumab|mesh-list
6695550|NCT01691807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6695551|NCT01691807|Alkylating Agents|alkylating agents|mesh-ancestor
6695552|NCT01691807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695553|NCT01691807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6695554|NCT01691872|Ezogabine|ezogabine|mesh-list
6695555|NCT01691872|Anticonvulsants|anticonvulsants|mesh-ancestor
6695556|NCT01691872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6695557|NCT01691872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695558|NCT01691937|Sufentanil|sufentanil|mesh-list
6695559|NCT01691937|Ropivacaine|ropivacaine|mesh-list
6695560|NCT01691937|Anesthetics, Local|anesthetics, local|mesh-ancestor
6695561|NCT01691937|Anesthetics|anesthetics|mesh-ancestor
6695562|NCT01691937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6695563|NCT01691937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695564|NCT01691937|Sensory System Agents|sensory system agents|mesh-ancestor
6695565|NCT01691937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6695566|NCT01691937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6695567|NCT01691937|Narcotics|narcotics|mesh-ancestor
6695568|NCT01691937|Analgesics|analgesics|mesh-ancestor
6695569|NCT01691937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6695570|NCT01691937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6695571|NCT01691937|Anesthetics, General|anesthetics, general|mesh-ancestor
6695572|NCT01691976|Estrogens|estrogens|mesh-list
6695573|NCT01691976|Hormones|hormones|mesh-ancestor
6695574|NCT01691976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6781133|NCT02184247|Theophylline|theophylline|mesh-list
6695575|NCT01691976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695576|NCT01692132|Prucalopride|prucalopride|mesh-list
6695577|NCT01692132|Laxatives|laxatives|mesh-ancestor
6695578|NCT01692132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6695579|NCT01692132|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
6695580|NCT01692132|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6695581|NCT01692132|Serotonin Agents|serotonin agents|mesh-ancestor
6695582|NCT01692132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6695583|NCT01692132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695584|NCT01692132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695585|NCT01692158|Heparin|heparin|mesh-list
6695586|NCT01692158|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6695587|NCT01692158|Tinzaparin|tinzaparin|mesh-list
6695588|NCT01692158|Dalteparin|dalteparin|mesh-list
6695589|NCT01692158|Anticoagulants|anticoagulants|mesh-ancestor
6695590|NCT01692158|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6695591|NCT01692158|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6695592|NCT01692158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695593|NCT01692171|Heparin|heparin|mesh-list
6695594|NCT01692171|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6695595|NCT01692171|Tinzaparin|tinzaparin|mesh-list
6695596|NCT01692171|Dalteparin|dalteparin|mesh-list
6695597|NCT01692171|Anticoagulants|anticoagulants|mesh-ancestor
6695598|NCT01692171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6695599|NCT01692171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6695600|NCT01692171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695601|NCT01692210|Dexmedetomidine|dexmedetomidine|mesh-list
6695602|NCT01692210|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6695603|NCT01692210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6695604|NCT01692210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695605|NCT01692210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6695606|NCT01692210|Analgesics|analgesics|mesh-ancestor
6695607|NCT01692210|Sensory System Agents|sensory system agents|mesh-ancestor
6695608|NCT01692210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6695609|NCT01692210|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6695610|NCT01692210|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6695611|NCT01692210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6695612|NCT01692210|Adrenergic Agents|adrenergic agents|mesh-ancestor
6695613|NCT01692210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6695614|NCT01692210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695615|NCT01692457|Golimumab|golimumab|mesh-list
6695616|NCT01692457|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6695617|NCT01692457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6695618|NCT01692457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6695619|NCT01692457|Immunologic Factors|immunologic factors|mesh-ancestor
6695620|NCT01692457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695621|NCT01692483|Prednisone|prednisone|mesh-list
6695622|NCT01692483|Abiraterone Acetate|abiraterone acetate|mesh-list
6695623|NCT01692483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6695624|NCT01692483|Glucocorticoids|glucocorticoids|mesh-ancestor
6695625|NCT01692483|Hormones|hormones|mesh-ancestor
6695626|NCT01692483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6695627|NCT01692483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695628|NCT01692483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6695629|NCT01692483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6695630|NCT01692483|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6695631|NCT01692483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6695632|NCT01692483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695633|NCT01692483|Hormone Antagonists|hormone antagonists|mesh-ancestor
6695634|NCT01692483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6695635|NCT01692652|Loteprednol Etabonate|loteprednol etabonate|mesh-list
6695636|NCT01692652|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6695637|NCT01692678|Dacarbazine|dacarbazine|mesh-list
6695638|NCT01692678|Trabectedin|trabectedin|mesh-list
6695639|NCT01692678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6695640|NCT01692678|Alkylating Agents|alkylating agents|mesh-ancestor
6695641|NCT01692678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695642|NCT01692678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6695643|NCT01692704|Gemcitabine|gemcitabine|mesh-list
6695644|NCT01692704|Floxuridine|floxuridine|mesh-list
6695645|NCT01692704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6695646|NCT01692704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6695647|NCT01692704|Antimetabolites|antimetabolites|mesh-ancestor
6781134|NCT02184247|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6695648|NCT01692704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695649|NCT01692704|Antiviral Agents|antiviral agents|mesh-ancestor
6695650|NCT01692704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6695651|NCT01692704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6695652|NCT01692704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6695653|NCT01692704|Immunologic Factors|immunologic factors|mesh-ancestor
6695654|NCT01692704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695655|NCT01692717|Losartan|losartan|mesh-list
6695656|NCT01692717|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6695657|NCT01692717|Atorvastatin|atorvastatin|mesh-list
6695658|NCT01692717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6695659|NCT01692717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6695660|NCT01692717|Antimetabolites|antimetabolites|mesh-ancestor
6695661|NCT01692717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695662|NCT01692717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6695663|NCT01692717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6695664|NCT01692717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6695665|NCT01692717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6695666|NCT01692717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6695667|NCT01692717|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6695668|NCT01692717|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6695669|NCT01692717|Diuretics|diuretics|mesh-ancestor
6695670|NCT01692717|Natriuretic Agents|natriuretic agents|mesh-ancestor
6695671|NCT01692717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695672|NCT01692717|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6695673|NCT01692717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6695674|NCT01692808|Vitamin D|vitamin d|mesh-list
6695675|NCT01692808|Ergocalciferols|ergocalciferols|mesh-list
6695676|NCT01692808|Cholecalciferol|cholecalciferol|mesh-list
6695677|NCT01692808|Vitamins|vitamins|mesh-list
6695678|NCT01692808|Micronutrients|micronutrients|mesh-ancestor
6695679|NCT01692808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695680|NCT01692808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6695681|NCT01692808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6695682|NCT01692834|Cyclosporine|cyclosporine|mesh-list
6695683|NCT01692834|Cyclosporins|cyclosporins|mesh-list
6695684|NCT01692834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6695685|NCT01692834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695686|NCT01692834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6695687|NCT01692834|Immunologic Factors|immunologic factors|mesh-ancestor
6695688|NCT01692834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695689|NCT01692834|Antifungal Agents|antifungal agents|mesh-ancestor
6695690|NCT01692834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6695691|NCT01692834|Dermatologic Agents|dermatologic agents|mesh-ancestor
6695692|NCT01692834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6695693|NCT01692834|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6695694|NCT01692886|Vaccines|vaccines|mesh-list
6695695|NCT01692886|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6695696|NCT01692886|Immunologic Factors|immunologic factors|mesh-ancestor
6695697|NCT01692886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695698|NCT01692925|Factor VIII|factor viii|mesh-list
6695699|NCT01692925|Coagulants|coagulants|mesh-ancestor
6695700|NCT01693003|Tiotropium Bromide|tiotropium bromide|mesh-list
6695701|NCT01693003|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6695702|NCT01693003|Autonomic Agents|autonomic agents|mesh-ancestor
6695703|NCT01693003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6695704|NCT01693003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695705|NCT01693003|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6695706|NCT01693003|Respiratory System Agents|respiratory system agents|mesh-ancestor
6695707|NCT01693003|Parasympatholytics|parasympatholytics|mesh-ancestor
6695708|NCT01693003|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6695709|NCT01693003|Cholinergic Agents|cholinergic agents|mesh-ancestor
6695710|NCT01693003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6695711|NCT01693003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781135|NCT02184247|Autonomic Agents|autonomic agents|mesh-ancestor
6781136|NCT02184247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6781137|NCT02184247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781138|NCT02184247|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6781139|NCT02184247|Respiratory System Agents|respiratory system agents|mesh-ancestor
6781140|NCT02184247|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6781141|NCT02184247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6781142|NCT02184247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781143|NCT02184247|Vasodilator Agents|vasodilator agents|mesh-ancestor
6781144|NCT02184247|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6695712|NCT01693081|Apomorphine|apomorphine|mesh-list
6695713|NCT01693081|Emetics|emetics|mesh-ancestor
6695714|NCT01693081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695715|NCT01693081|Autonomic Agents|autonomic agents|mesh-ancestor
6695716|NCT01693081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6695717|NCT01693081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6695718|NCT01693081|Dopamine Agonists|dopamine agonists|mesh-ancestor
6695719|NCT01693081|Dopamine Agents|dopamine agents|mesh-ancestor
6695720|NCT01693081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6695721|NCT01693081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695722|NCT01693159|Ethyl 2-cyanoacrylate|ethyl 2-cyanoacrylate|mesh-list
6695723|NCT01693159|Hemostatics|hemostatics|mesh-ancestor
6695724|NCT01693159|Coagulants|coagulants|mesh-ancestor
6695725|NCT01693276|Gemcitabine|gemcitabine|mesh-list
6695726|NCT01693276|Paclitaxel|paclitaxel|mesh-list
6695727|NCT01693276|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6695728|NCT01693276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6695729|NCT01693276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6695730|NCT01693276|Tubulin Modulators|tubulin modulators|mesh-ancestor
6695731|NCT01693276|Antimitotic Agents|antimitotic agents|mesh-ancestor
6695732|NCT01693276|Mitosis Modulators|mitosis modulators|mesh-ancestor
6695733|NCT01693276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695734|NCT01693276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6695735|NCT01693276|Antimetabolites|antimetabolites|mesh-ancestor
6695736|NCT01693276|Antiviral Agents|antiviral agents|mesh-ancestor
6695737|NCT01693276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6695738|NCT01693276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6695739|NCT01693276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6695740|NCT01693276|Immunologic Factors|immunologic factors|mesh-ancestor
6695741|NCT01693276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695742|NCT01693289|Metformin|metformin|mesh-list
6695743|NCT01693289|Letrozole|letrozole|mesh-list
6695744|NCT01693289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6695745|NCT01693289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695746|NCT01693289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6695747|NCT01693289|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6695748|NCT01693289|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6695749|NCT01693289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6695750|NCT01693289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695751|NCT01693289|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6695752|NCT01693289|Hormone Antagonists|hormone antagonists|mesh-ancestor
6695753|NCT01693289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6695754|NCT01693302|Insulin|insulin|mesh-list
6695755|NCT01693302|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6695756|NCT01693302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6695757|NCT01693302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695758|NCT01693328|Fentanyl|fentanyl|mesh-list
6695759|NCT01693328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6695760|NCT01693328|Narcotics|narcotics|mesh-ancestor
6695761|NCT01693328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6695762|NCT01693328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695763|NCT01693328|Analgesics|analgesics|mesh-ancestor
6695764|NCT01693328|Sensory System Agents|sensory system agents|mesh-ancestor
6695765|NCT01693328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6695766|NCT01693328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6695767|NCT01693328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6695768|NCT01693328|Anesthetics, General|anesthetics, general|mesh-ancestor
6695769|NCT01693328|Anesthetics|anesthetics|mesh-ancestor
6695770|NCT01693380|Vaccines|vaccines|mesh-list
6695771|NCT01693380|Immunologic Factors|immunologic factors|mesh-ancestor
6695772|NCT01693380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695773|NCT01693393|Cyclosporine|cyclosporine|mesh-list
6695774|NCT01693393|Cyclosporins|cyclosporins|mesh-list
6695775|NCT01693393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6695776|NCT01693393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695777|NCT01693393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6695778|NCT01693393|Immunologic Factors|immunologic factors|mesh-ancestor
6695779|NCT01693393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695780|NCT01693393|Antifungal Agents|antifungal agents|mesh-ancestor
6695781|NCT01693393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6695782|NCT01693393|Dermatologic Agents|dermatologic agents|mesh-ancestor
6695783|NCT01693393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6695784|NCT01693393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6695785|NCT01693419|Gemcitabine|gemcitabine|mesh-list
6695786|NCT01693419|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6695787|NCT01693419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6695788|NCT01693419|Antimetabolites|antimetabolites|mesh-ancestor
6695789|NCT01693419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695790|NCT01693419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6695791|NCT01693419|Antiviral Agents|antiviral agents|mesh-ancestor
6695792|NCT01693419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6695793|NCT01693419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6695794|NCT01693419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6695795|NCT01693419|Immunologic Factors|immunologic factors|mesh-ancestor
6695796|NCT01693419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695797|NCT01693419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6695798|NCT01693432|Docetaxel|docetaxel|mesh-list
6695799|NCT01693432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6695800|NCT01693432|Tubulin Modulators|tubulin modulators|mesh-ancestor
6695801|NCT01693432|Antimitotic Agents|antimitotic agents|mesh-ancestor
6695802|NCT01693432|Mitosis Modulators|mitosis modulators|mesh-ancestor
6695803|NCT01693432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695804|NCT01693445|Oxaliplatin|oxaliplatin|mesh-list
6695805|NCT01693445|Irinotecan|irinotecan|mesh-list
6695806|NCT01693445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6695807|NCT01693445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6695808|NCT01693445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6695809|NCT01693445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6695810|NCT01693445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695811|NCT01693601|Panobinostat|panobinostat|mesh-list
6695812|NCT01693601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6695813|NCT01693601|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6695814|NCT01693601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6695815|NCT01693601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695816|NCT01693640|Abatacept|abatacept|mesh-list
6695817|NCT01693640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6695818|NCT01693640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695819|NCT01693640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6695820|NCT01693640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6695821|NCT01693640|Immunologic Factors|immunologic factors|mesh-ancestor
6695822|NCT01693640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695823|NCT01693640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6695824|NCT01693679|Lamivudine|lamivudine|mesh-list
6695825|NCT01693679|Adefovir|adefovir|mesh-list
6695826|NCT01693679|Telbivudine|telbivudine|mesh-list
6695827|NCT01693679|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6695828|NCT01693679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6695829|NCT01693679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6695830|NCT01693679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695831|NCT01693679|Antiviral Agents|antiviral agents|mesh-ancestor
6695832|NCT01693679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6695833|NCT01693679|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6695834|NCT01693679|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6695835|NCT01693718|Fluorouracil|fluorouracil|mesh-list
6695836|NCT01693718|Hydroxyurea|hydroxyurea|mesh-list
6695837|NCT01693718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6695838|NCT01693718|Antimetabolites|antimetabolites|mesh-ancestor
6695839|NCT01693718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695840|NCT01693718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6695841|NCT01693718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6695842|NCT01693718|Immunologic Factors|immunologic factors|mesh-ancestor
6695843|NCT01693718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695844|NCT01693718|Antisickling Agents|antisickling agents|mesh-ancestor
6695845|NCT01693718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6695846|NCT01693718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6695847|NCT01693809|Caffeine|caffeine|mesh-list
6695848|NCT01693809|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6695849|NCT01693809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695850|NCT01693809|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6695851|NCT01693809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6695852|NCT01693809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695853|NCT01693809|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6695854|NCT01693809|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6695855|NCT01693809|Purinergic Agents|purinergic agents|mesh-ancestor
6695856|NCT01693809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6695857|NCT01693822|Axitinib|axitinib|mesh-list
6695858|NCT01693822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6695859|NCT01693822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6695860|NCT01693822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6695861|NCT01693822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695862|NCT01694017|Tenofovir|tenofovir|mesh-list
6695863|NCT01694017|Zidovudine|zidovudine|mesh-list
6695864|NCT01694017|Antiviral Agents|antiviral agents|mesh-ancestor
6695865|NCT01694017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6695866|NCT01694017|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6695867|NCT01694017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6695868|NCT01694017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6695869|NCT01694017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695870|NCT01694017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6695871|NCT01694017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6695872|NCT01694017|Antimetabolites|antimetabolites|mesh-ancestor
6695873|NCT01694134|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6695874|NCT01694134|Methylprednisolone|methylprednisolone|mesh-list
6695875|NCT01694134|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6695876|NCT01694134|Prednisolone|prednisolone|mesh-list
6695877|NCT01694134|Prednisolone acetate|prednisolone acetate|mesh-list
6695878|NCT01694134|Lidocaine|lidocaine|mesh-list
6695879|NCT01694134|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6695880|NCT01694134|Prednisolone phosphate|prednisolone phosphate|mesh-list
6695881|NCT01694134|Anesthetics, Local|anesthetics, local|mesh-ancestor
6695882|NCT01694134|Anesthetics|anesthetics|mesh-ancestor
6695883|NCT01694134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6695884|NCT01694134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695885|NCT01694134|Sensory System Agents|sensory system agents|mesh-ancestor
6695886|NCT01694134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6695887|NCT01694134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6695888|NCT01694134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6695889|NCT01694134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6695890|NCT01694134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6695891|NCT01694134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695892|NCT01694134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6695893|NCT01694134|Antiemetics|antiemetics|mesh-ancestor
6695894|NCT01694134|Autonomic Agents|autonomic agents|mesh-ancestor
6695895|NCT01694134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6695896|NCT01694134|Glucocorticoids|glucocorticoids|mesh-ancestor
6695897|NCT01694134|Hormones|hormones|mesh-ancestor
6695898|NCT01694134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6695899|NCT01694134|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6695900|NCT01694134|Protective Agents|protective agents|mesh-ancestor
6695901|NCT01694134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6695902|NCT01694134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6695903|NCT01694212|Diclofenac|diclofenac|mesh-list
6695904|NCT01694212|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6695905|NCT01694212|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6695906|NCT01694212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6695907|NCT01694212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6695908|NCT01694212|Analgesics|analgesics|mesh-ancestor
6695909|NCT01694212|Sensory System Agents|sensory system agents|mesh-ancestor
6695910|NCT01694212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6695911|NCT01694212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695912|NCT01694212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6695913|NCT01694212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6695914|NCT01694212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6695915|NCT01694212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6695916|NCT01694212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695917|NCT01694264|Entecavir|entecavir|mesh-list
6695918|NCT01694264|Antiviral Agents|antiviral agents|mesh-ancestor
6695919|NCT01694264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6695920|NCT01694355|Vitamin D|vitamin d|mesh-list
6695921|NCT01694355|Vitamins|vitamins|mesh-ancestor
6695922|NCT01694355|Micronutrients|micronutrients|mesh-ancestor
6695923|NCT01694355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695924|NCT01694355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6695925|NCT01694407|Tenofovir|tenofovir|mesh-list
6695926|NCT01694407|Emtricitabine|emtricitabine|mesh-list
6695927|NCT01694407|Antiviral Agents|antiviral agents|mesh-ancestor
6695928|NCT01694407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6695929|NCT01694407|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6695930|NCT01694407|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6695931|NCT01694407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6695932|NCT01694407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695933|NCT01694407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6695934|NCT01694407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6695935|NCT01694459|Heparin|heparin|mesh-list
6695936|NCT01694459|Calcium heparin|calcium heparin|mesh-list
6695937|NCT01694459|Anticoagulants|anticoagulants|mesh-ancestor
6695938|NCT01694459|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6695939|NCT01694459|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6695940|NCT01694459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695941|NCT01694498|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
6695942|NCT01694498|Hemostatics|hemostatics|mesh-ancestor
6695943|NCT01694498|Coagulants|coagulants|mesh-ancestor
6695944|NCT01694498|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6695945|NCT01694498|Natriuretic Agents|natriuretic agents|mesh-ancestor
6695946|NCT01694498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695947|NCT01694576|Paclitaxel|paclitaxel|mesh-list
6695948|NCT01694576|Nedaplatin|nedaplatin|mesh-list
6695949|NCT01694576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6695950|NCT01694576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6695951|NCT01694576|Tubulin Modulators|tubulin modulators|mesh-ancestor
6695952|NCT01694576|Antimitotic Agents|antimitotic agents|mesh-ancestor
6695953|NCT01694576|Mitosis Modulators|mitosis modulators|mesh-ancestor
6695954|NCT01694576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695955|NCT01694693|Abatacept|abatacept|mesh-list
6695956|NCT01694693|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6695957|NCT01694693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695958|NCT01694693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6695959|NCT01694693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6695960|NCT01694693|Immunologic Factors|immunologic factors|mesh-ancestor
6695961|NCT01694693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695962|NCT01694693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6781145|NCT02184247|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6781146|NCT02184247|Purinergic Agents|purinergic agents|mesh-ancestor
6781147|NCT02184247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6781148|NCT02184260|Dipyrone|dipyrone|mesh-list
6781149|NCT02184260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6781150|NCT02184260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6781151|NCT02184260|Analgesics|analgesics|mesh-ancestor
6781152|NCT02184260|Sensory System Agents|sensory system agents|mesh-ancestor
6781153|NCT02184260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6781154|NCT02184260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781155|NCT02184260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6781156|NCT02184260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6781157|NCT02184260|Antipyretics|antipyretics|mesh-ancestor
6781158|NCT02184273|Dipyrone|dipyrone|mesh-list
6781159|NCT02184273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6781160|NCT02184273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6781161|NCT02184273|Analgesics|analgesics|mesh-ancestor
6781162|NCT02184273|Sensory System Agents|sensory system agents|mesh-ancestor
6781163|NCT02184273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6781164|NCT02184273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781165|NCT02184273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6781166|NCT02184273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6781167|NCT02184273|Antipyretics|antipyretics|mesh-ancestor
6781168|NCT02184286|Nevirapine|nevirapine|mesh-list
6781169|NCT02184286|Saquinavir|saquinavir|mesh-list
6781170|NCT02184286|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6781171|NCT02184286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6781172|NCT02184286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6781173|NCT02184286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781174|NCT02184286|Antiviral Agents|antiviral agents|mesh-ancestor
6781175|NCT02184286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6781176|NCT02184286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6781177|NCT02184286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6781178|NCT02184286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6781179|NCT02184286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6781180|NCT02184286|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6781181|NCT02184286|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6781182|NCT02184286|Protease Inhibitors|protease inhibitors|mesh-ancestor
6781183|NCT02184286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6781184|NCT02184286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6781185|NCT02184299|Nevirapine|nevirapine|mesh-list
6781186|NCT02184299|Prednisone|prednisone|mesh-list
6781187|NCT02184299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6781188|NCT02184299|Glucocorticoids|glucocorticoids|mesh-ancestor
6781189|NCT02184299|Hormones|hormones|mesh-ancestor
6781190|NCT02184299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6781191|NCT02184299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781192|NCT02184299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6781193|NCT02184299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6781194|NCT02184299|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6781195|NCT02184299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6695963|NCT01694732|Varenicline|varenicline|mesh-list
6695964|NCT01694732|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6695965|NCT01694732|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6695966|NCT01694732|Cholinergic Agents|cholinergic agents|mesh-ancestor
6695967|NCT01694732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6695968|NCT01694732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695969|NCT01694732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695970|NCT01694797|Metoprolol|metoprolol|mesh-list
6695971|NCT01694797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6695972|NCT01694797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6695973|NCT01694797|Sympatholytics|sympatholytics|mesh-ancestor
6695974|NCT01694797|Autonomic Agents|autonomic agents|mesh-ancestor
6695975|NCT01694797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6695976|NCT01694797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695977|NCT01694797|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6695978|NCT01694797|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6695979|NCT01694797|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6695980|NCT01694797|Adrenergic Agents|adrenergic agents|mesh-ancestor
6695981|NCT01694797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6695982|NCT01694797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695983|NCT01695005|Prednisone|prednisone|mesh-list
6695984|NCT01695005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6695985|NCT01695005|Glucocorticoids|glucocorticoids|mesh-ancestor
6695986|NCT01695005|Hormones|hormones|mesh-ancestor
6695987|NCT01695005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6695988|NCT01695005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6695989|NCT01695005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6695990|NCT01695005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6695991|NCT01695057|Vorinostat|vorinostat|mesh-list
6695992|NCT01695057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6695993|NCT01695057|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6695994|NCT01695057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6695995|NCT01695057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695996|NCT01695070|Melatonin|melatonin|mesh-list
6695997|NCT01695070|Antioxidants|antioxidants|mesh-ancestor
6695998|NCT01695070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6695999|NCT01695070|Protective Agents|protective agents|mesh-ancestor
6696000|NCT01695070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696001|NCT01695070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6696002|NCT01695109|Liraglutide|liraglutide|mesh-list
6696003|NCT01695109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6696004|NCT01695109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696005|NCT01695109|Incretins|incretins|mesh-ancestor
6696006|NCT01695109|Hormones|hormones|mesh-ancestor
6696007|NCT01695109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6696008|NCT01695122|Valproic Acid|valproic acid|mesh-list
6696009|NCT01695122|Anticonvulsants|anticonvulsants|mesh-ancestor
6696010|NCT01695122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6696011|NCT01695122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6696012|NCT01695122|GABA Agents|gaba agents|mesh-ancestor
6696013|NCT01695122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6696014|NCT01695122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696015|NCT01695122|Antimanic Agents|antimanic agents|mesh-ancestor
6696016|NCT01695122|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6696017|NCT01695122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6696018|NCT01695122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6696019|NCT01695148|Carotenoids|carotenoids|mesh-list
6696020|NCT01695148|Antioxidants|antioxidants|mesh-ancestor
6696021|NCT01695148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6696022|NCT01695148|Protective Agents|protective agents|mesh-ancestor
6696023|NCT01695148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696024|NCT01695174|Rifaximin|rifaximin|mesh-list
6696025|NCT01695174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6696026|NCT01695174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6696027|NCT01695174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6696028|NCT01695187|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
6696029|NCT01695187|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
6696030|NCT01695187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6696031|NCT01695187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6696032|NCT01695226|Celecoxib|celecoxib|mesh-list
6696033|NCT01695226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6696034|NCT01695226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6696035|NCT01695226|Analgesics|analgesics|mesh-ancestor
6696036|NCT01695226|Sensory System Agents|sensory system agents|mesh-ancestor
6696037|NCT01695226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6696038|NCT01695226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696039|NCT01695226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6696040|NCT01695226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6696041|NCT01695226|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6696042|NCT01695226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6696043|NCT01695226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6696044|NCT01695226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6696045|NCT01695317|Acetylcarnitine|acetylcarnitine|mesh-list
6696046|NCT01695317|Vitamin B Complex|vitamin b complex|mesh-ancestor
6696047|NCT01695317|Vitamins|vitamins|mesh-ancestor
6696048|NCT01695317|Micronutrients|micronutrients|mesh-ancestor
6696049|NCT01695317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696050|NCT01695317|Nootropic Agents|nootropic agents|mesh-ancestor
6696051|NCT01695356|Sunscreening Agents|sunscreening agents|mesh-list
6696052|NCT01695356|Zinc Oxide|zinc oxide|mesh-list
6696053|NCT01695356|Titanium dioxide|titanium dioxide|mesh-list
6696054|NCT01695356|Avobenzone|avobenzone|mesh-list
6696055|NCT01695356|Terephthalylidene dicamphor sulfonic acid|terephthalylidene dicamphor sulfonic acid|mesh-list
6696056|NCT01695356|Benzophenone|benzophenone|mesh-list
6696057|NCT01695356|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6696058|NCT01695356|Protective Agents|protective agents|mesh-ancestor
6696059|NCT01695356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696060|NCT01695356|Dermatologic Agents|dermatologic agents|mesh-ancestor
6696061|NCT01695356|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6696062|NCT01695460|Cholecalciferol|cholecalciferol|mesh-list
6696063|NCT01695460|Vitamins|vitamins|mesh-list
6696064|NCT01695460|Micronutrients|micronutrients|mesh-ancestor
6696065|NCT01695460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696066|NCT01695460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6696067|NCT01695460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6696068|NCT01695707|Pioglitazone|pioglitazone|mesh-list
6696069|NCT01695707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6696070|NCT01695707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696071|NCT01695733|Vaccines|vaccines|mesh-list
6696072|NCT01695733|Immunologic Factors|immunologic factors|mesh-ancestor
6696073|NCT01695733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696074|NCT01695759|Epoetin Alfa|epoetin alfa|mesh-list
6696075|NCT01695759|Hematinics|hematinics|mesh-ancestor
6696076|NCT01695798|Vaccines|vaccines|mesh-list
6696077|NCT01695798|Immunologic Factors|immunologic factors|mesh-ancestor
6696078|NCT01695798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696079|NCT01695824|Warfarin|warfarin|mesh-list
6696080|NCT01695824|Anticoagulants|anticoagulants|mesh-ancestor
6696081|NCT01695850|Sennosides|sennosides|mesh-list
6696082|NCT01695850|Laxatives|laxatives|mesh-ancestor
6696083|NCT01695850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6696084|NCT01695902|Levonorgestrel|levonorgestrel|mesh-list
6696085|NCT01695902|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6696086|NCT01695902|Contraceptive Agents|contraceptive agents|mesh-ancestor
6696087|NCT01695902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6696088|NCT01695902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696089|NCT01695902|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6696090|NCT01695902|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6696091|NCT01695902|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6696092|NCT01696110|Heparin|heparin|mesh-list
6696093|NCT01696110|Calcium heparin|calcium heparin|mesh-list
6696094|NCT01696110|Tirofiban|tirofiban|mesh-list
6696095|NCT01696110|Bivalirudin|bivalirudin|mesh-list
6696096|NCT01696110|Anticoagulants|anticoagulants|mesh-ancestor
6696097|NCT01696110|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6696098|NCT01696110|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6696099|NCT01696110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6696100|NCT01696110|Antithrombins|antithrombins|mesh-ancestor
6696101|NCT01696110|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6696102|NCT01696110|Protease Inhibitors|protease inhibitors|mesh-ancestor
6696103|NCT01696110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6696104|NCT01696110|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6696105|NCT01696240|Udenafil|udenafil|mesh-list
6696106|NCT01696240|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6696107|NCT01696240|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6696108|NCT01696240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6696109|NCT01696240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781196|NCT02184299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6781197|NCT02184299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781198|NCT02184299|Antiviral Agents|antiviral agents|mesh-ancestor
6781199|NCT02184299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6781200|NCT02184299|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6696110|NCT01696370|Trimetazidine|trimetazidine|mesh-list
6696111|NCT01696370|Vasodilator Agents|vasodilator agents|mesh-ancestor
6696112|NCT01696383|Timolol|timolol|mesh-list
6696113|NCT01696383|Travoprost|travoprost|mesh-list
6696114|NCT01696383|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6696115|NCT01696383|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6696116|NCT01696383|Adrenergic Agents|adrenergic agents|mesh-ancestor
6696117|NCT01696383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6696118|NCT01696383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6696119|NCT01696383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696120|NCT01696383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6696121|NCT01696383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6696122|NCT01696409|Vitamin D|vitamin d|mesh-list
6696123|NCT01696409|Ergocalciferols|ergocalciferols|mesh-list
6696124|NCT01696409|Cholecalciferol|cholecalciferol|mesh-list
6696125|NCT01696409|Vitamins|vitamins|mesh-list
6696126|NCT01696409|Micronutrients|micronutrients|mesh-ancestor
6696127|NCT01696409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696128|NCT01696409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6696129|NCT01696409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6696130|NCT01696422|Vaccines|vaccines|mesh-list
6696131|NCT01696422|Immunologic Factors|immunologic factors|mesh-ancestor
6696132|NCT01696422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696133|NCT01696435|Vitamin D|vitamin d|mesh-list
6696134|NCT01696435|Ergocalciferols|ergocalciferols|mesh-list
6696135|NCT01696435|Cholecalciferol|cholecalciferol|mesh-list
6696136|NCT01696435|Vitamins|vitamins|mesh-list
6696137|NCT01696435|Micronutrients|micronutrients|mesh-ancestor
6696138|NCT01696435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696139|NCT01696435|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6696140|NCT01696435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6696141|NCT01696448|Thioctic Acid|thioctic acid|mesh-list
6696142|NCT01696448|Antioxidants|antioxidants|mesh-ancestor
6696143|NCT01696448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6696144|NCT01696448|Protective Agents|protective agents|mesh-ancestor
6696145|NCT01696448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696146|NCT01696448|Vitamin B Complex|vitamin b complex|mesh-ancestor
6696147|NCT01696448|Vitamins|vitamins|mesh-ancestor
6696148|NCT01696448|Micronutrients|micronutrients|mesh-ancestor
6696149|NCT01696461|Plerixafor|plerixafor|mesh-list
6696150|NCT01696461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6696151|NCT01696461|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6696152|NCT01696461|Antiviral Agents|antiviral agents|mesh-ancestor
6696153|NCT01696461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6696154|NCT01696474|Bortezomib|bortezomib|mesh-list
6696155|NCT01696474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6696156|NCT01696500|Immunoglobulins|immunoglobulins|mesh-list
6696157|NCT01696500|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6696158|NCT01696500|Antibodies|antibodies|mesh-list
6696159|NCT01696500|gamma-Globulins|gamma-globulins|mesh-list
6696160|NCT01696500|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6696161|NCT01696500|Immunologic Factors|immunologic factors|mesh-ancestor
6696162|NCT01696500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696163|NCT01696526|Vitamin D|vitamin d|mesh-list
6696164|NCT01696526|Vitamins|vitamins|mesh-ancestor
6696165|NCT01696526|Micronutrients|micronutrients|mesh-ancestor
6696166|NCT01696526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696167|NCT01696526|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6696168|NCT01696552|Cimetidine|cimetidine|mesh-list
6696169|NCT01696552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6696170|NCT01696552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6696171|NCT01696552|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6696172|NCT01696552|Histamine Antagonists|histamine antagonists|mesh-ancestor
6696173|NCT01696552|Histamine Agents|histamine agents|mesh-ancestor
6696174|NCT01696552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6696175|NCT01696552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6696176|NCT01696552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696177|NCT01696552|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6696178|NCT01696552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6696179|NCT01696552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6696180|NCT01696617|Aripiprazole|aripiprazole|mesh-list
6696181|NCT01696617|Antidepressive Agents|antidepressive agents|mesh-ancestor
6696182|NCT01696617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6696183|NCT01696617|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6696184|NCT01696617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6696185|NCT01696617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6696186|NCT01696617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696187|NCT01696617|Dopamine Agonists|dopamine agonists|mesh-ancestor
6696188|NCT01696617|Dopamine Agents|dopamine agents|mesh-ancestor
6696189|NCT01696617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6696190|NCT01696617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6696191|NCT01696617|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6696192|NCT01696617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6696193|NCT01696617|Serotonin Agents|serotonin agents|mesh-ancestor
6696194|NCT01696617|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6696195|NCT01696617|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6696196|NCT01696617|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6696197|NCT01696617|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6696198|NCT01696630|Desflurane|desflurane|mesh-list
6696199|NCT01696630|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6696200|NCT01696630|Anesthetics, General|anesthetics, general|mesh-ancestor
6696201|NCT01696630|Anesthetics|anesthetics|mesh-ancestor
6696202|NCT01696630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6696203|NCT01696630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696204|NCT01696656|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6696205|NCT01696656|Gastrointestinal Agents|gastrointestinal agents|mesh-list
6696206|NCT01696656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6696207|NCT01696734|Domperidone|domperidone|mesh-list
6696208|NCT01696734|Antiemetics|antiemetics|mesh-ancestor
6696209|NCT01696734|Autonomic Agents|autonomic agents|mesh-ancestor
6696210|NCT01696734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6696211|NCT01696734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696212|NCT01696734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6696213|NCT01696734|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6696214|NCT01696734|Dopamine Agents|dopamine agents|mesh-ancestor
6696215|NCT01696734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6696216|NCT01696734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6696217|NCT01696799|Econazole|econazole|mesh-list
6696218|NCT01696799|Antifungal Agents|antifungal agents|mesh-ancestor
6696219|NCT01696799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6696220|NCT01696799|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6696221|NCT01696799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6696222|NCT01696799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6696223|NCT01696799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6696224|NCT01696799|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6696225|NCT01696799|Hormone Antagonists|hormone antagonists|mesh-ancestor
6696226|NCT01696799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6696227|NCT01696799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696228|NCT01696825|Diazepam|diazepam|mesh-list
6696229|NCT01696825|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6696230|NCT01696825|Anticonvulsants|anticonvulsants|mesh-ancestor
6696231|NCT01696825|Antiemetics|antiemetics|mesh-ancestor
6696232|NCT01696825|Autonomic Agents|autonomic agents|mesh-ancestor
6696233|NCT01696825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6696234|NCT01696825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696235|NCT01696825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6696236|NCT01696825|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6696237|NCT01696825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6696238|NCT01696825|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6696239|NCT01696825|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6696240|NCT01696825|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6696241|NCT01696825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6696242|NCT01696825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6696243|NCT01696825|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6696244|NCT01696825|Anesthetics, General|anesthetics, general|mesh-ancestor
6696245|NCT01696825|Anesthetics|anesthetics|mesh-ancestor
6696246|NCT01696825|GABA Modulators|gaba modulators|mesh-ancestor
6696247|NCT01696825|GABA Agents|gaba agents|mesh-ancestor
6696248|NCT01696825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6696249|NCT01696825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6696250|NCT01697020|Mercaptopurine|mercaptopurine|mesh-list
6696251|NCT01697020|Antimetabolites|antimetabolites|mesh-ancestor
6696252|NCT01697020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6696253|NCT01697020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6696254|NCT01697020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6696255|NCT01697020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6696256|NCT01697020|Immunologic Factors|immunologic factors|mesh-ancestor
6696257|NCT01697020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696258|NCT01697020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6696259|NCT01697020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6696260|NCT01697046|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6696261|NCT01697046|Raltegravir Potassium|raltegravir potassium|mesh-list
6696262|NCT01697046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6696263|NCT01697046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6696264|NCT01697046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6696265|NCT01697046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6696266|NCT01697046|Antiviral Agents|antiviral agents|mesh-ancestor
6696267|NCT01697046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6696268|NCT01697046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6696269|NCT01697046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6696270|NCT01697046|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6696271|NCT01697046|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6696272|NCT01697059|Amoxicillin|amoxicillin|mesh-list
6696273|NCT01697059|Piperacillin|piperacillin|mesh-list
6696274|NCT01697059|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6696275|NCT01697059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6696276|NCT01697059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6696277|NCT01697059|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6696278|NCT01697059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6696279|NCT01697059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6696280|NCT01697098|Dexamethasone|dexamethasone|mesh-list
6696281|NCT01697098|Dexamethasone acetate|dexamethasone acetate|mesh-list
6696282|NCT01697098|Glucocorticoids|glucocorticoids|mesh-list
6696283|NCT01697098|BB 1101|bb 1101|mesh-list
6696284|NCT01697098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6696285|NCT01697098|Antiemetics|antiemetics|mesh-ancestor
6696286|NCT01697098|Autonomic Agents|autonomic agents|mesh-ancestor
6696287|NCT01697098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6696288|NCT01697098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696289|NCT01697098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6696290|NCT01697098|Hormones|hormones|mesh-ancestor
6696291|NCT01697098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6696292|NCT01697098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6696293|NCT01697098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6696294|NCT01697098|Protease Inhibitors|protease inhibitors|mesh-ancestor
6696295|NCT01697098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6696296|NCT01697098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6696297|NCT01697111|Dienogest|dienogest|mesh-list
6696298|NCT01697111|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6696299|NCT01697111|Contraceptive Agents|contraceptive agents|mesh-ancestor
6696300|NCT01697111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6696301|NCT01697111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696302|NCT01697111|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6696303|NCT01697111|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6696304|NCT01697111|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6696305|NCT01697111|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6696306|NCT01697111|Hormone Antagonists|hormone antagonists|mesh-ancestor
6696307|NCT01697111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6696308|NCT01697111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6696309|NCT01697111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6696310|NCT01697150|Pancrelipase|pancrelipase|mesh-list
6696311|NCT01697150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6696312|NCT01697228|Vitamin D|vitamin d|mesh-list
6696313|NCT01697228|Vitamins|vitamins|mesh-ancestor
6696314|NCT01697228|Micronutrients|micronutrients|mesh-ancestor
6696315|NCT01697228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696316|NCT01697228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6696317|NCT01697267|Rituximab|rituximab|mesh-list
6696318|NCT01697267|Azathioprine|azathioprine|mesh-list
6696319|NCT01697267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6696320|NCT01697267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6696321|NCT01697267|Immunologic Factors|immunologic factors|mesh-ancestor
6696322|NCT01697267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696323|NCT01697267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6696324|NCT01697267|Antimetabolites|antimetabolites|mesh-ancestor
6696325|NCT01697267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6696326|NCT01697267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6696327|NCT01697267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6696328|NCT01697280|Vaccines|vaccines|mesh-list
6696329|NCT01697280|Immunologic Factors|immunologic factors|mesh-ancestor
6696330|NCT01697280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696331|NCT01697293|Paclitaxel|paclitaxel|mesh-list
6696332|NCT01697293|Cyclophosphamide|cyclophosphamide|mesh-list
6696333|NCT01697293|Doxorubicin|doxorubicin|mesh-list
6696334|NCT01697293|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6696335|NCT01697293|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6696336|NCT01697293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6696337|NCT01697293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6696338|NCT01697293|Tubulin Modulators|tubulin modulators|mesh-ancestor
6696339|NCT01697293|Antimitotic Agents|antimitotic agents|mesh-ancestor
6696340|NCT01697293|Mitosis Modulators|mitosis modulators|mesh-ancestor
6696341|NCT01697293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6696342|NCT01697293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6696343|NCT01697293|Immunologic Factors|immunologic factors|mesh-ancestor
6696344|NCT01697293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696345|NCT01697293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6696346|NCT01697293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6696347|NCT01697293|Alkylating Agents|alkylating agents|mesh-ancestor
6696348|NCT01697293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6696349|NCT01697293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6696350|NCT01697293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6696351|NCT01697293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6696352|NCT01697293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6696353|NCT01697306|Gemcitabine|gemcitabine|mesh-list
6696354|NCT01697306|BCG Vaccine|bcg vaccine|mesh-list
6696355|NCT01697306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6696356|NCT01697306|Antimetabolites|antimetabolites|mesh-ancestor
6696357|NCT01697306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6696358|NCT01697306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6696359|NCT01697306|Antiviral Agents|antiviral agents|mesh-ancestor
6696360|NCT01697306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6696361|NCT01697306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6696362|NCT01697306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6696363|NCT01697306|Immunologic Factors|immunologic factors|mesh-ancestor
6696364|NCT01697306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696365|NCT01697306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6696366|NCT01697410|Terlipressin|terlipressin|mesh-list
6696367|NCT01697410|Norepinephrine|norepinephrine|mesh-list
6696368|NCT01697410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6696369|NCT01697410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6696370|NCT01697410|Adrenergic Agents|adrenergic agents|mesh-ancestor
6696371|NCT01697410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6696372|NCT01697410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6696373|NCT01697410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696374|NCT01697410|Sympathomimetics|sympathomimetics|mesh-ancestor
6696375|NCT01697410|Autonomic Agents|autonomic agents|mesh-ancestor
6696376|NCT01697410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6696377|NCT01697410|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6696378|NCT01697410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6696379|NCT01697436|Ribavirin|ribavirin|mesh-list
6696380|NCT01697436|Antimetabolites|antimetabolites|mesh-ancestor
6696381|NCT01697436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6696382|NCT01697436|Antiviral Agents|antiviral agents|mesh-ancestor
6696383|NCT01697436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6696384|NCT01697566|Metformin|metformin|mesh-list
6696385|NCT01697566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6696386|NCT01697566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696387|NCT01697605|Infigratinib|infigratinib|mesh-list
6696388|NCT01697605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6696389|NCT01697618|Insulin|insulin|mesh-list
6696390|NCT01697618|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6696391|NCT01697618|Insulin Aspart|insulin aspart|mesh-list
6696392|NCT01697618|Biphasic Insulins|biphasic insulins|mesh-list
6696393|NCT01697618|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6696394|NCT01697618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6696395|NCT01697618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696396|NCT01697631|Insulin|insulin|mesh-list
6696397|NCT01697631|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6696398|NCT01697631|Insulin Aspart|insulin aspart|mesh-list
6696399|NCT01697631|Insulin, Long-Acting|insulin, long-acting|mesh-list
6696400|NCT01697631|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6696401|NCT01697631|Biphasic Insulins|biphasic insulins|mesh-list
6696402|NCT01697631|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6696403|NCT01697631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6696404|NCT01697631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696405|NCT01697657|Insulin|insulin|mesh-list
6696406|NCT01697657|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6696407|NCT01697657|Insulin Aspart|insulin aspart|mesh-list
6696408|NCT01697657|Insulin Detemir|insulin detemir|mesh-list
6696409|NCT01697657|Isophane Insulin, Human|isophane insulin, human|mesh-list
6696410|NCT01697657|Insulin, Isophane|insulin, isophane|mesh-list
6696411|NCT01697657|Isophane insulin, beef|isophane insulin, beef|mesh-list
6696412|NCT01697657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6696413|NCT01697657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696414|NCT01697670|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6696415|NCT01697670|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6696416|NCT01697670|Dermatologic Agents|dermatologic agents|mesh-ancestor
6696417|NCT01697722|Beclomethasone|beclomethasone|mesh-list
6696418|NCT01697722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6696419|NCT01697722|Glucocorticoids|glucocorticoids|mesh-ancestor
6696420|NCT01697722|Hormones|hormones|mesh-ancestor
6696421|NCT01697722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6696422|NCT01697722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696423|NCT01697722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6696424|NCT01697722|Respiratory System Agents|respiratory system agents|mesh-ancestor
6696425|NCT01697735|Atorvastatin|atorvastatin|mesh-list
6696426|NCT01697735|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6696427|NCT01697735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6696428|NCT01697735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6696429|NCT01697735|Antimetabolites|antimetabolites|mesh-ancestor
6696430|NCT01697735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6696431|NCT01697735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6696432|NCT01697735|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6696433|NCT01697735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6696434|NCT01697787|Artesunate|artesunate|mesh-list
6696435|NCT01697787|Lumefantrine|lumefantrine|mesh-list
6696436|NCT01697787|Artemether|artemether|mesh-list
6696437|NCT01697787|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6696438|NCT01697787|Amodiaquine|amodiaquine|mesh-list
6696439|NCT01697787|Antimalarials|antimalarials|mesh-ancestor
6696440|NCT01697787|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6696441|NCT01697787|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6696442|NCT01697787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6696443|NCT01697787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6696444|NCT01697787|Antiviral Agents|antiviral agents|mesh-ancestor
6696445|NCT01697787|Schistosomicides|schistosomicides|mesh-ancestor
6696446|NCT01697787|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6696447|NCT01697787|Anthelmintics|anthelmintics|mesh-ancestor
6696448|NCT01697826|Clindamycin|clindamycin|mesh-list
6696449|NCT01697826|Clindamycin palmitate|clindamycin palmitate|mesh-list
6696450|NCT01697826|Clindamycin phosphate|clindamycin phosphate|mesh-list
6696451|NCT01697826|Clotrimazole|clotrimazole|mesh-list
6696452|NCT01697826|Miconazole|miconazole|mesh-list
6696453|NCT01697826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6696454|NCT01697826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6696455|NCT01697826|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6696456|NCT01697826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6696457|NCT01697826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6696458|NCT01697826|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6696459|NCT01697826|Antifungal Agents|antifungal agents|mesh-ancestor
6696460|NCT01697826|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6696461|NCT01697826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6696462|NCT01697826|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6696463|NCT01697826|Hormone Antagonists|hormone antagonists|mesh-ancestor
6696464|NCT01697826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6696465|NCT01697826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696466|NCT01697826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6696467|NCT01697826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6781201|NCT02184299|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6781202|NCT02184299|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6781203|NCT02184299|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6781204|NCT02184312|Nevirapine|nevirapine|mesh-list
6781205|NCT02184312|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6781206|NCT02184312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6781207|NCT02184312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6781208|NCT02184312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781209|NCT02184312|Antiviral Agents|antiviral agents|mesh-ancestor
6781210|NCT02184312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6781211|NCT02184312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6781212|NCT02184312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6781213|NCT02184312|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6781214|NCT02184312|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6781215|NCT02184351|Clotrimazole|clotrimazole|mesh-list
6781216|NCT02184351|Miconazole|miconazole|mesh-list
6781217|NCT02184351|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6781218|NCT02184351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6781219|NCT02184351|Antifungal Agents|antifungal agents|mesh-ancestor
6696468|NCT01698138|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6696469|NCT01698138|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6696470|NCT01698138|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6696471|NCT01698138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6696472|NCT01698138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696473|NCT01698138|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6696474|NCT01698138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6696475|NCT01698138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6696476|NCT01698138|Cholinergic Agents|cholinergic agents|mesh-ancestor
6696477|NCT01698138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6696478|NCT01698164|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6696479|NCT01698164|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6696480|NCT01698164|Estradiol|estradiol|mesh-list
6696481|NCT01698164|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6696482|NCT01698164|Progesterone|progesterone|mesh-list
6696483|NCT01698164|Estrogens|estrogens|mesh-ancestor
6696484|NCT01698164|Hormones|hormones|mesh-ancestor
6696485|NCT01698164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6696486|NCT01698164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696487|NCT01698164|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6696488|NCT01698164|Contraceptive Agents|contraceptive agents|mesh-ancestor
6696489|NCT01698164|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6696490|NCT01698164|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6696491|NCT01698164|Progestins|progestins|mesh-ancestor
6696492|NCT01698177|Vaccines|vaccines|mesh-list
6696493|NCT01698177|Immunologic Factors|immunologic factors|mesh-ancestor
6696494|NCT01698177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696495|NCT01698203|Ropivacaine|ropivacaine|mesh-list
6696496|NCT01698203|Anesthetics, Local|anesthetics, local|mesh-ancestor
6696497|NCT01698203|Anesthetics|anesthetics|mesh-ancestor
6696498|NCT01698203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6696499|NCT01698203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696500|NCT01698203|Sensory System Agents|sensory system agents|mesh-ancestor
6696501|NCT01698203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6696502|NCT01698476|Vitamin D|vitamin d|mesh-list
6696503|NCT01698476|Cholecalciferol|cholecalciferol|mesh-list
6696504|NCT01698476|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
6696505|NCT01698476|Vitamins|vitamins|mesh-ancestor
6696506|NCT01698476|Micronutrients|micronutrients|mesh-ancestor
6696507|NCT01698476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696508|NCT01698476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6696509|NCT01698476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6696510|NCT01698476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6696511|NCT01698541|Tacrolimus|tacrolimus|mesh-list
6696512|NCT01698541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6696513|NCT01698541|Immunologic Factors|immunologic factors|mesh-ancestor
6696514|NCT01698541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696515|NCT01698541|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6696516|NCT01698541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6696517|NCT01698541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6696518|NCT01698567|Antithrombins|antithrombins|mesh-list
6696519|NCT01698567|Antithrombin III|antithrombin iii|mesh-list
6696520|NCT01698567|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6696521|NCT01698567|Protease Inhibitors|protease inhibitors|mesh-ancestor
6696522|NCT01698567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6696523|NCT01698567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6696524|NCT01698567|Anticoagulants|anticoagulants|mesh-ancestor
6696525|NCT01698593|Epinephrine|epinephrine|mesh-list
6696526|NCT01698593|Bupivacaine|bupivacaine|mesh-list
6696527|NCT01698593|Anesthetics, Local|anesthetics, local|mesh-ancestor
6696528|NCT01698593|Anesthetics|anesthetics|mesh-ancestor
6696529|NCT01698593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6696530|NCT01698593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696531|NCT01698593|Sensory System Agents|sensory system agents|mesh-ancestor
6696532|NCT01698593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6696533|NCT01698593|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6696534|NCT01698593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6696535|NCT01698593|Adrenergic Agents|adrenergic agents|mesh-ancestor
6696536|NCT01698593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6696537|NCT01698593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6696538|NCT01698593|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6696539|NCT01698593|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6696540|NCT01698593|Autonomic Agents|autonomic agents|mesh-ancestor
6696541|NCT01698593|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6696542|NCT01698593|Respiratory System Agents|respiratory system agents|mesh-ancestor
6696543|NCT01698593|Mydriatics|mydriatics|mesh-ancestor
6696544|NCT01698593|Sympathomimetics|sympathomimetics|mesh-ancestor
6696545|NCT01698593|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6696546|NCT01698645|Fentanyl|fentanyl|mesh-list
6696547|NCT01698645|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6696548|NCT01698645|Narcotics|narcotics|mesh-ancestor
6696549|NCT01698645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6696550|NCT01698645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696551|NCT01698645|Analgesics|analgesics|mesh-ancestor
6696552|NCT01698645|Sensory System Agents|sensory system agents|mesh-ancestor
6696553|NCT01698645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6696554|NCT01698645|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6696555|NCT01698645|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6696556|NCT01698645|Anesthetics, General|anesthetics, general|mesh-ancestor
6696557|NCT01698645|Anesthetics|anesthetics|mesh-ancestor
6696558|NCT01698697|Insulin Aspart|insulin aspart|mesh-list
6696559|NCT01698697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6696560|NCT01698697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696561|NCT01698723|Ribavirin|ribavirin|mesh-list
6696562|NCT01698723|Antimetabolites|antimetabolites|mesh-ancestor
6696563|NCT01698723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6696564|NCT01698723|Antiviral Agents|antiviral agents|mesh-ancestor
6696565|NCT01698723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6696566|NCT01698749|Dexamethasone|dexamethasone|mesh-list
6696567|NCT01698749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6696568|NCT01698749|Antiemetics|antiemetics|mesh-ancestor
6696569|NCT01698749|Autonomic Agents|autonomic agents|mesh-ancestor
6696570|NCT01698749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6696571|NCT01698749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696572|NCT01698749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6696573|NCT01698749|Glucocorticoids|glucocorticoids|mesh-ancestor
6696574|NCT01698749|Hormones|hormones|mesh-ancestor
6696575|NCT01698749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6696576|NCT01698749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6696577|NCT01698749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6696578|NCT01698788|Dexamethasone|dexamethasone|mesh-list
6696579|NCT01698788|Dexamethasone acetate|dexamethasone acetate|mesh-list
6696580|NCT01698788|BB 1101|bb 1101|mesh-list
6696581|NCT01698788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6696582|NCT01698788|Antiemetics|antiemetics|mesh-ancestor
6696583|NCT01698788|Autonomic Agents|autonomic agents|mesh-ancestor
6696584|NCT01698788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6696585|NCT01698788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696586|NCT01698788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6696587|NCT01698788|Glucocorticoids|glucocorticoids|mesh-ancestor
6696588|NCT01698788|Hormones|hormones|mesh-ancestor
6696589|NCT01698788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6696590|NCT01698788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6696591|NCT01698788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6696592|NCT01698788|Protease Inhibitors|protease inhibitors|mesh-ancestor
6696593|NCT01698788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6696594|NCT01698788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6696595|NCT01698840|Vitamin D|vitamin d|mesh-list
6696596|NCT01698840|Vitamins|vitamins|mesh-ancestor
6696597|NCT01698840|Micronutrients|micronutrients|mesh-ancestor
6696598|NCT01698840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696599|NCT01698840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6696600|NCT01698931|Glyburide|glyburide|mesh-list
6696601|NCT01698931|Repaglinide|repaglinide|mesh-list
6696602|NCT01698931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6696603|NCT01698931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696604|NCT01699113|Rabeprazole|rabeprazole|mesh-list
6696605|NCT01699113|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6696606|NCT01699113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6696607|NCT01699113|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6696608|NCT01699113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6696609|NCT01699113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6696610|NCT01699126|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6696611|NCT01699126|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6696612|NCT01699126|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6696613|NCT01699126|Antimetabolites|antimetabolites|mesh-ancestor
6696614|NCT01699126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6696615|NCT01699126|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6696616|NCT01699126|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6696617|NCT01699126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6696618|NCT01699204|Acetylcysteine|acetylcysteine|mesh-list
6696619|NCT01699204|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6696620|NCT01699204|Antiviral Agents|antiviral agents|mesh-ancestor
6696621|NCT01699204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6696622|NCT01699204|Expectorants|expectorants|mesh-ancestor
6696623|NCT01699204|Respiratory System Agents|respiratory system agents|mesh-ancestor
6696624|NCT01699204|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6696625|NCT01699204|Antioxidants|antioxidants|mesh-ancestor
6696626|NCT01699204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6696627|NCT01699204|Protective Agents|protective agents|mesh-ancestor
6696628|NCT01699204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696629|NCT01699204|Antidotes|antidotes|mesh-ancestor
6696630|NCT01699282|Antivitamins K|antivitamins k|mesh-list
6696631|NCT01699282|Anticoagulants|anticoagulants|mesh-ancestor
6696632|NCT01699347|Picibanil|picibanil|mesh-list
6696633|NCT01699347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6696634|NCT01699360|Cyclosporine|cyclosporine|mesh-list
6696635|NCT01699360|Sirolimus|sirolimus|mesh-list
6696636|NCT01699360|Tacrolimus|tacrolimus|mesh-list
6696637|NCT01699360|Cyclosporins|cyclosporins|mesh-list
6696638|NCT01699360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6696639|NCT01699360|Immunologic Factors|immunologic factors|mesh-ancestor
6696640|NCT01699360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696641|NCT01699360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6696642|NCT01699360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6696643|NCT01699360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6696644|NCT01699360|Antifungal Agents|antifungal agents|mesh-ancestor
6696645|NCT01699360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6696646|NCT01699360|Dermatologic Agents|dermatologic agents|mesh-ancestor
6696647|NCT01699360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6696648|NCT01699360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6696649|NCT01699360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6696650|NCT01699360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6696651|NCT01699412|Dexamethasone|dexamethasone|mesh-list
6696652|NCT01699412|Clobetasol|clobetasol|mesh-list
6696653|NCT01699412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6696654|NCT01699412|Antiemetics|antiemetics|mesh-ancestor
6696655|NCT01699412|Autonomic Agents|autonomic agents|mesh-ancestor
6696656|NCT01699412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6696657|NCT01699412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696658|NCT01699412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6696659|NCT01699412|Glucocorticoids|glucocorticoids|mesh-ancestor
6696660|NCT01699412|Hormones|hormones|mesh-ancestor
6696661|NCT01699412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6696662|NCT01699412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6696663|NCT01699412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6696664|NCT01699438|Mesalamine|mesalamine|mesh-list
6696665|NCT01699438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6696666|NCT01699438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6696667|NCT01699438|Analgesics|analgesics|mesh-ancestor
6696668|NCT01699438|Sensory System Agents|sensory system agents|mesh-ancestor
6696669|NCT01699438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6696670|NCT01699438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696671|NCT01699438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6696672|NCT01699438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6696673|NCT01699490|Valsartan|valsartan|mesh-list
6696674|NCT01699490|Fluoxetine|fluoxetine|mesh-list
6696675|NCT01699490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6696676|NCT01699490|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6696677|NCT01699490|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6696678|NCT01699490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6696679|NCT01699490|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6696680|NCT01699490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6696681|NCT01699490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6696682|NCT01699490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6696683|NCT01699490|Serotonin Agents|serotonin agents|mesh-ancestor
6696684|NCT01699490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696685|NCT01699490|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6696686|NCT01699490|Antidepressive Agents|antidepressive agents|mesh-ancestor
6696687|NCT01699490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6696688|NCT01699490|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6696689|NCT01699490|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6696690|NCT01699490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6696691|NCT01699594|Mannitol|mannitol|mesh-list
6696692|NCT01699594|Methacholine Chloride|methacholine chloride|mesh-list
6696693|NCT01699594|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6696694|NCT01699594|Diuretics|diuretics|mesh-ancestor
6696695|NCT01699594|Natriuretic Agents|natriuretic agents|mesh-ancestor
6696696|NCT01699594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696697|NCT01699594|Miotics|miotics|mesh-ancestor
6696698|NCT01699594|Autonomic Agents|autonomic agents|mesh-ancestor
6696699|NCT01699594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6696700|NCT01699594|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6696701|NCT01699594|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
6696702|NCT01699594|Respiratory System Agents|respiratory system agents|mesh-ancestor
6696703|NCT01699594|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6696704|NCT01699594|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6696705|NCT01699594|Cholinergic Agents|cholinergic agents|mesh-ancestor
6696706|NCT01699594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6696707|NCT01699594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6696708|NCT01699711|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
6696709|NCT01699711|Antioxidants|antioxidants|mesh-ancestor
6696710|NCT01699711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6696711|NCT01699711|Protective Agents|protective agents|mesh-ancestor
6696712|NCT01699711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696713|NCT01699711|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
6696714|NCT01699711|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6696715|NCT01699711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6696716|NCT01699711|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6696717|NCT01699724|Sertraline|sertraline|mesh-list
6696718|NCT01699724|Antidepressive Agents|antidepressive agents|mesh-ancestor
6696719|NCT01699724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6696720|NCT01699724|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6696721|NCT01699724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6696722|NCT01699724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6696723|NCT01699724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6696724|NCT01699724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6696725|NCT01699724|Serotonin Agents|serotonin agents|mesh-ancestor
6696726|NCT01699724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696727|NCT01699776|Digoxin|digoxin|mesh-list
6696728|NCT01699776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6696729|NCT01699776|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6696730|NCT01699776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6696731|NCT01699776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6696732|NCT01699776|Protective Agents|protective agents|mesh-ancestor
6696733|NCT01699776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696734|NCT01699802|Anesthetics|anesthetics|mesh-list
6696735|NCT01699802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6696736|NCT01699802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781220|NCT02184351|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6781221|NCT02184351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6781222|NCT02184351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6781223|NCT02184351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781224|NCT02184351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6781225|NCT02184351|Hormone Antagonists|hormone antagonists|mesh-ancestor
6781226|NCT02184351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6781227|NCT02184351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781228|NCT02184351|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6781229|NCT02184351|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6781230|NCT02184364|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6696737|NCT01699828|Buspirone|buspirone|mesh-list
6696738|NCT01699828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6696739|NCT01699828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6696740|NCT01699828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6696741|NCT01699828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696742|NCT01699828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6696743|NCT01699828|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6696744|NCT01699828|Serotonin Agents|serotonin agents|mesh-ancestor
6696745|NCT01699828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6696746|NCT01699828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6696747|NCT01699854|Capsaicin|capsaicin|mesh-list
6696748|NCT01699854|Antipruritics|antipruritics|mesh-ancestor
6696749|NCT01699854|Dermatologic Agents|dermatologic agents|mesh-ancestor
6696750|NCT01699854|Sensory System Agents|sensory system agents|mesh-ancestor
6696751|NCT01699854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6696752|NCT01699854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696753|NCT01699919|Lidocaine|lidocaine|mesh-list
6696754|NCT01699919|Anesthetics, Local|anesthetics, local|mesh-ancestor
6696755|NCT01699919|Anesthetics|anesthetics|mesh-ancestor
6696756|NCT01699919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6696757|NCT01699919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696758|NCT01699919|Sensory System Agents|sensory system agents|mesh-ancestor
6696759|NCT01699919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6696760|NCT01699919|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6696761|NCT01699919|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6696762|NCT01699919|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6696763|NCT01699919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6696764|NCT01699919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6696765|NCT01699932|Metformin|metformin|mesh-list
6696766|NCT01699932|Glimepiride|glimepiride|mesh-list
6696767|NCT01699932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6696768|NCT01699932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696769|NCT01699932|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6696770|NCT01699932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6696771|NCT01699932|Immunologic Factors|immunologic factors|mesh-ancestor
6696772|NCT01699997|Oxytocin|oxytocin|mesh-list
6696773|NCT01699997|Oxytocics|oxytocics|mesh-ancestor
6696774|NCT01699997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6696775|NCT01699997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696776|NCT01700010|Paclitaxel|paclitaxel|mesh-list
6696777|NCT01700010|Lapatinib|lapatinib|mesh-list
6696778|NCT01700010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6696779|NCT01700010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6696780|NCT01700010|Tubulin Modulators|tubulin modulators|mesh-ancestor
6696781|NCT01700010|Antimitotic Agents|antimitotic agents|mesh-ancestor
6696782|NCT01700010|Mitosis Modulators|mitosis modulators|mesh-ancestor
6696783|NCT01700010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6696784|NCT01700010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6696785|NCT01700010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6696786|NCT01700270|Fluvoxamine|fluvoxamine|mesh-list
6696787|NCT01700270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6696788|NCT01700270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6696789|NCT01700270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6696790|NCT01700270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696791|NCT01700270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6696792|NCT01700270|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6696793|NCT01700270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6696794|NCT01700270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6696795|NCT01700270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6696796|NCT01700270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6696797|NCT01700270|Serotonin Agents|serotonin agents|mesh-ancestor
6696798|NCT01700270|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6696799|NCT01700270|Antidepressive Agents|antidepressive agents|mesh-ancestor
6696800|NCT01700270|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6696801|NCT01700270|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6696802|NCT01700270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6696803|NCT01700270|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6696804|NCT01700322|Clopidogrel|clopidogrel|mesh-list
6696805|NCT01700322|Ticagrelor|ticagrelor|mesh-list
6696806|NCT01700322|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6696807|NCT01700322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6696808|NCT01700322|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6696809|NCT01700322|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6781231|NCT02184364|Estrogens|estrogens|mesh-ancestor
6696810|NCT01700322|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6696811|NCT01700322|Purinergic Agents|purinergic agents|mesh-ancestor
6696812|NCT01700322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6696813|NCT01700322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6696814|NCT01700322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696815|NCT01700400|Bevacizumab|bevacizumab|mesh-list
6696816|NCT01700400|Carboplatin|carboplatin|mesh-list
6696817|NCT01700400|Pemetrexed|pemetrexed|mesh-list
6696818|NCT01700400|Everolimus|everolimus|mesh-list
6696819|NCT01700400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6696820|NCT01700400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6696821|NCT01700400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6696822|NCT01700400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6696823|NCT01700400|Growth Substances|growth substances|mesh-ancestor
6696824|NCT01700400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696825|NCT01700400|Growth Inhibitors|growth inhibitors|mesh-ancestor
6696826|NCT01700400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6696827|NCT01700400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6696828|NCT01700400|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6696829|NCT01700400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6696830|NCT01700400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6696831|NCT01700400|Immunologic Factors|immunologic factors|mesh-ancestor
6696832|NCT01700413|Idarubicin|idarubicin|mesh-list
6696833|NCT01700413|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6696834|NCT01700413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6696835|NCT01700413|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6696836|NCT01700413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6696837|NCT01700413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6696838|NCT01700413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6696839|NCT01700426|Vitamins|vitamins|mesh-list
6696840|NCT01700426|Vitamin E|vitamin e|mesh-list
6696841|NCT01700426|Tocopherols|tocopherols|mesh-list
6696842|NCT01700426|Tocotrienols|tocotrienols|mesh-list
6696843|NCT01700426|alpha-Tocopherol|alpha-tocopherol|mesh-list
6696844|NCT01700426|Micronutrients|micronutrients|mesh-ancestor
6696845|NCT01700426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696846|NCT01700426|Antioxidants|antioxidants|mesh-ancestor
6696847|NCT01700426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6696848|NCT01700426|Protective Agents|protective agents|mesh-ancestor
6696849|NCT01700478|Vasopressins|vasopressins|mesh-list
6696850|NCT01700478|Arginine Vasopressin|arginine vasopressin|mesh-list
6696851|NCT01700478|Misoprostol|misoprostol|mesh-list
6696852|NCT01700478|Diuretics|diuretics|mesh-list
6696853|NCT01700478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696854|NCT01700478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6696855|NCT01700478|Abortifacient Agents|abortifacient agents|mesh-ancestor
6696856|NCT01700478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6696857|NCT01700478|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6696858|NCT01700478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6696859|NCT01700478|Oxytocics|oxytocics|mesh-ancestor
6696860|NCT01700478|Natriuretic Agents|natriuretic agents|mesh-ancestor
6696861|NCT01700478|Hemostatics|hemostatics|mesh-ancestor
6696862|NCT01700478|Coagulants|coagulants|mesh-ancestor
6696863|NCT01700478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6696864|NCT01700478|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6696865|NCT01700491|Ropivacaine|ropivacaine|mesh-list
6696866|NCT01700491|Anesthetics, Local|anesthetics, local|mesh-ancestor
6696867|NCT01700491|Anesthetics|anesthetics|mesh-ancestor
6696868|NCT01700491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6696869|NCT01700491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696870|NCT01700491|Sensory System Agents|sensory system agents|mesh-ancestor
6696871|NCT01700491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6696872|NCT01700504|Gentamicins|gentamicins|mesh-list
6696873|NCT01700504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6696874|NCT01700504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6696875|NCT01700504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6696876|NCT01700504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6696877|NCT01700504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6696878|NCT01700569|Leucovorin|leucovorin|mesh-list
6696879|NCT01700569|Folic Acid|folic acid|mesh-list
6696880|NCT01700569|Temozolomide|temozolomide|mesh-list
6696881|NCT01700569|Levoleucovorin|levoleucovorin|mesh-list
6696882|NCT01700569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696883|NCT01700569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6696884|NCT01700569|Alkylating Agents|alkylating agents|mesh-ancestor
6696885|NCT01700569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6696886|NCT01700569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6696887|NCT01700569|Antidotes|antidotes|mesh-ancestor
6696888|NCT01700569|Protective Agents|protective agents|mesh-ancestor
6696889|NCT01700569|Vitamin B Complex|vitamin b complex|mesh-ancestor
6696890|NCT01700569|Vitamins|vitamins|mesh-ancestor
6696891|NCT01700569|Micronutrients|micronutrients|mesh-ancestor
6696892|NCT01700569|Hematinics|hematinics|mesh-ancestor
6696893|NCT01700608|Plerixafor|plerixafor|mesh-list
6696894|NCT01700608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6696895|NCT01700608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6696896|NCT01700608|Antiviral Agents|antiviral agents|mesh-ancestor
6696897|NCT01700608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6696898|NCT01700751|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6696899|NCT01700751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6696900|NCT01700751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6696901|NCT01700790|Ritonavir|ritonavir|mesh-list
6696902|NCT01700790|Lopinavir|lopinavir|mesh-list
6696903|NCT01700790|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6696904|NCT01700790|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6696905|NCT01700790|Protease Inhibitors|protease inhibitors|mesh-ancestor
6696906|NCT01700790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6696907|NCT01700790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6696908|NCT01700790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6696909|NCT01700790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6696910|NCT01700790|Antiviral Agents|antiviral agents|mesh-ancestor
6696911|NCT01700790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6696912|NCT01700790|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6696913|NCT01700790|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6696914|NCT01700803|Iodine|iodine|mesh-list
6696915|NCT01700803|Cadexomer iodine|cadexomer iodine|mesh-list
6696916|NCT01700803|Povidone-Iodine|povidone-iodine|mesh-list
6696917|NCT01700803|Povidone|povidone|mesh-list
6696918|NCT01700803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6696919|NCT01700803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6696920|NCT01700803|Trace Elements|trace elements|mesh-ancestor
6696921|NCT01700803|Micronutrients|micronutrients|mesh-ancestor
6696922|NCT01700803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696923|NCT01700803|Plasma Substitutes|plasma substitutes|mesh-ancestor
6696924|NCT01700803|Blood Substitutes|blood substitutes|mesh-ancestor
6696925|NCT01700881|Vitamin E|vitamin e|mesh-list
6696926|NCT01700881|Vitamins|vitamins|mesh-ancestor
6696927|NCT01700881|Micronutrients|micronutrients|mesh-ancestor
6696928|NCT01700881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696929|NCT01700881|Antioxidants|antioxidants|mesh-ancestor
6696930|NCT01700881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6696931|NCT01700881|Protective Agents|protective agents|mesh-ancestor
6696932|NCT01700946|Cytarabine|cytarabine|mesh-list
6696933|NCT01700946|Aldesleukin|aldesleukin|mesh-list
6696934|NCT01700946|Dexamethasone|dexamethasone|mesh-list
6696935|NCT01700946|Hydrocortisone|hydrocortisone|mesh-list
6696936|NCT01700946|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6696937|NCT01700946|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6696938|NCT01700946|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6696939|NCT01700946|Cyclophosphamide|cyclophosphamide|mesh-list
6696940|NCT01700946|Rituximab|rituximab|mesh-list
6696941|NCT01700946|Methotrexate|methotrexate|mesh-list
6696942|NCT01700946|Etoposide|etoposide|mesh-list
6696943|NCT01700946|Vincristine|vincristine|mesh-list
6696944|NCT01700946|Interleukin-2|interleukin-2|mesh-list
6696945|NCT01700946|Asparaginase|asparaginase|mesh-list
6696946|NCT01700946|Mercaptopurine|mercaptopurine|mesh-list
6696947|NCT01700946|Mitoxantrone|mitoxantrone|mesh-list
6696948|NCT01700946|Clofarabine|clofarabine|mesh-list
6696949|NCT01700946|Vinblastine|vinblastine|mesh-list
6696950|NCT01700946|Pegaspargase|pegaspargase|mesh-list
6696951|NCT01700946|Teniposide|teniposide|mesh-list
6696952|NCT01700946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6696953|NCT01700946|Immunologic Factors|immunologic factors|mesh-ancestor
6696954|NCT01700946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6696955|NCT01700946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6696956|NCT01700946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6696957|NCT01700946|Alkylating Agents|alkylating agents|mesh-ancestor
6696958|NCT01700946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6696959|NCT01700946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6696960|NCT01700946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6696961|NCT01700946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6696962|NCT01700946|Antiemetics|antiemetics|mesh-ancestor
6696963|NCT01700946|Autonomic Agents|autonomic agents|mesh-ancestor
6696964|NCT01700946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6696965|NCT01700946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6696966|NCT01700946|Glucocorticoids|glucocorticoids|mesh-ancestor
6696967|NCT01700946|Hormones|hormones|mesh-ancestor
6781232|NCT02184364|Hormones|hormones|mesh-ancestor
6696968|NCT01700946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6696969|NCT01700946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6696970|NCT01700946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6696971|NCT01700946|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6696972|NCT01700946|Abortifacient Agents|abortifacient agents|mesh-ancestor
6696973|NCT01700946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6696974|NCT01700946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6696975|NCT01700946|Antimetabolites|antimetabolites|mesh-ancestor
6696976|NCT01700946|Dermatologic Agents|dermatologic agents|mesh-ancestor
6696977|NCT01700946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6696978|NCT01700946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6696979|NCT01700946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6696980|NCT01700946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6696981|NCT01700946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6696982|NCT01700946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6696983|NCT01700946|Antiviral Agents|antiviral agents|mesh-ancestor
6696984|NCT01700946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6696985|NCT01700946|Tubulin Modulators|tubulin modulators|mesh-ancestor
6696986|NCT01700946|Antimitotic Agents|antimitotic agents|mesh-ancestor
6696987|NCT01700946|Mitosis Modulators|mitosis modulators|mesh-ancestor
6696988|NCT01700946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6696989|NCT01700946|Analgesics|analgesics|mesh-ancestor
6696990|NCT01700946|Sensory System Agents|sensory system agents|mesh-ancestor
6696991|NCT01700946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6696992|NCT01700946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6696993|NCT01701076|Dexamethasone|dexamethasone|mesh-list
6696994|NCT01701076|Lenalidomide|lenalidomide|mesh-list
6696995|NCT01701076|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6696996|NCT01701076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6696997|NCT01701076|Antiemetics|antiemetics|mesh-ancestor
6696998|NCT01701076|Autonomic Agents|autonomic agents|mesh-ancestor
6696999|NCT01701076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6697000|NCT01701076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697001|NCT01701076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6697002|NCT01701076|Glucocorticoids|glucocorticoids|mesh-ancestor
6697003|NCT01701076|Hormones|hormones|mesh-ancestor
6697004|NCT01701076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6697005|NCT01701076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6697006|NCT01701076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6697007|NCT01701076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697008|NCT01701076|Immunologic Factors|immunologic factors|mesh-ancestor
6697009|NCT01701076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6697010|NCT01701076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6697011|NCT01701076|Growth Substances|growth substances|mesh-ancestor
6697012|NCT01701076|Growth Inhibitors|growth inhibitors|mesh-ancestor
6697013|NCT01701076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6697014|NCT01701076|Alkylating Agents|alkylating agents|mesh-ancestor
6697015|NCT01701089|Selegiline|selegiline|mesh-list
6697016|NCT01701089|Antidepressive Agents|antidepressive agents|mesh-ancestor
6697017|NCT01701089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6697018|NCT01701089|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6697019|NCT01701089|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6697020|NCT01701089|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6697021|NCT01701089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6697022|NCT01701089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697023|NCT01701089|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6697024|NCT01701089|Protective Agents|protective agents|mesh-ancestor
6697025|NCT01701089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697026|NCT01701180|Oxytocin|oxytocin|mesh-list
6697027|NCT01701180|Oxytocics|oxytocics|mesh-ancestor
6697028|NCT01701180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6697029|NCT01701180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697030|NCT01701219|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
6697031|NCT01701219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6697032|NCT01701219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6697033|NCT01701232|Rituximab|rituximab|mesh-list
6697034|NCT01701232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6697035|NCT01701232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6697036|NCT01701232|Immunologic Factors|immunologic factors|mesh-ancestor
6697037|NCT01701232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697038|NCT01701232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6697039|NCT01701297|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6697040|NCT01701297|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6697041|NCT01701297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6697042|NCT01701297|Renal Agents|renal agents|mesh-ancestor
6697043|NCT01701297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6242745|NCT02655354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6242746|NCT02655354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6242747|NCT02655354|Anesthetics, Local|anesthetics, local|mesh-ancestor
6242748|NCT02655354|Anesthetics|anesthetics|mesh-ancestor
6242749|NCT02655354|Antiemetics|antiemetics|mesh-ancestor
6242750|NCT02655354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6242751|NCT02655354|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6242752|NCT02655354|Histamine Antagonists|histamine antagonists|mesh-ancestor
6242753|NCT02655354|Histamine Agents|histamine agents|mesh-ancestor
6242754|NCT02655354|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6242755|NCT02655354|Antipruritics|antipruritics|mesh-ancestor
6697044|NCT01701297|Antimalarials|antimalarials|mesh-ancestor
6697045|NCT01701297|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6697046|NCT01701297|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6697047|NCT01701323|Cytarabine|cytarabine|mesh-list
6697048|NCT01701323|Fludarabine|fludarabine|mesh-list
6697049|NCT01701323|Fludarabine phosphate|fludarabine phosphate|mesh-list
6697050|NCT01701323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6697051|NCT01701323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6697052|NCT01701323|Antimetabolites|antimetabolites|mesh-ancestor
6697053|NCT01701323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697054|NCT01701323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6697055|NCT01701323|Immunologic Factors|immunologic factors|mesh-ancestor
6697056|NCT01701323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697057|NCT01701323|Antiviral Agents|antiviral agents|mesh-ancestor
6697058|NCT01701323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6697059|NCT01701336|Cloricromen|cloricromen|mesh-list
6697060|NCT01701336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6697061|NCT01701349|Paclitaxel|paclitaxel|mesh-list
6697062|NCT01701349|Fosbretabulin|fosbretabulin|mesh-list
6697063|NCT01701349|Combretastatin|combretastatin|mesh-list
6697064|NCT01701349|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6697065|NCT01701349|Carboplatin|carboplatin|mesh-list
6697066|NCT01701349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6697067|NCT01701349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6697068|NCT01701349|Tubulin Modulators|tubulin modulators|mesh-ancestor
6697069|NCT01701349|Antimitotic Agents|antimitotic agents|mesh-ancestor
6697070|NCT01701349|Mitosis Modulators|mitosis modulators|mesh-ancestor
6697071|NCT01701349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697072|NCT01701453|Clopidogrel|clopidogrel|mesh-list
6697073|NCT01701453|Ticagrelor|ticagrelor|mesh-list
6697074|NCT01701453|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6697075|NCT01701453|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6697076|NCT01701453|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6697077|NCT01701453|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6697078|NCT01701453|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6697079|NCT01701453|Purinergic Agents|purinergic agents|mesh-ancestor
6697080|NCT01701453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6697081|NCT01701453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697082|NCT01701453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697083|NCT01701466|Silver Sulfadiazine|silver sulfadiazine|mesh-list
6697084|NCT01701466|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6697085|NCT01701466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6697086|NCT01701479|Aldesleukin|aldesleukin|mesh-list
6697087|NCT01701479|Interleukin-2|interleukin-2|mesh-list
6697088|NCT01701479|Dinutuximab|dinutuximab|mesh-list
6697089|NCT01701479|Isotretinoin|isotretinoin|mesh-list
6697090|NCT01701479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6697091|NCT01701479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6697092|NCT01701479|Analgesics|analgesics|mesh-ancestor
6697093|NCT01701479|Sensory System Agents|sensory system agents|mesh-ancestor
6697094|NCT01701479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6697095|NCT01701479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697096|NCT01701479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6697097|NCT01701479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6697098|NCT01701479|Antiviral Agents|antiviral agents|mesh-ancestor
6697099|NCT01701479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6697100|NCT01701479|Dermatologic Agents|dermatologic agents|mesh-ancestor
6697101|NCT01701518|Dexamethasone|dexamethasone|mesh-list
6697102|NCT01701518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6697103|NCT01701518|Antiemetics|antiemetics|mesh-ancestor
6697104|NCT01701518|Autonomic Agents|autonomic agents|mesh-ancestor
6242756|NCT02655354|Dermatologic Agents|dermatologic agents|mesh-ancestor
6697105|NCT01701518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6697106|NCT01701518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697107|NCT01701518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6697108|NCT01701518|Glucocorticoids|glucocorticoids|mesh-ancestor
6697109|NCT01701518|Hormones|hormones|mesh-ancestor
6697110|NCT01701518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6697111|NCT01701518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6697112|NCT01701518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6697113|NCT01701583|Omalizumab|omalizumab|mesh-list
6697114|NCT01701583|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6697115|NCT01701583|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6697116|NCT01701583|Respiratory System Agents|respiratory system agents|mesh-ancestor
6781233|NCT02184364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6781234|NCT02184364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781235|NCT02184429|PF-06669571|pf-06669571|mesh-list
6781236|NCT02184429|Dopamine Agonists|dopamine agonists|mesh-ancestor
6781237|NCT02184429|Dopamine Agents|dopamine agents|mesh-ancestor
6781238|NCT02184429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6781239|NCT02184429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781240|NCT02184429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781241|NCT02184533|Selenious Acid|selenious acid|mesh-list
6781242|NCT02184533|Sodium Selenite|sodium selenite|mesh-list
6781243|NCT02184533|Trace Elements|trace elements|mesh-ancestor
6781244|NCT02184533|Micronutrients|micronutrients|mesh-ancestor
6781245|NCT02184533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781246|NCT02184559|Ropivacaine|ropivacaine|mesh-list
6781247|NCT02184559|Anesthetics, Local|anesthetics, local|mesh-ancestor
6781248|NCT02184559|Anesthetics|anesthetics|mesh-ancestor
6781249|NCT02184559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6781250|NCT02184559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781251|NCT02184559|Sensory System Agents|sensory system agents|mesh-ancestor
6781252|NCT02184559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6781253|NCT02184637|Lumefantrine|lumefantrine|mesh-list
6781254|NCT02184637|Artemether|artemether|mesh-list
6781255|NCT02184637|Piperaquine|piperaquine|mesh-list
6781256|NCT02184637|Artenimol|artenimol|mesh-list
6781257|NCT02184637|Tafenoquine|tafenoquine|mesh-list
6781258|NCT02184637|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6781259|NCT02184637|Antimalarials|antimalarials|mesh-ancestor
6781260|NCT02184637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6781261|NCT02184637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6781262|NCT02184637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6781263|NCT02184819|Riboflavin|riboflavin|mesh-list
6781264|NCT02184819|Simendan|simendan|mesh-list
6781265|NCT02184819|Vitamin B Complex|vitamin b complex|mesh-ancestor
6781266|NCT02184819|Vitamins|vitamins|mesh-ancestor
6781267|NCT02184819|Micronutrients|micronutrients|mesh-ancestor
6781268|NCT02184819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781269|NCT02184819|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6781270|NCT02184819|Dermatologic Agents|dermatologic agents|mesh-ancestor
6781271|NCT02184819|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6781272|NCT02184819|Vasodilator Agents|vasodilator agents|mesh-ancestor
6781273|NCT02184819|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6781274|NCT02184819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6781275|NCT02184819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6781276|NCT02184819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781277|NCT02184819|Protective Agents|protective agents|mesh-ancestor
6781278|NCT02184832|Metformin|metformin|mesh-list
6781279|NCT02184832|Tryptophan|tryptophan|mesh-list
6781280|NCT02184832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6781281|NCT02184832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781282|NCT02184832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6781283|NCT02184832|Antidepressive Agents|antidepressive agents|mesh-ancestor
6781284|NCT02184832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6781285|NCT02184858|Lisinopril|lisinopril|mesh-list
6781286|NCT02184858|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6781287|NCT02184858|Protease Inhibitors|protease inhibitors|mesh-ancestor
6781288|NCT02184858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6781289|NCT02184858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781290|NCT02184858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6781291|NCT02184858|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6781292|NCT02184858|Protective Agents|protective agents|mesh-ancestor
6781293|NCT02184858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781294|NCT02184897|Lenograstim|lenograstim|mesh-list
6781295|NCT02184897|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6781296|NCT02184897|Immunologic Factors|immunologic factors|mesh-ancestor
6781297|NCT02184897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781298|NCT02184910|Gastrins|gastrins|mesh-list
6781299|NCT02184910|Hormones|hormones|mesh-ancestor
6697117|NCT01701739|Digoxin|digoxin|mesh-list
6697118|NCT01701739|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6697119|NCT01701739|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6697120|NCT01701739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6697121|NCT01701739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697122|NCT01701739|Protective Agents|protective agents|mesh-ancestor
6697123|NCT01701739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697124|NCT01701778|Dexmedetomidine|dexmedetomidine|mesh-list
6697125|NCT01701778|Sevoflurane|sevoflurane|mesh-list
6697126|NCT01701778|Levobupivacaine|levobupivacaine|mesh-list
6697127|NCT01701778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6697128|NCT01701778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6697129|NCT01701778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697130|NCT01701778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6697131|NCT01701778|Analgesics|analgesics|mesh-ancestor
6697132|NCT01701778|Sensory System Agents|sensory system agents|mesh-ancestor
6697133|NCT01701778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6697134|NCT01701778|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6697135|NCT01701778|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6697136|NCT01701778|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6697137|NCT01701778|Adrenergic Agents|adrenergic agents|mesh-ancestor
6697138|NCT01701778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6697139|NCT01701778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697140|NCT01701778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6697141|NCT01701778|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6697142|NCT01701778|Anesthetics, General|anesthetics, general|mesh-ancestor
6697143|NCT01701778|Anesthetics|anesthetics|mesh-ancestor
6697144|NCT01701778|Anesthetics, Local|anesthetics, local|mesh-ancestor
6697145|NCT01701843|Cromolyn Sodium|cromolyn sodium|mesh-list
6697146|NCT01701843|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
6697147|NCT01701843|Immunologic Factors|immunologic factors|mesh-ancestor
6697148|NCT01701843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697149|NCT01701843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6697150|NCT01701843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6697151|NCT01701843|Respiratory System Agents|respiratory system agents|mesh-ancestor
6697152|NCT01701856|Interferons|interferons|mesh-list
6697153|NCT01701856|Interferon-beta|interferon-beta|mesh-list
6697154|NCT01701856|Interferon beta-1b|interferon beta-1b|mesh-list
6697155|NCT01701856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6697156|NCT01701856|Antiviral Agents|antiviral agents|mesh-ancestor
6697157|NCT01701856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6697158|NCT01701856|Immunologic Factors|immunologic factors|mesh-ancestor
6697159|NCT01701856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697160|NCT01701856|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6697161|NCT01701882|Tenofovir|tenofovir|mesh-list
6697162|NCT01701882|Emtricitabine|emtricitabine|mesh-list
6697163|NCT01701882|Rilpivirine|rilpivirine|mesh-list
6697164|NCT01701882|Antiviral Agents|antiviral agents|mesh-ancestor
6697165|NCT01701882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6697166|NCT01701882|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6697167|NCT01701882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6697168|NCT01701882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6697169|NCT01701882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697170|NCT01701882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6697171|NCT01701882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6697172|NCT01701921|Pregabalin|pregabalin|mesh-list
6697173|NCT01701921|Analgesics|analgesics|mesh-ancestor
6697174|NCT01701921|Sensory System Agents|sensory system agents|mesh-ancestor
6697175|NCT01701921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6697176|NCT01701921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697177|NCT01701921|Anticonvulsants|anticonvulsants|mesh-ancestor
6697178|NCT01701921|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6697179|NCT01701921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6697180|NCT01701921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697181|NCT01701921|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6697182|NCT01701921|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6697183|NCT01701921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6697184|NCT01701921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6697185|NCT01701921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6697186|NCT01702038|Rituximab|rituximab|mesh-list
6697187|NCT01702038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6697188|NCT01702038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6697189|NCT01702038|Immunologic Factors|immunologic factors|mesh-ancestor
6697190|NCT01702038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697191|NCT01702038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6697192|NCT01702090|Ritonavir|ritonavir|mesh-list
6697193|NCT01702090|Darunavir|darunavir|mesh-list
6697194|NCT01702090|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6697195|NCT01702090|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6697196|NCT01702090|Protease Inhibitors|protease inhibitors|mesh-ancestor
6697197|NCT01702090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6697198|NCT01702090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697199|NCT01702090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6697200|NCT01702090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6697201|NCT01702090|Antiviral Agents|antiviral agents|mesh-ancestor
6697202|NCT01702090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6697203|NCT01702090|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6697204|NCT01702090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6697205|NCT01702103|Mometasone Furoate|mometasone furoate|mesh-list
6697206|NCT01702103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6697207|NCT01702103|Dermatologic Agents|dermatologic agents|mesh-ancestor
6697208|NCT01702103|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6697209|NCT01702129|Doxorubicin|doxorubicin|mesh-list
6697210|NCT01702129|Cetuximab|cetuximab|mesh-list
6697211|NCT01702129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6697212|NCT01702129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6697213|NCT01702129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6697214|NCT01702129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6697215|NCT01702129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6697216|NCT01702129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697217|NCT01702129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6697218|NCT01702181|Tacrolimus|tacrolimus|mesh-list
6697219|NCT01702181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6697220|NCT01702181|Immunologic Factors|immunologic factors|mesh-ancestor
6697221|NCT01702181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697222|NCT01702181|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6697223|NCT01702181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6697224|NCT01702181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697225|NCT01702207|Tacrolimus|tacrolimus|mesh-list
6697226|NCT01702207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6697227|NCT01702207|Immunologic Factors|immunologic factors|mesh-ancestor
6697228|NCT01702207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697229|NCT01702207|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6697230|NCT01702207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6697231|NCT01702207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697232|NCT01702376|Moxifloxacin|moxifloxacin|mesh-list
6697233|NCT01702376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6697234|NCT01702376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6697235|NCT01702376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6697236|NCT01702376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6697237|NCT01702376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6697238|NCT01702376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697239|NCT01702376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6697240|NCT01702389|Remifentanil|remifentanil|mesh-list
6697241|NCT01702389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6697242|NCT01702389|Narcotics|narcotics|mesh-ancestor
6697243|NCT01702389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6697244|NCT01702389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697245|NCT01702389|Analgesics|analgesics|mesh-ancestor
6697246|NCT01702389|Sensory System Agents|sensory system agents|mesh-ancestor
6697247|NCT01702389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6697248|NCT01702415|Zoledronic Acid|zoledronic acid|mesh-list
6697249|NCT01702415|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6697250|NCT01702415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697251|NCT01702506|Antacids|antacids|mesh-list
6697252|NCT01702506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697253|NCT01702506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6697254|NCT01702610|Temozolomide|temozolomide|mesh-list
6697255|NCT01702610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6697256|NCT01702610|Alkylating Agents|alkylating agents|mesh-ancestor
6697257|NCT01702610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697258|NCT01702610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6697259|NCT01702623|Oxcarbazepine|oxcarbazepine|mesh-list
6697260|NCT01702623|Anticonvulsants|anticonvulsants|mesh-ancestor
6697261|NCT01702623|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6697262|NCT01702623|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6697263|NCT01702623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6697264|NCT01702623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697265|NCT01702623|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6697266|NCT01702623|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6697267|NCT01702636|Tranexamic Acid|tranexamic acid|mesh-list
6697268|NCT01702636|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6697269|NCT01702636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6697270|NCT01702636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697271|NCT01702636|Hemostatics|hemostatics|mesh-ancestor
6697272|NCT01702636|Coagulants|coagulants|mesh-ancestor
6697273|NCT01702649|Biapenem|biapenem|mesh-list
6697274|NCT01702649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6697275|NCT01702688|Angiotensin II|angiotensin ii|mesh-list
6697276|NCT01702688|Giapreza|giapreza|mesh-list
6697277|NCT01702688|Angiotensinogen|angiotensinogen|mesh-list
6697278|NCT01702688|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6697279|NCT01702688|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6697280|NCT01702688|Protease Inhibitors|protease inhibitors|mesh-ancestor
6697281|NCT01702688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6697282|NCT01702688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697283|NCT01702701|Fluticasone|fluticasone|mesh-list
6697284|NCT01702701|Montelukast|montelukast|mesh-list
6697285|NCT01702701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6697286|NCT01702701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6697287|NCT01702701|Autonomic Agents|autonomic agents|mesh-ancestor
6697288|NCT01702701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6697289|NCT01702701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697290|NCT01702701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6697291|NCT01702701|Respiratory System Agents|respiratory system agents|mesh-ancestor
6697292|NCT01702701|Dermatologic Agents|dermatologic agents|mesh-ancestor
6697293|NCT01702701|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6697294|NCT01702701|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6697295|NCT01702701|Hormone Antagonists|hormone antagonists|mesh-ancestor
6697296|NCT01702701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6697297|NCT01702701|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6697298|NCT01702701|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6697299|NCT01702701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697300|NCT01702714|Gemcitabine|gemcitabine|mesh-list
6697301|NCT01702714|Paclitaxel|paclitaxel|mesh-list
6697302|NCT01702714|Carboplatin|carboplatin|mesh-list
6697303|NCT01702714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6697304|NCT01702714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6697305|NCT01702714|Tubulin Modulators|tubulin modulators|mesh-ancestor
6697306|NCT01702714|Antimitotic Agents|antimitotic agents|mesh-ancestor
6697307|NCT01702714|Mitosis Modulators|mitosis modulators|mesh-ancestor
6697308|NCT01702714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697309|NCT01702714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6697310|NCT01702714|Antimetabolites|antimetabolites|mesh-ancestor
6697311|NCT01702714|Antiviral Agents|antiviral agents|mesh-ancestor
6697312|NCT01702714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6697313|NCT01702714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6697314|NCT01702714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6697315|NCT01702714|Immunologic Factors|immunologic factors|mesh-ancestor
6697316|NCT01702714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697317|NCT01702831|Lenalidomide|lenalidomide|mesh-list
6697318|NCT01702831|Melphalan|melphalan|mesh-list
6697319|NCT01702831|Busulfan|busulfan|mesh-list
6697320|NCT01702831|Immunologic Factors|immunologic factors|mesh-ancestor
6697321|NCT01702831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697322|NCT01702831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6697323|NCT01702831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6697324|NCT01702831|Growth Substances|growth substances|mesh-ancestor
6697325|NCT01702831|Growth Inhibitors|growth inhibitors|mesh-ancestor
6697326|NCT01702831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6697327|NCT01702831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6697328|NCT01702831|Alkylating Agents|alkylating agents|mesh-ancestor
6697329|NCT01702831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697330|NCT01702831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6697331|NCT01702831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6697332|NCT01702857|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6697333|NCT01702857|Vaccines|vaccines|mesh-list
6697334|NCT01702857|Aluminum sulfate|aluminum sulfate|mesh-list
6697335|NCT01702857|Immunologic Factors|immunologic factors|mesh-ancestor
6697336|NCT01702857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697337|NCT01702857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6697338|NCT01702857|Antacids|antacids|mesh-ancestor
6697339|NCT01702857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697340|NCT01702857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6697341|NCT01702974|Vitamin D|vitamin d|mesh-list
6697342|NCT01702974|Cholecalciferol|cholecalciferol|mesh-list
6697343|NCT01702974|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
6697344|NCT01702974|Vitamins|vitamins|mesh-ancestor
6697345|NCT01702974|Micronutrients|micronutrients|mesh-ancestor
6697346|NCT01702974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697347|NCT01702974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6697348|NCT01702974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6697349|NCT01702974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6697350|NCT01703104|Folic Acid|folic acid|mesh-list
6697351|NCT01703104|Vitamin B Complex|vitamin b complex|mesh-list
6697352|NCT01703104|Proguanil|proguanil|mesh-list
6697353|NCT01703104|Hematinics|hematinics|mesh-ancestor
6697354|NCT01703104|Vitamins|vitamins|mesh-ancestor
6697355|NCT01703104|Micronutrients|micronutrients|mesh-ancestor
6697356|NCT01703104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697357|NCT01703104|Antimalarials|antimalarials|mesh-ancestor
6697358|NCT01703104|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6697359|NCT01703104|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6697360|NCT01703104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6697361|NCT01703104|Antimetabolites|antimetabolites|mesh-ancestor
6697362|NCT01703104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697363|NCT01703130|Ropivacaine|ropivacaine|mesh-list
6697364|NCT01703130|Anesthetics, Local|anesthetics, local|mesh-ancestor
6697365|NCT01703130|Anesthetics|anesthetics|mesh-ancestor
6697366|NCT01703130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6697367|NCT01703130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697368|NCT01703130|Sensory System Agents|sensory system agents|mesh-ancestor
6697369|NCT01703130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6697370|NCT01703234|Ramipril|ramipril|mesh-list
6697371|NCT01703234|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6697372|NCT01703234|Protease Inhibitors|protease inhibitors|mesh-ancestor
6697373|NCT01703234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6697374|NCT01703234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697375|NCT01703234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6697376|NCT01703312|Omalizumab|omalizumab|mesh-list
6697377|NCT01703312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6697378|NCT01703312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6697379|NCT01703312|Respiratory System Agents|respiratory system agents|mesh-ancestor
6697380|NCT01703325|Triamcinolone|triamcinolone|mesh-list
6697381|NCT01703325|Clobetasol|clobetasol|mesh-list
6697382|NCT01703325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6697383|NCT01703325|Glucocorticoids|glucocorticoids|mesh-ancestor
6697384|NCT01703325|Hormones|hormones|mesh-ancestor
6697385|NCT01703325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6697386|NCT01703325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697387|NCT01703351|Fentanyl|fentanyl|mesh-list
6697388|NCT01703351|Ropivacaine|ropivacaine|mesh-list
6697389|NCT01703351|Anesthetics, Local|anesthetics, local|mesh-ancestor
6697390|NCT01703351|Anesthetics|anesthetics|mesh-ancestor
6697391|NCT01703351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6697392|NCT01703351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697393|NCT01703351|Sensory System Agents|sensory system agents|mesh-ancestor
6697394|NCT01703351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6697395|NCT01703351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6697396|NCT01703351|Narcotics|narcotics|mesh-ancestor
6697397|NCT01703351|Analgesics|analgesics|mesh-ancestor
6697398|NCT01703351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6697399|NCT01703351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6697400|NCT01703351|Anesthetics, General|anesthetics, general|mesh-ancestor
6697401|NCT01703364|Lenalidomide|lenalidomide|mesh-list
6697402|NCT01703364|Immunologic Factors|immunologic factors|mesh-ancestor
6697403|NCT01703364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697404|NCT01703364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6697405|NCT01703364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6697406|NCT01703364|Growth Substances|growth substances|mesh-ancestor
6697407|NCT01703364|Growth Inhibitors|growth inhibitors|mesh-ancestor
6697408|NCT01703364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6781300|NCT02184910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6781301|NCT02184910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781302|NCT02184975|Hemostatics|hemostatics|mesh-list
6781303|NCT02184975|Coagulants|coagulants|mesh-ancestor
6781304|NCT02185066|Metformin|metformin|mesh-list
6781305|NCT02185066|Atorvastatin|atorvastatin|mesh-list
6781306|NCT02185066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6781307|NCT02185066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781308|NCT02185066|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6781309|NCT02185066|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6781310|NCT02185066|Antimetabolites|antimetabolites|mesh-ancestor
6697409|NCT01703390|Cetuximab|cetuximab|mesh-list
6697410|NCT01703390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6697411|NCT01703390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6697412|NCT01703455|Sorafenib|sorafenib|mesh-list
6697413|NCT01703455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6697414|NCT01703455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6697415|NCT01703455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6697416|NCT01703455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697417|NCT01703468|Oxcarbazepine|oxcarbazepine|mesh-list
6697418|NCT01703468|Anticonvulsants|anticonvulsants|mesh-ancestor
6697419|NCT01703468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6697420|NCT01703468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6697421|NCT01703468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6697422|NCT01703468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697423|NCT01703468|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6697424|NCT01703468|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6697425|NCT01703559|Phentolamine|phentolamine|mesh-list
6697426|NCT01703559|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6697427|NCT01703559|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6697428|NCT01703559|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6697429|NCT01703559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6697430|NCT01703559|Adrenergic Agents|adrenergic agents|mesh-ancestor
6697431|NCT01703559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6697432|NCT01703559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697433|NCT01703559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697434|NCT01703559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6697435|NCT01703624|Glycopyrrolate|glycopyrrolate|mesh-list
6697436|NCT01703624|Bromides|bromides|mesh-list
6697437|NCT01703624|Anticonvulsants|anticonvulsants|mesh-ancestor
6697438|NCT01703624|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6697439|NCT01703624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6697440|NCT01703624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6697441|NCT01703624|Cholinergic Agents|cholinergic agents|mesh-ancestor
6697442|NCT01703624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6697443|NCT01703624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697444|NCT01703624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697445|NCT01703637|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6697446|NCT01703637|Saxagliptin|saxagliptin|mesh-list
6697447|NCT01703637|Vildagliptin|vildagliptin|mesh-list
6697448|NCT01703637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6697449|NCT01703637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697450|NCT01703637|Incretins|incretins|mesh-ancestor
6697451|NCT01703637|Hormones|hormones|mesh-ancestor
6697452|NCT01703637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6697453|NCT01703637|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6697454|NCT01703637|Protease Inhibitors|protease inhibitors|mesh-ancestor
6697455|NCT01703637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6697456|NCT01703637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697457|NCT01703728|Menotropins|menotropins|mesh-list
6697458|NCT01703728|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6697459|NCT01703728|Fertility Agents|fertility agents|mesh-ancestor
6697460|NCT01703728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6697461|NCT01703728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697462|NCT01703754|Isophosphamide mustard|isophosphamide mustard|mesh-list
6697463|NCT01703754|Ifosfamide|ifosfamide|mesh-list
6697464|NCT01703754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6697465|NCT01703754|Alkylating Agents|alkylating agents|mesh-ancestor
6697466|NCT01703754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697467|NCT01703754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6697468|NCT01703910|Gemcitabine|gemcitabine|mesh-list
6697469|NCT01703910|Paclitaxel|paclitaxel|mesh-list
6697470|NCT01703910|Etoposide|etoposide|mesh-list
6697471|NCT01703910|Vinorelbine|vinorelbine|mesh-list
6697472|NCT01703910|Docetaxel|docetaxel|mesh-list
6697473|NCT01703910|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6697474|NCT01703910|Cisplatin|cisplatin|mesh-list
6697475|NCT01703910|Doxorubicin|doxorubicin|mesh-list
6697476|NCT01703910|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6697477|NCT01703910|Fluorouracil|fluorouracil|mesh-list
6697478|NCT01703910|Capecitabine|capecitabine|mesh-list
6697479|NCT01703910|Oxaliplatin|oxaliplatin|mesh-list
6697480|NCT01703910|Irinotecan|irinotecan|mesh-list
6697481|NCT01703910|Etoposide phosphate|etoposide phosphate|mesh-list
6697482|NCT01703910|Pemetrexed|pemetrexed|mesh-list
6697483|NCT01703910|Cetuximab|cetuximab|mesh-list
6697484|NCT01703910|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6697485|NCT01703910|Sorafenib|sorafenib|mesh-list
6697486|NCT01703910|Topotecan|topotecan|mesh-list
6697487|NCT01703910|Dasatinib|dasatinib|mesh-list
6697488|NCT01703910|Mitomycins|mitomycins|mesh-list
6697489|NCT01703910|Mitomycin|mitomycin|mesh-list
6697490|NCT01703910|Raltitrexed|raltitrexed|mesh-list
6697491|NCT01703910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6697492|NCT01703910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6697493|NCT01703910|Tubulin Modulators|tubulin modulators|mesh-ancestor
6697494|NCT01703910|Antimitotic Agents|antimitotic agents|mesh-ancestor
6697495|NCT01703910|Mitosis Modulators|mitosis modulators|mesh-ancestor
6697496|NCT01703910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697497|NCT01703910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6697498|NCT01703910|Antimetabolites|antimetabolites|mesh-ancestor
6697499|NCT01703910|Antiviral Agents|antiviral agents|mesh-ancestor
6697500|NCT01703910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6697501|NCT01703910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6697502|NCT01703910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6697503|NCT01703910|Immunologic Factors|immunologic factors|mesh-ancestor
6697504|NCT01703910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697505|NCT01703910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6697506|NCT01703910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6697507|NCT01703910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6697508|NCT01703910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6697509|NCT01703910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6697510|NCT01703910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6697511|NCT01703910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6697512|NCT01703910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6697513|NCT01703910|Alkylating Agents|alkylating agents|mesh-ancestor
6697514|NCT01704027|Androgens|androgens|mesh-list
6697515|NCT01704027|Hormones|hormones|mesh-ancestor
6697516|NCT01704027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6697517|NCT01704027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697518|NCT01704092|Dexmedetomidine|dexmedetomidine|mesh-list
6697519|NCT01704092|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6697520|NCT01704092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6697521|NCT01704092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697522|NCT01704092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6697523|NCT01704092|Analgesics|analgesics|mesh-ancestor
6697524|NCT01704092|Sensory System Agents|sensory system agents|mesh-ancestor
6697525|NCT01704092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6697526|NCT01704092|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6697527|NCT01704092|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6697528|NCT01704092|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6697529|NCT01704092|Adrenergic Agents|adrenergic agents|mesh-ancestor
6697530|NCT01704092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6697531|NCT01704092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697532|NCT01704248|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6697533|NCT01704248|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6697534|NCT01704339|Capsaicin|capsaicin|mesh-list
6697535|NCT01704339|Antipruritics|antipruritics|mesh-ancestor
6697536|NCT01704339|Dermatologic Agents|dermatologic agents|mesh-ancestor
6697537|NCT01704339|Sensory System Agents|sensory system agents|mesh-ancestor
6697538|NCT01704339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6697539|NCT01704339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697540|NCT01704378|Insulin Aspart|insulin aspart|mesh-list
6697541|NCT01704378|Biphasic Insulins|biphasic insulins|mesh-list
6697542|NCT01704378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6697543|NCT01704378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697544|NCT01704417|Insulin|insulin|mesh-list
6697545|NCT01704417|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6697546|NCT01704417|Insulin Glargine|insulin glargine|mesh-list
6697547|NCT01704417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6697548|NCT01704417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697549|NCT01704469|Anesthetics|anesthetics|mesh-list
6697550|NCT01704469|Anesthetics, Local|anesthetics, local|mesh-list
6697551|NCT01704469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6697552|NCT01704469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697553|NCT01704469|Sensory System Agents|sensory system agents|mesh-ancestor
6697554|NCT01704469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6697555|NCT01704482|Acetylcysteine|acetylcysteine|mesh-list
6697556|NCT01704482|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6697557|NCT01704482|Antiviral Agents|antiviral agents|mesh-ancestor
6697558|NCT01704482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6697559|NCT01704482|Expectorants|expectorants|mesh-ancestor
6697560|NCT01704482|Respiratory System Agents|respiratory system agents|mesh-ancestor
6697561|NCT01704482|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6697562|NCT01704482|Antioxidants|antioxidants|mesh-ancestor
6697563|NCT01704482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697564|NCT01704482|Protective Agents|protective agents|mesh-ancestor
6697565|NCT01704482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697566|NCT01704482|Antidotes|antidotes|mesh-ancestor
6697567|NCT01704508|Lumefantrine|lumefantrine|mesh-list
6697568|NCT01704508|Artemether|artemether|mesh-list
6697569|NCT01704508|Piperaquine|piperaquine|mesh-list
6697570|NCT01704508|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6697571|NCT01704508|Artenimol|artenimol|mesh-list
6697572|NCT01704508|Antimalarials|antimalarials|mesh-ancestor
6697573|NCT01704508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6697574|NCT01704508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6697575|NCT01704508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6697576|NCT01704534|Ustekinumab|ustekinumab|mesh-list
6697577|NCT01704534|Dermatologic Agents|dermatologic agents|mesh-ancestor
6697578|NCT01704612|Ropivacaine|ropivacaine|mesh-list
6697579|NCT01704612|Anesthetics, Local|anesthetics, local|mesh-ancestor
6697580|NCT01704612|Anesthetics|anesthetics|mesh-ancestor
6697581|NCT01704612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6697582|NCT01704612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697583|NCT01704612|Sensory System Agents|sensory system agents|mesh-ancestor
6697584|NCT01704612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6697585|NCT01704638|Digoxin|digoxin|mesh-list
6697586|NCT01704638|Fluvoxamine|fluvoxamine|mesh-list
6697587|NCT01704638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6697588|NCT01704638|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6697589|NCT01704638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6697590|NCT01704638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697591|NCT01704638|Protective Agents|protective agents|mesh-ancestor
6697592|NCT01704638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697593|NCT01704638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6697594|NCT01704638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6697595|NCT01704638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6697596|NCT01704638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6697597|NCT01704638|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6697598|NCT01704638|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6697599|NCT01704638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6697600|NCT01704638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6697601|NCT01704638|Serotonin Agents|serotonin agents|mesh-ancestor
6697602|NCT01704638|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6697603|NCT01704638|Antidepressive Agents|antidepressive agents|mesh-ancestor
6697604|NCT01704638|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6697605|NCT01704638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6697606|NCT01704638|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6697607|NCT01704690|Paclitaxel|paclitaxel|mesh-list
6697608|NCT01704690|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6697609|NCT01704690|Cisplatin|cisplatin|mesh-list
6697610|NCT01704690|Fluorouracil|fluorouracil|mesh-list
6697611|NCT01704690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6697612|NCT01704690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6697613|NCT01704690|Tubulin Modulators|tubulin modulators|mesh-ancestor
6697614|NCT01704690|Antimitotic Agents|antimitotic agents|mesh-ancestor
6697615|NCT01704690|Mitosis Modulators|mitosis modulators|mesh-ancestor
6697616|NCT01704690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697617|NCT01704690|Antimetabolites|antimetabolites|mesh-ancestor
6697618|NCT01704690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6697619|NCT01704690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6697620|NCT01704690|Immunologic Factors|immunologic factors|mesh-ancestor
6697621|NCT01704690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697622|NCT01704703|Panitumumab|panitumumab|mesh-list
6697623|NCT01704703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6697624|NCT01704703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6697625|NCT01704716|Aldesleukin|aldesleukin|mesh-list
6697626|NCT01704716|Cyclophosphamide|cyclophosphamide|mesh-list
6697627|NCT01704716|Melphalan|melphalan|mesh-list
6697628|NCT01704716|Busulfan|busulfan|mesh-list
6697629|NCT01704716|Carboplatin|carboplatin|mesh-list
6697630|NCT01704716|Doxorubicin|doxorubicin|mesh-list
6697631|NCT01704716|Etoposide|etoposide|mesh-list
6697632|NCT01704716|Vincristine|vincristine|mesh-list
6697633|NCT01704716|Interleukin-2|interleukin-2|mesh-list
6697634|NCT01704716|Dinutuximab|dinutuximab|mesh-list
6697635|NCT01704716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6697636|NCT01704716|Immunologic Factors|immunologic factors|mesh-ancestor
6697637|NCT01704716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697638|NCT01704716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6697639|NCT01704716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6697640|NCT01704716|Alkylating Agents|alkylating agents|mesh-ancestor
6697641|NCT01704716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697642|NCT01704716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6697643|NCT01704716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6697644|NCT01704716|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6697645|NCT01704716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6697646|NCT01704716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6697647|NCT01704716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6697648|NCT01704716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6697649|NCT01704716|Tubulin Modulators|tubulin modulators|mesh-ancestor
6697650|NCT01704716|Antimitotic Agents|antimitotic agents|mesh-ancestor
6697651|NCT01704716|Mitosis Modulators|mitosis modulators|mesh-ancestor
6697652|NCT01704716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6697653|NCT01704716|Analgesics|analgesics|mesh-ancestor
6697654|NCT01704716|Sensory System Agents|sensory system agents|mesh-ancestor
6697655|NCT01704716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6697656|NCT01704716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6697657|NCT01704716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6697658|NCT01704716|Antiviral Agents|antiviral agents|mesh-ancestor
6697659|NCT01704716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6697660|NCT01704794|Folic Acid|folic acid|mesh-list
6697661|NCT01704794|Vitamin B Complex|vitamin b complex|mesh-list
6697662|NCT01704794|Proguanil|proguanil|mesh-list
6697663|NCT01704794|Hematinics|hematinics|mesh-ancestor
6697664|NCT01704794|Vitamins|vitamins|mesh-ancestor
6697665|NCT01704794|Micronutrients|micronutrients|mesh-ancestor
6697666|NCT01704794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697667|NCT01704794|Antimalarials|antimalarials|mesh-ancestor
6697668|NCT01704794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6697669|NCT01704794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6697670|NCT01704794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6697671|NCT01704794|Antimetabolites|antimetabolites|mesh-ancestor
6697672|NCT01704794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697673|NCT01704872|Dinutuximab|dinutuximab|mesh-list
6697674|NCT01704872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6697675|NCT01704898|Efavirenz|efavirenz|mesh-list
6697676|NCT01704898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6697677|NCT01704898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6697678|NCT01704898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6697679|NCT01704898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697680|NCT01704898|Antiviral Agents|antiviral agents|mesh-ancestor
6697681|NCT01704898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6697682|NCT01704898|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6697683|NCT01704898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6697684|NCT01704898|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6697685|NCT01704898|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6697686|NCT01704898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6697687|NCT01704898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6697688|NCT01705002|Bevacizumab|bevacizumab|mesh-list
6697689|NCT01705002|Capecitabine|capecitabine|mesh-list
6697690|NCT01705002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6697691|NCT01705002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6697692|NCT01705002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6697693|NCT01705002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6697694|NCT01705002|Growth Substances|growth substances|mesh-ancestor
6697695|NCT01705002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697696|NCT01705002|Growth Inhibitors|growth inhibitors|mesh-ancestor
6697697|NCT01705002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6697698|NCT01705002|Antimetabolites|antimetabolites|mesh-ancestor
6697699|NCT01705002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697700|NCT01705041|Liver Extracts|liver extracts|mesh-list
6697701|NCT01705041|Hematinics|hematinics|mesh-ancestor
6781311|NCT02185066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781312|NCT02185066|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6781313|NCT02185066|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6781314|NCT02185066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6781315|NCT02185118|Sevoflurane|sevoflurane|mesh-list
6781316|NCT02185118|Isoflurane|isoflurane|mesh-list
6781317|NCT02185118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6781318|NCT02185118|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6781319|NCT02185118|Anesthetics, General|anesthetics, general|mesh-ancestor
6781320|NCT02185118|Anesthetics|anesthetics|mesh-ancestor
6781321|NCT02185118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6781322|NCT02185118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781323|NCT02185196|Vitamin D|vitamin d|mesh-list
6781324|NCT02185196|Cholecalciferol|cholecalciferol|mesh-list
6781325|NCT02185196|Vitamins|vitamins|mesh-ancestor
6781326|NCT02185196|Micronutrients|micronutrients|mesh-ancestor
6781327|NCT02185196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781328|NCT02185196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6781329|NCT02185196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6781330|NCT02185209|Amoxicillin|amoxicillin|mesh-list
6781331|NCT02185209|Metronidazole|metronidazole|mesh-list
6781332|NCT02185209|Penicillin V|penicillin v|mesh-list
6781333|NCT02185209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6781334|NCT02185209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6781335|NCT02185209|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6781336|NCT02185209|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6781337|NCT02185222|Cholecalciferol|cholecalciferol|mesh-list
6781338|NCT02185222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6781339|NCT02185222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781340|NCT02185222|Vitamins|vitamins|mesh-ancestor
6781341|NCT02185222|Micronutrients|micronutrients|mesh-ancestor
6781342|NCT02185222|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6781343|NCT02185261|Interferons|interferons|mesh-list
6781344|NCT02185261|Interferon-alpha|interferon-alpha|mesh-list
6781345|NCT02185261|Interferon alpha-2|interferon alpha-2|mesh-list
6781346|NCT02185261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6781347|NCT02185261|Antiviral Agents|antiviral agents|mesh-ancestor
6781348|NCT02185261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6781349|NCT02185261|Immunologic Factors|immunologic factors|mesh-ancestor
6781350|NCT02185261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781351|NCT02185300|Dolutegravir|dolutegravir|mesh-list
6781352|NCT02185300|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6781353|NCT02185300|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6781354|NCT02185300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6781355|NCT02185300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781356|NCT02185300|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6781357|NCT02185300|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6781358|NCT02185300|Antiviral Agents|antiviral agents|mesh-ancestor
6781359|NCT02185300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6781360|NCT02185326|Hormones|hormones|mesh-list
6781361|NCT02185326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6781362|NCT02185326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781363|NCT02185352|Cisplatin|cisplatin|mesh-list
6781364|NCT02185352|Etoposide|etoposide|mesh-list
6781365|NCT02185352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6697702|NCT01705158|Carboplatin|carboplatin|mesh-list
6697703|NCT01705158|Doxorubicin|doxorubicin|mesh-list
6697704|NCT01705158|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6697705|NCT01705158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6697706|NCT01705158|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6697707|NCT01705158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6697708|NCT01705158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6697709|NCT01705158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6697710|NCT01705158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697711|NCT01705184|Bevacizumab|bevacizumab|mesh-list
6697712|NCT01705184|Pemetrexed|pemetrexed|mesh-list
6697713|NCT01705184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6697714|NCT01705184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6697715|NCT01705184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6697716|NCT01705184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6697717|NCT01705184|Growth Substances|growth substances|mesh-ancestor
6697718|NCT01705184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697719|NCT01705184|Growth Inhibitors|growth inhibitors|mesh-ancestor
6697720|NCT01705184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6697721|NCT01705184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697722|NCT01705184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6697723|NCT01705184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6697724|NCT01705223|Vaccines|vaccines|mesh-list
6697725|NCT01705223|Immunologic Factors|immunologic factors|mesh-ancestor
6697726|NCT01705223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697727|NCT01705249|Norethindrone|norethindrone|mesh-list
6697728|NCT01705249|Norethindrone Acetate|norethindrone acetate|mesh-list
6697729|NCT01705249|Estradiol|estradiol|mesh-list
6697730|NCT01705249|Estrogens|estrogens|mesh-ancestor
6697731|NCT01705249|Hormones|hormones|mesh-ancestor
6697732|NCT01705249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6697733|NCT01705249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697734|NCT01705249|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6697735|NCT01705249|Contraceptive Agents|contraceptive agents|mesh-ancestor
6697736|NCT01705249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6697737|NCT01705249|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6697738|NCT01705249|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6697739|NCT01705249|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6697740|NCT01705249|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6697741|NCT01705314|Vitamin D|vitamin d|mesh-list
6697742|NCT01705314|Vitamins|vitamins|mesh-ancestor
6697743|NCT01705314|Micronutrients|micronutrients|mesh-ancestor
6697744|NCT01705314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697745|NCT01705314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6697746|NCT01705340|Trastuzumab|trastuzumab|mesh-list
6697747|NCT01705340|Lapatinib|lapatinib|mesh-list
6697748|NCT01705340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6697749|NCT01705340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6697750|NCT01705340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6697751|NCT01705340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6697752|NCT01705340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697753|NCT01705379|Lactitol|lactitol|mesh-list
6697754|NCT01705379|Cathartics|cathartics|mesh-ancestor
6697755|NCT01705379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6697756|NCT01705392|Bevacizumab|bevacizumab|mesh-list
6697757|NCT01705392|Dacarbazine|dacarbazine|mesh-list
6697758|NCT01705392|Propranolol|propranolol|mesh-list
6697759|NCT01705392|Enalapril|enalapril|mesh-list
6697760|NCT01705392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6697761|NCT01705392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6697762|NCT01705392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6697763|NCT01705392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6697764|NCT01705392|Growth Substances|growth substances|mesh-ancestor
6697765|NCT01705392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697766|NCT01705392|Growth Inhibitors|growth inhibitors|mesh-ancestor
6697767|NCT01705392|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6697768|NCT01705392|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6697769|NCT01705392|Adrenergic Agents|adrenergic agents|mesh-ancestor
6697770|NCT01705392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6697771|NCT01705392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697772|NCT01705392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6697773|NCT01705392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6697774|NCT01705392|Vasodilator Agents|vasodilator agents|mesh-ancestor
6697775|NCT01705392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6697776|NCT01705392|Alkylating Agents|alkylating agents|mesh-ancestor
6697777|NCT01705392|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6697778|NCT01705392|Protease Inhibitors|protease inhibitors|mesh-ancestor
6697779|NCT01705392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6697780|NCT01705457|Vitamin A|vitamin a|mesh-list
6697781|NCT01705457|Retinol palmitate|retinol palmitate|mesh-list
6697782|NCT01705457|Vitamins|vitamins|mesh-ancestor
6697783|NCT01705457|Micronutrients|micronutrients|mesh-ancestor
6697784|NCT01705457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697785|NCT01705457|Antioxidants|antioxidants|mesh-ancestor
6697786|NCT01705457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697787|NCT01705457|Protective Agents|protective agents|mesh-ancestor
6697788|NCT01705457|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6697789|NCT01705457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6697790|NCT01705470|Furosemide|furosemide|mesh-list
6697791|NCT01705470|Diuretics|diuretics|mesh-ancestor
6697792|NCT01705470|Natriuretic Agents|natriuretic agents|mesh-ancestor
6697793|NCT01705470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697794|NCT01705470|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6697795|NCT01705470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6697796|NCT01705470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697797|NCT01705483|Paclitaxel|paclitaxel|mesh-list
6697798|NCT01705483|Docetaxel|docetaxel|mesh-list
6697799|NCT01705483|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6697800|NCT01705483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6697801|NCT01705483|Tubulin Modulators|tubulin modulators|mesh-ancestor
6697802|NCT01705483|Antimitotic Agents|antimitotic agents|mesh-ancestor
6697803|NCT01705483|Mitosis Modulators|mitosis modulators|mesh-ancestor
6697804|NCT01705483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697805|NCT01705639|Melatonin|melatonin|mesh-list
6697806|NCT01705639|Antioxidants|antioxidants|mesh-ancestor
6697807|NCT01705639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697808|NCT01705639|Protective Agents|protective agents|mesh-ancestor
6697809|NCT01705639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697810|NCT01705639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6697811|NCT01705743|Nitrous Oxide|nitrous oxide|mesh-list
6697812|NCT01705743|Sevoflurane|sevoflurane|mesh-list
6697813|NCT01705743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6697814|NCT01705743|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6697815|NCT01705743|Anesthetics, General|anesthetics, general|mesh-ancestor
6697816|NCT01705743|Anesthetics|anesthetics|mesh-ancestor
6697817|NCT01705743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6697818|NCT01705743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697819|NCT01705743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6697820|NCT01705743|Analgesics|analgesics|mesh-ancestor
6697821|NCT01705743|Sensory System Agents|sensory system agents|mesh-ancestor
6697822|NCT01705743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6697823|NCT01705756|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6697824|NCT01705756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6697825|NCT01705769|Micronutrients|micronutrients|mesh-list
6697826|NCT01705769|Trace Elements|trace elements|mesh-list
6697827|NCT01705769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697828|NCT01705795|Antibodies|antibodies|mesh-list
6697829|NCT01705795|Immunologic Factors|immunologic factors|mesh-ancestor
6697830|NCT01705795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697831|NCT01705808|Protein C|protein c|mesh-list
6697832|NCT01705808|Anticoagulants|anticoagulants|mesh-ancestor
6697833|NCT01705808|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6697834|NCT01705808|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6697835|NCT01705808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697836|NCT01705938|Dolcanatide|dolcanatide|mesh-list
6697837|NCT01705938|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
6697838|NCT01705938|Enzyme Activators|enzyme activators|mesh-ancestor
6697839|NCT01705938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697840|NCT01705938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6697841|NCT01705951|Nicotine|nicotine|mesh-list
6697842|NCT01705951|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6697843|NCT01705951|Autonomic Agents|autonomic agents|mesh-ancestor
6697844|NCT01705951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6697845|NCT01705951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697846|NCT01705951|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6697847|NCT01705951|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6697848|NCT01705951|Cholinergic Agents|cholinergic agents|mesh-ancestor
6697849|NCT01705951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6697850|NCT01705951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697851|NCT01706055|Interferons|interferons|mesh-list
6697852|NCT01706055|Interferon-beta|interferon-beta|mesh-list
6697853|NCT01706055|Interferon beta-1b|interferon beta-1b|mesh-list
6697854|NCT01706055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6697855|NCT01706055|Antiviral Agents|antiviral agents|mesh-ancestor
6697856|NCT01706055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6697857|NCT01706055|Immunologic Factors|immunologic factors|mesh-ancestor
6697858|NCT01706055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697859|NCT01706055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6697860|NCT01706120|Paclitaxel|paclitaxel|mesh-list
6697861|NCT01706120|Bevacizumab|bevacizumab|mesh-list
6697862|NCT01706120|Carboplatin|carboplatin|mesh-list
6697863|NCT01706120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6697864|NCT01706120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6697865|NCT01706120|Tubulin Modulators|tubulin modulators|mesh-ancestor
6697866|NCT01706120|Antimitotic Agents|antimitotic agents|mesh-ancestor
6697867|NCT01706120|Mitosis Modulators|mitosis modulators|mesh-ancestor
6697868|NCT01706120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697869|NCT01706120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6697870|NCT01706120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6697871|NCT01706120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6697872|NCT01706120|Growth Substances|growth substances|mesh-ancestor
6697873|NCT01706120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697874|NCT01706120|Growth Inhibitors|growth inhibitors|mesh-ancestor
6697875|NCT01706172|Lidocaine|lidocaine|mesh-list
6697876|NCT01706172|Anesthetics, Local|anesthetics, local|mesh-ancestor
6697877|NCT01706172|Anesthetics|anesthetics|mesh-ancestor
6697878|NCT01706172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6697879|NCT01706172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697880|NCT01706172|Sensory System Agents|sensory system agents|mesh-ancestor
6697881|NCT01706172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6697882|NCT01706172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6697883|NCT01706172|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6697884|NCT01706172|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6697885|NCT01706172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6697886|NCT01706172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697887|NCT01706211|Rosiglitazone|rosiglitazone|mesh-list
6697888|NCT01706211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6697889|NCT01706211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697890|NCT01706341|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6697891|NCT01706354|Anesthetics|anesthetics|mesh-list
6697892|NCT01706354|Anesthetics, Local|anesthetics, local|mesh-list
6697893|NCT01706354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6697894|NCT01706354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697895|NCT01706354|Sensory System Agents|sensory system agents|mesh-ancestor
6697896|NCT01706354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6697897|NCT01706367|Vaccines|vaccines|mesh-list
6697898|NCT01706367|Immunologic Factors|immunologic factors|mesh-ancestor
6697899|NCT01706367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697900|NCT01706471|Mycophenolic Acid|mycophenolic acid|mesh-list
6697901|NCT01706471|Everolimus|everolimus|mesh-list
6697902|NCT01706471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6697903|NCT01706471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6697904|NCT01706471|Immunologic Factors|immunologic factors|mesh-ancestor
6697905|NCT01706471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697906|NCT01706471|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6697907|NCT01706471|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6697908|NCT01706471|Antitubercular Agents|antitubercular agents|mesh-ancestor
6697909|NCT01706471|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6697910|NCT01706471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6697911|NCT01706471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6697912|NCT01706471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697913|NCT01706510|Clopidogrel|clopidogrel|mesh-list
6697914|NCT01706510|Ticagrelor|ticagrelor|mesh-list
6697915|NCT01706510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6697916|NCT01706510|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6697917|NCT01706510|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6697918|NCT01706510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6697919|NCT01706510|Purinergic Agents|purinergic agents|mesh-ancestor
6697920|NCT01706510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6697921|NCT01706510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697922|NCT01706510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697923|NCT01706562|Itraconazole|itraconazole|mesh-list
6697924|NCT01706562|Antifungal Agents|antifungal agents|mesh-ancestor
6697925|NCT01706562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6697926|NCT01706562|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6697927|NCT01706562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6697928|NCT01706562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6697929|NCT01706562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697930|NCT01706562|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6697931|NCT01706562|Hormone Antagonists|hormone antagonists|mesh-ancestor
6697932|NCT01706562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6697933|NCT01706562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697934|NCT01706562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6697935|NCT01706627|Melatonin|melatonin|mesh-list
6697936|NCT01706627|Antioxidants|antioxidants|mesh-ancestor
6697937|NCT01706627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697938|NCT01706627|Protective Agents|protective agents|mesh-ancestor
6697939|NCT01706627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697940|NCT01706627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6697941|NCT01706679|Moxifloxacin|moxifloxacin|mesh-list
6697942|NCT01706679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6697943|NCT01706679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6697944|NCT01706679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6697945|NCT01706679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6697946|NCT01706679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6697947|NCT01706679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697948|NCT01706679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6697949|NCT01706692|Cyclosporine|cyclosporine|mesh-list
6697950|NCT01706692|Adalimumab|adalimumab|mesh-list
6697951|NCT01706692|Etanercept|etanercept|mesh-list
6697952|NCT01706692|Methotrexate|methotrexate|mesh-list
6697953|NCT01706692|Infliximab|infliximab|mesh-list
6697954|NCT01706692|Ustekinumab|ustekinumab|mesh-list
6697955|NCT01706692|Cyclosporins|cyclosporins|mesh-list
6697956|NCT01706692|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6697957|NCT01706692|Abortifacient Agents|abortifacient agents|mesh-ancestor
6697958|NCT01706692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6697959|NCT01706692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697960|NCT01706692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6697961|NCT01706692|Antimetabolites|antimetabolites|mesh-ancestor
6697962|NCT01706692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697963|NCT01706692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6697964|NCT01706692|Dermatologic Agents|dermatologic agents|mesh-ancestor
6697965|NCT01706692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6697966|NCT01706692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6697967|NCT01706692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6697968|NCT01706692|Immunologic Factors|immunologic factors|mesh-ancestor
6697969|NCT01706692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6697970|NCT01706692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6697971|NCT01706692|Antifungal Agents|antifungal agents|mesh-ancestor
6697972|NCT01706692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6697973|NCT01706692|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6697974|NCT01706692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6697975|NCT01706692|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6697976|NCT01706692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6697977|NCT01706692|Analgesics|analgesics|mesh-ancestor
6697978|NCT01706692|Sensory System Agents|sensory system agents|mesh-ancestor
6697979|NCT01706692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6697980|NCT01706692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6781366|NCT02185352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6781367|NCT02185352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6781368|NCT02185352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6781369|NCT02185352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6781370|NCT02185352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781371|NCT02185417|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6781372|NCT02185417|Chlorthalidone|chlorthalidone|mesh-list
6781373|NCT02185417|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6781374|NCT02185417|Diuretics|diuretics|mesh-ancestor
6781375|NCT02185417|Natriuretic Agents|natriuretic agents|mesh-ancestor
6781376|NCT02185417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781377|NCT02185417|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6781378|NCT02185417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6781379|NCT02185417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781380|NCT02185430|Dexmedetomidine|dexmedetomidine|mesh-list
6781381|NCT02185430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6781382|NCT02185430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6781383|NCT02185430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6242757|NCT02655354|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6697981|NCT01706874|Listerine|listerine|mesh-list
6697982|NCT01706874|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6697983|NCT01706874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6697984|NCT01706887|Amiloride|amiloride|mesh-list
6697985|NCT01706887|Diuretics|diuretics|mesh-ancestor
6697986|NCT01706887|Natriuretic Agents|natriuretic agents|mesh-ancestor
6697987|NCT01706887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6697988|NCT01706887|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
6697989|NCT01706887|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6697990|NCT01706887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6697991|NCT01706887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6697992|NCT01706887|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
6697993|NCT01706887|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6697994|NCT01706939|Carboplatin|carboplatin|mesh-list
6697995|NCT01706939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6697996|NCT01707082|Midazolam|midazolam|mesh-list
6697997|NCT01707082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6697998|NCT01707082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6697999|NCT01707082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6698000|NCT01707082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698001|NCT01707082|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6698002|NCT01707082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6698003|NCT01707082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6698004|NCT01707082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6698005|NCT01707082|Anesthetics, General|anesthetics, general|mesh-ancestor
6698006|NCT01707082|Anesthetics|anesthetics|mesh-ancestor
6698007|NCT01707082|GABA Modulators|gaba modulators|mesh-ancestor
6698008|NCT01707082|GABA Agents|gaba agents|mesh-ancestor
6698009|NCT01707082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6698010|NCT01707082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698011|NCT01707134|Insulin|insulin|mesh-list
6698012|NCT01707134|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6698013|NCT01707134|Insulin Aspart|insulin aspart|mesh-list
6698014|NCT01707134|Isophane Insulin, Human|isophane insulin, human|mesh-list
6698015|NCT01707134|Insulin, Isophane|insulin, isophane|mesh-list
6698016|NCT01707134|Isophane insulin, beef|isophane insulin, beef|mesh-list
6698017|NCT01707134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6698018|NCT01707134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698019|NCT01707160|Insulin|insulin|mesh-list
6698020|NCT01707160|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6698021|NCT01707160|Insulin Aspart|insulin aspart|mesh-list
6698022|NCT01707160|Biphasic Insulins|biphasic insulins|mesh-list
6698023|NCT01707160|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6698024|NCT01707160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6698025|NCT01707160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698026|NCT01707199|Artesunate|artesunate|mesh-list
6698027|NCT01707199|Pyrimethamine|pyrimethamine|mesh-list
6698028|NCT01707199|Sulfadoxine|sulfadoxine|mesh-list
6698029|NCT01707199|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6698030|NCT01707199|Antimalarials|antimalarials|mesh-ancestor
6698031|NCT01707199|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6698032|NCT01707199|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6698033|NCT01707199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6698034|NCT01707199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6698035|NCT01707199|Antiviral Agents|antiviral agents|mesh-ancestor
6698036|NCT01707199|Schistosomicides|schistosomicides|mesh-ancestor
6698037|NCT01707199|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6698038|NCT01707199|Anthelmintics|anthelmintics|mesh-ancestor
6698039|NCT01707199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6698040|NCT01707199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6698041|NCT01707199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698042|NCT01707199|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6698043|NCT01707199|Renal Agents|renal agents|mesh-ancestor
6698044|NCT01707251|Ibuprofen|ibuprofen|mesh-list
6698045|NCT01707251|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6698046|NCT01707251|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6698047|NCT01707251|Analgesics|analgesics|mesh-ancestor
6698048|NCT01707251|Sensory System Agents|sensory system agents|mesh-ancestor
6698049|NCT01707251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6698050|NCT01707251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698051|NCT01707251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6698052|NCT01707251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6698053|NCT01707251|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6698054|NCT01707251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6698055|NCT01707251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698056|NCT01707316|Canagliflozin|canagliflozin|mesh-list
6698057|NCT01707316|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6698058|NCT01707316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698059|NCT01707316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6698060|NCT01707316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698061|NCT01707342|Simeprevir|simeprevir|mesh-list
6698062|NCT01707342|Antiviral Agents|antiviral agents|mesh-ancestor
6698063|NCT01707342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6698064|NCT01707342|Protease Inhibitors|protease inhibitors|mesh-ancestor
6698065|NCT01707342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6698066|NCT01707342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698067|NCT01707394|Apixaban|apixaban|mesh-list
6698068|NCT01707394|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6698069|NCT01707394|Antithrombins|antithrombins|mesh-ancestor
6698070|NCT01707394|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6698071|NCT01707394|Protease Inhibitors|protease inhibitors|mesh-ancestor
6698072|NCT01707394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6698073|NCT01707394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698074|NCT01707394|Anticoagulants|anticoagulants|mesh-ancestor
6698075|NCT01707407|Ketoconazole|ketoconazole|mesh-list
6698076|NCT01707407|Pomalidomide|pomalidomide|mesh-list
6698077|NCT01707407|Carbamazepine|carbamazepine|mesh-list
6698078|NCT01707407|Fluvoxamine|fluvoxamine|mesh-list
6698079|NCT01707407|Immunologic Factors|immunologic factors|mesh-ancestor
6698080|NCT01707407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698081|NCT01707407|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6698082|NCT01707407|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6698083|NCT01707407|Growth Substances|growth substances|mesh-ancestor
6698084|NCT01707407|Growth Inhibitors|growth inhibitors|mesh-ancestor
6698085|NCT01707407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6698086|NCT01707407|Antifungal Agents|antifungal agents|mesh-ancestor
6698087|NCT01707407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6698088|NCT01707407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6698089|NCT01707407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6698090|NCT01707407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6698091|NCT01707407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698092|NCT01707407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6698093|NCT01707407|Hormone Antagonists|hormone antagonists|mesh-ancestor
6698094|NCT01707407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6698095|NCT01707407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6698096|NCT01707407|Anticonvulsants|anticonvulsants|mesh-ancestor
6698097|NCT01707407|Antimanic Agents|antimanic agents|mesh-ancestor
6698098|NCT01707407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6698099|NCT01707407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6698100|NCT01707407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6698101|NCT01707407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6698102|NCT01707407|Analgesics|analgesics|mesh-ancestor
6698103|NCT01707407|Sensory System Agents|sensory system agents|mesh-ancestor
6698104|NCT01707407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6698105|NCT01707407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6698106|NCT01707407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6698107|NCT01707407|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6698108|NCT01707407|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6698109|NCT01707407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6698110|NCT01707407|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6698111|NCT01707407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6698112|NCT01707407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6698113|NCT01707407|Serotonin Agents|serotonin agents|mesh-ancestor
6698114|NCT01707407|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6698115|NCT01707407|Antidepressive Agents|antidepressive agents|mesh-ancestor
6698116|NCT01707407|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6698117|NCT01707407|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6698118|NCT01707537|Vaccines|vaccines|mesh-list
6698119|NCT01707537|Immunologic Factors|immunologic factors|mesh-ancestor
6698120|NCT01707537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698121|NCT01707615|Proanthocyanidin|proanthocyanidin|mesh-list
6698122|NCT01707615|Antioxidants|antioxidants|mesh-ancestor
6698123|NCT01707615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698124|NCT01707615|Protective Agents|protective agents|mesh-ancestor
6698125|NCT01707615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698126|NCT01707615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6698127|NCT01707615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6698128|NCT01707615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6698129|NCT01707628|Vaccines|vaccines|mesh-list
6698130|NCT01707628|Immunologic Factors|immunologic factors|mesh-ancestor
6698131|NCT01707628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698132|NCT01707732|Enoxaparin|enoxaparin|mesh-list
6698133|NCT01707732|Anticoagulants|anticoagulants|mesh-ancestor
6698134|NCT01707732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6698135|NCT01707732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6698136|NCT01707732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698137|NCT01707745|Bevacizumab|bevacizumab|mesh-list
6698138|NCT01707745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6698139|NCT01707745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6698140|NCT01707745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6698141|NCT01707745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6698142|NCT01707745|Growth Substances|growth substances|mesh-ancestor
6698143|NCT01707745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698144|NCT01707745|Growth Inhibitors|growth inhibitors|mesh-ancestor
6698145|NCT01707823|Aspirin|aspirin|mesh-list
6698146|NCT01707823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6698147|NCT01707823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6698148|NCT01707823|Analgesics|analgesics|mesh-ancestor
6698149|NCT01707823|Sensory System Agents|sensory system agents|mesh-ancestor
6698150|NCT01707823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6698151|NCT01707823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698152|NCT01707823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6698153|NCT01707823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6698154|NCT01707823|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6698155|NCT01707823|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6698156|NCT01707823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698157|NCT01707823|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6698158|NCT01707823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6698159|NCT01707823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6698160|NCT01707823|Antipyretics|antipyretics|mesh-ancestor
6698161|NCT01707849|Everolimus|everolimus|mesh-list
6698162|NCT01707849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6698163|NCT01707849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6698164|NCT01707849|Immunologic Factors|immunologic factors|mesh-ancestor
6698165|NCT01707849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698166|NCT01707940|Ketoconazole|ketoconazole|mesh-list
6698167|NCT01707940|Antifungal Agents|antifungal agents|mesh-ancestor
6698168|NCT01707940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6698169|NCT01707940|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6698170|NCT01707940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6698171|NCT01707940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6698172|NCT01707940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698173|NCT01707940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6698174|NCT01707940|Hormone Antagonists|hormone antagonists|mesh-ancestor
6698175|NCT01707940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6698176|NCT01707940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698177|NCT01707940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6698178|NCT01707953|Midodrine|midodrine|mesh-list
6698179|NCT01707953|Sympathomimetics|sympathomimetics|mesh-ancestor
6698180|NCT01707953|Autonomic Agents|autonomic agents|mesh-ancestor
6698181|NCT01707953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6698182|NCT01707953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698183|NCT01707953|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6698184|NCT01707953|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6698185|NCT01707953|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6698186|NCT01707953|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6698187|NCT01707953|Adrenergic Agents|adrenergic agents|mesh-ancestor
6698188|NCT01707953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6698189|NCT01707953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698190|NCT01708005|Vitamin D|vitamin d|mesh-list
6698191|NCT01708005|Cholecalciferol|cholecalciferol|mesh-list
6698192|NCT01708005|Vitamins|vitamins|mesh-ancestor
6698193|NCT01708005|Micronutrients|micronutrients|mesh-ancestor
6698194|NCT01708005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698195|NCT01708005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6698196|NCT01708005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6698197|NCT01708044|Pramlintide|pramlintide|mesh-list
6698198|NCT01708044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6698199|NCT01708044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698200|NCT01708239|Fibrin fragment D|fibrin fragment d|mesh-list
6698201|NCT01708239|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6698202|NCT01708239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6698203|NCT01708239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698204|NCT01708239|Hemostatics|hemostatics|mesh-ancestor
6698205|NCT01708239|Coagulants|coagulants|mesh-ancestor
6698206|NCT01708330|Lidocaine|lidocaine|mesh-list
6698207|NCT01708330|Anesthetics, Local|anesthetics, local|mesh-ancestor
6698208|NCT01708330|Anesthetics|anesthetics|mesh-ancestor
6698209|NCT01708330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6698210|NCT01708330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698211|NCT01708330|Sensory System Agents|sensory system agents|mesh-ancestor
6698212|NCT01708330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6698213|NCT01708330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6698214|NCT01708330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6698215|NCT01708330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6698216|NCT01708330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6698217|NCT01708330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698218|NCT01708369|Aspirin|aspirin|mesh-list
6698219|NCT01708369|Ethanol|ethanol|mesh-list
6698220|NCT01708369|Oseltamivir|oseltamivir|mesh-list
6698221|NCT01708369|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6698222|NCT01708369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6698223|NCT01708369|Analgesics|analgesics|mesh-ancestor
6698224|NCT01708369|Sensory System Agents|sensory system agents|mesh-ancestor
6698225|NCT01708369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6698226|NCT01708369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698227|NCT01708369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6698228|NCT01708369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6698229|NCT01708369|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6698230|NCT01708369|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6698231|NCT01708369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698232|NCT01708369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6698233|NCT01708369|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6698234|NCT01708369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6698235|NCT01708369|Antipyretics|antipyretics|mesh-ancestor
6698236|NCT01708369|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6698237|NCT01708369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6698238|NCT01708369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6698239|NCT01708369|Antiviral Agents|antiviral agents|mesh-ancestor
6698240|NCT01708447|Lidocaine|lidocaine|mesh-list
6698241|NCT01708447|Anesthetics, Local|anesthetics, local|mesh-list
6698242|NCT01708447|Anesthetics|anesthetics|mesh-list
6698243|NCT01708447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6698244|NCT01708447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698245|NCT01708447|Sensory System Agents|sensory system agents|mesh-ancestor
6698246|NCT01708447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6698247|NCT01708447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6698248|NCT01708447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6698249|NCT01708447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6698250|NCT01708447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6698251|NCT01708447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698252|NCT01708616|Risperidone|risperidone|mesh-list
6698253|NCT01708616|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6698254|NCT01708616|Serotonin Agents|serotonin agents|mesh-ancestor
6698255|NCT01708616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6698256|NCT01708616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698257|NCT01708616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698258|NCT01708616|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6698259|NCT01708616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6698260|NCT01708616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6698261|NCT01708616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6698262|NCT01708616|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6698263|NCT01708616|Dopamine Agents|dopamine agents|mesh-ancestor
6698264|NCT01708642|Epinephrine|epinephrine|mesh-list
6698265|NCT01708642|Racepinephrine|racepinephrine|mesh-list
6698266|NCT01708642|Epinephryl borate|epinephryl borate|mesh-list
6698267|NCT01708642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6698268|NCT01708642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6698269|NCT01708642|Adrenergic Agents|adrenergic agents|mesh-ancestor
6698270|NCT01708642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6698271|NCT01708642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698272|NCT01708642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698273|NCT01708642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6698274|NCT01708642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6698275|NCT01708642|Autonomic Agents|autonomic agents|mesh-ancestor
6698276|NCT01708642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6698277|NCT01708642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6698278|NCT01708642|Respiratory System Agents|respiratory system agents|mesh-ancestor
6698279|NCT01708642|Mydriatics|mydriatics|mesh-ancestor
6698280|NCT01708642|Sympathomimetics|sympathomimetics|mesh-ancestor
6698281|NCT01708642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6781384|NCT02185430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6781385|NCT02185430|Analgesics|analgesics|mesh-ancestor
6781386|NCT02185430|Sensory System Agents|sensory system agents|mesh-ancestor
6781387|NCT02185430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6781388|NCT02185430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6781389|NCT02185430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6781390|NCT02185430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6781391|NCT02185430|Adrenergic Agents|adrenergic agents|mesh-ancestor
6781392|NCT02185430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6781393|NCT02185430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781394|NCT02185456|Metronidazole|metronidazole|mesh-list
6781395|NCT02185456|Miconazole|miconazole|mesh-list
6781396|NCT02185456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6781397|NCT02185456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6781398|NCT02185456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6781399|NCT02185456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6781400|NCT02185456|Antifungal Agents|antifungal agents|mesh-ancestor
6781401|NCT02185456|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6781402|NCT02185456|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6781403|NCT02185456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6781404|NCT02185456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781405|NCT02185456|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6781406|NCT02185456|Hormone Antagonists|hormone antagonists|mesh-ancestor
6781407|NCT02185456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6781408|NCT02185456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781409|NCT02185456|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6781410|NCT02185456|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6781411|NCT02185547|Sertraline|sertraline|mesh-list
6781412|NCT02185547|Antidepressive Agents|antidepressive agents|mesh-ancestor
6781413|NCT02185547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6781414|NCT02185547|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6781415|NCT02185547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6781416|NCT02185547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6781417|NCT02185547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781418|NCT02185547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6781419|NCT02185547|Serotonin Agents|serotonin agents|mesh-ancestor
6781420|NCT02185547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781421|NCT02185638|Appetite Depressants|appetite depressants|mesh-list
6781422|NCT02185638|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6781423|NCT02185651|Miglustat|miglustat|mesh-list
6781424|NCT02185651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6781425|NCT02185651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781426|NCT02185651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6781427|NCT02185651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6781428|NCT02185651|Antiviral Agents|antiviral agents|mesh-ancestor
6781429|NCT02185651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6781430|NCT02185651|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6781431|NCT02185651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6781432|NCT02185651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781433|NCT02185690|Carboplatin|carboplatin|mesh-list
6781434|NCT02185690|Pemetrexed|pemetrexed|mesh-list
6781435|NCT02185690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6781436|NCT02185690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6781437|NCT02185690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781438|NCT02185690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6781439|NCT02185690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6781440|NCT02185716|Levobupivacaine|levobupivacaine|mesh-list
6781441|NCT02185716|Anesthetics, Local|anesthetics, local|mesh-ancestor
6781442|NCT02185716|Anesthetics|anesthetics|mesh-ancestor
6781443|NCT02185716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6781444|NCT02185716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781445|NCT02185716|Sensory System Agents|sensory system agents|mesh-ancestor
6781446|NCT02185716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6781447|NCT02185768|Idarubicin|idarubicin|mesh-list
6781448|NCT02185768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6781449|NCT02185768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6781450|NCT02185768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6698282|NCT01708707|Morphine|morphine|mesh-list
6698283|NCT01708707|Buprenorphine|buprenorphine|mesh-list
6698284|NCT01708707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6698285|NCT01708707|Narcotics|narcotics|mesh-ancestor
6698286|NCT01708707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6698287|NCT01708707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698288|NCT01708707|Analgesics|analgesics|mesh-ancestor
6698289|NCT01708707|Sensory System Agents|sensory system agents|mesh-ancestor
6698290|NCT01708707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6698291|NCT01708707|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6698292|NCT01708720|Vaccines|vaccines|mesh-list
6698293|NCT01708720|Immunologic Factors|immunologic factors|mesh-ancestor
6698294|NCT01708720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698295|NCT01708798|Eplerenone|eplerenone|mesh-list
6698296|NCT01708798|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6698297|NCT01708798|Hormone Antagonists|hormone antagonists|mesh-ancestor
6698298|NCT01708798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6698299|NCT01708798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698300|NCT01708798|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6698301|NCT01708798|Diuretics|diuretics|mesh-ancestor
6698302|NCT01708798|Natriuretic Agents|natriuretic agents|mesh-ancestor
6698303|NCT01708798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6698304|NCT01708837|Propofol|propofol|mesh-list
6698305|NCT01708837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6698306|NCT01708837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6698307|NCT01708837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698308|NCT01708837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6698309|NCT01708837|Anesthetics, General|anesthetics, general|mesh-ancestor
6698310|NCT01708837|Anesthetics|anesthetics|mesh-ancestor
6698311|NCT01708850|Rivaroxaban|rivaroxaban|mesh-list
6698312|NCT01708850|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6698313|NCT01708850|Antithrombins|antithrombins|mesh-ancestor
6698314|NCT01708850|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6698315|NCT01708850|Protease Inhibitors|protease inhibitors|mesh-ancestor
6698316|NCT01708850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6698317|NCT01708850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698318|NCT01708850|Anticoagulants|anticoagulants|mesh-ancestor
6698319|NCT01708876|Artesunate|artesunate|mesh-list
6698320|NCT01708876|Chloroquine|chloroquine|mesh-list
6698321|NCT01708876|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
6698322|NCT01708876|Primaquine|primaquine|mesh-list
6698323|NCT01708876|Mefloquine|mefloquine|mesh-list
6698324|NCT01708876|Antimalarials|antimalarials|mesh-ancestor
6698325|NCT01708876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6698326|NCT01708876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6698327|NCT01708876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6698328|NCT01708876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6698329|NCT01708876|Antiviral Agents|antiviral agents|mesh-ancestor
6698330|NCT01708876|Schistosomicides|schistosomicides|mesh-ancestor
6698331|NCT01708876|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6698332|NCT01708876|Anthelmintics|anthelmintics|mesh-ancestor
6698333|NCT01708876|Amebicides|amebicides|mesh-ancestor
6698334|NCT01708876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6698335|NCT01708876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6698336|NCT01708876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6698337|NCT01708876|Analgesics|analgesics|mesh-ancestor
6698338|NCT01708876|Sensory System Agents|sensory system agents|mesh-ancestor
6698339|NCT01708876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6698340|NCT01708876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698341|NCT01708876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6698342|NCT01708876|Filaricides|filaricides|mesh-ancestor
6698343|NCT01708876|Antinematodal Agents|antinematodal agents|mesh-ancestor
6698344|NCT01708993|Docetaxel|docetaxel|mesh-list
6698345|NCT01708993|Pemetrexed|pemetrexed|mesh-list
6698346|NCT01708993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6698347|NCT01708993|Tubulin Modulators|tubulin modulators|mesh-ancestor
6698348|NCT01708993|Antimitotic Agents|antimitotic agents|mesh-ancestor
6698349|NCT01708993|Mitosis Modulators|mitosis modulators|mesh-ancestor
6698350|NCT01708993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698351|NCT01708993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6698352|NCT01708993|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6698353|NCT01708993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6698354|NCT01709019|Vaccines|vaccines|mesh-list
6698355|NCT01709019|Immunologic Factors|immunologic factors|mesh-ancestor
6698356|NCT01709019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698357|NCT01709071|Vaccines|vaccines|mesh-list
6698358|NCT01709071|Immunologic Factors|immunologic factors|mesh-ancestor
6698359|NCT01709071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698360|NCT01709123|Chromium|chromium|mesh-list
6698361|NCT01709123|Trace Elements|trace elements|mesh-ancestor
6698362|NCT01709123|Micronutrients|micronutrients|mesh-ancestor
6698363|NCT01709123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698364|NCT01709292|Vemurafenib|vemurafenib|mesh-list
6698365|NCT01709292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6698366|NCT01709292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6698367|NCT01709292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6698368|NCT01709292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698369|NCT01709370|Letrozole|letrozole|mesh-list
6698370|NCT01709370|Palbociclib|palbociclib|mesh-list
6698371|NCT01709370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6698372|NCT01709370|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6698373|NCT01709370|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6698374|NCT01709370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6698375|NCT01709370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698376|NCT01709370|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6698377|NCT01709370|Hormone Antagonists|hormone antagonists|mesh-ancestor
6698378|NCT01709370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6698379|NCT01709370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698380|NCT01709370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6698381|NCT01709630|Magnesium Sulfate|magnesium sulfate|mesh-list
6698382|NCT01709630|Analgesics|analgesics|mesh-ancestor
6698383|NCT01709630|Sensory System Agents|sensory system agents|mesh-ancestor
6698384|NCT01709630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6698385|NCT01709630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698386|NCT01709630|Anesthetics|anesthetics|mesh-ancestor
6698387|NCT01709630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6698388|NCT01709630|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6698389|NCT01709630|Anticonvulsants|anticonvulsants|mesh-ancestor
6698390|NCT01709630|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6698391|NCT01709630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6698392|NCT01709630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698393|NCT01709630|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6698394|NCT01709630|Tocolytic Agents|tocolytic agents|mesh-ancestor
6698395|NCT01709630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6698396|NCT01709656|Celecoxib|celecoxib|mesh-list
6698397|NCT01709656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6698398|NCT01709656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6698399|NCT01709656|Analgesics|analgesics|mesh-ancestor
6698400|NCT01709656|Sensory System Agents|sensory system agents|mesh-ancestor
6698401|NCT01709656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6698402|NCT01709656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698403|NCT01709656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6698404|NCT01709656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6698405|NCT01709656|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6698406|NCT01709656|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6698407|NCT01709656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6698408|NCT01709656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698409|NCT01709682|Amiodarone|amiodarone|mesh-list
6698410|NCT01709682|Sotalol|sotalol|mesh-list
6698411|NCT01709682|Flecainide|flecainide|mesh-list
6698412|NCT01709682|Propafenone|propafenone|mesh-list
6698413|NCT01709682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
6698414|NCT01709682|Vasodilator Agents|vasodilator agents|mesh-ancestor
6698415|NCT01709682|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6698416|NCT01709682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6698417|NCT01709682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698418|NCT01709682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6698419|NCT01709682|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6698420|NCT01709682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6698421|NCT01709682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6698422|NCT01709682|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6698423|NCT01709682|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6698424|NCT01709682|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6698425|NCT01709682|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6698426|NCT01709682|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6698427|NCT01709682|Adrenergic Agents|adrenergic agents|mesh-ancestor
6698428|NCT01709682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6698429|NCT01709682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698430|NCT01709682|Sympatholytics|sympatholytics|mesh-ancestor
6698431|NCT01709682|Autonomic Agents|autonomic agents|mesh-ancestor
6698432|NCT01709682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6698433|NCT01709682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6698434|NCT01709734|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
6698435|NCT01709734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6698436|NCT01709734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698437|NCT01709760|Methotrexate|methotrexate|mesh-list
6698438|NCT01709760|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6698439|NCT01709760|Abortifacient Agents|abortifacient agents|mesh-ancestor
6698440|NCT01709760|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6698441|NCT01709760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698442|NCT01709760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6698443|NCT01709760|Antimetabolites|antimetabolites|mesh-ancestor
6698444|NCT01709760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698445|NCT01709760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6698446|NCT01709760|Dermatologic Agents|dermatologic agents|mesh-ancestor
6698447|NCT01709760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6698448|NCT01709760|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6698449|NCT01709760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6698450|NCT01709760|Immunologic Factors|immunologic factors|mesh-ancestor
6698451|NCT01709760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6698452|NCT01709760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6698453|NCT01709825|Sulfalene|sulfalene|mesh-list
6698454|NCT01709825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6698455|NCT01709825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6698456|NCT01709825|Renal Agents|renal agents|mesh-ancestor
6698457|NCT01709825|Antimalarials|antimalarials|mesh-ancestor
6698458|NCT01709825|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6698459|NCT01709825|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6698460|NCT01709929|Insulin Detemir|insulin detemir|mesh-list
6698461|NCT01709929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6698462|NCT01709929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698463|NCT01709942|Cetrorelix|cetrorelix|mesh-list
6698464|NCT01709942|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6698465|NCT01709942|Fertility Agents|fertility agents|mesh-ancestor
6698466|NCT01709942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6698467|NCT01709942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698468|NCT01709942|Hormone Antagonists|hormone antagonists|mesh-ancestor
6698469|NCT01709942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6698470|NCT01709955|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
6698471|NCT01709955|Cathartics|cathartics|mesh-ancestor
6698472|NCT01709955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6698473|NCT01709994|Aspirin|aspirin|mesh-list
6698474|NCT01709994|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6698475|NCT01709994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6698476|NCT01709994|Analgesics|analgesics|mesh-ancestor
6698477|NCT01709994|Sensory System Agents|sensory system agents|mesh-ancestor
6698478|NCT01709994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6698479|NCT01709994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698480|NCT01709994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6698481|NCT01709994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6698482|NCT01709994|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6698483|NCT01709994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6698484|NCT01709994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698485|NCT01709994|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6698486|NCT01709994|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6698487|NCT01709994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6698488|NCT01709994|Antipyretics|antipyretics|mesh-ancestor
6698489|NCT01710007|Atorvastatin|atorvastatin|mesh-list
6698490|NCT01710007|Pitavastatin|pitavastatin|mesh-list
6698491|NCT01710007|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6698492|NCT01710007|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6698493|NCT01710007|Antimetabolites|antimetabolites|mesh-ancestor
6698494|NCT01710007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698495|NCT01710007|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6698496|NCT01710007|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6698497|NCT01710007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6698498|NCT01710059|Adrenergic Agents|adrenergic agents|mesh-list
6698499|NCT01710059|Adrenergic Agonists|adrenergic agonists|mesh-list
6698500|NCT01710059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6698501|NCT01710059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698502|NCT01710059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698503|NCT01710072|Aspirin|aspirin|mesh-list
6698504|NCT01710072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6698505|NCT01710072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6698506|NCT01710072|Analgesics|analgesics|mesh-ancestor
6698507|NCT01710072|Sensory System Agents|sensory system agents|mesh-ancestor
6698508|NCT01710072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6698509|NCT01710072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698510|NCT01710072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6698511|NCT01710072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6698512|NCT01710072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6698513|NCT01710072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6698514|NCT01710072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698515|NCT01710072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6698516|NCT01710072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6698517|NCT01710072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6698518|NCT01710072|Antipyretics|antipyretics|mesh-ancestor
6698519|NCT01710163|Aripiprazole|aripiprazole|mesh-list
6698520|NCT01710163|Antidepressive Agents|antidepressive agents|mesh-ancestor
6698521|NCT01710163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6698522|NCT01710163|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6698523|NCT01710163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6698524|NCT01710163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6698525|NCT01710163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698526|NCT01710163|Dopamine Agonists|dopamine agonists|mesh-ancestor
6698527|NCT01710163|Dopamine Agents|dopamine agents|mesh-ancestor
6698528|NCT01710163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6698529|NCT01710163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698530|NCT01710163|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6698531|NCT01710163|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6698532|NCT01710163|Serotonin Agents|serotonin agents|mesh-ancestor
6698533|NCT01710163|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6698534|NCT01710163|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6698535|NCT01710163|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6698536|NCT01710163|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6698537|NCT01710202|Hydrocortisone|hydrocortisone|mesh-list
6698538|NCT01710202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6698539|NCT01710228|Methylprednisolone|methylprednisolone|mesh-list
6698540|NCT01710228|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6698541|NCT01710228|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6698542|NCT01710228|Prednisolone|prednisolone|mesh-list
6698543|NCT01710228|Prednisolone acetate|prednisolone acetate|mesh-list
6698544|NCT01710228|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6698545|NCT01710228|Prednisolone phosphate|prednisolone phosphate|mesh-list
6698546|NCT01710228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6698547|NCT01710228|Antiemetics|antiemetics|mesh-ancestor
6698548|NCT01710228|Autonomic Agents|autonomic agents|mesh-ancestor
6698549|NCT01710228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6698550|NCT01710228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698551|NCT01710228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6698552|NCT01710228|Glucocorticoids|glucocorticoids|mesh-ancestor
6698553|NCT01710228|Hormones|hormones|mesh-ancestor
6698554|NCT01710228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6698555|NCT01710228|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6698556|NCT01710228|Protective Agents|protective agents|mesh-ancestor
6698557|NCT01710228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6698558|NCT01710228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6698559|NCT01710384|Betamethasone|betamethasone|mesh-list
6698560|NCT01710384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6698561|NCT01710384|Glucocorticoids|glucocorticoids|mesh-ancestor
6698562|NCT01710384|Hormones|hormones|mesh-ancestor
6698563|NCT01710384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6698564|NCT01710384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698565|NCT01710384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6698566|NCT01710384|Respiratory System Agents|respiratory system agents|mesh-ancestor
6698567|NCT01710462|Domperidone|domperidone|mesh-list
6698568|NCT01710462|Pantoprazole|pantoprazole|mesh-list
6698569|NCT01710462|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6698570|NCT01710462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6698571|NCT01710462|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6698572|NCT01710462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6698573|NCT01710462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698574|NCT01710462|Antiemetics|antiemetics|mesh-ancestor
6698575|NCT01710462|Autonomic Agents|autonomic agents|mesh-ancestor
6698576|NCT01710462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6698577|NCT01710462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698578|NCT01710462|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6698579|NCT01710462|Dopamine Agents|dopamine agents|mesh-ancestor
6698580|NCT01710462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6698581|NCT01710488|Levofloxacin|levofloxacin|mesh-list
6698582|NCT01710488|Ofloxacin|ofloxacin|mesh-list
6698583|NCT01710488|Prulifloxacin|prulifloxacin|mesh-list
6698584|NCT01710488|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6698585|NCT01710488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6698586|NCT01710488|Renal Agents|renal agents|mesh-ancestor
6698587|NCT01710488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6698588|NCT01710488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6698589|NCT01710488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6698590|NCT01710488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6698591|NCT01710488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698592|NCT01710488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6698593|NCT01710488|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6698594|NCT01710488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6698595|NCT01710540|Metformin|metformin|mesh-list
6698596|NCT01710540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6698597|NCT01710540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698598|NCT01710553|Metformin|metformin|mesh-list
6698599|NCT01710553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6698600|NCT01710553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698601|NCT01710566|Misoprostol|misoprostol|mesh-list
6698602|NCT01710566|Oxytocin|oxytocin|mesh-list
6698603|NCT01710566|Oxytocics|oxytocics|mesh-ancestor
6698604|NCT01710566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6698605|NCT01710566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698606|NCT01710566|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6698607|NCT01710566|Abortifacient Agents|abortifacient agents|mesh-ancestor
6698608|NCT01710566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6698609|NCT01710566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6781451|NCT02185768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6781452|NCT02185768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6781453|NCT02185768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781454|NCT02185820|Dexamethasone|dexamethasone|mesh-list
6781455|NCT02185820|Pomalidomide|pomalidomide|mesh-list
6781456|NCT02185820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6781457|NCT02185820|Antiemetics|antiemetics|mesh-ancestor
6781458|NCT02185820|Autonomic Agents|autonomic agents|mesh-ancestor
6781459|NCT02185820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6781460|NCT02185820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781461|NCT02185820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6781462|NCT02185820|Glucocorticoids|glucocorticoids|mesh-ancestor
6781463|NCT02185820|Hormones|hormones|mesh-ancestor
6781464|NCT02185820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6781465|NCT02185820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6781466|NCT02185820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6781467|NCT02185820|Immunologic Factors|immunologic factors|mesh-ancestor
6781468|NCT02185820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6781469|NCT02185820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6781470|NCT02185820|Growth Substances|growth substances|mesh-ancestor
6781471|NCT02185820|Growth Inhibitors|growth inhibitors|mesh-ancestor
6781472|NCT02185833|Dirithromycin|dirithromycin|mesh-list
6781473|NCT02185833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6781474|NCT02185833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6698610|NCT01710592|Docetaxel|docetaxel|mesh-list
6698611|NCT01710592|Capecitabine|capecitabine|mesh-list
6698612|NCT01710592|Oxaliplatin|oxaliplatin|mesh-list
6698613|NCT01710592|Epirubicin|epirubicin|mesh-list
6698614|NCT01710592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6698615|NCT01710592|Tubulin Modulators|tubulin modulators|mesh-ancestor
6698616|NCT01710592|Antimitotic Agents|antimitotic agents|mesh-ancestor
6698617|NCT01710592|Mitosis Modulators|mitosis modulators|mesh-ancestor
6698618|NCT01710592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698619|NCT01710592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6698620|NCT01710592|Antimetabolites|antimetabolites|mesh-ancestor
6698621|NCT01710592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6698622|NCT01710592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6698623|NCT01710592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6698624|NCT01710592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6698625|NCT01710631|Eszopiclone|eszopiclone|mesh-list
6698626|NCT01710631|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6698627|NCT01710631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6698628|NCT01710631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698629|NCT01710670|Ethanol|ethanol|mesh-list
6698630|NCT01710670|Brivaracetam|brivaracetam|mesh-list
6698631|NCT01710670|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6698632|NCT01710670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6698633|NCT01710670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6698634|NCT01710670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698635|NCT01710670|Anticonvulsants|anticonvulsants|mesh-ancestor
6698636|NCT01710696|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6698637|NCT01710696|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6698638|NCT01710696|Estradiol|estradiol|mesh-list
6698639|NCT01710696|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6698640|NCT01710696|Estrogens|estrogens|mesh-ancestor
6698641|NCT01710696|Hormones|hormones|mesh-ancestor
6698642|NCT01710696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6698643|NCT01710696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698644|NCT01710696|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6698645|NCT01710696|Contraceptive Agents|contraceptive agents|mesh-ancestor
6698646|NCT01710696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6698647|NCT01710696|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6698648|NCT01710722|Ephedrine|ephedrine|mesh-list
6698649|NCT01710722|Pseudoephedrine|pseudoephedrine|mesh-list
6698650|NCT01710722|Caffeine|caffeine|mesh-list
6698651|NCT01710722|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6698652|NCT01710722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698653|NCT01710722|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6698654|NCT01710722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6698655|NCT01710722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698656|NCT01710722|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6698657|NCT01710722|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6698658|NCT01710722|Purinergic Agents|purinergic agents|mesh-ancestor
6698659|NCT01710722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6698660|NCT01710722|Sympathomimetics|sympathomimetics|mesh-ancestor
6698661|NCT01710722|Autonomic Agents|autonomic agents|mesh-ancestor
6698662|NCT01710722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6698663|NCT01710722|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6698664|NCT01710722|Adrenergic Agents|adrenergic agents|mesh-ancestor
6698665|NCT01710722|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6698666|NCT01710722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6698667|NCT01710722|Respiratory System Agents|respiratory system agents|mesh-ancestor
6698668|NCT01710722|Nasal Decongestants|nasal decongestants|mesh-ancestor
6698669|NCT01710748|Everolimus|everolimus|mesh-list
6698670|NCT01710748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6698671|NCT01710748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6698672|NCT01710748|Immunologic Factors|immunologic factors|mesh-ancestor
6698673|NCT01710748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698674|NCT01710761|Caffeine|caffeine|mesh-list
6698675|NCT01710761|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6698676|NCT01710761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698677|NCT01710761|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6698678|NCT01710761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6698679|NCT01710761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698680|NCT01710761|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6698681|NCT01710761|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6698682|NCT01710761|Purinergic Agents|purinergic agents|mesh-ancestor
6698683|NCT01710761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6698684|NCT01710904|Oxycodone|oxycodone|mesh-list
6698685|NCT01710904|Naloxone|naloxone|mesh-list
6698686|NCT01710904|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6698687|NCT01710904|Narcotics|narcotics|mesh-ancestor
6698688|NCT01710904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6698689|NCT01710904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698690|NCT01710904|Analgesics|analgesics|mesh-ancestor
6698691|NCT01710904|Sensory System Agents|sensory system agents|mesh-ancestor
6698692|NCT01710904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6698693|NCT01710904|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6698694|NCT01710995|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
6698695|NCT01710995|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6698696|NCT01710995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6698697|NCT01710995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698698|NCT01711060|Oxytocin|oxytocin|mesh-list
6698699|NCT01711060|Oxytocics|oxytocics|mesh-ancestor
6698700|NCT01711060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6698701|NCT01711060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698702|NCT01711073|Plerixafor|plerixafor|mesh-list
6698703|NCT01711073|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6698704|NCT01711073|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6698705|NCT01711073|Antiviral Agents|antiviral agents|mesh-ancestor
6698706|NCT01711073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6698707|NCT01711086|Formoterol Fumarate|formoterol fumarate|mesh-list
6698708|NCT01711086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6698709|NCT01711086|Autonomic Agents|autonomic agents|mesh-ancestor
6698710|NCT01711086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6698711|NCT01711086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698712|NCT01711086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6698713|NCT01711086|Respiratory System Agents|respiratory system agents|mesh-ancestor
6698714|NCT01711086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6698715|NCT01711086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6698716|NCT01711086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6698717|NCT01711086|Adrenergic Agents|adrenergic agents|mesh-ancestor
6698718|NCT01711086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6698719|NCT01711086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698720|NCT01711112|Docetaxel|docetaxel|mesh-list
6698721|NCT01711112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6698722|NCT01711112|Tubulin Modulators|tubulin modulators|mesh-ancestor
6698723|NCT01711112|Antimitotic Agents|antimitotic agents|mesh-ancestor
6698724|NCT01711112|Mitosis Modulators|mitosis modulators|mesh-ancestor
6698725|NCT01711112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698726|NCT01711125|Baclofen|baclofen|mesh-list
6698727|NCT01711125|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6698728|NCT01711125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698729|NCT01711125|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6698730|NCT01711125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6698731|NCT01711125|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6698732|NCT01711125|GABA Agonists|gaba agonists|mesh-ancestor
6698733|NCT01711125|GABA Agents|gaba agents|mesh-ancestor
6698734|NCT01711125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6698735|NCT01711125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698736|NCT01711229|Acetaminophen|acetaminophen|mesh-list
6698737|NCT01711229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6698738|NCT01711229|Analgesics|analgesics|mesh-ancestor
6698739|NCT01711229|Sensory System Agents|sensory system agents|mesh-ancestor
6698740|NCT01711229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6698741|NCT01711229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698742|NCT01711229|Antipyretics|antipyretics|mesh-ancestor
6698743|NCT01711242|Capecitabine|capecitabine|mesh-list
6698744|NCT01711242|Oxaliplatin|oxaliplatin|mesh-list
6698745|NCT01711242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6698746|NCT01711242|Antimetabolites|antimetabolites|mesh-ancestor
6698747|NCT01711242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698748|NCT01711242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6698749|NCT01711320|Omeprazole|omeprazole|mesh-list
6698750|NCT01711320|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6698751|NCT01711320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6698752|NCT01711320|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6698753|NCT01711320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6698754|NCT01711320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698755|NCT01711437|Ascorbic Acid|ascorbic acid|mesh-list
6698756|NCT01711437|Simethicone|simethicone|mesh-list
6698757|NCT01711437|Picosulfate sodium|picosulfate sodium|mesh-list
6698758|NCT01711437|Magnesium Oxide|magnesium oxide|mesh-list
6698759|NCT01711437|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
6698760|NCT01711437|Citric Acid|citric acid|mesh-list
6698761|NCT01711437|Sodium Citrate|sodium citrate|mesh-list
6698762|NCT01711437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6698763|NCT01711437|Anticoagulants|anticoagulants|mesh-ancestor
6698764|NCT01711437|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6698765|NCT01711437|Chelating Agents|chelating agents|mesh-ancestor
6698766|NCT01711437|Sequestering Agents|sequestering agents|mesh-ancestor
6698767|NCT01711437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698768|NCT01711437|Antioxidants|antioxidants|mesh-ancestor
6698769|NCT01711437|Protective Agents|protective agents|mesh-ancestor
6698770|NCT01711437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698771|NCT01711437|Vitamins|vitamins|mesh-ancestor
6698772|NCT01711437|Micronutrients|micronutrients|mesh-ancestor
6698773|NCT01711437|Antifoaming Agents|antifoaming agents|mesh-ancestor
6698774|NCT01711437|Emollients|emollients|mesh-ancestor
6698775|NCT01711437|Dermatologic Agents|dermatologic agents|mesh-ancestor
6698776|NCT01711437|Cathartics|cathartics|mesh-ancestor
6698777|NCT01711437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6698778|NCT01711437|Antacids|antacids|mesh-ancestor
6698779|NCT01711437|Laxatives|laxatives|mesh-ancestor
6698780|NCT01711463|Fluticasone|fluticasone|mesh-list
6698781|NCT01711463|Xhance|xhance|mesh-list
6698782|NCT01711463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6698783|NCT01711463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6698784|NCT01711463|Autonomic Agents|autonomic agents|mesh-ancestor
6698785|NCT01711463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6698786|NCT01711463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698787|NCT01711463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6698788|NCT01711463|Respiratory System Agents|respiratory system agents|mesh-ancestor
6698789|NCT01711463|Dermatologic Agents|dermatologic agents|mesh-ancestor
6698790|NCT01711463|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6698791|NCT01711476|Complement Factor H|complement factor h|mesh-list
6698792|NCT01711476|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6698793|NCT01711476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6698794|NCT01711476|Immunologic Factors|immunologic factors|mesh-ancestor
6698795|NCT01711476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698796|NCT01711489|Mycophenolic Acid|mycophenolic acid|mesh-list
6698797|NCT01711489|Isavuconazole|isavuconazole|mesh-list
6698798|NCT01711489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6698799|NCT01711489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6698800|NCT01711489|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6698801|NCT01711489|Antitubercular Agents|antitubercular agents|mesh-ancestor
6698802|NCT01711489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6698803|NCT01711489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6698804|NCT01711489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6698805|NCT01711489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698806|NCT01711489|Antifungal Agents|antifungal agents|mesh-ancestor
6698807|NCT01711515|Cisplatin|cisplatin|mesh-list
6698808|NCT01711515|Ipilimumab|ipilimumab|mesh-list
6698809|NCT01711515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6698810|NCT01711515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6698811|NCT01711515|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6698812|NCT01711515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698813|NCT01711528|Dexamethasone|dexamethasone|mesh-list
6698814|NCT01711528|Dexamethasone acetate|dexamethasone acetate|mesh-list
6698815|NCT01711528|Bortezomib|bortezomib|mesh-list
6698816|NCT01711528|Ichthammol|ichthammol|mesh-list
6698817|NCT01711528|BB 1101|bb 1101|mesh-list
6698818|NCT01711528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6698819|NCT01711528|Antiemetics|antiemetics|mesh-ancestor
6698820|NCT01711528|Autonomic Agents|autonomic agents|mesh-ancestor
6698821|NCT01711528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6698822|NCT01711528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698823|NCT01711528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6698824|NCT01711528|Glucocorticoids|glucocorticoids|mesh-ancestor
6698825|NCT01711528|Hormones|hormones|mesh-ancestor
6698826|NCT01711528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6698827|NCT01711528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6698828|NCT01711528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6698829|NCT01711528|Protease Inhibitors|protease inhibitors|mesh-ancestor
6698830|NCT01711528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6698831|NCT01711528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698832|NCT01711528|Dermatologic Agents|dermatologic agents|mesh-ancestor
6698833|NCT01711554|Vitamin A|vitamin a|mesh-list
6698834|NCT01711554|Lenalidomide|lenalidomide|mesh-list
6698835|NCT01711554|Tretinoin|tretinoin|mesh-list
6698836|NCT01711554|Dinutuximab|dinutuximab|mesh-list
6698837|NCT01711554|Isotretinoin|isotretinoin|mesh-list
6698838|NCT01711554|Vitamins|vitamins|mesh-ancestor
6698839|NCT01711554|Micronutrients|micronutrients|mesh-ancestor
6698840|NCT01711554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698841|NCT01711554|Immunologic Factors|immunologic factors|mesh-ancestor
6698842|NCT01711554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6698843|NCT01711554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6698844|NCT01711554|Growth Substances|growth substances|mesh-ancestor
6698845|NCT01711554|Growth Inhibitors|growth inhibitors|mesh-ancestor
6698846|NCT01711554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6698847|NCT01711554|Keratolytic Agents|keratolytic agents|mesh-ancestor
6698848|NCT01711554|Dermatologic Agents|dermatologic agents|mesh-ancestor
6698849|NCT01711567|Tenofovir|tenofovir|mesh-list
6698850|NCT01711567|Entecavir|entecavir|mesh-list
6698851|NCT01711567|Antiviral Agents|antiviral agents|mesh-ancestor
6698852|NCT01711567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6698853|NCT01711567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6698854|NCT01711567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6698855|NCT01711567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6698856|NCT01711567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698857|NCT01711567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6698858|NCT01711567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6698859|NCT01711632|Vemurafenib|vemurafenib|mesh-list
6698860|NCT01711632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6698861|NCT01711632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6698862|NCT01711632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6698863|NCT01711632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698864|NCT01711671|Dexamethasone|dexamethasone|mesh-list
6698865|NCT01711671|Lenalidomide|lenalidomide|mesh-list
6698866|NCT01711671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6698867|NCT01711671|Antiemetics|antiemetics|mesh-ancestor
6698868|NCT01711671|Autonomic Agents|autonomic agents|mesh-ancestor
6698869|NCT01711671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6698870|NCT01711671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698871|NCT01711671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6698872|NCT01711671|Glucocorticoids|glucocorticoids|mesh-ancestor
6698873|NCT01711671|Hormones|hormones|mesh-ancestor
6698874|NCT01711671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6698875|NCT01711671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6698876|NCT01711671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6698877|NCT01711671|Immunologic Factors|immunologic factors|mesh-ancestor
6698878|NCT01711671|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6698879|NCT01711671|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6698880|NCT01711671|Growth Substances|growth substances|mesh-ancestor
6698881|NCT01711671|Growth Inhibitors|growth inhibitors|mesh-ancestor
6698882|NCT01711697|Paclitaxel|paclitaxel|mesh-list
6698883|NCT01711697|Carboplatin|carboplatin|mesh-list
6698884|NCT01711697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6698885|NCT01711697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6698886|NCT01711697|Tubulin Modulators|tubulin modulators|mesh-ancestor
6698887|NCT01711697|Antimitotic Agents|antimitotic agents|mesh-ancestor
6698888|NCT01711697|Mitosis Modulators|mitosis modulators|mesh-ancestor
6698889|NCT01711697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698890|NCT01711723|Darapladib|darapladib|mesh-list
6698891|NCT01711723|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
6698892|NCT01711723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6698893|NCT01711723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698894|NCT01711749|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6698895|NCT01711749|Calcium|calcium|mesh-list
6698896|NCT01711749|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6698897|NCT01711749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698898|NCT01711749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6698899|NCT01711749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6698900|NCT01711749|Antimetabolites|antimetabolites|mesh-ancestor
6698901|NCT01711749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698902|NCT01711749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6698903|NCT01711749|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6698904|NCT01711749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6698905|NCT01711814|Peficitinib|peficitinib|mesh-list
6698906|NCT01711814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6698907|NCT01711814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698908|NCT01711814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6698909|NCT01711814|Immunologic Factors|immunologic factors|mesh-ancestor
6698910|NCT01711814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698911|NCT01711827|Isavuconazole|isavuconazole|mesh-list
6698912|NCT01711827|Prednisone|prednisone|mesh-list
6698913|NCT01711827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6698914|NCT01711827|Glucocorticoids|glucocorticoids|mesh-ancestor
6698915|NCT01711827|Hormones|hormones|mesh-ancestor
6698916|NCT01711827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6698917|NCT01711827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698918|NCT01711827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6698919|NCT01711827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6698920|NCT01711827|Antifungal Agents|antifungal agents|mesh-ancestor
6698921|NCT01711827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6698922|NCT01711905|Vitamin D|vitamin d|mesh-list
6698923|NCT01711905|Cholecalciferol|cholecalciferol|mesh-list
6698924|NCT01711905|Vitamins|vitamins|mesh-ancestor
6698925|NCT01711905|Micronutrients|micronutrients|mesh-ancestor
6698926|NCT01711905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698927|NCT01711905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6698928|NCT01711905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6698929|NCT01711931|Everolimus|everolimus|mesh-list
6698930|NCT01711931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6698931|NCT01711931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6698932|NCT01711931|Immunologic Factors|immunologic factors|mesh-ancestor
6698933|NCT01711931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698934|NCT01711957|Liver Extracts|liver extracts|mesh-list
6698935|NCT01711957|Hematinics|hematinics|mesh-ancestor
6698936|NCT01711970|Paclitaxel|paclitaxel|mesh-list
6698937|NCT01711970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6698938|NCT01711970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6698939|NCT01711970|Tubulin Modulators|tubulin modulators|mesh-ancestor
6698940|NCT01711970|Antimitotic Agents|antimitotic agents|mesh-ancestor
6698941|NCT01711970|Mitosis Modulators|mitosis modulators|mesh-ancestor
6698942|NCT01711970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698943|NCT01712100|Irbesartan|irbesartan|mesh-list
6698944|NCT01712100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6698945|NCT01712100|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6698946|NCT01712100|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6698947|NCT01712100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698948|NCT01712113|Irbesartan|irbesartan|mesh-list
6698949|NCT01712113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6698950|NCT01712113|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6698951|NCT01712113|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6698952|NCT01712113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698953|NCT01712126|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6698954|NCT01712126|Irbesartan|irbesartan|mesh-list
6698955|NCT01712126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6698956|NCT01712126|Diuretics|diuretics|mesh-ancestor
6698957|NCT01712126|Natriuretic Agents|natriuretic agents|mesh-ancestor
6698958|NCT01712126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698959|NCT01712126|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6698960|NCT01712126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6698961|NCT01712126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698962|NCT01712126|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6698963|NCT01712126|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6698964|NCT01712139|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6698965|NCT01712139|Irbesartan|irbesartan|mesh-list
6698966|NCT01712139|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6698967|NCT01712139|Diuretics|diuretics|mesh-ancestor
6698968|NCT01712139|Natriuretic Agents|natriuretic agents|mesh-ancestor
6698969|NCT01712139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698970|NCT01712139|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6698971|NCT01712139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6698972|NCT01712139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698973|NCT01712139|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6698974|NCT01712139|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6698975|NCT01712295|Salicylic Acid|salicylic acid|mesh-list
6698976|NCT01712295|Salicylates|salicylates|mesh-list
6698977|NCT01712295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6698978|NCT01712295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6698979|NCT01712295|Analgesics|analgesics|mesh-ancestor
6698980|NCT01712295|Sensory System Agents|sensory system agents|mesh-ancestor
6698981|NCT01712295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6698982|NCT01712295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6698983|NCT01712295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6698984|NCT01712295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6698985|NCT01712295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6698986|NCT01712295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6698987|NCT01712295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698988|NCT01712295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6698989|NCT01712295|Antifungal Agents|antifungal agents|mesh-ancestor
6698990|NCT01712295|Keratolytic Agents|keratolytic agents|mesh-ancestor
6698991|NCT01712295|Dermatologic Agents|dermatologic agents|mesh-ancestor
6698992|NCT01712321|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
6698993|NCT01712321|Antidepressive Agents|antidepressive agents|mesh-ancestor
6698994|NCT01712321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6698995|NCT01712321|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6698996|NCT01712321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6698997|NCT01712321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6698998|NCT01712321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6698999|NCT01712321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6699000|NCT01712321|Serotonin Agents|serotonin agents|mesh-ancestor
6699001|NCT01712321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699002|NCT01712321|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6699003|NCT01712321|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6781475|NCT02185846|Dirithromycin|dirithromycin|mesh-list
6781476|NCT02185846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6781477|NCT02185846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6781478|NCT02185859|Lidocaine|lidocaine|mesh-list
6781479|NCT02185859|Magnesium Sulfate|magnesium sulfate|mesh-list
6781480|NCT02185859|Anesthetics, Local|anesthetics, local|mesh-ancestor
6781481|NCT02185859|Anesthetics|anesthetics|mesh-ancestor
6781482|NCT02185859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6781483|NCT02185859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781484|NCT02185859|Sensory System Agents|sensory system agents|mesh-ancestor
6781485|NCT02185859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6781486|NCT02185859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6781487|NCT02185859|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6781488|NCT02185859|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6781489|NCT02185859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6781490|NCT02185859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781491|NCT02185859|Analgesics|analgesics|mesh-ancestor
6781492|NCT02185859|Anticonvulsants|anticonvulsants|mesh-ancestor
6781493|NCT02185859|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6781494|NCT02185859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6781495|NCT02185859|Tocolytic Agents|tocolytic agents|mesh-ancestor
6781496|NCT02185859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6781497|NCT02185898|Menthol|menthol|mesh-list
6781498|NCT02185898|Nicotine|nicotine|mesh-list
6781499|NCT02185898|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6781500|NCT02185898|Autonomic Agents|autonomic agents|mesh-ancestor
6781501|NCT02185898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6781502|NCT02185898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781503|NCT02185898|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6781504|NCT02185898|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6781505|NCT02185898|Cholinergic Agents|cholinergic agents|mesh-ancestor
6781506|NCT02185898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6781507|NCT02185898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781508|NCT02185898|Antipruritics|antipruritics|mesh-ancestor
6781509|NCT02185898|Dermatologic Agents|dermatologic agents|mesh-ancestor
6781510|NCT02185924|Parecoxib|parecoxib|mesh-list
6781511|NCT02185924|Ropivacaine|ropivacaine|mesh-list
6781512|NCT02185924|Anesthetics, Local|anesthetics, local|mesh-ancestor
6781513|NCT02185924|Anesthetics|anesthetics|mesh-ancestor
6781514|NCT02185924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6781515|NCT02185924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781516|NCT02185924|Sensory System Agents|sensory system agents|mesh-ancestor
6781517|NCT02185924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6781518|NCT02185924|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6781519|NCT02185924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6699004|NCT01712347|Bevacizumab|bevacizumab|mesh-list
6699005|NCT01712347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6699006|NCT01712347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6699007|NCT01712347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6699008|NCT01712347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6699009|NCT01712347|Growth Substances|growth substances|mesh-ancestor
6699010|NCT01712347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699011|NCT01712347|Growth Inhibitors|growth inhibitors|mesh-ancestor
6699012|NCT01712464|Oxytocin|oxytocin|mesh-list
6699013|NCT01712464|Oxytocics|oxytocics|mesh-ancestor
6699014|NCT01712464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6699015|NCT01712464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699016|NCT01712477|Midazolam|midazolam|mesh-list
6699017|NCT01712477|Propofol|propofol|mesh-list
6699018|NCT01712477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6699019|NCT01712477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6699020|NCT01712477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699021|NCT01712477|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6699022|NCT01712477|Anesthetics, General|anesthetics, general|mesh-ancestor
6699023|NCT01712477|Anesthetics|anesthetics|mesh-ancestor
6699024|NCT01712477|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6699025|NCT01712477|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6699026|NCT01712477|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6699027|NCT01712477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6699028|NCT01712477|GABA Modulators|gaba modulators|mesh-ancestor
6699029|NCT01712477|GABA Agents|gaba agents|mesh-ancestor
6699030|NCT01712477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6699031|NCT01712477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699032|NCT01712568|Ropinirole|ropinirole|mesh-list
6699033|NCT01712568|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6699034|NCT01712568|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6699035|NCT01712568|Dopamine Agonists|dopamine agonists|mesh-ancestor
6699036|NCT01712568|Dopamine Agents|dopamine agents|mesh-ancestor
6699037|NCT01712568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6699038|NCT01712568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699039|NCT01712568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699040|NCT01712646|Oxytocin|oxytocin|mesh-list
6699041|NCT01712646|Oxytocics|oxytocics|mesh-ancestor
6699042|NCT01712646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6699043|NCT01712646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699054|NCT01712815|Clevudine|clevudine|mesh-list
6699055|NCT01712815|Antiviral Agents|antiviral agents|mesh-ancestor
6699056|NCT01712815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6699057|NCT01712828|Diphenhydramine|diphenhydramine|mesh-list
6699058|NCT01712828|Promethazine|promethazine|mesh-list
6699059|NCT01712828|Sirolimus|sirolimus|mesh-list
6699060|NCT01712828|Quinidine|quinidine|mesh-list
6699061|NCT01712828|Lenalidomide|lenalidomide|mesh-list
6699062|NCT01712828|Immunologic Factors|immunologic factors|mesh-ancestor
6699063|NCT01712828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699064|NCT01712828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6699065|NCT01712828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6699066|NCT01712828|Growth Substances|growth substances|mesh-ancestor
6699067|NCT01712828|Growth Inhibitors|growth inhibitors|mesh-ancestor
6699068|NCT01712828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6699069|NCT01712828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6699070|NCT01712828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6699071|NCT01712828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6699072|NCT01712828|Antifungal Agents|antifungal agents|mesh-ancestor
6699073|NCT01712828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6699074|NCT01712828|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6699075|NCT01712828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6699076|NCT01712828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6699077|NCT01712828|Anesthetics, Local|anesthetics, local|mesh-ancestor
6699078|NCT01712828|Anesthetics|anesthetics|mesh-ancestor
6699079|NCT01712828|Sensory System Agents|sensory system agents|mesh-ancestor
6699080|NCT01712828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6699081|NCT01712828|Antiemetics|antiemetics|mesh-ancestor
6699082|NCT01712828|Autonomic Agents|autonomic agents|mesh-ancestor
6699083|NCT01712828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6699084|NCT01712828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6699085|NCT01712828|Histamine Antagonists|histamine antagonists|mesh-ancestor
6699086|NCT01712828|Histamine Agents|histamine agents|mesh-ancestor
6699087|NCT01712828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6699088|NCT01712828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699089|NCT01712828|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6699090|NCT01712828|Antipruritics|antipruritics|mesh-ancestor
6699091|NCT01712828|Dermatologic Agents|dermatologic agents|mesh-ancestor
6699092|NCT01712828|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6699093|NCT01712828|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6699094|NCT01712828|Adrenergic Agents|adrenergic agents|mesh-ancestor
6699095|NCT01712828|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6699096|NCT01712828|Antimalarials|antimalarials|mesh-ancestor
6699097|NCT01712828|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6699098|NCT01712828|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6699099|NCT01712828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6699100|NCT01712828|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6699101|NCT01712828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6699102|NCT01712828|Cholinergic Agents|cholinergic agents|mesh-ancestor
6699103|NCT01712828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6699104|NCT01712828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6699105|NCT01712828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6699106|NCT01712828|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6699107|NCT01712828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6699108|NCT01712893|Goserelin|goserelin|mesh-list
6699109|NCT01712893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6699110|NCT01712893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6699111|NCT01712919|Paclitaxel|paclitaxel|mesh-list
6699112|NCT01712919|Cetuximab|cetuximab|mesh-list
6699113|NCT01712919|Nedaplatin|nedaplatin|mesh-list
6699114|NCT01712919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6699115|NCT01712919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6699116|NCT01712919|Tubulin Modulators|tubulin modulators|mesh-ancestor
6699117|NCT01712919|Antimitotic Agents|antimitotic agents|mesh-ancestor
6699118|NCT01712919|Mitosis Modulators|mitosis modulators|mesh-ancestor
6699119|NCT01712919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699120|NCT01712919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6699121|NCT01712945|Alemtuzumab|alemtuzumab|mesh-list
6699122|NCT01712945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6699123|NCT01712945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6699124|NCT01712997|Bosentan|bosentan|mesh-list
6699125|NCT01712997|Iloprost|iloprost|mesh-list
6699126|NCT01712997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6699127|NCT01712997|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6699128|NCT01712997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699129|NCT01712997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6699130|NCT01712997|Vasodilator Agents|vasodilator agents|mesh-ancestor
6699131|NCT01713049|Alovudine|alovudine|mesh-list
6699132|NCT01713049|Antiviral Agents|antiviral agents|mesh-ancestor
6699133|NCT01713049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6699134|NCT01713101|Tranylcypromine|tranylcypromine|mesh-list
6699135|NCT01713101|Tranexamic Acid|tranexamic acid|mesh-list
6699136|NCT01713101|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
6699137|NCT01713101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6699138|NCT01713101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699139|NCT01713101|Hemostatics|hemostatics|mesh-ancestor
6699140|NCT01713101|Coagulants|coagulants|mesh-ancestor
6699141|NCT01713101|Antidepressive Agents|antidepressive agents|mesh-ancestor
6699142|NCT01713101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6699143|NCT01713101|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6699144|NCT01713101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6699145|NCT01713101|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6699146|NCT01713101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6699147|NCT01713101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6699148|NCT01713101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699149|NCT01713127|Remifentanil|remifentanil|mesh-list
6699150|NCT01713127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6699151|NCT01713127|Narcotics|narcotics|mesh-ancestor
6699152|NCT01713127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6699153|NCT01713127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699154|NCT01713127|Analgesics|analgesics|mesh-ancestor
6699155|NCT01713127|Sensory System Agents|sensory system agents|mesh-ancestor
6699156|NCT01713127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6699157|NCT01713153|Misoprostol|misoprostol|mesh-list
6699158|NCT01713153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6699159|NCT01713153|Abortifacient Agents|abortifacient agents|mesh-ancestor
6699160|NCT01713153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6699161|NCT01713153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699162|NCT01713153|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6699163|NCT01713153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6699164|NCT01713153|Oxytocics|oxytocics|mesh-ancestor
6699165|NCT01713166|Plasma-lyte 148|plasma-lyte 148|mesh-list
6699166|NCT01713166|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6699167|NCT01713166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6699168|NCT01713179|Ambroxol|ambroxol|mesh-list
6699169|NCT01713179|Expectorants|expectorants|mesh-ancestor
6699170|NCT01713179|Respiratory System Agents|respiratory system agents|mesh-ancestor
6699171|NCT01713218|Gemcitabine|gemcitabine|mesh-list
6699172|NCT01713218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6699173|NCT01713218|Antimetabolites|antimetabolites|mesh-ancestor
6699174|NCT01713218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699175|NCT01713218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6699176|NCT01713218|Antiviral Agents|antiviral agents|mesh-ancestor
6699177|NCT01713218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6699178|NCT01713218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6699179|NCT01713218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6699180|NCT01713218|Immunologic Factors|immunologic factors|mesh-ancestor
6699181|NCT01713218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699182|NCT01713231|Vitamin D|vitamin d|mesh-list
6699183|NCT01713231|Ergocalciferols|ergocalciferols|mesh-list
6699184|NCT01713231|Vitamins|vitamins|mesh-list
6699185|NCT01713231|Micronutrients|micronutrients|mesh-ancestor
6699186|NCT01713231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699187|NCT01713231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6699188|NCT01713231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6699189|NCT01713309|Lenograstim|lenograstim|mesh-list
6699190|NCT01713309|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6699191|NCT01713309|Immunologic Factors|immunologic factors|mesh-ancestor
6699192|NCT01713309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699193|NCT01713361|Enoxaparin|enoxaparin|mesh-list
6699194|NCT01713361|Anticoagulants|anticoagulants|mesh-ancestor
6699195|NCT01713361|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6699196|NCT01713361|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6699197|NCT01713361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699198|NCT01713387|Gemcitabine|gemcitabine|mesh-list
6699199|NCT01713387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6699200|NCT01713387|Antimetabolites|antimetabolites|mesh-ancestor
6699201|NCT01713387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699202|NCT01713387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6699203|NCT01713387|Antiviral Agents|antiviral agents|mesh-ancestor
6699204|NCT01713387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6699205|NCT01713387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6699206|NCT01713387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6699207|NCT01713387|Immunologic Factors|immunologic factors|mesh-ancestor
6699208|NCT01713387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699209|NCT01713426|Pregabalin|pregabalin|mesh-list
6699210|NCT01713426|Capsaicin|capsaicin|mesh-list
6699211|NCT01713426|Analgesics|analgesics|mesh-ancestor
6699212|NCT01713426|Sensory System Agents|sensory system agents|mesh-ancestor
6699213|NCT01713426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6699214|NCT01713426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699215|NCT01713426|Anticonvulsants|anticonvulsants|mesh-ancestor
6699216|NCT01713426|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6699217|NCT01713426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6699218|NCT01713426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699219|NCT01713426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6699220|NCT01713426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6699221|NCT01713426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6699222|NCT01713426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6699223|NCT01713426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6699224|NCT01713426|Antipruritics|antipruritics|mesh-ancestor
6699225|NCT01713426|Dermatologic Agents|dermatologic agents|mesh-ancestor
6699226|NCT01713556|Propranolol|propranolol|mesh-list
6699227|NCT01713556|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6699228|NCT01713556|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6699229|NCT01713556|Adrenergic Agents|adrenergic agents|mesh-ancestor
6699230|NCT01713556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6699231|NCT01713556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699232|NCT01713556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699233|NCT01713556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6699234|NCT01713556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6699235|NCT01713556|Vasodilator Agents|vasodilator agents|mesh-ancestor
6699236|NCT01713647|Losartan|losartan|mesh-list
6699237|NCT01713647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6699238|NCT01713647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6699239|NCT01713647|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6699240|NCT01713647|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6699241|NCT01713647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699242|NCT01713725|Omalizumab|omalizumab|mesh-list
6699243|NCT01713725|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6699244|NCT01713725|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6699245|NCT01713725|Respiratory System Agents|respiratory system agents|mesh-ancestor
6699246|NCT01713738|Rituximab|rituximab|mesh-list
6699247|NCT01713738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6699248|NCT01713738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6699249|NCT01713738|Immunologic Factors|immunologic factors|mesh-ancestor
6699250|NCT01713738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699251|NCT01713738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6699252|NCT01713777|Lamotrigine|lamotrigine|mesh-list
6699253|NCT01713777|Anticonvulsants|anticonvulsants|mesh-list
6699254|NCT01713777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6699255|NCT01713777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6699256|NCT01713777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699257|NCT01713777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6699258|NCT01713777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699259|NCT01713777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6699260|NCT01713777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6699261|NCT01713777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6699262|NCT01713777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6699263|NCT01713777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6699264|NCT01713803|Buprenorphine|buprenorphine|mesh-list
6699265|NCT01713803|Naloxone|naloxone|mesh-list
6699266|NCT01713803|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6699267|NCT01713803|Narcotics|narcotics|mesh-ancestor
6699268|NCT01713803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6699269|NCT01713803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699270|NCT01713803|Analgesics|analgesics|mesh-ancestor
6699271|NCT01713803|Sensory System Agents|sensory system agents|mesh-ancestor
6699272|NCT01713803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6699273|NCT01713803|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6699274|NCT01713920|Amlodipine|amlodipine|mesh-list
6699275|NCT01713920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6699276|NCT01713920|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6699277|NCT01713920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6699278|NCT01713920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699279|NCT01713920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6699280|NCT01713920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699281|NCT01713920|Vasodilator Agents|vasodilator agents|mesh-ancestor
6699282|NCT01713972|Dabrafenib|dabrafenib|mesh-list
6699283|NCT01713972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6699284|NCT01713972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6699285|NCT01713972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6699286|NCT01713972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699287|NCT01714011|Aripiprazole|aripiprazole|mesh-list
6699288|NCT01714011|Ziprasidone|ziprasidone|mesh-list
6699289|NCT01714011|Antidepressive Agents|antidepressive agents|mesh-ancestor
6699290|NCT01714011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6699291|NCT01714011|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6699292|NCT01714011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6699293|NCT01714011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6699294|NCT01714011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699295|NCT01714011|Dopamine Agonists|dopamine agonists|mesh-ancestor
6699296|NCT01714011|Dopamine Agents|dopamine agents|mesh-ancestor
6699297|NCT01714011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6699298|NCT01714011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699299|NCT01714011|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6699300|NCT01714011|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6699301|NCT01714011|Serotonin Agents|serotonin agents|mesh-ancestor
6699302|NCT01714011|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6699303|NCT01714011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6699304|NCT01714011|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6699305|NCT01714011|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6699306|NCT01714037|Gemcitabine|gemcitabine|mesh-list
6699307|NCT01714037|Docetaxel|docetaxel|mesh-list
6699308|NCT01714037|Pemetrexed|pemetrexed|mesh-list
6699309|NCT01714037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6699310|NCT01714037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6699311|NCT01714037|Antimetabolites|antimetabolites|mesh-ancestor
6699312|NCT01714037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699313|NCT01714037|Antiviral Agents|antiviral agents|mesh-ancestor
6699314|NCT01714037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6699315|NCT01714037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6699316|NCT01714037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6699317|NCT01714037|Immunologic Factors|immunologic factors|mesh-ancestor
6699318|NCT01714037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699319|NCT01714037|Tubulin Modulators|tubulin modulators|mesh-ancestor
6699320|NCT01714037|Antimitotic Agents|antimitotic agents|mesh-ancestor
6699321|NCT01714037|Mitosis Modulators|mitosis modulators|mesh-ancestor
6699322|NCT01714037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6699323|NCT01714037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6781520|NCT02185924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6781521|NCT02185924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781522|NCT02185924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6781523|NCT02185924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6781524|NCT02185924|Analgesics|analgesics|mesh-ancestor
6781525|NCT02185924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6781526|NCT02185924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6781527|NCT02185963|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6781528|NCT02185963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6781529|NCT02185963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6781530|NCT02185963|Antimetabolites|antimetabolites|mesh-ancestor
6781531|NCT02185963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781532|NCT02185963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6781533|NCT02185963|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6781534|NCT02185963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6781535|NCT02186028|Vitamin D|vitamin d|mesh-list
6781536|NCT02186028|Vitamins|vitamins|mesh-ancestor
6781537|NCT02186028|Micronutrients|micronutrients|mesh-ancestor
6781538|NCT02186028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781539|NCT02186028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6781540|NCT02186106|Cholecalciferol|cholecalciferol|mesh-list
6781541|NCT02186106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6781542|NCT02186106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781543|NCT02186106|Vitamins|vitamins|mesh-ancestor
6781544|NCT02186106|Micronutrients|micronutrients|mesh-ancestor
6781545|NCT02186106|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6781546|NCT02186119|Ranibizumab|ranibizumab|mesh-list
6781547|NCT02186119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6781548|NCT02186119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6781549|NCT02186119|Growth Substances|growth substances|mesh-ancestor
6781550|NCT02186119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781551|NCT02186119|Growth Inhibitors|growth inhibitors|mesh-ancestor
6781552|NCT02186119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6781553|NCT02186132|Atropine|atropine|mesh-list
6781554|NCT02186132|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6781555|NCT02186132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6781556|NCT02186132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6781557|NCT02186132|Autonomic Agents|autonomic agents|mesh-ancestor
6781558|NCT02186132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6781559|NCT02186132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781560|NCT02186132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6781561|NCT02186132|Respiratory System Agents|respiratory system agents|mesh-ancestor
6781562|NCT02186132|Mydriatics|mydriatics|mesh-ancestor
6781563|NCT02186132|Parasympatholytics|parasympatholytics|mesh-ancestor
6781564|NCT02186132|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6781565|NCT02186132|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6781566|NCT02186132|Cholinergic Agents|cholinergic agents|mesh-ancestor
6781567|NCT02186132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6781568|NCT02186132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781569|NCT02186145|Metronidazole|metronidazole|mesh-list
6781570|NCT02186145|Nystatin|nystatin|mesh-list
6781571|NCT02186145|Dexamethasone|dexamethasone|mesh-list
6781572|NCT02186145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6781573|NCT02186145|Antiemetics|antiemetics|mesh-ancestor
6781574|NCT02186145|Autonomic Agents|autonomic agents|mesh-ancestor
6781575|NCT02186145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6781576|NCT02186145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781577|NCT02186145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6242758|NCT02655354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6699324|NCT01714089|Interferons|interferons|mesh-list
6699325|NCT01714089|Interferon-beta|interferon-beta|mesh-list
6699326|NCT01714089|Interferon beta-1a|interferon beta-1a|mesh-list
6699327|NCT01714089|RNS60|rns60|mesh-list
6699328|NCT01714089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6699329|NCT01714089|Antiviral Agents|antiviral agents|mesh-ancestor
6699330|NCT01714089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6699331|NCT01714089|Immunologic Factors|immunologic factors|mesh-ancestor
6699332|NCT01714089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699333|NCT01714089|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6699334|NCT01714089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6699335|NCT01714089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6699336|NCT01714089|Analgesics|analgesics|mesh-ancestor
6699337|NCT01714089|Sensory System Agents|sensory system agents|mesh-ancestor
6699338|NCT01714089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6699339|NCT01714089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6699340|NCT01714089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6699341|NCT01714089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6699342|NCT01714102|Resveratrol|resveratrol|mesh-list
6699343|NCT01714102|Antioxidants|antioxidants|mesh-ancestor
6699344|NCT01714102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699345|NCT01714102|Protective Agents|protective agents|mesh-ancestor
6699346|NCT01714102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699347|NCT01714102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6699348|NCT01714102|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6699349|NCT01714115|Aflibercept|aflibercept|mesh-list
6699350|NCT01714115|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6699351|NCT01714115|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6699352|NCT01714115|Growth Substances|growth substances|mesh-ancestor
6699353|NCT01714115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699354|NCT01714115|Growth Inhibitors|growth inhibitors|mesh-ancestor
6699355|NCT01714115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6699356|NCT01714128|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6699357|NCT01714128|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6699358|NCT01714128|Estradiol|estradiol|mesh-list
6699359|NCT01714128|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6699360|NCT01714128|Estrogens|estrogens|mesh-ancestor
6699361|NCT01714128|Hormones|hormones|mesh-ancestor
6699362|NCT01714128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6699363|NCT01714128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699364|NCT01714128|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6699365|NCT01714128|Contraceptive Agents|contraceptive agents|mesh-ancestor
6699366|NCT01714128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6699367|NCT01714128|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6699368|NCT01714154|Ritonavir|ritonavir|mesh-list
6699369|NCT01714154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6699370|NCT01714154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6699371|NCT01714154|Protease Inhibitors|protease inhibitors|mesh-ancestor
6699372|NCT01714154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6699373|NCT01714154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699374|NCT01714154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6699375|NCT01714154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6699376|NCT01714154|Antiviral Agents|antiviral agents|mesh-ancestor
6699377|NCT01714154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6699378|NCT01714154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6699379|NCT01714154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6699380|NCT01714193|Canagliflozin|canagliflozin|mesh-list
6699381|NCT01714193|Contraceptive Agents|contraceptive agents|mesh-list
6699382|NCT01714193|Contraceptives, Oral|contraceptives, oral|mesh-list
6699383|NCT01714193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6699384|NCT01714193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699385|NCT01714193|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6699386|NCT01714193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699387|NCT01714193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6699388|NCT01714193|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6699389|NCT01714206|Canagliflozin|canagliflozin|mesh-list
6699390|NCT01714206|Digoxin|digoxin|mesh-list
6699391|NCT01714206|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6699392|NCT01714206|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6699393|NCT01714206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6699394|NCT01714206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699395|NCT01714206|Protective Agents|protective agents|mesh-ancestor
6699396|NCT01714206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699397|NCT01714206|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6699398|NCT01714206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6699399|NCT01714297|Dalteparin|dalteparin|mesh-list
6699400|NCT01714297|Tinzaparin|tinzaparin|mesh-list
6699401|NCT01714297|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6699402|NCT01714297|Anticoagulants|anticoagulants|mesh-ancestor
6699403|NCT01714297|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6699404|NCT01714297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6699405|NCT01714297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699406|NCT01714388|Remifentanil|remifentanil|mesh-list
6699407|NCT01714388|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6699408|NCT01714388|Narcotics|narcotics|mesh-ancestor
6699409|NCT01714388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6699410|NCT01714388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699411|NCT01714388|Analgesics|analgesics|mesh-ancestor
6699412|NCT01714388|Sensory System Agents|sensory system agents|mesh-ancestor
6699413|NCT01714388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6699414|NCT01714401|Albuterol|albuterol|mesh-list
6699415|NCT01714401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6699416|NCT01714401|Autonomic Agents|autonomic agents|mesh-ancestor
6699417|NCT01714401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6699418|NCT01714401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699419|NCT01714401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6699420|NCT01714401|Respiratory System Agents|respiratory system agents|mesh-ancestor
6699421|NCT01714401|Tocolytic Agents|tocolytic agents|mesh-ancestor
6699422|NCT01714401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6699423|NCT01714401|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6699424|NCT01714401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6699425|NCT01714401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6699426|NCT01714401|Adrenergic Agents|adrenergic agents|mesh-ancestor
6699427|NCT01714401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6699428|NCT01714401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699429|NCT01714414|Lamivudine|lamivudine|mesh-list
6699430|NCT01714414|Zidovudine|zidovudine|mesh-list
6699431|NCT01714414|Efavirenz|efavirenz|mesh-list
6699432|NCT01714414|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6699433|NCT01714414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6699434|NCT01714414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6699435|NCT01714414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699436|NCT01714414|Antiviral Agents|antiviral agents|mesh-ancestor
6699437|NCT01714414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6699438|NCT01714414|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6699439|NCT01714414|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6699440|NCT01714414|Antimetabolites|antimetabolites|mesh-ancestor
6699441|NCT01714414|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6699442|NCT01714414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6699443|NCT01714414|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6699444|NCT01714414|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6699445|NCT01714414|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6699446|NCT01714414|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6699447|NCT01714427|Dexamethasone|dexamethasone|mesh-list
6699448|NCT01714427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6699449|NCT01714427|Antiemetics|antiemetics|mesh-ancestor
6699450|NCT01714427|Autonomic Agents|autonomic agents|mesh-ancestor
6699451|NCT01714427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6699452|NCT01714427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699453|NCT01714427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6699454|NCT01714427|Glucocorticoids|glucocorticoids|mesh-ancestor
6699455|NCT01714427|Hormones|hormones|mesh-ancestor
6699456|NCT01714427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6699457|NCT01714427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6699458|NCT01714427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6699459|NCT01714557|Tazobactam|tazobactam|mesh-list
6699460|NCT01714557|Piperacillin|piperacillin|mesh-list
6699461|NCT01714557|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
6699462|NCT01714557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6699463|NCT01714557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6699464|NCT01714557|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6699465|NCT01714557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6699466|NCT01714557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699467|NCT01714570|Tazobactam|tazobactam|mesh-list
6699468|NCT01714570|Piperacillin|piperacillin|mesh-list
6699469|NCT01714570|Imipenem|imipenem|mesh-list
6699470|NCT01714570|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
6699471|NCT01714570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6699472|NCT01714570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6781578|NCT02186145|Glucocorticoids|glucocorticoids|mesh-ancestor
6699473|NCT01714570|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6699474|NCT01714570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6699475|NCT01714570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699476|NCT01714596|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6699477|NCT01714596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6699478|NCT01714648|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6699479|NCT01714648|Luteolytic Agents|luteolytic agents|mesh-ancestor
6699480|NCT01714648|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6699481|NCT01714648|Contraceptive Agents|contraceptive agents|mesh-ancestor
6699482|NCT01714648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6699483|NCT01714648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699484|NCT01714648|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6699485|NCT01714648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6699486|NCT01714648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6699487|NCT01714765|Everolimus|everolimus|mesh-list
6699488|NCT01714765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6699489|NCT01714765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6699490|NCT01714765|Immunologic Factors|immunologic factors|mesh-ancestor
6699491|NCT01714765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699492|NCT01714817|Mycophenolic Acid|mycophenolic acid|mesh-list
6699493|NCT01714817|Prednisone|prednisone|mesh-list
6699494|NCT01714817|Abatacept|abatacept|mesh-list
6699495|NCT01714817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6699496|NCT01714817|Glucocorticoids|glucocorticoids|mesh-ancestor
6699497|NCT01714817|Hormones|hormones|mesh-ancestor
6699498|NCT01714817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6699499|NCT01714817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699500|NCT01714817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6699501|NCT01714817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6699502|NCT01714817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6699503|NCT01714817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6699504|NCT01714817|Antitubercular Agents|antitubercular agents|mesh-ancestor
6699505|NCT01714817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6699506|NCT01714817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6699507|NCT01714817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6699508|NCT01714817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699509|NCT01714817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6699510|NCT01714817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6699511|NCT01714817|Immunologic Factors|immunologic factors|mesh-ancestor
6699512|NCT01714817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6699513|NCT01714843|Linaclotide|linaclotide|mesh-list
6699514|NCT01714843|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
6699515|NCT01714843|Enzyme Activators|enzyme activators|mesh-ancestor
6699516|NCT01714843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699517|NCT01714843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6699518|NCT01714856|Ropinirole|ropinirole|mesh-list
6699519|NCT01714856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6699520|NCT01714856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6699521|NCT01714856|Dopamine Agonists|dopamine agonists|mesh-ancestor
6699522|NCT01714856|Dopamine Agents|dopamine agents|mesh-ancestor
6699523|NCT01714856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6699524|NCT01714856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699525|NCT01714856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699526|NCT01714895|Insulin|insulin|mesh-list
6699527|NCT01714895|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6699528|NCT01714895|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6699529|NCT01714895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699530|NCT01714908|Etoposide|etoposide|mesh-list
6699531|NCT01714908|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6699532|NCT01714908|Cisplatin|cisplatin|mesh-list
6699533|NCT01714908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6699534|NCT01714908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6699535|NCT01714908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6699536|NCT01714908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6699537|NCT01714908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6699538|NCT01714908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699539|NCT01714908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6699540|NCT01714960|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6699541|NCT01714960|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6699542|NCT01715077|Ipilimumab|ipilimumab|mesh-list
6699543|NCT01715077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6699544|NCT01715077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6699545|NCT01715077|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6699546|NCT01715077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699547|NCT01715090|Insulin|insulin|mesh-list
6699548|NCT01715090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6699549|NCT01715090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699550|NCT01715142|Gemcitabine|gemcitabine|mesh-list
6699551|NCT01715142|Paclitaxel|paclitaxel|mesh-list
6699552|NCT01715142|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6699553|NCT01715142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6699554|NCT01715142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6699555|NCT01715142|Tubulin Modulators|tubulin modulators|mesh-ancestor
6699556|NCT01715142|Antimitotic Agents|antimitotic agents|mesh-ancestor
6699557|NCT01715142|Mitosis Modulators|mitosis modulators|mesh-ancestor
6699558|NCT01715142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699559|NCT01715142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6699560|NCT01715142|Antimetabolites|antimetabolites|mesh-ancestor
6699561|NCT01715142|Antiviral Agents|antiviral agents|mesh-ancestor
6699562|NCT01715142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6699563|NCT01715142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6699564|NCT01715142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6699565|NCT01715142|Immunologic Factors|immunologic factors|mesh-ancestor
6699566|NCT01715142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699567|NCT01715168|Doxorubicin|doxorubicin|mesh-list
6699568|NCT01715168|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6699569|NCT01715168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6699570|NCT01715168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6699571|NCT01715168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6699572|NCT01715168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6699573|NCT01715168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6699574|NCT01715168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699575|NCT01715220|Nitroglycerin|nitroglycerin|mesh-list
6699576|NCT01715220|Vasodilator Agents|vasodilator agents|mesh-ancestor
6699577|NCT01715259|Abiraterone Acetate|abiraterone acetate|mesh-list
6699578|NCT01715259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6699579|NCT01715259|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6699580|NCT01715259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6699581|NCT01715259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699582|NCT01715259|Hormone Antagonists|hormone antagonists|mesh-ancestor
6699583|NCT01715259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6699584|NCT01715259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699585|NCT01715259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6699586|NCT01715311|Tiotropium Bromide|tiotropium bromide|mesh-list
6699587|NCT01715311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6699588|NCT01715311|Autonomic Agents|autonomic agents|mesh-ancestor
6699589|NCT01715311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6699590|NCT01715311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699591|NCT01715311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6699592|NCT01715311|Respiratory System Agents|respiratory system agents|mesh-ancestor
6699593|NCT01715311|Parasympatholytics|parasympatholytics|mesh-ancestor
6699594|NCT01715311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6699595|NCT01715311|Cholinergic Agents|cholinergic agents|mesh-ancestor
6699596|NCT01715311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6699597|NCT01715311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699598|NCT01715363|Leucovorin|leucovorin|mesh-list
6699599|NCT01715363|Folic Acid|folic acid|mesh-list
6699600|NCT01715363|Oxaliplatin|oxaliplatin|mesh-list
6699601|NCT01715363|Levoleucovorin|levoleucovorin|mesh-list
6699602|NCT01715363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6699603|NCT01715363|Antidotes|antidotes|mesh-ancestor
6699604|NCT01715363|Protective Agents|protective agents|mesh-ancestor
6699605|NCT01715363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699606|NCT01715363|Vitamin B Complex|vitamin b complex|mesh-ancestor
6699607|NCT01715363|Vitamins|vitamins|mesh-ancestor
6699608|NCT01715363|Micronutrients|micronutrients|mesh-ancestor
6699609|NCT01715363|Hematinics|hematinics|mesh-ancestor
6699610|NCT01715441|Irinotecan|irinotecan|mesh-list
6699611|NCT01715441|Sorafenib|sorafenib|mesh-list
6699612|NCT01715441|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6699613|NCT01715441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6699614|NCT01715441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6699615|NCT01715441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699616|NCT01715441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6699617|NCT01715441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6699618|NCT01715493|Muramidase|muramidase|mesh-list
6699619|NCT01715493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6699620|NCT01715519|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
6699621|NCT01715519|Antidepressive Agents|antidepressive agents|mesh-ancestor
6699622|NCT01715519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6699623|NCT01715519|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6699624|NCT01715519|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6699625|NCT01715519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6699626|NCT01715519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699627|NCT01715519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6699628|NCT01715519|Serotonin Agents|serotonin agents|mesh-ancestor
6699629|NCT01715519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699630|NCT01715519|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6699631|NCT01715519|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6699632|NCT01715584|Nitrous Oxide|nitrous oxide|mesh-list
6699633|NCT01715584|Sevoflurane|sevoflurane|mesh-list
6699634|NCT01715584|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6699635|NCT01715584|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6699636|NCT01715584|Anesthetics, General|anesthetics, general|mesh-ancestor
6699637|NCT01715584|Anesthetics|anesthetics|mesh-ancestor
6699638|NCT01715584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6699639|NCT01715584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699640|NCT01715584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6699641|NCT01715584|Analgesics|analgesics|mesh-ancestor
6699642|NCT01715584|Sensory System Agents|sensory system agents|mesh-ancestor
6699643|NCT01715584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6699644|NCT01715597|Ascorbic Acid|ascorbic acid|mesh-list
6699645|NCT01715597|Antioxidants|antioxidants|mesh-ancestor
6699646|NCT01715597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699647|NCT01715597|Protective Agents|protective agents|mesh-ancestor
6699648|NCT01715597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699649|NCT01715597|Vitamins|vitamins|mesh-ancestor
6699650|NCT01715597|Micronutrients|micronutrients|mesh-ancestor
6699651|NCT01715610|Clindamycin|clindamycin|mesh-list
6699652|NCT01715610|Clindamycin palmitate|clindamycin palmitate|mesh-list
6699653|NCT01715610|Clindamycin phosphate|clindamycin phosphate|mesh-list
6699654|NCT01715610|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6699655|NCT01715610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6699656|NCT01715610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6699657|NCT01715610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6699658|NCT01715610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6699659|NCT01715610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699660|NCT01715610|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6699661|NCT01715636|Tenofovir|tenofovir|mesh-list
6699662|NCT01715636|Emtricitabine|emtricitabine|mesh-list
6699663|NCT01715636|Rilpivirine|rilpivirine|mesh-list
6699664|NCT01715636|Antiviral Agents|antiviral agents|mesh-ancestor
6699665|NCT01715636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6699666|NCT01715636|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6699667|NCT01715636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6699668|NCT01715636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6699669|NCT01715636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699670|NCT01715636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6699671|NCT01715636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6699672|NCT01715688|Lidocaine|lidocaine|mesh-list
6699673|NCT01715688|Anesthetics, Local|anesthetics, local|mesh-ancestor
6699674|NCT01715688|Anesthetics|anesthetics|mesh-ancestor
6699675|NCT01715688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6699676|NCT01715688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699677|NCT01715688|Sensory System Agents|sensory system agents|mesh-ancestor
6699678|NCT01715688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6699679|NCT01715688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6699680|NCT01715688|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6699681|NCT01715688|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6699682|NCT01715688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6699683|NCT01715688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699684|NCT01715701|Iodine|iodine|mesh-list
6699685|NCT01715701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6699686|NCT01715701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6699687|NCT01715701|Trace Elements|trace elements|mesh-ancestor
6699688|NCT01715701|Micronutrients|micronutrients|mesh-ancestor
6699689|NCT01715701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699690|NCT01715714|Atorvastatin|atorvastatin|mesh-list
6699691|NCT01715714|Simvastatin|simvastatin|mesh-list
6699692|NCT01715714|Pravastatin|pravastatin|mesh-list
6699693|NCT01715714|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6699694|NCT01715714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6699695|NCT01715714|Antimetabolites|antimetabolites|mesh-ancestor
6699696|NCT01715714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699697|NCT01715714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6699698|NCT01715714|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6699699|NCT01715714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6781579|NCT02186145|Hormones|hormones|mesh-ancestor
6781580|NCT02186145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6781581|NCT02186145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6781582|NCT02186145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6781583|NCT02186145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6781584|NCT02186145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6781585|NCT02186145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6781586|NCT02186145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6781587|NCT02186145|Antifungal Agents|antifungal agents|mesh-ancestor
6781588|NCT02186145|Ionophores|ionophores|mesh-ancestor
6781589|NCT02186145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6781590|NCT02186145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781591|NCT02186158|Ascorbic Acid|ascorbic acid|mesh-list
6781592|NCT02186158|Vitamins|vitamins|mesh-ancestor
6781593|NCT02186158|Micronutrients|micronutrients|mesh-ancestor
6781594|NCT02186158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781595|NCT02186158|Antioxidants|antioxidants|mesh-ancestor
6781596|NCT02186158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781597|NCT02186158|Protective Agents|protective agents|mesh-ancestor
6781598|NCT02186249|Nivolumab|nivolumab|mesh-list
6781599|NCT02186249|Ipilimumab|ipilimumab|mesh-list
6781600|NCT02186249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6781601|NCT02186249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6781602|NCT02186249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6781603|NCT02186249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781604|NCT02186275|Vitamin D|vitamin d|mesh-list
6781605|NCT02186275|Ergocalciferols|ergocalciferols|mesh-list
6781606|NCT02186275|Cholecalciferol|cholecalciferol|mesh-list
6781607|NCT02186275|Vitamins|vitamins|mesh-list
6781608|NCT02186275|Micronutrients|micronutrients|mesh-ancestor
6781609|NCT02186275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781610|NCT02186275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6781611|NCT02186275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6781612|NCT02186366|Buspirone|buspirone|mesh-list
6781613|NCT02186366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6781614|NCT02186366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6781615|NCT02186366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6781616|NCT02186366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781617|NCT02186366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6781618|NCT02186366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6781619|NCT02186366|Serotonin Agents|serotonin agents|mesh-ancestor
6781620|NCT02186366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6781621|NCT02186366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781622|NCT02186457|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6781623|NCT02186457|Polymyxins|polymyxins|mesh-list
6781624|NCT02186457|Polymyxin B|polymyxin b|mesh-list
6781625|NCT02186457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6781626|NCT02186483|Metformin|metformin|mesh-list
6781627|NCT02186483|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6781628|NCT02186483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6781629|NCT02186483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781630|NCT02186483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6781631|NCT02186483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6781632|NCT02186483|Antimetabolites|antimetabolites|mesh-ancestor
6781633|NCT02186483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781634|NCT02186483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6781635|NCT02186483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6781636|NCT02186483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6781637|NCT02186496|Amlodipine|amlodipine|mesh-list
6781638|NCT02186496|Candesartan|candesartan|mesh-list
6781639|NCT02186496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6781640|NCT02186496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6781641|NCT02186496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6781642|NCT02186496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781643|NCT02186496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6781644|NCT02186496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781645|NCT02186496|Vasodilator Agents|vasodilator agents|mesh-ancestor
6781646|NCT02186496|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6781647|NCT02186496|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6781648|NCT02186535|Vitamin D|vitamin d|mesh-list
6781649|NCT02186535|Calcium|calcium|mesh-list
6781650|NCT02186535|Vitamins|vitamins|mesh-ancestor
6699700|NCT01715909|Oseltamivir|oseltamivir|mesh-list
6699701|NCT01715909|Antiviral Agents|antiviral agents|mesh-ancestor
6699702|NCT01715909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6699703|NCT01715909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6699704|NCT01715909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699705|NCT01715922|Fluconazole|fluconazole|mesh-list
6699706|NCT01715922|Flucytosine|flucytosine|mesh-list
6699707|NCT01715922|Antifungal Agents|antifungal agents|mesh-ancestor
6699708|NCT01715922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6699709|NCT01715922|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6699710|NCT01715922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6699711|NCT01715922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6699712|NCT01715922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699713|NCT01715922|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6699714|NCT01715922|Hormone Antagonists|hormone antagonists|mesh-ancestor
6699715|NCT01715922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6699716|NCT01715922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699717|NCT01715922|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6699718|NCT01715922|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6699719|NCT01715922|Antimetabolites|antimetabolites|mesh-ancestor
6699720|NCT01715935|Everolimus|everolimus|mesh-list
6699721|NCT01715935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6699722|NCT01715935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6699723|NCT01715935|Immunologic Factors|immunologic factors|mesh-ancestor
6699724|NCT01715935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699725|NCT01715974|Lenograstim|lenograstim|mesh-list
6699726|NCT01715974|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6699727|NCT01715974|Immunologic Factors|immunologic factors|mesh-ancestor
6699728|NCT01715974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699729|NCT01715987|Tenofovir|tenofovir|mesh-list
6699730|NCT01715987|Entecavir|entecavir|mesh-list
6699731|NCT01715987|Antiviral Agents|antiviral agents|mesh-ancestor
6699732|NCT01715987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6699733|NCT01715987|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6699734|NCT01715987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6699735|NCT01715987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6699736|NCT01715987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699737|NCT01715987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6699738|NCT01715987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6699739|NCT01716260|Chloroquine|chloroquine|mesh-list
6699740|NCT01716260|Primaquine|primaquine|mesh-list
6699741|NCT01716260|Amebicides|amebicides|mesh-ancestor
6699742|NCT01716260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6699743|NCT01716260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6699744|NCT01716260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6699745|NCT01716260|Antimalarials|antimalarials|mesh-ancestor
6699746|NCT01716260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6699747|NCT01716273|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6699748|NCT01716273|Laxatives|laxatives|mesh-ancestor
6699749|NCT01716273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6699750|NCT01716312|Omalizumab|omalizumab|mesh-list
6699751|NCT01716312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6699752|NCT01716312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6699753|NCT01716312|Respiratory System Agents|respiratory system agents|mesh-ancestor
6699754|NCT01716338|Glyburide|glyburide|mesh-list
6699755|NCT01716338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6699756|NCT01716338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699757|NCT01716377|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6699758|NCT01716377|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6699759|NCT01716377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6699760|NCT01716377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6699761|NCT01716377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699762|NCT01716377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6699763|NCT01716377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699764|NCT01716377|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6699765|NCT01716377|Antidepressive Agents|antidepressive agents|mesh-ancestor
6699766|NCT01716377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6699767|NCT01716416|Cetuximab|cetuximab|mesh-list
6699768|NCT01716416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6699769|NCT01716416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6699770|NCT01716442|Rituximab|rituximab|mesh-list
6699771|NCT01716442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6699772|NCT01716442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6699773|NCT01716442|Immunologic Factors|immunologic factors|mesh-ancestor
6781651|NCT02186535|Micronutrients|micronutrients|mesh-ancestor
6699774|NCT01716442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699775|NCT01716442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6699776|NCT01716572|Erythromycin|erythromycin|mesh-list
6699777|NCT01716572|Erythromycin Estolate|erythromycin estolate|mesh-list
6699778|NCT01716572|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
6699779|NCT01716572|Erythromycin stearate|erythromycin stearate|mesh-list
6699780|NCT01716572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6699781|NCT01716572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6699782|NCT01716572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6699783|NCT01716572|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6699784|NCT01716572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6699785|NCT01716572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699786|NCT01716611|Tolvaptan|tolvaptan|mesh-list
6699787|NCT01716611|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6699788|NCT01716611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699789|NCT01716611|Natriuretic Agents|natriuretic agents|mesh-ancestor
6699790|NCT01716611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699791|NCT01716624|Oxybutynin|oxybutynin|mesh-list
6699792|NCT01716624|Botulinum Toxins|botulinum toxins|mesh-list
6699793|NCT01716624|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6699794|NCT01716624|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6699795|NCT01716624|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6699796|NCT01716624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6699797|NCT01716624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699798|NCT01716624|Cholinergic Agents|cholinergic agents|mesh-ancestor
6699799|NCT01716624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6699800|NCT01716624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699801|NCT01716624|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6699802|NCT01716624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6699803|NCT01716624|Parasympatholytics|parasympatholytics|mesh-ancestor
6699804|NCT01716624|Autonomic Agents|autonomic agents|mesh-ancestor
6699805|NCT01716624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6699806|NCT01716624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6699807|NCT01716624|Urological Agents|urological agents|mesh-ancestor
6699808|NCT01716637|Etanercept|etanercept|mesh-list
6699809|NCT01716637|Curcumin|curcumin|mesh-list
6699810|NCT01716637|Resveratrol|resveratrol|mesh-list
6699811|NCT01716637|Quercetin|quercetin|mesh-list
6699812|NCT01716637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6699813|NCT01716637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6699814|NCT01716637|Analgesics|analgesics|mesh-ancestor
6699815|NCT01716637|Sensory System Agents|sensory system agents|mesh-ancestor
6699816|NCT01716637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6699817|NCT01716637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699818|NCT01716637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6699819|NCT01716637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6699820|NCT01716637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6699821|NCT01716637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6699822|NCT01716637|Immunologic Factors|immunologic factors|mesh-ancestor
6699823|NCT01716637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6699824|NCT01716637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6699825|NCT01716637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699826|NCT01716637|Antioxidants|antioxidants|mesh-ancestor
6699827|NCT01716637|Protective Agents|protective agents|mesh-ancestor
6699828|NCT01716637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6699829|NCT01716689|Cyclophosphamide|cyclophosphamide|mesh-list
6699830|NCT01716689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6699831|NCT01716689|Immunologic Factors|immunologic factors|mesh-ancestor
6699832|NCT01716689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699833|NCT01716689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6699834|NCT01716689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6699835|NCT01716689|Alkylating Agents|alkylating agents|mesh-ancestor
6699836|NCT01716689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699837|NCT01716689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6699838|NCT01716689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6699839|NCT01716767|Analgesics|analgesics|mesh-list
6699840|NCT01716767|Menthol|menthol|mesh-list
6699841|NCT01716767|Sensory System Agents|sensory system agents|mesh-ancestor
6699842|NCT01716767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6699843|NCT01716767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699844|NCT01716767|Antipruritics|antipruritics|mesh-ancestor
6699845|NCT01716767|Dermatologic Agents|dermatologic agents|mesh-ancestor
6699846|NCT01716858|Sulforaphane|sulforaphane|mesh-list
6699847|NCT01716858|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6699848|NCT01716858|Protective Agents|protective agents|mesh-ancestor
6699849|NCT01716858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699850|NCT01716858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6699851|NCT01716949|Fluorouracil|fluorouracil|mesh-list
6699852|NCT01716949|Capecitabine|capecitabine|mesh-list
6699853|NCT01716949|Oxaliplatin|oxaliplatin|mesh-list
6699854|NCT01716949|Antimetabolites|antimetabolites|mesh-ancestor
6699855|NCT01716949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699856|NCT01716949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6699857|NCT01716949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6699858|NCT01716949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6699859|NCT01716949|Immunologic Factors|immunologic factors|mesh-ancestor
6699860|NCT01716949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699861|NCT01717027|Oxycodone|oxycodone|mesh-list
6699862|NCT01717027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6699863|NCT01717027|Narcotics|narcotics|mesh-ancestor
6699864|NCT01717027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6699865|NCT01717027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699866|NCT01717027|Analgesics|analgesics|mesh-ancestor
6699867|NCT01717027|Sensory System Agents|sensory system agents|mesh-ancestor
6699868|NCT01717027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6699869|NCT01717066|Ginsenoside Rg3|ginsenoside rg3|mesh-list
6699870|NCT01717066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6699871|NCT01717066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6699872|NCT01717118|Vaccines|vaccines|mesh-list
6699873|NCT01717118|Immunologic Factors|immunologic factors|mesh-ancestor
6699874|NCT01717118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699875|NCT01717157|Fentanyl|fentanyl|mesh-list
6699876|NCT01717157|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6699877|NCT01717157|Narcotics|narcotics|mesh-ancestor
6699878|NCT01717157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6699879|NCT01717157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699880|NCT01717157|Analgesics|analgesics|mesh-ancestor
6699881|NCT01717157|Sensory System Agents|sensory system agents|mesh-ancestor
6699882|NCT01717157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6699883|NCT01717157|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6699884|NCT01717157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6699885|NCT01717157|Anesthetics, General|anesthetics, general|mesh-ancestor
6699886|NCT01717157|Anesthetics|anesthetics|mesh-ancestor
6699887|NCT01717222|Lidocaine|lidocaine|mesh-list
6699888|NCT01717222|Anesthetics, Local|anesthetics, local|mesh-ancestor
6699889|NCT01717222|Anesthetics|anesthetics|mesh-ancestor
6699890|NCT01717222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6699891|NCT01717222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699892|NCT01717222|Sensory System Agents|sensory system agents|mesh-ancestor
6699893|NCT01717222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6699894|NCT01717222|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6699895|NCT01717222|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6699896|NCT01717222|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6699897|NCT01717222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6699898|NCT01717222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699899|NCT01717235|Ropinirole|ropinirole|mesh-list
6699900|NCT01717235|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6699901|NCT01717235|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6699902|NCT01717235|Dopamine Agonists|dopamine agonists|mesh-ancestor
6699903|NCT01717235|Dopamine Agents|dopamine agents|mesh-ancestor
6699904|NCT01717235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6699905|NCT01717235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699906|NCT01717235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699907|NCT01717300|Oxazolidinones|oxazolidinones|mesh-list
6699908|NCT01717300|Anacetrapib|anacetrapib|mesh-list
6699909|NCT01717300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6699910|NCT01717300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6699911|NCT01717300|Antimetabolites|antimetabolites|mesh-ancestor
6699912|NCT01717300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699913|NCT01717300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6699914|NCT01717300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6699915|NCT01717300|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6699916|NCT01717300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6699917|NCT01717404|Mexiletine|mexiletine|mesh-list
6699918|NCT01717404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6699919|NCT01717404|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6699920|NCT01717404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6699921|NCT01717404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6699922|NCT01717404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781652|NCT02186535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781653|NCT02186535|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6781654|NCT02186535|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6781655|NCT02186574|Tenofovir|tenofovir|mesh-list
6781656|NCT02186574|Antiviral Agents|antiviral agents|mesh-ancestor
6781657|NCT02186574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6781658|NCT02186574|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6781659|NCT02186574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6781660|NCT02186574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6781661|NCT02186574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781662|NCT02186574|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6781663|NCT02186574|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6781664|NCT02186600|Vitamin D|vitamin d|mesh-list
6781665|NCT02186600|Cholecalciferol|cholecalciferol|mesh-list
6781666|NCT02186600|Risedronic Acid|risedronic acid|mesh-list
6781667|NCT02186600|Calcium Carbonate|calcium carbonate|mesh-list
6781668|NCT02186600|Calcium|calcium|mesh-list
6781669|NCT02186600|Vitamins|vitamins|mesh-ancestor
6781670|NCT02186600|Micronutrients|micronutrients|mesh-ancestor
6781671|NCT02186600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781672|NCT02186600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6781673|NCT02186600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6781674|NCT02186600|Antacids|antacids|mesh-ancestor
6781675|NCT02186600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781676|NCT02186600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6781677|NCT02186600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6781678|NCT02186600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6781679|NCT02186769|Risperidone|risperidone|mesh-list
6781680|NCT02186769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6781681|NCT02186769|Serotonin Agents|serotonin agents|mesh-ancestor
6781682|NCT02186769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6781683|NCT02186769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781684|NCT02186769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781685|NCT02186769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6781686|NCT02186769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6781687|NCT02186769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6781688|NCT02186769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6781689|NCT02186769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6781690|NCT02186769|Dopamine Agents|dopamine agents|mesh-ancestor
6781691|NCT02186782|Citric Acid|citric acid|mesh-list
6781692|NCT02186782|Sodium Citrate|sodium citrate|mesh-list
6781693|NCT02186782|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6781694|NCT02186782|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6781695|NCT02186782|Clomiphene|clomiphene|mesh-list
6781696|NCT02186782|Enclomiphene|enclomiphene|mesh-list
6781697|NCT02186782|Zuclomiphene|zuclomiphene|mesh-list
6781698|NCT02186782|Estradiol|estradiol|mesh-list
6781699|NCT02186782|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6781700|NCT02186782|Anticoagulants|anticoagulants|mesh-ancestor
6781701|NCT02186782|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6781702|NCT02186782|Chelating Agents|chelating agents|mesh-ancestor
6781703|NCT02186782|Sequestering Agents|sequestering agents|mesh-ancestor
6699923|NCT01717599|Diclofenac|diclofenac|mesh-list
6699924|NCT01717599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6699925|NCT01717599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6699926|NCT01717599|Analgesics|analgesics|mesh-ancestor
6699927|NCT01717599|Sensory System Agents|sensory system agents|mesh-ancestor
6699928|NCT01717599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6699929|NCT01717599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699930|NCT01717599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6699931|NCT01717599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6699932|NCT01717599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6699933|NCT01717599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6699934|NCT01717599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699935|NCT01717612|Thrombin|thrombin|mesh-list
6699936|NCT01717612|Hemostatics|hemostatics|mesh-ancestor
6699937|NCT01717612|Coagulants|coagulants|mesh-ancestor
6699938|NCT01717625|Montelukast|montelukast|mesh-list
6699939|NCT01717625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6699940|NCT01717625|Respiratory System Agents|respiratory system agents|mesh-ancestor
6699941|NCT01717625|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6699942|NCT01717625|Hormone Antagonists|hormone antagonists|mesh-ancestor
6699943|NCT01717625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6699944|NCT01717625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699945|NCT01717625|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6699946|NCT01717625|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6699947|NCT01717625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699948|NCT01717690|Chlorhexidine|chlorhexidine|mesh-list
6699949|NCT01717690|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6699950|NCT01717690|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
6699951|NCT01717690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6699952|NCT01717690|Disinfectants|disinfectants|mesh-ancestor
6699953|NCT01717690|Dermatologic Agents|dermatologic agents|mesh-ancestor
6699954|NCT01717729|Iodine|iodine|mesh-list
6699955|NCT01717729|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6699956|NCT01717729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6699957|NCT01717729|Trace Elements|trace elements|mesh-ancestor
6699958|NCT01717729|Micronutrients|micronutrients|mesh-ancestor
6699959|NCT01717729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699960|NCT01717807|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6699961|NCT01717807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6699962|NCT01717807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6699963|NCT01717807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6699964|NCT01717807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699965|NCT01717846|Abatacept|abatacept|mesh-list
6699966|NCT01717846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6699967|NCT01717846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699968|NCT01717846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6699969|NCT01717846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6699970|NCT01717846|Immunologic Factors|immunologic factors|mesh-ancestor
6699971|NCT01717846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699972|NCT01717846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6699973|NCT01717911|Metformin|metformin|mesh-list
6699974|NCT01717911|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6699975|NCT01717911|Isophane Insulin, Human|isophane insulin, human|mesh-list
6699976|NCT01717911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6699977|NCT01717911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699978|NCT01717911|Incretins|incretins|mesh-ancestor
6699979|NCT01717911|Hormones|hormones|mesh-ancestor
6699980|NCT01717911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6699981|NCT01717911|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6699982|NCT01717911|Protease Inhibitors|protease inhibitors|mesh-ancestor
6699983|NCT01717911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6699984|NCT01717911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699985|NCT01717950|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6699986|NCT01717950|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6699987|NCT01717950|Immunologic Factors|immunologic factors|mesh-ancestor
6699988|NCT01717950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6699989|NCT01717950|Antacids|antacids|mesh-ancestor
6699990|NCT01717950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6699991|NCT01717950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6699992|NCT01717963|Naltrexone|naltrexone|mesh-list
6699993|NCT01717963|Buprenorphine|buprenorphine|mesh-list
6699994|NCT01717963|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
6699995|NCT01717963|Naloxone|naloxone|mesh-list
6699996|NCT01717963|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6699997|NCT01717963|Narcotics|narcotics|mesh-ancestor
6699998|NCT01717963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6699999|NCT01717963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700000|NCT01717963|Analgesics|analgesics|mesh-ancestor
6700001|NCT01717963|Sensory System Agents|sensory system agents|mesh-ancestor
6700002|NCT01717963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6700003|NCT01717963|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6700004|NCT01717963|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6700005|NCT01718054|Chloroquine|chloroquine|mesh-list
6700006|NCT01718054|Amebicides|amebicides|mesh-ancestor
6700007|NCT01718054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6700008|NCT01718054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6700009|NCT01718054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6700010|NCT01718054|Antimalarials|antimalarials|mesh-ancestor
6700011|NCT01718054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6700012|NCT01718093|Metformin|metformin|mesh-list
6700013|NCT01718093|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6700014|NCT01718093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6700015|NCT01718093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700016|NCT01718093|Incretins|incretins|mesh-ancestor
6700017|NCT01718093|Hormones|hormones|mesh-ancestor
6700018|NCT01718093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6700019|NCT01718093|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6700020|NCT01718093|Protease Inhibitors|protease inhibitors|mesh-ancestor
6700021|NCT01718093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6700022|NCT01718093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700023|NCT01718223|Temoporfin|temoporfin|mesh-list
6700024|NCT01718223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6700025|NCT01718223|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6700026|NCT01718223|Dermatologic Agents|dermatologic agents|mesh-ancestor
6700027|NCT01718236|Rocuronium|rocuronium|mesh-list
6700028|NCT01718236|Succinylcholine|succinylcholine|mesh-list
6700029|NCT01718236|Neostigmine|neostigmine|mesh-list
6700030|NCT01718236|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6700031|NCT01718236|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6700032|NCT01718236|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6700033|NCT01718236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6700034|NCT01718236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700035|NCT01718236|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6700036|NCT01718236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6700037|NCT01718236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700038|NCT01718236|Cholinergic Agents|cholinergic agents|mesh-ancestor
6700039|NCT01718236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6700040|NCT01718236|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6700041|NCT01718236|Autonomic Agents|autonomic agents|mesh-ancestor
6700042|NCT01718236|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
6700043|NCT01718288|Aspirin|aspirin|mesh-list
6700044|NCT01718288|Iloprost|iloprost|mesh-list
6700045|NCT01718288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6700046|NCT01718288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6700047|NCT01718288|Analgesics|analgesics|mesh-ancestor
6700048|NCT01718288|Sensory System Agents|sensory system agents|mesh-ancestor
6700049|NCT01718288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6700050|NCT01718288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700051|NCT01718288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6700052|NCT01718288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6700053|NCT01718288|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6700054|NCT01718288|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6700055|NCT01718288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700056|NCT01718288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6700057|NCT01718288|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6700058|NCT01718288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6700059|NCT01718288|Antipyretics|antipyretics|mesh-ancestor
6700060|NCT01718288|Vasodilator Agents|vasodilator agents|mesh-ancestor
6700061|NCT01718301|Ribavirin|ribavirin|mesh-list
6700062|NCT01718301|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6700063|NCT01718301|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6700064|NCT01718301|Antimetabolites|antimetabolites|mesh-ancestor
6700065|NCT01718301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700066|NCT01718301|Antiviral Agents|antiviral agents|mesh-ancestor
6700067|NCT01718301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6700068|NCT01718314|Lidocaine|lidocaine|mesh-list
6700069|NCT01718314|Misoprostol|misoprostol|mesh-list
6700070|NCT01718314|Anesthetics, Local|anesthetics, local|mesh-ancestor
6700071|NCT01718314|Anesthetics|anesthetics|mesh-ancestor
6700072|NCT01718314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6700073|NCT01718314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700074|NCT01718314|Sensory System Agents|sensory system agents|mesh-ancestor
6700075|NCT01718314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6700076|NCT01718314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6700077|NCT01718314|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6700078|NCT01718314|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6700079|NCT01718314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6700080|NCT01718314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700081|NCT01718314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6700082|NCT01718314|Abortifacient Agents|abortifacient agents|mesh-ancestor
6700083|NCT01718314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6700084|NCT01718314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6700085|NCT01718314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6700086|NCT01718314|Oxytocics|oxytocics|mesh-ancestor
6700087|NCT01718327|Sunitinib|sunitinib|mesh-list
6700088|NCT01718327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6700089|NCT01718327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6700090|NCT01718327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6700091|NCT01718327|Growth Substances|growth substances|mesh-ancestor
6700092|NCT01718327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700093|NCT01718327|Growth Inhibitors|growth inhibitors|mesh-ancestor
6700094|NCT01718327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6700095|NCT01718327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6700096|NCT01718327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700097|NCT01718340|Metformin|metformin|mesh-list
6700098|NCT01718340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6700099|NCT01718340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700100|NCT01718366|Vitamin D|vitamin d|mesh-list
6700101|NCT01718366|Azacitidine|azacitidine|mesh-list
6700102|NCT01718366|Deferasirox|deferasirox|mesh-list
6700103|NCT01718366|Vitamins|vitamins|mesh-ancestor
6700104|NCT01718366|Micronutrients|micronutrients|mesh-ancestor
6700105|NCT01718366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700106|NCT01718366|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6700107|NCT01718366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6700108|NCT01718366|Antimetabolites|antimetabolites|mesh-ancestor
6700109|NCT01718366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700110|NCT01718366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6700111|NCT01718366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6700112|NCT01718366|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6700113|NCT01718366|Chelating Agents|chelating agents|mesh-ancestor
6700114|NCT01718366|Sequestering Agents|sequestering agents|mesh-ancestor
6700115|NCT01718379|Lenalidomide|lenalidomide|mesh-list
6700116|NCT01718379|Immunologic Factors|immunologic factors|mesh-ancestor
6700117|NCT01718379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700118|NCT01718379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6700119|NCT01718379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6700120|NCT01718379|Growth Substances|growth substances|mesh-ancestor
6700121|NCT01718379|Growth Inhibitors|growth inhibitors|mesh-ancestor
6700122|NCT01718379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6700123|NCT01718496|Morphine|morphine|mesh-list
6700124|NCT01718496|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6700125|NCT01718496|Narcotics|narcotics|mesh-ancestor
6700126|NCT01718496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6700127|NCT01718496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700128|NCT01718496|Analgesics|analgesics|mesh-ancestor
6700129|NCT01718496|Sensory System Agents|sensory system agents|mesh-ancestor
6700130|NCT01718496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6700131|NCT01718587|Lamivudine|lamivudine|mesh-list
6700132|NCT01718587|Antiviral Agents|antiviral agents|mesh-list
6700133|NCT01718587|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6700134|NCT01718587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6700135|NCT01718587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6700136|NCT01718587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700137|NCT01718587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6700138|NCT01718587|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6700139|NCT01718587|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6700140|NCT01718613|Vasopressins|vasopressins|mesh-list
6700141|NCT01718613|Arginine Vasopressin|arginine vasopressin|mesh-list
6700142|NCT01718613|Norepinephrine|norepinephrine|mesh-list
6700143|NCT01718613|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6700144|NCT01718613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6700145|NCT01718613|Adrenergic Agents|adrenergic agents|mesh-ancestor
6700146|NCT01718613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6700147|NCT01718613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700148|NCT01718613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700149|NCT01718613|Sympathomimetics|sympathomimetics|mesh-ancestor
6700150|NCT01718613|Autonomic Agents|autonomic agents|mesh-ancestor
6700151|NCT01718613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6700152|NCT01718613|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6700153|NCT01718613|Hemostatics|hemostatics|mesh-ancestor
6700154|NCT01718613|Coagulants|coagulants|mesh-ancestor
6700155|NCT01718613|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6700156|NCT01718613|Natriuretic Agents|natriuretic agents|mesh-ancestor
6700157|NCT01718626|Docetaxel|docetaxel|mesh-list
6700158|NCT01718626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6700159|NCT01718626|Tubulin Modulators|tubulin modulators|mesh-ancestor
6700160|NCT01718626|Antimitotic Agents|antimitotic agents|mesh-ancestor
6700161|NCT01718626|Mitosis Modulators|mitosis modulators|mesh-ancestor
6700162|NCT01718626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700163|NCT01718652|Canagliflozin|canagliflozin|mesh-list
6700164|NCT01718652|Cyclosporine|cyclosporine|mesh-list
6700165|NCT01718652|Cyclosporins|cyclosporins|mesh-list
6700166|NCT01718652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6700167|NCT01718652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700168|NCT01718652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6700169|NCT01718652|Immunologic Factors|immunologic factors|mesh-ancestor
6700170|NCT01718652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700171|NCT01718652|Antifungal Agents|antifungal agents|mesh-ancestor
6700172|NCT01718652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6700173|NCT01718652|Dermatologic Agents|dermatologic agents|mesh-ancestor
6700174|NCT01718652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6700175|NCT01718652|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6700176|NCT01718652|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6700177|NCT01718652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6700178|NCT01718678|Melatonin|melatonin|mesh-list
6700179|NCT01718678|Antioxidants|antioxidants|mesh-ancestor
6700180|NCT01718678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700181|NCT01718678|Protective Agents|protective agents|mesh-ancestor
6700182|NCT01718678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700183|NCT01718678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6700184|NCT01718717|Morphine|morphine|mesh-list
6700185|NCT01718717|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6700186|NCT01718717|Narcotics|narcotics|mesh-ancestor
6700187|NCT01718717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6700188|NCT01718717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700189|NCT01718717|Analgesics|analgesics|mesh-ancestor
6700190|NCT01718717|Sensory System Agents|sensory system agents|mesh-ancestor
6700191|NCT01718717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6700192|NCT01718808|Capecitabine|capecitabine|mesh-list
6700193|NCT01718808|Cetuximab|cetuximab|mesh-list
6700194|NCT01718808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6700195|NCT01718808|Antimetabolites|antimetabolites|mesh-ancestor
6700196|NCT01718808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700197|NCT01718808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6700198|NCT01718808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6700199|NCT01718834|Vaccines|vaccines|mesh-list
6700200|NCT01718834|Immunologic Factors|immunologic factors|mesh-ancestor
6700201|NCT01718834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700202|NCT01718873|Leucovorin|leucovorin|mesh-list
6700203|NCT01718873|Folic Acid|folic acid|mesh-list
6700204|NCT01718873|Bevacizumab|bevacizumab|mesh-list
6700205|NCT01718873|Fluorouracil|fluorouracil|mesh-list
6700206|NCT01718873|Capecitabine|capecitabine|mesh-list
6700207|NCT01718873|Oxaliplatin|oxaliplatin|mesh-list
6700208|NCT01718873|Levoleucovorin|levoleucovorin|mesh-list
6700209|NCT01718873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6700210|NCT01718873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6700211|NCT01718873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6700212|NCT01718873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6700213|NCT01718873|Growth Substances|growth substances|mesh-ancestor
6700214|NCT01718873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700215|NCT01718873|Growth Inhibitors|growth inhibitors|mesh-ancestor
6700216|NCT01718873|Antimetabolites|antimetabolites|mesh-ancestor
6700217|NCT01718873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700218|NCT01718873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6700219|NCT01718873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6700220|NCT01718873|Immunologic Factors|immunologic factors|mesh-ancestor
6700221|NCT01718873|Antidotes|antidotes|mesh-ancestor
6700222|NCT01718873|Protective Agents|protective agents|mesh-ancestor
6700223|NCT01718873|Vitamin B Complex|vitamin b complex|mesh-ancestor
6700224|NCT01718873|Vitamins|vitamins|mesh-ancestor
6700225|NCT01718873|Micronutrients|micronutrients|mesh-ancestor
6700226|NCT01718873|Hematinics|hematinics|mesh-ancestor
6700227|NCT01718899|Lenalidomide|lenalidomide|mesh-list
6700228|NCT01718899|Immunologic Factors|immunologic factors|mesh-ancestor
6700229|NCT01718899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700230|NCT01718899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6700231|NCT01718899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6700232|NCT01718899|Growth Substances|growth substances|mesh-ancestor
6700233|NCT01718899|Growth Inhibitors|growth inhibitors|mesh-ancestor
6700234|NCT01718899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6700235|NCT01718912|Metronidazole|metronidazole|mesh-list
6700236|NCT01718912|Nystatin|nystatin|mesh-list
6700237|NCT01718912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6700238|NCT01718912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6700239|NCT01718912|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6700240|NCT01718912|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6700241|NCT01718912|Antifungal Agents|antifungal agents|mesh-ancestor
6700242|NCT01718912|Ionophores|ionophores|mesh-ancestor
6700243|NCT01718912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6700244|NCT01718912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700245|NCT01718951|Pamidronate|pamidronate|mesh-list
6700246|NCT01718951|Golimumab|golimumab|mesh-list
6700247|NCT01718951|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6700248|NCT01718951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6700249|NCT01718951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6700250|NCT01718951|Immunologic Factors|immunologic factors|mesh-ancestor
6700251|NCT01718951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700252|NCT01718951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6700253|NCT01718964|Hydrocortisone|hydrocortisone|mesh-list
6700254|NCT01718964|Mannitol|mannitol|mesh-list
6700255|NCT01718964|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6700256|NCT01718964|Diuretics|diuretics|mesh-ancestor
6700257|NCT01718964|Natriuretic Agents|natriuretic agents|mesh-ancestor
6700258|NCT01718964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700259|NCT01718964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6700260|NCT01719016|Adenosine|adenosine|mesh-list
6700261|NCT01719016|Analgesics|analgesics|mesh-ancestor
6700262|NCT01719016|Sensory System Agents|sensory system agents|mesh-ancestor
6700263|NCT01719016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6700264|NCT01719016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700265|NCT01719016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6700266|NCT01719016|Vasodilator Agents|vasodilator agents|mesh-ancestor
6700267|NCT01719016|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6700268|NCT01719016|Purinergic Agonists|purinergic agonists|mesh-ancestor
6700269|NCT01719016|Purinergic Agents|purinergic agents|mesh-ancestor
6700270|NCT01719016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6700271|NCT01719016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700272|NCT01719042|Ondansetron|ondansetron|mesh-list
6700273|NCT01719042|Antiemetics|antiemetics|mesh-ancestor
6700274|NCT01719042|Autonomic Agents|autonomic agents|mesh-ancestor
6700275|NCT01719042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6700276|NCT01719042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700277|NCT01719042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6700278|NCT01719042|Antipruritics|antipruritics|mesh-ancestor
6700279|NCT01719042|Dermatologic Agents|dermatologic agents|mesh-ancestor
6700280|NCT01719042|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6700281|NCT01719042|Serotonin Agents|serotonin agents|mesh-ancestor
6700282|NCT01719042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6700283|NCT01719042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700284|NCT01719042|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6700285|NCT01719042|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6700286|NCT01719042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6700287|NCT01719042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6700288|NCT01719042|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6700289|NCT01719133|Histamine|histamine|mesh-list
6700290|NCT01719133|Histamine phosphate|histamine phosphate|mesh-list
6700291|NCT01719133|Histamine Agonists|histamine agonists|mesh-ancestor
6700292|NCT01719133|Histamine Agents|histamine agents|mesh-ancestor
6700293|NCT01719133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6700294|NCT01719133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700295|NCT01719133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781704|NCT02186782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781705|NCT02186782|Estrogens|estrogens|mesh-ancestor
6781706|NCT02186782|Hormones|hormones|mesh-ancestor
6781707|NCT02186782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6781708|NCT02186782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700296|NCT01719159|Rituximab|rituximab|mesh-list
6700297|NCT01719159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6700298|NCT01719159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6700299|NCT01719159|Immunologic Factors|immunologic factors|mesh-ancestor
6700300|NCT01719159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700301|NCT01719159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6700302|NCT01719185|Vitamin B 12|vitamin b 12|mesh-list
6700303|NCT01719185|Phentermine|phentermine|mesh-list
6700304|NCT01719185|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6700305|NCT01719185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700306|NCT01719185|Appetite Depressants|appetite depressants|mesh-ancestor
6700307|NCT01719185|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6700308|NCT01719185|Sympathomimetics|sympathomimetics|mesh-ancestor
6700309|NCT01719185|Autonomic Agents|autonomic agents|mesh-ancestor
6700310|NCT01719185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6700311|NCT01719185|Adrenergic Agents|adrenergic agents|mesh-ancestor
6700312|NCT01719185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6700313|NCT01719185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700314|NCT01719185|Vitamin B Complex|vitamin b complex|mesh-ancestor
6700315|NCT01719185|Vitamins|vitamins|mesh-ancestor
6700316|NCT01719185|Micronutrients|micronutrients|mesh-ancestor
6700317|NCT01719237|Ropivacaine|ropivacaine|mesh-list
6700318|NCT01719237|Chloroprocaine|chloroprocaine|mesh-list
6700319|NCT01719237|Anesthetics, Local|anesthetics, local|mesh-ancestor
6700320|NCT01719237|Anesthetics|anesthetics|mesh-ancestor
6700321|NCT01719237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6700322|NCT01719237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700323|NCT01719237|Sensory System Agents|sensory system agents|mesh-ancestor
6700324|NCT01719237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6700325|NCT01719302|Gemcitabine|gemcitabine|mesh-list
6700326|NCT01719302|Docetaxel|docetaxel|mesh-list
6700327|NCT01719302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6700328|NCT01719302|Antimetabolites|antimetabolites|mesh-ancestor
6700329|NCT01719302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700330|NCT01719302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6700331|NCT01719302|Antiviral Agents|antiviral agents|mesh-ancestor
6700332|NCT01719302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6700333|NCT01719302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6700334|NCT01719302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6700335|NCT01719302|Immunologic Factors|immunologic factors|mesh-ancestor
6700336|NCT01719302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700337|NCT01719302|Tubulin Modulators|tubulin modulators|mesh-ancestor
6700338|NCT01719302|Antimitotic Agents|antimitotic agents|mesh-ancestor
6700339|NCT01719302|Mitosis Modulators|mitosis modulators|mesh-ancestor
6700340|NCT01719419|Orlistat|orlistat|mesh-list
6700341|NCT01719419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6700342|NCT01719419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700343|NCT01719419|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6700344|NCT01719419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6700345|NCT01719588|Tapentadol|tapentadol|mesh-list
6700346|NCT01719588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6700347|NCT01719588|Narcotics|narcotics|mesh-ancestor
6700348|NCT01719588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6700349|NCT01719588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700350|NCT01719588|Analgesics|analgesics|mesh-ancestor
6700351|NCT01719588|Sensory System Agents|sensory system agents|mesh-ancestor
6700352|NCT01719588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6700353|NCT01719588|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6700354|NCT01719588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6700355|NCT01719588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6700356|NCT01719588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700357|NCT01719588|Adrenergic Agents|adrenergic agents|mesh-ancestor
6700358|NCT01719588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6700359|NCT01719601|Tapentadol|tapentadol|mesh-list
6700360|NCT01719601|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6700361|NCT01719601|Narcotics|narcotics|mesh-ancestor
6700362|NCT01719601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6700363|NCT01719601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700364|NCT01719601|Analgesics|analgesics|mesh-ancestor
6700365|NCT01719601|Sensory System Agents|sensory system agents|mesh-ancestor
6700366|NCT01719601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6700367|NCT01719601|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6700368|NCT01719601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6700369|NCT01719601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6700370|NCT01719601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700371|NCT01719601|Adrenergic Agents|adrenergic agents|mesh-ancestor
6700372|NCT01719601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6700373|NCT01719614|Metformin|metformin|mesh-list
6700374|NCT01719614|Rilpivirine|rilpivirine|mesh-list
6700375|NCT01719614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6700376|NCT01719614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700377|NCT01719614|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6700378|NCT01719614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6700379|NCT01719614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6700380|NCT01719614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700381|NCT01719614|Antiviral Agents|antiviral agents|mesh-ancestor
6700382|NCT01719614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6700383|NCT01719614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6700384|NCT01719614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6700385|NCT01719627|Maraviroc|maraviroc|mesh-list
6700386|NCT01719627|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6700387|NCT01719627|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6700388|NCT01719627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700389|NCT01719627|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6700390|NCT01719627|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6700391|NCT01719627|Antiviral Agents|antiviral agents|mesh-ancestor
6700392|NCT01719627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6700393|NCT01719627|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6700394|NCT01719640|Insulin|insulin|mesh-list
6700395|NCT01719640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6700396|NCT01719640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700397|NCT01719692|Rituximab|rituximab|mesh-list
6700398|NCT01719692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6700399|NCT01719692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6700400|NCT01719692|Immunologic Factors|immunologic factors|mesh-ancestor
6700401|NCT01719692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700402|NCT01719692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6700403|NCT01719705|Pregabalin|pregabalin|mesh-list
6700404|NCT01719705|Analgesics|analgesics|mesh-ancestor
6700405|NCT01719705|Sensory System Agents|sensory system agents|mesh-ancestor
6700406|NCT01719705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6700407|NCT01719705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700408|NCT01719705|Anticonvulsants|anticonvulsants|mesh-ancestor
6700409|NCT01719705|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6700410|NCT01719705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6700411|NCT01719705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700412|NCT01719705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6700413|NCT01719705|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6700414|NCT01719705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6700415|NCT01719705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6700416|NCT01719705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6700417|NCT01719770|Rocuronium|rocuronium|mesh-list
6700418|NCT01719770|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6700419|NCT01719770|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6700420|NCT01719770|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6700421|NCT01719770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6700422|NCT01719770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700423|NCT01719835|Gemcitabine|gemcitabine|mesh-list
6700424|NCT01719835|Methylprednisolone|methylprednisolone|mesh-list
6700425|NCT01719835|Prednisolone|prednisolone|mesh-list
6700426|NCT01719835|Cyclophosphamide|cyclophosphamide|mesh-list
6700427|NCT01719835|Doxorubicin|doxorubicin|mesh-list
6700428|NCT01719835|Vincristine|vincristine|mesh-list
6700429|NCT01719835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6700430|NCT01719835|Immunologic Factors|immunologic factors|mesh-ancestor
6700431|NCT01719835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700432|NCT01719835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6700433|NCT01719835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6700434|NCT01719835|Alkylating Agents|alkylating agents|mesh-ancestor
6700435|NCT01719835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700436|NCT01719835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6700437|NCT01719835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6700438|NCT01719835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6700439|NCT01719835|Antimetabolites|antimetabolites|mesh-ancestor
6700440|NCT01719835|Antiviral Agents|antiviral agents|mesh-ancestor
6700441|NCT01719835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6700442|NCT01719835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6700443|NCT01719835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6700444|NCT01719835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6700445|NCT01719835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6700446|NCT01719835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6700447|NCT01719835|Tubulin Modulators|tubulin modulators|mesh-ancestor
6700448|NCT01719835|Antimitotic Agents|antimitotic agents|mesh-ancestor
6700449|NCT01719835|Mitosis Modulators|mitosis modulators|mesh-ancestor
6700450|NCT01719835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6700451|NCT01719835|Antiemetics|antiemetics|mesh-ancestor
6700452|NCT01719835|Autonomic Agents|autonomic agents|mesh-ancestor
6700453|NCT01719835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6700454|NCT01719835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6700455|NCT01719835|Glucocorticoids|glucocorticoids|mesh-ancestor
6700456|NCT01719835|Hormones|hormones|mesh-ancestor
6700457|NCT01719835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6700458|NCT01719835|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6700459|NCT01719835|Protective Agents|protective agents|mesh-ancestor
6700460|NCT01719835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6700461|NCT01719926|Indomethacin|indomethacin|mesh-list
6700462|NCT01719926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6700463|NCT01719926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6700464|NCT01719926|Analgesics|analgesics|mesh-ancestor
6700465|NCT01719926|Sensory System Agents|sensory system agents|mesh-ancestor
6700466|NCT01719926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6700467|NCT01719926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700468|NCT01719926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6700469|NCT01719926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6700470|NCT01719926|Gout Suppressants|gout suppressants|mesh-ancestor
6700471|NCT01719926|Tocolytic Agents|tocolytic agents|mesh-ancestor
6700472|NCT01719926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6700473|NCT01719926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6700474|NCT01719926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6700475|NCT01719926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700476|NCT01719952|Oxytocin|oxytocin|mesh-list
6700477|NCT01719952|Carbetocin|carbetocin|mesh-list
6700478|NCT01719952|Oxytocics|oxytocics|mesh-ancestor
6700479|NCT01719952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6700480|NCT01719952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700481|NCT01719978|Epinephrine|epinephrine|mesh-list
6700482|NCT01719978|Racepinephrine|racepinephrine|mesh-list
6700483|NCT01719978|Mepivacaine|mepivacaine|mesh-list
6700484|NCT01719978|Epinephryl borate|epinephryl borate|mesh-list
6700485|NCT01719978|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6700486|NCT01719978|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6700487|NCT01719978|Adrenergic Agents|adrenergic agents|mesh-ancestor
6700488|NCT01719978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6700489|NCT01719978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700490|NCT01719978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700491|NCT01719978|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6700492|NCT01719978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6700493|NCT01719978|Autonomic Agents|autonomic agents|mesh-ancestor
6700494|NCT01719978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6700495|NCT01719978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6700496|NCT01719978|Respiratory System Agents|respiratory system agents|mesh-ancestor
6700497|NCT01719978|Mydriatics|mydriatics|mesh-ancestor
6700498|NCT01719978|Sympathomimetics|sympathomimetics|mesh-ancestor
6700499|NCT01719978|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6700500|NCT01719978|Anesthetics, Local|anesthetics, local|mesh-ancestor
6700501|NCT01719978|Anesthetics|anesthetics|mesh-ancestor
6700502|NCT01719978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6700503|NCT01719978|Sensory System Agents|sensory system agents|mesh-ancestor
6700504|NCT01720030|Simendan|simendan|mesh-list
6700505|NCT01720030|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6700506|NCT01720030|Vasodilator Agents|vasodilator agents|mesh-ancestor
6700507|NCT01720030|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6700508|NCT01720030|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6700509|NCT01720030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6700510|NCT01720030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700511|NCT01720030|Protective Agents|protective agents|mesh-ancestor
6700512|NCT01720030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700513|NCT01720056|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6700514|NCT01720056|Verapamil|verapamil|mesh-list
6700515|NCT01720056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6700516|NCT01720056|Glucocorticoids|glucocorticoids|mesh-ancestor
6700517|NCT01720056|Hormones|hormones|mesh-ancestor
6700518|NCT01720056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6700519|NCT01720056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700520|NCT01720056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6700521|NCT01720056|Immunologic Factors|immunologic factors|mesh-ancestor
6700522|NCT01720056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700523|NCT01720056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6700524|NCT01720056|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6700525|NCT01720056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6700526|NCT01720056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6700527|NCT01720056|Vasodilator Agents|vasodilator agents|mesh-ancestor
6700528|NCT01720095|Niacin|niacin|mesh-list
6700529|NCT01720095|Nicotinic Acids|nicotinic acids|mesh-list
6700530|NCT01720095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6700531|NCT01720095|Antimetabolites|antimetabolites|mesh-ancestor
6700532|NCT01720095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700533|NCT01720095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6700534|NCT01720095|Vasodilator Agents|vasodilator agents|mesh-ancestor
6700535|NCT01720095|Vitamin B Complex|vitamin b complex|mesh-ancestor
6700536|NCT01720095|Vitamins|vitamins|mesh-ancestor
6700537|NCT01720095|Micronutrients|micronutrients|mesh-ancestor
6700538|NCT01720095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700539|NCT01720108|Rivaroxaban|rivaroxaban|mesh-list
6700540|NCT01720108|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6700541|NCT01720108|Antithrombins|antithrombins|mesh-ancestor
6700542|NCT01720108|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6700543|NCT01720108|Protease Inhibitors|protease inhibitors|mesh-ancestor
6700544|NCT01720108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6700545|NCT01720108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700546|NCT01720108|Anticoagulants|anticoagulants|mesh-ancestor
6700547|NCT01720212|Mirabegron|mirabegron|mesh-list
6700548|NCT01720212|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6700549|NCT01720212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6700550|NCT01720212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6700551|NCT01720212|Adrenergic Agents|adrenergic agents|mesh-ancestor
6700552|NCT01720212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6700553|NCT01720212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700554|NCT01720212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700555|NCT01720212|Urological Agents|urological agents|mesh-ancestor
6700556|NCT01720238|Lamivudine|lamivudine|mesh-list
6700557|NCT01720238|Adefovir|adefovir|mesh-list
6700558|NCT01720238|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6700559|NCT01720238|Entecavir|entecavir|mesh-list
6700560|NCT01720238|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6700561|NCT01720238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6700562|NCT01720238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6700563|NCT01720238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700564|NCT01720238|Antiviral Agents|antiviral agents|mesh-ancestor
6700565|NCT01720238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6700566|NCT01720238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6700567|NCT01720238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6700568|NCT01720290|Metformin|metformin|mesh-list
6700569|NCT01720290|Repaglinide|repaglinide|mesh-list
6700570|NCT01720290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6700571|NCT01720290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700572|NCT01720303|Insulin|insulin|mesh-list
6700573|NCT01720303|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6700574|NCT01720303|Repaglinide|repaglinide|mesh-list
6700575|NCT01720303|Isophane Insulin, Human|isophane insulin, human|mesh-list
6700576|NCT01720303|Insulin, Isophane|insulin, isophane|mesh-list
6700577|NCT01720303|Isophane insulin, beef|isophane insulin, beef|mesh-list
6700578|NCT01720303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6700579|NCT01720303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700580|NCT01720394|Dinoprostone|dinoprostone|mesh-list
6700581|NCT01720394|Oxytocics|oxytocics|mesh-ancestor
6700582|NCT01720394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6700583|NCT01720394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700584|NCT01720407|Imiquimod|imiquimod|mesh-list
6700585|NCT01720407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6700586|NCT01720407|Immunologic Factors|immunologic factors|mesh-ancestor
6700587|NCT01720407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700588|NCT01720407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6700589|NCT01720407|Interferon Inducers|interferon inducers|mesh-ancestor
6700590|NCT01720459|Resveratrol|resveratrol|mesh-list
6700591|NCT01720459|Antioxidants|antioxidants|mesh-ancestor
6700592|NCT01720459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700593|NCT01720459|Protective Agents|protective agents|mesh-ancestor
6700594|NCT01720459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700595|NCT01720459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6700596|NCT01720459|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6700597|NCT01720485|Prednisolone|prednisolone|mesh-list
6700598|NCT01720485|Betamethasone|betamethasone|mesh-list
6700599|NCT01720485|Desloratadine|desloratadine|mesh-list
6700600|NCT01720485|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
6700601|NCT01720485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6700602|NCT01720485|Glucocorticoids|glucocorticoids|mesh-ancestor
6700603|NCT01720485|Hormones|hormones|mesh-ancestor
6700604|NCT01720485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6700605|NCT01720485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700606|NCT01720485|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6700607|NCT01720485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6700608|NCT01720485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6700609|NCT01720485|Respiratory System Agents|respiratory system agents|mesh-ancestor
6700610|NCT01720485|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6700611|NCT01720485|Cholinergic Agents|cholinergic agents|mesh-ancestor
6700612|NCT01720485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6700613|NCT01720485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700614|NCT01720485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6700615|NCT01720485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6700616|NCT01720485|Histamine Antagonists|histamine antagonists|mesh-ancestor
6700617|NCT01720485|Histamine Agents|histamine agents|mesh-ancestor
6700618|NCT01720498|Remifentanil|remifentanil|mesh-list
6700619|NCT01720498|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6700620|NCT01720498|Narcotics|narcotics|mesh-ancestor
6700621|NCT01720498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6700622|NCT01720498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700623|NCT01720498|Analgesics|analgesics|mesh-ancestor
6700624|NCT01720498|Sensory System Agents|sensory system agents|mesh-ancestor
6700625|NCT01720498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6700626|NCT01720537|Bococizumab|bococizumab|mesh-list
6700627|NCT01720537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6700628|NCT01720537|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6700629|NCT01720537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6700630|NCT01720537|Antimetabolites|antimetabolites|mesh-ancestor
6700631|NCT01720537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700632|NCT01720537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6700633|NCT01720537|Immunologic Factors|immunologic factors|mesh-ancestor
6700634|NCT01720537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700635|NCT01720563|Leucovorin|leucovorin|mesh-list
6700636|NCT01720563|Tegafur|tegafur|mesh-list
6700637|NCT01720563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6700638|NCT01720563|Antidotes|antidotes|mesh-ancestor
6700639|NCT01720563|Protective Agents|protective agents|mesh-ancestor
6700640|NCT01720563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700641|NCT01720563|Vitamin B Complex|vitamin b complex|mesh-ancestor
6700642|NCT01720563|Vitamins|vitamins|mesh-ancestor
6700643|NCT01720563|Micronutrients|micronutrients|mesh-ancestor
6700644|NCT01720563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6700645|NCT01720563|Antimetabolites|antimetabolites|mesh-ancestor
6700646|NCT01720563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700647|NCT01720615|Remifentanil|remifentanil|mesh-list
6700648|NCT01720615|Propofol|propofol|mesh-list
6700649|NCT01720615|Sevoflurane|sevoflurane|mesh-list
6700650|NCT01720615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6700651|NCT01720615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6700652|NCT01720615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700653|NCT01720615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6700654|NCT01720615|Anesthetics, General|anesthetics, general|mesh-ancestor
6700655|NCT01720615|Anesthetics|anesthetics|mesh-ancestor
6700656|NCT01720615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6700657|NCT01720615|Narcotics|narcotics|mesh-ancestor
6700658|NCT01720615|Analgesics|analgesics|mesh-ancestor
6700659|NCT01720615|Sensory System Agents|sensory system agents|mesh-ancestor
6700660|NCT01720615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6700661|NCT01720615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6700662|NCT01720615|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6700663|NCT01720628|Angiogenin|angiogenin|mesh-list
6700664|NCT01720628|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
6700665|NCT01720628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6700666|NCT01720628|Growth Substances|growth substances|mesh-ancestor
6700667|NCT01720628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700668|NCT01720719|Vitamin E|vitamin e|mesh-list
6700669|NCT01720719|Atorvastatin|atorvastatin|mesh-list
6700670|NCT01720719|Vitamins|vitamins|mesh-ancestor
6700671|NCT01720719|Micronutrients|micronutrients|mesh-ancestor
6700672|NCT01720719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700673|NCT01720719|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6700674|NCT01720719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6700675|NCT01720719|Antimetabolites|antimetabolites|mesh-ancestor
6700676|NCT01720719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700677|NCT01720719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6700678|NCT01720719|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6700679|NCT01720719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6700680|NCT01720719|Antioxidants|antioxidants|mesh-ancestor
6700681|NCT01720719|Protective Agents|protective agents|mesh-ancestor
6781709|NCT02186782|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6781710|NCT02186782|Contraceptive Agents|contraceptive agents|mesh-ancestor
6781711|NCT02186782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6781712|NCT02186782|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6781713|NCT02186782|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6781714|NCT02186782|Hormone Antagonists|hormone antagonists|mesh-ancestor
6781715|NCT02186782|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6781716|NCT02186782|Fertility Agents|fertility agents|mesh-ancestor
6781717|NCT02186782|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6781718|NCT02186782|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6781719|NCT02186886|Golimumab|golimumab|mesh-list
6781720|NCT02186886|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6781721|NCT02186886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6781722|NCT02186886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6781723|NCT02186886|Immunologic Factors|immunologic factors|mesh-ancestor
6781724|NCT02186886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781725|NCT02186899|Anesthetics|anesthetics|mesh-list
6781726|NCT02186899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6781727|NCT02186899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781728|NCT02186951|Amoxicillin|amoxicillin|mesh-list
6781729|NCT02186951|Clavulanic Acids|clavulanic acids|mesh-list
6781730|NCT02186951|Clavulanic Acid|clavulanic acid|mesh-list
6781731|NCT02186951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6781732|NCT02186951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6781733|NCT02186951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6781734|NCT02186951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781735|NCT02186951|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6781736|NCT02186990|Propofol|propofol|mesh-list
6781737|NCT02186990|Etomidate|etomidate|mesh-list
6781738|NCT02186990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6781739|NCT02186990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6781740|NCT02186990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781741|NCT02186990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6781742|NCT02186990|Anesthetics, General|anesthetics, general|mesh-ancestor
6781743|NCT02186990|Anesthetics|anesthetics|mesh-ancestor
6781744|NCT02187068|Dexmedetomidine|dexmedetomidine|mesh-list
6781745|NCT02187068|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6781746|NCT02187068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6781747|NCT02187068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781748|NCT02187068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6781749|NCT02187068|Analgesics|analgesics|mesh-ancestor
6781750|NCT02187068|Sensory System Agents|sensory system agents|mesh-ancestor
6781751|NCT02187068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6781752|NCT02187068|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6781753|NCT02187068|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6781754|NCT02187068|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6781755|NCT02187068|Adrenergic Agents|adrenergic agents|mesh-ancestor
6781756|NCT02187068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6781757|NCT02187068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781758|NCT02187081|Sorafenib|sorafenib|mesh-list
6781759|NCT02187081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6781760|NCT02187081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6781761|NCT02187081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6781762|NCT02187081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781763|NCT02187107|Darunavir|darunavir|mesh-list
6781764|NCT02187107|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6781765|NCT02187107|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6781766|NCT02187107|Protease Inhibitors|protease inhibitors|mesh-ancestor
6781767|NCT02187107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6781768|NCT02187107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781769|NCT02187107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6781770|NCT02187107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6781771|NCT02187107|Antiviral Agents|antiviral agents|mesh-ancestor
6781772|NCT02187107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6781773|NCT02187120|Tranexamic Acid|tranexamic acid|mesh-list
6781774|NCT02187120|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6781775|NCT02187120|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6781776|NCT02187120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700682|NCT01720836|Poly ICLC|poly iclc|mesh-list
6700683|NCT01720836|Interferon Inducers|interferon inducers|mesh-ancestor
6700684|NCT01720836|Immunologic Factors|immunologic factors|mesh-ancestor
6700685|NCT01720836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700686|NCT01720875|Dexamethasone|dexamethasone|mesh-list
6700687|NCT01720875|Bortezomib|bortezomib|mesh-list
6700688|NCT01720875|Vorinostat|vorinostat|mesh-list
6700689|NCT01720875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6700690|NCT01720875|Antiemetics|antiemetics|mesh-ancestor
6700691|NCT01720875|Autonomic Agents|autonomic agents|mesh-ancestor
6700692|NCT01720875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6700693|NCT01720875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700694|NCT01720875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6700695|NCT01720875|Glucocorticoids|glucocorticoids|mesh-ancestor
6700696|NCT01720875|Hormones|hormones|mesh-ancestor
6700697|NCT01720875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6700698|NCT01720875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6700699|NCT01720875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6700700|NCT01720875|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6700701|NCT01720875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6700702|NCT01720875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700703|NCT01720940|Vancomycin|vancomycin|mesh-list
6700704|NCT01720940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6700705|NCT01720940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6700706|NCT01721031|Tramadol|tramadol|mesh-list
6700707|NCT01721031|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6700708|NCT01721031|Narcotics|narcotics|mesh-ancestor
6700709|NCT01721031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6700710|NCT01721031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700711|NCT01721031|Analgesics|analgesics|mesh-ancestor
6700712|NCT01721031|Sensory System Agents|sensory system agents|mesh-ancestor
6700713|NCT01721031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6700714|NCT01721135|Moxifloxacin|moxifloxacin|mesh-list
6700715|NCT01721135|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6700716|NCT01721135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6700717|NCT01721135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6700718|NCT01721135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6700719|NCT01721135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6700720|NCT01721135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6700721|NCT01721135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700722|NCT01721135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6700723|NCT01721135|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6700724|NCT01721135|Contraceptive Agents|contraceptive agents|mesh-ancestor
6700725|NCT01721135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6700726|NCT01721135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700727|NCT01721135|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6700728|NCT01721135|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6700729|NCT01721135|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6700730|NCT01721291|Albuterol|albuterol|mesh-list
6700731|NCT01721291|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6700732|NCT01721291|Autonomic Agents|autonomic agents|mesh-ancestor
6700733|NCT01721291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6700734|NCT01721291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700735|NCT01721291|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6700736|NCT01721291|Respiratory System Agents|respiratory system agents|mesh-ancestor
6700737|NCT01721291|Tocolytic Agents|tocolytic agents|mesh-ancestor
6700738|NCT01721291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6700739|NCT01721291|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6700740|NCT01721291|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6700741|NCT01721291|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6700742|NCT01721291|Adrenergic Agents|adrenergic agents|mesh-ancestor
6700743|NCT01721291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6700744|NCT01721291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700745|NCT01721382|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6700746|NCT01721382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6700747|NCT01721382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700748|NCT01721382|Incretins|incretins|mesh-ancestor
6700749|NCT01721382|Hormones|hormones|mesh-ancestor
6700750|NCT01721382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6700751|NCT01721382|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6700752|NCT01721382|Protease Inhibitors|protease inhibitors|mesh-ancestor
6700753|NCT01721382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6700754|NCT01721382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700755|NCT01721434|Simendan|simendan|mesh-list
6700756|NCT01721434|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6700757|NCT01721434|Vasodilator Agents|vasodilator agents|mesh-ancestor
6700758|NCT01721434|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6700759|NCT01721434|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6700760|NCT01721434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6700761|NCT01721434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700762|NCT01721434|Protective Agents|protective agents|mesh-ancestor
6700763|NCT01721434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700764|NCT01721525|Ribavirin|ribavirin|mesh-list
6700765|NCT01721525|Paclitaxel|paclitaxel|mesh-list
6700766|NCT01721525|Carboplatin|carboplatin|mesh-list
6700767|NCT01721525|Afatinib|afatinib|mesh-list
6700768|NCT01721525|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6700769|NCT01721525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6700770|NCT01721525|Tubulin Modulators|tubulin modulators|mesh-ancestor
6700771|NCT01721525|Antimitotic Agents|antimitotic agents|mesh-ancestor
6700772|NCT01721525|Mitosis Modulators|mitosis modulators|mesh-ancestor
6700773|NCT01721525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700774|NCT01721525|Antimetabolites|antimetabolites|mesh-ancestor
6700775|NCT01721525|Antiviral Agents|antiviral agents|mesh-ancestor
6700776|NCT01721525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6700777|NCT01721525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6700778|NCT01721525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6700779|NCT01721616|Azithromycin|azithromycin|mesh-list
6700780|NCT01721616|Cefazolin|cefazolin|mesh-list
6700781|NCT01721616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6700782|NCT01721616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6700783|NCT01721655|Spironolactone|spironolactone|mesh-list
6700784|NCT01721655|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6700785|NCT01721655|Hormone Antagonists|hormone antagonists|mesh-ancestor
6700786|NCT01721655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6700787|NCT01721655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700788|NCT01721655|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6700789|NCT01721655|Diuretics|diuretics|mesh-ancestor
6700790|NCT01721655|Natriuretic Agents|natriuretic agents|mesh-ancestor
6700791|NCT01721694|Loteprednol Etabonate|loteprednol etabonate|mesh-list
6700792|NCT01721694|Azithromycin|azithromycin|mesh-list
6700793|NCT01721694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6700794|NCT01721694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6700795|NCT01721694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6700796|NCT01721707|Latanoprost|latanoprost|mesh-list
6700797|NCT01721707|Brinzolamide|brinzolamide|mesh-list
6700798|NCT01721707|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6700799|NCT01721707|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6700800|NCT01721707|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6700801|NCT01721707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6700802|NCT01721707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700803|NCT01721798|Copper|copper|mesh-list
6700804|NCT01721798|Levonorgestrel|levonorgestrel|mesh-list
6700805|NCT01721798|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6700806|NCT01721798|Contraceptive Agents|contraceptive agents|mesh-ancestor
6700807|NCT01721798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6700808|NCT01721798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700809|NCT01721798|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6700810|NCT01721798|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6700811|NCT01721798|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6700812|NCT01721798|Trace Elements|trace elements|mesh-ancestor
6700813|NCT01721798|Micronutrients|micronutrients|mesh-ancestor
6700814|NCT01721915|Vitamin D|vitamin d|mesh-list
6700815|NCT01721915|Vitamins|vitamins|mesh-ancestor
6700816|NCT01721915|Micronutrients|micronutrients|mesh-ancestor
6700817|NCT01721915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700818|NCT01721915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6700819|NCT01721993|Zoledronic Acid|zoledronic acid|mesh-list
6700820|NCT01721993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6700821|NCT01721993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700822|NCT01722110|Indomethacin|indomethacin|mesh-list
6700823|NCT01722110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6700824|NCT01722110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6700825|NCT01722110|Analgesics|analgesics|mesh-ancestor
6700826|NCT01722110|Sensory System Agents|sensory system agents|mesh-ancestor
6700827|NCT01722110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6700828|NCT01722110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700829|NCT01722110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6700830|NCT01722110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6700831|NCT01722110|Gout Suppressants|gout suppressants|mesh-ancestor
6700832|NCT01722110|Tocolytic Agents|tocolytic agents|mesh-ancestor
6700833|NCT01722110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6700834|NCT01722110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6700835|NCT01722110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6700836|NCT01722110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700837|NCT01722201|Risperidone|risperidone|mesh-list
6700838|NCT01722201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6700839|NCT01722201|Serotonin Agents|serotonin agents|mesh-ancestor
6700840|NCT01722201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6700841|NCT01722201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700842|NCT01722201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700843|NCT01722201|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6700844|NCT01722201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6700845|NCT01722201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6700846|NCT01722201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6700847|NCT01722201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6700848|NCT01722201|Dopamine Agents|dopamine agents|mesh-ancestor
6700849|NCT01722214|Adalimumab|adalimumab|mesh-list
6700850|NCT01722214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6700851|NCT01722214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6700852|NCT01722227|Liraglutide|liraglutide|mesh-list
6700853|NCT01722227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6700854|NCT01722227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700855|NCT01722227|Incretins|incretins|mesh-ancestor
6700856|NCT01722227|Hormones|hormones|mesh-ancestor
6700857|NCT01722227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6700858|NCT01722240|Liraglutide|liraglutide|mesh-list
6700859|NCT01722240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6700860|NCT01722240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700861|NCT01722240|Incretins|incretins|mesh-ancestor
6700862|NCT01722240|Hormones|hormones|mesh-ancestor
6700863|NCT01722240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6700864|NCT01722305|Dexamethasone|dexamethasone|mesh-list
6700865|NCT01722305|Dexamethasone acetate|dexamethasone acetate|mesh-list
6700866|NCT01722305|Pomalidomide|pomalidomide|mesh-list
6700867|NCT01722305|Ichthammol|ichthammol|mesh-list
6700868|NCT01722305|BB 1101|bb 1101|mesh-list
6700869|NCT01722305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6700870|NCT01722305|Antiemetics|antiemetics|mesh-ancestor
6700871|NCT01722305|Autonomic Agents|autonomic agents|mesh-ancestor
6700872|NCT01722305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6700873|NCT01722305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700874|NCT01722305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6700875|NCT01722305|Glucocorticoids|glucocorticoids|mesh-ancestor
6700876|NCT01722305|Hormones|hormones|mesh-ancestor
6700877|NCT01722305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6700878|NCT01722305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6700879|NCT01722305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6700880|NCT01722305|Protease Inhibitors|protease inhibitors|mesh-ancestor
6700881|NCT01722305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6700882|NCT01722305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700883|NCT01722305|Immunologic Factors|immunologic factors|mesh-ancestor
6700884|NCT01722305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6700885|NCT01722305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6700886|NCT01722305|Growth Substances|growth substances|mesh-ancestor
6700887|NCT01722305|Growth Inhibitors|growth inhibitors|mesh-ancestor
6700888|NCT01722305|Dermatologic Agents|dermatologic agents|mesh-ancestor
6700889|NCT01722396|Vitamin D|vitamin d|mesh-list
6700890|NCT01722396|Vitamins|vitamins|mesh-ancestor
6700891|NCT01722396|Micronutrients|micronutrients|mesh-ancestor
6700892|NCT01722396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700893|NCT01722396|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6700894|NCT01722409|Dexmedetomidine|dexmedetomidine|mesh-list
6700895|NCT01722409|Sevoflurane|sevoflurane|mesh-list
6700896|NCT01722409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6700897|NCT01722409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6700898|NCT01722409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700899|NCT01722409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6700900|NCT01722409|Analgesics|analgesics|mesh-ancestor
6700901|NCT01722409|Sensory System Agents|sensory system agents|mesh-ancestor
6700902|NCT01722409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6700903|NCT01722409|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6700904|NCT01722409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6700905|NCT01722409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6700906|NCT01722409|Adrenergic Agents|adrenergic agents|mesh-ancestor
6700907|NCT01722409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6700908|NCT01722409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700909|NCT01722409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6700910|NCT01722409|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6700911|NCT01722409|Anesthetics, General|anesthetics, general|mesh-ancestor
6700912|NCT01722409|Anesthetics|anesthetics|mesh-ancestor
6700913|NCT01722448|Choline|choline|mesh-list
6700914|NCT01722448|Lipotropic Agents|lipotropic agents|mesh-ancestor
6700915|NCT01722448|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6700916|NCT01722448|Antimetabolites|antimetabolites|mesh-ancestor
6700917|NCT01722448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700918|NCT01722448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6700919|NCT01722448|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6700920|NCT01722448|Nootropic Agents|nootropic agents|mesh-ancestor
6700921|NCT01722513|Alprostadil|alprostadil|mesh-list
6700922|NCT01722513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6700923|NCT01722513|Vasodilator Agents|vasodilator agents|mesh-ancestor
6700924|NCT01722513|Urological Agents|urological agents|mesh-ancestor
6700925|NCT01722539|Pyrimethamine|pyrimethamine|mesh-list
6700926|NCT01722539|Piperaquine|piperaquine|mesh-list
6700927|NCT01722539|Sulfadoxine|sulfadoxine|mesh-list
6700928|NCT01722539|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6700929|NCT01722539|Albendazole|albendazole|mesh-list
6700930|NCT01722539|Praziquantel|praziquantel|mesh-list
6700931|NCT01722539|Antimalarials|antimalarials|mesh-ancestor
6700932|NCT01722539|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6700933|NCT01722539|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6700934|NCT01722539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6700935|NCT01722539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6700936|NCT01722539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6700937|NCT01722539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700938|NCT01722539|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6700939|NCT01722539|Renal Agents|renal agents|mesh-ancestor
6700940|NCT01722539|Anthelmintics|anthelmintics|mesh-ancestor
6700941|NCT01722539|Anticestodal Agents|anticestodal agents|mesh-ancestor
6700942|NCT01722539|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6700943|NCT01722539|Tubulin Modulators|tubulin modulators|mesh-ancestor
6700944|NCT01722539|Antimitotic Agents|antimitotic agents|mesh-ancestor
6700945|NCT01722539|Mitosis Modulators|mitosis modulators|mesh-ancestor
6700946|NCT01722539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6700947|NCT01722578|N-Methylaspartate|n-methylaspartate|mesh-list
6700948|NCT01722578|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
6700949|NCT01722578|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6700950|NCT01722578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6700951|NCT01722578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700952|NCT01722578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700953|NCT01722630|Dopamine|dopamine|mesh-list
6700954|NCT01722630|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6700955|NCT01722630|Sympathomimetics|sympathomimetics|mesh-ancestor
6700956|NCT01722630|Autonomic Agents|autonomic agents|mesh-ancestor
6700957|NCT01722630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6700958|NCT01722630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700959|NCT01722630|Dopamine Agents|dopamine agents|mesh-ancestor
6700960|NCT01722630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6700961|NCT01722630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700962|NCT01722630|Protective Agents|protective agents|mesh-ancestor
6700963|NCT01722656|Aflibercept|aflibercept|mesh-list
6700964|NCT01722656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6700965|NCT01722656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6700966|NCT01722656|Growth Substances|growth substances|mesh-ancestor
6700967|NCT01722656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700968|NCT01722656|Growth Inhibitors|growth inhibitors|mesh-ancestor
6700969|NCT01722656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6781777|NCT02187120|Hemostatics|hemostatics|mesh-ancestor
6781778|NCT02187120|Coagulants|coagulants|mesh-ancestor
6781779|NCT02187133|Rituximab|rituximab|mesh-list
6781780|NCT02187133|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6781781|NCT02187133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6781782|NCT02187133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6781783|NCT02187133|Immunologic Factors|immunologic factors|mesh-ancestor
6781784|NCT02187133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781785|NCT02187133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6781786|NCT02187133|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6781787|NCT02187133|Alkylating Agents|alkylating agents|mesh-ancestor
6781788|NCT02187133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781789|NCT02187198|Buprenorphine|buprenorphine|mesh-list
6781790|NCT02187198|Naloxone|naloxone|mesh-list
6781791|NCT02187198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6781792|NCT02187198|Narcotics|narcotics|mesh-ancestor
6781793|NCT02187198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6781794|NCT02187198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781795|NCT02187198|Analgesics|analgesics|mesh-ancestor
6781796|NCT02187198|Sensory System Agents|sensory system agents|mesh-ancestor
6781797|NCT02187198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6781798|NCT02187198|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6781799|NCT02187211|Minocycline|minocycline|mesh-list
6781800|NCT02187211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6781801|NCT02187211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6781802|NCT02187250|Metformin|metformin|mesh-list
6781803|NCT02187250|Liraglutide|liraglutide|mesh-list
6781804|NCT02187250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6781805|NCT02187250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781806|NCT02187250|Incretins|incretins|mesh-ancestor
6781807|NCT02187250|Hormones|hormones|mesh-ancestor
6781808|NCT02187250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6781809|NCT02187276|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
6781810|NCT02187276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6781811|NCT02187276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781812|NCT02187276|Cholinergic Agents|cholinergic agents|mesh-ancestor
6781813|NCT02187276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6781814|NCT02187276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781815|NCT02187315|Cisplatin|cisplatin|mesh-list
6781816|NCT02187315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6781817|NCT02187354|Blinatumomab|blinatumomab|mesh-list
6781818|NCT02187354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6781819|NCT02187367|Cyclophosphamide|cyclophosphamide|mesh-list
6781820|NCT02187367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6781821|NCT02187367|Immunologic Factors|immunologic factors|mesh-ancestor
6781822|NCT02187367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781823|NCT02187367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6781824|NCT02187367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6781825|NCT02187367|Alkylating Agents|alkylating agents|mesh-ancestor
6781826|NCT02187367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700970|NCT01722708|Metronidazole|metronidazole|mesh-list
6700971|NCT01722708|Clindamycin|clindamycin|mesh-list
6700972|NCT01722708|Clindamycin palmitate|clindamycin palmitate|mesh-list
6700973|NCT01722708|Clindamycin phosphate|clindamycin phosphate|mesh-list
6700974|NCT01722708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6700975|NCT01722708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6700976|NCT01722708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6700977|NCT01722708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6700978|NCT01722708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6700979|NCT01722708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6700980|NCT01722708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700981|NCT01722799|Paclitaxel|paclitaxel|mesh-list
6700982|NCT01722799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6700983|NCT01722799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6700984|NCT01722799|Tubulin Modulators|tubulin modulators|mesh-ancestor
6700985|NCT01722799|Antimitotic Agents|antimitotic agents|mesh-ancestor
6700986|NCT01722799|Mitosis Modulators|mitosis modulators|mesh-ancestor
6700987|NCT01722799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6700988|NCT01722812|Cromolyn Sodium|cromolyn sodium|mesh-list
6700989|NCT01722812|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
6700990|NCT01722812|Immunologic Factors|immunologic factors|mesh-ancestor
6700991|NCT01722812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6700992|NCT01722812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6700993|NCT01722812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6700994|NCT01722812|Respiratory System Agents|respiratory system agents|mesh-ancestor
6700995|NCT01722942|Amiodarone|amiodarone|mesh-list
6700996|NCT01722942|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6700997|NCT01722942|Vasodilator Agents|vasodilator agents|mesh-ancestor
6700998|NCT01722942|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6700999|NCT01722942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6701000|NCT01722942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701001|NCT01722942|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6701002|NCT01722942|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6701003|NCT01722942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6701004|NCT01722942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6701005|NCT01722942|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6701006|NCT01722942|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6701007|NCT01722942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6701008|NCT01722968|Paclitaxel|paclitaxel|mesh-list
6701009|NCT01722968|Bevacizumab|bevacizumab|mesh-list
6701010|NCT01722968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6701011|NCT01722968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6701012|NCT01722968|Tubulin Modulators|tubulin modulators|mesh-ancestor
6701013|NCT01722968|Antimitotic Agents|antimitotic agents|mesh-ancestor
6701014|NCT01722968|Mitosis Modulators|mitosis modulators|mesh-ancestor
6701015|NCT01722968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701016|NCT01722968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6701017|NCT01722968|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6701018|NCT01722968|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6701019|NCT01722968|Growth Substances|growth substances|mesh-ancestor
6701020|NCT01722968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701021|NCT01722968|Growth Inhibitors|growth inhibitors|mesh-ancestor
6701022|NCT01723059|Amoxicillin|amoxicillin|mesh-list
6701023|NCT01723059|Metronidazole|metronidazole|mesh-list
6701024|NCT01723059|Clarithromycin|clarithromycin|mesh-list
6701025|NCT01723059|Omeprazole|omeprazole|mesh-list
6701026|NCT01723059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6701027|NCT01723059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6701028|NCT01723059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6701029|NCT01723059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6701030|NCT01723059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6701031|NCT01723059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6701032|NCT01723059|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6701033|NCT01723059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6701034|NCT01723059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701035|NCT01723059|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6701036|NCT01723059|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6701037|NCT01723059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6701038|NCT01723150|Ciprofloxacin|ciprofloxacin|mesh-list
6701039|NCT01723150|Ceftriaxone|ceftriaxone|mesh-list
6701040|NCT01723150|Ertapenem|ertapenem|mesh-list
6701041|NCT01723150|Trimethoprim|trimethoprim|mesh-list
6701042|NCT01723150|Sulfamethoxazole|sulfamethoxazole|mesh-list
6701043|NCT01723150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6701044|NCT01723150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6701045|NCT01723150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6701046|NCT01723150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6701047|NCT01723150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6701048|NCT01723150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701049|NCT01723150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6701050|NCT01723150|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6701051|NCT01723150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6701052|NCT01723150|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6701053|NCT01723150|Renal Agents|renal agents|mesh-ancestor
6701054|NCT01723150|Antimalarials|antimalarials|mesh-ancestor
6701055|NCT01723150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6701056|NCT01723150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6701057|NCT01723150|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6701058|NCT01723150|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6701059|NCT01723150|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6701060|NCT01723371|Carvedilol|carvedilol|mesh-list
6701061|NCT01723371|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6701062|NCT01723371|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6701063|NCT01723371|Adrenergic Agents|adrenergic agents|mesh-ancestor
6701064|NCT01723371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6701065|NCT01723371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701066|NCT01723371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701067|NCT01723371|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6701068|NCT01723371|Antioxidants|antioxidants|mesh-ancestor
6701069|NCT01723371|Protective Agents|protective agents|mesh-ancestor
6701070|NCT01723371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6701071|NCT01723371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6701072|NCT01723371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6701073|NCT01723371|Vasodilator Agents|vasodilator agents|mesh-ancestor
6701074|NCT01723371|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6701075|NCT01723371|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6701076|NCT01723501|Chlorhexidine|chlorhexidine|mesh-list
6701077|NCT01723501|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6701078|NCT01723501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6701079|NCT01723501|Disinfectants|disinfectants|mesh-ancestor
6701080|NCT01723527|Buprenorphine|buprenorphine|mesh-list
6701081|NCT01723527|Methadone|methadone|mesh-list
6701082|NCT01723527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6701083|NCT01723527|Narcotics|narcotics|mesh-ancestor
6701084|NCT01723527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6701085|NCT01723527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701086|NCT01723527|Analgesics|analgesics|mesh-ancestor
6701087|NCT01723527|Sensory System Agents|sensory system agents|mesh-ancestor
6701088|NCT01723527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6701089|NCT01723527|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6701090|NCT01723527|Antitussive Agents|antitussive agents|mesh-ancestor
6701091|NCT01723527|Respiratory System Agents|respiratory system agents|mesh-ancestor
6701092|NCT01723553|Corticosterone|corticosterone|mesh-list
6701093|NCT01723553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6701094|NCT01723657|Gemtuzumab|gemtuzumab|mesh-list
6701095|NCT01723657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6701096|NCT01723657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6701097|NCT01723670|Flurbiprofen|flurbiprofen|mesh-list
6701098|NCT01723670|Analgesics|analgesics|mesh-ancestor
6701099|NCT01723670|Sensory System Agents|sensory system agents|mesh-ancestor
6701100|NCT01723670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6701101|NCT01723670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701102|NCT01723670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6701103|NCT01723670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6701104|NCT01723670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6701105|NCT01723670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6701106|NCT01723670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6701107|NCT01723670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6701108|NCT01723670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701109|NCT01723683|Pulmonary Surfactants|pulmonary surfactants|mesh-list
6701110|NCT01723683|Respiratory System Agents|respiratory system agents|mesh-ancestor
6701111|NCT01723735|Ezetimibe|ezetimibe|mesh-list
6701112|NCT01723735|Fenofibrate|fenofibrate|mesh-list
6701113|NCT01723735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6701114|NCT01723735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6701115|NCT01723735|Antimetabolites|antimetabolites|mesh-ancestor
6701116|NCT01723735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701117|NCT01723735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6701118|NCT01723748|Hormones|hormones|mesh-list
6781827|NCT02187367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6701119|NCT01723748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6701120|NCT01723748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701121|NCT01723774|Anastrozole|anastrozole|mesh-list
6701122|NCT01723774|Goserelin|goserelin|mesh-list
6701123|NCT01723774|Palbociclib|palbociclib|mesh-list
6701124|NCT01723774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6701125|NCT01723774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6701126|NCT01723774|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6701127|NCT01723774|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6701128|NCT01723774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6701129|NCT01723774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701130|NCT01723774|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6701131|NCT01723774|Hormone Antagonists|hormone antagonists|mesh-ancestor
6701132|NCT01723774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6701133|NCT01723774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701134|NCT01723774|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6701135|NCT01723800|Carboplatin|carboplatin|mesh-list
6701136|NCT01723800|Pemetrexed|pemetrexed|mesh-list
6701137|NCT01723800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6701138|NCT01723800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6701139|NCT01723800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701140|NCT01723800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6701141|NCT01723800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6701142|NCT01723852|Vitamin D|vitamin d|mesh-list
6701143|NCT01723852|Ergocalciferols|ergocalciferols|mesh-list
6701144|NCT01723852|Vitamins|vitamins|mesh-list
6701145|NCT01723852|Micronutrients|micronutrients|mesh-ancestor
6701146|NCT01723852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701147|NCT01723852|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6701148|NCT01723852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6701149|NCT01724086|Interferons|interferons|mesh-list
6701150|NCT01724086|Ritonavir|ritonavir|mesh-list
6701151|NCT01724086|Ribavirin|ribavirin|mesh-list
6701152|NCT01724086|Interferon-alpha|interferon-alpha|mesh-list
6701153|NCT01724086|Interferon alpha-2|interferon alpha-2|mesh-list
6701154|NCT01724086|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6701155|NCT01724086|Simeprevir|simeprevir|mesh-list
6701156|NCT01724086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6701157|NCT01724086|Antiviral Agents|antiviral agents|mesh-ancestor
6701158|NCT01724086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6701159|NCT01724086|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6701160|NCT01724086|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6701161|NCT01724086|Protease Inhibitors|protease inhibitors|mesh-ancestor
6701162|NCT01724086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6701163|NCT01724086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701164|NCT01724086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6701165|NCT01724086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6701166|NCT01724086|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6701167|NCT01724086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6701168|NCT01724086|Antimetabolites|antimetabolites|mesh-ancestor
6701169|NCT01724086|Immunologic Factors|immunologic factors|mesh-ancestor
6701170|NCT01724086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701171|NCT01724138|Deferasirox|deferasirox|mesh-list
6701172|NCT01724138|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6701173|NCT01724138|Chelating Agents|chelating agents|mesh-ancestor
6701174|NCT01724138|Sequestering Agents|sequestering agents|mesh-ancestor
6701175|NCT01724138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701176|NCT01724190|Vitamin D|vitamin d|mesh-list
6701177|NCT01724190|Cholecalciferol|cholecalciferol|mesh-list
6701178|NCT01724190|Vitamins|vitamins|mesh-ancestor
6701179|NCT01724190|Micronutrients|micronutrients|mesh-ancestor
6701180|NCT01724190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701181|NCT01724190|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6701182|NCT01724190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6701183|NCT01724229|Antifungal Agents|antifungal agents|mesh-list
6701184|NCT01724229|Clotrimazole|clotrimazole|mesh-list
6701185|NCT01724229|Miconazole|miconazole|mesh-list
6701186|NCT01724229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6701187|NCT01724229|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6701188|NCT01724229|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6701189|NCT01724229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6701190|NCT01724229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6701191|NCT01724229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701192|NCT01724229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6701193|NCT01724229|Hormone Antagonists|hormone antagonists|mesh-ancestor
6701194|NCT01724229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6701195|NCT01724229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701196|NCT01724229|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6701197|NCT01724229|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6701198|NCT01724268|Prednisolone|prednisolone|mesh-list
6701199|NCT01724268|Methotrexate|methotrexate|mesh-list
6701200|NCT01724268|Methamphetamine|methamphetamine|mesh-list
6701201|NCT01724268|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6701202|NCT01724268|Abortifacient Agents|abortifacient agents|mesh-ancestor
6701203|NCT01724268|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6701204|NCT01724268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701205|NCT01724268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6701206|NCT01724268|Antimetabolites|antimetabolites|mesh-ancestor
6701207|NCT01724268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701208|NCT01724268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6701209|NCT01724268|Dermatologic Agents|dermatologic agents|mesh-ancestor
6701210|NCT01724268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6701211|NCT01724268|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6701212|NCT01724268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6701213|NCT01724268|Immunologic Factors|immunologic factors|mesh-ancestor
6701214|NCT01724268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6701215|NCT01724268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6701216|NCT01724268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6701217|NCT01724268|Glucocorticoids|glucocorticoids|mesh-ancestor
6701218|NCT01724268|Hormones|hormones|mesh-ancestor
6701219|NCT01724268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6701220|NCT01724268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6701221|NCT01724268|Autonomic Agents|autonomic agents|mesh-ancestor
6701222|NCT01724268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6701223|NCT01724268|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6701224|NCT01724268|Sympathomimetics|sympathomimetics|mesh-ancestor
6701225|NCT01724268|Dopamine Agents|dopamine agents|mesh-ancestor
6701226|NCT01724268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6701227|NCT01724268|Adrenergic Agents|adrenergic agents|mesh-ancestor
6701228|NCT01724268|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6701229|NCT01724268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6701230|NCT01724268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6701231|NCT01724268|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6701232|NCT01724346|Chlorambucil|chlorambucil|mesh-list
6701233|NCT01724346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6701234|NCT01724346|Alkylating Agents|alkylating agents|mesh-ancestor
6701235|NCT01724346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701236|NCT01724346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6781828|NCT02187367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6781829|NCT02187419|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
6781830|NCT02187419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6781831|NCT02187419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781832|NCT02187445|Budesonide|budesonide|mesh-list
6781833|NCT02187445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6781834|NCT02187445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6781835|NCT02187445|Autonomic Agents|autonomic agents|mesh-ancestor
6781836|NCT02187445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6781837|NCT02187445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781838|NCT02187445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6781839|NCT02187445|Respiratory System Agents|respiratory system agents|mesh-ancestor
6781840|NCT02187445|Glucocorticoids|glucocorticoids|mesh-ancestor
6781841|NCT02187445|Hormones|hormones|mesh-ancestor
6781842|NCT02187445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6781843|NCT02187484|Telmisartan|telmisartan|mesh-list
6781844|NCT02187484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6781845|NCT02187484|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6781846|NCT02187484|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6781847|NCT02187484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701237|NCT01724372|Aripiprazole|aripiprazole|mesh-list
6701238|NCT01724372|Antipsychotic Agents|antipsychotic agents|mesh-list
6701239|NCT01724372|Fluoxetine|fluoxetine|mesh-list
6701240|NCT01724372|Antidepressive Agents|antidepressive agents|mesh-list
6701241|NCT01724372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6701242|NCT01724372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6701243|NCT01724372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6701244|NCT01724372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701245|NCT01724372|Dopamine Agonists|dopamine agonists|mesh-ancestor
6701246|NCT01724372|Dopamine Agents|dopamine agents|mesh-ancestor
6701247|NCT01724372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6701248|NCT01724372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701249|NCT01724372|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6701250|NCT01724372|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6701251|NCT01724372|Serotonin Agents|serotonin agents|mesh-ancestor
6701252|NCT01724372|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6701253|NCT01724372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6701254|NCT01724372|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6701255|NCT01724372|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6701256|NCT01724372|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6701257|NCT01724372|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6701258|NCT01724372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6701259|NCT01724372|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6701260|NCT01724372|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6701261|NCT01724372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6701262|NCT01724372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6701263|NCT01724385|Bevacizumab|bevacizumab|mesh-list
6701264|NCT01724385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6701265|NCT01724385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6701266|NCT01724385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6701267|NCT01724385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6701268|NCT01724385|Growth Substances|growth substances|mesh-ancestor
6701269|NCT01724385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701270|NCT01724385|Growth Inhibitors|growth inhibitors|mesh-ancestor
6701271|NCT01724424|Melatonin|melatonin|mesh-list
6701272|NCT01724424|Antioxidants|antioxidants|mesh-ancestor
6701273|NCT01724424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701274|NCT01724424|Protective Agents|protective agents|mesh-ancestor
6701275|NCT01724424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701276|NCT01724424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6701277|NCT01724450|Carvedilol|carvedilol|mesh-list
6701278|NCT01724450|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6701279|NCT01724450|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6701280|NCT01724450|Adrenergic Agents|adrenergic agents|mesh-ancestor
6701281|NCT01724450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6701282|NCT01724450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701283|NCT01724450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701284|NCT01724450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6701285|NCT01724450|Antioxidants|antioxidants|mesh-ancestor
6701286|NCT01724450|Protective Agents|protective agents|mesh-ancestor
6701287|NCT01724450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6701288|NCT01724450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6701289|NCT01724450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6701290|NCT01724450|Vasodilator Agents|vasodilator agents|mesh-ancestor
6701291|NCT01724450|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6701292|NCT01724450|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6701293|NCT01724554|Aflibercept|aflibercept|mesh-list
6701294|NCT01724554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6701295|NCT01724554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6701296|NCT01724554|Growth Substances|growth substances|mesh-ancestor
6701297|NCT01724554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701298|NCT01724554|Growth Inhibitors|growth inhibitors|mesh-ancestor
6701299|NCT01724554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6701300|NCT01724606|Sorafenib|sorafenib|mesh-list
6701301|NCT01724606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6701302|NCT01724606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6701303|NCT01724606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6701304|NCT01724606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701305|NCT01724619|Dihydrotestosterone|dihydrotestosterone|mesh-list
6701306|NCT01724619|Androgens|androgens|mesh-ancestor
6701307|NCT01724619|Hormones|hormones|mesh-ancestor
6701308|NCT01724619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6701309|NCT01724619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701310|NCT01724658|Methyltestosterone|methyltestosterone|mesh-list
6701311|NCT01724658|Testosterone|testosterone|mesh-list
6701312|NCT01724658|Testosterone undecanoate|testosterone undecanoate|mesh-list
6701313|NCT01724658|Testosterone enanthate|testosterone enanthate|mesh-list
6701314|NCT01724658|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6701315|NCT01724658|Androgens|androgens|mesh-ancestor
6701316|NCT01724658|Hormones|hormones|mesh-ancestor
6701317|NCT01724658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6701318|NCT01724658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701319|NCT01724658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6701320|NCT01724658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6701321|NCT01724658|Anabolic Agents|anabolic agents|mesh-ancestor
6701322|NCT01724723|Entecavir|entecavir|mesh-list
6701323|NCT01724723|Antiviral Agents|antiviral agents|mesh-ancestor
6701324|NCT01724723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6701325|NCT01724788|Furosemide|furosemide|mesh-list
6701326|NCT01724788|Diuretics|diuretics|mesh-ancestor
6701327|NCT01724788|Natriuretic Agents|natriuretic agents|mesh-ancestor
6701328|NCT01724788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701329|NCT01724788|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6701330|NCT01724788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6701331|NCT01724788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701332|NCT01724814|Insulin|insulin|mesh-list
6701333|NCT01724814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6701334|NCT01724814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701335|NCT01724892|Loteprednol Etabonate|loteprednol etabonate|mesh-list
6701336|NCT01724892|Dexamethasone|dexamethasone|mesh-list
6701337|NCT01724892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6701338|NCT01724892|Antiemetics|antiemetics|mesh-ancestor
6701339|NCT01724892|Autonomic Agents|autonomic agents|mesh-ancestor
6701340|NCT01724892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6701341|NCT01724892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701342|NCT01724892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6701343|NCT01724892|Glucocorticoids|glucocorticoids|mesh-ancestor
6701344|NCT01724892|Hormones|hormones|mesh-ancestor
6701345|NCT01724892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6701346|NCT01724892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6701347|NCT01724892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6701348|NCT01724892|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6701349|NCT01724918|Lacosamide|lacosamide|mesh-list
6701350|NCT01724918|Anticonvulsants|anticonvulsants|mesh-ancestor
6701351|NCT01724918|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6701352|NCT01724918|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6701353|NCT01724918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6701354|NCT01724918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701355|NCT01724931|Aminopterin|aminopterin|mesh-list
6701356|NCT01724931|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6701357|NCT01724931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6701358|NCT01724931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701359|NCT01724983|Fentanyl|fentanyl|mesh-list
6701360|NCT01724983|Ketamine|ketamine|mesh-list
6701361|NCT01724983|Analgesics|analgesics|mesh-ancestor
6701362|NCT01724983|Sensory System Agents|sensory system agents|mesh-ancestor
6701363|NCT01724983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6701364|NCT01724983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701365|NCT01724983|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6701366|NCT01724983|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6701367|NCT01724983|Anesthetics, General|anesthetics, general|mesh-ancestor
6701368|NCT01724983|Anesthetics|anesthetics|mesh-ancestor
6701369|NCT01724983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6701370|NCT01724983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6701371|NCT01724983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6701372|NCT01724983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6701373|NCT01724983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701374|NCT01724983|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6701375|NCT01724983|Narcotics|narcotics|mesh-ancestor
6701376|NCT01724983|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6701377|NCT01725009|Levetiracetam|levetiracetam|mesh-list
6701378|NCT01725009|Anticonvulsants|anticonvulsants|mesh-ancestor
6701379|NCT01725009|Nootropic Agents|nootropic agents|mesh-ancestor
6701380|NCT01725048|Mirtazapine|mirtazapine|mesh-list
6701381|NCT01725048|Citalopram|citalopram|mesh-list
6701382|NCT01725048|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6701383|NCT01725048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6781848|NCT02187497|Telmisartan|telmisartan|mesh-list
6701384|NCT01725048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6701385|NCT01725048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701386|NCT01725048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6701387|NCT01725048|Serotonin Agents|serotonin agents|mesh-ancestor
6701388|NCT01725048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701389|NCT01725048|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6701390|NCT01725048|Antidepressive Agents|antidepressive agents|mesh-ancestor
6701391|NCT01725048|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6701392|NCT01725048|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6701393|NCT01725048|Histamine Antagonists|histamine antagonists|mesh-ancestor
6701394|NCT01725048|Histamine Agents|histamine agents|mesh-ancestor
6701395|NCT01725048|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6701396|NCT01725048|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6701397|NCT01725048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6701398|NCT01725048|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6701399|NCT01725048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6701400|NCT01725048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6701401|NCT01725048|Adrenergic Agents|adrenergic agents|mesh-ancestor
6701402|NCT01725048|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6701403|NCT01725048|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6701404|NCT01725048|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6701405|NCT01725087|Tapentadol|tapentadol|mesh-list
6701406|NCT01725087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6701407|NCT01725087|Narcotics|narcotics|mesh-ancestor
6701408|NCT01725087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6701409|NCT01725087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701410|NCT01725087|Analgesics|analgesics|mesh-ancestor
6701411|NCT01725087|Sensory System Agents|sensory system agents|mesh-ancestor
6701412|NCT01725087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6701413|NCT01725087|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6701414|NCT01725087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6701415|NCT01725087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6701416|NCT01725087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701417|NCT01725087|Adrenergic Agents|adrenergic agents|mesh-ancestor
6701418|NCT01725087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6701419|NCT01725100|Trametinib|trametinib|mesh-list
6701420|NCT01725100|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
6701421|NCT01725100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6701422|NCT01725100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6701423|NCT01725100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6701424|NCT01725100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701425|NCT01725100|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6701426|NCT01725100|Protective Agents|protective agents|mesh-ancestor
6701427|NCT01725100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701428|NCT01725100|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6701429|NCT01725100|Antioxidants|antioxidants|mesh-ancestor
6701430|NCT01725113|Calcitriol|calcitriol|mesh-list
6701431|NCT01725113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6701432|NCT01725113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701433|NCT01725113|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6701434|NCT01725113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6701435|NCT01725113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701436|NCT01725113|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6701437|NCT01725113|Vitamins|vitamins|mesh-ancestor
6701438|NCT01725113|Micronutrients|micronutrients|mesh-ancestor
6701439|NCT01725113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6701440|NCT01725204|Dasatinib|dasatinib|mesh-list
6701441|NCT01725204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6701442|NCT01725204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6701443|NCT01725204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6701444|NCT01725204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701445|NCT01725230|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6701446|NCT01725230|Simvastatin|simvastatin|mesh-list
6701447|NCT01725230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6701448|NCT01725230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6701449|NCT01725230|Antimetabolites|antimetabolites|mesh-ancestor
6701450|NCT01725230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701451|NCT01725230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6701452|NCT01725230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6701453|NCT01725230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6701454|NCT01725243|Carbetocin|carbetocin|mesh-list
6701455|NCT01725243|Oxytocics|oxytocics|mesh-ancestor
6701456|NCT01725243|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6701457|NCT01725243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701458|NCT01725256|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6701459|NCT01725360|Montelukast|montelukast|mesh-list
6701460|NCT01725360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6701461|NCT01725360|Respiratory System Agents|respiratory system agents|mesh-ancestor
6701462|NCT01725360|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6701463|NCT01725360|Hormone Antagonists|hormone antagonists|mesh-ancestor
6701464|NCT01725360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6701465|NCT01725360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701466|NCT01725360|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6701467|NCT01725360|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6701468|NCT01725360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701469|NCT01725412|Thiamine|thiamine|mesh-list
6701470|NCT01725412|Vitamin B Complex|vitamin b complex|mesh-ancestor
6701471|NCT01725412|Vitamins|vitamins|mesh-ancestor
6701472|NCT01725412|Micronutrients|micronutrients|mesh-ancestor
6701473|NCT01725412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701474|NCT01725477|Methylene Blue|methylene blue|mesh-list
6701475|NCT01725477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6701476|NCT01725477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701477|NCT01725490|Metformin|metformin|mesh-list
6701478|NCT01725490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6701479|NCT01725490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701480|NCT01725542|Ribavirin|ribavirin|mesh-list
6701481|NCT01725542|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6701482|NCT01725542|Asunaprevir|asunaprevir|mesh-list
6701483|NCT01725542|Antimetabolites|antimetabolites|mesh-ancestor
6701484|NCT01725542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701485|NCT01725542|Antiviral Agents|antiviral agents|mesh-ancestor
6701486|NCT01725542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6701487|NCT01725542|Protease Inhibitors|protease inhibitors|mesh-ancestor
6701488|NCT01725542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6701489|NCT01725555|Podophyllotoxin|podophyllotoxin|mesh-list
6701490|NCT01725555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6701491|NCT01725555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6701492|NCT01725555|Keratolytic Agents|keratolytic agents|mesh-ancestor
6701493|NCT01725555|Dermatologic Agents|dermatologic agents|mesh-ancestor
6701494|NCT01725555|Tubulin Modulators|tubulin modulators|mesh-ancestor
6701495|NCT01725555|Antimitotic Agents|antimitotic agents|mesh-ancestor
6701496|NCT01725555|Mitosis Modulators|mitosis modulators|mesh-ancestor
6701497|NCT01725555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701498|NCT01725607|Dexmedetomidine|dexmedetomidine|mesh-list
6701499|NCT01725607|Anesthetics|anesthetics|mesh-list
6701500|NCT01725607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6701501|NCT01725607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701502|NCT01725607|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6701503|NCT01725607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6701504|NCT01725607|Analgesics|analgesics|mesh-ancestor
6701505|NCT01725607|Sensory System Agents|sensory system agents|mesh-ancestor
6701506|NCT01725607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6701507|NCT01725607|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6701508|NCT01725607|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6701509|NCT01725607|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6701510|NCT01725607|Adrenergic Agents|adrenergic agents|mesh-ancestor
6701511|NCT01725607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6701512|NCT01725607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701513|NCT01725620|Etanercept|etanercept|mesh-list
6701514|NCT01725620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6701515|NCT01725620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6701516|NCT01725620|Analgesics|analgesics|mesh-ancestor
6701517|NCT01725620|Sensory System Agents|sensory system agents|mesh-ancestor
6701518|NCT01725620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6701519|NCT01725620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701520|NCT01725620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6701521|NCT01725620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6701522|NCT01725620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6701523|NCT01725620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6701524|NCT01725620|Immunologic Factors|immunologic factors|mesh-ancestor
6701525|NCT01725672|Metformin|metformin|mesh-list
6701526|NCT01725672|Glimepiride|glimepiride|mesh-list
6701527|NCT01725672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6701528|NCT01725672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701529|NCT01725672|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6701530|NCT01725672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6701531|NCT01725672|Immunologic Factors|immunologic factors|mesh-ancestor
6701532|NCT01725776|Milrinone|milrinone|mesh-list
6701533|NCT01725776|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6701534|NCT01725776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6701535|NCT01725776|Vasodilator Agents|vasodilator agents|mesh-ancestor
6701536|NCT01725776|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6701537|NCT01725776|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6701538|NCT01725776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6701539|NCT01725776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701540|NCT01725776|Protective Agents|protective agents|mesh-ancestor
6701541|NCT01725776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701542|NCT01725802|Levodopa|levodopa|mesh-list
6701543|NCT01725802|Carbidopa|carbidopa|mesh-list
6701544|NCT01725802|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6701545|NCT01725802|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6701546|NCT01725802|Dopamine Agents|dopamine agents|mesh-ancestor
6701547|NCT01725802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6701548|NCT01725802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701549|NCT01725802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701550|NCT01725802|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6701551|NCT01725802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6781849|NCT02187497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6781850|NCT02187497|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6781851|NCT02187497|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6781852|NCT02187497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781853|NCT02187523|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6781854|NCT02187523|Telmisartan|telmisartan|mesh-list
6781855|NCT02187523|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6781856|NCT02187523|Diuretics|diuretics|mesh-ancestor
6781857|NCT02187523|Natriuretic Agents|natriuretic agents|mesh-ancestor
6781858|NCT02187523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781859|NCT02187523|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6781860|NCT02187523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6781861|NCT02187523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781862|NCT02187523|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6781863|NCT02187523|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6781864|NCT02187536|Telmisartan|telmisartan|mesh-list
6781865|NCT02187536|Simvastatin|simvastatin|mesh-list
6781866|NCT02187536|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6781867|NCT02187536|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6781868|NCT02187536|Antimetabolites|antimetabolites|mesh-ancestor
6781869|NCT02187536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781870|NCT02187536|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6781871|NCT02187536|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6781872|NCT02187536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6781873|NCT02187536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6781874|NCT02187536|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6781875|NCT02187536|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6781876|NCT02187562|Aspirin|aspirin|mesh-list
6781877|NCT02187562|Meloxicam|meloxicam|mesh-list
6781878|NCT02187562|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6781879|NCT02187562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6781880|NCT02187562|Analgesics|analgesics|mesh-ancestor
6781881|NCT02187562|Sensory System Agents|sensory system agents|mesh-ancestor
6781882|NCT02187562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6781883|NCT02187562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781884|NCT02187562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6781885|NCT02187562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6781886|NCT02187562|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6781887|NCT02187562|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6781888|NCT02187562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781889|NCT02187562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6781890|NCT02187562|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6781891|NCT02187562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6781892|NCT02187562|Antipyretics|antipyretics|mesh-ancestor
6781893|NCT02187562|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6781894|NCT02187588|Ibuprofen|ibuprofen|mesh-list
6781895|NCT02187588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6781896|NCT02187588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6781897|NCT02187588|Analgesics|analgesics|mesh-ancestor
6781898|NCT02187588|Sensory System Agents|sensory system agents|mesh-ancestor
6781899|NCT02187588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6781900|NCT02187588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701552|NCT01725906|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6701553|NCT01725906|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6701554|NCT01725906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6701555|NCT01725906|Antitubercular Agents|antitubercular agents|mesh-ancestor
6701556|NCT01726075|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6701557|NCT01726075|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6701558|NCT01726075|Somatostatin|somatostatin|mesh-list
6701559|NCT01726075|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6701560|NCT01726075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6701561|NCT01726075|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6701562|NCT01726075|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6701563|NCT01726075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6701564|NCT01726075|Adrenergic Agents|adrenergic agents|mesh-ancestor
6701565|NCT01726075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6701566|NCT01726075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701567|NCT01726075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701568|NCT01726075|Hormones|hormones|mesh-ancestor
6701569|NCT01726075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6701570|NCT01726088|Modafinil|modafinil|mesh-list
6701571|NCT01726088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6701572|NCT01726088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701573|NCT01726088|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6701574|NCT01726088|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6701575|NCT01726088|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6701576|NCT01726088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701577|NCT01726192|Ropivacaine|ropivacaine|mesh-list
6701578|NCT01726192|Anesthetics, Local|anesthetics, local|mesh-ancestor
6701579|NCT01726192|Anesthetics|anesthetics|mesh-ancestor
6701580|NCT01726192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6701581|NCT01726192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701582|NCT01726192|Sensory System Agents|sensory system agents|mesh-ancestor
6701583|NCT01726192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6701584|NCT01726205|Pregabalin|pregabalin|mesh-list
6701585|NCT01726205|Ropivacaine|ropivacaine|mesh-list
6701586|NCT01726205|Anesthetics, Local|anesthetics, local|mesh-ancestor
6701587|NCT01726205|Anesthetics|anesthetics|mesh-ancestor
6701588|NCT01726205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6701589|NCT01726205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701590|NCT01726205|Sensory System Agents|sensory system agents|mesh-ancestor
6701591|NCT01726205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6701592|NCT01726205|Analgesics|analgesics|mesh-ancestor
6701593|NCT01726205|Anticonvulsants|anticonvulsants|mesh-ancestor
6701594|NCT01726205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6701595|NCT01726205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6701596|NCT01726205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701597|NCT01726205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6701598|NCT01726205|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6701599|NCT01726205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6701600|NCT01726205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6701601|NCT01726283|Riboflavin|riboflavin|mesh-list
6701602|NCT01726283|Vitamin B Complex|vitamin b complex|mesh-ancestor
6701603|NCT01726283|Vitamins|vitamins|mesh-ancestor
6701604|NCT01726283|Micronutrients|micronutrients|mesh-ancestor
6701605|NCT01726283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701606|NCT01726283|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6701607|NCT01726283|Dermatologic Agents|dermatologic agents|mesh-ancestor
6701608|NCT01726400|Interferons|interferons|mesh-list
6701609|NCT01726400|Ribavirin|ribavirin|mesh-list
6701610|NCT01726400|Interferon-alpha|interferon-alpha|mesh-list
6701611|NCT01726400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6701612|NCT01726400|Antiviral Agents|antiviral agents|mesh-ancestor
6701613|NCT01726400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6701614|NCT01726400|Antimetabolites|antimetabolites|mesh-ancestor
6701615|NCT01726400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701616|NCT01726400|Immunologic Factors|immunologic factors|mesh-ancestor
6701617|NCT01726400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701618|NCT01726465|Acetylcysteine|acetylcysteine|mesh-list
6701619|NCT01726465|Methylprednisolone|methylprednisolone|mesh-list
6701620|NCT01726465|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6701621|NCT01726465|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6701622|NCT01726465|Prednisolone|prednisolone|mesh-list
6701623|NCT01726465|Prednisolone acetate|prednisolone acetate|mesh-list
6701624|NCT01726465|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6701625|NCT01726465|Prednisolone phosphate|prednisolone phosphate|mesh-list
6701626|NCT01726465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6701627|NCT01726465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6701628|NCT01726465|Antiemetics|antiemetics|mesh-ancestor
6701629|NCT01726465|Autonomic Agents|autonomic agents|mesh-ancestor
6701630|NCT01726465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6701631|NCT01726465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701632|NCT01726465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6701633|NCT01726465|Glucocorticoids|glucocorticoids|mesh-ancestor
6701634|NCT01726465|Hormones|hormones|mesh-ancestor
6701635|NCT01726465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6701636|NCT01726465|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6701637|NCT01726465|Protective Agents|protective agents|mesh-ancestor
6701638|NCT01726465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6701639|NCT01726465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6701640|NCT01726465|Antiviral Agents|antiviral agents|mesh-ancestor
6701641|NCT01726465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6701642|NCT01726465|Expectorants|expectorants|mesh-ancestor
6701643|NCT01726465|Respiratory System Agents|respiratory system agents|mesh-ancestor
6701644|NCT01726465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6701645|NCT01726465|Antioxidants|antioxidants|mesh-ancestor
6701646|NCT01726465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701647|NCT01726465|Antidotes|antidotes|mesh-ancestor
6701648|NCT01726478|Oxytocin|oxytocin|mesh-list
6701649|NCT01726478|Oxytocics|oxytocics|mesh-ancestor
6701650|NCT01726478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6701651|NCT01726478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701652|NCT01726530|Fentanyl|fentanyl|mesh-list
6701653|NCT01726530|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6701654|NCT01726530|Narcotics|narcotics|mesh-ancestor
6701655|NCT01726530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6701656|NCT01726530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701657|NCT01726530|Analgesics|analgesics|mesh-ancestor
6701658|NCT01726530|Sensory System Agents|sensory system agents|mesh-ancestor
6701659|NCT01726530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6701660|NCT01726530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6701661|NCT01726530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6701662|NCT01726530|Anesthetics, General|anesthetics, general|mesh-ancestor
6701663|NCT01726530|Anesthetics|anesthetics|mesh-ancestor
6701664|NCT01726582|Leucovorin|leucovorin|mesh-list
6701665|NCT01726582|Gemcitabine|gemcitabine|mesh-list
6701666|NCT01726582|Paclitaxel|paclitaxel|mesh-list
6701667|NCT01726582|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6701668|NCT01726582|Capecitabine|capecitabine|mesh-list
6701669|NCT01726582|Oxaliplatin|oxaliplatin|mesh-list
6701670|NCT01726582|Irinotecan|irinotecan|mesh-list
6701671|NCT01726582|Cisplatin|cisplatin|mesh-list
6701672|NCT01726582|Folfirinox|folfirinox|mesh-list
6701673|NCT01726582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6701674|NCT01726582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6701675|NCT01726582|Tubulin Modulators|tubulin modulators|mesh-ancestor
6701676|NCT01726582|Antimitotic Agents|antimitotic agents|mesh-ancestor
6701677|NCT01726582|Mitosis Modulators|mitosis modulators|mesh-ancestor
6701678|NCT01726582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701679|NCT01726582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6701680|NCT01726582|Antimetabolites|antimetabolites|mesh-ancestor
6701681|NCT01726582|Antiviral Agents|antiviral agents|mesh-ancestor
6701682|NCT01726582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6701683|NCT01726582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6701684|NCT01726582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6701685|NCT01726582|Immunologic Factors|immunologic factors|mesh-ancestor
6701686|NCT01726582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701687|NCT01726582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6701688|NCT01726582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6701689|NCT01726582|Antidotes|antidotes|mesh-ancestor
6701690|NCT01726582|Protective Agents|protective agents|mesh-ancestor
6701691|NCT01726582|Vitamin B Complex|vitamin b complex|mesh-ancestor
6701692|NCT01726582|Vitamins|vitamins|mesh-ancestor
6701693|NCT01726582|Micronutrients|micronutrients|mesh-ancestor
6701694|NCT01726686|Ropivacaine|ropivacaine|mesh-list
6701695|NCT01726686|Anesthetics, Local|anesthetics, local|mesh-ancestor
6701696|NCT01726686|Anesthetics|anesthetics|mesh-ancestor
6701697|NCT01726686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6701698|NCT01726686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701699|NCT01726686|Sensory System Agents|sensory system agents|mesh-ancestor
6701700|NCT01726686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6701701|NCT01726725|Desflurane|desflurane|mesh-list
6701702|NCT01726725|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6701703|NCT01726725|Anesthetics, General|anesthetics, general|mesh-ancestor
6701704|NCT01726725|Anesthetics|anesthetics|mesh-ancestor
6701705|NCT01726725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6701706|NCT01726725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701707|NCT01726764|Metformin|metformin|mesh-list
6701708|NCT01726764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6701709|NCT01726764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701710|NCT01726777|Vitamin D|vitamin d|mesh-list
6701711|NCT01726777|Ergocalciferols|ergocalciferols|mesh-list
6701712|NCT01726777|Vitamins|vitamins|mesh-list
6701713|NCT01726777|Micronutrients|micronutrients|mesh-ancestor
6701714|NCT01726777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701715|NCT01726777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6701716|NCT01726777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6701717|NCT01726816|Probucol|probucol|mesh-list
6701718|NCT01726816|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6701719|NCT01726816|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6701720|NCT01726816|Antimetabolites|antimetabolites|mesh-ancestor
6701721|NCT01726816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701722|NCT01726816|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6701723|NCT01726816|Antioxidants|antioxidants|mesh-ancestor
6701724|NCT01726816|Protective Agents|protective agents|mesh-ancestor
6701725|NCT01726816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701726|NCT01726829|Pancrelipase|pancrelipase|mesh-list
6701727|NCT01726829|Pancreatin|pancreatin|mesh-list
6701728|NCT01726829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6701729|NCT01726920|Naproxen|naproxen|mesh-list
6701730|NCT01726920|Naratriptan|naratriptan|mesh-list
6701731|NCT01726920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6701732|NCT01726920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6701733|NCT01726920|Analgesics|analgesics|mesh-ancestor
6701734|NCT01726920|Sensory System Agents|sensory system agents|mesh-ancestor
6701735|NCT01726920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6701736|NCT01726920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701737|NCT01726920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6701738|NCT01726920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6701739|NCT01726920|Gout Suppressants|gout suppressants|mesh-ancestor
6701740|NCT01726920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6701741|NCT01726920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6701742|NCT01726920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701743|NCT01726920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6701744|NCT01726920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6701745|NCT01726920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6701746|NCT01726920|Serotonin Agents|serotonin agents|mesh-ancestor
6701747|NCT01726920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6701748|NCT01726933|Dimethyl Fumarate|dimethyl fumarate|mesh-list
6701749|NCT01726933|Dermatologic Agents|dermatologic agents|mesh-ancestor
6701750|NCT01726933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6701751|NCT01726933|Immunologic Factors|immunologic factors|mesh-ancestor
6701752|NCT01726933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701753|NCT01727050|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6701754|NCT01727050|Hemostatics|hemostatics|mesh-ancestor
6701755|NCT01727050|Coagulants|coagulants|mesh-ancestor
6701756|NCT01727193|Azathioprine|azathioprine|mesh-list
6701757|NCT01727193|Leflunomide|leflunomide|mesh-list
6701758|NCT01727193|Antimetabolites|antimetabolites|mesh-ancestor
6701759|NCT01727193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701760|NCT01727193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6701761|NCT01727193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6701762|NCT01727193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6701763|NCT01727193|Immunologic Factors|immunologic factors|mesh-ancestor
6701764|NCT01727193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701765|NCT01727193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6701766|NCT01727193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6701767|NCT01727271|Interferons|interferons|mesh-list
6701768|NCT01727271|Tenofovir|tenofovir|mesh-list
6701769|NCT01727271|Interferon-alpha|interferon-alpha|mesh-list
6701770|NCT01727271|Interferon alpha-2|interferon alpha-2|mesh-list
6701771|NCT01727271|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6701772|NCT01727271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6701773|NCT01727271|Antiviral Agents|antiviral agents|mesh-ancestor
6701774|NCT01727271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6701775|NCT01727271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6701776|NCT01727271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6701777|NCT01727271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6701778|NCT01727271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701779|NCT01727271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6701780|NCT01727271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6701781|NCT01727271|Immunologic Factors|immunologic factors|mesh-ancestor
6701782|NCT01727271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701783|NCT01727401|PENTA|penta|mesh-list
6701784|NCT01727401|Fondaparinux|fondaparinux|mesh-list
6701785|NCT01727401|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6701786|NCT01727401|Antithrombins|antithrombins|mesh-ancestor
6701787|NCT01727401|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6701788|NCT01727401|Protease Inhibitors|protease inhibitors|mesh-ancestor
6701789|NCT01727401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6701790|NCT01727401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701791|NCT01727401|Anticoagulants|anticoagulants|mesh-ancestor
6701792|NCT01727401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6701793|NCT01727401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6701794|NCT01727427|Aspirin|aspirin|mesh-list
6701795|NCT01727427|Vitamin K|vitamin k|mesh-list
6701796|NCT01727427|Heparin|heparin|mesh-list
6701797|NCT01727427|Enoxaparin|enoxaparin|mesh-list
6701798|NCT01727427|Dalteparin|dalteparin|mesh-list
6701799|NCT01727427|Tinzaparin|tinzaparin|mesh-list
6701800|NCT01727427|PENTA|penta|mesh-list
6701801|NCT01727427|Nadroparin|nadroparin|mesh-list
6701802|NCT01727427|Warfarin|warfarin|mesh-list
6701803|NCT01727427|Rivaroxaban|rivaroxaban|mesh-list
6701804|NCT01727427|Dabigatran|dabigatran|mesh-list
6701805|NCT01727427|Apixaban|apixaban|mesh-list
6701806|NCT01727427|Fondaparinux|fondaparinux|mesh-list
6701807|NCT01727427|Acenocoumarol|acenocoumarol|mesh-list
6701808|NCT01727427|Phenprocoumon|phenprocoumon|mesh-list
6701809|NCT01727427|Bemiparin|bemiparin|mesh-list
6701810|NCT01727427|Vitamins|vitamins|mesh-ancestor
6701811|NCT01727427|Micronutrients|micronutrients|mesh-ancestor
6701812|NCT01727427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701813|NCT01727427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6701814|NCT01727427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6701815|NCT01727427|Analgesics|analgesics|mesh-ancestor
6701816|NCT01727427|Sensory System Agents|sensory system agents|mesh-ancestor
6701817|NCT01727427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6701818|NCT01727427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6701819|NCT01727427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6701820|NCT01727427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6701821|NCT01727427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6701822|NCT01727427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701823|NCT01727427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6701824|NCT01727427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6701825|NCT01727427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6701826|NCT01727427|Antipyretics|antipyretics|mesh-ancestor
6701827|NCT01727427|Anticoagulants|anticoagulants|mesh-ancestor
6701828|NCT01727427|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6701829|NCT01727427|Antithrombins|antithrombins|mesh-ancestor
6701830|NCT01727427|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6701831|NCT01727427|Protease Inhibitors|protease inhibitors|mesh-ancestor
6701832|NCT01727427|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6701833|NCT01727427|Hemostatics|hemostatics|mesh-ancestor
6701834|NCT01727427|Coagulants|coagulants|mesh-ancestor
6701835|NCT01727453|Warfarin|warfarin|mesh-list
6701836|NCT01727453|Anticoagulants|anticoagulants|mesh-ancestor
6701837|NCT01727531|Chloroquine|chloroquine|mesh-list
6701838|NCT01727531|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
6701839|NCT01727531|Amebicides|amebicides|mesh-ancestor
6701840|NCT01727531|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6701841|NCT01727531|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6701842|NCT01727531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6701843|NCT01727531|Antimalarials|antimalarials|mesh-ancestor
6701844|NCT01727531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6701845|NCT01727531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6701846|NCT01727531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6701847|NCT01727531|Analgesics|analgesics|mesh-ancestor
6701848|NCT01727531|Sensory System Agents|sensory system agents|mesh-ancestor
6701849|NCT01727531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6701850|NCT01727531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701851|NCT01727531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6701852|NCT01727531|Filaricides|filaricides|mesh-ancestor
6701853|NCT01727531|Antinematodal Agents|antinematodal agents|mesh-ancestor
6701854|NCT01727531|Anthelmintics|anthelmintics|mesh-ancestor
6701855|NCT01727557|Anesthetics|anesthetics|mesh-list
6701856|NCT01727557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6701857|NCT01727557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701858|NCT01727622|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6701859|NCT01727622|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6701860|NCT01727622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781901|NCT02187588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6781902|NCT02187588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6781903|NCT02187588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6781904|NCT02187588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6701861|NCT01727778|Antibodies|antibodies|mesh-list
6701862|NCT01727778|Immunoglobulin M|immunoglobulin m|mesh-list
6701863|NCT01727778|Immunologic Factors|immunologic factors|mesh-ancestor
6701864|NCT01727778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701865|NCT01727843|Tranexamic Acid|tranexamic acid|mesh-list
6701866|NCT01727843|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6701867|NCT01727843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6701868|NCT01727843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701869|NCT01727843|Hemostatics|hemostatics|mesh-ancestor
6701870|NCT01727843|Coagulants|coagulants|mesh-ancestor
6701871|NCT01727869|Cetuximab|cetuximab|mesh-list
6701872|NCT01727869|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6701873|NCT01727869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6701874|NCT01727869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6701875|NCT01727869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6701876|NCT01727869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6701877|NCT01727869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701878|NCT01727973|Doxycycline|doxycycline|mesh-list
6701879|NCT01727973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6701880|NCT01727973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6701881|NCT01727973|Antimalarials|antimalarials|mesh-ancestor
6701882|NCT01727973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6701883|NCT01727973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6701884|NCT01728025|Ranolazine|ranolazine|mesh-list
6701885|NCT01728025|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6701886|NCT01728025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6701887|NCT01728025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701888|NCT01728051|Melphalan|melphalan|mesh-list
6701889|NCT01728051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6701890|NCT01728051|Alkylating Agents|alkylating agents|mesh-ancestor
6701891|NCT01728051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701892|NCT01728051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6701893|NCT01728051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6701894|NCT01728051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6701895|NCT01728051|Immunologic Factors|immunologic factors|mesh-ancestor
6701896|NCT01728051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701897|NCT01728090|Hand Sanitizers|hand sanitizers|mesh-list
6701898|NCT01728090|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6701899|NCT01728090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6701900|NCT01728090|Disinfectants|disinfectants|mesh-ancestor
6701901|NCT01728181|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6701902|NCT01728181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6701903|NCT01728181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6701904|NCT01728181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6701905|NCT01728181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701906|NCT01728259|Dexamethasone|dexamethasone|mesh-list
6701907|NCT01728259|Bortezomib|bortezomib|mesh-list
6701908|NCT01728259|Pomalidomide|pomalidomide|mesh-list
6701909|NCT01728259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6701910|NCT01728259|Antiemetics|antiemetics|mesh-ancestor
6701911|NCT01728259|Autonomic Agents|autonomic agents|mesh-ancestor
6701912|NCT01728259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6701913|NCT01728259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701914|NCT01728259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6701915|NCT01728259|Glucocorticoids|glucocorticoids|mesh-ancestor
6701916|NCT01728259|Hormones|hormones|mesh-ancestor
6701917|NCT01728259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6701918|NCT01728259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6701919|NCT01728259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6701920|NCT01728259|Immunologic Factors|immunologic factors|mesh-ancestor
6701921|NCT01728259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6701922|NCT01728259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6701923|NCT01728259|Growth Substances|growth substances|mesh-ancestor
6701924|NCT01728259|Growth Inhibitors|growth inhibitors|mesh-ancestor
6701925|NCT01728272|Metoprolol|metoprolol|mesh-list
6701926|NCT01728272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6701927|NCT01728272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6701928|NCT01728272|Sympatholytics|sympatholytics|mesh-ancestor
6701929|NCT01728272|Autonomic Agents|autonomic agents|mesh-ancestor
6701930|NCT01728272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6701931|NCT01728272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701932|NCT01728272|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6701933|NCT01728272|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6701934|NCT01728272|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6701935|NCT01728272|Adrenergic Agents|adrenergic agents|mesh-ancestor
6701936|NCT01728272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6701937|NCT01728272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701938|NCT01728363|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6701939|NCT01728363|Rifampin|rifampin|mesh-list
6701940|NCT01728363|Clindamycin|clindamycin|mesh-list
6701941|NCT01728363|Clavulanic Acid|clavulanic acid|mesh-list
6701942|NCT01728363|Ticarcillin|ticarcillin|mesh-list
6701943|NCT01728363|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
6701944|NCT01728363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6701945|NCT01728363|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6701946|NCT01728363|Antitubercular Agents|antitubercular agents|mesh-ancestor
6701947|NCT01728363|Leprostatic Agents|leprostatic agents|mesh-ancestor
6701948|NCT01728363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6701949|NCT01728363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6701950|NCT01728363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701951|NCT01728363|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6701952|NCT01728363|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6701953|NCT01728363|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6701954|NCT01728363|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6701955|NCT01728363|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6701956|NCT01728363|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6701957|NCT01728363|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6701958|NCT01728363|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6701959|NCT01728441|Paclitaxel|paclitaxel|mesh-list
6701960|NCT01728441|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6701961|NCT01728441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6701962|NCT01728441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6701963|NCT01728441|Tubulin Modulators|tubulin modulators|mesh-ancestor
6701964|NCT01728441|Antimitotic Agents|antimitotic agents|mesh-ancestor
6701965|NCT01728441|Mitosis Modulators|mitosis modulators|mesh-ancestor
6701966|NCT01728441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701967|NCT01728480|Cisplatin|cisplatin|mesh-list
6701968|NCT01728480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6701969|NCT01728571|Vitamin D|vitamin d|mesh-list
6701970|NCT01728571|Ergocalciferols|ergocalciferols|mesh-list
6701971|NCT01728571|Cholecalciferol|cholecalciferol|mesh-list
6701972|NCT01728571|Vitamins|vitamins|mesh-list
6701973|NCT01728571|Micronutrients|micronutrients|mesh-ancestor
6701974|NCT01728571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701975|NCT01728571|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6701976|NCT01728571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6701977|NCT01728740|Metformin|metformin|mesh-list
6701978|NCT01728740|Acarbose|acarbose|mesh-list
6701979|NCT01728740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6701980|NCT01728740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701981|NCT01728740|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6701982|NCT01728740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6701983|NCT01728740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701984|NCT01728818|Gemcitabine|gemcitabine|mesh-list
6701985|NCT01728818|Afatinib|afatinib|mesh-list
6701986|NCT01728818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6701987|NCT01728818|Antimetabolites|antimetabolites|mesh-ancestor
6701988|NCT01728818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6701989|NCT01728818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6701990|NCT01728818|Antiviral Agents|antiviral agents|mesh-ancestor
6701991|NCT01728818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6701992|NCT01728818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6701993|NCT01728818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6701994|NCT01728818|Immunologic Factors|immunologic factors|mesh-ancestor
6701995|NCT01728818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6701996|NCT01728818|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6701997|NCT01728909|Oxytocin|oxytocin|mesh-list
6701998|NCT01728909|Oxytocics|oxytocics|mesh-ancestor
6701999|NCT01728909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6702000|NCT01728909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702001|NCT01728922|Vitamin D|vitamin d|mesh-list
6702002|NCT01728922|Ergocalciferols|ergocalciferols|mesh-list
6702003|NCT01728922|Vitamins|vitamins|mesh-list
6702004|NCT01728922|Micronutrients|micronutrients|mesh-ancestor
6702005|NCT01728922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702006|NCT01728922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6702007|NCT01728922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6702008|NCT01728935|Tenofovir|tenofovir|mesh-list
6702009|NCT01728935|Antiviral Agents|antiviral agents|mesh-ancestor
6702010|NCT01728935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6702011|NCT01728935|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6702012|NCT01728935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6702013|NCT01728935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6702014|NCT01728935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6702015|NCT01728935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6702016|NCT01728935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6702017|NCT01728948|Sorafenib|sorafenib|mesh-list
6702018|NCT01728948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6702019|NCT01728948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6702020|NCT01728948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6702021|NCT01728948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6702022|NCT01728961|Lumefantrine|lumefantrine|mesh-list
6702023|NCT01728961|Artemether|artemether|mesh-list
6702024|NCT01728961|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6702025|NCT01728961|Antimalarials|antimalarials|mesh-ancestor
6702026|NCT01728961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6702027|NCT01728961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6702028|NCT01728961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6702029|NCT01728974|Anesthetics|anesthetics|mesh-list
6702030|NCT01728974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6702031|NCT01728974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702032|NCT01728987|Cholecalciferol|cholecalciferol|mesh-list
6702033|NCT01728987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6702034|NCT01728987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702035|NCT01728987|Vitamins|vitamins|mesh-ancestor
6702036|NCT01728987|Micronutrients|micronutrients|mesh-ancestor
6702037|NCT01728987|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6702038|NCT01729104|Rituximab|rituximab|mesh-list
6702039|NCT01729104|Lenalidomide|lenalidomide|mesh-list
6702040|NCT01729104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6702041|NCT01729104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6702042|NCT01729104|Immunologic Factors|immunologic factors|mesh-ancestor
6702043|NCT01729104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702044|NCT01729104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6702045|NCT01729104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6702046|NCT01729104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6702047|NCT01729104|Growth Substances|growth substances|mesh-ancestor
6702048|NCT01729104|Growth Inhibitors|growth inhibitors|mesh-ancestor
6702049|NCT01729195|Ciprofloxacin|ciprofloxacin|mesh-list
6702050|NCT01729195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6702051|NCT01729195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6702052|NCT01729195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6702053|NCT01729195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6702054|NCT01729195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6702055|NCT01729195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6702056|NCT01729195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6702057|NCT01729195|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6702058|NCT01729195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6702059|NCT01729260|Mebendazole|mebendazole|mesh-list
6702060|NCT01729260|Piperazine|piperazine|mesh-list
6702061|NCT01729260|Piperazine citrate|piperazine citrate|mesh-list
6702062|NCT01729260|DMP 777|dmp 777|mesh-list
6702063|NCT01729260|Antinematodal Agents|antinematodal agents|mesh-ancestor
6702064|NCT01729260|Anthelmintics|anthelmintics|mesh-ancestor
6702065|NCT01729260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6702066|NCT01729260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6702067|NCT01729260|Tubulin Modulators|tubulin modulators|mesh-ancestor
6702068|NCT01729260|Antimitotic Agents|antimitotic agents|mesh-ancestor
6702069|NCT01729260|Mitosis Modulators|mitosis modulators|mesh-ancestor
6702070|NCT01729260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6702071|NCT01729260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6702072|NCT01729260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6781905|NCT02187588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781906|NCT02187614|Acetaminophen|acetaminophen|mesh-list
6781907|NCT02187614|Diclofenac|diclofenac|mesh-list
6781908|NCT02187614|Morphine|morphine|mesh-list
6781909|NCT02187614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6781910|NCT02187614|Narcotics|narcotics|mesh-ancestor
6781911|NCT02187614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6781912|NCT02187614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781913|NCT02187614|Analgesics|analgesics|mesh-ancestor
6781914|NCT02187614|Sensory System Agents|sensory system agents|mesh-ancestor
6781915|NCT02187614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6781916|NCT02187614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6702073|NCT01729468|Aspirin|aspirin|mesh-list
6702074|NCT01729468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6702075|NCT01729468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6702076|NCT01729468|Analgesics|analgesics|mesh-ancestor
6702077|NCT01729468|Sensory System Agents|sensory system agents|mesh-ancestor
6702078|NCT01729468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6702079|NCT01729468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702080|NCT01729468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6702081|NCT01729468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6702082|NCT01729468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6702083|NCT01729468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6702084|NCT01729468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6702085|NCT01729468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6702086|NCT01729468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6702087|NCT01729468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6702088|NCT01729468|Antipyretics|antipyretics|mesh-ancestor
6702089|NCT01729481|Leucovorin|leucovorin|mesh-list
6702090|NCT01729481|Folic Acid|folic acid|mesh-list
6702091|NCT01729481|Gemcitabine|gemcitabine|mesh-list
6702092|NCT01729481|Oxaliplatin|oxaliplatin|mesh-list
6702093|NCT01729481|Irinotecan|irinotecan|mesh-list
6702094|NCT01729481|Levoleucovorin|levoleucovorin|mesh-list
6702095|NCT01729481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6702096|NCT01729481|Antimetabolites|antimetabolites|mesh-ancestor
6702097|NCT01729481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6702098|NCT01729481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6702099|NCT01729481|Antiviral Agents|antiviral agents|mesh-ancestor
6702100|NCT01729481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6702101|NCT01729481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6702102|NCT01729481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6702103|NCT01729481|Immunologic Factors|immunologic factors|mesh-ancestor
6702104|NCT01729481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702105|NCT01729481|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6702106|NCT01729481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6702107|NCT01729481|Antidotes|antidotes|mesh-ancestor
6702108|NCT01729481|Protective Agents|protective agents|mesh-ancestor
6702109|NCT01729481|Vitamin B Complex|vitamin b complex|mesh-ancestor
6702110|NCT01729481|Vitamins|vitamins|mesh-ancestor
6702111|NCT01729481|Micronutrients|micronutrients|mesh-ancestor
6702112|NCT01729481|Hematinics|hematinics|mesh-ancestor
6702113|NCT01729663|Interferons|interferons|mesh-list
6702114|NCT01729663|Interferon-alpha|interferon-alpha|mesh-list
6702115|NCT01729663|Interferon alpha-2|interferon alpha-2|mesh-list
6702116|NCT01729663|Molgramostim|molgramostim|mesh-list
6702117|NCT01729663|Sargramostim|sargramostim|mesh-list
6702118|NCT01729663|BCG Vaccine|bcg vaccine|mesh-list
6702119|NCT01729663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6702120|NCT01729663|Antiviral Agents|antiviral agents|mesh-ancestor
6702121|NCT01729663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6702122|NCT01729663|Immunologic Factors|immunologic factors|mesh-ancestor
6702123|NCT01729663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702124|NCT01729663|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6702125|NCT01729767|Acyclovir|acyclovir|mesh-list
6702126|NCT01729767|Antiviral Agents|antiviral agents|mesh-ancestor
6702127|NCT01729767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6702128|NCT01729806|Rituximab|rituximab|mesh-list
6702129|NCT01729806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6702130|NCT01729806|Ipilimumab|ipilimumab|mesh-list
6702131|NCT01729806|Antibodies|antibodies|mesh-list
6702132|NCT01729806|Immunoglobulins|immunoglobulins|mesh-list
6702133|NCT01729806|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6702134|NCT01729806|Immunologic Factors|immunologic factors|mesh-ancestor
6702135|NCT01729806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702136|NCT01729806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6702137|NCT01729806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6702138|NCT01729806|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6702139|NCT01729806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6702140|NCT01729897|Fentanyl|fentanyl|mesh-list
6702141|NCT01729897|Propofol|propofol|mesh-list
6702142|NCT01729897|Etomidate|etomidate|mesh-list
6702143|NCT01729897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6702144|NCT01729897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6702145|NCT01729897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702146|NCT01729897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6702147|NCT01729897|Anesthetics, General|anesthetics, general|mesh-ancestor
6702148|NCT01729897|Anesthetics|anesthetics|mesh-ancestor
6702149|NCT01729897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6702150|NCT01729897|Narcotics|narcotics|mesh-ancestor
6702151|NCT01729897|Analgesics|analgesics|mesh-ancestor
6702152|NCT01729897|Sensory System Agents|sensory system agents|mesh-ancestor
6781917|NCT02187614|Antipyretics|antipyretics|mesh-ancestor
6702153|NCT01729897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6702154|NCT01729897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6702155|NCT01730014|Insulin Glargine|insulin glargine|mesh-list
6702156|NCT01730014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6702157|NCT01730014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702158|NCT01730157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6702159|NCT01730157|Ipilimumab|ipilimumab|mesh-list
6702160|NCT01730157|Antibodies|antibodies|mesh-list
6702161|NCT01730157|Immunoglobulins|immunoglobulins|mesh-list
6702162|NCT01730157|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6702163|NCT01730157|Immunologic Factors|immunologic factors|mesh-ancestor
6702164|NCT01730157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702165|NCT01730157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6702166|NCT01730157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6702167|NCT01730157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6702168|NCT01730209|Everolimus|everolimus|mesh-list
6702169|NCT01730209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6702170|NCT01730209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6702171|NCT01730209|Immunologic Factors|immunologic factors|mesh-ancestor
6702172|NCT01730209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702173|NCT01730222|Gemcitabine|gemcitabine|mesh-list
6702174|NCT01730222|Paclitaxel|paclitaxel|mesh-list
6702175|NCT01730222|Capecitabine|capecitabine|mesh-list
6702176|NCT01730222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6702177|NCT01730222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6702178|NCT01730222|Tubulin Modulators|tubulin modulators|mesh-ancestor
6702179|NCT01730222|Antimitotic Agents|antimitotic agents|mesh-ancestor
6702180|NCT01730222|Mitosis Modulators|mitosis modulators|mesh-ancestor
6702181|NCT01730222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6702182|NCT01730222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6702183|NCT01730222|Antimetabolites|antimetabolites|mesh-ancestor
6702184|NCT01730222|Antiviral Agents|antiviral agents|mesh-ancestor
6702185|NCT01730222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6702186|NCT01730222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6702187|NCT01730222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6702188|NCT01730222|Immunologic Factors|immunologic factors|mesh-ancestor
6702189|NCT01730222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702190|NCT01730287|Calcium, Dietary|calcium, dietary|mesh-list
6702191|NCT01730287|Calcium|calcium|mesh-list
6702192|NCT01730287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6702193|NCT01730287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702194|NCT01730287|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6702195|NCT01730313|Pyridoxine|pyridoxine|mesh-list
6702196|NCT01730313|Vitamin B 6|vitamin b 6|mesh-list
6702197|NCT01730313|Phenytoin|phenytoin|mesh-list
6702198|NCT01730313|Valproic Acid|valproic acid|mesh-list
6702199|NCT01730313|Vitamins|vitamins|mesh-ancestor
6702200|NCT01730313|Micronutrients|micronutrients|mesh-ancestor
6702201|NCT01730313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702202|NCT01730313|Vitamin B Complex|vitamin b complex|mesh-ancestor
6702203|NCT01730313|Anticonvulsants|anticonvulsants|mesh-ancestor
6702204|NCT01730313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6702205|NCT01730313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6702206|NCT01730313|GABA Agents|gaba agents|mesh-ancestor
6702207|NCT01730313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6702208|NCT01730313|Antimanic Agents|antimanic agents|mesh-ancestor
6702209|NCT01730313|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6702210|NCT01730313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6702211|NCT01730313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6702212|NCT01730313|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6702213|NCT01730313|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6702214|NCT01730313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6702215|NCT01730313|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6702216|NCT01730313|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6702217|NCT01730326|Acetaminophen|acetaminophen|mesh-list
6702218|NCT01730326|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
6702219|NCT01730326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6702220|NCT01730326|Analgesics|analgesics|mesh-ancestor
6702221|NCT01730326|Sensory System Agents|sensory system agents|mesh-ancestor
6702222|NCT01730326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6702223|NCT01730326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702224|NCT01730326|Antipyretics|antipyretics|mesh-ancestor
6702225|NCT01730326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6702226|NCT01730326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6702227|NCT01730326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6702228|NCT01730417|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
6702229|NCT01730417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6702230|NCT01730417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6702231|NCT01730417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6702232|NCT01730417|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6702233|NCT01730495|Etanercept|etanercept|mesh-list
6702234|NCT01730495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6702235|NCT01730495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6702236|NCT01730495|Analgesics|analgesics|mesh-ancestor
6702237|NCT01730495|Sensory System Agents|sensory system agents|mesh-ancestor
6702238|NCT01730495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6702239|NCT01730495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702240|NCT01730495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6702241|NCT01730495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6702242|NCT01730495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6702243|NCT01730495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6702244|NCT01730495|Immunologic Factors|immunologic factors|mesh-ancestor
6702245|NCT01730508|Interferons|interferons|mesh-list
6702246|NCT01730508|Interferon-alpha|interferon-alpha|mesh-list
6702247|NCT01730508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6702248|NCT01730508|Antiviral Agents|antiviral agents|mesh-ancestor
6702249|NCT01730508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6702250|NCT01730508|Immunologic Factors|immunologic factors|mesh-ancestor
6702251|NCT01730508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702252|NCT01730612|Histamine|histamine|mesh-list
6702253|NCT01730612|Glycine|glycine|mesh-list
6702254|NCT01730612|Histamine Agonists|histamine agonists|mesh-ancestor
6702255|NCT01730612|Histamine Agents|histamine agents|mesh-ancestor
6702256|NCT01730612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6702257|NCT01730612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6702258|NCT01730612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702259|NCT01730612|Glycine Agents|glycine agents|mesh-ancestor
6702260|NCT01730638|Histamine|histamine|mesh-list
6702261|NCT01730638|Glycine|glycine|mesh-list
6702262|NCT01730638|Histamine Agonists|histamine agonists|mesh-ancestor
6702263|NCT01730638|Histamine Agents|histamine agents|mesh-ancestor
6702264|NCT01730638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6702265|NCT01730638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6702266|NCT01730638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702267|NCT01730638|Glycine Agents|glycine agents|mesh-ancestor
6702268|NCT01730664|Ertapenem|ertapenem|mesh-list
6702269|NCT01730664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6702270|NCT01730664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6702271|NCT01730677|Vinorelbine|vinorelbine|mesh-list
6702272|NCT01730677|Lapatinib|lapatinib|mesh-list
6702273|NCT01730677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6702274|NCT01730677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6702275|NCT01730677|Tubulin Modulators|tubulin modulators|mesh-ancestor
6702276|NCT01730677|Antimitotic Agents|antimitotic agents|mesh-ancestor
6702277|NCT01730677|Mitosis Modulators|mitosis modulators|mesh-ancestor
6702278|NCT01730677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6702279|NCT01730677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6702280|NCT01730677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6702281|NCT01730833|Paclitaxel|paclitaxel|mesh-list
6702282|NCT01730833|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6702283|NCT01730833|Trastuzumab|trastuzumab|mesh-list
6702284|NCT01730833|Pertuzumab|pertuzumab|mesh-list
6702285|NCT01730833|Antibodies|antibodies|mesh-list
6702286|NCT01730833|Immunoglobulins|immunoglobulins|mesh-list
6702287|NCT01730833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6702288|NCT01730833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6702289|NCT01730833|Tubulin Modulators|tubulin modulators|mesh-ancestor
6702290|NCT01730833|Antimitotic Agents|antimitotic agents|mesh-ancestor
6702291|NCT01730833|Mitosis Modulators|mitosis modulators|mesh-ancestor
6702292|NCT01730833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6702293|NCT01730833|Immunologic Factors|immunologic factors|mesh-ancestor
6702294|NCT01730833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702295|NCT01730833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6702296|NCT01730937|Sorafenib|sorafenib|mesh-list
6702297|NCT01730937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6702298|NCT01730937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6702299|NCT01730937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6702300|NCT01730937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6702301|NCT01730976|Vitamin D|vitamin d|mesh-list
6702302|NCT01730976|Vitamins|vitamins|mesh-list
6702303|NCT01730976|Micronutrients|micronutrients|mesh-ancestor
6702304|NCT01730976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702305|NCT01730976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6702306|NCT01731067|Fexofenadine|fexofenadine|mesh-list
6702307|NCT01731067|Flurbiprofen|flurbiprofen|mesh-list
6702308|NCT01731067|Midazolam|midazolam|mesh-list
6702309|NCT01731067|Dextromethorphan|dextromethorphan|mesh-list
6702310|NCT01731067|Caffeine|caffeine|mesh-list
6702311|NCT01731067|Bupropion|bupropion|mesh-list
6702312|NCT01731067|Omeprazole|omeprazole|mesh-list
6702313|NCT01731067|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6702314|NCT01731067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6702315|NCT01731067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6702316|NCT01731067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702317|NCT01731067|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6702318|NCT01731067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6702319|NCT01731067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6702320|NCT01731067|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6702321|NCT01731067|Anesthetics, General|anesthetics, general|mesh-ancestor
6702322|NCT01731067|Anesthetics|anesthetics|mesh-ancestor
6702323|NCT01731067|GABA Modulators|gaba modulators|mesh-ancestor
6702324|NCT01731067|GABA Agents|gaba agents|mesh-ancestor
6702325|NCT01731067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6702326|NCT01731067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6702327|NCT01731067|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6702328|NCT01731067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6702329|NCT01731067|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6702330|NCT01731067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6702331|NCT01731067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6702332|NCT01731067|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6702333|NCT01731067|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6702334|NCT01731067|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6702335|NCT01731067|Purinergic Agents|purinergic agents|mesh-ancestor
6702336|NCT01731067|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6702337|NCT01731067|Antidepressive Agents|antidepressive agents|mesh-ancestor
6702338|NCT01731067|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6702339|NCT01731067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6702340|NCT01731067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6702341|NCT01731067|Dopamine Agents|dopamine agents|mesh-ancestor
6702342|NCT01731067|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6702343|NCT01731067|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6702344|NCT01731067|Antitussive Agents|antitussive agents|mesh-ancestor
6702345|NCT01731067|Respiratory System Agents|respiratory system agents|mesh-ancestor
6702346|NCT01731067|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6702347|NCT01731067|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6702348|NCT01731067|Analgesics|analgesics|mesh-ancestor
6702349|NCT01731067|Sensory System Agents|sensory system agents|mesh-ancestor
6702350|NCT01731067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6702351|NCT01731067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6702352|NCT01731067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6702353|NCT01731067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6702354|NCT01731067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6702355|NCT01731067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6702356|NCT01731067|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6702357|NCT01731067|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6702358|NCT01731067|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6702359|NCT01731067|Histamine Antagonists|histamine antagonists|mesh-ancestor
6702360|NCT01731067|Histamine Agents|histamine agents|mesh-ancestor
6702361|NCT01731132|Copper|copper|mesh-list
6702362|NCT01731132|Levonorgestrel|levonorgestrel|mesh-list
6702363|NCT01731132|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6702364|NCT01731132|Contraceptive Agents|contraceptive agents|mesh-ancestor
6702365|NCT01731132|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6702366|NCT01731132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702367|NCT01731132|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6702368|NCT01731132|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6702369|NCT01731132|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6702370|NCT01731132|Trace Elements|trace elements|mesh-ancestor
6702371|NCT01731132|Micronutrients|micronutrients|mesh-ancestor
6702372|NCT01731158|Interferon alpha-2|interferon alpha-2|mesh-list
6702373|NCT01731158|Bevacizumab|bevacizumab|mesh-list
6702374|NCT01731158|Sunitinib|sunitinib|mesh-list
6702375|NCT01731158|Everolimus|everolimus|mesh-list
6702376|NCT01731158|Sorafenib|sorafenib|mesh-list
6702377|NCT01731158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6702378|NCT01731158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6702379|NCT01731158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6702380|NCT01731158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6702381|NCT01731158|Growth Substances|growth substances|mesh-ancestor
6702382|NCT01731158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702383|NCT01731158|Growth Inhibitors|growth inhibitors|mesh-ancestor
6702384|NCT01731158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6702385|NCT01731158|Immunologic Factors|immunologic factors|mesh-ancestor
6702386|NCT01731158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6702387|NCT01731158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6702388|NCT01731158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6702389|NCT01731158|Antiviral Agents|antiviral agents|mesh-ancestor
6702390|NCT01731158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6702391|NCT01731184|Midazolam|midazolam|mesh-list
6702392|NCT01731184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6702393|NCT01731184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6702394|NCT01731184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6702395|NCT01731184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702396|NCT01731184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6702397|NCT01731184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6702398|NCT01731184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6702399|NCT01731184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6702400|NCT01731184|Anesthetics, General|anesthetics, general|mesh-ancestor
6702401|NCT01731184|Anesthetics|anesthetics|mesh-ancestor
6702402|NCT01731184|GABA Modulators|gaba modulators|mesh-ancestor
6702403|NCT01731184|GABA Agents|gaba agents|mesh-ancestor
6702404|NCT01731184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6702405|NCT01731184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6702406|NCT01731236|Aspirin|aspirin|mesh-list
6702407|NCT01731236|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6702408|NCT01731236|Vancomycin|vancomycin|mesh-list
6702409|NCT01731236|Ciprofloxacin|ciprofloxacin|mesh-list
6702410|NCT01731236|Neomycin|neomycin|mesh-list
6702411|NCT01731236|Choline|choline|mesh-list
6702412|NCT01731236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6702413|NCT01731236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6702414|NCT01731236|Analgesics|analgesics|mesh-ancestor
6702415|NCT01731236|Sensory System Agents|sensory system agents|mesh-ancestor
6702416|NCT01731236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6702417|NCT01731236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702418|NCT01731236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6702419|NCT01731236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6702420|NCT01731236|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6702421|NCT01731236|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6702422|NCT01731236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6702423|NCT01731236|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6702424|NCT01731236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6702425|NCT01731236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6702426|NCT01731236|Antipyretics|antipyretics|mesh-ancestor
6702427|NCT01731236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6702428|NCT01731236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6702429|NCT01731236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6702430|NCT01731236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6702431|NCT01731236|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6702432|NCT01731236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6702433|NCT01731236|Lipotropic Agents|lipotropic agents|mesh-ancestor
6702434|NCT01731236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6702435|NCT01731236|Antimetabolites|antimetabolites|mesh-ancestor
6702436|NCT01731236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6702437|NCT01731236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6702438|NCT01731236|Nootropic Agents|nootropic agents|mesh-ancestor
6702439|NCT01731236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6702440|NCT01731275|Quetmolimab|quetmolimab|mesh-list
6702441|NCT01731275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6702442|NCT01731275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6702443|NCT01731275|Immunologic Factors|immunologic factors|mesh-ancestor
6702444|NCT01731275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702445|NCT01731301|Ribavirin|ribavirin|mesh-list
6702446|NCT01731301|Antimetabolites|antimetabolites|mesh-ancestor
6702447|NCT01731301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6702448|NCT01731301|Antiviral Agents|antiviral agents|mesh-ancestor
6702449|NCT01731301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6702450|NCT01731327|Tofacitinib|tofacitinib|mesh-list
6702451|NCT01731327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6702452|NCT01731327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6702453|NCT01731327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6702454|NCT01731340|Calcium, Dietary|calcium, dietary|mesh-list
6702455|NCT01731340|Calcium|calcium|mesh-list
6702456|NCT01731340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6702457|NCT01731340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702458|NCT01731340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6702459|NCT01731431|Glyburide|glyburide|mesh-list
6702460|NCT01731431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6702461|NCT01731431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702462|NCT01731444|Phenylephrine|phenylephrine|mesh-list
6702463|NCT01731444|Oxymetazoline|oxymetazoline|mesh-list
6702464|NCT01731444|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6702465|NCT01731444|Mydriatics|mydriatics|mesh-ancestor
6702466|NCT01731444|Autonomic Agents|autonomic agents|mesh-ancestor
6702467|NCT01731444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6702468|NCT01731444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702469|NCT01731444|Sympathomimetics|sympathomimetics|mesh-ancestor
6702470|NCT01731444|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6702471|NCT01731444|Nasal Decongestants|nasal decongestants|mesh-ancestor
6702472|NCT01731444|Respiratory System Agents|respiratory system agents|mesh-ancestor
6702473|NCT01731444|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6702474|NCT01731444|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6702475|NCT01731444|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6702476|NCT01731444|Adrenergic Agents|adrenergic agents|mesh-ancestor
6702477|NCT01731444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6702478|NCT01731444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6702479|NCT01731444|Protective Agents|protective agents|mesh-ancestor
6702480|NCT01731457|Etanercept|etanercept|mesh-list
6702481|NCT01731457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6702482|NCT01731457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6702483|NCT01731457|Analgesics|analgesics|mesh-ancestor
6702484|NCT01731457|Sensory System Agents|sensory system agents|mesh-ancestor
6702485|NCT01731457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6702486|NCT01731457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702487|NCT01731457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6702488|NCT01731457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6702489|NCT01731457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6702490|NCT01731457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6702491|NCT01731457|Immunologic Factors|immunologic factors|mesh-ancestor
6702492|NCT01731561|Rituximab|rituximab|mesh-list
6702493|NCT01731561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6702494|NCT01731561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6702495|NCT01731561|Immunologic Factors|immunologic factors|mesh-ancestor
6702496|NCT01731561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702497|NCT01731561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6702498|NCT01731574|Dapivirine|dapivirine|mesh-list
6702499|NCT01731574|Miconazole|miconazole|mesh-list
6702500|NCT01731574|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6702501|NCT01731574|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6702502|NCT01731574|Antiviral Agents|antiviral agents|mesh-ancestor
6702503|NCT01731574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6702504|NCT01731574|Antifungal Agents|antifungal agents|mesh-ancestor
6702505|NCT01731574|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6702506|NCT01731574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6702507|NCT01731574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6702508|NCT01731574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6702509|NCT01731574|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6702510|NCT01731574|Hormone Antagonists|hormone antagonists|mesh-ancestor
6702511|NCT01731574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6702512|NCT01731574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702513|NCT01731574|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6702514|NCT01731574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6702515|NCT01731587|Cyclophosphamide|cyclophosphamide|mesh-list
6702516|NCT01731587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6702517|NCT01731587|Immunologic Factors|immunologic factors|mesh-ancestor
6702518|NCT01731587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702519|NCT01731587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6702520|NCT01731587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6702521|NCT01731587|Alkylating Agents|alkylating agents|mesh-ancestor
6702522|NCT01731587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6702523|NCT01731587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6702524|NCT01731587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6702525|NCT01731652|Imiquimod|imiquimod|mesh-list
6702526|NCT01731652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6702527|NCT01731652|Immunologic Factors|immunologic factors|mesh-ancestor
6702528|NCT01731652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702529|NCT01731652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6702530|NCT01731652|Interferon Inducers|interferon inducers|mesh-ancestor
6702531|NCT01731756|Salicylic Acid|salicylic acid|mesh-list
6702532|NCT01731756|Salicylates|salicylates|mesh-list
6702533|NCT01731756|Petrolatum|petrolatum|mesh-list
6702534|NCT01731756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6702535|NCT01731756|Antifungal Agents|antifungal agents|mesh-ancestor
6702536|NCT01731756|Keratolytic Agents|keratolytic agents|mesh-ancestor
6702537|NCT01731756|Dermatologic Agents|dermatologic agents|mesh-ancestor
6702538|NCT01731756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6702539|NCT01731756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6702540|NCT01731756|Analgesics|analgesics|mesh-ancestor
6702541|NCT01731756|Sensory System Agents|sensory system agents|mesh-ancestor
6702542|NCT01731756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6702543|NCT01731756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702544|NCT01731756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6702545|NCT01731756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6702546|NCT01731756|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6702547|NCT01731756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6702548|NCT01731756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6702549|NCT01731756|Emollients|emollients|mesh-ancestor
6702550|NCT01731782|Bupivacaine|bupivacaine|mesh-list
6702551|NCT01731782|Anesthetics, Local|anesthetics, local|mesh-ancestor
6702552|NCT01731782|Anesthetics|anesthetics|mesh-ancestor
6702553|NCT01731782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6702554|NCT01731782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702555|NCT01731782|Sensory System Agents|sensory system agents|mesh-ancestor
6702556|NCT01731782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6702557|NCT01731795|Dexamethasone|dexamethasone|mesh-list
6702558|NCT01731795|Dexamethasone acetate|dexamethasone acetate|mesh-list
6702559|NCT01731795|BB 1101|bb 1101|mesh-list
6702560|NCT01731795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6702561|NCT01731795|Antiemetics|antiemetics|mesh-ancestor
6702562|NCT01731795|Autonomic Agents|autonomic agents|mesh-ancestor
6702563|NCT01731795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6702564|NCT01731795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702565|NCT01731795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6702566|NCT01731795|Glucocorticoids|glucocorticoids|mesh-ancestor
6702567|NCT01731795|Hormones|hormones|mesh-ancestor
6702568|NCT01731795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6702569|NCT01731795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6702570|NCT01731795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6702571|NCT01731795|Protease Inhibitors|protease inhibitors|mesh-ancestor
6702572|NCT01731795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6702573|NCT01731795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6702574|NCT01731899|S 20098|s 20098|mesh-list
6702575|NCT01731899|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6702576|NCT01731899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6702577|NCT01731899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702578|NCT01731925|Sunitinib|sunitinib|mesh-list
6702579|NCT01731925|Lanreotide|lanreotide|mesh-list
6702580|NCT01731925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6702581|NCT01731925|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6702582|NCT01731925|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6702583|NCT01731925|Growth Substances|growth substances|mesh-ancestor
6702584|NCT01731925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702585|NCT01731925|Growth Inhibitors|growth inhibitors|mesh-ancestor
6702586|NCT01731925|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6702587|NCT01731925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6702588|NCT01731925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6702589|NCT01732055|Antidepressive Agents|antidepressive agents|mesh-list
6702590|NCT01732055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6702591|NCT01732068|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6702592|NCT01732068|Luteolytic Agents|luteolytic agents|mesh-ancestor
6702593|NCT01732068|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6702594|NCT01732068|Contraceptive Agents|contraceptive agents|mesh-ancestor
6702595|NCT01732068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6702596|NCT01732068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702597|NCT01732068|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6702598|NCT01732068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6702599|NCT01732068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6702600|NCT01732094|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6702601|NCT01732094|Luteolytic Agents|luteolytic agents|mesh-ancestor
6702602|NCT01732094|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6702603|NCT01732094|Contraceptive Agents|contraceptive agents|mesh-ancestor
6702604|NCT01732094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6702605|NCT01732094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702606|NCT01732094|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6702607|NCT01732094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6702608|NCT01732094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6702609|NCT01732146|Epoetin Alfa|epoetin alfa|mesh-list
6702610|NCT01732146|Hematinics|hematinics|mesh-ancestor
6702611|NCT01732198|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6702612|NCT01732198|Immunologic Factors|immunologic factors|mesh-ancestor
6702613|NCT01732198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702614|NCT01732224|Tenofovir|tenofovir|mesh-list
6702615|NCT01732224|Telbivudine|telbivudine|mesh-list
6702616|NCT01732224|Antiviral Agents|antiviral agents|mesh-ancestor
6702617|NCT01732224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6702618|NCT01732224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6702619|NCT01732224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6702620|NCT01732224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6702621|NCT01732224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6702622|NCT01732224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6702623|NCT01732224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6702624|NCT01732250|Meropenem|meropenem|mesh-list
6702625|NCT01732250|Colistin|colistin|mesh-list
6702626|NCT01732250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6702627|NCT01732250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6702628|NCT01732276|Gefitinib|gefitinib|mesh-list
6702629|NCT01732276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6702630|NCT01732276|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6702631|NCT01732276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6702632|NCT01732276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6702633|NCT01732328|Vitamin D|vitamin d|mesh-list
6702634|NCT01732328|Calcium|calcium|mesh-list
6702635|NCT01732328|Vitamins|vitamins|mesh-ancestor
6702636|NCT01732328|Micronutrients|micronutrients|mesh-ancestor
6702637|NCT01732328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702638|NCT01732328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6702639|NCT01732328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6702640|NCT01732367|Tenofovir|tenofovir|mesh-list
6702641|NCT01732367|Lamivudine|lamivudine|mesh-list
6702642|NCT01732367|Adefovir|adefovir|mesh-list
6702643|NCT01732367|Antiviral Agents|antiviral agents|mesh-ancestor
6702644|NCT01732367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6702645|NCT01732367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6702646|NCT01732367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6702647|NCT01732367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6702648|NCT01732367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6702649|NCT01732367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6702650|NCT01732367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6702651|NCT01732380|Oxaliplatin|oxaliplatin|mesh-list
6702652|NCT01732380|Raltitrexed|raltitrexed|mesh-list
6702653|NCT01732380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6702654|NCT01732380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6702655|NCT01732380|Antimetabolites|antimetabolites|mesh-ancestor
6702656|NCT01732380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6702657|NCT01732380|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6702658|NCT01732380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6702659|NCT01732393|Quercetin|quercetin|mesh-list
6702660|NCT01732393|Antioxidants|antioxidants|mesh-ancestor
6702661|NCT01732393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6702662|NCT01732393|Protective Agents|protective agents|mesh-ancestor
6702663|NCT01732393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702664|NCT01732666|Remifentanil|remifentanil|mesh-list
6702665|NCT01732666|Nefopam|nefopam|mesh-list
6702666|NCT01732666|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6702667|NCT01732666|Narcotics|narcotics|mesh-ancestor
6702668|NCT01732666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6702669|NCT01732666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702670|NCT01732666|Analgesics|analgesics|mesh-ancestor
6702671|NCT01732666|Sensory System Agents|sensory system agents|mesh-ancestor
6702672|NCT01732666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6702673|NCT01732666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6781918|NCT02187614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6781919|NCT02187614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6781920|NCT02187614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6781921|NCT02187614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6781922|NCT02187614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6781923|NCT02187614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781924|NCT02187679|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6781925|NCT02187679|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6702674|NCT01732744|Sodium Hypochlorite|sodium hypochlorite|mesh-list
6702675|NCT01732744|Eusol|eusol|mesh-list
6702676|NCT01732744|Castor Oil|castor oil|mesh-list
6702677|NCT01732744|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6702678|NCT01732744|Disinfectants|disinfectants|mesh-ancestor
6702679|NCT01732744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6702680|NCT01732744|Cathartics|cathartics|mesh-ancestor
6702681|NCT01732744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6702682|NCT01732861|Lenalidomide|lenalidomide|mesh-list
6702683|NCT01732861|Immunologic Factors|immunologic factors|mesh-ancestor
6702684|NCT01732861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702685|NCT01732861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6702686|NCT01732861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6702687|NCT01732861|Growth Substances|growth substances|mesh-ancestor
6702688|NCT01732861|Growth Inhibitors|growth inhibitors|mesh-ancestor
6702689|NCT01732861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6702690|NCT01733017|Lycopene|lycopene|mesh-list
6702691|NCT01733017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6702692|NCT01733017|Antioxidants|antioxidants|mesh-ancestor
6702693|NCT01733017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6702694|NCT01733017|Protective Agents|protective agents|mesh-ancestor
6702695|NCT01733017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702696|NCT01733017|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6702697|NCT01733017|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6702698|NCT01733017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6702699|NCT01733030|Cycloserine|cycloserine|mesh-list
6702700|NCT01733030|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6702701|NCT01733030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6702702|NCT01733030|Renal Agents|renal agents|mesh-ancestor
6702703|NCT01733030|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6702704|NCT01733030|Antitubercular Agents|antitubercular agents|mesh-ancestor
6702705|NCT01733030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6702706|NCT01733030|Antimetabolites|antimetabolites|mesh-ancestor
6702707|NCT01733030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6702708|NCT01733043|Dexmedetomidine|dexmedetomidine|mesh-list
6702709|NCT01733043|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6702710|NCT01733043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6702711|NCT01733043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702712|NCT01733043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6702713|NCT01733043|Analgesics|analgesics|mesh-ancestor
6702714|NCT01733043|Sensory System Agents|sensory system agents|mesh-ancestor
6702715|NCT01733043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6702716|NCT01733043|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6702717|NCT01733043|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6702718|NCT01733043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6702719|NCT01733043|Adrenergic Agents|adrenergic agents|mesh-ancestor
6702720|NCT01733043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6702721|NCT01733043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6702722|NCT01733095|Ambrisentan|ambrisentan|mesh-list
6702723|NCT01733095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6702724|NCT01733108|Canagliflozin|canagliflozin|mesh-list
6702725|NCT01733108|Glyburide|glyburide|mesh-list
6702726|NCT01733108|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6702727|NCT01733108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6702728|NCT01733108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6702729|NCT01733108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702730|NCT01733134|Tolvaptan|tolvaptan|mesh-list
6702731|NCT01733134|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6702732|NCT01733134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6702733|NCT01733134|Natriuretic Agents|natriuretic agents|mesh-ancestor
6702734|NCT01733134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702735|NCT01733290|Botulinum Toxins|botulinum toxins|mesh-list
6702736|NCT01733290|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6702737|NCT01733290|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6702738|NCT01733290|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6702739|NCT01733290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6702740|NCT01733290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6702741|NCT01733290|Cholinergic Agents|cholinergic agents|mesh-ancestor
6702742|NCT01733290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6702743|NCT01733290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702744|NCT01733290|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6702745|NCT01733290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6702746|NCT01733342|Anesthetics|anesthetics|mesh-list
6702747|NCT01733342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6702748|NCT01733342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702749|NCT01733394|Lamotrigine|lamotrigine|mesh-list
6702750|NCT01733394|Anticonvulsants|anticonvulsants|mesh-list
6702751|NCT01733394|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6702752|NCT01733394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6702753|NCT01733394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6702754|NCT01733394|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6702755|NCT01733394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702756|NCT01733394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6702757|NCT01733394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6702758|NCT01733394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6702759|NCT01733394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6702760|NCT01733394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6702761|NCT01733459|Metformin|metformin|mesh-list
6702762|NCT01733459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6702763|NCT01733459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702764|NCT01733485|Aspirin|aspirin|mesh-list
6702765|NCT01733485|Indomethacin|indomethacin|mesh-list
6702766|NCT01733485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6702767|NCT01733485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6702768|NCT01733485|Analgesics|analgesics|mesh-ancestor
6702769|NCT01733485|Sensory System Agents|sensory system agents|mesh-ancestor
6702770|NCT01733485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6702771|NCT01733485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702772|NCT01733485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6702773|NCT01733485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6702774|NCT01733485|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6702775|NCT01733485|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6702776|NCT01733485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6702777|NCT01733485|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6702778|NCT01733485|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6702779|NCT01733485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6702780|NCT01733485|Antipyretics|antipyretics|mesh-ancestor
6702781|NCT01733485|Gout Suppressants|gout suppressants|mesh-ancestor
6702782|NCT01733485|Tocolytic Agents|tocolytic agents|mesh-ancestor
6702783|NCT01733485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6702784|NCT01733589|Etoposide|etoposide|mesh-list
6702785|NCT01733589|Cisplatin|cisplatin|mesh-list
6702786|NCT01733589|Endostatins|endostatins|mesh-list
6702787|NCT01733589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6702788|NCT01733589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6702789|NCT01733589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6702790|NCT01733589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6702791|NCT01733589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6702792|NCT01733589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6702793|NCT01733589|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6702794|NCT01733589|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6702795|NCT01733589|Growth Substances|growth substances|mesh-ancestor
6702796|NCT01733589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702797|NCT01733589|Growth Inhibitors|growth inhibitors|mesh-ancestor
6702798|NCT01733706|Nicotine|nicotine|mesh-list
6702799|NCT01733706|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6702800|NCT01733706|Autonomic Agents|autonomic agents|mesh-ancestor
6702801|NCT01733706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6702802|NCT01733706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702803|NCT01733706|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6702804|NCT01733706|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6702805|NCT01733706|Cholinergic Agents|cholinergic agents|mesh-ancestor
6702806|NCT01733706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6702807|NCT01733706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6702808|NCT01733823|Nimorazole|nimorazole|mesh-list
6702809|NCT01733823|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
6702810|NCT01733823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6702811|NCT01733823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6702812|NCT01733823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6702813|NCT01733836|Metformin|metformin|mesh-list
6702814|NCT01733836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6702815|NCT01733836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702816|NCT01733888|Hydrogen Peroxide|hydrogen peroxide|mesh-list
6702817|NCT01733888|Immunoconjugates|immunoconjugates|mesh-list
6702818|NCT01733888|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6702819|NCT01733888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6702820|NCT01733888|Immunologic Factors|immunologic factors|mesh-ancestor
6702821|NCT01733888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702822|NCT01733966|Amoxicillin|amoxicillin|mesh-list
6702823|NCT01733966|Clavulanic Acids|clavulanic acids|mesh-list
6702824|NCT01733966|Clavulanic Acid|clavulanic acid|mesh-list
6702825|NCT01733966|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6702826|NCT01733966|Ciprofloxacin|ciprofloxacin|mesh-list
6702827|NCT01733966|Secnidazole|secnidazole|mesh-list
6702828|NCT01733966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6702829|NCT01733966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6702830|NCT01733966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6702831|NCT01733966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6702832|NCT01733966|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6702833|NCT01733966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6702834|NCT01733966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6702835|NCT01733966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6702836|NCT01733966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6702837|NCT01733966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6702838|NCT01733966|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6702839|NCT01733966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6702840|NCT01733979|Iron|iron|mesh-list
6702841|NCT01733979|Trace Elements|trace elements|mesh-ancestor
6702842|NCT01733979|Micronutrients|micronutrients|mesh-ancestor
6702843|NCT01733979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702844|NCT01733992|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6702845|NCT01733992|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6702846|NCT01734044|Dexamethasone|dexamethasone|mesh-list
6702847|NCT01734044|Dexamethasone acetate|dexamethasone acetate|mesh-list
6702848|NCT01734044|BB 1101|bb 1101|mesh-list
6702849|NCT01734044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6702850|NCT01734044|Antiemetics|antiemetics|mesh-ancestor
6702851|NCT01734044|Autonomic Agents|autonomic agents|mesh-ancestor
6702852|NCT01734044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6702853|NCT01734044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702854|NCT01734044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6702855|NCT01734044|Glucocorticoids|glucocorticoids|mesh-ancestor
6702856|NCT01734044|Hormones|hormones|mesh-ancestor
6702857|NCT01734044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6702858|NCT01734044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6702859|NCT01734044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6702860|NCT01734044|Protease Inhibitors|protease inhibitors|mesh-ancestor
6702861|NCT01734044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6702862|NCT01734044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6702863|NCT01734057|Dexamethasone|dexamethasone|mesh-list
6702864|NCT01734057|Rituximab|rituximab|mesh-list
6702865|NCT01734057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6702866|NCT01734057|Antiemetics|antiemetics|mesh-ancestor
6702867|NCT01734057|Autonomic Agents|autonomic agents|mesh-ancestor
6702868|NCT01734057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6702869|NCT01734057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702870|NCT01734057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6702871|NCT01734057|Glucocorticoids|glucocorticoids|mesh-ancestor
6702872|NCT01734057|Hormones|hormones|mesh-ancestor
6702873|NCT01734057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6702874|NCT01734057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6702875|NCT01734057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6702876|NCT01734057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6702877|NCT01734057|Immunologic Factors|immunologic factors|mesh-ancestor
6702878|NCT01734057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6702879|NCT01734096|Candesartan|candesartan|mesh-list
6702880|NCT01734096|Candesartan cilexetil|candesartan cilexetil|mesh-list
6702881|NCT01734096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6702882|NCT01734096|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6702883|NCT01734096|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6702884|NCT01734096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6702885|NCT01734252|Argatroban|argatroban|mesh-list
6702886|NCT01734252|Antithrombins|antithrombins|mesh-ancestor
6702887|NCT01734252|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6702888|NCT01734252|Protease Inhibitors|protease inhibitors|mesh-ancestor
6702889|NCT01734252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6702890|NCT01734252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6702891|NCT01734252|Anticoagulants|anticoagulants|mesh-ancestor
6702892|NCT01734252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6702893|NCT01734304|Vaccines|vaccines|mesh-list
6702894|NCT01734304|Immunologic Factors|immunologic factors|mesh-ancestor
6702895|NCT01734304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702896|NCT01734330|Nicotine|nicotine|mesh-list
6702897|NCT01734330|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6702898|NCT01734330|Autonomic Agents|autonomic agents|mesh-ancestor
6702899|NCT01734330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6702900|NCT01734330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702901|NCT01734330|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6702902|NCT01734330|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6702903|NCT01734330|Cholinergic Agents|cholinergic agents|mesh-ancestor
6702904|NCT01734330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6702905|NCT01734330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6702906|NCT01734408|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6702907|NCT01734408|Aluminum sulfate|aluminum sulfate|mesh-list
6702908|NCT01734408|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6702909|NCT01734408|Immunologic Factors|immunologic factors|mesh-ancestor
6702910|NCT01734408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702911|NCT01734408|Antacids|antacids|mesh-ancestor
6702912|NCT01734408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6702913|NCT01734408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6702914|NCT01734473|Caseins|caseins|mesh-list
6702915|NCT01734473|Chelating Agents|chelating agents|mesh-ancestor
6702916|NCT01734473|Sequestering Agents|sequestering agents|mesh-ancestor
6702917|NCT01734473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6702918|NCT01734564|Poly I-C|poly i-c|mesh-list
6702919|NCT01734564|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6702920|NCT01734564|Poly ICLC|poly iclc|mesh-list
6702921|NCT01734564|Interferon Inducers|interferon inducers|mesh-ancestor
6702922|NCT01734564|Immunologic Factors|immunologic factors|mesh-ancestor
6702923|NCT01734564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702924|NCT01734564|Laxatives|laxatives|mesh-ancestor
6702925|NCT01734564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6702926|NCT01734564|Antiviral Agents|antiviral agents|mesh-ancestor
6702927|NCT01734564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6781926|NCT02187679|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6781927|NCT02187679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6781928|NCT02187679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781929|NCT02187679|Cholinergic Agents|cholinergic agents|mesh-ancestor
6781930|NCT02187679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6781931|NCT02187679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781932|NCT02187679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6781933|NCT02187679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6781934|NCT02187705|Telmisartan|telmisartan|mesh-list
6781935|NCT02187705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6781936|NCT02187705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6781937|NCT02187705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6781938|NCT02187705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781939|NCT02187718|Anesthetics|anesthetics|mesh-list
6781940|NCT02187718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6781941|NCT02187718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781942|NCT02187822|Taxane|taxane|mesh-list
6781943|NCT02187822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6781944|NCT02187874|Oxytocin|oxytocin|mesh-list
6781945|NCT02187874|Oxytocics|oxytocics|mesh-ancestor
6781946|NCT02187874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6781947|NCT02187874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781948|NCT02187900|Mycophenolic Acid|mycophenolic acid|mesh-list
6781949|NCT02187900|Cardiac Glycosides|cardiac glycosides|mesh-list
6781950|NCT02187900|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6781951|NCT02187900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6781952|NCT02187900|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6781953|NCT02187900|Antitubercular Agents|antitubercular agents|mesh-ancestor
6781954|NCT02187900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6781955|NCT02187900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6781956|NCT02187900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6781957|NCT02187900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781958|NCT02187900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6781959|NCT02187900|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6781960|NCT02187900|Protective Agents|protective agents|mesh-ancestor
6781961|NCT02187900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781962|NCT02188121|Losartan|losartan|mesh-list
6781963|NCT02188121|Simvastatin|simvastatin|mesh-list
6781964|NCT02188121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6781965|NCT02188121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6781966|NCT02188121|Antimetabolites|antimetabolites|mesh-ancestor
6781967|NCT02188121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781968|NCT02188121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6781969|NCT02188121|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6781970|NCT02188121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6702928|NCT01734694|Vancomycin|vancomycin|mesh-list
6702929|NCT01734694|Linezolid|linezolid|mesh-list
6702930|NCT01734694|Daptomycin|daptomycin|mesh-list
6702931|NCT01734694|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
6702932|NCT01734694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6702933|NCT01734694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6702934|NCT01734694|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6702935|NCT01734694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6702936|NCT01734694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6702937|NCT01734798|Gemcitabine|gemcitabine|mesh-list
6702938|NCT01734798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6702939|NCT01734798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6702940|NCT01734798|Antimetabolites|antimetabolites|mesh-ancestor
6702941|NCT01734798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6702942|NCT01734798|Antiviral Agents|antiviral agents|mesh-ancestor
6702943|NCT01734798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6702944|NCT01734798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6702945|NCT01734798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6702946|NCT01734798|Immunologic Factors|immunologic factors|mesh-ancestor
6702947|NCT01734798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702948|NCT01734824|Denosumab|denosumab|mesh-list
6702949|NCT01734824|Teriparatide|teriparatide|mesh-list
6702950|NCT01734824|Parathyroid Hormone|parathyroid hormone|mesh-list
6702951|NCT01734824|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6702952|NCT01734824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702953|NCT01734824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6702954|NCT01734915|Iproplatin|iproplatin|mesh-list
6702955|NCT01734915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6702956|NCT01734928|Thalidomide|thalidomide|mesh-list
6702957|NCT01734928|Dexamethasone|dexamethasone|mesh-list
6702958|NCT01734928|Bortezomib|bortezomib|mesh-list
6702959|NCT01734928|Pomalidomide|pomalidomide|mesh-list
6702960|NCT01734928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6702961|NCT01734928|Antiemetics|antiemetics|mesh-ancestor
6702962|NCT01734928|Autonomic Agents|autonomic agents|mesh-ancestor
6702963|NCT01734928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6702964|NCT01734928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702965|NCT01734928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6702966|NCT01734928|Glucocorticoids|glucocorticoids|mesh-ancestor
6702967|NCT01734928|Hormones|hormones|mesh-ancestor
6702968|NCT01734928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6702969|NCT01734928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6702970|NCT01734928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6702971|NCT01734928|Immunologic Factors|immunologic factors|mesh-ancestor
6702972|NCT01734928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6702973|NCT01734928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6702974|NCT01734928|Growth Substances|growth substances|mesh-ancestor
6702975|NCT01734928|Growth Inhibitors|growth inhibitors|mesh-ancestor
6702976|NCT01734928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6702977|NCT01734928|Leprostatic Agents|leprostatic agents|mesh-ancestor
6702978|NCT01734928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6702979|NCT01734928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6702980|NCT01734954|Midazolam|midazolam|mesh-list
6702981|NCT01734954|Analgesics|analgesics|mesh-list
6702982|NCT01734954|Anesthetics|anesthetics|mesh-list
6702983|NCT01734954|Levobupivacaine|levobupivacaine|mesh-list
6702984|NCT01734954|Anesthetics, Local|anesthetics, local|mesh-list
6702985|NCT01734954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6702986|NCT01734954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6702987|NCT01734954|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6702988|NCT01734954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6702989|NCT01734954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6702990|NCT01734954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6702991|NCT01734954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6702992|NCT01734954|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6702993|NCT01734954|Anesthetics, General|anesthetics, general|mesh-ancestor
6702994|NCT01734954|GABA Modulators|gaba modulators|mesh-ancestor
6702995|NCT01734954|GABA Agents|gaba agents|mesh-ancestor
6702996|NCT01734954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6702997|NCT01734954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6702998|NCT01734954|Sensory System Agents|sensory system agents|mesh-ancestor
6702999|NCT01734954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6703000|NCT01735006|Vaccines|vaccines|mesh-list
6703001|NCT01735006|Immunologic Factors|immunologic factors|mesh-ancestor
6703002|NCT01735006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703003|NCT01735019|Remifentanil|remifentanil|mesh-list
6703004|NCT01735019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6703005|NCT01735019|Narcotics|narcotics|mesh-ancestor
6703006|NCT01735019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6703007|NCT01735019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703008|NCT01735019|Analgesics|analgesics|mesh-ancestor
6703009|NCT01735019|Sensory System Agents|sensory system agents|mesh-ancestor
6703010|NCT01735019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6703011|NCT01735058|Hyaluronic Acid|hyaluronic acid|mesh-list
6703012|NCT01735058|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6703013|NCT01735058|Immunologic Factors|immunologic factors|mesh-ancestor
6703014|NCT01735058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703015|NCT01735058|Viscosupplements|viscosupplements|mesh-ancestor
6703016|NCT01735058|Protective Agents|protective agents|mesh-ancestor
6703017|NCT01735071|Bevacizumab|bevacizumab|mesh-list
6703018|NCT01735071|Carboplatin|carboplatin|mesh-list
6703019|NCT01735071|Trabectedin|trabectedin|mesh-list
6703020|NCT01735071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6703021|NCT01735071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6703022|NCT01735071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6703023|NCT01735071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6703024|NCT01735071|Growth Substances|growth substances|mesh-ancestor
6703025|NCT01735071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703026|NCT01735071|Growth Inhibitors|growth inhibitors|mesh-ancestor
6703027|NCT01735071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6703028|NCT01735071|Alkylating Agents|alkylating agents|mesh-ancestor
6703029|NCT01735071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703030|NCT01735084|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6703031|NCT01735084|Immunologic Factors|immunologic factors|mesh-ancestor
6703032|NCT01735084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703033|NCT01735097|Vitamin E|vitamin e|mesh-list
6703034|NCT01735097|Vitamins|vitamins|mesh-ancestor
6703035|NCT01735097|Micronutrients|micronutrients|mesh-ancestor
6703036|NCT01735097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703037|NCT01735097|Antioxidants|antioxidants|mesh-ancestor
6703038|NCT01735097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703039|NCT01735097|Protective Agents|protective agents|mesh-ancestor
6703040|NCT01735123|Caseins|caseins|mesh-list
6703041|NCT01735123|Chelating Agents|chelating agents|mesh-ancestor
6703042|NCT01735123|Sequestering Agents|sequestering agents|mesh-ancestor
6703043|NCT01735123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703044|NCT01735227|Omeprazole|omeprazole|mesh-list
6703045|NCT01735227|Pantoprazole|pantoprazole|mesh-list
6703046|NCT01735227|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6703047|NCT01735227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6703048|NCT01735227|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6703049|NCT01735227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6703050|NCT01735227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703051|NCT01735240|Ketoconazole|ketoconazole|mesh-list
6703052|NCT01735240|Antifungal Agents|antifungal agents|mesh-ancestor
6703053|NCT01735240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6703054|NCT01735240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6703055|NCT01735240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6703056|NCT01735240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6703057|NCT01735240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703058|NCT01735240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6703059|NCT01735240|Hormone Antagonists|hormone antagonists|mesh-ancestor
6703060|NCT01735240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6703061|NCT01735240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703062|NCT01735240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6703063|NCT01735318|Lisinopril|lisinopril|mesh-list
6703064|NCT01735318|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6703065|NCT01735318|Protease Inhibitors|protease inhibitors|mesh-ancestor
6703066|NCT01735318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6703067|NCT01735318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703068|NCT01735318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6703069|NCT01735318|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6703070|NCT01735318|Protective Agents|protective agents|mesh-ancestor
6703071|NCT01735318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703072|NCT01735344|Lisinopril|lisinopril|mesh-list
6703073|NCT01735344|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6703074|NCT01735344|Protease Inhibitors|protease inhibitors|mesh-ancestor
6703075|NCT01735344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6703076|NCT01735344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703077|NCT01735344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6703078|NCT01735344|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6703079|NCT01735344|Protective Agents|protective agents|mesh-ancestor
6703080|NCT01735344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703081|NCT01735370|Etodolac|etodolac|mesh-list
6703082|NCT01735370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6703083|NCT01735370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6703084|NCT01735370|Analgesics|analgesics|mesh-ancestor
6703085|NCT01735370|Sensory System Agents|sensory system agents|mesh-ancestor
6703086|NCT01735370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6703087|NCT01735370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703088|NCT01735370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6703089|NCT01735370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6703090|NCT01735370|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6703091|NCT01735370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6703092|NCT01735370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6703093|NCT01735370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703094|NCT01735383|Etodolac|etodolac|mesh-list
6703095|NCT01735383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6703096|NCT01735383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6703097|NCT01735383|Analgesics|analgesics|mesh-ancestor
6703098|NCT01735383|Sensory System Agents|sensory system agents|mesh-ancestor
6703099|NCT01735383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6703100|NCT01735383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703101|NCT01735383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6703102|NCT01735383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6703103|NCT01735383|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6703104|NCT01735383|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6703105|NCT01735383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6703106|NCT01735383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703107|NCT01735461|Calcium Carbonate|calcium carbonate|mesh-list
6703108|NCT01735461|Calcium|calcium|mesh-list
6703109|NCT01735461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6703110|NCT01735461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703111|NCT01735461|Antacids|antacids|mesh-ancestor
6703112|NCT01735461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703113|NCT01735461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6703114|NCT01735487|Nicotine|nicotine|mesh-list
6703115|NCT01735487|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6703116|NCT01735487|Autonomic Agents|autonomic agents|mesh-ancestor
6703117|NCT01735487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6703118|NCT01735487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703119|NCT01735487|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6703120|NCT01735487|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6703121|NCT01735487|Cholinergic Agents|cholinergic agents|mesh-ancestor
6703122|NCT01735487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6703123|NCT01735487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703124|NCT01735669|Remifentanil|remifentanil|mesh-list
6703125|NCT01735669|Nitrous Oxide|nitrous oxide|mesh-list
6703126|NCT01735669|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6703127|NCT01735669|Narcotics|narcotics|mesh-ancestor
6703128|NCT01735669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6703129|NCT01735669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703130|NCT01735669|Analgesics|analgesics|mesh-ancestor
6703131|NCT01735669|Sensory System Agents|sensory system agents|mesh-ancestor
6703132|NCT01735669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6703133|NCT01735669|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6703134|NCT01735669|Anesthetics, General|anesthetics, general|mesh-ancestor
6703135|NCT01735669|Anesthetics|anesthetics|mesh-ancestor
6703136|NCT01735669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6703137|NCT01735747|Vincristine|vincristine|mesh-list
6703138|NCT01735747|Temozolomide|temozolomide|mesh-list
6703139|NCT01735747|Nedaplatin|nedaplatin|mesh-list
6703140|NCT01735747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6703141|NCT01735747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6703142|NCT01735747|Tubulin Modulators|tubulin modulators|mesh-ancestor
6703143|NCT01735747|Antimitotic Agents|antimitotic agents|mesh-ancestor
6703144|NCT01735747|Mitosis Modulators|mitosis modulators|mesh-ancestor
6703145|NCT01735747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703146|NCT01735747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6703147|NCT01735747|Alkylating Agents|alkylating agents|mesh-ancestor
6703148|NCT01735825|Paclitaxel|paclitaxel|mesh-list
6703149|NCT01735825|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6703150|NCT01735825|Everolimus|everolimus|mesh-list
6703151|NCT01735825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6703152|NCT01735825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6703153|NCT01735825|Tubulin Modulators|tubulin modulators|mesh-ancestor
6703154|NCT01735825|Antimitotic Agents|antimitotic agents|mesh-ancestor
6703155|NCT01735825|Mitosis Modulators|mitosis modulators|mesh-ancestor
6703156|NCT01735825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703157|NCT01735825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6703158|NCT01735825|Immunologic Factors|immunologic factors|mesh-ancestor
6703159|NCT01735825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703160|NCT01735864|Indirubin|indirubin|mesh-list
6703161|NCT01735864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6703162|NCT01735864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6703163|NCT01735890|Amlodipine|amlodipine|mesh-list
6703164|NCT01735890|Valsartan|valsartan|mesh-list
6703165|NCT01735890|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
6703166|NCT01735890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6703167|NCT01735890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6703168|NCT01735890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6703169|NCT01735890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703170|NCT01735890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6703171|NCT01735890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703172|NCT01735890|Vasodilator Agents|vasodilator agents|mesh-ancestor
6703173|NCT01735890|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6703174|NCT01735890|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6703175|NCT01736020|Dexmedetomidine|dexmedetomidine|mesh-list
6703176|NCT01736020|Nitrous Oxide|nitrous oxide|mesh-list
6703177|NCT01736020|Ketamine|ketamine|mesh-list
6703178|NCT01736020|Propofol|propofol|mesh-list
6703179|NCT01736020|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6703180|NCT01736020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6703181|NCT01736020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703182|NCT01736020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6703183|NCT01736020|Anesthetics, General|anesthetics, general|mesh-ancestor
6703184|NCT01736020|Anesthetics|anesthetics|mesh-ancestor
6703185|NCT01736020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6703186|NCT01736020|Analgesics|analgesics|mesh-ancestor
6703187|NCT01736020|Sensory System Agents|sensory system agents|mesh-ancestor
6703188|NCT01736020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6703189|NCT01736020|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6703190|NCT01736020|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6703191|NCT01736020|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6703192|NCT01736020|Adrenergic Agents|adrenergic agents|mesh-ancestor
6703193|NCT01736020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6703194|NCT01736020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703195|NCT01736020|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6703196|NCT01736020|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6703197|NCT01736020|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6703198|NCT01736020|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6703199|NCT01736033|Tamsulosin|tamsulosin|mesh-list
6703200|NCT01736033|Finasteride|finasteride|mesh-list
6703201|NCT01736033|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6703202|NCT01736033|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6703203|NCT01736033|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6703204|NCT01736033|Adrenergic Agents|adrenergic agents|mesh-ancestor
6703205|NCT01736033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6703206|NCT01736033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703207|NCT01736033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703208|NCT01736033|Urological Agents|urological agents|mesh-ancestor
6703209|NCT01736033|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6703210|NCT01736033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6703211|NCT01736033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6703212|NCT01736033|Hormone Antagonists|hormone antagonists|mesh-ancestor
6703213|NCT01736033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6703214|NCT01736150|Sevelamer|sevelamer|mesh-list
6703215|NCT01736150|Chelating Agents|chelating agents|mesh-ancestor
6703216|NCT01736150|Sequestering Agents|sequestering agents|mesh-ancestor
6703217|NCT01736150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703218|NCT01736163|Hormones|hormones|mesh-list
6703219|NCT01736163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6703220|NCT01736163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781971|NCT02188121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6781972|NCT02188121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6781973|NCT02188121|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6781974|NCT02188121|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6781975|NCT02188173|Dexamethasone|dexamethasone|mesh-list
6781976|NCT02188173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6781977|NCT02188173|Antiemetics|antiemetics|mesh-ancestor
6781978|NCT02188173|Autonomic Agents|autonomic agents|mesh-ancestor
6781979|NCT02188173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6781980|NCT02188173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781981|NCT02188173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6781982|NCT02188173|Glucocorticoids|glucocorticoids|mesh-ancestor
6781983|NCT02188173|Hormones|hormones|mesh-ancestor
6781984|NCT02188173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6781985|NCT02188173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6781986|NCT02188173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6781987|NCT02188186|Metformin|metformin|mesh-list
6781988|NCT02188186|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6781989|NCT02188186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6781990|NCT02188186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6781991|NCT02188186|Incretins|incretins|mesh-ancestor
6781992|NCT02188186|Hormones|hormones|mesh-ancestor
6781993|NCT02188186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6781994|NCT02188186|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6781995|NCT02188186|Protease Inhibitors|protease inhibitors|mesh-ancestor
6781996|NCT02188186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6781997|NCT02188186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6781998|NCT02188225|Fluoxetine|fluoxetine|mesh-list
6781999|NCT02188225|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6782000|NCT02188225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6782001|NCT02188225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6782002|NCT02188225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782003|NCT02188225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6782004|NCT02188225|Serotonin Agents|serotonin agents|mesh-ancestor
6782005|NCT02188225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782006|NCT02188225|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6782007|NCT02188225|Antidepressive Agents|antidepressive agents|mesh-ancestor
6782008|NCT02188225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6782009|NCT02188225|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6782010|NCT02188225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6782011|NCT02188225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6782012|NCT02188264|Cyclosporine|cyclosporine|mesh-list
6782013|NCT02188264|Cyclosporins|cyclosporins|mesh-list
6782014|NCT02188264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6782015|NCT02188264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782016|NCT02188264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6782017|NCT02188264|Immunologic Factors|immunologic factors|mesh-ancestor
6782018|NCT02188264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782019|NCT02188264|Antifungal Agents|antifungal agents|mesh-ancestor
6782020|NCT02188264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6782021|NCT02188264|Dermatologic Agents|dermatologic agents|mesh-ancestor
6782022|NCT02188264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6782023|NCT02188264|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6782024|NCT02188277|Botulinum Toxins|botulinum toxins|mesh-list
6782025|NCT02188277|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6782026|NCT02188277|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6782027|NCT02188277|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
6703221|NCT01736371|Propofol|propofol|mesh-list
6703222|NCT01736371|Sevoflurane|sevoflurane|mesh-list
6703223|NCT01736371|Anesthetics|anesthetics|mesh-ancestor
6703224|NCT01736371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6703225|NCT01736371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703226|NCT01736371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6703227|NCT01736371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6703228|NCT01736371|Anesthetics, General|anesthetics, general|mesh-ancestor
6703229|NCT01736371|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6703230|NCT01736371|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6703231|NCT01736410|Trastuzumab|trastuzumab|mesh-list
6703232|NCT01736410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6703233|NCT01736410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6703234|NCT01736423|Ramosetron|ramosetron|mesh-list
6703235|NCT01736423|Antiemetics|antiemetics|mesh-ancestor
6703236|NCT01736423|Autonomic Agents|autonomic agents|mesh-ancestor
6703237|NCT01736423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6703238|NCT01736423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703239|NCT01736423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6703240|NCT01736423|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6703241|NCT01736423|Serotonin Agents|serotonin agents|mesh-ancestor
6703242|NCT01736423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6703243|NCT01736423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703244|NCT01736449|Bevacizumab|bevacizumab|mesh-list
6703245|NCT01736449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6703246|NCT01736449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6703247|NCT01736449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6703248|NCT01736449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6703249|NCT01736449|Growth Substances|growth substances|mesh-ancestor
6703250|NCT01736449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703251|NCT01736449|Growth Inhibitors|growth inhibitors|mesh-ancestor
6703252|NCT01736488|Atenolol|atenolol|mesh-list
6703253|NCT01736488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6703254|NCT01736488|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6703255|NCT01736488|Sympatholytics|sympatholytics|mesh-ancestor
6703256|NCT01736488|Autonomic Agents|autonomic agents|mesh-ancestor
6703257|NCT01736488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6703258|NCT01736488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703259|NCT01736488|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6703260|NCT01736488|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6703261|NCT01736488|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6703262|NCT01736488|Adrenergic Agents|adrenergic agents|mesh-ancestor
6703263|NCT01736488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6703264|NCT01736488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703265|NCT01736514|Allopurinol|allopurinol|mesh-list
6703266|NCT01736514|Febuxostat|febuxostat|mesh-list
6703267|NCT01736514|Antimetabolites|antimetabolites|mesh-ancestor
6703268|NCT01736514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703269|NCT01736514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6703270|NCT01736514|Gout Suppressants|gout suppressants|mesh-ancestor
6703271|NCT01736514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6703272|NCT01736514|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6703273|NCT01736514|Antioxidants|antioxidants|mesh-ancestor
6703274|NCT01736514|Protective Agents|protective agents|mesh-ancestor
6703275|NCT01736514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703276|NCT01736670|Triamcinolone|triamcinolone|mesh-list
6703277|NCT01736670|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6703278|NCT01736670|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6703279|NCT01736670|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6703280|NCT01736670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6703281|NCT01736670|Glucocorticoids|glucocorticoids|mesh-ancestor
6703282|NCT01736670|Hormones|hormones|mesh-ancestor
6703283|NCT01736670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6703284|NCT01736670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703285|NCT01736670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6703286|NCT01736670|Immunologic Factors|immunologic factors|mesh-ancestor
6703287|NCT01736670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6703288|NCT01736670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703289|NCT01736761|Ritonavir|ritonavir|mesh-list
6703290|NCT01736761|Darunavir|darunavir|mesh-list
6703291|NCT01736761|Rilpivirine|rilpivirine|mesh-list
6703292|NCT01736761|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6703293|NCT01736761|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6703294|NCT01736761|Protease Inhibitors|protease inhibitors|mesh-ancestor
6703295|NCT01736761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6703296|NCT01736761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703297|NCT01736761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6703298|NCT01736761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6703299|NCT01736761|Antiviral Agents|antiviral agents|mesh-ancestor
6703300|NCT01736761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6703301|NCT01736761|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6703302|NCT01736761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6703303|NCT01736761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6703304|NCT01736761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6703305|NCT01736800|Temozolomide|temozolomide|mesh-list
6703306|NCT01736800|Topotecan|topotecan|mesh-list
6703307|NCT01736800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6703308|NCT01736800|Alkylating Agents|alkylating agents|mesh-ancestor
6703309|NCT01736800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703310|NCT01736800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6703311|NCT01736800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6703312|NCT01736800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6703313|NCT01736800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6703314|NCT01736813|Maraviroc|maraviroc|mesh-list
6703315|NCT01736813|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6703316|NCT01736813|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6703317|NCT01736813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703318|NCT01736813|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6703319|NCT01736813|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6703320|NCT01736813|Antiviral Agents|antiviral agents|mesh-ancestor
6703321|NCT01736813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6703322|NCT01736813|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6703323|NCT01736878|Sorafenib|sorafenib|mesh-list
6703324|NCT01736878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6703325|NCT01736878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6703326|NCT01736878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6703327|NCT01736878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703328|NCT01736891|Rasagiline|rasagiline|mesh-list
6703329|NCT01736891|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6703330|NCT01736891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6703331|NCT01736891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703332|NCT01736891|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6703333|NCT01736891|Protective Agents|protective agents|mesh-ancestor
6703334|NCT01736891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703335|NCT01737008|Cisplatin|cisplatin|mesh-list
6703336|NCT01737008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6703337|NCT01737073|Analgesics, Opioid|analgesics, opioid|mesh-list
6703338|NCT01737073|Narcotics|narcotics|mesh-ancestor
6703339|NCT01737073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6703340|NCT01737073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703341|NCT01737073|Analgesics|analgesics|mesh-ancestor
6703342|NCT01737073|Sensory System Agents|sensory system agents|mesh-ancestor
6703343|NCT01737073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6703344|NCT01737086|Zinc Sulfate|zinc sulfate|mesh-list
6703345|NCT01737086|Astringents|astringents|mesh-ancestor
6703346|NCT01737086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703347|NCT01737086|Dermatologic Agents|dermatologic agents|mesh-ancestor
6703348|NCT01737112|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
6703349|NCT01737112|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6703350|NCT01737112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703351|NCT01737177|Rituximab|rituximab|mesh-list
6703352|NCT01737177|Lenalidomide|lenalidomide|mesh-list
6703353|NCT01737177|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6703354|NCT01737177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6703355|NCT01737177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6703356|NCT01737177|Immunologic Factors|immunologic factors|mesh-ancestor
6703357|NCT01737177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703358|NCT01737177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6703359|NCT01737177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6703360|NCT01737177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6703361|NCT01737177|Growth Substances|growth substances|mesh-ancestor
6703362|NCT01737177|Growth Inhibitors|growth inhibitors|mesh-ancestor
6703363|NCT01737177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6703364|NCT01737177|Alkylating Agents|alkylating agents|mesh-ancestor
6703365|NCT01737177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703366|NCT01737203|Sildenafil Citrate|sildenafil citrate|mesh-list
6703367|NCT01737203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703368|NCT01737203|Vasodilator Agents|vasodilator agents|mesh-ancestor
6703369|NCT01737203|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6703370|NCT01737203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6703371|NCT01737203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6703372|NCT01737203|Urological Agents|urological agents|mesh-ancestor
6703373|NCT01737216|Zoledronic Acid|zoledronic acid|mesh-list
6703374|NCT01737216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6703375|NCT01737216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703376|NCT01737294|Capsaicin|capsaicin|mesh-list
6703377|NCT01737294|Antipruritics|antipruritics|mesh-ancestor
6703378|NCT01737294|Dermatologic Agents|dermatologic agents|mesh-ancestor
6703379|NCT01737294|Sensory System Agents|sensory system agents|mesh-ancestor
6703380|NCT01737294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6703381|NCT01737294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703382|NCT01737307|Fluorides|fluorides|mesh-list
6703383|NCT01737307|Fluorides, Topical|fluorides, topical|mesh-list
6703384|NCT01737307|Cariostatic Agents|cariostatic agents|mesh-ancestor
6703385|NCT01737307|Protective Agents|protective agents|mesh-ancestor
6703386|NCT01737307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703387|NCT01737320|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6703388|NCT01737320|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6703389|NCT01737320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6703390|NCT01737320|Antitubercular Agents|antitubercular agents|mesh-ancestor
6703391|NCT01737346|Lomustine|lomustine|mesh-list
6703392|NCT01737346|Procarbazine|procarbazine|mesh-list
6703393|NCT01737346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6703394|NCT01737346|Alkylating Agents|alkylating agents|mesh-ancestor
6703395|NCT01737346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703396|NCT01737346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6703397|NCT01737359|Tenofovir|tenofovir|mesh-list
6703398|NCT01737359|Antiviral Agents|antiviral agents|mesh-ancestor
6703399|NCT01737359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6703400|NCT01737359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6703401|NCT01737359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6703402|NCT01737359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6703403|NCT01737359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703404|NCT01737359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6703405|NCT01737359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6703406|NCT01737411|Solifenacin Succinate|solifenacin succinate|mesh-list
6703407|NCT01737411|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6703408|NCT01737411|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6703409|NCT01737411|Cholinergic Agents|cholinergic agents|mesh-ancestor
6703410|NCT01737411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6703411|NCT01737411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703412|NCT01737411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703413|NCT01737411|Urological Agents|urological agents|mesh-ancestor
6703414|NCT01737541|Fluoxetine|fluoxetine|mesh-list
6703415|NCT01737541|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6703416|NCT01737541|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6703417|NCT01737541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6703418|NCT01737541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703419|NCT01737541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6703420|NCT01737541|Serotonin Agents|serotonin agents|mesh-ancestor
6703421|NCT01737541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703422|NCT01737541|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6703423|NCT01737541|Antidepressive Agents|antidepressive agents|mesh-ancestor
6703424|NCT01737541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6703425|NCT01737541|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6703426|NCT01737541|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6703427|NCT01737541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6703428|NCT01737671|Leucovorin|leucovorin|mesh-list
6703429|NCT01737671|Methotrexate|methotrexate|mesh-list
6703430|NCT01737671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6703431|NCT01737671|Abortifacient Agents|abortifacient agents|mesh-ancestor
6703432|NCT01737671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6703433|NCT01737671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703434|NCT01737671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6703435|NCT01737671|Antimetabolites|antimetabolites|mesh-ancestor
6703436|NCT01737671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703437|NCT01737671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6703438|NCT01737671|Dermatologic Agents|dermatologic agents|mesh-ancestor
6703439|NCT01737671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6703440|NCT01737671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6703441|NCT01737671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6703442|NCT01737671|Immunologic Factors|immunologic factors|mesh-ancestor
6703443|NCT01737671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6703444|NCT01737671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6703445|NCT01737671|Antidotes|antidotes|mesh-ancestor
6703446|NCT01737671|Protective Agents|protective agents|mesh-ancestor
6703447|NCT01737671|Vitamin B Complex|vitamin b complex|mesh-ancestor
6703448|NCT01737671|Vitamins|vitamins|mesh-ancestor
6703449|NCT01737671|Micronutrients|micronutrients|mesh-ancestor
6703450|NCT01737918|Solifenacin Succinate|solifenacin succinate|mesh-list
6703451|NCT01737918|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6703452|NCT01737918|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6703453|NCT01737918|Cholinergic Agents|cholinergic agents|mesh-ancestor
6703454|NCT01737918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6703455|NCT01737918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703456|NCT01737918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703457|NCT01737918|Urological Agents|urological agents|mesh-ancestor
6703458|NCT01738035|Budesonide|budesonide|mesh-list
6703459|NCT01738035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6703460|NCT01738035|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6703461|NCT01738035|Autonomic Agents|autonomic agents|mesh-ancestor
6703462|NCT01738035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6703463|NCT01738035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703464|NCT01738035|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6703465|NCT01738035|Respiratory System Agents|respiratory system agents|mesh-ancestor
6703466|NCT01738035|Glucocorticoids|glucocorticoids|mesh-ancestor
6703467|NCT01738035|Hormones|hormones|mesh-ancestor
6703468|NCT01738035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6703469|NCT01738087|Fluticasone|fluticasone|mesh-list
6703470|NCT01738087|Xhance|xhance|mesh-list
6703471|NCT01738087|Formoterol Fumarate|formoterol fumarate|mesh-list
6703472|NCT01738087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6703473|NCT01738087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6703474|NCT01738087|Autonomic Agents|autonomic agents|mesh-ancestor
6703475|NCT01738087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6703476|NCT01738087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703477|NCT01738087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6703478|NCT01738087|Respiratory System Agents|respiratory system agents|mesh-ancestor
6703479|NCT01738087|Dermatologic Agents|dermatologic agents|mesh-ancestor
6703480|NCT01738087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6703481|NCT01738087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6703482|NCT01738087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6703483|NCT01738087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6703484|NCT01738087|Adrenergic Agents|adrenergic agents|mesh-ancestor
6703485|NCT01738087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6703486|NCT01738087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703487|NCT01738100|Morphine|morphine|mesh-list
6703488|NCT01738100|Clopidogrel|clopidogrel|mesh-list
6703489|NCT01738100|Ticagrelor|ticagrelor|mesh-list
6703490|NCT01738100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6703491|NCT01738100|Narcotics|narcotics|mesh-ancestor
6703492|NCT01738100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6703493|NCT01738100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703494|NCT01738100|Analgesics|analgesics|mesh-ancestor
6703495|NCT01738100|Sensory System Agents|sensory system agents|mesh-ancestor
6703496|NCT01738100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6703497|NCT01738100|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6703498|NCT01738100|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6703499|NCT01738100|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6703500|NCT01738100|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6703501|NCT01738100|Purinergic Agents|purinergic agents|mesh-ancestor
6703502|NCT01738100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6703503|NCT01738100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782028|NCT02188277|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6782029|NCT02188277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6782030|NCT02188277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782031|NCT02188277|Cholinergic Agents|cholinergic agents|mesh-ancestor
6782032|NCT02188277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6782033|NCT02188277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782034|NCT02188277|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6782035|NCT02188277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6782036|NCT02188368|Clarithromycin|clarithromycin|mesh-list
6782037|NCT02188368|Dexamethasone|dexamethasone|mesh-list
6782038|NCT02188368|Prednisone|prednisone|mesh-list
6782039|NCT02188368|Cyclophosphamide|cyclophosphamide|mesh-list
6782040|NCT02188368|Bortezomib|bortezomib|mesh-list
6782041|NCT02188368|Pomalidomide|pomalidomide|mesh-list
6782042|NCT02188368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6703504|NCT01738139|Ipilimumab|ipilimumab|mesh-list
6703505|NCT01738139|Imatinib Mesylate|imatinib mesylate|mesh-list
6703506|NCT01738139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6703507|NCT01738139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6703508|NCT01738139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6703509|NCT01738139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703510|NCT01738139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6703511|NCT01738139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6703512|NCT01738178|Caffeine|caffeine|mesh-list
6703513|NCT01738178|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6703514|NCT01738178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703515|NCT01738178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6703516|NCT01738178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6703517|NCT01738178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703518|NCT01738178|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6703519|NCT01738178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6703520|NCT01738178|Purinergic Agents|purinergic agents|mesh-ancestor
6703521|NCT01738178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6703522|NCT01738243|Hyaluronic Acid|hyaluronic acid|mesh-list
6703523|NCT01738243|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6703524|NCT01738243|Immunologic Factors|immunologic factors|mesh-ancestor
6703525|NCT01738243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703526|NCT01738243|Viscosupplements|viscosupplements|mesh-ancestor
6703527|NCT01738243|Protective Agents|protective agents|mesh-ancestor
6703528|NCT01738282|Baclofen|baclofen|mesh-list
6703529|NCT01738282|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6703530|NCT01738282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703531|NCT01738282|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6703532|NCT01738282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6703533|NCT01738282|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6703534|NCT01738282|GABA Agonists|gaba agonists|mesh-ancestor
6703535|NCT01738282|GABA Agents|gaba agents|mesh-ancestor
6703536|NCT01738282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6703537|NCT01738282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703538|NCT01738295|Donepezil|donepezil|mesh-list
6703539|NCT01738295|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6703540|NCT01738295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6703541|NCT01738295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703542|NCT01738295|Cholinergic Agents|cholinergic agents|mesh-ancestor
6703543|NCT01738295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6703544|NCT01738295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703545|NCT01738295|Nootropic Agents|nootropic agents|mesh-ancestor
6703546|NCT01738360|Arsenic Trioxide|arsenic trioxide|mesh-list
6703547|NCT01738360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6703548|NCT01738373|Plerixafor|plerixafor|mesh-list
6703549|NCT01738373|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6703550|NCT01738373|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6703551|NCT01738373|Antiviral Agents|antiviral agents|mesh-ancestor
6703552|NCT01738373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6703553|NCT01738425|Hydrogen Sulfide|hydrogen sulfide|mesh-list
6703554|NCT01738425|Gasotransmitters|gasotransmitters|mesh-ancestor
6703555|NCT01738425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6703556|NCT01738425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703557|NCT01738425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703558|NCT01738451|Dabrafenib|dabrafenib|mesh-list
6703559|NCT01738451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6703560|NCT01738451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6703561|NCT01738451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6703562|NCT01738451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703563|NCT01738542|Bosentan|bosentan|mesh-list
6703564|NCT01738542|Antihypertensive Agents|antihypertensive agents|mesh-list
6703565|NCT01738542|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6703566|NCT01738542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703567|NCT01738607|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6703568|NCT01738607|Psyllium|psyllium|mesh-list
6703569|NCT01738607|Laxatives|laxatives|mesh-ancestor
6703570|NCT01738607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6703571|NCT01738607|Cathartics|cathartics|mesh-ancestor
6703572|NCT01738724|Goserelin|goserelin|mesh-list
6703573|NCT01738724|Dienogest|dienogest|mesh-list
6703574|NCT01738724|Desogestrel|desogestrel|mesh-list
6703575|NCT01738724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6703576|NCT01738724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6703577|NCT01738724|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6703578|NCT01738724|Contraceptive Agents|contraceptive agents|mesh-ancestor
6703579|NCT01738724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6703580|NCT01738724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703581|NCT01738724|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6703582|NCT01738724|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6703583|NCT01738724|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6703584|NCT01738724|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6703585|NCT01738724|Hormone Antagonists|hormone antagonists|mesh-ancestor
6703586|NCT01738724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6703587|NCT01738724|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6703588|NCT01738724|Progestins|progestins|mesh-ancestor
6703589|NCT01738724|Hormones|hormones|mesh-ancestor
6703590|NCT01738763|Inositol|inositol|mesh-list
6703591|NCT01738763|Vitamin B Complex|vitamin b complex|mesh-ancestor
6703592|NCT01738763|Vitamins|vitamins|mesh-ancestor
6703593|NCT01738763|Micronutrients|micronutrients|mesh-ancestor
6703594|NCT01738763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703595|NCT01738802|Micronutrients|micronutrients|mesh-list
6703596|NCT01738802|Trace Elements|trace elements|mesh-list
6703597|NCT01738802|Antioxidants|antioxidants|mesh-list
6703598|NCT01738802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703599|NCT01738802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703600|NCT01738802|Protective Agents|protective agents|mesh-ancestor
6703601|NCT01738815|Valproic Acid|valproic acid|mesh-list
6703602|NCT01738815|Anticonvulsants|anticonvulsants|mesh-ancestor
6703603|NCT01738815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6703604|NCT01738815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703605|NCT01738815|GABA Agents|gaba agents|mesh-ancestor
6703606|NCT01738815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6703607|NCT01738815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703608|NCT01738815|Antimanic Agents|antimanic agents|mesh-ancestor
6703609|NCT01738815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6703610|NCT01738815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6703611|NCT01738815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6703612|NCT01738867|Naltrexone|naltrexone|mesh-list
6703613|NCT01738867|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6703614|NCT01738867|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6703615|NCT01738867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703616|NCT01738867|Sensory System Agents|sensory system agents|mesh-ancestor
6703617|NCT01738867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6703618|NCT01738893|Gabapentin|gabapentin|mesh-list
6703619|NCT01738893|Analgesics|analgesics|mesh-ancestor
6703620|NCT01738893|Sensory System Agents|sensory system agents|mesh-ancestor
6703621|NCT01738893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6703622|NCT01738893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703623|NCT01738893|Anticonvulsants|anticonvulsants|mesh-ancestor
6703624|NCT01738893|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6703625|NCT01738893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6703626|NCT01738893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6703627|NCT01738893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6703628|NCT01738893|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6703629|NCT01738893|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6703630|NCT01738893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6703631|NCT01738893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703632|NCT01738893|Antimanic Agents|antimanic agents|mesh-ancestor
6703633|NCT01738945|Amlodipine|amlodipine|mesh-list
6703634|NCT01738945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6703635|NCT01738945|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6703636|NCT01738945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6703637|NCT01738945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703638|NCT01738945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6703639|NCT01738945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703640|NCT01738945|Vasodilator Agents|vasodilator agents|mesh-ancestor
6703641|NCT01739049|Liraglutide|liraglutide|mesh-list
6703642|NCT01739049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6703643|NCT01739049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703644|NCT01739049|Incretins|incretins|mesh-ancestor
6703645|NCT01739049|Hormones|hormones|mesh-ancestor
6703646|NCT01739049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6703647|NCT01739127|Risperidone|risperidone|mesh-list
6703648|NCT01739127|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6703649|NCT01739127|Aripiprazole|aripiprazole|mesh-list
6703650|NCT01739127|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6703651|NCT01739127|Serotonin Agents|serotonin agents|mesh-ancestor
6703652|NCT01739127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6703653|NCT01739127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703654|NCT01739127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703655|NCT01739127|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6703656|NCT01739127|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6703657|NCT01739127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6703658|NCT01739127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6703659|NCT01739127|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6703660|NCT01739127|Dopamine Agents|dopamine agents|mesh-ancestor
6703661|NCT01739127|Antidepressive Agents|antidepressive agents|mesh-ancestor
6703662|NCT01739127|Dopamine Agonists|dopamine agonists|mesh-ancestor
6703663|NCT01739127|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6703664|NCT01739127|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6703665|NCT01739127|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6703666|NCT01739127|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6703667|NCT01739192|Bupropion|bupropion|mesh-list
6703668|NCT01739192|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6703669|NCT01739192|Antidepressive Agents|antidepressive agents|mesh-ancestor
6703670|NCT01739192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6703671|NCT01739192|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6703672|NCT01739192|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6703673|NCT01739192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6703674|NCT01739192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703675|NCT01739192|Dopamine Agents|dopamine agents|mesh-ancestor
6703676|NCT01739192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6703677|NCT01739192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703678|NCT01739192|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6703679|NCT01739192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6703680|NCT01739192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6703681|NCT01739218|Paclitaxel|paclitaxel|mesh-list
6703682|NCT01739218|Bevacizumab|bevacizumab|mesh-list
6703683|NCT01739218|Carboplatin|carboplatin|mesh-list
6703684|NCT01739218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6703685|NCT01739218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6703686|NCT01739218|Tubulin Modulators|tubulin modulators|mesh-ancestor
6703687|NCT01739218|Antimitotic Agents|antimitotic agents|mesh-ancestor
6703688|NCT01739218|Mitosis Modulators|mitosis modulators|mesh-ancestor
6703689|NCT01739218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703690|NCT01739218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6703691|NCT01739218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6703692|NCT01739218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6703693|NCT01739218|Growth Substances|growth substances|mesh-ancestor
6703694|NCT01739218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703695|NCT01739218|Growth Inhibitors|growth inhibitors|mesh-ancestor
6703696|NCT01739413|Anesthetics|anesthetics|mesh-list
6703697|NCT01739413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6703698|NCT01739413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703699|NCT01739439|Gemcitabine|gemcitabine|mesh-list
6703700|NCT01739439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6703701|NCT01739439|Antimetabolites|antimetabolites|mesh-ancestor
6703702|NCT01739439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703703|NCT01739439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6703704|NCT01739439|Antiviral Agents|antiviral agents|mesh-ancestor
6703705|NCT01739439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6703706|NCT01739439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6703707|NCT01739439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6703708|NCT01739439|Immunologic Factors|immunologic factors|mesh-ancestor
6703709|NCT01739439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703710|NCT01739504|Anesthetics|anesthetics|mesh-list
6703711|NCT01739504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6703712|NCT01739504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703713|NCT01739556|Aspirin|aspirin|mesh-list
6703714|NCT01739556|Ticagrelor|ticagrelor|mesh-list
6703715|NCT01739556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6703716|NCT01739556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6703717|NCT01739556|Analgesics|analgesics|mesh-ancestor
6703718|NCT01739556|Sensory System Agents|sensory system agents|mesh-ancestor
6703719|NCT01739556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6703720|NCT01739556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703721|NCT01739556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6703722|NCT01739556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6703723|NCT01739556|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6703724|NCT01739556|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6703725|NCT01739556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703726|NCT01739556|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6703727|NCT01739556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6703728|NCT01739556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6703729|NCT01739556|Antipyretics|antipyretics|mesh-ancestor
6703730|NCT01739556|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6703731|NCT01739556|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6703732|NCT01739556|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6703733|NCT01739556|Purinergic Agents|purinergic agents|mesh-ancestor
6703734|NCT01739556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6703735|NCT01739582|Enclomiphene|enclomiphene|mesh-list
6703736|NCT01739582|Clomiphene|clomiphene|mesh-list
6703737|NCT01739582|Zuclomiphene|zuclomiphene|mesh-list
6703738|NCT01739582|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6703739|NCT01739582|Hormone Antagonists|hormone antagonists|mesh-ancestor
6703740|NCT01739582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6703741|NCT01739582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703742|NCT01739582|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6703743|NCT01739582|Fertility Agents|fertility agents|mesh-ancestor
6703744|NCT01739582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6703745|NCT01739582|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6703746|NCT01739582|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6703747|NCT01739634|Antidiarrheals|antidiarrheals|mesh-list
6703748|NCT01739634|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
6703749|NCT01739634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6703750|NCT01739673|Riboflavin|riboflavin|mesh-list
6703751|NCT01739673|Vitamin B Complex|vitamin b complex|mesh-ancestor
6703752|NCT01739673|Vitamins|vitamins|mesh-ancestor
6703753|NCT01739673|Micronutrients|micronutrients|mesh-ancestor
6703754|NCT01739673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703755|NCT01739673|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6703756|NCT01739673|Dermatologic Agents|dermatologic agents|mesh-ancestor
6782043|NCT02188368|Immunologic Factors|immunologic factors|mesh-ancestor
6782044|NCT02188368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782045|NCT02188368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6782046|NCT02188368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6782047|NCT02188368|Alkylating Agents|alkylating agents|mesh-ancestor
6782048|NCT02188368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782049|NCT02188368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6782050|NCT02188368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6782051|NCT02188368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6782052|NCT02188368|Antiemetics|antiemetics|mesh-ancestor
6782053|NCT02188368|Autonomic Agents|autonomic agents|mesh-ancestor
6782054|NCT02188368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6782055|NCT02188368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6782056|NCT02188368|Glucocorticoids|glucocorticoids|mesh-ancestor
6782057|NCT02188368|Hormones|hormones|mesh-ancestor
6782058|NCT02188368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6782059|NCT02188368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6782060|NCT02188368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6782061|NCT02188368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6782062|NCT02188368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6782063|NCT02188368|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6782064|NCT02188368|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6782065|NCT02188368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6782066|NCT02188368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6782067|NCT02188368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6782068|NCT02188368|Growth Substances|growth substances|mesh-ancestor
6782069|NCT02188368|Growth Inhibitors|growth inhibitors|mesh-ancestor
6782070|NCT02188394|Bupivacaine|bupivacaine|mesh-list
6782071|NCT02188394|Anesthetics|anesthetics|mesh-list
6782072|NCT02188394|Anesthetics, Local|anesthetics, local|mesh-ancestor
6782073|NCT02188394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6782074|NCT02188394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782075|NCT02188394|Sensory System Agents|sensory system agents|mesh-ancestor
6782076|NCT02188394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6782077|NCT02188407|Propofol|propofol|mesh-list
6782078|NCT02188407|Sevoflurane|sevoflurane|mesh-list
6782079|NCT02188407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6782080|NCT02188407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6782081|NCT02188407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782082|NCT02188407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6782083|NCT02188407|Anesthetics, General|anesthetics, general|mesh-ancestor
6782084|NCT02188407|Anesthetics|anesthetics|mesh-ancestor
6782085|NCT02188407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6782086|NCT02188407|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6782087|NCT02188472|Trimethoprim|trimethoprim|mesh-list
6703757|NCT01739855|Ergocalciferols|ergocalciferols|mesh-list
6703758|NCT01739855|Calcium Carbonate|calcium carbonate|mesh-list
6703759|NCT01739855|Calcium|calcium|mesh-list
6703760|NCT01739855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6703761|NCT01739855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703762|NCT01739855|Antacids|antacids|mesh-ancestor
6703763|NCT01739855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703764|NCT01739855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6703765|NCT01739855|Vitamins|vitamins|mesh-ancestor
6703766|NCT01739855|Micronutrients|micronutrients|mesh-ancestor
6703767|NCT01739855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6703768|NCT01739894|Paclitaxel|paclitaxel|mesh-list
6703769|NCT01739894|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6703770|NCT01739894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6703771|NCT01739894|Tubulin Modulators|tubulin modulators|mesh-ancestor
6703772|NCT01739894|Antimitotic Agents|antimitotic agents|mesh-ancestor
6703773|NCT01739894|Mitosis Modulators|mitosis modulators|mesh-ancestor
6703774|NCT01739894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703775|NCT01739907|Vitamin D|vitamin d|mesh-list
6703776|NCT01739907|Vitamins|vitamins|mesh-ancestor
6703777|NCT01739907|Micronutrients|micronutrients|mesh-ancestor
6703778|NCT01739907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703779|NCT01739907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6703780|NCT01739920|Povidone-Iodine|povidone-iodine|mesh-list
6703781|NCT01739920|Povidone|povidone|mesh-list
6703782|NCT01739920|Plasma Substitutes|plasma substitutes|mesh-ancestor
6703783|NCT01739920|Blood Substitutes|blood substitutes|mesh-ancestor
6703784|NCT01739920|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6703785|NCT01739920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6703786|NCT01739985|Dexamethasone|dexamethasone|mesh-list
6703787|NCT01739985|Dexamethasone acetate|dexamethasone acetate|mesh-list
6703788|NCT01739985|Droperidol|droperidol|mesh-list
6703789|NCT01739985|Ondansetron|ondansetron|mesh-list
6703790|NCT01739985|BB 1101|bb 1101|mesh-list
6703791|NCT01739985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6703792|NCT01739985|Antiemetics|antiemetics|mesh-ancestor
6703793|NCT01739985|Autonomic Agents|autonomic agents|mesh-ancestor
6703794|NCT01739985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6703795|NCT01739985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703796|NCT01739985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6703797|NCT01739985|Glucocorticoids|glucocorticoids|mesh-ancestor
6703798|NCT01739985|Hormones|hormones|mesh-ancestor
6703799|NCT01739985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6703800|NCT01739985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6703801|NCT01739985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6703802|NCT01739985|Protease Inhibitors|protease inhibitors|mesh-ancestor
6703803|NCT01739985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6703804|NCT01739985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703805|NCT01739985|Antipruritics|antipruritics|mesh-ancestor
6703806|NCT01739985|Dermatologic Agents|dermatologic agents|mesh-ancestor
6703807|NCT01739985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6703808|NCT01739985|Serotonin Agents|serotonin agents|mesh-ancestor
6703809|NCT01739985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6703810|NCT01739985|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6703811|NCT01739985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6703812|NCT01739985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6703813|NCT01739985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6703814|NCT01739985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6703815|NCT01739985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6703816|NCT01739985|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6703817|NCT01739985|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6703818|NCT01739985|Dopamine Agents|dopamine agents|mesh-ancestor
6703819|NCT01740245|Biguanides|biguanides|mesh-list
6703820|NCT01740245|Chlorhexidine|chlorhexidine|mesh-list
6703821|NCT01740245|Polihexanide|polihexanide|mesh-list
6703822|NCT01740245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6703823|NCT01740245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6703824|NCT01740245|Disinfectants|disinfectants|mesh-ancestor
6703825|NCT01740245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6703826|NCT01740245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703827|NCT01740271|Epirubicin|epirubicin|mesh-list
6703828|NCT01740271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6703829|NCT01740271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6703830|NCT01740271|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6703831|NCT01740271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6703832|NCT01740271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6703833|NCT01740271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703834|NCT01740336|Paclitaxel|paclitaxel|mesh-list
6703835|NCT01740336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6703836|NCT01740336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6703837|NCT01740336|Tubulin Modulators|tubulin modulators|mesh-ancestor
6703838|NCT01740336|Antimitotic Agents|antimitotic agents|mesh-ancestor
6703839|NCT01740336|Mitosis Modulators|mitosis modulators|mesh-ancestor
6703840|NCT01740336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703841|NCT01740453|Ropivacaine|ropivacaine|mesh-list
6703842|NCT01740453|Anesthetics, Local|anesthetics, local|mesh-ancestor
6703843|NCT01740453|Anesthetics|anesthetics|mesh-ancestor
6703844|NCT01740453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6703845|NCT01740453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703846|NCT01740453|Sensory System Agents|sensory system agents|mesh-ancestor
6703847|NCT01740453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6703848|NCT01740492|Ketamine|ketamine|mesh-list
6703849|NCT01740492|Analgesics|analgesics|mesh-ancestor
6703850|NCT01740492|Sensory System Agents|sensory system agents|mesh-ancestor
6703851|NCT01740492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6703852|NCT01740492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703853|NCT01740492|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6703854|NCT01740492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6703855|NCT01740492|Anesthetics, General|anesthetics, general|mesh-ancestor
6703856|NCT01740492|Anesthetics|anesthetics|mesh-ancestor
6703857|NCT01740492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6703858|NCT01740492|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6703859|NCT01740492|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6703860|NCT01740492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6703861|NCT01740492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703862|NCT01740518|Ascorbic Acid|ascorbic acid|mesh-list
6703863|NCT01740518|Antioxidants|antioxidants|mesh-ancestor
6703864|NCT01740518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703865|NCT01740518|Protective Agents|protective agents|mesh-ancestor
6703866|NCT01740518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703867|NCT01740518|Vitamins|vitamins|mesh-ancestor
6703868|NCT01740518|Micronutrients|micronutrients|mesh-ancestor
6703869|NCT01740921|Aspirin|aspirin|mesh-list
6703870|NCT01740921|Liraglutide|liraglutide|mesh-list
6703871|NCT01740921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6703872|NCT01740921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6703873|NCT01740921|Analgesics|analgesics|mesh-ancestor
6703874|NCT01740921|Sensory System Agents|sensory system agents|mesh-ancestor
6703875|NCT01740921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6703876|NCT01740921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703877|NCT01740921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6703878|NCT01740921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6703879|NCT01740921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6703880|NCT01740921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6703881|NCT01740921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703882|NCT01740921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6703883|NCT01740921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6703884|NCT01740921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6703885|NCT01740921|Antipyretics|antipyretics|mesh-ancestor
6703886|NCT01740921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6703887|NCT01740921|Incretins|incretins|mesh-ancestor
6703888|NCT01740921|Hormones|hormones|mesh-ancestor
6703889|NCT01740921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6703890|NCT01740947|Amphotericin B|amphotericin b|mesh-list
6703891|NCT01740947|Tobramycin|tobramycin|mesh-list
6703892|NCT01740947|Colistin|colistin|mesh-list
6703893|NCT01740947|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6703894|NCT01740947|Amebicides|amebicides|mesh-ancestor
6703895|NCT01740947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6703896|NCT01740947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6703897|NCT01740947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6703898|NCT01740947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6703899|NCT01740947|Antifungal Agents|antifungal agents|mesh-ancestor
6703900|NCT01740960|Dronabinol|dronabinol|mesh-list
6703901|NCT01740960|Hallucinogens|hallucinogens|mesh-ancestor
6703902|NCT01740960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703903|NCT01740960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6703904|NCT01740960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6703905|NCT01740960|Analgesics|analgesics|mesh-ancestor
6703906|NCT01740960|Sensory System Agents|sensory system agents|mesh-ancestor
6703907|NCT01740960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6703908|NCT01740960|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6703909|NCT01740960|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6703910|NCT01740960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6703911|NCT01740960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703912|NCT01740960|Hormones|hormones|mesh-ancestor
6703913|NCT01740960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6703914|NCT01741038|Cetuximab|cetuximab|mesh-list
6703915|NCT01741038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6703916|NCT01741038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6703917|NCT01741077|Folic Acid|folic acid|mesh-list
6703918|NCT01741077|Hematinics|hematinics|mesh-ancestor
6703919|NCT01741077|Vitamin B Complex|vitamin b complex|mesh-ancestor
6703920|NCT01741077|Vitamins|vitamins|mesh-ancestor
6703921|NCT01741077|Micronutrients|micronutrients|mesh-ancestor
6703922|NCT01741077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703923|NCT01741142|Citalopram|citalopram|mesh-list
6703924|NCT01741142|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6703925|NCT01741142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6703926|NCT01741142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6703927|NCT01741142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703928|NCT01741142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6703929|NCT01741142|Serotonin Agents|serotonin agents|mesh-ancestor
6703930|NCT01741142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703931|NCT01741142|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6703932|NCT01741142|Antidepressive Agents|antidepressive agents|mesh-ancestor
6703933|NCT01741142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6703934|NCT01741181|Vitamin D|vitamin d|mesh-list
6703935|NCT01741181|Ergocalciferols|ergocalciferols|mesh-list
6703936|NCT01741181|Cholecalciferol|cholecalciferol|mesh-list
6703937|NCT01741181|Vitamins|vitamins|mesh-list
6703938|NCT01741181|Micronutrients|micronutrients|mesh-ancestor
6703939|NCT01741181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703940|NCT01741181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6703941|NCT01741181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6703942|NCT01741285|Fluticasone|fluticasone|mesh-list
6703943|NCT01741285|Beclomethasone|beclomethasone|mesh-list
6703944|NCT01741285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6703945|NCT01741285|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6703946|NCT01741285|Autonomic Agents|autonomic agents|mesh-ancestor
6703947|NCT01741285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6703948|NCT01741285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703949|NCT01741285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6703950|NCT01741285|Respiratory System Agents|respiratory system agents|mesh-ancestor
6703951|NCT01741285|Dermatologic Agents|dermatologic agents|mesh-ancestor
6703952|NCT01741285|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6703953|NCT01741285|Glucocorticoids|glucocorticoids|mesh-ancestor
6703954|NCT01741285|Hormones|hormones|mesh-ancestor
6703955|NCT01741285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6703956|NCT01741324|Vitamin D|vitamin d|mesh-list
6703957|NCT01741324|Ergocalciferols|ergocalciferols|mesh-list
6703958|NCT01741324|Vitamins|vitamins|mesh-list
6703959|NCT01741324|Micronutrients|micronutrients|mesh-ancestor
6703960|NCT01741324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703961|NCT01741324|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6703962|NCT01741324|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6703963|NCT01741376|Progesterone|progesterone|mesh-list
6703964|NCT01741376|Progestins|progestins|mesh-ancestor
6703965|NCT01741376|Hormones|hormones|mesh-ancestor
6703966|NCT01741376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6703967|NCT01741376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703968|NCT01741389|Melatonin|melatonin|mesh-list
6703969|NCT01741389|Antioxidants|antioxidants|mesh-ancestor
6703970|NCT01741389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703971|NCT01741389|Protective Agents|protective agents|mesh-ancestor
6703972|NCT01741389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703973|NCT01741389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6782088|NCT02188472|Penicillins|penicillins|mesh-list
6782089|NCT02188472|Penicillin V|penicillin v|mesh-list
6782090|NCT02188472|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6703974|NCT01741493|Upadacitinib|upadacitinib|mesh-list
6703975|NCT01741493|Tofacitinib|tofacitinib|mesh-list
6703976|NCT01741493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6703977|NCT01741493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6703978|NCT01741493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703979|NCT01741493|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
6703980|NCT01741493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6703981|NCT01741506|Dalteparin|dalteparin|mesh-list
6703982|NCT01741506|Tinzaparin|tinzaparin|mesh-list
6703983|NCT01741506|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6703984|NCT01741506|Anticoagulants|anticoagulants|mesh-ancestor
6703985|NCT01741506|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6703986|NCT01741506|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6703987|NCT01741506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703988|NCT01741519|Landiolol|landiolol|mesh-list
6703989|NCT01741519|Esmolol|esmolol|mesh-list
6703990|NCT01741519|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6703991|NCT01741519|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6703992|NCT01741519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6703993|NCT01741519|Adrenergic Agents|adrenergic agents|mesh-ancestor
6703994|NCT01741519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6703995|NCT01741519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6703996|NCT01741519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6703997|NCT01741519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6703998|NCT01741558|Riboflavin|riboflavin|mesh-list
6703999|NCT01741558|Methotrexate|methotrexate|mesh-list
6704000|NCT01741558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6704001|NCT01741558|Abortifacient Agents|abortifacient agents|mesh-ancestor
6704002|NCT01741558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6704003|NCT01741558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704004|NCT01741558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6704005|NCT01741558|Antimetabolites|antimetabolites|mesh-ancestor
6704006|NCT01741558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704007|NCT01741558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6704008|NCT01741558|Dermatologic Agents|dermatologic agents|mesh-ancestor
6704009|NCT01741558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6704010|NCT01741558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6704011|NCT01741558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6704012|NCT01741558|Immunologic Factors|immunologic factors|mesh-ancestor
6704013|NCT01741558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6704014|NCT01741558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6704015|NCT01741558|Vitamin B Complex|vitamin b complex|mesh-ancestor
6704016|NCT01741558|Vitamins|vitamins|mesh-ancestor
6704017|NCT01741558|Micronutrients|micronutrients|mesh-ancestor
6704018|NCT01741558|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6704019|NCT01741623|Bisoprolol|bisoprolol|mesh-list
6704020|NCT01741623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6704021|NCT01741623|Sympatholytics|sympatholytics|mesh-ancestor
6704022|NCT01741623|Autonomic Agents|autonomic agents|mesh-ancestor
6704023|NCT01741623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6704024|NCT01741623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704025|NCT01741623|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6704026|NCT01741623|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6704027|NCT01741623|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6704028|NCT01741623|Adrenergic Agents|adrenergic agents|mesh-ancestor
6704029|NCT01741623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6704030|NCT01741623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704031|NCT01741649|Povidone|povidone|mesh-list
6704032|NCT01741649|Plasma Substitutes|plasma substitutes|mesh-ancestor
6704033|NCT01741649|Blood Substitutes|blood substitutes|mesh-ancestor
6704034|NCT01741753|Prednisone|prednisone|mesh-list
6704035|NCT01741753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6704036|NCT01741753|Glucocorticoids|glucocorticoids|mesh-ancestor
6704037|NCT01741753|Hormones|hormones|mesh-ancestor
6704038|NCT01741753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6704039|NCT01741753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704040|NCT01741753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6704041|NCT01741753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6704042|NCT01741831|Darunavir|darunavir|mesh-list
6704043|NCT01741831|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6704044|NCT01741831|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6704045|NCT01741831|Protease Inhibitors|protease inhibitors|mesh-ancestor
6704046|NCT01741831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6704047|NCT01741831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704048|NCT01741831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6704049|NCT01741831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6704050|NCT01741831|Antiviral Agents|antiviral agents|mesh-ancestor
6704051|NCT01741831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6704052|NCT01741948|Contraceptive Agents|contraceptive agents|mesh-list
6704053|NCT01741948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6704054|NCT01741948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704055|NCT01742247|Palmidrol|palmidrol|mesh-list
6704056|NCT01742247|Analgesics|analgesics|mesh-ancestor
6704057|NCT01742247|Sensory System Agents|sensory system agents|mesh-ancestor
6704058|NCT01742247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6704059|NCT01742247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704060|NCT01742247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6704061|NCT01742247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6704062|NCT01742247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6704063|NCT01742247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6704064|NCT01742247|Antiviral Agents|antiviral agents|mesh-ancestor
6704065|NCT01742247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6704066|NCT01742247|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6704067|NCT01742247|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6704068|NCT01742247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6704069|NCT01742247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704070|NCT01742247|Hormones|hormones|mesh-ancestor
6704071|NCT01742247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6704072|NCT01742273|Vitamin K|vitamin k|mesh-list
6704073|NCT01742273|Vitamin K 1|vitamin k 1|mesh-list
6704074|NCT01742273|Vitamins|vitamins|mesh-ancestor
6704075|NCT01742273|Micronutrients|micronutrients|mesh-ancestor
6704076|NCT01742273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704077|NCT01742273|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6704078|NCT01742273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6704079|NCT01742273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704080|NCT01742273|Hemostatics|hemostatics|mesh-ancestor
6704081|NCT01742273|Coagulants|coagulants|mesh-ancestor
6704082|NCT01742299|Imatinib Mesylate|imatinib mesylate|mesh-list
6704083|NCT01742299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6704084|NCT01742299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6704085|NCT01742299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6704086|NCT01742299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704087|NCT01742338|Prednisone|prednisone|mesh-list
6704088|NCT01742338|Methylprednisolone|methylprednisolone|mesh-list
6704089|NCT01742338|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6704090|NCT01742338|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6704091|NCT01742338|Prednisolone|prednisolone|mesh-list
6704092|NCT01742338|Prednisolone acetate|prednisolone acetate|mesh-list
6704093|NCT01742338|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6704094|NCT01742338|Prednisolone phosphate|prednisolone phosphate|mesh-list
6704095|NCT01742338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6704096|NCT01742338|Glucocorticoids|glucocorticoids|mesh-ancestor
6704097|NCT01742338|Hormones|hormones|mesh-ancestor
6704098|NCT01742338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6704099|NCT01742338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704100|NCT01742338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6704101|NCT01742338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6704102|NCT01742338|Antiemetics|antiemetics|mesh-ancestor
6704103|NCT01742338|Autonomic Agents|autonomic agents|mesh-ancestor
6704104|NCT01742338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6704105|NCT01742338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6704106|NCT01742338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6704107|NCT01742338|Protective Agents|protective agents|mesh-ancestor
6704108|NCT01742390|Risperidone|risperidone|mesh-list
6704109|NCT01742390|Aripiprazole|aripiprazole|mesh-list
6704110|NCT01742390|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6704111|NCT01742390|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6704112|NCT01742390|Serotonin Agents|serotonin agents|mesh-ancestor
6704113|NCT01742390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6704114|NCT01742390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704115|NCT01742390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704116|NCT01742390|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6704117|NCT01742390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6704118|NCT01742390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6704119|NCT01742390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6704120|NCT01742390|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6704121|NCT01742390|Dopamine Agents|dopamine agents|mesh-ancestor
6704122|NCT01742390|Antidepressive Agents|antidepressive agents|mesh-ancestor
6704123|NCT01742390|Dopamine Agonists|dopamine agonists|mesh-ancestor
6704124|NCT01742390|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6704125|NCT01742390|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6704126|NCT01742390|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6704127|NCT01742390|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6704128|NCT01742429|Amoxicillin|amoxicillin|mesh-list
6704129|NCT01742429|Metronidazole|metronidazole|mesh-list
6704130|NCT01742429|Levofloxacin|levofloxacin|mesh-list
6704131|NCT01742429|Ofloxacin|ofloxacin|mesh-list
6704132|NCT01742429|Tetracycline|tetracycline|mesh-list
6704133|NCT01742429|Bismuth|bismuth|mesh-list
6704134|NCT01742429|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
6704135|NCT01742429|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
6704136|NCT01742429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6704137|NCT01742429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6704138|NCT01742429|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6704139|NCT01742429|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6704140|NCT01742429|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6704141|NCT01742429|Renal Agents|renal agents|mesh-ancestor
6704142|NCT01742429|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6704143|NCT01742429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6704144|NCT01742429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6704145|NCT01742429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704146|NCT01742429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6704147|NCT01742429|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6704148|NCT01742429|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6704149|NCT01742429|Antacids|antacids|mesh-ancestor
6704150|NCT01742429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6704151|NCT01742429|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6704152|NCT01742429|Antidiarrheals|antidiarrheals|mesh-ancestor
6704153|NCT01742533|Hormones|hormones|mesh-list
6704154|NCT01742533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6704155|NCT01742533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704156|NCT01742624|Mycophenolic Acid|mycophenolic acid|mesh-list
6704157|NCT01742624|Tacrolimus|tacrolimus|mesh-list
6704158|NCT01742624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6704159|NCT01742624|Immunologic Factors|immunologic factors|mesh-ancestor
6704160|NCT01742624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704161|NCT01742624|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6704162|NCT01742624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6704163|NCT01742624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704164|NCT01742624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6704165|NCT01742624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6704166|NCT01742624|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6704167|NCT01742624|Antitubercular Agents|antitubercular agents|mesh-ancestor
6704168|NCT01742624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6704169|NCT01742624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6704170|NCT01742637|Adapalene|adapalene|mesh-list
6704171|NCT01742637|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6704172|NCT01742637|Dermatologic Agents|dermatologic agents|mesh-ancestor
6704173|NCT01742637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6704174|NCT01742637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6704175|NCT01742637|Analgesics|analgesics|mesh-ancestor
6704176|NCT01742637|Sensory System Agents|sensory system agents|mesh-ancestor
6704177|NCT01742637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6704178|NCT01742637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704179|NCT01742637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6704180|NCT01742637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6704181|NCT01742663|Diclofenac|diclofenac|mesh-list
6704182|NCT01742663|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6704183|NCT01742663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6704184|NCT01742663|Analgesics|analgesics|mesh-ancestor
6704185|NCT01742663|Sensory System Agents|sensory system agents|mesh-ancestor
6704186|NCT01742663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6704187|NCT01742663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704188|NCT01742663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6704189|NCT01742663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6242759|NCT02655354|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6242760|NCT02655354|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6242761|NCT02655354|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6242762|NCT02655354|Adrenergic Agents|adrenergic agents|mesh-ancestor
6242763|NCT02655354|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6704190|NCT01742663|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6704191|NCT01742663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6704192|NCT01742663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704193|NCT01742676|Tacrolimus|tacrolimus|mesh-list
6242764|NCT02655354|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6242765|NCT02655354|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6242766|NCT02655354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6242767|NCT02655354|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6242768|NCT02655354|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6242769|NCT02655354|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6242770|NCT02655419|Metronidazole|metronidazole|mesh-list
6242771|NCT02655419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6704194|NCT01742676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6704195|NCT01742676|Immunologic Factors|immunologic factors|mesh-ancestor
6704196|NCT01742676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704197|NCT01742676|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6704198|NCT01742676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6704199|NCT01742676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704200|NCT01742689|Indomethacin|indomethacin|mesh-list
6704201|NCT01742689|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
6704202|NCT01742689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6704203|NCT01742689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6704204|NCT01742689|Analgesics|analgesics|mesh-ancestor
6704205|NCT01742689|Sensory System Agents|sensory system agents|mesh-ancestor
6704206|NCT01742689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6704207|NCT01742689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704208|NCT01742689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6704209|NCT01742689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6704210|NCT01742689|Gout Suppressants|gout suppressants|mesh-ancestor
6704211|NCT01742689|Tocolytic Agents|tocolytic agents|mesh-ancestor
6704212|NCT01742689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6704213|NCT01742689|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6704214|NCT01742689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6704215|NCT01742689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704216|NCT01742689|Hemostatics|hemostatics|mesh-ancestor
6704217|NCT01742689|Coagulants|coagulants|mesh-ancestor
6704218|NCT01742689|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6704219|NCT01742689|Natriuretic Agents|natriuretic agents|mesh-ancestor
6704220|NCT01742702|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
6704221|NCT01742702|Bisoprolol|bisoprolol|mesh-list
6704222|NCT01742702|Nitroglycerin|nitroglycerin|mesh-list
6704223|NCT01742702|Albuterol|albuterol|mesh-list
6704224|NCT01742702|Caseins|caseins|mesh-list
6704225|NCT01742702|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6704226|NCT01742702|Autonomic Agents|autonomic agents|mesh-ancestor
6704227|NCT01742702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6704228|NCT01742702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704229|NCT01742702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6704230|NCT01742702|Respiratory System Agents|respiratory system agents|mesh-ancestor
6704231|NCT01742702|Tocolytic Agents|tocolytic agents|mesh-ancestor
6704232|NCT01742702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6704233|NCT01742702|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6704234|NCT01742702|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6704235|NCT01742702|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6704236|NCT01742702|Adrenergic Agents|adrenergic agents|mesh-ancestor
6704237|NCT01742702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6704238|NCT01742702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704239|NCT01742702|Vasodilator Agents|vasodilator agents|mesh-ancestor
6704240|NCT01742702|Chelating Agents|chelating agents|mesh-ancestor
6704241|NCT01742702|Sequestering Agents|sequestering agents|mesh-ancestor
6704242|NCT01742702|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6704243|NCT01742702|Sympatholytics|sympatholytics|mesh-ancestor
6704244|NCT01742702|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6704245|NCT01742702|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6704246|NCT01742702|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6704247|NCT01742702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6704248|NCT01742767|Pemetrexed|pemetrexed|mesh-list
6704249|NCT01742767|Cisplatin|cisplatin|mesh-list
6704250|NCT01742767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6704251|NCT01742767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6704252|NCT01742767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704253|NCT01742767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6704254|NCT01742767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6704255|NCT01742793|Lenalidomide|lenalidomide|mesh-list
6704256|NCT01742793|Romidepsin|romidepsin|mesh-list
6704257|NCT01742793|Immunologic Factors|immunologic factors|mesh-ancestor
6704258|NCT01742793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704259|NCT01742793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6704260|NCT01742793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6704261|NCT01742793|Growth Substances|growth substances|mesh-ancestor
6704262|NCT01742793|Growth Inhibitors|growth inhibitors|mesh-ancestor
6704263|NCT01742793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6704264|NCT01742793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6704265|NCT01742845|Ropivacaine|ropivacaine|mesh-list
6704266|NCT01742845|Anesthetics, Local|anesthetics, local|mesh-ancestor
6704267|NCT01742845|Anesthetics|anesthetics|mesh-ancestor
6704268|NCT01742845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6704269|NCT01742845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704270|NCT01742845|Sensory System Agents|sensory system agents|mesh-ancestor
6704271|NCT01742845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6782091|NCT02188472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6782092|NCT02188472|Renal Agents|renal agents|mesh-ancestor
6782093|NCT02188472|Antimalarials|antimalarials|mesh-ancestor
6782094|NCT02188472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6782095|NCT02188472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6782096|NCT02188472|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6782097|NCT02188472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6782098|NCT02188472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782099|NCT02188472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6782100|NCT02188472|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6782101|NCT02188472|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6782102|NCT02188472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6782103|NCT02188511|Nicotine|nicotine|mesh-list
6782104|NCT02188511|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6782105|NCT02188511|Autonomic Agents|autonomic agents|mesh-ancestor
6782106|NCT02188511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6782107|NCT02188511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782108|NCT02188511|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6782109|NCT02188511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6782110|NCT02188511|Cholinergic Agents|cholinergic agents|mesh-ancestor
6782111|NCT02188511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6782112|NCT02188511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782113|NCT02188537|Nelfinavir|nelfinavir|mesh-list
6782114|NCT02188537|Dexamethasone|dexamethasone|mesh-list
6782115|NCT02188537|Bortezomib|bortezomib|mesh-list
6782116|NCT02188537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6782117|NCT02188537|Antiemetics|antiemetics|mesh-ancestor
6782118|NCT02188537|Autonomic Agents|autonomic agents|mesh-ancestor
6782119|NCT02188537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6782120|NCT02188537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782121|NCT02188537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6782122|NCT02188537|Glucocorticoids|glucocorticoids|mesh-ancestor
6782123|NCT02188537|Hormones|hormones|mesh-ancestor
6782124|NCT02188537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6782125|NCT02188537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6782126|NCT02188537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6782127|NCT02188537|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6782128|NCT02188537|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6782129|NCT02188537|Protease Inhibitors|protease inhibitors|mesh-ancestor
6782130|NCT02188537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6782131|NCT02188537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782132|NCT02188537|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6782133|NCT02188537|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6782134|NCT02188537|Antiviral Agents|antiviral agents|mesh-ancestor
6782135|NCT02188537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6782136|NCT02188550|Everolimus|everolimus|mesh-list
6782137|NCT02188550|Letrozole|letrozole|mesh-list
6782138|NCT02188550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6782139|NCT02188550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6782140|NCT02188550|Immunologic Factors|immunologic factors|mesh-ancestor
6782141|NCT02188550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782142|NCT02188550|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6782143|NCT02188550|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6782144|NCT02188550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6782145|NCT02188550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782146|NCT02188550|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6782147|NCT02188550|Hormone Antagonists|hormone antagonists|mesh-ancestor
6782148|NCT02188550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6782149|NCT02188615|Vinorelbine|vinorelbine|mesh-list
6782150|NCT02188615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6782151|NCT02188615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6782152|NCT02188615|Tubulin Modulators|tubulin modulators|mesh-ancestor
6782153|NCT02188615|Antimitotic Agents|antimitotic agents|mesh-ancestor
6704272|NCT01742988|Rituximab|rituximab|mesh-list
6704273|NCT01742988|Venetoclax|venetoclax|mesh-list
6704274|NCT01742988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6704275|NCT01742988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6704276|NCT01742988|Immunologic Factors|immunologic factors|mesh-ancestor
6704277|NCT01742988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704278|NCT01742988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6704279|NCT01743014|Ramipril|ramipril|mesh-list
6704280|NCT01743014|Clopidogrel|clopidogrel|mesh-list
6704281|NCT01743014|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6704282|NCT01743014|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6704283|NCT01743014|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6704284|NCT01743014|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6704285|NCT01743014|Purinergic Agents|purinergic agents|mesh-ancestor
6704286|NCT01743014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6704287|NCT01743014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704288|NCT01743014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704289|NCT01743014|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6704290|NCT01743014|Protease Inhibitors|protease inhibitors|mesh-ancestor
6704291|NCT01743014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6704292|NCT01743014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6704293|NCT01743066|Vitamin E|vitamin e|mesh-list
6704294|NCT01743066|Vitamins|vitamins|mesh-ancestor
6704295|NCT01743066|Micronutrients|micronutrients|mesh-ancestor
6704296|NCT01743066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704297|NCT01743066|Antioxidants|antioxidants|mesh-ancestor
6704298|NCT01743066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704299|NCT01743066|Protective Agents|protective agents|mesh-ancestor
6704300|NCT01743079|Lamivudine|lamivudine|mesh-list
6704301|NCT01743079|Telbivudine|telbivudine|mesh-list
6704302|NCT01743079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6704303|NCT01743079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6704304|NCT01743079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6704305|NCT01743079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704306|NCT01743079|Antiviral Agents|antiviral agents|mesh-ancestor
6704307|NCT01743079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6704308|NCT01743079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6704309|NCT01743079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6704310|NCT01743118|Calcipotriene|calcipotriene|mesh-list
6704311|NCT01743118|Dermatologic Agents|dermatologic agents|mesh-ancestor
6704312|NCT01743144|Magnesium Sulfate|magnesium sulfate|mesh-list
6704313|NCT01743144|Analgesics|analgesics|mesh-ancestor
6704314|NCT01743144|Sensory System Agents|sensory system agents|mesh-ancestor
6704315|NCT01743144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6704316|NCT01743144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704317|NCT01743144|Anesthetics|anesthetics|mesh-ancestor
6704318|NCT01743144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6704319|NCT01743144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6704320|NCT01743144|Anticonvulsants|anticonvulsants|mesh-ancestor
6704321|NCT01743144|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6704322|NCT01743144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6704323|NCT01743144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704324|NCT01743144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6704325|NCT01743144|Tocolytic Agents|tocolytic agents|mesh-ancestor
6704326|NCT01743144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6704327|NCT01743157|Bevacizumab|bevacizumab|mesh-list
6704328|NCT01743157|Ipilimumab|ipilimumab|mesh-list
6704329|NCT01743157|Interleukin-2|interleukin-2|mesh-list
6704330|NCT01743157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6704331|NCT01743157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6704332|NCT01743157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6704333|NCT01743157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6704334|NCT01743157|Growth Substances|growth substances|mesh-ancestor
6704335|NCT01743157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704336|NCT01743157|Growth Inhibitors|growth inhibitors|mesh-ancestor
6704337|NCT01743157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6704338|NCT01743157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704339|NCT01743157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6704340|NCT01743157|Analgesics|analgesics|mesh-ancestor
6704341|NCT01743157|Sensory System Agents|sensory system agents|mesh-ancestor
6704342|NCT01743157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6704343|NCT01743235|Buspirone|buspirone|mesh-list
6704344|NCT01743235|Testosterone|testosterone|mesh-list
6704345|NCT01743235|Androgens|androgens|mesh-ancestor
6704346|NCT01743235|Hormones|hormones|mesh-ancestor
6782154|NCT02188615|Mitosis Modulators|mitosis modulators|mesh-ancestor
6704347|NCT01743235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6704348|NCT01743235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704349|NCT01743235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6704350|NCT01743235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6704351|NCT01743235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6704352|NCT01743235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6704353|NCT01743235|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6704354|NCT01743235|Serotonin Agents|serotonin agents|mesh-ancestor
6704355|NCT01743235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6704356|NCT01743235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704357|NCT01743300|Sunitinib|sunitinib|mesh-list
6704358|NCT01743300|Midazolam|midazolam|mesh-list
6704359|NCT01743300|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6704360|NCT01743300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6704361|NCT01743300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6704362|NCT01743300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704363|NCT01743300|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6704364|NCT01743300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6704365|NCT01743300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6704366|NCT01743300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6704367|NCT01743300|Anesthetics, General|anesthetics, general|mesh-ancestor
6704368|NCT01743300|Anesthetics|anesthetics|mesh-ancestor
6704369|NCT01743300|GABA Modulators|gaba modulators|mesh-ancestor
6704370|NCT01743300|GABA Agents|gaba agents|mesh-ancestor
6704371|NCT01743300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6704372|NCT01743300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704373|NCT01743300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6704374|NCT01743300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6704375|NCT01743300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6704376|NCT01743300|Growth Substances|growth substances|mesh-ancestor
6704377|NCT01743300|Growth Inhibitors|growth inhibitors|mesh-ancestor
6704378|NCT01743300|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6704379|NCT01743300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6704380|NCT01743326|Anesthetics|anesthetics|mesh-list
6704381|NCT01743326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6704382|NCT01743326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704383|NCT01743365|Afatinib|afatinib|mesh-list
6704384|NCT01743365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6704385|NCT01743365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6704386|NCT01743365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6704387|NCT01743365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704388|NCT01743378|Ropivacaine|ropivacaine|mesh-list
6704389|NCT01743378|Anesthetics, Local|anesthetics, local|mesh-ancestor
6704390|NCT01743378|Anesthetics|anesthetics|mesh-ancestor
6704391|NCT01743378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6704392|NCT01743378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704393|NCT01743378|Sensory System Agents|sensory system agents|mesh-ancestor
6704394|NCT01743378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6704395|NCT01743456|Anesthetics|anesthetics|mesh-list
6704396|NCT01743456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6704397|NCT01743456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704398|NCT01743508|Misoprostol|misoprostol|mesh-list
6704399|NCT01743508|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6704400|NCT01743508|Abortifacient Agents|abortifacient agents|mesh-ancestor
6704401|NCT01743508|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6704402|NCT01743508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704403|NCT01743508|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6704404|NCT01743508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6704405|NCT01743508|Oxytocics|oxytocics|mesh-ancestor
6704406|NCT01743690|Nystatin|nystatin|mesh-list
6704407|NCT01743690|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
6704408|NCT01743690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6704409|NCT01743690|Glucocorticoids|glucocorticoids|mesh-ancestor
6704410|NCT01743690|Hormones|hormones|mesh-ancestor
6704411|NCT01743690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6704412|NCT01743690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704413|NCT01743690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6704414|NCT01743690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6704415|NCT01743690|Antifungal Agents|antifungal agents|mesh-ancestor
6704416|NCT01743690|Ionophores|ionophores|mesh-ancestor
6704417|NCT01743690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6704418|NCT01743690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704419|NCT01743742|Vitamins|vitamins|mesh-list
6704420|NCT01743742|Ascorbic Acid|ascorbic acid|mesh-list
6704421|NCT01743742|Vitamin E|vitamin e|mesh-list
6704422|NCT01743742|Micronutrients|micronutrients|mesh-ancestor
6704423|NCT01743742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704424|NCT01743742|Antioxidants|antioxidants|mesh-ancestor
6704425|NCT01743742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704426|NCT01743742|Protective Agents|protective agents|mesh-ancestor
6704427|NCT01743755|Dexamethasone|dexamethasone|mesh-list
6704428|NCT01743755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6704429|NCT01743755|Antiemetics|antiemetics|mesh-ancestor
6704430|NCT01743755|Autonomic Agents|autonomic agents|mesh-ancestor
6704431|NCT01743755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6704432|NCT01743755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704433|NCT01743755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6704434|NCT01743755|Glucocorticoids|glucocorticoids|mesh-ancestor
6704435|NCT01743755|Hormones|hormones|mesh-ancestor
6704436|NCT01743755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6704437|NCT01743755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6704438|NCT01743755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6704439|NCT01743794|Ropivacaine|ropivacaine|mesh-list
6704440|NCT01743794|Anesthetics, Local|anesthetics, local|mesh-ancestor
6704441|NCT01743794|Anesthetics|anesthetics|mesh-ancestor
6704442|NCT01743794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6704443|NCT01743794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704444|NCT01743794|Sensory System Agents|sensory system agents|mesh-ancestor
6704445|NCT01743794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6704446|NCT01743820|Piperaquine|piperaquine|mesh-list
6704447|NCT01743820|Primaquine|primaquine|mesh-list
6704448|NCT01743820|Artenimol|artenimol|mesh-list
6704449|NCT01743820|Antimalarials|antimalarials|mesh-ancestor
6704450|NCT01743820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6704451|NCT01743820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6704452|NCT01743820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6704453|NCT01743885|Propranolol|propranolol|mesh-list
6704454|NCT01743885|Acebutolol|acebutolol|mesh-list
6704455|NCT01743885|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6704456|NCT01743885|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6704457|NCT01743885|Adrenergic Agents|adrenergic agents|mesh-ancestor
6704458|NCT01743885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6704459|NCT01743885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704460|NCT01743885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704461|NCT01743885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6704462|NCT01743885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6704463|NCT01743885|Vasodilator Agents|vasodilator agents|mesh-ancestor
6704464|NCT01743885|Sympathomimetics|sympathomimetics|mesh-ancestor
6704465|NCT01743885|Autonomic Agents|autonomic agents|mesh-ancestor
6704466|NCT01743885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6704467|NCT01743885|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6704468|NCT01743898|Rivaroxaban|rivaroxaban|mesh-list
6704469|NCT01743898|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6704470|NCT01743898|Antithrombins|antithrombins|mesh-ancestor
6704471|NCT01743898|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6704472|NCT01743898|Protease Inhibitors|protease inhibitors|mesh-ancestor
6704473|NCT01743898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6704474|NCT01743898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704475|NCT01743898|Anticoagulants|anticoagulants|mesh-ancestor
6704476|NCT01743911|Tadalafil|tadalafil|mesh-list
6704477|NCT01743911|Vasodilator Agents|vasodilator agents|mesh-ancestor
6704478|NCT01743911|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6704479|NCT01743911|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6704480|NCT01743911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6704481|NCT01743911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704482|NCT01743911|Urological Agents|urological agents|mesh-ancestor
6704483|NCT01743950|Bevacizumab|bevacizumab|mesh-list
6704484|NCT01743950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6704485|NCT01743950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6704486|NCT01743950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6704487|NCT01743950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6704488|NCT01743950|Growth Substances|growth substances|mesh-ancestor
6704489|NCT01743950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704490|NCT01743950|Growth Inhibitors|growth inhibitors|mesh-ancestor
6704491|NCT01744106|Pseudoephedrine|pseudoephedrine|mesh-list
6704492|NCT01744106|Ephedrine|ephedrine|mesh-list
6704493|NCT01744106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6704494|NCT01744106|Autonomic Agents|autonomic agents|mesh-ancestor
6704495|NCT01744106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6704496|NCT01744106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704497|NCT01744106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6704498|NCT01744106|Respiratory System Agents|respiratory system agents|mesh-ancestor
6704499|NCT01744106|Nasal Decongestants|nasal decongestants|mesh-ancestor
6704500|NCT01744106|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6704501|NCT01744106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6704502|NCT01744106|Sympathomimetics|sympathomimetics|mesh-ancestor
6704503|NCT01744106|Adrenergic Agents|adrenergic agents|mesh-ancestor
6704504|NCT01744106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6704505|NCT01744106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704506|NCT01744184|Midazolam|midazolam|mesh-list
6704507|NCT01744184|Nitrous Oxide|nitrous oxide|mesh-list
6704508|NCT01744184|Entonox|entonox|mesh-list
6704509|NCT01744184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6704510|NCT01744184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6704511|NCT01744184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6704512|NCT01744184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704513|NCT01744184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6704514|NCT01744184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6704515|NCT01744184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6704516|NCT01744184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6704517|NCT01744184|Anesthetics, General|anesthetics, general|mesh-ancestor
6704518|NCT01744184|Anesthetics|anesthetics|mesh-ancestor
6704519|NCT01744184|GABA Modulators|gaba modulators|mesh-ancestor
6704520|NCT01744184|GABA Agents|gaba agents|mesh-ancestor
6704521|NCT01744184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6704522|NCT01744184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704523|NCT01744184|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6704524|NCT01744184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6704525|NCT01744184|Analgesics|analgesics|mesh-ancestor
6704526|NCT01744184|Sensory System Agents|sensory system agents|mesh-ancestor
6704527|NCT01744184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6704528|NCT01744184|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
6704529|NCT01744236|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6704530|NCT01744236|Liraglutide|liraglutide|mesh-list
6704531|NCT01744236|Exenatide|exenatide|mesh-list
6704532|NCT01744236|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6704533|NCT01744236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704534|NCT01744236|Incretins|incretins|mesh-ancestor
6704535|NCT01744236|Hormones|hormones|mesh-ancestor
6704536|NCT01744236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6704537|NCT01744236|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6704538|NCT01744236|Protease Inhibitors|protease inhibitors|mesh-ancestor
6704539|NCT01744236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6704540|NCT01744236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704541|NCT01744236|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6704542|NCT01744249|Axitinib|axitinib|mesh-list
6704543|NCT01744249|Octreotide|octreotide|mesh-list
6704544|NCT01744249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6704545|NCT01744249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6704546|NCT01744249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6704547|NCT01744249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704548|NCT01744249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6704549|NCT01744249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6704550|NCT01744262|Anesthetics|anesthetics|mesh-list
6704551|NCT01744262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6704552|NCT01744262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704553|NCT01744288|Clopidogrel|clopidogrel|mesh-list
6704554|NCT01744288|Ticagrelor|ticagrelor|mesh-list
6704555|NCT01744288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6704556|NCT01744288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6704557|NCT01744288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6704558|NCT01744288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6704559|NCT01744288|Purinergic Agents|purinergic agents|mesh-ancestor
6704560|NCT01744288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6704561|NCT01744288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704562|NCT01744288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704563|NCT01744314|Indomethacin|indomethacin|mesh-list
6704564|NCT01744314|Pantoprazole|pantoprazole|mesh-list
6704565|NCT01744314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6704566|NCT01744314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6704567|NCT01744314|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6704568|NCT01744314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6704569|NCT01744314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704570|NCT01744314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6704571|NCT01744314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6704572|NCT01744314|Analgesics|analgesics|mesh-ancestor
6704573|NCT01744314|Sensory System Agents|sensory system agents|mesh-ancestor
6704574|NCT01744314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6704575|NCT01744314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704576|NCT01744314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6704577|NCT01744314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6704578|NCT01744314|Gout Suppressants|gout suppressants|mesh-ancestor
6704579|NCT01744314|Tocolytic Agents|tocolytic agents|mesh-ancestor
6704580|NCT01744314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6704581|NCT01744314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6704582|NCT01744366|Goserelin|goserelin|mesh-list
6704583|NCT01744366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6704584|NCT01744366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6704585|NCT01744379|Lesinurad|lesinurad|mesh-list
6704586|NCT01744379|Gout Suppressants|gout suppressants|mesh-ancestor
6704587|NCT01744379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6704588|NCT01744379|Uricosuric Agents|uricosuric agents|mesh-ancestor
6704589|NCT01744379|Renal Agents|renal agents|mesh-ancestor
6704590|NCT01744444|Gabapentin|gabapentin|mesh-list
6704591|NCT01744444|Memantine|memantine|mesh-list
6704592|NCT01744444|Analgesics|analgesics|mesh-ancestor
6704593|NCT01744444|Sensory System Agents|sensory system agents|mesh-ancestor
6704594|NCT01744444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6704595|NCT01744444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704596|NCT01744444|Anticonvulsants|anticonvulsants|mesh-ancestor
6704597|NCT01744444|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6704598|NCT01744444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6704599|NCT01744444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6704600|NCT01744444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6704601|NCT01744444|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6704602|NCT01744444|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6704603|NCT01744444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6704604|NCT01744444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704605|NCT01744444|Antimanic Agents|antimanic agents|mesh-ancestor
6704606|NCT01744444|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6704607|NCT01744444|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6704608|NCT01744444|Dopamine Agents|dopamine agents|mesh-ancestor
6704609|NCT01744470|Tacrolimus|tacrolimus|mesh-list
6704610|NCT01744470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6704611|NCT01744470|Immunologic Factors|immunologic factors|mesh-ancestor
6704612|NCT01744470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704613|NCT01744470|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6704614|NCT01744470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6704615|NCT01744470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704616|NCT01744587|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
6704617|NCT01744587|Antioxidants|antioxidants|mesh-ancestor
6704618|NCT01744587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704619|NCT01744587|Protective Agents|protective agents|mesh-ancestor
6704620|NCT01744587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704621|NCT01744587|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
6704622|NCT01744587|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6704623|NCT01744587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6704624|NCT01744587|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6782155|NCT02188615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782156|NCT02188654|Metformin|metformin|mesh-list
6782157|NCT02188654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6782158|NCT02188654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782159|NCT02188745|Letrozole|letrozole|mesh-list
6782160|NCT02188745|Anastrozole|anastrozole|mesh-list
6782161|NCT02188745|Exemestane|exemestane|mesh-list
6782162|NCT02188745|Estradiol|estradiol|mesh-list
6782163|NCT02188745|Aromatase Inhibitors|aromatase inhibitors|mesh-list
6782164|NCT02188745|Estrogens|estrogens|mesh-ancestor
6782165|NCT02188745|Hormones|hormones|mesh-ancestor
6782166|NCT02188745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6782167|NCT02188745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782168|NCT02188745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6782169|NCT02188745|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6782170|NCT02188745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6782171|NCT02188745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782172|NCT02188745|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6782173|NCT02188745|Hormone Antagonists|hormone antagonists|mesh-ancestor
6782174|NCT02188745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6782175|NCT02188771|Hyaluronic Acid|hyaluronic acid|mesh-list
6782176|NCT02188771|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6782177|NCT02188771|Immunologic Factors|immunologic factors|mesh-ancestor
6782178|NCT02188771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704625|NCT01744626|Rituximab|rituximab|mesh-list
6704626|NCT01744626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6704627|NCT01744626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6704628|NCT01744626|Immunologic Factors|immunologic factors|mesh-ancestor
6704629|NCT01744626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704630|NCT01744626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6704631|NCT01744652|Dasatinib|dasatinib|mesh-list
6704632|NCT01744652|Crizotinib|crizotinib|mesh-list
6704633|NCT01744652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6704634|NCT01744652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6704635|NCT01744652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6704636|NCT01744652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704637|NCT01744678|Immunoconjugates|immunoconjugates|mesh-list
6704638|NCT01744678|Immunologic Factors|immunologic factors|mesh-ancestor
6704639|NCT01744678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704640|NCT01744756|Bevacizumab|bevacizumab|mesh-list
6704641|NCT01744756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6704642|NCT01744756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6704643|NCT01744756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6704644|NCT01744756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6704645|NCT01744756|Growth Substances|growth substances|mesh-ancestor
6704646|NCT01744756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704647|NCT01744756|Growth Inhibitors|growth inhibitors|mesh-ancestor
6704648|NCT01744873|Bisoprolol|bisoprolol|mesh-list
6704649|NCT01744873|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6704650|NCT01744873|Sympatholytics|sympatholytics|mesh-ancestor
6704651|NCT01744873|Autonomic Agents|autonomic agents|mesh-ancestor
6704652|NCT01744873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6704653|NCT01744873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704654|NCT01744873|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6704655|NCT01744873|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6704656|NCT01744873|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6704657|NCT01744873|Adrenergic Agents|adrenergic agents|mesh-ancestor
6704658|NCT01744873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6704659|NCT01744873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704660|NCT01744886|Benzocaine|benzocaine|mesh-list
6704661|NCT01744886|Anesthetics, Local|anesthetics, local|mesh-ancestor
6704662|NCT01744886|Anesthetics|anesthetics|mesh-ancestor
6704663|NCT01744886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6704664|NCT01744886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704665|NCT01744886|Sensory System Agents|sensory system agents|mesh-ancestor
6704666|NCT01744886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6704667|NCT01744912|Lenalidomide|lenalidomide|mesh-list
6704668|NCT01744912|Immunologic Factors|immunologic factors|mesh-ancestor
6704669|NCT01744912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704670|NCT01744912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6704671|NCT01744912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6704672|NCT01744912|Growth Substances|growth substances|mesh-ancestor
6704673|NCT01744912|Growth Inhibitors|growth inhibitors|mesh-ancestor
6704674|NCT01744912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6704675|NCT01744964|Apomorphine|apomorphine|mesh-list
6704676|NCT01744964|Emetics|emetics|mesh-ancestor
6704677|NCT01744964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704678|NCT01744964|Autonomic Agents|autonomic agents|mesh-ancestor
6704679|NCT01744964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6704680|NCT01744964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6704681|NCT01744964|Dopamine Agonists|dopamine agonists|mesh-ancestor
6704682|NCT01744964|Dopamine Agents|dopamine agents|mesh-ancestor
6704683|NCT01744964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6704684|NCT01744964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704685|NCT01745081|Mannitol|mannitol|mesh-list
6704686|NCT01745081|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6704687|NCT01745081|Diuretics|diuretics|mesh-ancestor
6704688|NCT01745081|Natriuretic Agents|natriuretic agents|mesh-ancestor
6704689|NCT01745081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704690|NCT01745159|Tacrolimus|tacrolimus|mesh-list
6704691|NCT01745159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6704692|NCT01745159|Immunologic Factors|immunologic factors|mesh-ancestor
6704693|NCT01745159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704694|NCT01745159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6704695|NCT01745159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6704696|NCT01745159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704697|NCT01745263|Vitamin D|vitamin d|mesh-list
6704698|NCT01745263|Cholecalciferol|cholecalciferol|mesh-list
6704699|NCT01745263|Vitamins|vitamins|mesh-ancestor
6704700|NCT01745263|Micronutrients|micronutrients|mesh-ancestor
6704701|NCT01745263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704702|NCT01745263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6704703|NCT01745263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6704704|NCT01745302|Gefitinib|gefitinib|mesh-list
6704705|NCT01745302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6704706|NCT01745302|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6704707|NCT01745302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6704708|NCT01745302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704709|NCT01745328|Amoxicillin|amoxicillin|mesh-list
6704710|NCT01745328|Levofloxacin|levofloxacin|mesh-list
6704711|NCT01745328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6704712|NCT01745328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6704713|NCT01745328|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6704714|NCT01745328|Renal Agents|renal agents|mesh-ancestor
6704715|NCT01745328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6704716|NCT01745328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6704717|NCT01745328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6704718|NCT01745328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704719|NCT01745328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6704720|NCT01745328|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6704721|NCT01745328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6704722|NCT01745549|Insulin|insulin|mesh-list
6704723|NCT01745549|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6704724|NCT01745549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6704725|NCT01745549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704726|NCT01745562|Alprazolam|alprazolam|mesh-list
6704727|NCT01745562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6704728|NCT01745562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6704729|NCT01745562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704730|NCT01745562|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6704731|NCT01745562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6704732|NCT01745562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6704733|NCT01745562|GABA Modulators|gaba modulators|mesh-ancestor
6704734|NCT01745562|GABA Agents|gaba agents|mesh-ancestor
6704735|NCT01745562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6704736|NCT01745562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704737|NCT01745575|Alprazolam|alprazolam|mesh-list
6704738|NCT01745575|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6704739|NCT01745575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6704740|NCT01745575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704741|NCT01745575|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6704742|NCT01745575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6704743|NCT01745575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6704744|NCT01745575|GABA Modulators|gaba modulators|mesh-ancestor
6704745|NCT01745575|GABA Agents|gaba agents|mesh-ancestor
6704746|NCT01745575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6704747|NCT01745575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704748|NCT01745601|Dexetimide|dexetimide|mesh-list
6704749|NCT01745601|Citalopram|citalopram|mesh-list
6704750|NCT01745601|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6704751|NCT01745601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6704752|NCT01745601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6704753|NCT01745601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704754|NCT01745601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6704755|NCT01745601|Serotonin Agents|serotonin agents|mesh-ancestor
6704756|NCT01745601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704757|NCT01745601|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6704758|NCT01745601|Antidepressive Agents|antidepressive agents|mesh-ancestor
6704759|NCT01745601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6704760|NCT01745601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6704761|NCT01745601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6704762|NCT01745601|Parasympatholytics|parasympatholytics|mesh-ancestor
6704763|NCT01745601|Autonomic Agents|autonomic agents|mesh-ancestor
6704764|NCT01745601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6704765|NCT01745601|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6704766|NCT01745601|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6704767|NCT01745601|Cholinergic Agents|cholinergic agents|mesh-ancestor
6704768|NCT01745614|Nimesulide|nimesulide|mesh-list
6704769|NCT01745614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6704770|NCT01745614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6704771|NCT01745614|Analgesics|analgesics|mesh-ancestor
6704772|NCT01745614|Sensory System Agents|sensory system agents|mesh-ancestor
6704773|NCT01745614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6704774|NCT01745614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704775|NCT01745614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6704776|NCT01745614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6704777|NCT01745614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6704778|NCT01745614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6704779|NCT01745614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704780|NCT01745640|Dexamethasone|dexamethasone|mesh-list
6704781|NCT01745640|Pomalidomide|pomalidomide|mesh-list
6704782|NCT01745640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6704783|NCT01745640|Antiemetics|antiemetics|mesh-ancestor
6704784|NCT01745640|Autonomic Agents|autonomic agents|mesh-ancestor
6704785|NCT01745640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6704786|NCT01745640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704787|NCT01745640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6704788|NCT01745640|Glucocorticoids|glucocorticoids|mesh-ancestor
6704789|NCT01745640|Hormones|hormones|mesh-ancestor
6704790|NCT01745640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6704791|NCT01745640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6704792|NCT01745640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6704793|NCT01745640|Immunologic Factors|immunologic factors|mesh-ancestor
6704794|NCT01745640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6704795|NCT01745640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6704796|NCT01745640|Growth Substances|growth substances|mesh-ancestor
6704797|NCT01745640|Growth Inhibitors|growth inhibitors|mesh-ancestor
6704798|NCT01745666|Epinephrine|epinephrine|mesh-list
6704799|NCT01745666|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6704800|NCT01745666|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6704801|NCT01745666|Adrenergic Agents|adrenergic agents|mesh-ancestor
6704802|NCT01745666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6704803|NCT01745666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704804|NCT01745666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704805|NCT01745666|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6704806|NCT01745666|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6704807|NCT01745666|Autonomic Agents|autonomic agents|mesh-ancestor
6704808|NCT01745666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6704809|NCT01745666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6704810|NCT01745666|Respiratory System Agents|respiratory system agents|mesh-ancestor
6704811|NCT01745666|Mydriatics|mydriatics|mesh-ancestor
6704812|NCT01745666|Sympathomimetics|sympathomimetics|mesh-ancestor
6704813|NCT01745666|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6704814|NCT01745679|Ceftriaxone|ceftriaxone|mesh-list
6704815|NCT01745679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6704816|NCT01745679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6704817|NCT01745692|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6704818|NCT01745692|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6704819|NCT01745692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6704820|NCT01745692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704821|NCT01745757|Paclitaxel|paclitaxel|mesh-list
6704822|NCT01745757|Bevacizumab|bevacizumab|mesh-list
6704823|NCT01745757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6704824|NCT01745757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6704825|NCT01745757|Tubulin Modulators|tubulin modulators|mesh-ancestor
6704826|NCT01745757|Antimitotic Agents|antimitotic agents|mesh-ancestor
6704827|NCT01745757|Mitosis Modulators|mitosis modulators|mesh-ancestor
6704828|NCT01745757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704829|NCT01745757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6704830|NCT01745757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6704831|NCT01745757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6704832|NCT01745757|Growth Substances|growth substances|mesh-ancestor
6704833|NCT01745757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704834|NCT01745757|Growth Inhibitors|growth inhibitors|mesh-ancestor
6704835|NCT01745770|Mesalamine|mesalamine|mesh-list
6704836|NCT01745770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6704837|NCT01745770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6704838|NCT01745770|Analgesics|analgesics|mesh-ancestor
6704839|NCT01745770|Sensory System Agents|sensory system agents|mesh-ancestor
6704840|NCT01745770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6704841|NCT01745770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704842|NCT01745770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6704843|NCT01745770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6704844|NCT01745835|Bisacodyl|bisacodyl|mesh-list
6704845|NCT01745835|Cathartics|cathartics|mesh-ancestor
6704846|NCT01745835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6704847|NCT01745835|Laxatives|laxatives|mesh-ancestor
6704848|NCT01745965|Trastuzumab|trastuzumab|mesh-list
6704849|NCT01745965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6704850|NCT01745965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6704851|NCT01746199|Pyrimethamine|pyrimethamine|mesh-list
6704852|NCT01746199|Sulfadoxine|sulfadoxine|mesh-list
6704853|NCT01746199|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6704854|NCT01746199|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6704855|NCT01746199|Sulfamethoxazole|sulfamethoxazole|mesh-list
6704856|NCT01746199|Antimalarials|antimalarials|mesh-ancestor
6704857|NCT01746199|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6704858|NCT01746199|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6704859|NCT01746199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6704860|NCT01746199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6704861|NCT01746199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6704862|NCT01746199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704863|NCT01746199|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6704864|NCT01746199|Renal Agents|renal agents|mesh-ancestor
6704865|NCT01746199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6704866|NCT01746238|Bevacizumab|bevacizumab|mesh-list
6704867|NCT01746238|Doxorubicin|doxorubicin|mesh-list
6704868|NCT01746238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6704869|NCT01746238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6704870|NCT01746238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6704871|NCT01746238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6704872|NCT01746238|Growth Substances|growth substances|mesh-ancestor
6704873|NCT01746238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704874|NCT01746238|Growth Inhibitors|growth inhibitors|mesh-ancestor
6704875|NCT01746238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6704876|NCT01746238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6704877|NCT01746238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6704878|NCT01746238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6704879|NCT01746238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704880|NCT01746251|Afatinib|afatinib|mesh-list
6704881|NCT01746251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6704882|NCT01746251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6704883|NCT01746251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6704884|NCT01746251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704885|NCT01746277|Docetaxel|docetaxel|mesh-list
6704886|NCT01746277|Pemetrexed|pemetrexed|mesh-list
6704887|NCT01746277|Gefitinib|gefitinib|mesh-list
6704888|NCT01746277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6704889|NCT01746277|Tubulin Modulators|tubulin modulators|mesh-ancestor
6704890|NCT01746277|Antimitotic Agents|antimitotic agents|mesh-ancestor
6704891|NCT01746277|Mitosis Modulators|mitosis modulators|mesh-ancestor
6704892|NCT01746277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704893|NCT01746277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6704894|NCT01746277|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6704895|NCT01746277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6704896|NCT01746277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6782179|NCT02188771|Viscosupplements|viscosupplements|mesh-ancestor
6782180|NCT02188771|Protective Agents|protective agents|mesh-ancestor
6782181|NCT02188810|Vaccines|vaccines|mesh-list
6782182|NCT02188810|Immunologic Factors|immunologic factors|mesh-ancestor
6782183|NCT02188810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782184|NCT02188888|Esmolol|esmolol|mesh-list
6782185|NCT02188888|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6782186|NCT02188888|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6782187|NCT02188888|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6782188|NCT02188888|Adrenergic Agents|adrenergic agents|mesh-ancestor
6782189|NCT02188888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6782190|NCT02188888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782191|NCT02188888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782192|NCT02188953|Calcium, Dietary|calcium, dietary|mesh-list
6782193|NCT02188953|Calcium Carbonate|calcium carbonate|mesh-list
6782194|NCT02188953|Calcium|calcium|mesh-list
6782195|NCT02188953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6782196|NCT02188953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782197|NCT02188953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6782198|NCT02188953|Antacids|antacids|mesh-ancestor
6782199|NCT02188953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782200|NCT02188953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6704897|NCT01746485|Treprostinil|treprostinil|mesh-list
6704898|NCT01746485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6704899|NCT01746563|Ranibizumab|ranibizumab|mesh-list
6704900|NCT01746563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6704901|NCT01746563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6704902|NCT01746563|Growth Substances|growth substances|mesh-ancestor
6704903|NCT01746563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704904|NCT01746563|Growth Inhibitors|growth inhibitors|mesh-ancestor
6704905|NCT01746563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6704906|NCT01746602|Timolol|timolol|mesh-list
6704907|NCT01746602|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6704908|NCT01746602|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6704909|NCT01746602|Adrenergic Agents|adrenergic agents|mesh-ancestor
6704910|NCT01746602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6704911|NCT01746602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704912|NCT01746602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704913|NCT01746602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6704914|NCT01746602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6704915|NCT01746641|Remifentanil|remifentanil|mesh-list
6704916|NCT01746641|Propofol|propofol|mesh-list
6704917|NCT01746641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6704918|NCT01746641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6704919|NCT01746641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704920|NCT01746641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6704921|NCT01746641|Anesthetics, General|anesthetics, general|mesh-ancestor
6704922|NCT01746641|Anesthetics|anesthetics|mesh-ancestor
6704923|NCT01746641|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6704924|NCT01746641|Narcotics|narcotics|mesh-ancestor
6704925|NCT01746641|Analgesics|analgesics|mesh-ancestor
6704926|NCT01746641|Sensory System Agents|sensory system agents|mesh-ancestor
6704927|NCT01746641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6704928|NCT01746680|Methotrexate|methotrexate|mesh-list
6704929|NCT01746680|Tacrolimus|tacrolimus|mesh-list
6704930|NCT01746680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6704931|NCT01746680|Abortifacient Agents|abortifacient agents|mesh-ancestor
6704932|NCT01746680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6704933|NCT01746680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704934|NCT01746680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6704935|NCT01746680|Antimetabolites|antimetabolites|mesh-ancestor
6704936|NCT01746680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704937|NCT01746680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6704938|NCT01746680|Dermatologic Agents|dermatologic agents|mesh-ancestor
6704939|NCT01746680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6704940|NCT01746680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6704941|NCT01746680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6704942|NCT01746680|Immunologic Factors|immunologic factors|mesh-ancestor
6704943|NCT01746680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6704944|NCT01746680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6704945|NCT01746680|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6704946|NCT01746719|Etodolac|etodolac|mesh-list
6704947|NCT01746719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6704948|NCT01746719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6704949|NCT01746719|Analgesics|analgesics|mesh-ancestor
6704950|NCT01746719|Sensory System Agents|sensory system agents|mesh-ancestor
6704951|NCT01746719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6704952|NCT01746719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704953|NCT01746719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6704954|NCT01746719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6704955|NCT01746719|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6704956|NCT01746719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6704957|NCT01746719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6704958|NCT01746719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704959|NCT01746771|Paclitaxel|paclitaxel|mesh-list
6704960|NCT01746771|Trastuzumab|trastuzumab|mesh-list
6704961|NCT01746771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6704962|NCT01746771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6704963|NCT01746771|Tubulin Modulators|tubulin modulators|mesh-ancestor
6704964|NCT01746771|Antimitotic Agents|antimitotic agents|mesh-ancestor
6704965|NCT01746771|Mitosis Modulators|mitosis modulators|mesh-ancestor
6704966|NCT01746771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704967|NCT01746771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6704968|NCT01746823|Cyclosporine|cyclosporine|mesh-list
6704969|NCT01746823|Cyclosporins|cyclosporins|mesh-list
6704970|NCT01746823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6704971|NCT01746823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6704972|NCT01746823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6704973|NCT01746823|Immunologic Factors|immunologic factors|mesh-ancestor
6704974|NCT01746823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704975|NCT01746823|Antifungal Agents|antifungal agents|mesh-ancestor
6704976|NCT01746823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6704977|NCT01746823|Dermatologic Agents|dermatologic agents|mesh-ancestor
6704978|NCT01746823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6704979|NCT01746823|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6704980|NCT01746875|Aflibercept|aflibercept|mesh-list
6704981|NCT01746875|Verteporfin|verteporfin|mesh-list
6704982|NCT01746875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6704983|NCT01746875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6704984|NCT01746875|Growth Substances|growth substances|mesh-ancestor
6704985|NCT01746875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6704986|NCT01746875|Growth Inhibitors|growth inhibitors|mesh-ancestor
6704987|NCT01746875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6704988|NCT01746875|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6704989|NCT01746875|Dermatologic Agents|dermatologic agents|mesh-ancestor
6704990|NCT01746992|Prednisone|prednisone|mesh-list
6704991|NCT01746992|Cyclophosphamide|cyclophosphamide|mesh-list
6704992|NCT01746992|Ifosfamide|ifosfamide|mesh-list
6704993|NCT01746992|Doxorubicin|doxorubicin|mesh-list
6704994|NCT01746992|Methotrexate|methotrexate|mesh-list
6704995|NCT01746992|Etoposide|etoposide|mesh-list
6704996|NCT01746992|Vincristine|vincristine|mesh-list
6704997|NCT01746992|Etoposide phosphate|etoposide phosphate|mesh-list
6704998|NCT01746992|Pirarubicin|pirarubicin|mesh-list
6704999|NCT01746992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6705000|NCT01746992|Immunologic Factors|immunologic factors|mesh-ancestor
6705001|NCT01746992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705002|NCT01746992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6705003|NCT01746992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6705004|NCT01746992|Alkylating Agents|alkylating agents|mesh-ancestor
6705005|NCT01746992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705006|NCT01746992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6705007|NCT01746992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6705008|NCT01746992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6705009|NCT01746992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6705010|NCT01746992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6705011|NCT01746992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6705012|NCT01746992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6705013|NCT01746992|Glucocorticoids|glucocorticoids|mesh-ancestor
6705014|NCT01746992|Hormones|hormones|mesh-ancestor
6705015|NCT01746992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6705016|NCT01746992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6705017|NCT01746992|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6705018|NCT01746992|Abortifacient Agents|abortifacient agents|mesh-ancestor
6705019|NCT01746992|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6705020|NCT01746992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6705021|NCT01746992|Antimetabolites|antimetabolites|mesh-ancestor
6705022|NCT01746992|Dermatologic Agents|dermatologic agents|mesh-ancestor
6705023|NCT01746992|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6705024|NCT01746992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6705025|NCT01746992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6705026|NCT01746992|Tubulin Modulators|tubulin modulators|mesh-ancestor
6705027|NCT01746992|Antimitotic Agents|antimitotic agents|mesh-ancestor
6705028|NCT01746992|Mitosis Modulators|mitosis modulators|mesh-ancestor
6705029|NCT01747044|Milnacipran|milnacipran|mesh-list
6705030|NCT01747044|Levomilnacipran|levomilnacipran|mesh-list
6705031|NCT01747044|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6705032|NCT01747044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6705033|NCT01747044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6705034|NCT01747044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705035|NCT01747044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6705036|NCT01747044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705037|NCT01747044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6705038|NCT01747044|Analgesics|analgesics|mesh-ancestor
6705039|NCT01747044|Sensory System Agents|sensory system agents|mesh-ancestor
6705040|NCT01747044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6705041|NCT01747044|Antidepressive Agents|antidepressive agents|mesh-ancestor
6705042|NCT01747044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6705043|NCT01747083|Metformin|metformin|mesh-list
6705044|NCT01747083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6705045|NCT01747083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705046|NCT01747135|Betadex|betadex|mesh-list
6705047|NCT01747135|Sequestering Agents|sequestering agents|mesh-ancestor
6705048|NCT01747135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705049|NCT01747148|Radavirsen|radavirsen|mesh-list
6705050|NCT01747148|Antiviral Agents|antiviral agents|mesh-ancestor
6705051|NCT01747148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6705052|NCT01747161|Botulinum Toxins|botulinum toxins|mesh-list
6705053|NCT01747161|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6705054|NCT01747161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6705055|NCT01747161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705056|NCT01747161|Cholinergic Agents|cholinergic agents|mesh-ancestor
6705057|NCT01747161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6705058|NCT01747161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705059|NCT01747174|Adenosine|adenosine|mesh-list
6705060|NCT01747174|Nitroprusside|nitroprusside|mesh-list
6705061|NCT01747174|Analgesics|analgesics|mesh-ancestor
6705062|NCT01747174|Sensory System Agents|sensory system agents|mesh-ancestor
6705063|NCT01747174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6705064|NCT01747174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705065|NCT01747174|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6705066|NCT01747174|Vasodilator Agents|vasodilator agents|mesh-ancestor
6705067|NCT01747174|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6705068|NCT01747174|Purinergic Agonists|purinergic agonists|mesh-ancestor
6705069|NCT01747174|Purinergic Agents|purinergic agents|mesh-ancestor
6705070|NCT01747174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6705071|NCT01747174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705072|NCT01747174|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6705073|NCT01747174|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6705074|NCT01747226|Fluorides|fluorides|mesh-list
6705075|NCT01747226|Cariostatic Agents|cariostatic agents|mesh-ancestor
6705076|NCT01747226|Protective Agents|protective agents|mesh-ancestor
6705077|NCT01747226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705078|NCT01747252|Resveratrol|resveratrol|mesh-list
6705079|NCT01747252|Antioxidants|antioxidants|mesh-ancestor
6705080|NCT01747252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705081|NCT01747252|Protective Agents|protective agents|mesh-ancestor
6705082|NCT01747252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705083|NCT01747252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6705084|NCT01747252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6705085|NCT01747278|Trimethoprim|trimethoprim|mesh-list
6705086|NCT01747278|Sulfamethoxazole|sulfamethoxazole|mesh-list
6705087|NCT01747278|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6705088|NCT01747278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6705089|NCT01747278|Renal Agents|renal agents|mesh-ancestor
6705090|NCT01747278|Antimalarials|antimalarials|mesh-ancestor
6705091|NCT01747278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6705092|NCT01747278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6705093|NCT01747278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6705094|NCT01747278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6705095|NCT01747278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705096|NCT01747278|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6705097|NCT01747278|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6705098|NCT01747278|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6705099|NCT01747564|Mirabegron|mirabegron|mesh-list
6705100|NCT01747564|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6705101|NCT01747564|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6705102|NCT01747564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6705103|NCT01747564|Adrenergic Agents|adrenergic agents|mesh-ancestor
6705104|NCT01747564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6705105|NCT01747564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705106|NCT01747564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705107|NCT01747564|Urological Agents|urological agents|mesh-ancestor
6705108|NCT01747577|Solifenacin Succinate|solifenacin succinate|mesh-list
6705109|NCT01747577|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6705110|NCT01747577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6705111|NCT01747577|Cholinergic Agents|cholinergic agents|mesh-ancestor
6705112|NCT01747577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6705113|NCT01747577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705114|NCT01747577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705115|NCT01747577|Urological Agents|urological agents|mesh-ancestor
6705116|NCT01747590|Zolpidem|zolpidem|mesh-list
6705117|NCT01747590|Alprazolam|alprazolam|mesh-list
6705118|NCT01747590|Caffeine|caffeine|mesh-list
6705119|NCT01747590|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6705120|NCT01747590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705121|NCT01747590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6705122|NCT01747590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6705123|NCT01747590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705124|NCT01747590|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6705125|NCT01747590|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6705126|NCT01747590|Purinergic Agents|purinergic agents|mesh-ancestor
6705127|NCT01747590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6705128|NCT01747590|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6705129|NCT01747590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6705130|NCT01747590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6705131|NCT01747590|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6705132|NCT01747590|GABA Agonists|gaba agonists|mesh-ancestor
6705133|NCT01747590|GABA Agents|gaba agents|mesh-ancestor
6705134|NCT01747590|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6705135|NCT01747590|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6705136|NCT01747590|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6705137|NCT01747590|GABA Modulators|gaba modulators|mesh-ancestor
6705138|NCT01747616|Acetylcysteine|acetylcysteine|mesh-list
6705139|NCT01747616|Chitosan|chitosan|mesh-list
6705140|NCT01747616|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6705141|NCT01747616|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6705142|NCT01747616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6705143|NCT01747616|Antiviral Agents|antiviral agents|mesh-ancestor
6705144|NCT01747616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6705145|NCT01747616|Expectorants|expectorants|mesh-ancestor
6705146|NCT01747616|Respiratory System Agents|respiratory system agents|mesh-ancestor
6705147|NCT01747616|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6705148|NCT01747616|Antioxidants|antioxidants|mesh-ancestor
6705149|NCT01747616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705150|NCT01747616|Protective Agents|protective agents|mesh-ancestor
6705151|NCT01747616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705152|NCT01747616|Antidotes|antidotes|mesh-ancestor
6705153|NCT01747616|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6705154|NCT01747616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6705155|NCT01747616|Antimetabolites|antimetabolites|mesh-ancestor
6705156|NCT01747616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6705157|NCT01747616|Chelating Agents|chelating agents|mesh-ancestor
6705158|NCT01747616|Sequestering Agents|sequestering agents|mesh-ancestor
6705159|NCT01747616|Hemostatics|hemostatics|mesh-ancestor
6705160|NCT01747616|Coagulants|coagulants|mesh-ancestor
6705161|NCT01747642|Sorafenib|sorafenib|mesh-list
6705162|NCT01747642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6705163|NCT01747642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6705164|NCT01747642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6705165|NCT01747642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705166|NCT01747668|Tocopherols|tocopherols|mesh-list
6705167|NCT01747668|alpha-Tocopherol|alpha-tocopherol|mesh-list
6705168|NCT01747668|Vitamin E|vitamin e|mesh-list
6705169|NCT01747668|Vitamins|vitamins|mesh-ancestor
6705170|NCT01747668|Micronutrients|micronutrients|mesh-ancestor
6705171|NCT01747668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705172|NCT01747668|Antioxidants|antioxidants|mesh-ancestor
6705173|NCT01747668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705174|NCT01747668|Protective Agents|protective agents|mesh-ancestor
6705175|NCT01747707|Docetaxel|docetaxel|mesh-list
6705176|NCT01747707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6705177|NCT01747707|Tubulin Modulators|tubulin modulators|mesh-ancestor
6705178|NCT01747707|Antimitotic Agents|antimitotic agents|mesh-ancestor
6705179|NCT01747707|Mitosis Modulators|mitosis modulators|mesh-ancestor
6705180|NCT01747707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705181|NCT01747720|Vitamin D|vitamin d|mesh-list
6705182|NCT01747720|Cholecalciferol|cholecalciferol|mesh-list
6705183|NCT01747720|Vitamins|vitamins|mesh-ancestor
6705184|NCT01747720|Micronutrients|micronutrients|mesh-ancestor
6705185|NCT01747720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705186|NCT01747720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6705187|NCT01747720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6705188|NCT01747746|Enoxaparin|enoxaparin|mesh-list
6705189|NCT01747746|Warfarin|warfarin|mesh-list
6705190|NCT01747746|Rivaroxaban|rivaroxaban|mesh-list
6705191|NCT01747746|Anticoagulants|anticoagulants|mesh-ancestor
6705192|NCT01747746|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6705193|NCT01747746|Antithrombins|antithrombins|mesh-ancestor
6705194|NCT01747746|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6705195|NCT01747746|Protease Inhibitors|protease inhibitors|mesh-ancestor
6705196|NCT01747746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6705197|NCT01747746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705198|NCT01747746|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6705199|NCT01747746|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6705200|NCT01747798|Auranofin|auranofin|mesh-list
6705201|NCT01747798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6705202|NCT01747993|Tamsulosin|tamsulosin|mesh-list
6705203|NCT01747993|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6705204|NCT01747993|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6705205|NCT01747993|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6705206|NCT01747993|Adrenergic Agents|adrenergic agents|mesh-ancestor
6705207|NCT01747993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6705208|NCT01747993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705209|NCT01747993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705210|NCT01747993|Urological Agents|urological agents|mesh-ancestor
6705211|NCT01748019|Namitecan|namitecan|mesh-list
6705212|NCT01748019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6705213|NCT01748019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6782201|NCT02189304|Budesonide|budesonide|mesh-list
6782202|NCT02189304|Glycopyrrolate|glycopyrrolate|mesh-list
6782203|NCT02189304|Formoterol Fumarate|formoterol fumarate|mesh-list
6782204|NCT02189304|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6782205|NCT02189304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6782206|NCT02189304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6782207|NCT02189304|Autonomic Agents|autonomic agents|mesh-ancestor
6782208|NCT02189304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6782209|NCT02189304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782210|NCT02189304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6782211|NCT02189304|Respiratory System Agents|respiratory system agents|mesh-ancestor
6782212|NCT02189304|Glucocorticoids|glucocorticoids|mesh-ancestor
6782213|NCT02189304|Hormones|hormones|mesh-ancestor
6782214|NCT02189304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6782215|NCT02189304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6782216|NCT02189304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6782217|NCT02189304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6782218|NCT02189304|Adrenergic Agents|adrenergic agents|mesh-ancestor
6782219|NCT02189304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6782220|NCT02189304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782221|NCT02189304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6782222|NCT02189304|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6782223|NCT02189304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6782224|NCT02189304|Cholinergic Agents|cholinergic agents|mesh-ancestor
6782225|NCT02189343|Thalidomide|thalidomide|mesh-list
6782226|NCT02189343|Dexamethasone|dexamethasone|mesh-list
6782227|NCT02189343|Dexamethasone acetate|dexamethasone acetate|mesh-list
6782228|NCT02189343|Pomalidomide|pomalidomide|mesh-list
6782229|NCT02189343|Ricolinostat|ricolinostat|mesh-list
6782230|NCT02189343|BB 1101|bb 1101|mesh-list
6782231|NCT02189343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6782232|NCT02189343|Antiemetics|antiemetics|mesh-ancestor
6782233|NCT02189343|Autonomic Agents|autonomic agents|mesh-ancestor
6782234|NCT02189343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6782235|NCT02189343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782236|NCT02189343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6782237|NCT02189343|Glucocorticoids|glucocorticoids|mesh-ancestor
6782238|NCT02189343|Hormones|hormones|mesh-ancestor
6782239|NCT02189343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6782240|NCT02189343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6782241|NCT02189343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6782242|NCT02189343|Protease Inhibitors|protease inhibitors|mesh-ancestor
6782243|NCT02189343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6782244|NCT02189343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782245|NCT02189343|Immunologic Factors|immunologic factors|mesh-ancestor
6782246|NCT02189343|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6782247|NCT02189343|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6782248|NCT02189343|Growth Substances|growth substances|mesh-ancestor
6782249|NCT02189343|Growth Inhibitors|growth inhibitors|mesh-ancestor
6782250|NCT02189343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6782251|NCT02189343|Leprostatic Agents|leprostatic agents|mesh-ancestor
6782252|NCT02189343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6782253|NCT02189343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6782254|NCT02189343|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6782255|NCT02189395|Insulin|insulin|mesh-list
6782256|NCT02189395|Insulin Lispro|insulin lispro|mesh-list
6782257|NCT02189395|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6782258|NCT02189395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6782259|NCT02189395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782260|NCT02189577|Glycopyrrolate|glycopyrrolate|mesh-list
6782261|NCT02189577|Bromides|bromides|mesh-list
6782262|NCT02189577|Anticonvulsants|anticonvulsants|mesh-ancestor
6782263|NCT02189577|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6705214|NCT01748084|Rituximab|rituximab|mesh-list
6705215|NCT01748084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6705216|NCT01748084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6705217|NCT01748084|Immunologic Factors|immunologic factors|mesh-ancestor
6705218|NCT01748084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705219|NCT01748084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6705220|NCT01748123|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6705221|NCT01748123|Chlorthalidone|chlorthalidone|mesh-list
6705222|NCT01748123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6705223|NCT01748123|Diuretics|diuretics|mesh-ancestor
6705224|NCT01748123|Natriuretic Agents|natriuretic agents|mesh-ancestor
6705225|NCT01748123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705226|NCT01748123|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6705227|NCT01748123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6705228|NCT01748123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705229|NCT01748253|Amlodipine|amlodipine|mesh-list
6705230|NCT01748253|Telmisartan|telmisartan|mesh-list
6705231|NCT01748253|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
6705232|NCT01748253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6705233|NCT01748253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6705234|NCT01748253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6705235|NCT01748253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705236|NCT01748253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6705237|NCT01748253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705238|NCT01748253|Vasodilator Agents|vasodilator agents|mesh-ancestor
6705239|NCT01748253|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6705240|NCT01748253|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6705241|NCT01748279|Atorvastatin|atorvastatin|mesh-list
6705242|NCT01748279|Formoterol Fumarate|formoterol fumarate|mesh-list
6705243|NCT01748279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6705244|NCT01748279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6705245|NCT01748279|Antimetabolites|antimetabolites|mesh-ancestor
6705246|NCT01748279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705247|NCT01748279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6705248|NCT01748279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6705249|NCT01748279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6705250|NCT01748279|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6705251|NCT01748279|Autonomic Agents|autonomic agents|mesh-ancestor
6705252|NCT01748279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6705253|NCT01748279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705254|NCT01748279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6705255|NCT01748279|Respiratory System Agents|respiratory system agents|mesh-ancestor
6705256|NCT01748279|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6705257|NCT01748279|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6705258|NCT01748279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6705259|NCT01748279|Adrenergic Agents|adrenergic agents|mesh-ancestor
6705260|NCT01748279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6705261|NCT01748318|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6705262|NCT01748318|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6705263|NCT01748318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6705264|NCT01748318|Renal Agents|renal agents|mesh-ancestor
6705265|NCT01748318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6705266|NCT01748318|Antimalarials|antimalarials|mesh-ancestor
6705267|NCT01748318|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6705268|NCT01748318|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6705269|NCT01748344|Cetirizine|cetirizine|mesh-list
6705270|NCT01748344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6705271|NCT01748344|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6705272|NCT01748344|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6705273|NCT01748344|Histamine Antagonists|histamine antagonists|mesh-ancestor
6705274|NCT01748344|Histamine Agents|histamine agents|mesh-ancestor
6705275|NCT01748344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6705276|NCT01748344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705277|NCT01748344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705278|NCT01748370|Vitamin D|vitamin d|mesh-list
6705279|NCT01748370|Ergocalciferols|ergocalciferols|mesh-list
6705280|NCT01748370|Cholecalciferol|cholecalciferol|mesh-list
6705281|NCT01748370|Vitamins|vitamins|mesh-list
6705282|NCT01748370|Micronutrients|micronutrients|mesh-ancestor
6705283|NCT01748370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705284|NCT01748370|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6705285|NCT01748370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6705286|NCT01748396|Calcitriol|calcitriol|mesh-list
6705287|NCT01748396|Calcium Carbonate|calcium carbonate|mesh-list
6705288|NCT01748396|Calcium|calcium|mesh-list
6705289|NCT01748396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6705290|NCT01748396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705291|NCT01748396|Antacids|antacids|mesh-ancestor
6705292|NCT01748396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705293|NCT01748396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6705294|NCT01748396|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6705295|NCT01748396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6705296|NCT01748396|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6705297|NCT01748396|Vitamins|vitamins|mesh-ancestor
6705298|NCT01748396|Micronutrients|micronutrients|mesh-ancestor
6705299|NCT01748396|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6705300|NCT01748422|Capsaicin|capsaicin|mesh-list
6705301|NCT01748422|Antipruritics|antipruritics|mesh-ancestor
6705302|NCT01748422|Dermatologic Agents|dermatologic agents|mesh-ancestor
6705303|NCT01748422|Sensory System Agents|sensory system agents|mesh-ancestor
6705304|NCT01748422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6705305|NCT01748422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705306|NCT01748435|Capsaicin|capsaicin|mesh-list
6705307|NCT01748435|Antipruritics|antipruritics|mesh-ancestor
6705308|NCT01748435|Dermatologic Agents|dermatologic agents|mesh-ancestor
6705309|NCT01748435|Sensory System Agents|sensory system agents|mesh-ancestor
6705310|NCT01748435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6705311|NCT01748435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705312|NCT01748448|Vitamin D|vitamin d|mesh-list
6705313|NCT01748448|Cholecalciferol|cholecalciferol|mesh-list
6705314|NCT01748448|Vitamins|vitamins|mesh-ancestor
6705315|NCT01748448|Micronutrients|micronutrients|mesh-ancestor
6705316|NCT01748448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705317|NCT01748448|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6705318|NCT01748448|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6705319|NCT01748487|Dexamethasone|dexamethasone|mesh-list
6705320|NCT01748487|Dexamethasone acetate|dexamethasone acetate|mesh-list
6705321|NCT01748487|BB 1101|bb 1101|mesh-list
6705322|NCT01748487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6705323|NCT01748487|Antiemetics|antiemetics|mesh-ancestor
6705324|NCT01748487|Autonomic Agents|autonomic agents|mesh-ancestor
6705325|NCT01748487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6705326|NCT01748487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705327|NCT01748487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6705328|NCT01748487|Glucocorticoids|glucocorticoids|mesh-ancestor
6705329|NCT01748487|Hormones|hormones|mesh-ancestor
6705330|NCT01748487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6705331|NCT01748487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6705332|NCT01748487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6705333|NCT01748487|Protease Inhibitors|protease inhibitors|mesh-ancestor
6705334|NCT01748487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6705335|NCT01748487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705336|NCT01748500|Pantoprazole|pantoprazole|mesh-list
6705337|NCT01748500|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6705338|NCT01748500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6705339|NCT01748500|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6705340|NCT01748500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6705341|NCT01748500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705342|NCT01748526|Canagliflozin|canagliflozin|mesh-list
6705343|NCT01748526|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6705344|NCT01748526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705345|NCT01748526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6705346|NCT01748526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705347|NCT01748539|Brodalumab|brodalumab|mesh-list
6705348|NCT01748539|Dermatologic Agents|dermatologic agents|mesh-ancestor
6705349|NCT01748630|Fentanyl|fentanyl|mesh-list
6705350|NCT01748630|Midazolam|midazolam|mesh-list
6705351|NCT01748630|Dexmedetomidine|dexmedetomidine|mesh-list
6705352|NCT01748630|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6705353|NCT01748630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6705354|NCT01748630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705355|NCT01748630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6705356|NCT01748630|Analgesics|analgesics|mesh-ancestor
6705357|NCT01748630|Sensory System Agents|sensory system agents|mesh-ancestor
6705358|NCT01748630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6705359|NCT01748630|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6705360|NCT01748630|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6705361|NCT01748630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6705362|NCT01748630|Adrenergic Agents|adrenergic agents|mesh-ancestor
6705363|NCT01748630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6705364|NCT01748630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705365|NCT01748630|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6705366|NCT01748630|Narcotics|narcotics|mesh-ancestor
6705367|NCT01748630|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6705368|NCT01748630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6705369|NCT01748630|Anesthetics, General|anesthetics, general|mesh-ancestor
6705370|NCT01748630|Anesthetics|anesthetics|mesh-ancestor
6705371|NCT01748630|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6705372|NCT01748630|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6705373|NCT01748630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6705374|NCT01748630|GABA Modulators|gaba modulators|mesh-ancestor
6705375|NCT01748630|GABA Agents|gaba agents|mesh-ancestor
6705376|NCT01748669|Allyl sulfide|allyl sulfide|mesh-list
6705377|NCT01748669|Antioxidants|antioxidants|mesh-ancestor
6705378|NCT01748669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705379|NCT01748669|Protective Agents|protective agents|mesh-ancestor
6705380|NCT01748669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705381|NCT01748669|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6705382|NCT01748669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6705383|NCT01748669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6705384|NCT01748669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6705385|NCT01748721|Antibodies|antibodies|mesh-list
6705386|NCT01748721|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6705387|NCT01748721|Immunologic Factors|immunologic factors|mesh-ancestor
6705388|NCT01748721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705389|NCT01748773|Capecitabine|capecitabine|mesh-list
6705390|NCT01748773|Oxaliplatin|oxaliplatin|mesh-list
6705391|NCT01748773|Trastuzumab|trastuzumab|mesh-list
6705392|NCT01748773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6705393|NCT01748773|Antimetabolites|antimetabolites|mesh-ancestor
6705394|NCT01748773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705395|NCT01748773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6705396|NCT01748773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6705397|NCT01748838|Mannitol|mannitol|mesh-list
6705398|NCT01748838|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6705399|NCT01748838|Diuretics|diuretics|mesh-ancestor
6705400|NCT01748838|Natriuretic Agents|natriuretic agents|mesh-ancestor
6705401|NCT01748838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705402|NCT01748929|Albendazole|albendazole|mesh-list
6705403|NCT01748929|Anthelmintics|anthelmintics|mesh-ancestor
6705404|NCT01748929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6705405|NCT01748929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6705406|NCT01748929|Anticestodal Agents|anticestodal agents|mesh-ancestor
6705407|NCT01748929|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6705408|NCT01748929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6705409|NCT01748929|Tubulin Modulators|tubulin modulators|mesh-ancestor
6705410|NCT01748929|Antimitotic Agents|antimitotic agents|mesh-ancestor
6705411|NCT01748929|Mitosis Modulators|mitosis modulators|mesh-ancestor
6705412|NCT01748929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705413|NCT01748929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6705414|NCT01749072|Vinorelbine|vinorelbine|mesh-list
6705415|NCT01749072|Ifosfamide|ifosfamide|mesh-list
6705416|NCT01749072|Gefitinib|gefitinib|mesh-list
6705417|NCT01749072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6705418|NCT01749072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6705419|NCT01749072|Tubulin Modulators|tubulin modulators|mesh-ancestor
6705420|NCT01749072|Antimitotic Agents|antimitotic agents|mesh-ancestor
6705421|NCT01749072|Mitosis Modulators|mitosis modulators|mesh-ancestor
6705422|NCT01749072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705423|NCT01749072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6705424|NCT01749072|Alkylating Agents|alkylating agents|mesh-ancestor
6705425|NCT01749072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6705426|NCT01749072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6705427|NCT01749085|Ketoconazole|ketoconazole|mesh-list
6705428|NCT01749085|Antifungal Agents|antifungal agents|mesh-ancestor
6705429|NCT01749085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6705430|NCT01749085|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6705431|NCT01749085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6705432|NCT01749085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6705433|NCT01749085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705434|NCT01749085|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6705435|NCT01749085|Hormone Antagonists|hormone antagonists|mesh-ancestor
6705436|NCT01749085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6705437|NCT01749085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705438|NCT01749085|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6705439|NCT01749098|Ketamine|ketamine|mesh-list
6705440|NCT01749098|Analgesics|analgesics|mesh-ancestor
6705441|NCT01749098|Sensory System Agents|sensory system agents|mesh-ancestor
6705442|NCT01749098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6705443|NCT01749098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705444|NCT01749098|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6705445|NCT01749098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6705446|NCT01749098|Anesthetics, General|anesthetics, general|mesh-ancestor
6705447|NCT01749098|Anesthetics|anesthetics|mesh-ancestor
6705448|NCT01749098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6705449|NCT01749098|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6705450|NCT01749098|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6705451|NCT01749098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6705452|NCT01749098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705453|NCT01749111|Cyclophosphamide|cyclophosphamide|mesh-list
6705454|NCT01749111|Methotrexate|methotrexate|mesh-list
6705455|NCT01749111|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
6705456|NCT01749111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6705457|NCT01749111|Immunologic Factors|immunologic factors|mesh-ancestor
6705458|NCT01749111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705459|NCT01749111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6705460|NCT01749111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6705461|NCT01749111|Alkylating Agents|alkylating agents|mesh-ancestor
6705462|NCT01749111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705463|NCT01749111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6705464|NCT01749111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6705465|NCT01749111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6705466|NCT01749111|Abortifacient Agents|abortifacient agents|mesh-ancestor
6705467|NCT01749111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6705468|NCT01749111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6705469|NCT01749111|Antimetabolites|antimetabolites|mesh-ancestor
6705470|NCT01749111|Dermatologic Agents|dermatologic agents|mesh-ancestor
6705471|NCT01749111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6705472|NCT01749111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6705473|NCT01749111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6705474|NCT01749150|Ritonavir|ritonavir|mesh-list
6705475|NCT01749150|Ribavirin|ribavirin|mesh-list
6705476|NCT01749150|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6705477|NCT01749150|Interferon-alpha|interferon-alpha|mesh-list
6705478|NCT01749150|Lactams|lactams|mesh-list
6705479|NCT01749150|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6705480|NCT01749150|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6705481|NCT01749150|Protease Inhibitors|protease inhibitors|mesh-ancestor
6705482|NCT01749150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6705483|NCT01749150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705484|NCT01749150|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6705485|NCT01749150|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6705486|NCT01749150|Antiviral Agents|antiviral agents|mesh-ancestor
6705487|NCT01749150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6705488|NCT01749150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6705489|NCT01749150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6705490|NCT01749150|Antimetabolites|antimetabolites|mesh-ancestor
6705491|NCT01749150|Immunologic Factors|immunologic factors|mesh-ancestor
6705492|NCT01749150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705493|NCT01749150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6705494|NCT01749228|Etodolac|etodolac|mesh-list
6705495|NCT01749228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6705496|NCT01749228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6705497|NCT01749228|Analgesics|analgesics|mesh-ancestor
6705498|NCT01749228|Sensory System Agents|sensory system agents|mesh-ancestor
6705499|NCT01749228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6705500|NCT01749228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705501|NCT01749228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6705502|NCT01749228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6705503|NCT01749228|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6705504|NCT01749228|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6705505|NCT01749228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6705506|NCT01749228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705507|NCT01749241|Loteprednol Etabonate|loteprednol etabonate|mesh-list
6705508|NCT01749241|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6705509|NCT01749319|Baclofen|baclofen|mesh-list
6705510|NCT01749319|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6705511|NCT01749319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705512|NCT01749319|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6705513|NCT01749319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6705514|NCT01749319|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6705515|NCT01749319|GABA Agonists|gaba agonists|mesh-ancestor
6705516|NCT01749319|GABA Agents|gaba agents|mesh-ancestor
6705517|NCT01749319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6705518|NCT01749319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705519|NCT01749371|Vitamins|vitamins|mesh-list
6705520|NCT01749371|Vitamin E|vitamin e|mesh-list
6705521|NCT01749371|Tocopherols|tocopherols|mesh-list
6705522|NCT01749371|Tocotrienols|tocotrienols|mesh-list
6705523|NCT01749371|alpha-Tocopherol|alpha-tocopherol|mesh-list
6705524|NCT01749371|Micronutrients|micronutrients|mesh-ancestor
6705525|NCT01749371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705526|NCT01749371|Antioxidants|antioxidants|mesh-ancestor
6705527|NCT01749371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705528|NCT01749371|Protective Agents|protective agents|mesh-ancestor
6705529|NCT01749384|Bevacizumab|bevacizumab|mesh-list
6705530|NCT01749384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6705531|NCT01749384|Endothelial Growth Factors|endothelial growth factors|mesh-list
6705532|NCT01749384|Antibodies|antibodies|mesh-list
6705533|NCT01749384|Immunoglobulins|immunoglobulins|mesh-list
6705534|NCT01749384|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6705535|NCT01749384|Immunoglobulin G|immunoglobulin g|mesh-list
6705536|NCT01749384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6705537|NCT01749384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6705538|NCT01749384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6705539|NCT01749384|Growth Substances|growth substances|mesh-ancestor
6705540|NCT01749384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705541|NCT01749384|Growth Inhibitors|growth inhibitors|mesh-ancestor
6705542|NCT01749384|Immunologic Factors|immunologic factors|mesh-ancestor
6705543|NCT01749397|Fluorouracil|fluorouracil|mesh-list
6705544|NCT01749397|Floxuridine|floxuridine|mesh-list
6705545|NCT01749397|Veliparib|veliparib|mesh-list
6705546|NCT01749397|Deoxyuridine|deoxyuridine|mesh-list
6705547|NCT01749397|Antimetabolites|antimetabolites|mesh-ancestor
6705548|NCT01749397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705549|NCT01749397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6705550|NCT01749397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6705551|NCT01749397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6705552|NCT01749397|Immunologic Factors|immunologic factors|mesh-ancestor
6705553|NCT01749397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705554|NCT01749397|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6705555|NCT01749397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6705556|NCT01749423|Botulinum Toxins|botulinum toxins|mesh-list
6705557|NCT01749423|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6705558|NCT01749423|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6705559|NCT01749423|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6705560|NCT01749423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6705561|NCT01749423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705562|NCT01749423|Cholinergic Agents|cholinergic agents|mesh-ancestor
6705563|NCT01749423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6705564|NCT01749423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705565|NCT01749423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6705566|NCT01749423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6705567|NCT01749475|Midazolam|midazolam|mesh-list
6705568|NCT01749475|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6705569|NCT01749475|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6705570|NCT01749475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6705571|NCT01749475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705572|NCT01749475|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6705573|NCT01749475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6705574|NCT01749475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6705575|NCT01749475|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6705576|NCT01749475|Anesthetics, General|anesthetics, general|mesh-ancestor
6705577|NCT01749475|Anesthetics|anesthetics|mesh-ancestor
6705578|NCT01749475|GABA Modulators|gaba modulators|mesh-ancestor
6705579|NCT01749475|GABA Agents|gaba agents|mesh-ancestor
6705580|NCT01749475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6705581|NCT01749475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705582|NCT01749514|Luspatercept|luspatercept|mesh-list
6705583|NCT01749514|Hematinics|hematinics|mesh-ancestor
6705584|NCT01749540|Luspatercept|luspatercept|mesh-list
6705585|NCT01749540|Hematinics|hematinics|mesh-ancestor
6705586|NCT01749566|Maraviroc|maraviroc|mesh-list
6705587|NCT01749566|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6705588|NCT01749566|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6705589|NCT01749566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705590|NCT01749566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6705591|NCT01749566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6705592|NCT01749566|Antiviral Agents|antiviral agents|mesh-ancestor
6705593|NCT01749566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6705594|NCT01749566|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6705595|NCT01749579|Fentanyl|fentanyl|mesh-list
6705596|NCT01749579|Midazolam|midazolam|mesh-list
6705597|NCT01749579|Propofol|propofol|mesh-list
6705598|NCT01749579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6705599|NCT01749579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6705600|NCT01749579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705601|NCT01749579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6705602|NCT01749579|Anesthetics, General|anesthetics, general|mesh-ancestor
6705603|NCT01749579|Anesthetics|anesthetics|mesh-ancestor
6705604|NCT01749579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6705605|NCT01749579|Narcotics|narcotics|mesh-ancestor
6705606|NCT01749579|Analgesics|analgesics|mesh-ancestor
6705607|NCT01749579|Sensory System Agents|sensory system agents|mesh-ancestor
6705608|NCT01749579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6705609|NCT01749579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6705610|NCT01749579|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6705611|NCT01749579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6705612|NCT01749579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6705613|NCT01749579|GABA Modulators|gaba modulators|mesh-ancestor
6705614|NCT01749579|GABA Agents|gaba agents|mesh-ancestor
6705615|NCT01749579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6705616|NCT01749579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782264|NCT02189577|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6782265|NCT02189577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6782266|NCT02189577|Cholinergic Agents|cholinergic agents|mesh-ancestor
6782267|NCT02189577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6782268|NCT02189577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782269|NCT02189577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782270|NCT02189655|Bupivacaine|bupivacaine|mesh-list
6782271|NCT02189655|Anesthetics, Local|anesthetics, local|mesh-ancestor
6782272|NCT02189655|Anesthetics|anesthetics|mesh-ancestor
6782273|NCT02189655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6782274|NCT02189655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782275|NCT02189655|Sensory System Agents|sensory system agents|mesh-ancestor
6782276|NCT02189655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6782277|NCT02189681|Anesthetics|anesthetics|mesh-list
6782278|NCT02189681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6782279|NCT02189681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782280|NCT02189694|Hormones|hormones|mesh-list
6782281|NCT02189694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782282|NCT02189694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6782283|NCT02189720|Amifampridine|amifampridine|mesh-list
6782284|NCT02189720|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6782285|NCT02189720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6782286|NCT02189720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782287|NCT02189720|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6782288|NCT02189720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6782289|NCT02189720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782290|NCT02189772|Metadoxine|metadoxine|mesh-list
6782291|NCT02189772|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6782292|NCT02190149|Factor VIII|factor viii|mesh-list
6782293|NCT02190149|Coagulants|coagulants|mesh-ancestor
6782294|NCT02190305|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
6782295|NCT02190305|Immunologic Factors|immunologic factors|mesh-ancestor
6782296|NCT02190305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782297|NCT02190318|Losartan|losartan|mesh-list
6782298|NCT02190318|Spironolactone|spironolactone|mesh-list
6782299|NCT02190318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6782300|NCT02190318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6782301|NCT02190318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6782302|NCT02190318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6782303|NCT02190318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782304|NCT02190318|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6782305|NCT02190318|Hormone Antagonists|hormone antagonists|mesh-ancestor
6782306|NCT02190318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6782307|NCT02190318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782308|NCT02190318|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6782309|NCT02190318|Diuretics|diuretics|mesh-ancestor
6705617|NCT01749969|Dexamethasone|dexamethasone|mesh-list
6705618|NCT01749969|Lenalidomide|lenalidomide|mesh-list
6705619|NCT01749969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6705620|NCT01749969|Antiemetics|antiemetics|mesh-ancestor
6705621|NCT01749969|Autonomic Agents|autonomic agents|mesh-ancestor
6705622|NCT01749969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6705623|NCT01749969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705624|NCT01749969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6705625|NCT01749969|Glucocorticoids|glucocorticoids|mesh-ancestor
6705626|NCT01749969|Hormones|hormones|mesh-ancestor
6705627|NCT01749969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6705628|NCT01749969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6705629|NCT01749969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6705630|NCT01749969|Immunologic Factors|immunologic factors|mesh-ancestor
6705631|NCT01749969|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6705632|NCT01749969|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6705633|NCT01749969|Growth Substances|growth substances|mesh-ancestor
6705634|NCT01749969|Growth Inhibitors|growth inhibitors|mesh-ancestor
6705635|NCT01750060|Fentanyl|fentanyl|mesh-list
6705636|NCT01750060|Naltrexone|naltrexone|mesh-list
6705637|NCT01750060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6705638|NCT01750060|Narcotics|narcotics|mesh-ancestor
6705639|NCT01750060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6705640|NCT01750060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705641|NCT01750060|Analgesics|analgesics|mesh-ancestor
6705642|NCT01750060|Sensory System Agents|sensory system agents|mesh-ancestor
6705643|NCT01750060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6705644|NCT01750060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6705645|NCT01750060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6705646|NCT01750060|Anesthetics, General|anesthetics, general|mesh-ancestor
6705647|NCT01750060|Anesthetics|anesthetics|mesh-ancestor
6705648|NCT01750060|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6705649|NCT01750060|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6705650|NCT01750073|Paclitaxel|paclitaxel|mesh-list
6705651|NCT01750073|Cyclophosphamide|cyclophosphamide|mesh-list
6705652|NCT01750073|Doxorubicin|doxorubicin|mesh-list
6705653|NCT01750073|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6705654|NCT01750073|Trastuzumab|trastuzumab|mesh-list
6705655|NCT01750073|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6705656|NCT01750073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6705657|NCT01750073|Antibodies|antibodies|mesh-list
6705658|NCT01750073|Immunoglobulins|immunoglobulins|mesh-list
6705659|NCT01750073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6705660|NCT01750073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6705661|NCT01750073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6705662|NCT01750073|Tubulin Modulators|tubulin modulators|mesh-ancestor
6705663|NCT01750073|Antimitotic Agents|antimitotic agents|mesh-ancestor
6705664|NCT01750073|Mitosis Modulators|mitosis modulators|mesh-ancestor
6705665|NCT01750073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705666|NCT01750073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6705667|NCT01750073|Immunologic Factors|immunologic factors|mesh-ancestor
6705668|NCT01750073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705669|NCT01750073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6705670|NCT01750073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6705671|NCT01750073|Alkylating Agents|alkylating agents|mesh-ancestor
6705672|NCT01750073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6705673|NCT01750073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6705674|NCT01750073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6705675|NCT01750073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6705676|NCT01750073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6705677|NCT01750099|Lidocaine|lidocaine|mesh-list
6705678|NCT01750099|Epinephrine|epinephrine|mesh-list
6705679|NCT01750099|Fentanyl|fentanyl|mesh-list
6705680|NCT01750099|Bupivacaine|bupivacaine|mesh-list
6705681|NCT01750099|Anesthetics, Local|anesthetics, local|mesh-ancestor
6705682|NCT01750099|Anesthetics|anesthetics|mesh-ancestor
6705683|NCT01750099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6705684|NCT01750099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705685|NCT01750099|Sensory System Agents|sensory system agents|mesh-ancestor
6705686|NCT01750099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6705687|NCT01750099|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6705688|NCT01750099|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6705689|NCT01750099|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6705690|NCT01750099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6705691|NCT01750099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705692|NCT01750099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6705693|NCT01750099|Narcotics|narcotics|mesh-ancestor
6705694|NCT01750099|Analgesics|analgesics|mesh-ancestor
6705695|NCT01750099|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6705696|NCT01750099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6705697|NCT01750099|Anesthetics, General|anesthetics, general|mesh-ancestor
6705698|NCT01750099|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6705699|NCT01750099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6705700|NCT01750099|Adrenergic Agents|adrenergic agents|mesh-ancestor
6705701|NCT01750099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6705702|NCT01750099|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6705703|NCT01750099|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6705704|NCT01750099|Autonomic Agents|autonomic agents|mesh-ancestor
6705705|NCT01750099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6705706|NCT01750099|Respiratory System Agents|respiratory system agents|mesh-ancestor
6705707|NCT01750099|Mydriatics|mydriatics|mesh-ancestor
6705708|NCT01750099|Sympathomimetics|sympathomimetics|mesh-ancestor
6705709|NCT01750099|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6705710|NCT01750359|Curcumin|curcumin|mesh-list
6705711|NCT01750359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6705712|NCT01750359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6705713|NCT01750359|Analgesics|analgesics|mesh-ancestor
6705714|NCT01750359|Sensory System Agents|sensory system agents|mesh-ancestor
6705715|NCT01750359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6705716|NCT01750359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705717|NCT01750359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6705718|NCT01750359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6705719|NCT01750359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6705720|NCT01750359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6705721|NCT01750359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705722|NCT01750385|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6705723|NCT01750385|Cephalosporins|cephalosporins|mesh-list
6705724|NCT01750385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6705725|NCT01750437|Esomeprazole|esomeprazole|mesh-list
6705726|NCT01750437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6705727|NCT01750437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6705728|NCT01750437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6705729|NCT01750437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6705730|NCT01750437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705731|NCT01750476|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6705732|NCT01750476|Medroxyprogesterone|medroxyprogesterone|mesh-list
6705733|NCT01750476|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6705734|NCT01750476|Contraceptive Agents|contraceptive agents|mesh-ancestor
6705735|NCT01750476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6705736|NCT01750476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705737|NCT01750476|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6705738|NCT01750476|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6705739|NCT01750476|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6705740|NCT01750476|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6705741|NCT01750476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6705742|NCT01750476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6705743|NCT01750476|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6705744|NCT01750541|Valproic Acid|valproic acid|mesh-list
6705745|NCT01750541|Haloperidol|haloperidol|mesh-list
6705746|NCT01750541|Haloperidol decanoate|haloperidol decanoate|mesh-list
6705747|NCT01750541|Antiemetics|antiemetics|mesh-ancestor
6705748|NCT01750541|Autonomic Agents|autonomic agents|mesh-ancestor
6705749|NCT01750541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6705750|NCT01750541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705751|NCT01750541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6705752|NCT01750541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6705753|NCT01750541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6705754|NCT01750541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6705755|NCT01750541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6705756|NCT01750541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6705757|NCT01750541|Dopamine Agents|dopamine agents|mesh-ancestor
6705758|NCT01750541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6705759|NCT01750541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705760|NCT01750541|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6705761|NCT01750541|Anticonvulsants|anticonvulsants|mesh-ancestor
6705762|NCT01750541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6705763|NCT01750541|GABA Agents|gaba agents|mesh-ancestor
6705764|NCT01750541|Antimanic Agents|antimanic agents|mesh-ancestor
6705765|NCT01750580|Ipilimumab|ipilimumab|mesh-list
6705766|NCT01750580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6705767|NCT01750580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6705768|NCT01750580|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6705769|NCT01750580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705770|NCT01750645|Botulinum Toxins|botulinum toxins|mesh-list
6705771|NCT01750645|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6705772|NCT01750645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6705773|NCT01750645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705774|NCT01750645|Cholinergic Agents|cholinergic agents|mesh-ancestor
6705775|NCT01750645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6705776|NCT01750645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705777|NCT01750723|Acetazolamide|acetazolamide|mesh-list
6705778|NCT01750723|Anticonvulsants|anticonvulsants|mesh-ancestor
6705779|NCT01750723|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6705780|NCT01750723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6705781|NCT01750723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705782|NCT01750723|Diuretics|diuretics|mesh-ancestor
6705783|NCT01750723|Natriuretic Agents|natriuretic agents|mesh-ancestor
6705784|NCT01750723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705785|NCT01750762|Lenalidomide|lenalidomide|mesh-list
6705786|NCT01750762|Immunologic Factors|immunologic factors|mesh-ancestor
6705787|NCT01750762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705788|NCT01750762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6705789|NCT01750762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6705790|NCT01750762|Growth Substances|growth substances|mesh-ancestor
6705791|NCT01750762|Growth Inhibitors|growth inhibitors|mesh-ancestor
6705792|NCT01750762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6705793|NCT01750788|Rivaroxaban|rivaroxaban|mesh-list
6705794|NCT01750788|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6705795|NCT01750788|Antithrombins|antithrombins|mesh-ancestor
6705796|NCT01750788|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6705797|NCT01750788|Protease Inhibitors|protease inhibitors|mesh-ancestor
6705798|NCT01750788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6705799|NCT01750788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705800|NCT01750788|Anticoagulants|anticoagulants|mesh-ancestor
6705801|NCT01750801|Chlorhexidine|chlorhexidine|mesh-list
6705802|NCT01750801|Propolis|propolis|mesh-list
6705803|NCT01750801|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6705804|NCT01750801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6705805|NCT01750801|Disinfectants|disinfectants|mesh-ancestor
6705806|NCT01750866|Prednisone|prednisone|mesh-list
6705807|NCT01750866|Sargramostim|sargramostim|mesh-list
6705808|NCT01750866|Lenograstim|lenograstim|mesh-list
6705809|NCT01750866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6705810|NCT01750866|Glucocorticoids|glucocorticoids|mesh-ancestor
6705811|NCT01750866|Hormones|hormones|mesh-ancestor
6705812|NCT01750866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6705813|NCT01750866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705814|NCT01750866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6705815|NCT01750866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6705816|NCT01750866|Immunologic Factors|immunologic factors|mesh-ancestor
6705817|NCT01750866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6705818|NCT01750983|Lenalidomide|lenalidomide|mesh-list
6705819|NCT01750983|Ipilimumab|ipilimumab|mesh-list
6705820|NCT01750983|Immunologic Factors|immunologic factors|mesh-ancestor
6705821|NCT01750983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705822|NCT01750983|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6705823|NCT01750983|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6705824|NCT01750983|Growth Substances|growth substances|mesh-ancestor
6705825|NCT01750983|Growth Inhibitors|growth inhibitors|mesh-ancestor
6705826|NCT01750983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6705827|NCT01750983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6705828|NCT01750983|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6705829|NCT01750983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705830|NCT01751009|Vitamins|vitamins|mesh-list
6705831|NCT01751009|Vitamin A|vitamin a|mesh-list
6705832|NCT01751009|Retinol palmitate|retinol palmitate|mesh-list
6705833|NCT01751009|Micronutrients|micronutrients|mesh-ancestor
6705834|NCT01751009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705835|NCT01751009|Antioxidants|antioxidants|mesh-ancestor
6705836|NCT01751009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705837|NCT01751009|Protective Agents|protective agents|mesh-ancestor
6705838|NCT01751009|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6705839|NCT01751009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6705840|NCT01751074|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6705841|NCT01751074|Darapladib|darapladib|mesh-list
6705842|NCT01751074|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6705843|NCT01751074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6705844|NCT01751074|Antimetabolites|antimetabolites|mesh-ancestor
6705845|NCT01751074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705846|NCT01751074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6705847|NCT01751074|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6705848|NCT01751074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6705849|NCT01751074|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
6705850|NCT01751126|Cyclosporine|cyclosporine|mesh-list
6705851|NCT01751126|Cyclosporins|cyclosporins|mesh-list
6705852|NCT01751126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6705853|NCT01751126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705854|NCT01751126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6705855|NCT01751126|Immunologic Factors|immunologic factors|mesh-ancestor
6705856|NCT01751126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705857|NCT01751126|Antifungal Agents|antifungal agents|mesh-ancestor
6705858|NCT01751126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6705859|NCT01751126|Dermatologic Agents|dermatologic agents|mesh-ancestor
6705860|NCT01751126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6705861|NCT01751126|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6705862|NCT01751204|Calcium, Dietary|calcium, dietary|mesh-list
6705863|NCT01751204|Calcium|calcium|mesh-list
6705864|NCT01751204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6705865|NCT01751204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705866|NCT01751204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6705867|NCT01751269|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
6705868|NCT01751269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6705869|NCT01751269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705870|NCT01751269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6705871|NCT01751269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6705872|NCT01751295|Atorvastatin|atorvastatin|mesh-list
6705873|NCT01751295|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6705874|NCT01751295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6705875|NCT01751295|Antimetabolites|antimetabolites|mesh-ancestor
6705876|NCT01751295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705877|NCT01751295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6705878|NCT01751295|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6705879|NCT01751295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6705880|NCT01751321|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6705881|NCT01751321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6705882|NCT01751321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705883|NCT01751321|Incretins|incretins|mesh-ancestor
6705884|NCT01751321|Hormones|hormones|mesh-ancestor
6705885|NCT01751321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6705886|NCT01751321|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6705887|NCT01751321|Protease Inhibitors|protease inhibitors|mesh-ancestor
6705888|NCT01751321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6705889|NCT01751321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705890|NCT01751347|Lidocaine|lidocaine|mesh-list
6705891|NCT01751347|Bupivacaine|bupivacaine|mesh-list
6705892|NCT01751347|Anesthetics, Local|anesthetics, local|mesh-ancestor
6705893|NCT01751347|Anesthetics|anesthetics|mesh-ancestor
6705894|NCT01751347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6705895|NCT01751347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705896|NCT01751347|Sensory System Agents|sensory system agents|mesh-ancestor
6705897|NCT01751347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6705898|NCT01751347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6705899|NCT01751347|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6705900|NCT01751347|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6705901|NCT01751347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6705902|NCT01751347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705903|NCT01751373|Botulinum Toxins|botulinum toxins|mesh-list
6705904|NCT01751373|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6705905|NCT01751373|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6705906|NCT01751373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6705907|NCT01751373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705908|NCT01751373|Cholinergic Agents|cholinergic agents|mesh-ancestor
6705909|NCT01751373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6705910|NCT01751373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705911|NCT01751373|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6705912|NCT01751373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6705913|NCT01751425|Imatinib Mesylate|imatinib mesylate|mesh-list
6705914|NCT01751425|Dasatinib|dasatinib|mesh-list
6705915|NCT01751425|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
6705916|NCT01751425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6705917|NCT01751425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6705918|NCT01751425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6705919|NCT01751425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782310|NCT02190318|Natriuretic Agents|natriuretic agents|mesh-ancestor
6782311|NCT02190357|Rifaximin|rifaximin|mesh-list
6782312|NCT02190357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6782313|NCT02190357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6782314|NCT02190357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6782315|NCT02190526|Mesalamine|mesalamine|mesh-list
6782316|NCT02190526|Amitriptyline|amitriptyline|mesh-list
6782317|NCT02190526|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6782318|NCT02190526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6782319|NCT02190526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6782320|NCT02190526|Analgesics|analgesics|mesh-ancestor
6782321|NCT02190526|Sensory System Agents|sensory system agents|mesh-ancestor
6782322|NCT02190526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6782323|NCT02190526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782324|NCT02190526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6782325|NCT02190526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6782326|NCT02190526|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6782327|NCT02190526|Antidepressive Agents|antidepressive agents|mesh-ancestor
6782328|NCT02190526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6782329|NCT02190526|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6782330|NCT02190526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6782331|NCT02190526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6782332|NCT02190526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782333|NCT02190526|Adrenergic Agents|adrenergic agents|mesh-ancestor
6782334|NCT02190526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6782335|NCT02190526|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6782336|NCT02190526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6782337|NCT02190526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6705920|NCT01751763|Sorafenib|sorafenib|mesh-list
6705921|NCT01751763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6705922|NCT01751763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6705923|NCT01751763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6705924|NCT01751763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705925|NCT01751828|Sertraline|sertraline|mesh-list
6705926|NCT01751828|Antidepressive Agents|antidepressive agents|mesh-ancestor
6705927|NCT01751828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6705928|NCT01751828|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6705929|NCT01751828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6705930|NCT01751828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6705931|NCT01751828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705932|NCT01751828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6705933|NCT01751828|Serotonin Agents|serotonin agents|mesh-ancestor
6705934|NCT01751828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705935|NCT01751854|Citalopram|citalopram|mesh-list
6705936|NCT01751854|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6705937|NCT01751854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6705938|NCT01751854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6705939|NCT01751854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705940|NCT01751854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6705941|NCT01751854|Serotonin Agents|serotonin agents|mesh-ancestor
6705942|NCT01751854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705943|NCT01751854|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6705944|NCT01751854|Antidepressive Agents|antidepressive agents|mesh-ancestor
6705945|NCT01751854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6705946|NCT01751919|Imatinib Mesylate|imatinib mesylate|mesh-list
6705947|NCT01751919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6705948|NCT01751919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6705949|NCT01751919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6705950|NCT01751919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705951|NCT01752010|Immunologic Factors|immunologic factors|mesh-list
6705952|NCT01752010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705953|NCT01752075|Lenalidomide|lenalidomide|mesh-list
6705954|NCT01752075|Immunologic Factors|immunologic factors|mesh-ancestor
6705955|NCT01752075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705956|NCT01752075|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6705957|NCT01752075|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6705958|NCT01752075|Growth Substances|growth substances|mesh-ancestor
6705959|NCT01752075|Growth Inhibitors|growth inhibitors|mesh-ancestor
6705960|NCT01752075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6705961|NCT01752153|Silymarin|silymarin|mesh-list
6705962|NCT01752153|Deferoxamine|deferoxamine|mesh-list
6705963|NCT01752153|Antioxidants|antioxidants|mesh-ancestor
6705964|NCT01752153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705965|NCT01752153|Protective Agents|protective agents|mesh-ancestor
6705966|NCT01752153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705967|NCT01752153|Siderophores|siderophores|mesh-ancestor
6705968|NCT01752153|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6705969|NCT01752153|Chelating Agents|chelating agents|mesh-ancestor
6705970|NCT01752153|Sequestering Agents|sequestering agents|mesh-ancestor
6705971|NCT01752205|Paclitaxel|paclitaxel|mesh-list
6705972|NCT01752205|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6705973|NCT01752205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6705974|NCT01752205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6705975|NCT01752205|Tubulin Modulators|tubulin modulators|mesh-ancestor
6705976|NCT01752205|Antimitotic Agents|antimitotic agents|mesh-ancestor
6705977|NCT01752205|Mitosis Modulators|mitosis modulators|mesh-ancestor
6705978|NCT01752205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6705979|NCT01752205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6705980|NCT01752205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6705981|NCT01752244|Alfacalcidol|alfacalcidol|mesh-list
6705982|NCT01752244|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
6705983|NCT01752244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6705984|NCT01752244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705985|NCT01752244|Vitamins|vitamins|mesh-ancestor
6705986|NCT01752244|Micronutrients|micronutrients|mesh-ancestor
6705987|NCT01752270|Cyproterone Acetate|cyproterone acetate|mesh-list
6705988|NCT01752270|Cyproterone|cyproterone|mesh-list
6705989|NCT01752270|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
6705990|NCT01752270|Androgen Antagonists|androgen antagonists|mesh-ancestor
6705991|NCT01752270|Hormone Antagonists|hormone antagonists|mesh-ancestor
6705992|NCT01752270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6705993|NCT01752270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6705994|NCT01752270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6705995|NCT01752270|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6705996|NCT01752270|Contraceptive Agents|contraceptive agents|mesh-ancestor
6705997|NCT01752270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6705998|NCT01752322|Lidocaine|lidocaine|mesh-list
6705999|NCT01752322|Anesthetics, Local|anesthetics, local|mesh-ancestor
6706000|NCT01752322|Anesthetics|anesthetics|mesh-ancestor
6706001|NCT01752322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6706002|NCT01752322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706003|NCT01752322|Sensory System Agents|sensory system agents|mesh-ancestor
6706004|NCT01752322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6706005|NCT01752322|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6706006|NCT01752322|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6706007|NCT01752322|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6706008|NCT01752322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6706009|NCT01752322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6706010|NCT01752517|Vinorelbine|vinorelbine|mesh-list
6706011|NCT01752517|Ifosfamide|ifosfamide|mesh-list
6706012|NCT01752517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6706013|NCT01752517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6706014|NCT01752517|Tubulin Modulators|tubulin modulators|mesh-ancestor
6706015|NCT01752517|Antimitotic Agents|antimitotic agents|mesh-ancestor
6706016|NCT01752517|Mitosis Modulators|mitosis modulators|mesh-ancestor
6706017|NCT01752517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6706018|NCT01752517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6706019|NCT01752517|Alkylating Agents|alkylating agents|mesh-ancestor
6706020|NCT01752543|Conivaptan|conivaptan|mesh-list
6706021|NCT01752543|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6706022|NCT01752543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6706023|NCT01752543|Natriuretic Agents|natriuretic agents|mesh-ancestor
6706024|NCT01752543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706025|NCT01752686|Carboplatin|carboplatin|mesh-list
6706026|NCT01752686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6706027|NCT01752699|Methadone|methadone|mesh-list
6706028|NCT01752699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6706029|NCT01752699|Narcotics|narcotics|mesh-ancestor
6706030|NCT01752699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6706031|NCT01752699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706032|NCT01752699|Analgesics|analgesics|mesh-ancestor
6706033|NCT01752699|Sensory System Agents|sensory system agents|mesh-ancestor
6706034|NCT01752699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6706035|NCT01752699|Antitussive Agents|antitussive agents|mesh-ancestor
6706036|NCT01752699|Respiratory System Agents|respiratory system agents|mesh-ancestor
6706037|NCT01752790|Azathioprine|azathioprine|mesh-list
6706038|NCT01752790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6706039|NCT01752790|Antimetabolites|antimetabolites|mesh-ancestor
6706040|NCT01752790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6706041|NCT01752790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6706042|NCT01752790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6706043|NCT01752790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6706044|NCT01752790|Immunologic Factors|immunologic factors|mesh-ancestor
6706045|NCT01752790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706046|NCT01752881|Vaccines|vaccines|mesh-list
6706047|NCT01752881|Immunologic Factors|immunologic factors|mesh-ancestor
6706048|NCT01752881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706049|NCT01752959|Remifentanil|remifentanil|mesh-list
6706050|NCT01752959|Esmolol|esmolol|mesh-list
6706051|NCT01752959|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6706052|NCT01752959|Narcotics|narcotics|mesh-ancestor
6706053|NCT01752959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6706054|NCT01752959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706055|NCT01752959|Analgesics|analgesics|mesh-ancestor
6706056|NCT01752959|Sensory System Agents|sensory system agents|mesh-ancestor
6706057|NCT01752959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6706058|NCT01752959|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6706059|NCT01752959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6706060|NCT01752959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6706061|NCT01752959|Adrenergic Agents|adrenergic agents|mesh-ancestor
6706062|NCT01752959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6706063|NCT01752959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6706064|NCT01752998|Analgesics, Opioid|analgesics, opioid|mesh-list
6706065|NCT01752998|Narcotics|narcotics|mesh-ancestor
6706066|NCT01752998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6706067|NCT01752998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706068|NCT01752998|Analgesics|analgesics|mesh-ancestor
6706069|NCT01752998|Sensory System Agents|sensory system agents|mesh-ancestor
6706070|NCT01752998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6706071|NCT01753037|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
6706072|NCT01753037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6706073|NCT01753037|Immunologic Factors|immunologic factors|mesh-ancestor
6706074|NCT01753037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706075|NCT01753102|Estradiol|estradiol|mesh-list
6706076|NCT01753102|Estrogens|estrogens|mesh-ancestor
6706077|NCT01753102|Hormones|hormones|mesh-ancestor
6706078|NCT01753102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6706079|NCT01753102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706080|NCT01753128|Imipramine|imipramine|mesh-list
6706081|NCT01753128|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6706082|NCT01753128|Antidepressive Agents|antidepressive agents|mesh-ancestor
6706083|NCT01753128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6706084|NCT01753128|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6706085|NCT01753128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6706086|NCT01753128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6706087|NCT01753128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6706088|NCT01753128|Adrenergic Agents|adrenergic agents|mesh-ancestor
6706089|NCT01753128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6706090|NCT01753128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706091|NCT01753154|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6782338|NCT02190695|Carboplatin|carboplatin|mesh-list
6782339|NCT02190695|Decitabine|decitabine|mesh-list
6782340|NCT02190695|Arsenic Trioxide|arsenic trioxide|mesh-list
6782341|NCT02190695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6782342|NCT02190695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6782343|NCT02190695|Antimetabolites|antimetabolites|mesh-ancestor
6782344|NCT02190695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782345|NCT02190695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6782346|NCT02190708|Midazolam|midazolam|mesh-list
6782347|NCT02190708|Omeprazole|omeprazole|mesh-list
6782348|NCT02190708|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
6782349|NCT02190708|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6782350|NCT02190708|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6782351|NCT02190708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6782352|NCT02190708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782353|NCT02190708|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6782354|NCT02190708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6782355|NCT02190708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6782356|NCT02190708|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6782357|NCT02190708|Anesthetics, General|anesthetics, general|mesh-ancestor
6782358|NCT02190708|Anesthetics|anesthetics|mesh-ancestor
6782359|NCT02190708|GABA Modulators|gaba modulators|mesh-ancestor
6782360|NCT02190708|GABA Agents|gaba agents|mesh-ancestor
6782361|NCT02190708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6782362|NCT02190708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782363|NCT02190708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6782364|NCT02190708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6782365|NCT02190708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6782366|NCT02190760|Dexamethasone|dexamethasone|mesh-list
6782367|NCT02190760|Bupivacaine|bupivacaine|mesh-list
6782368|NCT02190760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6782369|NCT02190760|Antiemetics|antiemetics|mesh-ancestor
6782370|NCT02190760|Autonomic Agents|autonomic agents|mesh-ancestor
6782371|NCT02190760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6782372|NCT02190760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782373|NCT02190760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6782374|NCT02190760|Glucocorticoids|glucocorticoids|mesh-ancestor
6782375|NCT02190760|Hormones|hormones|mesh-ancestor
6782376|NCT02190760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6782377|NCT02190760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6782378|NCT02190760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6782379|NCT02190760|Anesthetics, Local|anesthetics, local|mesh-ancestor
6782380|NCT02190760|Anesthetics|anesthetics|mesh-ancestor
6782381|NCT02190760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6782382|NCT02190760|Sensory System Agents|sensory system agents|mesh-ancestor
6782383|NCT02190838|Metformin|metformin|mesh-list
6782384|NCT02190838|Dacarbazine|dacarbazine|mesh-list
6782385|NCT02190838|Melatonin|melatonin|mesh-list
6782386|NCT02190838|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6782387|NCT02190838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782388|NCT02190838|Antioxidants|antioxidants|mesh-ancestor
6706092|NCT01753349|Botulinum Toxins|botulinum toxins|mesh-list
6706093|NCT01753349|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6706094|NCT01753349|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6706095|NCT01753349|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6706096|NCT01753349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6706097|NCT01753349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6706098|NCT01753349|Cholinergic Agents|cholinergic agents|mesh-ancestor
6706099|NCT01753349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6706100|NCT01753349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706101|NCT01753349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6706102|NCT01753349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6706103|NCT01753375|Vitamin D|vitamin d|mesh-list
6706104|NCT01753375|Cholecalciferol|cholecalciferol|mesh-list
6706105|NCT01753375|Vitamins|vitamins|mesh-ancestor
6706106|NCT01753375|Micronutrients|micronutrients|mesh-ancestor
6706107|NCT01753375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706108|NCT01753375|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6706109|NCT01753375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6706110|NCT01753453|Plerixafor|plerixafor|mesh-list
6706111|NCT01753453|Sargramostim|sargramostim|mesh-list
6706112|NCT01753453|Lenograstim|lenograstim|mesh-list
6706113|NCT01753453|Immunologic Factors|immunologic factors|mesh-ancestor
6706114|NCT01753453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706115|NCT01753453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6706116|NCT01753453|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6706117|NCT01753453|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6706118|NCT01753453|Antiviral Agents|antiviral agents|mesh-ancestor
6706119|NCT01753453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6706120|NCT01753596|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6706121|NCT01753596|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6706122|NCT01753752|Acetylcysteine|acetylcysteine|mesh-list
6706123|NCT01753752|Chitosan|chitosan|mesh-list
6706124|NCT01753752|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6706125|NCT01753752|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6706126|NCT01753752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6706127|NCT01753752|Antiviral Agents|antiviral agents|mesh-ancestor
6706128|NCT01753752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6706129|NCT01753752|Expectorants|expectorants|mesh-ancestor
6706130|NCT01753752|Respiratory System Agents|respiratory system agents|mesh-ancestor
6706131|NCT01753752|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6706132|NCT01753752|Antioxidants|antioxidants|mesh-ancestor
6706133|NCT01753752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6706134|NCT01753752|Protective Agents|protective agents|mesh-ancestor
6706135|NCT01753752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706136|NCT01753752|Antidotes|antidotes|mesh-ancestor
6706137|NCT01753752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6706138|NCT01753752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6706139|NCT01753752|Antimetabolites|antimetabolites|mesh-ancestor
6706140|NCT01753752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6706141|NCT01753752|Chelating Agents|chelating agents|mesh-ancestor
6706142|NCT01753752|Sequestering Agents|sequestering agents|mesh-ancestor
6706143|NCT01753752|Hemostatics|hemostatics|mesh-ancestor
6706144|NCT01753752|Coagulants|coagulants|mesh-ancestor
6706145|NCT01753882|Citalopram|citalopram|mesh-list
6706146|NCT01753882|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6706147|NCT01753882|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6706148|NCT01753882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6706149|NCT01753882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6706150|NCT01753882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6706151|NCT01753882|Serotonin Agents|serotonin agents|mesh-ancestor
6706152|NCT01753882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706153|NCT01753882|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6706154|NCT01753882|Antidepressive Agents|antidepressive agents|mesh-ancestor
6706155|NCT01753882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6706156|NCT01754116|Cabotegravir|cabotegravir|mesh-list
6706157|NCT01754116|Midazolam|midazolam|mesh-list
6706158|NCT01754116|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6706159|NCT01754116|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6706160|NCT01754116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6706161|NCT01754116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706162|NCT01754116|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6706163|NCT01754116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6706164|NCT01754116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6706165|NCT01754116|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6706166|NCT01754116|Anesthetics, General|anesthetics, general|mesh-ancestor
6706167|NCT01754116|Anesthetics|anesthetics|mesh-ancestor
6706168|NCT01754116|GABA Modulators|gaba modulators|mesh-ancestor
6706169|NCT01754116|GABA Agents|gaba agents|mesh-ancestor
6706170|NCT01754116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6706171|NCT01754116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6706172|NCT01754116|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6706173|NCT01754116|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6706174|NCT01754116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6706175|NCT01754116|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6706176|NCT01754116|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6706177|NCT01754116|Antiviral Agents|antiviral agents|mesh-ancestor
6706178|NCT01754116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6706179|NCT01754181|Insulin|insulin|mesh-list
6706180|NCT01754181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6706181|NCT01754181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706182|NCT01754220|Montelukast|montelukast|mesh-list
6706183|NCT01754220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6706184|NCT01754220|Respiratory System Agents|respiratory system agents|mesh-ancestor
6706185|NCT01754220|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6706186|NCT01754220|Hormone Antagonists|hormone antagonists|mesh-ancestor
6706187|NCT01754220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6706188|NCT01754220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706189|NCT01754220|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6706190|NCT01754220|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6706191|NCT01754220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6706192|NCT01754285|Octreotide|octreotide|mesh-list
6706193|NCT01754285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6706194|NCT01754285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6706195|NCT01754285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6706196|NCT01754324|Methadone|methadone|mesh-list
6706197|NCT01754324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6706198|NCT01754324|Narcotics|narcotics|mesh-ancestor
6706199|NCT01754324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6706200|NCT01754324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706201|NCT01754324|Analgesics|analgesics|mesh-ancestor
6706202|NCT01754324|Sensory System Agents|sensory system agents|mesh-ancestor
6706203|NCT01754324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6706204|NCT01754324|Antitussive Agents|antitussive agents|mesh-ancestor
6706205|NCT01754324|Respiratory System Agents|respiratory system agents|mesh-ancestor
6706206|NCT01754649|Misoprostol|misoprostol|mesh-list
6706207|NCT01754649|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6706208|NCT01754649|Abortifacient Agents|abortifacient agents|mesh-ancestor
6706209|NCT01754649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6706210|NCT01754649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706211|NCT01754649|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6706212|NCT01754649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6706213|NCT01754649|Oxytocics|oxytocics|mesh-ancestor
6706214|NCT01754701|Iron|iron|mesh-list
6706215|NCT01754701|Trace Elements|trace elements|mesh-ancestor
6706216|NCT01754701|Micronutrients|micronutrients|mesh-ancestor
6706217|NCT01754701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706218|NCT01754792|Inositol|inositol|mesh-list
6706219|NCT01754792|Vitamin B Complex|vitamin b complex|mesh-ancestor
6706220|NCT01754792|Vitamins|vitamins|mesh-ancestor
6706221|NCT01754792|Micronutrients|micronutrients|mesh-ancestor
6706222|NCT01754792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706223|NCT01754805|Methotrexate|methotrexate|mesh-list
6706224|NCT01754805|Peficitinib|peficitinib|mesh-list
6706225|NCT01754805|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6706226|NCT01754805|Abortifacient Agents|abortifacient agents|mesh-ancestor
6706227|NCT01754805|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6706228|NCT01754805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706229|NCT01754805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6706230|NCT01754805|Antimetabolites|antimetabolites|mesh-ancestor
6706231|NCT01754805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6706232|NCT01754805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6706233|NCT01754805|Dermatologic Agents|dermatologic agents|mesh-ancestor
6706234|NCT01754805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6706235|NCT01754805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6706236|NCT01754805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6706237|NCT01754805|Immunologic Factors|immunologic factors|mesh-ancestor
6706238|NCT01754805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6706239|NCT01754805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6706240|NCT01754831|Fluorides|fluorides|mesh-list
6706241|NCT01754831|Fluorides, Topical|fluorides, topical|mesh-list
6706242|NCT01754831|Cariostatic Agents|cariostatic agents|mesh-ancestor
6706243|NCT01754831|Protective Agents|protective agents|mesh-ancestor
6706244|NCT01754831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706245|NCT01754844|AZD7624|azd7624|mesh-list
6706246|NCT01754844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6706247|NCT01754844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6706248|NCT01754844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6706249|NCT01754857|Rituximab|rituximab|mesh-list
6706250|NCT01754857|Lenalidomide|lenalidomide|mesh-list
6706251|NCT01754857|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6706252|NCT01754857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6706253|NCT01754857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6706254|NCT01754857|Immunologic Factors|immunologic factors|mesh-ancestor
6706255|NCT01754857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706256|NCT01754857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6706257|NCT01754857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6706258|NCT01754857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6706259|NCT01754857|Growth Substances|growth substances|mesh-ancestor
6706260|NCT01754857|Growth Inhibitors|growth inhibitors|mesh-ancestor
6706261|NCT01754857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6706262|NCT01754857|Alkylating Agents|alkylating agents|mesh-ancestor
6706263|NCT01754857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6706264|NCT01754870|Rituximab|rituximab|mesh-list
6706265|NCT01754870|Lenalidomide|lenalidomide|mesh-list
6706266|NCT01754870|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6706267|NCT01754870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6706268|NCT01754870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6706269|NCT01754870|Immunologic Factors|immunologic factors|mesh-ancestor
6706270|NCT01754870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706271|NCT01754870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6706272|NCT01754870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6706273|NCT01754870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6706274|NCT01754870|Growth Substances|growth substances|mesh-ancestor
6706275|NCT01754870|Growth Inhibitors|growth inhibitors|mesh-ancestor
6706276|NCT01754870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6706277|NCT01754870|Alkylating Agents|alkylating agents|mesh-ancestor
6706278|NCT01754870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6706279|NCT01754883|Lithium Carbonate|lithium carbonate|mesh-list
6706280|NCT01754883|Antidepressive Agents|antidepressive agents|mesh-ancestor
6706281|NCT01754883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6706282|NCT01754883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6706283|NCT01754883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6706284|NCT01754883|Antimanic Agents|antimanic agents|mesh-ancestor
6706285|NCT01754883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6706286|NCT01754883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6706287|NCT01754883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706288|NCT01754961|Vitamin D|vitamin d|mesh-list
6706289|NCT01754961|Ergocalciferols|ergocalciferols|mesh-list
6706290|NCT01754961|Vitamins|vitamins|mesh-list
6706291|NCT01754961|Micronutrients|micronutrients|mesh-ancestor
6706292|NCT01754961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706293|NCT01754961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6706294|NCT01754961|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6706295|NCT01754974|Ribavirin|ribavirin|mesh-list
6706296|NCT01754974|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6706297|NCT01754974|Antimetabolites|antimetabolites|mesh-ancestor
6706298|NCT01754974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6706299|NCT01754974|Antiviral Agents|antiviral agents|mesh-ancestor
6706300|NCT01754974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6782389|NCT02190838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782390|NCT02190838|Protective Agents|protective agents|mesh-ancestor
6782391|NCT02190838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6782392|NCT02190838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6782393|NCT02190838|Alkylating Agents|alkylating agents|mesh-ancestor
6782394|NCT02190838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6782395|NCT02190994|Prednisone|prednisone|mesh-list
6782396|NCT02190994|Hydrocortisone|hydrocortisone|mesh-list
6782397|NCT02190994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6782398|NCT02190994|Glucocorticoids|glucocorticoids|mesh-ancestor
6782399|NCT02190994|Hormones|hormones|mesh-ancestor
6782400|NCT02190994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6782401|NCT02190994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782402|NCT02190994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6782403|NCT02190994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6782404|NCT02191007|Calcitriol|calcitriol|mesh-list
6782405|NCT02191007|Betamethasone|betamethasone|mesh-list
6706301|NCT01755078|Calcium, Dietary|calcium, dietary|mesh-list
6706302|NCT01755078|Calcium Carbonate|calcium carbonate|mesh-list
6706303|NCT01755078|Calcium|calcium|mesh-list
6706304|NCT01755078|Sevelamer|sevelamer|mesh-list
6706305|NCT01755078|Calcium acetate|calcium acetate|mesh-list
6706306|NCT01755078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6706307|NCT01755078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706308|NCT01755078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6706309|NCT01755078|Antacids|antacids|mesh-ancestor
6706310|NCT01755078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6706311|NCT01755078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6706312|NCT01755078|Chelating Agents|chelating agents|mesh-ancestor
6706313|NCT01755078|Sequestering Agents|sequestering agents|mesh-ancestor
6706314|NCT01755117|Ropivacaine|ropivacaine|mesh-list
6706315|NCT01755117|Anesthetics, Local|anesthetics, local|mesh-ancestor
6706316|NCT01755117|Anesthetics|anesthetics|mesh-ancestor
6706317|NCT01755117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6706318|NCT01755117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706319|NCT01755117|Sensory System Agents|sensory system agents|mesh-ancestor
6706320|NCT01755117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6706321|NCT01755182|Somatostatin|somatostatin|mesh-list
6706322|NCT01755182|Hormones|hormones|mesh-ancestor
6706323|NCT01755182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6706324|NCT01755182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706325|NCT01755286|Ciprofloxacin|ciprofloxacin|mesh-list
6706326|NCT01755286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6706327|NCT01755286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6706328|NCT01755286|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6706329|NCT01755286|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6706330|NCT01755286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6706331|NCT01755286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6706332|NCT01755286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6706333|NCT01755286|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6706334|NCT01755286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6706335|NCT01755299|Caffeine|caffeine|mesh-list
6706336|NCT01755299|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6706337|NCT01755299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706338|NCT01755299|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6706339|NCT01755299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6706340|NCT01755299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6706341|NCT01755299|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6706342|NCT01755299|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6706343|NCT01755299|Purinergic Agents|purinergic agents|mesh-ancestor
6706344|NCT01755299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6706345|NCT01755338|Methylprednisolone|methylprednisolone|mesh-list
6706346|NCT01755338|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6706347|NCT01755338|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6706348|NCT01755338|Prednisolone|prednisolone|mesh-list
6706349|NCT01755338|Prednisolone acetate|prednisolone acetate|mesh-list
6706350|NCT01755338|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6706351|NCT01755338|Prednisolone phosphate|prednisolone phosphate|mesh-list
6706352|NCT01755338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6706353|NCT01755338|Antiemetics|antiemetics|mesh-ancestor
6706354|NCT01755338|Autonomic Agents|autonomic agents|mesh-ancestor
6706355|NCT01755338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6706356|NCT01755338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706357|NCT01755338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6706358|NCT01755338|Glucocorticoids|glucocorticoids|mesh-ancestor
6706359|NCT01755338|Hormones|hormones|mesh-ancestor
6706360|NCT01755338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6706361|NCT01755338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6706362|NCT01755338|Protective Agents|protective agents|mesh-ancestor
6706363|NCT01755338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6706364|NCT01755338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6706365|NCT01755377|Benzonidazole|benzonidazole|mesh-list
6706366|NCT01755377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6706367|NCT01755377|Immunologic Factors|immunologic factors|mesh-ancestor
6706368|NCT01755377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706369|NCT01755377|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6706370|NCT01755377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6706371|NCT01755377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6706372|NCT01755377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6706373|NCT01755403|Benzonidazole|benzonidazole|mesh-list
6706374|NCT01755403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6706375|NCT01755403|Immunologic Factors|immunologic factors|mesh-ancestor
6706376|NCT01755403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706377|NCT01755403|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6706378|NCT01755403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6706379|NCT01755403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6706380|NCT01755403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6706381|NCT01755468|Insulin|insulin|mesh-list
6706382|NCT01755468|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6706383|NCT01755468|Metformin|metformin|mesh-list
6706384|NCT01755468|Insulin Glargine|insulin glargine|mesh-list
6706385|NCT01755468|Insulin Lispro|insulin lispro|mesh-list
6706386|NCT01755468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6706387|NCT01755468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706388|NCT01755494|Metformin|metformin|mesh-list
6706389|NCT01755494|Saxagliptin|saxagliptin|mesh-list
6706390|NCT01755494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6706391|NCT01755494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706392|NCT01755494|Incretins|incretins|mesh-ancestor
6706393|NCT01755494|Hormones|hormones|mesh-ancestor
6706394|NCT01755494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6706395|NCT01755494|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6706396|NCT01755494|Protease Inhibitors|protease inhibitors|mesh-ancestor
6706397|NCT01755494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6706398|NCT01755494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6706399|NCT01755520|Aspirin|aspirin|mesh-list
6706400|NCT01755520|Ticagrelor|ticagrelor|mesh-list
6706401|NCT01755520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6706402|NCT01755520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6706403|NCT01755520|Analgesics|analgesics|mesh-ancestor
6706404|NCT01755520|Sensory System Agents|sensory system agents|mesh-ancestor
6706405|NCT01755520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6706406|NCT01755520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706407|NCT01755520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6706408|NCT01755520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6706409|NCT01755520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6706410|NCT01755520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6706411|NCT01755520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6706412|NCT01755520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6706413|NCT01755520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6706414|NCT01755520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6706415|NCT01755520|Antipyretics|antipyretics|mesh-ancestor
6706416|NCT01755520|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6706417|NCT01755520|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6706418|NCT01755520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6706419|NCT01755520|Purinergic Agents|purinergic agents|mesh-ancestor
6706420|NCT01755520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6706421|NCT01755559|Artesunate|artesunate|mesh-list
6706422|NCT01755559|Lumefantrine|lumefantrine|mesh-list
6706423|NCT01755559|Artemether|artemether|mesh-list
6706424|NCT01755559|Piperaquine|piperaquine|mesh-list
6706425|NCT01755559|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6706426|NCT01755559|Amodiaquine|amodiaquine|mesh-list
6706427|NCT01755559|Artenimol|artenimol|mesh-list
6706428|NCT01755559|Antimalarials|antimalarials|mesh-ancestor
6706429|NCT01755559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6706430|NCT01755559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6706431|NCT01755559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6706432|NCT01755559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6706433|NCT01755559|Antiviral Agents|antiviral agents|mesh-ancestor
6706434|NCT01755559|Schistosomicides|schistosomicides|mesh-ancestor
6706435|NCT01755559|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6706436|NCT01755559|Anthelmintics|anthelmintics|mesh-ancestor
6706437|NCT01755572|Liraglutide|liraglutide|mesh-list
6706438|NCT01755572|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6706439|NCT01755572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706440|NCT01755572|Incretins|incretins|mesh-ancestor
6706441|NCT01755572|Hormones|hormones|mesh-ancestor
6706442|NCT01755572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6706443|NCT01755611|Minocycline|minocycline|mesh-list
6706444|NCT01755611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6706445|NCT01755611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6706446|NCT01755663|Metoprolol|metoprolol|mesh-list
6706447|NCT01755663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6706448|NCT01755663|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6706449|NCT01755663|Sympatholytics|sympatholytics|mesh-ancestor
6706450|NCT01755663|Autonomic Agents|autonomic agents|mesh-ancestor
6706451|NCT01755663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6706452|NCT01755663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706453|NCT01755663|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6706454|NCT01755663|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6706455|NCT01755663|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6706456|NCT01755663|Adrenergic Agents|adrenergic agents|mesh-ancestor
6706457|NCT01755663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6706458|NCT01755663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6706459|NCT01755676|Orlistat|orlistat|mesh-list
6706460|NCT01755676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6706461|NCT01755676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6706462|NCT01755676|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6706463|NCT01755676|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6706464|NCT01755728|Acetaminophen|acetaminophen|mesh-list
6706465|NCT01755728|Ibuprofen|ibuprofen|mesh-list
6706466|NCT01755728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6706467|NCT01755728|Analgesics|analgesics|mesh-ancestor
6706468|NCT01755728|Sensory System Agents|sensory system agents|mesh-ancestor
6706469|NCT01755728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6706470|NCT01755728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706471|NCT01755728|Antipyretics|antipyretics|mesh-ancestor
6706472|NCT01755728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6706473|NCT01755728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6706474|NCT01755728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6706475|NCT01755728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6706476|NCT01755728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6706477|NCT01755728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6706478|NCT01755845|Paclitaxel|paclitaxel|mesh-list
6706479|NCT01755845|Cisplatin|cisplatin|mesh-list
6706480|NCT01755845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6706481|NCT01755845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6706482|NCT01755845|Tubulin Modulators|tubulin modulators|mesh-ancestor
6706483|NCT01755845|Antimitotic Agents|antimitotic agents|mesh-ancestor
6706484|NCT01755845|Mitosis Modulators|mitosis modulators|mesh-ancestor
6706485|NCT01755845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6706486|NCT01755871|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6706487|NCT01755871|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6706488|NCT01755871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6706489|NCT01755871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6706490|NCT01755871|Immunologic Factors|immunologic factors|mesh-ancestor
6706491|NCT01755871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706492|NCT01755897|Paclitaxel|paclitaxel|mesh-list
6706493|NCT01755897|Cisplatin|cisplatin|mesh-list
6706494|NCT01755897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6706495|NCT01755897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6706496|NCT01755897|Tubulin Modulators|tubulin modulators|mesh-ancestor
6706497|NCT01755897|Antimitotic Agents|antimitotic agents|mesh-ancestor
6706498|NCT01755897|Mitosis Modulators|mitosis modulators|mesh-ancestor
6706499|NCT01755897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6706500|NCT01755923|Docetaxel|docetaxel|mesh-list
6706501|NCT01755923|Gefitinib|gefitinib|mesh-list
6706502|NCT01755923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6706503|NCT01755923|Tubulin Modulators|tubulin modulators|mesh-ancestor
6706504|NCT01755923|Antimitotic Agents|antimitotic agents|mesh-ancestor
6706505|NCT01755923|Mitosis Modulators|mitosis modulators|mesh-ancestor
6706506|NCT01755923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6706507|NCT01755923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6706508|NCT01755923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6706509|NCT01756040|Lactulose|lactulose|mesh-list
6706510|NCT01756040|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6706511|NCT01756040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6706512|NCT01756105|Insulin|insulin|mesh-list
6706513|NCT01756105|Metformin|metformin|mesh-list
6706514|NCT01756105|Insulin, Isophane|insulin, isophane|mesh-list
6706515|NCT01756105|Isophane Insulin, Human|isophane insulin, human|mesh-list
6706516|NCT01756105|Isophane insulin, beef|isophane insulin, beef|mesh-list
6706517|NCT01756105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6706518|NCT01756105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706519|NCT01756118|Dactolisib|dactolisib|mesh-list
6706520|NCT01756118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6706521|NCT01756131|Cabotegravir|cabotegravir|mesh-list
6706522|NCT01756131|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6706523|NCT01756131|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6706524|NCT01756131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6706525|NCT01756131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6706526|NCT01756131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6706527|NCT01756131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6706528|NCT01756131|Antiviral Agents|antiviral agents|mesh-ancestor
6706529|NCT01756131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6706530|NCT01756170|Paclitaxel|paclitaxel|mesh-list
6706531|NCT01756170|Cisplatin|cisplatin|mesh-list
6706532|NCT01756170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6706533|NCT01756170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6706534|NCT01756170|Tubulin Modulators|tubulin modulators|mesh-ancestor
6706535|NCT01756170|Antimitotic Agents|antimitotic agents|mesh-ancestor
6706536|NCT01756170|Mitosis Modulators|mitosis modulators|mesh-ancestor
6706537|NCT01756170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6706538|NCT01756183|Paclitaxel|paclitaxel|mesh-list
6706539|NCT01756183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6706540|NCT01756183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6706541|NCT01756183|Tubulin Modulators|tubulin modulators|mesh-ancestor
6706542|NCT01756183|Antimitotic Agents|antimitotic agents|mesh-ancestor
6706543|NCT01756183|Mitosis Modulators|mitosis modulators|mesh-ancestor
6706544|NCT01756183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6706545|NCT01756248|Aflibercept|aflibercept|mesh-list
6706546|NCT01756248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6706547|NCT01756248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6706548|NCT01756248|Growth Substances|growth substances|mesh-ancestor
6706549|NCT01756248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706550|NCT01756248|Growth Inhibitors|growth inhibitors|mesh-ancestor
6706551|NCT01756248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6706552|NCT01756261|Aflibercept|aflibercept|mesh-list
6706553|NCT01756261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6706554|NCT01756261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6706555|NCT01756261|Growth Substances|growth substances|mesh-ancestor
6706556|NCT01756261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706557|NCT01756261|Growth Inhibitors|growth inhibitors|mesh-ancestor
6706558|NCT01756261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6706559|NCT01756404|Canagliflozin|canagliflozin|mesh-list
6706560|NCT01756404|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6706561|NCT01756404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6706562|NCT01756404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6706563|NCT01756404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706564|NCT01756417|Metformin|metformin|mesh-list
6706565|NCT01756417|Canagliflozin|canagliflozin|mesh-list
6706566|NCT01756417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6706567|NCT01756417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706568|NCT01756417|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6706569|NCT01756417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6706570|NCT01756430|Carvedilol|carvedilol|mesh-list
6706571|NCT01756430|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6706572|NCT01756430|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6706573|NCT01756430|Adrenergic Agents|adrenergic agents|mesh-ancestor
6706574|NCT01756430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6706575|NCT01756430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6706576|NCT01756430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706577|NCT01756430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6706578|NCT01756430|Antioxidants|antioxidants|mesh-ancestor
6706579|NCT01756430|Protective Agents|protective agents|mesh-ancestor
6706580|NCT01756430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6706581|NCT01756430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6706582|NCT01756430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6706583|NCT01756430|Vasodilator Agents|vasodilator agents|mesh-ancestor
6706584|NCT01756430|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6706585|NCT01756430|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6706586|NCT01756443|Lidocaine|lidocaine|mesh-list
6706587|NCT01756443|Epinephrine|epinephrine|mesh-list
6706588|NCT01756443|Racepinephrine|racepinephrine|mesh-list
6706589|NCT01756443|Bupivacaine|bupivacaine|mesh-list
6706590|NCT01756443|Epinephryl borate|epinephryl borate|mesh-list
6706591|NCT01756443|Anesthetics, Local|anesthetics, local|mesh-ancestor
6706592|NCT01756443|Anesthetics|anesthetics|mesh-ancestor
6706593|NCT01756443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6706594|NCT01756443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706595|NCT01756443|Sensory System Agents|sensory system agents|mesh-ancestor
6706596|NCT01756443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6706597|NCT01756443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6706598|NCT01756443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6706599|NCT01756443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6706600|NCT01756443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6706601|NCT01756443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6706602|NCT01756443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6706603|NCT01756443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6706604|NCT01756443|Adrenergic Agents|adrenergic agents|mesh-ancestor
6706605|NCT01756443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6706606|NCT01756443|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6706607|NCT01756443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6706608|NCT01756443|Autonomic Agents|autonomic agents|mesh-ancestor
6706609|NCT01756443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6706610|NCT01756443|Respiratory System Agents|respiratory system agents|mesh-ancestor
6706611|NCT01756443|Mydriatics|mydriatics|mesh-ancestor
6706612|NCT01756443|Sympathomimetics|sympathomimetics|mesh-ancestor
6706613|NCT01756443|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6706614|NCT01756495|Moxifloxacin|moxifloxacin|mesh-list
6706615|NCT01756495|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6706616|NCT01756495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6706617|NCT01756495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6706618|NCT01756495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6706619|NCT01756495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6706620|NCT01756495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6706621|NCT01756495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6706622|NCT01756495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6706623|NCT01756495|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6706624|NCT01756495|Contraceptive Agents|contraceptive agents|mesh-ancestor
6706625|NCT01756495|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6706626|NCT01756495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706627|NCT01756495|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6706628|NCT01756495|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6706629|NCT01756495|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6706630|NCT01756508|Eculizumab|eculizumab|mesh-list
6706631|NCT01756508|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6706632|NCT01756508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6706633|NCT01756508|Immunologic Factors|immunologic factors|mesh-ancestor
6706634|NCT01756508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706635|NCT01756521|Moxifloxacin|moxifloxacin|mesh-list
6706636|NCT01756521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6706637|NCT01756521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6706638|NCT01756521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6706639|NCT01756521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6706640|NCT01756521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6706641|NCT01756521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6706642|NCT01756521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6706643|NCT01756547|Potassium Citrate|potassium citrate|mesh-list
6706644|NCT01756547|Diuretics|diuretics|mesh-ancestor
6706645|NCT01756547|Natriuretic Agents|natriuretic agents|mesh-ancestor
6706646|NCT01756547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706647|NCT01756547|Expectorants|expectorants|mesh-ancestor
6706648|NCT01756547|Respiratory System Agents|respiratory system agents|mesh-ancestor
6706649|NCT01756612|Epoetin Alfa|epoetin alfa|mesh-list
6706650|NCT01756612|Hematinics|hematinics|mesh-ancestor
6706651|NCT01756638|Prednisolone|prednisolone|mesh-list
6706652|NCT01756638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6706653|NCT01756638|Glucocorticoids|glucocorticoids|mesh-ancestor
6706654|NCT01756638|Hormones|hormones|mesh-ancestor
6706655|NCT01756638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6706656|NCT01756638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706657|NCT01756638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6706658|NCT01756638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6706659|NCT01756651|Fentanyl|fentanyl|mesh-list
6706660|NCT01756651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6706661|NCT01756651|Narcotics|narcotics|mesh-ancestor
6706662|NCT01756651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6706663|NCT01756651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706664|NCT01756651|Analgesics|analgesics|mesh-ancestor
6706665|NCT01756651|Sensory System Agents|sensory system agents|mesh-ancestor
6706666|NCT01756651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6706667|NCT01756651|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6706668|NCT01756651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6706669|NCT01756651|Anesthetics, General|anesthetics, general|mesh-ancestor
6706670|NCT01756651|Anesthetics|anesthetics|mesh-ancestor
6706671|NCT01756664|Sunscreening Agents|sunscreening agents|mesh-list
6706672|NCT01756664|Petrolatum|petrolatum|mesh-list
6706673|NCT01756664|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6706674|NCT01756664|Protective Agents|protective agents|mesh-ancestor
6706675|NCT01756664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706676|NCT01756664|Dermatologic Agents|dermatologic agents|mesh-ancestor
6706677|NCT01756664|Emollients|emollients|mesh-ancestor
6706678|NCT01756768|Palbociclib|palbociclib|mesh-list
6782406|NCT02191007|Betamethasone Valerate|betamethasone valerate|mesh-list
6706679|NCT01756768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6706680|NCT01756768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6706681|NCT01756768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6706682|NCT01756768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6706683|NCT01756781|Palbociclib|palbociclib|mesh-list
6706684|NCT01756781|Midazolam|midazolam|mesh-list
6706685|NCT01756781|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6706686|NCT01756781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6706687|NCT01756781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6706688|NCT01756781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706689|NCT01756781|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6706690|NCT01756781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6706691|NCT01756781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6706692|NCT01756781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6706693|NCT01756781|Anesthetics, General|anesthetics, general|mesh-ancestor
6706694|NCT01756781|Anesthetics|anesthetics|mesh-ancestor
6706695|NCT01756781|GABA Modulators|gaba modulators|mesh-ancestor
6706696|NCT01756781|GABA Agents|gaba agents|mesh-ancestor
6706697|NCT01756781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6706698|NCT01756781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6706699|NCT01756781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6706700|NCT01756781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6706701|NCT01756781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6782407|NCT02191007|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
6782408|NCT02191007|Betamethasone benzoate|betamethasone benzoate|mesh-list
6782409|NCT02191007|Calcipotriene|calcipotriene|mesh-list
6782410|NCT02191007|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
6782411|NCT02191007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6782412|NCT02191007|Glucocorticoids|glucocorticoids|mesh-ancestor
6782413|NCT02191007|Hormones|hormones|mesh-ancestor
6782414|NCT02191007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6782415|NCT02191007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782416|NCT02191007|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6782417|NCT02191007|Respiratory System Agents|respiratory system agents|mesh-ancestor
6782418|NCT02191007|Dermatologic Agents|dermatologic agents|mesh-ancestor
6782419|NCT02191007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6782420|NCT02191007|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6782421|NCT02191007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6782422|NCT02191007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782423|NCT02191007|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6782424|NCT02191007|Vitamins|vitamins|mesh-ancestor
6782425|NCT02191007|Micronutrients|micronutrients|mesh-ancestor
6782426|NCT02191007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6782427|NCT02191020|Acitretin|acitretin|mesh-list
6782428|NCT02191020|Keratolytic Agents|keratolytic agents|mesh-ancestor
6782429|NCT02191020|Dermatologic Agents|dermatologic agents|mesh-ancestor
6782430|NCT02191059|Docetaxel|docetaxel|mesh-list
6782431|NCT02191059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6782432|NCT02191059|Tubulin Modulators|tubulin modulators|mesh-ancestor
6782433|NCT02191059|Antimitotic Agents|antimitotic agents|mesh-ancestor
6782434|NCT02191059|Mitosis Modulators|mitosis modulators|mesh-ancestor
6782435|NCT02191059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782436|NCT02191072|Omalizumab|omalizumab|mesh-list
6782437|NCT02191072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6782438|NCT02191072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6782439|NCT02191072|Respiratory System Agents|respiratory system agents|mesh-ancestor
6782440|NCT02191124|Mirtazapine|mirtazapine|mesh-list
6782441|NCT02191124|Paroxetine|paroxetine|mesh-list
6782442|NCT02191124|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6782443|NCT02191124|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6782444|NCT02191124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6782445|NCT02191124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782446|NCT02191124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6782447|NCT02191124|Serotonin Agents|serotonin agents|mesh-ancestor
6782448|NCT02191124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782449|NCT02191124|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6782450|NCT02191124|Antidepressive Agents|antidepressive agents|mesh-ancestor
6782451|NCT02191124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6782452|NCT02191124|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6782453|NCT02191124|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6782454|NCT02191124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6782455|NCT02191124|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6782456|NCT02191124|Histamine Antagonists|histamine antagonists|mesh-ancestor
6782457|NCT02191124|Histamine Agents|histamine agents|mesh-ancestor
6706702|NCT01756989|Thalidomide|thalidomide|mesh-list
6706703|NCT01756989|Celecoxib|celecoxib|mesh-list
6706704|NCT01756989|Etoposide|etoposide|mesh-list
6706705|NCT01756989|Etoposide phosphate|etoposide phosphate|mesh-list
6706706|NCT01756989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6706707|NCT01756989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6706708|NCT01756989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6706709|NCT01756989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6706710|NCT01756989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6706711|NCT01756989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6706712|NCT01756989|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6706713|NCT01756989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6706714|NCT01756989|Analgesics|analgesics|mesh-ancestor
6706715|NCT01756989|Sensory System Agents|sensory system agents|mesh-ancestor
6706716|NCT01756989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6706717|NCT01756989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706718|NCT01756989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6706719|NCT01756989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6706720|NCT01756989|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6706721|NCT01756989|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6706722|NCT01756989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6706723|NCT01756989|Immunologic Factors|immunologic factors|mesh-ancestor
6706724|NCT01756989|Leprostatic Agents|leprostatic agents|mesh-ancestor
6706725|NCT01756989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6706726|NCT01756989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6706727|NCT01756989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6706728|NCT01756989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6706729|NCT01756989|Growth Substances|growth substances|mesh-ancestor
6706730|NCT01756989|Growth Inhibitors|growth inhibitors|mesh-ancestor
6706731|NCT01757015|Glycopyrrolate|glycopyrrolate|mesh-list
6706732|NCT01757015|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6706733|NCT01757015|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6706734|NCT01757015|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6706735|NCT01757015|Cholinergic Agents|cholinergic agents|mesh-ancestor
6706736|NCT01757015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6706737|NCT01757015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6706738|NCT01757015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706739|NCT01757106|Sevoflurane|sevoflurane|mesh-list
6706740|NCT01757106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6706741|NCT01757106|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6706742|NCT01757106|Anesthetics, General|anesthetics, general|mesh-ancestor
6706743|NCT01757106|Anesthetics|anesthetics|mesh-ancestor
6706744|NCT01757106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6706745|NCT01757106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706746|NCT01757236|Vancomycin|vancomycin|mesh-list
6706747|NCT01757236|Rifampin|rifampin|mesh-list
6706748|NCT01757236|Clindamycin|clindamycin|mesh-list
6706749|NCT01757236|Ceftriaxone|ceftriaxone|mesh-list
6706750|NCT01757236|Linezolid|linezolid|mesh-list
6706751|NCT01757236|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6706752|NCT01757236|Fluoroquinolones|fluoroquinolones|mesh-list
6706753|NCT01757236|Trimethoprim|trimethoprim|mesh-list
6706754|NCT01757236|Sulfamethoxazole|sulfamethoxazole|mesh-list
6706755|NCT01757236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6706756|NCT01757236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6706757|NCT01757236|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6706758|NCT01757236|Antitubercular Agents|antitubercular agents|mesh-ancestor
6706759|NCT01757236|Leprostatic Agents|leprostatic agents|mesh-ancestor
6706760|NCT01757236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6706761|NCT01757236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6706762|NCT01757236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6706763|NCT01757236|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6706764|NCT01757236|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6706765|NCT01757236|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6706766|NCT01757236|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6706767|NCT01757236|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6706768|NCT01757236|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6706769|NCT01757236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6706770|NCT01757236|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6706771|NCT01757236|Renal Agents|renal agents|mesh-ancestor
6706772|NCT01757236|Antimalarials|antimalarials|mesh-ancestor
6706773|NCT01757236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6706774|NCT01757236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6706775|NCT01757236|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6782458|NCT02191124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6706776|NCT01757236|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6706777|NCT01757236|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6706778|NCT01757236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6706779|NCT01757249|Contraceptive Agents|contraceptive agents|mesh-list
6706780|NCT01757249|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
6706781|NCT01757249|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
6706782|NCT01757249|Contraceptives, Oral|contraceptives, oral|mesh-list
6706783|NCT01757249|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
6706784|NCT01757249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6706785|NCT01757249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706786|NCT01757249|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6706787|NCT01757249|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6706788|NCT01757249|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6706789|NCT01757249|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6706790|NCT01757249|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
6706791|NCT01757249|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6706792|NCT01757249|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6706793|NCT01757262|Clopidogrel|clopidogrel|mesh-list
6706794|NCT01757262|Ticagrelor|ticagrelor|mesh-list
6706795|NCT01757262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6706796|NCT01757262|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6706797|NCT01757262|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6706798|NCT01757262|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6706799|NCT01757262|Purinergic Agents|purinergic agents|mesh-ancestor
6706800|NCT01757262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6706801|NCT01757262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6706802|NCT01757262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706803|NCT01757366|Ginsenoside Rg3|ginsenoside rg3|mesh-list
6706804|NCT01757366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6706805|NCT01757366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6706806|NCT01757418|Immunoglobulins|immunoglobulins|mesh-list
6706807|NCT01757418|Antibodies|antibodies|mesh-list
6706808|NCT01757418|gamma-Globulins|gamma-globulins|mesh-list
6706809|NCT01757418|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6706810|NCT01757418|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6706811|NCT01757418|Immunologic Factors|immunologic factors|mesh-ancestor
6706812|NCT01757418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706813|NCT01757431|Eculizumab|eculizumab|mesh-list
6706814|NCT01757431|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6706815|NCT01757431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6706816|NCT01757431|Immunologic Factors|immunologic factors|mesh-ancestor
6706817|NCT01757431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706818|NCT01757457|Abciximab|abciximab|mesh-list
6706819|NCT01757457|Anticoagulants|anticoagulants|mesh-ancestor
6706820|NCT01757457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6706821|NCT01757574|Alemtuzumab|alemtuzumab|mesh-list
6706822|NCT01757574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6706823|NCT01757574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6706824|NCT01757587|Insulin|insulin|mesh-list
6706825|NCT01757587|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6706826|NCT01757587|Metformin|metformin|mesh-list
6706827|NCT01757587|Vildagliptin|vildagliptin|mesh-list
6706828|NCT01757587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6706829|NCT01757587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706830|NCT01757587|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6706831|NCT01757587|Protease Inhibitors|protease inhibitors|mesh-ancestor
6706832|NCT01757587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6706833|NCT01757587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6706834|NCT01757626|Molgramostim|molgramostim|mesh-list
6706835|NCT01757626|Sargramostim|sargramostim|mesh-list
6706836|NCT01757626|Immunologic Factors|immunologic factors|mesh-ancestor
6706837|NCT01757626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706838|NCT01757626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6706839|NCT01757639|Ipilimumab|ipilimumab|mesh-list
6706840|NCT01757639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6706841|NCT01757639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6706842|NCT01757639|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6706843|NCT01757639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6706844|NCT01757756|Midazolam|midazolam|mesh-list
6706845|NCT01757756|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6706846|NCT01757756|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6706847|NCT01757756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6706848|NCT01757756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706849|NCT01757756|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6706850|NCT01757756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6706851|NCT01757756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6706852|NCT01757756|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6706853|NCT01757756|Anesthetics, General|anesthetics, general|mesh-ancestor
6706854|NCT01757756|Anesthetics|anesthetics|mesh-ancestor
6706855|NCT01757756|GABA Modulators|gaba modulators|mesh-ancestor
6706856|NCT01757756|GABA Agents|gaba agents|mesh-ancestor
6706857|NCT01757756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6706858|NCT01757756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6706859|NCT01757769|Silodosin|silodosin|mesh-list
6706860|NCT01757769|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6706861|NCT01757769|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6706862|NCT01757769|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6706863|NCT01757769|Adrenergic Agents|adrenergic agents|mesh-ancestor
6706864|NCT01757769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6706865|NCT01757769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6706866|NCT01757769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706867|NCT01757769|Urological Agents|urological agents|mesh-ancestor
6706868|NCT01757782|Sildenafil Citrate|sildenafil citrate|mesh-list
6706869|NCT01757782|Vasodilator Agents|vasodilator agents|mesh-ancestor
6706870|NCT01757782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6706871|NCT01757782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6706872|NCT01757782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6706873|NCT01757782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6706874|NCT01757782|Urological Agents|urological agents|mesh-ancestor
6706875|NCT01757795|Otaplimastat|otaplimastat|mesh-list
6706876|NCT01757795|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6706877|NCT01757795|Protective Agents|protective agents|mesh-ancestor
6706878|NCT01757795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706879|NCT01757808|Ranolazine|ranolazine|mesh-list
6706880|NCT01757808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6706881|NCT01757808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6706882|NCT01757808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6706883|NCT01757860|Vitamin D|vitamin d|mesh-list
6706884|NCT01757860|Vitamins|vitamins|mesh-ancestor
6706885|NCT01757860|Micronutrients|micronutrients|mesh-ancestor
6706886|NCT01757860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706887|NCT01757860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6706888|NCT01757899|Methylprednisolone|methylprednisolone|mesh-list
6706889|NCT01757899|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6706890|NCT01757899|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6706891|NCT01757899|Prednisolone|prednisolone|mesh-list
6706892|NCT01757899|Prednisolone acetate|prednisolone acetate|mesh-list
6706893|NCT01757899|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6706894|NCT01757899|Prednisolone phosphate|prednisolone phosphate|mesh-list
6706895|NCT01757899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6706896|NCT01757899|Antiemetics|antiemetics|mesh-ancestor
6706897|NCT01757899|Autonomic Agents|autonomic agents|mesh-ancestor
6706898|NCT01757899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6706899|NCT01757899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706900|NCT01757899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6706901|NCT01757899|Glucocorticoids|glucocorticoids|mesh-ancestor
6706902|NCT01757899|Hormones|hormones|mesh-ancestor
6706903|NCT01757899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6706904|NCT01757899|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6706905|NCT01757899|Protective Agents|protective agents|mesh-ancestor
6706906|NCT01757899|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6706907|NCT01757899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6706908|NCT01758029|Methyltestosterone|methyltestosterone|mesh-list
6706909|NCT01758029|Testosterone|testosterone|mesh-list
6706910|NCT01758029|Testosterone undecanoate|testosterone undecanoate|mesh-list
6706911|NCT01758029|Testosterone enanthate|testosterone enanthate|mesh-list
6706912|NCT01758029|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6706913|NCT01758029|Androgens|androgens|mesh-ancestor
6706914|NCT01758029|Hormones|hormones|mesh-ancestor
6706915|NCT01758029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6706916|NCT01758029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706917|NCT01758029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6706918|NCT01758029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6706919|NCT01758029|Anabolic Agents|anabolic agents|mesh-ancestor
6706920|NCT01758081|Vitamin D|vitamin d|mesh-list
6706921|NCT01758081|Ergocalciferols|ergocalciferols|mesh-list
6706922|NCT01758081|Cholecalciferol|cholecalciferol|mesh-list
6706923|NCT01758081|Vitamins|vitamins|mesh-list
6706924|NCT01758081|Micronutrients|micronutrients|mesh-ancestor
6706925|NCT01758081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706926|NCT01758081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6706927|NCT01758081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6706928|NCT01758094|Testosterone|testosterone|mesh-list
6706929|NCT01758094|Androgens|androgens|mesh-ancestor
6706930|NCT01758094|Hormones|hormones|mesh-ancestor
6706931|NCT01758094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6706932|NCT01758094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706933|NCT01758107|Cyclosporine|cyclosporine|mesh-list
6706934|NCT01758107|Cyclosporins|cyclosporins|mesh-list
6706935|NCT01758107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6706936|NCT01758107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6706937|NCT01758107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6706938|NCT01758107|Immunologic Factors|immunologic factors|mesh-ancestor
6706939|NCT01758107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706940|NCT01758107|Antifungal Agents|antifungal agents|mesh-ancestor
6706941|NCT01758107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6706942|NCT01758107|Dermatologic Agents|dermatologic agents|mesh-ancestor
6706943|NCT01758107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6706944|NCT01758107|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6706945|NCT01758120|Prednisone|prednisone|mesh-list
6706946|NCT01758120|Cyclophosphamide|cyclophosphamide|mesh-list
6706947|NCT01758120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6706948|NCT01758120|Immunologic Factors|immunologic factors|mesh-ancestor
6706949|NCT01758120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706950|NCT01758120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6706951|NCT01758120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6706952|NCT01758120|Alkylating Agents|alkylating agents|mesh-ancestor
6706953|NCT01758120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6706954|NCT01758120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6706955|NCT01758120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6706956|NCT01758120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6706957|NCT01758120|Glucocorticoids|glucocorticoids|mesh-ancestor
6706958|NCT01758120|Hormones|hormones|mesh-ancestor
6706959|NCT01758120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6706960|NCT01758120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6706961|NCT01758146|Tamoxifen|tamoxifen|mesh-list
6706962|NCT01758146|Letrozole|letrozole|mesh-list
6706963|NCT01758146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6706964|NCT01758146|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6706965|NCT01758146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6706966|NCT01758146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6706967|NCT01758146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6706968|NCT01758146|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6706969|NCT01758146|Hormone Antagonists|hormone antagonists|mesh-ancestor
6706970|NCT01758146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6706971|NCT01758146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706972|NCT01758146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6706973|NCT01758146|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6706974|NCT01758146|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6706975|NCT01758146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6706976|NCT01758172|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
6706977|NCT01758172|Plasma Substitutes|plasma substitutes|mesh-ancestor
6706978|NCT01758172|Blood Substitutes|blood substitutes|mesh-ancestor
6706979|NCT01758185|Vaccines|vaccines|mesh-list
6706980|NCT01758185|Immunologic Factors|immunologic factors|mesh-ancestor
6706981|NCT01758185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706982|NCT01758198|Methotrexate|methotrexate|mesh-list
6706983|NCT01758198|Abatacept|abatacept|mesh-list
6706984|NCT01758198|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6706985|NCT01758198|Abortifacient Agents|abortifacient agents|mesh-ancestor
6706986|NCT01758198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6706987|NCT01758198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6706988|NCT01758198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6706989|NCT01758198|Antimetabolites|antimetabolites|mesh-ancestor
6706990|NCT01758198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6706991|NCT01758198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6706992|NCT01758198|Dermatologic Agents|dermatologic agents|mesh-ancestor
6706993|NCT01758198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6706994|NCT01758198|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6706995|NCT01758198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6706996|NCT01758198|Immunologic Factors|immunologic factors|mesh-ancestor
6706997|NCT01758198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6706998|NCT01758198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6706999|NCT01758198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6707000|NCT01758263|Metoprolol|metoprolol|mesh-list
6707001|NCT01758263|Nebivolol|nebivolol|mesh-list
6707002|NCT01758263|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6707003|NCT01758263|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6707004|NCT01758263|Sympatholytics|sympatholytics|mesh-ancestor
6707005|NCT01758263|Autonomic Agents|autonomic agents|mesh-ancestor
6707006|NCT01758263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6707007|NCT01758263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707008|NCT01758263|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6707009|NCT01758263|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6707010|NCT01758263|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6707011|NCT01758263|Adrenergic Agents|adrenergic agents|mesh-ancestor
6707012|NCT01758263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6707013|NCT01758263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6707014|NCT01758263|Vasodilator Agents|vasodilator agents|mesh-ancestor
6707015|NCT01758263|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6707016|NCT01758263|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6707017|NCT01758263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6707018|NCT01758367|Decitabine|decitabine|mesh-list
6707019|NCT01758367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6707020|NCT01758367|Antimetabolites|antimetabolites|mesh-ancestor
6707021|NCT01758367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6707022|NCT01758367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6707023|NCT01758367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6707024|NCT01758380|Metformin|metformin|mesh-list
6707025|NCT01758380|Vildagliptin|vildagliptin|mesh-list
6707026|NCT01758380|Gliclazide|gliclazide|mesh-list
6707027|NCT01758380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6707028|NCT01758380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707029|NCT01758380|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6707030|NCT01758380|Protease Inhibitors|protease inhibitors|mesh-ancestor
6707031|NCT01758380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6707032|NCT01758380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6707033|NCT01758393|Prednisone|prednisone|mesh-list
6707034|NCT01758393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6707035|NCT01758393|Glucocorticoids|glucocorticoids|mesh-ancestor
6707036|NCT01758393|Hormones|hormones|mesh-ancestor
6707037|NCT01758393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6707038|NCT01758393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707039|NCT01758393|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6707040|NCT01758393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6707041|NCT01758471|Acarbose|acarbose|mesh-list
6707042|NCT01758471|Glipizide|glipizide|mesh-list
6707043|NCT01758471|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6707044|NCT01758471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6707045|NCT01758471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6707046|NCT01758471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6707047|NCT01758471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782459|NCT02191124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6782460|NCT02191124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6782461|NCT02191124|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6782462|NCT02191124|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6782463|NCT02191124|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6782464|NCT02191124|Adrenergic Agents|adrenergic agents|mesh-ancestor
6782465|NCT02191124|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6782466|NCT02191124|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6782467|NCT02191124|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6782468|NCT02191176|Dextromethorphan|dextromethorphan|mesh-list
6782469|NCT02191176|Antitussive Agents|antitussive agents|mesh-ancestor
6782470|NCT02191176|Respiratory System Agents|respiratory system agents|mesh-ancestor
6782471|NCT02191176|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6782472|NCT02191176|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6782473|NCT02191176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6782474|NCT02191176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782475|NCT02191176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782476|NCT02191189|Nevirapine|nevirapine|mesh-list
6782477|NCT02191189|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6782478|NCT02191189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6782479|NCT02191189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6707048|NCT01758627|Icodextrin|icodextrin|mesh-list
6707049|NCT01758627|Dialysis Solutions|dialysis solutions|mesh-ancestor
6707050|NCT01758627|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6707051|NCT01758640|Warfarin|warfarin|mesh-list
6707052|NCT01758640|Phenindione|phenindione|mesh-list
6707053|NCT01758640|Anticoagulants|anticoagulants|mesh-ancestor
6707054|NCT01758666|Leucovorin|leucovorin|mesh-list
6707055|NCT01758666|Methotrexate|methotrexate|mesh-list
6707056|NCT01758666|Calcium|calcium|mesh-list
6707057|NCT01758666|Levoleucovorin|levoleucovorin|mesh-list
6707058|NCT01758666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6707059|NCT01758666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707060|NCT01758666|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6707061|NCT01758666|Abortifacient Agents|abortifacient agents|mesh-ancestor
6707062|NCT01758666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6707063|NCT01758666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6707064|NCT01758666|Antimetabolites|antimetabolites|mesh-ancestor
6707065|NCT01758666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6707066|NCT01758666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6707067|NCT01758666|Dermatologic Agents|dermatologic agents|mesh-ancestor
6707068|NCT01758666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6707069|NCT01758666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6707070|NCT01758666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6707071|NCT01758666|Immunologic Factors|immunologic factors|mesh-ancestor
6707072|NCT01758666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6707073|NCT01758666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6707074|NCT01758666|Antidotes|antidotes|mesh-ancestor
6707075|NCT01758666|Protective Agents|protective agents|mesh-ancestor
6707076|NCT01758666|Vitamin B Complex|vitamin b complex|mesh-ancestor
6707077|NCT01758666|Vitamins|vitamins|mesh-ancestor
6707078|NCT01758666|Micronutrients|micronutrients|mesh-ancestor
6707079|NCT01758744|Treprostinil|treprostinil|mesh-list
6707080|NCT01758744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6707081|NCT01758809|Bupivacaine|bupivacaine|mesh-list
6707082|NCT01758809|Anesthetics, Local|anesthetics, local|mesh-ancestor
6707083|NCT01758809|Anesthetics|anesthetics|mesh-ancestor
6707084|NCT01758809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6707085|NCT01758809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707086|NCT01758809|Sensory System Agents|sensory system agents|mesh-ancestor
6707087|NCT01758809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6707088|NCT01758835|Calpastatin|calpastatin|mesh-list
6707089|NCT01758835|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
6707090|NCT01758835|Protease Inhibitors|protease inhibitors|mesh-ancestor
6707091|NCT01758835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6707092|NCT01758835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6707093|NCT01758861|Anesthetics|anesthetics|mesh-list
6707094|NCT01758861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6707095|NCT01758861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707096|NCT01758913|Ibuprofen|ibuprofen|mesh-list
6707097|NCT01758913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6707098|NCT01758913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6707099|NCT01758913|Analgesics|analgesics|mesh-ancestor
6707100|NCT01758913|Sensory System Agents|sensory system agents|mesh-ancestor
6707101|NCT01758913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6707102|NCT01758913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707103|NCT01758913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6707104|NCT01758913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6707105|NCT01758913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6707106|NCT01758913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6707107|NCT01758913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6707108|NCT01758978|Hydrocodone|hydrocodone|mesh-list
6707109|NCT01758978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6707110|NCT01758978|Narcotics|narcotics|mesh-ancestor
6707111|NCT01758978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6707112|NCT01758978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707113|NCT01758978|Analgesics|analgesics|mesh-ancestor
6707114|NCT01758978|Sensory System Agents|sensory system agents|mesh-ancestor
6707115|NCT01758978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6707116|NCT01758978|Antitussive Agents|antitussive agents|mesh-ancestor
6707117|NCT01758978|Respiratory System Agents|respiratory system agents|mesh-ancestor
6707118|NCT01759030|Rituximab|rituximab|mesh-list
6707119|NCT01759030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6707120|NCT01759030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6707121|NCT01759030|Immunologic Factors|immunologic factors|mesh-ancestor
6707122|NCT01759030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707123|NCT01759030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6707124|NCT01759108|Rebamipide|rebamipide|mesh-list
6707125|NCT01759108|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6707126|NCT01759108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6707127|NCT01759108|Antioxidants|antioxidants|mesh-ancestor
6707128|NCT01759108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6707129|NCT01759108|Protective Agents|protective agents|mesh-ancestor
6707130|NCT01759108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707131|NCT01759108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6707132|NCT01759238|Bevacizumab|bevacizumab|mesh-list
6707133|NCT01759238|Capecitabine|capecitabine|mesh-list
6707134|NCT01759238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6707135|NCT01759238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6707136|NCT01759238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6707137|NCT01759238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6707138|NCT01759238|Growth Substances|growth substances|mesh-ancestor
6707139|NCT01759238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707140|NCT01759238|Growth Inhibitors|growth inhibitors|mesh-ancestor
6707141|NCT01759238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6707142|NCT01759238|Antimetabolites|antimetabolites|mesh-ancestor
6707143|NCT01759238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6707144|NCT01759394|Maleic acid|maleic acid|mesh-list
6707145|NCT01759394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6707146|NCT01759394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6707147|NCT01759459|Lidocaine|lidocaine|mesh-list
6707148|NCT01759459|Anesthetics, Local|anesthetics, local|mesh-ancestor
6707149|NCT01759459|Anesthetics|anesthetics|mesh-ancestor
6707150|NCT01759459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6707151|NCT01759459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707152|NCT01759459|Sensory System Agents|sensory system agents|mesh-ancestor
6707153|NCT01759459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6707154|NCT01759459|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6707155|NCT01759459|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6707156|NCT01759459|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6707157|NCT01759459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6707158|NCT01759459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6707159|NCT01759485|Vitamin D|vitamin d|mesh-list
6707160|NCT01759485|Cholecalciferol|cholecalciferol|mesh-list
6707161|NCT01759485|Vitamins|vitamins|mesh-ancestor
6707162|NCT01759485|Micronutrients|micronutrients|mesh-ancestor
6707163|NCT01759485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707164|NCT01759485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6707165|NCT01759485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6707166|NCT01759524|Lidocaine|lidocaine|mesh-list
6707167|NCT01759524|Clonidine|clonidine|mesh-list
6707168|NCT01759524|Bupivacaine|bupivacaine|mesh-list
6707169|NCT01759524|Anesthetics, Local|anesthetics, local|mesh-ancestor
6707170|NCT01759524|Anesthetics|anesthetics|mesh-ancestor
6707171|NCT01759524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6707172|NCT01759524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707173|NCT01759524|Sensory System Agents|sensory system agents|mesh-ancestor
6707174|NCT01759524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6707175|NCT01759524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6707176|NCT01759524|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6707177|NCT01759524|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6707178|NCT01759524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6707179|NCT01759524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6707180|NCT01759524|Analgesics|analgesics|mesh-ancestor
6707181|NCT01759524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6707182|NCT01759524|Sympatholytics|sympatholytics|mesh-ancestor
6707183|NCT01759524|Autonomic Agents|autonomic agents|mesh-ancestor
6707184|NCT01759524|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6707185|NCT01759524|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6707186|NCT01759524|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6707187|NCT01759524|Adrenergic Agents|adrenergic agents|mesh-ancestor
6707188|NCT01759524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6707189|NCT01759576|Canagliflozin|canagliflozin|mesh-list
6707190|NCT01759576|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6707191|NCT01759576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6707192|NCT01759576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6707193|NCT01759576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707194|NCT01759589|Remifentanil|remifentanil|mesh-list
6707195|NCT01759589|Propofol|propofol|mesh-list
6707196|NCT01759589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
6707197|NCT01759589|Sevoflurane|sevoflurane|mesh-list
6707198|NCT01759589|Anesthetics|anesthetics|mesh-list
6707199|NCT01759589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6707200|NCT01759589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6707201|NCT01759589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707202|NCT01759589|Anesthetics, General|anesthetics, general|mesh-ancestor
6707203|NCT01759589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6707204|NCT01759589|Narcotics|narcotics|mesh-ancestor
6707205|NCT01759589|Analgesics|analgesics|mesh-ancestor
6707206|NCT01759589|Sensory System Agents|sensory system agents|mesh-ancestor
6707207|NCT01759589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6707208|NCT01759589|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6707209|NCT01759589|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6707210|NCT01759706|Dexamethasone|dexamethasone|mesh-list
6707211|NCT01759706|Sufentanil|sufentanil|mesh-list
6707212|NCT01759706|Diazepam|diazepam|mesh-list
6707213|NCT01759706|Ondansetron|ondansetron|mesh-list
6707214|NCT01759706|Anesthetics|anesthetics|mesh-list
6707215|NCT01759706|Ropivacaine|ropivacaine|mesh-list
6707216|NCT01759706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6707217|NCT01759706|Antiemetics|antiemetics|mesh-ancestor
6707218|NCT01759706|Autonomic Agents|autonomic agents|mesh-ancestor
6707219|NCT01759706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6707220|NCT01759706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707221|NCT01759706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6707222|NCT01759706|Glucocorticoids|glucocorticoids|mesh-ancestor
6707223|NCT01759706|Hormones|hormones|mesh-ancestor
6707224|NCT01759706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6707225|NCT01759706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6707226|NCT01759706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6707227|NCT01759706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6707228|NCT01759706|Antipruritics|antipruritics|mesh-ancestor
6707229|NCT01759706|Dermatologic Agents|dermatologic agents|mesh-ancestor
6707230|NCT01759706|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6707231|NCT01759706|Serotonin Agents|serotonin agents|mesh-ancestor
6707232|NCT01759706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6707233|NCT01759706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6707234|NCT01759706|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6707235|NCT01759706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6707236|NCT01759706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6707237|NCT01759706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6707238|NCT01759706|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6707239|NCT01759706|Narcotics|narcotics|mesh-ancestor
6707240|NCT01759706|Analgesics|analgesics|mesh-ancestor
6707241|NCT01759706|Sensory System Agents|sensory system agents|mesh-ancestor
6707242|NCT01759706|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6707243|NCT01759706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6707244|NCT01759706|Anesthetics, General|anesthetics, general|mesh-ancestor
6707245|NCT01759706|Anesthetics, Local|anesthetics, local|mesh-ancestor
6707246|NCT01759706|Anticonvulsants|anticonvulsants|mesh-ancestor
6707247|NCT01759706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6707248|NCT01759706|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6707249|NCT01759706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6707250|NCT01759706|GABA Modulators|gaba modulators|mesh-ancestor
6707251|NCT01759706|GABA Agents|gaba agents|mesh-ancestor
6707252|NCT01759719|Chromium|chromium|mesh-list
6707253|NCT01759719|Trace Elements|trace elements|mesh-ancestor
6707254|NCT01759719|Micronutrients|micronutrients|mesh-ancestor
6707255|NCT01759719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707256|NCT01759732|Cyclophosphamide|cyclophosphamide|mesh-list
6707257|NCT01759732|Fludarabine|fludarabine|mesh-list
6707258|NCT01759732|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6707259|NCT01759732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6707260|NCT01759732|Immunologic Factors|immunologic factors|mesh-ancestor
6707261|NCT01759732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707262|NCT01759732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6707263|NCT01759732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6707264|NCT01759732|Alkylating Agents|alkylating agents|mesh-ancestor
6707265|NCT01759732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6707266|NCT01759732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6707267|NCT01759732|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6707268|NCT01759771|Vitamin D|vitamin d|mesh-list
6707269|NCT01759771|Cholecalciferol|cholecalciferol|mesh-list
6707270|NCT01759771|Vitamins|vitamins|mesh-ancestor
6707271|NCT01759771|Micronutrients|micronutrients|mesh-ancestor
6707272|NCT01759771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707273|NCT01759771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6707274|NCT01759771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6707275|NCT01759810|Vaccines|vaccines|mesh-list
6707276|NCT01759810|Immunologic Factors|immunologic factors|mesh-ancestor
6707277|NCT01759810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707278|NCT01759875|Ritonavir|ritonavir|mesh-list
6707279|NCT01759875|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6707280|NCT01759875|Rabeprazole|rabeprazole|mesh-list
6707281|NCT01759875|Betaine|betaine|mesh-list
6707282|NCT01759875|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6707283|NCT01759875|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6707284|NCT01759875|Protease Inhibitors|protease inhibitors|mesh-ancestor
6707285|NCT01759875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6707286|NCT01759875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6707287|NCT01759875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6707288|NCT01759875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6707289|NCT01759875|Antiviral Agents|antiviral agents|mesh-ancestor
6707290|NCT01759875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6707291|NCT01759875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6707292|NCT01759875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6707293|NCT01759875|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6707294|NCT01759875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6707295|NCT01759875|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6707296|NCT01759875|Lipotropic Agents|lipotropic agents|mesh-ancestor
6707297|NCT01759875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6707298|NCT01759875|Antimetabolites|antimetabolites|mesh-ancestor
6707299|NCT01759875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6707300|NCT01759940|Ropivacaine|ropivacaine|mesh-list
6707301|NCT01759940|Anesthetics, Local|anesthetics, local|mesh-ancestor
6707302|NCT01759940|Anesthetics|anesthetics|mesh-ancestor
6707303|NCT01759940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6707304|NCT01759940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707305|NCT01759940|Sensory System Agents|sensory system agents|mesh-ancestor
6707306|NCT01759940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6707307|NCT01760005|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6707308|NCT01760005|Immunologic Factors|immunologic factors|mesh-ancestor
6707309|NCT01760005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707310|NCT01760018|Desflurane|desflurane|mesh-list
6707311|NCT01760018|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6707312|NCT01760018|Anesthetics, General|anesthetics, general|mesh-ancestor
6707313|NCT01760018|Anesthetics|anesthetics|mesh-ancestor
6707314|NCT01760018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6707315|NCT01760018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782480|NCT02191189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782481|NCT02191189|Antiviral Agents|antiviral agents|mesh-ancestor
6782482|NCT02191189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6782483|NCT02191189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6782484|NCT02191189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6782485|NCT02191189|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6782486|NCT02191189|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6782487|NCT02191202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
6782488|NCT02191202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6782489|NCT02191202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6782490|NCT02191202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782491|NCT02191202|Antiviral Agents|antiviral agents|mesh-ancestor
6782492|NCT02191202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6782493|NCT02191215|Nevirapine|nevirapine|mesh-list
6782494|NCT02191215|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6782495|NCT02191215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6782496|NCT02191215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6782497|NCT02191215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782498|NCT02191215|Antiviral Agents|antiviral agents|mesh-ancestor
6782499|NCT02191215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6782500|NCT02191215|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6782501|NCT02191215|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6782502|NCT02191215|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6782503|NCT02191215|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6782504|NCT02191228|Linagliptin|linagliptin|mesh-list
6782505|NCT02191228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6782506|NCT02191228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782507|NCT02191228|Incretins|incretins|mesh-ancestor
6782508|NCT02191228|Hormones|hormones|mesh-ancestor
6782509|NCT02191228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6782510|NCT02191228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6782511|NCT02191228|Protease Inhibitors|protease inhibitors|mesh-ancestor
6782512|NCT02191228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6782513|NCT02191228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782514|NCT02191280|Quercetin|quercetin|mesh-list
6782515|NCT02191280|Antioxidants|antioxidants|mesh-ancestor
6707316|NCT01760096|Cyclosporine|cyclosporine|mesh-list
6707317|NCT01760096|Levamisole|levamisole|mesh-list
6707318|NCT01760096|Cyclosporins|cyclosporins|mesh-list
6707319|NCT01760096|Glucocorticoids|glucocorticoids|mesh-list
6707320|NCT01760096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6707321|NCT01760096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6707322|NCT01760096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6707323|NCT01760096|Immunologic Factors|immunologic factors|mesh-ancestor
6707324|NCT01760096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707325|NCT01760096|Antifungal Agents|antifungal agents|mesh-ancestor
6707326|NCT01760096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6707327|NCT01760096|Dermatologic Agents|dermatologic agents|mesh-ancestor
6707328|NCT01760096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6707329|NCT01760096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6707330|NCT01760096|Hormones|hormones|mesh-ancestor
6707331|NCT01760096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6707332|NCT01760096|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6707333|NCT01760096|Antinematodal Agents|antinematodal agents|mesh-ancestor
6707334|NCT01760096|Anthelmintics|anthelmintics|mesh-ancestor
6707335|NCT01760096|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6707336|NCT01760109|Piperacillin|piperacillin|mesh-list
6707337|NCT01760109|Sulbactam|sulbactam|mesh-list
6707338|NCT01760109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6707339|NCT01760109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6707340|NCT01760109|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6707341|NCT01760109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6707342|NCT01760109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6707343|NCT01760122|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6707344|NCT01760122|Antiviral Agents|antiviral agents|mesh-ancestor
6707345|NCT01760122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6707346|NCT01760148|Interferons|interferons|mesh-list
6707347|NCT01760148|Ribavirin|ribavirin|mesh-list
6707348|NCT01760148|Interferon-alpha|interferon-alpha|mesh-list
6707349|NCT01760148|Interferon alpha-2|interferon alpha-2|mesh-list
6707350|NCT01760148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6707351|NCT01760148|Antiviral Agents|antiviral agents|mesh-ancestor
6707352|NCT01760148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6707353|NCT01760148|Antimetabolites|antimetabolites|mesh-ancestor
6707354|NCT01760148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6707355|NCT01760148|Immunologic Factors|immunologic factors|mesh-ancestor
6707356|NCT01760148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707357|NCT01760161|Ropivacaine|ropivacaine|mesh-list
6707358|NCT01760161|Anesthetics, Local|anesthetics, local|mesh-ancestor
6707359|NCT01760161|Anesthetics|anesthetics|mesh-ancestor
6707360|NCT01760161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6707361|NCT01760161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707362|NCT01760161|Sensory System Agents|sensory system agents|mesh-ancestor
6707363|NCT01760161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6707364|NCT01760174|Bupivacaine|bupivacaine|mesh-list
6707365|NCT01760174|Ropivacaine|ropivacaine|mesh-list
6707366|NCT01760174|Anesthetics, Local|anesthetics, local|mesh-ancestor
6707367|NCT01760174|Anesthetics|anesthetics|mesh-ancestor
6707368|NCT01760174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6707369|NCT01760174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707370|NCT01760174|Sensory System Agents|sensory system agents|mesh-ancestor
6707371|NCT01760174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6707372|NCT01760226|Prednisone|prednisone|mesh-list
6707373|NCT01760226|Cyclophosphamide|cyclophosphamide|mesh-list
6707374|NCT01760226|Rituximab|rituximab|mesh-list
6707375|NCT01760226|Doxorubicin|doxorubicin|mesh-list
6707376|NCT01760226|Methotrexate|methotrexate|mesh-list
6707377|NCT01760226|Etoposide|etoposide|mesh-list
6707378|NCT01760226|Vincristine|vincristine|mesh-list
6707379|NCT01760226|Sargramostim|sargramostim|mesh-list
6707380|NCT01760226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6707381|NCT01760226|Immunologic Factors|immunologic factors|mesh-ancestor
6707382|NCT01760226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707383|NCT01760226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6707384|NCT01760226|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6707385|NCT01760226|Alkylating Agents|alkylating agents|mesh-ancestor
6707386|NCT01760226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6707387|NCT01760226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6707388|NCT01760226|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6707389|NCT01760226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6707390|NCT01760226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6707391|NCT01760226|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6707392|NCT01760226|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6707393|NCT01760226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6707394|NCT01760226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6707395|NCT01760226|Glucocorticoids|glucocorticoids|mesh-ancestor
6707396|NCT01760226|Hormones|hormones|mesh-ancestor
6707397|NCT01760226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6707398|NCT01760226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6707399|NCT01760226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6707400|NCT01760226|Abortifacient Agents|abortifacient agents|mesh-ancestor
6707401|NCT01760226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6707402|NCT01760226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6707403|NCT01760226|Antimetabolites|antimetabolites|mesh-ancestor
6707404|NCT01760226|Dermatologic Agents|dermatologic agents|mesh-ancestor
6707405|NCT01760226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6707406|NCT01760226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6707407|NCT01760226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6707408|NCT01760226|Tubulin Modulators|tubulin modulators|mesh-ancestor
6707409|NCT01760226|Antimitotic Agents|antimitotic agents|mesh-ancestor
6707410|NCT01760226|Mitosis Modulators|mitosis modulators|mesh-ancestor
6707411|NCT01760252|Capecitabine|capecitabine|mesh-list
6707412|NCT01760252|Oxaliplatin|oxaliplatin|mesh-list
6707413|NCT01760252|Irinotecan|irinotecan|mesh-list
6707414|NCT01760252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6707415|NCT01760252|Antimetabolites|antimetabolites|mesh-ancestor
6707416|NCT01760252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6707417|NCT01760252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6707418|NCT01760252|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6707419|NCT01760252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6707420|NCT01760252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6707421|NCT01760278|Cetrorelix|cetrorelix|mesh-list
6707422|NCT01760278|Hormones|hormones|mesh-list
6707423|NCT01760278|Progesterone|progesterone|mesh-list
6707424|NCT01760278|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6707425|NCT01760278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6707426|NCT01760278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707427|NCT01760278|Progestins|progestins|mesh-ancestor
6707428|NCT01760278|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6707429|NCT01760278|Fertility Agents|fertility agents|mesh-ancestor
6707430|NCT01760278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6707431|NCT01760278|Hormone Antagonists|hormone antagonists|mesh-ancestor
6707432|NCT01760330|Acetaminophen|acetaminophen|mesh-list
6707433|NCT01760330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6707434|NCT01760330|Analgesics|analgesics|mesh-ancestor
6707435|NCT01760330|Sensory System Agents|sensory system agents|mesh-ancestor
6707436|NCT01760330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6707437|NCT01760330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707438|NCT01760330|Antipyretics|antipyretics|mesh-ancestor
6707439|NCT01760421|Hydroxychloroquine|hydroxychloroquine|mesh-list
6707440|NCT01760421|Antimalarials|antimalarials|mesh-ancestor
6707441|NCT01760421|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6707442|NCT01760421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6707443|NCT01760421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6707444|NCT01760421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6707445|NCT01760421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6707446|NCT01760421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6707447|NCT01760460|Oxazolidinones|oxazolidinones|mesh-list
6707448|NCT01760460|Anacetrapib|anacetrapib|mesh-list
6707449|NCT01760460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6707450|NCT01760460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6707451|NCT01760460|Antimetabolites|antimetabolites|mesh-ancestor
6707452|NCT01760460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6707453|NCT01760460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6707454|NCT01760460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6707455|NCT01760460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6707456|NCT01760460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6707457|NCT01760564|Miglustat|miglustat|mesh-list
6707458|NCT01760564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6707459|NCT01760564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6707460|NCT01760564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6707461|NCT01760564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6707462|NCT01760564|Antiviral Agents|antiviral agents|mesh-ancestor
6707463|NCT01760564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6707464|NCT01760564|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6707465|NCT01760564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6707466|NCT01760564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707467|NCT01760577|Botulinum Toxins|botulinum toxins|mesh-list
6707468|NCT01760577|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6707469|NCT01760577|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6707470|NCT01760577|Hyaluronic Acid|hyaluronic acid|mesh-list
6707471|NCT01760577|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6707472|NCT01760577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6707473|NCT01760577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6707474|NCT01760577|Cholinergic Agents|cholinergic agents|mesh-ancestor
6707475|NCT01760577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6707476|NCT01760577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707477|NCT01760577|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6707478|NCT01760577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6707479|NCT01760577|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6707480|NCT01760577|Immunologic Factors|immunologic factors|mesh-ancestor
6707481|NCT01760577|Viscosupplements|viscosupplements|mesh-ancestor
6707482|NCT01760577|Protective Agents|protective agents|mesh-ancestor
6707483|NCT01760642|Rifampin|rifampin|mesh-list
6707484|NCT01760642|Ketoconazole|ketoconazole|mesh-list
6707485|NCT01760642|Midazolam|midazolam|mesh-list
6707486|NCT01760642|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6707487|NCT01760642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6707488|NCT01760642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6707489|NCT01760642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707490|NCT01760642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6707491|NCT01760642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6707492|NCT01760642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6707493|NCT01760642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6707494|NCT01760642|Anesthetics, General|anesthetics, general|mesh-ancestor
6707495|NCT01760642|Anesthetics|anesthetics|mesh-ancestor
6707496|NCT01760642|GABA Modulators|gaba modulators|mesh-ancestor
6707497|NCT01760642|GABA Agents|gaba agents|mesh-ancestor
6707498|NCT01760642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6707499|NCT01760642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6707500|NCT01760642|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6707501|NCT01760642|Antitubercular Agents|antitubercular agents|mesh-ancestor
6707502|NCT01760642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6707503|NCT01760642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6707504|NCT01760642|Leprostatic Agents|leprostatic agents|mesh-ancestor
6707505|NCT01760642|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6707506|NCT01760642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6707507|NCT01760642|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6707508|NCT01760642|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6707509|NCT01760642|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6707510|NCT01760642|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6707511|NCT01760642|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6707512|NCT01760642|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6707513|NCT01760642|Antifungal Agents|antifungal agents|mesh-ancestor
6707514|NCT01760642|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6707515|NCT01760642|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6707516|NCT01760642|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6707517|NCT01760642|Hormone Antagonists|hormone antagonists|mesh-ancestor
6707518|NCT01760642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6707519|NCT01760642|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6707520|NCT01760655|Vidarabine|vidarabine|mesh-list
6707521|NCT01760655|Mycophenolic Acid|mycophenolic acid|mesh-list
6707522|NCT01760655|Cyclophosphamide|cyclophosphamide|mesh-list
6707523|NCT01760655|Thiotepa|thiotepa|mesh-list
6707524|NCT01760655|Fludarabine|fludarabine|mesh-list
6707525|NCT01760655|Fludarabine phosphate|fludarabine phosphate|mesh-list
6707526|NCT01760655|Tacrolimus|tacrolimus|mesh-list
6707527|NCT01760655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6707528|NCT01760655|Immunologic Factors|immunologic factors|mesh-ancestor
6707529|NCT01760655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707530|NCT01760655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6707531|NCT01760655|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6707532|NCT01760655|Alkylating Agents|alkylating agents|mesh-ancestor
6707533|NCT01760655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6707534|NCT01760655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6707535|NCT01760655|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6707536|NCT01760655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6707537|NCT01760655|Antimetabolites|antimetabolites|mesh-ancestor
6707538|NCT01760655|Antiviral Agents|antiviral agents|mesh-ancestor
6707539|NCT01760655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6707540|NCT01760655|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6707541|NCT01760655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6707542|NCT01760655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6707543|NCT01760655|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6707544|NCT01760655|Antitubercular Agents|antitubercular agents|mesh-ancestor
6707545|NCT01760655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6707546|NCT01760694|Leucovorin|leucovorin|mesh-list
6707547|NCT01760694|Oxaliplatin|oxaliplatin|mesh-list
6707548|NCT01760694|Irinotecan|irinotecan|mesh-list
6707549|NCT01760694|Folfirinox|folfirinox|mesh-list
6707550|NCT01760694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6707551|NCT01760694|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6707552|NCT01760694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6707553|NCT01760694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6707554|NCT01760694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6707555|NCT01760694|Antidotes|antidotes|mesh-ancestor
6707556|NCT01760694|Protective Agents|protective agents|mesh-ancestor
6707557|NCT01760694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707558|NCT01760694|Vitamin B Complex|vitamin b complex|mesh-ancestor
6707559|NCT01760694|Vitamins|vitamins|mesh-ancestor
6707560|NCT01760694|Micronutrients|micronutrients|mesh-ancestor
6707561|NCT01760746|Bevacizumab|bevacizumab|mesh-list
6707562|NCT01760746|Ranibizumab|ranibizumab|mesh-list
6707563|NCT01760746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6707564|NCT01760746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6707565|NCT01760746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6707566|NCT01760746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6707567|NCT01760746|Growth Substances|growth substances|mesh-ancestor
6707568|NCT01760746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707569|NCT01760746|Growth Inhibitors|growth inhibitors|mesh-ancestor
6707570|NCT01760798|Teriparatide|teriparatide|mesh-list
6707571|NCT01760798|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6707572|NCT01760798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707573|NCT01760798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6707574|NCT01760811|Cetuximab|cetuximab|mesh-list
6707575|NCT01760811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6707576|NCT01760811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6707577|NCT01760824|Amoxicillin|amoxicillin|mesh-list
6707578|NCT01760824|Metronidazole|metronidazole|mesh-list
6707579|NCT01760824|Clarithromycin|clarithromycin|mesh-list
6707580|NCT01760824|Tetracycline|tetracycline|mesh-list
6707581|NCT01760824|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
6707582|NCT01760824|Esomeprazole|esomeprazole|mesh-list
6707583|NCT01760824|Bismuth|bismuth|mesh-list
6707584|NCT01760824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6707585|NCT01760824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6707586|NCT01760824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6707587|NCT01760824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6707588|NCT01760824|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6707589|NCT01760824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6707590|NCT01760824|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6707591|NCT01760824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6707592|NCT01760824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6707593|NCT01760824|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6707594|NCT01760824|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6707595|NCT01760824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6707596|NCT01760824|Antacids|antacids|mesh-ancestor
6707597|NCT01760863|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6707598|NCT01760863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6707599|NCT01760967|Dexmedetomidine|dexmedetomidine|mesh-list
6707600|NCT01760967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6707601|NCT01760967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6707602|NCT01760967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707603|NCT01760967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6707604|NCT01760967|Analgesics|analgesics|mesh-ancestor
6707605|NCT01760967|Sensory System Agents|sensory system agents|mesh-ancestor
6707606|NCT01760967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6707607|NCT01760967|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6707608|NCT01760967|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6707609|NCT01760967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6707610|NCT01760967|Adrenergic Agents|adrenergic agents|mesh-ancestor
6707611|NCT01760967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6707612|NCT01760967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6707613|NCT01760980|Exemestane|exemestane|mesh-list
6707614|NCT01760980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6707615|NCT01760980|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6707616|NCT01760980|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6707617|NCT01760980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6707618|NCT01760980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6707619|NCT01760980|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6707620|NCT01760980|Hormone Antagonists|hormone antagonists|mesh-ancestor
6707621|NCT01760980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6707622|NCT01760980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707623|NCT01761071|Diclofenac|diclofenac|mesh-list
6707624|NCT01761071|Ketorolac|ketorolac|mesh-list
6707625|NCT01761071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6707626|NCT01761071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6707627|NCT01761071|Analgesics|analgesics|mesh-ancestor
6707628|NCT01761071|Sensory System Agents|sensory system agents|mesh-ancestor
6707629|NCT01761071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6707630|NCT01761071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707631|NCT01761071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6707632|NCT01761071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6707633|NCT01761071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6707634|NCT01761071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6707635|NCT01761071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6707636|NCT01761110|Buprenorphine|buprenorphine|mesh-list
6707637|NCT01761110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6707638|NCT01761110|Narcotics|narcotics|mesh-ancestor
6707639|NCT01761110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6707640|NCT01761110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707641|NCT01761110|Analgesics|analgesics|mesh-ancestor
6707642|NCT01761110|Sensory System Agents|sensory system agents|mesh-ancestor
6707643|NCT01761110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6707644|NCT01761110|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6707645|NCT01761136|Vaccines|vaccines|mesh-list
6707646|NCT01761136|Immunologic Factors|immunologic factors|mesh-ancestor
6707647|NCT01761136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707648|NCT01761149|Remifentanil|remifentanil|mesh-list
6707649|NCT01761149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6707650|NCT01761149|Narcotics|narcotics|mesh-ancestor
6707651|NCT01761149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6707652|NCT01761149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707653|NCT01761149|Analgesics|analgesics|mesh-ancestor
6707654|NCT01761149|Sensory System Agents|sensory system agents|mesh-ancestor
6707655|NCT01761149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6707656|NCT01761201|Levofloxacin|levofloxacin|mesh-list
6707657|NCT01761201|Ofloxacin|ofloxacin|mesh-list
6707658|NCT01761201|Isoniazid|isoniazid|mesh-list
6707659|NCT01761201|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6707660|NCT01761201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6707661|NCT01761201|Renal Agents|renal agents|mesh-ancestor
6707662|NCT01761201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6707663|NCT01761201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6707664|NCT01761201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6707665|NCT01761201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6707666|NCT01761201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6707667|NCT01761201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6707668|NCT01761201|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6707669|NCT01761201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6707670|NCT01761201|Antitubercular Agents|antitubercular agents|mesh-ancestor
6707671|NCT01761201|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6707672|NCT01761201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6707673|NCT01761201|Antimetabolites|antimetabolites|mesh-ancestor
6707674|NCT01761201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6707675|NCT01761214|Amoxicillin|amoxicillin|mesh-list
6707676|NCT01761214|Moxifloxacin|moxifloxacin|mesh-list
6707677|NCT01761214|Ciprofloxacin|ciprofloxacin|mesh-list
6707678|NCT01761214|Clavulanic Acid|clavulanic acid|mesh-list
6707679|NCT01761214|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6707680|NCT01761214|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
6707681|NCT01761214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6707682|NCT01761214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6707683|NCT01761214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6707684|NCT01761214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6707685|NCT01761214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6707686|NCT01761214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6707687|NCT01761214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6707688|NCT01761214|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6707689|NCT01761214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6707690|NCT01761318|Liraglutide|liraglutide|mesh-list
6707691|NCT01761318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6707692|NCT01761318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707693|NCT01761318|Incretins|incretins|mesh-ancestor
6707694|NCT01761318|Hormones|hormones|mesh-ancestor
6707695|NCT01761318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6707696|NCT01761344|Hydrocortisone|hydrocortisone|mesh-list
6707697|NCT01761344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6707698|NCT01761461|Oxaliplatin|oxaliplatin|mesh-list
6707699|NCT01761461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6707700|NCT01761487|Gentamicins|gentamicins|mesh-list
6707701|NCT01761487|Polymyxins|polymyxins|mesh-list
6707702|NCT01761487|Colistin|colistin|mesh-list
6707703|NCT01761487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6707704|NCT01761487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6707705|NCT01761487|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6707706|NCT01761487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6707707|NCT01761487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6707708|NCT01761513|Esomeprazole|esomeprazole|mesh-list
6707709|NCT01761513|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6707710|NCT01761513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6707711|NCT01761513|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6707712|NCT01761513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6707713|NCT01761513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6707714|NCT01761526|Rotigotine|rotigotine|mesh-list
6707715|NCT01761526|Dopamine Agonists|dopamine agonists|mesh-ancestor
6707716|NCT01761526|Dopamine Agents|dopamine agents|mesh-ancestor
6707717|NCT01761526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6707718|NCT01761526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6707719|NCT01761526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707720|NCT01761552|Atropine|atropine|mesh-list
6707721|NCT01761552|Neostigmine|neostigmine|mesh-list
6707722|NCT01761552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6707723|NCT01761552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6707724|NCT01761552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6707725|NCT01761552|Autonomic Agents|autonomic agents|mesh-ancestor
6707726|NCT01761552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6707727|NCT01761552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707728|NCT01761552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6707729|NCT01761552|Respiratory System Agents|respiratory system agents|mesh-ancestor
6707730|NCT01761552|Mydriatics|mydriatics|mesh-ancestor
6707731|NCT01761552|Parasympatholytics|parasympatholytics|mesh-ancestor
6707732|NCT01761552|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6707733|NCT01761552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6707734|NCT01761552|Cholinergic Agents|cholinergic agents|mesh-ancestor
6707735|NCT01761552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6707736|NCT01761552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6707737|NCT01761552|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6707738|NCT01761552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6707739|NCT01761552|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6707740|NCT01761656|Atorvastatin|atorvastatin|mesh-list
6707741|NCT01761656|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6707742|NCT01761656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6707743|NCT01761656|Antimetabolites|antimetabolites|mesh-ancestor
6707744|NCT01761656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6707745|NCT01761656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6707746|NCT01761656|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6707747|NCT01761656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6782516|NCT02191280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782517|NCT02191280|Protective Agents|protective agents|mesh-ancestor
6782518|NCT02191280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782519|NCT02191293|Nevirapine|nevirapine|mesh-list
6782520|NCT02191293|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6782521|NCT02191293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6782522|NCT02191293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6782523|NCT02191293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782524|NCT02191293|Antiviral Agents|antiviral agents|mesh-ancestor
6782525|NCT02191293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6782526|NCT02191293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6782527|NCT02191293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6782528|NCT02191293|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6782529|NCT02191293|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6782530|NCT02191319|Nevirapine|nevirapine|mesh-list
6782531|NCT02191319|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6782532|NCT02191319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6782533|NCT02191319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6707748|NCT01761669|Vitamin D|vitamin d|mesh-list
6707749|NCT01761669|Vitamins|vitamins|mesh-ancestor
6707750|NCT01761669|Micronutrients|micronutrients|mesh-ancestor
6707751|NCT01761669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707752|NCT01761669|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6707753|NCT01761877|Sulindac|sulindac|mesh-list
6707754|NCT01761877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6707755|NCT01761877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6707756|NCT01761877|Analgesics|analgesics|mesh-ancestor
6707757|NCT01761877|Sensory System Agents|sensory system agents|mesh-ancestor
6707758|NCT01761877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6707759|NCT01761877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707760|NCT01761877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6707761|NCT01761877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6707762|NCT01761877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6707763|NCT01761877|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6707764|NCT01761877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6707765|NCT01761877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6707766|NCT01761916|Clonidine|clonidine|mesh-list
6707767|NCT01761916|Captopril|captopril|mesh-list
6707768|NCT01761916|Analgesics|analgesics|mesh-ancestor
6707769|NCT01761916|Sensory System Agents|sensory system agents|mesh-ancestor
6707770|NCT01761916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6707771|NCT01761916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707772|NCT01761916|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6707773|NCT01761916|Sympatholytics|sympatholytics|mesh-ancestor
6707774|NCT01761916|Autonomic Agents|autonomic agents|mesh-ancestor
6707775|NCT01761916|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6707776|NCT01761916|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6707777|NCT01761916|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6707778|NCT01761916|Adrenergic Agents|adrenergic agents|mesh-ancestor
6707779|NCT01761916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6707780|NCT01761916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6707781|NCT01761916|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6707782|NCT01761916|Protease Inhibitors|protease inhibitors|mesh-ancestor
6707783|NCT01761916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6707784|NCT01761968|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
6707785|NCT01761968|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6707786|NCT01761968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6707787|NCT01761968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6707788|NCT01761994|Nafamostat|nafamostat|mesh-list
6707789|NCT01761994|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6707790|NCT01761994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6707791|NCT01761994|Analgesics|analgesics|mesh-ancestor
6707792|NCT01761994|Sensory System Agents|sensory system agents|mesh-ancestor
6707793|NCT01761994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6707794|NCT01761994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707795|NCT01761994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6707796|NCT01761994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6707797|NCT01761994|Anticoagulants|anticoagulants|mesh-ancestor
6707798|NCT01761994|Protease Inhibitors|protease inhibitors|mesh-ancestor
6707799|NCT01761994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6707800|NCT01761994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6707801|NCT01761994|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6707802|NCT01761994|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6707803|NCT01761994|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6707804|NCT01761994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6707805|NCT01761994|Immunologic Factors|immunologic factors|mesh-ancestor
6707806|NCT01762046|Metformin|metformin|mesh-list
6707807|NCT01762046|Glipizide|glipizide|mesh-list
6707808|NCT01762046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6707809|NCT01762046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707810|NCT01762150|Gemcitabine|gemcitabine|mesh-list
6707811|NCT01762150|Sorafenib|sorafenib|mesh-list
6707812|NCT01762150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6707813|NCT01762150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6707814|NCT01762150|Antimetabolites|antimetabolites|mesh-ancestor
6707815|NCT01762150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6707816|NCT01762150|Antiviral Agents|antiviral agents|mesh-ancestor
6707817|NCT01762150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6707818|NCT01762150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6707819|NCT01762150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6707820|NCT01762150|Immunologic Factors|immunologic factors|mesh-ancestor
6707821|NCT01762150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707822|NCT01762150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6707823|NCT01762163|Aspirin|aspirin|mesh-list
6707824|NCT01762163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6707825|NCT01762163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6707826|NCT01762163|Analgesics|analgesics|mesh-ancestor
6707827|NCT01762163|Sensory System Agents|sensory system agents|mesh-ancestor
6707828|NCT01762163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6707829|NCT01762163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707830|NCT01762163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6707831|NCT01762163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6707832|NCT01762163|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6707833|NCT01762163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6707834|NCT01762163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6707835|NCT01762163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6707836|NCT01762163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6707837|NCT01762163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6707838|NCT01762163|Antipyretics|antipyretics|mesh-ancestor
6707839|NCT01762202|Cyclophosphamide|cyclophosphamide|mesh-list
6707840|NCT01762202|Fludarabine|fludarabine|mesh-list
6707841|NCT01762202|Ofatumumab|ofatumumab|mesh-list
6707842|NCT01762202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6707843|NCT01762202|Immunologic Factors|immunologic factors|mesh-ancestor
6707844|NCT01762202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707845|NCT01762202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6707846|NCT01762202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6707847|NCT01762202|Alkylating Agents|alkylating agents|mesh-ancestor
6707848|NCT01762202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6707849|NCT01762202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6707850|NCT01762202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6707851|NCT01762306|Folic Acid|folic acid|mesh-list
6707852|NCT01762306|Diclofenac|diclofenac|mesh-list
6707853|NCT01762306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6707854|NCT01762306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6707855|NCT01762306|Analgesics|analgesics|mesh-ancestor
6707856|NCT01762306|Sensory System Agents|sensory system agents|mesh-ancestor
6707857|NCT01762306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6707858|NCT01762306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707859|NCT01762306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6707860|NCT01762306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6707861|NCT01762306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6707862|NCT01762306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6707863|NCT01762306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6707864|NCT01762306|Hematinics|hematinics|mesh-ancestor
6707865|NCT01762306|Vitamin B Complex|vitamin b complex|mesh-ancestor
6707866|NCT01762306|Vitamins|vitamins|mesh-ancestor
6707867|NCT01762306|Micronutrients|micronutrients|mesh-ancestor
6707868|NCT01762319|Vitamin B 6|vitamin b 6|mesh-list
6707869|NCT01762319|Pyridoxal|pyridoxal|mesh-list
6707870|NCT01762319|Pyridoxine|pyridoxine|mesh-list
6707871|NCT01762319|Misoprostol|misoprostol|mesh-list
6707872|NCT01762319|Vitamins|vitamins|mesh-ancestor
6707873|NCT01762319|Micronutrients|micronutrients|mesh-ancestor
6707874|NCT01762319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707875|NCT01762319|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6707876|NCT01762319|Abortifacient Agents|abortifacient agents|mesh-ancestor
6707877|NCT01762319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6707878|NCT01762319|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6707879|NCT01762319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6707880|NCT01762319|Oxytocics|oxytocics|mesh-ancestor
6707881|NCT01762319|Vitamin B Complex|vitamin b complex|mesh-ancestor
6707882|NCT01762332|Remifentanil|remifentanil|mesh-list
6707883|NCT01762332|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
6707884|NCT01762332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6707885|NCT01762332|Narcotics|narcotics|mesh-ancestor
6707886|NCT01762332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6707887|NCT01762332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707888|NCT01762332|Analgesics|analgesics|mesh-ancestor
6707889|NCT01762332|Sensory System Agents|sensory system agents|mesh-ancestor
6707890|NCT01762332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6707891|NCT01762332|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6707892|NCT01762332|Adrenergic Agents|adrenergic agents|mesh-ancestor
6707893|NCT01762332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6707894|NCT01762332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6707895|NCT01762436|Atenolol|atenolol|mesh-list
6707896|NCT01762436|Bisoprolol|bisoprolol|mesh-list
6707897|NCT01762436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6707898|NCT01762436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6707899|NCT01762436|Sympatholytics|sympatholytics|mesh-ancestor
6707900|NCT01762436|Autonomic Agents|autonomic agents|mesh-ancestor
6707901|NCT01762436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6707902|NCT01762436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707903|NCT01762436|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6707904|NCT01762436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6707905|NCT01762436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6707906|NCT01762436|Adrenergic Agents|adrenergic agents|mesh-ancestor
6707907|NCT01762436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6707908|NCT01762436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6707909|NCT01762475|Sildenafil Citrate|sildenafil citrate|mesh-list
6707910|NCT01762475|Vasodilator Agents|vasodilator agents|mesh-ancestor
6707911|NCT01762475|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6707912|NCT01762475|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6707913|NCT01762475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6707914|NCT01762475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6707915|NCT01762475|Urological Agents|urological agents|mesh-ancestor
6707916|NCT01762514|Amifostine|amifostine|mesh-list
6707917|NCT01762514|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6707918|NCT01762514|Protective Agents|protective agents|mesh-ancestor
6707919|NCT01762514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707920|NCT01762540|Prednisolone|prednisolone|mesh-list
6707921|NCT01762540|Calcium|calcium|mesh-list
6707922|NCT01762540|Glucocorticoids|glucocorticoids|mesh-list
6707923|NCT01762540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6707924|NCT01762540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707925|NCT01762540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6707926|NCT01762540|Hormones|hormones|mesh-ancestor
6707927|NCT01762540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6707928|NCT01762540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6707929|NCT01762540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6707930|NCT01762644|Cyclosporine|cyclosporine|mesh-list
6707931|NCT01762644|Omeprazole|omeprazole|mesh-list
6707932|NCT01762644|Cyclosporins|cyclosporins|mesh-list
6707933|NCT01762644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6707934|NCT01762644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6707935|NCT01762644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6707936|NCT01762644|Immunologic Factors|immunologic factors|mesh-ancestor
6707937|NCT01762644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707938|NCT01762644|Antifungal Agents|antifungal agents|mesh-ancestor
6707939|NCT01762644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6707940|NCT01762644|Dermatologic Agents|dermatologic agents|mesh-ancestor
6707941|NCT01762644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6707942|NCT01762644|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6707943|NCT01762644|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6707944|NCT01762644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6707945|NCT01762644|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6707946|NCT01762657|Cyclosporine|cyclosporine|mesh-list
6707947|NCT01762657|Lansoprazole|lansoprazole|mesh-list
6707948|NCT01762657|Dexlansoprazole|dexlansoprazole|mesh-list
6707949|NCT01762657|Cyclosporins|cyclosporins|mesh-list
6707950|NCT01762657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6707951|NCT01762657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6707952|NCT01762657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6707953|NCT01762657|Immunologic Factors|immunologic factors|mesh-ancestor
6707954|NCT01762657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707955|NCT01762657|Antifungal Agents|antifungal agents|mesh-ancestor
6707956|NCT01762657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6707957|NCT01762657|Dermatologic Agents|dermatologic agents|mesh-ancestor
6707958|NCT01762657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6707959|NCT01762657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6707960|NCT01762657|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6707961|NCT01762657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6707962|NCT01762657|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6707963|NCT01762670|Metronidazole|metronidazole|mesh-list
6707964|NCT01762670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6707965|NCT01762670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6707966|NCT01762670|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6707967|NCT01762670|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6707968|NCT01762787|Aspirin|aspirin|mesh-list
6707969|NCT01762787|Prednisolone|prednisolone|mesh-list
6707970|NCT01762787|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6707971|NCT01762787|Methylprednisolone|methylprednisolone|mesh-list
6707972|NCT01762787|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6707973|NCT01762787|Prednisolone acetate|prednisolone acetate|mesh-list
6707974|NCT01762787|Cantharidin|cantharidin|mesh-list
6707975|NCT01762787|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6707976|NCT01762787|Prednisolone phosphate|prednisolone phosphate|mesh-list
6707977|NCT01762787|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6707978|NCT01762787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6707979|NCT01762787|Analgesics|analgesics|mesh-ancestor
6707980|NCT01762787|Sensory System Agents|sensory system agents|mesh-ancestor
6707981|NCT01762787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6707982|NCT01762787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6707983|NCT01762787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6707984|NCT01762787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6707985|NCT01762787|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6707986|NCT01762787|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6707987|NCT01762787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6707988|NCT01762787|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6707989|NCT01762787|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6707990|NCT01762787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6707991|NCT01762787|Antipyretics|antipyretics|mesh-ancestor
6707992|NCT01762787|Glucocorticoids|glucocorticoids|mesh-ancestor
6707993|NCT01762787|Hormones|hormones|mesh-ancestor
6707994|NCT01762787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6707995|NCT01762787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6707996|NCT01762787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6707997|NCT01762787|Antiemetics|antiemetics|mesh-ancestor
6707998|NCT01762787|Autonomic Agents|autonomic agents|mesh-ancestor
6707999|NCT01762787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6708000|NCT01762787|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6708001|NCT01762787|Protective Agents|protective agents|mesh-ancestor
6708002|NCT01762826|Inositol|inositol|mesh-list
6708003|NCT01762826|Vitamin B Complex|vitamin b complex|mesh-ancestor
6708004|NCT01762826|Vitamins|vitamins|mesh-ancestor
6708005|NCT01762826|Micronutrients|micronutrients|mesh-ancestor
6708006|NCT01762826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708007|NCT01762839|Moxifloxacin|moxifloxacin|mesh-list
6708008|NCT01762839|Oritavancin|oritavancin|mesh-list
6708009|NCT01762839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6708010|NCT01762839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6708011|NCT01762839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6708012|NCT01762839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6708013|NCT01762839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6708014|NCT01762839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708015|NCT01762839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6708016|NCT01762852|Belimumab|belimumab|mesh-list
6708017|NCT01762852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6708018|NCT01762852|Immunologic Factors|immunologic factors|mesh-ancestor
6708019|NCT01762852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708020|NCT01762878|Nemiralisib|nemiralisib|mesh-list
6708021|NCT01762878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6708022|NCT01762878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6708023|NCT01762878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708024|NCT01762891|Acetaminophen|acetaminophen|mesh-list
6708025|NCT01762891|Celecoxib|celecoxib|mesh-list
6708026|NCT01762891|Rofecoxib|rofecoxib|mesh-list
6708027|NCT01762891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6708028|NCT01762891|Analgesics|analgesics|mesh-ancestor
6708029|NCT01762891|Sensory System Agents|sensory system agents|mesh-ancestor
6708030|NCT01762891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6708031|NCT01762891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708032|NCT01762891|Antipyretics|antipyretics|mesh-ancestor
6708033|NCT01762891|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6708034|NCT01762891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6708035|NCT01762891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6708036|NCT01762891|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6708037|NCT01762891|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6708038|NCT01762891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6708039|NCT01762891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708040|NCT01762995|Ferrous fumarate|ferrous fumarate|mesh-list
6708041|NCT01762995|Dolutegravir|dolutegravir|mesh-list
6708042|NCT01762995|Calcium Carbonate|calcium carbonate|mesh-list
6708043|NCT01762995|Calcium|calcium|mesh-list
6708044|NCT01762995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6708045|NCT01762995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708046|NCT01762995|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6708047|NCT01762995|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6708048|NCT01762995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6708049|NCT01762995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708050|NCT01762995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6708051|NCT01762995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6708052|NCT01762995|Antiviral Agents|antiviral agents|mesh-ancestor
6708053|NCT01762995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6708054|NCT01762995|Antacids|antacids|mesh-ancestor
6708055|NCT01762995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6708056|NCT01762995|Trace Elements|trace elements|mesh-ancestor
6708057|NCT01762995|Micronutrients|micronutrients|mesh-ancestor
6708058|NCT01763021|Rifampin|rifampin|mesh-list
6708059|NCT01763021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6708060|NCT01763021|Antitubercular Agents|antitubercular agents|mesh-ancestor
6708061|NCT01763021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6708062|NCT01763021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6708063|NCT01763021|Leprostatic Agents|leprostatic agents|mesh-ancestor
6708064|NCT01763021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6708065|NCT01763021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6708066|NCT01763021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708067|NCT01763021|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6708068|NCT01763021|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6708069|NCT01763021|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6708070|NCT01763021|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6708071|NCT01763021|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6708072|NCT01763021|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6782534|NCT02191319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782535|NCT02191319|Antiviral Agents|antiviral agents|mesh-ancestor
6782536|NCT02191319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6782537|NCT02191319|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6782538|NCT02191319|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6782539|NCT02191319|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6782540|NCT02191319|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6782541|NCT02191332|Nevirapine|nevirapine|mesh-list
6782542|NCT02191332|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6782543|NCT02191332|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6782544|NCT02191332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6782545|NCT02191332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708073|NCT01763281|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
6708074|NCT01763281|Hormones|hormones|mesh-ancestor
6708075|NCT01763281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6708076|NCT01763281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708077|NCT01763385|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6708078|NCT01763385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6708079|NCT01763385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6708080|NCT01763385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6708081|NCT01763385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708082|NCT01763424|Calcitriol|calcitriol|mesh-list
6708083|NCT01763424|Niacinamide|niacinamide|mesh-list
6708084|NCT01763424|Niacin|niacin|mesh-list
6708085|NCT01763424|Nicotinic Acids|nicotinic acids|mesh-list
6708086|NCT01763424|Calcipotriene|calcipotriene|mesh-list
6708087|NCT01763424|Vitamin B Complex|vitamin b complex|mesh-ancestor
6708088|NCT01763424|Vitamins|vitamins|mesh-ancestor
6708089|NCT01763424|Micronutrients|micronutrients|mesh-ancestor
6708090|NCT01763424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708091|NCT01763424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6708092|NCT01763424|Antimetabolites|antimetabolites|mesh-ancestor
6708093|NCT01763424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708094|NCT01763424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6708095|NCT01763424|Vasodilator Agents|vasodilator agents|mesh-ancestor
6708096|NCT01763424|Dermatologic Agents|dermatologic agents|mesh-ancestor
6708097|NCT01763424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6708098|NCT01763424|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6708099|NCT01763424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6708100|NCT01763424|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6708101|NCT01763424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6708102|NCT01763437|Tetracycline|tetracycline|mesh-list
6708103|NCT01763437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6708104|NCT01763437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6708105|NCT01763437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6708106|NCT01763437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6708107|NCT01763437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708108|NCT01763450|Bevacizumab|bevacizumab|mesh-list
6708109|NCT01763450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6708110|NCT01763450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6708111|NCT01763450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6708112|NCT01763450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6708113|NCT01763450|Growth Substances|growth substances|mesh-ancestor
6708114|NCT01763450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708115|NCT01763450|Growth Inhibitors|growth inhibitors|mesh-ancestor
6708116|NCT01763463|Fluticasone|fluticasone|mesh-list
6708117|NCT01763463|Xhance|xhance|mesh-list
6708118|NCT01763463|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6708119|NCT01763463|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6708120|NCT01763463|Bronchodilator Agents|bronchodilator agents|mesh-list
6708121|NCT01763463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6708122|NCT01763463|Autonomic Agents|autonomic agents|mesh-ancestor
6708123|NCT01763463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6708124|NCT01763463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708125|NCT01763463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6708126|NCT01763463|Respiratory System Agents|respiratory system agents|mesh-ancestor
6708127|NCT01763463|Dermatologic Agents|dermatologic agents|mesh-ancestor
6708128|NCT01763463|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6708129|NCT01763463|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6708130|NCT01763463|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6708131|NCT01763463|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6708132|NCT01763463|Adrenergic Agents|adrenergic agents|mesh-ancestor
6708133|NCT01763463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6708134|NCT01763463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708135|NCT01763463|Glucocorticoids|glucocorticoids|mesh-ancestor
6708136|NCT01763463|Hormones|hormones|mesh-ancestor
6708137|NCT01763463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6708138|NCT01763463|Sympathomimetics|sympathomimetics|mesh-ancestor
6708139|NCT01763476|Paclitaxel|paclitaxel|mesh-list
6708140|NCT01763476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6708141|NCT01763476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6708142|NCT01763476|Tubulin Modulators|tubulin modulators|mesh-ancestor
6708143|NCT01763476|Antimitotic Agents|antimitotic agents|mesh-ancestor
6708144|NCT01763476|Mitosis Modulators|mitosis modulators|mesh-ancestor
6708145|NCT01763476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708146|NCT01763541|Anastrozole|anastrozole|mesh-list
6708147|NCT01763541|Leuprolide|leuprolide|mesh-list
6708148|NCT01763541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6708149|NCT01763541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6708150|NCT01763541|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6708151|NCT01763541|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6708152|NCT01763541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6708153|NCT01763541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708154|NCT01763541|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6708155|NCT01763541|Hormone Antagonists|hormone antagonists|mesh-ancestor
6708156|NCT01763541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6708157|NCT01763541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708158|NCT01763541|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6708159|NCT01763541|Fertility Agents|fertility agents|mesh-ancestor
6708160|NCT01763541|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6708161|NCT01763580|Prednisolone|prednisolone|mesh-list
6708162|NCT01763580|Tacrolimus|tacrolimus|mesh-list
6708163|NCT01763580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6708164|NCT01763580|Immunologic Factors|immunologic factors|mesh-ancestor
6708165|NCT01763580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708166|NCT01763580|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6708167|NCT01763580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6708168|NCT01763580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708169|NCT01763580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6708170|NCT01763580|Glucocorticoids|glucocorticoids|mesh-ancestor
6708171|NCT01763580|Hormones|hormones|mesh-ancestor
6708172|NCT01763580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6708173|NCT01763580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6708174|NCT01763580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6708175|NCT01763658|Dexamethasone|dexamethasone|mesh-list
6708176|NCT01763658|Prednisolone|prednisolone|mesh-list
6708177|NCT01763658|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6708178|NCT01763658|Immunoglobulins|immunoglobulins|mesh-list
6708179|NCT01763658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6708180|NCT01763658|gamma-Globulins|gamma-globulins|mesh-list
6708181|NCT01763658|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6708182|NCT01763658|Antioxidants|antioxidants|mesh-list
6708183|NCT01763658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6708184|NCT01763658|Antiemetics|antiemetics|mesh-ancestor
6708185|NCT01763658|Autonomic Agents|autonomic agents|mesh-ancestor
6708186|NCT01763658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6708187|NCT01763658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708188|NCT01763658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6708189|NCT01763658|Glucocorticoids|glucocorticoids|mesh-ancestor
6708190|NCT01763658|Hormones|hormones|mesh-ancestor
6708191|NCT01763658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6708192|NCT01763658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6708193|NCT01763658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6708194|NCT01763658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708195|NCT01763658|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6708196|NCT01763658|Protective Agents|protective agents|mesh-ancestor
6708197|NCT01763658|Immunologic Factors|immunologic factors|mesh-ancestor
6708198|NCT01763671|Paclitaxel|paclitaxel|mesh-list
6708199|NCT01763671|Docetaxel|docetaxel|mesh-list
6708200|NCT01763671|Bevacizumab|bevacizumab|mesh-list
6708201|NCT01763671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6708202|NCT01763671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6708203|NCT01763671|Tubulin Modulators|tubulin modulators|mesh-ancestor
6708204|NCT01763671|Antimitotic Agents|antimitotic agents|mesh-ancestor
6708205|NCT01763671|Mitosis Modulators|mitosis modulators|mesh-ancestor
6708206|NCT01763671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708207|NCT01763671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6708208|NCT01763671|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6708209|NCT01763671|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6708210|NCT01763671|Growth Substances|growth substances|mesh-ancestor
6708211|NCT01763671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708212|NCT01763671|Growth Inhibitors|growth inhibitors|mesh-ancestor
6708213|NCT01763710|Paclitaxel|paclitaxel|mesh-list
6708214|NCT01763710|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6708215|NCT01763710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6708216|NCT01763710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6708217|NCT01763710|Tubulin Modulators|tubulin modulators|mesh-ancestor
6708218|NCT01763710|Antimitotic Agents|antimitotic agents|mesh-ancestor
6708219|NCT01763710|Mitosis Modulators|mitosis modulators|mesh-ancestor
6708220|NCT01763710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708221|NCT01763749|Clopidogrel|clopidogrel|mesh-list
6708222|NCT01763749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6708223|NCT01763749|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6708224|NCT01763749|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6708225|NCT01763749|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6708226|NCT01763749|Purinergic Agents|purinergic agents|mesh-ancestor
6708227|NCT01763749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6708228|NCT01763749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708229|NCT01763749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708230|NCT01763788|Gemcitabine|gemcitabine|mesh-list
6708231|NCT01763788|Necitumumab|necitumumab|mesh-list
6708232|NCT01763788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6708233|NCT01763788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6708234|NCT01763788|Antimetabolites|antimetabolites|mesh-ancestor
6708235|NCT01763788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708236|NCT01763788|Antiviral Agents|antiviral agents|mesh-ancestor
6708237|NCT01763788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6708238|NCT01763788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6708239|NCT01763788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6708240|NCT01763788|Immunologic Factors|immunologic factors|mesh-ancestor
6708241|NCT01763788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708242|NCT01763788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6708243|NCT01764087|Paclitaxel|paclitaxel|mesh-list
6708244|NCT01764087|Tirbanibulin|tirbanibulin|mesh-list
6708245|NCT01764087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6708246|NCT01764087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6708247|NCT01764087|Tubulin Modulators|tubulin modulators|mesh-ancestor
6708248|NCT01764087|Antimitotic Agents|antimitotic agents|mesh-ancestor
6708249|NCT01764087|Mitosis Modulators|mitosis modulators|mesh-ancestor
6708250|NCT01764087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708251|NCT01764087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6708252|NCT01764126|Vaccines|vaccines|mesh-list
6708253|NCT01764126|Immunologic Factors|immunologic factors|mesh-ancestor
6708254|NCT01764126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708255|NCT01764139|Vitamin D|vitamin d|mesh-list
6708256|NCT01764139|Vitamins|vitamins|mesh-ancestor
6708257|NCT01764139|Micronutrients|micronutrients|mesh-ancestor
6708258|NCT01764139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708259|NCT01764139|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6708260|NCT01764178|Valsartan|valsartan|mesh-list
6708261|NCT01764178|Pitavastatin|pitavastatin|mesh-list
6708262|NCT01764178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6708263|NCT01764178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6708264|NCT01764178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6708265|NCT01764178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708266|NCT01764178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6708267|NCT01764178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6708268|NCT01764178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6708269|NCT01764178|Antimetabolites|antimetabolites|mesh-ancestor
6708270|NCT01764178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6708271|NCT01764178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6708272|NCT01764230|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6708273|NCT01764230|Luteolytic Agents|luteolytic agents|mesh-ancestor
6708274|NCT01764230|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6708275|NCT01764230|Contraceptive Agents|contraceptive agents|mesh-ancestor
6708276|NCT01764230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6708277|NCT01764230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708278|NCT01764230|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6708279|NCT01764230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6708280|NCT01764230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6708281|NCT01764295|Olmesartan|olmesartan|mesh-list
6708282|NCT01764295|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6708283|NCT01764295|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6708284|NCT01764295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6708285|NCT01764295|Antimetabolites|antimetabolites|mesh-ancestor
6708286|NCT01764295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708287|NCT01764295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6708288|NCT01764295|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6708289|NCT01764295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6708290|NCT01764295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6708291|NCT01764295|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6708292|NCT01764295|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6708293|NCT01764451|Simvastatin|simvastatin|mesh-list
6708294|NCT01764451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6708295|NCT01764451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6708296|NCT01764451|Antimetabolites|antimetabolites|mesh-ancestor
6708297|NCT01764451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708298|NCT01764451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6708299|NCT01764451|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6708300|NCT01764451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6708301|NCT01764555|Acetaminophen|acetaminophen|mesh-list
6708302|NCT01764555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6708303|NCT01764555|Analgesics|analgesics|mesh-ancestor
6708304|NCT01764555|Sensory System Agents|sensory system agents|mesh-ancestor
6708305|NCT01764555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6708306|NCT01764555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708307|NCT01764555|Antipyretics|antipyretics|mesh-ancestor
6708308|NCT01764581|Tacrolimus|tacrolimus|mesh-list
6708309|NCT01764581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6708310|NCT01764581|Immunologic Factors|immunologic factors|mesh-ancestor
6708311|NCT01764581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708312|NCT01764581|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6708313|NCT01764581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6708314|NCT01764581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708315|NCT01764672|Methylphenidate|methylphenidate|mesh-list
6708316|NCT01764672|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6708317|NCT01764672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708318|NCT01764672|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6708319|NCT01764672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6708320|NCT01764672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6708321|NCT01764672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708322|NCT01764672|Dopamine Agents|dopamine agents|mesh-ancestor
6708323|NCT01764672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6708324|NCT01764750|Vancomycin|vancomycin|mesh-list
6708325|NCT01764750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6708326|NCT01764750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6782546|NCT02191332|Antiviral Agents|antiviral agents|mesh-ancestor
6782547|NCT02191332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6782548|NCT02191332|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6782549|NCT02191332|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6782550|NCT02191332|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6782551|NCT02191332|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6782552|NCT02191371|Propofol|propofol|mesh-list
6782553|NCT02191371|Desflurane|desflurane|mesh-list
6782554|NCT02191371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6782555|NCT02191371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6782556|NCT02191371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782557|NCT02191371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6782558|NCT02191371|Anesthetics, General|anesthetics, general|mesh-ancestor
6782559|NCT02191371|Anesthetics|anesthetics|mesh-ancestor
6782560|NCT02191371|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6782561|NCT02191423|Oxytocin|oxytocin|mesh-list
6782562|NCT02191423|Oxytocics|oxytocics|mesh-ancestor
6782563|NCT02191423|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6782564|NCT02191423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782565|NCT02191475|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
6782566|NCT02191475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6782567|NCT02191475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6782568|NCT02191475|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6782569|NCT02191475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6782570|NCT02191475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782571|NCT02191488|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6782572|NCT02191488|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6782573|NCT02191488|Dermatologic Agents|dermatologic agents|mesh-ancestor
6782574|NCT02191566|Oxaliplatin|oxaliplatin|mesh-list
6782575|NCT02191566|Tegafur|tegafur|mesh-list
6782576|NCT02191566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6782577|NCT02191566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6782578|NCT02191566|Antimetabolites|antimetabolites|mesh-ancestor
6782579|NCT02191566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782580|NCT02191657|Deferiprone|deferiprone|mesh-list
6782581|NCT02191657|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6782582|NCT02191657|Chelating Agents|chelating agents|mesh-ancestor
6782583|NCT02191657|Sequestering Agents|sequestering agents|mesh-ancestor
6708327|NCT01764828|Gemcitabine|gemcitabine|mesh-list
6708328|NCT01764828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6708329|NCT01764828|Antimetabolites|antimetabolites|mesh-ancestor
6708330|NCT01764828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708331|NCT01764828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6708332|NCT01764828|Antiviral Agents|antiviral agents|mesh-ancestor
6708333|NCT01764828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6708334|NCT01764828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6708335|NCT01764828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6708336|NCT01764828|Immunologic Factors|immunologic factors|mesh-ancestor
6708337|NCT01764828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708338|NCT01764867|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6708339|NCT01764867|Dexetimide|dexetimide|mesh-list
6708340|NCT01764867|Mirtazapine|mirtazapine|mesh-list
6708341|NCT01764867|Trazodone|trazodone|mesh-list
6708342|NCT01764867|Fluvoxamine|fluvoxamine|mesh-list
6708343|NCT01764867|Citalopram|citalopram|mesh-list
6708344|NCT01764867|Bupropion|bupropion|mesh-list
6708345|NCT01764867|Fluoxetine|fluoxetine|mesh-list
6708346|NCT01764867|Paroxetine|paroxetine|mesh-list
6708347|NCT01764867|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6708348|NCT01764867|Sertraline|sertraline|mesh-list
6708349|NCT01764867|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6708350|NCT01764867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6708351|NCT01764867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6708352|NCT01764867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708353|NCT01764867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6708354|NCT01764867|Serotonin Agents|serotonin agents|mesh-ancestor
6708355|NCT01764867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708356|NCT01764867|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6708357|NCT01764867|Antidepressive Agents|antidepressive agents|mesh-ancestor
6708358|NCT01764867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6708359|NCT01764867|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6708360|NCT01764867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6708361|NCT01764867|Parasympatholytics|parasympatholytics|mesh-ancestor
6708362|NCT01764867|Autonomic Agents|autonomic agents|mesh-ancestor
6708363|NCT01764867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6708364|NCT01764867|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6708365|NCT01764867|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6708366|NCT01764867|Cholinergic Agents|cholinergic agents|mesh-ancestor
6708367|NCT01764867|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6708368|NCT01764867|Dopamine Agents|dopamine agents|mesh-ancestor
6708369|NCT01764867|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6708370|NCT01764867|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6708371|NCT01764867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6708372|NCT01764867|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6708373|NCT01764867|Analgesics|analgesics|mesh-ancestor
6708374|NCT01764867|Sensory System Agents|sensory system agents|mesh-ancestor
6708375|NCT01764867|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6708376|NCT01764867|Histamine Antagonists|histamine antagonists|mesh-ancestor
6708377|NCT01764867|Histamine Agents|histamine agents|mesh-ancestor
6708378|NCT01764867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6708379|NCT01764867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6708380|NCT01764867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6708381|NCT01764867|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6708382|NCT01764867|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6708383|NCT01764867|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6708384|NCT01764867|Adrenergic Agents|adrenergic agents|mesh-ancestor
6708385|NCT01764867|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6708386|NCT01764867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6708387|NCT01764867|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6708388|NCT01764867|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6708389|NCT01764867|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6708390|NCT01764893|Solifenacin Succinate|solifenacin succinate|mesh-list
6708391|NCT01764893|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6708392|NCT01764893|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6708393|NCT01764893|Cholinergic Agents|cholinergic agents|mesh-ancestor
6708394|NCT01764893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6708395|NCT01764893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708396|NCT01764893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708397|NCT01764893|Urological Agents|urological agents|mesh-ancestor
6708398|NCT01765010|Cholecalciferol|cholecalciferol|mesh-list
6708399|NCT01765010|Calcitriol|calcitriol|mesh-list
6708400|NCT01765010|Alfacalcidol|alfacalcidol|mesh-list
6708401|NCT01765010|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
6708402|NCT01765010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6708403|NCT01765010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708404|NCT01765010|Vitamins|vitamins|mesh-ancestor
6708405|NCT01765010|Micronutrients|micronutrients|mesh-ancestor
6708406|NCT01765010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6708407|NCT01765010|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6708408|NCT01765010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6708409|NCT01765010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708410|NCT01765010|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6708411|NCT01765023|Metformin|metformin|mesh-list
6708412|NCT01765023|Atorvastatin|atorvastatin|mesh-list
6708413|NCT01765023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6708414|NCT01765023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708415|NCT01765023|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6708416|NCT01765023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6708417|NCT01765023|Antimetabolites|antimetabolites|mesh-ancestor
6708418|NCT01765023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708419|NCT01765023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6708420|NCT01765023|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6708421|NCT01765023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6708422|NCT01765088|Temozolomide|temozolomide|mesh-list
6708423|NCT01765088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6708424|NCT01765088|Alkylating Agents|alkylating agents|mesh-ancestor
6708425|NCT01765088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708426|NCT01765088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6708427|NCT01765218|Topiramate|topiramate|mesh-list
6708428|NCT01765218|Anticonvulsants|anticonvulsants|mesh-ancestor
6708429|NCT01765218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6708430|NCT01765218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708431|NCT01765231|Entecavir|entecavir|mesh-list
6708432|NCT01765231|Antiviral Agents|antiviral agents|mesh-ancestor
6708433|NCT01765231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6708434|NCT01765257|Rasagiline|rasagiline|mesh-list
6708435|NCT01765257|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6708436|NCT01765257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6708437|NCT01765257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708438|NCT01765257|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6708439|NCT01765257|Protective Agents|protective agents|mesh-ancestor
6708440|NCT01765257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708441|NCT01765296|Celecoxib|celecoxib|mesh-list
6708442|NCT01765296|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6708443|NCT01765296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6708444|NCT01765296|Analgesics|analgesics|mesh-ancestor
6708445|NCT01765296|Sensory System Agents|sensory system agents|mesh-ancestor
6708446|NCT01765296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6708447|NCT01765296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708448|NCT01765296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6708449|NCT01765296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6708450|NCT01765296|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6708451|NCT01765296|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6708452|NCT01765296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6708453|NCT01765296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708454|NCT01765309|Botulinum Toxins|botulinum toxins|mesh-list
6708455|NCT01765309|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6708456|NCT01765309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6708457|NCT01765309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708458|NCT01765309|Cholinergic Agents|cholinergic agents|mesh-ancestor
6708459|NCT01765309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6708460|NCT01765309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708461|NCT01765374|Rituximab|rituximab|mesh-list
6708462|NCT01765374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6708463|NCT01765374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6708464|NCT01765374|Immunologic Factors|immunologic factors|mesh-ancestor
6708465|NCT01765374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708466|NCT01765374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6708467|NCT01765400|Clopidogrel|clopidogrel|mesh-list
6708468|NCT01765400|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6708469|NCT01765400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6708470|NCT01765400|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6708471|NCT01765400|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6708472|NCT01765400|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6708473|NCT01765400|Purinergic Agents|purinergic agents|mesh-ancestor
6708474|NCT01765400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6708475|NCT01765400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708476|NCT01765400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708477|NCT01765452|Clopidogrel|clopidogrel|mesh-list
6708478|NCT01765452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6708479|NCT01765452|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6708480|NCT01765452|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6708481|NCT01765452|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6708482|NCT01765452|Purinergic Agents|purinergic agents|mesh-ancestor
6708483|NCT01765452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6708484|NCT01765452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708485|NCT01765452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708486|NCT01765556|Ketoconazole|ketoconazole|mesh-list
6708487|NCT01765556|Vemurafenib|vemurafenib|mesh-list
6708488|NCT01765556|Antifungal Agents|antifungal agents|mesh-ancestor
6708489|NCT01765556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6708490|NCT01765556|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6708491|NCT01765556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6708492|NCT01765556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6708493|NCT01765556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708494|NCT01765556|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6708495|NCT01765556|Hormone Antagonists|hormone antagonists|mesh-ancestor
6708496|NCT01765556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6708497|NCT01765556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708498|NCT01765556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6708499|NCT01765556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6708500|NCT01765556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6708501|NCT01765608|Zonisamide|zonisamide|mesh-list
6708502|NCT01765608|Anticonvulsants|anticonvulsants|mesh-ancestor
6708503|NCT01765608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6708504|NCT01765608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6708505|NCT01765608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708506|NCT01765608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6708507|NCT01765608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708508|NCT01765738|Minocycline|minocycline|mesh-list
6708509|NCT01765738|Rifampin|rifampin|mesh-list
6708510|NCT01765738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6708511|NCT01765738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6708512|NCT01765738|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6708513|NCT01765738|Antitubercular Agents|antitubercular agents|mesh-ancestor
6708514|NCT01765738|Leprostatic Agents|leprostatic agents|mesh-ancestor
6708515|NCT01765738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6708516|NCT01765738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6708517|NCT01765738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708518|NCT01765738|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6708519|NCT01765738|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6708520|NCT01765738|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6708521|NCT01765738|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6708522|NCT01765738|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6708523|NCT01765738|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6708524|NCT01765790|Antibodies|antibodies|mesh-list
6708525|NCT01765790|Immunoglobulins|immunoglobulins|mesh-list
6708526|NCT01765790|Immunologic Factors|immunologic factors|mesh-ancestor
6708527|NCT01765790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708528|NCT01765829|Droperidol|droperidol|mesh-list
6708529|NCT01765829|Haloperidol|haloperidol|mesh-list
6708530|NCT01765829|Pimozide|pimozide|mesh-list
6708531|NCT01765829|Olanzapine|olanzapine|mesh-list
6708532|NCT01765829|Chlorpromazine|chlorpromazine|mesh-list
6708533|NCT01765829|Trifluoperazine|trifluoperazine|mesh-list
6708534|NCT01765829|Risperidone|risperidone|mesh-list
6708535|NCT01765829|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6708536|NCT01765829|Aripiprazole|aripiprazole|mesh-list
6708537|NCT01765829|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6708538|NCT01765829|Ziprasidone|ziprasidone|mesh-list
6708539|NCT01765829|Antipsychotic Agents|antipsychotic agents|mesh-list
6708540|NCT01765829|Clozapine|clozapine|mesh-list
6708541|NCT01765829|Asenapine|asenapine|mesh-list
6708542|NCT01765829|Amisulpride|amisulpride|mesh-list
6708543|NCT01765829|Perphenazine|perphenazine|mesh-list
6708544|NCT01765829|Sertindole|sertindole|mesh-list
6708545|NCT01765829|Sulpiride|sulpiride|mesh-list
6708546|NCT01765829|Clopenthixol|clopenthixol|mesh-list
6708547|NCT01765829|Clothiapine|clothiapine|mesh-list
6708548|NCT01765829|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6708549|NCT01765829|Serotonin Agents|serotonin agents|mesh-ancestor
6708550|NCT01765829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6708551|NCT01765829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708552|NCT01765829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708553|NCT01765829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6708554|NCT01765829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6708555|NCT01765829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6708556|NCT01765829|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6708557|NCT01765829|Dopamine Agents|dopamine agents|mesh-ancestor
6708558|NCT01765829|Antiemetics|antiemetics|mesh-ancestor
6708559|NCT01765829|Autonomic Agents|autonomic agents|mesh-ancestor
6708560|NCT01765829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6708561|NCT01765829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6708562|NCT01765829|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6708563|NCT01765829|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6708564|NCT01765829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6708565|NCT01765829|Antidepressive Agents|antidepressive agents|mesh-ancestor
6708566|NCT01765829|Dopamine Agonists|dopamine agonists|mesh-ancestor
6708567|NCT01765829|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6708568|NCT01765829|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6708569|NCT01765829|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6708570|NCT01765829|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6708571|NCT01765829|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6708572|NCT01765829|GABA Antagonists|gaba antagonists|mesh-ancestor
6708573|NCT01765829|GABA Agents|gaba agents|mesh-ancestor
6708574|NCT01765829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6708575|NCT01765829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6708576|NCT01765842|Rituximab|rituximab|mesh-list
6708577|NCT01765842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6708578|NCT01765842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6708579|NCT01765842|Immunologic Factors|immunologic factors|mesh-ancestor
6708580|NCT01765842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708581|NCT01765842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6708582|NCT01765855|Betrixaban|betrixaban|mesh-list
6708583|NCT01765855|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6708584|NCT01765855|Antithrombins|antithrombins|mesh-ancestor
6708585|NCT01765855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6708586|NCT01765855|Protease Inhibitors|protease inhibitors|mesh-ancestor
6708587|NCT01765855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6708588|NCT01765855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708589|NCT01765855|Anticoagulants|anticoagulants|mesh-ancestor
6708590|NCT01765868|Betrixaban|betrixaban|mesh-list
6708591|NCT01765868|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6708592|NCT01765868|Antithrombins|antithrombins|mesh-ancestor
6708593|NCT01765868|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6708594|NCT01765868|Protease Inhibitors|protease inhibitors|mesh-ancestor
6708595|NCT01765868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6708596|NCT01765868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708597|NCT01765868|Anticoagulants|anticoagulants|mesh-ancestor
6708598|NCT01765881|Misoprostol|misoprostol|mesh-list
6708599|NCT01765881|Dinoprostone|dinoprostone|mesh-list
6708600|NCT01765881|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6708601|NCT01765881|Abortifacient Agents|abortifacient agents|mesh-ancestor
6708602|NCT01765881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6708603|NCT01765881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708604|NCT01765881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6708605|NCT01765881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6708606|NCT01765881|Oxytocics|oxytocics|mesh-ancestor
6708607|NCT01765946|Metformin|metformin|mesh-list
6708608|NCT01765946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6708609|NCT01765946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708610|NCT01766063|Interferons|interferons|mesh-list
6708611|NCT01766063|Interferon-beta|interferon-beta|mesh-list
6708612|NCT01766063|Interferon beta-1b|interferon beta-1b|mesh-list
6708613|NCT01766063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6708614|NCT01766063|Antiviral Agents|antiviral agents|mesh-ancestor
6708615|NCT01766063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6708616|NCT01766063|Immunologic Factors|immunologic factors|mesh-ancestor
6708617|NCT01766063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708618|NCT01766063|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6708619|NCT01766089|Dexmedetomidine|dexmedetomidine|mesh-list
6708620|NCT01766089|Remifentanil|remifentanil|mesh-list
6708621|NCT01766089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6708622|NCT01766089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6708623|NCT01766089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708624|NCT01766089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6708625|NCT01766089|Analgesics|analgesics|mesh-ancestor
6708626|NCT01766089|Sensory System Agents|sensory system agents|mesh-ancestor
6708627|NCT01766089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6708628|NCT01766089|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6708629|NCT01766089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6708630|NCT01766089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6708631|NCT01766089|Adrenergic Agents|adrenergic agents|mesh-ancestor
6708632|NCT01766089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6708633|NCT01766089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708634|NCT01766089|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6708635|NCT01766089|Narcotics|narcotics|mesh-ancestor
6708636|NCT01766128|Zonisamide|zonisamide|mesh-list
6708637|NCT01766128|Anticonvulsants|anticonvulsants|mesh-ancestor
6708638|NCT01766128|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6708639|NCT01766128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6708640|NCT01766128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708641|NCT01766128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6708642|NCT01766128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708643|NCT01766154|Tirofiban|tirofiban|mesh-list
6708644|NCT01766154|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6708645|NCT01766154|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6708646|NCT01766154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708647|NCT01766154|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6708648|NCT01766180|Resveratrol|resveratrol|mesh-list
6708649|NCT01766180|Antioxidants|antioxidants|mesh-ancestor
6708650|NCT01766180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708651|NCT01766180|Protective Agents|protective agents|mesh-ancestor
6708652|NCT01766180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708653|NCT01766180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6708654|NCT01766180|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6708655|NCT01766258|Carbidopa|carbidopa|mesh-list
6708656|NCT01766258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6708657|NCT01766258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6708658|NCT01766258|Dopamine Agents|dopamine agents|mesh-ancestor
6708659|NCT01766258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6708660|NCT01766258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708661|NCT01766258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708662|NCT01766258|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6708663|NCT01766258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6708664|NCT01766323|Modafinil|modafinil|mesh-list
6708665|NCT01766323|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6708666|NCT01766323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708667|NCT01766323|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6708668|NCT01766323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6708669|NCT01766323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6708670|NCT01766323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708671|NCT01766375|Cyclosporine|cyclosporine|mesh-list
6708672|NCT01766375|Mycophenolic Acid|mycophenolic acid|mesh-list
6708673|NCT01766375|Methotrexate|methotrexate|mesh-list
6708674|NCT01766375|Cyclosporins|cyclosporins|mesh-list
6708675|NCT01766375|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6708676|NCT01766375|Abortifacient Agents|abortifacient agents|mesh-ancestor
6708677|NCT01766375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6708678|NCT01766375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708679|NCT01766375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6708680|NCT01766375|Antimetabolites|antimetabolites|mesh-ancestor
6708681|NCT01766375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708682|NCT01766375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6708683|NCT01766375|Dermatologic Agents|dermatologic agents|mesh-ancestor
6708684|NCT01766375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6708685|NCT01766375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6708686|NCT01766375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6708687|NCT01766375|Immunologic Factors|immunologic factors|mesh-ancestor
6708688|NCT01766375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6708689|NCT01766375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6708690|NCT01766375|Antifungal Agents|antifungal agents|mesh-ancestor
6708691|NCT01766375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6708692|NCT01766375|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6708693|NCT01766375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6708694|NCT01766375|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6708695|NCT01766375|Antitubercular Agents|antitubercular agents|mesh-ancestor
6708696|NCT01766375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6708697|NCT01766414|Complement C1s|complement c1s|mesh-list
6708698|NCT01766414|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
6708699|NCT01766414|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
6708700|NCT01766414|Immunologic Factors|immunologic factors|mesh-ancestor
6708701|NCT01766414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708702|NCT01766414|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6708703|NCT01766414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6708704|NCT01766518|Mycophenolic Acid|mycophenolic acid|mesh-list
6708705|NCT01766518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6708706|NCT01766518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6708707|NCT01766518|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6708708|NCT01766518|Antitubercular Agents|antitubercular agents|mesh-ancestor
6708709|NCT01766518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6708710|NCT01766518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6708711|NCT01766518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6708712|NCT01766518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782584|NCT02191657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782585|NCT02191670|Tenecteplase|tenecteplase|mesh-list
6782586|NCT02191670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6782587|NCT02191670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6782588|NCT02191670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782589|NCT02191709|Dextromethorphan|dextromethorphan|mesh-list
6782590|NCT02191709|Antitussive Agents|antitussive agents|mesh-ancestor
6782591|NCT02191709|Respiratory System Agents|respiratory system agents|mesh-ancestor
6782592|NCT02191709|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6782593|NCT02191709|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6782594|NCT02191709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6782595|NCT02191709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782596|NCT02191709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782597|NCT02191748|Triamcinolone|triamcinolone|mesh-list
6782598|NCT02191748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6782599|NCT02191748|Glucocorticoids|glucocorticoids|mesh-ancestor
6782600|NCT02191748|Hormones|hormones|mesh-ancestor
6782601|NCT02191748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6782602|NCT02191748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782603|NCT02191826|Tolcapone|tolcapone|mesh-list
6782604|NCT02191826|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6782605|NCT02191826|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6782606|NCT02191826|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6782607|NCT02191826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6782608|NCT02191826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782609|NCT02191839|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
6782610|NCT02191839|Protein C Inhibitor|protein c inhibitor|mesh-list
6782611|NCT02191839|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6782612|NCT02191839|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6782613|NCT02191839|Protease Inhibitors|protease inhibitors|mesh-ancestor
6782614|NCT02191839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6782615|NCT02191839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782616|NCT02191891|Afatinib|afatinib|mesh-list
6782617|NCT02191891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6782618|NCT02191891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6782619|NCT02191891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6782620|NCT02191891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782621|NCT02191930|Cyclophosphamide|cyclophosphamide|mesh-list
6782622|NCT02191930|Doxorubicin|doxorubicin|mesh-list
6782623|NCT02191930|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6782624|NCT02191930|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6782625|NCT02191930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6782626|NCT02191930|Immunologic Factors|immunologic factors|mesh-ancestor
6782627|NCT02191930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782628|NCT02191930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6782629|NCT02191930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6782630|NCT02191930|Alkylating Agents|alkylating agents|mesh-ancestor
6782631|NCT02191930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782632|NCT02191930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6782633|NCT02191930|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6782634|NCT02191930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6782635|NCT02191930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6782636|NCT02191930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6782637|NCT02191930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6782638|NCT02191930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6782639|NCT02191943|Fluorides|fluorides|mesh-list
6782640|NCT02191943|Fluorides, Topical|fluorides, topical|mesh-list
6782641|NCT02191943|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
6782642|NCT02191943|Cariostatic Agents|cariostatic agents|mesh-ancestor
6782643|NCT02191943|Protective Agents|protective agents|mesh-ancestor
6782644|NCT02191943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782645|NCT02192060|Triclosan|triclosan|mesh-list
6782646|NCT02192060|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6782647|NCT02192060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6782648|NCT02192060|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6708713|NCT01766583|Lenalidomide|lenalidomide|mesh-list
6708714|NCT01766583|Immunologic Factors|immunologic factors|mesh-ancestor
6708715|NCT01766583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708716|NCT01766583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6708717|NCT01766583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6708718|NCT01766583|Growth Substances|growth substances|mesh-ancestor
6708719|NCT01766583|Growth Inhibitors|growth inhibitors|mesh-ancestor
6708720|NCT01766583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6708721|NCT01766609|Triamcinolone|triamcinolone|mesh-list
6708722|NCT01766609|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6708723|NCT01766609|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6708724|NCT01766609|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6708725|NCT01766609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6708726|NCT01766609|Glucocorticoids|glucocorticoids|mesh-ancestor
6708727|NCT01766609|Hormones|hormones|mesh-ancestor
6708728|NCT01766609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6708729|NCT01766609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708730|NCT01766609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6708731|NCT01766609|Immunologic Factors|immunologic factors|mesh-ancestor
6708732|NCT01766609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6708733|NCT01766609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708734|NCT01766830|Immunoglobulin G|immunoglobulin g|mesh-list
6708735|NCT01766830|Immunoglobulin M|immunoglobulin m|mesh-list
6708736|NCT01766830|Immunologic Factors|immunologic factors|mesh-ancestor
6708737|NCT01766830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708738|NCT01766843|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6708739|NCT01766843|Charcoal|charcoal|mesh-list
6708740|NCT01766843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6708741|NCT01766843|Autonomic Agents|autonomic agents|mesh-ancestor
6708742|NCT01766843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6708743|NCT01766843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708744|NCT01766843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6708745|NCT01766843|Respiratory System Agents|respiratory system agents|mesh-ancestor
6708746|NCT01766843|Glucocorticoids|glucocorticoids|mesh-ancestor
6708747|NCT01766843|Hormones|hormones|mesh-ancestor
6708748|NCT01766843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6708749|NCT01766843|Sympathomimetics|sympathomimetics|mesh-ancestor
6708750|NCT01766843|Antidotes|antidotes|mesh-ancestor
6708751|NCT01766843|Protective Agents|protective agents|mesh-ancestor
6708752|NCT01766960|Morphine|morphine|mesh-list
6708753|NCT01766960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6708754|NCT01766960|Narcotics|narcotics|mesh-ancestor
6708755|NCT01766960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6708756|NCT01766960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708757|NCT01766960|Analgesics|analgesics|mesh-ancestor
6708758|NCT01766960|Sensory System Agents|sensory system agents|mesh-ancestor
6708759|NCT01766960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6708760|NCT01767025|Oxytocin|oxytocin|mesh-list
6708761|NCT01767025|Oxytocics|oxytocics|mesh-ancestor
6708762|NCT01767025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6708763|NCT01767025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708764|NCT01767090|Leuprolide|leuprolide|mesh-list
6708765|NCT01767090|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6708766|NCT01767090|Fertility Agents|fertility agents|mesh-ancestor
6708767|NCT01767090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6708768|NCT01767090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708769|NCT01767090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6708770|NCT01767090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6708771|NCT01767259|Valsartan|valsartan|mesh-list
6708772|NCT01767259|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6708773|NCT01767259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6708774|NCT01767259|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6708775|NCT01767259|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6708776|NCT01767259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708777|NCT01767259|Diuretics|diuretics|mesh-ancestor
6708778|NCT01767259|Natriuretic Agents|natriuretic agents|mesh-ancestor
6708779|NCT01767259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708780|NCT01767259|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6708781|NCT01767259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6708782|NCT01767272|Fexofenadine|fexofenadine|mesh-list
6708783|NCT01767272|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6708784|NCT01767272|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6708785|NCT01767272|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6708786|NCT01767272|Histamine Antagonists|histamine antagonists|mesh-ancestor
6708787|NCT01767272|Histamine Agents|histamine agents|mesh-ancestor
6708788|NCT01767272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6708789|NCT01767272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708790|NCT01767272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708791|NCT01767298|Valsartan|valsartan|mesh-list
6708792|NCT01767298|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6708793|NCT01767298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6708794|NCT01767298|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6708795|NCT01767298|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6708796|NCT01767298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708797|NCT01767298|Diuretics|diuretics|mesh-ancestor
6708798|NCT01767298|Natriuretic Agents|natriuretic agents|mesh-ancestor
6708799|NCT01767298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708800|NCT01767298|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6708801|NCT01767298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6708802|NCT01767363|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
6708803|NCT01767363|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
6708804|NCT01767363|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6708805|NCT01767363|Adrenergic Agents|adrenergic agents|mesh-ancestor
6708806|NCT01767363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6708807|NCT01767363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708808|NCT01767363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708809|NCT01767363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6708810|NCT01767363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6708811|NCT01767363|Hormone Antagonists|hormone antagonists|mesh-ancestor
6708812|NCT01767363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6708813|NCT01767389|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
6708814|NCT01767389|Protease Inhibitors|protease inhibitors|mesh-ancestor
6708815|NCT01767389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6708816|NCT01767389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708817|NCT01767389|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6708818|NCT01767389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708819|NCT01767402|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6708820|NCT01767402|Immunologic Factors|immunologic factors|mesh-ancestor
6708821|NCT01767402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708822|NCT01767428|Acetaminophen|acetaminophen|mesh-list
6708823|NCT01767428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6708824|NCT01767428|Analgesics|analgesics|mesh-ancestor
6708825|NCT01767428|Sensory System Agents|sensory system agents|mesh-ancestor
6708826|NCT01767428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6708827|NCT01767428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708828|NCT01767428|Antipyretics|antipyretics|mesh-ancestor
6708829|NCT01767454|Ipilimumab|ipilimumab|mesh-list
6708830|NCT01767454|Trametinib|trametinib|mesh-list
6708831|NCT01767454|Dabrafenib|dabrafenib|mesh-list
6708832|NCT01767454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6708833|NCT01767454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6708834|NCT01767454|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6708835|NCT01767454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708836|NCT01767454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6708837|NCT01767454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6708838|NCT01767532|Cephalexin|cephalexin|mesh-list
6708839|NCT01767532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6708840|NCT01767532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6708841|NCT01767545|Dexamethasone|dexamethasone|mesh-list
6708842|NCT01767545|Bevacizumab|bevacizumab|mesh-list
6708843|NCT01767545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6708844|NCT01767545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6708845|NCT01767545|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6708846|NCT01767545|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6708847|NCT01767545|Growth Substances|growth substances|mesh-ancestor
6708848|NCT01767545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708849|NCT01767545|Growth Inhibitors|growth inhibitors|mesh-ancestor
6708850|NCT01767545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6708851|NCT01767545|Antiemetics|antiemetics|mesh-ancestor
6708852|NCT01767545|Autonomic Agents|autonomic agents|mesh-ancestor
6708853|NCT01767545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6708854|NCT01767545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6708855|NCT01767545|Glucocorticoids|glucocorticoids|mesh-ancestor
6708856|NCT01767545|Hormones|hormones|mesh-ancestor
6708857|NCT01767545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6708858|NCT01767545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6708859|NCT01767571|Cephalexin|cephalexin|mesh-list
6708860|NCT01767571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6708861|NCT01767571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6708862|NCT01767584|Cephalexin|cephalexin|mesh-list
6708863|NCT01767584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6708864|NCT01767584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6708865|NCT01767610|Infliximab|infliximab|mesh-list
6708866|NCT01767610|Fenofibrate|fenofibrate|mesh-list
6708867|NCT01767610|Pitavastatin|pitavastatin|mesh-list
6708868|NCT01767610|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6708869|NCT01767610|Antimetabolites|antimetabolites|mesh-ancestor
6708870|NCT01767610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708871|NCT01767610|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6708872|NCT01767610|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6708873|NCT01767610|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6708874|NCT01767610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6708875|NCT01767610|Dermatologic Agents|dermatologic agents|mesh-ancestor
6708876|NCT01767610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6708877|NCT01767610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6708878|NCT01767623|Vemurafenib|vemurafenib|mesh-list
6708879|NCT01767623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6708880|NCT01767623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6708881|NCT01767623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6708882|NCT01767623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708883|NCT01767714|Plerixafor|plerixafor|mesh-list
6708884|NCT01767714|Lenograstim|lenograstim|mesh-list
6708885|NCT01767714|Sargramostim|sargramostim|mesh-list
6708886|NCT01767714|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6708887|NCT01767714|Immunologic Factors|immunologic factors|mesh-ancestor
6708888|NCT01767714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708889|NCT01767714|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6708890|NCT01767714|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6708891|NCT01767714|Antiviral Agents|antiviral agents|mesh-ancestor
6708892|NCT01767714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6708893|NCT01767896|Vaccines|vaccines|mesh-list
6708894|NCT01767896|Immunologic Factors|immunologic factors|mesh-ancestor
6708895|NCT01767896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708896|NCT01768039|Vitamin D|vitamin d|mesh-list
6708897|NCT01768039|Vitamins|vitamins|mesh-ancestor
6708898|NCT01768039|Micronutrients|micronutrients|mesh-ancestor
6708899|NCT01768039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708900|NCT01768039|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6708901|NCT01768078|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6708902|NCT01768078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6708903|NCT01768078|Betamethasone|betamethasone|mesh-list
6708904|NCT01768078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6708905|NCT01768078|Antitubercular Agents|antitubercular agents|mesh-ancestor
6708906|NCT01768078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6708907|NCT01768078|Glucocorticoids|glucocorticoids|mesh-ancestor
6708908|NCT01768078|Hormones|hormones|mesh-ancestor
6708909|NCT01768078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6708910|NCT01768078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708911|NCT01768078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6708912|NCT01768078|Respiratory System Agents|respiratory system agents|mesh-ancestor
6708913|NCT01768182|Leucovorin|leucovorin|mesh-list
6708914|NCT01768182|Folic Acid|folic acid|mesh-list
6708915|NCT01768182|Levoleucovorin|levoleucovorin|mesh-list
6708916|NCT01768182|Antidotes|antidotes|mesh-ancestor
6708917|NCT01768182|Protective Agents|protective agents|mesh-ancestor
6708918|NCT01768182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708919|NCT01768182|Vitamin B Complex|vitamin b complex|mesh-ancestor
6708920|NCT01768182|Vitamins|vitamins|mesh-ancestor
6708921|NCT01768182|Micronutrients|micronutrients|mesh-ancestor
6708922|NCT01768182|Hematinics|hematinics|mesh-ancestor
6708923|NCT01768195|Entecavir|entecavir|mesh-list
6708924|NCT01768195|Antiviral Agents|antiviral agents|mesh-ancestor
6708925|NCT01768195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6708926|NCT01768208|Saxagliptin|saxagliptin|mesh-list
6708927|NCT01768208|Incretins|incretins|mesh-ancestor
6708928|NCT01768208|Hormones|hormones|mesh-ancestor
6708929|NCT01768208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6708930|NCT01768208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708931|NCT01768208|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6708932|NCT01768208|Protease Inhibitors|protease inhibitors|mesh-ancestor
6708933|NCT01768208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6708934|NCT01768208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708935|NCT01768208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6708936|NCT01768247|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6708937|NCT01768247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6708938|NCT01768247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708939|NCT01768260|Aspirin|aspirin|mesh-list
6708940|NCT01768260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6708941|NCT01768260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6708942|NCT01768260|Analgesics|analgesics|mesh-ancestor
6708943|NCT01768260|Sensory System Agents|sensory system agents|mesh-ancestor
6708944|NCT01768260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6708945|NCT01768260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708946|NCT01768260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6708947|NCT01768260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6708948|NCT01768260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6708949|NCT01768260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6708950|NCT01768260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708951|NCT01768260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6708952|NCT01768260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6708953|NCT01768260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6708954|NCT01768260|Antipyretics|antipyretics|mesh-ancestor
6708955|NCT01768273|Midazolam|midazolam|mesh-list
6708956|NCT01768273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6708957|NCT01768273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6708958|NCT01768273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6708959|NCT01768273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708960|NCT01768273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6708961|NCT01768273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6708962|NCT01768273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6708963|NCT01768273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6708964|NCT01768273|Anesthetics, General|anesthetics, general|mesh-ancestor
6708965|NCT01768273|Anesthetics|anesthetics|mesh-ancestor
6708966|NCT01768273|GABA Modulators|gaba modulators|mesh-ancestor
6708967|NCT01768273|GABA Agents|gaba agents|mesh-ancestor
6708968|NCT01768273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6708969|NCT01768273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708970|NCT01768299|Misoprostol|misoprostol|mesh-list
6708971|NCT01768299|Mifepristone|mifepristone|mesh-list
6708972|NCT01768299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6708973|NCT01768299|Abortifacient Agents|abortifacient agents|mesh-ancestor
6708974|NCT01768299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6708975|NCT01768299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708976|NCT01768299|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6708977|NCT01768299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6708978|NCT01768299|Oxytocics|oxytocics|mesh-ancestor
6708979|NCT01768299|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6708980|NCT01768299|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6708981|NCT01768299|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6708982|NCT01768299|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6708983|NCT01768299|Contraceptive Agents|contraceptive agents|mesh-ancestor
6708984|NCT01768299|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6708985|NCT01768299|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6708986|NCT01768299|Hormone Antagonists|hormone antagonists|mesh-ancestor
6708987|NCT01768299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6708988|NCT01768299|Luteolytic Agents|luteolytic agents|mesh-ancestor
6708989|NCT01768299|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6708990|NCT01768299|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6708991|NCT01768312|Cyclosporine|cyclosporine|mesh-list
6708992|NCT01768312|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6708993|NCT01768312|Cyclosporins|cyclosporins|mesh-list
6708994|NCT01768312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6708995|NCT01768312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6708996|NCT01768312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6708997|NCT01768312|Immunologic Factors|immunologic factors|mesh-ancestor
6708998|NCT01768312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6708999|NCT01768312|Antifungal Agents|antifungal agents|mesh-ancestor
6709000|NCT01768312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6709001|NCT01768312|Dermatologic Agents|dermatologic agents|mesh-ancestor
6709002|NCT01768312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6709003|NCT01768312|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6709004|NCT01768312|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6709005|NCT01768338|Ofatumumab|ofatumumab|mesh-list
6709006|NCT01768338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6782649|NCT02192060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6782650|NCT02192060|Antimetabolites|antimetabolites|mesh-ancestor
6782651|NCT02192060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782652|NCT02192060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6709007|NCT01768351|Calcitriol|calcitriol|mesh-list
6709008|NCT01768351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6709009|NCT01768351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709010|NCT01768351|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6709011|NCT01768351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6709012|NCT01768351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709013|NCT01768351|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6709014|NCT01768351|Vitamins|vitamins|mesh-ancestor
6709015|NCT01768351|Micronutrients|micronutrients|mesh-ancestor
6709016|NCT01768351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6709017|NCT01768364|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6709018|NCT01768364|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6709019|NCT01768364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6709020|NCT01768364|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6709021|NCT01768364|Renal Agents|renal agents|mesh-ancestor
6709022|NCT01768364|Antimalarials|antimalarials|mesh-ancestor
6709023|NCT01768364|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6709024|NCT01768364|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6709025|NCT01768377|Lidocaine|lidocaine|mesh-list
6709026|NCT01768377|Fentanyl|fentanyl|mesh-list
6709027|NCT01768377|Midazolam|midazolam|mesh-list
6709028|NCT01768377|Anesthetics, Local|anesthetics, local|mesh-ancestor
6709029|NCT01768377|Anesthetics|anesthetics|mesh-ancestor
6709030|NCT01768377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6709031|NCT01768377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709032|NCT01768377|Sensory System Agents|sensory system agents|mesh-ancestor
6709033|NCT01768377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6709034|NCT01768377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6709035|NCT01768377|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6709036|NCT01768377|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6709037|NCT01768377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6709038|NCT01768377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709039|NCT01768377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6709040|NCT01768377|Narcotics|narcotics|mesh-ancestor
6709041|NCT01768377|Analgesics|analgesics|mesh-ancestor
6709042|NCT01768377|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6709043|NCT01768377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6709044|NCT01768377|Anesthetics, General|anesthetics, general|mesh-ancestor
6709045|NCT01768377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6709046|NCT01768377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6709047|NCT01768377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6709048|NCT01768377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6709049|NCT01768377|GABA Modulators|gaba modulators|mesh-ancestor
6709050|NCT01768377|GABA Agents|gaba agents|mesh-ancestor
6709051|NCT01768377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6709052|NCT01768390|Fluorides|fluorides|mesh-list
6709053|NCT01768390|Cariostatic Agents|cariostatic agents|mesh-ancestor
6709054|NCT01768390|Protective Agents|protective agents|mesh-ancestor
6709055|NCT01768390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709056|NCT01768455|Glimepiride|glimepiride|mesh-list
6709057|NCT01768455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6709058|NCT01768455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6709059|NCT01768455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709060|NCT01768455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6709061|NCT01768455|Immunologic Factors|immunologic factors|mesh-ancestor
6709062|NCT01768481|Atorvastatin|atorvastatin|mesh-list
6709063|NCT01768481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6709064|NCT01768481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6709065|NCT01768481|Antimetabolites|antimetabolites|mesh-ancestor
6709066|NCT01768481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709067|NCT01768481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6709068|NCT01768481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6709069|NCT01768481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6709070|NCT01768507|Resveratrol|resveratrol|mesh-list
6709071|NCT01768507|Antioxidants|antioxidants|mesh-ancestor
6709072|NCT01768507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709073|NCT01768507|Protective Agents|protective agents|mesh-ancestor
6709074|NCT01768507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709075|NCT01768507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6709076|NCT01768507|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6709077|NCT01768663|Itraconazole|itraconazole|mesh-list
6709078|NCT01768663|Ciprofloxacin|ciprofloxacin|mesh-list
6709079|NCT01768663|Rifampin|rifampin|mesh-list
6709080|NCT01768663|Ivacaftor|ivacaftor|mesh-list
6709081|NCT01768663|Antifungal Agents|antifungal agents|mesh-ancestor
6709082|NCT01768663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6709083|NCT01768663|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6709084|NCT01768663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6709085|NCT01768663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6709086|NCT01768663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709087|NCT01768663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6709088|NCT01768663|Hormone Antagonists|hormone antagonists|mesh-ancestor
6709089|NCT01768663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6709090|NCT01768663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709091|NCT01768663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6709092|NCT01768663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6709093|NCT01768663|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6709094|NCT01768663|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6709095|NCT01768663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6709096|NCT01768663|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6709097|NCT01768663|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6709098|NCT01768663|Antitubercular Agents|antitubercular agents|mesh-ancestor
6709099|NCT01768663|Leprostatic Agents|leprostatic agents|mesh-ancestor
6709100|NCT01768663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6709101|NCT01768663|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6709102|NCT01768663|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6709103|NCT01768663|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6709104|NCT01768663|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6709105|NCT01768663|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6709106|NCT01768663|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6709107|NCT01768663|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6709108|NCT01768663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6709109|NCT01768741|Liver Extracts|liver extracts|mesh-list
6709110|NCT01768741|Hematinics|hematinics|mesh-ancestor
6709111|NCT01768767|Ketamine|ketamine|mesh-list
6709112|NCT01768767|Analgesics|analgesics|mesh-ancestor
6709113|NCT01768767|Sensory System Agents|sensory system agents|mesh-ancestor
6709114|NCT01768767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6709115|NCT01768767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709116|NCT01768767|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6709117|NCT01768767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6709118|NCT01768767|Anesthetics, General|anesthetics, general|mesh-ancestor
6709119|NCT01768767|Anesthetics|anesthetics|mesh-ancestor
6709120|NCT01768767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6709121|NCT01768767|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6709122|NCT01768767|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6709123|NCT01768767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6709124|NCT01768767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709125|NCT01768780|Glycopyrrolate|glycopyrrolate|mesh-list
6709126|NCT01768780|Bupivacaine|bupivacaine|mesh-list
6709127|NCT01768780|Cholinergic Antagonists|cholinergic antagonists|mesh-list
6709128|NCT01768780|Anesthetics, Local|anesthetics, local|mesh-ancestor
6709129|NCT01768780|Anesthetics|anesthetics|mesh-ancestor
6709130|NCT01768780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6709131|NCT01768780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709132|NCT01768780|Sensory System Agents|sensory system agents|mesh-ancestor
6709133|NCT01768780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6709134|NCT01768780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6709135|NCT01768780|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6709136|NCT01768780|Cholinergic Agents|cholinergic agents|mesh-ancestor
6709137|NCT01768780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6709138|NCT01768780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709139|NCT01768884|Nitric Oxide|nitric oxide|mesh-list
6709140|NCT01768884|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6709141|NCT01768884|Autonomic Agents|autonomic agents|mesh-ancestor
6709142|NCT01768884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6709143|NCT01768884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709144|NCT01768884|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6709145|NCT01768884|Respiratory System Agents|respiratory system agents|mesh-ancestor
6709146|NCT01768884|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6709147|NCT01768884|Antioxidants|antioxidants|mesh-ancestor
6709148|NCT01768884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709149|NCT01768884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6709150|NCT01768884|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6709151|NCT01768884|Vasodilator Agents|vasodilator agents|mesh-ancestor
6709152|NCT01768884|Gasotransmitters|gasotransmitters|mesh-ancestor
6709153|NCT01768884|Protective Agents|protective agents|mesh-ancestor
6709154|NCT01768897|Thioctic Acid|thioctic acid|mesh-list
6709155|NCT01768897|Cytarabine|cytarabine|mesh-list
6709156|NCT01768897|Mitoxantrone|mitoxantrone|mesh-list
6709157|NCT01768897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6709158|NCT01768897|Antimetabolites|antimetabolites|mesh-ancestor
6709159|NCT01768897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709160|NCT01768897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6709161|NCT01768897|Antiviral Agents|antiviral agents|mesh-ancestor
6709162|NCT01768897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6709163|NCT01768897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6709164|NCT01768897|Immunologic Factors|immunologic factors|mesh-ancestor
6709165|NCT01768897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709166|NCT01768897|Analgesics|analgesics|mesh-ancestor
6709167|NCT01768897|Sensory System Agents|sensory system agents|mesh-ancestor
6709168|NCT01768897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6709169|NCT01768897|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6709170|NCT01768897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6709171|NCT01768897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6709172|NCT01768897|Antioxidants|antioxidants|mesh-ancestor
6709173|NCT01768897|Protective Agents|protective agents|mesh-ancestor
6709174|NCT01768897|Vitamin B Complex|vitamin b complex|mesh-ancestor
6709175|NCT01768897|Vitamins|vitamins|mesh-ancestor
6709176|NCT01768897|Micronutrients|micronutrients|mesh-ancestor
6709177|NCT01768988|Pregabalin|pregabalin|mesh-list
6709178|NCT01768988|Analgesics|analgesics|mesh-ancestor
6709179|NCT01768988|Sensory System Agents|sensory system agents|mesh-ancestor
6709180|NCT01768988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6709181|NCT01768988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709182|NCT01768988|Anticonvulsants|anticonvulsants|mesh-ancestor
6709183|NCT01768988|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6709184|NCT01768988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6709185|NCT01768988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709186|NCT01768988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6709187|NCT01768988|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6709188|NCT01768988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6709189|NCT01768988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6709190|NCT01768988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6709191|NCT01769027|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6709192|NCT01769027|Azithromycin|azithromycin|mesh-list
6709193|NCT01769027|Penicillins|penicillins|mesh-list
6709194|NCT01769027|Penicillin G Benzathine|penicillin g benzathine|mesh-list
6709195|NCT01769027|Sertraline|sertraline|mesh-list
6709196|NCT01769027|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6709197|NCT01769027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6709198|NCT01769027|Antidepressive Agents|antidepressive agents|mesh-ancestor
6709199|NCT01769027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6709200|NCT01769027|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6709201|NCT01769027|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6709202|NCT01769027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6709203|NCT01769027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709204|NCT01769027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6709205|NCT01769027|Serotonin Agents|serotonin agents|mesh-ancestor
6709206|NCT01769027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709207|NCT01769027|Immunologic Factors|immunologic factors|mesh-ancestor
6709208|NCT01769040|Rifaximin|rifaximin|mesh-list
6709209|NCT01769040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6709210|NCT01769040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6709211|NCT01769040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6709212|NCT01769066|Pemetrexed|pemetrexed|mesh-list
6709213|NCT01769066|Gefitinib|gefitinib|mesh-list
6709214|NCT01769066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6709215|NCT01769066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6709216|NCT01769066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709217|NCT01769066|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6709218|NCT01769066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6709219|NCT01769066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6709220|NCT01769079|Isosorbide|isosorbide|mesh-list
6709221|NCT01769079|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6709222|NCT01769079|Diuretics|diuretics|mesh-ancestor
6709223|NCT01769079|Natriuretic Agents|natriuretic agents|mesh-ancestor
6709224|NCT01769079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709225|NCT01769118|Caffeine|caffeine|mesh-list
6709226|NCT01769118|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6709227|NCT01769118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709228|NCT01769118|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6709229|NCT01769118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6709230|NCT01769118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709231|NCT01769118|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6709232|NCT01769118|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6709233|NCT01769118|Purinergic Agents|purinergic agents|mesh-ancestor
6709234|NCT01769118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6709235|NCT01769183|Squalamine|squalamine|mesh-list
6709236|NCT01769183|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6709237|NCT01769183|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6709238|NCT01769183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6709239|NCT01769183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6709240|NCT01769183|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6709241|NCT01769183|Protective Agents|protective agents|mesh-ancestor
6709242|NCT01769183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709243|NCT01769183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6709244|NCT01769183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6709245|NCT01769183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6709246|NCT01769183|Growth Substances|growth substances|mesh-ancestor
6709247|NCT01769183|Growth Inhibitors|growth inhibitors|mesh-ancestor
6709248|NCT01769235|Clindamycin|clindamycin|mesh-list
6709249|NCT01769235|Clindamycin palmitate|clindamycin palmitate|mesh-list
6709250|NCT01769235|Clindamycin phosphate|clindamycin phosphate|mesh-list
6709251|NCT01769235|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6709252|NCT01769235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6709253|NCT01769235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6709254|NCT01769235|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6709255|NCT01769235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6709256|NCT01769235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709257|NCT01769235|Dermatologic Agents|dermatologic agents|mesh-ancestor
6709258|NCT01769482|Udenafil|udenafil|mesh-list
6709259|NCT01769482|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6709260|NCT01769482|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6709261|NCT01769482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6709262|NCT01769482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709263|NCT01769625|Vitamin D|vitamin d|mesh-list
6709264|NCT01769625|Cholecalciferol|cholecalciferol|mesh-list
6709265|NCT01769625|Celecoxib|celecoxib|mesh-list
6709266|NCT01769625|Vitamins|vitamins|mesh-ancestor
6709267|NCT01769625|Micronutrients|micronutrients|mesh-ancestor
6709268|NCT01769625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709269|NCT01769625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6709270|NCT01769625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6709271|NCT01769625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6709272|NCT01769625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6709273|NCT01769625|Analgesics|analgesics|mesh-ancestor
6709274|NCT01769625|Sensory System Agents|sensory system agents|mesh-ancestor
6709275|NCT01769625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6709276|NCT01769625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6709277|NCT01769625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6709278|NCT01769625|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6709279|NCT01769625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6709280|NCT01769625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6709281|NCT01769625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709282|NCT01769651|Methadone|methadone|mesh-list
6709283|NCT01769651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6709284|NCT01769651|Narcotics|narcotics|mesh-ancestor
6709285|NCT01769651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6709286|NCT01769651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709287|NCT01769651|Analgesics|analgesics|mesh-ancestor
6709288|NCT01769651|Sensory System Agents|sensory system agents|mesh-ancestor
6709289|NCT01769651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6709290|NCT01769651|Antitussive Agents|antitussive agents|mesh-ancestor
6709291|NCT01769651|Respiratory System Agents|respiratory system agents|mesh-ancestor
6709292|NCT01769664|Clindamycin|clindamycin|mesh-list
6709293|NCT01769664|Clindamycin palmitate|clindamycin palmitate|mesh-list
6709294|NCT01769664|Clindamycin phosphate|clindamycin phosphate|mesh-list
6709295|NCT01769664|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6709296|NCT01769664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6709297|NCT01769664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6709298|NCT01769664|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6709299|NCT01769664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6709300|NCT01769664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709301|NCT01769664|Dermatologic Agents|dermatologic agents|mesh-ancestor
6709302|NCT01769677|Hydrocodone|hydrocodone|mesh-list
6709303|NCT01769677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6709304|NCT01769677|Narcotics|narcotics|mesh-ancestor
6709305|NCT01769677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6709306|NCT01769677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709307|NCT01769677|Analgesics|analgesics|mesh-ancestor
6709308|NCT01769677|Sensory System Agents|sensory system agents|mesh-ancestor
6709309|NCT01769677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6709310|NCT01769677|Antitussive Agents|antitussive agents|mesh-ancestor
6709311|NCT01769677|Respiratory System Agents|respiratory system agents|mesh-ancestor
6709312|NCT01769703|Dabigatran|dabigatran|mesh-list
6709313|NCT01769703|Antithrombins|antithrombins|mesh-ancestor
6709314|NCT01769703|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6709315|NCT01769703|Protease Inhibitors|protease inhibitors|mesh-ancestor
6709316|NCT01769703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6709317|NCT01769703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709318|NCT01769703|Anticoagulants|anticoagulants|mesh-ancestor
6709319|NCT01769768|Bupropion|bupropion|mesh-list
6709320|NCT01769768|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6709321|NCT01769768|Antidepressive Agents|antidepressive agents|mesh-ancestor
6709322|NCT01769768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6709323|NCT01769768|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6709324|NCT01769768|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6709325|NCT01769768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6709326|NCT01769768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709327|NCT01769768|Dopamine Agents|dopamine agents|mesh-ancestor
6709328|NCT01769768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6709329|NCT01769768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709330|NCT01769768|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6709331|NCT01769768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6709332|NCT01769768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6709333|NCT01769781|Anastrozole|anastrozole|mesh-list
6782653|NCT02192203|Diclofenac|diclofenac|mesh-list
6709334|NCT01769781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6709335|NCT01769781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6709336|NCT01769781|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6709337|NCT01769781|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6709338|NCT01769781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6709339|NCT01769781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709340|NCT01769781|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6709341|NCT01769781|Hormone Antagonists|hormone antagonists|mesh-ancestor
6709342|NCT01769781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6709343|NCT01769781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709344|NCT01769820|Dexamethasone|dexamethasone|mesh-list
6709345|NCT01769820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6709346|NCT01769820|Antiemetics|antiemetics|mesh-ancestor
6709347|NCT01769820|Autonomic Agents|autonomic agents|mesh-ancestor
6709348|NCT01769820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6709349|NCT01769820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709350|NCT01769820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6709351|NCT01769820|Glucocorticoids|glucocorticoids|mesh-ancestor
6709352|NCT01769820|Hormones|hormones|mesh-ancestor
6709353|NCT01769820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6709354|NCT01769820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6709355|NCT01769820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6709356|NCT01769833|Interferons|interferons|mesh-list
6709357|NCT01769833|Interferon-alpha|interferon-alpha|mesh-list
6709358|NCT01769833|Interferon alpha-2|interferon alpha-2|mesh-list
6709359|NCT01769833|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6709360|NCT01769833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6709361|NCT01769833|Antiviral Agents|antiviral agents|mesh-ancestor
6709362|NCT01769833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6709363|NCT01769833|Immunologic Factors|immunologic factors|mesh-ancestor
6709364|NCT01769833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709365|NCT01769898|Budesonide|budesonide|mesh-list
6709366|NCT01769898|Theophylline|theophylline|mesh-list
6709367|NCT01769898|Formoterol Fumarate|formoterol fumarate|mesh-list
6709368|NCT01769898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6709369|NCT01769898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6709370|NCT01769898|Autonomic Agents|autonomic agents|mesh-ancestor
6709371|NCT01769898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6709372|NCT01769898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709373|NCT01769898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6709374|NCT01769898|Respiratory System Agents|respiratory system agents|mesh-ancestor
6709375|NCT01769898|Glucocorticoids|glucocorticoids|mesh-ancestor
6709376|NCT01769898|Hormones|hormones|mesh-ancestor
6709377|NCT01769898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6709378|NCT01769898|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6709379|NCT01769898|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6709380|NCT01769898|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6709381|NCT01769898|Adrenergic Agents|adrenergic agents|mesh-ancestor
6709382|NCT01769898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6709383|NCT01769898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709384|NCT01769898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6709385|NCT01769898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6709386|NCT01769898|Vasodilator Agents|vasodilator agents|mesh-ancestor
6709387|NCT01769898|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6709388|NCT01769898|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6709389|NCT01769898|Purinergic Agents|purinergic agents|mesh-ancestor
6709390|NCT01769911|Cytarabine|cytarabine|mesh-list
6709391|NCT01769911|Etoposide|etoposide|mesh-list
6709392|NCT01769911|Etoposide phosphate|etoposide phosphate|mesh-list
6709393|NCT01769911|Melphalan|melphalan|mesh-list
6709394|NCT01769911|Carmustine|carmustine|mesh-list
6709395|NCT01769911|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
6709396|NCT01769911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6709397|NCT01769911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6709398|NCT01769911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6709399|NCT01769911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6709400|NCT01769911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6709401|NCT01769911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709402|NCT01769911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6709403|NCT01769911|Antimetabolites|antimetabolites|mesh-ancestor
6709404|NCT01769911|Antiviral Agents|antiviral agents|mesh-ancestor
6709405|NCT01769911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6709406|NCT01769911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6709407|NCT01769911|Immunologic Factors|immunologic factors|mesh-ancestor
6709408|NCT01769911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709409|NCT01769911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6709410|NCT01769911|Alkylating Agents|alkylating agents|mesh-ancestor
6709411|NCT01769911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6709412|NCT01769950|Choline|choline|mesh-list
6709413|NCT01769950|Lipotropic Agents|lipotropic agents|mesh-ancestor
6709414|NCT01769950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6709415|NCT01769950|Antimetabolites|antimetabolites|mesh-ancestor
6709416|NCT01769950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709417|NCT01769950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6709418|NCT01769950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6709419|NCT01769950|Nootropic Agents|nootropic agents|mesh-ancestor
6709420|NCT01770041|Acetaminophen|acetaminophen|mesh-list
6709421|NCT01770041|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6709422|NCT01770041|Analgesics|analgesics|mesh-ancestor
6709423|NCT01770041|Sensory System Agents|sensory system agents|mesh-ancestor
6709424|NCT01770041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6709425|NCT01770041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709426|NCT01770041|Antipyretics|antipyretics|mesh-ancestor
6782654|NCT02192203|Menthol|menthol|mesh-list
6782655|NCT02192203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6782656|NCT02192203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6782657|NCT02192203|Analgesics|analgesics|mesh-ancestor
6782658|NCT02192203|Sensory System Agents|sensory system agents|mesh-ancestor
6782659|NCT02192203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6782660|NCT02192203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782661|NCT02192203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6782662|NCT02192203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6782663|NCT02192203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6782664|NCT02192203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6782665|NCT02192203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782666|NCT02192203|Antipruritics|antipruritics|mesh-ancestor
6782667|NCT02192203|Dermatologic Agents|dermatologic agents|mesh-ancestor
6782668|NCT02192229|Vitamin D|vitamin d|mesh-list
6782669|NCT02192229|Cholecalciferol|cholecalciferol|mesh-list
6782670|NCT02192229|Vitamins|vitamins|mesh-ancestor
6782671|NCT02192229|Micronutrients|micronutrients|mesh-ancestor
6782672|NCT02192229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782673|NCT02192229|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6782674|NCT02192229|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6782675|NCT02192320|Dexamethasone|dexamethasone|mesh-list
6782676|NCT02192320|Atorvastatin|atorvastatin|mesh-list
6782677|NCT02192320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6782678|NCT02192320|Antiemetics|antiemetics|mesh-ancestor
6782679|NCT02192320|Autonomic Agents|autonomic agents|mesh-ancestor
6782680|NCT02192320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6782681|NCT02192320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782682|NCT02192320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6782683|NCT02192320|Glucocorticoids|glucocorticoids|mesh-ancestor
6782684|NCT02192320|Hormones|hormones|mesh-ancestor
6782685|NCT02192320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6782686|NCT02192320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6782687|NCT02192320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6782688|NCT02192320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6782689|NCT02192320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6782690|NCT02192320|Antimetabolites|antimetabolites|mesh-ancestor
6782691|NCT02192320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782692|NCT02192320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6782693|NCT02192320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6782694|NCT02192320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6782695|NCT02192398|Guanfacine|guanfacine|mesh-list
6782696|NCT02192398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6782697|NCT02192398|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6782698|NCT02192398|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6782699|NCT02192398|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6782700|NCT02192398|Adrenergic Agents|adrenergic agents|mesh-ancestor
6782701|NCT02192398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6782702|NCT02192398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782703|NCT02192398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782704|NCT02192411|Lidocaine|lidocaine|mesh-list
6782705|NCT02192411|Anesthetics, Local|anesthetics, local|mesh-ancestor
6782706|NCT02192411|Anesthetics|anesthetics|mesh-ancestor
6782707|NCT02192411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6782708|NCT02192411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782709|NCT02192411|Sensory System Agents|sensory system agents|mesh-ancestor
6709427|NCT01770080|Peppermint oil|peppermint oil|mesh-list
6709428|NCT01770080|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6709429|NCT01770080|Antiemetics|antiemetics|mesh-ancestor
6709430|NCT01770080|Autonomic Agents|autonomic agents|mesh-ancestor
6709431|NCT01770080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6709432|NCT01770080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709433|NCT01770080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6709434|NCT01770080|Parasympatholytics|parasympatholytics|mesh-ancestor
6709435|NCT01770106|Denosumab|denosumab|mesh-list
6709436|NCT01770106|Alendronate|alendronate|mesh-list
6709437|NCT01770106|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6709438|NCT01770106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709439|NCT01770119|Vaccines|vaccines|mesh-list
6709440|NCT01770119|Immunologic Factors|immunologic factors|mesh-ancestor
6709441|NCT01770119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709442|NCT01770132|Gemcitabine|gemcitabine|mesh-list
6709443|NCT01770132|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
6709444|NCT01770132|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
6709445|NCT01770132|Trioxsalen|trioxsalen|mesh-list
6709446|NCT01770132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6709447|NCT01770132|Antimetabolites|antimetabolites|mesh-ancestor
6709448|NCT01770132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709449|NCT01770132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6709450|NCT01770132|Antiviral Agents|antiviral agents|mesh-ancestor
6709451|NCT01770132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6709452|NCT01770132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6709453|NCT01770132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6709454|NCT01770132|Immunologic Factors|immunologic factors|mesh-ancestor
6709455|NCT01770132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709456|NCT01770132|Dermatologic Agents|dermatologic agents|mesh-ancestor
6709457|NCT01770132|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6709458|NCT01770171|Paclitaxel|paclitaxel|mesh-list
6709459|NCT01770171|Bevacizumab|bevacizumab|mesh-list
6709460|NCT01770171|Carboplatin|carboplatin|mesh-list
6709461|NCT01770171|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6709462|NCT01770171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6709463|NCT01770171|Tubulin Modulators|tubulin modulators|mesh-ancestor
6709464|NCT01770171|Antimitotic Agents|antimitotic agents|mesh-ancestor
6709465|NCT01770171|Mitosis Modulators|mitosis modulators|mesh-ancestor
6709466|NCT01770171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709467|NCT01770171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6709468|NCT01770171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6709469|NCT01770171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6709470|NCT01770171|Growth Substances|growth substances|mesh-ancestor
6709471|NCT01770171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709472|NCT01770171|Growth Inhibitors|growth inhibitors|mesh-ancestor
6709473|NCT01770197|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6709474|NCT01770197|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6709475|NCT01770197|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6709476|NCT01770197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709477|NCT01770210|Atorvastatin|atorvastatin|mesh-list
6709478|NCT01770210|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6709479|NCT01770210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6709480|NCT01770210|Antimetabolites|antimetabolites|mesh-ancestor
6709481|NCT01770210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709482|NCT01770210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6709483|NCT01770210|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6709484|NCT01770210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6709485|NCT01770223|Ribavirin|ribavirin|mesh-list
6709486|NCT01770223|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6709487|NCT01770223|Antimetabolites|antimetabolites|mesh-ancestor
6709488|NCT01770223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709489|NCT01770223|Antiviral Agents|antiviral agents|mesh-ancestor
6709490|NCT01770223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6709491|NCT01770236|Acetaminophen|acetaminophen|mesh-list
6709492|NCT01770236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6709493|NCT01770236|Analgesics|analgesics|mesh-ancestor
6709494|NCT01770236|Sensory System Agents|sensory system agents|mesh-ancestor
6709495|NCT01770236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6709496|NCT01770236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709497|NCT01770236|Antipyretics|antipyretics|mesh-ancestor
6709498|NCT01770301|Paclitaxel|paclitaxel|mesh-list
6709499|NCT01770301|Bevacizumab|bevacizumab|mesh-list
6709500|NCT01770301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6709501|NCT01770301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6709502|NCT01770301|Tubulin Modulators|tubulin modulators|mesh-ancestor
6709503|NCT01770301|Antimitotic Agents|antimitotic agents|mesh-ancestor
6709504|NCT01770301|Mitosis Modulators|mitosis modulators|mesh-ancestor
6709505|NCT01770301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709506|NCT01770301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6709507|NCT01770301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6709508|NCT01770301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6709509|NCT01770301|Growth Substances|growth substances|mesh-ancestor
6709510|NCT01770301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709511|NCT01770301|Growth Inhibitors|growth inhibitors|mesh-ancestor
6709512|NCT01770444|Cytarabine|cytarabine|mesh-list
6709513|NCT01770444|Thioguanine|thioguanine|mesh-list
6709514|NCT01770444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6709515|NCT01770444|Antimetabolites|antimetabolites|mesh-ancestor
6709516|NCT01770444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709517|NCT01770444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6709518|NCT01770444|Antiviral Agents|antiviral agents|mesh-ancestor
6709519|NCT01770444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6709520|NCT01770444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6709521|NCT01770444|Immunologic Factors|immunologic factors|mesh-ancestor
6709522|NCT01770444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709523|NCT01770470|Chitosan|chitosan|mesh-list
6709524|NCT01770470|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6709525|NCT01770470|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6709526|NCT01770470|Antimetabolites|antimetabolites|mesh-ancestor
6709527|NCT01770470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709528|NCT01770470|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6709529|NCT01770470|Chelating Agents|chelating agents|mesh-ancestor
6709530|NCT01770470|Sequestering Agents|sequestering agents|mesh-ancestor
6709531|NCT01770470|Hemostatics|hemostatics|mesh-ancestor
6709532|NCT01770470|Coagulants|coagulants|mesh-ancestor
6709533|NCT01770496|Vaccines|vaccines|mesh-list
6709534|NCT01770496|Immunologic Factors|immunologic factors|mesh-ancestor
6709535|NCT01770496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709536|NCT01770600|Risperidone|risperidone|mesh-list
6709537|NCT01770600|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6709538|NCT01770600|Serotonin Agents|serotonin agents|mesh-ancestor
6709539|NCT01770600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6709540|NCT01770600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709541|NCT01770600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709542|NCT01770600|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6709543|NCT01770600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6709544|NCT01770600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6709545|NCT01770600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6709546|NCT01770600|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6709547|NCT01770600|Dopamine Agents|dopamine agents|mesh-ancestor
6709548|NCT01770769|Cloxacillin|cloxacillin|mesh-list
6709549|NCT01770769|Cephalothin|cephalothin|mesh-list
6709550|NCT01770769|Dalteparin|dalteparin|mesh-list
6709551|NCT01770769|Tinzaparin|tinzaparin|mesh-list
6709552|NCT01770769|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6709553|NCT01770769|Anticoagulants|anticoagulants|mesh-ancestor
6709554|NCT01770769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6709555|NCT01770769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6709556|NCT01770769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709557|NCT01770769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6709558|NCT01770769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6709559|NCT01770795|Gemcitabine|gemcitabine|mesh-list
6709560|NCT01770795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6709561|NCT01770795|Antimetabolites|antimetabolites|mesh-ancestor
6709562|NCT01770795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709563|NCT01770795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6709564|NCT01770795|Antiviral Agents|antiviral agents|mesh-ancestor
6709565|NCT01770795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6709566|NCT01770795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6709567|NCT01770795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6709568|NCT01770795|Immunologic Factors|immunologic factors|mesh-ancestor
6709569|NCT01770795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709570|NCT01770899|Montelukast|montelukast|mesh-list
6709571|NCT01770899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6709572|NCT01770899|Respiratory System Agents|respiratory system agents|mesh-ancestor
6709573|NCT01770899|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6709574|NCT01770899|Hormone Antagonists|hormone antagonists|mesh-ancestor
6709575|NCT01770899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6709576|NCT01770899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709577|NCT01770899|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6709578|NCT01770899|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6709579|NCT01770899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709580|NCT01770964|Pregabalin|pregabalin|mesh-list
6709581|NCT01770964|Analgesics|analgesics|mesh-ancestor
6709582|NCT01770964|Sensory System Agents|sensory system agents|mesh-ancestor
6709583|NCT01770964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6709584|NCT01770964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709585|NCT01770964|Anticonvulsants|anticonvulsants|mesh-ancestor
6709586|NCT01770964|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6709587|NCT01770964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6709588|NCT01770964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709589|NCT01770964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6709590|NCT01770964|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6709591|NCT01770964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6709592|NCT01770964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6709593|NCT01770964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6709594|NCT01771081|Ranibizumab|ranibizumab|mesh-list
6709595|NCT01771081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6709596|NCT01771081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6709597|NCT01771081|Growth Substances|growth substances|mesh-ancestor
6709598|NCT01771081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709599|NCT01771081|Growth Inhibitors|growth inhibitors|mesh-ancestor
6709600|NCT01771081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6709601|NCT01771146|Oxaliplatin|oxaliplatin|mesh-list
6709602|NCT01771146|Irinotecan|irinotecan|mesh-list
6709603|NCT01771146|Folfirinox|folfirinox|mesh-list
6709604|NCT01771146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6709605|NCT01771146|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6709606|NCT01771146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6709607|NCT01771146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6709608|NCT01771146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709609|NCT01771185|Metformin|metformin|mesh-list
6709610|NCT01771185|Gliclazide|gliclazide|mesh-list
6709611|NCT01771185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6709612|NCT01771185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709613|NCT01771198|Simvastatin|simvastatin|mesh-list
6709614|NCT01771198|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6709615|NCT01771198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6709616|NCT01771198|Antimetabolites|antimetabolites|mesh-ancestor
6709617|NCT01771198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709618|NCT01771198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6709619|NCT01771198|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6709620|NCT01771198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6709621|NCT01771289|Docetaxel|docetaxel|mesh-list
6709622|NCT01771289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6709623|NCT01771289|Tubulin Modulators|tubulin modulators|mesh-ancestor
6709624|NCT01771289|Antimitotic Agents|antimitotic agents|mesh-ancestor
6709625|NCT01771289|Mitosis Modulators|mitosis modulators|mesh-ancestor
6709626|NCT01771289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709627|NCT01771302|Calcium|calcium|mesh-list
6709628|NCT01771302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6709629|NCT01771302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709630|NCT01771328|Hydrocortisone|hydrocortisone|mesh-list
6709631|NCT01771328|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6709632|NCT01771328|Cortisone|cortisone|mesh-list
6709633|NCT01771328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6709634|NCT01771406|Nebivolol|nebivolol|mesh-list
6709635|NCT01771406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6709636|NCT01771406|Vasodilator Agents|vasodilator agents|mesh-ancestor
6709637|NCT01771406|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6709638|NCT01771406|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6709639|NCT01771406|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6709640|NCT01771406|Adrenergic Agents|adrenergic agents|mesh-ancestor
6709641|NCT01771406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6709642|NCT01771406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709643|NCT01771406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709644|NCT01771432|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6709645|NCT01771432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6709646|NCT01771445|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6709647|NCT01771445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6709648|NCT01771458|Tamoxifen|tamoxifen|mesh-list
6709649|NCT01771458|Trastuzumab|trastuzumab|mesh-list
6709650|NCT01771458|Everolimus|everolimus|mesh-list
6709651|NCT01771458|Sorafenib|sorafenib|mesh-list
6709652|NCT01771458|Letrozole|letrozole|mesh-list
6709653|NCT01771458|Dasatinib|dasatinib|mesh-list
6709654|NCT01771458|Lapatinib|lapatinib|mesh-list
6709655|NCT01771458|Vemurafenib|vemurafenib|mesh-list
6709656|NCT01771458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6709657|NCT01771458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6709658|NCT01771458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6709659|NCT01771458|Immunologic Factors|immunologic factors|mesh-ancestor
6709660|NCT01771458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709661|NCT01771458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6709662|NCT01771458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6709663|NCT01771458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709664|NCT01771458|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6709665|NCT01771458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6709666|NCT01771458|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6709667|NCT01771458|Hormone Antagonists|hormone antagonists|mesh-ancestor
6709668|NCT01771458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6709669|NCT01771458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6709670|NCT01771458|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6709671|NCT01771458|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6709672|NCT01771458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6782710|NCT02192411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6782711|NCT02192411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6782712|NCT02192411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6782713|NCT02192411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6782714|NCT02192411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6782715|NCT02192411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782716|NCT02192424|Insulin|insulin|mesh-list
6782717|NCT02192424|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6782718|NCT02192424|Metformin|metformin|mesh-list
6782719|NCT02192424|Insulin Glargine|insulin glargine|mesh-list
6782720|NCT02192424|Insulin Lispro|insulin lispro|mesh-list
6782721|NCT02192424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6782722|NCT02192424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782723|NCT02192450|Insulin|insulin|mesh-list
6782724|NCT02192450|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6782725|NCT02192450|Insulin Aspart|insulin aspart|mesh-list
6782726|NCT02192450|Insulin, Long-Acting|insulin, long-acting|mesh-list
6782727|NCT02192450|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6782728|NCT02192450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6782729|NCT02192450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782730|NCT02192463|Nevirapine|nevirapine|mesh-list
6782731|NCT02192463|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6782732|NCT02192463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6782733|NCT02192463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6782734|NCT02192463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782735|NCT02192463|Antiviral Agents|antiviral agents|mesh-ancestor
6782736|NCT02192463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6782737|NCT02192463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6782738|NCT02192463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6782739|NCT02192463|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6782740|NCT02192463|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6782741|NCT02192632|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
6782742|NCT02192632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6782743|NCT02192632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6782744|NCT02192632|Analgesics|analgesics|mesh-ancestor
6782745|NCT02192632|Sensory System Agents|sensory system agents|mesh-ancestor
6782746|NCT02192632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6782747|NCT02192632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782748|NCT02192632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6782749|NCT02192632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6782750|NCT02192632|Dermatologic Agents|dermatologic agents|mesh-ancestor
6782751|NCT02192697|Naquotinib|naquotinib|mesh-list
6782752|NCT02192697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6782753|NCT02192697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6782754|NCT02192697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6782755|NCT02192697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782756|NCT02192710|Midazolam|midazolam|mesh-list
6782757|NCT02192710|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6782758|NCT02192710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6782759|NCT02192710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6782760|NCT02192710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782761|NCT02192710|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6782762|NCT02192710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6782763|NCT02192710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6709673|NCT01771783|Enzyme Inhibitors|enzyme inhibitors|mesh-list
6709674|NCT01771783|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6709675|NCT01771783|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
6709676|NCT01771783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709677|NCT01771783|Protease Inhibitors|protease inhibitors|mesh-ancestor
6709678|NCT01771822|Ibuprofen|ibuprofen|mesh-list
6709679|NCT01771822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6709680|NCT01771822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6709681|NCT01771822|Analgesics|analgesics|mesh-ancestor
6709682|NCT01771822|Sensory System Agents|sensory system agents|mesh-ancestor
6709683|NCT01771822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6709684|NCT01771822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709685|NCT01771822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6709686|NCT01771822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6709687|NCT01771822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6709688|NCT01771822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6709689|NCT01771822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709690|NCT01771874|Bupropion|bupropion|mesh-list
6709691|NCT01771874|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
6709692|NCT01771874|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6709693|NCT01771874|Antidepressive Agents|antidepressive agents|mesh-ancestor
6709694|NCT01771874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6709695|NCT01771874|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6709696|NCT01771874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6709697|NCT01771874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6709698|NCT01771874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709699|NCT01771874|Dopamine Agents|dopamine agents|mesh-ancestor
6709700|NCT01771874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6709701|NCT01771874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709702|NCT01771874|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6709703|NCT01771874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6709704|NCT01771874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6709705|NCT01771874|Hallucinogens|hallucinogens|mesh-ancestor
6709706|NCT01771874|Serotonin Agents|serotonin agents|mesh-ancestor
6709707|NCT01771874|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6709708|NCT01771874|Adrenergic Agents|adrenergic agents|mesh-ancestor
6709709|NCT01771978|Diltiazem|diltiazem|mesh-list
6709710|NCT01771978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6709711|NCT01771978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6709712|NCT01771978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6709713|NCT01771978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709714|NCT01771978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6709715|NCT01771978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709716|NCT01771978|Vasodilator Agents|vasodilator agents|mesh-ancestor
6709717|NCT01772056|Fluticasone|fluticasone|mesh-list
6709718|NCT01772056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6709719|NCT01772056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6709720|NCT01772056|Autonomic Agents|autonomic agents|mesh-ancestor
6709721|NCT01772056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6709722|NCT01772056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709723|NCT01772056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6709724|NCT01772056|Respiratory System Agents|respiratory system agents|mesh-ancestor
6709725|NCT01772056|Dermatologic Agents|dermatologic agents|mesh-ancestor
6709726|NCT01772056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6709727|NCT01772212|Terbinafine|terbinafine|mesh-list
6709728|NCT01772212|Antifungal Agents|antifungal agents|mesh-ancestor
6709729|NCT01772212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6709730|NCT01772212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6709731|NCT01772212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709732|NCT01772238|Amoxicillin|amoxicillin|mesh-list
6709733|NCT01772238|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6709734|NCT01772238|Clavulanic Acids|clavulanic acids|mesh-list
6709735|NCT01772238|Clavulanic Acid|clavulanic acid|mesh-list
6709736|NCT01772238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6709737|NCT01772238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6709738|NCT01772238|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6709739|NCT01772238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6709740|NCT01772238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709741|NCT01772251|Insulin|insulin|mesh-list
6709742|NCT01772251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6709743|NCT01772251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709744|NCT01772290|Itraconazole|itraconazole|mesh-list
6709745|NCT01772290|Fluconazole|fluconazole|mesh-list
6709746|NCT01772290|Rabeprazole|rabeprazole|mesh-list
6709747|NCT01772290|Antifungal Agents|antifungal agents|mesh-ancestor
6709748|NCT01772290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6709749|NCT01772290|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6709750|NCT01772290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6709751|NCT01772290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6709752|NCT01772290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709753|NCT01772290|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6709754|NCT01772290|Hormone Antagonists|hormone antagonists|mesh-ancestor
6709755|NCT01772290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6709756|NCT01772290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709757|NCT01772290|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6709758|NCT01772290|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6709759|NCT01772290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6709760|NCT01772290|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6709761|NCT01772290|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6709762|NCT01772290|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6709763|NCT01772381|Dexamethasone|dexamethasone|mesh-list
6709764|NCT01772381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6709765|NCT01772381|Antiemetics|antiemetics|mesh-ancestor
6709766|NCT01772381|Autonomic Agents|autonomic agents|mesh-ancestor
6709767|NCT01772381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6709768|NCT01772381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709769|NCT01772381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6709770|NCT01772381|Glucocorticoids|glucocorticoids|mesh-ancestor
6709771|NCT01772381|Hormones|hormones|mesh-ancestor
6709772|NCT01772381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6709773|NCT01772381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6709774|NCT01772381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6709775|NCT01772420|Lenalidomide|lenalidomide|mesh-list
6709776|NCT01772420|Immunologic Factors|immunologic factors|mesh-ancestor
6709777|NCT01772420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709778|NCT01772420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6709779|NCT01772420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6709780|NCT01772420|Growth Substances|growth substances|mesh-ancestor
6709781|NCT01772420|Growth Inhibitors|growth inhibitors|mesh-ancestor
6709782|NCT01772420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6709783|NCT01772563|Itraconazole|itraconazole|mesh-list
6709784|NCT01772563|Antifungal Agents|antifungal agents|mesh-ancestor
6709785|NCT01772563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6709786|NCT01772563|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6709787|NCT01772563|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6709788|NCT01772563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6709789|NCT01772563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709790|NCT01772563|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6709791|NCT01772563|Hormone Antagonists|hormone antagonists|mesh-ancestor
6709792|NCT01772563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6709793|NCT01772563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709794|NCT01772563|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6709795|NCT01772589|Pyrithione zinc|pyrithione zinc|mesh-list
6709796|NCT01772589|Keratolytic Agents|keratolytic agents|mesh-ancestor
6709797|NCT01772589|Dermatologic Agents|dermatologic agents|mesh-ancestor
6709798|NCT01772615|Ciprofloxacin|ciprofloxacin|mesh-list
6709799|NCT01772615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6709800|NCT01772615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6709801|NCT01772615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6709802|NCT01772615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6709803|NCT01772615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6709804|NCT01772615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709805|NCT01772615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6709806|NCT01772615|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6709807|NCT01772615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6709808|NCT01772641|Varenicline|varenicline|mesh-list
6709809|NCT01772641|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6709810|NCT01772641|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6709811|NCT01772641|Cholinergic Agents|cholinergic agents|mesh-ancestor
6709812|NCT01772641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6709813|NCT01772641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709814|NCT01772641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709815|NCT01772797|Ceritinib|ceritinib|mesh-list
6709816|NCT01772797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6709817|NCT01772797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6709818|NCT01772797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6709819|NCT01772797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709820|NCT01772836|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
6709821|NCT01772836|Biapenem|biapenem|mesh-list
6709822|NCT01772836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6709823|NCT01772836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709824|NCT01772836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6709825|NCT01772836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6709826|NCT01772940|Ritonavir|ritonavir|mesh-list
6709827|NCT01772940|Lopinavir|lopinavir|mesh-list
6709828|NCT01772940|Tenofovir|tenofovir|mesh-list
6709829|NCT01772940|Lamivudine|lamivudine|mesh-list
6709830|NCT01772940|Zidovudine|zidovudine|mesh-list
6709831|NCT01772940|Emtricitabine|emtricitabine|mesh-list
6709832|NCT01772940|Nevirapine|nevirapine|mesh-list
6709833|NCT01772940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6709834|NCT01772940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6709835|NCT01772940|Protease Inhibitors|protease inhibitors|mesh-ancestor
6709836|NCT01772940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6709837|NCT01772940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709838|NCT01772940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6709839|NCT01772940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6709840|NCT01772940|Antiviral Agents|antiviral agents|mesh-ancestor
6709841|NCT01772940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6709842|NCT01772940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6709843|NCT01772940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6709844|NCT01772940|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6709845|NCT01772940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6709846|NCT01772940|Antimetabolites|antimetabolites|mesh-ancestor
6709847|NCT01772940|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6709848|NCT01772940|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6709849|NCT01772953|Treosulfan|treosulfan|mesh-list
6709850|NCT01772953|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6709851|NCT01772953|Alkylating Agents|alkylating agents|mesh-ancestor
6709852|NCT01772953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709853|NCT01772953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6709854|NCT01772979|Trabectedin|trabectedin|mesh-list
6709855|NCT01772979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6709856|NCT01772979|Alkylating Agents|alkylating agents|mesh-ancestor
6709857|NCT01772979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709858|NCT01772979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6709859|NCT01773005|Acetaminophen|acetaminophen|mesh-list
6709860|NCT01773005|Ibuprofen|ibuprofen|mesh-list
6709861|NCT01773005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6709862|NCT01773005|Analgesics|analgesics|mesh-ancestor
6709863|NCT01773005|Sensory System Agents|sensory system agents|mesh-ancestor
6709864|NCT01773005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6709865|NCT01773005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709866|NCT01773005|Antipyretics|antipyretics|mesh-ancestor
6709867|NCT01773005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6709868|NCT01773005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6709869|NCT01773005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6709870|NCT01773005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6709871|NCT01773005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6709872|NCT01773005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709873|NCT01773044|Lidocaine|lidocaine|mesh-list
6709874|NCT01773044|Anesthetics, Local|anesthetics, local|mesh-ancestor
6709875|NCT01773044|Anesthetics|anesthetics|mesh-ancestor
6709876|NCT01773044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6709877|NCT01773044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709878|NCT01773044|Sensory System Agents|sensory system agents|mesh-ancestor
6709879|NCT01773044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6709880|NCT01773044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6709881|NCT01773044|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6709882|NCT01773044|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6709883|NCT01773044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6709884|NCT01773044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709885|NCT01773096|Methylnaltrexone|methylnaltrexone|mesh-list
6709886|NCT01773096|Bisacodyl|bisacodyl|mesh-list
6709887|NCT01773096|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
6709888|NCT01773096|Magnesium Hydroxide|magnesium hydroxide|mesh-list
6709889|NCT01773096|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
6709890|NCT01773096|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6709891|NCT01773096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709892|NCT01773096|Sensory System Agents|sensory system agents|mesh-ancestor
6709893|NCT01773096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6709894|NCT01773096|Cathartics|cathartics|mesh-ancestor
6709895|NCT01773096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6709896|NCT01773096|Laxatives|laxatives|mesh-ancestor
6709897|NCT01773096|Antacids|antacids|mesh-ancestor
6709898|NCT01773096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709899|NCT01773096|Antidiarrheals|antidiarrheals|mesh-ancestor
6709900|NCT01773174|Dabigatran|dabigatran|mesh-list
6709901|NCT01773174|Antithrombins|antithrombins|mesh-ancestor
6709902|NCT01773174|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6709903|NCT01773174|Protease Inhibitors|protease inhibitors|mesh-ancestor
6709904|NCT01773174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6709905|NCT01773174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709906|NCT01773174|Anticoagulants|anticoagulants|mesh-ancestor
6782764|NCT02192710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6782765|NCT02192710|Anesthetics, General|anesthetics, general|mesh-ancestor
6782766|NCT02192710|Anesthetics|anesthetics|mesh-ancestor
6782767|NCT02192710|GABA Modulators|gaba modulators|mesh-ancestor
6782768|NCT02192710|GABA Agents|gaba agents|mesh-ancestor
6782769|NCT02192710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6782770|NCT02192710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782771|NCT02192723|Olanzapine|olanzapine|mesh-list
6782772|NCT02192723|Risperidone|risperidone|mesh-list
6782773|NCT02192723|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6782774|NCT02192723|Aripiprazole|aripiprazole|mesh-list
6782775|NCT02192723|Ziprasidone|ziprasidone|mesh-list
6782776|NCT02192723|Antipsychotic Agents|antipsychotic agents|mesh-list
6782777|NCT02192723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6782778|NCT02192723|Serotonin Agents|serotonin agents|mesh-ancestor
6782779|NCT02192723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6782780|NCT02192723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782781|NCT02192723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782782|NCT02192723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6782783|NCT02192723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6782784|NCT02192723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6782785|NCT02192723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6782786|NCT02192723|Dopamine Agents|dopamine agents|mesh-ancestor
6782787|NCT02192723|Antiemetics|antiemetics|mesh-ancestor
6782788|NCT02192723|Autonomic Agents|autonomic agents|mesh-ancestor
6782789|NCT02192723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6782790|NCT02192723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6782791|NCT02192723|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6782792|NCT02192723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6782793|NCT02192723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6782794|NCT02192723|Antidepressive Agents|antidepressive agents|mesh-ancestor
6782795|NCT02192723|Dopamine Agonists|dopamine agonists|mesh-ancestor
6782796|NCT02192723|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6782797|NCT02192723|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6782798|NCT02192723|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6782799|NCT02192723|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6782800|NCT02192827|Dexamethasone|dexamethasone|mesh-list
6782801|NCT02192827|Dexamethasone acetate|dexamethasone acetate|mesh-list
6709907|NCT01773395|Methotrexate|methotrexate|mesh-list
6709908|NCT01773395|Fludarabine|fludarabine|mesh-list
6709909|NCT01773395|Busulfan|busulfan|mesh-list
6709910|NCT01773395|Tacrolimus|tacrolimus|mesh-list
6709911|NCT01773395|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6709912|NCT01773395|Abortifacient Agents|abortifacient agents|mesh-ancestor
6709913|NCT01773395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6709914|NCT01773395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709915|NCT01773395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6709916|NCT01773395|Antimetabolites|antimetabolites|mesh-ancestor
6709917|NCT01773395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709918|NCT01773395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6709919|NCT01773395|Dermatologic Agents|dermatologic agents|mesh-ancestor
6709920|NCT01773395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6709921|NCT01773395|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6709922|NCT01773395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6709923|NCT01773395|Immunologic Factors|immunologic factors|mesh-ancestor
6709924|NCT01773395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6709925|NCT01773395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6709926|NCT01773395|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6709927|NCT01773395|Alkylating Agents|alkylating agents|mesh-ancestor
6709928|NCT01773395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6709929|NCT01773395|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6709930|NCT01773408|Cytarabine|cytarabine|mesh-list
6709931|NCT01773408|Daunorubicin|daunorubicin|mesh-list
6709932|NCT01773408|Idarubicin|idarubicin|mesh-list
6709933|NCT01773408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6709934|NCT01773408|Antimetabolites|antimetabolites|mesh-ancestor
6709935|NCT01773408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709936|NCT01773408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6709937|NCT01773408|Antiviral Agents|antiviral agents|mesh-ancestor
6709938|NCT01773408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6709939|NCT01773408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6709940|NCT01773408|Immunologic Factors|immunologic factors|mesh-ancestor
6709941|NCT01773408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709942|NCT01773408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6709943|NCT01773408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6709944|NCT01773408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6709945|NCT01773408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6709946|NCT01773460|Everolimus|everolimus|mesh-list
6709947|NCT01773460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6709948|NCT01773460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6709949|NCT01773460|Immunologic Factors|immunologic factors|mesh-ancestor
6709950|NCT01773460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709951|NCT01773512|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6709952|NCT01773512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6709953|NCT01773512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6709954|NCT01773512|Antimetabolites|antimetabolites|mesh-ancestor
6709955|NCT01773512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709956|NCT01773512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6709957|NCT01773512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6709958|NCT01773512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6709959|NCT01773538|Rifaximin|rifaximin|mesh-list
6709960|NCT01773538|Lactulose|lactulose|mesh-list
6709961|NCT01773538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6709962|NCT01773538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6709963|NCT01773538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6709964|NCT01773616|Mycophenolic Acid|mycophenolic acid|mesh-list
6709965|NCT01773616|Prednisolone|prednisolone|mesh-list
6709966|NCT01773616|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6709967|NCT01773616|Methylprednisolone|methylprednisolone|mesh-list
6709968|NCT01773616|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6709969|NCT01773616|Prednisolone acetate|prednisolone acetate|mesh-list
6709970|NCT01773616|Rituximab|rituximab|mesh-list
6709971|NCT01773616|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6709972|NCT01773616|Prednisolone phosphate|prednisolone phosphate|mesh-list
6709973|NCT01773616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6709974|NCT01773616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6709975|NCT01773616|Immunologic Factors|immunologic factors|mesh-ancestor
6709976|NCT01773616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6709977|NCT01773616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6709978|NCT01773616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6709979|NCT01773616|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6709980|NCT01773616|Antitubercular Agents|antitubercular agents|mesh-ancestor
6709981|NCT01773616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6709982|NCT01773616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6709983|NCT01773616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6709984|NCT01773616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6709985|NCT01773616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6709986|NCT01773616|Glucocorticoids|glucocorticoids|mesh-ancestor
6709987|NCT01773616|Hormones|hormones|mesh-ancestor
6709988|NCT01773616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6709989|NCT01773616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6709990|NCT01773616|Antiemetics|antiemetics|mesh-ancestor
6709991|NCT01773616|Autonomic Agents|autonomic agents|mesh-ancestor
6709992|NCT01773616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6709993|NCT01773616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6709994|NCT01773616|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6709995|NCT01773616|Protective Agents|protective agents|mesh-ancestor
6709996|NCT01773681|Certolizumab Pegol|certolizumab pegol|mesh-list
6709997|NCT01773681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6709998|NCT01773681|Immunologic Factors|immunologic factors|mesh-ancestor
6709999|NCT01773681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710000|NCT01773681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6710001|NCT01773707|Abatacept|abatacept|mesh-list
6710002|NCT01773707|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6710003|NCT01773707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710004|NCT01773707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6710005|NCT01773707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6710006|NCT01773707|Immunologic Factors|immunologic factors|mesh-ancestor
6710007|NCT01773707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710008|NCT01773707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6710009|NCT01773772|Progesterone|progesterone|mesh-list
6710010|NCT01773772|Progestins|progestins|mesh-ancestor
6710011|NCT01773772|Hormones|hormones|mesh-ancestor
6710012|NCT01773772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6710013|NCT01773772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710014|NCT01773798|Insulin|insulin|mesh-list
6710015|NCT01773798|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6710016|NCT01773798|Insulin Aspart|insulin aspart|mesh-list
6710017|NCT01773798|Insulin, Long-Acting|insulin, long-acting|mesh-list
6710018|NCT01773798|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6710019|NCT01773798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6710020|NCT01773798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710021|NCT01773824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6710022|NCT01773824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6710023|NCT01773837|Methylphenidate|methylphenidate|mesh-list
6710024|NCT01773837|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6710025|NCT01773837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710026|NCT01773837|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6710027|NCT01773837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6710028|NCT01773837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6710029|NCT01773837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710030|NCT01773837|Dopamine Agents|dopamine agents|mesh-ancestor
6710031|NCT01773837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6710032|NCT01773876|Micafungin|micafungin|mesh-list
6710033|NCT01773876|Antifungal Agents|antifungal agents|mesh-ancestor
6710034|NCT01773876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6710035|NCT01774370|Dabigatran|dabigatran|mesh-list
6710036|NCT01774370|Antithrombins|antithrombins|mesh-ancestor
6710037|NCT01774370|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6710038|NCT01774370|Protease Inhibitors|protease inhibitors|mesh-ancestor
6710039|NCT01774370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6710040|NCT01774370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710041|NCT01774370|Anticoagulants|anticoagulants|mesh-ancestor
6710042|NCT01774396|Lidocaine|lidocaine|mesh-list
6710043|NCT01774396|Anesthetics, Local|anesthetics, local|mesh-ancestor
6710044|NCT01774396|Anesthetics|anesthetics|mesh-ancestor
6710045|NCT01774396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6710046|NCT01774396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710047|NCT01774396|Sensory System Agents|sensory system agents|mesh-ancestor
6710048|NCT01774396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6710049|NCT01774396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6710050|NCT01774396|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6710051|NCT01774396|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6710052|NCT01774396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6710053|NCT01774396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710054|NCT01774474|Dexamethasone|dexamethasone|mesh-list
6710055|NCT01774474|Dexamethasone acetate|dexamethasone acetate|mesh-list
6710056|NCT01774474|Triamcinolone|triamcinolone|mesh-list
6710057|NCT01774474|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6710058|NCT01774474|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6710059|NCT01774474|Bromfenac|bromfenac|mesh-list
6710060|NCT01774474|Bevacizumab|bevacizumab|mesh-list
6710061|NCT01774474|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6710062|NCT01774474|BB 1101|bb 1101|mesh-list
6710063|NCT01774474|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6710064|NCT01774474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6710065|NCT01774474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6710066|NCT01774474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6710067|NCT01774474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6710068|NCT01774474|Growth Substances|growth substances|mesh-ancestor
6710069|NCT01774474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710070|NCT01774474|Growth Inhibitors|growth inhibitors|mesh-ancestor
6710071|NCT01774474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6710072|NCT01774474|Antiemetics|antiemetics|mesh-ancestor
6710073|NCT01774474|Autonomic Agents|autonomic agents|mesh-ancestor
6710074|NCT01774474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6710075|NCT01774474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6710076|NCT01774474|Glucocorticoids|glucocorticoids|mesh-ancestor
6710077|NCT01774474|Hormones|hormones|mesh-ancestor
6710078|NCT01774474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6710079|NCT01774474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6710080|NCT01774474|Protease Inhibitors|protease inhibitors|mesh-ancestor
6710081|NCT01774474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6710082|NCT01774474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710083|NCT01774474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6710084|NCT01774474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6710085|NCT01774474|Immunologic Factors|immunologic factors|mesh-ancestor
6710086|NCT01774474|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6710087|NCT01774474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6710088|NCT01774474|Analgesics|analgesics|mesh-ancestor
6710089|NCT01774474|Sensory System Agents|sensory system agents|mesh-ancestor
6710090|NCT01774474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6710091|NCT01774487|Pentoxifylline|pentoxifylline|mesh-list
6710092|NCT01774487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6710093|NCT01774487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6710094|NCT01774487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710095|NCT01774487|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6710096|NCT01774487|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6710097|NCT01774487|Protective Agents|protective agents|mesh-ancestor
6710098|NCT01774487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710099|NCT01774487|Vasodilator Agents|vasodilator agents|mesh-ancestor
6710100|NCT01774487|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6710101|NCT01774487|Antioxidants|antioxidants|mesh-ancestor
6710102|NCT01774565|Insulin|insulin|mesh-list
6710103|NCT01774565|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6710104|NCT01774565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6710105|NCT01774565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710106|NCT01774812|Ergocalciferols|ergocalciferols|mesh-list
6710107|NCT01774812|Vitamin D|vitamin d|mesh-list
6710108|NCT01774812|Alfacalcidol|alfacalcidol|mesh-list
6710109|NCT01774812|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
6710110|NCT01774812|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6710111|NCT01774812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710112|NCT01774812|Vitamins|vitamins|mesh-ancestor
6710113|NCT01774812|Micronutrients|micronutrients|mesh-ancestor
6710114|NCT01774812|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6710115|NCT01774838|Clopidogrel|clopidogrel|mesh-list
6710116|NCT01774838|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6710117|NCT01774838|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6710118|NCT01774838|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6710119|NCT01774838|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6710120|NCT01774838|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6710121|NCT01774838|Purinergic Agents|purinergic agents|mesh-ancestor
6710122|NCT01774838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6710123|NCT01774838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710124|NCT01774838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710125|NCT01774864|Udenafil|udenafil|mesh-list
6710126|NCT01774864|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6710127|NCT01774864|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6710128|NCT01774864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6710129|NCT01774864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710130|NCT01774877|Leflunomide|leflunomide|mesh-list
6710131|NCT01774877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6710132|NCT01774877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710133|NCT01774877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6710134|NCT01774877|Immunologic Factors|immunologic factors|mesh-ancestor
6710135|NCT01774877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782802|NCT02192827|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
6782803|NCT02192827|BB 1101|bb 1101|mesh-list
6782804|NCT02192827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6782805|NCT02192827|Antiemetics|antiemetics|mesh-ancestor
6782806|NCT02192827|Autonomic Agents|autonomic agents|mesh-ancestor
6782807|NCT02192827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6782808|NCT02192827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782809|NCT02192827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6782810|NCT02192827|Glucocorticoids|glucocorticoids|mesh-ancestor
6782811|NCT02192827|Hormones|hormones|mesh-ancestor
6782812|NCT02192827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6782813|NCT02192827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6782814|NCT02192827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6782815|NCT02192827|Protease Inhibitors|protease inhibitors|mesh-ancestor
6782816|NCT02192827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6782817|NCT02192827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782818|NCT02192853|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6782819|NCT02192853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6782820|NCT02192853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782821|NCT02192853|Incretins|incretins|mesh-ancestor
6782822|NCT02192853|Hormones|hormones|mesh-ancestor
6782823|NCT02192853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6782824|NCT02192853|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6782825|NCT02192853|Protease Inhibitors|protease inhibitors|mesh-ancestor
6782826|NCT02192853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6782827|NCT02192853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782828|NCT02192944|Chloroquine|chloroquine|mesh-list
6782829|NCT02192944|Piperaquine|piperaquine|mesh-list
6782830|NCT02192944|Artenimol|artenimol|mesh-list
6782831|NCT02192944|Amebicides|amebicides|mesh-ancestor
6782832|NCT02192944|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6782833|NCT02192944|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6782834|NCT02192944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6782835|NCT02192944|Antimalarials|antimalarials|mesh-ancestor
6782836|NCT02192944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6782837|NCT02193022|Miltefosine|miltefosine|mesh-list
6782838|NCT02193022|Antifungal Agents|antifungal agents|mesh-ancestor
6782839|NCT02193022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6782840|NCT02193022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6782841|NCT02193022|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6782842|NCT02193022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6782843|NCT02193191|Plerixafor|plerixafor|mesh-list
6782844|NCT02193191|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6782845|NCT02193191|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6782846|NCT02193191|Antiviral Agents|antiviral agents|mesh-ancestor
6782847|NCT02193191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6782848|NCT02193217|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6782849|NCT02193217|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6782850|NCT02193217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710136|NCT01775098|Allopurinol|allopurinol|mesh-list
6710137|NCT01775098|Antimetabolites|antimetabolites|mesh-ancestor
6710138|NCT01775098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710139|NCT01775098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6710140|NCT01775098|Gout Suppressants|gout suppressants|mesh-ancestor
6710141|NCT01775098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6710142|NCT01775098|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6710143|NCT01775098|Antioxidants|antioxidants|mesh-ancestor
6710144|NCT01775098|Protective Agents|protective agents|mesh-ancestor
6710145|NCT01775098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710146|NCT01775215|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6710147|NCT01775215|Natriuretic Agents|natriuretic agents|mesh-ancestor
6710148|NCT01775215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710149|NCT01775397|Vancomycin|vancomycin|mesh-list
6710150|NCT01775397|Fidaxomicin|fidaxomicin|mesh-list
6710151|NCT01775397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6710152|NCT01775397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6710153|NCT01775475|Prednisone|prednisone|mesh-list
6710154|NCT01775475|Cyclophosphamide|cyclophosphamide|mesh-list
6710155|NCT01775475|Lomustine|lomustine|mesh-list
6710156|NCT01775475|Doxorubicin|doxorubicin|mesh-list
6710157|NCT01775475|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6710158|NCT01775475|Etoposide|etoposide|mesh-list
6710159|NCT01775475|Vincristine|vincristine|mesh-list
6710160|NCT01775475|Etoposide phosphate|etoposide phosphate|mesh-list
6710161|NCT01775475|Procarbazine|procarbazine|mesh-list
6710162|NCT01775475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6710163|NCT01775475|Immunologic Factors|immunologic factors|mesh-ancestor
6710164|NCT01775475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710165|NCT01775475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6710166|NCT01775475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6710167|NCT01775475|Alkylating Agents|alkylating agents|mesh-ancestor
6710168|NCT01775475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710169|NCT01775475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6710170|NCT01775475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6710171|NCT01775475|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6710172|NCT01775475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6710173|NCT01775475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6710174|NCT01775475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6710175|NCT01775475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6710176|NCT01775475|Glucocorticoids|glucocorticoids|mesh-ancestor
6710177|NCT01775475|Hormones|hormones|mesh-ancestor
6710178|NCT01775475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6710179|NCT01775475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6710180|NCT01775475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6710181|NCT01775475|Tubulin Modulators|tubulin modulators|mesh-ancestor
6710182|NCT01775475|Antimitotic Agents|antimitotic agents|mesh-ancestor
6710183|NCT01775475|Mitosis Modulators|mitosis modulators|mesh-ancestor
6710184|NCT01775540|Dexamethasone|dexamethasone|mesh-list
6710185|NCT01775540|Lubricant Eye Drops|lubricant eye drops|mesh-list
6710186|NCT01775540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6710187|NCT01775540|Antiemetics|antiemetics|mesh-ancestor
6710188|NCT01775540|Autonomic Agents|autonomic agents|mesh-ancestor
6710189|NCT01775540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6710190|NCT01775540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710191|NCT01775540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6710192|NCT01775540|Glucocorticoids|glucocorticoids|mesh-ancestor
6710193|NCT01775540|Hormones|hormones|mesh-ancestor
6710194|NCT01775540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6710195|NCT01775540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6710196|NCT01775540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6710197|NCT01775540|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6710198|NCT01775540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6710199|NCT01775579|Metformin|metformin|mesh-list
6710200|NCT01775579|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6710201|NCT01775579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6710202|NCT01775579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710203|NCT01775579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6710204|NCT01775579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6710205|NCT01775579|Antimetabolites|antimetabolites|mesh-ancestor
6710206|NCT01775579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710207|NCT01775579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6710208|NCT01775579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6710209|NCT01775579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6710210|NCT01775618|Factor VIII|factor viii|mesh-list
6710211|NCT01775618|Coagulants|coagulants|mesh-ancestor
6710212|NCT01775631|Rituximab|rituximab|mesh-list
6710213|NCT01775631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6710214|NCT01775631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6710215|NCT01775631|Immunologic Factors|immunologic factors|mesh-ancestor
6710216|NCT01775631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710217|NCT01775631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6710218|NCT01775761|Moxifloxacin|moxifloxacin|mesh-list
6710219|NCT01775761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6710220|NCT01775761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6710221|NCT01775761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6710222|NCT01775761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6710223|NCT01775761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6710224|NCT01775761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710225|NCT01775761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6710226|NCT01775839|Aspirin|aspirin|mesh-list
6710227|NCT01775839|Digoxin|digoxin|mesh-list
6710228|NCT01775839|Clopidogrel|clopidogrel|mesh-list
6710229|NCT01775839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6710230|NCT01775839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6710231|NCT01775839|Analgesics|analgesics|mesh-ancestor
6710232|NCT01775839|Sensory System Agents|sensory system agents|mesh-ancestor
6710233|NCT01775839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6710234|NCT01775839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710235|NCT01775839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6710236|NCT01775839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6710237|NCT01775839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6710238|NCT01775839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6710239|NCT01775839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710240|NCT01775839|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6710241|NCT01775839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6710242|NCT01775839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6710243|NCT01775839|Antipyretics|antipyretics|mesh-ancestor
6710244|NCT01775839|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6710245|NCT01775839|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6710246|NCT01775839|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6710247|NCT01775839|Purinergic Agents|purinergic agents|mesh-ancestor
6710248|NCT01775839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6710249|NCT01775839|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6710250|NCT01775839|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6710251|NCT01775839|Protective Agents|protective agents|mesh-ancestor
6710252|NCT01775891|Flecainide|flecainide|mesh-list
6710253|NCT01775891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
6710254|NCT01775891|Propafenone|propafenone|mesh-list
6710255|NCT01775891|Pilsicainide|pilsicainide|mesh-list
6710256|NCT01775891|Lidocaine|lidocaine|mesh-list
6710257|NCT01775891|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6710258|NCT01775891|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6710259|NCT01775891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6710260|NCT01775891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710261|NCT01775891|Anesthetics, Local|anesthetics, local|mesh-ancestor
6710262|NCT01775891|Anesthetics|anesthetics|mesh-ancestor
6710263|NCT01775891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6710264|NCT01775891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710265|NCT01775891|Sensory System Agents|sensory system agents|mesh-ancestor
6710266|NCT01775891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6710267|NCT01776047|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
6710268|NCT01776047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6710269|NCT01776203|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6710270|NCT01776203|Medroxyprogesterone|medroxyprogesterone|mesh-list
6710271|NCT01776203|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6710272|NCT01776203|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6710273|NCT01776203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6710274|NCT01776203|Contraceptive Agents|contraceptive agents|mesh-ancestor
6710275|NCT01776203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6710276|NCT01776203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710277|NCT01776203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6710278|NCT01776203|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6710279|NCT01776203|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6710280|NCT01776203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6710281|NCT01776203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6710282|NCT01776320|Alprostadil|alprostadil|mesh-list
6710283|NCT01776320|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6710284|NCT01776320|Vasodilator Agents|vasodilator agents|mesh-ancestor
6710285|NCT01776320|Urological Agents|urological agents|mesh-ancestor
6710286|NCT01776437|Talazoparib|talazoparib|mesh-list
6710287|NCT01776437|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6710288|NCT01776437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6710289|NCT01776437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710290|NCT01776437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6710291|NCT01776515|Acetaminophen|acetaminophen|mesh-list
6710292|NCT01776515|Tramadol|tramadol|mesh-list
6710293|NCT01776515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6710294|NCT01776515|Analgesics|analgesics|mesh-ancestor
6710295|NCT01776515|Sensory System Agents|sensory system agents|mesh-ancestor
6710296|NCT01776515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6710297|NCT01776515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710298|NCT01776515|Antipyretics|antipyretics|mesh-ancestor
6710299|NCT01776515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6710300|NCT01776515|Narcotics|narcotics|mesh-ancestor
6710301|NCT01776515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6710302|NCT01776567|Everolimus|everolimus|mesh-list
6710303|NCT01776567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6710304|NCT01776567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6710305|NCT01776567|Immunologic Factors|immunologic factors|mesh-ancestor
6710306|NCT01776567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710307|NCT01776671|Gabapentin|gabapentin|mesh-list
6710308|NCT01776671|Analgesics|analgesics|mesh-ancestor
6710309|NCT01776671|Sensory System Agents|sensory system agents|mesh-ancestor
6710310|NCT01776671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6710311|NCT01776671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710312|NCT01776671|Anticonvulsants|anticonvulsants|mesh-ancestor
6710313|NCT01776671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6710314|NCT01776671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6710315|NCT01776671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6710316|NCT01776671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6710317|NCT01776671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6710318|NCT01776671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6710319|NCT01776671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6710320|NCT01776671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710321|NCT01776671|Antimanic Agents|antimanic agents|mesh-ancestor
6710322|NCT01776684|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6710323|NCT01776684|Gefitinib|gefitinib|mesh-list
6710324|NCT01776684|Afatinib|afatinib|mesh-list
6710325|NCT01776684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6710326|NCT01776684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6710327|NCT01776684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6710328|NCT01776684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782851|NCT02193217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6782852|NCT02193217|Immunologic Factors|immunologic factors|mesh-ancestor
6782853|NCT02193217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782854|NCT02193256|Prazosin|prazosin|mesh-list
6782855|NCT02193256|Varenicline|varenicline|mesh-list
6782856|NCT02193256|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6782857|NCT02193256|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6782858|NCT02193256|Cholinergic Agents|cholinergic agents|mesh-ancestor
6782859|NCT02193256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6782860|NCT02193256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782861|NCT02193256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782862|NCT02193256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6782863|NCT02193256|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6782864|NCT02193256|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6782865|NCT02193256|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6782866|NCT02193256|Adrenergic Agents|adrenergic agents|mesh-ancestor
6782867|NCT02193269|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6782868|NCT02193269|Minocycline|minocycline|mesh-list
6782869|NCT02193269|Tetracycline|tetracycline|mesh-list
6782870|NCT02193269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6782871|NCT02193269|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6782872|NCT02193269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6782873|NCT02193269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782874|NCT02193308|Amlodipine|amlodipine|mesh-list
6782875|NCT02193308|Telmisartan|telmisartan|mesh-list
6782876|NCT02193308|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
6782877|NCT02193308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6782878|NCT02193308|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6782879|NCT02193308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6782880|NCT02193308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782881|NCT02193308|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6782882|NCT02193308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710329|NCT01776788|Insulin|insulin|mesh-list
6710330|NCT01776788|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6710331|NCT01776788|Exenatide|exenatide|mesh-list
6710332|NCT01776788|Insulin Lispro|insulin lispro|mesh-list
6710333|NCT01776788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6710334|NCT01776788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710335|NCT01776788|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6710336|NCT01776788|Incretins|incretins|mesh-ancestor
6710337|NCT01776788|Hormones|hormones|mesh-ancestor
6710338|NCT01776788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6710339|NCT01776853|Levan|levan|mesh-list
6710340|NCT01776853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6710341|NCT01776970|Nabiximols|nabiximols|mesh-list
6710342|NCT01776970|Analgesics|analgesics|mesh-ancestor
6710343|NCT01776970|Sensory System Agents|sensory system agents|mesh-ancestor
6710344|NCT01776970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6710345|NCT01776970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710346|NCT01777087|Capsaicin|capsaicin|mesh-list
6710347|NCT01777087|Antipruritics|antipruritics|mesh-ancestor
6710348|NCT01777087|Dermatologic Agents|dermatologic agents|mesh-ancestor
6710349|NCT01777087|Sensory System Agents|sensory system agents|mesh-ancestor
6710350|NCT01777087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6710351|NCT01777087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710352|NCT01777100|Sufentanil|sufentanil|mesh-list
6710353|NCT01777100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6710354|NCT01777100|Narcotics|narcotics|mesh-ancestor
6710355|NCT01777100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6710356|NCT01777100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710357|NCT01777100|Analgesics|analgesics|mesh-ancestor
6710358|NCT01777100|Sensory System Agents|sensory system agents|mesh-ancestor
6710359|NCT01777100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6710360|NCT01777100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6710361|NCT01777100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6710362|NCT01777100|Anesthetics, General|anesthetics, general|mesh-ancestor
6710363|NCT01777100|Anesthetics|anesthetics|mesh-ancestor
6710364|NCT01777347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6710365|NCT01777464|Histamine|histamine|mesh-list
6710366|NCT01777464|Histamine Agonists|histamine agonists|mesh-ancestor
6710367|NCT01777464|Histamine Agents|histamine agents|mesh-ancestor
6710368|NCT01777464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6710369|NCT01777464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710370|NCT01777464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710371|NCT01777477|Gemcitabine|gemcitabine|mesh-list
6710372|NCT01777477|Chloroquine|chloroquine|mesh-list
6710373|NCT01777477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6710374|NCT01777477|Antimetabolites|antimetabolites|mesh-ancestor
6710375|NCT01777477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710376|NCT01777477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6710377|NCT01777477|Antiviral Agents|antiviral agents|mesh-ancestor
6710378|NCT01777477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6710379|NCT01777477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6710380|NCT01777477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6710381|NCT01777477|Immunologic Factors|immunologic factors|mesh-ancestor
6710382|NCT01777477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710383|NCT01777477|Amebicides|amebicides|mesh-ancestor
6710384|NCT01777477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6710385|NCT01777477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6710386|NCT01777477|Antimalarials|antimalarials|mesh-ancestor
6710387|NCT01777477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6710388|NCT01777503|Clopidogrel|clopidogrel|mesh-list
6710389|NCT01777503|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6710390|NCT01777503|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6710391|NCT01777503|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6710392|NCT01777503|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6710393|NCT01777503|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6710394|NCT01777503|Purinergic Agents|purinergic agents|mesh-ancestor
6710395|NCT01777503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6710396|NCT01777503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710397|NCT01777503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710398|NCT01777685|Sulpiride|sulpiride|mesh-list
6710399|NCT01777685|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6710400|NCT01777685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6710401|NCT01777685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6710402|NCT01777685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710403|NCT01777685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6710404|NCT01777685|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6710405|NCT01777685|Dopamine Agents|dopamine agents|mesh-ancestor
6710406|NCT01777685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6710407|NCT01777685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710408|NCT01777685|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6710409|NCT01777685|Antidepressive Agents|antidepressive agents|mesh-ancestor
6710410|NCT01777737|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6710411|NCT01777737|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6710412|NCT01777737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6710413|NCT01777737|Renal Agents|renal agents|mesh-ancestor
6710414|NCT01777737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6710415|NCT01777737|Antimalarials|antimalarials|mesh-ancestor
6710416|NCT01777737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6710417|NCT01777737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6710418|NCT01777867|Methacholine Chloride|methacholine chloride|mesh-list
6710419|NCT01777867|Miotics|miotics|mesh-ancestor
6710420|NCT01777867|Autonomic Agents|autonomic agents|mesh-ancestor
6710421|NCT01777867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6710422|NCT01777867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710423|NCT01777867|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6710424|NCT01777867|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
6710425|NCT01777867|Respiratory System Agents|respiratory system agents|mesh-ancestor
6710426|NCT01777867|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6710427|NCT01777867|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6710428|NCT01777867|Cholinergic Agents|cholinergic agents|mesh-ancestor
6710429|NCT01777867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6710430|NCT01777867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710431|NCT01777919|Copper|copper|mesh-list
6710432|NCT01777919|Temozolomide|temozolomide|mesh-list
6710433|NCT01777919|Disulfiram|disulfiram|mesh-list
6710434|NCT01777919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6710435|NCT01777919|Alkylating Agents|alkylating agents|mesh-ancestor
6710436|NCT01777919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710437|NCT01777919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6710438|NCT01777919|Trace Elements|trace elements|mesh-ancestor
6710439|NCT01777919|Micronutrients|micronutrients|mesh-ancestor
6710440|NCT01777919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710441|NCT01777919|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6710442|NCT01777919|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
6710443|NCT01777919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6710444|NCT01778075|Acetaminophen|acetaminophen|mesh-list
6710445|NCT01778075|Tramadol|tramadol|mesh-list
6710446|NCT01778075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6710447|NCT01778075|Analgesics|analgesics|mesh-ancestor
6710448|NCT01778075|Sensory System Agents|sensory system agents|mesh-ancestor
6710449|NCT01778075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6710450|NCT01778075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710451|NCT01778075|Antipyretics|antipyretics|mesh-ancestor
6710452|NCT01778075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6710453|NCT01778075|Narcotics|narcotics|mesh-ancestor
6710454|NCT01778075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6710455|NCT01778101|Lansoprazole|lansoprazole|mesh-list
6710456|NCT01778101|Dexlansoprazole|dexlansoprazole|mesh-list
6710457|NCT01778101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6710458|NCT01778101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6710459|NCT01778101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6710460|NCT01778101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6710461|NCT01778101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710462|NCT01778114|Vitamin D|vitamin d|mesh-list
6710463|NCT01778114|Ergocalciferols|ergocalciferols|mesh-list
6710464|NCT01778114|Cholecalciferol|cholecalciferol|mesh-list
6710465|NCT01778114|Vitamins|vitamins|mesh-list
6710466|NCT01778114|Micronutrients|micronutrients|mesh-ancestor
6710467|NCT01778114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710468|NCT01778114|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6710469|NCT01778114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6710470|NCT01778192|Picosulfate sodium|picosulfate sodium|mesh-list
6710471|NCT01778192|Magnesium citrate|magnesium citrate|mesh-list
6710472|NCT01778192|Citric Acid|citric acid|mesh-list
6710473|NCT01778192|Sodium Citrate|sodium citrate|mesh-list
6710474|NCT01778192|Anticoagulants|anticoagulants|mesh-ancestor
6710475|NCT01778192|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6710476|NCT01778192|Chelating Agents|chelating agents|mesh-ancestor
6710477|NCT01778192|Sequestering Agents|sequestering agents|mesh-ancestor
6710478|NCT01778192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710479|NCT01778192|Cathartics|cathartics|mesh-ancestor
6710480|NCT01778192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6710481|NCT01778218|Deoxyglucose|deoxyglucose|mesh-list
6710482|NCT01778218|Antimetabolites|antimetabolites|mesh-ancestor
6710483|NCT01778218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710484|NCT01778218|Antiviral Agents|antiviral agents|mesh-ancestor
6710485|NCT01778218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6710486|NCT01778244|Metformin|metformin|mesh-list
6710487|NCT01778244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6710488|NCT01778244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710489|NCT01778283|Dialysis Solutions|dialysis solutions|mesh-list
6710490|NCT01778283|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6710491|NCT01778309|Acetylcysteine|acetylcysteine|mesh-list
6710492|NCT01778309|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6710493|NCT01778309|Antiviral Agents|antiviral agents|mesh-ancestor
6710494|NCT01778309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6710495|NCT01778309|Expectorants|expectorants|mesh-ancestor
6710496|NCT01778309|Respiratory System Agents|respiratory system agents|mesh-ancestor
6710497|NCT01778309|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6710498|NCT01778309|Antioxidants|antioxidants|mesh-ancestor
6710499|NCT01778309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710500|NCT01778309|Protective Agents|protective agents|mesh-ancestor
6710501|NCT01778309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710502|NCT01778309|Antidotes|antidotes|mesh-ancestor
6710503|NCT01778400|Ethanol|ethanol|mesh-list
6710504|NCT01778400|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6710505|NCT01778400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6710506|NCT01778400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6710507|NCT01778400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710508|NCT01778413|Tenofovir|tenofovir|mesh-list
6710509|NCT01778413|Emtricitabine|emtricitabine|mesh-list
6710510|NCT01778413|Efavirenz|efavirenz|mesh-list
6710511|NCT01778413|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6710512|NCT01778413|Antiviral Agents|antiviral agents|mesh-ancestor
6710513|NCT01778413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6710514|NCT01778413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6710515|NCT01778413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6710516|NCT01778413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6710517|NCT01778413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710518|NCT01778413|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6710519|NCT01778413|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6710520|NCT01778413|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6710521|NCT01778413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6710522|NCT01778413|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6710523|NCT01778413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6710524|NCT01778413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6710525|NCT01778413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6710526|NCT01778647|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
6710527|NCT01778647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710528|NCT01778686|Pindolol|pindolol|mesh-list
6710529|NCT01778686|Citalopram|citalopram|mesh-list
6710530|NCT01778686|Tryptophan|tryptophan|mesh-list
6710531|NCT01778686|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6710532|NCT01778686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6710533|NCT01778686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6710534|NCT01778686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710535|NCT01778686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6710536|NCT01778686|Serotonin Agents|serotonin agents|mesh-ancestor
6710537|NCT01778686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710538|NCT01778686|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6710539|NCT01778686|Antidepressive Agents|antidepressive agents|mesh-ancestor
6710540|NCT01778686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6710541|NCT01778686|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6710542|NCT01778686|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6710543|NCT01778686|Adrenergic Agents|adrenergic agents|mesh-ancestor
6710544|NCT01778686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6710545|NCT01778686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6710546|NCT01778686|Vasodilator Agents|vasodilator agents|mesh-ancestor
6782883|NCT02193308|Vasodilator Agents|vasodilator agents|mesh-ancestor
6782884|NCT02193308|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6782885|NCT02193308|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6782886|NCT02193334|Mitogens|mitogens|mesh-list
6782887|NCT02193334|Mitosis Modulators|mitosis modulators|mesh-ancestor
6782888|NCT02193334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782889|NCT02193568|Anesthetics|anesthetics|mesh-list
6782890|NCT02193568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6782891|NCT02193568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782892|NCT02193594|Oxaliplatin|oxaliplatin|mesh-list
6782893|NCT02193594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6782894|NCT02193620|Nalbuphine|nalbuphine|mesh-list
6782895|NCT02193620|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6710547|NCT01778803|Paclitaxel|paclitaxel|mesh-list
6710548|NCT01778803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6710549|NCT01778803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6710550|NCT01778803|Tubulin Modulators|tubulin modulators|mesh-ancestor
6710551|NCT01778803|Antimitotic Agents|antimitotic agents|mesh-ancestor
6710552|NCT01778803|Mitosis Modulators|mitosis modulators|mesh-ancestor
6710553|NCT01778803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710554|NCT01778842|Clopidogrel|clopidogrel|mesh-list
6710555|NCT01778842|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6710556|NCT01778842|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6710557|NCT01778842|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6710558|NCT01778842|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6710559|NCT01778842|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6710560|NCT01778842|Purinergic Agents|purinergic agents|mesh-ancestor
6710561|NCT01778842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6710562|NCT01778842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710563|NCT01778842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710564|NCT01778946|Nicotine|nicotine|mesh-list
6710565|NCT01778946|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6710566|NCT01778946|Autonomic Agents|autonomic agents|mesh-ancestor
6710567|NCT01778946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6710568|NCT01778946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710569|NCT01778946|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6710570|NCT01778946|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6710571|NCT01778946|Cholinergic Agents|cholinergic agents|mesh-ancestor
6710572|NCT01778946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6710573|NCT01778946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710574|NCT01779050|Paclitaxel|paclitaxel|mesh-list
6710575|NCT01779050|Docetaxel|docetaxel|mesh-list
6710576|NCT01779050|Cyclophosphamide|cyclophosphamide|mesh-list
6710577|NCT01779050|Carboplatin|carboplatin|mesh-list
6710578|NCT01779050|Doxorubicin|doxorubicin|mesh-list
6710579|NCT01779050|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6710580|NCT01779050|Fluorouracil|fluorouracil|mesh-list
6710581|NCT01779050|Trastuzumab|trastuzumab|mesh-list
6710582|NCT01779050|Epirubicin|epirubicin|mesh-list
6710583|NCT01779050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6710584|NCT01779050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6710585|NCT01779050|Tubulin Modulators|tubulin modulators|mesh-ancestor
6710586|NCT01779050|Antimitotic Agents|antimitotic agents|mesh-ancestor
6710587|NCT01779050|Mitosis Modulators|mitosis modulators|mesh-ancestor
6710588|NCT01779050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710589|NCT01779050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6710590|NCT01779050|Immunologic Factors|immunologic factors|mesh-ancestor
6710591|NCT01779050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710592|NCT01779050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6710593|NCT01779050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6710594|NCT01779050|Alkylating Agents|alkylating agents|mesh-ancestor
6710595|NCT01779050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6710596|NCT01779050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6710597|NCT01779050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6710598|NCT01779050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6710599|NCT01779050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6710600|NCT01779050|Antimetabolites|antimetabolites|mesh-ancestor
6710601|NCT01779050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6710602|NCT01779050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6710603|NCT01779089|Minocycline|minocycline|mesh-list
6710604|NCT01779089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6710605|NCT01779089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6710606|NCT01779206|Paclitaxel|paclitaxel|mesh-list
6710607|NCT01779206|Docetaxel|docetaxel|mesh-list
6710608|NCT01779206|Cyclophosphamide|cyclophosphamide|mesh-list
6710609|NCT01779206|Epirubicin|epirubicin|mesh-list
6710610|NCT01779206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6710611|NCT01779206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6710612|NCT01779206|Tubulin Modulators|tubulin modulators|mesh-ancestor
6710613|NCT01779206|Antimitotic Agents|antimitotic agents|mesh-ancestor
6710614|NCT01779206|Mitosis Modulators|mitosis modulators|mesh-ancestor
6710615|NCT01779206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710616|NCT01779206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6710617|NCT01779206|Immunologic Factors|immunologic factors|mesh-ancestor
6710618|NCT01779206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710619|NCT01779206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6710620|NCT01779206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6710621|NCT01779206|Alkylating Agents|alkylating agents|mesh-ancestor
6710622|NCT01779206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6710623|NCT01779206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6710624|NCT01779206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6710625|NCT01779206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6710626|NCT01779206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6710627|NCT01779232|Danazol|danazol|mesh-list
6710628|NCT01779232|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6710629|NCT01779232|Hormone Antagonists|hormone antagonists|mesh-ancestor
6710630|NCT01779232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6710631|NCT01779232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710632|NCT01779245|Calcium|calcium|mesh-list
6710633|NCT01779245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6710634|NCT01779245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710635|NCT01779258|Desonide|desonide|mesh-list
6710636|NCT01779258|Glycerol|glycerol|mesh-list
6710637|NCT01779258|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6710638|NCT01779258|Protective Agents|protective agents|mesh-ancestor
6710639|NCT01779258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710640|NCT01779258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6710641|NCT01779271|Loxoprofen|loxoprofen|mesh-list
6710642|NCT01779271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6710643|NCT01779271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6710644|NCT01779271|Analgesics|analgesics|mesh-ancestor
6710645|NCT01779271|Sensory System Agents|sensory system agents|mesh-ancestor
6710646|NCT01779271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6710647|NCT01779271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710648|NCT01779271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6710649|NCT01779271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6710650|NCT01779284|Timolol|timolol|mesh-list
6710651|NCT01779284|Travoprost|travoprost|mesh-list
6710652|NCT01779284|Latanoprost|latanoprost|mesh-list
6710653|NCT01779284|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6710654|NCT01779284|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6710655|NCT01779284|Adrenergic Agents|adrenergic agents|mesh-ancestor
6710656|NCT01779284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6710657|NCT01779284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710658|NCT01779284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710659|NCT01779284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6710660|NCT01779284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6710661|NCT01779284|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6710662|NCT01779284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6710663|NCT01779362|Metformin|metformin|mesh-list
6710664|NCT01779362|Insulin Glargine|insulin glargine|mesh-list
6710665|NCT01779362|Liraglutide|liraglutide|mesh-list
6710666|NCT01779362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6710667|NCT01779362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710668|NCT01779362|Incretins|incretins|mesh-ancestor
6710669|NCT01779362|Hormones|hormones|mesh-ancestor
6710670|NCT01779362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6710671|NCT01779401|Aspirin|aspirin|mesh-list
6710672|NCT01779401|Cilostazol|cilostazol|mesh-list
6710673|NCT01779401|Clopidogrel|clopidogrel|mesh-list
6710674|NCT01779401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6710675|NCT01779401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6710676|NCT01779401|Analgesics|analgesics|mesh-ancestor
6710677|NCT01779401|Sensory System Agents|sensory system agents|mesh-ancestor
6710678|NCT01779401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6710679|NCT01779401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710680|NCT01779401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6710681|NCT01779401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6710682|NCT01779401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6710683|NCT01779401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6710684|NCT01779401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710685|NCT01779401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6710686|NCT01779401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6710687|NCT01779401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6710688|NCT01779401|Antipyretics|antipyretics|mesh-ancestor
6710689|NCT01779401|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6710690|NCT01779401|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6710691|NCT01779401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6710692|NCT01779401|Purinergic Agents|purinergic agents|mesh-ancestor
6710693|NCT01779401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6710694|NCT01779401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6710695|NCT01779401|Autonomic Agents|autonomic agents|mesh-ancestor
6710696|NCT01779401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6710697|NCT01779401|Respiratory System Agents|respiratory system agents|mesh-ancestor
6710698|NCT01779401|Vasodilator Agents|vasodilator agents|mesh-ancestor
6710699|NCT01779401|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6710700|NCT01779401|Protective Agents|protective agents|mesh-ancestor
6710701|NCT01779401|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6710702|NCT01779401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6710703|NCT01779466|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
6710704|NCT01779466|Hemostatics|hemostatics|mesh-ancestor
6710705|NCT01779466|Coagulants|coagulants|mesh-ancestor
6710706|NCT01779466|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6710707|NCT01779466|Natriuretic Agents|natriuretic agents|mesh-ancestor
6710708|NCT01779466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710709|NCT01779479|Paclitaxel|paclitaxel|mesh-list
6710710|NCT01779479|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6710711|NCT01779479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6710712|NCT01779479|Tubulin Modulators|tubulin modulators|mesh-ancestor
6710713|NCT01779479|Antimitotic Agents|antimitotic agents|mesh-ancestor
6710714|NCT01779479|Mitosis Modulators|mitosis modulators|mesh-ancestor
6710715|NCT01779479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710716|NCT01779492|Oxycodone|oxycodone|mesh-list
6710717|NCT01779492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6710718|NCT01779492|Narcotics|narcotics|mesh-ancestor
6710719|NCT01779492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6710720|NCT01779492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710721|NCT01779492|Analgesics|analgesics|mesh-ancestor
6710722|NCT01779492|Sensory System Agents|sensory system agents|mesh-ancestor
6710723|NCT01779492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6710724|NCT01779518|Interferons|interferons|mesh-list
6710725|NCT01779518|Ribavirin|ribavirin|mesh-list
6710726|NCT01779518|Sofosbuvir|sofosbuvir|mesh-list
6710727|NCT01779518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6710728|NCT01779518|Antiviral Agents|antiviral agents|mesh-ancestor
6710729|NCT01779518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6710730|NCT01779518|Antimetabolites|antimetabolites|mesh-ancestor
6710731|NCT01779518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710732|NCT01779557|Dialysis Solutions|dialysis solutions|mesh-list
6710733|NCT01779557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6710734|NCT01779596|Bosentan|bosentan|mesh-list
6710735|NCT01779596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6710736|NCT01779596|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6710737|NCT01779596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710738|NCT01779609|Bosentan|bosentan|mesh-list
6710739|NCT01779609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6710740|NCT01779609|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6710741|NCT01779609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710742|NCT01779687|Raltegravir Potassium|raltegravir potassium|mesh-list
6710743|NCT01779687|Atorvastatin|atorvastatin|mesh-list
6710744|NCT01779687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6710745|NCT01779687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6710746|NCT01779687|Antimetabolites|antimetabolites|mesh-ancestor
6710747|NCT01779687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710748|NCT01779687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6710749|NCT01779687|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6710750|NCT01779687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6710751|NCT01779687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6710752|NCT01779687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6710753|NCT01779687|Antiviral Agents|antiviral agents|mesh-ancestor
6710754|NCT01779687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6710755|NCT01779687|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6710756|NCT01779687|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6710757|NCT01779830|Zolpidem|zolpidem|mesh-list
6710758|NCT01779830|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6710759|NCT01779830|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6710760|NCT01779830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6710761|NCT01779830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710762|NCT01779830|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6710763|NCT01779830|GABA Agonists|gaba agonists|mesh-ancestor
6710764|NCT01779830|GABA Agents|gaba agents|mesh-ancestor
6710765|NCT01779830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6710766|NCT01779830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710767|NCT01779843|Cytarabine|cytarabine|mesh-list
6710768|NCT01779843|Idarubicin|idarubicin|mesh-list
6710769|NCT01779843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6710770|NCT01779843|Antimetabolites|antimetabolites|mesh-ancestor
6710771|NCT01779843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710772|NCT01779843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6710773|NCT01779843|Antiviral Agents|antiviral agents|mesh-ancestor
6710774|NCT01779843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6710775|NCT01779843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6710776|NCT01779843|Immunologic Factors|immunologic factors|mesh-ancestor
6710777|NCT01779843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710778|NCT01779843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6710779|NCT01779843|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6710780|NCT01779843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6710781|NCT01779843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6710782|NCT01779882|Cyclophosphamide|cyclophosphamide|mesh-list
6710783|NCT01779882|Busulfan|busulfan|mesh-list
6710784|NCT01779882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6710785|NCT01779882|Immunologic Factors|immunologic factors|mesh-ancestor
6710786|NCT01779882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710787|NCT01779882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6710788|NCT01779882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6710789|NCT01779882|Alkylating Agents|alkylating agents|mesh-ancestor
6710790|NCT01779882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710791|NCT01779882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6710792|NCT01779882|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6710793|NCT01779908|Vitamin D|vitamin d|mesh-list
6710794|NCT01779908|Vitamins|vitamins|mesh-ancestor
6710795|NCT01779908|Micronutrients|micronutrients|mesh-ancestor
6710796|NCT01779908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710797|NCT01779908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6710798|NCT01779921|Thrombin|thrombin|mesh-list
6710799|NCT01779921|Hemostatics|hemostatics|mesh-ancestor
6710800|NCT01779921|Coagulants|coagulants|mesh-ancestor
6710801|NCT01780051|Metformin|metformin|mesh-list
6710802|NCT01780051|Repaglinide|repaglinide|mesh-list
6710803|NCT01780051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6710804|NCT01780051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710805|NCT01780181|Gemcitabine|gemcitabine|mesh-list
6710806|NCT01780181|Docetaxel|docetaxel|mesh-list
6710807|NCT01780181|Vinorelbine|vinorelbine|mesh-list
6710808|NCT01780181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6710809|NCT01780181|Antimetabolites|antimetabolites|mesh-ancestor
6710810|NCT01780181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710811|NCT01780181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6710812|NCT01780181|Antiviral Agents|antiviral agents|mesh-ancestor
6710813|NCT01780181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6710814|NCT01780181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6710815|NCT01780181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6710816|NCT01780181|Immunologic Factors|immunologic factors|mesh-ancestor
6710817|NCT01780181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710818|NCT01780181|Tubulin Modulators|tubulin modulators|mesh-ancestor
6710819|NCT01780181|Antimitotic Agents|antimitotic agents|mesh-ancestor
6710820|NCT01780181|Mitosis Modulators|mitosis modulators|mesh-ancestor
6710821|NCT01780181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6710822|NCT01780233|Fentanyl|fentanyl|mesh-list
6710823|NCT01780233|Naltrexone|naltrexone|mesh-list
6710824|NCT01780233|Citric Acid|citric acid|mesh-list
6710825|NCT01780233|Sodium Citrate|sodium citrate|mesh-list
6710826|NCT01780233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6710827|NCT01780233|Narcotics|narcotics|mesh-ancestor
6710828|NCT01780233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6710829|NCT01780233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710830|NCT01780233|Analgesics|analgesics|mesh-ancestor
6710831|NCT01780233|Sensory System Agents|sensory system agents|mesh-ancestor
6710832|NCT01780233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6710833|NCT01780233|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6710834|NCT01780233|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6710835|NCT01780233|Anesthetics, General|anesthetics, general|mesh-ancestor
6710836|NCT01780233|Anesthetics|anesthetics|mesh-ancestor
6710837|NCT01780233|Anticoagulants|anticoagulants|mesh-ancestor
6710838|NCT01780233|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6710839|NCT01780233|Chelating Agents|chelating agents|mesh-ancestor
6710840|NCT01780233|Sequestering Agents|sequestering agents|mesh-ancestor
6710841|NCT01780233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710842|NCT01780233|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6710843|NCT01780233|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6782896|NCT02193620|Narcotics|narcotics|mesh-ancestor
6782897|NCT02193620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6782898|NCT02193620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782899|NCT02193620|Analgesics|analgesics|mesh-ancestor
6782900|NCT02193620|Sensory System Agents|sensory system agents|mesh-ancestor
6782901|NCT02193620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6782902|NCT02193633|Paclitaxel|paclitaxel|mesh-list
6782903|NCT02193633|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6782904|NCT02193633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6710844|NCT01780259|Triazolam|triazolam|mesh-list
6710845|NCT01780259|Esketamine|esketamine|mesh-list
6710846|NCT01780259|Antidepressive Agents|antidepressive agents|mesh-ancestor
6710847|NCT01780259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6710848|NCT01780259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6710849|NCT01780259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6710850|NCT01780259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6710851|NCT01780259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6710852|NCT01780259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710853|NCT01780259|GABA Modulators|gaba modulators|mesh-ancestor
6710854|NCT01780259|GABA Agents|gaba agents|mesh-ancestor
6710855|NCT01780259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6710856|NCT01780259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710857|NCT01780311|Sotalol|sotalol|mesh-list
6710858|NCT01780311|Flecainide|flecainide|mesh-list
6710859|NCT01780311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
6710860|NCT01780311|Propafenone|propafenone|mesh-list
6710861|NCT01780311|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6710862|NCT01780311|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6710863|NCT01780311|Adrenergic Agents|adrenergic agents|mesh-ancestor
6710864|NCT01780311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6710865|NCT01780311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710866|NCT01780311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710867|NCT01780311|Sympatholytics|sympatholytics|mesh-ancestor
6710868|NCT01780311|Autonomic Agents|autonomic agents|mesh-ancestor
6710869|NCT01780311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6710870|NCT01780311|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6710871|NCT01780311|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6710872|NCT01780311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6710873|NCT01780467|Dopamine|dopamine|mesh-list
6710874|NCT01780467|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6710875|NCT01780467|Sympathomimetics|sympathomimetics|mesh-ancestor
6710876|NCT01780467|Autonomic Agents|autonomic agents|mesh-ancestor
6710877|NCT01780467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6710878|NCT01780467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710879|NCT01780467|Dopamine Agents|dopamine agents|mesh-ancestor
6710880|NCT01780467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6710881|NCT01780467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710882|NCT01780467|Protective Agents|protective agents|mesh-ancestor
6710883|NCT01780519|Lorazepam|lorazepam|mesh-list
6710884|NCT01780519|Anticonvulsants|anticonvulsants|mesh-ancestor
6710885|NCT01780519|Antiemetics|antiemetics|mesh-ancestor
6710886|NCT01780519|Autonomic Agents|autonomic agents|mesh-ancestor
6710887|NCT01780519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6710888|NCT01780519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710889|NCT01780519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6710890|NCT01780519|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6710891|NCT01780519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6710892|NCT01780519|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6710893|NCT01780519|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6710894|NCT01780519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6710895|NCT01780519|GABA Modulators|gaba modulators|mesh-ancestor
6710896|NCT01780519|GABA Agents|gaba agents|mesh-ancestor
6710897|NCT01780519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6710898|NCT01780519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710899|NCT01780558|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6710900|NCT01780558|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6710901|NCT01780558|Hormones|hormones|mesh-list
6710902|NCT01780558|Estradiol|estradiol|mesh-list
6710903|NCT01780558|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6710904|NCT01780558|Progesterone|progesterone|mesh-list
6710905|NCT01780558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6710906|NCT01780558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710907|NCT01780558|Estrogens|estrogens|mesh-ancestor
6710908|NCT01780558|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6710909|NCT01780558|Contraceptive Agents|contraceptive agents|mesh-ancestor
6710910|NCT01780558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6710911|NCT01780558|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6710912|NCT01780558|Progestins|progestins|mesh-ancestor
6710913|NCT01780610|Letrozole|letrozole|mesh-list
6710914|NCT01780610|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6710915|NCT01780610|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6710916|NCT01780610|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6710917|NCT01780610|Hormones|hormones|mesh-list
6710918|NCT01780610|Estradiol|estradiol|mesh-list
6710919|NCT01780610|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6710920|NCT01780610|Progesterone|progesterone|mesh-list
6710921|NCT01780610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6710922|NCT01780610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710923|NCT01780610|Estrogens|estrogens|mesh-ancestor
6710924|NCT01780610|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6710925|NCT01780610|Contraceptive Agents|contraceptive agents|mesh-ancestor
6710926|NCT01780610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6710927|NCT01780610|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6710928|NCT01780610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6710929|NCT01780610|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6710930|NCT01780610|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6710931|NCT01780610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6710932|NCT01780610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710933|NCT01780610|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6710934|NCT01780610|Hormone Antagonists|hormone antagonists|mesh-ancestor
6710935|NCT01780610|Progestins|progestins|mesh-ancestor
6710936|NCT01780740|Atorvastatin|atorvastatin|mesh-list
6710937|NCT01780740|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6710938|NCT01780740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6710939|NCT01780740|Antimetabolites|antimetabolites|mesh-ancestor
6710940|NCT01780740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710941|NCT01780740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6710942|NCT01780740|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6710943|NCT01780740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6710944|NCT01780753|Primaquine|primaquine|mesh-list
6710945|NCT01780753|Antimalarials|antimalarials|mesh-ancestor
6710946|NCT01780753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6710947|NCT01780753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6710948|NCT01780753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6710949|NCT01780883|Melatonin|melatonin|mesh-list
6710950|NCT01780883|Antioxidants|antioxidants|mesh-ancestor
6710951|NCT01780883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710952|NCT01780883|Protective Agents|protective agents|mesh-ancestor
6710953|NCT01780883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710954|NCT01780883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6710955|NCT01780909|Paromomycin|paromomycin|mesh-list
6710956|NCT01780909|Domperidone|domperidone|mesh-list
6710957|NCT01780909|Loperamide|loperamide|mesh-list
6710958|NCT01780909|Antidiarrheals|antidiarrheals|mesh-list
6710959|NCT01780909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6710960|NCT01780909|Antiemetics|antiemetics|mesh-ancestor
6710961|NCT01780909|Autonomic Agents|autonomic agents|mesh-ancestor
6710962|NCT01780909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6710963|NCT01780909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710964|NCT01780909|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6710965|NCT01780909|Dopamine Agents|dopamine agents|mesh-ancestor
6710966|NCT01780909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6710967|NCT01780909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710968|NCT01780909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6710969|NCT01780909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6710970|NCT01780909|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6710971|NCT01780909|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6710972|NCT01780948|Everolimus|everolimus|mesh-list
6710973|NCT01780948|Atorvastatin|atorvastatin|mesh-list
6710974|NCT01780948|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6710975|NCT01780948|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6710976|NCT01780948|Antimetabolites|antimetabolites|mesh-ancestor
6710977|NCT01780948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6710978|NCT01780948|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6710979|NCT01780948|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6710980|NCT01780948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6710981|NCT01780948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6710982|NCT01780948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6710983|NCT01780948|Immunologic Factors|immunologic factors|mesh-ancestor
6710984|NCT01780948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710985|NCT01781052|Iloprost|iloprost|mesh-list
6710986|NCT01781052|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6710987|NCT01781052|Vasodilator Agents|vasodilator agents|mesh-ancestor
6710988|NCT01781273|Ethanol|ethanol|mesh-list
6710989|NCT01781273|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6710990|NCT01781273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6710991|NCT01781273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6710992|NCT01781273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710993|NCT01781377|Metoclopramide|metoclopramide|mesh-list
6710994|NCT01781377|Propofol|propofol|mesh-list
6710995|NCT01781377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6710996|NCT01781377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6710997|NCT01781377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6710998|NCT01781377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6710999|NCT01781377|Anesthetics, General|anesthetics, general|mesh-ancestor
6711000|NCT01781377|Anesthetics|anesthetics|mesh-ancestor
6711001|NCT01781377|Antiemetics|antiemetics|mesh-ancestor
6711002|NCT01781377|Autonomic Agents|autonomic agents|mesh-ancestor
6711003|NCT01781377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6711004|NCT01781377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6711005|NCT01781377|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6711006|NCT01781377|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6711007|NCT01781377|Dopamine Agents|dopamine agents|mesh-ancestor
6711008|NCT01781377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6711009|NCT01781377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6711010|NCT01781442|Sirolimus|sirolimus|mesh-list
6711011|NCT01781442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6711012|NCT01781442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6711013|NCT01781442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6711014|NCT01781442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6711015|NCT01781442|Antifungal Agents|antifungal agents|mesh-ancestor
6711016|NCT01781442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6711017|NCT01781442|Immunologic Factors|immunologic factors|mesh-ancestor
6711018|NCT01781442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711019|NCT01781507|Cetirizine|cetirizine|mesh-list
6711020|NCT01781507|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6711021|NCT01781507|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6711022|NCT01781507|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6711023|NCT01781507|Histamine Antagonists|histamine antagonists|mesh-ancestor
6711024|NCT01781507|Histamine Agents|histamine agents|mesh-ancestor
6711025|NCT01781507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6711026|NCT01781507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6711027|NCT01781507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711028|NCT01781663|Petrolatum|petrolatum|mesh-list
6711029|NCT01781663|Emollients|emollients|mesh-ancestor
6711030|NCT01781663|Dermatologic Agents|dermatologic agents|mesh-ancestor
6711031|NCT01781702|Celecoxib|celecoxib|mesh-list
6711032|NCT01781702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6711033|NCT01781702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6711034|NCT01781702|Analgesics|analgesics|mesh-ancestor
6711035|NCT01781702|Sensory System Agents|sensory system agents|mesh-ancestor
6711036|NCT01781702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6711037|NCT01781702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711038|NCT01781702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6711039|NCT01781702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6711040|NCT01781702|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6711041|NCT01781702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6711042|NCT01781702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6711043|NCT01781702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6711044|NCT01781871|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6711045|NCT01781871|Immunologic Factors|immunologic factors|mesh-ancestor
6711046|NCT01781871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711047|NCT01781884|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
6711048|NCT01781884|GABA Agents|gaba agents|mesh-ancestor
6711049|NCT01781884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6711050|NCT01781884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6711051|NCT01781884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711052|NCT01781897|Mosapride|mosapride|mesh-list
6711053|NCT01781897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6711054|NCT01781897|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6711055|NCT01781897|Serotonin Agents|serotonin agents|mesh-ancestor
6711056|NCT01781897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6711057|NCT01781897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6711058|NCT01781897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711059|NCT01781936|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
6711060|NCT01781936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6711061|NCT01781936|Glucocorticoids|glucocorticoids|mesh-ancestor
6711062|NCT01781936|Hormones|hormones|mesh-ancestor
6711063|NCT01781936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6711064|NCT01781936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711065|NCT01781988|Gemcitabine|gemcitabine|mesh-list
6711066|NCT01781988|Carboplatin|carboplatin|mesh-list
6711067|NCT01781988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6711068|NCT01781988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6711069|NCT01781988|Antimetabolites|antimetabolites|mesh-ancestor
6711070|NCT01781988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6711071|NCT01781988|Antiviral Agents|antiviral agents|mesh-ancestor
6711072|NCT01781988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6711073|NCT01781988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6711074|NCT01781988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6711075|NCT01781988|Immunologic Factors|immunologic factors|mesh-ancestor
6711076|NCT01781988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711077|NCT01782001|Vitamins|vitamins|mesh-list
6711078|NCT01782001|Vitamin A|vitamin a|mesh-list
6711079|NCT01782001|Retinol palmitate|retinol palmitate|mesh-list
6711080|NCT01782001|Micronutrients|micronutrients|mesh-ancestor
6711081|NCT01782001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711082|NCT01782001|Antioxidants|antioxidants|mesh-ancestor
6711083|NCT01782001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6711084|NCT01782001|Protective Agents|protective agents|mesh-ancestor
6711085|NCT01782001|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6711086|NCT01782001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6782905|NCT02193633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6782906|NCT02193633|Tubulin Modulators|tubulin modulators|mesh-ancestor
6782907|NCT02193633|Antimitotic Agents|antimitotic agents|mesh-ancestor
6711087|NCT01782261|Liraglutide|liraglutide|mesh-list
6711088|NCT01782261|Saxagliptin|saxagliptin|mesh-list
6711089|NCT01782261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6711090|NCT01782261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711091|NCT01782261|Incretins|incretins|mesh-ancestor
6711092|NCT01782261|Hormones|hormones|mesh-ancestor
6711093|NCT01782261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6711094|NCT01782261|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6711095|NCT01782261|Protease Inhibitors|protease inhibitors|mesh-ancestor
6711096|NCT01782261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6711097|NCT01782261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6711098|NCT01782274|Vaccines|vaccines|mesh-list
6711099|NCT01782274|Immunologic Factors|immunologic factors|mesh-ancestor
6711100|NCT01782274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711101|NCT01782287|Vaccines|vaccines|mesh-list
6711102|NCT01782287|Immunologic Factors|immunologic factors|mesh-ancestor
6711103|NCT01782287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711104|NCT01782300|Vaccines|vaccines|mesh-list
6711105|NCT01782300|Immunologic Factors|immunologic factors|mesh-ancestor
6711106|NCT01782300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711107|NCT01782352|Vitamin D|vitamin d|mesh-list
6711108|NCT01782352|Ergocalciferols|ergocalciferols|mesh-list
6711109|NCT01782352|Cholecalciferol|cholecalciferol|mesh-list
6711110|NCT01782352|Vitamins|vitamins|mesh-list
6711111|NCT01782352|Micronutrients|micronutrients|mesh-ancestor
6711112|NCT01782352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711113|NCT01782352|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6711114|NCT01782352|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6711115|NCT01782404|Chlorhexidine|chlorhexidine|mesh-list
6711116|NCT01782404|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6711117|NCT01782404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6711118|NCT01782404|Disinfectants|disinfectants|mesh-ancestor
6711119|NCT01782443|Aflibercept|aflibercept|mesh-list
6711120|NCT01782443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6711121|NCT01782443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6711122|NCT01782443|Growth Substances|growth substances|mesh-ancestor
6711123|NCT01782443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711124|NCT01782443|Growth Inhibitors|growth inhibitors|mesh-ancestor
6711125|NCT01782443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6711126|NCT01782508|Interferons|interferons|mesh-list
6711127|NCT01782508|Imatinib Mesylate|imatinib mesylate|mesh-list
6711128|NCT01782508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6711129|NCT01782508|Antiviral Agents|antiviral agents|mesh-ancestor
6711130|NCT01782508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6711131|NCT01782508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6711132|NCT01782508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6711133|NCT01782508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6711134|NCT01782560|Omeprazole|omeprazole|mesh-list
6711135|NCT01782560|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6711136|NCT01782560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6711137|NCT01782560|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6711138|NCT01782560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6711139|NCT01782560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6711140|NCT01782573|Chlorhexidine|chlorhexidine|mesh-list
6711141|NCT01782573|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6711142|NCT01782573|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6711143|NCT01782573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6711144|NCT01782573|Disinfectants|disinfectants|mesh-ancestor
6711145|NCT01782573|Dermatologic Agents|dermatologic agents|mesh-ancestor
6711146|NCT01782599|Nicotine|nicotine|mesh-list
6711147|NCT01782599|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6711148|NCT01782599|Autonomic Agents|autonomic agents|mesh-ancestor
6711149|NCT01782599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6711150|NCT01782599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711151|NCT01782599|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6711152|NCT01782599|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6711153|NCT01782599|Cholinergic Agents|cholinergic agents|mesh-ancestor
6711154|NCT01782599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6711155|NCT01782599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6711156|NCT01782612|Analgesics|analgesics|mesh-list
6711157|NCT01782612|Sensory System Agents|sensory system agents|mesh-ancestor
6711158|NCT01782612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6711159|NCT01782612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711160|NCT01782651|Capecitabine|capecitabine|mesh-list
6711161|NCT01782651|Lapatinib|lapatinib|mesh-list
6711162|NCT01782651|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6711163|NCT01782651|Antimetabolites|antimetabolites|mesh-ancestor
6711164|NCT01782651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6711165|NCT01782651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6711166|NCT01782651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6711167|NCT01782651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6711168|NCT01782781|Epinephrine|epinephrine|mesh-list
6711169|NCT01782781|Ropivacaine|ropivacaine|mesh-list
6711170|NCT01782781|Anesthetics, Local|anesthetics, local|mesh-ancestor
6711171|NCT01782781|Anesthetics|anesthetics|mesh-ancestor
6711172|NCT01782781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6711173|NCT01782781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711174|NCT01782781|Sensory System Agents|sensory system agents|mesh-ancestor
6711175|NCT01782781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6711176|NCT01782781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6711177|NCT01782781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6711178|NCT01782781|Adrenergic Agents|adrenergic agents|mesh-ancestor
6711179|NCT01782781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6711180|NCT01782781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6711181|NCT01782781|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6711182|NCT01782781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6711183|NCT01782781|Autonomic Agents|autonomic agents|mesh-ancestor
6711184|NCT01782781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6711185|NCT01782781|Respiratory System Agents|respiratory system agents|mesh-ancestor
6711186|NCT01782781|Mydriatics|mydriatics|mesh-ancestor
6711187|NCT01782781|Sympathomimetics|sympathomimetics|mesh-ancestor
6711188|NCT01782781|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6711189|NCT01782846|Codeine|codeine|mesh-list
6711190|NCT01782846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6711191|NCT01782846|Narcotics|narcotics|mesh-ancestor
6711192|NCT01782846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6711193|NCT01782846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711194|NCT01782846|Analgesics|analgesics|mesh-ancestor
6711195|NCT01782846|Sensory System Agents|sensory system agents|mesh-ancestor
6711196|NCT01782846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6711197|NCT01782846|Antitussive Agents|antitussive agents|mesh-ancestor
6711198|NCT01782846|Respiratory System Agents|respiratory system agents|mesh-ancestor
6711199|NCT01782911|Resveratrol|resveratrol|mesh-list
6711200|NCT01782911|Antioxidants|antioxidants|mesh-ancestor
6711201|NCT01782911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6711202|NCT01782911|Protective Agents|protective agents|mesh-ancestor
6711203|NCT01782911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711204|NCT01782911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6711205|NCT01782911|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6711206|NCT01782924|Brodalumab|brodalumab|mesh-list
6711207|NCT01782924|Dermatologic Agents|dermatologic agents|mesh-ancestor
6711208|NCT01782937|Brodalumab|brodalumab|mesh-list
6711209|NCT01782937|Dermatologic Agents|dermatologic agents|mesh-ancestor
6711210|NCT01782950|Rifampin|rifampin|mesh-list
6711211|NCT01782950|Isoniazid|isoniazid|mesh-list
6711212|NCT01782950|Pyrazinamide|pyrazinamide|mesh-list
6711213|NCT01782950|Ethambutol|ethambutol|mesh-list
6711214|NCT01782950|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6711215|NCT01782950|Antitubercular Agents|antitubercular agents|mesh-ancestor
6711216|NCT01782950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6711217|NCT01782950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6711218|NCT01782950|Leprostatic Agents|leprostatic agents|mesh-ancestor
6711219|NCT01782950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6711220|NCT01782950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6711221|NCT01782950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6711222|NCT01782950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6711223|NCT01782950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6711224|NCT01782950|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6711225|NCT01782950|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6711226|NCT01782950|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6711227|NCT01782950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6711228|NCT01782950|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6711229|NCT01782950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6711230|NCT01782950|Antimetabolites|antimetabolites|mesh-ancestor
6711231|NCT01782950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6711232|NCT01782976|Bevacizumab|bevacizumab|mesh-list
6711233|NCT01782976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6711234|NCT01782976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6711235|NCT01782976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6711236|NCT01782976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6711237|NCT01782976|Growth Substances|growth substances|mesh-ancestor
6711238|NCT01782976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711239|NCT01782976|Growth Inhibitors|growth inhibitors|mesh-ancestor
6711240|NCT01782989|Doxycycline|doxycycline|mesh-list
6711241|NCT01782989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6711242|NCT01782989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6711243|NCT01782989|Antimalarials|antimalarials|mesh-ancestor
6711244|NCT01782989|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6711245|NCT01782989|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6711246|NCT01783002|Carbon-11 methionine|carbon-11 methionine|mesh-list
6711247|NCT01783002|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6711248|NCT01783002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6711249|NCT01783106|Hydroxychloroquine|hydroxychloroquine|mesh-list
6711250|NCT01783106|Doxycycline|doxycycline|mesh-list
6711251|NCT01783106|Ciprofloxacin|ciprofloxacin|mesh-list
6711252|NCT01783106|Budesonide|budesonide|mesh-list
6711253|NCT01783106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6711254|NCT01783106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6711255|NCT01783106|Autonomic Agents|autonomic agents|mesh-ancestor
6711256|NCT01783106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6711257|NCT01783106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711258|NCT01783106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6711259|NCT01783106|Respiratory System Agents|respiratory system agents|mesh-ancestor
6711260|NCT01783106|Glucocorticoids|glucocorticoids|mesh-ancestor
6711261|NCT01783106|Hormones|hormones|mesh-ancestor
6711262|NCT01783106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6711263|NCT01783106|Antimalarials|antimalarials|mesh-ancestor
6711264|NCT01783106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6711265|NCT01783106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6711266|NCT01783106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6711267|NCT01783106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6711268|NCT01783106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6711269|NCT01783106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6711270|NCT01783106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6711271|NCT01783106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6711272|NCT01783106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6711273|NCT01783106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6711274|NCT01783106|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6711275|NCT01783106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6711276|NCT01783197|Paclitaxel|paclitaxel|mesh-list
6711277|NCT01783197|Carboplatin|carboplatin|mesh-list
6711278|NCT01783197|Pemetrexed|pemetrexed|mesh-list
6711279|NCT01783197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6711280|NCT01783197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6711281|NCT01783197|Tubulin Modulators|tubulin modulators|mesh-ancestor
6711282|NCT01783197|Antimitotic Agents|antimitotic agents|mesh-ancestor
6711283|NCT01783197|Mitosis Modulators|mitosis modulators|mesh-ancestor
6711284|NCT01783197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6711285|NCT01783197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6711286|NCT01783197|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6711287|NCT01783197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6711288|NCT01783340|Azithromycin|azithromycin|mesh-list
6711289|NCT01783340|Vaccines|vaccines|mesh-list
6711290|NCT01783340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6711291|NCT01783340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6711292|NCT01783340|Immunologic Factors|immunologic factors|mesh-ancestor
6711293|NCT01783340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711294|NCT01783379|Micafungin|micafungin|mesh-list
6711295|NCT01783379|Antifungal Agents|antifungal agents|mesh-ancestor
6711296|NCT01783379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6711297|NCT01783431|Poly ICLC|poly iclc|mesh-list
6711298|NCT01783431|Interferon Inducers|interferon inducers|mesh-ancestor
6711299|NCT01783431|Immunologic Factors|immunologic factors|mesh-ancestor
6711300|NCT01783431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711301|NCT01783587|Docetaxel|docetaxel|mesh-list
6711302|NCT01783587|Afatinib|afatinib|mesh-list
6711303|NCT01783587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6711304|NCT01783587|Tubulin Modulators|tubulin modulators|mesh-ancestor
6711305|NCT01783587|Antimitotic Agents|antimitotic agents|mesh-ancestor
6711306|NCT01783587|Mitosis Modulators|mitosis modulators|mesh-ancestor
6711307|NCT01783587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6711308|NCT01783587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6711309|NCT01783587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6711310|NCT01783717|Exenatide|exenatide|mesh-list
6711311|NCT01783717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6711312|NCT01783717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711313|NCT01783717|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6711314|NCT01783717|Incretins|incretins|mesh-ancestor
6711315|NCT01783717|Hormones|hormones|mesh-ancestor
6782908|NCT02193633|Mitosis Modulators|mitosis modulators|mesh-ancestor
6711316|NCT01783717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6711317|NCT01783756|Capecitabine|capecitabine|mesh-list
6711318|NCT01783756|Everolimus|everolimus|mesh-list
6711319|NCT01783756|Lapatinib|lapatinib|mesh-list
6711320|NCT01783756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6711321|NCT01783756|Antimetabolites|antimetabolites|mesh-ancestor
6711322|NCT01783756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6711323|NCT01783756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6711324|NCT01783756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6711325|NCT01783756|Immunologic Factors|immunologic factors|mesh-ancestor
6711326|NCT01783756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711327|NCT01783756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6711328|NCT01783756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6711329|NCT01783834|Pemetrexed|pemetrexed|mesh-list
6711330|NCT01783834|Gefitinib|gefitinib|mesh-list
6711331|NCT01783834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6711332|NCT01783834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6711333|NCT01783834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6711334|NCT01783834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6711335|NCT01783834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6711336|NCT01783834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6711337|NCT01783925|Aflibercept|aflibercept|mesh-list
6711338|NCT01783925|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6711339|NCT01783925|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6711340|NCT01783925|Growth Substances|growth substances|mesh-ancestor
6711341|NCT01783925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711342|NCT01783925|Growth Inhibitors|growth inhibitors|mesh-ancestor
6711343|NCT01783925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6711344|NCT01783951|Cisplatin|cisplatin|mesh-list
6711345|NCT01783951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6711346|NCT01783964|Cytarabine|cytarabine|mesh-list
6711347|NCT01783964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6711348|NCT01783964|Antimetabolites|antimetabolites|mesh-ancestor
6711349|NCT01783964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6711350|NCT01783964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6711351|NCT01783964|Antiviral Agents|antiviral agents|mesh-ancestor
6711352|NCT01783964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6711353|NCT01783964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6711354|NCT01783964|Immunologic Factors|immunologic factors|mesh-ancestor
6711355|NCT01783964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711356|NCT01783977|Vaccines|vaccines|mesh-list
6711357|NCT01783977|Immunologic Factors|immunologic factors|mesh-ancestor
6711358|NCT01783977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782909|NCT02193633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782910|NCT02193698|Dexamethasone|dexamethasone|mesh-list
6782911|NCT02193698|Lenalidomide|lenalidomide|mesh-list
6782912|NCT02193698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6782913|NCT02193698|Antiemetics|antiemetics|mesh-ancestor
6782914|NCT02193698|Autonomic Agents|autonomic agents|mesh-ancestor
6782915|NCT02193698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6782916|NCT02193698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782917|NCT02193698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6782918|NCT02193698|Glucocorticoids|glucocorticoids|mesh-ancestor
6782919|NCT02193698|Hormones|hormones|mesh-ancestor
6782920|NCT02193698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6782921|NCT02193698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6782922|NCT02193698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6782923|NCT02193698|Immunologic Factors|immunologic factors|mesh-ancestor
6782924|NCT02193698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6782925|NCT02193698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6782926|NCT02193698|Growth Substances|growth substances|mesh-ancestor
6782927|NCT02193698|Growth Inhibitors|growth inhibitors|mesh-ancestor
6782928|NCT02193841|Calcium|calcium|mesh-list
6782929|NCT02193841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6782930|NCT02193841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782931|NCT02193893|Coal Tar|coal tar|mesh-list
6782932|NCT02193893|Keratolytic Agents|keratolytic agents|mesh-ancestor
6782933|NCT02193893|Dermatologic Agents|dermatologic agents|mesh-ancestor
6711359|NCT01784107|Ifosfamide|ifosfamide|mesh-list
6711360|NCT01784107|Belotecan|belotecan|mesh-list
6711361|NCT01784107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6711362|NCT01784107|Alkylating Agents|alkylating agents|mesh-ancestor
6711363|NCT01784107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6711364|NCT01784107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6711365|NCT01784107|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6711366|NCT01784107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6711367|NCT01784107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6711368|NCT01784120|Doxorubicin|doxorubicin|mesh-list
6711369|NCT01784120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6711370|NCT01784120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6711371|NCT01784120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6711372|NCT01784120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6711373|NCT01784120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6711374|NCT01784120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6711375|NCT01784159|Aspirin|aspirin|mesh-list
6711376|NCT01784159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6711377|NCT01784159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6711378|NCT01784159|Analgesics|analgesics|mesh-ancestor
6711379|NCT01784159|Sensory System Agents|sensory system agents|mesh-ancestor
6711380|NCT01784159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6711381|NCT01784159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711382|NCT01784159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6711383|NCT01784159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6711384|NCT01784159|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6711385|NCT01784159|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6711386|NCT01784159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6711387|NCT01784159|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6711388|NCT01784159|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6711389|NCT01784159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6711390|NCT01784159|Antipyretics|antipyretics|mesh-ancestor
6711391|NCT01784250|Propranolol|propranolol|mesh-list
6711392|NCT01784250|Clonidine|clonidine|mesh-list
6711393|NCT01784250|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6711394|NCT01784250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6711395|NCT01784250|Adrenergic Agents|adrenergic agents|mesh-ancestor
6711396|NCT01784250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6711397|NCT01784250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6711398|NCT01784250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711399|NCT01784250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6711400|NCT01784250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6711401|NCT01784250|Vasodilator Agents|vasodilator agents|mesh-ancestor
6711402|NCT01784250|Analgesics|analgesics|mesh-ancestor
6711403|NCT01784250|Sensory System Agents|sensory system agents|mesh-ancestor
6711404|NCT01784250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6711405|NCT01784250|Sympatholytics|sympatholytics|mesh-ancestor
6711406|NCT01784250|Autonomic Agents|autonomic agents|mesh-ancestor
6711407|NCT01784250|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6711408|NCT01784250|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6711409|NCT01784250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6711410|NCT01784302|Raltegravir Potassium|raltegravir potassium|mesh-list
6711411|NCT01784302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6711412|NCT01784302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6711413|NCT01784302|Antiviral Agents|antiviral agents|mesh-ancestor
6711414|NCT01784302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6711415|NCT01784302|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6711416|NCT01784302|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6711417|NCT01784302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6711418|NCT01784302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6711419|NCT01784315|Chloroquine|chloroquine|mesh-list
6711420|NCT01784315|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
6711421|NCT01784315|Primaquine|primaquine|mesh-list
6711422|NCT01784315|Artemisinins|artemisinins|mesh-list
6711423|NCT01784315|Artemisinin|artemisinin|mesh-list
6711424|NCT01784315|Amebicides|amebicides|mesh-ancestor
6711425|NCT01784315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6711426|NCT01784315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6711427|NCT01784315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6711428|NCT01784315|Antimalarials|antimalarials|mesh-ancestor
6711429|NCT01784315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6711430|NCT01784315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6711431|NCT01784315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6711432|NCT01784315|Analgesics|analgesics|mesh-ancestor
6711433|NCT01784315|Sensory System Agents|sensory system agents|mesh-ancestor
6711434|NCT01784315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6711435|NCT01784315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711436|NCT01784315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6711437|NCT01784315|Filaricides|filaricides|mesh-ancestor
6711438|NCT01784315|Antinematodal Agents|antinematodal agents|mesh-ancestor
6711439|NCT01784315|Anthelmintics|anthelmintics|mesh-ancestor
6711440|NCT01784380|Metformin|metformin|mesh-list
6711441|NCT01784380|Clomiphene|clomiphene|mesh-list
6711442|NCT01784380|Enclomiphene|enclomiphene|mesh-list
6711443|NCT01784380|Zuclomiphene|zuclomiphene|mesh-list
6711444|NCT01784380|Menotropins|menotropins|mesh-list
6711445|NCT01784380|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
6711446|NCT01784380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6711447|NCT01784380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711448|NCT01784380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6711449|NCT01784380|Hormone Antagonists|hormone antagonists|mesh-ancestor
6711450|NCT01784380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6711451|NCT01784380|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6711452|NCT01784380|Fertility Agents|fertility agents|mesh-ancestor
6711453|NCT01784380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6711454|NCT01784380|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6711455|NCT01784380|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6711456|NCT01784380|Androgen Antagonists|androgen antagonists|mesh-ancestor
6711457|NCT01784445|Ceftazidime|ceftazidime|mesh-list
6711458|NCT01784445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6711459|NCT01784445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6711460|NCT01784536|Oritavancin|oritavancin|mesh-list
6711461|NCT01784536|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6711462|NCT01784536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6711463|NCT01784549|Gemcitabine|gemcitabine|mesh-list
6711464|NCT01784549|Docetaxel|docetaxel|mesh-list
6711465|NCT01784549|Pemetrexed|pemetrexed|mesh-list
6711466|NCT01784549|Vinorelbine|vinorelbine|mesh-list
6711467|NCT01784549|Gefitinib|gefitinib|mesh-list
6711468|NCT01784549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6711469|NCT01784549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6711470|NCT01784549|Antimetabolites|antimetabolites|mesh-ancestor
6711471|NCT01784549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6711472|NCT01784549|Antiviral Agents|antiviral agents|mesh-ancestor
6711473|NCT01784549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6711474|NCT01784549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6711475|NCT01784549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6711476|NCT01784549|Immunologic Factors|immunologic factors|mesh-ancestor
6711477|NCT01784549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711478|NCT01784549|Tubulin Modulators|tubulin modulators|mesh-ancestor
6711479|NCT01784549|Antimitotic Agents|antimitotic agents|mesh-ancestor
6711480|NCT01784549|Mitosis Modulators|mitosis modulators|mesh-ancestor
6711481|NCT01784549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6711482|NCT01784549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6711483|NCT01784549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6711484|NCT01784549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6711485|NCT01784562|Riociguat|riociguat|mesh-list
6711486|NCT01784562|Enzyme Activators|enzyme activators|mesh-ancestor
6711487|NCT01784562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6711488|NCT01784640|Pemetrexed|pemetrexed|mesh-list
6711489|NCT01784640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6711490|NCT01784640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6711491|NCT01784640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6711492|NCT01784640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6711493|NCT01784640|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6711494|NCT01784718|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
6711495|NCT01784718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6711496|NCT01784900|Catumaxomab|catumaxomab|mesh-list
6711497|NCT01784900|Antibodies, Bispecific|antibodies, bispecific|mesh-list
6711498|NCT01784900|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6711499|NCT01784900|Immunologic Factors|immunologic factors|mesh-ancestor
6711500|NCT01784900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711501|NCT01784913|Sargramostim|sargramostim|mesh-list
6711502|NCT01784913|Immunologic Factors|immunologic factors|mesh-ancestor
6711503|NCT01784913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711504|NCT01784978|Everolimus|everolimus|mesh-list
6711505|NCT01784978|Sunitinib|sunitinib|mesh-list
6711506|NCT01784978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6711507|NCT01784978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6711508|NCT01784978|Immunologic Factors|immunologic factors|mesh-ancestor
6711509|NCT01784978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711510|NCT01784978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6711511|NCT01784978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6711512|NCT01784978|Growth Substances|growth substances|mesh-ancestor
6711513|NCT01784978|Growth Inhibitors|growth inhibitors|mesh-ancestor
6711514|NCT01784978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6711515|NCT01784978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6711516|NCT01784978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6711517|NCT01785004|Vitamin D|vitamin d|mesh-list
6711518|NCT01785004|Cholecalciferol|cholecalciferol|mesh-list
6711519|NCT01785004|Vitamins|vitamins|mesh-ancestor
6711520|NCT01785004|Micronutrients|micronutrients|mesh-ancestor
6711521|NCT01785004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711522|NCT01785004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6711523|NCT01785004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6711524|NCT01785030|Nitrous Oxide|nitrous oxide|mesh-list
6711525|NCT01785030|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6711526|NCT01785030|Anesthetics, General|anesthetics, general|mesh-ancestor
6711527|NCT01785030|Anesthetics|anesthetics|mesh-ancestor
6711528|NCT01785030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6711529|NCT01785030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711530|NCT01785030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6711531|NCT01785030|Analgesics|analgesics|mesh-ancestor
6711532|NCT01785030|Sensory System Agents|sensory system agents|mesh-ancestor
6711533|NCT01785030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6711534|NCT01785043|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6711535|NCT01785043|Liraglutide|liraglutide|mesh-list
6711536|NCT01785043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6711537|NCT01785043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711538|NCT01785043|Incretins|incretins|mesh-ancestor
6711539|NCT01785043|Hormones|hormones|mesh-ancestor
6711540|NCT01785043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6711541|NCT01785043|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6711542|NCT01785043|Protease Inhibitors|protease inhibitors|mesh-ancestor
6711543|NCT01785043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6711544|NCT01785043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6711545|NCT01785056|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6711546|NCT01785056|Immunologic Factors|immunologic factors|mesh-ancestor
6711547|NCT01785056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711548|NCT01785108|Vitamin D|vitamin d|mesh-list
6711549|NCT01785108|Ibuprofen|ibuprofen|mesh-list
6711550|NCT01785108|Aluminum sulfate|aluminum sulfate|mesh-list
6711551|NCT01785108|Vitamins|vitamins|mesh-ancestor
6711552|NCT01785108|Micronutrients|micronutrients|mesh-ancestor
6711553|NCT01785108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711554|NCT01785108|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6711555|NCT01785108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6711556|NCT01785108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6711557|NCT01785108|Analgesics|analgesics|mesh-ancestor
6711558|NCT01785108|Sensory System Agents|sensory system agents|mesh-ancestor
6711559|NCT01785108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6711560|NCT01785108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6711561|NCT01785108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6711562|NCT01785108|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6711563|NCT01785108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6711564|NCT01785108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6711565|NCT01785108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6711566|NCT01785108|Immunologic Factors|immunologic factors|mesh-ancestor
6711567|NCT01785290|Haloperidol|haloperidol|mesh-list
6711568|NCT01785290|Haloperidol decanoate|haloperidol decanoate|mesh-list
6711569|NCT01785290|Antiemetics|antiemetics|mesh-ancestor
6711570|NCT01785290|Autonomic Agents|autonomic agents|mesh-ancestor
6711571|NCT01785290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6711572|NCT01785290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711573|NCT01785290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6711574|NCT01785290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6711575|NCT01785290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6711576|NCT01785290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6711577|NCT01785290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6711578|NCT01785290|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6711579|NCT01785290|Dopamine Agents|dopamine agents|mesh-ancestor
6711580|NCT01785290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6711581|NCT01785290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6711582|NCT01785290|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6711583|NCT01785420|Trastuzumab|trastuzumab|mesh-list
6711584|NCT01785420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6711585|NCT01785420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6711586|NCT01785446|Sufentanil|sufentanil|mesh-list
6711587|NCT01785446|Dexmedetomidine|dexmedetomidine|mesh-list
6711588|NCT01785446|Dsuvia|dsuvia|mesh-list
6711589|NCT01785446|Atracurium|atracurium|mesh-list
6711590|NCT01785446|Cisatracurium|cisatracurium|mesh-list
6711591|NCT01785446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6711592|NCT01785446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6711593|NCT01785446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711594|NCT01785446|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6711595|NCT01785446|Analgesics|analgesics|mesh-ancestor
6711596|NCT01785446|Sensory System Agents|sensory system agents|mesh-ancestor
6711597|NCT01785446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6711598|NCT01785446|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6711599|NCT01785446|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6711600|NCT01785446|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6711601|NCT01785446|Adrenergic Agents|adrenergic agents|mesh-ancestor
6711602|NCT01785446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6711603|NCT01785446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6711604|NCT01785446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6711605|NCT01785446|Narcotics|narcotics|mesh-ancestor
6711606|NCT01785446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6711607|NCT01785446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6711608|NCT01785446|Anesthetics, General|anesthetics, general|mesh-ancestor
6711609|NCT01785446|Anesthetics|anesthetics|mesh-ancestor
6711610|NCT01785446|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6711611|NCT01785446|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6711612|NCT01785446|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6711613|NCT01785446|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
6711614|NCT01785446|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6711615|NCT01785446|Cholinergic Agents|cholinergic agents|mesh-ancestor
6711616|NCT01785589|Adenosine|adenosine|mesh-list
6711617|NCT01785589|Analgesics|analgesics|mesh-ancestor
6711618|NCT01785589|Sensory System Agents|sensory system agents|mesh-ancestor
6711619|NCT01785589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6711620|NCT01785589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711621|NCT01785589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6711622|NCT01785589|Vasodilator Agents|vasodilator agents|mesh-ancestor
6711623|NCT01785589|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6711624|NCT01785589|Purinergic Agonists|purinergic agonists|mesh-ancestor
6711625|NCT01785589|Purinergic Agents|purinergic agents|mesh-ancestor
6711626|NCT01785589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6711627|NCT01785589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6711628|NCT01785641|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6711629|NCT01785641|Ciprofloxacin|ciprofloxacin|mesh-list
6711630|NCT01785641|Gentamicins|gentamicins|mesh-list
6711631|NCT01785641|Cefazolin|cefazolin|mesh-list
6711632|NCT01785641|Ceftazidime|ceftazidime|mesh-list
6711633|NCT01785641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6711634|NCT01785641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6711635|NCT01785641|Antitubercular Agents|antitubercular agents|mesh-ancestor
6711636|NCT01785641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6711637|NCT01785641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6711638|NCT01785641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6711639|NCT01785641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6711640|NCT01785641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6711641|NCT01785641|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6711642|NCT01785641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6711643|NCT01785641|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6711644|NCT01785693|Clonidine|clonidine|mesh-list
6711645|NCT01785693|Levobupivacaine|levobupivacaine|mesh-list
6711646|NCT01785693|Anesthetics, Local|anesthetics, local|mesh-ancestor
6711647|NCT01785693|Anesthetics|anesthetics|mesh-ancestor
6711648|NCT01785693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6711649|NCT01785693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711650|NCT01785693|Sensory System Agents|sensory system agents|mesh-ancestor
6711651|NCT01785693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6711652|NCT01785693|Analgesics|analgesics|mesh-ancestor
6711653|NCT01785693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6711654|NCT01785693|Sympatholytics|sympatholytics|mesh-ancestor
6711655|NCT01785693|Autonomic Agents|autonomic agents|mesh-ancestor
6711656|NCT01785693|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6711657|NCT01785693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6711658|NCT01785693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6711659|NCT01785693|Adrenergic Agents|adrenergic agents|mesh-ancestor
6711660|NCT01785693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6711661|NCT01785693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782934|NCT02193971|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6782935|NCT02193971|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6782936|NCT02194049|Etoposide|etoposide|mesh-list
6782937|NCT02194049|Etoposide phosphate|etoposide phosphate|mesh-list
6782938|NCT02194049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6782939|NCT02194049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6782940|NCT02194049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6782941|NCT02194049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6782942|NCT02194049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6782943|NCT02194049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782944|NCT02194075|Fluvoxamine|fluvoxamine|mesh-list
6782945|NCT02194075|Methylphenidate|methylphenidate|mesh-list
6782946|NCT02194075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6782947|NCT02194075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711662|NCT01785797|Silicon|silicon|mesh-list
6711663|NCT01785797|Trace Elements|trace elements|mesh-ancestor
6711664|NCT01785797|Micronutrients|micronutrients|mesh-ancestor
6711665|NCT01785797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711666|NCT01785836|Dapsone|dapsone|mesh-list
6711667|NCT01785836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6711668|NCT01785836|Antimalarials|antimalarials|mesh-ancestor
6711669|NCT01785836|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6711670|NCT01785836|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6711671|NCT01785836|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6711672|NCT01785836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6711673|NCT01785836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6711674|NCT01785836|Leprostatic Agents|leprostatic agents|mesh-ancestor
6711675|NCT01785836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6711676|NCT01785862|Ibuprofen|ibuprofen|mesh-list
6711677|NCT01785862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6711678|NCT01785862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6711679|NCT01785862|Analgesics|analgesics|mesh-ancestor
6711680|NCT01785862|Sensory System Agents|sensory system agents|mesh-ancestor
6711681|NCT01785862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6711682|NCT01785862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711683|NCT01785862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6711684|NCT01785862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6711685|NCT01785862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6711686|NCT01785862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6711687|NCT01785862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6711688|NCT01785979|Chloroquine|chloroquine|mesh-list
6711689|NCT01785979|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
6711690|NCT01785979|Prednisone|prednisone|mesh-list
6711691|NCT01785979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6711692|NCT01785979|Glucocorticoids|glucocorticoids|mesh-ancestor
6711693|NCT01785979|Hormones|hormones|mesh-ancestor
6711694|NCT01785979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6711695|NCT01785979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711696|NCT01785979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6711697|NCT01785979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6711698|NCT01785979|Amebicides|amebicides|mesh-ancestor
6711699|NCT01785979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6711700|NCT01785979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6711701|NCT01785979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6711702|NCT01785979|Antimalarials|antimalarials|mesh-ancestor
6711703|NCT01785979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6711704|NCT01785979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6711705|NCT01785979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6711706|NCT01785979|Analgesics|analgesics|mesh-ancestor
6711707|NCT01785979|Sensory System Agents|sensory system agents|mesh-ancestor
6711708|NCT01785979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6711709|NCT01785979|Filaricides|filaricides|mesh-ancestor
6711710|NCT01785979|Antinematodal Agents|antinematodal agents|mesh-ancestor
6711711|NCT01785979|Anthelmintics|anthelmintics|mesh-ancestor
6711712|NCT01786018|Cyclosporine|cyclosporine|mesh-list
6711713|NCT01786018|Methotrexate|methotrexate|mesh-list
6711714|NCT01786018|Busulfan|busulfan|mesh-list
6711715|NCT01786018|Thiotepa|thiotepa|mesh-list
6711716|NCT01786018|Cyclosporins|cyclosporins|mesh-list
6711717|NCT01786018|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6711718|NCT01786018|Abortifacient Agents|abortifacient agents|mesh-ancestor
6711719|NCT01786018|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6711720|NCT01786018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711721|NCT01786018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6711722|NCT01786018|Antimetabolites|antimetabolites|mesh-ancestor
6711723|NCT01786018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6711724|NCT01786018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6711725|NCT01786018|Dermatologic Agents|dermatologic agents|mesh-ancestor
6711726|NCT01786018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6711727|NCT01786018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6711728|NCT01786018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6711729|NCT01786018|Immunologic Factors|immunologic factors|mesh-ancestor
6711730|NCT01786018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6711731|NCT01786018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6711732|NCT01786018|Antifungal Agents|antifungal agents|mesh-ancestor
6711733|NCT01786018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6711734|NCT01786018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6711735|NCT01786018|Alkylating Agents|alkylating agents|mesh-ancestor
6711736|NCT01786018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6711737|NCT01786018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6711738|NCT01786070|Budesonide|budesonide|mesh-list
6711739|NCT01786070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6711740|NCT01786070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6711741|NCT01786070|Autonomic Agents|autonomic agents|mesh-ancestor
6711742|NCT01786070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6711743|NCT01786070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711744|NCT01786070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6711745|NCT01786070|Respiratory System Agents|respiratory system agents|mesh-ancestor
6711746|NCT01786070|Glucocorticoids|glucocorticoids|mesh-ancestor
6711747|NCT01786070|Hormones|hormones|mesh-ancestor
6711748|NCT01786070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6711749|NCT01786200|Aspirin|aspirin|mesh-list
6711750|NCT01786200|Ibuprofen|ibuprofen|mesh-list
6711751|NCT01786200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6711752|NCT01786200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6711753|NCT01786200|Analgesics|analgesics|mesh-ancestor
6711754|NCT01786200|Sensory System Agents|sensory system agents|mesh-ancestor
6711755|NCT01786200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6711756|NCT01786200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711757|NCT01786200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6711758|NCT01786200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6711759|NCT01786200|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6711760|NCT01786200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6711761|NCT01786200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6711762|NCT01786200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6711763|NCT01786200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6711764|NCT01786200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6711765|NCT01786200|Antipyretics|antipyretics|mesh-ancestor
6711766|NCT01786226|Mifepristone|mifepristone|mesh-list
6711767|NCT01786226|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6711768|NCT01786226|Abortifacient Agents|abortifacient agents|mesh-ancestor
6711769|NCT01786226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6711770|NCT01786226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711771|NCT01786226|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6711772|NCT01786226|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6711773|NCT01786226|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6711774|NCT01786226|Contraceptive Agents|contraceptive agents|mesh-ancestor
6711775|NCT01786226|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6711776|NCT01786226|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6711777|NCT01786226|Hormone Antagonists|hormone antagonists|mesh-ancestor
6711778|NCT01786226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6711779|NCT01786226|Luteolytic Agents|luteolytic agents|mesh-ancestor
6711780|NCT01786226|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6711781|NCT01786226|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6711782|NCT01786382|Midazolam|midazolam|mesh-list
6711783|NCT01786382|Omeprazole|omeprazole|mesh-list
6711784|NCT01786382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6711785|NCT01786382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6711786|NCT01786382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6711787|NCT01786382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711788|NCT01786382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6711789|NCT01786382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6711790|NCT01786382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6711791|NCT01786382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6711792|NCT01786382|Anesthetics, General|anesthetics, general|mesh-ancestor
6711793|NCT01786382|Anesthetics|anesthetics|mesh-ancestor
6711794|NCT01786382|GABA Modulators|gaba modulators|mesh-ancestor
6711795|NCT01786382|GABA Agents|gaba agents|mesh-ancestor
6711796|NCT01786382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6711797|NCT01786382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6711798|NCT01786382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6711799|NCT01786382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6711800|NCT01786382|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6711801|NCT01786382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6711802|NCT01786395|Isopropyl unoprostone|isopropyl unoprostone|mesh-list
6711803|NCT01786395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6711804|NCT01786434|Fentanyl|fentanyl|mesh-list
6711805|NCT01786434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6711806|NCT01786434|Narcotics|narcotics|mesh-ancestor
6711807|NCT01786434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6711808|NCT01786434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711809|NCT01786434|Analgesics|analgesics|mesh-ancestor
6711810|NCT01786434|Sensory System Agents|sensory system agents|mesh-ancestor
6711811|NCT01786434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6711812|NCT01786434|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6711813|NCT01786434|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6711814|NCT01786434|Anesthetics, General|anesthetics, general|mesh-ancestor
6711815|NCT01786434|Anesthetics|anesthetics|mesh-ancestor
6711816|NCT01786538|Leucovorin|leucovorin|mesh-list
6711817|NCT01786538|Fluorouracil|fluorouracil|mesh-list
6711818|NCT01786538|Oxaliplatin|oxaliplatin|mesh-list
6711819|NCT01786538|Antimetabolites|antimetabolites|mesh-ancestor
6711820|NCT01786538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6711821|NCT01786538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6711822|NCT01786538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6711823|NCT01786538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6711824|NCT01786538|Immunologic Factors|immunologic factors|mesh-ancestor
6711825|NCT01786538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711826|NCT01786538|Antidotes|antidotes|mesh-ancestor
6711827|NCT01786538|Protective Agents|protective agents|mesh-ancestor
6711828|NCT01786538|Vitamin B Complex|vitamin b complex|mesh-ancestor
6711829|NCT01786538|Vitamins|vitamins|mesh-ancestor
6711830|NCT01786538|Micronutrients|micronutrients|mesh-ancestor
6711831|NCT01786616|Formoterol Fumarate|formoterol fumarate|mesh-list
6711832|NCT01786616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6711833|NCT01786616|Autonomic Agents|autonomic agents|mesh-ancestor
6711834|NCT01786616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6711835|NCT01786616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711836|NCT01786616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6711837|NCT01786616|Respiratory System Agents|respiratory system agents|mesh-ancestor
6711838|NCT01786616|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6711839|NCT01786616|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6711840|NCT01786616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6711841|NCT01786616|Adrenergic Agents|adrenergic agents|mesh-ancestor
6711842|NCT01786616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6711843|NCT01786616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6711844|NCT01786655|Epinephrine|epinephrine|mesh-list
6711845|NCT01786655|Bupivacaine|bupivacaine|mesh-list
6711846|NCT01786655|Neosaxitoxin|neosaxitoxin|mesh-list
6711847|NCT01786655|Anesthetics, Local|anesthetics, local|mesh-ancestor
6711848|NCT01786655|Anesthetics|anesthetics|mesh-ancestor
6711849|NCT01786655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6711850|NCT01786655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711851|NCT01786655|Sensory System Agents|sensory system agents|mesh-ancestor
6711852|NCT01786655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6711853|NCT01786655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6711854|NCT01786655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6711855|NCT01786655|Adrenergic Agents|adrenergic agents|mesh-ancestor
6711856|NCT01786655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6711857|NCT01786655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6711858|NCT01786655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6711859|NCT01786655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6711860|NCT01786655|Autonomic Agents|autonomic agents|mesh-ancestor
6711861|NCT01786655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6711862|NCT01786655|Respiratory System Agents|respiratory system agents|mesh-ancestor
6711863|NCT01786655|Mydriatics|mydriatics|mesh-ancestor
6711864|NCT01786655|Sympathomimetics|sympathomimetics|mesh-ancestor
6711865|NCT01786655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6711866|NCT01786655|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6711867|NCT01786655|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6711868|NCT01786759|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6711869|NCT01786759|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6711870|NCT01786759|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6711871|NCT01786759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6711872|NCT01787123|Cerebrolysin|cerebrolysin|mesh-list
6711873|NCT01787123|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6711874|NCT01787123|Protective Agents|protective agents|mesh-ancestor
6711875|NCT01787123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711876|NCT01787123|Nootropic Agents|nootropic agents|mesh-ancestor
6711877|NCT01787136|Dextromethorphan|dextromethorphan|mesh-list
6711878|NCT01787136|Antitussive Agents|antitussive agents|mesh-ancestor
6711879|NCT01787136|Respiratory System Agents|respiratory system agents|mesh-ancestor
6711880|NCT01787136|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6711881|NCT01787136|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6711882|NCT01787136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6711883|NCT01787136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6711884|NCT01787136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711885|NCT01787344|Botulinum Toxins|botulinum toxins|mesh-list
6711886|NCT01787344|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6711887|NCT01787344|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6711888|NCT01787344|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6711889|NCT01787344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6711890|NCT01787344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6711891|NCT01787344|Cholinergic Agents|cholinergic agents|mesh-ancestor
6711892|NCT01787344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6711893|NCT01787344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711894|NCT01787344|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6711895|NCT01787344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6711896|NCT01787357|Canagliflozin|canagliflozin|mesh-list
6711897|NCT01787357|Moxifloxacin|moxifloxacin|mesh-list
6711898|NCT01787357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6711899|NCT01787357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6711900|NCT01787357|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6711901|NCT01787357|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6711902|NCT01787357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6711903|NCT01787357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6711904|NCT01787357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6711905|NCT01787357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711906|NCT01787357|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6711907|NCT01787357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6711908|NCT01787396|Metformin|metformin|mesh-list
6711909|NCT01787396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6711910|NCT01787396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711911|NCT01787409|Vitamin D|vitamin d|mesh-list
6711912|NCT01787409|Cholecalciferol|cholecalciferol|mesh-list
6711913|NCT01787409|Vitamins|vitamins|mesh-ancestor
6711914|NCT01787409|Micronutrients|micronutrients|mesh-ancestor
6711915|NCT01787409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711916|NCT01787409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6711917|NCT01787409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6711918|NCT01787474|Cytarabine|cytarabine|mesh-list
6711919|NCT01787474|Fludarabine|fludarabine|mesh-list
6711920|NCT01787474|Fludarabine phosphate|fludarabine phosphate|mesh-list
6711921|NCT01787474|Lenograstim|lenograstim|mesh-list
6711922|NCT01787474|Sargramostim|sargramostim|mesh-list
6711923|NCT01787474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6711924|NCT01787474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6711925|NCT01787474|Antimetabolites|antimetabolites|mesh-ancestor
6711926|NCT01787474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6711927|NCT01787474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6711928|NCT01787474|Immunologic Factors|immunologic factors|mesh-ancestor
6711929|NCT01787474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711930|NCT01787474|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6711931|NCT01787474|Antiviral Agents|antiviral agents|mesh-ancestor
6711932|NCT01787474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6711933|NCT01787487|Azacitidine|azacitidine|mesh-list
6711934|NCT01787487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6711935|NCT01787487|Antimetabolites|antimetabolites|mesh-ancestor
6711936|NCT01787487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6711937|NCT01787487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6711938|NCT01787487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6782948|NCT02194075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6782949|NCT02194075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6782950|NCT02194075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6782951|NCT02194075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782952|NCT02194075|Dopamine Agents|dopamine agents|mesh-ancestor
6782953|NCT02194075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6711939|NCT01787630|Hyaluronic Acid|hyaluronic acid|mesh-list
6711940|NCT01787630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6711941|NCT01787630|Immunologic Factors|immunologic factors|mesh-ancestor
6711942|NCT01787630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711943|NCT01787630|Viscosupplements|viscosupplements|mesh-ancestor
6711944|NCT01787630|Protective Agents|protective agents|mesh-ancestor
6711945|NCT01787669|Dexamethasone|dexamethasone|mesh-list
6711946|NCT01787669|Bevacizumab|bevacizumab|mesh-list
6711947|NCT01787669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6711948|NCT01787669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6711949|NCT01787669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6711950|NCT01787669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6711951|NCT01787669|Growth Substances|growth substances|mesh-ancestor
6711952|NCT01787669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711953|NCT01787669|Growth Inhibitors|growth inhibitors|mesh-ancestor
6711954|NCT01787669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6711955|NCT01787669|Antiemetics|antiemetics|mesh-ancestor
6711956|NCT01787669|Autonomic Agents|autonomic agents|mesh-ancestor
6711957|NCT01787669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6711958|NCT01787669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6711959|NCT01787669|Glucocorticoids|glucocorticoids|mesh-ancestor
6711960|NCT01787669|Hormones|hormones|mesh-ancestor
6711961|NCT01787669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6711962|NCT01787669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6711963|NCT01788007|Imiquimod|imiquimod|mesh-list
6711964|NCT01788007|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6711965|NCT01788007|Immunologic Factors|immunologic factors|mesh-ancestor
6711966|NCT01788007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711967|NCT01788007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6711968|NCT01788007|Interferon Inducers|interferon inducers|mesh-ancestor
6711969|NCT01788020|Dexamethasone|dexamethasone|mesh-list
6711970|NCT01788020|Dexamethasone acetate|dexamethasone acetate|mesh-list
6711971|NCT01788020|Cyclophosphamide|cyclophosphamide|mesh-list
6711972|NCT01788020|Rituximab|rituximab|mesh-list
6711973|NCT01788020|Bortezomib|bortezomib|mesh-list
6711974|NCT01788020|BB 1101|bb 1101|mesh-list
6711975|NCT01788020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6711976|NCT01788020|Immunologic Factors|immunologic factors|mesh-ancestor
6711977|NCT01788020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6711978|NCT01788020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6711979|NCT01788020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6711980|NCT01788020|Alkylating Agents|alkylating agents|mesh-ancestor
6711981|NCT01788020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6711982|NCT01788020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6711983|NCT01788020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6711984|NCT01788020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6711985|NCT01788020|Antiemetics|antiemetics|mesh-ancestor
6711986|NCT01788020|Autonomic Agents|autonomic agents|mesh-ancestor
6711987|NCT01788020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6711988|NCT01788020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6711989|NCT01788020|Glucocorticoids|glucocorticoids|mesh-ancestor
6711990|NCT01788020|Hormones|hormones|mesh-ancestor
6711991|NCT01788020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6711992|NCT01788020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6711993|NCT01788020|Protease Inhibitors|protease inhibitors|mesh-ancestor
6711994|NCT01788020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6711995|NCT01788020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6711996|NCT01788072|Oxytocin|oxytocin|mesh-list
6711997|NCT01788072|Oxytocics|oxytocics|mesh-ancestor
6711998|NCT01788072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6711999|NCT01788072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712000|NCT01788176|Zoledronic Acid|zoledronic acid|mesh-list
6712001|NCT01788176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6712002|NCT01788176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712003|NCT01788189|Lenalidomide|lenalidomide|mesh-list
6712004|NCT01788189|Immunologic Factors|immunologic factors|mesh-ancestor
6712005|NCT01788189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712006|NCT01788189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6712007|NCT01788189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6712008|NCT01788189|Growth Substances|growth substances|mesh-ancestor
6712009|NCT01788189|Growth Inhibitors|growth inhibitors|mesh-ancestor
6712010|NCT01788189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6712011|NCT01788254|Talinolol|talinolol|mesh-list
6712012|NCT01788254|Torsemide|torsemide|mesh-list
6712013|NCT01788254|Midazolam|midazolam|mesh-list
6712014|NCT01788254|Codeine|codeine|mesh-list
6712015|NCT01788254|Pravastatin|pravastatin|mesh-list
6712016|NCT01788254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6712017|NCT01788254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6712018|NCT01788254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6712019|NCT01788254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712020|NCT01788254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6712021|NCT01788254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6712022|NCT01788254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6712023|NCT01788254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6712024|NCT01788254|Anesthetics, General|anesthetics, general|mesh-ancestor
6712025|NCT01788254|Anesthetics|anesthetics|mesh-ancestor
6712026|NCT01788254|GABA Modulators|gaba modulators|mesh-ancestor
6712027|NCT01788254|GABA Agents|gaba agents|mesh-ancestor
6712028|NCT01788254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6712029|NCT01788254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6712030|NCT01788254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6712031|NCT01788254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6712032|NCT01788254|Antimetabolites|antimetabolites|mesh-ancestor
6712033|NCT01788254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6712034|NCT01788254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6712035|NCT01788254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6712036|NCT01788254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6712037|NCT01788254|Narcotics|narcotics|mesh-ancestor
6712038|NCT01788254|Analgesics|analgesics|mesh-ancestor
6712039|NCT01788254|Sensory System Agents|sensory system agents|mesh-ancestor
6712040|NCT01788254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6712041|NCT01788254|Antitussive Agents|antitussive agents|mesh-ancestor
6712042|NCT01788254|Respiratory System Agents|respiratory system agents|mesh-ancestor
6712043|NCT01788254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6712044|NCT01788254|Diuretics|diuretics|mesh-ancestor
6712045|NCT01788254|Natriuretic Agents|natriuretic agents|mesh-ancestor
6712046|NCT01788254|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6712047|NCT01788254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6712048|NCT01788254|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6712049|NCT01788254|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6712050|NCT01788254|Adrenergic Agents|adrenergic agents|mesh-ancestor
6712051|NCT01788254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6712052|NCT01788280|Bevacizumab|bevacizumab|mesh-list
6712053|NCT01788280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6712054|NCT01788280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6712055|NCT01788280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6712056|NCT01788280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6712057|NCT01788280|Growth Substances|growth substances|mesh-ancestor
6712058|NCT01788280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712059|NCT01788280|Growth Inhibitors|growth inhibitors|mesh-ancestor
6712060|NCT01788332|Olaparib|olaparib|mesh-list
6712061|NCT01788332|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6712062|NCT01788332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6712063|NCT01788332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6712064|NCT01788332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6712065|NCT01788371|Lamivudine|lamivudine|mesh-list
6712066|NCT01788371|Telbivudine|telbivudine|mesh-list
6712067|NCT01788371|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6712068|NCT01788371|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6712069|NCT01788371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6712070|NCT01788371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6712071|NCT01788371|Antiviral Agents|antiviral agents|mesh-ancestor
6712072|NCT01788371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6712073|NCT01788371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6712074|NCT01788371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6712075|NCT01788384|Clindamycin|clindamycin|mesh-list
6712076|NCT01788384|Clindamycin palmitate|clindamycin palmitate|mesh-list
6712077|NCT01788384|Clindamycin phosphate|clindamycin phosphate|mesh-list
6712078|NCT01788384|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6712079|NCT01788384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6712080|NCT01788384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6712081|NCT01788384|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6712082|NCT01788384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6712083|NCT01788384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6712084|NCT01788384|Dermatologic Agents|dermatologic agents|mesh-ancestor
6712085|NCT01788462|Tesamorelin|tesamorelin|mesh-list
6712086|NCT01788462|Growth Substances|growth substances|mesh-ancestor
6712087|NCT01788462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712088|NCT01788501|Cyclosporine|cyclosporine|mesh-list
6712089|NCT01788501|Methotrexate|methotrexate|mesh-list
6712090|NCT01788501|Tacrolimus|tacrolimus|mesh-list
6712091|NCT01788501|Cyclosporins|cyclosporins|mesh-list
6712092|NCT01788501|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6712093|NCT01788501|Abortifacient Agents|abortifacient agents|mesh-ancestor
6712094|NCT01788501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6712095|NCT01788501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712096|NCT01788501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6712097|NCT01788501|Antimetabolites|antimetabolites|mesh-ancestor
6712098|NCT01788501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6712099|NCT01788501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6712100|NCT01788501|Dermatologic Agents|dermatologic agents|mesh-ancestor
6712101|NCT01788501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6712102|NCT01788501|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6712103|NCT01788501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6712104|NCT01788501|Immunologic Factors|immunologic factors|mesh-ancestor
6712105|NCT01788501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6712106|NCT01788501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6712107|NCT01788501|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6712108|NCT01788501|Antifungal Agents|antifungal agents|mesh-ancestor
6712109|NCT01788501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6712110|NCT01788540|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6712111|NCT01788540|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6712112|NCT01788540|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6712113|NCT01788540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6712114|NCT01788605|Ramosetron|ramosetron|mesh-list
6712115|NCT01788605|Antiemetics|antiemetics|mesh-ancestor
6712116|NCT01788605|Autonomic Agents|autonomic agents|mesh-ancestor
6712117|NCT01788605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6712118|NCT01788605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712119|NCT01788605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6712120|NCT01788605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6712121|NCT01788605|Serotonin Agents|serotonin agents|mesh-ancestor
6712122|NCT01788605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6712123|NCT01788605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6712124|NCT01788670|Ethanol|ethanol|mesh-list
6712125|NCT01788670|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6712126|NCT01788670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6712127|NCT01788670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6712128|NCT01788670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712129|NCT01788722|Dienogest|dienogest|mesh-list
6712130|NCT01788722|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6712131|NCT01788722|Contraceptive Agents|contraceptive agents|mesh-ancestor
6712132|NCT01788722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6712133|NCT01788722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712134|NCT01788722|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6712135|NCT01788722|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6712136|NCT01788722|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6712137|NCT01788722|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6712138|NCT01788722|Hormone Antagonists|hormone antagonists|mesh-ancestor
6712139|NCT01788722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6712140|NCT01788722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6712141|NCT01788722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6712142|NCT01788774|Risperidone|risperidone|mesh-list
6712143|NCT01788774|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6712144|NCT01788774|Serotonin Agents|serotonin agents|mesh-ancestor
6712145|NCT01788774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6712146|NCT01788774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6712147|NCT01788774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712148|NCT01788774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6712149|NCT01788774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6712150|NCT01788774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6712151|NCT01788774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6712152|NCT01788774|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6712153|NCT01788774|Dopamine Agents|dopamine agents|mesh-ancestor
6712154|NCT01788969|Citalopram|citalopram|mesh-list
6712155|NCT01788969|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6712156|NCT01788969|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6712157|NCT01788969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6712158|NCT01788969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6712159|NCT01788969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6712160|NCT01788969|Serotonin Agents|serotonin agents|mesh-ancestor
6712161|NCT01788969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712162|NCT01788969|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6712163|NCT01788969|Antidepressive Agents|antidepressive agents|mesh-ancestor
6712164|NCT01788969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6712165|NCT01788982|Nintedanib|nintedanib|mesh-list
6712166|NCT01788982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6712167|NCT01788982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6712168|NCT01788982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6712169|NCT01788982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6712170|NCT01789086|Liraglutide|liraglutide|mesh-list
6712171|NCT01789086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6712172|NCT01789086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712173|NCT01789086|Incretins|incretins|mesh-ancestor
6712174|NCT01789086|Hormones|hormones|mesh-ancestor
6712175|NCT01789086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6712176|NCT01789099|Sargramostim|sargramostim|mesh-list
6712177|NCT01789099|Immunologic Factors|immunologic factors|mesh-ancestor
6712178|NCT01789099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712179|NCT01789125|Nicotine|nicotine|mesh-list
6712180|NCT01789125|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6712181|NCT01789125|Autonomic Agents|autonomic agents|mesh-ancestor
6712182|NCT01789125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6712183|NCT01789125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712184|NCT01789125|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6712185|NCT01789125|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6712186|NCT01789125|Cholinergic Agents|cholinergic agents|mesh-ancestor
6712187|NCT01789125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6712188|NCT01789125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782954|NCT02194075|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6782955|NCT02194075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6782956|NCT02194075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6782957|NCT02194075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6782958|NCT02194075|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6782959|NCT02194075|Serotonin Agents|serotonin agents|mesh-ancestor
6782960|NCT02194075|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6782961|NCT02194075|Antidepressive Agents|antidepressive agents|mesh-ancestor
6782962|NCT02194075|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6782963|NCT02194075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6782964|NCT02194075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6782965|NCT02194075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6782966|NCT02194153|Tenecteplase|tenecteplase|mesh-list
6782967|NCT02194153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6782968|NCT02194153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6782969|NCT02194153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782970|NCT02194166|Paclitaxel|paclitaxel|mesh-list
6782971|NCT02194166|Docetaxel|docetaxel|mesh-list
6782972|NCT02194166|Trastuzumab|trastuzumab|mesh-list
6782973|NCT02194166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6782974|NCT02194166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6782975|NCT02194166|Tubulin Modulators|tubulin modulators|mesh-ancestor
6782976|NCT02194166|Antimitotic Agents|antimitotic agents|mesh-ancestor
6782977|NCT02194166|Mitosis Modulators|mitosis modulators|mesh-ancestor
6782978|NCT02194166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6712189|NCT01789216|Ketorolac|ketorolac|mesh-list
6712190|NCT01789216|Meloxicam|meloxicam|mesh-list
6712191|NCT01789216|Pregabalin|pregabalin|mesh-list
6712192|NCT01789216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6712193|NCT01789216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6712194|NCT01789216|Analgesics|analgesics|mesh-ancestor
6712195|NCT01789216|Sensory System Agents|sensory system agents|mesh-ancestor
6712196|NCT01789216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6712197|NCT01789216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712198|NCT01789216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6712199|NCT01789216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6712200|NCT01789216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6712201|NCT01789216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6712202|NCT01789216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6712203|NCT01789216|Anticonvulsants|anticonvulsants|mesh-ancestor
6712204|NCT01789216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6712205|NCT01789216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6712206|NCT01789216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6712207|NCT01789216|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6712208|NCT01789216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6712209|NCT01789216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6712210|NCT01789216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6712211|NCT01789216|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6712212|NCT01789242|Dexamethasone|dexamethasone|mesh-list
6712213|NCT01789242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6712214|NCT01789242|Antiemetics|antiemetics|mesh-ancestor
6712215|NCT01789242|Autonomic Agents|autonomic agents|mesh-ancestor
6712216|NCT01789242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6712217|NCT01789242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712218|NCT01789242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6712219|NCT01789242|Glucocorticoids|glucocorticoids|mesh-ancestor
6712220|NCT01789242|Hormones|hormones|mesh-ancestor
6712221|NCT01789242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6712222|NCT01789242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6712223|NCT01789242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6712224|NCT01789294|Mesalamine|mesalamine|mesh-list
6712225|NCT01789294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6712226|NCT01789294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6712227|NCT01789294|Analgesics|analgesics|mesh-ancestor
6712228|NCT01789294|Sensory System Agents|sensory system agents|mesh-ancestor
6712229|NCT01789294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6712230|NCT01789294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712231|NCT01789294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6712232|NCT01789294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6712233|NCT01789333|Riboflavin|riboflavin|mesh-list
6712234|NCT01789333|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6712235|NCT01789333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6712236|NCT01789333|Vitamin B Complex|vitamin b complex|mesh-ancestor
6712237|NCT01789333|Vitamins|vitamins|mesh-ancestor
6712238|NCT01789333|Micronutrients|micronutrients|mesh-ancestor
6712239|NCT01789333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712240|NCT01789333|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6712241|NCT01789333|Dermatologic Agents|dermatologic agents|mesh-ancestor
6712242|NCT01789385|Dexmedetomidine|dexmedetomidine|mesh-list
6712243|NCT01789385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6712244|NCT01789385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6712245|NCT01789385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712246|NCT01789385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6712247|NCT01789385|Analgesics|analgesics|mesh-ancestor
6712248|NCT01789385|Sensory System Agents|sensory system agents|mesh-ancestor
6712249|NCT01789385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6712250|NCT01789385|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6712251|NCT01789385|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6712252|NCT01789385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6712253|NCT01789385|Adrenergic Agents|adrenergic agents|mesh-ancestor
6712254|NCT01789385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6712255|NCT01789385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6712256|NCT01789437|Dexamethasone|dexamethasone|mesh-list
6712257|NCT01789437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6712258|NCT01789437|Antiemetics|antiemetics|mesh-ancestor
6712259|NCT01789437|Autonomic Agents|autonomic agents|mesh-ancestor
6712260|NCT01789437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6712261|NCT01789437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712262|NCT01789437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6712263|NCT01789437|Glucocorticoids|glucocorticoids|mesh-ancestor
6712264|NCT01789437|Hormones|hormones|mesh-ancestor
6712265|NCT01789437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6712266|NCT01789437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6712267|NCT01789437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6712268|NCT01789619|Tacrolimus|tacrolimus|mesh-list
6712269|NCT01789619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6712270|NCT01789619|Immunologic Factors|immunologic factors|mesh-ancestor
6712271|NCT01789619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712272|NCT01789619|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6712273|NCT01789619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6712274|NCT01789619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6712275|NCT01789710|Bupropion|bupropion|mesh-list
6712276|NCT01789710|Nicotine|nicotine|mesh-list
6712277|NCT01789710|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6712278|NCT01789710|Autonomic Agents|autonomic agents|mesh-ancestor
6712279|NCT01789710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6712280|NCT01789710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712281|NCT01789710|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6712282|NCT01789710|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6712283|NCT01789710|Cholinergic Agents|cholinergic agents|mesh-ancestor
6712284|NCT01789710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6712285|NCT01789710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6712286|NCT01789710|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6712287|NCT01789710|Antidepressive Agents|antidepressive agents|mesh-ancestor
6712288|NCT01789710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6712289|NCT01789710|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6712290|NCT01789710|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6712291|NCT01789710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6712292|NCT01789710|Dopamine Agents|dopamine agents|mesh-ancestor
6712293|NCT01789710|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6712294|NCT01789710|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6712295|NCT01789710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6712296|NCT01789723|Leucovorin|leucovorin|mesh-list
6712297|NCT01789723|Levoleucovorin|levoleucovorin|mesh-list
6712298|NCT01789723|Antidotes|antidotes|mesh-ancestor
6712299|NCT01789723|Protective Agents|protective agents|mesh-ancestor
6712300|NCT01789723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712301|NCT01789723|Vitamin B Complex|vitamin b complex|mesh-ancestor
6712302|NCT01789723|Vitamins|vitamins|mesh-ancestor
6712303|NCT01789723|Micronutrients|micronutrients|mesh-ancestor
6712304|NCT01789827|Interleukin-2|interleukin-2|mesh-list
6712305|NCT01789827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6712306|NCT01789827|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6712307|NCT01789827|Analgesics|analgesics|mesh-ancestor
6712308|NCT01789827|Sensory System Agents|sensory system agents|mesh-ancestor
6712309|NCT01789827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6712310|NCT01789827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712311|NCT01789879|Efavirenz|efavirenz|mesh-list
6712312|NCT01789879|Nevirapine|nevirapine|mesh-list
6712313|NCT01789879|Levonorgestrel|levonorgestrel|mesh-list
6712314|NCT01789879|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6712315|NCT01789879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6712316|NCT01789879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6712317|NCT01789879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6712318|NCT01789879|Antiviral Agents|antiviral agents|mesh-ancestor
6712319|NCT01789879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6712320|NCT01789879|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6712321|NCT01789879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6712322|NCT01789879|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6712323|NCT01789879|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6712324|NCT01789879|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6712325|NCT01789879|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6712326|NCT01789879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6712327|NCT01789879|Contraceptive Agents|contraceptive agents|mesh-ancestor
6712328|NCT01789879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6712329|NCT01789879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712330|NCT01789879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6712331|NCT01789879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6712332|NCT01789879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6712333|NCT01789879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6712334|NCT01789879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6712335|NCT01789892|Methylprednisolone|methylprednisolone|mesh-list
6712336|NCT01789892|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6712337|NCT01789892|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6712338|NCT01789892|Prednisolone|prednisolone|mesh-list
6712339|NCT01789892|Prednisolone acetate|prednisolone acetate|mesh-list
6712340|NCT01789892|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6712341|NCT01789892|Prednisolone phosphate|prednisolone phosphate|mesh-list
6712342|NCT01789892|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6712343|NCT01789892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6712344|NCT01789892|Antiemetics|antiemetics|mesh-ancestor
6712345|NCT01789892|Autonomic Agents|autonomic agents|mesh-ancestor
6712346|NCT01789892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6712347|NCT01789892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712348|NCT01789892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6712349|NCT01789892|Glucocorticoids|glucocorticoids|mesh-ancestor
6712350|NCT01789892|Hormones|hormones|mesh-ancestor
6712351|NCT01789892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6712352|NCT01789892|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6712353|NCT01789892|Protective Agents|protective agents|mesh-ancestor
6712354|NCT01789892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6712355|NCT01789892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6712356|NCT01789892|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6712357|NCT01789892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6712358|NCT01789957|Exenatide|exenatide|mesh-list
6712359|NCT01789957|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6712360|NCT01789957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712361|NCT01789957|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6712362|NCT01789957|Incretins|incretins|mesh-ancestor
6712363|NCT01789957|Hormones|hormones|mesh-ancestor
6712364|NCT01789957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6712365|NCT01790009|Acetaminophen|acetaminophen|mesh-list
6712366|NCT01790009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6712367|NCT01790009|Analgesics|analgesics|mesh-ancestor
6712368|NCT01790009|Sensory System Agents|sensory system agents|mesh-ancestor
6712369|NCT01790009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6712370|NCT01790009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712371|NCT01790009|Antipyretics|antipyretics|mesh-ancestor
6712372|NCT01790022|Methylprednisolone|methylprednisolone|mesh-list
6712373|NCT01790022|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6712374|NCT01790022|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6712375|NCT01790022|Prednisolone|prednisolone|mesh-list
6712376|NCT01790022|Prednisolone acetate|prednisolone acetate|mesh-list
6712377|NCT01790022|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6712378|NCT01790022|Prednisolone phosphate|prednisolone phosphate|mesh-list
6712379|NCT01790022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6712380|NCT01790022|Antiemetics|antiemetics|mesh-ancestor
6712381|NCT01790022|Autonomic Agents|autonomic agents|mesh-ancestor
6712382|NCT01790022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6712383|NCT01790022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712384|NCT01790022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6712385|NCT01790022|Glucocorticoids|glucocorticoids|mesh-ancestor
6712386|NCT01790022|Hormones|hormones|mesh-ancestor
6712387|NCT01790022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6712388|NCT01790022|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6712389|NCT01790022|Protective Agents|protective agents|mesh-ancestor
6712390|NCT01790022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6712391|NCT01790022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6712392|NCT01790087|Moxifloxacin|moxifloxacin|mesh-list
6712393|NCT01790087|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6712394|NCT01790087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6712395|NCT01790087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6712396|NCT01790087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6712397|NCT01790087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6712398|NCT01790087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6712399|NCT01790087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6712400|NCT01790139|Simethicone|simethicone|mesh-list
6712401|NCT01790139|Antifoaming Agents|antifoaming agents|mesh-ancestor
6712402|NCT01790139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6712403|NCT01790139|Emollients|emollients|mesh-ancestor
6712404|NCT01790139|Dermatologic Agents|dermatologic agents|mesh-ancestor
6712405|NCT01790165|Terbinafine|terbinafine|mesh-list
6712406|NCT01790165|Antifungal Agents|antifungal agents|mesh-ancestor
6712407|NCT01790165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6712408|NCT01790165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6712409|NCT01790165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6712410|NCT01790282|Estradiol|estradiol|mesh-list
6712411|NCT01790282|Progesterone|progesterone|mesh-list
6712412|NCT01790282|Estrogens|estrogens|mesh-ancestor
6712413|NCT01790282|Hormones|hormones|mesh-ancestor
6712414|NCT01790282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6712415|NCT01790282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712416|NCT01790282|Progestins|progestins|mesh-ancestor
6712417|NCT01790308|Liraglutide|liraglutide|mesh-list
6712418|NCT01790308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6712419|NCT01790308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712420|NCT01790308|Incretins|incretins|mesh-ancestor
6712421|NCT01790308|Hormones|hormones|mesh-ancestor
6712422|NCT01790308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6712423|NCT01790464|Lidocaine|lidocaine|mesh-list
6712424|NCT01790464|Anesthetics, Local|anesthetics, local|mesh-ancestor
6712425|NCT01790464|Anesthetics|anesthetics|mesh-ancestor
6712426|NCT01790464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6712427|NCT01790464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712428|NCT01790464|Sensory System Agents|sensory system agents|mesh-ancestor
6712429|NCT01790464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6712430|NCT01790464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6712431|NCT01790464|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6712432|NCT01790464|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6712433|NCT01790464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6712434|NCT01790464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6712435|NCT01790529|Metronidazole|metronidazole|mesh-list
6712436|NCT01790529|Cefuroxime|cefuroxime|mesh-list
6712437|NCT01790529|Cefuroxime axetil|cefuroxime axetil|mesh-list
6712438|NCT01790529|Anesthetics|anesthetics|mesh-list
6712439|NCT01790529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6712440|NCT01790529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712441|NCT01790529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6712442|NCT01790529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6712443|NCT01790529|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6712444|NCT01790529|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6712445|NCT01790542|Iron|iron|mesh-list
6712446|NCT01790542|Trace Elements|trace elements|mesh-ancestor
6712447|NCT01790542|Micronutrients|micronutrients|mesh-ancestor
6712448|NCT01790542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712449|NCT01790555|Diazepam|diazepam|mesh-list
6712450|NCT01790555|Dronabinol|dronabinol|mesh-list
6712451|NCT01790555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6712452|NCT01790555|Anticonvulsants|anticonvulsants|mesh-ancestor
6712453|NCT01790555|Antiemetics|antiemetics|mesh-ancestor
6712454|NCT01790555|Autonomic Agents|autonomic agents|mesh-ancestor
6712455|NCT01790555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6712456|NCT01790555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712457|NCT01790555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6712458|NCT01790555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6712459|NCT01790555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6712460|NCT01790555|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6712461|NCT01790555|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6712462|NCT01790555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6712463|NCT01790555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6712464|NCT01790555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6712465|NCT01790555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6712466|NCT01790555|Anesthetics, General|anesthetics, general|mesh-ancestor
6712467|NCT01790555|Anesthetics|anesthetics|mesh-ancestor
6712468|NCT01790555|GABA Modulators|gaba modulators|mesh-ancestor
6712469|NCT01790555|GABA Agents|gaba agents|mesh-ancestor
6712470|NCT01790555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6712471|NCT01790555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6712472|NCT01790555|Hallucinogens|hallucinogens|mesh-ancestor
6712473|NCT01790555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6712474|NCT01790555|Analgesics|analgesics|mesh-ancestor
6712475|NCT01790555|Sensory System Agents|sensory system agents|mesh-ancestor
6712476|NCT01790555|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6712477|NCT01790555|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6712478|NCT01790555|Hormones|hormones|mesh-ancestor
6712479|NCT01790555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6712480|NCT01790672|Ethanol|ethanol|mesh-list
6712481|NCT01790672|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6712482|NCT01790672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6712483|NCT01790672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6712484|NCT01790672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712485|NCT01790737|Cyclophosphamide|cyclophosphamide|mesh-list
6712486|NCT01790737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6712487|NCT01790737|Immunologic Factors|immunologic factors|mesh-ancestor
6712488|NCT01790737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712489|NCT01790737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6712490|NCT01790737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6712491|NCT01790737|Alkylating Agents|alkylating agents|mesh-ancestor
6712492|NCT01790737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6712493|NCT01790737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6712494|NCT01790737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6712495|NCT01790854|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6712496|NCT01790854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6712497|NCT01790893|Aflibercept|aflibercept|mesh-list
6712498|NCT01790893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6712499|NCT01790893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6712500|NCT01790893|Growth Substances|growth substances|mesh-ancestor
6712501|NCT01790893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712502|NCT01790893|Growth Inhibitors|growth inhibitors|mesh-ancestor
6712503|NCT01790893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6782979|NCT02194166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6782980|NCT02194179|Nevirapine|nevirapine|mesh-list
6782981|NCT02194179|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6782982|NCT02194179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6782983|NCT02194179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6782984|NCT02194179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6782985|NCT02194179|Antiviral Agents|antiviral agents|mesh-ancestor
6782986|NCT02194179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6782987|NCT02194179|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6782988|NCT02194179|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6782989|NCT02194179|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6782990|NCT02194179|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6782991|NCT02194192|Ephedrine|ephedrine|mesh-list
6782992|NCT02194192|Ondansetron|ondansetron|mesh-list
6782993|NCT02194192|Antiemetics|antiemetics|mesh-ancestor
6782994|NCT02194192|Autonomic Agents|autonomic agents|mesh-ancestor
6782995|NCT02194192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6782996|NCT02194192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6782997|NCT02194192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6782998|NCT02194192|Antipruritics|antipruritics|mesh-ancestor
6782999|NCT02194192|Dermatologic Agents|dermatologic agents|mesh-ancestor
6783000|NCT02194192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6783001|NCT02194192|Serotonin Agents|serotonin agents|mesh-ancestor
6783002|NCT02194192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6783003|NCT02194192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783004|NCT02194192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6783005|NCT02194192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6783006|NCT02194192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6783007|NCT02194192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6783008|NCT02194192|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6783009|NCT02194192|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6783010|NCT02194192|Sympathomimetics|sympathomimetics|mesh-ancestor
6783011|NCT02194192|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6783012|NCT02194192|Adrenergic Agents|adrenergic agents|mesh-ancestor
6783013|NCT02194218|Nevirapine|nevirapine|mesh-list
6783014|NCT02194218|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6783015|NCT02194218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6783016|NCT02194218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6783017|NCT02194218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783018|NCT02194218|Antiviral Agents|antiviral agents|mesh-ancestor
6783019|NCT02194218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6783020|NCT02194218|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6783021|NCT02194218|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6783022|NCT02194218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6783023|NCT02194218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6783024|NCT02194231|Trabectedin|trabectedin|mesh-list
6783025|NCT02194231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6783026|NCT02194231|Alkylating Agents|alkylating agents|mesh-ancestor
6783027|NCT02194231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783028|NCT02194231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6783029|NCT02194257|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6783030|NCT02194257|Ambroxol|ambroxol|mesh-list
6783031|NCT02194257|Expectorants|expectorants|mesh-ancestor
6783032|NCT02194257|Respiratory System Agents|respiratory system agents|mesh-ancestor
6783033|NCT02194270|Ambroxol|ambroxol|mesh-list
6783034|NCT02194270|Expectorants|expectorants|mesh-ancestor
6783035|NCT02194270|Respiratory System Agents|respiratory system agents|mesh-ancestor
6783036|NCT02194283|Ambroxol|ambroxol|mesh-list
6783037|NCT02194283|Expectorants|expectorants|mesh-ancestor
6783038|NCT02194283|Respiratory System Agents|respiratory system agents|mesh-ancestor
6783039|NCT02194296|Ambroxol|ambroxol|mesh-list
6783040|NCT02194296|Expectorants|expectorants|mesh-ancestor
6783041|NCT02194296|Respiratory System Agents|respiratory system agents|mesh-ancestor
6712504|NCT01790971|Morphine|morphine|mesh-list
6712505|NCT01790971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6712506|NCT01790971|Narcotics|narcotics|mesh-ancestor
6712507|NCT01790971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6712508|NCT01790971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712509|NCT01790971|Analgesics|analgesics|mesh-ancestor
6712510|NCT01790971|Sensory System Agents|sensory system agents|mesh-ancestor
6712511|NCT01790971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6712512|NCT01790997|Aspirin|aspirin|mesh-list
6712513|NCT01790997|Clopidogrel|clopidogrel|mesh-list
6712514|NCT01790997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6712515|NCT01790997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6712516|NCT01790997|Analgesics|analgesics|mesh-ancestor
6712517|NCT01790997|Sensory System Agents|sensory system agents|mesh-ancestor
6712518|NCT01790997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6712519|NCT01790997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712520|NCT01790997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6712521|NCT01790997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6712522|NCT01790997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6712523|NCT01790997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6712524|NCT01790997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6712525|NCT01790997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6712526|NCT01790997|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6712527|NCT01790997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6712528|NCT01790997|Antipyretics|antipyretics|mesh-ancestor
6712529|NCT01790997|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6712530|NCT01790997|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6712531|NCT01790997|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6712532|NCT01790997|Purinergic Agents|purinergic agents|mesh-ancestor
6712533|NCT01790997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6712534|NCT01791088|Sirolimus|sirolimus|mesh-list
6712535|NCT01791088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6712536|NCT01791088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6712537|NCT01791088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6712538|NCT01791088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6712539|NCT01791088|Antifungal Agents|antifungal agents|mesh-ancestor
6712540|NCT01791088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6712541|NCT01791088|Immunologic Factors|immunologic factors|mesh-ancestor
6712542|NCT01791088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712543|NCT01791114|Propranolol|propranolol|mesh-list
6712544|NCT01791114|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6712545|NCT01791114|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6712546|NCT01791114|Adrenergic Agents|adrenergic agents|mesh-ancestor
6712547|NCT01791114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6712548|NCT01791114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6712549|NCT01791114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712550|NCT01791114|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6712551|NCT01791114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6712552|NCT01791114|Vasodilator Agents|vasodilator agents|mesh-ancestor
6712553|NCT01791166|Antibodies|antibodies|mesh-list
6712554|NCT01791166|Immunologic Factors|immunologic factors|mesh-ancestor
6712555|NCT01791166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712556|NCT01791192|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6712557|NCT01791192|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6712558|NCT01791192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6712559|NCT01791192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6712560|NCT01791192|Immunologic Factors|immunologic factors|mesh-ancestor
6712561|NCT01791192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712562|NCT01791231|Canagliflozin|canagliflozin|mesh-list
6712563|NCT01791231|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6712564|NCT01791231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6712565|NCT01791231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6712566|NCT01791231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712567|NCT01791296|Dexmedetomidine|dexmedetomidine|mesh-list
6712568|NCT01791296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6712569|NCT01791296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6712570|NCT01791296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712571|NCT01791296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6712572|NCT01791296|Analgesics|analgesics|mesh-ancestor
6712573|NCT01791296|Sensory System Agents|sensory system agents|mesh-ancestor
6712574|NCT01791296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6712575|NCT01791296|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6712576|NCT01791296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6712577|NCT01791296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6712578|NCT01791296|Adrenergic Agents|adrenergic agents|mesh-ancestor
6712579|NCT01791296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6712580|NCT01791296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6712581|NCT01791309|Panitumumab|panitumumab|mesh-list
6712582|NCT01791309|Vemurafenib|vemurafenib|mesh-list
6712583|NCT01791309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6712584|NCT01791309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6712585|NCT01791309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6712586|NCT01791309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6712587|NCT01791309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6712588|NCT01791374|Rilotumumab|rilotumumab|mesh-list
6712589|NCT01791374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6712590|NCT01791374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6712591|NCT01791374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6712592|NCT01791374|Immunologic Factors|immunologic factors|mesh-ancestor
6712593|NCT01791374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712594|NCT01791400|Sumatriptan|sumatriptan|mesh-list
6712595|NCT01791400|Metoclopramide|metoclopramide|mesh-list
6712596|NCT01791400|Antiemetics|antiemetics|mesh-ancestor
6712597|NCT01791400|Autonomic Agents|autonomic agents|mesh-ancestor
6712598|NCT01791400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6712599|NCT01791400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712600|NCT01791400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6712601|NCT01791400|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6712602|NCT01791400|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6712603|NCT01791400|Dopamine Agents|dopamine agents|mesh-ancestor
6712604|NCT01791400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6712605|NCT01791400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6712606|NCT01791400|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6712607|NCT01791400|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6712608|NCT01791400|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6712609|NCT01791400|Serotonin Agents|serotonin agents|mesh-ancestor
6712610|NCT01791439|Lidocaine|lidocaine|mesh-list
6712611|NCT01791439|Anesthetics, Local|anesthetics, local|mesh-ancestor
6712612|NCT01791439|Anesthetics|anesthetics|mesh-ancestor
6712613|NCT01791439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6712614|NCT01791439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712615|NCT01791439|Sensory System Agents|sensory system agents|mesh-ancestor
6712616|NCT01791439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6712617|NCT01791439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6712618|NCT01791439|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6712619|NCT01791439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6712620|NCT01791439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6712621|NCT01791439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6712622|NCT01791478|Letrozole|letrozole|mesh-list
6712623|NCT01791478|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
6712624|NCT01791478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6712625|NCT01791478|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6712626|NCT01791478|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6712627|NCT01791478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6712628|NCT01791478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6712629|NCT01791478|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6712630|NCT01791478|Hormone Antagonists|hormone antagonists|mesh-ancestor
6712631|NCT01791478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6712632|NCT01791478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712633|NCT01791608|Zinc|zinc|mesh-list
6712634|NCT01791608|Zinc Sulfate|zinc sulfate|mesh-list
6712635|NCT01791608|Trace Elements|trace elements|mesh-ancestor
6712636|NCT01791608|Micronutrients|micronutrients|mesh-ancestor
6712637|NCT01791608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712638|NCT01791608|Astringents|astringents|mesh-ancestor
6712639|NCT01791608|Dermatologic Agents|dermatologic agents|mesh-ancestor
6712640|NCT01791647|Inositol|inositol|mesh-list
6712641|NCT01791647|Metformin|metformin|mesh-list
6712642|NCT01791647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6712643|NCT01791647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712644|NCT01791647|Vitamin B Complex|vitamin b complex|mesh-ancestor
6712645|NCT01791647|Vitamins|vitamins|mesh-ancestor
6712646|NCT01791647|Micronutrients|micronutrients|mesh-ancestor
6712647|NCT01791699|Moxonidine|moxonidine|mesh-list
6712648|NCT01791699|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6712649|NCT01791751|Clomiphene|clomiphene|mesh-list
6712650|NCT01791751|Enclomiphene|enclomiphene|mesh-list
6712651|NCT01791751|Zuclomiphene|zuclomiphene|mesh-list
6712652|NCT01791751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6712653|NCT01791751|Hormone Antagonists|hormone antagonists|mesh-ancestor
6712654|NCT01791751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6712655|NCT01791751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712656|NCT01791751|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6712657|NCT01791751|Fertility Agents|fertility agents|mesh-ancestor
6712658|NCT01791751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6712659|NCT01791751|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6712660|NCT01791751|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6712661|NCT01791816|Phenylephrine|phenylephrine|mesh-list
6712662|NCT01791816|Oxymetazoline|oxymetazoline|mesh-list
6712663|NCT01791816|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
6712664|NCT01791816|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6712665|NCT01791816|Mydriatics|mydriatics|mesh-ancestor
6712666|NCT01791816|Autonomic Agents|autonomic agents|mesh-ancestor
6712667|NCT01791816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6712668|NCT01791816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712669|NCT01791816|Sympathomimetics|sympathomimetics|mesh-ancestor
6712670|NCT01791816|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6712671|NCT01791816|Nasal Decongestants|nasal decongestants|mesh-ancestor
6712672|NCT01791816|Respiratory System Agents|respiratory system agents|mesh-ancestor
6712673|NCT01791816|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6712674|NCT01791816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6712675|NCT01791816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6712676|NCT01791816|Adrenergic Agents|adrenergic agents|mesh-ancestor
6712677|NCT01791816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6712678|NCT01791816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6712679|NCT01791816|Protective Agents|protective agents|mesh-ancestor
6712680|NCT01791816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6712681|NCT01791868|Valproic Acid|valproic acid|mesh-list
6712682|NCT01791868|Anticonvulsants|anticonvulsants|mesh-ancestor
6712683|NCT01791868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6712684|NCT01791868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6712685|NCT01791868|GABA Agents|gaba agents|mesh-ancestor
6712686|NCT01791868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6712687|NCT01791868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712688|NCT01791868|Antimanic Agents|antimanic agents|mesh-ancestor
6712689|NCT01791868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6712690|NCT01791868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6712691|NCT01791868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6712692|NCT01791881|Botulinum Toxins|botulinum toxins|mesh-list
6712693|NCT01791881|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6712694|NCT01791881|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6712695|NCT01791881|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6712696|NCT01791881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6712697|NCT01791881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6712698|NCT01791881|Cholinergic Agents|cholinergic agents|mesh-ancestor
6712699|NCT01791881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6712700|NCT01791881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712701|NCT01791881|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6712702|NCT01791881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6712703|NCT01791920|Botulinum Toxins|botulinum toxins|mesh-list
6712704|NCT01791920|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6712705|NCT01791920|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6712706|NCT01791920|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6712707|NCT01791920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6712708|NCT01791920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6712709|NCT01791920|Cholinergic Agents|cholinergic agents|mesh-ancestor
6712710|NCT01791920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6712711|NCT01791920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712712|NCT01791920|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6712713|NCT01791920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6712714|NCT01791985|Letrozole|letrozole|mesh-list
6712715|NCT01791985|Anastrozole|anastrozole|mesh-list
6712716|NCT01791985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6712717|NCT01791985|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6712718|NCT01791985|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6712719|NCT01791985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6712720|NCT01791985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6712721|NCT01791985|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6712722|NCT01791985|Hormone Antagonists|hormone antagonists|mesh-ancestor
6712723|NCT01791985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6712724|NCT01791985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712725|NCT01791985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6712726|NCT01792037|Methylprednisolone|methylprednisolone|mesh-list
6712727|NCT01792037|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6712728|NCT01792037|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6712729|NCT01792037|Prednisolone|prednisolone|mesh-list
6712730|NCT01792037|Prednisolone acetate|prednisolone acetate|mesh-list
6712731|NCT01792037|Midazolam|midazolam|mesh-list
6712732|NCT01792037|Etomidate|etomidate|mesh-list
6712733|NCT01792037|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6712734|NCT01792037|Prednisolone phosphate|prednisolone phosphate|mesh-list
6712735|NCT01792037|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6712736|NCT01792037|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6712737|NCT01792037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6712738|NCT01792037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712739|NCT01792037|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6712740|NCT01792037|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6712741|NCT01792037|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6712742|NCT01792037|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6712743|NCT01792037|Anesthetics, General|anesthetics, general|mesh-ancestor
6712744|NCT01792037|Anesthetics|anesthetics|mesh-ancestor
6712745|NCT01792037|GABA Modulators|gaba modulators|mesh-ancestor
6712746|NCT01792037|GABA Agents|gaba agents|mesh-ancestor
6712747|NCT01792037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6712748|NCT01792037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6712749|NCT01792037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6712750|NCT01792037|Antiemetics|antiemetics|mesh-ancestor
6712751|NCT01792037|Autonomic Agents|autonomic agents|mesh-ancestor
6712752|NCT01792037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6712753|NCT01792037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6712754|NCT01792037|Glucocorticoids|glucocorticoids|mesh-ancestor
6712755|NCT01792037|Hormones|hormones|mesh-ancestor
6712756|NCT01792037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6712757|NCT01792037|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6712758|NCT01792037|Protective Agents|protective agents|mesh-ancestor
6712759|NCT01792037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6712760|NCT01792037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6712761|NCT01792063|Sevoflurane|sevoflurane|mesh-list
6712762|NCT01792063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6712763|NCT01792063|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6712764|NCT01792063|Anesthetics, General|anesthetics, general|mesh-ancestor
6712765|NCT01792063|Anesthetics|anesthetics|mesh-ancestor
6712766|NCT01792063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6712767|NCT01792063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712768|NCT01792102|Dexamethasone|dexamethasone|mesh-list
6712769|NCT01792102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6712770|NCT01792102|Antiemetics|antiemetics|mesh-ancestor
6712771|NCT01792102|Autonomic Agents|autonomic agents|mesh-ancestor
6712772|NCT01792102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6712773|NCT01792102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712774|NCT01792102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6712775|NCT01792102|Glucocorticoids|glucocorticoids|mesh-ancestor
6712776|NCT01792102|Hormones|hormones|mesh-ancestor
6712777|NCT01792102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6712778|NCT01792102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6712779|NCT01792102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6712780|NCT01792323|Insulin Lispro|insulin lispro|mesh-list
6712781|NCT01792323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6712782|NCT01792323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712783|NCT01792375|Dinoprostone|dinoprostone|mesh-list
6712784|NCT01792375|Oxytocics|oxytocics|mesh-ancestor
6712785|NCT01792375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6712786|NCT01792375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712787|NCT01792388|Vitamin D|vitamin d|mesh-list
6712788|NCT01792388|Vitamins|vitamins|mesh-ancestor
6712789|NCT01792388|Micronutrients|micronutrients|mesh-ancestor
6712790|NCT01792388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712791|NCT01792388|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6712792|NCT01792505|Imiquimod|imiquimod|mesh-list
6712793|NCT01792505|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6712794|NCT01792505|Immunologic Factors|immunologic factors|mesh-ancestor
6712795|NCT01792505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712796|NCT01792505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6712797|NCT01792505|Interferon Inducers|interferon inducers|mesh-ancestor
6783042|NCT02194309|Amlodipine|amlodipine|mesh-list
6783043|NCT02194309|Telmisartan|telmisartan|mesh-list
6783044|NCT02194309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6783045|NCT02194309|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6783046|NCT02194309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6783047|NCT02194309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783048|NCT02194309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6783049|NCT02194309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783050|NCT02194309|Vasodilator Agents|vasodilator agents|mesh-ancestor
6783051|NCT02194309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6783052|NCT02194309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6783053|NCT02194374|Vidarabine|vidarabine|mesh-list
6783054|NCT02194374|Cyclophosphamide|cyclophosphamide|mesh-list
6783055|NCT02194374|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6783056|NCT02194374|Rituximab|rituximab|mesh-list
6783057|NCT02194374|Fludarabine|fludarabine|mesh-list
6783058|NCT02194374|Fludarabine phosphate|fludarabine phosphate|mesh-list
6783059|NCT02194374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6783060|NCT02194374|Immunologic Factors|immunologic factors|mesh-ancestor
6783061|NCT02194374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783062|NCT02194374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6783063|NCT02194374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6783064|NCT02194374|Alkylating Agents|alkylating agents|mesh-ancestor
6783065|NCT02194374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783066|NCT02194374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6783067|NCT02194374|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6783068|NCT02194374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6783069|NCT02194374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6783070|NCT02194374|Antimetabolites|antimetabolites|mesh-ancestor
6783071|NCT02194374|Antiviral Agents|antiviral agents|mesh-ancestor
6783072|NCT02194374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6783073|NCT02194452|Octreotide|octreotide|mesh-list
6783074|NCT02194452|Edotreotide|edotreotide|mesh-list
6783075|NCT02194452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6783076|NCT02194452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6783077|NCT02194452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6783078|NCT02194452|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6783079|NCT02194452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783080|NCT02194491|AS2471907|as2471907|mesh-list
6783081|NCT02194491|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6783082|NCT02194491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783083|NCT02194556|Gemcitabine|gemcitabine|mesh-list
6783084|NCT02194556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6783085|NCT02194556|Antimetabolites|antimetabolites|mesh-ancestor
6783086|NCT02194556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783087|NCT02194556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6783088|NCT02194556|Antiviral Agents|antiviral agents|mesh-ancestor
6783089|NCT02194556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6783090|NCT02194556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6783091|NCT02194556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6783092|NCT02194556|Immunologic Factors|immunologic factors|mesh-ancestor
6783093|NCT02194556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783094|NCT02194595|Insulin|insulin|mesh-list
6783095|NCT02194595|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6783096|NCT02194595|Insulin Glargine|insulin glargine|mesh-list
6783097|NCT02194595|Exenatide|exenatide|mesh-list
6783098|NCT02194595|Insulin Lispro|insulin lispro|mesh-list
6783099|NCT02194595|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6712798|NCT01792557|Phenol|phenol|mesh-list
6712799|NCT01792557|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6712800|NCT01792557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6712801|NCT01792557|Disinfectants|disinfectants|mesh-ancestor
6712802|NCT01792557|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
6712803|NCT01792557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6712804|NCT01792570|Darunavir|darunavir|mesh-list
6712805|NCT01792570|Rilpivirine|rilpivirine|mesh-list
6712806|NCT01792570|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6712807|NCT01792570|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6712808|NCT01792570|Protease Inhibitors|protease inhibitors|mesh-ancestor
6712809|NCT01792570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6712810|NCT01792570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6712811|NCT01792570|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6712812|NCT01792570|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6712813|NCT01792570|Antiviral Agents|antiviral agents|mesh-ancestor
6712814|NCT01792570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6712815|NCT01792570|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6712816|NCT01792570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6712817|NCT01792700|Amoxicillin|amoxicillin|mesh-list
6712818|NCT01792700|Moxifloxacin|moxifloxacin|mesh-list
6712819|NCT01792700|Metronidazole|metronidazole|mesh-list
6712820|NCT01792700|Tetracycline|tetracycline|mesh-list
6712821|NCT01792700|Esomeprazole|esomeprazole|mesh-list
6712822|NCT01792700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6712823|NCT01792700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6712824|NCT01792700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6712825|NCT01792700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6712826|NCT01792700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6712827|NCT01792700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6712828|NCT01792700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6712829|NCT01792700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6712830|NCT01792700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6712831|NCT01792700|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6712832|NCT01792700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6712833|NCT01792700|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6712834|NCT01792700|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6712835|NCT01792713|Sertaconazole|sertaconazole|mesh-list
6712836|NCT01792713|Antifungal Agents|antifungal agents|mesh-ancestor
6712837|NCT01792713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6712838|NCT01792804|Vancomycin|vancomycin|mesh-list
6712839|NCT01792804|Clindamycin|clindamycin|mesh-list
6712840|NCT01792804|Cefazolin|cefazolin|mesh-list
6712841|NCT01792804|Linezolid|linezolid|mesh-list
6712842|NCT01792804|Daptomycin|daptomycin|mesh-list
6712843|NCT01792804|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6712844|NCT01792804|Floxacillin|floxacillin|mesh-list
6712845|NCT01792804|Cloxacillin|cloxacillin|mesh-list
6712846|NCT01792804|Trimethoprim|trimethoprim|mesh-list
6712847|NCT01792804|Sulfamethoxazole|sulfamethoxazole|mesh-list
6712848|NCT01792804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6712849|NCT01792804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6712850|NCT01792804|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6712851|NCT01792804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6712852|NCT01792804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6712853|NCT01792804|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6712854|NCT01792804|Renal Agents|renal agents|mesh-ancestor
6712855|NCT01792804|Antimalarials|antimalarials|mesh-ancestor
6712856|NCT01792804|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6712857|NCT01792804|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6712858|NCT01792804|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6712859|NCT01792804|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6712860|NCT01792804|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6712861|NCT01792804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6712862|NCT01792934|Bevacizumab|bevacizumab|mesh-list
6712863|NCT01792934|Irinotecan|irinotecan|mesh-list
6712864|NCT01792934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6712865|NCT01792934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6712866|NCT01792934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6712867|NCT01792934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6712868|NCT01792934|Growth Substances|growth substances|mesh-ancestor
6712869|NCT01792934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712870|NCT01792934|Growth Inhibitors|growth inhibitors|mesh-ancestor
6712871|NCT01792934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6712872|NCT01792934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6712873|NCT01792934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6712874|NCT01792934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6712875|NCT01793038|Clomiphene|clomiphene|mesh-list
6712876|NCT01793038|Enclomiphene|enclomiphene|mesh-list
6712877|NCT01793038|Zuclomiphene|zuclomiphene|mesh-list
6712878|NCT01793038|Aromatase Inhibitors|aromatase inhibitors|mesh-list
6712879|NCT01793038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6712880|NCT01793038|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6712881|NCT01793038|Hormone Antagonists|hormone antagonists|mesh-ancestor
6712882|NCT01793038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6712883|NCT01793038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712884|NCT01793038|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6712885|NCT01793038|Fertility Agents|fertility agents|mesh-ancestor
6712886|NCT01793038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6712887|NCT01793038|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6712888|NCT01793038|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6712889|NCT01793038|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6712890|NCT01793038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6712891|NCT01793077|Leuprolide|leuprolide|mesh-list
6712892|NCT01793077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6712893|NCT01793077|Fertility Agents|fertility agents|mesh-ancestor
6712894|NCT01793077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6712895|NCT01793077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712896|NCT01793077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6712897|NCT01793077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6712898|NCT01793259|Methotrexate|methotrexate|mesh-list
6712899|NCT01793259|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6712900|NCT01793259|Abortifacient Agents|abortifacient agents|mesh-ancestor
6712901|NCT01793259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6712902|NCT01793259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712903|NCT01793259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6712904|NCT01793259|Antimetabolites|antimetabolites|mesh-ancestor
6712905|NCT01793259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6712906|NCT01793259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6712907|NCT01793259|Dermatologic Agents|dermatologic agents|mesh-ancestor
6712908|NCT01793259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6712909|NCT01793259|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6712910|NCT01793259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6712911|NCT01793259|Immunologic Factors|immunologic factors|mesh-ancestor
6712912|NCT01793259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6712913|NCT01793259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6712914|NCT01793272|Pentoxifylline|pentoxifylline|mesh-list
6712915|NCT01793272|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6712916|NCT01793272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6712917|NCT01793272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6712918|NCT01793272|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6712919|NCT01793272|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6712920|NCT01793272|Protective Agents|protective agents|mesh-ancestor
6712921|NCT01793272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712922|NCT01793272|Vasodilator Agents|vasodilator agents|mesh-ancestor
6712923|NCT01793272|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6712924|NCT01793272|Antioxidants|antioxidants|mesh-ancestor
6712925|NCT01793350|Benphothiamine|benphothiamine|mesh-list
6712926|NCT01793350|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6712927|NCT01793350|Immunologic Factors|immunologic factors|mesh-ancestor
6712928|NCT01793350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712929|NCT01793350|Chelating Agents|chelating agents|mesh-ancestor
6712930|NCT01793350|Sequestering Agents|sequestering agents|mesh-ancestor
6712931|NCT01793350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6712932|NCT01793480|Methadone|methadone|mesh-list
6712933|NCT01793480|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6712934|NCT01793480|Narcotics|narcotics|mesh-ancestor
6712935|NCT01793480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6712936|NCT01793480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712937|NCT01793480|Analgesics|analgesics|mesh-ancestor
6712938|NCT01793480|Sensory System Agents|sensory system agents|mesh-ancestor
6712939|NCT01793480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6712940|NCT01793480|Antitussive Agents|antitussive agents|mesh-ancestor
6712941|NCT01793480|Respiratory System Agents|respiratory system agents|mesh-ancestor
6712942|NCT01793519|Adalimumab|adalimumab|mesh-list
6712943|NCT01793519|Etanercept|etanercept|mesh-list
6712944|NCT01793519|Infliximab|infliximab|mesh-list
6712945|NCT01793519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6712946|NCT01793519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6712947|NCT01793519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6712948|NCT01793519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6712949|NCT01793519|Analgesics|analgesics|mesh-ancestor
6712950|NCT01793519|Sensory System Agents|sensory system agents|mesh-ancestor
6712951|NCT01793519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6712952|NCT01793519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712953|NCT01793519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6712954|NCT01793519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6712955|NCT01793519|Immunologic Factors|immunologic factors|mesh-ancestor
6712956|NCT01793519|Dermatologic Agents|dermatologic agents|mesh-ancestor
6712957|NCT01793636|Everolimus|everolimus|mesh-list
6712958|NCT01793636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6712959|NCT01793636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6712960|NCT01793636|Immunologic Factors|immunologic factors|mesh-ancestor
6712961|NCT01793636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712962|NCT01793753|Propofol|propofol|mesh-list
6712963|NCT01793753|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6712964|NCT01793753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6712965|NCT01793753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712966|NCT01793753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6712967|NCT01793753|Anesthetics, General|anesthetics, general|mesh-ancestor
6712968|NCT01793753|Anesthetics|anesthetics|mesh-ancestor
6712969|NCT01793870|Carvedilol|carvedilol|mesh-list
6712970|NCT01793870|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6712971|NCT01793870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6712972|NCT01793870|Adrenergic Agents|adrenergic agents|mesh-ancestor
6712973|NCT01793870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6712974|NCT01793870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6712975|NCT01793870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712976|NCT01793870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6712977|NCT01793870|Antioxidants|antioxidants|mesh-ancestor
6712978|NCT01793870|Protective Agents|protective agents|mesh-ancestor
6712979|NCT01793870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6712980|NCT01793870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6712981|NCT01793870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6712982|NCT01793870|Vasodilator Agents|vasodilator agents|mesh-ancestor
6712983|NCT01793870|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6712984|NCT01793870|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6712985|NCT01793948|Metformin|metformin|mesh-list
6712986|NCT01793948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6712987|NCT01793948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712988|NCT01794078|Ambrisentan|ambrisentan|mesh-list
6712989|NCT01794078|Aminophylline|aminophylline|mesh-list
6712990|NCT01794078|Theophylline|theophylline|mesh-list
6712991|NCT01794078|Ethylene|ethylene|mesh-list
6712992|NCT01794078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6712993|NCT01794078|Autonomic Agents|autonomic agents|mesh-ancestor
6712994|NCT01794078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6712995|NCT01794078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6712996|NCT01794078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6712997|NCT01794078|Respiratory System Agents|respiratory system agents|mesh-ancestor
6712998|NCT01794078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6712999|NCT01794078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6713000|NCT01794078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713001|NCT01794078|Vasodilator Agents|vasodilator agents|mesh-ancestor
6713002|NCT01794078|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6713003|NCT01794078|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6713004|NCT01794078|Purinergic Agents|purinergic agents|mesh-ancestor
6713005|NCT01794078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6713006|NCT01794078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6713007|NCT01794078|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6713008|NCT01794078|Protective Agents|protective agents|mesh-ancestor
6713009|NCT01794078|Plant Growth Regulators|plant growth regulators|mesh-ancestor
6713010|NCT01794078|Growth Substances|growth substances|mesh-ancestor
6713011|NCT01794091|Eplerenone|eplerenone|mesh-list
6713012|NCT01794091|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6713013|NCT01794091|Hormone Antagonists|hormone antagonists|mesh-ancestor
6713014|NCT01794091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6713015|NCT01794091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713016|NCT01794091|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6713017|NCT01794091|Diuretics|diuretics|mesh-ancestor
6713018|NCT01794091|Natriuretic Agents|natriuretic agents|mesh-ancestor
6713019|NCT01794091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6783100|NCT02194595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783101|NCT02194595|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6783102|NCT02194595|Incretins|incretins|mesh-ancestor
6783103|NCT02194595|Hormones|hormones|mesh-ancestor
6783104|NCT02194595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6783105|NCT02194686|Cilostazol|cilostazol|mesh-list
6783106|NCT02194686|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6783107|NCT02194686|Autonomic Agents|autonomic agents|mesh-ancestor
6783108|NCT02194686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6783109|NCT02194686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783110|NCT02194686|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6783111|NCT02194686|Respiratory System Agents|respiratory system agents|mesh-ancestor
6783112|NCT02194686|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6783113|NCT02194686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6783114|NCT02194686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783115|NCT02194686|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6783116|NCT02194686|Vasodilator Agents|vasodilator agents|mesh-ancestor
6783117|NCT02194686|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6783118|NCT02194686|Protective Agents|protective agents|mesh-ancestor
6783119|NCT02194686|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6783120|NCT02194686|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6783121|NCT02194686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6783122|NCT02194764|Naltrexone|naltrexone|mesh-list
6783123|NCT02194764|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6783124|NCT02194764|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6783125|NCT02194764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783126|NCT02194764|Sensory System Agents|sensory system agents|mesh-ancestor
6783127|NCT02194764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6783128|NCT02194829|Gemcitabine|gemcitabine|mesh-list
6783129|NCT02194829|Paclitaxel|paclitaxel|mesh-list
6783130|NCT02194829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6783131|NCT02194829|Adavosertib|adavosertib|mesh-list
6783132|NCT02194829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6783133|NCT02194829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6783134|NCT02194829|Tubulin Modulators|tubulin modulators|mesh-ancestor
6783135|NCT02194829|Antimitotic Agents|antimitotic agents|mesh-ancestor
6783136|NCT02194829|Mitosis Modulators|mitosis modulators|mesh-ancestor
6783137|NCT02194829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783138|NCT02194829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6783139|NCT02194829|Antimetabolites|antimetabolites|mesh-ancestor
6783140|NCT02194829|Antiviral Agents|antiviral agents|mesh-ancestor
6783141|NCT02194829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6783142|NCT02194829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6783143|NCT02194829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6783144|NCT02194829|Immunologic Factors|immunologic factors|mesh-ancestor
6783145|NCT02194829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783146|NCT02194855|Rocuronium|rocuronium|mesh-list
6783147|NCT02194855|Cisatracurium|cisatracurium|mesh-list
6783148|NCT02194855|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6783149|NCT02194855|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6783150|NCT02194855|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6783151|NCT02194855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6783152|NCT02194855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783153|NCT02194881|Ivacaftor|ivacaftor|mesh-list
6783154|NCT02194881|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6783155|NCT02194881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6783156|NCT02194881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783157|NCT02194894|Acetaminophen|acetaminophen|mesh-list
6783158|NCT02194894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6783159|NCT02194894|Analgesics|analgesics|mesh-ancestor
6783160|NCT02194894|Sensory System Agents|sensory system agents|mesh-ancestor
6783161|NCT02194894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6783162|NCT02194894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783163|NCT02194894|Antipyretics|antipyretics|mesh-ancestor
6783164|NCT02194920|Parathyroid Hormone|parathyroid hormone|mesh-list
6783165|NCT02194920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6783166|NCT02194920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783167|NCT02195089|Vaccines|vaccines|mesh-list
6783168|NCT02195089|Immunologic Factors|immunologic factors|mesh-ancestor
6783169|NCT02195089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783170|NCT02195115|Amitriptyline|amitriptyline|mesh-list
6713020|NCT01794143|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6713021|NCT01794143|Liraglutide|liraglutide|mesh-list
6713022|NCT01794143|Glimepiride|glimepiride|mesh-list
6713023|NCT01794143|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
6713024|NCT01794143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6713025|NCT01794143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713026|NCT01794143|Incretins|incretins|mesh-ancestor
6713027|NCT01794143|Hormones|hormones|mesh-ancestor
6713028|NCT01794143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6713029|NCT01794143|Protease Inhibitors|protease inhibitors|mesh-ancestor
6713030|NCT01794143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6713031|NCT01794143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713032|NCT01794143|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6713033|NCT01794143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6713034|NCT01794143|Immunologic Factors|immunologic factors|mesh-ancestor
6713035|NCT01794169|Cytarabine|cytarabine|mesh-list
6713036|NCT01794169|Azacitidine|azacitidine|mesh-list
6713037|NCT01794169|Daunorubicin|daunorubicin|mesh-list
6713038|NCT01794169|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6713039|NCT01794169|Antimetabolites|antimetabolites|mesh-ancestor
6713040|NCT01794169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713041|NCT01794169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6713042|NCT01794169|Antiviral Agents|antiviral agents|mesh-ancestor
6713043|NCT01794169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6713044|NCT01794169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6713045|NCT01794169|Immunologic Factors|immunologic factors|mesh-ancestor
6713046|NCT01794169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713047|NCT01794169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6713048|NCT01794169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6713049|NCT01794169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6713050|NCT01794169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6713051|NCT01794182|Glyburide|glyburide|mesh-list
6713052|NCT01794182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6713053|NCT01794182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713054|NCT01794208|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6713055|NCT01794208|Hormones|hormones|mesh-ancestor
6713056|NCT01794208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6713057|NCT01794208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713058|NCT01794247|Lidocaine|lidocaine|mesh-list
6713059|NCT01794247|Magnesium Sulfate|magnesium sulfate|mesh-list
6713060|NCT01794247|Fentanyl|fentanyl|mesh-list
6713061|NCT01794247|Anesthetics, Local|anesthetics, local|mesh-ancestor
6713062|NCT01794247|Anesthetics|anesthetics|mesh-ancestor
6713063|NCT01794247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6713064|NCT01794247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713065|NCT01794247|Sensory System Agents|sensory system agents|mesh-ancestor
6713066|NCT01794247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6713067|NCT01794247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6713068|NCT01794247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6713069|NCT01794247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6713070|NCT01794247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6713071|NCT01794247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713072|NCT01794247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6713073|NCT01794247|Narcotics|narcotics|mesh-ancestor
6713074|NCT01794247|Analgesics|analgesics|mesh-ancestor
6713075|NCT01794247|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6713076|NCT01794247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6713077|NCT01794247|Anesthetics, General|anesthetics, general|mesh-ancestor
6713078|NCT01794247|Anticonvulsants|anticonvulsants|mesh-ancestor
6713079|NCT01794247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6713080|NCT01794247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6713081|NCT01794247|Tocolytic Agents|tocolytic agents|mesh-ancestor
6713082|NCT01794247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6713083|NCT01794273|Phenylephrine|phenylephrine|mesh-list
6713084|NCT01794273|Oxymetazoline|oxymetazoline|mesh-list
6713085|NCT01794273|Ephedrine|ephedrine|mesh-list
6713086|NCT01794273|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6713087|NCT01794273|Mydriatics|mydriatics|mesh-ancestor
6713088|NCT01794273|Autonomic Agents|autonomic agents|mesh-ancestor
6713089|NCT01794273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6713090|NCT01794273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713091|NCT01794273|Sympathomimetics|sympathomimetics|mesh-ancestor
6713092|NCT01794273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6713093|NCT01794273|Nasal Decongestants|nasal decongestants|mesh-ancestor
6713094|NCT01794273|Respiratory System Agents|respiratory system agents|mesh-ancestor
6713095|NCT01794273|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6713096|NCT01794273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6713097|NCT01794273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6713098|NCT01794273|Adrenergic Agents|adrenergic agents|mesh-ancestor
6713099|NCT01794273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6713100|NCT01794273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713101|NCT01794273|Protective Agents|protective agents|mesh-ancestor
6713102|NCT01794273|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6713103|NCT01794351|Resveratrol|resveratrol|mesh-list
6713104|NCT01794351|Antioxidants|antioxidants|mesh-ancestor
6713105|NCT01794351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713106|NCT01794351|Protective Agents|protective agents|mesh-ancestor
6713107|NCT01794351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713108|NCT01794351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6713109|NCT01794351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6713110|NCT01794429|Exenatide|exenatide|mesh-list
6713111|NCT01794429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6713112|NCT01794429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713113|NCT01794429|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6713114|NCT01794429|Incretins|incretins|mesh-ancestor
6713115|NCT01794429|Hormones|hormones|mesh-ancestor
6713116|NCT01794429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6713117|NCT01794507|Dexamethasone|dexamethasone|mesh-list
6713118|NCT01794507|Bortezomib|bortezomib|mesh-list
6713119|NCT01794507|Venetoclax|venetoclax|mesh-list
6713120|NCT01794507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6713121|NCT01794507|Antiemetics|antiemetics|mesh-ancestor
6713122|NCT01794507|Autonomic Agents|autonomic agents|mesh-ancestor
6713123|NCT01794507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6713124|NCT01794507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713125|NCT01794507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6713126|NCT01794507|Glucocorticoids|glucocorticoids|mesh-ancestor
6713127|NCT01794507|Hormones|hormones|mesh-ancestor
6713128|NCT01794507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6713129|NCT01794507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6713130|NCT01794507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6713131|NCT01794533|Lidocaine|lidocaine|mesh-list
6713132|NCT01794533|Epinephrine|epinephrine|mesh-list
6713133|NCT01794533|Racepinephrine|racepinephrine|mesh-list
6713134|NCT01794533|Fentanyl|fentanyl|mesh-list
6713135|NCT01794533|Epinephryl borate|epinephryl borate|mesh-list
6713136|NCT01794533|Anesthetics, Local|anesthetics, local|mesh-ancestor
6713137|NCT01794533|Anesthetics|anesthetics|mesh-ancestor
6713138|NCT01794533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6713139|NCT01794533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713140|NCT01794533|Sensory System Agents|sensory system agents|mesh-ancestor
6713141|NCT01794533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6713142|NCT01794533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6713143|NCT01794533|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6713144|NCT01794533|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6713145|NCT01794533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6713146|NCT01794533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713147|NCT01794533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6713148|NCT01794533|Narcotics|narcotics|mesh-ancestor
6713149|NCT01794533|Analgesics|analgesics|mesh-ancestor
6713150|NCT01794533|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6713151|NCT01794533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6713152|NCT01794533|Anesthetics, General|anesthetics, general|mesh-ancestor
6713153|NCT01794533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6713154|NCT01794533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6713155|NCT01794533|Adrenergic Agents|adrenergic agents|mesh-ancestor
6713156|NCT01794533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6713157|NCT01794533|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6713158|NCT01794533|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6713159|NCT01794533|Autonomic Agents|autonomic agents|mesh-ancestor
6713160|NCT01794533|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6713161|NCT01794533|Respiratory System Agents|respiratory system agents|mesh-ancestor
6713162|NCT01794533|Mydriatics|mydriatics|mesh-ancestor
6713163|NCT01794533|Sympathomimetics|sympathomimetics|mesh-ancestor
6713164|NCT01794533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6713165|NCT01794572|Melphalan|melphalan|mesh-list
6713166|NCT01794572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6713167|NCT01794572|Alkylating Agents|alkylating agents|mesh-ancestor
6713168|NCT01794572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713169|NCT01794572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6713170|NCT01794572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6713171|NCT01794572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6713172|NCT01794572|Immunologic Factors|immunologic factors|mesh-ancestor
6713173|NCT01794572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713174|NCT01794767|Heparin|heparin|mesh-list
6713175|NCT01794767|Calcium heparin|calcium heparin|mesh-list
6713176|NCT01794767|Anticoagulants|anticoagulants|mesh-ancestor
6713177|NCT01794767|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6713178|NCT01794767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6713179|NCT01794767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713180|NCT01794793|Cabergoline|cabergoline|mesh-list
6713181|NCT01794793|Pasireotide|pasireotide|mesh-list
6713182|NCT01794793|Somatostatin|somatostatin|mesh-list
6713183|NCT01794793|Hormones|hormones|mesh-ancestor
6713184|NCT01794793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6713185|NCT01794793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713186|NCT01794793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6713187|NCT01794793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6713188|NCT01794793|Dopamine Agonists|dopamine agonists|mesh-ancestor
6713189|NCT01794793|Dopamine Agents|dopamine agents|mesh-ancestor
6713190|NCT01794793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6713191|NCT01794793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713192|NCT01794897|Valacyclovir|valacyclovir|mesh-list
6713193|NCT01794897|Antiviral Agents|antiviral agents|mesh-ancestor
6713194|NCT01794897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6713195|NCT01794975|Ketamine|ketamine|mesh-list
6713196|NCT01794975|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6713197|NCT01794975|Analgesics|analgesics|mesh-ancestor
6713198|NCT01794975|Sensory System Agents|sensory system agents|mesh-ancestor
6713199|NCT01794975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6713200|NCT01794975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713201|NCT01794975|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6713202|NCT01794975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6713203|NCT01794975|Anesthetics, General|anesthetics, general|mesh-ancestor
6713204|NCT01794975|Anesthetics|anesthetics|mesh-ancestor
6713205|NCT01794975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6713206|NCT01794975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6713207|NCT01794975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6713208|NCT01794975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6713209|NCT01794975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713210|NCT01794975|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6713211|NCT01794975|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6713212|NCT01794975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6713213|NCT01794975|Adrenergic Agents|adrenergic agents|mesh-ancestor
6713214|NCT01795027|Oxaliplatin|oxaliplatin|mesh-list
6713215|NCT01795027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6713216|NCT01795131|Vitamin B 12|vitamin b 12|mesh-list
6713217|NCT01795131|Hydroxocobalamin|hydroxocobalamin|mesh-list
6713218|NCT01795131|Vitamins|vitamins|mesh-ancestor
6713219|NCT01795131|Micronutrients|micronutrients|mesh-ancestor
6713220|NCT01795131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713221|NCT01795131|Vitamin B Complex|vitamin b complex|mesh-ancestor
6713222|NCT01795131|Hematinics|hematinics|mesh-ancestor
6713223|NCT01795144|Glucagon|glucagon|mesh-list
6713224|NCT01795144|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6713225|NCT01795144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6713226|NCT01795144|Hormones|hormones|mesh-ancestor
6713227|NCT01795144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6713228|NCT01795144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713229|NCT01795144|Incretins|incretins|mesh-ancestor
6713230|NCT01795170|Pyridoxine|pyridoxine|mesh-list
6713231|NCT01795170|Vitamin B Complex|vitamin b complex|mesh-ancestor
6713232|NCT01795170|Vitamins|vitamins|mesh-ancestor
6713233|NCT01795170|Micronutrients|micronutrients|mesh-ancestor
6713234|NCT01795170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713235|NCT01795183|Amisulpride|amisulpride|mesh-list
6713236|NCT01795183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6713237|NCT01795183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6713238|NCT01795183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6713239|NCT01795183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713240|NCT01795183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6713241|NCT01795183|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6713242|NCT01795183|Dopamine Agents|dopamine agents|mesh-ancestor
6713243|NCT01795183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6713244|NCT01795183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713245|NCT01795183|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6713246|NCT01795183|Antidepressive Agents|antidepressive agents|mesh-ancestor
6713247|NCT01795209|Ranibizumab|ranibizumab|mesh-list
6713248|NCT01795209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6713249|NCT01795209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6713250|NCT01795209|Growth Substances|growth substances|mesh-ancestor
6713251|NCT01795209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713252|NCT01795209|Growth Inhibitors|growth inhibitors|mesh-ancestor
6713253|NCT01795209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6713254|NCT01795222|Midazolam|midazolam|mesh-list
6713255|NCT01795222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6713256|NCT01795222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6713257|NCT01795222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6713258|NCT01795222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713259|NCT01795222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6713260|NCT01795222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6713261|NCT01795222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6713262|NCT01795222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6713263|NCT01795222|Anesthetics, General|anesthetics, general|mesh-ancestor
6713264|NCT01795222|Anesthetics|anesthetics|mesh-ancestor
6713265|NCT01795222|GABA Modulators|gaba modulators|mesh-ancestor
6713266|NCT01795222|GABA Agents|gaba agents|mesh-ancestor
6713267|NCT01795222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6713268|NCT01795222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713269|NCT01795235|Atenolol|atenolol|mesh-list
6713270|NCT01795235|Glucagon|glucagon|mesh-list
6713271|NCT01795235|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6713272|NCT01795235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6713273|NCT01795235|Hormones|hormones|mesh-ancestor
6713274|NCT01795235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6713275|NCT01795235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713276|NCT01795235|Incretins|incretins|mesh-ancestor
6713277|NCT01795235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6713278|NCT01795235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6713279|NCT01795235|Sympatholytics|sympatholytics|mesh-ancestor
6713280|NCT01795235|Autonomic Agents|autonomic agents|mesh-ancestor
6713281|NCT01795235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6713282|NCT01795235|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6713283|NCT01795235|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6713284|NCT01795235|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6713285|NCT01795235|Adrenergic Agents|adrenergic agents|mesh-ancestor
6713286|NCT01795235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6713287|NCT01795235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713288|NCT01795248|Liraglutide|liraglutide|mesh-list
6713289|NCT01795248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6713290|NCT01795248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713291|NCT01795248|Incretins|incretins|mesh-ancestor
6713292|NCT01795248|Hormones|hormones|mesh-ancestor
6713293|NCT01795248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6713294|NCT01795287|Anesthetics|anesthetics|mesh-list
6713295|NCT01795287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6713296|NCT01795287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713297|NCT01795313|Imiquimod|imiquimod|mesh-list
6713298|NCT01795313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6713299|NCT01795313|Immunologic Factors|immunologic factors|mesh-ancestor
6713300|NCT01795313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713301|NCT01795313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6713302|NCT01795313|Interferon Inducers|interferon inducers|mesh-ancestor
6713303|NCT01795430|Etoposide|etoposide|mesh-list
6713304|NCT01795430|Etoposide phosphate|etoposide phosphate|mesh-list
6713305|NCT01795430|Melphalan|melphalan|mesh-list
6713306|NCT01795430|Busulfan|busulfan|mesh-list
6713307|NCT01795430|Topotecan|topotecan|mesh-list
6713308|NCT01795430|Ifosfamide|ifosfamide|mesh-list
6713309|NCT01795430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6713310|NCT01795430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6713311|NCT01795430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6713312|NCT01795430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6713313|NCT01795430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6713314|NCT01795430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713315|NCT01795430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6713316|NCT01795430|Alkylating Agents|alkylating agents|mesh-ancestor
6713317|NCT01795430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6713318|NCT01795430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6713319|NCT01795430|Immunologic Factors|immunologic factors|mesh-ancestor
6713320|NCT01795430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713321|NCT01795430|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6713322|NCT01795599|Mifepristone|mifepristone|mesh-list
6713323|NCT01795599|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6713324|NCT01795599|Abortifacient Agents|abortifacient agents|mesh-ancestor
6713325|NCT01795599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6713326|NCT01795599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713327|NCT01795599|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6713328|NCT01795599|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6713329|NCT01795599|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6713330|NCT01795599|Contraceptive Agents|contraceptive agents|mesh-ancestor
6713331|NCT01795599|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6713332|NCT01795599|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6713333|NCT01795599|Hormone Antagonists|hormone antagonists|mesh-ancestor
6713334|NCT01795599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6713335|NCT01795599|Luteolytic Agents|luteolytic agents|mesh-ancestor
6713336|NCT01795599|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6713337|NCT01795599|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6713338|NCT01795664|Fluticasone|fluticasone|mesh-list
6713339|NCT01795664|Xhance|xhance|mesh-list
6713340|NCT01795664|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6713341|NCT01795664|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6713342|NCT01795664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6713343|NCT01795664|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6713344|NCT01795664|Autonomic Agents|autonomic agents|mesh-ancestor
6713345|NCT01795664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6713346|NCT01795664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713347|NCT01795664|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6713348|NCT01795664|Respiratory System Agents|respiratory system agents|mesh-ancestor
6713349|NCT01795664|Dermatologic Agents|dermatologic agents|mesh-ancestor
6713350|NCT01795664|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6713351|NCT01795664|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6713352|NCT01795664|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6713353|NCT01795664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6713354|NCT01795664|Adrenergic Agents|adrenergic agents|mesh-ancestor
6713355|NCT01795664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6713356|NCT01795664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713357|NCT01795664|Glucocorticoids|glucocorticoids|mesh-ancestor
6713358|NCT01795664|Hormones|hormones|mesh-ancestor
6713359|NCT01795664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6713360|NCT01795664|Sympathomimetics|sympathomimetics|mesh-ancestor
6713361|NCT01795703|Prednisolone|prednisolone|mesh-list
6713362|NCT01795703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6713363|NCT01795703|Glucocorticoids|glucocorticoids|mesh-ancestor
6713364|NCT01795703|Hormones|hormones|mesh-ancestor
6713365|NCT01795703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6713366|NCT01795703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713367|NCT01795703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6713368|NCT01795703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6783171|NCT02195115|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6783172|NCT02195115|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6783173|NCT02195115|Antidepressive Agents|antidepressive agents|mesh-ancestor
6783174|NCT02195115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6783175|NCT02195115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6783176|NCT02195115|Analgesics|analgesics|mesh-ancestor
6783177|NCT02195115|Sensory System Agents|sensory system agents|mesh-ancestor
6783178|NCT02195115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6783179|NCT02195115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783180|NCT02195115|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6783181|NCT02195115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6783182|NCT02195115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6783183|NCT02195115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783184|NCT02195115|Adrenergic Agents|adrenergic agents|mesh-ancestor
6783185|NCT02195115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6783186|NCT02195115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6783187|NCT02195115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6783188|NCT02195115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6783189|NCT02195180|Leucovorin|leucovorin|mesh-list
6783190|NCT02195180|Gemcitabine|gemcitabine|mesh-list
6783191|NCT02195180|Fluorouracil|fluorouracil|mesh-list
6783192|NCT02195180|Oxaliplatin|oxaliplatin|mesh-list
6783193|NCT02195180|Asparaginase|asparaginase|mesh-list
6783194|NCT02195180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6783195|NCT02195180|Antimetabolites|antimetabolites|mesh-ancestor
6783196|NCT02195180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783197|NCT02195180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6783198|NCT02195180|Antiviral Agents|antiviral agents|mesh-ancestor
6783199|NCT02195180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6783200|NCT02195180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6783201|NCT02195180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6783202|NCT02195180|Immunologic Factors|immunologic factors|mesh-ancestor
6783203|NCT02195180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783204|NCT02195180|Antidotes|antidotes|mesh-ancestor
6783205|NCT02195180|Protective Agents|protective agents|mesh-ancestor
6783206|NCT02195180|Vitamin B Complex|vitamin b complex|mesh-ancestor
6783207|NCT02195180|Vitamins|vitamins|mesh-ancestor
6783208|NCT02195180|Micronutrients|micronutrients|mesh-ancestor
6783209|NCT02195271|Melatonin|melatonin|mesh-list
6783210|NCT02195271|Antioxidants|antioxidants|mesh-ancestor
6783211|NCT02195271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783212|NCT02195271|Protective Agents|protective agents|mesh-ancestor
6783213|NCT02195271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783214|NCT02195271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6783215|NCT02195336|Paclitaxel|paclitaxel|mesh-list
6783216|NCT02195336|Bevacizumab|bevacizumab|mesh-list
6783217|NCT02195336|Carboplatin|carboplatin|mesh-list
6783218|NCT02195336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6783219|NCT02195336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6783220|NCT02195336|Tubulin Modulators|tubulin modulators|mesh-ancestor
6783221|NCT02195336|Antimitotic Agents|antimitotic agents|mesh-ancestor
6713369|NCT01795794|Omeprazole|omeprazole|mesh-list
6713370|NCT01795794|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6713371|NCT01795794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6713372|NCT01795794|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6713373|NCT01795794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6713374|NCT01795794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713375|NCT01795820|Ticagrelor|ticagrelor|mesh-list
6713376|NCT01795820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6713377|NCT01795820|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6713378|NCT01795820|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6713379|NCT01795820|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6713380|NCT01795820|Purinergic Agents|purinergic agents|mesh-ancestor
6713381|NCT01795820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6713382|NCT01795820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713383|NCT01795820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713384|NCT01795976|Cyclophosphamide|cyclophosphamide|mesh-list
6713385|NCT01795976|Fludarabine|fludarabine|mesh-list
6713386|NCT01795976|Interleukin-2|interleukin-2|mesh-list
6713387|NCT01795976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6713388|NCT01795976|Immunologic Factors|immunologic factors|mesh-ancestor
6713389|NCT01795976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713390|NCT01795976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6713391|NCT01795976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6713392|NCT01795976|Alkylating Agents|alkylating agents|mesh-ancestor
6713393|NCT01795976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713394|NCT01795976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6713395|NCT01795976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6713396|NCT01795976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6713397|NCT01795976|Analgesics|analgesics|mesh-ancestor
6713398|NCT01795976|Sensory System Agents|sensory system agents|mesh-ancestor
6713399|NCT01795976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6713400|NCT01796002|Romidepsin|romidepsin|mesh-list
6713401|NCT01796002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6713402|NCT01796002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6713403|NCT01796028|Metformin|metformin|mesh-list
6713404|NCT01796028|Docetaxel|docetaxel|mesh-list
6713405|NCT01796028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6713406|NCT01796028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713407|NCT01796028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6713408|NCT01796028|Tubulin Modulators|tubulin modulators|mesh-ancestor
6713409|NCT01796028|Antimitotic Agents|antimitotic agents|mesh-ancestor
6713410|NCT01796028|Mitosis Modulators|mitosis modulators|mesh-ancestor
6713411|NCT01796028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713412|NCT01796093|Digoxin|digoxin|mesh-list
6713413|NCT01796093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6713414|NCT01796093|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6713415|NCT01796093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6713416|NCT01796093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713417|NCT01796093|Protective Agents|protective agents|mesh-ancestor
6713418|NCT01796093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713419|NCT01796106|Fluorides|fluorides|mesh-list
6713420|NCT01796106|Fluorides, Topical|fluorides, topical|mesh-list
6713421|NCT01796106|Cariostatic Agents|cariostatic agents|mesh-ancestor
6713422|NCT01796106|Protective Agents|protective agents|mesh-ancestor
6713423|NCT01796106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713424|NCT01796132|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6713425|NCT01796132|Fluvoxamine|fluvoxamine|mesh-list
6713426|NCT01796132|Citalopram|citalopram|mesh-list
6713427|NCT01796132|Fluoxetine|fluoxetine|mesh-list
6713428|NCT01796132|Paroxetine|paroxetine|mesh-list
6713429|NCT01796132|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6713430|NCT01796132|Sertraline|sertraline|mesh-list
6713431|NCT01796132|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6713432|NCT01796132|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6713433|NCT01796132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6713434|NCT01796132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713435|NCT01796132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6713436|NCT01796132|Serotonin Agents|serotonin agents|mesh-ancestor
6713437|NCT01796132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713438|NCT01796132|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6713439|NCT01796132|Antidepressive Agents|antidepressive agents|mesh-ancestor
6713440|NCT01796132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6713441|NCT01796132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6713442|NCT01796132|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6713443|NCT01796132|Analgesics|analgesics|mesh-ancestor
6713444|NCT01796132|Sensory System Agents|sensory system agents|mesh-ancestor
6713445|NCT01796132|Dopamine Agents|dopamine agents|mesh-ancestor
6713446|NCT01796132|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6713447|NCT01796132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6713448|NCT01796132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6713449|NCT01796132|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6713450|NCT01796132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6713451|NCT01796132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6713452|NCT01796132|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6713453|NCT01796132|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6713454|NCT01796288|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6713455|NCT01796288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6713456|NCT01796288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6713457|NCT01796288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6713458|NCT01796288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713459|NCT01796366|Insulin|insulin|mesh-list
6713460|NCT01796366|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6713461|NCT01796366|Insulin Glargine|insulin glargine|mesh-list
6713462|NCT01796366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6713463|NCT01796366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713464|NCT01796405|Clofarabine|clofarabine|mesh-list
6713465|NCT01796405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6713466|NCT01796405|Antimetabolites|antimetabolites|mesh-ancestor
6713467|NCT01796405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713468|NCT01796405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6713469|NCT01796418|Beraprost|beraprost|mesh-list
6713470|NCT01796418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6713471|NCT01796418|Vasodilator Agents|vasodilator agents|mesh-ancestor
6713472|NCT01796444|Hormones|hormones|mesh-list
6713473|NCT01796444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6713474|NCT01796444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713475|NCT01796483|Clonidine|clonidine|mesh-list
6713476|NCT01796483|Analgesics|analgesics|mesh-ancestor
6713477|NCT01796483|Sensory System Agents|sensory system agents|mesh-ancestor
6713478|NCT01796483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6713479|NCT01796483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713480|NCT01796483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6713481|NCT01796483|Sympatholytics|sympatholytics|mesh-ancestor
6713482|NCT01796483|Autonomic Agents|autonomic agents|mesh-ancestor
6713483|NCT01796483|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6713484|NCT01796483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6713485|NCT01796483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6713486|NCT01796483|Adrenergic Agents|adrenergic agents|mesh-ancestor
6713487|NCT01796483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6713488|NCT01796483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713489|NCT01796522|Nifedipine|nifedipine|mesh-list
6713490|NCT01796522|Progesterone|progesterone|mesh-list
6713491|NCT01796522|Progestins|progestins|mesh-ancestor
6713492|NCT01796522|Hormones|hormones|mesh-ancestor
6713493|NCT01796522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6713494|NCT01796522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713495|NCT01796522|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6713496|NCT01796522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6713497|NCT01796522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713498|NCT01796522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6713499|NCT01796522|Vasodilator Agents|vasodilator agents|mesh-ancestor
6713500|NCT01796522|Tocolytic Agents|tocolytic agents|mesh-ancestor
6713501|NCT01796522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6713502|NCT01796613|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6713503|NCT01796613|Desogestrel|desogestrel|mesh-list
6713504|NCT01796613|Etonogestrel|etonogestrel|mesh-list
6713505|NCT01796613|NuvaRing|nuvaring|mesh-list
6713506|NCT01796613|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6713507|NCT01796613|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6713508|NCT01796613|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6713509|NCT01796613|Contraceptive Agents|contraceptive agents|mesh-ancestor
6713510|NCT01796613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6713511|NCT01796613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713512|NCT01796613|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6713513|NCT01796613|Estrogens|estrogens|mesh-ancestor
6713514|NCT01796613|Hormones|hormones|mesh-ancestor
6713515|NCT01796613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6713516|NCT01796613|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6713517|NCT01796613|Progestins|progestins|mesh-ancestor
6713518|NCT01796730|Bambuterol|bambuterol|mesh-list
6713519|NCT01796730|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6713520|NCT01796730|Autonomic Agents|autonomic agents|mesh-ancestor
6713521|NCT01796730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6713522|NCT01796730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713523|NCT01796730|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6713524|NCT01796730|Respiratory System Agents|respiratory system agents|mesh-ancestor
6713525|NCT01796782|Capecitabine|capecitabine|mesh-list
6713526|NCT01796782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6713527|NCT01796782|Antimetabolites|antimetabolites|mesh-ancestor
6713528|NCT01796782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713529|NCT01796782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6713530|NCT01796808|Lidocaine|lidocaine|mesh-list
6713531|NCT01796808|Epinephrine|epinephrine|mesh-list
6713532|NCT01796808|Anesthetics, Local|anesthetics, local|mesh-list
6713533|NCT01796808|Anesthetics|anesthetics|mesh-list
6713534|NCT01796808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6713535|NCT01796808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713536|NCT01796808|Sensory System Agents|sensory system agents|mesh-ancestor
6713537|NCT01796808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6713538|NCT01796808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6713539|NCT01796808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6713540|NCT01796808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6713541|NCT01796808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6713542|NCT01796808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713543|NCT01796808|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6713544|NCT01796808|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6713545|NCT01796808|Adrenergic Agents|adrenergic agents|mesh-ancestor
6713546|NCT01796808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6713547|NCT01796808|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6713548|NCT01796808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6713549|NCT01796808|Autonomic Agents|autonomic agents|mesh-ancestor
6713550|NCT01796808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6713551|NCT01796808|Respiratory System Agents|respiratory system agents|mesh-ancestor
6713552|NCT01796808|Mydriatics|mydriatics|mesh-ancestor
6713553|NCT01796808|Sympathomimetics|sympathomimetics|mesh-ancestor
6713554|NCT01796808|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6713555|NCT01796899|Brivaracetam|brivaracetam|mesh-list
6713556|NCT01796899|Anticonvulsants|anticonvulsants|mesh-ancestor
6713557|NCT01796938|Lacosamide|lacosamide|mesh-list
6713558|NCT01796938|Anticonvulsants|anticonvulsants|mesh-ancestor
6713559|NCT01796938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6713560|NCT01796938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6713561|NCT01796938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6713562|NCT01796938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713563|NCT01796951|Aspirin|aspirin|mesh-list
6713564|NCT01796951|Celecoxib|celecoxib|mesh-list
6713565|NCT01796951|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6713566|NCT01796951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6713567|NCT01796951|Analgesics|analgesics|mesh-ancestor
6713568|NCT01796951|Sensory System Agents|sensory system agents|mesh-ancestor
6713569|NCT01796951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6713570|NCT01796951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713571|NCT01796951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6713572|NCT01796951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6713573|NCT01796951|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6713574|NCT01796951|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6713575|NCT01796951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713576|NCT01796951|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6713577|NCT01796951|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6713578|NCT01796951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6713579|NCT01796951|Antipyretics|antipyretics|mesh-ancestor
6713580|NCT01796951|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6713581|NCT01797107|Azithromycin|azithromycin|mesh-list
6713582|NCT01797107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6713583|NCT01797107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6713584|NCT01797133|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6713585|NCT01797133|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6713586|NCT01797133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6713587|NCT01797133|Antitubercular Agents|antitubercular agents|mesh-ancestor
6713588|NCT01797198|Repaglinide|repaglinide|mesh-list
6713589|NCT01797198|Gemfibrozil|gemfibrozil|mesh-list
6713590|NCT01797198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6713591|NCT01797198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713592|NCT01797198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6713593|NCT01797198|Antimetabolites|antimetabolites|mesh-ancestor
6713594|NCT01797198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713595|NCT01797198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6713596|NCT01797198|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6713597|NCT01797198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6713598|NCT01797198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6713599|NCT01797289|Fibrin fragment D|fibrin fragment d|mesh-list
6713600|NCT01797289|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6713601|NCT01797289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6713602|NCT01797289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713603|NCT01797289|Hemostatics|hemostatics|mesh-ancestor
6713604|NCT01797289|Coagulants|coagulants|mesh-ancestor
6713605|NCT01797315|Sirolimus|sirolimus|mesh-list
6713606|NCT01797315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6713607|NCT01797315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6713608|NCT01797315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6713609|NCT01797315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6713610|NCT01797315|Antifungal Agents|antifungal agents|mesh-ancestor
6713611|NCT01797315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6713612|NCT01797315|Immunologic Factors|immunologic factors|mesh-ancestor
6713613|NCT01797315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713614|NCT01797341|Tacrolimus|tacrolimus|mesh-list
6713615|NCT01797341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6713616|NCT01797341|Immunologic Factors|immunologic factors|mesh-ancestor
6713617|NCT01797341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713618|NCT01797341|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6713619|NCT01797341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6713620|NCT01797341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783222|NCT02195336|Mitosis Modulators|mitosis modulators|mesh-ancestor
6783223|NCT02195336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783224|NCT02195336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6783225|NCT02195336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6783226|NCT02195336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6783227|NCT02195336|Growth Substances|growth substances|mesh-ancestor
6783228|NCT02195336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783229|NCT02195336|Growth Inhibitors|growth inhibitors|mesh-ancestor
6783230|NCT02195375|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6783231|NCT02195375|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6783232|NCT02195375|Autonomic Agents|autonomic agents|mesh-ancestor
6783233|NCT02195375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6783234|NCT02195375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783235|NCT02195375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6783236|NCT02195375|Respiratory System Agents|respiratory system agents|mesh-ancestor
6783237|NCT02195375|Glucocorticoids|glucocorticoids|mesh-ancestor
6783238|NCT02195375|Hormones|hormones|mesh-ancestor
6783239|NCT02195375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6783240|NCT02195375|Sympathomimetics|sympathomimetics|mesh-ancestor
6713621|NCT01797601|Insulin|insulin|mesh-list
6713622|NCT01797601|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6713623|NCT01797601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6713624|NCT01797601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713625|NCT01797666|Pioglitazone|pioglitazone|mesh-list
6713626|NCT01797666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6713627|NCT01797666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713628|NCT01797718|Letrozole|letrozole|mesh-list
6713629|NCT01797718|Testosterone|testosterone|mesh-list
6713630|NCT01797718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6713631|NCT01797718|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6713632|NCT01797718|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6713633|NCT01797718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6713634|NCT01797718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713635|NCT01797718|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6713636|NCT01797718|Hormone Antagonists|hormone antagonists|mesh-ancestor
6713637|NCT01797718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6713638|NCT01797718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713639|NCT01797718|Androgens|androgens|mesh-ancestor
6713640|NCT01797718|Hormones|hormones|mesh-ancestor
6713641|NCT01797757|Orlistat|orlistat|mesh-list
6713642|NCT01797757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6713643|NCT01797757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713644|NCT01797757|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6713645|NCT01797757|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6713646|NCT01797796|Capsaicin|capsaicin|mesh-list
6713647|NCT01797796|Antipruritics|antipruritics|mesh-ancestor
6713648|NCT01797796|Dermatologic Agents|dermatologic agents|mesh-ancestor
6713649|NCT01797796|Sensory System Agents|sensory system agents|mesh-ancestor
6713650|NCT01797796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6713651|NCT01797796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713652|NCT01797848|Ribavirin|ribavirin|mesh-list
6713653|NCT01797848|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6713654|NCT01797848|Antimetabolites|antimetabolites|mesh-ancestor
6713655|NCT01797848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713656|NCT01797848|Antiviral Agents|antiviral agents|mesh-ancestor
6713657|NCT01797848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6713658|NCT01797900|Paclitaxel|paclitaxel|mesh-list
6713659|NCT01797900|Cisplatin|cisplatin|mesh-list
6713660|NCT01797900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6713661|NCT01797900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6713662|NCT01797900|Tubulin Modulators|tubulin modulators|mesh-ancestor
6713663|NCT01797900|Antimitotic Agents|antimitotic agents|mesh-ancestor
6713664|NCT01797900|Mitosis Modulators|mitosis modulators|mesh-ancestor
6713665|NCT01797900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713666|NCT01797913|Gemcitabine|gemcitabine|mesh-list
6713667|NCT01797913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6713668|NCT01797913|Antimetabolites|antimetabolites|mesh-ancestor
6713669|NCT01797913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713670|NCT01797913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6713671|NCT01797913|Antiviral Agents|antiviral agents|mesh-ancestor
6713672|NCT01797913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6713673|NCT01797913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6713674|NCT01797913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6713675|NCT01797913|Immunologic Factors|immunologic factors|mesh-ancestor
6713676|NCT01797913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713677|NCT01797926|Losartan|losartan|mesh-list
6713678|NCT01797926|Amlodipine|amlodipine|mesh-list
6713679|NCT01797926|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6713680|NCT01797926|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6713681|NCT01797926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6713682|NCT01797926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713683|NCT01797926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6713684|NCT01797926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713685|NCT01797926|Vasodilator Agents|vasodilator agents|mesh-ancestor
6713686|NCT01797926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6713687|NCT01797926|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6713688|NCT01797926|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6713689|NCT01797978|Methylene Blue|methylene blue|mesh-list
6713690|NCT01797978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6713691|NCT01797978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713692|NCT01797991|Dexamethasone|dexamethasone|mesh-list
6713693|NCT01797991|Dexamethasone acetate|dexamethasone acetate|mesh-list
6713694|NCT01797991|BB 1101|bb 1101|mesh-list
6713695|NCT01797991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6713696|NCT01797991|Antiemetics|antiemetics|mesh-ancestor
6713697|NCT01797991|Autonomic Agents|autonomic agents|mesh-ancestor
6713698|NCT01797991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6713699|NCT01797991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713700|NCT01797991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6713701|NCT01797991|Glucocorticoids|glucocorticoids|mesh-ancestor
6713702|NCT01797991|Hormones|hormones|mesh-ancestor
6713703|NCT01797991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6713704|NCT01797991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6713705|NCT01797991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6713706|NCT01797991|Protease Inhibitors|protease inhibitors|mesh-ancestor
6713707|NCT01797991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6713708|NCT01797991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713709|NCT01798017|Misoprostol|misoprostol|mesh-list
6713710|NCT01798017|Mifepristone|mifepristone|mesh-list
6713711|NCT01798017|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6713712|NCT01798017|Abortifacient Agents|abortifacient agents|mesh-ancestor
6713713|NCT01798017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6713714|NCT01798017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713715|NCT01798017|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6713716|NCT01798017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6713717|NCT01798017|Oxytocics|oxytocics|mesh-ancestor
6713718|NCT01798017|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6713719|NCT01798017|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6713720|NCT01798017|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6713721|NCT01798017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6713722|NCT01798017|Contraceptive Agents|contraceptive agents|mesh-ancestor
6713723|NCT01798017|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6713724|NCT01798017|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6713725|NCT01798017|Hormone Antagonists|hormone antagonists|mesh-ancestor
6713726|NCT01798017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6713727|NCT01798017|Luteolytic Agents|luteolytic agents|mesh-ancestor
6713728|NCT01798017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6713729|NCT01798017|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6713730|NCT01798030|Vitamin D|vitamin d|mesh-list
6713731|NCT01798030|Vitamins|vitamins|mesh-ancestor
6713732|NCT01798030|Micronutrients|micronutrients|mesh-ancestor
6713733|NCT01798030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713734|NCT01798030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6713735|NCT01798108|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
6713736|NCT01798108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6713737|NCT01798251|Capecitabine|capecitabine|mesh-list
6713738|NCT01798251|Oxaliplatin|oxaliplatin|mesh-list
6713739|NCT01798251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6713740|NCT01798251|Antimetabolites|antimetabolites|mesh-ancestor
6713741|NCT01798251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713742|NCT01798251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6713743|NCT01798277|Amiodarone|amiodarone|mesh-list
6713744|NCT01798277|Sotalol|sotalol|mesh-list
6713745|NCT01798277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6713746|NCT01798277|Vasodilator Agents|vasodilator agents|mesh-ancestor
6713747|NCT01798277|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6713748|NCT01798277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6713749|NCT01798277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713750|NCT01798277|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6713751|NCT01798277|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6713752|NCT01798277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6713753|NCT01798277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6713754|NCT01798277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6713755|NCT01798277|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6713756|NCT01798277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6713757|NCT01798277|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6713758|NCT01798277|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6713759|NCT01798277|Adrenergic Agents|adrenergic agents|mesh-ancestor
6713760|NCT01798277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6713761|NCT01798277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713762|NCT01798277|Sympatholytics|sympatholytics|mesh-ancestor
6713763|NCT01798277|Autonomic Agents|autonomic agents|mesh-ancestor
6713764|NCT01798277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6713765|NCT01798446|Axitinib|axitinib|mesh-list
6713766|NCT01798446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6713767|NCT01798446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6713768|NCT01798446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6713769|NCT01798446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713770|NCT01798459|Methylphenidate|methylphenidate|mesh-list
6713771|NCT01798459|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6713772|NCT01798459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713773|NCT01798459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6713774|NCT01798459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6713775|NCT01798459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6713776|NCT01798459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713777|NCT01798459|Dopamine Agents|dopamine agents|mesh-ancestor
6713778|NCT01798459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6713779|NCT01798472|Cimetidine|cimetidine|mesh-list
6713780|NCT01798472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6713781|NCT01798472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6713782|NCT01798472|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6713783|NCT01798472|Histamine Antagonists|histamine antagonists|mesh-ancestor
6713784|NCT01798472|Histamine Agents|histamine agents|mesh-ancestor
6713785|NCT01798472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6713786|NCT01798472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713787|NCT01798472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713788|NCT01798472|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6713789|NCT01798472|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6713790|NCT01798472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6713791|NCT01798498|Hyaluronic Acid|hyaluronic acid|mesh-list
6713792|NCT01798498|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6713793|NCT01798498|Immunologic Factors|immunologic factors|mesh-ancestor
6713794|NCT01798498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713795|NCT01798498|Viscosupplements|viscosupplements|mesh-ancestor
6713796|NCT01798498|Protective Agents|protective agents|mesh-ancestor
6713797|NCT01798537|Vancomycin|vancomycin|mesh-list
6713798|NCT01798537|Colistin|colistin|mesh-list
6713799|NCT01798537|Nystatin|nystatin|mesh-list
6713800|NCT01798537|Neomycin|neomycin|mesh-list
6713801|NCT01798537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6713802|NCT01798537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6713803|NCT01798537|Antifungal Agents|antifungal agents|mesh-ancestor
6713804|NCT01798537|Ionophores|ionophores|mesh-ancestor
6713805|NCT01798537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6713806|NCT01798537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713807|NCT01798537|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6713808|NCT01798537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6713809|NCT01798576|Interferons|interferons|mesh-list
6713810|NCT01798576|Ribavirin|ribavirin|mesh-list
6713811|NCT01798576|Interferon-alpha|interferon-alpha|mesh-list
6713812|NCT01798576|Interferon alpha-2|interferon alpha-2|mesh-list
6713813|NCT01798576|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6713814|NCT01798576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6713815|NCT01798576|Antiviral Agents|antiviral agents|mesh-ancestor
6713816|NCT01798576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6713817|NCT01798576|Antimetabolites|antimetabolites|mesh-ancestor
6713818|NCT01798576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713819|NCT01798576|Immunologic Factors|immunologic factors|mesh-ancestor
6713820|NCT01798576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713821|NCT01798602|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6713822|NCT01798602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6713823|NCT01798602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6713824|NCT01798602|Antimetabolites|antimetabolites|mesh-ancestor
6713825|NCT01798602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713826|NCT01798602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6713827|NCT01798602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6713828|NCT01798602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6713829|NCT01798628|Abiraterone Acetate|abiraterone acetate|mesh-list
6713830|NCT01798628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6713831|NCT01798628|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6713832|NCT01798628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6713833|NCT01798628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713834|NCT01798628|Hormone Antagonists|hormone antagonists|mesh-ancestor
6713835|NCT01798628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6713836|NCT01798628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713837|NCT01798628|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6713838|NCT01798680|Vitamin D|vitamin d|mesh-list
6713839|NCT01798680|Cholecalciferol|cholecalciferol|mesh-list
6713840|NCT01798680|Vitamins|vitamins|mesh-ancestor
6713841|NCT01798680|Micronutrients|micronutrients|mesh-ancestor
6713842|NCT01798680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713843|NCT01798680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6713844|NCT01798680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6713845|NCT01798771|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6713846|NCT01798771|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6713847|NCT01798771|Dermatologic Agents|dermatologic agents|mesh-ancestor
6713848|NCT01798836|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6713849|NCT01798836|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6713850|NCT01798836|Estradiol|estradiol|mesh-list
6713851|NCT01798836|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6713852|NCT01798836|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
6713853|NCT01798836|Estrogens|estrogens|mesh-ancestor
6713854|NCT01798836|Hormones|hormones|mesh-ancestor
6713855|NCT01798836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6713856|NCT01798836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713857|NCT01798836|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6713858|NCT01798836|Contraceptive Agents|contraceptive agents|mesh-ancestor
6713859|NCT01798836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6713860|NCT01798836|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6713861|NCT01798875|Metformin|metformin|mesh-list
6713862|NCT01798875|Contraceptive Agents|contraceptive agents|mesh-list
6713863|NCT01798875|Contraceptives, Oral|contraceptives, oral|mesh-list
6713864|NCT01798875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6713865|NCT01798875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713866|NCT01798875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6713867|NCT01798875|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6713868|NCT01798901|Decitabine|decitabine|mesh-list
6713869|NCT01798901|Azacitidine|azacitidine|mesh-list
6713870|NCT01798901|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
6713871|NCT01798901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6713872|NCT01798901|Antimetabolites|antimetabolites|mesh-ancestor
6713873|NCT01798901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713874|NCT01798901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6713875|NCT01798901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6713876|NCT01798914|Insulin|insulin|mesh-list
6713877|NCT01798914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6713878|NCT01798914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713879|NCT01798940|Pioglitazone|pioglitazone|mesh-list
6713880|NCT01798940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6713881|NCT01798940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713882|NCT01798979|Midazolam|midazolam|mesh-list
6713883|NCT01798979|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6713884|NCT01798979|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6713885|NCT01798979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6713886|NCT01798979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713887|NCT01798979|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6713888|NCT01798979|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6713889|NCT01798979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6713890|NCT01798979|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6713891|NCT01798979|Anesthetics, General|anesthetics, general|mesh-ancestor
6713892|NCT01798979|Anesthetics|anesthetics|mesh-ancestor
6713893|NCT01798979|GABA Modulators|gaba modulators|mesh-ancestor
6713894|NCT01798979|GABA Agents|gaba agents|mesh-ancestor
6713895|NCT01798979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6713896|NCT01798979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713897|NCT01799005|Micronutrients|micronutrients|mesh-list
6713898|NCT01799005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713899|NCT01799057|Metformin|metformin|mesh-list
6713900|NCT01799057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6713901|NCT01799057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713902|NCT01799083|Decitabine|decitabine|mesh-list
6713903|NCT01799083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6713904|NCT01799083|Antimetabolites|antimetabolites|mesh-ancestor
6713905|NCT01799083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713906|NCT01799083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6713907|NCT01799083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6713908|NCT01799109|Magnesium Sulfate|magnesium sulfate|mesh-list
6713909|NCT01799109|Albuterol|albuterol|mesh-list
6713910|NCT01799109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6713911|NCT01799109|Autonomic Agents|autonomic agents|mesh-ancestor
6713912|NCT01799109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6713913|NCT01799109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713914|NCT01799109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6713915|NCT01799109|Respiratory System Agents|respiratory system agents|mesh-ancestor
6713916|NCT01799109|Tocolytic Agents|tocolytic agents|mesh-ancestor
6713917|NCT01799109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6713918|NCT01799109|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6713919|NCT01799109|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6713920|NCT01799109|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6713921|NCT01799109|Adrenergic Agents|adrenergic agents|mesh-ancestor
6713922|NCT01799109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6713923|NCT01799109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713924|NCT01799109|Analgesics|analgesics|mesh-ancestor
6713925|NCT01799109|Sensory System Agents|sensory system agents|mesh-ancestor
6713926|NCT01799109|Anesthetics|anesthetics|mesh-ancestor
6713927|NCT01799109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6713928|NCT01799109|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6713929|NCT01799109|Anticonvulsants|anticonvulsants|mesh-ancestor
6713930|NCT01799109|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6713931|NCT01799109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6713932|NCT01799109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6713933|NCT01799161|Theophylline|theophylline|mesh-list
6713934|NCT01799161|Vaccines|vaccines|mesh-list
6713935|NCT01799161|Immunologic Factors|immunologic factors|mesh-ancestor
6713936|NCT01799161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713937|NCT01799161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6713938|NCT01799161|Autonomic Agents|autonomic agents|mesh-ancestor
6713939|NCT01799161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6713940|NCT01799161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6713941|NCT01799161|Respiratory System Agents|respiratory system agents|mesh-ancestor
6713942|NCT01799161|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6713943|NCT01799161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6713944|NCT01799161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713945|NCT01799161|Vasodilator Agents|vasodilator agents|mesh-ancestor
6713946|NCT01799161|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6713947|NCT01799161|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6713948|NCT01799161|Purinergic Agents|purinergic agents|mesh-ancestor
6713949|NCT01799161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6783241|NCT02195466|Ritonavir|ritonavir|mesh-list
6783242|NCT02195466|Tipranavir|tipranavir|mesh-list
6783243|NCT02195466|Fluconazole|fluconazole|mesh-list
6783244|NCT02195466|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6783245|NCT02195466|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6783246|NCT02195466|Protease Inhibitors|protease inhibitors|mesh-ancestor
6783247|NCT02195466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6783248|NCT02195466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783249|NCT02195466|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6783250|NCT02195466|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6783251|NCT02195466|Antiviral Agents|antiviral agents|mesh-ancestor
6783252|NCT02195466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6783253|NCT02195466|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6783254|NCT02195466|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6783255|NCT02195466|Antifungal Agents|antifungal agents|mesh-ancestor
6783256|NCT02195466|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6783257|NCT02195466|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6783258|NCT02195466|Hormone Antagonists|hormone antagonists|mesh-ancestor
6783259|NCT02195466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6783260|NCT02195466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783261|NCT02195466|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6783262|NCT02195466|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6783263|NCT02195492|Hylan|hylan|mesh-list
6783264|NCT02195492|Viscosupplements|viscosupplements|mesh-ancestor
6783265|NCT02195492|Protective Agents|protective agents|mesh-ancestor
6783266|NCT02195492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783267|NCT02195544|Hylan|hylan|mesh-list
6783268|NCT02195544|Viscosupplements|viscosupplements|mesh-ancestor
6783269|NCT02195544|Protective Agents|protective agents|mesh-ancestor
6783270|NCT02195544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783271|NCT02195557|Hylan|hylan|mesh-list
6783272|NCT02195557|Viscosupplements|viscosupplements|mesh-ancestor
6783273|NCT02195557|Protective Agents|protective agents|mesh-ancestor
6783274|NCT02195557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783275|NCT02195635|Octreotide|octreotide|mesh-list
6783276|NCT02195635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6783277|NCT02195635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6783278|NCT02195635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6783279|NCT02195661|Melatonin|melatonin|mesh-list
6783280|NCT02195661|Chloral Hydrate|chloral hydrate|mesh-list
6783281|NCT02195661|Antioxidants|antioxidants|mesh-ancestor
6783282|NCT02195661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783283|NCT02195661|Protective Agents|protective agents|mesh-ancestor
6783284|NCT02195661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783285|NCT02195661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6783286|NCT02195661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6783287|NCT02195791|Pioglitazone|pioglitazone|mesh-list
6783288|NCT02195791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6783289|NCT02195791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783290|NCT02195804|Ranitidine|ranitidine|mesh-list
6783291|NCT02195804|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
6783292|NCT02195804|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6783293|NCT02195804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6783294|NCT02195804|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6713950|NCT01799317|Vitamin D|vitamin d|mesh-list
6713951|NCT01799317|Ergocalciferols|ergocalciferols|mesh-list
6713952|NCT01799317|Vitamins|vitamins|mesh-ancestor
6713953|NCT01799317|Micronutrients|micronutrients|mesh-ancestor
6713954|NCT01799317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713955|NCT01799317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6713956|NCT01799317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6713957|NCT01799356|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6713958|NCT01799356|Moxifloxacin|moxifloxacin|mesh-list
6713959|NCT01799356|Metronidazole|metronidazole|mesh-list
6713960|NCT01799356|Ofloxacin|ofloxacin|mesh-list
6713961|NCT01799356|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6713962|NCT01799356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6713963|NCT01799356|Antitubercular Agents|antitubercular agents|mesh-ancestor
6713964|NCT01799356|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6713965|NCT01799356|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6713966|NCT01799356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6713967|NCT01799356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713968|NCT01799356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6713969|NCT01799356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6713970|NCT01799356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6713971|NCT01799356|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6713972|NCT01799356|Renal Agents|renal agents|mesh-ancestor
6713973|NCT01799356|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6713974|NCT01799356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6713975|NCT01799460|Cyclosporine|cyclosporine|mesh-list
6713976|NCT01799460|Cyclophosphamide|cyclophosphamide|mesh-list
6713977|NCT01799460|Tacrolimus|tacrolimus|mesh-list
6713978|NCT01799460|Cyclosporins|cyclosporins|mesh-list
6713979|NCT01799460|Immunosuppressive Agents|immunosuppressive agents|mesh-list
6713980|NCT01799460|Glucocorticoids|glucocorticoids|mesh-list
6713981|NCT01799460|Immunologic Factors|immunologic factors|mesh-ancestor
6713982|NCT01799460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6713983|NCT01799460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6713984|NCT01799460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6713985|NCT01799460|Alkylating Agents|alkylating agents|mesh-ancestor
6713986|NCT01799460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6713987|NCT01799460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6713988|NCT01799460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6713989|NCT01799460|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6713990|NCT01799460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6713991|NCT01799460|Antifungal Agents|antifungal agents|mesh-ancestor
6713992|NCT01799460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6713993|NCT01799460|Dermatologic Agents|dermatologic agents|mesh-ancestor
6713994|NCT01799460|Hormones|hormones|mesh-ancestor
6713995|NCT01799460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6713996|NCT01799486|Adefovir|adefovir|mesh-list
6713997|NCT01799486|Telbivudine|telbivudine|mesh-list
6713998|NCT01799486|Antiviral Agents|antiviral agents|mesh-ancestor
6713999|NCT01799486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6714000|NCT01799486|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6714001|NCT01799486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6714002|NCT01799486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6714003|NCT01799486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714004|NCT01799603|Simeprevir|simeprevir|mesh-list
6714005|NCT01799603|Antiviral Agents|antiviral agents|mesh-ancestor
6714006|NCT01799603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6714007|NCT01799603|Protease Inhibitors|protease inhibitors|mesh-ancestor
6714008|NCT01799603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6714009|NCT01799603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714010|NCT01799616|Pamidronate|pamidronate|mesh-list
6714011|NCT01799616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6714012|NCT01799616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714013|NCT01799629|Glycerol|glycerol|mesh-list
6714014|NCT01799629|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6714015|NCT01799629|Protective Agents|protective agents|mesh-ancestor
6714016|NCT01799629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714017|NCT01799798|Denosumab|denosumab|mesh-list
6714018|NCT01799798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6714019|NCT01799798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714020|NCT01799850|Pioglitazone|pioglitazone|mesh-list
6714021|NCT01799850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6714022|NCT01799850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714023|NCT01799863|Ketorolac|ketorolac|mesh-list
6714024|NCT01799863|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6714025|NCT01799863|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6714026|NCT01799863|Lubricant Eye Drops|lubricant eye drops|mesh-list
6714027|NCT01799863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6714028|NCT01799863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6714029|NCT01799863|Analgesics|analgesics|mesh-ancestor
6714030|NCT01799863|Sensory System Agents|sensory system agents|mesh-ancestor
6714031|NCT01799863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6714032|NCT01799863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714033|NCT01799863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6714034|NCT01799863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6714035|NCT01799863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6714036|NCT01799863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6714037|NCT01799863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714038|NCT01799863|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6714039|NCT01799863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6714040|NCT01799863|Laxatives|laxatives|mesh-ancestor
6714041|NCT01799863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6714042|NCT01799902|Solifenacin Succinate|solifenacin succinate|mesh-list
6714043|NCT01799902|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6714044|NCT01799902|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6714045|NCT01799902|Cholinergic Agents|cholinergic agents|mesh-ancestor
6714046|NCT01799902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6714047|NCT01799902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714048|NCT01799902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714049|NCT01799902|Urological Agents|urological agents|mesh-ancestor
6714050|NCT01799954|Vaccines|vaccines|mesh-list
6714051|NCT01799954|Immunologic Factors|immunologic factors|mesh-ancestor
6714052|NCT01799954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714053|NCT01800006|Rivaroxaban|rivaroxaban|mesh-list
6714054|NCT01800006|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6714055|NCT01800006|Antithrombins|antithrombins|mesh-ancestor
6714056|NCT01800006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6714057|NCT01800006|Protease Inhibitors|protease inhibitors|mesh-ancestor
6714058|NCT01800006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6714059|NCT01800006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714060|NCT01800006|Anticoagulants|anticoagulants|mesh-ancestor
6714061|NCT01800019|Nicotine|nicotine|mesh-list
6714062|NCT01800019|Varenicline|varenicline|mesh-list
6714063|NCT01800019|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6714064|NCT01800019|Autonomic Agents|autonomic agents|mesh-ancestor
6714065|NCT01800019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6714066|NCT01800019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714067|NCT01800019|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6714068|NCT01800019|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6714069|NCT01800019|Cholinergic Agents|cholinergic agents|mesh-ancestor
6714070|NCT01800019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6714071|NCT01800019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714072|NCT01800097|Modafinil|modafinil|mesh-list
6714073|NCT01800097|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6714074|NCT01800097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714075|NCT01800097|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6714076|NCT01800097|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6714077|NCT01800097|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6714078|NCT01800097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714079|NCT01800227|Metformin|metformin|mesh-list
6714080|NCT01800227|Pioglitazone|pioglitazone|mesh-list
6714081|NCT01800227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6714082|NCT01800227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714083|NCT01800240|Metformin|metformin|mesh-list
6714084|NCT01800240|Pioglitazone|pioglitazone|mesh-list
6714085|NCT01800240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6714086|NCT01800240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714087|NCT01800292|Sildenafil Citrate|sildenafil citrate|mesh-list
6714088|NCT01800292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714089|NCT01800292|Vasodilator Agents|vasodilator agents|mesh-ancestor
6714090|NCT01800292|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6714091|NCT01800292|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6714092|NCT01800292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6714093|NCT01800292|Urological Agents|urological agents|mesh-ancestor
6714094|NCT01800357|Aspirin|aspirin|mesh-list
6714095|NCT01800357|3-(2,2,2-trimethylhydrazine)propionate|3-(2,2,2-trimethylhydrazine)propionate|mesh-list
6714096|NCT01800357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6714097|NCT01800357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6714098|NCT01800357|Analgesics|analgesics|mesh-ancestor
6714099|NCT01800357|Sensory System Agents|sensory system agents|mesh-ancestor
6714100|NCT01800357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6714101|NCT01800357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714102|NCT01800357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6714103|NCT01800357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6714104|NCT01800357|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6714105|NCT01800357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6714106|NCT01800357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714107|NCT01800357|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6714108|NCT01800357|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6714109|NCT01800357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6714110|NCT01800357|Antipyretics|antipyretics|mesh-ancestor
6714111|NCT01800357|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6714112|NCT01800357|Immunologic Factors|immunologic factors|mesh-ancestor
6714113|NCT01800396|Caseins|caseins|mesh-list
6714114|NCT01800396|Chelating Agents|chelating agents|mesh-ancestor
6714115|NCT01800396|Sequestering Agents|sequestering agents|mesh-ancestor
6714116|NCT01800396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714117|NCT01800422|Progesterone|progesterone|mesh-list
6714118|NCT01800422|Progestins|progestins|mesh-ancestor
6714119|NCT01800422|Hormones|hormones|mesh-ancestor
6714120|NCT01800422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6714121|NCT01800422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714122|NCT01800435|Tranexamic Acid|tranexamic acid|mesh-list
6714123|NCT01800435|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
6714124|NCT01800435|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6714125|NCT01800435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6714126|NCT01800435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714127|NCT01800435|Hemostatics|hemostatics|mesh-ancestor
6714128|NCT01800435|Coagulants|coagulants|mesh-ancestor
6714129|NCT01800487|Silymarin|silymarin|mesh-list
6714130|NCT01800487|Antioxidants|antioxidants|mesh-ancestor
6714131|NCT01800487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714132|NCT01800487|Protective Agents|protective agents|mesh-ancestor
6714133|NCT01800487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714134|NCT01800526|Acetylcysteine|acetylcysteine|mesh-list
6714135|NCT01800526|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6714136|NCT01800526|Antiviral Agents|antiviral agents|mesh-ancestor
6714137|NCT01800526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6714138|NCT01800526|Expectorants|expectorants|mesh-ancestor
6714139|NCT01800526|Respiratory System Agents|respiratory system agents|mesh-ancestor
6714140|NCT01800526|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6714141|NCT01800526|Antioxidants|antioxidants|mesh-ancestor
6714142|NCT01800526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714143|NCT01800526|Protective Agents|protective agents|mesh-ancestor
6714144|NCT01800526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714145|NCT01800526|Antidotes|antidotes|mesh-ancestor
6714146|NCT01800630|Gemcitabine|gemcitabine|mesh-list
6714147|NCT01800630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6714148|NCT01800630|Antimetabolites|antimetabolites|mesh-ancestor
6714149|NCT01800630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714150|NCT01800630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6714151|NCT01800630|Antiviral Agents|antiviral agents|mesh-ancestor
6714152|NCT01800630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6714153|NCT01800630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6714154|NCT01800630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6714155|NCT01800630|Immunologic Factors|immunologic factors|mesh-ancestor
6714156|NCT01800630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714157|NCT01800643|Busulfan|busulfan|mesh-list
6714158|NCT01800643|Alkylating Agents|alkylating agents|mesh-ancestor
6714159|NCT01800643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714160|NCT01800643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6714161|NCT01800643|Immunologic Factors|immunologic factors|mesh-ancestor
6714162|NCT01800643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714163|NCT01800643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6714164|NCT01800643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6714165|NCT01800643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6714166|NCT01800695|Temozolomide|temozolomide|mesh-list
6714167|NCT01800695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6714168|NCT01800695|Alkylating Agents|alkylating agents|mesh-ancestor
6714169|NCT01800695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714170|NCT01800695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6714171|NCT01800708|Prednisolone|prednisolone|mesh-list
6714172|NCT01800708|Triamcinolone|triamcinolone|mesh-list
6714173|NCT01800708|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6714174|NCT01800708|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6714175|NCT01800708|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6714176|NCT01800708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6714177|NCT01800708|Glucocorticoids|glucocorticoids|mesh-ancestor
6714178|NCT01800708|Hormones|hormones|mesh-ancestor
6714179|NCT01800708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6714180|NCT01800708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714181|NCT01800708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6714182|NCT01800708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6714183|NCT01800708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6714184|NCT01800708|Immunologic Factors|immunologic factors|mesh-ancestor
6714185|NCT01800708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6714186|NCT01800708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714187|NCT01800747|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6714188|NCT01800747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6783295|NCT02195804|Histamine Antagonists|histamine antagonists|mesh-ancestor
6783296|NCT02195804|Histamine Agents|histamine agents|mesh-ancestor
6783297|NCT02195804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6783298|NCT02195804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783299|NCT02195804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783300|NCT02195817|Nalmefene|nalmefene|mesh-list
6783301|NCT02195817|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6783302|NCT02195817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783303|NCT02195817|Sensory System Agents|sensory system agents|mesh-ancestor
6783304|NCT02195817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6783305|NCT02195908|Antiemetics|antiemetics|mesh-list
6783306|NCT02195908|Autonomic Agents|autonomic agents|mesh-ancestor
6783307|NCT02195908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6783308|NCT02195908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783309|NCT02195908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6783310|NCT02195973|Paclitaxel|paclitaxel|mesh-list
6783311|NCT02195973|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6783312|NCT02195973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6783313|NCT02195973|Tubulin Modulators|tubulin modulators|mesh-ancestor
6783314|NCT02195973|Antimitotic Agents|antimitotic agents|mesh-ancestor
6783315|NCT02195973|Mitosis Modulators|mitosis modulators|mesh-ancestor
6783316|NCT02195973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783317|NCT02196142|Hydrocortisone|hydrocortisone|mesh-list
6783318|NCT02196142|Mannitol|mannitol|mesh-list
6783319|NCT02196142|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6783320|NCT02196142|Diuretics|diuretics|mesh-ancestor
6783321|NCT02196142|Natriuretic Agents|natriuretic agents|mesh-ancestor
6783322|NCT02196142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783323|NCT02196142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6783324|NCT02196155|Cortisone|cortisone|mesh-list
6783325|NCT02196155|Botulinum Toxins|botulinum toxins|mesh-list
6783326|NCT02196155|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6783327|NCT02196155|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6783328|NCT02196155|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6783329|NCT02196155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6783330|NCT02196155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783331|NCT02196155|Cholinergic Agents|cholinergic agents|mesh-ancestor
6783332|NCT02196155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6783333|NCT02196155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783334|NCT02196155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6783335|NCT02196155|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6783336|NCT02196155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6783337|NCT02196194|Tiotropium Bromide|tiotropium bromide|mesh-list
6783338|NCT02196194|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6783339|NCT02196194|Autonomic Agents|autonomic agents|mesh-ancestor
6783340|NCT02196194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6783341|NCT02196194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783342|NCT02196194|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6783343|NCT02196194|Respiratory System Agents|respiratory system agents|mesh-ancestor
6783344|NCT02196194|Parasympatholytics|parasympatholytics|mesh-ancestor
6783345|NCT02196194|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6783346|NCT02196194|Cholinergic Agents|cholinergic agents|mesh-ancestor
6783347|NCT02196194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6783348|NCT02196194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783349|NCT02196207|Antibodies, Bispecific|antibodies, bispecific|mesh-list
6783350|NCT02196207|Immunologic Factors|immunologic factors|mesh-ancestor
6783351|NCT02196207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783352|NCT02196285|Vaccines|vaccines|mesh-list
6783353|NCT02196285|Immunologic Factors|immunologic factors|mesh-ancestor
6783354|NCT02196285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714189|NCT01800799|Anti-Infective Agents|anti-infective agents|mesh-list
6714190|NCT01800799|Celecoxib|celecoxib|mesh-list
6714191|NCT01800799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
6714192|NCT01800799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6714193|NCT01800799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6714194|NCT01800799|Analgesics|analgesics|mesh-ancestor
6714195|NCT01800799|Sensory System Agents|sensory system agents|mesh-ancestor
6714196|NCT01800799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6714197|NCT01800799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714198|NCT01800799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6714199|NCT01800799|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6714200|NCT01800799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6714201|NCT01800799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6714202|NCT01800799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714203|NCT01800825|Clindamycin|clindamycin|mesh-list
6714204|NCT01800825|Clindamycin palmitate|clindamycin palmitate|mesh-list
6714205|NCT01800825|Clindamycin phosphate|clindamycin phosphate|mesh-list
6714206|NCT01800825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6714207|NCT01800825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6714208|NCT01800825|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6714209|NCT01800825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6714210|NCT01800825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714211|NCT01800942|Azithromycin|azithromycin|mesh-list
6714212|NCT01800942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6714213|NCT01800942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6714214|NCT01801046|Cytarabine|cytarabine|mesh-list
6714215|NCT01801046|Mitoxantrone|mitoxantrone|mesh-list
6714216|NCT01801046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6714217|NCT01801046|Antimetabolites|antimetabolites|mesh-ancestor
6714218|NCT01801046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714219|NCT01801046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6714220|NCT01801046|Antiviral Agents|antiviral agents|mesh-ancestor
6714221|NCT01801046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6714222|NCT01801046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6714223|NCT01801046|Immunologic Factors|immunologic factors|mesh-ancestor
6714224|NCT01801046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714225|NCT01801046|Analgesics|analgesics|mesh-ancestor
6714226|NCT01801046|Sensory System Agents|sensory system agents|mesh-ancestor
6714227|NCT01801046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6714228|NCT01801046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6714229|NCT01801046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6714230|NCT01801046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6714231|NCT01801072|Levetiracetam|levetiracetam|mesh-list
6714232|NCT01801072|Anticonvulsants|anticonvulsants|mesh-ancestor
6714233|NCT01801072|Nootropic Agents|nootropic agents|mesh-ancestor
6714234|NCT01801137|Everolimus|everolimus|mesh-list
6714235|NCT01801137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6714236|NCT01801137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6714237|NCT01801137|Immunologic Factors|immunologic factors|mesh-ancestor
6714238|NCT01801137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714239|NCT01801163|Sorafenib|sorafenib|mesh-list
6714240|NCT01801163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6714241|NCT01801163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6714242|NCT01801163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6714243|NCT01801163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714244|NCT01801189|Pregabalin|pregabalin|mesh-list
6714245|NCT01801189|Analgesics|analgesics|mesh-ancestor
6714246|NCT01801189|Sensory System Agents|sensory system agents|mesh-ancestor
6714247|NCT01801189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6714248|NCT01801189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714249|NCT01801189|Anticonvulsants|anticonvulsants|mesh-ancestor
6714250|NCT01801189|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6714251|NCT01801189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6714252|NCT01801189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714253|NCT01801189|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6714254|NCT01801189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6714255|NCT01801189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6714256|NCT01801189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6714257|NCT01801189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6714258|NCT01801228|Eplerenone|eplerenone|mesh-list
6714259|NCT01801228|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6714260|NCT01801228|Hormone Antagonists|hormone antagonists|mesh-ancestor
6714261|NCT01801228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6714262|NCT01801228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714263|NCT01801228|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6714264|NCT01801228|Diuretics|diuretics|mesh-ancestor
6714265|NCT01801228|Natriuretic Agents|natriuretic agents|mesh-ancestor
6714266|NCT01801228|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6714267|NCT01801410|Misoprostol|misoprostol|mesh-list
6714268|NCT01801410|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6714269|NCT01801410|Abortifacient Agents|abortifacient agents|mesh-ancestor
6714270|NCT01801410|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6714271|NCT01801410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714272|NCT01801410|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6714273|NCT01801410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6714274|NCT01801410|Oxytocics|oxytocics|mesh-ancestor
6714275|NCT01801423|Hydroxyurea|hydroxyurea|mesh-list
6714276|NCT01801423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6714277|NCT01801423|Antisickling Agents|antisickling agents|mesh-ancestor
6714278|NCT01801423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6714279|NCT01801423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714280|NCT01801423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6714281|NCT01801644|Gemcitabine|gemcitabine|mesh-list
6714282|NCT01801644|Cisplatin|cisplatin|mesh-list
6714283|NCT01801644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6714284|NCT01801644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6714285|NCT01801644|Antimetabolites|antimetabolites|mesh-ancestor
6714286|NCT01801644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714287|NCT01801644|Antiviral Agents|antiviral agents|mesh-ancestor
6714288|NCT01801644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6714289|NCT01801644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6714290|NCT01801644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6714291|NCT01801644|Immunologic Factors|immunologic factors|mesh-ancestor
6714292|NCT01801644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714293|NCT01801774|Triamcinolone|triamcinolone|mesh-list
6714294|NCT01801774|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6714295|NCT01801774|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6714296|NCT01801774|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6714297|NCT01801774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6714298|NCT01801774|Glucocorticoids|glucocorticoids|mesh-ancestor
6714299|NCT01801774|Hormones|hormones|mesh-ancestor
6714300|NCT01801774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6714301|NCT01801774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714302|NCT01801774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6714303|NCT01801774|Immunologic Factors|immunologic factors|mesh-ancestor
6714304|NCT01801774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6714305|NCT01801774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714306|NCT01801904|Panitumumab|panitumumab|mesh-list
6714307|NCT01801904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6714308|NCT01801904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6714309|NCT01802255|Midazolam|midazolam|mesh-list
6714310|NCT01802255|Sevoflurane|sevoflurane|mesh-list
6714311|NCT01802255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6714312|NCT01802255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6714313|NCT01802255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6714314|NCT01802255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714315|NCT01802255|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6714316|NCT01802255|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6714317|NCT01802255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6714318|NCT01802255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6714319|NCT01802255|Anesthetics, General|anesthetics, general|mesh-ancestor
6714320|NCT01802255|Anesthetics|anesthetics|mesh-ancestor
6714321|NCT01802255|GABA Modulators|gaba modulators|mesh-ancestor
6714322|NCT01802255|GABA Agents|gaba agents|mesh-ancestor
6714323|NCT01802255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6714324|NCT01802255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714325|NCT01802255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6714326|NCT01802255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6714327|NCT01802268|Sirolimus|sirolimus|mesh-list
6714328|NCT01802268|Tacrolimus|tacrolimus|mesh-list
6714329|NCT01802268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6714330|NCT01802268|Immunologic Factors|immunologic factors|mesh-ancestor
6714331|NCT01802268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714332|NCT01802268|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6714333|NCT01802268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6714334|NCT01802268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714335|NCT01802268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6714336|NCT01802268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6714337|NCT01802268|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6714338|NCT01802268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6714339|NCT01802268|Antifungal Agents|antifungal agents|mesh-ancestor
6714340|NCT01802450|Dasatinib|dasatinib|mesh-list
6714341|NCT01802450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6714342|NCT01802450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6714343|NCT01802450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6714344|NCT01802450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714345|NCT01802476|Palbociclib|palbociclib|mesh-list
6714346|NCT01802476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6714347|NCT01802476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6714348|NCT01802476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6714349|NCT01802476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714350|NCT01802489|Amiloride|amiloride|mesh-list
6714351|NCT01802489|Diuretics|diuretics|mesh-ancestor
6714352|NCT01802489|Natriuretic Agents|natriuretic agents|mesh-ancestor
6714353|NCT01802489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714354|NCT01802489|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
6714355|NCT01802489|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6714356|NCT01802489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6714357|NCT01802489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714358|NCT01802489|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
6714359|NCT01802489|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6714360|NCT01802502|Rifampin|rifampin|mesh-list
6714361|NCT01802502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6714362|NCT01802502|Antitubercular Agents|antitubercular agents|mesh-ancestor
6714363|NCT01802502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6714364|NCT01802502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6714365|NCT01802502|Leprostatic Agents|leprostatic agents|mesh-ancestor
6714366|NCT01802502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6714367|NCT01802502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6714368|NCT01802502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714369|NCT01802502|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6714370|NCT01802502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6714371|NCT01802502|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6714372|NCT01802502|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6714373|NCT01802502|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6714374|NCT01802502|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6783355|NCT02196441|Bupivacaine|bupivacaine|mesh-list
6783356|NCT02196441|Anesthetics, Local|anesthetics, local|mesh-list
6783357|NCT02196441|Tetracaine|tetracaine|mesh-list
6783358|NCT02196441|Anesthetics|anesthetics|mesh-list
6783359|NCT02196441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6783360|NCT02196441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783361|NCT02196441|Sensory System Agents|sensory system agents|mesh-ancestor
6783362|NCT02196441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6783363|NCT02196493|Azithromycin|azithromycin|mesh-list
6783364|NCT02196493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6783365|NCT02196493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6783366|NCT02196662|Mesalamine|mesalamine|mesh-list
6783367|NCT02196662|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6783368|NCT02196662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6783369|NCT02196662|Analgesics|analgesics|mesh-ancestor
6783370|NCT02196662|Sensory System Agents|sensory system agents|mesh-ancestor
6783371|NCT02196662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6783372|NCT02196662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783373|NCT02196662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6783374|NCT02196662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6783375|NCT02196740|Metronidazole|metronidazole|mesh-list
6783376|NCT02196740|Ciprofloxacin|ciprofloxacin|mesh-list
6783377|NCT02196740|Clindamycin|clindamycin|mesh-list
6783378|NCT02196740|Clindamycin palmitate|clindamycin palmitate|mesh-list
6783379|NCT02196740|Clindamycin phosphate|clindamycin phosphate|mesh-list
6783380|NCT02196740|Gatifloxacin|gatifloxacin|mesh-list
6783381|NCT02196740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6783382|NCT02196740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6783383|NCT02196740|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6783384|NCT02196740|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6783385|NCT02196740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6783386|NCT02196740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6714375|NCT01802593|Methotrexate|methotrexate|mesh-list
6714376|NCT01802593|Mercaptopurine|mercaptopurine|mesh-list
6714377|NCT01802593|Azathioprine|azathioprine|mesh-list
6714378|NCT01802593|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6714379|NCT01802593|Abortifacient Agents|abortifacient agents|mesh-ancestor
6714380|NCT01802593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6714381|NCT01802593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714382|NCT01802593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6714383|NCT01802593|Antimetabolites|antimetabolites|mesh-ancestor
6714384|NCT01802593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714385|NCT01802593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6714386|NCT01802593|Dermatologic Agents|dermatologic agents|mesh-ancestor
6714387|NCT01802593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6714388|NCT01802593|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6714389|NCT01802593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6714390|NCT01802593|Immunologic Factors|immunologic factors|mesh-ancestor
6714391|NCT01802593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6714392|NCT01802593|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6714393|NCT01802619|Nitric Oxide|nitric oxide|mesh-list
6714394|NCT01802619|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6714395|NCT01802619|Autonomic Agents|autonomic agents|mesh-ancestor
6714396|NCT01802619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6714397|NCT01802619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714398|NCT01802619|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6714399|NCT01802619|Respiratory System Agents|respiratory system agents|mesh-ancestor
6714400|NCT01802619|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6714401|NCT01802619|Antioxidants|antioxidants|mesh-ancestor
6714402|NCT01802619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714403|NCT01802619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6714404|NCT01802619|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6714405|NCT01802619|Vasodilator Agents|vasodilator agents|mesh-ancestor
6714406|NCT01802619|Gasotransmitters|gasotransmitters|mesh-ancestor
6714407|NCT01802619|Protective Agents|protective agents|mesh-ancestor
6714408|NCT01802645|Leucovorin|leucovorin|mesh-list
6714409|NCT01802645|Folic Acid|folic acid|mesh-list
6714410|NCT01802645|Bevacizumab|bevacizumab|mesh-list
6714411|NCT01802645|Cetuximab|cetuximab|mesh-list
6714412|NCT01802645|Fluorouracil|fluorouracil|mesh-list
6714413|NCT01802645|Oxaliplatin|oxaliplatin|mesh-list
6714414|NCT01802645|Irinotecan|irinotecan|mesh-list
6714415|NCT01802645|Levoleucovorin|levoleucovorin|mesh-list
6714416|NCT01802645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6714417|NCT01802645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6714418|NCT01802645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6714419|NCT01802645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6714420|NCT01802645|Growth Substances|growth substances|mesh-ancestor
6714421|NCT01802645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714422|NCT01802645|Growth Inhibitors|growth inhibitors|mesh-ancestor
6714423|NCT01802645|Antimetabolites|antimetabolites|mesh-ancestor
6714424|NCT01802645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714425|NCT01802645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6714426|NCT01802645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6714427|NCT01802645|Immunologic Factors|immunologic factors|mesh-ancestor
6714428|NCT01802645|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6714429|NCT01802645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6714430|NCT01802645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6714431|NCT01802645|Antidotes|antidotes|mesh-ancestor
6714432|NCT01802645|Protective Agents|protective agents|mesh-ancestor
6714433|NCT01802645|Vitamin B Complex|vitamin b complex|mesh-ancestor
6714434|NCT01802645|Vitamins|vitamins|mesh-ancestor
6714435|NCT01802645|Micronutrients|micronutrients|mesh-ancestor
6714436|NCT01802645|Hematinics|hematinics|mesh-ancestor
6714437|NCT01802658|Zoledronic Acid|zoledronic acid|mesh-list
6714438|NCT01802658|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6714439|NCT01802658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714440|NCT01802684|Aflibercept|aflibercept|mesh-list
6714441|NCT01802684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6714442|NCT01802684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6714443|NCT01802684|Growth Substances|growth substances|mesh-ancestor
6714444|NCT01802684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714445|NCT01802684|Growth Inhibitors|growth inhibitors|mesh-ancestor
6714446|NCT01802684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6714447|NCT01802749|Gemcitabine|gemcitabine|mesh-list
6714448|NCT01802749|Paclitaxel|paclitaxel|mesh-list
6714449|NCT01802749|Bevacizumab|bevacizumab|mesh-list
6714450|NCT01802749|Carboplatin|carboplatin|mesh-list
6714451|NCT01802749|Doxorubicin|doxorubicin|mesh-list
6714452|NCT01802749|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6714453|NCT01802749|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6714454|NCT01802749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6714455|NCT01802749|Tubulin Modulators|tubulin modulators|mesh-ancestor
6714456|NCT01802749|Antimitotic Agents|antimitotic agents|mesh-ancestor
6714457|NCT01802749|Mitosis Modulators|mitosis modulators|mesh-ancestor
6714458|NCT01802749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714459|NCT01802749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6714460|NCT01802749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6714461|NCT01802749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6714462|NCT01802749|Growth Substances|growth substances|mesh-ancestor
6714463|NCT01802749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714464|NCT01802749|Growth Inhibitors|growth inhibitors|mesh-ancestor
6714465|NCT01802749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6714466|NCT01802749|Antimetabolites|antimetabolites|mesh-ancestor
6714467|NCT01802749|Antiviral Agents|antiviral agents|mesh-ancestor
6714468|NCT01802749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6714469|NCT01802749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6714470|NCT01802749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6714471|NCT01802749|Immunologic Factors|immunologic factors|mesh-ancestor
6714472|NCT01802749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6714473|NCT01802749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6714474|NCT01802749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6714475|NCT01802814|Epratuzumab|epratuzumab|mesh-list
6714476|NCT01802814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6714477|NCT01802814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6714478|NCT01802892|Plerixafor|plerixafor|mesh-list
6714479|NCT01802892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6714480|NCT01802892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6714481|NCT01802892|Antiviral Agents|antiviral agents|mesh-ancestor
6714482|NCT01802892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6714483|NCT01802918|Ritonavir|ritonavir|mesh-list
6714484|NCT01802918|GSK-2838232|gsk-2838232|mesh-list
6714485|NCT01802918|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6714486|NCT01802918|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6714487|NCT01802918|Protease Inhibitors|protease inhibitors|mesh-ancestor
6714488|NCT01802918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6714489|NCT01802918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714490|NCT01802918|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6714491|NCT01802918|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6714492|NCT01802918|Antiviral Agents|antiviral agents|mesh-ancestor
6714493|NCT01802918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6714494|NCT01802918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6714495|NCT01802918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6714496|NCT01802931|Ketoconazole|ketoconazole|mesh-list
6714497|NCT01802931|Antifungal Agents|antifungal agents|mesh-ancestor
6714498|NCT01802931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6714499|NCT01802931|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6714500|NCT01802931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6714501|NCT01802931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6714502|NCT01802931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714503|NCT01802931|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6714504|NCT01802931|Hormone Antagonists|hormone antagonists|mesh-ancestor
6714505|NCT01802931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6714506|NCT01802931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714507|NCT01802931|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6714508|NCT01802944|Insulin|insulin|mesh-list
6714509|NCT01802944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6714510|NCT01802944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714511|NCT01802970|Paclitaxel|paclitaxel|mesh-list
6714512|NCT01802970|Vinorelbine|vinorelbine|mesh-list
6714513|NCT01802970|Capecitabine|capecitabine|mesh-list
6714514|NCT01802970|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6714515|NCT01802970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6714516|NCT01802970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6714517|NCT01802970|Tubulin Modulators|tubulin modulators|mesh-ancestor
6714518|NCT01802970|Antimitotic Agents|antimitotic agents|mesh-ancestor
6714519|NCT01802970|Mitosis Modulators|mitosis modulators|mesh-ancestor
6714520|NCT01802970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714521|NCT01802970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6714522|NCT01802970|Antimetabolites|antimetabolites|mesh-ancestor
6714523|NCT01802970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6714524|NCT01803087|Formoterol Fumarate|formoterol fumarate|mesh-list
6714525|NCT01803087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6714526|NCT01803087|Autonomic Agents|autonomic agents|mesh-ancestor
6714527|NCT01803087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6714528|NCT01803087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714529|NCT01803087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6714530|NCT01803087|Respiratory System Agents|respiratory system agents|mesh-ancestor
6714531|NCT01803087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6714532|NCT01803087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6714533|NCT01803087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6714534|NCT01803087|Adrenergic Agents|adrenergic agents|mesh-ancestor
6714535|NCT01803087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6714536|NCT01803087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714537|NCT01803152|Gemcitabine|gemcitabine|mesh-list
6714538|NCT01803152|Imiquimod|imiquimod|mesh-list
6714539|NCT01803152|Vaccines|vaccines|mesh-list
6714540|NCT01803152|Immunologic Factors|immunologic factors|mesh-ancestor
6714541|NCT01803152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714542|NCT01803152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6714543|NCT01803152|Antimetabolites|antimetabolites|mesh-ancestor
6714544|NCT01803152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714545|NCT01803152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6714546|NCT01803152|Antiviral Agents|antiviral agents|mesh-ancestor
6714547|NCT01803152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6714548|NCT01803152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6714549|NCT01803152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6714550|NCT01803152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6714551|NCT01803152|Interferon Inducers|interferon inducers|mesh-ancestor
6714552|NCT01803191|Ciprofloxacin|ciprofloxacin|mesh-list
6714553|NCT01803191|Fosfomycin|fosfomycin|mesh-list
6714554|NCT01803191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6714555|NCT01803191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6714556|NCT01803191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6714557|NCT01803191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6714558|NCT01803191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6714559|NCT01803191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714560|NCT01803191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6714561|NCT01803191|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6714562|NCT01803191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6714563|NCT01803321|Rilonacept|rilonacept|mesh-list
6714564|NCT01803321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6714565|NCT01803347|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6714566|NCT01803347|Hemostatics|hemostatics|mesh-ancestor
6714567|NCT01803347|Coagulants|coagulants|mesh-ancestor
6714568|NCT01803399|Moxifloxacin|moxifloxacin|mesh-list
6714569|NCT01803399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6714570|NCT01803399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6714571|NCT01803399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6714572|NCT01803399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6714573|NCT01803399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6714574|NCT01803399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714575|NCT01803399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6714576|NCT01803438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
6714577|NCT01803503|Docetaxel|docetaxel|mesh-list
6714578|NCT01803503|Sunitinib|sunitinib|mesh-list
6714579|NCT01803503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6714580|NCT01803503|Tubulin Modulators|tubulin modulators|mesh-ancestor
6714581|NCT01803503|Antimitotic Agents|antimitotic agents|mesh-ancestor
6714582|NCT01803503|Mitosis Modulators|mitosis modulators|mesh-ancestor
6714583|NCT01803503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714584|NCT01803503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6714585|NCT01803503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6714586|NCT01803503|Growth Substances|growth substances|mesh-ancestor
6714587|NCT01803503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714588|NCT01803503|Growth Inhibitors|growth inhibitors|mesh-ancestor
6714589|NCT01803503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6714590|NCT01803503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6714591|NCT01803555|Budesonide|budesonide|mesh-list
6714592|NCT01803555|Formoterol Fumarate|formoterol fumarate|mesh-list
6714593|NCT01803555|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6714594|NCT01803555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6714595|NCT01803555|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6714596|NCT01803555|Autonomic Agents|autonomic agents|mesh-ancestor
6714597|NCT01803555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6714598|NCT01803555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714599|NCT01803555|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6714600|NCT01803555|Respiratory System Agents|respiratory system agents|mesh-ancestor
6714601|NCT01803555|Glucocorticoids|glucocorticoids|mesh-ancestor
6714602|NCT01803555|Hormones|hormones|mesh-ancestor
6714603|NCT01803555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6714604|NCT01803555|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6714605|NCT01803555|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6714606|NCT01803555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6714607|NCT01803555|Adrenergic Agents|adrenergic agents|mesh-ancestor
6714608|NCT01803555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6714609|NCT01803555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714610|NCT01803594|Nicotinic Acids|nicotinic acids|mesh-list
6714611|NCT01803594|Niacin|niacin|mesh-list
6714612|NCT01803594|Niacinamide|niacinamide|mesh-list
6714613|NCT01803594|Vitamin B Complex|vitamin b complex|mesh-ancestor
6714614|NCT01803594|Vitamins|vitamins|mesh-ancestor
6714615|NCT01803594|Micronutrients|micronutrients|mesh-ancestor
6714616|NCT01803594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714617|NCT01803594|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6714618|NCT01803594|Antimetabolites|antimetabolites|mesh-ancestor
6714619|NCT01803594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714620|NCT01803594|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6714621|NCT01803594|Vasodilator Agents|vasodilator agents|mesh-ancestor
6714622|NCT01803659|Vitamin A|vitamin a|mesh-list
6714623|NCT01803659|Retinol palmitate|retinol palmitate|mesh-list
6714624|NCT01803659|Carotenoids|carotenoids|mesh-list
6714625|NCT01803659|Antioxidants|antioxidants|mesh-ancestor
6714626|NCT01803659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714627|NCT01803659|Protective Agents|protective agents|mesh-ancestor
6714628|NCT01803659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714629|NCT01803659|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6714630|NCT01803659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6714631|NCT01803659|Vitamins|vitamins|mesh-ancestor
6714632|NCT01803659|Micronutrients|micronutrients|mesh-ancestor
6714633|NCT01803763|Omalizumab|omalizumab|mesh-list
6714634|NCT01803763|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6714635|NCT01803763|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6714636|NCT01803763|Respiratory System Agents|respiratory system agents|mesh-ancestor
6714637|NCT01803828|Tadalafil|tadalafil|mesh-list
6714638|NCT01803828|Vasodilator Agents|vasodilator agents|mesh-ancestor
6714639|NCT01803828|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6714640|NCT01803828|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6714641|NCT01803828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6714642|NCT01803828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714643|NCT01803828|Urological Agents|urological agents|mesh-ancestor
6714644|NCT01804127|Rituximab|rituximab|mesh-list
6714645|NCT01804127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6714646|NCT01804127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6714647|NCT01804127|Immunologic Factors|immunologic factors|mesh-ancestor
6714648|NCT01804127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714649|NCT01804127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6714650|NCT01804205|Magnesium Sulfate|magnesium sulfate|mesh-list
6714651|NCT01804205|Analgesics|analgesics|mesh-ancestor
6714652|NCT01804205|Sensory System Agents|sensory system agents|mesh-ancestor
6714653|NCT01804205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6714654|NCT01804205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714655|NCT01804205|Anesthetics|anesthetics|mesh-ancestor
6714656|NCT01804205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6714657|NCT01804205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6714658|NCT01804205|Anticonvulsants|anticonvulsants|mesh-ancestor
6714659|NCT01804205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6714660|NCT01804205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6714661|NCT01804205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714662|NCT01804205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6714663|NCT01804205|Tocolytic Agents|tocolytic agents|mesh-ancestor
6714664|NCT01804205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6714665|NCT01804218|Nadolol|nadolol|mesh-list
6714666|NCT01804218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6714667|NCT01804218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6714668|NCT01804218|Adrenergic Agents|adrenergic agents|mesh-ancestor
6714669|NCT01804218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6714670|NCT01804218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714671|NCT01804218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714672|NCT01804218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6714673|NCT01804218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6714674|NCT01804218|Sympatholytics|sympatholytics|mesh-ancestor
6714675|NCT01804218|Autonomic Agents|autonomic agents|mesh-ancestor
6714676|NCT01804218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6714677|NCT01804244|Rilpivirine|rilpivirine|mesh-list
6714678|NCT01804244|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6714679|NCT01804244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6714680|NCT01804244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6714681|NCT01804244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714682|NCT01804244|Antiviral Agents|antiviral agents|mesh-ancestor
6714683|NCT01804244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6714684|NCT01804244|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6714685|NCT01804244|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6783387|NCT02196740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6783388|NCT02196740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783389|NCT02196740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6783390|NCT02196740|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6783391|NCT02196740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6783392|NCT02196740|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6783393|NCT02196740|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6783394|NCT02196740|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6783395|NCT02196805|Probucol|probucol|mesh-list
6783396|NCT02196805|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6783397|NCT02196805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6783398|NCT02196805|Antimetabolites|antimetabolites|mesh-ancestor
6783399|NCT02196805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783400|NCT02196805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6783401|NCT02196805|Antioxidants|antioxidants|mesh-ancestor
6783402|NCT02196805|Protective Agents|protective agents|mesh-ancestor
6783403|NCT02196805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783404|NCT02197000|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
6783405|NCT02197000|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6783406|NCT02197000|Protective Agents|protective agents|mesh-ancestor
6783407|NCT02197000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783408|NCT02197000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6783409|NCT02197026|Hylan|hylan|mesh-list
6783410|NCT02197026|Viscosupplements|viscosupplements|mesh-ancestor
6783411|NCT02197026|Protective Agents|protective agents|mesh-ancestor
6783412|NCT02197026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783413|NCT02197039|Esomeprazole|esomeprazole|mesh-list
6783414|NCT02197039|Pantoprazole|pantoprazole|mesh-list
6783415|NCT02197039|Hemostatics|hemostatics|mesh-list
6783416|NCT02197039|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6783417|NCT02197039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6783418|NCT02197039|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6783419|NCT02197039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6783420|NCT02197039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783421|NCT02197039|Coagulants|coagulants|mesh-ancestor
6783422|NCT02197143|Esomeprazole|esomeprazole|mesh-list
6783423|NCT02197143|Ranitidine|ranitidine|mesh-list
6783424|NCT02197143|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
6783425|NCT02197143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6783426|NCT02197143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6783427|NCT02197143|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6783428|NCT02197143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6783429|NCT02197143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783430|NCT02197143|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6783431|NCT02197143|Histamine Antagonists|histamine antagonists|mesh-ancestor
6783432|NCT02197143|Histamine Agents|histamine agents|mesh-ancestor
6783433|NCT02197143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6783434|NCT02197143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783435|NCT02197156|Acetaminophen|acetaminophen|mesh-list
6783436|NCT02197156|Hydrocodone|hydrocodone|mesh-list
6783437|NCT02197156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6783438|NCT02197156|Analgesics|analgesics|mesh-ancestor
6783439|NCT02197156|Sensory System Agents|sensory system agents|mesh-ancestor
6783440|NCT02197156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6783441|NCT02197156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783442|NCT02197156|Antipyretics|antipyretics|mesh-ancestor
6783443|NCT02197156|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6783444|NCT02197156|Narcotics|narcotics|mesh-ancestor
6783445|NCT02197156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6783446|NCT02197156|Antitussive Agents|antitussive agents|mesh-ancestor
6783447|NCT02197156|Respiratory System Agents|respiratory system agents|mesh-ancestor
6783448|NCT02197169|Interferons|interferons|mesh-list
6783449|NCT02197169|Interferon-gamma|interferon-gamma|mesh-list
6783450|NCT02197169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6783451|NCT02197169|Antiviral Agents|antiviral agents|mesh-ancestor
6783452|NCT02197169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6783453|NCT02197182|Copper|copper|mesh-list
6783454|NCT02197182|Metronidazole|metronidazole|mesh-list
6783455|NCT02197182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6714686|NCT01804335|Trifarotene|trifarotene|mesh-list
6714687|NCT01804335|Dermatologic Agents|dermatologic agents|mesh-ancestor
6714688|NCT01804361|Cyclosporine|cyclosporine|mesh-list
6714689|NCT01804361|Cyclosporins|cyclosporins|mesh-list
6714690|NCT01804361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6714691|NCT01804361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714692|NCT01804361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6714693|NCT01804361|Immunologic Factors|immunologic factors|mesh-ancestor
6714694|NCT01804361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714695|NCT01804361|Antifungal Agents|antifungal agents|mesh-ancestor
6714696|NCT01804361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6714697|NCT01804361|Dermatologic Agents|dermatologic agents|mesh-ancestor
6714698|NCT01804361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6714699|NCT01804361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6714700|NCT01804374|Everolimus|everolimus|mesh-list
6714701|NCT01804374|Sorafenib|sorafenib|mesh-list
6714702|NCT01804374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6714703|NCT01804374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6714704|NCT01804374|Immunologic Factors|immunologic factors|mesh-ancestor
6714705|NCT01804374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714706|NCT01804374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6714707|NCT01804374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6714708|NCT01804374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714709|NCT01804387|Lamivudine|lamivudine|mesh-list
6714710|NCT01804387|Adefovir|adefovir|mesh-list
6714711|NCT01804387|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6714712|NCT01804387|Telbivudine|telbivudine|mesh-list
6714713|NCT01804387|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6714714|NCT01804387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6714715|NCT01804387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6714716|NCT01804387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714717|NCT01804387|Antiviral Agents|antiviral agents|mesh-ancestor
6714718|NCT01804387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6714719|NCT01804387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6714720|NCT01804387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6714721|NCT01804400|Montelukast|montelukast|mesh-list
6714722|NCT01804400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6714723|NCT01804400|Respiratory System Agents|respiratory system agents|mesh-ancestor
6714724|NCT01804400|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6714725|NCT01804400|Hormone Antagonists|hormone antagonists|mesh-ancestor
6714726|NCT01804400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6714727|NCT01804400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714728|NCT01804400|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6714729|NCT01804400|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6714730|NCT01804400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714731|NCT01804413|Insulin|insulin|mesh-list
6714732|NCT01804413|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6714733|NCT01804413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6714734|NCT01804413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714735|NCT01804543|Ranolazine|ranolazine|mesh-list
6714736|NCT01804543|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6714737|NCT01804543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6714738|NCT01804543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714739|NCT01804595|Sunscreening Agents|sunscreening agents|mesh-list
6714740|NCT01804595|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6714741|NCT01804595|Protective Agents|protective agents|mesh-ancestor
6714742|NCT01804595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714743|NCT01804595|Dermatologic Agents|dermatologic agents|mesh-ancestor
6714744|NCT01804634|Cyclophosphamide|cyclophosphamide|mesh-list
6714745|NCT01804634|Melphalan|melphalan|mesh-list
6714746|NCT01804634|Fludarabine|fludarabine|mesh-list
6714747|NCT01804634|Tacrolimus|tacrolimus|mesh-list
6714748|NCT01804634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6714749|NCT01804634|Immunologic Factors|immunologic factors|mesh-ancestor
6714750|NCT01804634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714751|NCT01804634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6714752|NCT01804634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6714753|NCT01804634|Alkylating Agents|alkylating agents|mesh-ancestor
6714754|NCT01804634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714755|NCT01804634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6714756|NCT01804634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6714757|NCT01804634|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6714758|NCT01804634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6714759|NCT01804712|Rituximab|rituximab|mesh-list
6714760|NCT01804712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6714761|NCT01804712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6714762|NCT01804712|Immunologic Factors|immunologic factors|mesh-ancestor
6714763|NCT01804712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714764|NCT01804712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6714765|NCT01804777|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6714766|NCT01804777|Amiloride|amiloride|mesh-list
6714767|NCT01804777|Diuretics|diuretics|mesh-ancestor
6714768|NCT01804777|Natriuretic Agents|natriuretic agents|mesh-ancestor
6714769|NCT01804777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714770|NCT01804777|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
6714771|NCT01804777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6714772|NCT01804777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6714773|NCT01804777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714774|NCT01804777|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
6714775|NCT01804777|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6714776|NCT01804777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6714777|NCT01804777|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6714778|NCT01804790|Capecitabine|capecitabine|mesh-list
6714779|NCT01804790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6714780|NCT01804790|Antimetabolites|antimetabolites|mesh-ancestor
6714781|NCT01804790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714782|NCT01804790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6714783|NCT01804985|Imatinib Mesylate|imatinib mesylate|mesh-list
6714784|NCT01804985|Dasatinib|dasatinib|mesh-list
6714785|NCT01804985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6714786|NCT01804985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6714787|NCT01804985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6714788|NCT01804985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714789|NCT01805115|Misoprostol|misoprostol|mesh-list
6714790|NCT01805115|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6714791|NCT01805115|Abortifacient Agents|abortifacient agents|mesh-ancestor
6714792|NCT01805115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6714793|NCT01805115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714794|NCT01805115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6714795|NCT01805115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6714796|NCT01805115|Oxytocics|oxytocics|mesh-ancestor
6714797|NCT01805232|Artesunate|artesunate|mesh-list
6714798|NCT01805232|Quinine|quinine|mesh-list
6714799|NCT01805232|Antimalarials|antimalarials|mesh-ancestor
6714800|NCT01805232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6714801|NCT01805232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6714802|NCT01805232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6714803|NCT01805232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6714804|NCT01805232|Antiviral Agents|antiviral agents|mesh-ancestor
6714805|NCT01805232|Schistosomicides|schistosomicides|mesh-ancestor
6714806|NCT01805232|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6714807|NCT01805232|Anthelmintics|anthelmintics|mesh-ancestor
6714808|NCT01805232|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6714809|NCT01805232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714810|NCT01805232|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6714811|NCT01805232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6714812|NCT01805232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6714813|NCT01805232|Analgesics|analgesics|mesh-ancestor
6714814|NCT01805232|Sensory System Agents|sensory system agents|mesh-ancestor
6714815|NCT01805258|Efavirenz|efavirenz|mesh-list
6714816|NCT01805258|Nevirapine|nevirapine|mesh-list
6714817|NCT01805258|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6714818|NCT01805258|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6714819|NCT01805258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6714820|NCT01805258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714821|NCT01805258|Antiviral Agents|antiviral agents|mesh-ancestor
6714822|NCT01805258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6714823|NCT01805258|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6714824|NCT01805258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6714825|NCT01805258|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6714826|NCT01805258|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6714827|NCT01805258|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6714828|NCT01805258|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6714829|NCT01805258|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6714830|NCT01805258|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6714831|NCT01805271|Everolimus|everolimus|mesh-list
6714832|NCT01805271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6714833|NCT01805271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6714834|NCT01805271|Immunologic Factors|immunologic factors|mesh-ancestor
6714835|NCT01805271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714836|NCT01805310|Magnesium citrate|magnesium citrate|mesh-list
6714837|NCT01805310|Cathartics|cathartics|mesh-ancestor
6714838|NCT01805310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6714839|NCT01805388|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6714840|NCT01805388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6714841|NCT01805453|Losartan|losartan|mesh-list
6714842|NCT01805453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6714843|NCT01805453|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6714844|NCT01805453|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6714845|NCT01805453|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6714846|NCT01805453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714847|NCT01805531|Rivaroxaban|rivaroxaban|mesh-list
6714848|NCT01805531|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6714849|NCT01805531|Antithrombins|antithrombins|mesh-ancestor
6714850|NCT01805531|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6714851|NCT01805531|Protease Inhibitors|protease inhibitors|mesh-ancestor
6714852|NCT01805531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6714853|NCT01805531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714854|NCT01805531|Anticoagulants|anticoagulants|mesh-ancestor
6714855|NCT01805544|Rivaroxaban|rivaroxaban|mesh-list
6714856|NCT01805544|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6714857|NCT01805544|Antithrombins|antithrombins|mesh-ancestor
6714858|NCT01805544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6714859|NCT01805544|Protease Inhibitors|protease inhibitors|mesh-ancestor
6714860|NCT01805544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6714861|NCT01805544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714862|NCT01805544|Anticoagulants|anticoagulants|mesh-ancestor
6714863|NCT01805570|Ticagrelor|ticagrelor|mesh-list
6714864|NCT01805570|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6714865|NCT01805570|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6714866|NCT01805570|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6714867|NCT01805570|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6714868|NCT01805570|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6714869|NCT01805570|Purinergic Agents|purinergic agents|mesh-ancestor
6714870|NCT01805570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6714871|NCT01805570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714872|NCT01805570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714873|NCT01805596|Clopidogrel|clopidogrel|mesh-list
6714874|NCT01805596|Ticagrelor|ticagrelor|mesh-list
6714875|NCT01805596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6714876|NCT01805596|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6714877|NCT01805596|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6714878|NCT01805596|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6714879|NCT01805596|Purinergic Agents|purinergic agents|mesh-ancestor
6714880|NCT01805596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6714881|NCT01805596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714882|NCT01805596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714883|NCT01805700|Caffeine|caffeine|mesh-list
6714884|NCT01805700|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6714885|NCT01805700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714886|NCT01805700|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6714887|NCT01805700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6714888|NCT01805700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714889|NCT01805700|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6714890|NCT01805700|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6714891|NCT01805700|Purinergic Agents|purinergic agents|mesh-ancestor
6714892|NCT01805700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6714893|NCT01805726|Dexmedetomidine|dexmedetomidine|mesh-list
6714894|NCT01805726|Alfentanil|alfentanil|mesh-list
6714895|NCT01805726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6714896|NCT01805726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6714897|NCT01805726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714898|NCT01805726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6714899|NCT01805726|Analgesics|analgesics|mesh-ancestor
6714900|NCT01805726|Sensory System Agents|sensory system agents|mesh-ancestor
6714901|NCT01805726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6714902|NCT01805726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6714903|NCT01805726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6714904|NCT01805726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6714905|NCT01805726|Adrenergic Agents|adrenergic agents|mesh-ancestor
6714906|NCT01805726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6714907|NCT01805726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714908|NCT01805726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6714909|NCT01805726|Narcotics|narcotics|mesh-ancestor
6714910|NCT01805726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6714911|NCT01805726|Anesthetics, General|anesthetics, general|mesh-ancestor
6714912|NCT01805726|Anesthetics|anesthetics|mesh-ancestor
6714913|NCT01805804|Valsartan|valsartan|mesh-list
6714914|NCT01805804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6714915|NCT01805804|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6714916|NCT01805804|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6714917|NCT01805804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714918|NCT01805817|Copper|copper|mesh-list
6714919|NCT01805817|Drospirenone|drospirenone|mesh-list
6714920|NCT01805817|Levonorgestrel|levonorgestrel|mesh-list
6714921|NCT01805817|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6714922|NCT01805817|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
6714923|NCT01805817|Estradiol|estradiol|mesh-list
6714924|NCT01805817|Estrogens|estrogens|mesh-ancestor
6714925|NCT01805817|Hormones|hormones|mesh-ancestor
6714926|NCT01805817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6714927|NCT01805817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714928|NCT01805817|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6714929|NCT01805817|Contraceptive Agents|contraceptive agents|mesh-ancestor
6714930|NCT01805817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6714931|NCT01805817|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6714932|NCT01805817|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6714933|NCT01805817|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6714934|NCT01805817|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6714935|NCT01805817|Trace Elements|trace elements|mesh-ancestor
6714936|NCT01805817|Micronutrients|micronutrients|mesh-ancestor
6714937|NCT01805817|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6714938|NCT01805817|Hormone Antagonists|hormone antagonists|mesh-ancestor
6714939|NCT01805817|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6714940|NCT01805817|Diuretics|diuretics|mesh-ancestor
6714941|NCT01805817|Natriuretic Agents|natriuretic agents|mesh-ancestor
6714942|NCT01805856|Cefazolin|cefazolin|mesh-list
6714943|NCT01805856|Piperacillin|piperacillin|mesh-list
6714944|NCT01805856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6714945|NCT01805856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6714946|NCT01805908|Pertuzumab|pertuzumab|mesh-list
6714947|NCT01805908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6714948|NCT01805908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6783456|NCT02197182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6783457|NCT02197182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6783458|NCT02197182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6783459|NCT02197182|Trace Elements|trace elements|mesh-ancestor
6783460|NCT02197182|Micronutrients|micronutrients|mesh-ancestor
6783461|NCT02197182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714949|NCT01805999|Psyllium|psyllium|mesh-list
6714950|NCT01805999|Calcium polycarbophil|calcium polycarbophil|mesh-list
6714951|NCT01805999|Cathartics|cathartics|mesh-ancestor
6714952|NCT01805999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6714953|NCT01805999|Antidiarrheals|antidiarrheals|mesh-ancestor
6714954|NCT01806090|Clopidogrel|clopidogrel|mesh-list
6714955|NCT01806090|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6714956|NCT01806090|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6714957|NCT01806090|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6714958|NCT01806090|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6714959|NCT01806090|Purinergic Agents|purinergic agents|mesh-ancestor
6714960|NCT01806090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6714961|NCT01806090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714962|NCT01806090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714963|NCT01806103|Anti-Infective Agents|anti-infective agents|mesh-list
6714964|NCT01806103|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6714965|NCT01806116|Decitabine|decitabine|mesh-list
6714966|NCT01806116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6714967|NCT01806116|Antimetabolites|antimetabolites|mesh-ancestor
6714968|NCT01806116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714969|NCT01806116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6714970|NCT01806116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6714971|NCT01806272|Vitamin B 12|vitamin b 12|mesh-list
6714972|NCT01806272|Hydroxocobalamin|hydroxocobalamin|mesh-list
6714973|NCT01806272|Vitamins|vitamins|mesh-ancestor
6714974|NCT01806272|Micronutrients|micronutrients|mesh-ancestor
6714975|NCT01806272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714976|NCT01806272|Vitamin B Complex|vitamin b complex|mesh-ancestor
6714977|NCT01806272|Hematinics|hematinics|mesh-ancestor
6714978|NCT01806311|Amlodipine|amlodipine|mesh-list
6714979|NCT01806311|Candesartan|candesartan|mesh-list
6714980|NCT01806311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6714981|NCT01806311|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6714982|NCT01806311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6714983|NCT01806311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714984|NCT01806311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6714985|NCT01806311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6714986|NCT01806311|Vasodilator Agents|vasodilator agents|mesh-ancestor
6714987|NCT01806311|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6714988|NCT01806311|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6714989|NCT01806324|Losartan|losartan|mesh-list
6714990|NCT01806324|Atorvastatin|atorvastatin|mesh-list
6714991|NCT01806324|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6714992|NCT01806324|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6714993|NCT01806324|Antimetabolites|antimetabolites|mesh-ancestor
6714994|NCT01806324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6714995|NCT01806324|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6714996|NCT01806324|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6714997|NCT01806324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6714998|NCT01806324|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6714999|NCT01806324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6715000|NCT01806324|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6715001|NCT01806324|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6715002|NCT01806337|Alemtuzumab|alemtuzumab|mesh-list
6715003|NCT01806337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6715004|NCT01806337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6715005|NCT01806363|Telmisartan|telmisartan|mesh-list
6715006|NCT01806363|Chlorthalidone|chlorthalidone|mesh-list
6715007|NCT01806363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6715008|NCT01806363|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6715009|NCT01806363|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6715010|NCT01806363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6715011|NCT01806363|Diuretics|diuretics|mesh-ancestor
6715012|NCT01806363|Natriuretic Agents|natriuretic agents|mesh-ancestor
6715013|NCT01806363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715014|NCT01806363|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6715015|NCT01806363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6715016|NCT01806376|Maleic acid|maleic acid|mesh-list
6715017|NCT01806376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6715018|NCT01806376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6715019|NCT01806415|Imidazole|imidazole|mesh-list
6715020|NCT01806415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6715021|NCT01806415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6715022|NCT01806454|Calcium|calcium|mesh-list
6715023|NCT01806454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6715024|NCT01806454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715025|NCT01806610|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6715026|NCT01806610|Immunologic Factors|immunologic factors|mesh-ancestor
6715027|NCT01806610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715028|NCT01806753|Midazolam|midazolam|mesh-list
6715029|NCT01806753|Propofol|propofol|mesh-list
6715030|NCT01806753|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6715031|NCT01806753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6715032|NCT01806753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715033|NCT01806753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6715034|NCT01806753|Anesthetics, General|anesthetics, general|mesh-ancestor
6715035|NCT01806753|Anesthetics|anesthetics|mesh-ancestor
6715036|NCT01806753|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6715037|NCT01806753|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6715038|NCT01806753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6715039|NCT01806753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6715040|NCT01806753|GABA Modulators|gaba modulators|mesh-ancestor
6715041|NCT01806753|GABA Agents|gaba agents|mesh-ancestor
6715042|NCT01806753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6715043|NCT01806753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6715044|NCT01806792|Cholecalciferol|cholecalciferol|mesh-list
6715045|NCT01806792|Risedronic Acid|risedronic acid|mesh-list
6715046|NCT01806792|Etidronic Acid|etidronic acid|mesh-list
6715047|NCT01806792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6715048|NCT01806792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715049|NCT01806792|Vitamins|vitamins|mesh-ancestor
6715050|NCT01806792|Micronutrients|micronutrients|mesh-ancestor
6715051|NCT01806792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6715052|NCT01806792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6715053|NCT01806792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6715054|NCT01806792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6715055|NCT01806805|Zonisamide|zonisamide|mesh-list
6715056|NCT01806805|Anticonvulsants|anticonvulsants|mesh-ancestor
6715057|NCT01806805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6715058|NCT01806805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6715059|NCT01806805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6715060|NCT01806805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6715061|NCT01806805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715062|NCT01806948|Ramosetron|ramosetron|mesh-list
6715063|NCT01806948|Antiemetics|antiemetics|mesh-ancestor
6715064|NCT01806948|Autonomic Agents|autonomic agents|mesh-ancestor
6715065|NCT01806948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6715066|NCT01806948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715067|NCT01806948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6715068|NCT01806948|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6715069|NCT01806948|Serotonin Agents|serotonin agents|mesh-ancestor
6715070|NCT01806948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6715071|NCT01806948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6715072|NCT01807078|Ezetimibe|ezetimibe|mesh-list
6715073|NCT01807078|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6715074|NCT01807078|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6715075|NCT01807078|Antimetabolites|antimetabolites|mesh-ancestor
6715076|NCT01807078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6715077|NCT01807078|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6715078|NCT01807117|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6715079|NCT01807117|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6715080|NCT01807117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6715081|NCT01807286|Dexamethasone|dexamethasone|mesh-list
6715082|NCT01807286|Melphalan|melphalan|mesh-list
6715083|NCT01807286|Pomalidomide|pomalidomide|mesh-list
6715084|NCT01807286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6715085|NCT01807286|Antiemetics|antiemetics|mesh-ancestor
6715086|NCT01807286|Autonomic Agents|autonomic agents|mesh-ancestor
6715087|NCT01807286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6715088|NCT01807286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715089|NCT01807286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6715090|NCT01807286|Glucocorticoids|glucocorticoids|mesh-ancestor
6715091|NCT01807286|Hormones|hormones|mesh-ancestor
6715092|NCT01807286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6715093|NCT01807286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6715094|NCT01807286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6715095|NCT01807286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6715096|NCT01807286|Alkylating Agents|alkylating agents|mesh-ancestor
6715097|NCT01807286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6715098|NCT01807286|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6715099|NCT01807286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6715100|NCT01807286|Immunologic Factors|immunologic factors|mesh-ancestor
6715101|NCT01807286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6715102|NCT01807286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6715103|NCT01807286|Growth Substances|growth substances|mesh-ancestor
6715104|NCT01807286|Growth Inhibitors|growth inhibitors|mesh-ancestor
6715105|NCT01807325|Pancrelipase|pancrelipase|mesh-list
6715106|NCT01807325|Pancreatin|pancreatin|mesh-list
6715107|NCT01807325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6715108|NCT01807377|Midazolam|midazolam|mesh-list
6715109|NCT01807377|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6715110|NCT01807377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6715111|NCT01807377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6715112|NCT01807377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715113|NCT01807377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6715114|NCT01807377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6715115|NCT01807377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6715116|NCT01807377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6715117|NCT01807377|Anesthetics, General|anesthetics, general|mesh-ancestor
6715118|NCT01807377|Anesthetics|anesthetics|mesh-ancestor
6715119|NCT01807377|GABA Modulators|gaba modulators|mesh-ancestor
6715120|NCT01807377|GABA Agents|gaba agents|mesh-ancestor
6715121|NCT01807377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6715122|NCT01807377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6715123|NCT01807429|Midazolam|midazolam|mesh-list
6715124|NCT01807429|Morphine|morphine|mesh-list
6715125|NCT01807429|Ketamine|ketamine|mesh-list
6715126|NCT01807429|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6715127|NCT01807429|Narcotics|narcotics|mesh-ancestor
6715128|NCT01807429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6715129|NCT01807429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715130|NCT01807429|Analgesics|analgesics|mesh-ancestor
6715131|NCT01807429|Sensory System Agents|sensory system agents|mesh-ancestor
6715132|NCT01807429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6715133|NCT01807429|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6715134|NCT01807429|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6715135|NCT01807429|Anesthetics, General|anesthetics, general|mesh-ancestor
6715136|NCT01807429|Anesthetics|anesthetics|mesh-ancestor
6715137|NCT01807429|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6715138|NCT01807429|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6715139|NCT01807429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6715140|NCT01807429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6715141|NCT01807429|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6715142|NCT01807429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6715143|NCT01807429|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6715144|NCT01807429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6715145|NCT01807429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6715146|NCT01807429|GABA Modulators|gaba modulators|mesh-ancestor
6715147|NCT01807429|GABA Agents|gaba agents|mesh-ancestor
6715148|NCT01807494|Cimetidine|cimetidine|mesh-list
6715149|NCT01807494|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6715150|NCT01807494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6715151|NCT01807494|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6715152|NCT01807494|Histamine Antagonists|histamine antagonists|mesh-ancestor
6715153|NCT01807494|Histamine Agents|histamine agents|mesh-ancestor
6715154|NCT01807494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6715155|NCT01807494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6715156|NCT01807494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715157|NCT01807494|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6715158|NCT01807494|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6715159|NCT01807494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6715160|NCT01807611|Mycophenolic Acid|mycophenolic acid|mesh-list
6715161|NCT01807611|Cyclophosphamide|cyclophosphamide|mesh-list
6715162|NCT01807611|Melphalan|melphalan|mesh-list
6715163|NCT01807611|Mechlorethamine|mechlorethamine|mesh-list
6715164|NCT01807611|Thiotepa|thiotepa|mesh-list
6715165|NCT01807611|Fludarabine|fludarabine|mesh-list
6715166|NCT01807611|Lenograstim|lenograstim|mesh-list
6715167|NCT01807611|Sargramostim|sargramostim|mesh-list
6715168|NCT01807611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6715169|NCT01807611|Immunologic Factors|immunologic factors|mesh-ancestor
6715170|NCT01807611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715171|NCT01807611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6715172|NCT01807611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6715173|NCT01807611|Alkylating Agents|alkylating agents|mesh-ancestor
6715174|NCT01807611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6715175|NCT01807611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6715176|NCT01807611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6715177|NCT01807611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6715178|NCT01807611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6715179|NCT01807611|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6715180|NCT01807611|Antitubercular Agents|antitubercular agents|mesh-ancestor
6715181|NCT01807611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6715182|NCT01807611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6715183|NCT01807611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6783462|NCT02197221|Bortezomib|bortezomib|mesh-list
6783463|NCT02197221|Melphalan|melphalan|mesh-list
6783464|NCT02197221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6783465|NCT02197221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6783466|NCT02197221|Alkylating Agents|alkylating agents|mesh-ancestor
6783467|NCT02197221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783468|NCT02197221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6783469|NCT02197221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6783470|NCT02197221|Immunologic Factors|immunologic factors|mesh-ancestor
6783471|NCT02197221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783472|NCT02197260|Amoxicillin|amoxicillin|mesh-list
6783473|NCT02197260|Metronidazole|metronidazole|mesh-list
6783474|NCT02197260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6783475|NCT02197260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6783476|NCT02197260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6783477|NCT02197260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6783478|NCT02197286|Vitamin D|vitamin d|mesh-list
6783479|NCT02197286|Ergocalciferols|ergocalciferols|mesh-list
6783480|NCT02197286|Cholecalciferol|cholecalciferol|mesh-list
6783481|NCT02197286|Vitamins|vitamins|mesh-list
6783482|NCT02197286|Micronutrients|micronutrients|mesh-ancestor
6715184|NCT01807741|Asenapine|asenapine|mesh-list
6715185|NCT01807741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6715186|NCT01807741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6715187|NCT01807741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6715188|NCT01807741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715189|NCT01807741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6715190|NCT01807767|Mycophenolic Acid|mycophenolic acid|mesh-list
6715191|NCT01807767|Everolimus|everolimus|mesh-list
6715192|NCT01807767|Tacrolimus|tacrolimus|mesh-list
6715193|NCT01807767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6715194|NCT01807767|Immunologic Factors|immunologic factors|mesh-ancestor
6715195|NCT01807767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715196|NCT01807767|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6715197|NCT01807767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6715198|NCT01807767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6715199|NCT01807767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6715200|NCT01807767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6715201|NCT01807767|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6715202|NCT01807767|Antitubercular Agents|antitubercular agents|mesh-ancestor
6715203|NCT01807767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6715204|NCT01807767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6715205|NCT01807832|Capsaicin|capsaicin|mesh-list
6715206|NCT01807832|Antipruritics|antipruritics|mesh-ancestor
6715207|NCT01807832|Dermatologic Agents|dermatologic agents|mesh-ancestor
6715208|NCT01807832|Sensory System Agents|sensory system agents|mesh-ancestor
6715209|NCT01807832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6715210|NCT01807832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715211|NCT01807910|Choline|choline|mesh-list
6715212|NCT01807910|Lipotropic Agents|lipotropic agents|mesh-ancestor
6715213|NCT01807910|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6715214|NCT01807910|Antimetabolites|antimetabolites|mesh-ancestor
6715215|NCT01807910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6715216|NCT01807910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6715217|NCT01807910|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6715218|NCT01807910|Nootropic Agents|nootropic agents|mesh-ancestor
6715219|NCT01807962|Lidocaine|lidocaine|mesh-list
6715220|NCT01807962|Anesthetics, Local|anesthetics, local|mesh-ancestor
6715221|NCT01807962|Anesthetics|anesthetics|mesh-ancestor
6715222|NCT01807962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6715223|NCT01807962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715224|NCT01807962|Sensory System Agents|sensory system agents|mesh-ancestor
6715225|NCT01807962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6715226|NCT01807962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6715227|NCT01807962|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6715228|NCT01807962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6715229|NCT01807962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6715230|NCT01807962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6715231|NCT01808014|Nefopam|nefopam|mesh-list
6715232|NCT01808014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6715233|NCT01808014|Analgesics|analgesics|mesh-ancestor
6715234|NCT01808014|Sensory System Agents|sensory system agents|mesh-ancestor
6715235|NCT01808014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6715236|NCT01808014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715237|NCT01808131|Lesinurad|lesinurad|mesh-list
6715238|NCT01808131|Gout Suppressants|gout suppressants|mesh-ancestor
6715239|NCT01808131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6715240|NCT01808131|Uricosuric Agents|uricosuric agents|mesh-ancestor
6715241|NCT01808131|Renal Agents|renal agents|mesh-ancestor
6715242|NCT01808300|Thioctic Acid|thioctic acid|mesh-list
6715243|NCT01808300|Pregabalin|pregabalin|mesh-list
6715244|NCT01808300|Analgesics|analgesics|mesh-ancestor
6715245|NCT01808300|Sensory System Agents|sensory system agents|mesh-ancestor
6715246|NCT01808300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6715247|NCT01808300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715248|NCT01808300|Anticonvulsants|anticonvulsants|mesh-ancestor
6715249|NCT01808300|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6715250|NCT01808300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6715251|NCT01808300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6715252|NCT01808300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6715253|NCT01808300|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6715254|NCT01808300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6715255|NCT01808300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6715256|NCT01808300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6715257|NCT01808300|Antioxidants|antioxidants|mesh-ancestor
6715258|NCT01808300|Protective Agents|protective agents|mesh-ancestor
6715259|NCT01808300|Vitamin B Complex|vitamin b complex|mesh-ancestor
6715260|NCT01808300|Vitamins|vitamins|mesh-ancestor
6715261|NCT01808300|Micronutrients|micronutrients|mesh-ancestor
6715262|NCT01808456|Vaccines|vaccines|mesh-list
6715263|NCT01808456|Immunologic Factors|immunologic factors|mesh-ancestor
6715264|NCT01808456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715265|NCT01808469|Antibodies|antibodies|mesh-list
6715266|NCT01808469|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6715267|NCT01808469|Immunologic Factors|immunologic factors|mesh-ancestor
6715268|NCT01808469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715269|NCT01808495|Mitomycins|mitomycins|mesh-list
6715270|NCT01808495|Mitomycin|mitomycin|mesh-list
6715271|NCT01808495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6715272|NCT01808495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6715273|NCT01808495|Alkylating Agents|alkylating agents|mesh-ancestor
6715274|NCT01808495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6715275|NCT01808495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6715276|NCT01808495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6715277|NCT01808521|Acetylcysteine|acetylcysteine|mesh-list
6715278|NCT01808521|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6715279|NCT01808521|Antiviral Agents|antiviral agents|mesh-ancestor
6715280|NCT01808521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6715281|NCT01808521|Expectorants|expectorants|mesh-ancestor
6715282|NCT01808521|Respiratory System Agents|respiratory system agents|mesh-ancestor
6715283|NCT01808521|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6715284|NCT01808521|Antioxidants|antioxidants|mesh-ancestor
6715285|NCT01808521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6715286|NCT01808521|Protective Agents|protective agents|mesh-ancestor
6715287|NCT01808521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715288|NCT01808521|Antidotes|antidotes|mesh-ancestor
6715289|NCT01808586|Dexamethasone|dexamethasone|mesh-list
6715290|NCT01808586|Betamethasone|betamethasone|mesh-list
6715291|NCT01808586|Lidocaine|lidocaine|mesh-list
6715292|NCT01808586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6715293|NCT01808586|Antiemetics|antiemetics|mesh-ancestor
6715294|NCT01808586|Autonomic Agents|autonomic agents|mesh-ancestor
6715295|NCT01808586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6715296|NCT01808586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715297|NCT01808586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6715298|NCT01808586|Glucocorticoids|glucocorticoids|mesh-ancestor
6715299|NCT01808586|Hormones|hormones|mesh-ancestor
6715300|NCT01808586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6715301|NCT01808586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6715302|NCT01808586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6715303|NCT01808586|Anesthetics, Local|anesthetics, local|mesh-ancestor
6715304|NCT01808586|Anesthetics|anesthetics|mesh-ancestor
6715305|NCT01808586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6715306|NCT01808586|Sensory System Agents|sensory system agents|mesh-ancestor
6715307|NCT01808586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6715308|NCT01808586|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6715309|NCT01808586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6715310|NCT01808586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6715311|NCT01808586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6715312|NCT01808586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6715313|NCT01808586|Respiratory System Agents|respiratory system agents|mesh-ancestor
6715314|NCT01808599|Rituximab|rituximab|mesh-list
6715315|NCT01808599|Chlorambucil|chlorambucil|mesh-list
6715316|NCT01808599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6715317|NCT01808599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6715318|NCT01808599|Immunologic Factors|immunologic factors|mesh-ancestor
6715319|NCT01808599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715320|NCT01808599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6715321|NCT01808599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6715322|NCT01808599|Alkylating Agents|alkylating agents|mesh-ancestor
6715323|NCT01808599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6715324|NCT01808638|Gemcitabine|gemcitabine|mesh-list
6715325|NCT01808638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6715326|NCT01808638|Antimetabolites|antimetabolites|mesh-ancestor
6715327|NCT01808638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6715328|NCT01808638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6715329|NCT01808638|Antiviral Agents|antiviral agents|mesh-ancestor
6715330|NCT01808638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6715331|NCT01808638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6715332|NCT01808638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6715333|NCT01808638|Immunologic Factors|immunologic factors|mesh-ancestor
6715334|NCT01808638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715335|NCT01808768|Alcaftadine|alcaftadine|mesh-list
6715336|NCT01808768|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6715337|NCT01808768|Histamine Antagonists|histamine antagonists|mesh-ancestor
6715338|NCT01808768|Histamine Agents|histamine agents|mesh-ancestor
6715339|NCT01808768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6715340|NCT01808768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6715341|NCT01808768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715342|NCT01808898|Bupivacaine|bupivacaine|mesh-list
6715343|NCT01808898|Anesthetics, Local|anesthetics, local|mesh-list
6715344|NCT01808898|Mepivacaine|mepivacaine|mesh-list
6715345|NCT01808898|Anesthetics|anesthetics|mesh-list
6715346|NCT01808898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6715347|NCT01808898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715348|NCT01808898|Sensory System Agents|sensory system agents|mesh-ancestor
6715349|NCT01808898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6715350|NCT01808911|Cyclophosphamide|cyclophosphamide|mesh-list
6715351|NCT01808911|Rituximab|rituximab|mesh-list
6715352|NCT01808911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6715353|NCT01808911|Immunologic Factors|immunologic factors|mesh-ancestor
6715354|NCT01808911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715355|NCT01808911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6715356|NCT01808911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6715357|NCT01808911|Alkylating Agents|alkylating agents|mesh-ancestor
6715358|NCT01808911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6715359|NCT01808911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6715360|NCT01808911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6715361|NCT01808911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6715362|NCT01809041|Remifentanil|remifentanil|mesh-list
6715363|NCT01809041|Propofol|propofol|mesh-list
6715364|NCT01809041|Sevoflurane|sevoflurane|mesh-list
6715365|NCT01809041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6715366|NCT01809041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6715367|NCT01809041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715368|NCT01809041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6715369|NCT01809041|Anesthetics, General|anesthetics, general|mesh-ancestor
6715370|NCT01809041|Anesthetics|anesthetics|mesh-ancestor
6715371|NCT01809041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6715372|NCT01809041|Narcotics|narcotics|mesh-ancestor
6715373|NCT01809041|Analgesics|analgesics|mesh-ancestor
6715374|NCT01809041|Sensory System Agents|sensory system agents|mesh-ancestor
6715375|NCT01809041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6715376|NCT01809041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6715377|NCT01809041|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6715378|NCT01809158|Minocycline|minocycline|mesh-list
6715379|NCT01809158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6715380|NCT01809158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6715381|NCT01809171|Vitamin D|vitamin d|mesh-list
6715382|NCT01809171|Cholecalciferol|cholecalciferol|mesh-list
6715383|NCT01809171|Vitamins|vitamins|mesh-ancestor
6715384|NCT01809171|Micronutrients|micronutrients|mesh-ancestor
6715385|NCT01809171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715386|NCT01809171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6715387|NCT01809171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6715388|NCT01809184|Insulin|insulin|mesh-list
6715389|NCT01809184|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6715390|NCT01809184|Insulin Glargine|insulin glargine|mesh-list
6715391|NCT01809184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6715392|NCT01809184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715393|NCT01809301|Niacin|niacin|mesh-list
6715394|NCT01809301|Nicotinic Acids|nicotinic acids|mesh-list
6715395|NCT01809301|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6715396|NCT01809301|Antimetabolites|antimetabolites|mesh-ancestor
6715397|NCT01809301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6715398|NCT01809301|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6715399|NCT01809301|Vasodilator Agents|vasodilator agents|mesh-ancestor
6715400|NCT01809301|Vitamin B Complex|vitamin b complex|mesh-ancestor
6715401|NCT01809301|Vitamins|vitamins|mesh-ancestor
6715402|NCT01809301|Micronutrients|micronutrients|mesh-ancestor
6715403|NCT01809301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715404|NCT01809340|Minocycline|minocycline|mesh-list
6715405|NCT01809340|Ketamine|ketamine|mesh-list
6715406|NCT01809340|Analgesics|analgesics|mesh-ancestor
6715407|NCT01809340|Sensory System Agents|sensory system agents|mesh-ancestor
6715408|NCT01809340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6715409|NCT01809340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715410|NCT01809340|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6715411|NCT01809340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6715412|NCT01809340|Anesthetics, General|anesthetics, general|mesh-ancestor
6715413|NCT01809340|Anesthetics|anesthetics|mesh-ancestor
6715414|NCT01809340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6715415|NCT01809340|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6715416|NCT01809340|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6715417|NCT01809340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6715418|NCT01809340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6715419|NCT01809340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6715420|NCT01809340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6715421|NCT01809379|Cisplatin|cisplatin|mesh-list
6715422|NCT01809379|Doxorubicin|doxorubicin|mesh-list
6715423|NCT01809379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6715424|NCT01809379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6715425|NCT01809379|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6715426|NCT01809379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6715427|NCT01809379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6715428|NCT01809379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6715429|NCT01809392|Decitabine|decitabine|mesh-list
6715430|NCT01809392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6715431|NCT01809392|Antimetabolites|antimetabolites|mesh-ancestor
6715432|NCT01809392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6715433|NCT01809392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6715434|NCT01809392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6715435|NCT01809444|Doxycycline|doxycycline|mesh-list
6715436|NCT01809444|Prednisone|prednisone|mesh-list
6715437|NCT01809444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6715438|NCT01809444|Glucocorticoids|glucocorticoids|mesh-ancestor
6715439|NCT01809444|Hormones|hormones|mesh-ancestor
6715440|NCT01809444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6715441|NCT01809444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715442|NCT01809444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6715443|NCT01809444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6715444|NCT01809444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6715445|NCT01809444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6715446|NCT01809444|Antimalarials|antimalarials|mesh-ancestor
6715447|NCT01809444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6715448|NCT01809444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6783483|NCT02197286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783484|NCT02197286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6783485|NCT02197286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6783486|NCT02197403|Dexmedetomidine|dexmedetomidine|mesh-list
6783487|NCT02197403|Propofol|propofol|mesh-list
6783488|NCT02197403|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6715449|NCT01809626|Zolpidem|zolpidem|mesh-list
6715450|NCT01809626|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6715451|NCT01809626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6715452|NCT01809626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6715453|NCT01809626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715454|NCT01809626|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6715455|NCT01809626|GABA Agonists|gaba agonists|mesh-ancestor
6715456|NCT01809626|GABA Agents|gaba agents|mesh-ancestor
6715457|NCT01809626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6715458|NCT01809626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6715459|NCT01809691|Bicalutamide|bicalutamide|mesh-list
6715460|NCT01809691|Androgen Antagonists|androgen antagonists|mesh-ancestor
6715461|NCT01809691|Hormone Antagonists|hormone antagonists|mesh-ancestor
6715462|NCT01809691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6715463|NCT01809691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715464|NCT01809691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6715465|NCT01809743|Adenosine|adenosine|mesh-list
6715466|NCT01809743|Regadenoson|regadenoson|mesh-list
6715467|NCT01809743|Analgesics|analgesics|mesh-ancestor
6715468|NCT01809743|Sensory System Agents|sensory system agents|mesh-ancestor
6715469|NCT01809743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6715470|NCT01809743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715471|NCT01809743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6715472|NCT01809743|Vasodilator Agents|vasodilator agents|mesh-ancestor
6715473|NCT01809743|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6715474|NCT01809743|Purinergic Agonists|purinergic agonists|mesh-ancestor
6715475|NCT01809743|Purinergic Agents|purinergic agents|mesh-ancestor
6715476|NCT01809743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6715477|NCT01809743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6715478|NCT01809743|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
6715479|NCT01809808|Hormones|hormones|mesh-list
6715480|NCT01809808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6715481|NCT01809808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715482|NCT01809847|Ofatumumab|ofatumumab|mesh-list
6715483|NCT01809847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6715484|NCT01809860|Sirolimus|sirolimus|mesh-list
6715485|NCT01809860|Isavuconazole|isavuconazole|mesh-list
6715486|NCT01809860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6715487|NCT01809860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6715488|NCT01809860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6715489|NCT01809860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6715490|NCT01809860|Antifungal Agents|antifungal agents|mesh-ancestor
6715491|NCT01809860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6715492|NCT01809860|Immunologic Factors|immunologic factors|mesh-ancestor
6715493|NCT01809860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715494|NCT01809886|Neostigmine|neostigmine|mesh-list
6715495|NCT01809886|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6715496|NCT01809886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6715497|NCT01809886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6715498|NCT01809886|Cholinergic Agents|cholinergic agents|mesh-ancestor
6715499|NCT01809886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6715500|NCT01809886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715501|NCT01809886|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6715502|NCT01809886|Autonomic Agents|autonomic agents|mesh-ancestor
6715503|NCT01809886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6715504|NCT01809925|Psyllium|psyllium|mesh-list
6715505|NCT01809925|Calcium polycarbophil|calcium polycarbophil|mesh-list
6715506|NCT01809925|Cathartics|cathartics|mesh-ancestor
6715507|NCT01809925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6715508|NCT01809925|Antidiarrheals|antidiarrheals|mesh-ancestor
6715509|NCT01810185|Naltrexone|naltrexone|mesh-list
6715510|NCT01810185|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6715511|NCT01810185|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6715512|NCT01810185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715513|NCT01810185|Sensory System Agents|sensory system agents|mesh-ancestor
6715514|NCT01810185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6715515|NCT01810237|Dabigatran|dabigatran|mesh-list
6715516|NCT01810237|Antithrombins|antithrombins|mesh-ancestor
6715517|NCT01810237|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6715518|NCT01810237|Protease Inhibitors|protease inhibitors|mesh-ancestor
6715519|NCT01810237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6715520|NCT01810237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6715521|NCT01810237|Anticoagulants|anticoagulants|mesh-ancestor
6715522|NCT01810315|Estradiol|estradiol|mesh-list
6715523|NCT01810315|Estrogens|estrogens|mesh-ancestor
6715524|NCT01810315|Hormones|hormones|mesh-ancestor
6715525|NCT01810315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6715526|NCT01810315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715527|NCT01810354|Cefazolin|cefazolin|mesh-list
6715528|NCT01810354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6715529|NCT01810354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6715530|NCT01810367|Gemcitabine|gemcitabine|mesh-list
6715531|NCT01810367|Cisplatin|cisplatin|mesh-list
6715532|NCT01810367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6715533|NCT01810367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6715534|NCT01810367|Antimetabolites|antimetabolites|mesh-ancestor
6715535|NCT01810367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6715536|NCT01810367|Antiviral Agents|antiviral agents|mesh-ancestor
6715537|NCT01810367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6715538|NCT01810367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6715539|NCT01810367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6715540|NCT01810367|Immunologic Factors|immunologic factors|mesh-ancestor
6715541|NCT01810367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715542|NCT01810393|Trastuzumab|trastuzumab|mesh-list
6715543|NCT01810393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6715544|NCT01810393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6715545|NCT01810458|Acetaminophen|acetaminophen|mesh-list
6715546|NCT01810458|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
6715547|NCT01810458|Lidocaine|lidocaine|mesh-list
6715548|NCT01810458|Fentanyl|fentanyl|mesh-list
6715549|NCT01810458|Midazolam|midazolam|mesh-list
6715550|NCT01810458|Oxycodone|oxycodone|mesh-list
6715551|NCT01810458|Lorazepam|lorazepam|mesh-list
6715552|NCT01810458|Ondansetron|ondansetron|mesh-list
6715553|NCT01810458|Liver Extracts|liver extracts|mesh-list
6715554|NCT01810458|Anesthetics, Local|anesthetics, local|mesh-ancestor
6715555|NCT01810458|Anesthetics|anesthetics|mesh-ancestor
6715556|NCT01810458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6715557|NCT01810458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715558|NCT01810458|Sensory System Agents|sensory system agents|mesh-ancestor
6715559|NCT01810458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6715560|NCT01810458|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6715561|NCT01810458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6715562|NCT01810458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6715563|NCT01810458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6715564|NCT01810458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6715565|NCT01810458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6715566|NCT01810458|Narcotics|narcotics|mesh-ancestor
6715567|NCT01810458|Analgesics|analgesics|mesh-ancestor
6715568|NCT01810458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6715569|NCT01810458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6715570|NCT01810458|Anesthetics, General|anesthetics, general|mesh-ancestor
6715571|NCT01810458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6715572|NCT01810458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6715573|NCT01810458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6715574|NCT01810458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6715575|NCT01810458|GABA Modulators|gaba modulators|mesh-ancestor
6715576|NCT01810458|GABA Agents|gaba agents|mesh-ancestor
6715577|NCT01810458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6715578|NCT01810458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6715579|NCT01810458|Antipyretics|antipyretics|mesh-ancestor
6715580|NCT01810458|Hematinics|hematinics|mesh-ancestor
6715581|NCT01810458|Antiemetics|antiemetics|mesh-ancestor
6715582|NCT01810458|Autonomic Agents|autonomic agents|mesh-ancestor
6715583|NCT01810458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6715584|NCT01810458|Antipruritics|antipruritics|mesh-ancestor
6715585|NCT01810458|Dermatologic Agents|dermatologic agents|mesh-ancestor
6715586|NCT01810458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6715587|NCT01810458|Serotonin Agents|serotonin agents|mesh-ancestor
6715588|NCT01810458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6715589|NCT01810458|Anticonvulsants|anticonvulsants|mesh-ancestor
6715590|NCT01810458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6715591|NCT01810458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6715592|NCT01810458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6715593|NCT01810549|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6715594|NCT01810549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6715595|NCT01810588|Vidarabine|vidarabine|mesh-list
6715596|NCT01810588|Mycophenolic Acid|mycophenolic acid|mesh-list
6715597|NCT01810588|Rituximab|rituximab|mesh-list
6715598|NCT01810588|Fludarabine|fludarabine|mesh-list
6715599|NCT01810588|Fludarabine phosphate|fludarabine phosphate|mesh-list
6715600|NCT01810588|Melphalan|melphalan|mesh-list
6715601|NCT01810588|Tacrolimus|tacrolimus|mesh-list
6715602|NCT01810588|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6715603|NCT01810588|Thymoglobulin|thymoglobulin|mesh-list
6715604|NCT01810588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6715605|NCT01810588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6715606|NCT01810588|Immunologic Factors|immunologic factors|mesh-ancestor
6715607|NCT01810588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715608|NCT01810588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6715609|NCT01810588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6715610|NCT01810588|Antimetabolites|antimetabolites|mesh-ancestor
6715611|NCT01810588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6715612|NCT01810588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6715613|NCT01810588|Antiviral Agents|antiviral agents|mesh-ancestor
6715614|NCT01810588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6715615|NCT01810588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6715616|NCT01810588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6715617|NCT01810588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6715618|NCT01810588|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6715619|NCT01810588|Antitubercular Agents|antitubercular agents|mesh-ancestor
6715620|NCT01810588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6715621|NCT01810588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6715622|NCT01810588|Alkylating Agents|alkylating agents|mesh-ancestor
6715623|NCT01810588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6715624|NCT01810601|Progesterone|progesterone|mesh-list
6715625|NCT01810601|Progestins|progestins|mesh-ancestor
6715626|NCT01810601|Hormones|hormones|mesh-ancestor
6715627|NCT01810601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6715628|NCT01810601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715629|NCT01810640|Liver Extracts|liver extracts|mesh-list
6715630|NCT01810640|Hematinics|hematinics|mesh-ancestor
6715631|NCT01810731|Vaccines|vaccines|mesh-list
6715632|NCT01810731|Immunologic Factors|immunologic factors|mesh-ancestor
6715633|NCT01810731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715634|NCT01810770|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
6715635|NCT01810770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6715636|NCT01810796|Ranolazine|ranolazine|mesh-list
6715637|NCT01810796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6715638|NCT01810796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6715639|NCT01810796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6715640|NCT01810809|Hylan|hylan|mesh-list
6715641|NCT01810809|Hyaluronic Acid|hyaluronic acid|mesh-list
6715642|NCT01810809|Viscosupplements|viscosupplements|mesh-ancestor
6715643|NCT01810809|Protective Agents|protective agents|mesh-ancestor
6715644|NCT01810809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715645|NCT01810809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6715646|NCT01810809|Immunologic Factors|immunologic factors|mesh-ancestor
6715647|NCT01810848|Hyaluronic Acid|hyaluronic acid|mesh-list
6715648|NCT01810848|Hylan|hylan|mesh-list
6715649|NCT01810848|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6715650|NCT01810848|Immunologic Factors|immunologic factors|mesh-ancestor
6715651|NCT01810848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715652|NCT01810848|Viscosupplements|viscosupplements|mesh-ancestor
6715653|NCT01810848|Protective Agents|protective agents|mesh-ancestor
6715654|NCT01810887|Ritonavir|ritonavir|mesh-list
6715655|NCT01810887|Darunavir|darunavir|mesh-list
6715656|NCT01810887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6715657|NCT01810887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6715658|NCT01810887|Protease Inhibitors|protease inhibitors|mesh-ancestor
6715659|NCT01810887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6715660|NCT01810887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6715661|NCT01810887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6715662|NCT01810887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6715663|NCT01810887|Antiviral Agents|antiviral agents|mesh-ancestor
6715664|NCT01810887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6715665|NCT01810887|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6715666|NCT01810887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6715667|NCT01810926|Cyclosporine|cyclosporine|mesh-list
6715668|NCT01810926|Rituximab|rituximab|mesh-list
6715669|NCT01810926|Methotrexate|methotrexate|mesh-list
6715670|NCT01810926|Fludarabine|fludarabine|mesh-list
6715671|NCT01810926|Thiotepa|thiotepa|mesh-list
6715672|NCT01810926|Treosulfan|treosulfan|mesh-list
6715673|NCT01810926|Antibodies|antibodies|mesh-list
6715674|NCT01810926|Cyclosporins|cyclosporins|mesh-list
6715675|NCT01810926|Immunologic Factors|immunologic factors|mesh-ancestor
6715676|NCT01810926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715677|NCT01810926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6715678|NCT01810926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6715679|NCT01810926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6715680|NCT01810926|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6715681|NCT01810926|Abortifacient Agents|abortifacient agents|mesh-ancestor
6715682|NCT01810926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6715683|NCT01810926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6715684|NCT01810926|Antimetabolites|antimetabolites|mesh-ancestor
6715685|NCT01810926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6715686|NCT01810926|Dermatologic Agents|dermatologic agents|mesh-ancestor
6715687|NCT01810926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6715688|NCT01810926|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6715689|NCT01810926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6715690|NCT01810926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6715691|NCT01810926|Antifungal Agents|antifungal agents|mesh-ancestor
6715692|NCT01810926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6715693|NCT01810926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6715694|NCT01810926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6715695|NCT01810926|Alkylating Agents|alkylating agents|mesh-ancestor
6715696|NCT01810926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6715697|NCT01811056|Mifepristone|mifepristone|mesh-list
6715698|NCT01811056|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6715699|NCT01811056|Abortifacient Agents|abortifacient agents|mesh-ancestor
6715700|NCT01811056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6715701|NCT01811056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715702|NCT01811056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6715703|NCT01811056|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6715704|NCT01811056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6715705|NCT01811056|Contraceptive Agents|contraceptive agents|mesh-ancestor
6715706|NCT01811056|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6715707|NCT01811056|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6715708|NCT01811056|Hormone Antagonists|hormone antagonists|mesh-ancestor
6715709|NCT01811056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6715710|NCT01811056|Luteolytic Agents|luteolytic agents|mesh-ancestor
6715711|NCT01811056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6715712|NCT01811056|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6715713|NCT01811160|Melatonin|melatonin|mesh-list
6715714|NCT01811160|Antioxidants|antioxidants|mesh-ancestor
6715715|NCT01811160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6715716|NCT01811160|Protective Agents|protective agents|mesh-ancestor
6715717|NCT01811160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715718|NCT01811160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6783489|NCT02197403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6783490|NCT02197403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783491|NCT02197403|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6783492|NCT02197403|Anesthetics, General|anesthetics, general|mesh-ancestor
6783493|NCT02197403|Anesthetics|anesthetics|mesh-ancestor
6783494|NCT02197403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6783495|NCT02197403|Analgesics|analgesics|mesh-ancestor
6783496|NCT02197403|Sensory System Agents|sensory system agents|mesh-ancestor
6783497|NCT02197403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6783498|NCT02197403|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6783499|NCT02197403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6783500|NCT02197403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6783501|NCT02197403|Adrenergic Agents|adrenergic agents|mesh-ancestor
6783502|NCT02197403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6783503|NCT02197403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783504|NCT02197442|Valsartan|valsartan|mesh-list
6783505|NCT02197442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6783506|NCT02197442|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6783507|NCT02197442|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6783508|NCT02197442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783509|NCT02197494|Valsartan|valsartan|mesh-list
6783510|NCT02197494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6783511|NCT02197494|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6783512|NCT02197494|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6783513|NCT02197494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783514|NCT02197598|Nalmefene|nalmefene|mesh-list
6783515|NCT02197598|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6783516|NCT02197598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783517|NCT02197598|Sensory System Agents|sensory system agents|mesh-ancestor
6783518|NCT02197598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6783519|NCT02197637|Vinorelbine|vinorelbine|mesh-list
6783520|NCT02197637|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6783521|NCT02197637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6783522|NCT02197637|Tubulin Modulators|tubulin modulators|mesh-ancestor
6715719|NCT01811251|Dexamethasone|dexamethasone|mesh-list
6715720|NCT01811251|Pregabalin|pregabalin|mesh-list
6715721|NCT01811251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6715722|NCT01811251|Antiemetics|antiemetics|mesh-ancestor
6715723|NCT01811251|Autonomic Agents|autonomic agents|mesh-ancestor
6715724|NCT01811251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6715725|NCT01811251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715726|NCT01811251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6715727|NCT01811251|Glucocorticoids|glucocorticoids|mesh-ancestor
6715728|NCT01811251|Hormones|hormones|mesh-ancestor
6715729|NCT01811251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6715730|NCT01811251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6715731|NCT01811251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6715732|NCT01811251|Analgesics|analgesics|mesh-ancestor
6715733|NCT01811251|Sensory System Agents|sensory system agents|mesh-ancestor
6715734|NCT01811251|Anticonvulsants|anticonvulsants|mesh-ancestor
6715735|NCT01811251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6715736|NCT01811251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6715737|NCT01811251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6715738|NCT01811251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6715739|NCT01811251|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6715740|NCT01811251|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6715741|NCT01811251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6715742|NCT01811251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6715743|NCT01811277|Oxaliplatin|oxaliplatin|mesh-list
6715744|NCT01811277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6715745|NCT01811381|Curcumin|curcumin|mesh-list
6715746|NCT01811381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6715747|NCT01811381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6715748|NCT01811381|Analgesics|analgesics|mesh-ancestor
6715749|NCT01811381|Sensory System Agents|sensory system agents|mesh-ancestor
6715750|NCT01811381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6715751|NCT01811381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715752|NCT01811381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6715753|NCT01811381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6715754|NCT01811381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6715755|NCT01811381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6715756|NCT01811381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6715757|NCT01811459|Haloperidol|haloperidol|mesh-list
6715758|NCT01811459|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6715759|NCT01811459|Haloperidol decanoate|haloperidol decanoate|mesh-list
6715760|NCT01811459|Antidepressive Agents|antidepressive agents|mesh-ancestor
6715761|NCT01811459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6715762|NCT01811459|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6715763|NCT01811459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6715764|NCT01811459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6715765|NCT01811459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715766|NCT01811459|Antiemetics|antiemetics|mesh-ancestor
6715767|NCT01811459|Autonomic Agents|autonomic agents|mesh-ancestor
6715768|NCT01811459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6715769|NCT01811459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6715770|NCT01811459|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6715771|NCT01811459|Dopamine Agents|dopamine agents|mesh-ancestor
6715772|NCT01811459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6715773|NCT01811459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6715774|NCT01811459|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6715775|NCT01811498|Bevacizumab|bevacizumab|mesh-list
6715776|NCT01811498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6715777|NCT01811498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6715778|NCT01811498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6715779|NCT01811498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6715780|NCT01811498|Growth Substances|growth substances|mesh-ancestor
6715781|NCT01811498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715782|NCT01811498|Growth Inhibitors|growth inhibitors|mesh-ancestor
6715783|NCT01811615|Ethanol|ethanol|mesh-list
6715784|NCT01811615|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6715785|NCT01811615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6715786|NCT01811615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6715787|NCT01811615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715788|NCT01811667|Sirolimus|sirolimus|mesh-list
6715789|NCT01811667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6715790|NCT01811667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6715791|NCT01811667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6715792|NCT01811667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6715793|NCT01811667|Antifungal Agents|antifungal agents|mesh-ancestor
6715794|NCT01811667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6715795|NCT01811667|Immunologic Factors|immunologic factors|mesh-ancestor
6715796|NCT01811667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715797|NCT01811810|Androgens|androgens|mesh-list
6715798|NCT01811810|Hormones|hormones|mesh-ancestor
6715799|NCT01811810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6715800|NCT01811810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715801|NCT01811836|Zinc|zinc|mesh-list
6715802|NCT01811836|Trace Elements|trace elements|mesh-ancestor
6715803|NCT01811836|Micronutrients|micronutrients|mesh-ancestor
6715804|NCT01811836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715805|NCT01811849|Insulin|insulin|mesh-list
6715806|NCT01811849|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6715807|NCT01811849|Insulin Lispro|insulin lispro|mesh-list
6715808|NCT01811849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6715809|NCT01811849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715810|NCT01812018|Gemcitabine|gemcitabine|mesh-list
6715811|NCT01812018|Docetaxel|docetaxel|mesh-list
6715812|NCT01812018|Endostar protein|endostar protein|mesh-list
6715813|NCT01812018|Endostatins|endostatins|mesh-list
6715814|NCT01812018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6715815|NCT01812018|Antimetabolites|antimetabolites|mesh-ancestor
6715816|NCT01812018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6715817|NCT01812018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6715818|NCT01812018|Antiviral Agents|antiviral agents|mesh-ancestor
6715819|NCT01812018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6715820|NCT01812018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6715821|NCT01812018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6715822|NCT01812018|Immunologic Factors|immunologic factors|mesh-ancestor
6715823|NCT01812018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715824|NCT01812018|Tubulin Modulators|tubulin modulators|mesh-ancestor
6715825|NCT01812018|Antimitotic Agents|antimitotic agents|mesh-ancestor
6715826|NCT01812018|Mitosis Modulators|mitosis modulators|mesh-ancestor
6715827|NCT01812018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6715828|NCT01812018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6715829|NCT01812018|Growth Substances|growth substances|mesh-ancestor
6715830|NCT01812018|Growth Inhibitors|growth inhibitors|mesh-ancestor
6715831|NCT01812096|Bortezomib|bortezomib|mesh-list
6715832|NCT01812096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6715833|NCT01812122|Glimepiride|glimepiride|mesh-list
6715834|NCT01812122|Vildagliptin|vildagliptin|mesh-list
6715835|NCT01812122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6715836|NCT01812122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6715837|NCT01812122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715838|NCT01812122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6715839|NCT01812122|Immunologic Factors|immunologic factors|mesh-ancestor
6715840|NCT01812122|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6715841|NCT01812122|Protease Inhibitors|protease inhibitors|mesh-ancestor
6715842|NCT01812122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6715843|NCT01812122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6715844|NCT01812135|Vaccines|vaccines|mesh-list
6715845|NCT01812135|Immunologic Factors|immunologic factors|mesh-ancestor
6715846|NCT01812135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715847|NCT01812200|Rivaroxaban|rivaroxaban|mesh-list
6715848|NCT01812200|Dabigatran|dabigatran|mesh-list
6715849|NCT01812200|Phenprocoumon|phenprocoumon|mesh-list
6715850|NCT01812200|Ticagrelor|ticagrelor|mesh-list
6715851|NCT01812200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6715852|NCT01812200|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6715853|NCT01812200|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6715854|NCT01812200|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6715855|NCT01812200|Purinergic Agents|purinergic agents|mesh-ancestor
6715856|NCT01812200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6715857|NCT01812200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6715858|NCT01812200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715859|NCT01812200|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6715860|NCT01812200|Antithrombins|antithrombins|mesh-ancestor
6715861|NCT01812200|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6715862|NCT01812200|Protease Inhibitors|protease inhibitors|mesh-ancestor
6715863|NCT01812200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6715864|NCT01812200|Anticoagulants|anticoagulants|mesh-ancestor
6715865|NCT01812239|Progesterone|progesterone|mesh-list
6715866|NCT01812239|Progestins|progestins|mesh-list
6715867|NCT01812239|Hormones|hormones|mesh-ancestor
6783523|NCT02197637|Antimitotic Agents|antimitotic agents|mesh-ancestor
6783524|NCT02197637|Mitosis Modulators|mitosis modulators|mesh-ancestor
6783525|NCT02197637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6715868|NCT01812239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6715869|NCT01812239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715870|NCT01812330|Clopidogrel|clopidogrel|mesh-list
6715871|NCT01812330|Ticagrelor|ticagrelor|mesh-list
6715872|NCT01812330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6715873|NCT01812330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6715874|NCT01812330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6715875|NCT01812330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6715876|NCT01812330|Purinergic Agents|purinergic agents|mesh-ancestor
6715877|NCT01812330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6715878|NCT01812330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6715879|NCT01812330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715880|NCT01812356|Nitrous Oxide|nitrous oxide|mesh-list
6715881|NCT01812356|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6715882|NCT01812356|Anesthetics, General|anesthetics, general|mesh-ancestor
6715883|NCT01812356|Anesthetics|anesthetics|mesh-ancestor
6715884|NCT01812356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6715885|NCT01812356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715886|NCT01812356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6715887|NCT01812356|Analgesics|analgesics|mesh-ancestor
6715888|NCT01812356|Sensory System Agents|sensory system agents|mesh-ancestor
6715889|NCT01812356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6715890|NCT01812369|Gemcitabine|gemcitabine|mesh-list
6715891|NCT01812369|Doxorubicin|doxorubicin|mesh-list
6715892|NCT01812369|Vinblastine|vinblastine|mesh-list
6715893|NCT01812369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6715894|NCT01812369|Antimetabolites|antimetabolites|mesh-ancestor
6715895|NCT01812369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6715896|NCT01812369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6715897|NCT01812369|Antiviral Agents|antiviral agents|mesh-ancestor
6715898|NCT01812369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6715899|NCT01812369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6715900|NCT01812369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6715901|NCT01812369|Immunologic Factors|immunologic factors|mesh-ancestor
6715902|NCT01812369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715903|NCT01812369|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6715904|NCT01812369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6715905|NCT01812369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6715906|NCT01812369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6715907|NCT01812369|Tubulin Modulators|tubulin modulators|mesh-ancestor
6715908|NCT01812369|Antimitotic Agents|antimitotic agents|mesh-ancestor
6715909|NCT01812369|Mitosis Modulators|mitosis modulators|mesh-ancestor
6715910|NCT01812382|Retapamulin|retapamulin|mesh-list
6715911|NCT01812382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6715912|NCT01812382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6715913|NCT01812434|Sildenafil Citrate|sildenafil citrate|mesh-list
6715914|NCT01812434|Vasodilator Agents|vasodilator agents|mesh-ancestor
6715915|NCT01812434|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6715916|NCT01812434|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6715917|NCT01812434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6715918|NCT01812434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6715919|NCT01812434|Urological Agents|urological agents|mesh-ancestor
6715920|NCT01812538|Diclofenac|diclofenac|mesh-list
6715921|NCT01812538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6715922|NCT01812538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6715923|NCT01812538|Analgesics|analgesics|mesh-ancestor
6715924|NCT01812538|Sensory System Agents|sensory system agents|mesh-ancestor
6715925|NCT01812538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6715926|NCT01812538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715927|NCT01812538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6715928|NCT01812538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6715929|NCT01812538|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6715930|NCT01812538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6715931|NCT01812538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6715932|NCT01812551|Alendronate|alendronate|mesh-list
6715933|NCT01812551|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6715934|NCT01812551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715935|NCT01812603|Nabiximols|nabiximols|mesh-list
6715936|NCT01812603|Analgesics|analgesics|mesh-ancestor
6715937|NCT01812603|Sensory System Agents|sensory system agents|mesh-ancestor
6715938|NCT01812603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6715939|NCT01812603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715940|NCT01812616|Nabiximols|nabiximols|mesh-list
6715941|NCT01812616|Analgesics|analgesics|mesh-ancestor
6715942|NCT01812616|Sensory System Agents|sensory system agents|mesh-ancestor
6715943|NCT01812616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6715944|NCT01812616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715945|NCT01812642|N-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|n-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|mesh-list
6715946|NCT01812642|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6715947|NCT01812642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6715948|NCT01812642|Dopamine Agents|dopamine agents|mesh-ancestor
6715949|NCT01812642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6715950|NCT01812642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6715951|NCT01812642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715952|NCT01812720|Dexamethasone|dexamethasone|mesh-list
6715953|NCT01812720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6715954|NCT01812720|Antiemetics|antiemetics|mesh-ancestor
6715955|NCT01812720|Autonomic Agents|autonomic agents|mesh-ancestor
6715956|NCT01812720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6715957|NCT01812720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715958|NCT01812720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6715959|NCT01812720|Glucocorticoids|glucocorticoids|mesh-ancestor
6715960|NCT01812720|Hormones|hormones|mesh-ancestor
6715961|NCT01812720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6715962|NCT01812720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6715963|NCT01812720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6715964|NCT01812889|TOL-463|tol-463|mesh-list
6715965|NCT01812889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6715966|NCT01812928|Diclofenac|diclofenac|mesh-list
6715967|NCT01812928|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
6715968|NCT01812928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
6715969|NCT01812928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6715970|NCT01812928|Analgesics|analgesics|mesh-ancestor
6715971|NCT01812928|Sensory System Agents|sensory system agents|mesh-ancestor
6715972|NCT01812928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6715973|NCT01812928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715974|NCT01812928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6715975|NCT01812928|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6715976|NCT01812928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6715977|NCT01812928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783526|NCT02197650|Asparaginase|asparaginase|mesh-list
6783527|NCT02197650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6783528|NCT02197676|Guadecitabine|guadecitabine|mesh-list
6783529|NCT02197676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6783530|NCT02197702|Vitamin D|vitamin d|mesh-list
6783531|NCT02197702|Cholecalciferol|cholecalciferol|mesh-list
6783532|NCT02197702|Vitamins|vitamins|mesh-ancestor
6783533|NCT02197702|Micronutrients|micronutrients|mesh-ancestor
6783534|NCT02197702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783535|NCT02197702|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6783536|NCT02197702|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6783537|NCT02197741|Opiate Alkaloids|opiate alkaloids|mesh-list
6783538|NCT02197741|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6783539|NCT02197741|Narcotics|narcotics|mesh-ancestor
6783540|NCT02197741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6783541|NCT02197741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783542|NCT02197741|Analgesics|analgesics|mesh-ancestor
6783543|NCT02197741|Sensory System Agents|sensory system agents|mesh-ancestor
6783544|NCT02197741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6783545|NCT02197884|Clarithromycin|clarithromycin|mesh-list
6783546|NCT02197884|Itraconazole|itraconazole|mesh-list
6783547|NCT02197884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6783548|NCT02197884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6783549|NCT02197884|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6783550|NCT02197884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6783551|NCT02197884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783552|NCT02197884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6783553|NCT02197884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6783554|NCT02197884|Antifungal Agents|antifungal agents|mesh-ancestor
6783555|NCT02197884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6783556|NCT02197884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6783557|NCT02197884|Hormone Antagonists|hormone antagonists|mesh-ancestor
6783558|NCT02197884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6783559|NCT02197884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783560|NCT02197988|Fentanyl|fentanyl|mesh-list
6783561|NCT02197988|Bupivacaine|bupivacaine|mesh-list
6783562|NCT02197988|Anesthetics, Local|anesthetics, local|mesh-ancestor
6715978|NCT01812954|Cyclosporine|cyclosporine|mesh-list
6715979|NCT01812954|Adalimumab|adalimumab|mesh-list
6715980|NCT01812954|Etanercept|etanercept|mesh-list
6715981|NCT01812954|Methotrexate|methotrexate|mesh-list
6715982|NCT01812954|Infliximab|infliximab|mesh-list
6715983|NCT01812954|Ustekinumab|ustekinumab|mesh-list
6715984|NCT01812954|Acitretin|acitretin|mesh-list
6715985|NCT01812954|Cyclosporins|cyclosporins|mesh-list
6715986|NCT01812954|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6715987|NCT01812954|Abortifacient Agents|abortifacient agents|mesh-ancestor
6715988|NCT01812954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6715989|NCT01812954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6715990|NCT01812954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6715991|NCT01812954|Antimetabolites|antimetabolites|mesh-ancestor
6715992|NCT01812954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6715993|NCT01812954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6715994|NCT01812954|Dermatologic Agents|dermatologic agents|mesh-ancestor
6715995|NCT01812954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6715996|NCT01812954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6715997|NCT01812954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6715998|NCT01812954|Immunologic Factors|immunologic factors|mesh-ancestor
6715999|NCT01812954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6716000|NCT01812954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6716001|NCT01812954|Antifungal Agents|antifungal agents|mesh-ancestor
6716002|NCT01812954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6716003|NCT01812954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6716004|NCT01812954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6716005|NCT01812954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6716006|NCT01812954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6716007|NCT01812954|Analgesics|analgesics|mesh-ancestor
6716008|NCT01812954|Sensory System Agents|sensory system agents|mesh-ancestor
6716009|NCT01812954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6716010|NCT01812954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6716011|NCT01812954|Keratolytic Agents|keratolytic agents|mesh-ancestor
6716012|NCT01812967|Caseins|caseins|mesh-list
6716013|NCT01812967|Chelating Agents|chelating agents|mesh-ancestor
6716014|NCT01812967|Sequestering Agents|sequestering agents|mesh-ancestor
6716015|NCT01812967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6716016|NCT01813162|Tenofovir|tenofovir|mesh-list
6716017|NCT01813162|Metronidazole|metronidazole|mesh-list
6716018|NCT01813162|Terconazole|terconazole|mesh-list
6716019|NCT01813162|Contraceptive Agents|contraceptive agents|mesh-list
6716020|NCT01813162|Antiviral Agents|antiviral agents|mesh-ancestor
6716021|NCT01813162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6716022|NCT01813162|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6716023|NCT01813162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6716024|NCT01813162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6716025|NCT01813162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6716026|NCT01813162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6716027|NCT01813162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6716028|NCT01813162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6716029|NCT01813162|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6716030|NCT01813162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6716031|NCT01813162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6716032|NCT01813162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716033|NCT01813162|Antifungal Agents|antifungal agents|mesh-ancestor
6716034|NCT01813201|Methyltestosterone|methyltestosterone|mesh-list
6716035|NCT01813201|Testosterone|testosterone|mesh-list
6716036|NCT01813201|Testosterone undecanoate|testosterone undecanoate|mesh-list
6716037|NCT01813201|Testosterone enanthate|testosterone enanthate|mesh-list
6716038|NCT01813201|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6716039|NCT01813201|Androgens|androgens|mesh-ancestor
6716040|NCT01813201|Hormones|hormones|mesh-ancestor
6716041|NCT01813201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6716042|NCT01813201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716043|NCT01813201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6716044|NCT01813201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6716045|NCT01813201|Anabolic Agents|anabolic agents|mesh-ancestor
6716046|NCT01813227|Dexamethasone|dexamethasone|mesh-list
6716047|NCT01813227|Rituximab|rituximab|mesh-list
6716048|NCT01813227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6716049|NCT01813227|Antiemetics|antiemetics|mesh-ancestor
6716050|NCT01813227|Autonomic Agents|autonomic agents|mesh-ancestor
6716051|NCT01813227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6716052|NCT01813227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716053|NCT01813227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6716054|NCT01813227|Glucocorticoids|glucocorticoids|mesh-ancestor
6716055|NCT01813227|Hormones|hormones|mesh-ancestor
6716056|NCT01813227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6716057|NCT01813227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6716058|NCT01813227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6716059|NCT01813227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6716060|NCT01813227|Immunologic Factors|immunologic factors|mesh-ancestor
6716061|NCT01813227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6716062|NCT01813240|Minocycline|minocycline|mesh-list
6716063|NCT01813240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6716064|NCT01813240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6716065|NCT01813253|Irinotecan|irinotecan|mesh-list
6716066|NCT01813253|Nimotuzumab|nimotuzumab|mesh-list
6716067|NCT01813253|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6716068|NCT01813253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6716069|NCT01813253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6716070|NCT01813253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6716071|NCT01813253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6716072|NCT01813253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6716073|NCT01813318|Acamprosate|acamprosate|mesh-list
6716074|NCT01813318|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6716075|NCT01813448|Fidaxomicin|fidaxomicin|mesh-list
6716076|NCT01813448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6716077|NCT01813448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6716078|NCT01813461|Isavuconazole|isavuconazole|mesh-list
6716079|NCT01813461|Antifungal Agents|antifungal agents|mesh-ancestor
6716080|NCT01813461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6716081|NCT01813487|Entecavir|entecavir|mesh-list
6716082|NCT01813487|Antiviral Agents|antiviral agents|mesh-ancestor
6716083|NCT01813487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6716084|NCT01813513|Simeprevir|simeprevir|mesh-list
6716085|NCT01813513|Antiviral Agents|antiviral agents|mesh-ancestor
6716086|NCT01813513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6716087|NCT01813513|Protease Inhibitors|protease inhibitors|mesh-ancestor
6716088|NCT01813513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6716089|NCT01813513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6716090|NCT01813552|Ritonavir|ritonavir|mesh-list
6716091|NCT01813552|Omeprazole|omeprazole|mesh-list
6716092|NCT01813552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6716093|NCT01813552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6716094|NCT01813552|Protease Inhibitors|protease inhibitors|mesh-ancestor
6716095|NCT01813552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6716096|NCT01813552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6716097|NCT01813552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6716098|NCT01813552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6716099|NCT01813552|Antiviral Agents|antiviral agents|mesh-ancestor
6716100|NCT01813552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6716101|NCT01813552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6716102|NCT01813552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6716103|NCT01813552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6716104|NCT01813552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6716105|NCT01813552|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6716106|NCT01813565|Hyaluronic Acid|hyaluronic acid|mesh-list
6716107|NCT01813565|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6716108|NCT01813565|Immunologic Factors|immunologic factors|mesh-ancestor
6716109|NCT01813565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716110|NCT01813565|Viscosupplements|viscosupplements|mesh-ancestor
6716111|NCT01813565|Protective Agents|protective agents|mesh-ancestor
6716112|NCT01813591|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6716113|NCT01813591|Hormones|hormones|mesh-ancestor
6716114|NCT01813591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6716115|NCT01813591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716116|NCT01813604|Vaccines|vaccines|mesh-list
6716117|NCT01813604|Immunologic Factors|immunologic factors|mesh-ancestor
6716118|NCT01813604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716119|NCT01813617|Prednisone|prednisone|mesh-list
6716120|NCT01813617|Methotrexate|methotrexate|mesh-list
6716121|NCT01813617|Azathioprine|azathioprine|mesh-list
6716122|NCT01813617|Immunosuppressive Agents|immunosuppressive agents|mesh-list
6716123|NCT01813617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6716124|NCT01813617|Glucocorticoids|glucocorticoids|mesh-ancestor
6716125|NCT01813617|Hormones|hormones|mesh-ancestor
6716126|NCT01813617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6716127|NCT01813617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716128|NCT01813617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6716129|NCT01813617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6783563|NCT02197988|Anesthetics|anesthetics|mesh-ancestor
6716130|NCT01813617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6716131|NCT01813617|Abortifacient Agents|abortifacient agents|mesh-ancestor
6716132|NCT01813617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6716133|NCT01813617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6716134|NCT01813617|Antimetabolites|antimetabolites|mesh-ancestor
6716135|NCT01813617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6716136|NCT01813617|Dermatologic Agents|dermatologic agents|mesh-ancestor
6716137|NCT01813617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6716138|NCT01813617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6716139|NCT01813617|Immunologic Factors|immunologic factors|mesh-ancestor
6716140|NCT01813617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6716141|NCT01813617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6716142|NCT01813643|Risperidone|risperidone|mesh-list
6716143|NCT01813643|Aripiprazole|aripiprazole|mesh-list
6716144|NCT01813643|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6716145|NCT01813643|Serotonin Agents|serotonin agents|mesh-ancestor
6716146|NCT01813643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6716147|NCT01813643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6716148|NCT01813643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716149|NCT01813643|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6716150|NCT01813643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6716151|NCT01813643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6716152|NCT01813643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6716153|NCT01813643|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6716154|NCT01813643|Dopamine Agents|dopamine agents|mesh-ancestor
6716155|NCT01813643|Antidepressive Agents|antidepressive agents|mesh-ancestor
6716156|NCT01813643|Dopamine Agonists|dopamine agonists|mesh-ancestor
6716157|NCT01813643|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6716158|NCT01813643|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6716159|NCT01813643|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6716160|NCT01813643|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6716161|NCT01813656|Aripiprazole|aripiprazole|mesh-list
6716162|NCT01813656|Antidepressive Agents|antidepressive agents|mesh-ancestor
6716163|NCT01813656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6716164|NCT01813656|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6716165|NCT01813656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6716166|NCT01813656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6716167|NCT01813656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716168|NCT01813656|Dopamine Agonists|dopamine agonists|mesh-ancestor
6716169|NCT01813656|Dopamine Agents|dopamine agents|mesh-ancestor
6716170|NCT01813656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6716171|NCT01813656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6716172|NCT01813656|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6716173|NCT01813656|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6716174|NCT01813656|Serotonin Agents|serotonin agents|mesh-ancestor
6716175|NCT01813656|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6716176|NCT01813656|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6716177|NCT01813656|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6716178|NCT01813656|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6716179|NCT01813773|Aflibercept|aflibercept|mesh-list
6716180|NCT01813773|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6716181|NCT01813773|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6716182|NCT01813773|Growth Substances|growth substances|mesh-ancestor
6716183|NCT01813773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716184|NCT01813773|Growth Inhibitors|growth inhibitors|mesh-ancestor
6716185|NCT01813773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6716186|NCT01813812|Rebamipide|rebamipide|mesh-list
6716187|NCT01813812|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6716188|NCT01813812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6716189|NCT01813812|Antioxidants|antioxidants|mesh-ancestor
6716190|NCT01813812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6716191|NCT01813812|Protective Agents|protective agents|mesh-ancestor
6716192|NCT01813812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716193|NCT01813812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6716194|NCT01813955|Papaverine|papaverine|mesh-list
6716195|NCT01813955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6716196|NCT01813955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6716197|NCT01813955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6716198|NCT01813955|Vasodilator Agents|vasodilator agents|mesh-ancestor
6716199|NCT01813955|Urological Agents|urological agents|mesh-ancestor
6716200|NCT01813981|Caffeine|caffeine|mesh-list
6716201|NCT01813981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6716202|NCT01813981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716203|NCT01813981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6716204|NCT01813981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6716205|NCT01813981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6716206|NCT01813981|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6716207|NCT01813981|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6716208|NCT01813981|Purinergic Agents|purinergic agents|mesh-ancestor
6716209|NCT01813981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6716210|NCT01813994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
6716211|NCT01813994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6716212|NCT01813994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6716213|NCT01813994|Antimetabolites|antimetabolites|mesh-ancestor
6716214|NCT01813994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6716215|NCT01813994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6716216|NCT01813994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6716217|NCT01814059|Sirolimus|sirolimus|mesh-list
6716218|NCT01814059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6716219|NCT01814059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6716220|NCT01814059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6716221|NCT01814059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6716222|NCT01814059|Antifungal Agents|antifungal agents|mesh-ancestor
6716223|NCT01814059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6716224|NCT01814059|Immunologic Factors|immunologic factors|mesh-ancestor
6716225|NCT01814059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716226|NCT01814085|Citalopram|citalopram|mesh-list
6716227|NCT01814085|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6716228|NCT01814085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6716229|NCT01814085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6716230|NCT01814085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6716231|NCT01814085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6716232|NCT01814085|Serotonin Agents|serotonin agents|mesh-ancestor
6716233|NCT01814085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716234|NCT01814085|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6716235|NCT01814085|Antidepressive Agents|antidepressive agents|mesh-ancestor
6716236|NCT01814085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6716237|NCT01814098|Citalopram|citalopram|mesh-list
6716238|NCT01814098|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6716239|NCT01814098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6716240|NCT01814098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6716241|NCT01814098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6716242|NCT01814098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6716243|NCT01814098|Serotonin Agents|serotonin agents|mesh-ancestor
6716244|NCT01814098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716245|NCT01814098|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6716246|NCT01814098|Antidepressive Agents|antidepressive agents|mesh-ancestor
6716247|NCT01814098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6716248|NCT01814163|Paclitaxel|paclitaxel|mesh-list
6716249|NCT01814163|Bevacizumab|bevacizumab|mesh-list
6716250|NCT01814163|Carboplatin|carboplatin|mesh-list
6716251|NCT01814163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6716252|NCT01814163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6716253|NCT01814163|Tubulin Modulators|tubulin modulators|mesh-ancestor
6716254|NCT01814163|Antimitotic Agents|antimitotic agents|mesh-ancestor
6716255|NCT01814163|Mitosis Modulators|mitosis modulators|mesh-ancestor
6716256|NCT01814163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6716257|NCT01814163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6716258|NCT01814163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6716259|NCT01814163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6716260|NCT01814163|Growth Substances|growth substances|mesh-ancestor
6716261|NCT01814163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716262|NCT01814163|Growth Inhibitors|growth inhibitors|mesh-ancestor
6716263|NCT01814189|Promethazine|promethazine|mesh-list
6716264|NCT01814189|Diphenhydramine|diphenhydramine|mesh-list
6716265|NCT01814189|Sumatriptan|sumatriptan|mesh-list
6716266|NCT01814189|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6716267|NCT01814189|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6716268|NCT01814189|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6716269|NCT01814189|Serotonin Agents|serotonin agents|mesh-ancestor
6716270|NCT01814189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6716271|NCT01814189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6716272|NCT01814189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716273|NCT01814189|Antipruritics|antipruritics|mesh-ancestor
6716274|NCT01814189|Dermatologic Agents|dermatologic agents|mesh-ancestor
6716275|NCT01814189|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6716276|NCT01814189|Histamine Antagonists|histamine antagonists|mesh-ancestor
6716277|NCT01814189|Histamine Agents|histamine agents|mesh-ancestor
6716278|NCT01814189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6716279|NCT01814189|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6716280|NCT01814189|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6716281|NCT01814189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6716282|NCT01814189|Anesthetics, Local|anesthetics, local|mesh-ancestor
6716283|NCT01814189|Anesthetics|anesthetics|mesh-ancestor
6716284|NCT01814189|Sensory System Agents|sensory system agents|mesh-ancestor
6716285|NCT01814189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6716286|NCT01814189|Antiemetics|antiemetics|mesh-ancestor
6716287|NCT01814189|Autonomic Agents|autonomic agents|mesh-ancestor
6716288|NCT01814189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6716289|NCT01814319|Probenecid|probenecid|mesh-list
6716290|NCT01814319|Uricosuric Agents|uricosuric agents|mesh-ancestor
6716291|NCT01814319|Gout Suppressants|gout suppressants|mesh-ancestor
6716292|NCT01814319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6716293|NCT01814319|Renal Agents|renal agents|mesh-ancestor
6716294|NCT01814410|Ethanol|ethanol|mesh-list
6716295|NCT01814410|Nicotine|nicotine|mesh-list
6716296|NCT01814410|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6716297|NCT01814410|Autonomic Agents|autonomic agents|mesh-ancestor
6716298|NCT01814410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6716299|NCT01814410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716300|NCT01814410|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6716301|NCT01814410|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6716302|NCT01814410|Cholinergic Agents|cholinergic agents|mesh-ancestor
6716303|NCT01814410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6716304|NCT01814410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6716305|NCT01814410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6716306|NCT01814410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6716307|NCT01814410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6716308|NCT01814423|Chloroquine|chloroquine|mesh-list
6716309|NCT01814423|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
6716310|NCT01814423|Amebicides|amebicides|mesh-ancestor
6716311|NCT01814423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6716312|NCT01814423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6716313|NCT01814423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6716314|NCT01814423|Antimalarials|antimalarials|mesh-ancestor
6716315|NCT01814423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6716316|NCT01814423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6716317|NCT01814423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6716318|NCT01814423|Analgesics|analgesics|mesh-ancestor
6716319|NCT01814423|Sensory System Agents|sensory system agents|mesh-ancestor
6716320|NCT01814423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6716321|NCT01814423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716322|NCT01814423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6716323|NCT01814423|Filaricides|filaricides|mesh-ancestor
6716324|NCT01814423|Antinematodal Agents|antinematodal agents|mesh-ancestor
6716325|NCT01814423|Anthelmintics|anthelmintics|mesh-ancestor
6716326|NCT01814449|Letrozole|letrozole|mesh-list
6716327|NCT01814449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6716328|NCT01814449|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6716329|NCT01814449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6716330|NCT01814449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6716331|NCT01814449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6716332|NCT01814449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6716333|NCT01814449|Hormone Antagonists|hormone antagonists|mesh-ancestor
6716334|NCT01814449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6716335|NCT01814449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716336|NCT01814475|Vidarabine|vidarabine|mesh-list
6716337|NCT01814475|Fludarabine|fludarabine|mesh-list
6716338|NCT01814475|Fludarabine phosphate|fludarabine phosphate|mesh-list
6716339|NCT01814475|Busulfan|busulfan|mesh-list
6716340|NCT01814475|Thiotepa|thiotepa|mesh-list
6716341|NCT01814475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6716342|NCT01814475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6716343|NCT01814475|Antimetabolites|antimetabolites|mesh-ancestor
6716344|NCT01814475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6716345|NCT01814475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6716346|NCT01814475|Immunologic Factors|immunologic factors|mesh-ancestor
6716347|NCT01814475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716348|NCT01814475|Antiviral Agents|antiviral agents|mesh-ancestor
6716349|NCT01814475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6716350|NCT01814475|Alkylating Agents|alkylating agents|mesh-ancestor
6716351|NCT01814475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6716352|NCT01814475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6716353|NCT01814501|Leucovorin|leucovorin|mesh-list
6716354|NCT01814501|Fluorouracil|fluorouracil|mesh-list
6716355|NCT01814501|Irinotecan|irinotecan|mesh-list
6716356|NCT01814501|Panitumumab|panitumumab|mesh-list
6716357|NCT01814501|Calcium|calcium|mesh-list
6716358|NCT01814501|Levoleucovorin|levoleucovorin|mesh-list
6716359|NCT01814501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6716360|NCT01814501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716361|NCT01814501|Antimetabolites|antimetabolites|mesh-ancestor
6716362|NCT01814501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6716363|NCT01814501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6716364|NCT01814501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6716365|NCT01814501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6716366|NCT01814501|Immunologic Factors|immunologic factors|mesh-ancestor
6716367|NCT01814501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6716368|NCT01814501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6716369|NCT01814501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6716370|NCT01814501|Antidotes|antidotes|mesh-ancestor
6716371|NCT01814501|Protective Agents|protective agents|mesh-ancestor
6716372|NCT01814501|Vitamin B Complex|vitamin b complex|mesh-ancestor
6716373|NCT01814501|Vitamins|vitamins|mesh-ancestor
6716374|NCT01814501|Micronutrients|micronutrients|mesh-ancestor
6716375|NCT01814501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6716376|NCT01814514|Timolol|timolol|mesh-list
6716377|NCT01814514|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6716378|NCT01814514|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6716379|NCT01814514|Adrenergic Agents|adrenergic agents|mesh-ancestor
6716380|NCT01814514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6716381|NCT01814514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6716382|NCT01814514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716383|NCT01814514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6716384|NCT01814514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6783564|NCT02197988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6783565|NCT02197988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783566|NCT02197988|Sensory System Agents|sensory system agents|mesh-ancestor
6783567|NCT02197988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6783568|NCT02197988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6783569|NCT02197988|Narcotics|narcotics|mesh-ancestor
6783570|NCT02197988|Analgesics|analgesics|mesh-ancestor
6783571|NCT02197988|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6783572|NCT02197988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6783573|NCT02197988|Anesthetics, General|anesthetics, general|mesh-ancestor
6783574|NCT02198001|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6783575|NCT02198001|Amoxicillin|amoxicillin|mesh-list
6783576|NCT02198001|Clavulanic Acid|clavulanic acid|mesh-list
6783577|NCT02198001|Clavulanic Acids|clavulanic acids|mesh-list
6783578|NCT02198001|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6783579|NCT02198001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6783580|NCT02198001|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6783581|NCT02198001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6783582|NCT02198001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783583|NCT02198027|Bupivacaine|bupivacaine|mesh-list
6783584|NCT02198027|Anesthetics, Local|anesthetics, local|mesh-ancestor
6783585|NCT02198027|Anesthetics|anesthetics|mesh-ancestor
6783586|NCT02198027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6783587|NCT02198027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783588|NCT02198027|Sensory System Agents|sensory system agents|mesh-ancestor
6783589|NCT02198027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6783590|NCT02198170|Ketoconazole|ketoconazole|mesh-list
6783591|NCT02198170|Lenvatinib|lenvatinib|mesh-list
6783592|NCT02198170|Antifungal Agents|antifungal agents|mesh-ancestor
6783593|NCT02198170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6783594|NCT02198170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6783595|NCT02198170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6783596|NCT02198170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6783597|NCT02198170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783598|NCT02198170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6783599|NCT02198170|Hormone Antagonists|hormone antagonists|mesh-ancestor
6783600|NCT02198170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6783601|NCT02198170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783602|NCT02198170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6783603|NCT02198170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6783604|NCT02198170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6783605|NCT02198209|Liraglutide|liraglutide|mesh-list
6783606|NCT02198209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6783607|NCT02198209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783608|NCT02198209|Incretins|incretins|mesh-ancestor
6783609|NCT02198209|Hormones|hormones|mesh-ancestor
6783610|NCT02198209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6783611|NCT02198248|Prednisolone|prednisolone|mesh-list
6783612|NCT02198248|Rituximab|rituximab|mesh-list
6783613|NCT02198248|Glucocorticoids|glucocorticoids|mesh-list
6783614|NCT02198248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6783615|NCT02198248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6783616|NCT02198248|Immunologic Factors|immunologic factors|mesh-ancestor
6783617|NCT02198248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783618|NCT02198248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6783619|NCT02198248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6783620|NCT02198248|Hormones|hormones|mesh-ancestor
6783621|NCT02198248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6783622|NCT02198248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6783623|NCT02198261|Minoxidil|minoxidil|mesh-list
6716385|NCT01814618|Budesonide|budesonide|mesh-list
6716386|NCT01814618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6716387|NCT01814618|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6716388|NCT01814618|Autonomic Agents|autonomic agents|mesh-ancestor
6716389|NCT01814618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6716390|NCT01814618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716391|NCT01814618|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6716392|NCT01814618|Respiratory System Agents|respiratory system agents|mesh-ancestor
6716393|NCT01814618|Glucocorticoids|glucocorticoids|mesh-ancestor
6716394|NCT01814618|Hormones|hormones|mesh-ancestor
6716395|NCT01814618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6716396|NCT01814657|Lidocaine|lidocaine|mesh-list
6716397|NCT01814657|Anesthetics, Local|anesthetics, local|mesh-ancestor
6716398|NCT01814657|Anesthetics|anesthetics|mesh-ancestor
6716399|NCT01814657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6716400|NCT01814657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716401|NCT01814657|Sensory System Agents|sensory system agents|mesh-ancestor
6716402|NCT01814657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6716403|NCT01814657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6716404|NCT01814657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6716405|NCT01814657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6716406|NCT01814657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6716407|NCT01814657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6716408|NCT01814683|Primaquine|primaquine|mesh-list
6716409|NCT01814683|Antimalarials|antimalarials|mesh-ancestor
6716410|NCT01814683|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6716411|NCT01814683|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6716412|NCT01814683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6716413|NCT01814709|Itraconazole|itraconazole|mesh-list
6716414|NCT01814709|Rifampin|rifampin|mesh-list
6716415|NCT01814709|Antifungal Agents|antifungal agents|mesh-ancestor
6716416|NCT01814709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6716417|NCT01814709|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6716418|NCT01814709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6716419|NCT01814709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6716420|NCT01814709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6716421|NCT01814709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6716422|NCT01814709|Hormone Antagonists|hormone antagonists|mesh-ancestor
6716423|NCT01814709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6716424|NCT01814709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716425|NCT01814709|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6716426|NCT01814709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6716427|NCT01814709|Antitubercular Agents|antitubercular agents|mesh-ancestor
6716428|NCT01814709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6716429|NCT01814709|Leprostatic Agents|leprostatic agents|mesh-ancestor
6716430|NCT01814709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6716431|NCT01814709|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6716432|NCT01814709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6716433|NCT01814709|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6716434|NCT01814709|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6716435|NCT01814709|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6716436|NCT01814709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6716437|NCT01814826|Azacitidine|azacitidine|mesh-list
6716438|NCT01814826|Pevonedistat|pevonedistat|mesh-list
6716439|NCT01814826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6716440|NCT01814826|Antimetabolites|antimetabolites|mesh-ancestor
6716441|NCT01814826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6716442|NCT01814826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6716443|NCT01814826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6716444|NCT01814865|Prednisone|prednisone|mesh-list
6716445|NCT01814865|Anastrozole|anastrozole|mesh-list
6716446|NCT01814865|Abiraterone Acetate|abiraterone acetate|mesh-list
6716447|NCT01814865|Aromatase Inhibitors|aromatase inhibitors|mesh-list
6716448|NCT01814865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6716449|NCT01814865|Glucocorticoids|glucocorticoids|mesh-ancestor
6716450|NCT01814865|Hormones|hormones|mesh-ancestor
6716451|NCT01814865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6716452|NCT01814865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716453|NCT01814865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6716454|NCT01814865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6716455|NCT01814865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6716456|NCT01814865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6716457|NCT01814865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6716458|NCT01814865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6716459|NCT01814865|Hormone Antagonists|hormone antagonists|mesh-ancestor
6716460|NCT01814865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6716461|NCT01814891|Vitamin A|vitamin a|mesh-list
6716462|NCT01814891|Vitamins|vitamins|mesh-ancestor
6716463|NCT01814891|Micronutrients|micronutrients|mesh-ancestor
6716464|NCT01814891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716465|NCT01814904|Bile Acids and Salts|bile acids and salts|mesh-list
6716466|NCT01814904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6716467|NCT01814930|Contraceptive Agents|contraceptive agents|mesh-list
6716468|NCT01814930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6716469|NCT01814930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716470|NCT01815021|Calcium, Dietary|calcium, dietary|mesh-list
6716471|NCT01815021|Calcium Carbonate|calcium carbonate|mesh-list
6716472|NCT01815021|Calcium|calcium|mesh-list
6716473|NCT01815021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6716474|NCT01815021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716475|NCT01815021|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6716476|NCT01815021|Antacids|antacids|mesh-ancestor
6716477|NCT01815021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6716478|NCT01815021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6716479|NCT01815047|Vitamin D|vitamin d|mesh-list
6716480|NCT01815047|Cholecalciferol|cholecalciferol|mesh-list
6716481|NCT01815047|Vitamins|vitamins|mesh-ancestor
6716482|NCT01815047|Micronutrients|micronutrients|mesh-ancestor
6716483|NCT01815047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716484|NCT01815047|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6716485|NCT01815047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6716486|NCT01815073|Vaccines|vaccines|mesh-list
6716487|NCT01815073|Immunologic Factors|immunologic factors|mesh-ancestor
6716488|NCT01815073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716489|NCT01815125|Ondansetron|ondansetron|mesh-list
6716490|NCT01815125|Antiemetics|antiemetics|mesh-ancestor
6716491|NCT01815125|Autonomic Agents|autonomic agents|mesh-ancestor
6716492|NCT01815125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6716493|NCT01815125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716494|NCT01815125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6716495|NCT01815125|Antipruritics|antipruritics|mesh-ancestor
6716496|NCT01815125|Dermatologic Agents|dermatologic agents|mesh-ancestor
6716497|NCT01815125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6716498|NCT01815125|Serotonin Agents|serotonin agents|mesh-ancestor
6716499|NCT01815125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6716500|NCT01815125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6716501|NCT01815125|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6716502|NCT01815125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6716503|NCT01815125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6716504|NCT01815125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6716505|NCT01815125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6716506|NCT01815203|Caffeine|caffeine|mesh-list
6716507|NCT01815203|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6716508|NCT01815203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716509|NCT01815203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6716510|NCT01815203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6716511|NCT01815203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6716512|NCT01815203|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6716513|NCT01815203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6716514|NCT01815203|Purinergic Agents|purinergic agents|mesh-ancestor
6716515|NCT01815203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6716516|NCT01815242|Gemcitabine|gemcitabine|mesh-list
6716517|NCT01815242|Paclitaxel|paclitaxel|mesh-list
6716518|NCT01815242|Carboplatin|carboplatin|mesh-list
6716519|NCT01815242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6716520|NCT01815242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6716521|NCT01815242|Tubulin Modulators|tubulin modulators|mesh-ancestor
6716522|NCT01815242|Antimitotic Agents|antimitotic agents|mesh-ancestor
6716523|NCT01815242|Mitosis Modulators|mitosis modulators|mesh-ancestor
6716524|NCT01815242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6716525|NCT01815242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6716526|NCT01815242|Antimetabolites|antimetabolites|mesh-ancestor
6716527|NCT01815242|Antiviral Agents|antiviral agents|mesh-ancestor
6716528|NCT01815242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6716529|NCT01815242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6716530|NCT01815242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6716531|NCT01815242|Immunologic Factors|immunologic factors|mesh-ancestor
6716532|NCT01815242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716533|NCT01815255|Tenofovir|tenofovir|mesh-list
6716534|NCT01815255|Antiviral Agents|antiviral agents|mesh-ancestor
6716535|NCT01815255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6716536|NCT01815255|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6716537|NCT01815255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6716538|NCT01815255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6716539|NCT01815255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6716540|NCT01815255|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6716541|NCT01815255|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6716542|NCT01815268|Vaccines|vaccines|mesh-list
6716543|NCT01815268|Immunologic Factors|immunologic factors|mesh-ancestor
6716544|NCT01815268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716545|NCT01815294|Doxorubicin|doxorubicin|mesh-list
6716546|NCT01815294|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6716547|NCT01815294|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6716548|NCT01815294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6716549|NCT01815294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6716550|NCT01815294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6716551|NCT01815294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6716552|NCT01815294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6716553|NCT01815307|Gemcitabine|gemcitabine|mesh-list
6716554|NCT01815307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6716555|NCT01815307|Antimetabolites|antimetabolites|mesh-ancestor
6716556|NCT01815307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6716557|NCT01815307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6716558|NCT01815307|Antiviral Agents|antiviral agents|mesh-ancestor
6716559|NCT01815307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6716560|NCT01815307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6716561|NCT01815307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6716562|NCT01815307|Immunologic Factors|immunologic factors|mesh-ancestor
6716563|NCT01815307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716564|NCT01815359|Leucovorin|leucovorin|mesh-list
6716565|NCT01815359|Mitomycins|mitomycins|mesh-list
6716566|NCT01815359|Mitomycin|mitomycin|mesh-list
6716567|NCT01815359|Antidotes|antidotes|mesh-ancestor
6716568|NCT01815359|Protective Agents|protective agents|mesh-ancestor
6716569|NCT01815359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716570|NCT01815359|Vitamin B Complex|vitamin b complex|mesh-ancestor
6716571|NCT01815359|Vitamins|vitamins|mesh-ancestor
6716572|NCT01815359|Micronutrients|micronutrients|mesh-ancestor
6716573|NCT01815359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6716574|NCT01815359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6716575|NCT01815359|Alkylating Agents|alkylating agents|mesh-ancestor
6716576|NCT01815359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6716577|NCT01815359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6716578|NCT01815359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6716579|NCT01815437|Vitamin D|vitamin d|mesh-list
6716580|NCT01815437|Ergocalciferols|ergocalciferols|mesh-list
6716581|NCT01815437|Cholecalciferol|cholecalciferol|mesh-list
6716582|NCT01815437|Vitamins|vitamins|mesh-list
6716583|NCT01815437|Micronutrients|micronutrients|mesh-ancestor
6716584|NCT01815437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716585|NCT01815437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6716586|NCT01815437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6716587|NCT01815528|Catumaxomab|catumaxomab|mesh-list
6716588|NCT01815528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6716589|NCT01815541|Teicoplanin|teicoplanin|mesh-list
6716590|NCT01815541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6716591|NCT01815541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6716592|NCT01815580|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6716593|NCT01815580|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6716594|NCT01815580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6716595|NCT01815580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6716596|NCT01815580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6716597|NCT01815580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6716598|NCT01815580|Antiviral Agents|antiviral agents|mesh-ancestor
6716599|NCT01815580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6716600|NCT01815580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6716601|NCT01815580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6716602|NCT01815658|Carbon Fiber|carbon fiber|mesh-list
6716603|NCT01815658|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6716604|NCT01815658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6716605|NCT01815723|Dimethyl Fumarate|dimethyl fumarate|mesh-list
6716606|NCT01815723|Dermatologic Agents|dermatologic agents|mesh-ancestor
6716607|NCT01815723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6716608|NCT01815723|Immunologic Factors|immunologic factors|mesh-ancestor
6716609|NCT01815723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716610|NCT01815892|Furosemide|furosemide|mesh-list
6716611|NCT01815892|Diuretics|diuretics|mesh-ancestor
6716612|NCT01815892|Natriuretic Agents|natriuretic agents|mesh-ancestor
6716613|NCT01815892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716614|NCT01815892|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6716615|NCT01815892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6716616|NCT01815892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6716617|NCT01815944|Ropivacaine|ropivacaine|mesh-list
6716618|NCT01815944|Anesthetics, Local|anesthetics, local|mesh-ancestor
6716619|NCT01815944|Anesthetics|anesthetics|mesh-ancestor
6716620|NCT01815944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6716621|NCT01815944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716622|NCT01815944|Sensory System Agents|sensory system agents|mesh-ancestor
6716623|NCT01815944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6716624|NCT01816009|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6716625|NCT01816009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6716626|NCT01816035|Trastuzumab|trastuzumab|mesh-list
6716627|NCT01816035|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
6716628|NCT01816035|Maytansine|maytansine|mesh-list
6716629|NCT01816035|Immunoconjugates|immunoconjugates|mesh-list
6716630|NCT01816035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6716631|NCT01816035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6716632|NCT01816035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6716633|NCT01816035|Tubulin Modulators|tubulin modulators|mesh-ancestor
6716634|NCT01816035|Antimitotic Agents|antimitotic agents|mesh-ancestor
6716635|NCT01816035|Mitosis Modulators|mitosis modulators|mesh-ancestor
6716636|NCT01816035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6716637|NCT01816035|Immunologic Factors|immunologic factors|mesh-ancestor
6716638|NCT01816035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716639|NCT01816191|Diltiazem|diltiazem|mesh-list
6716640|NCT01816191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6716641|NCT01816191|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6716642|NCT01816191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6716643|NCT01816191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6716644|NCT01816191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6716645|NCT01816191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716646|NCT01816191|Vasodilator Agents|vasodilator agents|mesh-ancestor
6783624|NCT02198261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6783625|NCT02198261|Vasodilator Agents|vasodilator agents|mesh-ancestor
6783626|NCT02198300|Clopidogrel|clopidogrel|mesh-list
6783627|NCT02198300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6783628|NCT02198300|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6783629|NCT02198300|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6783630|NCT02198300|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6783631|NCT02198300|Purinergic Agents|purinergic agents|mesh-ancestor
6783632|NCT02198300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6783633|NCT02198300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783634|NCT02198300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783635|NCT02198378|Acetaminophen|acetaminophen|mesh-list
6783636|NCT02198378|Morphine|morphine|mesh-list
6783637|NCT02198378|Entonox|entonox|mesh-list
6783638|NCT02198378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6783639|NCT02198378|Narcotics|narcotics|mesh-ancestor
6783640|NCT02198378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6783641|NCT02198378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783642|NCT02198378|Analgesics|analgesics|mesh-ancestor
6783643|NCT02198378|Sensory System Agents|sensory system agents|mesh-ancestor
6783644|NCT02198378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6783645|NCT02198378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6783646|NCT02198378|Antipyretics|antipyretics|mesh-ancestor
6783647|NCT02198378|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
6783648|NCT02198378|Anesthetics|anesthetics|mesh-ancestor
6783649|NCT02198404|Propofol|propofol|mesh-list
6783650|NCT02198404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6783651|NCT02198404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6783652|NCT02198404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783653|NCT02198404|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6783654|NCT02198404|Anesthetics, General|anesthetics, general|mesh-ancestor
6783655|NCT02198404|Anesthetics|anesthetics|mesh-ancestor
6783656|NCT02198417|Metformin|metformin|mesh-list
6783657|NCT02198417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6783658|NCT02198417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783659|NCT02198443|Ritonavir|ritonavir|mesh-list
6783660|NCT02198443|Lopinavir|lopinavir|mesh-list
6783661|NCT02198443|Tenofovir|tenofovir|mesh-list
6783662|NCT02198443|Emtricitabine|emtricitabine|mesh-list
6783663|NCT02198443|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6783664|NCT02198443|Cobicistat|cobicistat|mesh-list
6783665|NCT02198443|Elvitegravir|elvitegravir|mesh-list
6783666|NCT02198443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6783667|NCT02198443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6783668|NCT02198443|Protease Inhibitors|protease inhibitors|mesh-ancestor
6783669|NCT02198443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6783670|NCT02198443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783671|NCT02198443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6783672|NCT02198443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6783673|NCT02198443|Antiviral Agents|antiviral agents|mesh-ancestor
6783674|NCT02198443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6783675|NCT02198443|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6783676|NCT02198443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6783677|NCT02198443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6783678|NCT02198443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6783679|NCT02198443|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6783680|NCT02198469|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
6783681|NCT02198469|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6783682|NCT02198469|Dermatologic Agents|dermatologic agents|mesh-ancestor
6783683|NCT02198482|Cytarabine|cytarabine|mesh-list
6783684|NCT02198482|Daunorubicin|daunorubicin|mesh-list
6783685|NCT02198482|Mitoxantrone|mitoxantrone|mesh-list
6783686|NCT02198482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6783687|NCT02198482|Antimetabolites|antimetabolites|mesh-ancestor
6716647|NCT01816321|Ganirelix|ganirelix|mesh-list
6716648|NCT01816321|Hormone Antagonists|hormone antagonists|mesh-ancestor
6716649|NCT01816321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6716650|NCT01816321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716651|NCT01816334|Methylprednisolone|methylprednisolone|mesh-list
6716652|NCT01816334|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6716653|NCT01816334|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6716654|NCT01816334|Prednisolone|prednisolone|mesh-list
6716655|NCT01816334|Prednisolone acetate|prednisolone acetate|mesh-list
6716656|NCT01816334|Ketoprofen|ketoprofen|mesh-list
6716657|NCT01816334|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6716658|NCT01816334|Prednisolone phosphate|prednisolone phosphate|mesh-list
6716659|NCT01816334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6716660|NCT01816334|Antiemetics|antiemetics|mesh-ancestor
6716661|NCT01816334|Autonomic Agents|autonomic agents|mesh-ancestor
6716662|NCT01816334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6716663|NCT01816334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716664|NCT01816334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6716665|NCT01816334|Glucocorticoids|glucocorticoids|mesh-ancestor
6716666|NCT01816334|Hormones|hormones|mesh-ancestor
6716667|NCT01816334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6716668|NCT01816334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6716669|NCT01816334|Protective Agents|protective agents|mesh-ancestor
6716670|NCT01816334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6716671|NCT01816334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6716672|NCT01816334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6716673|NCT01816334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6716674|NCT01816334|Analgesics|analgesics|mesh-ancestor
6716675|NCT01816334|Sensory System Agents|sensory system agents|mesh-ancestor
6716676|NCT01816334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6716677|NCT01816334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6716678|NCT01816334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6716679|NCT01816334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6716680|NCT01816412|Paclitaxel|paclitaxel|mesh-list
6716681|NCT01816412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6716682|NCT01816412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6716683|NCT01816412|Tubulin Modulators|tubulin modulators|mesh-ancestor
6716684|NCT01816412|Antimitotic Agents|antimitotic agents|mesh-ancestor
6716685|NCT01816412|Mitosis Modulators|mitosis modulators|mesh-ancestor
6716686|NCT01816412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6716687|NCT01816490|Silybin|silybin|mesh-list
6716688|NCT01816490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6716689|NCT01816490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6716690|NCT01816490|Protective Agents|protective agents|mesh-ancestor
6716691|NCT01816490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716692|NCT01816529|Diltiazem|diltiazem|mesh-list
6716693|NCT01816529|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6716694|NCT01816529|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6716695|NCT01816529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6716696|NCT01816529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6716697|NCT01816529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6716698|NCT01816529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716699|NCT01816529|Vasodilator Agents|vasodilator agents|mesh-ancestor
6716700|NCT01816555|Vitamin D|vitamin d|mesh-list
6716701|NCT01816555|Vitamins|vitamins|mesh-ancestor
6716702|NCT01816555|Micronutrients|micronutrients|mesh-ancestor
6716703|NCT01816555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716704|NCT01816555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6716705|NCT01816581|Morphine|morphine|mesh-list
6716706|NCT01816581|Naloxone|naloxone|mesh-list
6716707|NCT01816581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6716708|NCT01816581|Narcotics|narcotics|mesh-ancestor
6716709|NCT01816581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6716710|NCT01816581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716711|NCT01816581|Analgesics|analgesics|mesh-ancestor
6716712|NCT01816581|Sensory System Agents|sensory system agents|mesh-ancestor
6716713|NCT01816581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6716714|NCT01816581|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6716715|NCT01816620|Dexamethasone|dexamethasone|mesh-list
6716716|NCT01816620|Lenalidomide|lenalidomide|mesh-list
6716717|NCT01816620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6716718|NCT01816620|Antiemetics|antiemetics|mesh-ancestor
6716719|NCT01816620|Autonomic Agents|autonomic agents|mesh-ancestor
6716720|NCT01816620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6716721|NCT01816620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716722|NCT01816620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6716723|NCT01816620|Glucocorticoids|glucocorticoids|mesh-ancestor
6716724|NCT01816620|Hormones|hormones|mesh-ancestor
6716725|NCT01816620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6716726|NCT01816620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6716727|NCT01816620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6716728|NCT01816620|Immunologic Factors|immunologic factors|mesh-ancestor
6716729|NCT01816620|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6716730|NCT01816620|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6716731|NCT01816620|Growth Substances|growth substances|mesh-ancestor
6716732|NCT01816620|Growth Inhibitors|growth inhibitors|mesh-ancestor
6716733|NCT01816646|Cidofovir|cidofovir|mesh-list
6716734|NCT01816646|Probenecid|probenecid|mesh-list
6716735|NCT01816646|Uricosuric Agents|uricosuric agents|mesh-ancestor
6716736|NCT01816646|Gout Suppressants|gout suppressants|mesh-ancestor
6716737|NCT01816646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6716738|NCT01816646|Renal Agents|renal agents|mesh-ancestor
6716739|NCT01816646|Antiviral Agents|antiviral agents|mesh-ancestor
6716740|NCT01816646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6716741|NCT01816646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6716742|NCT01816646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6716743|NCT01816659|Metformin|metformin|mesh-list
6716744|NCT01816659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6716745|NCT01816659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716746|NCT01816789|Buserelin|buserelin|mesh-list
6716747|NCT01816789|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6716748|NCT01816789|Fertility Agents|fertility agents|mesh-ancestor
6716749|NCT01816789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6716750|NCT01816789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716751|NCT01816958|Ketamine|ketamine|mesh-list
6716752|NCT01816958|Analgesics|analgesics|mesh-ancestor
6716753|NCT01816958|Sensory System Agents|sensory system agents|mesh-ancestor
6716754|NCT01816958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6716755|NCT01816958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716756|NCT01816958|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6716757|NCT01816958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6716758|NCT01816958|Anesthetics, General|anesthetics, general|mesh-ancestor
6716759|NCT01816958|Anesthetics|anesthetics|mesh-ancestor
6716760|NCT01816958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6716761|NCT01816958|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6716762|NCT01816958|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6716763|NCT01816958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6716764|NCT01816958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6716765|NCT01816971|Dexamethasone|dexamethasone|mesh-list
6716766|NCT01816971|Lenalidomide|lenalidomide|mesh-list
6716767|NCT01816971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6716768|NCT01816971|Antiemetics|antiemetics|mesh-ancestor
6716769|NCT01816971|Autonomic Agents|autonomic agents|mesh-ancestor
6716770|NCT01816971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6716771|NCT01816971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716772|NCT01816971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6716773|NCT01816971|Glucocorticoids|glucocorticoids|mesh-ancestor
6716774|NCT01816971|Hormones|hormones|mesh-ancestor
6716775|NCT01816971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6716776|NCT01816971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6716777|NCT01816971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6716778|NCT01816971|Immunologic Factors|immunologic factors|mesh-ancestor
6716779|NCT01816971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6716780|NCT01816971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6716781|NCT01816971|Growth Substances|growth substances|mesh-ancestor
6716782|NCT01816971|Growth Inhibitors|growth inhibitors|mesh-ancestor
6716783|NCT01816997|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6716784|NCT01816997|Pravastatin|pravastatin|mesh-list
6716785|NCT01816997|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6716786|NCT01816997|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6716787|NCT01816997|Antimetabolites|antimetabolites|mesh-ancestor
6716788|NCT01816997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6716789|NCT01816997|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6716790|NCT01816997|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6716791|NCT01816997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6716792|NCT01817023|Cisplatin|cisplatin|mesh-list
6716793|NCT01817023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6716794|NCT01817036|Vitamin D|vitamin d|mesh-list
6716795|NCT01817036|Vitamins|vitamins|mesh-ancestor
6716796|NCT01817036|Micronutrients|micronutrients|mesh-ancestor
6716797|NCT01817036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716798|NCT01817036|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6716799|NCT01817153|Hydrocortisone|hydrocortisone|mesh-list
6716800|NCT01817153|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6716801|NCT01817153|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6716802|NCT01817153|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6716803|NCT01817153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6716804|NCT01817218|Anti-Infective Agents|anti-infective agents|mesh-list
6716805|NCT01817218|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6716806|NCT01817257|Heparin|heparin|mesh-list
6716807|NCT01817257|Enoxaparin|enoxaparin|mesh-list
6716808|NCT01817257|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6716809|NCT01817257|Tinzaparin|tinzaparin|mesh-list
6716810|NCT01817257|Dalteparin|dalteparin|mesh-list
6716811|NCT01817257|Anticoagulants|anticoagulants|mesh-ancestor
6716812|NCT01817257|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6716813|NCT01817257|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6716814|NCT01817257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6716815|NCT01817283|Triptolide|triptolide|mesh-list
6716816|NCT01817283|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
6716817|NCT01817283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716818|NCT01817283|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6716819|NCT01817283|Contraceptive Agents|contraceptive agents|mesh-ancestor
6716820|NCT01817283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6716821|NCT01817283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6716822|NCT01817283|Immunologic Factors|immunologic factors|mesh-ancestor
6716823|NCT01817283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6716824|NCT01817283|Alkylating Agents|alkylating agents|mesh-ancestor
6716825|NCT01817283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6716826|NCT01817283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6716827|NCT01817322|Mycophenolic Acid|mycophenolic acid|mesh-list
6716828|NCT01817322|Methylprednisolone|methylprednisolone|mesh-list
6716829|NCT01817322|Prednisolone|prednisolone|mesh-list
6716830|NCT01817322|Deflazacort|deflazacort|mesh-list
6716831|NCT01817322|Basiliximab|basiliximab|mesh-list
6716832|NCT01817322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6716833|NCT01817322|Antiemetics|antiemetics|mesh-ancestor
6716834|NCT01817322|Autonomic Agents|autonomic agents|mesh-ancestor
6716835|NCT01817322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6716836|NCT01817322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716837|NCT01817322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6716838|NCT01817322|Glucocorticoids|glucocorticoids|mesh-ancestor
6716839|NCT01817322|Hormones|hormones|mesh-ancestor
6716840|NCT01817322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6716841|NCT01817322|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6716842|NCT01817322|Protective Agents|protective agents|mesh-ancestor
6716843|NCT01817322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6716844|NCT01817322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6716845|NCT01817322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6716846|NCT01817322|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6716847|NCT01817322|Antitubercular Agents|antitubercular agents|mesh-ancestor
6716848|NCT01817322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6716849|NCT01817322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6716850|NCT01817322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6716851|NCT01817322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6716852|NCT01817322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6716853|NCT01817322|Immunologic Factors|immunologic factors|mesh-ancestor
6716854|NCT01817348|Lidocaine|lidocaine|mesh-list
6716855|NCT01817348|Anesthetics, Local|anesthetics, local|mesh-ancestor
6716856|NCT01817348|Anesthetics|anesthetics|mesh-ancestor
6716857|NCT01817348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6716858|NCT01817348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716859|NCT01817348|Sensory System Agents|sensory system agents|mesh-ancestor
6716860|NCT01817348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6716861|NCT01817348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6716862|NCT01817348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6716863|NCT01817348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6716864|NCT01817348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6716865|NCT01817348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6716866|NCT01817400|Aspirin|aspirin|mesh-list
6716867|NCT01817400|Pioglitazone|pioglitazone|mesh-list
6716868|NCT01817400|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
6716869|NCT01817400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6716870|NCT01817400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6716871|NCT01817400|Analgesics|analgesics|mesh-ancestor
6716872|NCT01817400|Sensory System Agents|sensory system agents|mesh-ancestor
6716873|NCT01817400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6716874|NCT01817400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716875|NCT01817400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6716876|NCT01817400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6716877|NCT01817400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6716878|NCT01817400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6716879|NCT01817400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6716880|NCT01817400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6716881|NCT01817400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6716882|NCT01817400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6716883|NCT01817400|Antipyretics|antipyretics|mesh-ancestor
6716884|NCT01817400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6716885|NCT01817400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6716886|NCT01817426|Infliximab|infliximab|mesh-list
6716887|NCT01817426|Dermatologic Agents|dermatologic agents|mesh-ancestor
6716888|NCT01817426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6716889|NCT01817426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6716890|NCT01817439|Amiodarone|amiodarone|mesh-list
6716891|NCT01817439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6716892|NCT01817439|Vasodilator Agents|vasodilator agents|mesh-ancestor
6716893|NCT01817439|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6716894|NCT01817439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6716895|NCT01817439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6716896|NCT01817439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6716897|NCT01817439|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6716898|NCT01817439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6716899|NCT01817439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6716900|NCT01817439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6716901|NCT01817439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6716902|NCT01817439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6716903|NCT01817452|Paclitaxel|paclitaxel|mesh-list
6716904|NCT01817452|Trastuzumab|trastuzumab|mesh-list
6716905|NCT01817452|Pertuzumab|pertuzumab|mesh-list
6716906|NCT01817452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6716907|NCT01817452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6716908|NCT01817452|Tubulin Modulators|tubulin modulators|mesh-ancestor
6716909|NCT01817452|Antimitotic Agents|antimitotic agents|mesh-ancestor
6716910|NCT01817452|Mitosis Modulators|mitosis modulators|mesh-ancestor
6716911|NCT01817452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6716912|NCT01817452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6716913|NCT01817699|Vitamin D|vitamin d|mesh-list
6716914|NCT01817699|Cholecalciferol|cholecalciferol|mesh-list
6716915|NCT01817699|Vitamins|vitamins|mesh-ancestor
6716916|NCT01817699|Micronutrients|micronutrients|mesh-ancestor
6716917|NCT01817699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716918|NCT01817699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6716919|NCT01817699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6716920|NCT01817803|Metolazone|metolazone|mesh-list
6716921|NCT01817803|Furosemide|furosemide|mesh-list
6716922|NCT01817803|Spironolactone|spironolactone|mesh-list
6716923|NCT01817803|Diuretics|diuretics|mesh-ancestor
6716924|NCT01817803|Natriuretic Agents|natriuretic agents|mesh-ancestor
6716925|NCT01817803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716926|NCT01817803|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6716927|NCT01817803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6716928|NCT01817803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6716929|NCT01817803|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6716930|NCT01817803|Hormone Antagonists|hormone antagonists|mesh-ancestor
6716931|NCT01817803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6716932|NCT01817803|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6716933|NCT01817803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6716934|NCT01817803|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6716935|NCT01817816|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6716936|NCT01817816|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6716937|NCT01817816|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6716938|NCT01817816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6716939|NCT01817816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716940|NCT01817816|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6716941|NCT01817816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6716942|NCT01817816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6716943|NCT01817816|Cholinergic Agents|cholinergic agents|mesh-ancestor
6716944|NCT01817816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6716945|NCT01817829|Acetaminophen|acetaminophen|mesh-list
6716946|NCT01817829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6716947|NCT01817829|Analgesics|analgesics|mesh-ancestor
6716948|NCT01817829|Sensory System Agents|sensory system agents|mesh-ancestor
6716949|NCT01817829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6716950|NCT01817829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716951|NCT01817829|Antipyretics|antipyretics|mesh-ancestor
6716952|NCT01817868|Factor VIII|factor viii|mesh-list
6716953|NCT01817868|Coagulants|coagulants|mesh-ancestor
6716954|NCT01817894|Eflornithine|eflornithine|mesh-list
6716955|NCT01817894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6716956|NCT01817894|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6716957|NCT01817894|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6716958|NCT01817894|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6716959|NCT01817894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6716960|NCT01817894|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
6716961|NCT01817894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6716962|NCT01817894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783688|NCT02198482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783689|NCT02198482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6783690|NCT02198482|Antiviral Agents|antiviral agents|mesh-ancestor
6783691|NCT02198482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6783692|NCT02198482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6783693|NCT02198482|Immunologic Factors|immunologic factors|mesh-ancestor
6783694|NCT02198482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783695|NCT02198482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6783696|NCT02198482|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6783697|NCT02198482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6783698|NCT02198482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6783699|NCT02198482|Analgesics|analgesics|mesh-ancestor
6783700|NCT02198482|Sensory System Agents|sensory system agents|mesh-ancestor
6783701|NCT02198482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6783702|NCT02198495|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6783703|NCT02198495|Hematinics|hematinics|mesh-ancestor
6783704|NCT02198508|Deferasirox|deferasirox|mesh-list
6783705|NCT02198508|Deferiprone|deferiprone|mesh-list
6783706|NCT02198508|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6783707|NCT02198508|Chelating Agents|chelating agents|mesh-ancestor
6783708|NCT02198508|Sequestering Agents|sequestering agents|mesh-ancestor
6716963|NCT01817972|Azathioprine|azathioprine|mesh-list
6716964|NCT01817972|Certolizumab Pegol|certolizumab pegol|mesh-list
6716965|NCT01817972|Antimetabolites|antimetabolites|mesh-ancestor
6716966|NCT01817972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6716967|NCT01817972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6716968|NCT01817972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6716969|NCT01817972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6716970|NCT01817972|Immunologic Factors|immunologic factors|mesh-ancestor
6716971|NCT01817972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716972|NCT01817972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6716973|NCT01817985|Velpatasvir|velpatasvir|mesh-list
6716974|NCT01817985|Antiviral Agents|antiviral agents|mesh-ancestor
6716975|NCT01817985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6716976|NCT01818024|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6716977|NCT01818024|Immunologic Factors|immunologic factors|mesh-ancestor
6716978|NCT01818024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716979|NCT01818232|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
6716980|NCT01818232|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6716981|NCT01818232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6716982|NCT01818232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6716983|NCT01818232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716984|NCT01818375|Anesthetics|anesthetics|mesh-list
6716985|NCT01818375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6716986|NCT01818375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716987|NCT01818648|Exenatide|exenatide|mesh-list
6716988|NCT01818648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6716989|NCT01818648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6716990|NCT01818648|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6716991|NCT01818648|Incretins|incretins|mesh-ancestor
6716992|NCT01818648|Hormones|hormones|mesh-ancestor
6716993|NCT01818648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6716994|NCT01818713|Doxorubicin|doxorubicin|mesh-list
6716995|NCT01818713|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6716996|NCT01818713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6716997|NCT01818713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6716998|NCT01818713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6716999|NCT01818713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6717000|NCT01818713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6717001|NCT01818713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717002|NCT01818843|Carbon Monoxide|carbon monoxide|mesh-list
6717003|NCT01818843|Antimetabolites|antimetabolites|mesh-ancestor
6717004|NCT01818843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717005|NCT01818843|Gasotransmitters|gasotransmitters|mesh-ancestor
6717006|NCT01818843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6717007|NCT01818843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717008|NCT01818856|Ritonavir|ritonavir|mesh-list
6717009|NCT01818856|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6717010|NCT01818856|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6717011|NCT01818856|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6717012|NCT01818856|Protease Inhibitors|protease inhibitors|mesh-ancestor
6717013|NCT01818856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6717014|NCT01818856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717015|NCT01818856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6717016|NCT01818856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6717017|NCT01818856|Antiviral Agents|antiviral agents|mesh-ancestor
6717018|NCT01818856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6717019|NCT01818856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6717020|NCT01818856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6717021|NCT01818869|Adenosine|adenosine|mesh-list
6717022|NCT01818869|Analgesics|analgesics|mesh-ancestor
6717023|NCT01818869|Sensory System Agents|sensory system agents|mesh-ancestor
6717024|NCT01818869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6717025|NCT01818869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717026|NCT01818869|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6717027|NCT01818869|Vasodilator Agents|vasodilator agents|mesh-ancestor
6717028|NCT01818869|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6717029|NCT01818869|Purinergic Agonists|purinergic agonists|mesh-ancestor
6717030|NCT01818869|Purinergic Agents|purinergic agents|mesh-ancestor
6717031|NCT01818869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6717032|NCT01818869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717033|NCT01818908|Prednisone|prednisone|mesh-list
6717034|NCT01818908|Cyclophosphamide|cyclophosphamide|mesh-list
6717035|NCT01818908|Doxorubicin|doxorubicin|mesh-list
6717036|NCT01818908|Etoposide|etoposide|mesh-list
6717037|NCT01818908|Vincristine|vincristine|mesh-list
6717038|NCT01818908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6717039|NCT01818908|Immunologic Factors|immunologic factors|mesh-ancestor
6717040|NCT01818908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717041|NCT01818908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6717042|NCT01818908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6717043|NCT01818908|Alkylating Agents|alkylating agents|mesh-ancestor
6717044|NCT01818908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717045|NCT01818908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6717046|NCT01818908|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6717047|NCT01818908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6717048|NCT01818908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6717049|NCT01818908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6717050|NCT01818908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6717051|NCT01818908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6717052|NCT01818908|Glucocorticoids|glucocorticoids|mesh-ancestor
6717053|NCT01818908|Hormones|hormones|mesh-ancestor
6717054|NCT01818908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6717055|NCT01818908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6717056|NCT01818908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6717057|NCT01818908|Tubulin Modulators|tubulin modulators|mesh-ancestor
6717058|NCT01818908|Antimitotic Agents|antimitotic agents|mesh-ancestor
6717059|NCT01818908|Mitosis Modulators|mitosis modulators|mesh-ancestor
6717060|NCT01818973|Bevacizumab|bevacizumab|mesh-list
6717061|NCT01818973|Capecitabine|capecitabine|mesh-list
6717062|NCT01818973|Oxaliplatin|oxaliplatin|mesh-list
6717063|NCT01818973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6717064|NCT01818973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6717065|NCT01818973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6717066|NCT01818973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6717067|NCT01818973|Growth Substances|growth substances|mesh-ancestor
6717068|NCT01818973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717069|NCT01818973|Growth Inhibitors|growth inhibitors|mesh-ancestor
6717070|NCT01818973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6717071|NCT01818973|Antimetabolites|antimetabolites|mesh-ancestor
6717072|NCT01818973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717073|NCT01819012|Isoflurane|isoflurane|mesh-list
6717074|NCT01819012|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6717075|NCT01819012|Anesthetics, General|anesthetics, general|mesh-ancestor
6717076|NCT01819012|Anesthetics|anesthetics|mesh-ancestor
6717077|NCT01819012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6717078|NCT01819012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717079|NCT01819051|Anti-Infective Agents|anti-infective agents|mesh-list
6717080|NCT01819051|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6717081|NCT01819064|Atropine|atropine|mesh-list
6717082|NCT01819064|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6717083|NCT01819064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6717084|NCT01819064|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6717085|NCT01819064|Autonomic Agents|autonomic agents|mesh-ancestor
6717086|NCT01819064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6717087|NCT01819064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717088|NCT01819064|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6717089|NCT01819064|Respiratory System Agents|respiratory system agents|mesh-ancestor
6717090|NCT01819064|Mydriatics|mydriatics|mesh-ancestor
6717091|NCT01819064|Parasympatholytics|parasympatholytics|mesh-ancestor
6717092|NCT01819064|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6717093|NCT01819064|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6717094|NCT01819064|Cholinergic Agents|cholinergic agents|mesh-ancestor
6717095|NCT01819064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6717096|NCT01819064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717097|NCT01819155|Vaccines|vaccines|mesh-list
6717098|NCT01819155|Immunologic Factors|immunologic factors|mesh-ancestor
6717099|NCT01819155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717100|NCT01819220|Amlodipine|amlodipine|mesh-list
6717101|NCT01819220|Valsartan|valsartan|mesh-list
6717102|NCT01819220|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6717103|NCT01819220|Telmisartan|telmisartan|mesh-list
6717104|NCT01819220|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
6717105|NCT01819220|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
6717106|NCT01819220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6717107|NCT01819220|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6717108|NCT01819220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6717109|NCT01819220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717110|NCT01819220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6717111|NCT01819220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717112|NCT01819220|Vasodilator Agents|vasodilator agents|mesh-ancestor
6717113|NCT01819220|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6717114|NCT01819220|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6717115|NCT01819220|Diuretics|diuretics|mesh-ancestor
6717116|NCT01819220|Natriuretic Agents|natriuretic agents|mesh-ancestor
6717117|NCT01819220|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6717118|NCT01819259|Nicotine|nicotine|mesh-list
6717119|NCT01819259|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6717120|NCT01819259|Autonomic Agents|autonomic agents|mesh-ancestor
6717121|NCT01819259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6717122|NCT01819259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717123|NCT01819259|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6717124|NCT01819259|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6717125|NCT01819259|Cholinergic Agents|cholinergic agents|mesh-ancestor
6717126|NCT01819259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6717127|NCT01819259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717128|NCT01819285|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
6717129|NCT01819285|Hormones|hormones|mesh-ancestor
6717130|NCT01819285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6717131|NCT01819285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717132|NCT01819389|Imatinib Mesylate|imatinib mesylate|mesh-list
6717133|NCT01819389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6717134|NCT01819389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6717135|NCT01819389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6717136|NCT01819389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717137|NCT01819402|Pioglitazone|pioglitazone|mesh-list
6717138|NCT01819402|Glimepiride|glimepiride|mesh-list
6717139|NCT01819402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6717140|NCT01819402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717141|NCT01819402|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6717142|NCT01819402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6717143|NCT01819402|Immunologic Factors|immunologic factors|mesh-ancestor
6717144|NCT01819441|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6717145|NCT01819441|Perindopril|perindopril|mesh-list
6717146|NCT01819441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6717147|NCT01819441|Diuretics|diuretics|mesh-ancestor
6717148|NCT01819441|Natriuretic Agents|natriuretic agents|mesh-ancestor
6717149|NCT01819441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717150|NCT01819441|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6717151|NCT01819441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6717152|NCT01819441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717153|NCT01819441|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6717154|NCT01819441|Protease Inhibitors|protease inhibitors|mesh-ancestor
6717155|NCT01819441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6717156|NCT01819610|Ketorolac|ketorolac|mesh-list
6717157|NCT01819610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6717158|NCT01819610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6717159|NCT01819610|Analgesics|analgesics|mesh-ancestor
6717160|NCT01819610|Sensory System Agents|sensory system agents|mesh-ancestor
6717161|NCT01819610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6717162|NCT01819610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717163|NCT01819610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6717164|NCT01819610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6717165|NCT01819610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6717166|NCT01819610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6717167|NCT01819610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717168|NCT01819649|Selenium|selenium|mesh-list
6717169|NCT01819649|Antioxidants|antioxidants|mesh-ancestor
6717170|NCT01819649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717171|NCT01819649|Protective Agents|protective agents|mesh-ancestor
6717172|NCT01819649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717173|NCT01819649|Trace Elements|trace elements|mesh-ancestor
6717174|NCT01819649|Micronutrients|micronutrients|mesh-ancestor
6783709|NCT02198508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783710|NCT02198547|Magnesium Sulfate|magnesium sulfate|mesh-list
6783711|NCT02198547|Ropivacaine|ropivacaine|mesh-list
6783712|NCT02198547|Anesthetics, Local|anesthetics, local|mesh-ancestor
6783713|NCT02198547|Anesthetics|anesthetics|mesh-ancestor
6783714|NCT02198547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6783715|NCT02198547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783716|NCT02198547|Sensory System Agents|sensory system agents|mesh-ancestor
6717175|NCT01819701|Ubiquinone|ubiquinone|mesh-list
6717176|NCT01819701|Coenzyme Q10|coenzyme q10|mesh-list
6717177|NCT01819701|Micronutrients|micronutrients|mesh-ancestor
6717178|NCT01819701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717179|NCT01819701|Vitamins|vitamins|mesh-ancestor
6717180|NCT01819779|Amlodipine|amlodipine|mesh-list
6717181|NCT01819779|Valsartan|valsartan|mesh-list
6717182|NCT01819779|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
6717183|NCT01819779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6717184|NCT01819779|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6717185|NCT01819779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6717186|NCT01819779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717187|NCT01819779|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6717188|NCT01819779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717189|NCT01819779|Vasodilator Agents|vasodilator agents|mesh-ancestor
6717190|NCT01819779|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6717191|NCT01819779|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6717192|NCT01819857|Ondansetron|ondansetron|mesh-list
6717193|NCT01819857|Antiemetics|antiemetics|mesh-ancestor
6717194|NCT01819857|Autonomic Agents|autonomic agents|mesh-ancestor
6717195|NCT01819857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6717196|NCT01819857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717197|NCT01819857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6717198|NCT01819857|Antipruritics|antipruritics|mesh-ancestor
6717199|NCT01819857|Dermatologic Agents|dermatologic agents|mesh-ancestor
6717200|NCT01819857|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6717201|NCT01819857|Serotonin Agents|serotonin agents|mesh-ancestor
6717202|NCT01819857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6717203|NCT01819857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717204|NCT01819857|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6717205|NCT01819857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6717206|NCT01819857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6717207|NCT01819857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6717208|NCT01819857|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6717209|NCT01819870|Carvedilol|carvedilol|mesh-list
6717210|NCT01819870|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6717211|NCT01819870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6717212|NCT01819870|Adrenergic Agents|adrenergic agents|mesh-ancestor
6717213|NCT01819870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6717214|NCT01819870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717215|NCT01819870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717216|NCT01819870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6717217|NCT01819870|Antioxidants|antioxidants|mesh-ancestor
6717218|NCT01819870|Protective Agents|protective agents|mesh-ancestor
6717219|NCT01819870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6717220|NCT01819870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6717221|NCT01819870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6717222|NCT01819870|Vasodilator Agents|vasodilator agents|mesh-ancestor
6717223|NCT01819870|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6717224|NCT01819870|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6717225|NCT01819961|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6717226|NCT01819961|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6717227|NCT01819961|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6717228|NCT01819961|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6717229|NCT01820026|Amoxicillin|amoxicillin|mesh-list
6717230|NCT01820026|Azithromycin|azithromycin|mesh-list
6717231|NCT01820026|Vancomycin|vancomycin|mesh-list
6717232|NCT01820026|Imipenem|imipenem|mesh-list
6717233|NCT01820026|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6717234|NCT01820026|Cefotaxime|cefotaxime|mesh-list
6717235|NCT01820026|Cefoxitin|cefoxitin|mesh-list
6717236|NCT01820026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6717237|NCT01820026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6717238|NCT01820026|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6717239|NCT01820026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6717240|NCT01820026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717241|NCT01820091|Levoleucovorin|levoleucovorin|mesh-list
6717242|NCT01820091|Antidotes|antidotes|mesh-ancestor
6717243|NCT01820091|Protective Agents|protective agents|mesh-ancestor
6717244|NCT01820091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717245|NCT01820104|Lansoprazole|lansoprazole|mesh-list
6717246|NCT01820104|Dexlansoprazole|dexlansoprazole|mesh-list
6717247|NCT01820104|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6717248|NCT01820104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6717249|NCT01820104|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6717250|NCT01820104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6717251|NCT01820104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717252|NCT01820143|Esomeprazole|esomeprazole|mesh-list
6717253|NCT01820143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6717254|NCT01820143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6717255|NCT01820143|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6717256|NCT01820143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6717257|NCT01820143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717258|NCT01820299|Vitamin D|vitamin d|mesh-list
6717259|NCT01820299|Grape Seed Extract|grape seed extract|mesh-list
6717260|NCT01820299|Vitamins|vitamins|mesh-ancestor
6717261|NCT01820299|Micronutrients|micronutrients|mesh-ancestor
6717262|NCT01820299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717263|NCT01820299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6717264|NCT01820299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6717265|NCT01820299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6717266|NCT01820299|Antioxidants|antioxidants|mesh-ancestor
6717267|NCT01820299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717268|NCT01820299|Protective Agents|protective agents|mesh-ancestor
6717269|NCT01820312|Paclitaxel|paclitaxel|mesh-list
6717270|NCT01820312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6717271|NCT01820312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6717272|NCT01820312|Tubulin Modulators|tubulin modulators|mesh-ancestor
6717273|NCT01820312|Antimitotic Agents|antimitotic agents|mesh-ancestor
6717274|NCT01820312|Mitosis Modulators|mitosis modulators|mesh-ancestor
6717275|NCT01820312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717276|NCT01820325|Paclitaxel|paclitaxel|mesh-list
6717277|NCT01820325|Carboplatin|carboplatin|mesh-list
6717278|NCT01820325|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6717279|NCT01820325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6717280|NCT01820325|Tubulin Modulators|tubulin modulators|mesh-ancestor
6717281|NCT01820325|Antimitotic Agents|antimitotic agents|mesh-ancestor
6717282|NCT01820325|Mitosis Modulators|mitosis modulators|mesh-ancestor
6717283|NCT01820325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717284|NCT01820442|Lofexidine|lofexidine|mesh-list
6717285|NCT01820442|Clonidine|clonidine|mesh-list
6717286|NCT01820442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6717287|NCT01820442|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6717288|NCT01820442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717289|NCT01820442|Sensory System Agents|sensory system agents|mesh-ancestor
6717290|NCT01820442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6717291|NCT01820442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6717292|NCT01820442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6717293|NCT01820442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6717294|NCT01820442|Adrenergic Agents|adrenergic agents|mesh-ancestor
6717295|NCT01820442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6717296|NCT01820442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717297|NCT01820442|Analgesics|analgesics|mesh-ancestor
6717298|NCT01820442|Sympatholytics|sympatholytics|mesh-ancestor
6717299|NCT01820442|Autonomic Agents|autonomic agents|mesh-ancestor
6717300|NCT01820455|Chlorhexidine|chlorhexidine|mesh-list
6717301|NCT01820455|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6717302|NCT01820455|Mupirocin|mupirocin|mesh-list
6717303|NCT01820455|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6717304|NCT01820455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6717305|NCT01820455|Disinfectants|disinfectants|mesh-ancestor
6717306|NCT01820455|Dermatologic Agents|dermatologic agents|mesh-ancestor
6717307|NCT01820455|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6717308|NCT01820455|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6717309|NCT01820455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6717310|NCT01820455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717311|NCT01820624|Tretinoin|tretinoin|mesh-list
6717312|NCT01820624|Lithium Carbonate|lithium carbonate|mesh-list
6717313|NCT01820624|Antidepressive Agents|antidepressive agents|mesh-ancestor
6717314|NCT01820624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6717315|NCT01820624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6717316|NCT01820624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717317|NCT01820624|Antimanic Agents|antimanic agents|mesh-ancestor
6717318|NCT01820624|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6717319|NCT01820624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6717320|NCT01820624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717321|NCT01820624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6717322|NCT01820624|Keratolytic Agents|keratolytic agents|mesh-ancestor
6717323|NCT01820624|Dermatologic Agents|dermatologic agents|mesh-ancestor
6717324|NCT01820767|Ergocalciferols|ergocalciferols|mesh-list
6717325|NCT01820767|Atorvastatin|atorvastatin|mesh-list
6717326|NCT01820767|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6717327|NCT01820767|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6717328|NCT01820767|Antimetabolites|antimetabolites|mesh-ancestor
6717329|NCT01820767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717330|NCT01820767|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6717331|NCT01820767|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6717332|NCT01820767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6717333|NCT01820767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6717334|NCT01820767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717335|NCT01820767|Vitamins|vitamins|mesh-ancestor
6717336|NCT01820767|Micronutrients|micronutrients|mesh-ancestor
6717337|NCT01820767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6717338|NCT01820793|Cefoxitin|cefoxitin|mesh-list
6717339|NCT01820793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6717340|NCT01820793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6717341|NCT01820832|Cholecalciferol|cholecalciferol|mesh-list
6717342|NCT01820832|Calcitriol|calcitriol|mesh-list
6717343|NCT01820832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6717344|NCT01820832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717345|NCT01820832|Vitamins|vitamins|mesh-ancestor
6717346|NCT01820832|Micronutrients|micronutrients|mesh-ancestor
6717347|NCT01820832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6717348|NCT01820832|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6717349|NCT01820832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6717350|NCT01820832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717351|NCT01820832|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6717352|NCT01820858|Paclitaxel|paclitaxel|mesh-list
6717353|NCT01820858|Carboplatin|carboplatin|mesh-list
6717354|NCT01820858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6717355|NCT01820858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6717356|NCT01820858|Tubulin Modulators|tubulin modulators|mesh-ancestor
6717357|NCT01820858|Antimitotic Agents|antimitotic agents|mesh-ancestor
6717358|NCT01820858|Mitosis Modulators|mitosis modulators|mesh-ancestor
6717359|NCT01820858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717360|NCT01820897|Trimethoprim|trimethoprim|mesh-list
6717361|NCT01820897|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6717362|NCT01820897|Sulfamethoxazole|sulfamethoxazole|mesh-list
6717363|NCT01820897|Fosfomycin|fosfomycin|mesh-list
6717364|NCT01820897|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6717365|NCT01820897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6717366|NCT01820897|Renal Agents|renal agents|mesh-ancestor
6717367|NCT01820897|Antimalarials|antimalarials|mesh-ancestor
6717368|NCT01820897|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6717369|NCT01820897|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6717370|NCT01820897|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6717371|NCT01820897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6717372|NCT01820897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717373|NCT01820897|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6717374|NCT01820897|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6717375|NCT01820897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6717376|NCT01820897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6717377|NCT01820910|Doxycycline|doxycycline|mesh-list
6717378|NCT01820910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6717379|NCT01820910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6717380|NCT01820910|Antimalarials|antimalarials|mesh-ancestor
6717381|NCT01820910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6717382|NCT01820910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6717383|NCT01820962|Heparin|heparin|mesh-list
6717384|NCT01820962|Anticoagulants|anticoagulants|mesh-ancestor
6717385|NCT01820962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717386|NCT01820962|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6717387|NCT01820962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6717388|NCT01821001|Bromocriptine|bromocriptine|mesh-list
6717389|NCT01821001|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6717390|NCT01821001|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6717391|NCT01821001|Hormone Antagonists|hormone antagonists|mesh-ancestor
6717392|NCT01821001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6717393|NCT01821001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717394|NCT01821001|Dopamine Agonists|dopamine agonists|mesh-ancestor
6717395|NCT01821001|Dopamine Agents|dopamine agents|mesh-ancestor
6717396|NCT01821001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6717397|NCT01821001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717398|NCT01821027|Canagliflozin|canagliflozin|mesh-list
6717399|NCT01821027|Simvastatin|simvastatin|mesh-list
6717400|NCT01821027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6717401|NCT01821027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6717402|NCT01821027|Antimetabolites|antimetabolites|mesh-ancestor
6717403|NCT01821027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717404|NCT01821027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6717405|NCT01821027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6717406|NCT01821027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6717407|NCT01821027|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6717408|NCT01821027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6717409|NCT01821027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717410|NCT01821040|Prednisone|prednisone|mesh-list
6717411|NCT01821040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6717412|NCT01821040|Glucocorticoids|glucocorticoids|mesh-ancestor
6717413|NCT01821040|Hormones|hormones|mesh-ancestor
6717414|NCT01821040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6717415|NCT01821040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717416|NCT01821040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6717417|NCT01821040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6717418|NCT01821066|Tamoxifen|tamoxifen|mesh-list
6717419|NCT01821066|Palbociclib|palbociclib|mesh-list
6717420|NCT01821066|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6717421|NCT01821066|Hormone Antagonists|hormone antagonists|mesh-ancestor
6717422|NCT01821066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6717423|NCT01821066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717424|NCT01821066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6717425|NCT01821066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6717426|NCT01821066|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6717427|NCT01821066|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6717428|NCT01821066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6717429|NCT01821066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6717430|NCT01821066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6717431|NCT01821066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783717|NCT02198547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6783718|NCT02198547|Analgesics|analgesics|mesh-ancestor
6783719|NCT02198547|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6783720|NCT02198547|Anticonvulsants|anticonvulsants|mesh-ancestor
6783721|NCT02198547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6783722|NCT02198547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6783723|NCT02198547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783724|NCT02198547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6783725|NCT02198547|Tocolytic Agents|tocolytic agents|mesh-ancestor
6783726|NCT02198547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6717432|NCT01821170|Methylphenidate|methylphenidate|mesh-list
6717433|NCT01821170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6717434|NCT01821170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717435|NCT01821170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6717436|NCT01821170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6717437|NCT01821170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6717438|NCT01821170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717439|NCT01821170|Dopamine Agents|dopamine agents|mesh-ancestor
6717440|NCT01821170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6717441|NCT01821235|Gabapentin|gabapentin|mesh-list
6717442|NCT01821235|Analgesics|analgesics|mesh-ancestor
6717443|NCT01821235|Sensory System Agents|sensory system agents|mesh-ancestor
6717444|NCT01821235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6717445|NCT01821235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717446|NCT01821235|Anticonvulsants|anticonvulsants|mesh-ancestor
6717447|NCT01821235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6717448|NCT01821235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6717449|NCT01821235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6717450|NCT01821235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6717451|NCT01821235|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6717452|NCT01821235|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6717453|NCT01821235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6717454|NCT01821235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717455|NCT01821235|Antimanic Agents|antimanic agents|mesh-ancestor
6717456|NCT01821248|Gemcitabine|gemcitabine|mesh-list
6717457|NCT01821248|Cisplatin|cisplatin|mesh-list
6717458|NCT01821248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6717459|NCT01821248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6717460|NCT01821248|Antimetabolites|antimetabolites|mesh-ancestor
6717461|NCT01821248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717462|NCT01821248|Antiviral Agents|antiviral agents|mesh-ancestor
6717463|NCT01821248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6717464|NCT01821248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6717465|NCT01821248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6717466|NCT01821248|Immunologic Factors|immunologic factors|mesh-ancestor
6717467|NCT01821248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717468|NCT01821261|Chlorhexidine|chlorhexidine|mesh-list
6717469|NCT01821261|Fluorides|fluorides|mesh-list
6717470|NCT01821261|Cariostatic Agents|cariostatic agents|mesh-ancestor
6717471|NCT01821261|Protective Agents|protective agents|mesh-ancestor
6717472|NCT01821261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717473|NCT01821261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6717474|NCT01821261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6717475|NCT01821261|Disinfectants|disinfectants|mesh-ancestor
6717476|NCT01821274|Diltiazem|diltiazem|mesh-list
6717477|NCT01821274|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6717478|NCT01821274|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6717479|NCT01821274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6717480|NCT01821274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717481|NCT01821274|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6717482|NCT01821274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717483|NCT01821274|Vasodilator Agents|vasodilator agents|mesh-ancestor
6717484|NCT01821404|Atorvastatin|atorvastatin|mesh-list
6717485|NCT01821404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6717486|NCT01821404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6717487|NCT01821404|Antimetabolites|antimetabolites|mesh-ancestor
6717488|NCT01821404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717489|NCT01821404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6717490|NCT01821404|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6717491|NCT01821404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6717492|NCT01821430|Pregabalin|pregabalin|mesh-list
6717493|NCT01821430|Analgesics|analgesics|mesh-ancestor
6717494|NCT01821430|Sensory System Agents|sensory system agents|mesh-ancestor
6717495|NCT01821430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6717496|NCT01821430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717497|NCT01821430|Anticonvulsants|anticonvulsants|mesh-ancestor
6717498|NCT01821430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6717499|NCT01821430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6717500|NCT01821430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717501|NCT01821430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6717502|NCT01821430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6717503|NCT01821430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6717504|NCT01821430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6717505|NCT01821430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6717506|NCT01821456|Antiviral Agents|antiviral agents|mesh-list
6717507|NCT01821456|Anti-Infective Agents|anti-infective agents|mesh-list
6717508|NCT01821573|Botulinum Toxins|botulinum toxins|mesh-list
6717509|NCT01821573|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6717510|NCT01821573|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6717511|NCT01821573|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6717512|NCT01821573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6717513|NCT01821573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717514|NCT01821573|Cholinergic Agents|cholinergic agents|mesh-ancestor
6717515|NCT01821573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6717516|NCT01821573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717517|NCT01821573|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6717518|NCT01821573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6717519|NCT01821612|Leucovorin|leucovorin|mesh-list
6717520|NCT01821612|Gemcitabine|gemcitabine|mesh-list
6717521|NCT01821612|Fluorouracil|fluorouracil|mesh-list
6717522|NCT01821612|Capecitabine|capecitabine|mesh-list
6717523|NCT01821612|Oxaliplatin|oxaliplatin|mesh-list
6717524|NCT01821612|Irinotecan|irinotecan|mesh-list
6717525|NCT01821612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6717526|NCT01821612|Antimetabolites|antimetabolites|mesh-ancestor
6717527|NCT01821612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717528|NCT01821612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6717529|NCT01821612|Antiviral Agents|antiviral agents|mesh-ancestor
6717530|NCT01821612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6717531|NCT01821612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6717532|NCT01821612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6717533|NCT01821612|Immunologic Factors|immunologic factors|mesh-ancestor
6717534|NCT01821612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717535|NCT01821612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6717536|NCT01821612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6717537|NCT01821612|Antidotes|antidotes|mesh-ancestor
6717538|NCT01821612|Protective Agents|protective agents|mesh-ancestor
6717539|NCT01821612|Vitamin B Complex|vitamin b complex|mesh-ancestor
6717540|NCT01821612|Vitamins|vitamins|mesh-ancestor
6717541|NCT01821612|Micronutrients|micronutrients|mesh-ancestor
6717542|NCT01821664|Heparin|heparin|mesh-list
6717543|NCT01821664|Anticoagulants|anticoagulants|mesh-ancestor
6717544|NCT01821664|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6717545|NCT01821664|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6717546|NCT01821664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717547|NCT01821677|Danazol|danazol|mesh-list
6717548|NCT01821677|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6717549|NCT01821677|Hormone Antagonists|hormone antagonists|mesh-ancestor
6717550|NCT01821677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6717551|NCT01821677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717552|NCT01821703|Spironolactone|spironolactone|mesh-list
6717553|NCT01821703|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6717554|NCT01821703|Hormone Antagonists|hormone antagonists|mesh-ancestor
6783727|NCT02198807|Piperaquine|piperaquine|mesh-list
6783728|NCT02198807|Fosmidomycin|fosmidomycin|mesh-list
6717555|NCT01821703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6717556|NCT01821703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717557|NCT01821703|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6717558|NCT01821703|Diuretics|diuretics|mesh-ancestor
6717559|NCT01821703|Natriuretic Agents|natriuretic agents|mesh-ancestor
6717560|NCT01821781|Fludarabine|fludarabine|mesh-list
6717561|NCT01821781|Melphalan|melphalan|mesh-list
6717562|NCT01821781|Alemtuzumab|alemtuzumab|mesh-list
6717563|NCT01821781|Thiotepa|thiotepa|mesh-list
6717564|NCT01821781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6717565|NCT01821781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717566|NCT01821781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6717567|NCT01821781|Immunologic Factors|immunologic factors|mesh-ancestor
6717568|NCT01821781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717569|NCT01821781|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6717570|NCT01821781|Alkylating Agents|alkylating agents|mesh-ancestor
6717571|NCT01821781|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6717572|NCT01821781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6717573|NCT01821833|Paclitaxel|paclitaxel|mesh-list
6717574|NCT01821833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6717575|NCT01821833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6717576|NCT01821833|Tubulin Modulators|tubulin modulators|mesh-ancestor
6717577|NCT01821833|Antimitotic Agents|antimitotic agents|mesh-ancestor
6717578|NCT01821833|Mitosis Modulators|mitosis modulators|mesh-ancestor
6717579|NCT01821833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717580|NCT01821846|Liraglutide|liraglutide|mesh-list
6717581|NCT01821846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6717582|NCT01821846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717583|NCT01821846|Incretins|incretins|mesh-ancestor
6717584|NCT01821846|Hormones|hormones|mesh-ancestor
6717585|NCT01821846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6717586|NCT01821872|Acetaminophen|acetaminophen|mesh-list
6717587|NCT01821872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6717588|NCT01821872|Analgesics|analgesics|mesh-ancestor
6717589|NCT01821872|Sensory System Agents|sensory system agents|mesh-ancestor
6717590|NCT01821872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6717591|NCT01821872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717592|NCT01821872|Antipyretics|antipyretics|mesh-ancestor
6717593|NCT01821989|Lactoferrin|lactoferrin|mesh-list
6717594|NCT01821989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6717595|NCT01822015|Cytarabine|cytarabine|mesh-list
6717596|NCT01822015|Sirolimus|sirolimus|mesh-list
6717597|NCT01822015|Idarubicin|idarubicin|mesh-list
6717598|NCT01822015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6717599|NCT01822015|Antimetabolites|antimetabolites|mesh-ancestor
6717600|NCT01822015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717601|NCT01822015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6717602|NCT01822015|Antiviral Agents|antiviral agents|mesh-ancestor
6717603|NCT01822015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6717604|NCT01822015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6717605|NCT01822015|Immunologic Factors|immunologic factors|mesh-ancestor
6717606|NCT01822015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717607|NCT01822015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6717608|NCT01822015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6717609|NCT01822015|Antifungal Agents|antifungal agents|mesh-ancestor
6717610|NCT01822015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6717611|NCT01822015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6717612|NCT01822015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6717613|NCT01822028|Miglustat|miglustat|mesh-list
6717614|NCT01822028|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
6717615|NCT01822028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6717616|NCT01822028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717617|NCT01822028|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6717618|NCT01822028|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6717619|NCT01822028|Antiviral Agents|antiviral agents|mesh-ancestor
6717620|NCT01822028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6717621|NCT01822028|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6717622|NCT01822028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6717623|NCT01822028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717624|NCT01822080|Dienogest|dienogest|mesh-list
6717625|NCT01822080|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6717626|NCT01822080|Contraceptive Agents|contraceptive agents|mesh-ancestor
6717627|NCT01822080|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6717628|NCT01822080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717629|NCT01822080|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6717630|NCT01822080|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6717631|NCT01822080|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6717632|NCT01822080|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6717633|NCT01822080|Hormone Antagonists|hormone antagonists|mesh-ancestor
6717634|NCT01822080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6717635|NCT01822080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6717636|NCT01822080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6717637|NCT01822210|Botulinum Toxins|botulinum toxins|mesh-list
6717638|NCT01822210|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6717639|NCT01822210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6717640|NCT01822210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717641|NCT01822210|Cholinergic Agents|cholinergic agents|mesh-ancestor
6717642|NCT01822210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6717643|NCT01822210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717644|NCT01822275|Temozolomide|temozolomide|mesh-list
6717645|NCT01822275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6717646|NCT01822275|Alkylating Agents|alkylating agents|mesh-ancestor
6717647|NCT01822275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717648|NCT01822275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6717649|NCT01822314|Paclitaxel|paclitaxel|mesh-list
6717650|NCT01822314|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6717651|NCT01822314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6717652|NCT01822314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6717653|NCT01822314|Tubulin Modulators|tubulin modulators|mesh-ancestor
6717654|NCT01822314|Antimitotic Agents|antimitotic agents|mesh-ancestor
6717655|NCT01822314|Mitosis Modulators|mitosis modulators|mesh-ancestor
6717656|NCT01822314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717657|NCT01822405|Tocopherols|tocopherols|mesh-list
6717658|NCT01822405|Vitamin E|vitamin e|mesh-list
6717659|NCT01822405|Tocotrienols|tocotrienols|mesh-list
6717660|NCT01822405|alpha-Tocopherol|alpha-tocopherol|mesh-list
6717661|NCT01822405|Pentoxifylline|pentoxifylline|mesh-list
6717662|NCT01822405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6717663|NCT01822405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6717664|NCT01822405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717665|NCT01822405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6717666|NCT01822405|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6717667|NCT01822405|Protective Agents|protective agents|mesh-ancestor
6717668|NCT01822405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717669|NCT01822405|Vasodilator Agents|vasodilator agents|mesh-ancestor
6717670|NCT01822405|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6717671|NCT01822405|Antioxidants|antioxidants|mesh-ancestor
6717672|NCT01822405|Vitamins|vitamins|mesh-ancestor
6717673|NCT01822405|Micronutrients|micronutrients|mesh-ancestor
6717674|NCT01822418|S 20098|s 20098|mesh-list
6717675|NCT01822418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6717676|NCT01822418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6717677|NCT01822418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717678|NCT01822431|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
6717679|NCT01822431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6717680|NCT01822431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6717681|NCT01822431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717682|NCT01822431|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6717683|NCT01822483|Mycophenolic Acid|mycophenolic acid|mesh-list
6717684|NCT01822483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6717685|NCT01822483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6717686|NCT01822483|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6717687|NCT01822483|Antitubercular Agents|antitubercular agents|mesh-ancestor
6717688|NCT01822483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6717689|NCT01822483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6717690|NCT01822483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6717691|NCT01822483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717692|NCT01822509|Nivolumab|nivolumab|mesh-list
6717693|NCT01822509|Ipilimumab|ipilimumab|mesh-list
6717694|NCT01822509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6717695|NCT01822509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6717696|NCT01822509|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6717697|NCT01822509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717698|NCT01822600|Omeprazole|omeprazole|mesh-list
6717699|NCT01822600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6717700|NCT01822600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6717701|NCT01822600|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6717702|NCT01822600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6717703|NCT01822600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717704|NCT01822613|Paclitaxel|paclitaxel|mesh-list
6717705|NCT01822613|Docetaxel|docetaxel|mesh-list
6717706|NCT01822613|Irinotecan|irinotecan|mesh-list
6717707|NCT01822613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6717708|NCT01822613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6717709|NCT01822613|Tubulin Modulators|tubulin modulators|mesh-ancestor
6717710|NCT01822613|Antimitotic Agents|antimitotic agents|mesh-ancestor
6717711|NCT01822613|Mitosis Modulators|mitosis modulators|mesh-ancestor
6717712|NCT01822613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717713|NCT01822613|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6717714|NCT01822613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6717715|NCT01822613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6717716|NCT01822639|Amlodipine|amlodipine|mesh-list
6717717|NCT01822639|Enalapril|enalapril|mesh-list
6717718|NCT01822639|Enalaprilat|enalaprilat|mesh-list
6717719|NCT01822639|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6717720|NCT01822639|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6717721|NCT01822639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6717722|NCT01822639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717723|NCT01822639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6717724|NCT01822639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717725|NCT01822639|Vasodilator Agents|vasodilator agents|mesh-ancestor
6717726|NCT01822639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6717727|NCT01822639|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6717728|NCT01822639|Protease Inhibitors|protease inhibitors|mesh-ancestor
6717729|NCT01822730|Risperidone|risperidone|mesh-list
6717730|NCT01822730|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6717731|NCT01822730|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6717732|NCT01822730|Serotonin Agents|serotonin agents|mesh-ancestor
6717733|NCT01822730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6717734|NCT01822730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717735|NCT01822730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717736|NCT01822730|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6717737|NCT01822730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6717738|NCT01822730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6717739|NCT01822730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6717740|NCT01822730|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6717741|NCT01822730|Dopamine Agents|dopamine agents|mesh-ancestor
6717742|NCT01822730|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6717743|NCT01822730|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6717744|NCT01822808|Hydralazine|hydralazine|mesh-list
6717745|NCT01822808|Isosorbide|isosorbide|mesh-list
6717746|NCT01822808|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
6717747|NCT01822808|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
6717748|NCT01822808|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6717749|NCT01822808|Diuretics|diuretics|mesh-ancestor
6717750|NCT01822808|Natriuretic Agents|natriuretic agents|mesh-ancestor
6717751|NCT01822808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717752|NCT01822808|Vasodilator Agents|vasodilator agents|mesh-ancestor
6717753|NCT01822808|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6717754|NCT01822808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717755|NCT01822808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6717756|NCT01822860|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6717757|NCT01822860|Chlorthalidone|chlorthalidone|mesh-list
6717758|NCT01822860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6717759|NCT01822860|Diuretics|diuretics|mesh-ancestor
6717760|NCT01822860|Natriuretic Agents|natriuretic agents|mesh-ancestor
6717761|NCT01822860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717762|NCT01822860|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6717763|NCT01822860|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6717764|NCT01822860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717765|NCT01822951|Cerebrolysin|cerebrolysin|mesh-list
6717766|NCT01822951|Donepezil|donepezil|mesh-list
6717767|NCT01822951|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6717768|NCT01822951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6717769|NCT01822951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717770|NCT01822951|Cholinergic Agents|cholinergic agents|mesh-ancestor
6717771|NCT01822951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6717772|NCT01822951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717773|NCT01822951|Nootropic Agents|nootropic agents|mesh-ancestor
6717774|NCT01822951|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6717775|NCT01822951|Protective Agents|protective agents|mesh-ancestor
6717776|NCT01822977|Omeprazole|omeprazole|mesh-list
6717777|NCT01822977|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6717778|NCT01822977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6717779|NCT01822977|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6717780|NCT01822977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6717781|NCT01822977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717782|NCT01823029|Epoetin Alfa|epoetin alfa|mesh-list
6717783|NCT01823029|Hematinics|hematinics|mesh-ancestor
6783729|NCT02198807|Antimalarials|antimalarials|mesh-ancestor
6783730|NCT02198807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6783731|NCT02198807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6783732|NCT02198807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6783733|NCT02198807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6783734|NCT02198820|Anesthetics|anesthetics|mesh-list
6783735|NCT02198820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6783736|NCT02198820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783737|NCT02198846|Insulin|insulin|mesh-list
6783738|NCT02198846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6783739|NCT02198846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783740|NCT02198859|Lithium Carbonate|lithium carbonate|mesh-list
6783741|NCT02198859|Antidepressive Agents|antidepressive agents|mesh-ancestor
6783742|NCT02198859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6783743|NCT02198859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6783744|NCT02198859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783745|NCT02198859|Antimanic Agents|antimanic agents|mesh-ancestor
6783746|NCT02198859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6783747|NCT02198859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6783748|NCT02198859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783749|NCT02198924|Celecoxib|celecoxib|mesh-list
6783750|NCT02198924|Parecoxib|parecoxib|mesh-list
6783751|NCT02198924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6783752|NCT02198924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6783753|NCT02198924|Analgesics|analgesics|mesh-ancestor
6783754|NCT02198924|Sensory System Agents|sensory system agents|mesh-ancestor
6783755|NCT02198924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6783756|NCT02198924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783757|NCT02198924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6783758|NCT02198924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6783759|NCT02198924|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6783760|NCT02198924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6783761|NCT02198924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6783762|NCT02198924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783763|NCT02199171|Carboplatin|carboplatin|mesh-list
6783764|NCT02199171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6783765|NCT02199184|Prednisone|prednisone|mesh-list
6783766|NCT02199184|Cortisone|cortisone|mesh-list
6783767|NCT02199184|Cyclophosphamide|cyclophosphamide|mesh-list
6783768|NCT02199184|Rituximab|rituximab|mesh-list
6783769|NCT02199184|Doxorubicin|doxorubicin|mesh-list
6783770|NCT02199184|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6783771|NCT02199184|Etoposide|etoposide|mesh-list
6783772|NCT02199184|Vincristine|vincristine|mesh-list
6783773|NCT02199184|Etoposide phosphate|etoposide phosphate|mesh-list
6783774|NCT02199184|Ofatumumab|ofatumumab|mesh-list
6783775|NCT02199184|Podophyllotoxin|podophyllotoxin|mesh-list
6783776|NCT02199184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6783777|NCT02199184|Antibodies|antibodies|mesh-list
6783778|NCT02199184|Immunoglobulins|immunoglobulins|mesh-list
6783779|NCT02199184|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6783780|NCT02199184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6783781|NCT02199184|Immunologic Factors|immunologic factors|mesh-ancestor
6783782|NCT02199184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783783|NCT02199184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6783784|NCT02199184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6783785|NCT02199184|Alkylating Agents|alkylating agents|mesh-ancestor
6783786|NCT02199184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783787|NCT02199184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6783788|NCT02199184|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6783789|NCT02199184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6783790|NCT02199184|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6783791|NCT02199184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6783792|NCT02199184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6783793|NCT02199184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6783794|NCT02199184|Glucocorticoids|glucocorticoids|mesh-ancestor
6783795|NCT02199184|Hormones|hormones|mesh-ancestor
6783796|NCT02199184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6783797|NCT02199184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6783798|NCT02199184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6783799|NCT02199184|Tubulin Modulators|tubulin modulators|mesh-ancestor
6783800|NCT02199184|Antimitotic Agents|antimitotic agents|mesh-ancestor
6717784|NCT01823042|Azathioprine|azathioprine|mesh-list
6717785|NCT01823042|Antimetabolites|antimetabolites|mesh-ancestor
6717786|NCT01823042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717787|NCT01823042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6717788|NCT01823042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6717789|NCT01823042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6717790|NCT01823042|Immunologic Factors|immunologic factors|mesh-ancestor
6717791|NCT01823042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717792|NCT01823042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6717793|NCT01823081|Bevacizumab|bevacizumab|mesh-list
6717794|NCT01823081|Fasudil|fasudil|mesh-list
6717795|NCT01823081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6717796|NCT01823081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6717797|NCT01823081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6717798|NCT01823081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6717799|NCT01823081|Growth Substances|growth substances|mesh-ancestor
6717800|NCT01823081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717801|NCT01823081|Growth Inhibitors|growth inhibitors|mesh-ancestor
6717802|NCT01823081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6717803|NCT01823081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6717804|NCT01823081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717805|NCT01823081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6717806|NCT01823081|Vasodilator Agents|vasodilator agents|mesh-ancestor
6717807|NCT01823081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6717808|NCT01823081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6717809|NCT01823133|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6717810|NCT01823133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6717811|NCT01823133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6717812|NCT01823133|Antimetabolites|antimetabolites|mesh-ancestor
6717813|NCT01823133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717814|NCT01823133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6717815|NCT01823133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6717816|NCT01823133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6717817|NCT01823159|Ezogabine|ezogabine|mesh-list
6717818|NCT01823159|Anticonvulsants|anticonvulsants|mesh-ancestor
6717819|NCT01823159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6717820|NCT01823159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717821|NCT01823172|Methylene Blue|methylene blue|mesh-list
6717822|NCT01823172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6717823|NCT01823172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717824|NCT01823185|Clopidogrel|clopidogrel|mesh-list
6717825|NCT01823185|Ticagrelor|ticagrelor|mesh-list
6717826|NCT01823185|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6717827|NCT01823185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6717828|NCT01823185|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6717829|NCT01823185|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6717830|NCT01823185|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6717831|NCT01823185|Purinergic Agents|purinergic agents|mesh-ancestor
6717832|NCT01823185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6717833|NCT01823185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717834|NCT01823185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717835|NCT01823198|Aldesleukin|aldesleukin|mesh-list
6717836|NCT01823198|Fludarabine|fludarabine|mesh-list
6717837|NCT01823198|Fludarabine phosphate|fludarabine phosphate|mesh-list
6717838|NCT01823198|Busulfan|busulfan|mesh-list
6717839|NCT01823198|Interleukin-2|interleukin-2|mesh-list
6717840|NCT01823198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6717841|NCT01823198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6717842|NCT01823198|Antimetabolites|antimetabolites|mesh-ancestor
6717843|NCT01823198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717844|NCT01823198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6717845|NCT01823198|Immunologic Factors|immunologic factors|mesh-ancestor
6717846|NCT01823198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717847|NCT01823198|Alkylating Agents|alkylating agents|mesh-ancestor
6717848|NCT01823198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6717849|NCT01823198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6717850|NCT01823198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6717851|NCT01823198|Analgesics|analgesics|mesh-ancestor
6717852|NCT01823198|Sensory System Agents|sensory system agents|mesh-ancestor
6717853|NCT01823198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6717854|NCT01823198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6717855|NCT01823198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6717856|NCT01823198|Antiviral Agents|antiviral agents|mesh-ancestor
6717857|NCT01823198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6717858|NCT01823393|Heparin|heparin|mesh-list
6717859|NCT01823393|Calcium heparin|calcium heparin|mesh-list
6717860|NCT01823393|Anticoagulants|anticoagulants|mesh-ancestor
6717861|NCT01823393|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6717862|NCT01823393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6717863|NCT01823393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717864|NCT01823523|Clindamycin|clindamycin|mesh-list
6717865|NCT01823523|Clindamycin palmitate|clindamycin palmitate|mesh-list
6717866|NCT01823523|Clindamycin phosphate|clindamycin phosphate|mesh-list
6717867|NCT01823523|Cefazolin|cefazolin|mesh-list
6717868|NCT01823523|Cephalexin|cephalexin|mesh-list
6717869|NCT01823523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6717870|NCT01823523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6717871|NCT01823523|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6717872|NCT01823523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6717873|NCT01823523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717874|NCT01823744|Micronutrients|micronutrients|mesh-list
6717875|NCT01823744|Trace Elements|trace elements|mesh-list
6717876|NCT01823744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717877|NCT01823770|Rotigotine|rotigotine|mesh-list
6717878|NCT01823770|Dopamine Agonists|dopamine agonists|mesh-ancestor
6717879|NCT01823770|Dopamine Agents|dopamine agents|mesh-ancestor
6717880|NCT01823770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6717881|NCT01823770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717882|NCT01823770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717883|NCT01823809|Adenosine|adenosine|mesh-list
6717884|NCT01823809|Analgesics|analgesics|mesh-ancestor
6717885|NCT01823809|Sensory System Agents|sensory system agents|mesh-ancestor
6717886|NCT01823809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6717887|NCT01823809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717888|NCT01823809|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6717889|NCT01823809|Vasodilator Agents|vasodilator agents|mesh-ancestor
6717890|NCT01823809|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6717891|NCT01823809|Purinergic Agonists|purinergic agonists|mesh-ancestor
6717892|NCT01823809|Purinergic Agents|purinergic agents|mesh-ancestor
6717893|NCT01823809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6717894|NCT01823809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717895|NCT01823848|Mineral Oil|mineral oil|mesh-list
6717896|NCT01823848|Emollients|emollients|mesh-ancestor
6717897|NCT01823848|Dermatologic Agents|dermatologic agents|mesh-ancestor
6717898|NCT01823965|Ranibizumab|ranibizumab|mesh-list
6717899|NCT01823965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6717900|NCT01823965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6717901|NCT01823965|Growth Substances|growth substances|mesh-ancestor
6717902|NCT01823965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717903|NCT01823965|Growth Inhibitors|growth inhibitors|mesh-ancestor
6717904|NCT01823965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6717905|NCT01824043|Ranibizumab|ranibizumab|mesh-list
6717906|NCT01824043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6717907|NCT01824043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6717908|NCT01824043|Growth Substances|growth substances|mesh-ancestor
6717909|NCT01824043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717910|NCT01824043|Growth Inhibitors|growth inhibitors|mesh-ancestor
6717911|NCT01824043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6717912|NCT01824056|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6717913|NCT01824056|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6717914|NCT01824056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717915|NCT01824199|Omeprazole|omeprazole|mesh-list
6717916|NCT01824199|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6717917|NCT01824199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6717918|NCT01824199|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6717919|NCT01824199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6717920|NCT01824199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717921|NCT01824225|Aflibercept|aflibercept|mesh-list
6717922|NCT01824225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6717923|NCT01824225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6717924|NCT01824225|Growth Substances|growth substances|mesh-ancestor
6717925|NCT01824225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717926|NCT01824225|Growth Inhibitors|growth inhibitors|mesh-ancestor
6717927|NCT01824225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6717928|NCT01824238|Oxazolidinones|oxazolidinones|mesh-list
6717929|NCT01824238|Anacetrapib|anacetrapib|mesh-list
6717930|NCT01824238|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6717931|NCT01824238|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6717932|NCT01824238|Antimetabolites|antimetabolites|mesh-ancestor
6717933|NCT01824238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717934|NCT01824238|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6717935|NCT01824238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6717936|NCT01824238|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6717937|NCT01824238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6717938|NCT01824251|Immunoglobulins|immunoglobulins|mesh-list
6717939|NCT01824251|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6717940|NCT01824251|gamma-Globulins|gamma-globulins|mesh-list
6717941|NCT01824251|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6717942|NCT01824251|Immunologic Factors|immunologic factors|mesh-ancestor
6717943|NCT01824251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717944|NCT01824264|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6717945|NCT01824264|Licogliflozin|licogliflozin|mesh-list
6717946|NCT01824264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6717947|NCT01824264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717948|NCT01824264|Incretins|incretins|mesh-ancestor
6717949|NCT01824264|Hormones|hormones|mesh-ancestor
6717950|NCT01824264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6717951|NCT01824264|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6717952|NCT01824264|Protease Inhibitors|protease inhibitors|mesh-ancestor
6717953|NCT01824264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6717954|NCT01824264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717955|NCT01824264|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6717956|NCT01824420|Mandelic Acids|mandelic acids|mesh-list
6717957|NCT01824420|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6717958|NCT01824420|Oxybutynin|oxybutynin|mesh-list
6717959|NCT01824420|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6717960|NCT01824420|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6717961|NCT01824420|Cholinergic Agents|cholinergic agents|mesh-ancestor
6717962|NCT01824420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6717963|NCT01824420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717964|NCT01824420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717965|NCT01824420|Urological Agents|urological agents|mesh-ancestor
6717966|NCT01824420|Parasympatholytics|parasympatholytics|mesh-ancestor
6717967|NCT01824420|Autonomic Agents|autonomic agents|mesh-ancestor
6717968|NCT01824420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6717969|NCT01824420|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6717970|NCT01824420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6717971|NCT01824420|Renal Agents|renal agents|mesh-ancestor
6717972|NCT01824433|Fluoxetine|fluoxetine|mesh-list
6717973|NCT01824433|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6717974|NCT01824433|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6717975|NCT01824433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6717976|NCT01824433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6717977|NCT01824433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6717978|NCT01824433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6717979|NCT01824433|Serotonin Agents|serotonin agents|mesh-ancestor
6717980|NCT01824433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717981|NCT01824433|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6717982|NCT01824433|Antidepressive Agents|antidepressive agents|mesh-ancestor
6717983|NCT01824433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6717984|NCT01824433|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6717985|NCT01824433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6717986|NCT01824433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6717987|NCT01824433|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6717988|NCT01824459|Oxaliplatin|oxaliplatin|mesh-list
6783801|NCT02199184|Mitosis Modulators|mitosis modulators|mesh-ancestor
6717989|NCT01824459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6717990|NCT01824524|Hydromorphone|hydromorphone|mesh-list
6717991|NCT01824524|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6717992|NCT01824524|Narcotics|narcotics|mesh-ancestor
6717993|NCT01824524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6717994|NCT01824524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6717995|NCT01824524|Analgesics|analgesics|mesh-ancestor
6717996|NCT01824524|Sensory System Agents|sensory system agents|mesh-ancestor
6717997|NCT01824524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6717998|NCT01824537|Vaccines|vaccines|mesh-list
6717999|NCT01824537|Immunologic Factors|immunologic factors|mesh-ancestor
6718000|NCT01824537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718001|NCT01824615|Sunitinib|sunitinib|mesh-list
6718002|NCT01824615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6718003|NCT01824615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6718004|NCT01824615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6718005|NCT01824615|Growth Substances|growth substances|mesh-ancestor
6718006|NCT01824615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718007|NCT01824615|Growth Inhibitors|growth inhibitors|mesh-ancestor
6718008|NCT01824615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6718009|NCT01824615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6718010|NCT01824615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783802|NCT02199184|Keratolytic Agents|keratolytic agents|mesh-ancestor
6783803|NCT02199184|Dermatologic Agents|dermatologic agents|mesh-ancestor
6783804|NCT02199223|Panitumumab|panitumumab|mesh-list
6783805|NCT02199223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6783806|NCT02199223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6783807|NCT02199236|Capecitabine|capecitabine|mesh-list
6783808|NCT02199236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6783809|NCT02199236|Antimetabolites|antimetabolites|mesh-ancestor
6783810|NCT02199236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783811|NCT02199236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6783812|NCT02199327|Interferons|interferons|mesh-list
6783813|NCT02199327|Interferon-alpha|interferon-alpha|mesh-list
6783814|NCT02199327|Interferon alpha-2|interferon alpha-2|mesh-list
6783815|NCT02199327|Mitomycins|mitomycins|mesh-list
6783816|NCT02199327|Mitomycin|mitomycin|mesh-list
6783817|NCT02199327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6783818|NCT02199327|Antiviral Agents|antiviral agents|mesh-ancestor
6783819|NCT02199327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6783820|NCT02199327|Immunologic Factors|immunologic factors|mesh-ancestor
6783821|NCT02199327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783822|NCT02199327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6783823|NCT02199327|Alkylating Agents|alkylating agents|mesh-ancestor
6783824|NCT02199327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783825|NCT02199327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6783826|NCT02199327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6783827|NCT02199379|Lenvatinib|lenvatinib|mesh-list
6783828|NCT02199379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6783829|NCT02199379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6783830|NCT02199379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6783831|NCT02199379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783832|NCT02199392|Lenvatinib|lenvatinib|mesh-list
6783833|NCT02199392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6783834|NCT02199392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6783835|NCT02199392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6783836|NCT02199392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783837|NCT02199418|Paclitaxel|paclitaxel|mesh-list
6783838|NCT02199418|Cisplatin|cisplatin|mesh-list
6783839|NCT02199418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6783840|NCT02199418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6783841|NCT02199418|Tubulin Modulators|tubulin modulators|mesh-ancestor
6783842|NCT02199418|Antimitotic Agents|antimitotic agents|mesh-ancestor
6783843|NCT02199418|Mitosis Modulators|mitosis modulators|mesh-ancestor
6783844|NCT02199418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783845|NCT02199431|Itraconazole|itraconazole|mesh-list
6783846|NCT02199431|Antifungal Agents|antifungal agents|mesh-ancestor
6783847|NCT02199431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6783848|NCT02199431|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6783849|NCT02199431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6783850|NCT02199431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6783851|NCT02199431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783852|NCT02199431|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6783853|NCT02199431|Hormone Antagonists|hormone antagonists|mesh-ancestor
6783854|NCT02199431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6718011|NCT01824758|Lidocaine|lidocaine|mesh-list
6718012|NCT01824758|Rocuronium|rocuronium|mesh-list
6718013|NCT01824758|Esmolol|esmolol|mesh-list
6718014|NCT01824758|Anesthetics, Local|anesthetics, local|mesh-ancestor
6718015|NCT01824758|Anesthetics|anesthetics|mesh-ancestor
6718016|NCT01824758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6718017|NCT01824758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718018|NCT01824758|Sensory System Agents|sensory system agents|mesh-ancestor
6718019|NCT01824758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6718020|NCT01824758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6718021|NCT01824758|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6718022|NCT01824758|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6718023|NCT01824758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6718024|NCT01824758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718025|NCT01824758|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6718026|NCT01824758|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6718027|NCT01824758|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6718028|NCT01824758|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6718029|NCT01824758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6718030|NCT01824758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6718031|NCT01824758|Adrenergic Agents|adrenergic agents|mesh-ancestor
6718032|NCT01824758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6718033|NCT01824836|Anastrozole|anastrozole|mesh-list
6718034|NCT01824836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6718035|NCT01824836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6718036|NCT01824836|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6718037|NCT01824836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6718038|NCT01824836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6718039|NCT01824836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718040|NCT01824836|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6718041|NCT01824836|Hormone Antagonists|hormone antagonists|mesh-ancestor
6718042|NCT01824836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6718043|NCT01824836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718044|NCT01824888|Anti-Infective Agents|anti-infective agents|mesh-list
6718045|NCT01824888|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6718046|NCT01824927|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6718047|NCT01824927|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6718048|NCT01824992|Interferons|interferons|mesh-list
6718049|NCT01824992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6718050|NCT01824992|Antiviral Agents|antiviral agents|mesh-ancestor
6718051|NCT01824992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6718052|NCT01825031|Azithromycin|azithromycin|mesh-list
6718053|NCT01825031|Isoniazid|isoniazid|mesh-list
6718054|NCT01825031|Raltegravir Potassium|raltegravir potassium|mesh-list
6718055|NCT01825031|Fluconazole|fluconazole|mesh-list
6718056|NCT01825031|Albendazole|albendazole|mesh-list
6718057|NCT01825031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6718058|NCT01825031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6718059|NCT01825031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6718060|NCT01825031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6718061|NCT01825031|Antiviral Agents|antiviral agents|mesh-ancestor
6718062|NCT01825031|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6718063|NCT01825031|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6718064|NCT01825031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6718065|NCT01825031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718066|NCT01825031|Antifungal Agents|antifungal agents|mesh-ancestor
6718067|NCT01825031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6718068|NCT01825031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6718069|NCT01825031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6718070|NCT01825031|Hormone Antagonists|hormone antagonists|mesh-ancestor
6718071|NCT01825031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6718072|NCT01825031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718073|NCT01825031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6718074|NCT01825031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6718075|NCT01825031|Antitubercular Agents|antitubercular agents|mesh-ancestor
6718076|NCT01825031|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6718077|NCT01825031|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6718078|NCT01825031|Antimetabolites|antimetabolites|mesh-ancestor
6718079|NCT01825031|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6718080|NCT01825031|Anthelmintics|anthelmintics|mesh-ancestor
6718081|NCT01825031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6718082|NCT01825031|Anticestodal Agents|anticestodal agents|mesh-ancestor
6718083|NCT01825031|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6718084|NCT01825031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6718085|NCT01825031|Tubulin Modulators|tubulin modulators|mesh-ancestor
6718086|NCT01825031|Antimitotic Agents|antimitotic agents|mesh-ancestor
6718087|NCT01825031|Mitosis Modulators|mitosis modulators|mesh-ancestor
6718088|NCT01825031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6718089|NCT01825044|Cyclosporine|cyclosporine|mesh-list
6718090|NCT01825044|Cyclosporins|cyclosporins|mesh-list
6718091|NCT01825044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6718092|NCT01825044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718093|NCT01825044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6718094|NCT01825044|Immunologic Factors|immunologic factors|mesh-ancestor
6718095|NCT01825044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718096|NCT01825044|Antifungal Agents|antifungal agents|mesh-ancestor
6718097|NCT01825044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6718098|NCT01825044|Dermatologic Agents|dermatologic agents|mesh-ancestor
6718099|NCT01825044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6718100|NCT01825044|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6718101|NCT01825083|Ketamine|ketamine|mesh-list
6718102|NCT01825083|Analgesics|analgesics|mesh-ancestor
6718103|NCT01825083|Sensory System Agents|sensory system agents|mesh-ancestor
6718104|NCT01825083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6718105|NCT01825083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718106|NCT01825083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6718107|NCT01825083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6718108|NCT01825083|Anesthetics, General|anesthetics, general|mesh-ancestor
6718109|NCT01825083|Anesthetics|anesthetics|mesh-ancestor
6718110|NCT01825083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6718111|NCT01825083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6718112|NCT01825083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6718113|NCT01825083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6718114|NCT01825083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718115|NCT01825109|Vaccines|vaccines|mesh-list
6718116|NCT01825109|Immunologic Factors|immunologic factors|mesh-ancestor
6718117|NCT01825109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718118|NCT01825395|Amifampridine|amifampridine|mesh-list
6718119|NCT01825395|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6718120|NCT01825395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6718121|NCT01825395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718122|NCT01825395|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6718123|NCT01825395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6718124|NCT01825395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718125|NCT01825421|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6718126|NCT01825421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6718127|NCT01825447|Naltrexone|naltrexone|mesh-list
6718128|NCT01825447|Oxycodone|oxycodone|mesh-list
6718129|NCT01825447|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6718130|NCT01825447|Narcotics|narcotics|mesh-ancestor
6718131|NCT01825447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6718132|NCT01825447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718133|NCT01825447|Analgesics|analgesics|mesh-ancestor
6718134|NCT01825447|Sensory System Agents|sensory system agents|mesh-ancestor
6718135|NCT01825447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6718136|NCT01825447|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6718137|NCT01825447|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6718138|NCT01825473|Erythromycin|erythromycin|mesh-list
6718139|NCT01825473|Erythromycin Estolate|erythromycin estolate|mesh-list
6718140|NCT01825473|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
6718141|NCT01825473|Erythromycin stearate|erythromycin stearate|mesh-list
6718142|NCT01825473|Phenobarbital|phenobarbital|mesh-list
6718143|NCT01825473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6718144|NCT01825473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6718145|NCT01825473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6718146|NCT01825473|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6718147|NCT01825473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6718148|NCT01825473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718149|NCT01825473|Anticonvulsants|anticonvulsants|mesh-ancestor
6718150|NCT01825473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6718151|NCT01825473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6718152|NCT01825473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718153|NCT01825473|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6718154|NCT01825473|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6718155|NCT01825473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6718156|NCT01825473|GABA Modulators|gaba modulators|mesh-ancestor
6718157|NCT01825473|GABA Agents|gaba agents|mesh-ancestor
6718158|NCT01825473|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6718159|NCT01825473|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6718160|NCT01825473|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6718161|NCT01825551|Sargramostim|sargramostim|mesh-list
6718162|NCT01825551|Lenograstim|lenograstim|mesh-list
6718163|NCT01825551|Immunologic Factors|immunologic factors|mesh-ancestor
6718164|NCT01825551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718165|NCT01825551|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6718166|NCT01825590|Dialysis Solutions|dialysis solutions|mesh-list
6718167|NCT01825590|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6718168|NCT01825603|Gemcitabine|gemcitabine|mesh-list
6718169|NCT01825603|Cisplatin|cisplatin|mesh-list
6718170|NCT01825603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6718171|NCT01825603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6718172|NCT01825603|Antimetabolites|antimetabolites|mesh-ancestor
6718173|NCT01825603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718174|NCT01825603|Antiviral Agents|antiviral agents|mesh-ancestor
6718175|NCT01825603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6718176|NCT01825603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6718177|NCT01825603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6718178|NCT01825603|Immunologic Factors|immunologic factors|mesh-ancestor
6718179|NCT01825603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718180|NCT01825616|Vitamin D|vitamin d|mesh-list
6718181|NCT01825616|Ergocalciferols|ergocalciferols|mesh-list
6718182|NCT01825616|Vitamins|vitamins|mesh-ancestor
6718183|NCT01825616|Micronutrients|micronutrients|mesh-ancestor
6718184|NCT01825616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718185|NCT01825616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6718186|NCT01825616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6718187|NCT01825720|Insulin|insulin|mesh-list
6718188|NCT01825720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6718189|NCT01825720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718190|NCT01825733|Palonosetron|palonosetron|mesh-list
6718191|NCT01825733|Ramosetron|ramosetron|mesh-list
6718192|NCT01825733|Antiemetics|antiemetics|mesh-ancestor
6718193|NCT01825733|Autonomic Agents|autonomic agents|mesh-ancestor
6718194|NCT01825733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6718195|NCT01825733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718196|NCT01825733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6718197|NCT01825733|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6718198|NCT01825733|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6718199|NCT01825733|Serotonin Agents|serotonin agents|mesh-ancestor
6718200|NCT01825733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6718201|NCT01825733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718202|NCT01825850|Irbesartan|irbesartan|mesh-list
6718203|NCT01825850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6718204|NCT01825850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6718205|NCT01825850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6718206|NCT01825850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718207|NCT01825863|Ropivacaine|ropivacaine|mesh-list
6718208|NCT01825863|Anesthetics, Local|anesthetics, local|mesh-ancestor
6718209|NCT01825863|Anesthetics|anesthetics|mesh-ancestor
6718210|NCT01825863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6718211|NCT01825863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718212|NCT01825863|Sensory System Agents|sensory system agents|mesh-ancestor
6718213|NCT01825863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6718214|NCT01825902|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6718215|NCT01825902|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6718216|NCT01825902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718217|NCT01825928|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6718218|NCT01825928|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6718219|NCT01825928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6718220|NCT01825928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6718221|NCT01825928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718222|NCT01825928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6718223|NCT01825928|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6718224|NCT01825928|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6718225|NCT01825928|Serotonin Agents|serotonin agents|mesh-ancestor
6718226|NCT01825928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6718227|NCT01825928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718228|NCT01825928|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6718229|NCT01825928|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6718230|NCT01825928|Dopamine Agents|dopamine agents|mesh-ancestor
6718231|NCT01825993|Morphine|morphine|mesh-list
6718232|NCT01825993|Bupivacaine|bupivacaine|mesh-list
6718233|NCT01825993|Anesthetics, Local|anesthetics, local|mesh-ancestor
6718234|NCT01825993|Anesthetics|anesthetics|mesh-ancestor
6718235|NCT01825993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6718236|NCT01825993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718237|NCT01825993|Sensory System Agents|sensory system agents|mesh-ancestor
6718238|NCT01825993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6718239|NCT01825993|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6718240|NCT01825993|Narcotics|narcotics|mesh-ancestor
6718241|NCT01825993|Analgesics|analgesics|mesh-ancestor
6718242|NCT01826149|Propofol|propofol|mesh-list
6718243|NCT01826149|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6718244|NCT01826149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6718245|NCT01826149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718246|NCT01826149|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6718247|NCT01826149|Anesthetics, General|anesthetics, general|mesh-ancestor
6718248|NCT01826149|Anesthetics|anesthetics|mesh-ancestor
6718249|NCT01826175|Clopidogrel|clopidogrel|mesh-list
6718250|NCT01826175|Ticagrelor|ticagrelor|mesh-list
6718251|NCT01826175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6718252|NCT01826175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6718253|NCT01826175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6718254|NCT01826175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6718255|NCT01826175|Purinergic Agents|purinergic agents|mesh-ancestor
6718256|NCT01826175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6718257|NCT01826175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718258|NCT01826175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718259|NCT01826253|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
6718260|NCT01826253|Plasma Substitutes|plasma substitutes|mesh-ancestor
6718261|NCT01826253|Blood Substitutes|blood substitutes|mesh-ancestor
6718262|NCT01826279|Resveratrol|resveratrol|mesh-list
6718263|NCT01826279|Antioxidants|antioxidants|mesh-ancestor
6718264|NCT01826279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718265|NCT01826279|Protective Agents|protective agents|mesh-ancestor
6718266|NCT01826279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718267|NCT01826279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6718268|NCT01826279|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6783855|NCT02199431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783856|NCT02199431|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6783857|NCT02199444|Sevelamer|sevelamer|mesh-list
6783858|NCT02199444|Chelating Agents|chelating agents|mesh-ancestor
6783859|NCT02199444|Sequestering Agents|sequestering agents|mesh-ancestor
6783860|NCT02199444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783861|NCT02199522|Propofol|propofol|mesh-list
6783862|NCT02199522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6783863|NCT02199522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6783864|NCT02199522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783865|NCT02199522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6783866|NCT02199522|Anesthetics, General|anesthetics, general|mesh-ancestor
6783867|NCT02199522|Anesthetics|anesthetics|mesh-ancestor
6783868|NCT02199613|Darunavir|darunavir|mesh-list
6783869|NCT02199613|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6783870|NCT02199613|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6783871|NCT02199613|Protease Inhibitors|protease inhibitors|mesh-ancestor
6783872|NCT02199613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6783873|NCT02199613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783874|NCT02199613|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6783875|NCT02199613|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6783876|NCT02199613|Antiviral Agents|antiviral agents|mesh-ancestor
6783877|NCT02199613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6783878|NCT02199678|Ketamine|ketamine|mesh-list
6783879|NCT02199678|Analgesics|analgesics|mesh-ancestor
6783880|NCT02199678|Sensory System Agents|sensory system agents|mesh-ancestor
6783881|NCT02199678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6783882|NCT02199678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783883|NCT02199678|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6783884|NCT02199678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6783885|NCT02199678|Anesthetics, General|anesthetics, general|mesh-ancestor
6783886|NCT02199678|Anesthetics|anesthetics|mesh-ancestor
6783887|NCT02199678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6783888|NCT02199678|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6783889|NCT02199678|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6783890|NCT02199678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6783891|NCT02199678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783892|NCT02199925|gamma-Globulins|gamma-globulins|mesh-list
6783893|NCT02199925|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6783894|NCT02199925|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6783895|NCT02199925|Immunologic Factors|immunologic factors|mesh-ancestor
6783896|NCT02199925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783897|NCT02199951|Piperaquine|piperaquine|mesh-list
6783898|NCT02199951|Artenimol|artenimol|mesh-list
6783899|NCT02199951|Antimalarials|antimalarials|mesh-ancestor
6783900|NCT02199951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6718269|NCT01826396|Irinotecan|irinotecan|mesh-list
6718270|NCT01826396|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6718271|NCT01826396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6718272|NCT01826396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6718273|NCT01826396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718274|NCT01826396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6718275|NCT01826526|Taurolidine|taurolidine|mesh-list
6718276|NCT01826526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6718277|NCT01826526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6718278|NCT01826526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6718279|NCT01826747|Progesterone|progesterone|mesh-list
6718280|NCT01826747|Progestins|progestins|mesh-ancestor
6718281|NCT01826747|Hormones|hormones|mesh-ancestor
6718282|NCT01826747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6718283|NCT01826747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718284|NCT01826773|Palmitic Acid|palmitic acid|mesh-list
6718285|NCT01826773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6718286|NCT01826773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718287|NCT01826786|JNJ-42165279|jnj-42165279|mesh-list
6718288|NCT01826786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6718289|NCT01826786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718290|NCT01826864|Sargramostim|sargramostim|mesh-list
6718291|NCT01826864|Immunologic Factors|immunologic factors|mesh-ancestor
6718292|NCT01826864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718293|NCT01826916|Ecallantide|ecallantide|mesh-list
6718294|NCT01826916|Analgesics|analgesics|mesh-ancestor
6718295|NCT01826916|Sensory System Agents|sensory system agents|mesh-ancestor
6718296|NCT01826916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6718297|NCT01826916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718298|NCT01826916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6718299|NCT01826916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6718300|NCT01826916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6718301|NCT01826916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6718302|NCT01827007|Polygeline|polygeline|mesh-list
6718303|NCT01827007|Plasma Substitutes|plasma substitutes|mesh-ancestor
6718304|NCT01827007|Blood Substitutes|blood substitutes|mesh-ancestor
6718305|NCT01827020|Lidocaine|lidocaine|mesh-list
6718306|NCT01827020|Ketamine|ketamine|mesh-list
6718307|NCT01827020|Anesthetics, Local|anesthetics, local|mesh-ancestor
6718308|NCT01827020|Anesthetics|anesthetics|mesh-ancestor
6718309|NCT01827020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6718310|NCT01827020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718311|NCT01827020|Sensory System Agents|sensory system agents|mesh-ancestor
6718312|NCT01827020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6718313|NCT01827020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6718314|NCT01827020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6718315|NCT01827020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6718316|NCT01827020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6718317|NCT01827020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718318|NCT01827020|Analgesics|analgesics|mesh-ancestor
6718319|NCT01827020|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6718320|NCT01827020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6718321|NCT01827020|Anesthetics, General|anesthetics, general|mesh-ancestor
6718322|NCT01827020|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6718323|NCT01827020|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6718324|NCT01827020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6718325|NCT01827059|Bosentan|bosentan|mesh-list
6718326|NCT01827059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6718327|NCT01827059|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6718328|NCT01827059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718329|NCT01827072|Immunoglobulins|immunoglobulins|mesh-list
6718330|NCT01827072|Immunologic Factors|immunologic factors|mesh-ancestor
6718331|NCT01827072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718332|NCT01827124|Oxytocin|oxytocin|mesh-list
6718333|NCT01827124|Carbetocin|carbetocin|mesh-list
6718334|NCT01827124|Oxytocics|oxytocics|mesh-ancestor
6718335|NCT01827124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6718336|NCT01827124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718337|NCT01827137|Lenalidomide|lenalidomide|mesh-list
6718338|NCT01827137|Molgramostim|molgramostim|mesh-list
6718339|NCT01827137|Sargramostim|sargramostim|mesh-list
6718340|NCT01827137|Immunologic Factors|immunologic factors|mesh-ancestor
6718341|NCT01827137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718342|NCT01827137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6718343|NCT01827137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6718344|NCT01827137|Growth Substances|growth substances|mesh-ancestor
6718345|NCT01827137|Growth Inhibitors|growth inhibitors|mesh-ancestor
6718346|NCT01827137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6718347|NCT01827202|Candesartan|candesartan|mesh-list
6718348|NCT01827202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6718349|NCT01827202|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6718350|NCT01827202|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6718351|NCT01827202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718352|NCT01827228|HIV Antibodies|hiv antibodies|mesh-list
6718353|NCT01827228|Immunologic Factors|immunologic factors|mesh-ancestor
6718354|NCT01827228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718355|NCT01827280|Vildagliptin|vildagliptin|mesh-list
6718356|NCT01827280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6718357|NCT01827280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718358|NCT01827280|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6718359|NCT01827280|Protease Inhibitors|protease inhibitors|mesh-ancestor
6718360|NCT01827280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6718361|NCT01827280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718362|NCT01827293|Promethazine|promethazine|mesh-list
6718363|NCT01827293|Diphenhydramine|diphenhydramine|mesh-list
6718364|NCT01827293|Lorazepam|lorazepam|mesh-list
6718365|NCT01827293|Anticonvulsants|anticonvulsants|mesh-ancestor
6718366|NCT01827293|Antiemetics|antiemetics|mesh-ancestor
6718367|NCT01827293|Autonomic Agents|autonomic agents|mesh-ancestor
6718368|NCT01827293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6718369|NCT01827293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718370|NCT01827293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6718371|NCT01827293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6718372|NCT01827293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6718373|NCT01827293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6718374|NCT01827293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6718375|NCT01827293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6718376|NCT01827293|GABA Modulators|gaba modulators|mesh-ancestor
6718377|NCT01827293|GABA Agents|gaba agents|mesh-ancestor
6718378|NCT01827293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6718379|NCT01827293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718380|NCT01827293|Antipruritics|antipruritics|mesh-ancestor
6718381|NCT01827293|Dermatologic Agents|dermatologic agents|mesh-ancestor
6718382|NCT01827293|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6718383|NCT01827293|Histamine Antagonists|histamine antagonists|mesh-ancestor
6718384|NCT01827293|Histamine Agents|histamine agents|mesh-ancestor
6718385|NCT01827293|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6718386|NCT01827293|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6718387|NCT01827293|Anesthetics, Local|anesthetics, local|mesh-ancestor
6718388|NCT01827293|Anesthetics|anesthetics|mesh-ancestor
6718389|NCT01827293|Sensory System Agents|sensory system agents|mesh-ancestor
6718390|NCT01827345|Vitamin D|vitamin d|mesh-list
6718391|NCT01827345|Vitamins|vitamins|mesh-ancestor
6718392|NCT01827345|Micronutrients|micronutrients|mesh-ancestor
6718393|NCT01827345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718394|NCT01827345|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6718395|NCT01827384|Carboplatin|carboplatin|mesh-list
6718396|NCT01827384|Everolimus|everolimus|mesh-list
6718397|NCT01827384|Temozolomide|temozolomide|mesh-list
6718398|NCT01827384|Trametinib|trametinib|mesh-list
6718399|NCT01827384|Veliparib|veliparib|mesh-list
6718400|NCT01827384|Adavosertib|adavosertib|mesh-list
6718401|NCT01827384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6718402|NCT01827384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6718403|NCT01827384|Immunologic Factors|immunologic factors|mesh-ancestor
6718404|NCT01827384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718405|NCT01827384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6718406|NCT01827384|Alkylating Agents|alkylating agents|mesh-ancestor
6718407|NCT01827384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718408|NCT01827384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6718409|NCT01827384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6718410|NCT01827384|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6718411|NCT01827397|Vaccines|vaccines|mesh-list
6718412|NCT01827397|Immunologic Factors|immunologic factors|mesh-ancestor
6718413|NCT01827397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718414|NCT01827540|Dolutegravir|dolutegravir|mesh-list
6718415|NCT01827540|Cenicriviroc|cenicriviroc|mesh-list
6718416|NCT01827540|Midazolam|midazolam|mesh-list
6718417|NCT01827540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6718418|NCT01827540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6718419|NCT01827540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6718420|NCT01827540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718421|NCT01827540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6718422|NCT01827540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6718423|NCT01827540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6718424|NCT01827540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6718425|NCT01827540|Anesthetics, General|anesthetics, general|mesh-ancestor
6718426|NCT01827540|Anesthetics|anesthetics|mesh-ancestor
6718427|NCT01827540|GABA Modulators|gaba modulators|mesh-ancestor
6718428|NCT01827540|GABA Agents|gaba agents|mesh-ancestor
6718429|NCT01827540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6718430|NCT01827540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718431|NCT01827540|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6718432|NCT01827540|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6718433|NCT01827540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6718434|NCT01827540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6718435|NCT01827540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6718436|NCT01827540|Antiviral Agents|antiviral agents|mesh-ancestor
6718437|NCT01827540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6718438|NCT01827540|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6718439|NCT01827553|Gemcitabine|gemcitabine|mesh-list
6718440|NCT01827553|Folfirinox|folfirinox|mesh-list
6718441|NCT01827553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6718442|NCT01827553|Antimetabolites|antimetabolites|mesh-ancestor
6718443|NCT01827553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718444|NCT01827553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6718445|NCT01827553|Antiviral Agents|antiviral agents|mesh-ancestor
6718446|NCT01827553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6718447|NCT01827553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6718448|NCT01827553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6718449|NCT01827553|Immunologic Factors|immunologic factors|mesh-ancestor
6718450|NCT01827553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718451|NCT01827618|Sirolimus|sirolimus|mesh-list
6718452|NCT01827618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6718453|NCT01827618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6718454|NCT01827618|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6718455|NCT01827618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6718456|NCT01827618|Antifungal Agents|antifungal agents|mesh-ancestor
6718457|NCT01827618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6718458|NCT01827618|Immunologic Factors|immunologic factors|mesh-ancestor
6718459|NCT01827618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718460|NCT01827722|Dexamethasone|dexamethasone|mesh-list
6718461|NCT01827722|Dexamethasone acetate|dexamethasone acetate|mesh-list
6718462|NCT01827722|Ranibizumab|ranibizumab|mesh-list
6718463|NCT01827722|BB 1101|bb 1101|mesh-list
6718464|NCT01827722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6718465|NCT01827722|Antiemetics|antiemetics|mesh-ancestor
6718466|NCT01827722|Autonomic Agents|autonomic agents|mesh-ancestor
6718467|NCT01827722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6718468|NCT01827722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718469|NCT01827722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6718470|NCT01827722|Glucocorticoids|glucocorticoids|mesh-ancestor
6718471|NCT01827722|Hormones|hormones|mesh-ancestor
6718472|NCT01827722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6718473|NCT01827722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6718474|NCT01827722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6718475|NCT01827722|Protease Inhibitors|protease inhibitors|mesh-ancestor
6718476|NCT01827722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6718477|NCT01827722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718478|NCT01827722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6718479|NCT01827722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6718480|NCT01827722|Growth Substances|growth substances|mesh-ancestor
6718481|NCT01827722|Growth Inhibitors|growth inhibitors|mesh-ancestor
6718482|NCT01827735|Aldesleukin|aldesleukin|mesh-list
6718483|NCT01827735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6718484|NCT01827735|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6718485|NCT01827735|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6718486|NCT01827735|Antiviral Agents|antiviral agents|mesh-ancestor
6718487|NCT01827735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6718488|NCT01827865|Etodolac|etodolac|mesh-list
6718489|NCT01827865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6718490|NCT01827865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6718491|NCT01827865|Analgesics|analgesics|mesh-ancestor
6718492|NCT01827865|Sensory System Agents|sensory system agents|mesh-ancestor
6718493|NCT01827865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6718494|NCT01827865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718495|NCT01827865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6718496|NCT01827865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6783901|NCT02199951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6718497|NCT01827865|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6718498|NCT01827865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6718499|NCT01827865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6718500|NCT01827865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718501|NCT01827878|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6718502|NCT01827878|Lisinopril|lisinopril|mesh-list
6718503|NCT01827878|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
6718504|NCT01827878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6718505|NCT01827878|Diuretics|diuretics|mesh-ancestor
6718506|NCT01827878|Natriuretic Agents|natriuretic agents|mesh-ancestor
6718507|NCT01827878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718508|NCT01827878|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6718509|NCT01827878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6718510|NCT01827878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718511|NCT01827878|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6718512|NCT01827878|Protease Inhibitors|protease inhibitors|mesh-ancestor
6718513|NCT01827878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6718514|NCT01827878|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6718515|NCT01827878|Protective Agents|protective agents|mesh-ancestor
6718516|NCT01828125|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6718517|NCT01828125|Glucagon|glucagon|mesh-list
6718518|NCT01828125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6718519|NCT01828125|Hormones|hormones|mesh-ancestor
6718520|NCT01828125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6718521|NCT01828125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783902|NCT02199951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6783903|NCT02200094|Telmisartan|telmisartan|mesh-list
6783904|NCT02200094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6783905|NCT02200094|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6783906|NCT02200094|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6783907|NCT02200094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783908|NCT02200146|Hydroxychloroquine|hydroxychloroquine|mesh-list
6783909|NCT02200146|Prednisone|prednisone|mesh-list
6783910|NCT02200146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6783911|NCT02200146|Glucocorticoids|glucocorticoids|mesh-ancestor
6783912|NCT02200146|Hormones|hormones|mesh-ancestor
6783913|NCT02200146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6783914|NCT02200146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783915|NCT02200146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6783916|NCT02200146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6783917|NCT02200146|Antimalarials|antimalarials|mesh-ancestor
6783918|NCT02200146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6783919|NCT02200146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6783920|NCT02200146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6783921|NCT02200146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6783922|NCT02200146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783923|NCT02200146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6783924|NCT02200159|Dexmedetomidine|dexmedetomidine|mesh-list
6783925|NCT02200159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6783926|NCT02200159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6783927|NCT02200159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783928|NCT02200159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6783929|NCT02200159|Analgesics|analgesics|mesh-ancestor
6783930|NCT02200159|Sensory System Agents|sensory system agents|mesh-ancestor
6783931|NCT02200159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6783932|NCT02200159|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6783933|NCT02200159|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6783934|NCT02200159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6783935|NCT02200159|Adrenergic Agents|adrenergic agents|mesh-ancestor
6783936|NCT02200159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6783937|NCT02200159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783938|NCT02200172|Melatonin|melatonin|mesh-list
6783939|NCT02200172|Antioxidants|antioxidants|mesh-ancestor
6783940|NCT02200172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783941|NCT02200172|Protective Agents|protective agents|mesh-ancestor
6783942|NCT02200172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783943|NCT02200172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6783944|NCT02200185|Morphine|morphine|mesh-list
6783945|NCT02200185|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6783946|NCT02200185|Narcotics|narcotics|mesh-ancestor
6783947|NCT02200185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6783948|NCT02200185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718522|NCT01828203|Minocycline|minocycline|mesh-list
6718523|NCT01828203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6718524|NCT01828203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6718525|NCT01828294|Immunoglobulins|immunoglobulins|mesh-list
6718526|NCT01828294|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6718527|NCT01828294|Antibodies|antibodies|mesh-list
6718528|NCT01828294|Immunologic Factors|immunologic factors|mesh-ancestor
6718529|NCT01828294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718530|NCT01828346|Azacitidine|azacitidine|mesh-list
6718531|NCT01828346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6718532|NCT01828346|Antimetabolites|antimetabolites|mesh-ancestor
6718533|NCT01828346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718534|NCT01828346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6718535|NCT01828346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6718536|NCT01828359|Losartan|losartan|mesh-list
6718537|NCT01828359|Amlodipine|amlodipine|mesh-list
6718538|NCT01828359|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6718539|NCT01828359|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6718540|NCT01828359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6718541|NCT01828359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718542|NCT01828359|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6718543|NCT01828359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718544|NCT01828359|Vasodilator Agents|vasodilator agents|mesh-ancestor
6718545|NCT01828359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6718546|NCT01828359|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6718547|NCT01828359|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6718548|NCT01828385|Magnesium Sulfate|magnesium sulfate|mesh-list
6718549|NCT01828385|Analgesics|analgesics|mesh-ancestor
6718550|NCT01828385|Sensory System Agents|sensory system agents|mesh-ancestor
6718551|NCT01828385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6718552|NCT01828385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718553|NCT01828385|Anesthetics|anesthetics|mesh-ancestor
6718554|NCT01828385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6718555|NCT01828385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6718556|NCT01828385|Anticonvulsants|anticonvulsants|mesh-ancestor
6718557|NCT01828385|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6718558|NCT01828385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6718559|NCT01828385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718560|NCT01828385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6718561|NCT01828385|Tocolytic Agents|tocolytic agents|mesh-ancestor
6718562|NCT01828385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6718563|NCT01828437|Pyridoxine|pyridoxine|mesh-list
6718564|NCT01828437|Prednisolone|prednisolone|mesh-list
6718565|NCT01828437|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6718566|NCT01828437|Methylprednisolone|methylprednisolone|mesh-list
6718567|NCT01828437|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6718568|NCT01828437|Prednisolone acetate|prednisolone acetate|mesh-list
6718569|NCT01828437|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6718570|NCT01828437|Prednisolone phosphate|prednisolone phosphate|mesh-list
6718571|NCT01828437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6718572|NCT01828437|Glucocorticoids|glucocorticoids|mesh-ancestor
6718573|NCT01828437|Hormones|hormones|mesh-ancestor
6718574|NCT01828437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6718575|NCT01828437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718576|NCT01828437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6718577|NCT01828437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6718578|NCT01828437|Antiemetics|antiemetics|mesh-ancestor
6718579|NCT01828437|Autonomic Agents|autonomic agents|mesh-ancestor
6718580|NCT01828437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6718581|NCT01828437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6718582|NCT01828437|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6718583|NCT01828437|Protective Agents|protective agents|mesh-ancestor
6718584|NCT01828437|Vitamin B Complex|vitamin b complex|mesh-ancestor
6718585|NCT01828437|Vitamins|vitamins|mesh-ancestor
6718586|NCT01828437|Micronutrients|micronutrients|mesh-ancestor
6718587|NCT01828463|Nitisinone|nitisinone|mesh-list
6718588|NCT01828463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6718589|NCT01828463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718590|NCT01828489|Mitoxantrone|mitoxantrone|mesh-list
6718591|NCT01828489|Analgesics|analgesics|mesh-ancestor
6718592|NCT01828489|Sensory System Agents|sensory system agents|mesh-ancestor
6718593|NCT01828489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6718594|NCT01828489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718595|NCT01828489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6718596|NCT01828489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6718597|NCT01828489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6718598|NCT01828489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6718599|NCT01828489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718600|NCT01828606|Monensin|monensin|mesh-list
6718601|NCT01828606|Antifungal Agents|antifungal agents|mesh-ancestor
6718602|NCT01828606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6718603|NCT01828606|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6718604|NCT01828606|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6718605|NCT01828606|Coccidiostats|coccidiostats|mesh-ancestor
6718606|NCT01828606|Proton Ionophores|proton ionophores|mesh-ancestor
6718607|NCT01828606|Uncoupling Agents|uncoupling agents|mesh-ancestor
6718608|NCT01828606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6718609|NCT01828606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718610|NCT01828606|Ionophores|ionophores|mesh-ancestor
6718611|NCT01828606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6718612|NCT01828606|Sodium Ionophores|sodium ionophores|mesh-ancestor
6718613|NCT01828697|Enoxaparin|enoxaparin|mesh-list
6718614|NCT01828697|Dalteparin|dalteparin|mesh-list
6718615|NCT01828697|Tinzaparin|tinzaparin|mesh-list
6718616|NCT01828697|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6718617|NCT01828697|Nadroparin|nadroparin|mesh-list
6718618|NCT01828697|Enoxaparin sodium|enoxaparin sodium|mesh-list
6718619|NCT01828697|Anticoagulants|anticoagulants|mesh-ancestor
6718620|NCT01828697|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6718621|NCT01828697|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6718622|NCT01828697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718623|NCT01828710|Folic Acid|folic acid|mesh-list
6718624|NCT01828710|Inositol|inositol|mesh-list
6718625|NCT01828710|Hematinics|hematinics|mesh-ancestor
6718626|NCT01828710|Vitamin B Complex|vitamin b complex|mesh-ancestor
6718627|NCT01828710|Vitamins|vitamins|mesh-ancestor
6718628|NCT01828710|Micronutrients|micronutrients|mesh-ancestor
6718629|NCT01828710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718630|NCT01828736|Gemcitabine|gemcitabine|mesh-list
6718631|NCT01828736|Cisplatin|cisplatin|mesh-list
6718632|NCT01828736|Carboplatin|carboplatin|mesh-list
6718633|NCT01828736|Trastuzumab|trastuzumab|mesh-list
6718634|NCT01828736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6718635|NCT01828736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6718636|NCT01828736|Antimetabolites|antimetabolites|mesh-ancestor
6718637|NCT01828736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718638|NCT01828736|Antiviral Agents|antiviral agents|mesh-ancestor
6718639|NCT01828736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6718640|NCT01828736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6718641|NCT01828736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6718642|NCT01828736|Immunologic Factors|immunologic factors|mesh-ancestor
6718643|NCT01828736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718644|NCT01828736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6718645|NCT01828788|Ropivacaine|ropivacaine|mesh-list
6718646|NCT01828788|Anesthetics, Local|anesthetics, local|mesh-ancestor
6718647|NCT01828788|Anesthetics|anesthetics|mesh-ancestor
6718648|NCT01828788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6718649|NCT01828788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718650|NCT01828788|Sensory System Agents|sensory system agents|mesh-ancestor
6718651|NCT01828788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6718652|NCT01828840|Fentanyl|fentanyl|mesh-list
6718653|NCT01828840|Morphine|morphine|mesh-list
6718654|NCT01828840|Methadone|methadone|mesh-list
6718655|NCT01828840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6718656|NCT01828840|Narcotics|narcotics|mesh-ancestor
6718657|NCT01828840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6718658|NCT01828840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718659|NCT01828840|Analgesics|analgesics|mesh-ancestor
6718660|NCT01828840|Sensory System Agents|sensory system agents|mesh-ancestor
6718661|NCT01828840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6718662|NCT01828840|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6718663|NCT01828840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6718664|NCT01828840|Anesthetics, General|anesthetics, general|mesh-ancestor
6718665|NCT01828840|Anesthetics|anesthetics|mesh-ancestor
6718666|NCT01828840|Antitussive Agents|antitussive agents|mesh-ancestor
6718667|NCT01828840|Respiratory System Agents|respiratory system agents|mesh-ancestor
6718668|NCT01828879|Tacrolimus|tacrolimus|mesh-list
6718669|NCT01828879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6718670|NCT01828879|Immunologic Factors|immunologic factors|mesh-ancestor
6718671|NCT01828879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718672|NCT01828879|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6718673|NCT01828879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6718674|NCT01828879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718675|NCT01828892|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6718676|NCT01828892|Vancomycin|vancomycin|mesh-list
6718677|NCT01828892|Meropenem|meropenem|mesh-list
6718678|NCT01828892|Ceftazidime|ceftazidime|mesh-list
6718679|NCT01828892|Cefotaxime|cefotaxime|mesh-list
6718680|NCT01828892|Cefoxitin|cefoxitin|mesh-list
6718681|NCT01828892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6718682|NCT01828970|Insulin Aspart|insulin aspart|mesh-list
6718683|NCT01828970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6718684|NCT01828970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718685|NCT01829178|Cisplatin|cisplatin|mesh-list
6718686|NCT01829178|Docetaxel|docetaxel|mesh-list
6718687|NCT01829178|Fluorouracil|fluorouracil|mesh-list
6718688|NCT01829178|Silymarin|silymarin|mesh-list
6718689|NCT01829178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6718690|NCT01829178|Tubulin Modulators|tubulin modulators|mesh-ancestor
6718691|NCT01829178|Antimitotic Agents|antimitotic agents|mesh-ancestor
6718692|NCT01829178|Mitosis Modulators|mitosis modulators|mesh-ancestor
6718693|NCT01829178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718694|NCT01829178|Antimetabolites|antimetabolites|mesh-ancestor
6718695|NCT01829178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6718696|NCT01829178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6718697|NCT01829178|Immunologic Factors|immunologic factors|mesh-ancestor
6718698|NCT01829178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718699|NCT01829178|Antioxidants|antioxidants|mesh-ancestor
6718700|NCT01829178|Protective Agents|protective agents|mesh-ancestor
6718701|NCT01829334|Listerine|listerine|mesh-list
6718702|NCT01829334|Fluorides|fluorides|mesh-list
6718703|NCT01829334|Sodium Fluoride|sodium fluoride|mesh-list
6718704|NCT01829334|Fluorides, Topical|fluorides, topical|mesh-list
6718705|NCT01829334|Cariostatic Agents|cariostatic agents|mesh-ancestor
6718706|NCT01829334|Protective Agents|protective agents|mesh-ancestor
6718707|NCT01829334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718708|NCT01829334|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6718709|NCT01829334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6718710|NCT01829451|Hyaluronic Acid|hyaluronic acid|mesh-list
6718711|NCT01829451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6718712|NCT01829451|Immunologic Factors|immunologic factors|mesh-ancestor
6718713|NCT01829451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718714|NCT01829451|Viscosupplements|viscosupplements|mesh-ancestor
6718715|NCT01829451|Protective Agents|protective agents|mesh-ancestor
6718716|NCT01829529|Amoxicillin|amoxicillin|mesh-list
6718717|NCT01829529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6718718|NCT01829529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6718719|NCT01829659|Ticagrelor|ticagrelor|mesh-list
6718720|NCT01829659|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6718721|NCT01829659|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6718722|NCT01829659|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6718723|NCT01829659|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6718724|NCT01829659|Purinergic Agents|purinergic agents|mesh-ancestor
6718725|NCT01829659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6718726|NCT01829659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718727|NCT01829659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718728|NCT01829685|Entecavir|entecavir|mesh-list
6718729|NCT01829685|Adefovir|adefovir|mesh-list
6718730|NCT01829685|Antiviral Agents|antiviral agents|mesh-ancestor
6718731|NCT01829685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6718732|NCT01829685|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6718733|NCT01829685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6718734|NCT01829685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6718735|NCT01829685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718736|NCT01829698|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
6718737|NCT01829698|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6718738|NCT01829698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6718739|NCT01829711|Immunotoxin HA22|immunotoxin ha22|mesh-list
6718740|NCT01829711|Protective Agents|protective agents|mesh-list
6718741|NCT01829711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6718742|NCT01829711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718743|NCT01829802|Ritonavir|ritonavir|mesh-list
6718744|NCT01829802|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6718745|NCT01829802|Raltegravir Potassium|raltegravir potassium|mesh-list
6718746|NCT01829802|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6718747|NCT01829802|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6718748|NCT01829802|Protease Inhibitors|protease inhibitors|mesh-ancestor
6718749|NCT01829802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6718750|NCT01829802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718751|NCT01829802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6718752|NCT01829802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6718753|NCT01829802|Antiviral Agents|antiviral agents|mesh-ancestor
6718754|NCT01829802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6718755|NCT01829802|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6718756|NCT01829802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6718757|NCT01829802|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6718758|NCT01829802|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6718759|NCT01829841|Sunitinib|sunitinib|mesh-list
6718760|NCT01829841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6718761|NCT01829841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6718762|NCT01829841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6718763|NCT01829841|Growth Substances|growth substances|mesh-ancestor
6718764|NCT01829841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718765|NCT01829841|Growth Inhibitors|growth inhibitors|mesh-ancestor
6718766|NCT01829841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6718767|NCT01829841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6718768|NCT01829841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783949|NCT02200185|Analgesics|analgesics|mesh-ancestor
6783950|NCT02200185|Sensory System Agents|sensory system agents|mesh-ancestor
6783951|NCT02200185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6783952|NCT02200237|Aluminum phosphate|aluminum phosphate|mesh-list
6783953|NCT02200237|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6783954|NCT02200237|Immunologic Factors|immunologic factors|mesh-ancestor
6783955|NCT02200237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783956|NCT02200237|Antacids|antacids|mesh-ancestor
6783957|NCT02200237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783958|NCT02200237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6783959|NCT02200315|Anti-Infective Agents|anti-infective agents|mesh-list
6783960|NCT02200315|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6718769|NCT01829893|Tamsulosin|tamsulosin|mesh-list
6718770|NCT01829893|Finasteride|finasteride|mesh-list
6718771|NCT01829893|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6718772|NCT01829893|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6718773|NCT01829893|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6718774|NCT01829893|Adrenergic Agents|adrenergic agents|mesh-ancestor
6718775|NCT01829893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6718776|NCT01829893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718777|NCT01829893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718778|NCT01829893|Urological Agents|urological agents|mesh-ancestor
6718779|NCT01829893|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6718780|NCT01829893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6718781|NCT01829893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6718782|NCT01829893|Hormone Antagonists|hormone antagonists|mesh-ancestor
6718783|NCT01829893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6718784|NCT01829958|Prednisone|prednisone|mesh-list
6718785|NCT01829958|Rituximab|rituximab|mesh-list
6718786|NCT01829958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6718787|NCT01829958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6718788|NCT01829958|Immunologic Factors|immunologic factors|mesh-ancestor
6718789|NCT01829958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718790|NCT01829958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6718791|NCT01829958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6718792|NCT01829958|Glucocorticoids|glucocorticoids|mesh-ancestor
6718793|NCT01829958|Hormones|hormones|mesh-ancestor
6718794|NCT01829958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6718795|NCT01829958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6718796|NCT01830101|Temozolomide|temozolomide|mesh-list
6718797|NCT01830101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6718798|NCT01830101|Alkylating Agents|alkylating agents|mesh-ancestor
6718799|NCT01830101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718800|NCT01830101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6718801|NCT01830153|Everolimus|everolimus|mesh-list
6718802|NCT01830153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6718803|NCT01830153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6718804|NCT01830153|Immunologic Factors|immunologic factors|mesh-ancestor
6718805|NCT01830153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718806|NCT01830218|Anesthetics|anesthetics|mesh-list
6718807|NCT01830218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6718808|NCT01830218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718809|NCT01830244|Paclitaxel|paclitaxel|mesh-list
6718810|NCT01830244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6718811|NCT01830244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6718812|NCT01830244|Tubulin Modulators|tubulin modulators|mesh-ancestor
6718813|NCT01830244|Antimitotic Agents|antimitotic agents|mesh-ancestor
6718814|NCT01830244|Mitosis Modulators|mitosis modulators|mesh-ancestor
6718815|NCT01830244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718816|NCT01830270|Paclitaxel|paclitaxel|mesh-list
6718817|NCT01830270|Epirubicin|epirubicin|mesh-list
6718818|NCT01830270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6718819|NCT01830270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6718820|NCT01830270|Tubulin Modulators|tubulin modulators|mesh-ancestor
6718821|NCT01830270|Antimitotic Agents|antimitotic agents|mesh-ancestor
6718822|NCT01830270|Mitosis Modulators|mitosis modulators|mesh-ancestor
6718823|NCT01830270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718824|NCT01830270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6718825|NCT01830270|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6718826|NCT01830270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6718827|NCT01830270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6718828|NCT01830296|Morphine|morphine|mesh-list
6718829|NCT01830296|Remifentanil|remifentanil|mesh-list
6718830|NCT01830296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6718831|NCT01830296|Narcotics|narcotics|mesh-ancestor
6718832|NCT01830296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6718833|NCT01830296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718834|NCT01830296|Analgesics|analgesics|mesh-ancestor
6718835|NCT01830296|Sensory System Agents|sensory system agents|mesh-ancestor
6718836|NCT01830296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6718837|NCT01830322|Gemcitabine|gemcitabine|mesh-list
6718838|NCT01830322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6718839|NCT01830322|Antimetabolites|antimetabolites|mesh-ancestor
6718840|NCT01830322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718841|NCT01830322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6718842|NCT01830322|Antiviral Agents|antiviral agents|mesh-ancestor
6718843|NCT01830322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6718844|NCT01830322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6718845|NCT01830322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6718846|NCT01830322|Immunologic Factors|immunologic factors|mesh-ancestor
6718847|NCT01830322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718848|NCT01830335|Indomethacin|indomethacin|mesh-list
6718849|NCT01830335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6718850|NCT01830335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6718851|NCT01830335|Analgesics|analgesics|mesh-ancestor
6718852|NCT01830335|Sensory System Agents|sensory system agents|mesh-ancestor
6718853|NCT01830335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6718854|NCT01830335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718855|NCT01830335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6718856|NCT01830335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6718857|NCT01830335|Gout Suppressants|gout suppressants|mesh-ancestor
6718858|NCT01830335|Tocolytic Agents|tocolytic agents|mesh-ancestor
6718859|NCT01830335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6718860|NCT01830335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6718861|NCT01830335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6718862|NCT01830335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718863|NCT01830361|Midostaurin|midostaurin|mesh-list
6718864|NCT01830361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6718865|NCT01830361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6718866|NCT01830361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6718867|NCT01830361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718868|NCT01830400|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
6718869|NCT01830400|Anticonvulsants|anticonvulsants|mesh-ancestor
6718870|NCT01830400|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6718871|NCT01830400|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6718872|NCT01830400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6718873|NCT01830400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718874|NCT01830465|Rituximab|rituximab|mesh-list
6718875|NCT01830465|Bortezomib|bortezomib|mesh-list
6718876|NCT01830465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6718877|NCT01830465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6718878|NCT01830465|Immunologic Factors|immunologic factors|mesh-ancestor
6718879|NCT01830465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718880|NCT01830465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6718881|NCT01830478|Rituximab|rituximab|mesh-list
6718882|NCT01830478|Lenalidomide|lenalidomide|mesh-list
6718883|NCT01830478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6718884|NCT01830478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6718885|NCT01830478|Immunologic Factors|immunologic factors|mesh-ancestor
6718886|NCT01830478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718887|NCT01830478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6718888|NCT01830478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6718889|NCT01830478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6718890|NCT01830478|Growth Substances|growth substances|mesh-ancestor
6718891|NCT01830478|Growth Inhibitors|growth inhibitors|mesh-ancestor
6718892|NCT01830491|Aspirin|aspirin|mesh-list
6718893|NCT01830491|Clopidogrel|clopidogrel|mesh-list
6718894|NCT01830491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6718895|NCT01830491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6718896|NCT01830491|Analgesics|analgesics|mesh-ancestor
6718897|NCT01830491|Sensory System Agents|sensory system agents|mesh-ancestor
6718898|NCT01830491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6718899|NCT01830491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718900|NCT01830491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6718901|NCT01830491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6718902|NCT01830491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6718903|NCT01830491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6718904|NCT01830491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718905|NCT01830491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6718906|NCT01830491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6718907|NCT01830491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6718908|NCT01830491|Antipyretics|antipyretics|mesh-ancestor
6718909|NCT01830491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6718910|NCT01830491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6718911|NCT01830491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6718912|NCT01830491|Purinergic Agents|purinergic agents|mesh-ancestor
6718913|NCT01830491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6718914|NCT01830517|Losartan|losartan|mesh-list
6718915|NCT01830517|Amlodipine|amlodipine|mesh-list
6718916|NCT01830517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6718917|NCT01830517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6718918|NCT01830517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6718919|NCT01830517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718920|NCT01830517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6718921|NCT01830517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718922|NCT01830517|Vasodilator Agents|vasodilator agents|mesh-ancestor
6718923|NCT01830517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6718924|NCT01830517|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6718925|NCT01830517|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6718926|NCT01830530|Telmisartan|telmisartan|mesh-list
6718927|NCT01830530|Nifedipine|nifedipine|mesh-list
6718928|NCT01830530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6718929|NCT01830530|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6718930|NCT01830530|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6718931|NCT01830530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718932|NCT01830530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6718933|NCT01830530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6718934|NCT01830530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6718935|NCT01830530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718936|NCT01830530|Vasodilator Agents|vasodilator agents|mesh-ancestor
6718937|NCT01830530|Tocolytic Agents|tocolytic agents|mesh-ancestor
6718938|NCT01830530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6718939|NCT01830556|Cetuximab|cetuximab|mesh-list
6718940|NCT01830556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6718941|NCT01830556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6718942|NCT01830777|Cytarabine|cytarabine|mesh-list
6718943|NCT01830777|Etoposide|etoposide|mesh-list
6718944|NCT01830777|Mitoxantrone|mitoxantrone|mesh-list
6718945|NCT01830777|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6718946|NCT01830777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6718947|NCT01830777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6718948|NCT01830777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6718949|NCT01830777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6718950|NCT01830777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6718951|NCT01830777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718952|NCT01830777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6718953|NCT01830777|Antimetabolites|antimetabolites|mesh-ancestor
6718954|NCT01830777|Antiviral Agents|antiviral agents|mesh-ancestor
6718955|NCT01830777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6718956|NCT01830777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6718957|NCT01830777|Immunologic Factors|immunologic factors|mesh-ancestor
6718958|NCT01830777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718959|NCT01830777|Analgesics|analgesics|mesh-ancestor
6718960|NCT01830777|Sensory System Agents|sensory system agents|mesh-ancestor
6718961|NCT01830777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6718962|NCT01830777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6718963|NCT01830829|Tamsulosin|tamsulosin|mesh-list
6718964|NCT01830829|Dutasteride|dutasteride|mesh-list
6718965|NCT01830829|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6718966|NCT01830829|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6718967|NCT01830829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6718968|NCT01830829|Adrenergic Agents|adrenergic agents|mesh-ancestor
6718969|NCT01830829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6718970|NCT01830829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718971|NCT01830829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718972|NCT01830829|Urological Agents|urological agents|mesh-ancestor
6718973|NCT01830829|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6718974|NCT01830829|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6718975|NCT01830829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6718976|NCT01830829|Hormone Antagonists|hormone antagonists|mesh-ancestor
6718977|NCT01830829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6718978|NCT01830868|Zonisamide|zonisamide|mesh-list
6718979|NCT01830868|Anticonvulsants|anticonvulsants|mesh-ancestor
6718980|NCT01830868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6718981|NCT01830868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6718982|NCT01830868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718983|NCT01830868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6718984|NCT01830868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718985|NCT01830907|Vitamins|vitamins|mesh-list
6718986|NCT01830907|Micronutrients|micronutrients|mesh-ancestor
6718987|NCT01830907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6718988|NCT01830946|Caseins|caseins|mesh-list
6718989|NCT01830946|Chelating Agents|chelating agents|mesh-ancestor
6718990|NCT01830946|Sequestering Agents|sequestering agents|mesh-ancestor
6718991|NCT01830946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6718992|NCT01831011|Aspirin|aspirin|mesh-list
6718993|NCT01831011|Cinepazide|cinepazide|mesh-list
6718994|NCT01831011|3-(2,2,2-trimethylhydrazine)propionate|3-(2,2,2-trimethylhydrazine)propionate|mesh-list
6718995|NCT01831011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6718996|NCT01831011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6718997|NCT01831011|Analgesics|analgesics|mesh-ancestor
6718998|NCT01831011|Sensory System Agents|sensory system agents|mesh-ancestor
6718999|NCT01831011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6719000|NCT01831011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719001|NCT01831011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6719002|NCT01831011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6719003|NCT01831011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6719004|NCT01831011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6719005|NCT01831011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719006|NCT01831011|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6719007|NCT01831011|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6719008|NCT01831011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6719009|NCT01831011|Antipyretics|antipyretics|mesh-ancestor
6719010|NCT01831011|Vasodilator Agents|vasodilator agents|mesh-ancestor
6719011|NCT01831011|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6719012|NCT01831011|Immunologic Factors|immunologic factors|mesh-ancestor
6719013|NCT01831050|Vaccines|vaccines|mesh-list
6719014|NCT01831050|Immunologic Factors|immunologic factors|mesh-ancestor
6719015|NCT01831050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719016|NCT01831193|Curcumin|curcumin|mesh-list
6719017|NCT01831193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6719018|NCT01831193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6719019|NCT01831193|Analgesics|analgesics|mesh-ancestor
6719020|NCT01831193|Sensory System Agents|sensory system agents|mesh-ancestor
6719021|NCT01831193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6719022|NCT01831193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719023|NCT01831193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6719024|NCT01831193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6719025|NCT01831193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6719026|NCT01831193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6719027|NCT01831193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719028|NCT01831323|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6719029|NCT01831323|Rifaximin|rifaximin|mesh-list
6719030|NCT01831323|Mesalamine|mesalamine|mesh-list
6719031|NCT01831323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
6719032|NCT01831323|Psyllium|psyllium|mesh-list
6719033|NCT01831323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6719034|NCT01831323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6719035|NCT01831323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6719036|NCT01831323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6719037|NCT01831323|Analgesics|analgesics|mesh-ancestor
6719038|NCT01831323|Sensory System Agents|sensory system agents|mesh-ancestor
6719039|NCT01831323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6719040|NCT01831323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719041|NCT01831323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6719042|NCT01831323|Cathartics|cathartics|mesh-ancestor
6719043|NCT01831440|Antidepressive Agents|antidepressive agents|mesh-list
6719044|NCT01831440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6719045|NCT01831479|Olmesartan|olmesartan|mesh-list
6719046|NCT01831479|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6719047|NCT01831479|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6719048|NCT01831479|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6719049|NCT01831479|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6719050|NCT01831479|Antimetabolites|antimetabolites|mesh-ancestor
6719051|NCT01831479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719052|NCT01831479|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6719053|NCT01831479|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6719054|NCT01831479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6719055|NCT01831479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6719056|NCT01831479|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6719057|NCT01831479|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6719058|NCT01831505|Prednisolone|prednisolone|mesh-list
6719059|NCT01831505|Rituximab|rituximab|mesh-list
6719060|NCT01831505|Doxorubicin|doxorubicin|mesh-list
6719061|NCT01831505|Vincristine|vincristine|mesh-list
6719062|NCT01831505|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6719063|NCT01831505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6719064|NCT01831505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6719065|NCT01831505|Immunologic Factors|immunologic factors|mesh-ancestor
6719066|NCT01831505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719067|NCT01831505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6719068|NCT01831505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6719069|NCT01831505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6719070|NCT01831505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6719071|NCT01831505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6719072|NCT01831505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719073|NCT01831505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6719074|NCT01831505|Tubulin Modulators|tubulin modulators|mesh-ancestor
6719075|NCT01831505|Antimitotic Agents|antimitotic agents|mesh-ancestor
6719076|NCT01831505|Mitosis Modulators|mitosis modulators|mesh-ancestor
6719077|NCT01831505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6719078|NCT01831505|Glucocorticoids|glucocorticoids|mesh-ancestor
6719079|NCT01831505|Hormones|hormones|mesh-ancestor
6719080|NCT01831505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6719081|NCT01831505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6719082|NCT01831505|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6719083|NCT01831505|Alkylating Agents|alkylating agents|mesh-ancestor
6783961|NCT02200354|Bevacizumab|bevacizumab|mesh-list
6783962|NCT02200354|Pemetrexed|pemetrexed|mesh-list
6783963|NCT02200354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6783964|NCT02200354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6783965|NCT02200354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6783966|NCT02200354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6783967|NCT02200354|Growth Substances|growth substances|mesh-ancestor
6783968|NCT02200354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783969|NCT02200354|Growth Inhibitors|growth inhibitors|mesh-ancestor
6783970|NCT02200354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6783971|NCT02200354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783972|NCT02200354|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6783973|NCT02200354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6783974|NCT02200406|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6783975|NCT02200406|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6783976|NCT02200406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6783977|NCT02200406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6783978|NCT02200406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783979|NCT02200406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6783980|NCT02200406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6783981|NCT02200406|Antidepressive Agents|antidepressive agents|mesh-ancestor
6783982|NCT02200406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6783983|NCT02200562|Ipilimumab|ipilimumab|mesh-list
6783984|NCT02200562|Dabrafenib|dabrafenib|mesh-list
6783985|NCT02200562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6783986|NCT02200562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6783987|NCT02200562|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6783988|NCT02200562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783989|NCT02200562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6783990|NCT02200562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6783991|NCT02200575|Telmisartan|telmisartan|mesh-list
6783992|NCT02200575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6783993|NCT02200575|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6783994|NCT02200575|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6783995|NCT02200575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6783996|NCT02200640|Losartan|losartan|mesh-list
6783997|NCT02200640|Telmisartan|telmisartan|mesh-list
6783998|NCT02200640|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6783999|NCT02200640|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6784000|NCT02200640|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6784001|NCT02200640|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6784002|NCT02200640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784003|NCT02200653|Losartan|losartan|mesh-list
6784004|NCT02200653|Telmisartan|telmisartan|mesh-list
6784005|NCT02200653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6784006|NCT02200653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6784007|NCT02200653|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6784008|NCT02200653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6784009|NCT02200653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784010|NCT02200718|Freund's Adjuvant|freund's adjuvant|mesh-list
6784011|NCT02200718|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6784012|NCT02200718|Immunologic Factors|immunologic factors|mesh-ancestor
6784013|NCT02200718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784014|NCT02200757|Topotecan|topotecan|mesh-list
6784015|NCT02200757|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6784016|NCT02200757|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6784017|NCT02200757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6784018|NCT02200757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784019|NCT02200757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6784020|NCT02200822|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
6784021|NCT02200822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6784022|NCT02200822|Adrenergic Agents|adrenergic agents|mesh-ancestor
6784023|NCT02200822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6784024|NCT02200822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784025|NCT02200822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784026|NCT02200848|Rituximab|rituximab|mesh-list
6784027|NCT02200848|Lenalidomide|lenalidomide|mesh-list
6719084|NCT01831622|Methylphenidate|methylphenidate|mesh-list
6719085|NCT01831622|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6719086|NCT01831622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719087|NCT01831622|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6719088|NCT01831622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6719089|NCT01831622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6719090|NCT01831622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719091|NCT01831622|Dopamine Agents|dopamine agents|mesh-ancestor
6719092|NCT01831622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6719093|NCT01831661|Metformin|metformin|mesh-list
6719094|NCT01831661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6719095|NCT01831661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719096|NCT01831674|Metformin|metformin|mesh-list
6719097|NCT01831674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6719098|NCT01831674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719099|NCT01831687|Etodolac|etodolac|mesh-list
6719100|NCT01831687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6719101|NCT01831687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6719102|NCT01831687|Analgesics|analgesics|mesh-ancestor
6719103|NCT01831687|Sensory System Agents|sensory system agents|mesh-ancestor
6719104|NCT01831687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6719105|NCT01831687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719106|NCT01831687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6719107|NCT01831687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6719108|NCT01831687|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6719109|NCT01831687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6719110|NCT01831687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6719111|NCT01831687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719112|NCT01831700|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6719113|NCT01831700|Lisinopril|lisinopril|mesh-list
6719114|NCT01831700|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
6719115|NCT01831700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6719116|NCT01831700|Diuretics|diuretics|mesh-ancestor
6719117|NCT01831700|Natriuretic Agents|natriuretic agents|mesh-ancestor
6719118|NCT01831700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719119|NCT01831700|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6719120|NCT01831700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6719121|NCT01831700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719122|NCT01831700|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6719123|NCT01831700|Protease Inhibitors|protease inhibitors|mesh-ancestor
6719124|NCT01831700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6719125|NCT01831700|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6719126|NCT01831700|Protective Agents|protective agents|mesh-ancestor
6719127|NCT01831947|Ranibizumab|ranibizumab|mesh-list
6719128|NCT01831947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6719129|NCT01831947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6719130|NCT01831947|Growth Substances|growth substances|mesh-ancestor
6719131|NCT01831947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719132|NCT01831947|Growth Inhibitors|growth inhibitors|mesh-ancestor
6719133|NCT01831947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6719134|NCT01832051|Trastuzumab|trastuzumab|mesh-list
6719135|NCT01832051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6719136|NCT01832051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6719137|NCT01832129|Vitamins|vitamins|mesh-list
6719138|NCT01832129|Hydroxocobalamin|hydroxocobalamin|mesh-list
6719139|NCT01832129|Vitamin B 12|vitamin b 12|mesh-list
6719140|NCT01832129|Vitamin B Complex|vitamin b complex|mesh-list
6719141|NCT01832129|Micronutrients|micronutrients|mesh-ancestor
6719142|NCT01832129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719143|NCT01832129|Hematinics|hematinics|mesh-ancestor
6719144|NCT01832285|Fluvoxamine|fluvoxamine|mesh-list
6719145|NCT01832285|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6719146|NCT01832285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6719147|NCT01832285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6719148|NCT01832285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719149|NCT01832285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6719150|NCT01832285|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6719151|NCT01832285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6719152|NCT01832285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6719153|NCT01832285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719154|NCT01832285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6719155|NCT01832285|Serotonin Agents|serotonin agents|mesh-ancestor
6719156|NCT01832285|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6719157|NCT01832285|Antidepressive Agents|antidepressive agents|mesh-ancestor
6719158|NCT01832285|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6719159|NCT01832285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6719160|NCT01832285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6719161|NCT01832285|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6719162|NCT01832311|Ketorolac|ketorolac|mesh-list
6719163|NCT01832311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6719164|NCT01832311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6719165|NCT01832311|Analgesics|analgesics|mesh-ancestor
6719166|NCT01832311|Sensory System Agents|sensory system agents|mesh-ancestor
6719167|NCT01832311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6719168|NCT01832311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719169|NCT01832311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6719170|NCT01832311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6719171|NCT01832311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6719172|NCT01832311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6719173|NCT01832311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719174|NCT01832350|Quinidine|quinidine|mesh-list
6719175|NCT01832350|Dextromethorphan|dextromethorphan|mesh-list
6719176|NCT01832350|Antitussive Agents|antitussive agents|mesh-ancestor
6719177|NCT01832350|Respiratory System Agents|respiratory system agents|mesh-ancestor
6719178|NCT01832350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6719179|NCT01832350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6719180|NCT01832350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6719181|NCT01832350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719182|NCT01832350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719183|NCT01832350|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6719184|NCT01832350|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6719185|NCT01832350|Adrenergic Agents|adrenergic agents|mesh-ancestor
6719186|NCT01832350|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6719187|NCT01832350|Antimalarials|antimalarials|mesh-ancestor
6719188|NCT01832350|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6719189|NCT01832350|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6719190|NCT01832350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6719191|NCT01832350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6719192|NCT01832350|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6719193|NCT01832350|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6719194|NCT01832350|Cholinergic Agents|cholinergic agents|mesh-ancestor
6719195|NCT01832350|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6719196|NCT01832350|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6719197|NCT01832350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6719198|NCT01832350|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6719199|NCT01832350|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6719200|NCT01832363|Xenon|xenon|mesh-list
6719201|NCT01832363|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6719202|NCT01832363|Anesthetics, General|anesthetics, general|mesh-ancestor
6719203|NCT01832363|Anesthetics|anesthetics|mesh-ancestor
6719204|NCT01832363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6719205|NCT01832363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719206|NCT01832415|Bevacizumab|bevacizumab|mesh-list
6719207|NCT01832415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6719208|NCT01832415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6719209|NCT01832415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6719210|NCT01832415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6719211|NCT01832415|Growth Substances|growth substances|mesh-ancestor
6719212|NCT01832415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719213|NCT01832415|Growth Inhibitors|growth inhibitors|mesh-ancestor
6719214|NCT01832467|Cetuximab|cetuximab|mesh-list
6719215|NCT01832467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6719216|NCT01832467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6719217|NCT01832558|Eplerenone|eplerenone|mesh-list
6719218|NCT01832558|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6719219|NCT01832558|Hormone Antagonists|hormone antagonists|mesh-ancestor
6719220|NCT01832558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6719221|NCT01832558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719222|NCT01832558|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6719223|NCT01832558|Diuretics|diuretics|mesh-ancestor
6719224|NCT01832558|Natriuretic Agents|natriuretic agents|mesh-ancestor
6719225|NCT01832558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6719226|NCT01832571|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6719227|NCT01832571|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6719228|NCT01832571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6719229|NCT01832571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6719230|NCT01832571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719231|NCT01832571|Antiviral Agents|antiviral agents|mesh-ancestor
6719232|NCT01832571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6719233|NCT01832571|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6719234|NCT01832571|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6719235|NCT01832623|Vitamin D|vitamin d|mesh-list
6719236|NCT01832623|Vitamins|vitamins|mesh-ancestor
6719237|NCT01832623|Micronutrients|micronutrients|mesh-ancestor
6719238|NCT01832623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719239|NCT01832623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6719240|NCT01832662|Caffeine|caffeine|mesh-list
6719241|NCT01832662|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6719242|NCT01832662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719243|NCT01832662|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6719244|NCT01832662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6719245|NCT01832662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719246|NCT01832662|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6719247|NCT01832662|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6719248|NCT01832662|Purinergic Agents|purinergic agents|mesh-ancestor
6719249|NCT01832662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6719250|NCT01832675|Bupivacaine|bupivacaine|mesh-list
6719251|NCT01832675|Anesthetics, Local|anesthetics, local|mesh-ancestor
6719252|NCT01832675|Anesthetics|anesthetics|mesh-ancestor
6719253|NCT01832675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6719254|NCT01832675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719255|NCT01832675|Sensory System Agents|sensory system agents|mesh-ancestor
6719256|NCT01832675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6719257|NCT01832870|Ipilimumab|ipilimumab|mesh-list
6719258|NCT01832870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6719259|NCT01832870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6719260|NCT01832870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6719261|NCT01832870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719262|NCT01832896|Ecallantide|ecallantide|mesh-list
6719263|NCT01832896|Analgesics|analgesics|mesh-ancestor
6719264|NCT01832896|Sensory System Agents|sensory system agents|mesh-ancestor
6719265|NCT01832896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6719266|NCT01832896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719267|NCT01832896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6719268|NCT01832896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6719269|NCT01832896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6719270|NCT01832896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6719271|NCT01832922|Rituximab|rituximab|mesh-list
6719272|NCT01832922|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6719273|NCT01832922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6719274|NCT01832922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6719275|NCT01832922|Immunologic Factors|immunologic factors|mesh-ancestor
6719276|NCT01832922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719277|NCT01832922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6719278|NCT01832922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6719279|NCT01832922|Alkylating Agents|alkylating agents|mesh-ancestor
6719280|NCT01832922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719281|NCT01832935|Insulin|insulin|mesh-list
6719282|NCT01832935|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6719283|NCT01832935|Insulin Glargine|insulin glargine|mesh-list
6719284|NCT01832935|Isophane Insulin, Human|isophane insulin, human|mesh-list
6719285|NCT01832935|Insulin, Isophane|insulin, isophane|mesh-list
6719286|NCT01832935|Isophane insulin, beef|isophane insulin, beef|mesh-list
6719287|NCT01832935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6719288|NCT01832935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719289|NCT01832948|Leucovorin|leucovorin|mesh-list
6719290|NCT01832948|Folic Acid|folic acid|mesh-list
6719291|NCT01832948|Oxaliplatin|oxaliplatin|mesh-list
6719292|NCT01832948|Endostar protein|endostar protein|mesh-list
6719293|NCT01832948|Levoleucovorin|levoleucovorin|mesh-list
6719294|NCT01832948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6719295|NCT01832948|Antidotes|antidotes|mesh-ancestor
6719296|NCT01832948|Protective Agents|protective agents|mesh-ancestor
6719297|NCT01832948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719298|NCT01832948|Vitamin B Complex|vitamin b complex|mesh-ancestor
6719299|NCT01832948|Vitamins|vitamins|mesh-ancestor
6719300|NCT01832948|Micronutrients|micronutrients|mesh-ancestor
6719301|NCT01832948|Hematinics|hematinics|mesh-ancestor
6719302|NCT01832948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6719303|NCT01832948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6719304|NCT01832948|Growth Substances|growth substances|mesh-ancestor
6719305|NCT01832948|Growth Inhibitors|growth inhibitors|mesh-ancestor
6719306|NCT01832987|Trimethoprim|trimethoprim|mesh-list
6719307|NCT01832987|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6719308|NCT01832987|Sulfamethoxazole|sulfamethoxazole|mesh-list
6719309|NCT01832987|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6719310|NCT01832987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6719311|NCT01832987|Renal Agents|renal agents|mesh-ancestor
6719312|NCT01832987|Antimalarials|antimalarials|mesh-ancestor
6719313|NCT01832987|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6719314|NCT01832987|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6719315|NCT01832987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6719316|NCT01832987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6719317|NCT01832987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719318|NCT01832987|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6719319|NCT01832987|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6719320|NCT01832987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6719321|NCT01832987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6719322|NCT01833221|Lidocaine|lidocaine|mesh-list
6719323|NCT01833221|Anesthetics, Local|anesthetics, local|mesh-ancestor
6719324|NCT01833221|Anesthetics|anesthetics|mesh-ancestor
6719325|NCT01833221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6719326|NCT01833221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719327|NCT01833221|Sensory System Agents|sensory system agents|mesh-ancestor
6719328|NCT01833221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6719329|NCT01833221|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6719330|NCT01833221|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6719331|NCT01833221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6719332|NCT01833221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6719333|NCT01833221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719334|NCT01833299|Sorafenib|sorafenib|mesh-list
6719335|NCT01833299|Chlorotrianisene|chlorotrianisene|mesh-list
6719336|NCT01833299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6719337|NCT01833299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6719338|NCT01833299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6719339|NCT01833299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719340|NCT01833299|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6719341|NCT01833299|Estrogens|estrogens|mesh-ancestor
6719342|NCT01833299|Hormones|hormones|mesh-ancestor
6719343|NCT01833299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6719344|NCT01833299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719345|NCT01833299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6719346|NCT01833312|Meperidine|meperidine|mesh-list
6719347|NCT01833312|Buspirone|buspirone|mesh-list
6719348|NCT01833312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6719349|NCT01833312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6719350|NCT01833312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6719351|NCT01833312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719352|NCT01833312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6719353|NCT01833312|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6719354|NCT01833312|Serotonin Agents|serotonin agents|mesh-ancestor
6719355|NCT01833312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6719356|NCT01833312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719357|NCT01833312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6719358|NCT01833312|Narcotics|narcotics|mesh-ancestor
6719359|NCT01833312|Analgesics|analgesics|mesh-ancestor
6719360|NCT01833312|Sensory System Agents|sensory system agents|mesh-ancestor
6719361|NCT01833312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6719362|NCT01833312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6784028|NCT02200848|Glutarimide|glutarimide|mesh-list
6784029|NCT02200848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6784030|NCT02200848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6784031|NCT02200848|Immunologic Factors|immunologic factors|mesh-ancestor
6784032|NCT02200848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784033|NCT02200848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6784034|NCT02200848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6784035|NCT02200848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6784036|NCT02200848|Growth Substances|growth substances|mesh-ancestor
6784037|NCT02200848|Growth Inhibitors|growth inhibitors|mesh-ancestor
6784038|NCT02200848|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6784039|NCT02200848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6784040|NCT02200848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784041|NCT02200978|Cytarabine|cytarabine|mesh-list
6784042|NCT02200978|Methotrexate|methotrexate|mesh-list
6784043|NCT02200978|Mercaptopurine|mercaptopurine|mesh-list
6719363|NCT01833351|Vitamins|vitamins|mesh-list
6719364|NCT01833351|Ascorbic Acid|ascorbic acid|mesh-list
6719365|NCT01833351|Micronutrients|micronutrients|mesh-ancestor
6719366|NCT01833351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719367|NCT01833351|Antioxidants|antioxidants|mesh-ancestor
6719368|NCT01833351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719369|NCT01833351|Protective Agents|protective agents|mesh-ancestor
6719370|NCT01833559|Insulin|insulin|mesh-list
6719371|NCT01833559|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6719372|NCT01833559|Isophane Insulin, Human|isophane insulin, human|mesh-list
6719373|NCT01833559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6719374|NCT01833559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719375|NCT01833572|Gefitinib|gefitinib|mesh-list
6719376|NCT01833572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6719377|NCT01833572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6719378|NCT01833572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6719379|NCT01833572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719380|NCT01833611|Entecavir|entecavir|mesh-list
6719381|NCT01833611|Antiviral Agents|antiviral agents|mesh-ancestor
6719382|NCT01833611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6719383|NCT01833663|Solifenacin Succinate|solifenacin succinate|mesh-list
6719384|NCT01833663|Estrogens|estrogens|mesh-list
6719385|NCT01833663|Hormones|hormones|mesh-ancestor
6719386|NCT01833663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6719387|NCT01833663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719388|NCT01833663|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6719389|NCT01833663|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6719390|NCT01833663|Cholinergic Agents|cholinergic agents|mesh-ancestor
6719391|NCT01833663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6719392|NCT01833663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719393|NCT01833663|Urological Agents|urological agents|mesh-ancestor
6719394|NCT01833676|Sevoflurane|sevoflurane|mesh-list
6719395|NCT01833676|Desflurane|desflurane|mesh-list
6719396|NCT01833676|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6719397|NCT01833676|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6719398|NCT01833676|Anesthetics, General|anesthetics, general|mesh-ancestor
6719399|NCT01833676|Anesthetics|anesthetics|mesh-ancestor
6719400|NCT01833676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6719401|NCT01833676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719402|NCT01833715|Morphine|morphine|mesh-list
6719403|NCT01833715|Methadone|methadone|mesh-list
6719404|NCT01833715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6719405|NCT01833715|Narcotics|narcotics|mesh-ancestor
6719406|NCT01833715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6719407|NCT01833715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719408|NCT01833715|Analgesics|analgesics|mesh-ancestor
6719409|NCT01833715|Sensory System Agents|sensory system agents|mesh-ancestor
6719410|NCT01833715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6719411|NCT01833715|Antitussive Agents|antitussive agents|mesh-ancestor
6719412|NCT01833715|Respiratory System Agents|respiratory system agents|mesh-ancestor
6719413|NCT01833728|Acetaminophen|acetaminophen|mesh-list
6719414|NCT01833728|Propacetamol|propacetamol|mesh-list
6719415|NCT01833728|Nefopam|nefopam|mesh-list
6719416|NCT01833728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6719417|NCT01833728|Analgesics|analgesics|mesh-ancestor
6719418|NCT01833728|Sensory System Agents|sensory system agents|mesh-ancestor
6719419|NCT01833728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6719420|NCT01833728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719421|NCT01833728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6719422|NCT01833728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6719423|NCT01833728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6719424|NCT01833728|Antipyretics|antipyretics|mesh-ancestor
6719425|NCT01833767|Cyclophosphamide|cyclophosphamide|mesh-list
6719426|NCT01833767|Interleukin-2|interleukin-2|mesh-list
6719427|NCT01833767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6719428|NCT01833767|Immunologic Factors|immunologic factors|mesh-ancestor
6719429|NCT01833767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719430|NCT01833767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6719431|NCT01833767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6719432|NCT01833767|Alkylating Agents|alkylating agents|mesh-ancestor
6719433|NCT01833767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719434|NCT01833767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6719435|NCT01833767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6719436|NCT01833767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6719437|NCT01833767|Analgesics|analgesics|mesh-ancestor
6719438|NCT01833767|Sensory System Agents|sensory system agents|mesh-ancestor
6719439|NCT01833767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6719440|NCT01833793|Levonorgestrel|levonorgestrel|mesh-list
6719441|NCT01833793|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6719442|NCT01833793|Contraceptive Agents|contraceptive agents|mesh-ancestor
6719443|NCT01833793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6719444|NCT01833793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719445|NCT01833793|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6719446|NCT01833793|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6719447|NCT01833793|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6719448|NCT01833819|Lidocaine|lidocaine|mesh-list
6719449|NCT01833819|Dexmedetomidine|dexmedetomidine|mesh-list
6719450|NCT01833819|Remifentanil|remifentanil|mesh-list
6719451|NCT01833819|Anesthetics, Local|anesthetics, local|mesh-ancestor
6719452|NCT01833819|Anesthetics|anesthetics|mesh-ancestor
6719453|NCT01833819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6719454|NCT01833819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719455|NCT01833819|Sensory System Agents|sensory system agents|mesh-ancestor
6719456|NCT01833819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6719457|NCT01833819|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6719458|NCT01833819|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6719459|NCT01833819|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6719460|NCT01833819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6719461|NCT01833819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719462|NCT01833819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6719463|NCT01833819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6719464|NCT01833819|Analgesics|analgesics|mesh-ancestor
6719465|NCT01833819|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6719466|NCT01833819|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6719467|NCT01833819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6719468|NCT01833819|Adrenergic Agents|adrenergic agents|mesh-ancestor
6719469|NCT01833819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6719470|NCT01833819|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6719471|NCT01833819|Narcotics|narcotics|mesh-ancestor
6719472|NCT01833858|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6719473|NCT01833858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6719474|NCT01833858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719475|NCT01834014|Bevacizumab|bevacizumab|mesh-list
6719476|NCT01834014|Cetuximab|cetuximab|mesh-list
6719477|NCT01834014|Fluorouracil|fluorouracil|mesh-list
6719478|NCT01834014|Oxaliplatin|oxaliplatin|mesh-list
6719479|NCT01834014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6719480|NCT01834014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6719481|NCT01834014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6719482|NCT01834014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6719483|NCT01834014|Growth Substances|growth substances|mesh-ancestor
6719484|NCT01834014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719485|NCT01834014|Growth Inhibitors|growth inhibitors|mesh-ancestor
6719486|NCT01834014|Antimetabolites|antimetabolites|mesh-ancestor
6719487|NCT01834014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719488|NCT01834014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6719489|NCT01834014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6719490|NCT01834014|Immunologic Factors|immunologic factors|mesh-ancestor
6719491|NCT01834170|Gemcitabine|gemcitabine|mesh-list
6719492|NCT01834170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6719493|NCT01834170|Antimetabolites|antimetabolites|mesh-ancestor
6719494|NCT01834170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719495|NCT01834170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6719496|NCT01834170|Antiviral Agents|antiviral agents|mesh-ancestor
6719497|NCT01834170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6719498|NCT01834170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6719499|NCT01834170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6719500|NCT01834170|Immunologic Factors|immunologic factors|mesh-ancestor
6719501|NCT01834170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719502|NCT01834183|Gemcitabine|gemcitabine|mesh-list
6719503|NCT01834183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6719504|NCT01834183|Antimetabolites|antimetabolites|mesh-ancestor
6719505|NCT01834183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719506|NCT01834183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6719507|NCT01834183|Antiviral Agents|antiviral agents|mesh-ancestor
6719508|NCT01834183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6719509|NCT01834183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6719510|NCT01834183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6719511|NCT01834183|Immunologic Factors|immunologic factors|mesh-ancestor
6719512|NCT01834183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719513|NCT01834209|Prednisone|prednisone|mesh-list
6719514|NCT01834209|Prednisolone|prednisolone|mesh-list
6719515|NCT01834209|Abiraterone Acetate|abiraterone acetate|mesh-list
6719516|NCT01834209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6719517|NCT01834209|Glucocorticoids|glucocorticoids|mesh-ancestor
6719518|NCT01834209|Hormones|hormones|mesh-ancestor
6719519|NCT01834209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6719520|NCT01834209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719521|NCT01834209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6719522|NCT01834209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6719523|NCT01834209|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6719524|NCT01834209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6719525|NCT01834209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719526|NCT01834209|Hormone Antagonists|hormone antagonists|mesh-ancestor
6719527|NCT01834209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6719528|NCT01834235|Gemcitabine|gemcitabine|mesh-list
6719529|NCT01834235|Paclitaxel|paclitaxel|mesh-list
6719530|NCT01834235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6719531|NCT01834235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6719532|NCT01834235|Tubulin Modulators|tubulin modulators|mesh-ancestor
6719533|NCT01834235|Antimitotic Agents|antimitotic agents|mesh-ancestor
6719534|NCT01834235|Mitosis Modulators|mitosis modulators|mesh-ancestor
6719535|NCT01834235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719536|NCT01834235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6719537|NCT01834235|Antimetabolites|antimetabolites|mesh-ancestor
6719538|NCT01834235|Antiviral Agents|antiviral agents|mesh-ancestor
6719539|NCT01834235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6719540|NCT01834235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6719541|NCT01834235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6719542|NCT01834235|Immunologic Factors|immunologic factors|mesh-ancestor
6719543|NCT01834235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719544|NCT01834248|Poly I-C|poly i-c|mesh-list
6719545|NCT01834248|Decitabine|decitabine|mesh-list
6719546|NCT01834248|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6719547|NCT01834248|Poly ICLC|poly iclc|mesh-list
6719548|NCT01834248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6719549|NCT01834248|Antimetabolites|antimetabolites|mesh-ancestor
6719550|NCT01834248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719551|NCT01834248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6719552|NCT01834248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6719553|NCT01834248|Interferon Inducers|interferon inducers|mesh-ancestor
6719554|NCT01834248|Immunologic Factors|immunologic factors|mesh-ancestor
6719555|NCT01834248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719556|NCT01834248|Laxatives|laxatives|mesh-ancestor
6719557|NCT01834248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6719558|NCT01834248|Antiviral Agents|antiviral agents|mesh-ancestor
6719559|NCT01834248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6719560|NCT01834508|Entecavir|entecavir|mesh-list
6719561|NCT01834508|Adefovir|adefovir|mesh-list
6719562|NCT01834508|Antiviral Agents|antiviral agents|mesh-ancestor
6719563|NCT01834508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6719564|NCT01834508|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6719565|NCT01834508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6719566|NCT01834508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6719567|NCT01834508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719568|NCT01834547|Methylphenidate|methylphenidate|mesh-list
6719569|NCT01834547|Caffeine|caffeine|mesh-list
6719570|NCT01834547|Modafinil|modafinil|mesh-list
6719571|NCT01834547|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6719572|NCT01834547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719573|NCT01834547|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6719574|NCT01834547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6719575|NCT01834547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6719576|NCT01834547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719577|NCT01834547|Dopamine Agents|dopamine agents|mesh-ancestor
6719578|NCT01834547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6719579|NCT01834547|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6719580|NCT01834547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6719581|NCT01834547|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6719582|NCT01834547|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6719583|NCT01834547|Purinergic Agents|purinergic agents|mesh-ancestor
6719584|NCT01834547|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6719585|NCT01834547|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6719586|NCT01834547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6719587|NCT01834768|Eplerenone|eplerenone|mesh-list
6719588|NCT01834768|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6719589|NCT01834768|Hormone Antagonists|hormone antagonists|mesh-ancestor
6719590|NCT01834768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6719591|NCT01834768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719592|NCT01834768|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6719593|NCT01834768|Diuretics|diuretics|mesh-ancestor
6719594|NCT01834768|Natriuretic Agents|natriuretic agents|mesh-ancestor
6719595|NCT01834768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6719596|NCT01834820|Dexamethasone|dexamethasone|mesh-list
6719597|NCT01834820|Epinephrine|epinephrine|mesh-list
6719598|NCT01834820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6719599|NCT01834820|Antiemetics|antiemetics|mesh-ancestor
6719600|NCT01834820|Autonomic Agents|autonomic agents|mesh-ancestor
6719601|NCT01834820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6719602|NCT01834820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719603|NCT01834820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6719604|NCT01834820|Glucocorticoids|glucocorticoids|mesh-ancestor
6719605|NCT01834820|Hormones|hormones|mesh-ancestor
6719606|NCT01834820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6719607|NCT01834820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6719608|NCT01834820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6719609|NCT01834820|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6719610|NCT01834820|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6719611|NCT01834820|Adrenergic Agents|adrenergic agents|mesh-ancestor
6719612|NCT01834820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6719613|NCT01834820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719614|NCT01834820|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6719615|NCT01834820|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6719616|NCT01834820|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6719617|NCT01834820|Respiratory System Agents|respiratory system agents|mesh-ancestor
6719618|NCT01834820|Mydriatics|mydriatics|mesh-ancestor
6719619|NCT01834820|Sympathomimetics|sympathomimetics|mesh-ancestor
6719620|NCT01834820|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6719621|NCT01834885|Fluticasone|fluticasone|mesh-list
6719622|NCT01834885|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6719623|NCT01834885|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6719624|NCT01834885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6719625|NCT01834885|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6719626|NCT01834885|Autonomic Agents|autonomic agents|mesh-ancestor
6719627|NCT01834885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6719628|NCT01834885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719629|NCT01834885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6719630|NCT01834885|Respiratory System Agents|respiratory system agents|mesh-ancestor
6719631|NCT01834885|Dermatologic Agents|dermatologic agents|mesh-ancestor
6719632|NCT01834885|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6719633|NCT01834885|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6719634|NCT01834885|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6719635|NCT01834885|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6719636|NCT01834885|Adrenergic Agents|adrenergic agents|mesh-ancestor
6719637|NCT01834885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6719638|NCT01834885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719639|NCT01834885|Glucocorticoids|glucocorticoids|mesh-ancestor
6719640|NCT01834885|Hormones|hormones|mesh-ancestor
6719641|NCT01834885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6719642|NCT01834885|Sympathomimetics|sympathomimetics|mesh-ancestor
6719643|NCT01834898|Oxycodone|oxycodone|mesh-list
6719644|NCT01834898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6719645|NCT01834898|Narcotics|narcotics|mesh-ancestor
6719646|NCT01834898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6719647|NCT01834898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719648|NCT01834898|Analgesics|analgesics|mesh-ancestor
6719649|NCT01834898|Sensory System Agents|sensory system agents|mesh-ancestor
6719650|NCT01834898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6719651|NCT01834911|Tetrabenazine|tetrabenazine|mesh-list
6719652|NCT01834911|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6719653|NCT01834911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6719654|NCT01834911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6719655|NCT01834911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719656|NCT01834911|Adrenergic Agents|adrenergic agents|mesh-ancestor
6719657|NCT01834911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6719658|NCT01834911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719659|NCT01834963|Interferons|interferons|mesh-list
6719660|NCT01834963|Interferon-alpha|interferon-alpha|mesh-list
6719661|NCT01834963|Cisplatin|cisplatin|mesh-list
6719662|NCT01834963|Fluorouracil|fluorouracil|mesh-list
6719663|NCT01834963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6719664|NCT01834963|Antimetabolites|antimetabolites|mesh-ancestor
6719665|NCT01834963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719666|NCT01834963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6719667|NCT01834963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6719668|NCT01834963|Immunologic Factors|immunologic factors|mesh-ancestor
6719669|NCT01834963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719670|NCT01834963|Antiviral Agents|antiviral agents|mesh-ancestor
6719671|NCT01834963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6719672|NCT01834989|Mitogens|mitogens|mesh-list
6719673|NCT01834989|Mitosis Modulators|mitosis modulators|mesh-ancestor
6719674|NCT01834989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784044|NCT02200978|Mitoxantrone|mitoxantrone|mesh-list
6784045|NCT02200978|Tretinoin|tretinoin|mesh-list
6784046|NCT02200978|Arsenic Trioxide|arsenic trioxide|mesh-list
6784047|NCT02200978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6784048|NCT02200978|Abortifacient Agents|abortifacient agents|mesh-ancestor
6784049|NCT02200978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6784050|NCT02200978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784051|NCT02200978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6784052|NCT02200978|Antimetabolites|antimetabolites|mesh-ancestor
6784053|NCT02200978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784054|NCT02200978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6784055|NCT02200978|Dermatologic Agents|dermatologic agents|mesh-ancestor
6784056|NCT02200978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6784057|NCT02200978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6784058|NCT02200978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6784059|NCT02200978|Immunologic Factors|immunologic factors|mesh-ancestor
6784060|NCT02200978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6784061|NCT02200978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6784062|NCT02200978|Antiviral Agents|antiviral agents|mesh-ancestor
6784063|NCT02200978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6784064|NCT02200978|Analgesics|analgesics|mesh-ancestor
6784065|NCT02200978|Sensory System Agents|sensory system agents|mesh-ancestor
6784066|NCT02200978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6784067|NCT02200978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6784068|NCT02200978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6784069|NCT02200978|Keratolytic Agents|keratolytic agents|mesh-ancestor
6784070|NCT02200991|Insulin Glargine|insulin glargine|mesh-list
6784071|NCT02200991|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6784072|NCT02200991|Lixisenatide|lixisenatide|mesh-list
6784073|NCT02200991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6784074|NCT02200991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784075|NCT02200991|Incretins|incretins|mesh-ancestor
6784076|NCT02200991|Hormones|hormones|mesh-ancestor
6784077|NCT02200991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6784078|NCT02200991|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6784079|NCT02200991|Protease Inhibitors|protease inhibitors|mesh-ancestor
6784080|NCT02200991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6784081|NCT02200991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784082|NCT02201004|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
6784083|NCT02201004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6784084|NCT02201004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784085|NCT02201004|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6784086|NCT02201004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784087|NCT02201030|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6784088|NCT02201030|Immunologic Factors|immunologic factors|mesh-ancestor
6784089|NCT02201030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784090|NCT02201043|Thalidomide|thalidomide|mesh-list
6784091|NCT02201043|Tolnaftate|tolnaftate|mesh-list
6784092|NCT02201043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6784093|NCT02201043|Immunologic Factors|immunologic factors|mesh-ancestor
6784094|NCT02201043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784095|NCT02201043|Leprostatic Agents|leprostatic agents|mesh-ancestor
6784096|NCT02201043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6784097|NCT02201043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6784098|NCT02201043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6784099|NCT02201043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6784100|NCT02201043|Growth Substances|growth substances|mesh-ancestor
6784101|NCT02201043|Growth Inhibitors|growth inhibitors|mesh-ancestor
6784102|NCT02201043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6784103|NCT02201043|Antifungal Agents|antifungal agents|mesh-ancestor
6784104|NCT02201082|Amikacin|amikacin|mesh-list
6719675|NCT01835067|Ranibizumab|ranibizumab|mesh-list
6719676|NCT01835067|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6719677|NCT01835067|Plasminogen|plasminogen|mesh-list
6719678|NCT01835067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6719679|NCT01835067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6719680|NCT01835067|Growth Substances|growth substances|mesh-ancestor
6719681|NCT01835067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719682|NCT01835067|Growth Inhibitors|growth inhibitors|mesh-ancestor
6719683|NCT01835067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6719684|NCT01835067|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6719685|NCT01835067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6719686|NCT01835067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719687|NCT01835184|Vemurafenib|vemurafenib|mesh-list
6719688|NCT01835184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6719689|NCT01835184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6719690|NCT01835184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6719691|NCT01835184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719692|NCT01835197|Abrocitinib|abrocitinib|mesh-list
6719693|NCT01835197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6719694|NCT01835197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6719695|NCT01835197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719696|NCT01835236|Paclitaxel|paclitaxel|mesh-list
6719697|NCT01835236|Vinorelbine|vinorelbine|mesh-list
6719698|NCT01835236|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
6719699|NCT01835236|Trastuzumab|trastuzumab|mesh-list
6719700|NCT01835236|Pertuzumab|pertuzumab|mesh-list
6719701|NCT01835236|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6719702|NCT01835236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6719703|NCT01835236|Tubulin Modulators|tubulin modulators|mesh-ancestor
6719704|NCT01835236|Antimitotic Agents|antimitotic agents|mesh-ancestor
6719705|NCT01835236|Mitosis Modulators|mitosis modulators|mesh-ancestor
6719706|NCT01835236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719707|NCT01835236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6719708|NCT01835288|Arsenic Trioxide|arsenic trioxide|mesh-list
6719709|NCT01835288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6719710|NCT01835314|Stiripentol|stiripentol|mesh-list
6719711|NCT01835314|Anticonvulsants|anticonvulsants|mesh-ancestor
6719712|NCT01835340|Anesthetics|anesthetics|mesh-list
6719713|NCT01835340|Propofol|propofol|mesh-list
6719714|NCT01835340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6719715|NCT01835340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719716|NCT01835340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6719717|NCT01835340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6719718|NCT01835340|Anesthetics, General|anesthetics, general|mesh-ancestor
6719719|NCT01835353|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6719720|NCT01835353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6719721|NCT01835418|Amlodipine|amlodipine|mesh-list
6719722|NCT01835418|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6719723|NCT01835418|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6719724|NCT01835418|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6719725|NCT01835418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719726|NCT01835418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6719727|NCT01835418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719728|NCT01835418|Vasodilator Agents|vasodilator agents|mesh-ancestor
6719729|NCT01835561|Thalidomide|thalidomide|mesh-list
6719730|NCT01835561|Pomalidomide|pomalidomide|mesh-list
6719731|NCT01835561|Immunologic Factors|immunologic factors|mesh-ancestor
6719732|NCT01835561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719733|NCT01835561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6719734|NCT01835561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6719735|NCT01835561|Growth Substances|growth substances|mesh-ancestor
6719736|NCT01835561|Growth Inhibitors|growth inhibitors|mesh-ancestor
6719737|NCT01835561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6719738|NCT01835561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6719739|NCT01835561|Leprostatic Agents|leprostatic agents|mesh-ancestor
6719740|NCT01835561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6719741|NCT01835561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6719742|NCT01835639|Vitamin D|vitamin d|mesh-list
6719743|NCT01835639|Cholecalciferol|cholecalciferol|mesh-list
6719744|NCT01835639|Vitamins|vitamins|mesh-ancestor
6719745|NCT01835639|Micronutrients|micronutrients|mesh-ancestor
6719746|NCT01835639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719747|NCT01835639|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6719748|NCT01835639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6719749|NCT01835665|Nimodipine|nimodipine|mesh-list
6719750|NCT01835665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6719751|NCT01835665|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6719752|NCT01835665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6719753|NCT01835665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719754|NCT01835665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6719755|NCT01835665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719756|NCT01835665|Vasodilator Agents|vasodilator agents|mesh-ancestor
6719757|NCT01835678|Linagliptin|linagliptin|mesh-list
6719758|NCT01835678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6719759|NCT01835678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719760|NCT01835678|Incretins|incretins|mesh-ancestor
6719761|NCT01835678|Hormones|hormones|mesh-ancestor
6719762|NCT01835678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6719763|NCT01835678|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6719764|NCT01835678|Protease Inhibitors|protease inhibitors|mesh-ancestor
6719765|NCT01835678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6719766|NCT01835678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719767|NCT01835691|Vitamin D|vitamin d|mesh-list
6719768|NCT01835691|Ergocalciferols|ergocalciferols|mesh-list
6719769|NCT01835691|Cholecalciferol|cholecalciferol|mesh-list
6719770|NCT01835691|Vitamins|vitamins|mesh-list
6719771|NCT01835691|Micronutrients|micronutrients|mesh-ancestor
6719772|NCT01835691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719773|NCT01835691|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6719774|NCT01835691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6719775|NCT01835938|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6719776|NCT01835938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6719777|NCT01835938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6719778|NCT01835938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6719779|NCT01835938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719780|NCT01836016|Fluticasone|fluticasone|mesh-list
6719781|NCT01836016|Xhance|xhance|mesh-list
6719782|NCT01836016|Albuterol|albuterol|mesh-list
6719783|NCT01836016|Formoterol Fumarate|formoterol fumarate|mesh-list
6719784|NCT01836016|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6719785|NCT01836016|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6719786|NCT01836016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6719787|NCT01836016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6719788|NCT01836016|Autonomic Agents|autonomic agents|mesh-ancestor
6719789|NCT01836016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6719790|NCT01836016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719791|NCT01836016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6719792|NCT01836016|Respiratory System Agents|respiratory system agents|mesh-ancestor
6719793|NCT01836016|Dermatologic Agents|dermatologic agents|mesh-ancestor
6719794|NCT01836016|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6719795|NCT01836016|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6719796|NCT01836016|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6719797|NCT01836016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6719798|NCT01836016|Adrenergic Agents|adrenergic agents|mesh-ancestor
6719799|NCT01836016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6719800|NCT01836016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719801|NCT01836016|Tocolytic Agents|tocolytic agents|mesh-ancestor
6719802|NCT01836016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6719803|NCT01836016|Glucocorticoids|glucocorticoids|mesh-ancestor
6719804|NCT01836016|Hormones|hormones|mesh-ancestor
6719805|NCT01836016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6719806|NCT01836016|Sympathomimetics|sympathomimetics|mesh-ancestor
6719807|NCT01836094|Methylene Blue|methylene blue|mesh-list
6719808|NCT01836094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6719809|NCT01836094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719810|NCT01836120|Docetaxel|docetaxel|mesh-list
6719811|NCT01836120|Raltitrexed|raltitrexed|mesh-list
6719812|NCT01836120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6719813|NCT01836120|Tubulin Modulators|tubulin modulators|mesh-ancestor
6719814|NCT01836120|Antimitotic Agents|antimitotic agents|mesh-ancestor
6719815|NCT01836120|Mitosis Modulators|mitosis modulators|mesh-ancestor
6719816|NCT01836120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719817|NCT01836120|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6719818|NCT01836120|Antimetabolites|antimetabolites|mesh-ancestor
6719819|NCT01836120|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6719820|NCT01836120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6719821|NCT01836224|Terlipressin|terlipressin|mesh-list
6719822|NCT01836224|Norepinephrine|norepinephrine|mesh-list
6719823|NCT01836224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6719824|NCT01836224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6719825|NCT01836224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6719826|NCT01836224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6719827|NCT01836224|Adrenergic Agents|adrenergic agents|mesh-ancestor
6719828|NCT01836224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6719829|NCT01836224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719830|NCT01836224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719831|NCT01836224|Sympathomimetics|sympathomimetics|mesh-ancestor
6719832|NCT01836224|Autonomic Agents|autonomic agents|mesh-ancestor
6719833|NCT01836224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6719834|NCT01836289|Cyclophosphamide|cyclophosphamide|mesh-list
6719835|NCT01836289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6719836|NCT01836289|Immunologic Factors|immunologic factors|mesh-ancestor
6719837|NCT01836289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719838|NCT01836289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6719839|NCT01836289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6719840|NCT01836289|Alkylating Agents|alkylating agents|mesh-ancestor
6719841|NCT01836289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719842|NCT01836289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6719843|NCT01836289|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6719844|NCT01836328|Methadone|methadone|mesh-list
6719845|NCT01836328|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6719846|NCT01836328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6719847|NCT01836328|Narcotics|narcotics|mesh-ancestor
6719848|NCT01836328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6719849|NCT01836328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719850|NCT01836328|Analgesics|analgesics|mesh-ancestor
6719851|NCT01836328|Sensory System Agents|sensory system agents|mesh-ancestor
6719852|NCT01836328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6719853|NCT01836328|Antitussive Agents|antitussive agents|mesh-ancestor
6719854|NCT01836328|Respiratory System Agents|respiratory system agents|mesh-ancestor
6719855|NCT01836341|Carboplatin|carboplatin|mesh-list
6719856|NCT01836341|Pemetrexed|pemetrexed|mesh-list
6719857|NCT01836341|Afatinib|afatinib|mesh-list
6719858|NCT01836341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6719859|NCT01836341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6719860|NCT01836341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719861|NCT01836341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6719862|NCT01836341|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6719863|NCT01836341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6719864|NCT01836406|Ketorolac|ketorolac|mesh-list
6719865|NCT01836406|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6719866|NCT01836406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6719867|NCT01836406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6719868|NCT01836406|Analgesics|analgesics|mesh-ancestor
6719869|NCT01836406|Sensory System Agents|sensory system agents|mesh-ancestor
6719870|NCT01836406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6719871|NCT01836406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719872|NCT01836406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6719873|NCT01836406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6719874|NCT01836406|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6719875|NCT01836406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6719876|NCT01836406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719877|NCT01836484|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6719878|NCT01836484|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6719879|NCT01836484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719880|NCT01836536|Bevacizumab|bevacizumab|mesh-list
6719881|NCT01836536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6719882|NCT01836536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6719883|NCT01836536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6719884|NCT01836536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6719885|NCT01836536|Growth Substances|growth substances|mesh-ancestor
6719886|NCT01836536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719887|NCT01836536|Growth Inhibitors|growth inhibitors|mesh-ancestor
6719888|NCT01836575|Carboplatin|carboplatin|mesh-list
6719889|NCT01836575|Pemetrexed|pemetrexed|mesh-list
6719890|NCT01836575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6719891|NCT01836575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6719892|NCT01836575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719893|NCT01836575|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6719894|NCT01836575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6719895|NCT01836614|Lidocaine|lidocaine|mesh-list
6719896|NCT01836614|Anesthetics, Local|anesthetics, local|mesh-ancestor
6719897|NCT01836614|Anesthetics|anesthetics|mesh-ancestor
6719898|NCT01836614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6719899|NCT01836614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719900|NCT01836614|Sensory System Agents|sensory system agents|mesh-ancestor
6719901|NCT01836614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6719902|NCT01836614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6719903|NCT01836614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6719904|NCT01836614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6719905|NCT01836614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6719906|NCT01836614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719907|NCT01836653|Bevacizumab|bevacizumab|mesh-list
6719908|NCT01836653|Cetuximab|cetuximab|mesh-list
6719909|NCT01836653|Fluorouracil|fluorouracil|mesh-list
6719910|NCT01836653|Oxaliplatin|oxaliplatin|mesh-list
6719911|NCT01836653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6719912|NCT01836653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6719913|NCT01836653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6719914|NCT01836653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6719915|NCT01836653|Growth Substances|growth substances|mesh-ancestor
6719916|NCT01836653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719917|NCT01836653|Growth Inhibitors|growth inhibitors|mesh-ancestor
6719918|NCT01836653|Antimetabolites|antimetabolites|mesh-ancestor
6719919|NCT01836653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719920|NCT01836653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6719921|NCT01836653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6719922|NCT01836653|Immunologic Factors|immunologic factors|mesh-ancestor
6719923|NCT01836679|Paclitaxel|paclitaxel|mesh-list
6719924|NCT01836679|Carboplatin|carboplatin|mesh-list
6719925|NCT01836679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6719926|NCT01836679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6719927|NCT01836679|Tubulin Modulators|tubulin modulators|mesh-ancestor
6719928|NCT01836679|Antimitotic Agents|antimitotic agents|mesh-ancestor
6719929|NCT01836679|Mitosis Modulators|mitosis modulators|mesh-ancestor
6719930|NCT01836679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784105|NCT02201082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6784106|NCT02201082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6784107|NCT02201121|Phenylephrine|phenylephrine|mesh-list
6784108|NCT02201121|Dopamine|dopamine|mesh-list
6784109|NCT02201121|Oxymetazoline|oxymetazoline|mesh-list
6784110|NCT02201121|Ephedrine|ephedrine|mesh-list
6784111|NCT02201121|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6784112|NCT02201121|Mydriatics|mydriatics|mesh-ancestor
6784113|NCT02201121|Autonomic Agents|autonomic agents|mesh-ancestor
6784114|NCT02201121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6784115|NCT02201121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784116|NCT02201121|Sympathomimetics|sympathomimetics|mesh-ancestor
6784117|NCT02201121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6784118|NCT02201121|Nasal Decongestants|nasal decongestants|mesh-ancestor
6784119|NCT02201121|Respiratory System Agents|respiratory system agents|mesh-ancestor
6784120|NCT02201121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6784121|NCT02201121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6784122|NCT02201121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6784123|NCT02201121|Adrenergic Agents|adrenergic agents|mesh-ancestor
6784124|NCT02201121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6784125|NCT02201121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784126|NCT02201121|Protective Agents|protective agents|mesh-ancestor
6784127|NCT02201121|Dopamine Agents|dopamine agents|mesh-ancestor
6784128|NCT02201121|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6784129|NCT02201134|Sevoflurane|sevoflurane|mesh-list
6784130|NCT02201134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6784131|NCT02201134|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6784132|NCT02201134|Anesthetics, General|anesthetics, general|mesh-ancestor
6784133|NCT02201134|Anesthetics|anesthetics|mesh-ancestor
6784134|NCT02201134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6784135|NCT02201134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784136|NCT02201199|Insulin|insulin|mesh-list
6784137|NCT02201199|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6784138|NCT02201199|Insulin Glargine|insulin glargine|mesh-list
6784139|NCT02201199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6784140|NCT02201199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784141|NCT02201225|Micronutrients|micronutrients|mesh-list
6784142|NCT02201225|Trace Elements|trace elements|mesh-list
6784143|NCT02201225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784144|NCT02201238|Diclofenac|diclofenac|mesh-list
6784145|NCT02201238|Menthol|menthol|mesh-list
6784146|NCT02201238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6784147|NCT02201238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6784148|NCT02201238|Analgesics|analgesics|mesh-ancestor
6784149|NCT02201238|Sensory System Agents|sensory system agents|mesh-ancestor
6784150|NCT02201238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6784151|NCT02201238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784152|NCT02201238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6784153|NCT02201238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6784154|NCT02201238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6784155|NCT02201238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6784156|NCT02201238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784157|NCT02201238|Antipruritics|antipruritics|mesh-ancestor
6784158|NCT02201238|Dermatologic Agents|dermatologic agents|mesh-ancestor
6784159|NCT02201316|Mosapride|mosapride|mesh-list
6784160|NCT02201316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719931|NCT01836757|Dimethyl sulfone|dimethyl sulfone|mesh-list
6719932|NCT01836757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6719933|NCT01836900|Hemostatics|hemostatics|mesh-list
6719934|NCT01836900|Coagulants|coagulants|mesh-ancestor
6719935|NCT01837043|Cyclosporine|cyclosporine|mesh-list
6719936|NCT01837043|Abatacept|abatacept|mesh-list
6719937|NCT01837043|Tacrolimus|tacrolimus|mesh-list
6719938|NCT01837043|Cyclosporins|cyclosporins|mesh-list
6719939|NCT01837043|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
6719940|NCT01837043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6719941|NCT01837043|Immunologic Factors|immunologic factors|mesh-ancestor
6719942|NCT01837043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719943|NCT01837043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6719944|NCT01837043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719945|NCT01837043|Antifungal Agents|antifungal agents|mesh-ancestor
6719946|NCT01837043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6719947|NCT01837043|Dermatologic Agents|dermatologic agents|mesh-ancestor
6719948|NCT01837043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6719949|NCT01837043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6719950|NCT01837043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6719951|NCT01837108|Eplerenone|eplerenone|mesh-list
6719952|NCT01837108|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6719953|NCT01837108|Hormone Antagonists|hormone antagonists|mesh-ancestor
6719954|NCT01837108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6719955|NCT01837108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719956|NCT01837108|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6719957|NCT01837108|Diuretics|diuretics|mesh-ancestor
6719958|NCT01837108|Natriuretic Agents|natriuretic agents|mesh-ancestor
6719959|NCT01837108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6719960|NCT01837199|Amoxicillin|amoxicillin|mesh-list
6719961|NCT01837199|Metronidazole|metronidazole|mesh-list
6719962|NCT01837199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6719963|NCT01837199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6719964|NCT01837199|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6719965|NCT01837199|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6719966|NCT01837251|Bevacizumab|bevacizumab|mesh-list
6719967|NCT01837251|Carboplatin|carboplatin|mesh-list
6719968|NCT01837251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6719969|NCT01837251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6719970|NCT01837251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6719971|NCT01837251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6719972|NCT01837251|Growth Substances|growth substances|mesh-ancestor
6719973|NCT01837251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6719974|NCT01837251|Growth Inhibitors|growth inhibitors|mesh-ancestor
6719975|NCT01837277|Efavirenz|efavirenz|mesh-list
6719976|NCT01837277|Dolutegravir|dolutegravir|mesh-list
6719977|NCT01837277|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6719978|NCT01837277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6719979|NCT01837277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6719980|NCT01837277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6719981|NCT01837277|Antiviral Agents|antiviral agents|mesh-ancestor
6719982|NCT01837277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6719983|NCT01837277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6719984|NCT01837277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6719985|NCT01837277|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6719986|NCT01837277|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6719987|NCT01837277|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6719988|NCT01837277|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6719989|NCT01837277|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6719990|NCT01837277|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6719991|NCT01837277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6719992|NCT01837277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6719993|NCT01837290|Midazolam|midazolam|mesh-list
6719994|NCT01837290|Dexmedetomidine|dexmedetomidine|mesh-list
6719995|NCT01837290|Bupivacaine|bupivacaine|mesh-list
6719996|NCT01837290|Anesthetics, Local|anesthetics, local|mesh-ancestor
6719997|NCT01837290|Anesthetics|anesthetics|mesh-ancestor
6719998|NCT01837290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6719999|NCT01837290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720000|NCT01837290|Sensory System Agents|sensory system agents|mesh-ancestor
6720001|NCT01837290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6720002|NCT01837290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6720003|NCT01837290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6720004|NCT01837290|Analgesics|analgesics|mesh-ancestor
6720005|NCT01837290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6720006|NCT01837290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6720007|NCT01837290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6720008|NCT01837290|Adrenergic Agents|adrenergic agents|mesh-ancestor
6720009|NCT01837290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6720010|NCT01837290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720011|NCT01837290|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6720012|NCT01837290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6720013|NCT01837290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6720014|NCT01837290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6720015|NCT01837290|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6720016|NCT01837290|Anesthetics, General|anesthetics, general|mesh-ancestor
6720017|NCT01837290|GABA Modulators|gaba modulators|mesh-ancestor
6720018|NCT01837290|GABA Agents|gaba agents|mesh-ancestor
6720019|NCT01837329|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
6720020|NCT01837329|Chelating Agents|chelating agents|mesh-ancestor
6720021|NCT01837329|Sequestering Agents|sequestering agents|mesh-ancestor
6720022|NCT01837329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720023|NCT01837329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6720024|NCT01837329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6720025|NCT01837329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6720026|NCT01837329|Growth Substances|growth substances|mesh-ancestor
6720027|NCT01837329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720028|NCT01837329|Growth Inhibitors|growth inhibitors|mesh-ancestor
6720029|NCT01837329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6720030|NCT01837394|Acetaminophen|acetaminophen|mesh-list
6720031|NCT01837394|Morphine|morphine|mesh-list
6720032|NCT01837394|Ondansetron|ondansetron|mesh-list
6720033|NCT01837394|Metoclopramide|metoclopramide|mesh-list
6720034|NCT01837394|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6720035|NCT01837394|Narcotics|narcotics|mesh-ancestor
6720036|NCT01837394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6720037|NCT01837394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720038|NCT01837394|Analgesics|analgesics|mesh-ancestor
6720039|NCT01837394|Sensory System Agents|sensory system agents|mesh-ancestor
6720040|NCT01837394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6720041|NCT01837394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6720042|NCT01837394|Antipyretics|antipyretics|mesh-ancestor
6720043|NCT01837394|Antiemetics|antiemetics|mesh-ancestor
6720044|NCT01837394|Autonomic Agents|autonomic agents|mesh-ancestor
6720045|NCT01837394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6720046|NCT01837394|Antipruritics|antipruritics|mesh-ancestor
6720047|NCT01837394|Dermatologic Agents|dermatologic agents|mesh-ancestor
6720048|NCT01837394|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6720049|NCT01837394|Serotonin Agents|serotonin agents|mesh-ancestor
6720050|NCT01837394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6720051|NCT01837394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720052|NCT01837394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6720053|NCT01837394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6720054|NCT01837394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6720055|NCT01837394|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6720056|NCT01837394|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6720057|NCT01837394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6720058|NCT01837394|Dopamine Agents|dopamine agents|mesh-ancestor
6720059|NCT01837433|Prednisone|prednisone|mesh-list
6720060|NCT01837433|Glucocorticoids|glucocorticoids|mesh-list
6720061|NCT01837433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6720062|NCT01837433|Hormones|hormones|mesh-ancestor
6720063|NCT01837433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6720064|NCT01837433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720065|NCT01837433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6720066|NCT01837433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6720067|NCT01837446|Diphenhydramine|diphenhydramine|mesh-list
6720068|NCT01837446|Promethazine|promethazine|mesh-list
6720069|NCT01837446|Lidocaine|lidocaine|mesh-list
6720070|NCT01837446|Morphine|morphine|mesh-list
6720071|NCT01837446|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6720072|NCT01837446|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
6720073|NCT01837446|Anesthetics, Local|anesthetics, local|mesh-ancestor
6720074|NCT01837446|Anesthetics|anesthetics|mesh-ancestor
6720075|NCT01837446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6720076|NCT01837446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720077|NCT01837446|Sensory System Agents|sensory system agents|mesh-ancestor
6720078|NCT01837446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6720079|NCT01837446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6720080|NCT01837446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6720081|NCT01837446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6720082|NCT01837446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6784161|NCT02201316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6720083|NCT01837446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720084|NCT01837446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6720085|NCT01837446|Narcotics|narcotics|mesh-ancestor
6720086|NCT01837446|Analgesics|analgesics|mesh-ancestor
6720087|NCT01837446|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6720088|NCT01837446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6720089|NCT01837446|Antiemetics|antiemetics|mesh-ancestor
6720090|NCT01837446|Autonomic Agents|autonomic agents|mesh-ancestor
6720091|NCT01837446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6720092|NCT01837446|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6720093|NCT01837446|Histamine Antagonists|histamine antagonists|mesh-ancestor
6720094|NCT01837446|Histamine Agents|histamine agents|mesh-ancestor
6720095|NCT01837446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6720096|NCT01837446|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6720097|NCT01837446|Antipruritics|antipruritics|mesh-ancestor
6720098|NCT01837446|Dermatologic Agents|dermatologic agents|mesh-ancestor
6720099|NCT01837446|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6720100|NCT01837446|Immunologic Factors|immunologic factors|mesh-ancestor
6720101|NCT01837446|Antacids|antacids|mesh-ancestor
6720102|NCT01837498|Neostigmine|neostigmine|mesh-list
6720103|NCT01837498|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6720104|NCT01837498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6720105|NCT01837498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720106|NCT01837498|Cholinergic Agents|cholinergic agents|mesh-ancestor
6720107|NCT01837498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6720108|NCT01837498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720109|NCT01837498|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6720110|NCT01837498|Autonomic Agents|autonomic agents|mesh-ancestor
6720111|NCT01837498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6720112|NCT01837576|Calcipotriene|calcipotriene|mesh-list
6720113|NCT01837576|Dermatologic Agents|dermatologic agents|mesh-ancestor
6720114|NCT01837628|Lidocaine|lidocaine|mesh-list
6720115|NCT01837628|Mineral Oil|mineral oil|mesh-list
6720116|NCT01837628|Anesthetics, Local|anesthetics, local|mesh-ancestor
6720117|NCT01837628|Anesthetics|anesthetics|mesh-ancestor
6720118|NCT01837628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6720119|NCT01837628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720120|NCT01837628|Sensory System Agents|sensory system agents|mesh-ancestor
6720121|NCT01837628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6720122|NCT01837628|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6720123|NCT01837628|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6720124|NCT01837628|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6720125|NCT01837628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6720126|NCT01837628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720127|NCT01837628|Emollients|emollients|mesh-ancestor
6720128|NCT01837628|Dermatologic Agents|dermatologic agents|mesh-ancestor
6720129|NCT01837667|Docetaxel|docetaxel|mesh-list
6720130|NCT01837667|LB100|lb100|mesh-list
6720131|NCT01837667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6720132|NCT01837667|Tubulin Modulators|tubulin modulators|mesh-ancestor
6720133|NCT01837667|Antimitotic Agents|antimitotic agents|mesh-ancestor
6720134|NCT01837667|Mitosis Modulators|mitosis modulators|mesh-ancestor
6720135|NCT01837667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720136|NCT01837667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6720137|NCT01837810|Ibuprofen|ibuprofen|mesh-list
6720138|NCT01837810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6720139|NCT01837810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6720140|NCT01837810|Analgesics|analgesics|mesh-ancestor
6720141|NCT01837810|Sensory System Agents|sensory system agents|mesh-ancestor
6720142|NCT01837810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6720143|NCT01837810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720144|NCT01837810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6720145|NCT01837810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6720146|NCT01837810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6720147|NCT01837810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6720148|NCT01837810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720149|NCT01837862|Mebendazole|mebendazole|mesh-list
6720150|NCT01837862|Piperazine|piperazine|mesh-list
6720151|NCT01837862|Piperazine citrate|piperazine citrate|mesh-list
6720152|NCT01837862|Bevacizumab|bevacizumab|mesh-list
6720153|NCT01837862|Carboplatin|carboplatin|mesh-list
6720154|NCT01837862|Irinotecan|irinotecan|mesh-list
6720155|NCT01837862|Vincristine|vincristine|mesh-list
6720156|NCT01837862|Temozolomide|temozolomide|mesh-list
6720157|NCT01837862|DMP 777|dmp 777|mesh-list
6720158|NCT01837862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6720159|NCT01837862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6720160|NCT01837862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6720161|NCT01837862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6720162|NCT01837862|Growth Substances|growth substances|mesh-ancestor
6720163|NCT01837862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720164|NCT01837862|Growth Inhibitors|growth inhibitors|mesh-ancestor
6720165|NCT01837862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6720166|NCT01837862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6720167|NCT01837862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6720168|NCT01837862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720169|NCT01837862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6720170|NCT01837862|Tubulin Modulators|tubulin modulators|mesh-ancestor
6720171|NCT01837862|Antimitotic Agents|antimitotic agents|mesh-ancestor
6720172|NCT01837862|Mitosis Modulators|mitosis modulators|mesh-ancestor
6720173|NCT01837862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6720174|NCT01837862|Alkylating Agents|alkylating agents|mesh-ancestor
6720175|NCT01837862|Antinematodal Agents|antinematodal agents|mesh-ancestor
6720176|NCT01837862|Anthelmintics|anthelmintics|mesh-ancestor
6720177|NCT01837862|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6720178|NCT01837862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6720179|NCT01837927|Glycopyrrolate|glycopyrrolate|mesh-list
6720180|NCT01837927|Tiotropium Bromide|tiotropium bromide|mesh-list
6720181|NCT01837927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6720182|NCT01837927|Autonomic Agents|autonomic agents|mesh-ancestor
6720183|NCT01837927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6720184|NCT01837927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720185|NCT01837927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6720186|NCT01837927|Respiratory System Agents|respiratory system agents|mesh-ancestor
6720187|NCT01837927|Parasympatholytics|parasympatholytics|mesh-ancestor
6720188|NCT01837927|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6720189|NCT01837927|Cholinergic Agents|cholinergic agents|mesh-ancestor
6720190|NCT01837927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6720191|NCT01837927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720192|NCT01837927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6720193|NCT01837927|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6720194|NCT01837992|Primaquine|primaquine|mesh-list
6720195|NCT01837992|Antimalarials|antimalarials|mesh-ancestor
6720196|NCT01837992|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6720197|NCT01837992|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6720198|NCT01837992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6720199|NCT01838083|Insulin Glargine|insulin glargine|mesh-list
6720200|NCT01838083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6720201|NCT01838083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720202|NCT01838252|Hyaluronic Acid|hyaluronic acid|mesh-list
6720203|NCT01838252|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6720204|NCT01838252|Immunologic Factors|immunologic factors|mesh-ancestor
6720205|NCT01838252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720206|NCT01838252|Viscosupplements|viscosupplements|mesh-ancestor
6720207|NCT01838252|Protective Agents|protective agents|mesh-ancestor
6720208|NCT01838330|Psyllium|psyllium|mesh-list
6720209|NCT01838330|Cathartics|cathartics|mesh-ancestor
6720210|NCT01838330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6784162|NCT02201316|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6784163|NCT02201316|Serotonin Agents|serotonin agents|mesh-ancestor
6784164|NCT02201316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6784165|NCT02201316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784166|NCT02201342|Udenafil|udenafil|mesh-list
6784167|NCT02201342|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6784168|NCT02201342|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6784169|NCT02201342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6784170|NCT02201342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784171|NCT02201381|Metformin|metformin|mesh-list
6784172|NCT02201381|Doxycycline|doxycycline|mesh-list
6784173|NCT02201381|Mebendazole|mebendazole|mesh-list
6784174|NCT02201381|Atorvastatin|atorvastatin|mesh-list
6784175|NCT02201381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6784176|NCT02201381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784177|NCT02201381|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6784178|NCT02201381|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6784179|NCT02201381|Antimetabolites|antimetabolites|mesh-ancestor
6784180|NCT02201381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784181|NCT02201381|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6784182|NCT02201381|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6784183|NCT02201381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6784184|NCT02201381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6784185|NCT02201381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6784186|NCT02201381|Antimalarials|antimalarials|mesh-ancestor
6784187|NCT02201381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6784188|NCT02201381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6784189|NCT02201381|Antinematodal Agents|antinematodal agents|mesh-ancestor
6784190|NCT02201381|Anthelmintics|anthelmintics|mesh-ancestor
6784191|NCT02201381|Tubulin Modulators|tubulin modulators|mesh-ancestor
6784192|NCT02201381|Antimitotic Agents|antimitotic agents|mesh-ancestor
6784193|NCT02201381|Mitosis Modulators|mitosis modulators|mesh-ancestor
6784194|NCT02201381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6784195|NCT02201407|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6784196|NCT02201407|Antiviral Agents|antiviral agents|mesh-ancestor
6784197|NCT02201407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6784198|NCT02201459|Interferons|interferons|mesh-list
6784199|NCT02201459|Interferon-alpha|interferon-alpha|mesh-list
6784200|NCT02201459|Interferon alpha-2|interferon alpha-2|mesh-list
6784201|NCT02201459|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6784202|NCT02201459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6784203|NCT02201459|Antiviral Agents|antiviral agents|mesh-ancestor
6784204|NCT02201459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6784205|NCT02201459|Immunologic Factors|immunologic factors|mesh-ancestor
6784206|NCT02201459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784207|NCT02201563|Minocycline|minocycline|mesh-list
6784208|NCT02201563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6784209|NCT02201563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6720211|NCT01838395|Cytarabine|cytarabine|mesh-list
6720212|NCT01838395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6720213|NCT01838395|Antimetabolites|antimetabolites|mesh-ancestor
6720214|NCT01838395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720215|NCT01838395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6720216|NCT01838395|Antiviral Agents|antiviral agents|mesh-ancestor
6720217|NCT01838395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6720218|NCT01838395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6720219|NCT01838395|Immunologic Factors|immunologic factors|mesh-ancestor
6720220|NCT01838395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720221|NCT01838434|Lenalidomide|lenalidomide|mesh-list
6720222|NCT01838434|Idelalisib|idelalisib|mesh-list
6720223|NCT01838434|Immunologic Factors|immunologic factors|mesh-ancestor
6720224|NCT01838434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720225|NCT01838434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6720226|NCT01838434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6720227|NCT01838434|Growth Substances|growth substances|mesh-ancestor
6720228|NCT01838434|Growth Inhibitors|growth inhibitors|mesh-ancestor
6720229|NCT01838434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6720230|NCT01838434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6720231|NCT01838434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720232|NCT01838460|Lobeline|lobeline|mesh-list
6720233|NCT01838460|Nicotine|nicotine|mesh-list
6720234|NCT01838460|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6720235|NCT01838460|Autonomic Agents|autonomic agents|mesh-ancestor
6720236|NCT01838460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6720237|NCT01838460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720238|NCT01838460|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6720239|NCT01838460|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6720240|NCT01838460|Cholinergic Agents|cholinergic agents|mesh-ancestor
6720241|NCT01838460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6720242|NCT01838460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720243|NCT01838460|Respiratory System Agents|respiratory system agents|mesh-ancestor
6720244|NCT01838473|Lobeline|lobeline|mesh-list
6720245|NCT01838473|Nicotine|nicotine|mesh-list
6720246|NCT01838473|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6720247|NCT01838473|Autonomic Agents|autonomic agents|mesh-ancestor
6720248|NCT01838473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6720249|NCT01838473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720250|NCT01838473|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6720251|NCT01838473|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6720252|NCT01838473|Cholinergic Agents|cholinergic agents|mesh-ancestor
6720253|NCT01838473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6720254|NCT01838473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720255|NCT01838473|Respiratory System Agents|respiratory system agents|mesh-ancestor
6720256|NCT01838538|Paclitaxel|paclitaxel|mesh-list
6720257|NCT01838538|Bevacizumab|bevacizumab|mesh-list
6720258|NCT01838538|Carboplatin|carboplatin|mesh-list
6720259|NCT01838538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6720260|NCT01838538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6720261|NCT01838538|Tubulin Modulators|tubulin modulators|mesh-ancestor
6720262|NCT01838538|Antimitotic Agents|antimitotic agents|mesh-ancestor
6720263|NCT01838538|Mitosis Modulators|mitosis modulators|mesh-ancestor
6720264|NCT01838538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720265|NCT01838538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6720266|NCT01838538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6720267|NCT01838538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6720268|NCT01838538|Growth Substances|growth substances|mesh-ancestor
6720269|NCT01838538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720270|NCT01838538|Growth Inhibitors|growth inhibitors|mesh-ancestor
6720271|NCT01838668|Dimethyl Fumarate|dimethyl fumarate|mesh-list
6720272|NCT01838668|Dermatologic Agents|dermatologic agents|mesh-ancestor
6720273|NCT01838668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6720274|NCT01838668|Immunologic Factors|immunologic factors|mesh-ancestor
6720275|NCT01838668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720276|NCT01838707|Fentanyl|fentanyl|mesh-list
6720277|NCT01838707|Morphine|morphine|mesh-list
6720278|NCT01838707|Bupivacaine|bupivacaine|mesh-list
6720279|NCT01838707|Anesthetics, Local|anesthetics, local|mesh-ancestor
6720280|NCT01838707|Anesthetics|anesthetics|mesh-ancestor
6720281|NCT01838707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6720282|NCT01838707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720283|NCT01838707|Sensory System Agents|sensory system agents|mesh-ancestor
6720284|NCT01838707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6720285|NCT01838707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6720286|NCT01838707|Narcotics|narcotics|mesh-ancestor
6720287|NCT01838707|Analgesics|analgesics|mesh-ancestor
6720288|NCT01838707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6720289|NCT01838707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6720290|NCT01838707|Anesthetics, General|anesthetics, general|mesh-ancestor
6720291|NCT01838772|Interferons|interferons|mesh-list
6720292|NCT01838772|Ribavirin|ribavirin|mesh-list
6720293|NCT01838772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6720294|NCT01838772|Antiviral Agents|antiviral agents|mesh-ancestor
6720295|NCT01838772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6720296|NCT01838772|Antimetabolites|antimetabolites|mesh-ancestor
6720297|NCT01838772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720298|NCT01838850|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6720299|NCT01838850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6720300|NCT01838850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6720301|NCT01838850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6720302|NCT01838850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720303|NCT01838902|Primaquine|primaquine|mesh-list
6720304|NCT01838902|Antimalarials|antimalarials|mesh-ancestor
6720305|NCT01838902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6720306|NCT01838902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6720307|NCT01838902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6720308|NCT01838928|Bupivacaine|bupivacaine|mesh-list
6720309|NCT01838928|Anesthetics, Local|anesthetics, local|mesh-ancestor
6720310|NCT01838928|Anesthetics|anesthetics|mesh-ancestor
6720311|NCT01838928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6720312|NCT01838928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720313|NCT01838928|Sensory System Agents|sensory system agents|mesh-ancestor
6720314|NCT01838928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6720315|NCT01838993|Lidocaine|lidocaine|mesh-list
6720316|NCT01838993|Anesthetics, Local|anesthetics, local|mesh-ancestor
6720317|NCT01838993|Anesthetics|anesthetics|mesh-ancestor
6720318|NCT01838993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6720319|NCT01838993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720320|NCT01838993|Sensory System Agents|sensory system agents|mesh-ancestor
6720321|NCT01838993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6720322|NCT01838993|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6720323|NCT01838993|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6720324|NCT01838993|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6720325|NCT01838993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6720326|NCT01838993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720327|NCT01839032|Vinorelbine|vinorelbine|mesh-list
6720328|NCT01839032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6720329|NCT01839032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6720330|NCT01839032|Tubulin Modulators|tubulin modulators|mesh-ancestor
6720331|NCT01839032|Antimitotic Agents|antimitotic agents|mesh-ancestor
6720332|NCT01839032|Mitosis Modulators|mitosis modulators|mesh-ancestor
6720333|NCT01839032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720334|NCT01839084|Isoflurane|isoflurane|mesh-list
6720335|NCT01839084|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6720336|NCT01839084|Anesthetics, General|anesthetics, general|mesh-ancestor
6720337|NCT01839084|Anesthetics|anesthetics|mesh-ancestor
6720338|NCT01839084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6720339|NCT01839084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720340|NCT01839097|Prednisone|prednisone|mesh-list
6720341|NCT01839097|Cyclophosphamide|cyclophosphamide|mesh-list
6720342|NCT01839097|Doxorubicin|doxorubicin|mesh-list
6720343|NCT01839097|Vincristine|vincristine|mesh-list
6720344|NCT01839097|Belinostat|belinostat|mesh-list
6720345|NCT01839097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6720346|NCT01839097|Immunologic Factors|immunologic factors|mesh-ancestor
6720347|NCT01839097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720348|NCT01839097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6720349|NCT01839097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6720350|NCT01839097|Alkylating Agents|alkylating agents|mesh-ancestor
6720351|NCT01839097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720352|NCT01839097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6720353|NCT01839097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6720354|NCT01839097|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6720355|NCT01839097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6720356|NCT01839097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6720357|NCT01839097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6720358|NCT01839097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6720359|NCT01839097|Glucocorticoids|glucocorticoids|mesh-ancestor
6720360|NCT01839097|Hormones|hormones|mesh-ancestor
6720361|NCT01839097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6720362|NCT01839097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6720363|NCT01839097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6720364|NCT01839097|Tubulin Modulators|tubulin modulators|mesh-ancestor
6720365|NCT01839097|Antimitotic Agents|antimitotic agents|mesh-ancestor
6720366|NCT01839097|Mitosis Modulators|mitosis modulators|mesh-ancestor
6720367|NCT01839097|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6720368|NCT01839149|Oxytocin|oxytocin|mesh-list
6720369|NCT01839149|Oxytocics|oxytocics|mesh-ancestor
6720370|NCT01839149|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6720371|NCT01839149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720372|NCT01839175|Vaccines|vaccines|mesh-list
6720373|NCT01839175|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6720374|NCT01839175|Immunologic Factors|immunologic factors|mesh-ancestor
6720375|NCT01839175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720376|NCT01839240|Cytarabine|cytarabine|mesh-list
6720377|NCT01839240|Azacitidine|azacitidine|mesh-list
6720378|NCT01839240|Mitoxantrone|mitoxantrone|mesh-list
6720379|NCT01839240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6720380|NCT01839240|Antimetabolites|antimetabolites|mesh-ancestor
6720381|NCT01839240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720382|NCT01839240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6720383|NCT01839240|Antiviral Agents|antiviral agents|mesh-ancestor
6720384|NCT01839240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6720385|NCT01839240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6720386|NCT01839240|Immunologic Factors|immunologic factors|mesh-ancestor
6720387|NCT01839240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720388|NCT01839240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6720389|NCT01839240|Analgesics|analgesics|mesh-ancestor
6720390|NCT01839240|Sensory System Agents|sensory system agents|mesh-ancestor
6720391|NCT01839240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6720392|NCT01839240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6720393|NCT01839240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6720394|NCT01839253|Atenolol|atenolol|mesh-list
6720395|NCT01839253|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6720396|NCT01839253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6720397|NCT01839253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6720398|NCT01839253|Sympatholytics|sympatholytics|mesh-ancestor
6720399|NCT01839253|Autonomic Agents|autonomic agents|mesh-ancestor
6720400|NCT01839253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6720401|NCT01839253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720402|NCT01839253|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6720403|NCT01839253|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6720404|NCT01839253|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6720405|NCT01839253|Adrenergic Agents|adrenergic agents|mesh-ancestor
6720406|NCT01839253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6720407|NCT01839253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720408|NCT01839253|Protease Inhibitors|protease inhibitors|mesh-ancestor
6720409|NCT01839253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6720410|NCT01839344|Acarbose|acarbose|mesh-list
6720411|NCT01839344|Quercetin|quercetin|mesh-list
6720412|NCT01839344|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6720413|NCT01839344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6720414|NCT01839344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720415|NCT01839344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6720416|NCT01839344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720417|NCT01839344|Antioxidants|antioxidants|mesh-ancestor
6720418|NCT01839344|Protective Agents|protective agents|mesh-ancestor
6720419|NCT01839357|Rivaroxaban|rivaroxaban|mesh-list
6720420|NCT01839357|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6720421|NCT01839357|Antithrombins|antithrombins|mesh-ancestor
6720422|NCT01839357|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6720423|NCT01839357|Protease Inhibitors|protease inhibitors|mesh-ancestor
6720424|NCT01839357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6720425|NCT01839357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720426|NCT01839357|Anticoagulants|anticoagulants|mesh-ancestor
6720427|NCT01839370|Pramlintide|pramlintide|mesh-list
6720428|NCT01839370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6720429|NCT01839370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720430|NCT01839383|Dialysis Solutions|dialysis solutions|mesh-list
6720431|NCT01839383|Calcium|calcium|mesh-list
6720432|NCT01839383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6720433|NCT01839383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720434|NCT01839383|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6720435|NCT01839500|Trastuzumab|trastuzumab|mesh-list
6720436|NCT01839500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6720437|NCT01839500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6720438|NCT01839552|Fentanyl|fentanyl|mesh-list
6720439|NCT01839552|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6720440|NCT01839552|Narcotics|narcotics|mesh-ancestor
6720441|NCT01839552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6720442|NCT01839552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720443|NCT01839552|Analgesics|analgesics|mesh-ancestor
6720444|NCT01839552|Sensory System Agents|sensory system agents|mesh-ancestor
6720445|NCT01839552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6720446|NCT01839552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6720447|NCT01839552|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6720448|NCT01839552|Anesthetics, General|anesthetics, general|mesh-ancestor
6720449|NCT01839552|Anesthetics|anesthetics|mesh-ancestor
6720450|NCT01839578|Heparin|heparin|mesh-list
6720451|NCT01839578|Calcium heparin|calcium heparin|mesh-list
6720452|NCT01839578|Anticoagulants|anticoagulants|mesh-ancestor
6720453|NCT01839578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720454|NCT01839578|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6720455|NCT01839578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6720456|NCT01839630|Sorafenib|sorafenib|mesh-list
6720457|NCT01839630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6720458|NCT01839630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6720459|NCT01839630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6720460|NCT01839630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720461|NCT01839643|Meloxicam|meloxicam|mesh-list
6720462|NCT01839643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6720463|NCT01839643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6720464|NCT01839643|Analgesics|analgesics|mesh-ancestor
6720465|NCT01839643|Sensory System Agents|sensory system agents|mesh-ancestor
6720466|NCT01839643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6720467|NCT01839643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720468|NCT01839643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6720469|NCT01839643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6720470|NCT01839643|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6720471|NCT01839643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6720472|NCT01839643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6720473|NCT01839643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720474|NCT01839734|Lubiprostone|lubiprostone|mesh-list
6720475|NCT01839734|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6720476|NCT01839734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6720477|NCT01839734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720478|NCT01839773|Paclitaxel|paclitaxel|mesh-list
6720479|NCT01839773|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6720480|NCT01839773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6720481|NCT01839773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6720482|NCT01839773|Tubulin Modulators|tubulin modulators|mesh-ancestor
6720483|NCT01839773|Antimitotic Agents|antimitotic agents|mesh-ancestor
6720484|NCT01839773|Mitosis Modulators|mitosis modulators|mesh-ancestor
6784210|NCT02201576|Bortezomib|bortezomib|mesh-list
6720485|NCT01839773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720486|NCT01839812|Cosyntropin|cosyntropin|mesh-list
6720487|NCT01839812|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6720488|NCT01839812|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
6720489|NCT01839812|beta-Endorphin|beta-endorphin|mesh-list
6720490|NCT01839812|Hormones|hormones|mesh-ancestor
6720491|NCT01839812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6720492|NCT01839812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720493|NCT01839812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6720494|NCT01839812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720495|NCT01839851|Glucocorticoids|glucocorticoids|mesh-list
6720496|NCT01839851|Hormones|hormones|mesh-ancestor
6720497|NCT01839851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6720498|NCT01839851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720499|NCT01839890|Paclitaxel|paclitaxel|mesh-list
6720500|NCT01839890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6720501|NCT01839890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6720502|NCT01839890|Tubulin Modulators|tubulin modulators|mesh-ancestor
6720503|NCT01839890|Antimitotic Agents|antimitotic agents|mesh-ancestor
6720504|NCT01839890|Mitosis Modulators|mitosis modulators|mesh-ancestor
6784211|NCT02201576|Immunoglobulins|immunoglobulins|mesh-list
6784212|NCT02201576|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6784213|NCT02201576|Antibodies|antibodies|mesh-list
6784214|NCT02201576|gamma-Globulins|gamma-globulins|mesh-list
6784215|NCT02201576|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6784216|NCT02201576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6784217|NCT02201576|Immunologic Factors|immunologic factors|mesh-ancestor
6784218|NCT02201576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784219|NCT02201602|Gliclazide|gliclazide|mesh-list
6784220|NCT02201602|Glyburide|glyburide|mesh-list
6784221|NCT02201602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6784222|NCT02201602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784223|NCT02201641|Calcium|calcium|mesh-list
6784224|NCT02201641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6784225|NCT02201641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784226|NCT02201667|Aspirin|aspirin|mesh-list
6720505|NCT01839890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720506|NCT01839929|Tacrolimus|tacrolimus|mesh-list
6720507|NCT01839929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6720508|NCT01839929|Immunologic Factors|immunologic factors|mesh-ancestor
6720509|NCT01839929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720510|NCT01839929|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6720511|NCT01839929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6720512|NCT01839929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720513|NCT01839955|Quinacrine|quinacrine|mesh-list
6720514|NCT01839955|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6720515|NCT01839955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6720516|NCT01839955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6720517|NCT01839955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6720518|NCT01839955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720519|NCT01839955|Anticestodal Agents|anticestodal agents|mesh-ancestor
6720520|NCT01839955|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6720521|NCT01839955|Anthelmintics|anthelmintics|mesh-ancestor
6720522|NCT01839955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6720523|NCT01839955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6720524|NCT01839955|Antimalarials|antimalarials|mesh-ancestor
6720525|NCT01839955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6720526|NCT01839955|Antinematodal Agents|antinematodal agents|mesh-ancestor
6720527|NCT01839968|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6720528|NCT01839968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6720529|NCT01839981|Thioctic Acid|thioctic acid|mesh-list
6720530|NCT01839981|Antioxidants|antioxidants|mesh-ancestor
6720531|NCT01839981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720532|NCT01839981|Protective Agents|protective agents|mesh-ancestor
6720533|NCT01839981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720534|NCT01839981|Vitamin B Complex|vitamin b complex|mesh-ancestor
6720535|NCT01839981|Vitamins|vitamins|mesh-ancestor
6720536|NCT01839981|Micronutrients|micronutrients|mesh-ancestor
6720537|NCT01839994|Androgens|androgens|mesh-list
6720538|NCT01839994|Hormones|hormones|mesh-ancestor
6720539|NCT01839994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6720540|NCT01839994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720541|NCT01840007|Metformin|metformin|mesh-list
6720542|NCT01840007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6720543|NCT01840007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784227|NCT02201667|Clopidogrel|clopidogrel|mesh-list
6784228|NCT02201667|Ticagrelor|ticagrelor|mesh-list
6784229|NCT02201667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6784230|NCT02201667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6784231|NCT02201667|Analgesics|analgesics|mesh-ancestor
6784232|NCT02201667|Sensory System Agents|sensory system agents|mesh-ancestor
6784233|NCT02201667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6784234|NCT02201667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784235|NCT02201667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6784236|NCT02201667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6784237|NCT02201667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6784238|NCT02201667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6784239|NCT02201667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784240|NCT02201667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6784241|NCT02201667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6784242|NCT02201667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6784243|NCT02201667|Antipyretics|antipyretics|mesh-ancestor
6784244|NCT02201667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6784245|NCT02201667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6784246|NCT02201667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6784247|NCT02201667|Purinergic Agents|purinergic agents|mesh-ancestor
6784248|NCT02201667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6784249|NCT02201849|Dimethyl Fumarate|dimethyl fumarate|mesh-list
6784250|NCT02201849|Dermatologic Agents|dermatologic agents|mesh-ancestor
6784251|NCT02201849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6784252|NCT02201849|Immunologic Factors|immunologic factors|mesh-ancestor
6784253|NCT02201849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784254|NCT02201914|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6784255|NCT02201914|Clomiphene|clomiphene|mesh-list
6784256|NCT02201914|Enclomiphene|enclomiphene|mesh-list
6784257|NCT02201914|Zuclomiphene|zuclomiphene|mesh-list
6784258|NCT02201914|Cetrorelix|cetrorelix|mesh-list
6784259|NCT02201914|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6784260|NCT02201914|Hormone Antagonists|hormone antagonists|mesh-ancestor
6784261|NCT02201914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6784262|NCT02201914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720544|NCT01840046|Interleukin-2|interleukin-2|mesh-list
6720545|NCT01840046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6720546|NCT01840046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6720547|NCT01840046|Analgesics|analgesics|mesh-ancestor
6720548|NCT01840046|Sensory System Agents|sensory system agents|mesh-ancestor
6720549|NCT01840046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6720550|NCT01840046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720551|NCT01840189|Hydrocortisone|hydrocortisone|mesh-list
6720552|NCT01840189|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6720553|NCT01840189|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6720554|NCT01840189|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6720555|NCT01840189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6720556|NCT01840254|Dexmedetomidine|dexmedetomidine|mesh-list
6720557|NCT01840254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6720558|NCT01840254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6720559|NCT01840254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720560|NCT01840254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6720561|NCT01840254|Analgesics|analgesics|mesh-ancestor
6720562|NCT01840254|Sensory System Agents|sensory system agents|mesh-ancestor
6720563|NCT01840254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6720564|NCT01840254|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6720565|NCT01840254|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6720566|NCT01840254|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6720567|NCT01840254|Adrenergic Agents|adrenergic agents|mesh-ancestor
6720568|NCT01840254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6720569|NCT01840254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720570|NCT01840384|Micronutrients|micronutrients|mesh-list
6720571|NCT01840384|Trace Elements|trace elements|mesh-list
6720572|NCT01840384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720573|NCT01840423|Levodopa|levodopa|mesh-list
6720574|NCT01840423|Carbidopa|carbidopa|mesh-list
6720575|NCT01840423|Entacapone|entacapone|mesh-list
6720576|NCT01840423|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6720577|NCT01840423|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6720578|NCT01840423|Dopamine Agents|dopamine agents|mesh-ancestor
6720579|NCT01840423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6720580|NCT01840423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720581|NCT01840423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720582|NCT01840423|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6720583|NCT01840423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6720584|NCT01840423|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6720585|NCT01840449|Lanreotide|lanreotide|mesh-list
6720586|NCT01840449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6720587|NCT01840566|Cytarabine|cytarabine|mesh-list
6720588|NCT01840566|Etoposide|etoposide|mesh-list
6720589|NCT01840566|Melphalan|melphalan|mesh-list
6720590|NCT01840566|Carmustine|carmustine|mesh-list
6720591|NCT01840566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6720592|NCT01840566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6720593|NCT01840566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6720594|NCT01840566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6720595|NCT01840566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6720596|NCT01840566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720597|NCT01840566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6720598|NCT01840566|Antimetabolites|antimetabolites|mesh-ancestor
6720599|NCT01840566|Antiviral Agents|antiviral agents|mesh-ancestor
6720600|NCT01840566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6720601|NCT01840566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6720602|NCT01840566|Immunologic Factors|immunologic factors|mesh-ancestor
6720603|NCT01840566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720604|NCT01840566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6720605|NCT01840566|Alkylating Agents|alkylating agents|mesh-ancestor
6720606|NCT01840566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6720607|NCT01840592|Doxorubicin|doxorubicin|mesh-list
6720608|NCT01840592|Sorafenib|sorafenib|mesh-list
6720609|NCT01840592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6720610|NCT01840592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6720611|NCT01840592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6720612|NCT01840592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6720613|NCT01840592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6720614|NCT01840592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720615|NCT01840592|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6720616|NCT01840683|Heparin|heparin|mesh-list
6720617|NCT01840683|Anticoagulants|anticoagulants|mesh-ancestor
6720618|NCT01840683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6720619|NCT01840683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6720620|NCT01840683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720621|NCT01840696|Regadenoson|regadenoson|mesh-list
6720622|NCT01840696|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
6720623|NCT01840696|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6720624|NCT01840696|Purinergic Agonists|purinergic agonists|mesh-ancestor
6720625|NCT01840696|Purinergic Agents|purinergic agents|mesh-ancestor
6720626|NCT01840696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6720627|NCT01840696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720628|NCT01840696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720629|NCT01840774|Ketamine|ketamine|mesh-list
6720630|NCT01840774|Analgesics|analgesics|mesh-list
6720631|NCT01840774|Sensory System Agents|sensory system agents|mesh-ancestor
6720632|NCT01840774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6720633|NCT01840774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720634|NCT01840774|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6720635|NCT01840774|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6720636|NCT01840774|Anesthetics, General|anesthetics, general|mesh-ancestor
6720637|NCT01840774|Anesthetics|anesthetics|mesh-ancestor
6720638|NCT01840774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6720639|NCT01840774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6720640|NCT01840774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6720641|NCT01840774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6720642|NCT01840774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720643|NCT01840800|Ropivacaine|ropivacaine|mesh-list
6720644|NCT01840800|Anesthetics, Local|anesthetics, local|mesh-ancestor
6720645|NCT01840800|Anesthetics|anesthetics|mesh-ancestor
6720646|NCT01840800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6720647|NCT01840800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720648|NCT01840800|Sensory System Agents|sensory system agents|mesh-ancestor
6720649|NCT01840800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6720650|NCT01840813|Misoprostol|misoprostol|mesh-list
6720651|NCT01840813|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6720652|NCT01840813|Abortifacient Agents|abortifacient agents|mesh-ancestor
6720653|NCT01840813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6720654|NCT01840813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720655|NCT01840813|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6720656|NCT01840813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6720657|NCT01840813|Oxytocics|oxytocics|mesh-ancestor
6720658|NCT01841008|Tacrolimus|tacrolimus|mesh-list
6720659|NCT01841008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6720660|NCT01841008|Immunologic Factors|immunologic factors|mesh-ancestor
6720661|NCT01841008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720662|NCT01841008|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6720663|NCT01841008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6720664|NCT01841008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720665|NCT01841099|Mesalamine|mesalamine|mesh-list
6720666|NCT01841099|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6720667|NCT01841099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6720668|NCT01841099|Analgesics|analgesics|mesh-ancestor
6720669|NCT01841099|Sensory System Agents|sensory system agents|mesh-ancestor
6720670|NCT01841099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6720671|NCT01841099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720672|NCT01841099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6720673|NCT01841099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6720674|NCT01841112|BI 409306|bi 409306|mesh-list
6720675|NCT01841112|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6720676|NCT01841112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6720677|NCT01841112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720678|NCT01841125|Citalopram|citalopram|mesh-list
6720679|NCT01841125|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6720680|NCT01841125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6720681|NCT01841125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6720682|NCT01841125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720683|NCT01841125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6720684|NCT01841125|Serotonin Agents|serotonin agents|mesh-ancestor
6720685|NCT01841125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720686|NCT01841125|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6720687|NCT01841125|Antidepressive Agents|antidepressive agents|mesh-ancestor
6720688|NCT01841125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6720689|NCT01841164|Montelukast|montelukast|mesh-list
6720690|NCT01841164|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6720691|NCT01841164|Respiratory System Agents|respiratory system agents|mesh-ancestor
6720692|NCT01841164|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6720693|NCT01841164|Hormone Antagonists|hormone antagonists|mesh-ancestor
6720694|NCT01841164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6720695|NCT01841164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720696|NCT01841164|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6720697|NCT01841164|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6720698|NCT01841164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720699|NCT01841242|Chlorhexidine|chlorhexidine|mesh-list
6720700|NCT01841242|Povidone-Iodine|povidone-iodine|mesh-list
6720701|NCT01841242|Povidone|povidone|mesh-list
6720702|NCT01841242|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6720703|NCT01841242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6720704|NCT01841242|Disinfectants|disinfectants|mesh-ancestor
6720705|NCT01841242|Plasma Substitutes|plasma substitutes|mesh-ancestor
6720706|NCT01841242|Blood Substitutes|blood substitutes|mesh-ancestor
6720707|NCT01841294|Lidocaine|lidocaine|mesh-list
6720708|NCT01841294|Anesthetics, Local|anesthetics, local|mesh-ancestor
6720709|NCT01841294|Anesthetics|anesthetics|mesh-ancestor
6720710|NCT01841294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6720711|NCT01841294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720712|NCT01841294|Sensory System Agents|sensory system agents|mesh-ancestor
6720713|NCT01841294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6720714|NCT01841294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6720715|NCT01841294|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6720716|NCT01841294|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6720717|NCT01841294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6720718|NCT01841294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720719|NCT01841307|Cromolyn Sodium|cromolyn sodium|mesh-list
6720720|NCT01841307|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
6720721|NCT01841307|Immunologic Factors|immunologic factors|mesh-ancestor
6720722|NCT01841307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720723|NCT01841307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6720724|NCT01841307|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6720725|NCT01841307|Respiratory System Agents|respiratory system agents|mesh-ancestor
6720726|NCT01841320|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6720727|NCT01841320|Methadone|methadone|mesh-list
6720728|NCT01841320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6720729|NCT01841320|Narcotics|narcotics|mesh-ancestor
6720730|NCT01841320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6720731|NCT01841320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720732|NCT01841320|Analgesics|analgesics|mesh-ancestor
6720733|NCT01841320|Sensory System Agents|sensory system agents|mesh-ancestor
6720734|NCT01841320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6720735|NCT01841320|Antitussive Agents|antitussive agents|mesh-ancestor
6720736|NCT01841320|Respiratory System Agents|respiratory system agents|mesh-ancestor
6720737|NCT01841320|Antiviral Agents|antiviral agents|mesh-ancestor
6720738|NCT01841320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6720739|NCT01841359|Pramlintide|pramlintide|mesh-list
6720740|NCT01841359|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6720741|NCT01841359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720742|NCT01841411|Metronidazole|metronidazole|mesh-list
6720743|NCT01841411|Acetylcysteine|acetylcysteine|mesh-list
6720744|NCT01841411|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6720745|NCT01841411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6720746|NCT01841411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6720747|NCT01841411|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6720748|NCT01841411|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6720749|NCT01841411|Antiviral Agents|antiviral agents|mesh-ancestor
6720750|NCT01841411|Expectorants|expectorants|mesh-ancestor
6720751|NCT01841411|Respiratory System Agents|respiratory system agents|mesh-ancestor
6720752|NCT01841411|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6720753|NCT01841411|Antioxidants|antioxidants|mesh-ancestor
6720754|NCT01841411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720755|NCT01841411|Protective Agents|protective agents|mesh-ancestor
6720756|NCT01841411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720757|NCT01841411|Antidotes|antidotes|mesh-ancestor
6720758|NCT01841424|Benzocaine|benzocaine|mesh-list
6720759|NCT01841424|Anesthetics, Local|anesthetics, local|mesh-ancestor
6720760|NCT01841424|Anesthetics|anesthetics|mesh-ancestor
6720761|NCT01841424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6720762|NCT01841424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720763|NCT01841424|Sensory System Agents|sensory system agents|mesh-ancestor
6720764|NCT01841424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6720765|NCT01841463|Vemurafenib|vemurafenib|mesh-list
6720766|NCT01841463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6720767|NCT01841463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6720768|NCT01841463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6720769|NCT01841463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720770|NCT01841502|Paroxetine|paroxetine|mesh-list
6720771|NCT01841502|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6720772|NCT01841502|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6720773|NCT01841502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6720774|NCT01841502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720775|NCT01841502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6720776|NCT01841502|Serotonin Agents|serotonin agents|mesh-ancestor
6720777|NCT01841502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720778|NCT01841502|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6720779|NCT01841502|Antidepressive Agents|antidepressive agents|mesh-ancestor
6720780|NCT01841502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6720781|NCT01841502|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6720782|NCT01841502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6720783|NCT01841502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6720784|NCT01841515|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
6720785|NCT01841515|Hemostatics|hemostatics|mesh-ancestor
6720786|NCT01841515|Coagulants|coagulants|mesh-ancestor
6720787|NCT01841515|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6720788|NCT01841515|Natriuretic Agents|natriuretic agents|mesh-ancestor
6720789|NCT01841515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720790|NCT01841658|Folic Acid|folic acid|mesh-list
6720791|NCT01841658|Hematinics|hematinics|mesh-ancestor
6720792|NCT01841658|Vitamin B Complex|vitamin b complex|mesh-ancestor
6720793|NCT01841658|Vitamins|vitamins|mesh-ancestor
6720794|NCT01841658|Micronutrients|micronutrients|mesh-ancestor
6720795|NCT01841658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784263|NCT02201914|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6784264|NCT02201914|Fertility Agents|fertility agents|mesh-ancestor
6784265|NCT02201914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6784266|NCT02201914|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6784267|NCT02201914|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6784268|NCT02201914|Luteolytic Agents|luteolytic agents|mesh-ancestor
6784269|NCT02201914|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6784270|NCT02201914|Contraceptive Agents|contraceptive agents|mesh-ancestor
6784271|NCT02201914|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6784272|NCT02201914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6784273|NCT02201914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6784274|NCT02201992|Crizotinib|crizotinib|mesh-list
6784275|NCT02201992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6784276|NCT02201992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6784277|NCT02201992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6784278|NCT02201992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720796|NCT01841684|Anacetrapib|anacetrapib|mesh-list
6720797|NCT01841684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6720798|NCT01841684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6720799|NCT01841684|Antimetabolites|antimetabolites|mesh-ancestor
6720800|NCT01841684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720801|NCT01841684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6720802|NCT01841775|Interferons|interferons|mesh-list
6720803|NCT01841775|Ribavirin|ribavirin|mesh-list
6720804|NCT01841775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6720805|NCT01841775|Antiviral Agents|antiviral agents|mesh-ancestor
6720806|NCT01841775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6720807|NCT01841775|Antimetabolites|antimetabolites|mesh-ancestor
6720808|NCT01841775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720809|NCT01841827|Cilostazol|cilostazol|mesh-list
6720810|NCT01841827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6720811|NCT01841827|Autonomic Agents|autonomic agents|mesh-ancestor
6720812|NCT01841827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6720813|NCT01841827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720814|NCT01841827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6720815|NCT01841827|Respiratory System Agents|respiratory system agents|mesh-ancestor
6720816|NCT01841827|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6720817|NCT01841827|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6720818|NCT01841827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720819|NCT01841827|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6720820|NCT01841827|Vasodilator Agents|vasodilator agents|mesh-ancestor
6720821|NCT01841827|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6720822|NCT01841827|Protective Agents|protective agents|mesh-ancestor
6720823|NCT01841827|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6720824|NCT01841827|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6720825|NCT01841827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6720826|NCT01841996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6720827|NCT01842035|Regadenoson|regadenoson|mesh-list
6720828|NCT01842035|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
6720829|NCT01842035|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6720830|NCT01842035|Purinergic Agonists|purinergic agonists|mesh-ancestor
6720831|NCT01842035|Purinergic Agents|purinergic agents|mesh-ancestor
6720832|NCT01842035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6720833|NCT01842035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720834|NCT01842035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720835|NCT01842074|Bortezomib|bortezomib|mesh-list
6720836|NCT01842074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6720837|NCT01842087|Iproplatin|iproplatin|mesh-list
6720838|NCT01842087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6720839|NCT01842100|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6720840|NCT01842100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6720841|NCT01842113|Rifaximin|rifaximin|mesh-list
6720842|NCT01842113|Lactulose|lactulose|mesh-list
6720843|NCT01842113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6720844|NCT01842113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6720845|NCT01842113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6720846|NCT01842139|Poly I-C|poly i-c|mesh-list
6720847|NCT01842139|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6720848|NCT01842139|Poly ICLC|poly iclc|mesh-list
6720849|NCT01842139|Basiliximab|basiliximab|mesh-list
6720850|NCT01842139|Interferon Inducers|interferon inducers|mesh-ancestor
6720851|NCT01842139|Immunologic Factors|immunologic factors|mesh-ancestor
6720852|NCT01842139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720853|NCT01842139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6720854|NCT01842139|Laxatives|laxatives|mesh-ancestor
6720855|NCT01842139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6720856|NCT01842139|Antiviral Agents|antiviral agents|mesh-ancestor
6720857|NCT01842139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6720858|NCT01842165|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
6720859|NCT01842165|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6720860|NCT01842165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720861|NCT01842230|Niacin|niacin|mesh-list
6720862|NCT01842230|Amlodipine|amlodipine|mesh-list
6720863|NCT01842230|Telmisartan|telmisartan|mesh-list
6720864|NCT01842230|Atorvastatin|atorvastatin|mesh-list
6720865|NCT01842230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6720866|NCT01842230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6720867|NCT01842230|Antimetabolites|antimetabolites|mesh-ancestor
6720868|NCT01842230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720869|NCT01842230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6720870|NCT01842230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6720871|NCT01842230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6720872|NCT01842230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6720873|NCT01842230|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6720874|NCT01842230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6720875|NCT01842230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6720876|NCT01842230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720877|NCT01842230|Vasodilator Agents|vasodilator agents|mesh-ancestor
6720878|NCT01842230|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6720879|NCT01842230|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6720880|NCT01842230|Vitamin B Complex|vitamin b complex|mesh-ancestor
6720881|NCT01842230|Vitamins|vitamins|mesh-ancestor
6720882|NCT01842230|Micronutrients|micronutrients|mesh-ancestor
6720883|NCT01842256|Amlodipine|amlodipine|mesh-list
6720884|NCT01842256|Telmisartan|telmisartan|mesh-list
6720885|NCT01842256|Atorvastatin|atorvastatin|mesh-list
6720886|NCT01842256|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6720887|NCT01842256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6720888|NCT01842256|Antimetabolites|antimetabolites|mesh-ancestor
6720889|NCT01842256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720890|NCT01842256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6720891|NCT01842256|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6720892|NCT01842256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6720893|NCT01842256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6720894|NCT01842256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6720895|NCT01842256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6720896|NCT01842256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6720897|NCT01842256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720898|NCT01842256|Vasodilator Agents|vasodilator agents|mesh-ancestor
6720899|NCT01842256|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6720900|NCT01842256|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6720901|NCT01842269|Mycophenolic Acid|mycophenolic acid|mesh-list
6720902|NCT01842269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6720903|NCT01842269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6720904|NCT01842269|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6720905|NCT01842269|Antitubercular Agents|antitubercular agents|mesh-ancestor
6720906|NCT01842269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6720907|NCT01842269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6720908|NCT01842269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6720909|NCT01842269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720910|NCT01842321|Abiraterone Acetate|abiraterone acetate|mesh-list
6720911|NCT01842321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6720912|NCT01842321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6720913|NCT01842321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6720914|NCT01842321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720915|NCT01842321|Hormone Antagonists|hormone antagonists|mesh-ancestor
6720916|NCT01842321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6720917|NCT01842321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720918|NCT01842321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6720919|NCT01842373|Lidocaine|lidocaine|mesh-list
6720920|NCT01842373|Tetracaine|tetracaine|mesh-list
6720921|NCT01842373|Benzocaine|benzocaine|mesh-list
6720922|NCT01842373|Anesthetics, Local|anesthetics, local|mesh-ancestor
6720923|NCT01842373|Anesthetics|anesthetics|mesh-ancestor
6720924|NCT01842373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6720925|NCT01842373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720926|NCT01842373|Sensory System Agents|sensory system agents|mesh-ancestor
6720927|NCT01842373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6720928|NCT01842373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6720929|NCT01842373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6720930|NCT01842373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6720931|NCT01842373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6720932|NCT01842373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720933|NCT01842516|Delpazolid|delpazolid|mesh-list
6720934|NCT01842516|Oxazolidinones|oxazolidinones|mesh-list
6720935|NCT01842516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6720936|NCT01842516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6720937|NCT01842516|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6720938|NCT01842516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6720939|NCT01842516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720940|NCT01842529|Botulinum Toxins|botulinum toxins|mesh-list
6720941|NCT01842529|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6720942|NCT01842529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6720943|NCT01842529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720944|NCT01842529|Cholinergic Agents|cholinergic agents|mesh-ancestor
6720945|NCT01842529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6720946|NCT01842529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720947|NCT01842672|Mitoxantrone|mitoxantrone|mesh-list
6720948|NCT01842672|Clofarabine|clofarabine|mesh-list
6720949|NCT01842672|Analgesics|analgesics|mesh-ancestor
6720950|NCT01842672|Sensory System Agents|sensory system agents|mesh-ancestor
6720951|NCT01842672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6720952|NCT01842672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720953|NCT01842672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6720954|NCT01842672|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6720955|NCT01842672|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6720956|NCT01842672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6720957|NCT01842672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720958|NCT01842672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6720959|NCT01842672|Antimetabolites|antimetabolites|mesh-ancestor
6720960|NCT01842893|Fentanyl|fentanyl|mesh-list
6720961|NCT01842893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6720962|NCT01842893|Narcotics|narcotics|mesh-ancestor
6720963|NCT01842893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6720964|NCT01842893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720965|NCT01842893|Analgesics|analgesics|mesh-ancestor
6720966|NCT01842893|Sensory System Agents|sensory system agents|mesh-ancestor
6720967|NCT01842893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6720968|NCT01842893|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6720969|NCT01842893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6720970|NCT01842893|Anesthetics, General|anesthetics, general|mesh-ancestor
6720971|NCT01842893|Anesthetics|anesthetics|mesh-ancestor
6720972|NCT01842932|Bromides|bromides|mesh-list
6720973|NCT01842932|Cholinergic Antagonists|cholinergic antagonists|mesh-list
6720974|NCT01842932|Cimetropium|cimetropium|mesh-list
6720975|NCT01842932|Anticonvulsants|anticonvulsants|mesh-ancestor
6720976|NCT01842932|Cholinergic Agents|cholinergic agents|mesh-ancestor
6720977|NCT01842932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6720978|NCT01842932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720979|NCT01842932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720980|NCT01842932|Parasympatholytics|parasympatholytics|mesh-ancestor
6720981|NCT01842932|Autonomic Agents|autonomic agents|mesh-ancestor
6720982|NCT01842932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6720983|NCT01843010|Parecoxib|parecoxib|mesh-list
6720984|NCT01843010|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6720985|NCT01843010|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6720986|NCT01843010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6720987|NCT01843010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6720988|NCT01843010|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6720989|NCT01843010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6720990|NCT01843010|Analgesics|analgesics|mesh-ancestor
6720991|NCT01843010|Sensory System Agents|sensory system agents|mesh-ancestor
6720992|NCT01843010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6720993|NCT01843010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720994|NCT01843010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6720995|NCT01843010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6720996|NCT01843075|Liraglutide|liraglutide|mesh-list
6720997|NCT01843075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6720998|NCT01843075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6720999|NCT01843075|Incretins|incretins|mesh-ancestor
6721000|NCT01843075|Hormones|hormones|mesh-ancestor
6721001|NCT01843075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6721002|NCT01843088|Mannitol|mannitol|mesh-list
6721003|NCT01843088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6721004|NCT01843088|Diuretics|diuretics|mesh-ancestor
6721005|NCT01843088|Natriuretic Agents|natriuretic agents|mesh-ancestor
6721006|NCT01843088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721007|NCT01843127|Exenatide|exenatide|mesh-list
6721008|NCT01843127|Ranolazine|ranolazine|mesh-list
6721009|NCT01843127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6721010|NCT01843127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721011|NCT01843127|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6721012|NCT01843127|Incretins|incretins|mesh-ancestor
6721013|NCT01843127|Hormones|hormones|mesh-ancestor
6721014|NCT01843127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6721015|NCT01843127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6721016|NCT01843127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6721017|NCT01843127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721018|NCT01843153|Ropivacaine|ropivacaine|mesh-list
6721019|NCT01843153|Anesthetics, Local|anesthetics, local|mesh-ancestor
6721020|NCT01843153|Anesthetics|anesthetics|mesh-ancestor
6721021|NCT01843153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6721022|NCT01843153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721023|NCT01843153|Sensory System Agents|sensory system agents|mesh-ancestor
6721024|NCT01843153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6721025|NCT01843166|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6721026|NCT01843166|Estrogens|estrogens|mesh-ancestor
6721027|NCT01843166|Hormones|hormones|mesh-ancestor
6721028|NCT01843166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6721029|NCT01843166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721030|NCT01843179|Cytarabine|cytarabine|mesh-list
6721031|NCT01843179|Sulindac|sulindac|mesh-list
6721032|NCT01843179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6721033|NCT01843179|Antimetabolites|antimetabolites|mesh-ancestor
6721034|NCT01843179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721035|NCT01843179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6721036|NCT01843179|Antiviral Agents|antiviral agents|mesh-ancestor
6721037|NCT01843179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6721038|NCT01843179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6721039|NCT01843179|Immunologic Factors|immunologic factors|mesh-ancestor
6721040|NCT01843179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721041|NCT01843179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6721042|NCT01843179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6721043|NCT01843179|Analgesics|analgesics|mesh-ancestor
6721044|NCT01843179|Sensory System Agents|sensory system agents|mesh-ancestor
6721045|NCT01843179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6721046|NCT01843179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6721047|NCT01843179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6721048|NCT01843179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6721049|NCT01843179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6721050|NCT01843257|Ethanol|ethanol|mesh-list
6721051|NCT01843257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6721052|NCT01843257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6721053|NCT01843257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6721054|NCT01843257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721055|NCT01843296|Magnesium Sulfate|magnesium sulfate|mesh-list
6721056|NCT01843296|Fentanyl|fentanyl|mesh-list
6721057|NCT01843296|Bupivacaine|bupivacaine|mesh-list
6721058|NCT01843296|Anesthetics, Local|anesthetics, local|mesh-ancestor
6721059|NCT01843296|Anesthetics|anesthetics|mesh-ancestor
6721060|NCT01843296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6721061|NCT01843296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721062|NCT01843296|Sensory System Agents|sensory system agents|mesh-ancestor
6721063|NCT01843296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6721064|NCT01843296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6721065|NCT01843296|Narcotics|narcotics|mesh-ancestor
6721066|NCT01843296|Analgesics|analgesics|mesh-ancestor
6721067|NCT01843296|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6721068|NCT01843296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6721069|NCT01843296|Anesthetics, General|anesthetics, general|mesh-ancestor
6721070|NCT01843296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6721071|NCT01843296|Anticonvulsants|anticonvulsants|mesh-ancestor
6721072|NCT01843296|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6721073|NCT01843296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6721074|NCT01843296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721075|NCT01843296|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6721076|NCT01843296|Tocolytic Agents|tocolytic agents|mesh-ancestor
6721077|NCT01843296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6721078|NCT01843309|Spironolactone|spironolactone|mesh-list
6721079|NCT01843309|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6721080|NCT01843309|Hormone Antagonists|hormone antagonists|mesh-ancestor
6721081|NCT01843309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6721082|NCT01843309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721083|NCT01843309|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6721084|NCT01843309|Diuretics|diuretics|mesh-ancestor
6721085|NCT01843309|Natriuretic Agents|natriuretic agents|mesh-ancestor
6721086|NCT01843439|Pyridoxine|pyridoxine|mesh-list
6721087|NCT01843439|Vitamin B Complex|vitamin b complex|mesh-ancestor
6721088|NCT01843439|Vitamins|vitamins|mesh-ancestor
6721089|NCT01843439|Micronutrients|micronutrients|mesh-ancestor
6721090|NCT01843439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784279|NCT02202005|Nevirapine|nevirapine|mesh-list
6784280|NCT02202005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6784281|NCT02202005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6784282|NCT02202005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6784283|NCT02202005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784284|NCT02202005|Antiviral Agents|antiviral agents|mesh-ancestor
6784285|NCT02202005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6784286|NCT02202005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6784287|NCT02202005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6784288|NCT02202005|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6784289|NCT02202005|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6784290|NCT02202070|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6784291|NCT02202070|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6784292|NCT02202070|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6784293|NCT02202070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6784294|NCT02202070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784295|NCT02202070|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6784296|NCT02202070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6784297|NCT02202070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784298|NCT02202070|Cholinergic Agents|cholinergic agents|mesh-ancestor
6784299|NCT02202070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6784300|NCT02202200|Palbociclib|palbociclib|mesh-list
6784301|NCT02202200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6784302|NCT02202200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6784303|NCT02202200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6784304|NCT02202200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784305|NCT02202239|Fentanyl|fentanyl|mesh-list
6784306|NCT02202239|Midazolam|midazolam|mesh-list
6784307|NCT02202239|Remifentanil|remifentanil|mesh-list
6784308|NCT02202239|Propofol|propofol|mesh-list
6784309|NCT02202239|Etomidate|etomidate|mesh-list
6784310|NCT02202239|Sevoflurane|sevoflurane|mesh-list
6784311|NCT02202239|Cisatracurium|cisatracurium|mesh-list
6784312|NCT02202239|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6784313|NCT02202239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6784314|NCT02202239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784315|NCT02202239|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6784316|NCT02202239|Anesthetics, General|anesthetics, general|mesh-ancestor
6784317|NCT02202239|Anesthetics|anesthetics|mesh-ancestor
6784318|NCT02202239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6784319|NCT02202239|Narcotics|narcotics|mesh-ancestor
6784320|NCT02202239|Analgesics|analgesics|mesh-ancestor
6784321|NCT02202239|Sensory System Agents|sensory system agents|mesh-ancestor
6784322|NCT02202239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6784323|NCT02202239|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6784324|NCT02202239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6784325|NCT02202239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6784326|NCT02202239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6784327|NCT02202239|GABA Modulators|gaba modulators|mesh-ancestor
6784328|NCT02202239|GABA Agents|gaba agents|mesh-ancestor
6784329|NCT02202239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6784330|NCT02202239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784331|NCT02202239|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6784332|NCT02202239|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6784333|NCT02202239|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6784334|NCT02202239|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6784335|NCT02202304|Chlorhexidine|chlorhexidine|mesh-list
6784336|NCT02202304|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6784337|NCT02202304|Thymol|thymol|mesh-list
6721091|NCT01843452|Capecitabine|capecitabine|mesh-list
6721092|NCT01843452|Mitomycins|mitomycins|mesh-list
6721093|NCT01843452|Mitomycin|mitomycin|mesh-list
6721094|NCT01843452|Panitumumab|panitumumab|mesh-list
6721095|NCT01843452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6721096|NCT01843452|Antimetabolites|antimetabolites|mesh-ancestor
6721097|NCT01843452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721098|NCT01843452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6721099|NCT01843452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6721100|NCT01843452|Alkylating Agents|alkylating agents|mesh-ancestor
6721101|NCT01843452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6721102|NCT01843452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6721103|NCT01843452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6721104|NCT01843530|Cortisone|cortisone|mesh-list
6721105|NCT01843530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6721106|NCT01843556|Donepezil|donepezil|mesh-list
6721107|NCT01843556|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6721108|NCT01843556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6721109|NCT01843556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721110|NCT01843556|Cholinergic Agents|cholinergic agents|mesh-ancestor
6721111|NCT01843556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6721112|NCT01843556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721113|NCT01843556|Nootropic Agents|nootropic agents|mesh-ancestor
6721114|NCT01843647|Cisplatin|cisplatin|mesh-list
6721115|NCT01843647|Vinorelbine|vinorelbine|mesh-list
6721116|NCT01843647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6721117|NCT01843647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6721118|NCT01843647|Tubulin Modulators|tubulin modulators|mesh-ancestor
6721119|NCT01843647|Antimitotic Agents|antimitotic agents|mesh-ancestor
6721120|NCT01843647|Mitosis Modulators|mitosis modulators|mesh-ancestor
6721121|NCT01843647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721122|NCT01843699|Topiramate|topiramate|mesh-list
6721123|NCT01843699|Anticonvulsants|anticonvulsants|mesh-ancestor
6721124|NCT01843699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6721125|NCT01843699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721126|NCT01843725|Capecitabine|capecitabine|mesh-list
6721127|NCT01843725|Aflibercept|aflibercept|mesh-list
6721128|NCT01843725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6721129|NCT01843725|Antimetabolites|antimetabolites|mesh-ancestor
6721130|NCT01843725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721131|NCT01843725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6721132|NCT01843725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6721133|NCT01843725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6721134|NCT01843725|Growth Substances|growth substances|mesh-ancestor
6721135|NCT01843725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721136|NCT01843725|Growth Inhibitors|growth inhibitors|mesh-ancestor
6721137|NCT01843738|Vemurafenib|vemurafenib|mesh-list
6721138|NCT01843738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6721139|NCT01843738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6721140|NCT01843738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6721141|NCT01843738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721142|NCT01843829|Paclitaxel|paclitaxel|mesh-list
6721143|NCT01843829|Carboplatin|carboplatin|mesh-list
6721144|NCT01843829|Capecitabine|capecitabine|mesh-list
6721145|NCT01843829|Oxaliplatin|oxaliplatin|mesh-list
6721146|NCT01843829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6721147|NCT01843829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6721148|NCT01843829|Tubulin Modulators|tubulin modulators|mesh-ancestor
6721149|NCT01843829|Antimitotic Agents|antimitotic agents|mesh-ancestor
6721150|NCT01843829|Mitosis Modulators|mitosis modulators|mesh-ancestor
6721151|NCT01843829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721152|NCT01843829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6721153|NCT01843829|Antimetabolites|antimetabolites|mesh-ancestor
6721154|NCT01843868|Prednisolone|prednisolone|mesh-list
6721155|NCT01843868|Cyclophosphamide|cyclophosphamide|mesh-list
6721156|NCT01843868|Doxorubicin|doxorubicin|mesh-list
6721157|NCT01843868|Vincristine|vincristine|mesh-list
6721158|NCT01843868|Lorazepam|lorazepam|mesh-list
6721159|NCT01843868|Ondansetron|ondansetron|mesh-list
6721160|NCT01843868|Aprepitant|aprepitant|mesh-list
6721161|NCT01843868|Palonosetron|palonosetron|mesh-list
6721162|NCT01843868|Metoclopramide|metoclopramide|mesh-list
6721163|NCT01843868|Granisetron|granisetron|mesh-list
6721164|NCT01843868|Prochlorperazine|prochlorperazine|mesh-list
6721165|NCT01843868|Tropisetron|tropisetron|mesh-list
6721166|NCT01843868|Antiemetics|antiemetics|mesh-list
6721167|NCT01843868|Emetics|emetics|mesh-list
6721168|NCT01843868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6721169|NCT01843868|Immunologic Factors|immunologic factors|mesh-ancestor
6721170|NCT01843868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721171|NCT01843868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6721172|NCT01843868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6721173|NCT01843868|Alkylating Agents|alkylating agents|mesh-ancestor
6721174|NCT01843868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721175|NCT01843868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6721176|NCT01843868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6721177|NCT01843868|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6721178|NCT01843868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6721179|NCT01843868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6721180|NCT01843868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6721181|NCT01843868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6721182|NCT01843868|Tubulin Modulators|tubulin modulators|mesh-ancestor
6721183|NCT01843868|Antimitotic Agents|antimitotic agents|mesh-ancestor
6721184|NCT01843868|Mitosis Modulators|mitosis modulators|mesh-ancestor
6721185|NCT01843868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6721186|NCT01843868|Glucocorticoids|glucocorticoids|mesh-ancestor
6721187|NCT01843868|Hormones|hormones|mesh-ancestor
6721188|NCT01843868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6721189|NCT01843868|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6721190|NCT01843868|Autonomic Agents|autonomic agents|mesh-ancestor
6721191|NCT01843868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6721192|NCT01843868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6721193|NCT01843868|Antipruritics|antipruritics|mesh-ancestor
6721194|NCT01843868|Dermatologic Agents|dermatologic agents|mesh-ancestor
6721195|NCT01843868|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6721196|NCT01843868|Serotonin Agents|serotonin agents|mesh-ancestor
6721197|NCT01843868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6721198|NCT01843868|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6721199|NCT01843868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6721200|NCT01843868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6721201|NCT01843868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6721202|NCT01843868|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6721203|NCT01843868|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6721204|NCT01843868|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6721205|NCT01843868|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6721206|NCT01843868|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6721207|NCT01843868|Dopamine Agents|dopamine agents|mesh-ancestor
6721208|NCT01843868|Anticonvulsants|anticonvulsants|mesh-ancestor
6721209|NCT01843868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6721210|NCT01843868|GABA Modulators|gaba modulators|mesh-ancestor
6721211|NCT01843868|GABA Agents|gaba agents|mesh-ancestor
6721212|NCT01843998|Sirolimus|sirolimus|mesh-list
6721213|NCT01843998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6721214|NCT01843998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6721215|NCT01843998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6721216|NCT01843998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6721217|NCT01843998|Antifungal Agents|antifungal agents|mesh-ancestor
6721218|NCT01843998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6721219|NCT01843998|Immunologic Factors|immunologic factors|mesh-ancestor
6721220|NCT01843998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721221|NCT01844024|Misoprostol|misoprostol|mesh-list
6721222|NCT01844024|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6721223|NCT01844024|Abortifacient Agents|abortifacient agents|mesh-ancestor
6721224|NCT01844024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6721225|NCT01844024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721226|NCT01844024|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6721227|NCT01844024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6721228|NCT01844024|Oxytocics|oxytocics|mesh-ancestor
6721229|NCT01844063|Antiviral Agents|antiviral agents|mesh-list
6721230|NCT01844063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6721231|NCT01844141|Ethanol|ethanol|mesh-list
6721232|NCT01844141|Chlorhexidine|chlorhexidine|mesh-list
6721233|NCT01844141|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6721234|NCT01844141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6721235|NCT01844141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6721236|NCT01844141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6721237|NCT01844141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721238|NCT01844141|Disinfectants|disinfectants|mesh-ancestor
6721239|NCT01844141|Dermatologic Agents|dermatologic agents|mesh-ancestor
6721240|NCT01844323|Palbociclib|palbociclib|mesh-list
6721241|NCT01844323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6721242|NCT01844323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6721243|NCT01844323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6721244|NCT01844323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721245|NCT01844401|Albuterol|albuterol|mesh-list
6721246|NCT01844401|Procaterol|procaterol|mesh-list
6721247|NCT01844401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6721248|NCT01844401|Autonomic Agents|autonomic agents|mesh-ancestor
6721249|NCT01844401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6721250|NCT01844401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721251|NCT01844401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6721252|NCT01844401|Respiratory System Agents|respiratory system agents|mesh-ancestor
6721253|NCT01844401|Tocolytic Agents|tocolytic agents|mesh-ancestor
6721254|NCT01844401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6721255|NCT01844401|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6721256|NCT01844401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6721257|NCT01844401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6721258|NCT01844401|Adrenergic Agents|adrenergic agents|mesh-ancestor
6721259|NCT01844401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6721260|NCT01844401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721261|NCT01844401|Sympathomimetics|sympathomimetics|mesh-ancestor
6721262|NCT01844427|Memantine|memantine|mesh-list
6721263|NCT01844427|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6721264|NCT01844427|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6721265|NCT01844427|Dopamine Agents|dopamine agents|mesh-ancestor
6721266|NCT01844427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6721267|NCT01844427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721268|NCT01844427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721269|NCT01844427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6721270|NCT01844427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6721271|NCT01844622|Domperidone|domperidone|mesh-list
6721272|NCT01844622|Antiemetics|antiemetics|mesh-ancestor
6721273|NCT01844622|Autonomic Agents|autonomic agents|mesh-ancestor
6721274|NCT01844622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6721275|NCT01844622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721276|NCT01844622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6721277|NCT01844622|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6721278|NCT01844622|Dopamine Agents|dopamine agents|mesh-ancestor
6721279|NCT01844622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6721280|NCT01844622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721281|NCT01844635|Thymoglobulin|thymoglobulin|mesh-list
6721282|NCT01844635|Immunologic Factors|immunologic factors|mesh-ancestor
6721283|NCT01844635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721284|NCT01844635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6721285|NCT01844648|Tropicamide|tropicamide|mesh-list
6721286|NCT01844648|Mydriatics|mydriatics|mesh-ancestor
6721287|NCT01844648|Autonomic Agents|autonomic agents|mesh-ancestor
6721288|NCT01844648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6721289|NCT01844648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721290|NCT01844648|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6721291|NCT01844648|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6721292|NCT01844648|Cholinergic Agents|cholinergic agents|mesh-ancestor
6721293|NCT01844648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6721294|NCT01844648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721295|NCT01844674|Vemurafenib|vemurafenib|mesh-list
6721296|NCT01844674|Tizanidine|tizanidine|mesh-list
6721297|NCT01844674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6721298|NCT01844674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6721299|NCT01844674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6721300|NCT01844674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721301|NCT01844674|Analgesics|analgesics|mesh-ancestor
6721302|NCT01844674|Sensory System Agents|sensory system agents|mesh-ancestor
6721303|NCT01844674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6721304|NCT01844674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721305|NCT01844674|Anticonvulsants|anticonvulsants|mesh-ancestor
6721306|NCT01844674|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6721307|NCT01844674|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6721308|NCT01844674|Parasympatholytics|parasympatholytics|mesh-ancestor
6721309|NCT01844674|Autonomic Agents|autonomic agents|mesh-ancestor
6721310|NCT01844674|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6721311|NCT01844674|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6721312|NCT01844674|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6721313|NCT01844674|Adrenergic Agents|adrenergic agents|mesh-ancestor
6721314|NCT01844674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6721315|NCT01844791|Gemcitabine|gemcitabine|mesh-list
6721316|NCT01844791|Pentamidine|pentamidine|mesh-list
6721317|NCT01844791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6721318|NCT01844791|Antimetabolites|antimetabolites|mesh-ancestor
6721319|NCT01844791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721320|NCT01844791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6721321|NCT01844791|Antiviral Agents|antiviral agents|mesh-ancestor
6721322|NCT01844791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6721323|NCT01844791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6721324|NCT01844791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6721325|NCT01844791|Immunologic Factors|immunologic factors|mesh-ancestor
6721326|NCT01844791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721327|NCT01844791|Antifungal Agents|antifungal agents|mesh-ancestor
6721328|NCT01844791|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6721329|NCT01844791|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6721330|NCT01844791|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6721331|NCT01844804|Infliximab|infliximab|mesh-list
6721332|NCT01844804|Dermatologic Agents|dermatologic agents|mesh-ancestor
6721333|NCT01844804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6721334|NCT01844804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6721335|NCT01844869|Homoharringtonine|homoharringtonine|mesh-list
6721336|NCT01844869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6721337|NCT01844869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6721338|NCT01844869|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6721339|NCT01844869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6721340|NCT01844869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721341|NCT01844947|Sorafenib|sorafenib|mesh-list
6721342|NCT01844947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6721343|NCT01844947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6721344|NCT01844947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6721345|NCT01844947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721346|NCT01845012|Dialysis Solutions|dialysis solutions|mesh-list
6721347|NCT01845012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6721348|NCT01845038|Timolol|timolol|mesh-list
6721349|NCT01845038|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6721350|NCT01845038|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6721351|NCT01845038|Adrenergic Agents|adrenergic agents|mesh-ancestor
6721352|NCT01845038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6721353|NCT01845038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721354|NCT01845038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721355|NCT01845038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6721356|NCT01845038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6721357|NCT01845064|Kallikreins|kallikreins|mesh-list
6721358|NCT01845064|Coagulants|coagulants|mesh-ancestor
6721359|NCT01845064|Fertility Agents, Male|fertility agents, male|mesh-ancestor
6721360|NCT01845064|Fertility Agents|fertility agents|mesh-ancestor
6721361|NCT01845064|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6721362|NCT01845064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721363|NCT01845090|Calcium Carbonate|calcium carbonate|mesh-list
6721364|NCT01845090|Calcium|calcium|mesh-list
6721365|NCT01845090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6721366|NCT01845090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721367|NCT01845090|Antacids|antacids|mesh-ancestor
6721368|NCT01845090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721369|NCT01845090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6721370|NCT01845142|Vitamin D|vitamin d|mesh-list
6721371|NCT01845142|Cholecalciferol|cholecalciferol|mesh-list
6721372|NCT01845142|Vitamins|vitamins|mesh-ancestor
6721373|NCT01845142|Micronutrients|micronutrients|mesh-ancestor
6721374|NCT01845142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721375|NCT01845142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6721376|NCT01845142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6721377|NCT01845194|Metoprolol|metoprolol|mesh-list
6721378|NCT01845194|Talinolol|talinolol|mesh-list
6721379|NCT01845194|Torsemide|torsemide|mesh-list
6721380|NCT01845194|Midazolam|midazolam|mesh-list
6721381|NCT01845194|Codeine|codeine|mesh-list
6721382|NCT01845194|Caffeine|caffeine|mesh-list
6721383|NCT01845194|Pravastatin|pravastatin|mesh-list
6721384|NCT01845194|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6721385|NCT01845194|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6721386|NCT01845194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6721387|NCT01845194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721388|NCT01845194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6721389|NCT01845194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6721390|NCT01845194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6721391|NCT01845194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6721392|NCT01845194|Anesthetics, General|anesthetics, general|mesh-ancestor
6721393|NCT01845194|Anesthetics|anesthetics|mesh-ancestor
6721394|NCT01845194|GABA Modulators|gaba modulators|mesh-ancestor
6721395|NCT01845194|GABA Agents|gaba agents|mesh-ancestor
6721396|NCT01845194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6721397|NCT01845194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721398|NCT01845194|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6721399|NCT01845194|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6721400|NCT01845194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6721401|NCT01845194|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6721402|NCT01845194|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6721403|NCT01845194|Purinergic Agents|purinergic agents|mesh-ancestor
6721404|NCT01845194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6721405|NCT01845194|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6721406|NCT01845194|Sympatholytics|sympatholytics|mesh-ancestor
6721407|NCT01845194|Autonomic Agents|autonomic agents|mesh-ancestor
6721408|NCT01845194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6721409|NCT01845194|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6721410|NCT01845194|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6721411|NCT01845194|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6721412|NCT01845194|Adrenergic Agents|adrenergic agents|mesh-ancestor
6721413|NCT01845194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6721414|NCT01845194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6721415|NCT01845194|Antimetabolites|antimetabolites|mesh-ancestor
6721416|NCT01845194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6721417|NCT01845194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6721418|NCT01845194|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6721419|NCT01845194|Narcotics|narcotics|mesh-ancestor
6721420|NCT01845194|Analgesics|analgesics|mesh-ancestor
6721421|NCT01845194|Sensory System Agents|sensory system agents|mesh-ancestor
6721422|NCT01845194|Antitussive Agents|antitussive agents|mesh-ancestor
6721423|NCT01845194|Respiratory System Agents|respiratory system agents|mesh-ancestor
6721424|NCT01845194|Diuretics|diuretics|mesh-ancestor
6721425|NCT01845194|Natriuretic Agents|natriuretic agents|mesh-ancestor
6721426|NCT01845194|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6721427|NCT01845194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6721428|NCT01845246|Colistin|colistin|mesh-list
6721429|NCT01845246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6721430|NCT01845246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6721431|NCT01845259|Liraglutide|liraglutide|mesh-list
6721432|NCT01845259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6721433|NCT01845259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721434|NCT01845259|Incretins|incretins|mesh-ancestor
6721435|NCT01845259|Hormones|hormones|mesh-ancestor
6721436|NCT01845259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6721437|NCT01845272|Amlodipine|amlodipine|mesh-list
6721438|NCT01845272|Candesartan|candesartan|mesh-list
6721439|NCT01845272|Candesartan cilexetil|candesartan cilexetil|mesh-list
6721440|NCT01845272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6721441|NCT01845272|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6721442|NCT01845272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6721443|NCT01845272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721444|NCT01845272|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6721445|NCT01845272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721446|NCT01845272|Vasodilator Agents|vasodilator agents|mesh-ancestor
6721447|NCT01845272|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6721448|NCT01845272|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6784338|NCT02202304|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6784339|NCT02202304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6784340|NCT02202304|Disinfectants|disinfectants|mesh-ancestor
6784341|NCT02202304|Dermatologic Agents|dermatologic agents|mesh-ancestor
6784342|NCT02202304|Antifungal Agents|antifungal agents|mesh-ancestor
6784343|NCT02202473|Lamivudine|lamivudine|mesh-list
6784344|NCT02202473|Oxymatrine|oxymatrine|mesh-list
6784345|NCT02202473|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6784346|NCT02202473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6784347|NCT02202473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6784348|NCT02202473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784349|NCT02202473|Antiviral Agents|antiviral agents|mesh-ancestor
6784350|NCT02202473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6784351|NCT02202473|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6784352|NCT02202473|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6784353|NCT02202473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6784354|NCT02202512|Naproxen|naproxen|mesh-list
6784355|NCT02202512|Cimetidine|cimetidine|mesh-list
6784356|NCT02202512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6784357|NCT02202512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6784358|NCT02202512|Analgesics|analgesics|mesh-ancestor
6784359|NCT02202512|Sensory System Agents|sensory system agents|mesh-ancestor
6784360|NCT02202512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6784361|NCT02202512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784362|NCT02202512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6784363|NCT02202512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6721449|NCT01845298|Rifampin|rifampin|mesh-list
6721450|NCT01845298|Rifamycins|rifamycins|mesh-list
6721451|NCT01845298|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6721452|NCT01845298|Antitubercular Agents|antitubercular agents|mesh-ancestor
6721453|NCT01845298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6721454|NCT01845298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6721455|NCT01845298|Leprostatic Agents|leprostatic agents|mesh-ancestor
6721456|NCT01845298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6721457|NCT01845298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6721458|NCT01845298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721459|NCT01845298|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6721460|NCT01845298|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6721461|NCT01845298|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6721462|NCT01845298|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6721463|NCT01845298|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6721464|NCT01845298|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6721465|NCT01845337|Capecitabine|capecitabine|mesh-list
6721466|NCT01845337|Tegafur|tegafur|mesh-list
6721467|NCT01845337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6721468|NCT01845337|Antimetabolites|antimetabolites|mesh-ancestor
6721469|NCT01845337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721470|NCT01845337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6721471|NCT01845363|Anti-Infective Agents|anti-infective agents|mesh-list
6721472|NCT01845363|Cefazolin|cefazolin|mesh-list
6721473|NCT01845363|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6721474|NCT01845376|Anesthetics|anesthetics|mesh-list
6721475|NCT01845376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6721476|NCT01845376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721477|NCT01845428|Pravastatin|pravastatin|mesh-list
6721478|NCT01845428|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6721479|NCT01845428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6721480|NCT01845428|Antimetabolites|antimetabolites|mesh-ancestor
6721481|NCT01845428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721482|NCT01845428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6721483|NCT01845428|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6721484|NCT01845428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6721485|NCT01845441|Fentanyl|fentanyl|mesh-list
6721486|NCT01845441|Midazolam|midazolam|mesh-list
6721487|NCT01845441|Dexmedetomidine|dexmedetomidine|mesh-list
6721488|NCT01845441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6721489|NCT01845441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6721490|NCT01845441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721491|NCT01845441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6721492|NCT01845441|Analgesics|analgesics|mesh-ancestor
6721493|NCT01845441|Sensory System Agents|sensory system agents|mesh-ancestor
6721494|NCT01845441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6721495|NCT01845441|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6721496|NCT01845441|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6721497|NCT01845441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6721498|NCT01845441|Adrenergic Agents|adrenergic agents|mesh-ancestor
6721499|NCT01845441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6721500|NCT01845441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721501|NCT01845441|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6721502|NCT01845441|Narcotics|narcotics|mesh-ancestor
6721503|NCT01845441|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6721504|NCT01845441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6721505|NCT01845441|Anesthetics, General|anesthetics, general|mesh-ancestor
6721506|NCT01845441|Anesthetics|anesthetics|mesh-ancestor
6721507|NCT01845441|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6721508|NCT01845441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6721509|NCT01845441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6721510|NCT01845441|GABA Modulators|gaba modulators|mesh-ancestor
6721511|NCT01845441|GABA Agents|gaba agents|mesh-ancestor
6721512|NCT01845493|Sulforaphane|sulforaphane|mesh-list
6721513|NCT01845493|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6721514|NCT01845493|Protective Agents|protective agents|mesh-ancestor
6721515|NCT01845493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721516|NCT01845493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6721517|NCT01845532|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
6721518|NCT01845532|Anesthetics, Local|anesthetics, local|mesh-ancestor
6721519|NCT01845532|Anesthetics|anesthetics|mesh-ancestor
6721520|NCT01845532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6721521|NCT01845532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721522|NCT01845532|Sensory System Agents|sensory system agents|mesh-ancestor
6721523|NCT01845532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6721524|NCT01845532|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
6721525|NCT01845558|Wobenzym|wobenzym|mesh-list
6721526|NCT01845558|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6721527|NCT01845558|Immunologic Factors|immunologic factors|mesh-ancestor
6721528|NCT01845558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721529|NCT01845584|Immunoglobulins|immunoglobulins|mesh-list
6721530|NCT01845584|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6721531|NCT01845584|gamma-Globulins|gamma-globulins|mesh-list
6721532|NCT01845584|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6721533|NCT01845584|Immunologic Factors|immunologic factors|mesh-ancestor
6721534|NCT01845584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721535|NCT01845610|Manganese|manganese|mesh-list
6721536|NCT01845610|Trace Elements|trace elements|mesh-ancestor
6721537|NCT01845610|Micronutrients|micronutrients|mesh-ancestor
6721538|NCT01845610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721539|NCT01845675|Temozolomide|temozolomide|mesh-list
6721540|NCT01845675|Dacarbazine|dacarbazine|mesh-list
6721541|NCT01845675|Endostatins|endostatins|mesh-list
6721542|NCT01845675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6721543|NCT01845675|Alkylating Agents|alkylating agents|mesh-ancestor
6721544|NCT01845675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721545|NCT01845675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6721546|NCT01845675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6721547|NCT01845675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6721548|NCT01845675|Growth Substances|growth substances|mesh-ancestor
6721549|NCT01845675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721550|NCT01845675|Growth Inhibitors|growth inhibitors|mesh-ancestor
6721551|NCT01845688|Losartan|losartan|mesh-list
6721552|NCT01845688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6721553|NCT01845688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6721554|NCT01845688|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6721555|NCT01845688|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6721556|NCT01845688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721557|NCT01845701|Artesunate|artesunate|mesh-list
6721558|NCT01845701|Lumefantrine|lumefantrine|mesh-list
6721559|NCT01845701|Artemether|artemether|mesh-list
6721560|NCT01845701|Piperaquine|piperaquine|mesh-list
6721561|NCT01845701|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6721562|NCT01845701|Amodiaquine|amodiaquine|mesh-list
6721563|NCT01845701|Artenimol|artenimol|mesh-list
6721564|NCT01845701|Antimalarials|antimalarials|mesh-ancestor
6721565|NCT01845701|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6721566|NCT01845701|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6721567|NCT01845701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6721568|NCT01845701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6721569|NCT01845701|Antiviral Agents|antiviral agents|mesh-ancestor
6721570|NCT01845701|Schistosomicides|schistosomicides|mesh-ancestor
6721571|NCT01845701|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6721572|NCT01845701|Anthelmintics|anthelmintics|mesh-ancestor
6721573|NCT01845727|Amphotericin B|amphotericin b|mesh-list
6721574|NCT01845727|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6721575|NCT01845727|Amebicides|amebicides|mesh-ancestor
6721576|NCT01845727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6721577|NCT01845727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6721578|NCT01845727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6721579|NCT01845727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6721580|NCT01845727|Antifungal Agents|antifungal agents|mesh-ancestor
6721581|NCT01845805|Gemcitabine|gemcitabine|mesh-list
6721582|NCT01845805|Azacitidine|azacitidine|mesh-list
6721583|NCT01845805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6721584|NCT01845805|Antimetabolites|antimetabolites|mesh-ancestor
6721585|NCT01845805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721586|NCT01845805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6721587|NCT01845805|Antiviral Agents|antiviral agents|mesh-ancestor
6721588|NCT01845805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6721589|NCT01845805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6721590|NCT01845805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6721591|NCT01845805|Immunologic Factors|immunologic factors|mesh-ancestor
6721592|NCT01845805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721593|NCT01845844|Ranibizumab|ranibizumab|mesh-list
6721594|NCT01845844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6721595|NCT01845844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6721596|NCT01845844|Growth Substances|growth substances|mesh-ancestor
6721597|NCT01845844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721598|NCT01845844|Growth Inhibitors|growth inhibitors|mesh-ancestor
6721599|NCT01845844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6721600|NCT01846026|Vitamin D|vitamin d|mesh-list
6721601|NCT01846026|Cholecalciferol|cholecalciferol|mesh-list
6721602|NCT01846026|Vitamins|vitamins|mesh-ancestor
6721603|NCT01846026|Micronutrients|micronutrients|mesh-ancestor
6721604|NCT01846026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721605|NCT01846026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6721606|NCT01846026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6721607|NCT01846117|Vitamin D|vitamin d|mesh-list
6721608|NCT01846117|Secoisolariciresinol|secoisolariciresinol|mesh-list
6721609|NCT01846117|Vitamins|vitamins|mesh-ancestor
6721610|NCT01846117|Micronutrients|micronutrients|mesh-ancestor
6721611|NCT01846117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721612|NCT01846117|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6721613|NCT01846117|Phytoestrogens|phytoestrogens|mesh-ancestor
6721614|NCT01846117|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6721615|NCT01846117|Estrogens|estrogens|mesh-ancestor
6721616|NCT01846117|Hormones|hormones|mesh-ancestor
6721617|NCT01846117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6721618|NCT01846143|Poly ICLC|poly iclc|mesh-list
6721619|NCT01846143|Immunologic Factors|immunologic factors|mesh-ancestor
6721620|NCT01846143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721621|NCT01846143|Interferon Inducers|interferon inducers|mesh-ancestor
6721622|NCT01846273|Ranibizumab|ranibizumab|mesh-list
6721623|NCT01846273|Verteporfin|verteporfin|mesh-list
6721624|NCT01846273|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6721625|NCT01846273|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6721626|NCT01846273|Growth Substances|growth substances|mesh-ancestor
6721627|NCT01846273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721628|NCT01846273|Growth Inhibitors|growth inhibitors|mesh-ancestor
6721629|NCT01846273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6721630|NCT01846273|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6721631|NCT01846273|Dermatologic Agents|dermatologic agents|mesh-ancestor
6721632|NCT01846325|Vitamin E|vitamin e|mesh-list
6721633|NCT01846325|Vitamins|vitamins|mesh-ancestor
6721634|NCT01846325|Micronutrients|micronutrients|mesh-ancestor
6721635|NCT01846325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721636|NCT01846325|Antioxidants|antioxidants|mesh-ancestor
6721637|NCT01846325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721638|NCT01846325|Protective Agents|protective agents|mesh-ancestor
6721639|NCT01846364|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
6721640|NCT01846364|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6721641|NCT01846364|Protective Agents|protective agents|mesh-ancestor
6721642|NCT01846364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721643|NCT01846364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6721644|NCT01846390|Gemcitabine|gemcitabine|mesh-list
6721645|NCT01846390|Dexamethasone|dexamethasone|mesh-list
6721646|NCT01846390|Romidepsin|romidepsin|mesh-list
6721647|NCT01846390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6721648|NCT01846390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6721649|NCT01846390|Antiemetics|antiemetics|mesh-ancestor
6721650|NCT01846390|Autonomic Agents|autonomic agents|mesh-ancestor
6721651|NCT01846390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6721652|NCT01846390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721653|NCT01846390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6721654|NCT01846390|Glucocorticoids|glucocorticoids|mesh-ancestor
6721655|NCT01846390|Hormones|hormones|mesh-ancestor
6721656|NCT01846390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6721657|NCT01846390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6721658|NCT01846390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6721659|NCT01846390|Antimetabolites|antimetabolites|mesh-ancestor
6721660|NCT01846390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721661|NCT01846390|Antiviral Agents|antiviral agents|mesh-ancestor
6721662|NCT01846390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6721663|NCT01846390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6721664|NCT01846390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6721665|NCT01846390|Immunologic Factors|immunologic factors|mesh-ancestor
6721666|NCT01846390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6721667|NCT01846559|Clopidogrel|clopidogrel|mesh-list
6721668|NCT01846559|Ticagrelor|ticagrelor|mesh-list
6721669|NCT01846559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6721670|NCT01846559|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6721671|NCT01846559|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6721672|NCT01846559|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6721673|NCT01846559|Purinergic Agents|purinergic agents|mesh-ancestor
6721674|NCT01846559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6721675|NCT01846559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721676|NCT01846559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721677|NCT01846650|Capecitabine|capecitabine|mesh-list
6721678|NCT01846650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6721679|NCT01846650|Antimetabolites|antimetabolites|mesh-ancestor
6721680|NCT01846650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721681|NCT01846650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6721682|NCT01846806|Rifaximin|rifaximin|mesh-list
6721683|NCT01846806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6721684|NCT01846806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6721685|NCT01846806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6721686|NCT01846832|Interferons|interferons|mesh-list
6721687|NCT01846832|Ribavirin|ribavirin|mesh-list
6721688|NCT01846832|Interferon-alpha|interferon-alpha|mesh-list
6721689|NCT01846832|Interferon alpha-2|interferon alpha-2|mesh-list
6721690|NCT01846832|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6721691|NCT01846832|Simeprevir|simeprevir|mesh-list
6721692|NCT01846832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6721693|NCT01846832|Antiviral Agents|antiviral agents|mesh-ancestor
6721694|NCT01846832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6721695|NCT01846832|Antimetabolites|antimetabolites|mesh-ancestor
6721696|NCT01846832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721697|NCT01846832|Immunologic Factors|immunologic factors|mesh-ancestor
6721698|NCT01846832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721699|NCT01846832|Protease Inhibitors|protease inhibitors|mesh-ancestor
6721700|NCT01846832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6721701|NCT01846962|Fluticasone|fluticasone|mesh-list
6721702|NCT01846962|Budesonide|budesonide|mesh-list
6721703|NCT01846962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6721704|NCT01846962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6721705|NCT01846962|Autonomic Agents|autonomic agents|mesh-ancestor
6721706|NCT01846962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6721707|NCT01846962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721708|NCT01846962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6721709|NCT01846962|Respiratory System Agents|respiratory system agents|mesh-ancestor
6721710|NCT01846962|Dermatologic Agents|dermatologic agents|mesh-ancestor
6721711|NCT01846962|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6721712|NCT01846962|Glucocorticoids|glucocorticoids|mesh-ancestor
6721713|NCT01846962|Hormones|hormones|mesh-ancestor
6721714|NCT01846962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6721715|NCT01846975|Abatacept|abatacept|mesh-list
6721716|NCT01846975|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6721717|NCT01846975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721718|NCT01846975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6721719|NCT01846975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6721720|NCT01846975|Immunologic Factors|immunologic factors|mesh-ancestor
6721721|NCT01846975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721722|NCT01846975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6784364|NCT02202512|Gout Suppressants|gout suppressants|mesh-ancestor
6784365|NCT02202512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6784366|NCT02202512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6784367|NCT02202512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784368|NCT02202512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6784369|NCT02202512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6784370|NCT02202512|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6784371|NCT02202512|Histamine Antagonists|histamine antagonists|mesh-ancestor
6784372|NCT02202512|Histamine Agents|histamine agents|mesh-ancestor
6784373|NCT02202512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6784374|NCT02202512|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6784375|NCT02202512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6784376|NCT02202525|Telmisartan|telmisartan|mesh-list
6784377|NCT02202525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6784378|NCT02202525|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6784379|NCT02202525|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6784380|NCT02202525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784381|NCT02202564|Ganciclovir|ganciclovir|mesh-list
6784382|NCT02202564|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6784383|NCT02202564|Antiviral Agents|antiviral agents|mesh-ancestor
6784384|NCT02202564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6784385|NCT02202564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6784386|NCT02202564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6784387|NCT02202564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784388|NCT02202577|Chlorhexidine|chlorhexidine|mesh-list
6784389|NCT02202577|Povidone-Iodine|povidone-iodine|mesh-list
6784390|NCT02202577|Povidone|povidone|mesh-list
6784391|NCT02202577|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6784392|NCT02202577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6784393|NCT02202577|Disinfectants|disinfectants|mesh-ancestor
6784394|NCT02202577|Plasma Substitutes|plasma substitutes|mesh-ancestor
6784395|NCT02202577|Blood Substitutes|blood substitutes|mesh-ancestor
6784396|NCT02202603|Teriparatide|teriparatide|mesh-list
6784397|NCT02202603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6784398|NCT02202603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784399|NCT02202603|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6784400|NCT02202707|Gabapentin|gabapentin|mesh-list
6784401|NCT02202707|Analgesics|analgesics|mesh-ancestor
6784402|NCT02202707|Sensory System Agents|sensory system agents|mesh-ancestor
6784403|NCT02202707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6784404|NCT02202707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784405|NCT02202707|Anticonvulsants|anticonvulsants|mesh-ancestor
6784406|NCT02202707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6784407|NCT02202707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6784408|NCT02202707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6721723|NCT01847144|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6721724|NCT01847144|Gliclazide|gliclazide|mesh-list
6721725|NCT01847144|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
6721726|NCT01847144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6721727|NCT01847144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721728|NCT01847144|Incretins|incretins|mesh-ancestor
6721729|NCT01847144|Hormones|hormones|mesh-ancestor
6721730|NCT01847144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6721731|NCT01847144|Protease Inhibitors|protease inhibitors|mesh-ancestor
6721732|NCT01847144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6721733|NCT01847144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721734|NCT01847157|Anesthetics|anesthetics|mesh-list
6721735|NCT01847157|Prilocaine|prilocaine|mesh-list
6721736|NCT01847157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6721737|NCT01847157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721738|NCT01847157|Anesthetics, Local|anesthetics, local|mesh-ancestor
6721739|NCT01847157|Sensory System Agents|sensory system agents|mesh-ancestor
6721740|NCT01847157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6721741|NCT01847235|Temozolomide|temozolomide|mesh-list
6721742|NCT01847235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6721743|NCT01847235|Alkylating Agents|alkylating agents|mesh-ancestor
6721744|NCT01847235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721745|NCT01847235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6721746|NCT01847326|Paclitaxel|paclitaxel|mesh-list
6721747|NCT01847326|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6721748|NCT01847326|Carboplatin|carboplatin|mesh-list
6721749|NCT01847326|Fluorouracil|fluorouracil|mesh-list
6721750|NCT01847326|Hydroxyurea|hydroxyurea|mesh-list
6721751|NCT01847326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6721752|NCT01847326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6721753|NCT01847326|Tubulin Modulators|tubulin modulators|mesh-ancestor
6721754|NCT01847326|Antimitotic Agents|antimitotic agents|mesh-ancestor
6721755|NCT01847326|Mitosis Modulators|mitosis modulators|mesh-ancestor
6721756|NCT01847326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721757|NCT01847326|Antimetabolites|antimetabolites|mesh-ancestor
6721758|NCT01847326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6721759|NCT01847326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6721760|NCT01847326|Immunologic Factors|immunologic factors|mesh-ancestor
6721761|NCT01847326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721762|NCT01847326|Antisickling Agents|antisickling agents|mesh-ancestor
6721763|NCT01847326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6721764|NCT01847326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6721765|NCT01847339|Bupivacaine|bupivacaine|mesh-list
6721766|NCT01847339|Anesthetics, Local|anesthetics, local|mesh-ancestor
6721767|NCT01847339|Anesthetics|anesthetics|mesh-ancestor
6721768|NCT01847339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6721769|NCT01847339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721770|NCT01847339|Sensory System Agents|sensory system agents|mesh-ancestor
6721771|NCT01847339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6721772|NCT01847404|Aspirin|aspirin|mesh-list
6721773|NCT01847404|Pantoprazole|pantoprazole|mesh-list
6721774|NCT01847404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6721775|NCT01847404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6721776|NCT01847404|Analgesics|analgesics|mesh-ancestor
6721777|NCT01847404|Sensory System Agents|sensory system agents|mesh-ancestor
6721778|NCT01847404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6721779|NCT01847404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721780|NCT01847404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6721781|NCT01847404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6721782|NCT01847404|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6721783|NCT01847404|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6721784|NCT01847404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721785|NCT01847404|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6721786|NCT01847404|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6721787|NCT01847404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6721788|NCT01847404|Antipyretics|antipyretics|mesh-ancestor
6721789|NCT01847404|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6721790|NCT01847404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6721791|NCT01847404|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6721792|NCT01847417|Pantoprazole|pantoprazole|mesh-list
6721793|NCT01847417|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6721794|NCT01847417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6721795|NCT01847417|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6721796|NCT01847417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6721797|NCT01847417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721798|NCT01847456|Insulin|insulin|mesh-list
6721799|NCT01847456|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6721800|NCT01847456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6721801|NCT01847456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721802|NCT01847495|Irinotecan|irinotecan|mesh-list
6721803|NCT01847495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6721804|NCT01847495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6721805|NCT01847495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6721806|NCT01847495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721807|NCT01847495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6721808|NCT01847521|Quercetin|quercetin|mesh-list
6721809|NCT01847521|Antioxidants|antioxidants|mesh-ancestor
6721810|NCT01847521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721811|NCT01847521|Protective Agents|protective agents|mesh-ancestor
6721812|NCT01847521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721813|NCT01847599|Capecitabine|capecitabine|mesh-list
6721814|NCT01847599|Lapatinib|lapatinib|mesh-list
6721815|NCT01847599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6721816|NCT01847599|Antimetabolites|antimetabolites|mesh-ancestor
6721817|NCT01847599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721818|NCT01847599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6721819|NCT01847599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6721820|NCT01847599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6721821|NCT01847612|Methylene Blue|methylene blue|mesh-list
6721822|NCT01847612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6721823|NCT01847612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721824|NCT01847664|Rifamycins|rifamycins|mesh-list
6721825|NCT01847664|Rifamycin SV|rifamycin sv|mesh-list
6721826|NCT01847664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6721827|NCT01847664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6721828|NCT01847664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6721829|NCT01847677|Paclitaxel|paclitaxel|mesh-list
6721830|NCT01847677|Bevacizumab|bevacizumab|mesh-list
6721831|NCT01847677|Carboplatin|carboplatin|mesh-list
6721832|NCT01847677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6721833|NCT01847677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6721834|NCT01847677|Tubulin Modulators|tubulin modulators|mesh-ancestor
6721835|NCT01847677|Antimitotic Agents|antimitotic agents|mesh-ancestor
6721836|NCT01847677|Mitosis Modulators|mitosis modulators|mesh-ancestor
6721837|NCT01847677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721838|NCT01847677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6721839|NCT01847677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6721840|NCT01847677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6721841|NCT01847677|Growth Substances|growth substances|mesh-ancestor
6721842|NCT01847677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721843|NCT01847677|Growth Inhibitors|growth inhibitors|mesh-ancestor
6721844|NCT01847690|Hydrocortisone|hydrocortisone|mesh-list
6721845|NCT01847690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6721846|NCT01847768|Methacholine Chloride|methacholine chloride|mesh-list
6721847|NCT01847768|Miotics|miotics|mesh-ancestor
6721848|NCT01847768|Autonomic Agents|autonomic agents|mesh-ancestor
6721849|NCT01847768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6721850|NCT01847768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721851|NCT01847768|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6721852|NCT01847768|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
6721853|NCT01847768|Respiratory System Agents|respiratory system agents|mesh-ancestor
6721854|NCT01847768|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6721855|NCT01847768|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6721856|NCT01847768|Cholinergic Agents|cholinergic agents|mesh-ancestor
6721857|NCT01847768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6721858|NCT01847768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721859|NCT01847781|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6721860|NCT01847781|Immunologic Factors|immunologic factors|mesh-ancestor
6721861|NCT01847781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721862|NCT01847872|Vaccines|vaccines|mesh-list
6721863|NCT01847872|Immunologic Factors|immunologic factors|mesh-ancestor
6721864|NCT01847872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721865|NCT01847976|Doxycycline|doxycycline|mesh-list
6721866|NCT01847976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6721867|NCT01847976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6721868|NCT01847976|Antimalarials|antimalarials|mesh-ancestor
6721869|NCT01847976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6721870|NCT01847976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6721871|NCT01848106|Bivalirudin|bivalirudin|mesh-list
6721872|NCT01848106|Antithrombins|antithrombins|mesh-ancestor
6721873|NCT01848106|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6721874|NCT01848106|Protease Inhibitors|protease inhibitors|mesh-ancestor
6721875|NCT01848106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6721876|NCT01848106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721877|NCT01848106|Anticoagulants|anticoagulants|mesh-ancestor
6721878|NCT01848119|Gabapentin|gabapentin|mesh-list
6721879|NCT01848119|Analgesics|analgesics|mesh-ancestor
6721880|NCT01848119|Sensory System Agents|sensory system agents|mesh-ancestor
6721881|NCT01848119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6721882|NCT01848119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721883|NCT01848119|Anticonvulsants|anticonvulsants|mesh-ancestor
6721884|NCT01848119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6721885|NCT01848119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6721886|NCT01848119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6721887|NCT01848119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6721888|NCT01848119|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6721889|NCT01848119|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6721890|NCT01848119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6721891|NCT01848119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721892|NCT01848119|Antimanic Agents|antimanic agents|mesh-ancestor
6721893|NCT01848132|Prednisone|prednisone|mesh-list
6721894|NCT01848132|Cyclophosphamide|cyclophosphamide|mesh-list
6721895|NCT01848132|Rituximab|rituximab|mesh-list
6721896|NCT01848132|Doxorubicin|doxorubicin|mesh-list
6721897|NCT01848132|Vincristine|vincristine|mesh-list
6721898|NCT01848132|Bortezomib|bortezomib|mesh-list
6721899|NCT01848132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6721900|NCT01848132|Immunologic Factors|immunologic factors|mesh-ancestor
6721901|NCT01848132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721902|NCT01848132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6721903|NCT01848132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6721904|NCT01848132|Alkylating Agents|alkylating agents|mesh-ancestor
6721905|NCT01848132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721906|NCT01848132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6721907|NCT01848132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6721908|NCT01848132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6721909|NCT01848132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6721910|NCT01848132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6721911|NCT01848132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6721912|NCT01848132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6721913|NCT01848132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6721914|NCT01848132|Glucocorticoids|glucocorticoids|mesh-ancestor
6721915|NCT01848132|Hormones|hormones|mesh-ancestor
6721916|NCT01848132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6721917|NCT01848132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6721918|NCT01848132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6721919|NCT01848132|Tubulin Modulators|tubulin modulators|mesh-ancestor
6721920|NCT01848132|Antimitotic Agents|antimitotic agents|mesh-ancestor
6721921|NCT01848132|Mitosis Modulators|mitosis modulators|mesh-ancestor
6721922|NCT01848197|Paclitaxel|paclitaxel|mesh-list
6721923|NCT01848197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6721924|NCT01848197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6721925|NCT01848197|Tubulin Modulators|tubulin modulators|mesh-ancestor
6721926|NCT01848197|Antimitotic Agents|antimitotic agents|mesh-ancestor
6721927|NCT01848197|Mitosis Modulators|mitosis modulators|mesh-ancestor
6721928|NCT01848197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721929|NCT01848236|Vitamin D|vitamin d|mesh-list
6721930|NCT01848236|Ergocalciferols|ergocalciferols|mesh-list
6721931|NCT01848236|Cholecalciferol|cholecalciferol|mesh-list
6721932|NCT01848236|Vitamins|vitamins|mesh-list
6721933|NCT01848236|Micronutrients|micronutrients|mesh-ancestor
6721934|NCT01848236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721935|NCT01848236|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6721936|NCT01848236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6721937|NCT01848262|Pulmonary Surfactants|pulmonary surfactants|mesh-list
6721938|NCT01848262|Respiratory System Agents|respiratory system agents|mesh-ancestor
6721939|NCT01848301|Acetylcholine|acetylcholine|mesh-list
6721940|NCT01848301|Vasodilator Agents|vasodilator agents|mesh-ancestor
6721941|NCT01848301|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6721942|NCT01848301|Cholinergic Agents|cholinergic agents|mesh-ancestor
6721943|NCT01848301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6721944|NCT01848301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721945|NCT01848301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721946|NCT01848340|Cabotegravir|cabotegravir|mesh-list
6721947|NCT01848340|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6721948|NCT01848340|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6721949|NCT01848340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6784409|NCT02202707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6721950|NCT01848340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721951|NCT01848340|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6721952|NCT01848340|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6721953|NCT01848340|Antiviral Agents|antiviral agents|mesh-ancestor
6721954|NCT01848340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6721955|NCT01848379|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6721956|NCT01848379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721957|NCT01848613|Vinorelbine|vinorelbine|mesh-list
6721958|NCT01848613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6721959|NCT01848613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6721960|NCT01848613|Tubulin Modulators|tubulin modulators|mesh-ancestor
6721961|NCT01848613|Antimitotic Agents|antimitotic agents|mesh-ancestor
6721962|NCT01848613|Mitosis Modulators|mitosis modulators|mesh-ancestor
6721963|NCT01848613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721964|NCT01848639|Spironolactone|spironolactone|mesh-list
6721965|NCT01848639|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6721966|NCT01848639|Hormone Antagonists|hormone antagonists|mesh-ancestor
6721967|NCT01848639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6721968|NCT01848639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721969|NCT01848639|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6721970|NCT01848639|Diuretics|diuretics|mesh-ancestor
6721971|NCT01848639|Natriuretic Agents|natriuretic agents|mesh-ancestor
6721972|NCT01848652|Doxorubicin|doxorubicin|mesh-list
6721973|NCT01848652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6721974|NCT01848652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6721975|NCT01848652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6721976|NCT01848652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6721977|NCT01848652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6721978|NCT01848652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721979|NCT01848665|Indomethacin|indomethacin|mesh-list
6721980|NCT01848665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6721981|NCT01848665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6721982|NCT01848665|Analgesics|analgesics|mesh-ancestor
6721983|NCT01848665|Sensory System Agents|sensory system agents|mesh-ancestor
6721984|NCT01848665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6721985|NCT01848665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6721986|NCT01848665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6721987|NCT01848665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6721988|NCT01848665|Gout Suppressants|gout suppressants|mesh-ancestor
6721989|NCT01848665|Tocolytic Agents|tocolytic agents|mesh-ancestor
6721990|NCT01848665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6721991|NCT01848665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6721992|NCT01848665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6721993|NCT01848665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721994|NCT01848691|Carbon Monoxide|carbon monoxide|mesh-list
6721995|NCT01848691|Antimetabolites|antimetabolites|mesh-ancestor
6721996|NCT01848691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6721997|NCT01848691|Gasotransmitters|gasotransmitters|mesh-ancestor
6721998|NCT01848691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6721999|NCT01848691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784410|NCT02202707|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6784411|NCT02202707|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6784412|NCT02202707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6784413|NCT02202707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784414|NCT02202707|Antimanic Agents|antimanic agents|mesh-ancestor
6784415|NCT02202720|Sevoflurane|sevoflurane|mesh-list
6784416|NCT02202720|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6784417|NCT02202720|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6784418|NCT02202720|Anesthetics, General|anesthetics, general|mesh-ancestor
6784419|NCT02202720|Anesthetics|anesthetics|mesh-ancestor
6784420|NCT02202720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6722000|NCT01848743|Tenofovir|tenofovir|mesh-list
6722001|NCT01848743|Lamivudine|lamivudine|mesh-list
6722002|NCT01848743|Antiviral Agents|antiviral agents|mesh-ancestor
6722003|NCT01848743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6722004|NCT01848743|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6722005|NCT01848743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6722006|NCT01848743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6722007|NCT01848743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722008|NCT01848743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6722009|NCT01848743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6722010|NCT01848769|Beclomethasone|beclomethasone|mesh-list
6722011|NCT01848769|Formoterol Fumarate|formoterol fumarate|mesh-list
6722012|NCT01848769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6722013|NCT01848769|Autonomic Agents|autonomic agents|mesh-ancestor
6722014|NCT01848769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6722015|NCT01848769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722016|NCT01848769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6722017|NCT01848769|Respiratory System Agents|respiratory system agents|mesh-ancestor
6722018|NCT01848769|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6722019|NCT01848769|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6722020|NCT01848769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6722021|NCT01848769|Adrenergic Agents|adrenergic agents|mesh-ancestor
6722022|NCT01848769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6722023|NCT01848769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722024|NCT01848769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6722025|NCT01848769|Glucocorticoids|glucocorticoids|mesh-ancestor
6722026|NCT01848769|Hormones|hormones|mesh-ancestor
6722027|NCT01848769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6722028|NCT01848808|Wobenzym|wobenzym|mesh-list
6722029|NCT01848808|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6722030|NCT01848808|Immunologic Factors|immunologic factors|mesh-ancestor
6722031|NCT01848808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722032|NCT01848873|Amlodipine|amlodipine|mesh-list
6722033|NCT01848873|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6722034|NCT01848873|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6722035|NCT01848873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6722036|NCT01848873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722037|NCT01848873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6722038|NCT01848873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722039|NCT01848873|Vasodilator Agents|vasodilator agents|mesh-ancestor
6722040|NCT01848925|Hydroxyurea|hydroxyurea|mesh-list
6722041|NCT01848925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6722042|NCT01848925|Antisickling Agents|antisickling agents|mesh-ancestor
6722043|NCT01848925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6722044|NCT01848925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722045|NCT01848925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6722046|NCT01849016|Acetylcysteine|acetylcysteine|mesh-list
6722047|NCT01849016|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6722048|NCT01849016|Antiviral Agents|antiviral agents|mesh-ancestor
6722049|NCT01849016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6722050|NCT01849016|Expectorants|expectorants|mesh-ancestor
6722051|NCT01849016|Respiratory System Agents|respiratory system agents|mesh-ancestor
6722052|NCT01849016|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6722053|NCT01849016|Antioxidants|antioxidants|mesh-ancestor
6722054|NCT01849016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722055|NCT01849016|Protective Agents|protective agents|mesh-ancestor
6722056|NCT01849016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722057|NCT01849016|Antidotes|antidotes|mesh-ancestor
6722058|NCT01849042|Donepezil|donepezil|mesh-list
6722059|NCT01849042|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6722060|NCT01849042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6722061|NCT01849042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722062|NCT01849042|Cholinergic Agents|cholinergic agents|mesh-ancestor
6722063|NCT01849042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6722064|NCT01849042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722065|NCT01849042|Nootropic Agents|nootropic agents|mesh-ancestor
6722066|NCT01849094|Milrinone|milrinone|mesh-list
6722067|NCT01849094|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6722068|NCT01849094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6722069|NCT01849094|Vasodilator Agents|vasodilator agents|mesh-ancestor
6722070|NCT01849094|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6722071|NCT01849094|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6722072|NCT01849094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6722073|NCT01849094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722074|NCT01849094|Protective Agents|protective agents|mesh-ancestor
6722075|NCT01849094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722076|NCT01849146|Temozolomide|temozolomide|mesh-list
6722077|NCT01849146|Adavosertib|adavosertib|mesh-list
6722078|NCT01849146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6722079|NCT01849146|Alkylating Agents|alkylating agents|mesh-ancestor
6722080|NCT01849146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722081|NCT01849146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6722082|NCT01849146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6722083|NCT01849211|Rocuronium|rocuronium|mesh-list
6722084|NCT01849211|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6722085|NCT01849211|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6722086|NCT01849211|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6722087|NCT01849211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6722088|NCT01849211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722089|NCT01849406|Budesonide|budesonide|mesh-list
6722090|NCT01849406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6722091|NCT01849406|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6722092|NCT01849406|Autonomic Agents|autonomic agents|mesh-ancestor
6722093|NCT01849406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6722094|NCT01849406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722095|NCT01849406|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6722096|NCT01849406|Respiratory System Agents|respiratory system agents|mesh-ancestor
6722097|NCT01849406|Glucocorticoids|glucocorticoids|mesh-ancestor
6722098|NCT01849406|Hormones|hormones|mesh-ancestor
6722099|NCT01849406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6722100|NCT01849640|Piperaquine|piperaquine|mesh-list
6722101|NCT01849640|Primaquine|primaquine|mesh-list
6722102|NCT01849640|Antimalarials|antimalarials|mesh-ancestor
6722103|NCT01849640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6722104|NCT01849640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6722105|NCT01849640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6722106|NCT01849666|Vemurafenib|vemurafenib|mesh-list
6722107|NCT01849666|Phenprocoumon|phenprocoumon|mesh-list
6722108|NCT01849666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6722109|NCT01849666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6722110|NCT01849666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6722111|NCT01849666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722112|NCT01849666|Anticoagulants|anticoagulants|mesh-ancestor
6722113|NCT01849757|Plasma-lyte 148|plasma-lyte 148|mesh-list
6722114|NCT01849757|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6722115|NCT01849757|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6722116|NCT01849783|Thalidomide|thalidomide|mesh-list
6722117|NCT01849783|Dexamethasone|dexamethasone|mesh-list
6722118|NCT01849783|Cyclophosphamide|cyclophosphamide|mesh-list
6722119|NCT01849783|Melphalan|melphalan|mesh-list
6722120|NCT01849783|Doxorubicin|doxorubicin|mesh-list
6722121|NCT01849783|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6722122|NCT01849783|Etoposide|etoposide|mesh-list
6722123|NCT01849783|Bortezomib|bortezomib|mesh-list
6722124|NCT01849783|Etoposide phosphate|etoposide phosphate|mesh-list
6722125|NCT01849783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6722126|NCT01849783|Immunologic Factors|immunologic factors|mesh-ancestor
6722127|NCT01849783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722128|NCT01849783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6722129|NCT01849783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6722130|NCT01849783|Alkylating Agents|alkylating agents|mesh-ancestor
6722131|NCT01849783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722132|NCT01849783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6722133|NCT01849783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6722134|NCT01849783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6722135|NCT01849783|Antiemetics|antiemetics|mesh-ancestor
6722136|NCT01849783|Autonomic Agents|autonomic agents|mesh-ancestor
6722137|NCT01849783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6722138|NCT01849783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6722139|NCT01849783|Glucocorticoids|glucocorticoids|mesh-ancestor
6722140|NCT01849783|Hormones|hormones|mesh-ancestor
6722141|NCT01849783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6722142|NCT01849783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6722143|NCT01849783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6722144|NCT01849783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6722145|NCT01849783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6722146|NCT01849783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6722147|NCT01849783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6722148|NCT01849783|Leprostatic Agents|leprostatic agents|mesh-ancestor
6722149|NCT01849783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6722150|NCT01849783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6722151|NCT01849783|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6722152|NCT01849783|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6722153|NCT01849783|Growth Substances|growth substances|mesh-ancestor
6722154|NCT01849783|Growth Inhibitors|growth inhibitors|mesh-ancestor
6722155|NCT01849835|Menthol|menthol|mesh-list
6722156|NCT01849835|Antipruritics|antipruritics|mesh-ancestor
6722157|NCT01849835|Dermatologic Agents|dermatologic agents|mesh-ancestor
6722158|NCT01849861|Methimazole|methimazole|mesh-list
6722159|NCT01849861|Antithyroid Agents|antithyroid agents|mesh-ancestor
6722160|NCT01849861|Hormone Antagonists|hormone antagonists|mesh-ancestor
6722161|NCT01849861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6722162|NCT01849861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722163|NCT01849926|Amdinocillin|amdinocillin|mesh-list
6722164|NCT01849926|Ibuprofen|ibuprofen|mesh-list
6722165|NCT01849926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6722166|NCT01849926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6722167|NCT01849926|Analgesics|analgesics|mesh-ancestor
6722168|NCT01849926|Sensory System Agents|sensory system agents|mesh-ancestor
6722169|NCT01849926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6722170|NCT01849926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722171|NCT01849926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6722172|NCT01849926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6722173|NCT01849926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6722174|NCT01849926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6722175|NCT01849926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722176|NCT01849926|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6722177|NCT01849926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6722178|NCT01849926|Renal Agents|renal agents|mesh-ancestor
6722179|NCT01849926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6722180|NCT01849939|Immunosuppressive Agents|immunosuppressive agents|mesh-list
6722181|NCT01849939|Immunologic Factors|immunologic factors|mesh-ancestor
6722182|NCT01849939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722183|NCT01850017|Dexmedetomidine|dexmedetomidine|mesh-list
6722184|NCT01850017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6722185|NCT01850017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6722186|NCT01850017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722187|NCT01850017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6722188|NCT01850017|Analgesics|analgesics|mesh-ancestor
6722189|NCT01850017|Sensory System Agents|sensory system agents|mesh-ancestor
6722190|NCT01850017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6722191|NCT01850017|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6722192|NCT01850017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6722193|NCT01850017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6722194|NCT01850017|Adrenergic Agents|adrenergic agents|mesh-ancestor
6722195|NCT01850017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6722196|NCT01850017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722197|NCT01850095|Azelaic acid|azelaic acid|mesh-list
6722198|NCT01850095|Estradiol|estradiol|mesh-list
6722199|NCT01850095|Estrogens|estrogens|mesh-ancestor
6722200|NCT01850095|Hormones|hormones|mesh-ancestor
6722201|NCT01850095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6722202|NCT01850095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722203|NCT01850095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6722204|NCT01850095|Dermatologic Agents|dermatologic agents|mesh-ancestor
6722205|NCT01850121|Infliximab|infliximab|mesh-list
6722206|NCT01850121|Dermatologic Agents|dermatologic agents|mesh-ancestor
6722207|NCT01850121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6722208|NCT01850121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6722209|NCT01850147|Sunitinib|sunitinib|mesh-list
6722210|NCT01850147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6722211|NCT01850147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6722212|NCT01850147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6722213|NCT01850147|Growth Substances|growth substances|mesh-ancestor
6722214|NCT01850147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722215|NCT01850147|Growth Inhibitors|growth inhibitors|mesh-ancestor
6722216|NCT01850147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6722217|NCT01850147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6722218|NCT01850147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722219|NCT01850160|Valsartan|valsartan|mesh-list
6722220|NCT01850160|Chlorthalidone|chlorthalidone|mesh-list
6722221|NCT01850160|Antihypertensive Agents|antihypertensive agents|mesh-list
6722222|NCT01850160|Angiotensin II|angiotensin ii|mesh-list
6722223|NCT01850160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
6722224|NCT01850160|Diuretics|diuretics|mesh-list
6722225|NCT01850160|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
6722226|NCT01850160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6722227|NCT01850160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722228|NCT01850160|Natriuretic Agents|natriuretic agents|mesh-ancestor
6722229|NCT01850160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722230|NCT01850160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6722231|NCT01850160|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6722232|NCT01850251|Vitamin D|vitamin d|mesh-list
6722233|NCT01850251|Vitamins|vitamins|mesh-ancestor
6722234|NCT01850251|Micronutrients|micronutrients|mesh-ancestor
6722235|NCT01850251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722236|NCT01850251|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6722237|NCT01850277|Amiodarone|amiodarone|mesh-list
6722238|NCT01850277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6722239|NCT01850277|Vasodilator Agents|vasodilator agents|mesh-ancestor
6722240|NCT01850277|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6722241|NCT01850277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6722242|NCT01850277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722243|NCT01850277|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6722244|NCT01850277|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6722245|NCT01850277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6722246|NCT01850277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6722247|NCT01850277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6722248|NCT01850277|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6722249|NCT01850277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6722250|NCT01850303|Gemcitabine|gemcitabine|mesh-list
6722251|NCT01850303|Pemetrexed|pemetrexed|mesh-list
6722252|NCT01850303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6722253|NCT01850303|Antimetabolites|antimetabolites|mesh-ancestor
6722254|NCT01850303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722255|NCT01850303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6722256|NCT01850303|Antiviral Agents|antiviral agents|mesh-ancestor
6722257|NCT01850303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6722258|NCT01850303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6722259|NCT01850303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6722260|NCT01850303|Immunologic Factors|immunologic factors|mesh-ancestor
6722261|NCT01850303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722262|NCT01850303|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6722263|NCT01850303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6722264|NCT01850355|Buspirone|buspirone|mesh-list
6722265|NCT01850355|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6722266|NCT01850355|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6722267|NCT01850355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6722268|NCT01850355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722269|NCT01850355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6722270|NCT01850355|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6722271|NCT01850355|Serotonin Agents|serotonin agents|mesh-ancestor
6722272|NCT01850355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6722273|NCT01850355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784421|NCT02202720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784422|NCT02202889|Calcium|calcium|mesh-list
6784423|NCT02202889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6784424|NCT02202889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784425|NCT02202967|Misoprostol|misoprostol|mesh-list
6784426|NCT02202967|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6784427|NCT02202967|Abortifacient Agents|abortifacient agents|mesh-ancestor
6784428|NCT02202967|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6784429|NCT02202967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784430|NCT02202967|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6722274|NCT01850511|Phenylephrine|phenylephrine|mesh-list
6722275|NCT01850511|Oxymetazoline|oxymetazoline|mesh-list
6722276|NCT01850511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6722277|NCT01850511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6722278|NCT01850511|Adrenergic Agents|adrenergic agents|mesh-ancestor
6722279|NCT01850511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6722280|NCT01850511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722281|NCT01850511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722282|NCT01850511|Sympathomimetics|sympathomimetics|mesh-ancestor
6722283|NCT01850511|Autonomic Agents|autonomic agents|mesh-ancestor
6722284|NCT01850511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6722285|NCT01850511|Nasal Decongestants|nasal decongestants|mesh-ancestor
6722286|NCT01850511|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6722287|NCT01850511|Respiratory System Agents|respiratory system agents|mesh-ancestor
6722288|NCT01850511|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6722289|NCT01850511|Mydriatics|mydriatics|mesh-ancestor
6722290|NCT01850511|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6722291|NCT01850511|Protective Agents|protective agents|mesh-ancestor
6722292|NCT01850628|Paclitaxel|paclitaxel|mesh-list
6722293|NCT01850628|Trastuzumab|trastuzumab|mesh-list
6722294|NCT01850628|Pertuzumab|pertuzumab|mesh-list
6722295|NCT01850628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6722296|NCT01850628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6722297|NCT01850628|Tubulin Modulators|tubulin modulators|mesh-ancestor
6722298|NCT01850628|Antimitotic Agents|antimitotic agents|mesh-ancestor
6722299|NCT01850628|Mitosis Modulators|mitosis modulators|mesh-ancestor
6722300|NCT01850628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722301|NCT01850628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6722302|NCT01850680|Folic Acid|folic acid|mesh-list
6722303|NCT01850680|Methotrexate|methotrexate|mesh-list
6722304|NCT01850680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6722305|NCT01850680|Abortifacient Agents|abortifacient agents|mesh-ancestor
6722306|NCT01850680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6722307|NCT01850680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722308|NCT01850680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6722309|NCT01850680|Antimetabolites|antimetabolites|mesh-ancestor
6722310|NCT01850680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722311|NCT01850680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6722312|NCT01850680|Dermatologic Agents|dermatologic agents|mesh-ancestor
6722313|NCT01850680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6722314|NCT01850680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6722315|NCT01850680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6722316|NCT01850680|Immunologic Factors|immunologic factors|mesh-ancestor
6722317|NCT01850680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6722318|NCT01850680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6722319|NCT01850680|Hematinics|hematinics|mesh-ancestor
6722320|NCT01850680|Vitamin B Complex|vitamin b complex|mesh-ancestor
6722321|NCT01850680|Vitamins|vitamins|mesh-ancestor
6722322|NCT01850680|Micronutrients|micronutrients|mesh-ancestor
6722323|NCT01850940|Tolvaptan|tolvaptan|mesh-list
6722324|NCT01850940|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6722325|NCT01850940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722326|NCT01850940|Natriuretic Agents|natriuretic agents|mesh-ancestor
6722327|NCT01850940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722328|NCT01850953|Varenicline|varenicline|mesh-list
6722329|NCT01850953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6722330|NCT01850953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6722331|NCT01850953|Cholinergic Agents|cholinergic agents|mesh-ancestor
6722332|NCT01850953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6722333|NCT01850953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722334|NCT01850953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722335|NCT01850979|Tacrolimus|tacrolimus|mesh-list
6722336|NCT01850979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6722337|NCT01850979|Immunologic Factors|immunologic factors|mesh-ancestor
6722338|NCT01850979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722339|NCT01850979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6722340|NCT01850979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6722341|NCT01850979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722342|NCT01851005|Dexmedetomidine|dexmedetomidine|mesh-list
6722343|NCT01851005|Remifentanil|remifentanil|mesh-list
6722344|NCT01851005|Anesthetics|anesthetics|mesh-list
6722345|NCT01851005|Propofol|propofol|mesh-list
6722346|NCT01851005|Sevoflurane|sevoflurane|mesh-list
6722347|NCT01851005|Rocuronium|rocuronium|mesh-list
6722348|NCT01851005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6722349|NCT01851005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722350|NCT01851005|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6722351|NCT01851005|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6722352|NCT01851005|Anesthetics, General|anesthetics, general|mesh-ancestor
6722353|NCT01851005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6722354|NCT01851005|Analgesics|analgesics|mesh-ancestor
6722355|NCT01851005|Sensory System Agents|sensory system agents|mesh-ancestor
6722356|NCT01851005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6722357|NCT01851005|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6722358|NCT01851005|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6722359|NCT01851005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6722360|NCT01851005|Adrenergic Agents|adrenergic agents|mesh-ancestor
6722361|NCT01851005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6722362|NCT01851005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722363|NCT01851005|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6722364|NCT01851005|Narcotics|narcotics|mesh-ancestor
6722365|NCT01851005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6722366|NCT01851005|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6722367|NCT01851005|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6722368|NCT01851005|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6722369|NCT01851005|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6722370|NCT01851148|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-list
6722371|NCT01851148|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6722372|NCT01851148|Serotonin Agents|serotonin agents|mesh-ancestor
6722373|NCT01851148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6722374|NCT01851148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722375|NCT01851148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722376|NCT01851200|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6722377|NCT01851200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6722378|NCT01851200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6722379|NCT01851265|Olaparib|olaparib|mesh-list
6722380|NCT01851265|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6722381|NCT01851265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6722382|NCT01851265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722383|NCT01851265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6722384|NCT01851278|Triamcinolone|triamcinolone|mesh-list
6722385|NCT01851278|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6722386|NCT01851278|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6722387|NCT01851278|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6722388|NCT01851278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6722389|NCT01851278|Glucocorticoids|glucocorticoids|mesh-ancestor
6722390|NCT01851278|Hormones|hormones|mesh-ancestor
6722391|NCT01851278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6722392|NCT01851278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722393|NCT01851278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6722394|NCT01851278|Immunologic Factors|immunologic factors|mesh-ancestor
6722395|NCT01851278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6722396|NCT01851278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722397|NCT01851408|Sirolimus|sirolimus|mesh-list
6722398|NCT01851408|Sorafenib|sorafenib|mesh-list
6722399|NCT01851408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6722400|NCT01851408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6722401|NCT01851408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6722402|NCT01851408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722403|NCT01851408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6722404|NCT01851408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6722405|NCT01851408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6722406|NCT01851408|Antifungal Agents|antifungal agents|mesh-ancestor
6722407|NCT01851408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6722408|NCT01851408|Immunologic Factors|immunologic factors|mesh-ancestor
6722409|NCT01851408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722410|NCT01851473|Quinine|quinine|mesh-list
6722411|NCT01851473|Acetazolamide|acetazolamide|mesh-list
6722412|NCT01851473|Cocaine|cocaine|mesh-list
6722413|NCT01851473|Anticonvulsants|anticonvulsants|mesh-ancestor
6722414|NCT01851473|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6722415|NCT01851473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6722416|NCT01851473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722417|NCT01851473|Diuretics|diuretics|mesh-ancestor
6722418|NCT01851473|Natriuretic Agents|natriuretic agents|mesh-ancestor
6722419|NCT01851473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722420|NCT01851473|Anesthetics, Local|anesthetics, local|mesh-ancestor
6722421|NCT01851473|Anesthetics|anesthetics|mesh-ancestor
6722422|NCT01851473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6722423|NCT01851473|Sensory System Agents|sensory system agents|mesh-ancestor
6722424|NCT01851473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6722425|NCT01851473|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6722426|NCT01851473|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6722427|NCT01851473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6722428|NCT01851473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6722429|NCT01851473|Dopamine Agents|dopamine agents|mesh-ancestor
6722430|NCT01851473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6722431|NCT01851473|Antimalarials|antimalarials|mesh-ancestor
6722432|NCT01851473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6722433|NCT01851473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6722434|NCT01851473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6722435|NCT01851473|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6722436|NCT01851473|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6722437|NCT01851473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6722438|NCT01851473|Analgesics|analgesics|mesh-ancestor
6722439|NCT01851486|Clonidine|clonidine|mesh-list
6722440|NCT01851486|Naloxone|naloxone|mesh-list
6722441|NCT01851486|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6722442|NCT01851486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722443|NCT01851486|Sensory System Agents|sensory system agents|mesh-ancestor
6722444|NCT01851486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6722445|NCT01851486|Analgesics|analgesics|mesh-ancestor
6722446|NCT01851486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6722447|NCT01851486|Sympatholytics|sympatholytics|mesh-ancestor
6722448|NCT01851486|Autonomic Agents|autonomic agents|mesh-ancestor
6722449|NCT01851486|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6722450|NCT01851486|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6722451|NCT01851486|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6722452|NCT01851486|Adrenergic Agents|adrenergic agents|mesh-ancestor
6722453|NCT01851486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6722454|NCT01851486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722455|NCT01851512|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6722456|NCT01851512|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6722457|NCT01851512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722458|NCT01851551|Rituximab|rituximab|mesh-list
6722459|NCT01851551|Vincristine|vincristine|mesh-list
6722460|NCT01851551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6722461|NCT01851551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6722462|NCT01851551|Immunologic Factors|immunologic factors|mesh-ancestor
6722463|NCT01851551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722464|NCT01851551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6722465|NCT01851551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6722466|NCT01851551|Tubulin Modulators|tubulin modulators|mesh-ancestor
6722467|NCT01851551|Antimitotic Agents|antimitotic agents|mesh-ancestor
6722468|NCT01851551|Mitosis Modulators|mitosis modulators|mesh-ancestor
6722469|NCT01851551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722470|NCT01851642|Albuterol|albuterol|mesh-list
6722471|NCT01851642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6722472|NCT01851642|Autonomic Agents|autonomic agents|mesh-ancestor
6722473|NCT01851642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6722474|NCT01851642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722475|NCT01851642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6722476|NCT01851642|Respiratory System Agents|respiratory system agents|mesh-ancestor
6722477|NCT01851642|Tocolytic Agents|tocolytic agents|mesh-ancestor
6722478|NCT01851642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6722479|NCT01851642|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6722480|NCT01851642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6722481|NCT01851642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6722482|NCT01851642|Adrenergic Agents|adrenergic agents|mesh-ancestor
6722483|NCT01851642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6722484|NCT01851642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722485|NCT01851681|Amoxicillin|amoxicillin|mesh-list
6722486|NCT01851681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6722487|NCT01851681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6722488|NCT01851733|Doxorubicin|doxorubicin|mesh-list
6722489|NCT01851733|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6722490|NCT01851733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6722491|NCT01851733|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6722492|NCT01851733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6722493|NCT01851733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6722494|NCT01851733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722495|NCT01851759|Cinepazide|cinepazide|mesh-list
6722496|NCT01851759|Vasodilator Agents|vasodilator agents|mesh-ancestor
6722497|NCT01851824|Vemurafenib|vemurafenib|mesh-list
6722498|NCT01851824|Acenocoumarol|acenocoumarol|mesh-list
6722499|NCT01851824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6722500|NCT01851824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6722501|NCT01851824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6722502|NCT01851824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722503|NCT01851824|Anticoagulants|anticoagulants|mesh-ancestor
6722504|NCT01851850|Opicapone|opicapone|mesh-list
6722505|NCT01851850|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6722506|NCT01851850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6722507|NCT01851850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722508|NCT01851850|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6722509|NCT01851850|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6722510|NCT01851941|Leucovorin|leucovorin|mesh-list
6722511|NCT01851941|Folic Acid|folic acid|mesh-list
6722512|NCT01851941|Fluorouracil|fluorouracil|mesh-list
6722513|NCT01851941|Oxaliplatin|oxaliplatin|mesh-list
6722514|NCT01851941|Levoleucovorin|levoleucovorin|mesh-list
6722515|NCT01851941|Antimetabolites|antimetabolites|mesh-ancestor
6722516|NCT01851941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722517|NCT01851941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6722518|NCT01851941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6722519|NCT01851941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6722520|NCT01851941|Immunologic Factors|immunologic factors|mesh-ancestor
6722521|NCT01851941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722522|NCT01851941|Antidotes|antidotes|mesh-ancestor
6722523|NCT01851941|Protective Agents|protective agents|mesh-ancestor
6722524|NCT01851941|Vitamin B Complex|vitamin b complex|mesh-ancestor
6722525|NCT01851941|Vitamins|vitamins|mesh-ancestor
6722526|NCT01851941|Micronutrients|micronutrients|mesh-ancestor
6722527|NCT01851941|Hematinics|hematinics|mesh-ancestor
6722528|NCT01851954|Clarithromycin|clarithromycin|mesh-list
6722529|NCT01851954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6722530|NCT01851954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6722531|NCT01851954|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6722532|NCT01851954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6722533|NCT01851954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722534|NCT01851954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6722535|NCT01851954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6722536|NCT01851980|Furosemide|furosemide|mesh-list
6722537|NCT01851980|Diuretics|diuretics|mesh-ancestor
6722538|NCT01851980|Natriuretic Agents|natriuretic agents|mesh-ancestor
6722539|NCT01851980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722540|NCT01851980|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6722541|NCT01851980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6722542|NCT01851980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722543|NCT01851993|Ondansetron|ondansetron|mesh-list
6722544|NCT01851993|Antiemetics|antiemetics|mesh-ancestor
6722545|NCT01851993|Autonomic Agents|autonomic agents|mesh-ancestor
6722546|NCT01851993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6722547|NCT01851993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722548|NCT01851993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6722549|NCT01851993|Antipruritics|antipruritics|mesh-ancestor
6722550|NCT01851993|Dermatologic Agents|dermatologic agents|mesh-ancestor
6722551|NCT01851993|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6722552|NCT01851993|Serotonin Agents|serotonin agents|mesh-ancestor
6722553|NCT01851993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6722554|NCT01851993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722555|NCT01851993|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6722556|NCT01851993|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6722557|NCT01851993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6722558|NCT01851993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6722559|NCT01851993|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6722560|NCT01852253|Chlorhexidine|chlorhexidine|mesh-list
6722561|NCT01852253|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6722562|NCT01852253|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6722563|NCT01852253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6722564|NCT01852253|Disinfectants|disinfectants|mesh-ancestor
6722565|NCT01852253|Dermatologic Agents|dermatologic agents|mesh-ancestor
6722566|NCT01852266|Vaccines|vaccines|mesh-list
6722567|NCT01852266|Immunologic Factors|immunologic factors|mesh-ancestor
6722568|NCT01852266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784431|NCT02202967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6784432|NCT02202967|Oxytocics|oxytocics|mesh-ancestor
6784433|NCT02202993|Mibefradil|mibefradil|mesh-list
6784434|NCT02202993|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6784435|NCT02202993|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6784436|NCT02202993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6722569|NCT01852318|Fexofenadine|fexofenadine|mesh-list
6722570|NCT01852318|Pregabalin|pregabalin|mesh-list
6722571|NCT01852318|Analgesics|analgesics|mesh-ancestor
6722572|NCT01852318|Sensory System Agents|sensory system agents|mesh-ancestor
6722573|NCT01852318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6722574|NCT01852318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722575|NCT01852318|Anticonvulsants|anticonvulsants|mesh-ancestor
6722576|NCT01852318|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6722577|NCT01852318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6722578|NCT01852318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722579|NCT01852318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6722580|NCT01852318|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6722581|NCT01852318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6722582|NCT01852318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6722583|NCT01852318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6722584|NCT01852318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6722585|NCT01852318|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6722586|NCT01852318|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6722587|NCT01852318|Histamine Antagonists|histamine antagonists|mesh-ancestor
6722588|NCT01852318|Histamine Agents|histamine agents|mesh-ancestor
6722589|NCT01852318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6722590|NCT01852409|Bevacizumab|bevacizumab|mesh-list
6722591|NCT01852409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6722592|NCT01852409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6722593|NCT01852409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6722594|NCT01852409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6722595|NCT01852409|Growth Substances|growth substances|mesh-ancestor
6722596|NCT01852409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722597|NCT01852409|Growth Inhibitors|growth inhibitors|mesh-ancestor
6722598|NCT01852461|Poractant alfa|poractant alfa|mesh-list
6722599|NCT01852461|Beractant|beractant|mesh-list
6722600|NCT01852461|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
6722601|NCT01852461|Respiratory System Agents|respiratory system agents|mesh-ancestor
6722602|NCT01852539|Dexmedetomidine|dexmedetomidine|mesh-list
6722603|NCT01852539|Propofol|propofol|mesh-list
6722604|NCT01852539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6722605|NCT01852539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6722606|NCT01852539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722607|NCT01852539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6722608|NCT01852539|Anesthetics, General|anesthetics, general|mesh-ancestor
6722609|NCT01852539|Anesthetics|anesthetics|mesh-ancestor
6722610|NCT01852539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6722611|NCT01852539|Analgesics|analgesics|mesh-ancestor
6722612|NCT01852539|Sensory System Agents|sensory system agents|mesh-ancestor
6722613|NCT01852539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6722614|NCT01852539|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6722615|NCT01852539|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6722616|NCT01852539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6722617|NCT01852539|Adrenergic Agents|adrenergic agents|mesh-ancestor
6722618|NCT01852539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6722619|NCT01852539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722620|NCT01852565|Diltiazem|diltiazem|mesh-list
6722621|NCT01852565|Darapladib|darapladib|mesh-list
6722622|NCT01852565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6722623|NCT01852565|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6722624|NCT01852565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6722625|NCT01852565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722626|NCT01852565|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6722627|NCT01852565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722628|NCT01852565|Vasodilator Agents|vasodilator agents|mesh-ancestor
6722629|NCT01852565|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
6722630|NCT01852565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6722631|NCT01852604|Interferons|interferons|mesh-list
6722632|NCT01852604|Ritonavir|ritonavir|mesh-list
6722633|NCT01852604|Ribavirin|ribavirin|mesh-list
6722634|NCT01852604|Simeprevir|simeprevir|mesh-list
6722635|NCT01852604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6722636|NCT01852604|Antiviral Agents|antiviral agents|mesh-ancestor
6722637|NCT01852604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6722638|NCT01852604|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6722639|NCT01852604|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6722640|NCT01852604|Protease Inhibitors|protease inhibitors|mesh-ancestor
6722641|NCT01852604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6722642|NCT01852604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722643|NCT01852604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6722644|NCT01852604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6722645|NCT01852604|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6722646|NCT01852604|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6722647|NCT01852604|Antimetabolites|antimetabolites|mesh-ancestor
6722648|NCT01852630|Imipenem|imipenem|mesh-list
6722649|NCT01852630|Cefepime|cefepime|mesh-list
6722650|NCT01852630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6722651|NCT01852630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6722652|NCT01852786|Contraceptive Agents|contraceptive agents|mesh-list
6722653|NCT01852786|Contraceptives, Oral|contraceptives, oral|mesh-list
6722654|NCT01852786|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
6722655|NCT01852786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6722656|NCT01852786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722657|NCT01852786|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6722658|NCT01852890|Ascorbic Acid|ascorbic acid|mesh-list
6722659|NCT01852890|Gemcitabine|gemcitabine|mesh-list
6722660|NCT01852890|Vitamins|vitamins|mesh-ancestor
6722661|NCT01852890|Micronutrients|micronutrients|mesh-ancestor
6722662|NCT01852890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722663|NCT01852890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6722664|NCT01852890|Antimetabolites|antimetabolites|mesh-ancestor
6722665|NCT01852890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722666|NCT01852890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6722667|NCT01852890|Antiviral Agents|antiviral agents|mesh-ancestor
6722668|NCT01852890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6722669|NCT01852890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6722670|NCT01852890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6722671|NCT01852890|Immunologic Factors|immunologic factors|mesh-ancestor
6722672|NCT01852890|Antioxidants|antioxidants|mesh-ancestor
6722673|NCT01852890|Protective Agents|protective agents|mesh-ancestor
6722674|NCT01852903|Vitamins|vitamins|mesh-list
6722675|NCT01852903|Ascorbic Acid|ascorbic acid|mesh-list
6722676|NCT01852903|Calcium ascorbate|calcium ascorbate|mesh-list
6722677|NCT01852903|Calcium|calcium|mesh-list
6722678|NCT01852903|Micronutrients|micronutrients|mesh-ancestor
6722679|NCT01852903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722680|NCT01852903|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6722681|NCT01852903|Antioxidants|antioxidants|mesh-ancestor
6722682|NCT01852903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722683|NCT01852903|Protective Agents|protective agents|mesh-ancestor
6722684|NCT01852994|Methyltestosterone|methyltestosterone|mesh-list
6722685|NCT01852994|Testosterone|testosterone|mesh-list
6722686|NCT01852994|Testosterone undecanoate|testosterone undecanoate|mesh-list
6722687|NCT01852994|Testosterone enanthate|testosterone enanthate|mesh-list
6722688|NCT01852994|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6722689|NCT01852994|Androgens|androgens|mesh-ancestor
6722690|NCT01852994|Hormones|hormones|mesh-ancestor
6722691|NCT01852994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6722692|NCT01852994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722693|NCT01852994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6722694|NCT01852994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6722695|NCT01852994|Anabolic Agents|anabolic agents|mesh-ancestor
6722696|NCT01853111|Aldesleukin|aldesleukin|mesh-list
6722697|NCT01853111|Interleukin-2|interleukin-2|mesh-list
6722698|NCT01853111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6722699|NCT01853111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6722700|NCT01853111|Analgesics|analgesics|mesh-ancestor
6722701|NCT01853111|Sensory System Agents|sensory system agents|mesh-ancestor
6722702|NCT01853111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6722703|NCT01853111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722704|NCT01853111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6722705|NCT01853111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6722706|NCT01853111|Antiviral Agents|antiviral agents|mesh-ancestor
6722707|NCT01853111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6722708|NCT01853306|Veliparib|veliparib|mesh-list
6722709|NCT01853306|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6722710|NCT01853306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6722711|NCT01853306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722712|NCT01853306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6722713|NCT01853423|Sirolimus|sirolimus|mesh-list
6722714|NCT01853423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6722715|NCT01853423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6722716|NCT01853423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6722717|NCT01853423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6722718|NCT01853423|Antifungal Agents|antifungal agents|mesh-ancestor
6722719|NCT01853423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6722720|NCT01853423|Immunologic Factors|immunologic factors|mesh-ancestor
6722721|NCT01853423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722722|NCT01853449|Fentanyl|fentanyl|mesh-list
6722723|NCT01853449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6722724|NCT01853449|Narcotics|narcotics|mesh-ancestor
6722725|NCT01853449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6722726|NCT01853449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722727|NCT01853449|Analgesics|analgesics|mesh-ancestor
6722728|NCT01853449|Sensory System Agents|sensory system agents|mesh-ancestor
6722729|NCT01853449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6722730|NCT01853449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6722731|NCT01853449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6722732|NCT01853449|Anesthetics, General|anesthetics, general|mesh-ancestor
6722733|NCT01853449|Anesthetics|anesthetics|mesh-ancestor
6722734|NCT01853540|Sildenafil Citrate|sildenafil citrate|mesh-list
6722735|NCT01853540|Vasodilator Agents|vasodilator agents|mesh-ancestor
6722736|NCT01853540|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6722737|NCT01853540|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6722738|NCT01853540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6722739|NCT01853540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722740|NCT01853540|Urological Agents|urological agents|mesh-ancestor
6722741|NCT01853566|Hormones|hormones|mesh-list
6722742|NCT01853566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6722743|NCT01853566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722744|NCT01853709|Bisacodyl|bisacodyl|mesh-list
6722745|NCT01853709|Cathartics|cathartics|mesh-ancestor
6722746|NCT01853709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6722747|NCT01853709|Laxatives|laxatives|mesh-ancestor
6722748|NCT01853787|Formoterol Fumarate|formoterol fumarate|mesh-list
6722749|NCT01853787|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6722750|NCT01853787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6722751|NCT01853787|Autonomic Agents|autonomic agents|mesh-ancestor
6722752|NCT01853787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6722753|NCT01853787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722754|NCT01853787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6722755|NCT01853787|Respiratory System Agents|respiratory system agents|mesh-ancestor
6722756|NCT01853787|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6722757|NCT01853787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6722758|NCT01853787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6722759|NCT01853787|Adrenergic Agents|adrenergic agents|mesh-ancestor
6722760|NCT01853787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6722761|NCT01853787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722762|NCT01853800|Rivaroxaban|rivaroxaban|mesh-list
6722763|NCT01853800|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6722764|NCT01853800|Antithrombins|antithrombins|mesh-ancestor
6722765|NCT01853800|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6722766|NCT01853800|Protease Inhibitors|protease inhibitors|mesh-ancestor
6722767|NCT01853800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6722768|NCT01853800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722769|NCT01853800|Anticoagulants|anticoagulants|mesh-ancestor
6722770|NCT01853813|Bevacizumab|bevacizumab|mesh-list
6722771|NCT01853813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6722772|NCT01853813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6722773|NCT01853813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6722774|NCT01853813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6722775|NCT01853813|Growth Substances|growth substances|mesh-ancestor
6722776|NCT01853813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722777|NCT01853813|Growth Inhibitors|growth inhibitors|mesh-ancestor
6722778|NCT01853852|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
6722779|NCT01853852|Antiviral Agents|antiviral agents|mesh-ancestor
6722780|NCT01853852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6722781|NCT01853852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6722782|NCT01853852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722783|NCT01853956|Alprazolam|alprazolam|mesh-list
6722784|NCT01853956|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6722785|NCT01853956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6722786|NCT01853956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722787|NCT01853956|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6722788|NCT01853956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6722789|NCT01853956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6722790|NCT01853956|GABA Modulators|gaba modulators|mesh-ancestor
6722791|NCT01853956|GABA Agents|gaba agents|mesh-ancestor
6722792|NCT01853956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6722793|NCT01853956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722794|NCT01854021|Anesthetics|anesthetics|mesh-list
6722795|NCT01854021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6722796|NCT01854021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722797|NCT01854073|Scopolamine|scopolamine|mesh-list
6722798|NCT01854073|Bromides|bromides|mesh-list
6722799|NCT01854073|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
6722800|NCT01854073|Anticonvulsants|anticonvulsants|mesh-ancestor
6722801|NCT01854073|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6722802|NCT01854073|Antiemetics|antiemetics|mesh-ancestor
6722803|NCT01854073|Autonomic Agents|autonomic agents|mesh-ancestor
6722804|NCT01854073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6722805|NCT01854073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722806|NCT01854073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6722807|NCT01854073|Mydriatics|mydriatics|mesh-ancestor
6722808|NCT01854073|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6722809|NCT01854073|Cholinergic Agents|cholinergic agents|mesh-ancestor
6722810|NCT01854073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6722811|NCT01854073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722812|NCT01854073|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6722813|NCT01854073|Parasympatholytics|parasympatholytics|mesh-ancestor
6722814|NCT01854086|Diphosphonates|diphosphonates|mesh-list
6722815|NCT01854086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6722816|NCT01854086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784437|NCT02202993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784438|NCT02202993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6784439|NCT02202993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784440|NCT02202993|Vasodilator Agents|vasodilator agents|mesh-ancestor
6784441|NCT02202993|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6784442|NCT02202993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6784443|NCT02202993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6784444|NCT02203097|Propofol|propofol|mesh-list
6784445|NCT02203097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6784446|NCT02203097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6784447|NCT02203097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784448|NCT02203097|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6784449|NCT02203097|Anesthetics, General|anesthetics, general|mesh-ancestor
6784450|NCT02203097|Anesthetics|anesthetics|mesh-ancestor
6784451|NCT02203175|Fentanyl|fentanyl|mesh-list
6784452|NCT02203175|Propofol|propofol|mesh-list
6784453|NCT02203175|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6784454|NCT02203175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6784455|NCT02203175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784456|NCT02203175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6784457|NCT02203175|Anesthetics, General|anesthetics, general|mesh-ancestor
6784458|NCT02203175|Anesthetics|anesthetics|mesh-ancestor
6784459|NCT02203175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6722817|NCT01854203|Gemcitabine|gemcitabine|mesh-list
6722818|NCT01854203|Cisplatin|cisplatin|mesh-list
6722819|NCT01854203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6722820|NCT01854203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6722821|NCT01854203|Antimetabolites|antimetabolites|mesh-ancestor
6722822|NCT01854203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722823|NCT01854203|Antiviral Agents|antiviral agents|mesh-ancestor
6722824|NCT01854203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6722825|NCT01854203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6722826|NCT01854203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6722827|NCT01854203|Immunologic Factors|immunologic factors|mesh-ancestor
6722828|NCT01854203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722829|NCT01854216|Rotigotine|rotigotine|mesh-list
6722830|NCT01854216|Dopamine Agonists|dopamine agonists|mesh-ancestor
6722831|NCT01854216|Dopamine Agents|dopamine agents|mesh-ancestor
6722832|NCT01854216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6722833|NCT01854216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722834|NCT01854216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722835|NCT01854255|Cisplatin|cisplatin|mesh-list
6722836|NCT01854255|Doxorubicin|doxorubicin|mesh-list
6722837|NCT01854255|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6722838|NCT01854255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6722839|NCT01854255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6722840|NCT01854255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6722841|NCT01854255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6722842|NCT01854255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6722843|NCT01854255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722844|NCT01854411|Analgesics|analgesics|mesh-list
6722845|NCT01854411|Sensory System Agents|sensory system agents|mesh-ancestor
6722846|NCT01854411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6722847|NCT01854411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722848|NCT01854463|Vitamin D|vitamin d|mesh-list
6722849|NCT01854463|Cholecalciferol|cholecalciferol|mesh-list
6722850|NCT01854463|Vitamins|vitamins|mesh-ancestor
6722851|NCT01854463|Micronutrients|micronutrients|mesh-ancestor
6722852|NCT01854463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722853|NCT01854463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6722854|NCT01854463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6722855|NCT01854476|Tranexamic Acid|tranexamic acid|mesh-list
6722856|NCT01854476|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6722857|NCT01854476|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6722858|NCT01854476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722859|NCT01854476|Hemostatics|hemostatics|mesh-ancestor
6722860|NCT01854476|Coagulants|coagulants|mesh-ancestor
6722861|NCT01854489|Rifampin|rifampin|mesh-list
6722862|NCT01854489|Buprenorphine|buprenorphine|mesh-list
6722863|NCT01854489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6722864|NCT01854489|Narcotics|narcotics|mesh-ancestor
6722865|NCT01854489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6722866|NCT01854489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722867|NCT01854489|Analgesics|analgesics|mesh-ancestor
6722868|NCT01854489|Sensory System Agents|sensory system agents|mesh-ancestor
6722869|NCT01854489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6722870|NCT01854489|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6722871|NCT01854489|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6722872|NCT01854489|Antitubercular Agents|antitubercular agents|mesh-ancestor
6722873|NCT01854489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6722874|NCT01854489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6722875|NCT01854489|Leprostatic Agents|leprostatic agents|mesh-ancestor
6722876|NCT01854489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6722877|NCT01854489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6722878|NCT01854489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722879|NCT01854489|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6722880|NCT01854489|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6722881|NCT01854489|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6722882|NCT01854489|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6722883|NCT01854489|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6722884|NCT01854489|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6722885|NCT01854502|Fluorides|fluorides|mesh-list
6722886|NCT01854502|Cariostatic Agents|cariostatic agents|mesh-ancestor
6722887|NCT01854502|Protective Agents|protective agents|mesh-ancestor
6722888|NCT01854502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722889|NCT01854515|Dexamethasone|dexamethasone|mesh-list
6722890|NCT01854515|Budesonide|budesonide|mesh-list
6722891|NCT01854515|Dexamethasone acetate|dexamethasone acetate|mesh-list
6722892|NCT01854515|BB 1101|bb 1101|mesh-list
6722893|NCT01854515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6722894|NCT01854515|Antiemetics|antiemetics|mesh-ancestor
6722895|NCT01854515|Autonomic Agents|autonomic agents|mesh-ancestor
6722896|NCT01854515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6722897|NCT01854515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722898|NCT01854515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6722899|NCT01854515|Glucocorticoids|glucocorticoids|mesh-ancestor
6722900|NCT01854515|Hormones|hormones|mesh-ancestor
6722901|NCT01854515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6722902|NCT01854515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6722903|NCT01854515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6722904|NCT01854515|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6722905|NCT01854515|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6722906|NCT01854515|Respiratory System Agents|respiratory system agents|mesh-ancestor
6722907|NCT01854515|Protease Inhibitors|protease inhibitors|mesh-ancestor
6722908|NCT01854515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6722909|NCT01854515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722910|NCT01854606|Everolimus|everolimus|mesh-list
6722911|NCT01854606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6722912|NCT01854606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6722913|NCT01854606|Immunologic Factors|immunologic factors|mesh-ancestor
6722914|NCT01854606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722915|NCT01854619|Anti-Infective Agents|anti-infective agents|mesh-list
6722916|NCT01854619|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6722917|NCT01854684|Temoporfin|temoporfin|mesh-list
6722918|NCT01854684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6722919|NCT01854684|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6722920|NCT01854684|Dermatologic Agents|dermatologic agents|mesh-ancestor
6722921|NCT01854723|Insulin|insulin|mesh-list
6722922|NCT01854723|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6722923|NCT01854723|Insulin Glargine|insulin glargine|mesh-list
6722924|NCT01854723|Insulin, Isophane|insulin, isophane|mesh-list
6722925|NCT01854723|Isophane Insulin, Human|isophane insulin, human|mesh-list
6722926|NCT01854723|Isophane insulin, beef|isophane insulin, beef|mesh-list
6722927|NCT01854723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6722928|NCT01854723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722929|NCT01854749|Cisplatin|cisplatin|mesh-list
6722930|NCT01854749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6722931|NCT01854762|Ritonavir|ritonavir|mesh-list
6722932|NCT01854762|Lopinavir|lopinavir|mesh-list
6722933|NCT01854762|Raltegravir Potassium|raltegravir potassium|mesh-list
6722934|NCT01854762|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6722935|NCT01854762|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6722936|NCT01854762|Protease Inhibitors|protease inhibitors|mesh-ancestor
6722937|NCT01854762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6722938|NCT01854762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722939|NCT01854762|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6722940|NCT01854762|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6722941|NCT01854762|Antiviral Agents|antiviral agents|mesh-ancestor
6722942|NCT01854762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6722943|NCT01854762|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6722944|NCT01854762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6722945|NCT01854762|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6722946|NCT01854762|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6722947|NCT01854814|Mycophenolic Acid|mycophenolic acid|mesh-list
6722948|NCT01854814|Losartan|losartan|mesh-list
6722949|NCT01854814|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6722950|NCT01854814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6722951|NCT01854814|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6722952|NCT01854814|Antitubercular Agents|antitubercular agents|mesh-ancestor
6722953|NCT01854814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6722954|NCT01854814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6722955|NCT01854814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6722956|NCT01854814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722957|NCT01854814|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6722958|NCT01854814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6722959|NCT01854814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6722960|NCT01854814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6722961|NCT01854970|Esomeprazole|esomeprazole|mesh-list
6722962|NCT01854970|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6722963|NCT01854970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6722964|NCT01854970|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6722965|NCT01854970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6722966|NCT01854970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722967|NCT01855009|Calcium, Dietary|calcium, dietary|mesh-list
6722968|NCT01855009|Vitamin D|vitamin d|mesh-list
6722969|NCT01855009|Cholecalciferol|cholecalciferol|mesh-list
6722970|NCT01855009|Calcium Carbonate|calcium carbonate|mesh-list
6722971|NCT01855009|Calcium|calcium|mesh-list
6722972|NCT01855009|Vitamins|vitamins|mesh-ancestor
6722973|NCT01855009|Micronutrients|micronutrients|mesh-ancestor
6722974|NCT01855009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722975|NCT01855009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6722976|NCT01855009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6722977|NCT01855009|Antacids|antacids|mesh-ancestor
6722978|NCT01855009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722979|NCT01855009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6722980|NCT01855061|Midazolam|midazolam|mesh-list
6722981|NCT01855061|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6722982|NCT01855061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6722983|NCT01855061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6722984|NCT01855061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6722985|NCT01855061|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6722986|NCT01855061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6722987|NCT01855061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6722988|NCT01855061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6722989|NCT01855061|Anesthetics, General|anesthetics, general|mesh-ancestor
6722990|NCT01855061|Anesthetics|anesthetics|mesh-ancestor
6722991|NCT01855061|GABA Modulators|gaba modulators|mesh-ancestor
6722992|NCT01855061|GABA Agents|gaba agents|mesh-ancestor
6722993|NCT01855061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6722994|NCT01855061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6722995|NCT01855100|Rivaroxaban|rivaroxaban|mesh-list
6722996|NCT01855100|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6722997|NCT01855100|Antithrombins|antithrombins|mesh-ancestor
6722998|NCT01855100|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6722999|NCT01855100|Protease Inhibitors|protease inhibitors|mesh-ancestor
6723000|NCT01855100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6723001|NCT01855100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723002|NCT01855100|Anticoagulants|anticoagulants|mesh-ancestor
6723003|NCT01855139|Rivaroxaban|rivaroxaban|mesh-list
6723004|NCT01855139|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6723005|NCT01855139|Antithrombins|antithrombins|mesh-ancestor
6723006|NCT01855139|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6723007|NCT01855139|Protease Inhibitors|protease inhibitors|mesh-ancestor
6723008|NCT01855139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6723009|NCT01855139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723010|NCT01855139|Anticoagulants|anticoagulants|mesh-ancestor
6723011|NCT01855256|Oxybutynin|oxybutynin|mesh-list
6723012|NCT01855256|Parasympatholytics|parasympatholytics|mesh-ancestor
6723013|NCT01855256|Autonomic Agents|autonomic agents|mesh-ancestor
6723014|NCT01855256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6723015|NCT01855256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723016|NCT01855256|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6723017|NCT01855256|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6723018|NCT01855256|Cholinergic Agents|cholinergic agents|mesh-ancestor
6723019|NCT01855256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6723020|NCT01855256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723021|NCT01855256|Urological Agents|urological agents|mesh-ancestor
6723022|NCT01855321|Vitamin D|vitamin d|mesh-list
6723023|NCT01855321|Cholecalciferol|cholecalciferol|mesh-list
6723024|NCT01855321|Vitamins|vitamins|mesh-ancestor
6723025|NCT01855321|Micronutrients|micronutrients|mesh-ancestor
6723026|NCT01855321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723027|NCT01855321|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6723028|NCT01855321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6723029|NCT01855334|Spironolactone|spironolactone|mesh-list
6723030|NCT01855334|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6723031|NCT01855334|Hormone Antagonists|hormone antagonists|mesh-ancestor
6723032|NCT01855334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6723033|NCT01855334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723034|NCT01855334|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6723035|NCT01855334|Diuretics|diuretics|mesh-ancestor
6723036|NCT01855334|Natriuretic Agents|natriuretic agents|mesh-ancestor
6723037|NCT01855386|Liver Extracts|liver extracts|mesh-list
6723038|NCT01855386|Hematinics|hematinics|mesh-ancestor
6723039|NCT01855451|Cetuximab|cetuximab|mesh-list
6723040|NCT01855451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6723041|NCT01855451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6723042|NCT01855490|Exenatide|exenatide|mesh-list
6723043|NCT01855490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6723044|NCT01855490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723045|NCT01855490|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6723046|NCT01855490|Incretins|incretins|mesh-ancestor
6723047|NCT01855490|Hormones|hormones|mesh-ancestor
6723048|NCT01855490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6723049|NCT01855516|Heparin|heparin|mesh-list
6723050|NCT01855516|Anticoagulants|anticoagulants|mesh-ancestor
6723051|NCT01855516|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6723052|NCT01855516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6723053|NCT01855516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723054|NCT01855529|Ropivacaine|ropivacaine|mesh-list
6723055|NCT01855529|Anesthetics, Local|anesthetics, local|mesh-ancestor
6723056|NCT01855529|Anesthetics|anesthetics|mesh-ancestor
6723057|NCT01855529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6723058|NCT01855529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723059|NCT01855529|Sensory System Agents|sensory system agents|mesh-ancestor
6723060|NCT01855529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6723061|NCT01855542|Plasma-lyte 148|plasma-lyte 148|mesh-list
6723062|NCT01855542|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6723063|NCT01855542|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6723064|NCT01855555|Propofol|propofol|mesh-list
6723065|NCT01855555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6723066|NCT01855555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6723067|NCT01855555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723068|NCT01855555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6723069|NCT01855555|Anesthetics, General|anesthetics, general|mesh-ancestor
6723070|NCT01855555|Anesthetics|anesthetics|mesh-ancestor
6723071|NCT01855568|Methotrexate|methotrexate|mesh-list
6723072|NCT01855568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6723073|NCT01855568|Abortifacient Agents|abortifacient agents|mesh-ancestor
6723074|NCT01855568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6723075|NCT01855568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723076|NCT01855568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6723077|NCT01855568|Antimetabolites|antimetabolites|mesh-ancestor
6723078|NCT01855568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723079|NCT01855568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6723080|NCT01855568|Dermatologic Agents|dermatologic agents|mesh-ancestor
6723081|NCT01855568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6723082|NCT01855568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6723083|NCT01855568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6723084|NCT01855568|Immunologic Factors|immunologic factors|mesh-ancestor
6723085|NCT01855568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6723086|NCT01855568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6723087|NCT01855581|Ketamine|ketamine|mesh-list
6723088|NCT01855581|Propofol|propofol|mesh-list
6723089|NCT01855581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6723090|NCT01855581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6723091|NCT01855581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723092|NCT01855581|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6723093|NCT01855581|Anesthetics, General|anesthetics, general|mesh-ancestor
6723094|NCT01855581|Anesthetics|anesthetics|mesh-ancestor
6723095|NCT01855581|Analgesics|analgesics|mesh-ancestor
6723096|NCT01855581|Sensory System Agents|sensory system agents|mesh-ancestor
6723097|NCT01855581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6723098|NCT01855581|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6723099|NCT01855581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6723100|NCT01855581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6723101|NCT01855581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6723102|NCT01855581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723103|NCT01855594|Lithium Carbonate|lithium carbonate|mesh-list
6723104|NCT01855594|Antidepressive Agents|antidepressive agents|mesh-ancestor
6723105|NCT01855594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6723106|NCT01855594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6723107|NCT01855594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723108|NCT01855594|Antimanic Agents|antimanic agents|mesh-ancestor
6723109|NCT01855594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6723110|NCT01855594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6723111|NCT01855594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723112|NCT01855607|Menthol|menthol|mesh-list
6723113|NCT01855607|Antipruritics|antipruritics|mesh-ancestor
6723114|NCT01855607|Dermatologic Agents|dermatologic agents|mesh-ancestor
6723115|NCT01855711|Alosetron|alosetron|mesh-list
6723116|NCT01855711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6723117|NCT01855711|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6723118|NCT01855711|Serotonin Agents|serotonin agents|mesh-ancestor
6723119|NCT01855711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6723120|NCT01855711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723121|NCT01855711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723122|NCT01855724|Gemcitabine|gemcitabine|mesh-list
6723123|NCT01855724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6723124|NCT01855724|Antimetabolites|antimetabolites|mesh-ancestor
6723125|NCT01855724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723126|NCT01855724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6723127|NCT01855724|Antiviral Agents|antiviral agents|mesh-ancestor
6723128|NCT01855724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6723129|NCT01855724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6723130|NCT01855724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6723131|NCT01855724|Immunologic Factors|immunologic factors|mesh-ancestor
6723132|NCT01855724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723133|NCT01855737|Warfarin|warfarin|mesh-list
6723134|NCT01855737|Anticoagulants|anticoagulants|mesh-ancestor
6723135|NCT01855763|Insulin|insulin|mesh-list
6723136|NCT01855763|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6723137|NCT01855763|Metformin|metformin|mesh-list
6723138|NCT01855763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6723139|NCT01855763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723140|NCT01855867|Tenofovir|tenofovir|mesh-list
6723141|NCT01855867|Emtricitabine|emtricitabine|mesh-list
6723142|NCT01855867|Antiviral Agents|antiviral agents|mesh-ancestor
6723143|NCT01855867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6723144|NCT01855867|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6723145|NCT01855867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6723146|NCT01855867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6723147|NCT01855867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723148|NCT01855867|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6723149|NCT01855867|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6784460|NCT02203175|Narcotics|narcotics|mesh-ancestor
6784461|NCT02203175|Analgesics|analgesics|mesh-ancestor
6784462|NCT02203175|Sensory System Agents|sensory system agents|mesh-ancestor
6784463|NCT02203175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6784464|NCT02203175|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6784465|NCT02203227|Turmeric extract|turmeric extract|mesh-list
6784466|NCT02203227|Antioxidants|antioxidants|mesh-ancestor
6784467|NCT02203227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784468|NCT02203227|Protective Agents|protective agents|mesh-ancestor
6784469|NCT02203227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784470|NCT02203253|Thalidomide|thalidomide|mesh-list
6784471|NCT02203253|Dexamethasone|dexamethasone|mesh-list
6784472|NCT02203253|Palonosetron|palonosetron|mesh-list
6784473|NCT02203253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6784474|NCT02203253|Antiemetics|antiemetics|mesh-ancestor
6784475|NCT02203253|Autonomic Agents|autonomic agents|mesh-ancestor
6784476|NCT02203253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6784477|NCT02203253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784478|NCT02203253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6784479|NCT02203253|Glucocorticoids|glucocorticoids|mesh-ancestor
6784480|NCT02203253|Hormones|hormones|mesh-ancestor
6784481|NCT02203253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6784482|NCT02203253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6784483|NCT02203253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6784484|NCT02203253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6784485|NCT02203253|Immunologic Factors|immunologic factors|mesh-ancestor
6784486|NCT02203253|Leprostatic Agents|leprostatic agents|mesh-ancestor
6784487|NCT02203253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6784488|NCT02203253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6784489|NCT02203253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6784490|NCT02203253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6784491|NCT02203253|Growth Substances|growth substances|mesh-ancestor
6784492|NCT02203253|Growth Inhibitors|growth inhibitors|mesh-ancestor
6784493|NCT02203253|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6784494|NCT02203253|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6784495|NCT02203253|Serotonin Agents|serotonin agents|mesh-ancestor
6784496|NCT02203253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6784497|NCT02203253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784498|NCT02203396|Cyclosporine|cyclosporine|mesh-list
6784499|NCT02203396|Levamisole|levamisole|mesh-list
6784500|NCT02203396|Cyclosporins|cyclosporins|mesh-list
6784501|NCT02203396|Thymoglobulin|thymoglobulin|mesh-list
6784502|NCT02203396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6784503|NCT02203396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784504|NCT02203396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6784505|NCT02203396|Immunologic Factors|immunologic factors|mesh-ancestor
6784506|NCT02203396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784507|NCT02203396|Antifungal Agents|antifungal agents|mesh-ancestor
6784508|NCT02203396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6784509|NCT02203396|Dermatologic Agents|dermatologic agents|mesh-ancestor
6784510|NCT02203396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6784511|NCT02203396|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6784512|NCT02203396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6784513|NCT02203396|Antinematodal Agents|antinematodal agents|mesh-ancestor
6784514|NCT02203396|Anthelmintics|anthelmintics|mesh-ancestor
6784515|NCT02203396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6784516|NCT02203422|Cyclosporine|cyclosporine|mesh-list
6784517|NCT02203422|Cyclosporins|cyclosporins|mesh-list
6784518|NCT02203422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6784519|NCT02203422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784520|NCT02203422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6784521|NCT02203422|Immunologic Factors|immunologic factors|mesh-ancestor
6784522|NCT02203422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723150|NCT01855971|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
6723151|NCT01855971|Antioxidants|antioxidants|mesh-ancestor
6723152|NCT01855971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723153|NCT01855971|Protective Agents|protective agents|mesh-ancestor
6723154|NCT01855971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723155|NCT01855971|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
6723156|NCT01855971|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6723157|NCT01855971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6723158|NCT01855971|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6723159|NCT01855984|Tocotrienols|tocotrienols|mesh-list
6723160|NCT01855984|Vitamin E|vitamin e|mesh-list
6723161|NCT01855984|Tocopherols|tocopherols|mesh-list
6723162|NCT01855984|Tocovid|tocovid|mesh-list
6723163|NCT01855984|Antioxidants|antioxidants|mesh-ancestor
6723164|NCT01855984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723165|NCT01855984|Protective Agents|protective agents|mesh-ancestor
6723166|NCT01855984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723167|NCT01855984|Vitamins|vitamins|mesh-ancestor
6723168|NCT01855984|Micronutrients|micronutrients|mesh-ancestor
6723169|NCT01856023|Aldesleukin|aldesleukin|mesh-list
6723170|NCT01856023|Ipilimumab|ipilimumab|mesh-list
6723171|NCT01856023|Interleukin-2|interleukin-2|mesh-list
6723172|NCT01856023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6723173|NCT01856023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6723174|NCT01856023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6723175|NCT01856023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723176|NCT01856023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6723177|NCT01856023|Analgesics|analgesics|mesh-ancestor
6723178|NCT01856023|Sensory System Agents|sensory system agents|mesh-ancestor
6723179|NCT01856023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6723180|NCT01856023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723181|NCT01856023|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6723182|NCT01856023|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6723183|NCT01856023|Antiviral Agents|antiviral agents|mesh-ancestor
6723184|NCT01856023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6723185|NCT01856062|Dexamethasone|dexamethasone|mesh-list
6723186|NCT01856062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6723187|NCT01856062|Antiemetics|antiemetics|mesh-ancestor
6723188|NCT01856062|Autonomic Agents|autonomic agents|mesh-ancestor
6723189|NCT01856062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6723190|NCT01856062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723191|NCT01856062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6723192|NCT01856062|Glucocorticoids|glucocorticoids|mesh-ancestor
6723193|NCT01856062|Hormones|hormones|mesh-ancestor
6723194|NCT01856062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6723195|NCT01856062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6723196|NCT01856062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6723197|NCT01856101|Dactolisib|dactolisib|mesh-list
6723198|NCT01856101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6723199|NCT01856127|Sertraline|sertraline|mesh-list
6723200|NCT01856127|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
6723201|NCT01856127|Antidepressive Agents|antidepressive agents|mesh-ancestor
6723202|NCT01856127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6723203|NCT01856127|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6723204|NCT01856127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6723205|NCT01856127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6723206|NCT01856127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723207|NCT01856127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6723208|NCT01856127|Serotonin Agents|serotonin agents|mesh-ancestor
6723209|NCT01856127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723210|NCT01856127|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6723211|NCT01856127|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6723212|NCT01856166|Sufentanil|sufentanil|mesh-list
6723213|NCT01856166|Levobupivacaine|levobupivacaine|mesh-list
6723214|NCT01856166|Anesthetics, Local|anesthetics, local|mesh-ancestor
6723215|NCT01856166|Anesthetics|anesthetics|mesh-ancestor
6723216|NCT01856166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6723217|NCT01856166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723218|NCT01856166|Sensory System Agents|sensory system agents|mesh-ancestor
6723219|NCT01856166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6723220|NCT01856166|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6723221|NCT01856166|Narcotics|narcotics|mesh-ancestor
6723222|NCT01856166|Analgesics|analgesics|mesh-ancestor
6723223|NCT01856166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6723224|NCT01856166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6723225|NCT01856166|Anesthetics, General|anesthetics, general|mesh-ancestor
6723226|NCT01856205|Immunoglobulins|immunoglobulins|mesh-list
6723227|NCT01856205|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6723228|NCT01856205|Antibodies|antibodies|mesh-list
6723229|NCT01856205|gamma-Globulins|gamma-globulins|mesh-list
6723230|NCT01856205|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6723231|NCT01856205|Immunologic Factors|immunologic factors|mesh-ancestor
6723232|NCT01856205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723233|NCT01856348|Vitamin D|vitamin d|mesh-list
6723234|NCT01856348|Vitamins|vitamins|mesh-ancestor
6723235|NCT01856348|Micronutrients|micronutrients|mesh-ancestor
6723236|NCT01856348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723237|NCT01856348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6723238|NCT01856374|Sirolimus|sirolimus|mesh-list
6723239|NCT01856374|Everolimus|everolimus|mesh-list
6723240|NCT01856374|Atorvastatin|atorvastatin|mesh-list
6723241|NCT01856374|Pravastatin|pravastatin|mesh-list
6723242|NCT01856374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6723243|NCT01856374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6723244|NCT01856374|Antimetabolites|antimetabolites|mesh-ancestor
6723245|NCT01856374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723246|NCT01856374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6723247|NCT01856374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6723248|NCT01856374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6723249|NCT01856374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6723250|NCT01856374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6723251|NCT01856374|Immunologic Factors|immunologic factors|mesh-ancestor
6723252|NCT01856374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723253|NCT01856374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6723254|NCT01856374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6723255|NCT01856374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6723256|NCT01856374|Antifungal Agents|antifungal agents|mesh-ancestor
6723257|NCT01856413|Immunoglobulins|immunoglobulins|mesh-list
6723258|NCT01856413|Immunologic Factors|immunologic factors|mesh-ancestor
6723259|NCT01856413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723260|NCT01856517|Clonidine|clonidine|mesh-list
6723261|NCT01856517|Analgesics|analgesics|mesh-ancestor
6723262|NCT01856517|Sensory System Agents|sensory system agents|mesh-ancestor
6723263|NCT01856517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6723264|NCT01856517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723265|NCT01856517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6723266|NCT01856517|Sympatholytics|sympatholytics|mesh-ancestor
6723267|NCT01856517|Autonomic Agents|autonomic agents|mesh-ancestor
6723268|NCT01856517|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6723269|NCT01856517|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6723270|NCT01856517|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6723271|NCT01856517|Adrenergic Agents|adrenergic agents|mesh-ancestor
6723272|NCT01856517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6723273|NCT01856517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723274|NCT01856556|Glycine|glycine|mesh-list
6723275|NCT01856556|Glycine Agents|glycine agents|mesh-ancestor
6723276|NCT01856556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6723277|NCT01856556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723278|NCT01856556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723279|NCT01856621|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6723280|NCT01856621|Charcoal|charcoal|mesh-list
6723281|NCT01856621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6723282|NCT01856621|Autonomic Agents|autonomic agents|mesh-ancestor
6723283|NCT01856621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6723284|NCT01856621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723285|NCT01856621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6723286|NCT01856621|Respiratory System Agents|respiratory system agents|mesh-ancestor
6723287|NCT01856621|Glucocorticoids|glucocorticoids|mesh-ancestor
6723288|NCT01856621|Hormones|hormones|mesh-ancestor
6723289|NCT01856621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6723290|NCT01856621|Sympathomimetics|sympathomimetics|mesh-ancestor
6723291|NCT01856621|Antidotes|antidotes|mesh-ancestor
6723292|NCT01856621|Protective Agents|protective agents|mesh-ancestor
6723293|NCT01856738|Rivastigmine|rivastigmine|mesh-list
6723294|NCT01856738|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6723295|NCT01856738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6723296|NCT01856738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723297|NCT01856738|Cholinergic Agents|cholinergic agents|mesh-ancestor
6723298|NCT01856738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6723299|NCT01856738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723300|NCT01856738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6723301|NCT01856738|Protective Agents|protective agents|mesh-ancestor
6723302|NCT01856803|Thymoglobulin|thymoglobulin|mesh-list
6723303|NCT01856803|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6723304|NCT01856803|Immunologic Factors|immunologic factors|mesh-ancestor
6723305|NCT01856803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723306|NCT01856803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6723307|NCT01856946|Vitamin D|vitamin d|mesh-list
6723308|NCT01856946|Cholecalciferol|cholecalciferol|mesh-list
6723309|NCT01856946|Vitamins|vitamins|mesh-ancestor
6723310|NCT01856946|Micronutrients|micronutrients|mesh-ancestor
6723311|NCT01856946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723312|NCT01856946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6723313|NCT01856946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6723314|NCT01856959|Magnesium Sulfate|magnesium sulfate|mesh-list
6723315|NCT01856959|Albuterol|albuterol|mesh-list
6723316|NCT01856959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6723317|NCT01856959|Autonomic Agents|autonomic agents|mesh-ancestor
6723318|NCT01856959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6723319|NCT01856959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723320|NCT01856959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6723321|NCT01856959|Respiratory System Agents|respiratory system agents|mesh-ancestor
6723322|NCT01856959|Tocolytic Agents|tocolytic agents|mesh-ancestor
6723323|NCT01856959|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6723324|NCT01856959|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6723325|NCT01856959|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6723326|NCT01856959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6723327|NCT01856959|Adrenergic Agents|adrenergic agents|mesh-ancestor
6723328|NCT01856959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6723329|NCT01856959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723330|NCT01856959|Analgesics|analgesics|mesh-ancestor
6723331|NCT01856959|Sensory System Agents|sensory system agents|mesh-ancestor
6723332|NCT01856959|Anesthetics|anesthetics|mesh-ancestor
6723333|NCT01856959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6723334|NCT01856959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6723335|NCT01856959|Anticonvulsants|anticonvulsants|mesh-ancestor
6723336|NCT01856959|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6723337|NCT01856959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6723338|NCT01856959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6723339|NCT01856985|Misoprostol|misoprostol|mesh-list
6723340|NCT01856985|Mifepristone|mifepristone|mesh-list
6723341|NCT01856985|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6723342|NCT01856985|Abortifacient Agents|abortifacient agents|mesh-ancestor
6723343|NCT01856985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6723344|NCT01856985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723345|NCT01856985|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6723346|NCT01856985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6723347|NCT01856985|Oxytocics|oxytocics|mesh-ancestor
6723348|NCT01856985|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6723349|NCT01856985|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6723350|NCT01856985|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6723351|NCT01856985|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6723352|NCT01856985|Contraceptive Agents|contraceptive agents|mesh-ancestor
6723353|NCT01856985|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6723354|NCT01856985|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6723355|NCT01856985|Hormone Antagonists|hormone antagonists|mesh-ancestor
6723356|NCT01856985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6723357|NCT01856985|Luteolytic Agents|luteolytic agents|mesh-ancestor
6723358|NCT01856985|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6723359|NCT01856985|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6723360|NCT01856998|Propofol|propofol|mesh-list
6723361|NCT01856998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6723362|NCT01856998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6723363|NCT01856998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723364|NCT01856998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6723365|NCT01856998|Anesthetics, General|anesthetics, general|mesh-ancestor
6723366|NCT01856998|Anesthetics|anesthetics|mesh-ancestor
6723367|NCT01857011|Iron|iron|mesh-list
6723368|NCT01857011|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6723369|NCT01857011|Teferrol|teferrol|mesh-list
6723370|NCT01857011|Ferric Compounds|ferric compounds|mesh-list
6723371|NCT01857011|Trace Elements|trace elements|mesh-ancestor
6723372|NCT01857011|Micronutrients|micronutrients|mesh-ancestor
6723373|NCT01857011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723374|NCT01857011|Hematinics|hematinics|mesh-ancestor
6723375|NCT01857024|Sevelamer|sevelamer|mesh-list
6723376|NCT01857024|Chelating Agents|chelating agents|mesh-ancestor
6723377|NCT01857024|Sequestering Agents|sequestering agents|mesh-ancestor
6723378|NCT01857024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723379|NCT01857115|Dexamethasone|dexamethasone|mesh-list
6723380|NCT01857115|Cyclophosphamide|cyclophosphamide|mesh-list
6723381|NCT01857115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6723382|NCT01857115|Immunologic Factors|immunologic factors|mesh-ancestor
6723383|NCT01857115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723384|NCT01857115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6723385|NCT01857115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6723386|NCT01857115|Alkylating Agents|alkylating agents|mesh-ancestor
6723387|NCT01857115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723388|NCT01857115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6723389|NCT01857115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6723390|NCT01857115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6723391|NCT01857115|Antiemetics|antiemetics|mesh-ancestor
6723392|NCT01857115|Autonomic Agents|autonomic agents|mesh-ancestor
6723393|NCT01857115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6723394|NCT01857115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6723395|NCT01857115|Glucocorticoids|glucocorticoids|mesh-ancestor
6723396|NCT01857115|Hormones|hormones|mesh-ancestor
6723397|NCT01857115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6723398|NCT01857115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6723399|NCT01857141|Dexmedetomidine|dexmedetomidine|mesh-list
6723400|NCT01857141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6723401|NCT01857141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6723402|NCT01857141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723403|NCT01857141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6723404|NCT01857141|Analgesics|analgesics|mesh-ancestor
6723405|NCT01857141|Sensory System Agents|sensory system agents|mesh-ancestor
6723406|NCT01857141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6723407|NCT01857141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6723408|NCT01857141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6723409|NCT01857141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6723410|NCT01857141|Adrenergic Agents|adrenergic agents|mesh-ancestor
6723411|NCT01857141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6723412|NCT01857141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723413|NCT01857154|Calcium, Dietary|calcium, dietary|mesh-list
6723414|NCT01857154|Vitamin D|vitamin d|mesh-list
6723415|NCT01857154|Cholecalciferol|cholecalciferol|mesh-list
6723416|NCT01857154|Calcium Carbonate|calcium carbonate|mesh-list
6723417|NCT01857154|Calcium|calcium|mesh-list
6723418|NCT01857154|Vitamins|vitamins|mesh-ancestor
6723419|NCT01857154|Micronutrients|micronutrients|mesh-ancestor
6723420|NCT01857154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723421|NCT01857154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6723422|NCT01857154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6723423|NCT01857154|Antacids|antacids|mesh-ancestor
6723424|NCT01857154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723425|NCT01857154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6723426|NCT01857193|Everolimus|everolimus|mesh-list
6723427|NCT01857193|Exemestane|exemestane|mesh-list
6723428|NCT01857193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6723429|NCT01857193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6723430|NCT01857193|Immunologic Factors|immunologic factors|mesh-ancestor
6723431|NCT01857193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723432|NCT01857193|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6723433|NCT01857193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6723434|NCT01857193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6723435|NCT01857193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723436|NCT01857193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6723437|NCT01857193|Hormone Antagonists|hormone antagonists|mesh-ancestor
6723438|NCT01857193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6723439|NCT01857284|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
6723440|NCT01857284|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
6723441|NCT01857284|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6723442|NCT01857284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6723443|NCT01857284|Antiviral Agents|antiviral agents|mesh-ancestor
6723444|NCT01857284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6723445|NCT01857349|Ethanol|ethanol|mesh-list
6723446|NCT01857349|Chlorhexidine|chlorhexidine|mesh-list
6723447|NCT01857349|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6723448|NCT01857349|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6723449|NCT01857349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6723450|NCT01857349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6723451|NCT01857349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723452|NCT01857349|Disinfectants|disinfectants|mesh-ancestor
6723453|NCT01857349|Dermatologic Agents|dermatologic agents|mesh-ancestor
6723454|NCT01857375|Insulin|insulin|mesh-list
6723455|NCT01857375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6723456|NCT01857375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723457|NCT01857453|Etoposide|etoposide|mesh-list
6723458|NCT01857453|Carboplatin|carboplatin|mesh-list
6723459|NCT01857453|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6723460|NCT01857453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6723461|NCT01857453|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6723462|NCT01857453|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6723463|NCT01857453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6723464|NCT01857453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723465|NCT01857479|Amphotericin B|amphotericin b|mesh-list
6723466|NCT01857479|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6723467|NCT01857479|Budesonide|budesonide|mesh-list
6723468|NCT01857479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6723469|NCT01857479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6723470|NCT01857479|Autonomic Agents|autonomic agents|mesh-ancestor
6723471|NCT01857479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6723472|NCT01857479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723473|NCT01857479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6723474|NCT01857479|Respiratory System Agents|respiratory system agents|mesh-ancestor
6723475|NCT01857479|Glucocorticoids|glucocorticoids|mesh-ancestor
6723476|NCT01857479|Hormones|hormones|mesh-ancestor
6723477|NCT01857479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6723478|NCT01857479|Amebicides|amebicides|mesh-ancestor
6723479|NCT01857479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6723480|NCT01857479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6723481|NCT01857479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6723482|NCT01857479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6723483|NCT01857479|Antifungal Agents|antifungal agents|mesh-ancestor
6723484|NCT01857544|Aflibercept|aflibercept|mesh-list
6723485|NCT01857544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6723486|NCT01857544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6723487|NCT01857544|Growth Substances|growth substances|mesh-ancestor
6723488|NCT01857544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723489|NCT01857544|Growth Inhibitors|growth inhibitors|mesh-ancestor
6723490|NCT01857544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6723491|NCT01857596|Trazodone|trazodone|mesh-list
6723492|NCT01857596|Bupropion|bupropion|mesh-list
6723493|NCT01857596|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6723494|NCT01857596|Antidepressive Agents|antidepressive agents|mesh-ancestor
6723495|NCT01857596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6723496|NCT01857596|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6723497|NCT01857596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6723498|NCT01857596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6723499|NCT01857596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723500|NCT01857596|Dopamine Agents|dopamine agents|mesh-ancestor
6723501|NCT01857596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6723502|NCT01857596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723503|NCT01857596|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6723504|NCT01857596|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6723505|NCT01857596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6723506|NCT01857596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6723507|NCT01857596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6723508|NCT01857596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6723509|NCT01857596|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6723510|NCT01857596|Serotonin Agents|serotonin agents|mesh-ancestor
6723511|NCT01857609|Metformin|metformin|mesh-list
6723512|NCT01857609|Rabeprazole|rabeprazole|mesh-list
6723513|NCT01857609|Pantoprazole|pantoprazole|mesh-list
6723514|NCT01857609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6723515|NCT01857609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723516|NCT01857609|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6723517|NCT01857609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6723518|NCT01857609|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6723519|NCT01857609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6723520|NCT01857609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723521|NCT01857726|Doxorubicin|doxorubicin|mesh-list
6723522|NCT01857726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6723523|NCT01857726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6723524|NCT01857726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6723525|NCT01857726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6723526|NCT01857726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6723527|NCT01857726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723528|NCT01857752|Temozolomide|temozolomide|mesh-list
6723529|NCT01857752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6723530|NCT01857752|Alkylating Agents|alkylating agents|mesh-ancestor
6723531|NCT01857752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723532|NCT01857752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6784523|NCT02203422|Antifungal Agents|antifungal agents|mesh-ancestor
6723533|NCT01857804|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6723534|NCT01857804|Amoxicillin|amoxicillin|mesh-list
6723535|NCT01857804|Chlorhexidine|chlorhexidine|mesh-list
6723536|NCT01857804|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6723537|NCT01857804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6723538|NCT01857804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6723539|NCT01857804|Disinfectants|disinfectants|mesh-ancestor
6723540|NCT01857804|Dermatologic Agents|dermatologic agents|mesh-ancestor
6723541|NCT01857817|Etodolac|etodolac|mesh-list
6723542|NCT01857817|Propranolol|propranolol|mesh-list
6723543|NCT01857817|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6723544|NCT01857817|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6723545|NCT01857817|Adrenergic Agents|adrenergic agents|mesh-ancestor
6723546|NCT01857817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6723547|NCT01857817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723548|NCT01857817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723549|NCT01857817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6723550|NCT01857817|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6723551|NCT01857817|Vasodilator Agents|vasodilator agents|mesh-ancestor
6723552|NCT01857817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6723553|NCT01857817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6723554|NCT01857817|Analgesics|analgesics|mesh-ancestor
6723555|NCT01857817|Sensory System Agents|sensory system agents|mesh-ancestor
6723556|NCT01857817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6723557|NCT01857817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6723558|NCT01857817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6723559|NCT01857817|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6723560|NCT01857817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6723561|NCT01857817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6723562|NCT01857843|Everolimus|everolimus|mesh-list
6723563|NCT01857843|Simvastatin|simvastatin|mesh-list
6723564|NCT01857843|Ezetimibe|ezetimibe|mesh-list
6723565|NCT01857843|Pravastatin|pravastatin|mesh-list
6723566|NCT01857843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6723567|NCT01857843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6723568|NCT01857843|Immunologic Factors|immunologic factors|mesh-ancestor
6723569|NCT01857843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723570|NCT01857843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6723571|NCT01857843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6723572|NCT01857843|Antimetabolites|antimetabolites|mesh-ancestor
6723573|NCT01857843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723574|NCT01857843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6723575|NCT01857843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6723576|NCT01857843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6723577|NCT01857856|Eplerenone|eplerenone|mesh-list
6723578|NCT01857856|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6723579|NCT01857856|Hormone Antagonists|hormone antagonists|mesh-ancestor
6723580|NCT01857856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6723581|NCT01857856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723582|NCT01857856|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6723583|NCT01857856|Diuretics|diuretics|mesh-ancestor
6723584|NCT01857856|Natriuretic Agents|natriuretic agents|mesh-ancestor
6723585|NCT01857856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6723586|NCT01857895|Exenatide|exenatide|mesh-list
6723587|NCT01857895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6723588|NCT01857895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723589|NCT01857895|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6723590|NCT01857895|Incretins|incretins|mesh-ancestor
6723591|NCT01857895|Hormones|hormones|mesh-ancestor
6723592|NCT01857895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6723593|NCT01857921|Trimetazidine|trimetazidine|mesh-list
6723594|NCT01857921|Atorvastatin|atorvastatin|mesh-list
6723595|NCT01857921|Pravastatin|pravastatin|mesh-list
6723596|NCT01857921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6723597|NCT01857921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6723598|NCT01857921|Antimetabolites|antimetabolites|mesh-ancestor
6723599|NCT01857921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723600|NCT01857921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6723601|NCT01857921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6723602|NCT01857921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6723603|NCT01857921|Vasodilator Agents|vasodilator agents|mesh-ancestor
6723604|NCT01857999|Losartan|losartan|mesh-list
6723605|NCT01857999|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6723606|NCT01857999|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6723607|NCT01857999|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6723608|NCT01857999|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6723609|NCT01857999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723610|NCT01858025|Fluorouracil|fluorouracil|mesh-list
6723611|NCT01858025|Mitomycins|mitomycins|mesh-list
6723612|NCT01858025|Mitomycin|mitomycin|mesh-list
6723613|NCT01858025|Antimetabolites|antimetabolites|mesh-ancestor
6723614|NCT01858025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723615|NCT01858025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6723616|NCT01858025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6723617|NCT01858025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6723618|NCT01858025|Immunologic Factors|immunologic factors|mesh-ancestor
6723619|NCT01858025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723620|NCT01858025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6723621|NCT01858025|Alkylating Agents|alkylating agents|mesh-ancestor
6723622|NCT01858025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6723623|NCT01858025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6723624|NCT01858051|Cholecalciferol|cholecalciferol|mesh-list
6723625|NCT01858051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6723626|NCT01858051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723627|NCT01858051|Vitamins|vitamins|mesh-ancestor
6723628|NCT01858051|Micronutrients|micronutrients|mesh-ancestor
6723629|NCT01858051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6723630|NCT01858077|Everolimus|everolimus|mesh-list
6723631|NCT01858077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6723632|NCT01858077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6723633|NCT01858077|Immunologic Factors|immunologic factors|mesh-ancestor
6723634|NCT01858077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723635|NCT01858090|Diphenhydramine|diphenhydramine|mesh-list
6723636|NCT01858090|Promethazine|promethazine|mesh-list
6723637|NCT01858090|Diclofenac|diclofenac|mesh-list
6723638|NCT01858090|Atropine|atropine|mesh-list
6723639|NCT01858090|Ephedrine|ephedrine|mesh-list
6723640|NCT01858090|Fentanyl|fentanyl|mesh-list
6723641|NCT01858090|Sufentanil|sufentanil|mesh-list
6723642|NCT01858090|Meperidine|meperidine|mesh-list
6723643|NCT01858090|Metoclopramide|metoclopramide|mesh-list
6723644|NCT01858090|Propofol|propofol|mesh-list
6723645|NCT01858090|Levobupivacaine|levobupivacaine|mesh-list
6723646|NCT01858090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6723647|NCT01858090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6723648|NCT01858090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723649|NCT01858090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6723650|NCT01858090|Anesthetics, General|anesthetics, general|mesh-ancestor
6723651|NCT01858090|Anesthetics|anesthetics|mesh-ancestor
6723652|NCT01858090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6723653|NCT01858090|Narcotics|narcotics|mesh-ancestor
6723654|NCT01858090|Analgesics|analgesics|mesh-ancestor
6723655|NCT01858090|Sensory System Agents|sensory system agents|mesh-ancestor
6723656|NCT01858090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6723657|NCT01858090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6723658|NCT01858090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6723659|NCT01858090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6723660|NCT01858090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6723661|NCT01858090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6723662|NCT01858090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6723663|NCT01858090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6723664|NCT01858090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723665|NCT01858090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6723666|NCT01858090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6723667|NCT01858090|Autonomic Agents|autonomic agents|mesh-ancestor
6723668|NCT01858090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6723669|NCT01858090|Respiratory System Agents|respiratory system agents|mesh-ancestor
6723670|NCT01858090|Mydriatics|mydriatics|mesh-ancestor
6723671|NCT01858090|Parasympatholytics|parasympatholytics|mesh-ancestor
6723672|NCT01858090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6723673|NCT01858090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6723674|NCT01858090|Cholinergic Agents|cholinergic agents|mesh-ancestor
6723675|NCT01858090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6723676|NCT01858090|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6723677|NCT01858090|Anesthetics, Local|anesthetics, local|mesh-ancestor
6723678|NCT01858090|Antiemetics|antiemetics|mesh-ancestor
6723679|NCT01858090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6723680|NCT01858090|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6723681|NCT01858090|Histamine Antagonists|histamine antagonists|mesh-ancestor
6723682|NCT01858090|Histamine Agents|histamine agents|mesh-ancestor
6723683|NCT01858090|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6723684|NCT01858090|Antipruritics|antipruritics|mesh-ancestor
6723685|NCT01858090|Dermatologic Agents|dermatologic agents|mesh-ancestor
6723686|NCT01858090|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6723687|NCT01858090|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6723688|NCT01858090|Dopamine Agents|dopamine agents|mesh-ancestor
6723689|NCT01858090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6723690|NCT01858090|Sympathomimetics|sympathomimetics|mesh-ancestor
6723691|NCT01858090|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6723692|NCT01858090|Adrenergic Agents|adrenergic agents|mesh-ancestor
6723693|NCT01858155|Melatonin|melatonin|mesh-list
6723694|NCT01858155|Antioxidants|antioxidants|mesh-ancestor
6723695|NCT01858155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723696|NCT01858155|Protective Agents|protective agents|mesh-ancestor
6723697|NCT01858155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723698|NCT01858155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6723699|NCT01858168|Irinotecan|irinotecan|mesh-list
6723700|NCT01858168|Temozolomide|temozolomide|mesh-list
6723701|NCT01858168|Olaparib|olaparib|mesh-list
6723702|NCT01858168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6723703|NCT01858168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6723704|NCT01858168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6723705|NCT01858168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723706|NCT01858168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6723707|NCT01858168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6723708|NCT01858168|Alkylating Agents|alkylating agents|mesh-ancestor
6723709|NCT01858168|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6723710|NCT01858207|Doxorubicin|doxorubicin|mesh-list
6723711|NCT01858207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6723712|NCT01858207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6723713|NCT01858207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6723714|NCT01858207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6723715|NCT01858207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6723716|NCT01858207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723717|NCT01858311|Tocotrienols|tocotrienols|mesh-list
6723718|NCT01858311|Vitamin E|vitamin e|mesh-list
6723719|NCT01858311|Tocopherols|tocopherols|mesh-list
6723720|NCT01858311|Antioxidants|antioxidants|mesh-ancestor
6723721|NCT01858311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723722|NCT01858311|Protective Agents|protective agents|mesh-ancestor
6723723|NCT01858311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723724|NCT01858311|Vitamins|vitamins|mesh-ancestor
6723725|NCT01858311|Micronutrients|micronutrients|mesh-ancestor
6723726|NCT01858402|Acetaminophen|acetaminophen|mesh-list
6723727|NCT01858402|Dipyrone|dipyrone|mesh-list
6723728|NCT01858402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6723729|NCT01858402|Analgesics|analgesics|mesh-ancestor
6723730|NCT01858402|Sensory System Agents|sensory system agents|mesh-ancestor
6723731|NCT01858402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6723732|NCT01858402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723733|NCT01858402|Antipyretics|antipyretics|mesh-ancestor
6723734|NCT01858402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6723735|NCT01858402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6723736|NCT01858402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6723737|NCT01858441|Abiraterone Acetate|abiraterone acetate|mesh-list
6723738|NCT01858441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6723739|NCT01858441|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6723740|NCT01858441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6723741|NCT01858441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723742|NCT01858441|Hormone Antagonists|hormone antagonists|mesh-ancestor
6723743|NCT01858441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6723744|NCT01858441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723745|NCT01858441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6723746|NCT01858571|Thalidomide|thalidomide|mesh-list
6723747|NCT01858571|Celecoxib|celecoxib|mesh-list
6723748|NCT01858571|Cyclophosphamide|cyclophosphamide|mesh-list
6723749|NCT01858571|Etoposide|etoposide|mesh-list
6723750|NCT01858571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6723751|NCT01858571|Immunologic Factors|immunologic factors|mesh-ancestor
6723752|NCT01858571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723753|NCT01858571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6723754|NCT01858571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6723755|NCT01858571|Alkylating Agents|alkylating agents|mesh-ancestor
6723756|NCT01858571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723757|NCT01858571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6723758|NCT01858571|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6723759|NCT01858571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6723760|NCT01858571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6723761|NCT01858571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6723762|NCT01858571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6723763|NCT01858571|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6723764|NCT01858571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6723765|NCT01858571|Analgesics|analgesics|mesh-ancestor
6723766|NCT01858571|Sensory System Agents|sensory system agents|mesh-ancestor
6723767|NCT01858571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6723768|NCT01858571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6723769|NCT01858571|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6723770|NCT01858571|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6723771|NCT01858571|Leprostatic Agents|leprostatic agents|mesh-ancestor
6723772|NCT01858571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6723773|NCT01858571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6723774|NCT01858571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6723775|NCT01858571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6723776|NCT01858571|Growth Substances|growth substances|mesh-ancestor
6723777|NCT01858571|Growth Inhibitors|growth inhibitors|mesh-ancestor
6723778|NCT01858610|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6723779|NCT01858610|Irbesartan|irbesartan|mesh-list
6723780|NCT01858610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6723781|NCT01858610|Diuretics|diuretics|mesh-ancestor
6723782|NCT01858610|Natriuretic Agents|natriuretic agents|mesh-ancestor
6723783|NCT01858610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723784|NCT01858610|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6723785|NCT01858610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6723786|NCT01858610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723787|NCT01858610|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6723788|NCT01858610|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6723789|NCT01858623|Losartan|losartan|mesh-list
6723790|NCT01858623|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6723791|NCT01858623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6723792|NCT01858623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6723793|NCT01858623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6723794|NCT01858623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6723795|NCT01858623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723796|NCT01858623|Diuretics|diuretics|mesh-ancestor
6723797|NCT01858623|Natriuretic Agents|natriuretic agents|mesh-ancestor
6723798|NCT01858623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723799|NCT01858623|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6723800|NCT01858623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6723801|NCT01858649|Bevacizumab|bevacizumab|mesh-list
6723802|NCT01858649|Oxaliplatin|oxaliplatin|mesh-list
6723803|NCT01858649|Irinotecan|irinotecan|mesh-list
6723804|NCT01858649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6723805|NCT01858649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6723806|NCT01858649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6723807|NCT01858649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6723808|NCT01858649|Growth Substances|growth substances|mesh-ancestor
6723809|NCT01858649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723810|NCT01858649|Growth Inhibitors|growth inhibitors|mesh-ancestor
6723811|NCT01858649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6723812|NCT01858649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6723813|NCT01858649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6723814|NCT01858649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723815|NCT01858662|Leucovorin|leucovorin|mesh-list
6723816|NCT01858662|Oxaliplatin|oxaliplatin|mesh-list
6723817|NCT01858662|Irinotecan|irinotecan|mesh-list
6723818|NCT01858662|Cetuximab|cetuximab|mesh-list
6723819|NCT01858662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6723820|NCT01858662|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6723821|NCT01858662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6723822|NCT01858662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6723823|NCT01858662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723824|NCT01858662|Antidotes|antidotes|mesh-ancestor
6723825|NCT01858662|Protective Agents|protective agents|mesh-ancestor
6723826|NCT01858662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723827|NCT01858662|Vitamin B Complex|vitamin b complex|mesh-ancestor
6723828|NCT01858662|Vitamins|vitamins|mesh-ancestor
6723829|NCT01858662|Micronutrients|micronutrients|mesh-ancestor
6723830|NCT01858662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6723831|NCT01858792|Belimumab|belimumab|mesh-list
6723832|NCT01858792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6723833|NCT01858792|Immunologic Factors|immunologic factors|mesh-ancestor
6723834|NCT01858792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723835|NCT01858831|Atovaquone|atovaquone|mesh-list
6723836|NCT01858831|Proguanil|proguanil|mesh-list
6723837|NCT01858831|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
6723838|NCT01858831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6723839|NCT01858831|Antimalarials|antimalarials|mesh-ancestor
6723840|NCT01858831|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6723841|NCT01858831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6723842|NCT01858831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6723843|NCT01858831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723844|NCT01858831|Antimetabolites|antimetabolites|mesh-ancestor
6723845|NCT01858870|Lacosamide|lacosamide|mesh-list
6723846|NCT01858870|Anticonvulsants|anticonvulsants|mesh-ancestor
6723847|NCT01858870|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6723848|NCT01858870|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6723849|NCT01858870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6723850|NCT01858870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723851|NCT01858896|Glucagon|glucagon|mesh-list
6723852|NCT01858896|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6723853|NCT01858896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6723854|NCT01858896|Hormones|hormones|mesh-ancestor
6723855|NCT01858896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6723856|NCT01858896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723857|NCT01858896|Incretins|incretins|mesh-ancestor
6723858|NCT01858909|Melatonin|melatonin|mesh-list
6723859|NCT01858909|Antioxidants|antioxidants|mesh-ancestor
6723860|NCT01858909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723861|NCT01858909|Protective Agents|protective agents|mesh-ancestor
6723862|NCT01858909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723863|NCT01858909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6723864|NCT01858948|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6723865|NCT01858948|Antidepressive Agents|antidepressive agents|mesh-ancestor
6723866|NCT01858948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6723867|NCT01858948|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6723868|NCT01858948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6723869|NCT01858948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6723870|NCT01858948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723871|NCT01858961|Interferons|interferons|mesh-list
6723872|NCT01858961|Ribavirin|ribavirin|mesh-list
6723873|NCT01858961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6723874|NCT01858961|Antiviral Agents|antiviral agents|mesh-ancestor
6723875|NCT01858961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6723876|NCT01858961|Antimetabolites|antimetabolites|mesh-ancestor
6723877|NCT01858961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723878|NCT01859026|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6723879|NCT01859026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6723880|NCT01859026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6723881|NCT01859026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6723882|NCT01859026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723883|NCT01859234|Bevacizumab|bevacizumab|mesh-list
6723884|NCT01859234|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
6723885|NCT01859234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6723886|NCT01859234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6723887|NCT01859234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6723888|NCT01859234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6723889|NCT01859234|Growth Substances|growth substances|mesh-ancestor
6723890|NCT01859234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723891|NCT01859234|Growth Inhibitors|growth inhibitors|mesh-ancestor
6723892|NCT01859234|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6723893|NCT01859234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723894|NCT01859377|Ibuprofen|ibuprofen|mesh-list
6723895|NCT01859377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6723896|NCT01859377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6723897|NCT01859377|Analgesics|analgesics|mesh-ancestor
6723898|NCT01859377|Sensory System Agents|sensory system agents|mesh-ancestor
6723899|NCT01859377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6723900|NCT01859377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723901|NCT01859377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6723902|NCT01859377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6723903|NCT01859377|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6723904|NCT01859377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6723905|NCT01859377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723906|NCT01859455|Atorvastatin|atorvastatin|mesh-list
6723907|NCT01859455|Simvastatin|simvastatin|mesh-list
6723908|NCT01859455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6723909|NCT01859455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6723910|NCT01859455|Antimetabolites|antimetabolites|mesh-ancestor
6723911|NCT01859455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723912|NCT01859455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6723913|NCT01859455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6723914|NCT01859455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6723915|NCT01859468|Calcium Carbonate|calcium carbonate|mesh-list
6723916|NCT01859468|Calcium|calcium|mesh-list
6723917|NCT01859468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6723918|NCT01859468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723919|NCT01859468|Antacids|antacids|mesh-ancestor
6723920|NCT01859468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723921|NCT01859468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6723922|NCT01859481|Eletriptan|eletriptan|mesh-list
6723923|NCT01859481|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6723924|NCT01859481|Serotonin Agents|serotonin agents|mesh-ancestor
6723925|NCT01859481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6723926|NCT01859481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723927|NCT01859481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784524|NCT02203422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6784525|NCT02203422|Dermatologic Agents|dermatologic agents|mesh-ancestor
6784526|NCT02203422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6784527|NCT02203422|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6784528|NCT02203461|Ritonavir|ritonavir|mesh-list
6784529|NCT02203461|Lopinavir|lopinavir|mesh-list
6784530|NCT02203461|Darunavir|darunavir|mesh-list
6784531|NCT02203461|Tenofovir|tenofovir|mesh-list
6784532|NCT02203461|Emtricitabine|emtricitabine|mesh-list
6784533|NCT02203461|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6784534|NCT02203461|Cobicistat|cobicistat|mesh-list
6784535|NCT02203461|Elvitegravir|elvitegravir|mesh-list
6784536|NCT02203461|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6784537|NCT02203461|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6784538|NCT02203461|Protease Inhibitors|protease inhibitors|mesh-ancestor
6784539|NCT02203461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6784540|NCT02203461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784541|NCT02203461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6784542|NCT02203461|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6784543|NCT02203461|Antiviral Agents|antiviral agents|mesh-ancestor
6784544|NCT02203461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6784545|NCT02203461|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6784546|NCT02203461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6784547|NCT02203461|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6784548|NCT02203461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6784549|NCT02203461|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6784550|NCT02203500|Telmisartan|telmisartan|mesh-list
6784551|NCT02203500|Lacidipine|lacidipine|mesh-list
6723928|NCT01859585|Ketorolac|ketorolac|mesh-list
6723929|NCT01859585|Parecoxib|parecoxib|mesh-list
6723930|NCT01859585|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6723931|NCT01859585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6723932|NCT01859585|Analgesics|analgesics|mesh-ancestor
6723933|NCT01859585|Sensory System Agents|sensory system agents|mesh-ancestor
6723934|NCT01859585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6723935|NCT01859585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723936|NCT01859585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6723937|NCT01859585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6723938|NCT01859585|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6723939|NCT01859585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6723940|NCT01859585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723941|NCT01859585|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6723942|NCT01859624|Albuterol|albuterol|mesh-list
6723943|NCT01859624|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6723944|NCT01859624|Autonomic Agents|autonomic agents|mesh-ancestor
6723945|NCT01859624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6723946|NCT01859624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723947|NCT01859624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6723948|NCT01859624|Respiratory System Agents|respiratory system agents|mesh-ancestor
6723949|NCT01859624|Tocolytic Agents|tocolytic agents|mesh-ancestor
6723950|NCT01859624|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6723951|NCT01859624|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6723952|NCT01859624|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6723953|NCT01859624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6723954|NCT01859624|Adrenergic Agents|adrenergic agents|mesh-ancestor
6723955|NCT01859624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6723956|NCT01859624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723957|NCT01859728|Gemcitabine|gemcitabine|mesh-list
6723958|NCT01859728|Cisplatin|cisplatin|mesh-list
6723959|NCT01859728|Irinotecan|irinotecan|mesh-list
6723960|NCT01859728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6723961|NCT01859728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6723962|NCT01859728|Antimetabolites|antimetabolites|mesh-ancestor
6723963|NCT01859728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723964|NCT01859728|Antiviral Agents|antiviral agents|mesh-ancestor
6723965|NCT01859728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6723966|NCT01859728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6723967|NCT01859728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6723968|NCT01859728|Immunologic Factors|immunologic factors|mesh-ancestor
6723969|NCT01859728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723970|NCT01859728|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6723971|NCT01859728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6723972|NCT01859754|gamma-Globulins|gamma-globulins|mesh-list
6723973|NCT01859754|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6723974|NCT01859754|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6723975|NCT01859754|Immunologic Factors|immunologic factors|mesh-ancestor
6723976|NCT01859754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723977|NCT01859819|Cytarabine|cytarabine|mesh-list
6723978|NCT01859819|Rituximab|rituximab|mesh-list
6723979|NCT01859819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6723980|NCT01859819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6723981|NCT01859819|Immunologic Factors|immunologic factors|mesh-ancestor
6723982|NCT01859819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6723983|NCT01859819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6723984|NCT01859819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6723985|NCT01859819|Antimetabolites|antimetabolites|mesh-ancestor
6723986|NCT01859819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723987|NCT01859819|Antiviral Agents|antiviral agents|mesh-ancestor
6723988|NCT01859819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6723989|NCT01859819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6723990|NCT01859858|Curcumin|curcumin|mesh-list
6723991|NCT01859858|Irinotecan|irinotecan|mesh-list
6723992|NCT01859858|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6723993|NCT01859858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6723994|NCT01859858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6723995|NCT01859858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6723996|NCT01859858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6723997|NCT01859858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6723998|NCT01859858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6723999|NCT01859858|Analgesics|analgesics|mesh-ancestor
6724000|NCT01859858|Sensory System Agents|sensory system agents|mesh-ancestor
6724001|NCT01859858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6724002|NCT01859858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724003|NCT01859858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6724004|NCT01859858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6724005|NCT01860014|Poractant alfa|poractant alfa|mesh-list
6724006|NCT01860014|Beractant|beractant|mesh-list
6724007|NCT01860014|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
6724008|NCT01860014|Respiratory System Agents|respiratory system agents|mesh-ancestor
6724009|NCT01860066|Fluticasone|fluticasone|mesh-list
6724010|NCT01860066|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6724011|NCT01860066|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6724012|NCT01860066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6724013|NCT01860066|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6724014|NCT01860066|Autonomic Agents|autonomic agents|mesh-ancestor
6724015|NCT01860066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6724016|NCT01860066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724017|NCT01860066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6724018|NCT01860066|Respiratory System Agents|respiratory system agents|mesh-ancestor
6724019|NCT01860066|Dermatologic Agents|dermatologic agents|mesh-ancestor
6724020|NCT01860066|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6724021|NCT01860066|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6724022|NCT01860066|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6724023|NCT01860066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6724024|NCT01860066|Adrenergic Agents|adrenergic agents|mesh-ancestor
6724025|NCT01860066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6724026|NCT01860066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724027|NCT01860066|Glucocorticoids|glucocorticoids|mesh-ancestor
6724028|NCT01860066|Hormones|hormones|mesh-ancestor
6724029|NCT01860066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6724030|NCT01860066|Sympathomimetics|sympathomimetics|mesh-ancestor
6724031|NCT01860105|Clopidogrel|clopidogrel|mesh-list
6724032|NCT01860105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6724033|NCT01860105|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6724034|NCT01860105|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6724035|NCT01860105|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6724036|NCT01860105|Purinergic Agents|purinergic agents|mesh-ancestor
6724037|NCT01860105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6724038|NCT01860105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724039|NCT01860105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724040|NCT01860144|Bevacizumab|bevacizumab|mesh-list
6724041|NCT01860144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6724042|NCT01860144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6724043|NCT01860144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6724044|NCT01860144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6724045|NCT01860144|Growth Substances|growth substances|mesh-ancestor
6724046|NCT01860144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724047|NCT01860144|Growth Inhibitors|growth inhibitors|mesh-ancestor
6724048|NCT01860183|Mycophenolic Acid|mycophenolic acid|mesh-list
6724049|NCT01860183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6724050|NCT01860183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6724051|NCT01860183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6724052|NCT01860183|Antitubercular Agents|antitubercular agents|mesh-ancestor
6724053|NCT01860183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6724054|NCT01860183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6724055|NCT01860183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6724056|NCT01860183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724057|NCT01860196|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6724058|NCT01860196|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6724059|NCT01860196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6724060|NCT01860196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724061|NCT01860196|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6724062|NCT01860196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6724063|NCT01860196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724064|NCT01860196|Cholinergic Agents|cholinergic agents|mesh-ancestor
6724065|NCT01860196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6724066|NCT01860235|Anesthetics|anesthetics|mesh-list
6724067|NCT01860235|Benzocaine|benzocaine|mesh-list
6724068|NCT01860235|Anesthetics, Local|anesthetics, local|mesh-list
6724069|NCT01860235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6724070|NCT01860235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724071|NCT01860235|Sensory System Agents|sensory system agents|mesh-ancestor
6724072|NCT01860235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6724073|NCT01860300|Amoxicillin|amoxicillin|mesh-list
6724074|NCT01860300|Clavulanic Acid|clavulanic acid|mesh-list
6724075|NCT01860300|Clavulanic Acids|clavulanic acids|mesh-list
6724076|NCT01860300|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6724077|NCT01860300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6724078|NCT01860300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6724079|NCT01860300|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6724080|NCT01860300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6724081|NCT01860300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724082|NCT01860391|Fluorides|fluorides|mesh-list
6724083|NCT01860391|Cariostatic Agents|cariostatic agents|mesh-ancestor
6724084|NCT01860391|Protective Agents|protective agents|mesh-ancestor
6724085|NCT01860391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724086|NCT01860417|Mepivacaine|mepivacaine|mesh-list
6724087|NCT01860417|Anesthetics, Local|anesthetics, local|mesh-ancestor
6724088|NCT01860417|Anesthetics|anesthetics|mesh-ancestor
6724089|NCT01860417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6724090|NCT01860417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724091|NCT01860417|Sensory System Agents|sensory system agents|mesh-ancestor
6724092|NCT01860417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6724093|NCT01860469|Vancomycin|vancomycin|mesh-list
6724094|NCT01860469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6724095|NCT01860469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6724096|NCT01860482|Rabeprazole|rabeprazole|mesh-list
6724097|NCT01860482|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6724098|NCT01860482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6724099|NCT01860482|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6724100|NCT01860482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6724101|NCT01860482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724102|NCT01860508|Carboplatin|carboplatin|mesh-list
6724103|NCT01860508|Pemetrexed|pemetrexed|mesh-list
6724104|NCT01860508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6724105|NCT01860508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6724106|NCT01860508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724107|NCT01860508|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6724108|NCT01860508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6724109|NCT01860625|Donepezil|donepezil|mesh-list
6724110|NCT01860625|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6724111|NCT01860625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6724112|NCT01860625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724113|NCT01860625|Cholinergic Agents|cholinergic agents|mesh-ancestor
6724114|NCT01860625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6724115|NCT01860625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724116|NCT01860625|Nootropic Agents|nootropic agents|mesh-ancestor
6724117|NCT01860638|Bevacizumab|bevacizumab|mesh-list
6724118|NCT01860638|Temozolomide|temozolomide|mesh-list
6724119|NCT01860638|Lomustine|lomustine|mesh-list
6724120|NCT01860638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6724121|NCT01860638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6724122|NCT01860638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6724123|NCT01860638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6724124|NCT01860638|Growth Substances|growth substances|mesh-ancestor
6724125|NCT01860638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724126|NCT01860638|Growth Inhibitors|growth inhibitors|mesh-ancestor
6724127|NCT01860638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6724128|NCT01860638|Alkylating Agents|alkylating agents|mesh-ancestor
6724129|NCT01860638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724130|NCT01860664|Hydrocortisone|hydrocortisone|mesh-list
6724131|NCT01860664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6724132|NCT01860690|Methotrexate|methotrexate|mesh-list
6724133|NCT01860690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6724134|NCT01860690|Abortifacient Agents|abortifacient agents|mesh-ancestor
6724135|NCT01860690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6724136|NCT01860690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724137|NCT01860690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6724138|NCT01860690|Antimetabolites|antimetabolites|mesh-ancestor
6724139|NCT01860690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724140|NCT01860690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6724141|NCT01860690|Dermatologic Agents|dermatologic agents|mesh-ancestor
6724142|NCT01860690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6724143|NCT01860690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6724144|NCT01860690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6724145|NCT01860690|Immunologic Factors|immunologic factors|mesh-ancestor
6724146|NCT01860690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6724147|NCT01860690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6724148|NCT01860716|Melatonin|melatonin|mesh-list
6724149|NCT01860716|Antioxidants|antioxidants|mesh-ancestor
6724150|NCT01860716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724151|NCT01860716|Protective Agents|protective agents|mesh-ancestor
6724152|NCT01860716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724153|NCT01860716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6724154|NCT01860729|Anacetrapib|anacetrapib|mesh-list
6724155|NCT01860729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6724156|NCT01860729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6724157|NCT01860729|Antimetabolites|antimetabolites|mesh-ancestor
6724158|NCT01860729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724159|NCT01860729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6724160|NCT01860742|Interferons|interferons|mesh-list
6724161|NCT01860742|Interferon-alpha|interferon-alpha|mesh-list
6724162|NCT01860742|Interferon alpha-2|interferon alpha-2|mesh-list
6724163|NCT01860742|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
6724164|NCT01860742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6724165|NCT01860742|Antiviral Agents|antiviral agents|mesh-ancestor
6724166|NCT01860742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6724167|NCT01860742|Immunologic Factors|immunologic factors|mesh-ancestor
6724168|NCT01860742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724169|NCT01860742|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6724170|NCT01860742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724171|NCT01860781|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6724172|NCT01860781|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6724173|NCT01860781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6724174|NCT01860781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6724175|NCT01860781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724176|NCT01860781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6724177|NCT01860781|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6724178|NCT01860781|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6724179|NCT01860781|Serotonin Agents|serotonin agents|mesh-ancestor
6724180|NCT01860781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6724181|NCT01860781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724182|NCT01860781|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6724183|NCT01860781|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6724184|NCT01860781|Dopamine Agents|dopamine agents|mesh-ancestor
6724185|NCT01860833|Ibuprofen|ibuprofen|mesh-list
6724186|NCT01860833|Celecoxib|celecoxib|mesh-list
6724187|NCT01860833|Diclofenac|diclofenac|mesh-list
6724188|NCT01860833|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6724189|NCT01860833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6724190|NCT01860833|Analgesics|analgesics|mesh-ancestor
6724191|NCT01860833|Sensory System Agents|sensory system agents|mesh-ancestor
6724192|NCT01860833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6724193|NCT01860833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724194|NCT01860833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6724195|NCT01860833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6724196|NCT01860833|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6724197|NCT01860833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6724198|NCT01860833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724199|NCT01860833|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6724200|NCT01860911|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
6724201|NCT01860911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6724202|NCT01860911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724203|NCT01861015|Vasopressins|vasopressins|mesh-list
6724204|NCT01861015|Arginine Vasopressin|arginine vasopressin|mesh-list
6724205|NCT01861015|Epinephrine|epinephrine|mesh-list
6724206|NCT01861015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6724207|NCT01861015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6724208|NCT01861015|Adrenergic Agents|adrenergic agents|mesh-ancestor
6724209|NCT01861015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6724210|NCT01861015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724211|NCT01861015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724212|NCT01861015|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6724213|NCT01861015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6724214|NCT01861015|Autonomic Agents|autonomic agents|mesh-ancestor
6724215|NCT01861015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6724216|NCT01861015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6724217|NCT01861015|Respiratory System Agents|respiratory system agents|mesh-ancestor
6724218|NCT01861015|Mydriatics|mydriatics|mesh-ancestor
6724219|NCT01861015|Sympathomimetics|sympathomimetics|mesh-ancestor
6724220|NCT01861015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6724221|NCT01861015|Hemostatics|hemostatics|mesh-ancestor
6724222|NCT01861015|Coagulants|coagulants|mesh-ancestor
6724223|NCT01861015|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6724224|NCT01861015|Natriuretic Agents|natriuretic agents|mesh-ancestor
6724225|NCT01861041|Bupivacaine|bupivacaine|mesh-list
6724226|NCT01861041|Anesthetics, Local|anesthetics, local|mesh-ancestor
6724227|NCT01861041|Anesthetics|anesthetics|mesh-ancestor
6724228|NCT01861041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6724229|NCT01861041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724230|NCT01861041|Sensory System Agents|sensory system agents|mesh-ancestor
6724231|NCT01861041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6724232|NCT01861145|Mometasone Furoate|mometasone furoate|mesh-list
6724233|NCT01861145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6724234|NCT01861145|Dermatologic Agents|dermatologic agents|mesh-ancestor
6724235|NCT01861145|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6724236|NCT01861223|Afatinib|afatinib|mesh-list
6724237|NCT01861223|Nimotuzumab|nimotuzumab|mesh-list
6724238|NCT01861223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6724239|NCT01861223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6724240|NCT01861223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6724241|NCT01861223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724242|NCT01861223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6724243|NCT01861340|Dexamethasone|dexamethasone|mesh-list
6724244|NCT01861340|Lenalidomide|lenalidomide|mesh-list
6724245|NCT01861340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6724246|NCT01861340|Antiemetics|antiemetics|mesh-ancestor
6724247|NCT01861340|Autonomic Agents|autonomic agents|mesh-ancestor
6724248|NCT01861340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6724249|NCT01861340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724250|NCT01861340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6724251|NCT01861340|Glucocorticoids|glucocorticoids|mesh-ancestor
6724252|NCT01861340|Hormones|hormones|mesh-ancestor
6724253|NCT01861340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6724254|NCT01861340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6724255|NCT01861340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6724256|NCT01861340|Immunologic Factors|immunologic factors|mesh-ancestor
6724257|NCT01861340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6724258|NCT01861340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6724259|NCT01861340|Growth Substances|growth substances|mesh-ancestor
6724260|NCT01861340|Growth Inhibitors|growth inhibitors|mesh-ancestor
6784552|NCT02203500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6784553|NCT02203500|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6784554|NCT02203500|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6784555|NCT02203500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784556|NCT02203500|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6784557|NCT02203500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6784558|NCT02203500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6784559|NCT02203500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784560|NCT02203552|Minocycline|minocycline|mesh-list
6784561|NCT02203552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6784562|NCT02203552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6784563|NCT02203604|Aldesleukin|aldesleukin|mesh-list
6784564|NCT02203604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6784565|NCT02203604|Ipilimumab|ipilimumab|mesh-list
6784566|NCT02203604|Interleukin-2|interleukin-2|mesh-list
6784567|NCT02203604|Antibodies|antibodies|mesh-list
6784568|NCT02203604|Immunoglobulins|immunoglobulins|mesh-list
6784569|NCT02203604|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6784570|NCT02203604|Immunologic Factors|immunologic factors|mesh-ancestor
6784571|NCT02203604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784572|NCT02203604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6784573|NCT02203604|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6784574|NCT02203604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784575|NCT02203604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6784576|NCT02203604|Analgesics|analgesics|mesh-ancestor
6784577|NCT02203604|Sensory System Agents|sensory system agents|mesh-ancestor
6784578|NCT02203604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6784579|NCT02203604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6784580|NCT02203604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6784581|NCT02203604|Antiviral Agents|antiviral agents|mesh-ancestor
6784582|NCT02203604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6784583|NCT02203643|Dexamethasone|dexamethasone|mesh-list
6784584|NCT02203643|Cyclophosphamide|cyclophosphamide|mesh-list
6784585|NCT02203643|Lenalidomide|lenalidomide|mesh-list
6784586|NCT02203643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6784587|NCT02203643|Immunologic Factors|immunologic factors|mesh-ancestor
6784588|NCT02203643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784589|NCT02203643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6784590|NCT02203643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6784591|NCT02203643|Alkylating Agents|alkylating agents|mesh-ancestor
6784592|NCT02203643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784593|NCT02203643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6784594|NCT02203643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6784595|NCT02203643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6784596|NCT02203643|Antiemetics|antiemetics|mesh-ancestor
6784597|NCT02203643|Autonomic Agents|autonomic agents|mesh-ancestor
6784598|NCT02203643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6784599|NCT02203643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6784600|NCT02203643|Glucocorticoids|glucocorticoids|mesh-ancestor
6784601|NCT02203643|Hormones|hormones|mesh-ancestor
6784602|NCT02203643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6724261|NCT01861535|Imiquimod|imiquimod|mesh-list
6724262|NCT01861535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6724263|NCT01861535|Immunologic Factors|immunologic factors|mesh-ancestor
6724264|NCT01861535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724265|NCT01861535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6724266|NCT01861535|Interferon Inducers|interferon inducers|mesh-ancestor
6724267|NCT01861561|Cyclophosphamide|cyclophosphamide|mesh-list
6724268|NCT01861561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6724269|NCT01861561|Immunologic Factors|immunologic factors|mesh-ancestor
6724270|NCT01861561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724271|NCT01861561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6724272|NCT01861561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6724273|NCT01861561|Alkylating Agents|alkylating agents|mesh-ancestor
6724274|NCT01861561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724275|NCT01861561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6724276|NCT01861561|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6724277|NCT01861626|Isotretinoin|isotretinoin|mesh-list
6724278|NCT01861626|Dermatologic Agents|dermatologic agents|mesh-ancestor
6724279|NCT01861912|Arsenic Trioxide|arsenic trioxide|mesh-list
6724280|NCT01861912|Ethiodized Oil|ethiodized oil|mesh-list
6724281|NCT01861912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6724282|NCT01861951|Doxorubicin|doxorubicin|mesh-list
6724283|NCT01861951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6724284|NCT01861951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6724285|NCT01861951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6724286|NCT01861951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6724287|NCT01861951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6724288|NCT01861951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724289|NCT01861990|Valproic Acid|valproic acid|mesh-list
6724290|NCT01861990|Anticonvulsants|anticonvulsants|mesh-ancestor
6724291|NCT01861990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6724292|NCT01861990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724293|NCT01861990|GABA Agents|gaba agents|mesh-ancestor
6724294|NCT01861990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6724295|NCT01861990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724296|NCT01861990|Antimanic Agents|antimanic agents|mesh-ancestor
6724297|NCT01861990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6724298|NCT01861990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6724299|NCT01861990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6724300|NCT01862003|Leucovorin|leucovorin|mesh-list
6724301|NCT01862003|Folic Acid|folic acid|mesh-list
6724302|NCT01862003|Fluorouracil|fluorouracil|mesh-list
6724303|NCT01862003|Irinotecan|irinotecan|mesh-list
6724304|NCT01862003|Levoleucovorin|levoleucovorin|mesh-list
6724305|NCT01862003|Antimetabolites|antimetabolites|mesh-ancestor
6724306|NCT01862003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724307|NCT01862003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6724308|NCT01862003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6724309|NCT01862003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6724310|NCT01862003|Immunologic Factors|immunologic factors|mesh-ancestor
6724311|NCT01862003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724312|NCT01862003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6724313|NCT01862003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6724314|NCT01862003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6724315|NCT01862003|Antidotes|antidotes|mesh-ancestor
6724316|NCT01862003|Protective Agents|protective agents|mesh-ancestor
6724317|NCT01862003|Vitamin B Complex|vitamin b complex|mesh-ancestor
6724318|NCT01862003|Vitamins|vitamins|mesh-ancestor
6724319|NCT01862003|Micronutrients|micronutrients|mesh-ancestor
6724320|NCT01862003|Hematinics|hematinics|mesh-ancestor
6724321|NCT01862081|Paclitaxel|paclitaxel|mesh-list
6724322|NCT01862081|Docetaxel|docetaxel|mesh-list
6724323|NCT01862081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6724324|NCT01862081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6724325|NCT01862081|Tubulin Modulators|tubulin modulators|mesh-ancestor
6724326|NCT01862081|Antimitotic Agents|antimitotic agents|mesh-ancestor
6724327|NCT01862081|Mitosis Modulators|mitosis modulators|mesh-ancestor
6724328|NCT01862081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724329|NCT01862120|Interleukin-2|interleukin-2|mesh-list
6724330|NCT01862120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6724331|NCT01862120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6724332|NCT01862120|Analgesics|analgesics|mesh-ancestor
6724333|NCT01862120|Sensory System Agents|sensory system agents|mesh-ancestor
6724334|NCT01862120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6724335|NCT01862120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724336|NCT01862263|Vildagliptin|vildagliptin|mesh-list
6724337|NCT01862263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6724338|NCT01862263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724339|NCT01862263|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6724340|NCT01862263|Protease Inhibitors|protease inhibitors|mesh-ancestor
6724341|NCT01862263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6724342|NCT01862263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724343|NCT01862302|Haloperidol|haloperidol|mesh-list
6724344|NCT01862302|Haloperidol decanoate|haloperidol decanoate|mesh-list
6724345|NCT01862302|Antiemetics|antiemetics|mesh-ancestor
6724346|NCT01862302|Autonomic Agents|autonomic agents|mesh-ancestor
6724347|NCT01862302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6724348|NCT01862302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724349|NCT01862302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6724350|NCT01862302|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6724351|NCT01862302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6724352|NCT01862302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6724353|NCT01862302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6724354|NCT01862302|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6724355|NCT01862302|Dopamine Agents|dopamine agents|mesh-ancestor
6724356|NCT01862302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6724357|NCT01862302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724358|NCT01862302|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6724359|NCT01862315|Gemcitabine|gemcitabine|mesh-list
6724360|NCT01862315|Dexamethasone|dexamethasone|mesh-list
6724361|NCT01862315|Oxaliplatin|oxaliplatin|mesh-list
6724362|NCT01862315|Floxuridine|floxuridine|mesh-list
6724363|NCT01862315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6724364|NCT01862315|Antiemetics|antiemetics|mesh-ancestor
6724365|NCT01862315|Autonomic Agents|autonomic agents|mesh-ancestor
6724366|NCT01862315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6724367|NCT01862315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724368|NCT01862315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6724369|NCT01862315|Glucocorticoids|glucocorticoids|mesh-ancestor
6724370|NCT01862315|Hormones|hormones|mesh-ancestor
6724371|NCT01862315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6724372|NCT01862315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6724373|NCT01862315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6724374|NCT01862315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6724375|NCT01862315|Antimetabolites|antimetabolites|mesh-ancestor
6724376|NCT01862315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724377|NCT01862315|Antiviral Agents|antiviral agents|mesh-ancestor
6724378|NCT01862315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6724379|NCT01862315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6724380|NCT01862315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6724381|NCT01862315|Immunologic Factors|immunologic factors|mesh-ancestor
6724382|NCT01862354|Anesthetics|anesthetics|mesh-list
6724383|NCT01862354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6724384|NCT01862354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724385|NCT01862497|Carvedilol|carvedilol|mesh-list
6724386|NCT01862497|Prazosin|prazosin|mesh-list
6724387|NCT01862497|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6724388|NCT01862497|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6724389|NCT01862497|Adrenergic Agents|adrenergic agents|mesh-ancestor
6724390|NCT01862497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6724391|NCT01862497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724392|NCT01862497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724393|NCT01862497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6724394|NCT01862497|Antioxidants|antioxidants|mesh-ancestor
6724395|NCT01862497|Protective Agents|protective agents|mesh-ancestor
6724396|NCT01862497|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6724397|NCT01862497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6724398|NCT01862497|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6724399|NCT01862497|Vasodilator Agents|vasodilator agents|mesh-ancestor
6724400|NCT01862497|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6724401|NCT01862497|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6724402|NCT01862523|Capsaicin|capsaicin|mesh-list
6724403|NCT01862523|Antipruritics|antipruritics|mesh-ancestor
6724404|NCT01862523|Dermatologic Agents|dermatologic agents|mesh-ancestor
6724405|NCT01862523|Sensory System Agents|sensory system agents|mesh-ancestor
6724406|NCT01862523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6724407|NCT01862523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724408|NCT01862835|Anastrozole|anastrozole|mesh-list
6724409|NCT01862835|Testosterone|testosterone|mesh-list
6724410|NCT01862835|Estrogens|estrogens|mesh-list
6724411|NCT01862835|Androgens|androgens|mesh-ancestor
6724412|NCT01862835|Hormones|hormones|mesh-ancestor
6724413|NCT01862835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6724414|NCT01862835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724415|NCT01862835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6724416|NCT01862835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6724417|NCT01862835|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6724418|NCT01862835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6724419|NCT01862835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6724420|NCT01862835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724421|NCT01862835|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6724422|NCT01862835|Hormone Antagonists|hormone antagonists|mesh-ancestor
6724423|NCT01862887|Moxifloxacin|moxifloxacin|mesh-list
6724424|NCT01862887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6724425|NCT01862887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6724426|NCT01862887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6724427|NCT01862887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6724428|NCT01862887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6724429|NCT01862887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724430|NCT01862887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6724431|NCT01862926|Cyclophosphamide|cyclophosphamide|mesh-list
6724432|NCT01862926|Rituximab|rituximab|mesh-list
6724433|NCT01862926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6724434|NCT01862926|Immunologic Factors|immunologic factors|mesh-ancestor
6724435|NCT01862926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724436|NCT01862926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6724437|NCT01862926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6724438|NCT01862926|Alkylating Agents|alkylating agents|mesh-ancestor
6724439|NCT01862926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724440|NCT01862926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6724441|NCT01862926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6724442|NCT01862926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6724443|NCT01862952|Anticonvulsants|anticonvulsants|mesh-list
6724444|NCT01862978|Heparin|heparin|mesh-list
6724445|NCT01862978|Nadroparin|nadroparin|mesh-list
6724446|NCT01862978|Anticoagulants|anticoagulants|mesh-ancestor
6724447|NCT01862978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6724448|NCT01862978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6724449|NCT01862978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724450|NCT01863004|Bortezomib|bortezomib|mesh-list
6724451|NCT01863004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6724452|NCT01863069|Interferons|interferons|mesh-list
6724453|NCT01863069|Interferon-beta|interferon-beta|mesh-list
6724454|NCT01863069|Interferon beta-1a|interferon beta-1a|mesh-list
6724455|NCT01863069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6724456|NCT01863069|Antiviral Agents|antiviral agents|mesh-ancestor
6724457|NCT01863069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6724458|NCT01863069|Immunologic Factors|immunologic factors|mesh-ancestor
6724459|NCT01863069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724460|NCT01863069|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6784603|NCT02203643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6784604|NCT02203643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6784605|NCT02203643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6784606|NCT02203643|Growth Substances|growth substances|mesh-ancestor
6784607|NCT02203643|Growth Inhibitors|growth inhibitors|mesh-ancestor
6784608|NCT02203656|Methyltestosterone|methyltestosterone|mesh-list
6784609|NCT02203656|Testosterone|testosterone|mesh-list
6784610|NCT02203656|Testosterone undecanoate|testosterone undecanoate|mesh-list
6784611|NCT02203656|Testosterone enanthate|testosterone enanthate|mesh-list
6784612|NCT02203656|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6784613|NCT02203656|Androgens|androgens|mesh-ancestor
6784614|NCT02203656|Hormones|hormones|mesh-ancestor
6784615|NCT02203656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6784616|NCT02203656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784617|NCT02203656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6784618|NCT02203656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6784619|NCT02203656|Anabolic Agents|anabolic agents|mesh-ancestor
6784620|NCT02203760|Gemcitabine|gemcitabine|mesh-list
6784621|NCT02203760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6784622|NCT02203760|Antimetabolites|antimetabolites|mesh-ancestor
6784623|NCT02203760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784624|NCT02203760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6784625|NCT02203760|Antiviral Agents|antiviral agents|mesh-ancestor
6784626|NCT02203760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6784627|NCT02203760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6784628|NCT02203760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6784629|NCT02203760|Immunologic Factors|immunologic factors|mesh-ancestor
6784630|NCT02203760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784631|NCT02203773|Posaconazole|posaconazole|mesh-list
6784632|NCT02203773|Azacitidine|azacitidine|mesh-list
6784633|NCT02203773|Decitabine|decitabine|mesh-list
6784634|NCT02203773|Venetoclax|venetoclax|mesh-list
6784635|NCT02203773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6784636|NCT02203773|Antimetabolites|antimetabolites|mesh-ancestor
6784637|NCT02203773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784638|NCT02203773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6784639|NCT02203773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6784640|NCT02203773|Antifungal Agents|antifungal agents|mesh-ancestor
6784641|NCT02203773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6784642|NCT02203773|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6784643|NCT02203773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6784644|NCT02203773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6784645|NCT02203773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6784646|NCT02203773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6784647|NCT02203773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6784648|NCT02203773|Hormone Antagonists|hormone antagonists|mesh-ancestor
6784649|NCT02203773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6784650|NCT02203773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784651|NCT02203799|Immunologic Factors|immunologic factors|mesh-list
6784652|NCT02203799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724461|NCT01863147|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6724462|NCT01863147|Acarbose|acarbose|mesh-list
6724463|NCT01863147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6724464|NCT01863147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724465|NCT01863147|Incretins|incretins|mesh-ancestor
6724466|NCT01863147|Hormones|hormones|mesh-ancestor
6724467|NCT01863147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6724468|NCT01863147|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6724469|NCT01863147|Protease Inhibitors|protease inhibitors|mesh-ancestor
6724470|NCT01863147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6724471|NCT01863147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724472|NCT01863147|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6724473|NCT01863173|Metoprolol|metoprolol|mesh-list
6724474|NCT01863173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6724475|NCT01863173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6724476|NCT01863173|Sympatholytics|sympatholytics|mesh-ancestor
6724477|NCT01863173|Autonomic Agents|autonomic agents|mesh-ancestor
6724478|NCT01863173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6724479|NCT01863173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724480|NCT01863173|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6724481|NCT01863173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6724482|NCT01863173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6724483|NCT01863173|Adrenergic Agents|adrenergic agents|mesh-ancestor
6724484|NCT01863173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6724485|NCT01863173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724486|NCT01863199|Ranibizumab|ranibizumab|mesh-list
6724487|NCT01863199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6724488|NCT01863199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6724489|NCT01863199|Growth Substances|growth substances|mesh-ancestor
6724490|NCT01863199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724491|NCT01863199|Growth Inhibitors|growth inhibitors|mesh-ancestor
6724492|NCT01863199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6724493|NCT01863225|Atorvastatin|atorvastatin|mesh-list
6724494|NCT01863225|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6724495|NCT01863225|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6724496|NCT01863225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6724497|NCT01863225|Antimetabolites|antimetabolites|mesh-ancestor
6724498|NCT01863225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724499|NCT01863225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6724500|NCT01863225|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6724501|NCT01863225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6724502|NCT01863238|Ivacaftor|ivacaftor|mesh-list
6724503|NCT01863238|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6724504|NCT01863238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6724505|NCT01863238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724506|NCT01863251|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6724507|NCT01863251|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6724508|NCT01863251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6724509|NCT01863251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6724510|NCT01863251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724511|NCT01863251|Adrenergic Agents|adrenergic agents|mesh-ancestor
6724512|NCT01863251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6724513|NCT01863251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724514|NCT01863277|Melatonin|melatonin|mesh-list
6724515|NCT01863277|Antioxidants|antioxidants|mesh-ancestor
6724516|NCT01863277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724517|NCT01863277|Protective Agents|protective agents|mesh-ancestor
6724518|NCT01863277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724519|NCT01863277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6724520|NCT01863355|Fentanyl|fentanyl|mesh-list
6724521|NCT01863355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6724522|NCT01863355|Narcotics|narcotics|mesh-ancestor
6724523|NCT01863355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6724524|NCT01863355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724525|NCT01863355|Analgesics|analgesics|mesh-ancestor
6724526|NCT01863355|Sensory System Agents|sensory system agents|mesh-ancestor
6724527|NCT01863355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6724528|NCT01863355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6724529|NCT01863355|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6724530|NCT01863355|Anesthetics, General|anesthetics, general|mesh-ancestor
6724531|NCT01863355|Anesthetics|anesthetics|mesh-ancestor
6724532|NCT01863407|Metronidazole|metronidazole|mesh-list
6724533|NCT01863407|Dexamethasone|dexamethasone|mesh-list
6724534|NCT01863407|Allantoin|allantoin|mesh-list
6724535|NCT01863407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6724536|NCT01863407|Antiemetics|antiemetics|mesh-ancestor
6724537|NCT01863407|Autonomic Agents|autonomic agents|mesh-ancestor
6724538|NCT01863407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6724539|NCT01863407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724540|NCT01863407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6724541|NCT01863407|Glucocorticoids|glucocorticoids|mesh-ancestor
6724542|NCT01863407|Hormones|hormones|mesh-ancestor
6724543|NCT01863407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6724544|NCT01863407|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6724545|NCT01863407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6724546|NCT01863407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6724547|NCT01863407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6724548|NCT01863407|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6724549|NCT01863407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6724550|NCT01863407|Dermatologic Agents|dermatologic agents|mesh-ancestor
6724551|NCT01863459|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6724552|NCT01863459|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6724553|NCT01863459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724554|NCT01863459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6724555|NCT01863459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6724556|NCT01863459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6724557|NCT01863459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724558|NCT01863459|Dopamine Agents|dopamine agents|mesh-ancestor
6724559|NCT01863459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6724560|NCT01863485|Vorolanib|vorolanib|mesh-list
6724561|NCT01863485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6724562|NCT01863485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6724563|NCT01863485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724564|NCT01863511|Tolvaptan|tolvaptan|mesh-list
6724565|NCT01863511|Diuretics|diuretics|mesh-list
6724566|NCT01863511|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
6724567|NCT01863511|Natriuretic Agents|natriuretic agents|mesh-ancestor
6724568|NCT01863511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724569|NCT01863511|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6724570|NCT01863511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724571|NCT01863511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6724572|NCT01863589|Adefovir|adefovir|mesh-list
6724573|NCT01863589|Antiviral Agents|antiviral agents|mesh-ancestor
6724574|NCT01863589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6724575|NCT01863589|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6724576|NCT01863589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6724577|NCT01863589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6724578|NCT01863589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724579|NCT01863602|Lamotrigine|lamotrigine|mesh-list
6724580|NCT01863602|Anticonvulsants|anticonvulsants|mesh-ancestor
6724581|NCT01863602|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6724582|NCT01863602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6724583|NCT01863602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724584|NCT01863602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6724585|NCT01863602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724586|NCT01863602|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6724587|NCT01863602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6724588|NCT01863602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6724589|NCT01863602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6724590|NCT01863602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6724591|NCT01863615|Isotretinoin|isotretinoin|mesh-list
6724592|NCT01863615|Dermatologic Agents|dermatologic agents|mesh-ancestor
6724593|NCT01863641|Calcitriol|calcitriol|mesh-list
6724594|NCT01863641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6724595|NCT01863641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724596|NCT01863641|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6724597|NCT01863641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6724598|NCT01863641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724599|NCT01863641|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6724600|NCT01863641|Vitamins|vitamins|mesh-ancestor
6724601|NCT01863641|Micronutrients|micronutrients|mesh-ancestor
6724602|NCT01863641|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6724603|NCT01863654|Montelukast|montelukast|mesh-list
6724604|NCT01863654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6724605|NCT01863654|Respiratory System Agents|respiratory system agents|mesh-ancestor
6724606|NCT01863654|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6724607|NCT01863654|Hormone Antagonists|hormone antagonists|mesh-ancestor
6724608|NCT01863654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6724609|NCT01863654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724610|NCT01863654|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6724611|NCT01863654|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6724612|NCT01863654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724613|NCT01863706|Misoprostol|misoprostol|mesh-list
6724614|NCT01863706|Oxytocin|oxytocin|mesh-list
6724615|NCT01863706|Oxytocics|oxytocics|mesh-ancestor
6724616|NCT01863706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6724617|NCT01863706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724618|NCT01863706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6724619|NCT01863706|Abortifacient Agents|abortifacient agents|mesh-ancestor
6724620|NCT01863706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6724621|NCT01863706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6724622|NCT01863719|Colistin|colistin|mesh-list
6724623|NCT01863719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6724624|NCT01863719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6724625|NCT01863810|Pregabalin|pregabalin|mesh-list
6724626|NCT01863810|Analgesics|analgesics|mesh-ancestor
6724627|NCT01863810|Sensory System Agents|sensory system agents|mesh-ancestor
6724628|NCT01863810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6724629|NCT01863810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724630|NCT01863810|Anticonvulsants|anticonvulsants|mesh-ancestor
6724631|NCT01863810|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6724632|NCT01863810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6724633|NCT01863810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724634|NCT01863810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6724635|NCT01863810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6724636|NCT01863810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6724637|NCT01863810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6724638|NCT01863810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6724639|NCT01863823|Amoxicillin|amoxicillin|mesh-list
6724640|NCT01863823|Tetracycline|tetracycline|mesh-list
6724641|NCT01863823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6724642|NCT01863823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6724643|NCT01863823|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6724644|NCT01863823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6724645|NCT01863823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724646|NCT01863888|Teriflunomide|teriflunomide|mesh-list
6724647|NCT01863888|Cholestyramine Resin|cholestyramine resin|mesh-list
6724648|NCT01863888|Charcoal|charcoal|mesh-list
6724649|NCT01863888|Antidotes|antidotes|mesh-ancestor
6724650|NCT01863888|Protective Agents|protective agents|mesh-ancestor
6724651|NCT01863888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724652|NCT01863888|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6724653|NCT01863888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6724654|NCT01863888|Analgesics|analgesics|mesh-ancestor
6724655|NCT01863888|Sensory System Agents|sensory system agents|mesh-ancestor
6724656|NCT01863888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6724657|NCT01863888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6724658|NCT01863888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6724659|NCT01863888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6724660|NCT01863888|Immunologic Factors|immunologic factors|mesh-ancestor
6724661|NCT01863888|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6724662|NCT01863888|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6724663|NCT01863888|Antimetabolites|antimetabolites|mesh-ancestor
6724664|NCT01863888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724665|NCT01863888|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6724666|NCT01863914|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6724667|NCT01863914|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6724668|NCT01863914|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6724669|NCT01863914|Antimetabolites|antimetabolites|mesh-ancestor
6724670|NCT01863914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724671|NCT01863914|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6724672|NCT01863914|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6724673|NCT01863914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6724674|NCT01864057|Thiamine|thiamine|mesh-list
6724675|NCT01864057|Vitamin B Complex|vitamin b complex|mesh-ancestor
6724676|NCT01864057|Vitamins|vitamins|mesh-ancestor
6724677|NCT01864057|Micronutrients|micronutrients|mesh-ancestor
6724678|NCT01864057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724679|NCT01864070|Everolimus|everolimus|mesh-list
6724680|NCT01864070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6724681|NCT01864070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6724682|NCT01864070|Immunologic Factors|immunologic factors|mesh-ancestor
6724683|NCT01864070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724684|NCT01864083|Fluorides|fluorides|mesh-list
6724685|NCT01864083|Cariostatic Agents|cariostatic agents|mesh-ancestor
6724686|NCT01864083|Protective Agents|protective agents|mesh-ancestor
6724687|NCT01864083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724688|NCT01864096|Metformin|metformin|mesh-list
6724689|NCT01864096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6724690|NCT01864096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724691|NCT01864109|Cyclophosphamide|cyclophosphamide|mesh-list
6724692|NCT01864109|Temozolomide|temozolomide|mesh-list
6724693|NCT01864109|Ifosfamide|ifosfamide|mesh-list
6724694|NCT01864109|Doxorubicin|doxorubicin|mesh-list
6724695|NCT01864109|Irinotecan|irinotecan|mesh-list
6724696|NCT01864109|Etoposide|etoposide|mesh-list
6724697|NCT01864109|Vincristine|vincristine|mesh-list
6724698|NCT01864109|Dexrazoxane|dexrazoxane|mesh-list
6724699|NCT01864109|Razoxane|razoxane|mesh-list
6724700|NCT01864109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6724701|NCT01864109|Immunologic Factors|immunologic factors|mesh-ancestor
6724702|NCT01864109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724703|NCT01864109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6724704|NCT01864109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6724705|NCT01864109|Alkylating Agents|alkylating agents|mesh-ancestor
6724706|NCT01864109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724707|NCT01864109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6724708|NCT01864109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6724709|NCT01864109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6724710|NCT01864109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6724711|NCT01864109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6724712|NCT01864109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6724713|NCT01864109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6724714|NCT01864109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6724715|NCT01864109|Tubulin Modulators|tubulin modulators|mesh-ancestor
6724716|NCT01864109|Antimitotic Agents|antimitotic agents|mesh-ancestor
6724717|NCT01864109|Mitosis Modulators|mitosis modulators|mesh-ancestor
6724718|NCT01864109|Protective Agents|protective agents|mesh-ancestor
6724719|NCT01864109|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6724720|NCT01864161|Iron|iron|mesh-list
6724721|NCT01864161|Trace Elements|trace elements|mesh-ancestor
6724722|NCT01864161|Micronutrients|micronutrients|mesh-ancestor
6724723|NCT01864161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724724|NCT01864187|Dexmedetomidine|dexmedetomidine|mesh-list
6724725|NCT01864187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6724726|NCT01864187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6724727|NCT01864187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724728|NCT01864187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6724729|NCT01864187|Analgesics|analgesics|mesh-ancestor
6724730|NCT01864187|Sensory System Agents|sensory system agents|mesh-ancestor
6724731|NCT01864187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6724732|NCT01864187|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6724733|NCT01864187|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6724734|NCT01864187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6724735|NCT01864187|Adrenergic Agents|adrenergic agents|mesh-ancestor
6724736|NCT01864187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6724737|NCT01864187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724738|NCT01864213|Tetracaine|tetracaine|mesh-list
6724739|NCT01864213|Anesthetics, Local|anesthetics, local|mesh-ancestor
6724740|NCT01864213|Anesthetics|anesthetics|mesh-ancestor
6724741|NCT01864213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6724742|NCT01864213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724743|NCT01864213|Sensory System Agents|sensory system agents|mesh-ancestor
6724744|NCT01864213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6724745|NCT01864252|Nitroglycerin|nitroglycerin|mesh-list
6724746|NCT01864252|Vasodilator Agents|vasodilator agents|mesh-ancestor
6724747|NCT01864265|Certolizumab Pegol|certolizumab pegol|mesh-list
6724748|NCT01864265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6724749|NCT01864265|Immunologic Factors|immunologic factors|mesh-ancestor
6724750|NCT01864265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724751|NCT01864265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6724752|NCT01864551|Lamotrigine|lamotrigine|mesh-list
6724753|NCT01864551|Olanzapine|olanzapine|mesh-list
6724754|NCT01864551|Antiemetics|antiemetics|mesh-ancestor
6724755|NCT01864551|Autonomic Agents|autonomic agents|mesh-ancestor
6724756|NCT01864551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6724757|NCT01864551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724758|NCT01864551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6724759|NCT01864551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6724760|NCT01864551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6724761|NCT01864551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6724762|NCT01864551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6724763|NCT01864551|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6724764|NCT01864551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6724765|NCT01864551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6724766|NCT01864551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724767|NCT01864551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6724768|NCT01864551|Serotonin Agents|serotonin agents|mesh-ancestor
6724769|NCT01864551|Anticonvulsants|anticonvulsants|mesh-ancestor
6724770|NCT01864551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6724771|NCT01864551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6724772|NCT01864551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6724773|NCT01864616|Vitamin D|vitamin d|mesh-list
6724774|NCT01864616|Cholecalciferol|cholecalciferol|mesh-list
6724775|NCT01864616|Vitamins|vitamins|mesh-ancestor
6724776|NCT01864616|Micronutrients|micronutrients|mesh-ancestor
6724777|NCT01864616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724778|NCT01864616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6724779|NCT01864616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6724780|NCT01864655|Saracatinib|saracatinib|mesh-list
6724781|NCT01864655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6724782|NCT01864655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6724783|NCT01864655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724784|NCT01864681|Metformin|metformin|mesh-list
6724785|NCT01864681|Gefitinib|gefitinib|mesh-list
6724786|NCT01864681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6724787|NCT01864681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724788|NCT01864681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6724789|NCT01864681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6724790|NCT01864681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6724791|NCT01864681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784653|NCT02204020|Azacitidine|azacitidine|mesh-list
6784654|NCT02204020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6784655|NCT02204020|Antimetabolites|antimetabolites|mesh-ancestor
6724792|NCT01864746|Palbociclib|palbociclib|mesh-list
6724793|NCT01864746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6724794|NCT01864746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6724795|NCT01864746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6724796|NCT01864746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724797|NCT01864772|Cetuximab|cetuximab|mesh-list
6724798|NCT01864772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6724799|NCT01864772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6724800|NCT01864798|Denosumab|denosumab|mesh-list
6724801|NCT01864798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6724802|NCT01864798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724803|NCT01864824|Vitamins|vitamins|mesh-list
6724804|NCT01864824|Folic Acid|folic acid|mesh-list
6724805|NCT01864824|Vitamin B 12|vitamin b 12|mesh-list
6724806|NCT01864824|Vitamin B 6|vitamin b 6|mesh-list
6724807|NCT01864824|Vitamin B Complex|vitamin b complex|mesh-list
6724808|NCT01864824|Micronutrients|micronutrients|mesh-ancestor
6724809|NCT01864824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724810|NCT01864824|Hematinics|hematinics|mesh-ancestor
6724811|NCT01864863|Bosentan|bosentan|mesh-list
6724812|NCT01864863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6724813|NCT01864863|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6724814|NCT01864863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724815|NCT01864915|Prucalopride|prucalopride|mesh-list
6724816|NCT01864915|Laxatives|laxatives|mesh-ancestor
6724817|NCT01864915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6724818|NCT01864915|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
6724819|NCT01864915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6724820|NCT01864915|Serotonin Agents|serotonin agents|mesh-ancestor
6724821|NCT01864915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6724822|NCT01864915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724823|NCT01864915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724824|NCT01865110|Prednisone|prednisone|mesh-list
6724825|NCT01865110|Rituximab|rituximab|mesh-list
6724826|NCT01865110|Lenalidomide|lenalidomide|mesh-list
6724827|NCT01865110|Cyclophosphamide|cyclophosphamide|mesh-list
6724828|NCT01865110|Vincristine|vincristine|mesh-list
6724829|NCT01865110|Doxorubicin|doxorubicin|mesh-list
6724830|NCT01865110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6724831|NCT01865110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6724832|NCT01865110|Immunologic Factors|immunologic factors|mesh-ancestor
6724833|NCT01865110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724834|NCT01865110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6724835|NCT01865110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6724836|NCT01865110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6724837|NCT01865110|Growth Substances|growth substances|mesh-ancestor
6724838|NCT01865110|Growth Inhibitors|growth inhibitors|mesh-ancestor
6724839|NCT01865110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6724840|NCT01865110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6724841|NCT01865110|Alkylating Agents|alkylating agents|mesh-ancestor
6724842|NCT01865110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724843|NCT01865110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6724844|NCT01865110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6724845|NCT01865110|Glucocorticoids|glucocorticoids|mesh-ancestor
6724846|NCT01865110|Hormones|hormones|mesh-ancestor
6724847|NCT01865110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6724848|NCT01865110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6724849|NCT01865110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6724850|NCT01865110|Tubulin Modulators|tubulin modulators|mesh-ancestor
6724851|NCT01865110|Antimitotic Agents|antimitotic agents|mesh-ancestor
6724852|NCT01865110|Mitosis Modulators|mitosis modulators|mesh-ancestor
6724853|NCT01865110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6724854|NCT01865110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6724855|NCT01865110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6724856|NCT01865110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6724857|NCT01865175|Iron|iron|mesh-list
6724858|NCT01865175|Trace Elements|trace elements|mesh-ancestor
6724859|NCT01865175|Micronutrients|micronutrients|mesh-ancestor
6724860|NCT01865175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724861|NCT01865188|Amlodipine|amlodipine|mesh-list
6724862|NCT01865188|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
6724863|NCT01865188|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6724864|NCT01865188|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6724865|NCT01865188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6724866|NCT01865188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724867|NCT01865188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6724868|NCT01865188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724869|NCT01865188|Vasodilator Agents|vasodilator agents|mesh-ancestor
6724870|NCT01865188|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6724871|NCT01865201|Mannitol|mannitol|mesh-list
6724872|NCT01865201|Edaravone|edaravone|mesh-list
6724873|NCT01865201|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6724874|NCT01865201|Diuretics|diuretics|mesh-ancestor
6724875|NCT01865201|Natriuretic Agents|natriuretic agents|mesh-ancestor
6724876|NCT01865201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724877|NCT01865201|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6724878|NCT01865201|Antioxidants|antioxidants|mesh-ancestor
6724879|NCT01865201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724880|NCT01865201|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6724881|NCT01865201|Protective Agents|protective agents|mesh-ancestor
6724882|NCT01865279|Insulin|insulin|mesh-list
6724883|NCT01865279|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6724884|NCT01865279|Insulin, Long-Acting|insulin, long-acting|mesh-list
6724885|NCT01865279|Isophane Insulin, Human|isophane insulin, human|mesh-list
6724886|NCT01865279|Insulin, Isophane|insulin, isophane|mesh-list
6724887|NCT01865279|Isophane insulin, beef|isophane insulin, beef|mesh-list
6724888|NCT01865279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6724889|NCT01865279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724890|NCT01865292|Insulin|insulin|mesh-list
6724891|NCT01865292|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6724892|NCT01865292|Insulin Glargine|insulin glargine|mesh-list
6724893|NCT01865292|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6724894|NCT01865292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724895|NCT01865305|Insulin|insulin|mesh-list
6724896|NCT01865305|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6724897|NCT01865305|Insulin Aspart|insulin aspart|mesh-list
6724898|NCT01865305|Insulin, Long-Acting|insulin, long-acting|mesh-list
6724899|NCT01865305|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6724900|NCT01865305|Biphasic Insulins|biphasic insulins|mesh-list
6724901|NCT01865305|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6724902|NCT01865305|Insulin, Isophane|insulin, isophane|mesh-list
6724903|NCT01865305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6724904|NCT01865305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724905|NCT01865318|Insulin|insulin|mesh-list
6724906|NCT01865318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6724907|NCT01865318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724908|NCT01865331|Insulin|insulin|mesh-list
6724909|NCT01865331|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6724910|NCT01865331|Insulin Aspart|insulin aspart|mesh-list
6724911|NCT01865331|Insulin, Long-Acting|insulin, long-acting|mesh-list
6724912|NCT01865331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6724913|NCT01865331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724914|NCT01865500|Prednisolone|prednisolone|mesh-list
6724915|NCT01865500|Budesonide|budesonide|mesh-list
6724916|NCT01865500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6724917|NCT01865500|Glucocorticoids|glucocorticoids|mesh-ancestor
6724918|NCT01865500|Hormones|hormones|mesh-ancestor
6724919|NCT01865500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6724920|NCT01865500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724921|NCT01865500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6724922|NCT01865500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6724923|NCT01865500|Autonomic Agents|autonomic agents|mesh-ancestor
6724924|NCT01865500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6724925|NCT01865500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6724926|NCT01865500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6724927|NCT01865500|Respiratory System Agents|respiratory system agents|mesh-ancestor
6724928|NCT01865630|Etanercept|etanercept|mesh-list
6724929|NCT01865630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6724930|NCT01865630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6724931|NCT01865630|Analgesics|analgesics|mesh-ancestor
6724932|NCT01865630|Sensory System Agents|sensory system agents|mesh-ancestor
6724933|NCT01865630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6724934|NCT01865630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724935|NCT01865630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6724936|NCT01865630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6724937|NCT01865630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6724938|NCT01865630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6724939|NCT01865630|Immunologic Factors|immunologic factors|mesh-ancestor
6724940|NCT01865669|Oxytocin|oxytocin|mesh-list
6724941|NCT01865669|Oxytocics|oxytocics|mesh-ancestor
6724942|NCT01865669|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6724943|NCT01865669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724944|NCT01865721|Entonox|entonox|mesh-list
6724945|NCT01865721|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
6724946|NCT01865721|Anesthetics|anesthetics|mesh-ancestor
6724947|NCT01865721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6724948|NCT01865721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724949|NCT01865760|Octreotide|octreotide|mesh-list
6724950|NCT01865760|Somatostatin|somatostatin|mesh-list
6724951|NCT01865760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6724952|NCT01865760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6724953|NCT01865760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6724954|NCT01865760|Hormones|hormones|mesh-ancestor
6724955|NCT01865760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6724956|NCT01865760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724957|NCT01865916|Ascorbic Acid|ascorbic acid|mesh-list
6724958|NCT01865916|Bisacodyl|bisacodyl|mesh-list
6724959|NCT01865916|Antioxidants|antioxidants|mesh-ancestor
6724960|NCT01865916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724961|NCT01865916|Protective Agents|protective agents|mesh-ancestor
6724962|NCT01865916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724963|NCT01865916|Vitamins|vitamins|mesh-ancestor
6724964|NCT01865916|Micronutrients|micronutrients|mesh-ancestor
6724965|NCT01865916|Cathartics|cathartics|mesh-ancestor
6724966|NCT01865916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6724967|NCT01865916|Laxatives|laxatives|mesh-ancestor
6724968|NCT01865968|Vaccines|vaccines|mesh-list
6724969|NCT01865968|Immunologic Factors|immunologic factors|mesh-ancestor
6724970|NCT01865968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724971|NCT01866007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6724972|NCT01866007|Immunologic Factors|immunologic factors|mesh-ancestor
6724973|NCT01866007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724974|NCT01866059|Methamphetamine|methamphetamine|mesh-list
6724975|NCT01866059|Calcium|calcium|mesh-list
6724976|NCT01866059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6724977|NCT01866059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724978|NCT01866059|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6724979|NCT01866059|Sympathomimetics|sympathomimetics|mesh-ancestor
6724980|NCT01866059|Autonomic Agents|autonomic agents|mesh-ancestor
6724981|NCT01866059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6724982|NCT01866059|Dopamine Agents|dopamine agents|mesh-ancestor
6724983|NCT01866059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6724984|NCT01866059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6724985|NCT01866059|Adrenergic Agents|adrenergic agents|mesh-ancestor
6724986|NCT01866059|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6724987|NCT01866059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6724988|NCT01866059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6724989|NCT01866059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6784656|NCT02204020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784657|NCT02204020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6784658|NCT02204020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6784659|NCT02204202|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6784660|NCT02204202|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6784661|NCT02204202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784662|NCT02204241|Dexamethasone|dexamethasone|mesh-list
6784663|NCT02204241|Cyclophosphamide|cyclophosphamide|mesh-list
6784664|NCT02204241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6784665|NCT02204241|Immunologic Factors|immunologic factors|mesh-ancestor
6784666|NCT02204241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784667|NCT02204241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6784668|NCT02204241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6784669|NCT02204241|Alkylating Agents|alkylating agents|mesh-ancestor
6784670|NCT02204241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784671|NCT02204241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6784672|NCT02204241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6784673|NCT02204241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6784674|NCT02204241|Antiemetics|antiemetics|mesh-ancestor
6784675|NCT02204241|Autonomic Agents|autonomic agents|mesh-ancestor
6784676|NCT02204241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6784677|NCT02204241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6784678|NCT02204241|Glucocorticoids|glucocorticoids|mesh-ancestor
6784679|NCT02204241|Hormones|hormones|mesh-ancestor
6784680|NCT02204241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6784681|NCT02204241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6784682|NCT02204254|Doxycycline|doxycycline|mesh-list
6784683|NCT02204254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6784684|NCT02204254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6784685|NCT02204254|Antimalarials|antimalarials|mesh-ancestor
6724990|NCT01866241|Misoprostol|misoprostol|mesh-list
6724991|NCT01866241|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6724992|NCT01866241|Abortifacient Agents|abortifacient agents|mesh-ancestor
6724993|NCT01866241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6724994|NCT01866241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6724995|NCT01866241|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6724996|NCT01866241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6724997|NCT01866241|Oxytocics|oxytocics|mesh-ancestor
6724998|NCT01866254|Morphine|morphine|mesh-list
6724999|NCT01866254|Hydromorphone|hydromorphone|mesh-list
6725000|NCT01866254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6725001|NCT01866254|Narcotics|narcotics|mesh-ancestor
6725002|NCT01866254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6725003|NCT01866254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725004|NCT01866254|Analgesics|analgesics|mesh-ancestor
6725005|NCT01866254|Sensory System Agents|sensory system agents|mesh-ancestor
6725006|NCT01866254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6725007|NCT01866267|Maraviroc|maraviroc|mesh-list
6725008|NCT01866267|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6725009|NCT01866267|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6725010|NCT01866267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725011|NCT01866267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6725012|NCT01866267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6725013|NCT01866267|Antiviral Agents|antiviral agents|mesh-ancestor
6725014|NCT01866267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6725015|NCT01866267|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6725016|NCT01866397|Cidofovir|cidofovir|mesh-list
6725017|NCT01866397|Antiviral Agents|antiviral agents|mesh-ancestor
6725018|NCT01866397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6725019|NCT01866397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6725020|NCT01866397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725021|NCT01866488|Misoprostol|misoprostol|mesh-list
6725022|NCT01866488|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6725023|NCT01866488|Abortifacient Agents|abortifacient agents|mesh-ancestor
6725024|NCT01866488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6725025|NCT01866488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725026|NCT01866488|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6725027|NCT01866488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6725028|NCT01866488|Oxytocics|oxytocics|mesh-ancestor
6725029|NCT01866514|Lidocaine|lidocaine|mesh-list
6725030|NCT01866514|Anesthetics, Local|anesthetics, local|mesh-ancestor
6725031|NCT01866514|Anesthetics|anesthetics|mesh-ancestor
6725032|NCT01866514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6725033|NCT01866514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725034|NCT01866514|Sensory System Agents|sensory system agents|mesh-ancestor
6725035|NCT01866514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6725036|NCT01866514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6725037|NCT01866514|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6725038|NCT01866514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6725039|NCT01866514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6725040|NCT01866514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725041|NCT01866553|Interferons|interferons|mesh-list
6725042|NCT01866553|Interferon-alpha|interferon-alpha|mesh-list
6725043|NCT01866553|Interferon alpha-2|interferon alpha-2|mesh-list
6725044|NCT01866553|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6725045|NCT01866553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6725046|NCT01866553|Antiviral Agents|antiviral agents|mesh-ancestor
6725047|NCT01866553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6725048|NCT01866553|Immunologic Factors|immunologic factors|mesh-ancestor
6725049|NCT01866553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725050|NCT01866605|Midazolam|midazolam|mesh-list
6725051|NCT01866605|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6725052|NCT01866605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6725053|NCT01866605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6725054|NCT01866605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725055|NCT01866605|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6725056|NCT01866605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6725057|NCT01866605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6725058|NCT01866605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6725059|NCT01866605|Anesthetics, General|anesthetics, general|mesh-ancestor
6725060|NCT01866605|Anesthetics|anesthetics|mesh-ancestor
6725061|NCT01866605|GABA Modulators|gaba modulators|mesh-ancestor
6725062|NCT01866605|GABA Agents|gaba agents|mesh-ancestor
6725063|NCT01866605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6725064|NCT01866605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725065|NCT01866644|Acetylcysteine|acetylcysteine|mesh-list
6725066|NCT01866644|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6725067|NCT01866644|Antiviral Agents|antiviral agents|mesh-ancestor
6725068|NCT01866644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6725069|NCT01866644|Expectorants|expectorants|mesh-ancestor
6725070|NCT01866644|Respiratory System Agents|respiratory system agents|mesh-ancestor
6725071|NCT01866644|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6725072|NCT01866644|Antioxidants|antioxidants|mesh-ancestor
6725073|NCT01866644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725074|NCT01866644|Protective Agents|protective agents|mesh-ancestor
6725075|NCT01866644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725076|NCT01866644|Antidotes|antidotes|mesh-ancestor
6725077|NCT01866657|Phenylephrine|phenylephrine|mesh-list
6725078|NCT01866657|Dopamine|dopamine|mesh-list
6725079|NCT01866657|Ephedrine|ephedrine|mesh-list
6725080|NCT01866657|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
6725081|NCT01866657|Propofol|propofol|mesh-list
6725082|NCT01866657|Sevoflurane|sevoflurane|mesh-list
6725083|NCT01866657|Anesthetics|anesthetics|mesh-ancestor
6725084|NCT01866657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6725085|NCT01866657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725086|NCT01866657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6725087|NCT01866657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6725088|NCT01866657|Anesthetics, General|anesthetics, general|mesh-ancestor
6725089|NCT01866657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6725090|NCT01866657|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6725091|NCT01866657|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6725092|NCT01866657|Mydriatics|mydriatics|mesh-ancestor
6725093|NCT01866657|Autonomic Agents|autonomic agents|mesh-ancestor
6725094|NCT01866657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6725095|NCT01866657|Sympathomimetics|sympathomimetics|mesh-ancestor
6725096|NCT01866657|Nasal Decongestants|nasal decongestants|mesh-ancestor
6725097|NCT01866657|Respiratory System Agents|respiratory system agents|mesh-ancestor
6725098|NCT01866657|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6725099|NCT01866657|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6725100|NCT01866657|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6725101|NCT01866657|Adrenergic Agents|adrenergic agents|mesh-ancestor
6725102|NCT01866657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6725103|NCT01866657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725104|NCT01866657|Protective Agents|protective agents|mesh-ancestor
6725105|NCT01866657|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6725106|NCT01866657|Dopamine Agents|dopamine agents|mesh-ancestor
6725107|NCT01867138|Vancomycin|vancomycin|mesh-list
6725108|NCT01867138|Cefazolin|cefazolin|mesh-list
6725109|NCT01867138|Amikacin|amikacin|mesh-list
6725110|NCT01867138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6725111|NCT01867138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6725112|NCT01867255|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6725113|NCT01867255|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6725114|NCT01867255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6725115|NCT01867255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6725116|NCT01867255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725117|NCT01867255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6725118|NCT01867255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725119|NCT01867255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6725120|NCT01867255|Antidepressive Agents|antidepressive agents|mesh-ancestor
6725121|NCT01867255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6725122|NCT01867268|Acetazolamide|acetazolamide|mesh-list
6725123|NCT01867268|Anticonvulsants|anticonvulsants|mesh-ancestor
6725124|NCT01867268|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6725125|NCT01867268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6725126|NCT01867268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725127|NCT01867268|Diuretics|diuretics|mesh-ancestor
6725128|NCT01867268|Natriuretic Agents|natriuretic agents|mesh-ancestor
6725129|NCT01867268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725130|NCT01867281|Aspirin|aspirin|mesh-list
6725131|NCT01867281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6725132|NCT01867281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6725133|NCT01867281|Analgesics|analgesics|mesh-ancestor
6725134|NCT01867281|Sensory System Agents|sensory system agents|mesh-ancestor
6725135|NCT01867281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6725136|NCT01867281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725137|NCT01867281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6725138|NCT01867281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6725139|NCT01867281|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6725140|NCT01867281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6725141|NCT01867281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725142|NCT01867281|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6725143|NCT01867281|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6725144|NCT01867281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6725145|NCT01867281|Antipyretics|antipyretics|mesh-ancestor
6725146|NCT01867320|Raltegravir Potassium|raltegravir potassium|mesh-list
6725147|NCT01867320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6725148|NCT01867320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6725149|NCT01867320|Antiviral Agents|antiviral agents|mesh-ancestor
6725150|NCT01867320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6725151|NCT01867320|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6725152|NCT01867320|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6725153|NCT01867320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6725154|NCT01867320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725155|NCT01867463|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6725156|NCT01867463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6725157|NCT01867463|Immunologic Factors|immunologic factors|mesh-ancestor
6725158|NCT01867463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725159|NCT01867463|Antacids|antacids|mesh-ancestor
6725160|NCT01867463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725161|NCT01867463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6725162|NCT01867502|Metformin|metformin|mesh-list
6725163|NCT01867502|Vildagliptin|vildagliptin|mesh-list
6725164|NCT01867502|Glyburide|glyburide|mesh-list
6725165|NCT01867502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6725166|NCT01867502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725167|NCT01867502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6725168|NCT01867502|Protease Inhibitors|protease inhibitors|mesh-ancestor
6725169|NCT01867502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6725170|NCT01867502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725171|NCT01867593|Carbon-11 methionine|carbon-11 methionine|mesh-list
6725172|NCT01867593|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6725173|NCT01867593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725174|NCT01867645|Immunoglobulins|immunoglobulins|mesh-list
6725175|NCT01867645|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6725176|NCT01867645|Antibodies|antibodies|mesh-list
6725177|NCT01867645|gamma-Globulins|gamma-globulins|mesh-list
6725178|NCT01867645|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6725179|NCT01867645|Immunologic Factors|immunologic factors|mesh-ancestor
6725180|NCT01867645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725181|NCT01867697|Leucovorin|leucovorin|mesh-list
6725182|NCT01867697|Folic Acid|folic acid|mesh-list
6725183|NCT01867697|Oxaliplatin|oxaliplatin|mesh-list
6725184|NCT01867697|Irinotecan|irinotecan|mesh-list
6725185|NCT01867697|Cetuximab|cetuximab|mesh-list
6725186|NCT01867697|Calcium Carbonate|calcium carbonate|mesh-list
6725187|NCT01867697|Levoleucovorin|levoleucovorin|mesh-list
6725188|NCT01867697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725189|NCT01867697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6725190|NCT01867697|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6725191|NCT01867697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6725192|NCT01867697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6725193|NCT01867697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725194|NCT01867697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6725195|NCT01867697|Antidotes|antidotes|mesh-ancestor
6725196|NCT01867697|Protective Agents|protective agents|mesh-ancestor
6725197|NCT01867697|Vitamin B Complex|vitamin b complex|mesh-ancestor
6725198|NCT01867697|Vitamins|vitamins|mesh-ancestor
6725199|NCT01867697|Micronutrients|micronutrients|mesh-ancestor
6725200|NCT01867697|Hematinics|hematinics|mesh-ancestor
6725201|NCT01867697|Antacids|antacids|mesh-ancestor
6725202|NCT01867697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6725203|NCT01867775|Mirtazapine|mirtazapine|mesh-list
6725204|NCT01867775|Antidepressive Agents|antidepressive agents|mesh-ancestor
6725205|NCT01867775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6725206|NCT01867775|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6725207|NCT01867775|Histamine Antagonists|histamine antagonists|mesh-ancestor
6725208|NCT01867775|Histamine Agents|histamine agents|mesh-ancestor
6725209|NCT01867775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6725210|NCT01867775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725211|NCT01867775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725212|NCT01867775|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6725213|NCT01867775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6725214|NCT01867775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6725215|NCT01867775|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6725216|NCT01867775|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6725217|NCT01867775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6725218|NCT01867775|Adrenergic Agents|adrenergic agents|mesh-ancestor
6725219|NCT01867775|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6725220|NCT01867775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6725221|NCT01867775|Serotonin Agents|serotonin agents|mesh-ancestor
6725222|NCT01867775|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6725223|NCT01867866|Trifluridine|trifluridine|mesh-list
6725224|NCT01867866|Antimetabolites|antimetabolites|mesh-ancestor
6725225|NCT01867866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725226|NCT01867866|Antiviral Agents|antiviral agents|mesh-ancestor
6725227|NCT01867866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6725228|NCT01867892|Leucovorin|leucovorin|mesh-list
6725229|NCT01867892|Gemcitabine|gemcitabine|mesh-list
6725230|NCT01867892|Fluorouracil|fluorouracil|mesh-list
6725231|NCT01867892|Irinotecan|irinotecan|mesh-list
6725232|NCT01867892|Levoleucovorin|levoleucovorin|mesh-list
6725233|NCT01867892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6725234|NCT01867892|Antimetabolites|antimetabolites|mesh-ancestor
6725235|NCT01867892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725236|NCT01867892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6725237|NCT01867892|Antiviral Agents|antiviral agents|mesh-ancestor
6725238|NCT01867892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6725239|NCT01867892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6725240|NCT01867892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6725241|NCT01867892|Immunologic Factors|immunologic factors|mesh-ancestor
6725242|NCT01867892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725243|NCT01867892|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6725244|NCT01867892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6725245|NCT01867892|Antidotes|antidotes|mesh-ancestor
6725246|NCT01867892|Protective Agents|protective agents|mesh-ancestor
6725247|NCT01867892|Vitamin B Complex|vitamin b complex|mesh-ancestor
6725248|NCT01867892|Vitamins|vitamins|mesh-ancestor
6725249|NCT01867892|Micronutrients|micronutrients|mesh-ancestor
6784686|NCT02204254|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6784687|NCT02204254|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6784688|NCT02204397|Ustekinumab|ustekinumab|mesh-list
6784689|NCT02204397|Dermatologic Agents|dermatologic agents|mesh-ancestor
6784690|NCT02204475|Interferons|interferons|mesh-list
6784691|NCT02204475|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6784692|NCT02204475|Grazoprevir|grazoprevir|mesh-list
6784693|NCT02204475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6784694|NCT02204475|Antiviral Agents|antiviral agents|mesh-ancestor
6784695|NCT02204475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6784696|NCT02204501|Midazolam|midazolam|mesh-list
6784697|NCT02204501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6784698|NCT02204501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6784699|NCT02204501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6784700|NCT02204501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784701|NCT02204501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6784702|NCT02204501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6784703|NCT02204501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6784704|NCT02204501|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6784705|NCT02204501|Anesthetics, General|anesthetics, general|mesh-ancestor
6784706|NCT02204501|Anesthetics|anesthetics|mesh-ancestor
6784707|NCT02204501|GABA Modulators|gaba modulators|mesh-ancestor
6784708|NCT02204501|GABA Agents|gaba agents|mesh-ancestor
6784709|NCT02204501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6784710|NCT02204501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784711|NCT02204527|Vitamin D|vitamin d|mesh-list
6784712|NCT02204527|Ergocalciferols|ergocalciferols|mesh-list
6784713|NCT02204527|Cholecalciferol|cholecalciferol|mesh-list
6725250|NCT01867957|Vaccines|vaccines|mesh-list
6725251|NCT01867957|Immunologic Factors|immunologic factors|mesh-ancestor
6725252|NCT01867957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725253|NCT01868048|Nabiximols|nabiximols|mesh-list
6725254|NCT01868048|Analgesics|analgesics|mesh-ancestor
6725255|NCT01868048|Sensory System Agents|sensory system agents|mesh-ancestor
6725256|NCT01868048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6725257|NCT01868048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725258|NCT01868113|Fluticasone|fluticasone|mesh-list
6725259|NCT01868113|Xhance|xhance|mesh-list
6725260|NCT01868113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6725261|NCT01868113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6725262|NCT01868113|Autonomic Agents|autonomic agents|mesh-ancestor
6725263|NCT01868113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6725264|NCT01868113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725265|NCT01868113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6725266|NCT01868113|Respiratory System Agents|respiratory system agents|mesh-ancestor
6725267|NCT01868113|Dermatologic Agents|dermatologic agents|mesh-ancestor
6725268|NCT01868113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6725269|NCT01868126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6725270|NCT01868126|Latanoprost|latanoprost|mesh-list
6725271|NCT01868126|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6725272|NCT01868191|Thiamine|thiamine|mesh-list
6725273|NCT01868191|Benphothiamine|benphothiamine|mesh-list
6725274|NCT01868191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6725275|NCT01868191|Immunologic Factors|immunologic factors|mesh-ancestor
6725276|NCT01868191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725277|NCT01868191|Chelating Agents|chelating agents|mesh-ancestor
6725278|NCT01868191|Sequestering Agents|sequestering agents|mesh-ancestor
6725279|NCT01868191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725280|NCT01868191|Vitamin B Complex|vitamin b complex|mesh-ancestor
6725281|NCT01868191|Vitamins|vitamins|mesh-ancestor
6725282|NCT01868191|Micronutrients|micronutrients|mesh-ancestor
6725283|NCT01868269|Dexamethasone|dexamethasone|mesh-list
6725284|NCT01868269|Dexamethasone acetate|dexamethasone acetate|mesh-list
6725285|NCT01868269|Cyclophosphamide|cyclophosphamide|mesh-list
6725286|NCT01868269|Rituximab|rituximab|mesh-list
6725287|NCT01868269|BB 1101|bb 1101|mesh-list
6725288|NCT01868269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6725289|NCT01868269|Immunologic Factors|immunologic factors|mesh-ancestor
6725290|NCT01868269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725291|NCT01868269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6725292|NCT01868269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6725293|NCT01868269|Alkylating Agents|alkylating agents|mesh-ancestor
6725294|NCT01868269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725295|NCT01868269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6725296|NCT01868269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6725297|NCT01868269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6725298|NCT01868269|Antiemetics|antiemetics|mesh-ancestor
6725299|NCT01868269|Autonomic Agents|autonomic agents|mesh-ancestor
6725300|NCT01868269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6725301|NCT01868269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6725302|NCT01868269|Glucocorticoids|glucocorticoids|mesh-ancestor
6725303|NCT01868269|Hormones|hormones|mesh-ancestor
6725304|NCT01868269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6725305|NCT01868269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6725306|NCT01868269|Protease Inhibitors|protease inhibitors|mesh-ancestor
6725307|NCT01868269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6725308|NCT01868269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6725309|NCT01868360|Aflibercept|aflibercept|mesh-list
6725310|NCT01868360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6725311|NCT01868360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6725312|NCT01868360|Growth Substances|growth substances|mesh-ancestor
6725313|NCT01868360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725314|NCT01868360|Growth Inhibitors|growth inhibitors|mesh-ancestor
6725315|NCT01868360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6725316|NCT01868438|Artesunate|artesunate|mesh-list
6725317|NCT01868438|Pyronaridine|pyronaridine|mesh-list
6725318|NCT01868438|Antimalarials|antimalarials|mesh-ancestor
6725319|NCT01868438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6725320|NCT01868438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6725321|NCT01868438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6725322|NCT01868438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6725323|NCT01868438|Antiviral Agents|antiviral agents|mesh-ancestor
6725324|NCT01868438|Schistosomicides|schistosomicides|mesh-ancestor
6725325|NCT01868438|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6725326|NCT01868438|Anthelmintics|anthelmintics|mesh-ancestor
6725327|NCT01868451|Doxorubicin|doxorubicin|mesh-list
6725328|NCT01868451|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6725329|NCT01868451|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6725330|NCT01868451|Dacarbazine|dacarbazine|mesh-list
6725331|NCT01868451|Vinblastine|vinblastine|mesh-list
6725332|NCT01868451|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6725333|NCT01868451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6725334|NCT01868451|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6725335|NCT01868451|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6725336|NCT01868451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6725337|NCT01868451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725338|NCT01868451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6725339|NCT01868451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6725340|NCT01868451|Alkylating Agents|alkylating agents|mesh-ancestor
6725341|NCT01868451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6725342|NCT01868451|Tubulin Modulators|tubulin modulators|mesh-ancestor
6725343|NCT01868451|Antimitotic Agents|antimitotic agents|mesh-ancestor
6725344|NCT01868451|Mitosis Modulators|mitosis modulators|mesh-ancestor
6725345|NCT01868464|BCG Vaccine|bcg vaccine|mesh-list
6725346|NCT01868464|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6725347|NCT01868464|Immunologic Factors|immunologic factors|mesh-ancestor
6725348|NCT01868464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725349|NCT01868529|Insulin|insulin|mesh-list
6725350|NCT01868529|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6725351|NCT01868529|Insulin Glargine|insulin glargine|mesh-list
6725352|NCT01868529|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6725353|NCT01868529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725354|NCT01868555|Insulin|insulin|mesh-list
6725355|NCT01868555|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6725356|NCT01868555|Insulin Aspart|insulin aspart|mesh-list
6725357|NCT01868555|Insulin, Long-Acting|insulin, long-acting|mesh-list
6725358|NCT01868555|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6725359|NCT01868555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6725360|NCT01868555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725361|NCT01868568|Insulin|insulin|mesh-list
6725362|NCT01868568|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6725363|NCT01868568|Insulin Aspart|insulin aspart|mesh-list
6725364|NCT01868568|Insulin, Long-Acting|insulin, long-acting|mesh-list
6725365|NCT01868568|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6725366|NCT01868568|Biphasic Insulins|biphasic insulins|mesh-list
6725367|NCT01868568|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6725368|NCT01868568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6725369|NCT01868568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725370|NCT01868581|Insulin|insulin|mesh-list
6725371|NCT01868581|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6725372|NCT01868581|Insulin Aspart|insulin aspart|mesh-list
6725373|NCT01868581|Insulin, Long-Acting|insulin, long-acting|mesh-list
6725374|NCT01868581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6725375|NCT01868581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725376|NCT01868750|Calcitriol|calcitriol|mesh-list
6725377|NCT01868750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6725378|NCT01868750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725379|NCT01868750|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6725380|NCT01868750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6725381|NCT01868750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725382|NCT01868750|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6725383|NCT01868750|Vitamins|vitamins|mesh-ancestor
6725384|NCT01868750|Micronutrients|micronutrients|mesh-ancestor
6725385|NCT01868750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6725386|NCT01868802|Ketamine|ketamine|mesh-list
6725387|NCT01868802|Analgesics|analgesics|mesh-ancestor
6725388|NCT01868802|Sensory System Agents|sensory system agents|mesh-ancestor
6725389|NCT01868802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6725390|NCT01868802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725391|NCT01868802|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6725392|NCT01868802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6725393|NCT01868802|Anesthetics, General|anesthetics, general|mesh-ancestor
6725394|NCT01868802|Anesthetics|anesthetics|mesh-ancestor
6725395|NCT01868802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6725396|NCT01868802|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6725397|NCT01868802|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6725398|NCT01868802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6725399|NCT01868802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725400|NCT01868880|Bisoprolol|bisoprolol|mesh-list
6725401|NCT01868880|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
6725402|NCT01868880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6725403|NCT01868880|Adrenergic Agents|adrenergic agents|mesh-ancestor
6725404|NCT01868880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6725405|NCT01868880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725406|NCT01868880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725407|NCT01868880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6725408|NCT01868880|Sympatholytics|sympatholytics|mesh-ancestor
6725409|NCT01868880|Autonomic Agents|autonomic agents|mesh-ancestor
6725410|NCT01868880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6725411|NCT01868880|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6725412|NCT01868906|Temozolomide|temozolomide|mesh-list
6725413|NCT01868906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6725414|NCT01868906|Alkylating Agents|alkylating agents|mesh-ancestor
6725415|NCT01868906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725416|NCT01868906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6725417|NCT01868945|Vitamin D|vitamin d|mesh-list
6725418|NCT01868945|Cholecalciferol|cholecalciferol|mesh-list
6725419|NCT01868945|Calcifediol|calcifediol|mesh-list
6725420|NCT01868945|Vitamins|vitamins|mesh-ancestor
6725421|NCT01868945|Micronutrients|micronutrients|mesh-ancestor
6725422|NCT01868945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725423|NCT01868945|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6725424|NCT01868945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6725425|NCT01868984|Paclitaxel|paclitaxel|mesh-list
6725426|NCT01868984|Heparin|heparin|mesh-list
6725427|NCT01868984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6725428|NCT01868984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6725429|NCT01868984|Tubulin Modulators|tubulin modulators|mesh-ancestor
6725430|NCT01868984|Antimitotic Agents|antimitotic agents|mesh-ancestor
6725431|NCT01868984|Mitosis Modulators|mitosis modulators|mesh-ancestor
6725432|NCT01868984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725433|NCT01868984|Anticoagulants|anticoagulants|mesh-ancestor
6725434|NCT01868984|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6725435|NCT01868984|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6725436|NCT01869010|Tenofovir|tenofovir|mesh-list
6725437|NCT01869010|Antiviral Agents|antiviral agents|mesh-ancestor
6725438|NCT01869010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6725439|NCT01869010|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6725440|NCT01869010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6725441|NCT01869010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6725442|NCT01869010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725443|NCT01869010|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6725444|NCT01869010|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6725445|NCT01869023|Gemcitabine|gemcitabine|mesh-list
6725446|NCT01869023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6725447|NCT01869023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6725448|NCT01869023|Antimetabolites|antimetabolites|mesh-ancestor
6725449|NCT01869023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725450|NCT01869023|Antiviral Agents|antiviral agents|mesh-ancestor
6725451|NCT01869023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6725452|NCT01869023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6725453|NCT01869023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6725454|NCT01869023|Immunologic Factors|immunologic factors|mesh-ancestor
6725455|NCT01869023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725456|NCT01869036|Morphine|morphine|mesh-list
6725457|NCT01869036|Anesthetics|anesthetics|mesh-list
6725458|NCT01869036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6725459|NCT01869036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725460|NCT01869036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6725461|NCT01869036|Narcotics|narcotics|mesh-ancestor
6725462|NCT01869036|Analgesics|analgesics|mesh-ancestor
6725463|NCT01869036|Sensory System Agents|sensory system agents|mesh-ancestor
6725464|NCT01869036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6725465|NCT01869205|Ivermectin|ivermectin|mesh-list
6725466|NCT01869205|Abamectin|abamectin|mesh-list
6725467|NCT01869205|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6725468|NCT01869205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6725469|NCT01869205|Anthelmintics|anthelmintics|mesh-ancestor
6725470|NCT01869257|Triclosan|triclosan|mesh-list
6725471|NCT01869257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6725472|NCT01869257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6725473|NCT01869257|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6725474|NCT01869257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6725475|NCT01869257|Antimetabolites|antimetabolites|mesh-ancestor
6725476|NCT01869257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725477|NCT01869257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6725478|NCT01869309|Ticagrelor|ticagrelor|mesh-list
6725479|NCT01869309|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6725480|NCT01869309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6725481|NCT01869309|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6725482|NCT01869309|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6725483|NCT01869309|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6725484|NCT01869309|Purinergic Agents|purinergic agents|mesh-ancestor
6725485|NCT01869309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6725486|NCT01869309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725487|NCT01869309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725488|NCT01869413|Tranexamic Acid|tranexamic acid|mesh-list
6725489|NCT01869413|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6725490|NCT01869413|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6725491|NCT01869413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725492|NCT01869413|Hemostatics|hemostatics|mesh-ancestor
6725493|NCT01869413|Coagulants|coagulants|mesh-ancestor
6725494|NCT01869491|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
6725495|NCT01869491|Antacids|antacids|mesh-ancestor
6725496|NCT01869491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725497|NCT01869491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6725498|NCT01869556|Oxytocin|oxytocin|mesh-list
6725499|NCT01869556|Ergonovine|ergonovine|mesh-list
6725500|NCT01869556|Carboprost|carboprost|mesh-list
6725501|NCT01869556|Oxytocics|oxytocics|mesh-ancestor
6725502|NCT01869556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6725503|NCT01869556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725504|NCT01869556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6725505|NCT01869556|Abortifacient Agents|abortifacient agents|mesh-ancestor
6725506|NCT01869569|Pregabalin|pregabalin|mesh-list
6725507|NCT01869569|Analgesics|analgesics|mesh-ancestor
6725508|NCT01869569|Sensory System Agents|sensory system agents|mesh-ancestor
6725509|NCT01869569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6725510|NCT01869569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725511|NCT01869569|Anticonvulsants|anticonvulsants|mesh-ancestor
6725512|NCT01869569|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6725513|NCT01869569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6725514|NCT01869569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725515|NCT01869569|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6725516|NCT01869569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6725517|NCT01869569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6725518|NCT01869569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6725519|NCT01869569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6725520|NCT01869621|Metformin|metformin|mesh-list
6725521|NCT01869621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6725522|NCT01869621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784714|NCT02204527|Vitamins|vitamins|mesh-list
6784715|NCT02204527|Micronutrients|micronutrients|mesh-ancestor
6784716|NCT02204527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784717|NCT02204527|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6784718|NCT02204527|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6784719|NCT02204553|Panobinostat|panobinostat|mesh-list
6784720|NCT02204553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6784721|NCT02204553|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6784722|NCT02204553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6784723|NCT02204553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725523|NCT01869673|Anesthetics|anesthetics|mesh-list
6725524|NCT01869673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6725525|NCT01869673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725526|NCT01869751|Prucalopride|prucalopride|mesh-list
6725527|NCT01869751|Laxatives|laxatives|mesh-ancestor
6725528|NCT01869751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6725529|NCT01869751|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
6725530|NCT01869751|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6725531|NCT01869751|Serotonin Agents|serotonin agents|mesh-ancestor
6725532|NCT01869751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6725533|NCT01869751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725534|NCT01869751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725535|NCT01869803|Gemtuzumab|gemtuzumab|mesh-list
6725536|NCT01869803|Calicheamicins|calicheamicins|mesh-list
6725537|NCT01869803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6725538|NCT01869803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6725539|NCT01869803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6725540|NCT01869881|Sarpogrelate|sarpogrelate|mesh-list
6725541|NCT01869881|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6725542|NCT01869881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6725543|NCT01869881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725544|NCT01869881|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6725545|NCT01869881|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6725546|NCT01869881|Serotonin Agents|serotonin agents|mesh-ancestor
6725547|NCT01869881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6725548|NCT01869881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725549|NCT01869907|Minocycline|minocycline|mesh-list
6725550|NCT01869907|Amitriptyline|amitriptyline|mesh-list
6725551|NCT01869907|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6725552|NCT01869907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6725553|NCT01869907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6725554|NCT01869907|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6725555|NCT01869907|Antidepressive Agents|antidepressive agents|mesh-ancestor
6725556|NCT01869907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6725557|NCT01869907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6725558|NCT01869907|Analgesics|analgesics|mesh-ancestor
6725559|NCT01869907|Sensory System Agents|sensory system agents|mesh-ancestor
6725560|NCT01869907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6725561|NCT01869907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725562|NCT01869907|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6725563|NCT01869907|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6725564|NCT01869907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6725565|NCT01869907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725566|NCT01869907|Adrenergic Agents|adrenergic agents|mesh-ancestor
6725567|NCT01869907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6725568|NCT01869907|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6725569|NCT01869907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6725570|NCT01869907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6725571|NCT01869946|Ropivacaine|ropivacaine|mesh-list
6725572|NCT01869946|Anesthetics, Local|anesthetics, local|mesh-ancestor
6725573|NCT01869946|Anesthetics|anesthetics|mesh-ancestor
6725574|NCT01869946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6725575|NCT01869946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725576|NCT01869946|Sensory System Agents|sensory system agents|mesh-ancestor
6725577|NCT01869946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6725578|NCT01870011|Anesthetics|anesthetics|mesh-list
6725579|NCT01870011|Propofol|propofol|mesh-list
6725580|NCT01870011|Desflurane|desflurane|mesh-list
6725581|NCT01870011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6725582|NCT01870011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725583|NCT01870011|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6725584|NCT01870011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6725585|NCT01870011|Anesthetics, General|anesthetics, general|mesh-ancestor
6725586|NCT01870011|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6725587|NCT01870024|Fosphenytoin|fosphenytoin|mesh-list
6725588|NCT01870024|Lorazepam|lorazepam|mesh-list
6725589|NCT01870024|Clonazepam|clonazepam|mesh-list
6725590|NCT01870024|Anticonvulsants|anticonvulsants|mesh-ancestor
6725591|NCT01870024|Antiemetics|antiemetics|mesh-ancestor
6725592|NCT01870024|Autonomic Agents|autonomic agents|mesh-ancestor
6725593|NCT01870024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6725594|NCT01870024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725595|NCT01870024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6725596|NCT01870024|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6784724|NCT02204644|Imatinib Mesylate|imatinib mesylate|mesh-list
6725597|NCT01870024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6725598|NCT01870024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6725599|NCT01870024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6725600|NCT01870024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6725601|NCT01870024|GABA Modulators|gaba modulators|mesh-ancestor
6725602|NCT01870024|GABA Agents|gaba agents|mesh-ancestor
6725603|NCT01870024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6725604|NCT01870024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725605|NCT01870024|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6725606|NCT01870024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6725607|NCT01870050|Dapsone|dapsone|mesh-list
6725608|NCT01870050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6725609|NCT01870050|Antimalarials|antimalarials|mesh-ancestor
6725610|NCT01870050|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6725611|NCT01870050|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6725612|NCT01870050|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6725613|NCT01870050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6725614|NCT01870050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725615|NCT01870050|Leprostatic Agents|leprostatic agents|mesh-ancestor
6725616|NCT01870050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6725617|NCT01870115|Vitamin D|vitamin d|mesh-list
6725618|NCT01870115|Cholecalciferol|cholecalciferol|mesh-list
6725619|NCT01870115|Melatonin|melatonin|mesh-list
6725620|NCT01870115|Vitamins|vitamins|mesh-ancestor
6725621|NCT01870115|Micronutrients|micronutrients|mesh-ancestor
6725622|NCT01870115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725623|NCT01870115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6725624|NCT01870115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725625|NCT01870115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6725626|NCT01870115|Antioxidants|antioxidants|mesh-ancestor
6725627|NCT01870115|Protective Agents|protective agents|mesh-ancestor
6725628|NCT01870115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6725629|NCT01870128|Hydroxychloroquine|hydroxychloroquine|mesh-list
6725630|NCT01870128|Sulfasalazine|sulfasalazine|mesh-list
6725631|NCT01870128|Methylprednisolone|methylprednisolone|mesh-list
6725632|NCT01870128|Methotrexate|methotrexate|mesh-list
6725633|NCT01870128|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6725634|NCT01870128|Abortifacient Agents|abortifacient agents|mesh-ancestor
6725635|NCT01870128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6725636|NCT01870128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725637|NCT01870128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6725638|NCT01870128|Antimetabolites|antimetabolites|mesh-ancestor
6725639|NCT01870128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725640|NCT01870128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6725641|NCT01870128|Dermatologic Agents|dermatologic agents|mesh-ancestor
6725642|NCT01870128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6725643|NCT01870128|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6725644|NCT01870128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6725645|NCT01870128|Immunologic Factors|immunologic factors|mesh-ancestor
6725646|NCT01870128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6725647|NCT01870128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6725648|NCT01870128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6725649|NCT01870128|Antiemetics|antiemetics|mesh-ancestor
6725650|NCT01870128|Autonomic Agents|autonomic agents|mesh-ancestor
6725651|NCT01870128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6725652|NCT01870128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6725653|NCT01870128|Glucocorticoids|glucocorticoids|mesh-ancestor
6725654|NCT01870128|Hormones|hormones|mesh-ancestor
6725655|NCT01870128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6725656|NCT01870128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6725657|NCT01870128|Protective Agents|protective agents|mesh-ancestor
6725658|NCT01870128|Antimalarials|antimalarials|mesh-ancestor
6725659|NCT01870128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6725660|NCT01870128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6725661|NCT01870128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6725662|NCT01870128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6725663|NCT01870128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6725664|NCT01870128|Analgesics|analgesics|mesh-ancestor
6725665|NCT01870128|Sensory System Agents|sensory system agents|mesh-ancestor
6725666|NCT01870167|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6725667|NCT01870167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6725668|NCT01870167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6725669|NCT01870167|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6725670|NCT01870167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6725671|NCT01870167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725672|NCT01870219|Ketamine|ketamine|mesh-list
6725673|NCT01870219|Sevoflurane|sevoflurane|mesh-list
6725674|NCT01870219|Anesthetics|anesthetics|mesh-list
6725675|NCT01870219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
6725676|NCT01870219|Analgesics|analgesics|mesh-ancestor
6725677|NCT01870219|Sensory System Agents|sensory system agents|mesh-ancestor
6725678|NCT01870219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6725679|NCT01870219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725680|NCT01870219|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6725681|NCT01870219|Anesthetics, General|anesthetics, general|mesh-ancestor
6725682|NCT01870219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6725683|NCT01870219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6725684|NCT01870219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6725685|NCT01870219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6725686|NCT01870219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725687|NCT01870219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6725688|NCT01870219|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6725689|NCT01870284|Adalimumab|adalimumab|mesh-list
6725690|NCT01870284|Ixekizumab|ixekizumab|mesh-list
6725691|NCT01870284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6725692|NCT01870284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6725693|NCT01870284|Dermatologic Agents|dermatologic agents|mesh-ancestor
6725694|NCT01870427|Aflibercept|aflibercept|mesh-list
6725695|NCT01870427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6725696|NCT01870427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6725697|NCT01870427|Growth Substances|growth substances|mesh-ancestor
6725698|NCT01870427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725699|NCT01870427|Growth Inhibitors|growth inhibitors|mesh-ancestor
6725700|NCT01870427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6725701|NCT01870440|Dexamethasone|dexamethasone|mesh-list
6725702|NCT01870440|Dexamethasone acetate|dexamethasone acetate|mesh-list
6725703|NCT01870440|BB 1101|bb 1101|mesh-list
6725704|NCT01870440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6725705|NCT01870440|Antiemetics|antiemetics|mesh-ancestor
6725706|NCT01870440|Autonomic Agents|autonomic agents|mesh-ancestor
6725707|NCT01870440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6725708|NCT01870440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725709|NCT01870440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6725710|NCT01870440|Glucocorticoids|glucocorticoids|mesh-ancestor
6725711|NCT01870440|Hormones|hormones|mesh-ancestor
6725712|NCT01870440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6725713|NCT01870440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6725714|NCT01870440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6725715|NCT01870440|Protease Inhibitors|protease inhibitors|mesh-ancestor
6725716|NCT01870440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6725717|NCT01870440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725718|NCT01870466|Cilostazol|cilostazol|mesh-list
6725719|NCT01870466|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6725720|NCT01870466|Simvastatin|simvastatin|mesh-list
6725721|NCT01870466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6725722|NCT01870466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6725723|NCT01870466|Antimetabolites|antimetabolites|mesh-ancestor
6725724|NCT01870466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725725|NCT01870466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6725726|NCT01870466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6725727|NCT01870466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6725728|NCT01870466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6725729|NCT01870466|Autonomic Agents|autonomic agents|mesh-ancestor
6725730|NCT01870466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6725731|NCT01870466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725732|NCT01870466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6725733|NCT01870466|Respiratory System Agents|respiratory system agents|mesh-ancestor
6725734|NCT01870466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6725735|NCT01870466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6725736|NCT01870466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6725737|NCT01870466|Vasodilator Agents|vasodilator agents|mesh-ancestor
6725738|NCT01870466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6725739|NCT01870466|Protective Agents|protective agents|mesh-ancestor
6725740|NCT01870466|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6725741|NCT01870466|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6725742|NCT01870492|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6725743|NCT01870492|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6725744|NCT01870492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6725745|NCT01870492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725746|NCT01870505|Letrozole|letrozole|mesh-list
6725747|NCT01870505|Exemestane|exemestane|mesh-list
6725748|NCT01870505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6725749|NCT01870505|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6725750|NCT01870505|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6725751|NCT01870505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6725752|NCT01870505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725753|NCT01870505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6725754|NCT01870505|Hormone Antagonists|hormone antagonists|mesh-ancestor
6725755|NCT01870505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6725756|NCT01870505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725757|NCT01870635|Ondansetron|ondansetron|mesh-list
6725758|NCT01870635|Antiemetics|antiemetics|mesh-ancestor
6725759|NCT01870635|Autonomic Agents|autonomic agents|mesh-ancestor
6725760|NCT01870635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6725761|NCT01870635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725762|NCT01870635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6725763|NCT01870635|Antipruritics|antipruritics|mesh-ancestor
6725764|NCT01870635|Dermatologic Agents|dermatologic agents|mesh-ancestor
6725765|NCT01870635|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6725766|NCT01870635|Serotonin Agents|serotonin agents|mesh-ancestor
6725767|NCT01870635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6725768|NCT01870635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725769|NCT01870635|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6725770|NCT01870635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6725771|NCT01870635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6725772|NCT01870635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6725773|NCT01870635|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6725774|NCT01870648|Ondansetron|ondansetron|mesh-list
6725775|NCT01870648|Antiemetics|antiemetics|mesh-ancestor
6725776|NCT01870648|Autonomic Agents|autonomic agents|mesh-ancestor
6725777|NCT01870648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6725778|NCT01870648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725779|NCT01870648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6725780|NCT01870648|Antipruritics|antipruritics|mesh-ancestor
6725781|NCT01870648|Dermatologic Agents|dermatologic agents|mesh-ancestor
6725782|NCT01870648|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6725783|NCT01870648|Serotonin Agents|serotonin agents|mesh-ancestor
6725784|NCT01870648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6725785|NCT01870648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725786|NCT01870648|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6725787|NCT01870648|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6725788|NCT01870648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6725789|NCT01870648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6725790|NCT01870648|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6725791|NCT01870674|Prucalopride|prucalopride|mesh-list
6725792|NCT01870674|YH12852|yh12852|mesh-list
6725793|NCT01870674|Laxatives|laxatives|mesh-ancestor
6725794|NCT01870674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6725795|NCT01870674|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
6725796|NCT01870674|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6725797|NCT01870674|Serotonin Agents|serotonin agents|mesh-ancestor
6725798|NCT01870674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6725799|NCT01870674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725800|NCT01870674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725801|NCT01870804|Atorvastatin|atorvastatin|mesh-list
6725802|NCT01870804|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6725803|NCT01870804|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6725804|NCT01870804|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6725805|NCT01870804|Antimetabolites|antimetabolites|mesh-ancestor
6725806|NCT01870804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725807|NCT01870804|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6725808|NCT01870804|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6725809|NCT01870804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6725810|NCT01870895|Ramosetron|ramosetron|mesh-list
6725811|NCT01870895|Antiemetics|antiemetics|mesh-ancestor
6725812|NCT01870895|Autonomic Agents|autonomic agents|mesh-ancestor
6725813|NCT01870895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6725814|NCT01870895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725815|NCT01870895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6725816|NCT01870895|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6725817|NCT01870895|Serotonin Agents|serotonin agents|mesh-ancestor
6725818|NCT01870895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6725819|NCT01870895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725820|NCT01870908|Tacrolimus|tacrolimus|mesh-list
6725821|NCT01870908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6725822|NCT01870908|Immunologic Factors|immunologic factors|mesh-ancestor
6725823|NCT01870908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725824|NCT01870908|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6725825|NCT01870908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6725826|NCT01870908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725827|NCT01870986|Adalimumab|adalimumab|mesh-list
6725828|NCT01870986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6725829|NCT01870986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6725830|NCT01871129|Dexmedetomidine|dexmedetomidine|mesh-list
6725831|NCT01871129|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6725832|NCT01871129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6725833|NCT01871129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725834|NCT01871129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6725835|NCT01871129|Analgesics|analgesics|mesh-ancestor
6725836|NCT01871129|Sensory System Agents|sensory system agents|mesh-ancestor
6725837|NCT01871129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6725838|NCT01871129|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6725839|NCT01871129|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6725840|NCT01871129|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6725841|NCT01871129|Adrenergic Agents|adrenergic agents|mesh-ancestor
6725842|NCT01871129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6725843|NCT01871129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725844|NCT01871311|Cetuximab|cetuximab|mesh-list
6725845|NCT01871311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6725846|NCT01871311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6784725|NCT02204644|HH-GV-678|hh-gv-678|mesh-list
6784726|NCT02204644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6784727|NCT02204644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6784728|NCT02204644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6784729|NCT02204644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784730|NCT02204683|Aflibercept|aflibercept|mesh-list
6784731|NCT02204683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6784732|NCT02204683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6784733|NCT02204683|Growth Substances|growth substances|mesh-ancestor
6784734|NCT02204683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784735|NCT02204683|Growth Inhibitors|growth inhibitors|mesh-ancestor
6784736|NCT02204683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6784737|NCT02204722|Imatinib Mesylate|imatinib mesylate|mesh-list
6784738|NCT02204722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6784739|NCT02204722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6784740|NCT02204722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6784741|NCT02204722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784742|NCT02204839|Insulin|insulin|mesh-list
6784743|NCT02204839|Insulin Glargine|insulin glargine|mesh-list
6784744|NCT02204839|Insulin Detemir|insulin detemir|mesh-list
6784745|NCT02204839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6784746|NCT02204839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784747|NCT02204852|Iloprost|iloprost|mesh-list
6784748|NCT02204852|Eptifibatide|eptifibatide|mesh-list
6784749|NCT02204852|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6784750|NCT02204852|Vasodilator Agents|vasodilator agents|mesh-ancestor
6784751|NCT02204878|Parecoxib|parecoxib|mesh-list
6784752|NCT02204878|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6784753|NCT02204878|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6784754|NCT02204878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6784755|NCT02204878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784756|NCT02204878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6784757|NCT02204878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6784758|NCT02204878|Analgesics|analgesics|mesh-ancestor
6784759|NCT02204878|Sensory System Agents|sensory system agents|mesh-ancestor
6784760|NCT02204878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6784761|NCT02204878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784762|NCT02204878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6784763|NCT02204878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6784764|NCT02205034|Oxytocin|oxytocin|mesh-list
6784765|NCT02205034|Oxytocics|oxytocics|mesh-ancestor
6784766|NCT02205034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6784767|NCT02205034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784768|NCT02205047|Fluorouracil|fluorouracil|mesh-list
6784769|NCT02205047|Capecitabine|capecitabine|mesh-list
6784770|NCT02205047|Trastuzumab|trastuzumab|mesh-list
6784771|NCT02205047|Pertuzumab|pertuzumab|mesh-list
6784772|NCT02205047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6784773|NCT02205047|Antimetabolites|antimetabolites|mesh-ancestor
6784774|NCT02205047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784775|NCT02205047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6784776|NCT02205047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6784777|NCT02205047|Immunologic Factors|immunologic factors|mesh-ancestor
6784778|NCT02205047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784779|NCT02205047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6784780|NCT02205112|Levofloxacin|levofloxacin|mesh-list
6784781|NCT02205112|Ofloxacin|ofloxacin|mesh-list
6784782|NCT02205112|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6784783|NCT02205112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6784784|NCT02205112|Renal Agents|renal agents|mesh-ancestor
6784785|NCT02205112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6784786|NCT02205112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6784787|NCT02205112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6784788|NCT02205112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6784789|NCT02205112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784790|NCT02205112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6784791|NCT02205112|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6784792|NCT02205112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6784793|NCT02205151|Amlodipine|amlodipine|mesh-list
6784794|NCT02205151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6725847|NCT01871363|Capecitabine|capecitabine|mesh-list
6725848|NCT01871363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6725849|NCT01871363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6725850|NCT01871363|Antimetabolites|antimetabolites|mesh-ancestor
6725851|NCT01871363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725852|NCT01871376|Aflibercept|aflibercept|mesh-list
6725853|NCT01871376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6725854|NCT01871376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6725855|NCT01871376|Growth Substances|growth substances|mesh-ancestor
6725856|NCT01871376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725857|NCT01871376|Growth Inhibitors|growth inhibitors|mesh-ancestor
6725858|NCT01871376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6725859|NCT01871454|Pentoxifylline|pentoxifylline|mesh-list
6725860|NCT01871454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6725861|NCT01871454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6725862|NCT01871454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725863|NCT01871454|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6725864|NCT01871454|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6725865|NCT01871454|Protective Agents|protective agents|mesh-ancestor
6725866|NCT01871454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725867|NCT01871454|Vasodilator Agents|vasodilator agents|mesh-ancestor
6725868|NCT01871454|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6725869|NCT01871454|Antioxidants|antioxidants|mesh-ancestor
6725870|NCT01871467|Sargramostim|sargramostim|mesh-list
6725871|NCT01871467|Immunologic Factors|immunologic factors|mesh-ancestor
6725872|NCT01871467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725873|NCT01871480|Gefitinib|gefitinib|mesh-list
6725874|NCT01871480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6725875|NCT01871480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6725876|NCT01871480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6725877|NCT01871480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725878|NCT01871493|Insulin Lispro|insulin lispro|mesh-list
6725879|NCT01871493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6725880|NCT01871493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725881|NCT01871571|Leucovorin|leucovorin|mesh-list
6725882|NCT01871571|Bevacizumab|bevacizumab|mesh-list
6725883|NCT01871571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6725884|NCT01871571|Fluorouracil|fluorouracil|mesh-list
6725885|NCT01871571|Oxaliplatin|oxaliplatin|mesh-list
6725886|NCT01871571|Antibodies|antibodies|mesh-list
6725887|NCT01871571|Immunoglobulins|immunoglobulins|mesh-list
6725888|NCT01871571|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6725889|NCT01871571|Levoleucovorin|levoleucovorin|mesh-list
6725890|NCT01871571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6725891|NCT01871571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6725892|NCT01871571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6725893|NCT01871571|Growth Substances|growth substances|mesh-ancestor
6725894|NCT01871571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725895|NCT01871571|Growth Inhibitors|growth inhibitors|mesh-ancestor
6725896|NCT01871571|Immunologic Factors|immunologic factors|mesh-ancestor
6725897|NCT01871571|Antimetabolites|antimetabolites|mesh-ancestor
6725898|NCT01871571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725899|NCT01871571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6725900|NCT01871571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6725901|NCT01871571|Antidotes|antidotes|mesh-ancestor
6725902|NCT01871571|Protective Agents|protective agents|mesh-ancestor
6725903|NCT01871571|Vitamin B Complex|vitamin b complex|mesh-ancestor
6725904|NCT01871571|Vitamins|vitamins|mesh-ancestor
6725905|NCT01871571|Micronutrients|micronutrients|mesh-ancestor
6725906|NCT01871649|Golimumab|golimumab|mesh-list
6725907|NCT01871649|Methotrexate|methotrexate|mesh-list
6725908|NCT01871649|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6725909|NCT01871649|Abortifacient Agents|abortifacient agents|mesh-ancestor
6725910|NCT01871649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6725911|NCT01871649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725912|NCT01871649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6725913|NCT01871649|Antimetabolites|antimetabolites|mesh-ancestor
6725914|NCT01871649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725915|NCT01871649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6725916|NCT01871649|Dermatologic Agents|dermatologic agents|mesh-ancestor
6725917|NCT01871649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6725918|NCT01871649|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6725919|NCT01871649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6725920|NCT01871649|Immunologic Factors|immunologic factors|mesh-ancestor
6725921|NCT01871649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6725922|NCT01871649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6725923|NCT01871649|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6725924|NCT01871649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6725925|NCT01871662|Interferons|interferons|mesh-list
6725926|NCT01871662|Ribavirin|ribavirin|mesh-list
6725927|NCT01871662|Interferon-alpha|interferon-alpha|mesh-list
6725928|NCT01871662|Interferon alpha-2|interferon alpha-2|mesh-list
6725929|NCT01871662|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6725930|NCT01871662|Silybin|silybin|mesh-list
6725931|NCT01871662|Silymarin|silymarin|mesh-list
6725932|NCT01871662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6725933|NCT01871662|Antiviral Agents|antiviral agents|mesh-ancestor
6725934|NCT01871662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6725935|NCT01871662|Antimetabolites|antimetabolites|mesh-ancestor
6725936|NCT01871662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725937|NCT01871662|Immunologic Factors|immunologic factors|mesh-ancestor
6725938|NCT01871662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725939|NCT01871662|Antioxidants|antioxidants|mesh-ancestor
6725940|NCT01871662|Protective Agents|protective agents|mesh-ancestor
6725941|NCT01871662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6725942|NCT01871675|Rituximab|rituximab|mesh-list
6725943|NCT01871675|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6725944|NCT01871675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6725945|NCT01871675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6725946|NCT01871675|Immunologic Factors|immunologic factors|mesh-ancestor
6725947|NCT01871675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725948|NCT01871675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6725949|NCT01871675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6725950|NCT01871675|Alkylating Agents|alkylating agents|mesh-ancestor
6725951|NCT01871675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725952|NCT01871701|Moxifloxacin|moxifloxacin|mesh-list
6725953|NCT01871701|Dexetimide|dexetimide|mesh-list
6725954|NCT01871701|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6725955|NCT01871701|Citalopram|citalopram|mesh-list
6725956|NCT01871701|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6725957|NCT01871701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6725958|NCT01871701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6725959|NCT01871701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6725960|NCT01871701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6725961|NCT01871701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6725962|NCT01871701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6725963|NCT01871701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6725964|NCT01871701|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6725965|NCT01871701|Contraceptive Agents|contraceptive agents|mesh-ancestor
6725966|NCT01871701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6725967|NCT01871701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725968|NCT01871701|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6725969|NCT01871701|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6725970|NCT01871701|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6725971|NCT01871701|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6725972|NCT01871701|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6725973|NCT01871701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6725974|NCT01871701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6725975|NCT01871701|Serotonin Agents|serotonin agents|mesh-ancestor
6725976|NCT01871701|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6725977|NCT01871701|Antidepressive Agents|antidepressive agents|mesh-ancestor
6725978|NCT01871701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6725979|NCT01871701|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6725980|NCT01871701|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6725981|NCT01871701|Parasympatholytics|parasympatholytics|mesh-ancestor
6725982|NCT01871701|Autonomic Agents|autonomic agents|mesh-ancestor
6725983|NCT01871701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6725984|NCT01871701|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6725985|NCT01871701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6725986|NCT01871701|Cholinergic Agents|cholinergic agents|mesh-ancestor
6725987|NCT01871701|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6725988|NCT01871701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6725989|NCT01871701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6725990|NCT01871740|Folic Acid|folic acid|mesh-list
6725991|NCT01871740|Enalapril|enalapril|mesh-list
6725992|NCT01871740|Enalaprilat|enalaprilat|mesh-list
6725993|NCT01871740|Maleic acid|maleic acid|mesh-list
6725994|NCT01871740|Hematinics|hematinics|mesh-ancestor
6725995|NCT01871740|Vitamin B Complex|vitamin b complex|mesh-ancestor
6725996|NCT01871740|Vitamins|vitamins|mesh-ancestor
6725997|NCT01871740|Micronutrients|micronutrients|mesh-ancestor
6725998|NCT01871740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6725999|NCT01871740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6726000|NCT01871740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726001|NCT01871740|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6726002|NCT01871740|Protease Inhibitors|protease inhibitors|mesh-ancestor
6726003|NCT01871740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6726004|NCT01871753|Anti-Infective Agents|anti-infective agents|mesh-list
6726005|NCT01871766|Dactinomycin|dactinomycin|mesh-list
6726006|NCT01871766|Cyclophosphamide|cyclophosphamide|mesh-list
6726007|NCT01871766|Ifosfamide|ifosfamide|mesh-list
6726008|NCT01871766|Bevacizumab|bevacizumab|mesh-list
6726009|NCT01871766|Doxorubicin|doxorubicin|mesh-list
6726010|NCT01871766|Irinotecan|irinotecan|mesh-list
6726011|NCT01871766|Etoposide|etoposide|mesh-list
6726012|NCT01871766|Etoposide phosphate|etoposide phosphate|mesh-list
6726013|NCT01871766|Vincristine|vincristine|mesh-list
6726014|NCT01871766|Sorafenib|sorafenib|mesh-list
6726015|NCT01871766|Dexrazoxane|dexrazoxane|mesh-list
6726016|NCT01871766|Razoxane|razoxane|mesh-list
6726017|NCT01871766|Mitogens|mitogens|mesh-list
6726018|NCT01871766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6726019|NCT01871766|Immunologic Factors|immunologic factors|mesh-ancestor
6726020|NCT01871766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726021|NCT01871766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6726022|NCT01871766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6726023|NCT01871766|Alkylating Agents|alkylating agents|mesh-ancestor
6726024|NCT01871766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726025|NCT01871766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6726026|NCT01871766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6726027|NCT01871766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6726028|NCT01871766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6726029|NCT01871766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6726030|NCT01871766|Growth Substances|growth substances|mesh-ancestor
6726031|NCT01871766|Growth Inhibitors|growth inhibitors|mesh-ancestor
6726032|NCT01871766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6726033|NCT01871766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6726034|NCT01871766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6726035|NCT01871766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6726036|NCT01871766|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6726037|NCT01871766|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6726038|NCT01871766|Tubulin Modulators|tubulin modulators|mesh-ancestor
6726039|NCT01871766|Antimitotic Agents|antimitotic agents|mesh-ancestor
6726040|NCT01871766|Mitosis Modulators|mitosis modulators|mesh-ancestor
6726041|NCT01871766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6726042|NCT01871766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6726043|NCT01871766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6726044|NCT01871766|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6726045|NCT01871766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6726046|NCT01871766|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6726047|NCT01871766|Protective Agents|protective agents|mesh-ancestor
6726048|NCT01871792|Pitavastatin|pitavastatin|mesh-list
6726049|NCT01871792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6726050|NCT01871792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6726051|NCT01871792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6726052|NCT01871792|Antimetabolites|antimetabolites|mesh-ancestor
6726053|NCT01871792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726054|NCT01871792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6726055|NCT01871792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6726056|NCT01871844|Octreotide|octreotide|mesh-list
6726057|NCT01871844|Somatostatin|somatostatin|mesh-list
6726058|NCT01871844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6726059|NCT01871844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6726060|NCT01871844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6726061|NCT01871844|Hormones|hormones|mesh-ancestor
6726062|NCT01871844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6726063|NCT01871844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726064|NCT01871857|Epinephrine|epinephrine|mesh-list
6726065|NCT01871857|Racepinephrine|racepinephrine|mesh-list
6726066|NCT01871857|Epinephryl borate|epinephryl borate|mesh-list
6726067|NCT01871857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6726068|NCT01871857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6726069|NCT01871857|Adrenergic Agents|adrenergic agents|mesh-ancestor
6726070|NCT01871857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6726071|NCT01871857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726072|NCT01871857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726073|NCT01871857|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6726074|NCT01871857|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6726075|NCT01871857|Autonomic Agents|autonomic agents|mesh-ancestor
6726076|NCT01871857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6726077|NCT01871857|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6726078|NCT01871857|Respiratory System Agents|respiratory system agents|mesh-ancestor
6726079|NCT01871857|Mydriatics|mydriatics|mesh-ancestor
6726080|NCT01871857|Sympathomimetics|sympathomimetics|mesh-ancestor
6726081|NCT01871857|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6726082|NCT01871922|Atropine|atropine|mesh-list
6726083|NCT01871922|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6726084|NCT01871922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6726085|NCT01871922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6726086|NCT01871922|Autonomic Agents|autonomic agents|mesh-ancestor
6726087|NCT01871922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6726088|NCT01871922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726089|NCT01871922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6726090|NCT01871922|Respiratory System Agents|respiratory system agents|mesh-ancestor
6726091|NCT01871922|Mydriatics|mydriatics|mesh-ancestor
6726092|NCT01871922|Parasympatholytics|parasympatholytics|mesh-ancestor
6726093|NCT01871922|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6726094|NCT01871922|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6726095|NCT01871922|Cholinergic Agents|cholinergic agents|mesh-ancestor
6726096|NCT01871922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6726097|NCT01871922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726098|NCT01871935|Sufentanil|sufentanil|mesh-list
6726099|NCT01871935|Remifentanil|remifentanil|mesh-list
6726100|NCT01871935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6726101|NCT01871935|Narcotics|narcotics|mesh-ancestor
6726102|NCT01871935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6726103|NCT01871935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726104|NCT01871935|Analgesics|analgesics|mesh-ancestor
6726105|NCT01871935|Sensory System Agents|sensory system agents|mesh-ancestor
6726106|NCT01871935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6726107|NCT01871935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6726108|NCT01871935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6726109|NCT01871935|Anesthetics, General|anesthetics, general|mesh-ancestor
6726110|NCT01871935|Anesthetics|anesthetics|mesh-ancestor
6726111|NCT01871961|Methotrexate|methotrexate|mesh-list
6726112|NCT01871961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6726113|NCT01871961|Abortifacient Agents|abortifacient agents|mesh-ancestor
6726114|NCT01871961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6726115|NCT01871961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726116|NCT01871961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6726117|NCT01871961|Antimetabolites|antimetabolites|mesh-ancestor
6726118|NCT01871961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726119|NCT01871961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6726120|NCT01871961|Dermatologic Agents|dermatologic agents|mesh-ancestor
6726121|NCT01871961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6726122|NCT01871961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6726123|NCT01871961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6726124|NCT01871961|Immunologic Factors|immunologic factors|mesh-ancestor
6726125|NCT01871961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6726126|NCT01871961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6726127|NCT01871974|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6726128|NCT01871974|Antidepressive Agents|antidepressive agents|mesh-ancestor
6726129|NCT01871974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6726130|NCT01871974|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6726131|NCT01871974|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6726132|NCT01871974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6726133|NCT01871974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726134|NCT01871987|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6726135|NCT01871987|Antidepressive Agents|antidepressive agents|mesh-ancestor
6726136|NCT01871987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6726137|NCT01871987|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6726138|NCT01871987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6726139|NCT01871987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6726140|NCT01871987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726141|NCT01872013|ASP7991|asp7991|mesh-list
6726142|NCT01872013|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6726143|NCT01872013|Hormone Antagonists|hormone antagonists|mesh-ancestor
6726144|NCT01872013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6726145|NCT01872013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726146|NCT01872026|ASP7991|asp7991|mesh-list
6726147|NCT01872026|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6726148|NCT01872026|Hormone Antagonists|hormone antagonists|mesh-ancestor
6726149|NCT01872026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6726150|NCT01872026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726151|NCT01872039|Nicardipine|nicardipine|mesh-list
6726152|NCT01872039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6726153|NCT01872039|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6726154|NCT01872039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6726155|NCT01872039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726156|NCT01872039|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6726157|NCT01872039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726158|NCT01872039|Vasodilator Agents|vasodilator agents|mesh-ancestor
6726159|NCT01872351|Thioctic Acid|thioctic acid|mesh-list
6726160|NCT01872351|Acetylcarnitine|acetylcarnitine|mesh-list
6726161|NCT01872351|Antioxidants|antioxidants|mesh-ancestor
6726162|NCT01872351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726163|NCT01872351|Protective Agents|protective agents|mesh-ancestor
6726164|NCT01872351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726165|NCT01872351|Vitamin B Complex|vitamin b complex|mesh-ancestor
6726166|NCT01872351|Vitamins|vitamins|mesh-ancestor
6726167|NCT01872351|Micronutrients|micronutrients|mesh-ancestor
6726168|NCT01872351|Nootropic Agents|nootropic agents|mesh-ancestor
6726169|NCT01872403|Paclitaxel|paclitaxel|mesh-list
6726170|NCT01872403|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6726171|NCT01872403|Carboplatin|carboplatin|mesh-list
6726172|NCT01872403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6726173|NCT01872403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6726174|NCT01872403|Tubulin Modulators|tubulin modulators|mesh-ancestor
6726175|NCT01872403|Antimitotic Agents|antimitotic agents|mesh-ancestor
6726176|NCT01872403|Mitosis Modulators|mitosis modulators|mesh-ancestor
6726177|NCT01872403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726178|NCT01872416|Doxorubicin|doxorubicin|mesh-list
6726179|NCT01872416|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6726180|NCT01872416|Ifosfamide|ifosfamide|mesh-list
6726181|NCT01872416|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6726182|NCT01872416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6726183|NCT01872416|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6726184|NCT01872416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6726185|NCT01872416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6726186|NCT01872416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726187|NCT01872416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6726188|NCT01872416|Alkylating Agents|alkylating agents|mesh-ancestor
6726189|NCT01872442|Interferons|interferons|mesh-list
6726190|NCT01872442|Interferon-alpha|interferon-alpha|mesh-list
6726191|NCT01872442|Interferon alpha-2|interferon alpha-2|mesh-list
6726192|NCT01872442|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6726193|NCT01872442|Dasatinib|dasatinib|mesh-list
6726194|NCT01872442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6726195|NCT01872442|Antiviral Agents|antiviral agents|mesh-ancestor
6726196|NCT01872442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6726197|NCT01872442|Immunologic Factors|immunologic factors|mesh-ancestor
6726198|NCT01872442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726199|NCT01872442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6726200|NCT01872442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6726201|NCT01872442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726202|NCT01872494|Flurbiprofen|flurbiprofen|mesh-list
6726203|NCT01872494|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
6726204|NCT01872494|Pentazocine|pentazocine|mesh-list
6726205|NCT01872494|Palonosetron|palonosetron|mesh-list
6726206|NCT01872494|Ropivacaine|ropivacaine|mesh-list
6726207|NCT01872494|Anesthetics, Local|anesthetics, local|mesh-ancestor
6726208|NCT01872494|Anesthetics|anesthetics|mesh-ancestor
6726209|NCT01872494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6726210|NCT01872494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726211|NCT01872494|Sensory System Agents|sensory system agents|mesh-ancestor
6726212|NCT01872494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6726213|NCT01872494|Antiemetics|antiemetics|mesh-ancestor
6726214|NCT01872494|Autonomic Agents|autonomic agents|mesh-ancestor
6726215|NCT01872494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6726216|NCT01872494|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6726217|NCT01872494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6726218|NCT01872494|Serotonin Agents|serotonin agents|mesh-ancestor
6726219|NCT01872494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6726220|NCT01872494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726221|NCT01872494|Analgesics|analgesics|mesh-ancestor
6726222|NCT01872494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6726223|NCT01872494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6726224|NCT01872494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6726225|NCT01872494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6726226|NCT01872494|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6726227|NCT01872494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6726228|NCT01872494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6726229|NCT01872494|Narcotics|narcotics|mesh-ancestor
6726230|NCT01872494|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6726231|NCT01872494|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6726232|NCT01872546|Adalimumab|adalimumab|mesh-list
6726233|NCT01872546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6726234|NCT01872546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6726235|NCT01872702|Piperaquine|piperaquine|mesh-list
6726236|NCT01872702|Primaquine|primaquine|mesh-list
6726237|NCT01872702|Artenimol|artenimol|mesh-list
6726238|NCT01872702|Antimalarials|antimalarials|mesh-ancestor
6726239|NCT01872702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6726240|NCT01872702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6726241|NCT01872702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6726242|NCT01872728|Anesthetics|anesthetics|mesh-list
6726243|NCT01872728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6726244|NCT01872728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726245|NCT01872754|Remifentanil|remifentanil|mesh-list
6726246|NCT01872754|Propofol|propofol|mesh-list
6726247|NCT01872754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6726248|NCT01872754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6726249|NCT01872754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726250|NCT01872754|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6726251|NCT01872754|Anesthetics, General|anesthetics, general|mesh-ancestor
6726252|NCT01872754|Anesthetics|anesthetics|mesh-ancestor
6726253|NCT01872754|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6726254|NCT01872754|Narcotics|narcotics|mesh-ancestor
6726255|NCT01872754|Analgesics|analgesics|mesh-ancestor
6726256|NCT01872754|Sensory System Agents|sensory system agents|mesh-ancestor
6726257|NCT01872754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6726258|NCT01872780|Rosiglitazone|rosiglitazone|mesh-list
6726259|NCT01872780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6726260|NCT01872780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726261|NCT01872832|Verinurad|verinurad|mesh-list
6726262|NCT01872832|Gout Suppressants|gout suppressants|mesh-ancestor
6726263|NCT01872832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6726264|NCT01872845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6726265|NCT01872845|Pravastatin|pravastatin|mesh-list
6726266|NCT01872845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6726267|NCT01872845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6726268|NCT01872845|Antimetabolites|antimetabolites|mesh-ancestor
6726269|NCT01872845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726270|NCT01872845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6784795|NCT02205151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6726271|NCT01872845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6726272|NCT01872845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6726273|NCT01872858|Aspirin|aspirin|mesh-list
6726274|NCT01872858|Cilostazol|cilostazol|mesh-list
6726275|NCT01872858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6726276|NCT01872858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6726277|NCT01872858|Analgesics|analgesics|mesh-ancestor
6726278|NCT01872858|Sensory System Agents|sensory system agents|mesh-ancestor
6726279|NCT01872858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6726280|NCT01872858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726281|NCT01872858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6726282|NCT01872858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6726283|NCT01872858|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6726284|NCT01872858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6726285|NCT01872858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726286|NCT01872858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6726287|NCT01872858|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6726288|NCT01872858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6726289|NCT01872858|Antipyretics|antipyretics|mesh-ancestor
6726290|NCT01872858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6726291|NCT01872858|Autonomic Agents|autonomic agents|mesh-ancestor
6726292|NCT01872858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6726293|NCT01872858|Respiratory System Agents|respiratory system agents|mesh-ancestor
6726294|NCT01872858|Vasodilator Agents|vasodilator agents|mesh-ancestor
6726295|NCT01872858|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6726296|NCT01872858|Protective Agents|protective agents|mesh-ancestor
6726297|NCT01872858|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6726298|NCT01872858|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6726299|NCT01872871|Acetaminophen|acetaminophen|mesh-list
6726300|NCT01872871|Anesthetics|anesthetics|mesh-list
6726301|NCT01872871|Anesthetics, Local|anesthetics, local|mesh-list
6726302|NCT01872871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6726303|NCT01872871|Analgesics|analgesics|mesh-ancestor
6726304|NCT01872871|Sensory System Agents|sensory system agents|mesh-ancestor
6726305|NCT01872871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6726306|NCT01872871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726307|NCT01872871|Antipyretics|antipyretics|mesh-ancestor
6726308|NCT01872871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6726309|NCT01872884|Remifentanil|remifentanil|mesh-list
6726310|NCT01872884|Sevoflurane|sevoflurane|mesh-list
6726311|NCT01872884|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6726312|NCT01872884|Narcotics|narcotics|mesh-ancestor
6726313|NCT01872884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6726314|NCT01872884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726315|NCT01872884|Analgesics|analgesics|mesh-ancestor
6726316|NCT01872884|Sensory System Agents|sensory system agents|mesh-ancestor
6726317|NCT01872884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6726318|NCT01872884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6726319|NCT01872884|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6726320|NCT01872884|Anesthetics, General|anesthetics, general|mesh-ancestor
6726321|NCT01872884|Anesthetics|anesthetics|mesh-ancestor
6726322|NCT01872897|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
6726323|NCT01872897|Antacids|antacids|mesh-ancestor
6726324|NCT01872897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726325|NCT01872897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6726326|NCT01872923|Bleomycin|bleomycin|mesh-list
6726327|NCT01872923|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6726328|NCT01872923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6726329|NCT01872936|Ribavirin|ribavirin|mesh-list
6726330|NCT01872936|Antimetabolites|antimetabolites|mesh-ancestor
6726331|NCT01872936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726332|NCT01872936|Antiviral Agents|antiviral agents|mesh-ancestor
6726333|NCT01872936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6784796|NCT02205151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6784797|NCT02205151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784798|NCT02205151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6784799|NCT02205151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784800|NCT02205151|Vasodilator Agents|vasodilator agents|mesh-ancestor
6784801|NCT02205164|Aprepitant|aprepitant|mesh-list
6784802|NCT02205164|Palonosetron|palonosetron|mesh-list
6784803|NCT02205164|Antiemetics|antiemetics|mesh-ancestor
6784804|NCT02205164|Autonomic Agents|autonomic agents|mesh-ancestor
6784805|NCT02205164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6784806|NCT02205164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726334|NCT01872962|Gemcitabine|gemcitabine|mesh-list
6726335|NCT01872962|Cisplatin|cisplatin|mesh-list
6726336|NCT01872962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6726337|NCT01872962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6726338|NCT01872962|Antimetabolites|antimetabolites|mesh-ancestor
6726339|NCT01872962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726340|NCT01872962|Antiviral Agents|antiviral agents|mesh-ancestor
6726341|NCT01872962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6726342|NCT01872962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6726343|NCT01872962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6726344|NCT01872962|Immunologic Factors|immunologic factors|mesh-ancestor
6726345|NCT01872962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726346|NCT01872988|Tenofovir|tenofovir|mesh-list
6726347|NCT01872988|Antiviral Agents|antiviral agents|mesh-ancestor
6726348|NCT01872988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6726349|NCT01872988|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6726350|NCT01872988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6726351|NCT01872988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6726352|NCT01872988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726353|NCT01872988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6726354|NCT01872988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6726355|NCT01873001|Pioglitazone|pioglitazone|mesh-list
6726356|NCT01873001|Abiraterone Acetate|abiraterone acetate|mesh-list
6726357|NCT01873001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6726358|NCT01873001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726359|NCT01873001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6726360|NCT01873001|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6726361|NCT01873001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6726362|NCT01873001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726363|NCT01873001|Hormone Antagonists|hormone antagonists|mesh-ancestor
6726364|NCT01873001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6726365|NCT01873001|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6726366|NCT01873027|Sirolimus|sirolimus|mesh-list
6726367|NCT01873027|Umirolimus|umirolimus|mesh-list
6726368|NCT01873027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6726369|NCT01873027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6726370|NCT01873027|Immunologic Factors|immunologic factors|mesh-ancestor
6726371|NCT01873027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726372|NCT01873027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6726373|NCT01873027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6726374|NCT01873027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6726375|NCT01873027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6726376|NCT01873027|Antifungal Agents|antifungal agents|mesh-ancestor
6726377|NCT01873079|Esomeprazole|esomeprazole|mesh-list
6726378|NCT01873079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6726379|NCT01873079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6726380|NCT01873079|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6726381|NCT01873079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6726382|NCT01873079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726383|NCT01873131|Timolol|timolol|mesh-list
6726384|NCT01873131|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6726385|NCT01873131|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6726386|NCT01873131|Adrenergic Agents|adrenergic agents|mesh-ancestor
6726387|NCT01873131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6726388|NCT01873131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726389|NCT01873131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726390|NCT01873131|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6726391|NCT01873131|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6726392|NCT01873144|Epinephrine|epinephrine|mesh-list
6726393|NCT01873144|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6726394|NCT01873144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6726395|NCT01873144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6726396|NCT01873144|Adrenergic Agents|adrenergic agents|mesh-ancestor
6726397|NCT01873144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6726398|NCT01873144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726399|NCT01873144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726400|NCT01873144|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6726401|NCT01873144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6726402|NCT01873144|Autonomic Agents|autonomic agents|mesh-ancestor
6726403|NCT01873144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6726404|NCT01873144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6726405|NCT01873144|Respiratory System Agents|respiratory system agents|mesh-ancestor
6726406|NCT01873144|Mydriatics|mydriatics|mesh-ancestor
6726407|NCT01873144|Sympathomimetics|sympathomimetics|mesh-ancestor
6726408|NCT01873144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6726409|NCT01873157|Bortezomib|bortezomib|mesh-list
6726410|NCT01873157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6726411|NCT01873222|Sirolimus|sirolimus|mesh-list
6726412|NCT01873222|Umirolimus|umirolimus|mesh-list
6726413|NCT01873222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6726414|NCT01873222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6726415|NCT01873222|Immunologic Factors|immunologic factors|mesh-ancestor
6726416|NCT01873222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726417|NCT01873222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6726418|NCT01873222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6726419|NCT01873222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6726420|NCT01873222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6726421|NCT01873222|Antifungal Agents|antifungal agents|mesh-ancestor
6726422|NCT01873313|Ropivacaine|ropivacaine|mesh-list
6726423|NCT01873313|Anesthetics, Local|anesthetics, local|mesh-ancestor
6726424|NCT01873313|Anesthetics|anesthetics|mesh-ancestor
6726425|NCT01873313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6726426|NCT01873313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726427|NCT01873313|Sensory System Agents|sensory system agents|mesh-ancestor
6726428|NCT01873313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6726429|NCT01873326|Paclitaxel|paclitaxel|mesh-list
6726430|NCT01873326|Etoposide|etoposide|mesh-list
6726431|NCT01873326|Ifosfamide|ifosfamide|mesh-list
6726432|NCT01873326|Bleomycin|bleomycin|mesh-list
6726433|NCT01873326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6726434|NCT01873326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6726435|NCT01873326|Tubulin Modulators|tubulin modulators|mesh-ancestor
6726436|NCT01873326|Antimitotic Agents|antimitotic agents|mesh-ancestor
6726437|NCT01873326|Mitosis Modulators|mitosis modulators|mesh-ancestor
6726438|NCT01873326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726439|NCT01873326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6726440|NCT01873326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6726441|NCT01873326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6726442|NCT01873326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6726443|NCT01873326|Alkylating Agents|alkylating agents|mesh-ancestor
6726444|NCT01873326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6726445|NCT01873339|Midazolam|midazolam|mesh-list
6726446|NCT01873339|Darapladib|darapladib|mesh-list
6726447|NCT01873339|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6726448|NCT01873339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6726449|NCT01873339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6726450|NCT01873339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726451|NCT01873339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6726452|NCT01873339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6726453|NCT01873339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6726454|NCT01873339|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6726455|NCT01873339|Anesthetics, General|anesthetics, general|mesh-ancestor
6726456|NCT01873339|Anesthetics|anesthetics|mesh-ancestor
6726457|NCT01873339|GABA Modulators|gaba modulators|mesh-ancestor
6726458|NCT01873339|GABA Agents|gaba agents|mesh-ancestor
6726459|NCT01873339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6726460|NCT01873339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726461|NCT01873339|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
6726462|NCT01873339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6726463|NCT01873378|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6726464|NCT01873378|Luteolytic Agents|luteolytic agents|mesh-ancestor
6726465|NCT01873378|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6726466|NCT01873378|Contraceptive Agents|contraceptive agents|mesh-ancestor
6726467|NCT01873378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6726468|NCT01873378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726469|NCT01873378|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6726470|NCT01873378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6726471|NCT01873378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6726472|NCT01873430|Melatonin|melatonin|mesh-list
6726473|NCT01873430|Antioxidants|antioxidants|mesh-ancestor
6726474|NCT01873430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726475|NCT01873430|Protective Agents|protective agents|mesh-ancestor
6726476|NCT01873430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726477|NCT01873430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6726478|NCT01873443|Folic Acid|folic acid|mesh-list
6726479|NCT01873443|Rituximab|rituximab|mesh-list
6726480|NCT01873443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6726481|NCT01873443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6726482|NCT01873443|Immunologic Factors|immunologic factors|mesh-ancestor
6726483|NCT01873443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726484|NCT01873443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6726485|NCT01873443|Hematinics|hematinics|mesh-ancestor
6726486|NCT01873443|Vitamin B Complex|vitamin b complex|mesh-ancestor
6726487|NCT01873443|Vitamins|vitamins|mesh-ancestor
6726488|NCT01873443|Micronutrients|micronutrients|mesh-ancestor
6726489|NCT01873573|Triamcinolone|triamcinolone|mesh-list
6726490|NCT01873573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6726491|NCT01873573|Glucocorticoids|glucocorticoids|mesh-ancestor
6726492|NCT01873573|Hormones|hormones|mesh-ancestor
6726493|NCT01873573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6726494|NCT01873573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726495|NCT01873690|Ciprofloxacin|ciprofloxacin|mesh-list
6726496|NCT01873690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6726497|NCT01873690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6726498|NCT01873690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6726499|NCT01873690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6726500|NCT01873690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6726501|NCT01873690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726502|NCT01873690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6726503|NCT01873690|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6726504|NCT01873690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6726505|NCT01873768|Tranexamic Acid|tranexamic acid|mesh-list
6726506|NCT01873768|Aminocaproic Acid|aminocaproic acid|mesh-list
6726507|NCT01873768|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6726508|NCT01873768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6726509|NCT01873768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726510|NCT01873768|Hemostatics|hemostatics|mesh-ancestor
6726511|NCT01873768|Coagulants|coagulants|mesh-ancestor
6726512|NCT01873807|Cyclophosphamide|cyclophosphamide|mesh-list
6726513|NCT01873807|Etoposide|etoposide|mesh-list
6726514|NCT01873807|Idarubicin|idarubicin|mesh-list
6726515|NCT01873807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6726516|NCT01873807|Immunologic Factors|immunologic factors|mesh-ancestor
6726517|NCT01873807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726518|NCT01873807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6726519|NCT01873807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6726520|NCT01873807|Alkylating Agents|alkylating agents|mesh-ancestor
6726521|NCT01873807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726522|NCT01873807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6726523|NCT01873807|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6726524|NCT01873807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6726525|NCT01873807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6726526|NCT01873807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6726527|NCT01873807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6726528|NCT01873807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6726529|NCT01873820|Ascorbic Acid|ascorbic acid|mesh-list
6726530|NCT01873820|Calcium ascorbate|calcium ascorbate|mesh-list
6726531|NCT01873820|Calcium|calcium|mesh-list
6726532|NCT01873820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6726533|NCT01873820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726534|NCT01873820|Antioxidants|antioxidants|mesh-ancestor
6726535|NCT01873820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726536|NCT01873820|Protective Agents|protective agents|mesh-ancestor
6726537|NCT01873820|Vitamins|vitamins|mesh-ancestor
6726538|NCT01873820|Micronutrients|micronutrients|mesh-ancestor
6726539|NCT01873833|Cyclophosphamide|cyclophosphamide|mesh-list
6726540|NCT01873833|Capecitabine|capecitabine|mesh-list
6726541|NCT01873833|Trastuzumab|trastuzumab|mesh-list
6726542|NCT01873833|Lapatinib|lapatinib|mesh-list
6726543|NCT01873833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6726544|NCT01873833|Immunologic Factors|immunologic factors|mesh-ancestor
6726545|NCT01873833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726546|NCT01873833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6726547|NCT01873833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6726548|NCT01873833|Alkylating Agents|alkylating agents|mesh-ancestor
6726549|NCT01873833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726550|NCT01873833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6726551|NCT01873833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6726552|NCT01873833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6726553|NCT01873833|Antimetabolites|antimetabolites|mesh-ancestor
6726554|NCT01873833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6726555|NCT01873833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6726556|NCT01873833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6726557|NCT01873885|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
6726558|NCT01873885|Vasodilator Agents|vasodilator agents|mesh-ancestor
6726559|NCT01874002|Sirolimus|sirolimus|mesh-list
6726560|NCT01874002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6726561|NCT01874002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6726562|NCT01874002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6726563|NCT01874002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6726564|NCT01874002|Antifungal Agents|antifungal agents|mesh-ancestor
6726565|NCT01874002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6726566|NCT01874002|Immunologic Factors|immunologic factors|mesh-ancestor
6726567|NCT01874002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726568|NCT01874028|Trientine|trientine|mesh-list
6726569|NCT01874028|Chelating Agents|chelating agents|mesh-ancestor
6726570|NCT01874028|Sequestering Agents|sequestering agents|mesh-ancestor
6726571|NCT01874028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726572|NCT01874041|Salicylic Acid|salicylic acid|mesh-list
6726573|NCT01874041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6726574|NCT01874041|Antifungal Agents|antifungal agents|mesh-ancestor
6726575|NCT01874041|Keratolytic Agents|keratolytic agents|mesh-ancestor
6726576|NCT01874041|Dermatologic Agents|dermatologic agents|mesh-ancestor
6726577|NCT01874080|Metformin|metformin|mesh-list
6726578|NCT01874080|Saxagliptin|saxagliptin|mesh-list
6726579|NCT01874080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6726580|NCT01874080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726581|NCT01874080|Incretins|incretins|mesh-ancestor
6726582|NCT01874080|Hormones|hormones|mesh-ancestor
6726583|NCT01874080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6726584|NCT01874080|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6726585|NCT01874080|Protease Inhibitors|protease inhibitors|mesh-ancestor
6726586|NCT01874080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6726587|NCT01874080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726588|NCT01874171|Cetuximab|cetuximab|mesh-list
6726589|NCT01874171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6726590|NCT01874171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6726591|NCT01874236|Bupivacaine|bupivacaine|mesh-list
6726592|NCT01874236|Anesthetics, Local|anesthetics, local|mesh-ancestor
6726593|NCT01874236|Anesthetics|anesthetics|mesh-ancestor
6726594|NCT01874236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6726595|NCT01874236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726596|NCT01874236|Sensory System Agents|sensory system agents|mesh-ancestor
6726597|NCT01874236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6726598|NCT01874314|Moxifloxacin|moxifloxacin|mesh-list
6726599|NCT01874314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6726600|NCT01874314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6726601|NCT01874314|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6726602|NCT01874314|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6726603|NCT01874314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6726604|NCT01874314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726605|NCT01874314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6726606|NCT01874470|Antihypertensive Agents|antihypertensive agents|mesh-list
6726607|NCT01874470|Diuretics|diuretics|mesh-list
6726608|NCT01874470|Natriuretic Agents|natriuretic agents|mesh-ancestor
6726609|NCT01874470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726610|NCT01874561|Moxifloxacin|moxifloxacin|mesh-list
6726611|NCT01874561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6726612|NCT01874561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6726613|NCT01874561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6726614|NCT01874561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6726615|NCT01874561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6726616|NCT01874561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726617|NCT01874561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6726618|NCT01874574|Triamcinolone|triamcinolone|mesh-list
6726619|NCT01874574|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6726620|NCT01874574|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6726621|NCT01874574|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6726622|NCT01874574|Hylan|hylan|mesh-list
6726623|NCT01874574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6726624|NCT01874574|Glucocorticoids|glucocorticoids|mesh-ancestor
6726625|NCT01874574|Hormones|hormones|mesh-ancestor
6726626|NCT01874574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6726627|NCT01874574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726628|NCT01874574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6726629|NCT01874574|Immunologic Factors|immunologic factors|mesh-ancestor
6726630|NCT01874574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6726631|NCT01874574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726632|NCT01874574|Viscosupplements|viscosupplements|mesh-ancestor
6726633|NCT01874574|Protective Agents|protective agents|mesh-ancestor
6784807|NCT02205164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6784808|NCT02205164|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6784809|NCT02205164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6784810|NCT02205164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784811|NCT02205164|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6784812|NCT02205164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6784813|NCT02205164|Serotonin Agents|serotonin agents|mesh-ancestor
6784814|NCT02205190|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6784815|NCT02205190|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6784816|NCT02205190|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6784817|NCT02205190|Antimetabolites|antimetabolites|mesh-ancestor
6784818|NCT02205190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784819|NCT02205190|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6784820|NCT02205190|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6784821|NCT02205190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6784822|NCT02205242|Azithromycin|azithromycin|mesh-list
6784823|NCT02205242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6784824|NCT02205242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6784825|NCT02205255|Azithromycin|azithromycin|mesh-list
6784826|NCT02205255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6784827|NCT02205255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6784828|NCT02205398|Cetuximab|cetuximab|mesh-list
6784829|NCT02205398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6784830|NCT02205398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6784831|NCT02205489|Cetirizine|cetirizine|mesh-list
6784832|NCT02205489|Acyclovir|acyclovir|mesh-list
6784833|NCT02205489|Ibuprofen|ibuprofen|mesh-list
6784834|NCT02205489|Methylprednisolone|methylprednisolone|mesh-list
6784835|NCT02205489|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6784836|NCT02205489|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6784837|NCT02205489|Prednisolone|prednisolone|mesh-list
6726634|NCT01874639|Hemostatics|hemostatics|mesh-list
6726635|NCT01874639|Coagulants|coagulants|mesh-ancestor
6726636|NCT01874678|Cisplatin|cisplatin|mesh-list
6726637|NCT01874678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6726638|NCT01874717|Midazolam|midazolam|mesh-list
6726639|NCT01874717|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6726640|NCT01874717|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6726641|NCT01874717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6726642|NCT01874717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726643|NCT01874717|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6726644|NCT01874717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6726645|NCT01874717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6726646|NCT01874717|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6726647|NCT01874717|Anesthetics, General|anesthetics, general|mesh-ancestor
6726648|NCT01874717|Anesthetics|anesthetics|mesh-ancestor
6726649|NCT01874717|GABA Modulators|gaba modulators|mesh-ancestor
6726650|NCT01874717|GABA Agents|gaba agents|mesh-ancestor
6726651|NCT01874717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6726652|NCT01874717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726653|NCT01874730|Anesthetics|anesthetics|mesh-list
6726654|NCT01874730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6726655|NCT01874730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726656|NCT01874743|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6726657|NCT01874743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6726658|NCT01874743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6726659|NCT01874743|Antimetabolites|antimetabolites|mesh-ancestor
6726660|NCT01874743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726661|NCT01874743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6726662|NCT01874743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6726663|NCT01874743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6726664|NCT01874847|Melatonin|melatonin|mesh-list
6726665|NCT01874847|Antioxidants|antioxidants|mesh-ancestor
6726666|NCT01874847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726667|NCT01874847|Protective Agents|protective agents|mesh-ancestor
6726668|NCT01874847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726669|NCT01874847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6726670|NCT01874860|Doxycycline|doxycycline|mesh-list
6726671|NCT01874860|Clindamycin|clindamycin|mesh-list
6726672|NCT01874860|Clindamycin palmitate|clindamycin palmitate|mesh-list
6726673|NCT01874860|Clindamycin phosphate|clindamycin phosphate|mesh-list
6726674|NCT01874860|Hydrocortisone|hydrocortisone|mesh-list
6726675|NCT01874860|Methylprednisolone|methylprednisolone|mesh-list
6726676|NCT01874860|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6726677|NCT01874860|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6726678|NCT01874860|Prednisolone|prednisolone|mesh-list
6726679|NCT01874860|Prednisolone acetate|prednisolone acetate|mesh-list
6726680|NCT01874860|Sunscreening Agents|sunscreening agents|mesh-list
6726681|NCT01874860|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6726682|NCT01874860|Prednisolone phosphate|prednisolone phosphate|mesh-list
6726683|NCT01874860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6726684|NCT01874860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6726685|NCT01874860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6726686|NCT01874860|Antimalarials|antimalarials|mesh-ancestor
6726687|NCT01874860|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6726688|NCT01874860|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6726689|NCT01874860|Antiemetics|antiemetics|mesh-ancestor
6726690|NCT01874860|Autonomic Agents|autonomic agents|mesh-ancestor
6726691|NCT01874860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6726692|NCT01874860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726693|NCT01874860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6726694|NCT01874860|Glucocorticoids|glucocorticoids|mesh-ancestor
6726695|NCT01874860|Hormones|hormones|mesh-ancestor
6726696|NCT01874860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6726697|NCT01874860|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6726698|NCT01874860|Protective Agents|protective agents|mesh-ancestor
6726699|NCT01874860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6726700|NCT01874860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6726701|NCT01874860|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6726702|NCT01874860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6726703|NCT01874860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726704|NCT01874860|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6726705|NCT01874860|Dermatologic Agents|dermatologic agents|mesh-ancestor
6726706|NCT01874964|Methadone|methadone|mesh-list
6726707|NCT01874964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6726708|NCT01874964|Narcotics|narcotics|mesh-ancestor
6726709|NCT01874964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6726710|NCT01874964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726711|NCT01874964|Analgesics|analgesics|mesh-ancestor
6726712|NCT01874964|Sensory System Agents|sensory system agents|mesh-ancestor
6726713|NCT01874964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6726714|NCT01874964|Antitussive Agents|antitussive agents|mesh-ancestor
6726715|NCT01874964|Respiratory System Agents|respiratory system agents|mesh-ancestor
6726716|NCT01875107|Insulin|insulin|mesh-list
6726717|NCT01875107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6726718|NCT01875107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726719|NCT01875172|Bupropion|bupropion|mesh-list
6726720|NCT01875172|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6726721|NCT01875172|Antidepressive Agents|antidepressive agents|mesh-ancestor
6726722|NCT01875172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6726723|NCT01875172|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6726724|NCT01875172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6726725|NCT01875172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6726726|NCT01875172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726727|NCT01875172|Dopamine Agents|dopamine agents|mesh-ancestor
6726728|NCT01875172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6726729|NCT01875172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726730|NCT01875172|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6726731|NCT01875172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6726732|NCT01875172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6726733|NCT01875185|Aspirin|aspirin|mesh-list
6726734|NCT01875185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6726735|NCT01875185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6726736|NCT01875185|Analgesics|analgesics|mesh-ancestor
6726737|NCT01875185|Sensory System Agents|sensory system agents|mesh-ancestor
6726738|NCT01875185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6726739|NCT01875185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726740|NCT01875185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6726741|NCT01875185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6726742|NCT01875185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6726743|NCT01875185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6726744|NCT01875185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726745|NCT01875185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6726746|NCT01875185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6726747|NCT01875185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6726748|NCT01875185|Antipyretics|antipyretics|mesh-ancestor
6726749|NCT01875224|Abatacept|abatacept|mesh-list
6726750|NCT01875224|Tacrolimus|tacrolimus|mesh-list
6726751|NCT01875224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6726752|NCT01875224|Immunologic Factors|immunologic factors|mesh-ancestor
6726753|NCT01875224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726754|NCT01875224|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6726755|NCT01875224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6726756|NCT01875224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726757|NCT01875224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6726758|NCT01875224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6726759|NCT01875224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6726760|NCT01875263|Levofloxacin|levofloxacin|mesh-list
6726761|NCT01875263|Ofloxacin|ofloxacin|mesh-list
6726762|NCT01875263|Cloxacillin|cloxacillin|mesh-list
6726763|NCT01875263|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6726764|NCT01875263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6726765|NCT01875263|Renal Agents|renal agents|mesh-ancestor
6726766|NCT01875263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6726767|NCT01875263|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6726768|NCT01875263|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6726769|NCT01875263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6726770|NCT01875263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726771|NCT01875263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6726772|NCT01875263|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6726773|NCT01875263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6726774|NCT01875653|Molgramostim|molgramostim|mesh-list
6726775|NCT01875653|Sargramostim|sargramostim|mesh-list
6726776|NCT01875653|Immunologic Factors|immunologic factors|mesh-ancestor
6726777|NCT01875653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726778|NCT01875653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6726779|NCT01875666|Trastuzumab|trastuzumab|mesh-list
6726780|NCT01875666|Pertuzumab|pertuzumab|mesh-list
6726781|NCT01875666|Lapatinib|lapatinib|mesh-list
6726782|NCT01875666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6726783|NCT01875666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6726784|NCT01875666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6726785|NCT01875666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6726786|NCT01875666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726787|NCT01875705|Ravoxertinib|ravoxertinib|mesh-list
6726788|NCT01875705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6726789|NCT01875705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6726790|NCT01875705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6726791|NCT01875705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726792|NCT01875757|Vitamin D|vitamin d|mesh-list
6726793|NCT01875757|Cholecalciferol|cholecalciferol|mesh-list
6726794|NCT01875757|Vitamins|vitamins|mesh-ancestor
6726795|NCT01875757|Micronutrients|micronutrients|mesh-ancestor
6726796|NCT01875757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726797|NCT01875757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6726798|NCT01875757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6726799|NCT01875822|Curcumin|curcumin|mesh-list
6726800|NCT01875822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6726801|NCT01875822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6726802|NCT01875822|Analgesics|analgesics|mesh-ancestor
6726803|NCT01875822|Sensory System Agents|sensory system agents|mesh-ancestor
6726804|NCT01875822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6726805|NCT01875822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726806|NCT01875822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6726807|NCT01875822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6726808|NCT01875822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6726809|NCT01875822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6726810|NCT01875822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726811|NCT01875926|Gontivimab|gontivimab|mesh-list
6726812|NCT01875926|Antiviral Agents|antiviral agents|mesh-ancestor
6726813|NCT01875926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6726814|NCT01875952|Isoniazid|isoniazid|mesh-list
6726815|NCT01875952|Antitubercular Agents|antitubercular agents|mesh-ancestor
6726816|NCT01875952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6726817|NCT01875952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6726818|NCT01875952|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6726819|NCT01875952|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6726820|NCT01875952|Antimetabolites|antimetabolites|mesh-ancestor
6726821|NCT01875952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726822|NCT01875952|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6726823|NCT01876004|Methotrexate|methotrexate|mesh-list
6726824|NCT01876004|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6726825|NCT01876004|Abortifacient Agents|abortifacient agents|mesh-ancestor
6726826|NCT01876004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6726827|NCT01876004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726828|NCT01876004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6726829|NCT01876004|Antimetabolites|antimetabolites|mesh-ancestor
6726830|NCT01876004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726831|NCT01876004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6726832|NCT01876004|Dermatologic Agents|dermatologic agents|mesh-ancestor
6726833|NCT01876004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6726834|NCT01876004|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6726835|NCT01876004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6726836|NCT01876004|Immunologic Factors|immunologic factors|mesh-ancestor
6726837|NCT01876004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6726838|NCT01876004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6726839|NCT01876108|Amoxicillin|amoxicillin|mesh-list
6726840|NCT01876108|Azithromycin|azithromycin|mesh-list
6726841|NCT01876108|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
6726842|NCT01876108|Omeprazole|omeprazole|mesh-list
6726843|NCT01876108|Bismuth|bismuth|mesh-list
6726844|NCT01876108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6726845|NCT01876108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6726846|NCT01876108|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6726847|NCT01876108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6726848|NCT01876108|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6726849|NCT01876108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6726850|NCT01876108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726851|NCT01876108|Antacids|antacids|mesh-ancestor
6726852|NCT01876121|Celecoxib|celecoxib|mesh-list
6726853|NCT01876121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6726854|NCT01876121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6726855|NCT01876121|Analgesics|analgesics|mesh-ancestor
6726856|NCT01876121|Sensory System Agents|sensory system agents|mesh-ancestor
6726857|NCT01876121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6726858|NCT01876121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726859|NCT01876121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6726860|NCT01876121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6726861|NCT01876121|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6726862|NCT01876121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6726863|NCT01876121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6726864|NCT01876121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726865|NCT01876186|Solifenacin Succinate|solifenacin succinate|mesh-list
6726866|NCT01876186|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6726867|NCT01876186|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6726868|NCT01876186|Cholinergic Agents|cholinergic agents|mesh-ancestor
6726869|NCT01876186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6726870|NCT01876186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726871|NCT01876186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726872|NCT01876186|Urological Agents|urological agents|mesh-ancestor
6784838|NCT02205489|Prednisolone acetate|prednisolone acetate|mesh-list
6784839|NCT02205489|Alemtuzumab|alemtuzumab|mesh-list
6726873|NCT01876290|Dexamethasone|dexamethasone|mesh-list
6726874|NCT01876290|Ondansetron|ondansetron|mesh-list
6726875|NCT01876290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6726876|NCT01876290|Antiemetics|antiemetics|mesh-ancestor
6726877|NCT01876290|Autonomic Agents|autonomic agents|mesh-ancestor
6726878|NCT01876290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6726879|NCT01876290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726880|NCT01876290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6726881|NCT01876290|Glucocorticoids|glucocorticoids|mesh-ancestor
6726882|NCT01876290|Hormones|hormones|mesh-ancestor
6726883|NCT01876290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6726884|NCT01876290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6726885|NCT01876290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6726886|NCT01876290|Antipruritics|antipruritics|mesh-ancestor
6726887|NCT01876290|Dermatologic Agents|dermatologic agents|mesh-ancestor
6726888|NCT01876290|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6726889|NCT01876290|Serotonin Agents|serotonin agents|mesh-ancestor
6726890|NCT01876290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6726891|NCT01876290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726892|NCT01876290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6726893|NCT01876290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6726894|NCT01876290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6726895|NCT01876290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6726896|NCT01876290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6726897|NCT01876316|Moxifloxacin|moxifloxacin|mesh-list
6726898|NCT01876316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6726899|NCT01876316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6726900|NCT01876316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6726901|NCT01876316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6726902|NCT01876316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6726903|NCT01876316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726904|NCT01876316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6726905|NCT01876355|Clonidine|clonidine|mesh-list
6726906|NCT01876355|Analgesics|analgesics|mesh-ancestor
6726907|NCT01876355|Sensory System Agents|sensory system agents|mesh-ancestor
6726908|NCT01876355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6726909|NCT01876355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726910|NCT01876355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6726911|NCT01876355|Sympatholytics|sympatholytics|mesh-ancestor
6726912|NCT01876355|Autonomic Agents|autonomic agents|mesh-ancestor
6726913|NCT01876355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6726914|NCT01876355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6726915|NCT01876355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6726916|NCT01876355|Adrenergic Agents|adrenergic agents|mesh-ancestor
6726917|NCT01876355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6726918|NCT01876355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726919|NCT01876433|Mirabegron|mirabegron|mesh-list
6726920|NCT01876433|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6726921|NCT01876433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6726922|NCT01876433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6726923|NCT01876433|Adrenergic Agents|adrenergic agents|mesh-ancestor
6726924|NCT01876433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6726925|NCT01876433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726926|NCT01876433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726927|NCT01876433|Urological Agents|urological agents|mesh-ancestor
6726928|NCT01876550|Mupirocin|mupirocin|mesh-list
6726929|NCT01876550|Calcium|calcium|mesh-list
6726930|NCT01876550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6726931|NCT01876550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726932|NCT01876550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6726933|NCT01876550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6726934|NCT01876550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6726935|NCT01876550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6726936|NCT01876550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726937|NCT01876563|Vitamin D|vitamin d|mesh-list
6726938|NCT01876563|Vitamins|vitamins|mesh-ancestor
6726939|NCT01876563|Micronutrients|micronutrients|mesh-ancestor
6726940|NCT01876563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726941|NCT01876563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6726942|NCT01876615|Diclofenac|diclofenac|mesh-list
6726943|NCT01876615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6726944|NCT01876615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6726945|NCT01876615|Analgesics|analgesics|mesh-ancestor
6726946|NCT01876615|Sensory System Agents|sensory system agents|mesh-ancestor
6726947|NCT01876615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6726948|NCT01876615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726949|NCT01876615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6726950|NCT01876615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6726951|NCT01876615|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6726952|NCT01876615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6726953|NCT01876615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726954|NCT01876628|Clindamycin|clindamycin|mesh-list
6726955|NCT01876628|Clindamycin palmitate|clindamycin palmitate|mesh-list
6726956|NCT01876628|Clindamycin phosphate|clindamycin phosphate|mesh-list
6726957|NCT01876628|Floxacillin|floxacillin|mesh-list
6726958|NCT01876628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6726959|NCT01876628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6726960|NCT01876628|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6726961|NCT01876628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6726962|NCT01876628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726963|NCT01876641|Decitabine|decitabine|mesh-list
6726964|NCT01876641|Vemurafenib|vemurafenib|mesh-list
6726965|NCT01876641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6726966|NCT01876641|Antimetabolites|antimetabolites|mesh-ancestor
6726967|NCT01876641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726968|NCT01876641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6726969|NCT01876641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6726970|NCT01876641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6726971|NCT01876771|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
6726972|NCT01876771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726973|NCT01876771|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6726974|NCT01876797|Ticagrelor|ticagrelor|mesh-list
6726975|NCT01876797|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6726976|NCT01876797|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6726977|NCT01876797|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6726978|NCT01876797|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6726979|NCT01876797|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6726980|NCT01876797|Purinergic Agents|purinergic agents|mesh-ancestor
6726981|NCT01876797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6726982|NCT01876797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6726983|NCT01876797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726984|NCT01876849|Exenatide|exenatide|mesh-list
6726985|NCT01876849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6726986|NCT01876849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6726987|NCT01876849|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6726988|NCT01876849|Incretins|incretins|mesh-ancestor
6726989|NCT01876849|Hormones|hormones|mesh-ancestor
6726990|NCT01876849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6726991|NCT01876862|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6726992|NCT01876862|Antiviral Agents|antiviral agents|mesh-ancestor
6726993|NCT01876862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6726994|NCT01876966|Ritonavir|ritonavir|mesh-list
6726995|NCT01876966|Darunavir|darunavir|mesh-list
6726996|NCT01876966|Lumefantrine|lumefantrine|mesh-list
6726997|NCT01876966|Artemether|artemether|mesh-list
6726998|NCT01876966|Etravirine|etravirine|mesh-list
6726999|NCT01876966|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6727000|NCT01876966|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6727001|NCT01876966|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6727002|NCT01876966|Protease Inhibitors|protease inhibitors|mesh-ancestor
6727003|NCT01876966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6727004|NCT01876966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727005|NCT01876966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6727006|NCT01876966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6727007|NCT01876966|Antiviral Agents|antiviral agents|mesh-ancestor
6727008|NCT01876966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6727009|NCT01876966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6727010|NCT01876966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6727011|NCT01876966|Antimalarials|antimalarials|mesh-ancestor
6727012|NCT01876966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6727013|NCT01876966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6727014|NCT01876966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6727015|NCT01876966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6727016|NCT01877122|Ibuprofen|ibuprofen|mesh-list
6727017|NCT01877122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6727018|NCT01877122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6727019|NCT01877122|Analgesics|analgesics|mesh-ancestor
6727020|NCT01877122|Sensory System Agents|sensory system agents|mesh-ancestor
6727021|NCT01877122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6784840|NCT02205489|Esomeprazole|esomeprazole|mesh-list
6727022|NCT01877122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727023|NCT01877122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6727024|NCT01877122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6727025|NCT01877122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6727026|NCT01877122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6727027|NCT01877122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727028|NCT01877226|Tapentadol|tapentadol|mesh-list
6727029|NCT01877226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6727030|NCT01877226|Narcotics|narcotics|mesh-ancestor
6727031|NCT01877226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6727032|NCT01877226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727033|NCT01877226|Analgesics|analgesics|mesh-ancestor
6727034|NCT01877226|Sensory System Agents|sensory system agents|mesh-ancestor
6727035|NCT01877226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6727036|NCT01877226|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6727037|NCT01877226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6727038|NCT01877226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6727039|NCT01877226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727040|NCT01877226|Adrenergic Agents|adrenergic agents|mesh-ancestor
6727041|NCT01877226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6727042|NCT01877356|Anesthetics|anesthetics|mesh-list
6727043|NCT01877356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6727044|NCT01877356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727045|NCT01877512|Hormones|hormones|mesh-list
6727046|NCT01877512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6727047|NCT01877512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727048|NCT01877577|Vitamin D|vitamin d|mesh-list
6727049|NCT01877577|Ergocalciferols|ergocalciferols|mesh-list
6727050|NCT01877577|Cholecalciferol|cholecalciferol|mesh-list
6727051|NCT01877577|Vitamins|vitamins|mesh-list
6727052|NCT01877577|Micronutrients|micronutrients|mesh-ancestor
6727053|NCT01877577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727054|NCT01877577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6727055|NCT01877577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6727056|NCT01877590|Thioctic Acid|thioctic acid|mesh-list
6727057|NCT01877590|Antioxidants|antioxidants|mesh-ancestor
6727058|NCT01877590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727059|NCT01877590|Protective Agents|protective agents|mesh-ancestor
6727060|NCT01877590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727061|NCT01877590|Vitamin B Complex|vitamin b complex|mesh-ancestor
6727062|NCT01877590|Vitamins|vitamins|mesh-ancestor
6727063|NCT01877590|Micronutrients|micronutrients|mesh-ancestor
6727064|NCT01877746|Prednisone|prednisone|mesh-list
6727065|NCT01877746|Azathioprine|azathioprine|mesh-list
6727066|NCT01877746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6727067|NCT01877746|Glucocorticoids|glucocorticoids|mesh-ancestor
6727068|NCT01877746|Hormones|hormones|mesh-ancestor
6727069|NCT01877746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6727070|NCT01877746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727071|NCT01877746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6727072|NCT01877746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6727073|NCT01877746|Antimetabolites|antimetabolites|mesh-ancestor
6727074|NCT01877746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727075|NCT01877746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6727076|NCT01877746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6727077|NCT01877746|Immunologic Factors|immunologic factors|mesh-ancestor
6727078|NCT01877746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6727079|NCT01877811|Agerafenib|agerafenib|mesh-list
6727080|NCT01877811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6727081|NCT01877811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6727082|NCT01877811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727083|NCT01877889|Dapagliflozin|dapagliflozin|mesh-list
6727084|NCT01877889|Canagliflozin|canagliflozin|mesh-list
6727085|NCT01877889|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6727086|NCT01877889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727087|NCT01877889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6727088|NCT01877889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727089|NCT01877954|Fluticasone|fluticasone|mesh-list
6727090|NCT01877954|Xhance|xhance|mesh-list
6727091|NCT01877954|Beclomethasone|beclomethasone|mesh-list
6727092|NCT01877954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6727093|NCT01877954|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6727094|NCT01877954|Autonomic Agents|autonomic agents|mesh-ancestor
6727095|NCT01877954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6727096|NCT01877954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727097|NCT01877954|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6727098|NCT01877954|Respiratory System Agents|respiratory system agents|mesh-ancestor
6727099|NCT01877954|Dermatologic Agents|dermatologic agents|mesh-ancestor
6727100|NCT01877954|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6727101|NCT01877954|Glucocorticoids|glucocorticoids|mesh-ancestor
6727102|NCT01877954|Hormones|hormones|mesh-ancestor
6727103|NCT01877954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6784841|NCT02205489|Ranitidine|ranitidine|mesh-list
6784842|NCT02205489|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6784843|NCT02205489|Prednisolone phosphate|prednisolone phosphate|mesh-list
6784844|NCT02205489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6784845|NCT02205489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6784846|NCT02205489|Analgesics|analgesics|mesh-ancestor
6784847|NCT02205489|Sensory System Agents|sensory system agents|mesh-ancestor
6784848|NCT02205489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6784849|NCT02205489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784850|NCT02205489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6784851|NCT02205489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6784852|NCT02205489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6784853|NCT02205489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6784854|NCT02205489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784855|NCT02205489|Antiemetics|antiemetics|mesh-ancestor
6784856|NCT02205489|Autonomic Agents|autonomic agents|mesh-ancestor
6784857|NCT02205489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6784858|NCT02205489|Glucocorticoids|glucocorticoids|mesh-ancestor
6784859|NCT02205489|Hormones|hormones|mesh-ancestor
6784860|NCT02205489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6784861|NCT02205489|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6784862|NCT02205489|Protective Agents|protective agents|mesh-ancestor
6784863|NCT02205489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6784864|NCT02205489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6784865|NCT02205489|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6784866|NCT02205489|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6784867|NCT02205489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6784868|NCT02205489|Antiviral Agents|antiviral agents|mesh-ancestor
6784869|NCT02205489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6784870|NCT02205489|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6784871|NCT02205489|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6784872|NCT02205489|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6784873|NCT02205489|Histamine Antagonists|histamine antagonists|mesh-ancestor
6784874|NCT02205489|Histamine Agents|histamine agents|mesh-ancestor
6784875|NCT02205489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6784876|NCT02205489|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6784877|NCT02205502|Lidocaine|lidocaine|mesh-list
6784878|NCT02205502|Anesthetics, Local|anesthetics, local|mesh-ancestor
6784879|NCT02205502|Anesthetics|anesthetics|mesh-ancestor
6784880|NCT02205502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6727104|NCT01878136|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6727105|NCT01878136|Plasminogen|plasminogen|mesh-list
6727106|NCT01878136|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6727107|NCT01878136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6727108|NCT01878136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727109|NCT01878188|BCG Vaccine|bcg vaccine|mesh-list
6727110|NCT01878188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6727111|NCT01878188|Immunologic Factors|immunologic factors|mesh-ancestor
6727112|NCT01878188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727113|NCT01878201|Valsartan|valsartan|mesh-list
6727114|NCT01878201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6727115|NCT01878201|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6727116|NCT01878201|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6727117|NCT01878201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727118|NCT01878227|Fenofibrate|fenofibrate|mesh-list
6727119|NCT01878227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6727120|NCT01878227|Antimetabolites|antimetabolites|mesh-ancestor
6727121|NCT01878227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727122|NCT01878227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6727123|NCT01878318|Methotrexate|methotrexate|mesh-list
6727124|NCT01878318|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6727125|NCT01878318|Abortifacient Agents|abortifacient agents|mesh-ancestor
6727126|NCT01878318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6727127|NCT01878318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727128|NCT01878318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6727129|NCT01878318|Antimetabolites|antimetabolites|mesh-ancestor
6727130|NCT01878318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727131|NCT01878318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6727132|NCT01878318|Dermatologic Agents|dermatologic agents|mesh-ancestor
6727133|NCT01878318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6727134|NCT01878318|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6727135|NCT01878318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6727136|NCT01878318|Immunologic Factors|immunologic factors|mesh-ancestor
6727137|NCT01878318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6727138|NCT01878318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6727139|NCT01878357|Piperaquine|piperaquine|mesh-list
6727140|NCT01878357|Primaquine|primaquine|mesh-list
6727141|NCT01878357|Artenimol|artenimol|mesh-list
6727142|NCT01878357|Antimalarials|antimalarials|mesh-ancestor
6727143|NCT01878357|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6727144|NCT01878357|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6727145|NCT01878357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6727146|NCT01878422|Leucovorin|leucovorin|mesh-list
6727147|NCT01878422|Bevacizumab|bevacizumab|mesh-list
6727148|NCT01878422|Cetuximab|cetuximab|mesh-list
6727149|NCT01878422|Fluorouracil|fluorouracil|mesh-list
6727150|NCT01878422|Oxaliplatin|oxaliplatin|mesh-list
6727151|NCT01878422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6727152|NCT01878422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6727153|NCT01878422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6727154|NCT01878422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6727155|NCT01878422|Growth Substances|growth substances|mesh-ancestor
6727156|NCT01878422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727157|NCT01878422|Growth Inhibitors|growth inhibitors|mesh-ancestor
6727158|NCT01878422|Antimetabolites|antimetabolites|mesh-ancestor
6727159|NCT01878422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727160|NCT01878422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6727161|NCT01878422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6727162|NCT01878422|Immunologic Factors|immunologic factors|mesh-ancestor
6727163|NCT01878422|Antidotes|antidotes|mesh-ancestor
6727164|NCT01878422|Protective Agents|protective agents|mesh-ancestor
6727165|NCT01878422|Vitamin B Complex|vitamin b complex|mesh-ancestor
6727166|NCT01878422|Vitamins|vitamins|mesh-ancestor
6727167|NCT01878422|Micronutrients|micronutrients|mesh-ancestor
6727168|NCT01878513|Risperidone|risperidone|mesh-list
6727169|NCT01878513|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6727170|NCT01878513|Serotonin Agents|serotonin agents|mesh-ancestor
6727171|NCT01878513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6727172|NCT01878513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727173|NCT01878513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727174|NCT01878513|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6727175|NCT01878513|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6727176|NCT01878513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6727177|NCT01878513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6727178|NCT01878513|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6727179|NCT01878513|Dopamine Agents|dopamine agents|mesh-ancestor
6727180|NCT01878539|Anticoagulants|anticoagulants|mesh-list
6727181|NCT01878578|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
6727182|NCT01878578|Phenytoin|phenytoin|mesh-list
6727183|NCT01878578|Anticonvulsants|anticonvulsants|mesh-ancestor
6727184|NCT01878578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6727185|NCT01878578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6727186|NCT01878578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6727187|NCT01878578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727188|NCT01878578|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6727189|NCT01878578|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6727190|NCT01878643|Vancomycin|vancomycin|mesh-list
6727191|NCT01878643|Gentamicins|gentamicins|mesh-list
6727192|NCT01878643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6727193|NCT01878643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6727194|NCT01878643|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6727195|NCT01878643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6727196|NCT01878643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727197|NCT01878695|Acetylcysteine|acetylcysteine|mesh-list
6727198|NCT01878695|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6727199|NCT01878695|Antiviral Agents|antiviral agents|mesh-ancestor
6727200|NCT01878695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6727201|NCT01878695|Expectorants|expectorants|mesh-ancestor
6727202|NCT01878695|Respiratory System Agents|respiratory system agents|mesh-ancestor
6727203|NCT01878695|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6727204|NCT01878695|Antioxidants|antioxidants|mesh-ancestor
6727205|NCT01878695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727206|NCT01878695|Protective Agents|protective agents|mesh-ancestor
6727207|NCT01878695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727208|NCT01878695|Antidotes|antidotes|mesh-ancestor
6727209|NCT01878708|Dexamethasone|dexamethasone|mesh-list
6727210|NCT01878708|Dexamethasone acetate|dexamethasone acetate|mesh-list
6727211|NCT01878708|Asparaginase|asparaginase|mesh-list
6727212|NCT01878708|Pegaspargase|pegaspargase|mesh-list
6727213|NCT01878708|BB 1101|bb 1101|mesh-list
6727214|NCT01878708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6727215|NCT01878708|Antiemetics|antiemetics|mesh-ancestor
6727216|NCT01878708|Autonomic Agents|autonomic agents|mesh-ancestor
6727217|NCT01878708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6727218|NCT01878708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727219|NCT01878708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6727220|NCT01878708|Glucocorticoids|glucocorticoids|mesh-ancestor
6727221|NCT01878708|Hormones|hormones|mesh-ancestor
6727222|NCT01878708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6727223|NCT01878708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6727224|NCT01878708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6727225|NCT01878708|Protease Inhibitors|protease inhibitors|mesh-ancestor
6727226|NCT01878708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6727227|NCT01878708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727228|NCT01878734|Micronutrients|micronutrients|mesh-list
6727229|NCT01878734|Trace Elements|trace elements|mesh-list
6727230|NCT01878734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727231|NCT01878864|Lidocaine|lidocaine|mesh-list
6727232|NCT01878864|Bupivacaine|bupivacaine|mesh-list
6727233|NCT01878864|Anesthetics, Local|anesthetics, local|mesh-ancestor
6727234|NCT01878864|Anesthetics|anesthetics|mesh-ancestor
6727235|NCT01878864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6727236|NCT01878864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727237|NCT01878864|Sensory System Agents|sensory system agents|mesh-ancestor
6727238|NCT01878864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6727239|NCT01878864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6727240|NCT01878864|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6727241|NCT01878864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6727242|NCT01878864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6727243|NCT01878864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727244|NCT01878942|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
6727245|NCT01878942|Hallucinogens|hallucinogens|mesh-ancestor
6727246|NCT01878942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727247|NCT01878942|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6727248|NCT01878942|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6727249|NCT01878942|Serotonin Agents|serotonin agents|mesh-ancestor
6727250|NCT01878942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6727251|NCT01878942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727252|NCT01878942|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6727253|NCT01879007|Gemifloxacin|gemifloxacin|mesh-list
6727254|NCT01879007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6727255|NCT01879007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6727256|NCT01879007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6727257|NCT01879007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6727258|NCT01879007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6727259|NCT01879007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727260|NCT01879007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6727261|NCT01879033|Insulin|insulin|mesh-list
6727262|NCT01879033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6727263|NCT01879033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727264|NCT01879085|Gemcitabine|gemcitabine|mesh-list
6727265|NCT01879085|Docetaxel|docetaxel|mesh-list
6727266|NCT01879085|Vorinostat|vorinostat|mesh-list
6727267|NCT01879085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6727268|NCT01879085|Antimetabolites|antimetabolites|mesh-ancestor
6727269|NCT01879085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727270|NCT01879085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6727271|NCT01879085|Antiviral Agents|antiviral agents|mesh-ancestor
6727272|NCT01879085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6727273|NCT01879085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6727274|NCT01879085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6727275|NCT01879085|Immunologic Factors|immunologic factors|mesh-ancestor
6727276|NCT01879085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727277|NCT01879085|Tubulin Modulators|tubulin modulators|mesh-ancestor
6727278|NCT01879085|Antimitotic Agents|antimitotic agents|mesh-ancestor
6727279|NCT01879085|Mitosis Modulators|mitosis modulators|mesh-ancestor
6727280|NCT01879085|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6727281|NCT01879202|Methylphenidate|methylphenidate|mesh-list
6727282|NCT01879202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6727283|NCT01879202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727284|NCT01879202|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6727285|NCT01879202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6727286|NCT01879202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6727287|NCT01879202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727288|NCT01879202|Dopamine Agents|dopamine agents|mesh-ancestor
6727289|NCT01879202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6727290|NCT01879241|Rasagiline|rasagiline|mesh-list
6727291|NCT01879241|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6727292|NCT01879241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6727293|NCT01879241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727294|NCT01879241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6727295|NCT01879241|Protective Agents|protective agents|mesh-ancestor
6727296|NCT01879241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727297|NCT01879293|Metformin|metformin|mesh-list
6727298|NCT01879293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6727299|NCT01879293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727300|NCT01879358|Sirolimus|sirolimus|mesh-list
6727301|NCT01879358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6727302|NCT01879358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6727303|NCT01879358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6727304|NCT01879358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6727305|NCT01879358|Antifungal Agents|antifungal agents|mesh-ancestor
6727306|NCT01879358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6727307|NCT01879358|Immunologic Factors|immunologic factors|mesh-ancestor
6727308|NCT01879358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727309|NCT01879423|Lamotrigine|lamotrigine|mesh-list
6727310|NCT01879423|Anticonvulsants|anticonvulsants|mesh-list
6727311|NCT01879423|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6727312|NCT01879423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6727313|NCT01879423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727314|NCT01879423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6727315|NCT01879423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727316|NCT01879423|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6727317|NCT01879423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6727318|NCT01879423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6727319|NCT01879423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6727320|NCT01879423|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6727321|NCT01879488|Edetic Acid|edetic acid|mesh-list
6727322|NCT01879488|Pentetic Acid|pentetic acid|mesh-list
6727323|NCT01879488|Antidotes|antidotes|mesh-ancestor
6727324|NCT01879488|Protective Agents|protective agents|mesh-ancestor
6727325|NCT01879488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727326|NCT01879488|Chelating Agents|chelating agents|mesh-ancestor
6727327|NCT01879488|Sequestering Agents|sequestering agents|mesh-ancestor
6727328|NCT01879488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727329|NCT01879488|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6727330|NCT01879488|Anticoagulants|anticoagulants|mesh-ancestor
6727331|NCT01879488|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6727332|NCT01879514|Prednisone|prednisone|mesh-list
6727333|NCT01879514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6727334|NCT01879514|Glucocorticoids|glucocorticoids|mesh-ancestor
6727335|NCT01879514|Hormones|hormones|mesh-ancestor
6727336|NCT01879514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6727337|NCT01879514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727338|NCT01879514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6727339|NCT01879514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6727340|NCT01879527|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6727341|NCT01879527|Amiloride|amiloride|mesh-list
6727342|NCT01879527|Amiloride, hydrochlorothiazide drug combination|amiloride, hydrochlorothiazide drug combination|mesh-list
6727343|NCT01879527|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6727344|NCT01879527|Diuretics|diuretics|mesh-ancestor
6727345|NCT01879527|Natriuretic Agents|natriuretic agents|mesh-ancestor
6727346|NCT01879527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727347|NCT01879527|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6727348|NCT01879527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6727349|NCT01879527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727350|NCT01879527|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
6727351|NCT01879527|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6727352|NCT01879527|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
6727353|NCT01879527|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6727354|NCT01879605|Bisacodyl|bisacodyl|mesh-list
6727355|NCT01879605|Sorbitol|sorbitol|mesh-list
6727356|NCT01879605|Cathartics|cathartics|mesh-ancestor
6727357|NCT01879605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6727358|NCT01879605|Laxatives|laxatives|mesh-ancestor
6727359|NCT01879748|Rasagiline|rasagiline|mesh-list
6727360|NCT01879748|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6727361|NCT01879748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6727362|NCT01879748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727363|NCT01879748|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6727364|NCT01879748|Protective Agents|protective agents|mesh-ancestor
6727365|NCT01879748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727366|NCT01879917|Liraglutide|liraglutide|mesh-list
6727367|NCT01879917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6727368|NCT01879917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727369|NCT01879917|Incretins|incretins|mesh-ancestor
6727370|NCT01879917|Hormones|hormones|mesh-ancestor
6727371|NCT01879917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6784881|NCT02205502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784882|NCT02205502|Sensory System Agents|sensory system agents|mesh-ancestor
6784883|NCT02205502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6784884|NCT02205502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6784885|NCT02205502|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6784886|NCT02205502|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6784887|NCT02205502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6784888|NCT02205502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784889|NCT02205515|Everolimus|everolimus|mesh-list
6784890|NCT02205515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6784891|NCT02205515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6784892|NCT02205515|Immunologic Factors|immunologic factors|mesh-ancestor
6784893|NCT02205515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727372|NCT01879930|Doxycycline|doxycycline|mesh-list
6727373|NCT01879930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6727374|NCT01879930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6727375|NCT01879930|Antimalarials|antimalarials|mesh-ancestor
6727376|NCT01879930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6727377|NCT01879930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6727378|NCT01880112|Cefazolin|cefazolin|mesh-list
6727379|NCT01880112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6727380|NCT01880112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6727381|NCT01880125|Acetaminophen|acetaminophen|mesh-list
6727382|NCT01880125|Tramadol|tramadol|mesh-list
6727383|NCT01880125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6727384|NCT01880125|Analgesics|analgesics|mesh-ancestor
6727385|NCT01880125|Sensory System Agents|sensory system agents|mesh-ancestor
6727386|NCT01880125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6727387|NCT01880125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727388|NCT01880125|Antipyretics|antipyretics|mesh-ancestor
6727389|NCT01880125|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6727390|NCT01880125|Narcotics|narcotics|mesh-ancestor
6727391|NCT01880125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6727392|NCT01880138|Anesthetics|anesthetics|mesh-list
6727393|NCT01880138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6727394|NCT01880138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727395|NCT01880216|Enoxaparin|enoxaparin|mesh-list
6727396|NCT01880216|Enoxaparin sodium|enoxaparin sodium|mesh-list
6727397|NCT01880216|Bemiparin|bemiparin|mesh-list
6727398|NCT01880216|Anticoagulants|anticoagulants|mesh-ancestor
6727399|NCT01880216|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6727400|NCT01880216|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6727401|NCT01880216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727402|NCT01880307|Prednisolone|prednisolone|mesh-list
6727403|NCT01880307|Azathioprine|azathioprine|mesh-list
6727404|NCT01880307|Infliximab|infliximab|mesh-list
6727405|NCT01880307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6727406|NCT01880307|Glucocorticoids|glucocorticoids|mesh-ancestor
6727407|NCT01880307|Hormones|hormones|mesh-ancestor
6727408|NCT01880307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6727409|NCT01880307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727410|NCT01880307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6727411|NCT01880307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6727412|NCT01880307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6727413|NCT01880307|Dermatologic Agents|dermatologic agents|mesh-ancestor
6727414|NCT01880307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6727415|NCT01880307|Antimetabolites|antimetabolites|mesh-ancestor
6727416|NCT01880307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727417|NCT01880307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6727418|NCT01880307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6727419|NCT01880307|Immunologic Factors|immunologic factors|mesh-ancestor
6727420|NCT01880346|Vitamin D|vitamin d|mesh-list
6727421|NCT01880346|Ergocalciferols|ergocalciferols|mesh-list
6727422|NCT01880346|Cholecalciferol|cholecalciferol|mesh-list
6727423|NCT01880346|Vitamins|vitamins|mesh-list
6727424|NCT01880346|Micronutrients|micronutrients|mesh-ancestor
6727425|NCT01880346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727426|NCT01880346|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6727427|NCT01880346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6727428|NCT01880359|Nimorazole|nimorazole|mesh-list
6727429|NCT01880359|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
6727430|NCT01880359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6727431|NCT01880359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6727432|NCT01880359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6727433|NCT01880372|Thioctic Acid|thioctic acid|mesh-list
6727434|NCT01880372|Antioxidants|antioxidants|mesh-ancestor
6727435|NCT01880372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727436|NCT01880372|Protective Agents|protective agents|mesh-ancestor
6727437|NCT01880372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727438|NCT01880372|Vitamin B Complex|vitamin b complex|mesh-ancestor
6727439|NCT01880372|Vitamins|vitamins|mesh-ancestor
6727440|NCT01880372|Micronutrients|micronutrients|mesh-ancestor
6727441|NCT01880385|Cyclophosphamide|cyclophosphamide|mesh-list
6727442|NCT01880385|Bevacizumab|bevacizumab|mesh-list
6727443|NCT01880385|Docetaxel|docetaxel|mesh-list
6727444|NCT01880385|Fluorouracil|fluorouracil|mesh-list
6727445|NCT01880385|Trastuzumab|trastuzumab|mesh-list
6727446|NCT01880385|Epirubicin|epirubicin|mesh-list
6727447|NCT01880385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6727448|NCT01880385|Immunologic Factors|immunologic factors|mesh-ancestor
6727449|NCT01880385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727450|NCT01880385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6727451|NCT01880385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6727452|NCT01880385|Alkylating Agents|alkylating agents|mesh-ancestor
6727453|NCT01880385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727454|NCT01880385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6727455|NCT01880385|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6727456|NCT01880385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6727457|NCT01880385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6727458|NCT01880385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6727459|NCT01880385|Growth Substances|growth substances|mesh-ancestor
6727460|NCT01880385|Growth Inhibitors|growth inhibitors|mesh-ancestor
6727461|NCT01880385|Tubulin Modulators|tubulin modulators|mesh-ancestor
6727462|NCT01880385|Antimitotic Agents|antimitotic agents|mesh-ancestor
6727463|NCT01880385|Mitosis Modulators|mitosis modulators|mesh-ancestor
6727464|NCT01880385|Antimetabolites|antimetabolites|mesh-ancestor
6727465|NCT01880385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6727466|NCT01880385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6727467|NCT01880385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6727468|NCT01880385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6727469|NCT01880385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6727470|NCT01880463|Vitamin D|vitamin d|mesh-list
6727471|NCT01880463|Ergocalciferols|ergocalciferols|mesh-list
6727472|NCT01880463|Cholecalciferol|cholecalciferol|mesh-list
6727473|NCT01880463|Vitamins|vitamins|mesh-list
6727474|NCT01880463|Micronutrients|micronutrients|mesh-ancestor
6727475|NCT01880463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727476|NCT01880463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6727477|NCT01880463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6727478|NCT01880541|Anesthetics|anesthetics|mesh-list
6727479|NCT01880541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6727480|NCT01880541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727481|NCT01880619|Tamsulosin|tamsulosin|mesh-list
6727482|NCT01880619|Solifenacin Succinate|solifenacin succinate|mesh-list
6727483|NCT01880619|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6727484|NCT01880619|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6784894|NCT02205541|Eculizumab|eculizumab|mesh-list
6784895|NCT02205541|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6784896|NCT02205541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6784897|NCT02205541|Immunologic Factors|immunologic factors|mesh-ancestor
6784898|NCT02205541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784899|NCT02205554|Tramadol|tramadol|mesh-list
6784900|NCT02205554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6784901|NCT02205554|Narcotics|narcotics|mesh-ancestor
6727485|NCT01880619|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6727486|NCT01880619|Adrenergic Agents|adrenergic agents|mesh-ancestor
6727487|NCT01880619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6727488|NCT01880619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727489|NCT01880619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727490|NCT01880619|Urological Agents|urological agents|mesh-ancestor
6727491|NCT01880619|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6727492|NCT01880619|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6727493|NCT01880619|Cholinergic Agents|cholinergic agents|mesh-ancestor
6727494|NCT01880658|Capecitabine|capecitabine|mesh-list
6727495|NCT01880658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6727496|NCT01880658|Antimetabolites|antimetabolites|mesh-ancestor
6727497|NCT01880658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727498|NCT01880658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6727499|NCT01880749|Everolimus|everolimus|mesh-list
6727500|NCT01880749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6727501|NCT01880749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6727502|NCT01880749|Immunologic Factors|immunologic factors|mesh-ancestor
6727503|NCT01880749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727504|NCT01880775|Bupivacaine|bupivacaine|mesh-list
6727505|NCT01880775|Prilocaine|prilocaine|mesh-list
6727506|NCT01880775|Anesthetics, Local|anesthetics, local|mesh-ancestor
6727507|NCT01880775|Anesthetics|anesthetics|mesh-ancestor
6727508|NCT01880775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6727509|NCT01880775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727510|NCT01880775|Sensory System Agents|sensory system agents|mesh-ancestor
6727511|NCT01880775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6727512|NCT01880931|Remifentanil|remifentanil|mesh-list
6727513|NCT01880931|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6727514|NCT01880931|Narcotics|narcotics|mesh-ancestor
6727515|NCT01880931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6727516|NCT01880931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727517|NCT01880931|Analgesics|analgesics|mesh-ancestor
6727518|NCT01880931|Sensory System Agents|sensory system agents|mesh-ancestor
6727519|NCT01880931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6727520|NCT01880957|Lamotrigine|lamotrigine|mesh-list
6727521|NCT01880957|Lithium Carbonate|lithium carbonate|mesh-list
6727522|NCT01880957|Antidepressive Agents|antidepressive agents|mesh-ancestor
6727523|NCT01880957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6727524|NCT01880957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6727525|NCT01880957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727526|NCT01880957|Antimanic Agents|antimanic agents|mesh-ancestor
6727527|NCT01880957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6727528|NCT01880957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6727529|NCT01880957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727530|NCT01880957|Anticonvulsants|anticonvulsants|mesh-ancestor
6727531|NCT01880957|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6727532|NCT01880957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6727533|NCT01880957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6727534|NCT01880957|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6727535|NCT01880957|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6727536|NCT01881074|Listerine|listerine|mesh-list
6727537|NCT01881074|Triclosan|triclosan|mesh-list
6727538|NCT01881074|Sodium Fluoride|sodium fluoride|mesh-list
6727539|NCT01881074|Cariostatic Agents|cariostatic agents|mesh-ancestor
6727540|NCT01881074|Protective Agents|protective agents|mesh-ancestor
6727541|NCT01881074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727542|NCT01881074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6727543|NCT01881074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6727544|NCT01881074|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6727545|NCT01881074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6727546|NCT01881074|Antimetabolites|antimetabolites|mesh-ancestor
6727547|NCT01881074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727548|NCT01881074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6727549|NCT01881100|Listerine|listerine|mesh-list
6727550|NCT01881100|Fluorides|fluorides|mesh-list
6727551|NCT01881100|Fluorides, Topical|fluorides, topical|mesh-list
6727552|NCT01881100|Sodium Fluoride|sodium fluoride|mesh-list
6727553|NCT01881100|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
6727554|NCT01881100|Cariostatic Agents|cariostatic agents|mesh-ancestor
6727555|NCT01881100|Protective Agents|protective agents|mesh-ancestor
6727556|NCT01881100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727557|NCT01881100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6727558|NCT01881100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6727559|NCT01881308|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
6727560|NCT01881308|Antirheumatic Agents|antirheumatic agents|mesh-list
6727561|NCT01881308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6727562|NCT01881347|Resveratrol|resveratrol|mesh-list
6727563|NCT01881347|Antioxidants|antioxidants|mesh-ancestor
6727564|NCT01881347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727565|NCT01881347|Protective Agents|protective agents|mesh-ancestor
6727566|NCT01881347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727567|NCT01881347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6727568|NCT01881347|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6727569|NCT01881464|Adalimumab|adalimumab|mesh-list
6727570|NCT01881464|Infliximab|infliximab|mesh-list
6727571|NCT01881464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6727572|NCT01881464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6727573|NCT01881464|Dermatologic Agents|dermatologic agents|mesh-ancestor
6727574|NCT01881464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6727575|NCT01881503|HBOC 201|hboc 201|mesh-list
6727576|NCT01881503|Blood Substitutes|blood substitutes|mesh-ancestor
6727577|NCT01881568|Tranexamic Acid|tranexamic acid|mesh-list
6727578|NCT01881568|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6727579|NCT01881568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6727580|NCT01881568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727581|NCT01881568|Hemostatics|hemostatics|mesh-ancestor
6727582|NCT01881568|Coagulants|coagulants|mesh-ancestor
6784902|NCT02205554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6784903|NCT02205554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784904|NCT02205554|Analgesics|analgesics|mesh-ancestor
6784905|NCT02205554|Sensory System Agents|sensory system agents|mesh-ancestor
6784906|NCT02205554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6784907|NCT02205580|Sufentanil|sufentanil|mesh-list
6784908|NCT02205580|Dsuvia|dsuvia|mesh-list
6784909|NCT02205580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6784910|NCT02205580|Narcotics|narcotics|mesh-ancestor
6784911|NCT02205580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6784912|NCT02205580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784913|NCT02205580|Analgesics|analgesics|mesh-ancestor
6784914|NCT02205580|Sensory System Agents|sensory system agents|mesh-ancestor
6784915|NCT02205580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6784916|NCT02205580|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6784917|NCT02205580|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6784918|NCT02205580|Anesthetics, General|anesthetics, general|mesh-ancestor
6784919|NCT02205580|Anesthetics|anesthetics|mesh-ancestor
6784920|NCT02205619|Glycine|glycine|mesh-list
6784921|NCT02205619|Glycine Agents|glycine agents|mesh-ancestor
6784922|NCT02205619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6784923|NCT02205619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784924|NCT02205619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784925|NCT02205775|Atorvastatin|atorvastatin|mesh-list
6784926|NCT02205775|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6784927|NCT02205775|Ezetimibe|ezetimibe|mesh-list
6784928|NCT02205775|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6784929|NCT02205775|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6784930|NCT02205775|Antimetabolites|antimetabolites|mesh-ancestor
6784931|NCT02205775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784932|NCT02205775|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6784933|NCT02205775|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6784934|NCT02205775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6784935|NCT02205879|Pregabalin|pregabalin|mesh-list
6784936|NCT02205879|Analgesics|analgesics|mesh-ancestor
6784937|NCT02205879|Sensory System Agents|sensory system agents|mesh-ancestor
6784938|NCT02205879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6784939|NCT02205879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784940|NCT02205879|Anticonvulsants|anticonvulsants|mesh-ancestor
6784941|NCT02205879|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6784942|NCT02205879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6784943|NCT02205879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784944|NCT02205879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6784945|NCT02205879|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6784946|NCT02205879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6784947|NCT02205879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6784948|NCT02205879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6784949|NCT02205892|Lupeol|lupeol|mesh-list
6784950|NCT02205892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6784951|NCT02205931|Topiramate|topiramate|mesh-list
6784952|NCT02205931|Lamotrigine|lamotrigine|mesh-list
6784953|NCT02205931|Zonisamide|zonisamide|mesh-list
6784954|NCT02205931|Carbamazepine|carbamazepine|mesh-list
6784955|NCT02205931|Phenytoin|phenytoin|mesh-list
6784956|NCT02205931|Rufinamide|rufinamide|mesh-list
6784957|NCT02205931|Levetiracetam|levetiracetam|mesh-list
6727583|NCT01881763|Ketamine|ketamine|mesh-list
6727584|NCT01881763|Methohexital|methohexital|mesh-list
6727585|NCT01881763|Analgesics|analgesics|mesh-ancestor
6727586|NCT01881763|Sensory System Agents|sensory system agents|mesh-ancestor
6727587|NCT01881763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6727588|NCT01881763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727589|NCT01881763|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6727590|NCT01881763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6727591|NCT01881763|Anesthetics, General|anesthetics, general|mesh-ancestor
6727592|NCT01881763|Anesthetics|anesthetics|mesh-ancestor
6727593|NCT01881763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6727594|NCT01881763|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6727595|NCT01881763|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6727596|NCT01881763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6727597|NCT01881763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727598|NCT01881919|Quercetin|quercetin|mesh-list
6727599|NCT01881919|Antioxidants|antioxidants|mesh-ancestor
6727600|NCT01881919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727601|NCT01881919|Protective Agents|protective agents|mesh-ancestor
6727602|NCT01881919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727603|NCT01881971|Calcium|calcium|mesh-list
6727604|NCT01881971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6727605|NCT01881971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727606|NCT01881997|Fentanyl|fentanyl|mesh-list
6727607|NCT01881997|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6727608|NCT01881997|Narcotics|narcotics|mesh-ancestor
6727609|NCT01881997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6727610|NCT01881997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727611|NCT01881997|Analgesics|analgesics|mesh-ancestor
6727612|NCT01881997|Sensory System Agents|sensory system agents|mesh-ancestor
6727613|NCT01881997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6727614|NCT01881997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6727615|NCT01881997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6727616|NCT01881997|Anesthetics, General|anesthetics, general|mesh-ancestor
6727617|NCT01881997|Anesthetics|anesthetics|mesh-ancestor
6727618|NCT01882010|Sargramostim|sargramostim|mesh-list
6727619|NCT01882010|Immunologic Factors|immunologic factors|mesh-ancestor
6727620|NCT01882010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727621|NCT01882075|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
6727622|NCT01882075|Plasma Substitutes|plasma substitutes|mesh-ancestor
6727623|NCT01882075|Blood Substitutes|blood substitutes|mesh-ancestor
6727624|NCT01882127|Dexamethasone|dexamethasone|mesh-list
6727625|NCT01882127|Tretinoin|tretinoin|mesh-list
6727626|NCT01882127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6727627|NCT01882127|Antiemetics|antiemetics|mesh-ancestor
6727628|NCT01882127|Autonomic Agents|autonomic agents|mesh-ancestor
6727629|NCT01882127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6727630|NCT01882127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727631|NCT01882127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6727632|NCT01882127|Glucocorticoids|glucocorticoids|mesh-ancestor
6727633|NCT01882127|Hormones|hormones|mesh-ancestor
6727634|NCT01882127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6727635|NCT01882127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6727636|NCT01882127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6727637|NCT01882127|Keratolytic Agents|keratolytic agents|mesh-ancestor
6727638|NCT01882127|Dermatologic Agents|dermatologic agents|mesh-ancestor
6727639|NCT01882179|Canrenoic Acid|canrenoic acid|mesh-list
6727640|NCT01882179|Mineralocorticoids|mineralocorticoids|mesh-list
6727641|NCT01882179|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
6727642|NCT01882179|Hormones|hormones|mesh-ancestor
6727643|NCT01882179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6727644|NCT01882179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727645|NCT01882179|Hormone Antagonists|hormone antagonists|mesh-ancestor
6727646|NCT01882179|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6727647|NCT01882179|Diuretics|diuretics|mesh-ancestor
6727648|NCT01882179|Natriuretic Agents|natriuretic agents|mesh-ancestor
6727649|NCT01882296|Pantoprazole|pantoprazole|mesh-list
6727650|NCT01882296|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6727651|NCT01882296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6727652|NCT01882296|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6727653|NCT01882296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6727654|NCT01882296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727655|NCT01882322|Tacrolimus|tacrolimus|mesh-list
6727656|NCT01882322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6727657|NCT01882322|Immunologic Factors|immunologic factors|mesh-ancestor
6727658|NCT01882322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727659|NCT01882322|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6727660|NCT01882322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6727661|NCT01882322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727662|NCT01882361|Naltrexone|naltrexone|mesh-list
6727663|NCT01882361|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6727664|NCT01882361|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6727665|NCT01882361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727666|NCT01882361|Sensory System Agents|sensory system agents|mesh-ancestor
6727667|NCT01882361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6727668|NCT01882374|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
6727669|NCT01882374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6727670|NCT01882374|Vasodilator Agents|vasodilator agents|mesh-ancestor
6727671|NCT01882387|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
6727672|NCT01882387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6727673|NCT01882387|Vasodilator Agents|vasodilator agents|mesh-ancestor
6727674|NCT01882400|Alendronate|alendronate|mesh-list
6727675|NCT01882400|Risedronic Acid|risedronic acid|mesh-list
6727676|NCT01882400|Diphosphonates|diphosphonates|mesh-list
6727677|NCT01882400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6727678|NCT01882400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727679|NCT01882400|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6727680|NCT01882400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6727681|NCT01882400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727682|NCT01882400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6727683|NCT01882530|Acetaminophen|acetaminophen|mesh-list
6727684|NCT01882530|Ketoprofen|ketoprofen|mesh-list
6727685|NCT01882530|Morphine|morphine|mesh-list
6727686|NCT01882530|Nefopam|nefopam|mesh-list
6727687|NCT01882530|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6727688|NCT01882530|Narcotics|narcotics|mesh-ancestor
6727689|NCT01882530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6727690|NCT01882530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727691|NCT01882530|Analgesics|analgesics|mesh-ancestor
6727692|NCT01882530|Sensory System Agents|sensory system agents|mesh-ancestor
6727693|NCT01882530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6727694|NCT01882530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6727695|NCT01882530|Antipyretics|antipyretics|mesh-ancestor
6727696|NCT01882530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6727697|NCT01882530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6727698|NCT01882530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6727699|NCT01882530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6727700|NCT01882530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6727701|NCT01882530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727702|NCT01882556|Botulinum Toxins|botulinum toxins|mesh-list
6727703|NCT01882556|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6727704|NCT01882556|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6727705|NCT01882556|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6727706|NCT01882556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6727707|NCT01882556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727708|NCT01882556|Cholinergic Agents|cholinergic agents|mesh-ancestor
6727709|NCT01882556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6727710|NCT01882556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727711|NCT01882556|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6727712|NCT01882556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6727713|NCT01882660|Decitabine|decitabine|mesh-list
6727714|NCT01882660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6727715|NCT01882660|Antimetabolites|antimetabolites|mesh-ancestor
6727716|NCT01882660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727717|NCT01882660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6727718|NCT01882660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6727719|NCT01882920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6727720|NCT01883011|Piracetam|piracetam|mesh-list
6727721|NCT01883011|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6727722|NCT01883011|Protective Agents|protective agents|mesh-ancestor
6727723|NCT01883011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727724|NCT01883011|Nootropic Agents|nootropic agents|mesh-ancestor
6727725|NCT01883024|Insulin|insulin|mesh-list
6727726|NCT01883024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6727727|NCT01883024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727728|NCT01883102|Capsaicin|capsaicin|mesh-list
6727729|NCT01883102|Antipruritics|antipruritics|mesh-ancestor
6727730|NCT01883102|Dermatologic Agents|dermatologic agents|mesh-ancestor
6727731|NCT01883102|Sensory System Agents|sensory system agents|mesh-ancestor
6727732|NCT01883102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6784958|NCT02205931|Valproic Acid|valproic acid|mesh-list
6727733|NCT01883102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727734|NCT01883167|Febuxostat|febuxostat|mesh-list
6727735|NCT01883167|Verinurad|verinurad|mesh-list
6727736|NCT01883167|Gout Suppressants|gout suppressants|mesh-ancestor
6727737|NCT01883167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6727738|NCT01883193|Micronutrients|micronutrients|mesh-list
6727739|NCT01883193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727740|NCT01883232|Lidocaine|lidocaine|mesh-list
6727741|NCT01883232|Epinephrine|epinephrine|mesh-list
6727742|NCT01883232|Anesthetics, Local|anesthetics, local|mesh-ancestor
6727743|NCT01883232|Anesthetics|anesthetics|mesh-ancestor
6727744|NCT01883232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6727745|NCT01883232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727746|NCT01883232|Sensory System Agents|sensory system agents|mesh-ancestor
6727747|NCT01883232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6727748|NCT01883232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6727749|NCT01883232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6727750|NCT01883232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6727751|NCT01883232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6727752|NCT01883232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727753|NCT01883232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6727754|NCT01883232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6727755|NCT01883232|Adrenergic Agents|adrenergic agents|mesh-ancestor
6727756|NCT01883232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6727757|NCT01883232|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6727758|NCT01883232|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6727759|NCT01883232|Autonomic Agents|autonomic agents|mesh-ancestor
6727760|NCT01883232|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6727761|NCT01883232|Respiratory System Agents|respiratory system agents|mesh-ancestor
6727762|NCT01883232|Mydriatics|mydriatics|mesh-ancestor
6727763|NCT01883232|Sympathomimetics|sympathomimetics|mesh-ancestor
6727764|NCT01883232|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6784959|NCT02205931|Clonazepam|clonazepam|mesh-list
6784960|NCT02205931|Vigabatrin|vigabatrin|mesh-list
6784961|NCT02205931|Anticonvulsants|anticonvulsants|mesh-list
6784962|NCT02205931|Clobazam|clobazam|mesh-list
6784963|NCT02205931|Ethosuximide|ethosuximide|mesh-list
6784964|NCT02205931|Stiripentol|stiripentol|mesh-list
6784965|NCT02205931|Nitrazepam|nitrazepam|mesh-list
6784966|NCT02205931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6784967|NCT02205931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784968|NCT02205931|Nootropic Agents|nootropic agents|mesh-ancestor
6784969|NCT02205931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6784970|NCT02205931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6784971|NCT02205931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784972|NCT02205931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6784973|NCT02205931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6784974|NCT02205931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6784975|NCT02205931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6784976|NCT02205931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6784977|NCT02205931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6784978|NCT02205931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6784979|NCT02205931|GABA Agents|gaba agents|mesh-ancestor
6784980|NCT02205931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6784981|NCT02205931|Antimanic Agents|antimanic agents|mesh-ancestor
6784982|NCT02205931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6784983|NCT02205931|Analgesics|analgesics|mesh-ancestor
6784984|NCT02205931|Sensory System Agents|sensory system agents|mesh-ancestor
6784985|NCT02205931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6784986|NCT02205931|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6784987|NCT02205931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6784988|NCT02205931|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6784989|NCT02205931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6784990|NCT02205931|GABA Modulators|gaba modulators|mesh-ancestor
6784991|NCT02205931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6784992|NCT02205931|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6784993|NCT02205931|GABA Agonists|gaba agonists|mesh-ancestor
6784994|NCT02205931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6784995|NCT02205996|Insulin|insulin|mesh-list
6784996|NCT02205996|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6727765|NCT01883297|Aldesleukin|aldesleukin|mesh-list
6727766|NCT01883297|Cyclophosphamide|cyclophosphamide|mesh-list
6727767|NCT01883297|Interleukin-2|interleukin-2|mesh-list
6727768|NCT01883297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6727769|NCT01883297|Immunologic Factors|immunologic factors|mesh-ancestor
6727770|NCT01883297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727771|NCT01883297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6727772|NCT01883297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6727773|NCT01883297|Alkylating Agents|alkylating agents|mesh-ancestor
6727774|NCT01883297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727775|NCT01883297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6727776|NCT01883297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6727777|NCT01883297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6727778|NCT01883297|Analgesics|analgesics|mesh-ancestor
6727779|NCT01883297|Sensory System Agents|sensory system agents|mesh-ancestor
6727780|NCT01883297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6727781|NCT01883297|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6727782|NCT01883297|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6727783|NCT01883297|Antiviral Agents|antiviral agents|mesh-ancestor
6727784|NCT01883297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6727785|NCT01883323|Aldesleukin|aldesleukin|mesh-list
6727786|NCT01883323|Cyclophosphamide|cyclophosphamide|mesh-list
6727787|NCT01883323|Fludarabine|fludarabine|mesh-list
6727788|NCT01883323|Interleukin-2|interleukin-2|mesh-list
6727789|NCT01883323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6727790|NCT01883323|Immunologic Factors|immunologic factors|mesh-ancestor
6727791|NCT01883323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727792|NCT01883323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6727793|NCT01883323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6727794|NCT01883323|Alkylating Agents|alkylating agents|mesh-ancestor
6727795|NCT01883323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727796|NCT01883323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6727797|NCT01883323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6727798|NCT01883323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6727799|NCT01883323|Analgesics|analgesics|mesh-ancestor
6727800|NCT01883323|Sensory System Agents|sensory system agents|mesh-ancestor
6727801|NCT01883323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6727802|NCT01883323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6727803|NCT01883323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6727804|NCT01883323|Antiviral Agents|antiviral agents|mesh-ancestor
6727805|NCT01883323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6727806|NCT01883505|Levodopa|levodopa|mesh-list
6727807|NCT01883505|Carbidopa|carbidopa|mesh-list
6727808|NCT01883505|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6727809|NCT01883505|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6727810|NCT01883505|Dopamine Agents|dopamine agents|mesh-ancestor
6727811|NCT01883505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6727812|NCT01883505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727813|NCT01883505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727814|NCT01883505|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6727815|NCT01883505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6727816|NCT01883518|Vaccines|vaccines|mesh-list
6727817|NCT01883518|Immunologic Factors|immunologic factors|mesh-ancestor
6727818|NCT01883518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727819|NCT01883531|Mannitol|mannitol|mesh-list
6727820|NCT01883531|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6727821|NCT01883531|Diuretics|diuretics|mesh-ancestor
6727822|NCT01883531|Natriuretic Agents|natriuretic agents|mesh-ancestor
6727823|NCT01883531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727824|NCT01883596|Chlorhexidine|chlorhexidine|mesh-list
6727825|NCT01883596|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6727826|NCT01883596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6727827|NCT01883596|Disinfectants|disinfectants|mesh-ancestor
6727828|NCT01883869|Ticagrelor|ticagrelor|mesh-list
6727829|NCT01883869|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6727830|NCT01883869|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6727831|NCT01883869|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6727832|NCT01883869|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6727833|NCT01883869|Purinergic Agents|purinergic agents|mesh-ancestor
6727834|NCT01883869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6727835|NCT01883869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727836|NCT01883869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727837|NCT01883882|Analgesics, Opioid|analgesics, opioid|mesh-list
6727838|NCT01883882|Narcotics|narcotics|mesh-ancestor
6727839|NCT01883882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6727840|NCT01883882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727841|NCT01883882|Analgesics|analgesics|mesh-ancestor
6727842|NCT01883882|Sensory System Agents|sensory system agents|mesh-ancestor
6727843|NCT01883882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6727844|NCT01883921|Immunoglobulins|immunoglobulins|mesh-list
6727845|NCT01883921|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6727846|NCT01883921|Antibodies|antibodies|mesh-list
6727847|NCT01883921|Immunologic Factors|immunologic factors|mesh-ancestor
6727848|NCT01883921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727849|NCT01884038|Treprostinil|treprostinil|mesh-list
6727850|NCT01884038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6727851|NCT01884116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
6727852|NCT01884116|Capsaicin|capsaicin|mesh-list
6727853|NCT01884116|Antipruritics|antipruritics|mesh-ancestor
6727854|NCT01884116|Dermatologic Agents|dermatologic agents|mesh-ancestor
6727855|NCT01884116|Sensory System Agents|sensory system agents|mesh-ancestor
6727856|NCT01884116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6727857|NCT01884116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727858|NCT01884116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6727859|NCT01884116|Analgesics|analgesics|mesh-ancestor
6727860|NCT01884116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6727861|NCT01884116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6727862|NCT01884259|Docetaxel|docetaxel|mesh-list
6727863|NCT01884259|Fluorouracil|fluorouracil|mesh-list
6727864|NCT01884259|Cetuximab|cetuximab|mesh-list
6727865|NCT01884259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6727866|NCT01884259|Tubulin Modulators|tubulin modulators|mesh-ancestor
6727867|NCT01884259|Antimitotic Agents|antimitotic agents|mesh-ancestor
6727868|NCT01884259|Mitosis Modulators|mitosis modulators|mesh-ancestor
6727869|NCT01884259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727870|NCT01884259|Antimetabolites|antimetabolites|mesh-ancestor
6727871|NCT01884259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6727872|NCT01884259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6727873|NCT01884259|Immunologic Factors|immunologic factors|mesh-ancestor
6727874|NCT01884259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727875|NCT01884259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6727876|NCT01884272|Naproxen|naproxen|mesh-list
6727877|NCT01884272|Indomethacin|indomethacin|mesh-list
6727878|NCT01884272|Lesinurad|lesinurad|mesh-list
6727879|NCT01884272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6727880|NCT01884272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6727881|NCT01884272|Analgesics|analgesics|mesh-ancestor
6727882|NCT01884272|Sensory System Agents|sensory system agents|mesh-ancestor
6727883|NCT01884272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6727884|NCT01884272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727885|NCT01884272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6727886|NCT01884272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6727887|NCT01884272|Gout Suppressants|gout suppressants|mesh-ancestor
6727888|NCT01884272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6727889|NCT01884272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6727890|NCT01884272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727891|NCT01884272|Tocolytic Agents|tocolytic agents|mesh-ancestor
6727892|NCT01884272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6727893|NCT01884272|Uricosuric Agents|uricosuric agents|mesh-ancestor
6727894|NCT01884272|Renal Agents|renal agents|mesh-ancestor
6727895|NCT01884285|Abiraterone Acetate|abiraterone acetate|mesh-list
6727896|NCT01884285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6727897|NCT01884285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6727898|NCT01884285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6727899|NCT01884285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727900|NCT01884285|Hormone Antagonists|hormone antagonists|mesh-ancestor
6727901|NCT01884285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6727902|NCT01884285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727903|NCT01884285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6727904|NCT01884298|Lidocaine|lidocaine|mesh-list
6727905|NCT01884298|Remifentanil|remifentanil|mesh-list
6727906|NCT01884298|Anesthetics, Local|anesthetics, local|mesh-ancestor
6727907|NCT01884298|Anesthetics|anesthetics|mesh-ancestor
6727908|NCT01884298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6727909|NCT01884298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727910|NCT01884298|Sensory System Agents|sensory system agents|mesh-ancestor
6727911|NCT01884298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6727912|NCT01884298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6727913|NCT01884298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6727914|NCT01884298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6727915|NCT01884298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6727916|NCT01884298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727917|NCT01884298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6727918|NCT01884298|Narcotics|narcotics|mesh-ancestor
6727919|NCT01884298|Analgesics|analgesics|mesh-ancestor
6727920|NCT01884402|Ribavirin|ribavirin|mesh-list
6727921|NCT01884402|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6727922|NCT01884402|Antimetabolites|antimetabolites|mesh-ancestor
6727923|NCT01884402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727924|NCT01884402|Antiviral Agents|antiviral agents|mesh-ancestor
6727925|NCT01884402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6727926|NCT01884415|Vaccines|vaccines|mesh-list
6727927|NCT01884415|Immunologic Factors|immunologic factors|mesh-ancestor
6727928|NCT01884415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727929|NCT01884428|Gemcitabine|gemcitabine|mesh-list
6727930|NCT01884428|Prednisolone|prednisolone|mesh-list
6727931|NCT01884428|Vinorelbine|vinorelbine|mesh-list
6727932|NCT01884428|Ifosfamide|ifosfamide|mesh-list
6727933|NCT01884428|Panobinostat|panobinostat|mesh-list
6727934|NCT01884428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6727935|NCT01884428|Antimetabolites|antimetabolites|mesh-ancestor
6727936|NCT01884428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727937|NCT01884428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6727938|NCT01884428|Antiviral Agents|antiviral agents|mesh-ancestor
6727939|NCT01884428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6727940|NCT01884428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6727941|NCT01884428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6727942|NCT01884428|Immunologic Factors|immunologic factors|mesh-ancestor
6727943|NCT01884428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727944|NCT01884428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6727945|NCT01884428|Glucocorticoids|glucocorticoids|mesh-ancestor
6727946|NCT01884428|Hormones|hormones|mesh-ancestor
6727947|NCT01884428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6727948|NCT01884428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6727949|NCT01884428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6727950|NCT01884428|Tubulin Modulators|tubulin modulators|mesh-ancestor
6727951|NCT01884428|Antimitotic Agents|antimitotic agents|mesh-ancestor
6727952|NCT01884428|Mitosis Modulators|mitosis modulators|mesh-ancestor
6727953|NCT01884428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6727954|NCT01884428|Alkylating Agents|alkylating agents|mesh-ancestor
6727955|NCT01884428|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6727956|NCT01884441|Gemcitabine|gemcitabine|mesh-list
6727957|NCT01884441|Vinorelbine|vinorelbine|mesh-list
6727958|NCT01884441|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6727959|NCT01884441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6727960|NCT01884441|Antimetabolites|antimetabolites|mesh-ancestor
6727961|NCT01884441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727962|NCT01884441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6727963|NCT01884441|Antiviral Agents|antiviral agents|mesh-ancestor
6727964|NCT01884441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6727965|NCT01884441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6727966|NCT01884441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6727967|NCT01884441|Immunologic Factors|immunologic factors|mesh-ancestor
6727968|NCT01884441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727969|NCT01884441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6727970|NCT01884441|Tubulin Modulators|tubulin modulators|mesh-ancestor
6727971|NCT01884441|Antimitotic Agents|antimitotic agents|mesh-ancestor
6727972|NCT01884441|Mitosis Modulators|mitosis modulators|mesh-ancestor
6727973|NCT01884441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6727974|NCT01884441|Alkylating Agents|alkylating agents|mesh-ancestor
6727975|NCT01884467|Gentamicins|gentamicins|mesh-list
6727976|NCT01884467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6727977|NCT01884467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6727978|NCT01884467|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6727979|NCT01884467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6727980|NCT01884467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727981|NCT01884506|Iron|iron|mesh-list
6727982|NCT01884506|Ascorbic Acid|ascorbic acid|mesh-list
6727983|NCT01884506|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6727984|NCT01884506|Trace Elements|trace elements|mesh-ancestor
6727985|NCT01884506|Micronutrients|micronutrients|mesh-ancestor
6727986|NCT01884506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727987|NCT01884506|Antioxidants|antioxidants|mesh-ancestor
6727988|NCT01884506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6727989|NCT01884506|Protective Agents|protective agents|mesh-ancestor
6727990|NCT01884506|Vitamins|vitamins|mesh-ancestor
6727991|NCT01884558|Metformin|metformin|mesh-list
6727992|NCT01884558|Isavuconazole|isavuconazole|mesh-list
6727993|NCT01884558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6727994|NCT01884558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6727995|NCT01884558|Antifungal Agents|antifungal agents|mesh-ancestor
6727996|NCT01884558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6727997|NCT01884623|Methotrexate|methotrexate|mesh-list
6727998|NCT01884623|Cetuximab|cetuximab|mesh-list
6727999|NCT01884623|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6728000|NCT01884623|Abortifacient Agents|abortifacient agents|mesh-ancestor
6728001|NCT01884623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6728002|NCT01884623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728003|NCT01884623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6728004|NCT01884623|Antimetabolites|antimetabolites|mesh-ancestor
6728005|NCT01884623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728006|NCT01884623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6728007|NCT01884623|Dermatologic Agents|dermatologic agents|mesh-ancestor
6728008|NCT01884623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6728009|NCT01884623|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6728010|NCT01884623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6728011|NCT01884623|Immunologic Factors|immunologic factors|mesh-ancestor
6728012|NCT01884623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6728013|NCT01884623|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6728014|NCT01884623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6728015|NCT01884636|Isavuconazole|isavuconazole|mesh-list
6728016|NCT01884636|Methotrexate|methotrexate|mesh-list
6728017|NCT01884636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6728018|NCT01884636|Abortifacient Agents|abortifacient agents|mesh-ancestor
6728019|NCT01884636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6728020|NCT01884636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728021|NCT01884636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6728022|NCT01884636|Antimetabolites|antimetabolites|mesh-ancestor
6728023|NCT01884636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728024|NCT01884636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6728025|NCT01884636|Dermatologic Agents|dermatologic agents|mesh-ancestor
6728026|NCT01884636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6728027|NCT01884636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6728028|NCT01884636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6728029|NCT01884636|Immunologic Factors|immunologic factors|mesh-ancestor
6728030|NCT01884636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6728031|NCT01884636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6728032|NCT01884636|Antifungal Agents|antifungal agents|mesh-ancestor
6728033|NCT01884636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6728034|NCT01884740|Bevacizumab|bevacizumab|mesh-list
6728035|NCT01884740|Cetuximab|cetuximab|mesh-list
6728036|NCT01884740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6728037|NCT01884740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6728038|NCT01884740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6728039|NCT01884740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6728040|NCT01884740|Growth Substances|growth substances|mesh-ancestor
6728041|NCT01884740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728042|NCT01884740|Growth Inhibitors|growth inhibitors|mesh-ancestor
6728043|NCT01884857|Metoprolol|metoprolol|mesh-list
6728044|NCT01884857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6728045|NCT01884857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6728046|NCT01884857|Sympatholytics|sympatholytics|mesh-ancestor
6728047|NCT01884857|Autonomic Agents|autonomic agents|mesh-ancestor
6728048|NCT01884857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6728049|NCT01884857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728050|NCT01884857|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6728051|NCT01884857|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6728052|NCT01884857|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6728053|NCT01884857|Adrenergic Agents|adrenergic agents|mesh-ancestor
6728054|NCT01884857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6728055|NCT01884857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6784997|NCT02205996|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6784998|NCT02205996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6784999|NCT02206022|Remifentanil|remifentanil|mesh-list
6785000|NCT02206022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6785001|NCT02206022|Narcotics|narcotics|mesh-ancestor
6785002|NCT02206022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6785003|NCT02206022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785004|NCT02206022|Analgesics|analgesics|mesh-ancestor
6785005|NCT02206022|Sensory System Agents|sensory system agents|mesh-ancestor
6785006|NCT02206022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6785007|NCT02206035|Methotrexate|methotrexate|mesh-list
6785008|NCT02206035|Tacrolimus|tacrolimus|mesh-list
6728056|NCT01884896|Metoprolol|metoprolol|mesh-list
6728057|NCT01884896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6728058|NCT01884896|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6728059|NCT01884896|Sympatholytics|sympatholytics|mesh-ancestor
6728060|NCT01884896|Autonomic Agents|autonomic agents|mesh-ancestor
6728061|NCT01884896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6728062|NCT01884896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728063|NCT01884896|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6728064|NCT01884896|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6728065|NCT01884896|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6728066|NCT01884896|Adrenergic Agents|adrenergic agents|mesh-ancestor
6728067|NCT01884896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6728068|NCT01884896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728069|NCT01884909|Metoprolol|metoprolol|mesh-list
6728070|NCT01884909|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6728071|NCT01884909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6728072|NCT01884909|Sympatholytics|sympatholytics|mesh-ancestor
6728073|NCT01884909|Autonomic Agents|autonomic agents|mesh-ancestor
6728074|NCT01884909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6728075|NCT01884909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728076|NCT01884909|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6728077|NCT01884909|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6728078|NCT01884909|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6728079|NCT01884909|Adrenergic Agents|adrenergic agents|mesh-ancestor
6728080|NCT01884909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6728081|NCT01884909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728082|NCT01884922|Vinblastine|vinblastine|mesh-list
6728083|NCT01884922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6728084|NCT01884922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6728085|NCT01884922|Tubulin Modulators|tubulin modulators|mesh-ancestor
6728086|NCT01884922|Antimitotic Agents|antimitotic agents|mesh-ancestor
6728087|NCT01884922|Mitosis Modulators|mitosis modulators|mesh-ancestor
6728088|NCT01884922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728089|NCT01884935|Natalizumab|natalizumab|mesh-list
6728090|NCT01884935|Immunologic Factors|immunologic factors|mesh-ancestor
6728091|NCT01884935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728092|NCT01885013|Metformin|metformin|mesh-list
6728093|NCT01885013|Cyclophosphamide|cyclophosphamide|mesh-list
6728094|NCT01885013|Doxorubicin|doxorubicin|mesh-list
6728095|NCT01885013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6728096|NCT01885013|Immunologic Factors|immunologic factors|mesh-ancestor
6728097|NCT01885013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728098|NCT01885013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6728099|NCT01885013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6728100|NCT01885013|Alkylating Agents|alkylating agents|mesh-ancestor
6728101|NCT01885013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728102|NCT01885013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6728103|NCT01885013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6728104|NCT01885013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6728105|NCT01885013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6728106|NCT01885013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6728107|NCT01885013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6728108|NCT01885013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6728109|NCT01885091|Kinetin|kinetin|mesh-list
6728110|NCT01885091|Plant Growth Regulators|plant growth regulators|mesh-ancestor
6728111|NCT01885091|Growth Substances|growth substances|mesh-ancestor
6728112|NCT01885091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728113|NCT01885130|Dimenhydrinate|dimenhydrinate|mesh-list
6728114|NCT01885130|Antiemetics|antiemetics|mesh-ancestor
6728115|NCT01885130|Autonomic Agents|autonomic agents|mesh-ancestor
6728116|NCT01885130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6728117|NCT01885130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728118|NCT01885130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6728119|NCT01885130|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6728120|NCT01885130|Histamine Antagonists|histamine antagonists|mesh-ancestor
6728121|NCT01885130|Histamine Agents|histamine agents|mesh-ancestor
6728122|NCT01885130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6728123|NCT01885130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728124|NCT01885338|Acetylcysteine|acetylcysteine|mesh-list
6728125|NCT01885338|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6728126|NCT01885338|Antiviral Agents|antiviral agents|mesh-ancestor
6728127|NCT01885338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6728128|NCT01885338|Expectorants|expectorants|mesh-ancestor
6728129|NCT01885338|Respiratory System Agents|respiratory system agents|mesh-ancestor
6728130|NCT01885338|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6728131|NCT01885338|Antioxidants|antioxidants|mesh-ancestor
6728132|NCT01885338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728133|NCT01885338|Protective Agents|protective agents|mesh-ancestor
6728134|NCT01885338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728135|NCT01885338|Antidotes|antidotes|mesh-ancestor
6728136|NCT01885364|Remifentanil|remifentanil|mesh-list
6728137|NCT01885364|Propofol|propofol|mesh-list
6728138|NCT01885364|Esmolol|esmolol|mesh-list
6728139|NCT01885364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6728140|NCT01885364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6728141|NCT01885364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728142|NCT01885364|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6728143|NCT01885364|Anesthetics, General|anesthetics, general|mesh-ancestor
6728144|NCT01885364|Anesthetics|anesthetics|mesh-ancestor
6728145|NCT01885364|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6728146|NCT01885364|Narcotics|narcotics|mesh-ancestor
6728147|NCT01885364|Analgesics|analgesics|mesh-ancestor
6728148|NCT01885364|Sensory System Agents|sensory system agents|mesh-ancestor
6728149|NCT01885364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6728150|NCT01885364|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6728151|NCT01885364|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6728152|NCT01885364|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6728153|NCT01885364|Adrenergic Agents|adrenergic agents|mesh-ancestor
6728154|NCT01885364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6728155|NCT01885364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728156|NCT01885481|Dexamethasone|dexamethasone|mesh-list
6728157|NCT01885481|Dexamethasone acetate|dexamethasone acetate|mesh-list
6728158|NCT01885481|Betamethasone|betamethasone|mesh-list
6728159|NCT01885481|Betamethasone Valerate|betamethasone valerate|mesh-list
6728160|NCT01885481|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
6728161|NCT01885481|Betamethasone benzoate|betamethasone benzoate|mesh-list
6728162|NCT01885481|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
6728163|NCT01885481|BB 1101|bb 1101|mesh-list
6728164|NCT01885481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6728165|NCT01885481|Antiemetics|antiemetics|mesh-ancestor
6728166|NCT01885481|Autonomic Agents|autonomic agents|mesh-ancestor
6728167|NCT01885481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6728168|NCT01885481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728169|NCT01885481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6728170|NCT01885481|Glucocorticoids|glucocorticoids|mesh-ancestor
6728171|NCT01885481|Hormones|hormones|mesh-ancestor
6728172|NCT01885481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6728173|NCT01885481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6728174|NCT01885481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6728175|NCT01885481|Protease Inhibitors|protease inhibitors|mesh-ancestor
6728176|NCT01885481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6728177|NCT01885481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728178|NCT01885481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6728179|NCT01885481|Respiratory System Agents|respiratory system agents|mesh-ancestor
6728180|NCT01885585|Apixaban|apixaban|mesh-list
6728181|NCT01885585|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6728182|NCT01885585|Antithrombins|antithrombins|mesh-ancestor
6728183|NCT01885585|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6728184|NCT01885585|Protease Inhibitors|protease inhibitors|mesh-ancestor
6728185|NCT01885585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6728186|NCT01885585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728187|NCT01885585|Anticoagulants|anticoagulants|mesh-ancestor
6728188|NCT01885598|Apixaban|apixaban|mesh-list
6728189|NCT01885598|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6728190|NCT01885598|Antithrombins|antithrombins|mesh-ancestor
6728191|NCT01885598|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6728192|NCT01885598|Protease Inhibitors|protease inhibitors|mesh-ancestor
6728193|NCT01885598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6728194|NCT01885598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728195|NCT01885598|Anticoagulants|anticoagulants|mesh-ancestor
6728196|NCT01885715|Neostigmine|neostigmine|mesh-list
6728197|NCT01885715|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6728198|NCT01885715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6728199|NCT01885715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728200|NCT01885715|Cholinergic Agents|cholinergic agents|mesh-ancestor
6728201|NCT01885715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6728202|NCT01885715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728203|NCT01885715|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6728204|NCT01885715|Autonomic Agents|autonomic agents|mesh-ancestor
6728205|NCT01885715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6728206|NCT01885988|Nebivolol|nebivolol|mesh-list
6728207|NCT01885988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6728208|NCT01885988|Vasodilator Agents|vasodilator agents|mesh-ancestor
6728209|NCT01885988|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6728210|NCT01885988|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6728211|NCT01885988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6728212|NCT01885988|Adrenergic Agents|adrenergic agents|mesh-ancestor
6728213|NCT01885988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6728214|NCT01885988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728215|NCT01885988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728216|NCT01886001|Chlorhexidine|chlorhexidine|mesh-list
6728217|NCT01886001|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6728218|NCT01886001|Povidone-Iodine|povidone-iodine|mesh-list
6728219|NCT01886001|Povidone|povidone|mesh-list
6728220|NCT01886001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6728221|NCT01886001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6728222|NCT01886001|Disinfectants|disinfectants|mesh-ancestor
6728223|NCT01886001|Dermatologic Agents|dermatologic agents|mesh-ancestor
6728224|NCT01886001|Plasma Substitutes|plasma substitutes|mesh-ancestor
6728225|NCT01886001|Blood Substitutes|blood substitutes|mesh-ancestor
6728226|NCT01886014|Oxytocin|oxytocin|mesh-list
6728227|NCT01886014|Oxytocics|oxytocics|mesh-ancestor
6728228|NCT01886014|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6728229|NCT01886014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728230|NCT01886053|Ertapenem|ertapenem|mesh-list
6728231|NCT01886053|beta-Lactams|beta-lactams|mesh-list
6728232|NCT01886053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6728233|NCT01886053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6728234|NCT01886079|Dexmedetomidine|dexmedetomidine|mesh-list
6728235|NCT01886079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6728236|NCT01886079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6728237|NCT01886079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728238|NCT01886079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6728239|NCT01886079|Analgesics|analgesics|mesh-ancestor
6728240|NCT01886079|Sensory System Agents|sensory system agents|mesh-ancestor
6728241|NCT01886079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6728242|NCT01886079|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6728243|NCT01886079|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6728244|NCT01886079|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6728245|NCT01886079|Adrenergic Agents|adrenergic agents|mesh-ancestor
6728246|NCT01886079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6728247|NCT01886079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728248|NCT01886196|Ibuprofen|ibuprofen|mesh-list
6728249|NCT01886196|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
6728250|NCT01886196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
6728251|NCT01886196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6728252|NCT01886196|Analgesics|analgesics|mesh-ancestor
6728253|NCT01886196|Sensory System Agents|sensory system agents|mesh-ancestor
6728254|NCT01886196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6728255|NCT01886196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728256|NCT01886196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6728257|NCT01886196|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6728258|NCT01886196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6728259|NCT01886196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728260|NCT01886209|Prednisone|prednisone|mesh-list
6728261|NCT01886209|Methylprednisolone|methylprednisolone|mesh-list
6728262|NCT01886209|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6728263|NCT01886209|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6728264|NCT01886209|Prednisolone|prednisolone|mesh-list
6728265|NCT01886209|Prednisolone acetate|prednisolone acetate|mesh-list
6728266|NCT01886209|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6728267|NCT01886209|Prednisolone phosphate|prednisolone phosphate|mesh-list
6728268|NCT01886209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6728269|NCT01886209|Glucocorticoids|glucocorticoids|mesh-ancestor
6728270|NCT01886209|Hormones|hormones|mesh-ancestor
6728271|NCT01886209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6728272|NCT01886209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728273|NCT01886209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6728274|NCT01886209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6728275|NCT01886209|Antiemetics|antiemetics|mesh-ancestor
6728276|NCT01886209|Autonomic Agents|autonomic agents|mesh-ancestor
6728277|NCT01886209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6728278|NCT01886209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6728279|NCT01886209|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6728280|NCT01886209|Protective Agents|protective agents|mesh-ancestor
6728281|NCT01886248|Antithrombins|antithrombins|mesh-list
6728282|NCT01886248|Antithrombin III|antithrombin iii|mesh-list
6728283|NCT01886248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6728284|NCT01886248|Protease Inhibitors|protease inhibitors|mesh-ancestor
6728285|NCT01886248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6728286|NCT01886248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728287|NCT01886248|Anticoagulants|anticoagulants|mesh-ancestor
6728288|NCT01886352|Levobupivacaine|levobupivacaine|mesh-list
6728289|NCT01886352|Anesthetics, Local|anesthetics, local|mesh-ancestor
6728290|NCT01886352|Anesthetics|anesthetics|mesh-ancestor
6728291|NCT01886352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6728292|NCT01886352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728293|NCT01886352|Sensory System Agents|sensory system agents|mesh-ancestor
6728294|NCT01886352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6728295|NCT01886365|Insulin|insulin|mesh-list
6728296|NCT01886365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6728297|NCT01886365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728298|NCT01886404|Efavirenz|efavirenz|mesh-list
6728299|NCT01886404|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6728300|NCT01886404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6728301|NCT01886404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6728302|NCT01886404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728303|NCT01886404|Antiviral Agents|antiviral agents|mesh-ancestor
6728304|NCT01886404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6728305|NCT01886404|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6728306|NCT01886404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6728307|NCT01886404|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6728308|NCT01886404|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6728309|NCT01886404|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6728310|NCT01886404|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6728311|NCT01886443|Tocopherols|tocopherols|mesh-list
6728312|NCT01886443|Vitamin E|vitamin e|mesh-list
6728313|NCT01886443|alpha-Tocopherol|alpha-tocopherol|mesh-list
6728314|NCT01886443|Infliximab|infliximab|mesh-list
6728315|NCT01886443|Epoprostenol|epoprostenol|mesh-list
6728316|NCT01886443|Tezosentan|tezosentan|mesh-list
6728317|NCT01886443|Melatonin|melatonin|mesh-list
6728318|NCT01886443|Antithrombins|antithrombins|mesh-list
6728319|NCT01886443|Antithrombin III|antithrombin iii|mesh-list
6728320|NCT01886443|Epoetin Alfa|epoetin alfa|mesh-list
6728321|NCT01886443|Dermatologic Agents|dermatologic agents|mesh-ancestor
6728322|NCT01886443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6728323|NCT01886443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6728324|NCT01886443|Antioxidants|antioxidants|mesh-ancestor
6728325|NCT01886443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728326|NCT01886443|Protective Agents|protective agents|mesh-ancestor
6728327|NCT01886443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728328|NCT01886443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6728329|NCT01886443|Hematinics|hematinics|mesh-ancestor
6728330|NCT01886443|Vitamins|vitamins|mesh-ancestor
6728331|NCT01886443|Micronutrients|micronutrients|mesh-ancestor
6728332|NCT01886443|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6728333|NCT01886443|Protease Inhibitors|protease inhibitors|mesh-ancestor
6728334|NCT01886443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6728335|NCT01886443|Anticoagulants|anticoagulants|mesh-ancestor
6728336|NCT01886443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6728337|NCT01886443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6728338|NCT01886443|Vasodilator Agents|vasodilator agents|mesh-ancestor
6785009|NCT02206035|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6785010|NCT02206035|Abortifacient Agents|abortifacient agents|mesh-ancestor
6785011|NCT02206035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6785012|NCT02206035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785013|NCT02206035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6785014|NCT02206035|Antimetabolites|antimetabolites|mesh-ancestor
6785015|NCT02206035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785016|NCT02206035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6785017|NCT02206035|Dermatologic Agents|dermatologic agents|mesh-ancestor
6785018|NCT02206035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6785019|NCT02206035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6785020|NCT02206035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6785021|NCT02206035|Immunologic Factors|immunologic factors|mesh-ancestor
6785022|NCT02206035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6785023|NCT02206035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6785024|NCT02206035|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6785025|NCT02206048|Proflavine|proflavine|mesh-list
6785026|NCT02206048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6785027|NCT02206048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6785028|NCT02206165|Amlodipine|amlodipine|mesh-list
6785029|NCT02206165|Candesartan|candesartan|mesh-list
6785030|NCT02206165|Candesartan cilexetil|candesartan cilexetil|mesh-list
6785031|NCT02206165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6785032|NCT02206165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6785033|NCT02206165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6785034|NCT02206165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785035|NCT02206165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6785036|NCT02206165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785037|NCT02206165|Vasodilator Agents|vasodilator agents|mesh-ancestor
6785038|NCT02206165|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6785039|NCT02206165|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6785040|NCT02206178|Acetaminophen|acetaminophen|mesh-list
6785041|NCT02206178|Acetylcysteine|acetylcysteine|mesh-list
6785042|NCT02206178|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6785043|NCT02206178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6785044|NCT02206178|Analgesics|analgesics|mesh-ancestor
6785045|NCT02206178|Sensory System Agents|sensory system agents|mesh-ancestor
6785046|NCT02206178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6728339|NCT01886534|Diuretics|diuretics|mesh-list
6728340|NCT01886534|Natriuretic Agents|natriuretic agents|mesh-ancestor
6728341|NCT01886534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728342|NCT01886560|Doxycycline|doxycycline|mesh-list
6728343|NCT01886560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6728344|NCT01886560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6728345|NCT01886560|Antimalarials|antimalarials|mesh-ancestor
6728346|NCT01886560|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6728347|NCT01886560|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6728348|NCT01886573|Azacitidine|azacitidine|mesh-list
6728349|NCT01886573|Entinostat|entinostat|mesh-list
6728350|NCT01886573|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
6728351|NCT01886573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6728352|NCT01886573|Antimetabolites|antimetabolites|mesh-ancestor
6728353|NCT01886573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728354|NCT01886573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6728355|NCT01886573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6728356|NCT01886599|Asunaprevir|asunaprevir|mesh-list
6728357|NCT01886599|Protease Inhibitors|protease inhibitors|mesh-ancestor
6728358|NCT01886599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6728359|NCT01886599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728360|NCT01886638|Abacavir|abacavir|mesh-list
6728361|NCT01886638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6728362|NCT01886638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6728363|NCT01886638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6728364|NCT01886638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728365|NCT01886638|Antiviral Agents|antiviral agents|mesh-ancestor
6728366|NCT01886638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6728367|NCT01886638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6728368|NCT01886638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6728369|NCT01886664|Sevoflurane|sevoflurane|mesh-list
6728370|NCT01886664|Desflurane|desflurane|mesh-list
6728371|NCT01886664|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6728372|NCT01886664|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6728373|NCT01886664|Anesthetics, General|anesthetics, general|mesh-ancestor
6728374|NCT01886664|Anesthetics|anesthetics|mesh-ancestor
6728375|NCT01886664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6728376|NCT01886664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728377|NCT01886768|Anesthetics|anesthetics|mesh-list
6728378|NCT01886768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6728379|NCT01886768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728380|NCT01886794|Estrogens|estrogens|mesh-list
6728381|NCT01886794|Hormones|hormones|mesh-ancestor
6728382|NCT01886794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6728383|NCT01886794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728384|NCT01887119|Eplerenone|eplerenone|mesh-list
6728385|NCT01887119|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6728386|NCT01887119|Hormone Antagonists|hormone antagonists|mesh-ancestor
6728387|NCT01887119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6728388|NCT01887119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728389|NCT01887119|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6728390|NCT01887119|Diuretics|diuretics|mesh-ancestor
6728391|NCT01887119|Natriuretic Agents|natriuretic agents|mesh-ancestor
6728392|NCT01887119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6728393|NCT01887158|Bisacodyl|bisacodyl|mesh-list
6728394|NCT01887158|Cathartics|cathartics|mesh-ancestor
6728395|NCT01887158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6728396|NCT01887158|Laxatives|laxatives|mesh-ancestor
6728397|NCT01887184|Dexmedetomidine|dexmedetomidine|mesh-list
6728398|NCT01887184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6728399|NCT01887184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6728400|NCT01887184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728401|NCT01887184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6728402|NCT01887184|Analgesics|analgesics|mesh-ancestor
6728403|NCT01887184|Sensory System Agents|sensory system agents|mesh-ancestor
6728404|NCT01887184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6728405|NCT01887184|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6728406|NCT01887184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6728407|NCT01887184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6728408|NCT01887184|Adrenergic Agents|adrenergic agents|mesh-ancestor
6728409|NCT01887184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6728410|NCT01887184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728411|NCT01887197|Mannitol|mannitol|mesh-list
6728412|NCT01887197|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6728413|NCT01887197|Diuretics|diuretics|mesh-ancestor
6728414|NCT01887197|Natriuretic Agents|natriuretic agents|mesh-ancestor
6728415|NCT01887197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728416|NCT01887223|Timolol|timolol|mesh-list
6728417|NCT01887223|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6728418|NCT01887223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6728419|NCT01887223|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6728420|NCT01887223|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6728421|NCT01887223|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6728422|NCT01887223|Adrenergic Agents|adrenergic agents|mesh-ancestor
6728423|NCT01887223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6728424|NCT01887223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728425|NCT01887223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728426|NCT01887223|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6728427|NCT01887223|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6728428|NCT01887223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6728429|NCT01887249|Metronidazole|metronidazole|mesh-list
6728430|NCT01887249|Clarithromycin|clarithromycin|mesh-list
6728431|NCT01887249|Esomeprazole|esomeprazole|mesh-list
6728432|NCT01887249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6728433|NCT01887249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6728434|NCT01887249|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6728435|NCT01887249|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6728436|NCT01887249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6728437|NCT01887249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6728438|NCT01887249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6728439|NCT01887249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6728440|NCT01887249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728441|NCT01887249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6728442|NCT01887249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6728443|NCT01887249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6728444|NCT01887275|Interferons|interferons|mesh-list
6728445|NCT01887275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6728446|NCT01887275|Antiviral Agents|antiviral agents|mesh-ancestor
6728447|NCT01887275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6728448|NCT01887301|Nabiximols|nabiximols|mesh-list
6728449|NCT01887301|Analgesics|analgesics|mesh-ancestor
6728450|NCT01887301|Sensory System Agents|sensory system agents|mesh-ancestor
6728451|NCT01887301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6728452|NCT01887301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728453|NCT01887340|Carboplatin|carboplatin|mesh-list
6728454|NCT01887340|Etoposide|etoposide|mesh-list
6728455|NCT01887340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6728456|NCT01887340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6728457|NCT01887340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6728458|NCT01887340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6728459|NCT01887340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6728460|NCT01887340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728461|NCT01887379|Furosemide|furosemide|mesh-list
6728462|NCT01887379|Diuretics|diuretics|mesh-ancestor
6728463|NCT01887379|Natriuretic Agents|natriuretic agents|mesh-ancestor
6728464|NCT01887379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728465|NCT01887379|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6728466|NCT01887379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6728467|NCT01887379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728468|NCT01887405|Epinephrine|epinephrine|mesh-list
6728469|NCT01887405|Racepinephrine|racepinephrine|mesh-list
6728470|NCT01887405|Epinephryl borate|epinephryl borate|mesh-list
6728471|NCT01887405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6728472|NCT01887405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6728473|NCT01887405|Adrenergic Agents|adrenergic agents|mesh-ancestor
6728474|NCT01887405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6728475|NCT01887405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728476|NCT01887405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728477|NCT01887405|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6728478|NCT01887405|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6728479|NCT01887405|Autonomic Agents|autonomic agents|mesh-ancestor
6728480|NCT01887405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6728481|NCT01887405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6728482|NCT01887405|Respiratory System Agents|respiratory system agents|mesh-ancestor
6728483|NCT01887405|Mydriatics|mydriatics|mesh-ancestor
6728484|NCT01887405|Sympathomimetics|sympathomimetics|mesh-ancestor
6728485|NCT01887405|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6728486|NCT01887457|Voriconazole|voriconazole|mesh-list
6728487|NCT01887457|Antifungal Agents|antifungal agents|mesh-ancestor
6728488|NCT01887457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6728489|NCT01887457|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6728490|NCT01887457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6728491|NCT01887457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6728492|NCT01887457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728493|NCT01887457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6728494|NCT01887457|Hormone Antagonists|hormone antagonists|mesh-ancestor
6728495|NCT01887457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6728496|NCT01887457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728497|NCT01887457|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6728498|NCT01887522|Vinblastine|vinblastine|mesh-list
6728499|NCT01887522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6728500|NCT01887522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6728501|NCT01887522|Tubulin Modulators|tubulin modulators|mesh-ancestor
6728502|NCT01887522|Antimitotic Agents|antimitotic agents|mesh-ancestor
6728503|NCT01887522|Mitosis Modulators|mitosis modulators|mesh-ancestor
6728504|NCT01887522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728505|NCT01887561|Dasatinib|dasatinib|mesh-list
6728506|NCT01887561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6728507|NCT01887561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6728508|NCT01887561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6728509|NCT01887561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728510|NCT01887613|Gabapentin|gabapentin|mesh-list
6728511|NCT01887613|Analgesics|analgesics|mesh-ancestor
6728512|NCT01887613|Sensory System Agents|sensory system agents|mesh-ancestor
6728513|NCT01887613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6728514|NCT01887613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728515|NCT01887613|Anticonvulsants|anticonvulsants|mesh-ancestor
6728516|NCT01887613|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6728517|NCT01887613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6728518|NCT01887613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6728519|NCT01887613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6728520|NCT01887613|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6728521|NCT01887613|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6728522|NCT01887613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6728523|NCT01887613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728524|NCT01887613|Antimanic Agents|antimanic agents|mesh-ancestor
6728525|NCT01887626|Ticagrelor|ticagrelor|mesh-list
6728526|NCT01887626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6728527|NCT01887626|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6728528|NCT01887626|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6728529|NCT01887626|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6728530|NCT01887626|Purinergic Agents|purinergic agents|mesh-ancestor
6728531|NCT01887626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6728532|NCT01887626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728533|NCT01887626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728534|NCT01887691|Eszopiclone|eszopiclone|mesh-list
6728535|NCT01887691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6728536|NCT01887691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6728537|NCT01887691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728538|NCT01887704|Aspirin|aspirin|mesh-list
6728539|NCT01887704|Sirolimus|sirolimus|mesh-list
6728540|NCT01887704|Paclitaxel|paclitaxel|mesh-list
6728541|NCT01887704|Everolimus|everolimus|mesh-list
6728542|NCT01887704|Clopidogrel|clopidogrel|mesh-list
6728543|NCT01887704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6728544|NCT01887704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6728545|NCT01887704|Tubulin Modulators|tubulin modulators|mesh-ancestor
6728546|NCT01887704|Antimitotic Agents|antimitotic agents|mesh-ancestor
6728547|NCT01887704|Mitosis Modulators|mitosis modulators|mesh-ancestor
6728548|NCT01887704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728549|NCT01887704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6728550|NCT01887704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6728551|NCT01887704|Analgesics|analgesics|mesh-ancestor
6728552|NCT01887704|Sensory System Agents|sensory system agents|mesh-ancestor
6728553|NCT01887704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6728554|NCT01887704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728555|NCT01887704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6728556|NCT01887704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6728557|NCT01887704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6728558|NCT01887704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6728559|NCT01887704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6728560|NCT01887704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6728561|NCT01887704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6728562|NCT01887704|Antipyretics|antipyretics|mesh-ancestor
6728563|NCT01887704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6728564|NCT01887704|Immunologic Factors|immunologic factors|mesh-ancestor
6728565|NCT01887704|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6728566|NCT01887704|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6728567|NCT01887704|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6728568|NCT01887704|Purinergic Agents|purinergic agents|mesh-ancestor
6728569|NCT01887704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6728570|NCT01887704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6728571|NCT01887704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6728572|NCT01887704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6728573|NCT01887704|Antifungal Agents|antifungal agents|mesh-ancestor
6728574|NCT01887743|Pantoprazole|pantoprazole|mesh-list
6728575|NCT01887743|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6728576|NCT01887743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6728577|NCT01887743|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6728578|NCT01887743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6728579|NCT01887743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728580|NCT01887795|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6728581|NCT01887795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6728582|NCT01887795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6728583|NCT01887795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6728584|NCT01887795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728585|NCT01887821|Chloroquine|chloroquine|mesh-list
6728586|NCT01887821|Piperaquine|piperaquine|mesh-list
6728587|NCT01887821|Artenimol|artenimol|mesh-list
6728588|NCT01887821|Amebicides|amebicides|mesh-ancestor
6728589|NCT01887821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6728590|NCT01887821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6728591|NCT01887821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6728592|NCT01887821|Antimalarials|antimalarials|mesh-ancestor
6728593|NCT01887821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6728594|NCT01887847|Nicotine|nicotine|mesh-list
6728595|NCT01887847|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6728596|NCT01887847|Autonomic Agents|autonomic agents|mesh-ancestor
6728597|NCT01887847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6728598|NCT01887847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728599|NCT01887847|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6728600|NCT01887847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6728601|NCT01887847|Cholinergic Agents|cholinergic agents|mesh-ancestor
6728602|NCT01887847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6728603|NCT01887847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728604|NCT01887873|Hyaluronic Acid|hyaluronic acid|mesh-list
6728605|NCT01887873|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6728606|NCT01887873|Immunologic Factors|immunologic factors|mesh-ancestor
6728607|NCT01887873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728608|NCT01887873|Viscosupplements|viscosupplements|mesh-ancestor
6728609|NCT01887873|Protective Agents|protective agents|mesh-ancestor
6728610|NCT01887951|Tramadol|tramadol|mesh-list
6728611|NCT01887951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6728612|NCT01887951|Narcotics|narcotics|mesh-ancestor
6728613|NCT01887951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6728614|NCT01887951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728615|NCT01887951|Analgesics|analgesics|mesh-ancestor
6728616|NCT01887951|Sensory System Agents|sensory system agents|mesh-ancestor
6728617|NCT01887951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6728618|NCT01888042|Everolimus|everolimus|mesh-list
6728619|NCT01888042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6728620|NCT01888042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6728621|NCT01888042|Immunologic Factors|immunologic factors|mesh-ancestor
6728622|NCT01888042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728623|NCT01888107|Risperidone|risperidone|mesh-list
6728624|NCT01888107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6728625|NCT01888107|Serotonin Agents|serotonin agents|mesh-ancestor
6728626|NCT01888107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6728627|NCT01888107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728628|NCT01888107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728629|NCT01888107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6728630|NCT01888107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6728631|NCT01888107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6728632|NCT01888107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6728633|NCT01888107|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6728634|NCT01888107|Dopamine Agents|dopamine agents|mesh-ancestor
6785047|NCT02206178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785048|NCT02206178|Antipyretics|antipyretics|mesh-ancestor
6785049|NCT02206178|Antiviral Agents|antiviral agents|mesh-ancestor
6785050|NCT02206178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6785051|NCT02206178|Expectorants|expectorants|mesh-ancestor
6785052|NCT02206178|Respiratory System Agents|respiratory system agents|mesh-ancestor
6785053|NCT02206178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6785054|NCT02206178|Antioxidants|antioxidants|mesh-ancestor
6785055|NCT02206178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785056|NCT02206178|Protective Agents|protective agents|mesh-ancestor
6785057|NCT02206178|Antidotes|antidotes|mesh-ancestor
6785058|NCT02206204|Moxifloxacin|moxifloxacin|mesh-list
6785059|NCT02206204|Selexipag|selexipag|mesh-list
6785060|NCT02206204|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6785061|NCT02206204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6785062|NCT02206204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6785063|NCT02206204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6785064|NCT02206204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6785065|NCT02206204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6785066|NCT02206204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785067|NCT02206204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6785068|NCT02206204|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6785069|NCT02206204|Contraceptive Agents|contraceptive agents|mesh-ancestor
6785070|NCT02206204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6785071|NCT02206204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785072|NCT02206204|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6785073|NCT02206204|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6785074|NCT02206204|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6785075|NCT02206204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6785076|NCT02206295|Selexipag|selexipag|mesh-list
6785077|NCT02206295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6785078|NCT02206308|Antibodies|antibodies|mesh-list
6785079|NCT02206308|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6785080|NCT02206308|Immunologic Factors|immunologic factors|mesh-ancestor
6785081|NCT02206308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785082|NCT02206425|Ascorbic Acid|ascorbic acid|mesh-list
6785083|NCT02206425|Dexamethasone|dexamethasone|mesh-list
6785084|NCT02206425|Dexamethasone acetate|dexamethasone acetate|mesh-list
6785085|NCT02206425|Prednisone|prednisone|mesh-list
6785086|NCT02206425|Cyclophosphamide|cyclophosphamide|mesh-list
6785087|NCT02206425|Melphalan|melphalan|mesh-list
6785088|NCT02206425|Doxorubicin|doxorubicin|mesh-list
6785089|NCT02206425|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6785090|NCT02206425|Lenalidomide|lenalidomide|mesh-list
6785091|NCT02206425|Pomalidomide|pomalidomide|mesh-list
6785092|NCT02206425|BB 1101|bb 1101|mesh-list
6785093|NCT02206425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6785094|NCT02206425|Immunologic Factors|immunologic factors|mesh-ancestor
6785095|NCT02206425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785096|NCT02206425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6785097|NCT02206425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6785098|NCT02206425|Alkylating Agents|alkylating agents|mesh-ancestor
6785099|NCT02206425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785100|NCT02206425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6785101|NCT02206425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6785102|NCT02206425|Vitamins|vitamins|mesh-ancestor
6785103|NCT02206425|Micronutrients|micronutrients|mesh-ancestor
6785104|NCT02206425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6785105|NCT02206425|Antiemetics|antiemetics|mesh-ancestor
6785106|NCT02206425|Autonomic Agents|autonomic agents|mesh-ancestor
6785107|NCT02206425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6785108|NCT02206425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6785109|NCT02206425|Glucocorticoids|glucocorticoids|mesh-ancestor
6728635|NCT01888120|Ziconotide|ziconotide|mesh-list
6728636|NCT01888120|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6728637|NCT01888120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6728638|NCT01888120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728639|NCT01888120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6728640|NCT01888120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728641|NCT01888120|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6728642|NCT01888120|Protective Agents|protective agents|mesh-ancestor
6728643|NCT01888120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6728644|NCT01888120|Analgesics|analgesics|mesh-ancestor
6728645|NCT01888120|Sensory System Agents|sensory system agents|mesh-ancestor
6728646|NCT01888120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6728647|NCT01888224|Isotretinoin|isotretinoin|mesh-list
6728648|NCT01888224|Dermatologic Agents|dermatologic agents|mesh-ancestor
6728649|NCT01888250|Lamotrigine|lamotrigine|mesh-list
6728650|NCT01888250|Anticonvulsants|anticonvulsants|mesh-ancestor
6728651|NCT01888250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6728652|NCT01888250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6728653|NCT01888250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728654|NCT01888250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6728655|NCT01888250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728656|NCT01888250|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6728657|NCT01888250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6728658|NCT01888250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6728659|NCT01888250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6728660|NCT01888250|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6728661|NCT01888263|Lamotrigine|lamotrigine|mesh-list
6728662|NCT01888263|Anticonvulsants|anticonvulsants|mesh-ancestor
6728663|NCT01888263|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6728664|NCT01888263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6728665|NCT01888263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728666|NCT01888263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6728667|NCT01888263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728668|NCT01888263|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6728669|NCT01888263|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6728670|NCT01888263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6728671|NCT01888263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6728672|NCT01888263|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6728673|NCT01888289|Isotretinoin|isotretinoin|mesh-list
6728674|NCT01888289|Dermatologic Agents|dermatologic agents|mesh-ancestor
6728675|NCT01888302|Gemcitabine|gemcitabine|mesh-list
6728676|NCT01888302|Sirolimus|sirolimus|mesh-list
6728677|NCT01888302|Cisplatin|cisplatin|mesh-list
6728678|NCT01888302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6728679|NCT01888302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6728680|NCT01888302|Antimetabolites|antimetabolites|mesh-ancestor
6728681|NCT01888302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728682|NCT01888302|Antiviral Agents|antiviral agents|mesh-ancestor
6728683|NCT01888302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6728684|NCT01888302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6728685|NCT01888302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6728686|NCT01888302|Immunologic Factors|immunologic factors|mesh-ancestor
6728687|NCT01888302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728688|NCT01888302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6728689|NCT01888302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6728690|NCT01888302|Antifungal Agents|antifungal agents|mesh-ancestor
6728691|NCT01888328|Isotretinoin|isotretinoin|mesh-list
6728692|NCT01888328|Dermatologic Agents|dermatologic agents|mesh-ancestor
6728693|NCT01888341|Isotretinoin|isotretinoin|mesh-list
6728694|NCT01888341|Dermatologic Agents|dermatologic agents|mesh-ancestor
6728695|NCT01888354|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6728696|NCT01888354|Hormones|hormones|mesh-ancestor
6728697|NCT01888354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6728698|NCT01888354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728699|NCT01888393|Ivacaftor|ivacaftor|mesh-list
6728700|NCT01888393|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6728701|NCT01888393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6728702|NCT01888393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728703|NCT01888445|Darbepoetin alfa|darbepoetin alfa|mesh-list
6728704|NCT01888445|Hematinics|hematinics|mesh-ancestor
6728705|NCT01888458|Micafungin|micafungin|mesh-list
6728706|NCT01888458|Antifungal Agents|antifungal agents|mesh-ancestor
6728707|NCT01888458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6728708|NCT01888536|Pregabalin|pregabalin|mesh-list
6728709|NCT01888536|Alprostadil|alprostadil|mesh-list
6728710|NCT01888536|Analgesics|analgesics|mesh-ancestor
6728711|NCT01888536|Sensory System Agents|sensory system agents|mesh-ancestor
6728712|NCT01888536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6728713|NCT01888536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728714|NCT01888536|Anticonvulsants|anticonvulsants|mesh-ancestor
6728715|NCT01888536|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6728716|NCT01888536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6728717|NCT01888536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728718|NCT01888536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6728719|NCT01888536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6728720|NCT01888536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6728721|NCT01888536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6728722|NCT01888536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6728723|NCT01888536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6728724|NCT01888536|Vasodilator Agents|vasodilator agents|mesh-ancestor
6728725|NCT01888536|Urological Agents|urological agents|mesh-ancestor
6728726|NCT01888562|Ponatinib|ponatinib|mesh-list
6728727|NCT01888562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6728728|NCT01888562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6728729|NCT01888562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6728730|NCT01888562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728731|NCT01888575|Aspirin|aspirin|mesh-list
6728732|NCT01888575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6728733|NCT01888575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6728734|NCT01888575|Analgesics|analgesics|mesh-ancestor
6728735|NCT01888575|Sensory System Agents|sensory system agents|mesh-ancestor
6728736|NCT01888575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6728737|NCT01888575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728738|NCT01888575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6728739|NCT01888575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6728740|NCT01888575|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6728741|NCT01888575|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6728742|NCT01888575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728743|NCT01888575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6728744|NCT01888575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6728745|NCT01888575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6728746|NCT01888575|Antipyretics|antipyretics|mesh-ancestor
6728747|NCT01888718|Fexofenadine|fexofenadine|mesh-list
6728748|NCT01888718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6728749|NCT01888718|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6728750|NCT01888718|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6728751|NCT01888718|Histamine Antagonists|histamine antagonists|mesh-ancestor
6728752|NCT01888718|Histamine Agents|histamine agents|mesh-ancestor
6728753|NCT01888718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6728754|NCT01888718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728755|NCT01888718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728756|NCT01888731|Lamotrigine|lamotrigine|mesh-list
6728757|NCT01888731|Anticonvulsants|anticonvulsants|mesh-ancestor
6728758|NCT01888731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6728759|NCT01888731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6728760|NCT01888731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728761|NCT01888731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6728762|NCT01888731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728763|NCT01888731|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6728764|NCT01888731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6728765|NCT01888731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6728766|NCT01888731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6728767|NCT01888731|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6728768|NCT01888744|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6728769|NCT01888744|Cetrorelix|cetrorelix|mesh-list
6728770|NCT01888744|Progesterone|progesterone|mesh-list
6728771|NCT01888744|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
6728772|NCT01888744|Ganirelix|ganirelix|mesh-list
6728773|NCT01888744|Progestins|progestins|mesh-ancestor
6728774|NCT01888744|Hormones|hormones|mesh-ancestor
6728775|NCT01888744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6728776|NCT01888744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728777|NCT01888744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6728778|NCT01888744|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6728779|NCT01888744|Fertility Agents|fertility agents|mesh-ancestor
6728780|NCT01888744|Hormone Antagonists|hormone antagonists|mesh-ancestor
6728781|NCT01888757|Lamotrigine|lamotrigine|mesh-list
6728782|NCT01888757|Anticonvulsants|anticonvulsants|mesh-ancestor
6728783|NCT01888757|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6728784|NCT01888757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6728785|NCT01888757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728786|NCT01888757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6728787|NCT01888757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728788|NCT01888757|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6728789|NCT01888757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6728790|NCT01888757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6728791|NCT01888757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6728792|NCT01888757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6728793|NCT01888796|Linagliptin|linagliptin|mesh-list
6728794|NCT01888796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6728795|NCT01888796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728796|NCT01888796|Incretins|incretins|mesh-ancestor
6728797|NCT01888796|Hormones|hormones|mesh-ancestor
6728798|NCT01888796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6728799|NCT01888796|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6728800|NCT01888796|Protease Inhibitors|protease inhibitors|mesh-ancestor
6728801|NCT01888796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6728802|NCT01888796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728803|NCT01888822|Ciprofloxacin|ciprofloxacin|mesh-list
6728804|NCT01888822|Ampicillin|ampicillin|mesh-list
6728805|NCT01888822|Sulbactam|sulbactam|mesh-list
6728806|NCT01888822|Sultamicillin|sultamicillin|mesh-list
6728807|NCT01888822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6728808|NCT01888822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6728809|NCT01888822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6728810|NCT01888822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6728811|NCT01888822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6728812|NCT01888822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728813|NCT01888822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6728814|NCT01888822|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6728815|NCT01888822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6728816|NCT01888822|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6728817|NCT01888835|Mirtazapine|mirtazapine|mesh-list
6728818|NCT01888835|Antidepressive Agents|antidepressive agents|mesh-ancestor
6728819|NCT01888835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6728820|NCT01888835|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6728821|NCT01888835|Histamine Antagonists|histamine antagonists|mesh-ancestor
6728822|NCT01888835|Histamine Agents|histamine agents|mesh-ancestor
6728823|NCT01888835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6728824|NCT01888835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728825|NCT01888835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728826|NCT01888835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6728827|NCT01888835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6728828|NCT01888835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6728829|NCT01888835|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6728830|NCT01888835|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6728831|NCT01888835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6728832|NCT01888835|Adrenergic Agents|adrenergic agents|mesh-ancestor
6728833|NCT01888835|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6728834|NCT01888835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6728835|NCT01888835|Serotonin Agents|serotonin agents|mesh-ancestor
6728836|NCT01888835|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6728837|NCT01888861|Thioctic Acid|thioctic acid|mesh-list
6728838|NCT01888861|Antioxidants|antioxidants|mesh-ancestor
6728839|NCT01888861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728840|NCT01888861|Protective Agents|protective agents|mesh-ancestor
6728841|NCT01888861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728842|NCT01888861|Vitamin B Complex|vitamin b complex|mesh-ancestor
6728843|NCT01888861|Vitamins|vitamins|mesh-ancestor
6728844|NCT01888861|Micronutrients|micronutrients|mesh-ancestor
6728845|NCT01888978|Leucovorin|leucovorin|mesh-list
6728846|NCT01888978|Gemcitabine|gemcitabine|mesh-list
6728847|NCT01888978|Fluorouracil|fluorouracil|mesh-list
6728848|NCT01888978|Docetaxel|docetaxel|mesh-list
6728849|NCT01888978|Oxaliplatin|oxaliplatin|mesh-list
6728850|NCT01888978|Irinotecan|irinotecan|mesh-list
6728851|NCT01888978|Levoleucovorin|levoleucovorin|mesh-list
6728852|NCT01888978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6728853|NCT01888978|Antimetabolites|antimetabolites|mesh-ancestor
6728854|NCT01888978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728855|NCT01888978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6728856|NCT01888978|Antiviral Agents|antiviral agents|mesh-ancestor
6728857|NCT01888978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6728858|NCT01888978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6728859|NCT01888978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6728860|NCT01888978|Immunologic Factors|immunologic factors|mesh-ancestor
6728861|NCT01888978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728862|NCT01888978|Tubulin Modulators|tubulin modulators|mesh-ancestor
6728863|NCT01888978|Antimitotic Agents|antimitotic agents|mesh-ancestor
6728864|NCT01888978|Mitosis Modulators|mitosis modulators|mesh-ancestor
6728865|NCT01888978|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6728866|NCT01888978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6728867|NCT01888978|Antidotes|antidotes|mesh-ancestor
6728868|NCT01888978|Protective Agents|protective agents|mesh-ancestor
6728869|NCT01888978|Vitamin B Complex|vitamin b complex|mesh-ancestor
6728870|NCT01888978|Vitamins|vitamins|mesh-ancestor
6728871|NCT01888978|Micronutrients|micronutrients|mesh-ancestor
6728872|NCT01889004|Dexmedetomidine|dexmedetomidine|mesh-list
6728873|NCT01889004|Propofol|propofol|mesh-list
6728874|NCT01889004|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6728875|NCT01889004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6728876|NCT01889004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728877|NCT01889004|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6728878|NCT01889004|Anesthetics, General|anesthetics, general|mesh-ancestor
6728879|NCT01889004|Anesthetics|anesthetics|mesh-ancestor
6728880|NCT01889004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6728881|NCT01889004|Analgesics|analgesics|mesh-ancestor
6728882|NCT01889004|Sensory System Agents|sensory system agents|mesh-ancestor
6728883|NCT01889004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6728884|NCT01889004|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6728885|NCT01889004|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6728886|NCT01889004|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6728887|NCT01889004|Adrenergic Agents|adrenergic agents|mesh-ancestor
6728888|NCT01889004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6728889|NCT01889004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728890|NCT01889056|Epoetin Alfa|epoetin alfa|mesh-list
6728891|NCT01889056|Hematinics|hematinics|mesh-ancestor
6728892|NCT01889095|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6728893|NCT01889095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6728894|NCT01889095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728895|NCT01889134|Alendronate|alendronate|mesh-list
6728896|NCT01889134|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6728897|NCT01889134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728898|NCT01889173|Cyclobenzaprine|cyclobenzaprine|mesh-list
6728899|NCT01889173|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6728900|NCT01889173|Antidepressive Agents|antidepressive agents|mesh-ancestor
6728901|NCT01889173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6728902|NCT01889173|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6728903|NCT01889173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728904|NCT01889173|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6728905|NCT01889173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6728906|NCT01889173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6728907|NCT01889173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6728908|NCT01889212|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6728909|NCT01889212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6728910|NCT01889212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6728911|NCT01889212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6728912|NCT01889212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728913|NCT01889290|Methylnaltrexone|methylnaltrexone|mesh-list
6728914|NCT01889290|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6728915|NCT01889290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728916|NCT01889290|Sensory System Agents|sensory system agents|mesh-ancestor
6728917|NCT01889290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6728918|NCT01889368|Grape Seed Extract|grape seed extract|mesh-list
6728919|NCT01889368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6728920|NCT01889368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6728921|NCT01889368|Antioxidants|antioxidants|mesh-ancestor
6728922|NCT01889368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728923|NCT01889368|Protective Agents|protective agents|mesh-ancestor
6728924|NCT01889368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728925|NCT01889407|Idarubicin|idarubicin|mesh-list
6728926|NCT01889407|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6728927|NCT01889407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6728928|NCT01889407|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6728929|NCT01889407|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6728930|NCT01889407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6728931|NCT01889407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728932|NCT01889433|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6728933|NCT01889433|Antiviral Agents|antiviral agents|mesh-ancestor
6728934|NCT01889433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6728935|NCT01889446|Calcium|calcium|mesh-list
6728936|NCT01889446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6728937|NCT01889446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728938|NCT01889498|Acetazolamide|acetazolamide|mesh-list
6728939|NCT01889498|Anticonvulsants|anticonvulsants|mesh-ancestor
6728940|NCT01889498|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6728941|NCT01889498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6728942|NCT01889498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728943|NCT01889498|Diuretics|diuretics|mesh-ancestor
6728944|NCT01889498|Natriuretic Agents|natriuretic agents|mesh-ancestor
6728945|NCT01889498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728946|NCT01889576|Magnesium Oxide|magnesium oxide|mesh-list
6728947|NCT01889576|Antacids|antacids|mesh-ancestor
6728948|NCT01889576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728949|NCT01889576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6728950|NCT01889680|Leucovorin|leucovorin|mesh-list
6728951|NCT01889680|Fluorouracil|fluorouracil|mesh-list
6728952|NCT01889680|Oxaliplatin|oxaliplatin|mesh-list
6728953|NCT01889680|Aflibercept|aflibercept|mesh-list
6728954|NCT01889680|Levoleucovorin|levoleucovorin|mesh-list
6728955|NCT01889680|Antimetabolites|antimetabolites|mesh-ancestor
6728956|NCT01889680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728957|NCT01889680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6728958|NCT01889680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6728959|NCT01889680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6728960|NCT01889680|Immunologic Factors|immunologic factors|mesh-ancestor
6728961|NCT01889680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728962|NCT01889680|Antidotes|antidotes|mesh-ancestor
6728963|NCT01889680|Protective Agents|protective agents|mesh-ancestor
6728964|NCT01889680|Vitamin B Complex|vitamin b complex|mesh-ancestor
6728965|NCT01889680|Vitamins|vitamins|mesh-ancestor
6728966|NCT01889680|Micronutrients|micronutrients|mesh-ancestor
6728967|NCT01889680|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6728968|NCT01889680|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6728969|NCT01889680|Growth Substances|growth substances|mesh-ancestor
6728970|NCT01889680|Growth Inhibitors|growth inhibitors|mesh-ancestor
6785110|NCT02206425|Hormones|hormones|mesh-ancestor
6785111|NCT02206425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6785112|NCT02206425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6785113|NCT02206425|Protease Inhibitors|protease inhibitors|mesh-ancestor
6785114|NCT02206425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6785115|NCT02206425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6785116|NCT02206425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6785117|NCT02206425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6785118|NCT02206425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6785119|NCT02206425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6785120|NCT02206425|Growth Substances|growth substances|mesh-ancestor
6785121|NCT02206425|Growth Inhibitors|growth inhibitors|mesh-ancestor
6785122|NCT02206425|Antioxidants|antioxidants|mesh-ancestor
6785123|NCT02206425|Protective Agents|protective agents|mesh-ancestor
6785124|NCT02206477|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
6785125|NCT02206477|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6785126|NCT02206477|Protective Agents|protective agents|mesh-ancestor
6785127|NCT02206477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785128|NCT02206477|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6785129|NCT02206477|Antioxidants|antioxidants|mesh-ancestor
6785130|NCT02206477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785131|NCT02206490|Naltrexone|naltrexone|mesh-list
6785132|NCT02206490|Dextromethorphan|dextromethorphan|mesh-list
6785133|NCT02206490|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6785134|NCT02206490|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6728971|NCT01889758|Tacrolimus|tacrolimus|mesh-list
6728972|NCT01889758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6728973|NCT01889758|Immunologic Factors|immunologic factors|mesh-ancestor
6728974|NCT01889758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728975|NCT01889758|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6728976|NCT01889758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6728977|NCT01889758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728978|NCT01889771|Nicotine|nicotine|mesh-list
6728979|NCT01889771|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6728980|NCT01889771|Autonomic Agents|autonomic agents|mesh-ancestor
6728981|NCT01889771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6728982|NCT01889771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728983|NCT01889771|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6728984|NCT01889771|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6728985|NCT01889771|Cholinergic Agents|cholinergic agents|mesh-ancestor
6728986|NCT01889771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6728987|NCT01889771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6728988|NCT01889810|Vitamin D|vitamin d|mesh-list
6728989|NCT01889810|Cholecalciferol|cholecalciferol|mesh-list
6728990|NCT01889810|Vitamins|vitamins|mesh-ancestor
6728991|NCT01889810|Micronutrients|micronutrients|mesh-ancestor
6728992|NCT01889810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6728993|NCT01889810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6728994|NCT01889810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6728995|NCT01889849|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6728996|NCT01889849|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6728997|NCT01889849|Antiviral Agents|antiviral agents|mesh-ancestor
6728998|NCT01889849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6728999|NCT01889914|Insulin|insulin|mesh-list
6729000|NCT01889914|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6729001|NCT01889914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6729002|NCT01889914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729003|NCT01889966|Sildenafil Citrate|sildenafil citrate|mesh-list
6729004|NCT01889966|Vasodilator Agents|vasodilator agents|mesh-ancestor
6729005|NCT01889966|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6729006|NCT01889966|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6729007|NCT01889966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6729008|NCT01889966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6729009|NCT01889966|Urological Agents|urological agents|mesh-ancestor
6729010|NCT01889979|Tramadol|tramadol|mesh-list
6729011|NCT01889979|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6729012|NCT01889979|Narcotics|narcotics|mesh-ancestor
6729013|NCT01889979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6729014|NCT01889979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729015|NCT01889979|Analgesics|analgesics|mesh-ancestor
6729016|NCT01889979|Sensory System Agents|sensory system agents|mesh-ancestor
6729017|NCT01889979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6729018|NCT01889992|Sirolimus|sirolimus|mesh-list
6729019|NCT01889992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6729020|NCT01889992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6729021|NCT01889992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6729022|NCT01889992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6729023|NCT01889992|Antifungal Agents|antifungal agents|mesh-ancestor
6729024|NCT01889992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6729025|NCT01889992|Immunologic Factors|immunologic factors|mesh-ancestor
6729026|NCT01889992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729027|NCT01890005|Aspirin|aspirin|mesh-list
6729028|NCT01890005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6729029|NCT01890005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6729030|NCT01890005|Analgesics|analgesics|mesh-ancestor
6729031|NCT01890005|Sensory System Agents|sensory system agents|mesh-ancestor
6729032|NCT01890005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6729033|NCT01890005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729034|NCT01890005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6729035|NCT01890005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6729036|NCT01890005|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6729037|NCT01890005|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6729038|NCT01890005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6729039|NCT01890005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6729040|NCT01890005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6729041|NCT01890005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6729042|NCT01890005|Antipyretics|antipyretics|mesh-ancestor
6729043|NCT01890200|Ribavirin|ribavirin|mesh-list
6729044|NCT01890200|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6729045|NCT01890200|Antimetabolites|antimetabolites|mesh-ancestor
6729046|NCT01890200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6729047|NCT01890200|Antiviral Agents|antiviral agents|mesh-ancestor
6729048|NCT01890200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6729049|NCT01890408|Ropivacaine|ropivacaine|mesh-list
6729050|NCT01890408|Anesthetics, Local|anesthetics, local|mesh-ancestor
6729051|NCT01890408|Anesthetics|anesthetics|mesh-ancestor
6729052|NCT01890408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6729053|NCT01890408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729054|NCT01890408|Sensory System Agents|sensory system agents|mesh-ancestor
6729055|NCT01890408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6729056|NCT01890538|Dimenhydrinate|dimenhydrinate|mesh-list
6729057|NCT01890538|Piracetam|piracetam|mesh-list
6729058|NCT01890538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6729059|NCT01890538|Protective Agents|protective agents|mesh-ancestor
6729060|NCT01890538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729061|NCT01890538|Nootropic Agents|nootropic agents|mesh-ancestor
6729062|NCT01890538|Antiemetics|antiemetics|mesh-ancestor
6729063|NCT01890538|Autonomic Agents|autonomic agents|mesh-ancestor
6729064|NCT01890538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6729065|NCT01890538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6729066|NCT01890538|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6729067|NCT01890538|Histamine Antagonists|histamine antagonists|mesh-ancestor
6729068|NCT01890538|Histamine Agents|histamine agents|mesh-ancestor
6729069|NCT01890538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6729070|NCT01890538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6729071|NCT01890629|Metformin|metformin|mesh-list
6729072|NCT01890629|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6729073|NCT01890629|Glimepiride|glimepiride|mesh-list
6729074|NCT01890629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6729075|NCT01890629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729076|NCT01890629|Incretins|incretins|mesh-ancestor
6729077|NCT01890629|Hormones|hormones|mesh-ancestor
6729078|NCT01890629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6729079|NCT01890629|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6729080|NCT01890629|Protease Inhibitors|protease inhibitors|mesh-ancestor
6729081|NCT01890629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6729082|NCT01890629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6729083|NCT01890629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6729084|NCT01890629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6729085|NCT01890629|Immunologic Factors|immunologic factors|mesh-ancestor
6729086|NCT01890772|Vitamin D|vitamin d|mesh-list
6729087|NCT01890772|Ribavirin|ribavirin|mesh-list
6729088|NCT01890772|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6729089|NCT01890772|Vitamins|vitamins|mesh-ancestor
6729090|NCT01890772|Micronutrients|micronutrients|mesh-ancestor
6729091|NCT01890772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729092|NCT01890772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6729093|NCT01890772|Antimetabolites|antimetabolites|mesh-ancestor
6729094|NCT01890772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6729095|NCT01890772|Antiviral Agents|antiviral agents|mesh-ancestor
6729096|NCT01890772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6729097|NCT01890863|Fluticasone|fluticasone|mesh-list
6729098|NCT01890863|Xhance|xhance|mesh-list
6729099|NCT01890863|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6729100|NCT01890863|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6729101|NCT01890863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6729102|NCT01890863|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6729103|NCT01890863|Autonomic Agents|autonomic agents|mesh-ancestor
6729104|NCT01890863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6729105|NCT01890863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729106|NCT01890863|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6729107|NCT01890863|Respiratory System Agents|respiratory system agents|mesh-ancestor
6729108|NCT01890863|Dermatologic Agents|dermatologic agents|mesh-ancestor
6729109|NCT01890863|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6729110|NCT01890863|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6729111|NCT01890863|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6729112|NCT01890863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6729113|NCT01890863|Adrenergic Agents|adrenergic agents|mesh-ancestor
6729114|NCT01890863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6729115|NCT01890863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6729116|NCT01890863|Glucocorticoids|glucocorticoids|mesh-ancestor
6729117|NCT01890863|Hormones|hormones|mesh-ancestor
6729118|NCT01890863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6729119|NCT01890863|Sympathomimetics|sympathomimetics|mesh-ancestor
6729120|NCT01890889|Ezetimibe|ezetimibe|mesh-list
6729121|NCT01890889|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6729122|NCT01890889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6729123|NCT01890889|Antimetabolites|antimetabolites|mesh-ancestor
6729124|NCT01890889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6729125|NCT01890889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6729126|NCT01890902|Ketoprofen|ketoprofen|mesh-list
6729127|NCT01890902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6729128|NCT01890902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6729129|NCT01890902|Analgesics|analgesics|mesh-ancestor
6729130|NCT01890902|Sensory System Agents|sensory system agents|mesh-ancestor
6729131|NCT01890902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6729132|NCT01890902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729133|NCT01890902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6729134|NCT01890902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6729135|NCT01890902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6729136|NCT01890902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6729137|NCT01890902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6729138|NCT01890941|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6729139|NCT01890941|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6729140|NCT01890993|Liraglutide|liraglutide|mesh-list
6729141|NCT01890993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6729142|NCT01890993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729143|NCT01890993|Incretins|incretins|mesh-ancestor
6729144|NCT01890993|Hormones|hormones|mesh-ancestor
6729145|NCT01890993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6729146|NCT01891019|Thalidomide|thalidomide|mesh-list
6729147|NCT01891019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6729148|NCT01891019|Immunologic Factors|immunologic factors|mesh-ancestor
6729149|NCT01891019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729150|NCT01891019|Leprostatic Agents|leprostatic agents|mesh-ancestor
6729151|NCT01891019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6729152|NCT01891019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6729153|NCT01891019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6729154|NCT01891019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6729155|NCT01891019|Growth Substances|growth substances|mesh-ancestor
6729156|NCT01891019|Growth Inhibitors|growth inhibitors|mesh-ancestor
6729157|NCT01891019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6729158|NCT01891084|Acetaminophen|acetaminophen|mesh-list
6729159|NCT01891084|Ibuprofen|ibuprofen|mesh-list
6729160|NCT01891084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6729161|NCT01891084|Analgesics|analgesics|mesh-ancestor
6729162|NCT01891084|Sensory System Agents|sensory system agents|mesh-ancestor
6729163|NCT01891084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6729164|NCT01891084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729165|NCT01891084|Antipyretics|antipyretics|mesh-ancestor
6729166|NCT01891084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6729167|NCT01891084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6729168|NCT01891084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6729169|NCT01891084|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6729170|NCT01891084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6729171|NCT01891084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6729172|NCT01891175|Anesthetics|anesthetics|mesh-list
6729173|NCT01891175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6729174|NCT01891175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729175|NCT01891201|Oxytocin|oxytocin|mesh-list
6729176|NCT01891201|Oxytocics|oxytocics|mesh-ancestor
6729177|NCT01891201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6729178|NCT01891201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729179|NCT01891227|Capecitabine|capecitabine|mesh-list
6729180|NCT01891227|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6729181|NCT01891227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6729182|NCT01891227|Antimetabolites|antimetabolites|mesh-ancestor
6729183|NCT01891227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6729184|NCT01891227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6729185|NCT01891227|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6729186|NCT01891227|Alkylating Agents|alkylating agents|mesh-ancestor
6729187|NCT01891292|Acetylcysteine|acetylcysteine|mesh-list
6729188|NCT01891292|Enalapril|enalapril|mesh-list
6729189|NCT01891292|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6729190|NCT01891292|Antiviral Agents|antiviral agents|mesh-ancestor
6729191|NCT01891292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6729192|NCT01891292|Expectorants|expectorants|mesh-ancestor
6729193|NCT01891292|Respiratory System Agents|respiratory system agents|mesh-ancestor
6729194|NCT01891292|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6729195|NCT01891292|Antioxidants|antioxidants|mesh-ancestor
6729196|NCT01891292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6729197|NCT01891292|Protective Agents|protective agents|mesh-ancestor
6729198|NCT01891292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729199|NCT01891292|Antidotes|antidotes|mesh-ancestor
6729200|NCT01891292|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6729201|NCT01891292|Protease Inhibitors|protease inhibitors|mesh-ancestor
6729202|NCT01891292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6729203|NCT01891292|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6729204|NCT01891396|Hyaluronic Acid|hyaluronic acid|mesh-list
6729205|NCT01891396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6729206|NCT01891396|Immunologic Factors|immunologic factors|mesh-ancestor
6729207|NCT01891396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729208|NCT01891396|Viscosupplements|viscosupplements|mesh-ancestor
6729209|NCT01891396|Protective Agents|protective agents|mesh-ancestor
6729210|NCT01891435|Acetaminophen|acetaminophen|mesh-list
6729211|NCT01891435|Diclofenac|diclofenac|mesh-list
6729212|NCT01891435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6729213|NCT01891435|Analgesics|analgesics|mesh-ancestor
6729214|NCT01891435|Sensory System Agents|sensory system agents|mesh-ancestor
6729215|NCT01891435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6729216|NCT01891435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729217|NCT01891435|Antipyretics|antipyretics|mesh-ancestor
6729218|NCT01891435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6729219|NCT01891435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6729220|NCT01891435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6729221|NCT01891435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6729222|NCT01891435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6729223|NCT01891435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785135|NCT02206490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785136|NCT02206490|Sensory System Agents|sensory system agents|mesh-ancestor
6785137|NCT02206490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6785138|NCT02206490|Antitussive Agents|antitussive agents|mesh-ancestor
6785139|NCT02206490|Respiratory System Agents|respiratory system agents|mesh-ancestor
6785140|NCT02206490|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6785141|NCT02206490|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6785142|NCT02206490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6785143|NCT02206490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785144|NCT02206503|Dexamethasone|dexamethasone|mesh-list
6785145|NCT02206503|Cyclophosphamide|cyclophosphamide|mesh-list
6785146|NCT02206503|Lenalidomide|lenalidomide|mesh-list
6785147|NCT02206503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6785148|NCT02206503|Immunologic Factors|immunologic factors|mesh-ancestor
6785149|NCT02206503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785150|NCT02206503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6785151|NCT02206503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6785152|NCT02206503|Alkylating Agents|alkylating agents|mesh-ancestor
6785153|NCT02206503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785154|NCT02206503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6729224|NCT01891461|Hemostatics|hemostatics|mesh-list
6729225|NCT01891461|Coagulants|coagulants|mesh-ancestor
6729226|NCT01891487|Bimatoprost|bimatoprost|mesh-list
6729227|NCT01891487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6729228|NCT01891500|Nitric Oxide|nitric oxide|mesh-list
6729229|NCT01891500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6729230|NCT01891500|Autonomic Agents|autonomic agents|mesh-ancestor
6729231|NCT01891500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6729232|NCT01891500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729233|NCT01891500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6729234|NCT01891500|Respiratory System Agents|respiratory system agents|mesh-ancestor
6729235|NCT01891500|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6729236|NCT01891500|Antioxidants|antioxidants|mesh-ancestor
6729237|NCT01891500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6729238|NCT01891500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6729239|NCT01891500|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6729240|NCT01891500|Vasodilator Agents|vasodilator agents|mesh-ancestor
6729241|NCT01891500|Gasotransmitters|gasotransmitters|mesh-ancestor
6729242|NCT01891500|Protective Agents|protective agents|mesh-ancestor
6729243|NCT01891513|Losartan|losartan|mesh-list
6729244|NCT01891513|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6729245|NCT01891513|Perindopril|perindopril|mesh-list
6729246|NCT01891513|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
6729247|NCT01891513|Diuretics|diuretics|mesh-list
6729248|NCT01891513|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
6729249|NCT01891513|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6729250|NCT01891513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6729251|NCT01891513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6729252|NCT01891513|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6729253|NCT01891513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6729254|NCT01891513|Natriuretic Agents|natriuretic agents|mesh-ancestor
6729255|NCT01891513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729256|NCT01891513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6729257|NCT01891513|Protease Inhibitors|protease inhibitors|mesh-ancestor
6729258|NCT01891513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6729259|NCT01891526|Tretinoin|tretinoin|mesh-list
6729260|NCT01891526|Alitretinoin|alitretinoin|mesh-list
6729261|NCT01891526|Isotretinoin|isotretinoin|mesh-list
6729262|NCT01891526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6729263|NCT01891526|Keratolytic Agents|keratolytic agents|mesh-ancestor
6729264|NCT01891526|Dermatologic Agents|dermatologic agents|mesh-ancestor
6729265|NCT01891643|Dexamethasone|dexamethasone|mesh-list
6729266|NCT01891643|Dexamethasone acetate|dexamethasone acetate|mesh-list
6729267|NCT01891643|Lenalidomide|lenalidomide|mesh-list
6729268|NCT01891643|Elotuzumab|elotuzumab|mesh-list
6729269|NCT01891643|BB 1101|bb 1101|mesh-list
6729270|NCT01891643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6729271|NCT01891643|Antiemetics|antiemetics|mesh-ancestor
6729272|NCT01891643|Autonomic Agents|autonomic agents|mesh-ancestor
6729273|NCT01891643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6729274|NCT01891643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729275|NCT01891643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6729276|NCT01891643|Glucocorticoids|glucocorticoids|mesh-ancestor
6729277|NCT01891643|Hormones|hormones|mesh-ancestor
6729278|NCT01891643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6729279|NCT01891643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6729280|NCT01891643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6729281|NCT01891643|Protease Inhibitors|protease inhibitors|mesh-ancestor
6729282|NCT01891643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6729283|NCT01891643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6729284|NCT01891643|Immunologic Factors|immunologic factors|mesh-ancestor
6729285|NCT01891643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6729286|NCT01891643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6729287|NCT01891643|Growth Substances|growth substances|mesh-ancestor
6729288|NCT01891643|Growth Inhibitors|growth inhibitors|mesh-ancestor
6729289|NCT01891708|Bevacizumab|bevacizumab|mesh-list
6729290|NCT01891708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6729291|NCT01891708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6729292|NCT01891708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6729293|NCT01891708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6729294|NCT01891708|Growth Substances|growth substances|mesh-ancestor
6729295|NCT01891708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729296|NCT01891708|Growth Inhibitors|growth inhibitors|mesh-ancestor
6729297|NCT01891747|Ascorbic Acid|ascorbic acid|mesh-list
6729298|NCT01891747|Bevacizumab|bevacizumab|mesh-list
6729299|NCT01891747|Temozolomide|temozolomide|mesh-list
6729300|NCT01891747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6729301|NCT01891747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6729302|NCT01891747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6729303|NCT01891747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6729304|NCT01891747|Growth Substances|growth substances|mesh-ancestor
6729305|NCT01891747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729306|NCT01891747|Growth Inhibitors|growth inhibitors|mesh-ancestor
6729307|NCT01891747|Vitamins|vitamins|mesh-ancestor
6729308|NCT01891747|Micronutrients|micronutrients|mesh-ancestor
6729309|NCT01891747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6729310|NCT01891747|Alkylating Agents|alkylating agents|mesh-ancestor
6729311|NCT01891747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6729312|NCT01891747|Antioxidants|antioxidants|mesh-ancestor
6729313|NCT01891747|Protective Agents|protective agents|mesh-ancestor
6729314|NCT01891812|Nitrous Oxide|nitrous oxide|mesh-list
6729315|NCT01891812|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6729316|NCT01891812|Anesthetics, General|anesthetics, general|mesh-ancestor
6729317|NCT01891812|Anesthetics|anesthetics|mesh-ancestor
6729318|NCT01891812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6729319|NCT01891812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729320|NCT01891812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6729321|NCT01891812|Analgesics|analgesics|mesh-ancestor
6729322|NCT01891812|Sensory System Agents|sensory system agents|mesh-ancestor
6729323|NCT01891812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6729324|NCT01891851|Ritonavir|ritonavir|mesh-list
6729325|NCT01891851|Simeprevir|simeprevir|mesh-list
6729326|NCT01891851|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6729327|NCT01891851|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6729328|NCT01891851|Protease Inhibitors|protease inhibitors|mesh-ancestor
6729329|NCT01891851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6729330|NCT01891851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6729331|NCT01891851|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6729332|NCT01891851|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6729333|NCT01891851|Antiviral Agents|antiviral agents|mesh-ancestor
6729334|NCT01891851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6729335|NCT01891851|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6729336|NCT01891851|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6729337|NCT01891916|Caseins|caseins|mesh-list
6729338|NCT01891916|Chelating Agents|chelating agents|mesh-ancestor
6729339|NCT01891916|Sequestering Agents|sequestering agents|mesh-ancestor
6729340|NCT01891916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6729341|NCT01891981|Immunotoxin HA22|immunotoxin ha22|mesh-list
6729342|NCT01891981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6729343|NCT01892098|Zinc Sulfate|zinc sulfate|mesh-list
6729344|NCT01892098|Astringents|astringents|mesh-ancestor
6729345|NCT01892098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729346|NCT01892098|Dermatologic Agents|dermatologic agents|mesh-ancestor
6729347|NCT01892150|Sunscreening Agents|sunscreening agents|mesh-list
6729348|NCT01892150|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6729349|NCT01892150|Protective Agents|protective agents|mesh-ancestor
6729350|NCT01892150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729351|NCT01892150|Dermatologic Agents|dermatologic agents|mesh-ancestor
6729352|NCT01892176|Ubiquinone|ubiquinone|mesh-list
6729353|NCT01892176|Coenzyme Q10|coenzyme q10|mesh-list
6729354|NCT01892176|Micronutrients|micronutrients|mesh-ancestor
6729355|NCT01892176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729356|NCT01892176|Vitamins|vitamins|mesh-ancestor
6729357|NCT01892241|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6729358|NCT01892241|Entecavir|entecavir|mesh-list
6729359|NCT01892241|Antiviral Agents|antiviral agents|mesh-ancestor
6729360|NCT01892241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6729361|NCT01892254|Metformin|metformin|mesh-list
6729362|NCT01892254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6729363|NCT01892254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729364|NCT01892319|Insulin Detemir|insulin detemir|mesh-list
6729365|NCT01892319|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6729366|NCT01892319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729367|NCT01892332|Lidocaine|lidocaine|mesh-list
6729368|NCT01892332|Fentanyl|fentanyl|mesh-list
6729369|NCT01892332|Anesthetics, Local|anesthetics, local|mesh-ancestor
6729370|NCT01892332|Anesthetics|anesthetics|mesh-ancestor
6729371|NCT01892332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6729372|NCT01892332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729373|NCT01892332|Sensory System Agents|sensory system agents|mesh-ancestor
6729374|NCT01892332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6729375|NCT01892332|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6729376|NCT01892332|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6729377|NCT01892332|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6729378|NCT01892332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6729379|NCT01892332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6729380|NCT01892332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6729381|NCT01892332|Narcotics|narcotics|mesh-ancestor
6729382|NCT01892332|Analgesics|analgesics|mesh-ancestor
6729383|NCT01892332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6729384|NCT01892332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6729385|NCT01892332|Anesthetics, General|anesthetics, general|mesh-ancestor
6729386|NCT01892371|Cytarabine|cytarabine|mesh-list
6729387|NCT01892371|Azacitidine|azacitidine|mesh-list
6729388|NCT01892371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6729389|NCT01892371|Antimetabolites|antimetabolites|mesh-ancestor
6729390|NCT01892371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6729391|NCT01892371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6729392|NCT01892371|Antiviral Agents|antiviral agents|mesh-ancestor
6729393|NCT01892371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6729394|NCT01892371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6729395|NCT01892371|Immunologic Factors|immunologic factors|mesh-ancestor
6729396|NCT01892371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729397|NCT01892371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6729398|NCT01892384|BI 409306|bi 409306|mesh-list
6729399|NCT01892384|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6729400|NCT01892384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6729401|NCT01892384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6729402|NCT01892488|Sultamicillin|sultamicillin|mesh-list
6729403|NCT01892488|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
6729404|NCT01892488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6729405|NCT01892488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6729406|NCT01892488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6729407|NCT01892488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6729408|NCT01892527|Cetuximab|cetuximab|mesh-list
6729409|NCT01892527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6729410|NCT01892527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6729411|NCT01892618|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6729412|NCT01892618|Immunologic Factors|immunologic factors|mesh-ancestor
6729413|NCT01892618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729414|NCT01892631|Vaccines|vaccines|mesh-list
6729415|NCT01892631|Immunologic Factors|immunologic factors|mesh-ancestor
6729416|NCT01892631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729417|NCT01892644|Deferasirox|deferasirox|mesh-list
6729418|NCT01892644|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6729419|NCT01892644|Chelating Agents|chelating agents|mesh-ancestor
6729420|NCT01892644|Sequestering Agents|sequestering agents|mesh-ancestor
6729421|NCT01892644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6729422|NCT01892683|Propofol|propofol|mesh-list
6729423|NCT01892683|Anesthetics|anesthetics|mesh-ancestor
6729424|NCT01892683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6729425|NCT01892683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729426|NCT01892683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6729427|NCT01892683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6729428|NCT01892683|Anesthetics, General|anesthetics, general|mesh-ancestor
6729429|NCT01892748|Vitamin D|vitamin d|mesh-list
6729430|NCT01892748|Cholecalciferol|cholecalciferol|mesh-list
6729431|NCT01892748|Vitamins|vitamins|mesh-ancestor
6729432|NCT01892748|Micronutrients|micronutrients|mesh-ancestor
6729433|NCT01892748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729434|NCT01892748|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6729435|NCT01892748|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6729436|NCT01892787|Formoterol Fumarate|formoterol fumarate|mesh-list
6729437|NCT01892787|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6729438|NCT01892787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6729439|NCT01892787|Autonomic Agents|autonomic agents|mesh-ancestor
6729440|NCT01892787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6729441|NCT01892787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729442|NCT01892787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6729443|NCT01892787|Respiratory System Agents|respiratory system agents|mesh-ancestor
6729444|NCT01892787|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6729445|NCT01892787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6729446|NCT01892787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6729447|NCT01892787|Adrenergic Agents|adrenergic agents|mesh-ancestor
6729448|NCT01892787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6729449|NCT01892787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6729450|NCT01892813|Bupropion|bupropion|mesh-list
6729451|NCT01892813|Nicotine|nicotine|mesh-list
6729452|NCT01892813|Varenicline|varenicline|mesh-list
6729453|NCT01892813|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6729454|NCT01892813|Autonomic Agents|autonomic agents|mesh-ancestor
6729455|NCT01892813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6729456|NCT01892813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729457|NCT01892813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6729458|NCT01892813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6729459|NCT01892813|Cholinergic Agents|cholinergic agents|mesh-ancestor
6729460|NCT01892813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6729461|NCT01892813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6729462|NCT01892813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6729463|NCT01892813|Antidepressive Agents|antidepressive agents|mesh-ancestor
6729464|NCT01892813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6729465|NCT01892813|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6729466|NCT01892813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6729467|NCT01892813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6729468|NCT01892813|Dopamine Agents|dopamine agents|mesh-ancestor
6729469|NCT01892813|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6729470|NCT01892813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6729471|NCT01892813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6729472|NCT01892839|Dialysis Solutions|dialysis solutions|mesh-list
6729473|NCT01892839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6729474|NCT01892995|Ketamine|ketamine|mesh-list
6729475|NCT01892995|Analgesics|analgesics|mesh-ancestor
6729476|NCT01892995|Sensory System Agents|sensory system agents|mesh-ancestor
6729477|NCT01892995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6729478|NCT01892995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729479|NCT01892995|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6729480|NCT01892995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6729481|NCT01892995|Anesthetics, General|anesthetics, general|mesh-ancestor
6729482|NCT01892995|Anesthetics|anesthetics|mesh-ancestor
6729483|NCT01892995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6729484|NCT01892995|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6729485|NCT01892995|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6729486|NCT01892995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6729487|NCT01892995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785155|NCT02206503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6785156|NCT02206503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6785157|NCT02206503|Antiemetics|antiemetics|mesh-ancestor
6785158|NCT02206503|Autonomic Agents|autonomic agents|mesh-ancestor
6785159|NCT02206503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6785160|NCT02206503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6785161|NCT02206503|Glucocorticoids|glucocorticoids|mesh-ancestor
6785162|NCT02206503|Hormones|hormones|mesh-ancestor
6785163|NCT02206503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6785164|NCT02206503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6785165|NCT02206503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6785166|NCT02206503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6785167|NCT02206503|Growth Substances|growth substances|mesh-ancestor
6785168|NCT02206503|Growth Inhibitors|growth inhibitors|mesh-ancestor
6785169|NCT02206555|Tenofovir|tenofovir|mesh-list
6729488|NCT01893060|Chlorhexidine|chlorhexidine|mesh-list
6729489|NCT01893060|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6729490|NCT01893060|Povidone-Iodine|povidone-iodine|mesh-list
6729491|NCT01893060|Povidone|povidone|mesh-list
6729492|NCT01893060|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6729493|NCT01893060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6729494|NCT01893060|Disinfectants|disinfectants|mesh-ancestor
6729495|NCT01893060|Dermatologic Agents|dermatologic agents|mesh-ancestor
6729496|NCT01893060|Plasma Substitutes|plasma substitutes|mesh-ancestor
6729497|NCT01893060|Blood Substitutes|blood substitutes|mesh-ancestor
6729498|NCT01893099|Sorafenib|sorafenib|mesh-list
6729499|NCT01893099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6729500|NCT01893099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6729501|NCT01893099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6729502|NCT01893099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6729503|NCT01893177|Vaccines|vaccines|mesh-list
6729504|NCT01893177|Immunologic Factors|immunologic factors|mesh-ancestor
6729505|NCT01893177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729506|NCT01893229|Oxcarbazepine|oxcarbazepine|mesh-list
6729507|NCT01893229|Valproic Acid|valproic acid|mesh-list
6729508|NCT01893229|Olanzapine|olanzapine|mesh-list
6729509|NCT01893229|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6729510|NCT01893229|Ziprasidone|ziprasidone|mesh-list
6729511|NCT01893229|Lithium Carbonate|lithium carbonate|mesh-list
6729512|NCT01893229|Antiemetics|antiemetics|mesh-ancestor
6729513|NCT01893229|Autonomic Agents|autonomic agents|mesh-ancestor
6729514|NCT01893229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6729515|NCT01893229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729516|NCT01893229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6729517|NCT01893229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6729518|NCT01893229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6729519|NCT01893229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6729520|NCT01893229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6729521|NCT01893229|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6729522|NCT01893229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6729523|NCT01893229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6729524|NCT01893229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6729525|NCT01893229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6729526|NCT01893229|Serotonin Agents|serotonin agents|mesh-ancestor
6729527|NCT01893229|Antidepressive Agents|antidepressive agents|mesh-ancestor
6729528|NCT01893229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6729529|NCT01893229|Antimanic Agents|antimanic agents|mesh-ancestor
6729530|NCT01893229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6729531|NCT01893229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6729532|NCT01893229|Dopamine Agents|dopamine agents|mesh-ancestor
6729533|NCT01893229|Anticonvulsants|anticonvulsants|mesh-ancestor
6729534|NCT01893229|GABA Agents|gaba agents|mesh-ancestor
6729535|NCT01893229|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6729536|NCT01893229|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6729537|NCT01893229|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6729538|NCT01893229|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6729539|NCT01893294|Gemcitabine|gemcitabine|mesh-list
6729540|NCT01893294|Fluorouracil|fluorouracil|mesh-list
6729541|NCT01893294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6729542|NCT01893294|Antimetabolites|antimetabolites|mesh-ancestor
6729543|NCT01893294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6729544|NCT01893294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6729545|NCT01893294|Antiviral Agents|antiviral agents|mesh-ancestor
6729546|NCT01893294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6729547|NCT01893294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6729548|NCT01893294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6729549|NCT01893294|Immunologic Factors|immunologic factors|mesh-ancestor
6729550|NCT01893294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729551|NCT01893385|Vitamin D|vitamin d|mesh-list
6729552|NCT01893385|Vitamins|vitamins|mesh-ancestor
6729553|NCT01893385|Micronutrients|micronutrients|mesh-ancestor
6729554|NCT01893385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729555|NCT01893385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6729556|NCT01893424|Dronabinol|dronabinol|mesh-list
6729557|NCT01893424|Nabiximols|nabiximols|mesh-list
6729558|NCT01893424|Cannabidiol|cannabidiol|mesh-list
6729559|NCT01893424|Piperine|piperine|mesh-list
6729560|NCT01893424|Anticonvulsants|anticonvulsants|mesh-ancestor
6729561|NCT01893424|Hallucinogens|hallucinogens|mesh-ancestor
6729562|NCT01893424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729563|NCT01893424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6729564|NCT01893424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6729565|NCT01893424|Analgesics|analgesics|mesh-ancestor
6729566|NCT01893424|Sensory System Agents|sensory system agents|mesh-ancestor
6729567|NCT01893424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6729568|NCT01893424|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6729569|NCT01893424|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6729570|NCT01893424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6729571|NCT01893424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6729572|NCT01893424|Hormones|hormones|mesh-ancestor
6729573|NCT01893424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6729574|NCT01893424|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6729575|NCT01893424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6729576|NCT01893450|Pentoxifylline|pentoxifylline|mesh-list
6729577|NCT01893450|Bromocriptine|bromocriptine|mesh-list
6729578|NCT01893450|Methimazole|methimazole|mesh-list
6729579|NCT01893450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6729580|NCT01893450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6729581|NCT01893450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6729582|NCT01893450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6729583|NCT01893450|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6729584|NCT01893450|Protective Agents|protective agents|mesh-ancestor
6729585|NCT01893450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729586|NCT01893450|Vasodilator Agents|vasodilator agents|mesh-ancestor
6729587|NCT01893450|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6729588|NCT01893450|Antioxidants|antioxidants|mesh-ancestor
6729589|NCT01893450|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6729590|NCT01893450|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6729591|NCT01893450|Hormone Antagonists|hormone antagonists|mesh-ancestor
6729592|NCT01893450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6729593|NCT01893450|Dopamine Agonists|dopamine agonists|mesh-ancestor
6729594|NCT01893450|Dopamine Agents|dopamine agents|mesh-ancestor
6729595|NCT01893450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6729596|NCT01893450|Antithyroid Agents|antithyroid agents|mesh-ancestor
6729597|NCT01893541|Propranolol|propranolol|mesh-list
6729598|NCT01893541|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6729599|NCT01893541|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6729600|NCT01893541|Adrenergic Agents|adrenergic agents|mesh-ancestor
6729601|NCT01893541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6729602|NCT01893541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6729603|NCT01893541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729604|NCT01893541|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6729605|NCT01893541|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6729606|NCT01893541|Vasodilator Agents|vasodilator agents|mesh-ancestor
6729607|NCT01893658|Omalizumab|omalizumab|mesh-list
6729608|NCT01893658|Prednisone|prednisone|mesh-list
6729609|NCT01893658|Prednisolone|prednisolone|mesh-list
6729610|NCT01893658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6729611|NCT01893658|Glucocorticoids|glucocorticoids|mesh-ancestor
6729612|NCT01893658|Hormones|hormones|mesh-ancestor
6729613|NCT01893658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6729614|NCT01893658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729615|NCT01893658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6729616|NCT01893658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6729617|NCT01893658|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6729618|NCT01893658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6729619|NCT01893658|Respiratory System Agents|respiratory system agents|mesh-ancestor
6729620|NCT01893723|Remifentanil|remifentanil|mesh-list
6729621|NCT01893723|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6729622|NCT01893723|Narcotics|narcotics|mesh-ancestor
6729623|NCT01893723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6729624|NCT01893723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729625|NCT01893723|Analgesics|analgesics|mesh-ancestor
6729626|NCT01893723|Sensory System Agents|sensory system agents|mesh-ancestor
6729627|NCT01893723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6729628|NCT01893788|Eplerenone|eplerenone|mesh-list
6729629|NCT01893788|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6729630|NCT01893788|Hormone Antagonists|hormone antagonists|mesh-ancestor
6729631|NCT01893788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6729632|NCT01893788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729633|NCT01893788|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6729634|NCT01893788|Diuretics|diuretics|mesh-ancestor
6729635|NCT01893788|Natriuretic Agents|natriuretic agents|mesh-ancestor
6729636|NCT01893788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6729637|NCT01893996|Adalimumab|adalimumab|mesh-list
6729638|NCT01893996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6729639|NCT01893996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6729640|NCT01894035|Iloprost|iloprost|mesh-list
6729641|NCT01894035|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6729642|NCT01894035|Vasodilator Agents|vasodilator agents|mesh-ancestor
6729643|NCT01894048|Beclomethasone|beclomethasone|mesh-list
6729644|NCT01894048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6729645|NCT01894048|Glucocorticoids|glucocorticoids|mesh-ancestor
6729646|NCT01894048|Hormones|hormones|mesh-ancestor
6729647|NCT01894048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6729648|NCT01894048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729649|NCT01894048|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6729650|NCT01894048|Respiratory System Agents|respiratory system agents|mesh-ancestor
6729651|NCT01894061|Bevacizumab|bevacizumab|mesh-list
6729652|NCT01894061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6729653|NCT01894061|Antibodies|antibodies|mesh-list
6729654|NCT01894061|Immunoglobulins|immunoglobulins|mesh-list
6729655|NCT01894061|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6729656|NCT01894061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6729657|NCT01894061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6729658|NCT01894061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6729659|NCT01894061|Growth Substances|growth substances|mesh-ancestor
6729660|NCT01894061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729661|NCT01894061|Growth Inhibitors|growth inhibitors|mesh-ancestor
6729662|NCT01894061|Immunologic Factors|immunologic factors|mesh-ancestor
6729663|NCT01894269|Lamivudine|lamivudine|mesh-list
6729664|NCT01894269|Entecavir|entecavir|mesh-list
6729665|NCT01894269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6729666|NCT01894269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6729667|NCT01894269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6729668|NCT01894269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6729669|NCT01894269|Antiviral Agents|antiviral agents|mesh-ancestor
6729670|NCT01894269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6729671|NCT01894269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6729672|NCT01894269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6729673|NCT01894295|Vitamin D|vitamin d|mesh-list
6729674|NCT01894295|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
6729675|NCT01894295|Vitamins|vitamins|mesh-ancestor
6729676|NCT01894295|Micronutrients|micronutrients|mesh-ancestor
6729677|NCT01894295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729678|NCT01894295|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6729679|NCT01894308|Testosterone|testosterone|mesh-list
6729680|NCT01894308|Androgens|androgens|mesh-ancestor
6729681|NCT01894308|Hormones|hormones|mesh-ancestor
6729682|NCT01894308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6729683|NCT01894308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729684|NCT01894334|Edaravone|edaravone|mesh-list
6729685|NCT01894334|Tranexamic Acid|tranexamic acid|mesh-list
6729686|NCT01894334|Urinastatin|urinastatin|mesh-list
6729687|NCT01894334|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6729688|NCT01894334|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6729689|NCT01894334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6729690|NCT01894334|Hemostatics|hemostatics|mesh-ancestor
6729691|NCT01894334|Coagulants|coagulants|mesh-ancestor
6729692|NCT01894334|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6729693|NCT01894334|Antioxidants|antioxidants|mesh-ancestor
6729694|NCT01894334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6729695|NCT01894334|Protective Agents|protective agents|mesh-ancestor
6729696|NCT01894334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729697|NCT01894334|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6729698|NCT01894334|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6729699|NCT01894334|Protease Inhibitors|protease inhibitors|mesh-ancestor
6729700|NCT01894334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6729701|NCT01894360|Belimumab|belimumab|mesh-list
6729702|NCT01894360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6729703|NCT01894360|Immunologic Factors|immunologic factors|mesh-ancestor
6729704|NCT01894360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729705|NCT01894412|Etanercept|etanercept|mesh-list
6729706|NCT01894412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6729707|NCT01894412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6729708|NCT01894412|Analgesics|analgesics|mesh-ancestor
6729709|NCT01894412|Sensory System Agents|sensory system agents|mesh-ancestor
6729710|NCT01894412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6729711|NCT01894412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729712|NCT01894412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6729713|NCT01894412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6729714|NCT01894412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6729715|NCT01894412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6729716|NCT01894412|Immunologic Factors|immunologic factors|mesh-ancestor
6729717|NCT01894451|Bevacizumab|bevacizumab|mesh-list
6729718|NCT01894451|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
6729719|NCT01894451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6729720|NCT01894451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6729721|NCT01894451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6729722|NCT01894451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6729723|NCT01894451|Growth Substances|growth substances|mesh-ancestor
6729724|NCT01894451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729725|NCT01894451|Growth Inhibitors|growth inhibitors|mesh-ancestor
6729726|NCT01894451|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6729727|NCT01894451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6729728|NCT01894633|Chloroquine|chloroquine|mesh-list
6729729|NCT01894633|Amebicides|amebicides|mesh-ancestor
6729730|NCT01894633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6729731|NCT01894633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6729732|NCT01894633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6729733|NCT01894633|Antimalarials|antimalarials|mesh-ancestor
6729734|NCT01894633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6729735|NCT01894685|Mesalamine|mesalamine|mesh-list
6729736|NCT01894685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6729737|NCT01894685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6729738|NCT01894685|Analgesics|analgesics|mesh-ancestor
6729739|NCT01894685|Sensory System Agents|sensory system agents|mesh-ancestor
6729740|NCT01894685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6729741|NCT01894685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729742|NCT01894685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6729743|NCT01894685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6729744|NCT01894711|Trastuzumab|trastuzumab|mesh-list
6729745|NCT01894711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6729746|NCT01894711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6729747|NCT01894789|Clopidogrel|clopidogrel|mesh-list
6729748|NCT01894789|Ticagrelor|ticagrelor|mesh-list
6729749|NCT01894789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6729750|NCT01894789|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6729751|NCT01894789|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6729752|NCT01894789|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6729753|NCT01894789|Purinergic Agents|purinergic agents|mesh-ancestor
6729754|NCT01894789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6729755|NCT01894789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6729756|NCT01894789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729757|NCT01894815|Dexetimide|dexetimide|mesh-list
6729758|NCT01894815|Citalopram|citalopram|mesh-list
6729759|NCT01894815|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6729760|NCT01894815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6729761|NCT01894815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6729762|NCT01894815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6729763|NCT01894815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6729764|NCT01894815|Serotonin Agents|serotonin agents|mesh-ancestor
6729765|NCT01894815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729766|NCT01894815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6729767|NCT01894815|Antidepressive Agents|antidepressive agents|mesh-ancestor
6729768|NCT01894815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6729769|NCT01894815|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6729770|NCT01894815|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6729771|NCT01894815|Parasympatholytics|parasympatholytics|mesh-ancestor
6729772|NCT01894815|Autonomic Agents|autonomic agents|mesh-ancestor
6729773|NCT01894815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6729774|NCT01894815|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6729775|NCT01894815|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6729776|NCT01894815|Cholinergic Agents|cholinergic agents|mesh-ancestor
6785170|NCT02206555|Emtricitabine|emtricitabine|mesh-list
6785171|NCT02206555|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6785172|NCT02206555|Antiviral Agents|antiviral agents|mesh-ancestor
6785173|NCT02206555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6785174|NCT02206555|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6785175|NCT02206555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6785176|NCT02206555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6785177|NCT02206555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785178|NCT02206555|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6785179|NCT02206555|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6785180|NCT02206568|Insulin Lispro|insulin lispro|mesh-list
6785181|NCT02206568|Insulin, Short-Acting|insulin, short-acting|mesh-list
6785182|NCT02206568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6785183|NCT02206568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785184|NCT02206646|Tenecteplase|tenecteplase|mesh-list
6729777|NCT01894867|Magnesium Oxide|magnesium oxide|mesh-list
6729778|NCT01894867|Antacids|antacids|mesh-ancestor
6729779|NCT01894867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6729780|NCT01894867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6729781|NCT01895010|Tropisetron|tropisetron|mesh-list
6729782|NCT01895010|Antiemetics|antiemetics|mesh-ancestor
6729783|NCT01895010|Autonomic Agents|autonomic agents|mesh-ancestor
6729784|NCT01895010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6729785|NCT01895010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729786|NCT01895010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6729787|NCT01895010|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6729788|NCT01895010|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6729789|NCT01895010|Serotonin Agents|serotonin agents|mesh-ancestor
6729790|NCT01895010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6729791|NCT01895010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6729792|NCT01895023|Midazolam|midazolam|mesh-list
6729793|NCT01895023|Dexmedetomidine|dexmedetomidine|mesh-list
6729794|NCT01895023|GABA Modulators|gaba modulators|mesh-list
6729795|NCT01895023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6729796|NCT01895023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6729797|NCT01895023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729798|NCT01895023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6729799|NCT01895023|Analgesics|analgesics|mesh-ancestor
6729800|NCT01895023|Sensory System Agents|sensory system agents|mesh-ancestor
6729801|NCT01895023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6729802|NCT01895023|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6729803|NCT01895023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6729804|NCT01895023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6729805|NCT01895023|Adrenergic Agents|adrenergic agents|mesh-ancestor
6729806|NCT01895023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6729807|NCT01895023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6729808|NCT01895023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6729809|NCT01895023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6729810|NCT01895023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6729811|NCT01895023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6729812|NCT01895023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6729813|NCT01895023|Anesthetics, General|anesthetics, general|mesh-ancestor
6729814|NCT01895023|Anesthetics|anesthetics|mesh-ancestor
6729815|NCT01895023|GABA Agents|gaba agents|mesh-ancestor
6729816|NCT01895049|Mycophenolic Acid|mycophenolic acid|mesh-list
6729817|NCT01895049|Prednisone|prednisone|mesh-list
6729818|NCT01895049|Everolimus|everolimus|mesh-list
6729819|NCT01895049|Tacrolimus|tacrolimus|mesh-list
6729820|NCT01895049|Thymoglobulin|thymoglobulin|mesh-list
6729821|NCT01895049|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6729822|NCT01895049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6729823|NCT01895049|Glucocorticoids|glucocorticoids|mesh-ancestor
6729824|NCT01895049|Hormones|hormones|mesh-ancestor
6729825|NCT01895049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6729826|NCT01895049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729827|NCT01895049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6729828|NCT01895049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6729829|NCT01895049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6729830|NCT01895049|Immunologic Factors|immunologic factors|mesh-ancestor
6729831|NCT01895049|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6729832|NCT01895049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6729833|NCT01895049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6729834|NCT01895049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6729835|NCT01895049|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6729836|NCT01895049|Antitubercular Agents|antitubercular agents|mesh-ancestor
6729837|NCT01895049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6729838|NCT01895049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6729839|NCT01895075|Budesonide|budesonide|mesh-list
6729840|NCT01895075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6729841|NCT01895075|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6729842|NCT01895075|Autonomic Agents|autonomic agents|mesh-ancestor
6729843|NCT01895075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6729844|NCT01895075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729845|NCT01895075|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6729846|NCT01895075|Respiratory System Agents|respiratory system agents|mesh-ancestor
6729847|NCT01895075|Glucocorticoids|glucocorticoids|mesh-ancestor
6729848|NCT01895075|Hormones|hormones|mesh-ancestor
6729849|NCT01895075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6729850|NCT01895205|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
6729851|NCT01895205|Hematinics|hematinics|mesh-ancestor
6729852|NCT01895218|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
6729853|NCT01895218|Hematinics|hematinics|mesh-ancestor
6729854|NCT01895231|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
6729855|NCT01895231|Hematinics|hematinics|mesh-ancestor
6729856|NCT01895257|Leucovorin|leucovorin|mesh-list
6729857|NCT01895257|Fluorouracil|fluorouracil|mesh-list
6729858|NCT01895257|Levoleucovorin|levoleucovorin|mesh-list
6729859|NCT01895257|Antidotes|antidotes|mesh-ancestor
6729860|NCT01895257|Protective Agents|protective agents|mesh-ancestor
6729861|NCT01895257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729862|NCT01895257|Vitamin B Complex|vitamin b complex|mesh-ancestor
6729863|NCT01895257|Vitamins|vitamins|mesh-ancestor
6729864|NCT01895257|Micronutrients|micronutrients|mesh-ancestor
6729865|NCT01895257|Antimetabolites|antimetabolites|mesh-ancestor
6729866|NCT01895257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6729867|NCT01895257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6729868|NCT01895257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6729869|NCT01895257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6729870|NCT01895257|Immunologic Factors|immunologic factors|mesh-ancestor
6729871|NCT01895296|Pasireotide|pasireotide|mesh-list
6729872|NCT01895296|Hormones|hormones|mesh-ancestor
6729873|NCT01895296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6729874|NCT01895296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729875|NCT01895348|Dexmedetomidine|dexmedetomidine|mesh-list
6729876|NCT01895348|Remifentanil|remifentanil|mesh-list
6729877|NCT01895348|Propofol|propofol|mesh-list
6729878|NCT01895348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6729879|NCT01895348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6729880|NCT01895348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729881|NCT01895348|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6729882|NCT01895348|Anesthetics, General|anesthetics, general|mesh-ancestor
6729883|NCT01895348|Anesthetics|anesthetics|mesh-ancestor
6729884|NCT01895348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6729885|NCT01895348|Analgesics|analgesics|mesh-ancestor
6729886|NCT01895348|Sensory System Agents|sensory system agents|mesh-ancestor
6729887|NCT01895348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6729888|NCT01895348|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6729889|NCT01895348|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6729890|NCT01895348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6729891|NCT01895348|Adrenergic Agents|adrenergic agents|mesh-ancestor
6729892|NCT01895348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6729893|NCT01895348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6729894|NCT01895348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6729895|NCT01895348|Narcotics|narcotics|mesh-ancestor
6729896|NCT01895400|Cilostazol|cilostazol|mesh-list
6729897|NCT01895400|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6729898|NCT01895400|Autonomic Agents|autonomic agents|mesh-ancestor
6729899|NCT01895400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6729900|NCT01895400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729901|NCT01895400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6729902|NCT01895400|Respiratory System Agents|respiratory system agents|mesh-ancestor
6729903|NCT01895400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6729904|NCT01895400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6729905|NCT01895400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6729906|NCT01895400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6729907|NCT01895400|Vasodilator Agents|vasodilator agents|mesh-ancestor
6729908|NCT01895400|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6729909|NCT01895400|Protective Agents|protective agents|mesh-ancestor
6729910|NCT01895400|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6729911|NCT01895400|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6729912|NCT01895400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6729913|NCT01895569|Metformin|metformin|mesh-list
6729914|NCT01895569|Pioglitazone|pioglitazone|mesh-list
6729915|NCT01895569|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6729916|NCT01895569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6729917|NCT01895569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729918|NCT01895569|Incretins|incretins|mesh-ancestor
6729919|NCT01895569|Hormones|hormones|mesh-ancestor
6729920|NCT01895569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6729921|NCT01895569|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6729922|NCT01895569|Protease Inhibitors|protease inhibitors|mesh-ancestor
6729923|NCT01895569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6729924|NCT01895569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6729925|NCT01895621|Thioctic Acid|thioctic acid|mesh-list
6729926|NCT01895621|Antioxidants|antioxidants|mesh-ancestor
6729927|NCT01895621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6729928|NCT01895621|Protective Agents|protective agents|mesh-ancestor
6729929|NCT01895621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729930|NCT01895621|Vitamin B Complex|vitamin b complex|mesh-ancestor
6729931|NCT01895621|Vitamins|vitamins|mesh-ancestor
6729932|NCT01895621|Micronutrients|micronutrients|mesh-ancestor
6729933|NCT01895764|Adalimumab|adalimumab|mesh-list
6729934|NCT01895764|Methotrexate|methotrexate|mesh-list
6729935|NCT01895764|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6729936|NCT01895764|Abortifacient Agents|abortifacient agents|mesh-ancestor
6729937|NCT01895764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6729938|NCT01895764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729939|NCT01895764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6729940|NCT01895764|Antimetabolites|antimetabolites|mesh-ancestor
6729941|NCT01895764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6729942|NCT01895764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6729943|NCT01895764|Dermatologic Agents|dermatologic agents|mesh-ancestor
6729944|NCT01895764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6729945|NCT01895764|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6729946|NCT01895764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6729947|NCT01895764|Immunologic Factors|immunologic factors|mesh-ancestor
6729948|NCT01895764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6729949|NCT01895764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6729950|NCT01895764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6729951|NCT01895829|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
6729952|NCT01895829|Hematinics|hematinics|mesh-ancestor
6729953|NCT01895829|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6729954|NCT01895829|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6729955|NCT01895881|Estradiol|estradiol|mesh-list
6729956|NCT01895881|Estrogens|estrogens|mesh-ancestor
6729957|NCT01895881|Hormones|hormones|mesh-ancestor
6729958|NCT01895881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6729959|NCT01895881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729960|NCT01895894|Mycophenolic Acid|mycophenolic acid|mesh-list
6729961|NCT01895894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6729962|NCT01895894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6729963|NCT01895894|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6729964|NCT01895894|Antitubercular Agents|antitubercular agents|mesh-ancestor
6729965|NCT01895894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6729966|NCT01895894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6729967|NCT01895894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6729968|NCT01895894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6729969|NCT01895998|Albuterol|albuterol|mesh-list
6729970|NCT01895998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6729971|NCT01895998|Autonomic Agents|autonomic agents|mesh-ancestor
6729972|NCT01895998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6729973|NCT01895998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729974|NCT01895998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6729975|NCT01895998|Respiratory System Agents|respiratory system agents|mesh-ancestor
6729976|NCT01895998|Tocolytic Agents|tocolytic agents|mesh-ancestor
6729977|NCT01895998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6729978|NCT01895998|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6729979|NCT01895998|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6729980|NCT01895998|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6729981|NCT01895998|Adrenergic Agents|adrenergic agents|mesh-ancestor
6729982|NCT01895998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6729983|NCT01895998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6729984|NCT01896011|Teriparatide|teriparatide|mesh-list
6729985|NCT01896011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6729986|NCT01896011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729987|NCT01896011|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6729988|NCT01896180|Latanoprost|latanoprost|mesh-list
6729989|NCT01896180|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6729990|NCT01896180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6729991|NCT01896245|Sevoflurane|sevoflurane|mesh-list
6729992|NCT01896245|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6729993|NCT01896245|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6729994|NCT01896245|Anesthetics, General|anesthetics, general|mesh-ancestor
6729995|NCT01896245|Anesthetics|anesthetics|mesh-ancestor
6729996|NCT01896245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6729997|NCT01896245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6729998|NCT01896284|Aflibercept|aflibercept|mesh-list
6729999|NCT01896284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6730000|NCT01896284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6730001|NCT01896284|Growth Substances|growth substances|mesh-ancestor
6730002|NCT01896284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730003|NCT01896284|Growth Inhibitors|growth inhibitors|mesh-ancestor
6730004|NCT01896284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6730005|NCT01896323|Ketoconazole|ketoconazole|mesh-list
6730006|NCT01896323|Antifungal Agents|antifungal agents|mesh-ancestor
6730007|NCT01896323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6730008|NCT01896323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6730009|NCT01896323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6730010|NCT01896323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6730011|NCT01896323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730012|NCT01896323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6730013|NCT01896323|Hormone Antagonists|hormone antagonists|mesh-ancestor
6730014|NCT01896323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6730015|NCT01896323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730016|NCT01896323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6730017|NCT01896336|Zolpidem|zolpidem|mesh-list
6730018|NCT01896336|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6730019|NCT01896336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6730020|NCT01896336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6730021|NCT01896336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730022|NCT01896336|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6730023|NCT01896336|GABA Agonists|gaba agonists|mesh-ancestor
6730024|NCT01896336|GABA Agents|gaba agents|mesh-ancestor
6730025|NCT01896336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6730026|NCT01896336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730027|NCT01896349|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6730028|NCT01896349|Amitriptyline|amitriptyline|mesh-list
6730029|NCT01896349|Risperidone|risperidone|mesh-list
6730030|NCT01896349|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6730031|NCT01896349|Sulpiride|sulpiride|mesh-list
6730032|NCT01896349|Mirtazapine|mirtazapine|mesh-list
6730033|NCT01896349|Trazodone|trazodone|mesh-list
6730034|NCT01896349|Fluvoxamine|fluvoxamine|mesh-list
6730035|NCT01896349|Tranylcypromine|tranylcypromine|mesh-list
6730036|NCT01896349|Citalopram|citalopram|mesh-list
6730037|NCT01896349|Bupropion|bupropion|mesh-list
6730038|NCT01896349|Sertraline|sertraline|mesh-list
6730039|NCT01896349|Fluoxetine|fluoxetine|mesh-list
6730040|NCT01896349|Paroxetine|paroxetine|mesh-list
6730041|NCT01896349|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6730042|NCT01896349|Nortriptyline|nortriptyline|mesh-list
6730043|NCT01896349|Imipramine|imipramine|mesh-list
6730044|NCT01896349|Clomipramine|clomipramine|mesh-list
6730045|NCT01896349|Antidepressive Agents|antidepressive agents|mesh-list
6730046|NCT01896349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6730047|NCT01896349|Serotonin Agents|serotonin agents|mesh-ancestor
6730048|NCT01896349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6730049|NCT01896349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730050|NCT01896349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730051|NCT01896349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6730052|NCT01896349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6730053|NCT01896349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6730054|NCT01896349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6730055|NCT01896349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6730056|NCT01896349|Dopamine Agents|dopamine agents|mesh-ancestor
6730057|NCT01896349|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6730058|NCT01896349|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6730059|NCT01896349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6730060|NCT01896349|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6730061|NCT01896349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6730062|NCT01896349|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6730063|NCT01896349|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6730064|NCT01896349|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6730065|NCT01896349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6730066|NCT01896349|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6730067|NCT01896349|Analgesics|analgesics|mesh-ancestor
6730068|NCT01896349|Sensory System Agents|sensory system agents|mesh-ancestor
6730069|NCT01896349|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6730070|NCT01896349|Histamine Antagonists|histamine antagonists|mesh-ancestor
6730071|NCT01896349|Histamine Agents|histamine agents|mesh-ancestor
6730072|NCT01896349|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6730073|NCT01896349|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6730074|NCT01896349|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6730075|NCT01896349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6730076|NCT01896349|Adrenergic Agents|adrenergic agents|mesh-ancestor
6730077|NCT01896349|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6730078|NCT01896349|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6730079|NCT01896349|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6730080|NCT01896349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6730081|NCT01896349|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6730082|NCT01896349|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6730083|NCT01896349|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6730084|NCT01896349|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6730085|NCT01896388|Ifenprodil|ifenprodil|mesh-list
6730086|NCT01896388|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6730087|NCT01896388|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6730088|NCT01896388|Adrenergic Agents|adrenergic agents|mesh-ancestor
6730089|NCT01896388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6730090|NCT01896388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730091|NCT01896388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730092|NCT01896388|Vasodilator Agents|vasodilator agents|mesh-ancestor
6730093|NCT01896388|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6730094|NCT01896388|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6730095|NCT01896440|Ondansetron|ondansetron|mesh-list
6730096|NCT01896440|Antiemetics|antiemetics|mesh-ancestor
6730097|NCT01896440|Autonomic Agents|autonomic agents|mesh-ancestor
6730098|NCT01896440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6730099|NCT01896440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730100|NCT01896440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6730101|NCT01896440|Antipruritics|antipruritics|mesh-ancestor
6730102|NCT01896440|Dermatologic Agents|dermatologic agents|mesh-ancestor
6730103|NCT01896440|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6730104|NCT01896440|Serotonin Agents|serotonin agents|mesh-ancestor
6730105|NCT01896440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6730106|NCT01896440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730107|NCT01896440|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6730108|NCT01896440|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6730109|NCT01896440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6730110|NCT01896440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6730111|NCT01896440|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6730112|NCT01896518|Nicotine|nicotine|mesh-list
6730113|NCT01896518|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6730114|NCT01896518|Autonomic Agents|autonomic agents|mesh-ancestor
6730115|NCT01896518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6730116|NCT01896518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730117|NCT01896518|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6730118|NCT01896518|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6730119|NCT01896518|Cholinergic Agents|cholinergic agents|mesh-ancestor
6730120|NCT01896518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6730121|NCT01896518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730122|NCT01896609|Interferons|interferons|mesh-list
6730123|NCT01896609|Ribavirin|ribavirin|mesh-list
6730124|NCT01896609|Interferon-alpha|interferon-alpha|mesh-list
6730125|NCT01896609|Interferon alpha-2|interferon alpha-2|mesh-list
6730126|NCT01896609|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6730127|NCT01896609|Nitazoxanide|nitazoxanide|mesh-list
6730128|NCT01896609|Complement Factor H|complement factor h|mesh-list
6730129|NCT01896609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6730130|NCT01896609|Antiviral Agents|antiviral agents|mesh-ancestor
6730131|NCT01896609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6730132|NCT01896609|Antimetabolites|antimetabolites|mesh-ancestor
6730133|NCT01896609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730134|NCT01896609|Immunologic Factors|immunologic factors|mesh-ancestor
6730135|NCT01896609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730136|NCT01896609|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6730137|NCT01896609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6730138|NCT01896609|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6730139|NCT01896622|Ritonavir|ritonavir|mesh-list
6730140|NCT01896622|Cobicistat|cobicistat|mesh-list
6730141|NCT01896622|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6730142|NCT01896622|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6730143|NCT01896622|Protease Inhibitors|protease inhibitors|mesh-ancestor
6730144|NCT01896622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6730145|NCT01896622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730146|NCT01896622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6730147|NCT01896622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6730148|NCT01896622|Antiviral Agents|antiviral agents|mesh-ancestor
6730149|NCT01896622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6730150|NCT01896622|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6730151|NCT01896622|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6785185|NCT02206646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6785186|NCT02206646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6785187|NCT02206646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785188|NCT02206659|Telmisartan|telmisartan|mesh-list
6785189|NCT02206659|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6785190|NCT02206659|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6785191|NCT02206659|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6785192|NCT02206659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785193|NCT02206711|BMS-955176|bms-955176|mesh-list
6785194|NCT02206711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6785195|NCT02206711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6785196|NCT02206711|Antiviral Agents|antiviral agents|mesh-ancestor
6785197|NCT02206711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6785198|NCT02206737|Nicotine|nicotine|mesh-list
6785199|NCT02206737|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6785200|NCT02206737|Autonomic Agents|autonomic agents|mesh-ancestor
6785201|NCT02206737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6785202|NCT02206737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785203|NCT02206737|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6785204|NCT02206737|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6785205|NCT02206737|Cholinergic Agents|cholinergic agents|mesh-ancestor
6785206|NCT02206737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6785207|NCT02206737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785208|NCT02206763|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6785209|NCT02206763|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
6785210|NCT02206763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6785211|NCT02206763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6785212|NCT02206763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6785213|NCT02206763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785214|NCT02206789|Cyclosporine|cyclosporine|mesh-list
6785215|NCT02206789|Prednisolone|prednisolone|mesh-list
6785216|NCT02206789|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6785217|NCT02206789|Methylprednisolone|methylprednisolone|mesh-list
6785218|NCT02206789|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6785219|NCT02206789|Prednisolone acetate|prednisolone acetate|mesh-list
6785220|NCT02206789|Cyclosporins|cyclosporins|mesh-list
6785221|NCT02206789|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6785222|NCT02206789|Prednisolone phosphate|prednisolone phosphate|mesh-list
6785223|NCT02206789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6785224|NCT02206789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785225|NCT02206789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6785226|NCT02206789|Immunologic Factors|immunologic factors|mesh-ancestor
6785227|NCT02206789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785228|NCT02206789|Antifungal Agents|antifungal agents|mesh-ancestor
6785229|NCT02206789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6785230|NCT02206789|Dermatologic Agents|dermatologic agents|mesh-ancestor
6785231|NCT02206789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6785232|NCT02206789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6785233|NCT02206789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6785234|NCT02206789|Glucocorticoids|glucocorticoids|mesh-ancestor
6785235|NCT02206789|Hormones|hormones|mesh-ancestor
6785236|NCT02206789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6785237|NCT02206789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6785238|NCT02206789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6785239|NCT02206789|Antiemetics|antiemetics|mesh-ancestor
6785240|NCT02206789|Autonomic Agents|autonomic agents|mesh-ancestor
6785241|NCT02206789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6785242|NCT02206789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6730152|NCT01896661|Amlodipine|amlodipine|mesh-list
6730153|NCT01896661|Chlorthalidone|chlorthalidone|mesh-list
6730154|NCT01896661|Calcium Channel Blockers|calcium channel blockers|mesh-list
6730155|NCT01896661|Amiloride|amiloride|mesh-list
6730156|NCT01896661|Calcium|calcium|mesh-list
6730157|NCT01896661|Diuretics|diuretics|mesh-list
6730158|NCT01896661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6730159|NCT01896661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730160|NCT01896661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6730161|NCT01896661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6730162|NCT01896661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730163|NCT01896661|Vasodilator Agents|vasodilator agents|mesh-ancestor
6730164|NCT01896661|Natriuretic Agents|natriuretic agents|mesh-ancestor
6730165|NCT01896661|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6730166|NCT01896661|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
6730167|NCT01896661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6730168|NCT01896661|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
6730169|NCT01896661|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6730170|NCT01896739|Vaccines|vaccines|mesh-list
6730171|NCT01896739|Immunologic Factors|immunologic factors|mesh-ancestor
6730172|NCT01896739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730173|NCT01896960|Fentanyl|fentanyl|mesh-list
6730174|NCT01896960|Bupivacaine|bupivacaine|mesh-list
6730175|NCT01896960|Anesthetics, Local|anesthetics, local|mesh-ancestor
6730176|NCT01896960|Anesthetics|anesthetics|mesh-ancestor
6730177|NCT01896960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6730178|NCT01896960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730179|NCT01896960|Sensory System Agents|sensory system agents|mesh-ancestor
6730180|NCT01896960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6730181|NCT01896960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6730182|NCT01896960|Narcotics|narcotics|mesh-ancestor
6730183|NCT01896960|Analgesics|analgesics|mesh-ancestor
6730184|NCT01896960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6730185|NCT01896960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6730186|NCT01896960|Anesthetics, General|anesthetics, general|mesh-ancestor
6730187|NCT01897012|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6730188|NCT01897012|Romidepsin|romidepsin|mesh-list
6730189|NCT01897012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6730190|NCT01897012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6730191|NCT01897012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6730192|NCT01897038|Sorafenib|sorafenib|mesh-list
6730193|NCT01897038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6730194|NCT01897038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6730195|NCT01897038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6730196|NCT01897038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730197|NCT01897051|Rifaximin|rifaximin|mesh-list
6730198|NCT01897051|Propranolol|propranolol|mesh-list
6730199|NCT01897051|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6730200|NCT01897051|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6730201|NCT01897051|Adrenergic Agents|adrenergic agents|mesh-ancestor
6730202|NCT01897051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6730203|NCT01897051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730204|NCT01897051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730205|NCT01897051|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6730206|NCT01897051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6730207|NCT01897051|Vasodilator Agents|vasodilator agents|mesh-ancestor
6730208|NCT01897051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6730209|NCT01897051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6730210|NCT01897051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6730211|NCT01897116|Hydroxychloroquine|hydroxychloroquine|mesh-list
6730212|NCT01897116|Vemurafenib|vemurafenib|mesh-list
6730213|NCT01897116|Antimalarials|antimalarials|mesh-ancestor
6730214|NCT01897116|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6730215|NCT01897116|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6730216|NCT01897116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6730217|NCT01897116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6730218|NCT01897116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730219|NCT01897116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6730220|NCT01897116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6730221|NCT01897116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6730222|NCT01897324|Hormones|hormones|mesh-list
6730223|NCT01897324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6730224|NCT01897324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730225|NCT01897337|Aprepitant|aprepitant|mesh-list
6730226|NCT01897337|Antiemetics|antiemetics|mesh-ancestor
6730227|NCT01897337|Autonomic Agents|autonomic agents|mesh-ancestor
6730228|NCT01897337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6730229|NCT01897337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730230|NCT01897337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6730231|NCT01897337|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6730232|NCT01897337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6730233|NCT01897337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730234|NCT01897428|Bepotastine besilate|bepotastine besilate|mesh-list
6730235|NCT01897428|Salicylates|salicylates|mesh-list
6730236|NCT01897428|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6730237|NCT01897428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6730238|NCT01897428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6730239|NCT01897428|Analgesics|analgesics|mesh-ancestor
6730240|NCT01897428|Sensory System Agents|sensory system agents|mesh-ancestor
6730241|NCT01897428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6730242|NCT01897428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730243|NCT01897428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6730244|NCT01897428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6730245|NCT01897428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6730246|NCT01897428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6730247|NCT01897428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730248|NCT01897441|Paclitaxel|paclitaxel|mesh-list
6730249|NCT01897441|Cyclophosphamide|cyclophosphamide|mesh-list
6730250|NCT01897441|Doxorubicin|doxorubicin|mesh-list
6730251|NCT01897441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6730252|NCT01897441|Trastuzumab|trastuzumab|mesh-list
6730253|NCT01897441|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6730254|NCT01897441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6730255|NCT01897441|Antibodies|antibodies|mesh-list
6730256|NCT01897441|Immunoglobulins|immunoglobulins|mesh-list
6730257|NCT01897441|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6730258|NCT01897441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6730259|NCT01897441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6730260|NCT01897441|Tubulin Modulators|tubulin modulators|mesh-ancestor
6730261|NCT01897441|Antimitotic Agents|antimitotic agents|mesh-ancestor
6730262|NCT01897441|Mitosis Modulators|mitosis modulators|mesh-ancestor
6730263|NCT01897441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730264|NCT01897441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6730265|NCT01897441|Immunologic Factors|immunologic factors|mesh-ancestor
6730266|NCT01897441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730267|NCT01897441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6730268|NCT01897441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6730269|NCT01897441|Alkylating Agents|alkylating agents|mesh-ancestor
6730270|NCT01897441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6730271|NCT01897441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6730272|NCT01897441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6730273|NCT01897441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6730274|NCT01897441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6730275|NCT01897454|Calcium, Dietary|calcium, dietary|mesh-list
6730276|NCT01897454|Leucovorin|leucovorin|mesh-list
6730277|NCT01897454|Folic Acid|folic acid|mesh-list
6730278|NCT01897454|Gemcitabine|gemcitabine|mesh-list
6730279|NCT01897454|Fluorouracil|fluorouracil|mesh-list
6730280|NCT01897454|Oxaliplatin|oxaliplatin|mesh-list
6730281|NCT01897454|Irinotecan|irinotecan|mesh-list
6730282|NCT01897454|Camptothecin|camptothecin|mesh-list
6730283|NCT01897454|Calcium|calcium|mesh-list
6730284|NCT01897454|Levoleucovorin|levoleucovorin|mesh-list
6730285|NCT01897454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6730286|NCT01897454|Antimetabolites|antimetabolites|mesh-ancestor
6730287|NCT01897454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730288|NCT01897454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6730289|NCT01897454|Antiviral Agents|antiviral agents|mesh-ancestor
6730290|NCT01897454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6730291|NCT01897454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6730292|NCT01897454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6730293|NCT01897454|Immunologic Factors|immunologic factors|mesh-ancestor
6730294|NCT01897454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730295|NCT01897454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6730296|NCT01897454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6730297|NCT01897454|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6730298|NCT01897454|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6730299|NCT01897454|Antidotes|antidotes|mesh-ancestor
6730300|NCT01897454|Protective Agents|protective agents|mesh-ancestor
6730301|NCT01897454|Vitamin B Complex|vitamin b complex|mesh-ancestor
6730302|NCT01897454|Vitamins|vitamins|mesh-ancestor
6730303|NCT01897454|Micronutrients|micronutrients|mesh-ancestor
6730304|NCT01897454|Hematinics|hematinics|mesh-ancestor
6730305|NCT01897454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6730306|NCT01897636|Vaccines|vaccines|mesh-list
6730307|NCT01897636|Immunologic Factors|immunologic factors|mesh-ancestor
6730308|NCT01897636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730309|NCT01897740|Sildenafil Citrate|sildenafil citrate|mesh-list
6730310|NCT01897740|Vasodilator Agents|vasodilator agents|mesh-ancestor
6730311|NCT01897740|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6730312|NCT01897740|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6730313|NCT01897740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6730314|NCT01897740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730315|NCT01897740|Urological Agents|urological agents|mesh-ancestor
6730316|NCT01897753|Hormones|hormones|mesh-list
6730317|NCT01897753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6730318|NCT01897753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730319|NCT01897779|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
6730320|NCT01897779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6730321|NCT01897779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730322|NCT01897779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6730323|NCT01897779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6730324|NCT01897844|Somatostatin|somatostatin|mesh-list
6730325|NCT01897844|Hormones|hormones|mesh-ancestor
6730326|NCT01897844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6730327|NCT01897844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730328|NCT01898000|Chlorhexidine|chlorhexidine|mesh-list
6730329|NCT01898000|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6730330|NCT01898000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6730331|NCT01898000|Disinfectants|disinfectants|mesh-ancestor
6730332|NCT01898039|Cyclophosphamide|cyclophosphamide|mesh-list
6730333|NCT01898039|Vaccines|vaccines|mesh-list
6730334|NCT01898039|Immunologic Factors|immunologic factors|mesh-ancestor
6730335|NCT01898039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730336|NCT01898039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6730337|NCT01898039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6730338|NCT01898039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6730339|NCT01898039|Alkylating Agents|alkylating agents|mesh-ancestor
6730340|NCT01898039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730341|NCT01898039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6730342|NCT01898039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6730343|NCT01898052|Anesthetics|anesthetics|mesh-list
6730344|NCT01898052|Levobupivacaine|levobupivacaine|mesh-list
6730345|NCT01898052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6730346|NCT01898052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730347|NCT01898052|Anesthetics, Local|anesthetics, local|mesh-ancestor
6730348|NCT01898052|Sensory System Agents|sensory system agents|mesh-ancestor
6730349|NCT01898052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6730350|NCT01898065|Misonidazole|misonidazole|mesh-list
6730351|NCT01898065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6730352|NCT01898065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6730353|NCT01898065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6730354|NCT01898065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6730355|NCT01898104|Capecitabine|capecitabine|mesh-list
6730356|NCT01898104|Valproic Acid|valproic acid|mesh-list
6730357|NCT01898104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6730358|NCT01898104|Antimetabolites|antimetabolites|mesh-ancestor
6730359|NCT01898104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730360|NCT01898104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6730361|NCT01898104|Anticonvulsants|anticonvulsants|mesh-ancestor
6730362|NCT01898104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6730363|NCT01898104|GABA Agents|gaba agents|mesh-ancestor
6730364|NCT01898104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6730365|NCT01898104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730366|NCT01898104|Antimanic Agents|antimanic agents|mesh-ancestor
6730367|NCT01898104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6730368|NCT01898104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6730369|NCT01898104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6730370|NCT01898117|Paclitaxel|paclitaxel|mesh-list
6730371|NCT01898117|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6730372|NCT01898117|Cyclophosphamide|cyclophosphamide|mesh-list
6730373|NCT01898117|Carboplatin|carboplatin|mesh-list
6730374|NCT01898117|Atezolizumab|atezolizumab|mesh-list
6730375|NCT01898117|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6730376|NCT01898117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6730377|NCT01898117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6730378|NCT01898117|Tubulin Modulators|tubulin modulators|mesh-ancestor
6730379|NCT01898117|Antimitotic Agents|antimitotic agents|mesh-ancestor
6730380|NCT01898117|Mitosis Modulators|mitosis modulators|mesh-ancestor
6730381|NCT01898117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730382|NCT01898117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6730383|NCT01898117|Immunologic Factors|immunologic factors|mesh-ancestor
6730384|NCT01898117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730385|NCT01898117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6730386|NCT01898117|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6730387|NCT01898117|Alkylating Agents|alkylating agents|mesh-ancestor
6730388|NCT01898117|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6730389|NCT01898169|Nicotine|nicotine|mesh-list
6730390|NCT01898169|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6730391|NCT01898169|Autonomic Agents|autonomic agents|mesh-ancestor
6730392|NCT01898169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6730393|NCT01898169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730394|NCT01898169|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6730395|NCT01898169|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6730396|NCT01898169|Cholinergic Agents|cholinergic agents|mesh-ancestor
6730397|NCT01898169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6730398|NCT01898169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730399|NCT01898182|Kinetin|kinetin|mesh-list
6730400|NCT01898182|Plant Growth Regulators|plant growth regulators|mesh-ancestor
6730401|NCT01898182|Growth Substances|growth substances|mesh-ancestor
6730402|NCT01898182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730403|NCT01898221|Ethanol|ethanol|mesh-list
6730404|NCT01898221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6730405|NCT01898221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6730406|NCT01898221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6730407|NCT01898221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730408|NCT01898338|Daptomycin|daptomycin|mesh-list
6730409|NCT01898338|Fosfomycin|fosfomycin|mesh-list
6730410|NCT01898338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6730411|NCT01898338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6730412|NCT01898377|Mycophenolic Acid|mycophenolic acid|mesh-list
6730413|NCT01898377|Imatinib Mesylate|imatinib mesylate|mesh-list
6730414|NCT01898377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6730415|NCT01898377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6730416|NCT01898377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6730417|NCT01898377|Antitubercular Agents|antitubercular agents|mesh-ancestor
6730418|NCT01898377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6730419|NCT01898377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6730420|NCT01898377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6730421|NCT01898377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730422|NCT01898377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6730423|NCT01898416|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6730424|NCT01898416|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6730425|NCT01898416|Dermatologic Agents|dermatologic agents|mesh-ancestor
6785243|NCT02206789|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6785244|NCT02206789|Protective Agents|protective agents|mesh-ancestor
6785245|NCT02206802|Minoxidil|minoxidil|mesh-list
6785246|NCT02206802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6785247|NCT02206802|Vasodilator Agents|vasodilator agents|mesh-ancestor
6785248|NCT02206815|Aspirin|aspirin|mesh-list
6785249|NCT02206815|Warfarin|warfarin|mesh-list
6785250|NCT02206815|Clopidogrel|clopidogrel|mesh-list
6785251|NCT02206815|Ticagrelor|ticagrelor|mesh-list
6785252|NCT02206815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6785253|NCT02206815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6785254|NCT02206815|Analgesics|analgesics|mesh-ancestor
6785255|NCT02206815|Sensory System Agents|sensory system agents|mesh-ancestor
6785256|NCT02206815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6785257|NCT02206815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785258|NCT02206815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6785259|NCT02206815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6785260|NCT02206815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6785261|NCT02206815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6785262|NCT02206815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785263|NCT02206815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6785264|NCT02206815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6785265|NCT02206815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6785266|NCT02206815|Antipyretics|antipyretics|mesh-ancestor
6785267|NCT02206815|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6785268|NCT02206815|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6785269|NCT02206815|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6785270|NCT02206815|Purinergic Agents|purinergic agents|mesh-ancestor
6785271|NCT02206815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6785272|NCT02206815|Anticoagulants|anticoagulants|mesh-ancestor
6785273|NCT02206854|Flurbiprofen|flurbiprofen|mesh-list
6785274|NCT02206854|Analgesics|analgesics|mesh-ancestor
6785275|NCT02206854|Sensory System Agents|sensory system agents|mesh-ancestor
6785276|NCT02206854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6730426|NCT01898494|Carboplatin|carboplatin|mesh-list
6730427|NCT01898494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6730428|NCT01898507|Nicotine|nicotine|mesh-list
6730429|NCT01898507|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6730430|NCT01898507|Autonomic Agents|autonomic agents|mesh-ancestor
6730431|NCT01898507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6730432|NCT01898507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730433|NCT01898507|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6730434|NCT01898507|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6730435|NCT01898507|Cholinergic Agents|cholinergic agents|mesh-ancestor
6730436|NCT01898507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6730437|NCT01898507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730438|NCT01898520|Nabiximols|nabiximols|mesh-list
6730439|NCT01898520|Analgesics|analgesics|mesh-ancestor
6730440|NCT01898520|Sensory System Agents|sensory system agents|mesh-ancestor
6730441|NCT01898520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6730442|NCT01898520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730443|NCT01898585|Vemurafenib|vemurafenib|mesh-list
6730444|NCT01898585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6730445|NCT01898585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6730446|NCT01898585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6730447|NCT01898585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730448|NCT01898624|Mirabegron|mirabegron|mesh-list
6730449|NCT01898624|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6730450|NCT01898624|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6730451|NCT01898624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6730452|NCT01898624|Adrenergic Agents|adrenergic agents|mesh-ancestor
6730453|NCT01898624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6730454|NCT01898624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730455|NCT01898624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730456|NCT01898624|Urological Agents|urological agents|mesh-ancestor
6730457|NCT01898676|Valproic Acid|valproic acid|mesh-list
6730458|NCT01898676|Anticonvulsants|anticonvulsants|mesh-ancestor
6730459|NCT01898676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6730460|NCT01898676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730461|NCT01898676|GABA Agents|gaba agents|mesh-ancestor
6730462|NCT01898676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6730463|NCT01898676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730464|NCT01898676|Antimanic Agents|antimanic agents|mesh-ancestor
6730465|NCT01898676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6730466|NCT01898676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6730467|NCT01898676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6730468|NCT01898728|Iodine|iodine|mesh-list
6730469|NCT01898728|Cadexomer iodine|cadexomer iodine|mesh-list
6730470|NCT01898728|Povidone-Iodine|povidone-iodine|mesh-list
6730471|NCT01898728|Povidone|povidone|mesh-list
6730472|NCT01898728|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6730473|NCT01898728|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6730474|NCT01898728|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6730475|NCT01898728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6730476|NCT01898728|Trace Elements|trace elements|mesh-ancestor
6730477|NCT01898728|Micronutrients|micronutrients|mesh-ancestor
6730478|NCT01898728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730479|NCT01898728|Plasma Substitutes|plasma substitutes|mesh-ancestor
6730480|NCT01898728|Blood Substitutes|blood substitutes|mesh-ancestor
6730481|NCT01898819|Dexmedetomidine|dexmedetomidine|mesh-list
6730482|NCT01898819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6730483|NCT01898819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6730484|NCT01898819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730485|NCT01898819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6730486|NCT01898819|Analgesics|analgesics|mesh-ancestor
6730487|NCT01898819|Sensory System Agents|sensory system agents|mesh-ancestor
6730488|NCT01898819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6730489|NCT01898819|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6730490|NCT01898819|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6730491|NCT01898819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6730492|NCT01898819|Adrenergic Agents|adrenergic agents|mesh-ancestor
6730493|NCT01898819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6730494|NCT01898819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730495|NCT01898897|Anesthetics|anesthetics|mesh-list
6730496|NCT01898897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6730497|NCT01898897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730498|NCT01899027|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6730499|NCT01899027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6730500|NCT01899027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6730501|NCT01899027|Antimetabolites|antimetabolites|mesh-ancestor
6730502|NCT01899027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730503|NCT01899027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6730504|NCT01899027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6730505|NCT01899027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6730506|NCT01899066|Carboplatin|carboplatin|mesh-list
6730507|NCT01899066|Etoposide|etoposide|mesh-list
6730508|NCT01899066|Vincristine|vincristine|mesh-list
6730509|NCT01899066|Ranibizumab|ranibizumab|mesh-list
6730510|NCT01899066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6730511|NCT01899066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6730512|NCT01899066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6730513|NCT01899066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6730514|NCT01899066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6730515|NCT01899066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730516|NCT01899066|Tubulin Modulators|tubulin modulators|mesh-ancestor
6730517|NCT01899066|Antimitotic Agents|antimitotic agents|mesh-ancestor
6730518|NCT01899066|Mitosis Modulators|mitosis modulators|mesh-ancestor
6730519|NCT01899066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6730520|NCT01899066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6730521|NCT01899066|Growth Substances|growth substances|mesh-ancestor
6730522|NCT01899066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730523|NCT01899066|Growth Inhibitors|growth inhibitors|mesh-ancestor
6730524|NCT01899105|Ivacaftor|ivacaftor|mesh-list
6730525|NCT01899105|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6730526|NCT01899105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6730527|NCT01899105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730528|NCT01899118|Capecitabine|capecitabine|mesh-list
6730529|NCT01899118|Oxaliplatin|oxaliplatin|mesh-list
6730530|NCT01899118|Nimotuzumab|nimotuzumab|mesh-list
6730531|NCT01899118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6730532|NCT01899118|Antimetabolites|antimetabolites|mesh-ancestor
6730533|NCT01899118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730534|NCT01899118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6730535|NCT01899118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6730536|NCT01899170|Carfentanil|carfentanil|mesh-list
6730537|NCT01899170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6730538|NCT01899170|Narcotics|narcotics|mesh-ancestor
6730539|NCT01899170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6730540|NCT01899170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730541|NCT01899170|Analgesics|analgesics|mesh-ancestor
6730542|NCT01899170|Sensory System Agents|sensory system agents|mesh-ancestor
6730543|NCT01899170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6730544|NCT01899248|Sevoflurane|sevoflurane|mesh-list
6730545|NCT01899248|Desflurane|desflurane|mesh-list
6730546|NCT01899248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6730547|NCT01899248|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6730548|NCT01899248|Anesthetics, General|anesthetics, general|mesh-ancestor
6730549|NCT01899248|Anesthetics|anesthetics|mesh-ancestor
6730550|NCT01899248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6730551|NCT01899248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730552|NCT01899326|Desipramine|desipramine|mesh-list
6730553|NCT01899326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730554|NCT01899326|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6730555|NCT01899326|Antidepressive Agents|antidepressive agents|mesh-ancestor
6730556|NCT01899326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6730557|NCT01899326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6730558|NCT01899326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730559|NCT01899326|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6730560|NCT01899326|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6730561|NCT01899326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6730562|NCT01899326|Adrenergic Agents|adrenergic agents|mesh-ancestor
6730563|NCT01899326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6730564|NCT01899404|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6730565|NCT01899404|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6730566|NCT01899404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730567|NCT01899430|Metformin|metformin|mesh-list
6730568|NCT01899430|Liraglutide|liraglutide|mesh-list
6730569|NCT01899430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6730570|NCT01899430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730571|NCT01899430|Incretins|incretins|mesh-ancestor
6730572|NCT01899430|Hormones|hormones|mesh-ancestor
6730573|NCT01899430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6730574|NCT01899521|Zinc Sulfate|zinc sulfate|mesh-list
6730575|NCT01899521|Astringents|astringents|mesh-ancestor
6730576|NCT01899521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730577|NCT01899521|Dermatologic Agents|dermatologic agents|mesh-ancestor
6730578|NCT01899690|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6730579|NCT01899690|Clindamycin|clindamycin|mesh-list
6730580|NCT01899690|Cephalexin|cephalexin|mesh-list
6730581|NCT01899690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6730582|NCT01899690|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6730583|NCT01899690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6730584|NCT01899690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730585|NCT01899703|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
6730586|NCT01899703|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6730587|NCT01899703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6730588|NCT01899755|Adalimumab|adalimumab|mesh-list
6730589|NCT01899755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6730590|NCT01899755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6730591|NCT01899755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6730592|NCT01899781|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6730593|NCT01899781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6730594|NCT01899794|Mandelic Acids|mandelic acids|mesh-list
6730595|NCT01899794|Oxybutynin|oxybutynin|mesh-list
6730596|NCT01899794|Parasympatholytics|parasympatholytics|mesh-ancestor
6730597|NCT01899794|Autonomic Agents|autonomic agents|mesh-ancestor
6730598|NCT01899794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6730599|NCT01899794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730600|NCT01899794|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6730601|NCT01899794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6730602|NCT01899794|Cholinergic Agents|cholinergic agents|mesh-ancestor
6730603|NCT01899794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6730604|NCT01899794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730605|NCT01899794|Urological Agents|urological agents|mesh-ancestor
6730606|NCT01899794|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6730607|NCT01899794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6730608|NCT01899794|Renal Agents|renal agents|mesh-ancestor
6730609|NCT01899820|Lumefantrine|lumefantrine|mesh-list
6730610|NCT01899820|Artemether|artemether|mesh-list
6730611|NCT01899820|Piperaquine|piperaquine|mesh-list
6730612|NCT01899820|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6730613|NCT01899820|Artenimol|artenimol|mesh-list
6730614|NCT01899820|Antimalarials|antimalarials|mesh-ancestor
6730615|NCT01899820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6730616|NCT01899820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6730617|NCT01899820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6730618|NCT01899833|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
6730619|NCT01899833|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6730620|NCT01899833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730621|NCT01899846|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
6730622|NCT01899846|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
6730623|NCT01899846|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6730624|NCT01899846|Hormone Antagonists|hormone antagonists|mesh-ancestor
6730625|NCT01899846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6730626|NCT01899846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730627|NCT01899846|Progestins|progestins|mesh-ancestor
6730628|NCT01899846|Hormones|hormones|mesh-ancestor
6730629|NCT01899898|Anticonvulsants|anticonvulsants|mesh-list
6730630|NCT01900015|Efavirenz|efavirenz|mesh-list
6730631|NCT01900015|Raltegravir Potassium|raltegravir potassium|mesh-list
6730632|NCT01900015|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6730633|NCT01900015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6730634|NCT01900015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6730635|NCT01900015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730636|NCT01900015|Antiviral Agents|antiviral agents|mesh-ancestor
6730637|NCT01900015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6730638|NCT01900015|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6730639|NCT01900015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6730640|NCT01900015|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6730641|NCT01900015|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6730642|NCT01900015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6730643|NCT01900015|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6730644|NCT01900015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6730645|NCT01900015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6730646|NCT01900015|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6730647|NCT01900015|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6730648|NCT01900028|Itraconazole|itraconazole|mesh-list
6730649|NCT01900028|Olaparib|olaparib|mesh-list
6730650|NCT01900028|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6730651|NCT01900028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6730652|NCT01900028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730653|NCT01900028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6730654|NCT01900028|Antifungal Agents|antifungal agents|mesh-ancestor
6730655|NCT01900028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6730656|NCT01900028|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6730657|NCT01900028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6730658|NCT01900028|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6730659|NCT01900028|Hormone Antagonists|hormone antagonists|mesh-ancestor
6730660|NCT01900028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6730661|NCT01900028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730662|NCT01900028|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6785277|NCT02206854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785278|NCT02206854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6785279|NCT02206854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6785280|NCT02206854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6785281|NCT02206854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6785282|NCT02206854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6785283|NCT02206854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6785284|NCT02206854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785285|NCT02206867|Adalimumab|adalimumab|mesh-list
6785286|NCT02206867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6785287|NCT02206867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6785288|NCT02206932|Sofosbuvir|sofosbuvir|mesh-list
6785289|NCT02206932|Simeprevir|simeprevir|mesh-list
6785290|NCT02206932|Antiviral Agents|antiviral agents|mesh-ancestor
6785291|NCT02206932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6785292|NCT02206932|Protease Inhibitors|protease inhibitors|mesh-ancestor
6785293|NCT02206932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6785294|NCT02206932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785295|NCT02206984|Tamoxifen|tamoxifen|mesh-list
6785296|NCT02206984|Fulvestrant|fulvestrant|mesh-list
6785297|NCT02206984|Anastrozole|anastrozole|mesh-list
6785298|NCT02206984|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6785299|NCT02206984|Hormone Antagonists|hormone antagonists|mesh-ancestor
6785300|NCT02206984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6785301|NCT02206984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785302|NCT02206984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6785303|NCT02206984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6785304|NCT02206984|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6785305|NCT02206984|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6785306|NCT02206984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6785307|NCT02206984|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6785308|NCT02206984|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6785309|NCT02206984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6785310|NCT02206984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6785311|NCT02206984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785312|NCT02207010|Adavosertib|adavosertib|mesh-list
6785313|NCT02207010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6785314|NCT02207010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730663|NCT01900041|Minoxidil|minoxidil|mesh-list
6730664|NCT01900041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6730665|NCT01900041|Vasodilator Agents|vasodilator agents|mesh-ancestor
6730666|NCT01900093|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6730667|NCT01900093|Hormones|hormones|mesh-ancestor
6730668|NCT01900093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6730669|NCT01900093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730670|NCT01900106|Ritonavir|ritonavir|mesh-list
6730671|NCT01900106|Darunavir|darunavir|mesh-list
6730672|NCT01900106|Lamivudine|lamivudine|mesh-list
6730673|NCT01900106|Raltegravir Potassium|raltegravir potassium|mesh-list
6730674|NCT01900106|Abacavir|abacavir|mesh-list
6730675|NCT01900106|Dideoxynucleosides|dideoxynucleosides|mesh-list
6730676|NCT01900106|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6730677|NCT01900106|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6730678|NCT01900106|Protease Inhibitors|protease inhibitors|mesh-ancestor
6730679|NCT01900106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6730680|NCT01900106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730681|NCT01900106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6730682|NCT01900106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6730683|NCT01900106|Antiviral Agents|antiviral agents|mesh-ancestor
6730684|NCT01900106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6730685|NCT01900106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6730686|NCT01900106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6730687|NCT01900106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6730688|NCT01900106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6730689|NCT01900106|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6730690|NCT01900106|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6730691|NCT01900106|Antimetabolites|antimetabolites|mesh-ancestor
6730692|NCT01900158|Gemcitabine|gemcitabine|mesh-list
6730693|NCT01900158|Cisplatin|cisplatin|mesh-list
6730694|NCT01900158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6730695|NCT01900158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6730696|NCT01900158|Antimetabolites|antimetabolites|mesh-ancestor
6730697|NCT01900158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730698|NCT01900158|Antiviral Agents|antiviral agents|mesh-ancestor
6730699|NCT01900158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6730700|NCT01900158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6730701|NCT01900158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6730702|NCT01900158|Immunologic Factors|immunologic factors|mesh-ancestor
6730703|NCT01900158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730704|NCT01900197|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
6730705|NCT01900197|Hematinics|hematinics|mesh-ancestor
6730706|NCT01900301|Scopolamine|scopolamine|mesh-list
6730707|NCT01900301|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
6730708|NCT01900301|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6730709|NCT01900301|Antiemetics|antiemetics|mesh-ancestor
6730710|NCT01900301|Autonomic Agents|autonomic agents|mesh-ancestor
6730711|NCT01900301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6730712|NCT01900301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730713|NCT01900301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6730714|NCT01900301|Mydriatics|mydriatics|mesh-ancestor
6730715|NCT01900301|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6730716|NCT01900301|Cholinergic Agents|cholinergic agents|mesh-ancestor
6730717|NCT01900301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6730718|NCT01900301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730719|NCT01900301|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6730720|NCT01900301|Parasympatholytics|parasympatholytics|mesh-ancestor
6730721|NCT01900327|Gemcitabine|gemcitabine|mesh-list
6730722|NCT01900327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6730723|NCT01900327|Antimetabolites|antimetabolites|mesh-ancestor
6730724|NCT01900327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730725|NCT01900327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6730726|NCT01900327|Antiviral Agents|antiviral agents|mesh-ancestor
6730727|NCT01900327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6730728|NCT01900327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6730729|NCT01900327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6730730|NCT01900327|Immunologic Factors|immunologic factors|mesh-ancestor
6730731|NCT01900327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730732|NCT01900405|Dexmedetomidine|dexmedetomidine|mesh-list
6730733|NCT01900405|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6730734|NCT01900405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6730735|NCT01900405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730736|NCT01900405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6730737|NCT01900405|Analgesics|analgesics|mesh-ancestor
6730738|NCT01900405|Sensory System Agents|sensory system agents|mesh-ancestor
6730739|NCT01900405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6730740|NCT01900405|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6730741|NCT01900405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6730742|NCT01900405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6730743|NCT01900405|Adrenergic Agents|adrenergic agents|mesh-ancestor
6730744|NCT01900405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6730745|NCT01900405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730746|NCT01900496|Rituximab|rituximab|mesh-list
6730747|NCT01900496|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6730748|NCT01900496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6730749|NCT01900496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6730750|NCT01900496|Immunologic Factors|immunologic factors|mesh-ancestor
6730751|NCT01900496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730752|NCT01900496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6730753|NCT01900509|Dexamethasone|dexamethasone|mesh-list
6730754|NCT01900509|Etoposide|etoposide|mesh-list
6730755|NCT01900509|Etoposide phosphate|etoposide phosphate|mesh-list
6730756|NCT01900509|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6730757|NCT01900509|Clofarabine|clofarabine|mesh-list
6730758|NCT01900509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6730759|NCT01900509|Antiemetics|antiemetics|mesh-ancestor
6730760|NCT01900509|Autonomic Agents|autonomic agents|mesh-ancestor
6730761|NCT01900509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6730762|NCT01900509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730763|NCT01900509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6730764|NCT01900509|Glucocorticoids|glucocorticoids|mesh-ancestor
6730765|NCT01900509|Hormones|hormones|mesh-ancestor
6730766|NCT01900509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6730767|NCT01900509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6730768|NCT01900509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6730769|NCT01900509|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6730770|NCT01900509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6730771|NCT01900509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6730772|NCT01900509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6730773|NCT01900509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730774|NCT01900509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6730775|NCT01900509|Alkylating Agents|alkylating agents|mesh-ancestor
6730776|NCT01900509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6730777|NCT01900509|Antimetabolites|antimetabolites|mesh-ancestor
6730778|NCT01900587|Tapentadol|tapentadol|mesh-list
6730779|NCT01900587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6730780|NCT01900587|Narcotics|narcotics|mesh-ancestor
6730781|NCT01900587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6730782|NCT01900587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730783|NCT01900587|Analgesics|analgesics|mesh-ancestor
6730784|NCT01900587|Sensory System Agents|sensory system agents|mesh-ancestor
6730785|NCT01900587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6730786|NCT01900587|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6730787|NCT01900587|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6730788|NCT01900587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6730789|NCT01900587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730790|NCT01900587|Adrenergic Agents|adrenergic agents|mesh-ancestor
6730791|NCT01900587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6730792|NCT01900639|Aspirin|aspirin|mesh-list
6730793|NCT01900639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6730794|NCT01900639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6730795|NCT01900639|Analgesics|analgesics|mesh-ancestor
6730796|NCT01900639|Sensory System Agents|sensory system agents|mesh-ancestor
6730797|NCT01900639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6730798|NCT01900639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730799|NCT01900639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6730800|NCT01900639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6730801|NCT01900639|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6730802|NCT01900639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6730803|NCT01900639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730804|NCT01900639|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6730805|NCT01900639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6730806|NCT01900639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6730807|NCT01900639|Antipyretics|antipyretics|mesh-ancestor
6730808|NCT01900717|Leucovorin|leucovorin|mesh-list
6730809|NCT01900717|Bevacizumab|bevacizumab|mesh-list
6730810|NCT01900717|Fluorouracil|fluorouracil|mesh-list
6730811|NCT01900717|Oxaliplatin|oxaliplatin|mesh-list
6730812|NCT01900717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6730813|NCT01900717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6730814|NCT01900717|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6730815|NCT01900717|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6730816|NCT01900717|Growth Substances|growth substances|mesh-ancestor
6730817|NCT01900717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730818|NCT01900717|Growth Inhibitors|growth inhibitors|mesh-ancestor
6730819|NCT01900717|Antimetabolites|antimetabolites|mesh-ancestor
6730820|NCT01900717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730821|NCT01900717|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6730822|NCT01900717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6730823|NCT01900717|Immunologic Factors|immunologic factors|mesh-ancestor
6730824|NCT01900717|Antidotes|antidotes|mesh-ancestor
6730825|NCT01900717|Protective Agents|protective agents|mesh-ancestor
6730826|NCT01900717|Vitamin B Complex|vitamin b complex|mesh-ancestor
6730827|NCT01900717|Vitamins|vitamins|mesh-ancestor
6730828|NCT01900717|Micronutrients|micronutrients|mesh-ancestor
6730829|NCT01900795|Ibuprofen|ibuprofen|mesh-list
6730830|NCT01900795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6730831|NCT01900795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6730832|NCT01900795|Analgesics|analgesics|mesh-ancestor
6730833|NCT01900795|Sensory System Agents|sensory system agents|mesh-ancestor
6730834|NCT01900795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6730835|NCT01900795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730836|NCT01900795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6730837|NCT01900795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6730838|NCT01900795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6730839|NCT01900795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6730840|NCT01900795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730841|NCT01900847|Morphine|morphine|mesh-list
6730842|NCT01900847|Ketamine|ketamine|mesh-list
6730843|NCT01900847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6730844|NCT01900847|Narcotics|narcotics|mesh-ancestor
6730845|NCT01900847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6730846|NCT01900847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730847|NCT01900847|Analgesics|analgesics|mesh-ancestor
6730848|NCT01900847|Sensory System Agents|sensory system agents|mesh-ancestor
6730849|NCT01900847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6730850|NCT01900847|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6730851|NCT01900847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6730852|NCT01900847|Anesthetics, General|anesthetics, general|mesh-ancestor
6730853|NCT01900847|Anesthetics|anesthetics|mesh-ancestor
6730854|NCT01900847|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6730855|NCT01900847|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6730856|NCT01900847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6730857|NCT01900847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730858|NCT01900860|Vitamin D|vitamin d|mesh-list
6730859|NCT01900860|Ergocalciferols|ergocalciferols|mesh-list
6730860|NCT01900860|Cholecalciferol|cholecalciferol|mesh-list
6730861|NCT01900860|Vitamins|vitamins|mesh-list
6730862|NCT01900860|Micronutrients|micronutrients|mesh-ancestor
6730863|NCT01900860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730864|NCT01900860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6730865|NCT01900860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6730866|NCT01900886|Ribavirin|ribavirin|mesh-list
6730867|NCT01900886|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6730868|NCT01900886|Antimetabolites|antimetabolites|mesh-ancestor
6730869|NCT01900886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730870|NCT01900886|Antiviral Agents|antiviral agents|mesh-ancestor
6730871|NCT01900886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6730872|NCT01900938|Midazolam|midazolam|mesh-list
6730873|NCT01900938|Propofol|propofol|mesh-list
6730874|NCT01900938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6730875|NCT01900938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6730876|NCT01900938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730877|NCT01900938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6730878|NCT01900938|Anesthetics, General|anesthetics, general|mesh-ancestor
6730879|NCT01900938|Anesthetics|anesthetics|mesh-ancestor
6730880|NCT01900938|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6730881|NCT01900938|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6730882|NCT01900938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6730883|NCT01900938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6730884|NCT01900938|GABA Modulators|gaba modulators|mesh-ancestor
6730885|NCT01900938|GABA Agents|gaba agents|mesh-ancestor
6730886|NCT01900938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6730887|NCT01900938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730888|NCT01900951|Temozolomide|temozolomide|mesh-list
6730889|NCT01900951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6730890|NCT01900951|Alkylating Agents|alkylating agents|mesh-ancestor
6730891|NCT01900951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730892|NCT01900951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6730893|NCT01901003|Lorazepam|lorazepam|mesh-list
6730894|NCT01901003|Anticonvulsants|anticonvulsants|mesh-ancestor
6730895|NCT01901003|Antiemetics|antiemetics|mesh-ancestor
6730896|NCT01901003|Autonomic Agents|autonomic agents|mesh-ancestor
6730897|NCT01901003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6730898|NCT01901003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730899|NCT01901003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6730900|NCT01901003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6730901|NCT01901003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6730902|NCT01901003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6730903|NCT01901003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6730904|NCT01901003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6730905|NCT01901003|GABA Modulators|gaba modulators|mesh-ancestor
6730906|NCT01901003|GABA Agents|gaba agents|mesh-ancestor
6730907|NCT01901003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6730908|NCT01901003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730909|NCT01901120|Mirabegron|mirabegron|mesh-list
6730910|NCT01901120|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6730911|NCT01901120|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6730912|NCT01901120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6730913|NCT01901120|Adrenergic Agents|adrenergic agents|mesh-ancestor
6730914|NCT01901120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6730915|NCT01901120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730916|NCT01901120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730917|NCT01901120|Urological Agents|urological agents|mesh-ancestor
6730918|NCT01901172|Posaconazole|posaconazole|mesh-list
6730919|NCT01901172|Antifungal Agents|antifungal agents|mesh-ancestor
6730920|NCT01901172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6730921|NCT01901172|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6730922|NCT01901172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6730923|NCT01901172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6730924|NCT01901172|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6730925|NCT01901172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6730926|NCT01901172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6730927|NCT01901172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730928|NCT01901172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6730929|NCT01901172|Hormone Antagonists|hormone antagonists|mesh-ancestor
6730930|NCT01901172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6730931|NCT01901172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730932|NCT01901198|Interferons|interferons|mesh-list
6730933|NCT01901198|Interferon-alpha|interferon-alpha|mesh-list
6730934|NCT01901198|Interferon alpha-2|interferon alpha-2|mesh-list
6730935|NCT01901198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6730936|NCT01901198|Antiviral Agents|antiviral agents|mesh-ancestor
6730937|NCT01901198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6730938|NCT01901198|Immunologic Factors|immunologic factors|mesh-ancestor
6730939|NCT01901198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730940|NCT01901276|Omeprazole|omeprazole|mesh-list
6730941|NCT01901276|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6730942|NCT01901276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6730943|NCT01901276|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6730944|NCT01901276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6730945|NCT01901276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730946|NCT01901380|Caseins|caseins|mesh-list
6730947|NCT01901380|Chelating Agents|chelating agents|mesh-ancestor
6730948|NCT01901380|Sequestering Agents|sequestering agents|mesh-ancestor
6730949|NCT01901380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730950|NCT01901432|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
6730951|NCT01901432|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6730952|NCT01901432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6730953|NCT01901432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730954|NCT01901471|Cyclosporine|cyclosporine|mesh-list
6730955|NCT01901471|Cyclosporins|cyclosporins|mesh-list
6730956|NCT01901471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6730957|NCT01901471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730958|NCT01901471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6730959|NCT01901471|Immunologic Factors|immunologic factors|mesh-ancestor
6730960|NCT01901471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730961|NCT01901471|Antifungal Agents|antifungal agents|mesh-ancestor
6730962|NCT01901471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6730963|NCT01901471|Dermatologic Agents|dermatologic agents|mesh-ancestor
6730964|NCT01901471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6730965|NCT01901471|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6730966|NCT01901484|Praziquantel|praziquantel|mesh-list
6730967|NCT01901484|Anthelmintics|anthelmintics|mesh-ancestor
6730968|NCT01901484|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6730969|NCT01901484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6730970|NCT01901549|Metoprolol|metoprolol|mesh-list
6730971|NCT01901549|Lisinopril|lisinopril|mesh-list
6730972|NCT01901549|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6730973|NCT01901549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6730974|NCT01901549|Sympatholytics|sympatholytics|mesh-ancestor
6730975|NCT01901549|Autonomic Agents|autonomic agents|mesh-ancestor
6730976|NCT01901549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6730977|NCT01901549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730978|NCT01901549|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6730979|NCT01901549|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6730980|NCT01901549|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6730981|NCT01901549|Adrenergic Agents|adrenergic agents|mesh-ancestor
6730982|NCT01901549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6730983|NCT01901549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730984|NCT01901549|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6730985|NCT01901549|Protease Inhibitors|protease inhibitors|mesh-ancestor
6730986|NCT01901549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6730987|NCT01901549|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6730988|NCT01901549|Protective Agents|protective agents|mesh-ancestor
6730989|NCT01901601|Anesthetics|anesthetics|mesh-list
6730990|NCT01901601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6730991|NCT01901601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6730992|NCT01901640|Udenafil|udenafil|mesh-list
6730993|NCT01901640|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6730994|NCT01901640|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6730995|NCT01901640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6730996|NCT01901640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6730997|NCT01901666|Hormones|hormones|mesh-list
6730998|NCT01901666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6730999|NCT01901666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731000|NCT01901692|Sorafenib|sorafenib|mesh-list
6731001|NCT01901692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6731002|NCT01901692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6731003|NCT01901692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6731004|NCT01901692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785315|NCT02207335|Gemcitabine|gemcitabine|mesh-list
6785316|NCT02207335|Carboplatin|carboplatin|mesh-list
6785317|NCT02207335|Capecitabine|capecitabine|mesh-list
6785318|NCT02207335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6785319|NCT02207335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6785320|NCT02207335|Antimetabolites|antimetabolites|mesh-ancestor
6785321|NCT02207335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785322|NCT02207335|Antiviral Agents|antiviral agents|mesh-ancestor
6785323|NCT02207335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6785324|NCT02207335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6785325|NCT02207335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6785326|NCT02207335|Immunologic Factors|immunologic factors|mesh-ancestor
6785327|NCT02207335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785328|NCT02207348|Liraglutide|liraglutide|mesh-list
6785329|NCT02207348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6785330|NCT02207348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785331|NCT02207348|Incretins|incretins|mesh-ancestor
6785332|NCT02207348|Hormones|hormones|mesh-ancestor
6785333|NCT02207348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6785334|NCT02207361|Paclitaxel|paclitaxel|mesh-list
6785335|NCT02207361|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6785336|NCT02207361|Carboplatin|carboplatin|mesh-list
6785337|NCT02207361|Epirubicin|epirubicin|mesh-list
6785338|NCT02207361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6785339|NCT02207361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6785340|NCT02207361|Tubulin Modulators|tubulin modulators|mesh-ancestor
6785341|NCT02207361|Antimitotic Agents|antimitotic agents|mesh-ancestor
6785342|NCT02207361|Mitosis Modulators|mitosis modulators|mesh-ancestor
6785343|NCT02207361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785344|NCT02207361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6785345|NCT02207361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6785346|NCT02207361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6785347|NCT02207361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6785348|NCT02207387|Rasagiline|rasagiline|mesh-list
6785349|NCT02207387|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6785350|NCT02207387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6785351|NCT02207387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785352|NCT02207387|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6785353|NCT02207387|Protective Agents|protective agents|mesh-ancestor
6785354|NCT02207387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785355|NCT02207426|Tobramycin|tobramycin|mesh-list
6785356|NCT02207426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6731005|NCT01901861|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6731006|NCT01901861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6731007|NCT01901861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731008|NCT01901861|Incretins|incretins|mesh-ancestor
6731009|NCT01901861|Hormones|hormones|mesh-ancestor
6731010|NCT01901861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6731011|NCT01901861|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6731012|NCT01901861|Protease Inhibitors|protease inhibitors|mesh-ancestor
6731013|NCT01901861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6731014|NCT01901861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731015|NCT01902017|Ketotifen|ketotifen|mesh-list
6731016|NCT01902017|Antipruritics|antipruritics|mesh-ancestor
6731017|NCT01902017|Dermatologic Agents|dermatologic agents|mesh-ancestor
6731018|NCT01902017|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6731019|NCT01902017|Histamine Antagonists|histamine antagonists|mesh-ancestor
6731020|NCT01902017|Histamine Agents|histamine agents|mesh-ancestor
6731021|NCT01902017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6731022|NCT01902017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731023|NCT01902017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731024|NCT01902017|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6731025|NCT01902108|Clonidine|clonidine|mesh-list
6731026|NCT01902108|Bupivacaine|bupivacaine|mesh-list
6731027|NCT01902108|Anesthetics, Local|anesthetics, local|mesh-ancestor
6731028|NCT01902108|Anesthetics|anesthetics|mesh-ancestor
6731029|NCT01902108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6731030|NCT01902108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731031|NCT01902108|Sensory System Agents|sensory system agents|mesh-ancestor
6731032|NCT01902108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6731033|NCT01902108|Analgesics|analgesics|mesh-ancestor
6731034|NCT01902108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6731035|NCT01902108|Sympatholytics|sympatholytics|mesh-ancestor
6731036|NCT01902108|Autonomic Agents|autonomic agents|mesh-ancestor
6731037|NCT01902108|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6731038|NCT01902108|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6731039|NCT01902108|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6731040|NCT01902108|Adrenergic Agents|adrenergic agents|mesh-ancestor
6731041|NCT01902108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6731042|NCT01902108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731043|NCT01902121|Insulin|insulin|mesh-list
6731044|NCT01902121|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6731045|NCT01902121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6731046|NCT01902121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731047|NCT01902160|Sirolimus|sirolimus|mesh-list
6731048|NCT01902160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6731049|NCT01902160|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6731050|NCT01902160|Antibodies|antibodies|mesh-list
6731051|NCT01902160|Immunoglobulins|immunoglobulins|mesh-list
6731052|NCT01902160|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6731053|NCT01902160|Immunoconjugates|immunoconjugates|mesh-list
6731054|NCT01902160|Immunologic Factors|immunologic factors|mesh-ancestor
6731055|NCT01902160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731056|NCT01902160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6731057|NCT01902160|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6731058|NCT01902160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6731059|NCT01902160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6731060|NCT01902160|Antifungal Agents|antifungal agents|mesh-ancestor
6731061|NCT01902160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6731062|NCT01902186|Ritonavir|ritonavir|mesh-list
6731063|NCT01902186|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6731064|NCT01902186|Tenofovir|tenofovir|mesh-list
6731065|NCT01902186|Emtricitabine|emtricitabine|mesh-list
6731066|NCT01902186|Raltegravir Potassium|raltegravir potassium|mesh-list
6731067|NCT01902186|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6731068|NCT01902186|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6731069|NCT01902186|Protease Inhibitors|protease inhibitors|mesh-ancestor
6731070|NCT01902186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6731071|NCT01902186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731072|NCT01902186|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6731073|NCT01902186|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6731074|NCT01902186|Antiviral Agents|antiviral agents|mesh-ancestor
6731075|NCT01902186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6731076|NCT01902186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6731077|NCT01902186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6731078|NCT01902186|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6731079|NCT01902186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6731080|NCT01902186|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6731081|NCT01902186|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6731082|NCT01902225|Doxorubicin|doxorubicin|mesh-list
6731083|NCT01902225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6731084|NCT01902225|Romidepsin|romidepsin|mesh-list
6731085|NCT01902225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6731086|NCT01902225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6731087|NCT01902225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6731088|NCT01902225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6731089|NCT01902225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6731090|NCT01902225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731091|NCT01902238|Ethanol|ethanol|mesh-list
6731092|NCT01902238|Ethiodized Oil|ethiodized oil|mesh-list
6731093|NCT01902238|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6731094|NCT01902238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6731095|NCT01902238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6731096|NCT01902238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731097|NCT01902238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6731098|NCT01902342|Oseltamivir|oseltamivir|mesh-list
6731099|NCT01902342|Antiviral Agents|antiviral agents|mesh-ancestor
6731100|NCT01902342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6731101|NCT01902342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6731102|NCT01902342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731103|NCT01902446|Chlorhexidine|chlorhexidine|mesh-list
6731104|NCT01902446|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6731105|NCT01902446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6731106|NCT01902446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6731107|NCT01902446|Disinfectants|disinfectants|mesh-ancestor
6731108|NCT01902446|Dermatologic Agents|dermatologic agents|mesh-ancestor
6731109|NCT01902485|Contraceptive Agents|contraceptive agents|mesh-list
6731110|NCT01902485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6731111|NCT01902485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731112|NCT01902498|Aspirin|aspirin|mesh-list
6731113|NCT01902498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6731114|NCT01902498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6731115|NCT01902498|Analgesics|analgesics|mesh-ancestor
6731116|NCT01902498|Sensory System Agents|sensory system agents|mesh-ancestor
6731117|NCT01902498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6731118|NCT01902498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731119|NCT01902498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6731120|NCT01902498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6731121|NCT01902498|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6731122|NCT01902498|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6731123|NCT01902498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731124|NCT01902498|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6731125|NCT01902498|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6731126|NCT01902498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6731127|NCT01902498|Antipyretics|antipyretics|mesh-ancestor
6731128|NCT01902511|Epoetin Alfa|epoetin alfa|mesh-list
6731129|NCT01902511|Lenograstim|lenograstim|mesh-list
6731130|NCT01902511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6731131|NCT01902511|Immunologic Factors|immunologic factors|mesh-ancestor
6731132|NCT01902511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731133|NCT01902511|Hematinics|hematinics|mesh-ancestor
6731134|NCT01902524|Fentanyl|fentanyl|mesh-list
6731135|NCT01902524|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6731136|NCT01902524|Narcotics|narcotics|mesh-ancestor
6731137|NCT01902524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6731138|NCT01902524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731139|NCT01902524|Analgesics|analgesics|mesh-ancestor
6731140|NCT01902524|Sensory System Agents|sensory system agents|mesh-ancestor
6731141|NCT01902524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6731142|NCT01902524|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6731143|NCT01902524|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6731144|NCT01902524|Anesthetics, General|anesthetics, general|mesh-ancestor
6731145|NCT01902524|Anesthetics|anesthetics|mesh-ancestor
6731146|NCT01902537|Prucalopride|prucalopride|mesh-list
6731147|NCT01902537|Laxatives|laxatives|mesh-ancestor
6731148|NCT01902537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6731149|NCT01902537|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
6731150|NCT01902537|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6731151|NCT01902537|Serotonin Agents|serotonin agents|mesh-ancestor
6731152|NCT01902537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6731153|NCT01902537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731154|NCT01902537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731155|NCT01902550|Metoprolol|metoprolol|mesh-list
6731156|NCT01902550|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6731157|NCT01902550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6731158|NCT01902550|Sympatholytics|sympatholytics|mesh-ancestor
6731159|NCT01902550|Autonomic Agents|autonomic agents|mesh-ancestor
6731160|NCT01902550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6731161|NCT01902550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731162|NCT01902550|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6731163|NCT01902550|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6731164|NCT01902550|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6731165|NCT01902550|Adrenergic Agents|adrenergic agents|mesh-ancestor
6731166|NCT01902550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6731167|NCT01902550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731168|NCT01902641|Rocuronium|rocuronium|mesh-list
6731169|NCT01902641|Succinylcholine|succinylcholine|mesh-list
6731170|NCT01902641|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6731171|NCT01902641|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6731172|NCT01902641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6731173|NCT01902641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6731174|NCT01902641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731175|NCT01902641|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
6731176|NCT01902771|Imiquimod|imiquimod|mesh-list
6731177|NCT01902771|Vaccines|vaccines|mesh-list
6731178|NCT01902771|Immunologic Factors|immunologic factors|mesh-ancestor
6731179|NCT01902771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731180|NCT01902771|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6731181|NCT01902771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6731182|NCT01902771|Interferon Inducers|interferon inducers|mesh-ancestor
6731183|NCT01902810|Propranolol|propranolol|mesh-list
6731184|NCT01902810|Metoprolol|metoprolol|mesh-list
6731185|NCT01902810|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6731186|NCT01902810|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6731187|NCT01902810|Adrenergic Agents|adrenergic agents|mesh-ancestor
6731188|NCT01902810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6731189|NCT01902810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731190|NCT01902810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731191|NCT01902810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6731192|NCT01902810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6731193|NCT01902810|Vasodilator Agents|vasodilator agents|mesh-ancestor
6731194|NCT01902810|Sympatholytics|sympatholytics|mesh-ancestor
6731195|NCT01902810|Autonomic Agents|autonomic agents|mesh-ancestor
6731196|NCT01902810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6731197|NCT01902810|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6731198|NCT01902862|Rituximab|rituximab|mesh-list
6731199|NCT01902862|Bortezomib|bortezomib|mesh-list
6731200|NCT01902862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6731201|NCT01902862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6731202|NCT01902862|Immunologic Factors|immunologic factors|mesh-ancestor
6731203|NCT01902862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731204|NCT01902862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6731205|NCT01902875|Paclitaxel|paclitaxel|mesh-list
6731206|NCT01902875|Cisplatin|cisplatin|mesh-list
6731207|NCT01902875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6731208|NCT01902875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6731209|NCT01902875|Tubulin Modulators|tubulin modulators|mesh-ancestor
6731210|NCT01902875|Antimitotic Agents|antimitotic agents|mesh-ancestor
6731211|NCT01902875|Mitosis Modulators|mitosis modulators|mesh-ancestor
6731212|NCT01902875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731213|NCT01903018|Cisplatin|cisplatin|mesh-list
6731214|NCT01903018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6731215|NCT01903057|Azithromycin|azithromycin|mesh-list
6731216|NCT01903057|Ivermectin|ivermectin|mesh-list
6731217|NCT01903057|Albendazole|albendazole|mesh-list
6731218|NCT01903057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6731219|NCT01903057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6731220|NCT01903057|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6731221|NCT01903057|Anthelmintics|anthelmintics|mesh-ancestor
6731222|NCT01903057|Anticestodal Agents|anticestodal agents|mesh-ancestor
6731223|NCT01903057|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6731224|NCT01903057|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6731225|NCT01903057|Tubulin Modulators|tubulin modulators|mesh-ancestor
6731226|NCT01903057|Antimitotic Agents|antimitotic agents|mesh-ancestor
6731227|NCT01903057|Mitosis Modulators|mitosis modulators|mesh-ancestor
6731228|NCT01903057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731229|NCT01903057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6731230|NCT01903070|Linagliptin|linagliptin|mesh-list
6731231|NCT01903070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6731232|NCT01903070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731233|NCT01903070|Incretins|incretins|mesh-ancestor
6731234|NCT01903070|Hormones|hormones|mesh-ancestor
6731235|NCT01903070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6731236|NCT01903070|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6731237|NCT01903070|Protease Inhibitors|protease inhibitors|mesh-ancestor
6731238|NCT01903070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6731239|NCT01903070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731240|NCT01903083|Gemcitabine|gemcitabine|mesh-list
6731241|NCT01903083|Tadalafil|tadalafil|mesh-list
6731242|NCT01903083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6731243|NCT01903083|Antimetabolites|antimetabolites|mesh-ancestor
6731244|NCT01903083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731245|NCT01903083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6731246|NCT01903083|Antiviral Agents|antiviral agents|mesh-ancestor
6731247|NCT01903083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6731248|NCT01903083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6731249|NCT01903083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6731250|NCT01903083|Immunologic Factors|immunologic factors|mesh-ancestor
6731251|NCT01903083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731252|NCT01903083|Vasodilator Agents|vasodilator agents|mesh-ancestor
6731253|NCT01903083|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6731254|NCT01903083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6731255|NCT01903083|Urological Agents|urological agents|mesh-ancestor
6731256|NCT01903096|Antidepressive Agents|antidepressive agents|mesh-list
6731257|NCT01903096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6731258|NCT01903109|Cevimeline|cevimeline|mesh-list
6731259|NCT01903109|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6731260|NCT01903109|Autonomic Agents|autonomic agents|mesh-ancestor
6731261|NCT01903109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6731262|NCT01903109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731263|NCT01903109|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6731264|NCT01903109|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6731265|NCT01903109|Cholinergic Agents|cholinergic agents|mesh-ancestor
6731266|NCT01903109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6731267|NCT01903109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731268|NCT01903122|Cevimeline|cevimeline|mesh-list
6731269|NCT01903122|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6731270|NCT01903122|Autonomic Agents|autonomic agents|mesh-ancestor
6731271|NCT01903122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6731272|NCT01903122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731273|NCT01903122|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6731274|NCT01903122|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6731275|NCT01903122|Cholinergic Agents|cholinergic agents|mesh-ancestor
6731276|NCT01903122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6731277|NCT01903122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731278|NCT01903200|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6731279|NCT01903200|Antidepressive Agents|antidepressive agents|mesh-ancestor
6731280|NCT01903200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6731281|NCT01903200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6731282|NCT01903200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6731283|NCT01903200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6731284|NCT01903200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731285|NCT01903278|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6731286|NCT01903278|Antiviral Agents|antiviral agents|mesh-ancestor
6731287|NCT01903278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6731288|NCT01903291|Dimethyl Fumarate|dimethyl fumarate|mesh-list
6731289|NCT01903291|Dermatologic Agents|dermatologic agents|mesh-ancestor
6731290|NCT01903291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6731291|NCT01903291|Immunologic Factors|immunologic factors|mesh-ancestor
6731292|NCT01903291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731293|NCT01903330|Cyclophosphamide|cyclophosphamide|mesh-list
6731294|NCT01903330|Bevacizumab|bevacizumab|mesh-list
6731295|NCT01903330|Sargramostim|sargramostim|mesh-list
6731296|NCT01903330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6731297|NCT01903330|Immunologic Factors|immunologic factors|mesh-ancestor
6731298|NCT01903330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731299|NCT01903330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6731300|NCT01903330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6731301|NCT01903330|Alkylating Agents|alkylating agents|mesh-ancestor
6731302|NCT01903330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731303|NCT01903330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6731304|NCT01903330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6731305|NCT01903330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6731306|NCT01903330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6731307|NCT01903330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6731308|NCT01903330|Growth Substances|growth substances|mesh-ancestor
6731309|NCT01903330|Growth Inhibitors|growth inhibitors|mesh-ancestor
6785357|NCT02207426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6785358|NCT02207439|Nelfinavir|nelfinavir|mesh-list
6785359|NCT02207439|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6785360|NCT02207439|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6785361|NCT02207439|Protease Inhibitors|protease inhibitors|mesh-ancestor
6785362|NCT02207439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6785363|NCT02207439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785364|NCT02207439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6785365|NCT02207439|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6785366|NCT02207439|Antiviral Agents|antiviral agents|mesh-ancestor
6785367|NCT02207439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6785368|NCT02207452|Albuterol|albuterol|mesh-list
6785369|NCT02207452|Ipratropium|ipratropium|mesh-list
6785370|NCT02207452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6785371|NCT02207452|Autonomic Agents|autonomic agents|mesh-ancestor
6785372|NCT02207452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6785373|NCT02207452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785374|NCT02207452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6785375|NCT02207452|Respiratory System Agents|respiratory system agents|mesh-ancestor
6785376|NCT02207452|Tocolytic Agents|tocolytic agents|mesh-ancestor
6785377|NCT02207452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6785378|NCT02207452|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6785379|NCT02207452|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6785380|NCT02207452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6785381|NCT02207452|Adrenergic Agents|adrenergic agents|mesh-ancestor
6785382|NCT02207452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6785383|NCT02207452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785384|NCT02207452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6785385|NCT02207452|Cholinergic Agents|cholinergic agents|mesh-ancestor
6785386|NCT02207660|Fluorouracil|fluorouracil|mesh-list
6785387|NCT02207660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6785388|NCT02207660|Antimetabolites|antimetabolites|mesh-ancestor
6785389|NCT02207660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785390|NCT02207660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6785391|NCT02207660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6785392|NCT02207660|Immunologic Factors|immunologic factors|mesh-ancestor
6785393|NCT02207660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785394|NCT02207699|Moxifloxacin|moxifloxacin|mesh-list
6785395|NCT02207699|Benzonatate|benzonatate|mesh-list
6785396|NCT02207699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6785397|NCT02207699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6785398|NCT02207699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6785399|NCT02207699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6785400|NCT02207699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6785401|NCT02207699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785402|NCT02207699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6785403|NCT02207699|Antitussive Agents|antitussive agents|mesh-ancestor
6785404|NCT02207699|Respiratory System Agents|respiratory system agents|mesh-ancestor
6785405|NCT02207712|Ranibizumab|ranibizumab|mesh-list
6785406|NCT02207712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6785407|NCT02207712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6785408|NCT02207712|Growth Substances|growth substances|mesh-ancestor
6785409|NCT02207712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785410|NCT02207712|Growth Inhibitors|growth inhibitors|mesh-ancestor
6785411|NCT02207712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6785412|NCT02207855|Chloroprocaine|chloroprocaine|mesh-list
6785413|NCT02207855|Anesthetics, Local|anesthetics, local|mesh-ancestor
6785414|NCT02207855|Anesthetics|anesthetics|mesh-ancestor
6785415|NCT02207855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6785416|NCT02207855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785417|NCT02207855|Sensory System Agents|sensory system agents|mesh-ancestor
6785418|NCT02207855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6785419|NCT02207920|Vaccines|vaccines|mesh-list
6785420|NCT02207920|Immunologic Factors|immunologic factors|mesh-ancestor
6785421|NCT02207920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785422|NCT02207959|Proflavine|proflavine|mesh-list
6785423|NCT02207959|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6785424|NCT02207959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6785425|NCT02208128|Bevacizumab|bevacizumab|mesh-list
6785426|NCT02208128|Sunitinib|sunitinib|mesh-list
6785427|NCT02208128|Everolimus|everolimus|mesh-list
6785428|NCT02208128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6785429|NCT02208128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6731310|NCT01903421|Fentanyl|fentanyl|mesh-list
6731311|NCT01903421|Bupivacaine|bupivacaine|mesh-list
6731312|NCT01903421|Anesthetics|anesthetics|mesh-list
6731313|NCT01903421|Propofol|propofol|mesh-list
6731314|NCT01903421|Sevoflurane|sevoflurane|mesh-list
6731315|NCT01903421|Isoflurane|isoflurane|mesh-list
6731316|NCT01903421|Anesthetics, Local|anesthetics, local|mesh-ancestor
6731317|NCT01903421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6731318|NCT01903421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731319|NCT01903421|Sensory System Agents|sensory system agents|mesh-ancestor
6731320|NCT01903421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6731321|NCT01903421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6731322|NCT01903421|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6731323|NCT01903421|Anesthetics, General|anesthetics, general|mesh-ancestor
6731324|NCT01903421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6731325|NCT01903421|Narcotics|narcotics|mesh-ancestor
6731326|NCT01903421|Analgesics|analgesics|mesh-ancestor
6731327|NCT01903421|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6731328|NCT01903421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6731329|NCT01903421|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6731330|NCT01903473|Sirolimus|sirolimus|mesh-list
6731331|NCT01903473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6731332|NCT01903473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6731333|NCT01903473|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6731334|NCT01903473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6731335|NCT01903473|Antifungal Agents|antifungal agents|mesh-ancestor
6731336|NCT01903473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6731337|NCT01903473|Immunologic Factors|immunologic factors|mesh-ancestor
6731338|NCT01903473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731339|NCT01903681|Melatonin|melatonin|mesh-list
6731340|NCT01903681|Antioxidants|antioxidants|mesh-ancestor
6731341|NCT01903681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731342|NCT01903681|Protective Agents|protective agents|mesh-ancestor
6731343|NCT01903681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731344|NCT01903681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6731345|NCT01903694|Sorafenib|sorafenib|mesh-list
6731346|NCT01903694|Pravastatin|pravastatin|mesh-list
6731347|NCT01903694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6731348|NCT01903694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6731349|NCT01903694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6731350|NCT01903694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731351|NCT01903694|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6731352|NCT01903694|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6731353|NCT01903694|Antimetabolites|antimetabolites|mesh-ancestor
6731354|NCT01903694|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6731355|NCT01903694|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6731356|NCT01903785|Albuterol|albuterol|mesh-list
6731357|NCT01903785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6731358|NCT01903785|Autonomic Agents|autonomic agents|mesh-ancestor
6731359|NCT01903785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6731360|NCT01903785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731361|NCT01903785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6731362|NCT01903785|Respiratory System Agents|respiratory system agents|mesh-ancestor
6731363|NCT01903785|Tocolytic Agents|tocolytic agents|mesh-ancestor
6731364|NCT01903785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6731365|NCT01903785|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6731366|NCT01903785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6731367|NCT01903785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6731368|NCT01903785|Adrenergic Agents|adrenergic agents|mesh-ancestor
6731369|NCT01903785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6731370|NCT01903785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731371|NCT01903824|Modafinil|modafinil|mesh-list
6731372|NCT01903824|Donepezil|donepezil|mesh-list
6731373|NCT01903824|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6731374|NCT01903824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6731375|NCT01903824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731376|NCT01903824|Cholinergic Agents|cholinergic agents|mesh-ancestor
6731377|NCT01903824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6731378|NCT01903824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731379|NCT01903824|Nootropic Agents|nootropic agents|mesh-ancestor
6731380|NCT01903824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6731381|NCT01903824|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6731382|NCT01903824|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6731383|NCT01903824|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6731384|NCT01904032|Vitamin D|vitamin d|mesh-list
6731385|NCT01904032|Ergocalciferols|ergocalciferols|mesh-list
6731386|NCT01904032|Cholecalciferol|cholecalciferol|mesh-list
6731387|NCT01904032|Vitamins|vitamins|mesh-list
6731388|NCT01904032|Micronutrients|micronutrients|mesh-ancestor
6731389|NCT01904032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731390|NCT01904032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6731391|NCT01904032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6731392|NCT01904045|Tacrolimus|tacrolimus|mesh-list
6731393|NCT01904045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6731394|NCT01904045|Immunologic Factors|immunologic factors|mesh-ancestor
6731395|NCT01904045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731396|NCT01904045|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6731397|NCT01904045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6731398|NCT01904045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731399|NCT01904097|Pregabalin|pregabalin|mesh-list
6731400|NCT01904097|Analgesics|analgesics|mesh-ancestor
6731401|NCT01904097|Sensory System Agents|sensory system agents|mesh-ancestor
6731402|NCT01904097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6731403|NCT01904097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731404|NCT01904097|Anticonvulsants|anticonvulsants|mesh-ancestor
6731405|NCT01904097|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6731406|NCT01904097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6731407|NCT01904097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731408|NCT01904097|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6731409|NCT01904097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6731410|NCT01904097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6731411|NCT01904097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6731412|NCT01904097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6731413|NCT01904110|Cholecalciferol|cholecalciferol|mesh-list
6731414|NCT01904110|Risedronic Acid|risedronic acid|mesh-list
6731415|NCT01904110|Etidronic Acid|etidronic acid|mesh-list
6731416|NCT01904110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6731417|NCT01904110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731418|NCT01904110|Vitamins|vitamins|mesh-ancestor
6731419|NCT01904110|Micronutrients|micronutrients|mesh-ancestor
6731420|NCT01904110|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6731421|NCT01904110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6731422|NCT01904110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6731423|NCT01904110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731424|NCT01904123|Tyrphostins|tyrphostins|mesh-list
6731425|NCT01904123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6731426|NCT01904123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6731427|NCT01904123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731428|NCT01904136|Mycophenolic Acid|mycophenolic acid|mesh-list
6731429|NCT01904136|Cyclophosphamide|cyclophosphamide|mesh-list
6731430|NCT01904136|Melphalan|melphalan|mesh-list
6731431|NCT01904136|Mechlorethamine|mechlorethamine|mesh-list
6731432|NCT01904136|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
6731433|NCT01904136|Fludarabine|fludarabine|mesh-list
6731434|NCT01904136|Tacrolimus|tacrolimus|mesh-list
6731435|NCT01904136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6731436|NCT01904136|Immunologic Factors|immunologic factors|mesh-ancestor
6731437|NCT01904136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731438|NCT01904136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6731439|NCT01904136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6731440|NCT01904136|Alkylating Agents|alkylating agents|mesh-ancestor
6731441|NCT01904136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731442|NCT01904136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6731443|NCT01904136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6731444|NCT01904136|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6731445|NCT01904136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6731446|NCT01904136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6731447|NCT01904136|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6731448|NCT01904136|Antitubercular Agents|antitubercular agents|mesh-ancestor
6731449|NCT01904136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6731450|NCT01904136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6731451|NCT01904162|Finafloxacin|finafloxacin|mesh-list
6731452|NCT01904162|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6731453|NCT01904162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6731454|NCT01904162|Renal Agents|renal agents|mesh-ancestor
6731455|NCT01904162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6731456|NCT01904162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6731457|NCT01904162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6731458|NCT01904162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6731459|NCT01904162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731460|NCT01904162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6731461|NCT01904214|Siponimod|siponimod|mesh-list
6731462|NCT01904214|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6731463|NCT01904214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731464|NCT01904214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6731465|NCT01904214|Immunologic Factors|immunologic factors|mesh-ancestor
6731466|NCT01904214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731467|NCT01904253|Topotecan|topotecan|mesh-list
6731468|NCT01904253|Amrubicin|amrubicin|mesh-list
6731469|NCT01904253|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6731470|NCT01904253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6731471|NCT01904253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6731472|NCT01904253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731473|NCT01904253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6731474|NCT01904357|Cefazolin|cefazolin|mesh-list
6731475|NCT01904357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6731476|NCT01904357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6731477|NCT01904487|Tiagabine|tiagabine|mesh-list
6731478|NCT01904487|Flumazenil|flumazenil|mesh-list
6731479|NCT01904487|Antidotes|antidotes|mesh-ancestor
6731480|NCT01904487|Protective Agents|protective agents|mesh-ancestor
6731481|NCT01904487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731482|NCT01904487|GABA Modulators|gaba modulators|mesh-ancestor
6731483|NCT01904487|GABA Agents|gaba agents|mesh-ancestor
6731484|NCT01904487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6731485|NCT01904487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731486|NCT01904487|Anticonvulsants|anticonvulsants|mesh-ancestor
6731487|NCT01904487|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
6731488|NCT01904487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6731489|NCT01904487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6731490|NCT01904500|Cefazolin|cefazolin|mesh-list
6731491|NCT01904500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6731492|NCT01904500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6731493|NCT01904539|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
6731494|NCT01904539|Cathartics|cathartics|mesh-ancestor
6731495|NCT01904539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6731496|NCT01904591|Vitamin E|vitamin e|mesh-list
6731497|NCT01904591|Selenium|selenium|mesh-list
6731498|NCT01904591|Vitamins|vitamins|mesh-ancestor
6731499|NCT01904591|Micronutrients|micronutrients|mesh-ancestor
6731500|NCT01904591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731501|NCT01904591|Antioxidants|antioxidants|mesh-ancestor
6731502|NCT01904591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731503|NCT01904591|Protective Agents|protective agents|mesh-ancestor
6731504|NCT01904591|Trace Elements|trace elements|mesh-ancestor
6731505|NCT01904643|Cytarabine|cytarabine|mesh-list
6731506|NCT01904643|Etoposide|etoposide|mesh-list
6731507|NCT01904643|Mitoxantrone|mitoxantrone|mesh-list
6731508|NCT01904643|Lenalidomide|lenalidomide|mesh-list
6731509|NCT01904643|Etoposide phosphate|etoposide phosphate|mesh-list
6731510|NCT01904643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6731511|NCT01904643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6731512|NCT01904643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6731513|NCT01904643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6731514|NCT01904643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6731515|NCT01904643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731516|NCT01904643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6731517|NCT01904643|Antimetabolites|antimetabolites|mesh-ancestor
6731518|NCT01904643|Antiviral Agents|antiviral agents|mesh-ancestor
6731519|NCT01904643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6731520|NCT01904643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6731521|NCT01904643|Immunologic Factors|immunologic factors|mesh-ancestor
6731522|NCT01904643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731523|NCT01904643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6731524|NCT01904643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6731525|NCT01904643|Growth Substances|growth substances|mesh-ancestor
6731526|NCT01904643|Growth Inhibitors|growth inhibitors|mesh-ancestor
6731527|NCT01904643|Analgesics|analgesics|mesh-ancestor
6731528|NCT01904643|Sensory System Agents|sensory system agents|mesh-ancestor
6731529|NCT01904643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6731530|NCT01904682|ON 01910|on 01910|mesh-list
6731531|NCT01904682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6731532|NCT01904682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6731533|NCT01904682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6731534|NCT01904682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731535|NCT01904695|Antihypertensive Agents|antihypertensive agents|mesh-list
6731536|NCT01904695|Diuretics|diuretics|mesh-list
6731537|NCT01904695|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6731538|NCT01904695|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
6731539|NCT01904695|Natriuretic Agents|natriuretic agents|mesh-ancestor
6731540|NCT01904695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731541|NCT01904695|Protease Inhibitors|protease inhibitors|mesh-ancestor
6731542|NCT01904695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6731543|NCT01904695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731544|NCT01904695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6731545|NCT01904734|Clomiphene|clomiphene|mesh-list
6731546|NCT01904734|Enclomiphene|enclomiphene|mesh-list
6731547|NCT01904734|Zuclomiphene|zuclomiphene|mesh-list
6731548|NCT01904734|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6731549|NCT01904734|Hormone Antagonists|hormone antagonists|mesh-ancestor
6731550|NCT01904734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6731551|NCT01904734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731552|NCT01904734|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6731553|NCT01904734|Fertility Agents|fertility agents|mesh-ancestor
6731554|NCT01904734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6731555|NCT01904734|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6731556|NCT01904734|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6731557|NCT01904747|Palbociclib|palbociclib|mesh-list
6731558|NCT01904747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6731559|NCT01904747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6731560|NCT01904747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6731561|NCT01904747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731562|NCT01904786|Melatonin|melatonin|mesh-list
6731563|NCT01904786|Antioxidants|antioxidants|mesh-ancestor
6785430|NCT02208128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6785431|NCT02208128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6785432|NCT02208128|Growth Substances|growth substances|mesh-ancestor
6785433|NCT02208128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785434|NCT02208128|Growth Inhibitors|growth inhibitors|mesh-ancestor
6785435|NCT02208128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6785436|NCT02208128|Immunologic Factors|immunologic factors|mesh-ancestor
6785437|NCT02208128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6785438|NCT02208128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6785439|NCT02208128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785440|NCT02208154|Chlorhexidine|chlorhexidine|mesh-list
6785441|NCT02208154|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6785442|NCT02208154|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6785443|NCT02208154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6785444|NCT02208154|Disinfectants|disinfectants|mesh-ancestor
6785445|NCT02208154|Dermatologic Agents|dermatologic agents|mesh-ancestor
6785446|NCT02208245|Ropivacaine|ropivacaine|mesh-list
6785447|NCT02208245|Anesthetics, Local|anesthetics, local|mesh-ancestor
6785448|NCT02208245|Anesthetics|anesthetics|mesh-ancestor
6785449|NCT02208245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6785450|NCT02208245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785451|NCT02208245|Sensory System Agents|sensory system agents|mesh-ancestor
6785452|NCT02208245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6785453|NCT02208375|Olaparib|olaparib|mesh-list
6785454|NCT02208375|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
6785455|NCT02208375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6731564|NCT01904786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731565|NCT01904786|Protective Agents|protective agents|mesh-ancestor
6731566|NCT01904786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731567|NCT01904786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6731568|NCT01904981|Atenolol|atenolol|mesh-list
6731569|NCT01904981|Valsartan|valsartan|mesh-list
6731570|NCT01904981|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
6731571|NCT01904981|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
6731572|NCT01904981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6731573|NCT01904981|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6731574|NCT01904981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731575|NCT01904981|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6731576|NCT01904981|Adrenergic Agents|adrenergic agents|mesh-ancestor
6731577|NCT01904981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6731578|NCT01904981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731579|NCT01904981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6731580|NCT01904981|Sympatholytics|sympatholytics|mesh-ancestor
6731581|NCT01904981|Autonomic Agents|autonomic agents|mesh-ancestor
6731582|NCT01904981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6731583|NCT01904981|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6731584|NCT01904994|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6731585|NCT01904994|Antiviral Agents|antiviral agents|mesh-ancestor
6731586|NCT01904994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6731587|NCT01905059|Lamivudine|lamivudine|mesh-list
6731588|NCT01905059|Lopinavir|lopinavir|mesh-list
6731589|NCT01905059|Darunavir|darunavir|mesh-list
6731590|NCT01905059|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
6731591|NCT01905059|Protease Inhibitors|protease inhibitors|mesh-list
6731592|NCT01905059|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6731593|NCT01905059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6731594|NCT01905059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6731595|NCT01905059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731596|NCT01905059|Antiviral Agents|antiviral agents|mesh-ancestor
6731597|NCT01905059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6731598|NCT01905059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6731599|NCT01905059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6731600|NCT01905059|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6731601|NCT01905059|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6731602|NCT01905059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6785456|NCT02208375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785457|NCT02208375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6785458|NCT02208427|Isoniazid|isoniazid|mesh-list
6785459|NCT02208427|Rifapentine|rifapentine|mesh-list
6785460|NCT02208427|Antitubercular Agents|antitubercular agents|mesh-ancestor
6785461|NCT02208427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6785462|NCT02208427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6785463|NCT02208427|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6785464|NCT02208427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6785465|NCT02208427|Antimetabolites|antimetabolites|mesh-ancestor
6785466|NCT02208427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785467|NCT02208427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6785468|NCT02208427|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6785469|NCT02208427|Leprostatic Agents|leprostatic agents|mesh-ancestor
6785470|NCT02208492|Levetiracetam|levetiracetam|mesh-list
6785471|NCT02208492|Anticonvulsants|anticonvulsants|mesh-ancestor
6785472|NCT02208492|Nootropic Agents|nootropic agents|mesh-ancestor
6785473|NCT02208505|Dexmedetomidine|dexmedetomidine|mesh-list
6785474|NCT02208505|Remifentanil|remifentanil|mesh-list
6785475|NCT02208505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6785476|NCT02208505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6785477|NCT02208505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785478|NCT02208505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6785479|NCT02208505|Analgesics|analgesics|mesh-ancestor
6785480|NCT02208505|Sensory System Agents|sensory system agents|mesh-ancestor
6785481|NCT02208505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6785482|NCT02208505|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6785483|NCT02208505|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6785484|NCT02208505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6785485|NCT02208505|Adrenergic Agents|adrenergic agents|mesh-ancestor
6785486|NCT02208505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6785487|NCT02208505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785488|NCT02208505|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6785489|NCT02208505|Narcotics|narcotics|mesh-ancestor
6785490|NCT02208544|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6785491|NCT02208544|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6785492|NCT02208544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785493|NCT02208583|Prednisone|prednisone|mesh-list
6785494|NCT02208583|Cisplatin|cisplatin|mesh-list
6785495|NCT02208583|Docetaxel|docetaxel|mesh-list
6785496|NCT02208583|Etoposide|etoposide|mesh-list
6785497|NCT02208583|Etoposide phosphate|etoposide phosphate|mesh-list
6785498|NCT02208583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6785499|NCT02208583|Tubulin Modulators|tubulin modulators|mesh-ancestor
6785500|NCT02208583|Antimitotic Agents|antimitotic agents|mesh-ancestor
6785501|NCT02208583|Mitosis Modulators|mitosis modulators|mesh-ancestor
6785502|NCT02208583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785503|NCT02208583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6785504|NCT02208583|Glucocorticoids|glucocorticoids|mesh-ancestor
6785505|NCT02208583|Hormones|hormones|mesh-ancestor
6785506|NCT02208583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6785507|NCT02208583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785508|NCT02208583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6785509|NCT02208583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6785510|NCT02208583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6785511|NCT02208583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6785512|NCT02208583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6785513|NCT02208596|Pentazocine|pentazocine|mesh-list
6785514|NCT02208596|Propofol|propofol|mesh-list
6785515|NCT02208596|Etomidate|etomidate|mesh-list
6785516|NCT02208596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6785517|NCT02208596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6785518|NCT02208596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785519|NCT02208596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6785520|NCT02208596|Anesthetics, General|anesthetics, general|mesh-ancestor
6785521|NCT02208596|Anesthetics|anesthetics|mesh-ancestor
6785522|NCT02208596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6785523|NCT02208596|Narcotics|narcotics|mesh-ancestor
6785524|NCT02208596|Analgesics|analgesics|mesh-ancestor
6785525|NCT02208596|Sensory System Agents|sensory system agents|mesh-ancestor
6785526|NCT02208596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6785527|NCT02208596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6785528|NCT02208596|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6731603|NCT01905137|Botulinum Toxins|botulinum toxins|mesh-list
6731604|NCT01905137|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6731605|NCT01905137|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6731606|NCT01905137|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6731607|NCT01905137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6731608|NCT01905137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731609|NCT01905137|Cholinergic Agents|cholinergic agents|mesh-ancestor
6731610|NCT01905137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6731611|NCT01905137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731612|NCT01905137|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6731613|NCT01905137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6731614|NCT01905150|Leucovorin|leucovorin|mesh-list
6731615|NCT01905150|Ascorbic Acid|ascorbic acid|mesh-list
6731616|NCT01905150|Gemcitabine|gemcitabine|mesh-list
6731617|NCT01905150|Fluorouracil|fluorouracil|mesh-list
6731618|NCT01905150|Docetaxel|docetaxel|mesh-list
6731619|NCT01905150|Oxaliplatin|oxaliplatin|mesh-list
6731620|NCT01905150|Irinotecan|irinotecan|mesh-list
6731621|NCT01905150|Mitomycins|mitomycins|mesh-list
6731622|NCT01905150|Mitomycin|mitomycin|mesh-list
6731623|NCT01905150|Levoleucovorin|levoleucovorin|mesh-list
6731624|NCT01905150|Vitamins|vitamins|mesh-ancestor
6731625|NCT01905150|Micronutrients|micronutrients|mesh-ancestor
6731626|NCT01905150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731627|NCT01905150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6731628|NCT01905150|Antimetabolites|antimetabolites|mesh-ancestor
6731629|NCT01905150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731630|NCT01905150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6731631|NCT01905150|Antiviral Agents|antiviral agents|mesh-ancestor
6731632|NCT01905150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6731633|NCT01905150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6731634|NCT01905150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6731635|NCT01905150|Immunologic Factors|immunologic factors|mesh-ancestor
6731636|NCT01905150|Tubulin Modulators|tubulin modulators|mesh-ancestor
6731637|NCT01905150|Antimitotic Agents|antimitotic agents|mesh-ancestor
6731638|NCT01905150|Mitosis Modulators|mitosis modulators|mesh-ancestor
6731639|NCT01905150|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6731640|NCT01905150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6731641|NCT01905150|Antidotes|antidotes|mesh-ancestor
6731642|NCT01905150|Protective Agents|protective agents|mesh-ancestor
6731643|NCT01905150|Vitamin B Complex|vitamin b complex|mesh-ancestor
6731644|NCT01905150|Antioxidants|antioxidants|mesh-ancestor
6731645|NCT01905150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6731646|NCT01905150|Alkylating Agents|alkylating agents|mesh-ancestor
6731647|NCT01905150|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6731648|NCT01905215|Vaccines|vaccines|mesh-list
6731649|NCT01905215|Immunologic Factors|immunologic factors|mesh-ancestor
6731650|NCT01905215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731651|NCT01905371|Amphetamine|amphetamine|mesh-list
6731652|NCT01905371|Dextroamphetamine|dextroamphetamine|mesh-list
6731653|NCT01905371|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6731654|NCT01905371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731655|NCT01905371|Sympathomimetics|sympathomimetics|mesh-ancestor
6731656|NCT01905371|Autonomic Agents|autonomic agents|mesh-ancestor
6731657|NCT01905371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6731658|NCT01905371|Dopamine Agents|dopamine agents|mesh-ancestor
6731659|NCT01905371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6731660|NCT01905371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731661|NCT01905371|Adrenergic Agents|adrenergic agents|mesh-ancestor
6731662|NCT01905371|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6731663|NCT01905371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6731664|NCT01905371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6731665|NCT01905371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6731666|NCT01905501|Anesthetics|anesthetics|mesh-list
6731667|NCT01905501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6731668|NCT01905501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731669|NCT01905566|Clopidogrel|clopidogrel|mesh-list
6731670|NCT01905566|Ticagrelor|ticagrelor|mesh-list
6731671|NCT01905566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6731672|NCT01905566|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6731673|NCT01905566|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6731674|NCT01905566|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6731675|NCT01905566|Purinergic Agents|purinergic agents|mesh-ancestor
6731676|NCT01905566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6731677|NCT01905566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731678|NCT01905566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731679|NCT01905618|Nicotine|nicotine|mesh-list
6731680|NCT01905618|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6731681|NCT01905618|Autonomic Agents|autonomic agents|mesh-ancestor
6731682|NCT01905618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6731683|NCT01905618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731684|NCT01905618|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6731685|NCT01905618|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6731686|NCT01905618|Cholinergic Agents|cholinergic agents|mesh-ancestor
6731687|NCT01905618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6731688|NCT01905618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731689|NCT01905631|Diphenhydramine|diphenhydramine|mesh-list
6731690|NCT01905631|Promethazine|promethazine|mesh-list
6731691|NCT01905631|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6731692|NCT01905631|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6731693|NCT01905631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6731694|NCT01905631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731695|NCT01905631|Anesthetics, Local|anesthetics, local|mesh-ancestor
6731696|NCT01905631|Anesthetics|anesthetics|mesh-ancestor
6731697|NCT01905631|Sensory System Agents|sensory system agents|mesh-ancestor
6731698|NCT01905631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6731699|NCT01905631|Antiemetics|antiemetics|mesh-ancestor
6731700|NCT01905631|Autonomic Agents|autonomic agents|mesh-ancestor
6731701|NCT01905631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6731702|NCT01905631|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6731703|NCT01905631|Histamine Antagonists|histamine antagonists|mesh-ancestor
6731704|NCT01905631|Histamine Agents|histamine agents|mesh-ancestor
6731705|NCT01905631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6731706|NCT01905631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731707|NCT01905631|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6731708|NCT01905631|Antipruritics|antipruritics|mesh-ancestor
6731709|NCT01905631|Dermatologic Agents|dermatologic agents|mesh-ancestor
6731710|NCT01905696|Acetylcysteine|acetylcysteine|mesh-list
6731711|NCT01905696|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6731712|NCT01905696|Antiviral Agents|antiviral agents|mesh-ancestor
6731713|NCT01905696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6731714|NCT01905696|Expectorants|expectorants|mesh-ancestor
6731715|NCT01905696|Respiratory System Agents|respiratory system agents|mesh-ancestor
6731716|NCT01905696|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6731717|NCT01905696|Antioxidants|antioxidants|mesh-ancestor
6731718|NCT01905696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731719|NCT01905696|Protective Agents|protective agents|mesh-ancestor
6731720|NCT01905696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731721|NCT01905696|Antidotes|antidotes|mesh-ancestor
6731722|NCT01905774|Deferasirox|deferasirox|mesh-list
6731723|NCT01905774|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6731724|NCT01905774|Chelating Agents|chelating agents|mesh-ancestor
6731725|NCT01905774|Sequestering Agents|sequestering agents|mesh-ancestor
6731726|NCT01905774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731727|NCT01905904|Sevoflurane|sevoflurane|mesh-list
6731728|NCT01905904|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6731729|NCT01905904|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6731730|NCT01905904|Anesthetics, General|anesthetics, general|mesh-ancestor
6731731|NCT01905904|Anesthetics|anesthetics|mesh-ancestor
6731732|NCT01905904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6731733|NCT01905904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731734|NCT01906073|Fentanyl|fentanyl|mesh-list
6731735|NCT01906073|Morphine|morphine|mesh-list
6731736|NCT01906073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6731737|NCT01906073|Narcotics|narcotics|mesh-ancestor
6731738|NCT01906073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6731739|NCT01906073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731740|NCT01906073|Analgesics|analgesics|mesh-ancestor
6731741|NCT01906073|Sensory System Agents|sensory system agents|mesh-ancestor
6731742|NCT01906073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6731743|NCT01906073|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6731744|NCT01906073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6731745|NCT01906073|Anesthetics, General|anesthetics, general|mesh-ancestor
6731746|NCT01906073|Anesthetics|anesthetics|mesh-ancestor
6731747|NCT01906125|Palbociclib|palbociclib|mesh-list
6731748|NCT01906125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6731749|NCT01906125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6731750|NCT01906125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6731751|NCT01906125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731752|NCT01906216|Sorafenib|sorafenib|mesh-list
6731753|NCT01906216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6731754|NCT01906216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6731755|NCT01906216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6731756|NCT01906216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731757|NCT01906242|Chlorhexidine|chlorhexidine|mesh-list
6731758|NCT01906242|Sodium Hypochlorite|sodium hypochlorite|mesh-list
6731759|NCT01906242|Eusol|eusol|mesh-list
6731760|NCT01906242|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6731761|NCT01906242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6731762|NCT01906242|Disinfectants|disinfectants|mesh-ancestor
6731763|NCT01906294|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6731764|NCT01906294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731765|NCT01906307|Angiotensin II|angiotensin ii|mesh-list
6731766|NCT01906307|Giapreza|giapreza|mesh-list
6731767|NCT01906307|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6731768|NCT01906411|Dopamine|dopamine|mesh-list
6731769|NCT01906411|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6731770|NCT01906411|Sympathomimetics|sympathomimetics|mesh-ancestor
6731771|NCT01906411|Autonomic Agents|autonomic agents|mesh-ancestor
6731772|NCT01906411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6731773|NCT01906411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731774|NCT01906411|Dopamine Agents|dopamine agents|mesh-ancestor
6731775|NCT01906411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6731776|NCT01906411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731777|NCT01906411|Protective Agents|protective agents|mesh-ancestor
6731778|NCT01906450|Azithromycin|azithromycin|mesh-list
6731779|NCT01906450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6731780|NCT01906450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6731781|NCT01906528|Mivacurium|mivacurium|mesh-list
6731782|NCT01906528|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6731783|NCT01906528|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6731784|NCT01906528|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6731785|NCT01906528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6731786|NCT01906528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731787|NCT01906580|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6731788|NCT01906580|Entecavir|entecavir|mesh-list
6731789|NCT01906580|Antiviral Agents|antiviral agents|mesh-ancestor
6731790|NCT01906580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6731791|NCT01906671|Mercaptopurine|mercaptopurine|mesh-list
6731792|NCT01906671|Antimetabolites|antimetabolites|mesh-ancestor
6731793|NCT01906671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731794|NCT01906671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6731795|NCT01906671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6731796|NCT01906671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6731797|NCT01906671|Immunologic Factors|immunologic factors|mesh-ancestor
6731798|NCT01906671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731799|NCT01906671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6731800|NCT01906671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6785529|NCT02208778|Remifentanil|remifentanil|mesh-list
6785530|NCT02208778|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6785531|NCT02208778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6785532|NCT02208778|Narcotics|narcotics|mesh-ancestor
6785533|NCT02208778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6785534|NCT02208778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785535|NCT02208778|Analgesics|analgesics|mesh-ancestor
6785536|NCT02208778|Sensory System Agents|sensory system agents|mesh-ancestor
6785537|NCT02208778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6785538|NCT02208778|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6785539|NCT02208778|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6785540|NCT02208778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6785541|NCT02208778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785542|NCT02208778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6785543|NCT02208778|Antidepressive Agents|antidepressive agents|mesh-ancestor
6785544|NCT02208778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6785545|NCT02208778|Dopamine Agents|dopamine agents|mesh-ancestor
6785546|NCT02208791|Sirolimus|sirolimus|mesh-list
6785547|NCT02208791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6785548|NCT02208791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6785549|NCT02208791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6785550|NCT02208791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6785551|NCT02208791|Antifungal Agents|antifungal agents|mesh-ancestor
6785552|NCT02208791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6785553|NCT02208791|Immunologic Factors|immunologic factors|mesh-ancestor
6785554|NCT02208791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731801|NCT01906749|Colchicine|colchicine|mesh-list
6731802|NCT01906749|Gout Suppressants|gout suppressants|mesh-ancestor
6731803|NCT01906749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6731804|NCT01906749|Tubulin Modulators|tubulin modulators|mesh-ancestor
6731805|NCT01906749|Antimitotic Agents|antimitotic agents|mesh-ancestor
6731806|NCT01906749|Mitosis Modulators|mitosis modulators|mesh-ancestor
6731807|NCT01906749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731808|NCT01906749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6731809|NCT01906762|Acetaminophen|acetaminophen|mesh-list
6731810|NCT01906762|Morphine|morphine|mesh-list
6731811|NCT01906762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6731812|NCT01906762|Narcotics|narcotics|mesh-ancestor
6731813|NCT01906762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6731814|NCT01906762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731815|NCT01906762|Analgesics|analgesics|mesh-ancestor
6731816|NCT01906762|Sensory System Agents|sensory system agents|mesh-ancestor
6731817|NCT01906762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6731818|NCT01906762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6731819|NCT01906762|Antipyretics|antipyretics|mesh-ancestor
6731820|NCT01906788|Lumefantrine|lumefantrine|mesh-list
6731821|NCT01906788|Artemether|artemether|mesh-list
6731822|NCT01906788|Primaquine|primaquine|mesh-list
6731823|NCT01906788|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6731824|NCT01906788|Antimalarials|antimalarials|mesh-ancestor
6731825|NCT01906788|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6731826|NCT01906788|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6731827|NCT01906788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6731828|NCT01906801|Diacetylrhein|diacetylrhein|mesh-list
6731829|NCT01906801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6731830|NCT01906814|Carboplatin|carboplatin|mesh-list
6731831|NCT01906814|Etoposide|etoposide|mesh-list
6731832|NCT01906814|Etoposide phosphate|etoposide phosphate|mesh-list
6731833|NCT01906814|Vincristine|vincristine|mesh-list
6731834|NCT01906814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6731835|NCT01906814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6731836|NCT01906814|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6731837|NCT01906814|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6731838|NCT01906814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6731839|NCT01906814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731840|NCT01906814|Tubulin Modulators|tubulin modulators|mesh-ancestor
6731841|NCT01906814|Antimitotic Agents|antimitotic agents|mesh-ancestor
6731842|NCT01906814|Mitosis Modulators|mitosis modulators|mesh-ancestor
6731843|NCT01906853|Vaccines|vaccines|mesh-list
6731844|NCT01906853|BCG Vaccine|bcg vaccine|mesh-list
6731845|NCT01906853|Immunologic Factors|immunologic factors|mesh-ancestor
6731846|NCT01906853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731847|NCT01906853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6731848|NCT01906879|Bismuth|bismuth|mesh-list
6731849|NCT01906879|Antacids|antacids|mesh-ancestor
6731850|NCT01906879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731851|NCT01906879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6731852|NCT01906944|Triamcinolone|triamcinolone|mesh-list
6731853|NCT01906944|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6731854|NCT01906944|Bupivacaine|bupivacaine|mesh-list
6731855|NCT01906944|Anesthetics, Local|anesthetics, local|mesh-ancestor
6731856|NCT01906944|Anesthetics|anesthetics|mesh-ancestor
6731857|NCT01906944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6731858|NCT01906944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731859|NCT01906944|Sensory System Agents|sensory system agents|mesh-ancestor
6731860|NCT01906944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6731861|NCT01906944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6731862|NCT01906944|Glucocorticoids|glucocorticoids|mesh-ancestor
6731863|NCT01906944|Hormones|hormones|mesh-ancestor
6731864|NCT01906944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6731865|NCT01906944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6731866|NCT01906944|Immunologic Factors|immunologic factors|mesh-ancestor
6731867|NCT01907009|Melphalan|melphalan|mesh-list
6731868|NCT01907009|Lenograstim|lenograstim|mesh-list
6731869|NCT01907009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6731870|NCT01907009|Alkylating Agents|alkylating agents|mesh-ancestor
6731871|NCT01907009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731872|NCT01907009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6731873|NCT01907009|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6731874|NCT01907009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6731875|NCT01907009|Immunologic Factors|immunologic factors|mesh-ancestor
6731876|NCT01907009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731877|NCT01907009|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6731878|NCT01907048|Rivaroxaban|rivaroxaban|mesh-list
6731879|NCT01907048|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6731880|NCT01907048|Antithrombins|antithrombins|mesh-ancestor
6731881|NCT01907048|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6731882|NCT01907048|Protease Inhibitors|protease inhibitors|mesh-ancestor
6731883|NCT01907048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6731884|NCT01907048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731885|NCT01907048|Anticoagulants|anticoagulants|mesh-ancestor
6731886|NCT01907061|Acetylcysteine|acetylcysteine|mesh-list
6731887|NCT01907061|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6731888|NCT01907061|Antiviral Agents|antiviral agents|mesh-ancestor
6731889|NCT01907061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6731890|NCT01907061|Expectorants|expectorants|mesh-ancestor
6731891|NCT01907061|Respiratory System Agents|respiratory system agents|mesh-ancestor
6731892|NCT01907061|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6731893|NCT01907061|Antioxidants|antioxidants|mesh-ancestor
6731894|NCT01907061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731895|NCT01907061|Protective Agents|protective agents|mesh-ancestor
6731896|NCT01907061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731897|NCT01907061|Antidotes|antidotes|mesh-ancestor
6731898|NCT01907165|Copper|copper|mesh-list
6731899|NCT01907165|Temozolomide|temozolomide|mesh-list
6731900|NCT01907165|Disulfiram|disulfiram|mesh-list
6731901|NCT01907165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6731902|NCT01907165|Alkylating Agents|alkylating agents|mesh-ancestor
6731903|NCT01907165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731904|NCT01907165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6731905|NCT01907165|Trace Elements|trace elements|mesh-ancestor
6731906|NCT01907165|Micronutrients|micronutrients|mesh-ancestor
6731907|NCT01907165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731908|NCT01907165|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6731909|NCT01907165|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
6731910|NCT01907165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6731911|NCT01907191|Bupivacaine|bupivacaine|mesh-list
6731912|NCT01907191|Anesthetics, Local|anesthetics, local|mesh-ancestor
6731913|NCT01907191|Anesthetics|anesthetics|mesh-ancestor
6731914|NCT01907191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6731915|NCT01907191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731916|NCT01907191|Sensory System Agents|sensory system agents|mesh-ancestor
6731917|NCT01907191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6731918|NCT01907204|Methylprednisolone|methylprednisolone|mesh-list
6731919|NCT01907204|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6731920|NCT01907204|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6731921|NCT01907204|Prednisolone|prednisolone|mesh-list
6731922|NCT01907204|Prednisolone acetate|prednisolone acetate|mesh-list
6731923|NCT01907204|Budesonide|budesonide|mesh-list
6731924|NCT01907204|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6731925|NCT01907204|Prednisolone phosphate|prednisolone phosphate|mesh-list
6731926|NCT01907204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6731927|NCT01907204|Antiemetics|antiemetics|mesh-ancestor
6731928|NCT01907204|Autonomic Agents|autonomic agents|mesh-ancestor
6731929|NCT01907204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6731930|NCT01907204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731931|NCT01907204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6731932|NCT01907204|Glucocorticoids|glucocorticoids|mesh-ancestor
6731933|NCT01907204|Hormones|hormones|mesh-ancestor
6731934|NCT01907204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6731935|NCT01907204|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6731936|NCT01907204|Protective Agents|protective agents|mesh-ancestor
6731937|NCT01907204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6731938|NCT01907204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6731939|NCT01907204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6731940|NCT01907204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6731941|NCT01907204|Respiratory System Agents|respiratory system agents|mesh-ancestor
6731942|NCT01907230|Entecavir|entecavir|mesh-list
6731943|NCT01907230|Antiviral Agents|antiviral agents|mesh-ancestor
6731944|NCT01907230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6731945|NCT01907308|Docetaxel|docetaxel|mesh-list
6731946|NCT01907308|Trebananib|trebananib|mesh-list
6731947|NCT01907308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6731948|NCT01907308|Tubulin Modulators|tubulin modulators|mesh-ancestor
6731949|NCT01907308|Antimitotic Agents|antimitotic agents|mesh-ancestor
6731950|NCT01907308|Mitosis Modulators|mitosis modulators|mesh-ancestor
6731951|NCT01907308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731952|NCT01907308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6731953|NCT01907308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6731954|NCT01907308|Growth Substances|growth substances|mesh-ancestor
6731955|NCT01907308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731956|NCT01907308|Growth Inhibitors|growth inhibitors|mesh-ancestor
6731957|NCT01907373|Probenecid|probenecid|mesh-list
6731958|NCT01907373|Olmesartan|olmesartan|mesh-list
6731959|NCT01907373|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
6731960|NCT01907373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6731961|NCT01907373|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6731962|NCT01907373|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6731963|NCT01907373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731964|NCT01907373|Uricosuric Agents|uricosuric agents|mesh-ancestor
6731965|NCT01907373|Gout Suppressants|gout suppressants|mesh-ancestor
6731966|NCT01907373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6731967|NCT01907373|Renal Agents|renal agents|mesh-ancestor
6731968|NCT01907529|Cyclophosphamide|cyclophosphamide|mesh-list
6731969|NCT01907529|Docetaxel|docetaxel|mesh-list
6731970|NCT01907529|Epirubicin|epirubicin|mesh-list
6731971|NCT01907529|Endostar protein|endostar protein|mesh-list
6731972|NCT01907529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6731973|NCT01907529|Immunologic Factors|immunologic factors|mesh-ancestor
6731974|NCT01907529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731975|NCT01907529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6731976|NCT01907529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6731977|NCT01907529|Alkylating Agents|alkylating agents|mesh-ancestor
6731978|NCT01907529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6731979|NCT01907529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6731980|NCT01907529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6731981|NCT01907529|Tubulin Modulators|tubulin modulators|mesh-ancestor
6731982|NCT01907529|Antimitotic Agents|antimitotic agents|mesh-ancestor
6731983|NCT01907529|Mitosis Modulators|mitosis modulators|mesh-ancestor
6731984|NCT01907529|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6731985|NCT01907529|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6731986|NCT01907529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6731987|NCT01907529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6731988|NCT01907529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6731989|NCT01907529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6731990|NCT01907529|Growth Substances|growth substances|mesh-ancestor
6731991|NCT01907529|Growth Inhibitors|growth inhibitors|mesh-ancestor
6731992|NCT01907594|Cycloserine|cycloserine|mesh-list
6731993|NCT01907594|Nicotine|nicotine|mesh-list
6731994|NCT01907594|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6731995|NCT01907594|Autonomic Agents|autonomic agents|mesh-ancestor
6731996|NCT01907594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6731997|NCT01907594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6731998|NCT01907594|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6731999|NCT01907594|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6732000|NCT01907594|Cholinergic Agents|cholinergic agents|mesh-ancestor
6732001|NCT01907594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6732002|NCT01907594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732003|NCT01907594|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6732004|NCT01907594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6732005|NCT01907594|Renal Agents|renal agents|mesh-ancestor
6732006|NCT01907594|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6732007|NCT01907594|Antitubercular Agents|antitubercular agents|mesh-ancestor
6732008|NCT01907594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6732009|NCT01907594|Antimetabolites|antimetabolites|mesh-ancestor
6732010|NCT01907633|Domperidone|domperidone|mesh-list
6732011|NCT01907633|Antiemetics|antiemetics|mesh-ancestor
6732012|NCT01907633|Autonomic Agents|autonomic agents|mesh-ancestor
6732013|NCT01907633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6732014|NCT01907633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732015|NCT01907633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6732016|NCT01907633|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6732017|NCT01907633|Dopamine Agents|dopamine agents|mesh-ancestor
6732018|NCT01907633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6732019|NCT01907633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732020|NCT01907685|Docetaxel|docetaxel|mesh-list
6732021|NCT01907685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6732022|NCT01907685|Tubulin Modulators|tubulin modulators|mesh-ancestor
6732023|NCT01907685|Antimitotic Agents|antimitotic agents|mesh-ancestor
6732024|NCT01907685|Mitosis Modulators|mitosis modulators|mesh-ancestor
6732025|NCT01907685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732026|NCT01907724|Simeprevir|simeprevir|mesh-list
6732027|NCT01907724|Antiviral Agents|antiviral agents|mesh-ancestor
6732028|NCT01907724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6732029|NCT01907724|Protease Inhibitors|protease inhibitors|mesh-ancestor
6732030|NCT01907724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6732031|NCT01907724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732032|NCT01907776|Arbekacin|arbekacin|mesh-list
6732033|NCT01907776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6732034|NCT01907776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6732035|NCT01907802|Dabrafenib|dabrafenib|mesh-list
6732036|NCT01907802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6732037|NCT01907802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6732038|NCT01907802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6732039|NCT01907802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732040|NCT01907867|Finafloxacin|finafloxacin|mesh-list
6732041|NCT01907867|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6732042|NCT01907867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6732043|NCT01907867|Renal Agents|renal agents|mesh-ancestor
6732044|NCT01907867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6732045|NCT01907867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6732046|NCT01907867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6732047|NCT01907867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6732048|NCT01907867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732049|NCT01907867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6732050|NCT01907880|Zoledronic Acid|zoledronic acid|mesh-list
6732051|NCT01907880|Pamidronate|pamidronate|mesh-list
6732052|NCT01907880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6732053|NCT01907880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732054|NCT01907984|Diclofenac|diclofenac|mesh-list
6732055|NCT01907984|Midazolam|midazolam|mesh-list
6732056|NCT01907984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6732057|NCT01907984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6732058|NCT01907984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6732059|NCT01907984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732060|NCT01907984|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6732061|NCT01907984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6732062|NCT01907984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6732063|NCT01907984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6732064|NCT01907984|Anesthetics, General|anesthetics, general|mesh-ancestor
6732065|NCT01907984|Anesthetics|anesthetics|mesh-ancestor
6732066|NCT01907984|GABA Modulators|gaba modulators|mesh-ancestor
6732067|NCT01907984|GABA Agents|gaba agents|mesh-ancestor
6732068|NCT01907984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6732069|NCT01907984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732070|NCT01907984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6732071|NCT01907984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6732072|NCT01907984|Analgesics|analgesics|mesh-ancestor
6732073|NCT01907984|Sensory System Agents|sensory system agents|mesh-ancestor
6732074|NCT01907984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6732075|NCT01907984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6732076|NCT01907984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6732077|NCT01907984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6732078|NCT01907984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6732079|NCT01907997|Lidocaine|lidocaine|mesh-list
6732080|NCT01907997|Anesthetics, Local|anesthetics, local|mesh-ancestor
6732081|NCT01907997|Anesthetics|anesthetics|mesh-ancestor
6732082|NCT01907997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6732083|NCT01907997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732084|NCT01907997|Sensory System Agents|sensory system agents|mesh-ancestor
6732085|NCT01907997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6732086|NCT01907997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6732087|NCT01907997|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6732088|NCT01907997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6732089|NCT01907997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6732090|NCT01907997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732091|NCT01908075|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6732092|NCT01908075|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6732093|NCT01908075|Autonomic Agents|autonomic agents|mesh-ancestor
6732094|NCT01908075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6732095|NCT01908075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732096|NCT01908075|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6732097|NCT01908075|Respiratory System Agents|respiratory system agents|mesh-ancestor
6732098|NCT01908075|Glucocorticoids|glucocorticoids|mesh-ancestor
6732099|NCT01908075|Hormones|hormones|mesh-ancestor
6732100|NCT01908075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6732101|NCT01908075|Sympathomimetics|sympathomimetics|mesh-ancestor
6732102|NCT01908114|Vaccines|vaccines|mesh-list
6732103|NCT01908114|Immunologic Factors|immunologic factors|mesh-ancestor
6732104|NCT01908114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732105|NCT01908257|Lesinurad|lesinurad|mesh-list
6732106|NCT01908257|Ranitidine|ranitidine|mesh-list
6732107|NCT01908257|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
6732108|NCT01908257|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6732109|NCT01908257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6732110|NCT01908257|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6732111|NCT01908257|Histamine Antagonists|histamine antagonists|mesh-ancestor
6732112|NCT01908257|Histamine Agents|histamine agents|mesh-ancestor
6732113|NCT01908257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6732114|NCT01908257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732115|NCT01908257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732116|NCT01908257|Gout Suppressants|gout suppressants|mesh-ancestor
6732117|NCT01908257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6732118|NCT01908257|Uricosuric Agents|uricosuric agents|mesh-ancestor
6732119|NCT01908257|Renal Agents|renal agents|mesh-ancestor
6732120|NCT01908283|Vaccines|vaccines|mesh-list
6732121|NCT01908283|Immunologic Factors|immunologic factors|mesh-ancestor
6732122|NCT01908283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732123|NCT01908296|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6732124|NCT01908296|Fluvoxamine|fluvoxamine|mesh-list
6732125|NCT01908296|Antidepressive Agents|antidepressive agents|mesh-ancestor
6732126|NCT01908296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6732127|NCT01908296|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6732128|NCT01908296|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6732129|NCT01908296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6732130|NCT01908296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732131|NCT01908296|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6732132|NCT01908296|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6732133|NCT01908296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6732134|NCT01908296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6732135|NCT01908296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732136|NCT01908296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6732137|NCT01908296|Serotonin Agents|serotonin agents|mesh-ancestor
6732138|NCT01908296|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6732139|NCT01908296|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6732140|NCT01908296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6732141|NCT01908296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6732142|NCT01908296|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6785555|NCT02208882|Midazolam|midazolam|mesh-list
6785556|NCT02208882|BMS-986120|bms-986120|mesh-list
6785557|NCT02208882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6785558|NCT02208882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6785559|NCT02208882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6785560|NCT02208882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785561|NCT02208882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6785562|NCT02208882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6785563|NCT02208882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6785564|NCT02208882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6785565|NCT02208882|Anesthetics, General|anesthetics, general|mesh-ancestor
6785566|NCT02208882|Anesthetics|anesthetics|mesh-ancestor
6785567|NCT02208882|GABA Modulators|gaba modulators|mesh-ancestor
6785568|NCT02208882|GABA Agents|gaba agents|mesh-ancestor
6785569|NCT02208882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6785570|NCT02208882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785571|NCT02208882|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6785572|NCT02208986|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6785573|NCT02208986|Luteolytic Agents|luteolytic agents|mesh-ancestor
6785574|NCT02208986|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6785575|NCT02208986|Contraceptive Agents|contraceptive agents|mesh-ancestor
6785576|NCT02208986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6785577|NCT02208986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785578|NCT02208986|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6785579|NCT02208986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6785580|NCT02208986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6785581|NCT02209012|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6785582|NCT02209012|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6785583|NCT02209012|Dermatologic Agents|dermatologic agents|mesh-ancestor
6785584|NCT02209025|Theobromine|theobromine|mesh-list
6785585|NCT02209025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6785586|NCT02209025|Autonomic Agents|autonomic agents|mesh-ancestor
6785587|NCT02209025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6785588|NCT02209025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785589|NCT02209025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6785590|NCT02209025|Respiratory System Agents|respiratory system agents|mesh-ancestor
6785591|NCT02209025|Vasodilator Agents|vasodilator agents|mesh-ancestor
6785592|NCT02209155|Verapamil|verapamil|mesh-list
6785593|NCT02209155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6785594|NCT02209155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6785595|NCT02209155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6785596|NCT02209155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785597|NCT02209155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6785598|NCT02209155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785599|NCT02209155|Vasodilator Agents|vasodilator agents|mesh-ancestor
6785600|NCT02209350|Aspirin|aspirin|mesh-list
6785601|NCT02209350|Clopidogrel|clopidogrel|mesh-list
6785602|NCT02209350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6785603|NCT02209350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6785604|NCT02209350|Analgesics|analgesics|mesh-ancestor
6732143|NCT01908322|Sorafenib|sorafenib|mesh-list
6732144|NCT01908322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6732145|NCT01908322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6732146|NCT01908322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6732147|NCT01908322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732148|NCT01908335|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6732149|NCT01908335|Interferon-alpha|interferon-alpha|mesh-list
6732150|NCT01908335|Antiviral Agents|antiviral agents|mesh-ancestor
6732151|NCT01908335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6732152|NCT01908335|Immunologic Factors|immunologic factors|mesh-ancestor
6732153|NCT01908335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732154|NCT01908348|Erythritol|erythritol|mesh-list
6732155|NCT01908348|Vasodilator Agents|vasodilator agents|mesh-ancestor
6732156|NCT01908387|Azacitidine|azacitidine|mesh-list
6732157|NCT01908387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6732158|NCT01908387|Antimetabolites|antimetabolites|mesh-ancestor
6732159|NCT01908387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732160|NCT01908387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6732161|NCT01908387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6732162|NCT01908452|Pyridoxine|pyridoxine|mesh-list
6732163|NCT01908452|Vitamin B Complex|vitamin b complex|mesh-ancestor
6732164|NCT01908452|Vitamins|vitamins|mesh-ancestor
6732165|NCT01908452|Micronutrients|micronutrients|mesh-ancestor
6732166|NCT01908452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732167|NCT01908465|Ebastine|ebastine|mesh-list
6732168|NCT01908465|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6732169|NCT01908465|Histamine Antagonists|histamine antagonists|mesh-ancestor
6732170|NCT01908465|Histamine Agents|histamine agents|mesh-ancestor
6732171|NCT01908465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6732172|NCT01908465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732173|NCT01908465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732174|NCT01908478|Gemcitabine|gemcitabine|mesh-list
6732175|NCT01908478|Veliparib|veliparib|mesh-list
6732176|NCT01908478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6732177|NCT01908478|Antimetabolites|antimetabolites|mesh-ancestor
6732178|NCT01908478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732179|NCT01908478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6732180|NCT01908478|Antiviral Agents|antiviral agents|mesh-ancestor
6732181|NCT01908478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6732182|NCT01908478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6732183|NCT01908478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6732184|NCT01908478|Immunologic Factors|immunologic factors|mesh-ancestor
6732185|NCT01908478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732186|NCT01908478|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6732187|NCT01908556|Letrozole|letrozole|mesh-list
6732188|NCT01908556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6732189|NCT01908556|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6732190|NCT01908556|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6732191|NCT01908556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6732192|NCT01908556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732193|NCT01908556|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6732194|NCT01908556|Hormone Antagonists|hormone antagonists|mesh-ancestor
6732195|NCT01908556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6732196|NCT01908556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732197|NCT01908621|Cytarabine|cytarabine|mesh-list
6732198|NCT01908621|Lenograstim|lenograstim|mesh-list
6732199|NCT01908621|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6732200|NCT01908621|Immunologic Factors|immunologic factors|mesh-ancestor
6732201|NCT01908621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732202|NCT01908621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6732203|NCT01908621|Antimetabolites|antimetabolites|mesh-ancestor
6732204|NCT01908621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732205|NCT01908621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6732206|NCT01908621|Antiviral Agents|antiviral agents|mesh-ancestor
6732207|NCT01908621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6732208|NCT01908621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6732209|NCT01908660|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6732210|NCT01908660|Antiviral Agents|antiviral agents|mesh-ancestor
6732211|NCT01908660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6732212|NCT01908777|Cytarabine|cytarabine|mesh-list
6732213|NCT01908777|Etoposide|etoposide|mesh-list
6732214|NCT01908777|Melphalan|melphalan|mesh-list
6732215|NCT01908777|Carmustine|carmustine|mesh-list
6732216|NCT01908777|Romidepsin|romidepsin|mesh-list
6732217|NCT01908777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6732218|NCT01908777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6732219|NCT01908777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6732220|NCT01908777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6732221|NCT01908777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6732222|NCT01908777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732223|NCT01908777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6732224|NCT01908777|Antimetabolites|antimetabolites|mesh-ancestor
6732225|NCT01908777|Antiviral Agents|antiviral agents|mesh-ancestor
6732226|NCT01908777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6732227|NCT01908777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6732228|NCT01908777|Immunologic Factors|immunologic factors|mesh-ancestor
6732229|NCT01908777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732230|NCT01908777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6732231|NCT01908777|Alkylating Agents|alkylating agents|mesh-ancestor
6732232|NCT01908777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6732233|NCT01908777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6732234|NCT01908894|Insulin Lispro|insulin lispro|mesh-list
6732235|NCT01908894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6732236|NCT01908894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732237|NCT01909037|Curcumin|curcumin|mesh-list
6732238|NCT01909037|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6732239|NCT01909037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6732240|NCT01909037|Analgesics|analgesics|mesh-ancestor
6732241|NCT01909037|Sensory System Agents|sensory system agents|mesh-ancestor
6732242|NCT01909037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6732243|NCT01909037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732244|NCT01909037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6732245|NCT01909037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6732246|NCT01909037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6732247|NCT01909037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6732248|NCT01909037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732249|NCT01909063|Vitamin D|vitamin d|mesh-list
6732250|NCT01909063|Ergocalciferols|ergocalciferols|mesh-list
6732251|NCT01909063|Vitamins|vitamins|mesh-list
6732252|NCT01909063|Vitamin E|vitamin e|mesh-list
6732253|NCT01909063|Vitamin A|vitamin a|mesh-list
6732254|NCT01909063|Micronutrients|micronutrients|mesh-ancestor
6732255|NCT01909063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732256|NCT01909063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6732257|NCT01909063|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6732258|NCT01909063|Antioxidants|antioxidants|mesh-ancestor
6732259|NCT01909063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732260|NCT01909063|Protective Agents|protective agents|mesh-ancestor
6732261|NCT01909089|Chloroprocaine|chloroprocaine|mesh-list
6732262|NCT01909089|Anesthetics, Local|anesthetics, local|mesh-ancestor
6732263|NCT01909089|Anesthetics|anesthetics|mesh-ancestor
6732264|NCT01909089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6732265|NCT01909089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732266|NCT01909089|Sensory System Agents|sensory system agents|mesh-ancestor
6732267|NCT01909089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6732268|NCT01909115|Vitamin D|vitamin d|mesh-list
6732269|NCT01909115|Ergocalciferols|ergocalciferols|mesh-list
6732270|NCT01909115|Cholecalciferol|cholecalciferol|mesh-list
6732271|NCT01909115|Vitamins|vitamins|mesh-list
6732272|NCT01909115|Micronutrients|micronutrients|mesh-ancestor
6732273|NCT01909115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732274|NCT01909115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6732275|NCT01909115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6732276|NCT01909219|Picosulfate sodium|picosulfate sodium|mesh-list
6732277|NCT01909219|Magnesium citrate|magnesium citrate|mesh-list
6732278|NCT01909219|Cathartics|cathartics|mesh-ancestor
6732279|NCT01909219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6732280|NCT01909557|Acetylcarnitine|acetylcarnitine|mesh-list
6732281|NCT01909557|Vitamin B Complex|vitamin b complex|mesh-ancestor
6732282|NCT01909557|Vitamins|vitamins|mesh-ancestor
6732283|NCT01909557|Micronutrients|micronutrients|mesh-ancestor
6732284|NCT01909557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732285|NCT01909557|Nootropic Agents|nootropic agents|mesh-ancestor
6732286|NCT01909622|Vitamin D|vitamin d|mesh-list
6732287|NCT01909622|Ergocalciferols|ergocalciferols|mesh-list
6732288|NCT01909622|Vitamins|vitamins|mesh-list
6732289|NCT01909622|Micronutrients|micronutrients|mesh-ancestor
6732290|NCT01909622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732291|NCT01909622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6732292|NCT01909622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6732293|NCT01909661|Caseins|caseins|mesh-list
6732294|NCT01909661|Chelating Agents|chelating agents|mesh-ancestor
6732295|NCT01909661|Sequestering Agents|sequestering agents|mesh-ancestor
6732296|NCT01909661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732297|NCT01909752|Cyclophosphamide|cyclophosphamide|mesh-list
6732298|NCT01909752|Imiquimod|imiquimod|mesh-list
6732299|NCT01909752|Vaccines|vaccines|mesh-list
6732300|NCT01909752|Immunologic Factors|immunologic factors|mesh-ancestor
6732301|NCT01909752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732302|NCT01909752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6732303|NCT01909752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6732304|NCT01909752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6732305|NCT01909752|Alkylating Agents|alkylating agents|mesh-ancestor
6732306|NCT01909752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732307|NCT01909752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6732308|NCT01909752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6732309|NCT01909752|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6732310|NCT01909752|Interferon Inducers|interferon inducers|mesh-ancestor
6732311|NCT01909830|Gemcitabine|gemcitabine|mesh-list
6732312|NCT01909830|Pemetrexed|pemetrexed|mesh-list
6732313|NCT01909830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6732314|NCT01909830|Antimetabolites|antimetabolites|mesh-ancestor
6732315|NCT01909830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732316|NCT01909830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6732317|NCT01909830|Antiviral Agents|antiviral agents|mesh-ancestor
6732318|NCT01909830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6732319|NCT01909830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6732320|NCT01909830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6732321|NCT01909830|Immunologic Factors|immunologic factors|mesh-ancestor
6732322|NCT01909830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732323|NCT01909830|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6732324|NCT01909830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6732325|NCT01909843|Gontivimab|gontivimab|mesh-list
6732326|NCT01909843|Antiviral Agents|antiviral agents|mesh-ancestor
6732327|NCT01909843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6732328|NCT01909856|Dexamethasone|dexamethasone|mesh-list
6732329|NCT01909856|Palonosetron|palonosetron|mesh-list
6732330|NCT01909856|Granisetron|granisetron|mesh-list
6732331|NCT01909856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6732332|NCT01909856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6732333|NCT01909856|Antiemetics|antiemetics|mesh-ancestor
6732334|NCT01909856|Autonomic Agents|autonomic agents|mesh-ancestor
6732335|NCT01909856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6732336|NCT01909856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732337|NCT01909856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6732338|NCT01909856|Glucocorticoids|glucocorticoids|mesh-ancestor
6732339|NCT01909856|Hormones|hormones|mesh-ancestor
6732340|NCT01909856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6732341|NCT01909856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6732342|NCT01909856|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6732343|NCT01909856|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6732344|NCT01909856|Serotonin Agents|serotonin agents|mesh-ancestor
6732345|NCT01909856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6732346|NCT01909856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732347|NCT01910077|Tacrolimus|tacrolimus|mesh-list
6732348|NCT01910077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6732349|NCT01910077|Immunologic Factors|immunologic factors|mesh-ancestor
6732350|NCT01910077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732351|NCT01910077|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6732352|NCT01910077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6732353|NCT01910077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732354|NCT01910090|Flurbiprofen|flurbiprofen|mesh-list
6732355|NCT01910090|Famotidine|famotidine|mesh-list
6732356|NCT01910090|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6732357|NCT01910090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6732358|NCT01910090|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6732359|NCT01910090|Histamine Antagonists|histamine antagonists|mesh-ancestor
6732360|NCT01910090|Histamine Agents|histamine agents|mesh-ancestor
6732361|NCT01910090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6732362|NCT01910090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732363|NCT01910090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732364|NCT01910090|Analgesics|analgesics|mesh-ancestor
6732365|NCT01910090|Sensory System Agents|sensory system agents|mesh-ancestor
6732366|NCT01910090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6732367|NCT01910090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6732368|NCT01910090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6732369|NCT01910090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6732370|NCT01910090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6732371|NCT01910090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6732372|NCT01910090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6732373|NCT01910142|Vitamin K|vitamin k|mesh-list
6732374|NCT01910142|Calcium|calcium|mesh-list
6732375|NCT01910142|Vitamins|vitamins|mesh-ancestor
6732376|NCT01910142|Micronutrients|micronutrients|mesh-ancestor
6732377|NCT01910142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732378|NCT01910142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6732379|NCT01910142|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6732380|NCT01910142|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6732381|NCT01910142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732382|NCT01910142|Hemostatics|hemostatics|mesh-ancestor
6732383|NCT01910142|Coagulants|coagulants|mesh-ancestor
6732384|NCT01910155|Ciprofloxacin|ciprofloxacin|mesh-list
6732385|NCT01910155|Dexamethasone|dexamethasone|mesh-list
6732386|NCT01910155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6732387|NCT01910155|Antiemetics|antiemetics|mesh-ancestor
6732388|NCT01910155|Autonomic Agents|autonomic agents|mesh-ancestor
6732389|NCT01910155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6732390|NCT01910155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732391|NCT01910155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6732392|NCT01910155|Glucocorticoids|glucocorticoids|mesh-ancestor
6732393|NCT01910155|Hormones|hormones|mesh-ancestor
6732394|NCT01910155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6732395|NCT01910155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6732396|NCT01910155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6732397|NCT01910155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6732398|NCT01910155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6732399|NCT01910155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6732400|NCT01910155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6732401|NCT01910155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6732402|NCT01910155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732403|NCT01910155|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6732404|NCT01910155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6785605|NCT02209350|Sensory System Agents|sensory system agents|mesh-ancestor
6785606|NCT02209350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6785607|NCT02209350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785608|NCT02209350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6785609|NCT02209350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6785610|NCT02209350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6785611|NCT02209350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6785612|NCT02209350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785613|NCT02209350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6785614|NCT02209350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6785615|NCT02209350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6732405|NCT01910194|Insulin Glargine|insulin glargine|mesh-list
6732406|NCT01910194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6732407|NCT01910194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732408|NCT01910246|Metformin|metformin|mesh-list
6732409|NCT01910246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6732410|NCT01910246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732411|NCT01910259|Amiloride|amiloride|mesh-list
6732412|NCT01910259|Riluzole|riluzole|mesh-list
6732413|NCT01910259|Fluoxetine|fluoxetine|mesh-list
6732414|NCT01910259|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6732415|NCT01910259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6732416|NCT01910259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6785616|NCT02209350|Antipyretics|antipyretics|mesh-ancestor
6785617|NCT02209350|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6785618|NCT02209350|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6785619|NCT02209350|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6785620|NCT02209350|Purinergic Agents|purinergic agents|mesh-ancestor
6785621|NCT02209350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6785622|NCT02209428|Temozolomide|temozolomide|mesh-list
6785623|NCT02209428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6785624|NCT02209428|Alkylating Agents|alkylating agents|mesh-ancestor
6785625|NCT02209428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785626|NCT02209428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6785627|NCT02209441|Sorafenib|sorafenib|mesh-list
6785628|NCT02209441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6785629|NCT02209441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6732417|NCT01910259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732418|NCT01910259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6732419|NCT01910259|Serotonin Agents|serotonin agents|mesh-ancestor
6732420|NCT01910259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732421|NCT01910259|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6732422|NCT01910259|Antidepressive Agents|antidepressive agents|mesh-ancestor
6732423|NCT01910259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6732424|NCT01910259|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6732425|NCT01910259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6732426|NCT01910259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6732427|NCT01910259|Anticonvulsants|anticonvulsants|mesh-ancestor
6732428|NCT01910259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6732429|NCT01910259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6732430|NCT01910259|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6732431|NCT01910259|Protective Agents|protective agents|mesh-ancestor
6732432|NCT01910259|Diuretics|diuretics|mesh-ancestor
6732433|NCT01910259|Natriuretic Agents|natriuretic agents|mesh-ancestor
6732434|NCT01910259|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
6732435|NCT01910259|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6732436|NCT01910259|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
6732437|NCT01910259|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6732438|NCT01910285|Sufentanil|sufentanil|mesh-list
6732439|NCT01910285|Dsuvia|dsuvia|mesh-list
6732440|NCT01910285|Remifentanil|remifentanil|mesh-list
6732441|NCT01910285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6732442|NCT01910285|Narcotics|narcotics|mesh-ancestor
6732443|NCT01910285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6732444|NCT01910285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732445|NCT01910285|Analgesics|analgesics|mesh-ancestor
6732446|NCT01910285|Sensory System Agents|sensory system agents|mesh-ancestor
6732447|NCT01910285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6732448|NCT01910285|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6732449|NCT01910285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6732450|NCT01910285|Anesthetics, General|anesthetics, general|mesh-ancestor
6732451|NCT01910285|Anesthetics|anesthetics|mesh-ancestor
6732452|NCT01910363|Botulinum Toxins|botulinum toxins|mesh-list
6732453|NCT01910363|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6732454|NCT01910363|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6732455|NCT01910363|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6732456|NCT01910363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6732457|NCT01910363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732458|NCT01910363|Cholinergic Agents|cholinergic agents|mesh-ancestor
6732459|NCT01910363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6732460|NCT01910363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732461|NCT01910363|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6732462|NCT01910363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6732463|NCT01910415|Moxifloxacin|moxifloxacin|mesh-list
6732464|NCT01910415|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6732465|NCT01910415|Ivacaftor|ivacaftor|mesh-list
6732466|NCT01910415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6732467|NCT01910415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6732468|NCT01910415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6732469|NCT01910415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6732470|NCT01910415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6732471|NCT01910415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732472|NCT01910415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6732473|NCT01910415|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6732474|NCT01910415|Contraceptive Agents|contraceptive agents|mesh-ancestor
6732475|NCT01910415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6732476|NCT01910415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732477|NCT01910415|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6732478|NCT01910415|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6732479|NCT01910415|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6732480|NCT01910415|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6732481|NCT01910415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6732482|NCT01910428|Asparaginase|asparaginase|mesh-list
6732483|NCT01910428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6732484|NCT01910480|Ketoconazole|ketoconazole|mesh-list
6732485|NCT01910480|Antifungal Agents|antifungal agents|mesh-ancestor
6732486|NCT01910480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6732487|NCT01910480|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6732488|NCT01910480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6732489|NCT01910480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6785630|NCT02209441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6732490|NCT01910480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732491|NCT01910480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6732492|NCT01910480|Hormone Antagonists|hormone antagonists|mesh-ancestor
6732493|NCT01910480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6732494|NCT01910480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732495|NCT01910480|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6732496|NCT01910506|Verinurad|verinurad|mesh-list
6732497|NCT01910506|Gout Suppressants|gout suppressants|mesh-ancestor
6732498|NCT01910506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6732499|NCT01910532|Clevidipine|clevidipine|mesh-list
6732500|NCT01910532|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6732501|NCT01910532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6732502|NCT01910532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732503|NCT01910532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6732504|NCT01910532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732505|NCT01910545|OTS167|ots167|mesh-list
6732506|NCT01910545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6732507|NCT01910545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6732508|NCT01910545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732509|NCT01910610|Bevacizumab|bevacizumab|mesh-list
6732510|NCT01910610|Cetuximab|cetuximab|mesh-list
6732511|NCT01910610|Panitumumab|panitumumab|mesh-list
6732512|NCT01910610|Irinotecan|irinotecan|mesh-list
6732513|NCT01910610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6732514|NCT01910610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6732515|NCT01910610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6732516|NCT01910610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6732517|NCT01910610|Growth Substances|growth substances|mesh-ancestor
6732518|NCT01910610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732519|NCT01910610|Growth Inhibitors|growth inhibitors|mesh-ancestor
6732520|NCT01910610|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6732521|NCT01910610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6732522|NCT01910610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6732523|NCT01910610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732524|NCT01910766|Ubiquinone|ubiquinone|mesh-list
6732525|NCT01910766|Coenzyme Q10|coenzyme q10|mesh-list
6732526|NCT01910766|Clomiphene|clomiphene|mesh-list
6732527|NCT01910766|Enclomiphene|enclomiphene|mesh-list
6732528|NCT01910766|Zuclomiphene|zuclomiphene|mesh-list
6732529|NCT01910766|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6732530|NCT01910766|Hormone Antagonists|hormone antagonists|mesh-ancestor
6732531|NCT01910766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6732532|NCT01910766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732533|NCT01910766|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6732534|NCT01910766|Fertility Agents|fertility agents|mesh-ancestor
6732535|NCT01910766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6732536|NCT01910766|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6732537|NCT01910766|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6732538|NCT01910766|Micronutrients|micronutrients|mesh-ancestor
6732539|NCT01910766|Vitamins|vitamins|mesh-ancestor
6732540|NCT01910844|Cyclophosphamide|cyclophosphamide|mesh-list
6732541|NCT01910844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6732542|NCT01910844|Immunologic Factors|immunologic factors|mesh-ancestor
6732543|NCT01910844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732544|NCT01910844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6732545|NCT01910844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6732546|NCT01910844|Alkylating Agents|alkylating agents|mesh-ancestor
6732547|NCT01910844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732548|NCT01910844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6732549|NCT01910844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6732550|NCT01910870|Cyclophosphamide|cyclophosphamide|mesh-list
6732551|NCT01910870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6732552|NCT01910870|Immunologic Factors|immunologic factors|mesh-ancestor
6732553|NCT01910870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732554|NCT01910870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6732555|NCT01910870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6732556|NCT01910870|Alkylating Agents|alkylating agents|mesh-ancestor
6732557|NCT01910870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732558|NCT01910870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6732559|NCT01910870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6732560|NCT01910883|Finafloxacin|finafloxacin|mesh-list
6732561|NCT01910883|Fluoroquinolones|fluoroquinolones|mesh-list
6732562|NCT01910883|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6732563|NCT01910883|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6732564|NCT01910883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6732565|NCT01910883|Renal Agents|renal agents|mesh-ancestor
6732566|NCT01910883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6732567|NCT01910883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6732568|NCT01910883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6732569|NCT01910883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6732570|NCT01910883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732571|NCT01910883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6732572|NCT01910883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6732573|NCT01910987|Dexamethasone|dexamethasone|mesh-list
6732574|NCT01910987|Dexamethasone acetate|dexamethasone acetate|mesh-list
6732575|NCT01910987|Bortezomib|bortezomib|mesh-list
6732576|NCT01910987|BB 1101|bb 1101|mesh-list
6732577|NCT01910987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6732578|NCT01910987|Antiemetics|antiemetics|mesh-ancestor
6732579|NCT01910987|Autonomic Agents|autonomic agents|mesh-ancestor
6732580|NCT01910987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6732581|NCT01910987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732582|NCT01910987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6732583|NCT01910987|Glucocorticoids|glucocorticoids|mesh-ancestor
6732584|NCT01910987|Hormones|hormones|mesh-ancestor
6732585|NCT01910987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6732586|NCT01910987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6732587|NCT01910987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6732588|NCT01910987|Protease Inhibitors|protease inhibitors|mesh-ancestor
6732589|NCT01910987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6732590|NCT01910987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732591|NCT01911195|Isoflurane|isoflurane|mesh-list
6732592|NCT01911195|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6732593|NCT01911195|Anesthetics, General|anesthetics, general|mesh-ancestor
6732594|NCT01911195|Anesthetics|anesthetics|mesh-ancestor
6732595|NCT01911195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6732596|NCT01911195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732597|NCT01911234|Freund's Adjuvant|freund's adjuvant|mesh-list
6732598|NCT01911234|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6732599|NCT01911234|Immunologic Factors|immunologic factors|mesh-ancestor
6732600|NCT01911234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732601|NCT01911247|Metformin|metformin|mesh-list
6732602|NCT01911247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6732603|NCT01911247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732604|NCT01911299|Choline|choline|mesh-list
6732605|NCT01911299|Glycerol|glycerol|mesh-list
6732606|NCT01911299|Lipotropic Agents|lipotropic agents|mesh-ancestor
6732607|NCT01911299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6732608|NCT01911299|Antimetabolites|antimetabolites|mesh-ancestor
6732609|NCT01911299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732610|NCT01911299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6732611|NCT01911299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6732612|NCT01911299|Nootropic Agents|nootropic agents|mesh-ancestor
6732613|NCT01911299|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6732614|NCT01911299|Protective Agents|protective agents|mesh-ancestor
6732615|NCT01911299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732616|NCT01911325|Docetaxel|docetaxel|mesh-list
6732617|NCT01911325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6732618|NCT01911325|Tubulin Modulators|tubulin modulators|mesh-ancestor
6732619|NCT01911325|Antimitotic Agents|antimitotic agents|mesh-ancestor
6732620|NCT01911325|Mitosis Modulators|mitosis modulators|mesh-ancestor
6732621|NCT01911325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732622|NCT01911364|Tiotropium Bromide|tiotropium bromide|mesh-list
6732623|NCT01911364|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6732624|NCT01911364|Autonomic Agents|autonomic agents|mesh-ancestor
6732625|NCT01911364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6732626|NCT01911364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732627|NCT01911364|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6732628|NCT01911364|Respiratory System Agents|respiratory system agents|mesh-ancestor
6732629|NCT01911364|Parasympatholytics|parasympatholytics|mesh-ancestor
6732630|NCT01911364|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6732631|NCT01911364|Cholinergic Agents|cholinergic agents|mesh-ancestor
6732632|NCT01911364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6732633|NCT01911364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732634|NCT01911377|Botulinum Toxins|botulinum toxins|mesh-list
6732635|NCT01911377|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6732636|NCT01911377|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6732637|NCT01911377|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6732638|NCT01911377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6732639|NCT01911377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732640|NCT01911377|Cholinergic Agents|cholinergic agents|mesh-ancestor
6732641|NCT01911377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6732642|NCT01911377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732643|NCT01911377|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6732644|NCT01911377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6732645|NCT01911455|Acamprosate|acamprosate|mesh-list
6732646|NCT01911455|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6732647|NCT01911468|Metformin|metformin|mesh-list
6732648|NCT01911468|Liraglutide|liraglutide|mesh-list
6732649|NCT01911468|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6732650|NCT01911468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6732651|NCT01911468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732652|NCT01911468|Incretins|incretins|mesh-ancestor
6732653|NCT01911468|Hormones|hormones|mesh-ancestor
6732654|NCT01911468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6732655|NCT01911494|Magnesium Sulfate|magnesium sulfate|mesh-list
6732656|NCT01911494|Methyldopa|methyldopa|mesh-list
6732657|NCT01911494|Analgesics|analgesics|mesh-ancestor
6732658|NCT01911494|Sensory System Agents|sensory system agents|mesh-ancestor
6732659|NCT01911494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6732660|NCT01911494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732661|NCT01911494|Anesthetics|anesthetics|mesh-ancestor
6732662|NCT01911494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6732663|NCT01911494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6732664|NCT01911494|Anticonvulsants|anticonvulsants|mesh-ancestor
6732665|NCT01911494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6732666|NCT01911494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6732667|NCT01911494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732668|NCT01911494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6732669|NCT01911494|Tocolytic Agents|tocolytic agents|mesh-ancestor
6732670|NCT01911494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6732671|NCT01911494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6732672|NCT01911494|Sympatholytics|sympatholytics|mesh-ancestor
6732673|NCT01911494|Autonomic Agents|autonomic agents|mesh-ancestor
6732674|NCT01911494|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6732675|NCT01911494|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6732676|NCT01911494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6732677|NCT01911494|Adrenergic Agents|adrenergic agents|mesh-ancestor
6732678|NCT01911494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6732679|NCT01911507|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6732680|NCT01911507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6732681|NCT01911507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6732682|NCT01911507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6732683|NCT01911507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732684|NCT01911598|Paclitaxel|paclitaxel|mesh-list
6732685|NCT01911598|Carboplatin|carboplatin|mesh-list
6732686|NCT01911598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6732687|NCT01911598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6732688|NCT01911598|Tubulin Modulators|tubulin modulators|mesh-ancestor
6732689|NCT01911598|Antimitotic Agents|antimitotic agents|mesh-ancestor
6732690|NCT01911598|Mitosis Modulators|mitosis modulators|mesh-ancestor
6732691|NCT01911598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732692|NCT01911624|Enoxaparin|enoxaparin|mesh-list
6732693|NCT01911624|Dabigatran|dabigatran|mesh-list
6732694|NCT01911624|Argatroban|argatroban|mesh-list
6732695|NCT01911624|Thrombin|thrombin|mesh-list
6732696|NCT01911624|Anticoagulants|anticoagulants|mesh-ancestor
6732697|NCT01911624|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6732698|NCT01911624|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6732699|NCT01911624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732700|NCT01911624|Antithrombins|antithrombins|mesh-ancestor
6732701|NCT01911624|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6732702|NCT01911624|Protease Inhibitors|protease inhibitors|mesh-ancestor
6732703|NCT01911624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6732704|NCT01911624|Hemostatics|hemostatics|mesh-ancestor
6732705|NCT01911624|Coagulants|coagulants|mesh-ancestor
6732706|NCT01911624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6732707|NCT01911728|Pioglitazone|pioglitazone|mesh-list
6732708|NCT01911728|Midazolam|midazolam|mesh-list
6732709|NCT01911728|Omeprazole|omeprazole|mesh-list
6732710|NCT01911728|Warfarin|warfarin|mesh-list
6732711|NCT01911728|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6732712|NCT01911728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6732713|NCT01911728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6732714|NCT01911728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732715|NCT01911728|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6732716|NCT01911728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6732717|NCT01911728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6732718|NCT01911728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6732719|NCT01911728|Anesthetics, General|anesthetics, general|mesh-ancestor
6732720|NCT01911728|Anesthetics|anesthetics|mesh-ancestor
6732721|NCT01911728|GABA Modulators|gaba modulators|mesh-ancestor
6732722|NCT01911728|GABA Agents|gaba agents|mesh-ancestor
6732723|NCT01911728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6732724|NCT01911728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732725|NCT01911728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6732726|NCT01911728|Anticoagulants|anticoagulants|mesh-ancestor
6732727|NCT01911728|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6732728|NCT01911728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6732729|NCT01911728|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6732730|NCT01911728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6732731|NCT01911767|Dimethyl Fumarate|dimethyl fumarate|mesh-list
6732732|NCT01911767|Dermatologic Agents|dermatologic agents|mesh-ancestor
6732733|NCT01911767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6732734|NCT01911767|Immunologic Factors|immunologic factors|mesh-ancestor
6732735|NCT01911767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785631|NCT02209441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785632|NCT02209636|Ascorbic Acid|ascorbic acid|mesh-list
6785633|NCT02209636|Nitroglycerin|nitroglycerin|mesh-list
6785634|NCT02209636|Vitamins|vitamins|mesh-ancestor
6785635|NCT02209636|Micronutrients|micronutrients|mesh-ancestor
6785636|NCT02209636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785637|NCT02209636|Antioxidants|antioxidants|mesh-ancestor
6785638|NCT02209636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785639|NCT02209636|Protective Agents|protective agents|mesh-ancestor
6785640|NCT02209636|Vasodilator Agents|vasodilator agents|mesh-ancestor
6785641|NCT02209649|Telmisartan|telmisartan|mesh-list
6785642|NCT02209649|Lacidipine|lacidipine|mesh-list
6785643|NCT02209649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6785644|NCT02209649|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6785645|NCT02209649|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6785646|NCT02209649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785647|NCT02209649|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6785648|NCT02209649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6785649|NCT02209649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6785650|NCT02209649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785651|NCT02209701|Porfiromycin|porfiromycin|mesh-list
6785652|NCT02209701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6785653|NCT02209701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6785654|NCT02209740|Tenofovir|tenofovir|mesh-list
6785655|NCT02209740|Antiviral Agents|antiviral agents|mesh-ancestor
6785656|NCT02209740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6785657|NCT02209740|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6785658|NCT02209740|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6785659|NCT02209740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6785660|NCT02209740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785661|NCT02209740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6785662|NCT02209740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6785663|NCT02209831|Pantoprazole|pantoprazole|mesh-list
6785664|NCT02209831|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6785665|NCT02209831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6785666|NCT02209831|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6785667|NCT02209831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6785668|NCT02209831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785669|NCT02209909|Aspirin|aspirin|mesh-list
6785670|NCT02209909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6785671|NCT02209909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6785672|NCT02209909|Analgesics|analgesics|mesh-ancestor
6785673|NCT02209909|Sensory System Agents|sensory system agents|mesh-ancestor
6785674|NCT02209909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6785675|NCT02209909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785676|NCT02209909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6785677|NCT02209909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6785678|NCT02209909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6732736|NCT01911949|Epinephrine|epinephrine|mesh-list
6732737|NCT01911949|Bupivacaine|bupivacaine|mesh-list
6732738|NCT01911949|Anesthetics, Local|anesthetics, local|mesh-ancestor
6732739|NCT01911949|Anesthetics|anesthetics|mesh-ancestor
6732740|NCT01911949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6732741|NCT01911949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732742|NCT01911949|Sensory System Agents|sensory system agents|mesh-ancestor
6732743|NCT01911949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6732744|NCT01911949|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6732745|NCT01911949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6732746|NCT01911949|Adrenergic Agents|adrenergic agents|mesh-ancestor
6732747|NCT01911949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6732748|NCT01911949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732749|NCT01911949|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6732750|NCT01911949|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6732751|NCT01911949|Autonomic Agents|autonomic agents|mesh-ancestor
6732752|NCT01911949|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6732753|NCT01911949|Respiratory System Agents|respiratory system agents|mesh-ancestor
6732754|NCT01911949|Mydriatics|mydriatics|mesh-ancestor
6732755|NCT01911949|Sympathomimetics|sympathomimetics|mesh-ancestor
6732756|NCT01911949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6732757|NCT01911975|Lacosamide|lacosamide|mesh-list
6732758|NCT01911975|Anticonvulsants|anticonvulsants|mesh-ancestor
6732759|NCT01911975|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6732760|NCT01911975|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6732761|NCT01911975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6732762|NCT01911975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732763|NCT01912053|Gemcitabine|gemcitabine|mesh-list
6732764|NCT01912053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6732765|NCT01912053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6732766|NCT01912053|Antimetabolites|antimetabolites|mesh-ancestor
6732767|NCT01912053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732768|NCT01912053|Antiviral Agents|antiviral agents|mesh-ancestor
6732769|NCT01912053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6732770|NCT01912053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6732771|NCT01912053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6732772|NCT01912053|Immunologic Factors|immunologic factors|mesh-ancestor
6732773|NCT01912053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732774|NCT01912066|Aceclofenac|aceclofenac|mesh-list
6732775|NCT01912066|Misoprostol|misoprostol|mesh-list
6732776|NCT01912066|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6732777|NCT01912066|Abortifacient Agents|abortifacient agents|mesh-ancestor
6732778|NCT01912066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6732779|NCT01912066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732780|NCT01912066|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6732781|NCT01912066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6732782|NCT01912066|Oxytocics|oxytocics|mesh-ancestor
6732783|NCT01912066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6732784|NCT01912066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6732785|NCT01912066|Analgesics|analgesics|mesh-ancestor
6732786|NCT01912066|Sensory System Agents|sensory system agents|mesh-ancestor
6732787|NCT01912066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6732788|NCT01912066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6732789|NCT01912066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6732790|NCT01912118|Remifentanil|remifentanil|mesh-list
6732791|NCT01912118|Propofol|propofol|mesh-list
6732792|NCT01912118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6732793|NCT01912118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6732794|NCT01912118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732795|NCT01912118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6732796|NCT01912118|Anesthetics, General|anesthetics, general|mesh-ancestor
6732797|NCT01912118|Anesthetics|anesthetics|mesh-ancestor
6732798|NCT01912118|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6732799|NCT01912118|Narcotics|narcotics|mesh-ancestor
6732800|NCT01912118|Analgesics|analgesics|mesh-ancestor
6732801|NCT01912118|Sensory System Agents|sensory system agents|mesh-ancestor
6732802|NCT01912118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6732803|NCT01912378|Oxytocin|oxytocin|mesh-list
6732804|NCT01912378|Oxytocics|oxytocics|mesh-ancestor
6732805|NCT01912378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6732806|NCT01912378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732807|NCT01912391|Selegiline|selegiline|mesh-list
6732808|NCT01912391|Antidepressive Agents|antidepressive agents|mesh-ancestor
6732809|NCT01912391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6732810|NCT01912391|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6732811|NCT01912391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6732812|NCT01912391|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6732813|NCT01912391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6732814|NCT01912391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732815|NCT01912391|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6732816|NCT01912391|Protective Agents|protective agents|mesh-ancestor
6732817|NCT01912391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732818|NCT01912443|Bevacizumab|bevacizumab|mesh-list
6732819|NCT01912443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6732820|NCT01912443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6732821|NCT01912443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6732822|NCT01912443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6732823|NCT01912443|Growth Substances|growth substances|mesh-ancestor
6732824|NCT01912443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732825|NCT01912443|Growth Inhibitors|growth inhibitors|mesh-ancestor
6732826|NCT01912534|Valsartan|valsartan|mesh-list
6732827|NCT01912534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6732828|NCT01912534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6732829|NCT01912534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6732830|NCT01912534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732831|NCT01912573|Naloxone|naloxone|mesh-list
6732832|NCT01912573|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6732833|NCT01912573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732834|NCT01912573|Sensory System Agents|sensory system agents|mesh-ancestor
6732835|NCT01912573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6732836|NCT01912586|Sildenafil Citrate|sildenafil citrate|mesh-list
6732837|NCT01912586|Vasodilator Agents|vasodilator agents|mesh-ancestor
6732838|NCT01912586|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6732839|NCT01912586|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6732840|NCT01912586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6732841|NCT01912586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732842|NCT01912586|Urological Agents|urological agents|mesh-ancestor
6732843|NCT01912638|Hyaluronic Acid|hyaluronic acid|mesh-list
6732844|NCT01912638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6732845|NCT01912638|Immunologic Factors|immunologic factors|mesh-ancestor
6732846|NCT01912638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732847|NCT01912638|Viscosupplements|viscosupplements|mesh-ancestor
6732848|NCT01912638|Protective Agents|protective agents|mesh-ancestor
6732849|NCT01912651|Cephalexin|cephalexin|mesh-list
6732850|NCT01912651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6732851|NCT01912651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6732852|NCT01912677|Labetalol|labetalol|mesh-list
6732853|NCT01912677|Methyldopa|methyldopa|mesh-list
6732854|NCT01912677|Nifedipine|nifedipine|mesh-list
6732855|NCT01912677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6732856|NCT01912677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6732857|NCT01912677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732858|NCT01912677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6732859|NCT01912677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732860|NCT01912677|Vasodilator Agents|vasodilator agents|mesh-ancestor
6732861|NCT01912677|Tocolytic Agents|tocolytic agents|mesh-ancestor
6732862|NCT01912677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6732863|NCT01912677|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6732864|NCT01912677|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6732865|NCT01912677|Adrenergic Agents|adrenergic agents|mesh-ancestor
6732866|NCT01912677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6732867|NCT01912677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6732868|NCT01912677|Sympathomimetics|sympathomimetics|mesh-ancestor
6732869|NCT01912677|Autonomic Agents|autonomic agents|mesh-ancestor
6732870|NCT01912677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6732871|NCT01912677|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6732872|NCT01912677|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6732873|NCT01912677|Sympatholytics|sympatholytics|mesh-ancestor
6732874|NCT01912677|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6732875|NCT01912677|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6732876|NCT01912677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6732877|NCT01912755|Lidocaine|lidocaine|mesh-list
6732878|NCT01912755|Epinephrine|epinephrine|mesh-list
6732879|NCT01912755|Racepinephrine|racepinephrine|mesh-list
6732880|NCT01912755|Carticaine|carticaine|mesh-list
6732881|NCT01912755|Epinephryl borate|epinephryl borate|mesh-list
6732882|NCT01912755|Anesthetics, Local|anesthetics, local|mesh-ancestor
6732883|NCT01912755|Anesthetics|anesthetics|mesh-ancestor
6732884|NCT01912755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6732885|NCT01912755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732886|NCT01912755|Sensory System Agents|sensory system agents|mesh-ancestor
6732887|NCT01912755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6732888|NCT01912755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6732889|NCT01912755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6732890|NCT01912755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6732891|NCT01912755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6732892|NCT01912755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732893|NCT01912755|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6732894|NCT01912755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6732895|NCT01912755|Adrenergic Agents|adrenergic agents|mesh-ancestor
6732896|NCT01912755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6732897|NCT01912755|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6732898|NCT01912755|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6732899|NCT01912755|Autonomic Agents|autonomic agents|mesh-ancestor
6732900|NCT01912755|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6732901|NCT01912755|Respiratory System Agents|respiratory system agents|mesh-ancestor
6732902|NCT01912755|Mydriatics|mydriatics|mesh-ancestor
6732903|NCT01912755|Sympathomimetics|sympathomimetics|mesh-ancestor
6732904|NCT01912755|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6732905|NCT01912820|Quercetin|quercetin|mesh-list
6732906|NCT01912820|Antioxidants|antioxidants|mesh-ancestor
6732907|NCT01912820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732908|NCT01912820|Protective Agents|protective agents|mesh-ancestor
6732909|NCT01912820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732910|NCT01912898|Vitamin D|vitamin d|mesh-list
6732911|NCT01912898|Ergocalciferols|ergocalciferols|mesh-list
6732912|NCT01912898|Vitamins|vitamins|mesh-list
6732913|NCT01912898|Micronutrients|micronutrients|mesh-ancestor
6732914|NCT01912898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732915|NCT01912898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6732916|NCT01912898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6732917|NCT01912976|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
6732918|NCT01912976|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6732919|NCT01912976|Dermatologic Agents|dermatologic agents|mesh-ancestor
6732920|NCT01913002|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
6732921|NCT01913002|Moxifloxacin|moxifloxacin|mesh-list
6732922|NCT01913002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6732923|NCT01913002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6732924|NCT01913002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6732925|NCT01913002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6732926|NCT01913002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6732927|NCT01913002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732928|NCT01913002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6732929|NCT01913002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732930|NCT01913002|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6732931|NCT01913002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6732932|NCT01913015|Abiraterone Acetate|abiraterone acetate|mesh-list
6732933|NCT01913015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6732934|NCT01913015|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6732935|NCT01913015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6732936|NCT01913015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732937|NCT01913015|Hormone Antagonists|hormone antagonists|mesh-ancestor
6732938|NCT01913015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6732939|NCT01913015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732940|NCT01913015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6732941|NCT01913054|Fentanyl|fentanyl|mesh-list
6732942|NCT01913054|Propofol|propofol|mesh-list
6732943|NCT01913054|Etomidate|etomidate|mesh-list
6732944|NCT01913054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6732945|NCT01913054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6732946|NCT01913054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732947|NCT01913054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6732948|NCT01913054|Anesthetics, General|anesthetics, general|mesh-ancestor
6732949|NCT01913054|Anesthetics|anesthetics|mesh-ancestor
6732950|NCT01913054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6732951|NCT01913054|Narcotics|narcotics|mesh-ancestor
6732952|NCT01913054|Analgesics|analgesics|mesh-ancestor
6732953|NCT01913054|Sensory System Agents|sensory system agents|mesh-ancestor
6732954|NCT01913054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6732955|NCT01913054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6732956|NCT01913106|Valacyclovir|valacyclovir|mesh-list
6732957|NCT01913106|Antiviral Agents|antiviral agents|mesh-ancestor
6732958|NCT01913106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6732959|NCT01913119|Romidepsin|romidepsin|mesh-list
6732960|NCT01913119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6732961|NCT01913119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6732962|NCT01913379|Itraconazole|itraconazole|mesh-list
6732963|NCT01913379|Gemfibrozil|gemfibrozil|mesh-list
6732964|NCT01913379|Antifungal Agents|antifungal agents|mesh-ancestor
6732965|NCT01913379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6732966|NCT01913379|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6732967|NCT01913379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6732968|NCT01913379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6732969|NCT01913379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732970|NCT01913379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6732971|NCT01913379|Hormone Antagonists|hormone antagonists|mesh-ancestor
6732972|NCT01913379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6732973|NCT01913379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6732974|NCT01913379|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6732975|NCT01913379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6732976|NCT01913379|Antimetabolites|antimetabolites|mesh-ancestor
6732977|NCT01913379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6732978|NCT01913379|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6732979|NCT01913431|Entecavir|entecavir|mesh-list
6732980|NCT01913431|Antiviral Agents|antiviral agents|mesh-ancestor
6732981|NCT01913431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6732982|NCT01913444|Antithrombins|antithrombins|mesh-list
6732983|NCT01913444|Antithrombin III|antithrombin iii|mesh-list
6732984|NCT01913444|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6732985|NCT01913444|Protease Inhibitors|protease inhibitors|mesh-ancestor
6732986|NCT01913444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6732987|NCT01913444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732988|NCT01913444|Anticoagulants|anticoagulants|mesh-ancestor
6785679|NCT02209909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6785680|NCT02209909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785681|NCT02209909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6785682|NCT02209909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6785683|NCT02209909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6785684|NCT02209909|Antipyretics|antipyretics|mesh-ancestor
6785685|NCT02209974|Fluticasone|fluticasone|mesh-list
6785686|NCT02209974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6785687|NCT02209974|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6732989|NCT01913691|Ipilimumab|ipilimumab|mesh-list
6732990|NCT01913691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6732991|NCT01913691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6732992|NCT01913691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6732993|NCT01913691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6732994|NCT01913730|Dexamethasone|dexamethasone|mesh-list
6732995|NCT01913730|Bortezomib|bortezomib|mesh-list
6732996|NCT01913730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6732997|NCT01913730|Antiemetics|antiemetics|mesh-ancestor
6732998|NCT01913730|Autonomic Agents|autonomic agents|mesh-ancestor
6732999|NCT01913730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6733000|NCT01913730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733001|NCT01913730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6733002|NCT01913730|Glucocorticoids|glucocorticoids|mesh-ancestor
6733003|NCT01913730|Hormones|hormones|mesh-ancestor
6733004|NCT01913730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6733005|NCT01913730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6733006|NCT01913730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6733007|NCT01913808|Iron|iron|mesh-list
6733008|NCT01913808|Glycine|glycine|mesh-list
6733009|NCT01913808|Trace Elements|trace elements|mesh-ancestor
6733010|NCT01913808|Micronutrients|micronutrients|mesh-ancestor
6733011|NCT01913808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733012|NCT01913808|Glycine Agents|glycine agents|mesh-ancestor
6733013|NCT01913808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6733014|NCT01913808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733015|NCT01913834|Teriparatide|teriparatide|mesh-list
6733016|NCT01913834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6733017|NCT01913834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733018|NCT01913834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6733019|NCT01913847|Sildenafil Citrate|sildenafil citrate|mesh-list
6733020|NCT01913847|Vasodilator Agents|vasodilator agents|mesh-ancestor
6733021|NCT01913847|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6733022|NCT01913847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6733023|NCT01913847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6733024|NCT01913847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733025|NCT01913847|Urological Agents|urological agents|mesh-ancestor
6733026|NCT01913860|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6733027|NCT01913860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6733028|NCT01913951|Azacitidine|azacitidine|mesh-list
6733029|NCT01913951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6733030|NCT01913951|Antimetabolites|antimetabolites|mesh-ancestor
6733031|NCT01913951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733032|NCT01913951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6733033|NCT01913951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6733034|NCT01913964|Acetylcarnitine|acetylcarnitine|mesh-list
6733035|NCT01913964|Vitamin B Complex|vitamin b complex|mesh-ancestor
6733036|NCT01913964|Vitamins|vitamins|mesh-ancestor
6733037|NCT01913964|Micronutrients|micronutrients|mesh-ancestor
6733038|NCT01913964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733039|NCT01913964|Nootropic Agents|nootropic agents|mesh-ancestor
6733040|NCT01913990|Dexamethasone|dexamethasone|mesh-list
6733041|NCT01913990|Ondansetron|ondansetron|mesh-list
6733042|NCT01913990|Aprepitant|aprepitant|mesh-list
6733043|NCT01913990|Antiemetics|antiemetics|mesh-list
6733044|NCT01913990|Emetics|emetics|mesh-list
6733045|NCT01913990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6733046|NCT01913990|Autonomic Agents|autonomic agents|mesh-ancestor
6733047|NCT01913990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6733048|NCT01913990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733049|NCT01913990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6733050|NCT01913990|Glucocorticoids|glucocorticoids|mesh-ancestor
6733051|NCT01913990|Hormones|hormones|mesh-ancestor
6733052|NCT01913990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6733053|NCT01913990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6733054|NCT01913990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6733055|NCT01913990|Antipruritics|antipruritics|mesh-ancestor
6733056|NCT01913990|Dermatologic Agents|dermatologic agents|mesh-ancestor
6733057|NCT01913990|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6733058|NCT01913990|Serotonin Agents|serotonin agents|mesh-ancestor
6733059|NCT01913990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6733060|NCT01913990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733061|NCT01913990|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6733062|NCT01913990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6733063|NCT01913990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6733064|NCT01913990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6733065|NCT01913990|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6733066|NCT01913990|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6733067|NCT01914042|Morphine|morphine|mesh-list
6733068|NCT01914042|Milnacipran|milnacipran|mesh-list
6733069|NCT01914042|Levomilnacipran|levomilnacipran|mesh-list
6733070|NCT01914042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6733071|NCT01914042|Narcotics|narcotics|mesh-ancestor
6733072|NCT01914042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6733073|NCT01914042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733074|NCT01914042|Analgesics|analgesics|mesh-ancestor
6733075|NCT01914042|Sensory System Agents|sensory system agents|mesh-ancestor
6733076|NCT01914042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6733077|NCT01914042|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6733078|NCT01914042|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6733079|NCT01914042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6733080|NCT01914042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733081|NCT01914042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6733082|NCT01914042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6733083|NCT01914042|Antidepressive Agents|antidepressive agents|mesh-ancestor
6733084|NCT01914042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6733085|NCT01914081|Resveratrol|resveratrol|mesh-list
6733086|NCT01914081|Antioxidants|antioxidants|mesh-ancestor
6733087|NCT01914081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733088|NCT01914081|Protective Agents|protective agents|mesh-ancestor
6733089|NCT01914081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733090|NCT01914081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6733091|NCT01914081|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6733092|NCT01914133|Acarbose|acarbose|mesh-list
6733093|NCT01914133|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
6733094|NCT01914133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6733095|NCT01914133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733096|NCT01914133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6733097|NCT01914133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733098|NCT01914146|Insulin|insulin|mesh-list
6733099|NCT01914146|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6733100|NCT01914146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6733101|NCT01914146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733102|NCT01914211|Tranexamic Acid|tranexamic acid|mesh-list
6733103|NCT01914211|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6733104|NCT01914211|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6733105|NCT01914211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733106|NCT01914211|Hemostatics|hemostatics|mesh-ancestor
6733107|NCT01914211|Coagulants|coagulants|mesh-ancestor
6733108|NCT01914237|Castor Oil|castor oil|mesh-list
6733109|NCT01914237|Cathartics|cathartics|mesh-ancestor
6733110|NCT01914237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6733111|NCT01914250|Analgesics|analgesics|mesh-list
6733112|NCT01914250|Tetracaine|tetracaine|mesh-list
6733113|NCT01914250|Sensory System Agents|sensory system agents|mesh-ancestor
6733114|NCT01914250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6733115|NCT01914250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733116|NCT01914250|Anesthetics, Local|anesthetics, local|mesh-ancestor
6733117|NCT01914250|Anesthetics|anesthetics|mesh-ancestor
6733118|NCT01914250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6733119|NCT01914367|Vaccines|vaccines|mesh-list
6733120|NCT01914367|Immunologic Factors|immunologic factors|mesh-ancestor
6733121|NCT01914367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733122|NCT01914380|Aflibercept|aflibercept|mesh-list
6733123|NCT01914380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6733124|NCT01914380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6733125|NCT01914380|Growth Substances|growth substances|mesh-ancestor
6733126|NCT01914380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733127|NCT01914380|Growth Inhibitors|growth inhibitors|mesh-ancestor
6733128|NCT01914380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6733129|NCT01914419|Oxytocin|oxytocin|mesh-list
6733130|NCT01914419|Oxytocics|oxytocics|mesh-ancestor
6733131|NCT01914419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6733132|NCT01914419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733133|NCT01914432|Telmisartan|telmisartan|mesh-list
6733134|NCT01914432|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6733135|NCT01914432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6733136|NCT01914432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6733137|NCT01914432|Antimetabolites|antimetabolites|mesh-ancestor
6733138|NCT01914432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733139|NCT01914432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6733140|NCT01914432|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6733141|NCT01914432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6733142|NCT01914432|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6733143|NCT01914432|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6733144|NCT01914432|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6733145|NCT01914562|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
6733146|NCT01914562|Cathartics|cathartics|mesh-ancestor
6733147|NCT01914562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6733148|NCT01914627|Salicylic Acid|salicylic acid|mesh-list
6733149|NCT01914627|Salicylates|salicylates|mesh-list
6733150|NCT01914627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6733151|NCT01914627|Antifungal Agents|antifungal agents|mesh-ancestor
6733152|NCT01914627|Keratolytic Agents|keratolytic agents|mesh-ancestor
6733153|NCT01914627|Dermatologic Agents|dermatologic agents|mesh-ancestor
6733154|NCT01914627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6733155|NCT01914627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6733156|NCT01914627|Analgesics|analgesics|mesh-ancestor
6733157|NCT01914627|Sensory System Agents|sensory system agents|mesh-ancestor
6733158|NCT01914627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6733159|NCT01914627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733160|NCT01914627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6733161|NCT01914627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6733162|NCT01914627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6733163|NCT01914627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6733164|NCT01914627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733165|NCT01914692|Somatostatin|somatostatin|mesh-list
6733166|NCT01914692|Hormones|hormones|mesh-ancestor
6733167|NCT01914692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6733168|NCT01914692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733169|NCT01914718|Rituximab|rituximab|mesh-list
6733170|NCT01914718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6733171|NCT01914718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6733172|NCT01914718|Immunologic Factors|immunologic factors|mesh-ancestor
6733173|NCT01914718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733174|NCT01914718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6733175|NCT01914744|Lamivudine|lamivudine|mesh-list
6733176|NCT01914744|Entecavir|entecavir|mesh-list
6733177|NCT01914744|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6733178|NCT01914744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6733179|NCT01914744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6733180|NCT01914744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733181|NCT01914744|Antiviral Agents|antiviral agents|mesh-ancestor
6733182|NCT01914744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6733183|NCT01914744|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6733184|NCT01914744|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6733185|NCT01914770|Belimumab|belimumab|mesh-list
6733186|NCT01914770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6733187|NCT01914770|Immunologic Factors|immunologic factors|mesh-ancestor
6733188|NCT01914770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733189|NCT01914822|Methylphenidate|methylphenidate|mesh-list
6733190|NCT01914822|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6733191|NCT01914822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733192|NCT01914822|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6733193|NCT01914822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6733194|NCT01914822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6733195|NCT01914822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733196|NCT01914822|Dopamine Agents|dopamine agents|mesh-ancestor
6733197|NCT01914822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6733198|NCT01914900|Docetaxel|docetaxel|mesh-list
6733199|NCT01914900|Fluorouracil|fluorouracil|mesh-list
6733200|NCT01914900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6733201|NCT01914900|Tubulin Modulators|tubulin modulators|mesh-ancestor
6733202|NCT01914900|Antimitotic Agents|antimitotic agents|mesh-ancestor
6733203|NCT01914900|Mitosis Modulators|mitosis modulators|mesh-ancestor
6733204|NCT01914900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733205|NCT01914900|Antimetabolites|antimetabolites|mesh-ancestor
6733206|NCT01914900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6733207|NCT01914900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6733208|NCT01914900|Immunologic Factors|immunologic factors|mesh-ancestor
6733209|NCT01914900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733210|NCT01914939|Oxytocin|oxytocin|mesh-list
6733211|NCT01914939|Oxytocics|oxytocics|mesh-ancestor
6733212|NCT01914939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6733213|NCT01914939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733214|NCT01914965|Bupropion|bupropion|mesh-list
6733215|NCT01914965|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6733216|NCT01914965|Antidepressive Agents|antidepressive agents|mesh-ancestor
6733217|NCT01914965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6733218|NCT01914965|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6733219|NCT01914965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6733220|NCT01914965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6733221|NCT01914965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733222|NCT01914965|Dopamine Agents|dopamine agents|mesh-ancestor
6733223|NCT01914965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6733224|NCT01914965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733225|NCT01914965|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6733226|NCT01914965|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6733227|NCT01914965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6733228|NCT01915069|Cilostazol|cilostazol|mesh-list
6733229|NCT01915069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6733230|NCT01915069|Autonomic Agents|autonomic agents|mesh-ancestor
6733231|NCT01915069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6733232|NCT01915069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733233|NCT01915069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6733234|NCT01915069|Respiratory System Agents|respiratory system agents|mesh-ancestor
6733235|NCT01915069|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6733236|NCT01915069|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6733237|NCT01915069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733238|NCT01915069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6733239|NCT01915069|Vasodilator Agents|vasodilator agents|mesh-ancestor
6733240|NCT01915069|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6733241|NCT01915069|Protective Agents|protective agents|mesh-ancestor
6733242|NCT01915069|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6733243|NCT01915069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6733244|NCT01915069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6733245|NCT01915082|Azithromycin|azithromycin|mesh-list
6733246|NCT01915082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6733247|NCT01915082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6785688|NCT02209974|Autonomic Agents|autonomic agents|mesh-ancestor
6785689|NCT02209974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6785690|NCT02209974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785691|NCT02209974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6785692|NCT02209974|Respiratory System Agents|respiratory system agents|mesh-ancestor
6785693|NCT02209974|Dermatologic Agents|dermatologic agents|mesh-ancestor
6785694|NCT02209974|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6785695|NCT02209987|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6785696|NCT02209987|Immunologic Factors|immunologic factors|mesh-ancestor
6785697|NCT02209987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785698|NCT02210104|Cyclophosphamide|cyclophosphamide|mesh-list
6785699|NCT02210104|Ipilimumab|ipilimumab|mesh-list
6785700|NCT02210104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6785701|NCT02210104|Immunologic Factors|immunologic factors|mesh-ancestor
6785702|NCT02210104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785703|NCT02210104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6785704|NCT02210104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6785705|NCT02210104|Alkylating Agents|alkylating agents|mesh-ancestor
6785706|NCT02210104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785707|NCT02210104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6785708|NCT02210104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6785709|NCT02210104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6785710|NCT02210104|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6785711|NCT02210117|Bevacizumab|bevacizumab|mesh-list
6785712|NCT02210117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6785713|NCT02210117|Nivolumab|nivolumab|mesh-list
6785714|NCT02210117|Ipilimumab|ipilimumab|mesh-list
6785715|NCT02210117|Endothelial Growth Factors|endothelial growth factors|mesh-list
6785716|NCT02210117|Antibodies|antibodies|mesh-list
6733248|NCT01915134|Gemcitabine|gemcitabine|mesh-list
6733249|NCT01915134|Cisplatin|cisplatin|mesh-list
6733250|NCT01915134|Endostatins|endostatins|mesh-list
6733251|NCT01915134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6733252|NCT01915134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6733253|NCT01915134|Antimetabolites|antimetabolites|mesh-ancestor
6733254|NCT01915134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733255|NCT01915134|Antiviral Agents|antiviral agents|mesh-ancestor
6733256|NCT01915134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6733257|NCT01915134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6733258|NCT01915134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6733259|NCT01915134|Immunologic Factors|immunologic factors|mesh-ancestor
6733260|NCT01915134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733261|NCT01915134|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6733262|NCT01915134|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6733263|NCT01915134|Growth Substances|growth substances|mesh-ancestor
6733264|NCT01915134|Growth Inhibitors|growth inhibitors|mesh-ancestor
6733265|NCT01915186|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
6733266|NCT01915186|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6733267|NCT01915186|Immunologic Factors|immunologic factors|mesh-ancestor
6733268|NCT01915186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733269|NCT01915264|Metformin|metformin|mesh-list
6733270|NCT01915264|Acarbose|acarbose|mesh-list
6733271|NCT01915264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6733272|NCT01915264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733273|NCT01915264|Glycoside Hydrolase Inhibitors|glycoside hydrolase 